nct_id|nlm_download_date_description|first_received_date|last_changed_date|first_received_results_date|received_results_disposit_date|start_month_year|start_date_type|start_date|verification_month_year|verification_date|completion_month_year|completion_date_type|completion_date|primary_completion_month_year|primary_completion_date_type|primary_completion_date|target_duration|study_type|acronym|baseline_population|brief_title|official_title|overall_status|last_known_status|phase|enrollment|enrollment_type|source|limitations_and_caveats|number_of_arms|number_of_groups|why_stopped|has_expanded_access|expanded_access_type_individual|expanded_access_type_intermediate|expanded_access_type_treatment|has_dmc|is_fda_regulated_drug|is_fda_regulated_device|is_unapproved_device|is_ppsd|is_us_export|biospec_retention|biospec_description|plan_to_share_ipd|plan_to_share_ipd_description|created_at|updated_at
NCT03303261|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||April 18, 2016|Actual|2016-04-18|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|September 25, 2017|Actual|2017-09-25||Observational|||Study On Discopathie With Modic 1|Study On Discopathie With Modic 1|Recruiting||N/A|50|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||||2017-10-10 20:40:00.452499|2017-10-10 20:40:00.452499
NCT03292679|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Craniofacial Applications of 3D Printing|Craniofacial Applications of 3D Printing|Not yet recruiting||N/A|60|Anticipated|University of Maryland||2|||f|||||f|f||||||||2017-10-10 20:41:35.778202|2017-10-10 20:41:35.778202
NCT03296514|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-27|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|MBSR||Mindfulness Based Stress Reduction for Metabolic Syndrome|Mindfulness-Based Stress Reduction Study for Couples|Recruiting||N/A|40|Anticipated|Yale University||2|||f||||f|f|f||||||||2017-10-10 20:41:00.541701|2017-10-10 20:41:00.541701
NCT03128892|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||June 10, 2016||2016-06-10||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:03.623608|2017-10-10 21:08:03.623608
NCT03304275|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-02|||July 10, 2017|Actual|2017-07-10|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Feasibility of Pertussis Immunization in a Canadian Emergency Department|The Feasibility of Pertussis Immunization in a Canadian Emergency Department|Recruiting||N/A|750|Anticipated|University of Prince Edward Island||2|||f||||f|f|f|||f|||||2017-10-10 20:39:51.909043|2017-10-10 20:39:51.909043
NCT03304262|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-02|||July 18, 2017|Actual|2017-07-18|October 2017|2017-10-01|March 31, 2018|Anticipated|2018-03-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Metaplasticity in the Human Motor Cortex Experimental Design and Comparison of Motor Outcome Measure Sensitivity to Change|Metaplasticity in the Human Motor Cortex: Validation of an Experimental Design and Comparison of Motor Outcome Measure Sensitivity to Change|Recruiting||N/A|16|Anticipated|University of New Mexico||3|||f||||f|f|t|f|f||||||2017-10-10 20:39:52.031802|2017-10-10 20:39:52.031802
NCT03304249|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Rural Disparities in Pediatric Obesity: The iAmHealthy Intervention|Rural Disparities in Pediatric Obesity: The iAmHealthy Intervention|Not yet recruiting||N/A|288|Anticipated|University of Kansas Medical Center||2|||f|||||f|f||||||||2017-10-10 20:39:52.121516|2017-10-10 20:39:52.121516
NCT03304236|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||July 1, 2017|Actual|2017-07-01|October 2017|2017-10-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Motion Analysis of the Myelopathy Hand: New Insight Into the Classical Sign|Motion Analysis of the Myelopathy Hand: New Insight Into the Classical Sign|Recruiting||N/A|50|Anticipated|The University of Hong Kong|||1||f||||f|f|f||||||||2017-10-10 20:39:52.209022|2017-10-10 20:39:52.209022
NCT03304223|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-02|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||IL2 Imaging in Renal Transplantation|A Proof of Concept Study for [18F]FB-IL2 PET Imaging of Infiltrating T Cells After Renal Transplantation; a Diagnostic Tool for Acute Rejection|Not yet recruiting||Phase 1|20|Anticipated|University Medical Center Groningen||1|||f||||f|f|f||||||||2017-10-10 20:39:52.308279|2017-10-10 20:39:52.308279
NCT03304210|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-10-02|||October 4, 2017|Anticipated|2017-10-04|October 2017|2017-10-01|December 21, 2020|Anticipated|2020-12-21|September 21, 2020|Anticipated|2020-09-21||Interventional|||Intraperitoneal Aerosolisation of Albumin-stabilized Paclitaxel Nanoparticles for Recurrent GI and Ovarian Cancer|Intraperitoneal Aerosolisation of Albumin-stabilized Paclitaxel Nanoparticles for Recurrent GI and Ovarian Cancer|Recruiting||Phase 1/Phase 2|70|Anticipated|University Hospital, Ghent||2|||f||||t|f|f||||||||2017-10-10 20:39:52.38742|2017-10-10 20:39:52.38742
NCT03304197|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-02|||September 11, 2017|Actual|2017-09-11|October 2017|2017-10-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Hydration and Exercise Performance in Cycling|How Does Altering the Composition of Ingested Fluids Affect 15-minute Time Trial Performance in Cycling?|Recruiting||N/A|15|Anticipated|University of Exeter||4|||f||||f|f|f||||||||2017-10-10 20:39:52.747862|2017-10-10 20:39:52.747862
NCT03304184|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-03|2017-10-05|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life|The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life|Recruiting||Phase 3|40|Anticipated|University of Michigan||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:39:52.852319|2017-10-10 20:39:52.852319
NCT03304119|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||April 1, 2016|Actual|2016-04-01|September 2017|2017-09-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Observational|||Torsion of the Tibial Tuberosity, a New Factor for Patellar Instability?|Tipping of the Tibial Tuberosity, a New Factor for Patellar Instability?|Completed||N/A|85|Actual|Ramsay Générale de Santé|||2||f||||f|f|f||||||||2017-10-10 20:39:53.244311|2017-10-10 20:39:53.244311
NCT03304106|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-03|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population|Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population|Not yet recruiting||N/A|50|Anticipated|Cochlear||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:39:53.321177|2017-10-10 20:39:53.321177
NCT03304093|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|September 2020|Anticipated|2020-09-01|November 2017|Anticipated|2017-11-01||Interventional|CHIVA2||Immunotherapy by Nivolumab for HIV+ Patients|Immunotherapy by Nivolumab After Prior Chemotherapy for HIV+ Patients With Advanced Non-small Cell Lung Cancer (NSCLC): IFCT-CHIVA2 Phase IIa Trial|Not yet recruiting||Phase 2|30|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||1|||f||||t|f|f||||||||2017-10-10 20:39:53.396552|2017-10-10 20:39:53.396552
NCT03304080|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-03|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in Her-positive, Her2-positive Metastatic Breast|A Multicenter, Phase I/II Trial of Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HeR-positive, Her2-positive Metastatic Breast Cancer|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|t|f|||t|||||2017-10-10 20:39:53.51238|2017-10-10 20:39:53.51238
NCT03304041|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-10-01|||March 1, 2017|Actual|2017-03-01|October 2017|2017-10-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China|Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China - A Prospective Randomized Controlled Trial|Recruiting||N/A|86|Anticipated|Sir Run Run Shaw Hospital||2|||f||||t|f|f||||||||2017-10-10 20:39:53.852925|2017-10-10 20:39:53.852925
NCT03304015|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-10-02|||August 3, 2016|Actual|2016-08-03|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|May 31, 2018|Anticipated|2018-05-31||Interventional|HERrespect||HERrespect Evaluation|Measuring the Effect of HERrespect: An Intervention Addressing Violence Against Female Garment Workers in Four Factories of Bangladesh|Active, not recruiting||N/A|1195|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t|f|f||||||||2017-10-10 20:39:54.079426|2017-10-10 20:39:54.079426
NCT03304002|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 1, 2018|Anticipated|2018-11-01|August 31, 2018|Anticipated|2018-08-31||Observational|||Implementation of a Web-based Decision Aid for Breast Cancer Surgery|Implementation of a Web-based Decision Aid for Breast Cancer Surgery: Adapting to the Needs of Diverse Settings|Not yet recruiting||N/A|116|Anticipated|University of Wisconsin, Madison|||1||f|||||f|f||||||||2017-10-10 20:39:54.18984|2017-10-10 20:39:54.18984
NCT03303989|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-05|||December 31, 2017|Anticipated|2017-12-31|October 2017|2017-10-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|RECIPE||REduCing Immunogenicity to PegloticasE (RECIPE) Study|REduCing Immunogenicity to PegloticasE (RECIPE) Study|Not yet recruiting||Phase 2|32|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f||||||||2017-10-10 20:39:54.270874|2017-10-10 20:39:54.270874
NCT03303976|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-02|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Phase I to Test a New Pneumococcal Vaccine|Safety and Immunogenicity of a Candidate Bioconjugate Vaccine Against Streptococcus Pneumoniae When Administered to Adult and Elderly Healthy Subjects. A Phase I Randomized Study.|Recruiting||Phase 1|70|Anticipated|LimmaTech Biologics AG||4|||f||||f|f|f||||||||2017-10-10 20:39:54.35558|2017-10-10 20:39:54.35558
NCT03303963|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-10-02|||May 4, 2017|Actual|2017-05-04|October 2017|2017-10-01|May 31, 2021|Anticipated|2021-05-31|December 31, 2019|Anticipated|2019-12-31||Observational|DIAMA||DIAgnostics for Multidrug Resistant Tuberculosis in Africa|Culture Free Diagnosis and Follow-up of Multidrug Resistant Tuberculosis Patients|Recruiting||N/A|2840|Anticipated|Laboratoire de Référence des Mycobactéries|||2||f||||f|f|f||||Samples With DNA|"     Sputum.      At the enrôlment, three samples (spot-overnight-spot) will be collected for the comparison of     phenotypic results against molecular results.      During the treatment, two monthly samples (overnight-spot) will be collected for the     comparison of culture result against FDA Microscopy and GeneXpert Ct values.   "|||2017-10-10 20:39:54.44764|2017-10-10 20:39:54.44764
NCT03303950|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-05|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Busulfan, Fludarabine, Donor Stem Cell Transplant, and Cyclophosphamide in Treating Patients With Multiple Myeloma or Myelofibrosis|Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis|Not yet recruiting||Phase 2|24|Anticipated|University of Utah||1|||f||||t|t|f|||f|||||2017-10-10 20:39:54.606596|2017-10-10 20:39:54.606596
NCT03303937|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-05|||March 27, 2012|Actual|2012-03-27|October 2017|2017-10-01|June 6, 2016|Actual|2016-06-06|June 10, 2015|Actual|2015-06-10||Observational|COLOCOLI||Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients|Characteristics of Lower Respiratory Tract Escherichia Coli Isolates Colonizing and Infecting Mechanically Ventilated Intensive Care Patients: a French Multicenter Prospective Collection|Completed||N/A|289|Actual|Hôpital Louis Mourier|||1||f||||f|f|f||||||||2017-10-10 20:39:54.758087|2017-10-10 20:39:54.758087
NCT03303924|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-10-05|||August 21, 2017|Actual|2017-08-21|October 2017|2017-10-01|January 23, 2018|Anticipated|2018-01-23|December 15, 2017|Anticipated|2017-12-15||Interventional|||Study to Determine and Compare Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam in Healthy Subjects|A Phase I Study to Determine and Compare Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Intravenous ETX2514 and Sulbactam Administered to Healthy Adult Subjects|Recruiting||Phase 1|30|Anticipated|Entasis Therapeutics||1|||f||||f|t|f||||||||2017-10-10 20:39:54.829161|2017-10-10 20:39:54.829161
NCT03303898|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-03|2017-10-03|||November 10, 2017|Anticipated|2017-11-10|September 2017|2017-09-01|March 10, 2019|Anticipated|2019-03-10|November 10, 2017|Anticipated|2017-11-10||Interventional|Asymptoleish||ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE - POSTULATE PRIOR TO HUMAN VACCINAL TRIALS Immune Response of Asymptomatic Carriers to L. Infantum|ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE - POSTULATE PRIOR TO HUMAN VACCINAL TRIALS Immune Response of Asymptomatic Carriers to L. Infantum|Not yet recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||||2017-10-10 20:39:55.012478|2017-10-10 20:39:55.012478
NCT03303885|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-03|2017-10-03|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01|24 Months|Observational [Patient Registry]|FILIPO||The FGF/FGFR Signalling Pathway:|The FGF/FGFR Signalling Pathway: a Novel Therapeutic Target in Liposarcomas|Recruiting||N/A|250|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||f||||Samples Without DNA|"     Liposarcoma biopsy   "|||2017-10-10 20:39:55.087656|2017-10-10 20:39:55.087656
NCT03303846|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-03|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients|Combined Breast MRI/Biomarker Strategies to Identify Aggressive Biology|Recruiting||N/A|650|Anticipated|City of Hope Medical Center||1|||f||||t|f|f||||||||2017-10-10 20:39:55.533001|2017-10-10 20:39:55.533001
NCT03303833|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||July 1, 2006|Actual|2006-07-01|October 2017|2017-10-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Observational|GEOLynch||The GEOLynch Cohort Study|The GEOLynch Cohort Study: Genetic, Environmental and Other Factors That Influence Tumour Risk Among Persons With Lynch Syndrome|Recruiting||N/A|1000|Anticipated|Wageningen University|||1||f|||||f|f||||Samples With DNA|"     Buccal swabs and blood samples.   "|||2017-10-10 20:39:55.645706|2017-10-10 20:39:55.645706
NCT03303820|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-05|||May 27, 2016|Actual|2016-05-27|October 2017|2017-10-01|August 31, 2017|Actual|2017-08-31|May 27, 2017|Actual|2017-05-27||Observational|||Analysis of the Impact of the Undernutrition on the Cerebral Infarct in Thrombolized Patients|Analysis of the Impact of the Undernutrition on the Cerebral Infarct in Thrombolized Patients|Completed||N/A|73|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||||2017-10-10 20:39:55.783878|2017-10-10 20:39:55.783878
NCT03303807|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-02|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|COVAP||Correction by ECCO2-R of Hypercapnia in Patients With DVP in Moderate to Severe ARDS Under Protective Ventilation.|STUDY OF CARBON DIOXIDE REMOVAL TO ALLEVIATE RIGHT VENTRICLE DYSFUNCTION DURING ACUTE RESPIRATORY DISTRESS SYNDROME|Not yet recruiting||N/A|20|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||||2017-10-10 20:39:55.848259|2017-10-10 20:39:55.848259
NCT03303794|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-05|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka|Comparative Feasibility and Efficacy of a Five Compartment Technique Using 0.25% Bupivacaine vs a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka; a Single Blinded Randomized Controlled Study|Not yet recruiting||Phase 3|90|Anticipated|Montefiore Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:39:55.952568|2017-10-10 20:39:55.952568
NCT03303781|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Observational|||BeSingCardioRehab: CR in Belgium Versus Singapore|BeSingCardioRehab: An Intercontinental Retrospective Cohort Study Comparing Cardiac Rehabilitation in Belgium and Singapore|Not yet recruiting||N/A|2792|Anticipated|Hasselt University|||4||f||||f|f|f||||||||2017-10-10 20:39:56.064984|2017-10-10 20:39:56.064984
NCT03303768|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|CoA||Antenatal Diagnosis of Coarctations of the Aorta.|Antenatal Diagnosis of Coarctations of the Aorta. Prospective Observational Study.|Not yet recruiting||N/A|20|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:39:56.135657|2017-10-10 20:39:56.135657
NCT03303755|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||April 1, 2014|Actual|2014-04-01|October 2017|2017-10-01|April 1, 2021|Anticipated|2021-04-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Predictive Models of Weight and Height for the Evaluation of the Growth of Children and Adolescents With Cerebral Palsy|Elaboration, Development and Validation of Predictive Models of Weight and Height for the Evaluation of the Growth of Children and Adolescents With Cerebral Palsy|Enrolling by invitation||N/A|192|Anticipated|National Council of Scientific and Technical Research, Argentina|||1||f|||||f|f||||||||2017-10-10 20:39:56.230759|2017-10-10 20:39:56.230759
NCT03303742|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-03|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Feather Edge Versus Deep Chamfer Finish Line Marginal Design in Complete Coverage Bruxzir Zirconia Crowns|Evaluation of Patient Satisfaction, Color Difference, Marginal Integrity and Survival of Bruxzir Zirconia Complete Coverage Crowns With Feather Edge Versus Deep Chamfer Finish Line Marginal Design.|Not yet recruiting||N/A|34|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:39:56.301765|2017-10-10 20:39:56.301765
NCT03303716|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-05|||September 20, 2017|Actual|2017-09-20|October 2017|2017-10-01|September 2037|Anticipated|2037-09-01|September 2037|Anticipated|2037-09-01|20 Years|Observational [Patient Registry]|||Bohring-Opitz Syndrome and ASXL Registry|Bohring-Opitz Syndrome and ASXL-Related Phenotypes Registry|Recruiting||N/A|100|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f|||||f|f||||||||2017-10-10 20:39:56.568659|2017-10-10 20:39:56.568659
NCT03303703|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-05|||October 20, 2017|Anticipated|2017-10-20|October 2017|2017-10-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Partnering Physical and Emotional Fitness: Improving Cardiac Recovery With Training in Emotion Regulation|Partnering Physical and Emotional Fitness: Improving Cardiac Recovery With Training in Emotion Regulation|Not yet recruiting||N/A|20|Anticipated|Case Western Reserve University||2|||f|||||f|f||||||||2017-10-10 20:39:56.675157|2017-10-10 20:39:56.675157
NCT03303677|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-04|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Comparison of Topical Therapies in Post op Endoscopic Sinus Surgery Patients|Comparison of Post op Outcomes in Endoscopic Sinus Surgery Using Varying Nasal Sinus Irrigations. Saline vs. Saline and Budesonide vs Saline, Budesonide, and Culture Directed Topical Antibiotics|Not yet recruiting||Phase 3|55|Anticipated|University of Florida||3|||f||||f|t|f|||t|||||2017-10-10 20:39:56.882261|2017-10-10 20:39:56.882261
NCT03303664|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-10-02|||July 11, 2017|Actual|2017-07-11|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|IMPROVE||Inpatient Multimodal Path to RecOVEry|Inpatient Multimodal Path to RecOVEry|Recruiting||N/A|150000|Anticipated|Carolinas Healthcare System||2|||f||||f|f|f||||||||2017-10-10 20:39:56.992066|2017-10-10 20:39:56.992066
NCT03303651|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MOGADA||Monitor-Guided Analgesia During General Anesthesia - Part I|Investigation of the Effect of Opioid Titration Guided by Analgesia Indices During General Anesthesia|Not yet recruiting||N/A|100|Anticipated|Universitätsklinikum Hamburg-Eppendorf||4|||f||||f|f|f||||||||2017-10-10 20:39:57.113427|2017-10-10 20:39:57.113427
NCT03303638|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Investigating the Impact of Multi-sensory Environments on Behavior During Assisted Bathing for Veterans With Dementia|Investigating the Impact of Multi-sensory Environments on Behavior During Assisted Bathing for Veterans With Dementia|Not yet recruiting||N/A|23|Anticipated|University of Florida||1|||f||||t|f|f||||||||2017-10-10 20:39:57.203121|2017-10-10 20:39:57.203121
NCT03303612|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-10-05|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Clinical Monitoring Strategy vs EP-guided Algorithmic in LBBB Patients Post-TAVI|COME-TAVI: Comparison of a Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach to Patient Management After TAVI|Recruiting||N/A|134|Anticipated|Montreal Heart Institute||2|||f||||f|f|f||||||||2017-10-10 20:39:57.382173|2017-10-10 20:39:57.382173
NCT03303560|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-05|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase 1 Study of COR388 HCl in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study of COR388 HCl in Healthy Volunteers|Not yet recruiting||Phase 1|40|Anticipated|Cortexyme Inc.||6|||f||||t|t|f||||||||2017-10-10 20:39:57.795536|2017-10-10 20:39:57.795536
NCT03303547|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-05|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2023|Anticipated|2023-11-01|November 2018|Anticipated|2018-11-01||Interventional|COMET||Concordance in MRI and Pathology Diagnosis of Extranodal Tumour Deposits|Concordance in MRI and Pathology Diagnosis of Extranodal Tumour Deposits|Not yet recruiting||N/A|100|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t|f|f||||||||2017-10-10 20:39:57.872991|2017-10-10 20:39:57.872991
NCT03303534|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||September 14, 2017|Actual|2017-09-14|October 2017|2017-10-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Short-Term Endogenous Hydrogen Sulfide Upregulation|Short-Term Endogenous Hydrogen Sulfide Upregulation|Recruiting||N/A|40|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:39:57.987797|2017-10-10 20:39:57.987797
NCT03303521|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-02|||November 9, 2017|Anticipated|2017-11-09|October 2017|2017-10-01|October 25, 2018|Anticipated|2018-10-25|October 25, 2018|Anticipated|2018-10-25||Interventional|DIALIZE||A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.|A Phase 3b, Multicenter, Prospective, Randomized, Double Blind, Placebocontrolled Study to Reduce Incidence of Pre-dialysis Hyperkalemia With Sodium Zirconium Cyclosilicate (DIALIZE)|Not yet recruiting||Phase 3|180|Anticipated|AstraZeneca||2|||f||||f|t|f||||||||2017-10-10 20:39:58.382808|2017-10-10 20:39:58.382808
NCT03303508|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||September 1, 2018|Anticipated|2018-09-01|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Measurement of Anti-dsDNA by Both CLIFT & ELISA|Detection Of Anti-Double Stranded Deoxyribonucleic Acid Antibodies In Autoimmune Rheumatic Diseases: Comparison Between Immunofluorescence And Enzyme Immunoassay|Not yet recruiting||N/A|100|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:39:58.517915|2017-10-10 20:39:58.517915
NCT03303495|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-23|2017-10-02|||November 14, 2011|Actual|2011-11-14|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC|A Multinational, Randomized, Phase III Study of FOLFIRI With/Without Bevacizumab Versus Irinotecan With/Without Bevacizumab As Second-line Therapy in Patients With Metastatic Colorectal Cancer|Recruiting||Phase 3|280|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-10-10 20:39:58.589001|2017-10-10 20:39:58.589001
NCT03303482|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-02|||September 19, 2017|Actual|2017-09-19|October 2017|2017-10-01|May 8, 2018|Anticipated|2018-05-08|May 8, 2018|Anticipated|2018-05-08||Interventional|||A Randomized Controlled Trial of Trauma-awareness Training for Early Childhood Educators|A Randomized Controlled Trial of Trauma-awareness Training for Early Childhood Educators|Recruiting||N/A|128|Anticipated|Temple University||2|||f||||f|f|f||||||||2017-10-10 20:39:58.713591|2017-10-10 20:39:58.713591
NCT03303469|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-02|||October 30, 2017|Anticipated|2017-10-30|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: [18F]Fluoromisonidazole (FMISO) Imaging|Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: [18F]Fluoromisonidazole (FMISO) Imaging|Recruiting||Phase 2|20|Anticipated|University of Alabama at Birmingham||1|||f|||||t|f||||||||2017-10-10 20:39:58.805713|2017-10-10 20:39:58.805713
NCT03303456|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-10-02|||December 14, 2014|Actual|2014-12-14|October 2017|2017-10-01|November 1, 2015|Actual|2015-11-01|November 1, 2015|Actual|2015-11-01||Interventional|RWJFGinger||Using Mobile Technology to Enhance Early Psychosis Treatment Delivery|Using Mobile Technology To Detect Early Warning Signs of Mental Health Challenges and Enhance Treatment Delivery For Youth|Completed||N/A|79|Actual|University of California, Davis||3|||f||||f|f|f||||||||2017-10-10 20:39:58.902922|2017-10-10 20:39:58.902922
NCT03303443|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-10-04|||October 31, 2017|Anticipated|2017-10-31|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Empirical Mode Decomposition in the Electroencephalogram|Empirical Mode Decomposition in the Electroencephalogram During General Anesthesia Between Generations|Recruiting||N/A|120|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-10 20:39:58.997721|2017-10-10 20:39:58.997721
NCT03303430|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-05|||March 30, 2017|Actual|2017-03-30|October 2017|2017-10-01|March 30, 2019|Anticipated|2019-03-30|March 30, 2019|Anticipated|2019-03-30||Observational|||Microembolisation After Carotid Revascularisation|Correlation Between Cerebral Microembolisation and Plaque Characteristics After Carotid Revascularization|Recruiting||N/A|120|Anticipated|University Hospital, Geneva|||2||f||||f|t|t|f|f|f|||||2017-10-10 20:39:59.073062|2017-10-10 20:39:59.073062
NCT03303404|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|September 11, 2018|Anticipated|2018-09-11|September 11, 2018|Anticipated|2018-09-11||Interventional|||24-hour Blood Pressure Measurements and Ischemic Conditioning|24-hour Blood Pressure Measurements and Ischemic Conditioning|Recruiting||N/A|30|Anticipated|University of Texas at Austin||1|||f||||f|f|f||||||||2017-10-10 20:39:59.349027|2017-10-10 20:39:59.349027
NCT03303391|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|IBPS||Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration|Using Intradialytic Systolic Blood Pressure Slopes to Guide Ultrafiltration in Hemodialysis Patients: A Validation Study and Clinical Trial|Not yet recruiting||N/A|74|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:39:59.448561|2017-10-10 20:39:59.448561
NCT03303378|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Effects of Melatonin on Reperfusion Injury|Effects of Melatonin on Reperfusion Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Recruiting||N/A|190|Anticipated|Chinese PLA General Hospital||2|||f|||||f|f||||||||2017-10-10 20:39:59.529794|2017-10-10 20:39:59.529794
NCT03303352|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-30|2017-10-04|||July 24, 2017|Actual|2017-07-24|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|SMARTEUS||Connect Your Needle to Your Phone to Increase EUS FNA Diagnostic Yield?|Connect Your Needle to Your Phone to Increase EUS FNA Diagnostic Yield?|Recruiting||N/A|51|Anticipated|Carol Davila University of Medicine and Pharmacy||2|||f||||f|f|f||||||||2017-10-10 20:39:59.751997|2017-10-10 20:39:59.751997
NCT03303339|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-10-02|||October 31, 2017|Anticipated|2017-10-31|October 2017|2017-10-01|May 31, 2020|Anticipated|2020-05-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||PCM-075 in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).|A Phase 1b/2 Study of PCM-075 in Combination With Either Low-Dose Cytarabine or Decitabine in Subjects With Acute Myeloid Leukemia (AML)|Not yet recruiting||Phase 1/Phase 2|116|Anticipated|Trovagene, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:39:59.854549|2017-10-10 20:39:59.854549
NCT03303313|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-02|||September 19, 2017|Actual|2017-09-19|October 2017|2017-10-01|November 2020|Anticipated|2020-11-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome|A Phase 2, Open Label, Multicenter Study of ALN-CC5 Administered Subcutaneously in Adult Patients With Atypical Hemolytic Uremic Syndrome|Recruiting||Phase 2|24|Anticipated|Alnylam Pharmaceuticals||1|||f||||t|f|f||||||||2017-10-10 20:40:00.126428|2017-10-10 20:40:00.126428
NCT03303300|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-23|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|5R-STS||The Five-repetition Sit-to-stand Test for Lower Back Pain or Radiculopathy|The Five-repetition Sit-to-stand Test as an Objective Measure of Functional Impairment in Patients With Lower Back Pain or Radiculopathy|Not yet recruiting||N/A|100|Anticipated|Bergman Clinics|||1||f||||f|f|f||||||||2017-10-10 20:40:00.236941|2017-10-10 20:40:00.236941
NCT03303274|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-02|||October 20, 2017|Anticipated|2017-10-20|October 2017|2017-10-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||A Difference in Subclavian Vein Catheterization Between Supine and Lateral Tilt Position - Stage II|A Difference in the Cross-section Area of Subclavian Vein Between Supine and Lateral Tilt Position: Its Clinical Impact on Subclavian Venous Catheterization - Stage II|Not yet recruiting||N/A|220|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 20:40:00.38027|2017-10-10 20:40:00.38027
NCT03303248|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||October 16, 2017|Anticipated|2017-10-16|October 2017|2017-10-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Evaluation of Web-based Transition Education to Enhance Transition Readiness|Evaluation of Web-based Transition Education to Enhance Transition Readiness and Health Service Utilization in Adolescents/Young Adults With Congenital Heart Disease|Not yet recruiting||N/A|110|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 20:40:00.511084|2017-10-10 20:40:00.511084
NCT03303235|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections|How's the Tone? Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections|Not yet recruiting||Early Phase 1|4000|Anticipated|Johns Hopkins University||2|||f||||t|t|f|||t|||||2017-10-10 20:40:00.590233|2017-10-10 20:40:00.590233
NCT03303222|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||November 10, 2017|Anticipated|2017-11-10|October 2017|2017-10-01|November 30, 2020|Anticipated|2020-11-30|November 30, 2020|Anticipated|2020-11-30||Observational|||Study to Develop a Breath Analyser to Detect Chronic Kidney Disease|Pilot Study to Develop a Breath Analyser to Detect Chronic Kidney Disease|Not yet recruiting||N/A|100|Anticipated|University College, London|||2||f||||f|f|f||||||||2017-10-10 20:40:00.74276|2017-10-10 20:40:00.74276
NCT03303209|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||September 15, 2015|Actual|2015-09-15|October 2017|2017-10-01|August 10, 2017|Actual|2017-08-10|August 10, 2017|Actual|2017-08-10||Observational|||Patient-Centered Opioid Tapering Study|Patient-Centered Opioid Tapering in Outpatients With Chronic Pain and Long-Term Opioid Use|Completed||N/A|51|Actual|Stanford University|||1||f||||f|f|f||||||||2017-10-10 20:40:00.834178|2017-10-10 20:40:00.834178
NCT03303196|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes|Bihormonal Bionic Pancreas for the Treatment of Diabetes Post-Pancreatectomy in Children With Congenital Hyperinsulinism - A Pilot Study|Not yet recruiting||N/A|7|Anticipated|Children's Hospital of Philadelphia||2|||f|||||f|t|t|f||||||2017-10-10 20:40:00.923005|2017-10-10 20:40:00.923005
NCT03303170|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris|A Prospective, Multicenter, Randomized, Controlled, Evaluator-Blinded Study of the Safety and Effectiveness of Sebacia Microparticles as an Accessory to 1064 nm Nd:Yag Laser in the Treatment of Facial Inflammatory Acne Vulgaris|Recruiting||N/A|160|Anticipated|Sebacia, Inc.||2|||f||||f|f|t|t|f|f|||||2017-10-10 20:40:01.112853|2017-10-10 20:40:01.112853
NCT03303157|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||October 20, 2017|Anticipated|2017-10-20|October 2017|2017-10-01|August 20, 2018|Anticipated|2018-08-20|November 20, 2017|Anticipated|2017-11-20||Observational|||REM Sleep and Dreaming- a Case Study|REM Sleep and Dreaming- a Case Study|Not yet recruiting||N/A|1|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f|||||f|f||||||||2017-10-10 20:40:01.545408|2017-10-10 20:40:01.545408
NCT03303144|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients|Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Rockwell Medical Technologies, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:40:01.642271|2017-10-10 20:40:01.642271
NCT03303131|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||September 1, 2007|Actual|2007-09-01|October 2017|2017-10-01|December 31, 2011|Actual|2011-12-31|December 31, 2011|Actual|2011-12-31||Observational|||Use of a MUAC-based Criterion|Discharge From Community-based Management of Severe Acute Malnutrition Using Mid Upper Arm Circumference|Completed||N/A|50841|Actual|Epicentre|||2||f||||f|f|f||||||||2017-10-10 20:40:01.75228|2017-10-10 20:40:01.75228
NCT03303105|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||November 2018|Anticipated|2018-11-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine|A Multicenter, Randomized, Open-label Trial Evaluating the Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine|Recruiting||Phase 3|40|Anticipated|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:40:01.957165|2017-10-10 20:40:01.957165
NCT03303092|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine|Recruiting||Phase 2/Phase 3|330|Anticipated|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f|f|f||||||||2017-10-10 20:40:02.112085|2017-10-10 20:40:02.112085
NCT03303079|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine|Recruiting||Phase 2/Phase 3|540|Anticipated|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f|f|f||||||||2017-10-10 20:40:02.24654|2017-10-10 20:40:02.24654
NCT03303066|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|||Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Lower Risk MDS|A Phase 2/3 Trial of FG-4592 for Treatment of Anemia in Subjects With Lower Risk Myelodysplastic Syndrome|Not yet recruiting||Phase 2/Phase 3|175|Anticipated|FibroGen||2|||f||||t|t|f|||t|||||2017-10-10 20:40:02.353014|2017-10-10 20:40:02.353014
NCT03303053|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-01|||May 11, 2017|Actual|2017-05-11|October 2017|2017-10-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|ChoPS||Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism|A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism|Recruiting||Phase 3|135|Anticipated|Clinical Research Centre, Malaysia||3|||f||||f|f|f|||f|||||2017-10-10 20:40:02.477098|2017-10-10 20:40:02.477098
NCT03303040|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Effect of Diaphragm Stimulation During Surgery|The Effect of Intermittent Hemidiaphragm Stimulation During Surgery on Mitochondrial Function, Single Fiber Contractile Force and Catabolic Pathways in Humans|Not yet recruiting||N/A|54|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 20:40:02.655972|2017-10-10 20:40:02.655972
NCT03303027|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||April 27, 2016|Actual|2016-04-27|October 2017|2017-10-01|April 4, 2018|Anticipated|2018-04-04|October 27, 2016|Actual|2016-10-27||Interventional|||6-0 Fast Absorbing Gut Versus 5-0 Fast Absorbing Gut for Linear Wound Closure|Use of 6-0 Fast Absorbing Gut Versus 5-0 Fast Absorbing Gut for Linear Cutaneous Wound Closure: a Randomized Evaluator Blind Split Wound Comparative Effectiveness Trial.|Active, not recruiting||N/A|50|Anticipated|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 20:40:02.85264|2017-10-10 20:40:02.85264
NCT03303014|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||October 13, 2015|Actual|2015-10-13|October 2017|2017-10-01|September 13, 2019|Anticipated|2019-09-13|March 15, 2016|Actual|2016-03-15||Interventional|||5-0 Prolene Versus 5-0 Fast Absorbing Gut|Use of 5-0 Prolene Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure: a Randomized Evaluator Blinded Split Wound Comparative Effectiveness Trial|Active, not recruiting||N/A|50|Anticipated|University of California, Davis||2|||f|||||f|f||||||||2017-10-10 20:40:02.933023|2017-10-10 20:40:02.933023
NCT03303001|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-04|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|November 30, 2018|Anticipated|2018-11-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Comparison Between Subacromial Infiltrations|Subacromial Injection of High Volume Versus Conventional Steroid Injection Guided by Ultrasound in Shoulder Pain. Randomized Controlled Trial|Recruiting||N/A|22|Anticipated|Universidad Autonoma de Nuevo Leon||2|||f||||t|f|f|||t|||||2017-10-10 20:40:03.022425|2017-10-10 20:40:03.022425
NCT03302988|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||October 13, 2015|Actual|2015-10-13|October 2017|2017-10-01|July 25, 2018|Anticipated|2018-07-25|July 6, 2016|Actual|2016-07-06||Interventional|||Wound Eversion Versus Planar Closure for Face or Neck Wounds|Wound Eversion Versus Planar Closure for Wounds on the Face or Neck: a Randomized Split Wound Comparative Effectiveness Trial|Active, not recruiting||N/A|50|Anticipated|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 20:40:03.155659|2017-10-10 20:40:03.155659
NCT03302975|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Running Retraining to Minimize Braking Forces|The Effect of a Gait Modification Training Program on Impact Loading and Running-related Injuries|Enrolling by invitation||N/A|16|Anticipated|University of British Columbia||1|||f||||f|f|f||||||||2017-10-10 20:40:03.288853|2017-10-10 20:40:03.288853
NCT03302962|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-04|||March 14, 2013|Actual|2013-03-14|October 2017|2017-10-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|FIPA||Factors Influencing Pediatric Asthma|Factors Influencing Pediatric Asthma|Completed||N/A|324|Actual|Missouri Breaks Industries Research, Inc.||2|||f||||t|f|f||||||||2017-10-10 20:40:03.377026|2017-10-10 20:40:03.377026
NCT03302923|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-04|||June 1, 2016|Actual|2016-06-01|October 2017|2017-10-01|November 30, 2019|Anticipated|2019-11-30|August 31, 2018|Anticipated|2018-08-31||Interventional|||Brisk Walking Study in Nursing Home Residents|Effects of Brisk Walking on Autonomic Nervous System Reactivation in Nursing Home Residents. Additional Effects of Transcutaneous Vagus Nerve Stimulation.|Recruiting||N/A|100|Anticipated|Clinique Mutualiste Chirurgicale de la Loire||5|||f||||f|f|f||||||||2017-10-10 20:40:03.656584|2017-10-10 20:40:03.656584
NCT03302910|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|June 30, 2021|Anticipated|2021-06-30|March 31, 2021|Anticipated|2021-03-31||Interventional|SSU-AHF||Short Stay Unit vs Hospitalization in Acute Heart Failure|Using Short Stay Units Instead of Routine Admission to Improve Patient Centered Health Outcomes for AHF Patients|Not yet recruiting||Phase 2/Phase 3|534|Anticipated|Indiana University||2|||f||||t|t|f|||f|||||2017-10-10 20:40:03.784209|2017-10-10 20:40:03.784209
NCT03302897|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers|A Phase 1, Open Label, Antigen Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of LEP-F1 + GLA-SE in Healthy Adult Subjects|Recruiting||Phase 1|24|Anticipated|IDRI||2|||f||||f|t|f||||||||2017-10-10 20:40:03.891561|2017-10-10 20:40:03.891561
NCT03302884|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||October 30, 2017|Anticipated|2017-10-30|October 2017|2017-10-01|October 30, 2022|Anticipated|2022-10-30|October 30, 2022|Anticipated|2022-10-30||Interventional|CIDOC||Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma|Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma|Not yet recruiting||N/A|150|Anticipated|Institut Paoli-Calmettes||1|||f||||f|f|f||||||||2017-10-10 20:40:03.968387|2017-10-10 20:40:03.968387
NCT03302871|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-05|||January 18, 2016|Actual|2016-01-18|October 2017|2017-10-01|December 18, 2017|Anticipated|2017-12-18|November 18, 2017|Anticipated|2017-11-18||Interventional|||Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-A|Integrated Management With Brain Stimulation and Hybrid Training Enhances Functional Gains in Children With Cerebral Palsy Treated by Botulinum Toxin A|Recruiting||Phase 3|28|Anticipated|Kocaeli University||2|||f||||t|f|f||||||||2017-10-10 20:40:04.064385|2017-10-10 20:40:04.064385
NCT03302858|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand|A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand|Recruiting||Phase 2|70|Anticipated|Laser Surgery Care||1|||f||||f|f|t|f|f||||||2017-10-10 20:40:04.176431|2017-10-10 20:40:04.176431
NCT03302845|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||September 21, 2017|Actual|2017-09-21|October 2017|2017-10-01|November 19, 2017|Anticipated|2017-11-19|October 20, 2017|Anticipated|2017-10-20||Interventional|||A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects|A Phase 1, Open-label, Parallel Group, Drug-drug Pharmacokinetic Interaction Study to Evaluate the Effects of Multiple-dose Omeprazole and Famotidine on the Absorption of Single-dose Telotristat Ethyl in Healthy Male and Female Subjects|Recruiting||Phase 1|32|Anticipated|Lexicon Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 20:40:04.26032|2017-10-10 20:40:04.26032
NCT03302819|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-04|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|November 1, 2018|Anticipated|2018-11-01||Interventional|LIESL||London Investigation Into diElectric Scanning of Lesions|Performance Evaluation of the MARIA (Multi Static Array Processing of Radiowave Image Acquisition) Radar Breast Imaging System in Patients With Breast Cancer and in Patients Assessed in the Symptomatic Breast Clinic.|Not yet recruiting||N/A|994|Anticipated|Royal Marsden NHS Foundation Trust||3|||f|||||f|f||||||||2017-10-10 20:40:04.437509|2017-10-10 20:40:04.437509
NCT03302806|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||November 1, 2016|Actual|2016-11-01|October 2017|2017-10-01|March 1, 2018|Anticipated|2018-03-01|November 1, 2017|Anticipated|2017-11-01||Observational|BIOSEP||Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis|Observational Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis|Recruiting||N/A|100|Anticipated|Nantes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:40:04.523498|2017-10-10 20:40:04.523498
NCT03302793|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-01|||April 2015||2015-04-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Spinal Cord Injury|Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management|Recruiting||N/A|15|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 20:40:04.597862|2017-10-10 20:40:04.597862
NCT03302780|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-01|||April 2015||2015-04-01|October 2017|2017-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Healthy Subjects|Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management|Completed||N/A|6|Actual|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 20:40:04.92311|2017-10-10 20:40:04.92311
NCT03302767|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-10-04|||August 7, 2017|Actual|2017-08-07|October 2017|2017-10-01|June 27, 2018|Anticipated|2018-06-27|June 27, 2018|Anticipated|2018-06-27||Interventional|CAP'ONCO||CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology|CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology|Recruiting||N/A|30|Anticipated|Institut Bergonié||1|||f||||f|f|f||||||||2017-10-10 20:40:05.017147|2017-10-10 20:40:05.017147
NCT03302754|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Precision Dosing of Alemtuzumab|Precision Dosing of Alemtuzumab for Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Diseases|Recruiting||N/A|30|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t|f|f|||f|||||2017-10-10 20:40:05.123545|2017-10-10 20:40:05.123545
NCT03302741|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-01|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings|Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface|Not yet recruiting||Phase 4|16|Anticipated|The University of Texas Health Science Center, Houston||2|||f|||||t|t|f|f|f|||||2017-10-10 20:40:05.2094|2017-10-10 20:40:05.2094
NCT03175055|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-07|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 15, 2017|Anticipated|2017-09-15||Interventional|||Phoenix Exoskeleton for SCI Users|Phoenix Exoskeleton Clinical Study|Recruiting||N/A|40|Anticipated|US Bionics||1|||f|||||f|t|t|f|t|||||2017-10-10 21:00:40.27782|2017-10-10 21:00:40.27782
NCT03302702|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-01|||January 2014|Actual|2014-01-01|October 2017|2017-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Duration of Exercise Program in Interstitial Lung Diseases.|A Comparison Trial of Eight Weeks Versus Twelve Weeks of Exercise Program in Interstitial Lung Diseases.|Completed||N/A|14|Actual|Izmir Katip Celebi University||1|||f||||f|f|f||||||||2017-10-10 20:40:05.463595|2017-10-10 20:40:05.463595
NCT03302689|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-04|||September 25, 2017|Actual|2017-09-25|October 2017|2017-10-01|February 1, 2018|Anticipated|2018-02-01|December 25, 2017|Anticipated|2017-12-25||Interventional|||Comparison Levobupivacaine and Ropivacaine for TAP-block After Caesarean Section|The Double-blind, Randomized Controlled Trial: Comparison of Levobupivacaine and Ropivacaine for Postoperative Analgesia TAP-block After Caesarean Section|Recruiting||N/A|40|Anticipated|Tver Regional Perinatal Center||2|||f||||f|f|f||||||||2017-10-10 20:40:05.528458|2017-10-10 20:40:05.528458
NCT03302676|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-05|||September 2016|Actual|2016-09-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors|The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors|Recruiting||Phase 3|210|Anticipated|Odense University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:40:05.626897|2017-10-10 20:40:05.626897
NCT03302663|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-04|||August 1, 2013|Actual|2013-08-01|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Value of Advanced Imaging Sequences for Fetal MRI in Clinical Practice|The Value of Advanced Imaging Sequences for Fetal MRI in Clinical Practice|Recruiting||N/A|150|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||4|||f||||f|f|f||||||||2017-10-10 20:40:05.709018|2017-10-10 20:40:05.709018
NCT03302650|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-01|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|June 15, 2018|Anticipated|2018-06-15|June 1, 2018|Anticipated|2018-06-01||Interventional|||Angiotensin II for Treatment of Septic Shock: Effects on Microcirculation and Peripheral Perfusion|Angiotensin II for Treatment of Septic Shock: Effects on Microcirculation and Peripheral Perfusion|Not yet recruiting||Phase 3|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:40:05.850277|2017-10-10 20:40:05.850277
NCT03302637|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||December 1, 1992|Actual|1992-12-01|October 2017|2017-10-01|December 1, 2010|Actual|2010-12-01|December 1, 2010|Actual|2010-12-01||Observational|||Oral Microbiome and Pancreatic Cancer|Oral Microbiome and Pancreatic Cancer: a Prospective Case-Control Study|Completed||N/A|732|Actual|New York University School of Medicine|||2||f||||f|f|f||||Samples With DNA|"     Using DNA extracted from oral samples from these cohorts, 16S rRNA genes were amplified and     sequenced, followed by assignment of each sequence to a microbial taxa   "|||2017-10-10 20:40:05.951472|2017-10-10 20:40:05.951472
NCT03302624|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-05|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 1, 2017|Anticipated|2017-12-01||Observational|SURIA||Follow-up of Long-term Renal Function After Acute Kidney Injury in ICU|A Study on the Follow-up of Long-term Renal Function After Acute Kidney Injury in ICU|Recruiting||N/A|506|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 20:40:06.032957|2017-10-10 20:40:06.032957
NCT03302611|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||January 2018|Anticipated|2018-01-01|October 2017|2017-10-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Trial of Surf and Hike Therapy for Major Depressive Disorder|A Randomized Controlled Trial of Surf and Hike Therapy for Active-duty Service Members With Major Depressive Disorder|Not yet recruiting||N/A|86|Anticipated|United States Naval Medical Center, San Diego||2|||f||||f|f|f||||||||2017-10-10 20:40:06.135979|2017-10-10 20:40:06.135979
NCT03302598|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-10-04|||January 20, 2015|Actual|2015-01-20|October 2017|2017-10-01|April 15, 2017|Actual|2017-04-15|January 20, 2017|Actual|2017-01-20||Interventional|||Assessment of Relation Between Recurrence of Enterocutaneous Fistula and Preoperative C-reactive Protein Level After Complete Surgical Repair|Assessment of Relation Between Recurrence of Enterocutaneous Fistula and Preoperative C-reactive Protein Level After Complete Surgical Repair|Completed||N/A|40|Actual|Zagazig University||1|||f||||||||||||||2017-10-10 20:40:06.219522|2017-10-10 20:40:06.219522
NCT03302585|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-30|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2023|Anticipated|2023-04-01|October 2022|Anticipated|2022-10-01||Interventional|VitaDON2||High-Dose Vitamin D Induction in Optic Neuritis|A Phase II Trial of High-Dose Vitamin D Induction in Optic Neuritis (VitaDON 2)|Not yet recruiting||Phase 2|66|Anticipated|University of Calgary||2|||f||||f|f|f||||||||2017-10-10 20:40:06.297867|2017-10-10 20:40:06.297867
NCT03302572|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-04|||November 3, 2016|Actual|2016-11-03|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Effectiveness Brief Information Advanced Directives Primary Care|Effectiveness of a Brief Information About Advanced Directives in Primary Care: A Randomized Clinical Trial|Recruiting||N/A|330|Anticipated|Jordi Gol i Gurina Foundation||2|||f|||||f|f||||||||2017-10-10 20:40:06.425296|2017-10-10 20:40:06.425296
NCT03302559|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage|Assessing the Cosmetic Changes in the Facial Skin Utilizing Non-Invasive In Vivo Skin Imaging Instrumentation After Use of a Topical Retinoid Product In Subjects With Moderate to Severe Photodamage|Recruiting||N/A|50|Anticipated|Allergan||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:40:06.506065|2017-10-10 20:40:06.506065
NCT03302546|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-10-04|||April 4, 2017|Actual|2017-04-04|October 2017|2017-10-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Incremental Hemodialysis as a Starting Way of Renal Replacement Therapy|Incremental Hemodialysis as a Starting Way of Renal Replacement Therapy|Recruiting||N/A|7|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||f|f|f||||||||2017-10-10 20:40:06.599936|2017-10-10 20:40:06.599936
NCT03302533|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-30|2017-10-04|||January 21, 2013|Actual|2013-01-21|October 2017|2017-10-01|March 31, 2017|Actual|2017-03-31|March 31, 2016|Actual|2016-03-31||Observational|||Can Secondary Total Elbow Arthroplasty After Failed Internal Fixation or Non-operative Treatment of Distal Humeral Fractures Achieve Equal Results as Primary Arthroplasty?||Completed||N/A|23|Actual|Diakoniekrankenhaus Friederikenstift|||2||f||||t|f|f||||||||2017-10-10 20:40:06.684864|2017-10-10 20:40:06.684864
NCT03295409|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Testing Familial Self-affirmation for Smoking Cessation|Testing Familial Self-affirmation for Smoking Cessation|Not yet recruiting||N/A|150|Anticipated|University of Manchester||3|||f||||f|f|f||||||||2017-10-10 20:41:11.615513|2017-10-10 20:41:11.615513
NCT03302494|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-04|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 1, 2025|Anticipated|2025-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|WAVECREST2||WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2|WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2. A Prospective, Multicenter, Randomized, Active Controlled, Clinical Trial of the Coherex WaveCrest® Left Atrial Appendage Occlusion System Compared to the Watchman® LAA Closure Device for the Reduction in Risk of Ischemic Stroke or Systemic Embolism in Subjects With Non-valvular Atrial Fibrillation That Have an Appropriate Rationale to Seek a Non-pharmacologic Alternative to Chronic Oral Anticoagulation.|Not yet recruiting||Phase 3|1250|Anticipated|Coherex Medical||2|||f||||t|f|t|t|||||||2017-10-10 20:40:06.944538|2017-10-10 20:40:06.944538
NCT03302481|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-04|||January 2, 2018|Anticipated|2018-01-02|October 2017|2017-10-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|DMSO||Mitochondrial Metabolism and Hepatic Complications of Obesity|Prospective Physiopathology Study of the Links Between Mitochondrial Dynamics and Fatty Liver Disease During Obesity|Not yet recruiting||N/A|80|Anticipated|Nantes University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:40:07.040375|2017-10-10 20:40:07.040375
NCT03302468|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-04|||August 6, 2015|Actual|2015-08-06|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis|Development and Validation of the Endometriosis Health Profile-30 Traditional Chinese (Hong Kong) Version in Endometriosis and Adenomyosis|Recruiting||N/A|222|Anticipated|Chinese University of Hong Kong|||1||f||||f||||||||||2017-10-10 20:40:07.114046|2017-10-10 20:40:07.114046
NCT03302442|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||May 1, 2017|Actual|2017-05-01|October 2017|2017-10-01|October 1, 2017|Actual|2017-10-01|August 1, 2017|Actual|2017-08-01||Observational|COMP-RMS||Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis|Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis|Completed||N/A|3000|Actual|Nantes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:40:07.279116|2017-10-10 20:40:07.279116
NCT03302429|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-04|||January 2018|Anticipated|2018-01-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evaluation of Platelet Rich Fibrin / Biphasic Calcium Phosphate Effect Versus Autogenous Bone Graft on Reconstruction of Alveolar Cleft|Evaluation of Platelet-rich Fibrin / Biphasic Calcium Phosphate Effect Versus Autogenous Bone Graft on Reconstruction of Alveolar Cleft Defect in the Maxillary Arch: Randomized Controlled Clinical Trial|Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:40:07.349566|2017-10-10 20:40:07.349566
NCT03302416|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-03|||June 1, 2016|Actual|2016-06-01|October 2017|2017-10-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||CRF - Nociceptin Receptor Interactions|In Vivo Imaging of Corticotropin-releasing Factor - Nociceptin Receptor Interactions|Recruiting||Early Phase 1|20|Anticipated|University of Pittsburgh||1|||f||||f|f|f|||f|||||2017-10-10 20:40:07.44442|2017-10-10 20:40:07.44442
NCT03302403|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-30|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors|Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors|Not yet recruiting||N/A|48|Anticipated|First Affiliated Hospital of Wenzhou Medical Univeristy||1|||f||||t|f|f||||||||2017-10-10 20:40:07.807598|2017-10-10 20:40:07.807598
NCT03302390|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-09-29|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|August 10, 2021|Anticipated|2021-08-10|August 10, 2021|Anticipated|2021-08-10||Observational|||Role of Chemokine and Chemokine Receptor in Psoriasis|Role of Chemokine and Chemokine Receptor in Psoriasis|Recruiting||N/A|40|Anticipated|University of California, Davis|||1||f||||t|f|f||||||||2017-10-10 20:40:07.946892|2017-10-10 20:40:07.946892
NCT03302377|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-03|||October 3, 2017|Anticipated|2017-10-03|October 2017|2017-10-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|FFT||Fit for Two: Incorporating Wearable Trackers Into Clinical Care for Pregnant Women With Diabetes (FFT)|Fit for Two: Feasibility and Acceptability of Incorporating Wearable Trackers Into Clinical Care for Pregnant Women With Diabetes|Not yet recruiting||N/A|20|Anticipated|University of California, San Diego||1|||f||||f|f|f||||||||2017-10-10 20:40:08.029245|2017-10-10 20:40:08.029245
NCT03302364|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-29|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01|8 Weeks|Observational [Patient Registry]|||A Research in Pharmacogenomics and Accurate Medication of Risperidone|A Research in Pharmacogenomics and Accurate Medication of Risperidone|Not yet recruiting||N/A|800|Anticipated|Peking University First Hospital|||1||f|||||f|f||||||||2017-10-10 20:40:08.104185|2017-10-10 20:40:08.104185
NCT03302351|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-30|||December 26, 2016|Actual|2016-12-26|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Dexmedetomidine, Ketamine and Dexmetedomidine-Ketamine Combination for Control of Shivering During Regional Anaethesia|Comparing Dexmedetomidine, Ketamine and Dexmetedomidine-Ketamine Combination to Control Shivering During Regional Anaethesia|Recruiting||Phase 4|90|Anticipated|Assiut University||3|||f|||||f|f||||||||2017-10-10 20:40:08.194222|2017-10-10 20:40:08.194222
NCT03302338|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-09-30|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Simulated Amniotic Fluid Solution in Neonates Recovering From GIT Surgeries|Simulated Amniotic Fluid Like Solution Enterally Administrated in Neonates Recovering From GIT Surgeries|Recruiting||Phase 1|40|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 20:40:08.299845|2017-10-10 20:40:08.299845
NCT03302325|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-29|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Circulating Tumor DNA as Liquid Biopsy in Patients With Stage IV Solid Tumors, a Feasibility Study at MUSC HCC|Circulating Tumor DNA as Liquid Biopsy in Patients With Stage IV Solid Tumors, a Feasibility Study at MUSC HCC|Recruiting||N/A|20|Anticipated|Medical University of South Carolina|||1||f||||t|f|f||||Samples With DNA|"     circulating tumor DNA (ctDNA) in the blood   "|||2017-10-10 20:40:08.393051|2017-10-10 20:40:08.393051
NCT03302312|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|||Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Acceptability|A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms - Acceptability|Not yet recruiting||N/A|193|Anticipated|RTI International|||2||f||||f|f|f||||||||2017-10-10 20:40:08.468023|2017-10-10 20:40:08.468023
NCT03302299|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-29|||April 7, 2017|Actual|2017-04-07|September 2017|2017-09-01|August 31, 2021|Anticipated|2021-08-31|February 26, 2021|Anticipated|2021-02-26||Interventional|ADEPTT||Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)|URBAN ARCH (3/5) Uganda Cohort TB Preventive Therapy for HIV-infected Alcohol Users in Uganda: an Evaluation of Safety Tolerability and Adherence|Recruiting||Phase 4|300|Anticipated|University of California, San Francisco||1|||f||||t|f|f|||f|||||2017-10-10 20:40:08.559532|2017-10-10 20:40:08.559532
NCT03302286|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-03|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|Prime||Effects of Extra Corporeal Circuit Prime on Electrolytes Balance and Clinical Outcome Following Cardiac Surgery|Effects of Extra Corporeal Circuit Prime on Electrolytes Balance and Clinical Outcome Following Cardiac Surgery|Not yet recruiting||N/A|110|Anticipated|Region Skane||2|||f||||f|f|f||||||||2017-10-10 20:40:08.796436|2017-10-10 20:40:08.796436
NCT03302273|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-30|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Corneal Epithelial Stem Cells and Dry Eye Disease|Topical Cadaveric-Derived Corneal Epithelial Stem Cell Transplant Therapy for the Treatment of Severe Dry Eye Disease|Recruiting||N/A|30|Anticipated|Panhandle Eye Group, LLP||1|||f||||f|f|f||||||||2017-10-10 20:40:08.878135|2017-10-10 20:40:08.878135
NCT03302260|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-05|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|IMPROVE||Identifying Methods for Postpartum Reduction of Vascular Events: Pilot Randomized Controlled Trial|IMPROVE (Identifying Methods for Postpartum Reduction of Vascular Events): Pilot Randomized Controlled Trial|Not yet recruiting||N/A|84|Anticipated|University of Calgary||2|||f|||||f|f||||||||2017-10-10 20:40:08.968099|2017-10-10 20:40:08.968099
NCT03302234|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-04|||November 24, 2017|Anticipated|2017-11-24|September 2017|2017-09-01|February 22, 2024|Anticipated|2024-02-22|April 18, 2022|Anticipated|2022-04-18||Interventional|||Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-small Cell Lung Cancer (MK-3475-598/KEYNOTE-598)|A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo in Previously Untreated, Stage IV, Metastatic Non-small Cell Lung Cancer Subjects Whose Tumors Are PD-L1 Positive (TPS ≥ 50%) (KEYNOTE-598)|Not yet recruiting||Phase 3|548|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t|t|f||||||||2017-10-10 20:40:09.183386|2017-10-10 20:40:09.183386
NCT03302221|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-03|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|March 20, 2018|Anticipated|2018-03-20|February 28, 2018|Anticipated|2018-02-28||Interventional|||Doppler Ultrasonography Assessed Vascular Changes During Anesthesia Induction|Doppler Ultrasonography Assessed Vascular Changes During Anesthesia Induction|Not yet recruiting||N/A|100|Anticipated|China Medical University, China||1|||f||||t|f|f||||||||2017-10-10 20:40:10.149011|2017-10-10 20:40:10.149011
NCT03302208|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-10-03|||June 29, 2017|Actual|2017-06-29|October 2017|2017-10-01|September 20, 2017|Actual|2017-09-20|September 1, 2017|Actual|2017-09-01||Interventional|||Preoperative Oral Pregabalin Effect on Inhalational Anesthetic Requirements ln Hysterectomy Under General Anesthesia|Role of Preoperative Oral Pregabalin in Reducing Inhalational Anesthetic Requirements in Elective Abdominal Hysterectomy Under General Anesthesia: A Randomized Controlled Trial|Completed||Phase 3|50|Actual|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:40:10.231205|2017-10-10 20:40:10.231205
NCT03302195|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-03|||August 21, 2015|Actual|2015-08-21|October 2017|2017-10-01|August 31, 2025|Anticipated|2025-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery|Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery|Recruiting||N/A|410|Anticipated|Laval University||4|||f||||f|f|f||||||||2017-10-10 20:40:10.367482|2017-10-10 20:40:10.367482
NCT03302182|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-30|2017-09-30|||September 23, 2017|Actual|2017-09-23|September 2017|2017-09-01|December 4, 2017|Anticipated|2017-12-04|November 4, 2017|Anticipated|2017-11-04||Interventional|RTV||Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects|An Open-label, Randomized Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects|Recruiting||Phase 1|96|Anticipated|First Affiliated Hospital of Zhejiang University||2|||f||||f|f|f||||||||2017-10-10 20:40:10.478787|2017-10-10 20:40:10.478787
NCT03302169|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-30|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|November 1, 2019|Anticipated|2019-11-01||Interventional|RHABDO-PROST||Trial to Compare Urinary Continence Recovery After Robotic Radical Prostatectomy With or Without Rhabdosphincter Reconstruction.|Prospective Randomized Controlled Trial to Compare Early Urinary Continence Recovery After Robotic Assisted Radical Prostatectomy With or Without Posterior Rhabdosphincter Reconstruction.|Recruiting||N/A|146|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:40:10.589662|2017-10-10 20:40:10.589662
NCT03302156|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-29|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||PSMA PET and MRI in Gynecological Cancers|PSMA Positron Emission Tomography (PET) and Magnetic Resonance (MR) Imaging in Gynecological Cancers|Recruiting||Phase 2|52|Anticipated|University of Wisconsin, Madison||2|||f||||t|t|f||||||||2017-10-10 20:40:10.710829|2017-10-10 20:40:10.710829
NCT03302143|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||July 30, 2013|Actual|2013-07-30|September 2017|2017-09-01|May 15, 2016|Actual|2016-05-15|May 15, 2016|Actual|2016-05-15||Interventional|||Radiographic and the Esthetic Outcome of Two Different Bone Grafting Techniques in Early Implant Placement|A Comparative, Randomized, Prospective, Clinical Study to Evaluate the Facial Bone and Esthetic Outcome of Buccal Augmentation Bone Grafting Techniques in Early (Type 2) Implant Placement|Completed||N/A|48|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t|f|f|||t|||||2017-10-10 20:40:10.805795|2017-10-10 20:40:10.805795
NCT03302130|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-09-29|||January 8, 2016|Actual|2016-01-08|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effects of Mood on Cerebral Perfusion|The Effects of Mood on Cerebral Perfusion|Active, not recruiting||N/A|48|Anticipated|University Ghent||1|||f||||f||||||||||2017-10-10 20:40:10.888921|2017-10-10 20:40:10.888921
NCT03302117|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-03|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|February 8, 2018|Anticipated|2018-02-08|February 8, 2018|Anticipated|2018-02-08||Observational|||Pulmonary and Systemic Effects of Exposure to Wood Smoke|Pulmonary and Systemic Effects of Exposure to Wood Smoke|Recruiting||N/A|20|Anticipated|Umeå University|||1||f||||f|f|f||||Samples Without DNA|"     Bronchoalevolar lavage. Endobronchial biopsies. Peripheral blood sampling.   "|||2017-10-10 20:40:10.965191|2017-10-10 20:40:10.965191
NCT03302104|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-29|||January 1, 1999|Actual|1999-01-01|September 2017|2017-09-01|December 31, 2002|Actual|2002-12-31|December 31, 2002|Actual|2002-12-31||Observational|||Diet Quality and LTL in NHANES|Diet Quality Indices and Leukocyte Telomere Length Among Healthy US Adults: Data From the National Health and Nutrition Examination Surveys (NHANES) 1999-2002|Completed||N/A|4758|Actual|University of California, San Francisco|||1||f||||f|f|f||||||||2017-10-10 20:40:11.06775|2017-10-10 20:40:11.06775
NCT03302091|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-02|||October 17, 2017|Anticipated|2017-10-17|October 2017|2017-10-01|June 5, 2018|Anticipated|2018-06-05|June 5, 2018|Anticipated|2018-06-05||Interventional|||This Study Tests How BI 1467335 is Taken up in the Body of People With Normal Kidney Function and People With Reduced Kidney Function. The Study Also Looks at How Well the Participants Tolerate BI 1467335|Pharmacokinetics, Safety and Tolerability After Multiple Dose Administration of BI 1467335 in Subjects With Moderate Renal Impairment and Subjects With Normal Renal Function (a Mono-centric, Open-label Study in Matched-group Design)|Not yet recruiting||Phase 1|20|Anticipated|Boehringer Ingelheim||1|||f||||f|f|f||||||||2017-10-10 20:40:11.112796|2017-10-10 20:40:11.112796
NCT03302078|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||October 16, 2017|Anticipated|2017-10-16|October 2017|2017-10-01|December 6, 2017|Anticipated|2017-12-06|December 6, 2017|Anticipated|2017-12-06||Interventional|||Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects|Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects|Not yet recruiting||Phase 1|12|Anticipated|Boehringer Ingelheim||2|||f||||f|t|f||||||||2017-10-10 20:40:11.18407|2017-10-10 20:40:11.18407
NCT03302065|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-02|2017-10-02|||May 2016|Actual|2016-05-01|October 2017|2017-10-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference|Phase I Randomised, Four-period Balanced Incomplete Block Design Cross-over Study in Healthy Male and Female Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Four Test pMDI Products With One Reference Product|Completed||Phase 1|38|Actual|3M||4|||f||||f|f|f||||||||2017-10-10 20:40:11.248486|2017-10-10 20:40:11.248486
NCT03302052|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-01|||May 27, 2016|Actual|2016-05-27|September 2017|2017-09-01|December 31, 2016|Actual|2016-12-31|September 30, 2016|Actual|2016-09-30||Observational|||Investigation About Advance Directives|Investigation About Advance Directives|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||||2017-10-10 20:40:11.328176|2017-10-10 20:40:11.328176
NCT03302039|ClinicalTrials.gov processed this data on October 10, 2017|2017-10-01|2017-10-01|||October 6, 2017|Anticipated|2017-10-06|October 2017|2017-10-01|February 15, 2018|Anticipated|2018-02-15|February 1, 2018|Anticipated|2018-02-01||Interventional|||Three Protocols for Phenylephrine Administration in Cesarean Delivery|Three Protocols for Phenylephrine Administration for Prophylaxis Against Post-spinal Hypotension During Cesarean Delivery|Not yet recruiting||Phase 4|180|Anticipated|Cairo University||3|||f||||t|f|f||||||||2017-10-10 20:40:11.381821|2017-10-10 20:40:11.381821
NCT03302026|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Real Time fMRI and Quitting Smoking|A Proof-of-concept Study of Real-time fMRI Neurofeedback Training for Smoking Cessation|Recruiting||N/A|205|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 20:40:11.486811|2017-10-10 20:40:11.486811
NCT03302013|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-29|||September 5, 2016|Actual|2016-09-05|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|September 4, 2021|Anticipated|2021-09-04||Interventional|ALLIKAT||All Ligaments Left In Knee Arthroplasty Trial|Multi-center Clinical Study of Vanguard XP Bicruciate Knee System|Recruiting||N/A|260|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 20:40:11.571794|2017-10-10 20:40:11.571794
NCT03302000|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-30|2017-10-03|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Visual Stimulation of Preterm Infants|Early Visual Stimulation in Preterm Infants at Neonatal Unit Care and at Home From 0 to 3 Months|Not yet recruiting||N/A|100|Anticipated|Universidade Federal de Santa Catarina||1|||f|||||f|f||||||||2017-10-10 20:40:11.708155|2017-10-10 20:40:11.708155
NCT03127540|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||April 18, 2012||2012-04-18||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:16.269832|2017-10-10 21:08:16.269832
NCT03301987|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-30|2017-09-30|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 1, 2017|Anticipated|2017-12-01||Interventional|||Chronic Obstructive Kidney Disease & Therapeutic Exercise|Therapeutic Exercise in Patients With Chronic Obstructive Kidney Disease|Not yet recruiting||N/A|9|Anticipated|Universidad de León||1|||f||||t|f|f||||||||2017-10-10 20:40:11.807603|2017-10-10 20:40:11.807603
NCT03301974|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-29|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||A Comparison Between Surgical Techniques for Securing Conjunctival Autografting in Primary Pterygium Surgery|A Comparison Between Surgical Techniques for Securing Conjunctival Autografting in Primary Pterygium Surgery|Not yet recruiting||N/A|60|Anticipated|Assiut University||3|||f|||||f|f||||||||2017-10-10 20:40:11.922462|2017-10-10 20:40:11.922462
NCT03301961|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-30|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|||Multiplex Analysis of Circulating Tumor DNA|The Clinical Applications of Multiplex Analysis of Circulating Tumor DNA Biomarkers in Lung Cancer Patients|Not yet recruiting||N/A|400|Anticipated|Peking University People's Hospital|||1||f||||t|f|f||||Samples With DNA|"     A series of lung cancer patients plasma before and after surgery   "|||2017-10-10 20:40:12.034519|2017-10-10 20:40:12.034519
NCT03301948|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-29|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effects of a Single Day of Mixed Macronutrient Overfeeding on Energy Balance and Metabolic Responses|The Effects of a Single Day of Mixed Macronutrient Overfeeding on Energy Balance and Metabolic Responses in Healthy Young Men|Recruiting||N/A|12|Anticipated|Leeds Beckett University||2|||f||||f|f|f||||||||2017-10-10 20:40:12.145246|2017-10-10 20:40:12.145246
NCT03301935|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-29|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2018|Anticipated|2018-12-01||Observational|RASAP||Risk Assessment in Patients With Symptomatic- and Asymptomatic Preexcitation|Risk Assessment in Patients With Symptomatic- and Asymptomatic Preexcitation|Recruiting||N/A|150|Anticipated|Karolinska University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:40:12.277989|2017-10-10 20:40:12.277989
NCT03301922|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|||Work-focused Metacognitive Therapy for Patients on Sick Leave Due to Common Mental Disorders|Work-focused Metacognitive Therapy for Patients on Sick Leave Due to Common Mental Disorders: A Randomized Waiting List Controlled Trial|Not yet recruiting||N/A|240|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 20:40:12.395078|2017-10-10 20:40:12.395078
NCT03301909|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-04|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Interventional|||"Development of Applications of PillCam™ Endoscopy and Patency Systems and Clinical Evaluation of Their Performance in Healthy Volunteers (HEIGHT Study)"|"Development of Applications of PillCam™ Endoscopy and Patency Systems and Clinical Evaluation of Their Performance in Healthy Volunteers (HEIGHT Study)"|Not yet recruiting||N/A|1000|Anticipated|Medtronic - MITG||1|||f||||f|f|f||||||||2017-10-10 20:40:12.514877|2017-10-10 20:40:12.514877
NCT03301896|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-04|||November 21, 2017|Anticipated|2017-11-21|October 2017|2017-10-01|January 16, 2021|Anticipated|2021-01-16|January 16, 2021|Anticipated|2021-01-16||Interventional|||Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies|A Phase I/Ib, Open-label, Multi-center Dose-escalation and Dose-expansion Study of the Safety and Tolerability of Intra-tumorally Administered LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies|Not yet recruiting||Phase 1|200|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 20:40:12.607546|2017-10-10 20:40:12.607546
NCT03301883|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-03|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|December 2, 2020|Anticipated|2020-12-02|November 27, 2019|Anticipated|2019-11-27||Interventional|||A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)|A Phase IV, Multicenter, Single-Arm, Open-Label Study to Assess the Efficacy and Safety of Tocilizumab in Chinese Patients With Systemic Juvenile Idiopathic Arthritis|Not yet recruiting||Phase 4|65|Anticipated|Hoffmann-La Roche||1|||f|||||f|f||||||||2017-10-10 20:40:12.893223|2017-10-10 20:40:12.893223
NCT03301844|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-29|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis|Randomized, Controlled Study With a Closed Sequential Design to Compare the Efficacy, Safety and Patient Satisfaction of Blephapad Combo vs. Standard Treatment for Eyelid Cleansing in Patients Affected by Bilateral Posterior Blepharitis.|Recruiting||N/A|23|Anticipated|NTC srl||2|||f||||f|f|f||||||||2017-10-10 20:40:13.226261|2017-10-10 20:40:13.226261
NCT03301831|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-28|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Resourcefulness Intervention With Parents of Technology-Dependent Children|Intervention Pilot With Parents of Technology-Dependent Children|Not yet recruiting||N/A|94|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:40:13.326407|2017-10-10 20:40:13.326407
NCT03301467|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-29|||September 29, 2017|Actual|2017-09-29|September 2017|2017-09-01|October 28, 2019|Anticipated|2019-10-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Controlled Trial Evaluating Avacopan in C3 Glomerulopathy|A Randomized, Double Blind, Placebo Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan (CCX168) in Patients With C3 Glomerulopathy|Recruiting||Phase 2|44|Anticipated|ChemoCentryx||2|||||||t|t|f||||||||2017-10-10 20:40:16.471425|2017-10-10 20:40:16.471425
NCT03301805|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||June 1, 2018|Anticipated|2018-06-01|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||A Phase II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Gemcitabine Monotherapy in Patients With Advanced Inoperable or Metastatic Pancreatic Cancer|A Phase II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Gemcitabine Monotherapy in Patients With Advanced Inoperable or Metastatic Pancreatic Cancer|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Rgene Corporation||1|||f||||t|t|f||||||||2017-10-10 20:40:13.544238|2017-10-10 20:40:13.544238
NCT03301792|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-10-03|||September 14, 2017|Actual|2017-09-14|October 2017|2017-10-01|September 10, 2020|Anticipated|2020-09-10|June 10, 2020|Anticipated|2020-06-10||Interventional|||Group Versus Traditional Prenatal Care for Diabetes|Group Versus Traditional Prenatal Care for Diabetes: A Randomized Controlled Trial|Recruiting||N/A|106|Anticipated|Washington University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:40:13.630384|2017-10-10 20:40:13.630384
NCT03301779|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-29|||November 7, 2017|Anticipated|2017-11-07|September 2017|2017-09-01|May 10, 2018|Anticipated|2018-05-10|April 10, 2018|Anticipated|2018-04-10||Interventional|||Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial|Clinical Investigation to Evaluate the New Health Sciences Hemanext® Oxygen Reduction System for Leukoreduced Red Blood Cells With CP2D Anticoagulant and AS-3 Additive - Pivotal Trial|Not yet recruiting||Phase 2|100|Anticipated|Hemanext||2|||f||||f|f|t|t|||||||2017-10-10 20:40:13.762322|2017-10-10 20:40:13.762322
NCT03301766|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients|Adjunctive 5% Lidocaine Patches in the Treatment of Acute Non-radicular Low Back Pain in Patients Discharged From the Emergency Department|Not yet recruiting||Phase 4|100|Anticipated|John H. Stroger Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:13.882773|2017-10-10 20:40:13.882773
NCT03301753|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-03|||July 1, 2014|Actual|2014-07-01|October 2017|2017-10-01|June 30, 2019|Anticipated|2019-06-30|January 31, 2019|Anticipated|2019-01-31||Observational|(MILK)||Maternal Obesity, Breast Milk Composition, and Infant Growth|Maternal Obesity, Breast Milk Composition, and Infant Growth|Recruiting||N/A|720|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||Samples Without DNA|"     2 ml aliquots of breastmilk are stored for future chemical analysis.   "|||2017-10-10 20:40:14.06518|2017-10-10 20:40:14.06518
NCT03301740|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-29|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis|Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis|Not yet recruiting||N/A|36|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 20:40:14.196096|2017-10-10 20:40:14.196096
NCT03301727|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-29|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Sleeping for Two: RCT of CBT-Insomnia in Pregnancy|A Pilot Randomized Controlled Trial of Cognitive Behavioural Therapy for Insomnia in Pregnancy|Recruiting||N/A|45|Anticipated|University of Calgary||3|||f||||||||||||||2017-10-10 20:40:14.318387|2017-10-10 20:40:14.318387
NCT03301714|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-03|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Oral Health Education Interventions Among Seniors|Oral Health Education Interventions and Its Association With Behavioral Outcomes: A Clinical Trial|Recruiting||N/A|180|Anticipated|Temple University||3|||f||||f|f|f||||||||2017-10-10 20:40:14.471097|2017-10-10 20:40:14.471097
NCT03301701|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-10-03|||September 22, 2017|Actual|2017-09-22|October 2017|2017-10-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Interventional|PRORAD||Randomized Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer|Randomized Feasibility Trial of Prostate Radiotherapy vs Prostatectomy in Men With Hormone Sensitive Oligometastatic Prostate Cancer|Recruiting||N/A|30|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|f|f||||||||2017-10-10 20:40:14.558899|2017-10-10 20:40:14.558899
NCT03301675|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-29|||June 2016|Actual|2016-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2017|Actual|2017-05-01||Interventional|||Effect of Orange Juice and Healthy Diet on Cardiometabolic Risk Factors of Individuals With Metabolic Syndrome|Effect of Orange Juice Consumption Associated With Healthy Diet on Cardiometabolic Risk Factors of Individuals With Metabolic Syndrome|Active, not recruiting||N/A|76|Actual|São Paulo State University||2|||f|||||f|f||||||||2017-10-10 20:40:14.737669|2017-10-10 20:40:14.737669
NCT03301662|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|October 9, 2019|Anticipated|2019-10-09|October 9, 2018|Anticipated|2018-10-09||Observational|TEASE||Transient Electrocardiogram Assessment in Stroke Evaluation|Transient Electrocardiogram Assessment in Stroke Evaluation|Not yet recruiting||N/A|100|Anticipated|Region Gävleborg|||1||f||||f|f|f||||||||2017-10-10 20:40:14.83504|2017-10-10 20:40:14.83504
NCT03301272|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-02|||January 2018|Anticipated|2018-01-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Effectiveness of Botox on Reducing Rest Tremor in Parkinson's Disease|Effectiveness of Onabotulinumtoxin A on Reduction of Rest Tremor in Parkinson's Disease: a Pilot Study|Not yet recruiting||Phase 1|16|Anticipated|University of North Carolina, Chapel Hill||2|||f|||||t|f|||f|||||2017-10-10 20:40:17.921297|2017-10-10 20:40:17.921297
NCT03301649|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Endpoint Study of Ivermectin 0.5% Lotion|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Ivermectin Lotion 0.5% (Actavis Laboratories UT, Inc.) to SKLICE® (Ivermectin) Lotion, 0.5% (Arbor Pharmaceuticals, LLC) in the Treatment of Human Head Lice Infestation|Not yet recruiting||Phase 3|364|Anticipated|Actavis Inc.||3|||f||||f|t|f|||f|||||2017-10-10 20:40:14.909707|2017-10-10 20:40:14.909707
NCT03301636|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|December 2019|Anticipated|2019-12-01||Interventional|NLG2107||A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma|A Phase 2/3 (Adaptive Design) Study of the Concomitant Administration of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Adult Patients With Unresectable Stage III or Stage IV Malignant Melanoma|Not yet recruiting||Phase 2/Phase 3|624|Anticipated|NewLink Genetics Corporation||4|||||||t|t|f||||||||2017-10-10 20:40:14.992097|2017-10-10 20:40:14.992097
NCT03301623|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-04|||October 9, 2017|Anticipated|2017-10-09|October 2017|2017-10-01|March 13, 2020|Anticipated|2020-03-13|September 1, 2019|Anticipated|2019-09-01||Interventional|||Voices in Pain Care|Integrating the Patient Voice Into Comparative Effectiveness Trial of Communication Strategies in the Management of Chronic Pain|Not yet recruiting||N/A|1000|Anticipated|Cedars-Sinai Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:40:15.103846|2017-10-10 20:40:15.103846
NCT03301610|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-03|||October 23, 2017|Anticipated|2017-10-23|October 2017|2017-10-01|May 1, 2018|Anticipated|2018-05-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Mobile Educations Effect on Pain Outcomes|The Impact of Mobile Education Delivery on Postoperative Pain Outcomes|Not yet recruiting||N/A|128|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 20:40:15.199813|2017-10-10 20:40:15.199813
NCT03301597|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-03|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|LAUNCH||NLA101 in Adults Receiving High Dose Chemotherapy for AML|A Phase 2 Open-Label, Multi-Center, Randomized, Controlled, Dose-Finding Study of NLA101 in Adults Receiving High Dose Chemotherapy for Acute Myeloid Leukemia|Not yet recruiting||Phase 2|220|Anticipated|Nohla Therapeutics, Inc.||4|||f||||t|t|f||||||||2017-10-10 20:40:15.282314|2017-10-10 20:40:15.282314
NCT03301584|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-03|||September 1, 2013|Actual|2013-09-01|October 2017|2017-10-01|June 30, 2014|Actual|2014-06-30|June 30, 2014|Actual|2014-06-30||Interventional|||Early Coordinated Rehabilitation After Hip Fracture|Early Coordinated Rehabilitation in Acute Phase After Hip Fracture - a Model for Increased Patient Participation.|Completed||N/A|126|Actual|Göteborg University||2|||f||||f|f|f||||||||2017-10-10 20:40:15.365209|2017-10-10 20:40:15.365209
NCT03301571|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-28|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 3, 2018|Anticipated|2018-01-03||Interventional|ReVERSE||Right Ventricular Echocardiography in caRdiac SurgEry|Response in Right Ventricular Function to Change in Afterload, Preload and Inspired Oxygen in Patients Undergoing Coronary Artery Bypass Graft Surgery|Recruiting||N/A|30|Anticipated|Rigshospitalet, Denmark||1|||f||||f|f|f||||||||2017-10-10 20:40:15.485231|2017-10-10 20:40:15.485231
NCT03301558|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-03|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients|The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients|Not yet recruiting||Phase 2|53|Anticipated|Elisabethinen Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:15.605461|2017-10-10 20:40:15.605461
NCT03301545|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||The Metabolic Impact of Bariatric Surgery Compared to Best Diabetic Care on Manitoba's Urban Indigenous Population|The Metabolic Impact of Bariatric Surgery Compared to Best Diabetic Care on Manitoba's Urban Indigenous Population|Not yet recruiting||N/A|90|Anticipated|University of Manitoba||3|||f||||f|f|f||||||||2017-10-10 20:40:15.695982|2017-10-10 20:40:15.695982
NCT03301532|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2022|Anticipated|2022-11-01|November 1, 2022|Anticipated|2022-11-01||Interventional|||Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D|Compatibility of Triheptanoin (C7) With the Ketogenic Diet in Patients Diagnosed With Glucose Transporter Type 1 Deficiency|Not yet recruiting||Early Phase 1|15|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t|t|f||||||||2017-10-10 20:40:15.776806|2017-10-10 20:40:15.776806
NCT03301519|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-28|||July 1, 2001|Actual|2001-07-01|September 2017|2017-09-01|May 31, 2013|Actual|2013-05-31|May 31, 2013|Actual|2013-05-31||Observational|||Genetics of Beta Cell Failure in Mexican Americans|Genetics of Beta Cell Failure in Mexican Americans|Completed||N/A|1250|Actual|University of Southern California|||1||f||||f|f|f||||Samples With DNA|"     DNA, plasma samples from oral glucose tolerance test, plasma samples from intravenous glucose     tolerance test   "|||2017-10-10 20:40:15.856698|2017-10-10 20:40:15.856698
NCT03301506|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|March 2022|Anticipated|2022-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)|An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)|Not yet recruiting||Phase 2/Phase 3|356|Anticipated|CymaBay Therapeutics, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:40:16.208241|2017-10-10 20:40:16.208241
NCT03301493|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-03|||March 30, 2017|Actual|2017-03-30|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|1 Year|Observational [Patient Registry]|||Genomic Testing and Resulting Medical Decisions|The Use of Genomic Testing and the Resulting Medical Decisions According to Target Identification|Recruiting||N/A|500|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie|||1||f||||f|f|f||||||||2017-10-10 20:40:16.298421|2017-10-10 20:40:16.298421
NCT03301480|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-28|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|CHARA||Contraceptive/HIV Affecting Risk in Adolescents|Contraceptive/HIV Affecting Risk in Adolescents|Recruiting||N/A|210|Anticipated|University of Pittsburgh|||6||f||||f|f|f||||||||2017-10-10 20:40:16.391827|2017-10-10 20:40:16.391827
NCT03127527|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-24|||July 2012||2012-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:16.304567|2017-10-10 21:08:16.304567
NCT03301454|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|September 2021|Anticipated|2021-09-01|February 2020|Anticipated|2020-02-01||Interventional|E-DIS2||Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer|Phase II Randomized Study Measuring the Interest of Pursuing or Not the CT for Non-progressive Patients With Metastatic Esophageal Squamous-cell Cancer After 6 Weeks of LV5FU2-paclitaxel Given After a 1st Line Fluoropyrimidine/Pt Salt CT|Not yet recruiting||Phase 2|80|Anticipated|Centre Oscar Lambret||2|||f|||||f|f||||||||2017-10-10 20:40:16.567095|2017-10-10 20:40:16.567095
NCT03301441|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|SAMCO-MIG||Sensitivity to Acute Cerebral Ischemia in Migrainers|Sensitivity to Acute Middle Cerebral or Intracranial Carotid Artery Occlusion in MIGrainers - SAMCO-MIG|Not yet recruiting||N/A|600|Anticipated|University Hospital, Montpellier|||2||f||||f|f|f||||||||2017-10-10 20:40:16.704375|2017-10-10 20:40:16.704375
NCT03301428|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-28|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Educational Tools to Improve Beliefs About Pain and Reduce Pain-related Disability|Effectiveness of Different Educational Tools to Improve Beliefs About Pain and Reduce Pain-related Disability in Patients With Chronic Low Back Pain: a Randomized Controlled Trial|Not yet recruiting||N/A|300|Anticipated|University Hospital of Liege||3|||f||||f|f|f||||||||2017-10-10 20:40:16.784505|2017-10-10 20:40:16.784505
NCT03301415|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||December 1, 2017|Anticipated|2017-12-01|September 19, 2017|2017-09-19|December 1, 2023|Anticipated|2023-12-01|July 1, 2023|Anticipated|2023-07-01||Interventional|||Asymptomatic Congenital CMV Treatment|A Phase II, Single Stage, Single-Arm Investigation of Oral Valganciclovir Therapy in Infants With Asymptomatic Congenital Cytomegalovirus Infection|Not yet recruiting||Phase 2|229|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f|||||t|f|||f|||||2017-10-10 20:40:16.862157|2017-10-10 20:40:16.862157
NCT03301402|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-03|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Air Purifier to Improve Endothelial Function and Carotid Intima Thickness|A Randomized Controlled Trial of Air Purifier to Improve Endothelial Function and Carotid Intima Thickness in Older Diabetic People With Cognitive Impairment|Recruiting||N/A|140|Anticipated|Chinese University of Hong Kong||2|||f|||||f|f||||||||2017-10-10 20:40:16.946691|2017-10-10 20:40:16.946691
NCT03301376|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-04|||December 20, 2017|Anticipated|2017-12-20|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 20, 2018|Anticipated|2018-12-20||Observational|INTHEMO||Occupational Integration of Adults With Severe Haemophilia in France: a Study Based on the FranceCoag Cohort|INTHEMO: Occupational Integration of Adults With Severe Haemophilia in France: a Study Based on the FranceCoag Cohort|Not yet recruiting||N/A|1050|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f|f|f||||||||2017-10-10 20:40:17.180394|2017-10-10 20:40:17.180394
NCT03301363|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-04|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|SCOPE-CRT||Simultaneous or Sequential Multipoint Pacing|Simultaneous Or Sequential multiPoint Pacing in Cardiac Resynchronization Therapy|Not yet recruiting||N/A|50|Anticipated|IRCCS Policlinico S. Donato|||1||f||||t|f|f||||||||2017-10-10 20:40:17.258391|2017-10-10 20:40:17.258391
NCT03301350|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-03|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer|A Phase II Study of Neoadjuvant Carboplatin/Paclitaxel Followed by Dose-Dense Doxorubicin/Cyclophosphamide in Patients With Hormone Receptor Negative, HER2 Receptor Negative Breast Cancer|Not yet recruiting||Phase 2|50|Anticipated|University of Wisconsin, Madison||1|||f||||t|t|f|||t|||||2017-10-10 20:40:17.320969|2017-10-10 20:40:17.320969
NCT03301324|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-02|||September 12, 2017|Actual|2017-09-12|October 2017|2017-10-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|||Intubation Assist Clinical Study|Intubation Assist Clinical Study|Recruiting||N/A|66|Anticipated|Zoll Medical Corporation|||1||f||||f|f|t|f|f|t|||||2017-10-10 20:40:17.525247|2017-10-10 20:40:17.525247
NCT03301311|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|December 2, 2019|Anticipated|2019-12-02|December 2, 2019|Anticipated|2019-12-02||Interventional|PRODUCE||Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease|Using Single Subject (N-of-1) Designs to Answer Patient-Identified Research Questions--Aim 1: Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease|Not yet recruiting||N/A|120|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t|f|f||||||||2017-10-10 20:40:17.606826|2017-10-10 20:40:17.606826
NCT03301298|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Food Effect of SXC-2023 When Administered Orally to Healthy Adult Subjects|Recruiting||Phase 1|40|Anticipated|Promentis Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:40:17.737594|2017-10-10 20:40:17.737594
NCT03301285|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-28|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|ZOMETA||Efficacy of Zoledronic Acid in Osteoporosis of Children With Multiple Disabilities|Study of Efficacy of Zoledronic Acid in the Management of Osteoporosis in Children With Multiple Disabilities|Completed||N/A|60|Actual|Central Hospital, Nancy, France|||1||f||||f|f|f||||||||2017-10-10 20:40:17.830367|2017-10-10 20:40:17.830367
NCT03301259|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-28|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|August 15, 2018|Anticipated|2018-08-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Postoperative Pain Following Treatment of Asymptomatic Necrotic Mandibular Molars in Single Visit Using Wave-one Reciprocating Instruments Versus One-Shape Rotary Instruments|Evaluation of the Post Treatment Pain After Instrumentation of Root Canals With a Single File Reciprocating (Wave-One Ni Ti File, DENTSPLY Maillefer) or Rotary(One Shape, Micro Mega, France) File System in Patient With Asymptomatic Necrotic Molars|Not yet recruiting||N/A|42|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:40:18.048565|2017-10-10 20:40:18.048565
NCT03301246|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|May 20, 2018|Anticipated|2018-05-20|April 20, 2018|Anticipated|2018-04-20||Interventional|||Artimes Pro Low Profile Dilatation Catheters for Pre-Dilatation in Patients With Symptomatic Ischemic Heart Disease|Artimes Pro Low Profile 1.00mm and 1.25mm Dilatation Catheters for Pre-Dilatation of Stenosis and Occlusion in Patients With Symptomatic Ischemic Heart Disease|Not yet recruiting||N/A|60|Anticipated|Eminence Clinical Research, Inc.||1|||f||||t|f|t|t|f||||||2017-10-10 20:40:18.136076|2017-10-10 20:40:18.136076
NCT03301233|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women|The Effect of Estradiol Valerate With and Without Oral Sildenafil on Endometrial Thickness and Pregnancy Rates in Infertile Women: A R.C.T|Not yet recruiting||N/A|90|Anticipated|Ain Shams University||2|||f|||||f|f|||f|||||2017-10-10 20:40:18.218129|2017-10-10 20:40:18.218129
NCT03301220|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||November 8, 2017|Anticipated|2017-11-08|September 2017|2017-09-01|December 22, 2025|Anticipated|2025-12-22|December 16, 2021|Anticipated|2021-12-16||Interventional|||A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma|A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects With High-Risk Smoldering Multiple Myeloma|Not yet recruiting||Phase 3|360|Anticipated|Janssen Research & Development, LLC||2|||f||||t|t|f||||||||2017-10-10 20:40:18.338784|2017-10-10 20:40:18.338784
NCT03301207|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|January 20, 2019|Anticipated|2019-01-20|January 20, 2019|Anticipated|2019-01-20||Interventional|||A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy|A Drug-Drug Interaction Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Subjects With B Cell Malignancy|Not yet recruiting||Phase 1|18|Anticipated|Janssen Research & Development, LLC||1|||f||||f|t|f|||t|||||2017-10-10 20:40:18.687941|2017-10-10 20:40:18.687941
NCT03301194|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||April 1, 2016|Actual|2016-04-01|October 2017|2017-10-01|June 30, 2018|Anticipated|2018-06-30|December 2017|Anticipated|2017-12-01||Observational|||Cost-effectiveness of RAMP-HT for Patients With Uncontrolled Hypertension in Hong Kong|In-depth Study of the Cost-effectiveness of the Risk Assessment and Management Programme for Hypertension (RAMP-HT) for Patients With Uncontrolled Hypertension in Primary Care in Hong Kong|Recruiting||N/A|17362|Anticipated|The University of Hong Kong|||2||f|||||f|f||||||||2017-10-10 20:40:18.807077|2017-10-10 20:40:18.807077
NCT03301181|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-03|||September 18, 2017|Actual|2017-09-18|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects|A Phase 1, Open-label, Parallel-group, Fixed-sequence Study to Investigate the Effect of the CYP3A Inducer Rifampin and the CYP3A Inhibitor Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects|Recruiting||Phase 1|40|Anticipated|BeiGene||2|||||||f|t|f||||||||2017-10-10 20:40:18.894828|2017-10-10 20:40:18.894828
NCT03301168|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-03|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety Study of Gene Modified Donor T-cells Following TCR + Alpha Beta Depleted Stem Cell Transplant|Phase II Extension Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR αβ+T Cells in Pediatric Patients Affected by Hematological Disorders|Recruiting||Phase 1/Phase 2|175|Anticipated|Bellicum Pharmaceuticals||1|||f||||f|t|f|||t|||||2017-10-10 20:40:18.976776|2017-10-10 20:40:18.976776
NCT03301155|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-10-03|||October 3, 2017|Actual|2017-10-03|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other Acute Respiratory Viral Infections in Children During the Peaks of Seasonal Morbidity|International Multicenter Double-bind Placebo-controlled Randomized Parallel-group Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other Acute Respiratory Viral Infections in Children During the Peaks of Seasonal Morbidity|Recruiting||Phase 4|710|Anticipated|Materia Medica Holding||2|||f|||||f|f||||||||2017-10-10 20:40:19.071186|2017-10-10 20:40:19.071186
NCT03301142|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-27|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Study Comparing the Use of Laser and of Kinesiotherapy for the Treatment of Female Stress Urinary Incontinence|Randomized Trial Comparing the Use of Laser and of Kinesiotherapy for the Treatment of Female Stress Urinary Incontinence - a Pilot Study|Recruiting||N/A|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 20:40:19.403416|2017-10-10 20:40:19.403416
NCT03301129|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-23|2017-10-03|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|December 30, 2018|Anticipated|2018-12-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Role of Traditional Cigarettes, Electronic and IQOS Cigarettes on Oxidative Stress.|Effects on Oxidative Stress and Platelet Activation of Traditional Cigarettes, E-cigarettes and IQOS Cigarettes: A Randomized in Vivo Study.|Not yet recruiting||N/A|20|Anticipated|University of Roma La Sapienza||3|||f||||t|f|f||||||||2017-10-10 20:40:19.509441|2017-10-10 20:40:19.509441
NCT03301116|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-03|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|April 30, 2021|Anticipated|2021-04-30|May 31, 2020|Anticipated|2020-05-31||Interventional|||Promoting Seniors' Health With Home Care Aides|Promoting Seniors' Health With Home Care Aides: A Randomized Controlled Trial|Recruiting||Phase 2|300|Anticipated|University of Illinois at Chicago||2|||f||||t|f|f||||||||2017-10-10 20:40:19.57579|2017-10-10 20:40:19.57579
NCT03300908|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||July 5, 2016|Actual|2016-07-05|September 2017|2017-09-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|||Contextualizing & Responding to HIV Risk Behaviors|Contextualizing & Responding to HIV Risk Behaviors Among Black Drug Offenders|Completed||N/A|32|Actual|Columbia University||2|||f||||f|f|f||||||||2017-10-10 20:40:21.548966|2017-10-10 20:40:21.548966
NCT03301090|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||October 26, 2017|Anticipated|2017-10-26|September 22, 2017|2017-09-22|February 28, 2018|Anticipated|2018-02-28|December 30, 2017|Anticipated|2017-12-30||Interventional|||A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051|A Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051 vs. Placebo in Healthy Adults|Not yet recruiting||Phase 1|48|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f|||||t|f|||f|||||2017-10-10 20:40:19.766295|2017-10-10 20:40:19.766295
NCT03301077|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-09-28|||January 2013||2013-01-01|September 2017|2017-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|MHAT||Mental Health in Austrian Teenagers (MHAT)|The Mental Health in Austrian Teenagers (MHAT) - Study: First Epidemiological Survey|Completed||N/A|4000|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 20:40:19.896012|2017-10-10 20:40:19.896012
NCT03301064|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||November 15, 2017|Anticipated|2017-11-15|October 2017|2017-10-01|November 30, 2020|Anticipated|2020-11-30|November 30, 2020|Anticipated|2020-11-30||Interventional|||Brief Intervention by Community Health Workers for Unhealthy Drinking in Latinos|Brief Intervention by Community Health Workers for Unhealthy Drinking in Latinos|Not yet recruiting||N/A|260|Anticipated|University of California, Los Angeles||2|||f||||f|f|f||||||||2017-10-10 20:40:19.968567|2017-10-10 20:40:19.968567
NCT03301051|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-28|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Adults|A Randomized, Observer-blind, Placebo-controlled, Multicenter, Phase 3 Study to Assess the Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Adults 18-64 Years of Age|Recruiting||Phase 3|10000|Anticipated|Medicago||2|||f||||f|t|f||||||||2017-10-10 20:40:20.258928|2017-10-10 20:40:20.258928
NCT03301025|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-03|||August 8, 2017|Actual|2017-08-08|October 2017|2017-10-01|November 15, 2017|Anticipated|2017-11-15|November 1, 2017|Anticipated|2017-11-01||Interventional|||Pregabalin Effects on Hypotensive Anesthesia During Spine Surgery.|Pregabalin Effects on Hypotensive Anesthesia During Spine Surgery.|Recruiting||N/A|106|Anticipated|Mansoura University||2|||f||||t|f|f||||||||2017-10-10 20:40:20.673374|2017-10-10 20:40:20.673374
NCT03301012|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-29|||January 5, 2018|Anticipated|2018-01-05|September 2017|2017-09-01|May 31, 2022|Anticipated|2022-05-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Smartphone Addiction Recovery Coach for Adolescents (SARC-A) Experiment|Smartphone Addiction Recovery Coach for Adolescents (SARC-A) Experiment|Not yet recruiting||N/A|300|Anticipated|Chestnut Health Systems||2|||f||||t|f|f||||||||2017-10-10 20:40:20.80069|2017-10-10 20:40:20.80069
NCT03300999|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effects of Daily Ginger Tea Consumption in Reducing Discomfort During Menstruation|The Effects of Daily Ginger Tea Consumption in Reducing Discomfort During Menstruation|Not yet recruiting||N/A|50|Anticipated|Loma Linda University||2|||f||||f|f|f||||||||2017-10-10 20:40:20.906843|2017-10-10 20:40:20.906843
NCT03300986|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-28|||April 1, 2016|Actual|2016-04-01|September 2017|2017-09-01|May 2, 2017|Actual|2017-05-02|March 2017|Actual|2017-03-01||Observational|||Parameter Changes in Functional Electrical Stimulation||Completed||N/A|10|Anticipated|The Leeds Teaching Hospitals NHS Trust|||1||f||||f||||||||||2017-10-10 20:40:20.977108|2017-10-10 20:40:20.977108
NCT03300973|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-28|||January 15, 2016|Actual|2016-01-15|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Urodynamic Study and Stress Incontinence|Role of Urodynamic Study Before Surgery for Stress Urinary Incontinence.|Recruiting||Phase 2|125|Anticipated|Kasr El Aini Hospital||2|||f|||||f|f||||||||2017-10-10 20:40:21.031137|2017-10-10 20:40:21.031137
NCT03300960|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation|Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors.|Not yet recruiting||Phase 3|318|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||t|f|f||||||||2017-10-10 20:40:21.113097|2017-10-10 20:40:21.113097
NCT03300947|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-02|||January 2018|Anticipated|2018-01-01|October 2017|2017-10-01|July 2021|Anticipated|2021-07-01|December 2020|Anticipated|2020-12-01||Interventional|PSILOCD||Psilocybin for Treatment of Obsessive Compulsive Disorder|Psilocybin for Treatment of Obsessive Compulsive Disorder|Not yet recruiting||Phase 2|15|Anticipated|University of Arizona||3|||f||||t|t|f||||||||2017-10-10 20:40:21.190315|2017-10-10 20:40:21.190315
NCT03300934|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|July 1, 2018|Anticipated|2018-07-01||Interventional|SPIDIMAN2||Adolescence and Diabetes:Can an Automated Closed Loop System Improve Control ?|Adolescence and Diabetes: Can an Automated Closed Loop System Improve Control ?|Recruiting||N/A|14|Anticipated|Centre Hospitalier du Luxembourg||2|||f||||f|f|f||||||||2017-10-10 20:40:21.32204|2017-10-10 20:40:21.32204
NCT03300921|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|May 28, 2019|Anticipated|2019-05-28|March 28, 2019|Anticipated|2019-03-28||Interventional|||Version: V1.1 8/15/2017 A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer|A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer|Recruiting||Phase 1|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t|f|f||||||||2017-10-10 20:40:21.450066|2017-10-10 20:40:21.450066
NCT03300895|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|December 10, 2018|Anticipated|2018-12-10|December 10, 2018|Anticipated|2018-12-10||Interventional|||High-intensity Interval Training on Cardiorespiratory Fitness in Overweight Women|Effect of Low-volume High-intensity Interval Training on Cardiorespiratory Fitness and Total Body Fat in Overweight Women|Recruiting||N/A|36|Anticipated|Universidad de Antioquia||2|||f||||f|f|f||||||||2017-10-10 20:40:21.653642|2017-10-10 20:40:21.653642
NCT03300882|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|PREDICT CMV||PREDICT Cytomegalovirus (CMV)|Prospective Multicenter Cytomegalovirus (CMV) Specific Immune Monitoring to Predict Patient Risk After Lung Transplantation (CTOT-22)|Not yet recruiting||N/A|71|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t|f|f||||Samples With DNA|"     Peripheral blood mononuclear cells (PBMCs) and plasma.   "|||2017-10-10 20:40:21.757817|2017-10-10 20:40:21.757817
NCT03300869|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-02|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Natural History of Types 2 and 3 SMA in Taiwan|Natural History of Types 2 and 3 Spinal Muscular Atrophy in Taiwan|Not yet recruiting||N/A|300|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f|f|f||||||||2017-10-10 20:40:21.898407|2017-10-10 20:40:21.898407
NCT03300804|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-28|2017-10-02|||May 2008||2008-05-01|October 2017|2017-10-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|TCM-IBS||Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)|Dose Escalation Trial Of Traditional Chinese Medicine For Irritable Bowel Syndrome|Completed||Phase 2|104|Actual|University of Maryland||2|||f||||t||||||||||2017-10-10 20:40:22.428349|2017-10-10 20:40:22.428349
NCT03300791|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-02|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|November 1, 2017|Anticipated|2017-11-01||Observational|REIC||Predictive Models of Readmission in Heart Failure|Predictive Models of Readmission in Heart Failure: Profile of Readmitted Patients|Recruiting||N/A|1250|Anticipated|Hospital Galdakao-Usansolo|||1||f||||f|f|f||||||||2017-10-10 20:40:22.532787|2017-10-10 20:40:22.532787
NCT03300778|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|January 15, 2018|Anticipated|2018-01-15|January 9, 2018|Anticipated|2018-01-09||Interventional|||A Study of Aerobic Exercise for Adolescents With Subthreshold Mood Syndromes|A Clustered Randomised Controlled Trial of Aerobic Exercise for Adolescents With Subthreshold Depressive and/or Hypomanic Syndrome and for Non-clinical Adolescents|Not yet recruiting||N/A|224|Anticipated|Guangzhou Psychiatric Hospital||2|||f||||t|f|f||||||||2017-10-10 20:40:22.637563|2017-10-10 20:40:22.637563
NCT03300765|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|May 1, 2020|Anticipated|2020-05-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer|Intensity Modulated Radiation Therapy Combined With Apatinib for Inoperable or Iodine Refractory Thyroid Cancer: A Phase II Single-arm Study|Recruiting||Phase 2|20|Anticipated|Fudan University||1|||f|||||f|f||||||||2017-10-10 20:40:22.718125|2017-10-10 20:40:22.718125
NCT03300752|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-29|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Validation of the BREATHE Asthma Intervention Trial|Self-care Decision-making: Feasibility of the BREATHE Asthma Intervention Trial - Phase II (Part 2 - a Pilot Randomized Trial Phase)|Recruiting||N/A|93|Anticipated|Columbia University||2|||f||||t|f|f||||||||2017-10-10 20:40:22.802207|2017-10-10 20:40:22.802207
NCT03300739|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-28|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|||Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients|Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients|Recruiting||N/A|20|Anticipated|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-10 20:40:22.880704|2017-10-10 20:40:22.880704
NCT03300726|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-28|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Synaptic Injury and Functional Connectivity in Alzheimer's Disease|Cerebrospinal Fluid Markers of Synaptic Injury and Functional Connectivity in Alzheimer's Disease|Recruiting||N/A|30|Anticipated|Ohio State University|||2||f||||t|f|f||||Samples With DNA|"     Cerebrospinal fluid (CSF) and plasma   "|||2017-10-10 20:40:22.953835|2017-10-10 20:40:22.953835
NCT03300713|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|MOCITRAINING||MOther-Child Interaction Assessment TRAINING for Pediatricians|MOther-Child Interaction Assessment TRAINING for Pediatricians|Not yet recruiting||N/A|3504|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||||2017-10-10 20:40:23.03705|2017-10-10 20:40:23.03705
NCT03300700|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-28|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 1, 2020|Anticipated|2020-03-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Cardiopulmonary Exercise Test in Patient With Obstructive Sleep Apnea|Cardiopulmonary Exercise Test in Patient With Obstructive Sleep Apnea|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:40:23.104545|2017-10-10 20:40:23.104545
NCT03300687|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-28|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation|First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation|Recruiting||Early Phase 1|12|Anticipated|Frequency Therapeutics||2|||f|||||f|f||||||||2017-10-10 20:40:23.167818|2017-10-10 20:40:23.167818
NCT03300674|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Intravenous Lidocaine Randomized Comparative Effectiveness Trial|Intravenous Lidocaine Versus Hydromorphone for Acute Abdominal Pain. A Randomized Trial|Not yet recruiting||Phase 4|154|Anticipated|Montefiore Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 20:40:23.247933|2017-10-10 20:40:23.247933
NCT03300661|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||June 13, 2017|Actual|2017-06-13|September 2017|2017-09-01|December 13, 2018|Anticipated|2018-12-13|December 13, 2017|Anticipated|2017-12-13||Interventional|SEELN||Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine|Open-label, Non-Pharmacological, Intervention Cohort Study Without Control Arm, in Patients With Non Alcoholic Fatty Liver Disease and in Healthy Subjects.|Recruiting||N/A|100|Anticipated|Università degli Studi di Brescia||1|||f||||f|f|f||||||||2017-10-10 20:40:23.31388|2017-10-10 20:40:23.31388
NCT03300648|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||January 8, 2018|Anticipated|2018-01-08|September 2017|2017-09-01|November 30, 2023|Anticipated|2023-11-30|November 30, 2023|Anticipated|2023-11-30||Interventional|TBS||Treating Brain Swelling in Pediatric Cerebral Malaria|Treating Brain Swelling in Pediatric Cerebral Malaria|Not yet recruiting||Phase 3|261|Anticipated|Michigan State University||3|||f||||t|f|f||||||||2017-10-10 20:40:23.394156|2017-10-10 20:40:23.394156
NCT03300635|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-10-02|||September 5, 2015|Actual|2015-09-05|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Metabolism, Muscle Function and Psychological Factors in Fibromyalgia|Metaboliset Muutokset ja Lihastoiminta Fibromyalgiassa|Recruiting||N/A|60|Anticipated|Helsinki University Central Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:23.481609|2017-10-10 20:40:23.481609
NCT03300622|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-27|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Assessment in Patients After Thoracic Surgery|Evaluation of Hospitalized Patients After Thoracic Pulmonary Resection Surgery|Recruiting||N/A|40|Anticipated|Universidad de Granada|||1||f||||f|f|f||||||||2017-10-10 20:40:23.579533|2017-10-10 20:40:23.579533
NCT03300609|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|October 9, 2022|Anticipated|2022-10-09|October 9, 2021|Anticipated|2021-10-09||Interventional|||5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab|Randomized Phase III Trial of 5-FU Based Maintenance Therapy With or Without Panitumumab in Patients With RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX + Panitumumab|Not yet recruiting||Phase 3|450|Anticipated|University of Southern California||2|||f||||t|t|f|||t|||||2017-10-10 20:40:23.841716|2017-10-10 20:40:23.841716
NCT03300596|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|October 30, 2019|Anticipated|2019-10-30||Interventional|||Brief New Treatment for Suicide Attempts|Suicidal Adults With Alcohol or Drug Use Problems: A New Hospital-based Treatment|Not yet recruiting||N/A|40|Anticipated|University of Rochester||2|||f||||t|f|f||||||||2017-10-10 20:40:24.008899|2017-10-10 20:40:24.008899
NCT03300583|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 29, 2017|Anticipated|2017-10-29||Observational|||Toward Self-management in ILD|Toward a Model of Self-management; Identifying Gaps and Needs in Services for Patients With Interstitial Lung Disease|Not yet recruiting||N/A|30|Anticipated|Kingston University|||3||f||||f|f|f||||||||2017-10-10 20:40:24.086418|2017-10-10 20:40:24.086418
NCT03300505|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Interventional|||ARRx Followed by Pembrolizumab in Metastatic Castration Resistant Prostate Cancer|ARRO-CITO: Phase II Single-Arm Multi-Center Study of ARRx, the Androgen Receptor Antisense Oligonucleotide Followed by Pembrolizumab Immunotherapy in Metastatic Castration Resistant Prostate Cancer|Not yet recruiting||Phase 2|38|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:40:24.744637|2017-10-10 20:40:24.744637
NCT03300492|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-10-02|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS|A Phase I/II Single Center Study to Assess the Safety, Tolerability and Feasibility of Pre-emptive Immunotherapy With in Vitro Expanded Natural Killer Cells in Patients Treated With Haplo-HSCT for Myeloid Leukemia|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|University Hospital, Basel, Switzerland||1|||f||||f|f|f||||||||2017-10-10 20:40:24.825747|2017-10-10 20:40:24.825747
NCT03300479|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-10-02|||June 15, 2017|Actual|2017-06-15|October 2017|2017-10-01|September 30, 2019|Anticipated|2019-09-30|June 14, 2019|Anticipated|2019-06-14||Interventional|Clevidipine||Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®)|Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) for Blood Pressure Reduction in Patients With Primary Intracerebral Hemorrhage: A Randomized Controlled Trial|Recruiting||Phase 4|120|Anticipated|University of Zurich||2|||f||||f|f|f||||||||2017-10-10 20:40:24.935359|2017-10-10 20:40:24.935359
NCT03300453|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-10-02|||September 2013||2013-09-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome|Protocol AMT110-CD-001: A Phase I/II, Open-label, Study of Intracerebral Administration of Adeno-associated Viral Vector Containing the Human Alpha-N-acetylglucosaminidase cDNA in Children With Sanfilippo Type B Syndrome|Active, not recruiting||Phase 1/Phase 2|4|Actual|UniQure Biopharma B.V.||1|||f||||t||||||||||2017-10-10 20:40:25.155284|2017-10-10 20:40:25.155284
NCT03300440|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-04|||June 21, 2017|Actual|2017-06-21|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||PROVIT The Influence of Probiotics on Body and Mind in Individuals With Psychiatric Disorders|The Influence of Probiotics on Body and Mind in Individuals With Psychiatric Disorders - a Clinical Study|Recruiting||N/A|80|Anticipated|Medical University of Graz||2|||f|||||f|f||||||||2017-10-10 20:40:25.250441|2017-10-10 20:40:25.250441
NCT03300427|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-03|||January 31, 2018|Anticipated|2018-01-31|October 2017|2017-10-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|TurkuPET||The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients|Controlled Trial on the Short-term Effects of Sacubitril/Valsartan Therapy on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Patients With NYHA II-III Heart Failure and Reduced Systolic Function Using 11C-acetate Positron Emission Tomography and Echocardiography|Not yet recruiting||Phase 4|60|Anticipated|Novartis||2|||f||||f|f|f||||||||2017-10-10 20:40:25.360477|2017-10-10 20:40:25.360477
NCT03300414|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-03|||March 20, 2017|Actual|2017-03-20|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|March 19, 2018|Anticipated|2018-03-19||Observational|||Biologic Basis of Liver Cancer From Chronic Hepatitis B|Biologic Basis of Liver Cancer From Chronic Hepatitis B|Recruiting||N/A|10|Anticipated|University of California, Davis|||2||f||||f|f|f||||Samples With DNA|"     Approximately 30mL (2 tablespoons) of venous blood may be collected. A second blood draw may     occur if the first is inadequate in quantity or quality. However, the second blood draw will     not occur until eight (8) weeks following the first blood draw. In other words, no more than     50mL of venous blood may be collected in a period of eight (8) weeks. Blood samples will be     labeled with the patient assigned ID by the study coordinator before distributing to UC Davis     Cancer Center's Shared Genome Resource Center for DNA and/or RNA isolation.   "|||2017-10-10 20:40:25.453087|2017-10-10 20:40:25.453087
NCT03300401|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||October 9, 2017|Anticipated|2017-10-09|October 2017|2017-10-01|October 9, 2020|Anticipated|2020-10-09|October 9, 2019|Anticipated|2019-10-09||Interventional|||Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization|The Role of Quantitative Contrast-Enhanced Ultrasound in Yttrium-90 (90Y) Radioembolization of Hepatocellular Carcinoma|Not yet recruiting||N/A|19|Anticipated|University of Southern California||1|||f||||t|f|t|f||t|||||2017-10-10 20:40:25.552733|2017-10-10 20:40:25.552733
NCT03300388|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-10-02|||August 21, 2017|Actual|2017-08-21|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|OBELEX||Obesity, Inflammation and Aging: Effects of Physical Exercise and Omega-3 Fatty Acids.|Dysfunction of Adipose Tissue in Obesity, Inflammation and Aging: Mechanisms and Effects of Physical Exercise and Omega-3 Fatty Acids.|Recruiting||N/A|80|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||4|||f||||f|f|f||||||||2017-10-10 20:40:25.683789|2017-10-10 20:40:25.683789
NCT03300375|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Exercise Intervention for Unilateral Amputees With Low Back Pain|Exercise Intervention for Unilateral Amputees With Low Back Pain|Recruiting||N/A|40|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 20:40:25.939467|2017-10-10 20:40:25.939467
NCT03243266|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-04|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|||DxH520 Pediatric Reference Interval Verification|DxH520 Pediatric Reference Interval Verification|Recruiting||N/A|80|Anticipated|Beckman Coulter, Inc.|||1||f||||||||||||||2017-10-10 20:48:43.988296|2017-10-10 20:48:43.988296
NCT03300362|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|INVICTUS||Improved Novel VaccIne CombinaTion InflUenza Study|A Phase IIb Study to Determine the Safety and Efficacy of Candidate INfluenza Vaccine MVA-NP+M1 in Combination With Licensed InaCTivated inflUenza Vaccine in adultS Aged 65 Years and Above|Not yet recruiting||Phase 2|2030|Anticipated|Vaccitech Limited||2|||f||||t|f|f||||||||2017-10-10 20:40:26.026298|2017-10-10 20:40:26.026298
NCT03300349|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-05|||September 27, 2017|Actual|2017-09-27|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.|Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.|Recruiting||N/A|276|Anticipated|Hospital Universitario 12 de Octubre|||4||f||||f|f|f||||||||2017-10-10 20:40:26.121546|2017-10-10 20:40:26.121546
NCT03300336|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||October 5, 2017|Anticipated|2017-10-05|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|July 20, 2019|Anticipated|2019-07-20||Interventional|STRIDE||Optimizing Function and Independence Through STRIDE|Optimizing Function and Independence Through STRIDE|Not yet recruiting||N/A|2000|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 20:40:26.254509|2017-10-10 20:40:26.254509
NCT03300323|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Response to Varying the Rate of Administration of a Fluid Challenge|The Impact of Different Rates of Administration of a Fluid Challenge on the Proportion of Responders and Non-responders in the Post-operative Patient|Not yet recruiting||N/A|40|Anticipated|St George's Healthcare NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:40:26.352646|2017-10-10 20:40:26.352646
NCT03300310|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|IPIO-PA||Impact of the Nurse Visit on Observance of the Intake of Oral Carcinological Treatment in the Elderly|Impact of the Nurse Visit on Observance of the Intake of Oral Carcinological Treatment|Not yet recruiting||N/A|224|Anticipated|Nantes University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:26.441719|2017-10-10 20:40:26.441719
NCT03300297|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|||Cervical Spine Thrust Joint Manipulation for Temporomandibular Disorder|Thrust Joint Manipulation to the Cervical Spine in Participants With a Primary Complaint of Temporomandibular Disorder (TMD): A Randomized Clinical Trial|Not yet recruiting||N/A|42|Anticipated|Bradley University||2|||f||||f|f|f||||||||2017-10-10 20:40:26.535337|2017-10-10 20:40:26.535337
NCT03300284|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||August 7, 2017|Actual|2017-08-07|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer|Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer|Recruiting||N/A|120|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f|||||f|f||||||||2017-10-10 20:40:26.645353|2017-10-10 20:40:26.645353
NCT03300271|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of a Supportive Mobile Application for Life Style Modification on Blood Pressure and Insulin Resistance Improvement in People With Metabolic Syndrome|Effects of a Supportive Mobile Application for Life Style Modification on Blood Pressure and Insulin Resistance Improvement in People With Metabolic Syndrome|Not yet recruiting||N/A|150|Anticipated|Yonsei University||3|||f|||||f|f||||||||2017-10-10 20:40:26.740255|2017-10-10 20:40:26.740255
NCT03300258|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-27|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Robotic Pedaling Therapy for Targeted Neural Plasticity|Robotic Pedaling Therapy for Targeted Neural Plasticity|Not yet recruiting||N/A|100|Anticipated|University of Wisconsin, Madison||4|||f||||f|f|f|||f|||||2017-10-10 20:40:26.813754|2017-10-10 20:40:26.813754
NCT03300245|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|March 1, 2019|Anticipated|2019-03-01|January 1, 2019|Anticipated|2019-01-01||Observational|Nasalseptum||Nasal Septum Deviation May Affect Facial Morphologic Parameters.|The Relationship Between the Direction and Degree of Nasal Septal Deviation and Nasal Bone Morphology|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:40:26.89101|2017-10-10 20:40:26.89101
NCT03300232|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-27|||June 16, 2018|Anticipated|2018-06-16|September 2017|2017-09-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format|Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format|Not yet recruiting||N/A|135|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f|||||f|f||||||||2017-10-10 20:40:26.952979|2017-10-10 20:40:26.952979
NCT03300219|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-27|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Tele-rehabilitation Intervention for People Post Hip Fracture - Pilot Study|Effectiveness of a Tele-rehabilitation Intervention to Improve Performance and Reduce Morbidity for People Post Hip Fracture - Pilot Study|Recruiting||N/A|6|Anticipated|Herzog Hospital||1|||f||||f|f|f||||||||2017-10-10 20:40:27.006867|2017-10-10 20:40:27.006867
NCT03300206|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-04|||September 13, 2017|Actual|2017-09-13|October 2017|2017-10-01|April 13, 2018|Anticipated|2018-04-13|April 13, 2018|Anticipated|2018-04-13||Interventional|||A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System|A Prospective, Block Stratified Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System|Recruiting||N/A|525|Anticipated|Hologic, Inc.||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:40:27.07991|2017-10-10 20:40:27.07991
NCT03300193|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2017-09-27|||May 2016||2016-05-01|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|MRgFUS||The Effect of Lesion Characteristics in MRgFUS on Tremor in Essential Tremor and Parkinson's Disease|The Effect of Lesion Characteristics in Magnetic Resonance Guided Focused Ultrasound Surgery (MRgFUS) on Tremor in Essential Tremor and Parkinson's Disease|Completed||N/A|23|Actual|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-10 20:40:27.328397|2017-10-10 20:40:27.328397
NCT03300180|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-27|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|COADS||Caregiver Outcomes of Alzheimer's Disease Screening|Caregiver Outcomes of Alzheimer's Disease Screening|Not yet recruiting||N/A|4000|Anticipated|Indiana University||3|||f||||t|f|f||||||||2017-10-10 20:40:27.398324|2017-10-10 20:40:27.398324
NCT03300167|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-10-05|||March 5, 2018|Anticipated|2018-03-05|October 2017|2017-10-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|IN HEART||Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling|Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling|Not yet recruiting||N/A|18|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t|f|f|||f|||||2017-10-10 20:40:28.288172|2017-10-10 20:40:28.288172
NCT03300154|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||April 27, 2017|Actual|2017-04-27|September 2017|2017-09-01|October 23, 2017|Anticipated|2017-10-23|July 31, 2017|Actual|2017-07-31||Interventional|||Effectiveness of Financial Incentives and Text Messages to Improve Health Care in Population With Moderate and High Cardiovascular Risk|Effectiveness of Financial Incentives and Text Messages to Improve Health Care of Vulnerable Population With Moderate and High Cardiovascular Risk in Argentina: A Randomized Cluster Trial|Active, not recruiting||N/A|917|Actual|Institute for Clinical Effectiveness and Health Policy||3|||f||||f|f|f||||||||2017-10-10 20:40:28.381356|2017-10-10 20:40:28.381356
NCT03300141|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-04|||August 8, 2017|Actual|2017-08-08|October 2017|2017-10-01|November 8, 2021|Anticipated|2021-11-08|August 8, 2018|Anticipated|2018-08-08||Interventional|||Looking Glass: Bimanual Balanced Reaching With Visual Biofeedback|Bimanual Balanced Reaching With Visual Biofeedback|Recruiting||N/A|75|Anticipated|Shirley Ryan AbilityLab||5|||f||||f|f|f||||||||2017-10-10 20:40:28.489474|2017-10-10 20:40:28.489474
NCT03300128|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-02|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|IY-ASD||Incredible Years Program for Parents of Children With Autism|Evaluation of Incredible Years Parenting Program for Caregivers of Children With Autism|Recruiting||N/A|280|Anticipated|University of Maryland||2|||f||||f|f|f||||||||2017-10-10 20:40:28.603408|2017-10-10 20:40:28.603408
NCT03300102|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-27|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|Tumouroids||Acceptability and Feasibility Study of Patient-specific 'Tumouroids' as Personalised Treatment Screening Tools|A Single Site Study Accessing the Acceptability and Feasibility of Patient-specific 'Tumouroids' as Personalised Treatment Screening Tools|Not yet recruiting||N/A|25|Anticipated|University College, London|||1||f||||f|f|f||||||||2017-10-10 20:40:29.006914|2017-10-10 20:40:29.006914
NCT03300089|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||January 19, 2016|Actual|2016-01-19|September 2017|2017-09-01|July 20, 2017|Actual|2017-07-20|May 30, 2017|Actual|2017-05-30||Interventional|||Lumbar Spine Surgery: Regional vs. General Anaesthesia|Effect of Anaesthetic Techniques on Clinical Outcome After Lumbar Spine Surgery: Regional Versus General Anaesthesia. A Prospective Randomized Controlled Trial|Completed||N/A|100|Actual|St. Anna Clinic Luzern||2|||f||||t|f|f||||||||2017-10-10 20:40:29.155504|2017-10-10 20:40:29.155504
NCT03300076|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|COMPLETE||COMPLliancE and qualiTy of lifE in Asthma|Multicenter, Open-label, Non Interventional, Prospective, Observational Clinical Trial to Assess the Compliance and Quality of Life in Greek Asthmatic Patients|Not yet recruiting||N/A|800|Anticipated|Elpen Pharmaceutical Co. Inc.|||1||f||||f|f|f||||||||2017-10-10 20:40:29.244694|2017-10-10 20:40:29.244694
NCT03300063|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treating Sleep Apnea Induced Hypoxemia With Oxygen in Acute Stroke Patients|Effects of Treating Sleep Apnea-Induced Hypoxemia With Low-Flow Oxygen in Acute Stroke Patients: A Pilot Study|Recruiting||N/A|64|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 20:40:29.302538|2017-10-10 20:40:29.302538
NCT03300050|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||October 5, 2017|Anticipated|2017-10-05|September 2017|2017-09-01|March 5, 2019|Anticipated|2019-03-05|April 13, 2018|Anticipated|2018-04-13||Interventional|||Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine|A Phase 1, Randomized, Controlled, Observer-blind Study to Assess the Reactogenicity, Safety, and Immunogenicity of a Live Attenuated Universal Influenza Vaccine (cH8/1N1 LAIV) Administered as a Single Priming Dose Followed Three Months Later by a Single Booster Dose of an Inactivated Universal Influenza Vaccine (cH5/1N1 IIV) (Adjuvanted With AS03A or Unadjuvanted) in 18 Through 39 Year-old Healthy Subjects, Contrasted With a Two Dose Schedule of an Inactivated Universal Influenza Vaccine (cH8/1N1 IIV + AS03A Followed Three Months Later by cH5/1N1 IIV + AS03A)|Not yet recruiting||Phase 1|65|Anticipated|PATH||5|||f||||t|t|f||||||||2017-10-10 20:40:29.386916|2017-10-10 20:40:29.386916
NCT03300037|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-10-02|||September 1, 2014|Actual|2014-09-01|October 2017|2017-10-01|April 16, 2015|Actual|2015-04-16|April 16, 2015|Actual|2015-04-16||Observational|HYPNOS||HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor|HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor|Completed||N/A|46|Actual|LivaNova|||1||f|||||f|f||||||||2017-10-10 20:40:29.512416|2017-10-10 20:40:29.512416
NCT03300024|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-02|||February 1, 2015|Actual|2015-02-01|October 2017|2017-10-01|January 1, 2019|Anticipated|2019-01-01|October 26, 2018|Anticipated|2018-10-26||Interventional|||Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access|A Prospective Randomized Study of Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access|Recruiting||N/A|100|Anticipated|Johns Hopkins University||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:40:29.579145|2017-10-10 20:40:29.579145
NCT03300011|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||October 1, 2016|Actual|2016-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Ultrasonic Cardiogram Evaluate the Prognosis of Percutaneous Revascularization of Chronic Total Occlusions|Ultrasonic Cardiogram to Evaluate the Long-term Outcome and Prognosis of Coronary Artery Chronic Total Occlusions for Percutaneous Revascularization Versus Optimal Medical Treatment|Recruiting||N/A|200|Anticipated|Southeast University, China||3|||f||||t|f|f||||||||2017-10-10 20:40:29.677225|2017-10-10 20:40:29.677225
NCT03299998|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-02|||July 25, 2017|Actual|2017-07-25|October 2017|2017-10-01|August 10, 2017|Actual|2017-08-10|July 25, 2017|Actual|2017-07-25||Observational|||Evaluation of Maxillary and Mandibulary Nerve Blocks on Morphine Consumption|Evaluation of Maxillary and Mandibulary Nerve Blocks on Morphine Consumption in Double-jaw Surgery, a Retrospective Study|Completed||N/A|92|Actual|Hospices Civils de Lyon|||2||f|||||f|f||||||||2017-10-10 20:40:29.754772|2017-10-10 20:40:29.754772
NCT03299985|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|GERD||Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease|Effects of Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease|Not yet recruiting||N/A|30|Anticipated|Cardenal Herrera University||2|||f|||||f|f||||||||2017-10-10 20:40:31.472351|2017-10-10 20:40:31.472351
NCT03299972|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-10-03|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Resistance Exercise and Whey Protein Supplementation to Combat Age-related Sarcopenia|Effects of 12 Weeks Resistance Exercise and Whey Protein Supplementation on Multiple Indices of Sarcopenia in Older Men|Not yet recruiting||N/A|52|Anticipated|Coventry University||4|||f||||f|f|f|||t|||||2017-10-10 20:40:31.552639|2017-10-10 20:40:31.552639
NCT03299959|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||September 5, 2017||2017-09-05||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:40:31.677215|2017-10-10 20:40:31.677215
NCT03299946|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)|Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)|Not yet recruiting||Phase 1|15|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:40:31.732977|2017-10-10 20:40:31.732977
NCT03299933|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-27|||August 30, 2017||2017-08-30||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:40:31.883195|2017-10-10 20:40:31.883195
NCT03299920|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Opioid Consumption After Knee Arthroscopy|Opioid Consumption After Knee Arthroscopy With and Without the Use of New Standardized Patient/Family Instructions for Postoperative Analgesic Use|Recruiting||N/A|40|Anticipated|Nationwide Children's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:31.941004|2017-10-10 20:40:31.941004
NCT03299907|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||November 1, 2012|Actual|2012-11-01|September 2017|2017-09-01|May 30, 2014|Actual|2014-05-30|May 30, 2013|Actual|2013-05-30||Observational|BM3R||COPD MSA 3 Regions: Epidemiology and Risk Factors of COPD in Rural Environment (BM3R)|COPD MSA 3 Regions: Epidemiology and Risk Factors of COPD in Rural Environment (BPCO MSA 3Régions : épidémiologie et Facteurs de Risque de la BPCO en Milieu Rural)|Completed||N/A|5263|Actual|Centre Hospitalier Universitaire de Besancon|||2||f||||f|f|f||||||||2017-10-10 20:40:32.06693|2017-10-10 20:40:32.06693
NCT03299881|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss|Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss|Recruiting||N/A|300|Anticipated|Elira Therapeutics, Inc.||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:40:32.289048|2017-10-10 20:40:32.289048
NCT03299868|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-10-03|||May 1, 2017|Actual|2017-05-01|October 2017|2017-10-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Comparison Between Initial Routine PICC and General IV Access in Terminally Ill Cancer Patients|Comparison of Safety, Efficacy, and Patient-perceived Satisfaction Between Initial Routine Peripherally Inserted Central Catheters Insertion and General Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study|Recruiting||Phase 2|80|Anticipated|Pusan National University Yangsan Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:32.425226|2017-10-10 20:40:32.425226
NCT03299855|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|MOCA-2||MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?|MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?|Not yet recruiting||N/A|110|Anticipated|Centre Francois Baclesse||1|||f||||f|f|f||||||||2017-10-10 20:40:32.590706|2017-10-10 20:40:32.590706
NCT03299842|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-10-01|||August 23, 2017|Actual|2017-08-23|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome|An Exploratory, Pilot Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome: A Sub-study to the ZX008-1503 Open-Label Extension Trial|Enrolling by invitation||Phase 3|20|Anticipated|Zogenix, Inc.||1|||f||||t|t|f||||||||2017-10-10 20:40:32.738816|2017-10-10 20:40:32.738816
NCT03299829|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|January 31, 2018|Anticipated|2018-01-31||Observational|||A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients|A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients|Not yet recruiting||N/A|50|Anticipated|Excelsior|||1||f||||f|f|f||||||||2017-10-10 20:40:32.839131|2017-10-10 20:40:32.839131
NCT03299816|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-28|||October 23, 2017|Anticipated|2017-10-23|September 2017|2017-09-01|September 22, 2021|Anticipated|2021-09-22|September 22, 2021|Anticipated|2021-09-22||Interventional|||Five, Plus Nuts and Beans for Kidneys|Community-Based Dietary Approach for Hypertensive African Americans With Chronic Kidney Disease|Not yet recruiting||N/A|150|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||||2017-10-10 20:40:32.915979|2017-10-10 20:40:32.915979
NCT03299777|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-01|||September 5, 2017|Actual|2017-09-05|October 2017|2017-10-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|||Correlation Between Changes in Liver Stiffness and Preeclampsia as Shown by Fibroscan by Fibroscan|Correlation Between Changes in Liver Stiffness and Preeclampsia as Shown by Fibroscan|Recruiting||N/A|50|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||f|f|f||||||||2017-10-10 20:40:33.251249|2017-10-10 20:40:33.251249
NCT03299764|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Evaluation of Non-invasive Pursed-lip Breathing Ventilation (PLBV) in Advanced COPD|Evaluation of Non-invasive Pursed-lip Breathing Ventilation (PLBV) in Advanced COPD|Not yet recruiting||N/A|270|Anticipated|Research Center Borstel||2|||f||||t|f|f||||||||2017-10-10 20:40:33.329394|2017-10-10 20:40:33.329394
NCT03299738|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL|A Phase 1 Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-cell Non-Hodgkin Lymphoma (NHL)|Not yet recruiting||Phase 1|10|Anticipated|Cellular Biomedicine Group Ltd.||1|||f||||t|f|f||||||||2017-10-10 20:40:33.497381|2017-10-10 20:40:33.497381
NCT03299725|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Bismuth Based Quadruple Therapy 10 Days in Children|A Prospective Open-label Study on Efficacy and Tolerability of Colloidal Bismuth Sub-citrate as Adjunctive Therapy to a Combination of Esomeprazole, Amoxicillin and Metronidazole for 10 Days for Helicobacter Pylori Elimination in Children|Not yet recruiting||Phase 4|120|Anticipated|Queen Fabiola Children's University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:40:33.58123|2017-10-10 20:40:33.58123
NCT03299712|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-09-27|||September 2007||2007-09-01|September 2017|2017-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Protocol for the Post-approval Study of Artefill for Correction of Nasolabial Folds|Protocol for the Post-approval Study of Artefill for Correction of Nasolabial Folds|Completed||N/A|1008|Actual|Suneva Medical, Inc.||1|||f||||f||||||||||2017-10-10 20:40:33.681053|2017-10-10 20:40:33.681053
NCT03299699|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||December 15, 2017|Anticipated|2017-12-15|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|June 15, 2019|Anticipated|2019-06-15||Observational|FRATHEMO||Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia|FRATHEMO: Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia.|Not yet recruiting||N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f|f|f||||||||2017-10-10 20:40:33.755509|2017-10-10 20:40:33.755509
NCT03299686|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-27|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|September 18, 2019|Anticipated|2019-09-18|September 18, 2019|Anticipated|2019-09-18||Interventional|||Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma|A Randomized, Subject- and Investigator-blinded, Placebo Controlled, Multi-center, Multiple Dose Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Moderate to Severe Asthma|Not yet recruiting||Phase 2|110|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 20:40:33.841744|2017-10-10 20:40:33.841744
NCT03299673|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Observational|AHEAD||AdHerencE to Treatment and quAlity of Life in COPD|Observational Study to Investigate the Compliance of Patients With COPD With the 8-item Morisky Medication Adherence Scale and Assessing the Quality of Life of Patients as Shown by the Clinical COPD Questionnaire (CCQ) Questionnaire.|Not yet recruiting||N/A|600|Anticipated|Elpen Pharmaceutical Co. Inc.|||1||f||||f|f|f||||||||2017-10-10 20:40:33.924873|2017-10-10 20:40:33.924873
NCT03299660|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-10-01|||February 15, 2018|Anticipated|2018-02-15|September 2017|2017-09-01|April 1, 2022|Anticipated|2022-04-01|February 1, 2022|Anticipated|2022-02-01||Interventional|||Avelumab With Chemoradiation in Locally Advanced Rectal Cancer|Phase II Trial PD-L1/PD-1 Blockade Avelumab (MSB0010718C) With Chemoradiotherapy for Locally Advanced ResectableT3b-4/N1-2 Rectal Cancer|Not yet recruiting||Phase 2|45|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t|f|f||||||||2017-10-10 20:40:33.983715|2017-10-10 20:40:33.983715
NCT03299634|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|October 31, 2018|Anticipated|2018-10-31||Observational|||Prevalence of Oral Mucosal Lesions Among Smokers in an Egyptian Cohort: A Hospital-based Cross-Sectional Study (I)|Prevalence of Oral Mucosal Lesions Among Smokers in an Egyptian Cohort: A Hospital-based Cross-Sectional Study (II)|Not yet recruiting||N/A|700|Anticipated|Cairo University|||1||f||||t|f|f||||Samples Without DNA|"     Histopathological evaluation of clinically suspicious oral lesions to detect dysplasia   "|||2017-10-10 20:40:34.174139|2017-10-10 20:40:34.174139
NCT03299608|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-27|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Observational|RAISE||Rapid Analysis of Infections by Spectrometry of Exhaled Breath|Exhaled Breath Analysis for Rapid Diagnosis in Opportunistic Respiratory Infections in Hematological Patients|Not yet recruiting||N/A|246|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f|f|f||||||||2017-10-10 20:40:34.338856|2017-10-10 20:40:34.338856
NCT03299595|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-10-02|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|October 31, 2018|Anticipated|2018-10-31||Observational|||Prevalence of Oral Mucosal Lesions Among Smokers in an Egyptian Cohort: A Hospital-based Cross-Sectional Study (II)|Prevalence of Oral Mucosal Lesions Among Smokers in an Egyptian Cohort: A Hospital-based Cross-Sectional Study (II)|Not yet recruiting||N/A|700|Anticipated|Cairo University|||1||f||||t|f|f||||Samples Without DNA|"     Histopathological evaluation of clinically suspicious oral lesions to detect dysplasia     (Warnakulasuriy et al., 2007 and Rastogi et al., 2013).   "|||2017-10-10 20:40:34.420567|2017-10-10 20:40:34.420567
NCT03299582|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-10-01|||June 13, 2013|Actual|2013-06-13|August 2017|2017-08-01|February 15, 2017|Actual|2017-02-15|November 3, 2016|Actual|2016-11-03||Interventional|||PREventing CHemotherapy Induced Neuropathy (PreChIN)|PREventing CHemotherapy Induced Neuropathy (PreChIN)|Completed||N/A|89|Actual|National University Hospital, Singapore||4|||f||||f|f|f||||||||2017-10-10 20:40:34.477386|2017-10-10 20:40:34.477386
NCT03299569|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-28|2017-09-28|||July 29, 2016|Actual|2016-07-29|July 2016|2016-07-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31|13 Years|Observational [Patient Registry]|STARR||Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland|Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland - the STARR Study|Recruiting||N/A|800|Anticipated|University of Aberdeen|||2||f||||f|f|f||||||||2017-10-10 20:40:34.723274|2017-10-10 20:40:34.723274
NCT03299556|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health System|Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health System|Enrolling by invitation||N/A|240|Anticipated|Purdue Pharma LP|||3||f||||t|f|f||||||||2017-10-10 20:40:34.847604|2017-10-10 20:40:34.847604
NCT03299543|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-01|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|February 12, 2018|Anticipated|2018-02-12|February 12, 2018|Anticipated|2018-02-12||Observational|||Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate|Relationship Among Breath Acetone, Blood Beta-Hydroxybutyrate, and Blood Glucose|Recruiting||N/A|100|Anticipated|Medamonitor|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:40:34.952162|2017-10-10 20:40:34.952162
NCT03299530|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 10, 2017|Anticipated|2017-10-10|September 2017|2017-09-01|November 15, 2017|Anticipated|2017-11-15|November 10, 2017|Anticipated|2017-11-10||Observational|||Accuracy of Corneal Astigmatism in Different Region Modes|Accuracy of Corneal Astigmatism in Different Region Modes|Not yet recruiting||N/A|70|Anticipated|Wenzhou Medical University|||1||f||||f|f|f||||||||2017-10-10 20:40:35.058565|2017-10-10 20:40:35.058565
NCT03299517|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|August 2, 2022|Anticipated|2022-08-02|August 2, 2019|Anticipated|2019-08-02||Interventional|AMIOLIDO-VT||PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN SVT|PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN PATIENTS WITH STABLE VENTRICULAR TACHYCARDIA IN THE EMERGENCY ROOM|Recruiting||Phase 4|80|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:35.146891|2017-10-10 20:40:35.146891
NCT03299504|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-10-02|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation|Factors Predicting Success in Lung Transplant Recipients Who Have Participated in the COLTT Program (Daily Intensive Post-hospitalization Rehabilitation): A Retrospective Review|Recruiting||N/A|70|Anticipated|Indiana University Health Methodist Hospital|||1||f||||f|f|f||||||||2017-10-10 20:40:35.260239|2017-10-10 20:40:35.260239
NCT03299491|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 15, 2016|Actual|2016-10-15|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||An Implementation Study of Interventions to Promote Safe Motherhood in Jimma Zone Ethiopia|An Implementation Study of Interventions to Promote Safe Motherhood in Jimma Zone Ethiopia|Enrolling by invitation||N/A|3800|Anticipated|University of Ottawa||3|||f|||||f|f||||||||2017-10-10 20:40:35.362482|2017-10-10 20:40:35.362482
NCT03299478|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-03|||November 28, 2016|Actual|2016-11-28|September 2017|2017-09-01|November 2024|Anticipated|2024-11-01|November 2024|Anticipated|2024-11-01|5 Years|Observational [Patient Registry]|TNM-I||Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer|Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer|Recruiting||N/A|1000|Anticipated|University Hospital of North Norway|||1||f||||f|f|f||||Samples With DNA|"     Tumor specimen Blood   "|||2017-10-10 20:40:35.48568|2017-10-10 20:40:35.48568
NCT03299465|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Yoga for Fatigue in the Survivors of Bone Marrow Transplantation|Yoga for Persistent Fatigue in the Survivors of Bone Marrow Transplantation: A Feasibility Study|Not yet recruiting||N/A|20|Anticipated|University of Michigan||1|||f||||t|f|f||||||||2017-10-10 20:40:35.60519|2017-10-10 20:40:35.60519
NCT03299257|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-27|||October 3, 2017|Anticipated|2017-10-03|September 2017|2017-09-01|March 2, 2019|Anticipated|2019-03-02|September 4, 2018|Anticipated|2018-09-04||Interventional|||Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea|Donepezil for Residual Symptoms in CPAP Treated Obstructive Sleepapnea Patients: A Controlled Study|Not yet recruiting||Phase 4|36|Anticipated|Associação Fundo de Incentivo à Pesquisa||2|||f||||t|f|f|||f|||||2017-10-10 20:40:37.159935|2017-10-10 20:40:37.159935
NCT03299439|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-30|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|February 20, 2020|Anticipated|2020-02-20|January 20, 2020|Anticipated|2020-01-20||Interventional|||Acupuncture Treatment for Knee Osteoarthritis With Sensitive Acupoints and Tender Points|A Multi-center Randomized Controlled Trial of Acupuncture Treatment for Knee Osteoarthritis With Sensitive Acupoints and Tender Points|Not yet recruiting||N/A|666|Anticipated|West China Hospital||3|||f|||||f|f||||||||2017-10-10 20:40:35.836545|2017-10-10 20:40:35.836545
NCT03299426|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi|A Phase III Randomized, Double-Blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi|Not yet recruiting||Phase 3|24000|Anticipated|University of Maryland||2|||f||||t|f|f|||f|||||2017-10-10 20:40:35.934584|2017-10-10 20:40:35.934584
NCT03299413|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease|Ulcerative Colitis Stem Cell Therapy|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Jordan||1|||f||||t|f|f||||||||2017-10-10 20:40:36.042377|2017-10-10 20:40:36.042377
NCT03299400|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||May 9, 2016|Actual|2016-05-09|October 2017|2017-10-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Continuous Intraocular Pressure Patterns in Spine Surgery|Continuous Intraocular Pressure Patterns in Spine Surgery|Completed||N/A|10|Actual|The University of Hong Kong||1|||f||||f|f|f||||||||2017-10-10 20:40:36.169022|2017-10-10 20:40:36.169022
NCT03299387|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-27|||June 28, 2017|Actual|2017-06-28|September 2017|2017-09-01|July 14, 2019|Anticipated|2019-07-14|July 1, 2019|Anticipated|2019-07-01||Interventional|INSTANT||INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI|INtravesical Antimicrobial Agents Versus STANDard Oral Antibiotics for the Treatment of Acute Urinary Tract Infection in Women With Recurrent Urinary Tract Infection (INSTANT Study)|Recruiting||Phase 4|40|Anticipated|Mayo Clinic||2|||f||||f|t|f|||f|||||2017-10-10 20:40:36.270282|2017-10-10 20:40:36.270282
NCT03299374|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-30|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Effectiveness of the Pilates Method to Prevent and Reduce Falls in Older People|Estudio Comparativo de Los Beneficios Del Método Pilates Frente a un Programa específico de prevención de caídas|Enrolling by invitation||N/A|30|Anticipated|University of Valencia||2|||f||||f|f|f||||||||2017-10-10 20:40:36.362414|2017-10-10 20:40:36.362414
NCT03299361|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-30|||May 26, 2016|Actual|2016-05-26|September 2017|2017-09-01|March 7, 2017|Actual|2017-03-07|December 31, 2016|Actual|2016-12-31||Observational|||Diffusion Tensor Imaging of the Median Nerve Before and After Carpal Tunnel Corticosteroid Injection in Patients With Carpal Tunnel Syndrome: Feasibility Study|Diffusion Tensor Imaging of the Median Nerve Before and After Carpal Tunnel Corticosteroid Injection in Patients With Carpal Tunnel Syndrome: Feasibility Study|Completed||N/A|12|Actual|Tri-Service General Hospital|||1||f||||f|f|f||||||||2017-10-10 20:40:36.439968|2017-10-10 20:40:36.439968
NCT03299348|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-23|2017-09-27|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||AgingPLUS: Promoting Physical Activity in Adults|Testing Psychological Mechanisms to Promote Physical Activity in Adults|Not yet recruiting||N/A|288|Anticipated|Colorado State University||2|||f||||f|f|f||||||||2017-10-10 20:40:36.510473|2017-10-10 20:40:36.510473
NCT03299335|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|IBM-RNAseq||Molecular Profile of the Evolution of Inclusion Body Myositis|Molecular Profile of the Evolution of Inclusion Body Myositis|Recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f|f|f||||||||2017-10-10 20:40:36.588377|2017-10-10 20:40:36.588377
NCT03299309|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-30|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|March 2018|Anticipated|2018-03-01||Interventional|PRiME||PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma|The PRiME Study: PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma|Not yet recruiting||Phase 1|30|Anticipated|Duke University||1|||f||||t|t|f||||||||2017-10-10 20:40:36.761665|2017-10-10 20:40:36.761665
NCT03299296|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-30|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin|Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Focus on Cost-effective Analysis and Safety Comparison Between Rivaroxaban and Enoxaparin|Enrolling by invitation||Phase 3|100|Actual|Beni-Suef University||2|||f||||t|f|f|||f|||||2017-10-10 20:40:36.851327|2017-10-10 20:40:36.851327
NCT03299270|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-05|||February 27, 2017|Actual|2017-02-27|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|GOSAFE||Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery|GOSAFE Study Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery An International Prospective Audit to Evaluate Postoperative Functional Outcomes and Quality of Life After Cancer Surgery in Geriatric Patients|Recruiting||N/A|400|Anticipated|AUSL Romagna Rimini|||1||f||||f|f|f||||||||2017-10-10 20:40:37.003402|2017-10-10 20:40:37.003402
NCT03299244|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-27|||January 31, 2018|Anticipated|2018-01-31|September 2017|2017-09-01|April 11, 2019|Anticipated|2019-04-11|April 11, 2019|Anticipated|2019-04-11||Interventional|||Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian HD Subjects With SHPT|Multiple-dose, Double-blind, Double-dummy Study to Compare the Efficacy and Safety of Oral Doses of Cinacalcet Hydrochloride With Intravenous Doses of Etelcalcetide) in Asian Hemodialysis Subjects With Secondary Hyperparathyroidism|Not yet recruiting||Phase 3|660|Anticipated|Amgen||2|||f||||f|f|f||||||||2017-10-10 20:40:37.237884|2017-10-10 20:40:37.237884
NCT03299231|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|SIMPLE||Oscillating Positive Expiratory Pressure Devices and Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Oscillating Positive Expiratory Pressure Device for Mucous Clearing in Severe Exacerbation of COPD Requiring Hospitalization Targeting Outcome: A Randomized, Double Blind, Sham Controlled Trial (SIMPLE)|Not yet recruiting||N/A|160|Anticipated|Ain Shams University||2|||f||||t|f|f||||||||2017-10-10 20:40:37.42688|2017-10-10 20:40:37.42688
NCT03299218|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-09-27|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Effectiveness of SNF, Cash and BCC to Prevent Stunting Among Children 6-24 Months in Rahim Yar Khan, Pakistan|Effectiveness of a Programme Comprised of SNF, Cash-based Transfers and BCC to Prevent Stunting Among Children 6-24 Months in Rahim Yar Khan, Punjab, Pakistan|Recruiting||N/A|2000|Anticipated|Aga Khan University||5|||f||||f|f|f||||||||2017-10-10 20:40:37.523664|2017-10-10 20:40:37.523664
NCT03299205|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-29|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|December 2018|Anticipated|2018-12-01||Interventional|ALIVE-Ex||Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions|Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions|Enrolling by invitation||N/A|130|Anticipated|Louisiana State University Health Sciences Center in New Orleans||1|||f|||||f|f||||||||2017-10-10 20:40:37.629585|2017-10-10 20:40:37.629585
NCT03299192|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-29|||May 1, 2016|Actual|2016-05-01|September 2017|2017-09-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Tai Chi for Chronic Low Back Pain in Older Adults|Tai Chi for Chronic Low Back Pain in Older Adults|Recruiting||N/A|64|Anticipated|Kaiser Permanente||3|||f||||t|f|f||||||||2017-10-10 20:40:37.717164|2017-10-10 20:40:37.717164
NCT03299179|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-03|||October 3, 2016|Actual|2016-10-03|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||The Effects of the Female Hormones on Cerebral Perfusion|The Effects of the Female Sex Hormones and Hormonal Contraception on Cerebral Perfusion|Recruiting||N/A|30|Anticipated|University Ghent|||2||f||||f|f|f||||||||2017-10-10 20:40:37.844499|2017-10-10 20:40:37.844499
NCT03299153|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-29|||December 21, 2016|Actual|2016-12-21|September 2017|2017-09-01|August 5, 2017|Actual|2017-08-05|April 16, 2017|Actual|2017-04-16||Interventional|||The Effects of Barberry Juice Consumption in Patients With Type 2 Diabetes|The Effects of Barberry Juice Consumption on Glycaemic Control, Lipid Profile, Blood Pressure and Oxidative Stress in Patients With Type 2 Diabetes: A Randomized Clinical Trial|Completed||Phase 4|46|Actual|National Nutrition and Food Technology Institute||2|||f|||||f|f||||||||2017-10-10 20:40:38.048308|2017-10-10 20:40:38.048308
NCT03299140|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||June 18, 2014|Actual|2014-06-18|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Bipokid||Evaluation of a Prevention Program in Children and Teenagers at High Risk for Bipolar Disorder (Bipokid)|Evaluation of a Prevention Program in Children and Teenagers at High Risk for Bipolar Disorder|Active, not recruiting||N/A|64|Anticipated|University Hospital, Montpellier||1|||f||||f|f|f||||||||2017-10-10 20:40:38.113599|2017-10-10 20:40:38.113599
NCT03299127|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||April 1, 2017|Actual|2017-04-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|July 30, 2017|Actual|2017-07-30||Interventional|||Imagery Rescripting in Depression|A Self-help Manual of Imagery Rescripting Reduces Depressive Symptoms|Active, not recruiting||N/A|120|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f|f|f||||||||2017-10-10 20:40:38.174216|2017-10-10 20:40:38.174216
NCT03299114|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||November 1, 2015|Actual|2015-11-01|September 2017|2017-09-01|January 1, 2016|Actual|2016-01-01|January 1, 2016|Actual|2016-01-01||Interventional|||WHIRLPOOL FOR OSTEOARHRITIS|THE EFFECTIVENESS OF WHIRLPOOL FOR PATIENTS WITH NEUROPATHIC PAIN DUE TO KNEE OSTEOARTHRITIS|Completed||N/A|60|Actual|Ufuk University||2|||f||||f|f|f||||||||2017-10-10 20:40:38.262597|2017-10-10 20:40:38.262597
NCT03299101|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-29|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|November 30, 2018|Anticipated|2018-11-30||Interventional|||Pilot Testing a Home-Based Rehabilitation Intervention Designed to Improve Outcomes of Frail Veterans Following Cardiothoracic Surgery|Pilot Testing a Home-based Rehabilitation Intervention Designed to Improve Outcomes of Frail Veterans Following Cardiothoracic Surgery|Not yet recruiting||N/A|30|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 20:40:38.36716|2017-10-10 20:40:38.36716
NCT03299088|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|March 1, 2021|Anticipated|2021-03-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations|A Phase Ib Trial of Pembrolizumab (MK-3475) and Trametinib Focused on Advanced KRAS Mutant Non-small Cell Lung Cancer|Not yet recruiting||Phase 1|42|Anticipated|University of California, Davis||2|||f||||t|t|f|||f|||||2017-10-10 20:40:38.481967|2017-10-10 20:40:38.481967
NCT03299075|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|April 6, 2018|Anticipated|2018-04-06|April 6, 2018|Anticipated|2018-04-06||Interventional|||The Effect of Social Media Use on Eating Behaviours|The Effect of Social Media Use on Eating Behaviours|Recruiting||N/A|250|Anticipated|Yale-NUS College||3|||f|||||f|f||||||||2017-10-10 20:40:38.599877|2017-10-10 20:40:38.599877
NCT03299062|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders|Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders|Not yet recruiting||N/A|60|Anticipated|University of Arkansas||3|||f||||f|f|f||||||||2017-10-10 20:40:38.690032|2017-10-10 20:40:38.690032
NCT03299049|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-03|||October 26, 2017|Anticipated|2017-10-26|October 2017|2017-10-01|March 7, 2022|Anticipated|2022-03-07|May 31, 2019|Anticipated|2019-05-31||Interventional|||Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults|A Phase IIIb, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every 8 Weeks or Every 4 Weeks in HIV-1-infected Adults Who Are Virologically Suppressed|Not yet recruiting||Phase 3|1020|Anticipated|ViiV Healthcare||4|||f||||t|t|f||||||||2017-10-10 20:40:38.784025|2017-10-10 20:40:38.784025
NCT03299036|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-05|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|April 30, 2018|Anticipated|2018-04-30|March 1, 2018|Anticipated|2018-03-01||Interventional|||Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy|Hydrophilic Radiopaque Microsphere With Doxorubicin for Hepatoma Embolization Therapy|Recruiting||N/A|12|Anticipated|National Cheng-Kung University Hospital||1|||f||||t|f|f||||||||2017-10-10 20:40:38.922548|2017-10-10 20:40:38.922548
NCT03299023|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-29|||January 20, 2017|Actual|2017-01-20|September 2017|2017-09-01|June 10, 2018|Anticipated|2018-06-10|May 10, 2018|Anticipated|2018-05-10|1 Year|Observational [Patient Registry]|||The Effect of Tooth Position During Orthodontic Treatment on the Apnea/ Hypopnea Index (AHI)|The Effect of Tooth Position During Orthodontic Treatment on the Apnea/ Hypopnea Index (AHI)|Recruiting||N/A|54|Anticipated|Harvard School of Dental Medicine|||1||f||||f|f|f||||||||2017-10-10 20:40:39.013321|2017-10-10 20:40:39.013321
NCT03299010|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Observational|||10-year Risk Prediction Models of Complications and Mortality of DM in Hong Kong|10-year Risk Prediction Models of Complications and Mortality of Diabetes Mellitus in Chinese Patients in Primary Care in Hong Kong|Recruiting||N/A|70720|Anticipated|The University of Hong Kong|||1||f||||f|f|f||||||||2017-10-10 20:40:39.090767|2017-10-10 20:40:39.090767
NCT03298997|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-03|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|November 22, 2019|Anticipated|2019-11-22|November 22, 2018|Anticipated|2018-11-22||Interventional|||Ligation and Hemorrhoidopexy Technique Versus Ligation of Hemorrhoidal Arteries Using Ultrasound for Hemorrhoids|Comparison Between the Ligation and Hemorrhoidopexy Technique and the Conventional Ligation of Hemorrhoidal Arteries Using Ultrasound: a Prospective, Randomized Controlled Study|Recruiting||N/A|60|Anticipated|Larissa University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:40:39.168069|2017-10-10 20:40:39.168069
NCT03298971|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-29|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 1, 2018|Anticipated|2018-09-01||Observational|||The Impact of Cancer on the Physical and Psychosocial Well-being Among Childhood Osteosarcoma Survivors|The Impact of Cancer and Treatment-related Effects on the Physical and Psychosocial Well-being and Quality of Life Among Hong Kong Chinese Survivors of Childhood Osteosarcoma: An Exploratory Study|Recruiting||N/A|240|Anticipated|The University of Hong Kong|||2||f||||t|f|f||||||||2017-10-10 20:40:39.394427|2017-10-10 20:40:39.394427
NCT03298958|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|May 1, 2022|Anticipated|2022-05-01|February 1, 2022|Anticipated|2022-02-01||Interventional|||Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer|Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer|Not yet recruiting||Phase 3|260|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t|t|f||||||||2017-10-10 20:40:39.480364|2017-10-10 20:40:39.480364
NCT03298945|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||December 18, 2017|Anticipated|2017-12-18|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|December 21, 2020|Anticipated|2020-12-21||Interventional|||Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens|Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens|Not yet recruiting||Phase 4|10000|Anticipated|VA Office of Research and Development||2|||f||||f|t|f|||f|||||2017-10-10 20:40:39.55587|2017-10-10 20:40:39.55587
NCT03298932|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-26|||October 30, 2016|Actual|2016-10-30|October 2016|2016-10-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||2D Strain of Right Ventricle in Peroperative of Cardiac Surgery|2D Strain of Right Ventricle in Peroperative Cardiac Surgery : Evaluation of Early Signs of RV Dysfunction|Recruiting||N/A|40|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||||2017-10-10 20:40:39.672123|2017-10-10 20:40:39.672123
NCT03298919|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-02|||September 1, 2012|Actual|2012-09-01|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|August 29, 2016|Actual|2016-08-29||Interventional|||Efficacy of Exercise Videogames for Physical Activity Adoption and Maintenance|Efficacy of Exercise Videogames for Physical Activity Adoption and Maintenance|Completed||N/A|283|Actual|The Miriam Hospital||3|||f||||f|f|f||||||||2017-10-10 20:40:39.743804|2017-10-10 20:40:39.743804
NCT03298906|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|November 29, 2017|Anticipated|2017-11-29|November 29, 2017|Anticipated|2017-11-29||Interventional|||A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants|A Fixed-sequence, Open-label Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Subjects|Not yet recruiting||Phase 1|16|Anticipated|Janssen Research & Development, LLC||1|||f||||f|t|f|||t|||||2017-10-10 20:40:39.818112|2017-10-10 20:40:39.818112
NCT03298893|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|NiCOL||Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months|A Phase-I Study of Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months. NiCOL|Not yet recruiting||Phase 1/Phase 2|21|Anticipated|Institut Curie||1|||f||||t|f|f||||||||2017-10-10 20:40:39.89229|2017-10-10 20:40:39.89229
NCT03298867|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|OPTIC||Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study|A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease|Not yet recruiting||Phase 3|76|Anticipated|Horizon Pharma USA, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:40:40.09721|2017-10-10 20:40:40.09721
NCT03298854|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-23|2017-09-29|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||The Diagnostic Performance of Skeletal 99mTc-MDP SPECT/CT in Patients With Low Back Pain|The Diagnostic Performance of Skeletal 99mTc-MDP SPECT/CT in Patients With Low Back Pain|Not yet recruiting||N/A|40|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:40:40.234364|2017-10-10 20:40:40.234364
NCT03298841|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-29|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|September 20, 2017|Actual|2017-09-20|September 20, 2017|Actual|2017-09-20||Observational|||Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope|Zeiss Lumera Microscope With Callisto Software|Completed||N/A|100|Actual|Toyos Clinic|||1||f||||t|f|f||||||||2017-10-10 20:40:40.301602|2017-10-10 20:40:40.301602
NCT03298828|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-26|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Interventional|||CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma|CD19 Chimeric Antigen Receptor (CAR) and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma|Not yet recruiting||Phase 1|30|Anticipated|Third Military Medical University||2|||f||||f|f|f||||||||2017-10-10 20:40:40.360375|2017-10-10 20:40:40.360375
NCT03298815|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-26|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)|A Randomized, Double-Blinded, Placebo-Controlled Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)|Not yet recruiting||Phase 2|15|Anticipated|University of Utah||2|||f||||t|f|f||||||||2017-10-10 20:40:40.427878|2017-10-10 20:40:40.427878
NCT03298802|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-29|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 30, 2019|Anticipated|2019-05-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide|Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide: a Randomized Clinical Trial|Not yet recruiting||Phase 3|612|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t|t|f|||t|||||2017-10-10 20:40:40.498913|2017-10-10 20:40:40.498913
NCT03298789|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-26|||July 22, 2017|Actual|2017-07-22|September 2017|2017-09-01|July 30, 2017|Actual|2017-07-30|July 23, 2017|Actual|2017-07-23||Interventional|AESSW||Acute Effects of Static Stretching in Warm-up|Acute Effects of Static Stretching in Warm-up on Muscular Performance of Football Players|Completed||N/A|19|Actual|University of Primorska||2|||f||||f|f|f||||||||2017-10-10 20:40:40.684439|2017-10-10 20:40:40.684439
NCT03298776|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-26|||September 26, 2013|Actual|2013-09-26|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||I-Scan a Novel Endoscopic Tool for the Macroscopic Identification of Mucosal Lesions|I-Scan a Novel Endoscopic Tool for the Macroscopic Identification of Mucosal Lesions|Recruiting||N/A|600|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:40:40.786547|2017-10-10 20:40:40.786547
NCT03298763|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-29|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|March 1, 2024|Anticipated|2024-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|TACTICAL||Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer|Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer|Not yet recruiting||Phase 1/Phase 2|46|Anticipated|University College, London||3|||f||||t|f|f||||||||2017-10-10 20:40:40.886405|2017-10-10 20:40:40.886405
NCT03298737|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-26|||November 30, 2017|Anticipated|2017-11-30|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|||Visual Attention and Eye Movements|Visual Attention and Eye Movements|Not yet recruiting||N/A|20|Anticipated|University of Rochester|||1||f||||f|f|f||||||||2017-10-10 20:40:41.119992|2017-10-10 20:40:41.119992
NCT03298724|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-29|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Teachers and Parents as Partners During Middle School|Teachers and Parents as Partners During Middle School|Recruiting||N/A|100|Anticipated|University of Wisconsin, Madison||1|||f||||f|f|f||||||||2017-10-10 20:40:41.211075|2017-10-10 20:40:41.211075
NCT03298711|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||October 13, 2017|Anticipated|2017-10-13|September 2017|2017-09-01|April 12, 2018|Anticipated|2018-04-12|February 12, 2018|Anticipated|2018-02-12||Observational|||Central Sensitization and Alteration of Circulating Neurosteroid|Relationship Between Central Sensitization and Alteration of Circulating Neurosteroid Following Bilateral Total Knee Arthroplasty|Not yet recruiting||N/A|120|Anticipated|Seoul National University Bundang Hospital|||1||f||||||||||Samples Without DNA|"     The Saliva in which the concentrations of cortisol and DHEA will be measured and analyzed for     correlation between concentration-related changes and postoperative knee pain variations.   "|||2017-10-10 20:40:41.322802|2017-10-10 20:40:41.322802
NCT02806726|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-08-03|||July 13, 2016||2016-07-13||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:04:21.810336|2017-10-10 22:04:21.810336
NCT03298698|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome|Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone|Not yet recruiting||Phase 3|40|Anticipated|Radboud University||2|||f||||f|f|f|||f|||||2017-10-10 20:40:41.426753|2017-10-10 20:40:41.426753
NCT03298685|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-26|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|SAFETIM-needs||SAFETIM-needs : Exploring Adolescent's and Parent's Needs During Transition in French CF Centers|SAFETIM Besoins: Suivi Des Adolescents Des Familles et Des Equipes Pour Une Transition Idéale en Mucoviscidose Etude Des Besoins Adolescents et Parent Avant après Transition|Recruiting||N/A|50|Anticipated|University Hospital, Grenoble|||1||f||||t|f|f||||||||2017-10-10 20:40:41.581284|2017-10-10 20:40:41.581284
NCT03298659|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-26|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|January 1, 2025|Anticipated|2025-01-01|January 1, 2021|Anticipated|2021-01-01||Interventional|iMODERN||iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction|Instantaneous Wave-free Ratio Guided Multi-vessel revascularizatiOn During Percutaneous Coronary intervEntion for Acute myocaRdial iNfarction (iMODERN)|Not yet recruiting||N/A|1146|Anticipated|Radboud University||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:40:41.854476|2017-10-10 20:40:41.854476
NCT03298646|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy|Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy: A Randomized Controlled Trial|Recruiting||N/A|44|Anticipated|Ain Shams University||2|||f|||||f|f|||f|||||2017-10-10 20:40:41.980728|2017-10-10 20:40:41.980728
NCT03298633|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|ICSI/IVF-NSMI||ICSI Versus Conventional IVF in Couples With Non-severe Male Infertility|Intracytoplasmic Sperm Injection (ICSI) Versus Conventional in Vitro Fertilization (IVF) in Couples With Non-severe Male Infertility: a Randomized Controlled Trial|Not yet recruiting||N/A|2308|Anticipated|Peking University Third Hospital||2|||f||||t|f|f||||||||2017-10-10 20:40:42.101606|2017-10-10 20:40:42.101606
NCT03298620|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||August 1, 2011|Actual|2011-08-01|September 2017|2017-09-01|December 15, 2016|Actual|2016-12-15|February 28, 2013|Actual|2013-02-28||Interventional|||Electric and Manual Toothbrushes in Nursing Homes|Effect of Electric Toothbrush on Oral Hygiene in Nursing Home Residents- a Randomized Clinical Trial|Completed||N/A|233|Actual|University of Oslo||2|||f||||f|f|f||||||||2017-10-10 20:40:42.232968|2017-10-10 20:40:42.232968
NCT03298607|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-29|||October 3, 2017|Anticipated|2017-10-03|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||The Impact of Serelys PMS on Symptoms of PMS|The Impact of Sérélys PMS, a Herbal Remedy Based on Pollen Extraction and Saffron, on Symptoms of PMS: A Randomized, Double-blinded, Placebo Controlled Study|Not yet recruiting||Phase 3|100|Anticipated|University of Copenhagen||2|||f||||f|f|f||||||||2017-10-10 20:40:42.353418|2017-10-10 20:40:42.353418
NCT03298594|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||February 26, 2013|Actual|2013-02-26|September 2017|2017-09-01|October 11, 2016|Actual|2016-10-11|October 11, 2016|Actual|2016-10-11||Interventional|||A Specific Cervicograph for Women Attempting at Vaginal Delivery After Cesarean Section|A Specific Cervicograph for Women Attempting at Vaginal Delivery After Cesarean Section: is the Management of Labor Improved?|Completed||N/A|135|Actual|University Hospital, Geneva||2|||f||||t|f|f||||||||2017-10-10 20:40:42.45255|2017-10-10 20:40:42.45255
NCT03298581|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis|An Open-label Safety Study to Assess the Multiple-dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray Applied Twice Daily for 28 Days in Patients With Moderate to Severe Plaque Psoriasis|Not yet recruiting||Phase 2|40|Anticipated|Sun Pharmaceutical Industries Limited||1|||f||||f|t|f||||||||2017-10-10 20:40:42.538875|2017-10-10 20:40:42.538875
NCT03298568|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity|Pilotstudie Zur Untersuchung Der Wirkung Einer Oralen Supplementation Von Diaminooxidase (DAOsin®) Bei Histamin-Intoleranz in Bezug Auf Die Steigerung Der Erniedrigten Endogenen Diaminooxidase-Aktivität|Recruiting||N/A|30|Anticipated|Sciotec Diagnostic Technologies GmbH||1|||f|||||f|f||||||||2017-10-10 20:40:42.651184|2017-10-10 20:40:42.651184
NCT03298555|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-29|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||The HealthyMoms Trial to Promote Healthy Gestational Weight Gain|A Smartphone Application (HealthyMoms) to Promote Healthy Weight Gain, Diet and Physical Activity During Pregnancy: a Randomized Controlled Trial|Not yet recruiting||N/A|600|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 20:40:42.76352|2017-10-10 20:40:42.76352
NCT03298542|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-29|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|July 7, 2021|Anticipated|2021-07-07|July 7, 2021|Anticipated|2021-07-07||Interventional|||A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes|A Phase 1b Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes|Not yet recruiting||Phase 1|30|Anticipated|Janssen Research & Development, LLC||2|||f||||t|f|f|||t|||||2017-10-10 20:40:42.849429|2017-10-10 20:40:42.849429
NCT03298529|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-29|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 25, 2017|Actual|2017-09-25|September 15, 2017|Actual|2017-09-15||Interventional|||Glycemic Index of Traditional Egg Pasta|Study on Glycemic and Insulin Index Values of Five Types of Pasta With Different Flour Content, and Egg Components|Completed||N/A|12|Actual|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis||5|||f|||||f|f||||||||2017-10-10 20:40:42.984176|2017-10-10 20:40:42.984176
NCT03298516|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 14, 2017|Anticipated|2017-10-14|September 2017|2017-09-01|September 30, 2023|Anticipated|2023-09-30|September 30, 2023|Anticipated|2023-09-30||Interventional|||A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy|An Open-Label, Phase I, Dose-Escalation Study Evaluating the Safety and Tolerability of DCLL9718S in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Patients With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy|Recruiting||Phase 1|110|Anticipated|Genentech, Inc.||2|||f|||||t|f||||||||2017-10-10 20:40:43.117633|2017-10-10 20:40:43.117633
NCT03298503|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-26|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|September 2017|Anticipated|2017-09-01||Interventional|||Task-priority Effects on Postural-suprapostural Task in Patients With Parkinson's Disease|Effects of Task Prioritization on Postural-suprapostural Task and Brain Activity in Parkinson's Disease With Different Balance Ability: During Standing and Walking|Not yet recruiting||N/A|80|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:43.231421|2017-10-10 20:40:43.231421
NCT03298490|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-29|||April 5, 2017|Actual|2017-04-05|September 2017|2017-09-01|November 18, 2017|Anticipated|2017-11-18|October 5, 2017|Anticipated|2017-10-05||Observational|||Reliability, Validity Of The Turkish Version Of The Back Performance Scale|Reliability, Validity Of The Turkish Version Of The Back Performance Scale|Recruiting||N/A|180|Anticipated|Gazi University|||1||f||||f|f|f||||||||2017-10-10 20:40:43.36246|2017-10-10 20:40:43.36246
NCT03298477|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|May 2024|Anticipated|2024-05-01|May 2020|Anticipated|2020-05-01||Interventional|EVAS2||EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study|Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study (EVAS 2 Confirmatory IDE Study)|Not yet recruiting||N/A|90|Anticipated|Endologix||1|||f||||t|f|t|t|f||||||2017-10-10 20:40:43.444035|2017-10-10 20:40:43.444035
NCT03298464|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of NGM313 in Obese Participants|A Phase 1B, Single Center, Randomized, Open Label, Parallel Group Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single NGM313 Dose or Daily Oral Pioglitazone in Obese Participants With Insulin Resistance and Increased Liver Fat|Recruiting||Phase 1|30|Anticipated|NGM Biopharmaceuticals, Inc||2|||f||||f|t|f||||||||2017-10-10 20:40:43.542814|2017-10-10 20:40:43.542814
NCT03298451|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-26|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|March 29, 2021|Anticipated|2021-03-29|February 27, 2020|Anticipated|2020-02-27||Interventional|HIMALAYA||Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma|A Randomized, Open-label, Multi-center Phase III Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma|Not yet recruiting||Phase 3|1200|Anticipated|AstraZeneca||4|||f||||t|t|f||||||||2017-10-10 20:40:43.65614|2017-10-10 20:40:43.65614
NCT03298438|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-29|||July 15, 2016|Actual|2016-07-15|September 2017|2017-09-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|NF1||Study About Annoucement of the Diagnosis of Neurofibromatosis 1 in de Novo Forms||Completed||N/A|31|Actual|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 20:40:43.968733|2017-10-10 20:40:43.968733
NCT03298425|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-29|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||The Use of NMES With Pelvic Fracture Rehabilitation|The Use of Neuromuscular Electrical Muscle Stimulation With Pelvic Fracture Rehabilitation: A Double Blind, Placebo Controlled, Randomised Control Trial|Completed||N/A|58|Actual|Barts & The London NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:40:44.048039|2017-10-10 20:40:44.048039
NCT03298412|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-26|||February 5, 2018|Anticipated|2018-02-05|September 2017|2017-09-01|February 5, 2021|Anticipated|2021-02-05|May 14, 2020|Anticipated|2020-05-14||Interventional|||Effect of Blinatumomab on MRD in DLBCL Subjects Post aHSCT|A Phase 2 Open-Label Study to Determine the Effect of Blinatumomab on Minimal Residual Disease in Subjects With High-risk Diffuse Large B-cell Lymphoma Post-autologous Hematopoietic Stem-cell Transplantation.|Not yet recruiting||Phase 2|90|Anticipated|Amgen||1|||f||||t|t|f||||||||2017-10-10 20:40:44.146728|2017-10-10 20:40:44.146728
NCT03298399|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|||Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease|A Phase I Study of Mesenchymal Stromal Cells to Promote Stem Cell Engraftment in Patients With Severe Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation|Recruiting||Phase 1|18|Anticipated|Emory University||3|||f||||t|t|f||||||||2017-10-10 20:40:44.265347|2017-10-10 20:40:44.265347
NCT03298386|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|TAPAGE||Elderly Appropriate Treatment in Primary Care (EAT)|Elderly Appropriate Treatment in Primary Care (EAT)|Not yet recruiting||N/A|3032|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 20:40:44.400078|2017-10-10 20:40:44.400078
NCT03298373|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|CCN014A||28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men|28-Day Repeat-Dose, Dose Escalation Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men|Not yet recruiting||Phase 1|40|Anticipated|Health Decisions||2|||f||||t|t|f||||||||2017-10-10 20:40:44.515007|2017-10-10 20:40:44.515007
NCT03238274|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-07|||June 6, 2017|Actual|2017-06-06|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Sofia 2 Lyme FIA Whole Blood Clinical Study|Sofia 2 Lyme FIA Whole Blood Clinical Study|Recruiting||N/A|1800|Anticipated|Quidel Corporation|||3||f||||f|f|t|t|f||||||2017-10-10 20:49:26.625255|2017-10-10 20:49:26.625255
NCT03298360|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-29|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|ANRS EP63||A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a|A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a|Not yet recruiting||N/A|21|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f|f|f||||||||2017-10-10 20:40:44.624996|2017-10-10 20:40:44.624996
NCT03298347|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Caffeine for Preterm Infants With Apnea of Prematurity(AOP)|Caffeine for Preterm Infants With Apnea of Prematurity(AOP): a Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t|f|f|||f|||||2017-10-10 20:40:44.693484|2017-10-10 20:40:44.693484
NCT03298334|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-29|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2025|Anticipated|2025-11-01|November 1, 2022|Anticipated|2022-11-01||Interventional|||Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.|Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates: a Randomized Controlled Trial|Not yet recruiting||N/A|800|Anticipated|Inova Health Care Services||2|||f||||t|f|f||||||||2017-10-10 20:40:44.783782|2017-10-10 20:40:44.783782
NCT03298321|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|AVIFA||Action of the Vidaza on the Atrial Fibrillation|Action of the Vidaza on the Atrial Fibrillation|Not yet recruiting||N/A|14|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:40:44.901974|2017-10-10 20:40:44.901974
NCT03298308|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-26|||May 27, 2016|Actual|2016-05-27|September 2017|2017-09-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|||Brainwave Changes and Cranial Electrotherapy Stimulation|Effects of Cranial Electric Stimulation on Brain Wave Activity: A Pilot Study|Completed||N/A|50|Actual|Walter Reed National Military Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:40:44.997228|2017-10-10 20:40:44.997228
NCT03298295|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-04|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|IRCATT||Inflammatory Response to CSII Catheters in a Tummy Tuck Model|A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue|Not yet recruiting||N/A|20|Anticipated|Medical University of Graz||1|||f||||f|f|f|||f|||||2017-10-10 20:40:45.082854|2017-10-10 20:40:45.082854
NCT03298282|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|April 30, 2019|Anticipated|2019-04-30||Observational|||Integrated Coronary Imaging Registry|Integrated Coronary Imaging Registry|Not yet recruiting||N/A|180|Anticipated|Yonsei University|||1||f||||f|f|f||||||||2017-10-10 20:40:45.181305|2017-10-10 20:40:45.181305
NCT03298269|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|||Behavioral Interventions for Chronic Pain and Opioid-Related Problems|Behavioral Interventions for Chronic Pain and Opioid-Related Problems|Recruiting||N/A|150|Anticipated|University of Utah||2|||f||||f|f|f||||||||2017-10-10 20:40:45.476077|2017-10-10 20:40:45.476077
NCT03298256|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-28|||November 1, 2015|Actual|2015-11-01|September 2017|2017-09-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|||Three-dimensional Effects of Bracing in Adolescent Idiopathic Scoliosis|Three-dimensional Effects of Bracing in Adolescent Idiopathic Scoliosis|Completed||N/A|66|Actual|The University of Hong Kong|||1||f||||f|f|f||||||||2017-10-10 20:40:45.620856|2017-10-10 20:40:45.620856
NCT03298243|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Use of Sensory Substitution to Improve Arm Control After Stroke|Augmenting Kinesthetic Feedback to Improve Hemiparetic Arm Control After Stroke|Not yet recruiting||N/A|28|Anticipated|Marquette University||2|||f||||f|f|f||||||||2017-10-10 20:40:45.770257|2017-10-10 20:40:45.770257
NCT03298230|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-26|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The RESPECT-PAD Trial|A Pilot Randomised Controlled Trial of REmotely SuPervised Exercise Training for Patients With Peripheral Arterial Disease: The RESPECT-PAD Trial|Not yet recruiting||N/A|60|Anticipated|University of Manchester||2|||f||||f|f|f||||||||2017-10-10 20:40:45.896237|2017-10-10 20:40:45.896237
NCT03298217|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-26|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|April 1, 2018|Anticipated|2018-04-01||Interventional|DEBIB||Peak Tidal Inspiratory Flow in Infants With Moderate to Severe Acute Viral Bronchiolitis|Peak Tidal Inspiratory Flow in Infants With Moderate to Severe Acute Viral Bronchiolitis: a Physiologic Study|Not yet recruiting||N/A|50|Anticipated|University Hospital, Montpellier||1|||f||||f|f|f||||||||2017-10-10 20:40:46.006781|2017-10-10 20:40:46.006781
NCT03298191|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-09-26|||October 25, 2017|Anticipated|2017-10-25|September 2017|2017-09-01|May 25, 2018|Anticipated|2018-05-25|April 25, 2018|Anticipated|2018-04-25||Interventional|||Tocolysis in Prevention of Preterm Labor|Comparative Study on Tocolysis in Prevention of Preterm Labour|Recruiting||Phase 4|300|Anticipated|Assiut University||3|||f||||f|f|f||||||||2017-10-10 20:40:46.279195|2017-10-10 20:40:46.279195
NCT03124927|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-08|2017-05-08||April 23, 2008|Actual|2008-04-23|May 2017|2017-05-01|August 8, 2008|Actual|2008-08-08|August 8, 2008|Actual|2008-08-08||Interventional|||Accuracy of Methemoglobin Measurement for Rainbow DCI Sensors||Completed||N/A|25|Actual|Masimo Corporation||1|||f|||||f|t|f|f|f|||||2017-10-10 21:08:41.25773|2017-10-10 21:08:41.25773
NCT03298165|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 15, 2017|Anticipated|2017-12-15||Interventional|||The Microbiological Assessment of Deep Carious Lesions After Step-wise Excavation and Diode Laser Cavity Disinfection (A Six Month Randomized Clinical Trial).|Diode Laser Cavity Disinfection (A Six Month Randomized Clinical Trial).|Not yet recruiting||N/A|15|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:40:46.543207|2017-10-10 20:40:46.543207
NCT03298139|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 1, 2016|Actual|2016-10-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|ARGuide||THE INFLUENCE OF GRAVITY|THE INFLUENCE OF GRAVITY ON TARGET CUEING DURING VISUAL SEARCH USING AUGMENTED REALITY|Recruiting||N/A|18|Anticipated|University Hospital, Caen||1|||f||||f|f|f||||||||2017-10-10 20:40:46.759181|2017-10-10 20:40:46.759181
NCT03298126|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-26|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|July 30, 2017|Actual|2017-07-30||Interventional|||Is Conventional TR Band Deflation Protocol Inferior to Internationally Developed TR Band Removal Protocol in Reducing Occurrence of Radial Artery Occlusion|Is Conventional TR Band Deflation Protocol Inferior to Internationally Developed TR Band Removal Protocol in Reducing Occurrence of Radial Artery Occlusion|Completed||N/A|100|Actual|Aga Khan University||2|||f||||f|f|f||||||||2017-10-10 20:40:46.872957|2017-10-10 20:40:46.872957
NCT03298113|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-26|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparative Study to Assess an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis|Effects of an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis Compared to Hospital Standard Care Practice: an Exploratory Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|3M||2|||f|||||f|t|f|f|t|||||2017-10-10 20:40:46.970835|2017-10-10 20:40:46.970835
NCT03298100|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Observational|Cohort||Risk Scoring Model for Endometrial Cancer|Assessment of Risk Scoring Model for Prediction of Endometrial Cancer Among Symptomatic Postmenopausal Women(a Prospective Cohort Study).|Recruiting||N/A|100|Anticipated|Ain Shams University|||1||f|||||f|f||||||||2017-10-10 20:40:47.075674|2017-10-10 20:40:47.075674
NCT03298087|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2022|Anticipated|2022-09-30||Interventional|||Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer|Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer|Not yet recruiting||Phase 2|28|Anticipated|VA Office of Research and Development||1|||f||||t|t|f||||||||2017-10-10 20:40:47.160965|2017-10-10 20:40:47.160965
NCT03298074|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer|Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer: A Randomized Controlled Trial|Not yet recruiting||Phase 2|60|Anticipated|Guangxi Medical University||2|||f||||f|f|f||||||||2017-10-10 20:40:47.296784|2017-10-10 20:40:47.296784
NCT03298061|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||April 14, 2015|Actual|2015-04-14|September 2017|2017-09-01|September 7, 2018|Anticipated|2018-09-07|September 7, 2018|Anticipated|2018-09-07||Interventional|||Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921|Mepolizumab Long-term Access Programme for Subjects Who Participated in Study MEA115921 (Placebo-controlled Study of Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis in Subjects Receiving Standard-of-care Therapy)|Active, not recruiting||Phase 3|119|Anticipated|GlaxoSmithKline||1|||t||||t|t|f||||||||2017-10-10 20:40:47.389769|2017-10-10 20:40:47.389769
NCT03298048|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)|Phase II. Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)|Recruiting||Phase 2|300|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||t|t|f||||||||2017-10-10 20:40:47.535583|2017-10-10 20:40:47.535583
NCT03298035|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||September 27, 2017|Anticipated|2017-09-27|September 2017|2017-09-01|September 27, 2017|Anticipated|2017-09-27|September 27, 2017|Anticipated|2017-09-27||Interventional|||A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants|A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants|Not yet recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f|||||f|t|f|f|f|||||2017-10-10 20:40:47.639761|2017-10-10 20:40:47.639761
NCT03298022|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis|Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis: a 26-week, Open-label, Multi-center, Phase II Proof of Principle Trial|Not yet recruiting||Phase 2|40|Anticipated|AbGenomics International, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:40:47.726582|2017-10-10 20:40:47.726582
NCT03298009|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|November 1, 2018|Anticipated|2018-11-01||Interventional|Canacardia||Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF)|Subclinical Inflammation, Myocardial Function and Fatty Acid Metabolism in Patients With Type 2 Diabetes and Heart Failure: Impact of a Short-term Treatment With Canagliflozin - a Pilot Study|Not yet recruiting||N/A|13|Anticipated|Université de Sherbrooke||2|||f||||f|f|f||||||||2017-10-10 20:40:47.820968|2017-10-10 20:40:47.820968
NCT03297996|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-28|||November 23, 2011|Actual|2011-11-23|September 2017|2017-09-01|April 25, 2015|Actual|2015-04-25|April 25, 2015|Actual|2015-04-25||Observational|||Study of Gut Microbiome and Colorectal Tumors|The Gut Microbiota in Conventional and Serrated Precursors of Colorectal Cancer|Completed||N/A|540|Actual|New York University School of Medicine|||2||f||||f|f|f||||Samples With DNA|"     DNA was extracted from stool using the PowerLyzer PowerSoil Kit (Mo Bio Laboratory Inc., CA)     following the manufacturer's protocol. DNA was collected and eluted using silica columns     included with the PowerLyzer PowerSoil kit. Barcoded amplicons were generated covering the V4     region of the 16S rRNA gene using the F515/R806 primer pair.   "|||2017-10-10 20:40:47.915288|2017-10-10 20:40:47.915288
NCT03297983|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-27|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|February 20, 2018|Anticipated|2018-02-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule|Phase I, Open-label, Randomized, Two Part, Three-Period, Two-Sequence, Cross-over Study to Investigate the Relative Bioavailability of a Tablet Formulation Compared to Powder-in-Capsule of M7583 Including a Food Effect Evaluation for the Tablet in Healthy Volunteers|Not yet recruiting||Phase 1|18|Anticipated|Merck KGaA||2|||f||||f|f|f||||||||2017-10-10 20:40:47.987846|2017-10-10 20:40:47.987846
NCT03297970|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||February 1, 2006|Actual|2006-02-01|September 2017|2017-09-01|August 11, 2015|Actual|2015-08-11|August 11, 2015|Actual|2015-08-11||Observational|BoSCCo||Bogota School Children Cohort|Bogota School Children Cohort|Completed||N/A|3202|Actual|University of Michigan|||1||f||||f|f|f||||Samples With DNA|"     Whole blood, plasma, serum, and DNA   "|||2017-10-10 20:40:48.070052|2017-10-10 20:40:48.070052
NCT03297957|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-03|||September 14, 2017|Actual|2017-09-14|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Fluorescence Imaging in Sentinel Lymph Node Biopsy for Head and Neck Cancer|Evaluation of Fluorescence Imaging in Sentinel Lymph Node Biopsy for Head and Neck Cancer|Recruiting||Phase 1|50|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 20:40:48.143653|2017-10-10 20:40:48.143653
NCT03297944|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-05|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Sedative-Anxiolytic Effects on Simulated Driving Performance|Alprazolam and Simulated Driving Performance: Next Day Effects|Recruiting||Phase 4|30|Anticipated|University of Kentucky||6|||f||||f|t|f|||f|||||2017-10-10 20:40:48.234734|2017-10-10 20:40:48.234734
NCT03297931|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||July 19, 2017|Actual|2017-07-19|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Comparison of Pulse Chips and Commercial Snacks on Food Intake, Appetite and Blood Glucose in Healthy Young Adults|Comparison of Roasted Pulse Snacks, Pulse Chips and Commercial Snacks on Post-prandial Food Intake, Appetite and Glycemic Response in Healthy Young Adults|Recruiting||N/A|30|Anticipated|University of Toronto||6|||f||||t|f|f||||||||2017-10-10 20:40:48.321071|2017-10-10 20:40:48.321071
NCT03297918|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Impact of a Structural Phonation Training on Respiratory Muscle Function in Patients With Structural Heart Disease|Impact of a Structural Phonation Training on Respiratory Muscle Function in Patients With Structural Heart Disease - HeartChoir|Not yet recruiting||N/A|24|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f|f|f||||||||2017-10-10 20:40:48.42115|2017-10-10 20:40:48.42115
NCT03297905|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-26|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Functional Restoration and Integrative Therapies in Service Members With Neuromusculoskeletal Injury|Determinants of the Optimal Dose and Sequence of Functional Restoration and Integrative Therapies in Service Members With Neuromusculoskeletal Injury|Not yet recruiting||N/A|280|Anticipated|University of Washington||2|||f|||||f|f||||||||2017-10-10 20:40:48.487516|2017-10-10 20:40:48.487516
NCT03297892|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-03|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|CUSHING||Health Status of the Patients Followed for a Disease of Cushing in the Region Large-West of 1990 to 2015|Etat de santé Des Patients Suivis Pour Une Maladie de Cushing Dans la région Grand-Ouest de 1990 à 2015|Not yet recruiting||N/A|60|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 20:40:48.563281|2017-10-10 20:40:48.563281
NCT03297879|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||January 1, 2013|Actual|2013-01-01|September 2017|2017-09-01|February 28, 2016|Actual|2016-02-28|February 28, 2016|Actual|2016-02-28||Interventional|||Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes|Beijing Chao-Yang Hospital, Capital Medical University|Completed||Phase 4|230|Actual|Beijing Chao Yang Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:48.622063|2017-10-10 20:40:48.622063
NCT03297866|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||July 14, 2017|Actual|2017-07-14|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|January 31, 2018|Anticipated|2018-01-31||Observational|||Effectiveness of Different Incentive Models in Booster up the Second Follow up Response Rate|Effectiveness of Different Incentive Models in Booster up the Second Follow up Response Rate|Recruiting||N/A|1500|Anticipated|The University of Hong Kong|||4||f||||f|f|f||||||||2017-10-10 20:40:48.726734|2017-10-10 20:40:48.726734
NCT03297853|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||January 1, 2014|Actual|2014-01-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|July 31, 2017|Actual|2017-07-31||Observational|||Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics|Prevalence, Management and Follow-up of Patients With Addiction to Opioid Analgesics|Active, not recruiting||N/A|64|Actual|University Hospital, Montpellier|||1||f||||t|f|f||||||||2017-10-10 20:40:48.796122|2017-10-10 20:40:48.796122
NCT03297840|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-26|||May 4, 2017|Actual|2017-05-04|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Change in Mindfulness in Borderline Personality Disorder|Change in Mindfulness in Borderline Personality Disorder After Dialectic-behavioural Therapy (DBT): A Pre-post-comparison|Recruiting||N/A|30|Anticipated|University of Oldenburg|||2||f||||f|f|f||||||||2017-10-10 20:40:48.862388|2017-10-10 20:40:48.862388
NCT03297827|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-26|||October 5, 2017|Anticipated|2017-10-05|September 2017|2017-09-01|August 27, 2018|Anticipated|2018-08-27|August 27, 2018|Anticipated|2018-08-27|3 Years|Observational [Patient Registry]|CRISP||Cytokine Registry Database of Stroke Patients|A Prospective Cytokine Registry Database of Stroke (Ischemic and Hemorrhagic) Patients.|Recruiting||N/A|600|Anticipated|University of New Mexico|||2||f||||f|f|f||||Samples With DNA|"     Blood Specimens Urine Specimens   "|||2017-10-10 20:40:48.952256|2017-10-10 20:40:48.952256
NCT03297814|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD)|A Randomized, Double Blind, Placebo Controlled Trial, Investigating the Effect of Intramuscular Injection of Allogenic Platelet Lysate for the Treatment of PAD|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|University of Jordan||2|||f||||t|f|f||||||||2017-10-10 20:40:49.046672|2017-10-10 20:40:49.046672
NCT03297801|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||January 22, 2014|Actual|2014-01-22|September 2017|2017-09-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||The Effects of Omega-3 PUFAs on the Infant Microbiome and Immunity|The Effects of Omega-3 Polyunsaturated Fatty Acids on the Infant Microbiome and Immunity|Completed||N/A|109|Actual|University of British Columbia|||2||f||||f|f|f||||||||2017-10-10 20:40:49.113812|2017-10-10 20:40:49.113812
NCT03297788|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|ENCEPHALON||Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases|Whole Brain Radiation Therapy (WBRT) Alone Versus Radiosurgery (SRS) for Patients With 1-10 Brain Metastases From Small Cell Lung Cancer|Not yet recruiting||Phase 2|56|Anticipated|University Hospital Heidelberg||2|||f||||f|f|f||||||||2017-10-10 20:40:49.195017|2017-10-10 20:40:49.195017
NCT03297775|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-26|||June 22, 2017|Actual|2017-06-22|September 2017|2017-09-01|June 2027|Anticipated|2027-06-01|June 2027|Anticipated|2027-06-01|10 Years|Observational [Patient Registry]|RAPID||Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease|Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease|Recruiting||N/A|500|Anticipated|University of Colorado, Denver|||2||f||||f|f|f||||Samples With DNA|"     Depending on which one of the two cohorts subjects are assigned the following biospecimens     will be collected either yearly or every five years:      DNA, RNA, Serum, Plasma, Sputum   "|||2017-10-10 20:40:49.30757|2017-10-10 20:40:49.30757
NCT03297762|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|||Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes|Improving Adherence to Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes|Not yet recruiting||N/A|40|Anticipated|Stanford University||2|||f|||||f|t|f|f|t|||||2017-10-10 20:40:49.391393|2017-10-10 20:40:49.391393
NCT03297749|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||July 1, 2015|Actual|2015-07-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|September 30, 2017|Anticipated|2017-09-30||Observational|||Genetic Variants and Oxidative Stress as Links Between Periodontitis and Metabolic Syndrome|Genetic Variants and Oxidative Stress as Links Between Periodontitis and Metabolic Syndrome|Active, not recruiting||N/A|102|Anticipated|University College, London|||1||f||||f|f|f||||||||2017-10-10 20:40:49.458434|2017-10-10 20:40:49.458434
NCT03297736|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-28|||March 1, 2016|Actual|2016-03-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Improved Otologic Implants on Demand Intraoperatively With 3D CAD/CAM Autografts|Improved Otologic Implants on Demand Intraoperatively With 3D CAD/CAM Autografts|Recruiting||N/A|10|Anticipated|Nitinetics LLC||2|||f||||f|f|f||||||||2017-10-10 20:40:51.123419|2017-10-10 20:40:51.123419
NCT03297723|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|EFFADOL-K||Effectiveness of a Patient Therapeutic Education Program in Improving Pain Management|Effectiveness of a Patient Therapeutic Education Program in Improving Pain Management|Not yet recruiting||N/A|260|Anticipated|Centre Francois Baclesse|||2||f||||f|f|f||||||||2017-10-10 20:40:51.241766|2017-10-10 20:40:51.241766
NCT03297710|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-10-04|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery|Phase I Trial of TAS-102 and Concurrent Radiation Therapy for Patients With Locally Recurrent, Unresectable or Metastatic, Rectal Cancer|Not yet recruiting||Phase 1|24|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 20:40:51.36138|2017-10-10 20:40:51.36138
NCT03297697|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Minimal Residual Disease in Peripheral T-cell Lymphoma|A Multi-Institutional Prospective Cohort Study of Minimal Residual Disease in Peripheral T-cell Lymphoma|Recruiting||N/A|42|Anticipated|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:40:51.471107|2017-10-10 20:40:51.471107
NCT03297684|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-10-03|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|March 1, 2020|Anticipated|2020-03-01|December 31, 2019|Anticipated|2019-12-31||Observational|||Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection|Assessment of Biomarker Profile in Diabetic Macular Edema in Response to Treatment With Intravitreal Aflibercept|Not yet recruiting||N/A|40|Anticipated|Advanced Eye Research Associates|||1||f||||f|t|f|||t|||||2017-10-10 20:40:51.576784|2017-10-10 20:40:51.576784
NCT03297671|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||The Prevention of Rh Disease of Newborns in Pakistan|Early Identification of Rh Negative Women During Pregnancy and Use of Prophylaxis to Prevent Rh Disease of Newborns in Dadu District, Sindh, Pakistan|Not yet recruiting||N/A|2000|Anticipated|Aga Khan University|||2||f|||||t|t|f|f|f|||||2017-10-10 20:40:51.655204|2017-10-10 20:40:51.655204
NCT03297658|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-10-03|||October 10, 2017|Anticipated|2017-10-10|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Electro-acupuncture (EA) in Children Undergoing Procedures for Congenital Heart Defects.|Electro-acupuncture (EA) in Children Undergoing Procedures for Congenital Heart Defects.|Not yet recruiting||N/A|108|Anticipated|West Virginia University||2|||f||||f|f|t|f|f||||||2017-10-10 20:40:51.749924|2017-10-10 20:40:51.749924
NCT03297645|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-25|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||RVA Breathes: A Richmond City Collaboration to Reduce Pediatric Asthma Disparities|RVA Breathes: A Richmond City Collaboration to Reduce Pediatric Asthma Disparities|Not yet recruiting||N/A|300|Anticipated|Virginia Commonwealth University||3|||f||||t|f|f||||||||2017-10-10 20:40:51.832138|2017-10-10 20:40:51.832138
NCT03124797|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||March 2, 2016||2016-03-02|June 2017|2017-06-01|April 5, 2016|Actual|2016-04-05|April 5, 2016|Actual|2016-04-05||Interventional|||Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (RD DCI)||Completed||N/A|18|Actual|Masimo Corporation||1|||f|||||f|t|f|f|f|||||2017-10-10 21:08:43.012913|2017-10-10 21:08:43.012913
NCT03297632|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-25|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Improving Muscle Strength, Mass and Physical Function in Older Adults|Functionally Designed Resistance Exercise With the Aim of Improving Balance, Muscle Strength, Muscle Mass and Physical Function of the Elderly: a Randomized Controlled Study|Enrolling by invitation||N/A|214|Anticipated|Västerbotten County Council||3|||f||||f|f|f||||||||2017-10-10 20:40:51.918442|2017-10-10 20:40:51.918442
NCT03297619|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-28|||September 16, 2017|Actual|2017-09-16|September 2017|2017-09-01|September 15, 2019|Anticipated|2019-09-15|September 15, 2019|Anticipated|2019-09-15||Interventional|||Self-help Books for Social Anxiety|A Randomized Controlled Trial (RCT) Comparing Acceptance and Commitment Therapy (ACT) and Cognitive Behavioral Therapy (CBT) Self-help Books for Social Anxiety|Recruiting||N/A|100|Anticipated|Utah State University||2|||f||||f|f|f||||||||2017-10-10 20:40:52.106521|2017-10-10 20:40:52.106521
NCT03297606|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-27|2017-09-28|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|CAPTUR||Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)|Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial|Not yet recruiting||Phase 2|720|Anticipated|Canadian Cancer Trials Group||14|||f||||t|f|f||||||||2017-10-10 20:40:52.225999|2017-10-10 20:40:52.225999
NCT03297593|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-28|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 1, 2037|Anticipated|2037-12-01|March 31, 2020|Anticipated|2020-03-31||Interventional|||Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma|Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Single-arm Phase lI Trial|Not yet recruiting||Phase 2|37|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||t|f|f||||||||2017-10-10 20:40:52.364409|2017-10-10 20:40:52.364409
NCT03297580|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-28|||February 1, 2016|Actual|2016-02-01|September 2017|2017-09-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Observational|SCLERODERMIE||Itch and Clinacal Caracteristics in Systemic Sclerosis||Completed||N/A|61|Actual|University Hospital, Brest|||1||f|||||f|f||||||||2017-10-10 20:40:52.521436|2017-10-10 20:40:52.521436
NCT03297567|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|September 30, 2018|Anticipated|2018-09-30||Interventional|||Physical Therapy Guidelines For Hospitalized Elderly|Control Group, Randomized, Blind Assessment of Physical Therapy Guidelines For Hospitalized Elderly|Not yet recruiting||N/A|68|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:40:52.593069|2017-10-10 20:40:52.593069
NCT03297554|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-26|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Healthy Kids Pilot|Healthy Kids Pilot|Not yet recruiting||N/A|30|Anticipated|Pennington Biomedical Research Center||1|||f||||f|f|f||||||||2017-10-10 20:40:52.683209|2017-10-10 20:40:52.683209
NCT03297541|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-26|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Healthy Kids I-PAL|Healthy Kids at I-PAL (Interactive Physical Activity Lab)|Enrolling by invitation||N/A|30|Anticipated|Pennington Biomedical Research Center||1|||f||||f|f|f||||||||2017-10-10 20:40:52.767036|2017-10-10 20:40:52.767036
NCT03297515|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-28|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|MADEOS||Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease|Prospective, Randomised, Double-blind Study to Assess the Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease (Macular Degeneration Omega-3 Study - MADEOS|Not yet recruiting||N/A|60|Anticipated|Ophthalmos Research and Education Institute||2|||f||||f|f|f|||f|||||2017-10-10 20:40:52.929539|2017-10-10 20:40:52.929539
NCT03297502|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-28|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis|Multicenter Study of the Safety and Bioequivalence of Par's Pimecrolimus Cream, 1% and RLD Elidel® (Pimecrolimus Cream, 1%) and Compare Both Active Treatments to a Vehicle Control in Treatment of Mild to Moderate Atopic Dermatitis|Completed||Phase 3|582|Actual|Par Pharmaceutical, Inc.||3|||f||||f||||||||||2017-10-10 20:40:53.000445|2017-10-10 20:40:53.000445
NCT03297489|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|May 16, 2020|Anticipated|2020-05-16|May 16, 2019|Anticipated|2019-05-16||Interventional|||Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer|A Pilot Study of Feasibility of Performing Intravital Microscopy in Patients With Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Not yet recruiting||Early Phase 1|18|Anticipated|Roswell Park Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 20:40:53.084235|2017-10-10 20:40:53.084235
NCT03297463|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||December 11, 2017|Anticipated|2017-12-11|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma|A Phase 1b/2 Study of Hypofractionated Radiation and Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f|||||f|f||||||||2017-10-10 20:40:53.234447|2017-10-10 20:40:53.234447
NCT03297450|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-10-02|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|||tDCS and Aphasia Therapy in the Acute Phase After Stroke|The Neuromodulatory Effect of Combined Transcranial Direct Current Stimulation (tDCS) With Aphasia Therapy in the Acute Phase After Ischemic Stroke|Recruiting||Phase 2|25|Anticipated|University Hospital, Ghent||2|||f||||f|f|t|f||t|||||2017-10-10 20:40:53.317019|2017-10-10 20:40:53.317019
NCT03297437|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|Predictors||Predictors for Successful Neurofeedback Training|Predictors for Successful Neurofeedback Training|Recruiting||N/A|192|Anticipated|Psychiatric University Hospital, Zurich||1|||f||||f|f|f||||||||2017-10-10 20:40:53.3921|2017-10-10 20:40:53.3921
NCT03297424|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|December 2020|Anticipated|2020-12-01||Interventional|||A Study of PLX2853 in Advanced Malignancies.|A Phase 1b/2a Dose-escalation Study to Assess Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLX2853 in Subjects With Advanced Malignancies|Recruiting||Phase 1/Phase 2|166|Anticipated|Plexxikon||1|||f||||f|t|f||||||||2017-10-10 20:40:53.454339|2017-10-10 20:40:53.454339
NCT03297411|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-25|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|June 22, 2022|Anticipated|2022-06-22|June 22, 2022|Anticipated|2022-06-22||Interventional|||Clinical Outcomes With Electroconvulsive Therapy: Insights From Computational Modelling|Clinical Outcomes With Electroconvulsive Therapy: Insights From Computational Modelling|Recruiting||Phase 2|52|Anticipated|The University of New South Wales||4|||f||||f|f|f||||||||2017-10-10 20:40:53.539838|2017-10-10 20:40:53.539838
NCT03297398|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)|A Randomized, Double-blind, Placebo-controlled Dose-ranging Study of OPK-88004 Once-a-day Dosing for 16 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia|Not yet recruiting||Phase 2|126|Anticipated|Transition Therapeutics Ireland Limited||3|||f||||t|t|f||||||||2017-10-10 20:40:53.714649|2017-10-10 20:40:53.714649
NCT03297385|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-28|||August 28, 2014|Actual|2014-08-28|August 2017|2017-08-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|DARANA||Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation|Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation|Completed||Phase 2|50|Actual|The Netherlands Cancer Institute||1|||f|||||f|f|||f|||||2017-10-10 20:40:53.797091|2017-10-10 20:40:53.797091
NCT03297372|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Visual Performance Intraocular Lens (IOL) MicroPure 1.2.3.|Clinical Study to Investigate Visual Performance of Hydrophobic Monofocal IOL: MicroPure 1.2.3.|Recruiting||N/A|120|Anticipated|Physiol||1|||f||||f|f|f||||||||2017-10-10 20:40:53.882566|2017-10-10 20:40:53.882566
NCT03297359|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|WAVe||WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism|A Multicentre Prospective Cohort Study Assessing the Use of Weight-Adjusted Low-Molecular-Weight-Heparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism|Not yet recruiting||Phase 2|150|Anticipated|Ottawa Hospital Research Institute||1|||f||||t|f|f|||f|||||2017-10-10 20:40:53.982141|2017-10-10 20:40:53.982141
NCT03297346|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-28|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|May 31, 2021|Anticipated|2021-05-31|October 1, 2020|Anticipated|2020-10-01||Interventional|EARLY-HEART||Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer|Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer (EARLY HEART Study) in the Frame of the Implications of MEDIcal Low Dose RADiation Exposure (MEDIRAD) European Project|Recruiting||N/A|250|Anticipated|Institut de Radioprotection et de Surete Nucleaire||1|||f|||||f|f||||||||2017-10-10 20:40:54.071145|2017-10-10 20:40:54.071145
NCT03297320|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|ACP@LHSC||Advance Care Planning at London Health Sciences Centre|Advance Care Planning at London Health Sciences Centre|Recruiting||N/A|400|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:40:54.27722|2017-10-10 20:40:54.27722
NCT03297307|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-25|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|February 1, 2019|Anticipated|2019-02-01||Interventional|||Mother and Child Health Outcomes After Maternal Bariatric Surgery|Prospective: Mother and Child Health Outcomes After Maternal Bariatric Surgery|Not yet recruiting||N/A|30|Anticipated|University of Nebraska||2|||f||||f|f|f||||||||2017-10-10 20:40:54.361515|2017-10-10 20:40:54.361515
NCT03297294|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||March 15, 2018|Anticipated|2018-03-15|September 2017|2017-09-01|April 19, 2019|Anticipated|2019-04-19|April 12, 2019|Anticipated|2019-04-12||Interventional|EMPADINE||Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)|A Double-blind, Placebo-controlled, Randomized Trial to Determine the Safety and Efficacy of EMA401 in Reducing 24-hour Average Pain Intensity Score in Patients With Painful Diabetic Neuropathy (EMPADINE)|Not yet recruiting||Phase 2|400|Anticipated|Novartis||2|||f||||t|t|f||||||||2017-10-10 20:40:54.447916|2017-10-10 20:40:54.447916
NCT03297281|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 1, 2020|Anticipated|2020-05-01|November 30, 2019|Anticipated|2019-11-30||Interventional|SOAP||Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)|Multicenter Randomized Open-labelled Trial Which Aims to Show Non-inferiority of Adverse Events Risk During the Maintenance of Oral-anticoagulation in the Surgery of Benign Prostatic Hypertrophy by Laser Photovaporization|Not yet recruiting||N/A|386|Anticipated|Clinique Pasteur||2|||f|||||f|f||||||||2017-10-10 20:40:54.547071|2017-10-10 20:40:54.547071
NCT02698865|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-14|||January 1, 2016||2016-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:25:27.298886|2017-10-10 22:25:27.298886
NCT03297268|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-27|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|BESI||Behavioral and Environmental Sensing and Intervention|Behavioral and Environmental Sensing and Intervention for Dementia Caregiver Empowerment|Recruiting||N/A|24|Anticipated|University of Virginia|||3||f||||f|f|f||||||||2017-10-10 20:40:54.686766|2017-10-10 20:40:54.686766
NCT03297255|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||January 1, 2013|Actual|2013-01-01|September 2017|2017-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||Primary Liver Cancer Cohort of South China|Factors Influencing the Occurrence and Long-term Survival of Patients With Primary Liver Cancer: A Cohort Study in South China|Recruiting||N/A|4000|Anticipated|Sun Yat-sen University|||1||f||||||||||Samples With DNA|"     Blood and liver tissue were retented during therapy   "|||2017-10-10 20:40:54.806564|2017-10-10 20:40:54.806564
NCT03297242|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-23|2017-09-28|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients|A Retrospective Study of the Efficacy of Compound Lactobacillus Acidophilus Combined With Bismuth Quadruple Rescue Therapy on Patients With H Pylori Eradication Failures|Not yet recruiting||N/A|30|Anticipated|Changhai Hospital|||1||f|||||f|f||||||||2017-10-10 20:40:54.88277|2017-10-10 20:40:54.88277
NCT03297229|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Peer Mentoring and Blood Pressure Self-monitoring on Hypertension Control.|Effectiveness of Peer Mentoring and Blood Pressure Self-monitoring for Blood Pressure Control in Vulnerable Population in Argentina. A Randomized Clinical Trial.|Recruiting||N/A|430|Anticipated|Institute for Clinical Effectiveness and Health Policy||3|||f||||f|f|f||||||||2017-10-10 20:40:54.949743|2017-10-10 20:40:54.949743
NCT03297216|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|IPOP||Improving Pregnancy Outcomes With Progesterone|Z 31702 - Improving Pregnancy Outcomes With Progesterone (IPOP): a Trial of 17-Hydroxyprogesterone Caproate to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy|Recruiting||Phase 3|800|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|t|f|||t|||||2017-10-10 20:40:55.174175|2017-10-10 20:40:55.174175
NCT03297203|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-29|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|August 2, 2018|Anticipated|2018-08-02||Interventional|CriSIs||Innate Lymphoid Cells in Septic Shock|Role of Innate Lymphoid Cells in the Immunosuppression of Septic Shock|Recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f|f|f||||||||2017-10-10 20:40:55.263855|2017-10-10 20:40:55.263855
NCT03297190|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||January 15, 2018|Anticipated|2018-01-15|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|RISE||Impact on Nutritional Practices: SMS and Interpersonal Communication|Evaluating the Impact of Text Messages and Interpersonal Community Support Groups on MICN Practices in Tanzania|Not yet recruiting||N/A|1200|Anticipated|Helen Keller International||4|||f||||f|f|f||||||||2017-10-10 20:40:55.344644|2017-10-10 20:40:55.344644
NCT03297177|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 1, 2023|Anticipated|2023-12-01|December 1, 2022|Anticipated|2022-12-01||Interventional|NDD||Autologous Stem/Stromal Cells in Neurological Disorders and Disease|Use Of Autologous Stem Cell Use In Neurological Non-neoplastic Disorders And Disease|Not yet recruiting||N/A|300|Anticipated|Healeon Medical Inc||3|||f||||t|f|t|f|||||||2017-10-10 20:40:55.426646|2017-10-10 20:40:55.426646
NCT03297164|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment|One Year Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment-A Prospective,Multicenter,Cohort Study|Not yet recruiting||N/A|12000|Anticipated|Harbin Medical University|||2||f||||f|f|f||||||||2017-10-10 20:40:55.526959|2017-10-10 20:40:55.526959
NCT03297151|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-25|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Protein Supplementation and Recovery of Muscle Function|The Effect of Milk Derived Protein Supplementation on Muscle Recovery Following Resistance Exercise|Recruiting||N/A|24|Anticipated|University of Limerick||3|||f||||t|f|f||||||||2017-10-10 20:40:55.655339|2017-10-10 20:40:55.655339
NCT03297138|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-26|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Fistula Laser Closure|Fistula Laser Closure|Not yet recruiting||N/A|72|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||||2017-10-10 20:40:55.749538|2017-10-10 20:40:55.749538
NCT03297125|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI|Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI|Not yet recruiting||Phase 4|30|Anticipated|Medical College of Wisconsin||2|||f||||t|f|t|f||f|||||2017-10-10 20:40:55.808318|2017-10-10 20:40:55.808318
NCT03297112|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-25|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 29, 2018|Anticipated|2018-08-29||Interventional|||Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery|Subharmonic Contrast Ultrasound for Improved Characterization for Adnexal Masses-A Pilot Study|Recruiting||Early Phase 1|45|Anticipated|Thomas Jefferson University||1|||f||||t|t|f|||t|||||2017-10-10 20:40:55.910468|2017-10-10 20:40:55.910468
NCT03297099|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Robotic-Assisted Laparoscopic Versus Open Surgery for Complicated Hepatolithiasis|A Prospective Cohort Study: Robotic-Assisted Laparoscopic Versus Open Surgery for Complicated Hepatolithiasis|Recruiting||N/A|60|Anticipated|Southwest Hospital, China||2|||f||||t|f|f||||||||2017-10-10 20:40:55.986844|2017-10-10 20:40:55.986844
NCT03297086|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-25|||December 1, 2015|Actual|2015-12-01|September 2017|2017-09-01|September 11, 2017|Actual|2017-09-11|February 25, 2016|Actual|2016-02-25||Interventional|||Changes of Angle Kappa After Implantation of Multifocal Intraocular Lenses|Changes of Angle Kappa After Implantation of Multifocal Intraocular Lenses|Completed||N/A|30|Actual|Semmelweis University||2|||f||||f|f|||||||||2017-10-10 20:40:56.063982|2017-10-10 20:40:56.063982
NCT03297073|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PARAFOI||Paracetamol Metabolism Research in Postoperative Hepatic Surgery|Paracetamol Metabolism Research in Postoperative Hepatic Surgery|Not yet recruiting||N/A|90|Anticipated|University Hospital, Lille||3|||f||||t|f|f||||||||2017-10-10 20:40:56.131463|2017-10-10 20:40:56.131463
NCT03297060|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-25|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|IAMSBIRT||Implementing Alcohol Misuse SBIRT in a National Cohort of Pediatric Trauma Centers|Implementing Alcohol Misuse SBIRT in a National Cohort of Pediatric Trauma Centers|Not yet recruiting||N/A|540|Anticipated|Rhode Island Hospital||2|||f||||f|f|f||||||||2017-10-10 20:40:56.312529|2017-10-10 20:40:56.312529
NCT03297047|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Comparing Forearm and Upper Arm Combi Cast for Distal Forearm Fractures in Children|Randomized Controlled Trial Comparing Forearm and Upper Arm Combi Cast for Immobilization After Closed Reduced Distal Forearm Fractures in Children|Not yet recruiting||N/A|120|Anticipated|University Children's Hospital, Zurich||2|||f||||f|f|f|||f|||||2017-10-10 20:40:56.414604|2017-10-10 20:40:56.414604
NCT03297034|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||January 1, 2007|Actual|2007-01-01|September 2017|2017-09-01|January 2050|Anticipated|2050-01-01|January 2050|Anticipated|2050-01-01|50 Years|Observational [Patient Registry]|SCCSS||Swiss Childhood Cancer Survivor Study|Swiss Childhood Cancer Survivor Study (SCCSS)|Recruiting||N/A|2876|Anticipated|University of Bern|||1||f||||f|f|f||||||||2017-10-10 20:40:56.525055|2017-10-10 20:40:56.525055
NCT03297021|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting|Effects of Ondansetron Dose and Timing on Rates of Post-operative Nausea and Vomiting|Not yet recruiting||Phase 4|300|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||f|t|f|||t|||||2017-10-10 20:40:56.656646|2017-10-10 20:40:56.656646
NCT03297008|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||March 11, 2015|Actual|2015-03-11|September 2017|2017-09-01|February 11, 2018|Anticipated|2018-02-11|February 11, 2018|Anticipated|2018-02-11||Observational|||Biomarkers in Saliva and Stool|Understanding Innate and Adaptive Immunological Response in Stool and Saliva Samples in Healthy Donors|Recruiting||N/A|160|Anticipated|Danone Asia Pacific Holdings Pte, Ltd.|||1||f||||f|f|f||||Samples Without DNA|"     Saliva, Stool samples   "|||2017-10-10 20:40:56.765628|2017-10-10 20:40:56.765628
NCT03296995|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Accuracy, Feasibility and Acceptance of CGM Lupus|Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Systemic Lupus Erythematosus|Recruiting||N/A|30|Anticipated|RenJi Hospital||1|||f||||t|f|f||||||||2017-10-10 20:40:56.861567|2017-10-10 20:40:56.861567
NCT03296982|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-25|||December 2014||2014-12-01|September 2017|2017-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants|A Study to Determine the Inter/Intra Observer and Intra-Subject Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants|Completed||N/A|12|Actual|Perosphere, Inc.|||1||f||||f|t|f||||||||2017-10-10 20:40:56.954857|2017-10-10 20:40:56.954857
NCT03296969|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Rectus Muscle Re-approximation at Cesarean Delivery|The Value of Rectus Muscle Re-approximation at Cesarean Delivery|Not yet recruiting||N/A|200|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:40:57.041925|2017-10-10 20:40:57.041925
NCT03296956|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||November 11, 2017|Anticipated|2017-11-11|September 2017|2017-09-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||A Dietary Supplement for Mood Symptoms in Early Postpartum: A Double Blind Randomized Placebo Controlled Trial|A Dietary Supplement for Mood Symptoms in Early Postpartum: A Double Blind Randomized Placebo Controlled Trial|Not yet recruiting||Phase 2|60|Anticipated|Centre for Addiction and Mental Health||2|||f|||||f|f||||||||2017-10-10 20:40:57.12951|2017-10-10 20:40:57.12951
NCT03296943|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-26|||July 1, 2010|Actual|2010-07-01|September 2017|2017-09-01|November 30, 2010|Actual|2010-11-30|November 30, 2010|Actual|2010-11-30||Interventional|||Efficacy of Inhalation of Essential Oil on the Reduction of Inhalants Craving|A Novel Approach of Substitution Therapy With Inhalation of Essential Oil for the Reduction of Inhalants Craving: A Double-blinded Randomized Controlled Trial|Completed||Phase 3|34|Actual|Chulalongkorn University||2|||f||||f|f|f||||||||2017-10-10 20:40:57.23659|2017-10-10 20:40:57.23659
NCT03296930|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 31, 2018|Anticipated|2018-10-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Effect Of DAAs For Treatment Of HCV On Normal Kidney|Effect Of Interferon-Free Direct Acting Antiviral Agents For Treatment Of Hepatitis C Virus Patients On The Normal Kidney|Not yet recruiting||Phase 4|100|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:40:57.3369|2017-10-10 20:40:57.3369
NCT03296917|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-25|||December 11, 2015|Actual|2015-12-11|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study Examining PrEP-001 in Subjects With Asthma|A Phase II, Double-Blinded, Randomised, Controlled Study to Examine the Prophylactic Efficacy, Safety and Tolerability of PrEP-001 in Asthmatic Subjects Subsequently Challenged With Human Rhinovirus (HRV-16)|Completed||Phase 2|60|Actual|Hvivo||2|||f||||f||||||||||2017-10-10 20:40:57.453865|2017-10-10 20:40:57.453865
NCT03296904|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-25|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CLs++1stCS||The CYBERnetic LowEr-Limb CoGnitive Ortho-prosthesis Plus Plus, 1st Clinical Study|The CYBERnetic LowEr-Limb CoGnitive Ortho-prosthesis Plus Plus, 1st Clinical Study: Validation of the Efficacy of the CYBERnetic LowEr-Limb CoGnitive Ortho-prosthesis Plus Plus Modules in a Clinical Setting|Not yet recruiting||N/A|16|Anticipated|Fondazione Don Carlo Gnocchi Onlus||1|||f||||f|f|f||||||||2017-10-10 20:40:57.6224|2017-10-10 20:40:57.6224
NCT03296891|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|March 6, 2018|Anticipated|2018-03-06|March 6, 2018|Anticipated|2018-03-06||Interventional|||Point of Care Ultrasonography In The Management of Undifferentiated Shock: A Pilot Randomized Controlled Trial|Randomized Point of Care Ultrasound Guided Resuscitation and Usual Care Comparison in the Management of Undifferentiated Shock: a Pilot Study|Recruiting||N/A|50|Anticipated|Western University, Canada||2|||f||||f|f|f||||||||2017-10-10 20:40:57.746398|2017-10-10 20:40:57.746398
NCT03296878|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Food-for-Families: Experimental Grocery Store Study|Food-for-Families: Relationship Between Income, Obesity, and Food Purchasing Using an Experimental Grocery Store Study|Recruiting||N/A|80|Anticipated|USDA Grand Forks Human Nutrition Research Center||2|||f||||f|f|f||||||||2017-10-10 20:40:57.842718|2017-10-10 20:40:57.842718
NCT03296865|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-28|||March 1, 2014|Actual|2014-03-01|September 2017|2017-09-01|March 1, 2016|Actual|2016-03-01|March 3, 2015|Actual|2015-03-03||Interventional|||Taping in Children With Cerebral Palsy|Effects of Kinesio Taping in Rectus Femoris Activity and Sit-to-stand Movement in Children With Unilateral Cerebral Palsy: Placebo-controlled, Repeated-measure Design|Completed||N/A|11|Actual|Universidade Federal de Santa Catarina||3|||f||||t|f|f||||||||2017-10-10 20:40:57.942555|2017-10-10 20:40:57.942555
NCT03296852|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-27|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|February 20, 2018|Anticipated|2018-02-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke|SONAS Ultrasound Device for the Detection of Ischemic and Hemorrhagic Stroke|Recruiting||Early Phase 1|10|Anticipated|University of California, Los Angeles||1|||f||||f|t|t|t|f|f|||||2017-10-10 20:40:58.040215|2017-10-10 20:40:58.040215
NCT03296839|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-10-04|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|January 2023|Anticipated|2023-01-01|July 2021|Anticipated|2021-07-01||Interventional|OLIVER||Oligometastases of the Liver Treated With Chemotherapy With or Without Radiotherapy in Patients With Colorectal Cancer|Oligometastases of the LIVer Treated With Chemotherapy With or Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer|Not yet recruiting||Phase 3|210|Anticipated|UNICANCER||2|||f||||t|f|f||||||||2017-10-10 20:40:58.134449|2017-10-10 20:40:58.134449
NCT03296826|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 31, 2032|Anticipated|2032-03-31|March 31, 2032|Anticipated|2032-03-31||Observational|||Prospective Cohort Study of Variant Carriers With BRCA1 or BRCA2|Prospective Cohort Study of Variant Carriers With BRCA1 and BRCA2|Not yet recruiting||N/A|600|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||t|f|f||||Samples With DNA|"     Blood samples (all subjects) for Germ-line DNA sequencing, Biospy samples(when subjects have     RRSO within follow-up duration)   "|||2017-10-10 20:40:58.215913|2017-10-10 20:40:58.215913
NCT03296813|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-26|2017-09-26|||August 14, 2018|Anticipated|2018-08-14|September 2017|2017-09-01|August 14, 2022|Anticipated|2022-08-14|August 14, 2022|Anticipated|2022-08-14||Interventional|TRANSFORM-HF||TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure|TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure|Not yet recruiting||Phase 4|6000|Anticipated|Duke University||2|||f||||t|t|f|||f|||||2017-10-10 20:40:58.305803|2017-10-10 20:40:58.305803
NCT03296800|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||September 27, 2017|Anticipated|2017-09-27|September 2017|2017-09-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|||Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects|A Phase 1, Open-Label, Non-Randomized, Fixed-Sequence Composite Study to Evaluate the Effects of Probenecid, Rifampin, and Verapamil on the Pharmacokinetics and Pharmacodynamics of Bexagliflozin in Healthy Subjects|Not yet recruiting||Phase 1|48|Anticipated|Theracos||3|||f||||t|t|f||||||||2017-10-10 20:40:58.404344|2017-10-10 20:40:58.404344
NCT03296787|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||September 26, 2017|Anticipated|2017-09-26|September 2017|2017-09-01|March 23, 2018|Anticipated|2018-03-23|March 23, 2018|Anticipated|2018-03-23||Interventional|||A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954|A Phase 1, Open-Label, Parallel Group Trial to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single Intravenous Dose of TAK-954|Not yet recruiting||Phase 1|40|Anticipated|Takeda||5|||f||||f|t|f||||||||2017-10-10 20:40:58.505415|2017-10-10 20:40:58.505415
NCT03296774|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-27|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|May 30, 2017|Actual|2017-05-30|February 15, 2017|Actual|2017-02-15||Interventional|||Healthy Beyond Pregnancy: Improving Postpartum Care|Healthy Beyond Pregnancy: A Pilot Usability and Feasibility Trial|Completed||N/A|30|Actual|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 20:40:58.590535|2017-10-10 20:40:58.590535
NCT03296761|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 20, 2018|Anticipated|2018-02-20|December 20, 2017|Anticipated|2017-12-20||Observational|||Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury|Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury|Recruiting||N/A|70|Anticipated|Southeast University, China|||2||f||||t|f|f||||||||2017-10-10 20:40:58.653721|2017-10-10 20:40:58.653721
NCT03296748|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||June 1, 2016|Actual|2016-06-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Correction of Asymptomatic 2nd Degree Cystocele in Patient With Stress Incontinence|Is There Any Value of Concomitant Repair of Asymptomatic Grade II Anterior Vaginal Wall Prolapse During Mid Urethral Sling Surgery for Stress Urinary Incontinence ?|Recruiting||Phase 2/Phase 3|123|Anticipated|Kasr El Aini Hospital||2|||f|||||f|f||||||||2017-10-10 20:40:58.730757|2017-10-10 20:40:58.730757
NCT03296722|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-28|||January 18, 2016|Actual|2016-01-18|September 2017|2017-09-01|April 28, 2017|Actual|2017-04-28|December 13, 2016|Actual|2016-12-13||Interventional|||Effect of a Nutritional Intervention That Incorporates the Transtheoretical Model|Effect of a Nutritional Intervention That Incorporates the Transtheoretical Model of Motivation to Change in Healthy Eating in Patients With Cardiovascular Risk Factors: a Randomized Controlled Trial|Completed||N/A|2|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t|f|f||||||||2017-10-10 20:40:58.88128|2017-10-10 20:40:58.88128
NCT03296709|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-27|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|CPP Z-M||Preformed Pediatric Crown Zirconia Versus Preformed Pediatric Metal Crown|Preformed Pediatric Crown Zirconia Versus Preformed Pediatric Metal Crown CppZ-M|Not yet recruiting||N/A|101|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||||2017-10-10 20:40:58.944395|2017-10-10 20:40:58.944395
NCT03296696|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-27|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|January 20, 2021|Anticipated|2021-01-20|January 20, 2021|Anticipated|2021-01-20||Interventional|||Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma|Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 596 in Subjects With Glioblastoma Expressing Mutant Epidermal Growth Factor Receptor Variant III (EGFRvIII)|Not yet recruiting||Phase 1|82|Anticipated|Amgen||2|||f||||f|t|f||||||||2017-10-10 20:40:59.023819|2017-10-10 20:40:59.023819
NCT03296683|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-25|||May 23, 2017|Actual|2017-05-23|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer|Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer|Recruiting||N/A|1200|Anticipated|Real Imaging Ltd.||1|||f|||||f|f||||||||2017-10-10 20:40:59.125898|2017-10-10 20:40:59.125898
NCT03296670|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||August 1, 2015|Actual|2015-08-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|April 28, 2017|Actual|2017-04-28||Interventional|||Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP|Intracoronary Infusion of Alprostadil and Nitroglycerin With Targeted Perfusion Microcatheter in STEMI Patients With Coronary Slow Flow Phenomenon|Completed||Phase 4|57|Actual|RenJi Hospital||2|||f||||t|f|f||||||||2017-10-10 20:40:59.1996|2017-10-10 20:40:59.1996
NCT03296657|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-28|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|September 22, 2017|Actual|2017-09-22|September 22, 2017|Actual|2017-09-22||Interventional|||Analysis of Stannous Fluoride in GCF and Subgingival Plaque|A Pilot Study to Evaluate Stannous Fluoride in GCF and Subgingival Plaque|Completed||N/A|20|Actual|Procter and Gamble||1|||f||||f|f|f|||f|||||2017-10-10 20:40:59.304028|2017-10-10 20:40:59.304028
NCT03296644|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-25|||August 16, 2016|Actual|2016-08-16|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of Treatment Effects of PowerScope and Forsus Using CBCT|"Evaluation of Treatment Effects of Two Different Fixed Functional Appliances in Patients With Class II Div 1 Malocclusion Using CBCT- A Controlled Clinical Study"|Active, not recruiting||N/A|42|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f|||f|||||2017-10-10 20:40:59.374939|2017-10-10 20:40:59.374939
NCT03296631|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-27|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|METAKIDS||Phages Dynamics and Influences During Human Gut Microbiome Establishment|Phages Dynamics and Influences During Human Gut Microbiome Establishment|Recruiting||N/A|20|Anticipated|Institut Pasteur|||1||f||||f|f|f||||Samples With DNA|"     fresh stools in diapers. Genomic DNA will be extracted from feces but no human genetic     analysis will be realized.   "|||2017-10-10 20:40:59.448118|2017-10-10 20:40:59.448118
NCT03296618|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-03|||June 2012||2012-06-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke|Phase I Clinical Study of Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke|Active, not recruiting||Phase 1|18|Anticipated|Neuralstem Inc.||1|||f||||f|f|f||||||||2017-10-10 20:40:59.524405|2017-10-10 20:40:59.524405
NCT03296605|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-25|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|March 30, 2025|Anticipated|2025-03-30|March 30, 2022|Anticipated|2022-03-30||Observational|||Development of Obesity and Bariatric Surgery|Impacts of Bariatric Surgery on Obesity in China|Enrolling by invitation||N/A|150|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|||2||f||||f|f|f||||Samples With DNA|"     Blood, Adipose tissue, Liver tissue   "|||2017-10-10 20:40:59.598999|2017-10-10 20:40:59.598999
NCT03296579|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-29|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma|A Prospective Open Randomized Clinical Trial of Non-invasive Ventilation Versus Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma.|Not yet recruiting||N/A|100|Anticipated|University of British Columbia||3|||f||||t|f|f||||||||2017-10-10 20:40:59.737541|2017-10-10 20:40:59.737541
NCT03296566|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-25|||July 13, 2017|Actual|2017-07-13|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams|The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams|Recruiting||N/A|200|Anticipated|University of British Columbia||2|||f||||t|f|f||||||||2017-10-10 20:40:59.954972|2017-10-10 20:40:59.954972
NCT03296553|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-28|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|September 12, 2018|Anticipated|2018-09-12||Interventional|||Valganciclovir Four Weeks Prior to cART Initiation Compared to Standard Therapy for Disseminated Kaposi Sarcoma|Valganciclovir for Suppression of HHV-8 Four Weeks Prior to Initiation of cART in Patients With Disseminated Kaposi Sarcoma Compare With Standard Therapy, Its Impact on the Development of IRIS and Attributable Mortality|Recruiting||Phase 2|38|Anticipated|National Institute of Cancerología||2|||f||||t||||||||||2017-10-10 20:41:00.106879|2017-10-10 20:41:00.106879
NCT03296540|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2021|Anticipated|2021-04-01||Interventional|CompareCrush||CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI|COMPARison of Pre-hospital CRUSHed vs. Uncrushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Interventions|Not yet recruiting||Phase 4|674|Anticipated|Maasstad Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:00.205686|2017-10-10 20:41:00.205686
NCT03296527|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-25|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 15, 2020|Anticipated|2020-07-15|November 1, 2019|Anticipated|2019-11-01||Interventional|||Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women|A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Pan-Asian Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology Programme|Not yet recruiting||Phase 3|1000|Anticipated|Ferring Pharmaceuticals||2|||f||||f|f|f||||||||2017-10-10 20:41:00.35527|2017-10-10 20:41:00.35527
NCT03296501|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-04|||October 13, 2015|Actual|2015-10-13|October 2017|2017-10-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|ADIPOSTEM||Intraspinal Transplantation of Autologous ADRC in ALS Patients|Safety and Efficacy of Intraspinal Transplantation of Autologous ADRC in ALS Patients|Recruiting||Phase 1|30|Anticipated|Mossakowski Medical Research Centre Polish Academy of Sciences||1|||f||||t|f|f||||||||2017-10-10 20:41:00.779201|2017-10-10 20:41:00.779201
NCT03296488|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-23|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Efficacy and Safety of NALDEBAIN for the Treatment of Post-Laparotomy Surgery|A Randomized Controlled Trial to Compare the Efficacy and Safety of NALDEBAIN With Intravenous Patient-Controlled Analgesia With Fentanyl for the Treatment of Post-Laparotomy Surgery|Recruiting||Phase 4|110|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:00.939659|2017-10-10 20:41:00.939659
NCT03296475|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-27|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 1, 2021|Anticipated|2021-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Intraoperative Biomechanics in Complex Abdominal Wall Reconstruction|A Study of the Intra-operative Biomechanics in Complex Abdominal Wall Reconstruction: Do Changes in Abdominal Biomechanics Correlate With Significant Changes in Lung Compliance and Respiratory Function?|Not yet recruiting||N/A|20|Anticipated|University College, London||1|||f||||f|f|f||||||||2017-10-10 20:41:01.107945|2017-10-10 20:41:01.107945
NCT03296462|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-27|||November 3, 2016|Actual|2016-11-03|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|HER-Physio||Hip External Rotation Physical Therapy Trial|Physiotherapy for Stress Urinary Incontinence: Feasibility Study for a Randomized Controlled Trial of Hip External Rotation Exercise Training Versus Pelvic Floor Muscle Exercise Training|Recruiting||N/A|30|Anticipated|University of Alberta||3|||f||||f|f|f||||||||2017-10-10 20:41:01.201309|2017-10-10 20:41:01.201309
NCT03296449|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-23|||November 22, 2015|Actual|2015-11-22|September 2017|2017-09-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Comparison Between CPAP and HFJV During One-lung Ventilation in VATS|Comparison Between Continuous Positive Airway Pressure and High-frequency Jet Ventilation in Nondependent Lung During One-lung Ventilation in Video-assisted Thoracoscopic Surgery|Completed||N/A|60|Actual|Hospital General Universitario de Alicante||3|||f||||f|f|f|||f|||||2017-10-10 20:41:01.316314|2017-10-10 20:41:01.316314
NCT03296436|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Pilot Study to Assess the Efficacy of NEOX® CORD 1K® in the Treatment of Complex Diabetic Wounds|A Pilot Study to Assess the Efficacy of NEOX® CORD 1K® in the Treatment of Complex Diabetic Wounds|Not yet recruiting||Early Phase 1|10|Anticipated|Johns Hopkins University||1|||f||||t|f|f|||f|||||2017-10-10 20:41:01.421733|2017-10-10 20:41:01.421733
NCT03296423|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-23|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|August 31, 2019|Anticipated|2019-08-31||Interventional|ACTIVATE||Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly|A Randomized Clinical Trial for Enhanced Trained Immune Responses Through Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly|Recruiting||Phase 4|200|Anticipated|Hellenic Institute for the Study of Sepsis||2|||f||||f|f|f||||||||2017-10-10 20:41:01.517689|2017-10-10 20:41:01.517689
NCT03296410|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-27|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|September 2, 2019|Anticipated|2019-09-02|September 2, 2019|Anticipated|2019-09-02||Interventional|||The Phase IVd of Inactivated Enterovirus 71 Vaccine|The Safety and Immunogenicity of Enterovirus Type 71 Inactivated Vaccine (Human Diploid Cell) With Two Measles Attenuated Live Vaccine and Live Attenuated Japanese Encephalitis Vaccine at the Same Time Point in Infants (8-month-old)|Enrolling by invitation||Phase 4|1220|Anticipated|Chinese Academy of Medical Sciences||5|||f||||t|f|f||||||||2017-10-10 20:41:01.626672|2017-10-10 20:41:01.626672
NCT03296397|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-27|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|March 2020|Anticipated|2020-03-01||Interventional|CONDYVAC||Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response|Efficacy Study of the Quadrivalent Human Papilloma Virus (HPV) Vaccine to Prevent Recurrence of External Genital Warts (EGW) in Patients Who Were Cured in the First Place|Not yet recruiting||Phase 3|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||||2017-10-10 20:41:01.721314|2017-10-10 20:41:01.721314
NCT03296384|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-27|||March 2014|Actual|2014-03-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|Envschi||Influence of Environmental Factors and Schizophrenia|Influence of Environmental Factors on the Prevalence, Risk and the Clinical Manifestations of Schizophrenia|Recruiting||N/A|600|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 20:41:01.820296|2017-10-10 20:41:01.820296
NCT03296371|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-28|||January 7, 2018|Anticipated|2018-01-07|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 1, 2021|Anticipated|2021-05-01||Observational|||Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma|Genetics of Embryonal and Alveolar Rhabdomyosarcoma Study (GEARS)|Not yet recruiting||N/A|900|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-10 20:41:01.913489|2017-10-10 20:41:01.913489
NCT03296358|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-23|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|October 1, 2017|Anticipated|2017-10-01||Interventional|||Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.|A Randomized, Double-blinded, Controlled Trial of Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines|Not yet recruiting||N/A|69|Anticipated|Chulalongkorn University||3|||f||||t|f|f|||f|||||2017-10-10 20:41:02.003373|2017-10-10 20:41:02.003373
NCT03296345|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-09-23|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|January 2017|Actual|2017-01-01||Interventional|AKTSS||Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis|Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis (AKTSS)|Recruiting||Phase 2|90|Anticipated|Children's Hospital & Research Center Oakland||2|||f||||t||||||||||2017-10-10 20:41:02.083374|2017-10-10 20:41:02.083374
NCT03295799|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-27|||September 17, 2017|Actual|2017-09-17|September 2017|2017-09-01|September 17, 2018|Anticipated|2018-09-17|September 17, 2018|Anticipated|2018-09-17||Interventional|||Patient-Centred Care for Warfarin Management: A Pilot Study to Transition Care to High Risk Patients|Patient-Centred Care for Warfarin Management: A Pilot Study to Transition Care to High Risk Patients|Recruiting||N/A|50|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 20:41:07.131196|2017-10-10 20:41:07.131196
NCT03296332|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-09-23|||January 2011||2011-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|SMASH||Shandong and Ministry of Health Action on Salt and Hypertension Project|Shandong and Ministry of Health Action on Salt and Hypertension Project (SMASH)|Active, not recruiting||N/A|17160|Anticipated|Centers for Disease Control and Prevention, China|||1||f||||t||||||Samples With DNA|"     We used blood samples of 17,160 respondents to test blood glucose and blood lipids and     24-hour urinary samples of 1820 respondents in total to investigate the changes in     sodium/salt intake.   "|||2017-10-10 20:41:02.199902|2017-10-10 20:41:02.199902
NCT03296319|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-28|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Echocardiography Guided Fluid Resuscitation in Critically Ill Patients.|Echocardiography Guided Fluid Resuscitation in Critically Ill Patients|Not yet recruiting||N/A|100|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:41:02.286017|2017-10-10 20:41:02.286017
NCT03296306|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-09-23|||September 2016||2016-09-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|August 2021|Anticipated|2021-08-01||Interventional|FOCUS||Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma|Four Cycles of Cisplatin-Based Chemotherapy in Metastatic Urothelial Carcinoma Compared to Six Cycles: Randomized Phase III Trial - FOCUS Study -|Recruiting||Phase 3|330|Anticipated|Asan Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:41:02.385602|2017-10-10 20:41:02.385602
NCT03296293|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-28|||August 1, 2016|Actual|2016-08-01|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|June 15, 2017|Actual|2017-06-15||Interventional|PEEP，ICP，CVP||Effects of Positive End-expiratory Pressure on Intracranial Pressure in Patients With Severe Traumatic Brain Injury|Doctor of Department of Emergency and Critical Care Medicine, Zhoupu Hospital Affiliated With Shanghai University of Medicine and Health Sciences, Shanghai 201318, PR China|Completed||N/A|38|Actual|Zhoupu Hospital, Pudong New Area, Shanghai, China||3|||f||||f|f|f||||||||2017-10-10 20:41:02.538722|2017-10-10 20:41:02.538722
NCT03296280|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||October 3, 2016|Actual|2016-10-03|September 2017|2017-09-01|September 28, 2018|Anticipated|2018-09-28|May 31, 2018|Anticipated|2018-05-31||Observational|||Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program|Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program|Enrolling by invitation||N/A|120|Anticipated|VA Office of Research and Development|||2||f||||f|f|f|||f|||||2017-10-10 20:41:02.645747|2017-10-10 20:41:02.645747
NCT03296267|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-04|||January 2, 2017|Actual|2017-01-02|September 2017|2017-09-01|April 20, 2018|Anticipated|2018-04-20|April 20, 2018|Anticipated|2018-04-20||Interventional|||Influence of Bile Acids on Bacterial Uptake in Functional Dyspepsia|Translocation of Microorganisms in Duodenal Biopsies of Healthy Volunteers and Patients With Functional Dyspepsia|Recruiting||N/A|40|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f||||||||2017-10-10 20:41:02.735113|2017-10-10 20:41:02.735113
NCT03296254|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Comparison of Two Brief Mindfulness Intervention for Stress and Burnout in Mental Health Professionals|Comparison of Two Brief Mindfulness Intervention for Stress and Burnout in Mental Health Professionals: a Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Universidad Nacional de Educación a Distancia||2|||f||||f|f|f||||||||2017-10-10 20:41:02.813898|2017-10-10 20:41:02.813898
NCT03296241|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-27|||August 1, 2012|Actual|2012-08-01|September 2017|2017-09-01|August 30, 2013|Actual|2013-08-30|August 30, 2013|Actual|2013-08-30||Interventional|||Non-ablative Er:Yttrium Aluminum Garnet Laser for Stress Urinary Incontinence (SUI)|Non-ablative Er:Yttrium Aluminum Garnet (Er:YAG) Laser Therapy Effect on Stress Urinary Incontinence (SUI) Related Quality of Life and Sexual Function: a Randomized Controlled Trial|Completed||N/A|114|Actual|University Medical Centre Ljubljana||2|||f||||f|f|f||||||||2017-10-10 20:41:02.905863|2017-10-10 20:41:02.905863
NCT03296228|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||May 1, 2016|Actual|2016-05-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Comparison of Dynamic Radiographs in Determining Fusion Level in Adolescent Idiopathic Scoliosis Correction|Comparison of Dynamic Radiographs in Determining Fusion Level in Adolescent Idiopathic Scoliosis Correction|Recruiting||N/A|100|Anticipated|The University of Hong Kong|||2||f||||f|f|f||||||||2017-10-10 20:41:02.987349|2017-10-10 20:41:02.987349
NCT03296215|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-27|||September 2018|Anticipated|2018-09-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Observational|||Pattern of Admitted Cases in Respiratory Intensive Care Unit at Assiut University Hospitals|Pattern of Admitted Cases in Respiratory Intensive Care Unit at Assiut University Hospitals|Not yet recruiting||N/A|200|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:41:03.088801|2017-10-10 20:41:03.088801
NCT03296202|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-09-22|||July 18, 2017|Actual|2017-07-18|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|ANRSCO3||Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV|Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV: The ANRS CO3 Aquitaine Cohort|Recruiting||N/A|4500|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||Samples With DNA|"     Blood sampling   "|||2017-10-10 20:41:03.159849|2017-10-10 20:41:03.159849
NCT03296189|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-25|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|May 1, 2018|Anticipated|2018-05-01||Interventional|LASTE||Local Anaesthetic and Steroid in the Ureter|Intraluminal Ureteric Injection of High Concentration Alkalinised Long-acting Local Anaesthetic and STeroid Post urEteroscopy: A Prospective Double Blinded Randomised Controlled Trial (LASTE Trial)|Not yet recruiting||N/A|150|Anticipated|The Adelaide and Meath Hospital, incorporating The National Children's Hospital||3|||f||||f|f|f||||||||2017-10-10 20:41:03.304409|2017-10-10 20:41:03.304409
NCT03296176|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-22|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Metabolomic Study in Huntington's Disease (METABO-HD)|Metabolomic Study in Huntington's Disease|Recruiting||N/A|150|Anticipated|University Hospital, Angers||3|||f|||||f|f||||||||2017-10-10 20:41:03.400463|2017-10-10 20:41:03.400463
NCT03295994|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2022|Anticipated|2022-12-30||Interventional|ARC||Operative Versus Non-Operative Treatment for Atraumatic Rotator Cuff Tears|Operative Versus Non-Operative Treatment for Atraumatic Rotator Cuff Tears: A Multicenter Randomized Controlled Pragmatic Trial|Not yet recruiting||N/A|700|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:41:05.48845|2017-10-10 20:41:05.48845
NCT03296150|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-23|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|February 2019|Anticipated|2019-02-01||Interventional|ADOPT-PRESTAGE||ADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGE|ADOPT-PRESTAGE: Randomized Controlled Trial on Acceptability, Diffusion and Impact on Treatment Adherence and Persistence of the PRESTAGE Program (Program for Education and Support for Oral Cancer Treatments in the Elderly) - Randomized Controlled Study Evaluating the Impact of the Program PRESTAGE|Not yet recruiting||N/A|184|Anticipated|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 20:41:04.084014|2017-10-10 20:41:04.084014
NCT03296137|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-27|||October 14, 2017|Anticipated|2017-10-14|September 2017|2017-09-01|March 14, 2020|Anticipated|2020-03-14|October 14, 2019|Anticipated|2019-10-14||Interventional|||Adoptive Cell Therapy Across Cancer Diagnoses|Adoptive Cell Therapy Across Cancer Diagnoses|Not yet recruiting||Phase 1/Phase 2|25|Anticipated|Herlev Hospital||1|||f||||t|f|f|||f|||||2017-10-10 20:41:04.266472|2017-10-10 20:41:04.266472
NCT03296124|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|PRX32||Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)|Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy|Not yet recruiting||N/A|375|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-10 20:41:04.370687|2017-10-10 20:41:04.370687
NCT03296111|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||May 4, 2017|Actual|2017-05-04|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|QUALVIDON||Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life|Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life|Recruiting||N/A|35|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:41:04.4765|2017-10-10 20:41:04.4765
NCT03296098|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|CCN013B||Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive|A Multi-center, Open-label, Non-comparative Study of the Safety and Contraceptive Efficacy of Continuous Daily Oral 10 mg of Ulipristal Acetate (UPA)|Not yet recruiting||Phase 2|200|Anticipated|Health Decisions||1|||f||||t|t|f||||||||2017-10-10 20:41:04.566798|2017-10-10 20:41:04.566798
NCT03296085|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|EDEMA||Bedside Evaluation of Edema|A Simple Technique for Quantitative Evaluation of an Important Clinical Sign|Not yet recruiting||N/A|40|Anticipated|Geisinger Clinic|||1||f||||f|f|f||||||||2017-10-10 20:41:04.776508|2017-10-10 20:41:04.776508
NCT03296059|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||Transfusion of Red Blood Cells for Acute Respiratory Distress Syndrome(ARDS) in Neonates|Transfusion of Red Blood Cells for Acute Respiratory Distress Syndrome(ARDS) in Neonates: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t|f|f||||||||2017-10-10 20:41:04.946759|2017-10-10 20:41:04.946759
NCT03296046|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||November 13, 2012|Actual|2012-11-13|September 2017|2017-09-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|LPLB||Epidemiologic Study of Persistent Polyclonal B-cell Lymphocytosis (PPBL)|Epidemiologic Study of Persistent Polyclonal B-cell Lymphocytosis (PPBL) - Observatory 1990-2012|Completed||N/A|100|Actual|Central Hospital, Nancy, France|||1||f||||f|f|f||||Samples With DNA|"     Venous blood (30 ml) taken during routine care   "|||2017-10-10 20:41:05.093528|2017-10-10 20:41:05.093528
NCT03296033|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin|Evaluation of Residual Anti-Xa Activity As A Function Of Time Following The Last Treatment Dose of Enoxaparin In Patients Presenting For Elective Surgery|Not yet recruiting||Phase 4|150|Anticipated|Wake Forest University Health Sciences||2|||f||||f|t|f|||f|||||2017-10-10 20:41:05.18083|2017-10-10 20:41:05.18083
NCT03296020|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||The Efficacy of Honey on Improving the Post Surgical Course After Tonsillectomy in Children-prospective Study|The Efficacy of Honey on Improving the Post Surgical Course After Tonsillectomy in Children-prospective Study|Not yet recruiting||N/A|80|Anticipated|HaEmek Medical Center, Israel||2|||f||||f|f|f||||||||2017-10-10 20:41:05.309144|2017-10-10 20:41:05.309144
NCT03296007|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|August 9, 2018|Anticipated|2018-08-09|August 9, 2018|Anticipated|2018-08-09||Interventional|||Evaluating the Psychophysiological Effects of a Smartphone-Based Mindfulness Task|Evaluating the Psychophysiological Effects of a Smartphone-Based Mindfulness Task on Individuals With Clinically Significant Symptoms of Chronic Pain, Depression and Anxiety|Not yet recruiting||N/A|180|Anticipated|York University||2|||f||||f|f|f||||||||2017-10-10 20:41:05.40869|2017-10-10 20:41:05.40869
NCT02613143|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-20||||||November 2015|2015-11-01||||December 2015|Anticipated|2015-12-01||Observational|||Zonulo-hyaloido-vitrectomy for Malignant Glaucoma||Recruiting||N/A|10|Anticipated|Wenzhou Medical University|||1||f||||||||||||||2017-10-10 22:43:02.45034|2017-10-10 22:43:02.45034
NCT03295981|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-26|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone|Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone: A Prospective Randomized Controlled Trial|Not yet recruiting||Phase 3|120|Anticipated|St. Louis University||2|||f||||t|t|f|||t|||||2017-10-10 20:41:05.652696|2017-10-10 20:41:05.652696
NCT03295968|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||March 2016||2016-03-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||IL-6 in Exercise-Induced Anorexia|The Role of IL-6 in Exercise-Induced Anorexia in Normal-weight Boys|Completed||N/A|15|Actual|University of Toronto||4|||f||||f||||||||||2017-10-10 20:41:05.751492|2017-10-10 20:41:05.751492
NCT03295955|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-26|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|December 3, 2018|Anticipated|2018-12-03|September 3, 2018|Anticipated|2018-09-03||Interventional|POTO||Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy|Comparing Efficacy of Postoperative Antibiotic Use in Transoral Thyroidectomy: a Prospective Randomized Controlled Trial Study|Recruiting||N/A|50|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 20:41:05.836454|2017-10-10 20:41:05.836454
NCT03295942|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-27|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors|A Phase 1a Open-Label, Dose Escalation Study of the Safety and Pharmacokinetics of OMP-336B11 Administered as a Single Agent to Subjects With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|30|Anticipated|OncoMed Pharmaceuticals, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:41:05.926685|2017-10-10 20:41:05.926685
NCT03295929|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||3D Model of Posterior Membranous Labyrinth of the Inner Ear|3D Finite Element Model of Posterior Membranous Labyrinth From in Vivo MRI of Human Temporal Bone|Not yet recruiting||N/A|1|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||||2017-10-10 20:41:06.011966|2017-10-10 20:41:06.011966
NCT03295916|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 1, 2020|Anticipated|2020-04-01|October 1, 2019|Anticipated|2019-10-01||Interventional|STOMP||Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis|Stereotactic Body Radiotherapy (SBRT) for the Treatment of OligoMetastasis in Breast Cancer Patients (STOMP): A Prospective Feasibility Trial|Not yet recruiting||Early Phase 1|30|Anticipated|Juravinski Cancer Center||1|||f||||t|f|f||||||||2017-10-10 20:41:06.080364|2017-10-10 20:41:06.080364
NCT03295903|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-22|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Interventional|||Cannabinoid Supplementation on Vascular and Cognitive Function|The Effects of Cannabinoids on Vascular and Cognitive Function in Young and Old Healthy Adults.|Not yet recruiting||Early Phase 1|24|Anticipated|University of British Columbia||5|||f|||||f|f|||f|||||2017-10-10 20:41:06.190316|2017-10-10 20:41:06.190316
NCT03295890|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||July 29, 2016|Actual|2016-07-29|September 2017|2017-09-01|July 29, 2020|Anticipated|2020-07-29|June 5, 2018|Anticipated|2018-06-05||Interventional|||Dry Needling on the Treatment of Chronic Somatosensory Tinnitus: An Open Pilot Study|Dry Needling on the Treatment of Chronic Somatosensory Tinnitus: An Open Pilot Study|Recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:06.292057|2017-10-10 20:41:06.292057
NCT03295877|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-26|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|October 24, 2018|Anticipated|2018-10-24|October 24, 2018|Anticipated|2018-10-24||Interventional|||Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)|A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration|Recruiting||Phase 1|44|Anticipated|Genentech, Inc.||2|||f|||||t|f||||||||2017-10-10 20:41:06.375504|2017-10-10 20:41:06.375504
NCT03295864|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|MCoto||Arnold Chiari Malformation: the Otological Assessment as an Objective Criteria for Surgical Treatment|Arnold Chiari Malformation: the Otological Assessment as an Objective Criteria for Surgical Treatment|Not yet recruiting||N/A|50|Anticipated|University Hospital, Bordeaux||2|||f||||f|f|f||||||||2017-10-10 20:41:06.491315|2017-10-10 20:41:06.491315
NCT03295851|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-10-05|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|PIRCAS||Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial|Postoperative, Single-dose Intravenous Iron Formulation to Reduce Post-surgical Complications in Patients Undergoing Major Abdominal Surgery: a Pilot Randomised Control Trial (PIRCAS Trial - Pilot)|Not yet recruiting||Phase 4|60|Anticipated|Singapore General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:06.682402|2017-10-10 20:41:06.682402
NCT03295838|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-25|||February 1, 2007|Actual|2007-02-01|September 2017|2017-09-01|May 3, 2014|Actual|2014-05-03|May 3, 2014|Actual|2014-05-03||Interventional|||Outcomes of Mentalization-Based Treatment for Borderline Personality Disorder|Symptom, Alexithymia and Self-image Outcomes of Mentalization-Based Treatment for Borderline Personality Disorder: a Naturalistic Study|Completed||N/A|75|Actual|Karolinska Institutet||1|||f||||f|f|f||||||||2017-10-10 20:41:06.811401|2017-10-10 20:41:06.811401
NCT03295825|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-25|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|June 30, 2018|Anticipated|2018-06-30||Interventional|PROMPT||Heparin Binding Protein in Early Sepsis Diagnosis|Prospective Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein Assay to Indicate the Presence and Outcome of Sepsis in Patients With Suspected Infection Following Emergency Department Admission|Recruiting||N/A|400|Anticipated|Hellenic Institute for the Study of Sepsis||1|||f||||f|f|f||||||||2017-10-10 20:41:06.926106|2017-10-10 20:41:06.926106
NCT03295812|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2019|Anticipated|2019-12-30||Observational|SCALE||Stratification of Chronic Alcoholic Liver Diseases (SCALE Study)|Stratification of Chronic Alcoholic Liver Diseases (SCALE Study) Based on Organs Injury: a Multi-center Prospective Observational Study|Not yet recruiting||N/A|3000|Anticipated|Nanfang Hospital of Southern Medical University|||1||f|||||f|f||||||||2017-10-10 20:41:07.070696|2017-10-10 20:41:07.070696
NCT03295786|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-03|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|August 2019|Anticipated|2019-08-01||Interventional|||Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease|Phase 1-2, Randomised, Double-Blind, Placebo Controlled, Safety and Tolerability Study of Intraputamenal Cerebral Dopamine Neurotrophic Factor (CDNF) Infusions Via an Investigational Drug Delivery System to Patients With Parkinson's Disease|Recruiting||Phase 1/Phase 2|18|Anticipated|Herantis Pharma Plc.||3|||f||||t|f|f||||||||2017-10-10 20:41:07.242326|2017-10-10 20:41:07.242326
NCT03295773|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||August 22, 2016|Actual|2016-08-22|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Observational|||Morphologic Evolution and Remodeling of Intracranial Atherosclerosis: A Longitudinal Study by 3D-rotational Angiography|Morphologic Evolution and Remodeling of Intracranial Atherosclerosis: A Longitudinal Study by 3D-rotational Angiography|Recruiting||N/A|70|Anticipated|Chinese University of Hong Kong|||1||f||||f|f|f||||||||2017-10-10 20:41:07.373578|2017-10-10 20:41:07.373578
NCT03295760|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|COENZYME||Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children|Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children|Completed||N/A|15|Actual|Central Hospital, Nancy, France|||1||f||||f|f|f||||||||2017-10-10 20:41:07.458478|2017-10-10 20:41:07.458478
NCT03295747|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PMO||Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain|Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain|Not yet recruiting||Phase 1|30|Anticipated|Baylor College of Medicine||1|||||||t|t|f||||||||2017-10-10 20:41:07.520088|2017-10-10 20:41:07.520088
NCT03295734|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-22|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|ACES||ACES - Antihypertensives Combined With Exercise for Seniors With Hypertension|ACES - Antihypertensives Combined With Exercise for Seniors With Hypertension|Not yet recruiting||N/A|213|Anticipated|University of Alabama at Birmingham||3|||f||||t|f|f||||||||2017-10-10 20:41:09.022439|2017-10-10 20:41:09.022439
NCT03295721|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Bunionectomy Study for Postoperative Analgesia (EPOCH 1)|A Phase 3, Randomized, Double Blind, Saline Placebo and Active Controlled, Multicenter Study of HTX 011 Via Local Administration for Postoperative Analgesia and Decreased Opioid Use Following Unilateral Simple Bunionectomy|Not yet recruiting||Phase 3|400|Anticipated|Heron Therapeutics||3|||f|||||t|t|f|f|t|||||2017-10-10 20:41:09.10688|2017-10-10 20:41:09.10688
NCT03295695|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient|Pilot Study of PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient Before and After Neoadjuvant Chemotherapy|Not yet recruiting||Early Phase 1|10|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 20:41:09.310191|2017-10-10 20:41:09.310191
NCT03295682|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2020|Anticipated|2020-12-31|36 Months|Observational [Patient Registry]|CONNECT||Registry in Patients With Thoracoabdominal Aneurysms|Registry in Patients With Thoracoabdominal Aneurysms Treated With Multi-branch Stent Grafts Tailored to Their Individual Anatomies|Recruiting||N/A|40|Anticipated|JOTEC GmbH|||1||f||||f|f|f||||||||2017-10-10 20:41:09.407717|2017-10-10 20:41:09.407717
NCT03295669|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||November 2016||2016-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|CourbePVC||Continuous Monitoring of Right Ventricular Function, Based on the Correlation Between the C-X Segment of the Central Venous Pressure Curve, and the Echocardiographic Evaluation of Right Ventricular Systolic Function|Continuous Monitoring of Right Ventricular Function, Based on the Correlation Between the C-X Segment of the Central Venous Pressure Curve, and the Echocardiographic Evaluation of Right Ventricular Systolic Function|Recruiting||N/A|250|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:41:09.49133|2017-10-10 20:41:09.49133
NCT03295656|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis|Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis|Not yet recruiting||Phase 1|35|Anticipated|Boston Children’s Hospital||1|||f||||f|t|f|||f|||||2017-10-10 20:41:09.553665|2017-10-10 20:41:09.553665
NCT03295643|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||October 4, 2017||2017-10-04||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:41:09.630688|2017-10-10 20:41:09.630688
NCT03295630|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-27|||September 19, 2016|Actual|2016-09-19|September 2017|2017-09-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Observational|||Validity of an Actigraph Accelerometer Following Critical Illness|Criterion Validity of the Actigraph GT3X Accelerometer in Determination of Body Position and Walking in Hospital Ward Patients Recovering From Critical Illness|Completed||N/A|20|Actual|Hull and East Yorkshire Hospitals NHS Trust|||1||f|||||f|f||||||||2017-10-10 20:41:09.673469|2017-10-10 20:41:09.673469
NCT03295617|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|July 30, 2017|Actual|2017-07-30|July 30, 2017|Actual|2017-07-30||Observational|GHTT||Management of Giant Thoracic Disc Hernias by Thoracoscopy: Experience of 52 Cases|Management of Giant Thoracic Disc Hernias by Thoracoscopy: Experience of 52 Cases|Completed||N/A|52|Actual|Hopital Foch|||1||f||||f|f|f||||||||2017-10-10 20:41:09.773193|2017-10-10 20:41:09.773193
NCT03295604|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-24|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Novel Volumetric Analysis Using CAD/CAM Scanners in Gingival Recession Treatment|A Novel Volumetric Analysis Using CAD/CAM Scanners in Gingival Recession|Completed||N/A|35|Actual|Yuzuncu Yıl University||2|||f||||f|f|f||||||||2017-10-10 20:41:09.853004|2017-10-10 20:41:09.853004
NCT03295591|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-27|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|March 31, 2020|Anticipated|2020-03-31|November 30, 2019|Anticipated|2019-11-30||Observational|||Circulating Tumor Cells in mCRC for Liver Resection|Optimizing the Selection of Patients With Metastatic Colorectal Cancer for Liver Resection - An Immuno-clinical Scoring System Incorporating Circulating Tumor Cell Enumeration and Clinical Factors|Recruiting||N/A|77|Anticipated|The University of Hong Kong|||1||f||||f||||||Samples With DNA|"     blood in Streck tube will be processed for isolating circulating tumor cells and its DNA     content for subsequent sequencing if feasible   "|||2017-10-10 20:41:10.056282|2017-10-10 20:41:10.056282
NCT03295578|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-10-05|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|December 9, 2017|Anticipated|2017-12-09|November 16, 2017|Anticipated|2017-11-16||Interventional|||Blood Glucose, Cognition and Wellbeing @ Work|Blood Glucose Monitoring, Cognition, and Wellbeing in Relation to Food Intake @ Work - a Pilot Study|Active, not recruiting||N/A|45|Actual|TNO||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:41:10.151046|2017-10-10 20:41:10.151046
NCT03295565|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-22|||May 7, 2017|Actual|2017-05-07|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|OSTRICh||Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel|A Randomized, Open Label, Phase IIB Trial of Optimal Sequencing of Treatment Options for Poor Risk Metastasized Castration Resistant Prostate Cancer Previously Treated With Docetaxel|Recruiting||Phase 2/Phase 3|152|Anticipated|The Netherlands Cancer Institute||2|||f||||f|f|f||||||||2017-10-10 20:41:10.2709|2017-10-10 20:41:10.2709
NCT03295552|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-24|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|October 2019|Anticipated|2019-10-01||Interventional|DETECT||Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC|Decitabine Plus Carboplatin in the Treatment of Metastatic Triple Negative Breast Cancer|Not yet recruiting||Phase 2|59|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||t|f|f||||||||2017-10-10 20:41:10.443704|2017-10-10 20:41:10.443704
NCT03295539|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-24|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Critical Limb Ischaemia (CLI) Management With 'Indigo' Mechanical Aspiration System|MulticentRe pOst-market exPeriencE With the INdigo Thrombectomy System for the Treatment of Acute Lower Limb Ischaemia : (Re-Open Registry)|Not yet recruiting||N/A|400|Anticipated|Lancashire Care NHS Foundation Trust||1|||f||||t|f|t|f|f|t|||||2017-10-10 20:41:10.590663|2017-10-10 20:41:10.590663
NCT03295526|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-24|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer|Study on Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer|Recruiting||Phase 2|200|Anticipated|Fudan University||2|||f||||f|f|f||||||||2017-10-10 20:41:10.716233|2017-10-10 20:41:10.716233
NCT03295513|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-24|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Clinical Evaluation of Wear Behavior of Human Enamel and Chipping of Veneered Zirconia Against Monolithic Zirconia|Clinical Evaluation of Wear Behavior of Human Enamel and Chipping of Veneered Zirconia Against Monolithic Zirconia (Randomized Controlled Clinical Trial)|Not yet recruiting||N/A|26|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:41:10.833257|2017-10-10 20:41:10.833257
NCT03295487|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-22|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||ToT and Estrogen in Postmenopausal Females|The Value of Local Estrogen After TVT_O anti_incontinence Surgery in Postmenopausal Females.|Recruiting||Phase 2/Phase 3|200|Anticipated|Kasr El Aini Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:41:11.023736|2017-10-10 20:41:11.023736
NCT03295474|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-29|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|September 30, 2018|Anticipated|2018-09-30||Observational|||Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.|Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System (FA-TELE-REHAB)|Recruiting||N/A|100|Anticipated|ADIR Association|||1||f||||f|f|f||||||||2017-10-10 20:41:11.125427|2017-10-10 20:41:11.125427
NCT03295461|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-26|||March 2013|Actual|2013-03-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Emblica Officinalis Irrigation in Periodontitis|Effect of Emblica Officinalis (Amla) as an Adjunct to Scaling and Root Planing in Patients With Chronic Periodontitis|Completed||N/A|112|Actual|Postgraduate Institute of Dental Sciences Rohtak||5|||f||||t|f|f||||||||2017-10-10 20:41:11.244397|2017-10-10 20:41:11.244397
NCT03295448|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-02|||October 10, 2017|Anticipated|2017-10-10|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|CARBIO||Fatty Acid Biomarkers of Carbohydrate Intake|Circulating Fatty Acids as Biomarkers of Dietary Carbohydrates: a Randomized Trial|Recruiting||N/A|20|Anticipated|Uppsala University||6|||f||||f|f|f||||||||2017-10-10 20:41:11.336006|2017-10-10 20:41:11.336006
NCT03295435|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-24|||August 5, 2014|Actual|2014-08-05|September 2017|2017-09-01|July 13, 2016|Actual|2016-07-13|July 13, 2016|Actual|2016-07-13||Observational|CHAMP||Composition of Functional Tooth Units and Nutrient Intake in Older Men|Associations Between the Composition of Functional Tooth Units and Nutrient Intake in Older Men: the Concord Health and Ageing in Men Project.|Completed||N/A|781|Actual|University of Sydney|||1||f||||f|f|f||||||||2017-10-10 20:41:11.447648|2017-10-10 20:41:11.447648
NCT03295422|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-24|||August 25, 2017|Actual|2017-08-25|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Comparison of Two Pulmonary Vein Ablation Techniques for Persistent AF|Investigator Initiated Randomized Controlled Trial Comparing Two Radiofrequency Ablation Strategies in Patients With Persistent Atrial Fibrillation|Recruiting||N/A|200|Anticipated|Sequoia Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:11.530125|2017-10-10 20:41:11.530125
NCT03295396|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-26|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2020|Anticipated|2020-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||ONC201 in Adults With Recurrent High-grade Glioma|A Phase II, Open-label Study of ONC201 in Adults With Recurrent High-grade Glioma|Not yet recruiting||Phase 2|39|Anticipated|Oncoceutics, Inc.||1|||||||f|t|f||||||||2017-10-10 20:41:11.6807|2017-10-10 20:41:11.6807
NCT03295383|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||January 2, 2018|Anticipated|2018-01-02|September 2017|2017-09-01|July 2, 2023|Anticipated|2023-07-02|July 2, 2022|Anticipated|2022-07-02||Interventional|RITUX-MMP||Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid|Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid|Not yet recruiting||Phase 3|130|Anticipated|University Hospital, Rouen||2|||f||||t|f|f||||||||2017-10-10 20:41:11.754391|2017-10-10 20:41:11.754391
NCT03295370|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-21|||June 13, 2017|Actual|2017-06-13|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Electrical Stimulation of Accessory Spinal Nerve in Cortical Activation and Autonomic Response in Healthy Subjects|Electrical Stimulation of Accessory Spinal Nerve in Cortical Activation, Muscular Perfusion and Autonomic Response in Healthy Subjects: a Randomized, Crossover, Sham Controlled Trial.|Enrolling by invitation||N/A|14|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:41:12.077818|2017-10-10 20:41:12.077818
NCT03295357|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|EXTUB ECLS||Extubation of Patients on ECLS is Associated With a Reduction in Complications Related to Mechanical Ventilation: Retrospective Single-centre Study|Extubation of Patients on ECLS is Associated With a Reduction in Complications Related to Mechanical Ventilation: Retrospective Single-centre Study|Completed||N/A|60|Actual|Centre Hospitalier Universitaire Dijon|||2||f|||||f|f||||||||2017-10-10 20:41:12.18415|2017-10-10 20:41:12.18415
NCT03295344|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|DD||Study of Diaphragm Mobility on Tissue Doppler|Study of Diaphragm Mobility on Tissue Doppler (Thoracotomy vs Sternotomy in Diaphragm Dysfunction Following Heart Surgery)|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f|||||f|f||||||||2017-10-10 20:41:12.253144|2017-10-10 20:41:12.253144
NCT03295331|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-27|||January 3, 2017|Actual|2017-01-03|September 2017|2017-09-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Observational|ASCORE||Assessment of Asthma Control Level in Malaysia|A Non-Interventional Retrospective Study To Assess The Level Of Asthma Control Among Adults at 2 Tertiary Care Centres In Malaysia|Completed||N/A|398|Actual|AstraZeneca|||1||f||||f|f|f||||||||2017-10-10 20:41:12.336684|2017-10-10 20:41:12.336684
NCT03295318|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-27|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds|A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age|Not yet recruiting||Phase 2|375|Anticipated|Serum Institute of India Pvt. Ltd.||3|||f||||t|f|f||||||||2017-10-10 20:41:12.410311|2017-10-10 20:41:12.410311
NCT03295305|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-26|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|PRETEC-ABC||Effect of Action-Based Cognitive Remediation in Patients With Bipolar Disorder in Remission and First-degree Relatives|Effect of Action-Based Cognitive Remediation on Cognition and Frontal Lobe Activity in Patients With Bipolar Disorder in Remission and Healthy First-degree Relatives With Cognitive Impairment (PRETEC-ABC)|Recruiting||N/A|116|Anticipated|Mental Health Services in the Capital Region, Denmark||2|||f||||f|f|f||||||||2017-10-10 20:41:12.526|2017-10-10 20:41:12.526
NCT03295292|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-09-21|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Stem Cells for Corneal Haze|Pilot Clinical Trial to Assess the Safety of Limbus-derived Corneal Stem Cells in Prevention of Corneal Haze After Photo Therapeutic/Refractive Keratectomy (PTK/ PRK) and Collagen Cross Linking (CXL)|Recruiting||Phase 1|15|Anticipated|L.V. Prasad Eye Institute||2|||f||||t|f|f||||||||2017-10-10 20:41:12.651031|2017-10-10 20:41:12.651031
NCT03295279|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||January 15, 2013|Actual|2013-01-15|September 2017|2017-09-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2021|Anticipated|2021-08-31||Observational|||WTC Chest CT Imaging Archive|Pulmonary Diseases in WTC Workers: Symptoms, Function, and Chest CT Correlates|Active, not recruiting||N/A|1722|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f|f|f||||||||2017-10-10 20:41:12.767914|2017-10-10 20:41:12.767914
NCT03295266|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||October 10, 2017|Anticipated|2017-10-10|September 2017|2017-09-01|January 30, 2018|Anticipated|2018-01-30|January 16, 2018|Anticipated|2018-01-16||Interventional|||Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006)|An Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-3866 When Administered to Subjects With Moderate and Severe Hepatic Impairment|Not yet recruiting||Phase 1|24|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||f|t|f||||||||2017-10-10 20:41:12.874753|2017-10-10 20:41:12.874753
NCT03295253|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-22|||December 15, 2016|Actual|2016-12-15|September 2017|2017-09-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2018|Anticipated|2018-12-15||Interventional|||Fat Grafting Technique Using Autologous Adipose Tissue Lipogems in Patients Suffering From Stress Urinary Incontinence|Evaluation of Fat Grafting Technique Using Autologous Micro-fragmented Autologous Adipose Tissue Lipogems in Female Patients Suffering From Stress Urinary Incontinence|Recruiting||N/A|25|Anticipated|The Miriam Hospital||1|||f||||t|f|f|||f|||||2017-10-10 20:41:12.977074|2017-10-10 20:41:12.977074
NCT03295240|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-26|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|September 20, 2019|Anticipated|2019-09-20|September 20, 2019|Anticipated|2019-09-20||Interventional|||The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma|Phase I Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma|Recruiting||Early Phase 1|18|Anticipated|Memorial Sloan Kettering Cancer Center||1||||||||t|f||||||||2017-10-10 20:41:13.089386|2017-10-10 20:41:13.089386
NCT03295227|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Feasibility Trial of Pembrolizumab in Unresectable Thymoma and Thymic Carcinoma|Feasibility Trial of Pembrolizumab in Unresectable Thymoma and Thymic Carcinoma|Not yet recruiting||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:41:13.215029|2017-10-10 20:41:13.215029
NCT03295214|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Acetaminophen Given Per Os and Intravenous in Sinus Surgery|A Prospective Clinical Trial Evaluating the Post-Operative Analgesic Effects of Acetaminophen Given Per Os and Intravenous|Not yet recruiting||Phase 3|124|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||f|f|f||||||||2017-10-10 20:41:13.314806|2017-10-10 20:41:13.314806
NCT03295201|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-22|||March 5, 2017|Actual|2017-03-05|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Effects of Exercise Program Added to Pulmonary Rehabilitation in Patients With Cystic Fibrosis|Clinical Effects of Exercise Program Added to Pulmonary Rehabilitation in Patients With Cystic Fibrosis|Recruiting||N/A|22|Anticipated|Marmara University||2|||f|||||f|f||||||||2017-10-10 20:41:13.403687|2017-10-10 20:41:13.403687
NCT03295188|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-24|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Effects of Plasmalogen on Obese Subjects|A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Effects of Scallop-derived Plasmalogen on Obese Subjects|Recruiting||N/A|80|Anticipated|Japanese Plasmalogen Society||2|||f|||||f|f||||||||2017-10-10 20:41:13.495557|2017-10-10 20:41:13.495557
NCT03295175|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-10-01|||September 21, 2017|Actual|2017-09-21|October 2017|2017-10-01|January 31, 2020|Anticipated|2020-01-31|December 31, 2019|Anticipated|2019-12-31|5 Years|Observational [Patient Registry]|DISMUD||Distribution of Smooth Muscle In Dartos In The Non Conspicuous Penis|Distribution of Smooth Muscle In Dartos In The Non Conspicuous Penis, an Observational a Prospective, Descriptive, Observational Study|Recruiting||N/A|114|Anticipated|Hospital Universitario San Ignacio|||3||f|||||f|f||||||||2017-10-10 20:41:13.571716|2017-10-10 20:41:13.571716
NCT03295162|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-25|2017-09-25|||November 26, 2015|Actual|2015-11-26|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|March 1, 2017|Actual|2017-03-01||Interventional|||Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis|Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis|Completed||Phase 1/Phase 2|55|Actual|Ain Shams University||3|||f||||t|f|f||||||||2017-10-10 20:41:13.6636|2017-10-10 20:41:13.6636
NCT03295149|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-28|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|ScreenOX||ScreenOX - An Automated At-home Screening Test for Adult Sleep Apnea Using Nocturnal Oximetry|New Out-of-center Paradigms to Simplify Sleep Apnea Diagnosis. Design and Development of an Automated Screening Test Based on Oximetry (ScreenOX)|Recruiting||N/A|400|Anticipated|Hospital del Río Hortega|||1||f||||f|f|f||||||||2017-10-10 20:41:13.737379|2017-10-10 20:41:13.737379
NCT03295136|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-24|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Impact of Employee Health Promotion Course on Health Promotion in the Work Place.|Impact of Health Promotion Course for Female Employees on Health Promotion in the Work Place.|Recruiting||N/A|24|Anticipated|Hadassah Medical Organization||1|||f||||f|f|f||||||||2017-10-10 20:41:13.854102|2017-10-10 20:41:13.854102
NCT03295123|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-22|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 1, 2017|Actual|2017-08-01||Observational|||Outcome of Children Born After Pregnancy Denial|Outcome Children Born After Pregnancy Denial|Completed||N/A|55|Actual|Central Hospital, Nancy, France|||1||f|||||f|f||||||||2017-10-10 20:41:13.948838|2017-10-10 20:41:13.948838
NCT03295110|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|Lili smart||Connected Solution of Assistance Dedicated to Caregivers and People With Alzheimer's Disease or Related Diseases|Lili Smart Study - Connected Solution of Assistance Dedicated to Caregivers and People With Alzheimer's Disease or Related Diseases|Not yet recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 20:41:14.039411|2017-10-10 20:41:14.039411
NCT03295097|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 1, 2020|Anticipated|2020-02-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Characteristics and Clinical Implications of a Clinical Decision Support System|A Prospective Multicenter Cohort Study to Evaluate The Characteristics and Clinical Implications of a Clinical Decision Support System and of Pharmacogenomic Information Relevant to Polypharmacy Actions in Patients With Advanced Illness Who Are Receiving Multiple Drugs for Pain and Other Disorders|Not yet recruiting||N/A|100|Anticipated|Hospice of Henderson County, Inc.||1|||f||||f|f|f||||||||2017-10-10 20:41:14.15761|2017-10-10 20:41:14.15761
NCT03295084|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-26|||July 15, 2015|Actual|2015-07-15|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|March 31, 2018|Anticipated|2018-03-31||Interventional|||Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors|Irinotecan Gastro-resistant Tablet. An Open Label Phase I, Dose Escalating Study Evaluating Safety, Tolerability and Pharmacokinetics of Oral Administration of Irinotecan in Adult Patients With Solid Tumors|Enrolling by invitation||Phase 1|37|Anticipated|Herlev Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:14.239965|2017-10-10 20:41:14.239965
NCT03295071|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01|3 Years|Observational [Patient Registry]|REALITY||REALITY LHON Registry|Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients|Not yet recruiting||N/A|50|Anticipated|GenSight Biologics|||1||f|||||f|f||||||||2017-10-10 20:41:14.326894|2017-10-10 20:41:14.326894
NCT03295058|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-24|2017-09-24|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients|Outcome of Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin (ATG ) Conditioning Regimens in Severe Aplastic Anemia Patients|Not yet recruiting||N/A|50|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:41:14.407839|2017-10-10 20:41:14.407839
NCT03295045|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-26|||December 1, 2007|Actual|2007-12-01|September 2017|2017-09-01|December 31, 2010|Actual|2010-12-31|December 31, 2009|Actual|2009-12-31||Observational|EI2008||Evolution of the Profile of Infectious Endocarditis in France in 2008 (EI2008)|Evolution of the Profile of Infectious Endocarditis in France in 2008|Completed||N/A|484|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f|f|f||||||||2017-10-10 20:41:14.485369|2017-10-10 20:41:14.485369
NCT03295032|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-26|||March 1, 2016|Actual|2016-03-01|September 2017|2017-09-01|December 29, 2016|Actual|2016-12-29|December 29, 2016|Actual|2016-12-29||Interventional|||A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors|A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors and Their Carers: ACTivate Your Life After Stroke|Completed||N/A|53|Actual|Cardiff University||2|||f||||f|f|f||||||||2017-10-10 20:41:14.655633|2017-10-10 20:41:14.655633
NCT03295019|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||"Hyaluronan Formulation for Dry Mouth in Sleep Apnea Patients"|"Clinical Evaluation of the Efficacy of Hyaluronan Formulation for Dry Mouth in Sleep Apnea Patients."|Recruiting||N/A|26|Anticipated|You First Services||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:41:14.75166|2017-10-10 20:41:14.75166
NCT03295006|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-22|||October 31, 2016|Actual|2016-10-31|September 2017|2017-09-01|June 14, 2018|Anticipated|2018-06-14|June 14, 2018|Anticipated|2018-06-14||Observational|TARGET||A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC|A TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in Hepatocellular Carcinoma Treatment|Recruiting||N/A|300|Anticipated|BTG International Inc.|||1||f||||t|f|t|f||f|||||2017-10-10 20:41:14.842005|2017-10-10 20:41:14.842005
NCT03294993|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-03|||October 1, 2017|Actual|2017-10-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Doppler Ultrasonography Assessed Vascular Changes Before and After Radial Artery Puncture|Doppler Ultrasonography Assessed Vascular Changes Before and After Radial Artery Puncture|Recruiting||N/A|100|Anticipated|China Medical University, China||1|||f||||t|f|f||||||||2017-10-10 20:41:14.95075|2017-10-10 20:41:14.95075
NCT03294980|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-09-22|||November 2015||2015-11-01|September 2016|2016-09-01|November 2025|Anticipated|2025-11-01|November 2025|Anticipated|2025-11-01||Observational|OFICE||Chronic Lymphoid Leukaemia Observatory in Finistere Area, France||Recruiting||N/A|3000|Anticipated|University Hospital, Brest|||1||f||||||||||Samples Without DNA|"     cell pellet More than 95% CD5+CD19+ lymphocytes   "|||2017-10-10 20:41:15.044235|2017-10-10 20:41:15.044235
NCT03294967|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-22|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effect of Caffeine on Ocular Circulation in High Myopes|Effect of Caffeine on Ocular Circulation in High Myopes|Recruiting||N/A|20|Anticipated|The Hong Kong Polytechnic University||2|||f||||t|f|f||||||||2017-10-10 20:41:15.124002|2017-10-10 20:41:15.124002
NCT03294954|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-05|||January 15, 2019|Anticipated|2019-01-15|October 2017|2017-10-01|January 15, 2035|Anticipated|2035-01-15|February 15, 2020|Anticipated|2020-02-15||Interventional|GINAKIT2||GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma|GD2 Specific Chimeric Antigen Receptor (CAR) and Interleukin-15 Expressing Autologous Natural Killer T-cells to Treat Children With Neuroblastoma|Not yet recruiting||Phase 1|24|Anticipated|Baylor College of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 20:41:15.225066|2017-10-10 20:41:15.225066
NCT03294941|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-22|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|September 2018|Anticipated|2018-09-01||Interventional|||The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology|The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology|Not yet recruiting||Phase 2|72|Anticipated|HepQuant, LLC||1|||f||||f|t|t|t|f||||||2017-10-10 20:41:15.338296|2017-10-10 20:41:15.338296
NCT03294928|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-28|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|October 15, 2017|Anticipated|2017-10-15|October 5, 2017|Anticipated|2017-10-05||Interventional|||Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers|Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers|Recruiting||N/A|62|Anticipated|University of Pisa||1|||f|||||f|f||||||||2017-10-10 20:41:15.49896|2017-10-10 20:41:15.49896
NCT03294915|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-26|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|August 2019|Anticipated|2019-08-01||Interventional|||Effect of Resistant Starch on Insulin Sensitivity and Beta Cell Function in Subjects With Prediabetes|Effect of Resistant Starch From Green Banana Flour on the Insulin Sensitivity of Subjects With Prediabetes: Randomized Clinical Trial|Not yet recruiting||N/A|20|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:41:15.575531|2017-10-10 20:41:15.575531
NCT03294902|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-26|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|IROAD||Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System|Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System|Not yet recruiting||N/A|40|Anticipated|Pedra Technology, PTE LTD|||2||f||||f|f|f||||||||2017-10-10 20:41:15.693833|2017-10-10 20:41:15.693833
NCT03294889|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer|ONE-SHOT - Single Shot Radiotherapy for Localized Prostate Cancer. A Single Arm, Phase I/II Trial|Not yet recruiting||Phase 1/Phase 2|45|Anticipated|University Hospital, Geneva||1|||f||||t|f|f||||||||2017-10-10 20:41:15.774056|2017-10-10 20:41:15.774056
NCT03294876|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|RAAR||Rheumatoid Arthritis Adrenal Recovery Study|Investigating Recovery of the Hypothalamus-pituitary-adrenal Axis in Patients With Rheumatoid Arthritis Following Exposure to Prednisolone|Not yet recruiting||N/A|50|Anticipated|University of Edinburgh|||1||f||||f|f|f||||Samples With DNA|"     Blood Blood for DNA Saliva   "|||2017-10-10 20:41:15.856083|2017-10-10 20:41:15.856083
NCT03293758|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01|10 Months|Observational [Patient Registry]|||Food and Microbiome Longitudinal Investigation (FAMiLI)|Food and Microbiome Longitudinal Investigation (FAMiLI)|Recruiting||N/A|100|Anticipated|New York University School of Medicine|||1||f||||f|f|f||||||||2017-10-10 20:41:24.800301|2017-10-10 20:41:24.800301
NCT03294863|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-10-02|||March 15, 2017|Actual|2017-03-15|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure|Use of Embrace Device After Cutaneous Wound Closure: a Randomized Evaluator Blinded Split Wound Comparative Effectiveness Trial|Recruiting||N/A|50|Anticipated|University of California, Davis||2|||f||||f|f|t|f|f||||||2017-10-10 20:41:15.945469|2017-10-10 20:41:15.945469
NCT03294850|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|BARI||Evaluation of Biomarkers to Quantify Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis at Baseline and Following Bariatric Surgery|Evaluation of Biomarkers to Quantify Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis at Baseline and Following Bariatric Surgery|Not yet recruiting||N/A|35|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida||2|||f||||t|f|t|f|f||||||2017-10-10 20:41:16.039107|2017-10-10 20:41:16.039107
NCT03294837|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-09-22|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Observational|||Treatment of Ventilator Associated Pneumonia in Pediatric Intensive Care Unit|Treatment of Ventilator Associated Pneumonia in Pediatric Intensive Care Unit|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:41:16.140513|2017-10-10 20:41:16.140513
NCT03294824|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-21|||October 2013||2013-10-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|Allo-NK-CMV||Non Randomized Comparative Study With Control|Study of Natural Killer Immunity During Infections With CMV or AdV After Allogeneic Hematopoietic Stem Cells|Recruiting||N/A|90|Anticipated|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||||||2017-10-10 20:41:16.203249|2017-10-10 20:41:16.203249
NCT03294811|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-09-29|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|CardioCoach||A Two-way Communication System to Coach Elderly Patients With Heart Failure|CARDIOCOACH: Development of an Intelligent Two-way Communication System to Coach Elderly Patients With Heart Failure in Their Home Situation|Active, not recruiting||N/A|25|Actual|Hasselt University||2|||f||||f||||||||||2017-10-10 20:41:16.294287|2017-10-10 20:41:16.294287
NCT03294798|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||June 13, 2017|Actual|2017-06-13|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient|Evaluate the Pharmacokinetic and Pharmacodynamic Profile, Safety, and Tolerability of Escalating Single Dose & Multiple Dose by Using Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitits B Patients|Recruiting||Phase 1|32|Anticipated|Tianjin SinoBiotech Ltd.||2|||f||||f|f|f|||f|||||2017-10-10 20:41:16.382803|2017-10-10 20:41:16.382803
NCT03294785|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-23|2017-09-23|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparative Effectiveness and Cost-effectiveness of Chuna Manual Therapy for Chronic Neck Pain|Comparative Effectiveness and Cost-effectiveness of Chuna Manual Therapy for Chronic Neck Pain: A Multi-center Randomized Controlled Trial|Not yet recruiting||N/A|108|Anticipated|Jaseng Medical Foundation||2|||f||||f|f|f||||||||2017-10-10 20:41:16.478775|2017-10-10 20:41:16.478775
NCT03294772|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-26|||November 1, 2013|Actual|2013-11-01|September 2017|2017-09-01|December 30, 2015|Actual|2015-12-30|June 30, 2014|Actual|2014-06-30||Interventional|||Impact of a Multifactorial Program of Hand Hygiene on Infections in Children Attending in Day-care Centres|Socio-health Impact of a Multifactorial Program of Hand Hygiene on Respiratory and Gastrointestinal Infections in Children Attending in Day-care Centres|Completed||N/A|911|Actual|Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental||3|||f||||t|f|f||||||||2017-10-10 20:41:16.571878|2017-10-10 20:41:16.571878
NCT03294759|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-26|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|September 19, 2019|Anticipated|2019-09-19|September 19, 2019|Anticipated|2019-09-19||Interventional|Bio ACL RCT||Bio ACL Reconstruction Amnion Collagen Matrix Wrap and Stem Cells|Pilot Study: Augmentation of ACL Reconstruction With Bone Marrow Stem Cells and Amnion Collagen Matrix Wrap|Recruiting||N/A|40|Anticipated|Andrews Research & Education Foundation||2|||f||||t|f|f|||f|||||2017-10-10 20:41:16.654682|2017-10-10 20:41:16.654682
NCT03294746|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-27|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|ImageILD||Imaging Biomarker in Cancer Drug Induced ILD|Qualification of Imaging Methods to Assess Cancer Drug Induced Interstitial Lung Disease (ImageILD)|Not yet recruiting||N/A|70|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||t|f|f||||||||2017-10-10 20:41:16.755437|2017-10-10 20:41:16.755437
NCT03294733|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-25|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||The Relationship Between Age and Carpal Tunnel Size|The Relationship Between Age and Carpal Tunnel Size|Enrolling by invitation||N/A|100|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 20:41:16.823812|2017-10-10 20:41:16.823812
NCT03294720|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-27|||September 27, 2017|Anticipated|2017-09-27|September 2017|2017-09-01|September 25, 2019|Anticipated|2019-09-25|September 25, 2019|Anticipated|2019-09-25||Interventional|Bio ACL (CS)||Bio ACL Reconstruction With Amnion Collagen Matrix Wrap and Stem Cells Case Series|Augmentation of ACL Reconstruction With Bone Marrow Stem Cells and Amnion Collagen Matrix Wrap: a Case Series|Enrolling by invitation||N/A|10|Anticipated|Andrews Research & Education Foundation||1|||f||||t|f|f|||f|||||2017-10-10 20:41:16.891449|2017-10-10 20:41:16.891449
NCT03294707|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-22|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10|A Phase 1 Randomized, Placebo-controlled, Single and Multiple Ascending Dose Study of the Tolerability, Pharmacokinetics and Pharmacodynamics of AG10 in Healthy Subjects|Recruiting||Phase 1|96|Anticipated|Eidos Therapeutics||2|||f||||t|t|f||||||||2017-10-10 20:41:16.976808|2017-10-10 20:41:16.976808
NCT03294694|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer|A Phase 1 Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Combination With the PD-1 Inhibitor PDR001 in Patients With Metastatic Hormone Receptor-positive Breast Cancer and Metastatic Ovarian Cancer|Not yet recruiting||Phase 1|60|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 20:41:17.072915|2017-10-10 20:41:17.072915
NCT03294668|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 25, 2018|Anticipated|2018-12-25|February 10, 2018|Anticipated|2018-02-10||Interventional|||KONTAKT Australia a Social Skills Group Training for Adolescents on the Autism Spectrum|Developing and Evaluating a Social Skills Group Training for Adolescents on the Autism Spectrum|Not yet recruiting||N/A|96|Anticipated|Curtin University||2|||f||||t|f|f||||||||2017-10-10 20:41:17.246801|2017-10-10 20:41:17.246801
NCT03294655|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|RISE||A Resilience Building Intervention to Promote Successful Aging|A Resilience Building Intervention to Promote Successful Aging|Not yet recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f||||||||2017-10-10 20:41:17.325987|2017-10-10 20:41:17.325987
NCT03294642|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Potato Ingestion and Time-trial Performance|Ingestion of Potatoes as a Nutritional Strategy to Improve Cycling Time-trial Performance in Endurance Trained Cyclists|Not yet recruiting||N/A|18|Anticipated|University of Illinois at Urbana-Champaign||3|||f||||t|f|f||||||||2017-10-10 20:41:17.385033|2017-10-10 20:41:17.385033
NCT03294629|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-09-26|||March 2015|Actual|2015-03-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effectiveness of SensAwake™ for Continue Positive Airway Pressure Treatment of Obstructive Sleep Apnea Patients|Effects of Pressure Control Device (SensAwake™) on Obstructive Sleep Apnea (OSA) Patients Who Remove the Mask for Unknown Reasons During Automatic Continuous Positive Airway Pressure (Auto-CPAP) Therapy|Completed||N/A|35|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 20:41:17.457756|2017-10-10 20:41:17.457756
NCT03294616|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-21|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|August 31, 2018|Anticipated|2018-08-31||Interventional|||Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma|Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma|Not yet recruiting||N/A|20|Anticipated|Johns Hopkins University||3|||f||||t|f|f||||||||2017-10-10 20:41:17.53906|2017-10-10 20:41:17.53906
NCT03294603|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|October 16, 2017|Anticipated|2017-10-16|October 16, 2017|Anticipated|2017-10-16||Interventional|||Radiolabeled Study of CC-220 in Healthy Male Subjects|A Phase 1, Single-center, Open-label Study to Evaluate the Metabolism and Excretion of (14C)-CC-220 in Healthy Male Subjects|Recruiting||Phase 1|6|Anticipated|Celgene||1|||f||||f|t|f||||||||2017-10-10 20:41:17.705823|2017-10-10 20:41:17.705823
NCT03294590|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-22|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|iSmile||Interactive Parent-Targeted Text Messaging in Pediatric Clinics to Reduce Caries Among Urban Children|Randomized Controlled Trial of Interactive Parent-Targeted Text Messaging in Pediatric Clinics to Reduce Caries Among Urban Children|Not yet recruiting||N/A|850|Anticipated|Boston University||2|||f||||t|f|f||||||||2017-10-10 20:41:17.88173|2017-10-10 20:41:17.88173
NCT03294577|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-28|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 18, 2018|Anticipated|2018-12-18|July 1, 2018|Anticipated|2018-07-01||Interventional|||Plinabulin vs. Pegfilgrastim in Reducing the Duration of Severe Neutropenia in Breast Cancer Patients Receiving Myelosuppressive Chemotherapy With Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)|A Phase 2/3, Multicenter, Randomized Study to Evaluate Plinabulin Versus Pegfilgrastim in Reducing the Duration of Severe Neutropenia in Breast Cancer Patients Receiving Myelosuppressive Chemotherapy With Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) (Protective 2)|Not yet recruiting||Phase 2/Phase 3|180|Anticipated|BeyondSpring Pharmaceuticals Inc.||5|||f||||t|t|f||||||||2017-10-10 20:41:17.979929|2017-10-10 20:41:17.979929
NCT03294564|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Cognitive, Emotional, and Neural Responses to Acute Inflammation|Cognitive, Emotional, and Neural Responses to Acute Inflammation|Not yet recruiting||Early Phase 1|24|Anticipated|University of California, San Francisco||2|||f||||f|t|f|||t|||||2017-10-10 20:41:18.102375|2017-10-10 20:41:18.102375
NCT03294551|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||October 23, 2017|Anticipated|2017-10-23|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||HPV Centralized R/R RCT #2 - New York State|Enhancing HPV Vaccination Rates for 11-14 Year Old Adolescents Using New York State's Immunization Information System|Enrolling by invitation||N/A|33000|Anticipated|University of California, Los Angeles||3|||f||||f|f|f||||||||2017-10-10 20:41:18.236389|2017-10-10 20:41:18.236389
NCT03294538|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-29|||May 18, 2016|Actual|2016-05-18|September 2017|2017-09-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis|Study to Evaluate the Therapeutic Equivalence of Estradiol Vaginal Cream, 0.01% to Estrace® Estradiol Vaginal Cream 0.01% in Atrophic Vaginitis|Completed||Phase 3|663|Actual|Actavis Inc.||3|||f||||f|t|f|||f|||||2017-10-10 20:41:18.375436|2017-10-10 20:41:18.375436
NCT03294525|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-22|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders|Clinical Psychopharmacology Division|Recruiting||N/A|900|Anticipated|Peking University||2|||f||||f||||||||||2017-10-10 20:41:18.50424|2017-10-10 20:41:18.50424
NCT03294512|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-28|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|iMAWDS||Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform|Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform (iMAWDS Mobile HF Study)|Recruiting||N/A|15|Anticipated|Intermountain Health Care, Inc.||1|||f||||f|f|f||||||||2017-10-10 20:41:18.617254|2017-10-10 20:41:18.617254
NCT03294499|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-22|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|PACIFY||Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIV|Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIV|Recruiting||N/A|100|Anticipated|Imperial College London|||1||f||||f|f|f||||||||2017-10-10 20:41:18.734771|2017-10-10 20:41:18.734771
NCT03294486|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-22|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|May 2019|Anticipated|2019-05-01||Interventional|ONCOVIRAC||Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients|Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients|Not yet recruiting||Phase 1/Phase 2|78|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t|f|f||||||||2017-10-10 20:41:18.868287|2017-10-10 20:41:18.868287
NCT03294473|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||October 16, 2017|Anticipated|2017-10-16|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Centralized Reminder Recall - Flu RCT2|Centralized IIS-Based Reminder Recall to Increase Influenza Vaccination Rates in New York State - Second Trial in New York State|Enrolling by invitation||N/A|71000|Anticipated|University of California, Los Angeles||4|||f||||f|f|f||||||||2017-10-10 20:41:18.98691|2017-10-10 20:41:18.98691
NCT03294447|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-22|||November 2015||2015-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||An Occupational Therapist Fall Prevention Intervention in a Geriatric Primary Care Setting|The Association Between Fear of Falling and Fall Prevention Interventions Offered by an Occupational Therapist in a Geriatric Primary Care Setting|Recruiting||N/A|15|Anticipated|Rush University Medical Center||1|||f||||f||||||||||2017-10-10 20:41:19.225191|2017-10-10 20:41:19.225191
NCT03294434|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||March 2, 2017|Actual|2017-03-02|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|April 30, 2019|Anticipated|2019-04-30||Observational|PRaM-GBM||Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)|Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)|Recruiting||N/A|120|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f|f|f||||Samples With DNA|"     Patients that consent to participate in the optional PET sub-study will consent to the     collection of additional tissue biopsies to be taken at the time of their standard of care     surgery.   "|||2017-10-10 20:41:19.312433|2017-10-10 20:41:19.312433
NCT03294421|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-21|||February 1, 2016|Actual|2016-02-01|April 2017|2017-04-01|August 31, 2019|Anticipated|2019-08-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Combined Access Closed Tympanomastoidectomy: Microsurgery Allied to Endoscopy|Combined Access Closed Tympanomastoidectomy: Microsurgery Allied to Endoscopy|Recruiting||N/A|56|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:41:19.411073|2017-10-10 20:41:19.411073
NCT03294408|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-09-22|||November 29, 2016|Actual|2016-11-29|July 2017|2017-07-01|November 28, 2021|Anticipated|2021-11-28|November 28, 2019|Anticipated|2019-11-28||Interventional|MOSART||Multimodal Imaging of Subchondral Bone in Knee Osteoarthritis : Predictive Model|Capacity of Multimodal Imaging of Subchondral Bone for the Prediction of Structural Evolution in Knee Osteoarthritis|Recruiting||N/A|425|Anticipated|Centre Hospitalier Régional d'Orléans||1|||f||||f|f|f||||||||2017-10-10 20:41:19.517221|2017-10-10 20:41:19.517221
NCT03294395|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-22|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|December 18, 2019|Anticipated|2019-12-18|July 18, 2019|Anticipated|2019-07-18||Interventional|NABOGO||New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea|New Antibiotic Treatment Options for Uncomplicated Anogenital Gonorrhoea Infections - a Double-blind Randomized Controlled Non-inferiority Trial|Recruiting||Phase 3|548|Anticipated|Public Health Service of Amsterdam||4|||f||||t|f|f||||||||2017-10-10 20:41:19.613328|2017-10-10 20:41:19.613328
NCT03294382|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Botulinum Toxin to Improve Results in Epicanthoplasty|Botulinum Toxin to Improve Results in Epicanthoplasty|Recruiting||Phase 3|42|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t|f|f|||f|||||2017-10-10 20:41:19.736555|2017-10-10 20:41:19.736555
NCT03294369|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||April 1, 2011|Actual|2011-04-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|5 Years|Observational [Patient Registry]|RICARTO||CV Risk and Toledo|RIesgo CARdiovascular y Eventos Cardiovasculares en la población General Del área Sanitaria de TOledo|Recruiting||N/A|3125|Anticipated|La Sociedad Española de Médicos de Atención Primaria|||1||f||||t|f|f||||Samples With DNA|"     Total blood and serum samples will be frozen (-85ºC) for future genetic studies.   "|||2017-10-10 20:41:19.846577|2017-10-10 20:41:19.846577
NCT03294356|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|||CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes|CSD170304: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes|Recruiting||N/A|210|Anticipated|RAI Services Company||6|||f||||f|f|f||||||||2017-10-10 20:41:19.953076|2017-10-10 20:41:19.953076
NCT03294343|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2023|Anticipated|2023-09-01|September 1, 2022|Anticipated|2022-09-01||Interventional|||Risk-Reducing Surgeries for Hereditary Ovarian Cancer|Risk-Reducing Surgeries of Salpingo-oophorectomy With/Without Hysterectomy for Carriers With Mutation Genes of Hereditary Ovarian Cancer|Recruiting||N/A|600|Anticipated|Peking Union Medical College Hospital||3|||f|||||f|f||||||||2017-10-10 20:41:20.092754|2017-10-10 20:41:20.092754
NCT03294330|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|SPYX||SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer|SPY-X: A Study to Assess the Feasibility of Using Real-time Fluorescence Lymphangiography Alone for Sentinel Node Localization in Patients With Melanoma or Breast Cancer|Not yet recruiting||Phase 3|60|Anticipated|Milton S. Hershey Medical Center||1|||f||||t|t|f||||||||2017-10-10 20:41:20.199191|2017-10-10 20:41:20.199191
NCT03294317|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Observational|(IMAGE-HBP)||Imaging Study of Lead Implant for His Bundle Pacing|Imagining Study of Lead Implant for His Bundle Pacing|Not yet recruiting||N/A|55|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f|f|t|f|f||||||2017-10-10 20:41:20.276287|2017-10-10 20:41:20.276287
NCT03294304|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||November 21, 2017|Anticipated|2017-11-21|September 2017|2017-09-01|November 1, 2021|Anticipated|2021-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Nivolumab in Treatment of Bladder Cancer (MIBC) Undergoing Cystectomy|Phase II Trial of Neoadjuvant Nivolumab With Cisplatin and Gemcitabine in Muscle-Invasive Bladder Cancer (MIBC) Patients Undergoing Radical Cystectomy|Not yet recruiting||Phase 2|41|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f|||||t|f|||f|||||2017-10-10 20:41:20.384032|2017-10-10 20:41:20.384032
NCT03294291|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Ultrasound Guided Quadratus Lumborum Block Versus Caudal Block in Pediatric Patient|Quadratus Lumborum Block Versus Caudal Block|Recruiting||N/A|50|Anticipated|Kahramanmaras Sutcu Imam University||2|||f||||f|f|f||||||||2017-10-10 20:41:20.520408|2017-10-10 20:41:20.520408
NCT03294278|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Epicardial Ablation in Brugada Syndrome to Prevent Sudden Death|Epicardial Ablation in Brugada Syndrome in the Prevention of Sudden Cardiac Death. A Randomized Prospective Follow-up Study.|Recruiting||N/A|150|Anticipated|IRCCS Policlinico S. Donato||2|||f||||t|f|f||||||||2017-10-10 20:41:20.610507|2017-10-10 20:41:20.610507
NCT03294265|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||August 1, 2016|Actual|2016-08-01|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||A Peer Support Program to Enhance Treatment Adherence in Patients With Type 2 DM|A Peer Support Program to Enhance Treatment Adherence in Patients With Type 2 Diabetes Mellitus|Enrolling by invitation||N/A|500|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f|f|f||||||||2017-10-10 20:41:20.689396|2017-10-10 20:41:20.689396
NCT03294252|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-26|||May 24, 2017|Actual|2017-05-24|September 2017|2017-09-01|June 7, 2021|Anticipated|2021-06-07|September 12, 2019|Anticipated|2019-09-12||Interventional|PIPOX||Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers|Phase I / II Dose Escalation of Oxaliplatin Via a Laparoscopic Approach of Aerosol Pressurized Intraperitoneal Chemotherapy for Nonresectable Peritoneal Metastases of Digestive Cancers (Stomach, Hail and Colorectal)|Recruiting||Phase 1/Phase 2|50|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||f|f|f||||||||2017-10-10 20:41:20.788378|2017-10-10 20:41:20.788378
NCT03294226|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|May 31, 2018|Anticipated|2018-05-31||Interventional|||Comparison of AuraGain With I-gel for Pediatric Patients|A Randomized Trial of Ambu® AuraGain™ Versus I-gel® in Young Children|Not yet recruiting||N/A|100|Anticipated|Asan Medical Center||2|||f|||||f|f||||||||2017-10-10 20:41:20.970499|2017-10-10 20:41:20.970499
NCT03294213|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|January 25, 2019|Anticipated|2019-01-25|January 25, 2018|Anticipated|2018-01-25||Observational|||Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView|Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView|Not yet recruiting||N/A|100|Anticipated|Ambu A/S|||1||f||||f|f|f||||||||2017-10-10 20:41:21.049076|2017-10-10 20:41:21.049076
NCT03294200|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System|Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System|Recruiting||N/A|90|Anticipated|4Tech Cardio Ltd.||1|||f||||t|f|f||||||||2017-10-10 20:41:21.120413|2017-10-10 20:41:21.120413
NCT03294187|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-21|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|ISEAR||Encouragement-induced Movement Therapy in Daily Life|Encouragement-induced Movement Therapy in Daily Life - a Randomized Controlled, Assessor-blinded Multi-center Trial in Stroke Patients With a Unilateral Hemiparesis, Using a Wrist-worn Tracking and Feedback Device|Not yet recruiting||Phase 2|62|Anticipated|University of Zurich||2|||f||||f|f|f||||||||2017-10-10 20:41:21.205086|2017-10-10 20:41:21.205086
NCT03294174|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-09-21|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee Arthroplasty|Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee|Recruiting||N/A|90|Anticipated|University of Pittsburgh|||3||f||||||||||Samples With DNA|"     Synovial tissues will be collected from each study patient   "|||2017-10-10 20:41:21.289162|2017-10-10 20:41:21.289162
NCT03294161|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-25|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis|Transition-state Analog Inhibitor of Human Purine Nucleoside Phosphorylase as an Adjunct in Cutaneous Leishmaniasis Therapy: a Randomized and Controlled Trial|Completed||Phase 2|50|Actual|Hospital Universitário Professor Edgard Santos||2|||f||||t|f|f||||||||2017-10-10 20:41:21.374195|2017-10-10 20:41:21.374195
NCT03294148|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-25|||August 7, 2017|Actual|2017-08-07|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Mind-body Treatments for Chronic Back Pain|Mind-body Treatments for Chronic Back Pain|Recruiting||N/A|99|Anticipated|University of Colorado, Boulder||3|||f||||f|f|f||||||||2017-10-10 20:41:21.452012|2017-10-10 20:41:21.452012
NCT03294122|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-10-02|||February 2, 2017|Actual|2017-02-02|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Observational|MICROLEARNER||Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer|Microbiota, Inflammatory Environment, Clinical and Radiomic Features as Predictors of Normal Tissue Response in Radiotherapy for Prostate and Head-and-neck Cancer|Recruiting||N/A|400|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||4||f||||f|f|f||||Samples With DNA|"     Whole blood samples of all patients, stool samples of prostate cancer patients, salivary     samples of head and neck cancer patients   "|||2017-10-10 20:41:21.693636|2017-10-10 20:41:21.693636
NCT03294109|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy|Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy|Not yet recruiting||Phase 4|120|Anticipated|University of California, Los Angeles||2|||f|||||t|f|||t|||||2017-10-10 20:41:21.800894|2017-10-10 20:41:21.800894
NCT03294096|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients|Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients|Recruiting||N/A|30|Anticipated|Yonsei University||2|||f||||f|f|f||||||||2017-10-10 20:41:21.888994|2017-10-10 20:41:21.888994
NCT03294083|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study of Recombinant Vaccinia Virus in Combination With REGN2810 for Renal Cell Carcinoma|A Phase 1b, Dose-escalation Study of Pexa-Vec (Thymidine Kinase-Deactivated Vaccinia Virus Plus GM-CSF) in Combination With REGN2810 (Anti-PD-1) in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC)|Not yet recruiting||Phase 1|89|Anticipated|SillaJen, Inc.||4|||f|||||t|f||||||||2017-10-10 20:41:21.950083|2017-10-10 20:41:21.950083
NCT03294070|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-25|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension|A 24-week Open-label Clinical Trial to Assess Tolerability and Antihypertensive Effect and in Hemodynamic Parameters and Arterial Stiffness of Fimasartan 60 mg Plus Amlodipine Besylate 5 mg Given Once a Day in Patients With Hypertension in Stadiums 2/3|Not yet recruiting||Phase 4|53|Anticipated|Centro Universitario de Ciencias de la Salud, Mexico||1|||f||||f|f|f||||||||2017-10-10 20:41:22.018121|2017-10-10 20:41:22.018121
NCT03294057|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-10-03|||October 11, 2017|Anticipated|2017-10-11|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Collaborative Care With Smart Health Management Program for Patients With Chronic Illness|The Effectiveness of Collaborative Care With Smart Health Management Program for Patients With Chronic Illness: Randomized Controlled Trial|Not yet recruiting||N/A|105|Anticipated|Seoul National University Hospital||3|||f||||t|f|f||||||||2017-10-10 20:41:22.083445|2017-10-10 20:41:22.083445
NCT03294044|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-10-03|||October 11, 2017|Anticipated|2017-10-11|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effectiveness of Smart Health Management Program for Patients With Chronic Illness|The Effectiveness of Smart Health Management Program With Proactive Overcoming for Patients With Chronic Illness: Randomized Controlled Trial|Not yet recruiting||N/A|120|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:22.289279|2017-10-10 20:41:22.289279
NCT03294031|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||January 11, 2016|Actual|2016-01-11|September 2017|2017-09-01|May 27, 2016|Actual|2016-05-27|May 27, 2016|Actual|2016-05-27||Interventional|||Pilates as an Adjuvant Therapy in Parkinson Disease.|Pilates as an Adjuvant Physical Exercise Therapy in Patients With Parkinson Disease.|Completed||N/A|15|Actual|University of Vigo||2|||f||||f|f|f||||||||2017-10-10 20:41:22.400427|2017-10-10 20:41:22.400427
NCT03294005|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography|Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography|Enrolling by invitation||N/A|2000|Anticipated|China Medical University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:41:22.615087|2017-10-10 20:41:22.615087
NCT03293992|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|September 24, 2018|Anticipated|2018-09-24|September 10, 2018|Anticipated|2018-09-10||Interventional|||A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension|A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension|Recruiting||Phase 1|52|Anticipated|Hoffmann-La Roche||4|||f|||||t|f||||||||2017-10-10 20:41:22.721775|2017-10-10 20:41:22.721775
NCT03293979|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||March 1, 2016|Actual|2016-03-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis|Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis|Recruiting||N/A|50|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f|||||f|f||||||||2017-10-10 20:41:22.865419|2017-10-10 20:41:22.865419
NCT03293966|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-26|||July 7, 2016|Actual|2016-07-07|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Therapeutic CARE of the Bronchial Cancer Not in Small Cell: Implementation of a Coordination Card of Care Relative to the Medicinal Treatments Got Out of it From Hospitalization|Therapeutic CARE of the Bronchial Cancer Not in Small Cell: Security of the Dispensation of Medicine by the Implementation of a Card of Coordination of Care Relative to the Medicinal Treatments(Processings) Got Out of it From Hospitalization|Recruiting||N/A|150|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||f|f|f||||||||2017-10-10 20:41:22.979379|2017-10-10 20:41:22.979379
NCT03293953|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Observational|FULLFIBRO01||Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01)|Prospective Comparison Between Transient Elastography (TE), Shear Wave Elastography (SWE) and Magnetic Resonance Elastography (MRE) for Non-invasive Assessment of Liver Fibrosis in Patients Affected by Chronic Viral Hepatitis|Recruiting||N/A|100|Anticipated|Ente Ospedaliero Ospedali Galliera|||1||f||||t|f|f||||||||2017-10-10 20:41:23.091502|2017-10-10 20:41:23.091502
NCT03293940|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-04|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|July 25, 2018|Anticipated|2018-07-25|July 25, 2018|Anticipated|2018-07-25||Interventional|||Cryoablation for Post Mastectomy Pain Syndrome|Percutaneous Image Guided Cryoablation of the Intercostobrachial Nerve for Management of Post Mastectomy Pain Syndrome|Recruiting||N/A|22|Anticipated|Emory University||2|||f||||t|f|f||||||||2017-10-10 20:41:23.256675|2017-10-10 20:41:23.256675
NCT03293927|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-26|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Polypharmacy-related Adverse Events in Critically Ill Children|Investigating Polypharmacy-related Adverse Events in Critically Ill Children|Not yet recruiting||Phase 2|75|Anticipated|Duke University||4|||f||||f|t|f|||f|||||2017-10-10 20:41:23.426495|2017-10-10 20:41:23.426495
NCT03293914|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-25|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Addressing Uncontrolled Diabetes in Primary Care: A Lifestyle Redesign Approach|Addressing Uncontrolled Diabetes in Primary Care: A Lifestyle Redesign Approach|Recruiting||N/A|120|Anticipated|University of Southern California||2|||f||||f|f|f||||||||2017-10-10 20:41:23.571657|2017-10-10 20:41:23.571657
NCT03293901|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-20|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Calcium Kinetic Responses to Exercise|Skeletal Hormone and Calcium Kinetic Responses to Load Carriage Exercise in Females|Recruiting||N/A|50|Anticipated|United States Army Research Institute of Environmental Medicine||2|||f|||||f|f||||||||2017-10-10 20:41:23.719529|2017-10-10 20:41:23.719529
NCT03293888|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2025|Anticipated|2025-09-30|September 30, 2022|Anticipated|2022-09-30||Observational|||Spectral Analysis Probe to Identify Glioblastoma Cells|Pilot Study Utilizing a Spectral Analysis Probe to Identify Glioblastoma Cells in Patients With Glioblastoma Undergoing Standard Surgical Resection|Not yet recruiting||N/A|15|Anticipated|University of Oklahoma|||1||f||||t|f|f||||Samples With DNA|"     Tissue from surgically resected tumor   "|||2017-10-10 20:41:23.843514|2017-10-10 20:41:23.843514
NCT03293875|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-09-25|||August 2016||2016-08-01|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|December 2020|Anticipated|2020-12-01||Interventional|||Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border|Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border|Recruiting||N/A|1400|Anticipated|Lehigh University||2|||f||||t||||||||||2017-10-10 20:41:23.91878|2017-10-10 20:41:23.91878
NCT03293862|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-28|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|March 2017|Actual|2017-03-01||Interventional|||Prevention of Abdominal Wound Dehiscence After Midline Laparotomy With an Onlay Mesh|Prevention of Abdominal Wound Dehiscence After Midline Laparotomy With an Onlay Mesh|Recruiting||N/A|146|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:41:24.026892|2017-10-10 20:41:24.026892
NCT03293849|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-25|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumors|A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumors|Recruiting||N/A|134|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t|f|f||||||||2017-10-10 20:41:24.130902|2017-10-10 20:41:24.130902
NCT03293836|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-25|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|October 31, 2017|Anticipated|2017-10-31||Interventional|VUERT||Venous Ulcer: Endovenous Radiofrequency Treatment Trial|Venous Ulcer: Endovenous Radiofrequency Treatment of Insufficient Perforating and Saphenous Veins Versus Multilayer Compression Bandaging - Randomized Controlled Clinical Trial|Recruiting||N/A|84|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:41:24.241343|2017-10-10 20:41:24.241343
NCT03293823|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-05|||October 4, 2017|Actual|2017-10-04|October 2017|2017-10-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||HARP-Project 1 Cognitive Training|HARP-Project 1 Cognitive Training|Recruiting||N/A|30|Anticipated|University of Rochester||2|||f||||f|f|f||||||||2017-10-10 20:41:24.342328|2017-10-10 20:41:24.342328
NCT03293810|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-09-26|||June 2014||2014-06-01|September 2017|2017-09-01|June 2029|Anticipated|2029-06-01|February 2029|Anticipated|2029-02-01|15 Years|Observational [Patient Registry]|GENIALL||GENIALL Lipoprotein Lipase Deficiency (LPLD) Disease Registry|LPLD Registry, Observational Longitudinal Pharmaco-epidemiologic Study in Lipoprotein Lipase Deficient (LPLD) Patients, Either Treated or Not Treated With Alipogene Tiparvovec (Glybera®)|Recruiting||N/A|200|Anticipated|UniQure Biopharma B.V.|||1||f||||f||||||||||2017-10-10 20:41:24.442531|2017-10-10 20:41:24.442531
NCT03293797|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-22|2017-09-22|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Ultra-Brief Intervention to Reduce Depressive and Anxious Symptoms|Improving Access to Quality Mental Healthcare Through Innovations in Psychotherapy: A Pilot Study of a Novel, Ultra-Brief Intervention to Reduce Depressive and Anxious Symptoms|Not yet recruiting||N/A|25|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f|f|f||||||||2017-10-10 20:41:24.528075|2017-10-10 20:41:24.528075
NCT03293784|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|June 2019|Anticipated|2019-06-01||Interventional|TICIMEL||TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma|TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma - A Phase Ib Clinical Study|Not yet recruiting||Phase 1|30|Anticipated|Institut Claudius Regaud||2|||f||||t|f|f|||f|||||2017-10-10 20:41:24.615094|2017-10-10 20:41:24.615094
NCT03293771|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31|6 Weeks|Observational [Patient Registry]|||Transgender Post-reassignment Urogynecologic Measures and Perceptions|Assessment of Postoperative Urologic and Pelvic Floor Complaints in Male-to-female Transgender Patients: a Mixed Methods Study|Not yet recruiting||N/A|200|Anticipated|Weill Medical College of Cornell University|||2||f||||f|f|f||||||||2017-10-10 20:41:24.705529|2017-10-10 20:41:24.705529
NCT03293745|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Cognitive Behavioral Therapy for Insomnia: Face-to-Face Versus Telemedicine|Cognitive Behavioral Therapy for Insomnia: Face-to-Face Versus Telemedicine|Not yet recruiting||N/A|150|Anticipated|University of Michigan||2|||f|||||f|f||||||||2017-10-10 20:41:24.870142|2017-10-10 20:41:24.870142
NCT03293732|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-25|||November 28, 2012|Actual|2012-11-28|September 2017|2017-09-01|September 30, 2013|Actual|2013-09-30|March 30, 2013|Actual|2013-03-30||Interventional|||Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults|A Randomized, Double-blind Phase I Trial to Evaluate the Safety, Tolerability, and Immunogenicity of DCB07010 Adjuvant Given Intranasally at Ascending Dose Levels and Co-administered With Trivalent Inactivated Influenza Virus Antigen|Completed||Phase 1|36|Actual|Advagene Biopharma Co. Ltd.||5|||f||||t|f|f||||||||2017-10-10 20:41:24.952168|2017-10-10 20:41:24.952168
NCT03293719|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|April 1, 2025|Anticipated|2025-04-01|December 1, 2024|Anticipated|2024-12-01||Observational|||Post-market Follow up Study of the 'BPK-S Integration' UC as Primary Implant in the Variants CoCr or Ceramic|"Prospective, Open, Multi-center, Non-randomized, Non-interventional Explorative, Comparative, Uncontrolled Cohort Study for Post Market Clinical Follow-Up of the BPK-S Integration UC in the Variants CoCr or Ceramic as Primary Implant"|Not yet recruiting||N/A|200|Anticipated|Peter Brehm GmbH|||2||f||||t|f|f||||||||2017-10-10 20:41:25.052918|2017-10-10 20:41:25.052918
NCT03293693|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-25|||October 2016||2016-10-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects|Beta-glucan and Blood Glucose|Completed||N/A|14|Actual|Oslo and Akershus University College of Applied Sciences||3|||f||||f||||||||||2017-10-10 20:41:25.216538|2017-10-10 20:41:25.216538
NCT03293680|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-25|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|November 15, 2021|Anticipated|2021-11-15|June 15, 2019|Anticipated|2019-06-15||Interventional|||Pembrolizumab in Elderly Patients With Advanced Lung Cancer|Survival, Quality of Life and Self-reported Outcomes of Elderly Patients With Advanced Non-small Cell Lung Cancer Treated With Pembrolizumab (MK-3475) in the First Line Setting|Not yet recruiting||Phase 2|82|Anticipated|Spanish Lung Cancer Group||1|||f||||f|f|f||||||||2017-10-10 20:41:25.322299|2017-10-10 20:41:25.322299
NCT03293667|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-20|||March 30, 2017|Actual|2017-03-30|September 2017|2017-09-01|July 20, 2019|Anticipated|2019-07-20|September 20, 2018|Anticipated|2018-09-20||Interventional|CATERLIS||Characterization of Regulatory T Lymphocytes in the Synovial Fluid of Patients Affected by Rheumatoid Arthritis.|Phenotypic and Functional Characterization of Regulatory T Lymphocytes in the Synovial Fluid of Patients Affected by Rheumatoid Arthritis, a Pilot Study.|Recruiting||N/A|10|Anticipated|University Hospital, Montpellier||1|||f||||f|f|f||||||||2017-10-10 20:41:25.442704|2017-10-10 20:41:25.442704
NCT03293641|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-09-25|||May 20, 2016|Actual|2016-05-20|September 2017|2017-09-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|||Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya|The Effects of Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya: a Pilot Study|Completed||N/A|40|Actual|Kenya Medical Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:41:25.680499|2017-10-10 20:41:25.680499
NCT03293628|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-26|||October 1, 2014|Actual|2014-10-01|September 2017|2017-09-01|January 30, 2016|Actual|2016-01-30|June 30, 2015|Actual|2015-06-30||Interventional|||Comparing Two Techniques of Haemostasis After Cervical Conization|Randomized Clinical Trial Comparing Two Techniques of Haemostasis After Cervical Conization With High Frequency Surgery|Completed||Phase 2|100|Actual|Barretos Cancer Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:25.777767|2017-10-10 20:41:25.777767
NCT03293615|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-25|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 1, 2025|Anticipated|2025-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|MIDE||Exercise Capacity of Patients With Dermatomyosis|Exercise Capacity of Patients With Dermatomyosisthe Role of Muscle Mitochondria and Reactive Oxygen Species|Not yet recruiting||N/A|45|Anticipated|University Hospital, Strasbourg, France||3|||f||||f|f|f||||||||2017-10-10 20:41:25.87338|2017-10-10 20:41:25.87338
NCT03293602|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|MISOBOLD||MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET Imaging|MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET Imagin|Not yet recruiting||N/A|20|Anticipated|University Hospital, Bordeaux||1|||f||||f|f|f||||||||2017-10-10 20:41:25.972233|2017-10-10 20:41:25.972233
NCT03293589|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|September 20, 2017|Actual|2017-09-20||Observational|OERESRD||Open Versus Endovascular Revascularization in Patients With End-stage Renal Disease|Open Versus Endovascular Revascularization of Below-knee Arteries in Patients With End-stage Renal Disease and Critical Limb Ischemia|Recruiting||N/A|77|Anticipated|University Hospital Erlangen|||2||f|||||f|f||||||||2017-10-10 20:41:26.07974|2017-10-10 20:41:26.07974
NCT03293576|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|October 2019|Anticipated|2019-10-01||Interventional|ADAPT||A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates|Integrating Health Psychology Into Hepatitis c Treatment: a Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates|Not yet recruiting||N/A|126|Anticipated|University of Dundee||2|||f||||t|f|f||||||||2017-10-10 20:41:26.160656|2017-10-10 20:41:26.160656
NCT03293563|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-20|||December 2011||2011-12-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|UroCCR||UroCCR Database: French Research Network for Kidney Cancer|UroCCR Database: French Research Network for Kidney Cancer (National Multidisciplinary Clinical and Biological Database on Kidney Cancer)|Recruiting||N/A|6300|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 20:41:26.248808|2017-10-10 20:41:26.248808
NCT03293550|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Can a New EEG Based Tool Predict Post-operative Delirium and Cognitive Dysfunction?|The Association Between Minor Brain Injuries and Level of Anesthesia Detected by a New EEG Based Tool, to Delirium and Post-operative Cognitive Dysfunction After Cardiac and Non-cardiac Surgery - a Proof of Concept Study|Not yet recruiting||N/A|100|Anticipated|Rambam Health Care Campus|||1||f||||f|f|f||||||||2017-10-10 20:41:26.373826|2017-10-10 20:41:26.373826
NCT03293537|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Dementia Associated Apathy.|Skin Conductance and Heart Rate as Biomarkers to Uncover Covert Emotional Reactions in Patients With Dementia Associated Apathy; a Multi-centre Study.|Not yet recruiting||N/A|133|Anticipated|Zurich University of Applied Sciences||1|||f||||f|f|f||||||||2017-10-10 20:41:27.96139|2017-10-10 20:41:27.96139
NCT03293524|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||December 30, 2017|Anticipated|2017-12-30|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|REFLECT||Efficacy and Safety Study of Bilateral Intravitreal Injection of GS010 for the Treatment of Vision Loss up to 1 Year From Onset in LHON Due to the ND4 Mutation|Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year|Not yet recruiting||Phase 3|90|Anticipated|GenSight Biologics||2|||f||||t|t|f||||||||2017-10-10 20:41:28.782112|2017-10-10 20:41:28.782112
NCT03293511|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||June 9, 2017|Actual|2017-06-09|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Oxytocin Modulates Eye Gaze Behavior During Social Processing|Oxytocin Modulates Eye Gaze Behavior During Social Processing and Associations With Trait Autism|Recruiting||N/A|40|Anticipated|University of Electronic Science and Technology of China||2|||f|||||f|f||||||||2017-10-10 20:41:28.890561|2017-10-10 20:41:28.890561
NCT03293472|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-04|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|BuRoNe||Neurotoxicity of Spinal Anesthesia With Ropivacaine and Bupivacaine|Inflammatory Mediators, Neural Tissue Injury Markers and the Markers of Oxidative Stress in the CSF of Patients Undergoing Spinal Anesthesia With Ropivacaine and Bupivacaine|Not yet recruiting||Phase 4|60|Anticipated|University of Rzeszow||2|||f|||||f|f|||f|||||2017-10-10 20:41:29.276222|2017-10-10 20:41:29.276222
NCT03293459|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-25|||July 3, 2017|Actual|2017-07-03|June 2017|2017-06-01|December 25, 2017|Anticipated|2017-12-25|December 25, 2017|Anticipated|2017-12-25||Interventional|||Influence of Balloon Occluded Retrograde Transvenous Obliteration on Organ Functions in Hyperammonemic Cirrhotics With Shunt|Influence of Balloon Occluded Retrograde Transvenous Obliteration on Organ Functions in Hyperammonemic Cirrhotics With Shunt|Recruiting||N/A|40|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f|f|f||||||||2017-10-10 20:41:29.363948|2017-10-10 20:41:29.363948
NCT03293446|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||October 7, 2016|Actual|2016-10-07|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|AC/DC||AC/DC Study: Acidification Test in Patients With Chronic Kidney Disease and Healthy Controls|AC/DC Study: Acidification Test in Patients With Chronic Kidney Disease and Healthy Controls|Recruiting||N/A|24|Anticipated|Erasmus Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:41:29.451089|2017-10-10 20:41:29.451089
NCT03293433|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-21|||November 2015||2015-11-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|miR-Nod||Quantification of microRNAs in Diagnosis of Pulmonary Nodules|Quantification of microRNAs in Diagnosis of Pulmonary Nodules: Reproducibility Analysis of Intra- and Inter-observer and Inter-laboratory: Project miR-Nod|Recruiting||N/A|86|Anticipated|University Hospital, Toulouse|||1||f||||f||||||Samples With DNA|"     Total blood punction with micro RNA exctraction   "|||2017-10-10 20:41:29.529086|2017-10-10 20:41:29.529086
NCT03293420|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PRECOCE TC||Retrospective Analysis of a Population of Patients With With Severe Traumatic Head Injury and Woken Early|Retrospective Analysis of a Population of Patients With With Severe Traumatic Head Injury and Woken Early|Completed||N/A|61|Actual|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:41:29.728147|2017-10-10 20:41:29.728147
NCT03293407|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Observational|VENTASTEP||Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension|Ventavis® (Iloprost): Evaluation of Inhaled Iloprost Effects Using the Breelib™ Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension|Not yet recruiting||N/A|100|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 20:41:29.793428|2017-10-10 20:41:29.793428
NCT03293394|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-04|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|October 2, 2022|Anticipated|2022-10-02|April 2, 2022|Anticipated|2022-04-02||Interventional|tDCS_MND||Rehabilitative Trial With tDCS in Amyotrophic Lateral Sclerosis|Rehabilitative Trial With Transcranial Direct Current Stimulation (tDCS) in Amyotrophic Lateral Sclerosis|Recruiting||N/A|100|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||t|f|f||||||||2017-10-10 20:41:29.909443|2017-10-10 20:41:29.909443
NCT03293381|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||November 30, 2016|Actual|2016-11-30|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Observational|eMAP||Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial)|Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial)|Recruiting||N/A|60|Anticipated|University of Pennsylvania|||1||f||||t|f|t|f||f|||||2017-10-10 20:41:30.046302|2017-10-10 20:41:30.046302
NCT03293368|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Efficacy of Intralesional Injection of Platelet Rich Plasma in the Treatment of Patients With Erosive Oral Lichen Planus|Efficacy of Intralesional Injection of Autologous Platelet Rich Plasma Versus Intralesional Injection of Corticosteroids on Pain Relief and Ulcers Healing in Patients With Erosive Oral Lichen Planus; Randomized Clinical Trial|Not yet recruiting||Phase 2|14|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:41:30.155117|2017-10-10 20:41:30.155117
NCT03293355|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Multilevel Integration Strategies to Enhance Service Provider Networks in Vietnam|Multilevel Integration Strategies to Enhance Service Provider Networks in Vietnam|Not yet recruiting||N/A|320|Anticipated|University of California, Los Angeles||2|||f||||t|f|f||||||||2017-10-10 20:41:30.256952|2017-10-10 20:41:30.256952
NCT03293342|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-24|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|December 20, 2022|Anticipated|2022-12-20|December 20, 2020|Anticipated|2020-12-20||Interventional|||Cognitive Behavioural Therapy and Dental Fear|The Effect of a Dentist Administered Cognitive Behavioural Therapy (D-CBT) in Adult Patients With Dental Fear|Recruiting||N/A|70|Anticipated|University of Oslo||2|||f||||f|f|f||||||||2017-10-10 20:41:30.364688|2017-10-10 20:41:30.364688
NCT03293329|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-09-24|||November 21, 2017|Anticipated|2017-11-21|September 2017|2017-09-01|June 11, 2019|Anticipated|2019-06-11|November 20, 2018|Anticipated|2018-11-20||Interventional|||Effects of Diaphragm Muscle Therapy on Pain and Shoulder Movement in Subjects With Rotator Cuff Injuries|Effects of Diaphragm Muscle Therapy on Pain and Shoulder Movement in Subjects With Rotator Cuff Injuries|Not yet recruiting||N/A|60|Anticipated|Universidad Complutense de Madrid||3|||f||||f|f|f||||||||2017-10-10 20:41:30.483069|2017-10-10 20:41:30.483069
NCT03293316|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-29|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Using Electroencephalography (EEG) and Transcranial Current Stimulation (tCS) to Study and Modulate Cognition Study|Using Electroencephalography (EEG) and Transcranial Current Stimulation (tCS) to Study and Modulate Cognition Study|Completed||N/A|72|Actual|University of Oxford||3|||f||||||||||||||2017-10-10 20:41:30.569358|2017-10-10 20:41:30.569358
NCT03293303|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|December 14, 2020|Anticipated|2020-12-14|January 31, 2019|Anticipated|2019-01-31||Interventional|||The Feasibility, Effects and Costs of the 'Stay Active at Home Programme'|The Feasibility, Effects and Costs of the 'Stay Active at Home Programme': Evaluation of a Preventive Integral Approach in Primary Care That Stimulates Physical Activity Among Community-dwellin Older Adults|Recruiting||N/A|220|Anticipated|Maastricht University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:41:30.638684|2017-10-10 20:41:30.638684
NCT03293290|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|June 30, 2019|Anticipated|2019-06-30||Interventional|||Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks|Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks|Not yet recruiting||Phase 1|100|Anticipated|Yale University||1|||f||||t|t|f|||t|||||2017-10-10 20:41:30.716597|2017-10-10 20:41:30.716597
NCT03293277|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-24|||July 26, 2017|Actual|2017-07-26|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of Intranasal Dexmedetomidine in Healthy Subjects|A Phase I Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Intranasal Dexmedetomidine in Healthy Subjects|Recruiting||Phase 1|48|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||f|f|f||||||||2017-10-10 20:41:30.791824|2017-10-10 20:41:30.791824
NCT03293264|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-25|||October 26, 2017|Anticipated|2017-10-26|September 2017|2017-09-01|May 26, 2020|Anticipated|2020-05-26|October 26, 2019|Anticipated|2019-10-26||Interventional|||Exercise Training on Metabolic Syndrome Severity in Employees|Effects of a Workplace Health Service Program in Employees With Diagnosed Metabolic Syndrome|Not yet recruiting||N/A|300|Anticipated|Hannover Medical School||2|||f||||f|f|f||||||||2017-10-10 20:41:30.885941|2017-10-10 20:41:30.885941
NCT03293251|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-24|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 29, 2018|Anticipated|2018-12-29|October 29, 2018|Anticipated|2018-10-29||Observational|||Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors|Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors|Active, not recruiting||N/A|70|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:41:30.963892|2017-10-10 20:41:30.963892
NCT03293238|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-24|||November 3, 2011|Actual|2011-11-03|September 2017|2017-09-01|July 2023|Anticipated|2023-07-01|January 2023|Anticipated|2023-01-01||Interventional|PRISMM||Ultrasound Guided Knee Injections in Musculoskeletal Medicine|Practical Indications for Sonography in Musculoskeletal Medicine-Knee Joint Injections|Recruiting||N/A|120|Anticipated|Andrews Research & Education Foundation||4|||f||||f|f|f|||f|||||2017-10-10 20:41:31.04235|2017-10-10 20:41:31.04235
NCT03293225|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-24|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01|4 Weeks|Observational [Patient Registry]|OPEhRA||Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist|A Randomized Open Labeled Trial to Compare the Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist in Patients With Chronic Urticaria|Not yet recruiting||N/A|200|Anticipated|Ajou University School of Medicine|||4||f||||f|f|f||||||||2017-10-10 20:41:31.164253|2017-10-10 20:41:31.164253
NCT03121755|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-19|||January 21, 2015|Actual|2015-01-21|April 2017|2017-04-01|April 14, 2017|Actual|2017-04-14|March 1, 2017|Actual|2017-03-01||Observational|||CCK1R Function in Patient Leukocytes|CCK1R Function in Patient Leukocytes|Completed||N/A|112|Actual|Mayo Clinic|||1||f||||f|f|f||||||Undecided||2017-10-10 21:09:09.594271|2017-10-10 21:09:09.594271
NCT03293212|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-23|||June 29, 2017|Actual|2017-06-29|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Observational|||Characteristics and Medical Resource Utilization of Postoperative Patients|Characteristics and Medical Resource Utilization of Postoperative Patients: A Cross-sectional Survey of Outpatients|Recruiting||N/A|100|Anticipated|Jaseng Medical Foundation|||1||f||||f|f|f||||||||2017-10-10 20:41:31.263365|2017-10-10 20:41:31.263365
NCT03293199|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-21|||August 12, 2017|Actual|2017-08-12|September 2017|2017-09-01|October 12, 2018|Anticipated|2018-10-12|July 12, 2018|Anticipated|2018-07-12||Interventional|||Comparing Efficacy of Chest Tube Drainage and Needle Aspiration in Pneumothorax Treatment|Randomized Controlled Trial on Comparison of Chest Tube Drainage and Needle Aspiration in Treatment of Spontaneous Pneumothorax|Recruiting||N/A|70|Anticipated|Tabriz University of Medical Sciences||2|||f||||f|f|f|||f|||||2017-10-10 20:41:31.35842|2017-10-10 20:41:31.35842
NCT03293186|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-21|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||"Anti-adhesive Effect and Safety of Thermo-sensitive Adhesion Barrier (MEDICLORE)"|"Anti-adhesive Effect and Safety of Thermo-sensitive Adhesion Barrier (MEDICLORE) by Using Double-blind Test in Thyroid Surgery"|Recruiting||Phase 4|90|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 20:41:31.495846|2017-10-10 20:41:31.495846
NCT03293173|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-21|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2019|Anticipated|2019-06-01||Interventional|Bio-CHIC||Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis|Biomarker Driven and Dose Intensified Chemoimmunotherapy With Early CNS Prophylaxis in Patients Less Than 65 Years With High Risk Diffuse Large B-Cell Lymphoma|Recruiting||Phase 2|120|Anticipated|Nordic Lymphoma Group||2|||f||||t|f|f||||||||2017-10-10 20:41:31.64548|2017-10-10 20:41:31.64548
NCT03293160|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||An Evaluation of the Michigan State Innovation Model in Washtenaw and Livingston Counties|An Evaluation of the Michigan State Innovation Model in Washtenaw and Livingston Counties|Not yet recruiting||N/A|1800|Anticipated|University of Michigan|||2||f||||f|f|f||||||||2017-10-10 20:41:31.769502|2017-10-10 20:41:31.769502
NCT03293147|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-27|||September 2018|Anticipated|2018-09-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|December 2019|Anticipated|2019-12-01||Interventional|OUTREACH||OUTREACH: Urine Analysis and Antihypertensive Treatment|BiOmarkers in Urine, anTihypeRtensive trEAtment and Blood Pressure Control in Hypertensive Patients|Not yet recruiting||N/A|321|Anticipated|University of Manchester||2|||f||||f|f|f||||||||2017-10-10 20:41:31.846291|2017-10-10 20:41:31.846291
NCT03293134|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-21|||July 8, 2013|Actual|2013-07-08|March 2017|2017-03-01|October 6, 2016|Actual|2016-10-06|March 9, 2015|Actual|2015-03-09||Observational|VPCA||Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy|Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy|Completed||N/A|25|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||Samples With DNA|"     Whole blood, cells cultivated, extracted DNA and fetal tissue.   "|||2017-10-10 20:41:31.984415|2017-10-10 20:41:31.984415
NCT03293121|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-19|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Strength and Coordination Training on Biomechanics and Injury in New Runners|Effect of Strength and Coordination Training on Biomechanics and Injury in New Runners|Not yet recruiting||N/A|100|Anticipated|Virginia Commonwealth University||2|||f|||||f|f||||||||2017-10-10 20:41:32.069164|2017-10-10 20:41:32.069164
NCT03293108|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-23|||April 29, 2017|Actual|2017-04-29|September 2017|2017-09-01|December 20, 2019|Anticipated|2019-12-20|December 20, 2019|Anticipated|2019-12-20||Interventional|||Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Denosumab 60 mg (Dyenix) Versus Prolia® in Improvement of Bone Mineral Densitometry (BMD) Among Osteoporotic Postmenopausal Women|A Phase III, Randomized, Two Armed, Parallel, Double-blind, Active-controlled, Non-inferiority Clinical Trial to Determine the Non-inferior Therapeutic Efficacy and Safety Between Dyenix (60 mg, Denosumab, Produced by AryoGen Pharmed) Compared With Prolia® (60 mg, Denosumab, the Reference Drug, Produced by Amgen Company) in Improvement of Bone Mineral Densitometry (BMD) Among Osteoporotic Postmenopausal Women|Recruiting||Phase 3|190|Anticipated|AryoGen Pharmed Co.||2|||f||||f|f|f||||||||2017-10-10 20:41:32.199654|2017-10-10 20:41:32.199654
NCT03293095|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-04|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|June 30, 2019|Anticipated|2019-06-30|November 1, 2018|Anticipated|2018-11-01||Observational|||Functional Task Kinematic in Musculoskeletal Pathology.|Functional Task Kinematic in Patient With Musculoskeletal Pathology.|Not yet recruiting||N/A|80|Anticipated|University of Malaga|||2||f||||f|f|f||||||||2017-10-10 20:41:32.367426|2017-10-10 20:41:32.367426
NCT03293082|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-10-02|||September 30, 2017|Actual|2017-09-30|September 2017|2017-09-01|September 30, 2017|Actual|2017-09-30|September 30, 2017|Actual|2017-09-30|3 Years|Observational [Patient Registry]|||Preschool CGM Use and Glucose Variability in Type 1 Diabetes|The Effect of Continuous Glucose Monitoring Use on Glucose Variability in Preschool Children With Type 1 Diabetes|Completed||N/A|40|Actual|University of Ljubljana, Faculty of Medicine|||1||f|||||f|f||||||||2017-10-10 20:41:32.499347|2017-10-10 20:41:32.499347
NCT03293069|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|March 2022|Anticipated|2022-03-01||Interventional|FAIR-ALS II||Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis|Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis: Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone|Not yet recruiting||Phase 2/Phase 3|210|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||||2017-10-10 20:41:32.608175|2017-10-10 20:41:32.608175
NCT03293056|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|June 1, 2018|Anticipated|2018-06-01||Interventional|HIITxHMC||HIIH Versus HMC: Randomized Clinical Trial|Effectiveness of High-intensity Interval Versus Intensity Continuous Hydrogymnastics for Improvement of Health Outcomes: Randomized Clinical Trial.|Recruiting||N/A|75|Anticipated|Universidade Federal do vale do São Francisco||2|||f||||t|f|f||||||||2017-10-10 20:41:32.727045|2017-10-10 20:41:32.727045
NCT03293043|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-20|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|UA NPV-EVLP||The University of Alberta Negative Pressure Ventilation Ex-Vivo Lung Perfusion (NPV-EVLP) Trial|The University of Alberta Negative Pressure Ventilation Ex-Vivo Lung Perfusion (NPV-EVLP) Trial|Not yet recruiting||N/A|12|Anticipated|University of Alberta||1|||f||||t|f|f||||||||2017-10-10 20:41:32.843868|2017-10-10 20:41:32.843868
NCT03293030|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis|Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis|Not yet recruiting||Phase 4|15|Anticipated|University of California, San Francisco||1|||f|||||t|f|||f|||||2017-10-10 20:41:32.935631|2017-10-10 20:41:32.935631
NCT03293017|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-26|||February 1, 2016|Actual|2016-02-01|June 2017|2017-06-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||Baclofen in Managing Acute Alcohol Withdrawal|Baclofen Bij de Behandeling Van Acute Alcoholontwenning|Recruiting||Phase 4|90|Anticipated|Universitair Ziekenhuis Brussel||3|||f||||f|f|f||||||||2017-10-10 20:41:33.035254|2017-10-10 20:41:33.035254
NCT03293004|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-22|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|October 18, 2017|Anticipated|2017-10-18||Interventional|Collagen||Collagen Vitamin C Dose Response Performance|Effects of Hydrolyzed Collagen and Vitamin C on Collagen Synthesis and Explosive Performance|Active, not recruiting||N/A|9|Actual|University of California, Davis||4|||f||||t|f|f||||||||2017-10-10 20:41:33.123912|2017-10-10 20:41:33.123912
NCT03292991|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-20|||June 9, 2015|Actual|2015-06-09|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|2 Years|Observational [Patient Registry]|||REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN)|REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN)|Recruiting||N/A|100|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||f||||||||||2017-10-10 20:41:33.21143|2017-10-10 20:41:33.21143
NCT03292978|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 30, 2017|Anticipated|2017-12-30||Interventional|||An Intervention on Healthy Adults of Probiotics on Gut Flora Metabolisms of Choline|Probiotics Intervention on Gut Flora Metabolisms of Choline:A Randomized Double-Blind Control Trial|Recruiting||N/A|50|Anticipated|Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 20:41:33.290789|2017-10-10 20:41:33.290789
NCT03292965|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-22|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Interventional|||Monitoring of Postoperative Recurarization in Laparoscopic Surgery|Monitoring of Postoperative Recurarization in Laparoscopic Surgery: Comparison of Neostigmine and Sugammadex|Recruiting||N/A|160|Anticipated|Seoul National University Bundang Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:33.374076|2017-10-10 20:41:33.374076
NCT03292952|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-22|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||KP415 Classroom Study in Children (6-12 Years of Age) With ADHD|A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Efficacy Laboratory Classroom Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder|Not yet recruiting||Phase 3|140|Anticipated|KemPharm, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:41:33.467021|2017-10-10 20:41:33.467021
NCT03292926|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|October 2018|Anticipated|2018-10-01||Interventional|||A Novel Analgesia Technique for ACL Reconstruction|A Randomized Controlled Trial to Evaluate a Novel Analgesia Technique for ACL Reconstruction: Adductor Canal Block With an IPACK Versus Adductor Canal Block|Recruiting||Phase 4|120|Anticipated|Hospital for Special Surgery, New York||2|||f|||||t|f|||f|||||2017-10-10 20:41:33.618346|2017-10-10 20:41:33.618346
NCT03292913|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||January 5, 2018|Anticipated|2018-01-05|September 2017|2017-09-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|(PHC)||Positive Health Check Evaluation Trial|Positive Health Check Evaluation Trial|Not yet recruiting||N/A|1010|Anticipated|RTI International||2|||f||||f|f|f||||||||2017-10-10 20:41:33.738605|2017-10-10 20:41:33.738605
NCT03292900|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-22|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment|Association Between a Pharmacogenetic Algorithm to Predict Blood Pressure Therapy With Blood Pressure Response to Anti-Hypertensive Therapy|Not yet recruiting||N/A|2000|Anticipated|Geneticure, LLC|||1||f||||f|f|f||||||||2017-10-10 20:41:33.839263|2017-10-10 20:41:33.839263
NCT03292887|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||August 1, 2005|Actual|2005-08-01|September 2017|2017-09-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2022|Anticipated|2022-09-01|6 Months|Observational [Patient Registry]|HOS||Hunter Outcome Survey (HOS)|Hunter Outcome Survey: A Global, Multi-Center, Long-Term, Observational Registry of Patients With Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II)|Recruiting||N/A|2000|Anticipated|Shire|||2||f||||f|f|f||||||||2017-10-10 20:41:33.917358|2017-10-10 20:41:33.917358
NCT03292874|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-26|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||High Resolution MRI Study for Prostate Cancer|Evaluation of a Novel High-Resolution Diffusion-Weighted MRI Sequence|Active, not recruiting||N/A|59|Anticipated|Cedars-Sinai Medical Center||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:41:34.033564|2017-10-10 20:41:34.033564
NCT03292861|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-22|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients|A Pilot Randomized Study to Assess the Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients: A 12-month, Single Center, Randomized, Open-label Study of Efficacy Comparing Immediate Treatment With and Without Thymoglobulin® 1.5 mg/kg/d for 5 Consecutive Days in Heart Transplant Recipients|Not yet recruiting||N/A|60|Anticipated|Cedars-Sinai Medical Center||2|||f|||||f|f||||||||2017-10-10 20:41:34.136168|2017-10-10 20:41:34.136168
NCT03292692|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||August 13, 2013|Actual|2013-08-13|September 2017|2017-09-01|October 18, 2014|Actual|2014-10-18|October 18, 2014|Actual|2014-10-18||Interventional|||Empirically-Based Couple Interventions on the Web: Serving the Underserved|Empirically-Based Couple Interventions on the Web: Serving the Underserved|Completed||N/A|600|Actual|University of Miami||2|||f||||f|f|f||||||||2017-10-10 20:41:35.700052|2017-10-10 20:41:35.700052
NCT03292848|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders|A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders|Not yet recruiting||Phase 1|24|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f|||||t|f||||||||2017-10-10 20:41:34.245486|2017-10-10 20:41:34.245486
NCT03292822|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-22|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|April 1, 2019|Anticipated|2019-04-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line|Apoptotic and Anti-Proliferative Effects of Licorice Extract (Licochalcone A) and Paclitaxel Chemotherapy on Human Oral Squamous Cell Carcinoma Cell Line|Not yet recruiting||Early Phase 1|18|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:41:34.594786|2017-10-10 20:41:34.594786
NCT03292809|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)|A Phase 2b/3, Multicenter, Randomized, Double-masked, Vehicle-controlled Clinical Study to Assess the Efficacy and Safety of Topical CyclASol® for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)|Not yet recruiting||Phase 2/Phase 3|316|Anticipated|Novaliq GmbH||2|||f||||f|t|f||||||||2017-10-10 20:41:34.706999|2017-10-10 20:41:34.706999
NCT03292796|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-27|||December 7, 2016|Actual|2016-12-07|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|CMO||RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery.|A Randomised Control Study to Investigate if the Continuation of Prostaglandin Analogue Treatments in the Post-operative Phase of Glaucoma Patients Undergoing Cataract Surgery Increases the Incidence of Cystoid Macular Oedema.|Recruiting||Phase 2|60|Anticipated|Norfolk and Norwich University Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:41:34.827224|2017-10-10 20:41:34.827224
NCT03292783|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|December 27, 2019|Anticipated|2019-12-27|September 16, 2019|Anticipated|2019-09-16||Interventional|||A Study of NOV1501 (ABL001) in Subject With Advanced Solid Tumors|An Open-label, Phase 1 Clinical Trial to Identify the Optimal Dose and Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Anti-tumor Efficacy of NOV1501 (ABL001) in Patients With Advanced Solid Tumors|Recruiting||Phase 1|39|Anticipated|National OncoVenture||1|||f||||f|f|f||||||||2017-10-10 20:41:34.988457|2017-10-10 20:41:34.988457
NCT03292770|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-28|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|March 31, 2018|Anticipated|2018-03-31||Interventional|MUCRET||Mucus Removal Before Embryo Transfer|EFFICACY STUDY OF THE UTILIZATION OF A FLUSHING CATHETER FOR REMOVAL OF CERVICAL MUCUS BEFORE AN EMBRYO TRANSFER: A RANDOMIZED PILOT CONTROLLED TRIAL|Not yet recruiting||N/A|60|Anticipated|Institut Universitari Dexeus||2|||f||||f|f|f||||||||2017-10-10 20:41:35.087241|2017-10-10 20:41:35.087241
NCT03292757|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|FLOTOR||FLOTOR Pilot Study|FLuOrescence to Identify the Thoracic Duct During Oesophageal Resections|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Oxford University Hospitals NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:41:35.165736|2017-10-10 20:41:35.165736
NCT03292744|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||January 10, 2017|Actual|2017-01-10|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|October 10, 2017|Anticipated|2017-10-10||Interventional|||Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly|Effect of Alfacalcidol Supplementation to Respiratory Infection, Inflammatory Markers and CD4/CD8 Ratio of Indonesian Elderly|Recruiting||Phase 4|110|Anticipated|Indonesia University||2|||f||||f|f|f|||f|||||2017-10-10 20:41:35.275561|2017-10-10 20:41:35.275561
NCT03292731|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PRO||Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth|Relationship Between Plasma Concentration of (Hydroxyprogesterone Caproate) 17-OHPC and Preterm Birth|Not yet recruiting||Phase 2/Phase 3|300|Anticipated|University of Pittsburgh||2|||f||||t|t|f|||t|||||2017-10-10 20:41:35.387285|2017-10-10 20:41:35.387285
NCT03292718|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MyCyFAPP||Clinical Trial to Assess Influence of MyCyFAPP Use on GI Related QOL in Children With Cystic Fibrosis|Innovative Approach for Self-management and Social Welfare of Cystic Fibrosis Patients in Europe: Development, Validation and Implementation of a Telematics Tool. WP6.2: Impact Assessment Through a European Multicentre Clinical Trial: Validation of MyCyFAPP as a Portable System for Self-management in Children With CF|Not yet recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f||||||||2017-10-10 20:41:35.509424|2017-10-10 20:41:35.509424
NCT03292705|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|CogT-PACT||Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment|Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment|Not yet recruiting||N/A|50|Anticipated|University of Rochester||2|||f||||f|f|f||||||||2017-10-10 20:41:35.593859|2017-10-10 20:41:35.593859
NCT03292666|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||January 1, 2010|Actual|2010-01-01|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|December 31, 2019|Anticipated|2019-12-31||Observational|ALTERNATIVE||Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study|The Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Extended Treatment of Venous Thromboembolism|Recruiting||N/A|19200|Anticipated|University of California, San Francisco|||2||f||||f|t|f|||f|||||2017-10-10 20:41:35.880181|2017-10-10 20:41:35.880181
NCT03292653|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||November 7, 2017|Anticipated|2017-11-07|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients Hospitalized With Worsening Heart Failure|An Exploratory, Randomized, Double-blind, Placebo-controlled, Parallel Arm Trial of the Safety and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients Hospitalized With Worsening Heart Failure|Not yet recruiting||Phase 2|81|Anticipated|Sanofi||4|||f||||t|t|f||||||||2017-10-10 20:41:35.985467|2017-10-10 20:41:35.985467
NCT03292640|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-22|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks|A Multicenter, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks|Recruiting||Phase 3|550|Anticipated|Dr. Reddy's Laboratories Limited||2|||f|||||t|f||||||||2017-10-10 20:41:36.084366|2017-10-10 20:41:36.084366
NCT03292627|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Non-invasive Monitor in Endoscopic Invasive Procedure|Applying Non-invasive Hemodynamic Monitor to Predict the Risk of Perioperative Hypotension in Geriatric Patientsn Underwent Endoscopic Invasive Procedure|Not yet recruiting||N/A|120|Anticipated|National Taiwan University Hospital|||2||f|||||f|f||||||||2017-10-10 20:41:36.169772|2017-10-10 20:41:36.169772
NCT03292614|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Measurement of Refractive SE Following Implantation of LS313 MF30 IOL|Measurement of Refraction Following Cataract Surgery With Implantation of MICS Intraocular Lens LS313 MF30, Oculentis Berlin|Recruiting||N/A|100|Anticipated|Dietrich-Bonhoeffer-Klinikum|||1||f||||f|f|f||||||||2017-10-10 20:41:36.248607|2017-10-10 20:41:36.248607
NCT03292601|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)|Effect of Feedback and Monitoring on Patient Compliance With Spinal Orthoses for Scoliosis Treatment|Not yet recruiting||N/A|20|Anticipated|Columbia University||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:41:36.336812|2017-10-10 20:41:36.336812
NCT03292575|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|AOD||Study of the Follow-up of Stroke Treated With Anticoagulants|Prevention of Cardio-embolic Stroke Using Anti-vitamin K and Direct Oral Anticoagulants. A Model of Action in Burgundy.|Recruiting||N/A|422|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:41:36.583197|2017-10-10 20:41:36.583197
NCT03292562|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|October 31, 2018|Anticipated|2018-10-31|October 19, 2018|Anticipated|2018-10-19||Interventional|||A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation|A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation - a Feasibility Study|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:41:36.676465|2017-10-10 20:41:36.676465
NCT03292549|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-20|||April 2014|Actual|2014-04-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Observational|ROPAN||RObotic PArtial Nephrectomy National Study|RObotic PArtial Nephrectomy National Study (RoPaN Study)|Completed||N/A|452|Actual|University Hospital, Bordeaux|||1||f||||f|f|f||||||||2017-10-10 20:41:36.760761|2017-10-10 20:41:36.760761
NCT03292536|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-26|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|||Merestinib on Bone Metastases in Subjects With Breast Cancer|An Exploratory Phase 1B Study to Assess the Effects of Merestinib on Bone Metastases in Subjects With Breast Cancer|Not yet recruiting||Phase 1|16|Anticipated|University of Utah||1|||f||||t|t|f||||||||2017-10-10 20:41:36.865532|2017-10-10 20:41:36.865532
NCT03292523|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|WHY||Work Productivity in Hyperventilation Syndrome|Work Productivity in Hyperventilation Syndrome|Not yet recruiting||N/A|50|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||||2017-10-10 20:41:36.923498|2017-10-10 20:41:36.923498
NCT03292510|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||May 2018|Anticipated|2018-05-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Getting Older Adults OUT-of -Doors (GO-OUT)|Getting Older Adults OUT-of-doors (GO-OUT): A Randomized Controlled Trial of a Community-based Outdoor Walking Program|Not yet recruiting||N/A|240|Anticipated|University of Toronto||2|||f||||f|f|f||||||||2017-10-10 20:41:36.994193|2017-10-10 20:41:36.994193
NCT03292497|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Prospective Treatment Algorithm Guiding Repair of Severe Ischemic Mitral Regurgitation|Prospective Treatment Algorithm Guiding Repair of Severe Ischemic Mitral Regurgitation: Canadian Mitral Research Alliance (CAMRA) 2 Trial|Not yet recruiting||N/A|110|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t|f|f||||||||2017-10-10 20:41:37.068331|2017-10-10 20:41:37.068331
NCT03289949|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-20|||March 3, 2017|Actual|2017-03-03|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Neurobiological Effect of 5-HT2AR Modulation|The Neurobiological Effect of 5-HT2AR Modulation|Recruiting||Phase 1|45|Anticipated|Rigshospitalet, Denmark||3|||f||||t|f|f|||f|||||2017-10-10 20:41:58.477022|2017-10-10 20:41:58.477022
NCT03292484|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)|A Multicenter, Open-label, Long-term Safety Study of AR101 Characterized Oral Desensitization Immunotherapy in Subjects Who Participated in a Prior AR101 Study|Not yet recruiting||Phase 3|1100|Anticipated|Aimmune Therapeutics, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:41:37.147181|2017-10-10 20:41:37.147181
NCT03292471|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-19|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Effects of rTMS on Brain Activation in Aphasia|Immediate and Cumulative Effects of rTMS on Brain Activation in Chronic Aphasia|Not yet recruiting||N/A|20|Anticipated|VA Office of Research and Development||2|||f||||f|f|t|t|f|f|||||2017-10-10 20:41:37.215469|2017-10-10 20:41:37.215469
NCT03292458|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-24|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2022|Anticipated|2022-08-31||Interventional|||Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor|Central Mechanisms and Treatment Response of Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor|Active, not recruiting||Phase 2/Phase 3|175|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||t|t|f||||||||2017-10-10 20:41:37.295804|2017-10-10 20:41:37.295804
NCT03292445|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-20|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|February 14, 2024|Anticipated|2024-02-14|February 14, 2020|Anticipated|2020-02-14||Interventional|CIRM||Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation|Induction of Immune Tolerance by Total Lymphoid Irradiation, Anti-Thymocyte Globulin and Purified Donor CD34+ and T Cell Transfusion in HLA Haplotype Matched Related and 3 Antigen HLA Matched Unrelated Living Donor Kidney Transplantation|Recruiting||Early Phase 1|24|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 20:41:37.378485|2017-10-10 20:41:37.378485
NCT03292432|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||November 13, 2017|Anticipated|2017-11-13|September 2017|2017-09-01|May 31, 2020|Anticipated|2020-05-31|November 13, 2019|Anticipated|2019-11-13||Interventional|TERA||Triggered Escalating Real-time Adherence (TERA) Intervention|Triggered Escalating Real-time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing First Line Antiretroviral Therapy: The TERA Study|Not yet recruiting||N/A|120|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|f|||t|||||2017-10-10 20:41:37.479854|2017-10-10 20:41:37.479854
NCT03292419|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-30|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Topography-guided LASIK Surgery|A Prospective Evaluation of Topography-guided LASIK Surgery|Not yet recruiting||Phase 4|35|Anticipated|Stanford University||1|||f||||f|f|f|||f|||||2017-10-10 20:41:37.592745|2017-10-10 20:41:37.592745
NCT03292406|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-20|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|CTCL||A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)|A Randomized, Double-blind, Multi-centre, Placebo-controlled, Parallel-arm Phase 2 Trial to Assess Safety, Efficacy and Pharmacokinetics of CD11301 0.03% and 0.06% Gel in the Treatment of Cutaneous T-Cell Lymphoma (CTCL), Stages IA, IB and IIA|Not yet recruiting||Phase 2|84|Anticipated|Galderma R&D||3|||f||||t|t|f||||||||2017-10-10 20:41:37.656772|2017-10-10 20:41:37.656772
NCT03292393|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-09-22|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Social Norms and Antihypertensive Medication Adherence|Social Norms and Antihypertensive Medication Adherence|Not yet recruiting||N/A|40|Anticipated|Florida International University||3|||f||||f|f|f|||f|||||2017-10-10 20:41:37.724257|2017-10-10 20:41:37.724257
NCT03292380|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||July 6, 2015|Actual|2015-07-06|September 2017|2017-09-01|August 19, 2015|Actual|2015-08-19|August 19, 2015|Actual|2015-08-19||Observational|||Validation of a 24-hour Caffeine Intake Recall|Evaluation of a 24-hour Caffeine Intake Assessment Compared to Urinary Biomarkers of Caffeine Intake and a Brief Caffeinated Beverage Questionnaire|Completed||N/A|79|Actual|University of Waterloo|||1||f||||f|f|f||||||||2017-10-10 20:41:37.816251|2017-10-10 20:41:37.816251
NCT03292367|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-22|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||The Procedural Success and Complication Rate of the Left Distal Transradial Approach|The Procedural Success and Complication Rate of the Left Distal Transradial Approach for Coronary Angiography and Coronary Intervention. Prospective Observational Study|Not yet recruiting||N/A|200|Anticipated|Wonju Severance Christian Hospital|||1||f||||f|f|f||||||||2017-10-10 20:41:37.886151|2017-10-10 20:41:37.886151
NCT03292354|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||April 11, 2017|Actual|2017-04-11|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|PeopleCT||Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography|Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography|Recruiting||N/A|440|Anticipated|Maastricht University Medical Center||4|||f||||t|f|f||||||||2017-10-10 20:41:38.089574|2017-10-10 20:41:38.089574
NCT03292341|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|LaDecA||Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.|Evaluating a Decision Aid in Clinical Practice for Patients With T3/T4 Laryngeal Cancer|Recruiting||N/A|150|Anticipated|Maastricht Radiation Oncology||3|||f||||f|f|f||||||||2017-10-10 20:41:38.212088|2017-10-10 20:41:38.212088
NCT03292328|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|September 18, 2018|Anticipated|2018-09-18|September 18, 2018|Anticipated|2018-09-18||Interventional|||Yoga for Symptoms of Nerve Damage Caused by Chemotherapy|Yoga for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Pilot Study|Recruiting||N/A|40|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||f|f||||||||2017-10-10 20:41:38.333149|2017-10-10 20:41:38.333149
NCT03292315|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-22|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Once Weekly GLP-1 in Persons With Spinal Cord Injury|The Efficacy of a Once Weekly Glucagon-Like Peptide-1 Agonist on Body Weight/Composition and Metabolic Parameters in Persons With SCI|Not yet recruiting||Phase 4|30|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f|t|f||||||||2017-10-10 20:41:38.431722|2017-10-10 20:41:38.431722
NCT03292302|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-26|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1 Study of ELX-02 in Healthy Adults|A Phase 1a, Randomized, Double-blinded, Placebo-Controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ELX-02 in Healthy Adult Volunteers|Recruiting||Phase 1|18|Anticipated|Eloxx Pharmaceuticals, Inc.||2|||f||||t|f|f||||||||2017-10-10 20:41:38.53505|2017-10-10 20:41:38.53505
NCT03292289|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|June 2020|Anticipated|2020-06-01||Interventional|QUALI-PRO||Assessment of Symptoms and Consequences of Coloanal Continuity Reconstruction|Assessment of Symptoms and Their Consequences on Patients Quality of Life After Coloanal Continuity Reconstruction Following a Proctectomy for Rectal Cancer|Not yet recruiting||N/A|65|Anticipated|Centre Oscar Lambret||1|||f||||f|f|f||||||||2017-10-10 20:41:38.644904|2017-10-10 20:41:38.644904
NCT03292276|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-23|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 2017|Anticipated|2017-12-01||Interventional|||Improving Hand Motor Function After Stroke: Role of Robotics|Improving Hand Motor Function After Stroke: Role of Robotics|Not yet recruiting||N/A|20|Anticipated|"IRCCS Centro Neurolesi Bonino-Pulejo"||2|||f||||t|f|f|||f|||||2017-10-10 20:41:38.764845|2017-10-10 20:41:38.764845
NCT03292263|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-22|||April 24, 2017|Actual|2017-04-24|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||ASCT With Nivolumab in Patients With Multiple Myeloma|Autologous Stem Cell Transplantation With Nivolumab in Patients With Multiple Myeloma|Recruiting||Phase 1/Phase 2|30|Anticipated|St. Petersburg State Pavlov Medical University||1|||f||||f|f|f||||||||2017-10-10 20:41:38.853281|2017-10-10 20:41:38.853281
NCT03292237|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-20|||June 2018|Anticipated|2018-06-01|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|November 2020|Anticipated|2020-11-01||Interventional|||Intensive Nutrition in Critically Ill Adults|Intensive Nutrition in Critically Ill Adults: A Pilot Randomised Controlled Study|Not yet recruiting||Phase 2/Phase 3|240|Anticipated|Australian and New Zealand Intensive Care Research Centre||2|||f||||f|f|f||||||||2017-10-10 20:41:39.158494|2017-10-10 20:41:39.158494
NCT03292224|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-20|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|October 15, 2019|Anticipated|2019-10-15|September 1, 2018|Anticipated|2018-09-01|2 Weeks|Observational [Patient Registry]|||Systemic Fungal Infections in ICU Patients|Systemic Fungal Infections in Intensive Care Unit Patients|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:41:39.278628|2017-10-10 20:41:39.278628
NCT03292211|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-26|||September 12, 2017|Actual|2017-09-12|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|November 1, 2018|Anticipated|2018-11-01||Interventional|||The Effect of Early Mobilization in Mild to Moderate Hemorrhagic Stroke|Comparing the Benefits of Functional Recovery Between the Early Mobilization and Early Conventional Intervention After Stroke for the Patients With Mild to Moderate Hemorrhagic Stroke|Enrolling by invitation||N/A|40|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:39.366157|2017-10-10 20:41:39.366157
NCT03292198|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-22|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|November 2021|Anticipated|2021-11-01||Interventional|SLT||Subclinical Lymphedema Treatment Study|Treatment Indications for Breast Cancer-related Subclinical Lymphedema Identified Through a Bioimpedance Surveillance Model|Not yet recruiting||N/A|267|Anticipated|Mercy Research||2|||f||||f|f|f|||f|||||2017-10-10 20:41:39.479283|2017-10-10 20:41:39.479283
NCT03292185|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|February 9, 2018|Anticipated|2018-02-09|February 9, 2018|Anticipated|2018-02-09||Interventional|||A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects|A Single Centre, Randomised, Double-blind, Three-period Cross-over Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects|Not yet recruiting||Phase 1|24|Anticipated|Novo Nordisk A/S||6|||f||||f|t|f|||t|||||2017-10-10 20:41:39.57266|2017-10-10 20:41:39.57266
NCT03292172|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|July 23, 2019|Anticipated|2019-07-23|July 23, 2019|Anticipated|2019-07-23||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer|Open Label, Dose Finding Phase IB Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (Pd L1 Antibody) in Pateints With Advanced Ovarian Cancer or Triple Negative Breast Cancer|Not yet recruiting||Phase 1|30|Anticipated|Hoffmann-La Roche||2|||f||||f|t|f||||||||2017-10-10 20:41:39.707069|2017-10-10 20:41:39.707069
NCT03292159|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Transcutaneous Vagus Nerve Stimulation for Motor Recovery After Stroke|Safety and Effectiveness of Transcutaneous Vagus Nerve Stimulation Therapy to Improve Motor Recovery After Stroke|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Massachusetts General Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:41:39.806077|2017-10-10 20:41:39.806077
NCT03292146|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|||Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study|Effects of Denosumab on Bone Mineral Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot Study|Recruiting||Early Phase 1|75|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||||2017-10-10 20:41:39.920358|2017-10-10 20:41:39.920358
NCT03292133|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-22|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|March 31, 2025|Anticipated|2025-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer|A Phase 2 Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer|Not yet recruiting||Phase 2|36|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 20:41:40.050237|2017-10-10 20:41:40.050237
NCT03292107|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||June 1, 2016|Actual|2016-06-01|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|October 31, 2017|Anticipated|2017-10-31||Observational|GMaT||Study on Management Thrombosis in Greek Cancer Patients|Study on Management Thrombosis in Greek Cancer Patients (GMaT - Greek Management Thrombosis)|Recruiting||N/A|500|Anticipated|Hellenic Society of Medical Oncology|||1||f||||t|f|f||||||||2017-10-10 20:41:40.261727|2017-10-10 20:41:40.261727
NCT03292094|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-22|||February 4, 2013|Actual|2013-02-04|September 2017|2017-09-01|December 3, 2027|Anticipated|2027-12-03|November 30, 2017|Anticipated|2017-11-30||Observational|PREDICT||The African-PREDICT Study|African Prospective Study for the Early Detection and Identification of Cardiovascular Disease and Hypertension (African-PREDICT Study)|Recruiting||N/A|1200|Anticipated|North-West University, South Africa|||4||f||||f|f|f||||||||2017-10-10 20:41:40.32926|2017-10-10 20:41:40.32926
NCT03292081|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-22|||June 12, 2014|Actual|2014-06-12|September 2017|2017-09-01|October 25, 2017|Anticipated|2017-10-25|July 31, 2016|Actual|2016-07-31||Interventional|MISTIC-1||Comparison Between OFDI and IVUS in PCI Guidance for Biolimus A9 Eluting Stent Implantation|Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound in Percutaneous Coronary Intervention Guidance for Biolimus A9 Eluting Stent Implantation|Active, not recruiting||Phase 2|96|Anticipated|Fujita Health University||2|||f||||f|f|f||||||||2017-10-10 20:41:40.432358|2017-10-10 20:41:40.432358
NCT03292068|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-25|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|TONIST||Children Recovering From Tonsil Surgery|Children Recovering From Tonsil Surgery Following Day Surgery|Not yet recruiting||N/A|576|Anticipated|Lund University||3|||f||||f|f|f||||||||2017-10-10 20:41:40.519462|2017-10-10 20:41:40.519462
NCT03292055|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||January 13, 2017|Actual|2017-01-13|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||Food Frequency Questionnaire (FFQ) for Coronary Heart Disease (CHD) Patients|Evaluation of the Psychometric Properties of a Food Frequency Questionnaire Developed for Patients With Coronary Heart Disease in Northern China|Active, not recruiting||N/A|235|Actual|Chinese University of Hong Kong|||1||f||||t|f|f||||Samples With DNA|"     Blood testing for the blood glucose, lipid profile   "|||2017-10-10 20:41:40.624454|2017-10-10 20:41:40.624454
NCT03292042|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-25|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|August 31, 2018|Anticipated|2018-08-31||Interventional|||Effectiveness of a Lifestyle Intervention, for People With SMI Who Meet Metabolic Syndrome Criteria|Impact of a Physical Health Promotion Program for People With Serious Mental Illness|Recruiting||N/A|60|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f|||||f|f||||||||2017-10-10 20:41:40.697601|2017-10-10 20:41:40.697601
NCT03292029|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Pilot Medical Evaluation of the T50 Test|Pilot Medical Evaluation of the T50 Calcification Inhibition Test in NephroCare Clinics|Not yet recruiting||N/A|1000|Anticipated|Fresenius Medical Care Deutschland GmbH||1|||f||||f|f|f||||||||2017-10-10 20:41:40.792591|2017-10-10 20:41:40.792591
NCT03292016|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-21|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||"A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by OFF Episodes"|"A Comparative Bioavailability Study to Evaluate the Single Dose Pharmacokinetic Properties of APL-130277 With Two Different Formulations of Subcutaneous Apomorphine in a Randomized, 3-Period Crossover Design in Subjects With Parkinson's Disease Complicated by Motor Fluctuations (OFF Episodes)"|Recruiting||Phase 2|12|Anticipated|Sunovion||3|||f||||f|t|f||||||||2017-10-10 20:41:40.864669|2017-10-10 20:41:40.864669
NCT03292003|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-09-21|||December 30, 2016|Actual|2016-12-30|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|November 30, 2017|Anticipated|2017-11-30||Observational|||Journey II Bi-Cruciate Stabilized (BCS) Total Knee System Retrospective Study|Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study|Recruiting||N/A|2000|Anticipated|Smith & Nephew, Inc.|||1||f||||f|f|f|||f|||||2017-10-10 20:41:40.983174|2017-10-10 20:41:40.983174
NCT03291990|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-21|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme|A Pilot Study to Assess Feasibility of 5 Fraction Hypofractionated Stereotactic Radiosurgery Along With Standard Temozolomide as a Lymphocyte Sparing Therapy for Glioblastoma Multiforme|Not yet recruiting||Early Phase 1|46|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 20:41:41.119245|2017-10-10 20:41:41.119245
NCT03291964|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-21|||September 3, 2017|Actual|2017-09-03|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Rapid MRI for Acute Pediatric Head Trauma|QuickBrain MRI for Acute Pediatric Head Trauma|Recruiting||N/A|100|Anticipated|Oregon Health and Science University|||1||f||||t|f|f||||||||2017-10-10 20:41:41.31126|2017-10-10 20:41:41.31126
NCT03291951|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-20|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|FORCE||FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study|FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study|Not yet recruiting||N/A|180|Anticipated|Kaiser Permanente||2|||f||||t|f|f||||||||2017-10-10 20:41:41.389558|2017-10-10 20:41:41.389558
NCT03291938|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-21|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2024|Anticipated|2024-02-01|February 2024|Anticipated|2024-02-01||Interventional|||Study to Evaluate the Safety and Tolerability of IACS-010759 in Subjects With Advanced Solid Tumors and Lymphoma|A Phase 1 Study to Evaluate the Safety and Tolerability of IACS-010759 in Subjects With Advanced Solid Tumors and Lymphoma|Not yet recruiting||Phase 1|66|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 20:41:41.465364|2017-10-10 20:41:41.465364
NCT03291925|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-20|||November 2016||2016-11-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|CT-CA||Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiography Prior to TAVI|Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiography Prior to TAVI: A Randomized Controlled Pilot Trial (CT-CA Study)|Recruiting||N/A|200|Anticipated|BC Centre for Improved Cardiovascular Health||2|||f||||t||||||||||2017-10-10 20:41:41.561936|2017-10-10 20:41:41.561936
NCT03291912|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|CHERIE||Chuna Manual Therapy for Cervicogenic Dizziness|Therapeutic Effect of Adjuvant Chuna Manual Therapy (CMT) in Subjects With Cervicogenic Dizziness: a Prospective, Pragmatic, Assessor-blind, Randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|Kyunghee University||2|||f|||||f|f||||||||2017-10-10 20:41:41.656506|2017-10-10 20:41:41.656506
NCT03291899|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-23|||January 3, 2017|Actual|2017-01-03|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|FBI-TRAC||Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers|Phase II Trial of Infusional 5 FLUOROURACIL, LEUCOVORIN, OXALIPLATIN AND IRINOTECAN (FOLFIRINOX) in First Line Treatment of Advanced Biliary Tract Cancers|Recruiting||Phase 2|32|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||f|f|f||||||||2017-10-10 20:41:41.745691|2017-10-10 20:41:41.745691
NCT03291886|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-02|||September 22, 2017|Actual|2017-09-22|October 2017|2017-10-01|November 2021|Anticipated|2021-11-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer|Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer|Recruiting||Phase 2|124|Anticipated|Kyowa Hakko Kirin Co., Ltd||2|||f||||t|f|f||||||||2017-10-10 20:41:41.839853|2017-10-10 20:41:41.839853
NCT03291873|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|August 2018|Anticipated|2018-08-01||Interventional|||Topography-Guided Customized PRK Versus Q-value Adjusted PRK in Correction of Myopia With or Without Astigmatism|Topography-Guided Customized PRK (Photorefractive Keratectomy) Versus Q-value Adjusted PRK in Correction of Myopia With or Without Astigmatism|Not yet recruiting||N/A|50|Anticipated|Kasr El Aini Hospital||2|||f|||||f|f||||||||2017-10-10 20:41:41.95895|2017-10-10 20:41:41.95895
NCT03291860|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-22|||November 10, 2017|Anticipated|2017-11-10|September 2017|2017-09-01|October 10, 2018|Anticipated|2018-10-10|September 10, 2018|Anticipated|2018-09-10||Observational|||Antimullerian Hormone as an Indicator for Ovarian Response|Antimullerian Hormone as an Indicator fo Ovarian Response in Women Receiving Long GnRH Agonist Protocol in Intracytoplasmic Sperm Injection Cycles|Not yet recruiting||N/A|66|Anticipated|Ain Shams Maternity Hospital|||1||f|||||f|f||||||||2017-10-10 20:41:42.024821|2017-10-10 20:41:42.024821
NCT03291847|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-21|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|June 2022|Anticipated|2022-06-01||Interventional|||Maternal Buprenorphine-naloxone Treatment and the Infant|Maternal Buprenorphine-naloxone Treatment During the Perinatal Period: Fetal and Infant Effects|Not yet recruiting||Phase 2|80|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||||2017-10-10 20:41:42.078882|2017-10-10 20:41:42.078882
NCT03291834|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-21|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Sports Participation in Children and Adolescents With Type 1 Diabetes Mellitus|A Study on Sports Participation in Children and Adolescents With Type 1 Diabetes Mellitus|Recruiting||N/A|100|Anticipated|Jessa Hospital|||1||f||||f|f|f||||||||2017-10-10 20:41:42.156397|2017-10-10 20:41:42.156397
NCT03291821|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore|Double Ovarian Stimulation in Cases of Preimplantation Genetic Testing: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore|Not yet recruiting||N/A|136|Anticipated|IVI Madrid||2|||f||||f|f|f||||||||2017-10-10 20:41:42.225358|2017-10-10 20:41:42.225358
NCT03291808|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-21|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|July 2019|Anticipated|2019-07-01||Interventional|PLAN||Pilot of Lifestyle and Asthma Intervention|Pilot of Lifestyle and Asthma Intervention|Not yet recruiting||N/A|40|Anticipated|Johns Hopkins University||1|||f||||t|f|f||||||||2017-10-10 20:41:42.517546|2017-10-10 20:41:42.517546
NCT03291795|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-20|||August 20, 2017|Actual|2017-08-20|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Prehabilitation Exercise Plus Perioperative Optimization of Senior Health|Prehabilitation Exercise Plus Perioperative Optimization of Senior Health|Recruiting||N/A|40|Anticipated|Duke University||1|||f||||f|f|f||||||||2017-10-10 20:41:42.626831|2017-10-10 20:41:42.626831
NCT03291769|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01|10 Months|Observational [Patient Registry]|||Effects of Intraoperative Blood and Blood Product Consumption on Postoperative Results in Pediatric Cardiac Surgery|Effects of Intraoperative Blood Transfusion on Postoperative Results in Pediatric Cardiac Surgery|Not yet recruiting||N/A|150|Anticipated|Cukurova University|||1||f||||f|f|f||||||||2017-10-10 20:41:42.826635|2017-10-10 20:41:42.826635
NCT03291756|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-21|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|December 2100|Anticipated|2100-12-01|December 2100|Anticipated|2100-12-01||Observational|||Corrona Multiple Sclerosis (MS) Registry|Corrona Multiple Sclerosis (MS) Registry|Enrolling by invitation||N/A|1000|Anticipated|Corrona, LLC.|||1||f||||f|f|f||||||||2017-10-10 20:41:42.911293|2017-10-10 20:41:42.911293
NCT03291743|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||February 10, 2017|Actual|2017-02-10|September 2017|2017-09-01|February 10, 2020|Anticipated|2020-02-10|February 10, 2019|Anticipated|2019-02-10||Interventional|||The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives|The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives|Recruiting||N/A|144|Anticipated|Carilion Clinic||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:41:43.033395|2017-10-10 20:41:43.033395
NCT03291730|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|October 31, 2024|Anticipated|2024-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||A Nurse Led Project to Introduce Hand Lettering as a Form of Art Therapy to Patients in an Ambulatory Oncology Setting|A Nurse Led Project to Introduce Hand Lettering as a Form of Art Therapy to Patients in an Ambulatory Oncology Setting|Not yet recruiting||N/A|62|Anticipated|Dana-Farber Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 20:41:43.264574|2017-10-10 20:41:43.264574
NCT03291717|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|September 28, 2019|Anticipated|2019-09-28|September 28, 2019|Anticipated|2019-09-28||Interventional|BCGP||Bridging Community Gaps Photovoice|Randomized Trial of a Peer-led Intervention to Promote Community Living and Participation - The Bridging Community Gaps Photovoice|Recruiting||N/A|180|Anticipated|Boston University Charles River Campus||2|||f||||f|f|f||||||||2017-10-10 20:41:43.387745|2017-10-10 20:41:43.387745
NCT03291704|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-21|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Investigating the Effect of Thermal Therapy With UMAY REST on Dry Eye Patients With Meibomian Gland Dysfunction|Clinical Efficacy of Thermal Therapy Using a Rechargeable, Wireless Device (UMAY REST) for Meibomian Gland Dysfunction on Digital Device Users|Not yet recruiting||N/A|40|Anticipated|Bonsai Beta Inc.||2|||f||||f|f|f|||f|||||2017-10-10 20:41:43.53614|2017-10-10 20:41:43.53614
NCT03291691|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-20|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Observational|ProNerv||Protective Nerve Stimulation in Regional Anesthesia|The Use of Protective Nerve Stimulation in Different Regional Anesthetic Blocks (Interscalene, Axillary, Femoral and Sciatic Nerve Blocks)|Recruiting||N/A|60|Anticipated|Charite University, Berlin, Germany|||4||f||||f|f|f||||||||2017-10-10 20:41:43.631306|2017-10-10 20:41:43.631306
NCT03291678|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-24|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|September 6, 2018|Anticipated|2018-09-06|September 5, 2018|Anticipated|2018-09-05||Interventional|||Impact of Percutaneous Laparoscopic Assisted Internal Ring Ligation During Lap Orchiopexy|Randomized Control Study for Patient With Abdominal Undescended Testis Using New Technique|Not yet recruiting||N/A|60|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 20:41:43.767226|2017-10-10 20:41:43.767226
NCT03291665|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-28|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Thickness of the Plantar Fascia in Stretched and Relaxed Positions in Patients With Plantar Fasciopathy|Comparing Thickness of the Plantar Fascia in Stretched and Relaxed Positions and the Association With Pressure Pain Threshold in Patients With Plantar Fasciopathy|Recruiting||N/A|20|Anticipated|Aalborg University|||1||f||||f||||||||||2017-10-10 20:41:43.898084|2017-10-10 20:41:43.898084
NCT03291652|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||February 2010|Actual|2010-02-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 20, 2020|Anticipated|2020-12-20||Observational|||Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential|Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential|Recruiting||N/A|140|Anticipated|Chinese University of Hong Kong|||2||f||||f|f|f||||||||2017-10-10 20:41:43.998998|2017-10-10 20:41:43.998998
NCT03291639|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 4, 2018|Anticipated|2018-09-04|September 4, 2018|Anticipated|2018-09-04|1 Day|Observational [Patient Registry]|||Functional Plasticity of Human IL-17-producing CD8+ T Cells|Functional Plasticity of Human IL-17-producing CD8+ T Cells|Not yet recruiting||N/A|30|Anticipated|China Medical University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:41:44.102515|2017-10-10 20:41:44.102515
NCT03291626|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|September 2021|Anticipated|2021-09-01||Observational|||Postoperative Delirium: EEG Markers of Sleep and Wakefulness|Postoperative Delirium: EEG Markers of Sleep and Wakefulness|Not yet recruiting||N/A|220|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||||2017-10-10 20:41:44.176869|2017-10-10 20:41:44.176869
NCT03291613|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||January 15, 2017|Actual|2017-01-15|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Gaming Technology to Engage Adolescent Sickle Cell Patients in Pain Management|PINPOINT: Gaming Technology to Engage Adolescent Sickle Cell Patients in Precision Pain Management|Recruiting||N/A|30|Anticipated|Klein Buendel, Inc.||1|||f||||f|f|f||||||||2017-10-10 20:41:44.247282|2017-10-10 20:41:44.247282
NCT03291600|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|Virtual-PND||Virtual Psychiatric Care for Perinatal Depression|Virtual Psychiatric Care for Perinatal Depression (Virtual-PND): A Pilot Randomized Controlled Trial|Not yet recruiting||N/A|100|Anticipated|Women's College Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:44.360557|2017-10-10 20:41:44.360557
NCT03291587|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Implementation of Smoking Cessation Within NCI NCORP Community Sites|Implementation Of Smoking Cessation Services Within NCI NCORP Community Sites With Organized Lung Cancer Screening Programs|Not yet recruiting||N/A|1114|Anticipated|Wake Forest University Health Sciences||2|||f||||t|f|f||||||||2017-10-10 20:41:44.451122|2017-10-10 20:41:44.451122
NCT03291574|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-09-20|||July 29, 2017|Actual|2017-07-29|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|January 1, 2020|Anticipated|2020-01-01||Interventional|||Perioperative Electroacupuncture for Gastric Cancer Patients After Gastrectomy|Effect of Perioperative Electroacupuncture After Gastrectomy for Gastric Cancer Patients on Rapid Rehabilitation: A Randomized Clinical Trial|Recruiting||N/A|400|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 20:41:44.535958|2017-10-10 20:41:44.535958
NCT03289754|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2027|Anticipated|2027-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Prospective Study to Evaluate the iTotal Knee and iPoly XE Tibial Inserts|A Prospective Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System and iPoly XE Tibial Inserts|Not yet recruiting||N/A|50|Anticipated|ConforMIS, Inc.||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:42:00.166523|2017-10-10 20:42:00.166523
NCT03291561|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-09-21|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|January 1, 2020|Anticipated|2020-01-01||Interventional|||Perioperative Electroacupuncture After Operation|Effect of Perioperative Electroacupuncture After Operation for Pancreatic Cancer and Periampullary Carcinoma Patients: A Randomized Clinical Trial|Recruiting||N/A|400|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 20:41:44.63222|2017-10-10 20:41:44.63222
NCT03291548|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||February 13, 2017|Actual|2017-02-13|September 2017|2017-09-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||Quinoa Biscuit & CVD Risk Trial|Effect of a Quinoa-enriched Biscuit as Novel Food Product to Improve CVD Risk Markers in Older Adults: a Randomised Crossover Study|Completed||N/A|40|Actual|University of Ulster||2|||f||||f|f|f||||||||2017-10-10 20:41:44.736287|2017-10-10 20:41:44.736287
NCT03291535|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-21|||July 26, 2017|Actual|2017-07-26|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Virtual Hypertension Management Pilot|Virtual Hypertension Management Pilot: Randomized Evaluation of Electronic Health Record-connected Blood Pressure Cuffs in a Clinical Pharmacist Panel.|Recruiting||N/A|96|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 20:41:44.833248|2017-10-10 20:41:44.833248
NCT03291522|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|September 1, 2023|Anticipated|2023-09-01|January 1, 2023|Anticipated|2023-01-01||Observational|||Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration|Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration|Not yet recruiting||N/A|50|Anticipated|University of Pittsburgh|||1||f||||t|f|f||||||||2017-10-10 20:41:44.973506|2017-10-10 20:41:44.973506
NCT03291509|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|July 2020|Anticipated|2020-07-01||Interventional|||Remote Delivery of Weight Management for Adults With IDD|Remote Delivery of Weight Management for Adults With Intellectual and Developmental Disabilities (IDD)|Not yet recruiting||N/A|120|Anticipated|University of Kansas Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:41:45.069115|2017-10-10 20:41:45.069115
NCT03291496|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 1, 2022|Anticipated|2022-09-01||Observational|||Microfluidic Assessment of Clinical Outcomes in Preterm Newborns|Microfluidic Assessment of Clinical Outcomes in Preterm Newborns|Not yet recruiting||N/A|400|Anticipated|University of Florida|||2||f||||f|f|f||||Samples With DNA|"     Blood   "|||2017-10-10 20:41:45.161133|2017-10-10 20:41:45.161133
NCT03291483|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-28|||January 20, 2016|Actual|2016-01-20|September 2017|2017-09-01|August 13, 2016|Actual|2016-08-13|April 10, 2016|Actual|2016-04-10||Interventional|WBV||The Effects of Whole Body Vibration With Plyometric Training on Physical Performance in Basketball Players|The Effects of Whole Body Vibration With Plyometric Training on Physical Performance in Basketball Players|Completed||N/A|24|Actual|Hasan Kalyoncu University||2|||f||||f|f|f||||||||2017-10-10 20:41:45.281126|2017-10-10 20:41:45.281126
NCT03291470|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||April 30, 2018|Anticipated|2018-04-30|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||TGC15302: A Study to Determine the Efficacy and Effectiveness of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade (KLG) 2 or 3 Osteoarthritis of the Knee|Not yet recruiting||Phase 3|510|Anticipated|TissueGene, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:41:45.362261|2017-10-10 20:41:45.362261
NCT03291457|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||March 30, 2017|Actual|2017-03-30|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|COGNOS||A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice|A Prospective Non-Interventional Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice|Recruiting||N/A|100|Anticipated|Hoffmann-La Roche|||1||f||||||f||||||||2017-10-10 20:41:45.474552|2017-10-10 20:41:45.474552
NCT03291444|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-21|||September 23, 2017|Anticipated|2017-09-23|September 2017|2017-09-01|March 1, 2022|Anticipated|2022-03-01|March 1, 2021|Anticipated|2021-03-01||Interventional|||CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia|A Clinical Study of Chimeric Antigen Receptor T Cells Combined With Eps8 Peptide Specific Dendritic Cell for Patients With Relapsed/Refractory Leukemia|Recruiting||Phase 1|30|Anticipated|Zhujiang Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:45.613449|2017-10-10 20:41:45.613449
NCT03291431|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Intermittent Theta Burst for the Treatment of Alcohol Use Disorders in Veterans|Intermittent Theta Burst TMS for the Treatment of Alcohol Use Disorders in Veterans|Not yet recruiting||N/A|20|Anticipated|Stanford University||2|||f||||t|f|t|f|f||||||2017-10-10 20:41:45.699538|2017-10-10 20:41:45.699538
NCT03291418|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-21|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects|A Double-Blind, Controlled Study to Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects|Recruiting||Phase 1/Phase 2|240|Anticipated|Antibe Therapeutics Inc.||2|||f||||t|f|f|||f|||||2017-10-10 20:41:45.834543|2017-10-10 20:41:45.834543
NCT03291405|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|March 2, 2018|Anticipated|2018-03-02|March 1, 2018|Anticipated|2018-03-01||Observational|||Correlation Between Body Mass Index and Gonadotrophin Secretions in Pcos Patients and Their Effect on Ivf Outcome|Correlation Between Body Mass Index and Gonadotrophin Secretions in Pcos Patients and Their Effect on Ivf Outcome (Randamized Control Trial)|Recruiting||N/A|142|Anticipated|Ain Shams University|||2||f|||||f|f||||||||2017-10-10 20:41:45.929938|2017-10-10 20:41:45.929938
NCT03291392|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||June 15, 2015|Actual|2015-06-15|September 2017|2017-09-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2025|Anticipated|2025-12-31||Observational|||CUHK Stroke Biobank|CUHK Stroke Biobank|Recruiting||N/A|500|Anticipated|Chinese University of Hong Kong|||3||f||||f|f|f||||Samples With DNA|"     30ml of EDTA blood, buccal swab or saliva, body tissue, or cerebrospinal fluid to be     collected   "|||2017-10-10 20:41:46.000443|2017-10-10 20:41:46.000443
NCT02751541|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-05-03|||May 2, 2016|Actual|2016-05-02|May 2017|2017-05-01|May 6, 2016|Actual|2016-05-06|May 6, 2016|Actual|2016-05-06||Interventional|||Human Phototoxicity Test|Human Phototoxicity Test|Completed||N/A|35|Actual|Bayer||1|||f||||f|t|f||||||||2017-10-10 22:16:05.793562|2017-10-10 22:16:05.793562
NCT03291379|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-21|||May 17, 2017|Actual|2017-05-17|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|VEROnA||Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies|VEROnA: A Window of Opportunity Study of Vandetanib-eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies|Recruiting||Early Phase 1|12|Anticipated|Biocompatibles UK Ltd||1|||f||||f|f|f||||||||2017-10-10 20:41:46.079502|2017-10-10 20:41:46.079502
NCT03291366|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Mesenchymal Stem Cells in Central Nervous System injury2017|Intrathecal Injection of Mesenchymal Stem Cells in Central Nervous System injury2017|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Fuzhou General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:46.158078|2017-10-10 20:41:46.158078
NCT03291353|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-19|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|August 19, 2022|Anticipated|2022-08-19|August 19, 2019|Anticipated|2019-08-19||Interventional|||Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia|Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia|Not yet recruiting||Early Phase 1|10|Anticipated|University of Pittsburgh||1|||f||||t|t|f||||||||2017-10-10 20:41:46.216005|2017-10-10 20:41:46.216005
NCT03291340|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|DISCoVeR||Determining the Impact of Shunting and CerebroVascular Reactivity on 7T MRI (DISCoVeR 7T MRI)|A Pilot Cross-sectional Cohort Study of Right-to-left-shunt, Cerebrovascular Reactivity, Ischemic Infarct Burden on High Resolution MRI, and Cognitive Impairment in Elderly Subjects|Recruiting||N/A|42|Anticipated|University of Pennsylvania|||2||f||||f|f|f||||||||2017-10-10 20:41:46.287065|2017-10-10 20:41:46.287065
NCT03291327|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluation of Two Active Lactobacilli for the Maintenance of Gingival Health|Evaluation of Two Active Lactobacilli for the Maintenance of Gingival Health: Double-Blind, Randomised Placebo-controlled Trial in Young Healthy Adults - a Proof of Principle Study|Not yet recruiting||N/A|90|Anticipated|Queen Mary University of London||3|||f||||t|f|f||||||||2017-10-10 20:41:46.349501|2017-10-10 20:41:46.349501
NCT03291314|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-19|||May 3, 2017|Actual|2017-05-03|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|GliAvAx||Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma|Phase II Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma|Recruiting||Phase 2|52|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f|f|f|||f|||||2017-10-10 20:41:46.420379|2017-10-10 20:41:46.420379
NCT03291301|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Group Cognitive Behavioral Therapy and Acupressure for Insomnia|The Efficacy of Cognitive Behavioral Therapy (CBT) and Acupressure for Insomnia: A Pilot Randomized Controlled Trial|Not yet recruiting||N/A|45|Anticipated|Chinese University of Hong Kong||3|||f|||||f|f||||||||2017-10-10 20:41:46.515685|2017-10-10 20:41:46.515685
NCT03291288|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Pexidartinib Effects on How the Body Processes Midazolam and S-warfarin (Pharmacokinetics)|An Open-label, Single Sequence, Crossover Study Assessing the Effect of Pexidartinib on the Pharmacokinetics of Midazolam and S-warfarin in Patients|Not yet recruiting||Phase 1|30|Anticipated|Daiichi Sankyo, Inc.||4|||f||||f|t|f||||||||2017-10-10 20:41:48.211996|2017-10-10 20:41:48.211996
NCT03291275|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2023|Anticipated|2023-09-01|September 1, 2022|Anticipated|2022-09-01||Observational|||Survival Outcomes of Uterine Malignancies in Chinese Population|Survival Outcomes of Uterine Malignancies in Chinese Population|Recruiting||N/A|10000|Anticipated|Peking Union Medical College Hospital|||1||f|||||f|f||||||||2017-10-10 20:41:48.366041|2017-10-10 20:41:48.366041
NCT03291262|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-21|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|January 1, 2023|Anticipated|2023-01-01|January 1, 2022|Anticipated|2022-01-01|10 Years|Observational [Patient Registry]|||Survival Outcomes of Ovarian Malignancies in Chinese Population|Survival Outcomes of Ovarian Malignancies in Chinese Population|Recruiting||N/A|5000|Anticipated|Peking Union Medical College Hospital|||1||f||||f|f|f||||||||2017-10-10 20:41:48.432454|2017-10-10 20:41:48.432454
NCT03291249|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-24|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM|A Randomized, Placebo-controlled ,Double-blind, Phase IIa Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)|Not yet recruiting||Phase 2|48|Anticipated|Tiziana Life Sciences, PLC||4|||f||||f|f|f||||||||2017-10-10 20:41:48.499772|2017-10-10 20:41:48.499772
NCT03291236|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|January 1, 2023|Anticipated|2023-01-01|January 1, 2022|Anticipated|2022-01-01||Observational|||Survival Outcomes of Uterine Cervical Malignancies in Chinese Population|Survival Outcomes of Uterine Cervical Malignancies in Chinese Population|Recruiting||N/A|5000|Anticipated|Peking Union Medical College Hospital|||1||f|||||f|f||||||||2017-10-10 20:41:48.592777|2017-10-10 20:41:48.592777
NCT03291223|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-19|||July 27, 2010|Actual|2010-07-27|September 2017|2017-09-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01|6 Months|Observational [Patient Registry]|||Gaucher Disease Outcome Survey (GOS)|Gaucher Disease Outcome Survey (GOS)|Recruiting||N/A|1257|Anticipated|Shire|||1||f||||f|f|f||||||||2017-10-10 20:41:48.653979|2017-10-10 20:41:48.653979
NCT03291210|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|October 20, 2018|Anticipated|2018-10-20|September 20, 2018|Anticipated|2018-09-20||Interventional|||O2 Tension During TAVI|Effect of O2 Tension on Myocardial Injury During TAVI|Recruiting||N/A|72|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:48.721364|2017-10-10 20:41:48.721364
NCT03289559|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||January 1, 2006|Actual|2006-01-01|September 2017|2017-09-01|January 1, 2014|Actual|2014-01-01|January 1, 2011|Actual|2011-01-01||Interventional|||Effects of Testosterone and Fat Utilization|Testosterone Effects on Systemic Lipolysis and Whole Body Lipid Utilization|Completed||N/A|13|Actual|University of Colorado, Denver||3|||f||||t|f|f||||||||2017-10-10 20:42:01.961989|2017-10-10 20:42:01.961989
NCT03291197|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome|Assessing the Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome - a Feasibility Study|Not yet recruiting||Phase 4|10|Anticipated|Ottawa Hospital Research Institute||1|||f||||f|f|f||||||||2017-10-10 20:41:48.810061|2017-10-10 20:41:48.810061
NCT03291184|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|January 8, 2018|Anticipated|2018-01-08|January 2, 2018|Anticipated|2018-01-02||Interventional|||Postoperative Residual Paralysis After Cardiac Surgery|Is Postoperative Residual Curarisation Still an Issue at the Moment of Weaning of the ICU Patient Following Cardiac Surgery?|Recruiting||N/A|120|Anticipated|Onze Lieve Vrouw Hospital||1|||f||||f|f|f||||||||2017-10-10 20:41:48.889734|2017-10-10 20:41:48.889734
NCT03291171|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-19|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Adults With Type 2 Diabetes|A Randomized Controlled Trial to Identify the Effect and the Working Mechanisms of MyPlan 2.0, a Self-regulation-based e- and mHealth Intervention Targeting Physical Activity and Sedentary Behaviour, in Adults With Type 2 Diabetes.|Not yet recruiting||N/A|60|Anticipated|University Ghent||2|||f||||f|f|f||||||||2017-10-10 20:41:49.069853|2017-10-10 20:41:49.069853
NCT03291158|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-02|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV|A Phase 1, Randomized, Open-Label Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Intravenous Minocin (Minocylcine) for Injection|Not yet recruiting||Phase 1|25|Anticipated|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||1|||f||||f|f|f|||f|||||2017-10-10 20:41:49.173933|2017-10-10 20:41:49.173933
NCT03291145|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-22|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|June 27, 2018|Anticipated|2018-06-27||Interventional|TriQarr||Exploring Mechanisms and Morphology of QT Interval Prolongation|Exploring Mechanisms and Morphology of QT Interval Prolongation - An Inheritable as Well as an Inducible Phenomenon|Enrolling by invitation||N/A|50|Anticipated|Herlev and Gentofte Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:49.282647|2017-10-10 20:41:49.282647
NCT03291132|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-19|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Smoke-free Teens Programme|Evaluation Study on Smoke-free Teens Programme|Recruiting||N/A|1200|Anticipated|The University of Hong Kong||1|||f||||f|f|f||||||||2017-10-10 20:41:49.362502|2017-10-10 20:41:49.362502
NCT03291119|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-19|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Observational|CVJ-RISK||Risk Predictors of Extubation Failure for Cervico-medullary Junction Surgery|To Evaluate the Predictors of Risk Factors for Extubation Failure After Cervico-Vertebral Junction Surgery-A Prospective Observational Study.|Not yet recruiting||N/A|100|Anticipated|Postgraduate Institute of Medical Education and Research|||1||f||||t|f|f||||||||2017-10-10 20:41:49.456666|2017-10-10 20:41:49.456666
NCT03291106|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-21|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2019|Anticipated|2019-10-01||Observational|||Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer|Cohort Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer|Recruiting||N/A|1500|Anticipated|Peking Union Medical College Hospital|||1||f||||f|f|f||||||||2017-10-10 20:41:49.542431|2017-10-10 20:41:49.542431
NCT03291093|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||18F-Flutemetamol and Plaque Vulnerability|Identification of Plaque Vulnerability Wit PET/MRI: a Feasibility Study of 18F-Flutemetamol in Atherosclerosis|Not yet recruiting||Phase 2/Phase 3|25|Anticipated|Maastricht University Medical Center||3|||f|||||f|f|||f|||||2017-10-10 20:41:49.64786|2017-10-10 20:41:49.64786
NCT03291080|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-19|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|October 28, 2019|Anticipated|2019-10-28|August 28, 2019|Anticipated|2019-08-28||Interventional|My-CRA||Oral Liquid 13-cis-retinoic Acid (13-CRA)|Relative Bioavailability and Comparative Pharmacokinetics of 13-CRA Oral Liquid and Extracted Capsule Formulations: a Randomised, Open Label, Multi-dose, Cross-over Clinical Trial in Patients Requiring Treatment Cycles of 13-CRA.|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Nova BioPharma Limited||2|||f||||t|f|f||||||||2017-10-10 20:41:49.735304|2017-10-10 20:41:49.735304
NCT03291054|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Epacadostat and Pembrolizumab in Patients With GIST|A Phase II Study of Epacadostat and Pembrolizumab in Patients With Imatinib Refractory Advanced Gastrointestinal Stromal Tumors|Not yet recruiting||Phase 2|23|Anticipated|Columbia University||1|||f||||t|t|f||||||||2017-10-10 20:41:49.911036|2017-10-10 20:41:49.911036
NCT03291041|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-20|||September 2016||2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder|A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder|Recruiting||Phase 2|50|Anticipated|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-10 20:41:50.010071|2017-10-10 20:41:50.010071
NCT03290690|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Positive Predictive Value (PPV) of Pseudomonas Aeruginosa|A Prospective, Single-blind Evaluation of the Positive Predictive Value (PPV) of the MolecuLight i:X™ Imaging Device to Predict the Presence of Pseudomonas Aeruginosa in Chronic Wounds|Enrolling by invitation||N/A|65|Anticipated|MolecuLight Inc.|||1||f||||f|f|f||||||||2017-10-10 20:41:53.078196|2017-10-10 20:41:53.078196
NCT03291028|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-05|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma|Defining the Genomic and Histologic Landscape of Primary and Metastatic Tumors With Divergent Kinetics in Patients With Renal Cell Carcinoma (RCC) and Urothelial Carcinoma (UC) Treated With Immune Checkpoint Blockade (ICB)|Not yet recruiting||N/A|16|Anticipated|Fox Chase Cancer Center|||2||f||||f|f|f||||Samples With DNA|"     Biopsied/ resected tumor samples that have been stored in the biosample repository would be     used for the study   "|||2017-10-10 20:41:50.092813|2017-10-10 20:41:50.092813
NCT03291015|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-19|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Kienbock Disease Radiographic Guided Treatment Versus Arthroscopic Guided Treatment|Kienbock Disease Radiographic Guided Treatment Versus Arthroscopic Guided Treatment|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:41:50.164922|2017-10-10 20:41:50.164922
NCT03291002|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-27|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC|Phase I Study of Intratumoral CV8102 in Patients With Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma|Recruiting||Phase 1|104|Anticipated|CureVac AG||4|||f||||t|f|f||||||||2017-10-10 20:41:50.242326|2017-10-10 20:41:50.242326
NCT03290989|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-18|||April 1, 2015|Actual|2015-04-01|September 2017|2017-09-01|July 31, 2015|Actual|2015-07-31|April 1, 2015|Actual|2015-04-01||Observational|PRURITCC||Itch and Pain Characteristics in Skin Carcinomas|Itch and Pain Characteristics in Skin Carcinomas|Completed||N/A|100|Actual|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 20:41:50.341688|2017-10-10 20:41:50.341688
NCT03290976|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-26|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Integrative Medicine for Chemotherapy-Induced Peripheral Neuropathy|Impact of Integrative Medicine on Chemotherapy-Induced Peripheral Neuropathy: A Multi-centered, Randomized Controlled Trial|Not yet recruiting||N/A|120|Anticipated|The Chaim Sheba Medical Center||3|||f||||f|f|f||||||||2017-10-10 20:41:50.405434|2017-10-10 20:41:50.405434
NCT03290950|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-10-02|||September 25, 2017|Actual|2017-09-25|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma|Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly-Diagnosed Multiple Myeloma: A Clinical and Correlative Phase II Study|Recruiting||Phase 2|41|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:41:50.578928|2017-10-10 20:41:50.578928
NCT03290924|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||September 1, 2014|Actual|2014-09-01|September 2017|2017-09-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach|Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach|Completed||N/A|40|Actual|Jhpiego||2|||f||||f|f|f||||||||2017-10-10 20:41:50.968376|2017-10-10 20:41:50.968376
NCT03290911|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||January 1, 2010|Actual|2010-01-01|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|December 31, 2015|Actual|2015-12-31||Observational|||Retrospective Trial on Low Prognosis Infertile Patients|An Observational Retrospective Cohort Trial on Low Prognosis Infertile Patient's Accessing IVF Cycle Management|Completed||N/A|26883|Actual|Istituto Clinico Humanitas|||1||f|||||f|f||||||||2017-10-10 20:41:51.050132|2017-10-10 20:41:51.050132
NCT03290898|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-29|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|January 31, 2020|Anticipated|2020-01-31||Interventional|||REPLACE: Can Exercise Replace Inhaled Corticosteroid Treatment in Asthma? A RCT|REPLACE: Can Exercise Replace Inhaled Corticosteroid Treatment in Asthma? A Randomized Clinical Trial|Not yet recruiting||N/A|102|Anticipated|Bispebjerg Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:51.116401|2017-10-10 20:41:51.116401
NCT03290872|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Mitral Annuloplasty Rings RCT|A Study to Assess the Effects of Two Commonly Used Mitral Valve Annuloplasty Rings in Mitral Valve Repair on Short-term Outcomes.|Not yet recruiting||N/A|50|Anticipated|University Health Network, Toronto||2|||f||||f|f|f|||f|||||2017-10-10 20:41:51.370717|2017-10-10 20:41:51.370717
NCT03290859|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Observational|||Race-Specific Propofol Titration to Effect for Procedural Sedation|Pragmatic Clinical Trial of Race-Specific Response to Propofol Infusion Titrated to Effect for Procedural Sedation During Endoscopy|Not yet recruiting||N/A|20000|Anticipated|University of Florida|||2||f||||t|f|f||||Samples With DNA|"     Compare in buccal samples the frequency of cytochrome allele carrier status in patients     exhibiting sensitivity to propofol during the procedural time against published frequency     data in Single Nucleotide Polymorphism database (dbSNP) by race.   "|||2017-10-10 20:41:51.452371|2017-10-10 20:41:51.452371
NCT03290846|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||August 2, 2016|Actual|2016-08-02|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|December 20, 2017|Anticipated|2017-12-20||Interventional|GUTBAT||Secretin Activates Human Brown Adipose Tissue.|Secretin Increases Glucose Uptake in Human Brown Adipose Tissue.|Active, not recruiting||Phase 2/Phase 3|15|Anticipated|Turku University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:41:51.546455|2017-10-10 20:41:51.546455
NCT03290833|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-22|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Is the Rehabilitation Robotic a Safe and Effective Choice for Stroke Patients?|Is the Rehabilitation Robotic a Safe and Effective Choice for Stroke Patients?|Not yet recruiting||N/A|36|Anticipated|Ten-Chen General Hospital||2|||f|||||f|f||||||||2017-10-10 20:41:51.619808|2017-10-10 20:41:51.619808
NCT03290820|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-23|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2024|Anticipated|2024-09-30||Interventional|||Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients|Aspirin Improve Survival of Patients With N2-3 Nasopharyngeal Carcinoma: A Phase 2 Prospective Randomized Controlled Trial|Not yet recruiting||Phase 2|184|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 20:41:51.706557|2017-10-10 20:41:51.706557
NCT03290807|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-21|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|October 2019|Anticipated|2019-10-01||Observational|||The Role of Tc 99m MDP SPECT/CT in Osteoarthritis|The Role of Tc 99m MDP SPECT/CT in Osteoarthritis|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:41:51.813748|2017-10-10 20:41:51.813748
NCT03290794|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-20|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice|Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice|Not yet recruiting||N/A|50|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 20:41:51.88744|2017-10-10 20:41:51.88744
NCT03290781|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-10-04|||February 22, 2018|Anticipated|2018-02-22|October 2017|2017-10-01|September 12, 2021|Anticipated|2021-09-12|September 12, 2021|Anticipated|2021-09-12||Interventional|FIGARO UC 303||Study of the Effect of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Ulcerative Colitis Who Achieved Clinical Response in Induction Studies|A Phase 3 Randomized, Double-blind, Placebo Controlled, Parallel Group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)|Not yet recruiting||Phase 3|772|Anticipated|Shire||3|||f||||t|t|f||||||||2017-10-10 20:41:52.006041|2017-10-10 20:41:52.006041
NCT03290768|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|December 2027|Anticipated|2027-12-01|August 2018|Anticipated|2018-08-01||Interventional|CGM_IRB-3||Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)|Empowering Medicare Patients to Self-Manage Their Type 2 Diabetes Using Continuous Glucose Monitoring (CGM) - Investigational Device Pilot (SMA Investigational Device)|Enrolling by invitation||N/A|500|Anticipated|Savvysherpa, Inc.||1|||f|||||f|t|t|f|f|||||2017-10-10 20:41:52.546107|2017-10-10 20:41:52.546107
NCT03290755|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|HEPCSEX||Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux|Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux|Not yet recruiting||N/A|72|Anticipated|University Hospital, Bordeaux|||1||f||||f|f|f||||||||2017-10-10 20:41:52.619015|2017-10-10 20:41:52.619015
NCT03290742|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-20|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 20, 2017|Actual|2017-08-20||Observational|||Infection Among Patients Undergoing Radical Cystectomy.|Incidence of and Risk Factors for Perioperative Infection Among Patients Undergoing Radical Cystectomy|Completed||N/A|133|Actual|Pomeranian Medical University Szczecin|||2||f||||f|f|f||||||||2017-10-10 20:41:52.699913|2017-10-10 20:41:52.699913
NCT03290729|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-20|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|May 15, 2023|Anticipated|2023-05-15|November 15, 2018|Anticipated|2018-11-15||Interventional|||Wedge Implant Narrow Crests: Multi-center Clinical Study|Wedge Implant for Minimally Invasive Treatment of Narrow Crests: a Prospective Multi-center Clinical Study|Recruiting||N/A|96|Anticipated|International Piezosurgery Academy||1|||f||||f|f|f||||||||2017-10-10 20:41:52.776927|2017-10-10 20:41:52.776927
NCT03290716|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-27|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|DECIDE-Salt||Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China|Diet, Exercise and Cardiovascular Health - Effect of Salt Substitute and Stepwise Salt Supply Control in Reducing Blood Pressure in the Elderly in Nursing Homes in China: a Factorial Cluster-randomized Controlled Trial|Not yet recruiting||N/A|1080|Anticipated|Peking University||4|||f||||t|f|f||||||||2017-10-10 20:41:52.877602|2017-10-10 20:41:52.877602
NCT03290703|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|June 22, 2018|Anticipated|2018-06-22|June 11, 2018|Anticipated|2018-06-11||Interventional|||A Study to Investigate the Effect of Formulation, Food, and Rabeprazole on the Pharmacokinetics (PK) of GDC-0853 in Healthy Participants|A Phase I, Single Center, Randomized, Open-Label Study Investigating the Effect of Formulation, Food, and Rabeprazole on the Pharmacokinetics of GDC-0853 in Healthy Subjects|Recruiting||Phase 1|63|Anticipated|Genentech, Inc.||3|||f|||||f|f||||||||2017-10-10 20:41:52.959476|2017-10-10 20:41:52.959476
NCT03236116|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-28|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Almond Consumption and Glycemia|Almond Consumption and Glycemia|Not yet recruiting||N/A|120|Anticipated|Purdue University||2|||f||||f|f|f||||||||2017-10-10 20:49:45.124113|2017-10-10 20:49:45.124113
NCT03290677|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-20|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|March 31, 2025|Anticipated|2025-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer Receiving Post-progression Immune Checkpoint Inhibitor Therapy|A Phase II Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer Receiving Post-progression Immune Checkpoint Inhibitor Therapy|Not yet recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||t|f|f||||||||2017-10-10 20:41:53.13429|2017-10-10 20:41:53.13429
NCT03290664|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-20|||November 30, 2017|Anticipated|2017-11-30|September 2017|2017-09-01|June 30, 2023|Anticipated|2023-06-30|August 31, 2021|Anticipated|2021-08-31||Interventional|||CD3-/CD19- vs CD3-/CD56+ Haplo NK for AML Pts Who Failed 1-2 Inductions|A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts|Not yet recruiting||Phase 2|40|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t|t|f|||f|||||2017-10-10 20:41:53.319303|2017-10-10 20:41:53.319303
NCT03290651|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-20|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Probiotics and Breast Health|Re-setting the Breast Microbiome to Lower Inflammation and Risk of Cancer.|Not yet recruiting||N/A|40|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:41:53.410256|2017-10-10 20:41:53.410256
NCT03290638|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-17|||October 3, 2013|Actual|2013-10-03|September 2017|2017-09-01|October 1, 2016|Actual|2016-10-01|October 1, 2016|Actual|2016-10-01||Interventional|GBR||Comparison of Dehydrated Human Amnion-Chorion and Type 1 Bovine Collagen Membranes for Guided Bone Regeneration|Comparison of Dehydrated Human Amnion-Chorion and Type 1 Bovine Collagen Membranes for Guided Bone Regeneration (Socket Augmentation) : A Clinical and Histological Study|Completed||N/A|43|Actual|University of Kentucky||2|||f||||f|f|f||||||||2017-10-10 20:41:53.498746|2017-10-10 20:41:53.498746
NCT03290625|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-17|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Intranasal Sedation With Dexmedetomidine and Ketamine in Pediatric Dentistry (NASO II)|Intranasal Sedation With Dexmedetomidine and Ketamine in Pediatric Dentistry (NASO II): Randomized Clinical Trial|Not yet recruiting||Phase 4|182|Anticipated|Universidade Federal de Goias||2|||f||||f|f|f||||||||2017-10-10 20:41:53.579414|2017-10-10 20:41:53.579414
NCT03290612|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Vitamin C and Cardiovascular Risk|Chronotherapeutic Use of Vitamin C to Reduce Morning Cardiovascular Risk|Not yet recruiting||N/A|20|Anticipated|Oregon Health and Science University||2|||f||||f|f|f||||||||2017-10-10 20:41:53.682779|2017-10-10 20:41:53.682779
NCT03290599|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-20|||November 1, 2013|Actual|2013-11-01|September 2017|2017-09-01|September 30, 2014|Actual|2014-09-30|September 30, 2014|Actual|2014-09-30||Observational|||Effect of Preoperative Hospitalization Duration on Post-operative Cognitive Dysfunction|Effect of Preoperative Hospitalization Duration on Post-operative Cognitive Dysfunction in Patients Who Underwent Hip Surgery Under Regional Anesthesia|Completed||N/A|64|Actual|Kackar State Hospital|||2||f||||f|f|f||||||||2017-10-10 20:41:53.765458|2017-10-10 20:41:53.765458
NCT03290586|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||February 16, 2017|Actual|2017-02-16|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Fusion Rates and Cost Analysis of Patients Undergoing 1st Metatarsal Phalangeal Joint Arthrodesis|Fusion Rates and Cost Analysis of Patients Undergoing 1st Metatarsal Phalangeal Joint Arthrodesis; the Evaluation of a Novel, Single Use Sterile, Disposable Delivery System|Recruiting||N/A|50|Anticipated|JEM Research Institute|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:41:53.834021|2017-10-10 20:41:53.834021
NCT03290573|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-29|||September 29, 2017|Actual|2017-09-29|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 16, 2018|Anticipated|2018-03-16||Interventional|SPECIAL||Site Selection of Short Peripheral Venous Catheters|Site Selection of Peripheral Venous Access Via Short Peripheral Catheters in Adult Patients (SPECIAL Trial)|Recruiting||N/A|1500|Anticipated|The First Affiliated Hospital of Zhengzhou University||2|||f||||t|f|f|||f|||||2017-10-10 20:41:53.907603|2017-10-10 20:41:53.907603
NCT03290560|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-27|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|June 20, 2019|Anticipated|2019-06-20|April 30, 2019|Anticipated|2019-04-30||Interventional|REMEDY||Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke|A Randomized, Double-blind, Placebo-controlled Phase II Multi-Center Evaluation to Assess the Safety and Tolerability of DM199 Administered Intravenously and Subcutaneously in Subjects With Acute Ischemic Stroke|Not yet recruiting||Phase 2|60|Anticipated|DiaMedica USA Inc.||2|||f||||t|f|f|||f|||||2017-10-10 20:41:53.987426|2017-10-10 20:41:53.987426
NCT03290547|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||July 8, 2015|Actual|2015-07-08|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|December 2022|Anticipated|2022-12-01||Interventional|||Pilot Study of Multi-wavelength Laser for Tattoo Removal|A Multi-Center Pilot Study of a Novel Multi-Wavelength Laser for Tattoo Removal|Recruiting||N/A|75|Anticipated|Cutera Inc.||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:41:54.093713|2017-10-10 20:41:54.093713
NCT03290534|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-22|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®|Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|CivaTech Oncology||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:41:54.185812|2017-10-10 20:41:54.185812
NCT03290521|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|July 30, 2017|Actual|2017-07-30||Interventional|||Intraperitoneal Lavage for Reducing Pain in Laparoscopy|The Role of Intraperitoneal Irrigation and Lavage With Normal Saline for Reduction of Postoperative Pain After Laparoscopic Hysterectomy and Myomectomy: A Randomized Controlled Trial|Completed||N/A|91|Actual|Campus Bio-Medico University||2|||f||||t|f|f||||||||2017-10-10 20:41:54.261835|2017-10-10 20:41:54.261835
NCT03290326|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-19|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||tACS for Amyloid-β Reduction in Alzheimer's Disease|Feasibility and Safety of a High-Frequency Transcranial Alternating Current Stimulation Intervention for Amyloid-β Reduction in Alzheimer's Disease|Not yet recruiting||N/A|20|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||t|f|t|t|f|f|||||2017-10-10 20:41:55.747397|2017-10-10 20:41:55.747397
NCT03290508|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|September 2027|Anticipated|2027-09-01|September 2022|Anticipated|2022-09-01|8 Years|Observational [Patient Registry]|||Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer|Long-Term Prospective Registry to Evaluate Treatment Decisions and Clinical Outcomes in Patients With Favorable Intermediate-Risk Localized Prostate Cancer Following Cell Cycle Progression (CCP) Testing (Prolaris® Test)|Recruiting||N/A|6000|Anticipated|Myriad Genetic Laboratories, Inc.|||2||f||||f|f|f||||Samples With DNA|"     Formalin-fixed paraffin-embedded (FFPE) tissue from blocks or slides of prostatic     adenocarcinoma biopsies   "|||2017-10-10 20:41:54.357016|2017-10-10 20:41:54.357016
NCT03290482|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-19|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Observational|EoE||Natural History of Eosinophilic Esophagitis|Natural History of Eosinophilic Esophagitis: A Longitudinal Follow-up Over 10 Years|Recruiting||N/A|65|Anticipated|Mayo Clinic|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:41:54.578323|2017-10-10 20:41:54.578323
NCT03290469|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-19|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|January 31, 2019|Anticipated|2019-01-31|December 31, 2018|Anticipated|2018-12-31||Interventional|NICU-Seq||NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants|NICUSeq: A Prospective Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants|Recruiting||N/A|330|Anticipated|Illumina, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:41:54.693377|2017-10-10 20:41:54.693377
NCT03290443|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.|A Phase 1 Open-Label Single-Dose Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.|Not yet recruiting||Phase 1|32|Anticipated|Celgene||1|||f||||f|t|f||||||||2017-10-10 20:41:54.895322|2017-10-10 20:41:54.895322
NCT03290430|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|January 2021|Anticipated|2021-01-01||Interventional|||End Nicotine Dependence Clinic|End Nicotine Dependence (END) Clinic|Not yet recruiting||Early Phase 1|1000|Anticipated|Case Comprehensive Cancer Center||4|||f||||f|t|f|||f|||||2017-10-10 20:41:54.992722|2017-10-10 20:41:54.992722
NCT03290417|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer|Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Men Managed With Active Surveillance for Prostate Cancer|Recruiting||N/A|75|Anticipated|Case Comprehensive Cancer Center||2|||f||||f|f|f||||||||2017-10-10 20:41:55.123942|2017-10-10 20:41:55.123942
NCT03290404|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|fLACON||Descriptive Assessment of Practice in Anaesthesia : Lidocaine 1% Adrenaline Under in Axillary Block Realization|Descriptive Assessment of Practice in Anaesthesia : Lidocaine 1% Adrenaline Under in Axillary Block Realization|Not yet recruiting||N/A|292|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 20:41:55.232406|2017-10-10 20:41:55.232406
NCT03290391|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||April 2018|Anticipated|2018-04-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|August 2021|Anticipated|2021-08-01||Interventional|LINC-II||Linking Infectious and Narcology Care-Part II|Linking Infectious and Narcology Care-Part II|Not yet recruiting||N/A|240|Anticipated|Boston Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 20:41:55.32267|2017-10-10 20:41:55.32267
NCT03290365|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||The Combination Effect of Platelet-rich Plasma and Hyaluronic Acid for Knee Osteoarthritis|The Combination Long-term Effect of Platelet-rich Plasma and Hyaluronic Acid in Patients With Knee Osteoarthritis: a Prospective Randomized Double-blind Controlled Trial|Not yet recruiting||N/A|50|Anticipated|Tri-Service General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:41:55.509039|2017-10-10 20:41:55.509039
NCT03290352|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||November 1, 2010|Actual|2010-11-01|September 2017|2017-09-01|June 30, 2015|Actual|2015-06-30|June 30, 2014|Actual|2014-06-30||Observational|||Pretreatment Quality of Life as a Predictor of Distant Metastasis-Free Survival and Overall Survival in Patients With Head and Neck Cancer|Pretreatment Quality of Life as a Predictor of Distant Metastasis-Free Survival and Overall Survival in Patients With Head and Neck Cancer Who Underwent Free Flap Reconstruction|Completed||N/A|127|Actual|Taipei Medical University|||1||f||||t|f|f||||||||2017-10-10 20:41:55.60613|2017-10-10 20:41:55.60613
NCT03290313|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Trial Scheme of Shu Gan yi Yang Capsule|a Randomized, Double Blind, Placebo-controlled, Multicenter Clinical Trial of Efficacy and Safety of Shu Gan yi Yang Capsule in the Treatment of Depression Associated With Erectile Dysfunction (Stagnation of Liver qi and Kidney Deficiency)|Not yet recruiting||Phase 4|160|Anticipated|Beijing Hospital of Traditional Chinese Medicine||2|||f||||f|f|f||||||||2017-10-10 20:41:55.818577|2017-10-10 20:41:55.818577
NCT03290300|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Observational|||Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device|A Prospective, Multi-Center, Non-Randomized Study to Evaluate the Quality of Life Impact After Treatment of Nasal Airway Obstruction Using the Aerin Medical Vivaer Stylus|Enrolling by invitation||N/A|50|Anticipated|Aerin Medical|||1||f||||f||t|f|||||||2017-10-10 20:41:55.896928|2017-10-10 20:41:55.896928
NCT03290287|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-19|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|June 30, 2023|Anticipated|2023-06-30|June 30, 2023|Anticipated|2023-06-30||Observational|PASS||Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints|Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints: Common Study Protocol|Recruiting||N/A|15400|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-10-10 20:41:55.992223|2017-10-10 20:41:55.992223
NCT03290274|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-19|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|ECP-EA||Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease|Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease|Recruiting||N/A|6|Anticipated|Hospital San Carlos, Madrid||2|||f||||f|f|f||||||||2017-10-10 20:41:56.079224|2017-10-10 20:41:56.079224
NCT03290261|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-19|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|August 8, 2019|Anticipated|2019-08-08|August 8, 2019|Anticipated|2019-08-08||Interventional|HYPNOCYST||Hypnosis as a Therapeutic Tool in Patients With Reccurent Cystitis|Hypnosis as a Therapeutic Tool in Patients With Reccurent Cystitis|Recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f|f|f||||||||2017-10-10 20:41:56.155161|2017-10-10 20:41:56.155161
NCT03290248|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-10-02|||September 19, 2017|Actual|2017-09-19|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis|A Prospective, Controlled, Double Blind, Single Center, Randomized, 3 Arm, Phase 1b/2a Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 Delivered as an Intranasal Spray in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis|Recruiting||Phase 1/Phase 2|66|Anticipated|AOBiome LLC||3|||f||||f|t|f||||||||2017-10-10 20:41:56.234451|2017-10-10 20:41:56.234451
NCT03290235|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|October 2020|Anticipated|2020-10-01||Interventional|||Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children|The Extension Study of Phase IV Clinical Trial of Pegylated Somatropin (PEG Somatropin) to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children|Recruiting||Phase 4|700|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:41:56.319487|2017-10-10 20:41:56.319487
NCT03290222|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Observational|TRACK||TRACK: Validation of the Portuguese Version|Translation, Adaptation Into Portuguese (Brazilian Culture) and Validation of the Test for Respiratory and Asthma Control in Kids (TRACK)|Recruiting||N/A|220|Anticipated|Federal University of São Paulo|||1||f||||t|f|f||||||||2017-10-10 20:41:56.387829|2017-10-10 20:41:56.387829
NCT03290196|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||September 3, 2015|Actual|2015-09-03|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics|The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics|Recruiting||Phase 4|60|Anticipated|Andrews Research & Education Foundation||1|||f||||f|t|f|||f|||||2017-10-10 20:41:56.695798|2017-10-10 20:41:56.695798
NCT03290183|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-20|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|August 28, 2018|Anticipated|2018-08-28||Observational|||Confocal Laser Endomicroscopy in Pleural Malignancies|Confocal Laser Endomicroscopy in Pleural Malignancies: A Comparison With Pathology|Recruiting||N/A|20|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f|f|f||||||||2017-10-10 20:41:56.84201|2017-10-10 20:41:56.84201
NCT03290170|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Radiostereometric Analysis of Gap Balancing Versus Measured Resection for the Journey II Total Knee Replacement|Radiostereometric Analysis of Gap Balancing Versus Measured Resection for the Journey II Total Knee Replacement|Not yet recruiting||N/A|56|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:41:56.953997|2017-10-10 20:41:56.953997
NCT03290157|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-20|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|December 30, 2017|Anticipated|2017-12-30||Interventional|ColoprAPP||Improvement of Colonoscopy Preparation by Using a SPA|Evaluation of Improvement of Colonoscopy Preparation by Using a SPA|Recruiting||N/A|500|Anticipated|University of Ulm||2|||f||||f|f|f||||||||2017-10-10 20:41:57.030843|2017-10-10 20:41:57.030843
NCT03290144|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||February 2, 2015|Actual|2015-02-02|September 2017|2017-09-01|September 2, 2018|Anticipated|2018-09-02|September 2, 2018|Anticipated|2018-09-02|12 Months|Observational [Patient Registry]|MUCOG||Pregnancies and Cystic Fibrosis|Occurrence of Pregnancies in Women With Cystic Fibrosis|Active, not recruiting||N/A|450|Actual|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 20:41:57.116082|2017-10-10 20:41:57.116082
NCT03290131|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-20|||December 28, 2017|Anticipated|2017-12-28|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|OS440-3004||A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS|A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Investigate the Safety and Efficacy of Arbaclofen Extended-Release Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis|Not yet recruiting||Phase 3|510|Anticipated|Osmotica Pharmaceutical US LLC||3|||f||||t|t|f||||||||2017-10-10 20:41:57.173032|2017-10-10 20:41:57.173032
NCT03290118|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-18|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Efficacy of Front-of-package Labelling Schemes: an Experimental Study|The Efficacy of Front-of-package Labelling Schemes: an Experimental Study|Not yet recruiting||N/A|2000|Anticipated|University of Toronto||4|||f|||||f|f||||||||2017-10-10 20:41:57.245256|2017-10-10 20:41:57.245256
NCT03290105|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||January 27, 2014|Actual|2014-01-27|September 2017|2017-09-01|June 1, 2016|Actual|2016-06-01|March 31, 2014|Actual|2014-03-31||Observational|||Microbial and Pharmacological Assessment of Chlorhexidine|Efficacy of Chlorhexidine Mouth Wash in ICU Ventilated Patients: Microbiological Effects and Antiseptic Residual Concentrations|Completed||N/A|30|Actual|Hôpital Louis Mourier|||1||f||||f|||||f|Samples Without DNA|"     saliva for measurement of chlorhexidine concentration; swabbing of oropharyngeal secretions   "|||2017-10-10 20:41:57.328551|2017-10-10 20:41:57.328551
NCT03290092|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|TOTEM||Trial of Taselisib in Overgrowth|A Multi-Centre, Open Label, Single Arm, Phase IB/IIA, Trial of Taselisib (GDC0032) in PIK3CA-Related Overgrowth|Recruiting||Phase 1/Phase 2|30|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f|||||f|f||||||||2017-10-10 20:41:57.408884|2017-10-10 20:41:57.408884
NCT03290079|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Pembrolizumab in Advanced Poorly Differentiated and/or High Grade Neuroendocrine Tumors/Carcinomas|Phase II Study of Pembrolizumab in Advanced Poorly-Differentiated and/or High-Grade Neuroendocrine Tumors/Carcinomas|Not yet recruiting||Phase 2|30|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 20:41:57.484491|2017-10-10 20:41:57.484491
NCT03290066|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-15|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Effectiveness of Kinesiotaping in Primary Dysmenorrhea|Effectiveness of Kinesiotaping in Primary Dysmenorrhea|Recruiting||N/A|24|Anticipated|Universidad de Zaragoza||2|||f||||f|f|f||||||||2017-10-10 20:41:57.586055|2017-10-10 20:41:57.586055
NCT03290053|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-20|||October 5, 2017|Anticipated|2017-10-05|June 2017|2017-06-01|March 31, 2022|Anticipated|2022-03-31|December 31, 2021|Anticipated|2021-12-31||Interventional|CE-5S||Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S)|Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S)|Not yet recruiting||Phase 3|100|Anticipated|Umeå University||4|||f||||t|f|f|||f|||||2017-10-10 20:41:57.678739|2017-10-10 20:41:57.678739
NCT03290040|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-09-21|||January 2015||2015-01-01|September 2017|2017-09-01|February 2030|Anticipated|2030-02-01|December 2018|Anticipated|2018-12-01||Observational|||Identification of Predictors for Early Cognitive Decline in Men|Identification of Predictors for Early Cognitive Decline: a Longitudinal Cohort Study in Men Born in 1953|Recruiting||N/A|350|Anticipated|Rigshospitalet, Denmark|||1||f||||||||||Samples With DNA|"     Blood samples with DNA   "|||2017-10-10 20:41:57.771162|2017-10-10 20:41:57.771162
NCT03290027|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|DFD-03||A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris|A Multicenter, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks|Recruiting||Phase 3|550|Anticipated|Dr. Reddy's Laboratories Limited||2||||||||t|f||||||||2017-10-10 20:41:57.869504|2017-10-10 20:41:57.869504
NCT03290014|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-17|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Observational|COPD||Sleep Quality in (COPD) Patients (COPD: Chronic Obstructive Pulmonary Disease)|Sleep Quality in COPD Patients. A Clinical and Polysomnographic Study|Recruiting||N/A|58|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||2||f|||||f|f||||||||2017-10-10 20:41:57.949938|2017-10-10 20:41:57.949938
NCT03290001|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-18|||August 20, 2017|Actual|2017-08-20|September 2017|2017-09-01|September 20, 2022|Anticipated|2022-09-20|September 20, 2022|Anticipated|2022-09-20||Observational|||The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients|The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients: a Prospective Observational Cohort Study|Recruiting||N/A|1000|Anticipated|Sun Yat-sen University|||1||f||||t|f|f||||||||2017-10-10 20:41:58.043456|2017-10-10 20:41:58.043456
NCT03289988|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Observational|||Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel Expression|Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel Expression|Recruiting||N/A|964|Anticipated|Yonsei University|||4||f||||f|f|f||||Samples With DNA|"     Blood sampling for genetic analysis   "|||2017-10-10 20:41:58.13427|2017-10-10 20:41:58.13427
NCT03289975|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||March 12, 2016|Actual|2016-03-12|September 2017|2017-09-01|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29||Observational|ODR||Early Identification of Patients in Surgical Intensive Care With a Risk of Acute Respiratory Distress Following Visceral Surgery|Early Identification of Patients in Surgical Intensive Care With a Risk of Acute Respiratory Distress Following Visceral Surgery: Prognostic Value of Pulmonary Extravascular Water Revealed by Pulmonary Ultrasound.|Completed||N/A|165|Actual|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:41:58.217022|2017-10-10 20:41:58.217022
NCT03289962|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-21|||December 7, 2017|Anticipated|2017-12-07|September 2017|2017-09-01|September 11, 2020|Anticipated|2020-09-11|September 11, 2020|Anticipated|2020-09-11||Interventional|||A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors|A Phase 1a/1b Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors|Not yet recruiting||Phase 1|572|Anticipated|Genentech, Inc.||5|||f|||||t|f||||||||2017-10-10 20:41:58.291872|2017-10-10 20:41:58.291872
NCT03289936|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-21|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|May 1, 2018|Anticipated|2018-05-01||Interventional|SyncNIV||Short Term Effects of Synchronized vs. Non-synchronized NIPPV in Preterm Infants.|Short Term Effects of Synchronized vs. Non-synchronized Nasal Intermittent Positive Pressure Ventilation in Preterm Infants. A Randomized Crossover Study.|Not yet recruiting||N/A|30|Anticipated|University of Turin, Italy||2|||f||||t|f|f||||||||2017-10-10 20:41:58.576515|2017-10-10 20:41:58.576515
NCT03289910|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-20|2017-09-21|||May 18, 2018|Anticipated|2018-05-18|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia|A Phase II Randomized Study of Topotecan/Carboplatin With or Without Veliparib or Placebo in Advanced Myeloproliferative Disorders and CMML|Not yet recruiting||Phase 2|60|Anticipated|National Cancer Institute (NCI)||2|||||||f|t|f||||||||2017-10-10 20:41:58.819997|2017-10-10 20:41:58.819997
NCT03289897|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-22|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|September 4, 2019|Anticipated|2019-09-04||Interventional|RADIcAL1||Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan|Non-invasive Rapid Assessment of Non-alcoholic Fatty Liver Disease (NAFLD) Using Magnetic Resonance Imaging With LiverMultiScan (RADIcAL1)|Recruiting||N/A|2000|Anticipated|Perspectum Diagnostics Ltd||2|||f||||t|f|f||||||||2017-10-10 20:41:58.974483|2017-10-10 20:41:58.974483
NCT03289884|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-18|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|||MR Assessment of Hepatic Hydatid Disease|Multi-metric Quantitative MRI for the Assessment of Hepatic Hydatid Disease- a Pilot Study|Recruiting||N/A|24|Anticipated|University College, London|||2||f|||||f|f||||||||2017-10-10 20:41:59.093066|2017-10-10 20:41:59.093066
NCT03289871|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-18|||January 2015||2015-01-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Clinical Evaluation of the Efficacy of a Medical Device in Treatment of Toenail Onychomycosis|Clinical Evaluation of the Efficacy of a Medical Device in Treatment of Toenail Onychomycosis|Completed||N/A|112|Actual|Oystershell NV||2|||f||||f||||||||||2017-10-10 20:41:59.19094|2017-10-10 20:41:59.19094
NCT03289858|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-23|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Randomized Controlled Trial for Exparel Hip Fracture|Does the Use of Liposomal Bupivacaine Decrease Narcotic Requirements in Geriatric Hip Fractures? A Randomized, Double Blinded Control Trial|Active, not recruiting||Phase 4|50|Anticipated|University of Massachusetts, Worcester||2|||f|||||t|f|||t|||||2017-10-10 20:41:59.27859|2017-10-10 20:41:59.27859
NCT03289845|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-18|||November 5, 2015|Actual|2015-11-05|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 4, 2016|Actual|2016-01-04||Interventional|||Clinical Survey of Oticon Medical Ponto BHX Implant|Clinical Survey of Oticon Medical Ponto BHX Implant|Active, not recruiting||N/A|36|Actual|Oticon Medical||1|||f||||f|f|f||||||||2017-10-10 20:41:59.384208|2017-10-10 20:41:59.384208
NCT03289832|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-18|||September 22, 2017|Anticipated|2017-09-22|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|September 22, 2018|Anticipated|2018-09-22||Interventional|||Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin|Effect of Orally Delivered Phytochemicals, Alone, and in Combination, on Aging and Inflammation-Related Effects in the Skin|Recruiting||N/A|18|Anticipated|Johns Hopkins University||3|||f||||f|f|f||||||||2017-10-10 20:41:59.456091|2017-10-10 20:41:59.456091
NCT03289819|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|NIB||Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC|A Phase II One-arm Open-label Neoadjuvant Study of Pembrolizumab in Combination With Nab-paclitaxel Followed by Pembrolizumab in Combination With Epirubicin and Cyclophosphamide in Patients With Triple Negative Breast Cancer|Not yet recruiting||Phase 2|50|Anticipated|Institut fuer Frauengesundheit||1|||f||||t|t|f|||t|||||2017-10-10 20:41:59.55818|2017-10-10 20:41:59.55818
NCT03289806|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||January 12, 2016|Actual|2016-01-12|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|DHA||Effects of DHA on Post-operative Fibrosis of Trabulectomy Blebs in Glaucoma Surgery|Study of the Effects of Docosahexaneoic Acid (DHA) on Post-operative Fibrosis of Trabulectomy Blebs in Glaucoma Surgery|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f|||||f|f||||Samples Without DNA|"     fibroblasts of Tenon's capsule (surgical waste)   "|||2017-10-10 20:41:59.679563|2017-10-10 20:41:59.679563
NCT03289793|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-18|||February 2, 2017|Actual|2017-02-02|September 2017|2017-09-01|October 2, 2019|Anticipated|2019-10-02|October 2, 2019|Anticipated|2019-10-02||Interventional|MyB||NEUROFEEDBACK on Event-Related Potential (ERP)|Clinical Evaluation of a Brain Computer Interfaces (BCI)-Based Training of Attention in Children With Attention Deficit Hyperactivity Disorder (ADHD)|Recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||3|||f||||f|f|f||||||||2017-10-10 20:41:59.753266|2017-10-10 20:41:59.753266
NCT03289780|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-21|||April 4, 2016|Actual|2016-04-04|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Observational|INSIGHT||Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects|An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer|Recruiting||N/A|1000|Anticipated|Biodesix, Inc.|||1||f||||t|f|f||||||||2017-10-10 20:41:59.889893|2017-10-10 20:41:59.889893
NCT03289767|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-18|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Simple Preparation of Endotracheal Tube|Simple Preparation of Endotracheal Tube for Optimal Angulation During Intubation: A Randomized Controlled Trial|Not yet recruiting||N/A|140|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:42:00.102236|2017-10-10 20:42:00.102236
NCT03289741|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-22|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide|A Pilot Study To Evaluate Patient Experience With the Somatostatin Analogs Octreotide Long Acting Release and Lanreotide During the Treatment of Advanced, Nonfunctional, Well Differentiated Neuroendocrine Tumors|Recruiting||Phase 4|50|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f|||f|||||2017-10-10 20:42:00.266971|2017-10-10 20:42:00.266971
NCT03289728|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-20|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|EVAOLD||Evaluation of a Strategy Guided by Imaging Versus Systematic Coronary Angioplasty in Elderly Patients With Ischemia|Evaluation of a Strategy Guided by Imaging Versus Systematic Coronary Angioplasty in Elderly Patients With Ischemia: a Multicentric Randomized Non Inferiority Trial.|Not yet recruiting||N/A|1756|Anticipated|University Hospital, Grenoble||2|||f||||t|f|f||||||||2017-10-10 20:42:00.460975|2017-10-10 20:42:00.460975
NCT03289715|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Evaluation of an On-Demand Humidifier on Neuromuscular Patients Requiring Mechanical Ventilation|Evaluation of an On-Demand Humidifier on Neuromuscular Patients Requiring Mechanical Ventilation|Not yet recruiting||N/A|10|Anticipated|Philips Research||1|||f||||f|f|f||||||||2017-10-10 20:42:00.595132|2017-10-10 20:42:00.595132
NCT03289702|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||CORETOX® in Treatment of Post Stroke Upper Limb Spasticity|A Randomized, Double-blind, Active Drug Controlled, Multi-Center, Phase I/III Clinical Trial to Evaluate the Efficacy and Safety of CORETOX® in Treatment of Post Stroke Upper Limb Spasticity|Recruiting||Phase 3|250|Anticipated|Medy-Tox||2|||f|||||f|f||||||||2017-10-10 20:42:00.670388|2017-10-10 20:42:00.670388
NCT03289689|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-28|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|September 10, 2017|Actual|2017-09-10|August 31, 2017|Actual|2017-08-31||Interventional|||Whole-body Vibration and Manual Ability|The Acute Effects of Whole-Body Vibration on Manual Ability Performance: A Pilot Randomized Controlled Trial|Completed||N/A|38|Actual|Universidad Rey Juan Carlos||2|||f||||t|f|f||||||||2017-10-10 20:42:00.77649|2017-10-10 20:42:00.77649
NCT03289676|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-20|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|WISE||Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV|Determining the Feasibility and Acceptability of a Combined Storytelling Narrative Communication and HIV-tailored Smoking Cessation Intervention for Women Living With HIV|Recruiting||Phase 1|50|Anticipated|University of Massachusetts, Boston||2|||f||||f|t|f||||||||2017-10-10 20:42:00.866828|2017-10-10 20:42:00.866828
NCT03289663|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-20|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|Net-PBO||Effectiveness Study of New Generation Bednets in the Context of Conventional Insecticide Resistance in the Democratic Republic of the Congo|Effectiveness Study of Bednets Treated With Synegistic Combination of Insectcides in an Area With Pyrethroid-resistant Vectors in the Democratic Republic of the Congo|Not yet recruiting||Phase 4|1680|Anticipated|Université de Lubumbashi||2|||f||||f|f|f|||f|||||2017-10-10 20:42:00.979786|2017-10-10 20:42:00.979786
NCT03289650|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-18|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|October 30, 2021|Anticipated|2021-10-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Extended Release Tacrolimus vs. Twice-Daily Tacrolimus|Once-Daily Extended-Release Tacrolimus vs. Twice-Daily Tacrolimus: Impact on T-Cell Subpopulations and Markers of Renal Tubule-toxicity in Kidney Transplant Patients|Active, not recruiting||Phase 3|50|Anticipated|Northwestern University||2|||f||||f|t|f|||t|||||2017-10-10 20:42:01.064845|2017-10-10 20:42:01.064845
NCT03289637|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-20|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|D-Heart||Supplementation With Vitamin D to Patients With Heart Failure (D-Heart).|Supplementation With Vitamin D to Patients With Heart Failure. Effects on Symptoms, Quality-of-life and Disease Processes.|Not yet recruiting||N/A|200|Anticipated|Linkoeping University||2|||f||||t|f|f||||||||2017-10-10 20:42:01.195334|2017-10-10 20:42:01.195334
NCT03289624|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-18|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|February 28, 2018|Anticipated|2018-02-28||Interventional|SHARE-CC||SHARE for Persons With Chronic Conditions and Their Family Caregivers|Support, Health, Activities, Resources, and Education for Persons With Chronic Conditions and Their Family Caregivers: SHARE-Chronic Conditions (SHARE-CC)|Recruiting||N/A|240|Anticipated|Benjamin Rose Institute on Aging||2|||f||||f|f|f||||||||2017-10-10 20:42:01.316791|2017-10-10 20:42:01.316791
NCT03289611|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-20|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 1, 2021|Anticipated|2021-11-01|March 1, 2021|Anticipated|2021-03-01||Interventional|PRECOG||Preeclampsia Ratio (sFlt-1/PlGF)|Preeclampsia Ratio (sFlt-1/PlGF) Evaluation for Clinical and Obstetrical Guidance|Not yet recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 20:42:01.468229|2017-10-10 20:42:01.468229
NCT03289598|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-10-05|||February 15, 2017|Actual|2017-02-15|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Effect of Involving Community Dwelling Older People Receiving Meals-on-wheels in Activities in Relation to Meals|A Cluster Randomized Controlled Trial of the Effect of Involving Community Dwelling Older People Receiving Meals-on-wheels in Activities in Relation to Meals|Active, not recruiting||N/A|130|Anticipated|The Danish Dietetic Association||2|||f||||f|f|f||||||||2017-10-10 20:42:01.601404|2017-10-10 20:42:01.601404
NCT03289585|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-18|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||A National Registry For Patients With Hidradenitis Suppurativa|Development and Maintenance of a National Registry For Patients With Hidradenitis Suppurativa|Recruiting||N/A|400|Anticipated|Montefiore Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:42:01.720518|2017-10-10 20:42:01.720518
NCT03289572|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-22|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Observational|||Microgrid II - Electrocorticography Signals for Human Hand Prosthetics|Microgrid II - Electrocorticography Signals for Human Hand Prosthetics|Recruiting||N/A|20|Anticipated|University of Washington|||1||f||||f|f|f||||||||2017-10-10 20:42:01.861137|2017-10-10 20:42:01.861137
NCT03289546|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-18|||April 1, 2016|Actual|2016-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||The Active Mind Study|Exploring Synergistic Effects Of Aerobic Exercise And Mindfulness Training On Cognitive Function In Older Adults: A Pilot, Proof Of Concept Study|Recruiting||N/A|40|Anticipated|The Miriam Hospital||4|||f||||t|f|f||||||||2017-10-10 20:42:02.087922|2017-10-10 20:42:02.087922
NCT03289533|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-28|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|January 6, 2020|Anticipated|2020-01-06|September 30, 2019|Anticipated|2019-09-30||Interventional|||A Study Of Avelumab In Combination With Axitinib In Advanced HCC|An Open Label, Single Arm Phase 1b Study Of Avelumab Plus Axitinib As First Line Treatment In Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 1|20|Anticipated|Pfizer||1|||f||||f|f|f||||||||2017-10-10 20:42:02.239058|2017-10-10 20:42:02.239058
NCT03289520|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||January 7, 2003|Actual|2003-01-07|September 2017|2017-09-01|June 18, 2007|Actual|2007-06-18|June 18, 2007|Actual|2007-06-18||Interventional|FISTULA||Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis|Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis|Completed||Phase 3|877|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t|t|f||||||||2017-10-10 20:42:02.370297|2017-10-10 20:42:02.370297
NCT03289507|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-19|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|CRC||Longvida Curcumin Human Pharmacokinetics Study|Longvida Curcumin Human Pharmacokinetics (PK) Study|Recruiting||N/A|6|Anticipated|Institute for Food Safety and Health, United States||3|||f||||f|f|f||||||||2017-10-10 20:42:02.516524|2017-10-10 20:42:02.516524
NCT03289494|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-19|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2D Patients|A Pilot Randomized Controlled Trial Evaluating the Effect of Two Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile Measured by Continuous Glucose Monitoring System (CGMS), in Type 2 Diabetic Patients|Recruiting||N/A|8|Anticipated|Mondelēz International, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:42:02.620832|2017-10-10 20:42:02.620832
NCT03289481|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment of HFpEF With Nitrate Supplement|Treatment of HFpEF With Nitrate Supplement: A Double-blind, Placebo Controlled Trial Including Patients With Atrial Fibrillation|Recruiting||N/A|25|Anticipated|Penobscot Bay Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:42:02.743814|2017-10-10 20:42:02.743814
NCT03289468|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-19|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Study of Diagnosis of Color Power Doppler Combined Minimally Invasive Sampling for Endometrial Diseases|Study of Diagnosis of Color Power Doppler Combined Minimally Invasive Sampling for Endometrial Diseases|Recruiting||N/A|200|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||f|f|f||||Samples Without DNA|"     FirstXianJiaotongU   "|||2017-10-10 20:42:02.835737|2017-10-10 20:42:02.835737
NCT03289455|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-18|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|AMELIA||CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell ALL|A Single-Arm, Open-Label, Multi-Centre, Phase I/II Study Evaluating the Safety and Clinical Activity Of AUTO3, a CAR T Cell Treatment Targeting CD19 And CD22 in Paediatric And Young Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia|Recruiting||Phase 1/Phase 2|50|Anticipated|Autolus Limited||1|||f||||t|f|f||||||||2017-10-10 20:42:02.911137|2017-10-10 20:42:02.911137
NCT03289442|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-19|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Supine Position for Colonoscopy Insertion|Impact of Supine Position on Colonoscopy Insertion: a Randomized Controlled Trial|Recruiting||N/A|250|Anticipated|Changhai Hospital||2|||f||||t|f|f||||||||2017-10-10 20:42:03.03085|2017-10-10 20:42:03.03085
NCT03289429|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-23|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery|Comparative Study of the Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery|Recruiting||Phase 4|60|Anticipated|Assiut University||3|||f|||||f|f||||||||2017-10-10 20:42:03.122667|2017-10-10 20:42:03.122667
NCT03289416|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||December 5, 2013|Actual|2013-12-05|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|EmCyte||Bone Marrow Aspirate Compared to Platelet Rich Plasma for Treating Knee Osteoarthritis|Efficacy of Bone Marrow Aspirate Concentrate Compared With Platelet Rich Plasma for the Treatment of Symptomatic Knee Osteoarthritis: A Randomized, Controlled Clinical Trial|Recruiting||Phase 4|120|Anticipated|Andrews Research & Education Foundation||2|||f||||f|t|f|||f|||||2017-10-10 20:42:03.208359|2017-10-10 20:42:03.208359
NCT03289403|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-19|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis|The Role of Immunomodulatory Treatment in Success of ICSI in Patients Who Have Infertility With Autoimmune Thyroiditis|Recruiting||Phase 2|100|Anticipated|Aljazeera Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:42:03.332498|2017-10-10 20:42:03.332498
NCT03289390|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Observational|||Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications|Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications|Recruiting||N/A|62|Anticipated|Albany Medical College|||1||f||||f|t|f||||||||2017-10-10 20:42:03.425659|2017-10-10 20:42:03.425659
NCT03289377|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|RDAD&APNs||NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers|NRC: Improving Healthcare for Cognitively Impaired Elders and Their Caregivers|Not yet recruiting||N/A|50|Anticipated|University of Washington||1|||f||||f|f|f||||||||2017-10-10 20:42:03.507808|2017-10-10 20:42:03.507808
NCT02837133|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-14|||March 2014||2014-03-01|July 2016|2016-07-01||||December 2015|Actual|2015-12-01||Interventional|||Effects of a Single Session of Integrated Yoga Therapy Compared With Other Relaxation Techniques||Completed||Phase 3|145|Actual|Hiroshima University||1|||f||||||||||||||2017-10-10 21:59:08.211397|2017-10-10 21:59:08.211397
NCT03289364|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 1, 2020|Anticipated|2020-07-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients|A Phase 2 Study to Assess the Safety and Efficacy of Scalp Cooling Using PenguinTM Cold Caps for the Prevention or Reduction of Chemotherapy-induced Alopecia in Stage I-III Breast Cancer|Not yet recruiting||N/A|80|Anticipated|Providence Health & Services||1|||f||||f|f|f||||||||2017-10-10 20:42:03.601796|2017-10-10 20:42:03.601796
NCT03289351|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|May 22, 2018|Anticipated|2018-05-22|December 22, 2017|Anticipated|2017-12-22||Interventional|||Randomized Control Trial: Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis|Randomized Control Trial: Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis|Recruiting||N/A|242|Anticipated|Phoenix Children's Hospital||2|||f||||t|f|f||||||||2017-10-10 20:42:03.688015|2017-10-10 20:42:03.688015
NCT03289338|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||June 1, 2016|Actual|2016-06-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus|Zoledronic Acid or Methylprednisolone in the Management of Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus: A Randomized, Double-blind, Placebo Controlled Trial|Recruiting||Phase 2/Phase 3|30|Anticipated|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||||2017-10-10 20:42:03.850455|2017-10-10 20:42:03.850455
NCT03289325|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery|Impact of Perioperative Dexmedetomidine on Long-term Outcomes in Elderly Patients After Cardiac Surgery: 2-year Follow-up of a Randomized Controlled Trial|Active, not recruiting||Phase 4|285|Actual|Peking University First Hospital||2|||f||||t|f|f||||||||2017-10-10 20:42:03.964864|2017-10-10 20:42:03.964864
NCT03289312|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 1, 2018|Anticipated|2018-12-01||Observational|SLL||Dissecting How Peripheral Lymphocytes Are Lost During Sepsis：a Observational,Clinical Study.|Dissecting How Peripheral Lymphocytes Are Lost During Sepsis：a Observational,Clinical Study.|Not yet recruiting||N/A|54|Anticipated|Southeast University, China|||2||f||||t|f|f||||||||2017-10-10 20:42:04.091921|2017-10-10 20:42:04.091921
NCT03289299|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 1, 2026|Anticipated|2026-12-01|December 1, 2022|Anticipated|2022-12-01||Interventional|ASCENT||Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant|Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant (ASCENT): A Phase 2 Trial of Induction, Consolidation, and Maintenance in Subjects With High Risk Smoldering Multiple Myeloma (SMM)|Not yet recruiting||Phase 2|80|Anticipated|International Myeloma Foundation||2|||f||||f|t|f|||f|||||2017-10-10 20:42:04.159374|2017-10-10 20:42:04.159374
NCT03289286|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PITCA||Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast Cancer|Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast Cancer|Not yet recruiting||N/A|33|Anticipated|Institut Claudius Regaud||1|||f||||f|f|f||||||||2017-10-10 20:42:04.249364|2017-10-10 20:42:04.249364
NCT03289273|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|October 1, 2022|Anticipated|2022-10-01|July 30, 2022|Anticipated|2022-07-30||Observational|||Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)|REFINE: Regorafenib Observational Study in Hepatocellular Carcinoma|Recruiting||N/A|1000|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 20:42:04.319814|2017-10-10 20:42:04.319814
NCT03289247|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||September 1, 2015|Actual|2015-09-01|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|December 21, 2017|Anticipated|2017-12-21||Interventional|||Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty|A Prospective Single-blinded Randomized Controlled Study Evaluating Efficacy of Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty|Active, not recruiting||N/A|30|Actual|Hvidovre University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:42:04.467031|2017-10-10 20:42:04.467031
NCT03289234|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-26|||November 16, 2016|Actual|2016-11-16|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment|A Multi-Center, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Recruiting||Phase 1|24|Anticipated|Mitsubishi Tanabe Pharma Corporation||3|||f|||||f|f||||||||2017-10-10 20:42:04.530182|2017-10-10 20:42:04.530182
NCT03289221|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Effects of High-Intensity Focused Ultrasound (HIFU) Treatment on Fecal Continence and Anorretal Fisiology|Effects of High-Intensity Focused Ultrasound (HIFU) Treatment on Fecal Continence and Anorretal Fisiology|Not yet recruiting||N/A|30|Anticipated|Hospital de Transplante Doutor Euryclides de Jesus Zerbini||1|||f||||f|f|f||||||||2017-10-10 20:42:04.619299|2017-10-10 20:42:04.619299
NCT03289208|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-26|||October 27, 2016|Actual|2016-10-27|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment|An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of MCI-186 in Subjects With Mild or Moderate Renal Impairment Compared to Subjects With Normal Renal Function|Recruiting||Phase 1|27|Anticipated|Mitsubishi Tanabe Pharma Corporation||3|||f|||||f|f||||||||2017-10-10 20:42:06.730565|2017-10-10 20:42:06.730565
NCT03289195|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer|A Prospective Study To Evaluate The Accuracy Of Percutaneous Breast MRI Biopsy In Diagnosing A Pathologic Complete Response Following Neoadjuvant Chemotherapy|Recruiting||N/A|20|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||f|f||||||||2017-10-10 20:42:06.806204|2017-10-10 20:42:06.806204
NCT03289182|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-10-02|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|October 26, 2020|Anticipated|2020-10-26|October 26, 2020|Anticipated|2020-10-26||Observational|||An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)|Post-Marketing Surveillance of MabThera Subcutaneous in Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Recruiting||N/A|660|Anticipated|Hoffmann-La Roche|||1||f|||||f|f||||||||2017-10-10 20:42:06.906818|2017-10-10 20:42:06.906818
NCT03289169|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||December 30, 2016|Actual|2016-12-30|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines|A Single-Arm Trial, Open-label, Repeated, Long-term, Multi-center, A Phase IV Clinical Trial to Evaluate the Long-term Efficacy and Safety of Repeat Treatment With MEDITOXIN® in Treatment of Glabella Line|Active, not recruiting||Phase 4|300|Actual|Medy-Tox||1|||f||||f|f|f||||||||2017-10-10 20:42:07.00633|2017-10-10 20:42:07.00633
NCT03289156|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|December 20, 2018|Anticipated|2018-12-20|December 20, 2018|Anticipated|2018-12-20||Interventional|||Exercise and Responses to Challenges|Exercise and Responses to Challenges|Recruiting||N/A|220|Anticipated|University of Texas at Austin||4|||f||||f|f|f||||||||2017-10-10 20:42:07.088346|2017-10-10 20:42:07.088346
NCT03289143|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 22, 2017|Anticipated|2017-09-22|September 2017|2017-09-01|November 30, 2022|Anticipated|2022-11-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease|Recruiting||Phase 2|360|Anticipated|Genentech, Inc.||4|||f||||t|t|f||||||||2017-10-10 20:42:07.166301|2017-10-10 20:42:07.166301
NCT03289130|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 2004|Actual|2004-09-01|September 2017|2017-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|PCaP||Dietary Factors and Racial Disparities in Prostate Cancer Aggressiveness|The North Carolina-Louisiana Prostate Cancer Project, Project 3 Ancillary Study|Completed||N/A|2258|Actual|University of South Carolina|||1||f||||f|f|f||||Samples With DNA|"     Plasma, serum, urine, adipose tissue, DNA extracted from whole blood, frozen tissue   "|||2017-10-10 20:42:07.27608|2017-10-10 20:42:07.27608
NCT03289117|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||April 17, 2016|Actual|2016-04-17|September 2017|2017-09-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Urinary Catheters|Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Indwelling Urinary Catheters - a Randomized Controlled Study|Completed||N/A|32|Actual|Region Skane||2|||f||||f|f|f|||f|||||2017-10-10 20:42:07.335087|2017-10-10 20:42:07.335087
NCT03289104|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-20|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|Closure||Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX|Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX|Not yet recruiting||N/A|200|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t|f|f||||||||2017-10-10 20:42:07.414684|2017-10-10 20:42:07.414684
NCT03289091|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||September 18, 2017|Actual|2017-09-18|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Two Water-based Aerobic Training Programs in Elderly Women|Effects of Two Water-based Aerobic Training Programs on Cardiorespiratory and Neuromuscular Parameters in Elderly Women: a Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|Federal University of Pelotas||2|||f||||t|f|f||||||||2017-10-10 20:42:07.594845|2017-10-10 20:42:07.594845
NCT03289078|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|FONTCAUDE||Evaluation of Functional Improvement After Spa Therapy in Fontcaude Center|Evaluation of Functional Improvement After Spa Therapy in Fontcaude Center, for Knee Osteoarthritis|Not yet recruiting||N/A|407|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f||||||||2017-10-10 20:42:07.683904|2017-10-10 20:42:07.683904
NCT03289065|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-18|||April 1, 2001|Actual|2001-04-01|September 2017|2017-09-01|April 1, 2030|Anticipated|2030-04-01|April 1, 2030|Anticipated|2030-04-01|25 Years|Observational [Patient Registry]|FOS||Fabry Outcome Survey (FOS)|Fabry Outcome Survey (FOS)|Recruiting||N/A|4000|Anticipated|Shire|||1||f||||f|f|f||||||||2017-10-10 20:42:07.757432|2017-10-10 20:42:07.757432
NCT03289052|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|||Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency|A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Effectiveness and Safety of Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency|Not yet recruiting||N/A|168|Anticipated|Q-Med AB||2|||f||||f|f|f||||||||2017-10-10 20:42:07.846463|2017-10-10 20:42:07.846463
NCT03289039|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-26|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|March 31, 2025|Anticipated|2025-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer|A Phase 2 Study of Neratinib With or Without Fulvestrant in HER2-Positive, ER-Positive Metastatic Breast Cancer|Not yet recruiting||Phase 2|152|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 20:42:07.921856|2017-10-10 20:42:07.921856
NCT03289026|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-18|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study|A Multicenter, Open-label Study to Evaluate the Effectiveness and Safety of Aripiprazole in Patients With Acute Episode of Schizophrenia|Not yet recruiting||Phase 4|1000|Anticipated|Peking University||1|||f||||f|f|f||||||||2017-10-10 20:42:08.03944|2017-10-10 20:42:08.03944
NCT03289013|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-21|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 20, 2017|Anticipated|2017-10-20||Interventional|||Assessement of the Peal Force Needed to Peel New Adhesives From the Skin|A Pilot Evaluation Exploring New Adhesive Materials and Their Ability to Handle Moisture From Abdominal and Peristomal Skin|Recruiting||N/A|6|Anticipated|Coloplast A/S||1|||f||||f|f|f||||||||2017-10-10 20:42:08.183738|2017-10-10 20:42:08.183738
NCT03289000|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||April 24, 2017|Actual|2017-04-24|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||A Retrospective Study to Evaluate the ConforMIS iTotal® Posterior Stabilized (PS) Knee Replacement System|A Retrospective Study to Evaluate the ConforMIS iTotal® Posterior Stabilized (PS) Knee Replacement System|Recruiting||N/A|80|Anticipated|ConforMIS, Inc.|||1||f||||f|f|t|f|f|t|||||2017-10-10 20:42:08.277241|2017-10-10 20:42:08.277241
NCT03288987|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-20|||October 5, 2016|Actual|2016-10-05|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||A Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab (AryoGen Pharmed) Compared With Bevacizumab (Avastin®) in Metastatic Colorectal Cancer|A Phase III, Randomized, Two-armed, Double-blind (Patient and Assessors), Parallel Active Controlled Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab (Produced by AryoGen Pharmed) Plus FOLFIRI-3 Compared With Bevacizumab (Avastin®) Plus FOLFIRI-3 in Patients With Metastatic Colorectal Cancer (mCRC)|Active, not recruiting||Phase 3|126|Actual|AryoGen Pharmed Co.||2|||f||||||||||||||2017-10-10 20:42:08.365645|2017-10-10 20:42:08.365645
NCT03288974|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-18|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|June 8, 2023|Anticipated|2023-06-08|June 8, 2023|Anticipated|2023-06-08||Observational|Pomalyst PMS||Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea|Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea|Not yet recruiting||N/A|600|Anticipated|Celgene|||1||f||||||||||||||2017-10-10 20:42:08.444472|2017-10-10 20:42:08.444472
NCT03288961|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-19|2017-09-19|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Self Screening Tool for Crohn's Perianal Fistula|Development and Validation of Patient Self-screening and Monitoring Tool for Crohn's Perianal Fistula|Recruiting||N/A|146|Anticipated|Kyungpook National University|||1||f||||f|f|f||||||||2017-10-10 20:42:08.522509|2017-10-10 20:42:08.522509
NCT03288948|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Binocular Amblyopia Treatment|Binocular Amblyopia Treatment|Recruiting||N/A|120|Anticipated|Retina Foundation of the Southwest||3|||f||||f|f|f||||||||2017-10-10 20:42:08.581896|2017-10-10 20:42:08.581896
NCT03288935|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-26|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|January 15, 2019|Anticipated|2019-01-15|December 20, 2018|Anticipated|2018-12-20||Interventional|||Trauma Informed Care for Newly Resettled Refugees|Trauma Informed Care for Refugee Newcomers in Virginia: A Factorial Design of Effectiveness-Implementation Hybrid Research|Not yet recruiting||N/A|100|Anticipated|Virginia Commonwealth University||4|||f|||||f|f||||||||2017-10-10 20:42:08.667712|2017-10-10 20:42:08.667712
NCT03288922|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF|Comparison of Protein-bound Toxins Removals Between Limited Blood Flow Online Hemodiafiltration Using Super High-flux Dialyzer and High-Efficiency Online Hemodiafiltration With High-flux Dialyzer: An Randomized Crossover Trial|Recruiting||N/A|10|Anticipated|Chulalongkorn University||2|||f||||f|f|f||||||||2017-10-10 20:42:08.752397|2017-10-10 20:42:08.752397
NCT03288909|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 2015||2015-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease|Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease|Recruiting||N/A|18|Anticipated|Oregon Health and Science University|||3||f||||f||||||||||2017-10-10 20:42:08.841155|2017-10-10 20:42:08.841155
NCT03288896|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-19|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Alerta Alcohol. Web-based Computer-tailored Intervention for Binge-drinking Prevention in Spanish Adolescents|Alerta Alcohol. Design, Implementation, and Evaluation of a Tailored Web-based Computer-tailored Intervention for Selective Prevention of Binge-drinking in Spanish Adolescents.|Completed||N/A|1230|Actual|University of Seville||2|||f||||t|f|f||||||||2017-10-10 20:42:08.914054|2017-10-10 20:42:08.914054
NCT03288883|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-19|||October 4, 2017|Anticipated|2017-10-04|September 2017|2017-09-01|October 4, 2021|Anticipated|2021-10-04|October 4, 2019|Anticipated|2019-10-04||Interventional|||RCT of Laser Therapy for GSM|Fractional Microablative CO2-laser Versus Photothermal Non-ablative Erbium:YAG-laser for the Management of Genitourinary Syndrome of Menopause: A Non-inferiority, Single-blind Randomised Controlled Trial|Not yet recruiting||N/A|80|Anticipated|King's College Hospital NHS Trust||2|||f||||f|f|f|||f|||||2017-10-10 20:42:08.995473|2017-10-10 20:42:08.995473
NCT03288870|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-19|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|October 15, 2019|Anticipated|2019-10-15|October 15, 2019|Anticipated|2019-10-15||Interventional|DOMINUS||A Study of Efficacy, Safety and Pharmacokinetics of BCD-100 Monotherapy as Second Line Treatment of Patients With Non-small Cell Lung Cancer|International Multi-center Open-label Randomized Clinical Trial of Efficacy, Safety and Pharmacokinetics of BCD-100 (JSC BIOCAD, Russia) Monotherapy Compared to Docetaxel as Second-line Therapy of Patients With Advanced Inoperable or Metastatic Non-small Cell Lung Cancer|Not yet recruiting||Phase 2/Phase 3|218|Anticipated|Biocad||2|||f||||f|f|f||||||||2017-10-10 20:42:09.084512|2017-10-10 20:42:09.084512
NCT03288857|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Comparison of the Bulb Aspirator to a Nasal Oral Aspirator in the Treatment of Bronchiolitis|Comparison of the Bulb Aspirator to a Nasal Oral Aspirator in the Treatment of Bronchiolitis|Not yet recruiting||N/A|440|Anticipated|University of Texas at Austin||2|||f||||t|f|f||||||||2017-10-10 20:42:09.273147|2017-10-10 20:42:09.273147
NCT03288311|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-30|||October 1, 2017|Actual|2017-10-01|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|March 31, 2019|Anticipated|2019-03-31||Interventional|PROPER||Protocolized Post-Extubation Respiratory Support Study|Protocolized Post-Extubation Respiratory Support (PROPER) Study|Recruiting||N/A|630|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:42:13.475637|2017-10-10 20:42:13.475637
NCT03288844|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|HOLOCORE-FU||Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns|Multinational, Multicenter, Prospective, Long-term Safety and Efficacy Follow-up Study After Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency Due to Ocular Burns|Not yet recruiting||N/A|70|Anticipated|Chiesi Farmaceutici S.p.A.|||1||f||||f|f|f||||||||2017-10-10 20:42:09.34859|2017-10-10 20:42:09.34859
NCT03288831|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 15, 2018|Anticipated|2018-12-15|October 15, 2018|Anticipated|2018-10-15||Interventional|||Changes in Intestinal Permeability 4 Hours After Gluten Challenge|The Innate Response to and Changes in Intestinal Permeability 4 Hours After a Gluten Challenge in Subjects With Celiac Disease and Non Celiac Gluten Sensitivity|Not yet recruiting||N/A|60|Anticipated|Mayo Clinic||6|||f||||t|f|f||||||||2017-10-10 20:42:09.428333|2017-10-10 20:42:09.428333
NCT03288818|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides|IIS: Phase II Study of Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides|Not yet recruiting||Phase 2|68|Anticipated|Thomas Jefferson University||1|||f||||t|t|f|||t|||||2017-10-10 20:42:09.528826|2017-10-10 20:42:09.528826
NCT03288805|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Cohort Study in South China|Prospective Cohort Study of Chronic Diseases in South China|Recruiting||N/A|110000|Anticipated|Sun Yat-sen University|||1||f||||f|f|f||||Samples With DNA|"     Serum ,Urine and fecal samples for biochemical tests, biomarker examination and DNA     extraction   "|||2017-10-10 20:42:09.650096|2017-10-10 20:42:09.650096
NCT03288792|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts|A Prospective Multicenter Evaluation of Three Dimensional Functional Metabolic and Risk Assessment System in Women With Mammographically Dense Breasts|Not yet recruiting||N/A|2625|Anticipated|Real Imaging Ltd.||1|||f|||||f|t|t|f|f|||||2017-10-10 20:42:09.733826|2017-10-10 20:42:09.733826
NCT03288779|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Theta Burst Stimulation for Schizophrenia|Theta Burst Stimulation for Schizophrenia|Not yet recruiting||N/A|20|Anticipated|Duke University||1|||f||||t|f|t|f||f|||||2017-10-10 20:42:09.838873|2017-10-10 20:42:09.838873
NCT03288766|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|MODUS II||A Single-Arm Prospective, Multi-Centered Study to Assess the SHERLOCK 3CG™ Diamond Tip Confirmation System|A Single-Arm Prospective, Multi-Centered Study to Assess the SHERLOCK 3CG™ Diamond Tip Confirmation System|Not yet recruiting||N/A|196|Anticipated|C. R. Bard|||1||f||||f|f|f||||||||2017-10-10 20:42:09.93459|2017-10-10 20:42:09.93459
NCT03288753|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|September 25, 2017|Anticipated|2017-09-25||Interventional|||Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors|Comparison of Patient Satisfaction and Audiological Performance Between Neuro 1 and Neuro 2 Speech Processors|Not yet recruiting||N/A|98|Anticipated|Oticon Medical||2|||f||||f|f|f||||||||2017-10-10 20:42:10.00428|2017-10-10 20:42:10.00428
NCT03288740|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-28|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|June 18, 2018|Anticipated|2018-06-18||Interventional|||A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects|A Single-centre, Randomised, Double-blind, Placebo-controlled, Multiple-dose Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects|Recruiting||Phase 1|36|Anticipated|Novo Nordisk A/S||4|||f||||f|t|f|||t|||||2017-10-10 20:42:10.098107|2017-10-10 20:42:10.098107
NCT03288727|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|FIND||Secondary Findings From High-throughput Sequencing: How to Announce Them With Respect to the Patient's Needs|Incidental Findings Produced by Diagnostic HTS: From the Needs of Patients to Organisational Considerations|Not yet recruiting||N/A|250|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f|||||f|f||||||||2017-10-10 20:42:10.190935|2017-10-10 20:42:10.190935
NCT03288714|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder|A Prospective, Multicenter, Double-Blind, Sham-Controlled Adaptive Design Study to Confirm the Safety and Efficacy of NEST sTMS in Subjects With Major Depressive Disorder Who Have Not Responded to at Least One Antidepressant Medication in the Current Episode|Not yet recruiting||N/A|120|Anticipated|NeoSync, Inc.||2|||f||||t|f|t|t|f|f|||||2017-10-10 20:42:10.274705|2017-10-10 20:42:10.274705
NCT03288701|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-10-05|||September 4, 2017|Actual|2017-09-04|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SCALE HF||Smart SCALEs for Treatment Guidance in Decompensated Heart Failure|SCALE HF - Smart SCALEs for Treatment Guidance in Decompensated Heart Failure|Recruiting||N/A|153|Anticipated|University Hospital, Basel, Switzerland||1|||f||||t|f|f||||||||2017-10-10 20:42:10.356086|2017-10-10 20:42:10.356086
NCT03288688|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|November 17, 2017|Anticipated|2017-11-17|November 17, 2017|Anticipated|2017-11-17||Interventional|||Effect of an Exercise Program Designed for Orchestral Musicians|Effect of an Exercise Program Designed for Professional Orchestral Musicians on Performance-related Musculoskeletal Problems - a Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|Laval University||2|||f||||f|f|f||||||||2017-10-10 20:42:10.446028|2017-10-10 20:42:10.446028
NCT03288675|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-10-05|||October 5, 2017|Actual|2017-10-05|October 2017|2017-10-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|aiTBS2-Ghent||Stepped Care aiTBS 2 Depression Study (Ghent)|The Effects of Accelerated Intermittent Thetaburst Stimulation Followed by a Cognitive Control Training in Treatment Resistant Unipolar Depressed Patients|Recruiting||N/A|68|Anticipated|University Hospital, Ghent||4|||f|||||f|f||||||||2017-10-10 20:42:10.528574|2017-10-10 20:42:10.528574
NCT03288662|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-19|||October 1, 2013|Actual|2013-10-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 1, 2017|Actual|2017-07-01||Interventional|||Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors|Evaluate the Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors|Completed||N/A|2|Actual|Military Hospital 103||1|||f||||f|f|f||||||||2017-10-10 20:42:10.655111|2017-10-10 20:42:10.655111
NCT03288649|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-19|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|EVAADO||Qualitative Evaluation of Therapeutic Alliance in Adolescent Psychiatry|Qualitative Evaluation of Therapeutic Alliance in Adolescent Psychiatry: Crossing Perspectives of Adolescents, Parents and Physicians|Recruiting||N/A|180|Anticipated|Centre Hospitalier Victor Dupouy|||3||f||||f|f|f||||||||2017-10-10 20:42:10.731517|2017-10-10 20:42:10.731517
NCT03288623|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-28|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Dark Chocolate Implementation in Elite Athletes|The Effects of Dark Chocolate Implementation in the Reduction of Oxidative Stress and Improvement of Vascular Function and Physical Performance in Elite Athletes|Recruiting||N/A|24|Anticipated|University of Roma La Sapienza||2|||f||||t|f|f||||||||2017-10-10 20:42:10.881868|2017-10-10 20:42:10.881868
NCT03288610|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-20|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Observational|MicorSIRS||Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin Level|Prognostic Value of Copeptin Level Before Cardiac Surgery and Involvement in Systemic Inflammatory Response Syndrome After Cardiopulmonary Bypass|Completed||N/A|200|Actual|University Hospital, Montpellier|||1||f||||f|f|f||||Samples Without DNA|"     Plasma: preoperative, ICU admission at POD0 and POD1 samples   "|||2017-10-10 20:42:10.976734|2017-10-10 20:42:10.976734
NCT03288597|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-09-16|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2018|Anticipated|2018-09-01|12 Months|Observational [Patient Registry]|||Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms|A Prospective Exploration in the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms|Recruiting||N/A|146|Anticipated|Peking University|||2||f||||t|f|f||||||||2017-10-10 20:42:11.074524|2017-10-10 20:42:11.074524
NCT03288584|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-10-04|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Effects of Interleukin-6 Inhibition on Vascular, Endothelial and Left Ventricular Function in Rheumatoid Arthritis|The Effect of Inhibition of Interleukin-6 Activity on Vascular, Endothelial and Left Ventricular Function in Patients With Rheumatoid Arthritis|Recruiting||N/A|60|Anticipated|University of Athens|||3||f||||t|f|f||||||||2017-10-10 20:42:11.164506|2017-10-10 20:42:11.164506
NCT03288571|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-18|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Use of Wharton Jelly in Diabetic Nephropathy|The Safety of Intra-parenchymal Wharton Jelly Mesenchymal Stem Cell Injection in the Treatment of Diabetic Nephropathy|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|University of Jordan||1|||f||||t|f|f||||||||2017-10-10 20:42:11.254688|2017-10-10 20:42:11.254688
NCT03288558|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-19|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|June 1, 2020|Anticipated|2020-06-01|October 30, 2019|Anticipated|2019-10-30||Interventional|||Protective Mechanical VENTilation Strategy in Patients Undergoing CARDiac Surgery|Protective Mechanical VENTilation Strategy in Patients Undergoing CARDiac Surgery (VENT CARD Trial)|Recruiting||N/A|310|Anticipated|University Health Network, Toronto||2|||f||||t|f|f||||||||2017-10-10 20:42:11.32839|2017-10-10 20:42:11.32839
NCT03288545|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Safety Study of Enfortumab Vedotin Plus Immune Checkpoint Inhibitor Therapy for Patients With Urothelial Bladder Cancer (EV-103)|A Phase 1b Dose-escalation and Dose-expansion Study of Enfortumab Vedotin (ASG-22CE) in Combination With Immune Checkpoint Inhibitor (CPI) Therapy for Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer|Not yet recruiting||Phase 1|85|Anticipated|Astellas Pharma Inc||1|||f||||t|t|f||||||||2017-10-10 20:42:11.41308|2017-10-10 20:42:11.41308
NCT03288532|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-18|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 1, 2037|Anticipated|2037-12-01|December 1, 2023|Anticipated|2023-12-01||Interventional|RAMPART||Renal Adjuvant MultiPle Arm Randomised Trial|An International Investigator-led Phase III Multi Arm Multi Stage Multi-centre Randomised Controlled Platform Trial of Adjuvant Therapy in Patients With Resected Primary Renal Cell Carcinoma (RCC) at High or Intermediate Risk of Relapse|Not yet recruiting||Phase 3|1750|Anticipated|University College, London||3|||f||||t|f|f||||||||2017-10-10 20:42:11.508771|2017-10-10 20:42:11.508771
NCT03288519|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-18|||April 1, 2015|Actual|2015-04-01|September 2017|2017-09-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|||Use of Classic LMA During Endovascular Therapy|The Use of the Classic Laryngeal Mask Airway in Patients With Cerebral Aneurysm Undergoing Endovascular Therapy|Completed||N/A|60|Actual|Universidad de Antioquia|||1||f||||f|f|f||||||||2017-10-10 20:42:11.586524|2017-10-10 20:42:11.586524
NCT03288506|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-18|||October 13, 2016|Actual|2016-10-13|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Interventional|DES||Developing E-health Services (DES): The Feasibility and Acceptability of Video-conferencing for Adults With Depression|Developing E-health Services (DES): The Feasibility and Acceptability of Group Based Video-conferencing for Adults With Depression|Recruiting||N/A|100|Anticipated|Queen's University, Belfast||2|||f|||||f|f||||||||2017-10-10 20:42:11.782008|2017-10-10 20:42:11.782008
NCT03288116|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-15|||January 2, 2014|Actual|2014-01-02|September 2017|2017-09-01|February 5, 2015|Actual|2015-02-05|February 5, 2015|Actual|2015-02-05||Observational|||Objective and Subjective Diagnostic Parameters in the Fellow Eye of Unilateral Keratoconus|Literature in Mansoura Ophthalmic Center ,Mansoura University|Completed||N/A|48|Actual|Dar Al Shifa Hospital|||3||f|||||f|f||||||||2017-10-10 20:42:14.734114|2017-10-10 20:42:14.734114
NCT03288493|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-05|||September 20, 2017|Actual|2017-09-20|October 2017|2017-10-01|June 30, 2021|Anticipated|2021-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)|Open-Label, Multicenter, Single Ascending Dose Study to Assess the Safety of P-BCMA-101 in Subjects With Relapsed and/or Refractory Multiple Myeloma (MM)|Recruiting||Phase 1|40|Anticipated|Poseida Therapeutics, Inc.||1|||f||||t|t|f||||||||2017-10-10 20:42:11.933716|2017-10-10 20:42:11.933716
NCT03288480|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-18|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|May 31, 2019|Anticipated|2019-05-31||Interventional|||A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma|A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma|Not yet recruiting||Phase 1|34|Anticipated|Phosplatin Therapeutics||1|||||||f|t|f||||||||2017-10-10 20:42:12.036833|2017-10-10 20:42:12.036833
NCT03288467|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-18|||November 6, 2016|Actual|2016-11-06|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Effect of Sodium Hypochlorite Concentration on Success of Non-surgical Root Canal Treatment|Effect of Sodium Hypochlorite Concentration on Success of Non-surgical Root Canal Treatment: A Randomized Controlled Trial.|Active, not recruiting||N/A|90|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||||2017-10-10 20:42:12.143829|2017-10-10 20:42:12.143829
NCT03288454|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-25|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT|Phase 2 Placebo-Controlled, Single-Site, Single-Blind Study of Apixaban Reversal by Ciraparantag as Measured by WBCT|Recruiting||Phase 2|48|Anticipated|Perosphere, Inc.||3|||f|||||t|f||||||||2017-10-10 20:42:12.221006|2017-10-10 20:42:12.221006
NCT03288441|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|December 2018|Anticipated|2018-12-01|6 Months|Observational [Patient Registry]|MATTER||Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia|Management Patterns of AntiThrombotics and Outcomes in Patients With Hematological Malignancy and ThrombocytopEnia: a Prospective Registry (MATTER Study)|Not yet recruiting||N/A|300|Anticipated|Maastricht University Medical Center|||2||f||||f|f|f||||Samples Without DNA|"     After measuring the activity of anticoagulant drugs from the plasma when doses are modified,     remaining plasma will be retained for 5 years.   "|||2017-10-10 20:42:12.33831|2017-10-10 20:42:12.33831
NCT03288428|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-09-18|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy|Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy|Recruiting||Phase 4|80|Anticipated|Peking University First Hospital||2|||f|||||f|f||||||||2017-10-10 20:42:12.500272|2017-10-10 20:42:12.500272
NCT03288415|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-18|||January 2017||2017-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||SMZL Molecular Prognostic Index|Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma|Recruiting||N/A|300|Anticipated|Oncology Institute of Southern Switzerland|||1||f||||f|f|f||||Samples With DNA|"     FFPE splenic samples Frozen peripheral blood Frozen bone marrow aspirate   "|||2017-10-10 20:42:12.594277|2017-10-10 20:42:12.594277
NCT03288402|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-15|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|August 3, 2017|Actual|2017-08-03||Interventional|DIB-NET||Investigation of the Effects of Diet on the Measurement of Plasma Chromogranin in NET Patients|Investigation of the Effects of Breakfast or Caffeine Containing Beverages on the Measurement of Plasma Chromogranin A in Patients With Gastro-entero-pancreatic Neuroendocrine Tumours (GEP-NET)|Active, not recruiting||N/A|42|Actual|University Hospitals Coventry and Warwickshire NHS Trust||3|||f||||f|f|f||||||||2017-10-10 20:42:12.704919|2017-10-10 20:42:12.704919
NCT03288376|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||February 13, 2015|Actual|2015-02-13|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2015|Actual|2015-12-31||Observational|SNORESOUNDS||SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS|SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS|Active, not recruiting||N/A|20|Anticipated|Incyphae, Inc.|||1||f||||f|f|f||||||||2017-10-10 20:42:12.94424|2017-10-10 20:42:12.94424
NCT03288363|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-17|||June 6, 2017|Actual|2017-06-06|September 2017|2017-09-01|December 6, 2019|Anticipated|2019-12-06|June 6, 2019|Anticipated|2019-06-06||Interventional|tDCS-AD||Transcranial Direct Current Stimulation and Early Alzheimer's Disease (tDCS-AD)|Effects at 12 Weeks of Transcranial Direct Current Stimulation on the Cognitions of People Presenting Early Alzheimer's Disease (tDCS-AD)|Recruiting||N/A|80|Anticipated|Centre Hospitalier Esquirol||2|||f||||f|f|f||||||||2017-10-10 20:42:13.029756|2017-10-10 20:42:13.029756
NCT03288350|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|||mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)|Phase II Trial of Perioperative PD-L1 Inhibition With Avelumab and Docetaxel, Cisplatin and 5-Fluorouracil for Resectable Locally Advanced Esophago-Gastric Adenocarcinoma|Not yet recruiting||Phase 2|55|Anticipated|McGill University Health Center||1|||f||||t|f|f|||f|||||2017-10-10 20:42:13.139767|2017-10-10 20:42:13.139767
NCT03288337|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-18|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01|6 Months|Observational [Patient Registry]|||Impact of Hidradenitis Suppurativa on Quality of Life Functions|Impact of Hidradenitis Suppurativa on Quality of Life Functions: A Cross-Sectional Analysis of 400 Patients|Recruiting||N/A|400|Anticipated|Montefiore Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:42:13.234177|2017-10-10 20:42:13.234177
NCT03288324|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-18|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus|A 3-part Open-label Study Assessing Safety, Tolerability, Pharmacokinetic and -Dynamic Profiles, and Efficacy of Tofacitinib in Young Adults From Age 18 to 30 With Moderate to Severe Skin Involvement Due to Lupus|Recruiting||Phase 1/Phase 2|20|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||||||f|t|f||||||||2017-10-10 20:42:13.355428|2017-10-10 20:42:13.355428
NCT03288298|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-18|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|April 1, 2019|Anticipated|2019-04-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line|Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line: In Vitro Study|Not yet recruiting||Early Phase 1|4|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:42:13.56728|2017-10-10 20:42:13.56728
NCT03288285|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-24|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|August 31, 2018|Anticipated|2018-08-31||Observational|||Comparison of Post- and Pre-dilutional Hemodiafiltration in Hemodialysis Patients|Effects of Post- and Pre-dilutional Hemodiafiltration on Patients With End-stage Renal Disease|Recruiting||N/A|60|Anticipated|Tungs’ Taichung Metroharbour Hospital|||1||f||||t|f|f||||||||2017-10-10 20:42:13.649919|2017-10-10 20:42:13.649919
NCT03288272|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-09-16|||April 2016||2016-04-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ERASER||Evaluation of Repeated Whole Brain Radiotherapy Versus Best Supportive Care for Multiple Brain Metastases.|Evaluation of Repeated Whole Brain Radiotherapy Versus Best Supportive Care for Multiple Brain Metastases - the Randomized Trial ERASER.|Recruiting||Phase 2|60|Anticipated|Technische Universität München||3|||f||||f||||||||||2017-10-10 20:42:13.728028|2017-10-10 20:42:13.728028
NCT03288259|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-19|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2017|Actual|2017-08-01||Interventional|||Transnasal Endoscopy in Obese Patients Are Candidates for Bariatric Surgery|Transnasal Endoscopy in Obese Patients Are Candidates for Bariatric Surgery: Feasibility, Tolerance, Security and Cost-effectiveness.|Recruiting||N/A|100|Anticipated|Federal University of Minas Gerais||1|||f||||t|f|f||||||||2017-10-10 20:42:13.814515|2017-10-10 20:42:13.814515
NCT03288246|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||Point-of-care Viral Load Testing Among HIV-infected Adolescents in Haiti|Point-of-care Viral Load Testing Among HIV-infected Adolescents in Haiti|Not yet recruiting||N/A|150|Anticipated|Weill Medical College of Cornell University||2|||f||||f|f|f||||||||2017-10-10 20:42:13.900323|2017-10-10 20:42:13.900323
NCT03288233|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-09-15|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Observational|||Exhaled Carbon Monoxide and Red Blood Cell Turnover|Measurement of Exhaled Lower Respiratory Carbon Monoxide and Correlation With Previous Measures of Red Cell Lifespan|Recruiting||N/A|30|Anticipated|University of Cincinnati|||1||f||||f|f|f||||||||2017-10-10 20:42:13.981324|2017-10-10 20:42:13.981324
NCT03288194|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Improving Quality of Life in Heart Failure|Improving Quality of Life in Outpatients With Heart Failure: A Two-arm Randomized Controlled Trial|Recruiting||N/A|44|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:42:14.23911|2017-10-10 20:42:14.23911
NCT03288181|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||October 5, 2015|Actual|2015-10-05|September 2017|2017-09-01|June 15, 2016|Actual|2016-06-15|May 30, 2016|Actual|2016-05-30||Interventional|||Effects of Passive Muscle Stretching on Vascular Function and Symptoms of PAD|Effects of Muscle Stretching on Vascular Endothelial Function in Patients With Peripheral Arterial Disease|Completed||N/A|13|Actual|Tallahassee Research Institute, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:42:14.321794|2017-10-10 20:42:14.321794
NCT03288168|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Observational|CNOG-MB001||Multi-center Study on Children's and Adolescents' Medulloblastoma Molecular Subgroups in China|Multi-center Retrospective Study on Clinical Features and Molecular Subgroups of Children and Adolescents With Medulloblastoma in China|Recruiting||N/A|200|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f|f|f||||Samples With DNA|"     Either paraffin embedded tissue block or frozen tissue   "|||2017-10-10 20:42:14.38975|2017-10-10 20:42:14.38975
NCT03288155|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-19|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Can a Flavonoid-rich Pure Cocoa Reduce Fatigue in People With Parkinson's (PD)|A Study to Determine Whether the Daily Consumption of Flavonoid-rich Pure Cocoa Can Reduce Fatigue in People With Parkinson's (PD)|Recruiting||N/A|40|Anticipated|Oxford Brookes University||2|||f||||f|f|f|||f|||||2017-10-10 20:42:14.489351|2017-10-10 20:42:14.489351
NCT03288142|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-25|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|June 28, 2019|Anticipated|2019-06-28|September 18, 2018|Anticipated|2018-09-18||Interventional|iSmartHyp||The Smart Hypertension Control Study|Improving Hypertension Using a Smartphone-Enabled Personal Control Program: The Smart Hypertension Control Study|Recruiting||N/A|350|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 20:42:14.576944|2017-10-10 20:42:14.576944
NCT03288129|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures|Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures|Recruiting||Phase 4|300|Anticipated|Eisai Inc.||1|||f||||f|t|f||||||||2017-10-10 20:42:14.652922|2017-10-10 20:42:14.652922
NCT03288103|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-28|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency|Clinical Characterization and Trial of Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t|t|f||||||||2017-10-10 20:42:14.795742|2017-10-10 20:42:14.795742
NCT03288090|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|Fatigue AVC||Evaluate the Frequency of Fatigue After Cerebral Infarction|Fatigue After Stroke|Recruiting||N/A|370|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f|||||f|f||||||||2017-10-10 20:42:14.861683|2017-10-10 20:42:14.861683
NCT03288077|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-18|2017-09-18|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Nutrients to Enhance Sleep Quality and Quantity|Nutrients to Enhance Sleep Quality and Quantity|Active, not recruiting||N/A|62|Anticipated|PepsiCo Global R&D||1|||f||||f|f|f||||||||2017-10-10 20:42:14.931507|2017-10-10 20:42:14.931507
NCT03288064|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-19|||February 5, 2017|Actual|2017-02-05|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|June 30, 2017|Actual|2017-06-30||Interventional|||Ergogenic and Antioxidant Effects of Corinthian Currant|Effects of Corinthian Currant Supplementation on Redox Status, Inflammatory Markers, and Performance During Prolonged Exercise|Completed||N/A|11|Actual|University of Thessaly||3|||f||||f|f|f||||||||2017-10-10 20:42:14.993912|2017-10-10 20:42:14.993912
NCT03288051|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-15|||February 1, 2014|Actual|2014-02-01|August 2017|2017-08-01|February 20, 2017|Actual|2017-02-20|February 20, 2017|Actual|2017-02-20||Interventional|||Effects of Intraoperative, Goal-directed Crystalloid vs. Colloid Fluid Resuscitation on Free Flaps|Effects of Intraoperative, Goal-directed Crystalloid vs. Colloid Fluid Resuscitation on Microcirculation in Free Flap Reconstruction of Intraoral Tumours.|Completed||N/A|30|Actual|Szeged University||2|||f|||||f|f||||||||2017-10-10 20:42:15.104701|2017-10-10 20:42:15.104701
NCT03288038|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-15|||October 13, 2014|Actual|2014-10-13|August 2017|2017-08-01|November 19, 2015|Actual|2015-11-19|November 19, 2015|Actual|2015-11-19||Interventional|||The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia|A Multi-center, Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia|Completed||Phase 3|382|Actual|Shin Poong Pharmaceutical Co. Ltd.||6|||f|||||f|f||||||||2017-10-10 20:42:15.179564|2017-10-10 20:42:15.179564
NCT03288012|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||October 8, 2017|Anticipated|2017-10-08|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|June 1, 2019|Anticipated|2019-06-01||Observational|STARRING||Sikkle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics|Sikkle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics|Not yet recruiting||N/A|150|Anticipated|Sanquin Research & Blood Bank Divisions|||1||f||||||||||Samples With DNA|"     Blood samples for DNA analysis and analysis of immune system components involved in     alloimmune reactions following erythrocyte transfusion   "|||2017-10-10 20:42:15.497928|2017-10-10 20:42:15.497928
NCT03287999|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|October 2, 2019|Anticipated|2019-10-02|October 2, 2018|Anticipated|2018-10-02||Observational|InPath||Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B|Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B|Not yet recruiting||N/A|250|Anticipated|Royal Free Hospital NHS Foundation Trust|||2||f||||f|f|f||||Samples With DNA|"     Blood plasma   "|||2017-10-10 20:42:15.561802|2017-10-10 20:42:15.561802
NCT03287986|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Observational|SPAD IRM||Brain Markers of Suicide Risk and Psychological Pain in Elderly Depressed Patients|Brain Markers of Suicide Risk and Psychological Pain in Elderly Depressed Patients|Not yet recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nīmes|||3||f||||f|f|f||||None Retained|"     DNA, blood.   "|||2017-10-10 20:42:15.650172|2017-10-10 20:42:15.650172
NCT03287973|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Effect of Weight Loss and CPAP on OSA and Metabolic Profile Stratified by Craniofacial Phenotype|Effect of Weight Loss and CPAP on OSA and Metabolic Profile Stratified by Craniofacial Phenotype|Recruiting||N/A|192|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:42:15.730453|2017-10-10 20:42:15.730453
NCT03287960|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||Setmelanotide for the Treatment of LEPR Deficiency Obesity|An Open Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of Setmelanotide (RM-493), a Melanocortin 4 Receptor (MC4R) Agonist, in Early Onset Leptin Receptor (LEPR) Deficiency Obesity Due to Bi-Allelic Loss-of-Function LEPR Genetic Mutation|Not yet recruiting||Phase 3|10|Anticipated|Rhythm Pharmaceuticals, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:42:15.817477|2017-10-10 20:42:15.817477
NCT03287947|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 1, 2022|Anticipated|2022-03-01|September 1, 2021|Anticipated|2021-09-01||Interventional|||LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma|LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma|Not yet recruiting||Phase 2|39|Anticipated|Carolinas Healthcare System||1|||f||||t|f|f||||||||2017-10-10 20:42:15.912428|2017-10-10 20:42:15.912428
NCT03287934|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|RCT||Accuracy of Selective Laser Sintered Computer Guided Stents Versus Stereolithographic Stents|Accuracy of Selective Laser Sintered Computer Guided Stents Versus Stereolithographic Stents in Immediate Implant Placement in Esthetic Zone, a Randomized Controlled Study|Not yet recruiting||N/A|22|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:42:15.991487|2017-10-10 20:42:15.991487
NCT03287921|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-17|2017-09-17|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD|Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD|Not yet recruiting||N/A|25|Anticipated|Universitätsmedizin Mannheim|||2||f||||t|t|f|||f|Samples Without DNA|"     blood samples   "|||2017-10-10 20:42:16.072947|2017-10-10 20:42:16.072947
NCT03287895|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-15|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|iCANACP||Improving Decisions About CPR|A Multifaceted Tool to Improve Decision Making About Cardio-Pulmonary Resuscitation (CPR) for Hospitalized Patients Who Are Seriously Ill|Not yet recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:42:16.282497|2017-10-10 20:42:16.282497
NCT03287882|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-15|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Effect of Micronutrients and Life Skills Education on the Health and Nutrition of Adolescent and Young Women in Pakistan|Prospective, Cluster Randomized Effectiveness Trial of Multiple Micronutrient Supplementation and Life Skills Education Provided From Preconception on Health and Nutrition Outcomes of Young, Reproductive-age Pakistani Women (15-24 Years)|Recruiting||Phase 3|25400|Anticipated|Aga Khan University||2|||f||||t|f|f||||||||2017-10-10 20:42:16.375312|2017-10-10 20:42:16.375312
NCT03287869|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-15|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Bipolar I Disorder|A Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Bipolar I Disorder|Not yet recruiting||Phase 3|384|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f|||||t|f||||||||2017-10-10 20:42:16.488027|2017-10-10 20:42:16.488027
NCT03287856|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-15|||August 11, 2017|Actual|2017-08-11|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|September 2018|Anticipated|2018-09-01||Interventional|VIVALL||NVT ALLEGRA TAVI System TF in Failing Surgical Aortic Bioprosthesis|Investigation of the Safety and Performance of the NVT ALLEGRA TAVI System TF in Patients With Failed Surgical Aortic Bioprosthesis and Elevated Surgical Risk|Recruiting||N/A|30|Anticipated|NVT GmbH||1|||f||||t|f|f||||||||2017-10-10 20:42:16.583425|2017-10-10 20:42:16.583425
NCT03287843|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-17|||January 1, 2006|Actual|2006-01-01|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|January 1, 2017|Actual|2017-01-01||Interventional|||Appropriate Timing of Surgery After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer|Effect of Timing of Surgery After Neoadjuvant Chemoradiation on Histopathological Results, Complications, Recurrence and Survivals for Locally Advanced Rectal Cancer|Active, not recruiting||N/A|330|Anticipated|Ege University||2|||f||||t|f|f||||||||2017-10-10 20:42:16.679497|2017-10-10 20:42:16.679497
NCT03287830|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-17|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|F2T||Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine 2017-18|Flu2Text: A Multi-Site Study Assessing Text Message Reminders for 2nd Dose of Influenza Vaccine 2017-18|Not yet recruiting||N/A|1600|Anticipated|Columbia University||2|||f||||t|f|f||||||||2017-10-10 20:42:16.766838|2017-10-10 20:42:16.766838
NCT03287817|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-18|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|ALEXANDER||CD19/22 CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma|A Single Arm, Open-label, Multi-centre, Phase I/II Study Evaluating the Safety and Clinical Activity of AUTO3, a CAR T Cell Treatment Targeting CD19 and CD22 Followed by Consolidation With Anti PD1 Antibody in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma|Recruiting||Phase 1/Phase 2|120|Anticipated|Autolus Limited||1|||f||||t|f|f||||||||2017-10-10 20:42:16.865149|2017-10-10 20:42:16.865149
NCT03287804|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-17|||May 5, 2017|Actual|2017-05-05|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|APRIL||APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma|A Single-Arm, Open-Label, Multi-Centre, Phase I/II Study Evaluating the Safety and Clinical Activity of AUTO2, a CAR T Cell Treatment Targeting BCMA and TACI, in Patients With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|80|Anticipated|Autolus Limited||1|||f||||t|f|f||||||||2017-10-10 20:42:16.959654|2017-10-10 20:42:16.959654
NCT03287791|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||July 19, 2016|Actual|2016-07-19|September 2017|2017-09-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Patients With Rosacea|A Multicenter, Double-blind, Randomized, Parallel-group, Vehicle-controlled Study to Evaluate Safety and Clinical Equivalence of a Generic Azelaic Acid Foam, 15% and the Reference Finacea Foam, 15% in Patients With Moderate Facial Rosacea|Completed||Phase 3|978|Actual|Actavis Inc.||3|||f||||f|t|f||||||||2017-10-10 20:42:17.049509|2017-10-10 20:42:17.049509
NCT03287778|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|April 1, 2020|Anticipated|2020-04-01||Interventional|||Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia|Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia|Not yet recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|f||||||||2017-10-10 20:42:17.188297|2017-10-10 20:42:17.188297
NCT03287765|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-09-14|||May 2016||2016-05-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|May 2021|Anticipated|2021-05-01||Interventional|ADRC proj 1||Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans|Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD in Humans|Recruiting||Phase 2|80|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 20:42:17.291299|2017-10-10 20:42:17.291299
NCT03235180|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|August 31, 2023|Anticipated|2023-08-31|August 31, 2022|Anticipated|2022-08-31||Interventional|||Ultrasound Evaluation of Crohn's Disease|Ultrasound Evaluation of Crohn's Disease|Enrolling by invitation||Phase 4|100|Anticipated|Mayo Clinic||1|||f||||f|t|t|t|f|f|||||2017-10-10 20:49:54.401628|2017-10-10 20:49:54.401628
NCT03287752|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-18|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|BASKAMASK||BASKA Mask Versus Endo Tracheal Tube in Gynecological Laparoscopic Surgery|A Prospective Randomized Comparison of the Effect of BASKA Mask Versus Endo Tracheal Tube on Respiratory Function Parameters in Patients Undergoing Gynecological Laparoscopic Surgery|Recruiting||N/A|80|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 20:42:17.375317|2017-10-10 20:42:17.375317
NCT03287739|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|aRISE||Recovery of Impairments Early After Stroke|Recovery of Impairments Early After Stroke|Not yet recruiting||N/A|40|Anticipated|University of Zurich|||1||f||||f|f|f||||||||2017-10-10 20:42:17.473244|2017-10-10 20:42:17.473244
NCT03287726|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||November 16, 2017|Anticipated|2017-11-16|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||What is the Impact of Probiotics on Weight Loss Maintenance in Individuals With Obesity?|Evaluation of the Potential Impact of Probiotics on Weight Loss Maintenance in Individuals With Obesity|Not yet recruiting||N/A|115|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 20:42:17.5639|2017-10-10 20:42:17.5639
NCT03287713|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-15|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Can High-Flow Oxygen Therapy Improve Oxygenation During Exercise in ILD Patients?|Can Nasal High-Flow Oxygen Therapy Improve Oxygenation During Exercise, Optimizing Benefits of Pulmonary Rehabilitation in Patients With Interstitial Lung Disease (ILD) With Exercise Desaturation?|Not yet recruiting||N/A|60|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t|f|f||||||||2017-10-10 20:42:17.651063|2017-10-10 20:42:17.651063
NCT03287700|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-19|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|November 30, 2018|Anticipated|2018-11-30||Observational|FOUNDATION||Designing a Trial of Bilateral Cochlear Implantation in Adults|Designing a Randomised Controlled Trial to Examine the Benefit of Bilateral Cochlear Implantation Compared With Unilateral Cochlear Implantation in Adults With Severe to Profound Deafness|Recruiting||N/A|86|Anticipated|Nottingham University Hospitals NHS Trust|||6||f||||f|f|f||||||||2017-10-10 20:42:17.714812|2017-10-10 20:42:17.714812
NCT03287687|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Efficacy of CO2 for Endoscopy|The Safety and Efficacy of Carbon Dioxide for Insufflation During Endoscopy in Pediatric Patients|Not yet recruiting||N/A|250|Anticipated|University of Iowa||2|||f||||t|f|f|||f|||||2017-10-10 20:42:17.807396|2017-10-10 20:42:17.807396
NCT03287661|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-09-18|||September 21, 2017|Anticipated|2017-09-21|September 2017|2017-09-01|June 20, 2018|Anticipated|2018-06-20|April 20, 2018|Anticipated|2018-04-20||Interventional|||A Trial of an Online Chronic Pain Treatment for Military, Police and Veterans|A Randomized Controlled Trial of an Online Chronic Pain Treatment for Military, Police and Veterans|Recruiting||N/A|40|Anticipated|University of Manitoba||2|||f||||t|f|f||||||||2017-10-10 20:42:17.997214|2017-10-10 20:42:17.997214
NCT03287648|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Observational|||Simultaneous OCT and B-FAF in Eyes With Alteration of the Foveal Contour|Simultaneous Spectral-domain Optical Coherence Tomography and Blue-fundus Autofluorescence in Eyes With Alteration of the Foveal Contour|Recruiting||N/A|20|Anticipated|University of Molise|||1||f||||t|f|f||||||||2017-10-10 20:42:18.086229|2017-10-10 20:42:18.086229
NCT03287635|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-15|||November 8, 2017|Anticipated|2017-11-08|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Study Title: Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease|Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease|Not yet recruiting||Phase 4|12|Anticipated|Toyos Clinic||1|||f||||f|t|f|||f|||||2017-10-10 20:42:18.168154|2017-10-10 20:42:18.168154
NCT03287622|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|STOMP||Evaluation of an Interactive Opioid Risk Education Program (STOMP) for Parents|Scenario-tailored Opioid Messaging Program (STOMP): An Interactive Intervention to Prevent Opioid-related Adverse Drug Events in Children and Adolescents|Not yet recruiting||N/A|840|Anticipated|University of Michigan||4|||f||||t|f|f||||||||2017-10-10 20:42:18.245707|2017-10-10 20:42:18.245707
NCT03287609|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-14|||December 15, 2017|Anticipated|2017-12-15|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|March 31, 2019|Anticipated|2019-03-31||Interventional|EVOPACS||EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)|EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) - A Randomized, Double-blind, Placebo-controlled Multicenter Study|Not yet recruiting||Phase 3|308|Anticipated|University Hospital Inselspital, Berne||2|||f||||t|f|f||||||||2017-10-10 20:42:18.330692|2017-10-10 20:42:18.330692
NCT03287596|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2, 2019|Anticipated|2019-10-02|October 1, 2019|Anticipated|2019-10-01||Interventional|SILENZ||Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI|Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at3T MRI|Not yet recruiting||N/A|275|Anticipated|University Hospital, Bordeaux||4|||f||||f|f|f||||||||2017-10-10 20:42:18.439159|2017-10-10 20:42:18.439159
NCT03287583|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||SBIRT Intervention for Gambling Behaviors|Pilot Randomized Control Trial of an SBIRT Intervention for Gambling|Not yet recruiting||Phase 2|100|Anticipated|University of Maryland||2|||f||||f|f|f||||||||2017-10-10 20:42:18.523143|2017-10-10 20:42:18.523143
NCT03287570|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy and Safety of Cettum for Knee Osteoarthritis|Clinical Research on the Efficacy and Safety of Cettum on Knee Osteoarthritis|Not yet recruiting||N/A|138|Anticipated|DongGuk University||3|||f||||t|f|f||||||||2017-10-10 20:42:18.587238|2017-10-10 20:42:18.587238
NCT03287557|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 30, 2019|Anticipated|2019-07-30|July 30, 2019|Anticipated|2019-07-30||Observational|||Dysregulated CNS Inflammation After Acute Brain Injury|Dysregulated CNS Inflammation After Acute Brain Injury|Not yet recruiting||N/A|20|Anticipated|University of Kentucky|||1||f||||f|f|f||||Samples Without DNA|"     CSF will be collected from an external ventricular drain (EVD) at five time points     post-injury: 6, 12, 24, 48, 60 hrs   "|||2017-10-10 20:42:18.667731|2017-10-10 20:42:18.667731
NCT03287544|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-15|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|February 2018|Anticipated|2018-02-01||Interventional|ORACLE||Efficacy of a Combined Linguistic/Communication Therapy in Acute Aphasia After Stroke|Effect of a Combined Language Therapy (Linguistic/Communication) on Aphasia After Stroke in Acute Phase: A Prospective, Controlled, Monocentric Pilot Study|Not yet recruiting||N/A|18|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||||2017-10-10 20:42:18.726787|2017-10-10 20:42:18.726787
NCT03287531|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-09-18|||December 10, 2016|Actual|2016-12-10|September 2017|2017-09-01|August 23, 2017|Actual|2017-08-23|August 12, 2017|Actual|2017-08-12||Interventional|||Effect of Conventional Therapy and Low Level Laser Therapy on Pain and Function in Patients With Temporomandibular Joint Dysfunction|Effect of Conventional Therapy and Low Level Laser Therapy on Pain and Function in Patients|Completed||N/A|45|Actual|October 6 University||2|||f||||t||||||||||2017-10-10 20:42:18.813092|2017-10-10 20:42:18.813092
NCT03287518|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-10-02|||July 28, 2017|Actual|2017-07-28|October 2017|2017-10-01|September 15, 2018|Anticipated|2018-09-15|April 1, 2018|Anticipated|2018-04-01||Interventional|||Evaluatuation of the Benefit and Tolerability of WAK2017 on Endothelial Function, Blood Pressure and Lipid Profile|Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Benefit and Tolerability of WAK2017 on Endothelial Function, Blood Pressure and Lipid Profile|Recruiting||N/A|100|Anticipated|Analyze & Realize||2|||f||||f|f|f||||||||2017-10-10 20:42:18.888252|2017-10-10 20:42:18.888252
NCT03287505|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-14|||June 23, 2017|Actual|2017-06-23|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|July 2018|Anticipated|2018-07-01||Interventional|||Aripiprazole IM Depot for Chinese Patients With Schizophrenia|Evaluation of Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation by Single Administration in Chinese Patients With Schizophrenia: a Single-center, Uncontrolled, Open -Label Trial|Recruiting||Phase 1|24|Anticipated|Otsuka Beijing Research Institute||2|||f|||||f|f||||||||2017-10-10 20:42:19.011398|2017-10-10 20:42:19.011398
NCT03287492|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-25|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Trial of Two Different Information Materials in Patients With Advanced Cancer|A Randomized Controlled Trial of Two Different Information Materials in Patients With Advanced Cancer|Recruiting||N/A|136|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|f|f||||||||2017-10-10 20:42:19.128106|2017-10-10 20:42:19.128106
NCT03287479|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-18|||September 6, 2018|Anticipated|2018-09-06|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|Gavi||Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)|Prospective, Multi-center, Randomized, Controlled, Open Non-inferiority Trial Comparing a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)|Not yet recruiting||N/A|180|Anticipated|University of Luebeck||2|||f||||t|f|f||||||||2017-10-10 20:42:19.242057|2017-10-10 20:42:19.242057
NCT03287466|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-18|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|TOXYC||Targeted OXYgen Therapy in Critical Illness|A Randomised Controlled Trial of Targeted Oxygen Therapy in Mechanically Ventilated Critically Ill Patients|Not yet recruiting||N/A|60|Anticipated|University College, London||2|||f||||t|f|f||||||||2017-10-10 20:42:19.514936|2017-10-10 20:42:19.514936
NCT03287453|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||April 8, 2017|Actual|2017-04-08|September 2017|2017-09-01|April 8, 2020|Anticipated|2020-04-08|April 8, 2020|Anticipated|2020-04-08||Interventional|||Educational Intervention - Improving Knowledge and Screening Rates for Colorectal Cancer|Screen to Save Initiative|Recruiting||N/A|200|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-10 20:42:19.679014|2017-10-10 20:42:19.679014
NCT03287440|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-15|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|COPD Wellness||Rehabilitation in Safety-net Settings for Patients With COPD|Pilot Study of Rehabilitation in Safety-net Settings for Patients With COPD|Recruiting||N/A|60|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||||2017-10-10 20:42:19.820188|2017-10-10 20:42:19.820188
NCT03287427|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-15|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|MYPHISMO||MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial|First-in-human Phase Ia/II Clinical Trial of a Combined Immune Modulatory Approach Using TetMYB Vaccine and Anti-PD1 Antibody in Patients With Advanced Solid Cancer Including Colorectal or Adenoid Cystic Carcinoma.|Not yet recruiting||Phase 1/Phase 2|32|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t|f|f|||f|||||2017-10-10 20:42:19.971862|2017-10-10 20:42:19.971862
NCT03287414|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||December 15, 2017|Anticipated|2017-12-15|September 2017|2017-09-01|July 29, 2022|Anticipated|2022-07-29|July 29, 2022|Anticipated|2022-07-29||Interventional|||Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis|A Subject-, Investigator-, and Sponsor-blinded, Randomized, Placebo-controlled, Multicenter Study to Investigate Efficacy, Safety, and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis|Not yet recruiting||Phase 2|84|Anticipated|Novartis||2|||f||||t|t|f||||||||2017-10-10 20:42:20.157184|2017-10-10 20:42:20.157184
NCT03287401|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-27|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|PACUD-EEG||Prediction of PACU Delirium Using EEG - German Validation Study|Prediction of Postoperative Anesthesia Care Unit Delirium Using Electroencephalography - German Validation Study|Recruiting||N/A|250|Anticipated|Technische Universität München|||1||f||||f|f|f||||||||2017-10-10 20:42:20.257037|2017-10-10 20:42:20.257037
NCT03287388|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-18|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|RELAX-2||MRI Measurement of the Effects of Deep Neuromuscular Blockade on the Abdominal Working Space During Laparoscopy|MRI Measurement of the Effects of Moderate Versus Deep Neuromuscular Blockade on the Abdominal Working Space During Laparoscopic Surgery in a Prospective Cohort Study.|Not yet recruiting||N/A|8|Anticipated|Radboud University||3|||f||||f|f|f||||||||2017-10-10 20:42:20.371213|2017-10-10 20:42:20.371213
NCT03287375|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-18|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|PIPAC-OPC2||Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -|Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol - The PIPAC-OPC2 Trial|Recruiting||Phase 2|137|Anticipated|Odense University Hospital||1|||f||||t|f|f||||||||2017-10-10 20:42:20.484417|2017-10-10 20:42:20.484417
NCT03287362|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-19|||August 7, 2017|Actual|2017-08-07|September 2017|2017-09-01|August 2025|Anticipated|2025-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Effects of Schema Therapy vs. Cognitive Behavioral Therapy in Patients With Depression|The MPI-PT-Study: Schema Therapy vs. Cognitive Behavioral Therapy for Patients With Major or Persistent Depressive Disorder in an Inpatient and Day Clinic Setting: A Randomized, Controlled Trial|Recruiting||N/A|1666|Anticipated|Max-Planck-Institute of Psychiatry||3|||f||||f|f|f||||||||2017-10-10 20:42:20.580135|2017-10-10 20:42:20.580135
NCT03287349|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||May 10, 2017|Actual|2017-05-10|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Genomic Assessment of Patients With Severe Radiation Reactions|Genomic Assessment of Patients With Severe Radiation Reactions|Recruiting||N/A|10|Anticipated|Mayo Clinic|||1||f||||f|f|f||||||||2017-10-10 20:42:20.69394|2017-10-10 20:42:20.69394
NCT03287336|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-18|||September 18, 2017|Anticipated|2017-09-18|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 30, 2018|Anticipated|2018-09-30||Interventional|||Prevention of Postpartum Hemorrhage With Tranexamic Acid|Prevention of Postpartum Hemorrhage: Pharmacokinetics and Pharmacodynamics of Tranexamic Acid|Not yet recruiting||Phase 2/Phase 3|30|Anticipated|George Washington University||3|||||||t|t|f||||||||2017-10-10 20:42:20.77121|2017-10-10 20:42:20.77121
NCT03287323|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-15|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|April 2020|Anticipated|2020-04-01||Interventional|PALL-ICU||Proactive Palliative Care Intervention in a Surgical ICU: Influence on Family Satisfaction and Patient Distress|The Influence of a Proactive Palliative Care Intervention on Family Satisfaction and Biopsychosocial Problem-related Distress of Patients in a Surgical Intensive Care Unit: A Prospective Single-center Interventional Study|Recruiting||N/A|200|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f|f|f||||||||2017-10-10 20:42:20.863382|2017-10-10 20:42:20.863382
NCT03287297|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-16|2017-09-18|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Association Between Dietary Habits and Gestational Diabetes|Association Between Dietary Habits and Gestational Diabetes|Not yet recruiting||N/A|150|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:42:21.213974|2017-10-10 20:42:21.213974
NCT03287284|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Phototherapy in Association to Resistance Training in the Elderly: the Effect on Muscle Strength, Muscle Mass and Functional Capacity|Phototherapy in Association to Resistance Training in the Elderly: the Effect on Muscle Strength, Muscle Mass and Functional Capacity|Recruiting||N/A|30|Anticipated|Federal University of Health Science of Porto Alegre||2|||f|||||f|f|||t|||||2017-10-10 20:42:21.310761|2017-10-10 20:42:21.310761
NCT03287271|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2023|Anticipated|2023-10-01|September 2022|Anticipated|2022-09-01||Interventional|||ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK|ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK|Not yet recruiting||Phase 1/Phase 2|90|Anticipated|University of California, San Diego||1|||f||||t|t|f||||||||2017-10-10 20:42:21.402355|2017-10-10 20:42:21.402355
NCT03287258|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-09-18|||April 25, 2017|Actual|2017-04-25|September 2017|2017-09-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||Perineal Preparation for Pregnant Ladies.|Digital Perineal Massage and Pelvic Floor Muscle Exercise as an Antenatal Program for Prevention of Perineal Trauma in Elderly Women, a Randomized Controlled Trial.|Completed||N/A|90|Actual|Kasr El Aini Hospital||2|||f||||f|f|f||||||||2017-10-10 20:42:21.490388|2017-10-10 20:42:21.490388
NCT03287245|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-26|||October 6, 2017|Anticipated|2017-10-06|September 2017|2017-09-01|July 2, 2020|Anticipated|2020-07-02|January 10, 2019|Anticipated|2019-01-10||Interventional|||A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera|A Phase II, Single-Arm, Open-Label Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Patients With Hydroxyurea-Resistant/Intolerant Polycythemia Vera|Recruiting||Phase 2|20|Anticipated|Hoffmann-La Roche||1|||f||||f|t|f||||||||2017-10-10 20:42:21.574423|2017-10-10 20:42:21.574423
NCT03287232|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)|Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)|Not yet recruiting||Phase 3|600|Anticipated|EndoCeutics Inc.||2|||f||||f|t|f||||||||2017-10-10 20:42:21.702689|2017-10-10 20:42:21.702689
NCT03287219|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-18|||May 2, 2011|Actual|2011-05-02|September 2017|2017-09-01|January 16, 2012|Actual|2012-01-16|January 16, 2012|Actual|2012-01-16||Interventional|CRO-11-108||Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX|Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX® Modified Release Tablets Administered to Patients Undergoing Colonoscopy|Completed||Phase 2|122|Actual|Cosmo Technologies Ltd||2|||f||||f|t|f||||||||2017-10-10 20:42:21.774838|2017-10-10 20:42:21.774838
NCT03287206|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-18|||June 28, 2017|Actual|2017-06-28|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Observational|DISSEQ||Medico-economic Evaluation of Different High-throughput Sequencing Strategies in the Diagnosis of Patients With Intellectual Deficiency|Medico-economic Evaluation of Different High-throughput Sequencing Strategies in the Diagnosis of Patients With Intellectual Deficiency|Recruiting||N/A|330|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:42:21.836444|2017-10-10 20:42:21.836444
NCT03287193|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-18|||March 13, 2017|Actual|2017-03-13|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|March 2022|Anticipated|2022-03-01||Observational|DISCOVERY||Identification of the Molecular and/or Pathophysiological Bases of Developmental Diseases|Identification of the Molecular and/or Pathophysiological Bases of Developmental Diseases|Recruiting||N/A|500|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:42:21.898181|2017-10-10 20:42:21.898181
NCT03287180|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-15|||September 7, 2018|Anticipated|2018-09-07|September 2017|2017-09-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|A-CRA/MAT||Adolescent Community Reinforcement Approach in Combination With Buprenorphine/Naloxone for Severe Opioid Use|Adolescent Community Reinforcement Approach (A-CRA) Implementation in Combination With Buprenorphine/Naloxone for Young Adults Ages 18 to 25 With Severe Opioid Use Disorder|Not yet recruiting||N/A|20|Anticipated|Emory University||2|||f||||t|f|f|||f|||||2017-10-10 20:42:21.954508|2017-10-10 20:42:21.954508
NCT03287167|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-19|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 30, 2021|Anticipated|2021-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|||Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease|A Prospective, Double -Blind ,Multi-center,Randomized Controled Trial of Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Sirolimus- Eluting Stent With Abluminal Grooves Containing A Biodegradable Polymer (FirehawkTM Stent ) in High Bleeding Risk Patients With Coronary Artery Disease|Not yet recruiting||Phase 4|1580|Anticipated|Shanghai MicroPort Medical (Group) Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:42:22.043284|2017-10-10 20:42:22.043284
NCT03287154|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-18|||February 8, 2017|Actual|2017-02-08|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|ITAMAA||Interest of tDCS in Help for Supporting Alcohol Abstinence|Interest of tDCS in Help for Supporting Alcohol Abstinence|Recruiting||N/A|90|Anticipated|Centre Hospitalier Henri Laborit||2|||f||||t|f|f||||||||2017-10-10 20:42:22.122829|2017-10-10 20:42:22.122829
NCT03287141|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-19|||October 19, 2015||2015-10-19|September 2017|2017-09-01|March 23, 2016|Actual|2016-03-23|November 23, 2015|Actual|2015-11-23||Interventional|CHF||CPAP Versus Bi-level in Chronic Heart Failure|Comparison of CPAP and Bi-level Effects on Exercise Tolerance and Cardiorespiratory Responses in Individuals With Chronic Heart Failure.|Completed||N/A|18|Actual|Universidade Federal do Rio Grande do Norte||3|||f||||f|f|f||||||||2017-10-10 20:42:22.212445|2017-10-10 20:42:22.212445
NCT03287128|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|October 1, 2018|Anticipated|2018-10-01||Observational|MYLOR||Retrospective Analysis of the Outcome of Patients With Relapsed/Refractory Acute Myeloid Leukemia Included in a Patient Named Program of Gemtuzumab Ozogamicin/Mylotarg®|A Retrospective Analysis of the Outcome of Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) Included in a Patient Named Program of Gemtuzumab Ozogamicin/Mylotarg®|Not yet recruiting||N/A|300|Anticipated|Versailles Hospital|||1||f||||f|f|f||||||||2017-10-10 20:42:22.289589|2017-10-10 20:42:22.289589
NCT03287115|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Biomarkers of Broccoli Intake: A Pilot Study|Biomarkers of Broccoli Intake: A Pilot Study to Characterize Novel Metabolites by Targeted Metabolic Profiling and Non-Targeted Metabolomics|Recruiting||N/A|6|Anticipated|USDA Beltsville Human Nutrition Research Center||1|||f||||f|f|f||||||||2017-10-10 20:42:22.38191|2017-10-10 20:42:22.38191
NCT03287102|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|MARTIAL||Macular Hole Surgery With Temporal Inverted Internal Limiting Membrane Flap (MARTIAL)|Dissociated Optic Nerve Fiber Layer Appearance and Retinal Sensitivity After Macular Hole Surgery With Temporal Inverted Internal Limiting Membrane Flap Technique|Not yet recruiting||N/A|130|Anticipated|Central Hospital, Nancy, France||2|||f||||t|f|f||||||||2017-10-10 20:42:22.484319|2017-10-10 20:42:22.484319
NCT03287089|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-10-02|||September 29, 2017|Actual|2017-09-29|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|NAUTICA||Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery|Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery (NAUTICA): A Randomized Controlled Trial|Recruiting||Phase 4|180|Anticipated|Carolinas Healthcare System||2|||f||||t|t|f||||||||2017-10-10 20:42:22.57081|2017-10-10 20:42:22.57081
NCT03287076|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-17|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|TEXAIS||A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke|A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)|Not yet recruiting||Phase 2|528|Anticipated|Neuroscience Trials Australia||2|||f||||t|t|f|||t|||||2017-10-10 20:42:22.672823|2017-10-10 20:42:22.672823
NCT03286881|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||January 15, 2017||2017-01-15|September 2017|2017-09-01|January 15, 2019|Anticipated|2019-01-15|January 15, 2018|Anticipated|2018-01-15||Interventional|PsycBrief||Brief Evidence-based Psychological Treatments for Common Mental Disorders|Brief Evidence-based Psychological Treatments for Common Mental Disorders. A Randomized Clinical Trial in Primary and Secondary Care.|Recruiting||N/A|165|Anticipated|Universidad de Córdoba||5|||f||||t||||||||||2017-10-10 20:42:25.529425|2017-10-10 20:42:25.529425
NCT03287063|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Observational|||Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma|A Prospective Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma|Not yet recruiting||N/A|20|Anticipated|University of Michigan Cancer Center|||1||f||||t|f|f||||Samples With DNA|"     Specimens will be analyzed with next generation sequencing (NGS). The primary objective is to     identify candidate genes with differential expression in therapy-resistant imaging     subvolumes.   "|||2017-10-10 20:42:22.739869|2017-10-10 20:42:22.739869
NCT03287050|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2021|Anticipated|2021-11-01|March 1, 2020|Anticipated|2020-03-01||Interventional|||Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma|FAST: Feasibility Trial of Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma|Not yet recruiting||Early Phase 1|20|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f|||t|||||2017-10-10 20:42:22.795448|2017-10-10 20:42:22.795448
NCT03287037|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-16|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar Depression|To Investigate the Effect of Transcranial Direct Current Stimulation (tDCS) on Depressive Symptoms, Neurocognitive Function and Heart Rate Variability in Unipolar Depression and Bipolar Depression|Recruiting||N/A|120|Anticipated|Tri-Service General Hospital||1|||f||||f|f|f||||||||2017-10-10 20:42:22.877395|2017-10-10 20:42:22.877395
NCT03287024|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-15|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||BeGrow Study to Treat Pulmonary Artery (PA) Stenosis in Newborns and Infants|BeGrow First-in-Man Study to Assess the Safety and Performance of the BeGrow Stent System in Newborns and Infants to Treat PA Stenosis.|Not yet recruiting||N/A|18|Anticipated|Bentley InnoMed GmbH||1|||f||||t|f|f||||||||2017-10-10 20:42:22.954923|2017-10-10 20:42:22.954923
NCT03287011|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-16|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Efficacy of a Plaque Disclosing Toothpaste on Home Oral Hygiene Procedures|Efficacy of Shoplaq® Disclosing Toothpaste in Removing Dental Plaque: A Randomized Controlled Clinical Trial.|Recruiting||N/A|50|Anticipated|Segi University||2|||f||||t|f|f||||||||2017-10-10 20:42:23.015981|2017-10-10 20:42:23.015981
NCT03286998|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Observational|||Ultrasound in Prediction of Operative Findings in Cesarean Section Among Placenta Accreta Cases|The Efficacy of Ultrasound in Predicting Operative Findings and Co-morbidities in Cesarean Section Among Cases of Placenta Accreta|Not yet recruiting||N/A|60|Anticipated|Cairo University|||1||f||||t|f|f||||||||2017-10-10 20:42:23.087101|2017-10-10 20:42:23.087101
NCT03286985|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-16|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|preTIME||The Prevalence and Incidence of DVT in General ICU|The Prevalence and Incidence of Deep Venous Thrombosis in General ICU Patients Receiving Enoxaparine Prophylaxis|Recruiting||N/A|200|Anticipated|Masaryk Hospital Krajská zdravotní a.s.|||1||f||||f||||||||||2017-10-10 20:42:23.163766|2017-10-10 20:42:23.163766
NCT03286972|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Observational|||PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning|PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning|Not yet recruiting||N/A|40|Anticipated|University of Wisconsin, Madison|||1||f||||t|f|f||||||||2017-10-10 20:42:24.876085|2017-10-10 20:42:24.876085
NCT03286959|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-15|||November 6, 2016|Actual|2016-11-06|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Effect of Liners on Pulpal Outcome and Restoration Survival After Partial Caries Excavation|Effect of Different Liners on Pulpal Outcome and Survival of Composite Restorations After Partial Caries Removal: A Randomized Controlled Study.|Active, not recruiting||N/A|198|Actual|Postgraduate Institute of Dental Sciences Rohtak||3|||f||||t|f|f||||||||2017-10-10 20:42:24.978567|2017-10-10 20:42:24.978567
NCT03286946|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||October 20, 2016|Actual|2016-10-20|September 2017|2017-09-01|July 25, 2017|Actual|2017-07-25|July 1, 2017|Actual|2017-07-01||Interventional|||Detection of Intravascular Injection Between Blunt and Sharp Needles During Cervical Transforaminal Epidural Block.|The Difference of Intravascular Injection Rate During Cervical Transforaminal Epidural Block Using Blunt-type Block Needle Compared to Sharp-type Block Needle.|Completed||N/A|108|Actual|Kyungpook National University||2|||f|||||f|f||||||||2017-10-10 20:42:25.061171|2017-10-10 20:42:25.061171
NCT03286933|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||May 6, 2017|Actual|2017-05-06|September 2017|2017-09-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||Yoga Therapy for Adolescents With Juvenile Idiopathic Arthritis|Yoga Therapy for Adolescents With Juvenile Idiopathic Arthritis|Completed||N/A|10|Actual|Children's Hospital Los Angeles||1|||f||||t|f|f||||||||2017-10-10 20:42:25.125208|2017-10-10 20:42:25.125208
NCT03286920|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer|Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer|Not yet recruiting||N/A|600|Anticipated|Beijing Cancer Hospital|||3||f||||f|f|f||||||||2017-10-10 20:42:25.200481|2017-10-10 20:42:25.200481
NCT03286907|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-14|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||An RCT Promoting HPV Vaccination Among Chinese MSM|A Randomized Controlled Trial Evaluating Efficacy of Promoting Human Papillomavirus (HPV) Vaccination Among Chinese Men Who Have Sex With Men|Recruiting||N/A|624|Anticipated|Chinese University of Hong Kong||3|||f||||t|f|f||||||||2017-10-10 20:42:25.37815|2017-10-10 20:42:25.37815
NCT03286894|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|AQUAPed||AQUAPed: Validation Study of AQUA© Questionnaire Modified for Childhood|AQUAPed: Validation Study of AQUA© Questionnaire Modified for Childhood|Recruiting||N/A|248|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||1||f||||f|f|f||||||||2017-10-10 20:42:25.460569|2017-10-10 20:42:25.460569
NCT03286868|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-14|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Balancing Kinematically Aligned Total Knee Replacements During Total Primary Knee Arthroplasty Using Verasense|Balancing Kinematically Aligned Total Knee Replacements During Total Primary Knee Arthroplasty Using Verasense|Not yet recruiting||N/A|60|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:42:25.711356|2017-10-10 20:42:25.711356
NCT03286855|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-18|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)|A Randomized Controlled Trial of Bronchodilator Delivery by Vibrating Mesh (VM) Nebuliser Versus Small Volume Nebuliser During an Acute Exacerbation of COPD|Not yet recruiting||N/A|200|Anticipated|Beaumont Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:42:25.785864|2017-10-10 20:42:25.785864
NCT03286842|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-14|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|April 29, 2020|Anticipated|2020-04-29|April 29, 2020|Anticipated|2020-04-29||Interventional|||To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.|A Phase IIIb, Single-arm, Open-label Multicentre Study of Olaparib Monotherapy in the Treatment of HER2-ve Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.|Not yet recruiting||Phase 3|250|Anticipated|AstraZeneca||1|||f||||f|t|f||||||||2017-10-10 20:42:25.87433|2017-10-10 20:42:25.87433
NCT03286829|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Study to Investigate the Pharmacokinetic Profile|A Randomized, Open-label, Single-dose, Parallel-arm, Phase 1 Study to Investigate the Pharmacokinetic Profile of a Fixed-dose Combination Tablet of Tesofensine and Metoprolol (Tesomet) and Co-administration of Tesofensine Plus Commercial Metoprolol in Adult Healthy Subjects|Not yet recruiting||Phase 1|60|Anticipated|Saniona||4|||f||||f|f|f||||||||2017-10-10 20:42:25.957475|2017-10-10 20:42:25.957475
NCT03286816|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-14|||November 2016||2016-11-01|November 2016|2016-11-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|||The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia|The Effect of Intravenous Lactate Administration on Brain Lactate Concentrations and pH During Euglycemia and Hypoglycemia in Patients With Type 1 Diabetes With and Without Impaired Awareness of Hypoglycemia|Completed||N/A|19|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 20:42:26.056078|2017-10-10 20:42:26.056078
NCT03286803|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-14|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|April 30, 2019|Anticipated|2019-04-30||Interventional|CODI||Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in Pakistan|Comparison of Immunity Following Inactivated Poliovirus Vaccine Versus Fractional Dose Inactivated Poliovirus Vaccine: a Community Based Randomized Controlled Trial in Pakistan|Recruiting||Phase 4|500|Anticipated|Aga Khan University||4|||f||||t|f|f|||f|||||2017-10-10 20:42:26.146572|2017-10-10 20:42:26.146572
NCT03286790|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||May 2012|Actual|2012-05-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|INCUR||Incidence of pNeumonia and Related ConseqUences in Nursing Home Residents|Incidence of pNeumonia and Related ConseqUences in Nursing Home|Completed||N/A|800|Actual|University Hospital, Toulouse|||1||f||||f|f|f||||||||2017-10-10 20:42:26.2412|2017-10-10 20:42:26.2412
NCT03286777|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-18|||June 22, 2017|Actual|2017-06-22|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Increasing the Oral Bioavailability of 6-prenylnaringenin by Micellar Solubilization|Increasing the Oral Bioavailability of 6-prenylnaringenin by Micellar Solubilization|Active, not recruiting||N/A|6|Actual|University of Hohenheim||3|||f|||||f|f||||||||2017-10-10 20:42:26.314046|2017-10-10 20:42:26.314046
NCT03286764|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||November 2016||2016-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Use of Peppermint Oil During Screening Colonoscopy to Improve Visibility|Use of Peppermint Oil During Screening Colonoscopy to Improve Visibility|Recruiting||Phase 3|100|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 20:42:26.426466|2017-10-10 20:42:26.426466
NCT03286751|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants|A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 and Humalog Across Different Subcutaneous Doses in Healthy Subjects|Not yet recruiting||Phase 1|50|Anticipated|Eli Lilly and Company||2|||f||||f|t|f|||t|||||2017-10-10 20:42:26.50295|2017-10-10 20:42:26.50295
NCT03286738|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|3 Years|Observational [Patient Registry]|||Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal Cancer|Pattern of Use of Bevacizumab or Cetuximab in Patients With Metastatic Colorectal Cancer When Added to FOLFIRI Regimen as First-line Treatment; Multicenter, Registry Study|Recruiting||N/A|1800|Anticipated|Yonsei University|||1||f|||||f|f||||||||2017-10-10 20:42:26.580271|2017-10-10 20:42:26.580271
NCT03286725|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-13|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FTS||Physical Exercise for Education ('Fit to Study')|Physical Exercise for Education ('Fit to Study')|Active, not recruiting||N/A|20000|Actual|Oxford Brookes University||2|||f||||f|f|f||||||||2017-10-10 20:42:26.645183|2017-10-10 20:42:26.645183
NCT03286712|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-13|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients|A Study on the Effect of Hemoglobin Level and the Vascular Reactivity Using th Generic Erythropoeitin Alpha (Renogen) on Incident Peritoneal Dialysis Patients|Completed||Phase 4|30|Anticipated|National Kidney and Transplant Institute, Philippines||1|||f||||t||||||||||2017-10-10 20:42:26.717999|2017-10-10 20:42:26.717999
NCT03286699|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-13|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|LCBH||Lifestyle Change for Better Health|Leukocyte Telomere Length in Bladder Cancer Survivors: Diet and Exercise Trial|Recruiting||N/A|140|Anticipated|University of Pittsburgh||2|||f|||||f|f||||||||2017-10-10 20:42:26.805554|2017-10-10 20:42:26.805554
NCT03286686|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 1, 2023|Anticipated|2023-12-01|December 1, 2023|Anticipated|2023-12-01||Interventional|PPCfonctions||Sensori-motor and Perceptual Functions of the PPC.|Sensori-motor and Perceptual Functions of the Posterior Parietal Cortex (PPC) in Patients With Optic Ataxia (AO) and Healthy Subjects.|Not yet recruiting||N/A|155|Anticipated|Hospices Civils de Lyon||6|||f||||f|f|f||||||||2017-10-10 20:42:26.91321|2017-10-10 20:42:26.91321
NCT03286673|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||October 2006|Actual|2006-10-01|September 2017|2017-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Comparison of Three Calcium Supplements|Comparison of Three Calcium Supplements With Regard to Their Metabolic Effects in Healthy Adults|Completed||N/A|31|Actual|University of Jena||4|||f||||f||||||||||2017-10-10 20:42:27.000833|2017-10-10 20:42:27.000833
NCT03286660|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-13|||December 8, 2014|Actual|2014-12-08|September 2017|2017-09-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|3CRT||3 Minutes Chair Rise Test (3CRT) in Patients With COPD|Chair Rise Tests for a Simplified Evaluation of Functional Response After a Rehabilitation Program in Patients COPD.|Completed||N/A|127|Actual|University Hospital, Lille||1|||f||||f|f|f||||||||2017-10-10 20:42:27.074021|2017-10-10 20:42:27.074021
NCT03286647|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-14|||October 5, 2017|Anticipated|2017-10-05|September 2017|2017-09-01|October 5, 2018|Anticipated|2018-10-05|October 5, 2017|Anticipated|2017-10-05||Interventional|OHGRIEF||Oral Hygiene Self-efficacy in Patients With Grief|Evaluation of Oral Hygiene Self-efficacy in Patients With Grief: a Short-term Randomized Controlled Clinical Trial|Not yet recruiting||N/A|90|Anticipated|University of Sao Paulo General Hospital||3|||f||||f|f|f||||||||2017-10-10 20:42:27.191925|2017-10-10 20:42:27.191925
NCT03286634|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2027|Anticipated|2027-09-01|September 2027|Anticipated|2027-09-01||Interventional|||ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016|Asia-wide, Multicenter Open-label, Phase II Non-randomised Study Involving Children With Down Syndrome Under 21 Year-old With Newly Diagnosed, Treatment naïve Acute Lymphoblastic Leukemia|Not yet recruiting||Phase 2|60|Anticipated|National Hospital Organization Nagoya Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:42:27.37018|2017-10-10 20:42:27.37018
NCT03286621|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-20|||September 9, 2017|Actual|2017-09-09|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||Development of Eye-tracking Based Markers for Autism in Young Children|Evaluation of Five Different Eye-tracking Paradigms to Determine Autism in Young Children|Recruiting||N/A|35|Anticipated|University of Electronic Science and Technology of China|||3||f||||f|f|f||||||||2017-10-10 20:42:27.546021|2017-10-10 20:42:27.546021
NCT03286608|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||January 1, 1999|Actual|1999-01-01|September 2017|2017-09-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Polyphenols and Risk of Dementia|Pattern of Polyphenol Intake and the Long-term Risk of Dementia in Older Persons|Completed||N/A|1329|Actual|University of Bordeaux|||1||f||||f|f|f||||||||2017-10-10 20:42:27.631216|2017-10-10 20:42:27.631216
NCT03286595|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-13|||August 19, 2015|Actual|2015-08-19|September 2017|2017-09-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|BHCOEMobi||Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings|Smartphone Applications For Use in Youth With Early Psychosis in Community Outpatient Settings|Completed||N/A|60|Actual|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 20:42:27.692992|2017-10-10 20:42:27.692992
NCT03286582|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-18|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|May 15, 2018|Anticipated|2018-05-15||Interventional|||A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid|A Randomized, Open-Label, Controlled Trial of Topical AC-203 in Subjects With Bullous Pemphigoid|Recruiting||Phase 2|40|Anticipated|TWi Biotechnology, Inc.||2|||f|||||f|f||||||||2017-10-10 20:42:27.777139|2017-10-10 20:42:27.777139
NCT03286569|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2017-09-13|||April 1, 2018|Anticipated|2018-04-01|September 2017|2017-09-01|February 1, 2021|Anticipated|2021-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||Study the Effect of Upper Expansion Appliances on Lower Jaw Forward Projection/Growth|Study the Effect of Upper Expansion Appliances on Lower Jaw Forward Projection/Growth|Not yet recruiting||N/A|60|Anticipated|University of Alberta, Graduate Orthodontic Program||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:42:27.87085|2017-10-10 20:42:27.87085
NCT03286556|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2022|Anticipated|2022-09-30|August 1, 2021|Anticipated|2021-08-01||Interventional|STRIVE-IPF||Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis|Study of Therapeutic Plasma Exchange, Rituximab and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE-IPF)|Not yet recruiting||Phase 2|51|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||f|||||2017-10-10 20:42:27.955277|2017-10-10 20:42:27.955277
NCT03286543|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-13|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|October 2018|Anticipated|2018-10-01||Interventional|||Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System|A Prospective, Comparative Effectiveness Randomized Controlled Trial of SPR Peripheral Nerve Stimulation (PNS) Therapy for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Utilizing Preoperative Lead Placement|Recruiting||N/A|100|Anticipated|SPR Therapeutics, LLC||2|||f||||f|f|t|t|f||||||2017-10-10 20:42:28.099333|2017-10-10 20:42:28.099333
NCT03286530|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-15|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 1, 2024|Anticipated|2024-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Ruxolitinib + Allogeneic Stem Cell Transplantation in AML|Phase II Study of Maintenance Ruxolitinib After Allogeneic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)|Not yet recruiting||Phase 2|64|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 20:42:28.225607|2017-10-10 20:42:28.225607
NCT03286517|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||June 26, 2014|Actual|2014-06-26|September 2017|2017-09-01|March 5, 2015|Actual|2015-03-05|August 8, 2014|Actual|2014-08-08||Interventional|||Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.|Changes in the Responsiveness of the Hypothalamic-pituitary-gonadal (HPG) Axis to Kisspeptin-10 Administration During Pubertal Transition in Boys|Completed||Phase 3|30|Actual|Quaid-e-Azam University||6|||f||||t|f|f||||||||2017-10-10 20:42:28.334909|2017-10-10 20:42:28.334909
NCT03285061|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery|Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery|Not yet recruiting||N/A|100|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:42:41.562413|2017-10-10 20:42:41.562413
NCT03286504|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 1, 2022|Anticipated|2022-02-01|February 1, 2021|Anticipated|2021-02-01||Interventional|||FANMI: Community Cohort Care for HIV-Infected Adolescent Girls in Haiti|FANMI: Community Cohort Care for HIV-Infected Adolescent Girls in Haiti|Not yet recruiting||N/A|160|Anticipated|Weill Medical College of Cornell University||2|||f||||t|f|f||||||||2017-10-10 20:42:28.442651|2017-10-10 20:42:28.442651
NCT03286491|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||August 12, 2017|Actual|2017-08-12|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|December 12, 2017|Anticipated|2017-12-12||Observational|||Clinical Decision Support System to Define 30 Day Adverse Clinical Events for Emergency Department Acute Coronary Syndromes|Development of Clinical Decision Support System to Define 30 Day Adverse Clinical Events (Non Fatal Myocardial Infarction, Cardiac Related Death or Coronary Intervention) for Patients Presenting to Emergency Department With Acute Coronary Syndrome|Recruiting||N/A|400|Anticipated|Turkish Ministry of Health Izmir Teaching Hospital|||1||f||||f|f|f||||||||2017-10-10 20:42:29.104845|2017-10-10 20:42:29.104845
NCT03286478|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-19|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||A Trial of Three School-based Body Image Interventions Delivered by Teachers|A Cluster Randomised Controlled Trial of Three School-based Body Image Interventions Delivered by Teachers|Enrolling by invitation||N/A|2400|Anticipated|University of the West of England||4|||f||||f|f|f||||||||2017-10-10 20:42:29.20614|2017-10-10 20:42:29.20614
NCT03286465|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Use of Pediatric Size Phlebotomy Tubes in Adult Critically Ill Patients to Reduce Red Blood Cell Transfusions|Pilot, Randomized Trial of the Use of Pediatric Size Phlebotomy Tubes in Adult Critically Ill Patients to Reduce Red Blood Cell Transfusions|Not yet recruiting||N/A|200|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:42:29.327068|2017-10-10 20:42:29.327068
NCT03286452|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-09-15|||February 21, 2017|Actual|2017-02-21|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|July 1, 2018|Anticipated|2018-07-01|24 Weeks|Observational [Patient Registry]|RESPOND||The RESPOND Registry|Real-World Effectiveness Study of PuraPly™ AM on Wounds|Recruiting||N/A|300|Anticipated|Organogenesis|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:42:29.423219|2017-10-10 20:42:29.423219
NCT03286439|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-18|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Recovery After Medical or Surgical Treatment|Recovery After Medical or Surgical Treatment - A Prospective Cohort Study|Not yet recruiting||N/A|100|Anticipated|Zealand University Hospital|||1||f||||t|f|f||||||||2017-10-10 20:42:29.571536|2017-10-10 20:42:29.571536
NCT03286426|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|ICP||Ocular Screening in Children and Young Adults at Risk for Increased Intracranial Pressure|Ocular Screening in Children and Young Adults at Risk for Increased Intracranial Pressure|Not yet recruiting||N/A|200|Anticipated|Duke University||1|||f|||||f|t|f|f|f|||||2017-10-10 20:42:29.666129|2017-10-10 20:42:29.666129
NCT03286413|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-15|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Comparison of Microwave Ablation With Cryoablation for Breast Tumor|Comparison of Ultrasound Guided Percutaneous Microwave Ablation With Cryoablation for Breast Tumor|Recruiting||N/A|250|Anticipated|Chinese PLA General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:42:29.750748|2017-10-10 20:42:29.750748
NCT03286400|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01|12 Months|Observational [Patient Registry]|SURPASS||Observational Registry Characterizing the CTAG Device With ACTIVE CONTROL|Observational Registry Characterizing the Performance and Feature Use of the GORE® TAG® Conformable Thoracic Stent Graft Featuring ACTIVE CONTROL System|Not yet recruiting||N/A|125|Anticipated|W.L.Gore & Associates|||1||f||||t|f|f||||||||2017-10-10 20:42:29.825535|2017-10-10 20:42:29.825535
NCT03286387|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 22, 2021|Anticipated|2021-01-22|January 22, 2021|Anticipated|2021-01-22||Interventional|BREAL||Contextual Associations During Episodic Recall of Everyday or Virtual Reality|Contextual Associations During Episodic Recall of Everyday or Virtual Reality|Not yet recruiting||N/A|450|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 20:42:29.900497|2017-10-10 20:42:29.900497
NCT03286374|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Do Change in Life Style Improve Work Ability?|Do Change in Life Style Improve Work Ability? A Controlled Study of the Effect of Changes in Lifestyle on Work Participation.|Recruiting||N/A|60|Anticipated|Molde University College||1|||f||||f|f|f||||||||2017-10-10 20:42:29.982157|2017-10-10 20:42:29.982157
NCT03286361|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|November 2018|Anticipated|2018-11-01||Interventional|BeGraft+PMCF||Clinical Trial Investigating the BeGraft Peripheral Plus Stent Graft System for Iliac Lesion Treatment|Belgo-France Physician-initiated Trial Investigating the BeGraft Peripheral Plus Stent Graft System for the Treatment of Iliac Lesions (TASC A, B, C and D)|Not yet recruiting||N/A|70|Anticipated|ID3 Medical||1|||f|||||f|f||||||||2017-10-10 20:42:30.09452|2017-10-10 20:42:30.09452
NCT03286348|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|October 1, 2021|Anticipated|2021-10-01|September 1, 2018|Anticipated|2018-09-01|3 Years|Observational [Patient Registry]|||Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer|Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer|Recruiting||N/A|500|Anticipated|Fudan University|||1||f||||t|f|f||||||||2017-10-10 20:42:30.187239|2017-10-10 20:42:30.187239
NCT03286335|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy|Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy|Not yet recruiting||N/A|100|Anticipated|Massachusetts General Hospital||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:42:30.385325|2017-10-10 20:42:30.385325
NCT03286322|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||December 16, 2016|Actual|2016-12-16|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 15, 2018|Anticipated|2018-10-15||Interventional|SATRACE||Comparison of a Classical Rehabilitation Method and a Specific Rehabilitation Method of the Cervical Spine|Comparison of a Classical Rehabilitation Method and a Specific Rehabilitation Method of the Cervical Spine to Improve Balance in Elderly Patients|Recruiting||N/A|86|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||||2017-10-10 20:42:30.486762|2017-10-10 20:42:30.486762
NCT03286309|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||An Assistive Soft Robotic Hand for Stroke Rehabilitation|Soft Robotic Hand System for Stroke Rehabilitation|Recruiting||N/A|20|Anticipated|Chinese University of Hong Kong||2|||f|||||f|f||||||||2017-10-10 20:42:30.571194|2017-10-10 20:42:30.571194
NCT03286296|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-13|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|January 21, 2019|Anticipated|2019-01-21|December 19, 2018|Anticipated|2018-12-19||Interventional|||LZM009 to Treat Patients With Advanced Solid Tumors|A First-in-Human, Multicenter, Open-label, Phase 1 Dose-Escalation Study of LZM009 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|25|Anticipated|Livzon Pharmaceutical Group Inc.||1|||f||||f|t|f||||||||2017-10-10 20:42:30.655693|2017-10-10 20:42:30.655693
NCT03286283|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||The Use of J-Plasma® for Dermal Resurfacing|A Prospective, Multicenter, Single Arm Clinical Study Evaluating the Use of J-Plasma® for Dermal Resurfacing|Not yet recruiting||N/A|55|Anticipated|Bovie Medical Corporation||1|||f||||f|f|t|f|f||||||2017-10-10 20:42:30.746926|2017-10-10 20:42:30.746926
NCT03286270|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-18|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|mRUSTUS||A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones|A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones|Recruiting||N/A|450|Anticipated|Bone Therapeutics S.A|||1||f|||||f|f||||||||2017-10-10 20:42:30.853433|2017-10-10 20:42:30.853433
NCT03286257|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-13|||April 1, 2016|Actual|2016-04-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Can Exercise Training Reduce the Frequency and Severity of Hot Flushes Associated With Breast Cancer Treatment?|Can Exercise Training Reduce the Frequency and Severity of Hot Flushes Associated With Breast Cancer Treatment?|Recruiting||N/A|20|Anticipated|Liverpool John Moores University||1|||f||||f|f|f||||||||2017-10-10 20:42:30.940997|2017-10-10 20:42:30.940997
NCT03286244|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-09-15|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer|Safety and Preliminary Efficacy of CM082 in Combination With Paclitaxel for Treating Advanced Gastric Cancer Who Progressed on Standard First-line Treatment: a Phase 1, Dose-escalation Study|Not yet recruiting||Phase 1|21|Anticipated|AnewPharma||1|||f||||f|f|f||||||||2017-10-10 20:42:31.034961|2017-10-10 20:42:31.034961
NCT03286231|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Observational|||Anti-FLEX: Flexed Levering of Gluteal Vessels|"Anti-FLEX: Flexed Levering of Gluteal Vessels on OR Table May Lead to Extreme Danger During Gluteal Augmentation With Lipoaspirate, a Radio-graphically Studied Position of Superior and Inferior Gluteal Vessels During Flexion of OR Table or Jack-knife Position, Danger Zone."|Not yet recruiting||N/A|50|Anticipated|University of South Florida|||1||f||||f|f|f||||||||2017-10-10 20:42:31.117187|2017-10-10 20:42:31.117187
NCT03286218|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-15|2017-10-02|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users|A Randomized, Subject- and Investigator-Blind, Placebo and Active-Controlled Study to Assess the Abuse Potential of Lasmiditan|Recruiting||Phase 1|130|Anticipated|Eli Lilly and Company||5|||f||||f|t|f||||||||2017-10-10 20:42:31.214333|2017-10-10 20:42:31.214333
NCT03286205|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||April 14, 2015|Actual|2015-04-14|September 2017|2017-09-01|April 14, 2019|Anticipated|2019-04-14|April 14, 2018|Anticipated|2018-04-14||Interventional|||A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.|A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.|Recruiting||Phase 4|70|Anticipated|Sutter Gould Medical Foundation||2|||f||||f|t|f|||f|||||2017-10-10 20:42:31.310803|2017-10-10 20:42:31.310803
NCT03286192|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-13|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|August 5, 2018|Anticipated|2018-08-05|August 5, 2018|Anticipated|2018-08-05||Interventional|||Compassion Cultivation Training for Nurses|Compassion Cultivation Training for Nurses|Not yet recruiting||N/A|25|Anticipated|University of Miami||1|||f||||f|f|f||||||||2017-10-10 20:42:31.392299|2017-10-10 20:42:31.392299
NCT03286179|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-25|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Observational|STEWARD||Standardizing Emergency Work-ups Around Risk Data|Standardizing Emergency Work-ups Around Risk Data (STEWARD): The CREST Network Chest Pain Project|Not yet recruiting||N/A|15000|Anticipated|Kaiser Permanente|||1||f||||f|f|f||||||||2017-10-10 20:42:31.467726|2017-10-10 20:42:31.467726
NCT03286153|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-13|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Ideal vs. Actual Weight Base Factor Dosing|Comparison of Ideal vs. Actual Weight Base Factor Dosing|Recruiting||N/A|20|Anticipated|Bloodworks (Puget Sound Blood Center)||2|||f||||f|f|f||||||||2017-10-10 20:42:31.608818|2017-10-10 20:42:31.608818
NCT03286140|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-13|||September 1, 2013|Actual|2013-09-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|September 30, 2017|Anticipated|2017-09-30||Interventional|EVRA||Early Venous Reflux Ablation Ulcer Trial|A Randomised Clinical Trial to Compare Early Versus Delayed Endovenous Treatment of Superficial Venous Reflux in Patients With Chronic Venous Ulceration|Active, not recruiting||N/A|450|Actual|Imperial College London||2|||f||||t|f|f||||||||2017-10-10 20:42:31.733679|2017-10-10 20:42:31.733679
NCT03286127|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Observational|POEM I||Palliative Outcome Evaluation Muenster I|Assessment of Palliative Care in Inpatient and Outpatient Settings Using the Integrated Palliative Care Outcome Scale: a Multi-centric Observational Study|Recruiting||N/A|347|Anticipated|University Hospital Muenster|||3||f||||f|f|f||||||||2017-10-10 20:42:31.858426|2017-10-10 20:42:31.858426
NCT03286114|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab|Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab for Relapse of Primary Malignancy After Allogeneic Hematopoietic Stem Cell Transplant: A Feasibility Study|Not yet recruiting||Phase 1|20|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f|||t|||||2017-10-10 20:42:31.979657|2017-10-10 20:42:31.979657
NCT03286101|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos|A Randomized, Double-Blind, Placebo-Controlled Clinical Trial On The Efficacy And Safety Of Topical 0.5% Ivermectin Lotion For The Treatment Of Head Lice Infestation Among Filipino Children Age 3 Years Or Older|Recruiting||Phase 2|120|Anticipated|United Laboratories||2|||f|||||f|f|||f|||||2017-10-10 20:42:32.08199|2017-10-10 20:42:32.08199
NCT03286088|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-09-15|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection|Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection|Not yet recruiting||N/A|120|Anticipated|Philips Research||3|||f||||f|f|f||||||||2017-10-10 20:42:32.191447|2017-10-10 20:42:32.191447
NCT03286075|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-25|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|EmoStimH||Impact of tDCS on Emotional Processing in Healthy Subjects.|Impact of Transcranial Direct Current Stimulation of the Dorsolateral Prefrontal Cortex on Emotional Processing in Healthy Subjects.|Not yet recruiting||N/A|80|Anticipated|Hôpital le Vinatier||3|||f||||t|f|f||||||||2017-10-10 20:42:32.300913|2017-10-10 20:42:32.300913
NCT03286062|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 31, 2019|Anticipated|2019-01-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||VM110 in Detection of Microscopic Tumors: A Phase I Study|VM110 in Detection of Microscopic Tumors: A Phase I Study|Not yet recruiting||Phase 1|53|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|t|t|f||||||2017-10-10 20:42:32.40859|2017-10-10 20:42:32.40859
NCT03286049|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|Rhino-Rep||Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age|Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age - Rhino-Rep|Not yet recruiting||N/A|50|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||5||f||||f|f|f||||||||2017-10-10 20:42:32.485556|2017-10-10 20:42:32.485556
NCT03286036|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||January 1, 2013|Actual|2013-01-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31|3 Years|Observational [Patient Registry]|||Clinical and Molecular Staging of Lung Cancer Stages I and IIp|Clinical and Molecular Staging of Lung Cancer Stages I and IIp: Generation and Initial Analysis of a Clinical and Molecular Knowledge Database|Recruiting||N/A|300|Anticipated|Corporacion Parc Tauli|||1||f||||f|f|f||||Samples With DNA|"     tumoral tissue, non-tumoral tissue and blood samples   "|||2017-10-10 20:42:32.584685|2017-10-10 20:42:32.584685
NCT03286023|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-15|||October 2014||2014-10-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|October 2018|Anticipated|2018-10-01||Observational|CKBrainMeta||Stereotactic Radiotherapy for Brain Metastases|Stereotactic Radiotherapy for Patients With Brain Metastases|Recruiting||N/A|60|Anticipated|Centre Francois Baclesse, Luxembourg|||1||f||||t|f|f||||||||2017-10-10 20:42:32.683188|2017-10-10 20:42:32.683188
NCT03286010|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|October 2019|Anticipated|2019-10-01||Interventional|||Peer Support for Women With Heart Disease: Women@Heart|Cluster Randomization Trial of Peer Support for Women With Heart Disease: Women@ Heart|Not yet recruiting||N/A|240|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f|f|f||||||||2017-10-10 20:42:32.770149|2017-10-10 20:42:32.770149
NCT03285997|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age|A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age|Not yet recruiting||Phase 3|260|Anticipated|Green Cross Corporation||2|||f||||t|f|f||||||||2017-10-10 20:42:32.854848|2017-10-10 20:42:32.854848
NCT03285971|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-28|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Real-Time Decision Support for Improving Intraoperative Cerebral Perfusion Pressure|Real-Time Decision Support for Improving Intraoperative Cerebral Perfusion Pressure|Recruiting||Early Phase 1|50|Anticipated|University of Michigan||2|||f||||f|t|f||||||||2017-10-10 20:42:33.04855|2017-10-10 20:42:33.04855
NCT03285958|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Tracking Physical Activity for Chronic Pain Management Among Older Adults in Detroit|Promoting Physical Activity for Chronic Pain Management Among Older Adults in Detroit: Comparing Technology-Based Strategies|Not yet recruiting||N/A|80|Anticipated|University of Michigan||4|||f||||f|f|f||||||||2017-10-10 20:42:33.182942|2017-10-10 20:42:33.182942
NCT02836223|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-10-31|||July 2016||2016-07-01|July 2016|2016-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of the Addition of an Interdental Cleaning Device to Manual Brushing on Gingival Health||Completed||N/A|72|Actual|Water Pik, Inc.||2|||f||||f||||||||No||2017-10-10 21:59:18.825443|2017-10-10 21:59:18.825443
NCT03285945|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-09-15|||October 2014||2014-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||FDG Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid Treatment|Fluorine-18-fluorodeoxyglucose Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid Treatment - A Diagnostic Window of Opportunity?|Completed||N/A|24|Actual|University of Aarhus|||2||f||||f||||||Samples With DNA|"     Temporal artery biopsies, whole blood, serum, plasma   "|||2017-10-10 20:42:33.27816|2017-10-10 20:42:33.27816
NCT03285932|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|ESTRON||Stereotactic Radiotherapy of the Resection Cavity of Brain Metastases vs. Post-operative Whole-brain Radiotherapy|Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Post-operative Whole-brain Radiotherapy|Not yet recruiting||Phase 2|50|Anticipated|University Hospital Heidelberg||2|||f||||t|f|f||||||||2017-10-10 20:42:33.387493|2017-10-10 20:42:33.387493
NCT03285919|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-15|||December 5, 2016|Actual|2016-12-05|September 2017|2017-09-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|BALANCESI||Perturbed-balance Training During Treadmill Walking for Stroke Subjects|Feasibility of Perturbed-balance Training During Treadmill Walking in a High-functioning Chronic Stroke Subject: a Case-control Study|Completed||N/A|2|Actual|University Rehabilitation Institute, Republic of Slovenia||2|||f||||f|f|f||||||||2017-10-10 20:42:33.537206|2017-10-10 20:42:33.537206
NCT03285906|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-14|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric|An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric|Recruiting||Phase 2/Phase 3|30|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t|f|f||||||||2017-10-10 20:42:33.634431|2017-10-10 20:42:33.634431
NCT03285893|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|Oral Cell DNA||Oral Cell DNA Adducts in Smokers|Quantitation of Oral Cell DNA Adducts in Smokers|Not yet recruiting||N/A|300|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||3||f|||||f|f||||Samples With DNA|"     oral cell DNA and urine   "|||2017-10-10 20:42:33.715548|2017-10-10 20:42:33.715548
NCT03285880|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|June 30, 2023|Anticipated|2023-06-30|June 30, 2022|Anticipated|2022-06-30||Interventional|||Preschool Nap Study|The Benefits of Naps on Cognitive, Emotional, and Motor Learning in Preschoolers|Enrolling by invitation||N/A|382|Anticipated|University of Massachusetts, Amherst||3|||f||||f|f|f||||||||2017-10-10 20:42:33.792406|2017-10-10 20:42:33.792406
NCT03285854|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-18|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|January 31, 2022|Anticipated|2022-01-31|September 30, 2021|Anticipated|2021-09-30||Observational|Cal-Bal||Calcium Balance Studies in Children With CKD and on Dialysis|Assessing Calcium Balance in Children With Chronic Kidney Disease to Optimise Treatment Strategies|Recruiting||N/A|120|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust|||2||f||||t|f|f||||Samples Without DNA|"     blood, urine, stool and dialysis fluid samples will be collected   "|||2017-10-10 20:42:34.103858|2017-10-10 20:42:34.103858
NCT03285841|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|November 1, 2017|Anticipated|2017-11-01||Observational|||OCT-AF Imaging of Pre-cancers of Vulva and Cervix|Co-registered Multimodal Optical Imaging for the Early Detection and Management of Cancers of the Vulva and Cervix|Not yet recruiting||N/A|20|Anticipated|British Columbia Cancer Agency|||2||f||||f|f|f||||||||2017-10-10 20:42:34.236165|2017-10-10 20:42:34.236165
NCT03285828|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-15|||April 4, 2016|Actual|2016-04-04|September 2017|2017-09-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|FEMEM||Motivational Interviewing Training for Medical Students: a Pilot Pre-post Study|Optimising the Relationship Between Medical Students and Patients Through a Motivational Interviewing Training Programme: a Pilot Pre-post Study|Completed||N/A|20|Actual|Bicetre Hospital||2|||f||||f|f|f||||||||2017-10-10 20:42:34.836854|2017-10-10 20:42:34.836854
NCT03285815|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-15|||May 2016||2016-05-01|September 2017|2017-09-01|December 2025|Anticipated|2025-12-01|May 2024|Anticipated|2024-05-01||Interventional|||Prostate Cancer - Localized Adenocarcinoma Proton Therapy|A Phase II Randomized Trial of Hypofractionated Proton Therapy in Patients With a Localized Prostate Adenocarcinoma|Recruiting||N/A|156|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-10 20:42:34.934313|2017-10-10 20:42:34.934313
NCT03285802|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-19|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|September 19, 2019|Anticipated|2019-09-19||Interventional|||Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation|CRAD001X2401: Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation|Active, not recruiting||Phase 2/Phase 3|1|Actual|Greater Baltimore Medical Center||1|||||||f|t|f||||||||2017-10-10 20:42:35.051979|2017-10-10 20:42:35.051979
NCT03285789|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2, 2019|Anticipated|2019-12-02|December 2, 2019|Anticipated|2019-12-02||Interventional|||Dyslexics' Visual Attention Field|Evaluation of the Visuo-attention Field of Symbols Versus Objects Visual Search in Dyslexic Subjects. DyslexiaSPOTLIGHT|Not yet recruiting||N/A|63|Anticipated|Hospices Civils de Lyon||3|||f||||f|f|f||||||||2017-10-10 20:42:35.131676|2017-10-10 20:42:35.131676
NCT03285776|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-15|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Reliability and Validity of a Computerized Tool to Assess Proprioception and Motor Planning Among Children With Coordination Disorders|Reliability and Validity of a Computerized Tool to Assess Proprioception and Motor Planning Among Children With Coordination Disorders|Not yet recruiting||N/A|50|Anticipated|Meir Medical Center|||2||f|||||f|f||||||||2017-10-10 20:42:35.22342|2017-10-10 20:42:35.22342
NCT03285750|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-09-13|||August 2013||2013-08-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|GPR120||Expression of G-protein Coupled Receptor 120 (GPR120) Receptor in Adipose Tissue of German Diabetes Center (GDC) Cohort Subjects|Expression of GPR120 Receptor in Adipose Tissue of Type 2 Diabetic Subjects|Completed||N/A|50|Actual|German Diabetes Center|||2||f||||f||||||Samples With DNA|"     SNP Genotyping of GPR120   "|||2017-10-10 20:42:35.4416|2017-10-10 20:42:35.4416
NCT03285737|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||March 23, 2016|Actual|2016-03-23|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|December 15, 2016|Actual|2016-12-15||Interventional|DRI||Protein Intake and Step Reduction in Older Adults|Whey Protein Intake in the Amelioration of Skeletal Muscle Quantity and Function During Inactivity in Older Adults|Active, not recruiting||N/A|32|Actual|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:42:35.503985|2017-10-10 20:42:35.503985
NCT03285724|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||May 16, 2017||2017-05-16||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:42:35.585401|2017-10-10 20:42:35.585401
NCT03285698|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-25|||April 18, 2014|Actual|2014-04-18|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|August 31, 2019|Anticipated|2019-08-31||Interventional|||Comparing the Clinical Outcomes of DermACELL® With Integra® Bilayer Wound Matrix|A Randomized, Prospective Trial Comparing the Clinical Outcomes for DermACELL® Compared With Integra® Bilayer Wound Matrix|Recruiting||N/A|100|Anticipated|Georgetown University||2|||f||||t|f|t|f||f|||||2017-10-10 20:42:35.722387|2017-10-10 20:42:35.722387
NCT03285685|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|February 16, 2018|Anticipated|2018-02-16|January 26, 2018|Anticipated|2018-01-26||Interventional|||Effect of Noninvasive Neuromodulation on Chronic Pain|Effect of Noninvasive Neuromodulation on Chronic Pain and Anxiety Levels in Individuals With Temporomandibular Disorders|Recruiting||Phase 2|10|Anticipated|Federal University of Paraíba||3|||f|||||f|f||||||||2017-10-10 20:42:35.822238|2017-10-10 20:42:35.822238
NCT03285672|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-26|||December 4, 2017|Anticipated|2017-12-04|September 2017|2017-09-01|August 14, 2018|Anticipated|2018-08-14|May 20, 2018|Anticipated|2018-05-20||Interventional|||FP-101 for the Treatment of Hot Flashes in Postmenopausal Women|A Phase 2, Randomized, Double-blind, Placebo Controlled, Single Dose-level, Proof-of-concept Study Evaluating FP-101 for the Treatment of Vasomotor Symptoms in Postmenopausal Women|Not yet recruiting||Phase 2|112|Anticipated|Fervent Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 20:42:35.903152|2017-10-10 20:42:35.903152
NCT03285659|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|July 1, 2019|Anticipated|2019-07-01||Interventional|||Development and Assessment of the Implementation of a Collaborative Care Approach for Depression in Primary Care|Study Protocol: Development and Assessment of an Active Strategy for the Implementation of a Collaborative Care Approach for Depression in Primary Care. The INDI·i Project|Not yet recruiting||N/A|44|Anticipated|Jordi Gol i Gurina Foundation||2|||f|||||f|f||||||||2017-10-10 20:42:36.057916|2017-10-10 20:42:36.057916
NCT03285646|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|August 31, 2020|Anticipated|2020-08-31||Interventional|||Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee|Not yet recruiting||Phase 3|1020|Anticipated|Regeneron Pharmaceuticals||2|||f||||t|t|f||||||||2017-10-10 20:42:36.178485|2017-10-10 20:42:36.178485
NCT03285633|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Telephone-Based Mindfulness CBT for Patients in Community Settings With Advanced Cancer|Telephone-Based Mindfulness CBT for Patients in Community Settings With Advanced Cancer|Not yet recruiting||N/A|35|Anticipated|Duke University||1|||f||||f|f|f||||||||2017-10-10 20:42:36.271396|2017-10-10 20:42:36.271396
NCT03285620|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-21|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Subjects|A Phase 1, Double-blind, Randomized, Placebo-controlled, First-in-human Study of Orally Administered AL 034 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation (Part 1) and After Multiple Ascending Doses (Part 2) in Healthy Adult Subjects|Recruiting||Phase 1|81|Anticipated|Alios Biopharma Inc.||2|||f||||f|f|f||||||||2017-10-10 20:42:37.043189|2017-10-10 20:42:37.043189
NCT03285607|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|May 31, 2020|Anticipated|2020-05-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer|Phase I Study of MCS110 Combined With Neoadjuvant Dose-Dense Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer|Not yet recruiting||Phase 1|27|Anticipated|Washington University School of Medicine||3|||f||||t|t|f|||f|||||2017-10-10 20:42:37.15682|2017-10-10 20:42:37.15682
NCT03285581|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Pivotal Study of the Cutera truSculpt Radiofrequency Device for Wrinkle Reduction|Open-label, Prospective, Multicenter Pivotal Study of the Cutera truSculpt™ Radiofrequency Device for Wrinkle Reduction|Recruiting||N/A|40|Anticipated|Cutera Inc.||1|||f||||f|f|t|f||f|||||2017-10-10 20:42:37.409547|2017-10-10 20:42:37.409547
NCT03285568|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||February 3, 2015|Actual|2015-02-03|September 2017|2017-09-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Observational|||Patterns of Prescribing and Monitoring of Palbociclib|Patterns of Prescribing and Monitoring of Palbociclib|Completed||N/A|67|Actual|Rush University Medical Center|||1||f||||f|t|f||||||||2017-10-10 20:42:37.523006|2017-10-10 20:42:37.523006
NCT03285555|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|September 25, 2018|Anticipated|2018-09-25|September 25, 2018|Anticipated|2018-09-25||Interventional|||Prospective Randomized Trial of Stratafix vs. Vicryl in Total Hip Arthroplasty.|Prospective Randomized Trial of Stratafix vs. Vicryl on Operating Room Time and Wound Closure Time in Total Hip Arthroplasty.|Recruiting||N/A|60|Anticipated|The Cleveland Clinic||2|||f||||f|f|t|f||t|||||2017-10-10 20:42:37.614464|2017-10-10 20:42:37.614464
NCT03285542|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|September 15, 2018|Anticipated|2018-09-15|September 15, 2018|Anticipated|2018-09-15||Interventional|||Prospective Randomized Trial of Dermabond Prineo in Total Knee Arthroplasty|Prospective Randomized Trial of Dermabond Prineo Wound Closure System on Operating Room Time and Wound Closure Time in Total Knee Arthroplasty|Recruiting||N/A|60|Anticipated|The Cleveland Clinic||2|||f||||f|f|t|f||t|||||2017-10-10 20:42:37.720211|2017-10-10 20:42:37.720211
NCT03285529|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|September 25, 2018|Anticipated|2018-09-25|September 25, 2018|Anticipated|2018-09-25||Interventional|||The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty|The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty|Recruiting||N/A|60|Anticipated|The Cleveland Clinic||2|||f||||f|f|t|f||t|||||2017-10-10 20:42:37.831634|2017-10-10 20:42:37.831634
NCT03285516|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-14|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|START||Safety Aid Reduction Treatment for Rural Veterans|Improving Access to Evidence Based Care Among Rural Veterans Using a Transdiagnostic Treatment Approach|Not yet recruiting||N/A|24|Anticipated|Southeast Louisiana Veterans Health Care System||1|||f||||f|f|f||||||||2017-10-10 20:42:37.934479|2017-10-10 20:42:37.934479
NCT03285503|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-14|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|||PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia|A Single-center, Uncontrolled, Open-label Clinical Trial Evaluating the Pharmacokinetic Characteristics and Safety of Aripiprazole IM Depot in Chinese Patients With Schizophrenia After Multi-dose Administration|Not yet recruiting||Phase 1|12|Anticipated|Otsuka Beijing Research Institute||1|||f|||||f|f||||||||2017-10-10 20:42:38.05384|2017-10-10 20:42:38.05384
NCT03285490|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-10-03|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|June 29, 2019|Anticipated|2019-06-29|June 29, 2018|Anticipated|2018-06-29||Interventional|||A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp (AK004)|A Phase 3, Double-Blind, Vehicle-Controlled, Randomized, Parallel Group, Multicenter, Efficacy and Safety Study of KX2-391 Ointment 1% in Adult Subjects With Actinic Keratosis on the Face or Scalp|Recruiting||Phase 3|300|Anticipated|Kinex Pharmaceuticals Inc||2|||f||||f|t|f||||||||2017-10-10 20:42:38.15945|2017-10-10 20:42:38.15945
NCT03285477|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-10-03|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|June 28, 2019|Anticipated|2019-06-28|June 29, 2018|Anticipated|2018-06-29||Interventional|AK003||A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp|A Phase 3, Double-Blind, Vehicle-Controlled, Randomized, Parallel Group, Multicenter, Efficacy and Safety Study of KX2-391 Ointment 1% in Adult Subjects With Actinic Keratosis on the Face or Scalp|Recruiting||Phase 3|300|Anticipated|Kinex Pharmaceuticals Inc||2|||f||||f|t|f||||||||2017-10-10 20:42:38.374947|2017-10-10 20:42:38.374947
NCT03285464|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||August 9, 2017|Actual|2017-08-09|September 2017|2017-09-01|November 20, 2017|Anticipated|2017-11-20|November 11, 2017|Anticipated|2017-11-11||Interventional|||Utilizing the Trunk as a Proximal Lever to Strengthen the Hip Musculature and Alter Lower Extremity Function|Investigating the Effects of a Triplanar Rotary Based Hip Focused Therapeutic Exercise Program on Dynamic Lower Extremity Alignment and Functional Performance|Recruiting||N/A|30|Anticipated|High Point University||2|||f||||f|f|f||||||||2017-10-10 20:42:38.555288|2017-10-10 20:42:38.555288
NCT03285451|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Observational|||Drug Induced Submental Ultrasound in Obstructive Sleep Apnea Patients|Correlative Analysis of Upper Airway Collapse in Sleep Endoscope and Submental Ultrasound|Recruiting||N/A|100|Anticipated|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||1||f|||||f|f||||||||2017-10-10 20:42:38.6372|2017-10-10 20:42:38.6372
NCT03285438|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-15|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|October 9, 2022|Anticipated|2022-10-09|October 9, 2022|Anticipated|2022-10-09||Interventional|RENOVE||REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.|REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. The RENOVE Open-label, Randomized, Controlled Trial.|Not yet recruiting||Phase 3|2200|Anticipated|University Hospital, Brest||2|||f||||t|f|f||||||||2017-10-10 20:42:38.716961|2017-10-10 20:42:38.716961
NCT03285425|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-15|||January 2017||2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|Batten'sCLN6||Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae|Natural History Study of Batten's CLN6 Disease|Recruiting||N/A|15|Anticipated|Nationwide Children's Hospital|||1||f||||f|f|f||||||||2017-10-10 20:42:38.873996|2017-10-10 20:42:38.873996
NCT03285412|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|February 28, 2025|Anticipated|2025-02-28|February 28, 2021|Anticipated|2021-02-28||Interventional|LEADER||CDK 4/6 Inhibitor, LEE011 (Ribociclib), in Combination With Adjuvant Endocrine Therapy at Varying Duration for ER-positive Breast Cancer|Phase II Study of CDK 4/6 Inhibitor, LEE011 (Ribociclib), in Combination With Adjuvant Endocrine Therapy at Varying Duration for ER-positive Breast Cancer (LEADER).|Not yet recruiting||Phase 2|120|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f|||f|||||2017-10-10 20:42:38.94575|2017-10-10 20:42:38.94575
NCT03285399|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||January 12, 2008|Actual|2008-01-12|September 2017|2017-09-01|February 28, 2014|Actual|2014-02-28|February 28, 2010|Actual|2010-02-28||Observational|||Bhaktapur Maternal and Child Micronutrient Study|Micronutrient Status in Breastfeeding Women and Their Children in Bhaktapur Nepal|Completed||N/A|1000|Actual|Centre For International Health|||1||f||||f|f|f||||Samples Without DNA|"     Breastmilk Plasma Red blood cells Urine   "|||2017-10-10 20:42:39.03467|2017-10-10 20:42:39.03467
NCT03285386|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-18|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|PET1D||Priming Exercise in Type 1 Diabetes|The Effects of Prior Exercise on Pulmonary Oxygen Uptake Kinetics and the Power-Duration Relationship in Type 1 Diabetes|Not yet recruiting||N/A|8|Anticipated|Liverpool Hope University||2|||f||||f|f|f||||||||2017-10-10 20:42:39.107204|2017-10-10 20:42:39.107204
NCT03285373|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-03|||November 13, 2017|Anticipated|2017-11-13|October 2017|2017-10-01|May 28, 2018|Anticipated|2018-05-28|May 28, 2018|Anticipated|2018-05-28||Observational|RE-CONOCE||This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain|Non-Interventional, Cross-sectional Study to Describe NOACs Management ss in Patients With Non-valvular Atrial Fibrillation (NVAF) in Spain.|Not yet recruiting||N/A|1000|Anticipated|Boehringer Ingelheim|||1||f||||f|t|f||||||||2017-10-10 20:42:39.300854|2017-10-10 20:42:39.300854
NCT03285360|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of Bioactiveglass Air Abrasion Versus Fluoride Varnish in Management of Dentin Hypersensitivity|Effectiveness of Sylc Air Abrasion Bioactive Glass Technology Versus Fluoride Varnish Application in Management of Hypersensitivity of Non-Carious Cervical Lesions: Randomized Clinical Trial.|Not yet recruiting||Phase 1|50|Anticipated|Cairo University||2|||f||||f|f|f|||f|||||2017-10-10 20:42:39.389715|2017-10-10 20:42:39.389715
NCT03285347|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-20|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||The Effect of Computer-based Cognitive Training on Attention and Executive Functions in Patients With Parkinson's Disease|The Effect of Computer-based Cognitive Training on Attention and Executive Functions in Patients With Parkinson's Disease|Not yet recruiting||N/A|30|Anticipated|Bispebjerg Hospital||3|||f||||f|f|f||||||||2017-10-10 20:42:39.504636|2017-10-10 20:42:39.504636
NCT03285334|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|February 2018|Anticipated|2018-02-01||Interventional|||3D Instrumentation Versus Rotary Instrumentation|The Effect of 3D Instrumentation Versus Rotary Instrumentation on Postoperative Pain and Bacterial Reduction in Necrotic Oval Canals: A Randomized Clinical Trial|Not yet recruiting||N/A|50|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:42:39.618944|2017-10-10 20:42:39.618944
NCT03285321|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-19|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|||Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)|Phase II Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC): BTCRC-LUN16-081|Recruiting||Phase 2|108|Anticipated|Big Ten Cancer Research Consortium||2|||f|||||t|f||||||||2017-10-10 20:42:39.729285|2017-10-10 20:42:39.729285
NCT03285308|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||September 29, 2017|Actual|2017-09-29|October 2017|2017-10-01|October 30, 2020|Anticipated|2020-10-30|October 30, 2020|Anticipated|2020-10-30||Interventional|||A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis|A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis|Recruiting||Phase 3|600|Anticipated|Allergan||2|||f||||f|t|f||||||||2017-10-10 20:42:39.848361|2017-10-10 20:42:39.848361
NCT03285295|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||September 15, 2017||2017-09-15||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:42:39.969599|2017-10-10 20:42:39.969599
NCT03285282|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Thoracolumbar Interfascial Plane Block for Postoperative Analgesia After Herniated Lumbar Disc Surgery|Evaluation of Thoracolumbar Interfascial Plane Block for Postoperative Analgesia After Herniated Lumbar Disc Surgery|Recruiting||Early Phase 1|80|Anticipated|Ain Shams University||2|||f|||||f|f|||f|||||2017-10-10 20:42:40.024352|2017-10-10 20:42:40.024352
NCT03285269|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01|1 Month|Observational [Patient Registry]|||Extension of the RUSH Protocol for Volume Responsiveness|Extension of the Rapid Ultrasound for Shock and Hypotension to Evaluate Volume Responsiveness|Not yet recruiting||N/A|50|Anticipated|Kaiser Permanente|||1||f||||f|f|f||||||||2017-10-10 20:42:40.128446|2017-10-10 20:42:40.128446
NCT03285256|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|October 2020|Anticipated|2020-10-01||Interventional|||Effects of Repeated Memory Training on Memory Function and Addiction Related Processes|Effects of Repeated Memory Training on Memory Function and Addiction Related Processes|Not yet recruiting||N/A|105|Anticipated|Johns Hopkins University||3|||f||||f|f|f||||||||2017-10-10 20:42:40.225785|2017-10-10 20:42:40.225785
NCT03285243|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Monochromatic Light on Incidence of Emergence Delirium in Children|Effect of Monochromatic Light on Incidence of Emergence Delirium in Children|Not yet recruiting||N/A|110|Anticipated|Baylor College of Medicine||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:42:40.328635|2017-10-10 20:42:40.328635
NCT03285230|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-18|||June 15, 1990|Actual|1990-06-15|September 2017|2017-09-01|December 15, 2025|Anticipated|2025-12-15|November 15, 1991|Actual|1991-11-15||Observational|E3N||The French E3N Prospective Cohort Study|The French E3N Prospective Cohort Study (Etude Epidémiologique auprès de Femmes de la Mutuelle Générale de l'Education Nationale)|Active, not recruiting||N/A|100000|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||t||||||Samples With DNA|"     25000 blood samples; 47000 saliva samples   "|||2017-10-10 20:42:40.423376|2017-10-10 20:42:40.423376
NCT03285217|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-14|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Interventional|HEPATIC||HMB for Denutrition in Patients With Cirrhosis (HEPATIC)|HMB for Denutrition in Patients With Cirrhosis (HEPATIC)|Recruiting||N/A|60|Anticipated|Instituto Aragones de Ciencias de la Salud||2|||f||||f|f|f|||f|||||2017-10-10 20:42:40.522541|2017-10-10 20:42:40.522541
NCT03285204|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-12|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Observational|||Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia|Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia|Recruiting||N/A|90|Anticipated|Hospital General Universitario Gregorio Marañon|||3||f||||f|f|f||||||||2017-10-10 20:42:40.644041|2017-10-10 20:42:40.644041
NCT03285191|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-12|||July 3, 2017|Actual|2017-07-03|September 2017|2017-09-01|August 17, 2017|Actual|2017-08-17|August 17, 2017|Actual|2017-08-17||Observational|||Subject Insights to Understand Rheumatoid Arthritis (RA)|Patient Interviews to Better Understand Disease Experience and Unmet Treatment Needs in Rheumatoid Arthritis|Completed||N/A|30|Actual|GlaxoSmithKline|||2||f||||f|f|f||||||||2017-10-10 20:42:40.740938|2017-10-10 20:42:40.740938
NCT03285178|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-13|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|STRONG-SCD||A Study of the Effect of IW-1701, a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)|A Randomized, Placebo-controlled, Phase 2 Study to Evaluate the Safety and Pharmacodynamics of Once-daily Oral IW-1701 in Patients With Stable Sickle Cell Disease|Not yet recruiting||Phase 2|88|Anticipated|Ironwood Pharmaceuticals, Inc.||4|||f||||t|t|f||||||||2017-10-10 20:42:40.832888|2017-10-10 20:42:40.832888
NCT03285165|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|DEXSEDATION||Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients|Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients With and Without Traumatic Brain Injury.|Recruiting||Phase 2/Phase 3|60|Anticipated|Assiut University||4|||f||||t|f|f||||||||2017-10-10 20:42:40.912127|2017-10-10 20:42:40.912127
NCT03285152|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-10-05|||August 11, 2017|Actual|2017-08-11|October 2017|2017-10-01|August 11, 2019|Anticipated|2019-08-11|August 11, 2019|Anticipated|2019-08-11||Interventional|||A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients|A Feasibility Study Evaluating Metabolomic and Tissue Effects of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||f|f||||||||2017-10-10 20:42:41.009786|2017-10-10 20:42:41.009786
NCT03285139|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PL-CBT||Peer Administered CBT for PPD|Peer Administered Group Cognitive Behavioural Therapy for Postpartum Depression|Not yet recruiting||N/A|148|Anticipated|McMaster University||3|||f||||f|f|f||||||||2017-10-10 20:42:41.101259|2017-10-10 20:42:41.101259
NCT03285126|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Pompe Gene Therapy- Screening for Eligibility|Screening for Eligibility to Participate in a Clinical Trial of Gene Therapy for Late-onset Pompe Disease|Not yet recruiting||N/A|20|Anticipated|Duke University|||1||f||||f|f|f||||||||2017-10-10 20:42:41.19499|2017-10-10 20:42:41.19499
NCT03285113|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||March 3, 2017|Actual|2017-03-03|September 2017|2017-09-01|February 17, 2018|Anticipated|2018-02-17|February 17, 2018|Anticipated|2018-02-17||Interventional|||A Study to Confirm the Safety of High Frequency DRG Stimulator in Patients With Chronic Lower Limb Pain|A Single-arm, Open Label, Single Center Pilot Study to Confirm the Safety of Dorsal Root Ganglia (DRG) and Ultrahigh Frequency Spinal Cord Stimulator in Patients With Chronic Lower Limb Pain|Recruiting||N/A|10|Anticipated|GiMer Medical||1|||f|||||f|f||||||||2017-10-10 20:42:41.260757|2017-10-10 20:42:41.260757
NCT03285100|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-10-01|||October 1, 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|||The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation|Pilot Study to Assess the Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation|Recruiting||N/A|30|Anticipated|Canisius-Wilhelmina Hospital|||1||f||||f|f|f||||Samples With DNA|"     -  at baseline: blood sample of 15mL (EDTA-plasma), divided in four two portions (one for          determination of dp-ucMGP and one for desmosine)        -  at baseline: blood sample of 10mL (EDTA-plasma). DNA will be isolated from these samples          for determination of the VKORC1 polymorphisms        -  after six months: blood sample of 15mL (EDTA-plasma), divided in four two portions (one          for determination of dp-ucMGP and one for desmosine)   "|||2017-10-10 20:42:41.345658|2017-10-10 20:42:41.345658
NCT03285087|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|DEXSEDATION||Risk Prediction of Dexmedetomidine-associated Hemodynamic Instability|Risk Prediction and Consequences of Dexmedetomidine-associated Hemodynamic Instability in Intubated Mechanically Ventilated Intensive Care Unit Patients|Not yet recruiting||Phase 2/Phase 3|250|Anticipated|Assiut University||1|||f||||t|f|f|||f|||||2017-10-10 20:42:41.430239|2017-10-10 20:42:41.430239
NCT03285074|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||November 1, 2011|Actual|2011-11-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|December 1, 2012|Actual|2012-12-01||Observational|||The Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With Chronic Kidney Disease|The Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With Chronic Kidney Disease|Completed||N/A|326|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||1||f||||f|f|f||||||||2017-10-10 20:42:41.504662|2017-10-10 20:42:41.504662
NCT03285048|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-12|||January 2017||2017-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CaCRT||Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer|Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer: A Single-arm Proof of Concept Study.|Recruiting||N/A|30|Anticipated|Yale University||1|||f||||f||||||||||2017-10-10 20:42:41.637234|2017-10-10 20:42:41.637234
NCT03285035|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-19|||July 13, 2017|Actual|2017-07-13|September 2017|2017-09-01|January 13, 2020|Anticipated|2020-01-13|July 13, 2019|Anticipated|2019-07-13||Observational|Cryotherapy||Quality of Life Assessment in Patients Receiving Cryotherapy and Chemotherapy for Unresectable Esophageal or Gastroesophageal Cancer|Quality of Life Assessment in Patients Receiving Cryotherapy in Addition to Chemotherapy for Palliation of Unresectable Esophageal or Gastroesophageal Cancer|Recruiting||N/A|50|Anticipated|Western Regional Medical Center|||1||f||||f|f|t|f|f|t|Samples With DNA|"     Archival tissue or fresh tissue from gastrointestinal biopsies used for diagnostic purposes.   "|||2017-10-10 20:42:41.719793|2017-10-10 20:42:41.719793
NCT03285022|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|April 20, 2018|Anticipated|2018-04-20|April 20, 2018|Anticipated|2018-04-20||Interventional|||Postoperative Hypersensitivity and Digital Radiographic Assessment of a Zinc Modified Versus a Conventional Glass Ionomer Cement in Deep Carious Lesion: Randomized Controlled Clinical Trial|Postoperative Hypersensitivity and Digital Radiographic Assessment of a Zinc Modified Versus a Conventional Glass Ionomer Cement in Deep Carious Lesion: Randomized Controlled Clinical Trial|Not yet recruiting||N/A|52|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:42:41.80951|2017-10-10 20:42:41.80951
NCT03285009|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-25|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|||Movement Patterns in Young Volleyball Athletes|Optimizing Body and Movement Specific Characteristics in Volleyball Players to Reduces Injuries in Young Athletes.|Recruiting||N/A|15|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f||||||||2017-10-10 20:42:41.900091|2017-10-10 20:42:41.900091
NCT03284996|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|April 30, 2019|Anticipated|2019-04-30||Observational|||Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus.|Role of Doppler Ultrasound in Early Detection of Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus.|Not yet recruiting||N/A|80|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:42:41.973491|2017-10-10 20:42:41.973491
NCT03284983|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|SFD||Split Scar Study to Assess Cosmetic Outcome From Differing Suture Spacing|Split Scar Study to Assess Cosmetic Outcome From Differing Suture Spacing|Recruiting||N/A|30|Anticipated|Silver Falls Dermatology||1|||f||||f|f|f||||||||2017-10-10 20:42:42.033511|2017-10-10 20:42:42.033511
NCT03284970|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes|Effect of Interferon Beta-1a SC 44 µg Three Times Weekly (Tiw) (Rebif) and Dimethyl Fumarate (DMF, Tecfidera) on Infections and Lymphocytes in Patients 50 Years or Older From a Single Center Chart Review|Recruiting||N/A|34|Anticipated|EMD Serono|||2||f||||f||||||||||2017-10-10 20:42:42.122593|2017-10-10 20:42:42.122593
NCT03284957|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-25|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Phase 1 / 2 Study of SAR439859 Single Agent and in Combination With Palbociclib in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer|A Phase 1/2 Study for the Safety, Efficacy, Pharmacokinetic and Pharmacodynamics Evaluation of SAR439859, Administered Orally as Monotherapy, Then in Combination With Palbociclib in Postmenopausal Women With Estrogen Receptor-positive Advanced Breast Cancer|Recruiting||Phase 1/Phase 2|156|Anticipated|Sanofi||4|||f||||f|t|f||||||||2017-10-10 20:42:42.26131|2017-10-10 20:42:42.26131
NCT03284944|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS)|Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pilot Study|Not yet recruiting||N/A|450|Anticipated|Population Health Research Institute|||2||f||||f|f|f||||||||2017-10-10 20:42:42.37472|2017-10-10 20:42:42.37472
NCT03284918|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||January 2016||2016-01-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester|Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester on Serum Total and Lipoprotein Lipids|Completed||N/A|71|Actual|Raisio Group||2|||f||||||||||||||2017-10-10 20:42:42.53706|2017-10-10 20:42:42.53706
NCT03284892|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-13|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Screening and Intervention of Postextubation Dysphagia|Screen and Intervene : A Diagnostic Accuracy Study and A Randomized Controlled Trial for Postextubation Dysphagia|Not yet recruiting||N/A|172|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:42:42.672137|2017-10-10 20:42:42.672137
NCT03284879|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-13|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2021|Anticipated|2021-08-31||Observational|||Post-Marketing Surveillance Study of OTEZLA|OTEZLA® Tablets Drug Use-Results Survey|Recruiting||N/A|1000|Anticipated|Celgene|||1||f||||||||||||||2017-10-10 20:42:42.751586|2017-10-10 20:42:42.751586
NCT03284866|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|COVENANT||HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV|A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions Among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)|Not yet recruiting||Phase 3|536|Anticipated|AIDS Malignancy Consortium||2|||f||||t|t|f|||t|||||2017-10-10 20:42:42.832851|2017-10-10 20:42:42.832851
NCT03284853|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension|A Prospective, Double-masked, Randomized, Multicenter, Active-controlled, Parallel-group, 6-month Study Assessing the Safety and Ocular Hypotensive Efficacy of PG324 Ophthalmic Solution Compared to GANFORT® (Bimatoprost 0.03% / Timolol 0.5%) Ophthalmic Solution in Subjects With Elevated Intraocular Pressure (MERCURY 3)|Recruiting||Phase 3|472|Anticipated|Aerie Pharmaceuticals||2|||f|||||t|f||||||||2017-10-10 20:42:42.977664|2017-10-10 20:42:42.977664
NCT03284840|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|NUTRIHEALTH||Adults Nutrition as a Protective or Health-risk Factor|NUTRIHEALTH - Adults Nutrition as a Protective or Health-risk Factor|Enrolling by invitation||N/A|1133|Anticipated|Nutrition Institute, Slovenia|||2||f||||f|f|f||||Samples With DNA|"     Blood samples will be freezed for possible further analyses on markers related with nutrition     & health   "|||2017-10-10 20:42:44.733519|2017-10-10 20:42:44.733519
NCT03284827|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-18|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ADAPT-TAVR||Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement|a Multicenter, Randomized, Open-label, Active-treatment, Controlled Trial to Compare the Efficacy of NOAC With Edoxaban vs. Dual Antiplatelet Therapy (DAPT) for Prevention of Leaflet Thrombosis (Documented by Cardiac CT Imaging) and Cerebral Embolization (Documented With Brain DW-MRI Imaging) in Patients Without an Absolute Indication for Chronic OAC After Successful TAVR|Not yet recruiting||Phase 4|220|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:42:44.842124|2017-10-10 20:42:44.842124
NCT03284814|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||September 19, 2017|Anticipated|2017-09-19|September 2017|2017-09-01|October 20, 2018|Anticipated|2018-10-20|October 20, 2018|Anticipated|2018-10-20||Interventional|CoQ10-01||Bioavailability Study of CoQ10 Formulations in Healthy Elderly Adults|Single-dose and Multiple-dose Comparative Bioavailability Study of Three CoQ10 Formulations in Healthy Elderly Adults|Recruiting||Phase 1|21|Anticipated|Nutrition Institute, Slovenia||3|||f||||f|f|f||||||||2017-10-10 20:42:44.943109|2017-10-10 20:42:44.943109
NCT03284801|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-13|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Observational|||Management Of Acute Disseminating Encephalomyelitis|Management of Acute Disseminated Encephalomyelitis in Neurology Unit of Assiut University Children Hospital|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:42:45.055138|2017-10-10 20:42:45.055138
NCT03284749|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||January 14, 2016|Actual|2016-01-14|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 1, 2017|Anticipated|2017-12-01||Interventional|ECHO||Effect of Copper on the Healing of Obstetric Wounds|Randomised Controlled Trial on the Effect of Copper Impregnated Dressings and Maternity Pads on the Healing of Obstetric Wounds and Wound Infection|Recruiting||N/A|750|Anticipated|Croydon Health Services NHS Trust||4|||f||||f|f|f||||||||2017-10-10 20:42:45.437271|2017-10-10 20:42:45.437271
NCT03284736|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|||Guided Tissue Regeneration in the Healing of Through and Through Lesions|Effects of Guided Tissue Regeneration on the Healing of Through & Through Periradicular Lesions: A Randomized Controlled Study|Active, not recruiting||N/A|30|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||||2017-10-10 20:42:45.555461|2017-10-10 20:42:45.555461
NCT03284723|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-28|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||PF-06804103 Dose Escalation in HER2 Positive Solid Tumors|A Phase 1 Dose Escalation Study Evaluating The Safety And Tolerability Of Pf-06804103 In Patients With Human Epidermal Growth Factor Receptor 2 (her2) Positive Solid Tumors|Not yet recruiting||Phase 1|95|Anticipated|Pfizer||1|||f||||f|t|f||||||||2017-10-10 20:42:45.716924|2017-10-10 20:42:45.716924
NCT03284710|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|HVTN107||Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine|A Phase 1/2a Partially Double-blinded, Randomized Clinical Trial to Characterize the Safety and Immunogenicity of Clade C ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120 Alone, With MF59 Adjuvant, and With Alum Adjuvant in Healthy, HIV-uninfected Adult Participants|Recruiting||Phase 1/Phase 2|132|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t|t|f|||t|||||2017-10-10 20:42:45.806906|2017-10-10 20:42:45.806906
NCT03284697|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-15|||October 14, 2016|Actual|2016-10-14|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Direct Pulp Capping With MTA and Calcium Hydroxide.|Success of Direct Pulp Capping With Mineral Trioxide Aggregate and Calcium Hydroxide In Cariously Exposed Teeth: A Randomized Clinical Study.|Active, not recruiting||N/A|50|Anticipated|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||||2017-10-10 20:42:45.959736|2017-10-10 20:42:45.959736
NCT03284684|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|Periop ctDNA||Kinetics of Perioperative Circulating DNA in Cancer Surgery|Kinetics of Perioperative Circulating DNA in Cancer Surgery|Not yet recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f|||||f|f||||Samples With DNA|"     Blood samples   "|||2017-10-10 20:42:46.044601|2017-10-10 20:42:46.044601
NCT03284671|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-12|||February 19, 2016|Actual|2016-02-19|September 2017|2017-09-01|May 12, 2017|Actual|2017-05-12|February 19, 2016|Actual|2016-02-19||Interventional|tDCS-TOC||tDCS Stimulation to Treat Patients With Severe and Resistant Obsessive Compulsive Disorder-Pilot Study|Transcranial Direct Current Stimulation to Treat Patients With Severe and Resistant Obsessive Compulsive Disorders -Pilot Study (tDCS-TOC Pilot)|Completed||N/A|20|Actual|Centre Hospitalier Henri Laborit||1|||f||||f||||||||||2017-10-10 20:42:46.140379|2017-10-10 20:42:46.140379
NCT03284658|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|August 2020|Anticipated|2020-08-01||Observational|BioTyrosin||Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1|BioTyrosin - Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 - An International, Multicenter, Epidemiological Protocol|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f|||||f|f||||Samples With DNA|"     For the development of the new biomarker using the technique of mass-spectometry a dry blood     spot filter card are taken. To prove the correct diagnosis in those patients where up to the     enrollment in the study no genetic testing has been done, sequencing will be done.      The analyses are done in the Centogene AG, Schillingallee 68, 18055 Rostock (Germany)   "|||2017-10-10 20:42:46.217333|2017-10-10 20:42:46.217333
NCT03284645|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-27|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Observational|VADICT||Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids|Investigating Influence of Pregnancy-induced Changes in Antiretroviral Pharmacokinetics, Together With Polymorphisms in Drug Disposition Genes, on Viral Decay Dynamics in HIV Positive Women Starting Therapy Late in Pregnancy and Postpartum|Not yet recruiting||N/A|180|Anticipated|Obafemi Awolowo University|||3||f||||t|t|f|||f|||||2017-10-10 20:42:46.314629|2017-10-10 20:42:46.314629
NCT03284632|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||July 11, 2017|Actual|2017-07-11|September 2017|2017-09-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2021|Anticipated|2021-08-01||Observational|||e-Cigarette - DNA Adducts|e-Cigarettes: Formaldehyde DNA Adducts, Oxidative Damage, and Potential Toxicity and Carcinogenesis|Recruiting||N/A|402|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||3||f||||f|f|f||||Samples With DNA|"     Buffy Coat, Serum, Plasma, Urine, Buccal Cells, Saliva   "|||2017-10-10 20:42:46.409319|2017-10-10 20:42:46.409319
NCT03284619|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-12|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|FIM MR-Linac||First-In Man (FIM) Study MR-Linac|First-In Man (FIM) Study MR-Linac|Active, not recruiting||N/A|5|Actual|Nucletron Operations BV||1|||f||||f|f|f||||||||2017-10-10 20:42:46.494405|2017-10-10 20:42:46.494405
NCT03284606|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|September 2020|Anticipated|2020-09-01||Interventional|NEUROTAP||Effect of Taping in the Hemiplegic Patient With a Deficit of the Footbrowers|A Pilot Study of the Effect of Taping in the Hemiplegic Patient With a Deficit of the Footbrowers|Recruiting||N/A|60|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||||2017-10-10 20:42:46.566265|2017-10-10 20:42:46.566265
NCT03284593|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||December 2014||2014-12-01|July 2017|2017-07-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Observational|LAM-BDD||Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition|Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition at Toulouse and Bordeaux University Hospital|Active, not recruiting||N/A|199|Actual|University Hospital, Toulouse|||2||f||||f|f|f||||||||2017-10-10 20:42:46.643201|2017-10-10 20:42:46.643201
NCT03284580|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||January 8, 2017|Actual|2017-01-08|September 2017|2017-09-01|August 20, 2017|Actual|2017-08-20|August 9, 2017|Actual|2017-08-09||Interventional|||Effectiveness of a Home-based Ergonomic Intervention Program in Caregivers of Chronic Post-stroke Patients|Effectiveness of a Home-based Ergonomic Intervention Program on Overall Quality of Life, Health Satisfaction, and Home Ergonomics in Caregivers of Chronic Post-stroke Patients: a Randomized Controlled Clinical Trial|Completed||N/A|33|Actual|Universidad de Granada||3|||f|||||f|f||||||||2017-10-10 20:42:46.720925|2017-10-10 20:42:46.720925
NCT03284567|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|FFABC||Football Fitness After Breast Cancer|A Randomized Controlled Trial to Investigate the Health Promoting Effects of a Football Fitness Intervention for Women After Treatment for Breast Cancer|Recruiting||N/A|90|Anticipated|University of Copenhagen||2|||f||||f|f|f||||||||2017-10-10 20:42:46.801773|2017-10-10 20:42:46.801773
NCT03284554|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ENSURE||Encapsulated Nutrients' Acute Effects on Appetite; ENcapSulated, nUtRiEnts (ENSURE)|Encapsulated Nutrients' Acute Effects on Appetite|Not yet recruiting||N/A|30|Anticipated|University of Copenhagen||3|||f||||t|f|f||||||||2017-10-10 20:42:46.890642|2017-10-10 20:42:46.890642
NCT03284541|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|2GETHER||Online HIV Prevention for Young Male Couples|A New Approach to Integrating Primary and Secondary HIV Prevention in Young Male Couples|Not yet recruiting||Phase 3|400|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 20:42:46.985517|2017-10-10 20:42:46.985517
NCT03284528|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-20|||January 1, 2011|Actual|2011-01-01|September 2017|2017-09-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Observational|||"Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"|"Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"|Completed||N/A|100|Actual|University Children's Hospital, Zurich|||1||f||||t|f|f||||||||2017-10-10 20:42:47.067784|2017-10-10 20:42:47.067784
NCT03284515|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||September 13, 2017|Anticipated|2017-09-13|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|November 10, 2017|Anticipated|2017-11-10||Observational|||Vaccination In Pregnancy Gene Signature: VIP Signature Study|Vaccination In Pregnancy Gene Signature: VIP Signature Study|Recruiting||N/A|30|Anticipated|St George's, University of London|||1||f||||t|f|f||||Samples Without DNA|"     Blood samples will be taken from the women prior to and 24 hours following vaccination.   "|||2017-10-10 20:42:47.127274|2017-10-10 20:42:47.127274
NCT03284502|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-13|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Cobimetinib and HM95573 in Patients With Locally Advanced or Metastatic Solid Tumors|A Phase Ib, Open-label, Multicenter, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and HM95573 in Patients With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|272|Anticipated|Hanmi Pharmaceutical Company Limited||2|||f|||||f|f|||f|||||2017-10-10 20:42:47.203415|2017-10-10 20:42:47.203415
NCT03284489|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-26|||April 2013||2013-04-01|September 2017|2017-09-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|||Post Pancreatitis Complications Study (Based on a Prospective Data Base)|Prospective Cohort of Patients With Pancreatitis Hospitalized in West French Intensive Care Units|Active, not recruiting||N/A|300|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 20:42:47.399283|2017-10-10 20:42:47.399283
NCT03284476|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||April 2013||2013-04-01|September 2017|2017-09-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|||Post Surgically Treated Peritonitis Complications|A Prospective Cohort of Patients Hospitalized in West French Intensive Care Units for Peritonitis Surgically Treated|Active, not recruiting||N/A|300|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 20:42:47.487753|2017-10-10 20:42:47.487753
NCT03284463|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|SE-GRACE||Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism|Safety and Efficacy of Glibenclamide Combined With Rt-PA in Treating Acute Ischemic Stroke: a Prospective, Randomized, Double-blind, Placebo-control, Multi-center Study|Not yet recruiting||Phase 4|306|Anticipated|Nanfang Hospital of Southern Medical University||2|||f|||||f|f||||||||2017-10-10 20:42:47.569816|2017-10-10 20:42:47.569816
NCT03284450|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-12|||April 2014||2014-04-01|September 2017|2017-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Exercise Induced Muscle Damage Post Dance and Sprint Specific Exercise in Females|Exercise Induced Muscle Damage Post Dance and Sprint Specific Exercise in Females|Completed||N/A|29|Actual|Northumbria University||2|||f||||f||||||||||2017-10-10 20:42:47.661128|2017-10-10 20:42:47.661128
NCT03284437|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|ECTICU||Pilot Study of Early Cognitive Training in the Intensive Care Unit|Pilot Study of Early Cognitive Training in the Intensive Care Unit|Not yet recruiting||N/A|40|Anticipated|Mount Carmel Health System||2|||f||||f|f|f||||||||2017-10-10 20:42:47.746385|2017-10-10 20:42:47.746385
NCT03284424|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-14|||October 12, 2017|Anticipated|2017-10-12|September 2017|2017-09-01|December 7, 2020|Anticipated|2020-12-07|December 7, 2020|Anticipated|2020-12-07||Interventional|||Study of Pembrolizumab (MK-3475) in Adults With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) (MK-3475-629/KEYNOTE-629)|A Phase 2, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Pembrolizumab in Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC)|Not yet recruiting||Phase 2|120|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f|t|f||||||||2017-10-10 20:42:47.81967|2017-10-10 20:42:47.81967
NCT03284411|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Spinal Cord Stimulation (SCS) Dosing Study|Spinal Cord Stimulation (SCS) Dosing Study|Not yet recruiting||Phase 4|60|Anticipated|MedtronicNeuro||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:42:47.897391|2017-10-10 20:42:47.897391
NCT03284398|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Three-Chamber Bags Retrospective Study in Spain|Observational Retrospective Analysis Assessing the Influence of Three-Chamber Bags Compared to Hospital Compounded Parenteral Nutrition Bags on Blood Stream Infections|Not yet recruiting||N/A|3782|Anticipated|Fresenius Kabi|||1||f||||f|f|f||||||||2017-10-10 20:42:47.966305|2017-10-10 20:42:47.966305
NCT03284385|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-14|2017-09-19|||August 10, 2018|Anticipated|2018-08-10|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|||WEE1 Inhibitor AZD1775 in Treating Patients With SETD2-Deficient Locally Advanced or Metastatic Solid Tumors|A Phase 2 Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies|Not yet recruiting||Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 20:42:48.041549|2017-10-10 20:42:48.041549
NCT03284359|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||Use of Nudges To Enhance Enrollment in Critical Care Research|A Randomized Trial of Nudges To Enhance Enrollment in Critical Care Research|Not yet recruiting||N/A|273|Anticipated|University of Pennsylvania||3|||f||||t|f|f||||||||2017-10-10 20:42:48.240844|2017-10-10 20:42:48.240844
NCT03284346|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-09-12|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|August 17, 2021|Anticipated|2021-08-17|August 17, 2020|Anticipated|2020-08-17||Interventional|||Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors|Circuit, Interval-Based Aerobic and Resistance Exercise to Target Metabolic Dysregulation: The CARE Study for Breast and Prostate Cancer Survivors|Recruiting||N/A|100|Anticipated|University of Southern California||2|||f||||t|f|t|f|||||||2017-10-10 20:42:48.329262|2017-10-10 20:42:48.329262
NCT03284333|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||July 27, 2017|Actual|2017-07-27|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars|Open-label, Prospective, Multicenter Study to Evaluate the Cutera enLighten™ Laser and a Micro-Lens Array Handpiece Attachment for the Treatment of Moderate and Severe Acne Scars|Recruiting||N/A|45|Anticipated|Cutera Inc.||1|||f|||||f|t|f||t|||||2017-10-10 20:42:48.439882|2017-10-10 20:42:48.439882
NCT03284320|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-12|||April 18, 2017|Actual|2017-04-18|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|ReTraSarc||Retrospective Study in Sarcoma Patients|Retrospective Study to Evaluate Efficacy and Safety of Trabectedin (Yondelis®) in Sarcoma Patients|Recruiting||N/A|500|Anticipated|University Medicine Greifswald|||1||f||||f|f|f||||||||2017-10-10 20:42:48.540029|2017-10-10 20:42:48.540029
NCT03284307|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-14|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|August 10, 2021|Anticipated|2021-08-10|August 10, 2019|Anticipated|2019-08-10||Interventional|UN-CONSCIOUS||UNderstanding CONSciousness Connectedness and Intraoperative Unresponsiveness Study|UNderstanding CONSciousness Connectedness and Intraoperative Unresponsiveness Study|Recruiting||Phase 4|80|Anticipated|University of Wisconsin, Madison||1|||f||||t|t|f|||t|||||2017-10-10 20:42:48.62263|2017-10-10 20:42:48.62263
NCT03284294|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-14|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia|The Influence of Vitamin D Supplementation on Serum Brain Derived Neurotrophic Factor Level and Cognitive Function in Schizophrenia Treated With Atypical Antipsychotic|Not yet recruiting||Phase 3|40|Anticipated|Universitas Padjadjaran||2|||f||||t|f|f|||f|||||2017-10-10 20:42:48.720003|2017-10-10 20:42:48.720003
NCT03284281|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-14|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|TREAT MI||Low-Level Transcutaneous Vagus Stimulation in ST Segment Elevation Myocardial Infarction: TREAT MI Study|Low-Level Transcutaneous Vagus Stimulation in ST Segment Elevation Myocardial Infarction: TREAT MI Study|Not yet recruiting||N/A|80|Anticipated|University of Oklahoma||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:42:48.794917|2017-10-10 20:42:48.794917
NCT03284268|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-14|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|November 25, 2019|Anticipated|2019-11-25|September 25, 2019|Anticipated|2019-09-25||Interventional|RTB||Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma|Phase I Study, Single Site, Open Label With Dose Escalation, for Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma|Recruiting||Early Phase 1|13|Anticipated|Fundació Sant Joan de Déu||1|||f||||f|f|f||||||||2017-10-10 20:42:48.890361|2017-10-10 20:42:48.890361
NCT03284255|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-14|||October 10, 2017|Anticipated|2017-10-10|June 2017|2017-06-01|April 30, 2024|Anticipated|2024-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||BioheartRapamycin Drug-Eluting Bioresorbable Coronary Stent System RCT Study|A Randomized Controlled Trial of the BioheartRapamycin Drug-Eluting Bioresorbable Coronary Stent System in Patients With Coronary Artery Disease: BIOHEART-II|Not yet recruiting||N/A|430|Anticipated|Shanghai Bio-heart Biological Technology Co., Ltd.||2|||f|||||f|f||||||||2017-10-10 20:42:48.999782|2017-10-10 20:42:48.999782
NCT03284242|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients|Tolerance Induction Using Autologous Regulatory T Cell Infusion and Zortress (Everolimus) in Renal Transplant Recipients: a Pilot Study|Not yet recruiting||N/A|12|Anticipated|University of Kentucky||1|||f||||t|f|f|||f|||||2017-10-10 20:42:49.141069|2017-10-10 20:42:49.141069
NCT03284229|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ELCA-CAD||Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD|A Prospective, Open Label, Non-randomized, Single-Arm, Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA® in Treatment of Patients With Single or Multivessel Coronary Artery Disease (CAD)|Not yet recruiting||N/A|30|Anticipated|Spectranetics Corporation||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:42:49.219761|2017-10-10 20:42:49.219761
NCT03284216|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-12|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|August 1, 2018|Anticipated|2018-08-01||Interventional|GlucotoxEx||Hyperglycemia and Exercise.|The Effects of Hyperglycemia on the Response to Acute Exercise.|Recruiting||N/A|24|Anticipated|University of Birmingham||3|||f||||f|f|f||||||||2017-10-10 20:42:49.333262|2017-10-10 20:42:49.333262
NCT03284203|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-14|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Feasibility of SpiroPD|Feasibility of Inpatient and At-Home Use of Handheld Spirometry|Recruiting||N/A|150|Anticipated|University of Chicago||1|||f|||||f|t|f|||||||2017-10-10 20:42:49.423816|2017-10-10 20:42:49.423816
NCT03284190|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-11|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|SMASH||Scandinavian Multicentre Acute Subdural Hematoma (SMASH) Study|Scandinavian Multicentre Acute Subdural Hematoma (SMASH) Study: A Multi-national Population-based Consecutive Cohort|Not yet recruiting||N/A|1600|Anticipated|Karolinska University Hospital|||10||f||||f|f|f||||||||2017-10-10 20:42:49.494677|2017-10-10 20:42:49.494677
NCT03284177|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-14|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 24, 2018|Anticipated|2018-09-24||Interventional|||A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients|A Multicenter, Open-label Trial to Investigate the Safety of C13-CAC and the Relationship Among C13-CAC Breath Test, Gastric pH, and the Improvement of Symptoms in PPI Resistant GERD Patients|Not yet recruiting||Phase 2|100|Anticipated|Otsuka Pharmaceutical Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 20:42:49.57855|2017-10-10 20:42:49.57855
NCT03284164|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-14|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex|An Open-Label Study to Investigate the Effect of Renal Impairment on the Pharmacokinectics of Tenofovir Exalidex|Not yet recruiting||Phase 1|16|Anticipated|ContraVir Pharmaceuticals, Inc.||2|||||||f|t|f||||||||2017-10-10 20:42:49.636567|2017-10-10 20:42:49.636567
NCT03284151|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-14|||January 2015||2015-01-01|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01|3 Years|Observational [Patient Registry]|||Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma|Robotic and Focused Stereotactic Radiation Treatment of Good Prognosis Prostatic Adenocarcinoma|Recruiting||N/A|40|Anticipated|Centre Francois Baclesse, Luxembourg|||1||f||||t||||||||||2017-10-10 20:42:49.701631|2017-10-10 20:42:49.701631
NCT03284138|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-11|||October 6, 2018|Anticipated|2018-10-06|September 2017|2017-09-01|June 6, 2021|Anticipated|2021-06-06|October 6, 2020|Anticipated|2020-10-06||Interventional|Schirang||Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms (FRS) on Schizophrenia|Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms on Schizophrenia: Controlled, Randomised, Double Blind Trial|Not yet recruiting||N/A|140|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 20:42:49.874362|2017-10-10 20:42:49.874362
NCT03284125|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|MATPF||Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis|Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis|Not yet recruiting||N/A|15|Anticipated|University Hospital, Tours|||1||f||||f|f|f||||||||2017-10-10 20:42:49.976789|2017-10-10 20:42:49.976789
NCT03284112|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|||Old SCHOOL Hip-Hop: Improve Alzheimer's Disease Knowledge|Old SCHOOL Hip-Hop: A Randomized Controlled Trial to Improve Alzheimer's Disease Knowledge|Not yet recruiting||N/A|6000|Anticipated|Columbia University||2|||f||||t|f|f||||||||2017-10-10 20:42:50.081361|2017-10-10 20:42:50.081361
NCT03284099|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension|Is Bedtime Administration of ACEIs and ARBs More Effective for Reverting Non-dipper Status Than Morning Administration for Non-dipping Hypertension in Hong Kong Primary Care? A Pilot Study|Not yet recruiting||Phase 4|50|Anticipated|Chinese University of Hong Kong||2|||f|||||f|f|||f|||||2017-10-10 20:42:50.172791|2017-10-10 20:42:50.172791
NCT03284086|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||VO2peak and Exercise Efficiency in Upper-body Poling|Comparison of Peak Oxygen Uptake and Exercise Efficiency Between Upper-body Poling and Arm Crank Ergometry in Trained Paraplegic and Able-bodied Participants|Completed||N/A|18|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 20:42:50.234749|2017-10-10 20:42:50.234749
NCT03284073|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-17|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||First Clinical Live-Donor Uterus Transplantation Trial In Egypt|First Clinical Live-Donor Uterus Transplantation Trial In Egypt|Not yet recruiting||N/A|11|Anticipated|Talkha Central Hospital||1|||f||||t|f|f||||||||2017-10-10 20:42:50.311775|2017-10-10 20:42:50.311775
NCT03284060|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|April 15, 2020|Anticipated|2020-04-15|October 15, 2019|Anticipated|2019-10-15||Interventional|RCKID||Social Cognition Training and Cognitive Remediation|Social Cognition Training and Cognitive Remediation : a New Tool for 22q11.2 Deletion Syndrome|Not yet recruiting||N/A|10|Anticipated|Hôpital le Vinatier||1|||f||||f|f|f||||||||2017-10-10 20:42:50.405128|2017-10-10 20:42:50.405128
NCT03284047|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 1, 2018|Anticipated|2018-09-01||Interventional|||Botox for Gummy Smile|Evaluation of Different Doses of Botulinum Toxin Type A for the Treatment of Gummy Smile|Recruiting||N/A|21|Anticipated|Northwestern University||3|||f||||t|f|f|||f|||||2017-10-10 20:42:50.483888|2017-10-10 20:42:50.483888
NCT03284034|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat|Comparison of the Efficacy Between Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for the Treatment of Upper Back Fat: a Prospective Randomized Controlled Pilot Study.|Recruiting||N/A|34|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 20:42:50.567044|2017-10-10 20:42:50.567044
NCT03284021|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Fraxel Laser for Alopecia|A Pilot Study on 1550 nm Fractional Erbium-glass Laser for Alopecia Treatment|Not yet recruiting||N/A|20|Anticipated|Northwestern University||1|||f||||t|f|f||||||||2017-10-10 20:42:50.665432|2017-10-10 20:42:50.665432
NCT03284008|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-14|||July 16, 2013|Actual|2013-07-16|September 2017|2017-09-01|January 30, 2019|Anticipated|2019-01-30|January 12, 2016|Actual|2016-01-12||Interventional|||Assessing Efficacy of Axillary Web Syndrome Treatment|Assessing Efficacy of Axillary Web Syndrome Treatment|Active, not recruiting||N/A|60|Actual|European Institute of Oncology||2|||f||||f|f|f||||||||2017-10-10 20:42:50.749437|2017-10-10 20:42:50.749437
NCT03283995|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01|2 Days|Observational [Patient Registry]|||Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology|Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology|Not yet recruiting||N/A|64|Anticipated|Assistance Publique Hopitaux De Marseille|||4||f||||f|f|f||||||||2017-10-10 20:42:50.841732|2017-10-10 20:42:50.841732
NCT03283982|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-19|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM|Registry-Based, Prospective, Single-Blind, Randomized Controlled Trial: Robotic vs. Laparoscopic Ventral Hernia Repair With Intraperitoneal Onlay Mesh (IPOM)|Enrolling by invitation||N/A|74|Anticipated|The Cleveland Clinic||2|||f|||||f|t|f|f|f|||||2017-10-10 20:42:50.929213|2017-10-10 20:42:50.929213
NCT03283969|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-22|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|April 1, 2018|Anticipated|2018-04-01||Interventional|||Influence of Freeze Dried Strawberry Consumption on Gut Microbiota and Cardiovascular Health.|Probe Study Investigation on the Influence of Freeze Dried Strawberry Consumption on Gut Microbiota, Intestinal Health, Metabolic Phenotype and Cardiovascular Risk in Overweight and Obese Individuals.|Recruiting||N/A|20|Anticipated|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 20:42:51.027238|2017-10-10 20:42:51.027238
NCT03283956|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||September 13, 2017|Anticipated|2017-09-13|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|SERENADE-T||Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in Taiwan|Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)|Not yet recruiting||N/A|500|Anticipated|National Taiwan University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:42:51.122798|2017-10-10 20:42:51.122798
NCT03283943|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 16, 2020|Anticipated|2020-12-16|December 16, 2020|Anticipated|2020-12-16||Interventional|||PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.|Phase I (Safety Assessment) of Durvalumab (MEDI4736) With Focal Sensitizing Radiotherapy in Platinum Resistant Ovarian, Primary Peritoneal or Fallopian Tube Epithelial Carcinoma|Not yet recruiting||Phase 1|22|Anticipated|British Columbia Cancer Agency||1|||f|||||f|f|||f|||||2017-10-10 20:42:51.205248|2017-10-10 20:42:51.205248
NCT03283930|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||ABMT Augmentation of CBT|Attention Bias Modification Training as Augmentation of Cognitive Behavioral Therapy for Anxiety in Youth|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f|||||f|f||||||||2017-10-10 20:42:51.29281|2017-10-10 20:42:51.29281
NCT03283917|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Study of Daratumumab, Ixazomib, and Dexamethasone in Previously Treated Amyloid Light Chain (AL) Amyloidosis|A Safety Study of Daratumumab, Ixazomib, and Dexamethasone in Previously Treated Amyloid Light Chain (AL) Amyloidosis|Not yet recruiting||Phase 1|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:42:51.378493|2017-10-10 20:42:51.378493
NCT03283904|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|AS:Sk||Active Schools: Skelmersdale|Active Schools: Skelmersdale|Enrolling by invitation||N/A|250|Anticipated|Edge Hill University||1|||f||||f|f|f||||||||2017-10-10 20:42:51.479072|2017-10-10 20:42:51.479072
NCT03283891|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-19|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|ExpCare||Effects on Nurses' Quality of Working Life of an Educational Intervention to Strengthen Their Humanistic Practice|Effects on Nurses' Quality of Working Life and on Patients' Quality of Life of an Educational Intervention to Strengthen Humanistic Practice Among Haemodialysis Nurses in Switzerland: A Mixed Methods Cluster Randomised Controlled Trial|Enrolling by invitation||N/A|135|Anticipated|Institut et Haute Ecole de la Santé la Source||2|||f|||||f|f||||||||2017-10-10 20:42:51.554005|2017-10-10 20:42:51.554005
NCT03283878|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Antibiotic Prophylaxis in Patients Undergoing Elective TKA- Multi-center Trial|Perioperative Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty: A Prospective, Randomized, Open-label, Controlled Multi-center Trial|Not yet recruiting||Phase 4|8000|Anticipated|Duke University||2|||f|||||t|f|||f|||||2017-10-10 20:42:51.653121|2017-10-10 20:42:51.653121
NCT03283865|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Does Use of Ultrasound Reduce the Rate of Sham Caudal Block in Children|Does Use of Ultrasound Reduce the Rate of Sham Caudal Block in Children|Recruiting||N/A|100|Anticipated|Baylor College of Medicine||1|||f||||f|f|t|f|f||||||2017-10-10 20:42:51.725883|2017-10-10 20:42:51.725883
NCT03283852|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||February 21, 2017|Actual|2017-02-21|September 2017|2017-09-01|February 21, 2027|Anticipated|2027-02-21|February 21, 2027|Anticipated|2027-02-21||Observational|FORDEV||Identifying New Genetic Causes to Development Disorders|Identifying New Genetic Causes to the Disorders of Growth, Puberty and Sex Development|Recruiting||N/A|1100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f|||||f|f||||||||2017-10-10 20:42:51.800325|2017-10-10 20:42:51.800325
NCT03283839|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 25, 2020|Anticipated|2020-06-25|February 25, 2019|Anticipated|2019-02-25||Interventional|DAM||Consequences of Temporomandibular Disorder on Balance Control|Consequences of Temporomandibular Disorder on Balance Control|Not yet recruiting||N/A|200|Anticipated|Central Hospital, Nancy, France||2|||f||||t|f|f||||||||2017-10-10 20:42:51.882127|2017-10-10 20:42:51.882127
NCT03283826|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|February 2019|Anticipated|2019-02-01||Interventional|||Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis|An Open-Label Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis|Not yet recruiting||Phase 1|60|Anticipated|Atara Biotherapeutics||1|||f||||f|t|f||||||||2017-10-10 20:42:51.957423|2017-10-10 20:42:51.957423
NCT03283813|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-16|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|ZIMBA||ZIMBA: Clinical Trial in Paediatric Obesity|Effects of a Supplementation With Zinc and Myo-inositol in Paediatric Obesity|Not yet recruiting||Phase 4|60|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita||2|||f||||t|f|f||||||||2017-10-10 20:42:52.059979|2017-10-10 20:42:52.059979
NCT03283800|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||September 23, 2015|Actual|2015-09-23|September 2017|2017-09-01|January 9, 2017|Actual|2017-01-09|January 9, 2017|Actual|2017-01-09||Interventional|CIVIL||Copper Impact on Venous Insufficiency and Lipodermatosclerosis|Impact of Copper Compression Stockings on Venous Insufficiency and Lipodermatosclerosis: a Randomised Controlled Trial|Completed||N/A|16|Actual|Croydon Health Services NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:42:52.174969|2017-10-10 20:42:52.174969
NCT03283787|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries|A Single Site Randomized, Clinical Trial Comparing the Concomitant Use of MicroMatrix® With Cytal™ Wound Matrix 2-Layer to Standard of Care in Patients With Stage 3 or 4 Pressure Injuries|Recruiting||N/A|60|Anticipated|ACell Inc.||3|||f||||f|f|t|f|f|f|||||2017-10-10 20:42:52.270712|2017-10-10 20:42:52.270712
NCT03283774|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-09-14|||January 2015||2015-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|April 2015|Actual|2015-04-01|7 Years|Observational [Patient Registry]|eControl||Multifactorial Control of Type 2 Diabetes and Treatment Intensity in Primary Care|Multifactorial Control of Type 2 Diabetes and Treatment Intensity in Primary Care: A Cohort Study|Completed||N/A|300000|Actual|Jordi Gol i Gurina Foundation|||1||f||||t||||||||||2017-10-10 20:42:52.354319|2017-10-10 20:42:52.354319
NCT03221517|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-09-27|||September 27, 2017|Actual|2017-09-27|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Mapping the Shift Worker's Microbiome|Mapping the Shift Worker's Microbiome|Recruiting||N/A|12|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 20:51:52.450649|2017-10-10 20:51:52.450649
NCT03283761|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-28|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma|A Phase II Study of FOLFOX Combined With Nab-Paclitaxel (FOLFOX-A) in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma. Big Ten Cancer Research Consortium: BTCRC-GI15-015|Recruiting||Phase 2|39|Anticipated|Big Ten Cancer Research Consortium||1|||f||||f|t|f||||||||2017-10-10 20:42:52.420801|2017-10-10 20:42:52.420801
NCT03283748|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-13|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|December 30, 2017|Anticipated|2017-12-30||Interventional|DMS-WBAN||Detection of Motor Seizures Using WBAN|Detection of Motor Seizures Using Wireless Body Area Network|Not yet recruiting||N/A|5|Anticipated|Mohawk College||1|||f||||t|f|f||||||||2017-10-10 20:42:52.529188|2017-10-10 20:42:52.529188
NCT03283735|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-16|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|DePil17-20||Deprescribing: a Portrait and Out-comes of the Reduction of Polypharmacy in Portugal|Deprescribing: a Portrait and Out-comes of the Reduction of Polypharmacy in Portugal|Not yet recruiting||N/A|380|Anticipated|University of Beira Interior||2|||f||||t|f|f||||||||2017-10-10 20:42:52.600332|2017-10-10 20:42:52.600332
NCT03283722|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-11|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||PRESERVE-MITRAL Post-Market Registry|Prospective REgistry to Study Clinical OutcomEs of Repair of Mitral ValvEs in South Asia|Not yet recruiting||N/A|200|Anticipated|Medtronic Cardiovascular|||1||f||||f|f|f||||||||2017-10-10 20:42:52.68223|2017-10-10 20:42:52.68223
NCT03283709|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Removable Partial Denture Abutments Restored With Monolithic Zirconia Crowns|Removable Partial Denture Abutments Restored With Monolithic Zirconia Crowns: A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|University of Kentucky||2|||f||||f|f|t|f||t|||||2017-10-10 20:42:52.743886|2017-10-10 20:42:52.743886
NCT03283696|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-25|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|August 5, 2019|Anticipated|2019-08-05|August 5, 2019|Anticipated|2019-08-05||Interventional|||A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma|A Phase 1b Study of Olaratumab, Doxorubicin and Ifosfamide in the Treatment of Patients With Advanced or Metastatic Soft Tissue Sarcoma|Not yet recruiting||Phase 1|60|Anticipated|Eli Lilly and Company||1|||f||||f|t|f||||||||2017-10-10 20:42:52.842166|2017-10-10 20:42:52.842166
NCT03283683|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||May 25, 2016|Actual|2016-05-25|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Observational|AIPACa||A Feasibility Study of the Use of Actigraphy to Determine Prognosis in Patients With Advanced Cancer|A Feasibility Study of the Use of Actigraphy to Determine Prognosis in Patients With Advanced Cancer|Recruiting||N/A|50|Anticipated|Royal Surrey County Hospital NHS Foundation Trust|||1||f||||t|f|f||||Samples Without DNA|"     On first visit (Day 1 of the study), the researcher will collect total 7.5mls (1½ teaspoons)     of blood from a vein in the participant's arm. 5 mL of the venous blood sample will be sent     for analysis at the Royal Surrey County Hospital of haematological and biochemical     parameters, i.e. white blood cell count (WBC), neutrophil count, lymphocyte count, platelet     count, urea, alanine aminotransferase (ALT), alkaline phosphatase (ALP), albumin, C-reactive     protein (CRP). 2.5 mL of the venous blood sample will be sent for bio-banking at the Surrey     Clinical Research Centre at the University of Surrey (for future transcriptome analysis i.e.     RNA analysis.   "|||2017-10-10 20:42:52.953025|2017-10-10 20:42:52.953025
NCT03283670|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-09-13|||September 2016||2016-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|NARSAD||Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies|Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies|Recruiting||Phase 2|30|Anticipated|Washington University School of Medicine||3|||f||||f||||||||||2017-10-10 20:42:53.151238|2017-10-10 20:42:53.151238
NCT03283657|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-13|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|April 1, 2018|Anticipated|2018-04-01||Interventional|DiRECT||Diabetes Risk Education and Communication Trial|Diabetes Risk Education and Communication Trial (DiRECT)|Enrolling by invitation||N/A|120|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 20:42:53.247207|2017-10-10 20:42:53.247207
NCT03283644|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-12|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Observational|||Obesity-related Inflammation in Patients Prior to and After Bariatric Surgery|Obesity-related Inflammation in Patients Prior to and After Bariatric Surgery|Active, not recruiting||N/A|43|Actual|University of Birmingham|||2||f||||f|f|f||||||||2017-10-10 20:42:53.327367|2017-10-10 20:42:53.327367
NCT03283631|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|INTERCEPT||Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM|INTERCEPT: INTracerebral EGFR-vIII Chimeric Antigen Receptor Gene-Modified T CElls for PaTients With Recurrent GBM|Not yet recruiting||Phase 1|24|Anticipated|Duke University||1|||f||||f|t|f||||||||2017-10-10 20:42:53.406762|2017-10-10 20:42:53.406762
NCT03283618|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||November 16, 2015|Actual|2015-11-16|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Implementation of Medical Weight Management by Telemedicine|Implementation of Medical Weight Management by Telemedicine|Completed||N/A|30|Actual|California State University, Long Beach||2|||f||||t|f|f||||||||2017-10-10 20:42:53.514065|2017-10-10 20:42:53.514065
NCT03283605|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas|Phase I/II of Durvalumab (MEDI4736) + Tremelimumab + Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma|Not yet recruiting||Phase 1/Phase 2|45|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t|f|f||||||||2017-10-10 20:42:53.617269|2017-10-10 20:42:53.617269
NCT03283592|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|RANK||Review and Assessment of Network Meta-analyses for Knowledge Uptake Study|Review and Assessment of Network Meta-analyses for Knowledge Uptake (RANK) Study|Not yet recruiting||N/A|348|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 20:42:53.742129|2017-10-10 20:42:53.742129
NCT03283579|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||November 2003|Actual|2003-11-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms|Prenatal Omega-6/Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder Symptoms in Children: a Population-based Longitudinal Study|Completed||N/A|2644|Actual|Centre for Research in Environmental Epidemiology, Spain|||1||f|||||f|f||||||||2017-10-10 20:42:53.819017|2017-10-10 20:42:53.819017
NCT03283566|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-15|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|October 15, 2019|Anticipated|2019-10-15|October 15, 2019|Anticipated|2019-10-15||Interventional|||Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT|Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing Total Pancreatectomy and Autologous Islet Transplantation: A Clinical, Molecular, and Genomic Study|Not yet recruiting||Phase 2|10|Anticipated|The Cleveland Clinic||2|||f||||f|t|f|||f|||||2017-10-10 20:42:53.878446|2017-10-10 20:42:53.878446
NCT03283553|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-12|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Involving Family to Improve Communication in Breast Cancer Care|Involving Family to Improve Communication in Breast Cancer Care|Recruiting||N/A|70|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f|f|f||||||||2017-10-10 20:42:53.999834|2017-10-10 20:42:53.999834
NCT03283540|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-25|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence|The Short Term Implications of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer on Anal Physiology and Fecal Incontinence|Recruiting||N/A|56|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|f|f||||||||2017-10-10 20:42:54.128352|2017-10-10 20:42:54.128352
NCT03283527|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-12|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|RARESTEM/Org||Organoid Based Response Prediction in Esophageal Cancer|Chemoradioresistance in Prospectively Isolated Cancer Stem Cells in Esophageal Cancer-Organoid: RARE STEM-Organoid|Not yet recruiting||N/A|100|Anticipated|University Medical Center Groningen|||1||f||||t|f|f||||||||2017-10-10 20:42:54.257743|2017-10-10 20:42:54.257743
NCT03283514|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-12|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|September 1, 2017|Actual|2017-09-01||Observational|||Esthetic Expectations of Edentulous Patients Followed in a French Dental Clinic|Esthetic Expectations of Edentulous Patients Followed in a French Dental Clinic|Completed||N/A|42|Actual|Hôpital Rothschild|||1||f||||f||||||||||2017-10-10 20:42:54.332542|2017-10-10 20:42:54.332542
NCT03283501|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-12|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|REVIVAL||Revascularization After Transcatheter Aortic Valve Implantation (REVIVAL)|A Multicenter Observational Registry on Coronary Revascularization After Implantation of Transcatheter Aortic Valve Bioprosthesis|Recruiting||N/A|500|Anticipated|San Luigi Gonzaga Hospital|||1||f||||f|f|f||||||||2017-10-10 20:42:54.400577|2017-10-10 20:42:54.400577
NCT03283488|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-12|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.|Randomized, Double-blind Clinical Trial of the Use of Mirtazapine Versus Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.|Not yet recruiting||Phase 3|52|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||||2017-10-10 20:42:54.504005|2017-10-10 20:42:54.504005
NCT03283475|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-13|||May 14, 2017|Actual|2017-05-14|September 2017|2017-09-01|April 1, 2019|Anticipated|2019-04-01|October 22, 2018|Anticipated|2018-10-22||Interventional|thigh lift||Different Surgical Modalities for Thigh Lipodystrophy Including Liposuction,Thigh Lift and Liposuction Assisted Thigh Lift|Surgical Management of Thigh Lipodystrophy|Active, not recruiting||N/A|90|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:42:54.628792|2017-10-10 20:42:54.628792
NCT03283462|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial)|A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Impact of a Daily Dose of AMAZ-02, a Food Derived Ingredient, for 4 Months on Skeletal Muscle Energetics and Function in Healthy Elderly|Recruiting||N/A|90|Anticipated|Amazentis SA||3|||f||||f|f|f||||||||2017-10-10 20:42:54.739448|2017-10-10 20:42:54.739448
NCT03283449|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-09-13|||February 2016||2016-02-01|September 2017|2017-09-01|November 1, 2021||2021-11-01|February 2018|Anticipated|2018-02-01||Interventional|||Tau PET Imaging in Atypical Dementias|Tau PET Imaging in Atypical Dementias|Recruiting||Phase 1|10|Anticipated|Northwestern University||1|||f||||||||||||||2017-10-10 20:42:54.846064|2017-10-10 20:42:54.846064
NCT03283436|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||RCT Superior Hypogastric Block During LH|Superior Hypogastric Plexus Block During Laparoscopic Hysterectomy: a Randomized Controlled Trial.|Not yet recruiting||Phase 4|100|Anticipated|Brigham and Women's Hospital||2|||f||||f|t|f|||t|||||2017-10-10 20:42:54.965004|2017-10-10 20:42:54.965004
NCT03283423|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Image-guided Lymphadanectomy in AMIGO|Image-guided Lymphadanectomy in AMIGO|Not yet recruiting||N/A|20|Anticipated|Brigham and Women's Hospital||1|||f||||f|f|f|||t|||||2017-10-10 20:42:55.069153|2017-10-10 20:42:55.069153
NCT03283410|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-09-12|||January 30, 2017|Actual|2017-01-30|September 2017|2017-09-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||Determination of Propofol Target Concentration for Young and Elderly by Suppression Rate Analysis|Determination of Propofol Target Concentration for Young and Elderly by Suppression Rate Analysis|Withdrawn||Phase 4|0|Actual|Brasilia University Hospital||1||Local problems with BIS monitor, we wont have it anymore.|f||||f|f|f||||||||2017-10-10 20:42:55.146413|2017-10-10 20:42:55.146413
NCT03283228|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia|Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia|Not yet recruiting||N/A|30|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:42:56.728932|2017-10-10 20:42:56.728932
NCT03283384|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-12|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2024|Anticipated|2024-11-01|April 2020|Anticipated|2020-04-01||Interventional|NEOLBC||Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.|Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.|Not yet recruiting||Phase 2|100|Anticipated|Borstkanker Onderzoek Groep||3|||f||||t|f|f||||||||2017-10-10 20:42:55.333548|2017-10-10 20:42:55.333548
NCT03283371|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-10-02|||December 11, 2017|Anticipated|2017-12-11|October 2017|2017-10-01|April 22, 2022|Anticipated|2022-04-22|July 17, 2019|Anticipated|2019-07-17||Interventional|OPUS||Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Exploring the Efficacy, Safety, and Tolerability of Natalizumab (BG00002) as Adjunctive Therapy in Adult Subjects With Drug-Resistant Focal Epilepsy|Not yet recruiting||Phase 2|70|Anticipated|Biogen||2|||f||||t|t|f||||||||2017-10-10 20:42:55.567204|2017-10-10 20:42:55.567204
NCT03283358|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-09-12|||April 1, 2016|Actual|2016-04-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|FASTIC||Person-centered Follow up and Health Promotion Program After Revascularization for Intermittent Claudication|Person-centered Follow up and Health Promotion Program After Revascularization for Intermittent Claudication|Recruiting||N/A|210|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 20:42:55.66049|2017-10-10 20:42:55.66049
NCT03283345|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-09-15|||June 2008|Actual|2008-06-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Effect of Menstrual Cycle on Traumatic Systemic Response|ASSESSMENT OF SYSTEMIC RESPONSES TO TRAUMA IN DIFFERENT PHASES OF THE MENSTRUAL CYCLE: IN PATIENTS UNDERWENT MODIFIED RADICAL MASTECTOMY A Clinical Study|Active, not recruiting||N/A|89|Actual|Kocaeli University||2|||f||||t|f|f||||||||2017-10-10 20:42:55.802639|2017-10-10 20:42:55.802639
NCT03283332|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||December 1, 2011|Actual|2011-12-01|September 2017|2017-09-01|December 1, 2012|Actual|2012-12-01|December 1, 2012|Actual|2012-12-01||Observational|DASH||Determinants of Adolescent, Now Young Adults, Social Well-being and Health: Longitudinal Follow-up|Determinants of Adolescent Social Well-being and Health: a London Based Longitudinal Study of Young People From Different Ethnic Groups|Completed||N/A|6643|Actual|King's College London|||1||f||||f|f|f||||||||2017-10-10 20:42:55.904709|2017-10-10 20:42:55.904709
NCT03283306|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||August 9, 2017|Actual|2017-08-09|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30|12 Months|Observational [Patient Registry]|||Prognostic Value of Carotid CEUS in Acute Ischemic Stroke Patients|Prognostic Value of Carotid Contrast-Enhanced Ultrasound in Acute Ischemic Stroke Patients for Cerebrovascular and Cardiovascular Event|Recruiting||N/A|667|Anticipated|Seoul National University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:42:56.200315|2017-10-10 20:42:56.200315
NCT03283293|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||February 2001|Actual|2001-02-01|September 2017|2017-09-01|April 2008|Actual|2008-04-01|April 2007|Actual|2007-04-01||Interventional|||Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT|Study on Delineation of the Target Volumes and Determination of the Irradiation Doses in Untreated Nasopharyngeal Carcinoma (NPC) Treated With Intensity Modulated Radiation Therapy (IMRT)|Completed||Phase 2|112|Actual|Sun Yat-sen University||1|||f||||t|f|f||||||||2017-10-10 20:42:56.278093|2017-10-10 20:42:56.278093
NCT03283280|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|August 30, 2019|Anticipated|2019-08-30||Interventional|||Clinical Performance of Short Fiber Reinforced Resin Composite Versus Indirect Nanohybrid Resin Composite Onlay Restorations.|Clinical Performance of Short Fiber Reinforced Resin Composite Restorations Versus Indirect Nanohybrid Resin Composite Onlay Restorations in Complex Proximal Cavities of Molars|Not yet recruiting||N/A|76|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:42:56.355768|2017-10-10 20:42:56.355768
NCT03283267|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-12|||October 26, 2017|Anticipated|2017-10-26|September 2017|2017-09-01|November 29, 2017|Anticipated|2017-11-29|November 29, 2017|Anticipated|2017-11-29||Interventional|||A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)|A Single-center Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)|Not yet recruiting||Phase 1|22|Anticipated|AstraZeneca||2|||f||||f|f|f|||f|||||2017-10-10 20:42:56.431416|2017-10-10 20:42:56.431416
NCT03283254|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 10, 2022|Anticipated|2022-08-10|July 20, 2022|Anticipated|2022-07-20||Interventional|PREPP||PREPP: Preventing Postpartum Depression|Preventing Postpartum Depression: A Dyadic Approach Adjunctive to Obstetric Care|Not yet recruiting||N/A|300|Anticipated|New York State Psychiatric Institute||2|||f||||t|f|f||||||||2017-10-10 20:42:56.55402|2017-10-10 20:42:56.55402
NCT03283241|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-13|2017-09-14|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|November 30, 2020|Anticipated|2020-11-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Zolidd One ExHex Dental Implant Compared to Uncoated One ExHex Dental Implant in Subjects With Partial Edentulism|A Randomized, Multicentre, Double Blind, Parallel Study to Evaluate the Performance and Safety of the Zolidd One ExHex Dental Implant Compared to Uncoated One ExHex Dental Implant in Subjects With Partial Edentulism|Recruiting||N/A|70|Anticipated|Addbio AB||2|||f||||f|f|f||||||||2017-10-10 20:42:56.642399|2017-10-10 20:42:56.642399
NCT03283215|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Causes and Underlying Factors of Faltering Growth Among Infants|Causes and Underlying Factors of Faltering Growth Among Infants|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:42:56.812563|2017-10-10 20:42:56.812563
NCT03283202|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-12|||September 21, 2017|Anticipated|2017-09-21|September 2017|2017-09-01|May 28, 2022|Anticipated|2022-05-28|October 29, 2020|Anticipated|2020-10-29||Interventional|||Study of Safety and Efficacy of CC-122 Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors|A Phase 1/2 Open-label, Multicenter Study of CC-122 in Combination With R-CHOP-21 for Previously Untreated Poor-Risk (IPI ≥ 3) Diffuse Large B-Cell Lymphoma|Not yet recruiting||Phase 1/Phase 2|82|Anticipated|Celgene||1|||f||||t|t|f||||||||2017-10-10 20:42:56.860827|2017-10-10 20:42:56.860827
NCT03283189|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||January 2, 2018|Anticipated|2018-01-02|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|June 30, 2018|Anticipated|2018-06-30||Observational|PERICOS||Cosmetics and Pregnancy|Perception of the Risk Associated With the Use of Cosmetics Products During Pregnancy - a Qualitative Study|Not yet recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||6||f|||||f|f||||||||2017-10-10 20:42:56.939897|2017-10-10 20:42:56.939897
NCT03283176|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin|Changes in Hematologic Profile, Vitamin B12 and Folic Acid Level in Cirrhotic Patients Received Sofosbuvir and Daclatasvir With or Without Ribavirin|Not yet recruiting||N/A|50|Anticipated|Assiut University|||2||f|||||f|f||||||||2017-10-10 20:42:57.023101|2017-10-10 20:42:57.023101
NCT03283163|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||October 1, 2013|Actual|2013-10-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|EXCPPTSD||Neurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSD|Neurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSD|Recruiting||N/A|36|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 20:42:57.098795|2017-10-10 20:42:57.098795
NCT03283150|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-13|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Deep Brain Stimulation (DBS) Sedation|Effects of Anesthesia Drugs on Neuronal Activity in the Basal Ganglia and Thalamus During Deep Brain Stimulation Electrode Implantation Surgery|Not yet recruiting||N/A|180|Anticipated|University of Wisconsin, Madison||3|||f||||t|f|f||||||||2017-10-10 20:42:57.173878|2017-10-10 20:42:57.173878
NCT03283137|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL|A Phase I, Open-label, Dose-escalation Study to Assess the Safety, Tolerability and Efficacy of the Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-Cell Non-Hodgkin Lymphoma (NHL)|Not yet recruiting||Phase 1|36|Anticipated|University of Chicago||1|||f||||f|t|f|||t|||||2017-10-10 20:42:57.257294|2017-10-10 20:42:57.257294
NCT03283124|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-09-12|||September 12, 2017|Actual|2017-09-12|May 2017|2017-05-01|September 12, 2020|Anticipated|2020-09-12|September 12, 2018|Anticipated|2018-09-12||Interventional|||Comparing Transvaginal Self-tailored Titanium-coated Polypropylene Mesh Procedure With Mesh-kit Procedure.|A Multicenter Randomized Controlled Non-inferiority Trial Comparing Transvaginal Self-tailored Titanium-coated Polypropylene Mesh Procedure With Mesh-kit Procedure.|Recruiting||N/A|524|Anticipated|Peking Union Medical College Hospital||2|||f||||t|f|f||||||||2017-10-10 20:42:57.343594|2017-10-10 20:42:57.343594
NCT03283111|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma|Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma|Not yet recruiting||N/A|150|Anticipated|Peking University||1|||f|||||f|f||||||||2017-10-10 20:42:57.433169|2017-10-10 20:42:57.433169
NCT03283098|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-10-04|||November 24, 2017|Anticipated|2017-11-24|October 2017|2017-10-01|July 24, 2018|Anticipated|2018-07-24|July 24, 2018|Anticipated|2018-07-24||Interventional|||A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416|A Phase 1, Multiple Dose, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pharmacokinetics, Safety and Tolerability of AMG 416 Administered Intravenously to Chinese Subjects With Chronic Kidney Disease on Hemodialysis|Not yet recruiting||Phase 1|32|Anticipated|Amgen||2|||f||||f|t|f|||t|||||2017-10-10 20:42:57.5837|2017-10-10 20:42:57.5837
NCT03283085|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-10-04|||January 22, 2018|Anticipated|2018-01-22|October 2017|2017-10-01|February 11, 2025|Anticipated|2025-02-11|February 11, 2025|Anticipated|2025-02-11||Interventional|||A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis (AIDA)|A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis (AIDA)|Not yet recruiting||Phase 3|1114|Anticipated|Shire||2|||f||||t|t|f||||||||2017-10-10 20:42:57.69452|2017-10-10 20:42:57.69452
NCT03283046|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma|Phase 1 Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1||Similar to another study.|f||||f|t|f||||||||2017-10-10 20:42:58.452653|2017-10-10 20:42:58.452653
NCT03283033|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|June 2020|Anticipated|2020-06-01||Interventional|||School Lunch Salad Bars and Fruit and Vegetable Consumption|Salad Bars and Students' Fruit and Vegetable Consumption: A Group-randomized Trial With Objective Assessments|Not yet recruiting||N/A|6408|Anticipated|Arizona State University||4|||f||||t|f|f||||||||2017-10-10 20:42:58.6049|2017-10-10 20:42:58.6049
NCT03283020|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||November 11, 2017|Anticipated|2017-11-11|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Opioid-Induced Swallowing Dysfunction - The Impact of Bolus Volume|Opioid-Induced Swallowing Dysfunction - The Impact of Bolus Volume: a Randomized, Double-Blind Study in Healthy Volunteers|Not yet recruiting||Phase 4|20|Anticipated|Region Örebro County||2|||f||||t|f|f||||||||2017-10-10 20:42:58.704821|2017-10-10 20:42:58.704821
NCT03283007|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-11|||April 2018|Anticipated|2018-04-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|April 2021|Anticipated|2021-04-01||Interventional|INFINITx-BOS||Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 1-2|A Multi-center, Randomised, Double-blind Trial of Nintedanib in Lung Transplant (LTx) Recipients With Bronchiolitis Obliterans Syndrome (BOS) Grade 1-2|Not yet recruiting||Phase 3|80|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||||2017-10-10 20:42:58.826801|2017-10-10 20:42:58.826801
NCT03282994|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||July 19, 2017||2017-07-19||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:42:58.927156|2017-10-10 20:42:58.927156
NCT03282981|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 1, 2021|Anticipated|2021-09-01|January 1, 2021|Anticipated|2021-01-01||Interventional|BAART-DFU||Beta Adrenergic Antagonist for the Healing of Chronic DFU|Beta Adrenergic Antagonist For The Healing of Chronic Diabetic Foot Ulcers|Not yet recruiting||Phase 3|138|Anticipated|VA Office of Research and Development||2|||||||t|t|f|||f|||||2017-10-10 20:42:58.984038|2017-10-10 20:42:58.984038
NCT03282968|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||January 3, 2017|Actual|2017-01-03|September 2017|2017-09-01|September 12, 2017|Actual|2017-09-12|July 1, 2017|Actual|2017-07-01||Interventional|REWIRESI||Balance Training After Stroke With REWIRE|Balance Training With the Rehabilitative Wayout In Responsive Home Environments (REWIRE) System in Patients After Stroke|Completed||N/A|20|Actual|University Rehabilitation Institute, Republic of Slovenia||2|||f||||f|f|f||||||||2017-10-10 20:42:59.105285|2017-10-10 20:42:59.105285
NCT03282955|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-13|||September 21, 2017|Anticipated|2017-09-21|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|March 1, 2019|Anticipated|2019-03-01||Interventional|HOME||The HOME Study (HPN With OMEGA-3)|A Randomized, Controlled, Double-blind, Multicenter Clinical Trial on Home Parenteral Nutrition Using an Omega-3 Fatty Acid Enriched MCT/LCT Lipid Emulsion|Not yet recruiting||Phase 4|160|Anticipated|B. Braun Melsungen AG||2|||f||||f|f|f||||||||2017-10-10 20:42:59.203211|2017-10-10 20:42:59.203211
NCT03282942|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||January 2, 2018|Anticipated|2018-01-02|September 2017|2017-09-01|July 30, 2019|Anticipated|2019-07-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||CARDIOVASCULAR EFFECTS OF AEROBIC AND STRENGTH TRAINING IN HYPERTENSIVE MIDDLE AGES: A RANDOMIZED CLINICAL TRIAL.|EFFECTS OF AEROBIC AND STRENGTH TRAINING ON CARDIOVASCULAR, ENDOTHELIAL RESPONSE, OXIDATIVE STRESS AND BLOOD FLOW IN HYPERTENSIVE MIDDLE AGES: A RANDOMIZED Clinical Trial.|Not yet recruiting||N/A|60|Anticipated|Federal University of Rio Grande do Sul||2|||f||||t|f|f||||||||2017-10-10 20:42:59.309414|2017-10-10 20:42:59.309414
NCT03282929|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-13|||March 30, 2017|Actual|2017-03-30|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)|An Single-dose, Open Label, Randomized Cross-over Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)|Recruiting||Phase 1|56|Anticipated|Bausch & Lomb Incorporated||5|||f||||f|f|f||||||||2017-10-10 20:42:59.397096|2017-10-10 20:42:59.397096
NCT03282916|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Anti-viral Therapy in Alzheimer's Disease|Anti-viral Therapy in Alzheimer's Disease|Not yet recruiting||Phase 2|130|Anticipated|New York State Psychiatric Institute||2|||||||t|t|f||||||||2017-10-10 20:42:59.527982|2017-10-10 20:42:59.527982
NCT03282903|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-14|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2020|Anticipated|2020-10-31||Observational|PREdiCCt||The PRognostic Effect of Environmental Factors in Crohn's and Colitis|The PRognostic Effect of Environmental Factors in Crohn's and Colitis|Recruiting||N/A|1500|Anticipated|University of Edinburgh|||2||f||||f|f|f||||Samples With DNA|"     Stool sample (for microbiome analysis) Saliva sample (for genomic analysis) Blood sample (for     biochemical, haematological and genomic analysis)   "|||2017-10-10 20:42:59.649491|2017-10-10 20:42:59.649491
NCT03282890|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|March 2022|Anticipated|2022-03-01||Interventional|CHRP-BB||Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs|Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs|Not yet recruiting||N/A|300|Anticipated|University of Connecticut||2|||f||||t|f|f||||||||2017-10-10 20:42:59.79678|2017-10-10 20:42:59.79678
NCT03282877|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-13|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||iCST Web-application for People With Dementia|Adapting Individual Cognitive Stimulation Therapy (iCST) for Delivery by a Web-application|Not yet recruiting||N/A|60|Anticipated|University of Nottingham||2|||f||||f|f|f||||||||2017-10-10 20:42:59.916977|2017-10-10 20:42:59.916977
NCT03282864|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-13|||January 17, 2017|Actual|2017-01-17|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|April 22, 2017|Actual|2017-04-22||Interventional|||The Impact of Air Filtration on Asthmatic Children|The Impact of Air Filtration on Health Indicators of Asthmatic Children|Active, not recruiting||N/A|43|Actual|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:43:00.030028|2017-10-10 20:43:00.030028
NCT03282487|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Optimising Steroid Replacement in Patients With Adrenal Insufficiency|Optimising Steroid Replacement in Patients With Adrenal Insufficiency|Enrolling by invitation||Phase 4|60|Anticipated|The Adelaide and Meath Hospital, incorporating The National Children's Hospital||3|||f||||f|f|f||||||||2017-10-10 20:43:04.560601|2017-10-10 20:43:04.560601
NCT03282851|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-13|||October 17, 2017|Anticipated|2017-10-17|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456|Randomized, Double-Blind, Parallel-Group, Single-Dose Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability and Immunogenicity of MSB11456, US-licensed Actemra® and EU-approved RoActemra® in Healthy Adult Subjects|Not yet recruiting||Phase 1|318|Anticipated|Merck KGaA||3|||f|||||t|f||||||||2017-10-10 20:43:00.129505|2017-10-10 20:43:00.129505
NCT03282838|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-18|||June 24, 2017|Actual|2017-06-24|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|July 19, 2017|Actual|2017-07-19||Interventional|||Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects|Open-Label, Three Way, Randomized, Single Dose Crossover Study Comparing Bioavailability of DFN-15 Oral Solution Under Fasting Conditions vs Comparator Under Fed Conditions and to Determine Food Effect of DFN-15 in Healthy Adult Subjects|Active, not recruiting||Phase 1|24|Actual|Dr. Reddy's Laboratories Limited||3|||f||||f|t|f||||||||2017-10-10 20:43:00.224602|2017-10-10 20:43:00.224602
NCT03282825|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-13|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Study of Decitabine and Paclitaxel Combination Therapy|An Open-labelled, Parallel, Multiple Ascending Dose, Phase Ib Clinical Study of Decitabine and Paclitaxel Combination Therapy in Treating Patients With Metastatic and Locally Advanced Breast Cancer|Active, not recruiting||Phase 1|18|Anticipated|Dong Wha Pharmaceutical Co. Ltd.||1|||f|||||f|f|||f|||||2017-10-10 20:43:00.293933|2017-10-10 20:43:00.293933
NCT03282812|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||June 1998|Actual|1998-06-01|September 2017|2017-09-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Observational|||Metabolomics and Breast Cancer Risk in a Nested Case-control Study of the Cancer Prevention Study-II Nutrition Cohort|Cancer Prevention Study-II Nutrition Cohort|Completed||N/A|1547|Actual|American Cancer Society, Inc.|||2||f||||f|f|f||||||||2017-10-10 20:43:00.376763|2017-10-10 20:43:00.376763
NCT03282799|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women|Pharmacokinetic and Pharmacodynamic Evaluation of Etonogestrel Dose Escalation With Efavirenz-based Antiretroviral Therapy in HIV-infected Ugandan|Not yet recruiting||Phase 2|72|Anticipated|University of Pittsburgh||2|||f||||t|t|f||||||||2017-10-10 20:43:00.435761|2017-10-10 20:43:00.435761
NCT03282786|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-13|||September 3, 2017|Actual|2017-09-03|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|August 1, 2019|Anticipated|2019-08-01||Interventional|CO2-IBD||Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease|Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease|Recruiting||N/A|304|Anticipated|University Hospital Muenster||4|||f||||f|f|f||||||||2017-10-10 20:43:00.531959|2017-10-10 20:43:00.531959
NCT03282773|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-13|||October 8, 2017|Anticipated|2017-10-08|September 2017|2017-09-01|July 31, 2022|Anticipated|2022-07-31|December 31, 2021|Anticipated|2021-12-31||Interventional|OPTIMAL||Optimal Strategy of Primary PCI for Left Main Coronary Artery Occlusion Induced AMI|Optimal Strategy of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Due to Unprotected Left Main Coronary Artery Occlusion|Not yet recruiting||N/A|480|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f|f|f||||||||2017-10-10 20:43:00.66835|2017-10-10 20:43:00.66835
NCT03282760|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-12|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|February 28, 2021|Anticipated|2021-02-28|April 30, 2020|Anticipated|2020-04-30||Interventional|NSC-SPMS||Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients|A Phase I Multicenter Study of Allogenic, Intracerebroventricular Human Neural Stem Cells Transplantation for the Experimental Treatment of Secondary Progressive Multiple Sclerosis Patients|Recruiting||Phase 1|24|Anticipated|Casa Sollievo della Sofferenza IRCCS||1|||f||||t|f|f||||||||2017-10-10 20:43:00.766458|2017-10-10 20:43:00.766458
NCT03282747|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-12|||July 15, 2017|Actual|2017-07-15|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|July 15, 2018|Anticipated|2018-07-15||Observational|ANEMONE||Distribution of Risk Factors for Venous Thromboembolism in Blood Donors|Risk Factors for Venous Thrombosis and Pulmonary Embolism in Blood Donors|Recruiting||N/A|10000|Anticipated|Casa Sollievo della Sofferenza IRCCS|||1||f||||f|f|f||||||||2017-10-10 20:43:00.869895|2017-10-10 20:43:00.869895
NCT03282734|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-19|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|Smart-Rehab||Home-based Exercise Program With Smart Rehabilitation System|Effect of the Home-based Exercise Program With Smart Rehabilitation System on Balance and Gait Functions in Stroke Patients|Recruiting||N/A|100|Anticipated|Samsung Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:43:00.93737|2017-10-10 20:43:00.93737
NCT03282721|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-13|||January 1, 2012|Actual|2012-01-01|September 2017|2017-09-01|December 30, 2016|Actual|2016-12-30|January 30, 2016|Actual|2016-01-30||Observational|||Transverse Facial Cleft Repair Using Precise Location of Commissure|Short/Long-term Observation of Transverse Facial Cleft Repair Using Precise Location of Commissure|Completed||N/A|9|Actual|Peking Union Medical College Hospital|||2||f||||t|f|f||||||||2017-10-10 20:43:01.025842|2017-10-10 20:43:01.025842
NCT03282708|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-13|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|SHAPES-CAP||Comparative Study of Great Ape-caretaker Microbiome|Comparative Study of Captive Great Ape and Human Intestinal Microbiomes|Not yet recruiting||N/A|17|Anticipated|Institut Pasteur||2|||f||||f|f|f||||||||2017-10-10 20:43:01.098927|2017-10-10 20:43:01.098927
NCT03282695|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|September 30, 2021|Anticipated|2021-09-30||Observational|O3HDCIRUGIA||Ozone Therapy in Patients on Waiting List for Surgery Due to Disc Herniation: Prospective, Post-authorization Study|Ozone Therapy in Patients on Waiting List for Surgery Due to Disc Herniation: Prospective, Post-authorization Study|Not yet recruiting||N/A|80|Anticipated|Dr. Negrin University Hospital|||2||f||||t|f|f||||||||2017-10-10 20:43:01.192712|2017-10-10 20:43:01.192712
NCT03282682|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male|Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male (ADAM)|Recruiting||N/A|36|Anticipated|Comenius University||3|||f||||f|f|f||||||||2017-10-10 20:43:01.301864|2017-10-10 20:43:01.301864
NCT03282669|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||TC02 Obese Women Using It Morphine vs PCA IV Hydromorphone for Post-Cesarean Analgesia|Randomized Controlled Trial Evaluating the Transcutaneous Carbon Dioxide Measurements in Obese Women Using Intrathecal Morphine Versus Patient-Controlled Intravenous Hydromorphone for Post-Cesarean Analgesia|Recruiting||Phase 4|180|Anticipated|Northwestern University||2|||f||||t|t|f||||||||2017-10-10 20:43:01.424777|2017-10-10 20:43:01.424777
NCT03282643|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||February 16, 2016|Actual|2016-02-16|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients|Rivaroxaban Versus Low-molecular-weight Heparin in Preventing Thrombosis Among Cancer Patients After Femoral Venepuncture|Recruiting||Phase 1/Phase 2|300|Anticipated|Capital Medical University||3|||f||||f|f|f||||||||2017-10-10 20:43:03.375356|2017-10-10 20:43:03.375356
NCT03282630|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-13|||January 16, 2016|Actual|2016-01-16|September 2017|2017-09-01|February 20, 2017|Actual|2017-02-20|January 16, 2017|Actual|2017-01-16||Interventional|||The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic Rhinitis|The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic Rhinitis: A Randomized Trial|Completed||N/A|150|Actual|Beijing Tongren Hospital||2|||f||||t|f|f||||||||2017-10-10 20:43:03.455461|2017-10-10 20:43:03.455461
NCT03282617|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|August 14, 2020|Anticipated|2020-08-14|August 14, 2019|Anticipated|2019-08-14||Interventional|||Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma|Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma|Recruiting||Phase 1|55|Anticipated|National University Hospital, Singapore||2|||f||||f|f|f||||||||2017-10-10 20:43:03.539063|2017-10-10 20:43:03.539063
NCT03282591|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough|A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough|Not yet recruiting||Phase 2|170|Anticipated|Menlo Therapeutics Inc.||2|||f||||f|t|f||||||||2017-10-10 20:43:03.695826|2017-10-10 20:43:03.695826
NCT03282565|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Functional Resistance Training to Improve Knee Function After ACL Reconstruction|Functional Resistance Training During Gait: A Novel Intervention to Improve Knee Knee Function After ACL Reconstruction|Not yet recruiting||N/A|45|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 20:43:03.863103|2017-10-10 20:43:03.863103
NCT03282552|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-12|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||High Flow Oxygen Therapy Versus Conventional Oxygen Therapy in Cardiac Surgery Patients|High Flow Oxygen Therapy Versus Conventional Oxygen Therapy in Cardiac Surgery Patients-OPTICAR Study|Recruiting||N/A|63|Anticipated|National and Kapodistrian University of Athens||3|||f||||t|f|f||||||||2017-10-10 20:43:03.954377|2017-10-10 20:43:03.954377
NCT03282539|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-12|||May 2011|Actual|2011-05-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Lumen Apposing Metal Stents With and Without a Double Pigtail Stent in Pancreatic Collections|Lumen Apposing Metal Stents With and Without a Coaxial Double Pigtail Stent in the Management of Pancreatic Fluid Collections|Completed||N/A|37|Actual|Hospital Universitari de Bellvitge|||2||f|||||f|t|f|f|t|||||2017-10-10 20:43:04.178712|2017-10-10 20:43:04.178712
NCT03282526|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-09-12|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease|Volume Parameters Vs Flow Parameters In Assessment Of Reversibility In Stable Chronic Obstructive Pulmonary Disease Patients|Not yet recruiting||N/A|100|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:43:04.269843|2017-10-10 20:43:04.269843
NCT03282513|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic Function|A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic Function|Recruiting||Phase 1|32|Anticipated|Agios Pharmaceuticals, Inc.||4|||f||||f|t|f||||||||2017-10-10 20:43:04.361707|2017-10-10 20:43:04.361707
NCT03282500|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-18|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Advances in Treatment: Examining the Effectiveness of a Behavioral Intervention.|Advances in Treatment: Examining the Effectiveness of a Behavioral Intervention.|Recruiting||N/A|46|Anticipated|Kessler Foundation||2|||f||||f||||||||||2017-10-10 20:43:04.462555|2017-10-10 20:43:04.462555
NCT03282474|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)|HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)|Not yet recruiting||Phase 2|10|Anticipated|Hannover Medical School||1|||f||||f|f|f|||f|||||2017-10-10 20:43:04.651645|2017-10-10 20:43:04.651645
NCT03282461|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|September 30, 2018|Anticipated|2018-09-30||Interventional|||A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery|A Phase 0 Open Label, Single-center Clinical Trial of ABY-029, an Anti-EGFR Fluorescence Imaging Agent Via Single Intravenous Injection to Subjects With Operable Head and Neck Cancer.|Not yet recruiting||Early Phase 1|12|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t|t|f||||||||2017-10-10 20:43:04.768273|2017-10-10 20:43:04.768273
NCT03282448|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-22|||May 26, 2017|Actual|2017-05-26|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||Video-based Family Therapy for Peripartum Depression in Home Visited Mothers|Integrated Video-based Family Therapy for Peripartum Depression in Home Visited Mothers: A Pilot Study|Recruiting||N/A|24|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:43:04.851265|2017-10-10 20:43:04.851265
NCT03282435|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|||Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody|Treatment of Non-small Cell Lung Cancer With CIK Cells Blocked by PD-1 Antibody|Not yet recruiting||Phase 1|30|Anticipated|Dalian University||2|||f|||||f|f||||||||2017-10-10 20:43:04.96723|2017-10-10 20:43:04.96723
NCT03282422|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-11|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Effectiveness of the Functional Hand Splint and Specific Tasks in the Domiciliary Environment Applied to Children With Unilateral Cerebral Palsy|Effectiveness of the Functional Hand Splint and Specific Tasks in the Domiciliary Environment Applied to Children With Unilateral Cerebral Palsy. Randomized Clinical Trial|Enrolling by invitation||N/A|36|Anticipated|Universidad San Jorge||2|||f||||f|f|f||||||||2017-10-10 20:43:05.08926|2017-10-10 20:43:05.08926
NCT03282396|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||Ibrutinib in Newly Diagnosed Mantle Cell Lymphoma With Low-Risk Disease|A Phase II Trial of Ibrutinib in Newly Diagnosed Mantle Cell Lymphoma With Low-Risk Disease|Not yet recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:43:05.28656|2017-10-10 20:43:05.28656
NCT03282383|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||January 1, 2014|Actual|2014-01-01|September 2017|2017-09-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Observational|||Identification of Biomarkers for Severe Pneumonia|Shanghai Changhai Hospital,Second Military Medical University|Completed||N/A|600|Actual|Changhai Hospital|||1||f|||||f|f||||Samples With DNA|"     Serum   "|||2017-10-10 20:43:05.38186|2017-10-10 20:43:05.38186
NCT03282357|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||July 27, 2017|Actual|2017-07-27|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in China|Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds|Recruiting||N/A|174|Anticipated|Merz Pharmaceuticals, LLC||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:43:05.574467|2017-10-10 20:43:05.574467
NCT03282344|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma|A Pilot Study of NKTR-214 and Nivolumab in Selected Patients With Locally Advanced/Metastatic Sarcoma (CA209-9EM)|Recruiting||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:43:05.667829|2017-10-10 20:43:05.667829
NCT03282331|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-13|||June 2, 2016|Actual|2016-06-02|September 2017|2017-09-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Actual|2017-09-01||Interventional|MORPHEIT||Lung MORphological Modifications Evaluated by Electrical Impedance Tomography During Preoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation (MORPHEIT Study, an Ancillary Study of PREONIV Trial)|Lung MORphological Modifications Evaluated by Electrical Impedance Tomography During Preoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation (MORPHEIT Study, an Ancillary Study of PREONIV Trial)|Recruiting||N/A|30|Anticipated|University Hospital, Clermont-Ferrand||3|||f|||||f|f||||||||2017-10-10 20:43:05.784722|2017-10-10 20:43:05.784722
NCT03282318|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-10-05|||September 28, 2017|Actual|2017-09-28|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|SERENITY||A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis|A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof of Concept Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis|Recruiting||Phase 2|163|Anticipated|Astellas Pharma Inc||2|||f||||t|f|f||||||||2017-10-10 20:43:05.887743|2017-10-10 20:43:05.887743
NCT03282305|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2029|Anticipated|2029-10-01|October 2028|Anticipated|2028-10-01||Observational|||Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese|Prospective Cohort Assessing the Prevalence and Progress of Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) in Chinese|Not yet recruiting||N/A|5000|Anticipated|Humanity and Health Research Centre|||1||f||||t|f|f||||Samples With DNA|"     Whole blood will be stored for biomarkers analysis   "|||2017-10-10 20:43:06.110161|2017-10-10 20:43:06.110161
NCT03282292|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|October 12, 2019|Anticipated|2019-10-12|September 12, 2019|Anticipated|2019-09-12||Interventional|PRECiSE||Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery|Central Venous Catheter Insertion Site and Catheter Colonization and Bloodstream Infection in Pediatric Cardiac Surgery|Recruiting||N/A|160|Anticipated|IRCCS Policlinico S. Donato||2|||f||||t|f|f||||||||2017-10-10 20:43:06.194234|2017-10-10 20:43:06.194234
NCT03282279|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-19|||June 23, 1996|Actual|1996-06-23|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|TVOR||Retrospective Analysis of the Incidence of Complications From Transvaginal Oocyte Retrieval (TVOR).|Retrospective Analysis of the Incidence of Complications From Transvaginal Oocyte Retrieval (TVOR).|Active, not recruiting||N/A|23827|Actual|Istituto Clinico Humanitas|||1||f||||t|f|f||||||||2017-10-10 20:43:06.341035|2017-10-10 20:43:06.341035
NCT03282266|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 30, 2021|Anticipated|2021-07-30|July 30, 2021|Anticipated|2021-07-30||Interventional|PADN-CFDA||Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension: PADN Trial|A Randomised, Single-blind, Sham Operation-controlled Study to Evaluate the Safety and Efficacy of the Pulmonary Artery Denervation for the Treatment of Pulmonary Arterial Hypertension|Not yet recruiting||N/A|128|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t|f|f|||f|||||2017-10-10 20:43:06.455997|2017-10-10 20:43:06.455997
NCT03282253|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 30, 2018|Anticipated|2018-12-30|6 Months|Observational [Patient Registry]|||Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis|Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity and Clinical Outcomes of Severe Acute Pancreatitis|Not yet recruiting||N/A|216|Anticipated|Nanjing University School of Medicine|||1||f|||||f|f||||||||2017-10-10 20:43:06.567535|2017-10-10 20:43:06.567535
NCT03282240|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-18|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|October 27, 2017|Anticipated|2017-10-27|October 27, 2017|Anticipated|2017-10-27||Interventional|||Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US|Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Participants Aged 65 Years and Older|Active, not recruiting||Phase 3|2616|Anticipated|Sanofi||3|||||||f|t|f|||f|||||2017-10-10 20:43:06.666112|2017-10-10 20:43:06.666112
NCT03282227|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|ADAM||A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine|A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine|Not yet recruiting||Phase 3|250|Anticipated|Zosano Pharma Corporation||1|||f||||f|t|f||||||||2017-10-10 20:43:06.897102|2017-10-10 20:43:06.897102
NCT03282201|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-13|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||A Survey on Blood Transfusions in Major Artrhoplasty Operations|The Effect of Blood Transfusion on Recovery After Major Arthroplasties|Not yet recruiting||N/A|250|Anticipated|Diskapi Teaching and Research Hospital|||2||f||||f|f|f||||||||2017-10-10 20:43:07.156896|2017-10-10 20:43:07.156896
NCT03282188|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||REO13 Melanoma With of Without GM-CSF|A Clinical Study to Evaluate the Biological Effects of Intravenous Wild-type Reovirus (Reolysin®), With of Without GM-CSF, in Advanced Melanoma|Not yet recruiting||Phase 1/Phase 2|16|Anticipated|University of Leeds||2|||f||||f|t|f|||t|||||2017-10-10 20:43:07.279451|2017-10-10 20:43:07.279451
NCT03282175|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-26|||January 15, 2016|Actual|2016-01-15|September 2017|2017-09-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Effects of Elastic Resistance Training on Performance and Biochemical Parameters|Effects of Elastic Resistance Training on Physical Performance, Inflammatory Marker and Myokines in Elderly Women|Completed||N/A|20|Actual|University of Primorska||3|||f||||f|f|f||||||||2017-10-10 20:43:07.409163|2017-10-10 20:43:07.409163
NCT03282162|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-12|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effects of Oxytocin on Affective Touch|Oxytocin Effects on Neural Processing of Affective Touch and Associations With Trait Autism|Recruiting||N/A|40|Anticipated|University of Electronic Science and Technology of China||2|||f||||f|f|f||||||||2017-10-10 20:43:07.528329|2017-10-10 20:43:07.528329
NCT03282149|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|August 15, 2018|Anticipated|2018-08-15|April 30, 2018|Anticipated|2018-04-30||Interventional|||Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain|Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain|Not yet recruiting||Early Phase 1|16|Anticipated|Xalud Therapeutics, Inc.||4|||f||||f|f|f||||||||2017-10-10 20:43:07.651983|2017-10-10 20:43:07.651983
NCT03282136|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-12|2017-09-12|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|September 1, 2017|Actual|2017-09-01||Interventional|||Incretin and CRTd.|Incretin Treatment Effect in Type 2 Diabetes Mellitus Patients Affected by Heart Failure With Depressed Ejection Fraction, and Treated by Cardiac Resynchronization Therapy With a Defibrillator.|Completed||Phase 4|500|Actual|"University of Campania Luigi Vanvitelli"||2|||f|||||f|f||||||||2017-10-10 20:43:07.773478|2017-10-10 20:43:07.773478
NCT03282123|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD|An Open-Label, Multi-Site Phase 2 Study of the Safety and Effect of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder|Not yet recruiting||Phase 2|60|Anticipated|Multidisciplinary Association for Psychedelic Studies||1|||f||||f|t|f||||||||2017-10-10 20:43:07.860291|2017-10-10 20:43:07.860291
NCT03282110|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-13|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Comprehensive Acupuncture for Depressive Disorder With Comorbid Psychogenic Pain|Comprehensive Acupuncture for Depressive Disorder With Comorbid Psychogenic Pain: Randomized Controlled Study|Not yet recruiting||Early Phase 1|60|Anticipated|China Academy of Chinese Medical Sciences||2|||f|||||f|f||||||||2017-10-10 20:43:08.029379|2017-10-10 20:43:08.029379
NCT03282097|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|October 2021|Anticipated|2021-10-01||Interventional|DECAD||Decisions About Cancer Screening in Alzheimer's Disease|Decisions About Cancer Screening in Alzheimer's Disease|Not yet recruiting||N/A|426|Anticipated|Indiana University||2|||f||||t|f|f||||||||2017-10-10 20:43:08.115961|2017-10-10 20:43:08.115961
NCT03282084|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-12|||July 1, 2018|Anticipated|2018-07-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Observational|||A Prospective, Observational Study of the PPI Non-responder|A Prospective, Observational Study of the PPI Non-responder|Not yet recruiting||N/A|50|Anticipated|Dartmouth-Hitchcock Medical Center|||2||f||||f|f|f||||||||2017-10-10 20:43:08.192948|2017-10-10 20:43:08.192948
NCT03282071|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-25|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Joyful Parenting Pilot Project RCT Study|Community-based Mental Wellness Project for Adolescents and Adults: Joyful Parenting Pilot Project RCT Study|Recruiting||N/A|120|Anticipated|The University of Hong Kong||2|||f|||||f|f||||||||2017-10-10 20:43:08.314554|2017-10-10 20:43:08.314554
NCT03282058|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-11|||April 4, 2016|Actual|2016-04-04|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Silastic Stent Study|The Effect of Silastic Stenting on Post-Operative Intra-Nasal Re-Mucosalization|Active, not recruiting||N/A|26|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 20:43:08.420837|2017-10-10 20:43:08.420837
NCT03282045|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-11|||October 2016||2016-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat|A Multicenter, Single-blind, Randomized, Placebo-controlled Comparative Study on Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® Spray and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat in Common Cold|Recruiting||Phase 3|320|Anticipated|Bosnalijek D.D||4|||f||||f||||||||||2017-10-10 20:43:08.51292|2017-10-10 20:43:08.51292
NCT03282032|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-10|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Preconditioning of One-lung Ventilation|Preconditioning of One-lung Ventilation for Lung Protection|Not yet recruiting||N/A|148|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:43:08.623304|2017-10-10 20:43:08.623304
NCT03282019|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-11|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|FLOCOP||Study of Long-term HFNC for COPD Patients With HOT|Efficacy and Safety of Long-term High-flow Nasal Cannula Oxygen Therapy in Stable COPD Patients With Home Oxygen Therapy (HOT): a Multicenter, Prospective, Randomized Controlled Study|Recruiting||N/A|120|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t|f|f|||f|||||2017-10-10 20:43:08.705485|2017-10-10 20:43:08.705485
NCT03282006|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|MePUr||Treating Pyelonephritis an Urosepsis With Pivmecillinam|The Efficacy and Safety of Pivmecillinam in Treating Bacteriemic Urosepsis Caused by E.Coli|Not yet recruiting||Phase 4|80|Anticipated|Sykehuset i Vestfold HF||1|||f||||t|f|f||||||||2017-10-10 20:43:08.822925|2017-10-10 20:43:08.822925
NCT03281993|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-13|||June 25, 2015|Actual|2015-06-25|September 2017|2017-09-01|June 25, 2017|Actual|2017-06-25|June 25, 2015|Actual|2015-06-25||Observational|DiagBD||Apnea Tests as the Methods of Brain Death Diagnosis.|Alternative Apnea Test as the Method of Brain Death Diagnosis .|Completed||N/A|76|Actual|Pomeranian Medical University Szczecin|||1||f|||||f|f||||||||2017-10-10 20:43:08.912483|2017-10-10 20:43:08.912483
NCT03281980|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-12|||August 20, 2017|Actual|2017-08-20|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Effects of Psychosocial Stimulation and Cash on Children's Development and Behaviour|Effects of Adding Psychosocial Stimulation for Children of Lactating Mothers Enroled to Receive Unconditional Cash Transfer (UCT) and Health Education Awareness Programme on Children's Cognition and Behaviour in Rural Bangladesh|Enrolling by invitation||N/A|600|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||f|f|f||||||||2017-10-10 20:43:09.124199|2017-10-10 20:43:09.124199
NCT03281967|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-13|||June 9, 2017|Actual|2017-06-09|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Clinical Survey of Minimally Invasive Ponto Surgical Technique (MIPS)|Clinical Survey of Minimally Invasive Ponto Surgical Technique (MIPS)|Recruiting||N/A|25|Anticipated|Oticon Medical||1|||f||||f|f|f||||||||2017-10-10 20:43:09.237218|2017-10-10 20:43:09.237218
NCT03281954|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-11|||November 20, 2017|Anticipated|2017-11-20|August 2017|2017-08-01|June 30, 2024|Anticipated|2024-06-30|December 31, 2023|Anticipated|2023-12-31||Interventional|||Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo|A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo|Not yet recruiting||Phase 3|1520|Anticipated|NSABP Foundation Inc||2|||f||||t|t|f||||||||2017-10-10 20:43:09.355877|2017-10-10 20:43:09.355877
NCT03206242|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-06-30|||January 1, 2015|Actual|2015-01-01|May 2015|2015-05-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|HNC||Rehabilitation Outcomes in Head and Neck Survivors|Rehabilitation Outcomes in Head and Neck Survivors|Completed||N/A|65|Actual|Chang Gung Memorial Hospital|||3||f||||t||||||||||2017-10-10 20:54:07.586644|2017-10-10 20:54:07.586644
NCT03281941|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-11|||August 6, 2016|Actual|2016-08-06|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|ToAST||ToAST:Investigating the Effect of Bronchial Thermoplasty on Cough in Patients With Severe Asthma|ToAST: Investigating the Effect of Bronchial Thermoplasty on Cough in Patients With Severe Asthma|Recruiting||N/A|24|Anticipated|National Health Service, United Kingdom||2|||f||||t|f|f||||||||2017-10-10 20:43:09.471595|2017-10-10 20:43:09.471595
NCT03281928|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling|Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling|Not yet recruiting||N/A|52|Anticipated|University of Chicago||4|||f||||f|f|f||||||||2017-10-10 20:43:09.574294|2017-10-10 20:43:09.574294
NCT03281915|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-11|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|October 15, 2018|Anticipated|2018-10-15|October 15, 2018|Anticipated|2018-10-15||Observational|||the Effect of Different Modialites of Varicocelectomy on Semen Parameters in Patient With Normal Semen Analysis|Comparison Between Impact of Inguinal and Subinguinal Approaches of Varicocelectomy on Semen Parameters in Patients With Normal Semen Analysis|Not yet recruiting||N/A|32|Anticipated|Assiut University|||2||f||||t|f|f||||||||2017-10-10 20:43:09.651195|2017-10-10 20:43:09.651195
NCT03281889|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-11|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|March 31, 2025|Anticipated|2025-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||Proton Craniospinal Irradiation With Bone Sparing to Decrease Growth Decrement From Radiation|Craniospinal Irradiation Using Proton Beam Scanning With Selective Vertebral Body/Bone Sparing to Improve Marrow Reserve and Decrease Growth Decrement for Children|Not yet recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:43:09.88478|2017-10-10 20:43:09.88478
NCT03281876|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-11|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|February 24, 2020|Anticipated|2020-02-24|February 24, 2020|Anticipated|2020-02-24||Interventional|||A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response|An Observer-blind Study to Evaluate the Efficacy, Safety, Reactogenicity and Immunogenicity of the GSK Biologicals' Investigational Vaccine GSK3277511A When Administered to COPD Patients|Not yet recruiting||Phase 2|600|Anticipated|GlaxoSmithKline||2|||f|||||t|f||||||||2017-10-10 20:43:10.007061|2017-10-10 20:43:10.007061
NCT03281863|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 29, 2018|Anticipated|2018-09-29|September 29, 2018|Anticipated|2018-09-29||Observational|||Clinical Audit on the Managment in Assiut University Children Hospital|Clinical Audit on the Managment of Rheumatic Fever in Assiut University Children Hospital|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:43:10.186458|2017-10-10 20:43:10.186458
NCT03281850|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-27|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|December 30, 2024|Anticipated|2024-12-30|December 30, 2024|Anticipated|2024-12-30|2 Years|Observational [Patient Registry]|||The GLOWING Study: Growing Life, Optimizing Wellness 2|The GLOWING Study: Growing Life, Optimizing Wellness 2|Recruiting||N/A|300|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f|f|f||||Samples Without DNA|"     Urine collected   "|||2017-10-10 20:43:10.263909|2017-10-10 20:43:10.263909
NCT03281837|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)|A Post-market, Single Blind, Multicenter, Randomized, Controlled Trial of HYMOVIS® Intra-articular Injections in Active Subjects With Knee Osteoarthritis|Recruiting||N/A|146|Anticipated|Fidia Pharma USA Inc.||3|||f||||f|f|t|f|f|f|||||2017-10-10 20:43:10.343412|2017-10-10 20:43:10.343412
NCT03281824|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients|Open-Label, Dose Increase and Phase I Study of ALT-P7 to Determine Safety, Tolerability, Pharmacokinetics for HER2 Positive Metastatic Breast Cancer Patients Who Have Progressed on Previous Trastuzumab-Based Therapy|Not yet recruiting||Phase 1|30|Anticipated|Alteogen, Inc.||1|||f|||||f|f||||||||2017-10-10 20:43:10.506229|2017-10-10 20:43:10.506229
NCT03281798|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|LUTO||Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction (LUTO)|Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction (LUTO): A Prospective Trial|Not yet recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||t|f|t|t|f||||||2017-10-10 20:43:10.712954|2017-10-10 20:43:10.712954
NCT03281785|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Ultrasound of Diaphragmatic Musculature in Mechanically Ventilated Patients.|Ultrasound Evaluation of the Diaphragmatic Musculature in Mechanically Ventilated Patients in Intensive Care Unit|Not yet recruiting||N/A|93|Anticipated|Mansoura University||3|||f||||t|f|f||||||||2017-10-10 20:43:10.801381|2017-10-10 20:43:10.801381
NCT03281772|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||January 24, 2017|Actual|2017-01-24|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|June 30, 2018|Anticipated|2018-06-30||Observational|TEAM-HTN||Uncontrolled Hypertension Management (TEAM-HTN)|Technology Assisted Management of Uncontrolled Hypertension (TEAM-HTN): a Pilot Study|Recruiting||N/A|180|Anticipated|Madigan Army Medical Center|||2||f||||f|f|f||||||||2017-10-10 20:43:10.911499|2017-10-10 20:43:10.911499
NCT03281759|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|LED-TBI||Transcranial LED Therapy for Severe Acute Traumatic Brain Injury|Effects of Transcranial LED Therapy on the Cognitive Rehabilitation for Diffuse Axonal Injury Due to Severe Acute Traumatic Brain Injury: Randomized Clinical Trial.|Recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:43:11.021584|2017-10-10 20:43:11.021584
NCT03281746|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-11|||May 19, 2017|Actual|2017-05-19|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Effect of Prevention Education in Caries Formation in Pediatric Patients With Leukemia|Effect of Prevention Education on Factors of Importance in Caries Formation in Pediatric Patients With Leukemia|Recruiting||N/A|30|Anticipated|Virginia Commonwealth University||2|||f||||f|f|f||||||||2017-10-10 20:43:11.124814|2017-10-10 20:43:11.124814
NCT03281733|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-13|||November 25, 2015|Actual|2015-11-25|September 2017|2017-09-01|November 23, 2016|Actual|2016-11-23|June 5, 2016|Actual|2016-06-05||Observational|||Evaluating Gaps in Care of Malnourished Patients|Evaluating Gaps in Care of Malnourished Patients on General Medicine Floors in an Acute Care Setting|Completed||N/A|287|Actual|Weill Medical College of Cornell University|||1||f||||f|f|f||||||||2017-10-10 20:43:11.247074|2017-10-10 20:43:11.247074
NCT03281720|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||April 7, 2017|Actual|2017-04-07|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|TAD||Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node Metastases|Selective Image Guided Resection of Pathologically Documented Axillary Lymph Node Metastases|Recruiting||N/A|100|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-10 20:43:11.327852|2017-10-10 20:43:11.327852
NCT03281707|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30|7 Days|Observational [Patient Registry]|||NIRS and DO2i Correlation|Evaluation of NIRS and DO2i Correlation and Their Relationship With Organ Failure During Cardiac Surgery: a Prospective Monocentric Study.|Not yet recruiting||N/A|50|Anticipated|Centro Cardiologico Monzino|||1||f||||f|f|f||||||||2017-10-10 20:43:11.409847|2017-10-10 20:43:11.409847
NCT03281694|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine|The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine|Not yet recruiting||Phase 1|30|Anticipated|University of Maryland||1|||f||||t|t|f|||f|||||2017-10-10 20:43:11.4991|2017-10-10 20:43:11.4991
NCT03281681|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-21|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|REPROVe||A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer|A Phase 1/2, Open Label, Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer|Not yet recruiting||Phase 1/Phase 2|80|Anticipated|DelMar Pharmaceuticals, Inc.||1|||t||||f|t|f||||||||2017-10-10 20:43:11.588715|2017-10-10 20:43:11.588715
NCT03281668|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-11|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Feasibility of High Intensity Interval Training in Knee Osteoarthritis|Feasibility of High Intensity Interval Training in Knee Osteoarthritis|Not yet recruiting||N/A|30|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f|f|f||||||||2017-10-10 20:43:11.693772|2017-10-10 20:43:11.693772
NCT03281655|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women|Effects of a New Vaginal Cream Containing Visnadine, Prenylflavonoids and Bovine Colostrum in Postmenopausal Sexually Active Women Affected by Vulvovaginal Atrophy: a Prospective Cohort Analysis|Not yet recruiting||Phase 2|50|Anticipated|University of Messina||1|||f||||t|f|f||||||||2017-10-10 20:43:11.783443|2017-10-10 20:43:11.783443
NCT03281642|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Observational|HOT||Efficacy of a Nurse-based Intervention on Tobacco Consumption in Hospitalized Patients|Efficacy of a Nurse-based Intervention on Tobacco Consumption in Hospitalized Patients|Not yet recruiting||N/A|1200|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||||2017-10-10 20:43:11.863223|2017-10-10 20:43:11.863223
NCT03281616|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-18|||June 1, 2014|Actual|2014-06-01|September 2017|2017-09-01|September 30, 2015|Actual|2015-09-30|June 30, 2015|Actual|2015-06-30||Interventional|||Lifestyle in Turkish-Background Diabetics|Lifestyle Interventions in Turkish-background Patients With Metabolic Syndrome and Diabetes in Germany|Completed||N/A|110|Actual|Charite University, Berlin, Germany||2|||f|||||f|f||||||||2017-10-10 20:43:11.987065|2017-10-10 20:43:11.987065
NCT03281603|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Patient Satisfaction & Retention of Milled, 3D Printed and Conventional Complete Dentures|A Study Comparing Patient Satisfaction and Retention of CAD /CAM Milled Complete Dentures and 3D Printed CAD/CAM Complete Dentures Versus Conventional Complete Dentures: A Randomized Clinical Trial|Not yet recruiting||N/A|60|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:43:12.042972|2017-10-10 20:43:12.042972
NCT03281590|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31|1 Year|Observational [Patient Registry]|||Stroke and Cerebrovascular Diseases Registry|Stroke and Cerebrovascular Diseases Registry|Recruiting||N/A|10000|Anticipated|University of New Mexico|||2||f||||f|f|f||||||||2017-10-10 20:43:12.12839|2017-10-10 20:43:12.12839
NCT03281577|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||October 3, 2017|Anticipated|2017-10-03|September 2017|2017-09-01|December 21, 2018|Anticipated|2018-12-21|December 21, 2018|Anticipated|2018-12-21||Interventional|||Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants|A Dose-Ranging, Randomized, Parallel, Placebo-Controlled Study to Assess the Effect of TAK-954 on Gastrointestinal and Colonic Transit in Patients With Diabetic or Idiopathic Gastroparesis|Not yet recruiting||Phase 2|48|Anticipated|Takeda||4|||f|||||t|f||||||||2017-10-10 20:43:12.217848|2017-10-10 20:43:12.217848
NCT03281564|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Observational|ABLIMCO||Quality of Life After Laparoscopic Removal of Essure®|Prospective Study of Quality of Life After Laparoscopic Removal of Essure®|Not yet recruiting||N/A|72|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:43:12.289486|2017-10-10 20:43:12.289486
NCT03281551|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2020|Anticipated|2020-11-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma|Study of Anti-CD19 Chimeric Antigen Receptor T Cells（PZ01） for Relapsed/ Refractory B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma|Recruiting||Phase 1|50|Anticipated|Pinze Lifetechnology Co. Ltd.||1|||f|||||f|f||||||||2017-10-10 20:43:12.349892|2017-10-10 20:43:12.349892
NCT03281538|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-12|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus|An Open-Label, Multicenter, Extension Study to Evaluate the Long Term Safety of Intravenous CR845 in Hemodialysis Patients With Chronic Kidney Disease-Associated Pruritus|Enrolling by invitation||Phase 3|240|Anticipated|Cara Therapeutics, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:43:12.418023|2017-10-10 20:43:12.418023
NCT03281525|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-12|||April 11, 2017|Actual|2017-04-11|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|SQ_Heart||Sleep Quality Underwent Heart Transplant, an Observational Study|Sleep Quality: Comparison Between Patients With VAD and Patients That Underwent Heart Transplant, an Observational Study|Recruiting||N/A|109|Anticipated|University of Padova|||1||f|||||f|f||||||||2017-10-10 20:43:12.473834|2017-10-10 20:43:12.473834
NCT03281512|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||January 1, 1989|Actual|1989-01-01|September 2017|2017-09-01|December 31, 2012|Actual|2012-12-31|December 31, 2011|Actual|2011-12-31||Observational|||Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight|Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight in the China Health and Nutrition Survey (CHNS)|Completed||N/A|14383|Actual|Zhejiang University|||1||f|||||f|f||||||||2017-10-10 20:43:12.66145|2017-10-10 20:43:12.66145
NCT03281499|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-12|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|FIND||Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck Cancer|A Pilot Study Integrating Transoral Robotic Surgery, Histopathologic Localization, and Tailored De-Intensification of Radiotherapy for Unknown Primary and Small Oropharyngeal Head and Neck Squamous Cell Carcinoma(FIND Trial)|Recruiting||N/A|25|Anticipated|University Health Network, Toronto||1|||f||||t|f|f|||f|||||2017-10-10 20:43:12.718122|2017-10-10 20:43:12.718122
NCT03281486|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||"Hyaluronan Formulation for Type 2 Diabetic Patients With Dry Mouth"|"Clinical Evaluation of the Efficacy of Hyaluronan Formulation for Dry Mouth in Patients With Type 2 Diabetes"|Not yet recruiting||N/A|30|Anticipated|You First Services||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:43:12.822083|2017-10-10 20:43:12.822083
NCT03281473|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-12|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Comparison of Positive End Expiratory Pressure Titration Methods in ARDS Patients|Comparison of Positive End Expiratory Pressure Titration Methods in Patients With Acute Respiratory Distress Syndrome: a Physiological Study|Not yet recruiting||N/A|20|Anticipated|University Hospital, Angers||2|||f||||f|f|f||||||||2017-10-10 20:43:12.89976|2017-10-10 20:43:12.89976
NCT03281460|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2, 2019|Anticipated|2019-05-02|May 2, 2019|Anticipated|2019-05-02||Interventional|FIBROSAC||Efficacy of In-bag Morcellation|Efficacy of In-bag Morcellation|Not yet recruiting||N/A|48|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 20:43:12.981207|2017-10-10 20:43:12.981207
NCT03281447|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|NaviCan||Nurse Navigation Versus Current Care Coordination During Colorectal Cancer Trajectories|NaviCan. Navigation and Support to Cancer Patients - A Randomized Controlled Trial.|Enrolling by invitation||N/A|280|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-10 20:43:13.087937|2017-10-10 20:43:13.087937
NCT03281434|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effects of Whey vs. Collagen on MPS|The Effects of Whey Versus Collagen Protein Intake on Acute and Longer-term Skeletal Muscle Protein Synthesis in Older Adults|Not yet recruiting||N/A|24|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:43:13.194269|2017-10-10 20:43:13.194269
NCT03281421|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-14|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|September 25, 2018|Anticipated|2018-09-25|March 31, 2018|Anticipated|2018-03-31||Interventional|Mestrado||Immediate Effects of Ankle Mobilization on Dorsiflexion Range of Motion in Women With Patellofemoral Pain.|Immediate Effects of Ankle Mobilization on Dorsiflexion Range of Motion in Closed Kinetic Chain in Women With Patellofemoral Pain: A Random Clinical Trial|Recruiting||N/A|117|Anticipated|Universidade Federal do Ceara||3|||f||||f|f|f||||||||2017-10-10 20:43:13.271015|2017-10-10 20:43:13.271015
NCT03281408|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||January 3, 2018|Anticipated|2018-01-03|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|March 31, 2019|Anticipated|2019-03-31||Interventional|||Decreasing Post-operative Complications of Obstructive Sleep Apnea by Introducing an Intensified Monitoring and Care Protocol|Perioperative Obstructive Sleep Apnea Intervention Study|Not yet recruiting||Phase 4|160|Anticipated|University of British Columbia||2|||f||||f|t|f|||t|||||2017-10-10 20:43:13.368051|2017-10-10 20:43:13.368051
NCT03281395|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||August 30, 2011|Actual|2011-08-30|September 2017|2017-09-01|July 15, 2013|Actual|2013-07-15|January 15, 2013|Actual|2013-01-15||Observational|||Rapid Ventricular Pacing During Cerebral Aneurysm Surgery: a Retrospective Study Concerning the Safety for Heart and Brain|Rapid Ventricular Pacing During Cerebral Aneurysm Surgery: a Retrospective Study Concerning the Safety for Heart and Brain|Completed||N/A|27|Actual|University Hospital, Antwerp|||2||f||||f|f|f||||||||2017-10-10 20:43:13.457261|2017-10-10 20:43:13.457261
NCT03281382|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer|PHASE 1 TRIAL OF ONCOLYTIC ADENOVIRUS-MEDIATED CYTOTOXIC AND IL-12 GENE THERAPY IN COMBINATION WITH CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC PANCREATIC CANCER|Recruiting||Phase 1|9|Anticipated|Henry Ford Health System||1|||f||||t|t|f||||||||2017-10-10 20:43:13.543472|2017-10-10 20:43:13.543472
NCT03281369|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|November 13, 2021|Anticipated|2021-11-13|November 13, 2021|Anticipated|2021-11-13||Interventional|UMBRELLA||A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ)|A Phase Ib/II, Open-Label, Multicenter, Randomized, Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (Morpheus-Gastric Cancer)|Not yet recruiting||Phase 1/Phase 2|357|Anticipated|Hoffmann-La Roche||9|||f|||||t|f||||||||2017-10-10 20:43:13.639891|2017-10-10 20:43:13.639891
NCT03281356|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||May 9, 2017|Actual|2017-05-09|September 2017|2017-09-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Interventional|||Text Messaging Pilot Study|Text Messaging Pilot Study to Encourage Shared Reading Among a Sample of Urban Parents.|Completed||N/A|16|Actual|Rutgers, The State University of New Jersey||1|||f||||f|f|f||||||||2017-10-10 20:43:13.842392|2017-10-10 20:43:13.842392
NCT03281343|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|October 2019|Anticipated|2019-10-01||Interventional|||Linking Women to PrEP Care|Linkage to Community-Based HIV Pre-Exposure Prophylaxsis Care Among at Risk Women Upon Release From Incarceration|Not yet recruiting||N/A|80|Anticipated|Rhode Island Hospital||2|||f|||||f|f||||||||2017-10-10 20:43:13.910272|2017-10-10 20:43:13.910272
NCT03281330|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|||Effect of Motor Entrainment to Auditory Cues and Music During Walking on Quality of Movement and Perceived Fatigue in Persons With Multiple Sclerosis (PwMS)|Effect of Motor Entrainment to Auditory Cues and Music During Walking on Quality of Movement and Perceived Fatigue in Persons With Multiple Sclerosis (PwMS)|Recruiting||N/A|60|Anticipated|Hasselt University|||2||f||||f|f|f||||||||2017-10-10 20:43:13.997262|2017-10-10 20:43:13.997262
NCT03281317|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||December 15, 2017|Anticipated|2017-12-15|September 2017|2017-09-01|December 15, 2020|Anticipated|2020-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|ISYVACC||Vasoplegic Syndrome in Cardiac Surgery|Le Syndrome vasoplégique en Post-opératoire de Chirurgie Cardiaque: étude de Construction et de Validation d'un Score prédictif (Etude ISYVACC).|Not yet recruiting||N/A|3000|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f|f|f||||||||2017-10-10 20:43:14.102602|2017-10-10 20:43:14.102602
NCT03281291|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 16, 2017|Anticipated|2017-09-16|September 2017|2017-09-01|February 14, 2022|Anticipated|2022-02-14|February 14, 2022|Anticipated|2022-02-14||Observational|||"An Ancillary Study Protocol to GSK's Phase IIb Malaria Vaccine Trial Entitled Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age"|"An Ancillary Study Protocol to GlaxoSmithKline Phase IIb RTS,S/AS01E Malaria Vaccine Trial (Study Number 204889 [MALARIA-094]) Entitled, Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age"|Not yet recruiting||N/A|1500|Anticipated|GlaxoSmithKline|||5||f|||||f|f||||||||2017-10-10 20:43:14.252929|2017-10-10 20:43:14.252929
NCT03281278|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-25|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||A Prospective Study of Application of Platelet Mapping in HBV-related Acute-on-chronic-liver Failure in China|A Prospective Study of Application of Platelet Mapping in HBV-related Acute-on-chronic-liver Failure in China|Recruiting||N/A|188|Anticipated|Nanfang Hospital of Southern Medical University|||1||f|||||f|f||||||||2017-10-10 20:43:14.332463|2017-10-10 20:43:14.332463
NCT03281265|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-15|||January 1, 2012|Actual|2012-01-01|July 2017|2017-07-01||||December 30, 2016|Actual|2016-12-30||Observational|||A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China|A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China|Active, not recruiting||N/A|300|Actual|Nanfang Hospital of Southern Medical University|||1||f|||||f|f||||||||2017-10-10 20:43:14.404576|2017-10-10 20:43:14.404576
NCT03281252|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||April 16, 2017|Actual|2017-04-16|July 2017|2017-07-01|September 16, 2017|Anticipated|2017-09-16|September 16, 2017|Anticipated|2017-09-16||Observational|||A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in China|A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in China|Recruiting||N/A|100|Anticipated|Nanfang Hospital of Southern Medical University|||1||f|||||f|f||||||||2017-10-10 20:43:14.46138|2017-10-10 20:43:14.46138
NCT03281239|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-22|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RISCAS||Study of the Impact of Welding Fumes on the Arterial System : RISCAS Study|Study of the Impact of Welding Fumes on the Arterial System : RISCAS Study|Not yet recruiting||N/A|60|Anticipated|University Hospital, Brest||1|||f||||f|f|f||||||||2017-10-10 20:43:14.529741|2017-10-10 20:43:14.529741
NCT03281226|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-27|||December 7, 2016|Actual|2016-12-07|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RIPENACTB||RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection|An Open Label Randomized Phase 2 Clinical Trial to Assess Safety and Tolerability of RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/Aids and Pulmonary Tuberculosis|Recruiting||Phase 2|50|Anticipated|Fundação de Medicina Tropical Dr. Heitor Vieira Dourado||2|||f||||t|f|f||||||||2017-10-10 20:43:14.617167|2017-10-10 20:43:14.617167
NCT03281213|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||July 1, 2010||2010-07-01|September 2017|2017-09-01|June 1, 2016|Actual|2016-06-01|December 31, 2014|Actual|2014-12-31||Observational|||Acute Postthoracotomy Pain - Impact of Gender|No Impact of Gender on Acute Postthoracotomy Pain - a Retrospective Analysis|Completed||N/A|346|Actual|Medical University of Graz|||2||f||||f|f|f||||||||2017-10-10 20:43:14.713272|2017-10-10 20:43:14.713272
NCT03281200|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Observational|||Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain|A Multicentre, Retrospective Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain.|Not yet recruiting||N/A|175|Anticipated|Boehringer Ingelheim|||5||f||||f|t|f||||||||2017-10-10 20:43:14.783862|2017-10-10 20:43:14.783862
NCT03281187|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-18|||July 16, 2018|Anticipated|2018-07-16|September 2017|2017-09-01|January 13, 2020|Anticipated|2020-01-13|November 12, 2018|Anticipated|2018-11-12||Interventional|||Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.|A Randomized, Parallel, Double-dummy, Multi-center Phase III Study for Evaluation of Efficacy and Safety of Nasotestt Compared to Androgel Treating Hypogonadism in Male Research Participants.|Not yet recruiting||Phase 3|228|Anticipated|FBM Industria Brasileira Ltda||4|||f||||t|f|f||||||||2017-10-10 20:43:14.870571|2017-10-10 20:43:14.870571
NCT03281174|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||May 20, 2017|Actual|2017-05-20|September 2017|2017-09-01|May 21, 2017|Actual|2017-05-21|May 21, 2017|Actual|2017-05-21||Observational|||Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine|Phase IV, Open-labelled, Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine|Completed||N/A|343|Actual|Sinovac Biotech Co., Ltd|||2||f||||f|f|f||||Samples Without DNA|"     The venous blood was collected for EV71 neutralizing antibody detection   "|||2017-10-10 20:43:14.959725|2017-10-10 20:43:14.959725
NCT03281161|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||February 27, 2015|Actual|2015-02-27|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|April 30, 2017|Actual|2017-04-30||Interventional|SSW2||Sun Safe Workplaces: Assessment of Benefits and Costs of a Policy Intervention|Sun Safe Workplaces: Assessment of Benefits and Costs of a Policy Intervention|Completed||N/A|1990|Actual|Klein Buendel, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:43:15.041803|2017-10-10 20:43:15.041803
NCT03281148|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-12|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|RCT||Accuracy in Computer Guided Versus Free Hand Immediate Implantation|Evaluation of Accuracy in Computer Guided Versus Free Hand Immediate Implant Placement in Fresh Extraction Sockets: a Randomized Controlled Clinical Trial|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:43:15.122575|2017-10-10 20:43:15.122575
NCT03281135|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Optimizing Cervical Cancer Screening Modalities|Optimizing Cervical Cancer Screening Modalities and Identifying the Molecular Epidemiology of Human Papilloma Virus in Ethiopia: A Cluster Randomized Trial|Not yet recruiting||N/A|1760|Anticipated|Addis Ababa University||2|||f||||t|f|f||||||||2017-10-10 20:43:15.191585|2017-10-10 20:43:15.191585
NCT03281122|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-10-05|||September 22, 2017|Actual|2017-09-22|October 2017|2017-10-01|March 26, 2019|Anticipated|2019-03-26|March 24, 2019|Anticipated|2019-03-24||Interventional|||A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction|A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986224 in Healthy Subjects and Chronic Heart Failure Patients With Reduced Ejection Fraction|Recruiting||Phase 1|262|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f|||t|||||2017-10-10 20:43:15.262746|2017-10-10 20:43:15.262746
NCT03281109|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-12|||July 26, 2017|Actual|2017-07-26|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Effect of Menstrual Cycle On IL-6, TNF-α And Periodontal Status|The Effect of Menstrual Cycle on Periodontium|Active, not recruiting||N/A|25|Actual|Yuzuncu Yıl University|||1||f||||f|f|f||||||||2017-10-10 20:43:15.355139|2017-10-10 20:43:15.355139
NCT03281096|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-12|||August 29, 2017|Actual|2017-08-29|September 2017|2017-09-01|March 1, 2021|Anticipated|2021-03-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer|A Randomized Trial of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer|Recruiting||Phase 2/Phase 3|1000|Anticipated|Xijing Hospital of Digestive Diseases||2|||f|||||f|f||||||||2017-10-10 20:43:15.427709|2017-10-10 20:43:15.427709
NCT03281083|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-12|||March 28, 2014|Actual|2014-03-28|September 2017|2017-09-01|July 28, 2016|Actual|2016-07-28|July 28, 2016|Actual|2016-07-28||Interventional|||Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)|Effects of 4-month Therapy of Levothyroxine on Non-Alcoholic Fatty Liver Disease (NAFLD) and Diabetes Control in Diabetic Patients|Terminated||Phase 2|29|Actual|Duke-NUS Graduate Medical School||1||Difficult recruitment and end of funding.|f||||f|f|f|||f|||||2017-10-10 20:43:15.501057|2017-10-10 20:43:15.501057
NCT03281070|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Anastomotic Leakage After Anterior Resection of Rectal Cancer|The Incidence and Risk Factors of Anastomotic Leakage After Anterior Resection of Rectal Cancer: a Multi-site Observational Study|Recruiting||N/A|3000|Anticipated|Beijing Friendship Hospital|||1||f|||||f|f||||||||2017-10-10 20:43:15.573933|2017-10-10 20:43:15.573933
NCT03281057|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-13|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|CRAFT||Community Reinforcement and Family Training (CRAFT)|Community Reinforcement and Family Training (CRAFT)|Not yet recruiting||N/A|405|Anticipated|University of Southern Denmark||3|||f||||t|f|f||||||||2017-10-10 20:43:15.625035|2017-10-10 20:43:15.625035
NCT03281044|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-12|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Fecal Microbiota Transplantation in Depression|Oral Frozen Fecal Microbiota Transplantation (FMT) Capsules for Depression: a Double-blind, Placebo-controlled, Randomized Parallel Group Study|Not yet recruiting||Phase 2|40|Anticipated|Psychiatric Hospital of the University of Basel||2|||f||||f|f|f||||||||2017-10-10 20:43:15.686708|2017-10-10 20:43:15.686708
NCT03281031|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-12|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|IRMADA||MRI as an Alternative to CT for Exploration of Acute Abdominal Pain in Young Women|Diagnostic Performance of MRI as an Alternative to CT Following a Non-diagnostic Ultrasonography in Young Women With Acute/Subacute Abdominal Pain : a Prospective Multicenter Study|Not yet recruiting||N/A|347|Anticipated|University Hospital, Montpellier||1|||f||||t|f|f||||||||2017-10-10 20:43:15.753974|2017-10-10 20:43:15.753974
NCT03281018|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-12|||September 26, 2017|Anticipated|2017-09-26|September 2017|2017-09-01|November 26, 2018|Anticipated|2018-11-26|November 26, 2017|Anticipated|2017-11-26||Interventional|HYPPOGYN||Preoperative Hypnosis in Gynecology|Exploratory Study of the Impact of a Preoperative Formal Hypnosis Session on Perioperative Anxiety Among Female Patients Hospitalised for Hysterectomy Due to Pelvic Gynecological Cancer|Not yet recruiting||N/A|30|Anticipated|University Hospital, Bordeaux||2|||f||||f|f|f||||||||2017-10-10 20:43:15.819102|2017-10-10 20:43:15.819102
NCT03281005|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-10-02|||September 12, 2017|Actual|2017-09-12|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Development of Visual Function Evaluation Method|Calibration of Visual Function Evaluation Tests in Patients With Severe Vision Loss|Recruiting||N/A|6|Anticipated|Astellas Pharma Inc|||1||f||||f|f|f||||||||2017-10-10 20:43:15.88418|2017-10-10 20:43:15.88418
NCT03280992|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-12|||March 2, 2016|Actual|2016-03-02|September 2017|2017-09-01|June 16, 2016|Actual|2016-06-16|June 16, 2016|Actual|2016-06-16|3 Months|Observational [Patient Registry]|CASC||Community Acquired Sepsis Cohort|Community Acquired Sepsis Cohort|Terminated||N/A|751|Actual|Rennes University Hospital|||1|Study not feasible in practise|f||||f|f|f||||||||2017-10-10 20:43:15.944053|2017-10-10 20:43:15.944053
NCT03280979|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia|Comparison Between Rescue Regimen and High Dose Methotrexate in the Managment of Presistent Gestational Trophoplastic Neoplasia :( A Randomized Controlled Trial )|Not yet recruiting||Phase 2/Phase 3|170|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:43:15.995503|2017-10-10 20:43:15.995503
NCT03280953|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-12|||May 31, 2016|Actual|2016-05-31|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Assessing Fluid Responsiveness With PWTT|Finding the Cut-off Value of Pulse Wave Transit Time (PWTT) to Estimate the Fluid Responsibility|Recruiting||N/A|60|Anticipated|Johannes Gutenberg University Mainz|||1||f||||f|f|f||||||||2017-10-10 20:43:16.0569|2017-10-10 20:43:16.0569
NCT03280940|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-24|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Observational|INTATTI||Impact of Different Integrase Inhibitor Based Regimen on Immune Activation Among HIV naïve Patient (INTATTI)|Impact of Different Integrase Inhibitor Based Regimen on Markers of Inflammation and Immune Activation Among HIV naïve Patient During the First Year of Effective First-line Combination|Recruiting||N/A|40|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia|||4||f||||t||||||Samples Without DNA|"     Serum (Biospecimen retained as a normal clinical practice)   "|||2017-10-10 20:43:16.123341|2017-10-10 20:43:16.123341
NCT03280927|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|August 31, 2019|Anticipated|2019-08-31||Interventional|||Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis|A Multicenter, Open-label, Non-controlled, Single-arm Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis|Not yet recruiting||Phase 4|100|Anticipated|Dong-A ST Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 20:43:16.298838|2017-10-10 20:43:16.298838
NCT03280914|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-12|||August 1, 2017|Actual|2017-08-01|June 2017|2017-06-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Epidemiology and Intervention of Obstructive Sleep Apnea Based on Community|Epidemiology and Intervention of Obstructive Sleep Apnea Based on Community: a Real World Study|Recruiting||N/A|300|Anticipated|Guangdong General Hospital|||2||f||||t|f|f||||Samples Without DNA|"     Serum lipid, glucose.   "|||2017-10-10 20:43:16.397063|2017-10-10 20:43:16.397063
NCT03280901|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|HD-REMODEL||HaemoDialysis Interventions to REduce Multi-Organ Dysfunction and Effect on Quality of Life Assessed by MRI Scanning|HaemoDialysis Interventions to REduce Multi-Organ Dysfunction and Effect on Quality of Life (HD-REMODEL) Assessed by MRI Scanning|Not yet recruiting||N/A|12|Anticipated|Fresenius Medical Care Deutschland GmbH||2|||f||||f|f|f||||||||2017-10-10 20:43:16.512733|2017-10-10 20:43:16.512733
NCT03280888|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-12|||November 5, 2014|Actual|2014-11-05|September 2017|2017-09-01|November 5, 2017|Anticipated|2017-11-05|November 5, 2017|Anticipated|2017-11-05|1 Day|Observational [Patient Registry]|||Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)|Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f|f|f||||||||2017-10-10 20:43:16.627348|2017-10-10 20:43:16.627348
NCT03280875|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-12|||May 5, 2017|Actual|2017-05-05|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|EXOMODE||Creation of an Algorithm for the Personalisation of Pedalling Exercises|Personalisation of Exercise by Muscle Modulation, Step 1: Construction and Validation of an Algorithm for Personalisation for Pedalling Exercises|Recruiting||N/A|180|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f|||||f|f||||||||2017-10-10 20:43:16.703434|2017-10-10 20:43:16.703434
NCT03280680|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-10|||November 1, 2010|Actual|2010-11-01|July 2017|2017-07-01|December 31, 2014|Actual|2014-12-31|May 31, 2014|Actual|2014-05-31||Interventional|SAFE||Right to Health and Freedom From Violence|Growing up Safe and Healthy( SAFE): Addressing Sexual and Reproductive Health and Rights and Violence Against Women and Girls in Urban Bangladesh|Completed||N/A|11340|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||t|f|f||||||||2017-10-10 20:43:18.139176|2017-10-10 20:43:18.139176
NCT03280862|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-09-12|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 1, 2024|Anticipated|2024-08-01|August 31, 2023|Anticipated|2023-08-31||Interventional|||DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS|"Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT Implantation Reduce Incidence of the Combined Endpoint Death or Non-planned Hospitalisation for Heart Failure (HF) in Patients With HF and Prolonged QRS"|Not yet recruiting||N/A|1000|Anticipated|Aarhus University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:43:16.788166|2017-10-10 20:43:16.788166
NCT03280849|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-11|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Chitosan Scaffold for Sellar Floor Repair in Endoscopic Endonasal Transsphenoidal Surgery|Chitosan Scaffold for Sellar Floor Repair in Endoscopic Endonasal Transsphenoidal Surgery|Completed||N/A|1|Actual|University of Guadalajara||1|||f||||t|f|f||||||||2017-10-10 20:43:16.91023|2017-10-10 20:43:16.91023
NCT03280836|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-11|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|WISER-NET||Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy|Women In Steady Exercise Research - Neoadjuvant Exercise Trial|Recruiting||N/A|20|Anticipated|Milton S. Hershey Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:43:17.054197|2017-10-10 20:43:17.054197
NCT03280823|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-11|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Effect of Platelet Storage on Complement Activation|Effect of Platelet Storage on Complement Activation|Not yet recruiting||N/A|10|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:43:17.145462|2017-10-10 20:43:17.145462
NCT03280810|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-13|||December 2013|Actual|2013-12-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of a Psycho-corporal Training on Postural and Cognitive Dual-task Performances in Patients With Schizophrenia|Effects of a Psycho-corporal Training on Postural and Cognitive Dual-task Performances in Patients With Schizophrenia|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 20:43:17.216263|2017-10-10 20:43:17.216263
NCT03280797|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|IL-MAI||Feasibility of a Cytokine Expression Profile in Immune Cells as an Orientation Tool in Therapeutic Decisions for Auto-inflammatory and Auto-immune Diseases|Feasibility of a Cytokine Expression Profile in Immune Cells as an Orientation Tool in Therapeutic Decisions for Auto-inflammatory and Auto-immune Diseases|Not yet recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f|f|f||||||||2017-10-10 20:43:17.307946|2017-10-10 20:43:17.307946
NCT03280784|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-10|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 20, 2018|Anticipated|2018-09-20||Observational|CAOUOEUIAUCH||Clinical Audit on the Use of Upper Endoscopy in Assist University Children Hospital|Clinical Audit on the Use of Upper Gastrointestinal Endoscopy in Assiut University Children Hospital|Not yet recruiting||N/A|1|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:43:17.402247|2017-10-10 20:43:17.402247
NCT03280771|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||September 1, 2014|Actual|2014-09-01|September 2017|2017-09-01|December 15, 2015|Actual|2015-12-15|December 15, 2014|Actual|2014-12-15||Interventional|||The Hope Soap Study: a Hand-washing Intervention Among Children in South Africa|The Hope Soap Study: a Randomized Controlled Trial of a Hand-washing Intervention Among Children in South Africa|Completed||N/A|288|Actual|University of Cape Town||2|||f||||f|f|f||||||||2017-10-10 20:43:17.457394|2017-10-10 20:43:17.457394
NCT03280758|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 30, 2019|Anticipated|2019-08-30|January 30, 2019|Anticipated|2019-01-30||Interventional|||Muscle Strength Training for Older Adults With Type II Diabetes|Effects of Muscle Strength Training on Glycemic Control, Muscle Mass, Muscle Strength and Functional Capacity in Older Adults With Type II Diabetes: A Randomised Controlled Trial|Not yet recruiting||N/A|60|Anticipated|The University of Hong Kong||2|||f|||||f|f||||||||2017-10-10 20:43:17.527409|2017-10-10 20:43:17.527409
NCT03280745|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-12|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|HERACLES||Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery|Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery|Not yet recruiting||Phase 4|110|Anticipated|University Hospital Inselspital, Berne||2|||f|||||f|f|||f|||||2017-10-10 20:43:17.612608|2017-10-10 20:43:17.612608
NCT03280732|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-10|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|||Use of Lung Ultrasound in Children With Acute Bronchiolitis|Lung Ultrasound in Diagnosing and Monitoring of Pulmonary Complications in Children With Acute Bronchiolitis|Recruiting||N/A|150|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f|||||f|f||||||||2017-10-10 20:43:17.7095|2017-10-10 20:43:17.7095
NCT03280719|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2025|Anticipated|2025-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions|Whole Breast (WB) + Lymph Node Irradiation (LNI): Prone Compared to Supine Position in a Randomized Study With 15 or 5 Fractions|Not yet recruiting||N/A|388|Anticipated|University Hospital, Ghent||4|||f||||t|f|f||||||||2017-10-10 20:43:17.805704|2017-10-10 20:43:17.805704
NCT03280706|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-11|||September 9, 2017|Actual|2017-09-09|September 2017|2017-09-01|February 2, 2018|Anticipated|2018-02-02|February 1, 2018|Anticipated|2018-02-01||Interventional|GEMCO||Gastric Emptying During Labor at Term: Non-inferiority Clinical Trial|Gastric Emptying of Maltodextrin Compared to Coffee With Milk and Orange Juice During Labor at Term: Non-inferiority Clinical Trial|Recruiting||N/A|54|Anticipated|Brasilia University Hospital||3|||f||||f|f|f||||||||2017-10-10 20:43:17.955427|2017-10-10 20:43:17.955427
NCT03280693|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-11|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Relationships Among Body Mass Index, Body Balance and Bone Mineral Density in Postmenopausal Women|Relationships Among Body Mass Index, Body Balance and Bone Mineral Density|Completed||N/A|48|Actual|Cairo University|||1||f||||f|f|f||||||||2017-10-10 20:43:18.061569|2017-10-10 20:43:18.061569
NCT03124784|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-15|||January 3, 2017|Actual|2017-01-03|June 2017|2017-06-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Accuracy of SpO2 Noninvasive Pulse Oximeter Sensor (RD Disposable) Under Motion Conditions||Completed||N/A|37|Actual|Masimo Corporation||1|||f|||||f|t|f|f|f|||||2017-10-10 21:08:43.148192|2017-10-10 21:08:43.148192
NCT03280667|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-10|||October 4, 2017|Anticipated|2017-10-04|September 2017|2017-09-01|October 4, 2021|Anticipated|2021-10-04|April 4, 2021|Anticipated|2021-04-04||Interventional|KEYPAD||Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma|Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma: a Phase II Trial (ANZUP 1601)|Not yet recruiting||Phase 2|70|Anticipated|Australian and New Zealand Urogenital and Prostate Cancer Trials Group||1|||f||||t|f|f||||||||2017-10-10 20:43:18.249921|2017-10-10 20:43:18.249921
NCT03280654|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-09|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|July 1, 2017|Actual|2017-07-01|30 Months|Observational [Patient Registry]|||Visceral Adiposity Index and Overactive Bladder|Visceral Adiposity Index and Overactive Bladder: A Novel Predictive Risk Factor|Completed||N/A|9|Actual|Recep Tayyip Erdogan University Training and Research Hospital|||2||f||||f|f|f||||||||2017-10-10 20:43:18.330286|2017-10-10 20:43:18.330286
NCT03280641|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-10|||August 9, 2015|Actual|2015-08-09|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|July 30, 2017|Actual|2017-07-30||Observational|DIRECT||D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy|The Role of D-dimer in Patients With Atrial Fibrillation Receiving Anticoagulation Therapy|Completed||N/A|1194|Actual|Wuhan Asia Heart Hospital|||2||f||||t|f|f||||||||2017-10-10 20:43:18.399195|2017-10-10 20:43:18.399195
NCT03280628|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using Skin Glue, Medical Tape Versus Stitches|A Randomized Controlled Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using a Tissue Adhesive (Dermabond™) Versus Adhesive Strips (Steri-Strips™) Versus Absorbable Sutures|Not yet recruiting||N/A|90|Anticipated|Vanderbilt University Medical Center||3|||f||||f|f|f||||||||2017-10-10 20:43:18.472441|2017-10-10 20:43:18.472441
NCT03280615|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-11|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|||Omega 3 Fatty Acids in Patients With Chronic Renal Disease|Effects of the Supplementation With Omega 3 Fatty Acids in Patients With Chronic Renal Disease|Recruiting||Phase 3|100|Anticipated|University of Chile||2|||f||||t|f|f||||||||2017-10-10 20:43:18.5598|2017-10-10 20:43:18.5598
NCT03280602|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-11|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|October 15, 2031|Anticipated|2031-10-15|October 15, 2021|Anticipated|2021-10-15||Interventional|||Operative Treatment of Olecranon Fractures|Randomzied Controlled Trial Comparing Tension Band Wiring and Plate Fixation in the Treatment of Olecranon Fractures in Adults|Not yet recruiting||N/A|56|Anticipated|Oslo University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:43:18.646673|2017-10-10 20:43:18.646673
NCT03280589|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-11|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2018|Anticipated|2018-12-15||Interventional|PYAMA||Pranayama Practice on the Autonomic Nervous System|The Effect of Respiration Rate During Pranayama Practice on the Autonomic Nervous System|Recruiting||Early Phase 1|40|Anticipated|National University of Natural Medicine||5|||f||||t|f|f||||||||2017-10-10 20:43:18.737115|2017-10-10 20:43:18.737115
NCT03280576|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-11|||April 2015||2015-04-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|PROGRANULIN||Validation of Progranulin as a Biomarker for Sepsis|Sensitivity and Specificity of Progranulin as a Biomarker for Sepsis|Recruiting||N/A|380|Anticipated|Ludwig-Maximilians - University of Munich|||3||f||||f||||||Samples With DNA|"     Serum, EDTA blood, blood cells (PAXGENE)   "|||2017-10-10 20:43:18.827671|2017-10-10 20:43:18.827671
NCT03280563|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|October 7, 2022|Anticipated|2022-10-07|April 30, 2021|Anticipated|2021-04-30||Interventional|MORPHEUS||A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer|A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Hormone Receptor-Positive HER2-Negative Breast Cancer (MORPHEUS-HR+ Breast Cancer)|Not yet recruiting||Phase 1/Phase 2|111|Anticipated|Hoffmann-La Roche||7|||f|||||t|f||||||||2017-10-10 20:43:18.918403|2017-10-10 20:43:18.918403
NCT03280550|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-10-05|||October 27, 2017|Anticipated|2017-10-27|October 2017|2017-10-01|May 10, 2019|Anticipated|2019-05-10|May 10, 2019|Anticipated|2019-05-10||Interventional|POLYP 1||A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps|A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Clinical Trial of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps|Recruiting||Phase 3|120|Anticipated|Hoffmann-La Roche||2|||f||||f|t|f||||||||2017-10-10 20:43:19.063736|2017-10-10 20:43:19.063736
NCT03280537|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-10-05|||October 27, 2017|Anticipated|2017-10-27|October 2017|2017-10-01|May 10, 2019|Anticipated|2019-05-10|May 10, 2019|Anticipated|2019-05-10||Interventional|POLYP 2||A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps|A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Clinical Trial of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps|Recruiting||Phase 3|120|Anticipated|Hoffmann-La Roche||2|||f||||f|t|f||||||||2017-10-10 20:43:19.335327|2017-10-10 20:43:19.335327
NCT03280524|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-13|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Reflexology and Quality of Life|Reflexology and Quality of Life in Diabetics Patients|Completed||N/A|60|Actual|Universidade do Vale do Sapucai||2|||f||||t|f|f||||||||2017-10-10 20:43:21.011193|2017-10-10 20:43:21.011193
NCT03280498|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-09-08|||April 2015||2015-04-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|October 2015|Actual|2015-10-01||Interventional|||Effectiveness of Ultrasonography and The Cole Formula on the Evaluation of the Appropriate Endotracheal Tube Size|Effectiveness of Ultrasonography and The Cole Formula on the Evaluation of the Appropriate Endotracheal Tube Size|Completed||N/A|110|Actual|Istanbul University||1|||f||||f||||||||||2017-10-10 20:43:21.185151|2017-10-10 20:43:21.185151
NCT03280485|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-21|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31|3 Months|Observational [Patient Registry]|||Validation of the Scandinavian Guidelines for Management of TBI in Adults|Multicenter Validation of the Scandinavian Guidelines for Management of Minimal, Mild and Moderate Head Injury in Adults: a Study Protocol.|Recruiting||N/A|3000|Anticipated|Halmstad County Hospital|||1||f||||f|f|f||||Samples Without DNA|"     A 5ml blood sample is drawn from patient's cubital vein in the ED. Samples are analysed with     the fully automated Elecsys® S100 (Roche AB) at the Clinical Chemistry Department of HS, SUS,     Örebro University Hospital and Linköping University Hospital, Sweden. Cut-off level for     normal levels of S100B according to the SNC guidelines is less than 0.10μg/L and a window of     sampling of within 6 hours from the time of the injury.      From all patients seeking care within 24h form injury with medium and low risk TBI, according     to SNC13 (including multitrauma patients), a 5ml blood sample will be drawn, centrifuged and     frozen at -70 degrees Celsius. Samplings will be coded and registered for analysis of GFAP,     SBP-50 and TAU.   "|||2017-10-10 20:43:21.25094|2017-10-10 20:43:21.25094
NCT03280472|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-22|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Transition to College/Miami University|Transition to College/Miami University|Recruiting||N/A|60|Anticipated|Miami University||2|||f||||f|f|f||||||||2017-10-10 20:43:21.330643|2017-10-10 20:43:21.330643
NCT03280459|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-11|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|June 1, 2023|Anticipated|2023-06-01|June 1, 2023|Anticipated|2023-06-01|5 Years|Observational [Patient Registry]|iRARC-KSW||Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction|Prospective Cohort-study for Evaluation of Clinical Outcome of Robot-assisted Cystectomy With Intracorporeal Reconstruction of Urinary Diversion|Recruiting||N/A|200|Anticipated|Kantonsspital Winterthur KSW|||2||f||||f|f|f||||||||2017-10-10 20:43:21.4169|2017-10-10 20:43:21.4169
NCT03280446|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-10|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.|Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.|Recruiting||N/A|30|Anticipated|The American Association of Female Pelvic Medicine Specialists, Inc.||1|||f||||t|f|t|f|f|t|||||2017-10-10 20:43:21.50775|2017-10-10 20:43:21.50775
NCT03280433|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-13|||September 1, 2014|Actual|2014-09-01|September 2017|2017-09-01|November 25, 2018|Anticipated|2018-11-25|November 25, 2015|Actual|2015-11-25||Observational|EPICHEART||Influence of EPICardial Adipose Tissue in HEART Diseases: EPICHEART Study|Association of the Volume and Proteome of Epicardial Adipose Tissue With Coronary Artery Disease, Left Atrial Remodelling and Atrial Fibrillation in Severe Aortic Stenosis Patients|Recruiting||N/A|500|Anticipated|Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.|||1||f||||f|f|f||||Samples With DNA|"     Fat samples (Epicardial fat, mediastinal fat, and subcutaneous fat), blood samples,     pericardial fluid samples, right atrial appendage sample.   "|||2017-10-10 20:43:21.592532|2017-10-10 20:43:21.592532
NCT03280407|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-26|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|NEOLAR||NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer|NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer: a Randomized Phase II Trial|Recruiting||Phase 2|124|Anticipated|Zealand University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:43:21.860364|2017-10-10 20:43:21.860364
NCT03280394|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2027|Anticipated|2027-12-31||Observational|||Liquid Biopsy in Mature B-cell Tumors|Prospective, Observational, Multi-centred, Non-interventional Research Project on Plasma Cell Free DNA Genotyping as a Tool to Inform Mature B-cell Tumor Management|Recruiting||N/A|444|Anticipated|Oncology Institute of Southern Switzerland|||1||f||||f|f|f|||f|Samples With DNA|"     Blood samples (20 ml in EDTA tubes and 20 ml in Cell-Free DNA BCT tubes)   "|||2017-10-10 20:43:21.979604|2017-10-10 20:43:21.979604
NCT03280381|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||Nifty Feeding Cup Versus Generic Medicine Cup Preterm Infants Who Have Difficulty Breastfeeding|Randomized Crossover Trial of the Nifty Feeding Cup and a Medicine Cup in Preterm Infants Who Have Difficulty Breastfeeding|Recruiting||N/A|200|Anticipated|PATH||2|||f||||f|f|f||||||||2017-10-10 20:43:22.066575|2017-10-10 20:43:22.066575
NCT03280368|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-09-12|||June 2014||2014-06-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Observational|ARCADE||Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation|Adherence and the Role of Coagulation Assays in Patients Treated With Dabigatran Etexilate for Non-valvular Atrial Fibrillation|Recruiting||N/A|540|Anticipated|Hospitalsenheden Vest|||4||f||||f||||||||||2017-10-10 20:43:22.16358|2017-10-10 20:43:22.16358
NCT03280355|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-12|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||The Effects of Singing Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)|The Effects of Singing Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|220|Anticipated|University of Aarhus||2|||f||||t|f|f||||||||2017-10-10 20:43:22.282005|2017-10-10 20:43:22.282005
NCT03280329|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Music Therapy in the ICU|Music Therapy in the ICU as a Tool to Reduce Neuroactive Drugs: Generalized Versus Personalized Intervention|Recruiting||N/A|153|Anticipated|University of Milan||3|||f||||f|f|f||||||||2017-10-10 20:43:22.533942|2017-10-10 20:43:22.533942
NCT03280316|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery|Efficacy Comparison Between Different Management Strategies for Consistent Overactive Bladder (OAB) in Patients With Spinal Vascular Malformations After Surgery|Not yet recruiting||N/A|100|Anticipated|Xuanwu Hospital, Beijing||3|||f|||||f|f||||||||2017-10-10 20:43:22.633178|2017-10-10 20:43:22.633178
NCT03280303|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-28|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|January 1, 2022|Anticipated|2022-01-01|December 16, 2021|Anticipated|2021-12-16||Observational|||Palbociclib in Real World Practice|POLARIS: Palbociclib in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter Non-Interventional Study|Recruiting||N/A|1500|Anticipated|Pfizer|||1||f||||f|f|f||||Samples With DNA|"     blood   "|||2017-10-10 20:43:22.730895|2017-10-10 20:43:22.730895
NCT03280290|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-09-08|||March 20, 2012|Actual|2012-03-20|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|CCR7-CD4-DPL||Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft|Partial Selective Depletion in Lymphocytes Transplant T CD4+ CCR7+ in Hematopoeitic Stem Cells Allograft|Completed||N/A|20|Actual|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 20:43:22.979036|2017-10-10 20:43:22.979036
NCT03280277|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-08|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer|Novel Imaging of Lymph Nodes in Patients With Rectal Cancer Using Ferumoxytol Enhanced MRI|Recruiting||Phase 2|13|Anticipated|OHSU Knight Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 20:43:23.053556|2017-10-10 20:43:23.053556
NCT03280264|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism|An Intra-Subject Dose-Adjustment Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism Who Are Unable to Undergo Parathyroidectomy or Relapse After Parathyroidectomy|Recruiting||Phase 3|10|Anticipated|Kyowa Hakko Kirin Co., Ltd||1|||f||||f|f|f||||||||2017-10-10 20:43:23.177816|2017-10-10 20:43:23.177816
NCT03280251|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|PACTE-1||Methylphenidate and Cognitive Training in Elderly|Potentiation of Cognitive Functions in Healthy Elderly by Association of Methylphenidate and Cognitive Training: Proof of Concept Study in Order to Develop a Synergic Symptomatic Treatment for the Cognitive Disorders Before Dementia|Not yet recruiting||Phase 2|120|Anticipated|University Hospital, Lille||4|||f||||t|f|f||||||||2017-10-10 20:43:23.3286|2017-10-10 20:43:23.3286
NCT03280238|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-12|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Pupil Dilation and Analgesia Nociception Index|Do Pupil Dilation and Analgesia Nociception Index Reflect Pain: a Pilot Study in Healthy, Conscious Volunteers|Completed||N/A|19|Actual|Vrije Universiteit Brussel||1|||f|||||f|f||||||||2017-10-10 20:43:23.433989|2017-10-10 20:43:23.433989
NCT03280225|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-13|||September 18, 2017|Anticipated|2017-09-18|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|September 30, 2019|Anticipated|2019-09-30||Observational|REACH VET||REACH VET Program Evaluation|Risk Stratified Enhancements to Clinical Care: Targeting Care for Patients Identified Through Predictive Modeling as Being at High Risk for Suicide, With the Office of Mental Health Operations|Not yet recruiting||N/A|400|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|None Retained|"     No biospecimens will be collected.   "|||2017-10-10 20:43:23.516363|2017-10-10 20:43:23.516363
NCT03280212|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-13|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TRACE||Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma|Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma: A Single-centre, Observer-blinded, Randomized Controlled Trial.|Recruiting||Phase 3|60|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t|f|f||||||||2017-10-10 20:43:23.645542|2017-10-10 20:43:23.645542
NCT03280199|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||The Impact of Different Simulator Characteristics on Transfer of Learning|The Impact of Different Simulator Characteristics on Transfer of Learning|Not yet recruiting||N/A|30|Anticipated|Rigshospitalet, Denmark||4|||f||||f|f|f||||||||2017-10-10 20:43:23.754383|2017-10-10 20:43:23.754383
NCT03280186|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Measurement of Bladder Function Change In Patients With SVMs Before and After Surgical Intervention|Measurement of Bladder Function Change In Patients With Spinal Vascular Malformations Before and After Surgical Intervention|Not yet recruiting||N/A|100|Anticipated|Xuanwu Hospital, Beijing||1|||f||||f|f|f||||||||2017-10-10 20:43:23.848827|2017-10-10 20:43:23.848827
NCT03279783|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-10|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 1, 2017|Anticipated|2017-12-01||Interventional|||LCI (Linked Color Imaging) for Adenoma Detection in the Right Colon|LCI (Linked Color Imaging) for Adenoma Detection in the Right Colon|Recruiting||N/A|752|Anticipated|Valduce Hospital||2|||f||||f|f|f||||||||2017-10-10 20:43:28.07595|2017-10-10 20:43:28.07595
NCT03280160|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-12|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab|A Multicenter, Non-randomized, Open Label Study to Evaluate the Efficacy and Security of Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)|Recruiting||Phase 2|84|Anticipated|PETHEMA Foundation||1|||f||||f|t|f|||t|||||2017-10-10 20:43:24.064709|2017-10-10 20:43:24.064709
NCT03280147|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-13|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis|Comparison of the Efficacy of a 7-day Versus 14-day Course of Intravenous Antibiotics in the Treatment of Uncomplicated Neonatal Bacterial Sepsis: a Randomized Controlled Non-inferiority Trial|Not yet recruiting||Phase 3|700|Anticipated|Indian Council of Medical Research||2|||f||||t|f|f|||f|||||2017-10-10 20:43:24.236957|2017-10-10 20:43:24.236957
NCT03280134|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer|CK19 Combined With Contrast-enhanced Ultrasound for Predicting Non-sentinel Lymph Node Status in Early Breast Cancer: a Prospectively Validation Cohort Study of the Predictive Model|Not yet recruiting||N/A|388|Anticipated|Zhejiang Cancer Hospital||2|||f|||||f|f||||||||2017-10-10 20:43:24.385561|2017-10-10 20:43:24.385561
NCT03280121|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-09|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|March 30, 2018|Anticipated|2018-03-30||Interventional|HEURISTIC||Hernia Reduction Prior to Scheduled TIF Completion|Hernia Reduction Prior to Scheduled TIF Completion- The HEURISTIC Study|Not yet recruiting||N/A|50|Anticipated|EndoGastric Solutions||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:43:24.50519|2017-10-10 20:43:24.50519
NCT03280095|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-08|||September 23, 2014|Actual|2014-09-23|September 2017|2017-09-01|December 12, 2014|Actual|2014-12-12|December 12, 2014|Actual|2014-12-12||Interventional|||Bioequivalence Study of Co-codamol 15mg/500mg Capsules vs Co-codamol 30mg/500mg Tablets in Healthy Subjects|A Randomised, Open-label, Three-treatment, Single Dose, Crossover Study Investigating the Bioequivalence of Co-codamol 15/500mg Capsules With a Co-codamol 30/500mg Tablet in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|50|Actual|Galen Limited||3|||f||||||||||||||2017-10-10 20:43:24.718287|2017-10-10 20:43:24.718287
NCT03280082|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|August 30, 2019|Anticipated|2019-08-30|February 28, 2019|Anticipated|2019-02-28||Interventional|MUAC120||Use of MUAC as Basic Criterion for Admission, Follow-up and Exit From the Ambulatory Nutrition Program|Operational Experience for the Use of the Mid-Upper Arm Circumference (MUAC) as the Basic Criterion for Admission, Follow-up and Exit of the Ambulatory Nutrition Program in Two CRENAS, Madaoua District, Niger|Not yet recruiting||N/A|6200|Anticipated|Epicentre||2|||f||||f|f|f||||||||2017-10-10 20:43:24.81347|2017-10-10 20:43:24.81347
NCT03280069|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||July 25, 2017|Actual|2017-07-25|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Evaluation of Ocular Surface Changes Following RF Electrocoagulation Treatment of the Periorbital Region|Evaluation of Ocular Surface Changes Following RF Electrocoagulation Treatment of the Periorbital Region|Recruiting||N/A|30|Anticipated|Ophthalmic Consultants of Long Island|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:43:24.911391|2017-10-10 20:43:24.911391
NCT03280056|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-15|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|July 30, 2019|Anticipated|2019-07-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients|A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS|Recruiting||Phase 3|200|Anticipated|Brainstorm-Cell Therapeutics||2|||f||||t|t|f||||||||2017-10-10 20:43:25.021912|2017-10-10 20:43:25.021912
NCT03280043|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-08|||September 1, 2015|Actual|2015-09-01|September 2017|2017-09-01|August 20, 2017|Actual|2017-08-20|May 20, 2017|Actual|2017-05-20||Observational|||Risk of Hematoma After Ketorolac Use in Reduction Mammoplasty.|Does Ketorolac Increase the Risk of Hematoma After Reduction Mammoplasty? A Case-control Study.|Completed||N/A|80|Actual|McMaster University|||2||f||||f|f|f|||f|||||2017-10-10 20:43:25.167054|2017-10-10 20:43:25.167054
NCT03280030|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-17|||November 29, 2017|Anticipated|2017-11-29|September 2017|2017-09-01|September 16, 2020|Anticipated|2020-09-16|September 16, 2020|Anticipated|2020-09-16||Interventional|||A Study in Asia and Russia of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML|A Phase II, Randomized, Double-blind, Multi-center, Placebo-controlled Study in Asia and Russia to Evaluate the Efficacy and Safety of Twice Daily Oral Midostaurin in Combination With Daunorubicin/Cytarabine Induction, High-dose Cytarabine Consolidation, and Midostaurin Single Agent Continuation Therapy in Newly Diagnosed Patients With FLT3-mutated Acute Myeloid Leukemia (AML).|Not yet recruiting||Phase 2|66|Anticipated|Novartis||2|||f||||t|f|f||||||||2017-10-10 20:43:25.263968|2017-10-10 20:43:25.263968
NCT03280017|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-24|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain|Low Dose Intraoperative Intravenous Ketamine in Combination With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain: a Randomized Study|Recruiting||Phase 4|32|Anticipated|Mahidol University||2|||f||||f|f|f||||||||2017-10-10 20:43:25.346839|2017-10-10 20:43:25.346839
NCT03280004|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-10|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|August 31, 2019|Anticipated|2019-08-31|30 Days|Observational [Patient Registry]|RECAP||Reason Evaluation of Initial Treatment Failure in Patients With CAP|Reason Evaluation of Initial Treatment Failure in Patients With Community Acquired Pneumonia|Not yet recruiting||N/A|314|Anticipated|Peking Union Medical College Hospital|||2||f|||||t|f||||||||2017-10-10 20:43:25.439038|2017-10-10 20:43:25.439038
NCT03124771|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||December 27, 2011|Actual|2011-12-27|June 2017|2017-06-01|April 3, 2012|Actual|2012-04-03|April 3, 2012|Actual|2012-04-03||Interventional|||Accuracy of Noninvasive Hemoglobin Pulse Oximeter (Rainbow Resposable Adhesive Sensors)||Completed||N/A|132|Actual|Masimo Corporation||1|||f|||||f|t|f||f|||||2017-10-10 21:08:43.211977|2017-10-10 21:08:43.211977
NCT03279991|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||June 1, 2018|Anticipated|2018-06-01|September 2017|2017-09-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Observational|PLATONE||Neuromed- Integrated Health Life Platform and Biobank|Neuromed- Integrated Health Life Platform and Biobank|Not yet recruiting||N/A|120000|Anticipated|Neuromed IRCCS|||1||f||||f|f|f||||Samples With DNA|"     The residual portion of biological withdrawals and materials normally used for the patient's     therapeutic diagnostic route ( blood, urine, any fragments of biopsy tissue, surgical finds,     umbilical cord, placenta sections, cefalorachidian fluid etc). In order to carry out any     genetic-molecular investigations, DNA and DNA from these biological fluids and tissues will     be extracted.   "|||2017-10-10 20:43:25.510247|2017-10-10 20:43:25.510247
NCT03279965|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-11|||May 5, 2017|Actual|2017-05-05|September 2017|2017-09-01|May 5, 2018|Anticipated|2018-05-05|May 5, 2018|Anticipated|2018-05-05||Observational|||MRI in Cystic Fibrosis and Primary Ciliary Dyskinesia|A Pilot Study to Assess the Use of MRI in the Assessment of Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia|Recruiting||N/A|50|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||2||f||||f|f|f||||||||2017-10-10 20:43:25.693634|2017-10-10 20:43:25.693634
NCT03279952|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Neurophysiological Markers of Pediatric Irritability and Its Response to Intervention|Neurophysiological Markers of Pediatric Irritability and Its Response to Intervention|Not yet recruiting||Phase 4|47|Anticipated|Milton S. Hershey Medical Center||1|||f||||f|t|f|||f|||||2017-10-10 20:43:25.78139|2017-10-10 20:43:25.78139
NCT03278847|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-07|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Optimising Newborn Nutrition During Therapeutic Hypothermia.|Optimising Newborn Nutrition During Therapeutic Hypothermia: an Observational Study Using Routinely Collected Data|Not yet recruiting||N/A|7200|Anticipated|Imperial College London|||2||f||||f|f|f||||||||2017-10-10 20:43:25.937256|2017-10-10 20:43:25.937256
NCT03278834|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-08|||January 1, 2014|Actual|2014-01-01|July 2017|2017-07-01|June 1, 2014|Actual|2014-06-01|June 1, 2014|Actual|2014-06-01||Interventional|||NMES and Pelvic Fracture Rehabilitation|The Use of Neuromuscular Electrical Stimulation With Pelvic Fracture Rehabilitation: A Randomised, Double Blind, Pilot Study|Completed||N/A|9|Actual|Barts & The London NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:43:26.035784|2017-10-10 20:43:26.035784
NCT03278821|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-08|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|January 29, 2021|Anticipated|2021-01-29|May 1, 2019|Anticipated|2019-05-01||Interventional|||The Self Match Study: A Study of Informed Choice in the Treatment of Addiction|The Self Match Study|Recruiting||N/A|400|Anticipated|University of Southern Denmark||2|||f||||t|f|f||||||||2017-10-10 20:43:26.106133|2017-10-10 20:43:26.106133
NCT03278808|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|November 30, 2018|Anticipated|2018-11-30||Interventional|||Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis|A Phase 2a Open Label Study of the Safety and Efficacy of a Single Dose of Weekly Chloroquine (CQ) and Azithromycin (AZ) Administered in Combination for Malaria Prophylaxis in Healthy Adults Challenged With 7G8 Chloroquine-Resistant Plasmodium Falciparum in a Controlled Human Malaria Infection (CHMI) Model|Not yet recruiting||Phase 2|23|Anticipated|U.S. Army Medical Research and Materiel Command||3|||f||||t|t|f||||||||2017-10-10 20:43:26.191896|2017-10-10 20:43:26.191896
NCT03278795|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||VSV Versus PSV as a Weaning Mode of Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients|Volume Support Ventilation Versus Pressure Support Ventilation as a Weaning Mode of Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients|Not yet recruiting||N/A|50|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:43:26.310343|2017-10-10 20:43:26.310343
NCT03278782|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-10-05|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of Pembrolizumab (MK-3475) in Combination With Romidepsin|A Phase I/II Study of Pembrolizumab (MK-3475) in Combination With Romidepsin in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma|Not yet recruiting||Phase 1/Phase 2|39|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 20:43:26.403766|2017-10-10 20:43:26.403766
NCT03278769|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-08|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 1, 2022|Anticipated|2022-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||Ventilator Settings on Patients With Acute Brain Injury|Relation Between Lung Protective Mechanical Ventilation, Intracranial Pressure, Autoregulation and Brain Oxygenation in Neurointensive Care Patients|Not yet recruiting||N/A|30|Anticipated|University Hospital of North Norway||1|||f||||f|f|f||||||||2017-10-10 20:43:26.519577|2017-10-10 20:43:26.519577
NCT03278756|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-08|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Online Cognitive Control Training for Remitted Depressed Patients|Online Cognitive Control Training for Remitted Depressed Patients|Recruiting||N/A|68|Anticipated|University Ghent||2|||f||||f|f|f||||||||2017-10-10 20:43:26.602206|2017-10-10 20:43:26.602206
NCT03278743|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-08|||June 2006|Actual|2006-06-01|September 2017|2017-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Tea Consumption and Cognitive Performance in the Very Old|Higher Tea Consumption is Associated With Better Performance on Measures of Attention and Psychomotor Speed in the Very Old: The Newcastle 85+ Study|Completed||N/A|1042|Actual|Newcastle University|||2||f|||||f|f||||||||2017-10-10 20:43:26.709825|2017-10-10 20:43:26.709825
NCT03278730|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-07|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|March 31, 2020|Anticipated|2020-03-31|March 1, 2020|Anticipated|2020-03-01||Interventional|||Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis|Phase 2 Single Center, Randomized, Placebo-controlled, Double-blind, Parallel Group Study to Evaluate Efficacy of Para-Tyrosine Supplementation on the Survival and Clinical Outcome in Patients With Sepsis|Not yet recruiting||Phase 2|296|Anticipated|University of Pecs||2|||f||||t|f|f||||||||2017-10-10 20:43:26.805457|2017-10-10 20:43:26.805457
NCT03278717|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-07|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|ICON9||Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients|International Phase III Randomised Study to Evaluate the Efficacy of Maintenance Therapy With Olaparib and Cediranib or Olaparib Alone in Patients With Relapsed Ovarian Cancer Following a Response to Platinum-based Chemotherapy|Not yet recruiting||Phase 3|618|Anticipated|University College, London||2|||f||||t|f|f|||f|||||2017-10-10 20:43:26.942398|2017-10-10 20:43:26.942398
NCT03278704|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|CONTRADIA||Concurrent Training in Type 2 Diabetes|Effects of Concurrent Resistance Exercise and High-intensity Interval Exercise Training on Skeletal Muscle Adaptations in Individuals With Type 2 Diabetes Mellitus|Recruiting||N/A|14|Anticipated|University of Birmingham||2|||f||||f|f|f||||||||2017-10-10 20:43:27.034944|2017-10-10 20:43:27.034944
NCT03279939|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-11|||August 23, 2017||2017-08-23||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:43:27.142703|2017-10-10 20:43:27.142703
NCT03279926|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|PLAY||Preschoolers Learning and Active in PlaY|Preschoolers Learning and Active in PlaY|Not yet recruiting||N/A|90|Anticipated|Seattle Children's Hospital||4|||f||||f|f|f||||||||2017-10-10 20:43:27.184314|2017-10-10 20:43:27.184314
NCT03279913|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|November 1, 2018|Anticipated|2018-11-01||Interventional|NEUROFEEDSTIM||NEUROFEEDSTIM : Therapeutic Use of Neurofeedback in Depression in Association With TMS|NEUROFEEDSTIM : Therapeutic Use of Neurofeedback in Depression in Association With TMS|Not yet recruiting||N/A|10|Anticipated|Rennes University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:43:27.266015|2017-10-10 20:43:27.266015
NCT03279900|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy|Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy at Cipto Mangunkusumo Hospital and Its Affecting Factors|Not yet recruiting||N/A|100|Anticipated|Indonesia University|||1||f||||f|f|f||||||||2017-10-10 20:43:27.367196|2017-10-10 20:43:27.367196
NCT03279887|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-11|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|May 2015|Actual|2015-05-01||Observational|ECHOVAP||Lung Ultrasonography After Major Cardiac Surgery|Usefulness of Lung Ultrasonography for Diagnosis of Pneumonia After Major Cardiac Surgery: a Pilot Study|Completed||N/A|51|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||f|f|f||||||||2017-10-10 20:43:27.441668|2017-10-10 20:43:27.441668
NCT03279861|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-11|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD|Sacubitril-valsartan (Entresto) Versus Standard Anti-hypertensive Therapy in LVAD Patients - A Feasibility Pilot Study|Not yet recruiting||Phase 4|20|Anticipated|University of Maryland||2|||f||||f|f|f|||f|||||2017-10-10 20:43:27.578673|2017-10-10 20:43:27.578673
NCT03279848|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-10|||January 1, 2011|Actual|2011-01-01|September 2017|2017-09-01|June 1, 2016|Actual|2016-06-01|December 31, 2015|Actual|2015-12-31|4 Weeks|Observational [Patient Registry]|||Stratification of Stroke Rehabilitation: 5-year Profiles of Functional Outcomes|Stratification of Stroke Rehabilitation: 5-year Profiles of Functional Outcomes|Completed||N/A|2722|Actual|Tai Po Hospital|||1||f||||t|f|f||||||||2017-10-10 20:43:27.654099|2017-10-10 20:43:27.654099
NCT03279835|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-11|||March 16, 2017|Actual|2017-03-16|September 2017|2017-09-01|February 16, 2018|Anticipated|2018-02-16|February 16, 2018|Anticipated|2018-02-16||Observational|NEURACog||Evaluation of a Short Version Computerized Test for Processing Speed to Detect Cognitive Disorders in HIV+ Patients|Evaluation of a Short Version Computerized Test for Processing Speed to Detect Cognitive Disorders in HIV+ Patients|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Nice|||4||f|||||f|f||||||||2017-10-10 20:43:27.707072|2017-10-10 20:43:27.707072
NCT03279822|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-10|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Observational|||Association Analysis for Chronic Diseases Based on Resident Health Records by Using Big Data Methods|Association Analysis for Chronic Diseases Based on Resident Health Records in China by Using Big Data Methods|Recruiting||N/A|10000000|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||t|f|f||||||||2017-10-10 20:43:27.796284|2017-10-10 20:43:27.796284
NCT03279809|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-21|||October 10, 2017|Anticipated|2017-10-10|September 2017|2017-09-01|September 5, 2020|Anticipated|2020-09-05|September 12, 2019|Anticipated|2019-09-12||Interventional|||The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct Obstruction|The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct Obstruction|Recruiting||N/A|184|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:43:27.883175|2017-10-10 20:43:27.883175
NCT03279796|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells|Autologous Adipose-derived Mesenchymal Stem Cells in the Treatment of Tendon Disease: a Randomized Controlled Trial|Not yet recruiting||Phase 2|200|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||f|f|f||||||||2017-10-10 20:43:27.981118|2017-10-10 20:43:27.981118
NCT03279770|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-13|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Observational|||Circulating Non-coding RNAs and Cardiovascular Outcomes in Patients With Dyslipidemia and Atherosclerosis|Circulating Non-coding RNAs and Cardiovascular Outcomes in Patients With Dyslipidemia and Atherosclerosis|Recruiting||N/A|1000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples Without DNA|"     Plasma and serum Non-coding RNAs   "|||2017-10-10 20:43:28.178423|2017-10-10 20:43:28.178423
NCT03279757|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-10|||October 1, 2016|Actual|2016-10-01|September 2017|2017-09-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Fractional Laser Assisted Delivery of Anesthetics IIIb|Parameters in Fractional Laser Assisted Delivery of Topical Anesthetics: Role of Anesthetic and Application Time|Completed||Phase 4|15|Actual|Netherlands Institute for Pigment Disorders||7|||f||||f|f|f|||f|||||2017-10-10 20:43:28.27592|2017-10-10 20:43:28.27592
NCT03279744|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-10|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion|A Prospective, Single-Arm, Open-Label, Phase II. Study to Evaluate the Efficacy and Safety of Photodynamic Therapy Using Radion™-Pdt in Patients With Oral Precancerous Lesion (Oral Verrucous Hyperplasia or Oral Erythroleukoplakia)|Enrolling by invitation||Phase 2|42|Anticipated|Pharma Power Biotec Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 20:43:28.396903|2017-10-10 20:43:28.396903
NCT03279731|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-10-05|||September 29, 2017|Actual|2017-09-29|October 2017|2017-10-01|April 20, 2020|Anticipated|2020-04-20|April 1, 2020|Anticipated|2020-04-01||Interventional|BELIEVE||Binge Eating Liraglutide Intervention|Liraglutide 3.0mg/d for the Treatment of Binge Eating Disorder|Recruiting||Phase 3|152|Anticipated|University of Pennsylvania||2|||f||||t|t|f||||||||2017-10-10 20:43:28.493201|2017-10-10 20:43:28.493201
NCT03279718|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 31, 2020|Anticipated|2020-03-31|October 1, 2019|Anticipated|2019-10-01||Interventional|Expertention||Efficacy of Periodontal Treatment on Systemic Inflammation and for Prevention of Exacerbations in Patients With COPD|Exploring Efficacy of Periodontal Treatment on Systemic Inflammation and for Prevention of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD): A Pilot Study|Not yet recruiting||N/A|40|Anticipated|Heidelberg University||2|||f|||||f|f||||||||2017-10-10 20:43:28.602216|2017-10-10 20:43:28.602216
NCT03279705|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-13|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||The efﬁcacy of the Integrated Water Jet Channel Colonoscopy in Water Exchange Method|Division of Gastroenterology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan|Recruiting||N/A|120|Anticipated|Dalin Tzu Chi General Hospital||2|||f|||||f|f||||||||2017-10-10 20:43:28.688639|2017-10-10 20:43:28.688639
NCT03279692|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-09|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|March 31, 2025|Anticipated|2025-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma|Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma|Not yet recruiting||Phase 2|26|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 20:43:28.770169|2017-10-10 20:43:28.770169
NCT03279679|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-09|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison Between Costoclavicular and Paracoracoid Ultrasound-guided Infraclavicular Block for Forearm Surgery|A Randomized Comparison of Minimum Effective Volume With 0.5% Ropivacaine Between Costoclavicular and Paracoracoid Ultrasound-guided Infraclavicular Block for Forearm Surgery|Not yet recruiting||N/A|50|Anticipated|Huazhong University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 20:43:28.862952|2017-10-10 20:43:28.862952
NCT03279666|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-11|||June 15, 2017|Actual|2017-06-15|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Biopsy Size and Pain Perception During Colposcopic Biopsy|A Randomized Controlled Study: Patients' With or Without Tenaculum Placement and Intracervical Blockage/or Not During Colposcopic Biopsy|Recruiting||N/A|250|Anticipated|Bakirkoy Dr. Sadi Konuk Research and Training Hospital||4|||f||||f|f|f||||||||2017-10-10 20:43:28.957756|2017-10-10 20:43:28.957756
NCT03279653|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-12|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Pancreatic Exocrine Insufficiency After Bariatric Surgery|Effect of Sleeve Gastrectomy on Pancreatic Exocrine Insufficiency.|Recruiting||N/A|50|Anticipated|Umraniye Education and Research Hospital|||1||f|||||f|f||||||||2017-10-10 20:43:29.048595|2017-10-10 20:43:29.048595
NCT03279640|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-12|||March 1, 2014|Actual|2014-03-01|June 2017|2017-06-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Effects of Brain Network by Simultaneous Dual-mode Stimulation in Subacute Stroke Patients|Investigation for Individualized Noninvasive Neuromodulation in Neurorehabilitation of Brain Disease: Longitudinal Study|Completed||N/A|24|Actual|Samsung Medical Center||2|||f|||||f|f||||||||2017-10-10 20:43:29.264996|2017-10-10 20:43:29.264996
NCT03279627|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-08|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|August 28, 2018|Anticipated|2018-08-28|3 Months|Observational [Patient Registry]|||Comprehension of Discharge Instructions for Diabetes Therapy and Hospital Readmission|Association of Glycemic Control With Comprehension of Discharge Instructions for Diabetes Therapy and Hospital Readmission|Recruiting||N/A|300|Anticipated|University of Pittsburgh|||3||f||||t|f|f||||||||2017-10-10 20:43:29.894893|2017-10-10 20:43:29.894893
NCT03279614|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-10|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma|Phase II Study of SOX as the Seconde Line Chemotherapy in Advanced or Metastatic Neuroendocrine Carcinoma|Recruiting||Phase 2|45|Anticipated|Peking University||1|||f||||t|f|f||||||||2017-10-10 20:43:29.991568|2017-10-10 20:43:29.991568
NCT03279601|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-10|2017-09-10|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor|A Randomized, Controlled Phase II Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor|Recruiting||Phase 2|148|Anticipated|Peking University||2|||f||||t|f|f||||||||2017-10-10 20:43:30.077745|2017-10-10 20:43:30.077745
NCT03279588|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-09|||May 20, 2017|Actual|2017-05-20|September 2017|2017-09-01|December 20, 2018|Anticipated|2018-12-20|November 20, 2017|Anticipated|2017-11-20||Observational|||Diagnostic Accuracy of Bedside Ultrasound in Suspected Acute Diverticulitis|Diagnostic Accuracy and Role of Bedside Ultrasound in Patients With Suspected Acute Diverticulitis|Recruiting||N/A|316|Anticipated|Azienda Ospedaliero-Universitaria Careggi|||1||f||||f|f|f||||||||2017-10-10 20:43:30.189383|2017-10-10 20:43:30.189383
NCT03279575|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Testing the Efficacy of Two Behavioral Interventions at Recalibrating Physician Heuristics in Trauma Triage|Testing the Efficacy of Two Behavioral Interventions at Recalibrating Physician Heuristics in Trauma Triage: a Randomized Clinical Trial|Not yet recruiting||N/A|320|Anticipated|University of Pittsburgh||4|||f||||f|f|f||||||||2017-10-10 20:43:30.303232|2017-10-10 20:43:30.303232
NCT03279562|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Patient Driven Recovery With Nalmefene and Coaching|Patient Driven Recovery With Nalmefene and Coaching|Recruiting||Phase 2|30|Anticipated|Yale University||1|||f||||f|t|f|||f|||||2017-10-10 20:43:30.394194|2017-10-10 20:43:30.394194
NCT03279549|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Research on the Key Technology of Burn Wound Treatment|A Randomized, Controlled, Prospective Clinical Trial on the Key Technology of Burn Wound Treatment|Not yet recruiting||N/A|200|Anticipated|Xijing Hospital||4|||f|||||f|f||||||||2017-10-10 20:43:30.490423|2017-10-10 20:43:30.490423
NCT03279536|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-08|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|October 20, 2017|Anticipated|2017-10-20|September 30, 2017|Anticipated|2017-09-30||Interventional|TDI||Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing|Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing|Recruiting||Phase 1/Phase 2|99|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||f|f|f|||f|||||2017-10-10 20:43:30.590501|2017-10-10 20:43:30.590501
NCT03279523|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-14|||May 2016||2016-05-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|May 2021|Anticipated|2021-05-01||Interventional|||F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected|F 18 T807 Tau PET Imaging of Older (>= 50 Years Old) HIV Infected (HIV+) and HIV Uninfected (HIV-) Individuals|Recruiting||Phase 2|60|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 20:43:30.738376|2017-10-10 20:43:30.738376
NCT03279510|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Hearing Aids and the Brain|Hearing Aids and the Brain|Not yet recruiting||N/A|20|Anticipated|VA Office of Research and Development||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:43:30.850361|2017-10-10 20:43:30.850361
NCT03279497|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Health Game Intervention to Promote the Physical Activity of Early Adolescents|Health Game Intervention to Promote the Physical Activity of Early Adolescents|Not yet recruiting||N/A|180|Anticipated|University of Turku||2|||f|||||f|f||||||||2017-10-10 20:43:30.97584|2017-10-10 20:43:30.97584
NCT03279484|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-08|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|April 2018|Anticipated|2018-04-01||Interventional|NAVIGATOR||Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector|Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector|Not yet recruiting||Phase 3|262|Anticipated|LivaNova||1|||f||||f|f|f||||||||2017-10-10 20:43:31.067003|2017-10-10 20:43:31.067003
NCT03279471|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-10-03|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|September 14, 2022|Anticipated|2022-09-14|February 15, 2022|Anticipated|2022-02-15||Interventional|STAAR||Specifying and Treating Anxiety in Autism Research|Specifying and Treating the Anxiety Phenotype in Autism Spectrum Disorder|Recruiting||Phase 2|132|Anticipated|University of California, Davis||3|||f||||t|t|f|||f|||||2017-10-10 20:43:31.147975|2017-10-10 20:43:31.147975
NCT03279458|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device|Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device|Recruiting||N/A|40|Anticipated|University of Mississippi Medical Center||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:43:31.290131|2017-10-10 20:43:31.290131
NCT03279445|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-08|||August 9, 2017|Actual|2017-08-09|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Parkinson's Disease in African American and Caucasian Patients|Characteristics of African American People With Parkinson's Disease: A Hospital Based Study at the University of Chicago of the African American Community in Chicago's South Side|Recruiting||N/A|600|Anticipated|University of Chicago|||2||f||||f|f|f||||Samples With DNA|"     Two tubes of blood of 8 ml each will be obtained from patients for genetic testing   "|||2017-10-10 20:43:31.401873|2017-10-10 20:43:31.401873
NCT03279432|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-11|||August 18, 2004|Actual|2004-08-18|September 2017|2017-09-01|July 7, 2013|Actual|2013-07-07|July 7, 2013|Actual|2013-07-07||Observational|||Vitamin D-related Genes and Metabolic Disorders|Vitamin D Receptor and Megalin Gene Polymorphisms and Their Association With Obesity, Central Obesity and the Metabolic Syndrome|Completed||N/A|1021|Actual|National Institute on Aging (NIA)|||1||f||||f|f|f||||Samples With DNA|"     Study participants were genotyped to 907,763 single nucleotide polymorphisms (SNPs) using the     Illumina 1M and 1M-Duo genotyping arrays. Sample quality control inclusion criteria were: (1)     concordance between self-reported sex and X-chromosome estimated sex; (2) sample call rate     >95%, (3) concordance between self-reported African ancestry and ancestry estimated using     genotyped SNPs, and (4) proportional sharing of genotypes < 15% between samples, excluding     close relatives from the final sample. SNPs in HANDLS were selected when the following     criteria were met: (1) Hardy-Weinberg equilibrium p-value (HWE P >10-7); (2) Missing by     haplotype P > 10-7; (3) Minor allele frequency>0.01, and (4) SNP call rate >95%. Quality     control and data management for each genotype was conducted using PLINKv1.06.   "|||2017-10-10 20:43:31.49733|2017-10-10 20:43:31.49733
NCT03279419|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|September 1, 2019|Anticipated|2019-09-01||Observational|||Thermal Imaging in Liver Disease.|Thermal Imaging of the Peripheral Vasculature in Liver Disease.|Recruiting||N/A|30|Anticipated|University of Edinburgh|||2||f|||||f|f||||||||2017-10-10 20:43:31.590893|2017-10-10 20:43:31.590893
NCT03279406|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||February 1, 2012|Actual|2012-02-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31|60 Months|Observational [Patient Registry]|RELEXAO||REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion|REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion for Patients With Atrial Fibrillation in France|Enrolling by invitation||N/A|400|Anticipated|University Hospital, Tours|||1||f||||f|f|f||||||||2017-10-10 20:43:31.668258|2017-10-10 20:43:31.668258
NCT03279393|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||March 17, 2017|Actual|2017-03-17|September 2017|2017-09-01|February 28, 2022|Anticipated|2022-02-28|February 28, 2022|Anticipated|2022-02-28||Interventional|||PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients|Stress and Atherosclerotic Plaque Macrophages: A Systems Biology Approach - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients|Active, not recruiting||Early Phase 1|240|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||f|t|f||||||||2017-10-10 20:43:31.73595|2017-10-10 20:43:31.73595
NCT03279380|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|GE-EX||Gene-Exercise Interactions in Athletes|Acute Physiological Response to Exercise in Athletes Selected According to Candidate Gene Polymorphisms Associated With Endurance Phenotype|Recruiting||N/A|500|Anticipated|University of Primorska||3|||f||||f|f|f||||||||2017-10-10 20:43:31.8544|2017-10-10 20:43:31.8544
NCT03279367|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 1, 2018|Anticipated|2018-09-01||Observational|||Optimisation of Hearing Aid Fitting|Objective Response Detection to Natural Speech Stimuli for Optimisation of Hearing Aid Fitting Evaluation|Not yet recruiting||N/A|40|Anticipated|University of Southampton|||1||f|||||f|f||||||||2017-10-10 20:43:31.963726|2017-10-10 20:43:31.963726
NCT03279354|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-11|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|March 31, 2020|Anticipated|2020-03-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Smartphone Parent-child Partner Exercises Application Study|A Randomized Controlled Trial of the Effectiveness of a Smartphone Parent-child Partner Exercises Application on Enhancing Health-related Quality of Life of Children From Low-income Families|Recruiting||N/A|268|Anticipated|The University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:43:32.034101|2017-10-10 20:43:32.034101
NCT03279341|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-08|||December 3, 2012|Actual|2012-12-03|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects|An Open-label, Randomised, Crossover, Reader Blinded, Study to Compare the Effect of Polyethylene Glycol 3350, Bisacodyl and Prucalopride on Colonic Motility Assessed With Intraluminal Colonic Manometry in Healthy Subjects|Completed||Phase 4|10|Actual|University Hospital, Gasthuisberg||3|||f||||f|f|f|||f|||||2017-10-10 20:43:32.124074|2017-10-10 20:43:32.124074
NCT03279328|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 15, 2019|Anticipated|2019-09-15|September 15, 2018|Anticipated|2018-09-15||Interventional|||Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents|Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents|Recruiting||Phase 4|60|Anticipated|University of Arizona||3|||f||||f|t|f|||f|||||2017-10-10 20:43:32.208787|2017-10-10 20:43:32.208787
NCT03279315|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||November 20, 2014|Actual|2014-11-20|September 2017|2017-09-01|March 10, 2017|Actual|2017-03-10|December 19, 2014|Actual|2014-12-19||Interventional|||An Iodine Balance Experiment|Exploration of the Appropriate Recommended Nutrient Intake of Iodine in Chinese Euthyroid Women: an Iodine Balance Experiment|Completed||N/A|25|Actual|Tianjin Medical University||1|||f||||f|f|f||||||||2017-10-10 20:43:32.294111|2017-10-10 20:43:32.294111
NCT03279302|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-13|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects|A Phase 1, Open-Label, Partially Randomized, 3-Part, Parallel Group Trial to Evaluate the Pharmacokinetic Profile of Glepaglutide (ZP1848) After a Single Intravenous Injection and After Multiple Subcutaneous Injections in Healthy Subjects|Recruiting||Phase 1|75|Anticipated|Zealand Pharma||5|||f||||f|t|f||||||||2017-10-10 20:43:32.365193|2017-10-10 20:43:32.365193
NCT03279276|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-08|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2028|Anticipated|2028-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Selecting the Right Hip Prosthesis for Young Patients|Selection of Hip Prosthesis for Younger Patients? Primoris® Short Femur Component vs. Echo® Standard Femur Component. Comparison of Bone Re-modeling, Prosthetic Migration and Gait Function. Controlled Randomized Study of 60 Patients.|Not yet recruiting||N/A|60|Anticipated|Northern Orthopaedic Division, Denmark||2|||f||||t|f|f||||||||2017-10-10 20:43:32.558737|2017-10-10 20:43:32.558737
NCT03279263|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Add-on Study of MLR 1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy|Recruiting||Phase 2|400|Anticipated|Melior Pharmaceuticals||4|||f||||f|t|f||||||||2017-10-10 20:43:32.649015|2017-10-10 20:43:32.649015
NCT03279237|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|October 31, 2024|Anticipated|2024-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers|A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers|Not yet recruiting||Phase 1|25|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f|||f|||||2017-10-10 20:43:32.836392|2017-10-10 20:43:32.836392
NCT03279224|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|September 20, 2019|Anticipated|2019-09-20|September 20, 2019|Anticipated|2019-09-20||Interventional|||Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder|A Randomized Controlled Trial of the Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder|Recruiting||Phase 2/Phase 3|60|Anticipated|Women's College Hospital||2|||f||||t|f|f||||||||2017-10-10 20:43:32.952563|2017-10-10 20:43:32.952563
NCT03279211|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Amino Acid Digestibility of Whey and Zein Proteins|True Ileal Amino Acid Digestibility of Whey and Zein Proteins in Healthy Volunteers With Naso-ileal Tubes|Not yet recruiting||N/A|24|Anticipated|Institut National de la Recherche Agronomique||3|||f||||f|f|f||||||||2017-10-10 20:43:33.070449|2017-10-10 20:43:33.070449
NCT03279198|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-08|||July 22, 2010|Actual|2010-07-22|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|September 15, 2015|Actual|2015-09-15||Interventional|COBRA||Increasing Colorectal and Breast Cancer Screening in Women|Increasing Colorectal and Breast Cancer Screening in Women|Completed||N/A|1196|Actual|Indiana University||4|||f||||f|f|f||||||||2017-10-10 20:43:33.136745|2017-10-10 20:43:33.136745
NCT03279185|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2023|Anticipated|2023-10-01|October 1, 2023|Anticipated|2023-10-01||Observational|AMP Up Lite||Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite|Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite (AMP Up Lite)|Not yet recruiting||N/A|500|Anticipated|Harvard School of Public Health|||1||f||||f|f|f||||Samples With DNA|"     Serum, plasma, peripheral blood mononuclear cells (PBMCs)   "|||2017-10-10 20:43:33.295409|2017-10-10 20:43:33.295409
NCT03279172|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-11|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|August 4, 2017|Actual|2017-08-04|August 3, 2017|Actual|2017-08-03||Interventional|IOP||A Comparison of Videolaryngoscope and Direct Laryngoscope in IOP Changes, Throat Pain, IT and Hemodynamic Variables|A Comparison of Videolaryngoscope and Direct Laryngoscope in Intraocular Pressure Changes, Throat Pain, Intubation Time and Hemodynamic Variables|Completed||N/A|78|Actual|Diskapi Teaching and Research Hospital||2|||f|||||f|f||||||||2017-10-10 20:43:33.422934|2017-10-10 20:43:33.422934
NCT03279159|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-08|||March 22, 2017|Actual|2017-03-22|June 2017|2017-06-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||Hydrating Efficacy and Tolerance Evaluation of a Face Cream|Hydrating Efficacy and Tolerance Evaluation of a Face Cream|Completed||N/A|18|Actual|Derming SRL||1|||f||||f|f|f||||||||2017-10-10 20:43:33.499429|2017-10-10 20:43:33.499429
NCT03279146|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-13|||September 6, 2017|Actual|2017-09-06|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects|Open-Label, Part-Randomized Study Designed to Evaluate the PK Profile of Tenofovir Exalidex (TXL) Following Single Dose of Oral Formulations in Comparison to a Reference IR TXL Tablet in Healthy Subjects|Recruiting||Phase 1|30|Anticipated|ContraVir Pharmaceuticals, Inc.||3|||f||||f|f|f||||||||2017-10-10 20:43:33.562268|2017-10-10 20:43:33.562268
NCT03279133|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-14|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients.|A Pilot/Feasibility Study of Ledipasvir/Sofosbuvir as Treatment for Hepatitis C in Hematopoietic Cell Transplantation (HCT) Recipients.|Recruiting||Phase 4|20|Anticipated|Kaiser Permanente||1|||f||||f|t|f||||||||2017-10-10 20:43:33.636208|2017-10-10 20:43:33.636208
NCT03279120|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-08|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|TFV/LNG IVR||Safety, PK, and PD Study of IVRs Releasing TFV and LNG|Phase I, 90-Day Safety, Pharmacokinetic, And Pharmacodynamic Study Of Intravaginal Rings Releasing Tenofovir And Levonorgestrel|Not yet recruiting||Phase 1|60|Anticipated|CONRAD||4|||f|||||t|f||||||||2017-10-10 20:43:33.727359|2017-10-10 20:43:33.727359
NCT03279107|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||August 25, 2017|Actual|2017-08-25|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Different Types of Carbohydrates in Snacks and Beverages on Glycemia, Insulinemia and Appetite.|Effects of Different Types of Carbohydrates in Snacks and Beverages on Glycemia, Insulinemia and Appetite.|Recruiting||N/A|25|Anticipated|Clinical Nutrition Research Centre, Singapore||5|||f||||f|f|f||||||||2017-10-10 20:43:33.981902|2017-10-10 20:43:33.981902
NCT03279094|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease|A Pilot Study of Pre-transplant Immunosuppressive Therapy for Haploidentical Transplants in Patients With Sickle Cell Disease|Recruiting||Phase 1|15|Anticipated|City of Hope Medical Center||1|||f||||t|t|f|||f|||||2017-10-10 20:43:34.107639|2017-10-10 20:43:34.107639
NCT03279081|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-08|||September 11, 2017|Anticipated|2017-09-11|September 2017|2017-09-01|October 15, 2021|Anticipated|2021-10-15|October 1, 2021|Anticipated|2021-10-01||Interventional|ADMIRE-CD-II||Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease|Phase-III Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess Efficacy and Safety of Cx601, Allogeneic Expanded Adipose-derived Stem Cells for Complex Perianal Fistula(s) in Crohn's Disease.ADMIRE-CD-II|Not yet recruiting||Phase 3|326|Anticipated|Cellerix||2|||f||||f|f|f|||f|||||2017-10-10 20:43:34.2272|2017-10-10 20:43:34.2272
NCT03279055|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-09|2017-09-09|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors|Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors|Not yet recruiting||Phase 3|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|f|f||||||||2017-10-10 20:43:34.432995|2017-10-10 20:43:34.432995
NCT03279042|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-08|||September 12, 2016|Actual|2016-09-12|September 2017|2017-09-01|October 15, 2017|Anticipated|2017-10-15|August 12, 2017|Actual|2017-08-12||Interventional|||Effectiveness of Two Corticotomy Techniques in Retracting the Upper Anterior Teeth by Using Miniscrews|An Evaluation of the Efficacy of Conventional Corticotomy Versus Flapless Corticotomy in the En-Masse Retraction of Upper Anterior Teeth : A Randomized Controlled Trial|Active, not recruiting||N/A|20|Actual|Damascus University||2|||f||||t|f|f||||||||2017-10-10 20:43:34.536161|2017-10-10 20:43:34.536161
NCT03279016|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-08|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Arthroscopic Guided Synovial Biopsies|Diagnosis of Temporomandibular Joint Arthritic Disease Using Arthroscopic Guided Synovial Biopsies|Recruiting||N/A|20|Anticipated|Cairo University|||1||f|||||f|f||||||||2017-10-10 20:43:34.763219|2017-10-10 20:43:34.763219
NCT03279003|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-08|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|SENSILED||Study of the Efficacy and Tolerance of Light Therapy in Sensitive Skin|Study of the Efficacy and Tolerance of Light Therapy by Light-emitting Diode (LED) in Sensitive Skin|Not yet recruiting||N/A|15|Anticipated|University Hospital, Brest||1|||f||||f|f|f||||||||2017-10-10 20:43:34.853718|2017-10-10 20:43:34.853718
NCT03278990|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|October 31, 2018|Anticipated|2018-10-31||Interventional|SIIPA||Scalable Interventions to Increase PrEP Adherence: Value Affirmation and Future Selves|A Test of Scalable Behavioral Interventions to Increase PrEP Adherence for At-Risk HIV- Individuals: Value Affirmation and Future Selves|Not yet recruiting||Early Phase 1|170|Anticipated|BI Development, LLC||2|||f||||f|f|f||||||||2017-10-10 20:43:34.929907|2017-10-10 20:43:34.929907
NCT03278977|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|iALTE||Apparent Life Threatening Events, Sudden Infant Death Syndrome and Muscarinic Receptors|Apparent Life Threatening Events, Sudden Infant Death Syndrome and Muscarinic Receptors|Not yet recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||||2017-10-10 20:43:35.04307|2017-10-10 20:43:35.04307
NCT03278964|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-07|||February 5, 2015|Actual|2015-02-05|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy|Comparative Morphometric, Functional and Psychosocial Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy|Recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:43:35.164883|2017-10-10 20:43:35.164883
NCT03278951|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-13|||January 30, 2016|Actual|2016-01-30|September 2017|2017-09-01|May 30, 2017|Actual|2017-05-30|May 20, 2017|Actual|2017-05-20||Interventional|||Video Conferencing and In-person Health Coaching on Weight Loss, Physical Activity, and Metabolic Control|A Comparison of Video Conferencing and In-person Health Coaching Approaches in Combination With mHealth Devices on Weight Loss, Physical Activity, and Glycemic Control|Completed||N/A|30|Actual|University of New Mexico||3|||f||||f|f|f||||||||2017-10-10 20:43:35.280639|2017-10-10 20:43:35.280639
NCT03278938|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-09-07|||June 29, 2012|Actual|2012-06-29|September 2017|2017-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders|Add-on to Cognitive, ERP and EEG Asymmetry in Affective Disorders (#6559R) [Formerly #5723]|Completed||Phase 4|30|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-10 20:43:35.377726|2017-10-10 20:43:35.377726
NCT03278925|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-11|2017-09-11|||February 11, 2018|Anticipated|2018-02-11|September 2017|2017-09-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|||Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis|A Phase I Single-Arm, Multicenter Pilot Study Aimed at Validating γ-OHPdG as a Biomarker and Testing the Effects of Polyphenon E on Its Levels in Patients With Cirrhosis|Not yet recruiting||Phase 1|48|Anticipated|National Cancer Institute (NCI)||1|||f||||t|t|f||||||||2017-10-10 20:43:35.485936|2017-10-10 20:43:35.485936
NCT03278886|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|PETER-PAIN||St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene|Pilot Study of Opioid-receptor Antagonists to Reduce Pain and Inflammation Among HIV-Infected Persons With Alcohol Problems|Not yet recruiting||Phase 1/Phase 2|16|Anticipated|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:43:35.772741|2017-10-10 20:43:35.772741
NCT03278873|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-07|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|August 7, 2023|Anticipated|2023-08-07|July 10, 2023|Anticipated|2023-07-10||Interventional|||Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3|Long-term Follow-up Study of Participants Following an Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector for Gene Therapy of Adults and Children With Achromatopsia Owing to Defects in CNGB3|Recruiting||Phase 1/Phase 2|18|Anticipated|MeiraGTx UK II Ltd||3|||f||||t|f|f||||||||2017-10-10 20:43:35.873326|2017-10-10 20:43:35.873326
NCT03278860|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-11|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effects of Oxytocin on Social Touch|The Effects of Intranasal Oxytocin on Social Touch: an fMRI-based Study|Recruiting||N/A|50|Anticipated|University of Electronic Science and Technology of China||2|||f||||f|f|f||||||||2017-10-10 20:43:36.007594|2017-10-10 20:43:36.007594
NCT03278691|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-08|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|August 2, 2020|Anticipated|2020-08-02|August 2, 2020|Anticipated|2020-08-02||Interventional|||Ketorolac on Posterior Thoracolumbar Spinal Fusions|The Effect of Ketorolac on Posterior Thoracolumbar Spinal Fusions: a Prospective Randomized Controlled Trial|Recruiting||Phase 4|600|Anticipated|Ascension St John Providence||2|||f||||t|t|f|||t|||||2017-10-10 20:43:36.110786|2017-10-10 20:43:36.110786
NCT03278678|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-11|||May 1, 2016|Actual|2016-05-01|September 2017|2017-09-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|||Nutritional Screening in Older Individuals|Nutritional Screening in Community Living Older Individuals at High Risk of Hospital Admission.|Completed||N/A|791|Actual|Sanjuan, Silvia Forcano, M.D.|||1||f||||t||||||||||2017-10-10 20:43:36.189025|2017-10-10 20:43:36.189025
NCT03278665|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-10-04|||September 25, 2017|Actual|2017-09-25|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|SENSITIZE||A Study of 4SC-202 in Combination With Pembrolizumab in Patients With Unresectable Stage III/Metastatic Stage IV Cutaneous Melanoma Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy|An Open-label Phase Ib/II, Multi-center Study of 4SC-202 in Combination With Pembrolizumab in Patients With Unresectable Stage III/Metastatic Stage IV Cutaneous Melanoma Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy - The SENSITIZE Study|Recruiting||Phase 1/Phase 2|40|Anticipated|4SC AG||1|||f||||t|f|f||||||||2017-10-10 20:43:36.241019|2017-10-10 20:43:36.241019
NCT03278652|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-07|||April 19, 2016|Actual|2016-04-19|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|NEPHROPAIN||Use of Analgesic Drugs in Renal Colic in Emergency Room|Use of Analgesic Drugs in Renal Colic in Emergency Room|Recruiting||N/A|60|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:43:36.31656|2017-10-10 20:43:36.31656
NCT03278639|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|ERA-EP2||Efficacy and Safety or Rhythmic Auditory Stimulation (RAS) for Gait and Balance Disorders in Parkinson's Disease|Randomized, Blind, Controlled Clinical Trial to Assess the Efficacy and Safety or Rhythmic Auditory Stimulation (RAS) for Gait and Balance Disorders in Parkinson's Disease|Not yet recruiting||N/A|78|Anticipated|Pontifical Catholic University of Argentina||2|||f||||f|f|f||||||||2017-10-10 20:43:36.390227|2017-10-10 20:43:36.390227
NCT03278626|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-08|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma|A Phase I/II Open Label Multi Center Study of Immune Checkpoint Therapy With Nivolumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|10|Anticipated|New York University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 20:43:36.482193|2017-10-10 20:43:36.482193
NCT03278613|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|NOTABLe||Neuromodulation for Accidental Bowel Leakage|Neuromodulation for Accidental Bowel Leakage|Not yet recruiting||N/A|359|Anticipated|NICHD Pelvic Floor Disorders Network||2|||f||||t|f|t|f|||||||2017-10-10 20:43:36.571494|2017-10-10 20:43:36.571494
NCT03278587|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-14|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|VIEW II Pilot||Village-Integrated Eye Worker Trial II - Pilot|Village-Integrated Eye Worker Trial II - Pilot|Not yet recruiting||N/A|15000|Anticipated|Francis I. Proctor Foundation||4|||f|||||f|f||||||||2017-10-10 20:43:36.788208|2017-10-10 20:43:36.788208
NCT03278574|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-10|||September 5, 2011|Actual|2011-09-05|September 2017|2017-09-01|December 26, 2016|Actual|2016-12-26|September 29, 2014|Actual|2014-09-29||Interventional|||Flexible Band vs Rigid Ring for Degenerative Mitral Valve Disease|Mitral Valve Repair Using Flexible Bands Versus Complete Rings in Patients With Degenerative Mitral Valve Disease: a Prospective, Randomized Study|Completed||N/A|171|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f|f|f||||||||2017-10-10 20:43:36.871995|2017-10-10 20:43:36.871995
NCT03278561|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-09|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|GRANDMA||General Risk Factors and Inflammatory Determinants in Older Patients With Asthma|General Risk Factors and Inflammatory Determinants in Older Patients With Asthma|Recruiting||N/A|90|Anticipated|Franciscus Gasthuis|||3||f||||f|f|f||||Samples With DNA|"     sputum, blood, NP swab, feces   "|||2017-10-10 20:43:37.023061|2017-10-10 20:43:37.023061
NCT03278535|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-07|||July 4, 2017|Actual|2017-07-04|June 2017|2017-06-01|July 5, 2019|Anticipated|2019-07-05|July 4, 2019|Anticipated|2019-07-04||Observational|||Reference Gait Data for Healthy Subjects|Reference Gait Data for Healthy Subjects: Caren-based Gait Analysis|Recruiting||N/A|155|Anticipated|Maastricht University Medical Center|||7||f|||||f|f||||||||2017-10-10 20:43:37.220606|2017-10-10 20:43:37.220606
NCT03278522|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Ramosetron Pre-treatment for PONV and QT Prolongation|Comparison of Ramosetron Pre-treatment Time for Postoperative Nausea and Vomiting (PONV) and QTc Prolongation|Recruiting||Phase 4|42|Anticipated|Konkuk University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:43:37.302443|2017-10-10 20:43:37.302443
NCT03278509|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-11|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|August 31, 2025|Anticipated|2025-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)|Randomized Evaluation of Decreased Usage of betablocCkErs After Myocardial Infarction in the SWEDEHEART Registry - A Registry-based, Randomized, Parallel, Open-label, Multicenter Trial (REDUCE-SWEDEHEART)|Recruiting||Phase 4|7000|Anticipated|Karolinska Institutet||2|||f||||t|f|f|||f|||||2017-10-10 20:43:37.380333|2017-10-10 20:43:37.380333
NCT03278496|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-09-07|||April 2001||2001-04-01|September 2017|2017-09-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Recovery Housing and Drug Abuse Treatment Outcome|Recovery Housing and Drug Abuse Treatment Outcome|Completed||N/A|243|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-10-10 20:43:37.46368|2017-10-10 20:43:37.46368
NCT03278483|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-07|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|July 15, 2019|Anticipated|2019-07-15|December 16, 2018|Anticipated|2018-12-16||Interventional|TBL||Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)|Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2|Active, not recruiting||Phase 4|396|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||t|f|f|||f|||||2017-10-10 20:43:37.535765|2017-10-10 20:43:37.535765
NCT03278470|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-10|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|March 13, 2018|Anticipated|2018-03-13|March 13, 2018|Anticipated|2018-03-13||Interventional|||A Single Ascending Dose Clinical Trial to Find the Maximum Tolerable Dose of HL237 in Healthy Male Subject|A Dose Block-randomized, Double Blinded, Placebo Controlled, Dose-escalation Clinical Trial to Find the Maximum Tolerable Dose After Single Oral Dose of HL237 in Healthy Male Subject|Enrolling by invitation||Phase 1|56|Anticipated|Hanlim Pharm. Co., Ltd.||7|||f||||t|f|f||||||||2017-10-10 20:43:37.622415|2017-10-10 20:43:37.622415
NCT03278457|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-07|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|June 3, 2018|Anticipated|2018-06-03|January 3, 2018|Anticipated|2018-01-03||Observational|HCM-PET||Risk Stratification Using PET in HCM|Risk Stratification Using Positron Emission Tomography (PET) in Hypertrophic Cardiomyopathy (HCM)|Recruiting||N/A|25|Anticipated|Region Gävleborg|||1||f||||f|f|f||||||||2017-10-10 20:43:37.704188|2017-10-10 20:43:37.704188
NCT03278444|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-09|||July 18, 2017|Actual|2017-07-18|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|TAHCC||Treatment of Advanced Hepatocellular Carcinoma|The Efficacy and Safety of Arginine Hydrochloride Combined With Trimetazidine Hydrochloride Tablets in the Treatment of Patients With Hepatocellular Carcinoma. A Multicenter, Open, Randomized, Prospective Study|Recruiting||Phase 3|300|Anticipated|The First Affiliated Hospital of Zhengzhou University||3|||f|||||f|f||||||||2017-10-10 20:43:39.380661|2017-10-10 20:43:39.380661
NCT03278418|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|September 2021|Anticipated|2021-09-01||Interventional|RIGHT||Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach|Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach At The Time Of Left- Sided Valve Surgery. A Prospective Randomized Study|Not yet recruiting||N/A|280|Anticipated|Ettore Sansavini Health Science Foundation||2|||f||||t|f|f||||||||2017-10-10 20:43:39.591516|2017-10-10 20:43:39.591516
NCT03278405|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-08|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|September 20, 2020|Anticipated|2020-09-20|September 20, 2019|Anticipated|2019-09-20||Interventional|NET-001||Avelumab in G3 NEC|A Pilot Study of Avelumab in Unresectable/Metastatic, Progressive, Poorly Differentiated Grade 3 Neuroendocrine Carcinomas|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t|t|f|||t|||||2017-10-10 20:43:39.694418|2017-10-10 20:43:39.694418
NCT03278392|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|PEDIMet||Maternal Emotions and Diet in Pregnancy|Prenatal Emotion-Diet Interactions and the Metabolic Response|Not yet recruiting||N/A|40|Anticipated|University of California, Irvine||2|||f||||f|f|f||||||||2017-10-10 20:43:39.789773|2017-10-10 20:43:39.789773
NCT03278379|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-08|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|September 20, 2021|Anticipated|2021-09-20|September 20, 2020|Anticipated|2020-09-20||Interventional|NET-002||Avelumab in G2-3 NET|A Phase II Study of Avelumab in Unresectable/Metastatic, Progressive Grade 2-3 Neuroendocrine Tumors|Not yet recruiting||Phase 2|36|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t|t|f|||t|||||2017-10-10 20:43:39.881702|2017-10-10 20:43:39.881702
NCT03277989|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2032|Anticipated|2032-10-01|October 2030|Anticipated|2030-10-01||Observational|ITAR||INFINITY™Total Ankle Replacement Follow-up|INFINITY™Total Ankle Replacement Follow-up|Not yet recruiting||N/A|200|Anticipated|Wright Medical Technology|||1||f||||f|f|f|||t|||||2017-10-10 20:43:43.471363|2017-10-10 20:43:43.471363
NCT03278353|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Fulfillment of Expectations for Patients With FAI Syndrome|The Mediating Effect of Baseline Expectations of Conservative Care and Surgery Outcomes on Fulfillment of Expectations for Patients With Femoroacetabular Impingement Syndrome|Not yet recruiting||N/A|63|Anticipated|Duke University||1|||f||||f|f|f||||||||2017-10-10 20:43:40.065757|2017-10-10 20:43:40.065757
NCT03278340|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 31, 2022|Anticipated|2022-07-31|June 30, 2022|Anticipated|2022-06-30||Interventional|SSW-T||Using Technology to Scale-Up an Occupational Sun Protection Policy Program|Using Technology to Scale-Up an Occupational Sun Protection Policy Program|Not yet recruiting||N/A|11394|Anticipated|Klein Buendel, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:43:40.172069|2017-10-10 20:43:40.172069
NCT03278327|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-06|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2019|Anticipated|2019-06-01||Interventional|B-ARMS||Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's Oesophagus|Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's Oesophagus|Recruiting||N/A|30|Anticipated|Institut Paoli-Calmettes||1|||f||||f|f|f||||||||2017-10-10 20:43:40.442418|2017-10-10 20:43:40.442418
NCT03278314|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08||||||September 2017|2017-09-01||||||||Expanded Access|||Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic Fibrosis|Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic Fibrosis|Available||N/A|||Vertex Pharmaceuticals Incorporated||||||||t|||||||||||2017-10-10 20:43:40.593534|2017-10-10 20:43:40.593534
NCT03278301|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||August 27, 2017|Actual|2017-08-27|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31|3 Days|Observational [Patient Registry]|||PRECISION GRX Registry|A Multicenter Post-Market Registry for the Evaluation of the CorPath® GRX System Effectiveness in Percutaneous Coronary Interventions|Recruiting||N/A|1000|Anticipated|Corindus Inc.|||1||f||||f|f|f||||||||2017-10-10 20:43:40.680264|2017-10-10 20:43:40.680264
NCT03278288|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Gamified WellWe-intervention to Promote the Health and Wellbeing of Families With Small Children|Gamified WellWe-intervention to Promote the Health and Wellbeing of Families With Small Children|Recruiting||N/A|200|Anticipated|University of Turku||2|||f||||f|f|f||||||||2017-10-10 20:43:40.81503|2017-10-10 20:43:40.81503
NCT03278275|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-09|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105|PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105|Not yet recruiting||Phase 2|120|Anticipated|Rigshospitalet, Denmark||1|||f||||f|f|f||||||||2017-10-10 20:43:40.98426|2017-10-10 20:43:40.98426
NCT03278262|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-08|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Observational|INSIGHT||The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting|INSIGHT - The Impact of baseliNe viSual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical settinG. Analysis of Data From the SwedisH Macula RegisTer|Active, not recruiting||N/A|15000|Anticipated|Bayer|||3||f||||f|f|f||||||||2017-10-10 20:43:41.128996|2017-10-10 20:43:41.128996
NCT03278249|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma|Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma|Recruiting||N/A|30|Anticipated|University of Cincinnati||1|||f||||f|f|f||||||||2017-10-10 20:43:41.246904|2017-10-10 20:43:41.246904
NCT03278236|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-13|||September 21, 2017|Anticipated|2017-09-21|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|June 1, 2018|Anticipated|2018-06-01||Interventional|RESHAPE2||Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?|Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?|Not yet recruiting||N/A|10|Anticipated|University of Adelaide||1|||f||||f|f|f||||||||2017-10-10 20:43:41.384118|2017-10-10 20:43:41.384118
NCT03278223|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-27|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|November 15, 2017|Anticipated|2017-11-15|October 31, 2017|Anticipated|2017-10-31||Interventional|||One-month Clinical Evaluation of Oté Sensation Multi-Purpose Solution Care System|One-month Clinical Evaluation of Oté Sensation Multi-Purpose Solution Care System|Recruiting||N/A|200|Anticipated|OTE North America||2|||f||||f|f|t|t|f|f|||||2017-10-10 20:43:41.52441|2017-10-10 20:43:41.52441
NCT03278210|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-08|||April 13, 2011|Actual|2011-04-13|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|ENERGY||National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug|National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug|Recruiting||N/A|290|Anticipated|University Hospital, Lille|||2||f||||f||||||||||2017-10-10 20:43:41.670796|2017-10-10 20:43:41.670796
NCT03278197|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-06|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|ProDecA||Evaluation of a Web-based Decision Aid Tool for Prostate Cancer Patients|Evaluating a Decision Aid in Clinical Practice for Patients With Localized Prostate Cancer|Recruiting||N/A|150|Anticipated|Maastricht Radiation Oncology||3|||f||||f||||||||||2017-10-10 20:43:41.75184|2017-10-10 20:43:41.75184
NCT03278184|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Transcranial Direct Current Stimulation in Reduction of Pain and Postoperative Opioids Consumption After Spine Surgery|The Role of Transcranial Direct Current Stimulation in Reduction of Pain and Postoperative Opioids Consumption After Spine Surgery, Double Blinded Study|Completed||N/A|60|Actual|Assiut University||3|||f||||f|f|f||||||||2017-10-10 20:43:41.846325|2017-10-10 20:43:41.846325
NCT03276741|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Oral Intake During Labor|Unrestricted Low Fat, Low Residue Oral Intake During Labor: A Randomized Controlled Study|Not yet recruiting||N/A|200|Anticipated|David Grant U.S. Air Force Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:43:52.986289|2017-10-10 20:43:52.986289
NCT03278171|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|STRESSREA||Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit|Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit|Not yet recruiting||N/A|206|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:43:41.91225|2017-10-10 20:43:41.91225
NCT03278158|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-25|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in 24 Patients With Diabetes Mellitus Type 2|A Single-dose Dose Escalation Trial in a Randomised, Single-blind, Placebo-controlled Group-comparison Design to Investigate the Safety and Tolerability of XEN-D0501 in 24 Patients With Diabetes Mellitus Type 2|Recruiting||Phase 2|24|Anticipated|Pila Pharma||4|||f||||f|f|f|||f|||||2017-10-10 20:43:42.006368|2017-10-10 20:43:42.006368
NCT03278145|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-11|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Observational|||Dependence Receptors and Leukemia|Dependence Receptors in Childhood Acute Leukemia|Not yet recruiting||N/A|30|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||Samples With DNA|"     Bone marrow aspiration sample   "|||2017-10-10 20:43:42.093031|2017-10-10 20:43:42.093031
NCT03278132|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||July 16, 2017|Actual|2017-07-16|September 2017|2017-09-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Interventional|||Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine|A Phase IV Open-labelled, Single-centered, Stratified-randomized Clinical Trial in Zhejiang Province to Evaluate the Safety and Immunogenicity of EV71 Vaccine Developed by Sinovac Biotech Co., Ltd.|Recruiting||Phase 4|120|Anticipated|Sinovac Biotech Co., Ltd||3|||f||||f|f|f||||||||2017-10-10 20:43:42.172804|2017-10-10 20:43:42.172804
NCT03278093|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Observational|||Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy|The Feasibility and Effect of Ankle Foot Orthoses and Underfoot Vibration on the Postural Stability of People With Inherited Neuropathy|Not yet recruiting||N/A|15|Anticipated|St George's, University of London|||1||f||||f|f|f||||||||2017-10-10 20:43:42.526278|2017-10-10 20:43:42.526278
NCT03278080|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1|Development of Assessment Method of Driving Ability Using Driving Simulator in Healthy Volunteers #1: Measurement Setup of Assessment Criteria for Driving Ability|Not yet recruiting||N/A|20|Anticipated|Taisho Pharmaceutical Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:43:42.623406|2017-10-10 20:43:42.623406
NCT03278054|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-08|||May 1, 2015|Actual|2015-05-01|September 2017|2017-09-01|October 30, 2016|Actual|2016-10-30|November 30, 2015|Actual|2015-11-30||Interventional|||Effect of Different Instrumentation Technique on Endodontic Outcome|Effect of Different Instrumentation Technique on Outcome of Primary Non Surgical Endodontic Treatment|Completed||N/A|90|Actual|Postgraduate Institute of Dental Sciences Rohtak||3|||f||||t|f|f||||||||2017-10-10 20:43:42.802632|2017-10-10 20:43:42.802632
NCT03278041|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||January 30, 2018|Anticipated|2018-01-30|September 2017|2017-09-01|January 30, 2019|Anticipated|2019-01-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Effect of the Submental Artery Island Flap Versus Maxillary Obturator Prosthesis|Effect of the Submental Artery Island Flap Versus Maxillary Obturator Prosthesis on the Quality of Life in Patients With Palatal Defects. (Randomized Controlled Clinical Study)|Recruiting||N/A|30|Anticipated|Cairo University||2|||f||||t|f|f|||f|||||2017-10-10 20:43:42.878356|2017-10-10 20:43:42.878356
NCT03278015|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-08|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients|Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients|Not yet recruiting||Phase 2|90|Anticipated|Chinese PLA General Hospital||3|||f|||||f|f||||||||2017-10-10 20:43:43.085206|2017-10-10 20:43:43.085206
NCT03278002|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-21|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30|18 Months|Observational [Patient Registry]|SPHERE||A Registry for Patients Taking Uptravi|Uptravi® (SelexiPag): tHe usErs dRug rEgistry|Recruiting||N/A|500|Anticipated|Actelion|||1||f|||||f|f||||||||2017-10-10 20:43:43.214429|2017-10-10 20:43:43.214429
NCT03277976|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|August 31, 2018|Anticipated|2018-08-31|12 Months|Observational [Patient Registry]|AIR||Pulmonary Vein Isolation Guided by Ablation Index (Ablation Index Registry Study)|Pulmonary Vein Isolation Guided by Ablation Index|Not yet recruiting||N/A|320|Anticipated|Clinica Mediterranea|||4||f||||f|f|f||||||||2017-10-10 20:43:43.537701|2017-10-10 20:43:43.537701
NCT03277963|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-12|||February 4, 2010|Actual|2010-02-04|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|February 1, 2017|Actual|2017-02-01||Interventional|||Perception of Pain During Obstructive Sleep Apnea Syndrome in Obese Patient|Perception of Pain During Obstructive Sleep Apnea Syndrome in Obese Patient|Completed||N/A|120|Actual|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 20:43:43.636377|2017-10-10 20:43:43.636377
NCT03277950|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-08|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|September 15, 2019|Anticipated|2019-09-15|September 15, 2018|Anticipated|2018-09-15||Interventional|VRULS||Effect of Virtual Reality Game on Upper Limb Movement in Individuals With Stroke|Effect of Game-based Virtual Reality Training on Upper Extremity Movement in Individuals With Subacute Stroke|Not yet recruiting||N/A|21|Anticipated|Mahidol University||3|||f||||f|f|f||||||||2017-10-10 20:43:43.710927|2017-10-10 20:43:43.710927
NCT03277937|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-06|||July 1, 2015|Actual|2015-07-01|September 2017|2017-09-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Angiography for Evaluation of the Feeder Vessel in EUS-guided Coils and Cyanoacrylate Therapy for Gastric Varices|The Use of Angiography for Determination and Confirmation of the Feeder Vessel as a Modification of the Original EUS-guided Coils and Cyanoacrylate Therapy for Gastric Varices|Recruiting||N/A|30|Anticipated|Instituto Ecuatoriano de Enfermedades Digestivas||1|||f||||t|f|f||||||||2017-10-10 20:43:43.790546|2017-10-10 20:43:43.790546
NCT03277924|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-06|||May 31, 2017|Actual|2017-05-31|August 2017|2017-08-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|ImmunoSarc||Trial of Sunitinib Plus Nivolumab After Standard Treatment in Advanced Soft Tissue and Bone Sarcomas|Phase I-II Trial of Sunitinib Plus Nivolumab After Standard Treatment in Advanced Soft Tissue and Bone Sarcomas|Recruiting||Phase 1/Phase 2|75|Anticipated|Grupo Espanol de Investigacion en Sarcomas||1|||f|||||f|f|||f|||||2017-10-10 20:43:43.911557|2017-10-10 20:43:43.911557
NCT03277911|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||September 10, 2017|Anticipated|2017-09-10|September 2017|2017-09-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2018|Anticipated|2018-08-30||Observational|||Thyroid Dysfunction and Dyslipidemia in Patients With Chronic Kidney Diseases|Thyroid Dysfunction and Dyslipidemia in Patients With Chronic Kidney Diseases|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t||||||||||2017-10-10 20:43:44.041875|2017-10-10 20:43:44.041875
NCT03277898|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-06|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2020|Anticipated|2020-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|ACTIVATE||Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer|Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer: the ACTIVATE Trial|Not yet recruiting||N/A|84|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 20:43:44.099676|2017-10-10 20:43:44.099676
NCT03277885|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-07|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|November 1, 2018|Anticipated|2018-11-01||Observational|PREVADouleur||Prevalence of Pain Disorders in Employees of IKEA FRANCE Company|Evaluation of the Prevalence of Pain Disorders in a Professional Context Among Employees of IKEA FRANCE Company|Not yet recruiting||N/A|400|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 20:43:44.192659|2017-10-10 20:43:44.192659
NCT03277872|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-07|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|NoLint||NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope|NoL Index, Heart Rate and Mean Arterial Blood Pressure Responses to Tracheal Intubation Performed With MacIntosh Blade Versus Glidescope|Recruiting||N/A|50|Anticipated|Ciusss de L'Est de l'Île de Montréal||2|||f||||f|f|f||||||||2017-10-10 20:43:44.305402|2017-10-10 20:43:44.305402
NCT03277859|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|SAA-TBI||Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI)|Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI)|Recruiting||N/A|240|Anticipated|VA Eastern Colorado Health Care System||2|||f||||t|f|f||||||||2017-10-10 20:43:44.416671|2017-10-10 20:43:44.416671
NCT03277846|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|TES||The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of Depression|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Nexalin Electrical Brain Stimulation for the Treatment of Depression in Patients Referred to Electro-Convulsive Therapy|Enrolling by invitation||Phase 4|150|Anticipated|University of Pennsylvania||4|||f||||t|f|t|f|f||||||2017-10-10 20:43:44.493509|2017-10-10 20:43:44.493509
NCT03277833|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-09-08|||March 2013||2013-03-01|September 2017|2017-09-01|January 2014|Actual|2014-01-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety of Gynostemma Pentaphyllum(Dungkulcha) Extract on Alleviation of Chronic Stress-induced Strain|Efficacy and Safety of Gynostemma Pentaphyllum(Dungkulcha) Extract on Alleviation of Chronic Stress-induced Strain|Completed||N/A|72|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-10 20:43:44.57125|2017-10-10 20:43:44.57125
NCT03277820|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||April 3, 2017|Actual|2017-04-03|September 2017|2017-09-01|April 3, 2018|Anticipated|2018-04-03|April 3, 2018|Anticipated|2018-04-03||Interventional|||Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion|Effect of Probiotics on Microbiome of Adenoid Tissue and Middle Ear Fluid of Children With Otitis Media With Effusion|Recruiting||N/A|40|Anticipated|University Hospital, Antwerp||2|||f||||f|f|f||||||||2017-10-10 20:43:44.630336|2017-10-10 20:43:44.630336
NCT03277807|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-06|||February 4, 2013|Actual|2013-02-04|September 2017|2017-09-01|October 11, 2013|Actual|2013-10-11|October 11, 2013|Actual|2013-10-11||Observational|PAP||Physical Activity in Pregnancy|Effect of Physical Activity in Pregnancy on Low Grade Inflammation: a Pilot Study|Completed||N/A|53|Actual|Medical University of Graz|||3||f||||f|f|f||||Samples Without DNA|"     maternal venous blood (serum /plasma), cord blood (serum /plasma); placenta tissue (RNA     later);   "|||2017-10-10 20:43:44.696068|2017-10-10 20:43:44.696068
NCT03277794|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-08|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Generating Evidence for a Support Package to Stabilize Youth Trajectories Out of Homelessness|Generating Evidence for a Comprehensive Support Package to Stabilize Youth Trajectories Out of Homelessness: A Tertiary Prevention Strategy|Recruiting||N/A|56|Anticipated|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||||2017-10-10 20:43:44.860334|2017-10-10 20:43:44.860334
NCT03277781|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-06|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Observational|FAST||Female Aneurysm Screening STudy|Female Aneurysm Screening STudy|Recruiting||N/A|6612|Anticipated|University of Leicester|||3||f||||f|f|f||||||||2017-10-10 20:43:45.021812|2017-10-10 20:43:45.021812
NCT03277768|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-06|||May 1, 2015|Actual|2015-05-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.|Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.|Recruiting||N/A|50|Anticipated|University of Florida|||2||f||||f|f|f||||||||2017-10-10 20:43:45.10303|2017-10-10 20:43:45.10303
NCT03277742|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|May 2020|Anticipated|2020-05-01||Interventional|||Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz|Evaluation of an Integral Strategy for Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz.|Not yet recruiting||N/A|240|Anticipated|Instituto Nacional de Salud Publica, Mexico||2|||f||||t|f|f||||||||2017-10-10 20:43:45.295847|2017-10-10 20:43:45.295847
NCT03277716|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-09-11|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 30, 2021|Anticipated|2021-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge|Effectivity and Safety of Microwave Ablation Combined With Transcatheter Arterial Chemoembolization(TACE) for Huge Unresectable Hepatocellular Carcinoma: a Multicenter Analysis|Not yet recruiting||N/A|100|Anticipated|Sun Yat-sen University||1|||f||||t|f|f||||||||2017-10-10 20:43:45.540847|2017-10-10 20:43:45.540847
NCT03277703|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Flu Vaccine Response in Patients on Biologic Therapies|Booster Vaccine Strategy to Improve Serologic Responses to Influenza Vaccination in Children With Rheumatic Diseases and Inflammatory Bowel Disease Who Are Receiving Immunosuppressive Therapies|Not yet recruiting||Phase 2|54|Anticipated|Stony Brook University||2|||f||||t|f|f|||f|||||2017-10-10 20:43:45.698005|2017-10-10 20:43:45.698005
NCT03277690|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-11|||September 12, 2017|Anticipated|2017-09-12|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|May 30, 2018|Anticipated|2018-05-30||Interventional|||A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.|A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome|Not yet recruiting||Phase 3|35|Anticipated|Cortendo AB||2|||||||t|t|f||||||||2017-10-10 20:43:45.776551|2017-10-10 20:43:45.776551
NCT03277677|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-10|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||The Effect of Fluid Resuscitation With 0.9% Sodium Chloride Versus Balanced Crystalloid Solution on Renal Function of Sepsis Patients|The Effect of Fluid Resuscitation With 0.9% Sodium Chloride Versus Balanced Crystalloid Solution on Renal Function of Sepsis Patients|Recruiting||Phase 3|236|Anticipated|Chulalongkorn University||2|||f||||t|f|f|||f|||||2017-10-10 20:43:45.85537|2017-10-10 20:43:45.85537
NCT03277664|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|December 12, 2017|Anticipated|2017-12-12||Interventional|||A Novel Approach to Monitor the Adherence of Asthmatic Children Based on Electronic Device|A Novel Approach to Monitor the Adherence of Asthmatic Children Based on Electronic Device: a Randomised Controlled Clinical Trial|Recruiting||N/A|96|Anticipated|Shanghai Children's Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:43:45.955907|2017-10-10 20:43:45.955907
NCT03277638|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Laser Interstitial Thermotherapy Combined With Checkpoint Inhibitor for Recurrent Glioblastoma|Phase I/II Study of Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent Glioblastoma (RGBM)|Not yet recruiting||Phase 1/Phase 2|34|Anticipated|Case Comprehensive Cancer Center||3|||f||||t|t|f|||f|||||2017-10-10 20:43:46.149336|2017-10-10 20:43:46.149336
NCT03124758|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||April 20, 2010|Actual|2010-04-20|June 2017|2017-06-01|October 31, 2011|Actual|2011-10-31|October 31, 2011|Actual|2011-10-31||Interventional|||Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)||Completed||N/A|354|Actual|Masimo Corporation||1|||f|||||f|t|f|f|f|||||2017-10-10 21:08:43.350491|2017-10-10 21:08:43.350491
NCT03277625|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Observational|||Modified Reconstruction for Pancreatic Head Resection|Safety and Efficacy of Modified Single-loop Omega-shaped Reconstruction After Pancreaticoduodenectomy in Patients With High-risk Pancreas|Recruiting||N/A|200|Anticipated|St. Josef Hospital Bochum|||1||f||||t|f|f||||||||2017-10-10 20:43:46.25465|2017-10-10 20:43:46.25465
NCT03277612|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-07|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Observational|||Effects of C-section Delivery on Infant Brain Development|Effects of C-section Delivery on Infant Brain Development|Recruiting||N/A|70|Anticipated|Arkansas Children's Hospital Research Institute|||2||f||||t|f|f||||Samples Without DNA|"     Blood, urine, stool, vaginal swabs, and breast milk samples will be collected.   "|||2017-10-10 20:43:46.347853|2017-10-10 20:43:46.347853
NCT03277599|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-07|||July 5, 2016|Actual|2016-07-05|September 2017|2017-09-01|July 7, 2017|Actual|2017-07-07|December 5, 2016|Actual|2016-12-05||Interventional|||Comparison of Two Pain-treatment Techniques After Tympanomastoid Surgery Pain|Ultrasound Guided Superficial Cervical Plexus Block Versus Greater Auricular Nerve Block for Tympanomastoid Surgery Pain|Completed||N/A|50|Actual|Bursa Yüksek İhtisas Education and Research Hospital||2|||f|||||f|f||||||||2017-10-10 20:43:46.423905|2017-10-10 20:43:46.423905
NCT03277586|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|EPSD||Effects of Probiotics on Symptoms of Depression|Effects of Probiotics on Symptoms of Depression|Not yet recruiting||Phase 3|108|Anticipated|Queen's University||2|||f||||t|f|f|||f|||||2017-10-10 20:43:46.496384|2017-10-10 20:43:46.496384
NCT03277573|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-07|||July 21, 2017|Actual|2017-07-21|September 2017|2017-09-01|October 21, 2018|Anticipated|2018-10-21|October 21, 2018|Anticipated|2018-10-21||Interventional|SAL-AD||Salsalate in Patients Mild to Moderate Alzheimer's Disease|A Phase 1b, 12-Month, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Salsalate in Patients With Mild to Moderate Alzheimer's Disease|Recruiting||Phase 1|40|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||||2017-10-10 20:43:46.572607|2017-10-10 20:43:46.572607
NCT03277560|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-09-06|||April 2013|Actual|2013-04-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Observational|MaTOMS||MaTOMS: A Feasibility Study Into Collecting Major Trauma Outcomes|MaTOMS: A Feasibility Study Into the Validity and Acceptability of Routine Collection of Outcome Data in Major Trauma Patients in a Major Trauma Centre in England|Completed||N/A|70|Actual|Oxford University Hospitals NHS Trust|||1||f||||t||||||||||2017-10-10 20:43:46.714568|2017-10-10 20:43:46.714568
NCT03277547|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2022|Anticipated|2022-08-31||Observational|||Kidney Function in Sickle Cell Anemia|The Association of Biomarkers of Endothelial Function With Prospective Changes in Kidney Function in Sickle Cell Anemia|Not yet recruiting||N/A|300|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f|f|f||||Samples Without DNA|"     Plasma samples will be collected to measure biomarkers of endothelial function. Plasma and     urine samples will be collected for measurement of metabolic profiles.   "|||2017-10-10 20:43:46.795099|2017-10-10 20:43:46.795099
NCT03277534|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||August 28, 2013|Actual|2013-08-28|September 2017|2017-09-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Interventional|||Electrical Stimulation Combined With Motor Training on EEG-EMG Coherence and Motor Function in Individuals With Stroke|Effects of 8-week Sensory Electrical Stimulation Combined With Motor Training on EEG-EMG Coherence and Motor Function in Individuals With Stroke|Completed||N/A|12|Actual|National Yang Ming University||2|||f||||f|f|f||||||||2017-10-10 20:43:46.868394|2017-10-10 20:43:46.868394
NCT03277521|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Theta Burst Stimulation to Promote Motor Re-education in Tetraplegia|Intermittent Theta Burst Stimulation to Promote Motor Re-education After Upper Limb Reconstruction in Tetraplegia|Not yet recruiting||N/A|30|Anticipated|Virginia Commonwealth University||3|||f||||f|f|f||||||||2017-10-10 20:43:46.938422|2017-10-10 20:43:46.938422
NCT03277508|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-09-06|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Assistive Soft Robotic Glove Intervention Using Brain-Computer Interface for Elderly Stroke Patients|Assistive Soft Robotic Glove Intervention Using Brain-Computer Interface for Elderly Stroke Patients|Not yet recruiting||N/A|12|Anticipated|National University Hospital, Singapore||2|||f||||f|f|f||||||||2017-10-10 20:43:47.023828|2017-10-10 20:43:47.023828
NCT03277495|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Predictors and Consequences of Combustible Cigarette Smokers' Switch to Standardized Research E-Cigarettes|Predictors and Consequences of Combustible Cigarette Smokers' Switch to Standardized Research E-Cigarettes|Not yet recruiting||N/A|180|Anticipated|University of Illinois at Chicago||2|||f|||||f|f||||||||2017-10-10 20:43:47.112702|2017-10-10 20:43:47.112702
NCT03277482|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2020|Anticipated|2020-11-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer|A Phase 1 Study of Durvalumab, Tremelimumab and Radiotherapy in Recurrent Gynecologic Cancer|Not yet recruiting||Phase 1|32|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|t|f|f||||||2017-10-10 20:43:47.196906|2017-10-10 20:43:47.196906
NCT03277469|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|September 15, 2027|Anticipated|2027-09-15|September 15, 2022|Anticipated|2022-09-15||Interventional|||Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer|Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer|Not yet recruiting||N/A|100|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:43:47.306967|2017-10-10 20:43:47.306967
NCT03277456|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-10-02|||September 18, 2017|Actual|2017-09-18|October 2017|2017-10-01|October 19, 2017|Anticipated|2017-10-19|October 19, 2017|Anticipated|2017-10-19||Interventional|||A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1|A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1, Manufactured on the AGE1.CR.pIX Novel Avian Cell Line, in Healthy Adult Volunteers.|Recruiting||Early Phase 1|6|Anticipated|Vaccitech Limited||1|||f||||t|f|f||||||||2017-10-10 20:43:47.392596|2017-10-10 20:43:47.392596
NCT03277443|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Accuracy of Computer Guided Surgery (vs) Conventional Model Surgery in Treatment of Skeletal Open Bite|Accuracy of Computer Guided Surgery (vs) Conventional Model Surgery in Treatment of Skeletal Open Bite: A Randomized Clinical Trial|Not yet recruiting||N/A|14|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:43:47.467859|2017-10-10 20:43:47.467859
NCT03277430|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-12|||October 9, 2015|Actual|2015-10-09|September 2017|2017-09-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|UTxLD/DBD||Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study|Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study|Recruiting||Phase 3|20|Anticipated|Institute for Clinical and Experimental Medicine||2|||f||||t|f|f||||||||2017-10-10 20:43:47.542896|2017-10-10 20:43:47.542896
NCT03277417|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?|Does the Amniotic Fluid Index Affect the Fetal Cardiac Performance?|Not yet recruiting||N/A|90|Anticipated|Hillel Yaffe Medical Center|||3||f||||t|f|f||||||||2017-10-10 20:43:47.645637|2017-10-10 20:43:47.645637
NCT03277404|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-09-07|||May 7, 2015|Actual|2015-05-07|June 2017|2017-06-01|November 30, 2015|Actual|2015-11-30|November 30, 2015|Actual|2015-11-30||Interventional|||Effect of Smear Layer on Endodontic Outcome|Effect of Smear Layer on Endodontic Outcome: A Randomized Controlled Trial|Completed||N/A|86|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||||2017-10-10 20:43:47.715087|2017-10-10 20:43:47.715087
NCT03277391|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-06|||April 14, 2017|Actual|2017-04-14|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|Serrathos||Serratus Anterior Plane Block: Post-operative Analgesia in Video-assisted Thoracic Surgery|Serratus Anterior Plane Block: Post-operative Analgesia Technique in Video-assisted Thoracic Surgery. Efficacy Pilot Study and Population Pharmacokinetic Analysis|Recruiting||N/A|20|Anticipated|Université Libre de Bruxelles||2|||f||||f|f|f||||||||2017-10-10 20:43:47.779072|2017-10-10 20:43:47.779072
NCT03277378|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Observational|DELIVERY||EValuating Anatomic vErsus TaRgeted Lead Placement for BurstDR TherapY During the Trial|Randomized, ControlleD, Single Blind, ProspEctive, MuLtIcenter Study EValuating Anatomic vErsus TaRgeted Lead Placement for BurstDR TherapY During the Trial Evaluation Period. (DELIVERY)|Not yet recruiting||N/A|288|Anticipated|St. Jude Medical|||2||f||||f|f|t|f|f||||||2017-10-10 20:43:47.869859|2017-10-10 20:43:47.869859
NCT03277365|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-10-03|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|September 2030|Anticipated|2030-09-01|September 2027|Anticipated|2027-09-01||Interventional|||MyGeneRank: A Digital Platform for Next-Generation Genetic Studies|MyGeneRank: A Digital Platform for Next-Generation Genetic Studies|Recruiting||N/A|100000|Anticipated|Scripps Translational Science Institute||1|||f||||f|f|f||||||||2017-10-10 20:43:47.930874|2017-10-10 20:43:47.930874
NCT03277352|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-08|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|||INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies|A Phase 1/2 Safety and Efficacy Study of INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies|Not yet recruiting||Phase 1/Phase 2|166|Anticipated|Incyte Corporation||1|||f||||t|t|f||||||||2017-10-10 20:43:48.106022|2017-10-10 20:43:48.106022
NCT03277339|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-13|||January 19, 2017|Actual|2017-01-19|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|Insula-TOP||Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders|Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders (Insula-TOP)|Recruiting||Phase 4|60|Anticipated|Centre Hospitalier Henri Laborit||2|||f||||f|f|f||||||||2017-10-10 20:43:48.208234|2017-10-10 20:43:48.208234
NCT03277326|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||August 30, 2017|Actual|2017-08-30|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Interscalene vs Anterior and Posterior Suprascapular Nerve Block for Shoulder Arthroscopic Surgeries|Randomised, Controlled Trial Comparing Interscalene Versus Anterior and Posterior Approaches of Suprascapular Nerve Block for Shoulder Arthroscopic Surgeries|Recruiting||N/A|60|Anticipated|Changi General Hospital||3|||f||||f|f|f||||||||2017-10-10 20:43:48.317852|2017-10-10 20:43:48.317852
NCT03277313|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||September 11, 2017|Anticipated|2017-09-11|September 2017|2017-09-01|November 28, 2021|Anticipated|2021-11-28|November 28, 2021|Anticipated|2021-11-28||Interventional|||Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects|Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects With Primary Immunodeficiency Diseases|Not yet recruiting||Phase 3|40|Anticipated|Baxalta US Inc.||3|||f||||f|t|f||||||||2017-10-10 20:43:48.406771|2017-10-10 20:43:48.406771
NCT03277300|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-07|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 30, 2019|Anticipated|2019-01-30|January 1, 2019|Anticipated|2019-01-01||Observational|||Enteral and Parenteral Feeding in Critically Ill Patients|Enteral and Parenteral Feeding in Critically Ill Patients|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:43:48.523488|2017-10-10 20:43:48.523488
NCT03277287|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||Assessment of Fractional CO2 Laser in Treatment of Post-surgical Scarring of Cleft Lip|Assessment of Fractional CO2 Laser in Treatment of Post-surgical Scarring of Cleft Lip|Not yet recruiting||N/A|120|Anticipated|Assiut University||3|||f|||||f|f|||f|||||2017-10-10 20:43:48.58692|2017-10-10 20:43:48.58692
NCT03277274|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||September 19, 2017|Anticipated|2017-09-19|September 2017|2017-09-01|June 2, 2018|Anticipated|2018-06-02|June 2, 2018|Anticipated|2018-06-02||Interventional|||A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous (IV) TAK-954|A Phase 1, Non-Randomized, Open-Label Trial to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics of Intravenous TAK-954|Not yet recruiting||Phase 1|32|Anticipated|Takeda||4|||f||||f|t|f||||||||2017-10-10 20:43:48.655915|2017-10-10 20:43:48.655915
NCT03124745|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||November 4, 2013||2013-11-04||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:43.478013|2017-10-10 21:08:43.478013
NCT03277261|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|March 31, 2021|Anticipated|2021-03-31||Interventional|ULTIMATE 1||A Phase 3, Randomized, Multi-center, Double-blinded, Active-controlled Study to Assess the Efficacy and Safety/Tolerability of Ublituximab (TG-1101; UTX) as Compared to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (RMS)|UbLiTuximab In Multiple Sclerosis Treatment Effects (ULTIMATE I STUDY)|Recruiting||Phase 3|440|Anticipated|TG Therapeutics, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:43:48.73926|2017-10-10 20:43:48.73926
NCT03277248|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|March 31, 2021|Anticipated|2021-03-31||Interventional|||A Phase 3, Randomized, Multi-center, Double-blinded, Active-controlled Study to Assess the Efficacy and Safety/Tolerability of Ublituximab (TG-1101; UTX) as Compares to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (RMS) (ULTIMATE 2)|ubLiTuximab in Multiple Sclerosis Treatment Effects (ULTIMATE II STUDY)|Recruiting||Phase 3|440|Anticipated|TG Therapeutics, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:43:48.82118|2017-10-10 20:43:48.82118
NCT03277235|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients|Effect of a Resilience Model-Based Care Plan in Reducing Fear of Recurrence and GI Symptom Distress and Improving Quality of Life in Newly Diagnosed Colorectal Cancer Patients|Not yet recruiting||N/A|320|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:43:48.906175|2017-10-10 20:43:48.906175
NCT03277222|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Intranasal Treatment of HIV-associated Neurocognitive Disorders|HAND IN Insulin-001: Intranasal Treatment of HIV-associated Neurocognitive Disorders|Not yet recruiting||Phase 2|45|Anticipated|University of Calgary||3|||f||||t|t|f|||t|||||2017-10-10 20:43:49.003515|2017-10-10 20:43:49.003515
NCT03277209|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||July 25, 2017|Actual|2017-07-25|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas|To Assess the Safety of Continuous IV Administration of the CXCR4 Antagonist, Plerixafor at Potentially Active Plasma Concentrations and Assess Its Impact on the Immune Microenvironment in Patients With Advanced Pancreatic, High Grade Serous Ovarian and Colorectal Adenocarcinomas|Recruiting||Phase 1|28|Anticipated|Weill Medical College of Cornell University||1|||f||||t|t|f|||t|||||2017-10-10 20:43:49.146728|2017-10-10 20:43:49.146728
NCT03277196|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|June 7, 2021|Anticipated|2021-06-07|June 7, 2021|Anticipated|2021-06-07||Interventional|||A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have a CFTR Gating Mutation|A Phase 3, 2-Arm, Open-label Study to Evaluate the Safety and Pharmacodynamics of Long-term Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have a CFTR Gating Mutation|Recruiting||Phase 3|75|Anticipated|Vertex Pharmaceuticals Incorporated||2|||||||t|t|f||||||||2017-10-10 20:43:49.24345|2017-10-10 20:43:49.24345
NCT03277183|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|June 30, 2022|Anticipated|2022-06-30|March 2, 2021|Anticipated|2021-03-02||Interventional|||Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin|Frequent, Low-Dose Erythropoietin: A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin Therapy in Patients With Chronic Kidney Disease|Not yet recruiting||Phase 4|100|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||t|||||2017-10-10 20:43:49.336813|2017-10-10 20:43:49.336813
NCT03277170|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||September 2018|Anticipated|2018-09-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Pragmatic RCT of High-dose Montelukast for Pediatric Asthma Exacerbations|Pragmatic RCT of High-dose Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations|Not yet recruiting||Phase 2|250|Anticipated|Vanderbilt University Medical Center||2|||f||||t|t|f||||||||2017-10-10 20:43:49.431376|2017-10-10 20:43:49.431376
NCT03277157|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|May 30, 2018|Anticipated|2018-05-30||Interventional|||B. Lactis B94 Effects of Gastrointestinal Function|The Effects of Bifidobacterium Animalis Ssp. Lactis B94 on Gastrointestinal Function in Adults With Prader-Willi Syndrome: A Randomized, Double-blind Study|Not yet recruiting||N/A|36|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 20:43:49.52302|2017-10-10 20:43:49.52302
NCT03277144|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-15|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|September 11, 2018|Anticipated|2018-09-11||Interventional|DRTST||Incidence of Duodenal Stump Fistula After Gastrectomy for Gastric Cancer. A Randomized Controlled Trial|Does the Technique of Duodenal Resection Affect the Incidence of Duodenal Stump Fistula After Gastrectomy for Gastric Cancer ? A Randomized Controlled Trial (DRTST: Duodenal Resection Tri-staple Technology)|Recruiting||N/A|700|Anticipated|University of Turin, Italy||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:43:49.606761|2017-10-10 20:43:49.606761
NCT03277131|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||DURAFIBER Ag Post-Market Clinical Follow-Up|A Prospective, Open, Non-Comparative Multicentre Study to Evaluate a Fibrous Silver Dressing (DURAFIBER™ Ag) in the Treatment of Moderate to Highly Exuding Venous Leg Ulcers|Not yet recruiting||N/A|20|Anticipated|Smith & Nephew, Inc.||1|||f||||f|f|f||||||||2017-10-10 20:43:49.721593|2017-10-10 20:43:49.721593
NCT03277118|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-07|||April 18, 2017|Actual|2017-04-18|September 2017|2017-09-01|June 18, 2018|Anticipated|2018-06-18|April 18, 2018|Anticipated|2018-04-18||Observational|||Quantifying Activity Using Wireless Wearable Technology|Quantifying Activity After Cardiac Surgery Using Wireless Wearable Technology|Recruiting||N/A|100|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:43:49.79722|2017-10-10 20:43:49.79722
NCT03276559|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-06|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|June 28, 2020|Anticipated|2020-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|EMPOWER||Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience of Caregivers of ICU Patients (EMPOWER)|Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience of Caregivers of ICU Patients (EMPOWER)|Recruiting||N/A|120|Anticipated|Weill Medical College of Cornell University||2|||f|||||f|f||||||||2017-10-10 20:43:54.213261|2017-10-10 20:43:54.213261
NCT03277105|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-21|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 8, 2020|Anticipated|2020-10-08|November 5, 2019|Anticipated|2019-11-05||Interventional|||A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma|A Phase 3 Randomized, Multicenter Study of Subcutaneous vs. Intravenous Administration of Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma|Not yet recruiting||Phase 3|480|Anticipated|Janssen Research & Development, LLC||2|||f||||t|t|f||||||||2017-10-10 20:43:49.890931|2017-10-10 20:43:49.890931
NCT03277079|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|TACO||Low Dose Statins, Ezetimibe and Nutraceuticals|Low Dose Statins, Ezetimibe and Nutraceuticals in Coronary Artery Disease Patients Intolerant to High Intensity Statin Treatment (TArget ChOlesterol)|Not yet recruiting||Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f|f|f||||||||2017-10-10 20:43:50.269934|2017-10-10 20:43:50.269934
NCT03277066|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|HP-5000||A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis|A 4-week, Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2 Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis (OA) of the Knee|Not yet recruiting||Phase 2|300|Anticipated|Noven Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:43:50.356742|2017-10-10 20:43:50.356742
NCT03277053|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-06|||August 24, 2016|Actual|2016-08-24|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||A Mobile Device App to Improve Adherence to an Enhanced Recovery Program for Colorectal Surgery|A Mobile Device App to Improve Adherence to an Enhanced Recovery Program for Colorectal Surgery: A Randomized Control Trial|Recruiting||N/A|104|Anticipated|McGill University Health Center||3|||f||||t|f|f||||||||2017-10-10 20:43:50.466839|2017-10-10 20:43:50.466839
NCT03277040|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-10-03|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Diet Eating, and Lifestyle Improvement for Valued Employees and Their Relatives|DELIVER Trial: Diet Eating, and Lifestyle Improvement for Valued Employees and Their Relatives|Recruiting||N/A|60|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 20:43:50.551188|2017-10-10 20:43:50.551188
NCT03277027|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||May 26, 2017|Actual|2017-05-26|September 2017|2017-09-01|May 10, 2018|Anticipated|2018-05-10|May 10, 2018|Anticipated|2018-05-10||Observational|||Health Related Lifestyle and Quality of Life in Children With Cerebral Palsy|Health Related Lifestyle and Quality of Life in Children With Cerebral Palsy|Recruiting||N/A|60|Anticipated|The Catholic University of Korea|||1||f||||f|f|f||||||||2017-10-10 20:43:50.63942|2017-10-10 20:43:50.63942
NCT03277014|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-06|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Using IGF-1 for Nutritional Monitoring|Insulin-like Growth Factor-1 as a Nutritional Monitoring Factor in Patients With Chronic Intestinal Failure|Completed||N/A|197|Actual|Jinling Hospital, China|||1||f||||t|f|f||||||||2017-10-10 20:43:50.727989|2017-10-10 20:43:50.727989
NCT03277001|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|SUPREME||Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD|Multi-center、Randomize、Open、Non-inferiority Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD|Not yet recruiting||N/A|438|Anticipated|Huashan Hospital||2|||f||||t|f|f||||||||2017-10-10 20:43:50.778232|2017-10-10 20:43:50.778232
NCT03276988|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||September 11, 2017|Anticipated|2017-09-11|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients|A Prospective, Open-label, Dose Escalation, (Phase 1); Prospective, Randomized, Evaluator Blinded, Active-controlled, 2-sequence, 2-period, 2-treatment, Crossover (Phase 2); Phase 1/2 Clinical Trial to Evaluate the Tolerability, Pharmacokinetics, Safety and Efficacy of GX-30 Administered Intramuscularly in Patients Underwent Total Thyroidectomy or Near Total Thyroidectomy|Not yet recruiting||Phase 1/Phase 2|9|Anticipated|Genexine, Inc.||3|||f||||t|f|f||||||||2017-10-10 20:43:50.861119|2017-10-10 20:43:50.861119
NCT03276975|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|October 31, 2019|Anticipated|2019-10-31||Interventional|||A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment|A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment of Cerebrospinal Fluid Leaks in Spontaneous Intracranial Hypotension.|Not yet recruiting||Phase 2|200|Anticipated|Duke University||2|||f||||f|t|f|||f|||||2017-10-10 20:43:50.953762|2017-10-10 20:43:50.953762
NCT03276962|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-26|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|February 14, 2022|Anticipated|2022-02-14|January 15, 2020|Anticipated|2020-01-15||Interventional|||Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age|Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candi-date Malaria Vaccine (SB257049) Evaluating Schedules With or With-out Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age|Not yet recruiting||Phase 2|1500|Anticipated|GlaxoSmithKline||5|||f|||||f|f||||||||2017-10-10 20:43:51.025777|2017-10-10 20:43:51.025777
NCT03276949|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-07|||April 22, 2016|Actual|2016-04-22|September 2017|2017-09-01|March 13, 2017|Actual|2017-03-13|April 29, 2016|Actual|2016-04-29||Observational|(Raman)||Non-invasive Glucose Measurement Using Laser Technology|Non-Invasive Glucose Measurement Using Raman Spectroscopy During Oral Glucose Tolerance Test|Completed||N/A|20|Actual|University of Missouri-Columbia|||1||f||||f|f|f||||Samples With DNA|"     Blood samples   "|||2017-10-10 20:43:51.13057|2017-10-10 20:43:51.13057
NCT03124732|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||April 2008||2008-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:43.525057|2017-10-10 21:08:43.525057
NCT03276936|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-06|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 29, 2019|Anticipated|2019-03-29|January 25, 2019|Anticipated|2019-01-25||Interventional|||A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea|An Open-Label Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 for 40 Weeks in the Treatment of Moderate to Severe Facial Papulopustular Rosacea (Study FX2016-13)|Enrolling by invitation||Phase 3|400|Anticipated|Foamix Ltd.||1|||f||||f|t|f||||||||2017-10-10 20:43:51.195661|2017-10-10 20:43:51.195661
NCT03276923|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-07|||October 4, 2017|Anticipated|2017-10-04|September 2017|2017-09-01|January 1, 2027|Anticipated|2027-01-01|January 1, 2027|Anticipated|2027-01-01|100 Years|Observational [Patient Registry]|MADRA||Maternal Autoimmune Disease Research Alliance (MADRA) Registry|Maternal Autoimmune Disease Research Alliance (MADRA) Registry|Not yet recruiting||N/A|1000|Anticipated|Duke University|||1||f||||f|f|f||||Samples With DNA|"     Blood and urine samples will be collected.   "|||2017-10-10 20:43:51.512128|2017-10-10 20:43:51.512128
NCT03276910|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||September 8, 2017|Anticipated|2017-09-08|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|December 22, 2017|Anticipated|2017-12-22||Interventional|ERYTHROFER-01||Evaluation of Erythroferrone as a New Biomarker of Erythropoesis Stimulating Agents|Evaluation of Erythroferrone as a New Biomarker of Erythropoesis Stimulating Agents|Not yet recruiting||Phase 1|24|Anticipated|Association Athletes For Transparency||3|||f||||f|f|f||||||||2017-10-10 20:43:51.591047|2017-10-10 20:43:51.591047
NCT03276897|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||March 21, 2017|Actual|2017-03-21|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||"Efficacy and Tolerance Evaluation of a Revitalizing Face Treatment"|"Efficacy and Tolerance Evaluation of a Revitalizing Face Treatment"|Completed||N/A|22|Actual|Derming SRL||1|||f|||||f|f||||||||2017-10-10 20:43:51.684388|2017-10-10 20:43:51.684388
NCT03276871|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Telescopic Dissection vs. Balloon Dissection During Laparoscopic TEP Inguinal Hernia Repair|Randomized Controlled Trial Comparing Telescopic Dissection vs. Balloon Dissection During Laparoscopic TEP Inguinal Hernia Repair|Enrolling by invitation||N/A|50|Anticipated|The Cleveland Clinic||2|||f|||||f|t|f|f||||||2017-10-10 20:43:51.941984|2017-10-10 20:43:51.941984
NCT03276858|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||September 10, 2017|Anticipated|2017-09-10|September 2017|2017-09-01|April 15, 2018|Anticipated|2018-04-15|March 28, 2018|Anticipated|2018-03-28||Interventional|||Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers|Single- And-Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CRN00808 in Healthy Volunteers and to Determine the Effect of CRN00808 on Midazolam Pharmacokinetics|Recruiting||Phase 1|83|Anticipated|Crinetics Pharmaceuticals Inc.||5|||f||||t|f|f||||||||2017-10-10 20:43:52.051656|2017-10-10 20:43:52.051656
NCT03276845|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|April 2017|Actual|2017-04-01||Interventional|||Multiparametric High-resolution Ultrasound of the Breast|Multiparametric High-resolution 3-D Sonography With Color/Power-Doppler, Elastography and Contrast-enhanced Sonography for an Improved Detection and Characterization of Breast Tumors|Completed||N/A|124|Actual|Medical University of Vienna||1|||f||||f|f|f||||||||2017-10-10 20:43:52.177022|2017-10-10 20:43:52.177022
NCT03276832|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 15, 2021|Anticipated|2021-02-15|February 15, 2021|Anticipated|2021-02-15||Interventional|||Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma|Pilot Study to Test the Safety and Efficacy of the Combination of Imiquimod and Pembrolizumab for the Treatment of Metastatic Melanoma|Not yet recruiting||Early Phase 1|10|Anticipated|Mayo Clinic||1|||f||||t|t|f|||f|||||2017-10-10 20:43:52.240397|2017-10-10 20:43:52.240397
NCT03276819|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2025|Anticipated|2025-10-01|October 1, 2025|Anticipated|2025-10-01||Interventional|UMBRELLA||A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC|A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With Oral Potentially Malignant Lesions (OPML) or Head and Neck Squamous Cell Carcinoma (HNSCC) (IHNPACT UMBRELLA)|Not yet recruiting||N/A|650|Anticipated|Centre Leon Berard||3|||f||||f|f|f||||||||2017-10-10 20:43:52.360108|2017-10-10 20:43:52.360108
NCT03276793|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 31, 2022|Anticipated|2022-10-31|October 31, 2022|Anticipated|2022-10-31||Interventional|||Brain Connectivity in Depression|Using Human Brain Connectivity to Identify the Causal Neuroanatomical Substrate of Depression Symptoms|Not yet recruiting||N/A|60|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||t|f|f||||||||2017-10-10 20:43:52.648674|2017-10-10 20:43:52.648674
NCT03276780|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||NRT Sampling and Selection to Increase Medication Adherence|NRT Sampling and Selection to Increase Medication Adherence|Not yet recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f|||t|||||2017-10-10 20:43:52.719109|2017-10-10 20:43:52.719109
NCT03276767|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-12|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Comparing SMS and E-mail Reminders in an Online Smoking Cessation Intervention|An RCT Comparing Reminders Sendt by SMS or by E-mail in an Online Smoking Cessation Intervention|Recruiting||N/A|700|Anticipated|University of Oslo||2|||f||||f|f|f||||||||2017-10-10 20:43:52.802654|2017-10-10 20:43:52.802654
NCT03276715|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||June 1, 2016|Actual|2016-06-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|June 1, 2019|Anticipated|2019-06-01|3 Years|Observational [Patient Registry]|||Prognostic Factors on Malignant Pleural Effusion|A Cohort Study of Prognostic Factors in Lung Cancer Patients With Malignant Pleural Effusion (MPE).|Recruiting||N/A|40|Anticipated|The University of Hong Kong|||1||f|||||f|f||||||||2017-10-10 20:43:53.21653|2017-10-10 20:43:53.21653
NCT03276702|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Observational|||Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid Malignancies|A Protocol for Prospectively Collecting Fresh Tumor Tissue in Children and Adolescents With Recurrent or Progressive Solid Malignancies|Recruiting||N/A|120|Anticipated|St. Jude Children's Research Hospital|||1||f||||t|f|f||||Samples With DNA|"     DNA will be extracted from the patient's peripheral blood and tumor samples and RNA will be     extracted from the tumor sample and whole genome sequencing (WGS), whole exome sequencing     (WES) and transcriptome sequencing (RNA-Seq) will be performed on Illumina Next Generation     Sequencers. Both somatic and germline variants (single nucleotide variants, structural     variants, insertions/deletions, and copy number variants) will be identified using a     bioinformatics pipeline developed and validated at SJCRH. Separate reports will be generated     for the somatic lesions and germline lesions. In the event that there is not enough fresh     tissue to perform WGS, WES and RNAseq will be performed in FFPE material if available.   "|||2017-10-10 20:43:53.289838|2017-10-10 20:43:53.289838
NCT03276689|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|0381-16||'Fix the Dysfunction' Concept for Mechanism-based Pharmacological Treatment of Neuropathic Pain by Drug|'Fix the Dysfunction' Concept for Mechanism-based Pharmacological Treatment of Neuropathic Pain by Drug|Not yet recruiting||N/A|300|Anticipated|Rambam Health Care Campus||3|||f||||f|f|f|||f|||||2017-10-10 20:43:53.367764|2017-10-10 20:43:53.367764
NCT03276676|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-07|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|||[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors|[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors|Not yet recruiting||Phase 2|30|Anticipated|University of Utah||1|||f||||t|t|f||||||||2017-10-10 20:43:53.449396|2017-10-10 20:43:53.449396
NCT03276663|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-10-04|||September 18, 2017|Actual|2017-09-18|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|March 2019|Anticipated|2019-03-01||Interventional|||Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula|Effect of a New Formula With a Reduced Concentration of Partially Hydrolyzed Protein on Growth of Healthy Term Infants: an Open-label Study|Active, not recruiting||N/A|200|Anticipated|Nestlé||2|||f||||f|f|f||||||||2017-10-10 20:43:53.512006|2017-10-10 20:43:53.512006
NCT03276650|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Observational|Still-ICU||Admission of Adult-onset Still Disease Patients in the ICU|Admission of Adult-onset Still Disease Patients in the ICU: a French Retrospective Multicentric Study|Not yet recruiting||N/A|40|Anticipated|Central Hospital, Nancy, France|||1||f||||f|f|f||||||||2017-10-10 20:43:53.570831|2017-10-10 20:43:53.570831
NCT03276637|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-07|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|MilSeq||Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force|The MilSeq Project: Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force|Recruiting||N/A|75|Anticipated|Brigham and Women's Hospital||1|||f||||t|f|f||||||||2017-10-10 20:43:53.64147|2017-10-10 20:43:53.64147
NCT03276624|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|September 4, 2018|Anticipated|2018-09-04||Interventional|||Early Outcome in Unstable Angina Patients With Low EF After CABG|Early Outcome in Chronic Unstable Angina Patients With Low Ejection Fraction After CABG|Recruiting||N/A|30|Anticipated|Assiut University||1|||f||||t|f|f||||||||2017-10-10 20:43:53.757372|2017-10-10 20:43:53.757372
NCT03276611|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-06|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Assessment of Pulmonary Artery Pressure and Right Sided Hemodynamics in Patients With OSA Before and After CPAP TTT|Assessment of Pulmonary Artery Pressure and Right Sided Hemodynamics in Patients With OSA Before and After CPAP TTT|Recruiting||N/A|200|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:43:53.830365|2017-10-10 20:43:53.830365
NCT03276598|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||November 25, 1999|Actual|1999-11-25|September 2017|2017-09-01|April 1, 2004|Actual|2004-04-01|April 1, 2004|Actual|2004-04-01||Interventional|GENRES||A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension|A Randomised Double-blind Cross-over Single-centre Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension|Completed||Phase 4|233|Actual|Helsinki University Central Hospital||5|||f||||f|f|f|||f|||||2017-10-10 20:43:53.914603|2017-10-10 20:43:53.914603
NCT03276585|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-06|||September 10, 2017|Anticipated|2017-09-10|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|November 30, 2018|Anticipated|2018-11-30||Observational|KokaSleep||Cross-sectional Study on Insomnia and Depression Using Home Sleep Monitors|Epidemiological Study on Insomnia and Depression Using Home Sleep Monitors in a Japanese Rural City Population|Not yet recruiting||N/A|2000|Anticipated|Shiga University|||1||f||||f|f|f||||||||2017-10-10 20:43:54.054708|2017-10-10 20:43:54.054708
NCT03276572|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase I Trial of 225Ac−J591 in Patients With mCRPC|Phase I Dose−Escalation Trial of 225Ac−J591 in Patients With Metastatic Castration−Resistant Prostate Cancer|Not yet recruiting||Phase 1|42|Anticipated|Weill Medical College of Cornell University||1|||f||||t|t|f||||||||2017-10-10 20:43:54.134076|2017-10-10 20:43:54.134076
NCT03276546|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-06|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|SHARE-D||SHARE-D: a Decision Tool to Help Patients Make Informed Lifestyle Choices|SHARE-D: a Decision Tool to Help Patients With, or at Risk of, Coronary Heart Disease Make Informed Lifestyle Choices: Feasibility Study|Completed||N/A|23|Actual|Queen's University, Belfast||1|||f||||f|f|f||||||||2017-10-10 20:43:54.312526|2017-10-10 20:43:54.312526
NCT03276533|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-06|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Dexmedetomidine Combined With Lidocaine Infusion Affect Inflammation Cytokines|Effects of Intravenous Dexmedetomidine, Lidocaine and Their Combination on Postoperative Inflammation Cytokines After Laparoscopic Hysterectomy With General Anesthesia|Recruiting||N/A|160|Anticipated|Anqing Municipal Hospital||4|||f||||t|f|f||||||||2017-10-10 20:43:54.36725|2017-10-10 20:43:54.36725
NCT03276520|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-08|||December 14, 2016|Actual|2016-12-14|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 1, 2017|Actual|2017-07-01||Interventional|||Randomized Diagnostic Trial Comparing Ethylglucuronide and Ethanol|Filling the Gap Between Lab and Clinical Impact: an Open Randomized Diagnostic Trial Comparing Urinary Ethylglucuronide and Ethanol in Alcohol Dependent Outpatients.|Completed||N/A|162|Actual|Hospital Clinic of Barcelona||2|||f||||f|f|f||||||||2017-10-10 20:43:54.451628|2017-10-10 20:43:54.451628
NCT03276507|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|December 1, 2017|Anticipated|2017-12-01||Observational|MUSE||Multisystem Shortness of Breath Evaluation Study|Multisystem Shortness of Breath Evaluation Study|Recruiting||N/A|60|Anticipated|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz|||1||f||||f||||||||||2017-10-10 20:43:54.510348|2017-10-10 20:43:54.510348
NCT03276494|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-07|||April 21, 2017|Actual|2017-04-21|September 2017|2017-09-01|April 21, 2018|Anticipated|2018-04-21|April 21, 2018|Anticipated|2018-04-21||Interventional|IntraOsseous||A Pilot Study: Safety & TOlerability of Hypertonic Saline Administration Via IntraOsseous Access|The OHIO Trial: A Pilot Study: Safety & TOlerability of Hypertonic Saline Administration Via IntraOsseous Access|Recruiting||Phase 2|10|Anticipated|Ohio State University||1|||f||||f|t|t|f|f|t|||||2017-10-10 20:43:54.573648|2017-10-10 20:43:54.573648
NCT03276481|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|August 28, 2018|Anticipated|2018-08-28|August 28, 2018|Anticipated|2018-08-28||Observational|||Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation|Prospective Evaluation of Gustatory Function (Taste) In Patients Undergoing Autologous Hematopoietic Cell Transplantation for Multiple Myeloma|Recruiting||N/A|65|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||f|f|f||||||||2017-10-10 20:43:54.651828|2017-10-10 20:43:54.651828
NCT03276468|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-07|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas|A Phase II Trial Evaluating Combination of Atezolizumab, With Venetoclax and Obinutuzumab for Relapsed/Refractory Lymphomas|Not yet recruiting||Phase 2|138|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t|f|f||||||||2017-10-10 20:43:56.136438|2017-10-10 20:43:56.136438
NCT03276455|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|September 15, 2021|Anticipated|2021-09-15|September 15, 2020|Anticipated|2020-09-15||Interventional|||Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified|Evaluation of Safety and Efficacy of Transplantation of Autologous Hematopoietic Stem Cell Genetically Modified in Beta-Thalassemia Major|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||f|f|f||||||||2017-10-10 20:43:56.315561|2017-10-10 20:43:56.315561
NCT03276429|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-08|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|LCR||Lung Cancer Registry for Lung Cancer Patients|Development of an Electronic Data Base for Lung Cancer Registry Which Will Include All the Epidemiological, Clinical, Pathological, Molecular and Treatment Parameters in Lung Cancer Patients Who Are Referred to a Tertiary Oncology Unit|Recruiting||N/A|300|Anticipated|Oncology Center of Biochemical Education And Research|||1||f||||f|f|f||||||||2017-10-10 20:43:56.47956|2017-10-10 20:43:56.47956
NCT03276416|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|RAPP||RAPP-children, Rhinitis & Asthma in Patient Perspective: Development and Validation of a Questionnaire for Quality of Life Evaluation in Children With Asthma and Allergic Rhinitis|RAPP-children, Rhinitis & Asthma in Patient Perspective: Development and Validation of a Questionnaire for Quality of Life Evaluation in Children With Asthma and Allergic Rhinitis|Active, not recruiting||N/A|130|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||1||f||||f|f|f||||||||2017-10-10 20:43:56.553469|2017-10-10 20:43:56.553469
NCT03276403|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Primary Graft Dysfunction Score in Lung Transplantation|﻿Finding New Criteria for a Revised Primary Graft Dysfunction Score in Lung Transplantation - a Pilot Study|Recruiting||N/A|80|Anticipated|Medical University of Vienna|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:43:56.618479|2017-10-10 20:43:56.618479
NCT03276390|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Interventional|HKTP||A Culturally Targeted Transplant Program|A Culturally Targeted Transplant Program to Increase Live Donation in Hispanics|Recruiting||N/A|11445|Anticipated|Northwestern University||2|||f||||f|f|f||||||||2017-10-10 20:43:56.692963|2017-10-10 20:43:56.692963
NCT03276377|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-12|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|VIKING||VItamin K Inhibition and NeurocoGnition (VIKING)|Use of Vitamin K Antagonist and Neurocognitive Disorders in Older Adults : a Retrospective Study With Exposed and Non-exposed Groups|Not yet recruiting||N/A|100|Anticipated|University Hospital, Angers|||2||f||||f|f|f||||||||2017-10-10 20:43:56.799524|2017-10-10 20:43:56.799524
NCT03276364|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||July 21, 2014|Actual|2014-07-21|September 2017|2017-09-01|April 17, 2015|Actual|2015-04-17|April 17, 2015|Actual|2015-04-17||Observational|||The Impact of Point-of-Care Ultrasound|The Impact of Point-of-Care Ultrasound Performed by Trainees to Improve the Prediction of Fluid Responsiveness in Patients With Shock|Completed||N/A|112|Actual|Montefiore Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:43:57.416433|2017-10-10 20:43:57.416433
NCT03276351|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-19|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|||Evaluation of Fixation Achievable in Revision Total Knee Arthroplasty Implementing Latest-Generation Implant Technology|Evaluation of Fixation Achievable in Revision Total Knee Arthroplasty Implementing Latest-Generation Implant Technology|Not yet recruiting||N/A|60|Anticipated|Lawson Health Research Institute||3|||f|||||f|f||||||||2017-10-10 20:43:57.494385|2017-10-10 20:43:57.494385
NCT03276338|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-07|||April 1, 2011|Actual|2011-04-01|May 2017|2017-05-01|February 28, 2016|Actual|2016-02-28|June 1, 2015|Actual|2015-06-01||Interventional|HOLA||Using CBPR to Reduce HIV Risk Among Immigrant Latino MSM|Using CBPR to Reduce HIV Risk Among Immigrant Latino MSM|Completed||N/A|186|Actual|Wake Forest University Health Sciences||2|||f||||||||||||||2017-10-10 20:43:57.593595|2017-10-10 20:43:57.593595
NCT03276325|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Epidural Steroids With Intrathecal Nalbuphine for Lower Abdominal Oncologic Surgery|Epidural Steroids Combined With Intrathecal Nalbuphine: Analgesic and Side Effects Concept in Lower Abdominal Surgical Oncology Procedures|Not yet recruiting||N/A|70|Anticipated|Mansoura University||2|||f||||t|f|f||||||||2017-10-10 20:43:57.658844|2017-10-10 20:43:57.658844
NCT03276312|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-07|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Autologous Micro-fragmented Adipose Tissue in the Treatment of Minor Amputations of Diabetic Foot|Local Inoculation of Autologous Micro-fragmented Adipose Tissue in the Treatment of Minor Amputations of Diabetic Foot: A Randomized Controlled Trial|Recruiting||N/A|114|Anticipated|University of Modena and Reggio Emilia||2|||f||||f|f|f||||||||2017-10-10 20:43:57.761161|2017-10-10 20:43:57.761161
NCT03276299|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Learning and Encouragement Effect on 6 Minute Walking Test in Children Between 6 and 12 Years|Learning and Encouragement Effect on 6 Minute Walking Test in Children Between 6 and 12 Years|Completed||N/A|148|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||4|||f||||f|f|f||||||||2017-10-10 20:43:57.864455|2017-10-10 20:43:57.864455
NCT03276273|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-06|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Observational|BIS7||Bispectral-Electroencephalography (EEG) in First Time Hemodialysis|The Utility of Using the Bispectral Index (BIS) for Detecting Dialysis Disequilibrium Syndrome (DDS)|Recruiting||N/A|20|Anticipated|Medical University of Graz|||1||f||||f|f|f||||||||2017-10-10 20:43:58.041139|2017-10-10 20:43:58.041139
NCT03276260|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2, 2018|Anticipated|2018-09-02|September 2, 2018|Anticipated|2018-09-02||Observational|||Evaluation of Medasense's PMD-200 During Surgery and Post Anesthesia Care|Evaluation of Medasense's PMD-200 During Surgery and Post Anesthesia Care|Not yet recruiting||N/A|100|Anticipated|Medasense Biometrics Ltd|||1||f|||||f|f||||||||2017-10-10 20:43:58.130934|2017-10-10 20:43:58.130934
NCT03276247|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-07|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Observational|||Iron Status in Women of Reproductive Age Reproductive Age|Ethnic and Genetic Factors of Iron Status in Women of Reproductive Age|Completed||N/A|22042|Actual|University of Illinois at Chicago|||8||f|||||f|f||||||||2017-10-10 20:43:58.224479|2017-10-10 20:43:58.224479
NCT03276234|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-12|||September 13, 2017|Anticipated|2017-09-13|September 2017|2017-09-01|November 29, 2017|Anticipated|2017-11-29|November 1, 2017|Anticipated|2017-11-01||Observational|||Is There a Relationship Between Serum Sodium Level and Mean Platelet Volume (MPV) Value|Is There a Relationship Between Serum Sodium Level and Mean Platelet Volume (MPV) Value in Patients Undergoing Transurethral Prostate Resection (TUR)?|Recruiting||N/A|31|Anticipated|Tokat Gaziosmanpasa University|||1||f||||f|f|f||||||||2017-10-10 20:43:58.311913|2017-10-10 20:43:58.311913
NCT03276221|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2022|Anticipated|2022-01-31||Interventional|||Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents|Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents|Recruiting||N/A|210|Anticipated|Massachusetts General Hospital||3|||f||||f|f|f||||||||2017-10-10 20:43:58.373683|2017-10-10 20:43:58.373683
NCT03276208|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Pregnancy, Mindfulness, and Massage|Pregnancy Massage and Mindfulness Study for Tobacco Smoking Women|Not yet recruiting||N/A|60|Anticipated|Yale University||2|||f||||f|f|f||||||||2017-10-10 20:43:58.469825|2017-10-10 20:43:58.469825
NCT03276195|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-05|||May 2016||2016-05-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Observational|||Studies in Patients With Tuberous Sclerosis Complex|Studies in Patients With Rett Syndrome, Tuberous Sclerosis Complex, Neurofibromatoses, and Other Neurodevelopmental Disorders|Recruiting||N/A|1000|Anticipated|Translational Genomics Research Institute|||2||f||||t||||||Samples With DNA|"     Participant samples for this study may include blood, urine or saliva. An optional skin     biopsy may also be collected. Additional samples (such as cerebrospinal fluid, muscle     biopsies, and brain tissue) can be used when they are collected as part of a clinically     indicated procedure.      Where possible, parents of a child will be enrolled to identify genetic variants (genetic     modifiers). These and other biological relatives will be asked to donate blood samples and     optional skin biopsy samples for study participation. If the relative is unable to donate a     blood sample, a saliva sample can be collected instead.   "|||2017-10-10 20:43:58.56589|2017-10-10 20:43:58.56589
NCT03276182|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-06|||October 5, 2015|Actual|2015-10-05|August 2017|2017-08-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Interventional|||Evaluation of Meibomian Gland Dysfunction Before and After Cataract Surgery|Evaluation of Meibomian Gland Dysfunction Before and After Cataract Surgery|Completed||N/A|60|Actual|Yonsei University||1|||f||||f|f|f||||||||2017-10-10 20:43:58.648659|2017-10-10 20:43:58.648659
NCT03276169|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-10|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|October 2019|Anticipated|2019-10-01||Interventional|||Left Atrial Function Changes After Left Atrial Appendage Closure in Patients With Persistent Atrial Fibrillation|Left Atrial Function Changes After Left Atrial Appendage Closure in Patients With Persistent Atrial Fibrillation|Not yet recruiting||N/A|105|Anticipated|The Second Hospital of Hebei Medical University||3|||f|||||f|f|||f|||||2017-10-10 20:43:58.72009|2017-10-10 20:43:58.72009
NCT03276156|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||February 23, 2016|Actual|2016-02-23|May 2017|2017-05-01|February 22, 2018|Anticipated|2018-02-22|February 22, 2018|Anticipated|2018-02-22||Interventional|||Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer|Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma|Recruiting||Phase 1|12|Anticipated|Zhejiang Cancer Hospital||1|||f|||||f|f||||||||2017-10-10 20:43:58.797638|2017-10-10 20:43:58.797638
NCT03276130|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|MIND||Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B|Management of Health-Related Quality of LIfe Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B|Not yet recruiting||N/A|2300|Anticipated|Swedish Orphan Biovitrum|||3||f||||f||||||||||2017-10-10 20:43:59.203942|2017-10-10 20:43:59.203942
NCT03276117|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||February 2, 2017|Actual|2017-02-02|September 2017|2017-09-01|August 26, 2017|Actual|2017-08-26|August 21, 2017|Actual|2017-08-21||Observational|labourRecord||Wide Use of Paperless Partograph in Evaluation of Labour|Wide Using of Paperless Partograph in Evaluation of Labour|Completed||N/A|200|Actual|Assiut University|||1||f||||f|f|f||||Samples Without DNA|"     Inside labour room we record that when the labour women in active phase as cervical     dilatation 4cm or more   "|||2017-10-10 20:43:59.321541|2017-10-10 20:43:59.321541
NCT03276104|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-12|||September 9, 2017|Actual|2017-09-09|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|November 2020|Anticipated|2020-11-01||Interventional|LION||Late In-the-bag intraOcular Lens dislocatioN Surgery|Late In-the-bag intraOcular Lens dislocatioN Surgery: A Randomized Clinical Trial (LION Trial)|Recruiting||N/A|50|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:43:59.415561|2017-10-10 20:43:59.415561
NCT03276091|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||May 23, 2017|Actual|2017-05-23|September 2017|2017-09-01|March 16, 2018|Anticipated|2018-03-16|December 31, 2017|Anticipated|2017-12-31||Interventional|Colofit+||Colonoscopy Motivation for Patients With Positive Immunochemical Fecal Test|Evaluation of a Motivational Phone Call Strategy to Improve Colonoscopy Participation, for Patients With a Positive Immunochemical Fecal Test : Colofit + Study|Enrolling by invitation||N/A|127|Anticipated|Association pour le Dépistage Organisé des Cancers dans le Rhône||1|||f||||f|f|f||||||||2017-10-10 20:43:59.52366|2017-10-10 20:43:59.52366
NCT03276078|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-07|2017-09-18|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|April 2, 2018|Anticipated|2018-04-02|April 2, 2018|Anticipated|2018-04-02||Interventional|||Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Phase IIa, Open-Label, Repeat-Dose Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination Administered Twice-Daily by Inhalation in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|Not yet recruiting||Phase 2|20|Anticipated|AstraZeneca||1|||f|||||f|f||||||||2017-10-10 20:43:59.607865|2017-10-10 20:43:59.607865
NCT03276065|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Effectiveness of Laser Hair Removal in Pilonidal Disease|Randomized Controlled Trial of Laser Hair Depilation in Adolescents With Pilonidal Disease|Recruiting||N/A|212|Anticipated|Nationwide Children's Hospital||2|||f|||||f|t|f|f||||||2017-10-10 20:43:59.733702|2017-10-10 20:43:59.733702
NCT03276039|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-06|||April 15, 2014|Actual|2014-04-15|September 2017|2017-09-01|July 30, 2016|Actual|2016-07-30|April 15, 2016|Actual|2016-04-15||Observational|||Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C Virus|Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C Virus: A Comparative Egyptian Study|Completed||N/A|70|Actual|Ain Shams University|||3||f|||||f|f||||||||2017-10-10 20:43:59.996327|2017-10-10 20:43:59.996327
NCT03276026|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-05|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|July 15, 2018|Anticipated|2018-07-15||Observational|||A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery|A Qualitative Prospective Study to Compare the Effectiveness of Neostigmine Versus Sugammadex in Length of PACU Stay in ASA II and III Patients Undergoing Sleeve Gastrectomy Bariatric Surgery|Not yet recruiting||N/A|126|Anticipated|Virtua Health, Inc.|||2||f||||f|t|f|||t|||||2017-10-10 20:44:00.105597|2017-10-10 20:44:00.105597
NCT03276013|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-05|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|January 2020|Anticipated|2020-01-01||Interventional|TOPIC||Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer|Phase II Trial of Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer (TOPIC)|Not yet recruiting||Phase 2|51|Anticipated|Vall d'Hebron Institute of Oncology||1|||f||||t|f|f||||||||2017-10-10 20:44:00.231249|2017-10-10 20:44:00.231249
NCT03276000|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Misoprostol for Cervical Priming Before Office Hysteroscopy|Randomized Control Trial Comparing Patient Acceptability and Tolerance to Pain Using Oral Versus Vaginal Misoprostol for Cervical Priming Before Office Hysteroscopy.|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Kasr El Aini Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:44:00.3297|2017-10-10 20:44:00.3297
NCT03275987|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-07|||April 23, 2014|Actual|2014-04-23|September 2017|2017-09-01|May 10, 2017|Actual|2017-05-10|September 30, 2014|Actual|2014-09-30||Interventional|||Promoting Cancer Screening Among Medicaid Recipients in Minnesota|A Population-based Randomized Trial to Promote Cancer Screening Among Unscreened Medicaid Recipients in Minnesota|Completed||N/A|138554|Actual|Minnesota Department of Health||4|||f|||||f|f||||||||2017-10-10 20:44:00.413978|2017-10-10 20:44:00.413978
NCT03275974|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2022|Anticipated|2022-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Glutamine PET Imaging Colorectal Cancer|Glutamine PET Imaging of Colorectal Cancer|Not yet recruiting||Early Phase 1|30|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:44:00.50832|2017-10-10 20:44:00.50832
NCT03275961|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||November 29, 2016|Actual|2016-11-29|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Stress Management and Resiliency Training (SMART) Integrated Into Treatment of Major Depression|Stress Management and Resiliency Training (SMART) Integrated Into Comprehensive Treatment of Major Depression: A Feasibility Study|Recruiting||N/A|24|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 20:44:00.610883|2017-10-10 20:44:00.610883
NCT03275948|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-10-02|||November 1, 2016|Actual|2016-11-01|October 2017|2017-10-01|October 2, 2017|Actual|2017-10-02|February 28, 2017|Actual|2017-02-28||Interventional|||Effects of Whole Grain Rye on Metabolic Risk Markers and Mood|Effects of Whole Grain on Cognitive Performance and Mood, and the Relationships to Cardiometabolic Risk Markers|Completed||N/A|38|Actual|Lund University||2|||f||||f|f|f||||||||2017-10-10 20:44:00.699763|2017-10-10 20:44:00.699763
NCT03275935|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30|1 Month|Observational [Patient Registry]|||Evaluation of Inhalation Technique in Patients With COPD, Asthma or ACOS Using a Dry Powder Device (DPI)|Evaluation of Inhalation Technique in Patients With Chronic Obstructive Pulmonary Disease (COPD), Asthma or Asthma-COPD Overlap Syndrome(ACOS) Using a Dry Powder Device at Chest Clinic in Dhulikhel Hospital|Completed||N/A|307|Actual|Kathmandu University School of Medical Sciences|||1||f||||f|f|f|||f|||||2017-10-10 20:44:00.782473|2017-10-10 20:44:00.782473
NCT03275922|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-07|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|April 2020|Anticipated|2020-04-01||Interventional|||Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Evaluate The Efficacy And Safety Of Zolmitriptan Nasal Spray For The Treatment Of Acute Migraine In Subjects Ages 6 To 11 Years, With An Open-Label Extension|Not yet recruiting||Phase 3|426|Anticipated|IMPAX Laboratories, Inc.||2|||f||||f|t|f|||f|||||2017-10-10 20:44:00.870753|2017-10-10 20:44:00.870753
NCT03275909|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-07|||July 1, 2011|Actual|2011-07-01|September 2017|2017-09-01|December 31, 2015|Actual|2015-12-31|July 30, 2013|Actual|2013-07-30||Interventional|||Integrated Psychological Therapy for Chronic Schizophrenia|Integrated Psychological Therapy (IPT) + Emotional Management Therapy (EMT) in Chronic Schizophrenia: Study Protocol for a Randomized Controlled Trial|Completed||N/A|77|Actual|Basque Country University||2|||f||||t|f|f||||||||2017-10-10 20:44:00.975929|2017-10-10 20:44:00.975929
NCT03275896|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy|Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy|Recruiting||Early Phase 1|20|Anticipated|Singapore National Eye Centre||1|||f||||t|f|f||||||||2017-10-10 20:44:01.050905|2017-10-10 20:44:01.050905
NCT03275883|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-11|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|December 1, 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|||Arterial Patency in Liver Transplantation|Retrospective Analysis to Identify Independent Predictive Risk Factors for Early and Late Arterial Occlusion in Liver Transplantation and Compare Short and Long-term Outcomes for Aorto-hepatic Conduits in Liver Transplantation|Recruiting||N/A|300|Anticipated|University of Zurich|||1||f||||f|f|f||||||||2017-10-10 20:44:01.149793|2017-10-10 20:44:01.149793
NCT03275870|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa|Pilot Study of Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Pittsburgh||1|||f||||f|t|f|||t|||||2017-10-10 20:44:01.278224|2017-10-10 20:44:01.278224
NCT03275857|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Cisplatin in Castration Resistant Prostate Cancer|A Pilot Study of Cisplatin in Castration Resistant Prostate Cancer That is Becoming Refractory to Enzalutamide|Not yet recruiting||Early Phase 1|37|Anticipated|University of Rochester||1|||f||||t|f|f||||||||2017-10-10 20:44:01.414514|2017-10-10 20:44:01.414514
NCT03275844|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Observational|||Physical Capacity and Activity in Children With Congenital Heart Disease|Physical Capacity and Activity in Children With Congenital Heart Disease in Chile|Not yet recruiting||N/A|17|Anticipated|University of Chile|||2||f||||t|f|f||||||||2017-10-10 20:44:01.484153|2017-10-10 20:44:01.484153
NCT03124719|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||July 2012||2012-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:43.560989|2017-10-10 21:08:43.560989
NCT03275831|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-06|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|July 22, 2018|Anticipated|2018-07-22|July 22, 2018|Anticipated|2018-07-22||Interventional|||PluroGel on Wounds of Mixed Etiology|A Pilot Study to Investigate the Efficacy of PluroGel in Healing Venous and Mixed Aetiology Leg Ulcers|Not yet recruiting||N/A|40|Anticipated|Medline Industries||2|||f||||f|f|f||||||||2017-10-10 20:44:01.570115|2017-10-10 20:44:01.570115
NCT03275818|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-06|||May 9, 2017|Actual|2017-05-09|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|ABRADES||Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma|Phase II Trial of Nab-paclitaxel for the Treatment of Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma|Recruiting||Phase 2|61|Anticipated|Grupo Espanol de Investigacion en Sarcomas||1|||f||||f|f|f||||||||2017-10-10 20:44:01.65696|2017-10-10 20:44:01.65696
NCT03275805|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-10-03|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||How Should Stable Graf Type IIb or IIc Hips be Treated With Pavlik Harness?|How Should Stable Graf Type IIb or IIc Hips be Treated With Pavlik Harness?|Not yet recruiting||N/A|100|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||||2017-10-10 20:44:01.975049|2017-10-10 20:44:01.975049
NCT03275792|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-05|||May 2018|Anticipated|2018-05-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion|Inpatient Volume Expansion in Children With Shiga Toxin-Producing Escherichia Coli (STEC) Infection to Prevent Hemolytic Uremic Syndrome (HUS)|Not yet recruiting||Phase 1|30|Anticipated|University of Calgary||2|||f||||t|f|f||||||||2017-10-10 20:44:02.097322|2017-10-10 20:44:02.097322
NCT03275779|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-05|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|EXFREQ||Investigating the Role of Resistance Exercise Frequency in the Regulation of Skeletal Muscle Mass|Investigating the Role of Resistance Exercise Frequency in the Regulation of Skeletal Muscle Mass|Not yet recruiting||N/A|12|Anticipated|University of Birmingham||2|||f||||f|f|f||||||||2017-10-10 20:44:02.211986|2017-10-10 20:44:02.211986
NCT03275766|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-05|||June 1, 2016|Actual|2016-06-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Transcranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric Disorders|Effects of Transcranial Magnetic Stimulation on Motor Symptoms of Patients With Psychiatric Disorders|Recruiting||N/A|80|Anticipated|University of Bern||4|||f||||f|f|f||||||||2017-10-10 20:44:02.31604|2017-10-10 20:44:02.31604
NCT03275753|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Visual Function Tests in Age-related Macular Degeneration|Visual Function Tests in Non-Exudative Age-Related Macular Degeneration and Normal Subjects|Not yet recruiting||N/A|200|Anticipated|ORA, Inc.|||4||f||||f|f|f||||||||2017-10-10 20:44:02.469383|2017-10-10 20:44:02.469383
NCT03275740|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-05|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|June 26, 2018|Anticipated|2018-06-26|June 26, 2018|Anticipated|2018-06-26||Interventional|||A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347|A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo-controlled, First-in-human Trial To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Pf-06755347 After Single Ascending Intravenous Infusions To Healthy Adult Subjects|Suspended||Phase 1|73|Anticipated|Pfizer||2||Study is currently on hold by Sponsor for protocol amendment|f||||f|t|f||||||||2017-10-10 20:44:02.584738|2017-10-10 20:44:02.584738
NCT03275727|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-07|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|INNOVBC||A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer|Self-care Programs in Oncology: a Guided Internet-delivered Individually-tailored Acceptance and Commitment Therapy (ACT)-Influenced Cognitive Behavioural Intervention to Improve Psychosocial Outcomes in Breast Cancer Survivors|Not yet recruiting||Phase 2/Phase 3|128|Anticipated|Linkoeping University||2|||f|||||f|f||||||||2017-10-10 20:44:02.681944|2017-10-10 20:44:02.681944
NCT03275714|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder|Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder|Not yet recruiting||N/A|48|Anticipated|Medical University of Graz||2|||f||||f|f|f||||||||2017-10-10 20:44:02.780156|2017-10-10 20:44:02.780156
NCT03275701|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-05|||July 2016||2016-07-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|October 2019|Anticipated|2019-10-01||Interventional|STRUCTR||Evaluating BMD in Participants ≥50 Years Old Switching From EVG/COBI/FTC/TAF or EVG/COBI/FTC/TDF to ABC/DTG/3TC|Phase IV, Single-Arm, Open-Label Study Evaluating Bone Mineral Density in HIV-1-Infected Adults ≥50 Years Old Switching From EVG/COBI/FTC/TAF (Genvoya) or EVG/COBI/FTC/TDF (Stribild) to ABC/DTG/3TC (Triumeq)|Recruiting||N/A|50|Anticipated|Mills Clinical Research||1|||f||||f||||||||||2017-10-10 20:44:02.855837|2017-10-10 20:44:02.855837
NCT03275688|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-19|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||NanoSpectrometer Biomarker Discovery and Confirmation Study|NanoSpectrometer Biomarker Discovery and Confirmation Study|Recruiting||N/A|450|Anticipated|Johns Hopkins University|||3||f||||t|f|f||||Samples Without DNA|"     Breath sample   "|||2017-10-10 20:44:02.966927|2017-10-10 20:44:02.966927
NCT03275675|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-05|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Observational|ORCA||Evaluation of Patients' Satisfaction With the Dispensation of Their Oral Anticancer Treatment in Community Pharmacy|Evaluation of Patients' Satisfaction With the Dispensation of Their Oral Anticancer Treatment in Community Pharmacy: Observational and Transversal Study|Recruiting||N/A|150|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 20:44:03.075545|2017-10-10 20:44:03.075545
NCT03275662|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||August 29, 2016|Actual|2016-08-29|September 2017|2017-09-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|||Dietary Strategies to Restore Gut Microbiota Diversity of Americans: Fiber vs Probiotics|Dietary Strategies to Restore Gut Microbiota Diversity of Americans: Fiber vs Probiotics|Completed||N/A|37|Actual|Stanford University||2|||f|||||f|f||||||||2017-10-10 20:44:03.176663|2017-10-10 20:44:03.176663
NCT03275649|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-06|||July 21, 2017|Actual|2017-07-21|September 2017|2017-09-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Observational|PDHelp||Help-seeking for Health Problems in People With Parkinson's|Development of an Intervention to Increase Help-seeking for Non-motor Symptoms in People With Parkinson's|Recruiting||N/A|30|Anticipated|City, University of London|||1||f||||f|f|f||||||||2017-10-10 20:44:03.25823|2017-10-10 20:44:03.25823
NCT03275636|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2023|Anticipated|2023-10-01|October 2022|Anticipated|2022-10-01||Interventional|HAMLET||Haploidentical Donor vs mMUD in Hematological Malignancies|A Randomized Controlled Trial Comparing Outcome After Hematopoietic Cell Transplantation From a Partially Matched Unrelated Versus Haploidentical Donor|Not yet recruiting||Phase 2/Phase 3|266|Anticipated|DKMS gemeinnützige GmbH||2|||f||||t|f|f||||||||2017-10-10 20:44:03.333756|2017-10-10 20:44:03.333756
NCT03275623|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|July 15, 2018|Anticipated|2018-07-15|July 15, 2018|Anticipated|2018-07-15||Interventional|||Management of Sub-Clinical Bacteriuria in Pregnancy|Management of Sub-Clinical Bacteriuria in Pregnancy: A Feasibility Trial|Not yet recruiting||Phase 4|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f|||||t|f|||f|||||2017-10-10 20:44:03.42213|2017-10-10 20:44:03.42213
NCT03275610|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||April 24, 2017|Actual|2017-04-24|September 2017|2017-09-01|April 23, 2018|Anticipated|2018-04-23|April 23, 2018|Anticipated|2018-04-23||Observational|||Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty|Risk Stratification Using Genetic Markers of Patients With a History of Pulmonary Embolism Post Total Hip or Total Knee Arthroplasty|Enrolling by invitation||N/A|100|Anticipated|University of Southern California|||1||f||||f|f|f||||||||2017-10-10 20:44:03.512857|2017-10-10 20:44:03.512857
NCT03275584|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2027|Anticipated|2027-11-01|November 2027|Anticipated|2027-11-01||Interventional|||Safety of PET MPI Using the CRCHUM N-13 Ammonia|Sûreté de la Perfusion Myocardique Par la Tomographie d'émission Par Positron Avec l'Ammoniaque marqué au N-13 du Centre de Recherche du Centre Hospitalier de l'Université de Montréal|Not yet recruiting||Phase 4|20000|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f|||||f|f|||f|||||2017-10-10 20:44:03.678421|2017-10-10 20:44:03.678421
NCT03275571|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-13|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|September 23, 2018|Anticipated|2018-09-23|September 23, 2018|Anticipated|2018-09-23||Interventional|||HIV, Computerized Depression Therapy & Cognition|The Effects of Computerized Cognitive Behavior Therapy (cCBT) on Brain Health: A Feasibility Study|Enrolling by invitation||N/A|30|Anticipated|McGill University||1|||f||||f|f|f||||||||2017-10-10 20:44:03.740229|2017-10-10 20:44:03.740229
NCT03275558|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma|Phase I Clinical Trial of Nasal Spray in Treating Patients With Recurrent Glioblastoma, Gliosarcoma, Glioma|Suspended||Phase 1|60|Anticipated|Center Trials & Treatment||3||Suspended until approval of the Ethics Committee / Human Subjects Protection|f||||f|f|f||||||||2017-10-10 20:44:03.829156|2017-10-10 20:44:03.829156
NCT03275545|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|||Neural Correlates of Reward and Symptom Expression in Anorexia Nervosa|Neural Correlates of Reward and Symptom Expression in Anorexia Nervosa|Not yet recruiting||N/A|87|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f|f|f||||||||2017-10-10 20:44:03.926421|2017-10-10 20:44:03.926421
NCT03275532|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-05|||September 2017||2017-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:44:03.989865|2017-10-10 20:44:03.989865
NCT03275519|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-06|||January 19, 2015|Actual|2015-01-19|September 2017|2017-09-01|April 19, 2017|Actual|2017-04-19|February 17, 2017|Actual|2017-02-17||Interventional|||Antibiotic Use in Distal Hypospadias Repair|Randomized Trial of Antibiotic Prophylaxis for Prevention of Symptomatic UTI in Stented, Distal Hypospadias Repair|Completed||N/A|48|Actual|Arkansas Children's Hospital Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:44:04.035799|2017-10-10 20:44:04.035799
NCT03275506|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|NEOPEMBROV||PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .|A Randomized, Open-label, Multicentric Phase II Trial of PEMBROLIZUMAB (Keytruda®) With Chemotherapy Versus Chemotherapy Alone (Standard of Care) as Neo Adjuvant Treatment of Ovarian Cancer Not Amenable to Front Line Debulking Surgery.|Not yet recruiting||Phase 2|45|Anticipated|ARCAGY/ GINECO GROUP||2|||f||||t|f|f|||f|||||2017-10-10 20:44:04.127211|2017-10-10 20:44:04.127211
NCT03275480|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||January 18, 2016|Actual|2016-01-18|September 2017|2017-09-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Myelodysplastic Syndromes Database|Institut Paoli Calmettes Myelodysplastic Syndromes Database|Recruiting||N/A|10000|Anticipated|Institut Paoli-Calmettes|||1||f||||f|f|f||||||||2017-10-10 20:44:04.292982|2017-10-10 20:44:04.292982
NCT03124706|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||February 16, 2011||2011-02-16||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:43.593578|2017-10-10 21:08:43.593578
NCT03275467|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-07|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Faecal Microbiota Transplantation in Patients With Microscopic Colitis|Faecal Microbiota Transplantation in Patients With Microscopic Colitis|Enrolling by invitation||N/A|10|Anticipated|Örebro University, Sweden||1|||f||||f|f|f||||||||2017-10-10 20:44:04.362897|2017-10-10 20:44:04.362897
NCT03275454|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|May 2, 2018|Anticipated|2018-05-02|May 2, 2018|Anticipated|2018-05-02||Interventional|||A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose TNT009 in Participants With Chronic Immune Thrombocytopenia (ITP)|The Safety, Tolerability, and Pharmacokinetics & Pharmacodynamics of Multiple- Dose TNT009 in Patients With Chronic Immune Thrombocytopenia (ITP)|Recruiting||Phase 1|10|Anticipated|True North Therapeutics||1|||f||||f|t|f||||||||2017-10-10 20:44:04.44605|2017-10-10 20:44:04.44605
NCT03275441|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|SHERG||Electroretinography: Investigation of a Protocol Change|Investigation of a Protocol Change (Shorter Dark-adaptation) on the Electroretinogram (ERG) in an Adult Patient Population (SHERG)|Not yet recruiting||N/A|262|Anticipated|NHS Greater Glasgow and Clyde|||1||f||||f|f|f||||||||2017-10-10 20:44:04.534768|2017-10-10 20:44:04.534768
NCT03275428|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|September 10, 2018|Anticipated|2018-09-10|September 10, 2018|Anticipated|2018-09-10||Observational|||THRIVE and Non-intubated Thoracic Surgery|Efficacy and Safety of Transnasal Humidified Rapid-insufflation Ventilator Exchange (THRIVE) and Non-intubated Thoracic Surgery (NITS)|Not yet recruiting||N/A|40|Anticipated|Taipei Veterans General Hospital, Taiwan|||2||f||||f|f|f||||||||2017-10-10 20:44:04.612781|2017-10-10 20:44:04.612781
NCT03275415|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Intratracheal Budesonide/Surfactant Prevents BPD|Routine Administration of Surfactant/Budesonide to Prevent BPD in VLBW With RDS-A Double Blind Study|Not yet recruiting||Phase 4|380|Anticipated|Taipei Medical University||2|||f||||t|f|f||||||||2017-10-10 20:44:04.702681|2017-10-10 20:44:04.702681
NCT03275402|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-11|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||131I-burtomab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases|A Multicenter Phase 2/3 Trial of the Efficacy and Safety of Intracerebroventricular Radioimmunotherapy Using 131I-burtomab for Neuroblastoma Central Nervous System/Leptomeningeal Metastases|Not yet recruiting||Phase 2/Phase 3|32|Anticipated|Y-mAbs Therapeutics||1|||f||||t|t|f||||||||2017-10-10 20:44:04.784713|2017-10-10 20:44:04.784713
NCT03275363|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||September 1, 2014|Actual|2014-09-01|September 2017|2017-09-01|January 4, 2022|Anticipated|2022-01-04|January 1, 2022|Anticipated|2022-01-01|5 Years|Observational [Patient Registry]|||The University of Hong Kong Neurocognitive Disorder Cohort|The University of Hong Kong Neurocognitive Disorder Cohort|Recruiting||N/A|500|Anticipated|The University of Hong Kong|||5||f||||f|f|f||||Samples With DNA|"     Venous blood at baseline and at yearly follow up   "|||2017-10-10 20:44:05.080197|2017-10-10 20:44:05.080197
NCT03275350|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-05|||November 6, 2017|Anticipated|2017-11-06|September 2017|2017-09-01|March 6, 2020|Anticipated|2020-03-06|March 6, 2020|Anticipated|2020-03-06||Interventional|||Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up|Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up|Not yet recruiting||Phase 2/Phase 3|350|Anticipated|Oregon Health and Science University||2|||f||||t|t|f|||t|||||2017-10-10 20:44:05.190555|2017-10-10 20:44:05.190555
NCT03275337|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-27|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|July 31, 2022|Anticipated|2022-07-31|July 31, 2022|Anticipated|2022-07-31||Interventional|||Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy|Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy|Recruiting||N/A|96|Anticipated|Laureate Institute for Brain Research, Inc.||3|||f||||f|f|t|f|f|f|||||2017-10-10 20:44:05.397383|2017-10-10 20:44:05.397383
NCT03275324|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Use of Integrated Pulmonary Index to Predict Post-Operative Respiratory Adverse Events in High Risk Patients|Use of Integrated Pulmonary Index to Predict Post-Operative Respiratory Adverse Events in High Risk Patients|Not yet recruiting||N/A|600|Anticipated|Stony Brook University|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:44:05.503663|2017-10-10 20:44:05.503663
NCT03275311|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-05|||October 27, 2014|Actual|2014-10-27|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|ESME-MBC||Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008|Epidemio-Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Metastatic Breast Cancer Across the French Comprehensive Cancer Centers From 2008|Recruiting||N/A|30000|Anticipated|UNICANCER|||1||f||||t|f|f||||||||2017-10-10 20:44:05.580694|2017-10-10 20:44:05.580694
NCT03274440|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ECOS||Effects of Marijuana on Symptoms of OCD|Effects of Marijuana on Symptoms of Obsessive-Compulsive Disorder|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|New York State Psychiatric Institute||3|||f||||t|t|f||||||||2017-10-10 20:44:12.135299|2017-10-10 20:44:12.135299
NCT03275298|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-05|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|ESME-OVR||Evolution of the Therapeutic Care in Ovarian Cancer From 2011|Epidemio-Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform : Evolution of the Therapeutic Care in Ovarian Cancer Across the French Comprehensive Cancer Centers From 2011|Recruiting||N/A|14000|Anticipated|UNICANCER|||1||f||||t|f|f||||||||2017-10-10 20:44:05.75864|2017-10-10 20:44:05.75864
NCT03275285|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||October 23, 2017|Anticipated|2017-10-23|August 2017|2017-08-01|November 2023|Anticipated|2023-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients|Randomized, Open Label, Multicenter Study Assessing The Clinical Benefit Of Isatuximab Combined With Carfilzomib (Kyprolis®) And Dexamethasone Versus Carfilzomib With Dexamethasone In Patients With Relapse And/Or Refractory Multiple Myeloma Previously Treated With 1 to 3 Prior Lines|Not yet recruiting||Phase 3|300|Anticipated|Sanofi||2|||f||||t|t|f||||||||2017-10-10 20:44:05.918437|2017-10-10 20:44:05.918437
NCT03275272|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-06|2017-09-06|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Maternal BMI and Type of Infants Feeding on IGF-1 in Infant|Effect of maternalBMI and Type of Infants Feeding on IGF-1in Infants as Early Marker of Childand Adult Hood Obesity|Not yet recruiting||N/A|40|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:44:06.022604|2017-10-10 20:44:06.022604
NCT03275259|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-05|||April 3, 2017|Actual|2017-04-03|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|January 1, 2018|Anticipated|2018-01-01||Interventional|ESWT||Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat|Effect of Extracorporeal Shock Wave Therapy in the Treatment of Gynoid Lipodystrophy and Localized Fat|Enrolling by invitation||N/A|30|Actual|Indústria Brasileira Equipamentos Médicos - IBRAMED||1|||f||||f|f|f||||||||2017-10-10 20:44:06.091463|2017-10-10 20:44:06.091463
NCT03275246|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|X-PSI||Establish Implant Accuracy With X-PSI Knee System|Establish Implant Accuracy With X-PSI Knee System - A Multi-center, Prospective, Non-controlled Post Market Study|Not yet recruiting||N/A|70|Anticipated|Zimmer Biomet||1|||f||||f|f|f||||||||2017-10-10 20:44:06.180234|2017-10-10 20:44:06.180234
NCT03275233|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-06|||January 4, 2018|Anticipated|2018-01-04|September 2017|2017-09-01|January 4, 2020|Anticipated|2020-01-04|January 4, 2019|Anticipated|2019-01-04||Observational|||Psychiatric Comorbidities in Patients With Painful Peripheral Neuropathy|Psychiatric Comorbidities in Patient With Painful Peripheral Neuropathy|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:44:06.275419|2017-10-10 20:44:06.275419
NCT03275220|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-05|||September 10, 2017|Anticipated|2017-09-10|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Assessment Of Right Ventricular Function In Patients Undergoing Coronary Artery Bypass Graft In Assiut University|Assessment Of Right Ventricular Function In Patients Undergoing Coronary Artery Bypass Graft In Assiut University|Not yet recruiting||N/A|150|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:44:06.336882|2017-10-10 20:44:06.336882
NCT03275207|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-04|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Dexmedetomidine for Prevention of Chronic Postoperative Pain|a Randomized Controlled Trial of Dexmedetomidine on Chronic Postoperative Pain After Breast and Thoracic Surgery|Not yet recruiting||Phase 4|120|Anticipated|Zhongda Hospital||2|||f|||||f|f||||||||2017-10-10 20:44:06.431446|2017-10-10 20:44:06.431446
NCT03275194|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-06|||September 2, 2017|Actual|2017-09-02|September 2017|2017-09-01|December 1, 2025|Anticipated|2025-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy|Hyperthermic Intraperitoneal Chemotherapy in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy. Phase II Study|Recruiting||Phase 2|100|Anticipated|Instituto Nacional de Cancerologia de Mexico||2|||f||||t|f|f||||||||2017-10-10 20:44:06.549678|2017-10-10 20:44:06.549678
NCT03275181|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer|Effect of Androgen Deprivation Therapy on Left Ventricular Function in Prostate Cancer Patients and Survivors|Recruiting||N/A|60|Anticipated|Kansas State University|||3||f||||f|f|f||||||||2017-10-10 20:44:06.637807|2017-10-10 20:44:06.637807
NCT03275168|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2020|Anticipated|2020-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Developing a Dyadic Intervention for Sexually Transmitted Infection (STI)/HIV Prevention in Youth|Developing a Dyadic Intervention for STI/HIV Prevention in Youth|Not yet recruiting||N/A|40|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||||2017-10-10 20:44:06.728813|2017-10-10 20:44:06.728813
NCT03275155|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-05|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|August 31, 2018|Anticipated|2018-08-31||Observational|PARADISE||Pathophysiology and Risk of Atrial Fibrillation Detected After Ischemic Stroke|The PAthophysiology and Risk of Atrial Fibrillation Detected After Ischemic StrokE (PARADISE): Prospective Non-interventional Cohort Study|Recruiting||N/A|100|Anticipated|Lawson Health Research Institute|||3||f||||f|f|f||||||||2017-10-10 20:44:06.808838|2017-10-10 20:44:06.808838
NCT03275142|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-06|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Icare Tonometry Effects on Keratometry Readings, Topography Readings, and Corneal Staining|Icare Tonometry Effects on Keratometry Readings, Topography Readings, and Corneal Staining|Enrolling by invitation||N/A|60|Actual|Comprehensive EyeCare of Central Ohio||2|||f||||f|f|t|f|f||||||2017-10-10 20:44:06.906703|2017-10-10 20:44:06.906703
NCT03275129|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-05|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|June 1, 2019|Anticipated|2019-06-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Ultrasound Assessment of Heart and Lungs for Hip Fracture Procedure|Pushing the Envelope: Perioperative Cardiorespiratory US for Hip Fractures Procedure|Recruiting||N/A|250|Anticipated|Lawson Health Research Institute||1|||f||||f|f|f||||||||2017-10-10 20:44:06.986092|2017-10-10 20:44:06.986092
NCT03275116|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-09-05|||September 2017|Anticipated|2017-09-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|BOTH||The Effect of Twice Daily vs. Once Daily Bronchodilation on Hyperinflation in COPD Patients During 24 Hours.|The Effect of Twice Daily Aclidinium Bromide/Formoterol Fumarate 340/12 mcg vs. Once Daily Tiotropium 'Respimat' 5mcg on Static and Dynamic Hyperinflation in Patients With COPD During 24 Hours|Not yet recruiting||Phase 4|49|Anticipated|Maastricht University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:44:07.078106|2017-10-10 20:44:07.078106
NCT03275103|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Dose-Escalation Study of BFCR4350A in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)|An Open-Label, Multicenter, Phase I Trial Evaluating the Safety and Pharmacokinetics of Escalating Doses of BFCR4350A in Patients With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1|80|Anticipated|Genentech, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:44:07.199379|2017-10-10 20:44:07.199379
NCT03275090|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||February 1, 2016|Actual|2016-02-01|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis|The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis: a Randomized Controlled Trial|Recruiting||Phase 4|40|Anticipated|Mansoura University Children Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:44:07.337073|2017-10-10 20:44:07.337073
NCT03275077|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-05|||March 12, 2016|Actual|2016-03-12|September 2017|2017-09-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Observational|||To Compare TEG and Conventional Tests in CKD Patients|A Comparative Evaluation of Thromboelastogram and Conventional Coagulation Tests To Detect Coagulopathy in End Stage Renal Disease Patients|Completed||N/A|100|Actual|Institute of Liver and Biliary Sciences, India|||2||f||||||||||||||2017-10-10 20:44:07.470507|2017-10-10 20:44:07.470507
NCT03275064|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-05|||September 6, 2017|Anticipated|2017-09-06|September 2017|2017-09-01|September 28, 2018|Anticipated|2018-09-28|September 28, 2018|Anticipated|2018-09-28||Interventional|||Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions.|A Randomized, Placebo-controlled, Patient and Investigator Blinded, Study Investigating the Safety, Tolerability and Preliminary Efficacy of Intra-articular LNA043 Injections in Regenerating the Articular Cartilage of the Knee in Patients With Articular Cartilage Lesions.|Recruiting||Phase 2|60|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 20:44:07.55088|2017-10-10 20:44:07.55088
NCT03275051|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-05|||October 3, 2017|Anticipated|2017-10-03|September 2017|2017-09-01|May 1, 2026|Anticipated|2026-05-01|May 1, 2026|Anticipated|2026-05-01||Interventional|||Long-term Safety and Efficacy Follow-up of Subjects Treated With GSK2696277 for Transfusion Dependent Beta-thalassemia in San Raffaele Telethon Institute of Gene Therapy-Beta Thalassemia (TIGET-BTHAL) Study|A Long-term Safety and Efficacy follow-on Study in Participants With Transfusion Dependent Beta-thalassemia Who Have Previously Received GSK2696277 (Autologous Hematopoietic Stem Cells Genetically Modified With GLOBE Lentiviral Vector Encoding for the Human Beta-globin Gene) and Completed the TIGET-BTHAL Study|Not yet recruiting||Phase 2|10|Anticipated|GlaxoSmithKline||1|||f||||f|f|f||||||||2017-10-10 20:44:07.637722|2017-10-10 20:44:07.637722
NCT03275038|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-05|||August 31, 2017|Actual|2017-08-31|March 2017|2017-03-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Comparing Effects and Neural Mechanisms of Tai Chi and Light-to-Moderate Intensity Aerobic Exercises|Comparing Effects and Neural Mechanisms of Tai Chi and Light-to-Moderate Intensity on the Prevention of Leukoaraiosis and Declines in Brain, Physical, and Psychological Functions in Middle-aged and Older Adults With Cardiovascular Risks|Recruiting||N/A|120|Anticipated|National Taiwan University Hospital||3|||f|||||f|f||||||||2017-10-10 20:44:07.74151|2017-10-10 20:44:07.74151
NCT03275025|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-04|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||A Phase 2 Study to Evaluate the Safety, Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis|A Multicenter, Randomized, Double-blind, Placebo-controlled, Therapeutic Exploratory, Phase II Clinical Trial for the Efficacy Investigation and Safety Evaluation of YRA-1909 in Patients With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate (MTX) and Who Have an Inadequate Response to MTX (MTX-IR)|Recruiting||Phase 2|200|Anticipated|Yungjin Pharm. Co., Ltd.||4|||f||||f|f|f||||||||2017-10-10 20:44:07.840659|2017-10-10 20:44:07.840659
NCT03275012|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 3, 2019|Anticipated|2019-03-03|March 3, 2018|Anticipated|2018-03-03||Interventional|GABA-2||Efficacy and Safety Study of Gabapentin as add-on to Morphine in Paediatric Patients Affected by Chronic Pain|Randomized, Double-blind, Placebo Controlled, Superiority Phase II Study to Evaluate the Safety, Pharmacokinetic, Efficacy of Gabapentin as add-on to Morphine in Children From 3 Months to Less Than 18 Years|Not yet recruiting||Phase 2|66|Anticipated|Pharmaceutical Research Management srl||2|||f||||t|f|f||||||||2017-10-10 20:44:07.948961|2017-10-10 20:44:07.948961
NCT03274999|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|January 12, 2018|Anticipated|2018-01-12|January 12, 2018|Anticipated|2018-01-12||Interventional|||Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use|Randomized, Controlled, Single-Center, Cross-Over Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use|Not yet recruiting||N/A|35|Anticipated|Allergan||2|||f|||||f|t|f||t|||||2017-10-10 20:44:08.068847|2017-10-10 20:44:08.068847
NCT03274986|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||October 2017||2017-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:44:08.143962|2017-10-10 20:44:08.143962
NCT03274960|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-04|||February 23, 2017|Actual|2017-02-23|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|February 27, 2018|Anticipated|2018-02-27||Interventional|Pretermbirth||Screening and Treating Asymptomatic Bacteriuria Every Trimester and Preterm Birth|The Effect of Screening and Treatment of Asymptomatic Bacteriuria Every Trimester During Pregnancy on Incidence of Preterm Birth in Harare, Zimbabwe|Active, not recruiting||N/A|480|Actual|University of Zimbabwe||2|||f||||t|f|f|||t|||||2017-10-10 20:44:08.250909|2017-10-10 20:44:08.250909
NCT03274947|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-04|||July 2018|Anticipated|2018-07-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||The Utility of Cerebellar Transcranial Magnetic Stimulation in the Neurorehabilitation of Dysphagia After Stroke|An Exploration of the Application of Non-invasive Cerebellar Stimulation in the Neurorehabilitation of Dysphagia After Stroke|Not yet recruiting||N/A|72|Anticipated|University of Manchester||5|||f||||t|f|f|||f|||||2017-10-10 20:44:08.331871|2017-10-10 20:44:08.331871
NCT03274934|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-11|||September 21, 2017|Anticipated|2017-09-21|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 20, 2017|Anticipated|2017-12-20||Interventional|YouthCOMPASS||The Effectiveness of the Mobile-based Youth COMPASS Program to Promote Adolescent Well-being and Life-control|The Effectiveness of the Novel Web- and Mobile-based Acceptance- and Commitment Therapy Program Youth COMPASS to Promote Adolescent Well-being and Life-control|Enrolling by invitation||N/A|240|Anticipated|University of Jyvaskyla||3|||f||||f|f|f||||||||2017-10-10 20:44:08.434666|2017-10-10 20:44:08.434666
NCT03274921|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-04|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|BioClaCK||Biomarkers of Cardiovascular Complications in Chronic Kidney Disease|Identification of BIOmarkers for Detection and Understanding of Cardiovascular Complications in Chronic Kidney Disease|Not yet recruiting||N/A|176|Anticipated|University Hospital, Toulouse|||2||f||||f|f|f||||||||2017-10-10 20:44:08.52944|2017-10-10 20:44:08.52944
NCT03274908|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-10|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2020|Anticipated|2020-12-30|10 Years|Observational [Patient Registry]|||Real-world Clinical Study and Medical Machine Intelligence Study for Traditional Chinese Internal Medicine|Real-world Clinical Study and Medical Machine Intelligence Study for Traditional Chinese Internal Medicine by Using Medical Big Data and Artificial Intelligence Methods|Recruiting||N/A|2000000|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||t|f|f||||||||2017-10-10 20:44:08.626652|2017-10-10 20:44:08.626652
NCT03274895|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||August 13, 2017|Actual|2017-08-13|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Subjects Affected by Acanthamoeba Keratitis|Randomized, Active-Controlled, Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of 0.08% PHMB Ophthalmic Solution in Comparison With 0.02% PHMB + 0.1% Propamidine Combination Therapy in Subjects Affected by Acanthamoeba Keratitis|Recruiting||Phase 3|130|Anticipated|SIFI SpA||2|||f||||f|f|f||||||||2017-10-10 20:44:08.702477|2017-10-10 20:44:08.702477
NCT03274882|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-06|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|December 7, 2017|Anticipated|2017-12-07|December 7, 2017|Anticipated|2017-12-07||Interventional|||Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies|Open-label Multicentre Confirmatory Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Are Refractory or Intolerant to Standard Chemotherapies|Active, not recruiting||Phase 2/Phase 3|26|Actual|Servier||1|||f||||t|t|f|||t|||||2017-10-10 20:44:08.796436|2017-10-10 20:44:08.796436
NCT03274869|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-06|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 30, 2021|Anticipated|2021-08-30|August 30, 2020|Anticipated|2020-08-30||Observational|||Scrub Typhus Infection Induced Cardiovascular Disease|Prediction and Early Diagnosis for Cardiovascular Disease Complicated by Scrub Typhus Infection|Recruiting||N/A|100|Anticipated|Eulji University Hospital|||2||f||||t|f|f||||Samples With DNA|"     To find novel genotypes of Orientia tsutsugamushi isolated from Scrub typhus infection   "|||2017-10-10 20:44:08.874545|2017-10-10 20:44:08.874545
NCT03274856|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-27|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|June 29, 2018|Anticipated|2018-06-29|June 29, 2018|Anticipated|2018-06-29||Interventional|||A Study of GLWL-01 in Patients With Prader-Willi Syndrome|A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome|Not yet recruiting||Phase 2|34|Anticipated|GLWL Research Inc.||2|||f|||||t|f|||t|||||2017-10-10 20:44:08.954599|2017-10-10 20:44:08.954599
NCT03274843|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||January 19, 2016|Actual|2016-01-19|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|EVIC-AVC||Evaluation of the Improvement of Independence by the Resumption of a Significant Activity Such as a Cooking Workshop in Adult Patients With Stroke Benefiting From Traditional Rehabilitation|Evaluation of the Improvement of Independence by the Resumption of a Significant Activity Such as a Cooking Workshop in Adult Patients With Stroke Benefiting From Traditional Rehabilitation|Recruiting||N/A|15|Anticipated|Rennes University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:44:09.028471|2017-10-10 20:44:09.028471
NCT03274830|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-04|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2028|Anticipated|2028-09-01|September 2020|Anticipated|2020-09-01||Observational|||A Post Market Clinical Follow-up Study With the aneXys Cup|A Post Market Clinical Follow-up Study With the aneXys Cup|Not yet recruiting||N/A|150|Anticipated|Mathys Ltd Bettlach|||1||f||||f|f|f||||||||2017-10-10 20:44:09.10125|2017-10-10 20:44:09.10125
NCT03274817|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-19|||July 11, 2017|Actual|2017-07-11|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol|A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol|Recruiting||Phase 1|31|Anticipated|New York University School of Medicine||3|||f||||t|t|f|||f|||||2017-10-10 20:44:09.182263|2017-10-10 20:44:09.182263
NCT03274804|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-04|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|PICCASSO||Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC|A Phase I Trial of Combined PD-1 Inhibition (Pembrolizumab) and CCR5 Inhibition (Maraviroc) for the Treatment of Refractory Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)|Not yet recruiting||Phase 1|20|Anticipated|University Hospital Heidelberg||1|||f||||f|f|f||||||||2017-10-10 20:44:09.278541|2017-10-10 20:44:09.278541
NCT03274791|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-06|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|August 2016|Actual|2016-08-01||Observational|||Clinical Features and Airways Inflammation in Never Smokers and Smokers With COPD|Airway Inflammatory Profile and Clinical Presentation of COPD: A Comparison Between Never Smokers and Smokers|Completed||N/A|68|Actual|Ministry of Scientific Research, Tunisia|||3||f||||t|f|f||||||||2017-10-10 20:44:09.492716|2017-10-10 20:44:09.492716
NCT03274778|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells|An Exploratory proof-of Mechanism Study to Assess the Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells and Additional Immune Subsets in Prostate Cancer Patients|Recruiting||N/A|20|Anticipated|Oncology Institute of Southern Switzerland||1|||f||||f|f|f||||||||2017-10-10 20:44:09.62835|2017-10-10 20:44:09.62835
NCT03274765|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|December 15, 2018|Anticipated|2018-12-15|June 15, 2018|Anticipated|2018-06-15||Observational|NGAMP||Improved Medically Assisted Procreation Monitoring|Improved Medically Assisted Procreation (MAP) Monitoring|Not yet recruiting||N/A|30|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:44:09.729901|2017-10-10 20:44:09.729901
NCT03274739|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||February 2004|Actual|2004-02-01|September 2017|2017-09-01||||December 2012|Actual|2012-12-01||Observational|||Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood|Maternal Mediterranean Diet During Pregnancy in Association to Longitudinal Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood|Completed||N/A|2762|Actual|Centre for Research in Environmental Epidemiology, Spain|||1||f|||||f|f||||||||2017-10-10 20:44:09.946519|2017-10-10 20:44:09.946519
NCT03274726|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||January 1, 1999|Actual|1999-01-01|September 2017|2017-09-01|December 1, 2010|Actual|2010-12-01|December 1, 2010|Actual|2010-12-01||Observational|NHANES||Iron Status of Women and Young Children in the United States|Iron Status of Toddlers, Non-pregnant, and Pregnant Women in the United States|Completed||N/A|5000|Actual|Centers for Disease Control and Prevention|||1||f|||||f|f||||||||2017-10-10 20:44:10.027771|2017-10-10 20:44:10.027771
NCT03274713|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy of Electro-acupuncture Versus Manual Acupuncture on Knee Osteoarthritis|Efficacy of Electro-acupuncture Versus Manual Acupuncture for Knee Osteoarthritis: a Randomized Controlled Pilot Trial|Not yet recruiting||N/A|60|Anticipated|Beijing Hospital of Traditional Chinese Medicine||2|||f||||t|f|f||||||||2017-10-10 20:44:10.114978|2017-10-10 20:44:10.114978
NCT03274700|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms|The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms: A Prospective Randomized Study|Not yet recruiting||Early Phase 1|80|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:44:10.222791|2017-10-10 20:44:10.222791
NCT03274687|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||July 28, 2017|Actual|2017-07-28|September 2017|2017-09-01|July 31, 2026|Anticipated|2026-07-31|July 15, 2021|Anticipated|2021-07-15||Interventional|||Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer|A Randomized Phase III Trial of Hypofractionated Post-prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-prostatectomy Radiation Therapy (COPORT)|Recruiting||N/A|282|Anticipated|NRG Oncology||2|||f||||f|f|f||||||||2017-10-10 20:44:10.316092|2017-10-10 20:44:10.316092
NCT03274674|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|August 30, 2018|Anticipated|2018-08-30|June 24, 2018|Anticipated|2018-06-24||Interventional|||Use of Injectable-platelet-rich-fibrin (I-PRF) to Thicken Gingival Phenotype|New Approach to Increasing Gingival Thickness in Individuals With Fine Gingival Phenotype:Injectable Platelet Rich Fibrin (I-PRF)|Recruiting||N/A|29|Anticipated|Bezmialem Vakif University||2|||f|||||f|f||||||||2017-10-10 20:44:10.519884|2017-10-10 20:44:10.519884
NCT03274661|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|October 15, 2019|Anticipated|2019-10-15|October 15, 2018|Anticipated|2018-10-15||Interventional|||Pembrolizumab Activity in Patients With HR Competent and Deficient Tumors|Evaluating Immune Checkpoint Inhibition In Solid Tumor Patients With Homologous Recombination Repair Deficiency|Not yet recruiting||Phase 2|50|Anticipated|Baptist Health South Florida||1|||f||||t|t|f||||||||2017-10-10 20:44:10.622806|2017-10-10 20:44:10.622806
NCT03274648|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Dietary Interventions and Butyrate Production in Behçet's Patients|Therapeutic Modulation of Butyrate Production in Behçet's Patients: a Dietary Intervention Trial|Not yet recruiting||N/A|30|Anticipated|Azienda Ospedaliero-Universitaria Careggi||3|||f||||f|f|f|||f|||||2017-10-10 20:44:10.719089|2017-10-10 20:44:10.719089
NCT03274635|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Penn State Hershey Sitting and Health Study|Desk-Compatible Elliptical Device: Feasibility Evaluation|Not yet recruiting||N/A|60|Anticipated|Milton S. Hershey Medical Center||6|||f||||f|f|f||||||||2017-10-10 20:44:10.816581|2017-10-10 20:44:10.816581
NCT03274622|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-04|||February 16, 2016|Actual|2016-02-16|September 2017|2017-09-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|IMPACT||Efficacy of IMPACT in Infant Siblings of Children With ASD|Efficacy of Parent-implemented Treatment in Infant Siblings of Children With Autism Spectrum Disorder (ASD)|Recruiting||N/A|120|Anticipated|Vanderbilt University||2|||f||||f|f|f||||||||2017-10-10 20:44:10.894315|2017-10-10 20:44:10.894315
NCT03273504|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||July 14, 2017|Actual|2017-07-14|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy Evaluation of the Activity of a Cosmetic Product (Topical Use) on Hair Regrowth vs Placebo|Efficacy Evaluation of the Activity of a Cosmetic Product (Topical Use) on Hair Regrowth vs Placebo|Active, not recruiting||N/A|24|Actual|Derming SRL||1|||f|||||f|f||||||||2017-10-10 20:44:21.739823|2017-10-10 20:44:21.739823
NCT03274596|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||March 1, 2013|Actual|2013-03-01|September 2017|2017-09-01|December 1, 2015|Actual|2015-12-01|October 1, 2015|Actual|2015-10-01||Interventional|||Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial.|Effect of Vitamin E Supplementation on Oxidative Stress and Retinopathy of Prematurity in Preterm Infants <1500 g: A Randomized Clinical Trial.|Completed||N/A|90|Actual|Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes||2|||f||||t|f|f||||||||2017-10-10 20:44:11.07924|2017-10-10 20:44:11.07924
NCT03274583|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-12|||April 5, 2017|Actual|2017-04-05|September 2017|2017-09-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Observational|MODE-AF||Mobile Phone Detection of Atrial Fibrillation|Mobile Phone Detection of Atrial Fibrillation|Recruiting||N/A|300|Anticipated|University of Turku|||2||f||||f|f|f||||||||2017-10-10 20:44:11.161479|2017-10-10 20:44:11.161479
NCT03274570|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|October 30, 2018|Anticipated|2018-10-30||Observational|||Factors Affecting Hand Dysfunction in Patient With Rheumatoid Arthritis and Its Correlation With Quality of Life|Factors Affecting Hand Dysfunction in Patient With Rheumatoid Arthritis and Its Correlation With Quality of Life|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||Samples Without DNA|"     CBC;ESR,liver function test and kidney function test   "|||2017-10-10 20:44:11.242309|2017-10-10 20:44:11.242309
NCT03274557|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||January 2, 2016|Actual|2016-01-02|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|RFM||Radiofrequence Microtenotomy for Treatment of Achilles Tendinose|Treatment of Achilles Tendinose|Recruiting||N/A|40|Anticipated|University Hospital of North Norway||2|||f||||f|f|f||||||||2017-10-10 20:44:11.314465|2017-10-10 20:44:11.314465
NCT03274544|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF)|The Effectiveness of an Empirical Chinese Medicine Formulation for Idiopathic Pulmonary Fibrosis: an Open Label Clinical Trial|Not yet recruiting||N/A|30|Anticipated|The University of Hong Kong||1|||f||||f|f|f||||||||2017-10-10 20:44:11.399845|2017-10-10 20:44:11.399845
NCT03274531|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-08|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|APOTHECARE||Pharmacists Intervention to Improve Hypertension Management in Primary Care|Pharmacists Intervention to Improve Hypertension Management in Primary Care (APOTHECARE): A Cluster-randomized Trial|Not yet recruiting||N/A|1320|Anticipated|Wilhelminenspital Vienna||2|||f||||f|f|f||||||||2017-10-10 20:44:11.514915|2017-10-10 20:44:11.514915
NCT03274518|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Expanded Hemodialysis Versus Online Hemodiafiltration|Expanded Hemodialysis Versus Online Hemodiafiltration: a Pilot Study on Intradialytic Hemodynamics and Fluid Status|Not yet recruiting||N/A|16|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||||2017-10-10 20:44:11.587658|2017-10-10 20:44:11.587658
NCT03274505|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|SOMN'AIC||Sleep Disorders in Transient Ischemic Attack and Stroke: SOMN'AIC Study|Comparison of the Prevalence of Sleep Disorders in Transient Ischemic Attack and Stroke|Not yet recruiting||N/A|200|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 20:44:11.677604|2017-10-10 20:44:11.677604
NCT03274479|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|November 1, 2018|Anticipated|2018-11-01||Interventional|||PBF-1129 in Patients With NSCLC|Phase I Trial of PBF-1129 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Not yet recruiting||Phase 1|18|Anticipated|Palobiofarma SL||4|||||||f|t|f||||||||2017-10-10 20:44:11.896865|2017-10-10 20:44:11.896865
NCT03274466|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|PROMISES||Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty|Post-market, Randomized, Open-Label, Multicenter, Study to Evaluate the Effectiveness of Closed Incision Negative Pressure Therapy Versus Standard of Care Dressings in Reducing Surgical Site Complications in Subjects With Revision of a Failed Total Knee Arthroplasty (PROMISES)|Not yet recruiting||N/A|440|Anticipated|KCI USA, Inc.||2|||f|||||f|t|f|f|f|||||2017-10-10 20:44:11.976602|2017-10-10 20:44:11.976602
NCT03274453|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-10-03|||November 1, 2012|Actual|2012-11-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|November 1, 2014|Actual|2014-11-01||Interventional|||A Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion|A Prospective, Randomized, Double Blinded Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion|Completed||Phase 2|91|Actual|New York University School of Medicine||2|||f||||f|t|f|||f|||||2017-10-10 20:44:12.069821|2017-10-10 20:44:12.069821
NCT02826746|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-07|||October 2016||2016-10-01|July 2016|2016-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Intravenous Magnesium on Postoperative Sore Throat After Thyroidectomy||Not yet recruiting||N/A|80|Anticipated|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 22:00:53.325183|2017-10-10 22:00:53.325183
NCT03274427|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-14|||July 18, 2017|Actual|2017-07-18|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|TIHCC||Treatment of Intermediate-stage Hepatocellular Carcinoma|The Efficacy and Safety of TACE Combined With Arginine Hydrochloride and Trimetazidine Hydrochloride Tablets in With Hepatocellular Carcinoma. A Multicenter, Open, Randomized, Prospective Study|Recruiting||Phase 3|300|Anticipated|The First Affiliated Hospital of Zhengzhou University||3|||f|||||f|f||||||||2017-10-10 20:44:12.214585|2017-10-10 20:44:12.214585
NCT03274414|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages|A Phase II, Single-Arm Trial Assessing Local Control of Near Total Endoscopic Resection Followed by Concurrent Chemotherapy and Proton Radiation in the Treatment of Unresectable Sinonasal Tumors|Recruiting||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:44:12.327786|2017-10-10 20:44:12.327786
NCT03274401|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-03|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|September 2027|Anticipated|2027-09-01|September 11, 2022|Anticipated|2022-09-11||Interventional|SAFE-PE||Screening for Atrial Fibrillation in Pulmonary Embolism Study -SAFE-PE Study|Screening for Atrial Fibrillation in Pulmonary Embolism Study - SAFE-PE Study|Not yet recruiting||N/A|800|Anticipated|Danderyd Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:12.462382|2017-10-10 20:44:12.462382
NCT03274388|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-04|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Whole Body Electromyostimulation and Nutritional Therapy for Patients With Chronic Liver Disease|Influence of Individualized Nutritional Therapy Combined With Whole Body Electromyostimulation on Patients With Chronic Liver Disease|Recruiting||N/A|50|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f|||||f|f||||||||2017-10-10 20:44:12.555399|2017-10-10 20:44:12.555399
NCT03274375|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-04|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|IANMDAR||Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis|Prospective Assessment of Efficacy of Immunoadsorption Therapy in Managing Childhood NMDA-Receptor (NMDAR) Antibodies Encephalitis|Not yet recruiting||Phase 2|20|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||||2017-10-10 20:44:12.649304|2017-10-10 20:44:12.649304
NCT03274362|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Headspace Mindfulness App Trial|Evaluating the Effectiveness of Headspace Mindfulness Application Versus Standard Care on the HbA1C and Quality of Life in Patients With Diabetes: A Randomized Control Trial|Not yet recruiting||N/A|80|Anticipated|BCDiabetes.Ca||2|||f||||f|f|f||||||||2017-10-10 20:44:12.776289|2017-10-10 20:44:12.776289
NCT03274349|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-04|||March 17, 2017|Actual|2017-03-17|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma|Influence of Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma in Curative and Palliative Treatment|Recruiting||N/A|150|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f|f|f||||||||2017-10-10 20:44:12.873223|2017-10-10 20:44:12.873223
NCT03274336|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-09-04|||June 1, 2015|Actual|2015-06-01|August 2017|2017-08-01|September 30, 2015|Actual|2015-09-30|September 1, 2015|Actual|2015-09-01||Interventional|||Influence of Audiovisual Aids in the Preanesthetic Interview|Influence of Audiovisual Aids in the Preanesthetic Interview: A Comparison of the Effect of Face-to-face-interview Versus a Brochure and Video Assisted Interview|Completed||N/A|1172|Actual|Schulthess Klinik||3|||f||||t|f|f||||||||2017-10-10 20:44:12.952244|2017-10-10 20:44:12.952244
NCT03274323|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|TIPS||Trabeculectomy Versus 2-iStent and Prostaglandin Study|Trabeculectomy Versus 2-iStent and Prostaglandin Study|Not yet recruiting||N/A|20|Anticipated|Johns Hopkins University||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:44:13.018419|2017-10-10 20:44:13.018419
NCT03274310|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||FluSAFE: Flu SMS Alerts to Freeze Exposure|FluSAFE: Flu SMS Alerts to Freeze Exposure|Not yet recruiting||N/A|2140|Anticipated|Columbia University||2|||f||||t|f|f||||||||2017-10-10 20:44:13.09155|2017-10-10 20:44:13.09155
NCT03274297|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-10-03|||September 20, 2017|Actual|2017-09-20|October 2017|2017-10-01|April 26, 2018|Anticipated|2018-04-26|April 26, 2018|Anticipated|2018-04-26||Interventional|||A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA in Healthy Adult Women|A Randomized, Double-blind, 2-Way Crossover Bioequivalence and Adhesion Study of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA® in Healthy Adult Women|Recruiting||Phase 4|68|Anticipated|Janssen Research & Development, LLC||4|||f||||f|f|f||||||||2017-10-10 20:44:15.102976|2017-10-10 20:44:15.102976
NCT03274284|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Chemoradiotherapy for Recurrent T1G3 Bladder Cancer|Chemoradiotherapy for Recurrent T1G3 Bladder Cancer After BCG Failure|Not yet recruiting||Phase 4|20|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:44:15.245697|2017-10-10 20:44:15.245697
NCT03274271|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-03|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Efficacy of Different Behaviour Change Techniques in MyPlan 2.0|A Parallel-group Randomized Trial to Compare the Efficacy of Different Behaviour Change Techniques in the e- and M-health Intervention 'MyPlan 2.0'|Not yet recruiting||N/A|500|Anticipated|University Ghent||8|||f||||f|f|f||||||||2017-10-10 20:44:15.33495|2017-10-10 20:44:15.33495
NCT03274258|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-10-02|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma|Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma|Not yet recruiting||Phase 2|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:44:15.464017|2017-10-10 20:44:15.464017
NCT03274245|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-25|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Evaluating a Latrine Use Intervention in Odisha, India|Implementing and Evaluating a Multi-Level Intervention to Increase Latrine Use and Safe Feces Disposal Among Latrine Owning Households in Rural Puri District, Odisha, India|Not yet recruiting||N/A|16870|Anticipated|Emory University||3|||f||||f|f|f||||||||2017-10-10 20:44:15.567123|2017-10-10 20:44:15.567123
NCT03274232|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||October 27, 2016|Actual|2016-10-27|July 2017|2017-07-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|||Face Photoaging: Efficacy and Tolerance Evaluation of an Intradermal Injective Treatment|Efficacy and Tolerance of an Injectable Medical Device Containing Hyaluronic Acid and Amino Acids: a Monocentric Six-month Open-label Evaluation|Completed||N/A|25|Actual|Derming SRL||1|||f||||f|f|f||||||||2017-10-10 20:44:15.649566|2017-10-10 20:44:15.649566
NCT03274219|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of bb21217 in Multiple Myeloma|A Phase 1 Study of bb21217, an Anti-BCMA CAR T Cell Drug Product, in Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1|50|Anticipated|bluebird bio||1|||f||||f|t|f||||||||2017-10-10 20:44:15.732509|2017-10-10 20:44:15.732509
NCT03274206|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)|A Phase 2b Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)|Recruiting||Phase 2|126|Anticipated|BioLeaders Corporation||2|||f||||f|f|f||||||||2017-10-10 20:44:15.821002|2017-10-10 20:44:15.821002
NCT03274193|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-04|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effects of Yoga Training on Cardiovascular Reactivity to Psychological Stress in Patients With Hypertension|Effects of Yoga Training on Cardiovascular Reactivity to Psychological Stress in Patients With Hypertension|Not yet recruiting||N/A|80|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:15.965|2017-10-10 20:44:15.965
NCT03274180|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-27|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|August 1, 2019|Anticipated|2019-08-01|January 1, 2019|Anticipated|2019-01-01||Interventional|aCTIVE||Non-inferiority Trials of the Quality of Nurse Consultation Versus a Medical Consultation in Travel Medicine.|A Prospective, Single-blind, Randomized Trial, of Non-inferiority of the Quality of Nurse Consultation Versus a Medical Consultation in Travel Medicine|Recruiting||N/A|600|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 20:44:16.142256|2017-10-10 20:44:16.142256
NCT03274167|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy of Gabapentin in Alcohol Dependency Treatment|Efficacy of Gabapentin in Alcohol Dependency Treatment: a Double-blinded Randomized Placebo-controlled Trial|Completed||Phase 3|112|Actual|Chulalongkorn University||2|||f|||||f|f||||||||2017-10-10 20:44:16.233575|2017-10-10 20:44:16.233575
NCT03274154|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||October 11, 2016|Actual|2016-10-11|August 2017|2017-08-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|||Efficacy and Tolerance Evaluation of an Anti-age Food Supplement|Efficacy and Tolerance Evaluation of an Anti-age Food Supplement: a Randomized, Controlled Clinical Study Versus Untreated Group|Completed||N/A|66|Actual|Derming SRL||2|||f||||f|f|f||||||||2017-10-10 20:44:16.32645|2017-10-10 20:44:16.32645
NCT03274141|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-10-03|||October 31, 2011|Actual|2011-10-31|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|ABC||Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC)|The Abatacept Best Care (ABC) Trial|Recruiting||N/A|290|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 20:44:16.407014|2017-10-10 20:44:16.407014
NCT03274128|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-03|||March 1, 2015|Actual|2015-03-01|September 2017|2017-09-01|March 30, 2016|Actual|2016-03-30|April 30, 2015|Actual|2015-04-30||Interventional|||Evaluation of the Effectiveness of Spa Treatment in Swieradow Zdroj With Special Regard to the Action of Radon Waters||Completed||N/A|51|Actual|Wroclaw Medical University||2|||f||||t|f|f||||||||2017-10-10 20:44:16.53097|2017-10-10 20:44:16.53097
NCT03274115|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-03|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 1, 2017|Anticipated|2017-12-01||Interventional|||BLI (Blue Light Imaging) for the Histological Characterization of Colorectal Polyps|BLI (Blue Light Imaging) Application for the Histological Characterization of Colorectal Polyps|Recruiting||N/A|600|Anticipated|Valduce Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:16.635161|2017-10-10 20:44:16.635161
NCT03274102|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-07|||April 22, 2017|Actual|2017-04-22|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines|A Randomized, Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Recombinant Hepatitis B Vaccine/Group A Meningococcal Polysaccharide Vaccine|Recruiting||Phase 4|780|Anticipated|Sinovac Biotech Co., Ltd||3|||f||||f|f|f||||||||2017-10-10 20:44:16.752678|2017-10-10 20:44:16.752678
NCT03274089|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-09|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk|A Randomized Controlled Trial to Evaluate the Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk|Not yet recruiting||N/A|120|Anticipated|SingHealth Polyclinics||2|||f|||||f|f||||||||2017-10-10 20:44:16.886251|2017-10-10 20:44:16.886251
NCT03260998|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-27|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Observational|||ECG Changes in Children and Adolescents With Type 1 Diabetes|ECG Changes in Children and Adolescents With Type 1 Diabetes|Not yet recruiting||N/A|120|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:46:13.040562|2017-10-10 20:46:13.040562
NCT03274050|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-04|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|September 2020|Anticipated|2020-09-01||Observational|PECRoP||To Evaluate the Robotic Surgery in a Dedicated Multidisciplinary Pediatric Program and the Relative Cost of Robotic Surgery|To Evaluate the Clinical Safety, the Efficacy and the Relative Cost of Robotic Surgery|Not yet recruiting||N/A|410|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f|f|f||||||||2017-10-10 20:44:17.211954|2017-10-10 20:44:17.211954
NCT03274037|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-07|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|July 7, 2020|Anticipated|2020-07-07|July 7, 2020|Anticipated|2020-07-07||Interventional|g-BrainMRE||Evaluation of Cerebral Elastography by Magnetic Resonance: Comparison of Healthy Subjects and Patients With Glial Tumor|The Relevance of Cerebral MRI Elastography in the Mechanical Characterization of Glial Tumors|Recruiting||N/A|48|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||||2017-10-10 20:44:17.294325|2017-10-10 20:44:17.294325
NCT03274024|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-05|||September 28, 2016|Actual|2016-09-28|September 2017|2017-09-01|October 30, 2020|Anticipated|2020-10-30|October 30, 2020|Anticipated|2020-10-30||Interventional|TVT||The Asia Primary Tube Versus Trab (TVT) Study|The Asia Primary Tube Versus Trab (TVT) Study|Recruiting||N/A|300|Anticipated|Singapore Eye Research Institute||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:44:17.370492|2017-10-10 20:44:17.370492
NCT03274011|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-09-03|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma|Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: A Phase II, Prospective, Single-arm, Multicenter Trial|Recruiting||Phase 2|40|Anticipated|Fudan University||1|||f|||||f|f||||||||2017-10-10 20:44:17.467244|2017-10-10 20:44:17.467244
NCT03273998|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-09|||April 1, 2018|Anticipated|2018-04-01|September 2017|2017-09-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Observational|coagdef||Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital|Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Children Attending Assiut University Children Hospital ( a One Year Study)|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:44:17.550131|2017-10-10 20:44:17.550131
NCT03273985|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-30|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Interventional|DN-TS||Effectiveness of Dry Needling in Shortened Triceps Surae Muscle|Effectiveness of Deep Dry Needling in Subjects With Shortened Triceps Surae Originated by Myofascial Pain Syndrome|Recruiting||N/A|30|Anticipated|Universidad de León||2|||f||||t|f|f||||||||2017-10-10 20:44:17.609186|2017-10-10 20:44:17.609186
NCT03273972|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-06|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers|INvestigating the Lowest Threshold of Vascular bENefits From LDL Cholesterol Lowering With a PCSK9 mAb InhibiTor (Alirocumab) in healthY Volunteers|Recruiting||N/A|30|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:44:17.690382|2017-10-10 20:44:17.690382
NCT03273959|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|March 28, 2019|Anticipated|2019-03-28|August 28, 2018|Anticipated|2018-08-28||Interventional|||Program Of Exercises During The Hospitalization Of Children And Adolescents With Cystic Fibrosis|Effects Of An Exercise Program During The Hospitalization Of Children And Adolescents With Cystic Fibrosis: Randomized Clinical Test|Recruiting||N/A|50|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f|||||f|f||||||||2017-10-10 20:44:17.834324|2017-10-10 20:44:17.834324
NCT03273946|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||November 16, 2017|Anticipated|2017-11-16|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years|Post-Marketing Observational Study to Evaluate Safety Profile of Flixotide 50 μg pMDI Treatment in Chinese Subjects With Asthma Aged 1-<4 Years|Not yet recruiting||N/A|150|Anticipated|GlaxoSmithKline|||1||f||||f|t|f||||||||2017-10-10 20:44:17.938277|2017-10-10 20:44:17.938277
NCT03273933|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DragONE||DragONE Study: Acquisition and Maintenance of Paediatric Asthma Control: Usual Care vs Innovative Devices|DragONE Study: Acquisition and Maintenance of Paediatric Asthma Control: Usual Care vs Innovative Devices|Not yet recruiting||Phase 4|20|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy||2|||f||||f|f|f||||||||2017-10-10 20:44:18.141094|2017-10-10 20:44:18.141094
NCT03273920|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-05|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|September 25, 2022|Anticipated|2022-09-25|September 25, 2019|Anticipated|2019-09-25||Interventional|||Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer|Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer: a Multicenter Randomized Controlled Trial|Not yet recruiting||N/A|1110|Anticipated|Southwest Hospital, China||2|||f||||t|f|f||||||||2017-10-10 20:44:18.243453|2017-10-10 20:44:18.243453
NCT03273907|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|||Post Approval Study of the CyPass System|Post Approval Study of the CyPass System in Patients With Primary Open Angle Glaucoma Undergoing Cataract Surgery|Not yet recruiting||N/A|640|Anticipated|Alcon Research||1|||f|||||f|t|f||f|||||2017-10-10 20:44:18.509008|2017-10-10 20:44:18.509008
NCT03273894|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-06|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Observational|Peritemp||Perioperative Management of Temperature in Children and Influence of Hypothermia on Blood Clotting in Children.|Perioperative Management of Temperature in Children and Influence of Hypothermia on Blood Clotting in Children.|Recruiting||N/A|240|Anticipated|Brno University Hospital|||1||f||||t|f|f||||Samples With DNA|"     Blood samples will be tested for coagulation abnormalities - routine coagulation tests and     ROTEM   "|||2017-10-10 20:44:18.612785|2017-10-10 20:44:18.612785
NCT03273881|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Intrapartum Glucose and Insulin Compared to Glucose Alone in Diabetic Women|Effect of Intrapartum Glucose With Compared to Without Constant Intravenous Insulin on Neonatal Hypoglycemia Among Diabetic Women. A Randomized Controlled Trial|Not yet recruiting||N/A|200|Anticipated|HaEmek Medical Center, Israel||2|||f||||t|f|f||||||||2017-10-10 20:44:18.727608|2017-10-10 20:44:18.727608
NCT03273868|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-02|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Effect of Thoracic Spinal Manipulation on Autonomic Nervous System|The Effect of Thoracic Spinal Manipulation on Autonomic Nervous System and Its Relation to Experimental Pain on Healthy Subjects: a Randomized, Crossover, Sham Controlled Trial|Not yet recruiting||N/A|50|Anticipated|Institut Franco Europeen de Chiropratique||2|||f|||||f|f||||||||2017-10-10 20:44:18.871502|2017-10-10 20:44:18.871502
NCT03273855|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||February 1, 2018|Anticipated|2018-02-01|August 2017|2017-08-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|RCTFMTobesity||Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity|Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity|Not yet recruiting||N/A|60|Anticipated|University Hospital of North Norway||2|||f||||f|f|f||||||||2017-10-10 20:44:18.968159|2017-10-10 20:44:18.968159
NCT03273842|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-27|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 9, 2018|Anticipated|2018-06-09|June 9, 2018|Anticipated|2018-06-09||Interventional|||A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers|Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (sc) Doses Of The Proposed Pegfilgrastim Biosimilar (Pf-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers|Not yet recruiting||Phase 1|420|Anticipated|Pfizer||2|||f|||||t|f||||||||2017-10-10 20:44:19.086063|2017-10-10 20:44:19.086063
NCT03273816|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-04|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|SOPHROSTIM||Evaluation of the Benefit Provided by Sessions of Sophrology on the Per Operative Management of Parkinsonian Patients Planned for a Deep Brain Stimulation Surgery.|Evaluation of the Benefit Provided by Sessions of Sophrology on the Intraoperative Management of Parkinsonian Patients in the Context of Deep Brain Stimulation Surgery.|Not yet recruiting||N/A|56|Anticipated|Rennes University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:19.188852|2017-10-10 20:44:19.188852
NCT03273803|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-05|||August 24, 2016|Actual|2016-08-24|September 2017|2017-09-01|June 8, 2017|Actual|2017-06-08|October 31, 2016|Actual|2016-10-31||Observational|||Cardiac Auscultation Using Smartphones|Cardiac Auscultation Using Smartphones: a Proof-of-concept Study|Completed||N/A|46|Actual|Seoul National University Hospital|||1||f|||||f|f||||||||2017-10-10 20:44:19.324948|2017-10-10 20:44:19.324948
NCT03273790|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-05|2017-09-05|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|June 29, 2018|Anticipated|2018-06-29|June 29, 2018|Anticipated|2018-06-29||Observational|||A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan|Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients - Retrospective Study of Japanese Real-World Data Through Clinical Chart Review|Recruiting||N/A|1000|Anticipated|Bristol-Myers Squibb|||1||f||||f||f||||||||2017-10-10 20:44:19.455641|2017-10-10 20:44:19.455641
NCT03273777|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-04|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Skin Incision Skewness at Cesarean Section|Comparison of Skin Incision Skewness With or Without Previous Measurement and Drawing of the Incision Line at Cesarean Section - a Randomized Controlled Trial|Not yet recruiting||N/A|86|Anticipated|Medical University of Vienna||2|||f||||f|f|f||||||||2017-10-10 20:44:19.573606|2017-10-10 20:44:19.573606
NCT03273764|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-10|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|December 23, 2016|Actual|2016-12-23|September 30, 2016|Actual|2016-09-30||Observational|||Clinical RD (Respiratory Distress) Score for Objective Decision Making for Surfactant Therapy|Development And Validation Of A Clinical RD Score For Decision Making For Administration Of Surfactant In Preterm Babies With RDS (Respiratory Distress Syndrome) - A Prospective Observational Study|Completed||N/A|209|Actual|Lady Hardinge Medical College|||1||f||||t||||||||||2017-10-10 20:44:19.656519|2017-10-10 20:44:19.656519
NCT03273751|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy|The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy : A Randomized Controlled Trial|Not yet recruiting||N/A|86|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:19.742172|2017-10-10 20:44:19.742172
NCT03273738|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-06|||October 10, 2017|Anticipated|2017-10-10|September 2017|2017-09-01|November 15, 2018|Anticipated|2018-11-15|October 10, 2018|Anticipated|2018-10-10||Observational|||Vascular and Metabolic Changes in Postmenopausal Diabetics|Assessment of Vascular and Metabolic Changes in Post-menopausal Women With Type 2 Diabetes Mellitus|Not yet recruiting||N/A|100|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:44:19.872734|2017-10-10 20:44:19.872734
NCT03273725|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-09-01|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Maternal Vitamin D Levels in Pregnancy and Dental Caries in Children|The TRIP-Tooth Study: Maternal Pre- and Postnatal Vitamin D Levels and Dental Caries in Children 7-9 Years of Age.|Completed||N/A|178|Actual|Tannhelsetjenestens Kompetansesenter Midt-Norge|||1||f||||f||||||Samples Without DNA|"     Saliva samples   "|||2017-10-10 20:44:19.981054|2017-10-10 20:44:19.981054
NCT03273712|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-10-01|||September 29, 2017|Actual|2017-09-29|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)|Phase II, Dosimetry Guided, Peptide Receptor Radiotherapy (PRRT) Using 90Y-DOTA tyr3-Octreotide (90Y-DOTATOC) in Children and Adults With Neuroendocrine and Other Somatostatin Receptor Positive Tumors|Recruiting||Phase 2|20|Anticipated|University of Iowa||1|||f||||t|t|f||||||||2017-10-10 20:44:20.089774|2017-10-10 20:44:20.089774
NCT03260985|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-23|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Precision Psychiatry Continuity Clinic Project|Precision Psychiatry Continuity Clinic Project|Enrolling by invitation||N/A|75|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 20:46:13.110973|2017-10-10 20:46:13.110973
NCT03273699|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-05|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Mindfulness Meditation Utilizing an EEG Biofeedback Device for the Treatment for Obsessive Compulsive Disorder|Evaluating the Use of Mindfulness Meditation Utilizing a Consumer-Grade EEG Biofeedback Device for Patients Awaiting Treatment for Obsessive Compulsive Disorder|Recruiting||N/A|100|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|f|f||||||||2017-10-10 20:44:20.216454|2017-10-10 20:44:20.216454
NCT03273686|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|April 15, 2018|Anticipated|2018-04-15|January 15, 2018|Anticipated|2018-01-15||Interventional|||Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy|Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy: a Randomized Clinical Trial|Not yet recruiting||Phase 3|100|Anticipated|Fudan University||2|||f|||||f|f||||||||2017-10-10 20:44:20.330689|2017-10-10 20:44:20.330689
NCT03273673|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-04|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 31, 2020|Anticipated|2020-01-31|October 1, 2018|Anticipated|2018-10-01||Interventional|||Reduction of Risk Factors for ACL Re-injuries Using a Novel Biofeedback Approach|Reduction of Risk Factors for ACL Re-injuries Using an Innovative Biofeedback Approach|Enrolling by invitation||N/A|40|Anticipated|Virginia Polytechnic Institute and State University||2|||f||||t|f|f||||||||2017-10-10 20:44:20.427004|2017-10-10 20:44:20.427004
NCT03273660|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)|Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)|Active, not recruiting||N/A|22|Actual|Derming SRL||1|||f|||||f|f||||||||2017-10-10 20:44:20.520794|2017-10-10 20:44:20.520794
NCT03273647|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 15, 2024|Anticipated|2024-09-15|September 15, 2019|Anticipated|2019-09-15||Interventional|||Adjuvant Radiotherapy for T3N0M0 Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin|Adjuvant Radiotherapy for T3N0M0 Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin(a Randomized Controlled Trial)|Not yet recruiting||Phase 2|240|Anticipated|Fudan University||2|||f|||||f|f||||||||2017-10-10 20:44:20.609472|2017-10-10 20:44:20.609472
NCT03273634|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-05|||May 20, 2017|Actual|2017-05-20|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||The Effect of Proton Pump Inhibition on Palpitations|The Effect of Proton Pump Inhibition on Palpitations With no Apparent Cause. A Double Blinded Randomized Placebo Controlled Trial|Recruiting||Phase 4|150|Anticipated|Jordan Collaborating Cardiology Group||2|||f||||f|f|f||||||||2017-10-10 20:44:20.698209|2017-10-10 20:44:20.698209
NCT03273621|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-04|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Bariatric Surgery and Epicardial Adipose Tissue: a MRI Study|Effetti di Differenti Tipologie di Intervento di Chirurgia Bariatrica Sul Tessuto Adiposo Epicardico e su Alcuni Parametri Morfologici e Funzionali Cardiovascolari, Valutati Con Risonanza Magnetica Nucleare|Recruiting||N/A|28|Anticipated|IRCCS Policlinico S. Donato|||1||f||||f|f|f||||||||2017-10-10 20:44:20.81932|2017-10-10 20:44:20.81932
NCT03273608|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-04|||September 14, 2016|Actual|2016-09-14|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30|12 Months|Observational [Patient Registry]|||Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients|Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients: Safety & Efficacy Registry in Taiwan (SUPER- Taiwan)|Recruiting||N/A|120|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||f||||||||||2017-10-10 20:44:20.921644|2017-10-10 20:44:20.921644
NCT03273595|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-04|||July 2016||2016-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer|A Prospective, Open-label，Multicentre，Real-word Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy as Neoadjuvant Therapy for Women With HER2-positive and p95HER2-positive，PI3K Mutation，or PTEN Loss Breast Cancer|Recruiting||Phase 2|100|Anticipated|Xijing Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:21.023402|2017-10-10 20:44:21.023402
NCT03273569|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-09-04|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|March 30, 2018|Anticipated|2018-03-30||Interventional|PDIUC||PDIUC Protocol for Placental Accreta|Preplacental Delivery Intervention for Uterine Conservation Protocol: a Novel Approach for Management of Placenta Accreta|Not yet recruiting||N/A|30|Anticipated|Assiut University||1|||f||||t|f|f||||||||2017-10-10 20:44:21.14444|2017-10-10 20:44:21.14444
NCT03273556|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||April 28, 2017|Actual|2017-04-28|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%|Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%: Comparison Within Subjects (Half Face Method)|Completed||N/A|27|Actual|Derming SRL||1|||f|||||f|f||||||||2017-10-10 20:44:21.238255|2017-10-10 20:44:21.238255
NCT03273543|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Perioral Rejuvenation and Upper Lip Enhancement|Premaxillary Injection for Perioral Rejuvenation and Upper Lip Enhancement|Not yet recruiting||Phase 4|20|Anticipated|DeNova Research||2|||f|||||f|t|t|f|t|||||2017-10-10 20:44:21.468125|2017-10-10 20:44:21.468125
NCT03273530|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-05|||February 1, 2013|Actual|2013-02-01|September 2017|2017-09-01|December 20, 2015|Actual|2015-12-20|August 15, 2015|Actual|2015-08-15||Interventional|||Integrated Supported Employment in Mainland China|Integrated Supported Employment for People With Schizophrenia in Mainland China: A Randomized Controlled Trial|Completed||N/A|162|Actual|The Hong Kong Polytechnic University||3|||f|||||f|f||||||||2017-10-10 20:44:21.542369|2017-10-10 20:44:21.542369
NCT03273517|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-02|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|November 1, 2017|Anticipated|2017-11-01|September 1, 2017|Actual|2017-09-01||Observational|||Caregivers and Resident Doctors' Perceptions of Preoperative Fasting in Children|Caregivers and Resident Doctors' Perceptions of Preoperative Fasting in Children|Recruiting||N/A|120|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo|||1||f||||t|f|f||||||||2017-10-10 20:44:21.632898|2017-10-10 20:44:21.632898
NCT02806453|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-19|||July 2016||2016-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Magnesium Alginate on Gastroesophageal Reflux in Infants.||Not yet recruiting||Phase 4|99|Anticipated|Policlinico Hospital||2|||f||||||||||||||2017-10-10 22:04:26.32279|2017-10-10 22:04:26.32279
NCT03273491|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|May 2018|Anticipated|2018-05-01||Interventional|SWEMA||Self-Weighing: an Ecological Momentary Assessment|Self-weighing's Psychological Effects: a Randomized Controlled Trial Using Ecological Momentary Assessment|Recruiting||N/A|50|Anticipated|University of Delaware||2|||f||||f|f|f||||||||2017-10-10 20:44:21.827974|2017-10-10 20:44:21.827974
NCT03273478|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-31|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Observational|pToWin2||pCONUS2 Treatment of Wide Neck Intracranial Aneurysms 2|pCONUS2 Treatment of Wide Neck Intracranial Aneurysms 2|Not yet recruiting||N/A|100|Anticipated|Phenox GmbH|||1||f||||t|f|f||||||||2017-10-10 20:44:21.940521|2017-10-10 20:44:21.940521
NCT03273465|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Fecal Microbiota Transplantation in Ulcerative Colitis|Fecal Microbiota Transplantation in Newly Diagnosed Patients With Ulcerative Colitis - a Double Blind, Placebo-Controlled Trial|Recruiting||Phase 2|100|Anticipated|Assaf-Harofeh Medical Center||2|||f|||||f|f||||||||2017-10-10 20:44:22.053034|2017-10-10 20:44:22.053034
NCT03273452|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-20|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|PET||Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone, Etoposide and Thalidomide)|Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma, a Multicentric, Single Arm, Open Label Phase II Clinical Trial|Recruiting||Phase 2|30|Anticipated|Qingdao University||1|||f|||||f|f||||||||2017-10-10 20:44:22.186298|2017-10-10 20:44:22.186298
NCT03273439|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-05|||July 1, 2012|Actual|2012-07-01|September 2017|2017-09-01|June 30, 2015|Actual|2015-06-30|February 1, 2014|Actual|2014-02-01||Interventional|||A Study of rTMS for Cognitive Deficits in Chronic Patients With Schizophrenia|A Randomized, Double-blind Study of Repetitive Transcranial Magnetic Stimulation for Cognitive Deficits in Chronic Patients With Schizophrenia in a Chinese Han Population|Completed||N/A|47|Actual|Suzhou Psychiatric Hospital||2|||f||||t|f|f||||||||2017-10-10 20:44:22.312189|2017-10-10 20:44:22.312189
NCT03273426|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||September 8, 2016|Actual|2016-09-08|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.|Prediction of Pathologic Complete Response by Multiple Core Needle Biopsy or Vacuum Assisted Biopsy Before Surgery in Breast Cancer With Complete Clinical Response After Neoadjuvant Chemotherapy.|Recruiting||N/A|40|Anticipated|Seoul National University Hospital||1|||f|||||f|t|f||t|||||2017-10-10 20:44:22.425434|2017-10-10 20:44:22.425434
NCT03273413|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Statin Therapy in Patients With Early Stage ADPKD|Statin Therapy in Patients With Early Stage ADPKD|Recruiting||Phase 4|200|Anticipated|University of Colorado, Denver||2|||f||||t|t|f|||f|||||2017-10-10 20:44:22.539494|2017-10-10 20:44:22.539494
NCT03273387|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-03|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|June 1, 2018|Anticipated|2018-06-01||Interventional|TRIMETA-PH||The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension in National Cardiovascular Center Harapan Kita Hospital|The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension Patients in National Cardiovascular Center Harapan Kita Hospital Indonesia|Recruiting||Phase 2/Phase 3|25|Anticipated|Indonesia University||2|||f||||t|f|f||||||||2017-10-10 20:44:23.381232|2017-10-10 20:44:23.381232
NCT03273374|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-06|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Intraoperative Radiation Therapy for Resectable Pancreatic Cancer|A Prospective, Phase II Study Investigating Efficacy of Intraoperative Radiation Therapy for Resectable Pancreatic Cancer|Recruiting||Phase 2|42|Anticipated|Gangnam Severance Hospital||1|||f||||t|f|f||||||||2017-10-10 20:44:23.520131|2017-10-10 20:44:23.520131
NCT03273361|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-05|||August 1, 2016|Actual|2016-08-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Desk Cycling Work Performance Evaluation|Desk-Compatible Elliptical Device: Feasibility Evaluation|Active, not recruiting||N/A|96|Actual|Milton S. Hershey Medical Center||3|||f||||f|f|f||||||||2017-10-10 20:44:23.621599|2017-10-10 20:44:23.621599
NCT03273348|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-02|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|October 28, 2019|Anticipated|2019-10-28|September 28, 2019|Anticipated|2019-09-28||Interventional|||Role of Oncoplastic Breast Surgery In Breast Cancer Treatement|Role of Oncoplastic Breast Surgery In Breast Cancer Treatement|Not yet recruiting||N/A|30|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:44:23.715077|2017-10-10 20:44:23.715077
NCT03273335|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-25|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|August 3, 2022|Anticipated|2022-08-03|August 3, 2022|Anticipated|2022-08-03||Observational|INTUIT||Investigating NeuroinflammaTion UnderlyIng Postoperative Brain Connectivity Changes, POCD, Delirium in Older Adults|Investigating NeuroinflammaTion UnderlyIng Postoperative Brain Connectivity Changes, POCD, Delirium in Older Adults|Recruiting||N/A|200|Anticipated|Duke University|||1||f||||t|f|t|f||f|Samples With DNA|"     CSF, Blood/Serum   "|||2017-10-10 20:44:23.821505|2017-10-10 20:44:23.821505
NCT03273322|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-19|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|December 23, 2018|Anticipated|2018-12-23|September 23, 2018|Anticipated|2018-09-23||Interventional|ADRIFT||Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure|Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure: The Randomized ADRIFT Study|Recruiting||Phase 2/Phase 3|90|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t|f|f||||||||2017-10-10 20:44:23.933414|2017-10-10 20:44:23.933414
NCT03258775|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|August 1, 2016|Actual|2016-08-01|June 1, 2016|Actual|2016-06-01||Interventional|||Water Consumption, Hydration and Resting Energy Expenditure|Water Consumption, Hydration and Resting Energy Expenditure|Completed||N/A|16|Actual|George Mason University||2|||f||||f|f|f||||||||2017-10-10 20:46:32.606658|2017-10-10 20:46:32.606658
NCT03273296|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-04|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Antibiotics on Gut Microbiome and Plasma Metabolome|Effect of Antibiotics on Gut Microbiome and Plasma Metabolome|Not yet recruiting||Phase 4|36|Anticipated|National Institute for Health and Welfare, Finland||3|||f||||f|f|f|||f|||||2017-10-10 20:44:24.163218|2017-10-10 20:44:24.163218
NCT03273283|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||June 1, 2016|Actual|2016-06-01|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|February 28, 2018|Anticipated|2018-02-28||Interventional|PPAU||Feasibility and Effectiveness of a Specialized Brief Intervention for Hazardous Drinkers in an Emergency Department.|Prevenció Dels Problemes Relacionats Amb Alcohol a urgències.|Active, not recruiting||N/A|200|Actual|Hospital Clinic of Barcelona||2|||f||||t|f|f||||||||2017-10-10 20:44:24.287513|2017-10-10 20:44:24.287513
NCT03273270|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-02|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|TMS/FOG||Effects of Neuromodulation and Rehabilitation of the Locomotor Network in Freezing of Gait|Effects of Neuromodulation and Rehabilitation of the Locomotor Network in Freezing of Gait|Recruiting||N/A|15|Anticipated|Medical University of South Carolina||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:44:24.377772|2017-10-10 20:44:24.377772
NCT03273257|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-04|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|July 2019|Anticipated|2019-07-01||Interventional|||Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)|A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multicentre, Prospective Study to Assess Efficacy of Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy With High Preoperative Pulmonary Vascular Resistance|Not yet recruiting||Phase 2|80|Anticipated|International CTEPH Association||2|||f||||t|t|f||||||||2017-10-10 20:44:24.49426|2017-10-10 20:44:24.49426
NCT03273244|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-07|||May 12, 2017|Actual|2017-05-12|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|COMPAS||Measuring Comfort During Palliative Sedation|Towards a Better Understanding of What Palliative Sedated Patients Experience: Linking Numbers to Experiences|Recruiting||N/A|40|Anticipated|Vrije Universiteit Brussel|||1||f||||f|f|f||||||||2017-10-10 20:44:24.619466|2017-10-10 20:44:24.619466
NCT03273231|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer Resection|The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer Resection|Recruiting||N/A|100|Anticipated|Yonsei University||2|||f||||f|f|f||||||||2017-10-10 20:44:24.705182|2017-10-10 20:44:24.705182
NCT03273218|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-09-05|||December 2015||2015-12-01|August 2017|2017-08-01|July 20, 2016|Actual|2016-07-20|July 20, 2016|Actual|2016-07-20||Interventional|TICKET||Effectiveness of the Tiger Catheter on Transradial Coronariography: Randomized Compared to JudKins cathETers|Effectiveness of the Tiger Catheter as a Simple Multipurpuse Catheter in Transradial Coronariography: Randomized Comparerd to Judkins Catheters|Completed||N/A|120|Actual|Hospital San Roque||2|||f||||t|f|t|f||t|||||2017-10-10 20:44:24.797948|2017-10-10 20:44:24.797948
NCT03273205|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-02|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|SANO||Transcranial Direct Current Stimulation (tDCS) in the Treatment of Anorexia Nervosa|The Changes in the Body-perception and Perception of the Pain in Patients With Anorexia Nervosa Before and After Using the tDCS|Recruiting||N/A|40|Anticipated|Charles University, Czech Republic||2|||f||||f|f|f||||||||2017-10-10 20:44:24.906538|2017-10-10 20:44:24.906538
NCT03273192|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-03|||April 22, 2017|Actual|2017-04-22|September 2017|2017-09-01|August 6, 2017|Actual|2017-08-06|August 6, 2017|Actual|2017-08-06||Interventional|||A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects|A Randomised, Double-blind, Single-dose, Parallel-group Study in Healthy Subjects to Demonstrate Pharmacokinetic Equivalence of CinnoRA® (Produced by CinnaGen CO.) and Humira® (the Reference Drug, Produced by AbbVie Inc.)|Completed||Phase 1|74|Actual|Cinnagen||2|||f||||f|f|f||||||||2017-10-10 20:44:25.010027|2017-10-10 20:44:25.010027
NCT03273179|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-03|2017-09-03|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales|Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment|Not yet recruiting||N/A|100|Anticipated|Capital Medical University|||1||f|||||f|f||||||||2017-10-10 20:44:25.105409|2017-10-10 20:44:25.105409
NCT03273166|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||August 29, 2017||2017-08-29||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:44:25.165271|2017-10-10 20:44:25.165271
NCT03273153|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-26|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|October 30, 2024|Anticipated|2024-10-30|October 30, 2024|Anticipated|2024-10-30||Interventional|||A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma|A Phase III, Open-Label, Multicenter, Two Arm, Randomized Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Patients With Previously Untreated Advanced BRAF V600 Wild-Type Melanoma|Not yet recruiting||Phase 3|450|Anticipated|Hoffmann-La Roche||2|||f||||t|t|f||||||||2017-10-10 20:44:25.227356|2017-10-10 20:44:25.227356
NCT03273140|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-09-06|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||The Effectiveness of Gamification Diabetes Education Program for Poorly Controlled Type 2 Diabetic Patients|The Effectiveness of Gamification Diabetes Education Program for Poorly Controlled Type 2 Diabetic Patients: A Randomised Controlled Trial.|Recruiting||N/A|148|Anticipated|National Healthcare Group, Singapore||2|||f||||t|f|f||||||||2017-10-10 20:44:25.683459|2017-10-10 20:44:25.683459
NCT02679820|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-08|||January 2016||2016-01-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||PostPlacental IUD Insertion||Recruiting||N/A|100|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||t||||||||Undecided||2017-10-10 22:28:47.287598|2017-10-10 22:28:47.287598
NCT03273127|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-13|||September 26, 2017|Anticipated|2017-09-26|September 2017|2017-09-01|November 24, 2017|Anticipated|2017-11-24|November 24, 2017|Anticipated|2017-11-24||Interventional|||To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids|A Phase 1, Randomized, Single-Blind, Placebo Controlled Study to Assess Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids|Not yet recruiting||Phase 1|12|Anticipated|AstraZeneca||2|||f||||f|f|f||||||||2017-10-10 20:44:25.792922|2017-10-10 20:44:25.792922
NCT03273114|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-10-01|||September 6, 2017|Actual|2017-09-06|October 2017|2017-10-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|||Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain|Cognitive Functional Therapy (CFT) Compared With a Combined Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Non-specific Chronic Low Back Pain: a Randomized Controlled Trial|Recruiting||N/A|148|Anticipated|Centro Universitário Augusto Motta||2|||f||||f|f|f||||||||2017-10-10 20:44:25.913157|2017-10-10 20:44:25.913157
NCT03273101|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Interventional|||Sit-to-stand Training in Stroke Patient|Does Repetitive, Assistive Sit-to-stand Training Facilitate the Independence in Sit-to-stand? A Randomized Controlled Trial|Completed||N/A|38|Actual|Tai Po Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:26.048405|2017-10-10 20:44:26.048405
NCT03273088|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-06|||December 4, 2016|Actual|2016-12-04|September 2017|2017-09-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects|A Randomised, Two-period, Two-sequence, Single-dose and Cross-over Study in Healthy Subjects to Demonstrate Pharmacokinetic Equivalence of Altebrel (Produced by Aryogen Pharmed) and Humira® (the Reference Drug, Produced by Amgen Company)|Completed||Phase 1|34|Actual|AryoGen Pharmed Co.||2|||f||||f|f|f||||||||2017-10-10 20:44:26.125445|2017-10-10 20:44:26.125445
NCT03273075|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|May 2021|Anticipated|2021-05-01||Interventional|||Add-on Cangrelor in STEMI-triggered Cardiac Arrest|Pharmacokinetic/Pharmacodynamic Effects of add-on Antiplatelet Therapy With Parenteral Cangrelor as Compared to Standard Dual Antiplatelet Treatment in Patients With ST-elevation Myocardial Infarction Complicated by Out-of-hospital Cardiac Arrest and Treated With Targeted Temperature Management|Recruiting||Phase 4|60|Anticipated|Medical University of Vienna||4|||f||||f|f|f|||f|||||2017-10-10 20:44:26.238137|2017-10-10 20:44:26.238137
NCT03273062|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|July 20, 2018|Anticipated|2018-07-20|July 20, 2018|Anticipated|2018-07-20||Interventional|||A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury|A Double-blind, Placebo-controlled Clinical Trial to Evaluate the Effects of Catechol-O-Methyltransferase (COMT) Inhibition on Cognition and Neuropsychiatric Symptoms in Patients With a History of Acquired Brain Injuries|Recruiting||Phase 2|16|Anticipated|Sheppard Pratt Health System||2|||f||||t|t|f|||t|||||2017-10-10 20:44:26.353605|2017-10-10 20:44:26.353605
NCT03273049|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||July 21, 2016|Actual|2016-07-21|September 2017|2017-09-01|July 21, 2022|Anticipated|2022-07-21|December 21, 2021|Anticipated|2021-12-21||Observational|BA||Mapping Disease Pathways for Biliary Atresia|Coordinating Center- Mapping Disease Pathways for Biliary Atresia|Recruiting||N/A|1100|Anticipated|University of Pittsburgh|||1||f||||t|f|f||||Samples With DNA|"     Samples with DNA: blood, saliva or liver tissue.   "|||2017-10-10 20:44:26.457521|2017-10-10 20:44:26.457521
NCT03273036|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||May 1, 2014|Actual|2014-05-01|September 2017|2017-09-01|May 1, 2015|Actual|2015-05-01|May 1, 2015|Actual|2015-05-01||Interventional|||Perioperative Outcome of Corticosteroids in Transforaminal Endoscopic Lumbar Discectomy|Comparison of Perioperative Outcome Between Corticosteroids and Placebo in Transforaminal Endoscopic Lumbar Discectomy. A Single-center Randomized Placebo-controlled Trial.|Completed||Phase 4|30|Actual|Ramathibodi Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:44:26.537152|2017-10-10 20:44:26.537152
NCT03273023|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2019|Anticipated|2019-12-31|5 Years|Observational [Patient Registry]|||PROMUS PREMIER™ China Post-Approval Study|PROMUS PREMIER China Registry Study|Not yet recruiting||N/A|2000|Anticipated|Boston Scientific Corporation|||1||f||||f|f|t|f|f|t|||||2017-10-10 20:44:26.612924|2017-10-10 20:44:26.612924
NCT03273010|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-01|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Use of Cyanoacrylate on Palatal Wound|The Efficacy of Cyanoacrylate on Palatal Wound Healing and Postoperative Complaints|Completed||N/A|35|Actual|T.C. ORDU ÜNİVERSİTESİ||2|||f|||||f|f|||f|||||2017-10-10 20:44:26.672085|2017-10-10 20:44:26.672085
NCT03272997|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-01|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|||The Value of PET-CT in Pleural Effusions|The Diagnostic Power of 18F-FDG PET-CT Scanning for Discriminating Malignant From Non-malignant Causes in Unilateral Pleural Effusions|Not yet recruiting||N/A|200|Anticipated|Naestved Hospital|||1||f||||f|f|f||||||||2017-10-10 20:44:26.749135|2017-10-10 20:44:26.749135
NCT03272984|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-04|2017-09-05|||April 1, 2015|Actual|2015-04-01|September 2017|2017-09-01|July 6, 2017|Actual|2017-07-06|June 5, 2017|Actual|2017-06-05||Interventional|ERASNAC||ERAS for Patients Received Neoadjuvant Chemotherapy|Enhanced Recovery After Surgery Programs for Patients Received Neoadjuvant Chemotherapy With Locally Advanced Gastric Cancer: a Randomized Controlled Clinical Trial|Completed||N/A|114|Actual|Jinling Hospital, China||2|||f||||t|f|f||||||||2017-10-10 20:44:26.821881|2017-10-10 20:44:26.821881
NCT03272971|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-03|||September 27, 2017|Anticipated|2017-09-27|September 2017|2017-09-01|March 5, 2018|Anticipated|2018-03-05|November 30, 2017|Anticipated|2017-11-30||Interventional|||Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors|Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors|Not yet recruiting||N/A|10|Anticipated|Broncus Medical Inc||1|||f||||f|f|t|f||t|||||2017-10-10 20:44:26.89989|2017-10-10 20:44:26.89989
NCT03272958|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-03|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|PRURIPB||Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid|Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid|Not yet recruiting||N/A|50|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 20:44:27.003155|2017-10-10 20:44:27.003155
NCT03272945|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-10-04|||September 6, 2017|Actual|2017-09-06|October 2017|2017-10-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Linked-color Imaging for the Detection of Colorectal Flat Lesions|Linked-color Imaging Versus White Light for the Detection of Colorectal Flat Lesions: a Randomized, Controlled Trial|Recruiting||N/A|286|Anticipated|Showa Inan General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:27.085162|2017-10-10 20:44:27.085162
NCT03272932|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-10-03|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|September 15, 2021|Anticipated|2021-09-15|September 15, 2021|Anticipated|2021-09-15||Observational|||Clinical Characteristics of Asthma and COPD Overlap for Patients With Asthma and COPD in Hong Kong|A Cross-sectional Study to Assess the Proportion and Clinical Characteristics of Asthma and COPD Overlap for Patients With Asthma and COPD in Hong Kong.|Recruiting||N/A|1600|Anticipated|Chinese University of Hong Kong|||1||f||||f|f|f||||Samples With DNA|"     Blood will be stored for future genetic studies. As there is currently no good biomarker or     genetic tests that can identify the cause or suggest the diagnosis of Asthma COPD overlap,     this study would like to explore into this.   "|||2017-10-10 20:44:27.188684|2017-10-10 20:44:27.188684
NCT03272919|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-10-04|||September 28, 2017|Actual|2017-09-28|October 2017|2017-10-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||Chemotherapy Induced Peripheral Neuropathy (CIPN)|Chemotherapy Induced Peripheral Neuropathy (CIPN): A Pilot Study of Intraneural Facilitation for Managing Chemotherapy-Induced Peripheral Neuropathy|Recruiting||N/A|40|Anticipated|Loma Linda University||2|||f||||f|f|f||||||||2017-10-10 20:44:27.296009|2017-10-10 20:44:27.296009
NCT03272906|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-11|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Clinical Feasibility of Transcranial Direct Current Stimulation [tDCS] With Standard Aphasia Therapy|Clinical Feasibility of Transcranial Direct Current Stimulation [tDCS] With Standard Aphasia Therapy|Enrolling by invitation||N/A|20|Anticipated|Louisiana State University and A&M College||2|||f||||f|f|t|t|||||||2017-10-10 20:44:27.411037|2017-10-10 20:44:27.411037
NCT03272893|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-01|||December 6, 2016|Actual|2016-12-06|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Biomarkers in Pain and Pain Treatment|The Effect of Inflammation on Psychological Comorbidity and Behavioral Treatment in Chronic Pain|Enrolling by invitation||N/A|150|Anticipated|Karolinska Institutet|||1||f||||f|f|f||||Samples With DNA|"     plasma, whole blood   "|||2017-10-10 20:44:27.53466|2017-10-10 20:44:27.53466
NCT03272880|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers|Utilizing the Arts to Improve Health, Resilience, and Well-Being in Individuals With Cancer and Their Caregivers: A Feasibility Study|Not yet recruiting||N/A|20|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|f|f||||||||2017-10-10 20:44:27.624031|2017-10-10 20:44:27.624031
NCT03272867|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-02|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|PromAge||Effect of an Anti-ageing Supplement on Oxidative Stress|"Cross-over Randomized Placebo-controlled Pilot Study to Determine the Effect in Healthy Elderly Volunteers of the Anti-ageing Supplement Promanna™ on a Number of Biomarkers Associated With DNA-damage and Oxidative Stress (PromAge)"|Completed||N/A|20|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-10-10 20:44:27.715168|2017-10-10 20:44:27.715168
NCT03272854|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-02|||August 2001|Actual|2001-08-01|September 2017|2017-09-01|August 2031|Anticipated|2031-08-01|July 2003|Actual|2003-07-01|30 Years|Observational [Patient Registry]|TxL-IRI||TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study|TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study|Active, not recruiting||N/A|606|Actual|University Medical Center Groningen|||1||f||||f|f|f||||Samples Without DNA|"     EDTA plasma, serum, aliquots of 24h urine collections all stored at -80 degrees Centigrade.   "|||2017-10-10 20:44:27.807016|2017-10-10 20:44:27.807016
NCT03272841|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-02|||June 2015||2015-06-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|September 2020|Anticipated|2020-09-01|30 Years|Observational [Patient Registry]|||TransplantLines: the Transplantation Biobank|TransplantLines: the Transplantation Biobank|Active, not recruiting||N/A|3000|Anticipated|University Medical Center Groningen|||1||f||||t||||||Samples With DNA|"     1x serum      1x EDTA      1x Lithium-heparine      1x Citrate      1x PAXgene Faeces, hair and nails   "|||2017-10-10 20:44:27.951041|2017-10-10 20:44:27.951041
NCT03272828|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-02|||June 15, 2012|Actual|2012-06-15|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Implant Overdenture Study|A Prospective Randomized Study on the Immediate Loading of Mandibular Overdentures Supported by Parallel Sided or Tapered Dental Titanium Implants|Recruiting||N/A|50|Anticipated|University of Washington||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:44:28.039936|2017-10-10 20:44:28.039936
NCT03272815|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-02|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|December 30, 2019|Anticipated|2019-12-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Percussion Device (PD) for Detection of Pneumothorax|Evaluation of a Novel Point-of-care Percussion Device (PD) for Detection of Pneumothorax in Patients Following Thoracic Surgery|Not yet recruiting||N/A|150|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:44:28.169118|2017-10-10 20:44:28.169118
NCT03272802|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-02|2017-09-09|||September 16, 2017|Anticipated|2017-09-16|September 2017|2017-09-01|March 16, 2019|Anticipated|2019-03-16|March 16, 2019|Anticipated|2019-03-16||Interventional|||Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)|Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS) in a Representative Iranian Population|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Isfahan University of Medical Sciences||2|||f|||||f|f||||||||2017-10-10 20:44:28.269327|2017-10-10 20:44:28.269327
NCT03272789|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-06|||July 12, 2017|Actual|2017-07-12|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|REBOND||Onco-coaching of Sport-inspired for the Social, Professional and Psychological Restoring of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells|Onco-coaching of Sport-inspired for the Social, Professional and Psychological Restoring of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells: Pilot Study|Recruiting||N/A|32|Anticipated|Institut Paoli-Calmettes||1|||f||||f|f|f||||||||2017-10-10 20:44:28.38603|2017-10-10 20:44:28.38603
NCT03272776|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-01|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Multicenter Study of the Protector Laryngeal Mask|A Multicenter Study of the Protector Laryngeal Mask in Non Paralyzed, Anesthetized Patients|Recruiting||N/A|250|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||f|f|f||||||||2017-10-10 20:44:28.50233|2017-10-10 20:44:28.50233
NCT03272763|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-24|||October 2, 2017||2017-10-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:44:28.616029|2017-10-10 20:44:28.616029
NCT03272750|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||November 4, 2016|Actual|2016-11-04|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Evaluation of Tolerance and Trichological Efficacy of a Food Supplement|Controlled, Randomized, Double Blind Study, for the Evaluation of Tolerance and Trichological Efficacy of a Food Supplement: Bioscalin® New Formulation Versus Reference Formulation Currently on the Market and Placebo|Completed||N/A|51|Actual|Derming SRL||3|||f|||||f|f||||||||2017-10-10 20:44:28.6634|2017-10-10 20:44:28.6634
NCT03272737|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-21|||July 4, 2017|Actual|2017-07-04|June 2017|2017-06-01|March 4, 2019|Anticipated|2019-03-04|December 4, 2018|Anticipated|2018-12-04||Interventional|||Low Intensity Training Combined With KAATSU on Muscle Vasodilatation and Arterial Stiffness in the Elderly Population|Effect of Low Intensity Strength Training Combined With Moderate Blood Flow Restriction on Muscle Vasodilatation and Arterial Stiffness in Elders With Low Gait Velocity.|Recruiting||N/A|26|Anticipated|Hospital Israelita Albert Einstein||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:44:28.756815|2017-10-10 20:44:28.756815
NCT03272724|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-06|||January 1, 1991|Actual|1991-01-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|ObservatoireEI||French National Observatory on Infective Endocarditis|French National Observatory on Infective Endocarditis|Recruiting||N/A|2000|Anticipated|Central Hospital, Nancy, France|||1||f||||f|f|f||||Samples Without DNA|"     serum, plasma   "|||2017-10-10 20:44:28.921318|2017-10-10 20:44:28.921318
NCT03272711|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-08|||August 31, 2016|Actual|2016-08-31|September 2017|2017-09-01|July 15, 2019|Anticipated|2019-07-15|January 15, 2019|Anticipated|2019-01-15||Interventional|BBS||Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training|Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training|Recruiting||Phase 4|130|Anticipated|Washington University School of Medicine||2|||f|||||t|f|||f|||||2017-10-10 20:44:29.001829|2017-10-10 20:44:29.001829
NCT03272685|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-01|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace|"Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace Part of Evaluating New Nicotine Standards for Cigarettes"|Not yet recruiting||Phase 3|700|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f|||f|||||2017-10-10 20:44:29.208742|2017-10-10 20:44:29.208742
NCT03272672|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Effects of a Valgus Unloader Brace on Medial Femoral Cartilage|Effects of a Valgus Unloader Brace on Medial Femoral Cartilage Changes Following Walking Protocol|Recruiting||N/A|30|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 20:44:29.302109|2017-10-10 20:44:29.302109
NCT03272659|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-01|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|December 1, 2017|Anticipated|2017-12-01||Interventional|PDD||The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics|The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics (PDD): a Clinical Pilot Study|Not yet recruiting||Phase 2|5|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||1|||f|||||t|f||||||||2017-10-10 20:44:29.396686|2017-10-10 20:44:29.396686
NCT03272646|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||January 1, 2000|Actual|2000-01-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|December 31, 2015|Actual|2015-12-31|17 Years|Observational [Patient Registry]|NPS||Prognostic Performance of the Naples Prognostic Score|The Naples Prognostic Score in Gastric Cancer Patients Undergoing Surgery|Completed||N/A|477|Actual|"University of Campania Luigi Vanvitelli"|||3||f||||t|f|f||||||||2017-10-10 20:44:30.244481|2017-10-10 20:44:30.244481
NCT03272633|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-14|||November 5, 2017|Anticipated|2017-11-05|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies|Post-Transplant Use of Irradiated Haplo-Allogeneic Cells|Not yet recruiting||Phase 2|40|Anticipated|Rutgers, The State University of New Jersey||2|||||||t|t|f||||||||2017-10-10 20:44:30.326357|2017-10-10 20:44:30.326357
NCT03272620|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-01|||October 22, 2014|Actual|2014-10-22|September 2017|2017-09-01|January 1, 2030|Anticipated|2030-01-01|January 1, 2020|Anticipated|2020-01-01|10 Years|Observational [Patient Registry]|||Atrial Fibrillation at the Viennese University Emergency Department|Atrial Fibrillation Registry at the Emergency Department of the Medical University of Vienna: A Tool for Structured Diagnosis and Treatment|Recruiting||N/A|3000|Anticipated|Medical University of Vienna|||1||f|||||f|f||||||||2017-10-10 20:44:30.434669|2017-10-10 20:44:30.434669
NCT03272607|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention|Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention|Recruiting||N/A|8400|Anticipated|McGill University Health Center||2|||f||||t|f|f||||||||2017-10-10 20:44:30.6761|2017-10-10 20:44:30.6761
NCT03124693|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-08|2017-05-08||August 12, 2008|Actual|2008-08-12|May 2017|2017-05-01|September 9, 2008|Actual|2008-09-09|September 9, 2008|Actual|2008-09-09||Interventional|||Accuracy of Noninvasive Hemoglobin Measurement (SpHb) Using Rainbow DCI Pulse Oximeter Sensor||Completed||N/A|90|Actual|Masimo Corporation||1|||f||||f|f|t|f|||||No||2017-10-10 21:08:43.629169|2017-10-10 21:08:43.629169
NCT03272594|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|August 2018|Anticipated|2018-08-01||Interventional|iCAP||The Influence of Breastfeeding on Cortical Activity During Procedures|The Influence of Breastfeeding on Pain-specific Event-related Potentials and Bio-behavioural Indicators of Procedural Pain in Newborns: A Randomized Controlled Trial|Not yet recruiting||Phase 3|126|Anticipated|IWK Health Centre||2|||f||||t|f|f|||f|||||2017-10-10 20:44:30.810664|2017-10-10 20:44:30.810664
NCT03272581|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-01|||August 27, 2013|Actual|2013-08-27|September 2017|2017-09-01|March 17, 2015|Actual|2015-03-17|January 29, 2014|Actual|2014-01-29||Interventional|||The Purpose of This Study Was to Determine Whether or Not Functional Training Has Similar Effects on Muscular Strength, Flexibility, Agility, Speed and Anthropometric Measures in Basketball Players as Traditional Resistance Training|The Effects of Functional Training on Performance Related Physical Fitness Parameters in Professional Basketball Players|Completed||N/A|28|Actual|Hasan Kalyoncu University||2|||f||||t|f|f||||||||2017-10-10 20:44:30.924198|2017-10-10 20:44:30.924198
NCT03272568|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||September 18, 2017|Anticipated|2017-09-18|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|July 31, 2019|Anticipated|2019-07-31||Interventional|||Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers|A Feasibility Trial Using Extended Half Life Factor Products in the Reduction of Menstrual Bleeding in Symptomatic Hemophilia A and B Carriers|Recruiting||Early Phase 1|16|Anticipated|Emory University||2|||f||||t|t|t|t|f|f|||||2017-10-10 20:44:31.024805|2017-10-10 20:44:31.024805
NCT03272555|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||September 5, 2017|Anticipated|2017-09-05|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|October 10, 2017|Anticipated|2017-10-10||Interventional|||WILD 5 Wellness: A 30-Day Intervention|WILD 5 Wellness: A 30-Day Intervention|Enrolling by invitation||N/A|17|Anticipated|Beloit College||1|||f|||||f|f||||||||2017-10-10 20:44:31.156535|2017-10-10 20:44:31.156535
NCT03272542|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|PRIME||PRebiotic to IMprovE Calcium Absorption|Prebiotic Intervention to Improve Calcium Absorption After Gastric Bypass Surgery|Not yet recruiting||Phase 2|20|Anticipated|San Francisco Veterans Affairs Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:44:31.246317|2017-10-10 20:44:31.246317
NCT03272529|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-10-05|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|January 31, 2021|Anticipated|2021-01-31|October 31, 2020|Anticipated|2020-10-31||Observational|PCNL||Simulated Rehearsal for Percutaneous Nephrolithotomy|Comparative Effectiveness of Patient-Specific Simulated Rehearsal for Percutaneous Nephrolithotomy (PCNL)|Not yet recruiting||N/A|114|Anticipated|University of Rochester|||3||f||||f|f|f||||||||2017-10-10 20:44:31.361842|2017-10-10 20:44:31.361842
NCT03272516|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-17|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|October 10, 2019|Anticipated|2019-10-10|October 10, 2019|Anticipated|2019-10-10||Interventional|||Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients|Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients With Mild to Moderate Symptoms of Depression or Anxiety|Recruiting||N/A|165|Anticipated|University of Iceland||2|||f||||f|f|f||||||||2017-10-10 20:44:31.46233|2017-10-10 20:44:31.46233
NCT03272503|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15||Interventional|Pimozide2||A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Phase II Randomized, Placebo-Controlled, Double Blinded, Multi-Centre Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis|Not yet recruiting||Phase 2|100|Anticipated|University of Calgary||2|||f||||t|f|f||||||||2017-10-10 20:44:31.638512|2017-10-10 20:44:31.638512
NCT03272490|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||February 5, 2014|Actual|2014-02-05|September 2017|2017-09-01|July 1, 2017|Actual|2017-07-01|June 6, 2017|Actual|2017-06-06||Interventional|||Polyaxial Locking Plates in Treating Distal Humeral Fractures|Polyaxial Locking Plates in Treating Distal Humeral Fractures: a Comparative Randomized Trial for Clinical Outcome|Completed||N/A|20|Actual|Technische Universität München||2|||f||||f|f|f||||||||2017-10-10 20:44:31.75045|2017-10-10 20:44:31.75045
NCT03272477|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-19|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|November 15, 2024|Anticipated|2024-11-15|March 15, 2020|Anticipated|2020-03-15||Interventional|TP-II||Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients|A Prospective, Randomized, Multicenter, Open-label Comparison of Pre-surgical Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy Given for Twelve Weeks With a Quality of Life Assessment of Trastuzumab, Pertuzumab in Combination With Standard (Neo)Adjuvant Treatment in Patients With Operable HER2+/HR+ Breast Cancer.|Recruiting||Phase 2|259|Anticipated|Palleos Healthcare GmbH||2|||f||||t|f|f||||||||2017-10-10 20:44:31.847456|2017-10-10 20:44:31.847456
NCT03272464|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 30, 2023|Anticipated|2023-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Phase I Study of INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.|Phase I Study of INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.|Not yet recruiting||Phase 1|38|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f|||f|||||2017-10-10 20:44:32.086789|2017-10-10 20:44:32.086789
NCT03272451|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-07|||February 10, 2017|Actual|2017-02-10|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||ECG-guided Immediate Primary PCI for Culprit Vessel to Reduce Door to Device Time|ECG-guided Immediate pRimAry Percutaneous Coronary Intervention for Culprit Vessel Using a Transradial Single Guiding Catheter to Reduce Door to Device Time: RAPID II Study|Recruiting||N/A|386|Anticipated|Beijing Luhe Hospital||2|||f||||t|f|f||||||||2017-10-10 20:44:32.217891|2017-10-10 20:44:32.217891
NCT03272438|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Schedule Intervention to Increase Sustainable Walking Activity in Midlife Working Adults|Using a Schedule Intervention to Increase Sustainable Walking Activity in Midlife|Not yet recruiting||N/A|108|Anticipated|Brandeis University||3|||f||||t|f|f||||||||2017-10-10 20:44:32.319148|2017-10-10 20:44:32.319148
NCT03272074|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-31|||September 11, 2015|Actual|2015-09-11|August 2017|2017-08-01|August 5, 2017|Actual|2017-08-05|September 7, 2016|Actual|2016-09-07||Interventional|||Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes|Egg Consumption Positively Affects Glycemic Control and Insulin Sensitivity in Individuals With Pre- and Type II-diabetes|Completed||N/A|42|Actual|Florida State University||2|||f||||t|f|f||||||||2017-10-10 20:44:36.319764|2017-10-10 20:44:36.319764
NCT03272425|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-05|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|November 20, 2017|Anticipated|2017-11-20|October 4, 2017|Anticipated|2017-10-04||Interventional|||Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.|A Randomized, Open-label, Replicate, Crossover, 4-period Study to Assess the Bioequivalence of Lesinurad/Allopurinol Fixed-dose Combination 200/300 mg Tablets From Ardea Biosciences, Inc. (Test Drug) Versus Lesinurad, 200 mg Tablet From AstraZeneca (Comparator 1) Coadministered With Zyloric®, Allopurinol 300 mg Tablet From Aspen Pharma Industria Farmaceutica Ltda. (Comparator 2) in Healthy Female and Male Adult Subjects, Under Fasting Conditions.|Enrolling by invitation||Phase 1|32|Anticipated|Ardea Biosciences, Inc.||4|||f||||f|f|f||||||||2017-10-10 20:44:32.415591|2017-10-10 20:44:32.415591
NCT03272412|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-26|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Serum Progesterone on the Day of Embryo Transfer and Pregnancy Rate.|Impact of Serum Progesterone Levels on the Day of Embryo Transfer in Artificial Endometrial Preparation Cycles on the Ongoing Pregnancy Rate.|Recruiting||N/A|1197|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA|||1||f||||f|f|f||||Samples Without DNA|"     Serum   "|||2017-10-10 20:44:32.504251|2017-10-10 20:44:32.504251
NCT03272399|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-30|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Nutrition for Post-Traumatic Headache|Targeted Alteration in Omega-3 and Omega-6 Fatty Acids for Post-traumatic Headache (Nutrition for PTH)|Recruiting||Phase 2|300|Anticipated|Uniformed Services University of the Health Sciences||2|||f||||t|f|f||||||||2017-10-10 20:44:32.582715|2017-10-10 20:44:32.582715
NCT03272386|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-12|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|September 29, 2017|Anticipated|2017-09-29|September 18, 2017|Anticipated|2017-09-18||Observational|||Best Verbal Instruction to Obtain Voluntary Pelvic Floor Muscle Contraction|Verbal Instruction to Obtain Voluntary Pelvic Floor Muscle Contraction: Acceptability, Understanding and Best Instruction|Recruiting||N/A|33|Anticipated|Pierre and Marie Curie University|||1||f||||f|f|f||||||||2017-10-10 20:44:32.70518|2017-10-10 20:44:32.70518
NCT03272373|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|April 2021|Anticipated|2021-04-01|November 2019|Anticipated|2019-11-01||Interventional|||NexGen TM Tibia Clinical Outcomes Study|NexGen TM Tibia Clinical Outcomes Study|Recruiting||N/A|132|Anticipated|Zimmer Biomet||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:44:32.797093|2017-10-10 20:44:32.797093
NCT03272360|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-08-31|||September 2016||2016-09-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|EMBARK||Endometriosis Biomarker Discovery Study|A Prospective Sample Collection Study in Patients With Pelvic Pain Undergoing Laparoscopy for Biomarker Identification in Endometriosis|Withdrawn||N/A|0|Actual|Myriad Genetic Laboratories, Inc.|||2|company decision to suspend project|f||||||||||Samples Without DNA|"     Serum, plasma, whole blood, urine, and endometrial tissue   "|||2017-10-10 20:44:32.890371|2017-10-10 20:44:32.890371
NCT03272347|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-07|||November 13, 2017|Anticipated|2017-11-13|September 2017|2017-09-01|September 29, 2020|Anticipated|2020-09-29|April 9, 2019|Anticipated|2019-04-09||Interventional|DRIVE2Simplify||MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)|A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults|Not yet recruiting||Phase 2|120|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||t|t|f||||||||2017-10-10 20:44:32.957125|2017-10-10 20:44:32.957125
NCT03272334|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-31|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|September 30, 2027|Anticipated|2027-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|Breast-47||Her2-BATS and Pembrolizumab in Metastatic Breast Cancer|A Phase I/II Study of Anti-CD3 x Anti-HER2/Neu (Her2Bi) Armed Activated T Cells (ATC) and Pembrolizumab Combination Therapy in Women With Metastatic Breast Cancer|Not yet recruiting||Phase 1/Phase 2|33|Anticipated|University of Virginia||3|||f||||t|t|f||||||||2017-10-10 20:44:33.061208|2017-10-10 20:44:33.061208
NCT03272321|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-31|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Influence of Oxytocin on Neurophysiological Responses to Live Faces|Influence of Oxytocin on Neurophysiological Responses to Direct and Averted Gaze|Recruiting||Phase 1/Phase 2|50|Anticipated|Katholieke Universiteit Leuven||2|||f||||f|f|f||||||||2017-10-10 20:44:33.15751|2017-10-10 20:44:33.15751
NCT03272308|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||August 8, 2017||2017-08-08||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:44:33.243256|2017-10-10 20:44:33.243256
NCT03272295|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-31|||September 12, 2017|Anticipated|2017-09-12|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients|A Randomised, Controlled, Double-Blind Study to Examine Nicotine Pharmacokinetics and Smoking Behaviour in Healthy Smokers When Smoking Cigarettes Containing Different Commonly Used Ingredients|Not yet recruiting||N/A|48|Anticipated|British American Tobacco (Investments) Limited||2|||f||||f|f|f||||||||2017-10-10 20:44:33.283138|2017-10-10 20:44:33.283138
NCT03272282|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-01|||January 12, 2017|Actual|2017-01-12|September 2017|2017-09-01|September 12, 2017|Anticipated|2017-09-12|September 12, 2017|Anticipated|2017-09-12||Observational|labourRecord||Paperless Parotograph in Evaluation of Labour|Paperless Partograph Evaluation of Labour|Recruiting||N/A|450|Anticipated|Assiut University|||1||f||||f|f|f||||Samples Without DNA|"     By fellowing women during labour when cervical dilation reach 4cm in active phase of labour     all women with inclusion criteria are recorded all women with exclusion criteria are excluded   "|||2017-10-10 20:44:33.392381|2017-10-10 20:44:33.392381
NCT03272269|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes|A Phase I Placebo-controlled, Double-blind, Dose Escalation Clinical Trial to Evaluate the Safety and Immune Responses of Imcyse's IMCY-0098 in Patients With Recent Onset Type 1 Diabetes|Recruiting||Phase 1|40|Anticipated|Imcyse SA||3|||f||||t|f|f||||||||2017-10-10 20:44:33.482687|2017-10-10 20:44:33.482687
NCT03257501|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-01|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||FreeStyle Libre Flash Accuracy Study|FreeStyle Libre Flash Glucose Monitoring System Accuracy Study|Recruiting||N/A|150|Anticipated|Abbott Diabetes Care|||1||f||||f|f|t|t|f|f|||||2017-10-10 20:46:41.759993|2017-10-10 20:46:41.759993
NCT03272256|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase 1 Study of IM156 in Patients With Advanced Solid Tumor|A Single Center, Open-label, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IM156 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|ImmunoMet Therapeutics, Inc.||1|||f||||t|f|f||||||||2017-10-10 20:44:33.639408|2017-10-10 20:44:33.639408
NCT03272243|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||February 1, 2012|Actual|2012-02-01|September 2017|2017-09-01|November 30, 2016|Actual|2016-11-30|February 28, 2016|Actual|2016-02-28||Interventional|||Short Segment vs Long Segment Fixation in Traumatic Dorsolumbar Spine Fractures|Short Segment Posterior Fixation With Index Level Screws Versus Long Segment Posterior Fixation for Thoracolumbar Spine Fracture: Angle of Correction and Pain|Completed||N/A|91|Actual|Ain Shams University||2|||f||||f|f|f||||||||2017-10-10 20:44:33.70867|2017-10-10 20:44:33.70867
NCT03272230|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-08|||September 6, 2017|Actual|2017-09-06|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|ECOCAPTURE||Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System|Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System in Healthy Subject and Patient With Cerebral Disease|Recruiting||N/A|120|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||4|||f||||f|f|f||||||||2017-10-10 20:44:33.768122|2017-10-10 20:44:33.768122
NCT03272217|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-20|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Atezolizumab With or Without Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer|A Randomized Phase II Trial of Atezolizumab With or Without Bevacizumab in Cisplatin-ineligible Patients With Advanced/Unresectable Urothelial Cancer: Hoosier Cancer Research Network GU15-215|Not yet recruiting||Phase 2|118|Anticipated|Hoosier Cancer Research Network||2|||f||||t|t|f|||t|||||2017-10-10 20:44:33.883939|2017-10-10 20:44:33.883939
NCT03272204|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-01|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Pubic Hair and the Urinary and Vaginal Microbiome|Effects of Pubic Hair Grooming on Urinary and Vaginal Microbiome|Not yet recruiting||N/A|60|Anticipated|Northwestern University||2|||f||||f|f|f||||||||2017-10-10 20:44:33.963467|2017-10-10 20:44:33.963467
NCT03272191|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-08-31|||September 2016||2016-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study to Assess Safety & Effects of Autologous ADSCs During Recovery Phase of ST-Elevation MI Effects of Autologous ADSC Implantation During Subacute Recovery Phase of ST-Elevation Myocardial Infarction|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Cardiovascular Effects of Autologous ADSC Implantation by a Catheter Delivery System In Patients During the Subacute Recovery Phase of ST-Elevation MI|Withdrawn||N/A|0|Actual|Ageless Regenerative Institute||1||company dissolved|f||||f||||||||||2017-10-10 20:44:34.022391|2017-10-10 20:44:34.022391
NCT03272178|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Observational|||Impact of Component Design and Fixation in Total Knee Arthroplasty|Impact of Component Design and Fixation in Bone Remodeling After Total Knee Arthroplasty|Not yet recruiting||N/A|100|Anticipated|Washington University School of Medicine|||2||f||||f|f|t|f|f|f|||||2017-10-10 20:44:34.079272|2017-10-10 20:44:34.079272
NCT03272165|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-01|||November 2, 2017|Anticipated|2017-11-02|August 2017|2017-08-01|October 18, 2018|Anticipated|2018-10-18|October 18, 2018|Anticipated|2018-10-18||Interventional|||Single Ascending Dose Study of MEDI1341 in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of MEDI1341 in Healthy Male and Female Volunteers|Not yet recruiting||Phase 1|40|Anticipated|AstraZeneca||2|||f||||f|t|f|||f|||||2017-10-10 20:44:34.155268|2017-10-10 20:44:34.155268
NCT03272152|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30|3 Months|Observational [Patient Registry]|||Comprehensive DNA Methylation Profiling in Crohn's Disease|Comprehensive DNA Methylation Profiling of Inflammatory and Non-Inflammatory Mucosa in Crohn's Disease|Recruiting||N/A|14|Anticipated|Jinling Hospital, China|||3||f|||||f|f||||Samples With DNA|"     inflamed and non-inflamed ileal mucosa of patients with Crohn's disease and normal ileal     mucosa of healthy controls   "|||2017-10-10 20:44:34.23649|2017-10-10 20:44:34.23649
NCT03272139|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|STB||Interscalene Block Versus Superior Trunk Block|Interscalene Block Versus Superior Trunk Block: A Randomized Controlled Clinical Trial|Enrolling by invitation||Phase 4|126|Actual|Hospital for Special Surgery, New York||2|||f|||||t|f||||||||2017-10-10 20:44:35.90011|2017-10-10 20:44:35.90011
NCT03272126|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-01|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Importance of Dosing Regimen for the Effect of Vitamin D Supplementation|Importance of Dosing Regimen for the Effect of Vitamin D Supplementation|Not yet recruiting||Phase 3|60|Anticipated|University of Tromso||3|||f||||f|f|f||||||||2017-10-10 20:44:35.992563|2017-10-10 20:44:35.992563
NCT03272113|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|August 2018|Anticipated|2018-08-01||Interventional|SKIP-IT||SKIP-IT Smoking Cessation in Pregnancy|Promoting Smoking Cessation During Pregnancy: a Combined Feasibility and Pilot Trial of a Theory-based Intervention Using Narrative, Images and Embedded Behaviour Change Techniques, Delivered Via Text-messaging|Not yet recruiting||N/A|70|Anticipated|University of Stirling||2|||f||||f|f|f||||||||2017-10-10 20:44:36.080284|2017-10-10 20:44:36.080284
NCT03272100|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-01|||April 1, 2013|Actual|2013-04-01|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Observational|||Influence of Two Different Flap Designs for Sinus Floor Elevation|Influence of Two Different Flap Designs for Sinus Floor Elevation. A Split-mouth Randomised Controlled Clinical Trial|Completed||N/A|16|Actual|University of Firenze and Siena, Napoli, Italy|||2||f||||t|f|f||||||||2017-10-10 20:44:36.15091|2017-10-10 20:44:36.15091
NCT03272087|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-01|||May 2015||2015-05-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|REPEAT||Rational Approach to a Unilateral Pleural Effusion|Rational Approach to Unilateral Pleural Effusion in Patients Suspected of Malignancy. Efficacy, Pain, Quality of Life, and Economy|Recruiting||N/A|120|Anticipated|Naestved Hospital||2|||f||||t||||||||||2017-10-10 20:44:36.233135|2017-10-10 20:44:36.233135
NCT03272061|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Exercise and Brain Vascular Function|The Effects of Aerobic-based Exercise on Brain Vascular Function in Elderly Men|Not yet recruiting||N/A|17|Anticipated|Maastricht University Medical Center||2|||f|||||f|f||||||||2017-10-10 20:44:36.405015|2017-10-10 20:44:36.405015
NCT03272048|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-06|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Identifying Effective Approaches to Counseling on Firearm Safety|Identifying Effective Approaches to Counseling on Firearm Safety: A Randomized Experimental Design Among Firearm-familiar Individuals at Risk for Suicide|Recruiting||N/A|180|Anticipated|Florida State University||4|||f||||f|f|f||||||||2017-10-10 20:44:36.508934|2017-10-10 20:44:36.508934
NCT03272035|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-01|||September 18, 2017|Anticipated|2017-09-18|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|REGIDAQ||General Practitioners' Felt With Their Patients' Death (REGIDAQ)|General Practitioners' Felt With Their Patients' Death (REGIDAQ)|Not yet recruiting||N/A|590|Anticipated|University Hospital, Limoges|||1||f||||f|f|f||||||||2017-10-10 20:44:36.591647|2017-10-10 20:44:36.591647
NCT03272022|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-01|||December 14, 2011|Actual|2011-12-14|September 2017|2017-09-01|February 8, 2025|Anticipated|2025-02-08|February 8, 2025|Anticipated|2025-02-08||Observational|||Micronutrient Status During Pregnancy|Micronutrient Status in Pregnant and Lactating Women and Their Infants|Active, not recruiting||N/A|272|Actual|Haukeland University Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Serum and plasma from never-pregnant, pregnant and lactating women and infants aged six     months   "|||2017-10-10 20:44:36.651835|2017-10-10 20:44:36.651835
NCT03272009|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects|A Randomized, Double-blind, Placebo-controlled Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the FXR-agonist EYP001a in Chronically HBV Infected Subjects|Not yet recruiting||Phase 1|72|Anticipated|Enyo Pharma||9|||f||||t|f|f||||||||2017-10-10 20:44:36.83475|2017-10-10 20:44:36.83475
NCT03271996|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-01|||April 2012||2012-04-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Fistulectomy vs. Modified Karydakis Procedure for Pilonidal Sinus|Two Surgical Techniques for the Treatment of Pilinidal Sinus: A Randomized Controlled Trial|Terminated||N/A|60|Actual|Ente Ospedaliero Cantonale, Bellinzona||2|||f||||f|f|f||||||||2017-10-10 20:44:36.938765|2017-10-10 20:44:36.938765
NCT03271983|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 1, 2018|Anticipated|2018-11-01|August 31, 2018|Anticipated|2018-08-31||Interventional|||Pharmacokinetics of Metronidazole Dermal Products|Evaluation of the Bioavailability of Metronidazole Dermal Products|Not yet recruiting||Early Phase 1|12|Anticipated|University of Maryland||3|||f||||f|t|f|||f|||||2017-10-10 20:44:37.034558|2017-10-10 20:44:37.034558
NCT03271970|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Anatomic Determinants of Perforation Induced Hearing Loss|The Anatomic Determinants of Perforation Induced Hearing Loss|Not yet recruiting||N/A|20|Anticipated|Duke University|||1||f||||f|f|f||||||||2017-10-10 20:44:37.133371|2017-10-10 20:44:37.133371
NCT03271957|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-31|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|February 27, 2018|Anticipated|2018-02-27||Observational|||Manual Rotation in Persistent Occiput Posterior Position|Relation of Ultrasound Parameters Associated to Labor Progression and Manual Rotation's Success in Persistent Occiput Posterior Position|Not yet recruiting||N/A|50|Anticipated|University of Lisbon|||1||f||||t|f|f||||||||2017-10-10 20:44:37.215187|2017-10-10 20:44:37.215187
NCT03271944|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||December 29, 2016|Actual|2016-12-29|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Fractional Handpiece With CO2 Laser: Fractional Ablative Laser Treatment of Vulvovaginal Atrophy|Fractional Handpiece With CO2 Laser: Fractional Ablative Laser Treatment of Vulvovaginal Atrophy|Recruiting||N/A|30|Anticipated|The American Association of Female Pelvic Medicine Specialists, Inc.||1|||f||||t|f|t|t|f|t|||||2017-10-10 20:44:37.296941|2017-10-10 20:44:37.296941
NCT03271931|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Active Choice in the EHR to Promote Statin Therapy|Using Active Choice in the EHR to Promote Cardiologists to Prescribe Evidence-Based Statin Therapy|Not yet recruiting||N/A|10000|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 20:44:37.3799|2017-10-10 20:44:37.3799
NCT03271918|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||February 1, 2015|Actual|2015-02-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|February 1, 2017|Actual|2017-02-01||Interventional|||Cabergoline in Nonfunctioning Pituitary Adenomas|Dopamine Agonist Cabergoline in Residual Clinically Nonfunctioning Pituitary Adenoma After Transphenoidal Surgery: A Single Center, Open Label and Randomized Clinical Trial|Completed||Phase 3|140|Actual|University of Sao Paulo General Hospital||2|||f||||t|t|f|||t|||||2017-10-10 20:44:37.477884|2017-10-10 20:44:37.477884
NCT03271905|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-31|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|December 10, 2018|Anticipated|2018-12-10|December 10, 2017|Anticipated|2017-12-10||Interventional|||Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilator|Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilator in the Treatment of Patients With Obstructive Pulmonary Disease|Recruiting||N/A|10|Anticipated|Universidade Federal do Rio Grande do Norte||3|||f||||t|f|f||||||||2017-10-10 20:44:37.60928|2017-10-10 20:44:37.60928
NCT03271892|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-31|||May 11, 2016|Actual|2016-05-11|August 2017|2017-08-01|December 31, 2026|Anticipated|2026-12-31|May 11, 2026|Anticipated|2026-05-11||Observational|AS-PTC||Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer|Deciding on Active Surveillance as an Alternative Option to Surgery in the Primary Management of Low Risk Papillary Thyroid Cancer|Recruiting||N/A|200|Anticipated|University Health Network, Toronto|||2||f||||f|f|f||||||||2017-10-10 20:44:37.709821|2017-10-10 20:44:37.709821
NCT03271879|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-09-06|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 1, 2020|Anticipated|2020-06-01|September 1, 2019|Anticipated|2019-09-01||Interventional|ERA-HF||Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients|The Effect of Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients|Not yet recruiting||Phase 4|128|Anticipated|Rambam Health Care Campus||2|||f||||f|f|f|||f|||||2017-10-10 20:44:37.831658|2017-10-10 20:44:37.831658
NCT03271866|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-01|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome|The Effect of Metformin Treatment on Cognitive Impairment in Patients With Schizophrenia Co-morbid Metabolic Syndrome: a Prospective Cohort Study|Recruiting||N/A|120|Anticipated|Central South University||2|||f||||f|f|f|||f|||||2017-10-10 20:44:37.915309|2017-10-10 20:44:37.915309
NCT03271853|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-31|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2026|Anticipated|2026-09-01|September 1, 2021|Anticipated|2021-09-01||Observational|||Thermalogical Analysis of a Cohort of Women Undergoing Mammographic Analysis.|Thermalogical Analysis of a Cohort of Women Undergoing Mammographic Analysis.|Not yet recruiting||N/A|2000|Anticipated|First Sense Medical, LLC|||1||f||||t|f|t|f|f|f|||||2017-10-10 20:44:38.011749|2017-10-10 20:44:38.011749
NCT03271840|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-31|||August 26, 2017|Actual|2017-08-26|August 2017|2017-08-01|December 31, 2030|Anticipated|2030-12-31|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Registry for Primary Ciliary Dyskinesia|Registry for Primary Ciliary Dyskinesia: : Systematic Data Collection on Incidence, Clinical Presentation, Treatment and Course of the Disease|Recruiting||N/A|30|Anticipated|University of Alberta|||1||f||||f|f|f||||||||2017-10-10 20:44:38.100977|2017-10-10 20:44:38.100977
NCT03271827|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|||Apnoeic Oxygenation by Nasal Cannula During Airway Management in Children Undergoing General Anaesthesia.|"Apnoeic Oxygenation by Nasal Cannula During Airway Management in Children Undergoing General Anaesthesia: A Pilot Randomised Controlled Trial"|Completed||N/A|30|Actual|University of Birmingham||2|||f||||t|f|f||||||||2017-10-10 20:44:38.186204|2017-10-10 20:44:38.186204
NCT03271814|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||January 15, 2018|Anticipated|2018-01-15|August 2017|2017-08-01|December 15, 2025|Anticipated|2025-12-15|December 15, 2023|Anticipated|2023-12-15||Interventional|LPS||Brain Biomarker on Inflammation Response|Brain Biomarker on Inflammation Response|Not yet recruiting||Phase 1|75|Anticipated|University of Maryland||3|||f||||t|t|f|||f|||||2017-10-10 20:44:38.275898|2017-10-10 20:44:38.275898
NCT03271801|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-01|||June 1, 2016|Actual|2016-06-01|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Skills Training Within a Family-based Obesity Treatment Intervention|Skills Training in Stimulus Control of Meals and Snacks Within a Family-based Obesity Treatment Intervention|Recruiting||N/A|40|Anticipated|University of Delaware||2|||f||||f|f|f||||||||2017-10-10 20:44:38.360091|2017-10-10 20:44:38.360091
NCT03271788|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-01|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Can Stroke Patients and Their Caregiver Benefit From Additive Mindfulness Training|Pilot Study to Evaluate the Effect of MBSR on Motor Learning, Attention, and Quality of Life in Stroke Patients and Their Relatives- a Monocentric Study|Not yet recruiting||N/A|8|Anticipated|Zurich University of Applied Sciences||1|||f|||||f|f||||||||2017-10-10 20:44:38.441818|2017-10-10 20:44:38.441818
NCT03271775|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-31|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|VOR||Vestibulopathy With Vestibulo Ocular Reflex (VOR) Gain Deficit|Vestibulopathy With Vestibulo Ocular Reflex (VOR) Gain Deficit - Characteristics of Overt and Covert Saccadic Eye Movements Measured by the Video Head Impulse Test (vHIT)|Not yet recruiting||N/A|100|Anticipated|University of Haifa||3|||f||||t|f|f||||||||2017-10-10 20:44:38.520319|2017-10-10 20:44:38.520319
NCT03271762|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2023|Anticipated|2023-01-01|October 2021|Anticipated|2021-10-01||Interventional|MITRA-HR||Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery|Multicentre and Randomized Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery|Not yet recruiting||N/A|330|Anticipated|Nantes University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:44:38.612731|2017-10-10 20:44:38.612731
NCT03271749|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2024|Anticipated|2024-12-31|August 1, 2019|Anticipated|2019-08-01||Interventional|PROSM||Protocol for Accelerated Recovery in Patients Undergoing Thoracic Surgical Procedures (PROSM). Study Randomized Comparative Between the Adoption of the Proposed Guidelines and the Traditional Method Currently Used in the Institution|Protocol for Accelerated Recovery in Patients Undergoing Thoracic Surgical Procedures Adapted to the Conditions of Santa Marcelina - Itaquera Hospital - São Paulo - Brazil (PROSM). Study Randomized Comparative Between the Adoption of the Proposed Guidelines and the Traditional Method Currently Used in the Institution|Recruiting||N/A|200|Anticipated|Hospital Santa Marcelina||2|||f||||f|f|f||||||||2017-10-10 20:44:38.953362|2017-10-10 20:44:38.953362
NCT03271736|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-31|||February 8, 2017|Actual|2017-02-08|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Effects of Rhythmic Auditory Cueing on Stepping in Place in Patients With Parkinson's Disease|Effects of Rhythmic Auditory Cueing on Stepping in Place in Patients With Parkinson's Disease|Recruiting||N/A|36|Anticipated|National Taiwan University||3|||f||||f|f|f||||||||2017-10-10 20:44:39.070605|2017-10-10 20:44:39.070605
NCT03271723|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-31|||April 15, 2014|Actual|2014-04-15|August 2017|2017-08-01|December 31, 2015|Actual|2015-12-31|December 31, 2014|Actual|2014-12-31||Observational|||The 2015 Pelotas (Brazil) Birth Cohort Study|The 2015 Pelotas (Brazil) Birth Cohort Study|Completed||N/A|4275|Actual|Federal University of Pelotas|||1||f||||f|f|f||||Samples With DNA|"     Saliva   "|||2017-10-10 20:44:39.178653|2017-10-10 20:44:39.178653
NCT03271710|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|ENTRAP||Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System|A Single-Arm, Multicenter Study for the Lower Extremities Using the Vanguard IEP Peripheral Balloon Angioplasty System With Integrated Embolic Protection|Not yet recruiting||N/A|130|Anticipated|Contego Medical, LLC||1|||f||||f|f|f||||||||2017-10-10 20:44:39.27139|2017-10-10 20:44:39.27139
NCT03271697|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|AMASH||Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage|Efficacy Study of Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|China Medical University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:44:39.425689|2017-10-10 20:44:39.425689
NCT03271684|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-03|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||The Effectiveness of the Adapted Bridge's Self-management Programme|The Effectiveness of the Adapted Bridge's Self-management Programme in South African Community-dwelling Stroke Survivors: A Randomized Controlled Trial|Not yet recruiting||N/A|84|Anticipated|University of the Western Cape||2|||f||||f|f|f||||||||2017-10-10 20:44:39.524849|2017-10-10 20:44:39.524849
NCT03271671|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-04|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Pressure Support Ventilation (PSV) Versus Neurally Adjusted Ventilator Assist (NAVA) During Acute Respiratory Failure (ARF)|A Randomized Controlled Trial Comparing Non-invasive Ventilation (NIV) With Pressure Support Ventilation (PSV) Versus Neurally Adjusted Ventilator Assist (NAVA) During Acute Respiratory Failure (ARF)|Not yet recruiting||N/A|75|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t|f|f||||||||2017-10-10 20:44:39.643573|2017-10-10 20:44:39.643573
NCT03271658|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||June 1, 2014|Actual|2014-06-01|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|eLSDA||Mixed Methods Study Web-based Life Support Decision Aid|Development of an Individualized, Web-Based Life Support Decision Aid (eLSDA) Concerning Goals of Care for the Seriously Ill Patient|Recruiting||N/A|120|Anticipated|University of Saskatchewan||2|||f||||f|f|f||||||||2017-10-10 20:44:39.768791|2017-10-10 20:44:39.768791
NCT03271645|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-31|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|March 1, 2018|Anticipated|2018-03-01||Interventional|iCBT@Work||Internet-delivered Interventions for Stress, Anxiety and Depression in the Workplace|Internet-delivered Interventions for Stress, Anxiety and Depression in the Workplace|Not yet recruiting||N/A|101|Anticipated|Silver Cloud Health||4|||f||||t|f|f||||||||2017-10-10 20:44:39.917837|2017-10-10 20:44:39.917837
NCT03271632|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-31|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||BCMA/CD38 CAR T in the Treatment of Multiple Myeloma|Phase I/II Trials of Bispecific BCMA/CD38 CAR T Cells in the Treatment of Multiple Myeloma|Recruiting||Phase 1/Phase 2|10|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||f|f|f||||||||2017-10-10 20:44:40.057694|2017-10-10 20:44:40.057694
NCT03271619|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Electrical Safety of Implantable Cardioverter Defibrillators|Electrical Safety of Rescuers in Contact With Patients During Implanted Cardioverter Defibrillator Discharge|Recruiting||N/A|20|Anticipated|University Hospital Southampton NHS Foundation Trust|||2||f||||f|f|f||||||||2017-10-10 20:44:40.141494|2017-10-10 20:44:40.141494
NCT03271606|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-01|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|February 23, 2018|Anticipated|2018-02-23|February 23, 2018|Anticipated|2018-02-23||Interventional|||ERAS in Video-assisted Mediastinal Surgery|The Clinical Study of ERAS Protocol in Video-assisted Mediastinal Surgery|Recruiting||Phase 1|100|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:44:40.236886|2017-10-10 20:44:40.236886
NCT03271593|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-09-20|||November 2, 2015|Actual|2015-11-02|September 2017|2017-09-01|September 23, 2016|Actual|2016-09-23|September 23, 2016|Actual|2016-09-23||Observational|||Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study|Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f|||||f|f||||||||2017-10-10 20:44:40.310685|2017-10-10 20:44:40.310685
NCT03271580|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-30|||February 5, 2017|Actual|2017-02-05|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|February 5, 2018|Anticipated|2018-02-05||Observational|||Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing|Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing|Recruiting||N/A|28|Anticipated|Ohio State University|||2||f||||f|f|f||||Samples With DNA|"     Blood, Wound Vac Sponge, Wound Tissue biopsy   "|||2017-10-10 20:44:40.384078|2017-10-10 20:44:40.384078
NCT03271567|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|August 31, 2018|Anticipated|2018-08-31||Observational|||Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients|Detection of Circulating Mycobacterium Tuberculosis Antigen Peptides for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients|Not yet recruiting||N/A|100|Anticipated|Chinese University of Hong Kong|||1||f||||f|f|f||||||||2017-10-10 20:44:40.517826|2017-10-10 20:44:40.517826
NCT03271554|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-09-25|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Observational|||Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea|Treatment Registry of Alecensa in Korean Patients With Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Not yet recruiting||N/A|167|Anticipated|Hoffmann-La Roche|||1||f|||||t|f||||||||2017-10-10 20:44:40.593745|2017-10-10 20:44:40.593745
NCT03271541|ClinicalTrials.gov processed this data on October 10, 2017|2017-09-01|2017-10-04|||October 30, 2017|Anticipated|2017-10-30|October 2017|2017-10-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent Beta-Thalassemia|A Phase II, Single Arm, Multicenter, Proof-of-Mechanism Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent Βeta-Thalassemia|Recruiting||Phase 2|16|Anticipated|Hoffmann-La Roche||1|||f|||||f|f||||||||2017-10-10 20:44:40.682157|2017-10-10 20:44:40.682157
NCT03271528|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers|Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers|Not yet recruiting||Phase 1|28|Anticipated|Boston Medical Center||2|||f||||f|t|f|||t|||||2017-10-10 20:44:40.763843|2017-10-10 20:44:40.763843
NCT03271515|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL|Phase I Study of T Cells Expressing an Anti-CD19 and Anti-CD20 Bispecific Chimeric Receptor in Patients With B Cell Malignancies|Not yet recruiting||Phase 1|20|Anticipated|Beijing Doing Biomedical Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:44:40.851216|2017-10-10 20:44:40.851216
NCT03271502|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-19|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy|Effect of Inhalation Anesthesia With Sevoflurane and Total Intravenous Anesthesia With Propofol on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy|Recruiting||N/A|36|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:44:40.923918|2017-10-10 20:44:40.923918
NCT03271476|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|PSYCANCER||EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer Patient|EMDR Psychotherapy of Anxious-depressive Symptoms for Women That Present an Invasive Beast Cancer : a Faisability Study|Not yet recruiting||N/A|30|Anticipated|Centre Hospitalier Régional Metz-Thionville||1|||f||||f|f|f||||||||2017-10-10 20:44:41.542058|2017-10-10 20:44:41.542058
NCT03271463|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Observational|||Assessing Leg Control in People With Chronic Stroke|Lower Extremity Selective Voluntary Motor Control in Adults With Chronic Stroke: Comparing the SCALE Assessment to the Fugl-Meyer Assessment|Not yet recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||||||2017-10-10 20:44:41.639472|2017-10-10 20:44:41.639472
NCT03271450|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-31|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2021|Anticipated|2021-10-01|April 15, 2021|Anticipated|2021-04-15||Observational|||The DARE Warfarin CER Study|The Dabigatran, Apixaban, Rivaroxaban, Edoxaban, Warfarin Comparative Effectiveness Research Study|Enrolling by invitation||N/A|416000|Anticipated|Brigham and Women's Hospital|||30||f||||f|f|f||||||||2017-10-10 20:44:41.728134|2017-10-10 20:44:41.728134
NCT03271437|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Flash Open Trial With Therapists In Training|Flash Open Trial With Therapists In Training|Recruiting||N/A|200|Anticipated|Trauma Institute & Child Trauma Institute||2|||f|||||f|f||||||||2017-10-10 20:44:41.896638|2017-10-10 20:44:41.896638
NCT03271424|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||Innovations in HIV Testing (TI)|Innovations in HIV Testing to Enhance Care for Young Women and Their Peers and Partners|Completed||N/A|95|Actual|University of North Carolina, Chapel Hill||3|||f||||f|f|t|||t|||||2017-10-10 20:44:41.98134|2017-10-10 20:44:41.98134
NCT03271411|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Extension of EMDR vs. PC For Motor Vehicle Accident Trauma|Extension of EMDR vs. PC For Motor Vehicle Accident Trauma|Recruiting||N/A|20|Anticipated|Trauma Institute & Child Trauma Institute||2|||f|||||f|f||||||||2017-10-10 20:44:42.068951|2017-10-10 20:44:42.068951
NCT03271398|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31|12 Weeks|Observational [Patient Registry]|||Intensive Therapy Archival Research|Intensive Therapy Archival Research|Recruiting||N/A|1200|Anticipated|Trauma Institute & Child Trauma Institute|||6||f|||||f|f||||||||2017-10-10 20:44:42.161659|2017-10-10 20:44:42.161659
NCT03271385|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-31|||July 1, 2017|Actual|2017-07-01|June 2017|2017-06-01|July 1, 2020|Anticipated|2020-07-01|June 30, 2020|Anticipated|2020-06-30||Observational|||Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease|Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease: a Multi-center, Prospective, Controlled Clinical Trial|Recruiting||N/A|100|Anticipated|RenJi Hospital|||3||f||||t|f|f||||||||2017-10-10 20:44:42.269811|2017-10-10 20:44:42.269811
NCT03271372|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-25|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|September 1, 2024|Anticipated|2024-09-01|September 1, 2024|Anticipated|2024-09-01||Interventional|ADAM||Adjuvant Avelumab in Merkel Cell Cancer|A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial of Adjuvant Avelumab (Anti-PDL-1 Antibody) in Merkel Cell Carcinoma Patients With Clinically Detected Lymph Node Metastases|Not yet recruiting||Phase 3|100|Anticipated|University of Washington||2|||||||t|t|f||||||||2017-10-10 20:44:42.386559|2017-10-10 20:44:42.386559
NCT03271359|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||January 5, 2014|Actual|2014-01-05|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||EMDR vs. PC For Motor Vehicle Accident Trauma|EMDR vs. PC For Motor Vehicle Accident Trauma|Active, not recruiting||N/A|40|Anticipated|Trauma Institute & Child Trauma Institute||2|||f||||||||||||||2017-10-10 20:44:42.508438|2017-10-10 20:44:42.508438
NCT03271346|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-08-31|||February 2015||2015-02-01|August 2017|2017-08-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Observational|||Intensive Trauma Treatment for Children Exposed to Parental Conflict|Intensive Trauma Treatment for Children Exposed to Parental Conflict|Recruiting||N/A|4|Anticipated|Trauma Institute & Child Trauma Institute|||1||f||||f||||||||||2017-10-10 20:44:42.590538|2017-10-10 20:44:42.590538
NCT03271333|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|SCLERO-PID||Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.|Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma and Analysis of Associated Factors.|Not yet recruiting||N/A|70|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||||2017-10-10 20:44:42.67996|2017-10-10 20:44:42.67996
NCT03271320|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||December 19, 2016|Actual|2016-12-19|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|SCLERO-ESTHET||Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis|Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis|Recruiting||N/A|150|Anticipated|University Hospital, Lille|||2||f||||f|f|f||||||||2017-10-10 20:44:42.751953|2017-10-10 20:44:42.751953
NCT03271307|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners|Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners|Not yet recruiting||N/A|22500|Anticipated|University of California, Los Angeles||3|||f||||f|f|t|f||t|||||2017-10-10 20:44:42.842848|2017-10-10 20:44:42.842848
NCT03271294|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||April 19, 2013|Actual|2013-04-19|August 2017|2017-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Prospective Performance Analysis of the Exair(TM) Prolapse Repair System in the Treatment of Pelvic Organ Prolapse|Prospective Performance Analysis of the Exair(TM) Prolapse Repair System in the Treatment of Pelvic Organ Prolapse|Completed||N/A|80|Actual|Michigan Institution of Women's Health PC||1|||f||||f|f|f|||f|||||2017-10-10 20:44:42.960278|2017-10-10 20:44:42.960278
NCT03271268|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||August 6, 2017|Actual|2017-08-06|September 2017|2017-09-01|April 6, 2019|Anticipated|2019-04-06|February 6, 2019|Anticipated|2019-02-06||Observational|CAROLE||Cardiovascular Biomarkers and Lung Edema in Severe Burns Patients|The Role of CARdiovascular biOmarkers (NT-pro-BNP and CD146) in Predicting Lung Edema in Severely Burned Patients|Recruiting||N/A|36|Anticipated|Saint-Louis Hospital, Paris, France|||1||f||||f|f|f||||Samples Without DNA|"     Serum bank : 1 sample (5 ml of blood): on admission and from day 1 to day 7 of admission.   "|||2017-10-10 20:44:43.115279|2017-10-10 20:44:43.115279
NCT03271255|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-03|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|September 30, 2022|Anticipated|2022-09-30||Interventional|||Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)|Apatinib Versus Bevacizumab in Combination With Second-line FOLFIRI in Patients With Metastatic Colorectal Cancer That Progressed During or After First-line Bevacizumab Plus an Oxaliplatin-based Regimen: A Randomised Phase 2 Trial|Not yet recruiting||Phase 2|80|Anticipated|Shenzhen People's Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:44:43.208159|2017-10-10 20:44:43.208159
NCT03271242|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||June 22, 2016|Actual|2016-06-22|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Implementation of National Guidelines for Treatment of Psychoses|A Pairwise Randomized Study on Implementation of Guidelines and Evidence Based Treatments of Psychoses|Active, not recruiting||N/A|1074|Anticipated|University Hospital, Akershus|||2||f||||f|f|f||||||||2017-10-10 20:44:43.317144|2017-10-10 20:44:43.317144
NCT03271229|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee|A Randomized, Single-Blinded, Controlled Trial Comparing Conventional Platelet Rich Plasma (PRP) to Concentrated Bone Marrow Aspirate (BMAC) for Osteoarthritis of the Knee|Not yet recruiting||Phase 2|24|Anticipated|Mayo Clinic||2|||f||||f|t|f|||f|||||2017-10-10 20:44:43.434349|2017-10-10 20:44:43.434349
NCT03271216|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-31|||February 2014||2014-02-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Surveillance Monitoring on General Wards|Surveillance Monitoring on General Wards|Completed||N/A|422|Actual|Johns Hopkins University|||1||f||||t||||||||||2017-10-10 20:44:43.547135|2017-10-10 20:44:43.547135
NCT03271203|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-31|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Observational|||Subject Insights to Understand the Hand Osteoarthritis (HOA)|HO-16-16395 - Research to Understand the Key Concepts and Endpoints Within OA From Patient Perspective|Recruiting||N/A|20|Anticipated|GlaxoSmithKline|||2||f||||f|f|f||||||||2017-10-10 20:44:43.612471|2017-10-10 20:44:43.612471
NCT03271190|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-08-30|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of a Cognitive Intervention Enriched With Leisure Activities in Persons With Subjective Cognitive Decline|Impact of a Cognitive Intervention Enriched With Leisure Activities on Cognition, Daily Life Functioning and Brain Structure and Function in Persons With Subjective Cognitive Decline: The ENGAGE Program|Not yet recruiting||N/A|144|Anticipated|Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal||2|||f||||t|f|f||||||||2017-10-10 20:44:43.70113|2017-10-10 20:44:43.70113
NCT03271177|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-31|||February 25, 2016|Actual|2016-02-25|August 2017|2017-08-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|PRAGMATIC||Ultrasound Comparison of Radial Artery Hyperplasia After Use of a 7F Sheathless Guide vs. 6F Sheath/Guide Combination|The PRAGMATIC Study:A Prospective Randomized Clinical Trial Comparing Radial Artery Intimal Hyperplasia Resulting From a 7F Sheathless Guide (Mach 1TM) vs. a 6F Transradial Sheath/Guide Combination in Coronary Intervention|Completed||N/A|41|Actual|Tallahassee Research Institute, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:44:43.807656|2017-10-10 20:44:43.807656
NCT03271164|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||August 29, 2017|Actual|2017-08-29|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Evaluation of the Safety and Efficacy of FBPM10 System in the Treatment of Post-surgical Wounds|Prospective Randomized Controlled Case Series Evaluating the Safety and Efficacy of FBPM10 System When Compared to Standard of Care in the Treatment of Post-surgical Wounds|Recruiting||N/A|10|Anticipated|KLOX Technologies Inc.||2|||f||||f|f|f||||||||2017-10-10 20:44:43.877915|2017-10-10 20:44:43.877915
NCT03271151|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty|Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty: A Double-blinded Randomized Control Trial|Enrolling by invitation||Phase 4|175|Actual|Hospital for Special Surgery, New York||2|||f|||||t|f|||t|||||2017-10-10 20:44:43.959442|2017-10-10 20:44:43.959442
NCT03270384|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|March 2018|Anticipated|2018-03-01||Interventional|ROBUST-II||Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease|Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease|Not yet recruiting||N/A|15|Anticipated|Urotronic Inc.||1||||||||f|t|t|||||||2017-10-10 20:44:50.365464|2017-10-10 20:44:50.365464
NCT03271138|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms|A Randomized Controlled Trial of Dietary Supplementation With Bifidobacterium Infantis NLS Super Strain Among Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms|Recruiting||Phase 2|20|Anticipated|Global Institute of Probiotics||2|||f||||f|f|f||||||||2017-10-10 20:44:44.032965|2017-10-10 20:44:44.032965
NCT03271125|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||January 8, 2013|Actual|2013-01-08|August 2017|2017-08-01||||May 19, 2015|Actual|2015-05-19||Interventional|Treadmill||Intensive Multimodal Training for Persons With MS|Intensive Multimodal Training for Persons With Multiple Sclerosis: Random Controlled Trial|Completed||N/A|42|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f|f|f||||||||2017-10-10 20:44:44.119995|2017-10-10 20:44:44.119995
NCT03271112|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-04|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|5P-PILOTE||Frailty Prevention in Elders From Reunion Island|Frailty Prevention in Elderly People From Reunion Island: Effects of Adaptated Exercises on Physical Performance|Recruiting||N/A|115|Anticipated|Centre Hospitalier Universitaire de la Réunion||1|||f||||f|f|f||||||||2017-10-10 20:44:44.187862|2017-10-10 20:44:44.187862
NCT03271099|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Patient Navigation in Cancer Survivorship at a Safety Net Institution|Patient Navigation as Part of the Cancer Survivorship Care Plan at a Safety Net Institution|Not yet recruiting||N/A|100|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:44:44.265598|2017-10-10 20:44:44.265598
NCT03271086|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Relaxation Breathing Training for Children|Family Centered Relaxation Breathing Training in the Pediatrics Outpatient Clinic|Not yet recruiting||N/A|120|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:44:44.432173|2017-10-10 20:44:44.432173
NCT03271073|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer|A Exploratory Study of Apatinib in Combination With S1 in Patients With Advanced Gastric Evaluating the Efficacy and Safety|Recruiting||Phase 2|20|Anticipated|Beijing Friendship Hospital||1|||f||||||||||||||2017-10-10 20:44:44.650365|2017-10-10 20:44:44.650365
NCT03271060|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|August 30, 2018|Anticipated|2018-08-30||Interventional|||Comparative Study Between Posterior Lumbar Interbody Fusion(PLIF) and Intertransverse Process Fusion in Treatment of Spodylolithesis|Comparative Study Between Posterior Lumbar Interbody Fusion(PLF) and Intertransverse Process Fusion in Treatment of Spodylolithesis|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:44:44.770049|2017-10-10 20:44:44.770049
NCT03271047|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-10-05|||October 4, 2017|Actual|2017-10-04|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation|An Open-label Phase 1b/2 Study of Binimetinib Administered in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation|Recruiting||Phase 1/Phase 2|90|Anticipated|Array BioPharma||4|||f||||f|t|f||||||||2017-10-10 20:44:44.867818|2017-10-10 20:44:44.867818
NCT03271034|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|Lipedema||Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema|Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema|Not yet recruiting||N/A|20|Anticipated|Washington University School of Medicine||1|||f|||||f|f||||||||2017-10-10 20:44:44.997519|2017-10-10 20:44:44.997519
NCT03271021|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|September 3, 2018|Anticipated|2018-09-03|August 1, 2018|Anticipated|2018-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris|A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris (Study FX2017-22)|Recruiting||Phase 3|1500|Anticipated|Foamix Ltd.||2|||f||||f|t|f||||||||2017-10-10 20:44:45.291327|2017-10-10 20:44:45.291327
NCT03271008|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-31|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Comparison of the Vividtrac™ and Other Videolaryngoscopes in Clinical Practice|Comparison of Necessary Time for Successful Intubation With the Vividtrac™ and KingVision™ Videolaryngoscopes and Macintosh Blade Direct Laryngoscopy in Clinical Practice|Recruiting||N/A|150|Anticipated|University of Pecs||3|||f||||f|f|f||||||||2017-10-10 20:44:45.77194|2017-10-10 20:44:45.77194
NCT03270995|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-31|||October 2014||2014-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study|Efficacy of a Cognitive-existential Intervention to Address Fear of Recurrence in Women With Cancer: a Randomized Controlled Clinical Trial|Recruiting||N/A|144|Anticipated|McGill University||2|||f||||f||||||||||2017-10-10 20:44:45.87765|2017-10-10 20:44:45.87765
NCT03270982|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|December 2024|Anticipated|2024-12-01|April 2023|Anticipated|2023-04-01||Observational|||Comprehensive Segmental Revision System|Comprehensive Segmental Revision System|Recruiting||N/A|150|Anticipated|Zimmer Biomet|||1||f||||f|f|t|f|f|t|||||2017-10-10 20:44:46.001895|2017-10-10 20:44:46.001895
NCT03270969|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-30|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women|Pharmacokinetics of Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-exposure Prophylaxis in Transgender Women Receiving Feminizing Hormone Therapy|Not yet recruiting||Phase 1|15|Anticipated|University of Nebraska||1|||f||||f|t|f|||t|||||2017-10-10 20:44:46.124202|2017-10-10 20:44:46.124202
NCT03270956|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|||A Study of Autologous Neo-Kidney Augment™ (NKA) in Patients With Diabetic Chronic Kidney Disease|A Phase II, Open-Label Safety and Tolerability Study of an Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (REGEN-003)|Not yet recruiting||Phase 2|10|Anticipated|inRegen||1|||f|||||t|f||||||||2017-10-10 20:44:46.199283|2017-10-10 20:44:46.199283
NCT03270943|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens|Making Friends With Yourself: a Depression Prevention Program for Adolescents|Not yet recruiting||N/A|80|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|f||||||||2017-10-10 20:44:46.29302|2017-10-10 20:44:46.29302
NCT03270930|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-11|||April 1, 2015|Actual|2015-04-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|March 31, 2017|Actual|2017-03-31||Observational|||Operative Duration as a Predictor of Mortality in Pediatric Emergency Surgery|A Prospective Study of Evaluation of Operative Duration as a Predictor of Mortality in Pediatric Emergency Surgery: Concept of 100 Minutes Laparotomy in Resource-limited Setting|Completed||N/A|213|Actual|Jawaharlal Nehru Medical College|||2||f||||t|f|f||||||||2017-10-10 20:44:46.393406|2017-10-10 20:44:46.393406
NCT03270917|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-31|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||ORANGE SEGMENTS: Open Versus Laparoscopic Parenchymal Preserving Postero-Superior Liver Segment Resection|The ORANGE SEGMENTS - Trial: an International Multicentre Randomized Controlled Trial of Open Versus Laparoscopic Parenchymal Preserving Postero-superior Liver Segment Resection|Not yet recruiting||N/A|250|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:44:46.501326|2017-10-10 20:44:46.501326
NCT03270904|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Moleculight i:X™ in Wound Healing|The Use of Moleculight i:X™ in the Management of Diabetic Foot Ulcers: A Pilot Study|Not yet recruiting||N/A|60|Anticipated|The Leeds Teaching Hospitals NHS Trust||2|||f|||||f|f||||||||2017-10-10 20:44:46.637976|2017-10-10 20:44:46.637976
NCT03270891|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Pharmacogenomic Testing in Primary Care for the Treatment of Depression|Determining the Preliminary Feasibility, Acceptability, and Preliminary Effectiveness of Pharmacogenomic Testing in Primary Care for the Treatment of Depression|Not yet recruiting||N/A|120|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 20:44:46.702388|2017-10-10 20:44:46.702388
NCT03270878|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-28|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 6, 2017|Anticipated|2017-10-06||Interventional|||Glasdegib Absolute Bioavailability Study|A Phase One, Single Dose, Randomized, Open-label, Two-period, Two-sequence, Crossover, Absolute Bioavailability Study Of Glasdegib (Pf-04449913) In Healthy Volunteers|Recruiting||Phase 1|12|Anticipated|Pfizer||2|||f||||f|t|f||||||||2017-10-10 20:44:46.799358|2017-10-10 20:44:46.799358
NCT03270865|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-03|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|February 1, 2018|Anticipated|2018-02-01||Interventional|||Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging|Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging|Not yet recruiting||N/A|60|Anticipated|Notal Vision Ltd||1|||f||||f|f|f||||||||2017-10-10 20:44:46.878203|2017-10-10 20:44:46.878203
NCT03270852|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 30, 2018|Anticipated|2018-10-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Enhanced Reality for Hemiparetic Arm in the Stroke Patients|Enhanced Reality for Hemiparetic Arm in the Stroke Patients; Randomized Case-controlled Clinical Trial for Efficacy|Not yet recruiting||N/A|38|Anticipated|Ulsan University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:44:46.941778|2017-10-10 20:44:46.941778
NCT03270839|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-08-31|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Motion Sickness Medications and Vestibular Time Constant|Motion Sickness Medications and Vestibular Time Constant|Recruiting||Phase 4|80|Anticipated|Medical Corps, Israel Defense Force||8|||f||||f|t|f|||t|||||2017-10-10 20:44:47.030299|2017-10-10 20:44:47.030299
NCT03270826|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-30|||April 7, 2017|Actual|2017-04-07|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Observational|||Physiological Behavior of Respiratory Maneuvers|Physiological Behavior of Respiratory Maneuvers Through Electrical Impedance Tomography and Optoelectronic Plethymography|Recruiting||N/A|10|Anticipated|Universidade Federal de Pernambuco|||1||f||||t|f|f||||||||2017-10-10 20:44:47.143545|2017-10-10 20:44:47.143545
NCT03270813|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-31|||June 2015||2015-06-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play|RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play|Active, not recruiting||N/A|40|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 20:44:47.214799|2017-10-10 20:44:47.214799
NCT03270800|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-11|||January 30, 2017|Actual|2017-01-30|February 2017|2017-02-01|July 14, 2018|Anticipated|2018-07-14|May 5, 2018|Anticipated|2018-05-05||Interventional|IMX-02||Phase 1a/b Study on Safety of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers|A Randomized, Double-blind, Adjuvant-controlled Phase 1a/b Study on Safety and Tolerability With Ascending Multiple Doses of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers|Recruiting||Phase 1|72|Anticipated|ImevaX||2|||f||||t|f|f||||||||2017-10-10 20:44:47.316481|2017-10-10 20:44:47.316481
NCT03270787|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-08-30|||June 24, 2016|Actual|2016-06-24|August 2017|2017-08-01|July 13, 2017|Actual|2017-07-13|July 13, 2016|Actual|2016-07-13||Interventional|||Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness|A Randomized, Double Blind, Placebo-controlled Study of Compound Danshen Dripping Pills in Preventing and Treating Acute Mountain Sickness|Completed||Phase 1/Phase 2|58|Actual|Tasly Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 20:44:47.400084|2017-10-10 20:44:47.400084
NCT03270774|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||April 19, 2016|Actual|2016-04-19|August 2017|2017-08-01|April 19, 2017|Actual|2017-04-19|April 10, 2017|Actual|2017-04-10||Observational|||Central Venous Catheter Colonisation Among Critically Ill Patients in Intensive Care Units|Central Venous Catheter Colonisation: Prevalence and Associated Factors Among Critically Ill Patients Admitted to Ugandan Intensive Care Units|Completed||N/A|100|Actual|Makerere University|||1||f||||f|f|f||||||||2017-10-10 20:44:47.47669|2017-10-10 20:44:47.47669
NCT03270761|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-18|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2018|Anticipated|2018-09-30|1 Day|Observational [Patient Registry]|||Zhongshan Iridocorneal Endothelial Syndrome Study (ICEs)|A Multi-center Study on Iridocorneal Endothelial (ICE) Syndrome in China|Recruiting||N/A|200|Anticipated|Sun Yat-sen University|||1||f||||t|f|f||||Samples With DNA|"     12ml Blood will be collected. Aqueous humor，iris,or excised corneal will be gathered if     trabeculectomy,drainage shunt valve implantation, or penetrating keratoplasty needed.   "|||2017-10-10 20:44:47.534945|2017-10-10 20:44:47.534945
NCT03270748|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-30|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 1, 2021|Anticipated|2021-01-01|June 1, 2018|Anticipated|2018-06-01||Interventional|GITMO-PHYLOS||Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies|Post Transplant High-Dose Cyclophosphamide as GvHD Prophylaxis in Patients Receiving 1-Antigen/Allele HLA Mismatched (7/8 Matched) Unrelated Hemopoietic Stem Cell Transplantation for Myeloid Malignancies|Not yet recruiting||Phase 2|78|Anticipated|Gruppo Italiano Trapianto di Midollo Osseo||1|||f||||f|f|f||||||||2017-10-10 20:44:47.609217|2017-10-10 20:44:47.609217
NCT03270735|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-31|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Clinical Study to Evaluate the Efficacy and Safety of Hemocoagulase Injection|A Multi-centre, Randomised, Double Blind, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of Snake Venom Thrombin Injection in the Treatment of Moderate to Severe Hemoptysis|Recruiting||Phase 4|100|Anticipated|Lee's Pharmaceutical Limited||2|||f|||||f|f||||||||2017-10-10 20:44:47.694405|2017-10-10 20:44:47.694405
NCT03270722|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-30|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing|Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma|Not yet recruiting||N/A|60|Anticipated|Stanford University||3|||f||||f|f|t|f|f|f|||||2017-10-10 20:44:47.77842|2017-10-10 20:44:47.77842
NCT03270709|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||December 31, 2017|Anticipated|2017-12-31|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV|Effect of High-Dose Vitamin D3 on Alveolar Macrophage Function, LL-37, and Oxidative Stress in Smokers and Non-Smokers With and Without HIV|Not yet recruiting||Phase 1|44|Anticipated|Emory University||4|||f||||t|t|f|||f|||||2017-10-10 20:44:47.870145|2017-10-10 20:44:47.870145
NCT03270696|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-03|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Simultaneous Injection of Propofol and Rocuronium in Inducing General Anesthesia|Efficacy of Neuromuscular Blockade Before Facemask Ventilation in Inducing General Anesthesia|Recruiting||N/A|116|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 20:44:47.978385|2017-10-10 20:44:47.978385
NCT03270683|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||May 2, 2016|Actual|2016-05-02|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|DOTAC||Doppler Sonography of Cerebral Blood Flow for Early Prognostication After Out-of-hospital Cardiac Arrest|Doppler Sonography of Cerebral Blood Flow for Early Prognostication After Out-of-hospital Cardiac Arrest: the DOTAC Study|Recruiting||N/A|140|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:44:48.05144|2017-10-10 20:44:48.05144
NCT03270670|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Olympus - 19-gauge Needle|A Pilot Study Evaluating the Performance of 19-gauge Needles in Testing Molecular Markers in Samples Obtained Via Endobronchial Ultrasound Guided Needle Aspiration of Lymph Nodes in Patients With Lung Cancer|Recruiting||N/A|50|Anticipated|Duke University|||1||f||||f|f|f||||||||2017-10-10 20:44:48.117717|2017-10-10 20:44:48.117717
NCT03270657|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 30, 2021|Anticipated|2021-10-30|October 30, 2021|Anticipated|2021-10-30||Interventional|||Scalar Closed Loop Intraoperative Study|Scalar Closed-Loop STN/GPi DBS Based on Evoked and Spontaneous Potentials (Intraoperative Studies)|Not yet recruiting||N/A|32|Anticipated|Duke University||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:44:48.192566|2017-10-10 20:44:48.192566
NCT03270644|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-10-02|||August 31, 2017|Actual|2017-08-31|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of Lasmiditan and Propranolol in Healthy Participants|Effect of Lasmiditan on Heart Rate and Blood Pressure in Healthy Subjects Receiving Oral Doses of Propranolol|Recruiting||Phase 1|44|Anticipated|Eli Lilly and Company||3|||f||||f|t|f||||||||2017-10-10 20:44:48.256344|2017-10-10 20:44:48.256344
NCT03270631|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|March 31, 2021|Anticipated|2021-03-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Movement Control Exercises and Fascial Manipulation in Chronic Low Back Pain|Movement Control Exercises and Fascial Manipulation in Chronic Low Back Pain in Conjunction With Multidisciplinary Rehabilitation - a RCT|Enrolling by invitation||N/A|250|Anticipated|Oulu University Hospital||5|||f||||f|f|f||||||||2017-10-10 20:44:48.33265|2017-10-10 20:44:48.33265
NCT03270618|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|April 30, 2016|Actual|2016-04-30||Interventional|||Accuracy of a CAD/CAM Surgical Template for Mandible Distraction|Accuracy Evaluation of A CAD/CAM Surgical Template for Mandible Distraction|Recruiting||N/A|30|Anticipated|Shanghai 9th People's Hospital||1|||f|||||f|f||||||||2017-10-10 20:44:48.424217|2017-10-10 20:44:48.424217
NCT03270605|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|February 1, 2017|Actual|2017-02-01|January 9, 2017|Actual|2017-01-09||Observational|||Caesarean Myomectomy; A Retrospective Cohort Study|Myomectomy During Caesarean Section; A Retrospective Cohort Study|Completed||N/A|85|Actual|Mansoura University|||2||f|||||f|f||||||||2017-10-10 20:44:48.615114|2017-10-10 20:44:48.615114
NCT03270592|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-01|||September 17, 2009|Actual|2009-09-17|September 2017|2017-09-01|July 2, 2014|Actual|2014-07-02|July 2, 2014|Actual|2014-07-02||Interventional|||Assessment of Service and Hearing Dogs|Assessment of Service and Hearing Dogs|Completed||N/A|56|Actual|Linkoeping University||1|||f||||f|f|f||||||||2017-10-10 20:44:48.730691|2017-10-10 20:44:48.730691
NCT03270371|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|MCO-IF||Modulation of Inflammation by Medium Cut Off Membranes|Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients With End Stage Renal Disease|Recruiting||N/A|50|Anticipated|Technische Universität München||2|||f||||f|f|f||||||||2017-10-10 20:44:50.486651|2017-10-10 20:44:50.486651
NCT03270579|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-09-26|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|November 29, 2017|Anticipated|2017-11-29|November 29, 2017|Anticipated|2017-11-29||Interventional|||A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070|An Open-Label Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070|Recruiting||Phase 1|8|Anticipated|Janssen Research & Development, LLC||2|||f||||f|f|f||||||||2017-10-10 20:44:48.829783|2017-10-10 20:44:48.829783
NCT03270566|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|SOFTER||Softened Water for Eczema Prevention Pilot Trial|An Outcome Assessor-blinded Pilot Randomised Controlled Trial of an Ion-exchange Water Softener for the Prevention of Atopic Eczema in Neonates, With an Embedded Mechanistic Study|Not yet recruiting||N/A|80|Anticipated|King's College London||2|||f||||f|f|f||||||||2017-10-10 20:44:48.928351|2017-10-10 20:44:48.928351
NCT03270540|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-07|||March 13, 2017|Actual|2017-03-13|September 2017|2017-09-01|June 13, 2020|Anticipated|2020-06-13|March 13, 2020|Anticipated|2020-03-13||Observational|||Abdominal Ultrasonography in Urinary Tract Infection - When and Why?|Abdominal Ultrasonography in Urinary Tract Infection - When and Why?|Recruiting||N/A|150|Anticipated|Medical University of Warsaw|||1||f||||f|f|f||||||||2017-10-10 20:44:49.171125|2017-10-10 20:44:49.171125
NCT03270527|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|RISSCI-1||RISSCI-1 Blood Cholesterol Response Study|Reading Imperial Surrey Saturated Fat Cholesterol Intervention (RISSCI) Study. RISSCI-1 Blood Cholesterol Response Study|Not yet recruiting||N/A|150|Anticipated|University of Surrey||1|||f||||t|f|f||||||||2017-10-10 20:44:49.250859|2017-10-10 20:44:49.250859
NCT03270514|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-10-04|||November 15, 2017|Anticipated|2017-11-15|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride|Postoperative Analgesia After Cardiac Surgery - An Open-Label, Prospective and Randomized Comparison of Wound Infiltration With Liposomal Bupivacaine and Bupivacaine Hydrochloride|Not yet recruiting||Phase 3|117|Anticipated|University of Pittsburgh||2|||f||||t|t|f|||t|||||2017-10-10 20:44:49.386717|2017-10-10 20:44:49.386717
NCT03270501|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|GO-GUT||Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation|Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation, an Early Remission Induction Study|Not yet recruiting||Phase 3|147|Anticipated|University Ghent||1|||f|||||t|f|||t|||||2017-10-10 20:44:49.555025|2017-10-10 20:44:49.555025
NCT03270488|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-05|||March 24, 2017|Actual|2017-03-24|September 2017|2017-09-01|August 25, 2017|Actual|2017-08-25|August 15, 2017|Actual|2017-08-15||Interventional|Laser||Laser Therapy, Pain and Carpometacarpal Joint Osteoarthritis Treatment|Effects of Laser Therapy on Pain Intensity for Carpometacarpal Joint Osteoarthritis as a Isolated Treatment. A Randomized (Double-blind) Controlled Trial|Completed||N/A|43|Actual|University of Malaga||2|||f||||f|f|f||||||||2017-10-10 20:44:49.639941|2017-10-10 20:44:49.639941
NCT03270475|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Effect of Exercise on Muscle Proteome Signature|Effect of Exercise Training on Skeletal Muscle Proteome Signature of Young Men|Not yet recruiting||N/A|6|Anticipated|University of Copenhagen||1|||f||||t|f|f||||||||2017-10-10 20:44:49.723881|2017-10-10 20:44:49.723881
NCT03270462|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CNS Study of Patients Switching From Tacrolimus to Envarsus|A Pilot Study of Stable Kidney Transplant Recipients Taking Tacrolimus With CNS Symptoms Switched to Envarsus|Not yet recruiting||Phase 4|30|Anticipated|University of Colorado, Denver||1|||f||||f|t|f|||f|||||2017-10-10 20:44:49.797889|2017-10-10 20:44:49.797889
NCT03270449|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Community-based Intervention for Fibromyalgia: A Pilot Trial|A Multi-disciplinary, Community-based Group Intervention for Fibromyalgia: A Pilot Randomized Controlled Trial|Not yet recruiting||N/A|84|Anticipated|University of British Columbia||2|||f|||||f|f||||||||2017-10-10 20:44:49.890945|2017-10-10 20:44:49.890945
NCT03270436|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Diabetes Prevention Program Lifestyle Intervention in the Marshallese Population|Diabetes Prevention Program Lifestyle Intervention in the Marshallese Population|Not yet recruiting||N/A|378|Anticipated|University of Arkansas||2|||f||||t|f|f||||||||2017-10-10 20:44:49.992744|2017-10-10 20:44:49.992744
NCT03270423|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-17|||January 2017||2017-01-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|PM2||PathMate2: The Impact of Health Information System Services on the Effects of Therapy in Overweight Teenagers|PathMate2: The Impact of Health Information System Services on the Effects of Therapy in Overweight Teenagers|Recruiting||N/A|40|Anticipated|Ostschweizer Kinderspital||4|||f||||f||||||||||2017-10-10 20:44:50.086537|2017-10-10 20:44:50.086537
NCT03270410|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-31|||July 15, 2015|Actual|2015-07-15|August 2017|2017-08-01|July 15, 2018|Anticipated|2018-07-15|July 15, 2018|Anticipated|2018-07-15||Observational|VARI-NEONAT||Design of a Non-invasive Multi-modal Neonatal Monitoring System|Design of a Non-invasive Multi-modal Neonatal Monitoring System: Preliminary Observational Study|Recruiting||N/A|80|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:44:50.187792|2017-10-10 20:44:50.187792
NCT03270397|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-31|||August 1, 2013|Actual|2013-08-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||Addressing Body Image Issues While Teaching Academic Course: The Group- Theory and Practice|Addressing Body Image Issues While Teaching Academic Course: Efficacy Trial of Innovative Academic Initiative|Completed||N/A|139|Actual|Tel Hai College||2|||f||||t|f|f||||||||2017-10-10 20:44:50.283861|2017-10-10 20:44:50.283861
NCT03270345|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-01|||May 15, 2018|Anticipated|2018-05-15|September 2017|2017-09-01|May 18, 2018|Anticipated|2018-05-18|May 15, 2018|Anticipated|2018-05-15||Observational|DecubICUs||One-Day Prevalence Study on Pressure Injuries in Intensive Care Units|Multicentre International One-Day Prevalence Study on Pressure Injuries in Intensive Care Units|Not yet recruiting||N/A|1500|Anticipated|European Society of Intensive Care Medicine|||1||f||||f|f|f||||||||2017-10-10 20:44:50.674967|2017-10-10 20:44:50.674967
NCT03270332|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-20|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Inhaled Albuterol in Pulmonary Hypertension|Effect of Inhaled Albuterol on Pulmonary Hemodynamics in Patients With Group 1 Pulmonary Arterial Hypertension on Oral Pulmonary Vasodilator Therapy: A Proof of Concept Study|Not yet recruiting||Early Phase 1|6|Anticipated|University of Miami||2|||f||||f|t|f|||f|||||2017-10-10 20:44:50.756508|2017-10-10 20:44:50.756508
NCT03270319|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-31|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|3DICU||Evaluation of Three Dimensional Echocardiography in Critical Care Medicine|Evaluation of Three Dimensional Echocardiography in Critical Care Medicine|Recruiting||N/A|30|Anticipated|University Hospital Inselspital, Berne|||1||f||||f|f|f||||||||2017-10-10 20:44:50.839858|2017-10-10 20:44:50.839858
NCT03270306|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 30, 2018|Anticipated|2018-11-30|March 31, 2018|Anticipated|2018-03-31||Observational|||Eating Behaviours, Diet and Gastrointestinal Symptoms in Children With Autism Spectrum Disorders|Eating Behaviours, Diet Quality and Gastrointestinal Symptoms in Children With Autism Spectrum Disorders and Typically Developing Children: a Case-control Study|Not yet recruiting||N/A|130|Anticipated|Chinese University of Hong Kong|||1||f||||f|f|f||||Samples With DNA|"     Stool sample and blood sample   "|||2017-10-10 20:44:50.909291|2017-10-10 20:44:50.909291
NCT03270293|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-01|||March 2015||2015-03-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy and Tolerance Evaluation of a Bio-revitalizing Product Containing Hyaluronic Acid With High and Low Molecular Weight||Completed||N/A|64|Actual|Derming SRL||1|||f||||f||||||||||2017-10-10 20:44:50.969584|2017-10-10 20:44:50.969584
NCT03270280|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|April 11, 2018|Anticipated|2018-04-11|March 11, 2018|Anticipated|2018-03-11||Interventional|||Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis|Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis Before and After Treatment With Nigella Sativa (Kalonji) Oil|Not yet recruiting||Phase 2|25|Anticipated|University of Health Sciences Lahore||2|||f||||t|f|f|||f|||||2017-10-10 20:44:51.041941|2017-10-10 20:44:51.041941
NCT03270267|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|June 30, 2017|Actual|2017-06-30||Observational|MICI School||Chronic Inflammatory Bowel Diseases (IBD) and School Absenteeism|Chronic Inflammatory Bowel Diseases and School Absenteeism|Active, not recruiting||N/A|100|Actual|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:44:51.118671|2017-10-10 20:44:51.118671
NCT03270254|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|July 31, 2018|Anticipated|2018-07-31||Interventional|PDTV2||Photodynamic Therapy Plus Root Debridement in Gum Disease Treatment V2|A Split-mouth Randomised Controlled Clinical Trial of Photodynamic Therapy (PDT) as Adjunctive Therapy to Root Surface Debridement (RSD), Compared to RSD Alone in the Treatment of Residual Periodontal Pockets in Patients With Chronic Periodontitis|Not yet recruiting||N/A|35|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:44:51.176717|2017-10-10 20:44:51.176717
NCT03270241|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-20|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy|Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy|Recruiting||N/A|20|Anticipated|Johns Hopkins University||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:44:51.239951|2017-10-10 20:44:51.239951
NCT03270228|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-04|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|||Natural History of Nonspecific Pleuritis Diagnosed After Video-assisted-thoracoscopic-surgery|Natural History of Nonspecific Pleuritis Diagnosed After Video-assisted-thoracoscopic-surgery|Not yet recruiting||N/A|1000|Anticipated|Naestved Hospital|||1||f||||f|f|f||||||||2017-10-10 20:44:51.312999|2017-10-10 20:44:51.312999
NCT03270215|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|||The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion|The Added Value of CT Scanning for Discriminating Malignant From Non-malignant Causes in Patients With an Unilateral Pleural Effusion|Not yet recruiting||N/A|200|Anticipated|Naestved Hospital|||1||f||||f|f|f||||||||2017-10-10 20:44:51.373061|2017-10-10 20:44:51.373061
NCT03270189|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-10-02|||September 18, 2017|Actual|2017-09-18|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|PRISMADYS||Effect of the Visual Information Change in Functional Dystonia|Effect of the Visual Information Change in Functional Dystonia|Active, not recruiting||N/A|48|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f|f|f||||||||2017-10-10 20:44:51.550277|2017-10-10 20:44:51.550277
NCT03269643|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||August 31, 2017||2017-08-31||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:44:57.72547|2017-10-10 20:44:57.72547
NCT03270176|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-10-04|||October 9, 2017|Anticipated|2017-10-09|October 2017|2017-10-01|April 2020|Anticipated|2020-04-01|September 2019|Anticipated|2019-09-01||Interventional|||A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy|A Phase-Ib Dose-Finding Study of the SMAC Mimetic Debio 1143 When Given in Combination With the Anti-PD-L1 Antibody Avelumab to Patients With Advanced Solid Malignancies and, in an Expansion Cohort, to Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy|Recruiting||Phase 1|61|Anticipated|Debiopharm International SA||1|||f||||f|f|f||||||||2017-10-10 20:44:51.61472|2017-10-10 20:44:51.61472
NCT03270163|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-10-05|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|January 31, 2019|Anticipated|2019-01-31|December 31, 2018|Anticipated|2018-12-31||Interventional|STRENGHT-ICU||Evaluation of Muscle Strength by Transcutaneous Electrical Stimulation|Evaluation of Muscle Strength by Transcutaneous Electrical Stimulation in Intensive Care Unit Patients|Not yet recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 20:44:51.69237|2017-10-10 20:44:51.69237
NCT03270150|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||July 7, 2016|Actual|2016-07-07|August 2017|2017-08-01|September 15, 2017|Anticipated|2017-09-15|April 27, 2017|Actual|2017-04-27||Interventional|||Effect of the BTL-799 Therapy for Disruption of Adipocyte Cells of Abdomen|Effect of the BTL-799 Therapy for Disruption of Adipocyte Cells of Abdomen|Active, not recruiting||N/A|40|Anticipated|BTL Industries Ltd.||1|||f||||t|f|f|||f|||||2017-10-10 20:44:51.765021|2017-10-10 20:44:51.765021
NCT03270137|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-31|||March 10, 2016|Actual|2016-03-10|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|February 28, 2017|Actual|2017-02-28||Interventional|AD-EMTr||Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer Disease|Cognitive, Behavioral and Functional Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Potential Alzheimer Disease: Two Treatment Modalities Comparison|Active, not recruiting||N/A|19|Actual|Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente||2|||f||||t|f|f|||f|||||2017-10-10 20:44:51.818835|2017-10-10 20:44:51.818835
NCT03270124|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement|A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement (ACTIVE AFTER TAVR): A Pilot Study|Not yet recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:44:51.889657|2017-10-10 20:44:51.889657
NCT03270111|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women|High Energy Expenditure From Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women|Recruiting||N/A|25|Anticipated|University of Kansas Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:44:51.962957|2017-10-10 20:44:51.962957
NCT03270098|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-10-03|||October 31, 2017|Anticipated|2017-10-31|October 2017|2017-10-01|August 31, 2021|Anticipated|2021-08-31|April 30, 2021|Anticipated|2021-04-30||Interventional|||Improving Cognition Via Exercise in Schizophrenia|Improving Cognition Via Exercise in Schizophrenia|Not yet recruiting||N/A|200|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|f|f||||||||2017-10-10 20:44:52.053809|2017-10-10 20:44:52.053809
NCT03270072|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2027|Anticipated|2027-07-01|July 2022|Anticipated|2022-07-01||Observational|||The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients|The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients|Not yet recruiting||N/A|100|Anticipated|Massachusetts General Hospital|||2||f||||f|f|f||||||||2017-10-10 20:44:53.803368|2017-10-10 20:44:53.803368
NCT03270059|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|August 15, 2023|Anticipated|2023-08-15|August 15, 2022|Anticipated|2022-08-15||Interventional|||Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System|The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS|Not yet recruiting||Phase 2|150|Anticipated|OHSU Knight Cancer Institute||2|||||||t|t|f|||f|||||2017-10-10 20:44:53.875969|2017-10-10 20:44:53.875969
NCT03270046|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-04|||August 2013||2013-08-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effects of An Addition of Water Enema to PEG for Colon Preparation|The Effects of An Addition of Water Enema to PEG for Colon Preparation: A Randomized Controlled Trial|Completed||N/A|100|Actual|Mahidol University||2|||f||||f|f|f||||||||2017-10-10 20:44:53.96601|2017-10-10 20:44:53.96601
NCT03270033|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-10-03|||September 18, 2017|Actual|2017-09-18|October 2017|2017-10-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery|Analgesic Duration of Interscalene Block After Outpatient Arthroscopic Shoulder Surgery With Intravenous Dexamethasone, Dexmedetomidine or Their Combination: A Randomized Controlled Trial|Recruiting||Phase 4|189|Anticipated|University of Manitoba||3|||f||||f|f|f||||||||2017-10-10 20:44:54.043538|2017-10-10 20:44:54.043538
NCT03270020|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-09-08|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|February 28, 2020|Anticipated|2020-02-28||Interventional|||Denosumab for the Treatment of Adult LCH|Evaluation of Efficacy of Denosumab in Adult Patients With Langerhans Cell Histiocytosis (LCH): a Multiple-site, Single Arm, Open Label Clinical Trial|Recruiting||Phase 2|12|Anticipated|Hellenic Society for the Study of Bone Metabolism||1|||f||||f|f|f||||||||2017-10-10 20:44:54.191156|2017-10-10 20:44:54.191156
NCT03270007|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||September 18, 2017|Anticipated|2017-09-18|August 2017|2017-08-01|June 30, 2024|Anticipated|2024-06-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy|Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy|Not yet recruiting||Phase 4|304|Anticipated|Peking University||2|||f||||t|f|f||||||||2017-10-10 20:44:54.291473|2017-10-10 20:44:54.291473
NCT03269994|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-13|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|August 28, 2019|Anticipated|2019-08-28|August 28, 2019|Anticipated|2019-08-28||Interventional|||Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?|A Phase III Multicenter, Open Label Randomized Controlled Trial of Cefoxitin Versus Piperacillin-Tazobactam as Surgical Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy|Recruiting||Phase 3|100|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f||||||||2017-10-10 20:44:54.385136|2017-10-10 20:44:54.385136
NCT03269981|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|March 30, 2023|Anticipated|2023-03-30|March 30, 2021|Anticipated|2021-03-30||Interventional|||Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer|A Phase III Prospective Randomized Study of Elective Regional Lymph Node Irradiation in Pathologic N1 Breast Cancer Patients Treated With Breast Conserving Surgery|Recruiting||N/A|1926|Anticipated|Samsung Medical Center||2|||f|||||f|f||||||||2017-10-10 20:44:54.512966|2017-10-10 20:44:54.512966
NCT03269968|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery|Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery|Not yet recruiting||N/A|482|Anticipated|Medstar Health Research Institute||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:44:54.740861|2017-10-10 20:44:54.740861
NCT03269955|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-30|||February 27, 2017|Actual|2017-02-27|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effect of Application of TachoSil® in Pancreatoduodenectomy|The Effect of Application of Fibrinogen/Thrombin-coated Collagen Patch (TachoSil®) in Pancreaticojejunostomy for Prevention of Pancreatic Fistula After Pancreatoduodenectomy|Recruiting||Phase 4|126|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:44:54.849274|2017-10-10 20:44:54.849274
NCT03269942|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||March 14, 2015|Actual|2015-03-14|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|SCAT||Study of Complex Intracranial Aneurysm Treatment|Results of Revascularization Versus Endovascular Flow Diversion in Treatment of Complex Intracranial Aneurysms of Anterior Circulation|Active, not recruiting||N/A|110|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f|f|f||||||||2017-10-10 20:44:54.95623|2017-10-10 20:44:54.95623
NCT03269929|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-30|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|March 31, 2017|Actual|2017-03-31||Interventional|||Comparison Between Efficacy of Music Therapy and Intravenous Midazolam 0.02 mg/kgBW in Reducing Preoperative Anxiety|Comparison Between Music Therapy and Intravenous Midazolam 0,02 mg/kgBW in Reducing Preoperative Anxiety: Study on Patient Undergoing Brachytherapy With Spinal Anesthesia|Completed||N/A|60|Actual|Indonesia University||2|||f|||||f|f||||||||2017-10-10 20:44:55.047656|2017-10-10 20:44:55.047656
NCT03269916|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-29|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel Disease|Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel - a Cross-sectional Survey and Case Control Study|Recruiting||N/A|80|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 20:44:55.153376|2017-10-10 20:44:55.153376
NCT03269903|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-29|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|HILZO||TTS Esophageal HILZO Stent: A Safety and Feasibility Study|TTS Esophageal HILZO Covered Self-expandable Metal Stent for Palliation of Malignant Dysphagia: A Safety and Feasibility Study|Recruiting||N/A|30|Anticipated|Radboud University||1|||f||||f|f|f|||f|||||2017-10-10 20:44:55.253689|2017-10-10 20:44:55.253689
NCT03269877|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|October 1, 2018|Anticipated|2018-10-01||Observational|||Hypersplenism in Patients With Liver Cirrhosis and Portal Hypertension|Hypersplenism in Patients With Liver Cirrhosis and Portal Hypertension: Prevalence, Pattern, Correlations, and Therapy|Not yet recruiting||N/A|400|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:44:55.457468|2017-10-10 20:44:55.457468
NCT03269864|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||September 5, 2017|Anticipated|2017-09-05|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Use of Perforator Flaps for Leg and Foot Reconstruction|Use of Perforator Flaps for Leg and Foot Reconstruction|Not yet recruiting||N/A|40|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 20:44:55.525683|2017-10-10 20:44:55.525683
NCT03269838|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Correlation of QT Dispersion With Myocardial Perfusion in Patients With ST Elevation Myocardial Infarction Treated by Primary Per Cutaneous Coronary Intervention|Correlation of QT Dispersion With Myocardial Perfusion in Patients With ST Elevation Myocardial Infarction Treated by Primary Per Cutaneous Coronary Intervention|Recruiting||N/A|235|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:44:55.670381|2017-10-10 20:44:55.670381
NCT03269825|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-29|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||The Use of Computed Tomography (CT) to Measure Skeletal Muscle Quantity and Quality in Patients Receiving ECMO|The Use of Computed Tomography (CT) to Measure Skeletal Muscle Quantity and Quality in Patients Receiving ECMO|Recruiting||N/A|200|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 20:44:55.764976|2017-10-10 20:44:55.764976
NCT03269812|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Laparoscopic Assisted Pull-through Versus Other Surgical Procedures for Treatment of Hirschsprung Disease|Laparoscopic Assisted Pull-through Versus Other Surgical Procedures for Treatment of Hirschsprung Disease.|Not yet recruiting||N/A|60|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:44:55.839382|2017-10-10 20:44:55.839382
NCT03269799|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|August 19, 2018|Anticipated|2018-08-19|February 19, 2018|Anticipated|2018-02-19||Interventional|||Vitamin C as an Adjunct in Periodontal Treatment in Type 2 Diabetes Mellitus Patients|The Effect of Vitamin C as an Adjunct in Periodontal Treatment in Uncontrolled Type 2 Diabetes Mellitus Patients|Recruiting||Phase 2|30|Anticipated|Mahidol University||2|||f||||t|f|f||||||||2017-10-10 20:44:55.905479|2017-10-10 20:44:55.905479
NCT03269786|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-03|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|||Changes in Lab and Ultrasonography After Endoscopic Varisceal Treatment|Laoboratory and Ultrasonographic Changes After Endoscopic Varisceal Treatment|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||||2017-10-10 20:44:55.985719|2017-10-10 20:44:55.985719
NCT03269773|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-08-30|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Safery and Efficacy of FURESTEM-AD Inj. in Patients With Severe and Refractory Atopic Dermatitis(AD)|A Multi-center, Randomized, Double-blind, Parallel, Placebo-controlled Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of FURESTEM-AD Inj. for Severe and Refractory Atopic Dermatitis|Recruiting||Phase 2|206|Anticipated|Kang Stem Biotech Co., Ltd.||2|||f||||t|f|f||||||||2017-10-10 20:44:56.0556|2017-10-10 20:44:56.0556
NCT03269760|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|September 1, 2018|Anticipated|2018-09-01||Interventional|||Multimodal Sleep Pathway for Shoulder Arthroplasty|Advancing the Multimodal Pathway: Investigating the Use of Sleep and Zolpidem in the Recovery After Shoulder Arthroplasty|Recruiting||Phase 1|130|Anticipated|University of California, San Francisco||2|||f||||f|t|f|||t|||||2017-10-10 20:44:56.155045|2017-10-10 20:44:56.155045
NCT03269747|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|April 30, 2019|Anticipated|2019-04-30||Interventional|GlucoBAT||Short Term Effect of Glucocorticoids on Brown Adipose Tissue Thermogenesis in Humans|Short Term Effect of Glucocorticoids on Brown Adipose Tissue Thermogenesis in Humans|Not yet recruiting||Phase 4|16|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f|f|f|||f|||||2017-10-10 20:44:56.243796|2017-10-10 20:44:56.243796
NCT03269734|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|ARCHIBALD||Evaluation of the Accuracy of the Vessel Navigator Tool for Catheterization of Supra-aortic Vessels - ARCHIBALD|Evaluation of the Accuracy of the Vessel Navigator (Philips Healthcare) Tool for Catheterization of Aortic Arch and Supra-aortic Vessels - ARCHIBALD|Not yet recruiting||N/A|15|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:44:56.32606|2017-10-10 20:44:56.32606
NCT03269721|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-12|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|August 31, 2021|Anticipated|2021-08-31|December 31, 2020|Anticipated|2020-12-31||Observational|||COPD-Related Physiology and the Brain|Determinants of Altered Brain Structure and Function in Smokers With COPD-Related Lung Pathophysiology|Active, not recruiting||N/A|275|Anticipated|University of Iowa|||3||f||||t|f|f||||Samples With DNA|"     Stored blood samples may be used to evaluate additional biomarkers. These future studies may     provide additional information that will be helpful in understanding COPD and its     comorbidities. If consent is given, samples may also be used for potential genetic research.   "|||2017-10-10 20:44:56.404481|2017-10-10 20:44:56.404481
NCT03269708|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Improving Cardiac Secondary Prevention|Improving Cardiac Secondary Prevention Through Personalized Biomarker Knowledge|Not yet recruiting||N/A|200|Anticipated|Western University, Canada||2|||f||||f|f|f||||||||2017-10-10 20:44:56.62787|2017-10-10 20:44:56.62787
NCT03269695|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-10-03|||October 6, 2017|Anticipated|2017-10-06|October 2017|2017-10-01|March 24, 2020|Anticipated|2020-03-24|March 24, 2020|Anticipated|2020-03-24||Interventional|||Efficacy, Safety And Tolerability Of PF-06687234 As Add-On Therapy To Infliximab In Active UC Subjects Not In Remission|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-06687234 As Add-on Therapy To Infliximab In Active Ulcerative Colitis Subjects Who Are Not In Remission (BUILD UC)|Not yet recruiting||Phase 2|98|Anticipated|Pfizer||2|||f||||t|t|f||||||||2017-10-10 20:44:56.71433|2017-10-10 20:44:56.71433
NCT03269682|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|3D-III||Prevalence of Contrast Enhancement of the Oculomotor Nerve on 3D PD T1 MRI Sequence in Patients With Ophthalmoplegia|Prevalence of Contrast Enhancement of the Oculomotor Nerve on 3D PD T1 MRI Sequence in Patients With Ophthalmoplegia|Not yet recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:44:56.804495|2017-10-10 20:44:56.804495
NCT03269656|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||January 1, 2002|Actual|2002-01-01|August 2017|2017-08-01|December 31, 2014|Actual|2014-12-31|January 31, 2006|Actual|2006-01-31||Observational|AGES||Age Gene/Environment Susceptibility Reykjavik Study|Association of Pre-diagnostic Vitamin D Levels and Survival in Older Individuals With Cancer|Completed||N/A|5764|Actual|Icelandic Heart Association|||1||f||||f|f|f||||Samples With DNA|"     Serum samples   "|||2017-10-10 20:44:57.649516|2017-10-10 20:44:57.649516
NCT03269630|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2027|Anticipated|2027-10-01|October 2027|Anticipated|2027-10-01||Observational|NO-PH Biobank||New Orleans Pulmonary Hypertension Biobank|New Orleans Pulmonary Hypertension Biobank|Not yet recruiting||N/A|450|Anticipated|Louisiana State University Health Sciences Center in New Orleans|||3||f||||f|f|f||||Samples With DNA|"     Blood (serum, plasma, buffy coat, PBMCs) Urine Stool   "|||2017-10-10 20:44:57.763382|2017-10-10 20:44:57.763382
NCT03269617|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-30|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|||PHAGE Study: Bacteriophages as Novel Prebiotics|PreforPro: A Randomized, Placebo Controlled Crossover Study|Completed||N/A|43|Actual|Colorado State University||2|||f||||f|f|f||||||||2017-10-10 20:44:57.846385|2017-10-10 20:44:57.846385
NCT03269604|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Effectiveness of Three Times of Starting Antibiotic Prophylaxis in Patients With Asymptomatic Bacteriuria.|Effectiveness of Three Different Times of Starting Antibiotic Prophylaxis in Patients With Asymptomatic Bacteriuria Scheduled for Urological Surgery. A Randomized Multicentric Clinical Trial|Not yet recruiting||Phase 4|456|Anticipated|CES University||3|||f||||f|f|f||||||||2017-10-10 20:44:57.945017|2017-10-10 20:44:57.945017
NCT03269591|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|October 29, 2016|Actual|2016-10-29|September 30, 2016|Actual|2016-09-30||Interventional|magnetic||Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea|Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea: Arandomized Controlled Trial in the Egyptian Women|Completed||N/A|50|Actual|Cairo University||5|||f||||t|f|f|||f|||||2017-10-10 20:44:58.027726|2017-10-10 20:44:58.027726
NCT03269578|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-31|2017-08-31|||August 28, 2017|Actual|2017-08-28|August 23, 2017|2017-08-23|May 30, 2023|Anticipated|2023-05-30|May 23, 2023|Anticipated|2023-05-23||Observational|||Sample Collection and Tracking for the Developmental Therapeutics Clinic|Longitudinal Sample Collection and Tracking for the Developmental Therapeutics Clinic, National Cancer Institute|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f|||||f|f||||||||2017-10-10 20:44:58.121148|2017-10-10 20:44:58.121148
NCT03269565|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-19|||August 31, 2017|Actual|2017-08-31|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|MIRACULUM||International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma|An International Multicenter Open-label Randomized Trial of the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of BCD-100 (JSC BIOCAD, Russia) as Monotherapy in Patients With Unresectable/Metastatic Melanoma.|Recruiting||Phase 2/Phase 3|126|Anticipated|Biocad||2|||f||||t|f|f||||||||2017-10-10 20:44:58.186509|2017-10-10 20:44:58.186509
NCT03269552|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||October 11, 2017|Anticipated|2017-10-11|August 2017|2017-08-01|September 15, 2020|Anticipated|2020-09-15|September 15, 2020|Anticipated|2020-09-15||Interventional|||Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma|A Response-Adapted Clinical Trial of Weekly Carfilzomib With or Without Rituximab for Waldenström's Macroglobulinemia and Marginal Zone Lymphoma|Not yet recruiting||Phase 2|24|Anticipated|University of Washington||1|||||||t|t|f||||||||2017-10-10 20:44:58.270922|2017-10-10 20:44:58.270922
NCT03269539|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||November 2016||2016-11-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Observational|||Assessment of Siemens' GoBrain and DotBrain Software|Assessment of Siemens' GoBrain and DotBrain Software|Enrolling by invitation||N/A|60|Anticipated|University of Saskatchewan|||2||f||||f||||||||||2017-10-10 20:44:58.359413|2017-10-10 20:44:58.359413
NCT03269526|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-30|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||BATs Treatment for Pancreatic Cancer, Phase Ib/II|Phase Ib/II Treatment of Advanced Pancreatic Cancer With Anti-CD3 x Anti-EGFR-Bispecific Antibody Armed Activated T-Cells (BATs)|Recruiting||Phase 1/Phase 2|22|Anticipated|University of Virginia||1|||f||||t|t|f||||||||2017-10-10 20:44:58.421489|2017-10-10 20:44:58.421489
NCT03269513|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-30|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|December 8, 2017|Anticipated|2017-12-08|November 23, 2017|Anticipated|2017-11-23||Interventional|||OBESITY IN SCHOOLCHILDREN OF BASIC EDUCATION - Phase III 2017|OBESITY IN SCHOOLCHILDREN OF BASIC EDUCATION: a Study Interdisciplinary Intervention - Phase III|Enrolling by invitation||N/A|60|Actual|University of Santa Cruz do Sul||2|||f||||t|f|f||||||||2017-10-10 20:44:58.534162|2017-10-10 20:44:58.534162
NCT03269500|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-05|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|AlimAge||Evaluation of the Applicability of Personalized Tools About Nutrition Education for Malnourished Older People|Evaluation of the Applicability of Personalized Tools About Nutrition Education for Malnourished Older People|Recruiting||N/A|42|Anticipated|University Hospital, Bordeaux|||1||f||||f|f|f||||||||2017-10-10 20:44:58.628569|2017-10-10 20:44:58.628569
NCT03269487|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-30|||August 1, 2015|Actual|2015-08-01|May 2015|2015-05-01|September 1, 2016|Actual|2016-09-01|July 1, 2016|Actual|2016-07-01|1 Day|Observational [Patient Registry]|PERFECTED||PERFECTED WP2: Implementing Optimised Hospital Care|PERFECTED WP2: Implementing the Optimisation of Hospital Care Delivery to Older Adults by NHS Staff Via Action Research|Completed||N/A|270|Actual|University of East Anglia|||1||f||||f||||||||||2017-10-10 20:44:58.707892|2017-10-10 20:44:58.707892
NCT03269474|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Observational|||Computational Drug Repurposing for EBS|Computational Drug Repurposing for Epidermolysis Bullosa Simplex|Enrolling by invitation||N/A|16|Anticipated|Stanford University|||2||f||||f|f|f||||Samples With DNA|"     Punch biopsies of non-blistering and blistering skin, and peripheral blood mononuclear cells     (PBMCs): CD8+ cytotoxic T cells and CD4+ helper T cells.   "|||2017-10-10 20:44:58.762035|2017-10-10 20:44:58.762035
NCT03269461|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-10-03|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|REPAIR||Serial OCT Evaluation of Tissue Healing Score in Patients Submitted to Inspiron Drug Eluting Stent Implantation|Serial OCT Evaluation of Tissue Healing Score in Patients Submitted to Inspiron Drug Eluting Stent Implantation|Recruiting||N/A|60|Anticipated|Scitech Produtos Medicos Ltda||3|||f||||t|f|f||||||||2017-10-10 20:44:58.976829|2017-10-10 20:44:58.976829
NCT03256383|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Plan for Testing Fingerstick Bloods on Magellan Systems|Plan for Testing Fingerstick Bloods on Magellan Systems|Recruiting||N/A|190|Anticipated|Magellan Diagnostics|||3||f||||f|f|t|f|f|f|||||2017-10-10 20:46:51.61154|2017-10-10 20:46:51.61154
NCT03269448|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Correlation Between Peripheral and Central Venous Blood Partial Pressure of Carbon Dioxide in Critical Ill Patients|Correlation Between Peripheral and Central Venous Blood Partial Pressure of Carbon Dioxide in Critical Ill Patients|Not yet recruiting||N/A|100|Anticipated|Ramathibodi Hospital|||1||f||||f|f|f||||||||2017-10-10 20:44:59.121999|2017-10-10 20:44:59.121999
NCT03269435|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-30|||September 2018|Anticipated|2018-09-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|August 2020|Anticipated|2020-08-01||Interventional|||Greater Occipital Nerve Block Versus Metoclopramide|A Randomized Trial of Greater Occipital Nerve Block With Bupivacaine Versus Intravenous Metoclopramide for Acute Migraine|Not yet recruiting||Phase 4|170|Anticipated|Montefiore Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 20:44:59.198973|2017-10-10 20:44:59.198973
NCT03269422|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|August 28, 2019|Anticipated|2019-08-28|August 28, 2019|Anticipated|2019-08-28||Interventional|||Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)|A Phase I Feasibility Study of Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR Image-Guided, Intensity-Modulated Radiotherapy|Recruiting||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||f|t|f|||||||2017-10-10 20:44:59.279376|2017-10-10 20:44:59.279376
NCT03269409|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis|Double Blind, Phase I, Randomized, Parallel Group Study of Hip Decompression Compared to Hip Decompression Supplemented at the Point of Care With Adipose Derived Regenerative Cells for Bilateral Pre-Collapse Femoral Head Osteonecrosis|Not yet recruiting||N/A|25|Anticipated|Mayo Clinic||2|||f||||f|f|t|t|f||||||2017-10-10 20:44:59.388514|2017-10-10 20:44:59.388514
NCT03269396|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-30|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2032|Anticipated|2032-12-31|December 31, 2027|Anticipated|2027-12-31||Interventional|||Laryngeal Allograft Transplantation|A Prospective Nonrandomized Study of Laryngeal Allograft Transplantation Clinical Investigation|Enrolling by invitation||N/A|10|Anticipated|Mayo Clinic||1|||f||||t|f|f||||||||2017-10-10 20:44:59.48882|2017-10-10 20:44:59.48882
NCT03269383|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-30|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation|Study for the Evaluation of the Effectiveness of Stellate Ganglion Blockade in Preventing Postoperative Atrial Fibrillation|Not yet recruiting||Phase 4|707|Anticipated|Maine Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 20:44:59.572232|2017-10-10 20:44:59.572232
NCT03269370|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||August 2018|Anticipated|2018-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Family-Focused CBT Skills App and Standard Self Help Options for Childhood Anxiety|Randomized Controlled Trial of a Family-focused CBT Skills App and Standard Self Help Options for Childhood Anxiety and Related Conditions|Not yet recruiting||N/A|110|Anticipated|Kansas City Center for Anxiety Treatment, P.A.||4|||f||||f|f|f||||||||2017-10-10 20:44:59.700999|2017-10-10 20:44:59.700999
NCT03269357|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|LOWE||LARC Forward Counselling|Effectiveness of LARC Forward Contraceptive Counseling: LOWE - A Cluster Randomized Intervention Project|Not yet recruiting||N/A|1200|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 20:44:59.810704|2017-10-10 20:44:59.810704
NCT03269344|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-30|||June 5, 2017|Actual|2017-06-05|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer|Randomized Phase III, Double-Blind, Placebo Controlled Study of Prophylactic Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma|Recruiting||Phase 3|60|Anticipated|Henry Ford Health System||2|||f||||f|t|f||||||||2017-10-10 20:44:59.898448|2017-10-10 20:44:59.898448
NCT03269331|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-30|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|ARCC||Feasibility and Effectiveness of the Advancing Research and Clinical Practice Through Close Collaboration (ARCC)|Feasibility and Effectiveness of the Advancing Research and Clinical Practice Through Close Collaboration (ARCC) Model for Military Treatment Facility (MTF) Implementation of Nursing Evidence-Based Practice (EBP)|Enrolling by invitation||N/A|140|Anticipated|David Grant U.S. Air Force Medical Center|||2||f||||f|f|f||||||||2017-10-10 20:44:59.998395|2017-10-10 20:44:59.998395
NCT03269318|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-30|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|August 30, 2019|Anticipated|2019-08-30||Interventional|PRISTINE||PRISTINE - Personalised Approach to Improve aSThma prescrIbing iN childrEn|Feasibility of a Personalised Medicine Clinic for Children With Asthma Aged 5-11 Years|Active, not recruiting||Phase 4|60|Anticipated|Brighton and Sussex University Hospitals NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:45:00.134407|2017-10-10 20:45:00.134407
NCT03269305|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2017|Anticipated|2017-09-01||Observational|AAOMOCD||An Audit on Management of Chronic Diarrhea|An Audit on Management of Chronic Diarrhea|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:45:00.227993|2017-10-10 20:45:00.227993
NCT03269292|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Observational|||One Year Hospital Data Patients With AIHA in Assiut University Hospital - Clinical Hematology Unit|One Year Hospital Data Patients With Autoimmune Hemolytic Anaemia in Assiut University Hospital - Clinical Hematology Unit|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:00.282156|2017-10-10 20:45:00.282156
NCT03269279|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-30|||May 20, 2017|Actual|2017-05-20|August 2017|2017-08-01|May 19, 2018|Anticipated|2018-05-19|May 19, 2018|Anticipated|2018-05-19||Interventional|||Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso|Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy (13-22 Weeks LMP) in Burkina Faso|Recruiting||Phase 3|100|Anticipated|Gynuity Health Projects||1|||f||||t|f|f||||||||2017-10-10 20:45:00.350771|2017-10-10 20:45:00.350771
NCT03269266|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Scrub Typhus RDT Study|A Multicentre Observational Study to Describe the Prevalence of Scrub Typhus Defined as a Positive Rapid Diagnostic Test Among Selected Patients Presenting With Fever to Clinics in Myanmar|Not yet recruiting||N/A|600|Anticipated|Myanmar Oxford Clinical Research Unit|||1||f||||f|f|f||||||||2017-10-10 20:45:00.446456|2017-10-10 20:45:00.446456
NCT03269253|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Observational|||Maternal Loss of Control Eating|Maternal Loss of Control Eating: a Longitudinal Study of Maternal and Child Outcomes|Completed||N/A|14451|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f|f|f||||||||2017-10-10 20:45:00.529473|2017-10-10 20:45:00.529473
NCT03269240|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-30|||September 17, 2016|Actual|2016-09-17|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|LDHF-Nigeria||Simulation-based Low-dose High Frequency (LDHF) Plus Mobile Mentoring (m-Mentoring) Study in Nigeria|A Comparative Study of Simulation-based Low-dose High Frequency (LDHF) Plus Mobile Mentoring (m-Mentoring) Versus Traditional Group-based Training Approaches Among Maternal and Newborn Healthcare Providers in Ebonyi and Kogi States, Nigeria|Active, not recruiting||N/A|299|Actual|Jhpiego||2|||f||||f|f|f||||||||2017-10-10 20:45:00.609074|2017-10-10 20:45:00.609074
NCT03269227|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-07|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|MesoRT||Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma|Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma|Recruiting||N/A|30|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f|f|f||||||||2017-10-10 20:45:00.684423|2017-10-10 20:45:00.684423
NCT03269214|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-31|||September 1, 2012|Actual|2012-09-01|August 2017|2017-08-01|March 30, 2017|Actual|2017-03-30|October 31, 2016|Actual|2016-10-31||Interventional|||Use of Topical Phenytoin in Bisphosphonate-related Osteonecrosis of the Mandible|Does Topical Phenytoin Enhance Healing Process in Bisphosphonate-related Osteonecrosis of the Mandible. A Uni-blind Clinical Trial Study|Completed||N/A|20|Actual|Shiraz University of Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 20:45:00.771756|2017-10-10 20:45:00.771756
NCT03269201|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-29|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 15, 2022|Anticipated|2022-09-15|September 15, 2020|Anticipated|2020-09-15||Observational|BNA-MDi||Brain Network Activation in Patients With Movement Disorders|Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) EEG Signals in Patients With Movement Disorders|Not yet recruiting||N/A|300|Anticipated|Sheba Medical Center|||9||f||||f|f|f||||||||2017-10-10 20:45:00.846677|2017-10-10 20:45:00.846677
NCT03269188|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||July 6, 2016|Actual|2016-07-06|August 2017|2017-08-01|October 27, 2016|Actual|2016-10-27|October 10, 2016|Actual|2016-10-10||Observational|PPOPinC/S||Incidence and Associated Factors of Persistent Postoperative Incision Scar Pain Following C/s in Mulago Hospital|Incidence and Associated Factors of Persistent Postoperative Incision Scar Pain Following C/s in Mulago Hospital|Completed||N/A|277|Actual|Makerere University|||1||f||||f|f|f||||||||2017-10-10 20:45:00.932433|2017-10-10 20:45:00.932433
NCT03269175|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-26|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies|BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies|Not yet recruiting||Phase 4|300|Anticipated|Bayer||2|||f||||f|f|f||||||||2017-10-10 20:45:01.01302|2017-10-10 20:45:01.01302
NCT03269162|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-13|||September 30, 2016|Actual|2016-09-30|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection|The Prognosis Study of Postoperative Non-small-cell Lung Cancer Patients Treated Precisely With the Integrated Traditional Chinese and Western Medicine Based on CTC Detection|Active, not recruiting||Phase 3|144|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t|f|f||||||||2017-10-10 20:45:01.100773|2017-10-10 20:45:01.100773
NCT03269149|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-21|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Tango for Alzheimer's Disease Patients' Caregivers|Effects of Adapted Tango on African-American Women Caregivers of Alzheimer's Disease Patients|Recruiting||N/A|60|Anticipated|Emory University||2|||f||||t|f|f||||||||2017-10-10 20:45:01.18723|2017-10-10 20:45:01.18723
NCT03269136|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|December 2020|Anticipated|2020-12-01||Interventional|||Phase 1 Study Of PF-06863135, A BCMA- CD3 Bispecific Ab, In Relapse/ Refractory Multiple Myeloma|A Phase I, Open Label Study To Evaluate The Safety, Pharmacokinetic, Pharmacodynamic And Clinical Activity Of Pf-06863135, A B-cell Maturation Antigen (Bcma)-cd3 Bispecific Antibody, In Patients With Relapsed/Refractory Advanced Multiple Myeloma (mm)|Not yet recruiting||Phase 1|140|Anticipated|Pfizer||1|||f||||f|t|f||||||||2017-10-10 20:45:01.310095|2017-10-10 20:45:01.310095
NCT03269123|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-29|||March 2, 2010|Actual|2010-03-02|August 2017|2017-08-01|August 8, 2011|Actual|2011-08-08|August 8, 2011|Actual|2011-08-08||Interventional|||A Mechanical Device for Blepharospasm|Clinical Trial of a Mechanical Device for the Treatment of Blepharospasm|Completed||N/A|58|Actual|Oxford University Hospitals NHS Trust||1|||f||||f|f|f||||||||2017-10-10 20:45:01.424295|2017-10-10 20:45:01.424295
NCT03269110|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-29|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Observational|||Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)|Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)|Active, not recruiting||N/A|2578|Anticipated|Ottawa Hospital Research Institute|||1||f||||t|f|f||||||||2017-10-10 20:45:01.578557|2017-10-10 20:45:01.578557
NCT03269097|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||July 3, 2017||2017-07-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:45:01.875731|2017-10-10 20:45:01.875731
NCT03269084|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||November 7, 1994|Actual|1994-11-07|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|DIPP||Type 1 Diabetes Prediction and Prevention (DIPP) Study|Type 1 Diabetes Prediction and Prevention (DIPP) Study|Recruiting||N/A|17000|Anticipated|University of Oulu|||1||f||||f|f|f||||||||2017-10-10 20:45:01.931681|2017-10-10 20:45:01.931681
NCT03269071|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-31|||May 17, 2017|Actual|2017-05-17|August 2017|2017-08-01|August 15, 2020|Anticipated|2020-08-15|August 15, 2020|Anticipated|2020-08-15||Interventional|STEMS||Neural Stem Cell Transplantation in Multiple Sclerosis Patients|Neural Stem Cell Transplantation in Multiple Sclerosis Patient: a Phase I Study|Enrolling by invitation||Phase 1|4|Actual|IRCCS San Raffaele||4|||f||||t|f|f||||||||2017-10-10 20:45:02.090931|2017-10-10 20:45:02.090931
NCT03269058|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|Cinétique DAPA||Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes|Effects of Dapagliflozin on Lipoprotein Kinetics in Patients With Type 2 Diabetes|Not yet recruiting||Phase 4|28|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f|||||f|f||||||||2017-10-10 20:45:02.329262|2017-10-10 20:45:02.329262
NCT03269045|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||August 31, 2013|Actual|2013-08-31|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Study of Biotin in Patients With Biotinidase Deficiency|An Open-label, Single-arm, Phase 2 Study of Biotin in Patients With Biotinidase Deficiency|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Orpha Labs||1|||f||||t|f|f|||f|||||2017-10-10 20:45:02.425477|2017-10-10 20:45:02.425477
NCT03269032|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Mediterranean Diet and the Gut Microbiome|Impact of the Mediterranean Diet on the Gut Microbiome and Symptoms of Diarrhea-Predominant Irritable Bowel Syndrome|Not yet recruiting||N/A|30|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-10 20:45:02.498197|2017-10-10 20:45:02.498197
NCT03269019|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||November 20, 2017|Anticipated|2017-11-20|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|August 19, 2019|Anticipated|2019-08-19||Observational|||Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia|Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia|Not yet recruiting||N/A|200|Anticipated|Wuhan Asia Heart Hospital|||3||f||||t|f|f||||||||2017-10-10 20:45:02.619839|2017-10-10 20:45:02.619839
NCT03269006|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-30|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|April 30, 2016|Actual|2016-04-30||Interventional|||Improved Case Detection and Vector Control for Visceral Leishmaniasis|Improved Visceral Leishmaniasis (VL) Case Detection and Vector Control to Support the VL Elimination Initiative in Bangladesh|Enrolling by invitation||N/A|202|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||5|||f||||t|f|f||||||||2017-10-10 20:45:02.704457|2017-10-10 20:45:02.704457
NCT03268993|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-28|||June 26, 2017|Actual|2017-06-26|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer|A Phase 0 Study Evaluating the Systemic Bioavailability and Pharmacodynamic Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer|Recruiting||N/A|36|Anticipated|University of Pittsburgh||1|||f||||t|f|f||||||||2017-10-10 20:45:02.802284|2017-10-10 20:45:02.802284
NCT03268980|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Observational|TABAC-HCL||Smoking Prevalence at a University Hospital|"Study of Smoking Prevalence at the Hospices Civils de Lyon"|Not yet recruiting||N/A|15693|Anticipated|Hospices Civils de Lyon|||3||f||||f|f|f||||||||2017-10-10 20:45:02.906893|2017-10-10 20:45:02.906893
NCT03268967|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||April 1, 2014|Actual|2014-04-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|October 1, 2017|Anticipated|2017-10-01||Interventional|||Optimized Admission to the Intensive Care Unit by Using Crisis Resource Management (CRM)|Optimized Admission to the Intensive Care Unit by Using Crisis Resource Management (CRM)|Active, not recruiting||N/A|1800|Anticipated|Hillerod Hospital, Denmark||2|||f||||t|f|f||||||||2017-10-10 20:45:02.989315|2017-10-10 20:45:02.989315
NCT03268941|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-15|||September 22, 2017|Anticipated|2017-09-22|September 2017|2017-09-01|January 5, 2018|Anticipated|2018-01-05|January 5, 2018|Anticipated|2018-01-05||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)|A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis|Not yet recruiting||Phase 1|48|Anticipated|Takeda||6|||f||||f|t|f||||||||2017-10-10 20:45:03.209069|2017-10-10 20:45:03.209069
NCT03268928|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Evaluating the Impact of Story Starters on Children's Language Development|Evaluating the Impact of Story Starters on Children's Language Development|Not yet recruiting||N/A|240|Anticipated|University of Liverpool||2|||f||||f|f|f||||||||2017-10-10 20:45:03.315475|2017-10-10 20:45:03.315475
NCT03268915|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-04|||February 9, 2017|Actual|2017-02-09|September 2017|2017-09-01|April 9, 2018|Anticipated|2018-04-09|February 9, 2018|Anticipated|2018-02-09||Interventional|ST2-IPF||Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test|Assessment of the Reproducibility of the 3 Minutes Sit-to-stand Test in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Recruiting||N/A|40|Anticipated|University Hospital, Grenoble||1|||f||||t|f|f||||||||2017-10-10 20:45:03.437205|2017-10-10 20:45:03.437205
NCT03268902|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-11|||September 5, 2017|Actual|2017-09-05|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|ELICIT||Early Life Interventions for Childhood Growth and Development In Tanzania|Early Life Interventions for Childhood Growth and Development In Tanzania|Recruiting||Phase 2/Phase 3|1188|Anticipated|Haydom Lutheran Hospital||4|||f||||t|t|f|||t|||||2017-10-10 20:45:03.562051|2017-10-10 20:45:03.562051
NCT03268889|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|September 15, 2020|Anticipated|2020-09-15|June 15, 2020|Anticipated|2020-06-15||Interventional|CHOP||Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)|Chidamide With Cyclophosphamide, Etoposide, Vincristine and Prednisone for de Novo Peripheral T Cell Lymphoma Patients|Recruiting||N/A|39|Anticipated|The First Affiliated Hospital of Soochow University||1|||f|||||f|f||||||||2017-10-10 20:45:03.695302|2017-10-10 20:45:03.695302
NCT03268876|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|INFLUENCE||The INFLUENCE of Cytoreduction on PRO in EOC|The INFLUENCE of Cytoreduction on Patient Reported Outcomes in Patients With Epithelial Ovarian Cancer|Not yet recruiting||N/A|70|Anticipated|Haukeland University Hospital|||1||f||||f|f|f||||Samples With DNA|"     Blood, urine and tumor biopsies   "|||2017-10-10 20:45:03.791297|2017-10-10 20:45:03.791297
NCT03268863|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-29|||September 10, 2017|Anticipated|2017-09-10|August 2017|2017-08-01|December 20, 2017|Anticipated|2017-12-20|December 10, 2017|Anticipated|2017-12-10||Interventional|||Evaluating VR Therapy Using Cold Pressor Test|Using the Cold Pressor Test to Assess Effectiveness of Low-Cost, Immersive Virtual Reality Therapy|Recruiting||N/A|80|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 20:45:03.877435|2017-10-10 20:45:03.877435
NCT03268850|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-30|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Interventional|||Living Kidney Donor Lost Wages Trial|Living Donor Lost Wages Trial|Not yet recruiting||N/A|735|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:45:03.977547|2017-10-10 20:45:03.977547
NCT03268837|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|October 2019|Anticipated|2019-10-01||Interventional|||Programmed Intermittent Bolus for Infusion of Local Anesthetic During Continuous Interscalene Nerve Blockade for Total Shoulder Arthroplasty: a Randomized Controlled Trial|Programmed Intermittent Bolus for Infusion of Local Anesthetic During Continuous Interscalene Nerve Blockade for Total Shoulder Arthroplasty: a Randomized Controlled Trial|Not yet recruiting||N/A|110|Anticipated|Lawson Health Research Institute||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:45:04.05535|2017-10-10 20:45:04.05535
NCT03268824|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|EPITRACT||Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain|Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain: Combination of Intracerebral Stereotactic Electroencephalography Recording and Diffusion Tensor Imaging in Children With Drug-resistant Focal Epilepsy|Not yet recruiting||N/A|82|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||f|f|f||||||||2017-10-10 20:45:04.140014|2017-10-10 20:45:04.140014
NCT03268811|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-20|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302|A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Japanese Pediatric Subjects With Short Bowel Syndrome Who Completed SHP633-302|Recruiting||Phase 3|5|Anticipated|Shire||1|||f||||t|t|f|||t|||||2017-10-10 20:45:04.231334|2017-10-10 20:45:04.231334
NCT03268798|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-29|||March 2015||2015-03-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|||Unilateral Wrist Extension Training After Stroke|Unilateral Wrist Extension Training After Stroke|Completed||N/A|24|Actual|University of Victoria||1|||f||||f||||||||||2017-10-10 20:45:04.321422|2017-10-10 20:45:04.321422
NCT03268785|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Intra-operative Rapid Identification of Lymph Node and Parathyroid|Intra-operative Rapid Identification of Lymph Node and Parathyroid by Fine Needle Puncture for Thyroid Carcinoma|Recruiting||N/A|200|Anticipated|Xijing Hospital||2|||f||||t|f|f||||||||2017-10-10 20:45:04.400944|2017-10-10 20:45:04.400944
NCT03268772|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||April 1, 2015|Actual|2015-04-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS|Pegylated-liposome Doxorubicin Combined With Ifosfamide As First-line Treatment for Patients With Advanced or Metastatic Soft Tissue Sarcoma|Recruiting||Phase 2|40|Anticipated|Fudan University||1|||f||||f|f|f||||||||2017-10-10 20:45:04.500338|2017-10-10 20:45:04.500338
NCT03268759|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 14, 2022|Anticipated|2022-09-14|September 14, 2020|Anticipated|2020-09-14||Observational|||Development of Reward Processing in Prenatally Exposed Adolescents and Young Adults|Development of Reward Processing in Prenatally Exposed Adolescents and Young Adults|Not yet recruiting||N/A|92|Anticipated|Yale University|||2||f||||f|f|f||||||||2017-10-10 20:45:04.594207|2017-10-10 20:45:04.594207
NCT03268746|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||October 2017||2017-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:45:04.66598|2017-10-10 20:45:04.66598
NCT03268733|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|FolicacidPCOS||The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome|The Clinical and Biochemical Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome (PCOS)|Recruiting||Phase 1/Phase 2|90|Anticipated|University of Khartoum||2|||f||||f|f|f||||||||2017-10-10 20:45:04.707778|2017-10-10 20:45:04.707778
NCT03268720|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-29|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|NCGS||Influence of the Immunosystem in Non-celiac Glutensensitivity|Influence of the Immunosystem in Non-celiac Glutensensitivity|Completed||N/A|29|Actual|University of Erlangen-Nürnberg Medical School||2|||f|||||f|f||||||||2017-10-10 20:45:04.816655|2017-10-10 20:45:04.816655
NCT03268707|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-28|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|TRACE-AF||Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization|Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization And Quality of Life After Cryoballoon Pulmonary vEin Isolation in Patients With Paroxysmal Atrial Fibrillation|Recruiting||N/A|100|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f|f|f||||||||2017-10-10 20:45:04.910028|2017-10-10 20:45:04.910028
NCT03268694|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|July 31, 2022|Anticipated|2022-07-31|July 31, 2022|Anticipated|2022-07-31||Interventional|||Investigation of Oscillations Underlying Human Cognitive and Affective Processing Using Intracranial EEG|Investigation of Oscillations Underlying Human Cognitive and Affective Processing Using Intracranial EEG|Enrolling by invitation||N/A|30|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f|f|f||||||||2017-10-10 20:45:05.026445|2017-10-10 20:45:05.026445
NCT03268681|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-05|||July 26, 2017|Actual|2017-07-26|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Observational|BIOTIN||BIOtinidase Test In Optic-Neuropathy|BIOtinidase Test In Optic-Neuropathy|Recruiting||N/A|30|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:45:05.293583|2017-10-10 20:45:05.293583
NCT03268668|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|COMPO-CLOT||Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis|Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis|Recruiting||N/A|1200|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:45:05.374434|2017-10-10 20:45:05.374434
NCT03268642|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-31|||February 1, 2016||2016-02-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Clinical Assessment of New Treatment Regimen for Adult Fulminant Myocarditis|"Assesment of Clinical Therapeutic Efficacy of Life-support Based Comprehensive Treatment Regimen for Adult Fulminant Myocarditis"|Recruiting||N/A|150|Anticipated|Tongji Hospital|||2||f||||||||||||||2017-10-10 20:45:05.553731|2017-10-10 20:45:05.553731
NCT03268629|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-30|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Mindfulness Based Intervention for Insomnia ('Joyful Sleep') in Young and Middle-aged Patients With Insomnia|Efficacy of Mindfulness Based Intervention for Insomnia ('Joyful Sleep') in Young and Middle-aged Patients With Insomnia in China|Not yet recruiting||N/A|150|Anticipated|Central South University||3|||f||||f|f|f||||||||2017-10-10 20:45:05.628597|2017-10-10 20:45:05.628597
NCT03268616|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-31|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|July 2, 2017|Actual|2017-07-02|March 7, 2017|Actual|2017-03-07||Interventional|||Analyse the Correlation Between sEMG and EMGdi|Investigation of the Correlation of Surface Respiratory EMG With Esophageal Diaphragm EMG|Completed||N/A|20|Actual|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||f|f|f||||||||2017-10-10 20:45:05.70561|2017-10-10 20:45:05.70561
NCT03268603|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-09-15|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)|A Phase II Study of Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis|Recruiting||Phase 2|60|Anticipated|Mayo Clinic||1|||f||||f|t|f||||||||2017-10-10 20:45:05.779502|2017-10-10 20:45:05.779502
NCT03268590|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Neuroimaging During Pure Oxygen Breathing|"Hyperoxia: An Unrecognized Mechanism for Inducing Hypoxia-Like Symptoms"|Enrolling by invitation||Phase 4|32|Anticipated|Case Western Reserve University||2|||f||||t|t|f||||||||2017-10-10 20:45:05.853569|2017-10-10 20:45:05.853569
NCT03268577|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-30|2017-08-30|||January 1, 2012|Actual|2012-01-01|August 2017|2017-08-01|December 31, 2013|Actual|2013-12-31|December 31, 2013|Actual|2013-12-31||Observational|||Internet-Based and Self-Reports in Assessing Diet and Physical Activity Within AARP|Interactive Diet and Activity Tracking in AARP (IDATA): Biomarker Based Validation Study of Internet-Based and Conventional Self-Report Instruments for Assessing Diet and Physical Activity Within AARP|Completed||N/A|1130|Actual|National Cancer Institute (NCI)|||1||f||||f||||||Samples With DNA|"     saliva, urine, blood   "|||2017-10-10 20:45:05.920633|2017-10-10 20:45:05.920633
NCT03268564|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Promoting HIV Self-testing With Real-time Online Counseling for MSM in Hong Kong|An Evidence-based Knowledge Transfer Program Promoting HIV Self-testing With Real-time Online Counseling for Men Who Have Sex With Men in Hong Kong|Recruiting||N/A|350|Anticipated|Chinese University of Hong Kong||1|||f||||t|f|f||||||||2017-10-10 20:45:06.001544|2017-10-10 20:45:06.001544
NCT03268551|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-29|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Observational|||MEMO-Medical Marijuana and Opioids Study|Does Medical Cannabis Reduce Opioid Analgesics in HIV+ and HIV- Adults With Pain?|Not yet recruiting||N/A|250|Anticipated|Albert Einstein College of Medicine, Inc.|||1||f||||f|f|f||||||||2017-10-10 20:45:06.081602|2017-10-10 20:45:06.081602
NCT03268538|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||April 3, 2017|Actual|2017-04-03|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Finger Wearable Device to Monitor Heart Rate Variability and Oxygen Saturation|Evaluation of Finger Wearable Device to Monitor Heart Rate Variability and Oxygen Saturation in Older People|Recruiting||N/A|300|Anticipated|Chinese University of Hong Kong|||1||f|||||f|f||||||||2017-10-10 20:45:06.161398|2017-10-10 20:45:06.161398
NCT03268525|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||The Effect of Local Anesthesia on Postoperative Pain in Vaginal Hysterectomy|The Effect of Local Anesthesia on Postoperative Pain in Vaginal Hysterectomy: A Randomized Controlled Trial|Not yet recruiting||Early Phase 1|50|Anticipated|Wolfson Medical Center||2|||f||||t|f|f|||f|||||2017-10-10 20:45:06.218203|2017-10-10 20:45:06.218203
NCT03268512|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||August 22, 2015|Actual|2015-08-22|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of L-PRF and A-PRF in Ridge Preservation|The Use of L-PRF and A-PRF in Ridge Preservation: a Randomized Controlled Clinical Trial|Recruiting||N/A|22|Anticipated|Universitaire Ziekenhuizen Leuven||3|||f|||||f|f||||||||2017-10-10 20:45:06.415575|2017-10-10 20:45:06.415575
NCT03268499|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||TACE Emulsion Versus Suspension|Lipiodol-based Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Randomized Controlled Trial of Aqueous Cisplatin Emulsion Versus Cisplatin Particle Suspension|Recruiting||Phase 2|368|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:45:06.518212|2017-10-10 20:45:06.518212
NCT03268486|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|May 1, 2018|Anticipated|2018-05-01|6 Months|Observational [Patient Registry]|||Evaluation of a Novel Signal Acquisition Technique for Intrapartum Cardiotocography|Evaluation of a Novel Signal Acquisition Technique for Intrapartum Cardiotocography|Not yet recruiting||N/A|50|Anticipated|University of Lisbon|||1||f||||f|f|f||||||||2017-10-10 20:45:06.623937|2017-10-10 20:45:06.623937
NCT03268473|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-05|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|OSAS||Effect of Non-surgical Periodontal Treatment on Oxidative Stress and Antioxidant Status in OSAS|Effect of Non-surgical Periodontal Treatment on Oxidative Stress and Antioxidant Status in Obstructive Sleep Apnea Syndrome (OSAS)|Recruiting||N/A|60|Anticipated|Bezmialem Vakif University||2|||f|||||f|f||||||||2017-10-10 20:45:06.707588|2017-10-10 20:45:06.707588
NCT03268460|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Incidence of Renal Tubular Acidosis in Nephrology Unit in Assiut University Childern Hospital|Incidence of Renal Tubular Acidosis in Nephrology Unit in Assiut University Childern Hospital (AUCH)|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:06.851731|2017-10-10 20:45:06.851731
NCT03268447|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-30|||June 5, 2017|Actual|2017-06-05|August 2017|2017-08-01|June 5, 2018|Anticipated|2018-06-05|June 5, 2018|Anticipated|2018-06-05||Interventional|P8||Lactobacillus Plantarum P8 for Its Brain Health Promotion Potential|Lactobacillus Plantarum P8 for Its Brain Health Promotion Potential|Recruiting||N/A|176|Anticipated|University of Science Malaysia||2|||f||||f|f|f||||||||2017-10-10 20:45:06.935956|2017-10-10 20:45:06.935956
NCT03268434|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Evaluation of Metacognitive Training for Depression (D-MCT) in Outpatient Care|Evaluation of Metacognitive Training for Depression (D-MCT) in Outpatient Psychiatric-psychotherapeutic Care: Randomized Controlled Trial|Recruiting||N/A|86|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f|f|f||||||||2017-10-10 20:45:07.062276|2017-10-10 20:45:07.062276
NCT03268421|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2023|Anticipated|2023-01-01|May 2022|Anticipated|2022-05-01||Interventional|FIT Teens||Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia|Multi-site Randomized Clinical Trial of FIT Teens for Juvenile Fibromyalgia|Not yet recruiting||N/A|420|Anticipated|Children's Hospital Medical Center, Cincinnati||3|||f||||t|f|f||||||||2017-10-10 20:45:07.220931|2017-10-10 20:45:07.220931
NCT03268408|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-30|||September 1, 2014|Actual|2014-09-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2015|Actual|2015-12-31||Observational|BabyNewsletter||"Impact Evaluation of the Baby Newsletter"|"Impact Evaluation of the Baby Newsletter Project: an Intervention to Improve Parenting Self-efficacy in the First Year of Newborn's Life"|Active, not recruiting||N/A|136|Actual|Azienda Unità Sanitaria Locale Reggio Emilia|||2||f||||f|f|f||||||||2017-10-10 20:45:07.380982|2017-10-10 20:45:07.380982
NCT03268395|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||August 29, 2017|Actual|2017-08-29|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|August 29, 2018|Anticipated|2018-08-29||Interventional|||Correlation of CO2 Measured by Blood Gas vs Transcutaneous Monitor|The Correlation of CO2 Measured by SenTec Transcutaneous Monitoring With Arterial Blood Gas CO2 Levels in Neonates|Recruiting||N/A|266|Anticipated|Memorial Health University Medical Center||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:45:07.490205|2017-10-10 20:45:07.490205
NCT03268382|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-10-03|||July 31, 2017|Actual|2017-07-31|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246|PiSARRO-R: p53 Suppressor Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Phase II Study of Systemic Pegylated Liposomal Doxorubicin Chemotherapy With APR-246|Recruiting||Phase 2|25|Anticipated|Aprea Therapeutics AB||1|||f||||t|t|f||||||||2017-10-10 20:45:07.58733|2017-10-10 20:45:07.58733
NCT03268369|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-30|||February 2012|Actual|2012-02-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|NICOPET||PET Study of the Nicotinic System in Epilepsy|PET Study of the Nicotinic System in Epilepsy|Completed||N/A|48|Actual|University Hospital, Geneva||5|||f||||f|f|f||||||||2017-10-10 20:45:07.719217|2017-10-10 20:45:07.719217
NCT03268356|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||August 15, 2017||2017-08-15||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:45:07.812223|2017-10-10 20:45:07.812223
NCT03268343|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-22|||August 7, 2017|Actual|2017-08-07|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Actual|2017-09-01||Interventional|||A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine|A Phase 1 Open Label, Randomized, Two-Way Crossover Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine|Recruiting||Phase 1|24|Anticipated|Achieve Life Sciences||2|||f||||f|t|f||||||||2017-10-10 20:45:07.862163|2017-10-10 20:45:07.862163
NCT03268330|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|||Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis|Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:45:07.968864|2017-10-10 20:45:07.968864
NCT03268317|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs|Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:45:08.097124|2017-10-10 20:45:08.097124
NCT03268304|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Observational|||Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments|Feasibility of Two Novel Interactive Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments Using the YouGrabber Training System — the KAYO Study Protocol|Not yet recruiting||N/A|75|Anticipated|Reha Rheinfelden|||1||f||||f||||||||||2017-10-10 20:45:08.218316|2017-10-10 20:45:08.218316
NCT03268291|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||"Communicational Program Trust to Improve Adherence to Medications"|"Impact of Communicational Program Trust on Adherence to Medications in Patients With Prior Myocardial Infarction Who Underwent Successful Revascularization by Stenting or Thrombolysis: A Prospective Multicenter Randomized Trial"|Recruiting||N/A|2000|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f|f|f||||||||2017-10-10 20:45:08.335871|2017-10-10 20:45:08.335871
NCT03268278|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-28|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|EBPEA||Efficacy of Buprenorphine on Postoperative Endodontic Analgesia|Efficacy of Buprenorphine on Postoperative Endodontic Analgesia|Not yet recruiting||Phase 1|20|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 20:45:08.475407|2017-10-10 20:45:08.475407
NCT03268265|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-12|||September 4, 2017||2017-09-04||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:45:08.571855|2017-10-10 20:45:08.571855
NCT03268252|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-08-28|||June 2012||2012-06-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|MDA||Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG|Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis: Monitoring Efficacy of Ongoing Treatment Programs in Papua New Guinea|Recruiting||N/A|3200|Anticipated|University Hospitals Cleveland Medical Center|||2||f||||t||||||Samples With DNA|"     Any remaining from the finger stick/stool samples will be cryopreserved for subsequent     testing for presence of other infections that have public health importance in PNG (e.g.,     malaria) using molecular or serological assays. Genetic testing of samples for the LF,     malaria or common blood borne or intestinal infections will be performed using microsatellite     markers or highly polymorphic genes as confirmatory diagnostic tests and/or to assess the     diversity of the parasite populations in the communities.   "|||2017-10-10 20:45:08.616538|2017-10-10 20:45:08.616538
NCT03268239|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|COGITE||Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions|Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions|Recruiting||N/A|180|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||f|f|f||||||||2017-10-10 20:45:08.712907|2017-10-10 20:45:08.712907
NCT03268226|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-21|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|January 30, 2019|Anticipated|2019-01-30|July 31, 2018|Anticipated|2018-07-31||Interventional|FRI||Functional Respiratory Imaging Study (FRI)|Open Label, Prospective, Exploratory Study to Investigate the Effect of Inhaled CHF5993 pMDI on Central and Peripheral Airway Dimensions in COPD Patients by Functional Respiratory Imaging|Not yet recruiting||Phase 3|30|Anticipated|Chiesi Farmaceutici S.p.A.||1|||f||||f|f|f||||||||2017-10-10 20:45:08.818411|2017-10-10 20:45:08.818411
NCT03268213|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-28|||November 2013||2013-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|August 2018|Anticipated|2018-08-01||Interventional|FMT||Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis|Fecal Microbial Transplantation in Patients With Medication Refractory Clostridium Difficile and/or Ulcerative Colitis or Indeterminate Colitis|Recruiting||Early Phase 1|50|Anticipated|Stony Brook University||1|||f||||t||||||||||2017-10-10 20:45:08.917302|2017-10-10 20:45:08.917302
NCT03268200|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-03|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||The Effect of Segmental Re-examination of Colon for Adenoma Detection in Colonoscopy|The Effect of Segmental Re-examination of Colon for Adenoma Detection in Colonoscopy: a Randomized, Controlled Trial|Recruiting||N/A|1052|Anticipated|The Catholic University of Korea||2|||f|||||f|f||||||||2017-10-10 20:45:09.004041|2017-10-10 20:45:09.004041
NCT03268187|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-04|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Biofeedback-based Relaxation Training or Self-alert Training to Alleviate Fatigue in Multiple Sclerosis Patients.|Biofeedback-based Relaxation Training or Self-alert Training to Alleviate Fatigue in Multiple Sclerosis Patients.|Recruiting||N/A|56|Anticipated|Rehazentrum Wilhelmshaven||2|||f||||f|f|f||||||||2017-10-10 20:45:09.090508|2017-10-10 20:45:09.090508
NCT03268174|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||May 11, 2016|Actual|2016-05-11|August 2017|2017-08-01|February 13, 2017|Actual|2017-02-13|February 13, 2017|Actual|2017-02-13||Interventional|||Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.|A Placebo-Controlled, Double-Blind, Bilateral Cosmetic Study With an Open Label Extension to Evaluate the Performance of a Cosmetic Product Designed to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.|Completed||N/A|19|Actual|AOBiome LLC||2|||f||||f|f|f||||||||2017-10-10 20:45:09.172306|2017-10-10 20:45:09.172306
NCT03268161|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||October 21, 2015|Actual|2015-10-21|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 1, 2017|Actual|2017-07-01||Observational|GENOMAG||Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies|Observational Study of the Prevalence of Some Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies.|Completed||N/A|21|Actual|Rennes University Hospital|||1||f||||f|f|f||||Samples With DNA|"     Medullary or blood sample stored in a bio-bank during lymphocyte phenotyping   "|||2017-10-10 20:45:09.247922|2017-10-10 20:45:09.247922
NCT03268148|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-02|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Analgesic Effect of Low Level Laser for Procedural Pain in Newborn Infants|Analgesic Effect of Low Level Laser for Procedural Pain in Newborn Infants: an Open-label, Randomized-controlled Trial|Recruiting||N/A|130|Anticipated|Chang Gung Memorial Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:45:09.327761|2017-10-10 20:45:09.327761
NCT03268135|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-28|||June 30, 2016|Actual|2016-06-30|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|RNA-HF-AS||Heart Failure and Aortic Stenosis Transcriptome|Study of the Transcriptomic Alterations in Heart Failure and Aortic Stenosis|Recruiting||N/A|500|Anticipated|IRCCS Policlinico S. Donato|||4||f||||t|f|f||||Samples Without DNA|"     cardiac tissue and blood samples   "|||2017-10-10 20:45:09.412586|2017-10-10 20:45:09.412586
NCT03268122|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-13|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|CONTACT-PILOT||Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE|Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE: A Pilot Clinical Trial|Recruiting||N/A|1764|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:45:09.512288|2017-10-10 20:45:09.512288
NCT03268109|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|COGITO||COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old|COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old.|Recruiting||N/A|330|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f|||||f|f||||||||2017-10-10 20:45:09.67031|2017-10-10 20:45:09.67031
NCT03268096|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-31|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|DB-SEP15||Disability, MRI Lesions and Thickness of Retinal Fibers: Evaluation 15 Years After a First Episode of Demyelination|Disability, MRI Lesions and Thickness of Retinal Fibers: Evaluation 15 Years After a First Episode of Demyelination|Recruiting||N/A|298|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:45:09.744944|2017-10-10 20:45:09.744944
NCT03268083|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-29|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Interventional|||A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 2 to 35 Months Old|An Open-Label, Dose-Finding, Phase II Study to Evaluate the Immunogenicity and Safety of the Bioreactor-generated EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 2 to 35 Months Old|Active, not recruiting||Phase 2|140|Actual|Enimmune Corporation||6|||f||||t||||||||||2017-10-10 20:45:09.809453|2017-10-10 20:45:09.809453
NCT03268070|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||October 2, 2017|Anticipated|2017-10-02|August 2017|2017-08-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|||Transcranial Magnetic Stimulation in Stroke Motor Rehabilitation Treatment|Targeting Motor Areas for Customized Transcranial Magnetic Stimulation in Motor Rehabilitation Treatment of Chronic Stroke Patients|Not yet recruiting||N/A|70|Anticipated|Emory University||5|||f||||t|f|t|t|f|f|||||2017-10-10 20:45:09.897105|2017-10-10 20:45:09.897105
NCT03268044|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||October 18, 2016|Actual|2016-10-18|August 2017|2017-08-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Observational|||Surgical Admission at the Weekend and 30-day Mortality in Ontario, Canada: a Matched Cohort Study|The Association Between Weekend Admission and Perioperative Adverse Outcomes for Adults Undergoing Surgery: A Matched Cohort Study|Recruiting||N/A|340000|Anticipated|The Hospital for Sick Children|||2||f||||f|f|f||||||||2017-10-10 20:45:10.121608|2017-10-10 20:45:10.121608
NCT03268031|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-30|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|September 1, 2019|Anticipated|2019-09-01||Observational|AGE||Artificial Intelligence-assissted Glaucoma Evaluation|Development of Artificial Intelligence-assissted Diagnostic Program of Glaucoma|Recruiting||N/A|5000|Anticipated|Sun Yat-sen University|||2||f|||||f|f||||||||2017-10-10 20:45:10.213941|2017-10-10 20:45:10.213941
NCT03268018|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-28|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|October 31, 2017|Anticipated|2017-10-31||Interventional|MODIFY||ModificatiOn and Treatment of stenoseD Calcified inFrainguinal Lesions With Laser atherectomY in a Pilot Study|ModificatiOn and Treatment of stenoseD Calcified inFrainguinal Lesions With Laser atherectomY in a Pilot Study|Recruiting||N/A|10|Anticipated|Spectranetics Corporation||1|||f||||f|f|f||||||||2017-10-10 20:45:10.296264|2017-10-10 20:45:10.296264
NCT03268005|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-26|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|January 29, 2019|Anticipated|2019-01-29|January 8, 2019|Anticipated|2019-01-08||Interventional|onset 9||"Research Study Comparing a New Medicine Fast-acting Insulin Aspart to Another Already Available Medicine NovoRapid/NovoLog in People With Type 2 Diabetes"|Efficacy and Safety of Fast-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec With or Without Metformin in Adults With Type 2 Diabetes (Onset® 9)|Recruiting||Phase 3|1072|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 20:45:10.379157|2017-10-10 20:45:10.379157
NCT03267992|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||March 7, 2017|Actual|2017-03-07|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|March 31, 2017|Actual|2017-03-31|1 Year|Observational [Patient Registry]|Co-Pilot Air||COPD Co-Pilot AIR Substudy of CLN0014|Observational Study of HGE COPD Co-Pilot AIRTM Application in Subjects Undergoing the PneumRx®, Endobronchial Coil Procedure as Part of EU Registry|Enrolling by invitation||N/A|20|Actual|PneumRx, Inc.|||1||f||||f|f|f||||||||2017-10-10 20:45:12.345841|2017-10-10 20:45:12.345841
NCT03267979|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||November 2, 2014|Actual|2014-11-02|August 2017|2017-08-01|March 31, 2015|Actual|2015-03-31|March 31, 2015|Actual|2015-03-31||Interventional|PREVANS||Assessing Pain in the Postoperative Period by Automatically Measuring the Variation Coefficient of Pupillary Diameter: PREVANS Study|Assessing Pain in the Postoperative Period by Automatically Measuring the Variation Coefficient of Pupillary Diameter: PREVANS Study|Completed||N/A|345|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 20:45:12.43718|2017-10-10 20:45:12.43718
NCT03267966|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-29|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2015|Actual|2015-06-01||Interventional|||Margin Status After Pancreaticoduodenectomy for Cancer|Margin Status After Pancreaticoduodenectomy for Cancer. Results of a Multicentric Prospective Randomized Trial|Active, not recruiting||N/A|168|Actual|Campus Bio-Medico University||2|||f||||f|f|f||||||||2017-10-10 20:45:12.53132|2017-10-10 20:45:12.53132
NCT03267953|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Adaptive Internet-based Stress Management Among Adults With a Cardiovascular Disease: A Pilot Sequential Multiple Assignment Randomized Trial (SMART) Design|Adaptive Internet-based Stress Management Among Adults With a Cardiovascular Disease: A Pilot Sequential Multiple Assignment Randomized Trial (SMART) Design|Not yet recruiting||N/A|56|Anticipated|St. Mary's Research Center, Canada||3|||f||||f|f|f||||||||2017-10-10 20:45:12.638119|2017-10-10 20:45:12.638119
NCT03267940|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-28|||October 31, 2017|Anticipated|2017-10-31|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|||Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma|A Phase 1b, Randomized, Open-Label Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination With Cisplatin Plus Gemcitabine and PEGPH20 in Combination With Atezolizumab and Cisplatin Plus Gemcitabine Compared With Cisplatin Plus Gemcitabine in Hyaluronan-High (HA-high) Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma|Not yet recruiting||Phase 1|70|Anticipated|Halozyme Therapeutics||5|||f|||||t|f||||||||2017-10-10 20:45:12.755679|2017-10-10 20:45:12.755679
NCT03267914|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-28|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|February 28, 2019|Anticipated|2019-02-28||Interventional|||Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy|Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy|Recruiting||N/A|45|Anticipated|A.T. Still University of Health Sciences||2|||f||||f|f|f||||||||2017-10-10 20:45:13.05151|2017-10-10 20:45:13.05151
NCT03267901|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-28|||May 1, 2015|Actual|2015-05-01|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|July 30, 2017|Actual|2017-07-30||Interventional|||Effects of Daily Walnut Intake Among the Subjects With Metabolic Syndrome|Effects of Daily Walnut Intake Among the Subjects With Metabolic Syndrome in South Korea|Completed||N/A|119|Actual|ICAN Nutrition Education and Research||2|||f|||||f|f||||||||2017-10-10 20:45:13.157241|2017-10-10 20:45:13.157241
NCT03267888|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||March 1, 2018|Anticipated|2018-03-01|August 2017|2017-08-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma|Pilot Study of Pembrolizumab and Single-Fraction, Low-Dose, Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma|Not yet recruiting||Phase 1|24|Anticipated|Emory University||1|||||||t|t|f|||f|||||2017-10-10 20:45:13.237303|2017-10-10 20:45:13.237303
NCT03267875|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood|A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood|Not yet recruiting||N/A|300|Anticipated|Meir Medical Center||1|||f||||t|f|f||||||||2017-10-10 20:45:13.336545|2017-10-10 20:45:13.336545
NCT03267862|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||September 17, 2014|Actual|2014-09-17|August 2017|2017-08-01|August 29, 2017|Actual|2017-08-29|August 29, 2017|Actual|2017-08-29||Observational|||Scleral Response to Intraocular Pressure (IOP)|Scleral Response to Intraocular Pressure (IOP)|Completed||N/A|27|Actual|Johns Hopkins University|||1||f||||f|f|f||||||||2017-10-10 20:45:13.404936|2017-10-10 20:45:13.404936
NCT03267849|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-05|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Lamina Cribrosa Depth Change With Change in Eye Pressure|Lamina Cribrosa Depth Change With Change in Eye Pressure|Recruiting||N/A|200|Anticipated|Johns Hopkins University||1|||f||||f|f|f||||||||2017-10-10 20:45:13.470737|2017-10-10 20:45:13.470737
NCT03267836|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-07|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma|A Phase Ib Study of Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma|Not yet recruiting||Phase 1|12|Anticipated|Washington University School of Medicine||1|||f||||t|t|t|f|f|t|||||2017-10-10 20:45:13.553326|2017-10-10 20:45:13.553326
NCT03267823|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-29|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||INR Comparison Testing in Cardiac Surgery|Comparison of INR Determined by Point-of-Care to Standard Laboratory Testing Before and After Reversal of Heparin in Cardiac Surgery|Recruiting||N/A|50|Anticipated|University of Miami|||1||f||||f|f|f||||||||2017-10-10 20:45:13.667297|2017-10-10 20:45:13.667297
NCT03267810|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-29|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2021|Anticipated|2021-10-01||Interventional|TENS||TENS Trial to Prevent Neuropathic Pain in SCI|Randomized, Double-blinded, Controlled Trial of Early-intervention TENS for the Reduction of the Prevalence and Severity of Chronic Neuropathic Pain During the First Year After Spinal Cord Injury|Recruiting||N/A|98|Anticipated|University of Miami||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:45:13.756862|2017-10-10 20:45:13.756862
NCT03267797|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-12|||October 7, 2017|Anticipated|2017-10-07|September 2017|2017-09-01|October 7, 2019|Anticipated|2019-10-07|September 9, 2018|Anticipated|2018-09-09||Interventional|||The Effects of Lymphocyte Therapy on Pregnancy Rate of Patient With Recurrent Implantation Failure|The Effect of Intrauterine Lymphocyte Therapy on Fertility in Women With Recurrent Implantation Failure (RIF): Clinical Trial|Recruiting||Phase 2|20|Anticipated|SCARM Institute, Tabriz, Iran||2|||f||||t|f|f||||||||2017-10-10 20:45:13.981506|2017-10-10 20:45:13.981506
NCT03267784|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-29|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|February 24, 2019|Anticipated|2019-02-24|May 24, 2018|Anticipated|2018-05-24||Interventional|||"Allogeneic ABCB5-positive Stem Cells for Treatment of DFU Malum Perforans"|An Interventional, Multicenter, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-DFU on Wound Healing of Diabetic Neuropathic Ulcer (DFU)|Recruiting||Phase 1/Phase 2|37|Anticipated|Rheacell GmbH & Co. KG||1|||f||||f|f|f||||||||2017-10-10 20:45:14.088806|2017-10-10 20:45:14.088806
NCT03267771|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 5, 2019|Anticipated|2019-12-05|August 5, 2019|Anticipated|2019-08-05||Interventional|||Progesterone and Doppler in Recurrent Abortion|Role of Serum Progesterone and Doppler Ultrasound in Prediction of Pregnancy Outcome in Women With Recurrent Unexplained Abortion|Not yet recruiting||Phase 4|50|Anticipated|Assiut University||2|||f|||||f|f|||f|||||2017-10-10 20:45:14.200744|2017-10-10 20:45:14.200744
NCT03267758|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-29|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Effect of Probiotic Supplementation on Endothelial Function II|Effect of Probiotic Supplementation on Endothelial Function II|Recruiting||N/A|50|Anticipated|Medical College of Wisconsin||2|||f||||f|f|f||||||||2017-10-10 20:45:14.320797|2017-10-10 20:45:14.320797
NCT03267745|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-29|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Amino Acid Formulation on Healthy Men Undergoing Unilateral Knee Immobilization|Effects of Amino Acid Formulation on Healthy Men Undergoing Unilateral Knee Immobilization|Not yet recruiting||N/A|20|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:45:14.420263|2017-10-10 20:45:14.420263
NCT03267732|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-05|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|December 4, 2017|Anticipated|2017-12-04|November 9, 2017|Anticipated|2017-11-09||Interventional|||A Study to Evaluate the Pharmacokinetics in Pts After Dosing With AM0010|A Phase 1 Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of AM0010 in Healthy Adult Subjects|Recruiting||Phase 1|24|Anticipated|ARMO BioSciences||2|||f||||f|t|f||||||||2017-10-10 20:45:14.520421|2017-10-10 20:45:14.520421
NCT03267719|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-31|||August 31, 2017|Actual|2017-08-31|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|laser||Intravaginal Laser Treatment of Mild and Moderate Stress Incontinence|Intravaginal Laser Treatment of Mild and Moderate Stress Incontinence|Recruiting||N/A|30|Anticipated|University Women's Hospital Tübingen||1|||f||||f|f|f||||||||2017-10-10 20:45:14.627866|2017-10-10 20:45:14.627866
NCT03267706|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Introducing the Palliative Care Comprehensive Tool in Family Medicine|Introducing the Comprehensive Palliative Care Tool in Family Medicine : A Pilot Randomized Controlled Trial|Not yet recruiting||N/A|149|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:45:14.711853|2017-10-10 20:45:14.711853
NCT03267693|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|||Gastrointestinal Complications in Association With Oropharyngeal and Respiratory Infections in Mechanical Ventilation|Gastrointestinal Complications in Association With Oropharyngeal and Respiratory Infections in Mechanical Ventilation|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:14.816845|2017-10-10 20:45:14.816845
NCT03267680|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-01|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|October 30, 2022|Anticipated|2022-10-30|October 30, 2021|Anticipated|2021-10-30||Interventional|||IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3|A Two-Cohort Randomized Phase 2 Trial of the IRX-2 Regimen in Women With Squamous Cervical Intraepithelial Neoplasia 3 (CIN 3) or Vulvar Intraepithelial Neoplasia 3 (VIN 3)|Not yet recruiting||Phase 2|60|Anticipated|University of Southern California||2|||f||||t|t|f||||||||2017-10-10 20:45:14.891406|2017-10-10 20:45:14.891406
NCT03267667|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Observational|||Effect of OSA on RV Heamodynamics and Function|Effect of Obstructive Sleep Apnea on Right Ventricle Heamodynamics and Function|Not yet recruiting||N/A|100|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:45:15.037853|2017-10-10 20:45:15.037853
NCT03267654|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-29|||September 20, 2017|Anticipated|2017-09-20|August 2017|2017-08-01|August 20, 2019|Anticipated|2019-08-20|August 20, 2019|Anticipated|2019-08-20||Interventional|||Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance|Gefitinib Versus Combination of Gefitinib With Chemotherapy or Anti-angiogenesis as 1st Line Treatment in Advanced NSCLC Patients Detected With Bim Deletion or Low EGFR Activating Mutation Abundance：A Randomized, Multicentre, Phase II Study|Not yet recruiting||Phase 2|150|Anticipated|Qilu Pharmaceutical Co., Ltd.||3|||f|||||f|f||||||||2017-10-10 20:45:15.136948|2017-10-10 20:45:15.136948
NCT03267641|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-04|||May 16, 2016|Actual|2016-05-16|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|PLANET||Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma|A Multi-National Cohort Study On The Impact Of Intra-Tumoural Genomic Heterogeneity And The Immune Micro-Environment On The Clinical Trajectory Of Resected Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|National Cancer Centre, Singapore|||1||f||||f|f|f||||Samples With DNA|"     Tumour samples Blood samples Urine samples   "|||2017-10-10 20:45:15.234119|2017-10-10 20:45:15.234119
NCT03267628|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-28|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|November 1, 2019|Anticipated|2019-11-01||Interventional|||Comparison of Intrathecal Morphine With the Quadratus Lumborum Type 2 Block for Post-operative Analgesia Following Elective Caesarean Section (QLBvITM Study)|Quadratus Lumborum Type 2 Block Versus Intrathecal Morphine for Analgesia Following Elective Caesarean Sections|Not yet recruiting||N/A|100|Anticipated|Sunshine Coast Hospital and Health Service||4|||f||||f|f|f||||||||2017-10-10 20:45:15.331841|2017-10-10 20:45:15.331841
NCT03267615|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2026|Anticipated|2026-12-31|10 Years|Observational [Patient Registry]|VICIS||VICIS - Vienna Cirrhosis Study|VICIS - Vienna Cirrhosis Study|Recruiting||N/A|1000|Anticipated|Medical University of Vienna|||1||f||||f|f|f||||||||2017-10-10 20:45:15.434506|2017-10-10 20:45:15.434506
NCT03267602|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-31|||December 2012|Actual|2012-12-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Role of Sleep Apnea in the Neuropsychological Function in Down Syndrome People|Role of Sleep Apnea in the Neuropsychological Function in Down Syndrome People|Completed||N/A|45|Actual|National Taiwan University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:45:15.531997|2017-10-10 20:45:15.531997
NCT03256188|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-16|||August 15, 2016|Actual|2016-08-15|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|InPACT||Interrupting Prolonged Sitting With Activity|Interrupting Prolonged Sitting With Activity Feasibility Study|Completed||N/A|500|Actual|University of Michigan||1|||f||||f|f|f||||||||2017-10-10 20:46:52.982823|2017-10-10 20:46:52.982823
NCT03267589|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-29|||November 30, 2017|Anticipated|2017-11-30|August 2017|2017-08-01|September 30, 2022|Anticipated|2022-09-30|March 30, 2019|Anticipated|2019-03-30||Interventional|||Trial in Patients With Relapsed Ovarian Cancer|NSGO-OV-UMB1; ENGOT-OV30 / NSGO: A Phase II Umbrella Trial in Patients With Relapsed Ovarian Cancer|Not yet recruiting||Phase 2|75|Anticipated|Nordic Society for Gynaecologic Oncology||3|||f||||t|f|f|||t|||||2017-10-10 20:45:15.61532|2017-10-10 20:45:15.61532
NCT03267576|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-07|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|June 29, 2018|Anticipated|2018-06-29|March 30, 2018|Anticipated|2018-03-30||Interventional|COMETA||An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin|Canagliflozin Continuous Glucose Monitoring (CANA CGM) Trial: A Pilot Randomized, Double-Blind, Controlled, Crossover Study on the Effects of the SGLT-2 Inhibitor Canagliflozin (vs. the DPP-4 Inhibitor Sitagliptin) on Glucose Variability in Mexican Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin|Not yet recruiting||Phase 4|60|Anticipated|Janssen Research & Development, LLC||2|||f||||f|t|f|||t|||||2017-10-10 20:45:15.737497|2017-10-10 20:45:15.737497
NCT03267563|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||June 1, 2018|Anticipated|2018-06-01|August 2017|2017-08-01|May 31, 2022|Anticipated|2022-05-31|April 30, 2022|Anticipated|2022-04-30||Interventional|ROSE||Minimum Intervention to Maintain a Postpartum Depression Prevention Program in Clinics Serving Low-income Women|Implementing to Sustain: Determining the Minimum Necessary Intervention to Maintain a Postpartum Depression Prevention Program (ROSE) in Clinics Providing Prenatal Services to Low-income Women|Not yet recruiting||N/A|90|Anticipated|Michigan State University||2|||f||||f|f|f||||||||2017-10-10 20:45:15.85522|2017-10-10 20:45:15.85522
NCT03267550|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-30|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||The Safety of Remote DBS Programming System|A Pilot Study to Investigating Safety of A Remote and Wireless Deep Brain Stimulation Programming System for Parkinson's Disease|Recruiting||N/A|6|Anticipated|Ruijin Hospital||1|||f|||||f|f||||||||2017-10-10 20:45:15.947181|2017-10-10 20:45:15.947181
NCT03267537|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-31|||June 13, 2017|Actual|2017-06-13|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Non-inferiority Study of Telemedicine Versus Conventional CBT-I in Recently Hospitalized Patients With Insomnia|Non-inferiority Study of Telemedicine Versus Conventional CBT-I in Recently Hospitalized Patients With Insomnia|Recruiting||N/A|74|Anticipated|University of Arizona||2|||f||||f|f|f||||||||2017-10-10 20:45:16.038254|2017-10-10 20:45:16.038254
NCT03267524|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers|Walking for Recovery From Surgery: Pilot Study of a Prehabilitation Intervention for Older Adults With Cancer and Their Family Caregivers|Recruiting||N/A|60|Anticipated|City of Hope Medical Center||1|||f||||t|f|f||||||||2017-10-10 20:45:16.15816|2017-10-10 20:45:16.15816
NCT03267511|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||September 25, 2017|Anticipated|2017-09-25|August 2017|2017-08-01|December 2, 2017|Anticipated|2017-12-02|December 2, 2017|Anticipated|2017-12-02||Interventional|||A Study to Investigate the Stain and Plaque Removal Capability of Two Experimental Potassium Nitrate Dentifrices|A Randomized, Examiner-blind, Proof of Principal Study to Investigate the Stain and Plaque Removal Capability of Two Experimental 5% Potassium Nitrate Dentifrices in Healthy Subjects With the Propensity for Extrinsic Dental Stain|Not yet recruiting||Phase 2|124|Anticipated|GlaxoSmithKline||4|||f||||f|t|f|||t|||||2017-10-10 20:45:16.267039|2017-10-10 20:45:16.267039
NCT03267498|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-30|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|October 15, 2020|Anticipated|2020-10-15|October 15, 2019|Anticipated|2019-10-15||Interventional|||Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)|Nivolumab in Combination With Chemoradiation for Patients With Stage II-IVB Nasopharyngeal Carcinoma, A Phase II Study With Correlative Biomarkers|Not yet recruiting||Phase 2|40|Anticipated|University of California, San Francisco||1|||f||||t|t|f||||||||2017-10-10 20:45:16.467185|2017-10-10 20:45:16.467185
NCT03267485|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|||Expression of TET1 Gene in Acute Leukaemia|Expression of TET1 Gene in Acute Leukaemia|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:16.572988|2017-10-10 20:45:16.572988
NCT03267472|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-09-06|||October 20, 2017|Anticipated|2017-10-20|August 2017|2017-08-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Observational|||Pattern of Genitourinary Fistula in Upper Egypt|the Genitourinary Fistula Experience in Upper Egypt|Not yet recruiting||N/A|35|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:16.643548|2017-10-10 20:45:16.643548
NCT03267459|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||September 15, 2017|Anticipated|2017-09-15|February 2017|2017-02-01|February 15, 2024|Anticipated|2024-02-15|February 15, 2024|Anticipated|2024-02-15||Observational|PREDIR||Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?|Prediction of the Response Using Dynamic Contrast-enhanced Magnetic Resonance Imaging Before Intra-arterial Chemotherapy in Children With Retinoblastoma|Not yet recruiting||N/A|60|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:45:16.716318|2017-10-10 20:45:16.716318
NCT03267446|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||August 29, 2017|Actual|2017-08-29|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Doppler Imaging and Morbidly Adherent Placenta|The Role of Grey Scale Ultrasound, 2D, and 3D Power Doppler in Diagnosing and Predicting the Surgical Risks in Patients With Morbidly Adherent Placenta.|Recruiting||N/A|60|Anticipated|Cairo University||1|||f||||t|f|f||||||||2017-10-10 20:45:16.786254|2017-10-10 20:45:16.786254
NCT03267433|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||August 29, 2017|Actual|2017-08-29|August 2017|2017-08-01|January 31, 2026|Anticipated|2026-01-31|January 31, 2021|Anticipated|2021-01-31||Interventional|||Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission|A Randomized Phase III Trial of Consolidation With Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients With Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission|Recruiting||Phase 3|689|Anticipated|Eastern Cooperative Oncology Group||2|||f||||t|t|f||||||||2017-10-10 20:45:16.866716|2017-10-10 20:45:16.866716
NCT03267420|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Blood Pressure Measurement: Should Technique Define Targets?|Blood Pressure Measurement: Should Technique Define Targets?|Not yet recruiting||N/A|90|Anticipated|Ottawa Hospital Research Institute||3|||f||||f|f|f||||||||2017-10-10 20:45:16.966343|2017-10-10 20:45:16.966343
NCT03267407|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-09-10|||August 14, 2015|Actual|2015-08-14|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Vietnam Cryptococcal Retention in Care Study - Version 2.1|Vietnam Cryptococcal Retention in Care Study (CRICS) - Version 2.1|Active, not recruiting||N/A|1184|Actual|National Hospital for Tropical Diseases, Hanoi, Vietnam|||3||f|||||f|f||||Samples With DNA|"     Whole blood samples   "|||2017-10-10 20:45:17.075682|2017-10-10 20:45:17.075682
NCT03267394|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-29|2017-08-29|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|||Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis|Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis|Not yet recruiting||N/A|75|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:17.187544|2017-10-10 20:45:17.187544
NCT03267381|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy|Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy|Not yet recruiting||N/A|30|Anticipated|Vanderbilt-Ingram Cancer Center|||3||f||||f|f|f||||||||2017-10-10 20:45:17.258313|2017-10-10 20:45:17.258313
NCT03267368|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-13|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Comprehensive Care Program SBRT|Pilot Trial of Clinical Implementation of a Comprehensive Care Program for Early Stage Medically Inoperable/Borderline Operable Lung Cancer Patients Undergoing Stereotactic Radiotherapy (SBRT)|Recruiting||N/A|30|Anticipated|William Beaumont Hospitals||1|||f||||t|f|f||||||||2017-10-10 20:45:17.380192|2017-10-10 20:45:17.380192
NCT03267355|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-27|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Indications and Outcomes of Endoscopic Ultrasound in Tanta|Indications and Outcomes of Gastrointestinal Endoscopic Ultrasound in Tanta-Egypt: Initial Experience.|Recruiting||N/A|50|Anticipated|Tanta University||1|||f||||t|f|f||||||||2017-10-10 20:45:17.48668|2017-10-10 20:45:17.48668
NCT03267342|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||August 1, 2015|Actual|2015-08-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|July 31, 2017|Actual|2017-07-31||Interventional|||Financial and Mental Health: Exploratory Research|Financial and Mental Health: Exploratory Research|Active, not recruiting||N/A|31|Actual|Yale University||1|||f||||f|f|f||||||||2017-10-10 20:45:17.623908|2017-10-10 20:45:17.623908
NCT03267329|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension|A Randomized, Open, Parallel, Multicenter, Phase 4 Study to Evaluate the Central Aortic Pressure Effect Between Fixed Dose Combination (Duowell® Tab) and Monotherapy of Telmisartan in Mild Dyslipidemia Patients With Hypertension|Not yet recruiting||Phase 4|158|Anticipated|Yuhan Corporation||2|||f|||||f|f||||||||2017-10-10 20:45:17.787811|2017-10-10 20:45:17.787811
NCT03267303|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Study to Evaluate the Safety and Efficacy of TS-091 in Patients With Narcolepsy|A Phase II, Double-blind, Parallel-group Comparative Study 2 of TS-091 in Patients With Narcolepsy|Recruiting||Phase 2|48|Anticipated|Taisho Pharmaceutical Co., Ltd.||3|||f||||f|f|f||||||||2017-10-10 20:45:18.078645|2017-10-10 20:45:18.078645
NCT03267290|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-27|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRI|A Prospective Clinical Study for Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of Contrast-enhanced Ultrasound and Contrast-enhanced Magnetic Resonance Imaging Versus Contrast-enhanced Computed Tomography and Contrast-enhanced Magnetic Resonance Imaging|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:45:18.201927|2017-10-10 20:45:18.201927
NCT03267264|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle|Nucleus Claims Study: Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle|Not yet recruiting||N/A|260|Anticipated|Becton, Dickinson and Company||4|||f||||f|f|t|t|f||||||2017-10-10 20:45:18.498835|2017-10-10 20:45:18.498835
NCT03267251|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-28|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|August 31, 2019|Anticipated|2019-08-31||Interventional|EPICC-HPV||Engaging Patients and Providers in Collaborative Communication on HPV Vaccination (EPICC-HPV)|Engaging Patients and Providers in Collaborative Communication on HPV Vaccination (EPICC-HPV)|Not yet recruiting||N/A|1800|Anticipated|University of New Mexico||2|||f||||t|f|f||||||||2017-10-10 20:45:18.668501|2017-10-10 20:45:18.668501
NCT02672007|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-03-23|||January 2016||2016-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Methods for the Measurement of Respiratory Rate|Methods for the Measurement of Respiratory Rate|Completed||N/A|50|Actual|Herlev Hospital||1|||f||||f||||||||||2017-10-10 22:30:12.259156|2017-10-10 22:30:12.259156
NCT03267238|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-28|||June 16, 2017|Actual|2017-06-16|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Fecal Microbial Transplantation in Patients With Crohn's Disease|Fecal Microbial Transplantation in Patients With Crohn's Disease|Recruiting||Early Phase 1|40|Anticipated|Stony Brook University||1|||f||||t|t|f||||||||2017-10-10 20:45:18.790232|2017-10-10 20:45:18.790232
NCT03267225|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-09-18|||January 2016||2016-01-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Observational|CLINDA-RIFAM||Study on the Genetic Determinants of Clindamycin/Rifampin Interaction||Recruiting||N/A|100|Anticipated|Groupe Hospitalier Diaconesses Croix Saint-Simon|||1||f||||t||||||||||2017-10-10 20:45:18.919638|2017-10-10 20:45:18.919638
NCT03267212|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-28|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|NIV-Ex-CS||Acute Effect of Ventilatory Support During Exercise in Spinal Cord Injury|Acute Effect of Ventilatory Support During Exercise in Spinal Cord Injury|Recruiting||N/A|15|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:45:18.995491|2017-10-10 20:45:18.995491
NCT03267199|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|December 2019|Anticipated|2019-12-01||Observational|||The Relationship Between MPV,PDW,PFT and ST Segment Resolution in STEMI Patients Treated With Thrombolytic or Primary PCI|The Relationship Between Mean Platelet Volume , Platelet Distribution Width , Platelet Function and ST Segment Resolution in STEMI Patients Treated With Either Thrombolytic Therapy or Primary Percutaneous Coronary Intervention|Not yet recruiting||N/A|200|Anticipated|Assiut University|||2||f|||||f|f||||||||2017-10-10 20:45:19.108377|2017-10-10 20:45:19.108377
NCT03267173|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-27|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.|Evaluate the Safety and Efficacy of Chimeric Antigen Receptor Engineered T Cell Immunotherapy (CAR-T) in the Treatment of Pancreatic Cancer in a Single Center, Non Controlled Clinical Study.|Recruiting||Early Phase 1|10|Anticipated|First Affiliated Hospital of Harbin Medical University||1|||f||||t|f|f||||||||2017-10-10 20:45:19.306867|2017-10-10 20:45:19.306867
NCT03267160|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-27|||January 18, 2017|Actual|2017-01-18|October 2016|2016-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||A Study of Exosome Proteomics and Hemodynamics in Sepsis|An Observation Study of Exosome Proteomics Released From Cardiopulmonary Organs and Hemodynamic Parameters in Sepsis|Recruiting||N/A|30|Anticipated|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||2||f||||f|f|f||||Samples Without DNA|"     Blood and urine, extract exosome collection   "|||2017-10-10 20:45:19.411695|2017-10-10 20:45:19.411695
NCT03267147|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-28|||April 27, 2017|Actual|2017-04-27|August 2017|2017-08-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2021|Anticipated|2021-04-30||Observational|PANORA||PREVALENCE OF Anti-CCP POSITIVITY AND SUBCLINICAL SIGNS OF INFLAMMATION IN PATIENTS WITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS|PREVALENCE OF ANTI-CYCLIC CITRULLINATED PEPTIDE (Anti-CCP) POSITIVITY AND SUBCLINICAL SIGNS OF INFLAMMATION IN PATIENTS WITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS POSSIBLY RELATED TO EARLY RHEUMATOID ARTHRITIS IN GENERAL PRACTICES IN GERMANY|Recruiting||N/A|1000|Anticipated|Fraunhofer Institute for Molecular Biology and Applied Ecology|||2||f|||||f|f||||Samples With DNA|"     blood samples   "|||2017-10-10 20:45:19.535953|2017-10-10 20:45:19.535953
NCT03267134|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-05|||August 1, 2017||2017-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:45:19.695668|2017-10-10 20:45:19.695668
NCT03267121|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 1, 2020|Anticipated|2020-04-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck|A Non-randomized Phase II Study of Apatinib and Tegafur Gimeracil Oteracil Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck|Not yet recruiting||Phase 2|45|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||1|||f||||t|f|f||||||||2017-10-10 20:45:19.753668|2017-10-10 20:45:19.753668
NCT03267108|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-27|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)|A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL STUDY TO ASSESS THE SAFETY AND EFFICACY OF PULSED, INHALED NITRIC OXIDE (iNO) IN SUBJECTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY FIBROSIS ON LONG TERM OXYGEN THERAPY (PART 1 AND PART 2)|Not yet recruiting||Phase 2|40|Anticipated|Bellerophon||2|||f||||t|t|f||||||||2017-10-10 20:45:19.871459|2017-10-10 20:45:19.871459
NCT03267095|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-04|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Use Music Therapy In Autism Spectrum Disorder|The Use Of Music Therapy In Autism Spectrum Disorder|Not yet recruiting||N/A|60|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:45:19.999278|2017-10-10 20:45:19.999278
NCT03267082|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-27|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Evaluation the Role of Laparoscopic Management of Perforated Appendicitis|Evaluation the Role of Laparoscopic Management of Perforated Appendicitis|Not yet recruiting||N/A|30|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:45:20.084263|2017-10-10 20:45:20.084263
NCT03267069|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-28|||November 27, 2016|Actual|2016-11-27|August 2017|2017-08-01|November 1, 2027|Anticipated|2027-11-01|November 1, 2026|Anticipated|2026-11-01|10 Years|Observational [Patient Registry]|||Evaluating Alcohol Use in Alcoholic Liver Disease|Evaluating Alcohol Use in Alcoholic Liver Disease|Recruiting||N/A|160|Anticipated|New York Presbyterian Hospital|||1||f||||t|f|f||||||||2017-10-10 20:45:20.13888|2017-10-10 20:45:20.13888
NCT03267056|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-29|||May 1, 2018|Anticipated|2018-05-01|August 2017|2017-08-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01|2 Years|Observational [Patient Registry]|||AcoArt SFA Registry in China|Real-World Registry Assessing the Clinical Use of the Orchid Drug Coated Balloon Catheter|Not yet recruiting||N/A|150|Anticipated|Acotec Scientific Co., Ltd|||1||f||||f|f|f||||||||2017-10-10 20:45:20.32757|2017-10-10 20:45:20.32757
NCT03267043|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Family Nurture Intervention in the NICU at The Valley Hospital|Family Nurture Intervention in the NICU at The Valley Hospital|Not yet recruiting||N/A|173|Anticipated|Columbia University||2|||f||||t|f|f||||||||2017-10-10 20:45:20.393432|2017-10-10 20:45:20.393432
NCT03267030|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-29|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase|Single-Arm PharmacoKinetic/PharmacoDynamic and Safety Study of Eryaspase (GRASPA®) for Patients With Hypersensitivity to PEG-Asparaginase, Diagnosed With Ph(-) Acute Lymphoblastic Leukemia|Recruiting||Phase 2|30|Anticipated|Aarhus University Hospital||1|||f||||t|f|f||||||||2017-10-10 20:45:20.512125|2017-10-10 20:45:20.512125
NCT03267017|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|November 1, 2018|Anticipated|2018-11-01||Observational|||Correlation Between Respiratory Variability of R-R Intervals and Systolic Pressure Variability|Correlation Between Respiratory Variability of R-R Intervals and in Invasive Systolic Blood Pressure During Changes in Posture and Positive End Expiratory Pressure|Not yet recruiting||N/A|40|Anticipated|Rambam Health Care Campus|||1||f||||f|f|f||||||||2017-10-10 20:45:20.6421|2017-10-10 20:45:20.6421
NCT03267004|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-26|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|August 3, 2018|Anticipated|2018-08-03|August 3, 2018|Anticipated|2018-08-03||Interventional|||Dietary Assessment Study Via Digital Images|Validation Study of a Passive Image-Assisted Dietary Assessment With Automated Image Analysis Process|Recruiting||N/A|30|Anticipated|University of Tennessee||2|||f|||||f|t|f|f|f|||||2017-10-10 20:45:20.710915|2017-10-10 20:45:20.710915
NCT03266991|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|DOT-LTBI||Treatment of Latent Tuberculosis in Socially Marginalised Citizens|A Randomised Controlled Trial of a 12-dose Rifapentine and Isoniazid (RPT+INH) Regimen Using Direct Observed Therapy (DOT) Versus 6 Months of Daily Isoniazid for Latent Tuberculosis Infection (LTBI) in Socially Marginalised People|Not yet recruiting||Phase 4|150|Anticipated|Aarhus University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:45:20.852287|2017-10-10 20:45:20.852287
NCT03266978|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-29|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Observational|||Impact of Glycemic State on Patients ST Elevation Myocardial Infarction With Primary Percutaneous Coronary Angioplasty|Impact of the Glycemic State on the in Hospital and Short Term Outcomes of Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Angioplasty|Not yet recruiting||N/A|150|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:45:20.973574|2017-10-10 20:45:20.973574
NCT03266965|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-26|||February 27, 2018|Anticipated|2018-02-27|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach|Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach|Not yet recruiting||Phase 1|15|Anticipated|University of Miami||1|||f||||t|t|f|||f|||||2017-10-10 20:45:21.089582|2017-10-10 20:45:21.089582
NCT03266952|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-29|||January 1993|Actual|1993-01-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|NOMAS||Stroke Incidence and Risk Factors in a Tri-ethnic Region|Stroke Incidence and Risk Factors in a Tri-ethnic Region|Completed||N/A|3497|Actual|University of Miami|||1||f||||f|f|f||||||||2017-10-10 20:45:21.258817|2017-10-10 20:45:21.258817
NCT03266939|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Rebalancing the Serotonergic System in Cocaine Dependence|Rebalancing the Serotonergic System in Cocaine Dependence|Not yet recruiting||Phase 1|10|Anticipated|Mclean Hospital||2|||f||||f|t|f|||t|||||2017-10-10 20:45:21.382702|2017-10-10 20:45:21.382702
NCT03266926|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-26|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30|6 Weeks|Observational [Patient Registry]|||Does the Use of Bupivacaine Soaked Vaginal Packing Following Vaginal Surgery Decrease Postoperative Pain?|Does the Use of Bupivacaine Soaked Vaginal Packing Following Vaginal Surgery Decrease Postoperative Pain?|Enrolling by invitation||N/A|120|Anticipated|Sunnybrook Health Sciences Centre|||2||f||||f|t|f|||f|||||2017-10-10 20:45:21.500813|2017-10-10 20:45:21.500813
NCT03266913|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia|Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia|Recruiting||Phase 3|126|Anticipated|Hormozgan University of Medical Sciences||2|||f||||t|f|f|||f|||||2017-10-10 20:45:21.65339|2017-10-10 20:45:21.65339
NCT03266900|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|RESECT||A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival|A Pilot, Single-centre, Randomized, 5-year, Parallel-group, Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival|Not yet recruiting||Early Phase 1|18|Anticipated|University Health Network, Toronto||2|||f||||t|f|f||||||||2017-10-10 20:45:21.775358|2017-10-10 20:45:21.775358
NCT03266887|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||January 1, 2002|Actual|2002-01-01|August 2017|2017-08-01|December 30, 2006|Actual|2006-12-30|December 30, 2006|Actual|2006-12-30||Observational|||Vitamin D Levels and Survival in Cancer Patients|Association of Pre-diagnostic Vitamin D Levels and Survival in Older Individuals With Cancer|Completed||N/A|5764|Actual|Icelandic Heart Association|||1||f||||f||||||Samples With DNA|"     Serum   "|||2017-10-10 20:45:21.903545|2017-10-10 20:45:21.903545
NCT03266874|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2031|Anticipated|2031-08-01|August 2029|Anticipated|2029-08-01||Observational|||G7 BiSpherical Acetabular Shell PMCF Study|Prospective Multicenter Observational Evaluation of the Use of the G7 BiSpherical Acetabular Shell|Not yet recruiting||N/A|175|Anticipated|Zimmer Biomet|||1||f||||f|f|f|||f|||||2017-10-10 20:45:21.99789|2017-10-10 20:45:21.99789
NCT03266861|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-10-02|||October 2, 2017|Actual|2017-10-02|August 2017|2017-08-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Observational|STELLA||Lactate Increase in Peripheral Artery Disease|Study of Transcutaneous Exercise Oxymetry, reLationship to LActates Increase in Claudication|Enrolling by invitation||N/A|750|Anticipated|University Hospital, Angers|||1||f||||f|f|f||||||||2017-10-10 20:45:22.133593|2017-10-10 20:45:22.133593
NCT03266848|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-30|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI|Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI|Enrolling by invitation||N/A|15|Anticipated|Theranano LLC|||1||f||||t|f|f||||||||2017-10-10 20:45:22.249356|2017-10-10 20:45:22.249356
NCT03266835|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|PROSPECTOR||SoundBite™ Crossing System Pivotal Peripheral CTO Crossing Study|A Multinational, Single-Arm Pivotal Study to Assess the Performance Rate Of SoundBite™ Active Wire for PEripheral Chronic Total Occlusion Recanalization (PROSPECTOR)|Not yet recruiting||N/A|100|Anticipated|SoundBite Medical Solutions, Inc.||1|||f||||t|f|t|t|f|f|||||2017-10-10 20:45:22.360475|2017-10-10 20:45:22.360475
NCT03266822|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-29|||January 2, 2013|Actual|2013-01-02|August 2017|2017-08-01|May 31, 2016|Actual|2016-05-31|December 30, 2015|Actual|2015-12-30||Observational|||T-cell Subsets in Rheumatoid Arthritis Patients on Long-term Anti-TNF or IL6-receptor-blocker Therapy|T-cell Subsets in Rheumatoid Arthritis Patients on Long-term Anti-TNF or IL6-receptor-blocker Therapy|Completed||N/A|122|Actual|Szeged University|||3||f||||f|f|f||||||||2017-10-10 20:45:22.507339|2017-10-10 20:45:22.507339
NCT03266809|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|CARE-B||CARdiac Function Evaluation in Breast Cancer Patients|Longitudinal Characterisation of Cardiac Function in Recently-diagnosed Breast Cancer Patients|Recruiting||N/A|25|Anticipated|Swansea University|||1||f||||t|f|f||||||||2017-10-10 20:45:22.599429|2017-10-10 20:45:22.599429
NCT03266796|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-29|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|January 31, 2018|Anticipated|2018-01-31||Observational|||Shared Decision Making in Physical Therapy: a Cross-sectional Observational Study|Shared Decision Making in Physical Therapy: a Cross-sectional Observational Study|Not yet recruiting||N/A|30|Anticipated|Klinik Valens|||1||f||||t|f|f||||||||2017-10-10 20:45:22.699947|2017-10-10 20:45:22.699947
NCT03266783|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|September 2021|Anticipated|2021-09-01||Interventional|COBRRA||Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism|Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: A Randomized Controlled Trial|Not yet recruiting||Phase 4|2760|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|f||||||||2017-10-10 20:45:22.781229|2017-10-10 20:45:22.781229
NCT03266770|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-25|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position|The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position|Not yet recruiting||N/A|30|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||t|f|t|t|f|f|||||2017-10-10 20:45:22.906485|2017-10-10 20:45:22.906485
NCT03266757|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-29|||February 11, 2016|Actual|2016-02-11|July 2017|2017-07-01|February 11, 2018|Anticipated|2018-02-11|February 11, 2017|Actual|2017-02-11||Observational|||Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma|Observational Study of the Clinical Practice in Patients With Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma in Greece|Active, not recruiting||N/A|200|Actual|Hellenic Society of Medical Oncology|||1||f|||||f|f||||||||2017-10-10 20:45:22.993131|2017-10-10 20:45:22.993131
NCT03266744|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-29|||April 21, 2016|Actual|2016-04-21|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|RESPECT||Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study|Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study|Active, not recruiting||N/A|40|Anticipated|East and North Hertfordshire NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:45:23.054921|2017-10-10 20:45:23.054921
NCT03266731|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||January 4, 2018|Anticipated|2018-01-04|August 2017|2017-08-01|January 4, 2020|Anticipated|2020-01-04|January 4, 2019|Anticipated|2019-01-04||Interventional|||Role of Anti-platelet in Treatment of Acute Ischemic Stroke|Role of Anti-platelet in Treatment of Acute Ischemic Stroke|Not yet recruiting||N/A|120|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:45:23.140168|2017-10-10 20:45:23.140168
NCT03266718|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-28|||July 1, 2015|Actual|2015-07-01|August 2017|2017-08-01|December 11, 2016|Actual|2016-12-11|September 26, 2016|Actual|2016-09-26||Interventional|||Move 2 Health: A Couple-Based Physical Activity Intervention for Cancer Survivors|A Couple-Based Physical Activity Intervention for Cancer Survivors|Completed||N/A|40|Actual|Duke University||2|||f||||f|f|f||||||||2017-10-10 20:45:23.234341|2017-10-10 20:45:23.234341
NCT03266692|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-28|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma|A Phase 1 Study of ACTR087, an Autologous T Cell Product, in Combination With SEA-BCMA, a Monoclonal Antibody, in Subjects With Relapsed or Refractory Multiple Myeloma|Not yet recruiting||Phase 1|30|Anticipated|Unum Therapeutics Inc.||1|||f||||t|t|f||||||||2017-10-10 20:45:23.420895|2017-10-10 20:45:23.420895
NCT03266679|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-28|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Psychological Factors In The Treatment Of Bipolar Mood Disorders|Bipolar Mood Disorders: A Recovery-Oriented Intervention Approach Addressing Deficits In Metacognitive Capacities|Recruiting||N/A|10|Anticipated|Queensland University of Technology||1|||f||||f|f|f||||||||2017-10-10 20:45:23.524353|2017-10-10 20:45:23.524353
NCT03266666|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|WellnessRX||Welcome to WellnessRX: Steps Toward a Healthier Life!|An Evaluation of Lifestyle Change Classes and Grocery Credits to Promote Healthy Behavior Change|Not yet recruiting||N/A|80|Anticipated|ProofPilot||1|||f||||f|f|f||||||||2017-10-10 20:45:23.640387|2017-10-10 20:45:23.640387
NCT03266653|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection|A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection With Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients|Not yet recruiting||Phase 2|20|Anticipated|New York Medical College||1|||f||||t|t|f||||||||2017-10-10 20:45:23.721707|2017-10-10 20:45:23.721707
NCT03266640|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)|A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections With Related Donor CMV Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients|Not yet recruiting||Phase 2|20|Anticipated|New York Medical College||1|||f||||t|t|f||||||||2017-10-10 20:45:23.82478|2017-10-10 20:45:23.82478
NCT03266627|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection|A Pilot Study in the Treatment of Refractory Adenovirus (ADV) Infection With Related Donor ADV Cytotoxic T-Lymphocytes (ADV-CTLs)in Children, Adolescents and Young Adult Recipients|Not yet recruiting||Phase 2|20|Anticipated|New York Medical College||1|||f||||t|t|f||||||||2017-10-10 20:45:23.905539|2017-10-10 20:45:23.905539
NCT03266614|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-22|||April 7, 2017|Actual|2017-04-07|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|R4US||"Recovery 4 US - A Photovoice-based Social Media Program"|"Recovery 4 US - A Photovoice-based Social Media Program to Enhance the Recovery and Community Participation of Individuals With Psychiatric Disabilities"|Recruiting||N/A|60|Anticipated|Boston University Charles River Campus||2|||f||||f|f|f||||||||2017-10-10 20:45:23.991587|2017-10-10 20:45:23.991587
NCT03266601|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-28|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Aerosol Inhalation of Recombinant Human Interferon α-2b on Herpangina|Effect and Safety of Aerosol Inhalation of Recombinant Human Interferon α-2b on Herpangina in Pediatric Patients|Recruiting||Phase 4|440|Anticipated|Children's Hospital of Fudan University||2|||f|||||f|f||||||||2017-10-10 20:45:24.076069|2017-10-10 20:45:24.076069
NCT03266575|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-29|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Pulmonary Rehabilitation in End-Stage Liver Disease|Does Pulmonary Rehabilitation Improve Frailty and Sarcopenia in End Stage Liver Disease?|Not yet recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 20:45:24.433459|2017-10-10 20:45:24.433459
NCT03266562|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-08-29|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|PEM-FES||Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography|Assessment of the Heterogeneity of Estrogen Receptor Expression in Patients With Estrogen Receptor Positive Breast Cancer Using F-18 Fluoroestradiol and High Resolution Positron Emission Mammography|Not yet recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|||||||2017-10-10 20:45:24.639644|2017-10-10 20:45:24.639644
NCT03266549|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Botulinum Toxin Augmented Surgery vs Conventional Surgery in the Management of Large Angle Infantile Esotropia|Botulinum Toxin Augmented Surgery Versus Conventional Surgery in the Management of Large Angle Infantile Esotropia|Not yet recruiting||N/A|46|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 20:45:24.753431|2017-10-10 20:45:24.753431
NCT03266536|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-08-28|||January 2017||2017-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2017|Actual|2017-06-01||Interventional|Microbiota||Small Bowel Microbiota Characterization in Healthy Individuals Before and After Consumption of a Western Diet|Small Bowel Microbiota Characterization in Healthy Individuals Before and After Consumption of a Western Diet|Active, not recruiting||N/A|16|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 20:45:24.871601|2017-10-10 20:45:24.871601
NCT03266523|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-10-03|||October 3, 2017|Actual|2017-10-03|October 2017|2017-10-01|December 3, 2017|Anticipated|2017-12-03|December 3, 2017|Anticipated|2017-12-03||Observational|VERTIM||Influence of Natural Images on Patients' Anxiety in the Waiting Rooms of Imaging Ward|Pilot Study on the Influence of the Integration of Natural Images, According to Various Esthetic Approaches, in the Waiting Rooms of Imaging on the Anxiety Felt by the Patients|Recruiting||N/A|400|Anticipated|University Hospital, Bordeaux|||4||f||||f||||||||||2017-10-10 20:45:24.965685|2017-10-10 20:45:24.965685
NCT03266510|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-27|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||Inspiratory Muscle Strength Training to Improve Blood Pressure and Physiological Function|Inspiratory Muscle Strength Training to Improve Blood Pressure and Physiological Function|Recruiting||N/A|48|Anticipated|University of Colorado, Boulder||2|||f||||t|f|f||||||||2017-10-10 20:45:25.150103|2017-10-10 20:45:25.150103
NCT03266497|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||January 2003|Actual|2003-01-01|August 2017|2017-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Diet Quality Among U.S.-Born and Foreign-born Non-Hispanic Blacks|Diet Quality Among U.S.-Born and Foreign-born Non-Hispanic Blacks: NHANES 2003-2012 Data|Completed||N/A|4243|Actual|Tufts University|||1||f||||f|f|f||||||||2017-10-10 20:45:25.282721|2017-10-10 20:45:25.282721
NCT03124173|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-26|||January 14, 2015|Actual|2015-01-14|April 2017|2017-04-01|January 14, 2018|Anticipated|2018-01-14|December 14, 2017|Anticipated|2017-12-14||Interventional|LANGUAGE||Cognitive Control of Language|Cognitive Control of Language and Frontal Cortex|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||1|||f|||||f|f||||||||2017-10-10 21:08:46.442553|2017-10-10 21:08:46.442553
NCT03266484|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-28|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease|Effect of Dietary Therapy With a Probiotic Mixture on the Gut Microbiome and Fatigue Symptoms in Patients With Quiescent Inflammatory Bowel Disease - A Clinical Trial|Not yet recruiting||N/A|100|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:45:25.353866|2017-10-10 20:45:25.353866
NCT03266471|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|||Cytokines and Genes in Therapeutic Response in Crohn's Disease|Cytokines and Genes in Therapeutic Response in Crohn's Disease|Enrolling by invitation||N/A|185|Anticipated|Vanderbilt University Medical Center|||2||f||||f|f|f||||Samples With DNA|"     Any remaining serum or tissue samples may be evaluated for other markers of IBD or stored for     future studies.   "|||2017-10-10 20:45:25.465797|2017-10-10 20:45:25.465797
NCT03266458|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|November 30, 2018|Anticipated|2018-11-30|2 Days|Observational [Patient Registry]|||Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention|Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention|Not yet recruiting||N/A|210|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:25.578165|2017-10-10 20:45:25.578165
NCT03266445|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-11|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use|A Prospective, Randomized Trial of the Effect of Buprenorphine/Naloxone Continuation on Pain Control and Post Operative Opioid Use|Not yet recruiting||Phase 4|120|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:45:25.690233|2017-10-10 20:45:25.690233
NCT03266432|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|March 30, 2019|Anticipated|2019-03-30|October 30, 2018|Anticipated|2018-10-30||Interventional|DIC||Thromboelastometry Guided DIC Prevention After Cesarean Section in Pregnant Women With Placenta Previa|Thromboelastometry Guided Disseminated Intravascular Coagulation Prevention After Cesarean Section in Pregnant Women With Placenta Previa|Recruiting||N/A|60|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:45:25.803455|2017-10-10 20:45:25.803455
NCT03266419|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-28|||March 2018|Anticipated|2018-03-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Effectiveness of Deep Versus Moderate Neuromuscular Blockade|A Double-blind, Randomized, Parallel Design to Compare the Effectiveness of Deep Versus Moderate Neuromuscular Blockade With Standard-pressure Pneumoperitoneum During Laparoscopic Gastrectomy on Postoperative Pain in Surgical Patients|Not yet recruiting||N/A|100|Anticipated|Asan Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:45:25.91685|2017-10-10 20:45:25.91685
NCT03266406|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of Hyaluronidase on Intraocular Pressure|Effect of Hyaluronidase on Intraocular Pressure After Retrobulbar Anaesthesia During Cataract Surgery|Not yet recruiting||N/A|50|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:45:26.001544|2017-10-10 20:45:26.001544
NCT03266393|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-25|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|EnvarsusXR||Envarsus XR® in Adolescent Renal Transplant Recipients|A Prospective, Randomized, Single-center, Pilot Study of Envarsus XR® to Examine Safety, Medication Adherence, and Patient Reported Outcomes in Adolescent Renal Transplant Recipients|Not yet recruiting||Phase 4|28|Anticipated|University of California, Los Angeles||2|||f||||f|t|f|||f|||||2017-10-10 20:45:26.074268|2017-10-10 20:45:26.074268
NCT03266380|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-09-06|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 30, 2019|Anticipated|2019-12-30|December 1, 2019|Anticipated|2019-12-01||Observational|||Risk Factors and Common Preventive Measures for Ventilator Associated Pneumonia in Patients With Severe Traumatic Brain Injury|Risk Factors and Common Preventive Measures for Ventilator Associated Pneumonia in Patients With Severe Traumatic Brain Injury|Not yet recruiting||N/A|80|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:45:26.187693|2017-10-10 20:45:26.187693
NCT03266367|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-31|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 15, 2019|Anticipated|2019-09-15|December 1, 2018|Anticipated|2018-12-01||Observational|||Neutrophil Gelatinase Associated Liocalin in Predicting AKI in Coronary Artery Disease|The Role of Serum Neutrophil Gelatinase Associated Lipocalin in Predicting Acute Kidney Injury in Patients With Coronary Artery Disease|Not yet recruiting||N/A|45|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:45:26.255644|2017-10-10 20:45:26.255644
NCT03266354|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|September 30, 2019|Anticipated|2019-09-30||Observational|||Changes of the Corneal Endothelial Cell Count After Artisan Phakic Intraocular Lens Implantation|Changes of the Corneal Endothelial Cell Count After Artisan Phakic Intraocular Lens Implantation|Not yet recruiting||N/A|10|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:26.341798|2017-10-10 20:45:26.341798
NCT03266341|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Observational|||Detection of Anaerobes in Different Clinicalsamples|Detection of Anaerobes in Different Clinical Samples|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:26.442045|2017-10-10 20:45:26.442045
NCT03266328|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevated Myocardial Infarction in Assiut University|Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevated Myocardial Infarction in Assiut University|Not yet recruiting||N/A|117|Anticipated|Assiut University|||2||f|||||f|f||||||||2017-10-10 20:45:26.523503|2017-10-10 20:45:26.523503
NCT03266315|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|ProPS||Probiotics Supplementation and Length of Hospital Stay in Neonates With Gastrointestinal Surgery|Probiotics Supplementation and Length of Hospital Stay in Neonates With Gastrointestinal Surgery|Not yet recruiting||N/A|88|Anticipated|University of Calgary||2|||f||||t|f|f||||||||2017-10-10 20:45:26.646118|2017-10-10 20:45:26.646118
NCT03266302|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|October 2019|Anticipated|2019-10-01||Interventional|REMOVE||Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective Endocarditis|Revealing Mechanisms and Investigating Efficacy of Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective Endocarditis - a Multicentric Randomized Controlled Group Sequential Trial|Not yet recruiting||N/A|250|Anticipated|Jena University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:45:26.746114|2017-10-10 20:45:26.746114
NCT03266289|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|September 1, 2018|Anticipated|2018-09-01||Observational|||Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab|Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:26.845499|2017-10-10 20:45:26.845499
NCT03266276|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics|Assessing the Impact of Cancer Care Ontario's Psychosocial Oncology & Palliative Care Pathway in Ambulatory Head and Neck Cancer Clinics|Not yet recruiting||N/A|81|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|f|f||||||||2017-10-10 20:45:26.909279|2017-10-10 20:45:26.909279
NCT03266263|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-27|||August 1, 2016|Actual|2016-08-01|August 2016|2016-08-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||A Study of Improving Education of Community Chain of Survival|Improving Education of Community Chain of Survival Through Innovative Teaching, Implementing Teamwork Skills, and Survey on Attitude and Willingness: A Pilot Study|Recruiting||N/A|500|Anticipated|National Taiwan University Hospital||2|||f|||||f|f||||||||2017-10-10 20:45:26.99904|2017-10-10 20:45:26.99904
NCT03266250|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Observational|||Transthoracic Echocardiography of Inferior Vena Cava Before Spinal Anesthesia Can Predict Hypotension|Transthoracic Echocardiography of Inferior Vena Cava Before Spinal Anesthesia Can Predict Hypotension in Elderly Orthopaedic Patients|Recruiting||N/A|60|Anticipated|National and Kapodistrian University of Athens|||2||f||||t|f|f||||||||2017-10-10 20:45:27.094854|2017-10-10 20:45:27.094854
NCT03266237|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-27|||December 2013||2013-12-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Immune Response to Influenza Vaccinations in Elderly Individuals|Multi-parameter Immune Profile Associated With the Humoral Response to Influenza Vaccine, Vaxigrip® in Healthy and Frail Elderly Subjects Aged 65-90 Years in Singapore|Completed||Phase 4|240|Actual|National University Hospital, Singapore||4|||f||||t||||||||||2017-10-10 20:45:27.201134|2017-10-10 20:45:27.201134
NCT03266224|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-30|||April 30, 2013|Actual|2013-04-30|August 2017|2017-08-01|August 15, 2015|Actual|2015-08-15|August 15, 2015|Actual|2015-08-15||Observational|||Digital Analysis of Ultrasonographic Images in Children With Wry Neck|Digital Analysis of Ultrasonographic Images in Children With Wry Neck|Completed||N/A|29|Actual|Chang Gung Memorial Hospital|||1||f||||f|f|f||||||||2017-10-10 20:45:27.317143|2017-10-10 20:45:27.317143
NCT03266211|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|VAT65||Antitetanus Vaccination for People Older Than 65 Years.|Antitetanus Vaccination for People Older Than 65 Years in the Auvergne-Rhône-Alpes (France) Region Depending on the Demographic and Medical Practice of Their Medical Practitioner.|Not yet recruiting||N/A|12600|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 20:45:27.39867|2017-10-10 20:45:27.39867
NCT03266198|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||April 27, 2016|Actual|2016-04-27|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Observational|||Fetal 3D Study (Fetal Body Composition and Volumes Study)|Fetal Body Composition and Volumes Study|Active, not recruiting||N/A|2973|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f|||||f|f||||||||2017-10-10 20:45:27.484997|2017-10-10 20:45:27.484997
NCT03266185|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-26|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|COP||Shorter Scalp Cooling Time in Paclitaxel|Prospective, Multi-centre Trial to Evaluate Effectiveness of 45-min and 20-min Post-infusion Cooling Time for Patients Treated With Scalp Cooling to Prevent Paclitaxel-induced Alopecia|Not yet recruiting||N/A|90|Anticipated|Leiden University Medical Center||3|||f||||f|f|f||||||||2017-10-10 20:45:27.55636|2017-10-10 20:45:27.55636
NCT03266172|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-10-05|||September 27, 2017|Actual|2017-09-27|October 2017|2017-10-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||A Study to Compare the Pharmacokinetics of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule Relative to an Immediate Release (IR) Tablet Formulation and to Investigate the Pharmacokinetics of a Selected MR Formulation in Capsule Following Repeat Doses|A Two Part, Non-randomized, Open Label Study Designed to Assess the Pharmacokinetics of GSK2982772 Following Administration of Modified Release Formulations in Capsule Relative to an Immediate Release Reference Tablet Formulation (Part A) and the Pharmacokinetics of Escalating, Repeat Doses of a Selected Modified Release Prototype (Part B) in Healthy Subjects|Recruiting||Phase 1|26|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 20:45:27.681581|2017-10-10 20:45:27.681581
NCT03266159|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|August 19, 2020|Anticipated|2020-08-19|August 19, 2020|Anticipated|2020-08-19||Interventional|||A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors|A Phase I/II Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Small Cell Lung Cancer and Ras-Mutated Solid Tumors|Not yet recruiting||Phase 2|150|Anticipated|GlaxoSmithKline||6|||f||||f|t|f||||||||2017-10-10 20:45:27.806175|2017-10-10 20:45:27.806175
NCT03266146|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-09-03|||September 2, 2017|Actual|2017-09-02|August 2017|2017-08-01|August 27, 2021|Anticipated|2021-08-27|August 27, 2021|Anticipated|2021-08-27||Interventional|||36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI|The Efficacy and Safety of 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-Induced Liver Injury|Recruiting||Phase 1/Phase 2|82|Anticipated|Beijing 302 Hospital||2|||f||||t|f|f||||||||2017-10-10 20:45:27.932489|2017-10-10 20:45:27.932489
NCT03266120|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-14|||August 3, 2017|Actual|2017-08-03|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Health Benefits of Gardening|Assessing Human Health Benefits of Gardening|Recruiting||N/A|40|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 20:45:28.149766|2017-10-10 20:45:28.149766
NCT03266107|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-28|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Open-Label, Single-Arm, Single-Center Study of Basivertebral Nerve Ablation Treatment of Chronic Low Back Pain|A Prospective, Open-Label, Single-Arm, Single-Center Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain|Not yet recruiting||N/A|50|Anticipated|Relievant Medsystems, Inc.||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:45:28.258691|2017-10-10 20:45:28.258691
NCT03266094|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-28|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy|A Prospective, Multi-center, Single Arm Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy|Not yet recruiting||N/A|60|Anticipated|Medtronic - MITG||1|||f||||f|f|t|f|f||||||2017-10-10 20:45:28.338145|2017-10-10 20:45:28.338145
NCT03266081|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-28|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bupivacaine Epiphora Trial|Improving Epiphora & Ptosis With Bupivacaine|Recruiting||Phase 2|10|Anticipated|McMaster University||1|||f|||||t|f||||||||2017-10-10 20:45:28.428537|2017-10-10 20:45:28.428537
NCT03266068|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-28|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Observational|||Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders|Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders|Recruiting||N/A|150|Anticipated|Mayo Clinic|||3||f||||f|f|f||||Samples With DNA|"     Blood, stool, and tissue samples   "|||2017-10-10 20:45:30.687826|2017-10-10 20:45:30.687826
NCT03266055|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-28|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Blueberry on Gut Microbiota and Metabolic Syndrome|Prebiotic Effects of Blueberry in Overweight/Obese Individuals: Potential Role of the Gut Microbiota in Alleviating the Metabolic Syndrome.|Not yet recruiting||N/A|56|Anticipated|Laval University||2|||f||||f|f|f||||||||2017-10-10 20:45:30.791423|2017-10-10 20:45:30.791423
NCT03266042|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-28|||January 14, 2016|Actual|2016-01-14|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01|2 Years|Observational [Patient Registry]|||Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy|Collection of Safety, Efficacy and Resource Utilization Information in Patients Who Have Received Melphalan PHP With the Delcath Hepatic Delivery System for the Treatment of Unresectable Hepatic Malignancy|Recruiting||N/A|200|Anticipated|Delcath Systems Inc.|||1||f||||f|f|f||||||||2017-10-10 20:45:30.860372|2017-10-10 20:45:30.860372
NCT03266029|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-28|||May 24, 2015|Actual|2015-05-24|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical Evaluation of Cordio App in Adult Patients With CHF|Single-Arm Observational Double - Blind Study Designed to Clinically Evaluate Cordio Application in Adult Patients With CHF|Recruiting||N/A|200|Anticipated|Cordio Medical|||1||f||||f|f|f||||||||2017-10-10 20:45:30.949175|2017-10-10 20:45:30.949175
NCT03266016|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 1, 2022|Anticipated|2022-09-01|June 1, 2022|Anticipated|2022-06-01||Interventional|REDvent||Real-time Effort Driven VENTilator Management|Identifying and Preventing Ventilator Induced Diaphragm Dysfunction in Children|Not yet recruiting||N/A|300|Anticipated|Children's Hospital Los Angeles||4|||f||||t|f|f||||||||2017-10-10 20:45:31.025754|2017-10-10 20:45:31.025754
NCT03266003|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-28|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment|An Evaluation of Traditional Directly Observed Therapy and Electronic Forms of Directly Observed Therapy for Tuberculosis Treatment|Recruiting||N/A|304|Anticipated|Centers for Disease Control and Prevention||2|||f||||f|f|f||||||||2017-10-10 20:45:31.134783|2017-10-10 20:45:31.134783
NCT03265990|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 1, 2019|Anticipated|2019-02-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Haemorrhoidectomy by Ligasure and Conventional Surgery|Comparison Between Haemorrhoidectomy by Ligasure and Conventional Surgery|Not yet recruiting||N/A|40|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:45:31.240339|2017-10-10 20:45:31.240339
NCT03265977|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-28|||December 31, 2017|Anticipated|2017-12-31|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|November 30, 2020|Anticipated|2020-11-30||Interventional|A-043||A Phase II Study of H56:IC31 in Healthy Adolescents|A Randomized, Placebo Controlled, Double-Blind Phase II Study to Evaluate Safety, Immunogenicity, and Prevention of Infection With Mycobacterium Tuberculosis (Mtb) of H56:IC31 in Healthy Adolescents|Not yet recruiting||Phase 2|1400|Anticipated|Aeras||2|||f||||t|f|f||||||||2017-10-10 20:45:31.308414|2017-10-10 20:45:31.308414
NCT03265964|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-01|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 1, 2023|Anticipated|2023-02-01|March 1, 2022|Anticipated|2022-03-01||Interventional|||Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation|Clinical and Imaging Biomarker Trial of Uridine for Veterans With Suicidal Ideation|Not yet recruiting||Phase 4|90|Anticipated|VA Office of Research and Development||2|||f||||t|t|f||||||||2017-10-10 20:45:31.530674|2017-10-10 20:45:31.530674
NCT03265951|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|September 30, 2019|Anticipated|2019-09-30||Interventional|DORMI||Ramelteon for Complex Insomnia in Veterans With PTSD|A Pilot, Randomized, Double-blind, Placebo Controlled, Trial of Ramelteon for CPAP Non-Adherent Veterans With PTSD and Complex Insomnia|Not yet recruiting||Phase 4|32|Anticipated|State University of New York at Buffalo||2|||f||||f|t|f|||f|||||2017-10-10 20:45:31.652535|2017-10-10 20:45:31.652535
NCT03265938|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|July 5, 2019|Anticipated|2019-07-05|July 5, 2019|Anticipated|2019-07-05||Observational|||Evaluation of Video Laryngoscopy in Patients With Head and Neck Pathology|Evaluation of Video Laryngoscopy in Patients With Head and Neck Pathology|Recruiting||N/A|100|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||f|f|t|f|f||||||2017-10-10 20:45:31.765367|2017-10-10 20:45:31.765367
NCT03265925|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-27|||May 26, 2017|Actual|2017-05-26|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Brain Network Activation Analysis in Epilepsy|Brain Network Activation Analysis in Epilepsy|Recruiting||N/A|90|Anticipated|ElMindA Ltd|||3||f||||||||||||||2017-10-10 20:45:31.870655|2017-10-10 20:45:31.870655
NCT03265912|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-27|||January 26, 2017|Actual|2017-01-26|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment|Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment - A GE Healthcare Companion Study: Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 (mTBI-phase2)|Enrolling by invitation||N/A|210|Anticipated|ElMindA Ltd|||2||f|||||f|||||||||2017-10-10 20:45:31.960516|2017-10-10 20:45:31.960516
NCT03265899|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-25|||July 1, 2015|Actual|2015-07-01|August 2017|2017-08-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Oxytocin and the Processing of Social Stress-Associated Chemosignals|Double-blind, Placebo-controlled, Randomized Study: Oxytocin Modulation of Stress-Associated Chemosignals Processing|Completed||Phase 1|60|Actual|University Hospital, Bonn||2|||f||||f|f|f|||f|||||2017-10-10 20:45:32.04286|2017-10-10 20:45:32.04286
NCT03265873|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|CONTOUR||Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers|Contribution of the ENT Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers|Not yet recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:45:32.306989|2017-10-10 20:45:32.306989
NCT03265860|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-29|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|IMPROVES||Intravoxel Incoherent Motion Prognostic Value in the Initial Evaluation of Patients With Acute Ischemic Strokes Using 3 Tesla Magnetic Resonance Imaging|Intravoxel Incoherent Motion Prognostic Value in the Initial Evaluation of Patients With Acute Ischemic Strokes Using 3 Tesla Magnetic Resonance Imaging|Recruiting||N/A|250|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 20:45:32.43305|2017-10-10 20:45:32.43305
NCT03265847|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-25|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||The weWomen and ourCircle Intervention for Immigrant, Refugee and Indigenous Women|Impact of Culturally-Specific Danger Assessment on Safety, Mental Health and Empowerment|Not yet recruiting||N/A|1250|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||||2017-10-10 20:45:32.527709|2017-10-10 20:45:32.527709
NCT03265834|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-25|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|CABI||CABI: Antibiotic Duration for Complicated Intra-ABdominal Infection|The CABI Trial: An Unblinded Parallel Group Randomised Controlled Feasibility Trial of Long Course Antibiotic Therapy (28 Days) Compared to Short Course (≤10 Days) in the Prevention of Complicated Intra-ABdominal Infection Relapses in Adults Treated for Complicated Intra-ABdominal Infection|Recruiting||Phase 2|60|Anticipated|University of Leeds||2|||f||||f|f|f|||f|||||2017-10-10 20:45:32.609577|2017-10-10 20:45:32.609577
NCT03265821|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Influence of Smoking on Periodontal Healing One Year After Active Treatment||Completed||N/A|4227|Actual|Dalarna County Council, Sweden|||1||f|||||f|f||||||||2017-10-10 20:45:32.711649|2017-10-10 20:45:32.711649
NCT03265808|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-25|||February 2018|Anticipated|2018-02-01|August 2017|2017-08-01|February 2026|Anticipated|2026-02-01|February 2025|Anticipated|2025-02-01||Interventional|Alaunus||Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.|A Phase I/II, Prospective, Randomized, Double-Blind, PlAcebo-ControLled Trial to EvAluate the Potential Efficacy of Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.|Not yet recruiting||Phase 1/Phase 2|80|Anticipated|University of Miami||2|||||||t|t|f||||||||2017-10-10 20:45:32.770563|2017-10-10 20:45:32.770563
NCT03265795|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-29|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Validity of PEEK PSI Containing Autogenous Bone Graft for Maxillary Reconstruction Following Lesion Enucleation|Validity of PEEK PSI Containing Autogenous Bone Graft for Maxillary Reconstruction Following Lesion Enucleation|Not yet recruiting||N/A|8|Anticipated|Cairo University||1|||f||||f|f|f||||||||2017-10-10 20:45:32.875731|2017-10-10 20:45:32.875731
NCT03265782|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-08-28|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Paracetamol Versus Ibuprofen for PDA Closure|Comparison Between the Effect of Oral Paracetamol Versus Oral Ibuprofen in the Treatment of Patent Ductus Arteriosus in Preterm and Low Birth Weight Infants|Active, not recruiting||Phase 4|30|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 20:45:32.947515|2017-10-10 20:45:32.947515
NCT03265769|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-29|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Femoral or Radial Approach in Coronary Chronic Total Occlusion|Femoral or Radial Approach in the Treatment of Coronary Chronic Total Occlusion: A Randomized Clinical Trial (FORT CTO TRİAL)|Recruiting||N/A|400|Anticipated|Acibadem University||2|||f||||f|f|f||||||||2017-10-10 20:45:33.018519|2017-10-10 20:45:33.018519
NCT03265756|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-28|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Multimometer - Vital Signs Device for Diagnosis of Pneumonia|Multimometer - Vital Signs Device for Diagnosis of Pneumonia|Recruiting||N/A|350|Anticipated|University of Alberta|||2||f||||f|f|f||||||||2017-10-10 20:45:33.101278|2017-10-10 20:45:33.101278
NCT03265743|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-28|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Observational|VACCIN-HPV-MUC||HPV Vaccination in Women With Cystic Fibrosis|HPV (Papilloma Human Virus) Vaccination in Young Women With Cystic Fibrosis and Followed in the Auvergne Rhône-Alpes Region|Not yet recruiting||N/A|62|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:45:33.186344|2017-10-10 20:45:33.186344
NCT03265730|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-08-26|||August 2016||2016-08-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|TURPENADA||Pediatric Antibiotic Associated Diarrhea|Incidence, Risk Factors and Severity of Pediatric Antibiotic Associated Diarrhea|Recruiting||N/A|2000|Anticipated|Hacettepe University|||1||f||||f|f|f||||||||2017-10-10 20:45:33.259542|2017-10-10 20:45:33.259542
NCT03265717|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-26|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Invac-1 in Chronic Lymphocytic Leukemia|A Phase II Study of INVAC-1 as Treatment of Patients With High-risk Chronic Lymphocytic Leukemia|Not yet recruiting||Phase 2|84|Anticipated|Invectys||2|||f||||t|t|f||||||||2017-10-10 20:45:33.332448|2017-10-10 20:45:33.332448
NCT03265704|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-26|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|August 25, 2017|Actual|2017-08-25|August 25, 2017|Actual|2017-08-25||Observational|MPIHHPN||Maternal High Blood Pressure and Newborn's Blood Profile|Maternal Pregnancy Induced Hypertension and Hematological Profile of Newborns|Completed||N/A|6108|Actual|Romanian Society of Anesthesia and Intensive Care|||4||f||||t|f|f||||||||2017-10-10 20:45:33.528453|2017-10-10 20:45:33.528453
NCT03265691|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-28|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PRECAHI||Hyponatremia in the Prevention of Hospitalized Patients Falls|Effectiveness of Early Intervention in the Diagnosis and Treatment of Hyponatremia in the Prevention of Hospitalized Patients Falls|Completed||N/A|124|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-10 20:45:33.648361|2017-10-10 20:45:33.648361
NCT03265678|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||June 2, 2017|Actual|2017-06-02|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|SASAC||Skin Ageing Signatures and Cancer|Identification of a Genomic/Transcriptomic Signature for Ageing and Predisposition to Skin Cancer in Normal Sun-exposed Skin|Recruiting||N/A|10|Anticipated|Queen Mary University of London|||1||f||||f|f|f||||Samples With DNA|"     Skin and blood samples   "|||2017-10-10 20:45:33.728846|2017-10-10 20:45:33.728846
NCT03265665|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-27|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 30, 2020|Anticipated|2020-04-30|May 2019|Anticipated|2019-05-01||Interventional|ACTION||physicAl aCtiviTy In minOrity womeN With Asthma Intervention|ACTION: physicAl aCtiviTy In minOrity womeN With Asthma Intervention|Not yet recruiting||N/A|80|Anticipated|University of Illinois at Chicago||2|||f||||f|f|f||||||||2017-10-10 20:45:33.802195|2017-10-10 20:45:33.802195
NCT03265652|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||IPL and MGX Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to MGD|Intense Pulsed Light and Meibomian Gland Expression (MGX) Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to Meibomian Gland Dysfunction|Not yet recruiting||N/A|24|Anticipated|Lumenis Ltd.||2|||f||||f|f|f|||f|||||2017-10-10 20:45:33.890417|2017-10-10 20:45:33.890417
NCT03265639|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-25|||April 21, 2016|Actual|2016-04-21|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Prebiotics in Peritoneal Dialysis|Prebiotics in Peritoneal Dialysis|Recruiting||Phase 1|10|Anticipated|George Washington University||3|||f||||f|f|f||||||||2017-10-10 20:45:33.99333|2017-10-10 20:45:33.99333
NCT03265626|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-29|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Community Based Intervention to Prevent Domestic Violence Against Women in Ethiopia; a Protocol for Quasi-Experimental Implementation Research|Community Based Intervention to Prevent Domestic Violence Against Women in Ethiopia; a Protocol for Quasi-Experimental Implementation Research|Not yet recruiting||N/A|1758|Anticipated|Haramaya Unversity||3|||f||||t|f|f||||||||2017-10-10 20:45:34.114433|2017-10-10 20:45:34.114433
NCT03265613|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-04|||August 24, 2017|Actual|2017-08-24|September 2017|2017-09-01|August 30, 2018|Anticipated|2018-08-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Efficacy and Safety of Expanded Allogeneic AD-MSCs With Moderate to Severe Psoriasis|Efficacy and Safety of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells With Moderate to Severe Psoriasis|Recruiting||Phase 1/Phase 2|5|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||1|||f||||t|f|f||||||||2017-10-10 20:45:34.20114|2017-10-10 20:45:34.20114
NCT03265600|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-28|2017-08-28|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|February 28, 2018|Anticipated|2018-02-28||Interventional|MINDFUL-PC||MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home|MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Comparative Effectiveness Trial of Chronic Illness Self-Management and Action Plan Initiation Among Primary Care Patients With Depression, Anxiety, and Stress Disorders|Recruiting||N/A|135|Anticipated|Cambridge Health Alliance||2|||f||||f|f|f||||||||2017-10-10 20:45:34.309922|2017-10-10 20:45:34.309922
NCT03265587|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-25|||January 6, 2017|Actual|2017-01-06|August 2017|2017-08-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Observational|FARCE||Feng Shui And Emotional Response in the Critical Care Environment Study|FARCE Study: Feng Shui And Emotional Response in the Critical Care Environment|Completed||N/A|408|Actual|Doncaster And Bassetlaw Hospitals NHS Foundation Trust|||3||f||||f|f|f||||||||2017-10-10 20:45:34.433249|2017-10-10 20:45:34.433249
NCT03265574|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|September 1, 2019|Anticipated|2019-09-01||Interventional|PROACT||PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer?|Preventing Cardiac Damage in Patients Treated for Breast Cancer: a Phase 3 Randomised, Open Label, Blinded Endpoint, Superiority Trial of Enalapril to Prevent Anthracycline-induced CardioToxicity|Not yet recruiting||Phase 3|170|Anticipated|South Tees Hospitals NHS Foundation Trust||2|||f||||t|f|f||||||||2017-10-10 20:45:34.518337|2017-10-10 20:45:34.518337
NCT03265561|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||May 14, 2015|Actual|2015-05-14|August 2017|2017-08-01|August 4, 2019|Anticipated|2019-08-04|April 4, 2019|Anticipated|2019-04-04||Interventional|||Spinal Infection Management With Structural Allograft|Spinal Infection Management With Structural Allograft|Recruiting||N/A|38|Anticipated|Universidad Autonoma de Nuevo Leon||2|||f||||t|f|f||||||||2017-10-10 20:45:34.603841|2017-10-10 20:45:34.603841
NCT03265548|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Video Laryngoscopy in Newborn Babies V1|Comparison Between Direct Laryngoscopy and Video Laryngoscopy for Neonatal Intubation. Confidence of Staff and Number of Attempts to Successful Intubation|Recruiting||N/A|40|Anticipated|Royal Devon and Exeter NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:45:34.712431|2017-10-10 20:45:34.712431
NCT03265535|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-26|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging|Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital|||2||f||||f|t|t|f|f|f|||||2017-10-10 20:45:34.798219|2017-10-10 20:45:34.798219
NCT03265522|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-25|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|January 1, 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||Tailored Mediterranean Lifestyle Education in Patients With Mild Cognitive Impairment|The Development and Pilot Testing of Tailored Mediterranean Lifestyle Education to Encourage Behaviour Change in Patients With Mild Cognitive Impairment|Recruiting||N/A|60|Anticipated|Queen's University, Belfast||3|||f||||f|f|f||||||||2017-10-10 20:45:34.880723|2017-10-10 20:45:34.880723
NCT03265509|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-09-26|||January 2016||2016-01-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Glutamine on Urinary Incontinence|Assessment of the Effect of Glutamine Supplementation in Addition to Exercise on Pelvic Floor Muscle Strength and Clinical Parameters in Women With Urinary Incontinence or Pelvic Organ Prolapse|Recruiting||N/A|100|Anticipated|Istanbul University||2|||f||||f||||||||||2017-10-10 20:45:34.997351|2017-10-10 20:45:34.997351
NCT03265496|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-28|||February 2016||2016-02-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|CONCORDE||Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation|Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation|Recruiting||N/A|117|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||||2017-10-10 20:45:35.113774|2017-10-10 20:45:35.113774
NCT03265483|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-28|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Magnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer Trial|Effect of Magnesium Treatment on Vitamin D Resistance|Completed||N/A|180|Actual|Vanderbilt University Medical Center||4|||f||||f|f|f||||||||2017-10-10 20:45:35.227777|2017-10-10 20:45:35.227777
NCT03265470|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-26|||December 1, 2015|Actual|2015-12-01|December 2016|2016-12-01|September 30, 2017|Anticipated|2017-09-30|May 30, 2016|Actual|2016-05-30||Interventional|||Renal Protection of Intravenous Dexmedetomidine During Radical Cystectomy|The Potential Renal Protective Effect of Intravenous Dexmedetomidine for Patients During Radical Cystectomy|Recruiting||N/A|100|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 20:45:35.305222|2017-10-10 20:45:35.305222
NCT03265457|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-26|2017-08-26|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|||The Endothelial Count in Pxf|The Corneal Endothelial Cell Count in Eyes With Pseudoexfoliation Syndrome|Not yet recruiting||N/A|20|Anticipated|Assiut University|||2||f|||||f|f||||||||2017-10-10 20:45:35.391988|2017-10-10 20:45:35.391988
NCT03265444|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-25|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|February 1, 2018|Anticipated|2018-02-01||Interventional|||Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System Atrophy|A Phase 1 Study to Evaluate the Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Multiple System Atrophy|Not yet recruiting||Phase 1|9|Anticipated|Corestem, Inc.||1|||f||||t|f|f||||||||2017-10-10 20:45:35.463534|2017-10-10 20:45:35.463534
NCT03265431|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|June 1, 2023|Anticipated|2023-06-01|June 1, 2022|Anticipated|2022-06-01||Interventional|||Evaluation of PET/MR in Patients Selected for Ablation Therapy|Evaluation of PET/MR in Patients Selected for Ablation Therapy|Recruiting||Phase 2|150|Anticipated|Massachusetts General Hospital||3|||||||f|t|f||||||||2017-10-10 20:45:35.550711|2017-10-10 20:45:35.550711
NCT03265418|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||BioXmark, Rectal Feasibility Trial|BioXmark Liquid Fiducials to Enable Radiotherapy Tumor Boosting in Rectal Cancer, a Feasibility Trial|Not yet recruiting||N/A|20|Anticipated|Maastricht Radiation Oncology||1|||f||||t|f|f||||||||2017-10-10 20:45:35.628057|2017-10-10 20:45:35.628057
NCT03265405|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-29|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|SARCORT||Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of Sarcoidosis|Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of Sarcoidosis: a Randomized Controlled Trial|Recruiting||Phase 4|86|Anticipated|Postgraduate Institute of Medical Education and Research||3|||f||||f|f|f||||||||2017-10-10 20:45:35.715518|2017-10-10 20:45:35.715518
NCT03265392|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|DECOUVRIR-M||Impact of Food Combination on Starch Digestion and Gastric Processing|DECOUVRIR-M Digestion: COnstruire Une Meilleure santé et Mieux Comprendre Les Processus Digestifs grâce à l'Imagerie Par Résonance Magnétique|Not yet recruiting||N/A|20|Anticipated|Institut National de la Recherche Agronomique||9|||f||||f|f|f||||||||2017-10-10 20:45:35.816393|2017-10-10 20:45:35.816393
NCT03265379|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-28|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|August 22, 2022|Anticipated|2022-08-22|August 22, 2022|Anticipated|2022-08-22||Observational|||Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection|Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection|Recruiting||N/A|104|Anticipated|University Health Network, Toronto|||4||f||||f|f|f||||||||2017-10-10 20:45:35.912891|2017-10-10 20:45:35.912891
NCT03265366|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ABPA-MR||Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses|Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses|Not yet recruiting||N/A|27|Anticipated|University Hospital, Bordeaux||2|||f||||f|f|f||||||||2017-10-10 20:45:36.006279|2017-10-10 20:45:36.006279
NCT03265353|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-29|||July 25, 2013|Actual|2013-07-25|August 2017|2017-08-01|July 25, 2020|Anticipated|2020-07-25|July 25, 2019|Anticipated|2019-07-25||Interventional|||Vascular Effects of Dietary Potassium|Vascular Effects of Dietary Potassium in Humans|Recruiting||N/A|75|Anticipated|University of Delaware||3|||f||||f|f|f||||||||2017-10-10 20:45:36.223209|2017-10-10 20:45:36.223209
NCT03265340|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-08-25|||September 2014||2014-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Effect of dTMS in Major Depressive Disorder|Clinical Effect of Deep Transcranial Magnetic Stimulation (dTMS) in Three Different Doses for the Treatment of Major Depressive Disorder|Recruiting||N/A|30|Anticipated|Section for Affective Disorders; Northern Stockholm Psychiatry||3|||f||||f||||||||||2017-10-10 20:45:36.321218|2017-10-10 20:45:36.321218
NCT03265327|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|TURMERIC||Effect of an Oral Supplement Containing Omega-3 and Omega-6 on Dry Eye Symptoms|The Use of a Novel Oral Supplement Containing Omega-3 and Omega-6 Fatty Acids on Dry Eye Symptoms (TURMERIC)|Recruiting||N/A|60|Anticipated|Nature's Way Canada||2|||f||||f|f|f||||||||2017-10-10 20:45:36.437047|2017-10-10 20:45:36.437047
NCT03265314|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|December 2020|Anticipated|2020-12-01||Interventional|||LeadHer, a Gender-specific Teen Pregnancy Prevention Curriculum|Alternatives For Girls (AFG) LeadHer|Recruiting||N/A|600|Anticipated|Alternatives For Girls||2|||f||||f|f|f||||||||2017-10-10 20:45:36.54616|2017-10-10 20:45:36.54616
NCT03265301|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-27|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Hysteroscopic Surgery in Treatment of Intrauterine Abnormalities|Corrective Office Hysteroscopic Surgery Versus Conventional Hysteroscopy in Treatment of Intrauterine Abnormalities|Recruiting||N/A|70|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:45:36.630754|2017-10-10 20:45:36.630754
NCT03265288|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-25|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|APPLAUD||Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults|APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults|Not yet recruiting||Phase 2|136|Anticipated|Laurent Pharmaceuticals Inc.||2|||f||||t|t|f|||f|||||2017-10-10 20:45:36.70652|2017-10-10 20:45:36.70652
NCT03265275|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Observational|||Why Still in Hospital After Hip Fracture Surgery?|Why Still in Hospital After Hip Fracture Surgery?|Not yet recruiting||N/A|200|Anticipated|University Hospital, Akershus|||1||f||||f|f|f||||||||2017-10-10 20:45:36.809349|2017-10-10 20:45:36.809349
NCT03265262|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy|Evaluation of Technical and Predictive Value of the Basophil Activation Test for Food Allergy Diagnosis in Children|Recruiting||N/A|110|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f|f|f||||||||2017-10-10 20:45:36.879243|2017-10-10 20:45:36.879243
NCT03265249|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-25|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|BRIDGE||BRIDGE Device for Post-operative Pain Control|Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) Using the BRIDGE Device for Post-Operative Pain Control in Patients Undergoing Liver Transplantation|Not yet recruiting||N/A|50|Anticipated|Duke University||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:45:36.967504|2017-10-10 20:45:36.967504
NCT03265236|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-27|2017-08-27|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|February 1, 2019|Anticipated|2019-02-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Diagnostic Value of Anti-MCV in Pts With RA|Diagnostic Value of Antibodies Against a Modified Citrullinated Vimentin in Patients With Rheumatoid Arthritis|Not yet recruiting||N/A|85|Anticipated|Assiut University|||3||f|||||f|f||||||||2017-10-10 20:45:37.057697|2017-10-10 20:45:37.057697
NCT03265210|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|Relief||A Behavioral Intervention for Depression and Chronic Pain in Primary Care|"Relief: A Behavioral Intervention for Depression and Chronic Pain in Primary Care"|Not yet recruiting||N/A|60|Anticipated|Weill Medical College of Cornell University||2|||f||||t|f|f||||||||2017-10-10 20:45:37.242366|2017-10-10 20:45:37.242366
NCT03265197|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-25|||March 2015||2015-03-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|tinnitus||Evaluation of Adding Lidocaine to Dexamethasone in Intra-tympanic Injection for Management of Tinnitus|Evaluation of Adding Lidocaine to Dexamethasone in Intra-tympanic Injection for Management of Tinnitus|Completed||Phase 1|44|Actual|Kafrelsheikh University||2|||f||||f||||||||||2017-10-10 20:45:37.323225|2017-10-10 20:45:37.323225
NCT03265184|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|July 18, 2017|Actual|2017-07-18|June 12, 2017|Actual|2017-06-12||Interventional|||Green Coffee Extract Supplementation and Oxidative Stress, Systemic and Vascular Inflammation|Effects of Green Coffee Extract Supplementation on Oxidative Stress, Systemic and Vascular Inflammation in Patients With Metabolic Syndrome: A Randomized Clinical Trial|Completed||N/A|48|Actual|National Nutrition and Food Technology Institute||2|||f||||t|f|f|||f|||||2017-10-10 20:45:37.424395|2017-10-10 20:45:37.424395
NCT03265171|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25||||||August 2017|2017-08-01||||||||Expanded Access|||A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous|A Single-patient Study of Repeat-dose Administration of ProMetic Plasminogen (Human) Intravenous Infusion in an Adult With Hypoplasminogenemia|Available||N/A|||ProMetic BioTherapeutics, Inc||||||t|||||||||||||2017-10-10 20:45:37.492396|2017-10-10 20:45:37.492396
NCT03265158|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Observational|BMPB||Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0|Evaluation of Peripheral Blood (PB) Immunophenotyping in the Detection of Bone Marrow Involvement in Cases of Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL) and Marginal Zone Lymphoma (MZL).|Recruiting||N/A|108|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f|f|f||||Samples Without DNA|"     peripheral blood   "|||2017-10-10 20:45:37.550916|2017-10-10 20:45:37.550916
NCT03265145|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-10-03|||September 20, 2017|Actual|2017-09-20|October 2017|2017-10-01|January 23, 2020|Anticipated|2020-01-23|December 13, 2019|Anticipated|2019-12-13||Interventional|||Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]|Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO® RESPIMAT® vs. ICS-LABA Plus LAMA in Patients With COPD|Recruiting||Phase 4|3200|Anticipated|Boehringer Ingelheim||2|||f||||f|t|f||||||||2017-10-10 20:45:37.630734|2017-10-10 20:45:37.630734
NCT03265132|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-10-05|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|September 15, 2019|Anticipated|2019-09-15||Interventional|anaSTILLs||A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)|A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of 2 Dose Levels of Subcutaneous Anakinra (Kineret®) in Patients With Still's Disease (SJIA and AOSD)|Recruiting||Phase 3|81|Anticipated|Swedish Orphan Biovitrum||2|||f||||t|t|f||||||||2017-10-10 20:45:37.721851|2017-10-10 20:45:37.721851
NCT03265119|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-28|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations|A Multicenter, 3-Part, 6-Week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of AEVI-001 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Implicated in Glutamatergic Signaling and Neuronal Activity|Enrolling by invitation||Phase 2|64|Anticipated|Aevi Genomic Medicine||2|||||||f|t|f||||||||2017-10-10 20:45:37.84582|2017-10-10 20:45:37.84582
NCT03265106|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects|A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Relapse or Refractory Childhood Acute Lymphoblastic Leukemia and Lymphoma Subjects|Recruiting||Phase 1/Phase 2|20|Anticipated|Shenzhen BinDeBio Ltd.||1|||f||||t|f|f||||||||2017-10-10 20:45:37.928189|2017-10-10 20:45:37.928189
NCT03265093|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-05|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|December 29, 2018|Anticipated|2018-12-29|August 24, 2018|Anticipated|2018-08-24||Interventional|||Use of Injectable Platelet Rich Fibrin in Lichen Planus|Current Approach in the Treatment of Lichen Planus: Injectable Platelet Rich Fibrin ((İ-PRF)|Recruiting||N/A|20|Anticipated|Bezmialem Vakif University||2|||f||||t|f|f||||||||2017-10-10 20:45:38.005453|2017-10-10 20:45:38.005453
NCT03265080|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|NEO||Expressing Personalized Tumor Antigens Study|A Phase 1 Dose-Escalation Study of Advaxis (ADXS) NEO Expressing Personalized Tumor Antigens in Subjects With Metastatic Microsatellite Stable Colon Cancer, Metastatic Squamous Histology Head and Neck Cancer, and Metastatic Non-Small Cell Lung Cancer|Not yet recruiting||Phase 1|48|Anticipated|Advaxis, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:45:38.103566|2017-10-10 20:45:38.103566
NCT03265067|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-25|||July 4, 2016|Actual|2016-07-04|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Observational|FIRST||Field Implementation of the autoRIC Device in STEMI|Field Implementation of the autoRIC Device in STEMI|Recruiting||N/A|1800|Anticipated|William Osler Health System|||2||f||||f||||||||||2017-10-10 20:45:38.186455|2017-10-10 20:45:38.186455
NCT03265054|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|MICROREVE||Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis|Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis|Not yet recruiting||N/A|300|Anticipated|Assistance Publique Hopitaux De Marseille|||2||f||||f|f|f||||||||2017-10-10 20:45:38.273715|2017-10-10 20:45:38.273715
NCT03265041|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Long Term Predictors of Graft Patency After Coronary Artery Bypass Graft Surgery (Multi-slice CT Coronary Angiography Study Validated by Coronary Angiography)|Predictors of Long Term Graft Patency After Coronary Artery Bypass Graft Surgery (Multi-slice CT Coronary Angiography Study Validated by Coronary Angiography)|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:38.353233|2017-10-10 20:45:38.353233
NCT03265028|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||TRACE E-learning Implementation in Belgium|National Implementation of a Multifaceted Web-based Communication Training to Reduce of Inappropriate Antibiotic Prescribing for (Lower) Respiratory Tract Infections|Not yet recruiting||N/A|15000|Anticipated|Universiteit Antwerpen||2|||f|||||f|f||||||||2017-10-10 20:45:38.422309|2017-10-10 20:45:38.422309
NCT03265015|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-14|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Interventional|||Theta Burst Stimulation for Compulsive Behavior Non-invasive Brain Stimulation Study|Testing the Causal Role of Orbitofrontal Cortex in Human Compulsive Behavior: a Non-invasive Brain Stimulation Study|Recruiting||N/A|70|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 20:45:38.507784|2017-10-10 20:45:38.507784
NCT03265002|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-28|||March 2018|Anticipated|2018-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|EFIGI||Fibre and Gas in Irritable Bowel Syndrome|Effects of Fibre on Intestinal Volume and Gas in Irritable Bowel Syndrome|Not yet recruiting||N/A|25|Anticipated|University of Nottingham||4|||f||||f|f|f|||f|||||2017-10-10 20:45:38.594327|2017-10-10 20:45:38.594327
NCT03264976|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||July 1, 2018|Anticipated|2018-07-01|August 2017|2017-08-01|July 1, 2023|Anticipated|2023-07-01|July 1, 2023|Anticipated|2023-07-01||Observational|||Role of the Serum Exosomal miRNA in Diabetic Retinopathy (DR)|Prognostic Role of Serum Exosomal miRNA and Its Function in Pathogenesis of Diabetic Retinopathy (DR)|Not yet recruiting||N/A|200|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|||5||f|||||f|f||||Samples Without DNA|"     5ml serum will be obtained from each participant.   "|||2017-10-10 20:45:38.781645|2017-10-10 20:45:38.781645
NCT03264963|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||December 15, 2016|Actual|2016-12-15|August 2017|2017-08-01|May 18, 2017|Actual|2017-05-18|April 15, 2017|Actual|2017-04-15||Interventional|||Upper Airway Training for Treatment of Snoring|Upper Airway Training for Treatment of Snoring Using Smartphone Application|Completed||N/A|32|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|f||||||||2017-10-10 20:45:38.849756|2017-10-10 20:45:38.849756
NCT03264950|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|CFALD||Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric CF Patients|The Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric Cystic Fibrosis Patients|Not yet recruiting||N/A|60|Anticipated|University of Manitoba||1|||f||||f|f|f||||||||2017-10-10 20:45:38.915747|2017-10-10 20:45:38.915747
NCT03264937|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-28|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|September 1, 2019|Anticipated|2019-09-01||Observational|SMART||Social Software to iMprove mAnagement of oRal Anticoagulation Therapy|A Social Software-based Management Strategy to Improve Quality of Oral Anticoagulation Therapy|Recruiting||N/A|400|Anticipated|Wuhan Asia Heart Hospital|||2||f||||t|f|f||||||||2017-10-10 20:45:38.995426|2017-10-10 20:45:38.995426
NCT03264924|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-14|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|January 30, 2019|Anticipated|2019-01-30||Observational|IPAiR||Improving Physical Activity in Rehabilitation|A Single-Centre, Feasibility Study to Promote Physical Activity Uptake and Adherence in Cardiac and Pulmonary Rehabilitation|Recruiting||N/A|82|Anticipated|Liverpool Heart and Chest Hospital NHS Foundation Trust|||4||f||||f|f|f||||||||2017-10-10 20:45:39.076722|2017-10-10 20:45:39.076722
NCT03264911|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-28|||January 27, 2017|Actual|2017-01-27|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|GASPARD||Group A Pharyngitis in Children: The GASPARD Study|Group A Streptococcal Pharyngitis: Six Days Amoxicillin, oR Six Days Placebo in Children Between 3 and 15 Years Old:a Randomized, Double Blinded, Multicentred, Non-inferiority Trial|Recruiting||Phase 4|360|Anticipated|University Hospital, Geneva||2|||f||||t|f|f|||f|||||2017-10-10 20:45:39.180414|2017-10-10 20:45:39.180414
NCT03264898|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|July 31, 2022|Anticipated|2022-07-31|July 31, 2022|Anticipated|2022-07-31||Observational|||Comparative Effectiveness of FITs With Colonoscopy|Comparative Effectiveness of Fecal Immunochemical Tests With Optical Colonoscopy|Not yet recruiting||N/A|3600|Anticipated|University of Iowa|||1||f||||f|f|f||||||||2017-10-10 20:45:39.277508|2017-10-10 20:45:39.277508
NCT03264885|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-28|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Randomized Controlled Trial Evaluating an Incentive-based Community Eye-care Programme|Randomized Controlled Trial Evaluating an Incentive-based Community Eye-care Programme for Elderly With Visual Impairment|Active, not recruiting||N/A|140|Actual|Singapore National Eye Centre||2|||f||||f|f|f||||||||2017-10-10 20:45:39.358137|2017-10-10 20:45:39.358137
NCT03264872|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||March 8, 2017|Actual|2017-03-08|August 2017|2017-08-01|October 31, 2021|Anticipated|2021-10-31|October 1, 2021|Anticipated|2021-10-01||Interventional|||Peer MI for Substance-using Emerging Adults|Peer-enhanced Motivational Interviewing for Emerging Adults With Risky Substance Use|Recruiting||N/A|180|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f|f|f||||||||2017-10-10 20:45:39.500924|2017-10-10 20:45:39.500924
NCT03264859|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-28|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|||NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction|Neutrophil Gelatinase-associated Lipocalin (NGAL) and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:45:39.602116|2017-10-10 20:45:39.602116
NCT03264846|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-29|||May 3, 2016|Actual|2016-05-03|August 2017|2017-08-01|August 7, 2017|Actual|2017-08-07|June 29, 2017|Actual|2017-06-29|1 Day|Observational [Patient Registry]|||Endocan Levels at Polycystic Ovary Syndrome and Periodontal Inflammation|The Levels of Interleukin-6 and Endocan at Individuals With Polycystic Ovary Syndrome and Periodontal Inflammation|Completed||N/A|87|Actual|Bezmialem Vakif University|||4||f||||f|f|f||||Samples With DNA|"     Serum and Saliva   "|||2017-10-10 20:45:39.700463|2017-10-10 20:45:39.700463
NCT03263585|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-30|||May 3, 2012|Actual|2012-05-03|August 2017|2017-08-01|December 22, 2014|Actual|2014-12-22|November 22, 2012|Actual|2012-11-22||Interventional|||Treatment With a Spinal Orthosis Compared to Equipment Group Training and a Control Group|Identification and Treatment of Back Pain in Elderly Women With Osteoporosis|Completed||N/A|113|Actual|Karolinska Institutet||3|||f||||f|f|f||||||||2017-10-10 20:45:50.744592|2017-10-10 20:45:50.744592
NCT03264833|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-25|||December 15, 2016|Actual|2016-12-15|August 2017|2017-08-01|September 1, 2017|Anticipated|2017-09-01|February 1, 2017|Actual|2017-02-01||Observational|||Accuracy and Precision Comparison of Temptraq|Accuracy and Precision Test of TempTraq® Compared to Pulmonary Artery Catheter for Monitoring Temperature in Adults in Intensive Care Unit|Active, not recruiting||N/A|50|Actual|The Cleveland Clinic|||1||f||||f|f|f||||||||2017-10-10 20:45:39.78399|2017-10-10 20:45:39.78399
NCT03264820|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-28|||August 31, 2017|Anticipated|2017-08-31|July 2017|2017-07-01|April 15, 2019|Anticipated|2019-04-15|March 31, 2019|Anticipated|2019-03-31||Interventional|REPROLASER||Study of the Reproducibility of Laser Measurement in the Detection of Digital Obstructive Arterial Disease (DOAD)|Study of the Reproducibility of Laser Measurement in the Detection of Digital|Not yet recruiting||N/A|44|Anticipated|Rennes University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:45:39.862952|2017-10-10 20:45:39.862952
NCT03264807|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-28|||August 6, 2015|Actual|2015-08-06|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 30, 2020|Anticipated|2020-12-30||Interventional|||Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer|A Multicenter Randomized Controlled Trial of D2 Versus D2 + Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer (14VIGTORY Trial)|Recruiting||Phase 3|518|Anticipated|National Cancer Center, Korea||2|||f||||f|f|f||||||||2017-10-10 20:45:39.950075|2017-10-10 20:45:39.950075
NCT03264794|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-28|||August 2017|Anticipated|2017-08-01|January 2017|2017-01-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Interventional|||the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)|Evaluation of the Efficacy of Domestic Gefitinib Tablets in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients Using a Multicenter, Randomized, Positive Drug Gefitinib Pharmacodynamics and Pharmacodynamics|Not yet recruiting||Phase 4|100|Anticipated|Jiangsu Famous Medical Technology Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:45:40.101788|2017-10-10 20:45:40.101788
NCT03264781|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-29|||August 2016||2016-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users|The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users; a Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|44|Anticipated|Chulalongkorn University||2|||f||||||||||||||2017-10-10 20:45:40.176266|2017-10-10 20:45:40.176266
NCT03264768|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-28|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|BEVA||Endoscopic Long Volume Reduction by Endobronchial Valves in Belgium|Endoscopic Long Volume Reduction by Endobronchial Valves in Belgium|Not yet recruiting||N/A|40|Anticipated|Katholieke Universiteit Leuven||2|||f||||f|f|f|||f|||||2017-10-10 20:45:40.268923|2017-10-10 20:45:40.268923
NCT03264755|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-28|||January 4, 2018|Anticipated|2018-01-04|August 2017|2017-08-01|January 4, 2020|Anticipated|2020-01-04|January 4, 2019|Anticipated|2019-01-04||Interventional|||Cortical Excitability and Role of rTMS in Nicotine Use Disorder|Cortical Excitability and Role of rTMS in Nicotine Use Disorder|Not yet recruiting||N/A|60|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:45:40.36497|2017-10-10 20:45:40.36497
NCT03264742|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-14|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|||Ghrelintrial With Patients With Stroke|Longitudinal Trial to Investigate a Neuroprotective Effect of Ghrelin After Acute Ischemic Stroke|Recruiting||N/A|100|Anticipated|Kantonsspital Winterthur KSW|||1||f||||t|f|f||||||||2017-10-10 20:45:40.45535|2017-10-10 20:45:40.45535
NCT03264729|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-10-04|||August 24, 2017|Actual|2017-08-24|October 2017|2017-10-01|October 3, 2017|Actual|2017-10-03|October 3, 2017|Actual|2017-10-03||Interventional|||The Acute Effect of Isotonic Versus Isometric Exercise Versus Walking on Pain in Individuals With Plantar Fasciopathy|The Acute Effect of Isotonic Versus Isometric Exercise Versus Walking on Pain in Individuals With Plantar Fasciopathy: a Randomised, Participant-blinded, Cross-over Trial|Completed||N/A|20|Actual|Aalborg University||3|||f||||f|f|f||||||||2017-10-10 20:45:40.532547|2017-10-10 20:45:40.532547
NCT03264716|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-28|||August 31, 2017|Anticipated|2017-08-31|January 2017|2017-01-01|December 23, 2018|Anticipated|2018-12-23|December 23, 2018|Anticipated|2018-12-23||Interventional|||A Study of Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis|A Prospective Open-label Study of Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis|Enrolling by invitation||N/A|15|Anticipated|National Taiwan University Hospital||1|||f||||t|f|f||||||||2017-10-10 20:45:40.625705|2017-10-10 20:45:40.625705
NCT03264703|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|HUMAN||Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World|"An Observational Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus Anti-TNF Versus cDMARDs in Real World [HUMAN Study]"|Not yet recruiting||N/A|460|Anticipated|Eisai Inc.|||1||f||||f|f|f||||||||2017-10-10 20:45:40.713034|2017-10-10 20:45:40.713034
NCT03264690|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|HUMAN||Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients|A Prospective Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients|Not yet recruiting||N/A|40|Anticipated|Eisai Inc.|||1||f||||f|f|f||||||||2017-10-10 20:45:40.821815|2017-10-10 20:45:40.821815
NCT03264677|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-24|||May 18, 2017|Actual|2017-05-18|August 2017|2017-08-01|July 25, 2017|Actual|2017-07-25|July 25, 2017|Actual|2017-07-25||Interventional|||An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)|An 8-week Full Face HUT Design, Single Center, Double Blinded, Controlled and Randomized Study to Evaluate Different Product Regimens' Performance on Protecting Skin With Resilience Under Tracked City Environmental Aggressors|Completed||N/A|122|Actual|Johnson & Johnson Pte Ltd||3|||f||||t|f|f||||||||2017-10-10 20:45:40.909139|2017-10-10 20:45:40.909139
NCT03264664|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|November 2019|Anticipated|2019-11-01||Interventional|||Study of E7386 in Subjects With Selected Advanced Neoplasms|An Open-Label Multicenter Phase 1 Study of E7386 in Subjects With Selected Advanced Neoplasms|Recruiting||Phase 1|140|Anticipated|Eisai Inc.||1|||f||||t|f|f||||||||2017-10-10 20:45:41.033764|2017-10-10 20:45:41.033764
NCT03264651|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-28|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|March 1, 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density|A Single-Centre Pilot Trial Investigating the Efficacy and Safety of Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density|Recruiting||Phase 1|10|Anticipated|Havah Therapeutics Pty Ltd||1|||f||||t|f|f||||||||2017-10-10 20:45:41.137051|2017-10-10 20:45:41.137051
NCT03264638|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-28|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS|A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of Polycystic Ovary Syndrome|Recruiting||Phase 2|315|Anticipated|Peking Union Medical College Hospital||3|||f||||t|f|f||||||||2017-10-10 20:45:41.26692|2017-10-10 20:45:41.26692
NCT03264625|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-08-28|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis|The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis|Recruiting||Phase 2|60|Anticipated|Peking University First Hospital||2|||f||||t|f|f||||||||2017-10-10 20:45:41.381494|2017-10-10 20:45:41.381494
NCT03264612|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||April 3, 2016|Actual|2016-04-03|August 2017|2017-08-01|August 12, 2017|Actual|2017-08-12|May 14, 2017|Actual|2017-05-14||Interventional|||Effect of Swimming on Premenstrual Syndrome|Effect of Aeropbic Exercise as Swimming on Premenstrual Syndrome|Completed||N/A|70|Actual|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:45:41.473349|2017-10-10 20:45:41.473349
NCT03264599|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||July 11, 2016|Actual|2016-07-11|August 2017|2017-08-01|August 20, 2017|Actual|2017-08-20|July 21, 2017|Actual|2017-07-21||Observational|||Measurement of the Fetal Occiput-spine Angle During the First Stage of Labor as Predictor of the Outcome of Labor|Measurement of the Fetal Occiput-spine Angle During the First Stage of Labor as Predictor of the Maternal and Fetal Outcome of Labor|Completed||N/A|400|Actual|Cairo University|||2||f||||t|f|f||||||||2017-10-10 20:45:41.547805|2017-10-10 20:45:41.547805
NCT03264586|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Lidocaine - Prilocaine Cream (EMLA) Versus Mepivacaine Infiltration on Pain Relief During And After Mediolateral Episiotomies|The Effect of Lidocaine - Prilocaine Cream (EMLA) Versus Mepivacaine Infiltration on Pain Relief During And After Mediolateral Episiotomies: A Randomized Clinical Trial|Not yet recruiting||Phase 4|200|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:45:41.626296|2017-10-10 20:45:41.626296
NCT03264573|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-28|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|February 2017|Actual|2017-02-01||Interventional|||Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars|Role of Stem Cells, Platelet Rich Plasma and Combination of Them in Treatment of Scars|Completed||N/A|40|Actual|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:45:41.708792|2017-10-10 20:45:41.708792
NCT03264560|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-01|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|August 28, 2023|Anticipated|2023-08-28|August 28, 2022|Anticipated|2022-08-28||Interventional|CATeleST||Comparison of Asynchronous Telepsychiatry vs. Synchronous Telepsychiatry in Skilled Nursing Facilities|Comparison of Asynchronous Telepsychiatry vs. Synchronous Telepsychiatry in Skilled Nursing Facilities: A Randomized, Controlled, Non-inferiority Trial (CATeleST)|Recruiting||N/A|250|Anticipated|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 20:45:41.781541|2017-10-10 20:45:41.781541
NCT03264547|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-19|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|October 31, 2023|Anticipated|2023-10-31|April 30, 2022|Anticipated|2022-04-30||Interventional|||A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab|A Phase III Clinical Study to Compare the Combination Therapy of Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab (EMERALD)|Recruiting||Phase 3|480|Anticipated|Japan Breast Cancer Research Group||2|||f||||t|f|f||||||||2017-10-10 20:45:41.858709|2017-10-10 20:45:41.858709
NCT03264534|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Manually Performed Limbal Relaxing Incisions vs Femtosecond Laser-guided Astigmatic Keratotomy|Manually Performed Limbal Relaxing Incisions vs Femtosecond Laser-guided Astigmatic Keratotomy for Correction of Corneal Astigmatism After Phacoemulsification|Not yet recruiting||N/A|80|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:45:41.971708|2017-10-10 20:45:41.971708
NCT03264521|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-25|||January 23, 2017|Actual|2017-01-23|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|PECS||Patient Engagement Via Crowdsourcing|Feasibility of Crowdsourcing for Eliciting Patient Experiences of Chronic Pain|Recruiting||N/A|300|Anticipated|RAND|||1||f||||t|f|f||||||||2017-10-10 20:45:42.052065|2017-10-10 20:45:42.052065
NCT03264508|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Passive Heat Therapy and Age-associated Physiological Function|Passive Heat Therapy and Age-associated Physiological Function|Not yet recruiting||N/A|40|Anticipated|University of Colorado, Boulder||2|||f||||t|f|f||||||||2017-10-10 20:45:42.140857|2017-10-10 20:45:42.140857
NCT03264495|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-25|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|PESALI||Measuring the Quantities of Food Consumed by Patients Hospitalised in a Geriatric Centre|Recording Food Consumption in Patients Hospitalised in a Geriatric Centre|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:45:42.244388|2017-10-10 20:45:42.244388
NCT03264482|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-25|||May 20, 2017|Actual|2017-05-20|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPH|Treatment of Benign Prostatic Hyperplasia: High Power Thulium Laser Front Fire Vaporization VS Transurethral Resection - A Randomized Controlled Trial|Enrolling by invitation||N/A|90|Anticipated|Mansoura University||2|||f||||t|f|f||||||||2017-10-10 20:45:42.324234|2017-10-10 20:45:42.324234
NCT03263221|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-26|||December 1, 2018|Anticipated|2018-12-01|August 2017|2017-08-01|February 1, 2020|Anticipated|2020-02-01|December 1, 2019|Anticipated|2019-12-01||Observational|||Traumatic Proximal Femoral Fractures in Adults|Traumatic Proximal Femoral Fractures in Adults|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:54.501121|2017-10-10 20:45:54.501121
NCT03264469|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-09-18|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|PSYCHIC||Improvement of the Diagnosis and Medico-legal Management of Psychological Trauma in Patients Involved in the Terrorist Attack in Nice on the 14th July 2016|DIAGNOSIS and FORENSIC MANAGEMENT OF PSYCHOLOGICAL TRAUMA IN PATIENTS INVOLVED IN THE TERRORIST ATTACK IN NICE ON THE 14TH JULY 2016|Completed||N/A|50|Actual|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:45:42.389933|2017-10-10 20:45:42.389933
NCT03264456|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI|Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI|Not yet recruiting||Phase 2|15|Anticipated|University of Alabama at Birmingham||1|||f|||||t|f|||f|||||2017-10-10 20:45:42.442453|2017-10-10 20:45:42.442453
NCT03264443|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-04|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|HAEL||Hypertension Approaches in the Elderly: a Lifestyle Study|Combined Training and Health Education for Hypertensive Elders: a Multicenter Randomized Clinical Trial|Recruiting||N/A|184|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t|f|f||||||||2017-10-10 20:45:42.502493|2017-10-10 20:45:42.502493
NCT03264430|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-29|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Adding Ketamine to Low Dose Bupivacaine in Saddle Block for Perianal Surgery|Adding Ketamine to Low Dose Bupivacaine in Saddle Block for Perianal Surgery|Active, not recruiting||Early Phase 1|60|Actual|Assiut University||2|||f||||f|f|f|||f|||||2017-10-10 20:45:42.610337|2017-10-10 20:45:42.610337
NCT03264417|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-25|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Pulmonary Function Test Study - Automated Interpretation|Pulmonary Function Test Study - Automated Interpretation|Not yet recruiting||N/A|50|Anticipated|Katholieke Universiteit Leuven|||1||f||||f|f|f||||||||2017-10-10 20:45:42.680272|2017-10-10 20:45:42.680272
NCT03264404|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Azacitidine and Pembrolizumab in Pancreatic Cancer|Phase II Open-Label, Single-Center Study Evaluating Safety and Efficacy of Pembrolizumab Following Induction With the Hypomethylating Agent Azacitidine in Patients With Advanced Pancreatic Cancer After Failure of First-Line Therapy|Recruiting||Phase 2|31|Anticipated|Columbia University||1|||f||||t|t|f|||f|||||2017-10-10 20:45:42.752798|2017-10-10 20:45:42.752798
NCT03264391|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-25|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography|Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f|||||f|||||||||2017-10-10 20:45:42.842426|2017-10-10 20:45:42.842426
NCT03264378|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-28|||February 1, 2019|Anticipated|2019-02-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Partnership in Implementation Science for Geriatric Mental Health (PRISM)|Partnership in Implementation Science for Geriatric Mental Health (PRISM)|Not yet recruiting||N/A|350|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:45:42.905801|2017-10-10 20:45:42.905801
NCT03264365|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||December 15, 2012|Actual|2012-12-15|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2015|Actual|2015-12-31||Interventional|RAPIT-II||The Effectiveness of a Post-ICU Recovery Program on Relatives|The Effectiveness of a Post-ICU Recovery Program on Relatives to Patients Receiving Mechanically Ventilatory Support: Data Linked to RAPIT-I Investigation|Active, not recruiting||N/A|181|Actual|Holbaek Sygehus||2|||f||||t|f|f||||||||2017-10-10 20:45:42.969312|2017-10-10 20:45:42.969312
NCT03264352|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|IPAD||Intervention for High-normal or Borderline-elevated Blood Pressure in Adults With Type 2 Diabetes|Intervention for High-normal or Borderline-elevated Blood Pressure in Adults With Type 2 Diabetes|Not yet recruiting||Phase 4|12000|Anticipated|Guangdong General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:45:43.058673|2017-10-10 20:45:43.058673
NCT03264339|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-08|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy|The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy|Recruiting||N/A|15|Anticipated|St. Olavs Hospital||1|||f||||f|f|f||||||||2017-10-10 20:45:43.158272|2017-10-10 20:45:43.158272
NCT03264326|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-24|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy of BFR Training Combined With Eccentric Exercise as Assessed by SWE in Subjects With Chronic AT|Efficacy of Blood Flow Restriction Training Combined With Eccentric Exercise as Assessed by Shear Wave Elastography in Subjects With Chronic Achilles Tendinopathy: A Randomized Single Blinded Controlled Trial|Recruiting||N/A|70|Anticipated|Womack Army Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:45:43.256072|2017-10-10 20:45:43.256072
NCT03264313|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-31|||January 16, 2017|Actual|2017-01-16|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|SmokCessdTMS||Deep Transcranial Magnetic Stimulation (dTMS) to Induce Smoking Cessation|A Prospective, Placebo-controlled, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of the Use of Deep Transcranial Magnetic Stimulation (dTMS) on Smoking Cessation.|Recruiting||N/A|100|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|||||f|||||2017-10-10 20:45:43.346407|2017-10-10 20:45:43.346407
NCT03264300|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-24|||June 26, 2017|Actual|2017-06-26|August 2017|2017-08-01|October 26, 2022|Anticipated|2022-10-26|June 26, 2022|Anticipated|2022-06-26||Interventional|||Development and Validation of Advanced MRI Methods for Clinical Applications|Development and Validation of Advanced MRI Methods for Clinical Applications|Recruiting||N/A|220|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:45:43.430234|2017-10-10 20:45:43.430234
NCT03264287|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-03|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 30, 2020|Anticipated|2020-12-30|December 31, 2019|Anticipated|2019-12-31||Interventional|||Efficacy of Acupuncture Combined With Moving Cupping and Ear Point Tapping for Moderate and Severe Acne Vulgaris|Efficacy of Acupuncture Combined With Moving Cupping and Ear Point Tapping for Moderate and Severe Acne Vulgaris: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 20:45:43.526308|2017-10-10 20:45:43.526308
NCT03264274|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-08-30|||February 6, 2017|Actual|2017-02-06|August 2017|2017-08-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|AUSCOR||Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal Cancer|A Phase II Trial of Aflibercept Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Metastatic Colorectal Cancer|Withdrawn||Phase 2|0|Actual|Barts & The London NHS Trust||1||Funding restrictions - study never opened to recruitment|f||||f|f|f||||||||2017-10-10 20:45:43.76298|2017-10-10 20:45:43.76298
NCT03264261|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-28|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|||Constraint Induced Movement Therapy for Walking in Individuals Post Stroke|Constraint Induced Movement Therapy for Walking in Individuals Post Stroke|Recruiting||N/A|36|Anticipated|Shirley Ryan AbilityLab||2|||f||||t|f|t|f|f||||||2017-10-10 20:45:43.87559|2017-10-10 20:45:43.87559
NCT03264248|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-10-05|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Daily Weight Feedback for Wheelchair Users to Promote Weight Loss|Daily Self-weighing Feedback for Wheelchair Users to Promote Weight Loss Through Use of the E-scale|Recruiting||N/A|15|Anticipated|University of Pittsburgh||1|||f||||f|f|t|t|||||||2017-10-10 20:45:44.016489|2017-10-10 20:45:44.016489
NCT03264235|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||The Effect of Powered-Knee Exoskeleton Assist on Stair Climbing in Acute CVA|The Effect of Powered-Knee Exoskeleton Assist on Stair Climbing in Acute Cerebrovascular Accidents|Not yet recruiting||N/A|30|Anticipated|Shirley Ryan AbilityLab||2|||f||||t|f|t|t||f|||||2017-10-10 20:45:44.129975|2017-10-10 20:45:44.129975
NCT03264222|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-30|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety of a New Security Device in Patients With Implanted Cardiac Electronic Devices|Safety of a New Security Device in Patients With Implanted Cardiac Electronic Devices|Recruiting||N/A|300|Anticipated|Deutsches Herzzentrum Muenchen||1|||f||||f|f|f||||||||2017-10-10 20:45:44.242276|2017-10-10 20:45:44.242276
NCT03264209|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-28|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Smart After-Care in Patients With Prostate Cancer|Smart After-Care in Patients With Prostate Cancer: a Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Seoul St. Mary's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:45:44.342177|2017-10-10 20:45:44.342177
NCT03264196|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 1, 2022|Anticipated|2022-10-01|September 1, 2022|Anticipated|2022-09-01||Interventional|CHOC1||Condylar Head Operative or Conservative 1|Condylar Head Operative or Conservative 1, Randomised Controlled Trial|Not yet recruiting||N/A|36|Anticipated|Oxford University Hospitals NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:45:44.457553|2017-10-10 20:45:44.457553
NCT03264183|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-18|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Observational|TEE||Validating TEE Measurements of Right Ventricular Function|Validating Transesophageal Echocardiographic Measurements of Right Ventricular Function|Recruiting||N/A|125|Anticipated|Milton S. Hershey Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:45:44.557658|2017-10-10 20:45:44.557658
NCT03264170|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|April 2018|Anticipated|2018-04-01||Interventional|IMPROVE||Predicting Early Pregnancy Outcomes in Women With Pregnancy of Uncertain Viability: a Psychological Impact Study|"Introduction of a New Model for Predicting Early Pregnancy Outcome in Women With Initial Pregnancy of Uncertain Viability: a Tablet App and Psychological Impact Study"|Not yet recruiting||N/A|260|Anticipated|Chelsea and Westminster NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:45:44.704143|2017-10-10 20:45:44.704143
NCT03264157|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects|A Prospective, Randomized, Double-Blind Parallel-group, Non-inferiority Phase II/III Study of the Safety and Effectiveness of BPL HRIG With Co Administration of Active Rabies Vaccine in Healthy Subjects|Not yet recruiting||Phase 2/Phase 3|162|Anticipated|Bio Products Laboratory||2|||f||||f|f|f||||||||2017-10-10 20:45:44.81106|2017-10-10 20:45:44.81106
NCT03264144|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Address Tobacco Use Among Adolescents in Hong Kong|Changing Social Norms Around Smoking: A Cluster Randomized Controlled Trial to Address Tobacco Use Among Adolescents in Hong Kong|Not yet recruiting||N/A|12868|Anticipated|The University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:45:44.898489|2017-10-10 20:45:44.898489
NCT03264131|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-12|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|May 19, 2025|Anticipated|2025-05-19|May 19, 2020|Anticipated|2020-05-19||Interventional|||BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma|Brentuximab Vedotin With Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Adult T-Cell Leukemia/Lymphoma: A Phase II Trial of the Rare Lymphoma Working Group|Not yet recruiting||Phase 2|28|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:45:44.992367|2017-10-10 20:45:44.992367
NCT03264118|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||April 2, 2017|Actual|2017-04-02|August 2017|2017-08-01|December 22, 2018|Anticipated|2018-12-22|December 22, 2018|Anticipated|2018-12-22||Interventional|||Effects of Antimicrobial Photodynamic Therapy on Regeneration of Class II Furcation Lesions|Effects of Antimicrobial Photodynamic Therapy Associated to Biomaterials on Regeneration of Class II Furcation Lesions|Recruiting||N/A|25|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:45:45.116188|2017-10-10 20:45:45.116188
NCT03099538|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-18|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Ixekizumab in the Treatment of Bullous Pemphigoid|Ixekizumab in the Treatment of Bullous Pemphigoid|Recruiting||Phase 2|12|Anticipated|Mayo Clinic||1|||f||||t|t|f|||f|||||2017-10-10 21:12:46.749795|2017-10-10 21:12:46.749795
NCT03264105|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-23|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Retention Rate of Hydroxyapatite Nano-Fiber Reinforced Flowable Composite Versus Conventional|Retention Rate of Hydroxyapatite Nano-Fiber Reinforced Flowable Composite Versus Conventional Resin-Based Flowable Composite in Initially Demineralized Pits and Fissure: A One Year, Randomized Clinical Trial|Not yet recruiting||N/A|19|Anticipated|Cairo University||2|||f||||t|f|f|||t|||||2017-10-10 20:45:45.225872|2017-10-10 20:45:45.225872
NCT03264079|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults|An Open-Label Study of the Effect of a Strong CYP3A4 Inhibitor (Itraconazole) on the Pharmacokinetics of Bardoxolone Methyl in Healthy Volunteers|Not yet recruiting||Phase 1|16|Anticipated|Reata Pharmaceuticals, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:45:45.405343|2017-10-10 20:45:45.405343
NCT03264066|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-26|||October 21, 2017|Anticipated|2017-10-21|September 2017|2017-09-01|October 11, 2019|Anticipated|2019-10-11|September 14, 2018|Anticipated|2018-09-14||Interventional|||A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors|A Phase II, Open-Label, Multicenter, Multicohort Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Patients With Solid Tumors|Not yet recruiting||Phase 2|120|Anticipated|Hoffmann-La Roche||3|||f||||f|t|f||||||||2017-10-10 20:45:45.497885|2017-10-10 20:45:45.497885
NCT03264053|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-14|||August 20, 2017|Actual|2017-08-20|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|August 20, 2018|Anticipated|2018-08-20||Interventional|||Socket Shield Technique Versus Conventional Immediate Implant Placement in Thin Buccofacial Bone|Socket Shield Technique Versus Conventional Immediate Implant Placement in Thin Buccofacial Bone to Evaluate Buccal Bone Resorption: A Randomized Controlled Trial|Recruiting||N/A|86|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:45:45.633646|2017-10-10 20:45:45.633646
NCT03264040|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||August 25, 2017|Actual|2017-08-25|August 2017|2017-08-01|August 25, 2020|Anticipated|2020-08-25|August 25, 2020|Anticipated|2020-08-25||Observational|BioMannosido||Biomarker for Alpha-Mannosidosis Disease|BioMannosidosis - Biomarker for Alpha-Mannosidosis Disease - an International, Multicentre, Epidemiological Protocol|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t|f|f||||Samples With DNA|"     For the development of the new biomarker using the technique of Mass-spectometry a dry blood     spot filter card are taken. To prove the correct diagnosis in those patients where up to the     enrollment in the study no genetic testing has been done, sequencing will be done. The     analyses are done in the Centogene AG, Schillingallee 68, 18055 Rostock (Germany)   "|||2017-10-10 20:45:45.735682|2017-10-10 20:45:45.735682
NCT03264027|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-24|||January 6, 2017|Actual|2017-01-06|August 2017|2017-08-01|January 12, 2018|Anticipated|2018-01-12|January 12, 2018|Anticipated|2018-01-12||Interventional|||Carbon Dioxide Versus Air Insufflation for the Application of Argon Plasma to Reduce the Gastrojejunal Anastomosis|A Multicenter Randomized Clinical Trial of Carbon Dioxide (CO2) Versus Air Insufflation for the Application of Argon Plasma to Reduce the Gastrojejunal Anastomosis in Individuals With Weight Regain After Bypass Surgery.|Recruiting||N/A|200|Anticipated|Kaiser Clinic and Hospital||2|||f||||f|f|f||||||||2017-10-10 20:45:45.840348|2017-10-10 20:45:45.840348
NCT03264014|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||May 2015||2015-05-01|August 2017|2017-08-01|September 30, 2015|Actual|2015-09-30|September 2015|Actual|2015-09-01||Observational|TARGET-H||Combining Registry Data in Haemophilia: TARGET H|An Observational Pilot sTudy to Assess the Feasibility of Combining Data From Patient Registries in Countries With Developing Health Care Systems to EvaluaTe Haemophilia Management|Completed||N/A|100|Actual|University of Pretoria|||1||f||||f||||||||||2017-10-10 20:45:45.937839|2017-10-10 20:45:45.937839
NCT03264001|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-24|||April 4, 2017|Actual|2017-04-04|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Effects of Progressive Negative Energy Balance on Glucose Tolerance, Insulin Sensitivity, and Beta-cell Function|Effects of Progressive Negative Energy Balance Induced by Diet or Exercise on Glucose Tolerance, Insulin Sensitivity, and Beta-cell Function|Recruiting||N/A|60|Anticipated|Clinical Nutrition Research Centre, Singapore||2|||f||||f|f|f||||||||2017-10-10 20:45:45.999052|2017-10-10 20:45:45.999052
NCT03263988|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||HD Sense Pilot Study - A Novel Method of Hemodynamic Monitoring|A Novel Method of Hemodynamic Monitoring by Piezocapacitative Interlayer Sensor Technology - A Pilot Study|Not yet recruiting||N/A|60|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:45:46.123006|2017-10-10 20:45:46.123006
NCT03263975|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-28|||October 31, 2014|Actual|2014-10-31|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|December 8, 2016|Actual|2016-12-08||Interventional|||Effects of Dehydration on Neuromuscular Performance and Sympathetic Control of Cardiovascular Function|Effects of Dehydration on Neuromuscular Performance and Sympathetic Control of Cardiovascular Function|Active, not recruiting||N/A|43|Actual|United States Army Research Institute of Environmental Medicine||2|||f||||f|f|f||||||||2017-10-10 20:45:46.228003|2017-10-10 20:45:46.228003
NCT03263962|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|September 10, 2017|Anticipated|2017-09-10|September 10, 2017|Anticipated|2017-09-10||Observational|THE COFFEE-IT||CANRENONE EFFECTS ON CARDIOVASCULAR MORTALITY IN PATIENTS WITH CONGESTIVE HEART FAILURE (THE COFFEE-IT STUDY)|CANRENONE EFFECTS ON CARDIOVASCULAR MORTALITY IN PATIENTS WITH CONGESTIVE HEART FAILURE: THE COFFEE-IT STUDY|Recruiting||N/A|600|Anticipated|University of Pavia|||2||f||||f|f|f||||||||2017-10-10 20:45:46.297576|2017-10-10 20:45:46.297576
NCT03263949|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||January 9, 2017|Actual|2017-01-09|August 2017|2017-08-01|January 9, 2022|Anticipated|2022-01-09|January 9, 2020|Anticipated|2020-01-09||Observational|PREDICT-VT||Predicting Ventricular Tachyarrhythmias Following Acute ST Elevation Myocardial Infarction|Predicting Ventricular Tachyarrhythmias Following Acute ST Elevation Myocardial Infarction|Recruiting||N/A|600|Anticipated|Clinical Centre of Serbia|||1||f||||f|f|f||||||||2017-10-10 20:45:46.406958|2017-10-10 20:45:46.406958
NCT03263936|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Epigenetic Reprogramming in Relapse/Refractory AML|Epigenetic Reprogramming in Relapse AML: A Phase 1 Study of Decitabine and Vorinostat Followed by Fludarabine, Cytarabine and G-CSF (FLAG) in Children and Young Adults With Relapsed/Refractory AML|Recruiting||Phase 1|24|Anticipated|Therapeutic Advances in Childhood Leukemia Consortium||1|||f||||t|t|f|||t|||||2017-10-10 20:45:46.495813|2017-10-10 20:45:46.495813
NCT03263923|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|July 31, 2020|Anticipated|2020-07-31||Interventional|GIFT||The Grandmother Study: Grandmother Initiatives in Family Transformation|GIFT Web Based Resourcefulness Training for Grandmother Caregivers|Recruiting||N/A|334|Anticipated|Case Western Reserve University||2|||f||||t|f|f||||||||2017-10-10 20:45:46.691711|2017-10-10 20:45:46.691711
NCT03263910|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy|Phase Ⅲ Placebo-controlled Study of NPO-11 in Chinese Patients Undergoing Gastrointestinal Endoscopy|Recruiting||Phase 3|220|Anticipated|Nihon Pharmaceutical Co., Ltd||2|||f||||f|f|f||||||||2017-10-10 20:45:46.767112|2017-10-10 20:45:46.767112
NCT03263897|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief|Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief|Recruiting||N/A|50|Anticipated|Caps Research Network||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:45:46.839854|2017-10-10 20:45:46.839854
NCT03263884|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Repetitive Transcranial Magnetic Stimulation and the Development of Ongoing Muscle Pain|Repetitive Transcranial Magnetic Stimulation and the Development of Ongoing Muscle Pain|Recruiting||N/A|30|Anticipated|Aalborg University||2|||f||||t|f|f||||||||2017-10-10 20:45:46.976208|2017-10-10 20:45:46.976208
NCT03263871|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||September 25, 2017|Anticipated|2017-09-25|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|October 25, 2018|Anticipated|2018-10-25||Interventional|||PTM202 for the Treatment of Environmental Enteric Dysfunction (EED)|Pilot Study of PTM202 for the Treatment of Environmental Enteric Dysfunction (EED)|Not yet recruiting||N/A|200|Anticipated|University of Virginia||2|||f||||f|f|f||||||||2017-10-10 20:45:47.051368|2017-10-10 20:45:47.051368
NCT03263858|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-13|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|BIOVITESSE||Vascular Implant Safety and Efficacy Study|Vascular Implant Safety and Efficacy Study|Recruiting||N/A|66|Anticipated|Biotronik CRC Inc.||1|||f||||t|f|f||||||||2017-10-10 20:45:47.118238|2017-10-10 20:45:47.118238
NCT03263845|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||July 5, 2016|Actual|2016-07-05|August 2017|2017-08-01|January 13, 2017|Actual|2017-01-13|January 13, 2017|Actual|2017-01-13||Observational|SONDAPU||Evaluation of Pain in Urinary Collections in Pediatric Emergencies in Children Who Have Not Acquired Cleanliness|Round-trip Survey or Urine Bag: Evaluation of Pain in Urinary Collections in Pediatric Emergencies in Children Who Have Not Acquired Cleanliness (SONDAPU)|Completed||N/A|100|Actual|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:45:47.203605|2017-10-10 20:45:47.203605
NCT03263832|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||June 1, 2015|Actual|2015-06-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|BJIBiofilm||Evaluation of the Antibiofilmogramme Test During Orthopaedic Device-Related Infection|Demonstration of Clinical Value of Antibiofilmogramme Test for Monomicrobial S. Aureus Orthopaedic Device-Related Infection|Recruiting||N/A|40|Anticipated|BioFilm Control|||2||f||||f|f|f||||Samples Without DNA|"     The S. aureus strains isolated will be maintained in a collection for future ancillary     studies.   "|||2017-10-10 20:45:47.26115|2017-10-10 20:45:47.26115
NCT03263819|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|POTS-GUT||Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome|POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME AND GASTROINTESTINAL SYMPTOMS: Contribution of Gastrointestinal Peptides|Recruiting||N/A|48|Anticipated|Vanderbilt University Medical Center|||4||f||||f|f|f||||Samples With DNA|"     Whole blood will be retain for DNA extraction.   "|||2017-10-10 20:45:47.363321|2017-10-10 20:45:47.363321
NCT03263806|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-25|||August 24, 2017|Actual|2017-08-24|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|CTFFR-STAT||The Computed Tomography-derived Fractional Flow Reserve STAT Trial|Computed Tomography-derived Fractional Flow Reserve in the Systematic Triage of Emergency Department Acute Chest Pain Patients to Treatment. (The CTFFR-STAT Trial)|Recruiting||N/A|200|Anticipated|William Beaumont Hospitals||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:45:47.473111|2017-10-10 20:45:47.473111
NCT03263793|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|August 22, 2019|Anticipated|2019-08-22|August 22, 2018|Anticipated|2018-08-22||Interventional|||High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease|High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease|Recruiting||Phase 2|20|Anticipated|New York University School of Medicine||1|||f||||f|f|f||||||||2017-10-10 20:45:47.55401|2017-10-10 20:45:47.55401
NCT03263780|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||High Resolution PET-MRI Before Prostate Cancer HIFU|High-Resolution, 18F-fluciclovine PET-MRI for Mapping Prostate Cancer in Patients Considering Focal High-Intensity Focused Ultrasound (HIFU) Therapy|Not yet recruiting||Early Phase 1|20|Anticipated|Cedars-Sinai Medical Center||1|||f||||t|t|f||||||||2017-10-10 20:45:47.632213|2017-10-10 20:45:47.632213
NCT03263767|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|January 2020|Anticipated|2020-01-01||Interventional|CYRIC||PTCY as Sole GVHD Prophylaxis for Matched Allotransplant: CYRIC|Phase II Study Testing Prophylaxis Feasibility of Graft Versus Host Disease With Only High Dose Cyclophosphamide Post-transplantation for Patients Eligible to a Reduced-intensity Conditioning Regiment Prior to Allogenic Transplantation With a Compatible Familial or Non-familial Donor.|Not yet recruiting||Phase 2|59|Anticipated|Nantes University Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:45:49.212445|2017-10-10 20:45:49.212445
NCT03263754|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||December 3, 2016|Actual|2016-12-03|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Do Educational Digital Films Enhance Patient COPD Outcomes?|Do Patients With Chronic Obstructive Pulmonary Disease Engaging With Educational Films in Addition to Pulmonary Rehabilitation Gain Health-related Improvements?|Recruiting||N/A|80|Anticipated|Aberystwyth University||2|||f||||t|f|f||||||||2017-10-10 20:45:49.343901|2017-10-10 20:45:49.343901
NCT03263741|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-11|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer|Exploratory Study on the Efficiency and Safety of Paclitaxel + S-1 + Oxaliplatin Chemotherapy in the Patients With Locally Advanced or Advanced Gastric Cancer|Recruiting||Phase 2|20|Anticipated|Affiliated Hospital of Qinghai University||1|||f|||||f|f||||||||2017-10-10 20:45:49.432633|2017-10-10 20:45:49.432633
NCT03263728|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 30, 2018|Anticipated|2018-06-30||Interventional|CATCH||Cardiac Magnetic Resonance for Asymptomatic Type 2 Diabetics With Cardiovascular High Risk (CATCH) - Pilot Study|Cardiac Magnetic Resonance for Asymptomatic Type 2 Diabetics With Cardiovascular High Risk (CATCH) - Pilot Study|Recruiting||N/A|60|Anticipated|The University of Hong Kong||1|||f||||f|f|f||||||||2017-10-10 20:45:49.518215|2017-10-10 20:45:49.518215
NCT03263715|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-23|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)|Not yet recruiting||Phase 3|32|Anticipated|Medical University of Vienna||2|||f||||f|f|f||||||||2017-10-10 20:45:49.602962|2017-10-10 20:45:49.602962
NCT03263702|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-19|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|June 15, 2019|Anticipated|2019-06-15|June 15, 2019|Anticipated|2019-06-15||Interventional|||RADAR Clinical Trial|Real-time Electrogram Analysis for Drivers of AtRial Fibrillation (RADAR)|Recruiting||N/A|65|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|f|t|f|f||||||2017-10-10 20:45:49.727402|2017-10-10 20:45:49.727402
NCT03263689|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-23|||March 15, 2014|Actual|2014-03-15|August 2017|2017-08-01|June 20, 2016|Actual|2016-06-20|June 20, 2016|Actual|2016-06-20||Interventional|||Transversus Abdominis Plane Block Versus Spinal Morphine After Caesarean Section : A Comparison Study|The Analgesic Effects of Intrathecal Morphine in Comparison to Ultrasound-guided Transversus Abdominis Plane Block After Cesarean Section: a Randomized Controlled Trial at a Ugandan Regional Referral Hospital|Completed||Phase 3|130|Actual|Mbarara University of Science and Technology||2|||f||||f|t|f|||t|||||2017-10-10 20:45:49.832577|2017-10-10 20:45:49.832577
NCT03263676|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|April 1, 2017|Actual|2017-04-01|March 1, 2017|Actual|2017-03-01||Interventional|||Randomized Controlled Crossover Comparison of Icon Underwear to Disposable Pads|Randomized Controlled Crossover Comparison of Icon Underwear to Disposable Pads|Completed||N/A|70|Actual|Medstar Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:45:49.907839|2017-10-10 20:45:49.907839
NCT03263663|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|January 1, 2025|Anticipated|2025-01-01|January 1, 2021|Anticipated|2021-01-01||Observational|2016-003295-46||Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model|Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model (Colon-Resist-Net)|Recruiting||N/A|1000|Anticipated|Ludwig-Maximilians - University of Munich|||2||f||||f|f|f||||Samples With DNA|"     Primary tumormaterial   "|||2017-10-10 20:45:49.974721|2017-10-10 20:45:49.974721
NCT03263650|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-10-03|||October 3, 2017|Actual|2017-10-03|October 2017|2017-10-01|October 2021|Anticipated|2021-10-01|October 27, 2020|Anticipated|2020-10-27||Interventional|||Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC|Randomized Phase II Study of Olaparib Maintenance Following Cabazitaxel-Carboplatin Induction Chemotherapy in Men With Aggressive Variant Prostate Cancer (AVPC)|Recruiting||Phase 2|96|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f|||f|||||2017-10-10 20:45:50.173768|2017-10-10 20:45:50.173768
NCT03263624|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-25|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 1, 2018|Anticipated|2018-11-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease|Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic: Nail Disease a Single-blind, Intrapatient Left-to-right Controlled Study.|Not yet recruiting||Phase 4|30|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:45:50.468685|2017-10-10 20:45:50.468685
NCT03263611|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-24|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain|A Phase 1b, Multicenter, Double-blind, Randomized, Placebo-controlled, Single Ascending-Dose, Clinical Study Evaluating the Safety, Tolerability and Exploratory Efficacy of a Targeted Single Injection of an Intradiscal Nuclear Factor-κB Decoy Oligodeoxynucleotide (AMG0103) in Subjects With Chronic Discogenic Lumbar Back Pain|Not yet recruiting||Phase 1|24|Anticipated|AnGes, Inc.||4|||f||||t|t|f||||||||2017-10-10 20:45:50.565205|2017-10-10 20:45:50.565205
NCT03263598|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-23|||May 2016||2016-05-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|2 Years|Observational [Patient Registry]|urine Na/K||Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites|Clinical Significance and Correlation Between the 24-Hour Urine Sodium Excretion and the Spot Urine Na/K Ratio in Cirrhotic Patients With Ascites.|Recruiting||N/A|188|Anticipated|Keimyung University Dongsan Medical Center|||1||f||||f||||||||||2017-10-10 20:45:50.663157|2017-10-10 20:45:50.663157
NCT03263572|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Blinatumomab and Ponatinib in Patients With Philadelphia Chromosome (Ph)-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)|Phase II Study of the Combination of Blinatumomab and Ponatinib in Patients With Philadelphia Chromosome (Ph)-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)|Not yet recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 20:45:50.880501|2017-10-10 20:45:50.880501
NCT03263559|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2024|Anticipated|2024-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Haploidentical Bone Marrow Transplantation in Sickle Cell Patients|Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients With Symptomatic Sickle Cell Disease|Not yet recruiting||Phase 2|80|Anticipated|Medical College of Wisconsin||1|||f||||t|t|f|||f|||||2017-10-10 20:45:51.018476|2017-10-10 20:45:51.018476
NCT03263533|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-07|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||HDAC Inhibitor Augmentation to Clozapine|HDAC Inhibitor Augmentation to Clozapine|Not yet recruiting||Early Phase 1|6|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f||||||||2017-10-10 20:45:51.2554|2017-10-10 20:45:51.2554
NCT03263520|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-25|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|August 30, 2017|Anticipated|2017-08-30||Interventional|||Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer|Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer|Recruiting||N/A|60|Anticipated|Hospital Erasto Gaertner||2|||f||||t|f|f||||||||2017-10-10 20:45:51.337924|2017-10-10 20:45:51.337924
NCT03263507|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-23|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-PKK-LRx Administered Subcutaneously to Healthy Volunteers|A Double-Blind, Placebo-Controlled, Dose-Escalation Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 721744, an Antisense Oligonucleotide Inhibitor of PKK, Administered Subcutaneously to Healthy Volunteers|Recruiting||Phase 1|32|Anticipated|Ionis Pharmaceuticals, Inc.||2|||f||||t|f|f||||||||2017-10-10 20:45:51.450225|2017-10-10 20:45:51.450225
NCT03263494|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||November 30, 2017|Anticipated|2017-11-30|August 2017|2017-08-01|July 31, 2019|Anticipated|2019-07-31|November 30, 2018|Anticipated|2018-11-30||Interventional|CITY||CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)|CGM Intervention in Teens and Young Adults With T1D (CITY): A Randomized Clinical Trial to Assess the Efficacy and Safety of Continuous Glucose Monitoring in Young Adults 14-<25 With Type 1 Diabetes|Not yet recruiting||Phase 3|200|Anticipated|Jaeb Center for Health Research||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:45:51.550196|2017-10-10 20:45:51.550196
NCT03263481|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-04|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|IDST||Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?|Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?|Recruiting||Phase 4|36|Anticipated|Indiana University||1|||f||||t|t|f|||f|||||2017-10-10 20:45:51.646584|2017-10-10 20:45:51.646584
NCT03263468|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-25|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|ASSIST-MI||Revascularization StrategIes for ST Elevation Myocardial Infarction Trial|Revascularization StrategIes for ST Elevation Myocardial Infarction Trial|Not yet recruiting||N/A|3520|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t|f|f||||||||2017-10-10 20:45:51.759006|2017-10-10 20:45:51.759006
NCT03263455|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-25|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|November 30, 2017|Anticipated|2017-11-30||Interventional|k-neglect||Kinesio-Taping in Stroke Patients With Visuospatial Neglect|The Effects of Kinesis-Taping Application on Cognitive Deficit and Motor Ability in Stroke Patients With Visuospatial Neglect: a Randomized Controlled Study|Not yet recruiting||N/A|50|Anticipated|Universita di Verona||2|||f||||t|f|f||||||||2017-10-10 20:45:51.877213|2017-10-10 20:45:51.877213
NCT03263442|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation|Randomized Placebo Controlled Trial of High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation|Not yet recruiting||Phase 2|60|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|t|f|||f|||||2017-10-10 20:45:52.010976|2017-10-10 20:45:52.010976
NCT03263429|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-13|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|September 2020|Anticipated|2020-09-01||Interventional|||Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer|Phase I/II Study to Evaluate the Safety, Efficacy, and Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:45:52.367037|2017-10-10 20:45:52.367037
NCT03263416|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-23|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|ADHESIPH||Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up Compared to Standard Follow-up.|Regional, Multicentric, Randomized Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up (Using a Telephone Follow-up by a Nurse and a Pharmaceutical Conciliation) Compared to Standard Follow-up.|Recruiting||N/A|240|Anticipated|Institut Claudius Regaud||2|||f||||f|f|f||||||||2017-10-10 20:45:52.565252|2017-10-10 20:45:52.565252
NCT03263403|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-09-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|November 2017|Anticipated|2017-11-01||Interventional|||Non Inferiority Trial of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladesh.|A Randomized Observer-blinded Controlled Non-inferiority Trial to Evaluate the Immunogenicity of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladeshi Healthy Adults.|Not yet recruiting||Phase 2/Phase 3|88|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t|f|f||||||||2017-10-10 20:45:52.748603|2017-10-10 20:45:52.748603
NCT03263390|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-27|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2027|Anticipated|2027-01-01|January 2022|Anticipated|2022-01-01||Observational|||Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells|Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells|Not yet recruiting||N/A|50|Anticipated|University of California, San Diego|||2||f||||f|f|f||||Samples With DNA|"     Fibroblasts, iPSCs, and DNA sequencing information generated from skin biopsies will be     expanded and stored for potential future use.   "|||2017-10-10 20:45:52.906531|2017-10-10 20:45:52.906531
NCT03263377|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2017-08-23|||September 2011||2011-09-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Interventional|schoolfeed||The Impact on School Feeding on Children's Growth and Development|The Impact on School Feeding on Children's Growth and Development|Completed||N/A|3006|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 20:45:53.031963|2017-10-10 20:45:53.031963
NCT03263364|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-25|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|GENRED||Genomic Screening for Hereditary Erythrocytosis and Related Diseases|Genomic Screening for Hereditary Erythrocytosis and Related Diseases|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:45:53.160066|2017-10-10 20:45:53.160066
NCT03263351|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 1, 2022|Anticipated|2022-04-01|April 1, 2021|Anticipated|2021-04-01||Interventional|||Depression & Insulin Sensitivity in Adolescents|Depression and Insulin Sensitivity in Adolescents|Not yet recruiting||N/A|200|Anticipated|Colorado State University||2|||f||||t|f|f||||||||2017-10-10 20:45:53.269824|2017-10-10 20:45:53.269824
NCT03263338|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-31|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Mobile Sleep and Growth Study|Mobile Health Sleep and Growth Study|Not yet recruiting||N/A|35|Anticipated|Children's Hospital of Philadelphia||3|||f||||f|f|f||||||||2017-10-10 20:45:53.4037|2017-10-10 20:45:53.4037
NCT03263325|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-29|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|February 1, 2019|Anticipated|2019-02-01||Observational|||Evaluation of UDP-glucose as a Urinary Biomarker for Early Detection of Cardiac Surgery-associated Pediatric Acute Kidney Injury|Evaluation of UDP-glucose as a Urinary Biomarker for Early Detection of Cardiac Surgery-associated Pediatric Acute Kidney Injury|Not yet recruiting||N/A|250|Anticipated|Boston Children’s Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Urine Samples   "|||2017-10-10 20:45:53.509129|2017-10-10 20:45:53.509129
NCT03263312|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient|Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient|Not yet recruiting||N/A|50|Anticipated|Children's Medical Center Dallas||1|||f||||f|f|f||||||||2017-10-10 20:45:53.617647|2017-10-10 20:45:53.617647
NCT03263299|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol|Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET Using Microdose GnRH Agonist Flare-Up-Protocol|Not yet recruiting||Phase 4|120|Anticipated|Cairo University||3|||f||||t|f|f|||f|||||2017-10-10 20:45:53.70395|2017-10-10 20:45:53.70395
NCT03263286|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||April 15, 2017|Actual|2017-04-15|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|HandSOME||Home Therapy for Stroke Rehabilitation Using the HandSOME Exoskeleton|Home Therapy for Upper Limb Stroke Rehabilitation Using the HandSOME Exoskeleton|Recruiting||Phase 1|23|Anticipated|The Catholic University of America||1|||f||||f|f|t|f|||||||2017-10-10 20:45:53.837024|2017-10-10 20:45:53.837024
NCT03263273|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||October 30, 2017|Anticipated|2017-10-30|August 2017|2017-08-01|September 28, 2018|Anticipated|2018-09-28|September 28, 2018|Anticipated|2018-09-28||Interventional|||Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea|A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea|Not yet recruiting||Phase 2|249|Anticipated|Hovione Scientia Limited||3|||f|||||t|f||||||||2017-10-10 20:45:53.97001|2017-10-10 20:45:53.97001
NCT03263260|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||June 2, 2017|Actual|2017-06-02|August 2017|2017-08-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2021|Anticipated|2021-12-30|24 Months|Observational [Patient Registry]|Inspiron RL II||Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent|Prospective, Multicentric, Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent for Treatment of Patients With Native Coronary Artery Lesions (Inspiron Real Life II)|Recruiting||N/A|5000|Anticipated|Scitech Produtos Medicos Ltda|||1||f||||t|f|f|||f|||||2017-10-10 20:45:54.123859|2017-10-10 20:45:54.123859
NCT03263247|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||January 2, 2017|Actual|2017-01-02|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Cognitive Training in Patients With MCI Using fMRI|Randomized Double Blind Study on the Efficacy of Cognitive Training in Patients With Mild Cognitive Impairment Using fMRI.|Recruiting||N/A|60|Anticipated|São Paulo State University||3|||f||||t|f|f||||||||2017-10-10 20:45:54.258171|2017-10-10 20:45:54.258171
NCT03263234|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-25|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|March 22, 2018|Anticipated|2018-03-22|March 21, 2018|Anticipated|2018-03-21||Interventional|Lightel||Circadian Adjusted LED Light's Effect in People Living in Elderly Housing|Circadian Adjusted LED Light's Effect on Sleep, Circadian Rhythm, and Well-being in People Living in Elderly Housing: a Cross-over Non-blinded Randomized Trial.|Enrolling by invitation||N/A|39|Anticipated|Hvidovre University Hospital||3|||f||||t|f|f||||||||2017-10-10 20:45:54.387953|2017-10-10 20:45:54.387953
NCT03263208|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.|A Study of CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-cell Acute Lymphoblastic Leukemia|Recruiting||Phase 1/Phase 2|20|Anticipated|Henan Cancer Hospital||1|||f||||f|f|f||||||||2017-10-10 20:45:54.563547|2017-10-10 20:45:54.563547
NCT03263195|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-30|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2024|Anticipated|2024-07-01|July 2024|Anticipated|2024-07-01||Observational|HIV ZIP||Prospective Cohort Study of HIV and Zika in Infants and Pregnancy|Prospective Cohort Study of HIV and Zika in Infants and Pregnancy|Recruiting||N/A|3800|Anticipated|Westat|||4||f||||t|f|f||||Samples With DNA|"     Maternal blood, maternal urine, cord blood, and placenta tissue. Infant blood and infant     urine.   "|||2017-10-10 20:45:54.708184|2017-10-10 20:45:54.708184
NCT03263182|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-25|||September 4, 2017|Anticipated|2017-09-04|August 2017|2017-08-01|April 27, 2018|Anticipated|2018-04-27|April 16, 2018|Anticipated|2018-04-16||Observational|||Impact of the Safe Childbirth Checklist in Luapula Province of Zambia Province of Zambia|Impact of the Safe Childbirth Checklist on Health Worker Childbirth Practices in Luapula Province of Zambia|Not yet recruiting||N/A|28|Anticipated|Clinton Health Access Initiative Inc.|||1||f||||f|f|f||||||||2017-10-10 20:45:54.838393|2017-10-10 20:45:54.838393
NCT03263169|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30|2 Years|Observational [Patient Registry]|||Community-based Personalized Care and QOL|A Pragmatic Trial to Evaluate the Impact of Community-based Personalized Care on Quality of Life in Older and Disabled Adults|Recruiting||N/A|1100|Anticipated|Windsor-Essex Compassionate Care Community|||2||f||||f|f|f||||||||2017-10-10 20:45:54.9414|2017-10-10 20:45:54.9414
NCT03263156|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-29|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||A Brief Parent-based Sleep Intervention for ADHD Children|Effects of a Brief Parent-based Sleep Intervention for Children With Attention Deficit Hyperactivity Disorder|Recruiting||N/A|60|Anticipated|The University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:45:55.063102|2017-10-10 20:45:55.063102
NCT03263143|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-23|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|||Palliative Care in the ICU|Early Palliative Care in the Medical Intensive Care Unit|Not yet recruiting||N/A|400|Anticipated|Washington University School of Medicine|||2||f|||||f|f||||||||2017-10-10 20:45:55.168293|2017-10-10 20:45:55.168293
NCT03263130|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-23|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|December 1, 2022|Anticipated|2022-12-01|January 1, 2022|Anticipated|2022-01-01|2 Months|Observational [Patient Registry]|||Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap|Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap|Recruiting||N/A|60|Anticipated|Gelb, Arthur F., M.D.|||1||f||||t|f|f||||||||2017-10-10 20:45:55.253628|2017-10-10 20:45:55.253628
NCT03263117|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-23|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|SEGA||SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke|SEGA - SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke - a Randomized Comparative Effectiveness Trial.|Not yet recruiting||Phase 4|250|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t|t|f|||f|||||2017-10-10 20:45:55.364145|2017-10-10 20:45:55.364145
NCT03263104|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-25|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|PROBIOCHOL||The Cholesterol-lowering Efficacy of Probiotic Lactobacillus Plantarum in Hypercholesterolaemic Adults|Single-centre, Prospective, Randomised, Placebo-controlled, Parallel-group Design to Determine the Cholesterol-lowering Efficacy of Lactobacillus Plantarum ECGC 13110402 in Normal to Mildly Hypercholesterolaemic Adults|Completed||N/A|49|Actual|University of Roehampton||2|||f||||t|f|f||||||||2017-10-10 20:45:55.472202|2017-10-10 20:45:55.472202
NCT03263091|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-10-02|||September 7, 2017|Actual|2017-09-07|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden|A Phase 3 Randomized Double-Blind Placebo-Controlled Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients With Lower Risk Myelodysplastic Syndrome (MDS) With Low Red Blood Cell (RBC) Transfusion Burden (LTB)|Recruiting||Phase 3|184|Anticipated|FibroGen||2|||f||||t|t|f||||||||2017-10-10 20:45:55.663165|2017-10-10 20:45:55.663165
NCT03263065|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-25|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|March 9, 2018|Anticipated|2018-03-09|March 9, 2018|Anticipated|2018-03-09||Interventional|NOPAL||A Study of the Effect of Bran, Psyllium and Nopal on Intestinal Water Content Using Magnetic Resonance Imaging|A Pilot Participant-blind Study of the Effect of Bran, Psyllium and Nopal on Intestinal Water Content Using Magnetic Resonance Imaging|Not yet recruiting||N/A|12|Anticipated|University of Nottingham||3|||f||||f|f|f|||f|||||2017-10-10 20:45:55.904351|2017-10-10 20:45:55.904351
NCT03263052|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-25|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological AE and Improve QOL|An Evaluation of Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological Adverse Events and Improve Quality of Life|Recruiting||N/A|40|Anticipated|University of Illinois at Chicago|||1||f||||f|t|f|||f|||||2017-10-10 20:45:55.988781|2017-10-10 20:45:55.988781
NCT03263039|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-23|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|August 21, 2020|Anticipated|2020-08-21|August 21, 2018|Anticipated|2018-08-21||Interventional|RESPONDER||Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab|Biomarker Discovery Study to Identify Patients With Advanced Urothelial Cancer Benefitting From Pembrolizumab Treatment|Recruiting||Phase 2|80|Anticipated|Erasmus Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:45:56.078137|2017-10-10 20:45:56.078137
NCT03263026|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|June 2020|Anticipated|2020-06-01||Interventional|||Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™|A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects With High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel Genomic Biomarker DGM1™|Not yet recruiting||Phase 3|235|Anticipated|Denovo Biopharma LLC||2|||f||||t|t|f||||||||2017-10-10 20:45:56.188536|2017-10-10 20:45:56.188536
NCT03262987|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|October 31, 2018|Anticipated|2018-10-31||Observational|USvsCTV||Color Doppler U/S vs MSCT Venography in May-Thurner Syndrome|Color Doppler U/S vs MSCT Venography in the Diagnosis of May-Thurner Syndrome|Not yet recruiting||N/A|25|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:45:56.471112|2017-10-10 20:45:56.471112
NCT03262974|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-25|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Observational|||Effect of Pharmacogenetics on Imatinib Plasma Level and Response|Investigation of the Possible Role of Genetic Polymorphism in Certain Metabolizing Enzymes and Membrane Transporters on Both Plasma Level and Molecular Response of Imatinib in Patients With Chronic Myeloid Leukemia|Not yet recruiting||N/A|100|Anticipated|Assiut University|||2||f||||f|f|f||||Samples With DNA|"     DNA will be extracted from blood samples and frozen at -80 for further analysis   "|||2017-10-10 20:45:56.53918|2017-10-10 20:45:56.53918
NCT03262961|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-24|||September 15, 2016|Actual|2016-09-15|August 2017|2017-08-01|January 15, 2018|Anticipated|2018-01-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Use of Sildenafil Citrate in Management of Mild Pre-eclampsia|Use of Sildenafil Citrate in Management of Mild Pre-eclampsia: A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|80|Anticipated|Assiut University||2|||f||||t|f|f|||f|||||2017-10-10 20:45:56.62356|2017-10-10 20:45:56.62356
NCT03262948|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-23|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer|The Randomized,Open, Multicenter Phase III Study to Compare the Effectiveness and Safety of Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin First-Line Therapy Advanced Non Small Cell Lung Cancer Squamous Cell Carcinoma|Not yet recruiting||Phase 3|388|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||2|||f|||||f|f||||||||2017-10-10 20:45:56.741859|2017-10-10 20:45:56.741859
NCT03262935|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-23|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|TULIP||SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer|A Multi-centre, Open-label, Randomized Clinical Trial Comparing the Efficacy and Safety of the Antibody-drug Conjugate SYD985 to Physician's Choice in Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer|Not yet recruiting||Phase 3|345|Anticipated|Synthon Biopharmaceuticals BV||2|||f||||t|t|f||||||||2017-10-10 20:45:56.83788|2017-10-10 20:45:56.83788
NCT03262922|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||July 29, 2016|Actual|2016-07-29|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|December 31, 2020|Anticipated|2020-12-31||Observational|PRESSY||Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment|Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment|Recruiting||N/A|250|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:45:56.9254|2017-10-10 20:45:56.9254
NCT03262909|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-20|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|November 2023|Anticipated|2023-11-01|April 2021|Anticipated|2021-04-01||Interventional|SAGE||Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects|A Prospective, Open-Label, Multicenter Pivotal Study to Evaluate the Safety and Efficacy of GelrinC® for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle: A Comparison to Historical Control Microfracture|Recruiting||N/A|181|Anticipated|Regentis Biomaterials||2|||f||||f|f|t|f|||||||2017-10-10 20:45:57.004229|2017-10-10 20:45:57.004229
NCT03262896|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-24|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|December 15, 2018|Anticipated|2018-12-15|May 15, 2018|Anticipated|2018-05-15||Observational|||Neurophysiological Examination in Patients With Brain Death|Neurophysiological Study in Patients With Brain Death: A Single Center Prospective Study|Active, not recruiting||N/A|20|Anticipated|Yuzuncu Yıl University|||1||f||||t|f|f||||||||2017-10-10 20:45:57.078932|2017-10-10 20:45:57.078932
NCT03262870|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-27|||January 4, 2018|Anticipated|2018-01-04|August 2017|2017-08-01|January 4, 2020|Anticipated|2020-01-04|January 4, 2019|Anticipated|2019-01-04||Observational|||Gut Microbiota and Multiple Sclerosis|Gut Microbiota and Multiple Sclerosis|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:45:57.234124|2017-10-10 20:45:57.234124
NCT03252301|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Assessment of Pain in Surgical Patient by PMD 200|Assessment of Pain in Surgical Patient by PMD 200|Not yet recruiting||N/A|25|Anticipated|Meir Hospital, Kfar Saba, Israel||1|||f||||f|f|f||||||||2017-10-10 20:47:26.593471|2017-10-10 20:47:26.593471
NCT03262857|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-25|||September 21, 2016|Actual|2016-09-21|August 2017|2017-08-01|September 21, 2018|Anticipated|2018-09-21|September 21, 2018|Anticipated|2018-09-21||Interventional|||Effect of Lidocaine With Magnesium Sulfate on the Success of the Inferior Alveolar Nerve Block|Comparison of the Success Rate of Anesthesia Between Lidocaine 2% and Lidocaine 2% Mixed With 10% Magnesium Sulfate in the Inferior Alveolar Nerve Block in Posterior Teeth With Irreversible Pulpitis|Active, not recruiting||Phase 2|2|Anticipated|Isfahan University of Medical Sciences||2|||f|||||f|f||||||||2017-10-10 20:45:57.288651|2017-10-10 20:45:57.288651
NCT03262844|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-09-17|||June 16, 2017|Actual|2017-06-16|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Efficacy and Safety of Nerve Root Axial Decompression Surgery in The Treatment of Tethered Cord Syndrome|Efficacy and Safety of Nerve Root Axial Decompression Surgery in The Treatment of Tethered Cord Syndrome: A Conservative Treatment- Controlled, Randomized, Clinical Study|Recruiting||N/A|36|Anticipated|Shanghai Changzheng Hospital||2|||f|||||f|f||||||||2017-10-10 20:45:57.365435|2017-10-10 20:45:57.365435
NCT03262818|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|February 29, 2020|Anticipated|2020-02-29|February 29, 2020|Anticipated|2020-02-29||Interventional|||Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary|Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary|Recruiting||Phase 1|7|Anticipated|Washington University School of Medicine||1|||f|||||f|t|f|f|f|||||2017-10-10 20:45:57.573514|2017-10-10 20:45:57.573514
NCT03262805|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|April 20, 2018|Anticipated|2018-04-20|February 14, 2018|Anticipated|2018-02-14||Interventional|LEAP||To Assess the Lanconone® (E-OA-07) Efficacy in Physical Activity-related Pain- LEAP Study|To Assess the Lanconone® (E-OA-07) Efficacy in Physical Activity-related Pain- LEAP Study|Not yet recruiting||N/A|72|Anticipated|Vedic Lifesciences Pvt. Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:45:57.679436|2017-10-10 20:45:57.679436
NCT03262792|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||October 10, 2017|Anticipated|2017-10-10|August 2017|2017-08-01|May 30, 2018|Anticipated|2018-05-30|April 30, 2018|Anticipated|2018-04-30||Interventional|ParActin||Assessment of the Efficacy of ParActin® in Subjects With Mild to Moderate Osteoarthritis|A Double-blind, Randomized, Placebo Controlled Study to Assess the Efficacy of ParActin® in Subjects With Mild to Moderate Osteoarthritis Over a 12-weeks Period|Not yet recruiting||N/A|108|Anticipated|Vedic Lifesciences Pvt. Ltd.||3|||f||||f|f|f||||||||2017-10-10 20:45:57.76837|2017-10-10 20:45:57.76837
NCT03262779|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-27|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|November 1, 2020|Anticipated|2020-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.|A Phase II Study of Combination Immunotherapy With Ipilimumab and Nivolumab in Patients With Advanced Non-small Cell Lung Cancer Resistant to Anti-PD-1-axis Therapy|Recruiting||Phase 2|50|Anticipated|Yale University||1|||f||||t|t|f||||||||2017-10-10 20:45:57.84794|2017-10-10 20:45:57.84794
NCT03262766|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-29|||June 24, 2017|Actual|2017-06-24|August 2017|2017-08-01|October 30, 2020|Anticipated|2020-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|||Daily Intermittent Hypoxia and Task-Specific Upper Limb Training in Persons With Chronic Incomplete SCI|Daily Intermittent Hypoxia and Task-Specific Upper Limb Training in Persons With Chronic Incomplete SCI|Recruiting||N/A|80|Anticipated|Shirley Ryan AbilityLab||4|||f|||||f|f||||||||2017-10-10 20:45:57.938663|2017-10-10 20:45:57.938663
NCT03262753|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-24|||June 1, 2013|Actual|2013-06-01|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|September 30, 2017|Anticipated|2017-09-30||Observational|LOVE-COARCT||Long-term Outcomes and Vascular Evaluation After Coarctation of the Aorta Treatment|LOVE-COARCT Study: Long-term Outcomes and Vascular Evaluation After Coarctation of the Aorta Treatment|Recruiting||N/A|90|Anticipated|Centro Hospitalar de Lisboa Central|||3||f||||f|f|f||||||||2017-10-10 20:45:58.043944|2017-10-10 20:45:58.043944
NCT03262740|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-26|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|March 14, 2018|Anticipated|2018-03-14|March 13, 2018|Anticipated|2018-03-13||Interventional|||The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients|The Effect of BMS-986195 on the Pharmacokinetics of a Combined Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Subjects|Recruiting||Phase 1|24|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 20:45:58.202122|2017-10-10 20:45:58.202122
NCT03262727|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-09-14|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|November 22, 2017|Anticipated|2017-11-22|November 21, 2017|Anticipated|2017-11-21||Interventional|||The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients|The Effect of BMS-986165 on the Pharmacokinetics of a Combined Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Subjects|Recruiting||Phase 1|20|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 20:45:58.283492|2017-10-10 20:45:58.283492
NCT03262714|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-23|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Dancing on Cardiovascular and Functional Risk Factors in Older Women.|Effects of Dancing and Walking on Cardiovascular Risk Factors and Functional Capacity in Older Women: a Randomized Controlled Trial.|Recruiting||N/A|30|Anticipated|Federal University of Rio Grande do Sul||3|||f||||t|f|f||||||||2017-10-10 20:45:58.38511|2017-10-10 20:45:58.38511
NCT03262701|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|AHP||Adjunctive Hydrogen Peroxide for Periodontal Therapy|Custom Tray Application of Peroxide Gel as an Adjunct to Scaling and Root Planing in the Treatment of Periodontitis: A 12-Month Randomized Trial|Not yet recruiting||Phase 4|60|Anticipated|Loma Linda University||3|||f||||f|t|f|||f|||||2017-10-10 20:45:58.489258|2017-10-10 20:45:58.489258
NCT03262493|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Feeding Tube Attachment Device Versus Conventional Fixation and Its Impact on Accidental Exit of Enteral Feeding Tubes|Use of Feeding Tube Attachment Device Versus Conventional Fixation and Its Impact on Accidental Exit of Enteral Feeding Tubes: Randomized Clinical Trial|Recruiting||N/A|50|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t|f|f||||||||2017-10-10 20:45:59.994458|2017-10-10 20:45:59.994458
NCT03262688|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-29|||June 16, 2017|Actual|2017-06-16|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair|A Multicenter, Randomized, Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Analgesic Effect of the INL-001 Bupivacaine HCl Collagen Implant in Children 2 to <17 Years of Age Following Open Inguinal Hernia Repair|Active, not recruiting||Phase 2/Phase 3|159|Anticipated|Innocoll||2|||f||||t|t|f||||||||2017-10-10 20:45:58.584104|2017-10-10 20:45:58.584104
NCT03262675|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||October 2, 2017|Anticipated|2017-10-02|August 2017|2017-08-01|November 5, 2018|Anticipated|2018-11-05|November 6, 2017|Anticipated|2017-11-06|12 Months|Observational [Patient Registry]|NATURE-HF||NAtional TUnisian REgistry of Heart Failure|National Tunisian Registry of Heart Failure|Not yet recruiting||N/A|1700|Anticipated|Dacima Consulting|||1||f||||t|f|f||||||||2017-10-10 20:45:58.69308|2017-10-10 20:45:58.69308
NCT03262662|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|May 2021|Anticipated|2021-05-01||Interventional|EVarQuit||EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking|EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking|Recruiting||Phase 3|320|Anticipated|State University of New York at Buffalo||2|||f|||||t|f||||||||2017-10-10 20:45:58.7652|2017-10-10 20:45:58.7652
NCT03262649|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-23|||March 1, 2002|Actual|2002-03-01|August 2017|2017-08-01|October 1, 2016|Actual|2016-10-01|March 1, 2016|Actual|2016-03-01||Observational|||Manitoba Inflammatory Bowel Disease Cohort Study|Manitoba Inflammatory Bowel Disease Cohort Study|Completed||N/A|388|Actual|University of Manitoba|||2||f||||f|f|f||||Samples With DNA|"     Plasma, DNA   "|||2017-10-10 20:45:58.852315|2017-10-10 20:45:58.852315
NCT03262636|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-08-23|||June 2015||2015-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Indocyanine Green for Central Nervous System Tumors|A Pilot and Feasibility Study of Intraoperative Image-Guided Surgery of Central Nervous System Tumors With Indocyanine Green|Enrolling by invitation||Phase 1|75|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 20:45:59.077587|2017-10-10 20:45:59.077587
NCT03262623|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||Radial Nerve Block for Treatment of Tennis Elbow:|Localized Radial Nerve Block for Treatment of Tennis Elbow: a Prospective, Randomized Clinical Trial|Not yet recruiting||N/A|50|Anticipated|Makassed General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:45:59.153447|2017-10-10 20:45:59.153447
NCT03262610|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22||||||August 2017|2017-08-01||||||||Expanded Access|||Setemelanotide in a Single Patient With Partial Lipodystrophy|Expanded-access for the Use of Setemelanotide in a Single Patient With Partial Lipodystrophy (LD) Associated With Leptin Deficiency and Multiple Autoimmune Diseases|No longer available||N/A|||Rhythm Pharmaceuticals, Inc.||||||t||t|||||||||||2017-10-10 20:45:59.233769|2017-10-10 20:45:59.233769
NCT03262597|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-10-03|||February 17, 2017|Actual|2017-02-17|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||"Beverage Hydration Index of Commercial Therapeutic Beverages"|Beverage Hydration Index of Three Commercial Oral Rehydration Therapy ORT Beverages|Active, not recruiting||N/A|50|Anticipated|Sonoma State University||1|||f||||f|f|f||||||||2017-10-10 20:45:59.295461|2017-10-10 20:45:59.295461
NCT03262584|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-25|||May 17, 2017|Actual|2017-05-17|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients|Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients|Enrolling by invitation||N/A|50|Anticipated|Karius, Inc.|||1||f||||f|f|f||||Samples Without DNA|"     Plasma   "|||2017-10-10 20:45:59.383169|2017-10-10 20:45:59.383169
NCT03262571|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||December 2010|Actual|2010-12-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Usefulness of Lung Ultrasound in Ambulatory Management of Patients With Chronic Heart Failure|Usefulness of Lung Ultrasound in Ambulatory Management of Patients With Chronic Heart Failure|Terminated||Phase 3|244|Actual|IRCCS San Raffaele||2||"Because at the interim analysis the pre-specified stopping boundary for an overwhelming benefit   had been crossed."|f||||t|f|f||||||||2017-10-10 20:45:59.451354|2017-10-10 20:45:59.451354
NCT03262558|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||July 4, 2016|Actual|2016-07-04|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|MEDIASTAPH||Mediastinitis and Staphylococcus Aureus|Immunological and Bacteriological Approaches to the Development of Postoperative Mediastinitis With Staphylococcus Aureus|Recruiting||N/A|40|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:45:59.533208|2017-10-10 20:45:59.533208
NCT03262545|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-25|||August 27, 2017|Anticipated|2017-08-27|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|August 2020|Anticipated|2020-08-01||Interventional|||Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer|Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer|Recruiting||Phase 2|60|Anticipated|Sichuan Cancer Hospital and Research Institute||2|||f|||||f|f||||||||2017-10-10 20:45:59.639569|2017-10-10 20:45:59.639569
NCT03262532|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-23|||March 13, 2017|Actual|2017-03-13|May 2017|2017-05-01|March 13, 2018|Anticipated|2018-03-13|February 13, 2018|Anticipated|2018-02-13||Observational|Web-SimTEE||Assessment of a Web-Based Simulation in Transesophageal Echocardiography (TEE) Views|Assessment of a Web-Based Simulation Module to Improve Performance in Obtaining Standard Transesophageal Echocardiography (TEE) Views|Recruiting||N/A|20|Anticipated|University Health Network, Toronto|||2||f||||f||||||||||2017-10-10 20:45:59.731797|2017-10-10 20:45:59.731797
NCT03262519|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-15|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||The Effect of Obstructive Sleep Apnea and Its Treatment on Decision Making|The Effect of Obstructive Sleep Apnea and Its Treatment on Decision Making|Enrolling by invitation||N/A|100|Anticipated|University of California, San Diego|||1||f||||f|f|f||||||||2017-10-10 20:45:59.817649|2017-10-10 20:45:59.817649
NCT03262506|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-23|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Evaluation of Adherence and Engagement in a Cognitive Training Program for Older Adults|Evaluation of Adherence and Engagement in a Cognitive Training Program for Older Adults|Recruiting||N/A|100|Anticipated|Universidade Federal do Rio de Janeiro||1|||f||||f|f|f||||||||2017-10-10 20:45:59.905571|2017-10-10 20:45:59.905571
NCT03262480|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-05|||September 1, 2017|Actual|2017-09-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||The Stroke Volume Optimization of Goal Directed Fluid Therapy During Radical Cystectomy|Perioperative Goal Directed Fluid Therapy During Radical Cystectomy: the Impact of Stroke Volume Optimization|Recruiting||N/A|128|Anticipated|Mansoura University||2|||f||||t|f|f||||||||2017-10-10 20:46:00.165579|2017-10-10 20:46:00.165579
NCT03262467|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|AVAH||Aneurysmorrhaphy of Vascular Access for Haemodialysis|Aneurysmorrhaphy of Vascular Access for Haemodialysis|Not yet recruiting||N/A|152|Anticipated|Faculty Hospital Kralovske Vinohrady||2|||f||||t|f|f||||||||2017-10-10 20:46:00.26064|2017-10-10 20:46:00.26064
NCT03262454|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|July 31, 2024|Anticipated|2024-07-31|December 31, 2019|Anticipated|2019-12-31||Interventional|Atezolizumab||Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC|Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for Recurrent or Refractory Small Cell Lung Cancer|Not yet recruiting||Phase 2|35|Anticipated|National Cancer Center, Korea||1|||f||||f|f|f||||||||2017-10-10 20:46:00.35471|2017-10-10 20:46:00.35471
NCT03262441|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||MMF for HIV Reservoir Reduction|Mycophenolate Mofetil Therapy for Reduction of the HIV Reservoir|Recruiting||Phase 1/Phase 2|5|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f|||f|||||2017-10-10 20:46:00.451873|2017-10-10 20:46:00.451873
NCT03262428|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|CoSMaS-ql||Collaborative Self-Management Support in Chronic Conditions - Qualitative Study|Collaborative Self-Management Support in Chronic Conditions: a Qualitative Study of Patients', Caregivers' and Health Care Professionals' Views and Experiences of Integrated Care in Asthma, Breast Cancer and Stroke|Not yet recruiting||N/A|150|Anticipated|Hospices Civils de Lyon|||3||f||||f|f|f||||||||2017-10-10 20:46:00.583011|2017-10-10 20:46:00.583011
NCT03262415|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-23|||February 17, 2017|Actual|2017-02-17|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|||PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor|PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor|Recruiting||N/A|30|Anticipated|Joslin Diabetes Center|||1||f||||f|f|f||||Samples Without DNA|"     20 to 22 blood sample( A total of about 110 mL of blood will be drawn during the visit).   "|||2017-10-10 20:46:00.671767|2017-10-10 20:46:00.671767
NCT03262402|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-21|||July 2, 2017|Actual|2017-07-02|August 2017|2017-08-01|August 8, 2018|Anticipated|2018-08-08|January 2, 2018|Anticipated|2018-01-02||Interventional|||Effects of Periodontal Treatment on HIV-infected Patients|Determination of Factors Involved in the Pathogenesis of Periodontal Diseases in HIV-infected Patients|Recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:46:00.766872|2017-10-10 20:46:00.766872
NCT03262389|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma|Comparison of F-18 FDG PET CT and PET MRI With C-11 Acetate PET CT and PET MRI in the Diagnosis of Active Multiple Myeloma Disease: a Pilot Study|Not yet recruiting||Phase 1|10|Anticipated|Mayo Clinic||1|||f||||f|t|f||||||||2017-10-10 20:46:00.883085|2017-10-10 20:46:00.883085
NCT03262376|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Minerals and Botanicals for Acute Stress|Acute Effect of Minerals and Botanicals in Combination or Isolation on Cognitive Performance, Neural Activity, and Subjective and Cortisol Response to Acute Stress|Not yet recruiting||N/A|100|Anticipated|University of Leeds||4|||f||||f|f|f||||||||2017-10-10 20:46:00.990714|2017-10-10 20:46:00.990714
NCT03262363|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-04|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|June 30, 2018|Anticipated|2018-06-30||Interventional|CURCUNRF2||Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy|Interaction of Polymorphism rs35652124 With Curcumin Supplementation on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function in Patients With Early Diabetic Nephropathy|Not yet recruiting||Phase 2/Phase 3|176|Anticipated|Unidad de Investigacion Medica en Enfermedades Renales||2|||f||||t|f|f||||||||2017-10-10 20:46:01.100828|2017-10-10 20:46:01.100828
NCT03262350|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-23|||February 6, 2017|Actual|2017-02-06|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|August 30, 2017|Anticipated|2017-08-30||Interventional|||The Effects of Yoga on Body Image in College Women|Can Yoga Reduce Body Image Concerns in Females, Thereby Reducing Risk of Obesity and Eating Disorders?|Active, not recruiting||N/A|53|Actual|University of Delaware||2|||f||||t|f|f||||||||2017-10-10 20:46:01.207767|2017-10-10 20:46:01.207767
NCT03262337|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-21|||September 18, 2017|Anticipated|2017-09-18|August 2017|2017-08-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|TOURIST2||TOURIST 2: Tracking Of Urgent Risks In Swiss Travelers|An Observational Study Using a Smartphone-app Supported Electronic Survey and Localization Tracking to Map Risk Behaviors and Symptoms of Swiss Travelers to Thailand, China, India, Brazil, Peru and Tanzania From 2 Swiss Travel Clinics|Not yet recruiting||N/A|1000|Anticipated|University of Zurich|||3||f||||f|f|f||||||||2017-10-10 20:46:01.284886|2017-10-10 20:46:01.284886
NCT03262324|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|May 30, 2018|Anticipated|2018-05-30|March 30, 2018|Anticipated|2018-03-30||Observational|||The Aim of Study is Translate and Adapt the Visual Analog Scale Foot and Ankle (VAS-FA) Instrument Into Turkish and Psycho-metrically Test Its Reliability and Validity Among Patients Who Had Foot and Ankle Disorders or Surgery|Reliability and Validity of the Turkish Version of the Visual Analogue Scale Foot and Ankle (VAS-FA)|Not yet recruiting||N/A|200|Anticipated|Hasan Kalyoncu University|||1||f||||f|f|f||||||||2017-10-10 20:46:01.368461|2017-10-10 20:46:01.368461
NCT03262311|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-22|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours|Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours|Not yet recruiting||N/A|20|Anticipated|Institute of Cancer Research, United Kingdom||1|||f||||f|f|f||||||||2017-10-10 20:46:01.448945|2017-10-10 20:46:01.448945
NCT03262298|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-22|||August 20, 2017|Actual|2017-08-20|August 2017|2017-08-01|August 20, 2021|Anticipated|2021-08-20|August 20, 2019|Anticipated|2019-08-20||Interventional|||Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies|Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy Targeting CD22 in Treating Patients With B Cell Malignancies|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t|f|f||||||||2017-10-10 20:46:01.528976|2017-10-10 20:46:01.528976
NCT03262285|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|September 30, 2019|Anticipated|2019-09-30||Observational|||Corneal Endothelial Cell Loss After Phacoemulsification Compared With Extracapsular Cataract Extraction|Corneal Endothelial Cell Loss After Phacoemulsification Compared With Extracapsular Cataract Extraction in Management of Senile Cataract|Not yet recruiting||N/A|70|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:46:01.618727|2017-10-10 20:46:01.618727
NCT03262272|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-22|||November 21, 2016|Actual|2016-11-21|August 2017|2017-08-01|December 21, 2017|Anticipated|2017-12-21|September 21, 2017|Anticipated|2017-09-21||Interventional|BIOMODAL||Evaluation of Biocompatibility and Performances of 4 Dialyzers in Different Mode Treatments|Evaluation of Dialyzers' Biocompatibility and Performances Compared in Different Dialysis Treatments : Conventional Hemodialysis and Post-dilution Hemodialfiltration|Recruiting||N/A|32|Anticipated|Hemotech||4|||f||||t|f|f||||||||2017-10-10 20:46:01.700249|2017-10-10 20:46:01.700249
NCT03262246|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-24|2017-08-24|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 30, 2016|Actual|2016-10-30||Observational|||Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid|Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid|Active, not recruiting||N/A|225|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||||2017-10-10 20:46:01.930156|2017-10-10 20:46:01.930156
NCT03262233|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||April 1, 2015|Actual|2015-04-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Stress Neuroadaptation in Tobacco Dependence|Clinical Relevance of Stress Neuroadaptation in Tobacco Dependence|Recruiting||Phase 4|128|Anticipated|University of Wisconsin, Madison||2|||f||||f|t|f|||f|||||2017-10-10 20:46:01.99673|2017-10-10 20:46:01.99673
NCT03262220|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||April 11, 2017|Actual|2017-04-11|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI|Pilot Study of Dose Escalated Total Marrow Irradiation With Volumetric Arc Therapy for Patients With Hematological Malignancies Unfit for a Standard 12 Gy TBI Conditioning Regimen.|Recruiting||N/A|10|Anticipated|University Hospital, Geneva||1|||f||||t|f|f||||||||2017-10-10 20:46:02.081015|2017-10-10 20:46:02.081015
NCT03262207|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|GAMETH||Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours|Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours: Potential Risks and Consequences for the Conceptus|Active, not recruiting||N/A|90|Actual|Centre Hospitalier Universitaire Dijon|||3||f|||||f|f||||||||2017-10-10 20:46:02.159445|2017-10-10 20:46:02.159445
NCT03262181|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||The Acute Effects of an Isometric Loading Intervention on Lower Extremity Landing Biomechanics in Individuals With Patellar Tendinopathy|The Acute Effects of an Isometric Loading Intervention on Lower Extremity Landing Biomechanics in Individuals With Patellar Tendinopathy|Not yet recruiting||N/A|45|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 20:46:02.27999|2017-10-10 20:46:02.27999
NCT03262168|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-23|||June 2, 2017|Actual|2017-06-02|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|SEACHange||Supported Exercise Programme for Adults With Congenital Heart Disease|Supported Exercise Programme for Adults With Congenital Heart Disease (SEA CHange)|Recruiting||N/A|30|Anticipated|Golden Jubilee National Hospital||4|||f||||f|f|f||||||||2017-10-10 20:46:02.35883|2017-10-10 20:46:02.35883
NCT03262155|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||July 4, 2016|Actual|2016-07-04|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|IMPEC||Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)|Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)|Recruiting||N/A|40|Anticipated|Rennes University Hospital|||2||f||||f|f|f||||Samples Without DNA|"     plasma   "|||2017-10-10 20:46:02.44956|2017-10-10 20:46:02.44956
NCT03262142|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|Target-ABC||Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease|Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease: A Randomized, Multicenter Trial Investigating if Targeted Antibiotic Therapy Can Improve the Prognosis in COPD Patients Infected With Pseudomonas Aeruginosa|Not yet recruiting||Phase 4|150|Anticipated|Chronic Obstructive Pulmonary Disease Trial Network, Denmark||2|||f||||t|f|f||||||||2017-10-10 20:46:02.523832|2017-10-10 20:46:02.523832
NCT03262129|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-08-23|||January 1, 2012|Actual|2012-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Observational|MEN1-GTEcohort||Type 1 Multiple Endocrine Neoplasia Cohort Study|Type 1 Multiple Endocrine Neoplasia : a Cohort Study of the Endocrine Tumor Study Group (GTE)|Recruiting||N/A|2000|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 20:46:02.601353|2017-10-10 20:46:02.601353
NCT03261193|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-10-03|||September 5, 2017|Actual|2017-09-05|October 2017|2017-10-01|June 1, 2018|Anticipated|2018-06-01|January 1, 2018|Anticipated|2018-01-01||Interventional|qlcsection||ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain|QL Block for Post-cesarean Delivery Pain|Recruiting||Phase 3|60|Anticipated|University of Pittsburgh||2|||f||||f|t|f||||||||2017-10-10 20:46:11.338167|2017-10-10 20:46:11.338167
NCT03262116|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas|Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas|Not yet recruiting||N/A|20|Anticipated|Massachusetts General Hospital||3|||f||||t|f|t|t|||||||2017-10-10 20:46:02.659046|2017-10-10 20:46:02.659046
NCT03262103|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer|Phase I Study of In Situ Autologous Vaccination Against Prostate Cancer With Intratumoral and Systemic Hiltonol® (Poly-ICLC) Prior To Radical Prostatectomy|Recruiting||Phase 1|24|Anticipated|Icahn School of Medicine at Mount Sinai||4|||f|||||t|f||||||||2017-10-10 20:46:02.76814|2017-10-10 20:46:02.76814
NCT03262090|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-28|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Effect of Dexmedetomidine on the Prevention of Emergence Agitation in Children Undergoing Day Surgery|Efficacy of Different Doses of Dexmedetomidine on the Prevention of Emergence Agitation in Children Undergoing Day Surgery With Desoflurane Anesthesia|Not yet recruiting||N/A|400|Anticipated|Guangzhou Women and Children's Medical Center||6|||f||||t|f|f|||f|||||2017-10-10 20:46:02.890362|2017-10-10 20:46:02.890362
NCT03262077|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||October 11, 2016|Actual|2016-10-11|August 2017|2017-08-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||Dose Parameters for Photodynamic Therapy on Periodontal Disease|Evaluation of Parameters of Tissue Dosimetry in Photodynamic Therapy for the Treatment of Periodontal Disease - Clinical Study|Completed||N/A|30|Actual|University of Nove de Julho||6|||f|||||f|f|||f|||||2017-10-10 20:46:02.978839|2017-10-10 20:46:02.978839
NCT03262064|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-10|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Different Phenotypes of Bronchiectasis|Different Phenotypes of Bronchiectasis|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:46:03.079076|2017-10-10 20:46:03.079076
NCT03262051|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-27|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Impact of Acute and Chronic Inflammation on Cytochromes P450 Activity Measured With Dried Blood Spot|Impact of Acute and Chronic Inflammation on Cytochromes P450 Activity Measured With Dried Blood Spot|Recruiting||N/A|76|Anticipated|University Hospital, Geneva|||2||f||||f|f|f||||||||2017-10-10 20:46:03.144599|2017-10-10 20:46:03.144599
NCT03262038|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-13|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 1, 2021|Anticipated|2021-11-01|November 1, 2021|Anticipated|2021-11-01||Interventional|||Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?|A Randomized Double Blinded, Placebo-controlled Trial of IV Ondansetron to Prevent Pruritus in Children Who Receive Intrathecal Morphine|Not yet recruiting||Phase 4|130|Anticipated|University of Michigan||2|||f||||f|t|f||||||||2017-10-10 20:46:03.222539|2017-10-10 20:46:03.222539
NCT03261999|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-09-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer|An Open-Label, Single-Arm Study of The Efficacy, Safety, and Pharmacokinetic Behavior of Leuprolide Mesylate Injectable Suspension (LMIS 25 mg) in Subjects With Prostate Cancer|Recruiting||Phase 3|133|Anticipated|Foresee Pharmaceuticals Co., Ltd.||1|||f||||f|t|f||||||||2017-10-10 20:46:03.938529|2017-10-10 20:46:03.938529
NCT03261986|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||June 9, 2017|Actual|2017-06-09|August 2017|2017-08-01|February 9, 2022|Anticipated|2022-02-09|October 9, 2020|Anticipated|2020-10-09||Interventional|||A Prospective RSA and Clinical Evaluation of the Trident II Acetabular Cup|A Prospective RSA and Clinical Evaluation of the Trident II Acetabular Cup|Recruiting||N/A|50|Anticipated|Central DuPage Hospital||1|||f||||f|f|t|f||t|||||2017-10-10 20:46:04.104931|2017-10-10 20:46:04.104931
NCT03261973|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Esophageal Deviation in Atrial Fibrillation Ablation|Esophageal Deviation in Atrial Fibrillation Ablation|Not yet recruiting||Phase 4|54|Anticipated|Massachusetts General Hospital||1|||f|||||f|f||||||||2017-10-10 20:46:04.21255|2017-10-10 20:46:04.21255
NCT03261960|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy|A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy|Recruiting||Phase 3|450|Anticipated|Braintree Laboratories||2|||f||||f|t|f||||||||2017-10-10 20:46:04.284091|2017-10-10 20:46:04.284091
NCT03261947|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|March 30, 2020|Anticipated|2020-03-30|March 30, 2020|Anticipated|2020-03-30||Interventional|||A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer or Metastatic Colorectal Cancer|An Open-Label, Phase 2, Parallel Arm Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 Single Agent in Patients With Metastatic Pancreatic Cancer or Metastatic Colorectal Cancer|Not yet recruiting||Phase 2|88|Anticipated|Takeda||1|||f||||f|t|f||||||||2017-10-10 20:46:04.424008|2017-10-10 20:46:04.424008
NCT03261934|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 31, 2030|Anticipated|2030-12-31|December 31, 2030|Anticipated|2030-12-31|10 Years|Observational [Patient Registry]|||Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation|Risk Assessment and Syndrome Evolution Models Combining Traditional Chinese Medicine and Modern Medicine Indicators for Chronic Atrophic Gastritis Malignant Transformation: a Registry Study|Not yet recruiting||N/A|2000|Anticipated|Beijing University of Chinese Medicine|||1||f||||t|f|f||||||||2017-10-10 20:46:04.528733|2017-10-10 20:46:04.528733
NCT03261921|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-22|||June 5, 2016|Actual|2016-06-05|August 2017|2017-08-01|July 7, 2017|Actual|2017-07-07|June 22, 2017|Actual|2017-06-22||Interventional|||Caudal Combination of Dexamethasone and/or Dexmedetomidine to Bupivacaine in Pediatric Hypospadias Surgery|Adjuncts to Caudal Block in Pediatrics|Completed||Phase 1|63|Actual|Cairo University||3|||f||||f|f|f||||||||2017-10-10 20:46:04.604247|2017-10-10 20:46:04.604247
NCT03261908|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction|A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction|Not yet recruiting||N/A|2200|Anticipated|Peking University First Hospital|||2||f|||||f|f||||||||2017-10-10 20:46:04.710332|2017-10-10 20:46:04.710332
NCT03261895|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||May 4, 2017|Actual|2017-05-04|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|NIHaW||Effectiveness of a Nurse-led Integrative Health and Wellness Programme Among Newly Diagnosed Type 2 Diabetes Patients|Effects of a Nurse-led Integrative Health and Wellness (NIHaW) Programme on Behavioural, Psychosocial and Biomedical Outcomes Among Newly Diagnosed Type 2 Diabetes Patients: A Randomized Controlled Trial|Active, not recruiting||N/A|128|Actual|Chinese University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:46:04.805842|2017-10-10 20:46:04.805842
NCT03261882|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|July 30, 2017|Actual|2017-07-30||Observational|||Loss of a Healthy Weight Advantage Among Mexican-American Children|Loss of a Healthy Weight Advantage Among Foreign-born Children of Mexican Origin: Analysis of Overweight/Obesity Trends From 1988-1994 to 2005-2014|Completed||N/A|11987|Actual|University of North Carolina, Chapel Hill|||3||f|||||f|f||||||||2017-10-10 20:46:04.923169|2017-10-10 20:46:04.923169
NCT03261869|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||EFFICACY OF ICE PACK THERAPY AFTER IMPACTED THIRD MOLAR SURGERY|EFFICACY OF ICE PACK THERAPY AFTER IMPACTED THIRD MOLAR SURGERY: A RANDOMIZED CONTROLLED CLINICAL TRIAL|Completed||N/A|18|Actual|Baskent University||2|||f||||t|f|f||||||||2017-10-10 20:46:05.013219|2017-10-10 20:46:05.013219
NCT03261856|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical Utility of Breath Tests in GI|Clinical Utility of Carbohydrate Breath Tests in Unexplained GI Symptoms|Not yet recruiting||N/A|1000|Anticipated|Augusta University|||1||f||||f|f|f||||||||2017-10-10 20:46:05.092285|2017-10-10 20:46:05.092285
NCT03261843|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||The Effect of Using Autologous Platelet Rich Plasma on Posterior Lumbar Interbody Fusion|The Effect of Using Autologous Platelet Rich Plasma on Posterior Lumbar Interbody Fusion : a Randomized Comparative Trial|Not yet recruiting||Phase 4|60|Anticipated|Assiut University||2|||f||||t|f|f|||f|||||2017-10-10 20:46:05.176461|2017-10-10 20:46:05.176461
NCT03261830|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)|Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)|Recruiting||N/A|200|Anticipated|University of Missouri-Columbia||2|||f|||||f|f||||||||2017-10-10 20:46:05.263105|2017-10-10 20:46:05.263105
NCT03261817|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-22|||September 8, 2017|Anticipated|2017-09-08|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|PEPSYV@SI||A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders|Clinical and Brain Effects of Remote Web-based Adapted Physical Activity (e-APA) in Patients With Psychotic Disorders and Healthy Subjects: A Controlled, Multicenter Study|Not yet recruiting||N/A|84|Anticipated|University Hospital, Caen||4|||f||||f|f|f||||||||2017-10-10 20:46:05.377028|2017-10-10 20:46:05.377028
NCT03261804|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users|Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users|Not yet recruiting||N/A|608|Anticipated|Assiut University|||2||f|||||f|f||||||||2017-10-10 20:46:05.482392|2017-10-10 20:46:05.482392
NCT03261791|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|April 20, 2020|Anticipated|2020-04-20|January 20, 2020|Anticipated|2020-01-20||Interventional|||Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection|A Exploratory Study of Apatinib Adjuvant Therapy for Hepatocellular Carcinoma With Portal Vein Invasion Who Underwent Radical Resection|Recruiting||Phase 2|30|Anticipated|Shanghai Zhongshan Hospital||1|||f||||f|f|f||||||||2017-10-10 20:46:05.559097|2017-10-10 20:46:05.559097
NCT03261778|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-24|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||Comparison of Two Types of Braces in the Treatment of Rockwood Type III AC-dislocations|Conservative Treatment of Rockwood Type III Acromioclavicular Dislocation With Two Different Types of Braces: a Comparative Prospective Randomized Trial|Recruiting||N/A|40|Anticipated|Bürgerspital Solothurn||2|||f||||f|f|f||||||||2017-10-10 20:46:05.677812|2017-10-10 20:46:05.677812
NCT03261765|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|||Effect of Multiple Repeat Cesarean Sections on Intra-abdominal Adhesions|Effect of Multiple Repeat Cesarean Sections on Intra-abdominal Adhesions|Not yet recruiting||N/A|160|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:46:05.79208|2017-10-10 20:46:05.79208
NCT03261752|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-09-25|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Molecular Pathways in Carcinogenesis of Colo Rectal Cancer|Molecular Pathways in Carcinogenesis of Colorectal Cancer: Implications in Vivo and Vitro|Not yet recruiting||N/A|100|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:46:05.875162|2017-10-10 20:46:05.875162
NCT03261726|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-25|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|February 1, 2021|Anticipated|2021-02-01|August 4, 2020|Anticipated|2020-08-04||Interventional|||Maintaining Cochlear Patency After VIIIth Nerve Surgery|Maintaining Cochlear Patency After VIIIth Nerve Surgery|Recruiting||N/A|15|Anticipated|Ascension St John Providence||1|||f||||t|f|t|f|f||||||2017-10-10 20:46:06.131704|2017-10-10 20:46:06.131704
NCT03261713|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-21|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Home-based Virtual Reality Training After Stroke|Home-based Virtual Reality Training After Discharge From Hospital-based Stroke Rehabilitation: A Parallel Randomised Feasibility Trial.|Recruiting||N/A|40|Anticipated|Bruyere Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:46:06.227218|2017-10-10 20:46:06.227218
NCT03261700|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-22|||October 23, 2017|Anticipated|2017-10-23|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|RISE||Recovering From Intimate Partner Violence Using Strengths and Empowerment (RISE)|Recovering From Intimate Partner Violence Through Strengths and Empowerment (RISE): Tailoring and Evaluating a Patient-Centered Counseling Intervention for Women Veterans|Not yet recruiting||Phase 1|60|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 20:46:06.368988|2017-10-10 20:46:06.368988
NCT03261687|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||May 27, 2016|Actual|2016-05-27|August 2017|2017-08-01|January 31, 2017|Actual|2017-01-31|December 31, 2016|Actual|2016-12-31||Interventional|||The Effects of a Water Based Exercise Programme and a Land Based Exercise Programme on Women Experiencing Pregnancy Related Pelvic Girdle Pain|The Effects of a Water Based Exercise Programme and a Land Based Exercise Programme on Women Experiencing Pregnancy Related Pelvic Girdle Pain : a Randomised Controlled Feasibility Study.|Completed||N/A|23|Actual|University of Bradford||2|||f||||f|f|f||||||||2017-10-10 20:46:06.4773|2017-10-10 20:46:06.4773
NCT03261674|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-22|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Non-Pharmacological Treatments for Insomnia in Chronic Traumatic Brain Injury|Cognitive Behavioral Therapy for Insomnia in Chronic Traumatic Brain Injury|Not yet recruiting||N/A|120|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 20:46:06.554209|2017-10-10 20:46:06.554209
NCT03261661|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-08|||August 18, 2017|Actual|2017-08-18|September 2017|2017-09-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Improving Response to Intervention in Students With or at Risk of Reading Disabilities|Improving Response to Intervention in Students With or at Risk of Reading Disabilities|Recruiting||N/A|864|Anticipated|Vanderbilt University||4|||f||||f|f|f||||||||2017-10-10 20:46:06.654003|2017-10-10 20:46:06.654003
NCT03261648|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-30|||May 23, 2017|Actual|2017-05-23|August 2017|2017-08-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Observational|ANXURG||Anxiety of Patient and His Partner During Admission to Emergency Department|Anxiety of Patient and His Partner During Admission to Emergency Department|Completed||N/A|200|Actual|University Hospital, Toulouse|||2||f||||f|f|f||||||||2017-10-10 20:46:06.78708|2017-10-10 20:46:06.78708
NCT03261635|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-22|||January 7, 2016|Actual|2016-01-07|August 2017|2017-08-01|July 25, 2017|Actual|2017-07-25|December 7, 2016|Actual|2016-12-07||Interventional|||Ranibizumab Plus Indomethacin|Prospective Randomized Controlled Trial of Combination Ranibizumab and Indomethacin for Exudative Age-Related Macular Degeneration|Completed||Phase 4|58|Actual|Università degli Studi di Brescia||2|||f|||||f|f||||||||2017-10-10 20:46:06.860314|2017-10-10 20:46:06.860314
NCT03261622|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-22|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|November 1, 2020|Anticipated|2020-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|SNS||Sacral Nerve Stimulation for Faecal Incontinence - Placebo or Clinical Effective|Sacral Nerve Stimulation for Faecal Incontinence - Placebo or Clinical Effective: A Randomized Blinded Study|Recruiting||N/A|75|Anticipated|University of Aarhus||2|||f||||f|f|f||||||||2017-10-10 20:46:06.916357|2017-10-10 20:46:06.916357
NCT03261609|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-24|||December 1, 2011|Actual|2011-12-01|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28|1 Day|Observational [Patient Registry]|||Risk of Chronic Diseases in Young Adults Born Preterm: Relationship With Inflammation and Oxidative Stress Biomarkers.|Risk of Chronic Diseases in Young Adults Born Preterm: Relationship With Inflammation and Oxidative Stress Biomarkers.|Recruiting||N/A|250|Anticipated|St. Justine's Hospital|||2||f||||f|f|f||||Samples With DNA|"     The team collected the blood and urine of the participants. They kept whole blood and urine     the the biobank. The group also isolated the plasma and serum to perform assays.   "|||2017-10-10 20:46:07.001813|2017-10-10 20:46:07.001813
NCT03261596|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana|Efficacy and Safety of a Single-dose Regimen and a Multi-dose Regimen of Mebendazole Against Hookworm Infections in Children and Adolescents in Ghana: a Randomized Controlled Trial|Not yet recruiting||Phase 4|300|Anticipated|PATH||2|||f||||t|f|f||||||||2017-10-10 20:46:07.099484|2017-10-10 20:46:07.099484
NCT03261583|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||November 14, 2016|Actual|2016-11-14|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CARMATS||Impact of Preoperative Martial Deficiency on the Level of Blood Transfusion in Programmed Cardiac Surgery|Impact of Preoperative Martial Deficiency on the Level of Blood Transfusion in Programmed Cardiac Surgery (CARMATS)|Recruiting||N/A|600|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:46:07.18969|2017-10-10 20:46:07.18969
NCT03261570|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-24|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|September 1, 2021|Anticipated|2021-09-01|June 30, 2021|Anticipated|2021-06-30||Interventional|||Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS|Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in Postural Tachycardia Syndrome|Recruiting||Early Phase 1|80|Anticipated|New York Medical College||2|||f||||t|f|f||||||||2017-10-10 20:46:07.258778|2017-10-10 20:46:07.258778
NCT03261557|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||February 22, 2017|Actual|2017-02-22|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|February 2020|Anticipated|2020-02-01||Interventional|||Cognitive Behavioral Social Skills Training in Early Onset Psychosis|Cognitive Behavioral Social Skills Training in Early-onset Psychosis: Efficacy in Psychotic Symptoms, Psyshosocial Functioning and Neurobiological and Epigenetic Stress Markers.|Recruiting||N/A|30|Anticipated|Hospital Clinic of Barcelona||2|||f||||t|f|f||||||||2017-10-10 20:46:07.354944|2017-10-10 20:46:07.354944
NCT03261544|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2027|Anticipated|2027-11-01|November 2022|Anticipated|2022-11-01||Observational|||Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?|Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?|Not yet recruiting||N/A|50|Anticipated|Duke University|||1||f||||f|f|f||||||||2017-10-10 20:46:07.430316|2017-10-10 20:46:07.430316
NCT03261531|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-22|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Dermatome Electrical Stimulation on Individuals With Overweight and Class I Obesity|Effect of T6 Dermatome Electrical Stimulation on Gastric Motor Functions, Appetite, Satiation, Satiety and Weight Loss in Individuals With Overweight and Class I Obesity|Recruiting||N/A|16|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:46:08.973719|2017-10-10 20:46:08.973719
NCT03261518|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||August 24, 2017|Anticipated|2017-08-24|August 2017|2017-08-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||Investigation of Relationship Between Contrast Nephropathy and Caval Index Measurement in Patients With Ileus in ED|Investigation of Relationship Between Contrast Nephropathy and Caval Index Measurement in Patients With Suspected Ileus in Emergency Department|Not yet recruiting||N/A|250|Anticipated|Derince Training and Research Hospital|||1||f||||f|f|f||||||||2017-10-10 20:46:09.120198|2017-10-10 20:46:09.120198
NCT03261505|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|||Mechanistic Studies on Video-guided Acupuncture Imagery Treatment of Knee Pain|Mechanistic Studies on Video-guided Acupuncture Imagery Treatment of Knee Pain|Not yet recruiting||N/A|100|Anticipated|Massachusetts General Hospital||4|||f||||f|f|f||||||||2017-10-10 20:46:09.177658|2017-10-10 20:46:09.177658
NCT03261492|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-22|||January 30, 2017|Actual|2017-01-30|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|August 2019|Anticipated|2019-08-01||Interventional|SAGE||Sustainability Via Active Garden Education|Partnering for PA in Early Childhood: Sustainability Via Active Garden Education|Enrolling by invitation||N/A|1275|Anticipated|Arizona State University||2|||f||||t|f|f||||||||2017-10-10 20:46:09.243899|2017-10-10 20:46:09.243899
NCT03261479|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||April 13, 2016|Actual|2016-04-13|August 2017|2017-08-01|April 13, 2018|Anticipated|2018-04-13|December 31, 2017|Anticipated|2017-12-31||Observational|||Validation of Thermal Imaging to Detect Pneumonia|Validation of Thermal Imaging to Detect Pneumonia|Recruiting||N/A|138|Anticipated|Massachusetts General Hospital|||1||f||||f|f|f||||||||2017-10-10 20:46:09.321245|2017-10-10 20:46:09.321245
NCT03261466|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-24|||November 20, 2013|Actual|2013-11-20|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|BIFI-OBESE||BIFI-OBESE: Clinical Trial in Paediatric Obesity|BIFI-OBESE: Effect of Probiotic Bifidobacterium Breve BR03 and Bifidobacterium Breve B632 in Paediatric Obesity|Recruiting||Phase 4|100|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita||2|||f||||t|f|f|||f|||||2017-10-10 20:46:09.406208|2017-10-10 20:46:09.406208
NCT03261453|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-22|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||THE ENLIGHTEN STUDY|A Randomized, Multi-Center, Phased, Pivotal Safety and Efficacy Study Comparing the Elipse™ Gastric Balloon System vs. Sham for the Treatment of Obese Adults|Not yet recruiting||N/A|400|Anticipated|Allurion Technologies||2|||f||||t|f|t|f|f||||||2017-10-10 20:46:09.510444|2017-10-10 20:46:09.510444
NCT03261440|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|WEAN US||Cardiac, Pulmonary and Diaphragm Sonography for the Early Diagnosis of the Different Etiologies Underlying Failure of Weaning From Mechanical Ventilation|Combined Cardiac, Pulmonary and Diaphragm Sonography for the Evaluation of Failure in Ventilation Weaning|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:46:09.576754|2017-10-10 20:46:09.576754
NCT03261427|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluate the Pharmacokinetic Characteristics and Safety/Tolerability of YNP-1807 Compared to Lyrica® After Oral Administration Adult Volunteers|A Randomized, Open-label, Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics and Safety/Tolerability of YNP-1807 Compared to Lyrica® After Oral Administration in Healthy Adult Volunteers: Part I- Single Dosing/Part II- Multiple Dosing|Not yet recruiting||Phase 1|48|Anticipated|Yungjin Pharm. Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:46:09.637478|2017-10-10 20:46:09.637478
NCT03261414|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-24|||May 27, 2015|Actual|2015-05-27|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|HYSTERIA||HYSTERIA Evaluation of Clinical HYpnosis After Surgical Resection for Crohn Disease on Post-operative Analgesia|Prospective Randomized Study Evaluating the Effect of Pre-operative Hypnosis on Anesthesia, Analgesia and Perioperative Stress Laparoscopic Ileo-caecal Resections of Crohn's Disease.|Recruiting||N/A|68|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||||2017-10-10 20:46:09.71717|2017-10-10 20:46:09.71717
NCT03261401|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-20|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Subjects|A Phase I, First-in-Human, Randomized, Double-Blind, Placebo-Controlled Trial of Single and Multiple Ascending Doses of M5717 to Assess the Safety, Tolerability and Pharmacokinetic Profile of Oral Doses, and to Assess the Antimalarial Activity of M5717 Against Plasmodium Falciparum in Healthy Male and Female Adult Subjects|Recruiting||Phase 1|88|Anticipated|Merck KGaA||5|||f||||f|f|f||||||||2017-10-10 20:46:09.890861|2017-10-10 20:46:09.890861
NCT03261388|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-22|||November 7, 2016|Actual|2016-11-07|August 2017|2017-08-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2022|Anticipated|2022-01-31||Observational|ABLE-POWER||Activity Based Locomotor Exercise PrOgram—Wait-list controllEd Research|ABLE POWER - Activity Based Locomotor Exercise PrOgram: Wait-list controllEd Research|Recruiting||N/A|50|Anticipated|Allina Health System|||1||f||||f|f|f||||||||2017-10-10 20:46:10.049531|2017-10-10 20:46:10.049531
NCT03261375|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||August 27, 2017|Anticipated|2017-08-27|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||A Clinical Trial to Evaluate Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension|A Prospective, Multicentre, Randomized, Controlled Trial for Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension|Recruiting||N/A|110|Anticipated|Shanghai Golden Leaf MedTec Co. Ltd||2|||f|||||f|f||||||||2017-10-10 20:46:10.124482|2017-10-10 20:46:10.124482
NCT03261362|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||March 2016||2016-03-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|BRAAWO||Impact of Branched-chain Amino Acids in the Development of Insulin Resistance|Branched-Chain Amino Acid Dietary Reduction Under Weight Maintainance in Overweight Patients With Type 2 Diabetes|Recruiting||N/A|12|Anticipated|German Diabetes Center||2|||f||||||||||||||2017-10-10 20:46:10.251387|2017-10-10 20:46:10.251387
NCT03261349|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-23|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 15, 2021|Anticipated|2021-08-15|December 31, 2020|Anticipated|2020-12-31||Interventional|||Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma|A Pilot Phase II Study of New Direct-Acting Antiviral Agent, HARVONI® (Ledipasvir/Sofosbuvir), for the Treatment of Genotype 1 or 2 HCV-Associated Indolent B-Cell Non- Hodgkin's Lymphoma|Not yet recruiting||Phase 2|21|Anticipated|National Taiwan University Hospital||1|||f||||f|t|f|||t|||||2017-10-10 20:46:10.325661|2017-10-10 20:46:10.325661
NCT03261336|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-23|||January 6, 2017|Actual|2017-01-06|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Oral Calcitriol With Ketoconazole in CRPC|A Phase II Study of Oral Calcitriol in Combination With Ketoconazole in Castration Resistant Prostate Cancer, Progressing Despite Primary ADT and Abiraterone|Recruiting||Phase 2|15|Anticipated|Inova Health Care Services||1|||f||||t|t|f||||||||2017-10-10 20:46:10.411185|2017-10-10 20:46:10.411185
NCT03261323|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-23|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|||Breast Reconstruction Following Breast Cancer in Very High Risk Patients|Evaluating Breast Reconstruction Timing and Risk Reduction Strategies in Patients at a Higher Risk for Developing Breast Reconstruction Surgical Complications: A Prospective Randomized Study|Not yet recruiting||N/A|300|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|f|f||||||||2017-10-10 20:46:10.580282|2017-10-10 20:46:10.580282
NCT03261310|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-08-23|||May 2013||2013-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Use of IV Acetaminophen in the Treatment of Post Operative Pain in Patients Undergoing Craniotomy and Spine Surgery|Use of IV Acetaminophen in the Treatment of Post Operative Pain in Patients Undergoing Craniotomy and Spine Surgery|Recruiting||N/A|55|Anticipated|Brooke Army Medical Center||4|||f||||t||||||||||2017-10-10 20:46:10.67812|2017-10-10 20:46:10.67812
NCT03261297|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-23|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|August 22, 2018|Anticipated|2018-08-22|August 22, 2017|Actual|2017-08-22||Observational|||Epidemiology of Chronic Diarrhea Among Children Admitted to Gastroenterology Unit at Assuit University Children Hospital|Epidemiology of Chronic Diarrhea Among Children Admitted to Gastroenterology Unit at Assuit University Children Hospital|Recruiting||N/A|50|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:46:10.769385|2017-10-10 20:46:10.769385
NCT03261284|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-23|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|DATA-AF||D-dimer to Guide Anticoagulation Therapy in Patients With Atrial Fibrillation|D-dimer to Determine Intensity of Anticoagulation to Reduce Clinical Outcomes in Patients With Atrial Fibrillation|Recruiting||N/A|600|Anticipated|Wuhan Asia Heart Hospital||3|||f||||t|f|f||||||||2017-10-10 20:46:10.831024|2017-10-10 20:46:10.831024
NCT03261271|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-28|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|WARRIOR||Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy|Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy|Recruiting||N/A|40|Anticipated|University of Kansas Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:46:10.92129|2017-10-10 20:46:10.92129
NCT03261258|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|REPERE II/III||Comparison of Criteria for the Designation of a Contact Person in ICU Patients and Close Friends and Relatives|ICU and Contact Person: Comparison of Criteria for Designation in Patients and Close Friends and Relatives|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f|||||f|f||||||||2017-10-10 20:46:10.994853|2017-10-10 20:46:10.994853
NCT03261245|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|HTA-BQuA||Relationship Between Multi-exposure to Noise and Air Pollution and the Onset of Hypertension Disorders During Pregnancy|Hypertension Disorders During Pregnancy and Multi-exposure to Environmental Noise and Atmospheric Pollution in an Urban Setting: Case-control Study in Women Who Gave Birth at Dijon and Besançon CHUs Between 2005 and 2009|Recruiting||N/A|2650|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f|||||f|f||||||||2017-10-10 20:46:11.060233|2017-10-10 20:46:11.060233
NCT03261232|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|Pro-ACR||Search for Prognostic Factors Associated With Better Survival in Refractory Cardiac Arrest|Prognostic Factors in Refractory Cardiac Arrest Treated With Extracorporeal Life Support at Dijon CHU|Active, not recruiting||N/A|65|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:46:11.125671|2017-10-10 20:46:11.125671
NCT03261219|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-10-05|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||IPV vs CPT for Airway Clearance During CF Exacerbation|Intrapulmonary Percussive Ventilation vs Chest Physiotherapy Vest in Airway Clearance During Cystic Fibrosis Pulmonary Exacerbation|Not yet recruiting||N/A|50|Anticipated|University of Florida||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:46:11.180195|2017-10-10 20:46:11.180195
NCT03261206|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-23|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|STATIC||Stopping Aminosalicylate Therapy in Inactive Crohn's Disease|Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority Trial|Not yet recruiting||Phase 4|1580|Anticipated|Robarts Clinical Trials Inc.||2|||f|||||f|f||||||||2017-10-10 20:46:11.248118|2017-10-10 20:46:11.248118
NCT03261180|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-19|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 9, 2021|Anticipated|2021-08-09|August 10, 2020|Anticipated|2020-08-10||Interventional|||Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer|Perioperative Nutritional Optimization in Head and Neck Cancer Patients|Not yet recruiting||N/A|330|Anticipated|OHSU Knight Cancer Institute||2|||f||||t|f|f|||f|||||2017-10-10 20:46:11.550604|2017-10-10 20:46:11.550604
NCT03261154|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-23|||January 1, 2012|Actual|2012-01-01|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Serum iPTH, Calcium and Phosphate, and the Risk of Mortality in Beijing Elderly Hemodialysis Population|Serum iPTH, Calcium and Phosphate, and the Risk of Mortality in Beijing Elderly Hemodialysis Population|Completed||N/A|1000|Actual|Beijing Friendship Hospital|||1||f||||f|f|f||||||||2017-10-10 20:46:11.869702|2017-10-10 20:46:11.869702
NCT03261128|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-22|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|D-FOG||Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)|Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment. Feasibility and Acceptability Study.|Not yet recruiting||N/A|50|Anticipated|Poitiers University Hospital|||1||f|||||f|f||||||||2017-10-10 20:46:12.012343|2017-10-10 20:46:12.012343
NCT03261102|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||January 17, 2017|Actual|2017-01-17|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||TDM Guided Early Optimization of ADAL in Crohn's Disease|Therapeutic Drug Monitoring Guided Early Optimization of Adalimumab in Crohn's Disease; A Randomized Open Label Study|Recruiting||N/A|200|Anticipated|McGill University Health Center||2|||f||||f|f|f||||||||2017-10-10 20:46:12.17443|2017-10-10 20:46:12.17443
NCT03261089|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-22|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|August 1, 2027|Anticipated|2027-08-01|August 1, 2022|Anticipated|2022-08-01|5 Years|Observational [Patient Registry]|MOCHA||Multimodal Outcome CHAracterization in Comatose Cardiac Arrest Patients Registry and Tissue Repository|MOCHA Study: Multimodal Outcome CHAracterization in Comatose Cardiac Arrest Patients Data Registry and Tissue Repository|Recruiting||N/A|2500|Anticipated|Boston Medical Center|||1||f||||t|f|f||||||||2017-10-10 20:46:12.305314|2017-10-10 20:46:12.305314
NCT03261076|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-22|||September 4, 2017|Anticipated|2017-09-04|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|SERIOUS||Reading Remediation and Outcomes in Detention|Severe LD in Juvenile Delinquents: Presentation, Course, and Remediation|Not yet recruiting||N/A|192|Anticipated|Baylor College of Medicine||1|||f||||f|f|f||||||||2017-10-10 20:46:12.394391|2017-10-10 20:46:12.394391
NCT03261063|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||October 31, 2017|Anticipated|2017-10-31|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||China Evera MRI® Study|China Evera MRI® Study|Not yet recruiting||N/A|15|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f|f|f||||||||2017-10-10 20:46:12.501645|2017-10-10 20:46:12.501645
NCT03261050|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-22|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Observational|||Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders|Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders|Recruiting||N/A|180|Anticipated|Oregon Research Institute|||2||f||||t|f|f||||||||2017-10-10 20:46:12.568109|2017-10-10 20:46:12.568109
NCT03261037|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-10-02|||November 30, 2017|Anticipated|2017-11-30|October 2017|2017-10-01|May 29, 2020|Anticipated|2020-05-29|May 29, 2020|Anticipated|2020-05-29||Interventional|||A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period|An International Study to Characterize the Disease Behaviour of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease During the Peri-Diagnostic Period|Not yet recruiting||N/A|180|Anticipated|Hoffmann-La Roche||1|||f||||f|f|f||||||||2017-10-10 20:46:12.685021|2017-10-10 20:46:12.685021
NCT03261024|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Friction Versus Frictionless Mechanics During Maxillary En-masse Retraction in Adult Patients|Friction Versus Frictionless Mechanics During Maxillary En-masse Retraction in Adult Patients With Class I Bimaxillary Dentoalveolar Protrusion: A Randomized Clinical Trial|Not yet recruiting||N/A|30|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:46:12.856486|2017-10-10 20:46:12.856486
NCT03261011|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|||Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors|A Phase 1A/1B Multicenter, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors|Not yet recruiting||Phase 1|153|Anticipated|Akesobio Australia Pty Ltd||1|||f||||f|f|f||||||||2017-10-10 20:46:12.95212|2017-10-10 20:46:12.95212
NCT03260972|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-25|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Intraabdominal Chloroprocaine During Cesarean Delivery for Pain Control|An Evaluation of Intraabdominal Chloroprocaine During Cesarean Delivery and Its Effect on Postoperative Pain and Nausea; a Randomized Controlled Trial & Pharmacokinetic-pharmacodynamics (PKPD) Analysis.|Not yet recruiting||Phase 3|150|Anticipated|Johns Hopkins University||2|||f||||t|f|f|||f|||||2017-10-10 20:46:13.18023|2017-10-10 20:46:13.18023
NCT03260959|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|October 10, 2017|Anticipated|2017-10-10|October 10, 2017|Anticipated|2017-10-10||Observational|||Experience of the Father Following the Announcement of a First Pregnancy|Experience of the Father Following the Announcement of a First Pregnancy|Recruiting||N/A|80|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:46:13.263992|2017-10-10 20:46:13.263992
NCT03260946|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|July 11, 2018|Anticipated|2018-07-11|July 11, 2018|Anticipated|2018-07-11||Observational|||The Use of Alternative Medicine by Palliative Care Patients|The Use of Complementary Medicine in Palliative/Supportive Care Centres in Lyon, France|Recruiting||N/A|300|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:46:13.36066|2017-10-10 20:46:13.36066
NCT03260933|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-22|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Integrated Care for Frail Older People|A Qualitative Study to Investigate Patients', Carers' and Providers' Perspectives on Integrated Care and Integrated Care Pathways for Frail Older People in Lambeth and Southwark, South London|Recruiting||N/A|45|Anticipated|King's College London|||1||f||||f|f|f||||||||2017-10-10 20:46:13.440552|2017-10-10 20:46:13.440552
NCT03260920|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-22|||September 1, 2017|Anticipated|2017-09-01|March 2017|2017-03-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|FOXY||Intranasal Oxytocin for Frontotemporal Dementia|A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia|Not yet recruiting||Phase 2|112|Anticipated|Lawson Health Research Institute||3|||f||||t|t|f||||||||2017-10-10 20:46:13.507738|2017-10-10 20:46:13.507738
NCT03260907|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||March 2, 2018|Anticipated|2018-03-02|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Efficacy and Safety of Electroacupuncture and Acupuncture in Postmenopausal Women With Overactive Bladder|Efficacy and Safety of Electroacupuncture and Acupuncture in Postmenopausal Women With Overactive Bladder ; A Multicenter, Randomized, Controlled, Parallel Clinical Trial|Not yet recruiting||N/A|98|Anticipated|DongGuk University||2|||f||||f|f|f||||||||2017-10-10 20:46:13.640192|2017-10-10 20:46:13.640192
NCT03260894|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-19|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 2023|Anticipated|2023-06-01|May 2023|Anticipated|2023-05-01||Interventional|||Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC|A Randomized, Open-Label, Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care (Sunitinib or Pazopanib) as First-Line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-679/ECHO-302)|Not yet recruiting||Phase 3|630|Anticipated|Incyte Corporation||2|||f||||t|t|f||||||||2017-10-10 20:46:13.824834|2017-10-10 20:46:13.824834
NCT03260881|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Liraglutide Effects on Epicardial Fat Inflammatory Genes|Effects of Liraglutide on Epicardial Fat Pro-Inflammatory Genes in Type 2 Diabetes and Coronary Artery Disease|Not yet recruiting||Phase 4|40|Anticipated|University of Miami||2|||f||||f|t|f|||f|||||2017-10-10 20:46:13.923034|2017-10-10 20:46:13.923034
NCT03260855|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|PResEnCE||Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship|Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship|Not yet recruiting||N/A|200|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||||2017-10-10 20:46:14.123983|2017-10-10 20:46:14.123983
NCT03260842|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2022|Anticipated|2022-04-30||Observational|||Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer|Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer|Not yet recruiting||N/A|500|Anticipated|Stanford University|||2||f||||f|f|f||||Samples With DNA|"     Blood and Pancreatic Cyst Fluid   "|||2017-10-10 20:46:14.232812|2017-10-10 20:46:14.232812
NCT03260829|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-08-25|||January 2014||2014-01-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|mesotherapy||Efficacy of Injectable Vitamin C on Accelerating Canine Movement: A Clinical Study|Evaluation of the Effect of Local Injected Vitamin C on Accelerating the Orthodontic Movement of Maxillary Canine Impaction: A Clinical Trial|Completed||N/A|12|Actual|Cairo University||2|||f||||f|f|f|||f|||||2017-10-10 20:46:14.311473|2017-10-10 20:46:14.311473
NCT03260816|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-23|||March 16, 2016|Actual|2016-03-16|August 2017|2017-08-01|March 16, 2021|Anticipated|2021-03-16|March 16, 2021|Anticipated|2021-03-16||Interventional|ACCESS||Advancing Child Competencies by Extending Supported Services (ACCESS) for Families Program|Advancing Child Competencies by Extending Supported Services (ACCESS) for Families Program|Recruiting||N/A|124|Anticipated|Florida International University||2|||f||||t|f|f||||||||2017-10-10 20:46:14.401592|2017-10-10 20:46:14.401592
NCT03260803|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-26|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|October 5, 2018|Anticipated|2018-10-05|August 15, 2018|Anticipated|2018-08-15||Interventional|||Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women|Valuating the Effects of Oligopin Supplementation on the Turnover of Bone Formation and Antioxidant Changes in Postmenopausal Osteopenic Women: A Randomized Double-blind Clinical Trial With Placebo-concurrent Controls|Enrolling by invitation||Phase 3|44|Actual|Tehran University of Medical Sciences||2|||f|||||f|f||||||||2017-10-10 20:46:14.551233|2017-10-10 20:46:14.551233
NCT03260777|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||November 18, 2017|Anticipated|2017-11-18|August 2017|2017-08-01|January 1, 2019|Anticipated|2019-01-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Relevance of Trichoscopy in Differential Diagnosis of Focal Non-cicatricial Alopecia in Children|Relevance of Trichoscopy in Differential Diagnosis of Focal Non-cicatricial Alopecia in Children|Not yet recruiting||N/A|100|Anticipated|Assiut University|||4||f||||f|f|f||||||||2017-10-10 20:46:14.725037|2017-10-10 20:46:14.725037
NCT03260764|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||August 20, 2017|Actual|2017-08-20|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Multifocal Contact Lenses vs Bifocal Spectacles for Congenital Cataracts|the Comparison of Multifocal Contact Lenses and Bifocal Spectacles for Congenital Cataracts|Active, not recruiting||N/A|80|Anticipated|Sun Yat-sen University||4|||f||||t|f|f||||||||2017-10-10 20:46:14.810115|2017-10-10 20:46:14.810115
NCT03260751|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Zingiber Officinale Roscoe Extract on Body Fat|A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Zingiber Officinale Roscoe Extract on Body Fat|Recruiting||Phase 2/Phase 3|120|Anticipated|Chonbuk National University Hospital||3|||f||||t|f|f||||||||2017-10-10 20:46:14.895525|2017-10-10 20:46:14.895525
NCT03260738|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-23|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|RCOOL||Robot Coach of Chronic Low Back Pain Patient|"Preliminary Feasibility Study of Rehabilitation by Robot Coach of Chronic Low Back Pain Patient"|Not yet recruiting||N/A|30|Anticipated|University Hospital, Brest||2|||f||||f|f|f||||||||2017-10-10 20:46:14.977014|2017-10-10 20:46:14.977014
NCT03260725|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||April 4, 2011|Actual|2011-04-04|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Evaluating the Feasibility of Internet-delivered PCIT|Evaluating the Feasibility of Internet-delivered Parent-Child Interaction Therapy|Completed||N/A|40|Actual|Florida International University||2|||f||||f|f|f||||||||2017-10-10 20:46:15.080555|2017-10-10 20:46:15.080555
NCT03260712|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-21|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Pembrolizumab in Biliary Tract Cancer|Open-label First Line, Single-arm Phase II Study of CisGem Combined With Pembrolizumab in Patients With Advanced or Metastatic Biliary Tract Cancer|Not yet recruiting||Phase 2|50|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||t|f|f|||t|||||2017-10-10 20:46:15.166304|2017-10-10 20:46:15.166304
NCT03260686|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||November 28, 2016|Actual|2016-11-28|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Video Guided Exercise After Stroke|The Effectiveness of Video Guided Exercise After Stroke|Completed||N/A|14|Actual|University of Leeds||2|||f||||||||||||||2017-10-10 20:46:15.325568|2017-10-10 20:46:15.325568
NCT03260673|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-21|||September 1, 2015|Actual|2015-09-01|August 2017|2017-08-01|July 30, 2016|Actual|2016-07-30|June 30, 2016|Actual|2016-06-30||Observational|||Corneal Endothelial Cell Changes After Phacoemulsification in Patients With Type 2 Diabetes Mellitus|白内障超声乳化术对2型糖尿病患者角膜内皮细胞的影响 Corneal Endothelial Cell Changes After Phacoemulsification in Patients With Type 2 Diabetes Mellitus|Completed||N/A|30|Actual|Beijing Tsinghua Chang Gung Hospital|||2||f||||t|f|f||||||||2017-10-10 20:46:15.394366|2017-10-10 20:46:15.394366
NCT03260660|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-28|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Observational|||Comparison of MR Elastography Methods Without and With Compressed Sensing|Comparison of MR Elastography Methods Without and With Compressed Sensing|Recruiting||N/A|20|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f|f|f|||f|||||2017-10-10 20:46:15.463239|2017-10-10 20:46:15.463239
NCT03260647|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-28|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2019|Anticipated|2019-08-01||Observational|MAMBO||Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction in Gynecological Cancers|Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction (MAMBO) Program for Women With Advanced Gynecological Cancers|Recruiting||N/A|150|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||Samples With DNA|"     Patients with MBO who undergo palliative procedures or surgical intervention will be offered     optional consent for tissue collection for research. Fresh-frozen and formalin-fixed     paraffin-embedded (FFPE) tumour tissue specimens, as well as ascites will be collected for     translational studies   "|||2017-10-10 20:46:15.540823|2017-10-10 20:46:15.540823
NCT03260634|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-21|||January 1, 2016|Actual|2016-01-01|January 2017|2017-01-01|January 1, 2018|Anticipated|2018-01-01|October 1, 2017|Anticipated|2017-10-01||Observational|||The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.|The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital.|Active, not recruiting||N/A|92|Anticipated|Chulalongkorn University|||1||f||||f|f|f|||f|||||2017-10-10 20:46:15.643315|2017-10-10 20:46:15.643315
NCT03260621|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-23|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|August 2018|Anticipated|2018-08-01||Interventional|HFpEF-Stress||CMR Exercise Stress Testing in HFpEF|Cardiovascular Magnetic Resonance Real-time Exercise Stress Testing in Heart Failure With Preserved Ejection Fraction|Recruiting||N/A|70|Anticipated|University of Göttingen||2|||f|||||f|f||||||||2017-10-10 20:46:15.723231|2017-10-10 20:46:15.723231
NCT03260608|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-23|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Effectiveness of a Psychoeducation and Support Protocol by Phone in the Aid of Caregivers of Patients With Dementia.|Randomized Clinical Assessment to Evaluate the Effectiveness of a Psychoeducation and Support Protocol by Telephone, in the Aid of Caregivers of Patients With Dementia in Specialized Ambulatory Accompanying|Not yet recruiting||N/A|148|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:46:15.801844|2017-10-10 20:46:15.801844
NCT03260595|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-25|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|November 25, 2017|Anticipated|2017-11-25|November 25, 2017|Anticipated|2017-11-25||Interventional|||A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis|A Phase 1, Single-center, Randomized, Vehicle-controlled, Parallel-cohort Study Of Crisaborole Ointment 2% To Evaluate The Skin Irritation Potential In Adult Japanese Healthy Subjects, And To Evaluate The Safety, Tolerability And Pharmacokinetics In Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis|Recruiting||Phase 1|32|Anticipated|Pfizer||2|||f||||f|f|f||||||||2017-10-10 20:46:15.88977|2017-10-10 20:46:15.88977
NCT03260582|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-23|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Implementation and Assessment of a Life-style Focused Patient Support Application in Myocardial Infarction Patients|Implementation and Assessment of a Life-style Focused Patient Support Application (App) and Activity Trackers for Improving Risk Factor Management, Physical Activity, Quality of Life and Prognosis in Post-myocardial Infarction Patients|Recruiting||N/A|250|Anticipated|Lund University||3|||f||||f|f|f||||||||2017-10-10 20:46:15.977793|2017-10-10 20:46:15.977793
NCT03260569|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Inhaled Nitric Oxide in Brain Injury|Respiratory Mechanics Following Brain Injury: The Role of Inhaled Nitric Oxide|Not yet recruiting||Phase 3|38|Anticipated|University of Cincinnati||2|||f||||f|t|f|||t|||||2017-10-10 20:46:16.091588|2017-10-10 20:46:16.091588
NCT03260556|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-27|||September 27, 2017|Actual|2017-09-27|September 2017|2017-09-01|March 30, 2020|Anticipated|2020-03-30|December 31, 2019|Anticipated|2019-12-31||Interventional|PirFS||Pirfenidone for Progressive Fibrotic Sarcoidosis|Pirfenidone for Progressive Fibrotic Sarcoidosis|Recruiting||Phase 4|60|Anticipated|University of Cincinnati||2|||f||||t|t|f|||t|||||2017-10-10 20:46:16.166152|2017-10-10 20:46:16.166152
NCT03260543|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-08-21|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy and Safety of Fermented Ginseng Powder on Liver Function|A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Fermented Ginseng Powder on Liver Function|Recruiting||N/A|90|Anticipated|Chonbuk National University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:46:16.250806|2017-10-10 20:46:16.250806
NCT03260530|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-18|||May 5, 2017|Actual|2017-05-05|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|May 2022|Anticipated|2022-05-01||Observational|PROTEOR||Overall Functional Evaluation After Amputation of the Lower Limb; Locomotion, Energy Efficiency and Strategies to Adapt to the Prosthesis|Overall Functional Evaluation After Amputation of the Lower Limb; Locomotion, Energy Efficiency and Strategies to Adapt to the Prosthesis|Recruiting||N/A|140|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:46:16.333003|2017-10-10 20:46:16.333003
NCT03260517|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-11|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|March 2018|Anticipated|2018-03-01||Interventional|PREVAIL||The PREVAIL Study|A Clinical PeRformance EVAluatIon of a New Medtronic Coronary Drug-Coated BaLloon Catheter for the Treatment of De Novo Lesions, In-Stent Restenosis and Small Vessel Disease in Coronary Arteries: The PREVAIL Study|Recruiting||N/A|50|Anticipated|Medtronic Vascular||1|||f||||t|f|f||||||||2017-10-10 20:46:16.388471|2017-10-10 20:46:16.388471
NCT03260504|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 17, 2022|Anticipated|2022-03-17|March 17, 2022|Anticipated|2022-03-17||Interventional|||Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer|A Phase I Trial of Interleukin-2 and Pembrolizumab (MK-3475) Combination Therapy for Patients With Advanced Renal Cell Carcinoma|Not yet recruiting||Phase 1|27|Anticipated|University of Washington||1|||f||||t|t|f||||||||2017-10-10 20:46:16.466844|2017-10-10 20:46:16.466844
NCT03260491|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Interventional|||U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer|A Multicenter, Open-Label Phase 1 Study of U3-1402 in Subjects With Metastatic or Unresectable EGFR-mutant Non-small Cell Lung Cancer|Not yet recruiting||Phase 1|63|Anticipated|Daiichi Sankyo, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:46:16.563377|2017-10-10 20:46:16.563377
NCT03260478|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-11|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 1, 2021|Anticipated|2021-12-01|June 1, 2021|Anticipated|2021-06-01||Interventional|HEMOTION||HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial|HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial|Recruiting||N/A|712|Anticipated|CHU de Quebec-Universite Laval||2|||f||||t|f|f||||||||2017-10-10 20:46:16.641415|2017-10-10 20:46:16.641415
NCT03260465|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup|A Randomized Controlled Trial With the seleXys PC Cup and RM Pressfit Vitamys Cup in Combination With the Optimys Short Stem|Not yet recruiting||N/A|60|Anticipated|Cantonal Hosptal, Baselland||2|||f||||f|f|f||||||||2017-10-10 20:46:16.800338|2017-10-10 20:46:16.800338
NCT03260452|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|WAT2DO||Comparison of Hematopoietic Stem Cell Activity in Adipose Tissue From Type 2 Diabetic Patients and Healthy Volunteers|Comparison of Hematopoietic Stem Cell Activity in Adipose Tissue From Type 2 Diabetic Patients and Healthy Volunteers: Proof of Concept Study. White Adipose Tissue and Type 2 Diabetes Onset: WAT2DO|Not yet recruiting||N/A|20|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||||2017-10-10 20:46:16.93881|2017-10-10 20:46:16.93881
NCT03260439|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-21|||June 2014|Actual|2014-06-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Tramadol in Penial Block Does it Improve Efficiency of Postoperative Analgesia in Circumcision|Doses Tramadol With Bupivacaine in Penial Block Improve Efficiency of Postoperative Analgésia in Children in Circumcision|Completed||N/A|106|Actual|University of Monastir||2|||f||||t||||||||||2017-10-10 20:46:17.059347|2017-10-10 20:46:17.059347
NCT03260426|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-30|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Trial of Low Residue Diet Versus Clear Liquids Following Elective Colorectal Surgery|Prospective Randomized Controlled Trial Investigating Commencement of Low Residue Diet Versus Clear Liquids on Postoperative Zero Following Elective Colorectal Surgery|Recruiting||N/A|100|Anticipated|Cedars-Sinai Medical Center||2|||f||||t|f|t|f||t|||||2017-10-10 20:46:17.152855|2017-10-10 20:46:17.152855
NCT03260413|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||February 12, 2018|Anticipated|2018-02-12|August 2017|2017-08-01|March 9, 2018|Anticipated|2018-03-09|March 9, 2018|Anticipated|2018-03-09||Observational|||Pneumonia Chart Review Cambodia|Quantifying the Burden of Hospitalizations for Pneumonia Among Children in Rural|Not yet recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||||||2017-10-10 20:46:17.261074|2017-10-10 20:46:17.261074
NCT03260400|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-21|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|||Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control Signals|Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control Signals|Recruiting||N/A|10|Anticipated|University of Michigan||2|||f||||f|f|t|f|||||||2017-10-10 20:46:17.330695|2017-10-10 20:46:17.330695
NCT03260387|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2020|Anticipated|2020-04-01||Observational|POST||A Prospective Observational Study of TPIAT|Advancing Treatment for Pancreatitis: A Prospective Observational Study of TPIAT (POST)|Recruiting||N/A|450|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||Samples With DNA|"     Optional (opt in) biorepository samples:        1. Blood (plasma, serum, buffy coat)        2. Urine        3. Saliva        4. Pancreas biopsy at time of surgery   "|||2017-10-10 20:46:17.414425|2017-10-10 20:46:17.414425
NCT03260374|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-22|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|August 31, 2019|Anticipated|2019-08-31||Observational|||Objective Measures in Cochlear Implant|Objective Measures in Cochlear Implant in Children and Its Correlation to Outcome|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f||||t|f|f|||f|||||2017-10-10 20:46:17.538332|2017-10-10 20:46:17.538332
NCT03260361|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|ProHKM-SDRC||Hypnosis and MEOPA|Hypnosis and MEOPA|Not yet recruiting||N/A|86|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||||2017-10-10 20:46:17.609368|2017-10-10 20:46:17.609368
NCT03260348|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 31, 2023|Anticipated|2023-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Acute Respiratory Distress Syndrome in Taiwan|Epidemiology and Long-term Outcomes of Patients With Acute Respiratory Distress Syndrome in Taiwan|Not yet recruiting||N/A|2000|Anticipated|Chang Gung Memorial Hospital|||1||f|||||f|f||||||||2017-10-10 20:46:17.711133|2017-10-10 20:46:17.711133
NCT03260335|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Biofeedback Intervention for the Prevention of Challenging Behaviour|A Biofeedback Intervention for the Prevention of Challenging Behaviour in People With Acquired Brain Injury|Not yet recruiting||N/A|6|Anticipated|University of Glasgow||1|||f||||f|f|f||||||||2017-10-10 20:46:17.772102|2017-10-10 20:46:17.772102
NCT03260322|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-28|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, in Subjects With Advanced Solid Tumors|A Phase 1 Study of ASP8374, an Immune Checkpoint Inhibitor, in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|200|Anticipated|Astellas Pharma Inc||1|||f||||f|t|f||||||||2017-10-10 20:46:17.852262|2017-10-10 20:46:17.852262
NCT03260309|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-08-25|||October 2013||2013-10-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||The Influence of Perioperative Optimisation to the Hip Arthroplasty Outcomes|The Influence of Perioperative Optimisation to the Primary Hip Arthroplasty Outcomes|Completed||N/A|100|Actual|Vilnius University||2|||f||||t||||||||||2017-10-10 20:46:17.948969|2017-10-10 20:46:17.948969
NCT03260296|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-23|||October 2018|Anticipated|2018-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|May 2019|Anticipated|2019-05-01||Observational|||Smartphones Addiction in Assiut University Students|Smartphones Addiction and Its Correlations Among Assiut University Students|Not yet recruiting||N/A|693|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:46:18.034016|2017-10-10 20:46:18.034016
NCT03260283|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-21|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations.|Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations.|Recruiting||Phase 2/Phase 3|104|Anticipated|Saint Savvas Anticancer Hospital||2|||f||||f|f|f||||||||2017-10-10 20:46:18.118665|2017-10-10 20:46:18.118665
NCT03260270|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01|1 Week|Observational [Patient Registry]|||Detection of Asymptomatic Venous Thrombosis in Gynecological Patients With Pelvic Masses|Detection of Asymptomatic Venous Thrombosis in Gynecological Patients With Pelvic Masses|Not yet recruiting||N/A|60|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:46:18.216865|2017-10-10 20:46:18.216865
NCT03260257|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Neurofeedback to Improve Working Memory in Schizophrenia|Enhancing Gamma Band Response in Schizophrenia to Improve Working|Not yet recruiting||N/A|30|Anticipated|University of California, San Diego||1|||f||||t|f|f||||||||2017-10-10 20:46:18.294055|2017-10-10 20:46:18.294055
NCT03260244|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-27|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Observational|||EnSite Precision Observational Study|A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment|Recruiting||N/A|1053|Anticipated|St. Jude Medical|||1||f||||f|f|||||||||2017-10-10 20:46:18.358274|2017-10-10 20:46:18.358274
NCT03260231|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-21|||May 12, 2017|Actual|2017-05-12|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|Lymphoseed||Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma|Effects of Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma|Recruiting||N/A|40|Anticipated|University of Belgrade||2|||f|||||f|f||||||||2017-10-10 20:46:18.442865|2017-10-10 20:46:18.442865
NCT03089658|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-08-08||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)|Temporary Authorization for Use (ATU) to Avelumab for Treatment of Adult Patients With Metastatic Merkel Cell Carcinoma (mMCC)|Available||N/A|||Merck KGaA|||||f||||||||||||||2017-10-10 21:14:31.257415|2017-10-10 21:14:31.257415
NCT03260218|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-29|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Protocol for Observational Study of Post op Delirium Following Total Joint Arthroplasties|Protocol for a Single-Centre Prospective Observational Study of Postoperative Delirium Following Total Joint Arthroplasties Among South East Asians|Recruiting||N/A|500|Anticipated|Singapore General Hospital|||1||f||||f|f|f||||||||2017-10-10 20:46:18.538294|2017-10-10 20:46:18.538294
NCT03260205|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-08|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|June 7, 2019|Anticipated|2019-06-07|June 7, 2019|Anticipated|2019-06-07||Interventional|||Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)|A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder|Recruiting||Phase 3|195|Anticipated|Shire||2|||f||||t|t|f||||||||2017-10-10 20:46:18.615673|2017-10-10 20:46:18.615673
NCT03260192|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-21|||September 1, 2013|Actual|2013-09-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer|Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer|Recruiting||N/A|50|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|||1||f||||t|f|f||||Samples With DNA|"     plasma separated within 2 hours, stored in -80 celsius refrigerator   "|||2017-10-10 20:46:18.713123|2017-10-10 20:46:18.713123
NCT03260179|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-21|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|January 31, 2019|Anticipated|2019-01-31||Interventional|||Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810|An Open-label Phase Ib, Study, to Determine Safety of Oral AL3810 in Patients With Locally Advanced or Metastatic Gastric, Hepatocellular or Nasopharyngeal Carcinoma|Not yet recruiting||Phase 1|60|Anticipated|ShangHai HaiHe Pharmaceutical||3|||f||||t|f|f||||||||2017-10-10 20:46:18.794795|2017-10-10 20:46:18.794795
NCT03260166|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-22|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus|An Open-label Study for Assessing the Efficacy and Safety of Nicotinamide Treatment for Lupus-associated Skin Lesions in Patients With Cutaneous Lupus Erythematosus or Systemic Lupus Erythematosus|Recruiting||Phase 2|40|Anticipated|Second Xiangya Hospital of Central South University||1|||f|||||f|f|||f|||||2017-10-10 20:46:18.910249|2017-10-10 20:46:18.910249
NCT03260153|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-28|||January 2017||2017-01-01|August 2017|2017-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Deproteinised Calf Blood Serum Injection for the Treatment of Acute Intracerebral Hemorrhage||Recruiting||N/A|60|Anticipated|Beijing Tiantan Hospital||2|||f||||f||||||||||2017-10-10 20:46:19.025759|2017-10-10 20:46:19.025759
NCT03260140|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-21|||April 1, 2018|Anticipated|2018-04-01|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|April 1, 2021|Anticipated|2021-04-01||Interventional|D-ELITE||DVD Lifestyle Intervention|DVD Lifestyle Intervention (D-ELITE)|Not yet recruiting||N/A|500|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 20:46:19.124857|2017-10-10 20:46:19.124857
NCT03260127|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-24|||January 3, 2018|Anticipated|2018-01-03|August 2017|2017-08-01|September 30, 2022|Anticipated|2022-09-30|February 1, 2022|Anticipated|2022-02-01||Interventional|||Enhancement of PTSD Treatment With Computerized Executive Function Training|Enhancement of PTSD Treatment With Computerized Executive Function Training|Not yet recruiting||N/A|110|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 20:46:19.212865|2017-10-10 20:46:19.212865
NCT03260114|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-23|2017-08-24|||August 24, 2017|Actual|2017-08-24|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Personal Activity Intelligence and Body Weight|Personal Activity Intelligence and Body Weight|Recruiting||N/A|30|Anticipated|Norwegian University of Science and Technology||3|||f||||t|f|f||||||||2017-10-10 20:46:19.30396|2017-10-10 20:46:19.30396
NCT03260101|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study|A Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study|Not yet recruiting||N/A|12|Anticipated|Cellect Biotechnology|||1||f||||f|f|f||||||||2017-10-10 20:46:19.392638|2017-10-10 20:46:19.392638
NCT03260088|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-23|||October 30, 2017|Anticipated|2017-10-30|August 2017|2017-08-01|January 30, 2020|Anticipated|2020-01-30|October 30, 2019|Anticipated|2019-10-30||Observational|||Evaluation Of Pleural Effusion At Assiut University Hospital|Evaluation Of Pleural Effusion At Assiut University Hospital|Not yet recruiting||N/A|1|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:46:19.458806|2017-10-10 20:46:19.458806
NCT03260075|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Effects of Ward Cats in Patients With Substance Abuse, Depression and Psychosis at UPK Basel|Effects of the Presence of Ward Cats on Patient Satisfaction and Ward Atmosphere for Patients With Substance Abuse, Depression and Psychosis at UPK Basel|Recruiting||N/A|150|Anticipated|Swiss Tropical & Public Health Institute|||2||f||||f|f|f||||||||2017-10-10 20:46:19.524848|2017-10-10 20:46:19.524848
NCT03260062|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||April 11, 2016|Actual|2016-04-11|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|PEARLS||PEARLS Intervention|Pilot Intervention to Improve Language in Deaf Children With Cochlear Implants|Recruiting||N/A|30|Anticipated|University of Miami||2|||f||||f|f|f||||||||2017-10-10 20:46:19.596597|2017-10-10 20:46:19.596597
NCT03260049|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||April 2012|Actual|2012-04-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients|The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients|Completed||N/A|30|Actual|Chongqing Medical University|||3||f||||f|f|f||||||||2017-10-10 20:46:19.69072|2017-10-10 20:46:19.69072
NCT03260036|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-23|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|August 21, 2021|Anticipated|2021-08-21|August 21, 2021|Anticipated|2021-08-21||Observational|||Hepatic Urea Nitrogen Handling in Patients With NASH|The Effect of Bariatric Surgery on Hepatic Urea Nitrogen Handling and Cognitive Functions in Patients With Severe Non-alcoholic Fatty Liver Disease|Recruiting||N/A|20|Anticipated|University of Aarhus|||1||f||||f|f|f||||Samples With DNA|"     Liver tissue Blood   "|||2017-10-10 20:46:19.755237|2017-10-10 20:46:19.755237
NCT03260023|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-20|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers and Expansion Cohort to Oropharyngeal SCCHN|A Phase Ib/II Trial Evaluating the Combination of TG4001 and Avelumab in Patients With HPV-16 Positive Recurrent or Metastatic Malignancies and Expansion Cohort to Oropharyngeal Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 1/Phase 2|52|Anticipated|Transgene||1|||f||||t|f|f||||||||2017-10-10 20:46:19.831731|2017-10-10 20:46:19.831731
NCT03260010|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-10-04|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|April 15, 2021|Anticipated|2021-04-15|April 15, 2020|Anticipated|2020-04-15||Interventional|PROOF||Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection|"Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection (PJI) Caused by Staphylococci, Streptococci, Enterococci and Gram-negative Bacilli, Including Mixed Infections and Culture Negative PJI's (PROOF-Study)"|Not yet recruiting||Phase 4|224|Anticipated|Pro-Implant Foundation||1|||f||||f|f|f||||||||2017-10-10 20:46:19.920571|2017-10-10 20:46:19.920571
NCT03259997|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of Probiotics on Physical Performance|Efficacy of Probiotics on Physical Performance|Recruiting||N/A|40|Anticipated|Probi AB||2|||f||||f|f|f||||||||2017-10-10 20:46:20.046275|2017-10-10 20:46:20.046275
NCT03259984|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Epigenetics of Muscle Insulin Resistance|Epigenetics and the Origin of Muscle Insulin Resistance in Humans Aims 1-3|Recruiting||N/A|72|Anticipated|University of Arizona|||3||f||||t|f|f||||Samples With DNA|"     DNA will be extracted from vastus lateralis skeletal muscle biopsies and blood samples   "|||2017-10-10 20:46:20.144888|2017-10-10 20:46:20.144888
NCT03259971|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-21|||August 25, 2017|Anticipated|2017-08-25|August 2017|2017-08-01|August 20, 2020|Anticipated|2020-08-20|August 20, 2019|Anticipated|2019-08-20||Interventional|||The Role of Probiotics PS128 in Movement Disorders|The Role of Probiotics PS128 in Movement Disorders|Not yet recruiting||N/A|500|Anticipated|National Taiwan University Hospital||4|||f||||f|f|f||||||||2017-10-10 20:46:20.25146|2017-10-10 20:46:20.25146
NCT03259958|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Oral Aricept®|A Study to Assess the Steady-State Bioequivalence of Once-Weekly Corplex™ Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept®|Recruiting||Phase 1|60|Anticipated|Corium International Inc.||2|||f||||f|t|f||||||||2017-10-10 20:46:20.350223|2017-10-10 20:46:20.350223
NCT03259945|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||February 16, 2017|Actual|2017-02-16|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Observational|ORVAS||Retrospective Observational Study of Patients With a Sutureless Aortic Valve Implanted in the Cardiovascular and Thoracic Surgery Department of Dijon CHU|Retrospective Observational Study of Patients With a Sutureless Aortic Valve Implanted in the Cardiovascular and Thoracic Surgery Department of Dijon CHU|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:46:20.443729|2017-10-10 20:46:20.443729
NCT03259932|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-23|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|March 2019|Anticipated|2019-03-01||Interventional|FRAM||Comparison of Fatigue and Recovery After Stroke Depending on the Usual Management With or Without Physical Training|Personalised Physical Training Associated With Usual Management Versus Usual Management Alone on Fatigue and Recovery After Minor Stroke: Randomised Controlled Trial|Not yet recruiting||N/A|160|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f|||||f|f||||||||2017-10-10 20:46:20.512351|2017-10-10 20:46:20.512351
NCT03259919|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-17|||October 2000|Actual|2000-10-01|September 2017|2017-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|pilPregMet||Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study|Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study|Completed||Phase 2|40|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 20:46:20.58614|2017-10-10 20:46:20.58614
NCT03259906|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|PAPPO||Comparison of Functional Recovery After Distal Intra-articular Radius Fracture With a Dorsal Tilt Treated With an Anterior Plate Versus a Posterior Plate|Comparison of Functional Recovery After Distal Intra-articular Radius Fracture With a Dorsal Tilt Treated With an Anterior Plate Versus a Posterior Plate|Recruiting||N/A|66|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f|||||f|f||||||||2017-10-10 20:46:20.68787|2017-10-10 20:46:20.68787
NCT03259893|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-23|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|October 1, 2018|Anticipated|2018-10-01||Interventional|||Secondary Prevention of Atrial Fibrilation|Boston Medical Center Secondary Prevention of Atrial Fibrillation Randomized Pilot Study|Not yet recruiting||N/A|50|Anticipated|Boston Medical Center||2|||f||||t|f|f|||t|||||2017-10-10 20:46:20.766435|2017-10-10 20:46:20.766435
NCT03259880|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-23|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Searching the Best Prognostic Factor in Out Come Evaluation in Patients With Acute Pancreatitis Admitted at Assiut University Hospitals|Searching the Best Best Prognostic Factor in Out Come Evaluation in Patients With Acute Pancreatitis Admitted at Assiut University Hospitals|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:46:20.984692|2017-10-10 20:46:20.984692
NCT03259867|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-22|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|March 30, 2019|Anticipated|2019-03-30||Interventional|TATE-PD1||Combination of TATE and PD-1 Inhibitor in Liver Cancer|Phase IIA Single-Arm Study of Treatment of Patients With Advanced Liver Cancer With a Combination of TATE (Transarterial Tirapazamine Embolization) Followed by an Anti-PD-1 Monoclonal Antibody|Recruiting||Phase 2|40|Anticipated|Teclison Ltd.||2|||f||||f|t|f||||||||2017-10-10 20:46:21.06168|2017-10-10 20:46:21.06168
NCT03259854|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-21|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Non Invasive Mechanical Ventilation VERSUS Oxygen MASK|Non Invasive Mechanical Ventilation VERSUS Oxygen MASK After Successful Weaning From Invasive Mechanical Ventilation in Pediatrics|Not yet recruiting||N/A|104|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:46:21.185749|2017-10-10 20:46:21.185749
NCT03259841|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-22|||September 14, 2017|Anticipated|2017-09-14|August 2017|2017-08-01|October 14, 2019|Anticipated|2019-10-14|September 14, 2018|Anticipated|2018-09-14||Observational|||Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy|Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy|Not yet recruiting||N/A|240|Anticipated|SMG-SNU Boramae Medical Center|||1||f||||t|f|f||||||||2017-10-10 20:46:21.282732|2017-10-10 20:46:21.282732
NCT03259828|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Sigmoid Colon Organ Motion in Radiotherapy|Interfraction and Intrafraction Organ Motion of the Sigmoid Colon in Patients With Colorectal Cancer Undergoing Adjuvant Radiotherapy|Recruiting||N/A|30|Anticipated|National Cheng-Kung University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:46:21.388934|2017-10-10 20:46:21.388934
NCT03259815|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-22|||September 4, 2017|Anticipated|2017-09-04|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|March 31, 2019|Anticipated|2019-03-31||Interventional|Target-FFR||How Often Can Optimal Post Percutaneous Coronary Intervention (PCI) Fractional Flow Reserve (FFR) Results be Achieved?|How Often Can Optimal Post Percutaneous Coronary Intervention (PCI) Fractional Flow Reserve (FFR) Results be Achieved? A Randomised Controlled Trial of FFR Targeted PCI (the Target FFR Study)|Not yet recruiting||N/A|260|Anticipated|NHS National Waiting Times Centre Board||2|||f||||f|f|f||||||||2017-10-10 20:46:21.499922|2017-10-10 20:46:21.499922
NCT03259789|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-18|||October 16, 2017|Anticipated|2017-10-16|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Bexagliflozin in Subjects With Type 2 Diabetes Mellitus Who Are Not Adequately Controlled by Metformin Alone|Not yet recruiting||Phase 3|350|Anticipated|Theracos||2|||f||||t|t|f||||||||2017-10-10 20:46:21.62144|2017-10-10 20:46:21.62144
NCT03259776|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|VISIT_ICU||Experiences of Visitors to a Regional Major Trauma Intensive Care Unit|Experiences of Visitors to a Regional Major Trauma Intensive Care Unit|Not yet recruiting||N/A|110|Anticipated|Kingston University|||1||f||||f|f|f||||||||2017-10-10 20:46:21.727124|2017-10-10 20:46:21.727124
NCT03259763|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||EUS-GE vs ES for Palliation of GOO|EUS-guided Gastroenterostomy Versus Enteral Stenting for Palliation of Malignant Gastric Outlet Obstruction: A Randomized Clinical Trial|Not yet recruiting||N/A|96|Anticipated|Johns Hopkins University||2|||f||||t|f|t|f||t|||||2017-10-10 20:46:21.819023|2017-10-10 20:46:21.819023
NCT03259750|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-21|||August 20, 2009|Actual|2009-08-20|August 2017|2017-08-01|July 12, 2015|Actual|2015-07-12|May 20, 2014|Actual|2014-05-20||Observational|||The Foot and Ankle Ability Measure (FAAM) is Translated From English to Turkish and Assess the Validity and Reliability in Athletic Population Who Have Foot and Ankle Disorders.|Validity and Reliability of the Foot and Ankle Ability Measure Turkish Version for Athletes|Completed||N/A|51|Actual|Hasan Kalyoncu University|||1||f||||f|f|f|||f|||||2017-10-10 20:46:21.948736|2017-10-10 20:46:21.948736
NCT03259737|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-31|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|September 1, 2018|Anticipated|2018-09-01||Observational|SPET-72||An Observational Study of Stroke Patients.|An Observational Study of Stroke Patients With Focus on Examinations and Therapeutic Improvement the First 72 Hours.|Not yet recruiting||N/A|120|Anticipated|Sykehuset Innlandet HF|||1||f||||f|f|f||||||||2017-10-10 20:46:22.042453|2017-10-10 20:46:22.042453
NCT03259724|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||January 30, 2017|Actual|2017-01-30|August 2017|2017-08-01|August 30, 2017|Anticipated|2017-08-30|June 30, 2017|Actual|2017-06-30||Observational|NVFS&GC||The Effect of NVFS on GC in Individuals With DM: SR & MA of RCTs|The Effect of Non-Viscous Fibre Supplementation on Glycemic Control in Individuals With Diabetes Mellitus: A Systematic Review & Meta-analysis of RCTs|Active, not recruiting||N/A|514|Anticipated|St. Michael's Hospital, Toronto|||1||f|||||f|f||||||||2017-10-10 20:46:22.142179|2017-10-10 20:46:22.142179
NCT03259711|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-21|||January 2001|Actual|2001-01-01|August 2017|2017-08-01|August 14, 2017|Actual|2017-08-14|August 14, 2017|Actual|2017-08-14||Observational|SERENA||Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase|Cardiotoxicity of Selective Estrogen Receptor Modulators and Aromatase Inhibitors in the European Pharmacovigilance Database|Completed||N/A|20000|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f|||||f|f||||||||2017-10-10 20:46:22.217601|2017-10-10 20:46:22.217601
NCT03259698|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Optimizing the Delivery of HIV nPEP|Optimizing the Delivery of HIV Post-exposure Prophylaxis: A Randomized Controlled Trial of Text Messaging Support and Physician to Nurse Task-shifting|Not yet recruiting||Phase 2|358|Anticipated|St. Michael's Hospital, Toronto||4|||f||||t|f|f||||||||2017-10-10 20:46:22.310646|2017-10-10 20:46:22.310646
NCT03259685|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of Non-nutritive Sweeteners of High Sugar Sweetened Beverages on Metabolic Health and Gut Microbiome|Effect of Free Sugar Replacement With Non-nutritive Sweeteners on Metabolic Health of High Sugar Sweetened Beverages Consumers: Potential Role of the Gut Microbiome|Not yet recruiting||N/A|66|Anticipated|Laval University||3|||f||||f|f|f||||||||2017-10-10 20:46:22.455448|2017-10-10 20:46:22.455448
NCT03259672|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 1, 2018|Anticipated|2018-11-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Influence of Sevoflurane and Desflurane on Postoperative Sore Throat|Influence of Sevoflurane and Desflurane on Postoperative Sore Throat|Not yet recruiting||N/A|100|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:46:22.536834|2017-10-10 20:46:22.536834
NCT03259659|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-21|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31|1 Day|Observational [Patient Registry]|||Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis|Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis|Not yet recruiting||N/A|30|Anticipated|Johns Hopkins University|||2||f|||||f|f||||Samples With DNA|"     blood sample for inflammatory cytokines, fecal sample for microbiota   "|||2017-10-10 20:46:22.623849|2017-10-10 20:46:22.623849
NCT03259646|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||May 26, 2017|Actual|2017-05-26|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women|The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women|Enrolling by invitation||N/A|6000|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||||2017-10-10 20:46:22.753859|2017-10-10 20:46:22.753859
NCT03259633|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21||||||August 2017|2017-08-01||||||||Expanded Access|||An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1|An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1 With Inoperable, Progressive/Symptomatic Plexiform Neurofibromas (PN)|Available||N/A|||AstraZeneca|||||f||t||||||||||||2017-10-10 20:46:22.848384|2017-10-10 20:46:22.848384
NCT03259620|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-20|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts|A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts|Recruiting||Phase 3|480|Anticipated|Cutanea Life Sciences, Inc.||2|||f|||||t|f||||||||2017-10-10 20:46:22.928579|2017-10-10 20:46:22.928579
NCT03259607|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-23|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers|A Single Dose, Randomized, Four Period, Fasting, Crossover Study to Assess Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Mint Gum 2 and 4 mg - in Adult Healthy Male and Female Smokers|Recruiting||Phase 1|76|Anticipated|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||f|f|f||||||||2017-10-10 20:46:23.014262|2017-10-10 20:46:23.014262
NCT03259594|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-22|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Measurement of Renal Functional Reserve Change In Patients With SRC Before and After Laparoscopic Deroofing|Measurement of Renal Functional Reserve Change In Patients With Simple Renal Cysts Before and After Laparoscopic Deroofing|Not yet recruiting||N/A|200|Anticipated|Xuanwu Hospital, Beijing||2|||f||||f|f|f||||||||2017-10-10 20:46:23.135082|2017-10-10 20:46:23.135082
NCT03259581|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin|Safety of Transarterial Chemoembolization in Patients With Elevated Bilirubin|Not yet recruiting||Phase 1|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f|||||f|f|||f|||||2017-10-10 20:46:23.216499|2017-10-10 20:46:23.216499
NCT03259568|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-11|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|||Effects of rTMS on Human Brain Activity Measured With EEG and fMRI|Effects of rTMS on Human Brain Activity Measured With EEG and fMRI|Not yet recruiting||N/A|264|Anticipated|Duke University||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:46:23.283823|2017-10-10 20:46:23.283823
NCT03259555|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-22|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder|A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder|Not yet recruiting||Phase 3|320|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f|||||t|f||||||||2017-10-10 20:46:23.36861|2017-10-10 20:46:23.36861
NCT03259542|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-15|||August 9, 2017|Actual|2017-08-09|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 12, 2017|Anticipated|2017-10-12||Interventional|||Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor|A Phase 1, Open-Label, Drug-Drug Interaction Study in Healthy Subjects to Determine the Effects of a Strong Inhibitor (Itraconazole) of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites|Recruiting||Phase 1|32|Anticipated|Corcept Therapeutics||1|||f||||f|t|f||||||||2017-10-10 20:46:23.466733|2017-10-10 20:46:23.466733
NCT03259529|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||March 27, 2017|Actual|2017-03-27|July 2017|2017-07-01|April 27, 2020|Anticipated|2020-04-27|April 27, 2019|Anticipated|2019-04-27||Interventional|BeGeRN||Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL|A Phase I/II Clinical Trial to Evaluate the Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab Combination (BeGeRN) in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma|Recruiting||Phase 1/Phase 2|30|Anticipated|St. Petersburg State Pavlov Medical University||3|||f|||||f|f||||||||2017-10-10 20:46:23.544794|2017-10-10 20:46:23.544794
NCT03259516|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||May 25, 2017|Actual|2017-05-25|August 2017|2017-08-01|December 25, 2021|Anticipated|2021-12-25|May 25, 2020|Anticipated|2020-05-25||Interventional|||Nivolumab With Chemotherapy in Refractory MDS|Pilot Open-label Trial of Nivolumab Combined With Chemotherapy in Refractory Myelodysplastic Syndromes.|Recruiting||Phase 1/Phase 2|50|Anticipated|St. Petersburg State Pavlov Medical University||5|||f||||f|f|f||||||||2017-10-10 20:46:23.664683|2017-10-10 20:46:23.664683
NCT03259503|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-08-22|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Olaparib Combined With High-Dose Chemotherapy for Refractory Lymphomas|Olaparib Combined With High-Dose Chemotherapy for Refractory Lymphomas|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:46:23.792541|2017-10-10 20:46:23.792541
NCT03259490|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-28|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|November 3, 2017|Anticipated|2017-11-03|November 3, 2017|Anticipated|2017-11-03||Interventional|||This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood|Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin/Metformin Extended Release Compared to the Free Combination of Empagliflozin, Linagliptin, and Metformin Extended Release Tablets Following Oral Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Study)|Active, not recruiting||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 20:46:23.945822|2017-10-10 20:46:23.945822
NCT03259477|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCC|Renal Functional Reserve Change of Precise Segmental Versus Complete Renal Arterial Clamping During Laparoscopic Partial Nephrectomy for Clinical T1 Renal Cell Carcinoma|Not yet recruiting||N/A|100|Anticipated|Xuanwu Hospital, Beijing||2|||f||||f|f|f||||||||2017-10-10 20:46:24.018953|2017-10-10 20:46:24.018953
NCT03259464|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-10-02|||September 4, 2017|Actual|2017-09-04|October 2017|2017-10-01|March 31, 2018|Anticipated|2018-03-31|March 1, 2018|Anticipated|2018-03-01||Interventional|||This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 685509 in Healthy Chinese and Japanese Male Volunteers (Randomised, Single-blind, Placebo-controlled Trial)|Recruiting||Phase 1|72|Anticipated|Boehringer Ingelheim||2|||f|||||f|f||||||||2017-10-10 20:46:24.130831|2017-10-10 20:46:24.130831
NCT03259451|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||September 26, 2016|Actual|2016-09-26|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|rTMS-CIC||Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Neuropathic Pain|Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Neuropathic Pain: Retrospective Study on a Cohort of 149 Patients at Rennes University Hospital, From January 2014 to December 2015|Recruiting||N/A|149|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:46:24.219978|2017-10-10 20:46:24.219978
NCT03259438|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-21|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|January 30, 2018|Anticipated|2018-01-30|December 20, 2017|Anticipated|2017-12-20||Interventional|||The Vitality Project for Fatigued Female Cancer Survivors|Testing the Effects of Movement Based Interventions on Brain-Body Mechanisms in Fatigued Cancer Survivors|Recruiting||N/A|75|Anticipated|The Miriam Hospital||2|||f||||f|f|f||||||||2017-10-10 20:46:24.289898|2017-10-10 20:46:24.289898
NCT03259425|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma|Phase II Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma (Neo-NivoHF10)|Not yet recruiting||Phase 2|20|Anticipated|University of Utah||1|||f||||t|t|f||||||||2017-10-10 20:46:24.397645|2017-10-10 20:46:24.397645
NCT03259412|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-22|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20||Interventional|FAT||Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance|Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance, Inflammation, Gene Expression and Epigenetic Signatures|Recruiting||N/A|20|Anticipated|Loughborough University||2|||f||||f|f|f||||||||2017-10-10 20:46:24.507914|2017-10-10 20:46:24.507914
NCT03259399|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Pharmacogenomics Study of Enalapril-Induced Adverse Drug Reaction|A Pharmacogenomics Study of Enalapril-Induced Adverse Drug Reaction|Recruiting||N/A|2200|Anticipated|Peking University First Hospital|||2||f|||||f|f||||||||2017-10-10 20:46:24.583748|2017-10-10 20:46:24.583748
NCT03259373|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-22|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|IMPACT-AFib||IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation|IMplementation of a Randomized Controlled Trial to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation|Not yet recruiting||N/A|40000|Anticipated|Harvard Pilgrim Health Care||2|||f||||f|f|f||||||||2017-10-10 20:46:24.734996|2017-10-10 20:46:24.734996
NCT03259360|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Facebook Intervention for Young Sexual and Gender Minority Smokers|A Facebook Intervention for Young Sexual and Gender Minority Smokers|Not yet recruiting||N/A|120|Anticipated|University of California, San Francisco||2|||f|||||f|f||||||||2017-10-10 20:46:24.843024|2017-10-10 20:46:24.843024
NCT03259347|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-22|||June 1, 2012|Actual|2012-06-01|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Eating Disorders Programs: An Indicated Trial|Eating Disorders Programs: An Indicated Trial|Active, not recruiting||N/A|534|Anticipated|Oregon Research Institute||2|||f|||||f|f||||||||2017-10-10 20:46:26.717835|2017-10-10 20:46:26.717835
NCT03259334|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-10-04|||November 30, 2017|Anticipated|2017-11-30|October 2017|2017-10-01|November 29, 2020|Anticipated|2020-11-29|November 29, 2020|Anticipated|2020-11-29||Interventional|||A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)|A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel Group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)|Not yet recruiting||Phase 3|825|Anticipated|Shire||3|||f||||t|t|f||||||||2017-10-10 20:46:26.807692|2017-10-10 20:46:26.807692
NCT03259321|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||January 1, 1989|Actual|1989-01-01|July 2017|2017-07-01|December 31, 2012|Actual|2012-12-31|December 31, 2011|Actual|2011-12-31||Observational|||Fish, Polyunsaturated Fatty Acids Intake and Type 2 Diabetes|Fish, Polyunsaturated Fatty Acids Intake and Type 2 Diabetes in CHNS|Completed||N/A|15100|Actual|Zhejiang University|||1||f|||||f|f||||||||2017-10-10 20:46:27.068743|2017-10-10 20:46:27.068743
NCT03259126|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-22|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|EXTRA-RAD||EXTended pRotective Curtain Under Table to Reduce Operator RAdiation Dose in Percutaneous Coronary Procedures|Evaluation of a New Device Placed Under the Angiographic Table to Reduce Operator Radiation Exposure During Percutaneous Coronary Procedures Through Transradial Approach|Recruiting||N/A|138|Anticipated|Ospedale Sandro Pertini, Roma||2|||f||||f|f|f||||||||2017-10-10 20:46:29.083947|2017-10-10 20:46:29.083947
NCT03259308|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-10-04|||November 30, 2017|Anticipated|2017-11-30|October 2017|2017-10-01|November 29, 2020|Anticipated|2020-11-29|November 29, 2020|Anticipated|2020-11-29||Interventional|||A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)|A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel Group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)|Not yet recruiting||Phase 3|825|Anticipated|Shire||3|||f||||t|t|f||||||||2017-10-10 20:46:27.140412|2017-10-10 20:46:27.140412
NCT03259295|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study to Evaluate the Efficacy of Removing Skin Tags With Digiclamp|Research on Current Prototypes of the Digiclamp. Short Term and Long Term Outcomes of Treating Adults With Achrocordons (Skin Tags)|Recruiting||N/A|100|Anticipated|University of Florida||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:46:27.596779|2017-10-10 20:46:27.596779
NCT03259282|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||September 2, 2016|Actual|2016-09-02|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|GAMES||Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis|Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis|Recruiting||N/A|100|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:46:27.714332|2017-10-10 20:46:27.714332
NCT03259269|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||February 9, 2016|Actual|2016-02-09|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Observational|||Expand New Drugs for TB [endTB]|endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB With Regimens Containing Bedaquiline or Delamanid|Recruiting||N/A|2600|Anticipated|Partners in Health|||2||f|||||f|f||||||||2017-10-10 20:46:27.792212|2017-10-10 20:46:27.792212
NCT03259256|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-09-24|||April 23, 2017|Actual|2017-04-23|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|August 31, 2018|Anticipated|2018-08-31||Interventional|||Islet Allotransplantation for Type 1 Diabetic Patients|Islet Allotransplantation for Type 1 Diabetic Patients|Recruiting||Phase 3|5|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||1|||f|||||f|f||||||||2017-10-10 20:46:27.978034|2017-10-10 20:46:27.978034
NCT03259243|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-19|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|October 30, 2017|Anticipated|2017-10-30||Interventional|||Comparison of Efficacy of Bupivacaine for Relief Postoperative Pain in Women Undergoing Laparoscopic Gynecologic Surgery|Port Site Infiltration With Bupivacaine for Reduction of Postoperative Pain in Woman Undergoing Gynecologic Laparoscopy: A Randomized, Factorial, Double-Blind, Controlled Trial|Recruiting||Phase 4|100|Anticipated|Rajavithi Hospital||4|||f||||t|f|f||||||||2017-10-10 20:46:28.06971|2017-10-10 20:46:28.06971
NCT03259230|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-22|||October 13, 2016|Actual|2016-10-13|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|||Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH)|An Observational, Multicenter Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH)|Recruiting||N/A|50|Anticipated|NovImmune SA|||2||f||||f|f|f|||||"     Approximate volume of 500 µl - 1 ml of serum or plasma required per time point. Minimum of 1     ml of whole blood collected for genetic characterization.   "|||2017-10-10 20:46:28.186011|2017-10-10 20:46:28.186011
NCT03259217|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers|Prospects of Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers|Not yet recruiting||Phase 1|40|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:46:28.299925|2017-10-10 20:46:28.299925
NCT03259204|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-23|||March 1, 2018|Anticipated|2018-03-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|StopLegClots||Swedish Multicenter Trial of Outpatient Prevention of Leg Clots|Prevention of Thromboembolism and Failed Healing During Lower Limb Immobilization - Multicenter Study With Adjuvant Intermittent Pneumatic Compression Therapy|Not yet recruiting||N/A|1300|Anticipated|Karolinska University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:46:28.392921|2017-10-10 20:46:28.392921
NCT03259191|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-20|||August 20, 2017|Actual|2017-08-20|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|November 20, 2017|Anticipated|2017-11-20||Interventional|||Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD)|Department of Gastroenterology, Zhongda Hospital|Recruiting||N/A|20|Anticipated|Zhongda Hospital||2|||f|||||f|f||||||||2017-10-10 20:46:28.509278|2017-10-10 20:46:28.509278
NCT03259178|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-22|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|March 1, 2018|Anticipated|2018-03-01||Observational|||Correlation Between Changes in Measures of the Visual System and Changes in Concussion-associated Symptoms|Correlation Between Changes in Measures of the Visual System and Changes in Concussion-associated Symptoms|Recruiting||N/A|46|Anticipated|McGill University|||1||f|||||f|f||||||||2017-10-10 20:46:28.589373|2017-10-10 20:46:28.589373
NCT03259165|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|N-FURIOUS||Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial|Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial (N-FURIOUS)|Not yet recruiting||Phase 2|70|Anticipated|Indiana University||2|||f||||f|t|f|||f|||||2017-10-10 20:46:28.683831|2017-10-10 20:46:28.683831
NCT03259152|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-23|||May 1, 2016|Actual|2016-05-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|D-Gct||Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone|Clinical, Pathologic Characteristics and Its Mechansim of Denosumab Treated Giant Cell Tumor of Bone|Recruiting||Phase 3|30|Anticipated|Hebei Medical University Third Hospital||2|||f||||t||f|||f|||||2017-10-10 20:46:28.803488|2017-10-10 20:46:28.803488
NCT03259139|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-08-22|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Media Violence and Gun Violence - Experiment 3 Follow Up|Exposure to Gun Violence in Video Games Increases Interest in Real Guns|Recruiting||N/A|384|Anticipated|Ohio State University||3|||f||||f|f|f||||||||2017-10-10 20:46:28.901435|2017-10-10 20:46:28.901435
NCT03259113|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-24|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|April 16, 2019|Anticipated|2019-04-16|February 16, 2019|Anticipated|2019-02-16||Interventional|ElucidateHcm||Insertable Cardiac Monitors in Hypertrophic Cardiomyopathy|EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic CardioMyopathy|Recruiting||N/A|30|Anticipated|Region Gävleborg||1|||f||||f|f|f||||||||2017-10-10 20:46:29.187488|2017-10-10 20:46:29.187488
NCT03259100|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-22|||January 1, 2011|Actual|2011-01-01|August 2017|2017-08-01|February 1, 2013|Actual|2013-02-01|January 1, 2012|Actual|2012-01-01||Observational|||Temperature and Mortality|Impact of Increasing Temperature Over the Coming Century on Mortality From CVD and Stroke|Completed||N/A|17000000|Actual|Chinese Academy of Sciences|||1||f|||||f|f||||||||2017-10-10 20:46:29.290561|2017-10-10 20:46:29.290561
NCT03259087|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-14|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 5, 2018|Anticipated|2018-03-05|February 23, 2018|Anticipated|2018-02-23||Interventional|||Pharmacokinetics (PK) and Safety of A Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)|A 2-Part, Open-Label Trial to Evaluate the Pharmacokinetics of MK-3866 Following the Administration of a Single IV Dose to Subjects With Mild, Moderate, and Severe Renal Impairment and End Stage Renal Disease|Recruiting||Phase 1|56|Anticipated|Merck Sharp & Dohme Corp.||5|||f||||f|t|f||||||||2017-10-10 20:46:29.374509|2017-10-10 20:46:29.374509
NCT03259074|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||November 8, 2017|Anticipated|2017-11-08|August 2017|2017-08-01|November 11, 2021|Anticipated|2021-11-11|October 28, 2021|Anticipated|2021-10-28||Interventional|SURPASS||Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)|A Randomized, Partially-blinded Study of Secukinumab to Demonstrate Reduction of Radiographic Progression Versus GP2017 (Adalimumab Biosimilar) at 104 Weeks and to Assess the Long Term Safety, Tolerability and Efficacy up to 2 Years in Patients With Active Ankylosing Spondylitis|Not yet recruiting||Phase 3|837|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 20:46:29.52008|2017-10-10 20:46:29.52008
NCT03259061|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-19|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Observational|||A Study of Border Line Cases of Velopharyngeal Incompetence Using Cephalometry and Nasofibroscopy|A Study of Border Line Cases of Velopharyngeal Incompetence and Insufficiency Using Cephalometry and Nasofibroscopy|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:46:29.635136|2017-10-10 20:46:29.635136
NCT03259048|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-19|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Observational|||Role of Ultrasound in Diagnosis of Acute Abdomen in Pediatric Group|Role of Ultrasound in Diagnosis of Acute Abdomen in Pediatric Group|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:46:29.714921|2017-10-10 20:46:29.714921
NCT03259035|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-29|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Chemotherapy, Excision and Observation for Early Rectal Cancer|Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer|Not yet recruiting||Phase 2|58|Anticipated|Canadian Cancer Trials Group||1|||f||||t|f|f||||||||2017-10-10 20:46:29.799682|2017-10-10 20:46:29.799682
NCT03259022|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-08-21|||November 2016||2016-11-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|||Bronchial Infection in Patients With COPD and Frequent Exacerbations.|Bronchial Infection in Patients With COPD and Frequent Exacerbations; Role of Innate Immunity and the Use of an Electronic Nose for Diagnosis.|Recruiting||N/A|50|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||Samples With DNA|"     Quantitative sputum culture, oral lavage, peripheral blood and exhaled air intake will be     conducted.   "|||2017-10-10 20:46:29.89274|2017-10-10 20:46:29.89274
NCT03259009|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 1, 2020|Anticipated|2020-06-01|January 1, 2020|Anticipated|2020-01-01|6 Months|Observational [Patient Registry]|RASINTRO||RAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO)|Predictive Impact of RAS Mutations in Circulating Tumor DNA for Efficacy of Anti-EGFR Reintroduction Treatment in Patients With Metastatic Colorectal Cancer|Not yet recruiting||N/A|73|Anticipated|Association des Gastroentérologues Oncologues|||1||f||||f|f|f||||Samples With DNA|"     Circulating tumor DNA      During the inclusion period, a blood sample will be taken just before the first 3 cycles of     chemotherapy (C1, C2 and C3) and at tumor progression for mCRC patients treated in one of the     participating AGEO centers. These samples will not require any additional invasive procedures     since they will be made from the Huber needle previously implanted in the catheter for     previously scheduled chemotherapy cycles.      The patient will sign an information letter and a specific informed consent for blood     collection and biological studies. In case of specific refusal, the patient will not be     included.   "|||2017-10-10 20:46:29.992735|2017-10-10 20:46:29.992735
NCT03258983|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-08-19|||November 24, 1993|Actual|1993-11-24|August 2017|2017-08-01|July 10, 2013|Actual|2013-07-10|July 10, 2013|Actual|2013-07-10||Observational|||Alpha-linolenic Acid and the Risk of ASCVD|Alpha-linolenic Acid and the Risk of Atherosclerotic Cardiovascular Disease|Completed||N/A|57053|Actual|Aalborg Universitetshospital|||1||f||||f|f|f||||Samples With DNA|"     Subcutaneous adipose tissue, serum, plasma, ''buffycoat'', erytrocytes and urine is stored in     nitrogen vapour at the biobank of the Diet, Cancer and Health cohort study. Also, whole blood     in filter paper and toenail clippings has been stored within the biobank.   "|||2017-10-10 20:46:30.832876|2017-10-10 20:46:30.832876
NCT03258970|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-21|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|August 10, 2017|Actual|2017-08-10|August 10, 2017|Actual|2017-08-10||Observational|CoLaus||No Association Between Vitamin C and E Supplementation, Frailty, and Grip Strength Over Five Years: The CoLaus Study|No Association Between Vitamin C and E Supplementation, Frailty, and Grip Strength Over Five Years: The CoLaus Study|Completed||N/A|2711|Actual|Centre Hospitalier Universitaire Vaudois|||1||f||||f|f|f||||Samples With DNA|"     Urine, blood and DNA samples available, but not used in this study   "|||2017-10-10 20:46:30.928521|2017-10-10 20:46:30.928521
NCT03258957|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-08-18|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Pilot Study of the Feasibility of Feeding Preterm Infants With Fresh Versus Frozen Mother's Own Breast Milk in the NICU|Pilot Study of the Feasibility of Feeding Preterm Infants With Fresh Versus Frozen Mother's Own Breast Milk in the NICU|Recruiting||N/A|100|Anticipated|Zhengzhou Children's Hospital, China||1|||f|||||f|f||||||||2017-10-10 20:46:31.029331|2017-10-10 20:46:31.029331
NCT03258944|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-21|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Ventilatory Muscle Training by Breath-Stacking in Healthy Youngsters|Breath-Stacking and Ventilatory Muscle Strength|Not yet recruiting||N/A|34|Anticipated|Federal University of Health Science of Porto Alegre||1|||f||||f|f|f||||||||2017-10-10 20:46:31.149728|2017-10-10 20:46:31.149728
NCT03258931|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2024|Anticipated|2024-11-01|November 2022|Anticipated|2022-11-01||Interventional|||Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML|Phase III Randomized Study of Crenolanib Versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects With FLT3 Mutated Acute Myeloid Leukemia|Not yet recruiting||Phase 3|510|Anticipated|Arog Pharmaceuticals, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:46:31.217291|2017-10-10 20:46:31.217291
NCT03258918|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-28|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||A Low-Carbohydrate Diabetes Prevention Program|A Mixed Methods Pilot Study of a Low-Carbohydrate Diabetes Prevention Program Among Individuals With Prediabetes|Recruiting||N/A|22|Anticipated|University of Michigan||1|||f||||f|f|f||||||||2017-10-10 20:46:31.301019|2017-10-10 20:46:31.301019
NCT03258905|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-22|||May 30, 2018|Anticipated|2018-05-30|August 2017|2017-08-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|||Phone App for Grounding|Phone App for Grounding (De-escalation) of Substance-abusing Transition-age Youth|Not yet recruiting||Phase 2|68|Anticipated|Treatment Innovations||2|||f||||f|f|f||||||||2017-10-10 20:46:31.398807|2017-10-10 20:46:31.398807
NCT03258892|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-22|||May 16, 2017|Actual|2017-05-16|August 2017|2017-08-01|May 16, 2020|Anticipated|2020-05-16|May 16, 2020|Anticipated|2020-05-16||Interventional|||Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy|Sarcoma Treatment Guide Pilot Study|Recruiting||N/A|50|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t|f|f||||||||2017-10-10 20:46:31.498575|2017-10-10 20:46:31.498575
NCT03258879|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-18|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparison of Labor Analgesia Between Modified Combined Spinal-Epidural and Dural Puncture Epidural Techniques|Comparing the Quality of Labor Analgesia Between Modified Combined Spinal-Epidural and Dural Puncture Epidural Techniques: A Randomized Double Blinded Clinical Trial|Not yet recruiting||N/A|80|Anticipated|Western University, Canada||2|||f||||f|f|f||||||||2017-10-10 20:46:31.614144|2017-10-10 20:46:31.614144
NCT03258866|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-22|||January 1, 2010|Actual|2010-01-01|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||The Study of Different Dose Rituximab in the Treatment of ITP|The Clinical Randomized Controlled Study of Different Dose Rituximab in the Treatment of Primary Immune Thrombocytopenia|Completed||Phase 4|62|Actual|Shandong University||2|||f||||t|f|f||||||||2017-10-10 20:46:31.707731|2017-10-10 20:46:31.707731
NCT03258853|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Feasibility of Outpatient Closed Loop Control With the Bionic Pancreas in Cystic Fibrosis Related Diabetes|Feasibility of Outpatient Automated Blood Glucose Control With the Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes|Not yet recruiting||N/A|129|Anticipated|Massachusetts General Hospital||3|||f||||t|f|t|t|||||||2017-10-10 20:46:31.804963|2017-10-10 20:46:31.804963
NCT03258840|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-08-22|||January 2013||2013-01-01|December 2011|2011-12-01|August 2014|Actual|2014-08-01|April 2013|Actual|2013-04-01||Interventional|||EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus|The Effect of EPA on the Serum Activities of Paraoxonase 1, Homocystein, Thiolactonase and Some Indicators of Vascular Inflammation and PON2 Gene Expression in PBMC Ofthe Patients With Type II Diabetes|Completed||N/A|36|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 20:46:31.896294|2017-10-10 20:46:31.896294
NCT03258827|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-22|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Outcome of Exercise With a Towel in Elderly With Sarcopenia|Chang Gung Medical Hospital|Not yet recruiting||N/A|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||t|f|f||||||||2017-10-10 20:46:32.004746|2017-10-10 20:46:32.004746
NCT03258814|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|February 24, 2020|Anticipated|2020-02-24|February 24, 2020|Anticipated|2020-02-24||Observational|Treat & Train||A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (SpA)|Treat and Train - A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis|Not yet recruiting||N/A|600|Anticipated|AbbVie|||2||f||||f|f|f||||||||2017-10-10 20:46:32.110336|2017-10-10 20:46:32.110336
NCT03258801|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Observational|||Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis|Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis|Not yet recruiting||N/A|50|Anticipated|Medical University of Vienna|||2||f||||f|f|f||||||||2017-10-10 20:46:32.451012|2017-10-10 20:46:32.451012
NCT03258788|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-22|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Observational|PD-RAD||A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer|A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer (NSCLC)|Not yet recruiting||N/A|30|Anticipated|The Christie NHS Foundation Trust|||1||f|||||f|f||||Samples With DNA|"     Original diagnostic tumour blocks will be returned at the end of the study. New biopsy and     blood samples taken may be used in future research.   "|||2017-10-10 20:46:32.518203|2017-10-10 20:46:32.518203
NCT03258749|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-22|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|August 31, 2018|Anticipated|2018-08-31||Interventional|FACT||Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD|Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD: a Randomised, Open-label, Multicentre Trial|Not yet recruiting||N/A|120|Anticipated|Huashan Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:46:32.787451|2017-10-10 20:46:32.787451
NCT03258736|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-22|||April 4, 2016|Actual|2016-04-04|August 2017|2017-08-01|May 30, 2017|Actual|2017-05-30|March 30, 2017|Actual|2017-03-30||Interventional|||Caudal Block Versus Ultrasound Guided Ilioinguinal/Iliohypogastric Block in Pediatric Patient|Comparison of Caudal Block and Ultrasound Guided Ilioinguinal/Iliohypogastric Block for Bilateral Inguinal Surgery in Pediatric Patient: A Prospective Randomized Trial|Completed||N/A|110|Actual|Istanbul University||2|||f||||f|f|f||||||||2017-10-10 20:46:32.883997|2017-10-10 20:46:32.883997
NCT03258723|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-10-03|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|LIME||Diabetes Prevention With Lifestyle Intervention and Metformin Escalation|Diabetes Prevention With Lifestyle Intervention and Metformin Escalation|Not yet recruiting||Phase 4|750|Anticipated|Yale University||2|||f||||f|t|f|||t|||||2017-10-10 20:46:32.959574|2017-10-10 20:46:32.959574
NCT03258697|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-22|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 28, 2020|Anticipated|2020-02-28|August 31, 2019|Anticipated|2019-08-31||Interventional|||The Pharmacokinetics and Effectiveness of Local LevoBupivacaine Injection on Primary Total Joint Replacement Model.|The Pharmacokinetics and Effectiveness of Different Methods of Local LevoBupivacaine Injection, a Prospective Randomized Case Control Clinical Study on Primary Total Joint Replacement Model.|Enrolling by invitation||N/A|180|Anticipated|Chang Gung Memorial Hospital||3|||f||||f|f|f|||f|||||2017-10-10 20:46:33.210762|2017-10-10 20:46:33.210762
NCT03258684|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-26|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|HYVCTTSSS||Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock|Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock: A Prospective Study|Enrolling by invitation||N/A|140|Anticipated|Zhujiang Hospital||2|||f||||f|f|f||||||||2017-10-10 20:46:33.309073|2017-10-10 20:46:33.309073
NCT03258671|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-23|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer|IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer: Results of a Randomised,Openlabel,Multicentre Study|Not yet recruiting||N/A|160|Anticipated|Guizhou Medical University||2|||f||||t|f|f||||||||2017-10-10 20:46:33.409813|2017-10-10 20:46:33.409813
NCT03258658|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-20|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 1, 2023|Anticipated|2023-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures|A Phase 1 Pilot Safety and Feasibility Study of Autologous Engineered Urethral|Recruiting||Phase 1|10|Anticipated|Wake Forest University Health Sciences||1|||||||t|t|f||||||||2017-10-10 20:46:33.495518|2017-10-10 20:46:33.495518
NCT03258645|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-22|||August 25, 2017|Anticipated|2017-08-25|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke|Pradaxa Initiation Post-Stroke Study: SITS-Pradaxa 1. A Retrospective Analysis From the SITS-AF Registry on Treatment Initiation of Dabigatran Etexilate in Non-valvular Atrial Fibrillation Patients Hospitalized With Acute Ischemic Stroke|Not yet recruiting||N/A|1000|Anticipated|Boehringer Ingelheim|||1||f||||f|t|f||||||||2017-10-10 20:46:33.576534|2017-10-10 20:46:33.576534
NCT03258632|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-21|||September 1, 2018|Anticipated|2018-09-01|August 2017|2017-08-01|August 31, 2021|Anticipated|2021-08-31|March 1, 2021|Anticipated|2021-03-01||Interventional|||Improving Outcomes Among Medical/Surgical Inpatients With Alcohol Use Disorders|Improving Outcomes Among Medical/Surgical Inpatients With Alcohol Use Disorders|Not yet recruiting||N/A|292|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 20:46:33.648285|2017-10-10 20:46:33.648285
NCT03258619|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||February 27, 2017|Actual|2017-02-27|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|NARCOSE||Natriuresis as a Predictor of the Haemodynamic Response to Steroid Replacement Therapy in Patients in Septic Shock|Natriuresis as a Predictor of the Haemodynamic Response to Steroid Replacement Therapy in Patients in Septic Shock|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:46:33.733168|2017-10-10 20:46:33.733168
NCT03258255|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-22|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Analgesic Efficiency of Pudendal Nerve Block Versus Penil Block for Circumsion in Children|Comparison of Analgesic Efficiency of Pudendal Nerve Block and Penil Block for Circumsion in Children|Completed||N/A|80|Actual|Istanbul University||2|||f|||||f|f||||||||2017-10-10 20:46:36.349398|2017-10-10 20:46:36.349398
NCT03258554|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-22|2017-09-04|||December 12, 2017|Anticipated|2017-12-12|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Stage III-IVB Head and Neck Cancer Who Cannot Take Cisplatin|Randomized Phase II/III Trial of Radiotherapy With Concurrent Durvalumab vs. Radiotherapy With Concurrent Cetuximab in Patients With Stage III-IVB Head and Neck Cancer With a Contraindication to Cisplatin|Not yet recruiting||Phase 2/Phase 3|533|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 20:46:34.161563|2017-10-10 20:46:34.161563
NCT03258541|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-22|||January 15, 2017|Actual|2017-01-15|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy|TraceIT® Hydrogel Spacer Injections for Vagina and Erectile Bundles Sparing in Rectal Cancer Patients Treated With Neoadjuvant Radiotherapy: a Feasibility Study|Recruiting||N/A|10|Anticipated|University Hospital, Geneva||1|||f||||t|f|t|f|f|t|||||2017-10-10 20:46:34.29134|2017-10-10 20:46:34.29134
NCT03258528|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-22|||March 5, 2016|Actual|2016-03-05|August 2017|2017-08-01|December 14, 2016|Actual|2016-12-14|December 14, 2016|Actual|2016-12-14||Interventional|||Effect of Right Lateral Position on Ventilated Preterm Neonates|Effect of Right Lateral Position With Head Elevation on Tracheal Aspirate Pepsin in Ventilated Preterm Neonates: Randomized Controlled Trial|Completed||N/A|60|Actual|Ain Shams University||2|||f||||f|f|f||||||||2017-10-10 20:46:34.389971|2017-10-10 20:46:34.389971
NCT03258515|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-29|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|January 9, 2018|Anticipated|2018-01-09|January 9, 2018|Anticipated|2018-01-09||Interventional|||A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers|A Single-center, Randomized, Double-blind, Placebo-controlled, Three-way Crossover Phase I Study to Investigate the Effect on the QTc Interval of a Single Dose of AZD6094 (600 mg) Compared With Placebo, Using Open-label Moxifloxacin (Avelox®) as a Positive Control, in Healthy Volunteers|Recruiting||Phase 1|45|Anticipated|AstraZeneca||6|||f||||f|t|f||||||||2017-10-10 20:46:34.461468|2017-10-10 20:46:34.461468
NCT03258502|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-21|||July 30, 2017|Actual|2017-07-30|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety, Pharmacokinetics and Antiviral Activity of RV521 Against RSV|A Randomised, Phase 2a, Double-Blind, Placebo-Controlled Study To Evaluate The Safety, Pharmacokinetics And Antiviral Activity Of Multiple Doses Of RV521 Against Respiratory Syncytial Virus Infection In The Virus Challenge Model|Recruiting||Phase 2|66|Anticipated|ReViral Ltd||2|||f||||f|f|f||||||||2017-10-10 20:46:34.56625|2017-10-10 20:46:34.56625
NCT03258489|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-20|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Effects of TENS and IES on the Autonomous Balance of Normotens Volunteers and Hypertensive Patients|Effects of Transcutaneous Nervous Electric Stimulation (TENS) and Interferential Electrical Stimulation (IES) on the Autonomous Balance of Normotens Volunteers and Hypertensive Patients|Recruiting||N/A|60|Anticipated|Universidade Federal de Santa Maria||3|||f||||f|f|f||||||||2017-10-10 20:46:34.639696|2017-10-10 20:46:34.639696
NCT03258476|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-18|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 2022|Anticipated|2022-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Guanfacine Extended Release and Mindfulness Skills Therapy|Guanfacine Extended Release and Mindfulness in Traumatically Stressed Children and Adolescents Study|Not yet recruiting||Phase 4|20|Anticipated|UConn Health||2|||f||||f|t|f|||f|||||2017-10-10 20:46:34.722022|2017-10-10 20:46:34.722022
NCT03258463|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||February 10, 2016|Actual|2016-02-10|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|TOR||Travelling for Rights|Travelling for Rights|Active, not recruiting||N/A|700|Anticipated|University of New Mexico|||2||f||||f|f|f||||||||2017-10-10 20:46:34.821778|2017-10-10 20:46:34.821778
NCT03258450|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|C3||Coping With Advanced Colorectal Cancer|The Feasibility and Acceptability of a Psychosocial Intervention for Advanced Colorectal Cancer Patients|Not yet recruiting||N/A|60|Anticipated|Duke-NUS Graduate Medical School||2|||f|||||f|f||||||||2017-10-10 20:46:34.882906|2017-10-10 20:46:34.882906
NCT03258437|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-21|||April 12, 2016|Actual|2016-04-12|August 2017|2017-08-01|June 11, 2018|Anticipated|2018-06-11|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy and Safety of DA-9401 on Improvement of Sperm Motility|A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Allium Cepa L. and Cuscuta Chinensis Lam. Extract Mixtures (DA-9401) on Improvement of Sperm Motility|Recruiting||N/A|92|Anticipated|Korean Society for Sexual Medicine and Andrology||2|||f||||t|f|f||||||||2017-10-10 20:46:34.953238|2017-10-10 20:46:34.953238
NCT03085160|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-21|||October 27, 2014|Actual|2014-10-27|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|September 2017|Anticipated|2017-09-01||Interventional|||Project EAT: Eating and Attitudes in Teens|Project EAT: Eating and Attitudes in Teens|Recruiting||N/A|60|Anticipated|Colorado State University||2|||f||||f|f|f||||||No||2017-10-10 21:15:14.864723|2017-10-10 21:15:14.864723
NCT03258424|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy|A Phase I, Randomized, Placebo-Controlled, Study Designed to Assess the Safety, Tolerability, and Pharmakinetics of PTI-428 in Subjects With Cystic Fibrosis.|Recruiting||Phase 1|16|Anticipated|Proteostasis Therapeutics, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:46:35.039189|2017-10-10 20:46:35.039189
NCT03258411|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-08-21|||February 10, 2015|Actual|2015-02-10|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation Of Different Rapid Orthodontic Expansion Devices|Comparison of The Short Term Effects of Different Palatal Expanders Using CBCT.|Recruiting||N/A|21|Anticipated|King Abdulaziz University||3|||f||||t||||||||||2017-10-10 20:46:35.13705|2017-10-10 20:46:35.13705
NCT03258398|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-09-13|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer|A Phase 2, Open-Label, Randomized, Non-Comparative Study With Preliminary Dose Finding to Evaluate eFT508 Monotherapy or eFT508 in Combination With Avelumab in Subjects With Microsatellite Stable Relapsed or Refractory Colorectal Cancer|Recruiting||Phase 2|70|Anticipated|Effector Therapeutics||3|||f||||f|t|f||||||||2017-10-10 20:46:35.210557|2017-10-10 20:46:35.210557
NCT03258385|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-20|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|April 30, 2019|Anticipated|2019-04-30||Interventional|||Vitamin B12 Supplementation to Improve B12 Status and Child Development|Effects of Vitamin B12 Fortified Milk Supplementation During Pregnancy and 6 Month Postpartum to Improve B12 Status and Child Development|Not yet recruiting||N/A|148|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f|f|f||||||||2017-10-10 20:46:35.449297|2017-10-10 20:46:35.449297
NCT03258372|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-22|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites|A Phase 1, Open-Label, Fixed-Sequence, Crossover Drug-Drug Interaction Study in Healthy Subjects to Determine the Effects of a Strong Inducer of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites|Active, not recruiting||Phase 1|56|Anticipated|Corcept Therapeutics||2|||f||||f|t|f||||||||2017-10-10 20:46:35.537509|2017-10-10 20:46:35.537509
NCT03258359|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)|A Phase 1 Clinical Trial of Personalized, Adoptive Cellular Immunotherapy Targeting Patient-specific Neoplastic Stem Cell Neoantigens (PACTN) in Patients With Myelodysplastic Syndromes (MDS)|Not yet recruiting||Phase 1|9|Anticipated|PersImmune, Inc||1|||f||||t|t|f||||||||2017-10-10 20:46:35.625156|2017-10-10 20:46:35.625156
NCT03258346|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-18|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|September 15, 2018|Anticipated|2018-09-15||Interventional|||Reversing Muscle Loss With Exercise Training and Daily Consumption of Pomegranate Juice|Reversing Muscle Loss With Exercise Training and Daily Consumption of Pomegranate Juice|Not yet recruiting||N/A|40|Anticipated|University of Texas at Austin||2|||f||||f|f|f||||||||2017-10-10 20:46:35.728569|2017-10-10 20:46:35.728569
NCT03258333|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-20|||February 18, 2017|Actual|2017-02-18|August 2017|2017-08-01|July 1, 2022|Anticipated|2022-07-01|January 1, 2022|Anticipated|2022-01-01||Observational|||Small Aortic Annulus - a New Solution to the Old Problem|Small Aortic Annulus - a New Solution to the Old Problem|Active, not recruiting||N/A|60|Actual|The Federal Centre of Cardiovascular Surgery, Russia|||2||f||||t|f|f||||||||2017-10-10 20:46:35.823022|2017-10-10 20:46:35.823022
NCT03258320|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-22|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Without Metastasis|A Phase I Study of Neoadjuvant Chemotherapy Involving Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Followed by Surgery for Patients With High Risk Localized Prostate Cancer|Recruiting||Phase 1|50|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t|f|f||||||||2017-10-10 20:46:35.913518|2017-10-10 20:46:35.913518
NCT03258307|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-21|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Comparison of Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone Levels Pre-post Omentectomy|Comparison of Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone Levels Derivated From Adipose Tissue Pre-postoperatively in Patient Diagnosed With Gynecological Malignancy Performed Omentectomy or Not|Recruiting||N/A|25|Anticipated|Istanbul Training and Research Hospital||3|||f||||t|f|f||||||||2017-10-10 20:46:36.008269|2017-10-10 20:46:36.008269
NCT03258294|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-20|||January 13, 2016|Actual|2016-01-13|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease|Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease: Double Blind, Randomized, Placebo Controlled Trial|Enrolling by invitation||Phase 4|82|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 20:46:36.09314|2017-10-10 20:46:36.09314
NCT03258281|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-21|||May 1, 2018|Anticipated|2018-05-01|August 2017|2017-08-01|January 1, 2019|Anticipated|2019-01-01|November 1, 2018|Anticipated|2018-11-01||Interventional|ISS-DMII||Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus After Elective Percutaneous Coronary Intervention|Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus After Elective Percutaneous Coronary Intervention|Not yet recruiting||Early Phase 1|150|Anticipated|Inova Health Care Services||2|||f|||||t|f||||||||2017-10-10 20:46:36.184148|2017-10-10 20:46:36.184148
NCT03258268|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-20|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|October 7, 2018|Anticipated|2018-10-07|September 7, 2018|Anticipated|2018-09-07||Interventional|EASY-1||Easy Diabetes Treatment Study 1|A 26-week, Multicenter, Controlled Trial of the Glycemic Outcomes of Individualized Treatment Support in Patients With Type 2 Diabetes|Recruiting||N/A|484|Anticipated|Läkarexpressen AB||2|||f||||t|f|f||||||||2017-10-10 20:46:36.268602|2017-10-10 20:46:36.268602
NCT03258242|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-22|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|February 28, 2020|Anticipated|2020-02-28|August 31, 2019|Anticipated|2019-08-31||Interventional|||A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy|A Randomized, Double-masked, Multicenter, Placebo Controlled Study of Keluo Xin Capsule on Efficacy and Safety in Patients With Diabetic Retinopathy|Not yet recruiting||Phase 2|198|Anticipated|Chengdu Kanghong Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:46:36.414546|2017-10-10 20:46:36.414546
NCT03258229|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-21|||January 12, 2017|Actual|2017-01-12|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Hyperglycemia|A 8-week, Randomized, Double-blind, Placebo-controlled 2x2 Cross-over Design Human Trial to Evaluate the Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Hyperglycemia|Recruiting||N/A|40|Anticipated|Chonbuk National University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:46:36.509412|2017-10-10 20:46:36.509412
NCT03258216|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||TCM Tongue Diagnosis Indices of UGI Disorders|The Traditional Chinese Medicine (TCM) Tongue Diagnosis Indices of Upper Gastrointestinal (UGI) Disorders|Recruiting||N/A|500|Anticipated|Chang Gung Memorial Hospital|||2||f|||||f|f||||||||2017-10-10 20:46:36.593866|2017-10-10 20:46:36.593866
NCT03258203|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-21|||September 2003|Actual|2003-09-01|August 2017|2017-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Gene-Environment Interaction on Adiposity, Glycemic and Lipids Changes|Obesity Genes, Energy Regulation in Response to Weight-Loss|Completed||N/A|811|Actual|Tulane University||4|||f||||f|f|f||||||||2017-10-10 20:46:36.68884|2017-10-10 20:46:36.68884
NCT03258190|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-20|||July 1, 2014|Actual|2014-07-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Lime Powder Regimen (LPR) for Prevention of Renal Stone Recurrence|Lime Powder Regimen Supplement Alleviates Urinary Metabolic Abnormalities to Prevent Urolithiasis Recurrence.|Active, not recruiting||Phase 2|200|Anticipated|Chulalongkorn University||2|||f||||t|f|f||||||||2017-10-10 20:46:36.763265|2017-10-10 20:46:36.763265
NCT03258177|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-09-03|||August 18, 2017|Actual|2017-08-18|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Virtual Visits (Utilization of Virtual Care in Postoperative Patients to Improve the Patient Experience)|Utilization of Virtual Care in Postoperative Patients to Improve the Patient Experience|Recruiting||N/A|752|Anticipated|Carolinas Healthcare System||2|||f||||f|f|f||||||||2017-10-10 20:46:36.839671|2017-10-10 20:46:36.839671
NCT03258164|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-18|||March 22, 2017|Actual|2017-03-22|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|October 22, 2018|Anticipated|2018-10-22||Interventional|||Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts|Fat Transplantation Enriched With Expanded Adipose-derived Autologous Mesenchymal Stromal Cells in Cosmetic Breast Augmentation and Cosmetic Facial Filling|Active, not recruiting||Phase 3|32|Actual|Stemform||2|||f||||t|f|f||||||||2017-10-10 20:46:36.919242|2017-10-10 20:46:36.919242
NCT03258151|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients|Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients|Recruiting||N/A|2200|Anticipated|Peking University First Hospital|||2||f|||||f|f||||||||2017-10-10 20:46:36.993441|2017-10-10 20:46:36.993441
NCT03258138|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Feasibility and Implementation of a Healthy Lifestyles Program|Feasibility and Implementation of a Healthy Lifestyles Program: A Pilot Study|Not yet recruiting||N/A|30|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:46:37.091109|2017-10-10 20:46:37.091109
NCT03258125|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-23|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|January 1, 2019|Anticipated|2019-01-01||Observational|||miRNA-452 in Patients With Preeclampsia and Its Correlation With MMP-9|Expression of miRNA-452 in Patients With Early Onset Preeclampsia and Its Correlation With MMP-9|Not yet recruiting||N/A|50|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:46:37.22703|2017-10-10 20:46:37.22703
NCT03258112|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-20|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Efficacy of Catheter Ablation of Idiopathic Ventricular Arrhythmias Arising From Cardiac Outflow Tracts|Safety and Efficacy of Catheter Ablation of Idiopathic Ventricular Arrhythmias Arising From Cardiac Outflow Tracts|Not yet recruiting||N/A|57|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:46:37.291844|2017-10-10 20:46:37.291844
NCT03258099|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-23|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients|Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients|Recruiting||N/A|2200|Anticipated|Peking University First Hospital|||2||f|||||f|f||||||||2017-10-10 20:46:37.369761|2017-10-10 20:46:37.369761
NCT03258086|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-20|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Vitamin D in Diabetic Children|Assessment of Vitamin D in Children With Type 1 Diabetes|Recruiting||N/A|80|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:46:37.446071|2017-10-10 20:46:37.446071
NCT03258073|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-19|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|SimForLife||Does Simulation Scenario Execution Improve Acute Care Skills and Confidence Related to Maternal and Pediatric Care Emergencies?|Impact of Simulation Scenario Execution on Acute Care Skills and Confidence Related to Maternal and Pediatric Care Emergencies Among Pre-service Health Professional Trainees in Uganda|Not yet recruiting||N/A|120|Anticipated|Mbarara University of Science and Technology||1|||f||||f|f|f||||||||2017-10-10 20:46:37.513644|2017-10-10 20:46:37.513644
NCT03257878|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-18|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Health-related Quality of Life in Korean Patients With Rheumatic Diseases|Comparative Study Between Systemic Sclerosis and Other Rheumatic Diseases for Health-related Quality of Life in Korean Patients|Recruiting||N/A|500|Anticipated|Seoul National University Hospital|||5||f||||t|f|f||||||||2017-10-10 20:46:38.645641|2017-10-10 20:46:38.645641
NCT03258060|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-08-18|||April 2014||2014-04-01|August 2017|2017-08-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Interventional|||CRT In Narrow QRS Heart Failure: Mechanistic Insights From Cardiac MRI And Electroanatomical Mapping|Cardiac Resynchronisation Therapy In Patients With Narrow QRS Morphology And Heart Failure: Mechanistic Insights From Cardiac MRI And Electroanatomical Mapping|Terminated||N/A|1|Actual|Guy's and St Thomas' NHS Foundation Trust||2||release of other trial indicating futility of this study after recruitment of 1 patient|f||||f||||||||||2017-10-10 20:46:37.588138|2017-10-10 20:46:37.588138
NCT03258047|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-21|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|July 30, 2019|Anticipated|2019-07-30|May 31, 2019|Anticipated|2019-05-31||Interventional|||Novel Autologou CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma|Novel Autologou CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma|Not yet recruiting||Phase 2|60|Anticipated|First Affiliated Hospital of Zhejiang University||1|||f|||||f|f||||||||2017-10-10 20:46:37.668889|2017-10-10 20:46:37.668889
NCT03258034|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-21|||August 24, 2017|Anticipated|2017-08-24|August 2017|2017-08-01|October 22, 2021|Anticipated|2021-10-22|August 22, 2020|Anticipated|2020-08-22||Interventional|||A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer|Phase II Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer|Enrolling by invitation||Phase 2|50|Anticipated|The First Affiliated Hospital of Zhejiang Chinese Medical University||1|||f|||||f|f||||||||2017-10-10 20:46:37.729173|2017-10-10 20:46:37.729173
NCT03258021|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-12|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Observational|TIGER||TTFields In GErmany in Routine Clinical Care|The Use of TTFields for Newly Diagnosed GBM Patients in Germany in Routine Clinical Care - TIGER Study|Recruiting||N/A|1000|Anticipated|NovoCure Ltd.|||1||f|||||f|t|f||f|||||2017-10-10 20:46:37.801837|2017-10-10 20:46:37.801837
NCT03258008|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-21|2017-08-21|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer|Phase II Trial of Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer|Not yet recruiting||Phase 2|44|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 20:46:37.897221|2017-10-10 20:46:37.897221
NCT03257995|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-18|||August 22, 2017|Anticipated|2017-08-22|August 2017|2017-08-01|June 7, 2018|Anticipated|2018-06-07|June 7, 2018|Anticipated|2018-06-07||Interventional|||Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.|A Randomized, Double-blind, Placebo-controlled, Three-period Cross-over Study to Assess the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts (Maleate and Acetate) Delivered Via the Concept1 Inhalation Device in Patients With Asthma|Not yet recruiting||Phase 2|54|Anticipated|Novartis||6|||f||||f|t|f||||||||2017-10-10 20:46:37.991206|2017-10-10 20:46:37.991206
NCT03257982|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Patient Self-managed BCI-FES|A Feasibility Study of Patient Self-Managed Brain-computer Interface Functional Electrical Stimulation (BCI-FES) Hand Therapy for Spinal Cord Injured Patients|Not yet recruiting||N/A|24|Anticipated|NHS Greater Glasgow and Clyde||1|||f||||f|f|f||||||||2017-10-10 20:46:38.107415|2017-10-10 20:46:38.107415
NCT03257969|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-18|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|DROP-SFPO||Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients With Risk Factors|Impact of the DROP (Drug Related Problems in Oncology Practice) Program of Pharmaceutical Interventions of the French Society of Oncological Pharmacology Versus Usual Care on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients With Risk Factors|Not yet recruiting||N/A|248|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 20:46:38.183383|2017-10-10 20:46:38.183383
NCT03257956|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-21|||August 2, 2017||2017-08-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:46:38.263835|2017-10-10 20:46:38.263835
NCT03257943|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-18|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|August 18, 2017|Actual|2017-08-18|June 27, 2017|Actual|2017-06-27||Interventional|||A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%|A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-group Study, Comparing Ivermectin Lotion, 0.5% in the Treatment of Subjects With Active Infestation With Head Lice and Their Ova|Completed||Phase 1|413|Actual|Taro Pharmaceuticals USA||3|||f||||f|t|f|||f|||||2017-10-10 20:46:38.296581|2017-10-10 20:46:38.296581
NCT03257917|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-18|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|June 12, 2019|Anticipated|2019-06-12|September 30, 2017|Anticipated|2017-09-30||Observational|||Understanding Value in Metastatic Breast Cancer|Understanding Out-of-pocket Expenses and Patient Time Spent on Healthcare in Metastatic Breast Cancer Patients (Understanding Value in Metastatic Breast Cancer)|Recruiting||N/A|100|Anticipated|University of Alabama at Birmingham|||1||f||||t|f|f||||||||2017-10-10 20:46:38.435425|2017-10-10 20:46:38.435425
NCT03257904|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-19|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|SynapseICU||iNtrAcranial PreSsurE in ICU Intensive Care (ICU) (SynapseICU)|International Prospective Observational StudY on iNtrAcranial PreSsurE in Intensive Care (ICU) (SynapseICU)|Not yet recruiting||N/A|1000|Anticipated|University of Milano Bicocca|||1||f||||t|f|f||||||||2017-10-10 20:46:38.502596|2017-10-10 20:46:38.502596
NCT03257891|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-19|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|CabACC||Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines|Multicenter, Prospective, Non-randomized, Phase II Trial Designed to Evaluate the Activity of Cabazitaxel in Patients With Advanced Adreno-Cortical- Carcinoma Progressing After Previous Chemotherapy Lines|Not yet recruiting||Phase 2|25|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||1|||f||||t|f|f||||||||2017-10-10 20:46:38.565729|2017-10-10 20:46:38.565729
NCT03257865|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-18|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder|A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder|Not yet recruiting||Phase 3|320|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f|||||t|f||||||||2017-10-10 20:46:38.731823|2017-10-10 20:46:38.731823
NCT03257852|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-20|2017-08-20|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate|Phase 2a Study of ASP5094 A Phase 2a, Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate|Not yet recruiting||Phase 2|60|Anticipated|Astellas Pharma Inc||2|||f||||f|f|f||||||||2017-10-10 20:46:38.814435|2017-10-10 20:46:38.814435
NCT03257839|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|SV PCC ARM1||Delphinus SoftVue Prospective Case Collection - ARM 1|ARM 1: A Prospective, Multicenter, Multi-arm, Clinical Case Collection Program to Acquire Breast Image Data and Establish an Image Library of Exams for Use in Future Research Studies, Training, and Product Development Efforts.|Enrolling by invitation||N/A|10000|Anticipated|Delphinus Medical Technologies, Inc.|||1||f||||f||||||||||2017-10-10 20:46:39.019466|2017-10-10 20:46:39.019466
NCT03257826|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-19|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||The Effect of Percutaneous Kirschner Wire Technique in Management of CPT Under One Year Old|The Effect of Percutaneous Kirschner Wire Technique in Management of Congenital Pseudarthrosis of Tibia Under One Year Old|Recruiting||N/A|100|Anticipated|Hunan Children's Hospital||1|||f|||||f|f||||||||2017-10-10 20:46:39.202691|2017-10-10 20:46:39.202691
NCT03257813|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-10-04|||April 1, 2016|Actual|2016-04-01|October 2017|2017-10-01|June 18, 2017|Actual|2017-06-18|March 1, 2017|Actual|2017-03-01||Interventional|CONFORTK||Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)|Clinical Study to Evaluate the Non-inferiority of PRO-122 an Ophthlamic Solution Manufactured by Laboratorios Sophia, Previous Treatment With Krytantek Ofteno ®, in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension.|Completed||Phase 3|60|Actual|Laboratorios Sophia S.A de C.V.||2|||f||||t|f|f||||||||2017-10-10 20:46:39.309114|2017-10-10 20:46:39.309114
NCT03257800|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-08-18|||June 1, 2013|Actual|2013-06-01|August 2017|2017-08-01|December 31, 2013|Actual|2013-12-31|December 30, 2013|Actual|2013-12-30||Interventional|||Laryngeal Mask Insertion Conditions And Hemodynamic Effects|Laryngeal Mask Insertion Conditions And Hemodynamic Effects After Propofol And Ketamine-Propofol Co-induction|Completed||N/A|120|Actual|University of Monastir||2|||f||||f|f|f||||||||2017-10-10 20:46:39.408233|2017-10-10 20:46:39.408233
NCT03257787|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Evaluation of the Performance of a New Adhesive Strip|A Pilot Evaluation of Newly Developed Adhesives and How They Are Impacted by Output|Recruiting||N/A|6|Anticipated|Coloplast A/S||1|||f||||f|f|f||||||||2017-10-10 20:46:39.516892|2017-10-10 20:46:39.516892
NCT03257774|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|September 10, 2017|Anticipated|2017-09-10||Interventional|||Evaluation of the Effect of Output on New Adhesives|A Pilot Evaluation of Newly Developed Adhesives and How They Are Impacted by Output|Recruiting||N/A|6|Anticipated|Coloplast A/S||1|||f||||f|f|f||||||||2017-10-10 20:46:39.638447|2017-10-10 20:46:39.638447
NCT03257761|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-19|2017-10-02|||October 30, 2017|Anticipated|2017-10-30|October 2017|2017-10-01|October 30, 2020|Anticipated|2020-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|||Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer|A Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients With Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder Cancer|Not yet recruiting||Phase 1|90|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 20:46:39.768927|2017-10-10 20:46:39.768927
NCT03257748|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-21|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20||Interventional|||Effects of Laser Therapy and LED Therapy on Elderly Individuals With Temporomandibular Disorder|Effects of Laser Therapy and LED Therapy on Elderly Individuals With Temporomandibular Disorder: a Randomized, Controlled, Double-blind, Clinical Trial|Recruiting||Phase 2|80|Anticipated|University of Nove de Julho||2|||f|||||f|f||||||||2017-10-10 20:46:39.956097|2017-10-10 20:46:39.956097
NCT03257735|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-21|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|December 31, 2018|Anticipated|2018-12-31||Observational|||A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases|A Prospective and Observational Study of the Consistency of Gene Mutation Status Between Cerebrospinal Fluid, Blood and Tumor Tissue,and Correlation With Efficacy in Non-small Cell Lung Cancer Patients With Brain Metastases|Recruiting||N/A|50|Anticipated|Sun Yat-sen University|||1||f||||t|f|f||||Samples With DNA|"     We plan to detect the patients' cerebrospinal fluid,blood and tumor tissue with the method of     next-generation sequencing.   "|||2017-10-10 20:46:40.10536|2017-10-10 20:46:40.10536
NCT03257722|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-27|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|PIL||Pembrolizumab + Idelalisib for Lung Cancer Study|A Phase Ib /II Trial of Pembrolizumab and Idelalisib in Patients With Non-small Cell Lung Cancer (NSCLC) Who Have Failed Immune Checkpoint Inhibitor|Recruiting||Phase 1/Phase 2|40|Anticipated|Augusta University||2|||f||||t|t|f||||||||2017-10-10 20:46:40.192771|2017-10-10 20:46:40.192771
NCT03257709|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-18|||December 2016||2016-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALERT||The Arthroscopic Labral Excision or Repair Trial (ALERT)|The Arthroscopic Labral Excision or Repair Trial (ALERT) - A Randomised Controlled Trial to Determine the Effectiveness of Arthroscopic Hip Labral Surgery|Recruiting||N/A|96|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 20:46:40.296065|2017-10-10 20:46:40.296065
NCT03257696|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-22|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 7, 2018|Anticipated|2018-10-07|September 30, 2018|Anticipated|2018-09-30||Observational|YNQ||Yes/No Questionnaire for Aphasic Patients (YNQ)|Diagnostic Accuracy Study of an Answer Reliability Assessment Tool for Aphasic Patients|Not yet recruiting||N/A|165|Anticipated|Groupe Hospitalier de la Rochelle Ré Aunis|||1||f||||f|f|f||||||||2017-10-10 20:46:40.401285|2017-10-10 20:46:40.401285
NCT03257683|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-18|||April 14, 2017|Actual|2017-04-14|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||RANOLAZINE STUDY: Speckle Tracking Derived Myocardial Strain|RANOLAZINE STUDY: The Effect of Ranolazine on Speckle Tracking Derived Myocardial Strain in Regions of Non-Revascularizable Ischemic Myocardium|Enrolling by invitation||N/A|20|Anticipated|Saint Thomas Health|||1||f||||f|t|f|||t|||||2017-10-10 20:46:40.47789|2017-10-10 20:46:40.47789
NCT03257670|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-18|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 1, 2018|Anticipated|2018-11-01|October 1, 2018|Anticipated|2018-10-01||Interventional|BCLS||Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors|Prospective Randomized Trial Comparing Treatment of Dyspareunia With Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel in the Setting of Breast Cancer Survivors.|Not yet recruiting||N/A|70|Anticipated|University of Cincinnati||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:46:40.572413|2017-10-10 20:46:40.572413
NCT03257657|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-18|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Helping Moms to be Healthy After Baby|Helping Moms to be Healthy After Baby|Recruiting||N/A|80|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:46:40.698507|2017-10-10 20:46:40.698507
NCT03257644|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-28|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis|An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis|Recruiting||Phase 1|20|Anticipated|Incyte Corporation||2|||f||||f|t|f||||||||2017-10-10 20:46:40.801224|2017-10-10 20:46:40.801224
NCT03257631|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-22|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|August 13, 2018|Anticipated|2018-08-13|August 13, 2018|Anticipated|2018-08-13||Interventional|||A Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors|A PHASE 2 CLINICAL STUDY OF POMALIDOMIDE (CC-4047) MONOTHERAPY FOR CHILDREN AND YOUNG ADULTS WITH RECURRENT OR PROGRESSIVE PRIMARY BRAIN TUMORS|Recruiting||Phase 2|36|Anticipated|Celgene||1|||f||||t|t|f||||||||2017-10-10 20:46:40.916741|2017-10-10 20:46:40.916741
NCT03257618|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01||Interventional|TEMOIN||Quality of Life and Neurocognitive Functioning|Quality of Life and Neurocognitive Functioning in Diffuse Low-grade Glioma (TEMOIN)|Recruiting||N/A|24|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f|f|f||||||||2017-10-10 20:46:41.062529|2017-10-10 20:46:41.062529
NCT03257605|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2016|Actual|2016-06-01||Observational|PACE||A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly|Implementation of a Pharmacist-Led Pharmacogenomics Service for the Program of All-inclusive Care for the Elderly (PHARM-GENOME-PACE)|Completed||N/A|296|Actual|Tabula Rasa HealthCare|||1||f||||f|f|f||||||||2017-10-10 20:46:41.154096|2017-10-10 20:46:41.154096
NCT03257592|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-18|||August 2010||2010-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States|PET Imaging of Glial Activation in Psychotic Disease States|Active, not recruiting||N/A|60|Anticipated|Johns Hopkins University||3|||f||||f||||||||||2017-10-10 20:46:41.217391|2017-10-10 20:46:41.217391
NCT03257579|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-18|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|MIPAD||Myocardial Infarction Prescription Duration Adherence Study|Length of Initial Prescription at Hospital Discharge and Long-term Medication Adherence for Elderly Patients Post-Myocardial Infarction: An Interventional Study|Not yet recruiting||N/A|5000|Anticipated|Hamilton Health Sciences Corporation||4|||f||||f|f|f||||||||2017-10-10 20:46:41.284324|2017-10-10 20:46:41.284324
NCT03257566|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-18|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Observational|||Hypothyroidism in Patients With Type 1 Diabetes|Risk Factors of Incidence of Hypothyroidism in Patients With Type 1 Diabetes|Not yet recruiting||N/A|300|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:46:41.362189|2017-10-10 20:46:41.362189
NCT03257553|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-18|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||Ultrasound, Doppler ,and Calprotectin in Necrotizing Enterocolitis Diagnosis|Role of Ultrasound ,Doppler and Calprotectin in Diagnosis of Necrotizing Enterocolitis in Neonates|Not yet recruiting||N/A|50|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:46:41.417985|2017-10-10 20:46:41.417985
NCT03257540|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|January 2019|Anticipated|2019-01-01||Observational|||Early Weight-Bearing After Lapidus Arthrodesis|Prospective Clinical Evaluation of Early Weight-Bearing After Lapidus Arthrodesis Using the Phantom™ Intramedullary Nail|Not yet recruiting||N/A|77|Anticipated|Paragon 28|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:46:41.499411|2017-10-10 20:46:41.499411
NCT03257527|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-21|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Enduring Happiness and Continued Self-Enhancement (ENHANCE) 2.0|Enduring Happiness and Continued Self-Enhancement (ENHANCE) 2.0: A Well-Being Program|Recruiting||N/A|80|Anticipated|University of British Columbia||2|||f|||||f|f||||||||2017-10-10 20:46:41.593868|2017-10-10 20:46:41.593868
NCT03257514|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section|Assessing The Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section by Using Saline Contrast Sonohysterography|Not yet recruiting||Phase 4|80|Anticipated|Ain Shams University||2|||f|||||f|f||||||||2017-10-10 20:46:41.695643|2017-10-10 20:46:41.695643
NCT03257488|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-21|||April 2015||2015-04-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Screening of Obstructive Sleep Apnea Syndrome in Patients With Resistant Systemic Arterial Hypertension: Pilot Study|Screening of Obstructive Sleep Apnea Syndrome in Patients With Resistant Systemic Arterial Hypertension: Pilot Study|Recruiting||N/A|100|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||||2017-10-10 20:46:41.846185|2017-10-10 20:46:41.846185
NCT03257475|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-21|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|August 30, 2019|Anticipated|2019-08-30|February 28, 2019|Anticipated|2019-02-28||Observational|||Evaluation of Vaginal Dose in Cervical Cancer Patients Treated With Radiotherapy|Evaluation of Vaginal Dose in Cervical Cancer Patients Treated With Radiotherapy|Active, not recruiting||N/A|500|Anticipated|Health Science Center of Xi’an Jiaotong University|||1||f||||f|f|f||||||||2017-10-10 20:46:41.954975|2017-10-10 20:46:41.954975
NCT03257449|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||March 2016||2016-03-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Effect of Viscous Soluble Fibres on Body Weight|Effect of Viscous Soluble Fibres on Body Weight Parameters: Review and Meta-analyses|Active, not recruiting||N/A|1268|Anticipated|St. Michael's Hospital, Toronto|||1||f|||||f|f|||f|||||2017-10-10 20:46:42.125842|2017-10-10 20:46:42.125842
NCT03257436|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01||Interventional|SMARTMSP||Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)|Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)|Not yet recruiting||N/A|586|Anticipated|Boston Scientific Corporation||1|||f||||t|f|t|f|f|t|||||2017-10-10 20:46:42.204771|2017-10-10 20:46:42.204771
NCT03257423|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-21|||April 4, 2017|Actual|2017-04-04|August 2017|2017-08-01|April 4, 2019|Anticipated|2019-04-04|April 4, 2019|Anticipated|2019-04-04||Interventional|MAPPAC||Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects|Acute Appendicitis and Microbiota - Ethology of Appendicitis and Effects of the Antimicrobial Treatment - The MAPPAC (Microbiology Appendicitis Acuta) Trial|Enrolling by invitation||N/A|200|Anticipated|Turku University Hospital||6|||f||||f|f|f||||||||2017-10-10 20:46:42.270329|2017-10-10 20:46:42.270329
NCT03257410|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-08|||September 20, 2017||2017-09-20||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:46:42.358527|2017-10-10 20:46:42.358527
NCT03257397|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||TBS in Major Depression|Theta-burst Transcranial Magnetic Stimulation for the Treatment of Major Depression|Recruiting||Phase 4|80|Anticipated|Medical University of Vienna||2|||f||||f|f|f||||||||2017-10-10 20:46:42.390639|2017-10-10 20:46:42.390639
NCT03257384|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-29|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|August 10, 2019|Anticipated|2019-08-10|August 10, 2019|Anticipated|2019-08-10||Observational|||Minimizing Peri-operative Time Delays, Maximizing Operating Room Efficiency: A Pilot Study|Minimizing Peri-operative Time Delays, Maximizing Operating Room Efficiency: A Pilot Study|Enrolling by invitation||N/A|30|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f|f|f||||||||2017-10-10 20:46:42.47133|2017-10-10 20:46:42.47133
NCT03257371|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||December 30, 2016|Actual|2016-12-30|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Observational|||A Biologic Joint Replacement Strategy to Treat Patients With Severe Knee Trauma and Post-Traumatic Knee Osteoarthritis|A Biologic Joint Replacement Strategy to Treat Patients With Severe Knee Trauma and Post-Traumatic Knee Osteoarthritis|Recruiting||N/A|10|Anticipated|University of Missouri-Columbia|||1||f||||f|f|f||||||||2017-10-10 20:46:42.52832|2017-10-10 20:46:42.52832
NCT03257345|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||February 3, 2017|Actual|2017-02-03|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2019|Anticipated|2019-09-30|1 Year|Observational [Patient Registry]|VEST||VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease|VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease|Recruiting||N/A|360|Anticipated|University Hospital Southampton NHS Foundation Trust|||1||f||||f||f||||||||2017-10-10 20:46:42.676315|2017-10-10 20:46:42.676315
NCT03257332|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31|2 Years|Observational [Patient Registry]|EDFI-Cohort||Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Curative Surgery for Rectal Cancer.|Cohort Study of Early Development of Faecal Incontinence (Low Anterior Resection Syndrome), Quality of Life and Anorectal Muscle Function After Curative Treatment With Rectal Cancer Surgery. The EDFI-Cohort Study|Not yet recruiting||N/A|150|Anticipated|Slagelse Hospital|||1||f||||t||||||||||2017-10-10 20:46:44.214087|2017-10-10 20:46:44.214087
NCT03257319|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-21|||August 23, 2017|Anticipated|2017-08-23|July 2017|2017-07-01|August 24, 2019|Anticipated|2019-08-24|August 24, 2019|Anticipated|2019-08-24||Interventional|CLIN-AEROMORPH||Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department|Inhaled Versus Intravenous Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department|Not yet recruiting||Phase 3|850|Anticipated|University Hospital, Rouen||2|||f||||f|f|f||||||||2017-10-10 20:46:44.322947|2017-10-10 20:46:44.322947
NCT02620813|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-06-19|||October 2015||2015-10-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||De Novo Lipogenesis of Sebaceous Glands in Acne||Recruiting||Phase 4|30|Anticipated|University of California, Davis||3|||f||||||||||||||2017-10-10 22:41:31.7886|2017-10-10 22:41:31.7886
NCT03257306|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MAGUSS||Magnetic Ureteral Stent Symptoms - a Comparison to Standard Ureteral Stent as Perceived By the Patient (MAGUSS)|Magnetic Ureteral Stent Symptoms - a Comparison to Standard Ureteral Stent as Perceived By the Patient (MAGUSS)|Not yet recruiting||N/A|170|Anticipated|Turku University Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:46:44.499049|2017-10-10 20:46:44.499049
NCT03257293|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||A Trial of a Modified Cystoscopy Method to Reduce Pain Perception|A Randomized Control Trial of a Modified Cystoscopy Method to Reduce Pain Perception|Not yet recruiting||N/A|296|Anticipated|Western University, Canada||2|||f||||f|f|f||||||||2017-10-10 20:46:44.581101|2017-10-10 20:46:44.581101
NCT03257280|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2022|Anticipated|2022-09-01|March 2020|Anticipated|2020-03-01||Interventional|||Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015)|Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Gastric Cancer Patients After Total Gastrectomy: A Prospective Randomized Control Trial (DOPGT_2015)|Not yet recruiting||N/A|84|Anticipated|Hospital Universitari de Bellvitge||2|||f|||||f|f||||||||2017-10-10 20:46:44.656432|2017-10-10 20:46:44.656432
NCT03257267|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-29|||October 3, 2017|Anticipated|2017-10-03|September 2017|2017-09-01|February 27, 2023|Anticipated|2023-02-27|May 6, 2020|Anticipated|2020-05-06||Interventional|||Study of REGN2810 in Adults With Cervical Cancer|An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator's Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma|Recruiting||Phase 3|436|Anticipated|Regeneron Pharmaceuticals||2|||f||||t|t|f|||t|||||2017-10-10 20:46:44.76678|2017-10-10 20:46:44.76678
NCT03257254|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01|12 Months|Observational [Patient Registry]|VIEW-VLU||Effect of VarIthena on Wound Healing in VLU|Observational Study of the Effect of VarIthena® on Wound Healing in the Treatment of Venous Leg Ulcers Resulting From Chronic Venous Insufficiency|Not yet recruiting||N/A|200|Anticipated|Provensis Ltd|||1||f||||f|t|f|||t|||||2017-10-10 20:46:44.853736|2017-10-10 20:46:44.853736
NCT03257241|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-21|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|April 1, 2018|Anticipated|2018-04-01||Interventional|PALG-AML1/2016||A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old|A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old|Recruiting||Phase 3|582|Anticipated|Polish Adult Leukemia Group||4|||f||||t|f|f|||f|||||2017-10-10 20:46:45.021441|2017-10-10 20:46:45.021441
NCT03257228|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-29|||November 1, 2014|Actual|2014-11-01|August 2017|2017-08-01|November 1, 2015|Actual|2015-11-01|November 1, 2015|Actual|2015-11-01||Observational|||The Association Between Diabetes Mellitus, Oral Lichen Planus and Insulin-like Growth Factors 1 and 2 (IGF1 and IGF2)|The Association Between Diabetes Mellitus, Oral Lichen Planus and Insulin-like Growth Factors 1 and 2 (IGF1 and IGF2)|Completed||N/A|24|Actual|University of Zagreb|||3||f||||f|f|f||||Samples With DNA|"     Biopsy samples of oral mucosa   "|||2017-10-10 20:46:45.16831|2017-10-10 20:46:45.16831
NCT03257215|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-17|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|D-Vex||Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? The D-Vex Pilot Study|A Phase IV, Double-blind, Randomised, Placebo-controlled Trial to Assess the Efficacy and Safety of Stoss Versus Daily Dose Oral Vitamin D Compared to Placebo for the Treatment of Atopic Dermatitis in Pre-school Aged Children- a Pilot Study|Not yet recruiting||Phase 4|50|Anticipated|Murdoch Childrens Research Institute||3|||f||||f|f|f|||f|||||2017-10-10 20:46:45.2505|2017-10-10 20:46:45.2505
NCT03257202|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-12|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Topical Treatment and Prevalence of P. Acnes|Pre-operative Topical Treatment and the Prevalence of Propionibacterium Acnes|Enrolling by invitation||Phase 2|12|Actual|University of Southern California||4|||f||||t|t|f|||t|||||2017-10-10 20:46:45.351297|2017-10-10 20:46:45.351297
NCT03257189|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||July 31, 2017||2017-07-31||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:46:45.458067|2017-10-10 20:46:45.458067
NCT03257176|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-17|||May 2, 2012|Actual|2012-05-02|August 2017|2017-08-01|July 30, 2013|Actual|2013-07-30|July 30, 2013|Actual|2013-07-30||Interventional|||Stepping Stones and Creating Futures Intervention Pilot|Stepping Stones and Creating Futures Intervention Pilot|Completed||Phase 2|232|Actual|University of KwaZulu||1|||f||||f|f|f||||||||2017-10-10 20:46:45.501207|2017-10-10 20:46:45.501207
NCT03257150|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-27|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer|Irreversible Electroporation for Locally Advanced Pancreatic Ductal Adenocarcinoma (LEAP TRIAL): A Phase I/II Prospective Trial|Recruiting||N/A|47|Anticipated|University Health Network, Toronto||1|||f|||||f|f||||||||2017-10-10 20:46:45.683978|2017-10-10 20:46:45.683978
NCT03257137|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Diet and Sleep Monitoring|Diet and Sleep Monitoring|Recruiting||N/A|12|Anticipated|University of Chicago||2|||f||||f|f|f||||||||2017-10-10 20:46:45.781915|2017-10-10 20:46:45.781915
NCT03257124|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-09-03|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS|An Open Label, Multicenter, Phase II Study of AZD9291 in Non-small Cell Lung Cancer (NSCLC) Patients Harboring T790M Mutation Who Failed EGFR TKIs and With Brain and/or Leptomeningeal Metastasis|Recruiting||Phase 2|80|Anticipated|Samsung Medical Center||1|||f||||t|f|f|||f|||||2017-10-10 20:46:45.885453|2017-10-10 20:46:45.885453
NCT03257111|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-18|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2017|Anticipated|2017-08-01||Observational|||Activity Levels and Rehabilitation Outcomes of Patients Post-stroke|The Correlation Between Activity Levels and Rehabilitation Outcomes of Patients Post-stroke in an In-patient Rehabilitation Center|Not yet recruiting||N/A|120|Anticipated|Florida Gulf Coast University|||1||f||||f|f|f||||||||2017-10-10 20:46:45.976332|2017-10-10 20:46:45.976332
NCT03257098|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-28|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|February 21, 2019|Anticipated|2019-02-21|May 21, 2018|Anticipated|2018-05-21||Interventional|||Allogeneic ABCB5-positive Stem Cells for Treatment of CVU|An Interventional, Single Arm, Multicenter, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Chronic Venous Ulcer (CVU)|Recruiting||Phase 1/Phase 2|37|Anticipated|Rheacell GmbH & Co. KG||1|||f||||f|f|f||||||||2017-10-10 20:46:46.049908|2017-10-10 20:46:46.049908
NCT03257085|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-17|||March 9, 2017|Actual|2017-03-09|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|CALIBER||CALIBER Phase 1: A Pilot Study in Normal-weight and Overweight Adults.|CALIBER (Carbohydrates, Lipids and Biomarkers of Traditional and Emerging Cardiometabolic Risk Factors) Phase 1: A Pilot Study in Normal-weight and Overweight Adults.|Recruiting||N/A|20|Anticipated|Liverpool John Moores University||2|||f||||t|f|f||||||||2017-10-10 20:46:46.146608|2017-10-10 20:46:46.146608
NCT03257072|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-17|||January 4, 2018|Anticipated|2018-01-04|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|May 31, 2018|Anticipated|2018-05-31||Interventional|ReCHHI1||Repeated Controlled Human Hookworm Infection|Repeated Controlled Human Hookworm Infection in Healthy Dutch Volunteers|Not yet recruiting||N/A|24|Anticipated|Leiden University Medical Center||3|||f||||f|f|f||||||||2017-10-10 20:46:46.253003|2017-10-10 20:46:46.253003
NCT03257059|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-18|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|BEGIN||Breakfast Consumption and Its Effects on Glycemic, Insulinemic and Non-Esterified Fatty Acids Responses|Breakfast Consumption and Its Effects on Glycemic, Insulinemic and Non-Esterified Fatty Acids Responses|Recruiting||N/A|20|Anticipated|Clinical Nutrition Research Centre, Singapore||2|||f||||f|f|f||||||||2017-10-10 20:46:46.334258|2017-10-10 20:46:46.334258
NCT03257046|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-10-03|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease|A Randomized, Placebo-Controlled, Double-Blind Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ITI-214 in Patients With Idiopathic Parkinson's Disease|Recruiting||Phase 1/Phase 2|24|Anticipated|Intra-Cellular Therapies, Inc.||4||||||||t|f||||||||2017-10-10 20:46:46.41049|2017-10-10 20:46:46.41049
NCT03257033|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|TIGeR-PaC||Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC|Trans(Intra)-Arterial Gemcitabine vs. Continuation of IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for Locally Advanced Pancreatic Cancer|Not yet recruiting||Phase 4|200|Anticipated|RenovoRx||2|||f||||t|t|t|f|f|t|||||2017-10-10 20:46:46.56914|2017-10-10 20:46:46.56914
NCT03257020|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-24|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||The Diagnostic Performance of BMO-MRW and RNFL Thickness and Their Combinational Index Using Artificial Neural Network|The Comparison of Bruch's Membrane Opening-minimum Rim Width and Retinal Nerve Fiber Layer Thickness and Their Combinational Index Using Artificial Neural Network|Completed||N/A|402|Actual|Pusan National University Hospital|||2||f||||t||t|f||f|||||2017-10-10 20:46:46.656573|2017-10-10 20:46:46.656573
NCT03257007|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||May 2, 2017|Actual|2017-05-02|August 2017|2017-08-01|December 22, 2017|Anticipated|2017-12-22|December 22, 2017|Anticipated|2017-12-22||Interventional|MEANING||Mindfulness to Enhance Quality of Life and Support Advance Care Planning|Mindfulness to Enhance Quality of Life and Support Advance Care Planning (MEANING): A Randomized Controlled Pilot Trial for Adults With Metastatic Cancer and Their Family Caregivers|Recruiting||N/A|60|Anticipated|Indiana University||2|||f||||t|f|f||||||||2017-10-10 20:46:46.733428|2017-10-10 20:46:46.733428
NCT03256994|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-18|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|February 1, 2022|Anticipated|2022-02-01|May 1, 2021|Anticipated|2021-05-01|24 Months|Observational [Patient Registry]|CIRT-FR||CIRSE Registry for SIR-Spheres in France (CIRT-FR)|CIRSE Registry for SIR-Spheres in France (CIRT-FR)|Recruiting||N/A|200|Anticipated|Cardiovascular and Interventional Radiological Society of Europe|||1||f||||t|f|f||||||||2017-10-10 20:46:46.838604|2017-10-10 20:46:46.838604
NCT03256981|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-17|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2021|Anticipated|2021-09-30|March 31, 2021|Anticipated|2021-03-31||Interventional|HALT||Stereotactic Body Radiotherapy for the Treatment of OPD|Targeted Therapy With or Without Dose Intensified Radiotherapy for Oligo-progressive Disease in Oncogene-addicted Lung Tumours|Not yet recruiting||Phase 2/Phase 3|110|Anticipated|Institute of Cancer Research, United Kingdom||2|||f||||t|f|f||||||||2017-10-10 20:46:46.937286|2017-10-10 20:46:46.937286
NCT03256968|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-24|||January 27, 2017|Actual|2017-01-27|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|January 1, 2018|Anticipated|2018-01-01||Interventional|||PTC Study to Evaluate Ataluren in Combination With Ivacaftor|An Open Label N of 1 Study to Evaluate the Study and Efficacy of Long-Term Treatment With Ivacaftor in Combination With Ataluren (PTC124) in Subjects With Nonsense Mutation Cystic Fibrosis|Active, not recruiting||Phase 4|1|Anticipated|University of Alabama at Birmingham||1|||f||||f|t|f|||f|||||2017-10-10 20:46:47.031061|2017-10-10 20:46:47.031061
NCT03256955|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-21|||June 23, 2017|Actual|2017-06-23|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Validation of the TOF Cuff Monitor® Which Measures Neuromuscular Block on the Upper Arm|The Comparison of the TOF Cuff Monitor® With the TOF Watch SX® Monitor:|Recruiting||N/A|40|Anticipated|University Hospital, Geneva||1|||f||||f|f|f||||||||2017-10-10 20:46:47.096138|2017-10-10 20:46:47.096138
NCT03256942|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-21|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ELISE||Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation|Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation|Recruiting||N/A|72|Anticipated|Merz Pharmaceuticals GmbH||2|||f||||f|f|f||||||||2017-10-10 20:46:47.196277|2017-10-10 20:46:47.196277
NCT03256916|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-21|||September 25, 2017|Anticipated|2017-09-25|August 2017|2017-08-01|September 30, 2025|Anticipated|2025-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|NELCER||Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix|A Phase III Randomized Clinical Trial to Study the Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Uterine Cervix.|Not yet recruiting||Phase 3|300|Anticipated|Tata Memorial Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:46:47.393018|2017-10-10 20:46:47.393018
NCT03256903|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-22|||July 7, 2017|Actual|2017-07-07|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|September 30, 2017|Anticipated|2017-09-30||Interventional|InMEDIATE||Methoxyflurane vs Standard Analgesic Treatment for Trauma Pain in Spanish Emergency Units|Open Randomized Clinical Trial to Compare Pain Relief Between Methoxyflurane and Standard of Care for Treating Patients With Trauma Pain in Spanish Emergency Units.|Recruiting||Phase 3|310|Anticipated|Mundipharma Pharmaceuticals S.L.||2|||f||||t|f|f||||||||2017-10-10 20:46:47.535915|2017-10-10 20:46:47.535915
NCT03256890|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-18|||June 13, 2017|Actual|2017-06-13|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|MB-BP||Mindfulness-Based Pressure Reduction: Stage 2a RCT|Mindfulness-Based Pressure Reduction: Stage 2a Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Brown University||2|||f||||t|f|f||||||||2017-10-10 20:46:47.698969|2017-10-10 20:46:47.698969
NCT03256877|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-17|||October 18, 2016|Actual|2016-10-18|July 2017|2017-07-01|April 18, 2019|Anticipated|2019-04-18|April 18, 2018|Anticipated|2018-04-18||Observational|TransTuFo||Detecting Transitional Cell Carcinoma From Haematuria|Detecting Transitional Cell Carcinoma From Haematuria: A Study of Urinary Tissue Factor|Recruiting||N/A|700|Anticipated|Hull and East Yorkshire Hospitals NHS Trust|||1||f||||f|f|f||||Samples With DNA|"     Urine samples.   "|||2017-10-10 20:46:47.824223|2017-10-10 20:46:47.824223
NCT03256864|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-08-21|||January 2016||2016-01-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient|A Six-month, Prospective, Single-center, Pilot Study Determining the Pharmacokinetics and Effectiveness of Twice-daily Tacolimus and Everolimus Regimen Convert to Once-daily Tacrolimus and Everolimus Regimen in Liver Transplant Patients|Recruiting||Phase 4|10|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 20:46:47.895082|2017-10-10 20:46:47.895082
NCT03256851|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Telephone-Delivered Exercise for Multiple Sclerosis Fatigue|Telephone-Delivered Interventions to Target Multiple Sclerosis Fatigue|Recruiting||N/A|20|Anticipated|Wayne State University||2|||f||||f|f|f||||||||2017-10-10 20:46:47.981174|2017-10-10 20:46:47.981174
NCT03256838|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-20|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|December 1, 2018|Anticipated|2018-12-01||Interventional|||Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis|A Long-Term, Open-Label, Prospective Phase IV Study to Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis|Recruiting||Phase 4|200|Anticipated|Panion & BF Biotech Inc.||1|||f|||||f|f|||f|||||2017-10-10 20:46:48.065573|2017-10-10 20:46:48.065573
NCT03256825|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|RUDE||Rapid Urinary Tract Infection Diagnosis and Real-time Antimicrobial Stewardship Decision Support|Rapid Urinary Tract Infection Diagnosis and Real-time Antimicrobial Stewardship Decision Support - Accuracy and Effect on Antibiotic Consumption|Not yet recruiting||N/A|550|Anticipated|Helse Møre og Romsdal HF||2|||f|||||f|f||||||||2017-10-10 20:46:48.207048|2017-10-10 20:46:48.207048
NCT03256812|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-20|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||ICT-based Monitoring for Arrhythmia Detection After AF Ablation|Efficacy and Stability of an Information and Communication Technology (ICT)-Based Centralized Monitoring System for Arrhythmia Detection After Atrial Fibrillation Ablation: a Prospective, Randomized Controlled, Multicenter Study|Recruiting||N/A|50|Anticipated|Keimyung University Dongsan Medical Center||2|||f|||||f|f||||||||2017-10-10 20:46:48.306958|2017-10-10 20:46:48.306958
NCT03256799|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||March 17, 2017|Actual|2017-03-17|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations|An Open Label Study to Investigate the Role of Ivacaftor for the Treatment of Cystic Fibrosis in Combination With Ataluren (PTC124) in Cystic Fibrosis Patients Using Ataluren for Nonsense Mutations|Recruiting||Phase 4|1|Anticipated|University of Alabama at Birmingham||1|||f||||f|t|f|||f|||||2017-10-10 20:46:48.387579|2017-10-10 20:46:48.387579
NCT03256786|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-20|||July 12, 2017|Actual|2017-07-12|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Observational|||Effects of Preanesthetic Forced Air Warming and Administration of Warmed Intravascular Fluid|Effects of Preanesthetic Forced Air Warming and Administration of Warmed Intravascular Fluid on Preventing Hypothermia and Shivering During Cesarean Delivery Under Spinal Anesthesia|Recruiting||N/A|50|Anticipated|Hallym University Kangnam Sacred Heart Hospital|||2||f||||f|f|f||||||||2017-10-10 20:46:48.454875|2017-10-10 20:46:48.454875
NCT03256773|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-24|||April 15, 2016|Actual|2016-04-15|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||High Resolution Micro OCT Imaging|Imaging of Human Epithelial Airway Using a High Resolution Micro OCT Catheter (Functional Anatomic Imaging of CF Patients With Early Lung Disease Using Micro OCT)|Recruiting||N/A|60|Anticipated|University of Alabama at Birmingham|||4||f||||f|f|f||||||||2017-10-10 20:46:48.534639|2017-10-10 20:46:48.534639
NCT03256760|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-20|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|May 30, 2023|Anticipated|2023-05-30|May 30, 2022|Anticipated|2022-05-30||Interventional|SHARE-D||Sleep and Healthy Aging Research for Depression (SHARE-D) Study|Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms|Active, not recruiting||Phase 1|160|Anticipated|University of California, Los Angeles||2|||f||||t|t|f||||||||2017-10-10 20:46:48.607284|2017-10-10 20:46:48.607284
NCT03256747|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of Neuromuscular Electrical Stimulation on Glucose Variability in Patients With Type 2 Diabetes|Effects of Neuromuscular Electrical Stimulation on Glucose Levels and Glucose Variability in Patients With Type 2 Diabetes: a Randomized Clinical Trial|Not yet recruiting||N/A|28|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:46:48.694701|2017-10-10 20:46:48.694701
NCT03256734|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Observational|||Does a Complex Care Discharge Planning Initiative Reduce Unplanned Hospital Readmissions? (G78717-Readmits)|Does a Complex Care Discharge Planning Initiative Reduce Unplanned Hospital Readmissions?|Not yet recruiting||N/A|300000|Anticipated|University of British Columbia|||1||f||||f|f|f||||||||2017-10-10 20:46:48.773033|2017-10-10 20:46:48.773033
NCT03256721|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-20|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|May 26, 2019|Anticipated|2019-05-26|August 26, 2018|Anticipated|2018-08-26||Interventional|||Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC|A Randomized, Parallel Control, Exploratory Trial to Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in Subjects With Advanced or Metastatic of the Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|135|Anticipated|Fuzhou General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:46:48.835744|2017-10-10 20:46:48.835744
NCT03256708|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PAADI||Prevention of Antibiotic-Associated Diarrhoea With Prolardii|Double-blind Randomised Placebo-controlled Study of Prolardii Gastro-resistant (GR) Caps in the Prevention and Treatment of Antibiotic-associated Diarrhoea.|Not yet recruiting||N/A|220|Anticipated|Therabel Pharma SA/NV||2|||f||||f|f|f||||||||2017-10-10 20:46:49.048667|2017-10-10 20:46:49.048667
NCT03256695|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||September 5, 2017|Anticipated|2017-09-05|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule and Exacerbations in Patients With Chronic Obstructive Pulmonary Disease|"A 12-Week, Open-Label Study to Evaluate the Relationship Between Use of Albuterol eMDPI, an Inhaled Short-Acting Beta Agonist Rescue Agent With an eModule, and Exacerbations in Patients (40 Years of Age or Older) With Chronic Obstructive Pulmonary Disease"|Not yet recruiting||Phase 3|400|Anticipated|Teva Pharmaceutical Industries||1|||f||||f|t|f||||||||2017-10-10 20:46:49.140915|2017-10-10 20:46:49.140915
NCT03256682|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||August 21, 2017|Anticipated|2017-08-21|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Efficacy of Mobile Video Counseling for Employees With Emotional Labor|The Efficacy of a Mobile Video Counseling Targeted for Stress Reduction and Resilience Enhancement in Employees With Emotional Labor|Not yet recruiting||N/A|100|Anticipated|Seoul National University Hospital||3|||f||||f|f|f||||||||2017-10-10 20:46:49.21871|2017-10-10 20:46:49.21871
NCT03256669|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-08-20|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|August 1, 2017|Actual|2017-08-01||Interventional|||Umblical Incision for Neonatal Surgery|Umblical Incision for Neonatal Surgey; is it Suitable|Enrolling by invitation||N/A|6|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:46:49.318865|2017-10-10 20:46:49.318865
NCT03256656|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-08-17|||January 2017||2017-01-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||The Effect of Lower Urinary Tract Electrical Stimulation on Renal Urine Production (Diuresis)||Active, not recruiting||N/A|30|Anticipated|University of Zurich||2|||f||||||||||||||2017-10-10 20:46:49.397767|2017-10-10 20:46:49.397767
NCT03256643|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-08-19|||May 1, 2016|Actual|2016-05-01|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Interventional|BITEEE||Brain Injury Therapy of Exercise and Enriched Environment|Cognitive and Physical Effects of Exercise or Exercise With Enrichment on People With TBI|Recruiting||N/A|45|Anticipated|Wayne State University||3|||f||||f|f|f||||||||2017-10-10 20:46:49.464758|2017-10-10 20:46:49.464758
NCT03256630|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Evaluation of Urine and Blood Biomarkers to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer|A Laboratory Study to Evaluate Urine and Blood Biomarkers That Can Distinguish Between the Presence or Absence of Aggressive Prostate Cancer|Not yet recruiting||N/A|240|Anticipated|Genomic Health®, Inc.|||1||f||||f|f|f|||||"     Blood, Urine   "|||2017-10-10 20:46:49.639034|2017-10-10 20:46:49.639034
NCT03256617|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-19|||May 19, 2017|Actual|2017-05-19|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|August 25, 2017|Anticipated|2017-08-25||Interventional|||The Development of a Cognitive Reassurance Training Program|The Development of a Cognitive Reassurance Training Program and Its Impact on Physical Therapist and Patient Outcomes|Recruiting||N/A|200|Anticipated|University of Utah||1|||f||||f|f|f||||||||2017-10-10 20:46:49.725288|2017-10-10 20:46:49.725288
NCT03256604|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-19|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|February 5, 2016|Actual|2016-02-05||Observational|self-test||A Sputum Screening Test to Rule-out Pneumonia at an Early Stage||Completed||N/A|467|Actual|University Hospital, Linkoeping|||1||f|||||f|f||||Samples Without DNA|"     Sputum samples from all included cases are kept frozen -70 C coded.   "|||2017-10-10 20:46:49.844449|2017-10-10 20:46:49.844449
NCT03256591|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-19|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|SimHBB||Implementation of HBB Training With Facilitators That Have Undergone Simulation Methodology Training|A Comparison of the Implementation of HBB Training Using Facilitators With and Without Simulation Methodology Training|Not yet recruiting||N/A|100|Anticipated|Mbarara University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 20:46:49.933098|2017-10-10 20:46:49.933098
NCT03256578|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-18|||February 20, 2017|Actual|2017-02-20|August 2017|2017-08-01|August 20, 2019|Anticipated|2019-08-20|February 20, 2019|Anticipated|2019-02-20||Interventional|MONITOR||Monitoring Neonatal Resuscitation Trial|A Multi-center Randomized Controlled Trial of Respiratory Function Monitoring During Stabilization of Preterm Infants at Birth|Recruiting||N/A|286|Anticipated|University of Pennsylvania||2|||f||||t|f|t|t|f|f|||||2017-10-10 20:46:50.019049|2017-10-10 20:46:50.019049
NCT03256565|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-17|||June 30, 2017|Actual|2017-06-30|May 2017|2017-05-01|September 10, 2017|Anticipated|2017-09-10|August 31, 2017|Anticipated|2017-08-31||Observational|||Q-tip Test and Urodynamic Study|Correlation Between Q-tip Test and Urodynamic Study in Women With Stress Urinary Incontinence|Recruiting||N/A|30|Anticipated|Far Eastern Memorial Hospital|||1||f|||||f|f||||||||2017-10-10 20:46:50.174473|2017-10-10 20:46:50.174473
NCT03256552|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||January 28, 2015|Actual|2015-01-28|August 2017|2017-08-01|September 5, 2015|Actual|2015-09-05|September 5, 2015|Actual|2015-09-05||Interventional|||Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD|A Randomized, Double-Blind, Chronic Dosing (7-Day), Four-Period, Four-Treatment, Placebo-Controlled, Cross-Over, Multi-Center Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD|Completed||Phase 2|66|Actual|Pearl Therapeutics, Inc.||4|||f||||f|t|f|||t|||||2017-10-10 20:46:50.282568|2017-10-10 20:46:50.282568
NCT03256539|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-18|||September 2019|Anticipated|2019-09-01|August 2017|2017-08-01|May 2022|Anticipated|2022-05-01|August 2021|Anticipated|2021-08-01||Interventional|||Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease|Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease|Not yet recruiting||N/A|40|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||||2017-10-10 20:46:50.406858|2017-10-10 20:46:50.406858
NCT03256513|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-17|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization|The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization for Ischemic Cerebral Vascular Disease|Recruiting||N/A|2270|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t|f|f||||||||2017-10-10 20:46:50.588354|2017-10-10 20:46:50.588354
NCT03256500|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-18|||September 2016||2016-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transcranial Direct Current Stimulation for the Treatment of Delirium|Transcranial Direct Current Stimulation for the Treatment of Delirium|Recruiting||N/A|100|Anticipated|North Florida/South Georgia Veterans Health System||2|||f||||||||||||||2017-10-10 20:46:50.67755|2017-10-10 20:46:50.67755
NCT03256487|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-27|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department|Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department|Recruiting||Phase 2|122|Anticipated|Alameda Health System||2|||f||||f|t|f|||t|||||2017-10-10 20:46:50.768839|2017-10-10 20:46:50.768839
NCT03256474|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-17|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|||Managing Bacterial Pneumonia in Children Without Antimicrobials|Can Community-acquired Bacterial Pneumonia in Children be Safely Managed Without Antibiotics in an Integrative Medicine Context? A Retrospective Cohort Analysis|Not yet recruiting||N/A|350|Anticipated|ARCIM Institute Academic Research in Complementary and Integrative Medicine|||1||f|||||f|f||||||||2017-10-10 20:46:50.855467|2017-10-10 20:46:50.855467
NCT03256461|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-21|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Lactate Clearance Goal-directed Therapy in Sepsis|Multi-center Clinical Trial of Lactate Clearance Goal-directed Fluid Resuscitation in Patients With Sepsis|Recruiting||N/A|1128|Anticipated|Nanfang Hospital of Southern Medical University||3|||f||||t|f|f||||||||2017-10-10 20:46:50.924309|2017-10-10 20:46:50.924309
NCT03256435|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-08-18|||September 7, 2016|Actual|2016-09-07|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||PrEP Intervention for African American MSM in Mississippi|PrEP Uptake, Retention, and Adherence for African American MSM in Mississippi|Recruiting||N/A|80|Anticipated|Brown University||2|||f||||f|f|f||||||||2017-10-10 20:46:51.024022|2017-10-10 20:46:51.024022
NCT03256422|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-17|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|QUATUOR||Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients|Randomized, Open-label and Multicentric Trial Evaluating the Non-inferiority of Antiretroviral Treatment Taken 4 Consecutive Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients With Controlled Viral Load Under Antiretroviral Therapy|Not yet recruiting||Phase 3|640|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t|f|f||||||||2017-10-10 20:46:51.130921|2017-10-10 20:46:51.130921
NCT03256409|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-19|||January 5, 2016|Actual|2016-01-05|August 2017|2017-08-01|June 20, 2017|Actual|2017-06-20|January 11, 2017|Actual|2017-01-11||Interventional|||Bar and Ball Joint Overdentures Surface Roughness and Microbial Adherence|Bar and Ball Joint Overdentures Surface Roughness and Microbial Adherence|Completed||N/A|10|Actual|Gastrovital||2|||f||||t|f|f|||t|||||2017-10-10 20:46:51.453934|2017-10-10 20:46:51.453934
NCT03256396|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-18|||October 9, 2017|Anticipated|2017-10-09|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|January 31, 2018|Anticipated|2018-01-31||Interventional|||Intraoperative PEEP Setting During Laparoscopic Gynecologic Surgery|Intraoperative Positive End-Expiratory Pressure Setting Guided By Esophageal Pressure Measurement in Patients Undergoing Laparoscopic Gynecologic Surgery|Not yet recruiting||N/A|44|Anticipated|Mahidol University||2|||f|||||f|f||||||||2017-10-10 20:46:51.536984|2017-10-10 20:46:51.536984
NCT03256370|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|||Association of HMOs and Allergic Manifestations|The Association Between Human Milk Oligosaccharide and Development of Allergic Manifestations in Infants|Not yet recruiting||N/A|150|Anticipated|Chulalongkorn University|||3||f||||||||||Samples Without DNA|"     human breast-milk   "|||2017-10-10 20:46:51.701111|2017-10-10 20:46:51.701111
NCT03256357|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-17|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Constraint-Induced Movement Therapy and Action Observation Training in Children With Unilateral Cerebral Palsy|Effectiveness of Intensive Upper Limb Training Combining Constraint-Induced Movement Therapy and Action Observation Training in Children With Unilateral Cerebral Palsy|Recruiting||N/A|40|Anticipated|Katholieke Universiteit Leuven||2|||f||||||||||||||2017-10-10 20:46:51.784573|2017-10-10 20:46:51.784573
NCT03256344|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-10-05|||February 2, 2018|Anticipated|2018-02-02|October 2017|2017-10-01|April 25, 2021|Anticipated|2021-04-25|June 24, 2019|Anticipated|2019-06-24||Interventional|||A Safety Study of Talimogene Laherparepvec Combined With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases|A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects With Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases|Not yet recruiting||Phase 1|36|Anticipated|Amgen||1|||f||||f|t|f||||||||2017-10-10 20:46:51.873296|2017-10-10 20:46:51.873296
NCT03256331|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-17|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients|A Phase I, Open-Label, Dose Escalation and Extension Study to Evaluate the Safety, Tolerability and Preliminary Effects of Oral BEL-X-HG in Patients With Advanced Refractory Solid Malignancies|Recruiting||Phase 1|48|Anticipated|Belx Bio-Pharmaceutical (Taiwan) Corporation||1|||||||t|t|f||||||||2017-10-10 20:46:51.950344|2017-10-10 20:46:51.950344
NCT03256318|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-09-07|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|December 31, 2030|Anticipated|2030-12-31|December 31, 2027|Anticipated|2027-12-31||Observational|PLAY-LONG||PLAY LONG: The Effect of Sports and Recreation Participation for Young chiLdren With physicAl disabilitY|PLAY LONG: The Effect of Sports and Recreation Participation for Young chiLdren With physicAl disabilitY - Longitudinal Study|Recruiting||N/A|300|Anticipated|Allina Health System|||2||f||||f|f|f||||||||2017-10-10 20:46:52.11811|2017-10-10 20:46:52.11811
NCT03256305|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-31|||December 2016||2016-12-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of rTMS Personalized Precision Treatment of Post-stroke Depression|A Clinical Control Study of rTMS Personalized Precision Treatment of Post-stroke Depression Based on Mechanism of Emotional Circuit Imbalance|Recruiting||N/A|120|Anticipated|Zhujiang Hospital||2|||f||||f||||||||||2017-10-10 20:46:52.194539|2017-10-10 20:46:52.194539
NCT03256292|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|LITE||Long-term Lifestyle Change and Testosterone Replacement|Long-term Lifestyle Change in Obese Older Veterans|Enrolling by invitation||N/A|72|Anticipated|Baylor College of Medicine|||1||f||||t|t|f|||t|||||2017-10-10 20:46:52.296862|2017-10-10 20:46:52.296862
NCT03256279|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-24|||July 8, 2017|Actual|2017-07-08|August 2017|2017-08-01|December 4, 2018|Anticipated|2018-12-04|February 10, 2018|Anticipated|2018-02-10||Interventional|(NiTi)||Mechanical Properties and Clinical Efficacy of Two Nickel-Titanium (NiTi) Archwires|Comparison of Mechanical Properties and Clinical Efficacy Between Heat-activated and Superelastic Nickel-Titanium (NiTi) Archwires.|Recruiting||N/A|54|Anticipated|Fundación Universitaria CIEO||2|||f||||f|f|f||||||||2017-10-10 20:46:52.408551|2017-10-10 20:46:52.408551
NCT03256266|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-16|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Observational|||Effect of Antigens or Therapeutic Agents on in Vitro Human Intestinal Organoids|Establishment of Small Intestinal Human Organoids to Check the Influence of Nutrient Antigens or Therapeutic Agents|Recruiting||N/A|375|Anticipated|University of Erlangen-Nürnberg Medical School|||3||f||||f|f|f||||||||2017-10-10 20:46:52.500131|2017-10-10 20:46:52.500131
NCT03256253|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||An Open-Label Pilot Study of Pregabalin as Treatment for Alcohol Use Disorder|An Open-Label Pilot Study of Pregabalin as Treatment for Alcohol Use Disorder|Not yet recruiting||Phase 2|20|Anticipated|New York State Psychiatric Institute||1|||f||||f|t|f|||f|||||2017-10-10 20:46:52.567443|2017-10-10 20:46:52.567443
NCT03256240|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-08-16|||March 2014||2014-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis|Prospective Randomized Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis in the Prevention of Post-operative Recurrence of Crohn's Disease|Recruiting||N/A|88|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-10 20:46:52.651444|2017-10-10 20:46:52.651444
NCT03256227|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-16|||February 1, 2018|Anticipated|2018-02-01|August 2017|2017-08-01|January 31, 2021|Anticipated|2021-01-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families|Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families|Not yet recruiting||N/A|312|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 20:46:52.73933|2017-10-10 20:46:52.73933
NCT03256214|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-16|||February 2, 2015|Actual|2015-02-02|August 2017|2017-08-01|April 17, 2017|Actual|2017-04-17|July 15, 2016|Actual|2016-07-15||Interventional|||Acute Effects of Open and Closed Suction Systems in Mechanically Ventilated Patients|Acute Effects of Open and Closed Suction Systems on Pulmonary Mechanics and Cardiovascular Function in Mechanically Ventilated Patients|Completed||N/A|71|Actual|University of Sao Paulo||2|||f||||f|f|f||||||||2017-10-10 20:46:52.82426|2017-10-10 20:46:52.82426
NCT03256201|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-08-18|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Exercise and Nutrition to Improve Pancreatic Outcomes|Preoperative Exercise and Nutrition to Improve Pancreatic Cancer Outcomes by Targeting Sarcopenia: A Translational Pilot RCT|Recruiting||N/A|60|Anticipated|University of Oklahoma||2|||f||||t|f|f||||||||2017-10-10 20:46:52.888742|2017-10-10 20:46:52.888742
NCT03256175|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-18|||July 1, 2015|Actual|2015-07-01|August 2017|2017-08-01|June 30, 2016|Actual|2016-06-30|December 31, 2015|Actual|2015-12-31||Interventional|||The Effect of Peri-percutaneous Coronary Intervention Oxygenation on Myocardial Protection & Cardiovascular Fitness|The Effects Of Peri-Percutaneous Coronary Intervention Oxygenation On Myocardial Protection And Cardiovascular Function: A Pilot Study|Completed||N/A|40|Actual|University of Malaya||2|||f|||||f|f||||||||2017-10-10 20:46:53.057343|2017-10-10 20:46:53.057343
NCT03256162|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-20|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|KARMA-dep||Ketamine as an Adjunctive Therapy for Major Depression|Ketamine as an Adjunctive Therapy for Major Depression - a Randomised Controlled Pilot Trial: The KARMA-Dep Trial|Recruiting||Phase 1|20|Anticipated|St Patrick's Hospital, Ireland||2|||f||||t|f|f||||||||2017-10-10 20:46:53.142065|2017-10-10 20:46:53.142065
NCT03256149|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||March 24, 2015|Actual|2015-03-24|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|SHDD||High Dose Steroids for Dysphagia|Effect of High Dose Steroids on Dysphagia After Anterior Spinal Surgery: a Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t|f|f|||f|||||2017-10-10 20:46:53.251745|2017-10-10 20:46:53.251745
NCT03256136|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-10-04|||October 31, 2017|Anticipated|2017-10-31|October 2017|2017-10-01|October 31, 2024|Anticipated|2024-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC|A Phase II Study of Nivolumab in Combination With Carboplatin and Pemetrexed, or Nivolumab in Combination With Ipilimumab, in Patients With Advanced, EGFR-mutant or ALK-rearranged, Non-Small Cell Lung Cancer|Not yet recruiting||Phase 2|100|Anticipated|Massachusetts General Hospital||4|||f||||f|t|f||||||||2017-10-10 20:46:53.350465|2017-10-10 20:46:53.350465
NCT03256123|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||The Effects of Biscuits Containing Red Palm Oil on School Children With Vitamin A Deficiency in West and East Malaysia|The Effect of Biscuits Containing Red Palm Oil on School Children With Vitamin A Deficiency in West and East Malaysia|Recruiting||N/A|300|Anticipated|Malaysia Palm Oil Board||2|||f|||||f|f||||||||2017-10-10 20:46:53.467346|2017-10-10 20:46:53.467346
NCT03256110|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-18|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|PALL||Palliative Care Communication With Alaska Native and American Indian People|Exploring Palliative Care Communication With Alaska Native and American Indian People at Two Sites|Not yet recruiting||N/A|60|Anticipated|Southcentral Foundation||2|||f||||t|f|f||||||||2017-10-10 20:46:53.582394|2017-10-10 20:46:53.582394
NCT03256097|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-18|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Voice Guard Processing Evaluation in a Cohort of Subjects Implanted With the Neuro Cochlear Implant System|Voice Guard Processing Evaluation in a Cohort of Subjects Implanted With the Neuro Cochlear Implant System|Not yet recruiting||N/A|20|Anticipated|Oticon Medical||3|||f||||t|f|f||||||||2017-10-10 20:46:53.661243|2017-10-10 20:46:53.661243
NCT03256084|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-18|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|July 17, 2022|Anticipated|2022-07-17|July 17, 2022|Anticipated|2022-07-17||Interventional|||Tumoral Circulating Cells and Colorectal Cancer Progression|Characterization of Tumoral Circulating Cells According to Stage of Progression of Colorectal Cancers|Recruiting||N/A|160|Anticipated|Institut Paoli-Calmettes||1|||f||||f|f|f||||||||2017-10-10 20:46:53.732343|2017-10-10 20:46:53.732343
NCT03256071|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-08-18|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT|Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT|Recruiting||Phase 2/Phase 3|90|Anticipated|The First Affiliated Hospital of Soochow University||2|||f|||||f|f|||f|||||2017-10-10 20:46:53.817064|2017-10-10 20:46:53.817064
NCT03256058|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Tourniquet Application on Total Knee Arthroplasty|The Effect of Different Applications of Tourniquet on Total Knee Arthroplasty|Not yet recruiting||N/A|60|Anticipated|The Affiliated Hospital of Xuzhou Medical University||2|||f||||t|f|f||||||||2017-10-10 20:46:53.919328|2017-10-10 20:46:53.919328
NCT03256045|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-25|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|September 16, 2023|Anticipated|2023-09-16|September 16, 2020|Anticipated|2020-09-16||Interventional|||Panobinostat, Carfilzomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|CLBH589DUS108T: Panobinostat With Carfilzomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Correlation With In Vitro Chemosensitivity Testing|Not yet recruiting||Phase 2|40|Anticipated|University of Washington||1|||f||||t|t|f||||||||2017-10-10 20:46:54.022053|2017-10-10 20:46:54.022053
NCT03256032|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-18|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|||Prevalence and Factors Associated With Postoperative Hypothermia in Mulago Hospital|Prevalence and Factors Associated With Postoperative Hypothermia Among Patients Undergoing Anaesthesia and Surgery in Mulago National Referral Hospital|Completed||N/A|770|Actual|Makerere University|||1||f||||||||||||||2017-10-10 20:46:54.160603|2017-10-10 20:46:54.160603
NCT03256019|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||March 1, 2011|Actual|2011-03-01|August 2017|2017-08-01|March 1, 2015|Actual|2015-03-01|March 1, 2015|Actual|2015-03-01||Interventional|||Compare Outcomes of CPR Between the VL Users and DL Users|Improvement of Recovery of Spontaneous Circulation and Survival Using the Videolaryngoscopy for out-of Hospital Cardiac Arrest Patient|Completed||N/A|500|Actual|Konkuk University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:46:54.218323|2017-10-10 20:46:54.218323
NCT03256006|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-16|||October 18, 2017|Anticipated|2017-10-18|August 2017|2017-08-01|October 29, 2017|Anticipated|2017-10-29|October 18, 2017|Anticipated|2017-10-18||Observational|TRAIL PHYSIO||Study Inflammation During a 100 Miles|Per Effort Study of Inflammation During a 100 Miles|Not yet recruiting||N/A|20|Anticipated|Hôpital Necker-Enfants Malades|||1||f||||f|f|f||||Samples Without DNA|"     pro and anti inflammatory biomarkers (reactive oxygen species)   "|||2017-10-10 20:46:54.300561|2017-10-10 20:46:54.300561
NCT03255993|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-30|||September 20, 2017|Anticipated|2017-09-20|August 2017|2017-08-01|September 20, 2018|Anticipated|2018-09-20|September 20, 2018|Anticipated|2018-09-20||Interventional|||The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People|Multiple Doses Study to Evaluate the Tolerability and Pharmacokinetics of SPH3127 in Chinese Healthy People|Not yet recruiting||Phase 1|24|Anticipated|Shanghai Pharmaceuticals Holding Co., Ltd||6|||f|||||f|f||||||||2017-10-10 20:46:54.365271|2017-10-10 20:46:54.365271
NCT03255980|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-21|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®|Monocenter, Open Label Clinical Investigation on the Treatment With Xonrid®, a Medical Device for the Prevention and Treatment of Radiotherapy-induced Dermatitis, in Breast and Head & Neck Cancer Patients Receiving Curative Treatment.|Recruiting||N/A|80|Anticipated|Helsinn Healthcare SA||2|||f||||f|f|f|||f|||||2017-10-10 20:46:54.457003|2017-10-10 20:46:54.457003
NCT03255967|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-07|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Dementia Symptom Management at Home Program|A Multisite Cluster RCT of the Dementia Symptom Management at Home Program|Not yet recruiting||N/A|300|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:46:54.541135|2017-10-10 20:46:54.541135
NCT03255954|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-17|||February 10, 2017|Actual|2017-02-10|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||IPC for University Counseling Centers|Interpersonal Counseling (IPC) for University Counseling Centers|Recruiting||N/A|40|Anticipated|Johns Hopkins University||1|||f||||f|f|f||||||||2017-10-10 20:46:54.60206|2017-10-10 20:46:54.60206
NCT03255928|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-16|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|June 29, 2021|Anticipated|2021-06-29|June 29, 2020|Anticipated|2020-06-29|2 Years|Observational [Patient Registry]|PASVAD||Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)|Analysis of the Platelet Activity State in Patients Implanted With Ventricular Assist Device (VAD)|Recruiting||N/A|60|Anticipated|Scientific Institute San Raffaele|||2||f||||f|f|t|f|f|t|Samples Without DNA|"     Platelet-free-plasma   "|||2017-10-10 20:46:54.789951|2017-10-10 20:46:54.789951
NCT03255915|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-16|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|PrEP-Pod-IVR||PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study)|Randomized Order, Controlled, Double Blind, Crossover Early Phase 1 Pilot Study to Assess Safety and Pharmacokinetics of a Tenofovir Disoproxil Fumarate and Emtricitabine (TDF-FTC) Releasing IVR Over 28 Days Compared to Placebo|Not yet recruiting||Early Phase 1|10|Anticipated|Oak Crest Institute of Science||2|||f|||||t|f||||||||2017-10-10 20:46:54.886961|2017-10-10 20:46:54.886961
NCT03255902|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||May 24, 2016|Actual|2016-05-24|August 2017|2017-08-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||Family Routines - Healthy Families|Family Routine - Healthy Families|Completed||N/A|8|Actual|William Beaumont Hospitals||1|||f||||f|f|f||||||||2017-10-10 20:46:54.963664|2017-10-10 20:46:54.963664
NCT03255889|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-18|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|March 28, 2018|Anticipated|2018-03-28|September 24, 2017|Anticipated|2017-09-24||Interventional|||Absorption and Tolerability Studies of an Emulsion Containing the Coconut Oil-derived Glycerol Tridecanoate in Healthy Men|Absorption and Tolerability Studies of an Emulsion Containing the Coconut Oil-derived Glycerol Tridecanoate in Healthy Men|Not yet recruiting||Phase 1|24|Anticipated|National University Hospital, Singapore||2|||f||||t|f|f||||||||2017-10-10 20:46:55.030445|2017-10-10 20:46:55.030445
NCT03255876|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-21|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|February 9, 2018|Anticipated|2018-02-09||Interventional|PolyGlucHeal||Effects of Enriched Fruit Juice on Blood Glucose Levels After a Meal in Healthy Subjects|Effects of Enriched Fruit Juice on Blood Glucose Levels After a Meal in Healthy Subjects|Recruiting||N/A|24|Anticipated|University of Leeds||2|||f||||f|f|f||||||||2017-10-10 20:46:55.108446|2017-10-10 20:46:55.108446
NCT03255863|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|UTEP||Determinants of Patients' Uptake of Therapeutic Education Programme|Determinants of Patients' Uptake of Therapeutic Education Programme|Not yet recruiting||N/A|459|Anticipated|University Hospital, Lille||1|||f||||f|f|f||||||||2017-10-10 20:46:55.193731|2017-10-10 20:46:55.193731
NCT03255850|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Psychological Well Being and Quality of Life of Adolescents Congenital Heart Disease Patients in Hong Kong|Psychological Well Being and Quality of Life of Adolescents Congenital Heart Disease Patients in Hong Kong|Recruiting||N/A|300|Anticipated|The University of Hong Kong|||3||f||||t|f|f||||||||2017-10-10 20:46:55.263248|2017-10-10 20:46:55.263248
NCT03255837|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||tDCS on Working Memory (WM) in Adults With ASD|A Single Blind, Randomized Controlled Trial of Anodal Transcranial Direct-current Stimulation (tDCS) Against Cathodal and Sham Stimulation in Adults With High-Functioning Autism|Not yet recruiting||N/A|48|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f|f|f||||||||2017-10-10 20:46:55.341234|2017-10-10 20:46:55.341234
NCT03255824|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation|A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation|Not yet recruiting||Phase 4|20|Anticipated|Montefiore Medical Center||2|||f|||||t|f|||t|||||2017-10-10 20:46:55.413506|2017-10-10 20:46:55.413506
NCT03251040|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-18|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|May 1, 2017|Actual|2017-05-01|April 1, 2016|Actual|2016-04-01||Interventional|SEAL||Fibrin Sealant in Esophageal Surgery|Autologous Activated Fibrin Sealant for the Esophageal Anastomosis, a Feasibility Study|Completed||N/A|15|Actual|VU University Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:47:39.225476|2017-10-10 20:47:39.225476
NCT03255811|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||March 25, 2017|Actual|2017-03-25|August 2017|2017-08-01|March 25, 2019|Anticipated|2019-03-25|January 25, 2019|Anticipated|2019-01-25||Interventional|||Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer|Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer -- Multicenter, Open, One Arm Exploratory Study|Enrolling by invitation||N/A|40|Anticipated|Guangdong General Hospital||1|||f||||t|f|f||||||||2017-10-10 20:46:55.495277|2017-10-10 20:46:55.495277
NCT03255798|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|GCF-041||A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra|A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects Treated With Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent|Recruiting||Phase 4|50|Anticipated|Glaukos Corporation||1|||f||||f|f|t|t|f||||||2017-10-10 20:46:55.558323|2017-10-10 20:46:55.558323
NCT03255785|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent Supra|A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent|Not yet recruiting||Phase 4|50|Anticipated|Glaukos Corporation||1|||f||||f|f|t|t|f||||||2017-10-10 20:46:55.754552|2017-10-10 20:46:55.754552
NCT03255772|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-31|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|November 30, 2017|Anticipated|2017-11-30||Observational|||Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients|Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients|Recruiting||N/A|100|Anticipated|Genetesis LLC|||1||f||||f|f|t|t|f|f|||||2017-10-10 20:46:55.85141|2017-10-10 20:46:55.85141
NCT03255759|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|November 30, 2018|Anticipated|2018-11-30|July 31, 2018|Anticipated|2018-07-31||Interventional|||Actionable Results: Bloodstream Infection Molecular Assay Evaluation|Assessment of the Use and Impact of a Molecular Identification Assay in the Diagnosis and Management of Bloodstream Infections at in Healthcare Settings in Princess Marina Hospital, Botswana|Not yet recruiting||N/A|560|Anticipated|Foundation for Innovative New Diagnostics, Switzerland||2|||f||||t|f|f||||||||2017-10-10 20:46:55.990008|2017-10-10 20:46:55.990008
NCT03255746|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-10-05|||January 1, 2018|Anticipated|2018-01-01|October 2017|2017-10-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Interventional|||HELP-HY: Health Education and sLeep Program in HYpertension|HELP-HY: Health Education and sLeep Program in HYpertension|Not yet recruiting||N/A|94|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 20:46:56.078368|2017-10-10 20:46:56.078368
NCT03255720|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-23|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 1, 2022|Anticipated|2022-12-01|4 Years|Observational [Patient Registry]|||Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes|Application of Diffusion Tensor Imaging in Alzheimer's Disease:Quantification of White Matter Micro-structural Changes|Not yet recruiting||N/A|40|Anticipated|Assiut University|||2||f||||t|f|f||||||||2017-10-10 20:46:56.298195|2017-10-10 20:46:56.298195
NCT03255707|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-17|||November 24, 2016|Actual|2016-11-24|August 2017|2017-08-01|November 24, 2020|Anticipated|2020-11-24|November 24, 2017|Anticipated|2017-11-24||Interventional|||A Comparative Study Between Dissociative Treatment and Binocular Interactive Treatment in Amblyopia|A Comparative Study Between Dissociative Treatment and Binocular Interactive Treatment in Amblyopia|Recruiting||N/A|100|Anticipated|Ain Shams University||2|||f|||||f|f|||f|||||2017-10-10 20:46:56.396991|2017-10-10 20:46:56.396991
NCT03255694|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-16|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|June 2026|Anticipated|2026-06-01|December 2022|Anticipated|2022-12-01||Interventional|||A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature|A Phase 2 Study Extension Period of Pegylated Somatropin (PEG-somatropin) in the Treatment of Children With Idiopathic Short Stature: An Open, Non-controlled Observational Study.|Recruiting||Phase 2|360|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:46:56.604606|2017-10-10 20:46:56.604606
NCT03255681|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-19|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|PRP||PRP Administration in the Nasojugal Folds|Efficacy of Platelet-Rich Plasma Filler for Treatment of Tear Trough Deformities|Not yet recruiting||N/A|50|Anticipated|David Grant U.S. Air Force Medical Center||1|||f||||t|f|f|||f|||||2017-10-10 20:46:56.804288|2017-10-10 20:46:56.804288
NCT03255668|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01|1 Day|Observational [Patient Registry]|||Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia|Haematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia: Focus on Genotyping and Phenotyping of Mercaptopurine|Recruiting||N/A|100|Anticipated|Indonesia University|||1||f||||f|f|f||||||||2017-10-10 20:46:56.945039|2017-10-10 20:46:56.945039
NCT03255655|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-18|||October 22, 2014|Actual|2014-10-22|August 2017|2017-08-01|March 1, 2016|Actual|2016-03-01|March 1, 2016|Actual|2016-03-01||Interventional|ITU||Intense Therapeutic Ultrasound - Treatment for Chronic Plantar Fascia Musculoskeletal Pain Reduction|Intense Therapeutic Ultrasound for Chronic Plantar Fascia Musculoskeletal Pain Reduction|Completed||N/A|37|Actual|Guided Therapy Systems||2|||f|||||f|t|t|f|t|||||2017-10-10 20:46:57.076018|2017-10-10 20:46:57.076018
NCT03255642|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Melatonin and Clonazepam for IRBD: Cross-over Study|Efficacy and Safety of Melatonin and Rivotril Treatment for Idiopathic Rapid Eye Movement Sleep Disorder: Prospective Randomized Cross-over Study.|Not yet recruiting||N/A|24|Anticipated|Kyung Hee University Hospital at Gangdong||2|||f||||t|f|f|||f|||||2017-10-10 20:46:57.193908|2017-10-10 20:46:57.193908
NCT03255629|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-22|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia|Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia|Recruiting||Phase 1/Phase 2|40|Anticipated|Joslin Diabetes Center||2|||f||||f|t|t|f|||||||2017-10-10 20:46:57.303648|2017-10-10 20:46:57.303648
NCT03255616|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-22|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Refining the Homunculus as a Basis to Unravel Its Role in Non-Specific Chronic Back Pain|Refining the Homunculus as a Basis to Unravel Its Role in Non-Specific Chronic Back Pain (CLBP)|Not yet recruiting||N/A|80|Anticipated|Balgrist University Hospital||4|||f||||f|f|f||||||||2017-10-10 20:46:57.420718|2017-10-10 20:46:57.420718
NCT03255603|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-01|||September 1, 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 22, 2018|Anticipated|2018-12-22|December 22, 2017|Anticipated|2017-12-22||Interventional|||Gastrointestinal Assessment of Three Novel RS4|Gastrointestinal Assessment of Three Novel Resistant Starch Type IV|Recruiting||N/A|40|Anticipated|University of Alberta||4|||f||||f|f|f||||||||2017-10-10 20:46:57.510294|2017-10-10 20:46:57.510294
NCT03255590|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-16|||March 3, 2017|Actual|2017-03-03|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Can we Train Patients With Chronic Stroke Out of Abnormal Hand Synergy?|Training and Non-Invasive Brain Stimulation in Chronic Stroke Reduce Abnormal Hand Synergy|Recruiting||N/A|40|Anticipated|Johns Hopkins University||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:46:57.614264|2017-10-10 20:46:57.614264
NCT03255577|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-22|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer|Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients Presenting With Locally Advanced Breast Cancer: A Prospective Study|Recruiting||N/A|100|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||f|f||||||||2017-10-10 20:46:57.733921|2017-10-10 20:46:57.733921
NCT03255564|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|September 30, 2019|Anticipated|2019-09-30||Observational|||Monitor Faecal Calprotectin Concentration in Infants With Heart Defects|Monitor Faecal Calprotectin Concentration in Infants With Heart Defects|Not yet recruiting||N/A|100|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust|||1||f||||t|f|f||||||||2017-10-10 20:46:57.853224|2017-10-10 20:46:57.853224
NCT03255551|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|December 31, 2015|Actual|2015-12-31|June 30, 2015|Actual|2015-06-30||Observational|||Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure|Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients With Hypertension: Prospective, Multicenter, Observational Study|Completed||N/A|50|Actual|Seoul National University Bundang Hospital|||1||f||||f|f|f||||||||2017-10-10 20:46:57.920235|2017-10-10 20:46:57.920235
NCT03255538|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|September 14, 2017|Anticipated|2017-09-14|September 14, 2017|Anticipated|2017-09-14||Interventional|||Deep Friction Massage: Symptomatic|Deep Friction Massage Effects on Pain and Function in Patellar Tendinopathy|Recruiting||N/A|20|Anticipated|Cooperativa de Ensino Superior, Politécnico e Universitário||3|||f|||||f|f||||||||2017-10-10 20:46:57.988762|2017-10-10 20:46:57.988762
NCT03255525|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|August 16, 2017|Actual|2017-08-16|August 16, 2017|Actual|2017-08-16||Interventional|DFM_Asymp||Deep Friction Massage Effects: Asymptomatic|Deep Friction Massage Effects on Analgesia of the Asymptomatic Patellar Tendon|Completed||N/A|30|Actual|Cooperativa de Ensino Superior, Politécnico e Universitário||3|||f|||||f|f||||||||2017-10-10 20:46:58.089273|2017-10-10 20:46:58.089273
NCT03255499|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-24|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Efficacy of the MovinCog Intervention in Children|Efficacy of the MovinCog Intervention in Children: A Randomized, Placebo-controlled Trial|Recruiting||N/A|1000|Anticipated|University of Auckland, New Zealand||4|||f||||f|f|f||||||||2017-10-10 20:46:58.251805|2017-10-10 20:46:58.251805
NCT03255486|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-16|||July 2013||2013-07-01|September 2016|2016-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|IDEASEIN||Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN)|Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy and Establishment of Preclinical Models of Resistance in Locally Advanced Breast Cancer|Completed||N/A|164|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-10 20:46:58.354152|2017-10-10 20:46:58.354152
NCT03255473|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-19|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|September 2019|Anticipated|2019-09-01||Interventional|||High Dose Oral Steroids in Sudden Sensorineural Hearing Loss|High Dose Oral Steroids in Sudden Sensorineural Hearing Loss|Recruiting||Phase 2|208|Anticipated|University of Colorado, Denver||2|||f||||f|t|f|||f|||||2017-10-10 20:46:58.418517|2017-10-10 20:46:58.418517
NCT03255460|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-18|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|||The Relationship Between Fatigue and Physical Activity Level in Patients With Multiple Sclerosis|Investigation of the Relationship Between Fatigue and Physical Activity Level in Patients With Multiple Sclerosis|Recruiting||N/A|74|Anticipated|Gazi University|||2||f||||f||||||||||2017-10-10 20:46:58.511195|2017-10-10 20:46:58.511195
NCT03255447|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-16|||November 30, 2016|Actual|2016-11-30|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Interventional|PRISM||Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy|Phase II Trial Investigating the Safety and Feasibility of Peptide GAM Immunoadsorption in Anti-PLA2R Positive Autoimmune Membranous Nephropathy|Recruiting||Phase 2|12|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||1|||f||||t|f|f|||f|||||2017-10-10 20:46:58.595511|2017-10-10 20:46:58.595511
NCT03255434|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-30|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|March 2019|Anticipated|2019-03-01||Interventional|LEANOX||LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy|LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy for Stage III Colon Cancer Patients Treated in Adjuvant Setting: Impact on Oxaliplatin-induced Sensitive Neurotoxicity. A Multicenter Phase II Randomized Trial (LEANOX)|Recruiting||Phase 2|308|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||f|f|f||||||||2017-10-10 20:46:58.686865|2017-10-10 20:46:58.686865
NCT03255421|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-28|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|September 29, 2017|Anticipated|2017-09-29|August 28, 2017|Anticipated|2017-08-28||Observational|||"Filling and Emptying Cystometries (Backwards Cystometry): a Feasibility and Validation Study"|Filling and Emptying Cystometries: a Feasibility and Validation Study in Order to Simplify the Manometric Follow-up of Overactive Detrusor in Neurological Patients Under Anticholinergic or Botulinum Toxin Injections.|Recruiting||N/A|12|Anticipated|Pierre and Marie Curie University|||1||f||||f|f|f||||||||2017-10-10 20:46:58.763156|2017-10-10 20:46:58.763156
NCT03255408|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-16|||October 30, 2017|Anticipated|2017-10-30|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia|Role of Cerebral Blood Flow on Ventilatory Stability During Sleep in Normoxia and Intermittent Hypoxia|Not yet recruiting||Phase 1/Phase 2|12|Anticipated|University of Calgary||4|||f|||||f|f|||f|||||2017-10-10 20:46:58.841449|2017-10-10 20:46:58.841449
NCT03255395|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-28|||April 24, 2017|Actual|2017-04-24|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Focused Ultrasound Treatment of Stump Neuromas for the Relief of Chronic Post-Amputation Neuropathic Pain|Focused Ultrasound Treatment of Stump Neuromas for the Relief of Chronic Post-Amputation Neuropathic Pain|Recruiting||N/A|10|Anticipated|Rambam Health Care Campus||1|||f||||f|f|f||||||||2017-10-10 20:46:58.956688|2017-10-10 20:46:58.956688
NCT03255382|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-21|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|August 14, 2018|Anticipated|2018-08-14|August 14, 2018|Anticipated|2018-08-14||Interventional|||A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy|A Randomized, Controlled, Multicenter, Open Label Study With Blinded Assessment of the Efficacy of the Humanized Anti-IL 23p19 Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy|Recruiting||Phase 3|110|Anticipated|AbbVie||2|||f||||f|f|f||||||||2017-10-10 20:46:59.040402|2017-10-10 20:46:59.040402
NCT03255369|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-23|||January 2, 2016|Actual|2016-01-02|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2017|Anticipated|2017-12-30|3 Years|Observational [Patient Registry]|ZIKVIRUSIFF||Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment (ZIKVIRUSIFF)|Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment: Cohort Study in Fiocruz/IFF|Recruiting||N/A|500|Anticipated|Oswaldo Cruz Foundation|||3||f||||t|f|f||||Samples With DNA|"     Urine and blood for RT-PCR Blood for IgG and IgM Saliva for RT-PCR placenta oral swab for     genetic studies fetal tissues stillborn for necropsy CSF and amniotic fluid if affected     babies breastmilk   "|||2017-10-10 20:46:59.181491|2017-10-10 20:46:59.181491
NCT03255356|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-18|||November 1, 2017|Anticipated|2017-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|VENICE||Ventilation in Cardiac Surgery|International Multicentre Observational Trial of Perioperative Ventilatory Management in Cardiac Surgery|Not yet recruiting||N/A|1000|Anticipated|University Hospital, Caen|||1||f||||f|f|f||||||||2017-10-10 20:46:59.276579|2017-10-10 20:46:59.276579
NCT03255343|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-18|||March 13, 2017|Actual|2017-03-13|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|ImDendrim||Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim|"Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim [188Re]Rhenium Complex Coupled to an Imidazolic Ligand and Associated With a Dendrimer"|Recruiting||N/A|10|Anticipated|French Association for the Advancement Medical Research||1|||f||||t|f|f|||f|||||2017-10-10 20:46:59.387158|2017-10-10 20:46:59.387158
NCT03255330|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-18|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|February 2020|Anticipated|2020-02-01||Interventional|GabaNeuBol||The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma|The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma|Not yet recruiting||Phase 3|120|Anticipated|Masaryk University||2|||f||||f|f|f||||||||2017-10-10 20:46:59.462983|2017-10-10 20:46:59.462983
NCT03255317|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-30|||August 24, 2017|Actual|2017-08-24|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|January 31, 2018|Anticipated|2018-01-31||Interventional|SARA||SARA - Substance Abuse Research Assistant|Developing a Flexible App Data Collection Tool for Substance Use Research|Recruiting||N/A|130|Anticipated|University of Michigan||1|||f||||f|f|f||||||||2017-10-10 20:46:59.537015|2017-10-10 20:46:59.537015
NCT03255304|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-18|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Influence of Priming on Goal-directed and Cue-dependent Behavior|Influence of Priming on Goal-directed and Cue-dependent Behavior|Not yet recruiting||N/A|100|Anticipated|University Hospital Tuebingen||2|||f||||f|f|f||||||||2017-10-10 20:47:01.047109|2017-10-10 20:47:01.047109
NCT03255291|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-18|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Communicating Multiple Disease Risks: A Translation of Risk Prediction Science|Communicating Multiple Disease Risks: A Translation of Risk Prediction Science|Recruiting||N/A|500|Anticipated|Washington University School of Medicine||5|||f||||f|f|f||||||||2017-10-10 20:47:01.185334|2017-10-10 20:47:01.185334
NCT03255278|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-20|||January 15, 2017|Actual|2017-01-15|August 2017|2017-08-01|February 15, 2018|Anticipated|2018-02-15|December 15, 2017|Anticipated|2017-12-15||Interventional|GamTBvac||"Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine GamTBvac Against the Tuberculosis."|"Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine GamTBvac Against the Tuberculosis. Comparative Placebo-controlled Study With a Two-fold Increase of the Vaccine Dose in Healthy Volunteers Aged 18-49 Years."|Recruiting||Phase 1|60|Anticipated|Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation||5|||f||||f|f|f||||||||2017-10-10 20:47:01.398512|2017-10-10 20:47:01.398512
NCT03255265|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-08-16|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|December 31, 2021|Anticipated|2021-12-31|September 28, 2021|Anticipated|2021-09-28||Observational|CSMCDTITAROT||Clinical Study of Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation|Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation|Recruiting||N/A|950|Anticipated|Fuzhou General Hospital|||2||f||||||||||Samples With DNA|"     blood   "|||2017-10-10 20:47:01.53184|2017-10-10 20:47:01.53184
NCT03255252|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-18|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|IMMUVIX||Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy|Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy (IMMUVIX)|Not yet recruiting||Phase 2|100|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f|f|f||||||||2017-10-10 20:47:01.690575|2017-10-10 20:47:01.690575
NCT03255239|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-22|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|August 1, 2017|Actual|2017-08-01||Interventional|||Open Preperitoneal Mesh Versus Retromuscular Mesh Versus Suture Repair for Abdominal Wall Hernias|Randomized Clinical Trial Comparing Open Preperitoneal Mesh, Retromuscular Mesh and Suture Repair for Abdominal Wall Hernias Less Than 3 cm Diameter|Recruiting||N/A|120|Anticipated|Hôpital Universitaire Taher Sfar||3|||f||||t|f|f||||||||2017-10-10 20:47:01.771187|2017-10-10 20:47:01.771187
NCT03255226|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-18|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload|A Multicenter, Open-labeled, Dose-defining Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload|Recruiting||Phase 3|60|Anticipated|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:47:01.869475|2017-10-10 20:47:01.869475
NCT03255213|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-10-02|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Lingual Muscle Training in Late-Onset Pompe Disease (LOPD)|Lingual Muscle Training in Late-Onset Pompe Disease (LOPD)|Not yet recruiting||N/A|5|Anticipated|Duke University||1|||f||||f|f|f||||||||2017-10-10 20:47:01.9435|2017-10-10 20:47:01.9435
NCT03255200|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-17|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|October 2019|Anticipated|2019-10-01|2 Years|Observational [Patient Registry]|ReActiv8-C||ReActiv8 Post Market Surveillance Registry|ReActiv8 Post Market Surveillance Registry for the ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain|Not yet recruiting||N/A|50|Anticipated|Mainstay Medical|||1||f||||f||||||||||2017-10-10 20:47:02.017998|2017-10-10 20:47:02.017998
NCT03255187|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-16|||August 13, 2017|Actual|2017-08-13|August 2017|2017-08-01|January 28, 2018|Anticipated|2018-01-28|January 28, 2018|Anticipated|2018-01-28||Interventional|||Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution|Effect of Dietary Supplementation With Fish Oil in Alleviating Cardiopulmonary Hazards Associated With Air Pollution|Recruiting||N/A|70|Anticipated|Fudan University||2|||f||||t|f|f||||||||2017-10-10 20:47:02.09364|2017-10-10 20:47:02.09364
NCT03255174|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-18|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|November 30, 2019|Anticipated|2019-11-30||Interventional|||The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding US Study|A Prospective Study Evaluating the Safety and Effectiveness of EVARREST® Fibrin Sealant Patch in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic and Thoracic (Non-cardiac) Surgery in Pediatric Patients|Not yet recruiting||Phase 4|35|Anticipated|Ethicon, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:47:02.30202|2017-10-10 20:47:02.30202
NCT03255161|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-22|||August 19, 2015|Actual|2015-08-19|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Randomized Controlled Trial of a Community Health Worker Program on Hearing Loss (Oyendo Bien)|Oyendo Bien: Reducing Disparities in Access to Hearing Health Care on the U.S.-Mexico Border|Recruiting||N/A|120|Anticipated|University of Arizona||2|||f||||f|f|f||||||||2017-10-10 20:47:02.386693|2017-10-10 20:47:02.386693
NCT03255148|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-18|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Influence of Oxytocin on Resting State Neurophysiological Measures|Influence of Oxytocin on Resting State Neurophysiological Measures|Recruiting||Phase 1|50|Anticipated|Katholieke Universiteit Leuven||2|||f||||f|f|f||||||||2017-10-10 20:47:02.471195|2017-10-10 20:47:02.471195
NCT03255135|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-16|||September 20, 2017|Anticipated|2017-09-20|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|December 20, 2017|Anticipated|2017-12-20||Interventional|||Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.|Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.|Not yet recruiting||N/A|50|Anticipated|Hospital de Transplante Doutor Euryclides de Jesus Zerbini||1|||f||||t|f|f||||||||2017-10-10 20:47:02.567978|2017-10-10 20:47:02.567978
NCT03255122|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-08-23|||November 3, 2016|Actual|2016-11-03|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|May 7, 2019|Anticipated|2019-05-07||Interventional|||Technology and Early Anxiety Treatment|Harnessing Technology to Extend the Reach of Supported Care for Families Affected by Early Child Social Anxiety|Recruiting||N/A|40|Anticipated|Florida International University||2|||f|||||f|f||||||||2017-10-10 20:47:02.671784|2017-10-10 20:47:02.671784
NCT03058861|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-16|||January 2017||2017-01-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Mitigating ACEs in Pediatric Primary Care|Mitigating ACEs in Pediatric Primary Care|Recruiting||N/A|400|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 21:19:36.487282|2017-10-10 21:19:36.487282
NCT03255109|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-16|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|March 31, 2018|Anticipated|2018-03-31|90 Days|Observational [Patient Registry]|WEAN SAFE||WorldwidE AssessmeNt of Separation of pAtients From Ventilatory assistancE|WEAN SAFE (WorldwidE AssessmeNt of Separation of pAtients From Ventilatory assistancE)|Not yet recruiting||N/A|5000|Anticipated|European Society of Intensive Care Medicine|||1||f||||t|f|f||||||||2017-10-10 20:47:02.803103|2017-10-10 20:47:02.803103
NCT03255096|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-22|||August 24, 2017|Anticipated|2017-08-24|August 2017|2017-08-01|July 15, 2020|Anticipated|2020-07-15|July 15, 2020|Anticipated|2020-07-15||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of the Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Open-Label, Dose Escalation/Expansion Phase Ib Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of the Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Recruiting||Phase 1|94|Anticipated|Hoffmann-La Roche||2|||f||||f|t|f||||||||2017-10-10 20:47:02.909359|2017-10-10 20:47:02.909359
NCT03255083|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-10-03|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|October 15, 2020|Anticipated|2020-10-15|October 15, 2020|Anticipated|2020-10-15||Interventional|||DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer|A Multicenter, Open-Label Phase 1 Study of DS-1205c in Combination With Osimertinib in Subjects With Metastatic or Unresectable EGFR-Mutant Non-Small Cell Lung Cancer|Not yet recruiting||Phase 1|118|Anticipated|Daiichi Sankyo, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:47:03.040652|2017-10-10 20:47:03.040652
NCT03255070|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-16|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression|A Phase 1, Multicenter, Open-label, Multiple Dose-escalation Study of ARX788, Intravenously Administered as a Single Agent in Subjects With Advanced Cancers With HER2 Expression|Not yet recruiting||Phase 1|60|Anticipated|Ambrx, Inc.||5|||f||||f|t|f||||||||2017-10-10 20:47:03.162258|2017-10-10 20:47:03.162258
NCT03255057|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-27|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|VENT-AVOID||Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD|A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support|Not yet recruiting||N/A|500|Anticipated|Alung Technologies||2|||f||||t|f|t|t|f||||||2017-10-10 20:47:03.282049|2017-10-10 20:47:03.282049
NCT03255044|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-18|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||Comparison of Lipophilic Versus Hydrophilic Statins on Patients With Heart Failure|Impact of Lipophilic Versus Hydrophilic Statin Administration on The Clinical Outcome and Cardiac Markers of Patients With Heart Failure|Recruiting||Phase 4|60|Anticipated|Ain Shams University||2|||f||||t|f|f||||||||2017-10-10 20:47:03.379868|2017-10-10 20:47:03.379868
NCT03255005|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-22|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Endomina Controlled Study|A Controlled Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) as an Aid for Endoscopic Gastric Reduction|Recruiting||N/A|60|Anticipated|Erasme University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:47:03.704122|2017-10-10 20:47:03.704122
NCT03254992|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-17|||November 2, 2016|Actual|2016-11-02|August 2017|2017-08-01|August 20, 2017|Anticipated|2017-08-20|June 20, 2017|Actual|2017-06-20||Interventional|||Real and Virtual Environments in Autism Spectrum Disorder|Motor Learning Transfer Between Real and Virtual Environments in Autism Spectrum Disorder.|Active, not recruiting||N/A|100|Anticipated|University of Sao Paulo||4|||f||||f|f|f||||||||2017-10-10 20:47:03.805682|2017-10-10 20:47:03.805682
NCT03254979|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||March 15, 2017|Actual|2017-03-15|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|PREDIAPS||Optimizing the Primary Prevention of Type-2 Diabetes in Primary Health Care|How to Engage Primary Health Care Providers in an Inter-professional Collaborative Modeling Process for the Optimization of Type-2 Diabetes Primary Prevention: a Randomized Hybrid Implementation Trial|Active, not recruiting||N/A|606|Anticipated|Basque Health Service||2|||f||||f|f|f||||||||2017-10-10 20:47:03.887368|2017-10-10 20:47:03.887368
NCT03254966|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|March 2019|Anticipated|2019-03-01||Interventional|||Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients|Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Study to Assess the Safety and Efficacy of SHR0302 in Patients With Moderate to Severe Active Rheumatoid Arthritis|Not yet recruiting||Phase 2|170|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||f|f|f||||||||2017-10-10 20:47:03.956634|2017-10-10 20:47:03.956634
NCT03254927|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-18|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma|A Phase 2, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of CDX-3379 in Combination With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma|Not yet recruiting||Phase 2|30|Anticipated|Celldex Therapeutics||1|||f||||f|t|f||||||||2017-10-10 20:47:04.514333|2017-10-10 20:47:04.514333
NCT03254914|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|February 28, 2019|Anticipated|2019-02-28|12 Weeks|Observational [Patient Registry]|||Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study|A Multi-center, Cluster-randomized, Prospective, Observational Study|Recruiting||N/A|4320|Anticipated|Boryung Pharmaceutical Co., Ltd|||2||f||||f|f|f||||||||2017-10-10 20:47:04.613494|2017-10-10 20:47:04.613494
NCT03254901|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers|Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers in Assiut Governorate and Treatment Outcome Among True Positive Cases|Not yet recruiting||N/A|1200|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 20:47:04.706327|2017-10-10 20:47:04.706327
NCT03254888|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-24|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|October 1, 2020|Anticipated|2020-10-01||Observational|||Autophagy Bladder Cancer|Identification of Novel Autophagy Markers in Bladder Cancer Patients|Not yet recruiting||N/A|150|Anticipated|Assiut University|||4||f|||||f|f||||||||2017-10-10 20:47:04.81023|2017-10-10 20:47:04.81023
NCT03254875|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-16|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|REBECCA II||Rehabilitation After Breast Cancer|Individually Tailored Rehabilitation After Breast Cancer|Recruiting||N/A|324|Anticipated|Danish Cancer Society||2|||f||||f|f|f||||||||2017-10-10 20:47:04.90665|2017-10-10 20:47:04.90665
NCT03254862|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Different Stimulation Patterns to Reduce Muscle Fatigue During FES|Investigation of Different Stimulation Patterns to Reduce Muscle Fatigue During Functional Electrical Stimulation (FES)|Recruiting||N/A|10|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f|f|f||||||||2017-10-10 20:47:05.076006|2017-10-10 20:47:05.076006
NCT03254849|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-10-02|||November 22, 2017|Anticipated|2017-11-22|October 2017|2017-10-01|September 15, 2019|Anticipated|2019-09-15|September 15, 2019|Anticipated|2019-09-15||Interventional|||Empagliflozin and Sympathetic Nerve Traffic|Effects on Blood Pressure and Central Sympathetic Nerve Traffic by SGLT2-inhibition With Empagliflozin Compared to Hydrochlorothiazide in Patients With Type 2 Diabetes Mellitus|Not yet recruiting||Phase 4|40|Anticipated|Profil Institut für Stoffwechselforschung GmbH||2|||f|||||f|f||||||||2017-10-10 20:47:05.167028|2017-10-10 20:47:05.167028
NCT03254836|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-18|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|July 31, 2023|Anticipated|2023-07-31|July 31, 2018|Anticipated|2018-07-31|5 Years|Observational [Patient Registry]|||Sleep and Survival in Colorectal Cancer|Sleep-wake Rhythm in the Perioperative Period in Patients Admitted for Elective Radical Surgery for Colorectal Cancer: an Observational Prospective Cohort Study.|Recruiting||N/A|200|Anticipated|Zealand University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:05.271772|2017-10-10 20:47:05.271772
NCT03254823|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-18|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Observational|||Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|Defining Autoimmune Aspects of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|Enrolling by invitation||N/A|20|Anticipated|University of East Anglia|||2||f||||f|f|f||||Samples With DNA|"     faecal samples serum plasma peripheral blood mononuclear cells   "|||2017-10-10 20:47:05.376963|2017-10-10 20:47:05.376963
NCT03254810|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects|A Phase 1 Randomized Blinded Single Dose Comparison of the Safety and Pharmacokinetics of SYN060 Compared to Adalimumab (Humira®) From North American and European Sources in Healthy Adult Subjects|Not yet recruiting||Phase 1|90|Anticipated|Synermore Biologics Co., Ltd.||3|||f|||||f|f||||||||2017-10-10 20:47:05.474934|2017-10-10 20:47:05.474934
NCT03254797|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-18|||April 20, 2017|Actual|2017-04-20|August 2017|2017-08-01|July 20, 2019|Anticipated|2019-07-20|July 20, 2018|Anticipated|2018-07-20||Interventional|||Stepping Training Using External Feedback in Spinal Cord Injury Patients|Effects of Stepping Training With External Feedback on Walking and Functional Ability in Ambulatory Patients With Spinal Cord Injury|Recruiting||N/A|17|Anticipated|Khon Kaen University||2|||f||||t|f|f||||||||2017-10-10 20:47:05.563927|2017-10-10 20:47:05.563927
NCT03254784|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-26|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|October 12, 2017|Anticipated|2017-10-12|October 11, 2017|Anticipated|2017-10-11||Interventional|||A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation|A Phase 1, Randomized, Open-Label, Single-Dose, Crossover Study To Evaluate the Bioavailability of BMS-986165 Tablet Formulation Relative To BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal And Increased Gastric pH on the Bioavailability of BMS-986165 Tablet Formulation in Healthy Subjects|Recruiting||Phase 1|12|Anticipated|Bristol-Myers Squibb||6|||f||||f|t|f||||||||2017-10-10 20:47:05.680495|2017-10-10 20:47:05.680495
NCT03254771|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-16|||August 16, 2017|Anticipated|2017-08-16|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effectiveness of a Decision Aid for Knee Osteoarthritis|Effectiveness of a Decision Aid for Patients With Knee Osteoarthritis Candidates for Primary Total Arthroplasty|Recruiting||N/A|226|Anticipated|Servicio Canario de Salud||2|||f||||f|f|f||||||||2017-10-10 20:47:05.797211|2017-10-10 20:47:05.797211
NCT03254758|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-17|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of ADR-001 in Patients With Liver Cirrhosis|A Phase 1/2 Study of ADR-001 in Patients With Liver Cirrhosis|Recruiting||Phase 1/Phase 2|15|Anticipated|Rohto Pharmaceutical Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 20:47:05.891053|2017-10-10 20:47:05.891053
NCT03254732|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-09-25|||July 14, 2017|Actual|2017-07-14|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers|Phase 1B Study of ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers|Recruiting||Phase 1|47|Anticipated|Polaris Group||1|||f||||f|t|f||||||||2017-10-10 20:47:06.076881|2017-10-10 20:47:06.076881
NCT03254719|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|COCOV||Care Outcomes for Chiropractic Outpatient Veterans|Care Outcomes for Chiropractic Outpatient Veterans Aim 3-pilot Trial|Not yet recruiting||N/A|40|Anticipated|Palmer College of Chiropractic||1|||f||||t|f|f||||||||2017-10-10 20:47:06.164587|2017-10-10 20:47:06.164587
NCT03254706|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-27|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|RCT||Effect of Increased Improve Time on Adhesive System|Effect of Increased Improve Time on Adhesive System: A RANDOMIZED CLINICAL TRIAL|Completed||N/A|35|Actual|Universidade Estadual de Ponta Grossa||4|||f||||t|f|f||||||||2017-10-10 20:47:06.331084|2017-10-10 20:47:06.331084
NCT03254693|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-27|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|RCT||BONDING TO ENAMEL USING A UNIVERSAL ADHESIVE|STRATEGIES FOR BONDING TO ENAMEL USING A UNIVERSAL ADHESIVE ON SELF-ETCHING MODE|Completed||Phase 4|35|Actual|Universidade Estadual de Ponta Grossa||4|||f||||t|f|f||||||||2017-10-10 20:47:06.423382|2017-10-10 20:47:06.423382
NCT03254680|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Turmeric as Treatment in Epilepsy|Turmeric as Treatment in Epilepsy|Not yet recruiting||N/A|20|Anticipated|New York University School of Medicine||1|||f||||f|f|f|||f|||||2017-10-10 20:47:06.505047|2017-10-10 20:47:06.505047
NCT03254667|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-17|||March 15, 2018|Anticipated|2018-03-15|August 2017|2017-08-01|November 2031|Anticipated|2031-11-01|November 10, 2030|Anticipated|2030-11-10|8 Years|Observational [Patient Registry]|||Study to Assess the Long-Term Safety of Brodalumab Compared With Other Therapies in the Treatment of Adults With Moderate-to-Severe Psoriasis|Prospective, Observational Study to Assess the Long-Term Safety of Brodalumab Compared With Other Therapies in the Treatment of Adults With Moderate-to-Severe Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy in the Course of Actual Clinical Care|Not yet recruiting||N/A|3500|Anticipated|Valeant Pharmaceuticals International, Inc.|||2||f||||t|t|f|||f|None Retained|"     Neutrophil count   "|||2017-10-10 20:47:06.585001|2017-10-10 20:47:06.585001
NCT03254654|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-10|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer|A Phase II, Single-center, Randomized Study of Vinorelbine Plus Apatinib Versus Vinorelbine as Second-Line or Third-Line Treatment in Patients With Advanced Triple-Negative Breast Cancer (NAN Trail)|Recruiting||Phase 2|66|Anticipated|Fudan University||2|||f||||f|f|f||||||||2017-10-10 20:47:06.65447|2017-10-10 20:47:06.65447
NCT03254641|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|||Calciotropic Effects After hCG Stimulation Test|Calciotropic Effects After hCG Stimulation Test|Recruiting||N/A|100|Anticipated|Rigshospitalet, Denmark|||1||f||||f|t|f|||f|Samples Without DNA|"     serum   "|||2017-10-10 20:47:06.835415|2017-10-10 20:47:06.835415
NCT03254628|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-18|||November 14, 2014|Actual|2014-11-14|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Saving Lives at Birth in Uganda: Building and Sustaining Capacity of Frontline Health Workers - A Program Evaluation|Saving Lives at Birth in Uganda: Building and Sustaining Capacity of Frontline Health Workers - A Program Evaluation|Completed||N/A|3440|Actual|Jhpiego||3|||f||||f|f|f||||||||2017-10-10 20:47:06.943287|2017-10-10 20:47:06.943287
NCT03254615|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-16|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|August 2020|Anticipated|2020-08-01||Interventional|ECCA001LCE||Effectiveness of the Numerous Educational Strategy Interventions Seeking to Increase the Water Consume in Child|Effectiveness of the Numerous Educational Strategy Interventions Seeking to Increase the Percentage of Water Consumed Among Early Elementary School Students With a 1-year Follow up|Not yet recruiting||N/A|329|Anticipated|National Institute of Pediatrics, Mexico||3|||f||||t|f|f||||||||2017-10-10 20:47:07.055398|2017-10-10 20:47:07.055398
NCT03254589|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis|Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis|Not yet recruiting||Phase 4|124|Anticipated|Flinders University||4|||f||||f|f|f|||f|||||2017-10-10 20:47:07.244044|2017-10-10 20:47:07.244044
NCT03254576|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Observational|Child Learn||Cue-Reward Learning and Weight Gain in Youth||Recruiting||N/A|132|Anticipated|University of California, San Diego|||2||f||||t|f|f||||||||2017-10-10 20:47:07.361593|2017-10-10 20:47:07.361593
NCT03254563|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Copeptin and NAFLD|Copeptin and Nonalcoholic Fatty Liver Disease|Not yet recruiting||N/A|40|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:47:07.475814|2017-10-10 20:47:07.475814
NCT03254550|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|July 31, 2018|Anticipated|2018-07-31||Observational|||PrEP Demonstration Study in Swaziland|Expanding Options for HIV Prevention Through Pre-exposure Prophylaxis in Hhohho Region, Swaziland|Recruiting||N/A|538|Anticipated|Clinton Health Access Initiative Inc.|||1||f||||f|f|f||||||||2017-10-10 20:47:07.601243|2017-10-10 20:47:07.601243
NCT03254537|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-17|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|August 1, 2017|Actual|2017-08-01||Interventional|||Effect of Mediterranean Diets Based on Organic and Conventional Foods|Effect of Mediterranean Diets Based on Organic and Conventional Foods on Health Related Physiological Parameters in Urine and Blood/Plasma|Enrolling by invitation||N/A|27|Anticipated|Newcastle University||2|||f||||f|f|f||||||||2017-10-10 20:47:07.717326|2017-10-10 20:47:07.717326
NCT03254524|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||August 20, 2014|Actual|2014-08-20|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|||Geography of ED Use and Population Health|Statewide Analysis of Emergency Department Use for Determining Geographic Patterns of Emergency Care Use, Hospital Choice and Measures of Population Health.|Active, not recruiting||N/A|100|Anticipated|New York University School of Medicine|||1||f||||f|f|f||||||||2017-10-10 20:47:07.817687|2017-10-10 20:47:07.817687
NCT03254511|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-21|||July 22, 2016|Actual|2016-07-22|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer|The Effect of Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer on the Clinical and Pathologic Response|Recruiting||Phase 2|100|Anticipated|Mashhad University of Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 20:47:07.923258|2017-10-10 20:47:07.923258
NCT03254498|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-17|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|DETECT||Detection in Tandem Endocuff Cap Trial|Is Endocuff Vision Assisted Colonoscopy Superior to Cap Assisted Colonoscopy to Detect Adenomas|Completed||N/A|154|Actual|London North West Healthcare NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:47:08.048011|2017-10-10 20:47:08.048011
NCT03254485|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|CAPACITY-HFpEF||A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 Over 12 Weeks in Patients With Heart Failure With Preserved Ejection Fraction|Not yet recruiting||Phase 2|332|Anticipated|Ironwood Pharmaceuticals, Inc.||4|||f||||t|t|f|||t|||||2017-10-10 20:47:08.156684|2017-10-10 20:47:08.156684
NCT03254472|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||February 17, 2010|Actual|2010-02-17|August 2017|2017-08-01|September 10, 2015|Actual|2015-09-10|August 30, 2015|Actual|2015-08-30||Observational|rUBIDIuM||Big Data Analysis of the Use of bIomarkers Concentration|Defining Use and Misuse of BIoMarkers Dosage and Trends in Observed Concentration Over Time: a BIg Data Analysis|Completed||N/A|585745|Actual|Hospital Avicenne|||1||f||||f|f|f||||||||2017-10-10 20:47:08.253383|2017-10-10 20:47:08.253383
NCT03254459|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-10-03|||September 12, 2017|Actual|2017-09-12|October 2017|2017-10-01|October 28, 2017|Anticipated|2017-10-28|October 28, 2017|Anticipated|2017-10-28||Interventional|||Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain|A Phase 2, Randomized, Open Label, Multiple-Dose, Comparator, Parallel-Group, Safety and Tolerance Study of Buprenorphine Sublingual Spray (0.5 mg TID) Versus Standard of Care Post-Operative Narcotic Therapy for the Treatment of Post-Operative Pain|Recruiting||Phase 2|100|Anticipated|INSYS Therapeutics Inc||2|||f||||t|t|f||||||||2017-10-10 20:47:08.347495|2017-10-10 20:47:08.347495
NCT03254446|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|April 2020|Anticipated|2020-04-01||Interventional|||Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension|A Phase III Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-centre, Multinational Study to Evaluate Efficacy and Safety of TRC150094 as an Add On to Standard of Care in Improving Cardiovascular Risk in Subjects With Diabetes, Dyslipidemia and Hypertension|Not yet recruiting||Phase 3|1250|Anticipated|Torrent Pharmaceuticals Limited||2|||f||||t|f|f||||||||2017-10-10 20:47:08.463594|2017-10-10 20:47:08.463594
NCT03254420|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||August 30, 2016|Actual|2016-08-30|August 2017|2017-08-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Interventional|RCMIGI||Study Evaluating Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.|Randomized Phase II Study Evaluating Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. (RCMIGI)|Recruiting||Phase 2|166|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||f|f|f||||||||2017-10-10 20:47:08.698905|2017-10-10 20:47:08.698905
NCT03254407|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-15|||August 2015||2015-08-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|STORM||Switch Timely to Oral Medication|Comparison of Cost-effectiveness Between Electronic Notes Versus Telephone Calls to Alert the Prescriber of a Possible IV to Oral Switch.|Completed||N/A|8000|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f||||||||2017-10-10 20:47:08.806652|2017-10-10 20:47:08.806652
NCT03254394|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-29|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Lidocaine for Oxaliplatin-induced Neuropathy|Intravenous Lidocaine for Preventing Painful Oxaliplatin-induced Peripheral Neuropathy (OIPN)|Recruiting||Phase 1/Phase 2|38|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 20:47:08.902025|2017-10-10 20:47:08.902025
NCT03254381|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-15|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Exercise on Cognition in Older Adults At-risk for Diabetes: A Feasibility Pilot Study|The Effect of Aerobic Versus Resistance Training on Cognitive Function and Brain Health in Older Adults At-risk for Diabetes: A Feasibility Pilot Study|Not yet recruiting||N/A|30|Anticipated|Western University, Canada||3|||f||||f|f|f||||||||2017-10-10 20:47:09.039887|2017-10-10 20:47:09.039887
NCT03254368|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-15|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes|Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of ZGN-1061 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus to Evaluate Glycemic Control, Safety, and Tolerability Over 12 Weeks|Recruiting||Phase 2|120|Anticipated|Zafgen, Inc.||4|||f||||t|f|f||||||||2017-10-10 20:47:09.170927|2017-10-10 20:47:09.170927
NCT03254355|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-28|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Efficacy of Physiotherapy for Urinary Incontinence in Women With a Puborectalis Avulsion|Efficacy of Physiotherapy for Urinary Incontinence in Women With a Known Avulsion Injury of the Puborectalis Muscle: A Randomized Controlled Trial|Recruiting||N/A|160|Anticipated|Université de Sherbrooke||2|||f|||||f|f||||||||2017-10-10 20:47:09.355271|2017-10-10 20:47:09.355271
NCT03254342|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||August 6, 2013|Actual|2013-08-06|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 6, 2018|Anticipated|2018-08-06||Observational|||MRS and Medication Response: A Pilot Study|Magnetic Resonance Spectroscopy and Medication Response: A Pilot Study|Recruiting||N/A|20|Anticipated|Stanford University|||2||f||||t|f|||||||||2017-10-10 20:47:09.452756|2017-10-10 20:47:09.452756
NCT03254329|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 1, 2020|Anticipated|2020-05-01|January 1, 2020|Anticipated|2020-01-01||Observational|MILQ||Establishing Global Reference Values for Human Milk|Establishing Global Reference Values for Human Milk Composition in a Multi-Center Collaborative Study|Not yet recruiting||N/A|1000|Anticipated|USDA, Western Human Nutrition Research Center|||1||f||||f|f|f||||Samples With DNA|"     Breast Milk, blood, saliva, urine and feces   "|||2017-10-10 20:47:09.536118|2017-10-10 20:47:09.536118
NCT03254316|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Health Care Associated Infection Surveillance in NICU|Healthcare Associated Infection Surveillance in NICU of Assiut University Children's Hospital|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||||2017-10-10 20:47:09.619665|2017-10-10 20:47:09.619665
NCT03254303|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-17|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Interventional|||Intravenous Cannulation In Children During Sevoflurane Induction|Intravenous Cannulation In Children During Sevoflurane Induction: Which Time is Adequate|Completed||N/A|90|Actual|University of Monastir||3|||f||||f|f|f||||||||2017-10-10 20:47:09.671378|2017-10-10 20:47:09.671378
NCT03254290|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-17|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Color Stability of NeoMTA Pulpotomized Primary Teeth|Color Stability of NeoMTA Pulpotomized Primary Teeth|Not yet recruiting||Early Phase 1|15|Anticipated|Texas A & M University Baylor College Of Dentistry||2|||f||||f|f|f||||||||2017-10-10 20:47:09.74934|2017-10-10 20:47:09.74934
NCT03254277|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-01|||August 31, 2017|Actual|2017-08-31|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|February 2019|Anticipated|2019-02-01||Interventional|||3BNC117-LS First-in-Human Phase 1 Study|A Phase 1, Dose Escalation, First-in-human Study of the Safety and Pharmacokinetics of 3BNC117-LS Administered Intravenously in HIV-infected and HIV-uninfected Individuals|Recruiting||Phase 1|30|Anticipated|Rockefeller University||5|||f||||t|t|f||||||||2017-10-10 20:47:09.822907|2017-10-10 20:47:09.822907
NCT03254264|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||May 29, 2017|Actual|2017-05-29|August 2017|2017-08-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|IDEAEYE||Impact of Early Interventions on Neurocognitive Profile of Children With Autism Spectrum Disorder|Impact of Early Intervention on Neurocognitive Profile of Children With Autism Spectrum Disorder|Recruiting||N/A|124|Anticipated|Hôpital le Vinatier||2|||f||||t|f|f||||||||2017-10-10 20:47:09.922936|2017-10-10 20:47:09.922936
NCT03254251|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||January 9, 2017|Actual|2017-01-09|August 2017|2017-08-01|April 10, 2017|Actual|2017-04-10|April 3, 2017|Actual|2017-04-03||Interventional|||The Effects of Stair Climbing on Arterial Stiffness, Blood Pressure and Leg Strength in Stage-1 Postmenopausal Women|The Effects of a 12-week Stair Climbing Regimen on Arterial Stiffness, BP and Leg Strength in Stage-1 Hypertensive Postmenopausal Women|Completed||N/A|41|Actual|Pusan National University||2|||f|||||f|f||||||||2017-10-10 20:47:09.999865|2017-10-10 20:47:09.999865
NCT03254238|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-18|||December 20, 2017|Anticipated|2017-12-20|August 2017|2017-08-01|December 20, 2020|Anticipated|2020-12-20|May 20, 2018|Anticipated|2018-05-20||Observational|MEGADOSE||Monitoring prEscriptiondruG Abuse Using DOctor Shopping bEhavior|Monitoring prEscriptiondruG Abuse Using DOctor Shopping bEhavior|Not yet recruiting||N/A|10000000|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f|f|f||||||||2017-10-10 20:47:10.098368|2017-10-10 20:47:10.098368
NCT03254225|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-19|||January 4, 2018|Anticipated|2018-01-04|September 2017|2017-09-01|April 30, 2021|Anticipated|2021-04-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Sixteen Weeks of Resistance Training in Hypertensive Elderly, Effects on Heart Rate Variability|Sixteen Weeks of Resistance Training in Hypertensive Elderly, Effects on Heart Rate Variability|Not yet recruiting||N/A|40|Anticipated|Federal University of São Paulo||2|||f||||f|f|f||||||||2017-10-10 20:47:10.160179|2017-10-10 20:47:10.160179
NCT03254212|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-15|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|September 30, 2018|Anticipated|2018-09-30||Interventional|HO2F||Nocturnal Oxygen Needs and Central Sleep Apnea in Patients With Chronic Heart Failure.|Evaluation of Nocturnal Oxygen Needs in the Treatment of Central Sleep Apnea in Patients With Chronic Heart Failure.|Not yet recruiting||Phase 4|14|Anticipated|Laval University||1|||f||||f|f|f||||||||2017-10-10 20:47:10.23155|2017-10-10 20:47:10.23155
NCT03254186|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-09-21|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia|Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia|Recruiting||Phase 2/Phase 3|15|Anticipated|Emory University||2|||f||||t|t|f|||f|||||2017-10-10 20:47:10.355318|2017-10-10 20:47:10.355318
NCT03254173|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-08-15|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|April 1, 2018|Anticipated|2018-04-01||Interventional|MCACS100||Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia|Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia : a Randomized Controlled Clinical Trial|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Kasr El Aini Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:47:10.547729|2017-10-10 20:47:10.547729
NCT03254160|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-10-02|||October 30, 2017|Anticipated|2017-10-30|October 2017|2017-10-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|SPIRIT||DNS-3379 vs. Placebo in Stroke Rehabilitation|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 42-Day Treatment Study to Evaluate the Effect of DNS-3379 on Upper Extremity Motor Function Following Ischemic Stroke|Recruiting||Phase 2|140|Anticipated|Dart NeuroScience, LLC||3|||f||||f|t|f||||||||2017-10-10 20:47:10.647219|2017-10-10 20:47:10.647219
NCT03254147|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-10-03|||October 6, 2017|Anticipated|2017-10-06|October 2017|2017-10-01|December 14, 2017|Anticipated|2017-12-14|November 30, 2017|Anticipated|2017-11-30||Observational|||Medical Need of OAC Reversal|Medical Need of Oral Anti-coagulant Reversal in Japan: Epidemiological Assessment of Head Trauma, Fracture, and Emergency Surgery Using Large Scale Claims Database (Please Note That This Study Contains no Patients Treated With Idarucizumab Although the Study Number Begins With 1321; the Study Contains Only Patients Treated With OACs, Namely Warfarin, Dabigatran, Edoxaban, Apixaban, Rivaroxaban, Edoxaban)|Not yet recruiting||N/A|12000|Anticipated|Boehringer Ingelheim|||1||f||||f|f|f||||||||2017-10-10 20:47:10.775652|2017-10-10 20:47:10.775652
NCT03254134|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-18|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|October 25, 2017|Anticipated|2017-10-25|October 12, 2017|Anticipated|2017-10-12||Observational|||Comparative Effectiveness and Safety Between Warfarin and Dabigatran|Comparative Effectiveness and Safety Between Warfarin and Dabigatran Using Real World Claims Data of Japanese Non-valvular Atrial Fibrillation Patients|Not yet recruiting||N/A|8000|Anticipated|Boehringer Ingelheim|||1||f||||f|t|f||||||||2017-10-10 20:47:10.857673|2017-10-10 20:47:10.857673
NCT03254121|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-02|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|January 1, 2027|Anticipated|2027-01-01|January 1, 2021|Anticipated|2021-01-01||Observational|HEPCASUS||Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response|Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response|Recruiting||N/A|100|Anticipated|Karolinska Institutet|||1||f||||f|f|f||||Samples With DNA|"     Liver tissue from HCC and adjacent non-HCC   "|||2017-10-10 20:47:10.939321|2017-10-10 20:47:10.939321
NCT03254108|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-10-05|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure|A Multicenter, Double-blind, Randomized, Active-controlled, Parallel-group Comparison Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure|Recruiting||N/A|55|Anticipated|Otsuka Pharmaceutical Co., Ltd.||5|||f||||f|f|f||||||||2017-10-10 20:47:11.022179|2017-10-10 20:47:11.022179
NCT03254095|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-15|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|June 3, 2018|Anticipated|2018-06-03|May 31, 2017|Actual|2017-05-31|1 Year|Observational [Patient Registry]|||Predictors of Skin Temperature, Plantar Pressure and Ulceration in Diabetic Foot Patients.|Thermal and Biomechanical Characterization of Diabetic Foot Patients, Predictors of Skin Temperature, Barefoot Plantar Pressure and Ulceration.|Active, not recruiting||N/A|100|Anticipated|Universidade do Porto|||1||f||||||||||||||2017-10-10 20:47:11.113826|2017-10-10 20:47:11.113826
NCT03254082|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-15|||September 2010||2010-09-01|August 2017|2017-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Glycemic Response of Sorghum|Glycemic Response of Cooked Grains Including Sorghum|Completed||N/A|10|Actual|Kansas State University||5|||f||||f||||||||||2017-10-10 20:47:11.19756|2017-10-10 20:47:11.19756
NCT03254069|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-08-15|||November 2011||2011-11-01|August 2017|2017-08-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|OBF||Occlusal Bite Force Changes After Placement of Stainless Steel Crowns in Children|Changes in Occlusal Bite Force Following Placement of Stainless Steel Crowns on Primary Molars in Children|Completed||N/A|44|Actual|Jordan University of Science and Technology||2|||f||||t||||||||||2017-10-10 20:47:11.280555|2017-10-10 20:47:11.280555
NCT03254043|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-17|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Evaluating a Novel Medication Device for Methadone Dosing|Evaluating a Novel Medication Device for Methadone Dosing|Not yet recruiting||N/A|54|Anticipated|Johns Hopkins University||3|||f||||f|f|f||||||||2017-10-10 20:47:11.471245|2017-10-10 20:47:11.471245
NCT03254030|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-08-17|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|January 1, 2018|Anticipated|2018-01-01||Interventional|INWARD||Does Inspection of Colonic Mucosa During Insertion Improve Adenoma Detection?|Does Careful Inspection of Colonic Mucosa During Insertion and Withdrawal During Bowel Scope Improve Rate of Adenoma Detection?|Recruiting||N/A|478|Anticipated|London North West Healthcare NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:47:11.548832|2017-10-10 20:47:11.548832
NCT03254017|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-21|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|August 30, 2019|Anticipated|2019-08-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Remotely Programmed Deep Brain Stimulation of the Bilateral Habeluna for Treatment- Resistant Major Depression: An Open Label Pilot Trial|Remotely Programmed Deep Brain Stimulation of the Bilateral Habeluna for Treatment- Resistant Major Depression: An Open Label Pilot Trial|Recruiting||N/A|6|Anticipated|Ruijin Hospital||1|||f||||t|f|f||||||||2017-10-10 20:47:11.637489|2017-10-10 20:47:11.637489
NCT03253640|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-15|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Observational|ECONI||Evaluation of Cost of Nosocomial Infection|Evaluation of Cost of Nosocomial Infection|Not yet recruiting||N/A|2000|Anticipated|Glasgow Caledonian University|||2||f||||f||||||||||2017-10-10 20:47:14.942655|2017-10-10 20:47:14.942655
NCT03254004|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 30, 2021|Anticipated|2021-11-30|November 30, 2020|Anticipated|2020-11-30||Interventional|||Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor no More Than 4 cm|Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor no More Than 4 cm|Not yet recruiting||Phase 2|70|Anticipated|Samsung Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:47:11.754414|2017-10-10 20:47:11.754414
NCT03253991|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-15|||November 17, 2014|Actual|2014-11-17|July 2017|2017-07-01|January 1, 2023|Anticipated|2023-01-01|January 1, 2023|Anticipated|2023-01-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of ExAblate MRgFUS on Escential Tremor|A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects|Recruiting||N/A|100|Anticipated|InSightec||1|||f||||t|f|f||||||||2017-10-10 20:47:11.8307|2017-10-10 20:47:11.8307
NCT03253978|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||January 18, 2016|Actual|2016-01-18|August 2017|2017-08-01|December 31, 2028|Anticipated|2028-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|SPORT||SPORT High-Risk Trial Evaluating SABR in Prostate Cancer|A Randomised Feasibility Study Evaluating Stereotactic Prostate Radiotherapy In High-Risk Localised Prostate Cancer With or Without Elective Nodal Irradiation|Recruiting||N/A|30|Anticipated|Belfast Health and Social Care Trust||2|||f||||t|f|f||||||||2017-10-10 20:47:11.939341|2017-10-10 20:47:11.939341
NCT03253965|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease|The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease|Not yet recruiting||N/A|40|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 20:47:12.035|2017-10-10 20:47:12.035
NCT03253952|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-15|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2020|Anticipated|2020-07-31||Observational|||A Study of Autonomic Dynamic Dysfunction to Predict Infections After Spinal Cord Injury.|PROSPECT ADDITION SCI - A PROSPECTive Study of Autonomic Dynamic Dysfunction to Predict infecTIONs After Spinal Cord Injury|Recruiting||N/A|50|Anticipated|Ohio State University|||2||f|||||f|f||||||||2017-10-10 20:47:12.124805|2017-10-10 20:47:12.124805
NCT03253939|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-17|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|CYTO-CHIP||Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer|Completed||N/A|275|Actual|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 20:47:12.195166|2017-10-10 20:47:12.195166
NCT03253926|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Effect of Lorcaserin on Cannabis Withdrawal and Self-administration|Effect of Lorcaserin on Cannabis Withdrawal and Self-administration|Recruiting||Phase 1/Phase 2|16|Anticipated|New York State Psychiatric Institute||2|||f|||||t|f||||||||2017-10-10 20:47:12.260662|2017-10-10 20:47:12.260662
NCT03253913|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-17|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|January 30, 2020|Anticipated|2020-01-30||Interventional|RESULT||Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial|Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial (RESULT)|Not yet recruiting||Phase 2|25|Anticipated|University of Cincinnati||1|||f||||t|t|f||||||||2017-10-10 20:47:12.33584|2017-10-10 20:47:12.33584
NCT03253900|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-17|||May 1, 2016|Actual|2016-05-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|October 1, 2016|Actual|2016-10-01||Interventional|RowBio||Rowing Biomechanics - Effects of (In)Stability and Fatigue|Changes of Biomechanical Parameters During Race Simulation Rowing - The Effect of (In)Stability of the Simulator|Completed||N/A|11|Actual|University of Primorska||1|||f||||f|f|f||||||||2017-10-10 20:47:12.429154|2017-10-10 20:47:12.429154
NCT03253887|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-15|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|April 2017|Actual|2017-04-01||Interventional|E-LockPed||Effectiveness of Ethanol-Lock Therapy on Prevention of Short-Term CVC Infections in Pediatric Patients (E-LockPed)|Effectiveness of Ethanol-Lock Therapy on Prevention of Short-Term Central Venous Catheter Infections in Pediatric Patients: A Randomised Controlled Trial|Recruiting||Phase 3|80|Anticipated|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||f|f|f||||||||2017-10-10 20:47:12.516847|2017-10-10 20:47:12.516847
NCT03253874|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-15|||October 2014||2014-10-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CW-CATARACT||Pre-Operative Testing for Cataract Surgery Among Adults in LA County|Evaluation of a Choosing Wisely™ Intervention to Reduce Low Value Pre-Operative Care for Patients Undergoing Cataract Surgery|Completed||N/A|1798|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 20:47:12.633014|2017-10-10 20:47:12.633014
NCT03253861|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-16|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|January 1, 2017|Actual|2017-01-01||Observational|PancRea||PancRea: Risk Factors and Outcomes of Infected Pancreatic Necrosis|Risk Factors and Outcomes of Infected Pancreatic Necrosis: Retrospective Cohort of 148 Patients Admitted to the ICU for Acute Pancreatitis|Completed||N/A|148|Actual|Nantes University Hospital|||2||f||||f|f|f||||||||2017-10-10 20:47:12.70539|2017-10-10 20:47:12.70539
NCT03253848|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-10-03|||August 16, 2017|Actual|2017-08-16|October 2017|2017-10-01|August 18, 2025|Anticipated|2025-08-18|August 18, 2022|Anticipated|2022-08-18||Observational|||Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia|A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)|Recruiting||N/A|200|Anticipated|Eastern Cooperative Oncology Group|||1||f||||t||||||||||2017-10-10 20:47:12.824802|2017-10-10 20:47:12.824802
NCT03253835|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||November 21, 2013|Actual|2013-11-21|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|CMR-LHD||Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage|Cardiac Blood Flow Patterns Associated With Regional and Global Left Ventricular Myocardial Damage: an Explorative Study by Cardiac Magnetic Resonance|Enrolling by invitation||N/A|150|Anticipated|Medical University of Graz|||2||f||||f|f|f||||||||2017-10-10 20:47:13.377849|2017-10-10 20:47:13.377849
NCT03047902|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-08|||November 2016||2016-11-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Disclosure of Smoking in Adolescents With Asthma|Disclosure of Smoking in Adolescents With Asthma|Recruiting||N/A|30|Anticipated|Imperial College London||2|||f||||f||||||||No||2017-10-10 21:21:22.003896|2017-10-10 21:21:22.003896
NCT03253822|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-15|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|LEAD||The Effect of a Colorectal Cancer Screening Decision Aid Tailored to Lower Educational Attainment Citizens|The Effect of a Colorectal Cancer Screening Decision Aid Tailored for People With Lower Educational Attainment in the Central Denmark Region on Colorectal Cancer Knowledge and Colorectal Cancer Screening Attitude and Participation Rate|Not yet recruiting||N/A|15000|Anticipated|University of Aarhus||3|||f||||f|f|f||||||||2017-10-10 20:47:13.440604|2017-10-10 20:47:13.440604
NCT03253809|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-25|||July 12, 2017|Actual|2017-07-12|August 2017|2017-08-01|May 25, 2018|Anticipated|2018-05-25|May 25, 2018|Anticipated|2018-05-25||Interventional|||Survey of QRS Frequency at Various Left Ventricular Pacing Sites for Cardiac Resynchronization|Survey of QRS Frequency at Various Left Ventricular Pacing Sites for Cardiac Resynchronization|Recruiting||N/A|30|Anticipated|The Cleveland Clinic||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:47:13.516683|2017-10-10 20:47:13.516683
NCT03253796|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-31|||October 31, 2017|Anticipated|2017-10-31|August 2017|2017-08-01|October 3, 2022|Anticipated|2022-10-03|April 18, 2022|Anticipated|2022-04-18||Interventional|||Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (MK-8259-038)|A Phase-IV, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of Golimumab (MK-8259 [SCH 900259]) After Treatment Withdrawal, Compared With Continued Treatment (Either Full- or Reduced-Treatment Regimen), In Subjects With Non-Radiographic Axial Spondyloarthritis|Not yet recruiting||Phase 4|300|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||f|t|f||||||||2017-10-10 20:47:13.587367|2017-10-10 20:47:13.587367
NCT03253783|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||The Evaluation of Pulse: A Mobile Health App and Teen Pregnancy Prevention Program|The Evaluation of Pulse: A Mobile Health App and Teen Pregnancy Prevention Program|Recruiting||N/A|||Healthy Teen Network|||||f||||f|f|f||||||||2017-10-10 20:47:13.680535|2017-10-10 20:47:13.680535
NCT03253770|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-16|2017-08-17|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|August 16, 2017|Actual|2017-08-16|August 1, 2017|Actual|2017-08-01||Interventional|SIMMAX2||Use of a Hand-held Digital Cognitive Aid in Simulated Cardiac Arrest.|Use of a Hand-held Digital Cognitive Aid in Simulated Cardiac Arrest.|Completed||N/A|60|Actual|Claude Bernard University||3|||f||||f|f|f||||||||2017-10-10 20:47:13.757884|2017-10-10 20:47:13.757884
NCT03253757|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-15|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Observational|||PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation|PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation|Not yet recruiting||N/A|10000|Anticipated|St Stephens Aids Trust|||1||f||||f|f|f||||||||2017-10-10 20:47:13.845723|2017-10-10 20:47:13.845723
NCT03253705|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-22|||September 14, 2017|Actual|2017-09-14|August 9, 2017|2017-08-09|August 1, 2027|Anticipated|2027-08-01|August 1, 2027|Anticipated|2027-08-01||Observational|||Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research|Obtaining Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||2||f||||||||||||||2017-10-10 20:47:14.305151|2017-10-10 20:47:14.305151
NCT03253679|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-17|2017-09-04|||April 6, 2018|Anticipated|2018-04-06|August 2017|2017-08-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||WEE1 Inhibitor AZD1775 in Treating Patients With Advanced Refractory Solid Tumors With CCNE1 Amplification|A Phase 2 Study of AZD1775, a Wee1 Inhibitor, in Patients With CCNE1 Amplification|Not yet recruiting||Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 20:47:14.62395|2017-10-10 20:47:14.62395
NCT03253666|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||August 1980|Actual|1980-08-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01|30 Years|Observational [Patient Registry]|||Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)|Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)|Enrolling by invitation||N/A|173229|Actual|Harvard School of Public Health|||2||f||||t|f|f||||||||2017-10-10 20:47:14.735758|2017-10-10 20:47:14.735758
NCT03253653|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-15|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessing Toxicity of Waterpipe Tobacco Smoking|Assessing Toxicity of Waterpipe Tobacco Smoking in Laboratory and Naturalistic Settings|Recruiting||N/A|75|Anticipated|San Diego State University||2|||f||||t|f|f|||f|||||2017-10-10 20:47:14.834715|2017-10-10 20:47:14.834715
NCT03253627|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-15|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||MBSR During AI Therapy for Breast Cancer|Mindfulness-Based Stress Reduction To Improve Cognitive Function for Postmenopausal Women With Breast Cancer|Not yet recruiting||N/A|32|Anticipated|New York University||2|||f|||||f|f||||||||2017-10-10 20:47:15.066368|2017-10-10 20:47:15.066368
NCT03253614|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-16|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 15, 2019|Anticipated|2019-09-15|September 15, 2018|Anticipated|2018-09-15||Observational|AURORA||Auditive and Renal Long Term Outcomes - Risk After Aminoglycoside Therapy in Neonates (AURORA)|Auditive and Renal Long Term Outcomes - Risk After Aminoglycoside Therapy in Neonates (AURORA-study)|Not yet recruiting||N/A|250|Anticipated|University Hospital of North Norway|||2||f|||||f|f||||Samples Without DNA|"     Urine biomarkers   "|||2017-10-10 20:47:15.188572|2017-10-10 20:47:15.188572
NCT03253601|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-16|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|||iADAPTS to Support Strategy Training After Stroke|iADAPTS to Support Strategy Training After Stroke|Recruiting||N/A|30|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 20:47:15.277545|2017-10-10 20:47:15.277545
NCT03253588|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-17|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|October 15, 2017|Anticipated|2017-10-15|September 15, 2017|Anticipated|2017-09-15||Observational|||Laparoscopic Tubal Preservation Surgery|Clinical Outcome of Laparoscopic Tubal Preservation Surgery for Ectopic Pregnancy|Recruiting||N/A|100|Anticipated|Far Eastern Memorial Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:15.390213|2017-10-10 20:47:15.390213
NCT03253575|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-17|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|December 15, 2019|Anticipated|2019-12-15|July 31, 2019|Anticipated|2019-07-31||Observational|ANCERS-2||CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2|CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2: A Prospective, Multicenter, Observational Study Examining the Clinical Utility of CANscriptTM in Routine Clinical Practice|Recruiting||N/A|800|Anticipated|Mitra RxDx, Inc.|||5||f||||f||f||||Samples With DNA|"     Tumor tissue biopsies and resections embedded formalin fixed paraffin and blood   "|||2017-10-10 20:47:15.472326|2017-10-10 20:47:15.472326
NCT03253562|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-15|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||Metformin Versus Vildagliptin for Diabetic Hypertensive Patients|Comparative Efficacy and Safety of Vildagliptin Versus Metformin in Reduction of Cardiovascular Complications in Type 2 Diabetic Patients With Hypertension|Completed||Phase 4|120|Actual|MTI University||4|||f||||f|f|f|||f|||||2017-10-10 20:47:15.583802|2017-10-10 20:47:15.583802
NCT03253549|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|January 2020|Anticipated|2020-01-01||Interventional|SMArTVIEW||THE SMArTVIEW, CoVeRed|TecHnology Enabled Self-MAnagemenT - VIsion for Remote Automated Patient Monitoring and EmpoWerment Following Cardiac and VasculaR Surgery|Not yet recruiting||N/A|600|Anticipated|McMaster University||2|||f||||t|f|f||||||||2017-10-10 20:47:15.702296|2017-10-10 20:47:15.702296
NCT03253536|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-16|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|July 10, 2027|Anticipated|2027-07-10|July 10, 2022|Anticipated|2022-07-10||Observational|LIVERCARE||Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma|Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||f|f|f||||||||2017-10-10 20:47:15.794247|2017-10-10 20:47:15.794247
NCT03253523|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Post-traumatic Occipital Neuralgia - Surgical Versus Medical Management|Post-traumatic Occipital Neuralgia - Surgical Versus Medical Management|Not yet recruiting||N/A|25|Anticipated|Johns Hopkins University||2|||f|||||f|f||||||||2017-10-10 20:47:15.906058|2017-10-10 20:47:15.906058
NCT03253510|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Measuring Biting Force of Poly-amide Complete Dentures|Comparison Between Biting Force of Heat Cured Poly Methylmethacrylate and Metal Reinforced Polyamide for Mandibular Complete Denture|Not yet recruiting||N/A|24|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:47:15.975554|2017-10-10 20:47:15.975554
NCT03253497|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||September 2, 2017|Anticipated|2017-09-02|August 2017|2017-08-01|November 2, 2017|Anticipated|2017-11-02|October 2, 2017|Anticipated|2017-10-02||Interventional|||To Evaluate the Effect of Chlorhexidine-benzidamine Administration|To Evaluate the Effect of Chlorhexidine-benzidamine Administration Prior to the Use of the Laryngeal Mask|Not yet recruiting||Phase 4|50|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||2|||f|||||f|f||||||||2017-10-10 20:47:16.062598|2017-10-10 20:47:16.062598
NCT03253484|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||August 18, 2017|Anticipated|2017-08-18|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Laser Treatment in Early Wound Healing to Promote Physiological Skin Remodeling|Laser Treatment in Early Wound Healing to Promote Physiological Skin Remodeling|Not yet recruiting||N/A|32|Anticipated|Bispebjerg Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:47:16.139844|2017-10-10 20:47:16.139844
NCT03253471|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-11|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection|A Randomized, Double-blind, Placebo-controlled, First-in-human, 3 Part Study of Orally Administered AL-611 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (Part 3) of Single Ascending Doses in Healthy Volunteers (Parts 1-2), and Multiple Ascending Doses in Subjects With Chronic Hepatitis C Virus Infection (Part 3)|Recruiting||Phase 1|156|Anticipated|Alios Biopharma Inc.||2|||f||||f|f|f||||||||2017-10-10 20:47:16.22385|2017-10-10 20:47:16.22385
NCT03253458|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-15|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 1, 2020|Anticipated|2020-07-01|December 31, 2019|Anticipated|2019-12-31||Interventional|FPI||Focal Prostate Imaging With CLE and OCT|In-vivo Focal Prostate Imaging With Confocal Laser Endomicroscopy and Optical Coherence Tomography|Recruiting||N/A|14|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:47:16.344183|2017-10-10 20:47:16.344183
NCT03253445|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-08-15|||July 2014||2014-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Individual Acceptance and Commitment Therapy (ACT) for Smoking Cessation for Schizophrenic Patients|Individual, Acceptance and Commitment Therapy (ACT) in Smoking Cessation for People With Schizophrenia: a Randomized Controlled Trial|Recruiting||N/A|160|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-10 20:47:16.43775|2017-10-10 20:47:16.43775
NCT03253432|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-28|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||IN-TANDEM Familial Hypercholesterolemia Pilot Study|INTegrating Active Case-finding With Next-generation Sequencing for Diagnosis Through Electronic Medical Records (IN-TANDEM): Familial Hypercholesterolemia Pilot Study|Recruiting||N/A|400|Anticipated|University of Pennsylvania|||5||f||||f|f|f||||||||2017-10-10 20:47:16.532702|2017-10-10 20:47:16.532702
NCT03253419|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|HotShOT||HotShOT: Home Safety Occupational Therapy|Exploration of Home Safety Application Impact on Perceived Risk of Falling and Actual Falls Post Hospital Discharge|Recruiting||N/A|125|Anticipated|Cedars-Sinai Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:47:16.623824|2017-10-10 20:47:16.623824
NCT03253406|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-13|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Health Wearables and College Student Health|Use of Health Wearables to Improve Physical Activity and Eating Behaviors Among College Students: A 12-week Randomized Pilot Study|Recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|f||||||||2017-10-10 20:47:16.699926|2017-10-10 20:47:16.699926
NCT03253393|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-03|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Smart Touch Non-dispensing Handling Studies|Microbial Contamination Rates on the Back Surface of Soft Contact Lenses in Two Short-term, Randomized, Contralateral Non-dispensing Studies|Not yet recruiting||Phase 4|20|Anticipated|The University of New South Wales||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:47:16.80406|2017-10-10 20:47:16.80406
NCT03253380|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Early Rehabilitation Program In Critically Ill Chronic Obstructed Airway Disease Patients|Targets Of Early Rehabilitation Program In Critically Ill Chronic Obstructed Airway Disease Patients|Not yet recruiting||N/A|60|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:47:16.872141|2017-10-10 20:47:16.872141
NCT03253367|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-14|||January 19, 2016|Actual|2016-01-19|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|CLOZIN||Phenomics and Genomics of Clozapine Pharmacotherapy|Phenomics and Genomics in Clozapine Pharmacotherapy: Current, Former and New Clozapine Users|Recruiting||N/A|4000|Anticipated|UMC Utrecht|||2||f||||f|f|f||||Samples With DNA|"     For current and former users we obtain DNA and for new users we also obtain RNA   "|||2017-10-10 20:47:16.941822|2017-10-10 20:47:16.941822
NCT03253354|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Neurostimulation for Dysphagia in Parkinson's Disease|Exploring Novel Neurostimulation Based Therapies for Swallowing Impairments in Parkinson's Disease|Recruiting||N/A|66|Anticipated|University of Manchester||4|||f||||f|f|f||||||||2017-10-10 20:47:17.047471|2017-10-10 20:47:17.047471
NCT03253341|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||June 1, 2018|Anticipated|2018-06-01|August 2017|2017-08-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Prescribing Smart Aging: Integrating Health Systems With Community-Based Lifestyle Interventions|Prescribing Smart Aging: Integrating Health Systems With Community-Based Lifestyle Interventions|Not yet recruiting||N/A|220|Anticipated|University of Kansas Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:47:17.123323|2017-10-10 20:47:17.123323
NCT03253328|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-16|||December 15, 2016|Actual|2016-12-15|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes|N-Acetyl-Cysteine for Healing of Amputation Stumps in the Setting of Diabetes|Recruiting||N/A|50|Anticipated|Washington University School of Medicine||2|||f||||t||f||||||||2017-10-10 20:47:17.204037|2017-10-10 20:47:17.204037
NCT03253315|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01|15 Days|Observational [Patient Registry]|||Management of Pericarditis in Children.|Clinical Audit of the Management of Pericarditis in Children.|Not yet recruiting||N/A|20|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:47:17.332146|2017-10-10 20:47:17.332146
NCT03253302|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-19|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01|3 Years|Observational [Patient Registry]|LATERAL-01||Laparoscopic Assisted Transanal Total Mesorectal Excision for Rectal Cancer in Low Site|Laparoscopic Assisted transAnal Total Mesorectal Excision for Rectal cAncer in Low Site :A Prospective,Multi-center, Patients Registry Trial in China (LATERAL Trial)|Enrolling by invitation||N/A|80|Anticipated|Beijing Friendship Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:17.39296|2017-10-10 20:47:17.39296
NCT03253289|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|February 26, 2019|Anticipated|2019-02-26||Interventional|OPTIM||Meclizine for Hepatocellular Carcinoma|A Window of Opportunity Trial With Meclizine in Hepatocellular Carcinoma|Not yet recruiting||Phase 1|13|Anticipated|Baylor College of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 20:47:17.466407|2017-10-10 20:47:17.466407
NCT03253276|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-08-18|||May 19, 2016|Actual|2016-05-19|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|January 20, 2018|Anticipated|2018-01-20||Interventional|||Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT|Effect of Obeticholic Acid (INT-747, Intercept) on the Hepatobiliary Transport of Bile Acids in Patients With PBC Examined by 11C-cholyl-sarcosine PET/CT|Recruiting||Early Phase 1|8|Anticipated|University of Aarhus||2|||f||||f|f|f|||f|||||2017-10-10 20:47:17.551192|2017-10-10 20:47:17.551192
NCT03253081|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-12|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Interventional|||Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response|Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response|Not yet recruiting||N/A|120|Anticipated|University of California, Los Angeles||2|||f||||f|f|f||||||||2017-10-10 20:47:20.40302|2017-10-10 20:47:20.40302
NCT03253263|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||December 31, 2017|Anticipated|2017-12-31|August 2017|2017-08-01|March 30, 2022|Anticipated|2022-03-30|March 30, 2022|Anticipated|2022-03-30||Interventional|||Preventing Chronic Lung Disease in Extremely Premature Infants|A Phase 2b/3, Multicenter, Randomized, Open-label, Controlled, 3-Arm Study to Evaluate the Clinical Efficacy and Safety of SHP607 in Preventing Chronic Lung Disease Through 12 Months Corrected Age (CA) Compared to Standard Neonatal Care in Extremely Premature Infants|Not yet recruiting||Phase 2/Phase 3|1053|Anticipated|Shire||3|||f||||t|t|f||||||||2017-10-10 20:47:17.636387|2017-10-10 20:47:17.636387
NCT03253250|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-06|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection|A Prospective, Randomized, Multicenter, Open-label, Exploratory Study of Utilizing of Peginterferon Alfa-2a on the Relapse Rate of the Subjects With Hepatocellular Carcinoma Who Have Been Treated by Resection|Recruiting||Phase 4|432|Anticipated|Huashan Hospital||2|||f|||||f|f||||||||2017-10-10 20:47:17.712293|2017-10-10 20:47:17.712293
NCT03253237|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-17|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|October 7, 2017|Anticipated|2017-10-07|September 30, 2017|Anticipated|2017-09-30||Observational|PC-COSMO||Primary Care - Continuous Glucose Monitoring|Continuous Glucose Monitoring in Patients With Diabetes Mellitus Type 2 in Primary Care|Recruiting||N/A|100|Anticipated|University of Zagreb|||1||f||||f|f|f||||||||2017-10-10 20:47:17.816906|2017-10-10 20:47:17.816906
NCT03253224|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||September 10, 2017|Anticipated|2017-09-10|August 2017|2017-08-01|July 10, 2018|Anticipated|2018-07-10|June 20, 2018|Anticipated|2018-06-20||Interventional|||Magnesium and Postoperative Pain|The Influence of Intraoperative Magnesium Sulfate Administration on Postoperative Pain After Total Knee Arthroplasty in Patients Sedated With Dexmedetomidine Under Spinal Anesthesia: A Randomized-controlled Trial|Not yet recruiting||Phase 4|86|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:47:17.884084|2017-10-10 20:47:17.884084
NCT03253211|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-13|||September 1, 2018|Anticipated|2018-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina|Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina|Not yet recruiting||N/A|2270|Anticipated|Duke University|||4||f||||||||||||||2017-10-10 20:47:17.960963|2017-10-10 20:47:17.960963
NCT03253198|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-16|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Prospective RCT Comparing Perioperative Pain|Preoperative Interscalene Nerve Block Plus Postoperative Local Intra-operative Analgesic Injection vs Preoperative Interscalene Nerve Block Plus Postoperative Saline Injection in Patients Undergoing Shoulder Arthroplasty: a Randomized Trial|Completed||N/A|156|Actual|Rothman Institute Orthopaedics||2|||f|||||t|f|||f|||||2017-10-10 20:47:18.032878|2017-10-10 20:47:18.032878
NCT03253185|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-27|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|July 28, 2021|Anticipated|2021-07-28|September 1, 2020|Anticipated|2020-09-01||Interventional|||A Study of SC-007 in Subjects With Advanced Cancer|An Open Label Study of SC-007 in Subjects With Advanced Cancer|Recruiting||Phase 1|146|Anticipated|AbbVie||1|||f||||f|t|f||||||||2017-10-10 20:47:19.552249|2017-10-10 20:47:19.552249
NCT03253172|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-16|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|October 1, 2023|Anticipated|2023-10-01|October 1, 2022|Anticipated|2022-10-01||Interventional|K+ in CKD||Potassium Supplementation in CKD|Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease (CKD)|Active, not recruiting||N/A|532|Anticipated|Erasmus Medical Center||3|||f||||t|f|f||||||||2017-10-10 20:47:19.641671|2017-10-10 20:47:19.641671
NCT03253159|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-18|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2016|Actual|2016-09-01||Interventional|HYPNOSEIN||Added Conversational Hypnosis Reduced General Anesthesia Side Effects for Day Case Breast Surgery|Added Conversational Hypnosis Reduced General Anesthesia Side Effects for Day Case Breast Surgery: A Prospective Randomized Phase III Clinical Trial (HYPNOSEIN)|Recruiting||Phase 2|150|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||f||||||||||2017-10-10 20:47:19.737393|2017-10-10 20:47:19.737393
NCT03253146|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||July 1, 2016|Actual|2016-07-01|May 2016|2016-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||The Role and Mechanism of Vimentin in Sepsis Patients|The Role and Mechanism of Vimentin in Sepsis Patients|Recruiting||N/A|200|Anticipated|Peking Union Medical College Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Within 24 h (the first day of study) after ICU admission, blood samples was collected.Blood     was centrifuged at 3,000 rpm for 15 minutes. The supernatants were transferred to Eppendorf     tubes and stored at -80°C.   "|||2017-10-10 20:47:19.812695|2017-10-10 20:47:19.812695
NCT03253133|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-16|||February 2016||2016-02-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|NIPOX||Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC|Phase I Study Assessing Safety of Intraperitoneal Chemotherapy in Neoadjuvant Treatment of Peritoneal Carcinomatosis of Colorectal Origin|Recruiting||Phase 1|24|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-10 20:47:19.881754|2017-10-10 20:47:19.881754
NCT03253120|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-14|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Alterations of Attention in POTS Depending on Body Position and Hydration|Alterations of Attention in Patients With Postural Tachycardia Syndrome and Healthy Controls Depending on Body Position and Hydration|Recruiting||N/A|30|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f||||||||2017-10-10 20:47:19.960398|2017-10-10 20:47:19.960398
NCT03253107|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||November 30, 2015|Actual|2015-11-30|August 2017|2017-08-01|November 30, 2021|Anticipated|2021-11-30|November 30, 2018|Anticipated|2018-11-30||Observational|||Predicting Biomarker of Gastric Cancer Chemotherapy Response|Postgenome-based Systemic Discovery of Strong Biomarkers Predict Gastric Cancer Chemotherapy Response|Recruiting||N/A|800|Anticipated|Kyungpook National University|||4||f||||t|f|f||||Samples With DNA|"     RNA from gastric tissue and blood      DNA from blood   "|||2017-10-10 20:47:20.059815|2017-10-10 20:47:20.059815
NCT03253094|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-10-05|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|DOVE||An Active-Controlled, Dose-Finding Study of SCY-078 vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis|A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis|Recruiting||Phase 2|180|Anticipated|Scynexis, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:47:20.155598|2017-10-10 20:47:20.155598
NCT03253068|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-16|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|February 28, 2020|Anticipated|2020-02-28||Interventional|||Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer|A Phase II Study of Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer|Not yet recruiting||Phase 2|25|Anticipated|Wakayama Medical University||1|||f||||t|f|f||||||||2017-10-10 20:47:20.499344|2017-10-10 20:47:20.499344
NCT03253055|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-16|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 23, 2018|Anticipated|2018-03-23|March 23, 2018|Anticipated|2018-03-23||Observational|D-BIICEP||The D-BIICEP Study|The Interrelationship Between Vitamin D, Bone, Illness, Injury and Its Impact on Exercise Performance|Not yet recruiting||N/A|63|Anticipated|University of Surrey|||3||f||||f|f|f||||Samples With DNA|"     Plasma and Serum samples obtained at baseline and visit 2   "|||2017-10-10 20:47:20.582092|2017-10-10 20:47:20.582092
NCT03253042|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-16|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Immediate and Chronic Effects of Whole-Body Vibration on Neuromuscular Performance and Postural Control in Elderly|Immediate and Chronic Effects of Whole-Body Vibration on Neuromuscular Performance and Postural Control in Elderly: A Randomized Controlled Trial|Recruiting||N/A|48|Anticipated|Universidade Federal do Rio Grande do Norte||2|||f||||f|f|f||||||||2017-10-10 20:47:20.71718|2017-10-10 20:47:20.71718
NCT03253029|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-22|||April 2015|Anticipated|2015-04-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of Branched-chain Amino Acids in Cancer Cachexia|Use of Branched-chain Amino Acids in Cancer Cachexia|Withdrawn||N/A|0|Actual|Western Regional Medical Center||2||Withdrawal of institutional support|f||||f||||||||||2017-10-10 20:47:20.818085|2017-10-10 20:47:20.818085
NCT03253016|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||March 26, 2017|Actual|2017-03-26|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The Impact of Cervical Cerclage or Vaginal Progesterone on Vaginal Microbiome Distribution|A Comparative Evaluation to Evaluate the Correlation Between Cervical Cerclage or Vaginal Progesterone and Maternal Vaginal Microbiome Distribution During Pregnancy|Recruiting||N/A|100|Anticipated|Western Galilee Hospital-Nahariya||3|||f||||f|f|f||||||||2017-10-10 20:47:20.894265|2017-10-10 20:47:20.894265
NCT03253003|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-21|||August 7, 2017|Actual|2017-08-07|September 2017|2017-09-01|August 25, 2017|Actual|2017-08-25|August 25, 2017|Actual|2017-08-25||Interventional|||Quality Control of CE-Certified Phonak Hearing Aids - 2017_27|Quality Control of CE-Certified Phonak Hearing Aids - 2017_27|Completed||N/A|19|Actual|Sonova AG||1|||f|||||f|f||||||||2017-10-10 20:47:20.984326|2017-10-10 20:47:20.984326
NCT03252990|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-07|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability|Molecular Imaging of Coronary Plaque Vulnerability Using 18F-fluorocholine PET-MRI in Patients With Coronary Artery Disease|Not yet recruiting||N/A|35|Anticipated|Maastricht University Medical Center|||3||f||||t|f|f||||||||2017-10-10 20:47:21.067171|2017-10-10 20:47:21.067171
NCT03252977|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-10|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Tailored PCA Based on Preoperative Pain Sensitivity|The Effectiveness of Tailored Patient Controlled Analgesia Based on Preoperative Pain Sensitivity in Gynecological Patients|Recruiting||N/A|118|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 20:47:21.169754|2017-10-10 20:47:21.169754
NCT03252964|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-15|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|February 2028|Anticipated|2028-02-01|February 2018|Anticipated|2018-02-01||Interventional|CGM IRB2||Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics|Empowering Medicare Patients to Self-Manage Their Type 2 Diabetes Using Continuous Glucose Monitoring (CGM) - Investigational Device Pilot|Enrolling by invitation||N/A|100|Anticipated|Savvysherpa, Inc.||1|||f|||||f|t|t|f|f|||||2017-10-10 20:47:21.256578|2017-10-10 20:47:21.256578
NCT03252951|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Physical Therapy for Anal Incontinence|An Innovative Rehabilitation Approach for Women With Anal Incontinence|Not yet recruiting||N/A|300|Anticipated|San Diego State University||4|||f||||t|f|f|||f|||||2017-10-10 20:47:21.34099|2017-10-10 20:47:21.34099
NCT03252938|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-13|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Feasibility and Safety of IMP321 for Advanced Stage Solid Tumors|An Explorative, Single Center, Open-labeled, Phase I Study to Evaluate the Feasibility and Safety of Intra-tumoral, Intra-peritoneal, and Subcutaneous Injections With IMP321 (LAG-3Ig Fusion Protein) for Advanced Stage Solid Tumor Entities|Recruiting||Phase 1|38|Anticipated|Krankenhaus Nordwest||3|||f||||t|f|f||||||||2017-10-10 20:47:21.423113|2017-10-10 20:47:21.423113
NCT03252925|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-08-16|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||A Safety and Efficacy Study of NAC in Patients With TA-TMA|A Safety and Efficacy Study of N-acetylcysteine in Patients With Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy|Recruiting||Phase 3|300|Anticipated|The First Affiliated Hospital of Soochow University||2|||||||t|t|f||||||||2017-10-10 20:47:21.512322|2017-10-10 20:47:21.512322
NCT03252912|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-16|||January 6, 2017|Actual|2017-01-06|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|LCS Bio Sein||Study in Leptomeningeal Metastases of Breast Cancer|Cerebrospinal Fluid Biomarkers Value: Exploratory and Prospective Study in Leptomeningeal Metastases of Breast Cancer (LCS Bio Sein)|Recruiting||N/A|51|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f|f|f||||||||2017-10-10 20:47:21.605529|2017-10-10 20:47:21.605529
NCT03252899|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-16|||December 15, 2016|Actual|2016-12-15|August 2017|2017-08-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Observational|||Current Practices of Upper Limb Rehabilitation After Stroke|Current Practices of Upper Limb Rehabilitation After Stroke: a Survey Among Stroke Survivors and Therapists|Completed||N/A|300|Actual|University Ghent|||3||f||||f|f|f||||||||2017-10-10 20:47:21.683915|2017-10-10 20:47:21.683915
NCT03252886|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||March 1, 2011|Actual|2011-03-01|August 2017|2017-08-01|March 1, 2015|Actual|2015-03-01|March 1, 2015|Actual|2015-03-01||Interventional|||Videolaryngoscopy During CPR for Trauma Patients|The Efficacy of Videolaryngoscopy During Cardiac-pulmonary Resuscitation (CPR) for Trauma Patients Wearing Neck Collar|Completed||N/A|30|Actual|Konkuk University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:47:21.749484|2017-10-10 20:47:21.749484
NCT03252873|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-16|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||THE FACTORS AFFECTING THE ADHERENCE TO THE PULMONARY REHABILITATION PROGRAM IN COPD|INVESTIGATION THE FACTORS AFFECTING THE ADHERENCE TO THE OUTPATIENT PULMONARY REHABILITATION PROGRAM IN COPD|Completed||N/A|359|Actual|Izmir Katip Celebi University|||1||f||||f|f|f||||||||2017-10-10 20:47:21.830782|2017-10-10 20:47:21.830782
NCT03252860|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-16|||April 1, 2016|Actual|2016-04-01|August 2017|2017-08-01|August 12, 2016|Actual|2016-08-12|July 31, 2016|Actual|2016-07-31||Observational|||WHO SSC : Compliance and Associated Surgical Outcomes in Uganda's Referral Hospitals|World Health Organization Surgical Safety Checklist: Compliance and Associated Surgical Outcomes in Uganda's Referral Hospitals|Completed||N/A|850|Actual|Makerere University|||1||f||||f|f|f||||||||2017-10-10 20:47:21.887479|2017-10-10 20:47:21.887479
NCT03252847|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-07|||July 14, 2017|Actual|2017-07-14|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Retinitis Pigmentosa GTPase Regulator (RPGR)|An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV2/5-hRKp.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)|Recruiting||Phase 1/Phase 2|36|Anticipated|MeiraGTx UK II Ltd||3|||f||||t|f|f||||||||2017-10-10 20:47:22.051796|2017-10-10 20:47:22.051796
NCT03252834|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-16|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Genetic Variants and Chemotherapy-induced Abnormal Thermal Sensation|To Study the Individual Variants of Chemotherapy-induced Abnormal Thermal Sensation in Cancer Patients|Recruiting||N/A|100|Anticipated|National Cheng-Kung University Hospital|||2||f|||||f|f||||||||2017-10-10 20:47:22.144771|2017-10-10 20:47:22.144771
NCT03252821|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-10-03|||August 15, 2017|Actual|2017-08-15|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 1, 2019|Anticipated|2019-08-01||Interventional|||Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy|Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy|Recruiting||N/A|72|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f|||||f|f||||||||2017-10-10 20:47:22.234405|2017-10-10 20:47:22.234405
NCT03252808|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-29|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|January 31, 2019|Anticipated|2019-01-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Japanese Patients With Unresectable Pancreatic Cancer.|Phase I Study of Combination With TBI-1401(HF10), a Replication-competent HSV-1 Oncolytic Virus, and Chemotherapy in Japanese Patients With Stage III or IV Unresectable Pancreatic Cancer.|Recruiting||Phase 1|6|Anticipated|Takara Bio Inc.||1|||f||||t|f|f||||||||2017-10-10 20:47:22.33816|2017-10-10 20:47:22.33816
NCT03252795|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-16|||November 3, 2016|Actual|2016-11-03|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Uterus Transplantation From a Multi-organ Donor|Uterus Transplantation From a Multi-organ Donor: A Prospective Trial|Recruiting||N/A|20|Anticipated|University Hospital, Ghent||1|||f|||||f|f||||||||2017-10-10 20:47:22.448452|2017-10-10 20:47:22.448452
NCT03252782|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|February 20, 2018|Anticipated|2018-02-20|December 30, 2017|Anticipated|2017-12-30||Interventional|||Comparison of Distalization and Functional Appliance Therapy|Three Dimentional Stereophotogrammetric Comparison of Intraoral Maxillary Molar Distalization and Functional Mandibular Advancement on Facial Soft Tissues|Active, not recruiting||N/A|30|Actual|Izmir Katip Celebi University||2|||f|||||f|f||||||||2017-10-10 20:47:22.549791|2017-10-10 20:47:22.549791
NCT03252769|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Vaginal Self-sampling for Non-attenders|Vaginal Self-sampling for High-risk HPV Detection in Women Who do Not Attend Cervical Screening|Enrolling by invitation||N/A|1950|Anticipated|Western Health and Social Care Trust||1|||f||||f||||||||||2017-10-10 20:47:22.63128|2017-10-10 20:47:22.63128
NCT03252756|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Cannabidiol in Alcohol Use Disorder|Effects of Cannabidiol in Alcohol Use Disorder|Not yet recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||t|f|f||||||||2017-10-10 20:47:22.702956|2017-10-10 20:47:22.702956
NCT03252743|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.|Internet-delivered Exposure-based Cognitive Behavior Therapy for Pain-predominant Functional Gastrointestinal Disorders in Children and Adolescents: an Implementation Study.|Recruiting||N/A|80|Anticipated|Karolinska Institutet||1|||f||||f|f|f||||||||2017-10-10 20:47:22.798566|2017-10-10 20:47:22.798566
NCT03252730|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-17|||January 30, 2017|Actual|2017-01-30|August 2017|2017-08-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||In-Use Test With a Cosmetic Product|In-Use Test With a Cosmetic Product (WO 4260) for Topical Use on the Scalp|Completed||N/A|34|Actual|Dr. August Wolff GmbH & Co. KG Arzneimittel||1|||f||||f|f|f||||||||2017-10-10 20:47:22.910086|2017-10-10 20:47:22.910086
NCT03252717|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-16|||August 2014||2014-08-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2017|Anticipated|2017-08-01||Interventional|BIORISE||Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)|Radiation-induced Late Side-effects: Predictive Role of New Biomarkers for Selecting Hypersensitive Patients to Ionizing Radiation in Breast Cancer (BIORISE)|Recruiting||N/A|500|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-10 20:47:22.990049|2017-10-10 20:47:22.990049
NCT03252704|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-16|||March 31, 2016|Actual|2016-03-31|August 2017|2017-08-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Interventional|||Post-prandial Glycemic Response to Fiber in Healthy Adults|Post-prandial Glucose and Insulin Response to High-fiber Muffin Top Containing Resistant Starch in Healthy Adults|Completed||N/A|28|Actual|Ingredion Incorporated||2|||f||||f|f|f||||||||2017-10-10 20:47:23.084542|2017-10-10 20:47:23.084542
NCT03252691|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|USLSI||Incidence of Large Annular Defects in Primary Lumbar Discectomy Patients|Study to Determine Incidence of Large Annular Defects And Measurement of Volume of Nucleus Removed in Primary Discectomy Patients|Not yet recruiting||N/A|150|Anticipated|Intrinsic Therapeutics|||1||f||||t|f|f||||||||2017-10-10 20:47:23.167209|2017-10-10 20:47:23.167209
NCT03252678|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-17|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|September 30, 2017|Anticipated|2017-09-30||Interventional|||Efficacy of Self-education Program for Advanced Care Planning(RCT)|Efficacy of Self-education Program for Advanced Care Planning: A Randomized Controlled Trial|Recruiting||N/A|238|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:47:23.247462|2017-10-10 20:47:23.247462
NCT03252665|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-14|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI|Efficacy of Intracoronary Infusion of Different Medicine With Targeted Perfusion Catheter on Myocardial Perfusion in Patients With STEMI Undergoing Primary PCI:an Open,Prospective,Randomized,Multicenter Trial.|Not yet recruiting||Phase 4|600|Anticipated|RenJi Hospital||3|||f||||t|f|f||||||||2017-10-10 20:47:23.348038|2017-10-10 20:47:23.348038
NCT03252652|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-16|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Observational|||Normal Parameters of Cranial Vessels Using Cranial Vascular Duplex Among Egyptian Population|Standardization of Normal Parameters of Cranial Vessels by Using Extra and Trans Cranial Vascular Duplex Among Egyptian Population|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:47:23.471439|2017-10-10 20:47:23.471439
NCT03252639|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-14|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||A Study of Using Parenchymal Blood Volume(PBV) for Endovascular Treatment of Renal Arterial Stenosis|A Prospective Study of Using Parenchymal Blood Volume(PBV) for Endovascular Treatment of Renal Arterial Stenosis|Recruiting||N/A|60|Anticipated|Peking Union Medical College Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:23.557424|2017-10-10 20:47:23.557424
NCT03252626|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-15|||August 18, 2017|Anticipated|2017-08-18|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke|Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke|Not yet recruiting||Phase 4|950|Anticipated|First Hospital of Jilin University||2|||f|||||f|f||||||||2017-10-10 20:47:23.642371|2017-10-10 20:47:23.642371
NCT03252613|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||May 19, 2017|Actual|2017-05-19|August 2017|2017-08-01|October 27, 2018|Anticipated|2018-10-27|October 27, 2018|Anticipated|2018-10-27||Observational|TASC01||Translational Approaches to Septic Cardiomyopathy|Translational Approaches to Septic Cardiomyopathy|Recruiting||N/A|24|Anticipated|Intermountain Health Care, Inc.|||1||f||||f|f|f||||||||2017-10-10 20:47:23.712746|2017-10-10 20:47:23.712746
NCT03252600|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-07|||August 25, 2017|Actual|2017-08-25|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis|A Randomized Phase 2 Trial of Lenalidomide/ Dexamethasone/ Elotuzumab +/- Cyclophosphamide Followed by Lenalidomide/ Dexamethasone/Elotuzumab Maintenance as Second-Line Therapy for Patients With Relapsed AL Amyloidosis|Recruiting||Phase 2|53|Anticipated|Barbara Ann Karmanos Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 20:47:23.79418|2017-10-10 20:47:23.79418
NCT03252587|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-27|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|April 29, 2020|Anticipated|2020-04-29|April 8, 2020|Anticipated|2020-04-08||Interventional|||An Investigational Study to Evaluate BMS-986165 in Patients With Systemic Lupus Erythematosus|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects With Systemic Lupus Erythematosus|Recruiting||Phase 2|400|Anticipated|Bristol-Myers Squibb||4|||f||||t|t|f||||||||2017-10-10 20:47:23.994896|2017-10-10 20:47:23.994896
NCT03252574|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-16|||July 2016||2016-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|||A Randomised Crossover Study to Explore the Physiological Impact of AIR+ Smart Masks on Children|To Explore the Physiological Impact of AIR+ Smart Masks on Children|Enrolling by invitation||N/A|100|Anticipated|Innosparks Pte Ltd.||2|||f||||t||||||||||2017-10-10 20:47:24.67063|2017-10-10 20:47:24.67063
NCT03252561|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-08-14|||August 2014||2014-08-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||TAP Block for Laparoscopic Appendicectomy in Adults|Ultrasound Guided Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Appendicectomy in Adults: A Double Blind Randomised Controlled Trial|Terminated||N/A|72|Actual|Oxford University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 20:47:24.757218|2017-10-10 20:47:24.757218
NCT03252548|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|||Pediatric Primary Immunodeficiency Disease (PID) in China|Clinical Characteristics and Prognosis of Primary Immunodeficiency Disease (PID) in Chinese Children|Not yet recruiting||N/A|400|Anticipated|Beijing Children's Hospital|||1||f||||t|f|f||||||||2017-10-10 20:47:24.850994|2017-10-10 20:47:24.850994
NCT03252535|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-16|||April 15, 2018|Anticipated|2018-04-15|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|April 15, 2020|Anticipated|2020-04-15||Interventional|ADORE-DH||Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease|Dose-Response Evaluation of the Investigational Product Cellavita HD After Intravenous Administration in Patients With Huntington's Disease|Not yet recruiting||Phase 2|35|Anticipated|Azidus Brasil||3|||f||||t|f|f||||||||2017-10-10 20:47:24.916095|2017-10-10 20:47:24.916095
NCT03252522|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-14|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|MADDY||Micronutrients for ADHD in Youth|"Micronutrients for ADHD in Youth: The MADDY Study"|Not yet recruiting||Phase 4|120|Anticipated|Oregon Health and Science University||2|||||||t|t|f||||||||2017-10-10 20:47:25.018147|2017-10-10 20:47:25.018147
NCT03252314|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-26|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|RAGE||Ruptured Aneurysms Treated With Hydrogel Coils|Ruptured Aneurysms Treated With Hydrogel Coils|Enrolling by invitation||N/A|1000|Anticipated|Microvention-Terumo, Inc.|||1||f||||f|f|t|f|f||||||2017-10-10 20:47:26.506415|2017-10-10 20:47:26.506415
NCT03252496|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-19|||August 19, 2017|Actual|2017-08-19|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Combined Colloids And Crystalloids Versus Crystalloids in Women With Preeclampsia Undergoing Cesarean Delivery|Combined Colloids And Crystalloids Versus Crystalloids in Women With Preeclampsia Undergoing Cesarean Delivery Under Spinal Anesthesia: A Randomized Controlled Trial|Recruiting||N/A|140|Anticipated|Mansoura University||2|||f||||f|f|f||||||||2017-10-10 20:47:25.204221|2017-10-10 20:47:25.204221
NCT03252483|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-15|||December 2012|Actual|2012-12-01|August 2017|2017-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Integrating HIV and Hepatitis C Screening in an Urban Emergency Department|A Randomized Controlled Trial to Evaluate Feasibility of Bundled HCV/HIV Rapid Screening|Completed||N/A|478|Actual|New York City Health and Hospitals Corporation||2|||f|||||f|f||||||||2017-10-10 20:47:25.328538|2017-10-10 20:47:25.328538
NCT03252470|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|||The BlackBox Study|A Prospective, Post Market, Feasibility Study to Assess the Practical Utility of the OR BlackBox Platform When Used to Compare Surgical Technique During 2D Versus 3D Laparoscopic Bariatric Surgery|Not yet recruiting||N/A|50|Anticipated|Olympus Corporation of the Americas|||2||f||||f|f|f||||||||2017-10-10 20:47:25.414295|2017-10-10 20:47:25.414295
NCT03252457|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP|A Multicenter Prospective Randomized Study of Dexamethasone Combined With Decitabine Versus Dexamethasone in the Treatment of Newly Diagnosed Primary Immune Thrombocytopenia (ITP)|Not yet recruiting||Phase 3|200|Anticipated|Shandong University||2|||f||||t|f|f|||f|||||2017-10-10 20:47:25.499825|2017-10-10 20:47:25.499825
NCT03252444|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-20|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Therapeutic Approaches for Subjects With Scapula Dyskinesis|Therapeutic Approaches for Subjects With Scapula Dyskinesis: Conscious Control, EMG Biofeedback Training, and Intensive Scapula-focused Intervention|Recruiting||N/A|170|Anticipated|National Taiwan University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:47:25.593601|2017-10-10 20:47:25.593601
NCT03252431|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-16|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy|A Phase III, Randomized, Multi-Centre, Open-Label, Fixed Dose, Neulasta® Active-Controlled Clinical Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy|Not yet recruiting||Phase 3|400|Anticipated|Generon (Shanghai) Corporation Ltd.||2|||f|||||t|f||||||||2017-10-10 20:47:25.678834|2017-10-10 20:47:25.678834
NCT03252418|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-18|||October 7, 2015|Actual|2015-10-07|August 2017|2017-08-01|September 10, 2016|Actual|2016-09-10|September 10, 2016|Actual|2016-09-10||Interventional|||Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation|Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation: Histological and Clinical Randomized Study|Completed||Phase 4|10|Actual|Ain Shams University||2|||f||||t|f|f||||||||2017-10-10 20:47:25.760381|2017-10-10 20:47:25.760381
NCT03252405|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-15|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Induction Method in Post Operative Agitation|the Effect of Two Different Method; Mask Ventilation or Intravenous Canulation on Emergence Agitation and Recovery Conditions on Pediatric Adenotonsillectomy|Not yet recruiting||N/A|70|Anticipated|Ahi Evran University Education and Research Hospital||2|||f||||t|f|f||||||||2017-10-10 20:47:25.833505|2017-10-10 20:47:25.833505
NCT03252392|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Observational|||/Autism Spectrum Disorder(ASD)Hearing Abnormalities Study|Does Autism Spectrum Disorder(ASD)Show Any Degree of Hearing Abnormalities? :A Preliminary Study|Not yet recruiting||N/A|80|Anticipated|Assiut University|||2||f||||t|f|f||||||||2017-10-10 20:47:25.923311|2017-10-10 20:47:25.923311
NCT03252379|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|December 1, 2019|Anticipated|2019-12-01||Interventional|||Endoscopic Access Loop With Bilio-enteric Anastomosis: A Prospective Randomized Comparison Between Gastric and Subcutaneous Accesses|Endoscopic Access Loop With Bilio-enteric Anastomosis: A Prospective Randomized Comparison Between Gastric and Subcutaneous Accesses|Not yet recruiting||N/A|30|Anticipated|Assiut University||3|||f||||f|f|f||||||||2017-10-10 20:47:25.985637|2017-10-10 20:47:25.985637
NCT03252366|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Maxillary Sinus Elevation and Simultaneous Implant Placement|MAXILLARY SINUS ELEVATION USING GELFOAM (ABSORBABLE GELATIN) VERSUS XENOGRAFT (TUTOGEN) and SIMULTANEOUS IMPLANT PLACEMENT:Randomized Clinical Trial|Active, not recruiting||N/A|18|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:47:26.067683|2017-10-10 20:47:26.067683
NCT03252353|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-10-05|||September 1, 2017|Actual|2017-09-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|OPTIMAL||Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly|A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Efficacy and Safety of Octreotide Capsules in Patients Who Demonstrated Biochemical Control on Injectable Somatostatin Receptor Ligands (SRL) Treatment|Recruiting||Phase 3|50|Anticipated|Chiasma, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:47:26.154134|2017-10-10 20:47:26.154134
NCT03252340|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-21|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|September 19, 2022|Anticipated|2022-09-19|September 19, 2022|Anticipated|2022-09-19||Observational|||Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis|Observational Study to Evaluate the Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis|Enrolling by invitation||N/A|13|Anticipated|EHL Bio Co., Ltd.|||1||f||||f|f|f||||||||2017-10-10 20:47:26.357556|2017-10-10 20:47:26.357556
NCT03252327|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-12|||August 26, 2017|Actual|2017-08-26|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Effects of the Interventions Using Multiple Sensory Integrations on Preterm Infants' Stress-Related Outcomes|Effects of the Interventions Using Multiple Sensory Integrations on Relieving Pain and Distress in Preterm Infants During Peripheral Venous Puncture Procedures|Recruiting||N/A|4|Anticipated|National Defense Medical Center, Taiwan||4|||f|||||f|f||||||||2017-10-10 20:47:26.427582|2017-10-10 20:47:26.427582
NCT03252288|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-27|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|MINT||mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations|mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Childhood Vaccinations|Recruiting||N/A|600|Anticipated|Duke University||3|||f||||f|f|f||||||||2017-10-10 20:47:26.651051|2017-10-10 20:47:26.651051
NCT03252275|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|January 2020|Anticipated|2020-01-01||Interventional|SimForLife||Peer Learning and HBB in Managing Maternal Newborn and Child Health Emergencies in Rural Uganda|Use of Simulation Based Education With Peer Learning to Enhance HBB Training for Managing Maternal Newborn and Child Health Emergencies in Rural Uganda: A Cluster-randomized Trial|Not yet recruiting||N/A|77|Anticipated|Mbarara University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 20:47:26.73239|2017-10-10 20:47:26.73239
NCT03252262|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-08-14|||January 30, 2014|Actual|2014-01-30|April 2017|2017-04-01|December 30, 2015|Actual|2015-12-30|December 30, 2015|Actual|2015-12-30||Interventional|||Power V360 - Promoting Optimal Wellness Among Elders Through Vitalize 360|Power V360 - Promoting Optimal Wellness Among Elders Through Vitalize 360|Completed||N/A|161|Actual|Hebrew Rehabilitation Center, Boston||3|||f||||f|f|f||||||||2017-10-10 20:47:26.809746|2017-10-10 20:47:26.809746
NCT03252249|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Duration of Dual Anti-Platelet Therapy (DUAL-ACS2)|Duration of Dual Anti-Platelet Therapy in Acute Coronary Syndrome in Scotland|Not yet recruiting||Phase 4|19424|Anticipated|University of Edinburgh||2|||f||||t|f|f||||||||2017-10-10 20:47:26.870571|2017-10-10 20:47:26.870571
NCT03252236|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-16|||October 1, 2014|Actual|2014-10-01|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Tai Chi Training in Stroke Survivors|Effects of Mind-body Exercise on Cardiovascular Functions and Dual-tasking Performance in Chronic Stroke Survivors - a Randomized Controlled Clinical Trial|Completed||N/A|56|Actual|The Hong Kong Polytechnic University||3|||f|||||f|f||||||||2017-10-10 20:47:26.941123|2017-10-10 20:47:26.941123
NCT03252223|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-25|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|August 31, 2019|Anticipated|2019-08-31||Interventional|||Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS|Ovarian Function in Women With Polycystic Ovary Syndrome|Recruiting||Phase 4|42|Anticipated|University of California, San Diego||2|||f|||||t|f||||||||2017-10-10 20:47:27.124842|2017-10-10 20:47:27.124842
NCT03252210|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-14|||August 16, 2017|Anticipated|2017-08-16|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|PSLVML||Preoperative Stereoscopic Localization Versus Methylene Blue Localization in GGO Wedge Resection|Preoperative Stereoscopic Localization Versus Methylene Blue Localization in GGO Patients With Lung Wedge Resection:A Prospective Self-control Study.|Not yet recruiting||N/A|20|Anticipated|Guangdong Provincial People's Hospital||1|||f|||||f|f||||||||2017-10-10 20:47:27.23438|2017-10-10 20:47:27.23438
NCT03252197|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-14|||March 11, 2017|Actual|2017-03-11|August 2017|2017-08-01|June 24, 2017|Actual|2017-06-24|June 24, 2017|Actual|2017-06-24||Interventional|||A Randomized Parallel Study for Simulated Internal Jugular Vein Cannulation Using Simple Needle Guide Device|A Randomized Parallel Study for Simulated Internal Jugular Vein Cannulation Using Simple Needle Guide Device|Completed||N/A|88|Actual|Yonsei University||2|||f||||f|f|f||||||||2017-10-10 20:47:27.321145|2017-10-10 20:47:27.321145
NCT03252184|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-23|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|October 15, 2017|Anticipated|2017-10-15||Interventional|||Effects of Photobiostimulation on Endothelial Function in Healthy|Effects of Photobiostimulation on Endothelial Function, Blood and Endothelial Markers, and Nitric Oxide Metabolites in Healthy Subjects.|Not yet recruiting||N/A|12|Anticipated|Federal University of Health Science of Porto Alegre||4|||f||||t|f|f||||||||2017-10-10 20:47:27.407091|2017-10-10 20:47:27.407091
NCT03252171|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-08-14|||October 2015|Actual|2015-10-01|October 2015|2015-10-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients|Chimeric Antigen Receptor-Modified T Cells for GD2 Positive Recurrent and Metastatic Glioma|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 20:47:27.484716|2017-10-10 20:47:27.484716
NCT03252158|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||August 17, 2017|Anticipated|2017-08-17|August 2017|2017-08-01|March 28, 2018|Anticipated|2018-03-28|March 28, 2018|Anticipated|2018-03-28||Interventional|||Altering the Availability of Healthier vs. Less Healthy Items in Vending Machines|Impact of the Availability of Healthier vs. Less Healthy Foods and Beverages on Purchasing From Hospital Vending Machines|Enrolling by invitation||N/A|9|Anticipated|University of Cambridge||2|||f||||f|f|f||||||||2017-10-10 20:47:27.567658|2017-10-10 20:47:27.567658
NCT03252145|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device|Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device: A Feasibility Study|Not yet recruiting||N/A|80|Anticipated|University of California, San Francisco||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:47:27.649924|2017-10-10 20:47:27.649924
NCT03252132|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-14|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Resistance Training in Patients With Diabetic Neuropathy|Resistance Training in Patients With Diabetic Neuropathy|Recruiting||N/A|180|Anticipated|Danish Pain Research Center||2|||f||||t|f|f||||||||2017-10-10 20:47:27.779399|2017-10-10 20:47:27.779399
NCT03252119|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-14|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|August 2019|Anticipated|2019-08-01||Interventional|||High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis|High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis|Recruiting||N/A|130|Anticipated|Chris Hani Baragwanath Academic Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:47:27.878957|2017-10-10 20:47:27.878957
NCT03252106|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-14|||October 10, 2016|Actual|2016-10-10|August 2017|2017-08-01|November 10, 2016|Actual|2016-11-10|November 10, 2016|Actual|2016-11-10||Interventional|||Long-term Effectiveness of Contour Augmentation in Sites With Early Implant Placement|Long-term Effectiveness of Contour Augmentation in Sites With Early Implant Placement|Completed||N/A|20|Actual|University of Bern||1|||f||||t|f|f||||||||2017-10-10 20:47:27.994749|2017-10-10 20:47:27.994749
NCT03252093|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-21|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Evaluation of the Safety and Efficacy of Angiotensin 1-7 (Ang-(1-7)) to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) Surgery.|A Randomized, Placebo-controlled, Double Blind Evaluation of the Safety and Efficacy of Angiotensin 1-7 (Ang-(1-7)) to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) Surgery.|Recruiting||Phase 2|104|Anticipated|University of Arizona||2|||f||||t|t|f||||||||2017-10-10 20:47:28.097099|2017-10-10 20:47:28.097099
NCT03252080|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-14|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Holistic Management on the Patients With Type 2 Diabetes|Effect of Holistic Management on the Patients With Type 2 Diabetes Who Received or Did Not Receive a Short-term Intensive Education|Not yet recruiting||N/A|200|Anticipated|Chongqing Medical University||2|||f|||||f|f||||||||2017-10-10 20:47:28.235568|2017-10-10 20:47:28.235568
NCT03252067|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-14|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Tear Concentrations and Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers|Tear Concentrations and Pharmacokinetics of Azithromycin Following Topical Administration of a Single Dose of Azithromycin Eyedrops in Healthy Volunteers|Recruiting||Phase 1|42|Anticipated|Beijing Tongren Hospital||1|||f||||f|f|f||||||||2017-10-10 20:47:28.324068|2017-10-10 20:47:28.324068
NCT03252054|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Memory and Attention Disorders and Malnutrition in Hospital Setting|Prevalence of Memory and Attention Disorders and Malnutrition in Hospitalized Older Adults (Muistitoimintojen ja Tarkkaavaisuuden häiriöiden ja Vajaaravitsemuksen Yleisyys iäkkäillä Sairaalahoidossa Olevilla Potilailla [Finnish])|Active, not recruiting||N/A|151|Actual|Tampere University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:28.414703|2017-10-10 20:47:28.414703
NCT03252041|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|September 30, 2018|Anticipated|2018-09-30||Observational|PCS||MRI & MRV in Pelvic Congestion Syndrome in Females|MRI & MRV in Pelvic Congestion Syndrome in Females|Not yet recruiting||N/A|25|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:47:28.49338|2017-10-10 20:47:28.49338
NCT03252028|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-18|||December 2, 2015|Actual|2015-12-02|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Observational|||Rapid Test for Detection of the Focus of Infection in Post Neurosurgical Patients.|Rapid Test for Detection of the Focus of Infection in Post Neurosurgical Patients.|Recruiting||N/A|150|Anticipated|University Hospital, Linkoeping|||1||f||||f|f|f||||Samples With DNA|"     Samples from CSF, Sputum, Urine, Blood   "|||2017-10-10 20:47:28.566271|2017-10-10 20:47:28.566271
NCT03252015|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-10-02|||August 15, 2017|Actual|2017-08-15|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of Multiple Doses of Lasmiditan in Healthy Participants|Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Drug-Drug Interaction Study of Lasmiditan|Recruiting||Phase 1|70|Anticipated|Eli Lilly and Company||5|||f||||f|t|f||||||||2017-10-10 20:47:28.677192|2017-10-10 20:47:28.677192
NCT03252002|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-13|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|March 28, 2018|Anticipated|2018-03-28||Interventional|||Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects|Single/Multiple Dose Escalation Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAY1101042 Given as 5 mg MR Tablet After Single Oral Dosing Followed by Once Daily Dosing for 7 Days in 12 Healthy Male Subjects Per Dose Step in a Randomized, Placebo Controlled, Single Blind, Group Comparison Design|Recruiting||Phase 1|72|Anticipated|Bayer||6|||f||||f|f|f||||||||2017-10-10 20:47:28.791|2017-10-10 20:47:28.791
NCT03251976|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-18|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|March 31, 2018|Anticipated|2018-03-31||Interventional|||CPR Decision Aid For Patients With Advanced Gynecologic Malignancies|The Effect of a CPR Decision Aid on CPR Knowledge and Code-Status Preferences in Patients With Advanced Gynecologic Malignancies|Not yet recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 20:47:28.979845|2017-10-10 20:47:28.979845
NCT03251963|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients|Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients|Not yet recruiting||Phase 2|116|Anticipated|University of Utah||2|||f||||f|t|f|||t|||||2017-10-10 20:47:29.068092|2017-10-10 20:47:29.068092
NCT03251950|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-26|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|September 1, 2018|Anticipated|2018-09-01||Interventional|FRESH||Food Resource Equity and Sustainability for Health|Food Resource Equity and Sustainability for Health|Recruiting||N/A|1000|Anticipated|University of Oklahoma||2|||f||||f|f|f||||||||2017-10-10 20:47:29.152751|2017-10-10 20:47:29.152751
NCT03251937|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|March 2019|Anticipated|2019-03-01||Interventional|VERITAS||Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System|VERITAS - A Study to Demonstrate the Value of Multiple Modalities Using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain|Not yet recruiting||N/A|64|Anticipated|Boston Scientific Corporation||1|||f|||||f|t|f||f|||||2017-10-10 20:47:29.243021|2017-10-10 20:47:29.243021
NCT03251924|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-10-02|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|December 5, 2020|Anticipated|2020-12-05|April 7, 2020|Anticipated|2020-04-07||Interventional|||A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors|A Phase 1/2 Dose Escalation and Combination Cohort Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Efficacy of BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|277|Anticipated|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 20:47:29.336598|2017-10-10 20:47:29.336598
NCT03251911|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-08|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||VX-770 for the Treatment of Chronic Bronchitis|An Open Label Study to Investigate the Role of Ivacaftor (VX-770) for the Treatment of Chronic Bronchitis With CFTR Dysfunction|Not yet recruiting||Phase 4|1|Anticipated|University of Alabama at Birmingham||1|||f||||f|t|f|||f|||||2017-10-10 20:47:29.463132|2017-10-10 20:47:29.463132
NCT03251898|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-08-15|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|January 31, 2018|Anticipated|2018-01-31|3 Weeks|Observational [Patient Registry]|||Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections|Multicenter Study on Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections|Recruiting||N/A|4600|Anticipated|Bayi Children's Hospital Affiliated to PLA Army General Hospital, China|||2||f|||||f|f||||||||2017-10-10 20:47:29.554234|2017-10-10 20:47:29.554234
NCT03251885|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-04|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Extended-spectrum β-lactamase -Producing Enterobacteriaceae (ESBL) Vertical Transmission in Preterm Labor|Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL) Vertical Transmission in Preterm Labor|Recruiting||N/A|200|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||f|f|f||||Samples Without DNA|"     Two swabs will be taken at each screen: one from the vagina and the other from the rectum for     vaginal and rectal assessment of maternal colonization. Maternal colonizing ESBL strain will     be compared with infant's strain, if detected by the routine weekly NICU rectal surveillance     for ESBL carriage.   "|||2017-10-10 20:47:29.647068|2017-10-10 20:47:29.647068
NCT03251872|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-15|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||PARP-1 Inhibition in Pulmonary Arterial Hypertension|PARP-1 Inhibition in Pulmonary Arterial Hypertension|Not yet recruiting||Early Phase 1|6|Anticipated|Laval University||1|||f||||f|f|f||||||||2017-10-10 20:47:29.723629|2017-10-10 20:47:29.723629
NCT03251859|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-16|||August 11, 2017|Actual|2017-08-11|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study|A Randomized, Open-label, Pharmacodynamic and Pharmacokinetic Trial Assessing the Effect of Lowering Ticagrelor Maintenance Dose Early After Myocardial Infarction on Platelet Inhibition (ELECTRA Pilot Study).|Recruiting||Phase 3|50|Anticipated|Collegium Medicum w Bydgoszczy||2|||f||||f|f|f|||f|||||2017-10-10 20:47:29.849172|2017-10-10 20:47:29.849172
NCT03251846|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|POPS!||Pediatrics Owning Performance Study|Pediatrics Owning Performance Study|Recruiting||N/A|50|Anticipated|Children's Hospitals and Clinics of Minnesota||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:47:29.947832|2017-10-10 20:47:29.947832
NCT03251833|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||The Impact of Obesity on Maternal and Perinatal Outcomes|The Impact of Obesity on Maternal and Perinatal Outcomes; Analytic Cross Sectional Study|Not yet recruiting||N/A|2000|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:47:30.031482|2017-10-10 20:47:30.031482
NCT03251820|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|||Management Strategies For Electrical Status Epilepticus During Sleep|Management Strategies for Electrical Status Epilepticus During Sleep|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||t|f|f|||f|||||2017-10-10 20:47:30.098787|2017-10-10 20:47:30.098787
NCT03251807|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-13|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of Low-Intensity Pulsed Ultrasound on Functional Treatment of Class II Malocclusion|Effect of Low-Intensity Pulsed Ultrasound Applied on Temporomandibular Joint Region on Functional Treatment of Class II Malocclusion: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Damascus University||2|||f||||t|f|f||||||||2017-10-10 20:47:30.179359|2017-10-10 20:47:30.179359
NCT03251794|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-13|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Prediction of Preterm Labor by Fetal Adrenal Gland Evaluation|Prediction of Preterm Labor by Fetal Adrenal Gland Evaluation|Recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:47:30.293351|2017-10-10 20:47:30.293351
NCT03251781|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-21|||April 1, 2013|Actual|2013-04-01|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|May 31, 2017|Actual|2017-05-31||Interventional|||Minimal Important Difference for the Glittre-ADL Test and London Chest Activity of Daily Living Scale|Determination of Minimal Important Difference for the Glittre-ADL Test and London Chest Activity of Daily Living Scale in Patients With COPD|Active, not recruiting||N/A|60|Anticipated|University of the State of Santa Catarina||1|||f||||f|f|f||||||||2017-10-10 20:47:30.8182|2017-10-10 20:47:30.8182
NCT03251768|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-15|||August 14, 2017|Anticipated|2017-08-14|May 2017|2017-05-01|November 30, 2018|Anticipated|2018-11-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients|Efficacy and Safety Phase IIb Study of Recombinant Human Serum Albumin/ Granulocyte Colony-Stimulating Factor Fusion Protein for Injection to Prevent Neutrophilic Granulocytopenia Among Chemotherapy Breast Cancer Patients|Recruiting||Phase 2|80|Anticipated|Tianjin SinoBiotech Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:47:30.920631|2017-10-10 20:47:30.920631
NCT03251755|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-15|||May 24, 2017|Actual|2017-05-24|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 30, 2018|Anticipated|2018-05-30||Interventional|Yoga||Exercise Using Chinese Yoga Improving Insomnia|The Effectiveness of Dao-in (Chinese Yoga) on Insomnia in Type 2 Diabetes Mellitus|Recruiting||N/A|60|Anticipated|Taichung Veterans General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:47:31.015241|2017-10-10 20:47:31.015241
NCT03251742|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-30|||October 20, 2017|Anticipated|2017-10-20|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|July 1, 2018|Anticipated|2018-07-01||Interventional|FONTAN-CMR||Feasibility and Efficacy of Portable Non-invasive Negative Pressure Ventilation in Fontan Patients|Feasibility and Efficacy Of Negative Pressure Ventilation in Fontan populatioN: Cardiovascular Flow Assessment by Magnetic Resonance Imaging|Recruiting||N/A|20|Anticipated|University Health Network, Toronto||2|||f||||f|f|f||||||||2017-10-10 20:47:31.094442|2017-10-10 20:47:31.094442
NCT03251729|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-14|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|COLORS||Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix|Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length: a Randomized Clinical Trial|Recruiting||N/A|206|Anticipated|Thomas Jefferson University||2|||f||||t|f|f||||||||2017-10-10 20:47:31.193907|2017-10-10 20:47:31.193907
NCT03251716|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-28|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Berberine Treat Metabolic Syndrome in Schizophrenia|Berberine in the Treatment of Metabolic Syndrome : an Open Label Clinical Study in Female Schizophrenia Patients|Recruiting||N/A|30|Anticipated|Tianjin Anding Hospital||1|||f||||t|f|f||||||||2017-10-10 20:47:31.287337|2017-10-10 20:47:31.287337
NCT03251703|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-15|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|March 1, 2017|Actual|2017-03-01|January 1, 2016|Actual|2016-01-01||Observational|PRF||Ultrasound-Guided Suprascapular Pulsed Radiofrequency|Effects of Ultrasound-Guided Suprascapular Pulsed Radiofrequency Therapy on Chronic Shoulder Pain|Completed||N/A|74|Actual|Sakarya University|||1||f||||f|f|f||||||||2017-10-10 20:47:31.365918|2017-10-10 20:47:31.365918
NCT03251690|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||October 27, 2016|Actual|2016-10-27|August 2017|2017-08-01|January 30, 2018|Anticipated|2018-01-30|December 30, 2017|Anticipated|2017-12-30||Interventional|STEREOS||Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression|Switching Tenofovir/Emtricitabine/Efavirenz to Tenofovir/Emtricitabine/Rilpivirine Versus Continuing Tenofovir/Emtricitabine/Efavirenz in HIV1-infected Patients With Complete Virological Suppression|Active, not recruiting||N/A|244|Anticipated|Mahidol University||2|||f||||f|f|f||||||||2017-10-10 20:47:31.414022|2017-10-10 20:47:31.414022
NCT03251677|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-15|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Total Laparoscopic Hysterectomy vs Minilap Hysterectomy|A Prospective Randomized Study Comparing Total Laparoscopic Hysterectomy (Lap Hysterectomy) vs Minilaparotomy (Mini-lap Hysterectomy) for Benign Uterine Lesions: Peri-operative Outcome|Not yet recruiting||N/A|20|Anticipated|Mansoura University||2|||f|||||f|f||||||||2017-10-10 20:47:31.488213|2017-10-10 20:47:31.488213
NCT03251664|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-17|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|February 20, 2016|Actual|2016-02-20|February 20, 2016|Actual|2016-02-20|1 Day|Observational [Patient Registry]|||Food Groups Associated With Anaemia in Pregnant Women|The Relation of Locally Available Food Items With Anemia Status Among Pregnant Women in Ethiopia|Completed||N/A|592|Actual|Tehran University of Medical Sciences|||2||f|||||f|f||||||||2017-10-10 20:47:31.547451|2017-10-10 20:47:31.547451
NCT03251651|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|June 15, 2019|Anticipated|2019-06-15||Interventional|||Intraoperative Sedatives and Postoperative Deilirium|The Incidence of Postoperative Delirium According to the Different Intraoperative Sedatives, Dexmedetomidine vs. Propofol, in Elderly Patients Undergoing Orthopedic Lower Limb Surgery With Spinal Anesthesia: A Randomized Trial|Recruiting||N/A|748|Anticipated|Seoul National University Bundang Hospital||2|||f|||||f|f||||||||2017-10-10 20:47:31.74393|2017-10-10 20:47:31.74393
NCT03251638|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-19|||March 2018|Anticipated|2018-03-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Observational|||Neonatal Hearing Screening in Assiut Hospital|Neonatal Hearing Screening at Neonatal Intensive Care Unit of Assiut University Hospital|Not yet recruiting||N/A|300|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:47:31.865429|2017-10-10 20:47:31.865429
NCT03251625|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Multi-strain Probiotic in the Management of IBS-D|Supplementation With a Multi-strain Probiotic Formulation (Bio-Kult®) in the Management of Diarrhea-predominant Irritable Bowel Syndrome - a Randomized, Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 4|270|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f|||||f|f|||f|||||2017-10-10 20:47:31.94646|2017-10-10 20:47:31.94646
NCT03251612|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|February 2020|Anticipated|2020-02-01||Interventional|||Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer|Predictive Value of In-vitro Testing Anti-cancer Therapy Sensitivity on Tumorspheres From Patients With Metastatic Colorectal Cancer|Not yet recruiting||Phase 2|90|Anticipated|Vejle Hospital||1|||f||||f|f|f||||||||2017-10-10 20:47:32.034908|2017-10-10 20:47:32.034908
NCT03251599|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-23|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|October 30, 2017|Anticipated|2017-10-30|October 27, 2017|Anticipated|2017-10-27||Interventional|nitrotherm||The Effect of Nitroglycerin Infusion Rate on Cerebral Rewarming During Hypothermic Coronary Artery Bypass Grafting|The Effect of Two Different Rates of Nitroglycerin Infusion on Cerebral Rewarming During Rewarming Period of Hypothermic Cardiopulmonary Bypass|Recruiting||Phase 4|96|Anticipated|Rize Üniversitesi||2|||f||||t|f|f|||f|||||2017-10-10 20:47:32.153768|2017-10-10 20:47:32.153768
NCT03251586|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Test-Retest Reliability of oVEMP's Across Different Electrode Montages|Test-Retest Reliability of oVEMP's Across Different Electrode Montages|Not yet recruiting||N/A|80|Anticipated|Vanderbilt University Medical Center||8|||f||||f|f|t|f|f||||||2017-10-10 20:47:32.293877|2017-10-10 20:47:32.293877
NCT03251573|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-31|||September 1, 2017|Actual|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01|2 Years|Observational [Patient Registry]|CODE||The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients|The Cohort Study of Cognitive Impairment and Its Association With Clinical Outcomes in Chinese Maintenance Hemodialysis Patients|Enrolling by invitation||N/A|600|Anticipated|Beijing Shijitan Hospital|||1||f|||||f|f||||||||2017-10-10 20:47:32.42658|2017-10-10 20:47:32.42658
NCT03251560|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-13|||December 1, 2016|Actual|2016-12-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Clinical Effect of Fuke Qianjin Capsule on Chronic Pelvic Pain Caused by Pelvic Inflammation|The Clinical Effect of Fuke Qianjin Capsule on Chronic Pelvic Pain Caused by Pelvic Inflammation|Recruiting||Phase 2|240|Anticipated|Peking Union Medical College Hospital||2|||f|||||f|f||||||||2017-10-10 20:47:32.50979|2017-10-10 20:47:32.50979
NCT03251547|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-27|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|November 15, 2017|Anticipated|2017-11-15|October 15, 2017|Anticipated|2017-10-15||Observational|||Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia|Recombinant Activated Factor VII (rFVIIa/ NovoSeven®) in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia|Recruiting||N/A|70|Anticipated|University of Science Malaysia|||1||f||||f|t|f|||f|||||2017-10-10 20:47:32.64148|2017-10-10 20:47:32.64148
NCT03251534|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|FEOS||Contribution of Stereography (EOS Imaging System) in the Quantification of Femoral Shaft Fractures.|Contribution of Stereography in the Quantification of Malunions Femoral Shaft Fractures Operated by Centromedullary Nailing. A Case Serie of 40 Patients|Active, not recruiting||N/A|40|Actual|University Hospital, Grenoble|||1||f||||f|f|f||||||||2017-10-10 20:47:32.766263|2017-10-10 20:47:32.766263
NCT03251521|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||March 2012|Actual|2012-03-01|August 2017|2017-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|DOLOTOX||Pain During Injection With Botulinum Toxin in Post-stroke Spasticity Treatment|Evaluation of Pain Intensity in Different Steps of Injection With Botulinum Toxin in the Treatment of Spasticity in Post-stroke Patients|Completed||N/A|46|Actual|University Hospital, Grenoble|||1||f||||f|f|f||||||||2017-10-10 20:47:32.866216|2017-10-10 20:47:32.866216
NCT03251508|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2023|Anticipated|2023-09-01|September 2022|Anticipated|2022-09-01||Interventional|SOIT||Salvage Peanut Oral Immunotherapy Study|Salvage Peanut Oral Immunotherapy Study: A Single-arm, Open Label Trial of Peanut Flour With 6 Month Active Treatment and 6 Month Follow-up|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t|t|f||||||||2017-10-10 20:47:32.952385|2017-10-10 20:47:32.952385
NCT03251495|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-29|||August 29, 2017|Actual|2017-08-29|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Immunologic Responses to a Live Attenuated Oral Cholera Vaccine|Immunologic Responses to a Live Attenuated Oral Cholera Vaccine|Recruiting||Phase 2|10|Anticipated|Emory University||1|||f||||f|t|f|||f|||||2017-10-10 20:47:33.06327|2017-10-10 20:47:33.06327
NCT03251482|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-22|||October 23, 2017|Anticipated|2017-10-23|September 2017|2017-09-01|September 24, 2019|Anticipated|2019-09-24|May 3, 2019|Anticipated|2019-05-03||Interventional|TEXT-TKR||A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery|A Randomized, Double-blind, Double-dummy, Multicenter, Adaptive Design, Dose Escalation (Part 1) and Dose-Response (Part 2) Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Subjects Undergoing Elective Total Knee Replacement Surgery|Not yet recruiting||Phase 2|1500|Anticipated|Janssen Research & Development, LLC||11|||f||||t|t|f|||t|||||2017-10-10 20:47:33.204986|2017-10-10 20:47:33.204986
NCT03251469|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-15|||January 2013||2013-01-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture|Single Dose of Tranexamic Acid at the Time of Surgery and Blood Loss, in Elderly Patients Undergoing Hip Fracture Surgery|Recruiting||Phase 2|200|Anticipated|National and Kapodistrian University of Athens||2|||f||||f||||||||||2017-10-10 20:47:33.641408|2017-10-10 20:47:33.641408
NCT03251456|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-31|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Tertiary Care for Visual Developmental Disorders in Pre-school Children|Tertiary Care Based Visual Developmental Diseases Management Model Among Preschool Children in China: a Cluster Randomized Controlled Trial|Recruiting||N/A|10000|Anticipated|Zhongshan Ophthalmic Center, Sun Yet-sen University||2|||f||||t|f|f||||||||2017-10-10 20:47:33.743147|2017-10-10 20:47:33.743147
NCT03251443|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|September 8, 2018|Anticipated|2018-09-08|August 8, 2018|Anticipated|2018-08-08||Interventional|||A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma|Single Center, Single Arm, Open Study, to Explore and Evaluate Treatment of Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma|Recruiting||Phase 3|30|Anticipated|Peking Union Medical College Hospital||1|||f||||t|f|f||||||||2017-10-10 20:47:33.831262|2017-10-10 20:47:33.831262
NCT03251430|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-13|||August 20, 2017|Anticipated|2017-08-20|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 1, 2019|Anticipated|2019-03-01|1 Day|Observational [Patient Registry]|||Bone Microstructure by Using HR-pQCT in Long Courses After Gastrectomy|Assessment of Bone Microstructure by Using High-resolution Peripheral Quantitative Computed Tomography in Long Courses After Gastrectomy : a Prospective Observational Study|Recruiting||N/A|114|Anticipated|Nagasaki University|||3||f||||f|f|f|||f|Samples Without DNA|"     Protein   "|||2017-10-10 20:47:33.915318|2017-10-10 20:47:33.915318
NCT03251417|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-26|||September 10, 2017|Anticipated|2017-09-10|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|||Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma|Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma Patients Failed in First-line Chemotherapy: A Phase II Study|Recruiting||Phase 2|50|Anticipated|Peking University||1|||f||||f|f|f||||||||2017-10-10 20:47:34.005845|2017-10-10 20:47:34.005845
NCT03251404|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-13|2017-08-13|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of Injury Prevention Exercises on Performance and Neuromuscular Function|Effects of Two Injury Prevention Exercise Programs on Performance and Neuromuscular Function in Youth Football|Recruiting||N/A|120|Anticipated|Linkoeping University||2|||f||||f|f|f||||||||2017-10-10 20:47:34.104283|2017-10-10 20:47:34.104283
NCT03251391|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||April 13, 2017|Actual|2017-04-13|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Cardiac Rehabilitation Program in Peripheral Arterial Disease|To Assess the Safety and Feasibility of a Structured Cardiac Rehabilitation Program in Patients With Peripheral Arterial Disease After Successful Revascularization Procedures: A Pilot Study.|Recruiting||N/A|20|Anticipated|University of Kansas Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:47:34.693529|2017-10-10 20:47:34.693529
NCT03251014|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-14|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Thrombotic Effects of Yellowstripe Scad|The Thrombotic Effects of Yellowstripe Scad (YSS) Compared to Salmon Among Healthy Overweight Subjects: A Randomized Cross Over Trial|Completed||N/A|50|Actual|Universiti Putra Malaysia||2|||f||||f|f|f||||||||2017-10-10 20:47:39.380251|2017-10-10 20:47:39.380251
NCT03251378|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-21|||December 15, 2017|Anticipated|2017-12-15|September 2017|2017-09-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|||The Evaluation of Safety, Tolerability, and Pharmacokinetics for Fruquintinib in Solid Tumors|A Multi-Center, Open-Label, Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fruquintinib in Advanced Solid Tumors|Not yet recruiting||Phase 1|18|Anticipated|Hutchison Medipharma Limited||3|||f||||t|t|f||||||||2017-10-10 20:47:34.780657|2017-10-10 20:47:34.780657
NCT03251365|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-13|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer|Intrabdominal Hyperthermic Chemotherapy Using Gemcitabine to Treat Pancreatic Carcinomatosis|Recruiting||Phase 2/Phase 3|42|Anticipated|Hospital General de Ciudad Real||2|||f||||t|f|f|||f|||||2017-10-10 20:47:34.862253|2017-10-10 20:47:34.862253
NCT03251352|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-08-15|||October 1, 2017|Anticipated|2017-10-01|March 2017|2017-03-01|March 30, 2021|Anticipated|2021-03-30|September 30, 2020|Anticipated|2020-09-30||Observational|TFR_china||TKI Discontinuation in CML Patients of China|Tyrosine Kinase Inhibitor Discontinuation in Adults Patients With Chronic Myeloid Leukemia in China|Not yet recruiting||N/A|98|Anticipated|Shenzhen Second People's Hospital|||1||f|||||f|f||||Samples With DNA|"     whole blood   "|||2017-10-10 20:47:34.951144|2017-10-10 20:47:34.951144
NCT03251339|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-15|2017-09-07|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Safety and Immunogenicity of MSB11455 in Healthy Subjects|A Randomized, Double-blind, Parallel Group,Controlled Study to Compare the Immunogenicity and Safety of MSB11455 and Neulasta® in Healthy Adult Subjects|Recruiting||Phase 1|404|Anticipated|Merck KGaA||2|||f||||t|t|f||||||||2017-10-10 20:47:35.016934|2017-10-10 20:47:35.016934
NCT03251326|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Nabilone in Cannabis Users With PTSD|Effects of Nabilone on Trauma Related Cue Reactivity in Cannabis Users With PTSD|Recruiting||Phase 1/Phase 2|14|Anticipated|New York State Psychiatric Institute||4|||f||||t|t|f||||||||2017-10-10 20:47:35.149684|2017-10-10 20:47:35.149684
NCT03251313|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) Patients|Recombinant Humanized PD-1 Monoclonal Antibody (JS001) Combined With Gemcitabine and Cisplatin (GP) as First Line Treatment for Triple Negative Breast Cancer patients-a Phase 1 Clinical Trial|Not yet recruiting||Phase 1|33|Anticipated|Fudan University||4|||f||||t|f|f|||f|||||2017-10-10 20:47:35.311387|2017-10-10 20:47:35.311387
NCT03251300|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-13|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Mirabegron for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing|Mirabegron for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing: A Randomized Controlled Trial|Recruiting||Phase 4|120|Anticipated|Far Eastern Memorial Hospital||2|||f|||||f|f||||||||2017-10-10 20:47:35.400758|2017-10-10 20:47:35.400758
NCT03251287|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Nitrite in Hypertrophic Cardiomyopathy (HCM) Study|Mechanistic Study of the Effect of Inorganic Sodium Nitrate on Cardiac and Skeletal Muscle Metabolic Efficiency in Patients With Hypertrophic Cardiomyopathy|Recruiting||Phase 1|18|Anticipated|University of East Anglia||2|||f||||f|f|f||||||||2017-10-10 20:47:35.478381|2017-10-10 20:47:35.478381
NCT03251274|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-06|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|September 5, 2017|Actual|2017-09-05||Interventional|||Bath Machine on Sleep Quality in Nursing Home|The Effect of Eddy Current Function of Bath Machine on Sleep Quality in Nursing Home|Recruiting||N/A|30|Anticipated|China Medical University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:47:35.560218|2017-10-10 20:47:35.560218
NCT03251261|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-15|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|CMV||Detection of Cytomegalovirus Virus in Neonates|Illumigene CMV Clinical Trial Protocol|Recruiting||N/A|1000|Anticipated|Meridian Bioscience, Inc.|||1||f||||f|f|t|t|f|t|Samples With DNA|"     Prospectively collected saliva swabs from neonates up to 21 days of age Retrospective well     characterized positive saliva samples will also be tested   "|||2017-10-10 20:47:35.634046|2017-10-10 20:47:35.634046
NCT03251248|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-09-07|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Pharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy Subjects|A Randomized, Double-blind, Crossover Study to Compare the Pharmacokinetic and Pharmacodynamic Bioequivalence of a Single Injection of MSB11455 and Neulasta in Healthy Adult Subjects|Recruiting||Phase 1|344|Anticipated|Merck KGaA||2|||f||||t|t|f||||||||2017-10-10 20:47:35.698572|2017-10-10 20:47:35.698572
NCT03251235|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-11|||January 1, 2011|Actual|2011-01-01|August 2017|2017-08-01|February 1, 2016|Actual|2016-02-01|September 4, 2013|Actual|2013-09-04||Interventional|||Neural Effects of Cognitive-behaviour Therapy in Panic Disorder|Neural Effects of Cognitive-behaviour Therapy in Panic Disorder|Completed||N/A|28|Actual|University of Oxford||2|||f||||f|f|f||||||||2017-10-10 20:47:35.782265|2017-10-10 20:47:35.782265
NCT03251222|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-11|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Intranasal Sedation With Dexmedetomidine|Intranasal Sedation With Dexmedetomidine for Vitroretinal Procedures|Recruiting||Phase 4|40|Anticipated|University Medical Centre Ljubljana||2|||f||||t||||||||||2017-10-10 20:47:35.850709|2017-10-10 20:47:35.850709
NCT03251209|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-15|||April 20, 2017|Actual|2017-04-20|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|June 10, 2017|Actual|2017-06-10||Interventional|||Mental Practice in Post-stroke Subjects|Influence of Mental Practice on Manual Dexterity Associated Before and After Physical Practice in Patients With Stroke Sequelae|Enrolling by invitation||N/A|30|Anticipated|Universidade Federal do Rio Grande do Norte||3|||f|||||f|f||||||||2017-10-10 20:47:35.963256|2017-10-10 20:47:35.963256
NCT03251027|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-14|2017-08-14|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2021|Anticipated|2021-01-01||Interventional|||Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma|Intensity-Modulated Stereotactic Radiotherapy as an Upfront Scalp-Sparing Intervention for the Treatment of Newly Diagnosed Grade II-IV Gliomas|Recruiting||Phase 2|3|Anticipated|Thomas Jefferson University||1|||f||||t|f|f||||||||2017-10-10 20:47:39.296738|2017-10-10 20:47:39.296738
NCT03251196|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-15|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30|2 Years|Observational [Patient Registry]|TBSEQUEL||TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB|TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB Defining Individual Outcomes and Public Health Impact|Not yet recruiting||N/A|1600|Anticipated|The Aurum Institute NPC|||1||f||||f|f|f||||Samples With DNA|"     Collection Bloods, Urine and Sputum will be obtained from each patient at different     time-points for analysis and storage. They will include, but are not limited to: native     urine, native sputum, extracted DNA from positive liquid culture, sputum pellet and     surpernatant and whole blood (PAXgene, plasma, serum, PBMC).   "|||2017-10-10 20:47:37.794811|2017-10-10 20:47:37.794811
NCT03251183|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-08-12|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|DECIPHER-HFpEF||Validation of CMR Against Invasive Haemodynamics in Patients With HFpEF|Validation of Cardiovascular Magnetic Resonance Against Invasive Haemodynamics in Patients With Heart Failure With Preserved Ejection Fraction (DECIPHER HFpEF)|Not yet recruiting||N/A|185|Anticipated|Goethe University|||4||f||||f|f|f||||||||2017-10-10 20:47:37.942004|2017-10-10 20:47:37.942004
NCT03251170|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-15|||September 20, 2017|Anticipated|2017-09-20|August 2017|2017-08-01|April 15, 2018|Anticipated|2018-04-15|April 10, 2018|Anticipated|2018-04-10||Interventional|||Ketamine Versus Fentanyl for Induction of Anesthesia in Septic Shock|Ketamine-based Versus Opioid-based for Rapid-sequence Induction of Anesthesia in Patients With Septic Shock|Not yet recruiting||Phase 4|28|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:47:38.049464|2017-10-10 20:47:38.049464
NCT03251157|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-15|||January 1, 2007|Actual|2007-01-01|August 2017|2017-08-01|December 31, 2010|Actual|2010-12-31|December 31, 2010|Actual|2010-12-31||Observational|||Dietary Intake in Adults From the GA2LEN Folow-up Survey|Dietary Intake, Allergy and Respiratory Diseases in European Adults From the GA2LEN Follow-up Survey|Completed||N/A|3500|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f|||||f|f||||Samples Without DNA|"     Participants had serum taken which was stored frozen and subsequently analysed in a central     laboratory to estimate concentration of several biomarkers including hormones (e.g. leptin),     markers of inflammation (cytokines CRP, Interleukin 6 (IL-6), Interleukin 8 (IL-8), Tumour     Necrosis Factor alpha (TNF-α) Transforming Growth Factor beta (TGF-β) and Myeloperoxidase     (MPO)), and serum levels of total and allergen-specific IgEs.   "|||2017-10-10 20:47:38.147528|2017-10-10 20:47:38.147528
NCT03251144|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-11|||January 8, 2018|Anticipated|2018-01-08|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|January 8, 2020|Anticipated|2020-01-08||Interventional|UCLACAREMITO||Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)|In Vitro and in Vivo Studies of the Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)|Recruiting||Phase 1/Phase 2|35|Anticipated|University of California, Los Angeles||1|||f||||f|t|f|||t|||||2017-10-10 20:47:38.260752|2017-10-10 20:47:38.260752
NCT03251131|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-12|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|REVERSE-AKI||REVERSE-AKI Randomized Controlled Pilot Trial|REstricted Fluid Therapy VERsus Standard trEatment in Acute Kidney Injury - REVERSE-AKI Randomized Controlled Pilot Trial|Not yet recruiting||Phase 2|100|Anticipated|Helsinki University Central Hospital||2|||f||||f|f|f||||||||2017-10-10 20:47:38.382882|2017-10-10 20:47:38.382882
NCT03251118|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-29|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|July 2025|Anticipated|2025-07-01|July 2025|Anticipated|2025-07-01|5 Years|Observational [Patient Registry]|TARGET-IBD||A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease|A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease|Recruiting||N/A|15000|Anticipated|Target PharmaSolutions, Inc.|||1||f||||f|f|f||||Samples With DNA|"     Patients enrolled in TARGET-IBD may be invited to participate in the Biorepository Bank     (BSB). Blood samples for biomarker and DNA assays will be collected on a voluntary basis and     participation in this project will not affect participation in the main study. These samples     will be shipped to a central repository for storage to use in future studies. Samples stored     at the biorepository will be identified only with the participant's unique study ID number     and the date the sample was obtained. The link between the participant's study ID number and     their name will be available only at the site where the samples were obtained.   "|||2017-10-10 20:47:38.549902|2017-10-10 20:47:38.549902
NCT03251105|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-11|||April 27, 2016|Actual|2016-04-27|August 2017|2017-08-01|January 31, 2017|Actual|2017-01-31|December 31, 2016|Actual|2016-12-31||Interventional|||Supreme Versus Proseal Laryngeal Mask Airways in Infants|Comparison of the Supreme™ And Proseal™ Laryngeal Mask Airways in Infants: A Prospective Randomised Clinical Study|Completed||N/A|120|Actual|Sisli Etfal Training & Research Hospital||2|||f||||t|f|f||||||||2017-10-10 20:47:38.691971|2017-10-10 20:47:38.691971
NCT03251092|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-24|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|November 14, 2017|Anticipated|2017-11-14|November 14, 2017|Anticipated|2017-11-14||Interventional|||Study Designed to Assess the Safety, Tolerability, PK and Food Effect of PTI-808 in Healthy Volunteers|A Randomized, Placebo-Controlled, Phase 1 Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, and Food Effect of PTI-808 in Healthy Volunteers|Recruiting||Phase 1|60|Anticipated|Proteostasis Therapeutics, Inc.||6|||f||||t|t|f||||||||2017-10-10 20:47:38.864264|2017-10-10 20:47:38.864264
NCT03251079|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-11|||July 25, 2017||2017-07-25||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:47:38.981074|2017-10-10 20:47:38.981074
NCT03251066|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-16|||April 27, 2017|Actual|2017-04-27|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Immediate Effect of Proponent-Nasal-Spray on Unspecific Discomfort in the Nose|Open, Not Randomised, Non-blinded Observation Study to Investigate the Immediate Effect of Proponent - Nasal - Spray in Case of Unspecific Discomfort in the Nose|Completed||N/A|54|Actual|PRECLIN Biosystems AG||1|||f||||f|f|f||||||||2017-10-10 20:47:39.029376|2017-10-10 20:47:39.029376
NCT03251053|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-11|||March 28, 2016|Actual|2016-03-28|August 2017|2017-08-01|March 28, 2021|Anticipated|2021-03-28|March 28, 2021|Anticipated|2021-03-28||Interventional|||Adverse Airway Effects From Tobacco and E-Cigarettes|Adverse Airway Effects of Inhaled Nicotine From Tobacco and E-Cigarettes|Recruiting||N/A|200|Anticipated|Miami VA Healthcare System||2|||f|||||f|t|t|||||||2017-10-10 20:47:39.132639|2017-10-10 20:47:39.132639
NCT03251001|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||February 1, 1999|Actual|1999-02-01|August 2017|2017-08-01|December 20, 2017|Anticipated|2017-12-20|November 30, 2017|Anticipated|2017-11-30||Interventional|||Acellular Dermal Matrix Allograft Versus Free Gingival Graft|Acellular Dermal Matrix Allograft Versus Free Gingival Graft: a Histological Evaluation and Split-mouth Randomized Clinical Trial|Active, not recruiting||N/A|25|Actual|University of Sao Paulo||2|||f||||t|f|f|||t|||||2017-10-10 20:47:39.466997|2017-10-10 20:47:39.466997
NCT03250988|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-14|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility|Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility|Not yet recruiting||N/A|140|Anticipated|Vanderbilt University Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:47:39.555782|2017-10-10 20:47:39.555782
NCT03250975|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-13|||August 19, 2017|Actual|2017-08-19|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Incidence of Acute Laryngeal Injury Following Endotracheal Intubation|Incidence of Acute Laryngeal Injury Following Endotracheal Intubation|Recruiting||N/A|100|Anticipated|Vanderbilt University Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:47:39.663368|2017-10-10 20:47:39.663368
NCT03250962|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-15|||September 4, 2017|Anticipated|2017-09-04|August 2017|2017-08-01|March 21, 2019|Anticipated|2019-03-21|August 21, 2018|Anticipated|2018-08-21||Interventional|||SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma|PD-1 Blockade With SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma:an Open-label Phase I/II Trial|Recruiting||Phase 1/Phase 2|40|Anticipated|Chinese PLA General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:47:39.762486|2017-10-10 20:47:39.762486
NCT03250949|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-14|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|RCT||Clinical Evaluation Of Dental Implants Stability Placed In Healed Bony Sites Following Over-drilling Compared To Conventional-Drilling Protocol|Clinical Evaluation Of Dental Implants Stability Placed In Healed Bony Sites Following Over-drilling Compared To Conventional-Drilling Protocol: A Randomized Controlled Trial.|Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:47:39.869325|2017-10-10 20:47:39.869325
NCT03250936|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-28|||December 6, 2016|Actual|2016-12-06|August 2017|2017-08-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Observational|TRAUMPO||Descriptive Study of Trampoline Accidents in the Pediatric Emergency Department of Rennes|Descriptive Study of Trampoline Accidents in the Pediatric Emergency Department of Rennes|Completed||N/A|4000|Actual|Rennes University Hospital|||2||f||||f|f|f||||||||2017-10-10 20:47:39.930808|2017-10-10 20:47:39.930808
NCT03250910|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-14|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 15, 2017|Actual|2017-07-15||Interventional|||Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients|Generic Velpatasvir Plus Sofosbuvir With or Without Ribavirin for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus|Completed||Phase 4|178|Actual|National Taiwan University Hospital||4|||f||||f|f|f||||||||2017-10-10 20:47:40.086974|2017-10-10 20:47:40.086974
NCT03250897|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Observational|Caract-Aires||Phenotypic Characterization of Alveolar Macrophages 2016 (Caract-Aires-2016)|Phenotypic Characterization of Alveolar Macrophages 2016|Recruiting||N/A|18|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||Samples With DNA|"     Broncho-alveolar lavage fluids of patients with non-infectious lung diseases   "|||2017-10-10 20:47:40.170172|2017-10-10 20:47:40.170172
NCT03250884|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-28|||August 30, 2016|Actual|2016-08-30|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test.|Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test.|Recruiting||N/A|200|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:40.236122|2017-10-10 20:47:40.236122
NCT03250858|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-19|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|EatWellUK||Online Nutrition Advice in the UK (EatWellUK)|Randomized Control Trial to Evaluate the Effectiveness of Online Nutrition Advice in the UK (The EatWellUK Study)|Recruiting||N/A|330|Anticipated|University of Reading||2|||f||||f|f|f||||||||2017-10-10 20:47:40.375052|2017-10-10 20:47:40.375052
NCT03250845|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-11|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|MULTISIM||Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder|Comparison of Multigam IV (5% vs. 10%) as Substitution Therapy in Patients With an Immunodeficiency Secondary to a Hematological Disorder to Evaluate Infusion Time, Tolerance and Satisfaction. A Monocentric Observational Belgian Study|Active, not recruiting||N/A|15|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-10 20:47:40.449928|2017-10-10 20:47:40.449928
NCT03250819|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-28|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Observational|||Gene Polymorphisms of Corticosteroid-induced Ocular Hypertension|Genetic Association Study on Corticosteroid-induced Elevation of the Intraocular Pressure|Enrolling by invitation||N/A|450|Anticipated|Maastricht University Medical Center|||2||f||||f|f|f||||Samples With DNA|"     Whole blood   "|||2017-10-10 20:47:40.735212|2017-10-10 20:47:40.735212
NCT03250806|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-11|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Observational|FluClinic||Early Detection of Aortic Stenosis in the Community During Flu Vaccination|Early Detection of Aortic Stenosis in the Community: Role of Clinical and Echocardiographic Screening During Influenza Vaccination Multi-center, Prospective, Observational Cohort Study|Not yet recruiting||N/A|200|Anticipated|Institut für Pharmakologie und Präventive Medizin|||1||f||||f|f|f||||||||2017-10-10 20:47:40.819315|2017-10-10 20:47:40.819315
NCT03250793|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-11|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|NAVA-DIAPH||Work of Breathing Description in Neonates With Congenital Diaphragmatic Hernia in NAVA and in Conventional Ventilation.|Physiologic Pilot Study: Work of Breathing Description in Neonates With Congenital Diaphragmatic Hernia in Post-surgical Period Alternatively in Conventional Ventilation (Pressure Controlled) and in NAVA (Neurally Adjusted Ventilatory Assist) Ventilation.|Not yet recruiting||N/A|12|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 20:47:40.912664|2017-10-10 20:47:40.912664
NCT03250780|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-12|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01||||January 2020|Anticipated|2020-01-01||Interventional|||Chromoendoscopy in Inflammatory Bowel Disease|Chromoendoscopy With 0.03% Indigo-carmine Delivered Via a Foot Pump Compared With 0.2% Indigo-carmine Delivered Via Spray Catheter for Detecting Dysplasia in Patients Undergoing Surveillance in Inflammatory Bowel Disease. A Randomized Control Trial.|Recruiting||N/A|300|Anticipated|The Leeds Teaching Hospitals NHS Trust||1|||f||||||||||||||2017-10-10 20:47:41.029873|2017-10-10 20:47:41.029873
NCT03250767|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|April 1, 2029|Anticipated|2029-04-01|August 1, 2021|Anticipated|2021-08-01||Observational|||Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement|A Post-Market, Prospective, Multi-Center, Open-Label, Single Arm Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement|Recruiting||N/A|140|Anticipated|Integra LifeSciences Corporation|||1||f||||f|f|t|f|f||||||2017-10-10 20:47:41.108887|2017-10-10 20:47:41.108887
NCT03250754|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|December 20, 2017|Anticipated|2017-12-20|July 30, 2017|Actual|2017-07-30||Observational|CRHACU||Treatment of Chronic Refractory Headache With Acupuncture: Observational Study: OBSERVATIONAL STUDY (CRHACU)|Treatment of Chronic Refractory Headache With Acupuncture: Observational Study (CRHACU)|Active, not recruiting||N/A|320|Anticipated|Hospital Son Llatzer|||2||f||||t||||||||||2017-10-10 20:47:41.186956|2017-10-10 20:47:41.186956
NCT03250741|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-31|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|DOPAD||Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease|Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease: a Phase II 24-week, Randomized, Double-blind Placebo Controlled Study.|Recruiting||Phase 2|100|Anticipated|I.R.C.C.S. Fondazione Santa Lucia||2|||f||||f|f||||f|||||2017-10-10 20:47:41.285272|2017-10-10 20:47:41.285272
NCT03250728|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-06|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|PECDG||Role of the Endothelium in Stroke-like Episode Among CDG Patients|Role of the Endothelium in Stroke-like Episode Among CDG Patients|Not yet recruiting||N/A|8|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 20:47:41.387869|2017-10-10 20:47:41.387869
NCT03250715|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-23|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|February 2, 2018|Anticipated|2018-02-02||Interventional|||Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure|Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure on Hemodialysis: Randomized Clinical Trial|Not yet recruiting||N/A|28|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t|f|f||||||||2017-10-10 20:47:41.47677|2017-10-10 20:47:41.47677
NCT03250702|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|DUCS-HTN||DUCS-DHD Determinants of Hypertension in Tanzania|Dar es Salaam Urban Cohort Hypertension Study|Completed||N/A|2290|Actual|Harvard School of Public Health|||1||f||||f|f|f||||||||2017-10-10 20:47:41.562941|2017-10-10 20:47:41.562941
NCT03250689|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-10-03|||November 3, 2017|Anticipated|2017-11-03|October 2017|2017-10-01|July 10, 2018|Anticipated|2018-07-10|July 10, 2018|Anticipated|2018-07-10||Interventional|||Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)|Randomized Double Blind (Sponsor Unblind) Study Evaluating the Effect of 14 Days of Treatment With Danirixin (GSK1325756) on Neutrophil Extracellular Traps (NETs) Formation in Participants With Stable Chronic Obstructive Pulmonary Disease (COPD)|Not yet recruiting||Phase 2|24|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 20:47:41.637788|2017-10-10 20:47:41.637788
NCT03250676|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-29|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Trial of H3B-6545, a Covalent Antagonist of Estrogen Receptor Alpha, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer|A Phase I-II Multicenter, Open Label Trial of H3B-6545, a Covalent Antagonist of Estrogen Receptor Alpha, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer|Recruiting||Phase 1/Phase 2|110|Anticipated|Eisai Inc.||2|||f||||f|t|f||||||||2017-10-10 20:47:41.77501|2017-10-10 20:47:41.77501
NCT03250663|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-29|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 1, 2019|Anticipated|2019-08-01|May 31, 2019|Anticipated|2019-05-31||Interventional|||Eucrisa for Atopic Dermatitis|Eucrisa for Atopic Dermatitis: Measuring and Improving Adherence to Topical Eucrisa in Patients With Atopic Dermatitis|Not yet recruiting||N/A|40|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-10 20:47:41.884879|2017-10-10 20:47:41.884879
NCT03250650|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-10|||March 9, 2017|Actual|2017-03-09|August 2017|2017-08-01|September 21, 2017|Anticipated|2017-09-21|August 25, 2017|Anticipated|2017-08-25||Interventional|OAB||Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment|Percutaneous Electrical Stimulation Combined With Transvaginal Electrical Stimulation in Overactive Bladder Syndrome Treatment: Clinical Trial|Recruiting||N/A|86|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:47:41.961473|2017-10-10 20:47:41.961473
NCT03250637|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-14|||December 1993|Actual|1993-12-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|May 1997|Actual|1997-05-01||Observational|||Diet, Genes and Colorectal Cancer - With Focus on Toll-like Receptor Polymorphisms|Meat and Fiber Intake and Interaction With Pattern Recognition Receptors (TLR1, TLR2, TLR4, and TLR10) in Relation to Colorectal Cancer in a Danish Prospective, Case-cohort Study|Completed||N/A|2895|Actual|University of Southern Denmark|||2||f||||t|f|f||||Samples With DNA|"     DNA extracted from buffy coeats   "|||2017-10-10 20:47:42.046629|2017-10-10 20:47:42.046629
NCT03250624|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-16|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis|Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis|Completed||Phase 2|64|Actual|Galderma R&D||2|||f||||f||||||||||2017-10-10 20:47:42.124558|2017-10-10 20:47:42.124558
NCT03250611|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-12|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Interventional|||Occipito-Cervical Stabilization Using Occipital Condyle Screw|Occipito-Cervical Stabilization Using Occipital Condyle as a Cranial Anchor|Not yet recruiting||N/A|20|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:47:42.210448|2017-10-10 20:47:42.210448
NCT03250598|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||August 9, 2017|Actual|2017-08-09|July 2017|2017-07-01|October 8, 2017|Anticipated|2017-10-08|October 2, 2017|Anticipated|2017-10-02||Interventional|||Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin|A Phase 1, Single-Dose, Open-Label Study to Characterize and Compare the Pharmacokinetics, Safety, and Effect on QTc Interval of AG-348 in Healthy Subjects of Japanese Origin and Healthy Subjects of Non-Asian Origin|Recruiting||Phase 1|60|Anticipated|Agios Pharmaceuticals, Inc.||3|||f|||||t|f||||||||2017-10-10 20:47:42.288132|2017-10-10 20:47:42.288132
NCT03250572|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-12|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Observational|||Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients|Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among Non-alcoholic Fatty Liver Disease Patients|Completed||N/A|113|Actual|Ain Shams University|||3||f|||||f|f||||||||2017-10-10 20:47:42.45006|2017-10-10 20:47:42.45006
NCT03250559|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-27|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|August 2020|Anticipated|2020-08-01||Interventional|||Ultrasonic vs. Fluoroscopic Guided PNL in Pediatric Renal Stones|Ultrasonic Versus Fluoroscopic Guided Percutaneous Nephrolithotripsy in Pediatric Renal Stones: a Prospective Randomized Study|Recruiting||N/A|6|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 20:47:42.515729|2017-10-10 20:47:42.515729
NCT03250546|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-14|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2022|Anticipated|2022-09-30||Interventional|ALTERGREF||Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant|Randomized Prospective Phase II Clinical Trial Using Post-Transplantation Cyclophosphamide for Prevention of GVHD in Haploidentical and HLA-9/10 Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant|Not yet recruiting||Phase 2|184|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 20:47:42.613924|2017-10-10 20:47:42.613924
NCT03250533|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Analysis of the Effects of LED Phototherapy and Electrical Stimulation in the Healing of Diabetic Ulcers|Analysis of the Effects of Phototherapy With Light-emitting Diodes (LED) and Electrical Stimulation in the Healing of Ulcers of Lower Diabetic Limbs: a Blind Controlled Randomized Clinical Test|Not yet recruiting||N/A|52|Anticipated|University of Sao Paulo||4|||f||||t|f|f||||||||2017-10-10 20:47:42.706535|2017-10-10 20:47:42.706535
NCT03250520|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-08-11|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-Ca|Pilot Study of the Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial Platinum Acetylacetonate (1% wt) Supported by Sol-gel Technology Functionalized Titania (NPt-Ca)|Not yet recruiting||Early Phase 1|10|Anticipated|Hospital Infantil de Mexico Federico Gomez||2|||f||||f|f|f||||||||2017-10-10 20:47:42.809638|2017-10-10 20:47:42.809638
NCT03250507|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-08-15|||March 13, 2017|Actual|2017-03-13|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy|Mixture of Liposomal Bupivicaine and Bupivicaine Hydrogen Chloride (HCl) May Provide Faster and Longer Lasting Analgesia in Transversus Abdominis Block for Patient Having Open Abdominal Hysterectomies|Recruiting||Phase 4|90|Anticipated|Henry Ford Health System||3|||f||||f|t|f||||||||2017-10-10 20:47:42.883764|2017-10-10 20:47:42.883764
NCT03250494|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Duloxetine and Dexamethasone for Improving Postoperative Pain|Impact of Duloxetine and Dexamethasone for Improving Postoperative Pain After Laparoscopic Gynecological Surgeries: a Randomized Clinical Trial|Completed||Phase 4|75|Actual|Ain Shams University||3|||f|||||f|f|||f|||||2017-10-10 20:47:42.983414|2017-10-10 20:47:42.983414
NCT03249246|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-11|||January 27, 2016|Actual|2016-01-27|August 2017|2017-08-01|February 27, 2016|Actual|2016-02-27|January 28, 2016|Actual|2016-01-28||Observational|||Epidemiology of Sepsis in Turkish ICUs.|Epidemiology of Sepsis in Turkish ICUs :a National Point Prevalence Multi-centre Study.|Completed||N/A|1499|Actual|Turkish Intensive Care Society|||4||f||||t|f|f||||||||2017-10-10 20:47:53.442838|2017-10-10 20:47:53.442838
NCT03250481|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-11|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|August 15, 2017|Anticipated|2017-08-15|August 15, 2017|Anticipated|2017-08-15||Interventional|||Responsiveness Index Versus the RASS Based Method for Adjusting Sedation in Critically Ill Patients|Responsiveness Index Versus the RASS Based Method for Adjusting Sedation in Critically Ill Patients|Recruiting||N/A|32|Anticipated|Helsinki University Central Hospital||2|||f|||||f|f||||||||2017-10-10 20:47:43.057388|2017-10-10 20:47:43.057388
NCT03250468|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-10|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Sleep to Your Heart's Content - Insomnia Intervention for Cardiac Patients|Sleep to Your Heart's Content - Insomnia Intervention for Cardiac Patients|Not yet recruiting||N/A|126|Anticipated|Ottawa Heart Institute Research Corporation||2|||f|||||f|f||||||||2017-10-10 20:47:43.286048|2017-10-10 20:47:43.286048
NCT03250455|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|November 2020|Anticipated|2020-11-01|3 Years|Observational [Patient Registry]|VALIDITY||Prognostic Value of CT dynamIc Myocardial Perfusion in Patients With Obstructive Coronary Artery Stenosis|Prognostic Value of CT dynamIc Myocardial Perfusion in Patients With Obstructive Coronary Artery Stenosis|Recruiting||N/A|1748|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||2||f||||f|f|f||||||||2017-10-10 20:47:43.38014|2017-10-10 20:47:43.38014
NCT03250429|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-13|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 21, 2019|Anticipated|2019-08-21|August 21, 2018|Anticipated|2018-08-21||Observational|||Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention|Nasal and Peripheral Blood Biomarkers of CRS Patients Before and After Surgical Intervention|Recruiting||N/A|100|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f|f|f||||Samples With DNA|"     Whole blood, urine, nasal lavage fluid, nasal epithelial lining fluid   "|||2017-10-10 20:47:43.590659|2017-10-10 20:47:43.590659
NCT03250416|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-06|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|30 Days|Observational [Patient Registry]|||Management of Noninvasive Ventilation in Hypoxemic Patients|The First Affiliated Hospital of Chongqing Medical University|Recruiting||N/A|2000|Anticipated|Chongqing Medical University|||1||f||||f|f|f||||||||2017-10-10 20:47:43.700764|2017-10-10 20:47:43.700764
NCT03250403|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-14|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|August 1, 2017|Actual|2017-08-01||Interventional|||Efficacy of Platelet Rich Plasma Injection in Diabetic Neuropathy|Efficacy of Platelet Rich Plasma Injection in Diabetic Neuropathy: Double Blinded Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 20:47:43.802416|2017-10-10 20:47:43.802416
NCT03250390|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|CATOCOV||Breath Analysis to Diagnose Lung Cancer|Analysis of Volatile Organic Compounds in Exhaled Air as a Diagnostic Tool for Thoracic Cancers|Not yet recruiting||N/A|2000|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||||2017-10-10 20:47:43.940403|2017-10-10 20:47:43.940403
NCT03250364|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-10|||December 2009|Actual|2009-12-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|CB-ULL||Compression Bandages in Upper Limb Lymphedema|Compression Bandages in Upper Limb Lymphedema After Breast Cancer|Active, not recruiting||N/A|100|Actual|University of Alcala||5|||f||||t|f|f||||||||2017-10-10 20:47:44.188777|2017-10-10 20:47:44.188777
NCT03250351|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-10|||December 2012|Actual|2012-12-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|PT-ND-BC||Nerve Mobilization Techniques After Breast Cancer Surgery|Effectiveness of Nerve Mobilization Techniques at Improving Upper Limb Morbidity Following Breast Cancer Surgery|Active, not recruiting||N/A|140|Actual|University of Alcala||2|||f||||t|f|f||||||||2017-10-10 20:47:44.33414|2017-10-10 20:47:44.33414
NCT03250338|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML|Phase III Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of the Addition of Crenolanib to Salvage Chemotherapy Versus Salvage Chemotherapy Alone in Subjects ≤ 75 Years of Age With Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia|Not yet recruiting||Phase 3|322|Anticipated|Arog Pharmaceuticals, Inc.||2|||f|||||t|f||||||||2017-10-10 20:47:44.438824|2017-10-10 20:47:44.438824
NCT03250312|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-15|||September 13, 2017|Anticipated|2017-09-13|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|November 15, 2017|Anticipated|2017-11-15||Interventional|||The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers|The Effects of Osteopathic Manipulations on the Expression Patterns of Immune Cell Biomarkers|Not yet recruiting||N/A|40|Anticipated|A.T. Still University of Health Sciences||2|||f||||t|f|f||||||||2017-10-10 20:47:44.73358|2017-10-10 20:47:44.73358
NCT03250299|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-28|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|July 15, 2021|Anticipated|2021-07-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma|Phase I Study to Determine the Safety and Tolerability of the Oral Microtubule Destabilizer BAL101553 in Combination With Standard Radiation in Patients With MGMT Promoter Unmethylated Newly Diagnosed Glioblastoma|Recruiting||Phase 1|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||4|||f||||t|t|f||||||||2017-10-10 20:47:44.854429|2017-10-10 20:47:44.854429
NCT03250286|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-14|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Role of EUS in High Risk of Choledocholithiasis|Role of EUS in High Risk of Choledocholithiasis|Recruiting||N/A|90|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:47:45.098058|2017-10-10 20:47:45.098058
NCT03250273|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-14|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma|A Phase 2 Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma|Not yet recruiting||Phase 2|54|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-10 20:47:45.238582|2017-10-10 20:47:45.238582
NCT03250260|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-10|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Simulating Outcomes From Breast Conserving Surgery Using 3D Surface Imaging|The Use of 3D Surface Imaging to Simulate Outcome After Breast Conserving Therapy|Recruiting||N/A|117|Anticipated|Royal Marsden NHS Foundation Trust||3|||f||||f|f|f||||||||2017-10-10 20:47:45.401186|2017-10-10 20:47:45.401186
NCT03250247|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-01|||April 1, 2018|Anticipated|2018-04-01|September 2017|2017-09-01|July 1, 2023|Anticipated|2023-07-01|December 31, 2021|Anticipated|2021-12-31||Interventional|C-TRACT||Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)|Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial|Not yet recruiting||N/A|374|Anticipated|Washington University School of Medicine||2|||f||||t|f|t|f|f||||||2017-10-10 20:47:45.544335|2017-10-10 20:47:45.544335
NCT03250234|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-10|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Carbohydrate Availability and microRNA Expression|Influence of Carbohydrate Availability on Skeletal Muscle and Circulating microRNA Expression|Recruiting||N/A|12|Anticipated|United States Army Research Institute of Environmental Medicine||2|||f||||f|f|f||||||||2017-10-10 20:47:45.801546|2017-10-10 20:47:45.801546
NCT03250221|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-14|||March 3, 2017|Actual|2017-03-03|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy With Barbed Sutures|Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy With Barbed Sutures|Recruiting||N/A|120|Anticipated|Far Eastern Memorial Hospital|||1||f|||||f|f||||||||2017-10-10 20:47:45.920307|2017-10-10 20:47:45.920307
NCT03250208|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-28|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|May 30, 2019|Anticipated|2019-05-30|September 30, 2018|Anticipated|2018-09-30||Interventional|ProFUM||Probiotics Effect on the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)|Probiotics and the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)|Recruiting||N/A|21|Anticipated|Loyola University||2|||f||||f|f|f||||||||2017-10-10 20:47:46.046186|2017-10-10 20:47:46.046186
NCT03250195|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|August 7, 2019|Anticipated|2019-08-07|August 7, 2018|Anticipated|2018-08-07||Interventional|||Non-invasive Detection of Male Infertility With FDG-PET/MRI (Spectroscopy and DWI)|Non-invasive Detection of Male Infertility With FDG-PET/MRI (Spectroscopy and DWI)|Recruiting||N/A|20|Anticipated|Rigshospitalet, Denmark||1|||f||||f|f|f||||||||2017-10-10 20:47:46.197245|2017-10-10 20:47:46.197245
NCT03250182|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-14|||August 11, 2017|Actual|2017-08-11|August 2017|2017-08-01|December 21, 2017|Anticipated|2017-12-21|December 21, 2017|Anticipated|2017-12-21||Interventional|||A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose|A Study to Assess the Pharmacokinetics and Safety of PT010 in Subjects With Moderate to Severe COPD Following Single and Repeat Dose Administration|Recruiting||Phase 1|30|Anticipated|Pearl Therapeutics, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:47:46.311088|2017-10-10 20:47:46.311088
NCT03250169|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-10|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Observational|||Neurofilaments for NEDA Assessing in MS|Neurofilament Heavy and Light Chain Testing for NEDA (No Evidence of Disease Activity) Assessing in Multiple Sclerosis: a Longitudinal Biomarker Study|Recruiting||N/A|60|Anticipated|Queen Mary University of London|||1||f||||f|t|f|||f|||||2017-10-10 20:47:46.42543|2017-10-10 20:47:46.42543
NCT03250156|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-20|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|October 6, 2018|Anticipated|2018-10-06|March 6, 2018|Anticipated|2018-03-06||Interventional|TTT||Investigating Train the Trainer Delivery of Mindfulness-based Training|Investigating Train the Trainer Delivery of Mindfulness-based Training- Ft. Drum Soldiers|Recruiting||N/A|135|Anticipated|University of Miami||3|||f||||f|f|f||||||||2017-10-10 20:47:46.532268|2017-10-10 20:47:46.532268
NCT03250143|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-08-14|||December 6, 2016|Actual|2016-12-06|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||To Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory Urticaria|A Randomised Study to Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory Urticaria|Recruiting||Phase 1/Phase 2|56|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t|f|f||||||||2017-10-10 20:47:46.682682|2017-10-10 20:47:46.682682
NCT03250130|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-10|||June 2015|Actual|2015-06-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2016|Actual|2016-11-01||Interventional|HYPNOVAL||Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)|Medical Ericksonian Hypnosis on Patients Treated With Adjuvant Chemotherapy for Breast Cancer at the ICM Val d'Aurelle - Montpellier: a Feasibility Study|Recruiting||N/A|35|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-10 20:47:46.793932|2017-10-10 20:47:46.793932
NCT03250104|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-14|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|ABSOLUTE||Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives|Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives|Recruiting||N/A|80000|Anticipated|University Hospital of Cologne|||1||f||||t|f|f||||||||2017-10-10 20:47:47.037129|2017-10-10 20:47:47.037129
NCT03250091|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-14|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|December 2027|Anticipated|2027-12-01|May 2027|Anticipated|2027-05-01||Observational|||Surveillance of Patients With Precancerous Lesions of the Stomach|Surveillance Strategies of Patients With Precancerous Conditions and Lesions in the Stomach|Recruiting||N/A|2000|Anticipated|University of Latvia|||7||f||||f|f|f||||Samples With DNA|"     Human biopsy samples that are used for histopathology analysis are containing human DNA   "|||2017-10-10 20:47:47.175233|2017-10-10 20:47:47.175233
NCT03250078|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-08-14|||November 2016||2016-11-01|August 2017|2017-08-01|November 2023|Anticipated|2023-11-01|November 2021|Anticipated|2021-11-01||Observational|||A Pancreatic Cancer Screening Study in High Risk Individuals Including Those With New-Onset Diabetes Mellitus|A Pancreatic Cancer Screening Study in High Risk Individuals Including Those With New-Onset Diabetes Mellitus|Recruiting||N/A|800|Anticipated|Western Connecticut Health Network|||2||f||||t|f|f||||Samples With DNA|"     Serum sample   "|||2017-10-10 20:47:47.315252|2017-10-10 20:47:47.315252
NCT03250065|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||March 3, 2017|Actual|2017-03-03|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|July 31, 2017|Actual|2017-07-31||Interventional|SETT||The Sensing ET Tube|"Development of the Sensing Endotracheal Tube: an Optical Multi-parameter Monitoring System."|Suspended||N/A|30|Anticipated|City, University of London||1||"Recruitment period ended with low number of participants, investigators seeking an extension to   recruit more patients."|f||||t|f|f||||||||2017-10-10 20:47:47.402304|2017-10-10 20:47:47.402304
NCT03250052|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-30|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|October 9, 2017|Anticipated|2017-10-09|September 10, 2017|Anticipated|2017-09-10||Interventional|||A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers|A Phase I Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers|Recruiting||Phase 1|37|Anticipated|Boryung Pharmaceutical Co., Ltd||2|||f||||f|f|f||||||||2017-10-10 20:47:47.467994|2017-10-10 20:47:47.467994
NCT03250026|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-17|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|CO-WORK-CARE||Cooperation for Primary Care Patients on Sick Leave for Depression and Anxiety: Care Manager and Workplace Intervention - CO-WORK-CARE|Cooperation for Patients With Common Mental Disorders: Care Manager Function at the Primary Care Centre and Intervention at the Workplace - CO-WORK-CARE|Not yet recruiting||N/A|300|Anticipated|Göteborg University||2|||f||||t|f|f||||||||2017-10-10 20:47:47.722009|2017-10-10 20:47:47.722009
NCT03250013|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-14|||April 2014||2014-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|LMA||Long-term Effects of Medication for ADHD|Long-term Effects of Medication for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents on Cognition, Everyday Function and Quality of Life|Recruiting||N/A|100|Anticipated|Göteborg University|||1||f||||f||||||||||2017-10-10 20:47:47.817978|2017-10-10 20:47:47.817978
NCT03250000|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-07|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|COPD-EX||Changes in Microcirculation and Functional Status During Exacerbation of COPD|Changes in Microcirculation and Functional Status During Exacerbation of COPD|Recruiting||N/A|100|Anticipated|Hasselt University|||2||f||||f|f|f||||Samples Without DNA|"     Blood plasma samples   "|||2017-10-10 20:47:47.895505|2017-10-10 20:47:47.895505
NCT03249987|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||August 30, 2016|Actual|2016-08-30|August 2017|2017-08-01|August 29, 2018|Anticipated|2018-08-29|August 29, 2018|Anticipated|2018-08-29||Interventional|||Comparing the Usability of an Electronic Bladder Diary and a Paper Bladder Diary|Comparing the Usability of an Electronic Bladder Diary and a Paper Bladder Diary: a Two-way Crossover Study|Recruiting||N/A|50|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:47:47.980121|2017-10-10 20:47:47.980121
NCT03249974|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-24|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|July 4, 2018|Anticipated|2018-07-04|July 4, 2018|Anticipated|2018-07-04||Observational|||Comparison Between Enlite and Flash Glucose Monitoring|A Comparative Study on the Accuracy, Ease of Use and Skin Reactions Between the Enlite Sensor With Guardian 2 Link Transmitter and the FreeStyle Libre Flash Glucose Sensor|Recruiting||N/A|20|Anticipated|Jessa Hospital|||1||f|||||f|f||||Samples Without DNA|"     blood samples   "|||2017-10-10 20:47:48.068789|2017-10-10 20:47:48.068789
NCT03249961|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-14|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||How Many Days Would You Want to Practice a Skill to Achieve it?|How Many Days Would You Want to Practice a Skill to Achieve it?|Not yet recruiting||N/A|74|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t|f|f||||||||2017-10-10 20:47:48.180703|2017-10-10 20:47:48.180703
NCT03249948|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-14|||May 2018|Anticipated|2018-05-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|DOSE-VF||DOuble SEquential External Defibrillation for Refractory VF|DOuble SEquential External Defibrillation for Refractory Ventricular Fibrillation - DOSE VF Pilot Study|Not yet recruiting||N/A|110|Anticipated|Sunnybrook Health Sciences Centre||3|||f|||||f|f||||||||2017-10-10 20:47:48.273166|2017-10-10 20:47:48.273166
NCT03249922|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-07|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 8, 2019|Anticipated|2019-09-08|September 8, 2019|Anticipated|2019-09-08||Observational|||Quality of Life Outcomes in Spinal Cord Stimulation|A Prospective Analysis of Quality of Life Outcomes in Spinal Cord Stimulation|Recruiting||N/A|76|Anticipated|Rutgers, The State University of New Jersey|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:47:48.447864|2017-10-10 20:47:48.447864
NCT03249896|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-05|||September 5, 2017|Actual|2017-09-05|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SMART-GDM||Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes|Effects of a Web/Smartphone-based Lifestyle Coaching Program on Gestational Weight Gain in Pregnant Women With Gestational Diabetes|Recruiting||N/A|340|Anticipated|National University Hospital, Singapore||2|||f||||f|f|f||||||||2017-10-10 20:47:48.642945|2017-10-10 20:47:48.642945
NCT03249883|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-13|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|CPF||Comparison of Prosthetic Feet for the Geriatric Patients(CPF)|Evaluation of a Geriatric Foot- 1M10 ADJUST Versus the Solid Ankle Cushioned Heel Foot for Low Activity Amputees|Not yet recruiting||N/A|14|Anticipated|Loewenstein Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:47:48.777794|2017-10-10 20:47:48.777794
NCT03249870|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|EWALL-INO||Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL|A Phase 2 Study of Inotuzumab Ozogamicin (INO) Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor Acute Lymphoblastic Leukemia|Not yet recruiting||Phase 2|130|Anticipated|Versailles Hospital||1|||f||||t|f|f||||||||2017-10-10 20:47:48.863043|2017-10-10 20:47:48.863043
NCT03249857|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.|Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.|Not yet recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 20:47:48.933258|2017-10-10 20:47:48.933258
NCT03249844|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2022|Anticipated|2022-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|PASTA||Paediatric Arteriopathy Steroid Aspirin Project|High Dose Steroids in Children With Stroke and Unilateral Focal Arteriopathy: Paediatric Arteriopathy Steroid Aspirin (PASTA) Project. A Multicentre Randomized Trial.|Not yet recruiting||Phase 3|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 20:47:49.034243|2017-10-10 20:47:49.034243
NCT03249831|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-07|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Non-Myeloablative Conditioning Regimen With Haploidentical T-Cell-Depleted Peripheral Blood Transplant for Patients With Severe Sickle Cell Disease|Pilot Study to Evaluate the Safety and Feasibility of Induction of Mixed Chimerism in Sickle Cell Disease Patients With COH-MC-17: a Non-Myeloablative, Conditioning Regimen and CD4+ T-cell-depleted Haploidentical Hematopoietic Transplant|Not yet recruiting||Phase 1|6|Anticipated|City of Hope Medical Center||1|||||||t|t|f||||||||2017-10-10 20:47:49.138391|2017-10-10 20:47:49.138391
NCT03249818|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-26|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||HITT Device Pilot Testing for Traumatic Brain Injury|Feasibility Study of Head and Intraocular Trauma Test (HITT) Device for Potential Detection of Brain Dysfunction|Recruiting||N/A|10|Anticipated|Rebiscan, Inc.||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:47:49.266441|2017-10-10 20:47:49.266441
NCT03249805|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-10|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|June 6, 2018|Anticipated|2018-06-06|December 7, 2017|Anticipated|2017-12-07||Interventional|mFAB||MiracleFeet Foot Abduction Brace Sensor Trial|Efficacy of a New Design of Foot Abduction Brace (FAB) Compared to Standard FAB During Ponseti Treatment of Idiopathic Clubfoot by Measuring Rate of Recurrence and Compliance Using Novel Touch Sensors|Recruiting||N/A|80|Anticipated|MiracleFeet||2|||f|||||f|t|f|f|t|||||2017-10-10 20:47:49.339029|2017-10-10 20:47:49.339029
NCT03249779|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-14|||December 2016||2016-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|RLS/WED||Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation|Electrical Stimulation Via the Scrambler Device as a Treatment for Restless Legs Syndrome/Willis Ekbom Disease|Recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 20:47:49.577056|2017-10-10 20:47:49.577056
NCT03249766|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-21|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|August 21, 2018|Anticipated|2018-08-21|August 21, 2018|Anticipated|2018-08-21||Observational|||Study of Prevalence of Ipsilateral Shoulder Pain in Patients After Thoracic Surgeries|Prospective Observational Study of Prevalence of Ipsilateral Shoulder Pain in Patients After Thoracic Surgeries|Recruiting||N/A|250|Anticipated|Tata Memorial Hospital|||1||f||||t|f|f||||||||2017-10-10 20:47:49.698277|2017-10-10 20:47:49.698277
NCT03249753|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-30|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects|to Evaluate the Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects|Not yet recruiting||Phase 1|20|Anticipated|Shanghai Pharmaceuticals Holding Co., Ltd||2|||f|||||f|f||||||||2017-10-10 20:47:49.773258|2017-10-10 20:47:49.773258
NCT03249740|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-28|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration|A Phase 1/2 Multicenter Study Evaluating the Safety, Tolerability, and Efficacy of an Intravitreal Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular Age-related Macular Degeneration|Recruiting||Phase 1/Phase 2|482|Anticipated|Graybug Vision||3|||f|||||t|f||||||||2017-10-10 20:47:49.849418|2017-10-10 20:47:49.849418
NCT03249727|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-22|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|ANKA-HR||Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy|Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy|Recruiting||N/A|1200|Anticipated|ATGen Canada Inc||1|||f||||f|f|f||||||||2017-10-10 20:47:49.976763|2017-10-10 20:47:49.976763
NCT03249714|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-06|||December 22, 2017|Anticipated|2017-12-22|September 2017|2017-09-01|June 19, 2020|Anticipated|2020-06-19|June 19, 2020|Anticipated|2020-06-19||Interventional|||Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab|A 24-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Ofatumumab in Patients With Relapsing Multiple Sclerosis Followed by an Extended Treatment of at Least 24 Weeks With Open-label Ofatumumab|Not yet recruiting||Phase 2|60|Anticipated|Novartis||2|||f||||t|f|f||||||||2017-10-10 20:47:50.082914|2017-10-10 20:47:50.082914
NCT03249701|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|September 1, 2018|Anticipated|2018-09-01||Interventional|TEAS||Transcutaneous Electrical Acupoint Stimulation Administered in Peri-operation|Transcutaneous Electrical Acupoint Stimulation Administered in Peri-operation for Preventing Postoperative Complications, Safety and Effectiveness. A Randomized, Double-blind, Clinical Trial.|Not yet recruiting||N/A|99|Anticipated|Shandong University of Traditional Chinese Medicine||3|||f||||t|f|f||||||||2017-10-10 20:47:50.158257|2017-10-10 20:47:50.158257
NCT03249688|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-08-10|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|MIND-ADmini||Multimodal Preventive Trial for Alzheimer's Disease|Multimodal Preventive Trial for Alzheimer's Disease (MIND-ADmini Pilot Trial)|Not yet recruiting||N/A|150|Anticipated|Karolinska Institutet||3|||f||||t|f|f||||||||2017-10-10 20:47:50.27718|2017-10-10 20:47:50.27718
NCT03249675|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-13|||August 16, 2017|Anticipated|2017-08-16|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment, Young Adults and Adults|Clinical Trial Protocol for the Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment, Young Adults and Adults|Recruiting||N/A|100|Anticipated|ElMindA Ltd|||2||f|||||||||f|||||2017-10-10 20:47:50.384104|2017-10-10 20:47:50.384104
NCT03249662|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-12|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Efficacy of Pain Control in Different Bupivacaine Dose in Periarticular Injection in Bilateral Total Knee Arthroplasty|Efficacy of Pain Management in Different Concentrations of Bupivacaine in Periarticular Injection and Plasma Concentrations of Bupivacaine in Patients Undergoing Bilateral Knee Arthroplasty|Not yet recruiting||N/A|60|Anticipated|Mahidol University||2|||f||||t|f|f||||||||2017-10-10 20:47:50.462774|2017-10-10 20:47:50.462774
NCT03249649|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|FGC||Female Genital Cutting in the Arizona Somali Refugee Community|Enhancing Culturally-Informed Health Care Services for Women Affected by Female Genital Cutting in Arizona|Recruiting||N/A|2150|Anticipated|Arizona State University|||2||f||||t|f|f||||||||2017-10-10 20:47:50.55632|2017-10-10 20:47:50.55632
NCT03249636|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-28|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01|15 Days|Observational [Patient Registry]|||New Markers for Minimal Residual Disease in Acute Lymphoblastic Leukemia|Evaluation of New Markers for Minimal Residual Disease in Precursor B Acute Lymphoblastic Leukemia|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:47:50.639726|2017-10-10 20:47:50.639726
NCT03249623|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-12|||September 4, 2017|Anticipated|2017-09-04|August 2017|2017-08-01|August 30, 2019|Anticipated|2019-08-30|December 30, 2018|Anticipated|2018-12-30||Interventional|iCareWean_CW||Individualised Weaning From Mechanical Ventilation in General ICU|Weaning From Mechanical Ventilation: Comparison of Open‐Loop Decision Support System and Routine Care, in the General Intensive Care Unit|Not yet recruiting||N/A|274|Anticipated|Chelsea and Westminster NHS Foundation Trust||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:47:50.712058|2017-10-10 20:47:50.712058
NCT03249610|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-08-12|||March 11, 2014|Actual|2014-03-11|August 2017|2017-08-01|June 15, 2017|Actual|2017-06-15|March 12, 2017|Actual|2017-03-12||Interventional|||Randomized Control Trial for Overweight Employees in Worksites|Worksite Intervention Trial With Multi-Component Lifestyle Intervention and Digital Health Platform for Reduction of Body Weight and Cardio-metabolic Risk Factors|Completed||N/A|300|Actual|Diabetes Foundation, India||4|||f||||t|f|f||||||||2017-10-10 20:47:50.787706|2017-10-10 20:47:50.787706
NCT03249233|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-14|||June 22, 2017|Actual|2017-06-22|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Corneal Thickness Changes With Scleral Contact Lenses|Changes in Corneal Thickness in Keratoconic Eyes With Variation in Scleral Contact Lens Central Clearance|Recruiting||N/A|40|Anticipated|University of Waterloo||4|||f||||f|f|f||||||||2017-10-10 20:47:53.523125|2017-10-10 20:47:53.523125
NCT03249597|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-08-17|||April 3, 2017|Actual|2017-04-03|August 2017|2017-08-01|April 3, 2018|Anticipated|2018-04-03|April 3, 2018|Anticipated|2018-04-03||Observational|||Predict Sepsis; the Predictive Value of Bedside Measures in the Ambulance|Predict Sepsis; the Predictive Value of Bedside Measures in the Ambulance|Recruiting||N/A|648|Anticipated|Karolinska Institutet|||2||f||||f|f|f||||Samples With DNA|"     A total of maximum 24 mL venous blood will be drawn from each included patient. P-(plasma)     glucose (<1 ml, will be analyzed in the ambulance). An additional 5 tubes of venous blood     will be taken: 1. P-lactate (Sodium fluoride tube, 4 ml), 2. P-SuPAR (EDTA tube, 4 ml), 3.     P-HBP (EDTA tube, 6 ml- in the pilot study 4 ml), 4. EDTA tube 6 ml: whole blood for     cytokines (caspase-1 generated interleukins: IL-1β, IL-18, IL-37), glucose metabolites and     downstream regulators of immunometabolic processes (pyruvate, lactate, HIF, mTOR, etc) and 5.     PAXgene tube 2,5 ml: whole blood for priming step of the inflammasome mRNA levels of pro-IL     and NLRP3.   "|||2017-10-10 20:47:50.851557|2017-10-10 20:47:50.851557
NCT03249558|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|Duloxetine||Effect of Combined Morphine and Duloxetine on Chronic Pain|Effect of Combined Morphine and Duloxetine on Chronic Pain|Not yet recruiting||Phase 4|135|Anticipated|Massachusetts General Hospital||3|||f||||t|t|f|||t|||||2017-10-10 20:47:51.086552|2017-10-10 20:47:51.086552
NCT03249545|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-09|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|March 1, 2019|Anticipated|2019-03-01|December 31, 2018|Anticipated|2018-12-31||Observational|||Late Effect of Ablation on Premature Ventricular Complex Ablation|Late Effect of Ablation on Premature Ventricular Complex Ablation|Recruiting||N/A|30|Anticipated|Yuksek Ihtisas Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:51.161147|2017-10-10 20:47:51.161147
NCT03249532|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-09|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 1, 2020|Anticipated|2020-09-01|March 1, 2019|Anticipated|2019-03-01||Interventional|HOLLANT||Effect of Dialysis Techniques on Blood Pressure and Cardiac Function During Dialysis|Effect of High-volume Online hemodiafiLtration on Intra-diaLytic hemodynAmic (iN)sTability and Cardiac Function in Chronic Hemodialysis Patients (the HOLLANT Study)|Not yet recruiting||N/A|40|Anticipated|VU University Medical Center||4|||f||||f|f|f||||||||2017-10-10 20:47:51.21707|2017-10-10 20:47:51.21707
NCT03249519|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2099|Anticipated|2099-12-31|December 31, 2094|Anticipated|2094-12-31||Interventional|||Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer|Multimodal Therapy of Advanced Cervical Cancer With Radiotherapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia|Recruiting||N/A|999|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f|f|f||||||||2017-10-10 20:47:51.320889|2017-10-10 20:47:51.320889
NCT03249506|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-25|||May 12, 2016|Actual|2016-05-12|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)|Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||N/A|25358|Anticipated|Janssen Research & Development, LLC|||2||f||||f||f||||||||2017-10-10 20:47:51.40099|2017-10-10 20:47:51.40099
NCT03249493|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-30|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|August 15, 2020|Anticipated|2020-08-15|August 15, 2020|Anticipated|2020-08-15||Observational|MOVIDA-2||Monitoring Of Viral Load In Decentralised Area in Vietnam|Monitoring Of Viral Load In Decentralised Area in Vietnam : Improving Access to Viral Load Monitoring in HIV-infected Patients on ART|Recruiting||N/A|1000|Anticipated|Institut Pasteur|||2||f||||f|f|f||||Samples With DNA|"     Whole blood samples on Dried Blood spot cards   "|||2017-10-10 20:47:51.478824|2017-10-10 20:47:51.478824
NCT03249480|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-10|||January 2015|Actual|2015-01-01|July 2017|2017-07-01||||August 2017|Anticipated|2017-08-01||Interventional|||Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency|Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency: A Multicenter, Open-label, Phase IV Clinical Trial With Different Administration Dosage of PEG Somatropin|Recruiting||Phase 4|900|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:47:51.662802|2017-10-10 20:47:51.662802
NCT03249467|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-24|||October 17, 2015|Actual|2015-10-17|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|HAQ-II||Validation of the French Version of the Health Assessment Questionnaire II (HAQ-II) for Rheumatoid Arthritis|Validation of the French Version of the Health Assessment Questionnaire II (HAQ-II) for Rheumatoid Arthritis|Completed||N/A|129|Actual|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:51.855645|2017-10-10 20:47:51.855645
NCT03249454|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-09|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Effects of Transcutaneous Spinal Direct Current Stimulation in Incomplete Spinal Cord Injury|Effects of Transcutaneous Spinal Direct Current Stimulation in Incomplete Spinal Cord Injury|Not yet recruiting||N/A|15|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||f|f|t|t|f|f|||||2017-10-10 20:47:51.929388|2017-10-10 20:47:51.929388
NCT03249441|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-15|||September 15, 2016|Actual|2016-09-15|August 2017|2017-08-01|September 15, 2017|Anticipated|2017-09-15|May 15, 2017|Actual|2017-05-15||Interventional|CFT||Compassion-Focused Therapy for People With Severe Obesity.|Compassion-Focused Therapy for People With Severe Obesity: A Randomised Controlled Study.|Active, not recruiting||N/A|91|Actual|National University of Ireland, Galway, Ireland||2|||f||||f|f|f||||||||2017-10-10 20:47:52.040662|2017-10-10 20:47:52.040662
NCT03248869|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||March 15, 2015|Actual|2015-03-15|August 2017|2017-08-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||Asthma Mobile Health Application 2.0|Asthma Mobile Health Application 2.0|Completed||N/A|7752|Actual|Icahn School of Medicine at Mount Sinai||2|||f|||||f|f||||||||2017-10-10 20:47:57.619084|2017-10-10 20:47:57.619084
NCT03249428|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Interventional|||E-Cigarette Inner City RCT|A Community-Based Participatory Action Pragmatic Randomized Controlled Trial Using Electronic-Cigarette for Tobacco Dependence in the Inner City Population With a Holistic Approach|Not yet recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|t|f||t|||||2017-10-10 20:47:52.125207|2017-10-10 20:47:52.125207
NCT03249415|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-14|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Use of PRP in Endometrial Reconstruction|Endometrial Reconstruction by Human Regenerative Factors Derived From Platelet-Rich Plasma in Mice Models|Recruiting||N/A|10|Anticipated|Fundación IVI|||1||f||||||||||Samples Without DNA|"     Platelet-Rich Plasma from Whole Blood.   "|||2017-10-10 20:47:52.224153|2017-10-10 20:47:52.224153
NCT03249402|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-09-13|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|November 8, 2017|Anticipated|2017-11-08|November 8, 2017|Anticipated|2017-11-08||Interventional|||A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants|An Open-label Drug-drug Interaction Study in Healthy Female Adult Subjects to Investigate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel|Recruiting||Phase 1|24|Anticipated|Janssen-Cilag International NV||1|||f||||f|f|f||||||||2017-10-10 20:47:52.307776|2017-10-10 20:47:52.307776
NCT03249389|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-14|||October 2015|Actual|2015-10-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|CALCIOBS||Assessing the Changes in Markers of Calcium Vitamin Metabolism of for Breast Cancer Adjuvant (CALCIOBS)|Study Assessing the Changes in Markers of Calcium Vitamin Metabolism of Patients Taken in Charge by Chemotherapy for Breast Cancer Adjuvant|Completed||N/A|146|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-10 20:47:52.408247|2017-10-10 20:47:52.408247
NCT03249376|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-11|2017-08-11|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally|Not yet recruiting||Phase 3|250|Anticipated|Intra-Cellular Therapies, Inc.||2|||||||f|t|f||||||||2017-10-10 20:47:52.489292|2017-10-10 20:47:52.489292
NCT03249363|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-14|||January 1, 2010|Actual|2010-01-01|August 2017|2017-08-01|January 1, 2012|Actual|2012-01-01|January 1, 2012|Actual|2012-01-01||Interventional|||Intraoperative Disinfection by Pulse Irrigation With Povidone-Iodine Solution in Spine Surgery|Intraoperative Disinfection by Pulse Irrigation With Povidone-Iodine Solution in Spine Surgery|Completed||N/A|50|Actual|University of Rome Tor Vergata||2|||f||||f|f|f||||||||2017-10-10 20:47:52.572714|2017-10-10 20:47:52.572714
NCT03249350|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-14|||March 2018|Anticipated|2018-03-01|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||Enhancing Adolescent Substance Abuse Treatment|Experimental Mediation Research Aimed at Enhancing Adolescent Substance Abuse Treatment|Not yet recruiting||N/A|172|Anticipated|Oregon Social Learning Center||2|||f||||t|f|f||||||||2017-10-10 20:47:52.675364|2017-10-10 20:47:52.675364
NCT03249337|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy|A Pilot Study For Efficacy And Safety Of Glanatec® Opthalmic Solution 0.4% On Corneal Edema And Endothelial Cell Counts In Subjects With Fuchs Endothelial Dystrophy Undergoing Descemet Stripping Without Endothelial Keratoplasty|Not yet recruiting||Phase 4|30|Anticipated|NorthShore University HealthSystem||2|||f||||t|t|f||||||||2017-10-10 20:47:52.761013|2017-10-10 20:47:52.761013
NCT03249324|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-08-10|||November 2014||2014-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Preventing Obesity in Military Communities: Mother-Baby|Preventing Obesity in Military Communities: Mother-Baby|Active, not recruiting||N/A|58|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-10-10 20:47:52.837891|2017-10-10 20:47:52.837891
NCT03249311|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-09|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Levomilnacipran in Healthy Males|Effectiveness of the Norepinephrine and Serotonin Reuptake Inhibitor Levomilnacipran in Healthy Males|Recruiting||Phase 4|36|Anticipated|University of Ottawa||3|||f||||t|f|f|||f|||||2017-10-10 20:47:52.93453|2017-10-10 20:47:52.93453
NCT03249298|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-10-04|||December 1, 2016|Actual|2016-12-01|October 2017|2017-10-01|November 15, 2017|Anticipated|2017-11-15|November 1, 2017|Anticipated|2017-11-01||Interventional|KOKR||Fluid Optimization With Crystalloids and Colloids in Neurosurgery|Comparison of Crystaloids and Colloids for Fluid Optimization in Patients Undergoing Neurosurgical Procedure|Recruiting||N/A|80|Anticipated|University Medical Centre Ljubljana||2|||f||||||||||||||2017-10-10 20:47:53.046574|2017-10-10 20:47:53.046574
NCT03249285|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-08-10|||March 2016||2016-03-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|PGX-HT||Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)|Pharmacogenomics Of Hypertension: A New Approach For A Personalized Medicine|Recruiting||Phase 3|300|Anticipated|Ospedale San Raffaele||4|||f||||t||||||||||2017-10-10 20:47:53.134172|2017-10-10 20:47:53.134172
NCT03249272|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-22|||September 5, 2017|Actual|2017-09-05|August 2017|2017-08-01|September 21, 2019|Anticipated|2019-09-21|September 21, 2019|Anticipated|2019-09-21||Interventional|||Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve|Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve|Recruiting||Phase 4|75|Anticipated|Duke University||3|||f||||f|t|f|||f|||||2017-10-10 20:47:53.251481|2017-10-10 20:47:53.251481
NCT03249220|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|CBMS FIH||Clinical Pilot Study to Evaluate a New Multi-parameter Neuromonitoring Device in Brain-injured Patients|Clinical Pilot Study to Evaluate a New Multi-parameter Neuromonitoring Device That Allows the Measurement of Regional Cerebral Blood Flow (rCBF), Intracranial Pressure (ICP), Brain Temperature Monitoring and Ventricular Cerebrospinal Fluid (CSF) Drainage in Brain-injured Patients|Not yet recruiting||N/A|10|Anticipated|Carag AG||1|||f|||||f|f||||||||2017-10-10 20:47:53.623389|2017-10-10 20:47:53.623389
NCT03249207|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|SCIL||SC IL-1Ra in SAH - Phase III Trial (SCIL)|Does Interleukin-1 Receptor Antagonist Improve Outcome Following Aneurysmal Subarachnoid Haemorrhage (aSAH)? A Phase III Trial|Not yet recruiting||Phase 3|1000|Anticipated|University of Manchester||2|||f||||t|f|f||||||||2017-10-10 20:47:53.708735|2017-10-10 20:47:53.708735
NCT03249194|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-22|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients|Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients: A Novel Application of Direct-Acting Antiviral Drugs|Recruiting||Early Phase 1|6|Anticipated|Virginia Commonwealth University||1|||f||||t|t|f|||t|||||2017-10-10 20:47:53.790288|2017-10-10 20:47:53.790288
NCT03249181|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|September 2020|Anticipated|2020-09-01||Interventional|DolPHIN-2||Dolutegravir in Pregnant HIV Mothers and Their Neonates|Dolutegravir in Pregnant HIV Mothers and Their Neonates|Not yet recruiting||Phase 3|250|Anticipated|University of Liverpool||2|||f||||t|f|f||||||||2017-10-10 20:47:53.868192|2017-10-10 20:47:53.868192
NCT03249168|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-10|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Duloxetine for Post Laparoscopic Shoulder Pain|Preoperative Duloxetine to Prevent Postoperative Shoulder Pain After Gynecological Laparoscopies|Not yet recruiting||Phase 3|60|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:47:53.972519|2017-10-10 20:47:53.972519
NCT03249155|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||March 2, 2015|Actual|2015-03-02|August 2017|2017-08-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Interventional|AOFREEPD||Action Observation Plus Sonification Therapeutic Protocol|Action Observation Plus Sonification. A Novel Therapeutic Protocol for Parkinson's Patient With Freezing of Gait|Completed||N/A|24|Actual|University of Trieste||2|||f||||f|f|f||||||||2017-10-10 20:47:54.046078|2017-10-10 20:47:54.046078
NCT03249142|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|INeOV||Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer|A Multicentre Feasibility Randomized Study of Anti-PD-L1 Durvalumab (MEDI4736) With or Without Anti-CTLA-4 Tremelimumab in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma, Treated With a First-line Neo-adjuvant Strategy|Not yet recruiting||Phase 1/Phase 2|66|Anticipated|ARCAGY/ GINECO GROUP||2|||f||||t|f|f||||||||2017-10-10 20:47:54.126885|2017-10-10 20:47:54.126885
NCT03249129|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|TRAME||Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma|Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma|Not yet recruiting||N/A|40|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||||2017-10-10 20:47:54.250572|2017-10-10 20:47:54.250572
NCT03249103|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-10-03|||August 14, 2017|Actual|2017-08-14|October 2017|2017-10-01|July 30, 2018|Anticipated|2018-07-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia|A Phase 2, Single-Blind, Exploratory, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Daily Oral NYX-2925 in Subjects With Fibromyalgia|Recruiting||Phase 2|24|Anticipated|Aptinyx||3|||f||||f|t|f||||||||2017-10-10 20:47:54.391715|2017-10-10 20:47:54.391715
NCT03249090|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-18|||November 30, 2017|Anticipated|2017-11-30|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|December 2019|Anticipated|2019-12-01||Interventional|PRO-TECT||Electronic Patient Reporting of Symptoms During Cancer Treatment|"PRO-TECT Patient Reported Outcomes to Enhance Cancer Treatment"|Not yet recruiting||N/A|1000|Anticipated|Alliance Foundation Trials, LLC.||2|||f||||t|f|f||||||||2017-10-10 20:47:54.476921|2017-10-10 20:47:54.476921
NCT03249077|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-31|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Evaluating the Implementation of the Diabetes Prevention Program in an Integrated Health System|Evaluating the Implementation of the Diabetes Prevention Program in an Integrated Health System|Active, not recruiting||N/A|6000|Anticipated|Kaiser Permanente||2|||f||||f|f|f||||||||2017-10-10 20:47:54.590418|2017-10-10 20:47:54.590418
NCT03249064|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-21|||October 27, 2015|Actual|2015-10-27|August 2017|2017-08-01|September 13, 2016|Actual|2016-09-13|September 13, 2016|Actual|2016-09-13||Observational|||Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo|Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo|Completed||N/A|28|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||t|f|f||||Samples Without DNA|"     Periferic blood /serum   "|||2017-10-10 20:47:54.666004|2017-10-10 20:47:54.666004
NCT03249051|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-10-04|||January 11, 2016|Actual|2016-01-11|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|ONCA||Optimization of Nutritional Therapy in Mechanically Ventilated, Critically Ill Patients.|Optimization of Nutritional Therapy by Variation of Methods to Determine Energy Needs in Mechanically Ventilated, Critically Ill Patients.|Completed||N/A|40|Actual|University of Hohenheim||2|||f||||f|f|f||||||||2017-10-10 20:47:54.760748|2017-10-10 20:47:54.760748
NCT03249038|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-06|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|August 1, 2017|Actual|2017-08-01||Observational|||Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.|Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.|Completed||N/A|100|Actual|Hospital Clinic of Barcelona|||1||f||||f|f|f||||Samples Without DNA|"     -  Serum hemoglobin concentration.        -  Hemoglobin concentration of external blood loss.   "|||2017-10-10 20:47:54.824235|2017-10-10 20:47:54.824235
NCT03249025|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Lidocaine-Ketamine for Management of Chronic Pain|Ambulatory Infusion of Lidocaine and Ketamine for Management of Chronic Pain: An Observational Prospective Study|Not yet recruiting||N/A|72|Anticipated|Hamilton Health Sciences Corporation||1|||f||||f|f|f||||||||2017-10-10 20:47:54.875986|2017-10-10 20:47:54.875986
NCT03249012|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-10|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Quality of Life Related to Different Treatment Protocols for Post-thyroidectomy Hypoparathyroidism|Comparing the Quality of Life Associated With Empiric Calcium Repletion and Parathormone (PTH) Based Calcium Repletion for Post Thyroidectomy Hypoparathyroidism|Not yet recruiting||N/A|120|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f|f|f||||||||2017-10-10 20:47:54.943657|2017-10-10 20:47:54.943657
NCT03248999|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-10|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|R'EHPAD||Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.|Determination of the Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes in Franche-Comté (France).|Not yet recruiting||N/A|1084|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t|f|f||||||||2017-10-10 20:47:55.01031|2017-10-10 20:47:55.01031
NCT03248986|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-16|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01|8 Weeks|Observational [Patient Registry]|||Dry Needling in Stroke to Improve the Upper Limb Functionality|Effectiveness of Dry Needling in Improving the Functionality of the Affected Arm in the Patient With Stroke|Recruiting||N/A|51|Anticipated|Guadarrama Hospital|||1||f||||t|f|f||||||||2017-10-10 20:47:55.081458|2017-10-10 20:47:55.081458
NCT03248973|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester|Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester of Pregnancy: a Case Report and Review of Literatures|Recruiting||N/A|1|Anticipated|Far Eastern Memorial Hospital|||1||f|||||f|f||||||||2017-10-10 20:47:55.148734|2017-10-10 20:47:55.148734
NCT03248960|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.|A Prospective Multi-Centre Study of the Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.|Recruiting||N/A|400|Anticipated|Ellume Pty Ltd||1|||f||||f|f|f|||f|||||2017-10-10 20:47:55.204914|2017-10-10 20:47:55.204914
NCT03248947|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-14|||November 2017|Anticipated|2017-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Pharm-OUD-Care||Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075|Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: Clinical Trials Network 0075|Not yet recruiting||Early Phase 1|70|Anticipated|Duke University||1|||f||||t|t|f|||t|||||2017-10-10 20:47:56.869692|2017-10-10 20:47:56.869692
NCT03248934|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-14|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Patient Performed Examination for Patients With Intra-articular Hip Pain|Delineating the Concurrent Validity and Diagnostic Accuracy of a Patient Performed Examination for Patients With Intra-Articular Hip Pain: A Proof of Concept Study|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 20:47:57.008157|2017-10-10 20:47:57.008157
NCT03248921|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||November 2014||2014-11-01|August 2017|2017-08-01|November 2025|Anticipated|2025-11-01|November 2020|Anticipated|2020-11-01||Observational|OPOS||The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery|The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery|Recruiting||N/A|610|Anticipated|Cardiovascular Research New Brunswick|||2||f||||f||||||Samples With DNA|"     The following biological samples have been approved for collection: 4 types of adipose tissue     (subcutaneous adipose tissue; epicardial adipose tissue; pericardial adipose tissue;     peri-aortic adipose tissue); atrial appendage tissue sample; and 8-10mL blood sample (plasma     and serum sample).   "|||2017-10-10 20:47:57.087263|2017-10-10 20:47:57.087263
NCT03248908|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-09|||August 20, 2017|Anticipated|2017-08-20|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|January 31, 2018|Anticipated|2018-01-31||Interventional|PUP-AIT||Pupillary Dilation Reflex Assessment for Intraoperative Analgesic Titration.|Pupillary Dilation Reflex Assessment for Intraoperative Analgesic Titration [PUP-AIT]. A Double Blinded Randomized Trial.|Not yet recruiting||N/A|120|Anticipated|University Hospital, Antwerp||4|||f|||||f|f||||||||2017-10-10 20:47:57.184835|2017-10-10 20:47:57.184835
NCT03248895|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-14|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluation of a Mobile Direct Observation Therapy (DOT) Approach in Children and Young People With Asthma|Evaluation of a Mobile Direct Observation Therapy (DOT) Approach in Children and Young People With Asthma. Pilot Study|Completed||N/A|22|Actual|Queen's University, Belfast||2|||f||||f|f|f||||||||2017-10-10 20:47:57.278479|2017-10-10 20:47:57.278479
NCT03248882|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-10-02|||August 23, 2017|Actual|2017-08-23|October 2017|2017-10-01|November 29, 2018|Anticipated|2018-11-29|November 1, 2018|Anticipated|2018-11-01||Interventional|||Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)|A Phase 2a, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Study To Evaluate Safety, Tolerability, And Pharmacodynamics Of Pf-05221304 Administered Daily For 16-weeks To Adult Subjects With Nonalcoholic Fatty Liver Disease|Recruiting||Phase 2|360|Anticipated|Pfizer||5|||f||||t|t|f||||||||2017-10-10 20:47:57.357757|2017-10-10 20:47:57.357757
NCT03248856|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||October 2, 2017|Anticipated|2017-10-02|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Triamcinolone Levels in Cochlear Perilymph|Triamcinolone Levels in Cochlear Perilymph|Not yet recruiting||Phase 1|40|Anticipated|Medical University of Vienna||4|||f||||t|f|f|||f|||||2017-10-10 20:47:57.749802|2017-10-10 20:47:57.749802
NCT03248843|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-11|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors|A Phase I, Open Label, Dose Escalation Study of The Safety and Pharmacokinetics of Anti-PD-L1 Monoclonal Antibody KN035 Administered in Subcutaneous Injection as A Single Agent to Japanese Subjects With Locally Advanced or Metastatic Solid Tumors|Not yet recruiting||Phase 1|18|Anticipated|3D Medicines (Sichuan) Co., Ltd.||1|||f||||t|f|f||||||||2017-10-10 20:47:57.838349|2017-10-10 20:47:57.838349
NCT03248830|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-23|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|January 10, 2018|Anticipated|2018-01-10|January 1, 2018|Anticipated|2018-01-01||Observational|||Non-invasive Hemoglobin Monitoring in Congenital Heart Diseased Children|Evaluation of Non-invasive Hemoglobin Monitoring in Children With Congenital Heart Diseases|Not yet recruiting||N/A|46|Anticipated|Cairo University|||1||f||||t|f|f||||||||2017-10-10 20:47:57.922032|2017-10-10 20:47:57.922032
NCT03248817|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-29|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|February 25, 2018|Anticipated|2018-02-25|February 15, 2018|Anticipated|2018-02-15||Interventional|||Three Protocols of Phenylephrine Infusion in Cesarean Delivery|Comparison of Three Protocols of Phenylephrine Infusion for Prophylaxis Against Post-spinal Hypotension During Cesarean Delivery|Recruiting||Phase 4|255|Anticipated|Cairo University||3|||f||||t|f|f||||||||2017-10-10 20:47:58.017338|2017-10-10 20:47:58.017338
NCT03248804|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-11|||March 10, 2015|Actual|2015-03-10|August 2017|2017-08-01|October 29, 2016|Actual|2016-10-29|October 29, 2016|Actual|2016-10-29||Interventional|||Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance|The Effect of Incorporating Soy Protein Foods in the Colorado Diet for Weight Loss and Maintenance.|Completed||N/A|72|Actual|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:47:58.130277|2017-10-10 20:47:58.130277
NCT03248791|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-28|||August 20, 2017|Actual|2017-08-20|August 2017|2017-08-01|December 10, 2017|Anticipated|2017-12-10|December 1, 2017|Anticipated|2017-12-01||Interventional|||Norepinephrine Versus Phenylephrine Variable Infusion in Cesarean Delivery|Norepinephrine Versus Phenylephrine Continuous Variable Infusion for Prevention of Post-spinal Hypotension During Cesarean Delivery: A Randomized Controlled Trial|Recruiting||Phase 4|120|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:47:58.249562|2017-10-10 20:47:58.249562
NCT03248778|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Readiness to Disclose Mother's HIV Diagnosis to Their Children in Beijing, China|Readiness to Disclose Mother's HIV Diagnosis to Their Children in Beijing, China|Recruiting||N/A|10|Anticipated|Yale University||2|||f||||f|f|f||||||||2017-10-10 20:47:58.356768|2017-10-10 20:47:58.356768
NCT03248765|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-30|||August 30, 2017|Actual|2017-08-30|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use|Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use|Recruiting||N/A|60|Anticipated|Washington University School of Medicine|||2||f||||f|f|f||||Samples With DNA|"     Genotype analysis will be performed to control for A118G single nucleotide polymorphism     (SNP).   "|||2017-10-10 20:47:58.435667|2017-10-10 20:47:58.435667
NCT03248752|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-09|||July 4, 2017|Actual|2017-07-04|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Monitoring Physical Activity (Fitbit)|Physical Activity Promotion Through Wearable Monitors: A Test of Self-, Partner-proxy, and Physician-proxy Monitoring Strategies.|Recruiting||N/A|80|Anticipated|University of Victoria||4|||f||||f|f|f||||||||2017-10-10 20:47:58.517953|2017-10-10 20:47:58.517953
NCT03248739|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-09|||June 12, 2017|Actual|2017-06-12|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Comparison of EVD Catheter Diameter on Occlusion and Replacement|A Comparison of External Ventricular Drain Catheter Diameter on Occlusion and Replacement: A Randomized Trial|Recruiting||N/A|120|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:47:58.613971|2017-10-10 20:47:58.613971
NCT03248726|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-09|||December 2017|Anticipated|2017-12-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparing Single-dose Low-volume PEG Plus Bisacodyl vs. Split-dose PEG for Bowel Preparation in Morning Colonoscopy|Comparison of Single-dose (Morning) Low-volume Polyethylene Glycol Plus Bisacodyl Versus Split-dose Polyethylene Glycol for Bowel Preparation Efficacy in Patient Receiving Morning Colonoscopy|Not yet recruiting||N/A|272|Anticipated|Taipei Medical University WanFang Hospital||2|||f||||f|f|f||||||||2017-10-10 20:47:58.708366|2017-10-10 20:47:58.708366
NCT03248713|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Glucocorticoid Antagonist Treatment for Tobacco Use Disorder|Glucocorticoid Antagonist Treatment for Tobacco Use Disorder|Not yet recruiting||Early Phase 1|40|Anticipated|Yale University||2|||f||||t|t|f||||||||2017-10-10 20:47:58.786555|2017-10-10 20:47:58.786555
NCT03248700|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-11|||March 2008|Actual|2008-03-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|September 2008|Actual|2008-09-01||Interventional|||Vitamin A Kinetics and Mathematical Modeling in American Women|Vitamin A Kinetics and Mathematical Modeling in American Women|Completed||N/A|8|Actual|University of Wisconsin, Madison||1|||f||||f|f|f||||||||2017-10-10 20:47:58.870369|2017-10-10 20:47:58.870369
NCT03248687|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-17|||February 1, 2018|Anticipated|2018-02-01|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Distal Radius Buckle Fracture Follow up Study|Home Management Versus Primary Care Physician Follow up in Children With Distal Radius Fractures: A Randomized Control Trial|Not yet recruiting||N/A|125|Anticipated|The Hospital for Sick Children||2|||f||||f|f|f||||||||2017-10-10 20:47:58.979721|2017-10-10 20:47:58.979721
NCT03248674|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Diagnostic Performance of Coronary CT Angiography With CT FFR in Kidney Transplantation Candidates|Diagnostic Performance of Coronary Computed Tomography Angiography With Computed Tomography Fractional Flow Reserve in Kidney Transplantation Candidates|Not yet recruiting||N/A|100|Anticipated|Stanford University|||1||f||||f|f|t|f|f||||||2017-10-10 20:47:59.050742|2017-10-10 20:47:59.050742
NCT03248661|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-08-11|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ARFT||Assessing Repeat Fit Testing for CRC|Assessing Repeat Annual FIT Screening for Colo-Rectal Cancer (CRC)|Recruiting||Phase 3|220|Anticipated|University of Kentucky||2|||f||||f||||||||||2017-10-10 20:47:59.108818|2017-10-10 20:47:59.108818
NCT03248648|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-09-11|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Actual|2017-09-01||Interventional|||Efficacy of Intra-articular Neostigmine Versus Ketamine for Postoperative Analgesia in Arthroscopic Knee Surgery|Efficacy of Intra-articular Neostigmine Versus Ketamine for Postoperative Analgesia in Arthroscopic Knee Surgery|Recruiting||Phase 2/Phase 3|100|Anticipated|Assiut University||2|||f||||t|f|f|||f|||||2017-10-10 20:47:59.180893|2017-10-10 20:47:59.180893
NCT03248609|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-28|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Glycemic Index of Table Grape Varietals|Investigation of the Glycemic Index of Table Grape Varietals|Active, not recruiting||N/A|12|Anticipated|University of California, Davis||4|||f||||f|f|f||||||||2017-10-10 20:47:59.51694|2017-10-10 20:47:59.51694
NCT03248596|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ECMO PFA-100||Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)|Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)|Recruiting||N/A|30|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:47:59.604254|2017-10-10 20:47:59.604254
NCT03248583|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-11|||January 13, 2016|Actual|2016-01-13|August 2017|2017-08-01|September 29, 2016|Actual|2016-09-29|September 29, 2016|Actual|2016-09-29||Interventional|||Decision-Making Processes While Online Grocery Shopping|Decision-Making Processes While Online Grocery Shopping|Completed||N/A|60|Actual|University at Albany||3|||f||||f|f|f||||||||2017-10-10 20:47:59.677524|2017-10-10 20:47:59.677524
NCT03248570|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-11|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects|Phase 2 Open Label Study of Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects|Not yet recruiting||Phase 2|50|Anticipated|University of California, San Francisco||2|||f||||t|t|f|||t|||||2017-10-10 20:47:59.754247|2017-10-10 20:47:59.754247
NCT03248557|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-13|||June 2016||2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|AWAKE||Prognostic Value of Ventricular Fibrillation Spectral Analysis in Sudden Cardiac Death|Early Prognostic Value of an Algorithm Based on Spectral Variables of Ventricular fibrillAtion From the EKG of Patients With suddEn Cardiac Death: a Multicenter Observational Trial|Recruiting||N/A|143|Anticipated|Hospital San Carlos, Madrid|||2||f||||f|f|f||||||||2017-10-10 20:47:59.849273|2017-10-10 20:47:59.849273
NCT03248531|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-27|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.|A Phase 2 Multicenter, Investigator-Blind, Subject-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa|Not yet recruiting||Phase 2|160|Anticipated|UCB Pharma||3|||f||||t|t|f|||t|||||2017-10-10 20:48:00.084106|2017-10-10 20:48:00.084106
NCT03248505|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||May 29, 2017|Actual|2017-05-29|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|CTLBP||Cryotherapy and TENS on Low Back Pain|Immediate Effects of Conventional TENS and Burst TENS Combined With Cryotherapy in the Non-specific Low Back Pain|Recruiting||N/A|120|Anticipated|Universidade Federal do Rio Grande do Norte||6|||f||||f|f|f||||||||2017-10-10 20:48:00.31483|2017-10-10 20:48:00.31483
NCT03247777|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-08-09|||November 2013||2013-11-01|August 2017|2017-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Benefits of Traditional and Golf-specific Resistance Training in Amateur Female Golfers|Benefits of Traditional and Golf-specific Resistance Training in Amateur Female Golfers|Completed||N/A|45|Actual|High Point University||2|||f||||f||||||||||2017-10-10 20:48:06.624169|2017-10-10 20:48:06.624169
NCT03248479|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination With Azacitidine in Patients With Hematological Malignancies|A Phase 1b Trial of Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination With Azacitidine in Patients With Hematological Malignancies|Not yet recruiting||Phase 1|96|Anticipated|Forty Seven, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:48:00.514852|2017-10-10 20:48:00.514852
NCT03248466|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-11|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|July 1, 2020|Anticipated|2020-07-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer|Transplantation of Autologous Platelet Rich Gel Combined With Autologous Bone Marrow Mesenchymal Stem Cells for Treatment of Diabetic Foot Ulcer|Recruiting||Early Phase 1|60|Anticipated|Third Military Medical University||3|||f||||t|f|f||||||||2017-10-10 20:48:00.60766|2017-10-10 20:48:00.60766
NCT03248453|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-11|||December 2016||2016-12-01|August 2017|2017-08-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Feedback Given by an Automatic and Objective System in Simulated Colonoscopy Increase Learning and Time Spent Practicing|Do Feedback Given by an Automatic and Objective System in Simulated Colonoscopy Increase Learning and Time Spent Practicing? A Randomized Trial|Completed||N/A|44|Actual|Rigshospitalet, Denmark||2|||f||||f|f|f||||||||2017-10-10 20:48:00.705768|2017-10-10 20:48:00.705768
NCT03248440|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|SUNRISE||Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion (SUN-131-03)|Recruiting||Phase 3|260|Anticipated|Senju USA, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:48:00.810374|2017-10-10 20:48:00.810374
NCT03248388|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-09|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Argus II/ORCAM Device Study|Utility of Visual Pattern Recognition Technology in Retinal Prosthesis Patients: the ARGUSII/ORCAM Device Study|Recruiting||N/A|5|Anticipated|Mayo Clinic||1|||f||||f|f|t|t|f|t|||||2017-10-10 20:48:01.604011|2017-10-10 20:48:01.604011
NCT03248375|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||August 3, 2016|Actual|2016-08-03|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Impact of Y90 Radiation Segmentectomy on HCC|The Impact of 90Yttrium (Y90) Radiation Segmentectomy on Hepatocellular Carcinoma and Cirrhosis|Recruiting||N/A|30|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|f|t|f|f||||||2017-10-10 20:48:01.690549|2017-10-10 20:48:01.690549
NCT03248362|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-09|||January 4, 2018|Anticipated|2018-01-04|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|January 4, 2019|Anticipated|2019-01-04||Interventional|ELECTRIC||ELECtric Tibial Nerve Stimulation to Reduce Incontinence in Care Homes|ELECtric Tibial Nerve Stimulation to Reduce Incontinence in Care Homes: ELECTRIC|Not yet recruiting||N/A|500|Anticipated|Glasgow Caledonian University||2|||f||||t|f|f||||||||2017-10-10 20:48:01.799156|2017-10-10 20:48:01.799156
NCT03248349|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-09|||May 24, 2017|Actual|2017-05-24|May 2017|2017-05-01|October 1, 2020|Anticipated|2020-10-01|May 1, 2020|Anticipated|2020-05-01||Observational|POPSICLE||Population Pharmacokinetics of Antibiotics in Critically Ill Children (POPSICLE)|Population Pharmacokinetics of Antibiotics in Critically Ill Children|Recruiting||N/A|200|Anticipated|Radboud University|||1||f||||f|t|f|||f|Samples With DNA|"     -  Blood plasma for antibiotic concentrations during admission (max. 14 days)        -  Whole blood sample for future DNA-analysis        -  Urine samples during admission (max. 14 days)   "|||2017-10-10 20:48:01.904897|2017-10-10 20:48:01.904897
NCT03248336|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||September 2, 2016|Actual|2016-09-02|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children|Objective Assessment of Disparity Vergence After Treatment of Symptomatic Convergence Insufficiency (CI) in Children|Recruiting||N/A|60|Anticipated|Salus University||1|||f||||f|f|f||||||||2017-10-10 20:48:02.005465|2017-10-10 20:48:02.005465
NCT03248323|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-11|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01|1 Year|Observational [Patient Registry]|||A Prospective Study: the Value of Using iFlow and PBV in the Endovascular Treatment of Infrapopliteal Arterial Occlusive Diseases|A Prospective Study: the Value of Using Parametric Color Coding of Digital Subtraction Angiography and Flat-panel Detector Computed Tomography Parenchymal Blood Volume Imaging in the Endovascular Treatment of Infrapopliteal Arterial Occlusive Diseases|Recruiting||N/A|120|Anticipated|Peking Union Medical College Hospital|||1||f||||||||||||||2017-10-10 20:48:02.090533|2017-10-10 20:48:02.090533
NCT03247387|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||May 2, 2017|Actual|2017-05-02|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||eOnOff - D1 Extension|Evaluation of the eON-OFF Mobile Application and Four Actigraphy Devices in Subjects With Parkinson's Disease|Recruiting||N/A|34|Anticipated|Boston University|||1||f||||f|f|f||||||||2017-10-10 20:48:09.62808|2017-10-10 20:48:09.62808
NCT03248310|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-11|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|||A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Vascularized Lymph Node Transfer Versus Non-Surgical Management|A Prospective Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Vascularized Lymph Node Transfer Versus Non-Surgical Management|Recruiting||N/A|150|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f|||||f|f||||||||2017-10-10 20:48:02.167878|2017-10-10 20:48:02.167878
NCT03248297|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-11|||January 2, 2018|Anticipated|2018-01-02|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries|Azithromycin With or Without Amoxicillin to Prevent Peripartum Infection and Sepsis in Laboring High-risk Women: 3-Arm RCT|Not yet recruiting||Phase 4|750|Anticipated|University of Alabama at Birmingham||3|||f||||t|f|f||||||||2017-10-10 20:48:02.280404|2017-10-10 20:48:02.280404
NCT03248284|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-18|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|September 21, 2019|Anticipated|2019-09-21|June 21, 2019|Anticipated|2019-06-21||Observational|IMPAACT||Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons|Stereological Quantification of Immune-Competent Cells in Biopsies From Painful Achilles Tendons of Psoriatic Arthritis Patients With Ultrasonic Verified Enthesitis: An Exploratory Prospective Cohort Study|Recruiting||N/A|30|Anticipated|Odense University Hospital|||1||f||||f|f|f||||Samples With DNA|"     Achilles tendon tissue specimens, blood- and fecal samples   "|||2017-10-10 20:48:02.379663|2017-10-10 20:48:02.379663
NCT03248271|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Effects of Insulin on Hypotension and Sarcopenia|Effects of Insulin on Hypotension and Sarcopenia|Not yet recruiting||N/A|30|Anticipated|University of British Columbia|||1||f||||f|f|f||||||||2017-10-10 20:48:02.480233|2017-10-10 20:48:02.480233
NCT03248258|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-09|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|June 27, 2019|Anticipated|2019-06-27|December 31, 2017|Anticipated|2017-12-31||Observational|||Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)|Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)|Recruiting||N/A|25|Anticipated|University of Alabama at Birmingham|||1||f|||||f|f||||||||2017-10-10 20:48:02.605694|2017-10-10 20:48:02.605694
NCT03248245|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-11|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|June 30, 2025|Anticipated|2025-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Improving Interprofessional Collaboration in Norwegian Primary Schools|Improving Interprofessional Collaboration in Norwegian Primary Schools - A Cluster-randomised Study Evaluating the Effects of the LOG-model.|Recruiting||N/A|1776|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f|f|f||||||||2017-10-10 20:48:02.701163|2017-10-10 20:48:02.701163
NCT03248232|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-12|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Assessments of Thrombus Formation in TAVI|AssessmenTs of ThRombogenicity for trAnsCatheter aorTIc valVE Implantation by Total Thrombus-formation Analysis System (ATTRACTIVE-TTAS)|Recruiting||N/A|30|Anticipated|Kumamoto University|||1||f||||f|f|f||||||||2017-10-10 20:48:02.933308|2017-10-10 20:48:02.933308
NCT03248219|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-11|||March 15, 2017|Actual|2017-03-15|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|March 15, 2018|Anticipated|2018-03-15||Observational|SiP||The Sleep in Pregnancy Study|Sleep Disordered Breathing Accounts for Abnormal Glycemic Profiles in Pregnant Women: The Sleep in Pregnancy (SiP) Study|Recruiting||N/A|17|Anticipated|University of Colorado, Denver|||1||f||||f|f|f||||||||2017-10-10 20:48:03.007254|2017-10-10 20:48:03.007254
NCT03248206|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-12|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Home-based Proprioceptive Neuromuscular Facilitation for Subjects With Type 2 Diabetes Mellitus|Effects of a Home-based Proprioceptive Neuromuscular Facilitation in Conjunction With Tendon Gliding Exercises on Sensorimotor Function in Upper Extremity of Subjects With Type 2 Diabetes Mellitus|Recruiting||N/A|57|Anticipated|National Cheng-Kung University Hospital||2|||f|||||f|f||||||||2017-10-10 20:48:03.096811|2017-10-10 20:48:03.096811
NCT03248193|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-09|||August 4, 2017|Actual|2017-08-04|July 2017|2017-07-01|April 30, 2020|Anticipated|2020-04-30|August 31, 2019|Anticipated|2019-08-31||Interventional|||Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia|Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia|Recruiting||N/A|50|Anticipated|National University Hospital, Singapore||2|||f||||f|f|f||||||||2017-10-10 20:48:03.187269|2017-10-10 20:48:03.187269
NCT03248180|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-09|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|GDR||Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States|Impact of Guided Antipsychotic Dose Reduction in Patients With Psychosis Under Remitted States: a Randomized Control Trial and Prospective Follow-up Study|Recruiting||N/A|160|Anticipated|National Taiwan University Hospital|||2||f||||f|f|f|||f|Samples Without DNA|"     plasma for determining concentration of antipsychotics   "|||2017-10-10 20:48:03.289702|2017-10-10 20:48:03.289702
NCT03248167|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-09|||February 1, 2018|Anticipated|2018-02-01|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Cannabidiol as a Treatment for AUD Comorbid With PTSD|Cannabidiol as a Treatment for Alcohol Use Disorder Comorbid With Posttraumatic Stress Disorder|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|New York University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 20:48:03.389469|2017-10-10 20:48:03.389469
NCT03248154|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-08-09|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Biofilm Infection in Adults and Children Burn Injury|Burn Biofilm Infection in Adults and Children|Recruiting||N/A|300|Anticipated|Ohio State University||3|||f||||||||||||||2017-10-10 20:48:03.495456|2017-10-10 20:48:03.495456
NCT03248141|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-06|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Understanding Hemophilia A and B Drug Dosage Administration Patterns|Understanding Hemophilia A And B Drug Dosage Administration Patterns|Active, not recruiting||N/A|300|Anticipated|Pfizer|||2||f||||f|t|f|||f|||||2017-10-10 20:48:03.628192|2017-10-10 20:48:03.628192
NCT03031379|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-01-22|||April 2012||2012-04-01|February 2012|2012-02-01||||April 2014|Actual|2014-04-01||Interventional|||Shortened Preoperative Fasts in ICU|Feasibility of Shortened Preoperative Fasts in Intubated ICU Patients Undergoing Tracheotomy|Completed||N/A|24|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 21:25:47.917667|2017-10-10 21:25:47.917667
NCT03248128|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-05|||October 4, 2017|Anticipated|2017-10-04|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma|A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids|Not yet recruiting||Phase 3|870|Anticipated|GlaxoSmithKline||4|||f||||f|t|f||||||||2017-10-10 20:48:03.740025|2017-10-10 20:48:03.740025
NCT03248115|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-16|||April 10, 2013|Actual|2013-04-10|August 2017|2017-08-01|October 18, 2013|Actual|2013-10-18|October 18, 2013|Actual|2013-10-18||Interventional|POBAS||Bioavailability of Green Tea and Coffee Polyphenols|Bioavailability of Green Tea and Coffee Polyphenols in Healthy Participants|Completed||N/A|11|Actual|MRC Human Nutrition Research||1|||f|||||f|f||||||||2017-10-10 20:48:03.845437|2017-10-10 20:48:03.845437
NCT03248102|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-11|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|FETOR||Finding Evidence to Treat Or Reassure in Appendicitis (FETOR)|Finding Evidence to Treat Or Reassure in Appendicitis (FETOR)|Recruiting||N/A|75|Anticipated|The Leeds Teaching Hospitals NHS Trust||1|||f|||||f|f||||||||2017-10-10 20:48:03.934242|2017-10-10 20:48:03.934242
NCT03248089|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-07|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Observational|SLLIP||Spanish Lung Liquid vs. Invasive Biopsy Program (SLLIP)|Spanish Lung Liquid vs. Invasive Biopsy Program|Active, not recruiting||N/A|182|Anticipated|MedSIR|||1||f||||f|f|||||Samples With DNA|"     Approximately 20 mL of peripheral blood will be collected in StreckTM tubeS. cfDNA will be     drawn following blood withdraws following standard of care of the participating site, which     would be, before treatment (v2); on the same date as the first standard of care labs (V3),     which would be approximately 2 weeks (14 days) into first-line treatment and after one year     from enrollment or upon progression whichever occurs first (EoS visit).      enrollment or upon progression whichever occurs first (EoS visit).   "|||2017-10-10 20:48:04.034216|2017-10-10 20:48:04.034216
NCT03248076|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|October 10, 2018|Anticipated|2018-10-10|August 31, 2018|Anticipated|2018-08-31||Observational|||Effect of Fentanyl on Main Opioid Receptor (OPRM1) on Human Granulosa Cells.|Effect of Fentanyl on Expression of Main Opioid Receptor (OPRM1) on Human Granulosa Cells During Ultrasound-guided Transvaginal Oocyte Retrieval.|Recruiting||N/A|30|Anticipated|George Papanicolaou Hospital|||1||f||||f|f|f||||||||2017-10-10 20:48:04.115951|2017-10-10 20:48:04.115951
NCT03248063|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-11|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|March 2022|Anticipated|2022-03-01|January 2022|Anticipated|2022-01-01||Interventional|CLOCEBA||Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia|A Multicenter Non-inferiority Randomized Trial Comparing Cloxacillin Versus Cefazolin Efficacy for the Treatment of Bacteremia Caused by Methicillin-susceptible Staphylococcus Aureus (MSSA)|Not yet recruiting||N/A|320|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 20:48:04.194676|2017-10-10 20:48:04.194676
NCT03248050|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-09|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|June 15, 2018|Anticipated|2018-06-15|April 15, 2018|Anticipated|2018-04-15||Interventional|||Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion|Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion, and the Effectiveness of Call Centre Support for Correct Use of Medical Abortion: A Cluster Randomised-controlled Trial With Nested Observational Study|Not yet recruiting||N/A|1359|Anticipated|Marie Stopes International||2|||f||||f|f|f||||||||2017-10-10 20:48:04.285694|2017-10-10 20:48:04.285694
NCT03248037|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation|Randomized, Double-masked, Placebo-controlled Evaluation of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation|Not yet recruiting||Phase 3|186|Anticipated|Cornea Research Foundation of America||2|||f||||t|t|f||||||||2017-10-10 20:48:04.351444|2017-10-10 20:48:04.351444
NCT03248024|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||November 28, 2016|Actual|2016-11-28|July 2017|2017-07-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Observational|FECPEC MICI||An Explanatory Factors Analysis of Inflammatory Bowel Diseases(IBD's) Management Costs for Adults Patients Treated by Biotherapy and Followed at Nancy University Hospital|Etude Des Facteurs Explicatifs Des Coûts de la Prise En Charge Des Patients Adultes Atteints d'Une MICI Suivis au CHRU de Nancy et traités Par biothérapie|Completed||N/A|119|Actual|Central Hospital, Nancy, France|||1||f||||t|f|f||||||||2017-10-10 20:48:04.44237|2017-10-10 20:48:04.44237
NCT03247998|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-09|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||GA vs. CS for Endovascular Stroke Therapy|GASTROKE- the Effect of General Anesthesia Versus Sedation for Patients With Acute Ischemic STROKE Undergoing Endovascular Treatment on Three Month Morbidity and Mortality: a Feasibility Study.|Not yet recruiting||N/A|20|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:48:04.597649|2017-10-10 20:48:04.597649
NCT03247985|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-08-10|||June 2013||2013-06-01|August 2017|2017-08-01|November 30, 2015|Actual|2015-11-30|November 30, 2015|Actual|2015-11-30||Interventional|||Tacking Mesh Versus Self-fixating Mesh for Inguinal Hernia Repair|Randomized Prospective Single-Blinded Study of Totally Extra Peritoneal Inguinal Hernia Repair: Tacking Mesh Versus Self-fixating Mesh|Completed||N/A|38|Actual|Mayo Clinic||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:48:04.693016|2017-10-10 20:48:04.693016
NCT03247972|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-09|||August 11, 2017|Anticipated|2017-08-11|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease|Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease|Recruiting||N/A|60|Anticipated|Inova Health Care Services|||1||f|||||t|f||||||||2017-10-10 20:48:04.969683|2017-10-10 20:48:04.969683
NCT03247959|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-09|||April 3, 2017|Actual|2017-04-03|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Active and Passive Distraction Techniques on Reducing Fear and Anxiety and Improving Oral Health Knowledge of Children Undergoing Extraction in the Dental Operatory- A Randomized Controlled Trial|Effectiveness of Active and Passive Distraction Techniques on Reducing Fear and Anxiety and Improving Oral Health Knowledge of Children Undergoing Extraction in the Dental Operatory - A Randomized Controlled Trial|Recruiting||N/A|114|Anticipated|Indira Gandhi Institute of Dental Science||3|||f||||t|f|f||||||||2017-10-10 20:48:05.065076|2017-10-10 20:48:05.065076
NCT03247946|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-12|||September 13, 2010|Actual|2010-09-13|August 2017|2017-08-01|August 19, 2012|Actual|2012-08-19|August 19, 2012|Actual|2012-08-19||Interventional|||The Influence of Upright Feeding Position on Pulmonary and Ear Morbidity|The Influence of Upright Feeding Position on Pulmonary and Ear Morbidity|Completed||N/A|163|Actual|Hadassah Medical Organization||2|||f|||||f|f||||||||2017-10-10 20:48:05.161359|2017-10-10 20:48:05.161359
NCT03247933|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-08-29|||October 2014||2014-10-01|August 2017|2017-08-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Interventional|TELEREHAB||TELEMEDICINE,Maintenance of a Respiratory Rehabilitation Program in Patients With Chronic Obstructive Pulmonary Disease.|"Clinical Trial Randomized, Controlled, Parallel-group and Open About the Use ofTELEMEDICINEin the Management of the Maintenance of a Respiratory Rehabilitation Program Phase in Patients With Chronic Respiratory Diseases"|Completed||N/A|94|Actual|Hospital de Cruces||2|||f||||f||||||||||2017-10-10 20:48:05.255168|2017-10-10 20:48:05.255168
NCT03247920|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-09|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|RAIN||Reduction of Intravenous Antibiotics In Neonates|Intravenous to Oral Antibiotic Switch Therapy for Suspected Neonatal Bacterial Infections: Clinical Efficacy, Safety and Cost-effectiveness|Not yet recruiting||Phase 4|550|Anticipated|Franciscus Gasthuis||2|||f||||t|f|f|||f|||||2017-10-10 20:48:05.351903|2017-10-10 20:48:05.351903
NCT03247907|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Humidification Needs|Humidification Needs|Not yet recruiting||N/A|30|Anticipated|Fisher and Paykel Healthcare||8|||f||||t|f|f|||f|||||2017-10-10 20:48:05.470268|2017-10-10 20:48:05.470268
NCT03247894|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-09|||August 1, 2014|Actual|2014-08-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|July 31, 2017|Actual|2017-07-31|10 Months|Observational [Patient Registry]|OBAANAMS||Obstetric Anesthesia and Analgesia and Multiple Sclerosis|Influence of Obstetric Anesthesia and Analgesia on the Progression of the Disease in Multiple Sclerosis Parturients: Retrospective Cohort Study|Completed||N/A|70|Actual|Brno University Hospital|||1||f||||t|f|f||||||||2017-10-10 20:48:05.61949|2017-10-10 20:48:05.61949
NCT03247881|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-18|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|November 6, 2017|Anticipated|2017-11-06|November 6, 2017|Anticipated|2017-11-06||Interventional|||Pilot Study on Mixed Nuts and Food Intake|Pilot Study on Mixed Nuts and Food Intake|Active, not recruiting||N/A|12|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f|f|f||||||||2017-10-10 20:48:05.727996|2017-10-10 20:48:05.727996
NCT03247868|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-11|||March 16, 2016||2016-03-16|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|March 28, 2018|Anticipated|2018-03-28||Interventional|SPRInt||A Multimodal Approach to Cervical Dystonia Treatment With Association of Botulinum Toxin and Motor Learning Techniques|Multimodal Treatment of Cervical Dystonia With Botulinum Toxin Injections Associated With a Sensory-motor Perceptive Rehabilitation Integrated Approach (SPRInt) Based on Motor Learning Techniques|Recruiting||N/A|20|Anticipated|Fondazione Don Carlo Gnocchi Onlus||1|||f||||f|f|f|||f|||||2017-10-10 20:48:05.845475|2017-10-10 20:48:05.845475
NCT03247855|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-09|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Safety and Efficacy of Multivessel Minimally Invasive Coronary Artery Bypass Graft Surgery|Safety and Efficacy of Multivessel Minimally Invasive Coronary Artery Bypass Graft Surgery|Not yet recruiting||N/A|60|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:48:05.979045|2017-10-10 20:48:05.979045
NCT03247842|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-08|||April 25, 2017|Actual|2017-04-25|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||The Analgesic Efficacy Supra-scapular Nerve After Breast Surgery|The Analgesic and Rehabilitative Efficacy of Supra-scapular Nerve Radiofrequency in Patients With Shoulder Dystocia After Breast Surgery|Recruiting||N/A|60|Anticipated|Tanta University||2|||f||||t|f|f||||||||2017-10-10 20:48:06.089022|2017-10-10 20:48:06.089022
NCT03247829|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-17|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2019|Anticipated|2019-06-30||Observational|Intellect2||Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™|Investigation to Optimize Hemodynamic Management of HeartMate II™ Left Ventricular Assist Device Patients Using the CardioMEMS™ Pulmonary Artery Pressure Sensor in Advanced Heart Failure|Recruiting||N/A|100|Anticipated|St. Jude Medical|||1||f||||f|f|f||||||||2017-10-10 20:48:06.193228|2017-10-10 20:48:06.193228
NCT03247816|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-08-08|||August 14, 2017|Anticipated|2017-08-14|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|February 1, 2018|Anticipated|2018-02-01||Observational|FRESH||Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH )|Feraccru® Real World Effectiveness Study in Hospital Practice (FRESH): A Real World Study to Describe the Outcomes Associated With the Use of Ferric Maltol (Feraccru) for the Management of Iron Deficiency Anaemia in Patients With Inflammatory Bowel Disease in the UK.|Not yet recruiting||N/A|100|Anticipated|Shield Therapeutics|||1||f||||f|f|f||||||||2017-10-10 20:48:06.301532|2017-10-10 20:48:06.301532
NCT03247803|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-15|||August 20, 2017|Anticipated|2017-08-20|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Air-Q® SP Versus Williams Intubating Airway for Single-Operator FOI|Comparison of Use of a Shortened Air-Q® Self-Pressurizing Intubating Laryngeal Airway Versus the Williams Intubating Airway for Single-Operator Flexible Bronchoscopic Intubation.|Not yet recruiting||N/A|60|Anticipated|University of Wisconsin, Madison||2|||f||||f|f|f||||||||2017-10-10 20:48:06.390364|2017-10-10 20:48:06.390364
NCT03247790|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-10|2017-10-02|||August 16, 2017|Actual|2017-08-16|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of Lasmiditan in Participants With Migraine|An Open-Label, Two-Period Study to Evaluate the Pharmacokinetics of Lasmiditan in Migraineurs During Acute Migraine Attacks and During Inter-Ictal Periods|Recruiting||Phase 1|20|Anticipated|Eli Lilly and Company||2|||f||||f|t|f||||||||2017-10-10 20:48:06.516582|2017-10-10 20:48:06.516582
NCT03247764|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-08|||October 8, 2017|Anticipated|2017-10-08|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|September 30, 2020|Anticipated|2020-09-30|6 Months|Observational [Patient Registry]|||A Registration Study on Depression in Patients With Epilepsy|A Registration Study on Diagnosis and Treatment for Comorbid Depression in Patients With Epilepsy From the East China|Not yet recruiting||N/A|1200|Anticipated|Shanghai Zhongshan Hospital|||1||f||||t|f|f||||||||2017-10-10 20:48:06.721007|2017-10-10 20:48:06.721007
NCT03247751|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-04|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of the Rotational Stability|Rotational Stability of the Blue Light-absorbing Hydrophobic Acrylic Posterior Chamber Single Piece Intraocular Lens|Active, not recruiting||N/A|125|Anticipated|Nidek Co. LTD.||1|||f|||||f|f||||||||2017-10-10 20:48:06.802317|2017-10-10 20:48:06.802317
NCT03247738|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|CANTIC||Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI|Platelet Inhibition With CANgrelor and Crushed TICagrelor in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: The CANTIC Study|Not yet recruiting||Phase 4|50|Anticipated|University of Florida||2|||f||||t|t|f|||f|||||2017-10-10 20:48:06.886474|2017-10-10 20:48:06.886474
NCT03247725|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Efficacy of Pain Monitor, a Smartphone App for Chronic Pain|Pain Monitor: a Randomized Controlled Trial to Test the Efficacy of a Pain App in the Treatment of Chronic Pain|Not yet recruiting||N/A|150|Anticipated|Universitat Jaume I||3|||f||||f|f|f||||||||2017-10-10 20:48:07.000097|2017-10-10 20:48:07.000097
NCT03247712|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2026|Anticipated|2026-09-01|September 2025|Anticipated|2025-09-01||Interventional|||Neoadjuvant Immunoradiotherapy in Head & Neck Cancer|Neoadjuvant Immunoradiotherapy in Head & Neck Cancer|Not yet recruiting||Phase 1/Phase 2|6|Anticipated|Providence Health & Services||1|||f||||f|t|f|||t|||||2017-10-10 20:48:07.143167|2017-10-10 20:48:07.143167
NCT03247699|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-20|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|July 30, 2017|Actual|2017-07-30|July 1, 2017|Actual|2017-07-01||Interventional|CombiCapsIII||Pharmacokinetics of the Basel Phenotyping Cocktail Combination Capsule|Pharmacokinetics of the Basel Phenotyping Cocktail Combination Capsule|Completed||N/A|12|Actual|University Hospital, Basel, Switzerland||2|||f||||t|f|f|||f|||||2017-10-10 20:48:07.30501|2017-10-10 20:48:07.30501
NCT03247686|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-10|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|January 15, 2018|Anticipated|2018-01-15|November 15, 2017|Anticipated|2017-11-15||Interventional|RSLV-132||A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome|A Phase 2, Double-blind, Placebo-controlled Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome|Recruiting||Phase 2|28|Anticipated|Resolve Therapeutics||2|||f||||f|t|f||||||||2017-10-10 20:48:07.416483|2017-10-10 20:48:07.416483
NCT03247673|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-10|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin|A Randomized, Double-blind, Three-arm, Parallel Group, Single-dose Study to Compare the Pharmacokinetics and Safety of Three Formulations of Bevacizumab (CT-P16, EU-approved Avastin and US-licensed Avastin) in Healthy Male Subjects|Recruiting||Phase 1|141|Anticipated|Celltrion||3|||f||||f|f|f||||||||2017-10-10 20:48:07.505461|2017-10-10 20:48:07.505461
NCT03247660|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-11|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PT-POSTPARTO||Perineal Physiotherapy in Postpartum|Effectiveness of the Perineal Physiotherapy in the Prevention and Treatment of Pelvic Floor Dysfunction in Postpartum|Recruiting||N/A|240|Anticipated|University of Alcala||3|||f||||t|f|f||||||||2017-10-10 20:48:07.629511|2017-10-10 20:48:07.629511
NCT03247647|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-18|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Personal Values and Mandated Students|Enhancing the Efficacy and Duration of a Brief Alcohol Intervention Using Self-Affirmation|Not yet recruiting||N/A|450|Anticipated|Brown University||2|||f||||t|f|f||||||||2017-10-10 20:48:07.738766|2017-10-10 20:48:07.738766
NCT03247634|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-11|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Getting Ahead for Cancer Control|Getting Ahead for Cancer Control|Not yet recruiting||N/A|128|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|f|f||||||||2017-10-10 20:48:07.844566|2017-10-10 20:48:07.844566
NCT03247621|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Exploring the Effects of Social Media Use and Environmental Factors|External Eating: An Investigation of Social Media and Environmental Factors Influencing Eating Behaviours|Recruiting||N/A|180|Anticipated|Yale-NUS College||3|||f|||||f|f||||||||2017-10-10 20:48:07.934097|2017-10-10 20:48:07.934097
NCT03247608|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||November 2015||2015-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CHH||ConnectedHeartHealth - Heart Failure Readmission Intervention|ConnectedHeartHealth - Heart Failure Readmission Intervention|Recruiting||N/A|50|Anticipated|LifeBridge Health||1|||f||||f||||||||||2017-10-10 20:48:08.016832|2017-10-10 20:48:08.016832
NCT03247595|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy|Efficacy of Magnesium Citrate Capsules in Colonoscopy Preparation: A Randomized, Investigator-blinded Non-inferiority Trial Using Polyethylene Glycol as the Active Control.|Recruiting||N/A|180|Anticipated|LifeBridge Health||2|||f||||f|f|f|||f|||||2017-10-10 20:48:08.118606|2017-10-10 20:48:08.118606
NCT03247582|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-29|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|August 2021|Anticipated|2021-08-01||Observational|||Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)|Non-interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)|Recruiting||N/A|200|Anticipated|Daiichi Sankyo, Inc.|||1||f||||f|f|f|||f|||||2017-10-10 20:48:08.224497|2017-10-10 20:48:08.224497
NCT03031002|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-24|||February 2015||2015-02-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Extinction Generalization in Exposure Therapy|Extinction Generalization in Exposure Therapy for Spider Phobia|Completed||N/A|77|Actual|Ruhr University of Bochum||2|||f||||f||||||||No||2017-10-10 21:25:51.802673|2017-10-10 21:25:51.802673
NCT03247569|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)|Non-interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Thailand)|Not yet recruiting||N/A|300|Anticipated|Daiichi Sankyo, Inc.|||1||f||||f|f|f|||f|||||2017-10-10 20:48:08.310528|2017-10-10 20:48:08.310528
NCT03247556|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Evaluation of SPN-812 ER High Dose in Adolescents With ADHD|Evaluation of SPN-812 ER High Dose in Adolescents With ADHD|Not yet recruiting||Phase 3|234|Anticipated|Supernus Pharmaceuticals, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:48:08.409921|2017-10-10 20:48:08.409921
NCT03247543|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Evaluation of SPN-812 ER High Dose in Children With ADHD|Evaluation of SPN-812 ER High Dose in Children With ADHD|Not yet recruiting||Phase 3|300|Anticipated|Supernus Pharmaceuticals, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:48:08.488208|2017-10-10 20:48:08.488208
NCT03247530|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Evaluation of SPN-812 ER Low Dose in Children With ADHD|Evaluation of SPN-812 ER Low Dose in Children With ADHD|Not yet recruiting||Phase 3|432|Anticipated|Supernus Pharmaceuticals, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:48:08.560301|2017-10-10 20:48:08.560301
NCT03247517|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Evaluation of SPN-812 ER Low Dose in Adolescents With ADHD|Evaluation of SPN-812 ER Low Dose in Adolescents With ADHD|Not yet recruiting||Phase 3|300|Anticipated|Supernus Pharmaceuticals, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:48:08.62321|2017-10-10 20:48:08.62321
NCT03247504|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Adherence to Opioids in Oncology Out Patients|Adherence to Opioids in Oncology Out Patients|Not yet recruiting||N/A|300|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:48:08.694125|2017-10-10 20:48:08.694125
NCT03247491|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-11|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effectiveness of a Mindfulness and Compassion Intervention for Pregnant Women and Their Partners for the Prevention of Stress and Depression During Pregnancy and Breastfeeding|Effectiveness of a Mindfulness and Compassion Group Intervention Applied to Pregnant Women and Their Partners to Decrease Stress, Negative Affect and Depression During Pregnancy and Breastfeeding. Controlled and Randomized Study|Recruiting||N/A|120|Anticipated|Hospital Miguel Servet||2|||f||||f|f|f||||||||2017-10-10 20:48:08.752282|2017-10-10 20:48:08.752282
NCT03247478|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-24|||August 25, 2017|Actual|2017-08-25|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|October 31, 2019|Anticipated|2019-10-31||Observational|CTREP||Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure|Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure: a Prospective Observational Study Evaluating Response in Axillary Lymph Nodes of Breast Cancer After Neoadjuvant Chemotherapy|Recruiting||N/A|156|Anticipated|Peking University|||1||f||||f|f|f||||Samples Without DNA|"     Axillary lymph node status are determined in FNA/CNB and surgical specimen.   "|||2017-10-10 20:48:08.880566|2017-10-10 20:48:08.880566
NCT03247465|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-11|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|TAVI||Image Fusion and Calcification Raising in Trans Aortic Valve Implantation|Value of Fusion of 3D Images With 2D Images, Associated With Calcification Raising During Trans Aortic Valve Implantation Procedures|Not yet recruiting||N/A|40|Anticipated|Nantes University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:48:08.955731|2017-10-10 20:48:08.955731
NCT03247452|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Interventional|DIETPREP||Impact of Low Fiber Diet on Colonic Cleansing Quality (DIETPREP)|Impact of Low Fiber Diet on Colonic Cleansing Quality Prior to Colonoscopy: Randomized Study Comparing 1 Day Versus 3 Days of Low Fiber Diet|Not yet recruiting||N/A|404|Anticipated|Hospital Universitario de Canarias||2|||f||||f|f|f||||||||2017-10-10 20:48:09.038663|2017-10-10 20:48:09.038663
NCT03247439|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-09|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|January 2024|Anticipated|2024-01-01|January 2023|Anticipated|2023-01-01||Interventional|GRIP2||Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis Compared to LRTI (GRIP 2)|A Prospective Study to Evaluate the Safety and Effectiveness of the Cartiva® Synthetic Cartilage Implant for CMC in the Treatment of First Carpometacarpal Joint Osteoarthritis as Compared to LRTI Comparator|Not yet recruiting||N/A|74|Anticipated|Cartiva, Inc.||1|||||||t|f|t|f|f||||||2017-10-10 20:48:09.124186|2017-10-10 20:48:09.124186
NCT03247426|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-24|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|September 15, 2017|Anticipated|2017-09-15|September 10, 2017|Anticipated|2017-09-10||Observational|||Sleep Quality, Job Satisfaction, Quality of Life, Occupational Burnout Levels in Individuals|Comparison of Sleep Quality, Job Satisfaction, Quality of Life, Occupational Burnout Levels Among Individuals Who do or do Not do Exercise|Recruiting||N/A|100|Anticipated|Hacettepe University|||2||f||||f|f|f||||||||2017-10-10 20:48:09.200816|2017-10-10 20:48:09.200816
NCT03247413|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation|Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation|Recruiting||Phase 4|366|Anticipated|Johns Hopkins University||2|||f||||f|t|f|||f|||||2017-10-10 20:48:09.391889|2017-10-10 20:48:09.391889
NCT03247400|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-09-27|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|December 31, 2017|Anticipated|2017-12-31||Interventional|EVRAAS||The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo|The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (EVRAAS)|Recruiting||Phase 1/Phase 2|20|Anticipated|Nicolaus Copernicus University||3|||f||||f|f|f||||||||2017-10-10 20:48:09.510309|2017-10-10 20:48:09.510309
NCT03247374|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-21|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|August 1, 2018|Anticipated|2018-08-01||Interventional|BIO_DYS||Bio-feedback Treatment for Dysphagic Post-stroke Patients|Bio-feedback Treatment Versus Standard Treatment for Dysphagic Post-stroke Patients: a Randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|IRCCS San Camillo, Venezia, Italy||2|||f|||||f|f||||||||2017-10-10 20:48:09.723792|2017-10-10 20:48:09.723792
NCT03247361|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-10|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||High-intensity vs. Low-intensity Inspiratory Muscle Training in Patients With Heart Failure|The Addition of High-intensity vs. Low-intensity Inspiratory Muscle Training to Combined Aerobic and Resistance Exercise in Patients With Heart Failure|Recruiting||N/A|90|Anticipated|Federal University of Bahia||3|||f||||f|f|f||||||||2017-10-10 20:48:09.821867|2017-10-10 20:48:09.821867
NCT03247348|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-08|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|ReSeT-FM||Reducing Sedentary Time in Fibromyalgia Patients|Reducing Sedentary Time in Fibromyalgia (ReSeT-FM): A Feasibility Study|Not yet recruiting||N/A|24|Anticipated|Indiana University|||1||f||||f|f|f||||||||2017-10-10 20:48:09.935235|2017-10-10 20:48:09.935235
NCT03247335|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01|1 Year|Observational [Patient Registry]|||Follow-up of Arthrosurface HemiCAP Implants|Follow-up of Arthrosurface HemiCAP Implants|Recruiting||N/A|118|Anticipated|The Cleveland Clinic|||1||f||||f|f|f||||||||2017-10-10 20:48:10.029726|2017-10-10 20:48:10.029726
NCT03247309|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-26|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|December 31, 2033|Anticipated|2033-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|ACTengine||TCR-engineered T Cells in NSCLC and HNSCC Patients (ACTengine)|Phase I Trial Evaluating Genetically Modified Autologous T Cells Expressing a T-Cell Receptor Recognizing a Cancer/Germline Antigen in Patients With Squamous Cell Non-small Cell Lung Cancer or Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1|16|Anticipated|Immatics US, Inc.||1|||f||||t|t|t|t|f||||||2017-10-10 20:48:10.234667|2017-10-10 20:48:10.234667
NCT03247296|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-10|||February 28, 2017|Actual|2017-02-28|August 2017|2017-08-01|November 10, 2017|Anticipated|2017-11-10|October 31, 2017|Anticipated|2017-10-31||Observational|||Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir|Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir|Active, not recruiting||N/A|200|Actual|MTI University|||2||f|||||f|f||||||||2017-10-10 20:48:10.37014|2017-10-10 20:48:10.37014
NCT03247283|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|August 26, 2017|Anticipated|2017-08-26|August 26, 2017|Anticipated|2017-08-26||Interventional|||Pharmacokinetics and Metabolism Study in Healthy Male Participants|Pharmacokinetics and Metabolism of [14C] BMS-986205 in Healthy Male Participants|Recruiting||Phase 1|9|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 20:48:10.488957|2017-10-10 20:48:10.488957
NCT03247270|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|June 15, 2021|Anticipated|2021-06-15|December 15, 2020|Anticipated|2020-12-15||Interventional|PHYSBI||Physical Fitness and Brain - Interventional Study|Physical Fitness and Brain - Interventional Study of the Importance of Physical Fitness on Symptoms of Anxiety, Cognitive Ability and Sick Leave, in Primary Care.|Not yet recruiting||N/A|192|Anticipated|Göteborg University||3|||f||||t|f|f||||||||2017-10-10 20:48:10.595143|2017-10-10 20:48:10.595143
NCT03247257|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-08|||February 2015||2015-02-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparing Epidural Versus General Anesthesia for LESS Cholecystectomies|Epidural Versus General Anesthesia for Laparoendoscopic Single Site Cholecystectomy: A Prospective, Comparative, Controlled, Blinded Study|Enrolling by invitation||N/A|70|Actual|Florida Hospital Tampa Bay Division||2|||f||||f|f|f||||||||2017-10-10 20:48:10.716861|2017-10-10 20:48:10.716861
NCT03247244|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-07|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Efficacy of Cannabis in Tourette Syndrome|A Double-blind, Randomized, Placebo-controlled Crossover Pilot Trial of Medical Cannabis in Adults With Tourette Syndrome|Recruiting||Phase 2|12|Anticipated|University Health Network, Toronto||4|||f||||f|f|f|||f|||||2017-10-10 20:48:10.816503|2017-10-10 20:48:10.816503
NCT03247231|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-08|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01|2 Years|Observational [Patient Registry]|||Banding Without Resection in Small Submucosal Tumours|Endoscopic Banding Without Resection of Small Submucosal Tumors (<15mm): a Multicenter Prospective Study|Recruiting||N/A|146|Anticipated|Hospital Universitari de Bellvitge|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:48:10.9263|2017-10-10 20:48:10.9263
NCT03247218|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-21|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|December 1, 2019|Anticipated|2019-12-01||Interventional|MeMAGEN||A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD|A Phase - IIa - IIb, Open Label, Single Center Trial to Study the Safety, Tolerability and Efficacy of Memantine Teva® as Supportive Long-term Treatment in Symptomatic Sickle Cell Disease|Not yet recruiting||Phase 2|40|Anticipated|HaEmek Medical Center, Israel||1|||f||||t|f|f|||f|||||2017-10-10 20:48:11.020983|2017-10-10 20:48:11.020983
NCT03247205|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|HipERS||Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study|Feasibility of Extended Post-Acute Intervention for Hip Fracture Patients With Cognitive Limitations: Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study (HipERS)|Not yet recruiting||N/A|5|Anticipated|University of Maryland||1|||f||||t|f|f||||||||2017-10-10 20:48:11.09998|2017-10-10 20:48:11.09998
NCT03246828|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-08|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Glucagon in MODY (Maturity Onset Diabetes of the Young)|Investigating Glucagon Secretion in HNF1-alpha and HNF4-alpha MODY|Recruiting||N/A|10|Anticipated|University of Oxford||1|||f||||f|f|f||||||||2017-10-10 20:48:15.053105|2017-10-10 20:48:15.053105
NCT03247192|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||December 8, 2015||2015-12-08|August 2017|2017-08-01|September 30, 2016|Actual|2016-09-30|February 10, 2016|Actual|2016-02-10||Interventional|||Whey Protein Supplementation Associated With Resistance Training on Health Indicators in Trained Older Women|Effect of Whey Protein Supplementation Associated With Resistance Training on Body Composition, Cellular Hydration, Phase Angle, Muscle Strength, Glycemic and Lipid Profile, Inflammatory and Oxidative Stress Markers in Trained Older Women|Completed||N/A|66|Actual|Universidade Estadual de Londrina||3|||f||||f|f|||||||||2017-10-10 20:48:11.186562|2017-10-10 20:48:11.186562
NCT03247179|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-19|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||The Mobile PTSD Coach App in Acute Injury Survivors|Secondary Prevention With the Mobile PTSD Coach App to Improve Health Outcomes and the Continuity of Care Following Traumatic Physical Injury: A Randomized Controlled Trial|Recruiting||N/A|67|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||||2017-10-10 20:48:11.294539|2017-10-10 20:48:11.294539
NCT03247166|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of the TOPS™ SP System|A Study to Evaluate the Safety and Effectiveness of the TOPS™ SP System|Not yet recruiting||N/A|10|Anticipated|Hillel Yaffe Medical Center||1|||f||||t|f|f||||||||2017-10-10 20:48:11.392815|2017-10-10 20:48:11.392815
NCT03247153|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Influence of Corticosteroids on Heart Function|Influence of Corticosteroid Therapy on Heart Function|Not yet recruiting||N/A|30|Anticipated|Hillel Yaffe Medical Center||1|||f||||t|f|f||||||||2017-10-10 20:48:11.483049|2017-10-10 20:48:11.483049
NCT03247140|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-10|||June 10, 2017|Actual|2017-06-10|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers|An Open Label, Randomized, Single-dose, 4-period Cross-over Study to Compare the Pharmacokinetics and Safety Following Administration of JLP-1401 and Coadministration of Rosuvastatin and Telmisartan/Amlodipine in Healthy Adult Volunteers|Recruiting||Phase 1|40|Anticipated|Jeil Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:48:11.558637|2017-10-10 20:48:11.558637
NCT03247127|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-08|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Memory Preservation of Hippocampal Avoidance Whole Brain Radiotherapy|The Memory Preservation Study of Whole Brain Radiotherapy With Hippocampal Avoidance for Patients With Brain Metastases|Recruiting||N/A|30|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||t|f|f||||||||2017-10-10 20:48:11.638558|2017-10-10 20:48:11.638558
NCT03247114|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||February 22, 2015|Actual|2015-02-22|August 2017|2017-08-01|May 22, 2015|Actual|2015-05-22|May 22, 2015|Actual|2015-05-22||Interventional|||fMRI of Hypothalamic Responses to Glucose, Fructose, Sucrose and Sucralose|Functional Magnetic Resonance Imaging of Human Hypothalamic Responses to Glucose, Fructose, Sucrose and Sucralose|Completed||N/A|16|Actual|Unilever R&D||10|||f||||f|f|f||||||||2017-10-10 20:48:11.72566|2017-10-10 20:48:11.72566
NCT03247101|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||February 2016||2016-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Probiotics for Gallstones in Post-bariatric Surgery Patients：A Prospective Randomized Trial|Probiotics for Gallstones in Post-bariatric Surgery Patients：A Prospective|Active, not recruiting||N/A|180|Anticipated|Min-Sheng General Hospital||3|||f||||t||||||||||2017-10-10 20:48:11.840521|2017-10-10 20:48:11.840521
NCT03247088|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||July 30, 2017|Actual|2017-07-30|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Study Of Sorafenib Added To Busulfan And Fludarabine Conditioning Regimen In Patients With Relapsed/Refractory AML Undergoing Stem Cell Transplantation|Phase I/II Study Of Sorafenib Added To Busulfan And Fludarabine Conditioning Regimen In Patients With Relapsed/Refractory AML Undergoing Stem Cell Transplantation|Recruiting||Phase 1/Phase 2|74|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f|||f|||||2017-10-10 20:48:11.918928|2017-10-10 20:48:11.918928
NCT03247075|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-10-02|||September 19, 2017|Actual|2017-09-19|October 2017|2017-10-01|September 30, 2019|Anticipated|2019-09-30|December 30, 2018|Anticipated|2018-12-30||Interventional|SOFT RCT||Internet-delivered CBT vs Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - An RCT|Internet-delivered Cognitive Behavior Therapy Versus Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - A Randomized Controlled Trial|Recruiting||N/A|101|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 20:48:12.033428|2017-10-10 20:48:12.033428
NCT03247062|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-08-10|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Sleep Bundle for Improving Sleep in ICU Patients|"Improving the Quality of Sleep in ICU Patients With a Sleep Bundle"|Not yet recruiting||N/A|130|Anticipated|University Hospital, Geneva||1|||f||||f|f|f||||||||2017-10-10 20:48:12.125886|2017-10-10 20:48:12.125886
NCT03247049|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-12|||July 27, 2015|Actual|2015-07-27|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|December 31, 2016|Actual|2016-12-31|10 Years|Observational [Patient Registry]|ICHCat||Prognosis in Intracerebral Hemorrhage. The ICHCat Score in Primary Care.|Predicting Long Term Survival in Patients With Primary Intracerebral Hemorrhage. Development and Validation of the ICHCat in Primary Care.|Completed||N/A|262|Actual|Jordi Gol i Gurina Foundation|||1||f||||t|f|f||||||||2017-10-10 20:48:12.187204|2017-10-10 20:48:12.187204
NCT03247036|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-12|||January 13, 2017|Actual|2017-01-13|August 2017|2017-08-01|August 5, 2017|Actual|2017-08-05|July 30, 2017|Actual|2017-07-30|5 Years|Observational [Patient Registry]|EBRICTUS||Long-Term Survival After Ischaemic Stroke: Ebrictus Study|Long Survival After Ischemic Stroke and Thombolysis in Catalonia. Differences by Sex|Completed||N/A|21000|Actual|Jordi Gol i Gurina Foundation|||1||f||||t|f|f||||||||2017-10-10 20:48:12.242034|2017-10-10 20:48:12.242034
NCT03247023|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2029|Anticipated|2029-09-01|September 2021|Anticipated|2021-09-01||Observational|||Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement|Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement|Not yet recruiting||N/A|60|Anticipated|Integra LifeSciences Corporation|||1||f||||f|f|f||||||||2017-10-10 20:48:12.310879|2017-10-10 20:48:12.310879
NCT03247010|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01||Observational|||Bone Marrow Suppression and Recovery During Radionuclide Treatment|Characterization of Bone Marrow Suppression and Recovery During Radionuclide Treatment Using Functional Tests of Thrombocytes and Hemostasis|Recruiting||N/A|100|Anticipated|Rigshospitalet, Denmark|||1||f||||t|f|f||||||||2017-10-10 20:48:12.406806|2017-10-10 20:48:12.406806
NCT03246997|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|June 21, 2018|Anticipated|2018-06-21|June 21, 2018|Anticipated|2018-06-21||Interventional|||Project Powerfood: Promoting Food Security, Equity, and Health|Project Powerfood: Promoting Food Security, Equity, and Health|Recruiting||N/A|100|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|f||||||||2017-10-10 20:48:12.4649|2017-10-10 20:48:12.4649
NCT03246984|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|February 2019|Anticipated|2019-02-01||Interventional|VALUE||VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ|A Post Market Surveillance Multi-center Prospective Study to Evaluate the Safety and Efficacy of the VasQ External Support for Arteriovenous Fistula|Not yet recruiting||N/A|50|Anticipated|Laminate Medical Technologies||1|||f||||f|f|f||||||||2017-10-10 20:48:12.541868|2017-10-10 20:48:12.541868
NCT03246971|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-08|||August 24, 2017|Actual|2017-08-24|September 2017|2017-09-01|March 28, 2018|Anticipated|2018-03-28|March 28, 2018|Anticipated|2018-03-28||Interventional|||Study of Wafermine™ for Post-bunionectomy Pain|A Phase 2, Multiple-Dose Study of The Efficacy and Safety of Wafermine™ (Sublingual Ketamine) in Participants Experiencing Acute Post-Operative Bunionectomy Pain|Recruiting||Phase 2|135|Anticipated|iX Biopharma Ltd.||2|||f|||||t|f||||||||2017-10-10 20:48:12.623717|2017-10-10 20:48:12.623717
NCT03246945|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-29|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PQRS||"Photograph Quality Rating Scale Study (PQRS Study)"|Assessing Parental Photographs of Skin Disease and the Concordance of a Virtual Diagnosis: Can 3 Simple Instructions Improve Photograph Quality?|Completed||N/A|40|Actual|Children's Hospital of Philadelphia||2|||f||||f|f|f||||||||2017-10-10 20:48:12.770857|2017-10-10 20:48:12.770857
NCT03246932|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Peer-led Psycho-education for Schizophrenia|The Effectiveness of a Peer-led Psycho-education Group in Schizophrenia: A Multi-site Randomised Controlled Trial|Active, not recruiting||N/A|342|Anticipated|The Hong Kong Polytechnic University||3|||f|||||f|f||||||||2017-10-10 20:48:12.833136|2017-10-10 20:48:12.833136
NCT03246919|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-10|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|I-TOPICS||Ideal Time of Oxytocin Infusion During Cesarean Section|Ideal Time of Oxytocin Infusion During Cesarean Section|Not yet recruiting||Phase 4|180|Anticipated|Loyola University||2|||f||||f|t|f|||f|||||2017-10-10 20:48:12.912115|2017-10-10 20:48:12.912115
NCT03246906|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-21|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|August 15, 2022|Anticipated|2022-08-15|August 15, 2022|Anticipated|2022-08-15||Interventional|||Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation|A Randomized Phase II Study to Compare the Net Clinical Benefit of Cyclosporine and Sirolimus Combined With MMF or Post-transplant Cyclophosphamide as GVHD Prophylaxis After HLA-Matched or HLA-Mismatched Unrelated G-CSF Mobilized Blood Cell Transplantation Using Nonmyeloablative or Reduced Intensity Conditioning for Patients With Hematologic Malignancies: A Multi-center Trial|Not yet recruiting||Phase 2|160|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t|t|f||||||||2017-10-10 20:48:13.000483|2017-10-10 20:48:13.000483
NCT03246893|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-08|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|April 30, 2020|Anticipated|2020-04-30||Interventional|||Efficacy of HFNC Versus NIV for Prevent Reintubation in Sepsis Patients|Efficacy of High Flow Oxygen Nasal Cannula Versus Noninvasive Positive Pressure Ventilation After Extubation in Sepsis Patients|Recruiting||N/A|210|Anticipated|Mahidol University||2|||f||||f|f|f||||||||2017-10-10 20:48:14.611194|2017-10-10 20:48:14.611194
NCT03246880|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-08|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients||Completed||Phase 3|455|Actual|Chong Kun Dang Pharmaceutical||3|||f||||||||||||||2017-10-10 20:48:14.716048|2017-10-10 20:48:14.716048
NCT03246867|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-26|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|March 15, 2018|Anticipated|2018-03-15|February 15, 2018|Anticipated|2018-02-15||Interventional|||The Acute Effects of Different Stretching Methods in Individuals With Subacromial Impingement Syndrome|The Acute Effects of Different Stretching Methods on Posterior Shoulder Tightness, Pain, Joint Range of Motion, Subacromial Space and Strength in Individuals Having Subacromial Impingement Syndrome With Glenohumeral Internal Rotation Deficit|Recruiting||N/A|69|Anticipated|Dokuz Eylul University||3|||f||||t|f|f||||||||2017-10-10 20:48:14.797908|2017-10-10 20:48:14.797908
NCT03246854|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-08|||July 18, 2017|Actual|2017-07-18|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer|Phase I, Open-Label, Multiple Dose, Dose-Finding and Expansion Clinical Study to Assess the Safety, Pharmacokinetics, and Efficacy of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer|Recruiting||Phase 1|24|Anticipated|National Health Research Institutes, Taiwan||1|||f|||||t|f||||||||2017-10-10 20:48:14.888159|2017-10-10 20:48:14.888159
NCT03246841|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-25|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|December 31, 2023|Anticipated|2023-12-31|September 30, 2023|Anticipated|2023-09-30||Interventional|TUMOSPEC||Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.|Investigation of Tumour Spectrum, Penetrance and Clinical Utility of Germline Mutations in New Breast and Ovarian Cancer Susceptibility Genes.|Recruiting||N/A|500|Anticipated|UNICANCER||1|||f||||t|f|f||||||||2017-10-10 20:48:14.971533|2017-10-10 20:48:14.971533
NCT03246815|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-08|||June 12, 2017|Actual|2017-06-12|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|STOP||STD Testing in Outpatient Practices|STD Testing in Outpatient Practices-The STOP STDs Study|Recruiting||N/A|4000|Anticipated|University of Pittsburgh|||2||f||||f|f|f||||||||2017-10-10 20:48:15.139744|2017-10-10 20:48:15.139744
NCT03246802|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|SalvageHDR||Partial Prostate Salvage High Dose Rate Brachytherapy|High Dose Rate Partial Prostate Brachytherapy as Salvage Treatment for Local Failures After Previous External Beam Radiotherapy|Not yet recruiting||N/A|15|Anticipated|British Columbia Cancer Agency||1|||f||||t|f|f||||||||2017-10-10 20:48:15.207708|2017-10-10 20:48:15.207708
NCT03246763|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ARCHES||Active Recreation Through Community-Healthcare Engagement Study|Active Recreation Through Community-Healthcare Engagement Study|Not yet recruiting||N/A|400|Anticipated|Duke University||4|||f||||f|f|f||||||||2017-10-10 20:48:15.605601|2017-10-10 20:48:15.605601
NCT03246750|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-08|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|June 2021|Anticipated|2021-06-01||Interventional|||B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma|Phase I/II Study of Brentuximab Vedotin and Methotrexate/ L-asparaginase/ Dexamethasone (B-MAD) Chemotherapy in Patients With Newly-diagnosed Extranodal NK/ T-cell Lymphoma|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|The Thai Lymphoma Study Group||1|||f|||||f|f||||||||2017-10-10 20:48:15.71876|2017-10-10 20:48:15.71876
NCT03246737|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-08|||January 2015||2015-01-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|Premom||Premom: Pregnancy Remote Monitoring|Premom: Pregnancy Remote Monitoring|Completed||N/A|60|Actual|Hasselt University|||1||f||||f||||||||||2017-10-10 20:48:15.80783|2017-10-10 20:48:15.80783
NCT03246724|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Oral Versus Intravenous Sedation for Ocular Procedures|A Randomized, Double-blind, Clinical Trial to Compare Oral Sedation to Intravenous Sedation for Ocular Procedures|Not yet recruiting||Phase 4|360|Anticipated|Boston Medical Center||4|||f||||t|t|f|||t|||||2017-10-10 20:48:15.879108|2017-10-10 20:48:15.879108
NCT03246711|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-08-09|||June 18, 2015|Actual|2015-06-18|August 2017|2017-08-01|July 1, 2016|Actual|2016-07-01|July 17, 2015|Actual|2015-07-17|3 Months|Observational [Patient Registry]|||Can Fasting Ramadan in the Third Trimester in Pregnancy Affects the Fetal Growth.|The Effect of 3rd Trimester Ramdan Fasting on Obestetric Outcome|Completed||N/A|159|Actual|Ain Shams Maternity Hospital|||3||f||||f|f|f||||||||2017-10-10 20:48:16.006869|2017-10-10 20:48:16.006869
NCT03246698|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-26|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|September 20, 2018|Anticipated|2018-09-20|August 20, 2018|Anticipated|2018-08-20||Interventional|||The Effect of Isolytic and Static Stretching Training in Individuals With Subacromial Impingement Syndrome|The Effect of Isolytic and Static Stretching Training in Individuals Having Subacromial Impingement Syndrome With Glenohumeral Internal Rotation Deficit|Recruiting||N/A|69|Anticipated|Dokuz Eylul University||3|||f||||t|f|f||||||||2017-10-10 20:48:16.077975|2017-10-10 20:48:16.077975
NCT03246685|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD|A Multicenter, Open-label, Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv Squamous Cell Carcinoma of H&N (SCCHN) Who Failed Pembro Monotherapy or Experiencing SD Following Completion of 4 to 8 Cycles of Pembro Monotherapy|Not yet recruiting||Phase 2|87|Anticipated|Biothera||2|||f||||f|t|f||||||||2017-10-10 20:48:16.176982|2017-10-10 20:48:16.176982
NCT03246672|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|June 1, 2018|Anticipated|2018-06-01||Interventional|MAINTAIN-B||Development of a Weight Maintenance Intervention for Bariatric Surgery Patients|Development of a Weight Maintenance Intervention for Bariatric Surgery Patients|Not yet recruiting||N/A|30|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 20:48:16.261639|2017-10-10 20:48:16.261639
NCT03246659|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-12|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|GRAN-T-MTC||Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC|Phase I Clinical Trial Using a Novel CCK-2/Gastrin Receptor-localizing Radiolabelled Peptide Probe for Personalized Diagnosis and Therapy of Patients With Progressive or Metastatic Medullary Thyroid Carcinoma|Recruiting||Phase 1|25|Anticipated|Azienda Ospedaliero, Universitaria Pisana||2|||f||||t|f|f||||||||2017-10-10 20:48:16.351881|2017-10-10 20:48:16.351881
NCT03246646|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|Coaching CRAFT||Telephone Coaching of Family Members of Veterans With Substance Abuse Problems|Telephone Coaching of Family Members of Veterans With Substance Abuse Problems|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 20:48:16.479294|2017-10-10 20:48:16.479294
NCT03246633|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-21|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|||Perceptual Expertise Training for Triage of Moles|Perceptual Training to Improve Early Detection of Melanoma by Future Healthcare Providers: to Accuarate Triage of Benign vs. Malignant Pigmented Skin Lesions|Recruiting||N/A|350|Anticipated|Northwestern University||1|||f|||||f|f||||||||2017-10-10 20:48:16.561374|2017-10-10 20:48:16.561374
NCT03246620|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-11|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||Oral Olanzapine Versus Haloperidol or Diazepam|Oro-dispersible Olanzapine (Wafer) Versus Conventional Oral Haloperidol or Diazepam Tablets for the Management of Acute Agitation in the Accident and Emergency Department - a Multicentre Randomised Clinical Trial|Not yet recruiting||Phase 4|282|Anticipated|The University of Hong Kong||3|||f||||t|f|f|||f|||||2017-10-10 20:48:16.643678|2017-10-10 20:48:16.643678
NCT03246607|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||December 13, 2017|Anticipated|2017-12-13|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|April 2, 2018|Anticipated|2018-04-02||Observational|||Venous and Cerebral Glucose Microdialysis in Neurocritical Care: Validation & Correlation|Investigation of Venous and Cerebral Extracellular Glucose Concentration Relationship Using Continuous Microdialysis, in Acquired Brain Injury in Neurocritical Care, With External Validation of Venous Microdialysis System|Not yet recruiting||N/A|20|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 20:48:16.738021|2017-10-10 20:48:16.738021
NCT03246594|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|OPERA||Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation|Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation|Recruiting||N/A|200|Anticipated|Heartcenter Leipzig GmbH||2|||f||||f|f|f||||||||2017-10-10 20:48:16.826991|2017-10-10 20:48:16.826991
NCT03246581|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-09|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers|Protocol With Amendments 1 and 2: Phase I Randomised, Two-period 21 Day Crossover Study in Healthy Male and Female Volunteers to Compare the Steadystate Pharmacokinetics of Tiotropium Delivered From a Test pMDI Product With Spiriva Respimat|Recruiting||Phase 1|40|Anticipated|3M||2|||f||||f|f|f||||||||2017-10-10 20:48:16.936662|2017-10-10 20:48:16.936662
NCT03246568|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-11|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|||Renal Nerve Denervation After Pulmonary Vein Isolation for Persistent Atrial Fibrillation|Renal Artery Sympathetic Denervation by Catheter Ablation After Pulmonary Vein Isolation for Persistent Atrial Fibrillation|Not yet recruiting||N/A|40|Anticipated|Chinese University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:48:17.039595|2017-10-10 20:48:17.039595
NCT03246555|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-07|||August 7, 2017|Actual|2017-08-07|July 2017|2017-07-01|November 30, 2019|Anticipated|2019-11-30|February 28, 2018|Anticipated|2018-02-28||Interventional|FITNESS||Fimasartan in the Senior Subjects|A Randomized, Double-blind, Active-controlled, 2-parallel Group, Optional Titration, Multicenter, Phase 3b Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without Diuretics Combination in Elderly Patients With Essential Hypertension|Recruiting||Phase 3|238|Anticipated|Boryung Pharmaceutical Co., Ltd||2|||f||||f|f|f||||||||2017-10-10 20:48:17.122065|2017-10-10 20:48:17.122065
NCT03246542|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-09|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|June 1, 2016|Actual|2016-06-01|December 1, 2015|Actual|2015-12-01|2 Days|Observational [Patient Registry]|||Promising Bimarker Prediction of Outcome of HELLP Syndrome.|Association Between the Quantitative Assessment of Schistocytes in Peripheral Blood Smear and Prognosis of Patient Initially Diagnosed as HELLP Syndrome.|Completed||N/A|100|Actual|Ain Shams Maternity Hospital|||1||f||||f|f|f||||||||2017-10-10 20:48:17.206779|2017-10-10 20:48:17.206779
NCT03246529|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-16|||November 22, 2017|Anticipated|2017-11-22|August 2017|2017-08-01|September 22, 2019|Anticipated|2019-09-22|April 22, 2019|Anticipated|2019-04-22||Interventional|GENESIS||A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM|A Phase III, Randomized, Placebo-Controlled, Multi-Centre Study Evaluating the Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With Multiple Myeloma - The GENESIS Study|Not yet recruiting||Phase 3|207|Anticipated|BioLineRx, Ltd.||2|||f||||t|t|f||||||||2017-10-10 20:48:17.375226|2017-10-10 20:48:17.375226
NCT03246516|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||December 2016||2016-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|DELOGAST||Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers|Individual and Socio-economic Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers|Recruiting||N/A|300|Anticipated|University Hospital, Lille||1|||f||||f|f|f||||||||2017-10-10 20:48:17.469716|2017-10-10 20:48:17.469716
NCT03246503|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||August 15, 2017||2017-08-15||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:48:17.586241|2017-10-10 20:48:17.586241
NCT03246477|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-07|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|MIMOSA||Long-term Impact of Maxillomandibular Advancement Osteotomy on Sleep Apnea Patients|Evaluation of the Long-term Impact of Maxillomandibular Advancement Osteotomy on Patients With Obstructive Sleep Apnea Syndrome|Active, not recruiting||N/A|12|Anticipated|AZ Sint-Jan AV|||1||f||||f|f|f||||||||2017-10-10 20:48:17.696398|2017-10-10 20:48:17.696398
NCT03246464|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-29|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Clinical Study Of Nearsightedness; TReatment With Orthokeratology Lenses|Orthokeratology Contact Lenses for the Treatment of Myopia in a Group of Danish Children|Recruiting||N/A|50|Anticipated|Vejle Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:48:17.767845|2017-10-10 20:48:17.767845
NCT03246451|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-10|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|December 10, 2017|Anticipated|2017-12-10|December 10, 2017|Anticipated|2017-12-10||Interventional|||The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D|The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin During Meal Ingestion in Patients With T2D|Recruiting||N/A|15|Anticipated|University Hospital, Gentofte, Copenhagen||4|||f||||t|f|f||||||||2017-10-10 20:48:17.864319|2017-10-10 20:48:17.864319
NCT03246438|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-27|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Choice Architecture and Colorectal Cancer Screening Outreach|Choice Architecture and Mailed Outreach for Colorectal Cancer Screening|Active, not recruiting||N/A|423|Anticipated|University of Pennsylvania||3|||f||||f|f|f||||||||2017-10-10 20:48:17.964336|2017-10-10 20:48:17.964336
NCT03246425|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-07|||September 12, 2016|Actual|2016-09-12|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|September 11, 2017|Anticipated|2017-09-11||Interventional|||Influence of Mechanical Ventilation Mode on Arterial Pressure Variations- a Pilot Study|Influence of Mechanical Ventilation Mode on Arterial Pressure Variations- a Pilot Study|Recruiting||N/A|60|Anticipated|State University of New York - Upstate Medical University||3|||f||||f|f|t|f|f|f|||||2017-10-10 20:48:18.045346|2017-10-10 20:48:18.045346
NCT03246412|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-11|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||Nevus Doctor Clinical Decision Support for GPs|Nevus or Melanoma? Nevus Doctor - Computer Aided Clinical Decision Support in Primary Health Care|Not yet recruiting||N/A|390|Anticipated|University Hospital of North Norway||2|||f||||f|f|f||||||||2017-10-10 20:48:18.129954|2017-10-10 20:48:18.129954
NCT03246399|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease|A Phase 1, Open-label Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease|Recruiting||Phase 1|18|Anticipated|Samumed LLC||3|||f||||f|t|f||||||||2017-10-10 20:48:18.202901|2017-10-10 20:48:18.202901
NCT03246386|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DONUT||Dosing Obese With Noxafil® Under a Trial (DONUT)|Pharmacokinetics of Posaconazole Given as a Single Intravenous Dose to Obese Subjects: Dosing Obese With Noxafil® Under a Trial (DONUT)|Not yet recruiting||Phase 4|24|Anticipated|Radboud University||2|||f|||||f|f|||f|||||2017-10-10 20:48:18.297383|2017-10-10 20:48:18.297383
NCT03246373|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|December 30, 2019|Anticipated|2019-12-30|1 Year|Observational [Patient Registry]|||the Effects of Cerebral Collateral Circulation on the Outcome of Leukoaraiosis in High-risk Population|Prospective, Single Center, Observational, Clinical Trial of the Effects of Cerebral Collateral Circulation on the Outcome of Leukoaraiosis in High-risk Population|Not yet recruiting||N/A|1037|Anticipated|Shanghai Zhongshan Hospital|||1||f||||f|f|f||||Samples With DNA|"     blood sample fingernail sample hair sample   "|||2017-10-10 20:48:18.375233|2017-10-10 20:48:18.375233
NCT03246360|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-08|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|CLOXA Continue||Pharmacological Comparison of Continuous and Intermittent Infusions of Cloxacillin|Pharmacological Comparison of Continuous and Intermittent Infusions of Cloxacillin During Bone and Joint Infections: a Prospective, Randomized, Open-label, Monocentric Crossover Study.|Not yet recruiting||N/A|12|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||||2017-10-10 20:48:18.435579|2017-10-10 20:48:18.435579
NCT03246347|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-21|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer|A Phase II Trial of Androgen Deprivation, Docetaxel and Enzalutamide in Patients With Metastatic Hormone Sensitive Prostate Cancer|Recruiting||Phase 2|39|Anticipated|Carolinas Healthcare System||1|||f||||t|t|f|||f|||||2017-10-10 20:48:18.505658|2017-10-10 20:48:18.505658
NCT03246334|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-11|||July 1, 2016|Actual|2016-07-01|April 2017|2017-04-01|August 2026|Anticipated|2026-08-01|August 2026|Anticipated|2026-08-01||Observational|MONITOR-IC||MONITOR-IC: Determining Long-term Consequences of ICU Care|MONITOR-IC: a Mixed Methods Multicenter Prospective Controlled Cohort Study Determining the Five-year Outcomes of ICU Survivors|Recruiting||N/A|12000|Anticipated|Radboud University|||1||f||||f|f|f||||||||2017-10-10 20:48:18.597454|2017-10-10 20:48:18.597454
NCT03246321|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|CRC-PIPAC||PIPAC for Peritoneal Metastases of Colorectal Cancer|Safety, Feasibility, Tolerability, and Preliminary Oncological Efficacy of Upfront Repeated Laparoscopic PIPAC With Oxaliplatin and Simultaneous Intravenous Bolus 5-fluorouracil/Leucovorin for Isolated Unresectable Colorectal Peritoneal Metastases: a Single Center, Single Arm Phase I/II Study|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Catharina Ziekenhuis Eindhoven||1|||f||||t|f|f|||f|||||2017-10-10 20:48:18.684956|2017-10-10 20:48:18.684956
NCT03246308|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-11|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|July 7, 2020|Anticipated|2020-07-07|July 7, 2020|Anticipated|2020-07-07||Observational|||Investigation of Vitamin Levels During Phototherapy|Investigation of Vitamin Levels During Phototherapy|Recruiting||N/A|100|Anticipated|Medical University of Vienna|||1||f||||f|f|f||||||||2017-10-10 20:48:18.827061|2017-10-10 20:48:18.827061
NCT03246295|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-07|||October 20, 2015|Actual|2015-10-20|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Anticipated|2017-09-01||Observational|||Identification of Gestational Diabetes Mellitus Related Urinary Biomarkers Along Pregnancy (From Early Pregnancy to Postpartum) by Using Proteomics and Metabolomics Analysis|Identification of Gestational Diabetes Mellitus Related Urinary Biomarkers Along Pregnancy (From Early Pregnancy to Postpartum) by Using Proteomics and Metabolomics Analysis|Active, not recruiting||N/A|140|Actual|Peking Union Medical College Hospital|||2||f||||t|f|f||||Samples Without DNA|"     Urinary samples   "|||2017-10-10 20:48:18.902013|2017-10-10 20:48:18.902013
NCT03246282|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-09|||February 8, 2017|Actual|2017-02-08|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Feasibility of Polychromatic Light Emitting Diode System to Reduce Pain|A Polychromatic Light Emitting Diode System to Deliver Low Dose Light Directly Into a Peripheral Intravascular Catheter: A Pain Reduction Study|Recruiting||Early Phase 1|150|Anticipated|White Clover Research Foundation||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:48:18.974631|2017-10-10 20:48:18.974631
NCT03246269|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|MoCA-Norm||Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)|Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)|Completed||N/A|334|Actual|University Hospital, Basel, Switzerland|||1||f||||f|f|f||||||||2017-10-10 20:48:19.100718|2017-10-10 20:48:19.100718
NCT03246256|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-10|||December 21, 2016|Actual|2016-12-21|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Information Recall on Informed Consent to Intravenous Thrombolysis in Patients With Acute Ischaemic Stroke.|Recall of Information on Intravenous Thrombolysis in Acute Ischaemic Stroke Patients Given During Informed Consent: a Prospective Observational Study.|Recruiting||N/A|260|Anticipated|Charite University, Berlin, Germany|||5||f||||f|f|f||||||||2017-10-10 20:48:19.163039|2017-10-10 20:48:19.163039
NCT03246243|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-08|||March 29, 2017|Actual|2017-03-29|August 2017|2017-08-01|June 18, 2019|Anticipated|2019-06-18|December 18, 2018|Anticipated|2018-12-18||Observational|||Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk|Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk|Recruiting||N/A|60|Anticipated|Boston Children’s Hospital|||3||f||||f|f|f|||f|||||2017-10-10 20:48:19.250649|2017-10-10 20:48:19.250649
NCT03246230|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|August 20, 2021|Anticipated|2021-08-20|August 20, 2019|Anticipated|2019-08-20||Interventional|EPIC-HIPC||Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity|Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity|Not yet recruiting||N/A|720|Anticipated|Boston Children’s Hospital||4|||f||||f|f|f||||||||2017-10-10 20:48:19.334687|2017-10-10 20:48:19.334687
NCT03246217|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-15|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|||Therapeutic Instrumental Music Performance With Sensory-Enhanced Motor Imagery in Chronic Post-Stroke Rehabilitation|Efficacy of Therapeutic Instrumental Music Performance With Sensory-Enhanced Motor Imagery in Improving Therapeutic Outcomes for Individuals With Chronic Post-Stroke Hemiparesis|Recruiting||N/A|30|Anticipated|University of Toronto||3|||f||||f|f|f||||||||2017-10-10 20:48:19.414405|2017-10-10 20:48:19.414405
NCT03246204|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-08|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Observational|||Chinese Observational Prospective Study of Aging Population With Chronic Kidney Disease(C-OPTION)|Chinese Observational Prospective Study of Aging Population With Chronic Kidney Disease(C-OPTION)|Not yet recruiting||N/A|3000|Anticipated|Chinese PLA General Hospital|||1||f||||f||||||Samples With DNA|"     serum, whole blood，urine   "|||2017-10-10 20:48:19.503203|2017-10-10 20:48:19.503203
NCT03246191|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-08|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease|Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease：a Cross - Sectional Study|Not yet recruiting||N/A|900|Anticipated|Chinese PLA General Hospital|||1||f||||f|f|f||||Samples With DNA|"     serum, whole blood，urine   "|||2017-10-10 20:48:19.565892|2017-10-10 20:48:19.565892
NCT03246178|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-08|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Haploidentical Transplantation in Severe Aplastic Anemia|A Research on Haploidentical Transplantation in Severe Aplastic Anemia Using Reduced-intensity Fludarabine-based Conditioning|Enrolling by invitation||N/A|60|Anticipated|Chinese PLA General Hospital||2|||f|||||f|f||||||||2017-10-10 20:48:19.62441|2017-10-10 20:48:19.62441
NCT03246165|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||September 1, 2011|Actual|2011-09-01|August 2017|2017-08-01|June 30, 2015|Actual|2015-06-30|December 30, 2013|Actual|2013-12-30||Observational|||Predictive Factors and Complications of Delirium|Incidence, Predictive Factors and Complications of Delirium in Postoperative Cardiac Surgery Elderly Patients|Completed||N/A|173|Actual|University of Sao Paulo|||1||f||||f|f|f||||||||2017-10-10 20:48:19.69998|2017-10-10 20:48:19.69998
NCT03246152|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA|Evaluation of the Effect of Repeated Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using Optical Coherence Tomography Angiography|Not yet recruiting||Phase 4|25|Anticipated|Cairo University||1|||f||||f|t|f|||t|||||2017-10-10 20:48:19.856477|2017-10-10 20:48:19.856477
NCT03246139|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-08|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Action Observation, Imagery and Execution for Stroke Rehabilitation|Action Observation, Imagery and Execution as a New Intervention Strategy for Stroke Rehabilitation: Short- and Long-term Treatment Effects and Neural Mechanism|Recruiting||N/A|96|Anticipated|Chang Gung Memorial Hospital||3|||f||||f|f|f||||||||2017-10-10 20:48:19.97053|2017-10-10 20:48:19.97053
NCT03246113|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-07|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma|Investigation of Cannabis For Tolerability and Feasibility in Patients Receiving Concurrent Chemoradiation for Glioblastoma.|Not yet recruiting||Phase 1|15|Anticipated|New York State Psychiatric Institute||1|||f||||f|t|f||||||||2017-10-10 20:48:20.22694|2017-10-10 20:48:20.22694
NCT03246100|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||October 2, 2017|Anticipated|2017-10-02|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado|Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates, 2nd Trial in Colorado|Not yet recruiting||N/A|30000|Anticipated|University of Colorado, Denver||3|||f||||f|f|f||||||||2017-10-10 20:48:20.33137|2017-10-10 20:48:20.33137
NCT03246087|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-10|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Acupuncture for Plantar Fasciosis in the Primary Care Setting|Acupuncture for Plantar Fasciosis in the Primary Care Setting|Not yet recruiting||N/A|100|Anticipated|Mike O'Callaghan Federal Hospital||3|||f||||f|f|t|f|f||||||2017-10-10 20:48:20.419704|2017-10-10 20:48:20.419704
NCT03246074|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-09|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer|Phase I Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer|Not yet recruiting||Phase 1|18|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:48:20.529767|2017-10-10 20:48:20.529767
NCT03246061|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|December 2018|Anticipated|2018-12-01||Interventional|CLBP||Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP|A Prospective, Randomized, Multi-center Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain (CLBP)|Not yet recruiting||N/A|150|Anticipated|Relievant Medsystems, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:48:20.613284|2017-10-10 20:48:20.613284
NCT03246048|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-16|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|January 2021|Anticipated|2021-01-01||Observational|||Long Term Follow-up of Hepatitis C Cured Patients|Predicting Outcomes in Hepatitis C Patients With Compensated Advanced Chronic Liver Disease Cured With New Antivirals|Active, not recruiting||N/A|300|Actual|Hospital Universitari Vall d'Hebron Research Institute|||1||f|||||f|f||||||||2017-10-10 20:48:20.690986|2017-10-10 20:48:20.690986
NCT03246035|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-09|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|HFF-ED||Reducing Readmission for Frail Elderly Patients With Decompensated Heart Failure|A Prospective Randomized Pilot Trial to Reduce Readmission for Frail Elderly Patients With Acute Decompensated Heart Failure|Not yet recruiting||N/A|60|Anticipated|Jewish General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:48:20.765994|2017-10-10 20:48:20.765994
NCT03246022|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-09|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Characteristics of Obstructive Sleep Apnea Syndrome Related Hypertension and the Effect of Continuous Positive Airway Pressure Treatment on Blood Pressure|Huai'an First People's Hospital|Recruiting||N/A|150|Anticipated|Huai'an No.1 People's Hospital||1|||f||||t|f|f||||||||2017-10-10 20:48:20.889385|2017-10-10 20:48:20.889385
NCT03246009|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-09|||January 21, 2016|Actual|2016-01-21|August 2017|2017-08-01|April 10, 2017|Actual|2017-04-10|April 10, 2017|Actual|2017-04-10||Interventional|||Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients|Efficacy and Safety Phase Ib Study of Recombinant Human Serum Albumin/ Granulocyte Colony-Stimulating Factor Fusion Protein for Injection to Prevent Neutrophilic Granulocytopenia Among Chemotherapy Patients|Completed||Phase 1|24|Actual|Tianjin SinoBiotech Ltd.||6|||f||||f|f|f||||||||2017-10-10 20:48:20.991419|2017-10-10 20:48:20.991419
NCT03245996|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-09|||June 2015||2015-06-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker|The Impact of Heart Rate on Central Hemodynamics in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker|Completed||N/A|27|Actual|Tartu University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:48:21.13817|2017-10-10 20:48:21.13817
NCT03245983|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||February 6, 2017|Actual|2017-02-06|August 2017|2017-08-01|October 6, 2019|Anticipated|2019-10-06|February 6, 2019|Anticipated|2019-02-06||Interventional|SPIQOL||Spirituality, Experience of Disease and Quality of Life in Cancer Patients|Spirituality, Experience of Disease and Quality of Life in Cancer Patients|Recruiting||N/A|300|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f|f|f||||||||2017-10-10 20:48:21.222692|2017-10-10 20:48:21.222692
NCT03245970|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||April 24, 2017|Actual|2017-04-24|August 2017|2017-08-01|April 24, 2019|Anticipated|2019-04-24|April 24, 2018|Anticipated|2018-04-24||Interventional|||Impedance Cardiography to Decrease the Risk of Preeclampsia|Use of Impedance Cardiography to Decrease the Risk of Preeclampsia|Recruiting||Early Phase 1|400|Anticipated|High Risk Obstetrical Consultants||2|||f||||t|t|f|||t|||||2017-10-10 20:48:21.309628|2017-10-10 20:48:21.309628
NCT03245957|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-10|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Observational|RUSH||HDL Dysfunction During the Acute Stage of Stroke|HDL Dysfunction During the Acute Stage of Stroke|Not yet recruiting||N/A|112|Anticipated|Centre Hospitalier Universitaire de la Réunion|||3||f||||f|f|f||||||||2017-10-10 20:48:21.412171|2017-10-10 20:48:21.412171
NCT03245944|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-12|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 1, 2021|Anticipated|2021-02-01|February 1, 2021|Anticipated|2021-02-01||Interventional|||Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas|Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas|Not yet recruiting||N/A|112|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 20:48:21.490681|2017-10-10 20:48:21.490681
NCT03245931|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-07|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1|Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1|Recruiting||N/A|7|Anticipated|TriHealth Inc.|||1||f||||f|f|f||||||||2017-10-10 20:48:21.567453|2017-10-10 20:48:21.567453
NCT03245918|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||August 10, 2017|Anticipated|2017-08-10|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Healthy Adult Volunteers|Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Healthy Adult Volunteers|Not yet recruiting||Phase 1|17|Anticipated|The Hospital for Sick Children||2|||f||||f|f|f|||f|||||2017-10-10 20:48:21.639195|2017-10-10 20:48:21.639195
NCT03245905|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||August 20, 2017|Anticipated|2017-08-20|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL|Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)|Not yet recruiting||Phase 2|100|Anticipated|Sun Yat-sen University||1|||f||||f|f|f||||||||2017-10-10 20:48:21.707963|2017-10-10 20:48:21.707963
NCT03245892|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-09|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab in Patients With Ovarian Cancer|A Pilot Study of Nivolumab in Combination With Front-Line Neoadjuvant Dose Dense Paclitaxel and Carboplatin Chemotherapy and Post-Surgical Dose Dense Paclitaxel and Carboplatin Chemotherapy in Patients With High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 1|20|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:48:21.779697|2017-10-10 20:48:21.779697
NCT03245879|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||July 2013|Actual|2013-07-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SCORE||Antibiotic Stewardship in Small Hospitals|Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster-Randomized Trial Intervention|Completed||N/A|30000|Actual|Intermountain Health Care, Inc.||3|||f||||f|f|f||||||||2017-10-10 20:48:21.882048|2017-10-10 20:48:21.882048
NCT03245866|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2017-08-07|||January 1, 2009|Actual|2009-01-01|August 2017|2017-08-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2020|Anticipated|2020-12-31|5 Years|Observational [Patient Registry]|Swiss SOS||Swiss Study on Subarachnoid Hemorrhage|Swiss Study on Subarachnoid Hemorrhage (Swiss SOS)|Recruiting||N/A|5000|Anticipated|University Hospital, Geneva|||1||f||||t|f|f||||||||2017-10-10 20:48:21.974045|2017-10-10 20:48:21.974045
NCT03245853|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-09|2017-08-14|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 1, 2018|Anticipated|2018-09-01||Interventional|||Epi-On Corneal Crosslinking for Keratoconus|Epithelium-On Corneal Collagen Crosslinking for Keratoconus|Enrolling by invitation||Phase 4|20|Anticipated|Comprehensive EyeCare of Central Ohio||1|||f||||f|t|f|||t|||||2017-10-10 20:48:22.11693|2017-10-10 20:48:22.11693
NCT03245827|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Hypogonadotropic Hypogonadism in Obese Young Males|Hypogonadotropic Hypogonadism in Obese Young Males|Not yet recruiting||Phase 2|90|Anticipated|St. Louis University||4|||f||||t|t|f|||f|||||2017-10-10 20:48:22.293353|2017-10-10 20:48:22.293353
NCT03245814|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-25|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|May 2019|Anticipated|2019-05-01||Interventional|||Quantifying the Efficacy and Role of Service Dogs for Military Veterans With PTSD|Quantifying the Efficacy and Role of Service Dogs for Military Veterans With PTSD|Enrolling by invitation||N/A|100|Anticipated|Purdue University||2|||f||||t|f|f||||||||2017-10-10 20:48:22.379657|2017-10-10 20:48:22.379657
NCT03245801|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-09|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|February 1, 2026|Anticipated|2026-02-01|February 1, 2026|Anticipated|2026-02-01|10 Years|Observational [Patient Registry]|||CAPRI National Juvenile Idiopathic Arthritis Registry|The Canadian Alliance of Pediatric Rheumatology Investigators National Juvenile Idiopathic Arthritis Registry|Recruiting||N/A|300|Anticipated|University of British Columbia|||1||f||||f|f|f||||||||2017-10-10 20:48:22.488744|2017-10-10 20:48:22.488744
NCT03245788|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-09|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|August 15, 2018|Anticipated|2018-08-15||Interventional|||Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study|Pilot Project to Better Understand Non-Clinical Needs of Cancer Patients|Recruiting||N/A|1000|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 20:48:22.627221|2017-10-10 20:48:22.627221
NCT03245775|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|May 29, 2020|Anticipated|2020-05-29|November 30, 2019|Anticipated|2019-11-30||Interventional|||A Trial of Two Family-based Childhood Obesity Treatment Programs|A Randomized-controlled Trial to Compare the Reach, Effectiveness and Maintenance of Two Family-based Childhood Obesity Treatment Programs in a Medically Underserved Region|Recruiting||N/A|348|Anticipated|University of Virginia||2|||f||||t|f|f||||||||2017-10-10 20:48:22.710348|2017-10-10 20:48:22.710348
NCT03245762|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-01|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Intranasal Oxytocin for Infants With Prader-Willi Syndrome|Intranasal Oxytocin for Treatment of Infants and Children With Prader-Willi Syndrome in Nutritional Phase 1a - Phase 2 Study|Recruiting||Phase 1/Phase 2|15|Anticipated|University of Florida||2|||f||||t|t|f||||||||2017-10-10 20:48:22.7809|2017-10-10 20:48:22.7809
NCT03245749|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||June 2003|Actual|2003-06-01|August 2017|2017-08-01|March 2006|Actual|2006-03-01|September 2005|Actual|2005-09-01||Observational|||Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition|Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition|Completed||N/A|374|Actual|University of Southampton|||1||f||||f|f|f|||f|Samples With DNA|"     Blood and plasma samples   "|||2017-10-10 20:48:22.861745|2017-10-10 20:48:22.861745
NCT03245736|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||August 10, 2017|Anticipated|2017-08-10|August 2017|2017-08-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2022|Anticipated|2022-01-01||Interventional|||Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.|A Multi-center, Open-label Trial Investigating the Efficacy and Safety of Continued Treatment With Tisotumab Vedotin in Patients With Solid Tumors Known to Express Tissue Factor.|Recruiting||Phase 2|25|Anticipated|Genmab||1|||f|||||t|f||||||||2017-10-10 20:48:22.926344|2017-10-10 20:48:22.926344
NCT03245723|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-21|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|PET-MRI||Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI)|Cardiac Function and Metabolism in Young Adults Born Premature|Recruiting||N/A|40|Anticipated|University of Wisconsin, Madison|||2||f||||f|f|f||||Samples Without DNA|"     Blood   "|||2017-10-10 20:48:23.007395|2017-10-10 20:48:23.007395
NCT03245710|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-09|||August 2017|Anticipated|2017-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||To Investigate the Traditional Chinese Medicine Formula Powder Product in the Treatment of Osteopenia|To Investigate the Traditional Chinese Medicine Formula Powder Product in the Treatment of Osteopenia|Recruiting||Phase 2|80|Anticipated|Taipei Medical University WanFang Hospital||2|||f||||t|f|f||||||||2017-10-10 20:48:23.092918|2017-10-10 20:48:23.092918
NCT03245697|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||July 19, 2016|Actual|2016-07-19|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|December 1, 2016|Actual|2016-12-01||Observational|||Breast Milk Composition: Interindividual Variations and Dietary Factors in Galicia|Breast Milk Composition: Interindividual Variations and Dietary Factors in Galicia|Active, not recruiting||N/A|100|Anticipated|University of Santiago de Compostela|||1||f||||f|f|f||||||||2017-10-10 20:48:23.160597|2017-10-10 20:48:23.160597
NCT03245684|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-09|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|ASCOVENT||Assisted or Controlled Ventilation in Ards (Ascovent)|Assessment of the Inflammatory Response Associated With the Increase of Transpulmonary Pressure in Ipoxiemic Patients During Assisted Mechanical Ventilation|Not yet recruiting||N/A|40|Anticipated|University of Roma La Sapienza||2|||f||||f|f|f||||||||2017-10-10 20:48:23.313397|2017-10-10 20:48:23.313397
NCT03245671|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Particulate vs. Nonparticulate Epidural Steroid Injections for Lumbar Foraminal Stenosis|Particulate vs. Nonparticulate Epidural Steroid Injections for the Treatment of Symptomatic Unilateral Lumbar Foraminal Stenosis: a Prospective Double-blinded Randomized Study|Not yet recruiting||Phase 4|60|Anticipated|Hospital for Special Surgery, New York||2|||f|||||t|f||||||||2017-10-10 20:48:23.382419|2017-10-10 20:48:23.382419
NCT03245658|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-09|||October 6, 2017|Anticipated|2017-10-06|August 2017|2017-08-01|October 6, 2018|Anticipated|2018-10-06|May 6, 2018|Anticipated|2018-05-06||Interventional|||The Effect of Cannabis in Pancreatic Cancer|The Effect of Medical Cannabis Inpatients With Palliative Pancreatic Cancer|Not yet recruiting||Phase 2|32|Anticipated|University of Copenhagen||2|||f||||f|f|f||||||||2017-10-10 20:48:23.483035|2017-10-10 20:48:23.483035
NCT03245645|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-09|||March 24, 2017|Actual|2017-03-24|August 2017|2017-08-01|July 24, 2019|Anticipated|2019-07-24|July 24, 2018|Anticipated|2018-07-24||Interventional|||FODMAP Reintroduction in Irritable Bowel Syndrome|FODMAP Reintroduction in Irritable Bowel Syndrome|Enrolling by invitation||N/A|30|Anticipated|University of California, Los Angeles||3|||f||||f|f|f||||||||2017-10-10 20:48:23.592748|2017-10-10 20:48:23.592748
NCT03245632|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-09|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01|2 Months|Observational [Patient Registry]|||Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China|Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China|Not yet recruiting||N/A|800|Anticipated|Sir Run Run Shaw Hospital|||2||f||||t|f|f||||||||2017-10-10 20:48:23.678062|2017-10-10 20:48:23.678062
NCT03245619|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-08|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|August 19, 2018|Anticipated|2018-08-19|August 19, 2018|Anticipated|2018-08-19||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults|Randomized, Double-blind, Placebo Controlled Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses (Intravenous Bolus) and Constant Intravenous Infusion Over 7 Days of GSK3335065 in Healthy Adult Subjects|Recruiting||Phase 1|64|Anticipated|GlaxoSmithKline||8|||f||||f|f|f||||||||2017-10-10 20:48:23.752167|2017-10-10 20:48:23.752167
NCT03245606|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-22|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|March 1, 2020|Anticipated|2020-03-01|October 15, 2019|Anticipated|2019-10-15||Observational|FibroMR||Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease|Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non-Alcoholic Fatty Liver Disease (NAFLD)|Not yet recruiting||N/A|240|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:48:23.893827|2017-10-10 20:48:23.893827
NCT03245593|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|ShareD-BD||Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder|Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder|Not yet recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f|||||f|f||||||||2017-10-10 20:48:24.008733|2017-10-10 20:48:24.008733
NCT03245580|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|BLOCS||Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)|Comparison of 2 Techniques Using EUS Guided Liver Biopsies Via 19g CORE Biopsy Needle to Obtain Optimal Core Liver Biopsies in Benign Disease|Not yet recruiting||N/A|100|Anticipated|Parkview Health||2|||f||||t|f|f||||||||2017-10-10 20:48:24.195849|2017-10-10 20:48:24.195849
NCT03245554|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol|Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol|Not yet recruiting||Early Phase 1|80|Anticipated|Central South University||1|||f||||t|f|f||||||||2017-10-10 20:48:24.36406|2017-10-10 20:48:24.36406
NCT03245541|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-21|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|DurvaRad||Study of Durvalumab and Stereotactive Ablative Body Radiotherapy in Advanced Pancreatic Adenocarcinoma|A Phase I/II Study of Durvalumab and Stereotactive Ablative Body Radiotherapy in Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma|Recruiting||Phase 1/Phase 2|30|Anticipated|Cedars-Sinai Medical Center||1|||||||t|t|f||||||||2017-10-10 20:48:24.442732|2017-10-10 20:48:24.442732
NCT03245528|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access for LJPC-501|Expanded Access for LJPC-501|Available||N/A|||La Jolla Pharmaceutical Company||||||||t|||||||||||2017-10-10 20:48:24.579944|2017-10-10 20:48:24.579944
NCT03245515|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-14|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|November 21, 2017|Anticipated|2017-11-21|November 20, 2017|Anticipated|2017-11-20||Interventional|||A Study of BMS-986195 in Healthy Male Subjects|Pharmacokinetics and Metabolism of [14C] BMS-986195 in Healthy Male Subjects|Recruiting||Phase 1|9|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f|||t|||||2017-10-10 20:48:24.667069|2017-10-10 20:48:24.667069
NCT03241953|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||April 23, 2014|Actual|2014-04-23|August 2017|2017-08-01|December 22, 2016|Actual|2016-12-22|November 20, 2016|Actual|2016-11-20||Interventional|||COMPARISION OF DIFFERENT TREATMENT METHODS OF PERI-IMPLANTITIS|COMPARISION OF DIFFERENT TREATMENT METHODS OF PERI-IMPLANTITIS|Completed||N/A|18|Actual|Necmettin Erbakan University||2|||f||||t|f|f||||||||2017-10-10 20:48:54.772379|2017-10-10 20:48:54.772379
NCT03245502|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-23|||August 20, 2017|Actual|2017-08-20|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Observational|||The Effect of Blood Transfusion on Venoarterial pco2 Difference in Cardiac Surgery|The Effect of Blood Transfusion on Venoarterial pco2 Difference in Cardiac Surgery|Enrolling by invitation||N/A|150|Anticipated|Turkiye Yuksek Ihtisas Education and Research Hospital|||2||f||||f|f|f||||Samples With DNA|"     blood   "|||2017-10-10 20:48:24.826422|2017-10-10 20:48:24.826422
NCT03245489|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-29|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Not yet recruiting||Phase 1|20|Anticipated|Medical University of South Carolina||2|||f||||t|f|f|||f|||||2017-10-10 20:48:24.928608|2017-10-10 20:48:24.928608
NCT03245476|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||September 4, 2017|Anticipated|2017-09-04|August 2017|2017-08-01|September 4, 2019|Anticipated|2019-09-04|September 4, 2019|Anticipated|2019-09-04||Interventional|||Education-based Physical Therapy Approach for Adhesive Capsulitis|Physiotherapy in Adhesive Capsulitis Pathology: Effect of an Education Based Approach on Arthroscopic Evaluation Results, Joint Range of Motion, Psychosocial Factors, Shoulder Pain and Arm Function|Not yet recruiting||N/A|100|Anticipated|Hasselt University||2|||f||||f|f|f||||||||2017-10-10 20:48:25.063147|2017-10-10 20:48:25.063147
NCT03245463|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluation of Methods of Teaching Self-management Strategies to Patients With Symptomatic Knee Osteoarthritis|Evaluation of Different Methods of Teaching Self-management Strategies to Patients With Symptomatic Knee Osteoarthritis|Recruiting||Phase 4|24|Anticipated|Hospital for Special Surgery, New York||2|||f|||||t|f||||||||2017-10-10 20:48:25.243528|2017-10-10 20:48:25.243528
NCT03245450|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-09-22|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|June 30, 2020|Anticipated|2020-06-30||Interventional|||Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors|A Phase 1/2 Single-arm Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan in Children With Refractory or Recurrent Solid Tumors|Recruiting||Phase 1/Phase 2|86|Anticipated|Eisai Inc.||1|||f||||f|t|f||||||||2017-10-10 20:48:25.360807|2017-10-10 20:48:25.360807
NCT03245437|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|||Target Engagement and Response to Oxytocin|Effects of Oxytocin on Social Cognition Training: Relationship to Target Engagement|Not yet recruiting||Phase 4|120|Anticipated|University of California, Los Angeles||4|||||||f|t|f||||||||2017-10-10 20:48:25.459773|2017-10-10 20:48:25.459773
NCT03245424|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07||||||August 2017|2017-08-01||||||||Expanded Access|||Ivosidenib Expanded Access Program in Relapsed/Refractory AML With an IDH1 Mutation|Expanded Access Program for Ivosidenib (AG-120) Monotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH1 Mutation|Available||N/A|||Agios Pharmaceuticals, Inc.||||||||t|||||||||||2017-10-10 20:48:25.544673|2017-10-10 20:48:25.544673
NCT03245411|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-09|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|July 20, 2019|Anticipated|2019-07-20|January 20, 2018|Anticipated|2018-01-20||Interventional|||Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients|A Randomized, Controlled Trial to Assess Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients in a Socioeconomically Disadvantaged Community|Active, not recruiting||N/A|110|Actual|Albert Einstein Healthcare Network||2|||f||||t|f|f||||||||2017-10-10 20:48:25.599374|2017-10-10 20:48:25.599374
NCT03245398|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-08-09|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of a Multi-dose Regimen of Mebendazole Against Hookworm in Children|Efficacy and Safety of a Single-dose Regimen and a Multi-dose Regimen of Mebendazole Against Hookworm Infections in School Children: a Randomized Controlled Trial|Recruiting||Phase 4|180|Anticipated|Swiss Tropical & Public Health Institute||2|||f|||||f|f|||f|||||2017-10-10 20:48:25.678143|2017-10-10 20:48:25.678143
NCT03245385|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-09-19|||June 29, 2017|Actual|2017-06-29|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis|An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis|Active, not recruiting||Phase 2|20|Actual|Sun Pharmaceutical Industries Limited||1|||f||||f|t|f||||||||2017-10-10 20:48:25.786217|2017-10-10 20:48:25.786217
NCT03245372|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-07|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|GDT-thorax||Goal Directed Therapy Versus Standard Care in Lung Resection Surgery (GDT-thorax Study).|Goal Directed Therapy Versus Standard Care in Lung Resection Surgery, a Randomized, Controlled Trial (GDT-thorax Study).|Not yet recruiting||N/A|30|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f|f|f|||t|||||2017-10-10 20:48:25.893427|2017-10-10 20:48:25.893427
NCT03245359|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-10-04|||September 28, 2017|Actual|2017-09-28|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Pain Management After TKA: Comparison of Short- and Long-term Nerve Blocks|Pain Management After TKA: Comparison of Short- and Long-term Concurrent Saphenous (Adductor Canal) and Posterior Nerve Blocks Using the ON-Q Pump System|Recruiting||N/A|50|Anticipated|Florida Hospital||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:48:25.992505|2017-10-10 20:48:25.992505
NCT03245333|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-07|||December 2014|Actual|2014-12-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)|Phase Ⅲ Clinical Study of Recombinant Human Growth Hormone Injection (JINTOPIN AQ) for Short Children With Small for Gestational Age(SGA)|Recruiting||Phase 3|120|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||4|||f||||f|f|f||||||||2017-10-10 20:48:26.174403|2017-10-10 20:48:26.174403
NCT03245320|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-07|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|June 2028|Anticipated|2028-06-01|June 2020|Anticipated|2020-06-01||Observational|||Clinical Evaluation of the TITAN™ Total Shoulder System|A Post-Market Observational Study to Evaluate Performance and Safety of the TITAN™ Total Shoulder System|Recruiting||N/A|50|Anticipated|Integra LifeSciences Corporation|||1||f||||f|f|t|f|f||||||2017-10-10 20:48:26.279021|2017-10-10 20:48:26.279021
NCT03245307|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-07|||August 31, 2017|Anticipated|2017-08-31|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Study To Test The Effect Of Apatinib On P450 Enzymes|A Single-center, Open-Label, Drug Interaction Study to Determine the Effects of Apatinib on the Metabolism of CYP3A4/5 and CYP2C9 Probe Drugs in Patients With Solid Tumors|Not yet recruiting||Phase 1|20|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:48:26.357464|2017-10-10 20:48:26.357464
NCT03245294|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01|1 Week|Observational [Patient Registry]|||Factors Contributing to the Pressure Wave Form Changes|Analysis of Factors Contributing to the Pressure Wave Form Changes During Lumbar Epidural Injections|Not yet recruiting||N/A|93|Anticipated|Keimyung University Dongsan Medical Center|||1||f|||||f|f||||||||2017-10-10 20:48:26.427117|2017-10-10 20:48:26.427117
NCT03245281|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|LEAN HF||LINQ for impEdance meAsuremeNt While Off From HF Medication Study|LINQ for impEdance meAsuremeNt While Off From HF Medication Study|Not yet recruiting||Phase 4|30|Anticipated|Medtronic BRC||3|||f||||f|f|f||||||||2017-10-10 20:48:26.495742|2017-10-10 20:48:26.495742
NCT03245268|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-09|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01|2 Years|Observational [Patient Registry]|||International BPA Registry|International BPA Registry|Not yet recruiting||N/A|500|Anticipated|International CTEPH Association|||1||f||||f|f|f||||||||2017-10-10 20:48:26.585925|2017-10-10 20:48:26.585925
NCT03245242|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-23|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|||Pediatric Urology Recovery After Surgery Endeavor (PURSUE)|Multicenter Pilot and Exploration Study of Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Urologic Reconstructive Surgery|Recruiting||N/A|85|Anticipated|Washington University School of Medicine|||2||f||||f|f|f||||||||2017-10-10 20:48:26.738726|2017-10-10 20:48:26.738726
NCT03245216|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-07|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|November 30, 2017|Anticipated|2017-11-30||Interventional|FAST-PD||Facilitating Motor Skill Learning in Parkinson's Disease|Facilitating Motor Skill Learning by Aerobic Training in Parkinson's Disease|Active, not recruiting||N/A|30|Anticipated|University of Erlangen-Nürnberg||2|||f||||f|f|f||||||||2017-10-10 20:48:26.890935|2017-10-10 20:48:26.890935
NCT03245203|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Pilot Study of Neoadjuvant Chemotherapy Combined With Bevacizumab for Locally Advanced Rectal Cancer|A Pilot Study of Neoadjuvant Chemotherapy Combined With Bevacizumab for Locally Advanced Rectal Cancer|Not yet recruiting||N/A|70|Anticipated|Chinese PLA General Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:48:26.960595|2017-10-10 20:48:26.960595
NCT03245190|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma|Efficacy and Safety of Chiauranib in Advanced Hepatocellular Carcinoma: a Single-arm, Open-label, Multi-center, Exploratory Phase Ib Study|Not yet recruiting||Phase 1|35|Anticipated|Chipscreen Biosciences, Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:48:27.029702|2017-10-10 20:48:27.029702
NCT03245177|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|August 2018|Anticipated|2018-08-01||Interventional|PARIS||Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase I Study of Pembrolizumab Anti PD-1 Monoclonal Antibody in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Not yet recruiting||Phase 1|25|Anticipated|The Christie NHS Foundation Trust||1|||f||||t|f|f||||||||2017-10-10 20:48:27.101365|2017-10-10 20:48:27.101365
NCT03245151|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 30, 2022|Anticipated|2022-12-30|March 31, 2022|Anticipated|2022-03-31||Interventional|||Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors|A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors|Not yet recruiting||Phase 1/Phase 2|132|Anticipated|Eisai Inc.||4|||f||||f|t|f||||||||2017-10-10 20:48:27.242971|2017-10-10 20:48:27.242971
NCT03245138|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-07|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Endoscopic Third Ventriculostomy Versus Ventriculo-peritoneal Shunting in Idiopathic Normal Pressure Hydrocephalus|Endoscopic Third Ventriculostomy Versus Ventriculo-peritoneal Shunting in Idiopathic Normal Pressure Hydrocephalus|Recruiting||N/A|100|Anticipated|University Medicine Greifswald||2|||f||||f|f|f||||||||2017-10-10 20:48:27.485155|2017-10-10 20:48:27.485155
NCT03245125|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-08|||January 1, 2009|Actual|2009-01-01|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|December 31, 2016|Actual|2016-12-31|5 Years|Observational [Patient Registry]|||HIIT Improves Survival of Heart Failure Patients|Impacts of High-intensity Interval Training on Long-term Survival of Heart Failure Patients|Completed||N/A|329|Actual|Chang Gung Memorial Hospital|||4||f||||f|f|f||||||||2017-10-10 20:48:27.60049|2017-10-10 20:48:27.60049
NCT03245112|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-08|2017-08-13|||March 3, 2014|Actual|2014-03-03|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|2 Years|Observational [Patient Registry]|||Halaven Patient Registry (Metastatic Breast Cancer, MBC)|Retrospective Data Collection and Analysis of the Therapeutic Effect of Eribulin for Advanced Breast Cancer Patients.|Recruiting||N/A|500|Anticipated|Chang Gung Memorial Hospital|||1||f|||||t|f||||||||2017-10-10 20:48:27.719398|2017-10-10 20:48:27.719398
NCT03245099|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Observational|||Management of Non Convulsive Status Epilepticus|Management of Non Convulsive Status Epilepticus|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t||||||||||2017-10-10 20:48:27.848233|2017-10-10 20:48:27.848233
NCT03245086|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||August 17, 2016|Actual|2016-08-17|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01|1 Year|Observational [Patient Registry]|||Multicenter Prospective Trial on Hemorrhoids|Multi-center, Non-randomized Prospective Observation Study Comparing Ferguson Hemorrhoidectomy and Transanal Hemorrhoidal Dearterialization (THD) for Prolapsed, Nonincarcerated, Reducible Hemorrhoids in Terms of 1-year Recurrence|Recruiting||N/A|492|Anticipated|Stony Brook University|||2||f||||t|f|t|f|f|f|||||2017-10-10 20:48:27.982225|2017-10-10 20:48:27.982225
NCT03245073|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-09|||September 15, 2017|Anticipated|2017-09-15|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|September 15, 2018|Anticipated|2018-09-15||Interventional|||Effects of Action Observation Therapy on Pain, Functional Level and Brain Hemodynamic in Patients With Knee Osteoarthritis|Effects of Action Observation Therapy on Pain, Functional Level and Brain Hemodynamic in Patients With Knee Osteoarthritis|Not yet recruiting||N/A|30|Anticipated|Acibadem University||2|||f|||||f|f||||||||2017-10-10 20:48:28.100152|2017-10-10 20:48:28.100152
NCT03245060|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-09|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|SOFIA||Adapted Solution Focused Therapy for People With Aphasia (SOFIA Trial)|Adapted Solution Focused Brief Therapy in Post-stroke Aphasia (SOFIA Trial): a Feasibility Study|Not yet recruiting||N/A|32|Anticipated|City, University of London||2|||f||||f|f|f||||||||2017-10-10 20:48:28.199379|2017-10-10 20:48:28.199379
NCT03245047|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-11|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|August 2019|Anticipated|2019-08-01||Interventional|NHERC||The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study)|A Prospective Randomized Double Blind Clinical Study to Determine the Clinical Impact of ONS in Community-dwelling Elderly|Recruiting||N/A|800|Anticipated|Abbott Nutrition||2|||f||||f|f|f||||||||2017-10-10 20:48:28.307515|2017-10-10 20:48:28.307515
NCT03245021|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-06|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2022|Anticipated|2022-06-01||Interventional|1stFLOR||Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A|First-line Treatment for Grade 1-3A Follicular Lymphoma Using Opdivo (Nivolumab) Plus Rituximab: The 1st FLOR Study|Recruiting||Phase 1|39|Anticipated|Austin Health||1|||f||||f|t|f|||t|||||2017-10-10 20:48:28.52713|2017-10-10 20:48:28.52713
NCT03245008|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-11|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain|A Phase 2/3 (Placebo-Controlled, Double-Blind, Comparative) Study on MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain|Recruiting||Phase 2/Phase 3|568|Anticipated|Mitsubishi Tanabe Pharma Corporation||4|||f|||||f|f|||t|||||2017-10-10 20:48:28.679969|2017-10-10 20:48:28.679969
NCT03244995|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-16|||August 6, 2017|Actual|2017-08-06|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||An Online Dyadic Mind-Body Intervention for Glioma Patients and Their Partners|An Online Dyadic Mind-Body Intervention for Glioma Patients and Their Partners|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 20:48:28.848593|2017-10-10 20:48:28.848593
NCT03244982|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein|Comparison of Timing and Image Quality of Different Phases of Optos Fluorescein Angiography Between Two Doses of Intravenous Fluorescein: 250mg Versus 500mg|Not yet recruiting||Phase 4|100|Anticipated|Kresge Eye Institute||2|||f||||f|t|f|||f|||||2017-10-10 20:48:28.97873|2017-10-10 20:48:28.97873
NCT03244969|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Bone Healing Study|Study of the Granulation Tissue Formation in the Early Fracture Hematoma|Enrolling by invitation||N/A|10|Anticipated|Kazan Federal University|||1||f||||f||||||||||2017-10-10 20:48:29.08437|2017-10-10 20:48:29.08437
NCT03244774|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-08-08|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|August 14, 2019|Anticipated|2019-08-14|August 14, 2018|Anticipated|2018-08-14||Interventional|||Study of the Combination of Apatinib and POF|Phase I Study of the Combination of Apatinib and POF (Paclitaxel Plus Oxaliplatin Plus 5-fluorouracil Plus Leucovorin)|Not yet recruiting||Phase 1|9|Anticipated|Fujian Cancer Hospital||1|||f||||t|f|f|||f|||||2017-10-10 20:48:30.348578|2017-10-10 20:48:30.348578
NCT03244956|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2019|Anticipated|2019-08-01||Interventional|MERAIODE||Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer|Efficacy of a Selective MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors Associated With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer With RAS or BRAFV600E Mutation|Active, not recruiting||Phase 2|87|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f|f|f||||||||2017-10-10 20:48:29.148284|2017-10-10 20:48:29.148284
NCT03244943|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||August 1, 2015||2015-08-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|December 12, 2016|Actual|2016-12-12||Interventional|||Cytokine Profiles in Breast Cancer Patients Undergoing Chemotherapy|Effects of Non-surgical Periodontal Treatment on the Gingival Crevicular Fluid Cytokine Profiles in Breast Cancer Patients Undergoing Chemotherapy|Completed||N/A|40|Actual|University of Sao Paulo||1|||f||||t|f|f||||||||2017-10-10 20:48:29.238955|2017-10-10 20:48:29.238955
NCT03244930|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|June 10, 2018|Anticipated|2018-06-10|May 10, 2018|Anticipated|2018-05-10||Interventional|||Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation|Low Dose Plerixafor Plus G-CSF Efficiency in Mobilizing Stem Cells From Lymphoma and Myeloma Patients for Autologous Peripheral Blood Transplantation|Recruiting||Phase 2|20|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||t|f|f|||f|||||2017-10-10 20:48:29.310583|2017-10-10 20:48:29.310583
NCT03244917|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-10|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|August 2020|Anticipated|2020-08-01||Interventional|TRAIN-AD||Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias|Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias (TRAIN-AD)|Not yet recruiting||N/A|480|Anticipated|Hebrew Rehabilitation Center, Boston||2|||f||||t|f|f||||||||2017-10-10 20:48:29.403947|2017-10-10 20:48:29.403947
NCT03244904|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-05|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Observational|||Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment|a Prospective Cohort Study for Small Cell Lung Cancer to Identify Susceptibility Gene and Assess DNA Dynamic Change by Next-generation Sequencing|Not yet recruiting||N/A|80|Anticipated|Fujian Cancer Hospital|||1||f||||||||||||||2017-10-10 20:48:29.505458|2017-10-10 20:48:29.505458
NCT03244891|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Autonomic Challenges From Mild Hypovolemia and Mechanical Ventilation|Effects of Low Central Volume and Intermittent Positive Pressure Ventilation on the Heart Rate Variability|Not yet recruiting||N/A|12|Anticipated|ASST Fatebenefratelli Sacco||1|||f||||f|f|f||||||||2017-10-10 20:48:29.573722|2017-10-10 20:48:29.573722
NCT03244878|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-09|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|February 15, 2019|Anticipated|2019-02-15||Interventional|||Thrive, a Computerized Cognitive Behavior Therapy Program to Treat Depression|Randomized Controlled Trial of a Culturally-adapted Version of Thrive, a Computerized Cognitive Behavior Therapy (cCBT) Program to Treat Depressive Symptoms, Syndromes, and Disorders Among Rural Montanans|Recruiting||N/A|459|Anticipated|Montana State University||2|||f||||f|f|f||||||||2017-10-10 20:48:29.657124|2017-10-10 20:48:29.657124
NCT03244865|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-09|||September 29, 2016|Actual|2016-09-29|August 2017|2017-08-01|September 29, 2018|Anticipated|2018-09-29|September 29, 2018|Anticipated|2018-09-29||Observational|||Refinement of LaborView|Refinement of LaborView Electronic Fetal Monitor|Recruiting||N/A|150|Anticipated|OBMedical Company|||1||||||f|f|t|f||f|||||2017-10-10 20:48:29.746765|2017-10-10 20:48:29.746765
NCT03244852|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-07|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|July 2018|Anticipated|2018-07-01||Observational|PERFECT DBS||Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD|Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD|Not yet recruiting||N/A|11|Anticipated|Massachusetts General Hospital|||1||f||||f|f|f||||||||2017-10-10 20:48:29.823546|2017-10-10 20:48:29.823546
NCT03244839|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-08|||January 2016||2016-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Prevalence of Major Nutrients Deficiency in Diabetic Patient Before and After Bariatric Surgery|Prevalence of Major Nutrients Deficiency in Diabetic Patient Before and After Bariatric Surgery|Active, not recruiting||N/A|200|Anticipated|Min-Sheng General Hospital|||1||f||||t||||||||||2017-10-10 20:48:29.908836|2017-10-10 20:48:29.908836
NCT03244826|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation|Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation|Not yet recruiting||N/A|408|Anticipated|Dana-Farber Cancer Institute||3|||f||||t|f|f||||||||2017-10-10 20:48:29.971576|2017-10-10 20:48:29.971576
NCT03244813|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-07|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ACTIPARK||Evaluation of the Impact of a Personalized Program of Adapted Physical Activates in Patients With Parkinson Disease|Evaluation of the Impact of a Personalized Program of Adapted Physical Activates in Patients With Parkinson Disease|Not yet recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f|f|f||||||||2017-10-10 20:48:30.075424|2017-10-10 20:48:30.075424
NCT03244800|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-18|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|February 27, 2018|Anticipated|2018-02-27|February 27, 2018|Anticipated|2018-02-27||Interventional|||A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.|A Phase 2, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Different Doses of MEDI0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus|Recruiting||Phase 2|63|Anticipated|MedImmune LLC||2|||f||||f|f|f||||||||2017-10-10 20:48:30.170854|2017-10-10 20:48:30.170854
NCT03244787|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-08|||January 2017||2017-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Patient Navigation for Colorectal Cancer Screening for Patients With Mental Illness and/or Substance Use Disorder|Patient Navigation for Colorectal Cancer Screening for Patients With Mental Illness and/or Substance Use Disorder|Enrolling by invitation||N/A|380|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 20:48:30.275842|2017-10-10 20:48:30.275842
NCT03244761|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-08|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|September 15, 2017|Anticipated|2017-09-15||Observational|||Physiological Effects of High-Flow Tracheal Oxygen Via An Modified Interface|Physiological Effects of High-Flow Tracheal Oxygen Via An Modified Interface in Tracheostomized Patients|Recruiting||N/A|20|Anticipated|Capital Medical University|||2||f|||||f|f||||||||2017-10-10 20:48:30.428179|2017-10-10 20:48:30.428179
NCT03244748|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-05|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01|1 Year|Observational [Patient Registry]|||Amiodarone Usage After Ischemic Ventricular Tachycardia Ablation|Effect of Amiodarone After Ischemic Ventricular Tachycardia Ablation|Recruiting||N/A|100|Anticipated|Yuksek Ihtisas Hospital|||2||f||||f|f|f||||||||2017-10-10 20:48:30.975857|2017-10-10 20:48:30.975857
NCT03244735|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-10|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|CCHD||Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: a Prospective Case Series|Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache. A Prospective Case Series|Completed||N/A|18|Actual|University of Roma La Sapienza||1|||f||||f|f|f||||||||2017-10-10 20:48:31.082252|2017-10-10 20:48:31.082252
NCT03244722|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|||Preconception Maternal Nutrition and Obesity and Impact on Fetal Outcomes, Child Health and Weight|Effects of a Preconception Intervention for Obese Women on Reproductive, Maternal, Fetal, and Child Weight and Health Outcomes|Recruiting||N/A|540|Anticipated|University of Michigan||3|||f||||f|f|f||||||||2017-10-10 20:48:31.183181|2017-10-10 20:48:31.183181
NCT03244709|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-09|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.|Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission: a Prospective, Pilot Study.|Recruiting||Phase 4|15|Anticipated|Hospital of Prato||1|||f||||f||||||||||2017-10-10 20:48:31.257915|2017-10-10 20:48:31.257915
NCT03244696|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Behavior and Activity Monitoring in MS|Behavior and Activity Monitoring in Multiple Sclerosis|Not yet recruiting||N/A|200|Anticipated|Ohio State University||2|||f||||f|f|f||||||||2017-10-10 20:48:31.331|2017-10-10 20:48:31.331
NCT03244683|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-09-18|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|June 27, 2019|Anticipated|2019-06-27||Interventional|INSPIRE||A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated With Pancreatic Surgery|A Study of the Efficacy of Oral Nutritional Supplementation to Reduce Postoperative Complications Associated With Pancreatic Surgery|Recruiting||N/A|150|Anticipated|Ohio State University||2|||f|||||f|f||||||||2017-10-10 20:48:31.422974|2017-10-10 20:48:31.422974
NCT03244670|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-31|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|September 30, 2019|Anticipated|2019-09-30||Observational|||The Incidence and Progression of Myopia: Cohort Study|A Cohort Study on Incidence and Progression of Myopia in a Group of Medical Students|Recruiting||N/A|350|Anticipated|Sun Yat-sen University|||1||f|||||f|f||||||||2017-10-10 20:48:31.51904|2017-10-10 20:48:31.51904
NCT03244657|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||April 25, 2017|Actual|2017-04-25|July 2017|2017-07-01|February 28, 2020|Anticipated|2020-02-28|October 31, 2019|Anticipated|2019-10-31||Interventional|||Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy|Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy|Recruiting||Phase 4|200|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.||2|||f|||||f|f||||||||2017-10-10 20:48:31.589581|2017-10-10 20:48:31.589581
NCT03244644|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-24|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)|A Phase 3 Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of RBX2660 (Microbiota Suspension) for the Prevention of Clostridium Difficile Infection|Recruiting||Phase 3|270|Anticipated|Rebiotix Inc.||2|||f||||t|t|f||||||||2017-10-10 20:48:33.421367|2017-10-10 20:48:33.421367
NCT03244631|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-04|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pain Control in Hip Arthroscopy: Comparing Lumbar Plexus Versus Peri-capsular Injection|Prospective, Single Blind Randomzied Controlled Trial Comparing Lumbar Plexus Peripheral Nerve Block Versus Peri-capsular Injection for Hip Arthroscopy|Not yet recruiting||N/A|100|Anticipated|Washington Orthopaedics and Sports Medicine||2|||f||||f|f|f||||||||2017-10-10 20:48:33.513425|2017-10-10 20:48:33.513425
NCT03244618|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-04|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Measure the Efficacy of a Toothpaste on Dentinal Hypersensitivity|A Medical Device Study to Measure the Efficacy of a Toothpaste Containing Calcium-silicate/Phosphate on Dentinal Hypersensitivity Compared to a Control Toothpaste Containing Fluoride.|Recruiting||N/A|280|Anticipated|Unilever R&D||2|||f|||||f|f||||||||2017-10-10 20:48:33.583496|2017-10-10 20:48:33.583496
NCT03244605|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-06|||October 1, 2016|Actual|2016-10-01|October 2016|2016-10-01|December 30, 2019|Anticipated|2019-12-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients|Clinical Study on the Effect of Comprehensive Rehabilitation Program on Quality of Life and Long-term Survival in Postoperative Non Small Cell Lung Cancer Patients|Enrolling by invitation||Phase 3|236|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t|f|f||||||||2017-10-10 20:48:33.67546|2017-10-10 20:48:33.67546
NCT03244592|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-06|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|August 1, 2023|Anticipated|2023-08-01|February 1, 2023|Anticipated|2023-02-01||Interventional|||Minocycline for Alcohol Use Disorder|Development of Minocycline as a Neuroimmune Therapy for Alcohol Use Disorder|Not yet recruiting||Phase 1/Phase 2|32|Anticipated|University of California, Los Angeles||2|||f||||f|t|f|||t|||||2017-10-10 20:48:33.764979|2017-10-10 20:48:33.764979
NCT03243474|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|August 30, 2019|Anticipated|2019-08-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Non-invasive Monitoring for Early Detection of Atrial Fibrillation|Non-invasive Monitoring for Early Detection of Atrial Fibrillation|Recruiting||N/A|3000|Anticipated|Kardio-Med Silesia|||6||f||||f|f|f||||||||2017-10-10 20:48:42.303249|2017-10-10 20:48:42.303249
NCT03244579|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-06|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|December 20, 2018|Anticipated|2018-12-20|May 20, 2018|Anticipated|2018-05-20||Interventional|||Carbohydrate Counting and DASH Intervention and Pregnancy Outcomes Among Women With Gestational Diabetes|Studying the Effectiveness of Carbohydrate Counting and Dietary Approach to Stop Hypertension Dietary Intervention on Glycemic Control and Maternal and Newborn Health Outcomes Among Jordanian Pregnant Women With Gestational Diabetes|Not yet recruiting||N/A|180|Anticipated|University of Jordan||3|||f||||t|f|f||||||||2017-10-10 20:48:33.853586|2017-10-10 20:48:33.853586
NCT03244566|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-06|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|PETCLMESCC||PET in Guiding Cervical Lymphadenectomy|The Utility of Positron Emission Tomography (PET) in Predicting Cervical Lymphatic Metastasis for Mid-lower Thoracic Esophageal Squamous Cell Carcinoma|Not yet recruiting||N/A|100|Anticipated|Fudan University|||1||f||||f|f|f||||||||2017-10-10 20:48:33.934814|2017-10-10 20:48:33.934814
NCT03244553|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-08|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|IEMPru||Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study|Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study|Enrolling by invitation||Phase 2|30|Anticipated|University of Calgary||1|||f||||f|f|f||||||||2017-10-10 20:48:33.986553|2017-10-10 20:48:33.986553
NCT03244540|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||September 4, 2017|Anticipated|2017-09-04|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Regional Analgesia After Cesarean Section|Efficacy of Regional Analgesia Techniques (Quadratus Lumborum Block and Transversus Abdominis Plane Block) in Acute and Chronic Pain Treatment in Patients After Cesarean Delivery|Not yet recruiting||Phase 4|300|Anticipated|Medical University of Lublin||3|||f||||f|f|f||||||||2017-10-10 20:48:34.070547|2017-10-10 20:48:34.070547
NCT03244527|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-30|||August 29, 2017|Actual|2017-08-29|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|February 28, 2019|Anticipated|2019-02-28||Interventional|||Use of Branched Chain Amino Acid (BCAA) Supplements for Chronic Stroke Patients|Use of Branched Chain Amino Acid (BCAA) Supplements for Chronic Stroke Patients to Improve the Functional Performance|Recruiting||N/A|40|Anticipated|Taipei Medical University WanFang Hospital||2|||f||||f|f|f||||||||2017-10-10 20:48:34.268145|2017-10-10 20:48:34.268145
NCT03244514|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-08|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|PrevAKI-mc||Biomarker-guided Implementation of the AKI Bundle|Biomarker-guided Implementation of the Cardiovascular (CV) Surgery AKI Bundle to Reduce the Occurrence of AKI After Cardiac Surgery- Prevention of AKI|Not yet recruiting||N/A|310|Anticipated|University Hospital Muenster||2|||f||||t|f|f||||||||2017-10-10 20:48:34.35176|2017-10-10 20:48:34.35176
NCT03244501|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-13|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Transcranial Static Magnetic Field Stimulation of Frontal Cortex|Modulation of Frontal Cortical Activity With Transcranial Static Magnetic Field Stimulation|Active, not recruiting||N/A|24|Actual|University of North Carolina, Chapel Hill||3|||f||||f|f|f||||||||2017-10-10 20:48:34.433594|2017-10-10 20:48:34.433594
NCT03244488|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-04|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Mental Ability Challenge Study in Adults With and Without HIV|Cholinergic Correlates of Impaired Cognitive Ability in HIV-Associated Neurocognitive Disorders|Recruiting||N/A|30|Anticipated|Vanderbilt University Medical Center|||2||f||||f|t|f||||Samples With DNA|"     Blood samples collected from all participants for routine screening labs and APOE genotyping.   "|||2017-10-10 20:48:34.510955|2017-10-10 20:48:34.510955
NCT03244475|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-04|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|TES for mTBI||Transcranial Electrical Stimulation for mTBI|Passive Electrical Neurofeedback Treatment of mTBI: MEG and Behavioral Outcomes|Not yet recruiting||N/A|175|Anticipated|VA Office of Research and Development||3|||f||||t|f|t|t|f|f|||||2017-10-10 20:48:34.602408|2017-10-10 20:48:34.602408
NCT03244449|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||August 26, 2014|Actual|2014-08-26|August 2017|2017-08-01|December 16, 2016|Actual|2016-12-16|October 30, 2016|Actual|2016-10-30||Observational|||New IR Biomarkers (Myokines) in Colombian People|Identification and Validation of Myonectin, Myostatin and FGF-21 as Insulin Resistance Biomarkers in Colombian People|Completed||N/A|81|Actual|University of Los Andes, Columbia|||1||f||||t|f|f||||||||2017-10-10 20:48:34.831349|2017-10-10 20:48:34.831349
NCT03244436|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||June 15, 2013|Actual|2013-06-15|August 2017|2017-08-01|June 15, 2015|Actual|2015-06-15|June 15, 2015|Actual|2015-06-15||Observational|||Emergency Surgery Following Pediatric Catheterization|Emergency Surgery Following Pediatric Cardiac Catheterization|Completed||N/A|190|Actual|Cairo University|||1||f||||t|f|f||||||||2017-10-10 20:48:34.909768|2017-10-10 20:48:34.909768
NCT03244423|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-12|||January 2009|Actual|2009-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Tranexamic Acid in Cyanotic Heart Defects|Tranexamic Acid in Cyanotic Heart Defects: a Risk-benefit Analysis.|Completed||Phase 2|120|Actual|Assiut University||3|||f||||t|f|f||||||||2017-10-10 20:48:34.969182|2017-10-10 20:48:34.969182
NCT03244410|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||Lymphocyte Counts in Immune Thrombocytopenic Purpura|Initial Lymphocyte Counts Predictive Value in Immune Thrombocytopenic Purpura|Not yet recruiting||N/A|1|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:48:35.068918|2017-10-10 20:48:35.068918
NCT03244397|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-08|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|PT-POP||Physical Therapy on Pelvic Organ Prolapse|Effectiveness of Physical Therapy on Pelvic Organ Prolapse Stages I & II|Active, not recruiting||N/A|120|Actual|University of Alcala||2|||f||||t|f|f||||||||2017-10-10 20:48:35.12677|2017-10-10 20:48:35.12677
NCT03244371|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||August 31, 2016|Actual|2016-08-31|August 2017|2017-08-01|February 28, 2019|Anticipated|2019-02-28|August 31, 2018|Anticipated|2018-08-31||Interventional|HCURE||Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients|Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients|Recruiting||N/A|20|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f|f|f||||||||2017-10-10 20:48:35.458564|2017-10-10 20:48:35.458564
NCT03244358|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-08|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer|Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer:A Single Arm,Single Center,Phase II Study|Active, not recruiting||Phase 2|30|Anticipated|Sun Yat-sen University||1|||f|||||f|f|||f|||||2017-10-10 20:48:35.527064|2017-10-10 20:48:35.527064
NCT03244345|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-07|||February 20, 2017|Actual|2017-02-20|August 2017|2017-08-01|February 20, 2021|Anticipated|2021-02-20|February 20, 2020|Anticipated|2020-02-20||Interventional|||Depression, Stress and Vulnerability Factors in Drug Resistant Focal Epilepsies|Depression, Stress and Vulnerability Factors in Drug Resistant Focal Epilepsies|Recruiting||N/A|150|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f|f|f||||||||2017-10-10 20:48:35.600561|2017-10-10 20:48:35.600561
NCT03244332|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-08|||October 18, 2013|Actual|2013-10-18|July 2017|2017-07-01|July 15, 2017|Actual|2017-07-15|July 15, 2017|Actual|2017-07-15||Interventional|HEMOCC||HEMOCC Study. Hemostasis in Cirrhotic Children.|HEMOCC Study Hemostasis in Cirrhotic Children : Assessment of Risk Factors of Spontaneous Bleeding From Oesophageal Varices in Cirrhotic Children Waiting for a Graft.|Completed||N/A|30|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f|f|f||||||||2017-10-10 20:48:35.676809|2017-10-10 20:48:35.676809
NCT03244306|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-10|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|June 15, 2019|Anticipated|2019-06-15|June 15, 2019|Anticipated|2019-06-15||Interventional|PLAT-04||A Phase 1 Study of CD22 CAR T-Cell Immunotherapy for CD22+ Leukemia|Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-04: A Phase 1 Feasibility and Safety Study of CD22 CAR T-Cell Immunotherapy for CD22+ Leukemia|Recruiting||Phase 1|33|Anticipated|Seattle Children's Hospital||1|||||||t|t|f||||||||2017-10-10 20:48:35.919978|2017-10-10 20:48:35.919978
NCT03244293|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-08|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|BIS6||Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis|Sensitivity and Specificity of Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis, Severe Sepsis and Septic Shock and Multiple Organ Failure (MOF)|Recruiting||N/A|20|Anticipated|Medical University of Graz|||1||f||||f|f|f||||||||2017-10-10 20:48:36.005268|2017-10-10 20:48:36.005268
NCT03244280|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-08|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of the Systemic Absorption of MOB015B|A Study of the Systemic Absorption of Once Daily MOB015B When Applied for 28 Days in Subjects With Moderate to Severe Onychomycosis of the Toenails.|Not yet recruiting||Phase 1|20|Anticipated|Moberg Pharma AB||1|||f|||||t|f||||||||2017-10-10 20:48:36.08667|2017-10-10 20:48:36.08667
NCT03244267|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-10-04|||October 3, 2017|Actual|2017-10-03|September 2017|2017-09-01|April 24, 2020|Anticipated|2020-04-24|April 24, 2020|Anticipated|2020-04-24||Interventional|||App Reminder on ASA Adherence|Impact of a Smartphone App Reminder on Adherence Aspirin Prescribed as Anti-Thrombotic Therapy|Recruiting||N/A|200|Anticipated|Emory University||2|||f||||f|f|f||||||||2017-10-10 20:48:36.164647|2017-10-10 20:48:36.164647
NCT03244254|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-10-03|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||Intestinal Fatty Acid-binding Protein (I-FABP) Levels in Pediatric Celiac Patients|I-FABP Levels in Pediatric Celiac Patients in Transition From Active Disease to Remission|Not yet recruiting||N/A|70|Anticipated|Schneider Children's Medical Center, Israel|||2||f||||f|f|f||||||||2017-10-10 20:48:36.268257|2017-10-10 20:48:36.268257
NCT03244241|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-08|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study|Basal-bolus Insulin Therapy With Insulin Degludec and Insulin Aspart Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study|Recruiting||Phase 4|100|Anticipated|Hvidovre University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:48:36.345361|2017-10-10 20:48:36.345361
NCT03244228|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-06|||August 25, 2017|Actual|2017-08-25|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Two Part Study to Assess Safety, PK, PD, and Food Effect of Oral HTL0016878|A Two-part, Randomised, Double-blind, Placebo-controlled Single and Multiple Ascending Dose Study to Assess Safety, Pharmacokinetics and Pharmacodynamics of Oral HTL0016878 in Healthy Younger Adult and Elderly Subjects With a Randomised, Open-label, Crossover Arm to Assess the Effect of Food on Bioavailability of Oral HTL0016878.|Recruiting||Phase 1|106|Anticipated|Heptares Therapeutics Limited||5|||f|||||f|f||||||||2017-10-10 20:48:36.454367|2017-10-10 20:48:36.454367
NCT03244215|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-08-08|||February 17, 2016|Actual|2016-02-17|August 2017|2017-08-01|May 17, 2018|Anticipated|2018-05-17|February 17, 2018|Anticipated|2018-02-17||Interventional|||The Recurrence Study|Evaluation Of Risk Of Recurrence Of Stroke And Vascular Events In Patients Presenting With Acute Stroke And Tia To Hamad General Hospital|Recruiting||N/A|300|Anticipated|Hamad Medical Corporation||2|||f||||f|f|f||||||||2017-10-10 20:48:36.558284|2017-10-10 20:48:36.558284
NCT03244202|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-10|||September 12, 2016|Actual|2016-09-12|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of a Decision Aid for Incidental Genomic Findings|Randomized Controlled Trial of a Decision Aid for Incidental Genomic Findings|Recruiting||N/A|128|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 20:48:36.658393|2017-10-10 20:48:36.658393
NCT03244189|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-14|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|PUSH||Prevention of Urinary Stones With Hydration|Prevention of Urinary Stones With Hydration|Recruiting||N/A|1642|Anticipated|Duke University||2|||f||||t|f|f||||||||2017-10-10 20:48:36.774604|2017-10-10 20:48:36.774604
NCT03244176|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-07|2017-08-09|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|July 2025|Anticipated|2025-07-01|February 2021|Anticipated|2021-02-01||Interventional|AvR-CHOP||Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study|Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse Large B Cell Lymphoma (DLBCL): The AvR-CHOP Study|Recruiting||Early Phase 1|28|Anticipated|Austin Health||1|||f||||f|f|f|||f|||||2017-10-10 20:48:36.936973|2017-10-10 20:48:36.936973
NCT03244163|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-08|||June 14, 2016|Actual|2016-06-14|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Spyglass DS Peroral Cholangioscope Guided LL or EHL Versus BML for Endoscopic Removal of Complicated Bile Duct Stones|Randomized Controlled Trial of Spyglass DS Peroral Cholangioscope Guided Laser Lithotripsy or Electrohydraulic Lithotripsy Versus Conventional Basket Mechanical Lithotripsy for Endoscopic Removal of Complicated Bile Duct Stones|Recruiting||N/A|86|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:48:37.051895|2017-10-10 20:48:37.051895
NCT03244150|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-08|||August 1, 1983|Actual|1983-08-01|August 2017|2017-08-01|August 1, 2005|Actual|2005-08-01|August 1, 2005|Actual|2005-08-01||Observational|YSS||Youth and Sport Study|Youth and Sport Study - a 20 Year Follow-up Study of Danish Teenagers Born Between 1964 and 1969|Completed||N/A|3008|Actual|Bispebjerg Hospital|||2||f||||f|f|f||||Samples With DNA|"     DNA samples were collected by cheek scrapings, which were distributed and returned through     mail.   "|||2017-10-10 20:48:37.141021|2017-10-10 20:48:37.141021
NCT03244137|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-05|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|November 1, 2019|Anticipated|2019-11-01||Observational|||Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease|Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease|Recruiting||N/A|100|Anticipated|ADIR Association|||1||f||||f|f|f||||||||2017-10-10 20:48:37.213902|2017-10-10 20:48:37.213902
NCT03244124|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||September 3, 2016|Actual|2016-09-03|July 2017|2017-07-01|November 30, 2020|Anticipated|2020-11-30|May 31, 2017|Actual|2017-05-31||Interventional|FUUC||Different Application Strategies When Using Futurabond Universal in Class V Cavities|Clinical Evaluation of Different Application Strategies When Using a Futurabond Universal Adhesive System in Class V Cavities|Active, not recruiting||N/A|50|Actual|Universidade Federal Fluminense||4|||f||||f||||||||||2017-10-10 20:48:37.327788|2017-10-10 20:48:37.327788
NCT03244111|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-06|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Examining the Effect of a Simple Memory Tool|Examining the Effect of a Simple Memory Tool|Recruiting||N/A|30|Anticipated|University of Manitoba||2|||f||||f|f|f||||||||2017-10-10 20:48:37.446478|2017-10-10 20:48:37.446478
NCT03244098|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-26|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||In-Home Adjustment of New Spinal Cord Injury Caregivers|In-Home Adjustment of New Spinal Cord Injury Caregivers|Not yet recruiting||N/A|88|Anticipated|Virginia Commonwealth University||2|||f|||||f|f||||||||2017-10-10 20:48:37.526791|2017-10-10 20:48:37.526791
NCT03244085|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-05|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|August 20, 2018|Anticipated|2018-08-20|March 20, 2018|Anticipated|2018-03-20||Interventional|||A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients|An Open-Label Phase 1b Study to Evaluate the Dose-Related Safety, Efficacy, and Pharmacokinetic Profile of Different Doses of QL-007 in Chronic Hepatitis B Patients|Not yet recruiting||Phase 1|18|Anticipated|Qilu Pharmaceutical Co., Ltd.||3|||f||||t|f|f||||||||2017-10-10 20:48:37.60645|2017-10-10 20:48:37.60645
NCT03244072|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery|Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery|Not yet recruiting||Phase 2/Phase 3|15000|Anticipated|Zion Therapeutics, LLC||2|||f||||f|t|f||||||||2017-10-10 20:48:37.682106|2017-10-10 20:48:37.682106
NCT03244059|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|BOTEGA||Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies|Proof-of-concept Randomized, Double-blind, Phase IIa Study to Show Feasibility, Validate Assays and Approaches, and Explore Dosing and Safety of Belimumab in Pulmonary Emphysema Patients|Not yet recruiting||Phase 2|18|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||t|||||2017-10-10 20:48:37.778264|2017-10-10 20:48:37.778264
NCT03244046|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-04|||January 5, 2016|Actual|2016-01-05|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Low Back Pain and Comorbid Posttraumatic Stress Disorder|Somatic Experiencing for Patients With Low Back Pain and Comorbid Posttraumatic Stress Disorder: A Randomized Controlled Trial|Enrolling by invitation||N/A|140|Anticipated|University of Southern Denmark||2|||f||||f|f|f||||||||2017-10-10 20:48:37.866086|2017-10-10 20:48:37.866086
NCT03244033|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-04|||July 1, 2018|Anticipated|2018-07-01|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Integrating Contextual Factors Into Clinical Decision Support|Integrating Contextual Factors Into Clinical Decision Support to Reduce Contextual Error and Improve Outcomes in Ambulatory Care|Not yet recruiting||N/A|500|Anticipated|University of Illinois at Chicago||2|||f||||t|f|f||||||||2017-10-10 20:48:37.953141|2017-10-10 20:48:37.953141
NCT03244020|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-05|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|July 1, 2024|Anticipated|2024-07-01|December 31, 2023|Anticipated|2023-12-31||Interventional|||Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology|Low Molecular Weight Heparin Versus Aspirin for Venous Thromboembolism Prophylaxis in Orthopaedic Oncology|Not yet recruiting||Phase 4|2868|Anticipated|Massachusetts General Hospital||6|||f||||f|t|f|||t|||||2017-10-10 20:48:38.065141|2017-10-10 20:48:38.065141
NCT03244007|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-05|||December 12, 2015|Actual|2015-12-12|August 2017|2017-08-01|June 11, 2017|Actual|2017-06-11|December 11, 2016|Actual|2016-12-11||Observational|||Evaluation of Retinal Microstructure Detected With Intraoperative Optical Coherence Tomography During Vitrectomy|Evaluation of Retinal Microstructure Detected With Intraoperative Optical Coherence Tomography During Vitrectomy|Completed||N/A|30|Actual|Kyorin University|||2||f||||t|f|f||||||||2017-10-10 20:48:38.16308|2017-10-10 20:48:38.16308
NCT03243994|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-04|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|October 1, 2016|Actual|2016-10-01|October 1, 2016|Actual|2016-10-01||Interventional|||Small Intestinal Absorption in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale|Small Intestinal Absorption in Patients With Chronic Obstructive Pulmonary Disease Complicated by Cor Pulmonale: A Pilot Study|Completed||N/A|14|Actual|University of Copenhagen||2|||f||||f|f|f||||||||2017-10-10 20:48:38.229191|2017-10-10 20:48:38.229191
NCT03243981|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-07|||November 20, 2016|Actual|2016-11-20|August 2017|2017-08-01|December 20, 2017|Anticipated|2017-12-20|August 20, 2017|Anticipated|2017-08-20||Interventional|||Infrared and Broadband Light for Skin Aging|Augmentation of Skin Aging Reversal By Broadband Light With Skin Tightening Properties Via Gene Expression Analysis|Active, not recruiting||N/A|6|Anticipated|Stanford University||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:48:38.392906|2017-10-10 20:48:38.392906
NCT03243968|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-04|||March 1, 2014|Actual|2014-03-01|August 2017|2017-08-01|August 30, 2015|Actual|2015-08-30|August 30, 2015|Actual|2015-08-30||Observational|||Endothelial and Microvascular Functions in Patients With Myocardial Ischemia|Evaluation of Endothelial and Microvascular Functions in Patients With Myocardial Ischemia Detected by Scintilography and Normal Coronariography|Completed||N/A|50|Actual|Rio de Janeiro State University|||2||f||||f|f|f||||||||2017-10-10 20:48:38.504601|2017-10-10 20:48:38.504601
NCT03243955|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-08|||February 28, 2017|Actual|2017-02-28|August 2017|2017-08-01|February 26, 2019|Anticipated|2019-02-26|February 27, 2018|Anticipated|2018-02-27||Interventional|||Transcutaneous Electrical Acupoint Stimulation (TEAS) for Chronic Constipation|Transcutaneous Electrical Acupoint Stimulation (TEAS) for Chronic Constipation|Recruiting||N/A|100|Anticipated|University of California, Los Angeles||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:48:38.593251|2017-10-10 20:48:38.593251
NCT03243942|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-04|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement|Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement|Recruiting||Phase 2|56|Anticipated|Thomas Jefferson University||1|||f||||f|t|f|||t|||||2017-10-10 20:48:38.706071|2017-10-10 20:48:38.706071
NCT03243929|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-08|||January 13, 2014|Actual|2014-01-13|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|January 18, 2018|Anticipated|2018-01-18||Interventional|SSS||Translation of District Sun Safe Policies to Schools|Translation of District Sun Safe Policies to Schools|Active, not recruiting||N/A|118|Actual|Claremont Graduate University||2|||f||||f|f|f||||||||2017-10-10 20:48:38.825022|2017-10-10 20:48:38.825022
NCT03243916|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-06|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|July 14, 2020|Anticipated|2020-07-14|July 14, 2019|Anticipated|2019-07-14||Interventional|||Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC|A Prospective Single-arm Study on Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of Massive Hepatocellular Carcinoma|Not yet recruiting||N/A|40|Anticipated|Chinese PLA General Hospital||1|||f|||||f|f||||||||2017-10-10 20:48:38.906524|2017-10-10 20:48:38.906524
NCT03243903|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-06|2017-08-06|||May 19, 2017|Actual|2017-05-19|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Comparison of Safety and Efficacy of QS-M Needle- Free Injector and Insulin Pen in Controlling T2DM Patient's Glucose|The Safety and Efficacy of QS-M Needle -Free Injector Versus Needle-insulin Pen as a Drug Carrier for Controlling the Blood Glucose in T2DM：a Randomized, Parallel Controlled, Open-label, Multicenter Trial|Recruiting||N/A|420|Anticipated|Beijing QS Medical Technology Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:48:39.008672|2017-10-10 20:48:39.008672
NCT03243890|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-04|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|AVADEC||The Aortic Valve DECalcification (AVADEC) Trial|The Effects of Menaquinone-7 Supplementation in Patients With Aortic Valves Calcification|Not yet recruiting||Phase 1|400|Anticipated|Odense University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:48:39.114636|2017-10-10 20:48:39.114636
NCT03243877|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-07|||June 17, 2017|Actual|2017-06-17|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|October 30, 2017|Anticipated|2017-10-30||Observational|||Performance of MammoAlert™, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older|Multi-Centric Screening of Breast Cancer Patients to Determine Efficiency and to Assess Sensitivity & Accuracy of Pandora CDx MammoAlertTM in Screening of Breast Cancer.|Recruiting||N/A|2400|Anticipated|POC Medical Systems, Inc.|||2||f||||f|f|f||||Samples Without DNA|"     Plasma   "|||2017-10-10 20:48:39.201301|2017-10-10 20:48:39.201301
NCT03243864|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-04|||March 13, 2017|Actual|2017-03-13|August 2017|2017-08-01|October 21, 2019|Anticipated|2019-10-21|March 21, 2019|Anticipated|2019-03-21||Observational|||Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiring Continuous Dialysis|: Pharmacokinetics of Ceftazidime-Avibactam in Critically Ill Patients With Renal Failure Requiring Continuous Venovenous Hemodiafiltration|Recruiting||N/A|10|Anticipated|Temple University|||1||f||||f|t|f|||f|None Retained|"     Whole blood, plasma, effluent fluid from dialysis machine   "|||2017-10-10 20:48:39.359865|2017-10-10 20:48:39.359865
NCT03243851|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-08-04|||November 21, 2016|Actual|2016-11-21|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|METT||Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma|Efficacy and Safety of Low Dose Temozolomide Plus Metformin as Combination Chemotherapy Compared With Low Dose Temozolomide Plus Placebo in Patient With Recurrent or Refractory Glioblastoma|Recruiting||Phase 2|108|Anticipated|Seoul St. Mary's Hospital||2|||f||||t|f|f||||||||2017-10-10 20:48:39.466609|2017-10-10 20:48:39.466609
NCT03243838|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-05|2017-08-08|||August 14, 2017|Anticipated|2017-08-14|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|August 30, 2019|Anticipated|2019-08-30||Interventional|||Neoadjuvant Chemotherapy Combined With Small Dose of Apatinib in the Treatment of Early Triple-negative Breast Cancer|A Open-label, Randomized , Prospective, Phase 2 Trial of Neoadjuvant Chemotherapy Combined With Small Dose of Apatinib in the Treatment of Early Triple-negative Breast Cancer|Not yet recruiting||Phase 2|60|Anticipated|Guangdong General Hospital||2|||f|||||f|f||||||||2017-10-10 20:48:39.619207|2017-10-10 20:48:39.619207
NCT03243825|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2017-08-08|||November 2012||2012-11-01|August 2017|2017-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer|Comparative Study of Neoadjuvant Chemo/Brachytherapy and Chemotherapy Alone Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer|Completed||N/A|120|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 20:48:39.718988|2017-10-10 20:48:39.718988
NCT03243812|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-08|||September 30, 2017|Anticipated|2017-09-30|June 2017|2017-06-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|DREPAMUSCLE||Muscle Function and Its Biological and Physiological Determinants in Sickle Cell Disease|Muscle Function and Its Biological and Physiological Determinants in Sickle Cell Disease|Not yet recruiting||N/A|80|Anticipated|Hospices Civils de Lyon||3|||f||||f|f|f||||||||2017-10-10 20:48:39.821029|2017-10-10 20:48:39.821029
NCT03243799|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-04|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|PsiCoDep||Effectiveness of a Psychoeducational Group Intervention in Patients With Depression and Physical Comorbidity|Effectiveness of a Psychoeducational Group Intervention Conducted by Primary Health Care Nurses in Patients With Depression and Physical Comorbidity|Not yet recruiting||N/A|504|Anticipated|Jordi Gol i Gurina Foundation||2|||f|||||f|f||||||||2017-10-10 20:48:39.935346|2017-10-10 20:48:39.935346
NCT03243786|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-09|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Stay on Track: A Study of Exercise Effects During Radiation|Stay on Track: A Pilot Study of the Effects of Exercise on Mitigating Side Effects and Altering Inflammatory Biomarker Profiles During Radiation Therapy for Breast Cancer|Recruiting||N/A|60|Anticipated|Medical College of Wisconsin||2|||f||||t|f|f||||||||2017-10-10 20:48:40.045668|2017-10-10 20:48:40.045668
NCT03243773|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||March 1, 2016|Actual|2016-03-01|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|ELUSIA||Evaluation of Lung Ultrasound in Acute Heart Failure|Evaluation of Lung UltraSound In Acute Heart Failure (ELUSIA)|Recruiting||N/A|300|Anticipated|Cantonal Hosptal, Baselland|||1||f||||t||||||Samples Without DNA|"     Standard laboratory samples for blood cell count, blood chemistry including NT-proBNP   "|||2017-10-10 20:48:40.210173|2017-10-10 20:48:40.210173
NCT03243760|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-04|||February 10, 2016|Actual|2016-02-10|August 2017|2017-08-01|August 20, 2016|Actual|2016-08-20|July 20, 2016|Actual|2016-07-20||Interventional|||Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients|A Double-blind (Sponsor Unblind), Randomized, Placebo-controlled, Single and Repeat Escalating Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CCI15106 Capsules for Inhalation in Healthy Subjects and Patients With Moderate Chronic Obstructive Pulmonary Disease (COPD)|Terminated||Phase 1|60|Actual|GlaxoSmithKline||11||"The trial is terminated before investigation of repeat escalating doses as these will be   conducted with the new formulation instead."|f||||f||||||||||2017-10-10 20:48:40.295805|2017-10-10 20:48:40.295805
NCT03243747|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||March 19, 2013|Actual|2013-03-19|August 2017|2017-08-01|October 14, 2016|Actual|2016-10-14|October 14, 2016|Actual|2016-10-14||Observational|||Implementation of a Computer-based Questionnaire for Preoperative Evaluation in Anesthesia Ambulance|Implementation of a Computer-based Questionnaire for Preoperative Evaluation in Anesthesia Ambulance|Completed||N/A|131|Actual|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:48:40.445012|2017-10-10 20:48:40.445012
NCT03243708|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients|Title: EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients|Not yet recruiting||N/A|50000|Anticipated|The Cleveland Clinic||2|||f||||t|f|f||||||||2017-10-10 20:48:40.708251|2017-10-10 20:48:40.708251
NCT03243695|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-03|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Influence of Abutment Angulation on Implant Failure in Immediately Placed and Restored Implants in the Esthetic Zone Using Computer Aided Surgical Guides: RCT|Implant Failure When Using Angled Versus Straight Abutments in Immediately Placed and Restored Implants in the Esthetic Zone Using Computer Aided Surgical Guides:A Randomized Clinical Trial|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:48:40.798566|2017-10-10 20:48:40.798566
NCT03243682|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-08-07|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones|The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones. A Randomized Clinical Trial|Active, not recruiting||N/A|240|Anticipated|Mansoura University||2|||f||||t|f|f||||||||2017-10-10 20:48:40.872904|2017-10-10 20:48:40.872904
NCT03243669|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-08-03|||December 1, 2010|Actual|2010-12-01|August 2017|2017-08-01|December 31, 2014|Actual|2014-12-31|June 30, 2014|Actual|2014-06-30||Interventional|||High Definition Endoscopy and Virtual Chromoendoscopy Versus Standard Resolution Endoscopy in Detection of Colon Polyps|High Definition Endoscopy and Virtual Chromoendoscopy Versus Standard Resolution Endoscopy in Detection of Colon Polyps|Completed||N/A|2146|Actual|Universitaire Ziekenhuizen Leuven||11|||f||||f|f|f||||||||2017-10-10 20:48:40.963777|2017-10-10 20:48:40.963777
NCT03243656|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-04|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|Eltroplastic||Eltrombopag in Children With Idiopathic Aplastic Anemia|Randomized Clinical Trial of the Use of Eltrombopag in Children With Idiopathic Aplastic Anemia|Not yet recruiting||Phase 4|20|Anticipated|Assiut University||2|||f||||f|f|f|||f|||||2017-10-10 20:48:41.057956|2017-10-10 20:48:41.057956
NCT03243643|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-06|||August 8, 2017|Actual|2017-08-08|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|HS:Hansoh;||Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors|Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors|Recruiting||Phase 1|80|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 20:48:41.145603|2017-10-10 20:48:41.145603
NCT03243630|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Effects of Flavors on Nicotine Reinforcement in Smokers|Effects of Flavors on Nicotine Reinforcement in Smokers|Not yet recruiting||Early Phase 1|50|Anticipated|Yale University||3|||||||t|t|f||||||||2017-10-10 20:48:41.217429|2017-10-10 20:48:41.217429
NCT03243617|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-08|||December 4, 2015|Actual|2015-12-04|August 2017|2017-08-01|September 3, 2016|Actual|2016-09-03|June 8, 2016|Actual|2016-06-08||Interventional|||Cosmetic Study of AO+Mist in Improving the Appearance of Skin Afflicted With Keratosis Pilaris|A Placebo-Controlled, Double-Blind, Bi-Lateral Study to Evaluate the Performance and Tolerability of a Cosmetic Product Designed to Improve the Appearance of Skin Afflicted With Keratosis Pilaris|Completed||N/A|26|Actual|AOBiome LLC||2|||f||||f|f|f||||||||2017-10-10 20:48:41.31381|2017-10-10 20:48:41.31381
NCT03243604|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-04|||May 16, 2017|Actual|2017-05-16|July 2017|2017-07-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Observational|ARBITRAGE||ARBITRAGE : cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study|Cardiotoxicity of Abiraterone in the National French Pharmacovigilance Database and in the European Clinical Trials Database (EudraCT)|Completed||N/A|1717|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f|||||f|f||||||||2017-10-10 20:48:41.383331|2017-10-10 20:48:41.383331
NCT03243591|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-25|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|August 15, 2018|Anticipated|2018-08-15|January 15, 2018|Anticipated|2018-01-15||Interventional|||Impact of Oral Hygiene Gels on Peri-implant Mucositis|Impact of Oral Hygiene Gels on Peri-implant Mucositis|Recruiting||Phase 4|21|Anticipated|University of Nebraska||2|||f||||f|f|f||||||||2017-10-10 20:48:41.470327|2017-10-10 20:48:41.470327
NCT03243578|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||April 2007|Actual|2007-04-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|December 2010|Actual|2010-12-01||Observational|||Relationship Between Dietary Protein Intake and Fatal and Non-fatal Health Outcomes|Relationship Between Dietary Protein Intake and Fatal and Non-fatal Health Outcomes in 180,031 UK Biobank Participants|Completed||N/A|502628|Actual|University of Glasgow|||1||f||||f|f|f||||||||2017-10-10 20:48:41.546602|2017-10-10 20:48:41.546602
NCT03243565|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-10-04|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Effect of OM-85 on Respiratory Tract Infections and Adenoid Tissue in Children With Adenoid Hypertrophy|Effect of Vaxoral® (OM-85) on Frequency of Respiratory Tract Infections and Size of Adenoid Tissue in Preschool Children With Adenoid Hypertrophy|Not yet recruiting||Phase 4|68|Anticipated|Dr. Sami Ulus Children's Hospital||2|||f||||t|f|f||||||||2017-10-10 20:48:41.597352|2017-10-10 20:48:41.597352
NCT03243552|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-08|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|ACEP4||Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD|Proof of Mecahism Study for the Treatment of Social Anhedonia in ASD|Not yet recruiting||Phase 2|56|Anticipated|University of California, Los Angeles||2|||f||||t|f|f||||||||2017-10-10 20:48:41.672906|2017-10-10 20:48:41.672906
NCT03243539|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-28|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|August 15, 2018|Anticipated|2018-08-15||Interventional|NEUROVENT||Implementation of Neuro Lung Protective Ventilation|Implementation of Neuro Lung Protective Ventilation in Patients With Acute Brain Injury|Recruiting||N/A|728|Anticipated|Intermountain Health Care, Inc.||1|||f||||f|f|f||||||||2017-10-10 20:48:41.843987|2017-10-10 20:48:41.843987
NCT03243526|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-03|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Fluid Management Guided by Pulse Pressure Variation Vs Central Venous Pressure on Lung Water Assessed by Lung Ultrasound During Liver Transplantation|The Effect of Fluid Management Guided by Pulse Pressure Variation Versus Central Venous Pressure on Extra Vascular Lung Water Assessed by Lung Ultrasound Score During Liver Transplantation. A Randomized Controlled Trial.|Recruiting||N/A|40|Anticipated|Kasr El Aini Hospital||2|||f||||f|f|f||||||||2017-10-10 20:48:41.95718|2017-10-10 20:48:41.95718
NCT03243513|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Abo Follow-up Study|Abortion Follow-up Study|Active, not recruiting||N/A|1500|Anticipated|University of New Mexico|||1||f||||f|f|f||||||||2017-10-10 20:48:42.041809|2017-10-10 20:48:42.041809
NCT03243500|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-08|||May 1, 2015|Actual|2015-05-01|August 2017|2017-08-01|May 1, 2016|Actual|2016-05-01|May 1, 2016|Actual|2016-05-01||Interventional|||Efficacy and Safety of Adding Atracurium to Percaruncular Block for High Myopes Undergoing Cataract Surgery|Efficacy and Safety of Low Dose Atracurium Added to Lidocaine, Bupivacaine and Hyaluronidase Mixture in Percaruncular Peribulbar Anesthesia for High Myopes Undergoing Phacoemulsification: A Randomized Controlled Trial.|Completed||Phase 4|91|Actual|Kasr El Aini Hospital||2|||f||||t|f|f||||||||2017-10-10 20:48:42.107978|2017-10-10 20:48:42.107978
NCT03243487|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||ThErapy Adherence Management in Veterans|ThErapy Adherence Management in Veterans: A Randomized Trial|Recruiting||N/A|250|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 20:48:42.207498|2017-10-10 20:48:42.207498
NCT03243461|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 1, 2022|Anticipated|2022-05-01|December 1, 2020|Anticipated|2020-12-01||Interventional|HIT-HGG-2013||International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)|International Cooperative Phase III Trial of the HIT-HGG Study Group for the Treatment of High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and Gliomatosis Cerebri in Children and Adolescents < 18 Years.(HIT-HGG-2013)|Not yet recruiting||Phase 3|198|Anticipated|University of Göttingen||2|||f||||t|f|f||||||||2017-10-10 20:48:42.411644|2017-10-10 20:48:42.411644
NCT03243448|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-03|||August 1, 2016|Actual|2016-08-01|August 2016|2016-08-01|July 31, 2026|Anticipated|2026-07-31|July 31, 2026|Anticipated|2026-07-31|1 Year|Observational [Patient Registry]|||Skin Sympathetic Nerve Activity and Sympathetic Tone|Using Skin Sympathetic Nerve Activity to Estimate Sympathetic Tone in Human|Enrolling by invitation||N/A|1000|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||2||f||||||||||Samples With DNA|"     Blood sample   "|||2017-10-10 20:48:42.50206|2017-10-10 20:48:42.50206
NCT03243435|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-03|||July 2016||2016-07-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Sienna+MR Long-term Uptake|Feasibility of Breast MRI After Sentinel Procedure for Breast Cancer With Superparamagnetic Tracers|Completed||N/A|34|Actual|Kantonsspital Baden|||1||f||||f||||||||||2017-10-10 20:48:42.556857|2017-10-10 20:48:42.556857
NCT03243422|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-03|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|ACHIEVE||Aging and Cognitive Health Evaluation in Elders (ACHIEVE)|Aging and Cognitive Health Evaluation in Elders (ACHIEVE) Randomized Trial|Not yet recruiting||N/A|850|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t|f|f||||||||2017-10-10 20:48:42.628779|2017-10-10 20:48:42.628779
NCT03243409|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-03|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Perioperative Complications in Reversed Shoulder Arthroplasties|Perioperative Complications in Proximal Humeral Fractures Treated With Reversed Shoulder Arthroplasties|Recruiting||N/A|105|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||t|f|f||||||||2017-10-10 20:48:42.740288|2017-10-10 20:48:42.740288
NCT03243396|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-04|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|BASIC||Building and Sustaining Interventions for Children: Task-sharing Mental Health Care in Low-resource Settings|Building and Sustaining Interventions for Children (BASIC): Task-sharing Mental Health Care in Low-resource Settings|Not yet recruiting||N/A|3072|Anticipated|Duke University||2|||f||||t|f|f||||||||2017-10-10 20:48:42.858309|2017-10-10 20:48:42.858309
NCT03243383|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-07|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Readmission Prevention Pilot Trial in Diabetes Patients|A Pilot Trial to Prevent Hospital Readmission of Patients With Diabetes|Recruiting||N/A|235|Anticipated|Temple University||3|||f||||f|f|f||||||||2017-10-10 20:48:43.104147|2017-10-10 20:48:43.104147
NCT03243370|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-04|||April 2014|Actual|2014-04-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|Clock'N'test||Clock'N' Test: Development and Validation of a Test to Evaluate Emotional Disorders|Clock'N' Test: Development and Validation (in a Control Population) of a Test Based on Time Estimations and Aiming to Evaluate Emotional Disorders|Completed||N/A|150|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||f|f|f||||||||2017-10-10 20:48:43.218994|2017-10-10 20:48:43.218994
NCT03243357|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-08|||September 4, 2017|Anticipated|2017-09-04|August 2017|2017-08-01|December 10, 2018|Anticipated|2018-12-10|January 4, 2018|Anticipated|2018-01-04||Interventional|||In Vivo Assessment of Endodontics Procedures|In Vivo Assessment of Endodontics Procedures|Recruiting||N/A|75|Anticipated|Federal University of Uberlandia||3|||f||||f|f|f||||||||2017-10-10 20:48:43.286731|2017-10-10 20:48:43.286731
NCT03243344|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-04|||March 2010||2010-03-01|March 2010|2010-03-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|PRHEPOCE||Randomized Assessment of Devices Used to Prevent Post-operative Hemorrhagic Risk in Endonasal Surgery|Randomized Medico-economic Assessment of Preventive Devices Used for Post-operative Hemorrhagic Risk in Endonasal Surgery|Completed||N/A|571|Actual|Centre Hospitalier Universitaire de Besancon||4|||f||||t||||||||||2017-10-10 20:48:43.406668|2017-10-10 20:48:43.406668
NCT03243331|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer|An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer|Not yet recruiting||Phase 1|18|Anticipated|Indiana University||1|||f||||t|t|f||||||||2017-10-10 20:48:43.498643|2017-10-10 20:48:43.498643
NCT03243318|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|||Motor Evoked Potential in the Affected Upper Limb Predicts the Potential of Motor Recovery After Ischemic Stroke|Motor Evoked Potential in the Affected Upper Limb Predicts the Potential of Motor Recovery After Ischemic Stroke|Not yet recruiting||N/A|30|Anticipated|Hospital Authority, Hong Kong|||2||f||||t|f|t|f|f|f|||||2017-10-10 20:48:43.589439|2017-10-10 20:48:43.589439
NCT03243305|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-07|||July 27, 2017|Actual|2017-07-27|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||AMP002 Phase III Contraceptive Study|AMPOWER A Single-are, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of AMPHORA® Contraceptive Vaginal Gel|Recruiting||Phase 3|1350|Anticipated|Evofem Inc.||1|||f||||t|t|f||||||||2017-10-10 20:48:43.660643|2017-10-10 20:48:43.660643
NCT03243292|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-03|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|||Bronchial Thermoplasty 10+ Year Study|Ten Year Follow-up of Subjects From 3 Landmark Randomized Controlled Bronchial Thermoplasty (BT) Studies|Not yet recruiting||N/A|196|Anticipated|Boston Scientific Corporation|||3||f||||f|f|f||||||||2017-10-10 20:48:43.752146|2017-10-10 20:48:43.752146
NCT03243279|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-18|||September 15, 2017|Actual|2017-09-15|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||BRS and Outcomes in Cardiothoracic Surgery|Role of Preoperative Baroreflex Sensitivity on Major Outcomes After Cardiothoracic Surgery|Recruiting||N/A|95|Anticipated|Duke University|||1||f||||f|f|f||||Samples With DNA|"     Arterial blood   "|||2017-10-10 20:48:43.906217|2017-10-10 20:48:43.906217
NCT03243253|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-03|||January 1, 2011|Actual|2011-01-01|August 2017|2017-08-01|February 1, 2013|Actual|2013-02-01|January 1, 2012|Actual|2012-01-01||Observational|||The Association of Fast Food Densities With Mortality From Cardiovascular Disease|The Association of Fast Food and Full Service Restaurant Densities With Mortality From Cardiovascular Disease and Stroke, and the Prevalence of Diabetes|Completed||N/A|17000000|Actual|Chinese Academy of Sciences|||1||f|||||f|f||||||||2017-10-10 20:48:44.071413|2017-10-10 20:48:44.071413
NCT03243240|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-04|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Computed Tomography in Gastrointestinal Bleeding|Role of Triphasic Computed Tomography Imaging in the Detection of Acute Non-variceal Gastrointestinal Bleeding|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:48:44.130696|2017-10-10 20:48:44.130696
NCT03243227|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Effectiveness of Neurodynamic Techniques for the Treatment of Carpal Tunnel Syndrome: A Randomized Controlled Trial|Effectiveness of Neurodynamic Techniques for the Treatment of Carpal Tunnel Syndrome: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|University of Jordan||2|||f||||t|f|f||||||||2017-10-10 20:48:44.199819|2017-10-10 20:48:44.199819
NCT03243214|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-03|||October 24, 2016|Actual|2016-10-24|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|PD-MCI-TMS||Effect of Transcranial Magnetic Stimulation on Cognition and Neural Changes in Parkinson's Disease|Effect of Excitatory Theta-Burst Transcranial Magnetic Stimulation on Cognition in Patients With Both Parkinson's Disease and Mild Cognitive Impairment and Analysis of Functional and Structural Brain Changes After Stimulation|Recruiting||N/A|64|Anticipated|University of Calgary||2|||f||||f|f|f||||||||2017-10-10 20:48:44.301886|2017-10-10 20:48:44.301886
NCT03243201|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SNITCH||Silver Nanoparticle Investigation for Treating Chronic Sinusitis|The Efficacy and Safety of Intranasal Colloidal Silver Nanoparticles for Chronic Rhinosinusitis: A Proof-Of-Concept, Double-Blinded, Placebo-Controlled, Randomized Trial|Not yet recruiting||Phase 1|40|Anticipated|Washington University School of Medicine||2|||f|||||f|f||||||||2017-10-10 20:48:44.396469|2017-10-10 20:48:44.396469
NCT03243188|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-03|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Palliative Care in General Practice: Cancer Patient/Carer Experience|Palliative Care in General Practice: Cancer Patients' and Carers' Experience of Their General Practitioner's (GP's) Role|Not yet recruiting||N/A|30|Anticipated|King's College London|||1||f|||||f|f||||||||2017-10-10 20:48:44.460042|2017-10-10 20:48:44.460042
NCT03243175|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|A3ICH||Avoiding Anticoagulation After IntraCerebral Haemorrhage|Avoiding Anticoagulation After IntraCerebral Haemorrhage|Not yet recruiting||Phase 3|300|Anticipated|University Hospital, Lille||3|||f||||t|f|f||||||||2017-10-10 20:48:44.526209|2017-10-10 20:48:44.526209
NCT03243162|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-08|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Improving ACL Reconstruction Outcomes: CBPT|Improving ACL Reconstruction Outcomes: Cognitive-Behavioral Based Physical Therapy|Recruiting||N/A|70|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:48:44.609606|2017-10-10 20:48:44.609606
NCT03243149|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-25|||June 2018|Anticipated|2018-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Neurofeedback With Real-Time fMRI for Treatment of PTSD|Neurofeedback With Real-Time fMRI for Treatment of Posttraumatic Stress Disorder|Not yet recruiting||N/A|20|Anticipated|Duke University||3|||f||||t|f|t|t|f||||||2017-10-10 20:48:44.699951|2017-10-10 20:48:44.699951
NCT03243136|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||January 1, 2004|Actual|2004-01-01|August 2017|2017-08-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Observational|||The Association Between Food Insecurity and Incident Type 2 Diabetes in Canada: A Population-based Cohort Study|The Association Between Food Insecurity and Incident Type 2 Diabetes in Canada: A Population-based Cohort Study|Completed||N/A|4739|Actual|University of Toronto|||1||f||||f|f|f||||||||2017-10-10 20:48:44.796915|2017-10-10 20:48:44.796915
NCT03243123|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||June 1, 2014|Actual|2014-06-01|August 2017|2017-08-01|December 23, 2014|Actual|2014-12-23|November 15, 2014|Actual|2014-11-15||Interventional|||Upper Limb Robotic Rehabilitation After Stroke|Passive Mobilization With Robotic Assistance Improve Hemiparetic Upper Limb Circulation and Functional Status in Stroke Survivors.|Completed||N/A|23|Actual|Università degli Studi di Brescia||1|||f|||||f|f||||||||2017-10-10 20:48:44.858549|2017-10-10 20:48:44.858549
NCT03243110|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||December 2010|Actual|2010-12-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|September 2013|Actual|2013-09-01||Observational|PopData||The Economic Burden of Asthma in Canada|The Economic Burden of Asthma in Canada|Completed||N/A|613|Actual|University of British Columbia|||1||f||||||||||||||2017-10-10 20:48:44.910729|2017-10-10 20:48:44.910729
NCT03243097|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-30|||August 24, 2017|Actual|2017-08-24|August 2017|2017-08-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|CROS||CROS Application in CI|Contralateral Routing of Signal in Unilateral Cochlear Implant Users|Recruiting||N/A|15|Anticipated|University of Miami||1|||f|||||f|t|f|f|f|||||2017-10-10 20:48:44.96968|2017-10-10 20:48:44.96968
NCT03243084|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-13|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|BPS||Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy|Effect of Transcranial Alternating Current Stimulation in Chronic Low Back Pain: A Pilot Study|Recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|t|t|f|f|||||2017-10-10 20:48:45.054924|2017-10-10 20:48:45.054924
NCT03243071|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-16|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|SUMMIT||Securing Under-represented Minorities Involvement in Trials Using a Patient-Centered Website: A Community-Engaged Approach|Securing Under-represented Minorities Involvement in Trials Using a Patient-Centered Website: A Community-Engaged Approach|Recruiting||N/A|100|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:48:45.13657|2017-10-10 20:48:45.13657
NCT03243058|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-03|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01||Interventional|IL-2||Administration of Low-dose IL-2 in Established T1D|A Randomized, Double Blind, Phase I/II Trial of Low-Dose Interlekin-2 Immunotherapy in Established Type 1 Diabetes|Not yet recruiting||Phase 1/Phase 2|54|Anticipated|University of Miami||2|||f||||t|t|f||||||||2017-10-10 20:48:45.234945|2017-10-10 20:48:45.234945
NCT03243045|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01|1 Year|Observational [Patient Registry]|||Systemic Microvascular Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation|Evaluation of Systemic Microvascular Density and Endothelial Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation|Recruiting||N/A|40|Anticipated|National Institute of Cardiology, Laranjeiras, Brazil|||1||f||||f|f|f||||||||2017-10-10 20:48:45.33244|2017-10-10 20:48:45.33244
NCT03243032|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-23|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|July 30, 2019|Anticipated|2019-07-30||Interventional|||Pre-Emptive Analgesia in Dental Implant Surgery|Pain Management Using Pre-Emptive Analgesia in Dental Implant Surgery - A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial|Not yet recruiting||Early Phase 1|70|Anticipated|University of Iowa||2|||f||||f|t|f|||f|||||2017-10-10 20:48:45.42359|2017-10-10 20:48:45.42359
NCT03243019|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|RAPAMALYMPH||Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations|Evaluation of the Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations of Poor Prognosis|Not yet recruiting||Phase 2|28|Anticipated|University Hospital, Lille||1|||f||||f|f|f||||||||2017-10-10 20:48:45.513396|2017-10-10 20:48:45.513396
NCT03243006|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-08-07|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Effect of Early Pain Management at Triage on Opioid Consumption|Effect of Early Analgesic Treatment on Opioid Consumption|Completed||N/A|1500|Actual|University of Monastir||3|||f||||f|f|f||||||||2017-10-10 20:48:45.583647|2017-10-10 20:48:45.583647
NCT03242993|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-07|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|March 1, 2019|Anticipated|2019-03-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging|Biodistribution, Tumor Detection, and Radiation Dosimentry of [18F]-AZAFOL as POSITRON EMISSION TOMOGRAPHY (PET) Tracer in Folate Receptor Positive Cancer Imaging|Recruiting||Phase 1|36|Anticipated|University of Lausanne Hospitals||1|||f||||t|f|f||||||||2017-10-10 20:48:45.648874|2017-10-10 20:48:45.648874
NCT03242980|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||May 18, 2017|Actual|2017-05-18|August 2017|2017-08-01|March 1, 2019|Anticipated|2019-03-01|October 1, 2018|Anticipated|2018-10-01||Interventional|SAVIR||Short Adherence Intervention for Viral Re-suppression|Short Adherence Intervention for Viral Re-suppression (SAVIR) Study: A Stepped Wedge Randomized Controlled Study to Assess the Effect of Standardized Adherence Counselling in Individuals With Unsuppressed Viral Load in Lesotho|Recruiting||N/A|350|Anticipated|Swiss Tropical & Public Health Institute||2|||f||||f|f|f||||||||2017-10-10 20:48:45.842719|2017-10-10 20:48:45.842719
NCT03242967|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|||Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)|Phase 3, Randomized, Open Label, Active Controlled Study Evaluating the Efficacy and Safety of Three Times Per Week (TIW) Oral Dosing of Vadadustat for the Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (TRILO2GY)|Not yet recruiting||Phase 3|272|Anticipated|Akebia Therapeutics||2|||f|||||t|f||||||||2017-10-10 20:48:46.008324|2017-10-10 20:48:46.008324
NCT03242954|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-21|||October 15, 2017|Anticipated|2017-10-15|July 2017|2017-07-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Innovative Approaches for Minor Consent: Consent 2.0|Innovative Approaches for Minor Consent: Consent 2.0 - A Multi-Center Study of the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)|Not yet recruiting||N/A|240|Anticipated|University of North Carolina, Chapel Hill||4|||f||||f|f|f||||||||2017-10-10 20:48:46.132904|2017-10-10 20:48:46.132904
NCT03242941|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|November 2018|Anticipated|2018-11-01||Interventional|||AF Septal Pacing (Clinical Investigation Plan)|AF Septal Pacing (Clinical Investigation Plan)|Not yet recruiting||N/A|15|Anticipated|Medtronic BRC||1|||f||||f|f|f||||||||2017-10-10 20:48:46.272429|2017-10-10 20:48:46.272429
NCT03242928|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||November 30, 2017|Anticipated|2017-11-30|August 2017|2017-08-01|April 19, 2019|Anticipated|2019-04-19|April 19, 2019|Anticipated|2019-04-19||Interventional|||Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)|A Randomized, Subject and Investigator Blinded, Placebo-controlled, Parallel Group Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)|Not yet recruiting||Phase 2|60|Anticipated|Novartis||2|||f||||f|t|f|||f|||||2017-10-10 20:48:46.353924|2017-10-10 20:48:46.353924
NCT03242915|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Pembrolizumab in Combination With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation and ALK Positive NSCLC (Non-Small Cell Lung Cancer) With Progressive Disease Following Prior Tyrosine Kinase Inhibitors (TKIs)|Phase II Multi-center Study of Pembrolizumab in Combination With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation and ALK Positive NSCLC (Non-Small Cell Lung Cancer) With Progressive Disease Following Prior Tyrosine Kinase Inhibitors (TKIs)|Not yet recruiting||Phase 2|62|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 20:48:46.451436|2017-10-10 20:48:46.451436
NCT03242902|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|SPARKLE||To Decrease Fatigue With Light Therapy|Improving Sleep Quality, Psychosocial Functioning, and Cancer Related Fatigue With Light Therapy|Recruiting||Phase 3|160|Anticipated|The Netherlands Cancer Institute||2|||f||||f|f|f||||||||2017-10-10 20:48:46.598902|2017-10-10 20:48:46.598902
NCT03241381|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Prevalence of Serum-Vitamin D Abnormalities, Periodontitis and Anaemia in Patients With Melasma|A Cross Sectional Observational Study|Completed||N/A|100|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||2||f||||t|f|f||||||||2017-10-10 20:48:59.596874|2017-10-10 20:48:59.596874
NCT03242876|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-17|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effects of Citric and Malic Acid Found in Pomegranate Juice on Glycaemic Response to White Bread.|The Effects of Citric and Malic Acid Found in Pomegranate Juice on Glycaemic Response|Active, not recruiting||N/A|16|Actual|University of Leeds||2|||f|||||f|f||||||||2017-10-10 20:48:46.896931|2017-10-10 20:48:46.896931
NCT03242863|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-18|||November 6, 2017|Anticipated|2017-11-06|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Effect of Varying Proportions of Low and High Energy Dense Foods Over 5 Days in Preschool Children|Strategies to Moderate Energy Intake for the Prevention of Obesity in Children|Not yet recruiting||N/A|65|Anticipated|Penn State University||3|||f||||f|f|f||||||||2017-10-10 20:48:46.992801|2017-10-10 20:48:46.992801
NCT03242850|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|APLUS||Assuring Patient-centered Literacy Promotion for Underserved Children Study|Assuring Patient-centered Literacy Promotion for Underserved Children to Promote School Readiness|Not yet recruiting||N/A|150|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||||2017-10-10 20:48:47.08586|2017-10-10 20:48:47.08586
NCT03242837|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-30|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|February 28, 2018|Anticipated|2018-02-28||Interventional|OpPHX||Psychobiological Evaluation of the Army Resilience Training|Psychobiological Evaluation of the Army Resilience Training|Active, not recruiting||N/A|100|Anticipated|Military Academy at ETH Zurich||2|||f||||t|f|f||||||||2017-10-10 20:48:47.195394|2017-10-10 20:48:47.195394
NCT03242798|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||March 2016||2016-03-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|October 2018|Anticipated|2018-10-01||Observational|||Assessment of Nutritional Status of Patients With Liver Cirrhosis|Assessment of Nutritional Status of Patients With Liver Cirrhosis|Recruiting||N/A|170|Anticipated|Harokopio University|||1||f||||f||||||||||2017-10-10 20:48:47.538665|2017-10-10 20:48:47.538665
NCT03242785|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ADAMPA||Impact of Self-monitoring of Blood Pressure and Self-titration of Medication in the Control of Hypertension (ADAMPA)|Impact of Self-monitoring of Blood Pressure and Self-titration of Antihypertensive Medication in the Control of Hypertension and Adherence to Treatment. A Pragmatic, Randomized, Controlled Clinical Trial (ADAMPA Study).|Recruiting||N/A|458|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f|||||f|f||||||||2017-10-10 20:48:47.642245|2017-10-10 20:48:47.642245
NCT03242772|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Impact of Combined Medication and Behavioral Treatment for ASD & ADHD|Impact of Combined Medication and Behavioral Treatment in Young Children With Comorbid ASD and ADHD|Not yet recruiting||Phase 2|78|Anticipated|Duke University||2|||f||||t|t|f|||f|||||2017-10-10 20:48:47.751053|2017-10-10 20:48:47.751053
NCT03242759|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-10-03|||August 17, 2017|Actual|2017-08-17|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan|Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan|Recruiting||N/A|100|Anticipated|Boehringer Ingelheim|||1||f||||f|f|f||||||||2017-10-10 20:48:47.853956|2017-10-10 20:48:47.853956
NCT03242746|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-09-12|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2020|Anticipated|2020-09-01|3 Years|Observational [Patient Registry]|||Cervical Morphological Changes on Pregnancy Outcome|The Effect of Cervical Morphological Changes on Pregnancy Outcome After Loop Electrosurgical Excision Procedure|Recruiting||N/A|300|Anticipated|The Second Affiliated Hospital of Chongqing Medical University|||2||f||||t|f|f||||||||2017-10-10 20:48:47.989384|2017-10-10 20:48:47.989384
NCT03242733|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Ultrasound Assessment of Gastric Contents in Fasted Elderly Patients With Hip Fracture|Ultrasound Assessment of Gastric Contents in Fasted Elderly Patients With Hip|Not yet recruiting||N/A|200|Anticipated|SMG-SNU Boramae Medical Center|||1||f||||t|f|f||||||||2017-10-10 20:48:48.078987|2017-10-10 20:48:48.078987
NCT03242720|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|OSA-AFIB||Effects of PAP on Afib Recurrence Risk After Catheter Ablation in OSA Patients|Effects of Positive Airway Pressure on Atrial Fibrillation Recurrence Risk After Catheter Ablation in Patients With Atrial Fibrillation and Obstructive Sleep Apnea-A Pilot Randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|Stanford University||2|||f||||f|f|f|||t|||||2017-10-10 20:48:48.162812|2017-10-10 20:48:48.162812
NCT03242694|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-03|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|LAMPP||Left Atrial Function Analysis for Patients With Persistent Atrial Fibrillation Undergoing Pulmonary Vein Isolation|Left Atrial Function Analysis With Multimodal Techniques for Patients With Persistent Atrial Fibrillation Undergoing Pulmonary Vein Isolation|Recruiting||N/A|100|Anticipated|Semmelweis University Heart and Vascular Center|||1||f||||f|f|f||||Samples Without DNA|"     venous blood samples   "|||2017-10-10 20:48:48.326146|2017-10-10 20:48:48.326146
NCT03242681|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-06|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|Non||Endoscopy Assisted Probing Versus Simple Probing in Primary Congenital Nasolacrimal Duct Obstruction|Endoscopy Assisted Probing Versus Simple Probing in Patients With Primary Congenital Nasolacrimal Duct Obstruction: A Randomized Clinical Trial|Recruiting||N/A|320|Anticipated|Tehran University of Medical Sciences||2|||f|||||f|f|||f|||||2017-10-10 20:48:48.414702|2017-10-10 20:48:48.414702
NCT03242655|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention|Adaptation and Testing of a Primary Care HCV Group Medical Treatment Intervention|Recruiting||N/A|96|Anticipated|Montefiore Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:48:48.578443|2017-10-10 20:48:48.578443
NCT03242642|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||August 2017||2017-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:48:48.650059|2017-10-10 20:48:48.650059
NCT03242629|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-03|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Comparison Between Oral and Enema of Chloral Hydrate|Effects Comparison Between Oral and Enema of Chloral Hydrate in Pediatric Ophthalmic Examination|Completed||N/A|120|Actual|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 20:48:48.690931|2017-10-10 20:48:48.690931
NCT03242616|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-03|||February 17, 2017|Actual|2017-02-17|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||PemVin vs Vin in Previously Treated Metastatic Breast Cancer|Randomized Phase II Trial of Pemetrexed Plus Vinorelbine Versus Vinorelbine in Patients With Recurrent or Metastatic Breast Cancer Previously Treated With or Resistant to Anthracycline and Taxane|Recruiting||Phase 2|125|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:48:48.759263|2017-10-10 20:48:48.759263
NCT03242603|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-23|||October 30, 2017|Anticipated|2017-10-30|June 2017|2017-06-01|August 15, 2020|Anticipated|2020-08-15|August 15, 2019|Anticipated|2019-08-15||Interventional|NKEXPGD2||Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells|Pilot Study of Anti-GD2 and Expanded, Activated Natural Killer Cell Infusion for Neuroblastoma|Recruiting||Phase 1/Phase 2|5|Anticipated|National University Hospital, Singapore||1|||f||||f|f|f||||||||2017-10-10 20:48:48.857678|2017-10-10 20:48:48.857678
NCT03242590|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|DV||Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).|Validation of Dosing Regimen of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men.|Completed||Phase 1|95|Actual|Lipocine Inc.||1|||f||||f|t|f||||||||2017-10-10 20:48:48.950606|2017-10-10 20:48:48.950606
NCT03242577|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Observational|||Micro-Technique Sampling|An Exploratory Comparative Pilot Study to Identify the Most Appropriate Method for Microbial Consortia Sampling From the Skin-II|Completed||N/A|10|Actual|Kimberly-Clark Corporation|||1||f||||f|f|f||||||||2017-10-10 20:48:49.045513|2017-10-10 20:48:49.045513
NCT03242564|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-03|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||Effects of Red Light LED Therapy on Body Contouring|A Retrospective Analysis of the Effects of Red Light LED Therapy on Body Contouring|Completed||N/A|66|Actual|Vevazz, LLC||1|||f||||f|f|t|f||t|||||2017-10-10 20:48:49.09403|2017-10-10 20:48:49.09403
NCT03242551|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-07|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|August 31, 2022|Anticipated|2022-08-31||Interventional|BINC-B||Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer|The Role of Multimodal Imaging and Circulating Biomarkers in Predicting the Response of Neoadjuvant Chemotherapy for Breast Cancer|Not yet recruiting||Phase 2|120|Anticipated|Shenzhen People's Hospital||1|||f||||t|f|f||||||||2017-10-10 20:48:49.165499|2017-10-10 20:48:49.165499
NCT03242538|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-03|||June 23, 2017|Actual|2017-06-23|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Prehabilitation for Pelvic Cancer: Changes in Setup Variability|Prehabilitation for Port Films: Phase 1. Evaluating Orthopedic Measurements of Pelvic Tilt During Radiation Treatments for Pelvic Cancer|Recruiting||N/A|20|Anticipated|University of Massachusetts, Worcester||1|||f||||f|f|f||||||||2017-10-10 20:48:49.240811|2017-10-10 20:48:49.240811
NCT03242525|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Observational|||Examination of the Time Advantage of Point of Care Testing (POCT) Compared to the Conventional Central Laboratory Analysis in Intraclinical Patient Care|Examination of the Time Advantage of Point of Care Testing (POCT) Compared to the Conventional Central Laboratory Analysis in Intraclinical Patient Care|Not yet recruiting||N/A|24|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f|f|f||||||||2017-10-10 20:48:49.339146|2017-10-10 20:48:49.339146
NCT03242512|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-21|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Assessment of Anti-RANKL Antibody in Post-menopausal Women|Phase I Trial of Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Fully Human Monoclonal Antibody to RANKL (TK006) in Post-menopausal Women.|Not yet recruiting||Phase 1|24|Anticipated|Jiangsu T-Mab Biopharma Co.,Ltd||3|||f||||f|f|f||||||||2017-10-10 20:48:49.405828|2017-10-10 20:48:49.405828
NCT03242499|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-07|||August 15, 2017|Anticipated|2017-08-15|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease|Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease: a Single-center, Double-blind, Placebo-controlled Randomized Trial|Recruiting||Phase 2|80|Anticipated|National Taiwan University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:48:49.49218|2017-10-10 20:48:49.49218
NCT03242486|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-03|||December 2014|Actual|2014-12-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|May 2017|Actual|2017-05-01||Interventional|||Clinical Evaluation of Toric Intraocular Lens|Safety and Effectiveness Evaluation of Toric Intraocular Lens|Active, not recruiting||N/A|64|Actual|Nidek Co. LTD.||1|||f|||||f|f||||||||2017-10-10 20:48:49.565286|2017-10-10 20:48:49.565286
NCT03242473|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-09-06|||December 2014||2014-12-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparing the Effects of Lactated Ringers and Normal Saline in Acute Pancreatitis|Mitigating the Inflammatory Response in Acute Pancreatitis With Appropriate Fluid Management; A Randomized Clinical Control Trial Comparing the Effects of Lactated Ringers and Normal Saline|Recruiting||N/A|80|Anticipated|Children's Hospital of The King's Daughters||2|||f||||f||||||||||2017-10-10 20:48:49.624502|2017-10-10 20:48:49.624502
NCT03242460|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-06|||May 12, 2015||2015-05-12|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|PORYOU||The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)|The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM) Who Had Lenalidomide Plus Dexamethasone (LD) Following Frontline Bortezomib Combined Chemotherapy, Open-labeled, Multicenter Phase II Study|Recruiting||Phase 2|55|Anticipated|Kosin University Gospel Hospital||1|||f||||f|f|f||||||||2017-10-10 20:48:49.716062|2017-10-10 20:48:49.716062
NCT03242447|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-03|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluation of e-Practice Self-Regulation (e-PS-R)|Evaluation of e-Practice Self-Regulation (e-PS-R)|Not yet recruiting||N/A|600|Anticipated|The Policy & Research Group||2|||f||||f|f|f||||||||2017-10-10 20:48:51.257444|2017-10-10 20:48:51.257444
NCT03242434|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-28|||October 16, 2017|Anticipated|2017-10-16|September 2017|2017-09-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants|A Prospective, Longitudinal Study to Investigate the Effect of Thermal Injury on Intestinal Permeability and Systemic Inflammation (HESTIA)|Not yet recruiting||Phase 1|40|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 20:48:51.367595|2017-10-10 20:48:51.367595
NCT03242421|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-09|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|December 1, 2017|Anticipated|2017-12-01||Observational|||Test-retest Reliability of Two Measurements of the Visual System|Determining the Consistency of Scores Across Two Measurements of the Visual System: Test-retest Reliability|Recruiting||N/A|20|Anticipated|McGill University|||1||f|||||f|f||||||||2017-10-10 20:48:51.446144|2017-10-10 20:48:51.446144
NCT03242408|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Interventional|DF||Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)|Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men.|Completed||Phase 1|100|Actual|Lipocine Inc.||1|||f||||f|t|f||||||||2017-10-10 20:48:51.518793|2017-10-10 20:48:51.518793
NCT03242395|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-07|||October 2014||2014-10-01|December 2016|2016-12-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Observational|PRIME||PRIME: Cognitive Outcome Following Major Burns|Perioperative Research Into Memory (PRiMe): The Use of fMRI to Investigate Neuroinflammation, Cognitive Dysfunction and Quality of Life Following a Major Burn Injury and Critical Care Admission|Completed||N/A|30|Actual|Chelsea and Westminster NHS Foundation Trust|||2||f||||t||||||||||2017-10-10 20:48:51.582008|2017-10-10 20:48:51.582008
NCT03242382|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-07|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|PalboSarc||Phase II Multicenter Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.|Phase II Multicenter Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.|Recruiting||Phase 2|38|Anticipated|Grupo Espanol de Investigacion en Sarcomas||1|||f||||f|f|f||||||||2017-10-10 20:48:51.673841|2017-10-10 20:48:51.673841
NCT03242369|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Comparison of the Effectiveness of Bowel Preparations Before Colonoscopy|Comparison of the Effectiveness of Bowel Preparations in Bowel Cleansing Before Colonoscopy - Prospective, Randomized Study|Not yet recruiting||N/A|400|Anticipated|Military University Hospital, Prague||4|||f|||||f|f||||||||2017-10-10 20:48:51.790814|2017-10-10 20:48:51.790814
NCT03242343|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|May 2019|Anticipated|2019-05-01||Interventional|||VasQ External Support for Arteriovenous Fistula|A Multi-center Prospective Study to Evaluate the Safety and Effectiveness of the VasQ External Support for Arteriovenous Fistula|Not yet recruiting||N/A|129|Anticipated|Laminate Medical Technologies||1|||f||||t|f|t|t|f||||||2017-10-10 20:48:51.943365|2017-10-10 20:48:51.943365
NCT03242330|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-03|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Two-piece Versus Single-piece Patient-specific Titanium Subperiosteal Implants|Implant Survival in Two-piece Versus Single-piece Patient-specific Titanium Subperiosteal Implants in Atrophied Edentulous Mandibles: Randomized Clinical Trial|Not yet recruiting||N/A|156|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:48:52.147811|2017-10-10 20:48:52.147811
NCT03242317|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||June 16, 2017|Actual|2017-06-16|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||A Prospective Study to Evaluate the Raindrop Near Vision Inlay With Mitomycin C|A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopes Treated With Mitomycin C During Surgery and Extended Steroid After Surgery|Recruiting||Phase 4|40|Anticipated|Fichte, Endl & Elmer Eyecare||1|||f||||f|t|t|f|f|t|||||2017-10-10 20:48:52.249818|2017-10-10 20:48:52.249818
NCT03242304|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||April 1, 2016|Actual|2016-04-01|August 2017|2017-08-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Observational|Cortisol||Neuroactive Steroids in Acute Ischemic Stroke|Changes in Plasma Cortisol, Brain-derived Neurotrophic Factor, and Nitrites in Patients With Acute Ischemic Stroke|Completed||N/A|40|Actual|Hospital Militar Central, Argentina|||2||f||||t|f|f||||||||2017-10-10 20:48:52.343195|2017-10-10 20:48:52.343195
NCT03242291|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-07|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluation of Marginal Integrity of Hydroxyapatite Nano-Fiber Reinforced Flowable Composite Versus Conventional Resin-Based Flowable Composite in Initially Demineralized Pits and Fissure: A One Year, Randomized Clinical Trial|Evaluation of Marginal Integrity of Hydroxyapatite Nano-Fiber Reinforced Flowable Composite Versus Conventional Resin-Based Flowable Composite in Initially Demineralized Pits and Fissure: A One Year, Randomized Clinical Trial|Not yet recruiting||N/A|26|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:48:52.43876|2017-10-10 20:48:52.43876
NCT03242278|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-03|||February 12, 2016|Actual|2016-02-12|August 2017|2017-08-01|March 1, 2016|Actual|2016-03-01|March 1, 2016|Actual|2016-03-01||Observational|||Real-world Dosing Patterns of Rivaroxaban in the United States|Real-world Dosing Patterns of Rivaroxaban in the United States (RIVA-D)|Completed||N/A|12507|Actual|Bayer|||2||f||||f|f|f||||||||2017-10-10 20:48:52.514136|2017-10-10 20:48:52.514136
NCT03242265|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||April 4, 2017|Actual|2017-04-04|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|ANKA-PCA||Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy|Open Label, Prospective, Cross-Sectional Clinical Performance Study of the in Vitro Diagnostic Device NK VueTM: Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy|Recruiting||N/A|200|Anticipated|ATGen Canada Inc||1|||f||||f|f|f||||||||2017-10-10 20:48:52.604047|2017-10-10 20:48:52.604047
NCT03242239|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-18|||February 9, 2016|Actual|2016-02-09|August 2017|2017-08-01|September 30, 2016|Actual|2016-09-30|August 4, 2016|Actual|2016-08-04||Interventional|||A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects|A Randomized, Double-Blind, Parallel, Phase I Pharmacokinetic Trial Comparing The Potential Biosimilar ALT02(Trastuzumab) With Herceptin in Healthy Volunteers|Completed||Phase 1|105|Actual|Alteogen, Inc.||3|||f|||||f|f||||||||2017-10-10 20:48:52.806903|2017-10-10 20:48:52.806903
NCT03242226|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||October 11, 2016|Actual|2016-10-11|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Effect of +3.00ADD on Myopia Progression in Chinese Children|The Effect of +3.00ADD on Myopia Progression in Chinese Children: A Cluster Randomized Controlled Clinical Trial|Recruiting||N/A|440|Anticipated|Zhongshan Ophthalmic Center, Sun Yet-sen University||2|||f||||t|f|f||||||||2017-10-10 20:48:52.890545|2017-10-10 20:48:52.890545
NCT03242213|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-03|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement|Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement|Recruiting||N/A|40|Anticipated|Advocate Health Care||2|||f||||f|f|f||||||||2017-10-10 20:48:52.98377|2017-10-10 20:48:52.98377
NCT03242187|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||May 25, 2017|Actual|2017-05-25|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|January 25, 2019|Anticipated|2019-01-25||Interventional|MansTaTME||Trans-anal Versus Laparoscopic TME for Mid and Low Rectal Cancer|(MansTaTME) Trans-anal Versus Laparoscopic Total Mesorectal Excision for Mid and Low Rectal Cancer|Recruiting||Phase 2/Phase 3|30|Anticipated|Mansoura University||2|||f||||f|f|f||||||||2017-10-10 20:48:53.166602|2017-10-10 20:48:53.166602
NCT03242174|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Health Behaviors in Pregnancy|Health Behaviors in Pregnancy|Not yet recruiting||N/A|1000|Anticipated|Pennington Biomedical Research Center|||2||f||||f|f|f||||||||2017-10-10 20:48:53.256194|2017-10-10 20:48:53.256194
NCT03242161|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2019|Anticipated|2019-10-01||Observational|||Development of LabPatch-alcohol as a Noninvasive Skin Patch to Detect Blood Alcohol Concentrations|Development of LabPatch-alcohol: A Wearable Biosensor for Detecting Alcohol in Interstitial Fluid|Not yet recruiting||N/A|8|Anticipated|Mclean Hospital|||1||f||||f|f|f||||||||2017-10-10 20:48:53.33483|2017-10-10 20:48:53.33483
NCT03242148|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-18|||September 2017||2017-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:48:53.411349|2017-10-10 20:48:53.411349
NCT03026660|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-18|||July 2015||2015-07-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Moringa Oleifera on Bone Density|Effect of Moringa Oleifera on Bone Density in Post-Menopausal Women|Completed||N/A|20|Actual|Appalachian State University||2|||f||||f|f|f||||||No||2017-10-10 21:26:31.613789|2017-10-10 21:26:31.613789
NCT03242135|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||September 21, 2016|Actual|2016-09-21|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|February 21, 2018|Anticipated|2018-02-21||Observational|RDW||Role of RDW as Anon Invasive Index for Predicting Liver Cell Failure and Portal Hypertension in Cirrhotic Patient|Role of Red Cell Distribution Width as Anon Invasive Index for Predicting Liver Cell Failure and Portal Hypertension in Cirrhotic Patient|Recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||||2017-10-10 20:48:53.451946|2017-10-10 20:48:53.451946
NCT03242122|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-31|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Interventional|||Evaluation of Carbohydrates|Evaluation of Carbohydrates|Completed||N/A|10|Actual|Abbott Nutrition||6|||f||||f|f|f||||||||2017-10-10 20:48:53.51883|2017-10-10 20:48:53.51883
NCT03242109|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||March 1, 2005|Actual|2005-03-01|July 2017|2017-07-01|April 30, 2010|Actual|2010-04-30|April 30, 2010|Actual|2010-04-30||Observational|||The Moli-sani Study|An Epidemiological Study of Risk Factors for Cardiovascular Disease and Tumors in an Adult Population of the Molise Region|Completed||N/A|24325|Actual|Neuromed IRCCS|||1||f||||t|f|f||||Samples With DNA|"     Blood samples obtained from participants who had fasted overnight and had refrained from     smoking for at least 6 h and stored in liquid nitrogen in the Biological bank of the     Moli-sani study.   "|||2017-10-10 20:48:53.6183|2017-10-10 20:48:53.6183
NCT03242096|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-05|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon|Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated SEQUENT® SCB RAPID EXCHANGE PTCA Balloon Catheter or a Paclitaxel Coated SEQUENT® PLEASE PTCA Balloon Catheter|Recruiting||Phase 2/Phase 3|50|Anticipated|University Hospital, Saarland||2|||f||||t|f|f||||||||2017-10-10 20:48:53.68622|2017-10-10 20:48:53.68622
NCT03242070|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-12|||January 17, 2017|Actual|2017-01-17|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|October 18, 2017|Anticipated|2017-10-18||Interventional|||A Theory-Based Patient Portal eLearning Program for Older Adults With Chronic Illnesses|A Theory-Based Patient Portal eLearning Program for Older Adults With Chronic Illnesses|Recruiting||N/A|276|Anticipated|University of Maryland||2|||f||||f|f|f||||||||2017-10-10 20:48:53.936159|2017-10-10 20:48:53.936159
NCT03242057|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-10-05|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA|Comparison of Primary Extubation Failure Between Non-invasive Positive Pressure Ventilation (NIPPV) and Non Invasive Neural Access Ventilatory Assist (NI-NAVA)|Not yet recruiting||N/A|30|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 20:48:54.034964|2017-10-10 20:48:54.034964
NCT03242044|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|August 31, 2019|Anticipated|2019-08-31||Interventional|||Resuscitation of Infants With Congenital Diaphragmatic Hernia With an Intact Umbilical Cord|Resuscitation of Infants With Congenital Diaphragmatic Hernia With an Intact Umbilical Cord|Not yet recruiting||N/A|10|Anticipated|University of Colorado, Denver||1|||f||||f|f|f||||||||2017-10-10 20:48:54.146556|2017-10-10 20:48:54.146556
NCT03242031|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-23|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|LIGHT||Medico-economic Comparison Between Treatment With Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy|Medico-economic Evaluation of Treatment With Panretinal Photocoagulation in One Session Using Multispot Laser Versus Four Sessions Using Single-spot Laser in Patients With Severe Non-proliferative and Early Proliferative Diabetic Retinopathy|Recruiting||N/A|96|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f|||||f|f||||||||2017-10-10 20:48:54.24206|2017-10-10 20:48:54.24206
NCT03242005|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-12|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||The PSIQS Study - User Experience With Pro-Set|The PSIQS Study - User Experience With the Pro-Set Over Intended Wear of 3 Days With New Instructions and Requirement to be Inserted With the Quick-Serter|Withdrawn||N/A|0|Actual|Becton, Dickinson and Company||1||Sponsor decision to not proceed with study - no subjects enrolled|f||||f|f|t|f|f|t|||||2017-10-10 20:48:54.456272|2017-10-10 20:48:54.456272
NCT03241992|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|MyIBD||MyChart in Patients With Inflammatory Bowel Disease.|Utility of MyChart for Improving Quality of Life and Patient Satisfaction in Patients With Inflammatory Bowel Disease.|Not yet recruiting||N/A|150|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:48:54.533478|2017-10-10 20:48:54.533478
NCT03241979|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-05|||August 7, 2017|Anticipated|2017-08-07|August 2017|2017-08-01|July 16, 2018|Anticipated|2018-07-16|July 16, 2018|Anticipated|2018-07-16||Observational|||THRIVE in Pediatric Laryngeal Microsurgery|The Effects of Transnasal Humidified Rapid Insufflation Ventilator Exchange (THRIVE) on the Oxygenation in Pediatric Patients Under Tubeless Airway Surgery - a Physiologic Study|Not yet recruiting||N/A|30|Anticipated|Seoul National University Hospital|||1||f|||||f|f||||||||2017-10-10 20:48:54.627248|2017-10-10 20:48:54.627248
NCT03241966|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-07|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Observational|||Perception, Cognition, and Gait in Parkinson's Disease|Perception, Cognition, and Gait in Parkinson's Disease|Recruiting||N/A|1536|Anticipated|Boston University Charles River Campus|||2||f||||f|f|f||||||||2017-10-10 20:48:54.690005|2017-10-10 20:48:54.690005
NCT03241940|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 1, 2035|Anticipated|2035-08-01|August 1, 2025|Anticipated|2025-08-01||Interventional|||CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Children or Young Adults With Recurrent or Refractory CD19 Positive B Acute Lymphoblastic Leukemia|Phase I Dose Escalation Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies|Not yet recruiting||Phase 1|47|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 20:48:54.864687|2017-10-10 20:48:54.864687
NCT03241927|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-05|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 19, 2022|Anticipated|2022-07-19|July 19, 2020|Anticipated|2020-07-19||Interventional|||Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)|A Phase II Study Assessing the Effect of Pembrolizumab Induced Changes to the NK Cell Exhaustion Phenotype on the Efficacy of PD-1 Targeted Treatment in Patients With Unresectable Stage III or Stage IV Melanoma|Recruiting||Phase 2|125|Anticipated|Icahn School of Medicine at Mount Sinai||2|||||||t|t|f||||||||2017-10-10 20:48:55.007916|2017-10-10 20:48:55.007916
NCT03241914|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-05|||July 4, 2017|Actual|2017-07-04|August 2017|2017-08-01|July 3, 2020|Anticipated|2020-07-03|July 3, 2020|Anticipated|2020-07-03||Interventional|||Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer|Megestrol Acetate Plus LNG-IUS to Megestrol Acetate in Young Women With Early Endometrial Cancer|Active, not recruiting||Phase 2/Phase 3|40|Anticipated|Fudan University||2|||f|||||f|f||||||||2017-10-10 20:48:55.131807|2017-10-10 20:48:55.131807
NCT03241901|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-24|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|November 10, 2017|Anticipated|2017-11-10|October 10, 2017|Anticipated|2017-10-10||Interventional|ALU-PQ||"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"|"Aiming at Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in an Era of Imminent Plasmodium Falciparum Resistance in Bagamoyo District, Tanzania - New Strategies With Old Tools"|Recruiting||Phase 4|280|Anticipated|Muhimbili University of Health and Allied Sciences||2|||f||||t|f|f||||||||2017-10-10 20:48:55.222824|2017-10-10 20:48:55.222824
NCT03241888|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-05|||July 4, 2017|Actual|2017-07-04|August 2017|2017-08-01|July 3, 2020|Anticipated|2020-07-03|July 3, 2020|Anticipated|2020-07-03||Interventional|||Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia|Megestrol Acetate Plus LNG-IUS to Megestrol Acetate or LNG-IUS in Young Women With Endometrial Atypical Hyperplasia|Active, not recruiting||Phase 2/Phase 3|120|Anticipated|Fudan University||3|||f|||||f|f||||||||2017-10-10 20:48:55.37729|2017-10-10 20:48:55.37729
NCT03241875|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-09-28|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|September 28, 2017|Actual|2017-09-28|August 30, 2017|Actual|2017-08-30||Interventional|||Effects of Preoperative Gabapentin Versus Pregabalin on Shoulder Pain After Laparoscopic Cholecystectomy|Effects of Preoperative Gabapentin Versus Pregabalin on Shoulder Pain After Laparoscopic Cholecystectomy. A Randomized Clinical Trial|Completed||Phase 4|90|Actual|Faculty of Medicine, Sousse||3|||f|||||f|f|||f|||||2017-10-10 20:48:55.490534|2017-10-10 20:48:55.490534
NCT03241862|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-08-02|||September 2015||2015-09-01|August 2017|2017-08-01|June 16, 2017|Actual|2017-06-16|June 2017|Actual|2017-06-01||Interventional|||An Open-Label Study to Assess the Impact of Lip Rejuvenation on Projected First Impressions and Mood Perceptions|An Open-Label, Post-Market Study to Assess the Impact of Lip Rejuvenation With Restylane® Silk on Projected First Impressions and Mood Perceptions|Completed||N/A|20|Actual|DeNova Research||1|||f||||f||||||||||2017-10-10 20:48:55.583855|2017-10-10 20:48:55.583855
NCT03241849|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-05|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|August 2019|Anticipated|2019-08-01||Interventional|||Surgical Technique To Control Postpartum Hemorrhage|New Surgical Technique To Control Postpartum Hemorrhage Due To Placenta Accreta|Recruiting||N/A|200|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:48:55.651642|2017-10-10 20:48:55.651642
NCT03241836|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-05|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|October 2018|Anticipated|2018-10-01||Observational|||Magnetic Resonance Imaging and Three Dimensional Ultrasonography in Mullerian Duct Anomalies|Role of Pelvic Magnetic Resonance Imaging and Three Dimensional Trans-vaginal Ultrasonography in Diagnosis of Mullerian Duct Anomalies|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:48:55.715434|2017-10-10 20:48:55.715434
NCT03241823|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-05|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Observational|||Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.|Assessment of Hepatic Fibrosis, Hemodynamics, and Disease Severity of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:48:55.77947|2017-10-10 20:48:55.77947
NCT03241797|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-08-04|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis|Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis: a Prospective, Single-center Study|Completed||N/A|27|Actual|Huazhong University of Science and Technology||1|||f||||t|f|f||||||||2017-10-10 20:48:56.004421|2017-10-10 20:48:56.004421
NCT03241784|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-04|||May 16, 2016|Actual|2016-05-16|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||T-Regulatory Cells in Amyotrophic Lateral Sclerosis|Expansion and Infusion of T-Regulatory Cells in Amyotrophic Lateral Sclerosis|Active, not recruiting||Phase 1|4|Anticipated|The Methodist Hospital System||1|||f||||f|t|f||||||||2017-10-10 20:48:56.098986|2017-10-10 20:48:56.098986
NCT03241771|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-04|||August 14, 2017|Anticipated|2017-08-14|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders|Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders|Not yet recruiting||N/A|300|Anticipated|Kaiser Permanente||2|||f||||t|f|f||||||||2017-10-10 20:48:56.187336|2017-10-10 20:48:56.187336
NCT03241758|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-04|||November 29, 2011|Actual|2011-11-29|August 2017|2017-08-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Observational|||Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy|Valuation Of Vascular Changes And Their Impact On Erectile Function By Penile Doppler Ultrasound And Analysis Of The Quality Of Life Of Patients Undergoing Laparoscopic Radical Prostatectomy|Completed||N/A|110|Actual|Corporacion Parc Tauli|||1||f||||f|f|f||||||||2017-10-10 20:48:56.264472|2017-10-10 20:48:56.264472
NCT03241745|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-04|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Study of Nivolumab in Selected Uterine Cancer Patients|Phase II Trial of Single-Agent Nivolumab in Patients With Microsatellite Unstable/Mismatch Repair Deficient/Hypermutated Uterine Cancer|Recruiting||Phase 2|40|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:48:56.334552|2017-10-10 20:48:56.334552
NCT03241732|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-04|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|February 11, 2021|Anticipated|2021-02-11|February 10, 2020|Anticipated|2020-02-10||Interventional|||PET-MRI and the Effect of N-Acetyl Cysteine (NAC) and Anti-Inflammatory Diet in Traumatic Brain Injury|Defining Neurobiological Signatures for Chronic Traumatic Brain Injury Using PET-MRI|Recruiting||N/A|120|Anticipated|Thomas Jefferson University||3|||f||||f|f|f||||||||2017-10-10 20:48:56.474743|2017-10-10 20:48:56.474743
NCT03241719|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-04|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA|Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in Vascularized Composite Allotransplantation|Not yet recruiting||Early Phase 1|5|Anticipated|Brigham and Women's Hospital||1|||f||||f|t|f||||||||2017-10-10 20:48:56.653317|2017-10-10 20:48:56.653317
NCT03241706|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-04|2017-08-04|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 31, 2022|Anticipated|2022-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Liver Glycogen and Hypoglycemia in Humans|Effect of Liver Glycogen Content on Hypoglycemic Counterregulation|Not yet recruiting||Phase 1|40|Anticipated|University of Cincinnati||4|||f||||f|t|f||||||||2017-10-10 20:48:56.727083|2017-10-10 20:48:56.727083
NCT03241693|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-01|||September 2010|Actual|2010-09-01|August 2017|2017-08-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Blended-learning in Physiotherapy: Professional Ethics|Effect of a Blended-learning Programme on Physiotherapy Students´ Attitude, Knowledge and Opinions Towards Learning Professional Ethics.|Completed||N/A|130|Actual|University of Valencia||2|||f||||f|f|f||||||||2017-10-10 20:48:56.84315|2017-10-10 20:48:56.84315
NCT03241680|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)|Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)|Recruiting||N/A|80|Anticipated|Universidade do Vale do Sapucai||4|||f||||t|f|f||||||||2017-10-10 20:48:57.392206|2017-10-10 20:48:57.392206
NCT03241667|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-01|||November 15, 2017|Anticipated|2017-11-15|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|February 15, 2018|Anticipated|2018-02-15||Observational|||Blood Flow Effects on Silicon Substrates|Blood Flow Effects on Silicon Substrates|Not yet recruiting||N/A|6|Anticipated|University of California, San Francisco|||1||f||||f|f|t|t|f||Samples Without DNA|"     Blood testing, hemocartridge system   "|||2017-10-10 20:48:57.481062|2017-10-10 20:48:57.481062
NCT03241654|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-04|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|September 1, 2017|Anticipated|2017-09-01|August 20, 2017|Anticipated|2017-08-20||Observational|||Decreasing Trigger Sensitivity Could Assist PEEP to Further Improve Regional Ventilation Distribution|Decreasing Trigger Sensitivity Could Assist PEEP to Further Improve Regional Aeration and Homogeneity During Pressure Assist Ventilation: A Preliminarily Physiological Study|Recruiting||N/A|10|Anticipated|Capital Medical University|||2||f|||||f|f||||||||2017-10-10 20:48:57.549746|2017-10-10 20:48:57.549746
NCT03241641|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.|Switching From Tenofovir Disoproxil Fumarate(TDF) to Tenofovir AlaFenamide(TAF) vs. Maintaining TDF Monotherapy in Chronic Hepatitis B Patients With Genotypic Resistance to Adefovir or Entecavir|Not yet recruiting||Phase 4|174|Anticipated|Asan Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:48:57.633531|2017-10-10 20:48:57.633531
NCT03241628|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-09|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Proof of Concept Study for a Dressing Glove|Generation and Evaluation of Hand Therapy Devices for Epidermolysis Bullosa (GLOVE Project): Proof of Concept Study for a Dressing Glove|Recruiting||N/A|14|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 20:48:57.756863|2017-10-10 20:48:57.756863
NCT03241615|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-09-08|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|September 8, 2017|Actual|2017-09-08|September 8, 2017|Actual|2017-09-08||Observational|||Dysphagia Symptom Severity and Quality of Life|The Relationship Between Dysphagia Symptom Severity and Quality of Life|Completed||N/A|84|Actual|Hacettepe University|||1||f||||f|f|f||||||||2017-10-10 20:48:57.861748|2017-10-10 20:48:57.861748
NCT03241602|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-04|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Pulmonary Recruitment and Intra-peritoneal Lidocaine in Decreasing Post Laproscopy Shoulder and Abdominal Pain|Effect of Pulmonary Recruitment and Intra-peritoneal Lidocaine in Decreasing Post Laproscopy Shoulder and Abdominal Pain: A Randomized Controlled Trial|Not yet recruiting||Phase 4|88|Anticipated|Cairo University||4|||f||||t|f|f||||||||2017-10-10 20:48:57.953947|2017-10-10 20:48:57.953947
NCT03241589|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-04|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Teledermatology Mobile Apps|Teledermatology Mobile Apps: Implementation and Impact on Veterans' Access to Dermatology|Not yet recruiting||N/A|60|Anticipated|VA Office of Research and Development||4|||f||||f|f|f|||f|||||2017-10-10 20:48:58.053139|2017-10-10 20:48:58.053139
NCT03241576|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-04|||May 1, 2015|Actual|2015-05-01|August 2017|2017-08-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Provision of Small vs. Large Portion Sizes and Later Food Intake|Provision of Small vs. Large Portion Sizes and Later Self-selected Food Intake: 3 Experimental Laboratory Studies in UK Participants|Completed||N/A|307|Actual|University of Liverpool||2|||f||||f|f|f||||||||2017-10-10 20:48:58.200914|2017-10-10 20:48:58.200914
NCT03241563|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-04|||April 2016||2016-04-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat|A Randomized, Double-blind Comparison Trial of Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat|Completed||Phase 4|20|Actual|Goldman, Butterwick, Fitzpatrick and Groff||2|||f||||f||||||||||2017-10-10 20:48:58.27761|2017-10-10 20:48:58.27761
NCT03241537|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||January 15, 2016|Actual|2016-01-15|July 2017|2017-07-01|January 14, 2026|Anticipated|2026-01-14|January 14, 2019|Anticipated|2019-01-14||Interventional|||COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer|Open Label, Randomized Phase III Trial of Hormone Therapy Alone Versus COmbined HOrmone With Radiation Therapy in Clinical Pelvic Lymph Node Metastatic Prostate Cancer (COHORT Trial)|Recruiting||N/A|246|Anticipated|Samsung Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:48:58.485388|2017-10-10 20:48:58.485388
NCT03241524|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-02|||March 12, 2016|Actual|2016-03-12|August 2017|2017-08-01|September 12, 2016|Actual|2016-09-12|June 20, 2016|Actual|2016-06-20||Interventional|||Consistency of Questionnaires to Evaluating Sexual Functions in Young Healthy Women|Consistency of Three Different Questionnaires to Evaluating Sexual Functions in Young Healthy Women Before and After a Pelvic Floor Muscle Training Program|Completed||N/A|31|Actual|Universidade Federal do Rio Grande do Norte||1|||f||||t||f||||||||2017-10-10 20:48:58.564715|2017-10-10 20:48:58.564715
NCT03241511|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-28|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|ESRD||Novel Paradigm to Improve Inflammatory Burden in ESRD|Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21)|Not yet recruiting||N/A|90|Anticipated|UConn Health||2|||f||||f|f|f||||||||2017-10-10 20:48:58.659207|2017-10-10 20:48:58.659207
NCT03241498|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||December 1, 2016|Actual|2016-12-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||General Practitioner (GP) Practice Based Pharmacist Input to Medicines Optimisation|GP Practice Based Pharmacist Input to Medicines Optimisation|Active, not recruiting||N/A|800|Anticipated|Queen's University, Belfast||2|||f||||f|f|f||||||||2017-10-10 20:48:58.773852|2017-10-10 20:48:58.773852
NCT03241485|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|||Trial Comparing Intrathecal Morphine With Placebo In Patients Undergoing Robotic Cardiac Surgery|Randomized, Double Blinded, Trial Comparing Intrathecal Morphine With Placebo in Patients Undergoing Robotic Totally Endoscopic Beating Heart Coronary Revascularization and Intraoperative Extubation|Not yet recruiting||Phase 4|120|Anticipated|University of Chicago||2|||f|||||t|f||||||||2017-10-10 20:48:58.878427|2017-10-10 20:48:58.878427
NCT03241472|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Induction of Ovulation Using Clomiphene Citrate and N-acetyl Cysteine Versus Letrozole|Induction of Ovulation Using Clomiphene Citrate and N-acetyl Cysteine Versus Letrozole|Completed||Phase 3|100|Actual|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:48:58.968546|2017-10-10 20:48:58.968546
NCT03241459|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 2024|Anticipated|2024-04-01|April 2020|Anticipated|2020-04-01||Interventional|TRANSCEND||Safety and Efficacy of the SurVeil™ Drug-Coated Balloon|The Randomized And Controlled Noninferiority Trial to Evaluate Safety and Clinical Efficacy of the SurVeil™ Drug-Coated Balloon iN the Treatment of Subjects With Stenotic Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT® Admiral® Drug-Coated Balloon|Not yet recruiting||N/A|446|Anticipated|SurModics, Inc.||2|||||||t|f|t|t|||||||2017-10-10 20:48:59.051058|2017-10-10 20:48:59.051058
NCT03241446|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)|A Phase I, Open-Label Study to Investigate the Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis|Not yet recruiting||Phase 1|9|Anticipated|Navidea Biopharmaceuticals||3|||f||||f|t|f||||||||2017-10-10 20:48:59.165911|2017-10-10 20:48:59.165911
NCT03241433|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|November 2018|Anticipated|2018-11-01||Interventional|HALT-AF||High-Intensity Aerobic Lifelong Training--AF|High-Intensity Interval Training and Moderate-Intensity Continuous Training in Reducing Atrial Fibrillation Burden|Not yet recruiting||N/A|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f|||||f|f||||||||2017-10-10 20:48:59.242474|2017-10-10 20:48:59.242474
NCT03241420|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-18|||April 24, 2017|Actual|2017-04-24|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease|Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease|Recruiting||Phase 3|600|Anticipated|National Jewish Health||2|||f||||f|f|t|f|f||||||2017-10-10 20:48:59.336299|2017-10-10 20:48:59.336299
NCT03241407|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||July 1, 2013|Actual|2013-07-01|August 2017|2017-08-01|April 30, 2015|Actual|2015-04-30|September 1, 2013|Actual|2013-09-01||Interventional|||Triclosan Toothpaste as a Preventive Strategy of Mucositis in Smokers|Effect of a Triclosan-containing Toothpaste as a Preventive Strategy of Peri-implant Experimental Mucositis in Cigarette Smokers: Clinical and Osteo-immunoinflammatory Response in a Randomized Crossover Study.|Completed||N/A|26|Actual|Paulista University||2|||f||||t|f|f||||||||2017-10-10 20:48:59.430084|2017-10-10 20:48:59.430084
NCT03241394|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Observational|||The Monocyte Subsets in Obese Patients With and Without Metabolic Syndrome|The Investigation of the Role of Inflammation in the Insulin Resistance Syndrome: The Monocyte Subsets in Obese Patients With and Without Metabolic Syndrome|Recruiting||N/A|100|Anticipated|University Hospital, Ioannina|||3||f||||f|f|f||||||||2017-10-10 20:48:59.528249|2017-10-10 20:48:59.528249
NCT03241368|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-20|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|BLINK||Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease|Multicenter, Prospective, Randomized Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease|Not yet recruiting||N/A|352|Anticipated|Medtronic - MITG||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:48:59.673647|2017-10-10 20:48:59.673647
NCT03241355|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||September 16, 2013|Actual|2013-09-16|August 2017|2017-08-01|April 28, 2014|Actual|2014-04-28|April 28, 2014|Actual|2014-04-28||Interventional|||Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children|Double-blind, Parallel, Randomized, (Placebo-controlled) Explorative Study on the Effect of a Mixture of Prebiotic Oligosaccharides on the Composition of Intestinal Microbiota and Selected Health Outcomes in Children 3 to 6 Years of Age|Completed||N/A|258|Actual|Beneo-Institute||2|||f||||f|f|f||||||||2017-10-10 20:48:59.753123|2017-10-10 20:48:59.753123
NCT03241342|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-01|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|February 21, 2019|Anticipated|2019-02-21|February 21, 2019|Anticipated|2019-02-21||Interventional|ASTRID||Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence|Double-Blind, Placebo-Controlled, Parallel Design, Phase 2 Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence|Recruiting||Phase 2|400|Anticipated|GTx||3|||f||||f|t|f||||||||2017-10-10 20:48:59.81716|2017-10-10 20:48:59.81716
NCT03241329|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|EndOvo||Endometriosis Impact on Oocyte Quality|Characterization of Normal and Pathological Oocyte Cohort After Controlled Ovarian Stimulation: Example of Endometriosis|Not yet recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f|f|f||||Samples With DNA|"     1. Samples without DNA : follicular fluids        2. Samples with DNA : cumulus cells from which RNA will be extracted in order to perform          transcriptomics analysis   "|||2017-10-10 20:48:59.888196|2017-10-10 20:48:59.888196
NCT03241316|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-02|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|April 30, 2018|Anticipated|2018-04-30||Observational|ESRC||Antibiotics and Activity Spaces: An Exploratory Study of Behaviour, Marginalisation, and Knowledge Diffusion|Antibiotics and Activity Spaces: An Exploratory Study of Behaviour, Marginalisation, and Knowledge Diffusion|Not yet recruiting||N/A|2400|Anticipated|University of Oxford|||2||f||||t|f|f||||||||2017-10-10 20:48:59.958577|2017-10-10 20:48:59.958577
NCT03241303|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|December 1, 2017|Anticipated|2017-12-01||Interventional|AlfaEx||Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines|The Role of Glucagon-like Peptide-1 Receptor Signalling in the Glucose-lowering Effect of Increased Carbohydrate Content in the Distal Small Intestines After Meal Ingestion in Patients With Type 2 Diabetes|Recruiting||N/A|15|Anticipated|University Hospital, Gentofte, Copenhagen||4|||f||||t|f|f|||f|||||2017-10-10 20:49:00.057923|2017-10-10 20:49:00.057923
NCT03241290|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-04|||May 29, 2017|Actual|2017-05-29|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Assessement of the C-ARM ARCO FP-Rk521 S in Surgical Conventional Practice|Prospective Assessment of the Quality of the Image and the Usability of the C-ARM ARCO FP-Rk521S Used in Surgical Conventional Practice|Recruiting||N/A|45|Anticipated|University Hospital, Grenoble|||1||f||||f|f|f||||||||2017-10-10 20:49:00.154281|2017-10-10 20:49:00.154281
NCT03241277|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-04|||October 5, 2017|Anticipated|2017-10-05|July 2017|2017-07-01|October 5, 2019|Anticipated|2019-10-05|May 5, 2019|Anticipated|2019-05-05||Interventional|NSPTSP||Nonsurgical Periodontal Treatment in Patients With Social Phobia|Evaluation of Nonsurgical Periodontal Treatment in Patients With Social Phobia: a Randomized Controlled Clinical Trial|Not yet recruiting||N/A|45|Anticipated|University of Sao Paulo General Hospital||3|||f||||t|f|f||||||||2017-10-10 20:49:00.227947|2017-10-10 20:49:00.227947
NCT03241264|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-03|||August 28, 2016|Actual|2016-08-28|July 2017|2017-07-01|October 21, 2016|Actual|2016-10-21|October 21, 2016|Actual|2016-10-21||Interventional|||A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body|A Phase 1, Open-Label, Randomized-Sequence, Single-Crossover, Bridging Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Two ND-L02-s0201 Formulations, Frozen Versus Lyophilized, Administered by Intravenous Infusion to Healthy Male and Female Subjects|Completed||Phase 1|12|Actual|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 20:49:00.327999|2017-10-10 20:49:00.327999
NCT03241251|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-04|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Screening for Psychosocial Risk in Flemish Families of a Child With Cancer|Screening for Psychosocial Risk in Flemish Families of a Child With Cancer|Not yet recruiting||N/A|250|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f|f|f||||||||2017-10-10 20:49:00.523902|2017-10-10 20:49:00.523902
NCT03241238|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-04|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Dietary Fiber on Food Liking|The Effect of Dietary Fiber on Food Liking|Recruiting||N/A|20|Anticipated|University of Tennessee||3|||f||||f|f|f||||||||2017-10-10 20:49:00.614279|2017-10-10 20:49:00.614279
NCT03241212|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-12|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ASKED-IT||Adolescent Self-Care and Knowledge Education in Diabetes--Improved by Texting|Adolescent Self-Care and Knowledge Education in Diabetes--Improved by Texting (ASKED-IT)|Recruiting||N/A|150|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:49:00.822804|2017-10-10 20:49:00.822804
NCT03225209|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-20|||September 15, 2017|Anticipated|2017-09-15|July 2017|2017-07-01|August 15, 2018|Anticipated|2018-08-15|July 15, 2018|Anticipated|2018-07-15||Interventional|MRB||Medically Reproducing Bariatric Surgery|Medically Reproducing Bariatric Surgery|Not yet recruiting||Phase 2|5|Anticipated|East Carolina University||1|||f||||f|t|f|||f|||||2017-10-10 20:51:19.253882|2017-10-10 20:51:19.253882
NCT03241199|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|January 1, 2021|Anticipated|2021-01-01|June 13, 2020|Anticipated|2020-06-13||Interventional|||The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia|A Phase II Study to Determine the Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic-Phase Chronic Myelogenous Leukaemia|Recruiting||Phase 2|15|Anticipated|The University of Hong Kong||1|||f||||t|f|f||||||||2017-10-10 20:49:00.922334|2017-10-10 20:49:00.922334
NCT03241186|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma|Single Arm Phase II Study of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma (SALVO Study). HCRN: MEL16-252|Not yet recruiting||Phase 2|36|Anticipated|Hoosier Cancer Research Network||1|||f||||f|t|f|||t|||||2017-10-10 20:49:01.019539|2017-10-10 20:49:01.019539
NCT03241173|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-08|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|May 2021|Anticipated|2021-05-01||Interventional|||A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies|A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies|Not yet recruiting||Phase 1/Phase 2|651|Anticipated|Incyte Corporation||3|||f||||t|t|f||||||||2017-10-10 20:49:01.131556|2017-10-10 20:49:01.131556
NCT03241160|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-08|||August 5, 2017|Actual|2017-08-05|September 2017|2017-09-01|September 8, 2017|Actual|2017-09-08|September 8, 2017|Actual|2017-09-08||Observational|||Chewing Disorders, Gross Motor Function and Trunk Control in Cerebral Palsy|The Severity of Chewing Disorders is Related to Gross Motor Function and Trunk Control in Cerebral Palsy|Completed||N/A|119|Actual|Hacettepe University|||1||f||||f|f|f||||||||2017-10-10 20:49:01.308266|2017-10-10 20:49:01.308266
NCT03241147|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment|Interventional, Open Label, Reduced/Staged, Single Dose Study Investigating the Pharmacokinetic Properties of Lu AF35700 in Subjects With Renal Impairment and in Healthy Subjects|Recruiting||Phase 1|32|Anticipated|H. Lundbeck A/S||4|||f||||f|f|f||||||||2017-10-10 20:49:01.389601|2017-10-10 20:49:01.389601
NCT03241134|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-23|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Changes in Surface EMG Activity After Dry Needling Compared to Sham Needling|Changes in Surface Electromyographic Activity of the Upper Trapezius After Dry Needling, Compared to Sham Needling, in Office Workers With Work-related Trapezius Myalgia.|Recruiting||N/A|50|Anticipated|University Ghent||2|||f||||f|f|f||||||||2017-10-10 20:49:01.489397|2017-10-10 20:49:01.489397
NCT03241121|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome|Study of Eating Patterns With a Smartphone App and the Metabolic Effects of Time Restricted Feeding (TRF) in the Metabolic Syndrome - An Open-label Randomized Controlled Trial of TRF vs Regular Dietary Advices|Not yet recruiting||N/A|500|Anticipated|University of Lausanne Hospitals||2|||f||||f|f|f||||||||2017-10-10 20:49:01.591106|2017-10-10 20:49:01.591106
NCT03241108|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-24|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of an Anti-TLR4 mAb in Rheumatoid Arthritis|Randomized, Placebo-Controlled, Double Blind, Multicenter Phase 2 Study to Explore Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Intravenous Multiple Infusions of NI-0101, an Anti-Toll Like Receptor 4 Monoclonal Antibody in Patients With Rheumatoid Arthritis|Recruiting||Phase 2|81|Anticipated|NovImmune SA||2|||f|||||f|f||||||||2017-10-10 20:49:01.722895|2017-10-10 20:49:01.722895
NCT03241095|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-10-04|||August 17, 2017|Actual|2017-08-17|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||The Efficacy of Osteopathic Manipulative Treatment (OMT) on the Golf Swing|The Efficacy of Osteopathic Manipulative Treatment (OMT) on the Swing Via Objective Data From Golf Simulator Swing Analysis and Subjective Data|Recruiting||N/A|75|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f|f|f||||||||2017-10-10 20:49:01.902354|2017-10-10 20:49:01.902354
NCT03241082|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||September 2, 2017|Anticipated|2017-09-02|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|October 1, 2019|Anticipated|2019-10-01||Observational|||Ultrasound Assessment of BC in the NICU|Use of Bedside Ultrasound to Assess Neonatal Body Composition in the Neonatal Intensive Care Unit|Not yet recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||||||2017-10-10 20:49:01.991288|2017-10-10 20:49:01.991288
NCT03241069|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2017-08-01|||July 2012|Actual|2012-07-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|DYVIC||Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF)|Dynamic Variation of Impedance Cardiography (ICG) a Diagnostic Tool of Acute Heart Failure (AHF) in Emergency Department (ED) Patients Admitted for Acute Dyspnea|Completed||N/A|500|Actual|University of Monastir||5|||f||||t|f|f||||||||2017-10-10 20:49:02.059803|2017-10-10 20:49:02.059803
NCT03241056|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Cognitive Checking Intervention for Maladaptive Beliefs About Memory|Increasing Memory Confidence: A Novel Intervention for Obsessive-Compulsive Disorder|Not yet recruiting||N/A|50|Anticipated|University of Manitoba||2|||f|||||f|f||||||||2017-10-10 20:49:02.158416|2017-10-10 20:49:02.158416
NCT03241043|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-08-02|||May 2016||2016-05-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients|Single Center, Open-label, Randomized, Controlled, Cross Over Study to Evaluate the Pharmacokinetic and Bioavailability of Envarsus® in Comparison to Advagraf® in de Novo Liver Transplant Recipients|Recruiting||Phase 3|20|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 20:49:02.229224|2017-10-10 20:49:02.229224
NCT03234816|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-05|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|October 30, 2017|Anticipated|2017-10-30|October 25, 2017|Anticipated|2017-10-25||Interventional|||Norepinephrine in Cesarean Delivery: A Dose Finding Study|Norepinephrine Infusion in Cesarean Delivery: A Randomized Dose Finding Study|Recruiting||Phase 4|270|Anticipated|Cairo University||3|||f||||t|f|f||||||||2017-10-10 20:49:57.770403|2017-10-10 20:49:57.770403
NCT03241030|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial|Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial|Not yet recruiting||Phase 2|100|Anticipated|University of Texas at Austin||2|||f||||f|t|f|||f|||||2017-10-10 20:49:02.320529|2017-10-10 20:49:02.320529
NCT03241017|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-02|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|October 2021|Anticipated|2021-10-01||Interventional|IDA-D||Durvalumab in DLBCL After Autologous Transplant|A Phase II Trial Investigating the Benefit of Immunotherapy With Durvalumab After Autologous Transplant in High-risk Diffuse-large B-cell Lymphomas (the IDA-D Trial)|Not yet recruiting||Phase 2|46|Anticipated|University Hospital Inselspital, Berne||1|||f||||f|f|f||||||||2017-10-10 20:49:02.400028|2017-10-10 20:49:02.400028
NCT03241004|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-04|||July 7, 2017|Actual|2017-07-07|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Does Melatonin Affect Anesthetic MAC (Minimum Alveolar Concentration)?|Does Melatonin Affect Anesthetic MAC (Minimum Alveolar Concentration)?|Recruiting||N/A|20|Anticipated|Englewood Hospital and Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:49:02.479465|2017-10-10 20:49:02.479465
NCT03240991|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-04|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|QUALANGIO||Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)||Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 20:49:02.581361|2017-10-10 20:49:02.581361
NCT03240978|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-02|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Exercise Intervention for the Prevention of Prediabetes in Overweight Chinese|An Interventional Study for the Effects of Physical Exercise on the Prevention of Prediabetes in Overweight Chinese: Role of Gut Microbiota and Adipokines|Completed||N/A|60|Actual|The University of Hong Kong||3|||f||||t|f|f||||||||2017-10-10 20:49:02.686443|2017-10-10 20:49:02.686443
NCT03240965|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|5S||Changes in Sensitivity, Taste and Smell in Stroke Patients|Changes in Sensitivity of Swallowing-relevant Structures, Taste and Smell in Stroke Patients|Not yet recruiting||N/A|200|Anticipated|University of Giessen|||3||f||||f|f|f||||||||2017-10-10 20:49:02.754981|2017-10-10 20:49:02.754981
NCT03240952|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-11|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Observational|NHERC||The Nutritional Health for the Elderly Reference Centre Study (NHERC Study)|Establishing Reference Range for Community-dwelling Elderly Nutrition|Recruiting||N/A|1200|Anticipated|Abbott Nutrition|||1||f||||f|f|f||||||||2017-10-10 20:49:02.845773|2017-10-10 20:49:02.845773
NCT03240939|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-03|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|July 7, 2017|Actual|2017-07-07||Interventional|||Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil|A Randomized, Open Label, Single Dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil Administered in Healthy Male Volunteer|Active, not recruiting||Phase 1|36|Actual|Yuyu Pharma, Inc.||2|||f||||f|f|f|||f|||||2017-10-10 20:49:02.947719|2017-10-10 20:49:02.947719
NCT03240926|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|February 21, 2018|Anticipated|2018-02-21|February 21, 2018|Anticipated|2018-02-21||Interventional|||Loop Band Validation Study|Loop Band Validation Study|Recruiting||N/A|250|Anticipated|Spry Health||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:49:03.029453|2017-10-10 20:49:03.029453
NCT03240913|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||A PROMs Based Educational Tool (PROM-DA) for Patients Considering Total Knee Arthroplasty|A PROMs Based Educational Tool (PROM-DA) for Patients Considering Total Knee Arthroplasty: Development and a Pilot Randomized Controlled Trial.|Recruiting||N/A|280|Anticipated|University of Calgary||2|||f||||f|f|f||||||||2017-10-10 20:49:03.124569|2017-10-10 20:49:03.124569
NCT03240900|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-04|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Electrical Stimulation for Improving Postoperative Breast Sensation|Electrical Stimulation for Improving Postoperative Breast Sensation|Not yet recruiting||N/A|30|Anticipated|University of Alberta||2|||f||||f|f|f|||t|||||2017-10-10 20:49:03.245998|2017-10-10 20:49:03.245998
NCT03240887|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-02|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluation of Peer Group Connection|The Evaluation of Peer Group Connection in Rural North Carolina and New York City, New York|Recruiting||N/A|2000|Anticipated|The Policy & Research Group||2|||f||||f|f|f||||||||2017-10-10 20:49:03.346788|2017-10-10 20:49:03.346788
NCT03240874|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-12|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women|SweetMama Usability and Feasibility: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women|Recruiting||N/A|40|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 20:49:03.444931|2017-10-10 20:49:03.444931
NCT03240861|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|NYESO SCT||Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer|Adoptive Transfer of NY-ESO-1 TCR Engineered Peripheral Blood Mononuclear Cells (PBMC) and Peripheral Blood Stem Cells (PBSC) After a Myeloablative Conditioning Regimen, With Administration of Interleukin-2, in Patients With Advanced Malignancies|Not yet recruiting||Phase 1|12|Anticipated|Jonsson Comprehensive Cancer Center||1|||||||t|t|f||||||||2017-10-10 20:49:03.546113|2017-10-10 20:49:03.546113
NCT03240835|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-12|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients|The Function of Pre-Albumin, Retinol Conjugated Protein and Transferrin in Early Malnutrition Detecting and Nutritional Status Dynamic Monitoring for Local Advanced Nasopharyngeal Carcinoma Patients With Chemoradiotherapy|Recruiting||N/A|50|Anticipated|Sun Yat-sen University|||1||f||||f|f|f||||||||2017-10-10 20:49:03.767091|2017-10-10 20:49:03.767091
NCT03240822|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2025|Anticipated|2025-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital Trauma|Vascularized Composite Allotransplantation (VCA) for Devastating Penile and Concomitant Genital Trauma|Recruiting||Phase 1|5|Anticipated|Wake Forest University Health Sciences||1|||f||||t|t|f|||f|||||2017-10-10 20:49:03.852729|2017-10-10 20:49:03.852729
NCT03240809|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||December 12, 2017|Anticipated|2017-12-12|August 2017|2017-08-01|June 15, 2019|Anticipated|2019-06-15|January 15, 2019|Anticipated|2019-01-15||Interventional|||An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects|An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects (6 to < 18 Years Old) With Severe Plaque Psoriasis|Not yet recruiting||Phase 4|16|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:49:03.935826|2017-10-10 20:49:03.935826
NCT03240796|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-01|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Intraocular Lens Implantation Surgery vs Traditional Cataract Surgery|Comparison of Intraocular Lens Implantation Surgery and Traditional Cataract Surgery for Treating Congenital Cataracts|Not yet recruiting||N/A|80|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 20:49:03.995934|2017-10-10 20:49:03.995934
NCT03240783|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||July 8, 2017|Actual|2017-07-08|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|SCIATICA||A Comparative Effectiveness Randomised Placebo Controlled Pilot Trial of the Management of Acute Lumbar Radicular Pain|A Comparative Effectiveness Randomised Placebo Controlled Pilot Trial of the Management of Acute Lumbar Radicular Pain: Evaluate Route Versus Pharmacology of Intervention, and Feasibility in Public Hospital and Community Practice Settings.|Recruiting||Phase 2|60|Anticipated|St George Hospital, Australia||4|||f||||t|f|f|||t|||||2017-10-10 20:49:04.070713|2017-10-10 20:49:04.070713
NCT03240770|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-02|||February 3, 2017|Actual|2017-02-03|August 2017|2017-08-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||Effect of VPro5 Therapy on Clear Aligner Therapy|Effect of VPro5 Therapy on Clear Aligner Tracking: a Randomized Clinical Trial|Completed||N/A|60|Actual|Consortium for Translational Orthodontic Research||5|||f||||f|f|t|f||t|||||2017-10-10 20:49:04.18437|2017-10-10 20:49:04.18437
NCT03240757|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-04|||July 14, 2009|Actual|2009-07-14|August 2017|2017-08-01|May 28, 2010|Actual|2010-05-28|May 28, 2010|Actual|2010-05-28||Interventional|||Metabolic and Functional Impact of Various Breakfast Models|Metabolic Responses of a Single Bout of Low-intensity Exercise Following Mixed Meals in Healthy Individuals|Completed||N/A|19|Actual|Ospedale San Donato||2|||f||||f|f|f||||||||2017-10-10 20:49:04.256583|2017-10-10 20:49:04.256583
NCT03240744|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-01|||June 22, 2017|Actual|2017-06-22|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell)|Study on Immunogenicity of Inactivated Enterovirus 71 (EV71) Vaccine (Human Diploid Cell, KMB-17) in Large-scale Healthy Children in China|Active, not recruiting||Phase 4|800|Anticipated|Chinese Academy of Medical Sciences||1|||f|||||f|f||||||||2017-10-10 20:49:04.327309|2017-10-10 20:49:04.327309
NCT03240731|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|DREPHAPLO||HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease|Bone Marrow Transplantation HLA Haploidentical After a Reduced Intensity Conditioning and Prevention of GvHD Based on Post-transplant Cyclophosphamide Administration in Patients With Severe Sickle Cell Disease|Not yet recruiting||Phase 2|15|Anticipated|Centre Hospitalier Intercommunal Creteil||1|||f||||t|f|f||||||||2017-10-10 20:49:04.399993|2017-10-10 20:49:04.399993
NCT03240718|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-15|||February 2015||2015-02-01|December 2015|2015-12-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Pilot Study of the Ablative Fractional CO2 Laser in Hypertrophic Scars in Adult Burn Patients|Randomized, Controlled, Within-patient, Single-blinded Pilot Study to Evaluate the Efficacy of the Ablative Fractional CO2 Laser in the Treatment of Hypertrophic Scars in Adult Burn Patients|Completed||N/A|12|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-10 20:49:04.661255|2017-10-10 20:49:04.661255
NCT03240705|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-02|||August 16, 2017|Anticipated|2017-08-16|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Increasing Medical Student Well-being Through Gratitude Journaling|Randomised Controlled Trial of Gratitude Reporting vs no Intervention on Well-being of Medical Students During Clerkship|Not yet recruiting||N/A|150|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f|f|f||||||||2017-10-10 20:49:04.736975|2017-10-10 20:49:04.736975
NCT03240692|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2017-08-01|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|September 30, 2017|Anticipated|2017-09-30||Interventional|aTBS||Accelerated Theta Burst Stimulation in Treatment-Resistant Depression|Accelerated Theta Burst Stimulation in Treatment-Resistant Depression|Enrolling by invitation||N/A|5|Anticipated|Stanford University||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:49:04.851525|2017-10-10 20:49:04.851525
NCT03240679|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-08-02|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Endoscopic Mucosal Resection and Cellular Matrix|A Randomized Study of Biologic Scaffolds And Esophageal Healing Following Endoscopic Resection|Enrolling by invitation||N/A|20|Anticipated|Mayo Clinic||2|||f||||f|f|t|f|||||||2017-10-10 20:49:04.960703|2017-10-10 20:49:04.960703
NCT03240666|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-02|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|April 10, 2019|Anticipated|2019-04-10||Observational|Paro-Proto||Protozoans in Biofilm From Patients With Periodontitis|Multicentric Clinical Trials on the Prevalence of Entamoeba Gingivalis and Its Associated Bacterial Flora in Patients With Periodontitis|Recruiting||N/A|231|Anticipated|Central Hospital, Nancy, France|||1||f||||f|f|f||||Samples With DNA|"     Bacterial DNA, protozoan DNA   "|||2017-10-10 20:49:05.096939|2017-10-10 20:49:05.096939
NCT03240653|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-11|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|Gaucherite||Gaucherite - A Study to Stratify Gaucher Disease|Predictive Measures to Stratify Clinical Outcomes in Children and Adults With Gaucher Disease and Responses to Specific Therapies|Recruiting||N/A|250|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||2||f||||f|f|f||||Samples With DNA|"     Urine, Blood (Plasma, Serum, EDTA) Fresh Tissue, Biopsy, Bone Marrow Aspiration & Cerebral     Spinal fluid (rarely).   "|||2017-10-10 20:49:05.205485|2017-10-10 20:49:05.205485
NCT03240640|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-08-07|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effects of Inspiratory Muscle Training on Shortness of Breath (Dyspnea) and Postural Control in Patients With COPD|Effects of Inspiratory Muscle Training on Shortness of Breath (Dyspnea) and Postural Control in Patients With COPD|Recruiting||N/A|24|Anticipated|Katholieke Universiteit Leuven||2|||f||||t|f|f||||||||2017-10-10 20:49:05.373346|2017-10-10 20:49:05.373346
NCT03240627|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|June 30, 2019|Anticipated|2019-06-30||Interventional|AA||Efficacy and Safety of LH-8 in Paediatric Alopecia Areata|Double-blind, Vehicle-controlled, Randomised, Multi-centre Study to Evaluate the Efficacy and Safety of LH-8 Cutaneous Solution in Children and Adolescents With Moderate to Severe Scalp Alopecia Areata.|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Legacy Healthcare SA||2|||f||||t|f|f||||||||2017-10-10 20:49:05.523634|2017-10-10 20:49:05.523634
NCT03240614|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-09|||October 14, 2017|Anticipated|2017-10-14|August 2017|2017-08-01|October 14, 2019|Anticipated|2019-10-14|March 15, 2019|Anticipated|2019-03-15||Interventional|POET||PreOxygenation for EndoTracheal Intubations|PreOxygenation for Airway Management: High Flow Versus Conventional Preoxygenation Therapy|Not yet recruiting||N/A|150|Anticipated|Nova Scotia Health Authority||6|||f||||f|f|f|||f|||||2017-10-10 20:49:05.631262|2017-10-10 20:49:05.631262
NCT03240601|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-01|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Spinal Cord Stimulation to Augment Activity Based Therapy|Combined Influence of Transcutaneous Spinal Cord Stimulation and Locomotor Training on Spasticity and Walking Outcomes After Spinal Cord Injury|Recruiting||N/A|28|Anticipated|Shepherd Center, Atlanta GA||2|||f|||||f|t|f|f||||||2017-10-10 20:49:05.749646|2017-10-10 20:49:05.749646
NCT03240588|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-07|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Interventional|||NAVITAS: A Study to Characterize the Relationship Between Select Objective Metrics and Clinical Outcomes in Chronic Pain Patients Treated With Boston Scientific Neurostimulation Systems|NAVITAS: A Study to Characterize the Relationship Between Select Objective Metrics and Clinical Outcomes in Chronic Pain Patients Treated With Boston Scientific Neurostimulation Systems|Recruiting||N/A|960|Anticipated|Boston Scientific Corporation||2|||f|||||f|t|f|f|t|||||2017-10-10 20:49:05.901516|2017-10-10 20:49:05.901516
NCT03240575|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-10-03|||August 14, 2017|Actual|2017-08-14|October 2017|2017-10-01|August 1, 2018|Anticipated|2018-08-01|July 11, 2018|Anticipated|2018-07-11||Interventional|||The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus|A Randomized, Double-blind, Double-dummy, Active-controlled, Multi-center, Parallel Group Study to Show the Superiority in Lung Function of 12 Weeks Once Daily Treatment With Orally Inhaled Tiotropium+Olodaterol Fixed Dose Combination Delivered by the Respimat® Inhaler vs. 12 Weeks Twice Daily Treatment With Fluticasone Propionate+Salmeterol Fixed Dose Combination Delivered by the Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [ENERGITO® 2]|Recruiting||Phase 4|288|Anticipated|Boehringer Ingelheim||2|||f||||f|t|f||||||||2017-10-10 20:49:06.02434|2017-10-10 20:49:06.02434
NCT03240562|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-07|||August 3, 2017|Actual|2017-08-03|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Ultrasound-guided Block for Thoracic Surgery Pain|Ultrasound-guided Serratus Anterior Plane Block Versus Paravertebral Block for Thoracic Surgery Pain?|Recruiting||N/A|165|Anticipated|Samsung Medical Center||3|||f|||||f|f||||||||2017-10-10 20:49:06.311123|2017-10-10 20:49:06.311123
NCT03240549|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|August 31, 2018|Anticipated|2018-08-31||Interventional|||Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease|Effectiveness and Safety of Adding Bevacizumab to Chemotherapy in Patients With Advanced Lung Adenocarcinoma With Stable Disease After 2 Cycles of First Line Combination Chemotherapy: a Multicenter, Prospective Cohort Study|Not yet recruiting||Phase 2|159|Anticipated|Beijing Hospital||2|||f|||||t|f|||t|||||2017-10-10 20:49:06.421581|2017-10-10 20:49:06.421581
NCT03240536|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-02|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|August 15, 2019|Anticipated|2019-08-15|August 15, 2019|Anticipated|2019-08-15||Interventional|||Choosing Tests Wisely in Rheumatology|Choosing Tests Wisely in Rheumatology|Not yet recruiting||N/A|200|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:49:06.51947|2017-10-10 20:49:06.51947
NCT03240523|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-26|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|September 28, 2021|Anticipated|2021-09-28|May 31, 2020|Anticipated|2020-05-31||Interventional|ASTEROID 5||Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids Compare to Ulipristal|A Randomized, Parallel-group, Double-blind, Double-dummy, Active-controlled, Multicenter Study to Assess the Efficacy and Safety of Vilaprisan in Subjects With Uterine Fibroids|Recruiting||Phase 3|996|Anticipated|Bayer||4|||f||||f|f|f||||||||2017-10-10 20:49:06.647937|2017-10-10 20:49:06.647937
NCT03240510|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|December 31, 2016|Actual|2016-12-31||Observational|||Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience|Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience|Active, not recruiting||N/A|150|Anticipated|Salah Azaïz Cancer Institute|||1||f||||||||||||||2017-10-10 20:49:07.148183|2017-10-10 20:49:07.148183
NCT03240497|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-02|||April 12, 2016|Actual|2016-04-12|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|EXPOCOL||Effects of Cold Exposure and Breathing Techniques on Immune Response|The Influence of Breathing Techniques and Exposure to Cold on Inflammation During Human Endotoxemia, an Explorative Study'|Active, not recruiting||N/A|48|Anticipated|Radboud University||4|||f||||f|f|f||||||||2017-10-10 20:49:07.205055|2017-10-10 20:49:07.205055
NCT03240484|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-18|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Examining Effects of Spinal Fusion on Outcomes Following Total Hip Replacement|Examining Effects of Lumbar Arthrodesis on Outcomes Following Total Hip Arthroplasty|Recruiting||N/A|90|Anticipated|Ottawa Hospital Research Institute|||2||f||||f|f|f||||||||2017-10-10 20:49:07.297474|2017-10-10 20:49:07.297474
NCT03240471|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-25|||August 17, 2017|Actual|2017-08-17|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Cast-OFF||Cast OFF Trial: One Versus Four-five Weeks of Plaster Cast Immobilization|Cast OFF Trial: One Versus Four-five Weeks of Plaster Cast Immobilization for Non-reduced Distal Radius Fractures: A Randomized Clinical Trial - A Feasibility Trial|Recruiting||N/A|40|Anticipated|Radboud University||2|||f||||t|f|f||||||||2017-10-10 20:49:07.381571|2017-10-10 20:49:07.381571
NCT03240458|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-02|||August 10, 2017|Anticipated|2017-08-10|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|January 31, 2018|Anticipated|2018-01-31||Observational|||Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography|Screening For Diabetic Macular Edema Among Diabetic Patients In Assiut University Hospital Using Optical Coherence Tomography|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:49:07.497381|2017-10-10 20:49:07.497381
NCT03240445|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-19|||August 24, 2017|Actual|2017-08-24|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KIPEV||Impact of Changing the Dosing Regimen on the PK Profile of ODM-203|A Part-randomised, Single Centre, Single Dose, Crossover,Phase I Study to Investigate the Impact of Changes to the Dosing Regimen on the Pharmacokinetic Profile of ODM-203 in Healthy Male Volunteers|Recruiting||Phase 1|16|Anticipated|Orion Corporation, Orion Pharma||3|||f||||f|f|f|||f|||||2017-10-10 20:49:07.568756|2017-10-10 20:49:07.568756
NCT03240432|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-02|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|WISDM||Wireless Innovation for Seniors With Diabetes Mellitus|Wireless Innovation for Seniors With Diabetes Mellitus (WISDM)|Not yet recruiting||N/A|200|Anticipated|Jaeb Center for Health Research||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:49:07.6561|2017-10-10 20:49:07.6561
NCT03240419|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-11|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Prenatal Probiotic Intervention|Probiotic Supplementation in Obese Pregnant Women. A Feasibility Study.|Recruiting||N/A|60|Anticipated|Arkansas Children's Hospital Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:49:07.827087|2017-10-10 20:49:07.827087
NCT03240406|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-04|||May 1, 2018|Anticipated|2018-05-01|August 2017|2017-08-01|August 31, 2022|Anticipated|2022-08-31|December 31, 2021|Anticipated|2021-12-31||Interventional|MHD||Multicultural Healthy Diet to Reduce Cognitive Decline|Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk|Not yet recruiting||N/A|406|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t|f|f||||||||2017-10-10 20:49:07.911028|2017-10-10 20:49:07.911028
NCT03240380|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|JCPUKE||Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care.|A Randomized Controlled Trial Comparing Joint Crisis Plans With Crisis Cards for People With Bipolar Disorders, Schizophrenia and Other Psychotic Disorders to Reduce Involuntary Admission and Coercive Measures.|Recruiting||N/A|160|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f|f|f||||||||2017-10-10 20:49:08.074981|2017-10-10 20:49:08.074981
NCT03240367|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-04|||December 4, 2016|Actual|2016-12-04|July 2017|2017-07-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Interventional|||Comparison of Stapler Line Bleeding Control Techniquessurgery|Comparison of Stapler Line Bleeding Control Techniques in Laparoscopic Gastric Bypass|Completed||N/A|50|Actual|Inonu University||2|||f||||t|f|f||||||||2017-10-10 20:49:09.673222|2017-10-10 20:49:09.673222
NCT03240354|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-12|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|MicroCuff||Paediatric Microcuff Pressure Study|Reducing Intra-operative Pressure Variations in Paediatric Microcuff Endotracheal Tube Cuffs|Not yet recruiting||N/A|50|Anticipated|Nottingham University Hospitals NHS Trust||2|||f||||f|f|f|||f|||||2017-10-10 20:49:09.745643|2017-10-10 20:49:09.745643
NCT03240341|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-02|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 31, 2019|Anticipated|2019-05-31||Interventional|PARACT||Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway|Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway|Not yet recruiting||N/A|600|Anticipated|Institut de Cancérologie de la Loire||1|||f||||f|f|f||||||||2017-10-10 20:49:09.82969|2017-10-10 20:49:09.82969
NCT03240328|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-08-02|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function|The Effect of CAR-T Cell Therapy on the Reconstitution of HIV-specific Immune Function|Not yet recruiting||Phase 1|40|Anticipated|Guangzhou 8th People's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:49:09.88977|2017-10-10 20:49:09.88977
NCT03240315|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Observational|||Personalized Prediction Strategy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Establishment of Individualized Prediction System for Acute Exacerbation of Chronic Obstructive Pulmonary Disease Based on Cloud Platform|Recruiting||N/A|400|Anticipated|Guangzhou Institute of Respiratory Disease|||1||f||||||||||Samples With DNA|"     Whole blood, serum, plasma,sputum   "|||2017-10-10 20:49:09.968858|2017-10-10 20:49:09.968858
NCT03240302|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Comparative Study of Sibling Oocytes: ICSI vs. the PICSI Sperm Selection Method|A Comparative Study of Sibling Oocytes, Which Examines Two Sperm Selection Methods for Top Quality of Spermatozoa , Prior Intracytoplasmic Sperm Injection (ICSI) Performance, and Their Effect on Embryo Quality and IVF Outcome: A Common Selection Method Based on Morphology (ICSI) vs. a Selection Method for Mature Spermatozoa With CD44 Receptors for Hyaluronic Acid (PICSI - Physiological Selected Intracytoplasmic Sperm Injection)|Not yet recruiting||N/A|50|Anticipated|Hillel Yaffe Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:49:10.045429|2017-10-10 20:49:10.045429
NCT03240289|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-01|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Texting for Diabetes Success in Pregnancy|Use of Text Messaging to Reduce Barriers to Self-care for Low-income Pregnant Women With Diabetes|Completed||N/A|33|Actual|Northwestern University||1|||f||||t|f|f||||||||2017-10-10 20:49:10.125726|2017-10-10 20:49:10.125726
NCT03240276|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Comparative Study of Sibling Oocytes: ICSI vs. the IMSI Sperm Selection Method|A Comparative Study of Sibling Oocytes, Which Examines Two Sperm Selection Methods for Top Quality of Spermatozoa , Prior Intracytoplasmic Sperm Injection (ICSI) Performance, and Their Effect on Embryo Quality and IVF Outcome: A Common Selection Method Based on Morphology (ICSI) vs. an Ultra Morphology Section Method - Intracytoplasmic Morphology Selected Sperm Injection (IMSI)|Not yet recruiting||N/A|50|Anticipated|Hillel Yaffe Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:49:10.195538|2017-10-10 20:49:10.195538
NCT03240263|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Inspiratory Muscle Training in Difficult to Wean Patients|Inspiratory Muscle Training in Difficult to Wean Patients: a Randomised Controlled Trial|Not yet recruiting||N/A|90|Anticipated|Katholieke Universiteit Leuven||2|||f|||||f|f||||||||2017-10-10 20:49:10.281533|2017-10-10 20:49:10.281533
NCT03240250|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-02|||March 12, 2017|Actual|2017-03-12|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|March 1, 2019|Anticipated|2019-03-01||Observational|||Randomized Study on Effects of Uniportal VATS Versus Triportal VATS|Randomized Study on Effects of Uniportal VATS Versus Triportal VATS for the Treatment of Stage I-II NSCLC|Recruiting||N/A|120|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||2||f||||f|f|f||||||||2017-10-10 20:49:10.355818|2017-10-10 20:49:10.355818
NCT03240237|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|August 1, 2018|Anticipated|2018-08-01||Interventional|||CCM in Heart Failure With Preserved Ejection Fraction|Cardiac Contractility Modulation (CCM™) Therapy in Subjects With Heart Failure With Preserved Ejection Fraction|Not yet recruiting||N/A|50|Anticipated|Impulse Dynamics||1|||f||||f|f|f||||||||2017-10-10 20:49:10.55632|2017-10-10 20:49:10.55632
NCT03240224|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||September 2, 2017|Anticipated|2017-09-02|August 2017|2017-08-01|September 2, 2020|Anticipated|2020-09-02|September 2, 2018|Anticipated|2018-09-02||Interventional|||Bioinformation Therapy for Breast Cancer|Combination of Cancer Ablation and Life Information Rehabilitation Therapy for Unresectable Breast Cancer|Recruiting||Phase 2/Phase 3|120|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f|||||f|f||||||||2017-10-10 20:49:10.655685|2017-10-10 20:49:10.655685
NCT03240211|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-25|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 10, 2020|Anticipated|2020-12-10|September 10, 2019|Anticipated|2019-09-10||Interventional|||Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL|Novel Immuno-epigenetic Based Platform for Patients With Peripheral T-cell Lymphoma (PTCL) and Cutaneous T-cell Lymphoma (CTCL): an International Phase Ib Study of Pembrolizumab Combined With Decitabine and Pralatrexate|Not yet recruiting||Phase 1|42|Anticipated|Columbia University||3|||f||||t|t|f||||||||2017-10-10 20:49:10.749844|2017-10-10 20:49:10.749844
NCT03240198|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-08-29|||January 2010||2010-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2016|Actual|2016-01-01||Observational|MB2PROF||Biological Markers for Professional COPD|Marqueurs Biologiques Des Bronchopneumopathies Chroniques Obstructives Professionnelles|Recruiting||N/A|400|Anticipated|Centre Hospitalier Intercommunal Creteil|||2||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 20:49:10.866792|2017-10-10 20:49:10.866792
NCT03240185|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-10-03|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|||Post Hemorrhoidectomy Anorectal Pain|Effectiveness of Guided Breathing Exercises on Anorectal Pain in Patients With Symptomatic Hemorrhoids|Enrolling by invitation||N/A|200|Anticipated|Boston Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:49:10.950912|2017-10-10 20:49:10.950912
NCT03240172|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-15|||July 20, 2016|Actual|2016-07-20|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Assessment of DNA Damage Due to Ionizing Radiation|Assessment of DNA Damage and Capacity of DNA Repair System Among Nuclear Medicine and Clinical Oncology Workers Exposing to Ionizing Radiation|Recruiting||N/A|100|Anticipated|Assiut University|||1||f||||||||||||||2017-10-10 20:49:11.039353|2017-10-10 20:49:11.039353
NCT03240159|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-03|||January 2, 2017|Actual|2017-01-02|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix|Long Antagonist Protocol for IVF: a Proof of Concept for a Single Luteal GnRH- Antagonist Protocol|Recruiting||Phase 3|120|Anticipated|Assisting Nature||3|||f||||t|f|f||||||||2017-10-10 20:49:11.107493|2017-10-10 20:49:11.107493
NCT03240146|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|PSWT||Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain|Pulsed Shortwave Therapy (PSWT) Treatment for Chronic Musculoskeletal Low Back Pain|Not yet recruiting||N/A|60|Anticipated|BioElectronics Corporation||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:49:11.195088|2017-10-10 20:49:11.195088
NCT03240120|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-04|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism|A Prospective Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism|Not yet recruiting||Phase 3|99|Anticipated|The University of Hong Kong||1|||f||||f|f|f||||||||2017-10-10 20:49:11.39107|2017-10-10 20:49:11.39107
NCT03240094|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-03|||February 26, 2016|Actual|2016-02-26|July 2017|2017-07-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Feasibility and Effectiveness of Nutritional Telemonitoring in Community-dwelling Elderly.|PhysioDom Home Dietary Intake Monitoring: Telemonitoring of Nutritional Parameters and Other Outcomes in Community Dwelling Elderly People: a Process and Effect Study.|Completed||N/A|213|Actual|Wageningen University||2|||f||||f|f|f||||||||2017-10-10 20:49:11.583875|2017-10-10 20:49:11.583875
NCT03240081|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-03|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Treating Where it Hurts|Treating Where it Hurts: A Randomized Blinded Clinical Trial of Local Estrogen to the Vulvar Vestibule for Dyspareunia in Postmenopausal Women|Recruiting||Phase 4|50|Anticipated|Oregon Health and Science University||2|||f|||||t|f|||f|||||2017-10-10 20:49:11.688275|2017-10-10 20:49:11.688275
NCT03240068|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-17|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Angiotensin-(1-7) in Peripheral Arterial Disease|Protective Effects of Angiotensin-(1-7) in Peripheral Arterial Disease|Recruiting||Early Phase 1|16|Anticipated|Milton S. Hershey Medical Center||2|||f||||t|t|f||||||||2017-10-10 20:49:11.782224|2017-10-10 20:49:11.782224
NCT03240055|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-02|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|July 15, 2017|Actual|2017-07-15|July 15, 2017|Actual|2017-07-15||Interventional|LOC||The Effects of Spinal Anesthesia on ED50 and BIS50 of Etomidate for the Loss of Consciousness|The Effects of Spinal Anesthesia on ED50 and BIS50 of Etomidate for the Loss of Consciousness|Completed||N/A|54|Actual|General Hospital of Ningxia Medical University||2|||f||||t|f|f||||||||2017-10-10 20:49:11.886668|2017-10-10 20:49:11.886668
NCT03240042|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-15|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Initial Increase in Cuff Pressure in Anterior Cervical Spinal Surgery|Initial Increase in Cuff Pressure After Neck Retraction for Anterior Spine Surgery: Comparison Between Orotracheal and Nasotracheal Intubation|Not yet recruiting||N/A|200|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f|||||f|f||||||||2017-10-10 20:49:11.973632|2017-10-10 20:49:11.973632
NCT03240029|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-07|||October 7, 2010|Actual|2010-10-07|August 2017|2017-08-01|September 11, 2013|Actual|2013-09-11|September 11, 2013|Actual|2013-09-11||Interventional|QdV leucémie||Life Quality of Children in Cancer Remission During School Reintegration|Life Quality of Children in Cancer Remission During School Reintegration|Completed||N/A|100|Actual|Central Hospital, Nancy, France||2|||f||||f|f|f||||||||2017-10-10 20:49:12.06295|2017-10-10 20:49:12.06295
NCT03240003|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-29|||August 25, 2017|Actual|2017-08-25|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||A Novel Computer-Based Therapy for Social Anxiety|A Novel Computer-Based Therapy for Social Anxiety|Recruiting||N/A|60|Anticipated|New York State Psychiatric Institute||3|||f||||f|f|f||||||||2017-10-10 20:49:12.217559|2017-10-10 20:49:12.217559
NCT03239990|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-03|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Group-based Parenting Program to Reduce Child Conduct Disorder Symptoms in Finland|"Group-based Parenting Program Incredible Years to Reduce Child Conduct Disorder Symptoms in Families With Child Protection and Other Family Support Services in Finland"|Active, not recruiting||N/A|101|Actual|National Institute for Health and Welfare, Finland||2|||f||||f|f|f||||||||2017-10-10 20:49:12.426169|2017-10-10 20:49:12.426169
NCT03239977|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-01|||September 9, 2017|Anticipated|2017-09-09|August 2017|2017-08-01|October 31, 2022|Anticipated|2022-10-31|December 30, 2021|Anticipated|2021-12-30||Interventional|||Social Intelligence Training for Custodial Grandfamilies|Social Intelligence Training for Custodial Grandmothers and Their Adolescent Grandchildren|Not yet recruiting||Phase 2|680|Anticipated|Kent State University||2|||f||||t|f|f||||||||2017-10-10 20:49:12.539326|2017-10-10 20:49:12.539326
NCT03239964|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-09-14|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence|Combined Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence.A Randomized Controlled Trial.|Recruiting||Phase 4|146|Anticipated|Kasr El Aini Hospital||2|||f|||||f|f||||||||2017-10-10 20:49:12.630159|2017-10-10 20:49:12.630159
NCT03239951|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-06|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Study to Assess the Tolerability, Safety and Efficacy of (iTIND)|Randomized, Controlled, Multi-Center Prospective Study to Assess the Tolerability, Safety and Efficacy iTIND in Subjects With Acute Urinary Retention Secondary to Benign Prostatic Obstruction (BPO)|Not yet recruiting||N/A|44|Anticipated|Medi-Tate Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:49:12.741196|2017-10-10 20:49:12.741196
NCT03238469|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-19|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|November 1, 2018|Anticipated|2018-11-01|September 1, 2018|Anticipated|2018-09-01||Interventional|WAVE||Microwave Ablation in Mild Axillary Hidradenitis Suppurativa|Long-term Efficacy and Safety of Microwave Ablation in the Treatment of Mild Axillary Hidradenitis Suppurativa|Recruiting||N/A|20|Anticipated|Erasmus Medical Center||2|||f||||f|f|t|f|f||||||2017-10-10 20:49:25.286235|2017-10-10 20:49:25.286235
NCT03239938|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-16|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|February 27, 2020|Anticipated|2020-02-27||Interventional|||Modern Pain Neuroscience Applied to Chronic Pain in Patients With Chronic Whiplash Associated Disorders|Contemporary Pain Neuroscience Compared to Usual Care Evidence-based Physiotherapy Applied to Chronic Pain in Patients With Chronic Whiplash Associated Disorders: Can we Decrease Central Sensitization?|Recruiting||N/A|120|Anticipated|Vrije Universiteit Brussel||2|||f||||f|f|f||||||||2017-10-10 20:49:12.82232|2017-10-10 20:49:12.82232
NCT03239925|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-04|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|September 1, 2017|Anticipated|2017-09-01|August 15, 2017|Anticipated|2017-08-15||Interventional|||Acute Effects of Cell Phone Exposure on Immediate Attention Levels and Concentration of Emergency Physicians|Acute Effects of Cell Phone Exposure on Immediate Attention Levels and Concentration of Emergency Physicians|Recruiting||N/A|30|Anticipated|Karadeniz Technical University||2|||f||||f|f|f||||||||2017-10-10 20:49:12.975938|2017-10-10 20:49:12.975938
NCT03239912|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-03|||July 16, 2017|Actual|2017-07-16|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Treatment of Class II Malocclusion Combined With Low-level Laser|The Effects of Combined Treatment With Low-level Laser and Functional Appliances on the Correction of Class II Malocclusion: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Damascus University||2|||f||||t|f|f||||||||2017-10-10 20:49:13.092455|2017-10-10 20:49:13.092455
NCT03239886|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-01|||December 15, 2016|Actual|2016-12-15|May 2017|2017-05-01|January 31, 2020|Anticipated|2020-01-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log|Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log|Recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||1|||f||||f|f|f||||||||2017-10-10 20:49:13.338372|2017-10-10 20:49:13.338372
NCT03239860|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-01|||June 6, 2017|Actual|2017-06-06|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ANGEL-MS||Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis|A Long-Term International, Extension of Study GNC-003 With GNbAC1 in Patients With Relapsing Remitting Multiple Sclerosis|Recruiting||Phase 2|200|Anticipated|GeNeuro SA||3|||f||||t|f|f||||||||2017-10-10 20:49:13.577686|2017-10-10 20:49:13.577686
NCT03239847|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-01|||September 6, 2016|Actual|2016-09-06|August 2017|2017-08-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|||Cost Effectiveness of the EndoPhys Pressure Sensing Access System vs. Radial A-line for Intra-operative Blood Pressure Monitoring|Cost Effectiveness of the EndoPhys Pressure Sensing Access System vs. Radial A-line for Intra-operative Blood Pressure Monitoring|Completed||N/A|40|Actual|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:49:13.692067|2017-10-10 20:49:13.692067
NCT03239834|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-01|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making|Clinical Evaluation of the OncAlert RAPID; Impact on Decision-Making|Recruiting||N/A|1000|Anticipated|Vigilant Biosciences, Inc.|||3||f||||t|f|t|t|f|f|||||2017-10-10 20:49:13.774649|2017-10-10 20:49:13.774649
NCT03239821|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ANTERO-1||Clinical Evaluation of the VIPUN Balloon Catheter 0.1|ANTERO-1: a Clinical Evaluation of an Investigational Device: the VIPUN Balloon Catheter 0.1 Used for the Evaluation of Gastric Motility|Recruiting||N/A|23|Anticipated|Universitaire Ziekenhuizen Leuven||4|||f|||||f|f||||||||2017-10-10 20:49:13.873906|2017-10-10 20:49:13.873906
NCT03239808|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-09-13|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|April 2019|Anticipated|2019-04-01||Interventional|IHDIP||Assessment of the Incremental Haemodialysis Security and Effectiveness in Incident Patients|Assessment of the Incremental Haemodialysis Security and Effectiveness in Incident Patients|Not yet recruiting||N/A|152|Anticipated|Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura||2|||f||||f|f|f||||||||2017-10-10 20:49:13.965863|2017-10-10 20:49:13.965863
NCT03239795|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||October 15, 2014|Actual|2014-10-15|August 2017|2017-08-01|May 19, 2017|Actual|2017-05-19|February 28, 2015|Actual|2015-02-28||Interventional|ProFluGP||Promoting Influenza Vaccination In General Practice Waiting Rooms|Promoting Influenza Vaccination In General Practice Waiting Rooms By Posters And Pamphlets: A Registry Based Cluster Randomized Controlled Trial|Completed||N/A|10597|Actual|Berkhout, Christophe||2|||f||||f|f|f||||||||2017-10-10 20:49:14.096968|2017-10-10 20:49:14.096968
NCT03239782|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-03|2017-08-04|||March 29, 2016|Actual|2016-03-29|August 2017|2017-08-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||"The Metabolically-obese Normal-weight Phenotype and Its Reversal by Calorie Restriction"|"The Metabolically-obese Normal-weight Phenotype in Two Asian Ethnic Groups and Its Reversal by Calorie Restriction"|Active, not recruiting||N/A|120|Anticipated|Clinical Nutrition Research Centre, Singapore||1|||f||||f|f|f||||||||2017-10-10 20:49:14.190205|2017-10-10 20:49:14.190205
NCT03239756|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-21|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases|Phase 1 Trial of a Fully Human Monoclonal Antibody of Receptor Activator for Nuclear Factor-κ B Ligand (RNAKL, TK006) Safety, Pharmacokinetics, and Pharmacodynamics in Patients With Breast Cancer-related Bone Metastases|Recruiting||Phase 1|40|Anticipated|Jiangsu T-Mab Biopharma Co.,Ltd||4|||f||||f|f|f||||||||2017-10-10 20:49:14.37304|2017-10-10 20:49:14.37304
NCT03239743|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-03|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects of Virtual Reality on Pre-Operative Anxiety and Induction of Anesthesia in Children and Adolescents|A Pilot Study to Evaluate the Efficacy of Virtual Reality on Pre-Operative Anxiety and Induction of Anesthesia in a Children's Hospital|Recruiting||N/A|80|Anticipated|Valley Anesthesiology Consultants||2|||f|||||f|f||||||||2017-10-10 20:49:14.463853|2017-10-10 20:49:14.463853
NCT03239730|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||May 23, 2013|Actual|2013-05-23|August 2017|2017-08-01|May 30, 2014|Actual|2014-05-30|May 30, 2014|Actual|2014-05-30||Observational|||Arterial pH Selectively Predicts Intensive Care Unit Transfer From the Emergency Department in Obese Patients With Acute Dyspnea|Arterial pH Selectively Predicts ICU Transfer in Obese Patients With Acute Dyspnea Presenting to the Emergency Department: a Prospective Comparative Cohort Study|Completed||N/A|400|Actual|Association pour la Formation du Personnel à la Medecine d'Urgence|||1||f||||f|f|f||||||||2017-10-10 20:49:14.559394|2017-10-10 20:49:14.559394
NCT03239717|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-08-03|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|October 5, 2018|Anticipated|2018-10-05|October 5, 2018|Anticipated|2018-10-05||Interventional|SOAR||SOAR: Can we Stop Obesity and Diabetes by Amino Acid Reduction?|The Metabolic Response to Reduced Branched-chain Amino Acids in Humans|Recruiting||N/A|12|Anticipated|University of Wisconsin, Madison||2|||f||||f|f|f||||||||2017-10-10 20:49:14.643732|2017-10-10 20:49:14.643732
NCT03239704|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease|Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease (URGENT-IBD)|Not yet recruiting||N/A|450|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f|f|f||||||||2017-10-10 20:49:14.768392|2017-10-10 20:49:14.768392
NCT03239691|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-22|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients|A Phase 2a, Multi-center, Single-blind, Within-subject, Placebo-controlled Study to Assess the Pharmacodynamics of ACT-709478 in Subjects With Photosensitive Epilepsy|Not yet recruiting||Phase 2|16|Anticipated|Actelion||2|||f||||f|f|f||||||||2017-10-10 20:49:14.884102|2017-10-10 20:49:14.884102
NCT03239678|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-19|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|STAP||Safe Time for Apnea After Preoxygenation|Safe Time for Apnea After Preoxygenation With Different Oxygen Concentration During the Induction of General Anesthesia|Recruiting||N/A|90|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||3|||f|||||f|f||||||||2017-10-10 20:49:14.97243|2017-10-10 20:49:14.97243
NCT03239665|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-18|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|VEPSC||Vaccination Education Through Pharmacists and Senior Centers (VEPSC)|Randomized Trial of Peer-to-Peer Versus Pharmacist Education to Improve Older Adults' Vaccination Knowledge Through the Senior Center Model of Care|Not yet recruiting||N/A|316|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||||2017-10-10 20:49:15.065499|2017-10-10 20:49:15.065499
NCT03239652|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-02|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|November 1, 2017|Anticipated|2017-11-01||Interventional|||Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia|Safety and Efficacy of Prostatic Artery Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia|Recruiting||N/A|12|Anticipated|National Cheng-Kung University Hospital||1|||f||||t|f|f||||||||2017-10-10 20:49:15.283695|2017-10-10 20:49:15.283695
NCT03239639|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-08-02|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||RCT of Advance Care Planning in Primary Care|A Randomized Trial of an Advance Care Planning Intervention to Engaged Substitute Decision-makers in Primary Care|Not yet recruiting||Phase 2|128|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:49:15.388407|2017-10-10 20:49:15.388407
NCT03239600|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-23|||September 5, 2017|Anticipated|2017-09-05|August 2017|2017-08-01|June 8, 2020|Anticipated|2020-06-08|June 8, 2020|Anticipated|2020-06-08||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS)|A Two Part Phase IIa Study, to Evaluate the Safety and Tolerability, Pharmacokinetics, Proof of Mechanism and Potential for Efficacy of an Anti-IL-7 Receptor-α Monoclonal Antibody (GSK2618960) in the Treatment of Primary Sjögren's Syndrome|Not yet recruiting||Phase 2|22|Anticipated|GlaxoSmithKline||2|||f||||t|f|f||||||||2017-10-10 20:49:15.680256|2017-10-10 20:49:15.680256
NCT03239249|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-31|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|March 1, 2019|Anticipated|2019-03-01||Interventional|IKO||The Cluster-randomized Evaluation of the IKO-model|Systematic Follow-up in Order to Reduce Drop-out in Upper Secondary Schools: A Cluster-randomized Evaluation of the IKO-model|Recruiting||N/A|7500|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f|f|f||||||||2017-10-10 20:49:18.106888|2017-10-10 20:49:18.106888
NCT03239587|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-08|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|July 2031|Anticipated|2031-07-01|July 2031|Anticipated|2031-07-01||Observational|||Investigating the Effect of Simulated Live Piano Music on Preoperative Cancer Patients, Health Care Providers and Hospital Volunteers Using Validated Questionnaires and Proteomic Analysis|Investigating the Effect of Simulated Live Piano Music on Preoperative Cancer Patients, Health Care Providers and Hospital Volunteers Using Validated Questionnaires and Proteomic Analysis|Recruiting||N/A|304|Anticipated|M.D. Anderson Cancer Center|||2||f||||f|f|f||||Samples With DNA|"     Blood (about 1½ teaspoons each time) drawn before and about 30 minutes after participant     either listens to music or stands in the waiting room without music.   "|||2017-10-10 20:49:15.808678|2017-10-10 20:49:15.808678
NCT03239574|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||July 10, 2017||2017-07-10||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:49:15.907747|2017-10-10 20:49:15.907747
NCT03239561|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-01|||September 6, 2017|Anticipated|2017-09-06|September 2017|2017-09-01|November 20, 2017|Anticipated|2017-11-20|November 3, 2017|Anticipated|2017-11-03||Interventional|||Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants|Phase 0 Exploratory Study of [18F]MNI-1020 (Also Known as [18F]JNJ-64326067) as an Imaging Marker for Tau Protein in the Brain of Subjects With Alzheimer's Disease Compared to Healthy Subjects|Not yet recruiting||Early Phase 1|6|Anticipated|Janssen Research & Development, LLC||1|||f||||f|t|f||||||||2017-10-10 20:49:15.94794|2017-10-10 20:49:15.94794
NCT03239548|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|INMP||"Opinion of Doctors,Nurses and Key Informants About Independent Nurse Midwifery Practitioner in Northern India"|"A Study to Assess the Opinion of Doctors, Nurses and Key Informants Regarding Independent Nurse Midwifery Practitioner at Selected Hospitals and Colleges of Nursing in Haryana."|Completed||N/A|400|Actual|Maharishi Markendeswar University|||3||f||||t|f|f||||||||2017-10-10 20:49:16.035884|2017-10-10 20:49:16.035884
NCT03239535|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-01|||October 1, 2013|Actual|2013-10-01|August 2017|2017-08-01|November 1, 2018|Anticipated|2018-11-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy|Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy|Recruiting||Phase 1/Phase 2|40|Anticipated|Federal Research Clinical Center of Federal Medical & Biological Agency, Russia||2|||f||||f|f|f||||||||2017-10-10 20:49:16.105128|2017-10-10 20:49:16.105128
NCT03239522|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-23|||October 2, 2017|Anticipated|2017-10-02|August 2017|2017-08-01|November 20, 2017|Anticipated|2017-11-20|November 20, 2017|Anticipated|2017-11-20||Interventional|||Absorption and Elimination of Radiolabeled Daprodustat|An Open-label Study in Healthy Male Participants to Determine the Mass Balance, Absolute Bioavailability and Pharmacokinetics of Daprodustat, Administered as a Single Intravenous Microtracer (Concomitant With an Oral Dose of Non-radiolabelled Daprodustat) and a Single, Oral Radiolabelled Dose|Not yet recruiting||Phase 1|6|Anticipated|GlaxoSmithKline||1|||f||||f|t|f|||t|||||2017-10-10 20:49:16.206949|2017-10-10 20:49:16.206949
NCT03239509|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-01|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ANDALVALVE||15 Years Outcomes Following Bioprosthetic vs Mechanical Aortic Valve Replacement Between 50-65 Years|15 Years Outcomes Following Bioprosthetic vs Mechanical Isolated Aortic Valve Replacement for Aortic Stenosis in Patients Aged 50 to 65 Years in South Spain. The Andalousian Aortic Valve Multicentric Study (ANDALVALVE)|Active, not recruiting||N/A|1200|Actual|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud|||2||f||||f|f|f||||||||2017-10-10 20:49:16.319427|2017-10-10 20:49:16.319427
NCT03239496|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|||A Study to Evaluate Immunogenicity of Various Schedules of Intramuscular Full-Dose and Intradermal Fractional Dose of Inactivated Polio Vaccine|A Phase 3, Open-label, Multicenter Randomized Trial to Evaluate Humoral Immunogenicity of Various Schedules of Intramuscular Full-Dose and Intradermal Fractional Dose of Inactivated Polio Vaccine in Latin American Infants|Not yet recruiting||Phase 3|773|Anticipated|Fidec Corporation||4|||f||||f|f|f||||||||2017-10-10 20:49:16.405356|2017-10-10 20:49:16.405356
NCT03239483|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults|A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults|Not yet recruiting||Phase 1|27|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 20:49:16.489031|2017-10-10 20:49:16.489031
NCT03239470|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-22|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus|A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults With Active Pemphigus (APG01)|Recruiting||Phase 1|12|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 20:49:16.584112|2017-10-10 20:49:16.584112
NCT03239457|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||December 2015||2015-12-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Efficacy and Safety of Heberprot-P® in Patients With Advanced Diabetic Foot Ulcer in Dasman Diabetes Institute.|Efficacy and Safety of Heberprot-P® in Patients With Advanced Diabetic Foot Ulcer in Dasman Diabetes Institute. Demonstrative Study|Completed||N/A|50|Actual|Dasman Diabetes Institute|||1||f||||||||||||||2017-10-10 20:49:16.694921|2017-10-10 20:49:16.694921
NCT03239444|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-01|||April 24, 2017|Actual|2017-04-24|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Foresight Intracardiac Echocardiography System (ICE)|Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System|Recruiting||Phase 1|10|Anticipated|Conavi||1|||f|||||f|f|||f|||||2017-10-10 20:49:16.783535|2017-10-10 20:49:16.783535
NCT03239236|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-31|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Modified Rapid Sequence Induction in Morbidly Obese Patients|Modified Rapid Sequence Induction in Morbidly Obese Patients|Not yet recruiting||N/A|100|Anticipated|Medical University of Vienna||4|||f||||f|f|f||||||||2017-10-10 20:49:18.411463|2017-10-10 20:49:18.411463
NCT03239431|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|January 31, 2022|Anticipated|2022-01-31|December 31, 2021|Anticipated|2021-12-31|3 Years|Observational [Patient Registry]|||A Study to Determine the Clinical Characteristics, Comorbidities, Treatment Status and Exacerbations of Asthma Patients|A 3 Year Longitudinal Study of the Level of Asthma Control and Treatment of Asthma Patients in Hong Kong|Not yet recruiting||N/A|400|Anticipated|Chinese University of Hong Kong|||1||f||||f|f|f||||Samples With DNA|"     Genetic markers in blood sample that can help to predict exacerbation and level of control in     patients with asthma   "|||2017-10-10 20:49:16.870929|2017-10-10 20:49:16.870929
NCT03239418|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||January 6, 2017|Actual|2017-01-06|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EyeStim||NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy|A Novel Treatment Using Neuromuscular Electrical Stimulation to Improve Eyelid Function in Patients With CN III and CN VII Palsy.|Recruiting||N/A|60|Anticipated|Brooks Rehabilitation||2|||f||||f|f|t|f|f||||||2017-10-10 20:49:16.978847|2017-10-10 20:49:16.978847
NCT03239405|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|VS1||Comparing the Cost Savings Potential of Orogastric Tubes in Laparoscopic Sleeve Gastrectomy|Comparing the Cost Savings Potential of Orogastric Tubes in Laparoscopic Sleeve Gastrectomy|Active, not recruiting||N/A|100|Anticipated|Boehringer Labs LLC|||2||f||||f|f|t|f|f|t|||||2017-10-10 20:49:17.089863|2017-10-10 20:49:17.089863
NCT03239392|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-18|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL|A Dose-Ranging Study of Intravenous BNZ132-1-40 in Patients With Large Granular Lymphocyte Leukemia or Refractory Cutaneous T‑Cell Lymphoma|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Bioniz Therapeutics||1|||f||||f|t|f||||||||2017-10-10 20:49:17.17495|2017-10-10 20:49:17.17495
NCT03239379|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 30, 2018|Anticipated|2018-01-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||A Multiple-Dose Study of Intravenous BNZ132‑1-40 in Healthy Adult Subjects|A Multiple-Dose Study of Intravenous BNZ132‑1-40 in Healthy Adult Subjects|Recruiting||Phase 1|30|Anticipated|Bioniz Therapeutics||2|||f||||f|t|f||||||||2017-10-10 20:49:17.259707|2017-10-10 20:49:17.259707
NCT03239366|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population|A Double-blind, Randomized Placebo Controlled Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population|Not yet recruiting||Phase 2|130|Anticipated|Bio-K Plus International Inc.||2|||f||||t|f|f||||||||2017-10-10 20:49:17.346097|2017-10-10 20:49:17.346097
NCT03239353|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-10-05|||October 20, 2017|Anticipated|2017-10-20|October 2017|2017-10-01|February 28, 2018|Anticipated|2018-02-28|December 29, 2017|Anticipated|2017-12-29||Interventional|||A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects|A Phase 1, Randomized, Partially-Blind, Parallel-Group, Active and Placebo Controlled Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of Entecavir Extended Release (XR) in Healthy Subjects|Not yet recruiting||Phase 1|40|Anticipated|Aucta Pharmaceuticals, Inc||5|||f||||t|f|f|||f|||||2017-10-10 20:49:17.43434|2017-10-10 20:49:17.43434
NCT03239327|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-01|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Vaginal Misoprostol to Improve the Neonatal Respiratory Outcome|Vaginal Misoprostol Before Elective Cesarean Section to Improve Neonatal Respiratory Outcomes . Randomized Controlled Clinical Study|Recruiting||N/A|292|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:49:17.641117|2017-10-10 20:49:17.641117
NCT03239314|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-03|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|July 22, 2017|Actual|2017-07-22|June 2017|Actual|2017-06-01||Interventional|||Analgesic Effect of Adductor Canal Block With and Without Dexamethasone for Knee Arthroscopy|The Effect of Adding Dexamethasone to Bupivacaine in Ultrasound Guided Adductor Canal Block for Postoperative Analgesia Following Knee Arthroscopic Anterior Cruciate Ligament Reconstruction|Completed||N/A|60|Actual|Assiut University||2|||f||||t|f|f|||f|||||2017-10-10 20:49:17.737039|2017-10-10 20:49:17.737039
NCT03239301|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||Robotic-assisted Upper Extremity Training in Spinal Cord Injury Patients|Robotic-assisted Upper Extremity Training in Spinal Cord Injury Patients|Completed||N/A|40|Actual|Ankara Physical Medicine and Rehabilitation Education and Research Hospital||2|||f||||f|f|f||||||||2017-10-10 20:49:17.808247|2017-10-10 20:49:17.808247
NCT03239288|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||June 22, 2017|Actual|2017-06-22|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|||A Randomized, Controlled, Crossover Study to Assess the Glucose and Insulin Excursions of a Test Fiber|A Randomized, Controlled, Crossover Study to Assess the Glucose and Insulin Excursions of a Test Fiber|Completed||N/A|22|Actual|Cargill||2|||f|||||f|f||||||||2017-10-10 20:49:17.876281|2017-10-10 20:49:17.876281
NCT03239275|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||January 17, 2016|Actual|2016-01-17|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Clinical Evaluation of Bio-creative Therapy for En Masse Retraction of the Maxillary Anterior Teeth|Evaluation of Labial Versus Lingual Biocreative Therapy for en Masse Retraction of Maxillary Anterior Teeth: A Randomized Clinical Trial|Active, not recruiting||N/A|30|Actual|Ain Shams University||2|||f||||t|f|f||||||||2017-10-10 20:49:17.949916|2017-10-10 20:49:17.949916
NCT03239262|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-31|||July 1, 2012|Actual|2012-07-01|July 2017|2017-07-01|February 28, 2016|Actual|2016-02-28|January 31, 2016|Actual|2016-01-31||Interventional|||Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation|Assessment of the Effect of Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation in Patients Undergoing Open Heart Surgery|Completed||N/A|100|Actual|University Hospital Ostrava||2|||f||||f|f|f||||||||2017-10-10 20:49:18.031854|2017-10-10 20:49:18.031854
NCT03239210|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||June 16, 2017|Actual|2017-06-16|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Effects of Ondansetron in Obsessive-compulsive and Tic Disorders|Effects of Ondansetron in Obsessive-compulsive and Tic Disorders|Recruiting||Phase 4|60|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|t|f||||||||2017-10-10 20:49:18.615152|2017-10-10 20:49:18.615152
NCT03239197|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-05|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|||Project SHARE (motherS Have All the Right microbEs)|An Exploratory Study to Evaluate the Transfer of the Maternal Microbial Consortia to Infants During and Following Birth|Recruiting||N/A|12|Anticipated|Kimberly-Clark Corporation|||1||f||||f|f|f||||None Retained|"     staphlococci isolates   "|||2017-10-10 20:49:18.715498|2017-10-10 20:49:18.715498
NCT03239184|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Bioinformation Therapy for Pancreatic Cancer|Combination of Cancer Ablation and Life Information Rehabilitation Therapy for Unresectable Pancreatic Cancer|Recruiting||Phase 2/Phase 3|120|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f|||||f|f|||f|||||2017-10-10 20:49:18.794958|2017-10-10 20:49:18.794958
NCT03239171|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||September 2, 2017|Anticipated|2017-09-02|August 2017|2017-08-01|September 2, 2020|Anticipated|2020-09-02|September 2, 2018|Anticipated|2018-09-02||Interventional|||Bioinformation Therapy for Lung Cancer|Combination of Cancer Ablation and Life Information Rehabilitation Therapy for Unresectable Lung Cancer|Recruiting||Phase 2/Phase 3|120|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f|||||f|f||||||||2017-10-10 20:49:18.903835|2017-10-10 20:49:18.903835
NCT03239158|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||September 2, 2017|Anticipated|2017-09-02|August 2017|2017-08-01|September 2, 2020|Anticipated|2020-09-02|September 2, 2018|Anticipated|2018-09-02||Interventional|||Bioinformation Therapy for Liver Cancer|Combination of Cancer Ablation and Life Information Rehabilitation Therapy for Unresectable Liver Cancer|Recruiting||Phase 2/Phase 3|120|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f|||||f|f||||||||2017-10-10 20:49:19.001009|2017-10-10 20:49:19.001009
NCT03239145|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-31|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|August 31, 2024|Anticipated|2024-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor|Phase Ib Study to Test the Safety and Potential Synergy of Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor|Recruiting||Phase 1|60|Anticipated|Dana-Farber Cancer Institute||5|||f||||t|t|f||||||||2017-10-10 20:49:19.094585|2017-10-10 20:49:19.094585
NCT03239132|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|MEND||MEditation for Post Stroke Depression|MEditation for Post Stroke Depression|Not yet recruiting||N/A|72|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|f||||||||2017-10-10 20:49:19.205712|2017-10-10 20:49:19.205712
NCT03239119|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||November 30, 2017|Anticipated|2017-11-30|July 2017|2017-07-01|January 15, 2019|Anticipated|2019-01-15|December 30, 2018|Anticipated|2018-12-30||Interventional|||The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus|A Phase 3, Randomized, Double-Blind,Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) and Safety of rE-4 in Subjects With Type 2 Diabetes Mellitus Treated With Metformin, a Sulfonylurea, or Metformin and Sulfonylurea Combination|Not yet recruiting||Phase 3|456|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||4|||f||||f|f|f||||||||2017-10-10 20:49:19.293099|2017-10-10 20:49:19.293099
NCT03239106|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-02|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||A Study Examining the Medication Apremilast as Treatment for Chronic Itch|An Open Label Study of Apremilast in Chronic Idiopathic Pruritus|Not yet recruiting||Phase 2|10|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 20:49:19.385872|2017-10-10 20:49:19.385872
NCT03239093|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|July 29, 2017|Actual|2017-07-29|July 29, 2017|Actual|2017-07-29||Observational|||Sixteen Years Trends in Reported Undernutrition in Switzerland|Sixteen Years Trends in Reported Undernutrition in Switzerland|Completed||N/A|13297188|Actual|Centre Hospitalier Universitaire Vaudois|||1||f|||||f|f||||||||2017-10-10 20:49:19.460946|2017-10-10 20:49:19.460946
NCT03239080|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|||Effect of Denosumab in Erosion Healing in RA|Effect of RANKL Inhibition on Healing of Bone Erosion in Rheumatoid Arthritis Using HR-pQCT|Recruiting||Phase 2|110|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f|||t|||||2017-10-10 20:49:19.528274|2017-10-10 20:49:19.528274
NCT03239067|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-02|||August 1, 2014|Actual|2014-08-01|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2019|Anticipated|2019-07-31||Observational|COSTIC||Comparison Of Efficacy and Safety Between Ticagrelor and Clopidogrel In Chinese|Comparison of Short- and Long-term Efficacy and Safety Between Ticagrelor and Clopidogrel in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention|Recruiting||N/A|9000|Anticipated|Tongji Hospital|||2||f||||||||||Samples With DNA|"     blood   "|||2017-10-10 20:49:19.623298|2017-10-10 20:49:19.623298
NCT03239054|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-09-13|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|August 31, 2019|Anticipated|2019-08-31||Interventional|||Prescribing Exercise as Medicine in Pregnancy|Prescribing Exercise as Medicine in Pregnancy: A Randomized Controlled Trial|Not yet recruiting||N/A|118|Anticipated|St. Louis University||2|||f||||f|f|f||||||||2017-10-10 20:49:19.702352|2017-10-10 20:49:19.702352
NCT03239041|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Social Navigation for Adolescents in ED|Health Related Social Problems in Emergency Department Patients: Can the Highest Risk Patients by Identified and Social Navigation Provided?|Recruiting||N/A|400|Anticipated|Children's Research Institute||2|||f||||t|f|f||||||||2017-10-10 20:49:19.780262|2017-10-10 20:49:19.780262
NCT03239028|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|December 31, 2016|Actual|2016-12-31||Observational|||Dietary Quality During Adolescence is Associated With Mother's Dietary Quality During Pregnancy|Dietary Quality During Adolescence is Associated With Mother's Dietary Quality During Pregnancy: 15 Years Follow up From a Large National Birth Cohort|Completed||N/A|19620|Actual|Centre for Fetal Programming, Denmark|||1||f||||f|f|f||||||||2017-10-10 20:49:19.867387|2017-10-10 20:49:19.867387
NCT03239015|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Efficacy and Safety of Targeted Precision Therapy in Refractory Tumor With Druggable Molecular Event|Efficacy and Safety of Targeted Precision Therapy in Refractory Tumor With Druggable Molecular Event|Recruiting||Phase 2|60|Anticipated|Shanghai Changzheng Hospital||1|||f||||t|f|f||||||||2017-10-10 20:49:19.946443|2017-10-10 20:49:19.946443
NCT03239002|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||July 2011||2011-07-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|CGH Array||Antenatal Detection by Array CGH Genomic Rearrangements Unbalanced Front Uninsulated Thick Neck or a Combination of Two Signs of Ultrasound Calling Normal Karyotype|Antenatal Detection by Array CGH Genomic Rearrangements Unbalanced Front Uninsulated Thick Neck or a Combination of Two Signs of Ultrasound Calling Normal Karyotype|Recruiting||N/A|200|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||||2017-10-10 20:49:20.056416|2017-10-10 20:49:20.056416
NCT03238989|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||January 5, 2014|Actual|2014-01-05|August 2017|2017-08-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Observational|ILD Registry||Interstitial Lung Disease Registry Construction|Interstitial Lung Disease Registry Construction|Recruiting||N/A|300|Anticipated|Seoul National University Hospital|||1||f|||||f|f||||||||2017-10-10 20:49:20.125203|2017-10-10 20:49:20.125203
NCT03238976|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy|Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy: A Randomized Study|Not yet recruiting||N/A|200|Anticipated|University of Chicago||2|||f||||f|f|f||||||||2017-10-10 20:49:20.210014|2017-10-10 20:49:20.210014
NCT03238963|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-10-02|||September 19, 2017|Actual|2017-09-19|October 2017|2017-10-01|November 21, 2018|Anticipated|2018-11-21|August 29, 2018|Anticipated|2018-08-29||Interventional|||A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.|A Randomized, Double-masked, Placebo-controlled Exploratory Study to Evaluate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Orally Administered BI 1467335 for 12 Weeks With a 12 Week Follow up Period in Patients With Nonproliferative Diabetic Retinopathy Without Center-involved Diabetic Macular Edema|Recruiting||Phase 2|100|Anticipated|Boehringer Ingelheim||2|||f||||f|t|f||||||||2017-10-10 20:49:20.289275|2017-10-10 20:49:20.289275
NCT03238950|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-01|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Cricothyroidotomy Training for Physicians Outcomes Study|In Cricothyroidotomy Training for Physicians Does Simulated Practice With Tissue Specimens Produce Better Outcomes Than Using Synthetics Manikins?|Not yet recruiting||N/A|30|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:49:20.371711|2017-10-10 20:49:20.371711
NCT03238937|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-28|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|July 10, 2022|Anticipated|2022-07-10|July 10, 2022|Anticipated|2022-07-10||Interventional|STIMULATE-CSA||Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea|Treatment of Central Sleep Apnea in Patients With Heart Failure With a Cervically Implanted Phrenic Nerve Stimulator|Recruiting||N/A|40|Anticipated|Steward St. Elizabeth's Medical Center of Boston, Inc.||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:49:20.452917|2017-10-10 20:49:20.452917
NCT03238924|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-31|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Prolonged Exposure and Oxytocin|Augmenting Prolonged Exposure Therapy for PTSD With Intranasal Oxytocin|Completed||Phase 2|17|Actual|Medical University of South Carolina||2|||f||||f|t|f||||||||2017-10-10 20:49:20.541437|2017-10-10 20:49:20.541437
NCT03238911|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-01|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|||A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-04)|A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-04)|Not yet recruiting||Phase 3|120|Anticipated|Pharmacosmos A/S||2|||f|||||t|f||||||||2017-10-10 20:49:20.618212|2017-10-10 20:49:20.618212
NCT03238898|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-02|||September 27, 2014|Actual|2014-09-27|August 2017|2017-08-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Interventional|||Botulinum Toxin for Cramps in Diabetic Neuropathy|Botulinum Toxin for Muscle Cramps in Diabetic Patients With Diabetic Neuropathy|Completed||Phase 2|50|Actual|Presidio Ospedaliero Garibaldi-Centro||2|||f||||f|||||f|||||2017-10-10 20:49:20.692361|2017-10-10 20:49:20.692361
NCT03238885|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-09|||March 1, 2013|Actual|2013-03-01|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Observational|||Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics|Predicting Pathological Complete Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy With MR Radiomics Method|Recruiting||N/A|490|Anticipated|Beijing Cancer Hospital|||1||f||||t|f|f||||||||2017-10-10 20:49:20.773005|2017-10-10 20:49:20.773005
NCT03238872|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||November 9, 2015|Actual|2015-11-09|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Trial of Prompt Mental Health Care|Randomized Controlled Trial of Prompt Mental Health Care|Recruiting||N/A|1100|Anticipated|Norwegian Institute of Public Health||2|||f||||f|f|f||||||||2017-10-10 20:49:20.869702|2017-10-10 20:49:20.869702
NCT03238859|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-07-31|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|December 20, 2017|Anticipated|2017-12-20||Interventional|||10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence|10 Days of Medial Prefrontal Cortex Theta Burst Stimulation (MPFC cTBS) as a Tool to Improve Clinical Outcomes and Decrease Frontal-striatal Reactivity to Cues Among Treatment-engaged Cocaine and Alcohol Users|Recruiting||Phase 2|50|Anticipated|Medical University of South Carolina||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:49:20.984293|2017-10-10 20:49:20.984293
NCT03238846|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||July 28, 2017|Actual|2017-07-28|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Operations Research of the 'Real World' Effectiveness of Multi-Month Dispensing of ART for Stable Patients in CARGs in Zimbabwe|Outcomes of Differentiated Models of Care: Multi-Month Dispensing (MMD) and Community ART Refill Groups (CARGs) in Stable ART Patients|Recruiting||N/A|5760|Anticipated|Kheth'Impilo||3|||f||||t|f|f||||||||2017-10-10 20:49:21.112339|2017-10-10 20:49:21.112339
NCT03238833|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||May 3, 2017|Actual|2017-05-03|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Poor Ovarian Responders Undergoing IVF Using Luteal Ovarian Stimulation Versus Follicular Ovarian Stimulation|Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital|Recruiting||N/A|30|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t|f|f||||||||2017-10-10 20:49:21.377721|2017-10-10 20:49:21.377721
NCT03238820|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||January 10, 2014|Actual|2014-01-10|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|August 5, 2016|Actual|2016-08-05||Interventional|||Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center Study|Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center Study|Completed||N/A|50|Actual|Jinling Hospital, China||1|||f||||f|f|f||||||||2017-10-10 20:49:21.487437|2017-10-10 20:49:21.487437
NCT03238807|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 1, 2020|Anticipated|2020-04-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Effect of Intrauterine Injection of Hcg Before ET on Clinical Outcomes in IVF/ICSI Cycles|Effect of Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer on Clinical Outcomes in In-vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: a Randomized Controlled Trial|Not yet recruiting||Early Phase 1|220|Anticipated|Assiut University||2|||f||||f|f|f|||f|||||2017-10-10 20:49:21.575067|2017-10-10 20:49:21.575067
NCT03238794|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Bariatric Surgery Versus Diet Alone in the Bile Acid Pathway and Weight Loss|Effect of Weight Loss Through RYGB Versus Weight Loss Through Caloric Restriction on the Bile Acid Pathway|Not yet recruiting||N/A|16|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 20:49:21.652014|2017-10-10 20:49:21.652014
NCT03238768|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-22|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Enhanced Nutrition for Preterm Infants|Enhanced Early Nutrition for Preterm Infants to Improve Neurodevelopment and Minimize Metabolic Risk|Recruiting||N/A|80|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||||2017-10-10 20:49:21.87855|2017-10-10 20:49:21.87855
NCT03238755|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: A Cardiac MRI Study|Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: A Cardiac MRI Study|Recruiting||N/A|130|Anticipated|Massachusetts General Hospital|||2||f|||||t|f||||Samples Without DNA|"     whole blood, plasma, and serum   "|||2017-10-10 20:49:21.967227|2017-10-10 20:49:21.967227
NCT03238742|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-10-03|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|February 28, 2020|Anticipated|2020-02-28|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Efficacy of Xuebijing Injection on Sepsis|The Efficacy of Xuebijing Injection in Adult Patients With Sepsis|Recruiting||Phase 4|1800|Anticipated|Southeast University, China||2|||f||||t|f|f||||||||2017-10-10 20:49:22.055599|2017-10-10 20:49:22.055599
NCT03238729|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-29|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Proof-of-Concept Study of Heart Habits Application for Patients With Heart Failure|Proof-of-Concept Study of a Smartphone Application Created to Improve Management of Ambulatory Patients With Heart Failure: the Heart Failure Heart Habits Application|Recruiting||N/A|24|Anticipated|Jana Care||2|||f||||f|f|f||||||||2017-10-10 20:49:22.270926|2017-10-10 20:49:22.270926
NCT03238716|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Neuromuscular Re-eduaction, Exercise and Electric Dry Needling vs. Electric Dry Needling for Stress Urinary Incontinence|Neuromuscular Re-eduaction, Impairment-based Exercise and Electric Dry Needling vs. Electric Dry Needling for Stress Urinary Incontinence|Recruiting||N/A|60|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||f|f|f||||||||2017-10-10 20:49:22.43047|2017-10-10 20:49:22.43047
NCT03238703|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||September 14, 2017|Anticipated|2017-09-14|July 2017|2017-07-01|September 14, 2024|Anticipated|2024-09-14|September 14, 2022|Anticipated|2022-09-14||Interventional|||Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer|An Investigator Initiated Registry of Simple Oral Therapy for Low Risk Breast Cancer (SOLR)|Not yet recruiting||Phase 4|600|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f|t|f||||||||2017-10-10 20:49:22.589285|2017-10-10 20:49:22.589285
NCT03238690|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||June 23, 2017|Actual|2017-06-23|July 2017|2017-07-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||LVAD Conditioning for Cardiac Recovery|Sequential Left Ventricular Assist Device (LVAD) Unloading and Conditioning to Induce Sustained Cardiac Recovery|Recruiting||N/A|100|Anticipated|University of Utah||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:49:23.220515|2017-10-10 20:49:23.220515
NCT03238677|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-10-03|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|October 30, 2020|Anticipated|2020-10-30|August 31, 2020|Anticipated|2020-08-31||Interventional|||Treating Childhood Apraxia of Speech|Treating Childhood Apraxia of Speech: Role of Biofeedback & Practice Distribution|Recruiting||N/A|40|Anticipated|Syracuse University||4|||f||||t|f|f|||f|||||2017-10-10 20:49:23.342501|2017-10-10 20:49:23.342501
NCT03238482|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-19|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)|Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler 50/250 µg/Dose Products and Seretide Diskus 50/250 µg/Dose in Healthy Subjects|Recruiting||Phase 1|64|Anticipated|Orion Corporation, Orion Pharma||4|||f||||f|f|f||||||||2017-10-10 20:49:25.182265|2017-10-10 20:49:25.182265
NCT03238664|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||October 9, 2017|Anticipated|2017-10-09|July 2017|2017-07-01|October 9, 2019|Anticipated|2019-10-09|October 9, 2018|Anticipated|2018-10-09||Interventional|||Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors|Robot-Assisted Laparoscopic HIFU (High-Intensity Focused Ultrasound) of the Bladder Wall for Thermal Ablation of Muscle Invasive Cells of Bladder Tumors: Corroborating With Robot-Assisted Radical Cystectomy|Not yet recruiting||N/A|20|Anticipated|University of Southern California||2|||f||||t|f|t|f||f|||||2017-10-10 20:49:23.511236|2017-10-10 20:49:23.511236
NCT03238651|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-09-08|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 28, 2020|Anticipated|2020-08-28|March 13, 2020|Anticipated|2020-03-13||Interventional|||A Study of TAK-659 as a Single Agent in Adult East Asian Participants With Non-Hodgkin Lymphoma (NHL)|A Phase 1, Open-label Study of TAK-659 as a Single Agent in Adult East Asian Patients With Non-Hodgkin Lymphoma|Recruiting||Phase 1|38|Anticipated|Takeda||2|||f||||f|f|f||||||||2017-10-10 20:49:23.712186|2017-10-10 20:49:23.712186
NCT03238625|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-02|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|October 18, 2017|Anticipated|2017-10-18||Interventional|||Painless Local Anaesthesia With Bicarbonate Admixture|Painless Local Anaesthesia With Bicarbonate Admixture: A Phase II, Monocentric, Double-blind, Randomized, Placebo-controlled Crossover Trial|Recruiting||Phase 2|48|Anticipated|University of Zurich||2|||f||||t|f|f||||||||2017-10-10 20:49:23.983246|2017-10-10 20:49:23.983246
NCT03238599|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-02|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|PAMAL||Pedometer Activity Monitoring After ASCT|Clinical Trial Investigating Pedometer-based Activity Monitoring After Autologous Transplantation in Lymphoma and Myeloma Patients|Not yet recruiting||Phase 2|168|Anticipated|University Hospital Inselspital, Berne||1|||f||||f|f|f||||||||2017-10-10 20:49:24.253075|2017-10-10 20:49:24.253075
NCT03238586|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||November 2012|Actual|2012-11-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|WELL||HIV/AIDS & Alcohol-Related Outcomes: Translational Evidence-Based Interventions|HIV/AIDS & Alcohol-Related Outcomes: Translational Evidence-Based Interventions|Recruiting||N/A|269|Anticipated|Louisiana State University Health Sciences Center in New Orleans||2|||f||||||||||||||2017-10-10 20:49:24.363342|2017-10-10 20:49:24.363342
NCT03238573|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|August 1, 2019|Anticipated|2019-08-01||Observational|||The Real-time Optical Diagnosis Value of Optical Enhancement Endoscopy in Colorectal Sessile Serrated Adenomas/Polyps|The Real-time Optical Diagnosis Value of Optical Enhancement Endoscopy in Colorectal Sessile Serrated Adenomas/Polyps :A Prospective Study|Recruiting||N/A|40|Anticipated|Shandong University|||1||f||||t|f|f||||||||2017-10-10 20:49:24.488913|2017-10-10 20:49:24.488913
NCT03238560|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||The Population Pharmacokinetics of Montelukast in Infants and Children|Population Pharmacokinetics of Montelukast in Infants and Children|Recruiting||N/A|100|Anticipated|Shandong University|||1||f||||t|t|f|||f|||||2017-10-10 20:49:24.580803|2017-10-10 20:49:24.580803
NCT03238547|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-08-02|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|18 Months|Observational [Patient Registry]|||Screening of Microalbuminuria Using a Semi-quantitative UACR Test|Accuracy of a Semi-quantitative Urine Albumin-to-creatinine Ratio Test as a Screening Tool for Microalbuminuria in Patients With Diabetes|Not yet recruiting||N/A|1000|Anticipated|Seoul National University Hospital|||1||f|||||f|t|f|f||||||2017-10-10 20:49:24.670252|2017-10-10 20:49:24.670252
NCT03238534|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS|Relief of Heartburn and Epigastric Pain Comparing Neobianacid® With Omeprazole: a Randomized, Double Blind, Double Dummy, Reference Product Controlled, Parallel Group, Non-inferiority Clinical Study|Not yet recruiting||Phase 4|276|Anticipated|Aboca Spa Societa' Agricola||2|||f||||f|f|f||||||||2017-10-10 20:49:24.74864|2017-10-10 20:49:24.74864
NCT03238521|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-02|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|PEDI-PDS||Could the Intraoperative Radiation Exposure (Fluoroscopy) of Percutaneous Pedicle Screw Fixation be Reduced Using an Electronic Conductivity Device?|Could the Intraoperative Radiation Exposure (Fluoroscopy) of Percutaneous Pedicle Screw Fixation be Reduced Using an Electronic Conductivity Device? A Prospective, Randomized Study|Not yet recruiting||N/A|32|Anticipated|Rennes University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:49:24.896602|2017-10-10 20:49:24.896602
NCT03238508|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-07|||January 1, 2013|Actual|2013-01-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|August 30, 2017|Anticipated|2017-08-30|1 Year|Observational [Patient Registry]|||Index of Microcirculatory Resistance After Immediate Versus Deferred Stenting in Patients With Acute Myocardial Infarction|Index of Microcirculatory Resistance After Immediate Versus Deferred Stenting in Patients With Acute Myocardial Infarction|Recruiting||N/A|60|Anticipated|Sejong General Hospital|||2||f||||f|f|f||||||||2017-10-10 20:49:24.97223|2017-10-10 20:49:24.97223
NCT03238495|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-07|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|August 1, 2019|Anticipated|2019-08-01||Interventional|HERMET||Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer|Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer|Recruiting||Phase 2|100|Anticipated|University of Kansas Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 20:49:25.069505|2017-10-10 20:49:25.069505
NCT03238456|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-02|||July 11, 2013|Actual|2013-07-11|August 2017|2017-08-01|May 31, 2015|Actual|2015-05-31|December 3, 2014|Actual|2014-12-03||Interventional|MPACT||Smoking Cessation for Young Adult Pacific Islanders: Motivating Pacifika Against Cigarettes and Tobacco|Weaving an Islander Network for Cancer Awareness, Research and Training (WINCART): Technology & Smoking Cessation for Late Adolescent/Young Adult Pacific Islanders|Completed||N/A|278|Actual|Claremont Graduate University||2|||f||||f|f|f||||||||2017-10-10 20:49:25.392069|2017-10-10 20:49:25.392069
NCT03238443|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-03|||February 16, 2016|Actual|2016-02-16|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|vaLIDLIver||Interest of the Donor-specific Antibodies After Liver Transplantation|Interest of the Donor-specific and Complement-binding Anti-HLA Antibodies (C1q) Assays for the Management and the Monitoring After Liver Transplant|Recruiting||N/A|120|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||||2017-10-10 20:49:25.480774|2017-10-10 20:49:25.480774
NCT03238430|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||May 2015||2015-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CATHEPAT||Management of Pain Post Hepatectomy : Infiltration of Local Anesthetics Versus Continuous Spinal Analgesia .|Management of Pain Post Hepatectomy : Infiltration of Local Anesthetics Versus Continuous Spinal Analgesia .|Recruiting||Phase 2/Phase 3|186|Anticipated|University Hospital, Lille||3|||f||||t|f|f||||||||2017-10-10 20:49:25.549391|2017-10-10 20:49:25.549391
NCT03238417|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-31|||January 9, 2017|Actual|2017-01-09|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2019|Anticipated|2019-06-30||Interventional|WHS/QUERI PEI||Evaluating Evidence-Based Quality Improvement of Comprehensive Women's Health Care Implementation in Low-Performing VA Facilities|Evaluating Evidence-Based Quality Improvement of Comprehensive Women's Health Care Implementation in Low-Performing VA Facilities (PEC 16-352)|Enrolling by invitation||N/A|24|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 20:49:25.657042|2017-10-10 20:49:25.657042
NCT03238404|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-02|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|December 20, 2016|Actual|2016-12-20|August 10, 2016|Actual|2016-08-10||Interventional|||Neoadjuvant Chemotherapy for Patients With Advanced Gastric Cancer in ERAS Programs for Radical Gastrectomy|The Application of Neoadjuvant Chemotherapy for Patients With Advanced Gastric Cancer in Enhanced Recovery After Surgery Programs for Radical Gastrectomy|Completed||N/A|88|Actual|Jinling Hospital, China||2|||f||||t|f|f||||||||2017-10-10 20:49:25.785508|2017-10-10 20:49:25.785508
NCT03238391|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|February 15, 2018|Anticipated|2018-02-15|February 15, 2018|Anticipated|2018-02-15||Interventional|||Ischemic Preconditioning for Prevention of Contrast Nephropathy in The Emergency Department|Ischemic Preconditioning for Prevention of Contrast Nephropathy in The Emergency Department: Randomised, Double Blind Clinical Trial|Not yet recruiting||N/A|350|Anticipated|Derince Training and Research Hospital||2|||f||||t|f|f||||||||2017-10-10 20:49:25.860909|2017-10-10 20:49:25.860909
NCT03238378|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|HyBT-H&N||Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours|SALVAGE BRACHYTHERAPY WITH INTERSTITIAL HYPERTHERMIA FOR LOCALLY RECURRENT HEAD & NECK CARCINOMA FOLLOWING PREVIOUSLY EXTERNAL BEAM RADIATION THERAPY: A PROSPECTIVE PHASE II STUDY|Recruiting||N/A|96|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f|f|f||||||||2017-10-10 20:49:25.978326|2017-10-10 20:49:25.978326
NCT03238352|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-25|||August 7, 2017||2017-08-07||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:49:26.1567|2017-10-10 20:49:26.1567
NCT03238339|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 30, 2019|Anticipated|2019-03-30|December 30, 2018|Anticipated|2018-12-30||Observational|||The Clinical Application and Popularization of Portable Home Noninvasive Ventilator|The Clinical Application and Popularization of Portable Home Noninvasive Ventilator|Not yet recruiting||N/A|40|Anticipated|Third Military Medical University|||2||f||||f|f|f||||||||2017-10-10 20:49:26.190429|2017-10-10 20:49:26.190429
NCT03238326|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-29|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia|A Long-term, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Flexible-Dose Brexpiprazole as Maintenance Treatment in Adolescents (13-17 Years Old) With Schizophrenia|Recruiting||Phase 3|350|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t|t|f||||||||2017-10-10 20:49:26.25404|2017-10-10 20:49:26.25404
NCT03238313|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||June 15, 2016|Actual|2016-06-15|August 2017|2017-08-01|November 30, 2019|Anticipated|2019-11-30|October 31, 2018|Anticipated|2018-10-31||Interventional|||"Evaluation of Plan A"|"Evaluation of Plan A Video Intervention"|Recruiting||N/A|2520|Anticipated|The Policy & Research Group||2|||f||||f|f|f||||||||2017-10-10 20:49:26.356454|2017-10-10 20:49:26.356454
NCT03238300|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Neuroscience-Informed Treatment Development for Adolescent Alcohol Use|Neuroscience-Informed Treatment Development for Adolescent Alcohol Use|Not yet recruiting||Phase 2|50|Anticipated|Medical University of South Carolina||2|||f||||t|t|f||||||||2017-10-10 20:49:26.445882|2017-10-10 20:49:26.445882
NCT03238287|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-02|||August 1, 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Manual and Mechanical Chest Compression During In-hospital Witnessed Cardiac Arrests Using Cerebral Oximetry|Evaluation of Effectiveness of Cardiopulmonary Resuscitation With Manual and Mechanical Chest Compression Systems During In-hospital (at the Emergency Department) Witnessed Cardiac Arrests Using Cerebral Oximetry|Not yet recruiting||N/A|126|Anticipated|Eskisehir Osmangazi University||2|||f||||f|f|f||||||||2017-10-10 20:49:26.538006|2017-10-10 20:49:26.538006
NCT03238261|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-09|||August 1, 2007|Actual|2007-08-01|July 2017|2017-07-01|May 1, 2016|Actual|2016-05-01|February 1, 2012|Actual|2012-02-01||Interventional|||Chemotherapy / Radiotherapy in Uterine Cervical Neoplasms|CHEMOTHERAPY AND CONCOMITANT RADIOTHERAPY VS. RADIOTHERAPY IN THE TREATMENT OF PATIENTS WITH STAGE IIIB UTERINE CANCER|Completed||N/A|147|Actual|Instituto Nacional de Cancerologia, Columbia||2|||f||||t|f|f||||||||2017-10-10 20:49:28.190759|2017-10-10 20:49:28.190759
NCT03238248|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-10-03|||August 7, 2017|Actual|2017-08-07|October 2017|2017-10-01|July 2023|Anticipated|2023-07-01|July 2022|Anticipated|2022-07-01||Interventional|||Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors|A Phase II Trial of Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors|Recruiting||Phase 2|71|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:49:28.255409|2017-10-10 20:49:28.255409
NCT03238235|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-28|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy|A Randomised, Double Blind, Placebo Controlled Study to Evaluate the Micro-macroscopic Effects on Muscles, the Safety and Tolerability, and the Efficacy of Givinostat in Patients With Becker Muscular Dystrophy (BMD)|Not yet recruiting||Phase 2|48|Anticipated|Italfarmaco||2|||f||||f|f|f||||||||2017-10-10 20:49:28.359147|2017-10-10 20:49:28.359147
NCT03238222|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|MOSAIC||Motivating Structured Walking Activity in Intermittent Claudication|A Brief Physiotherapist-led Behaviour Change Intervention to Facilitate Walking in Older People With Peripheral Arterial Disease: a Randomised Controlled Trial|Not yet recruiting||N/A|192|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t|f|f||||||||2017-10-10 20:49:28.457731|2017-10-10 20:49:28.457731
NCT03238209|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|December 30, 2016|Actual|2016-12-30|December 15, 2016|Actual|2016-12-15||Interventional|||Surface Respiratory Electromyography Measurements During Treadmill Exercise in Stable Patients With COPD|Correlation and Compatibility Between Surface Respiratory Electromyography and Transesophageal Diaphragmatic Electromyography Measurements During Treadmill Exercise in Stable Patients With COPD|Completed||N/A|20|Actual|Guangzhou Institute of Respiratory Disease||1|||f||||f|f|f||||||||2017-10-10 20:49:28.559667|2017-10-10 20:49:28.559667
NCT03238196|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-11|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer|A Phase Ib Trial of Fulvestrant, Palbociclib (CDK4/6 Inhibitor) and Erdafitinib (JNJ- 42756493,Pan-FGFR Tyrosine Kinase Inhibitor) in ER+/HER2-/FGFR-Amplified Metastatic Breast Cancer (MBC)|Recruiting||Phase 1|32|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t|t|f||||||||2017-10-10 20:49:28.634675|2017-10-10 20:49:28.634675
NCT03238183|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Effects of Dextrose on Knee Osteoarthritis|Additional Therapeutic Effects of Dextrose to Hyaluronic Acid on Knee Osteoarthritis: a Double Blind, Randomized-controlled Clinical Trial|Not yet recruiting||Phase 4|106|Anticipated|Taipei Medical University||2|||f||||t|f|f||||||||2017-10-10 20:49:28.753523|2017-10-10 20:49:28.753523
NCT03238170|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-07-31|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|FIMRA-P||MR-simulation in Radiotherapy for Prostate Cancer|An Exploratory Study to Assess the Feasibility of Incorporating MR in the Radiotherapy Pathway of Patients With Prostate Cancer|Recruiting||N/A|20|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f|f|f||||||||2017-10-10 20:49:28.86047|2017-10-10 20:49:28.86047
NCT03238157|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Steroids for Early Treatment of Radiation Retinopathy|Steroids for Early Treatment of Radiation Retinopathy|Not yet recruiting||Phase 2/Phase 3|90|Anticipated|The Cleveland Clinic||2|||||||f|t|f||||||||2017-10-10 20:49:28.936215|2017-10-10 20:49:28.936215
NCT03238144|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-07-31|||November 2016||2016-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Tissue Stresses of Cancer (Force Horizon 2020)|Tissue Stresses of Cancer: A Phase I/II,Multi-centre, Feasibility Study to Image the Tissue Stiffness/Stresses to Predict Outcome in Breast Cancer|Recruiting||Phase 1/Phase 2|200|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 20:49:29.116338|2017-10-10 20:49:29.116338
NCT03238131|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-28|||April 2012||2012-04-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|April 2015|Actual|2015-04-01||Interventional|||IVM Alone vs ALB + IVM Against Onchocerciasis|Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis|Completed||Phase 3|272|Actual|University Hospitals Cleveland Medical Center||4|||f||||f||||||||||2017-10-10 20:49:29.203693|2017-10-10 20:49:29.203693
NCT03238118|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|November 15, 2018|Anticipated|2018-11-15|March 15, 2018|Anticipated|2018-03-15||Interventional|||Attention Bias Modification, Attention Control and Psychoeducation for Irritability in Children and Adolescents|Randomized Clinical Trial Comparing Attention Bias Modification, Attention Control and Psychoeducation for Irritability in Children and Adolescents|Not yet recruiting||N/A|140|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f|f|f||||||||2017-10-10 20:49:29.308169|2017-10-10 20:49:29.308169
NCT03238105|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light|Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light: a Randomized Trial|Not yet recruiting||Phase 4|29|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:49:29.40118|2017-10-10 20:49:29.40118
NCT03238092|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-01|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort|Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort: a Randomized Clinical Trial|Not yet recruiting||Phase 3|26|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f|f|f||||||||2017-10-10 20:49:29.500816|2017-10-10 20:49:29.500816
NCT03238066|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-31|||April 2015||2015-04-01|July 2017|2017-07-01|April 2022|Anticipated|2022-04-01|April 2018|Anticipated|2018-04-01||Interventional|Prostata-BT-HT||Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy|A Prospective Phase II Study of Salvage Brachytherapy in Combination With Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following External Beam Radiation Therapy|Recruiting||N/A|77|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-10-10 20:49:29.716214|2017-10-10 20:49:29.716214
NCT03238053|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-01|2017-08-03|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Laser Treatment of Genito-urinary Syndrome in Women|Laser Treatment of Genito-urinary Syndrome in Women With Breast and Endometrial Cancer and Menopausal Women|Not yet recruiting||N/A|60|Anticipated|Herning Hospital||6|||f||||f|f|f||||||||2017-10-10 20:49:29.821508|2017-10-10 20:49:29.821508
NCT03238040|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-31|||April 1, 2014|Actual|2014-04-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|BASIC||Biomarkers of Acute Serious Illness in Children|Biomarkers of Acute Serious Illness in Children (BASIC): Understanding the Genetic Basis and Biological Pathways Underlying Critical Illness and How They Influence Outcome in Children Requiring Emergency Intensive Care|Active, not recruiting||N/A|800|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust|||1||f||||f|f|f||||Samples With DNA|"     Blood in EDTA tube (DNA), PAX gene tube (RNA), Plasma, Serum (5 ml in total, or 0.8 ml/kg     whichever is lower)      Urine in universal container (5-10 ml)   "|||2017-10-10 20:49:29.931339|2017-10-10 20:49:29.931339
NCT03238027|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase 1, Open-label, Dose Escalation Trial to Investigate SNDX-6352 in Patients With Solid Tumors|A Phase 1, Open-label, Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of SNDX-6352 in Patients With Unresectable, Recurrent, Locally-advanced, or Metastatic Solid Tumors|Recruiting||Phase 1|24|Anticipated|Syndax Pharmaceuticals||4|||f||||t|t|f||||||||2017-10-10 20:49:30.036559|2017-10-10 20:49:30.036559
NCT03238014|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|NPPV;COPD||Efficacy of High-intensity NPPV and Low-intensity NPPV in Patients With Chronic Hypercapnic COPD|Efficacy of High-intensity Noninvasive Positive Pressure Ventilation and Low-intensity Noninvasive Positive Pressure Ventilation in Patients With Chronic Hypercapnic Chronic Obstructive Pulmonary Disease|Recruiting||N/A|14|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f|||||f|f||||||||2017-10-10 20:49:30.139268|2017-10-10 20:49:30.139268
NCT03238001|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||July 11, 2017||2017-07-11||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:49:30.218181|2017-10-10 20:49:30.218181
NCT03237988|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-31|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|September 20, 2017|Anticipated|2017-09-20|August 20, 2017|Anticipated|2017-08-20||Interventional|||Study to Evaluate the Pharmacokinetics of a New Tablet Formulation of CPI-444 in Fed and Fasted Healthy Male and Female Subjects|A Phase 1, Open-label, Randomized, Single-dose, Three-way Crossover Study to Evaluate the Pharmacokinetics of a New Tablet Formulation of CPI-444 in Fed and Fasted Healthy Male and Female Subjects|Active, not recruiting||Phase 1|24|Actual|Corvus Pharmaceuticals, Inc.||3|||f|||||t|f||||||||2017-10-10 20:49:30.253521|2017-10-10 20:49:30.253521
NCT03237975|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-31|||March 27, 2017|Actual|2017-03-27|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|BEYO||BEYO Project to Promote Sense of Coherence and Self-care of Elderly People With Type 2 Diabetes|A Strengths-based Intervention Based on Salutogenic Theory to Promote Sense of Coherence and Self-care of Elderly People With Type 2 Diabetes|Active, not recruiting||N/A|132|Actual|Chinese University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:49:30.331122|2017-10-10 20:49:30.331122
NCT03237962|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-31|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High Flow Nasal Cannula During Pulmonary Rehabilitation|Effectiveness of High Flow Nasal Nannula on Exercise Endurance Among Patients During Pulmonary Rehabilitation|Recruiting||N/A|70|Anticipated|Chang Gung University||2|||f||||f|f|f||||||||2017-10-10 20:49:30.442529|2017-10-10 20:49:30.442529
NCT03237949|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||May 30, 2017|Actual|2017-05-30|May 2017|2017-05-01|November 22, 2018|Anticipated|2018-11-22|November 22, 2018|Anticipated|2018-11-22||Interventional|||Text Messaging and Telephone Counseling for Supporting Post-discharge Quit Attempts|Comparative Effectiveness of Text Messaging and Telephone Counseling for Supporting Post-discharge Quit Attempts Among Hospitalized Smokers in Brazil|Recruiting||N/A|400|Anticipated|Federal University of Juiz de Fora||2|||f||||f|f|f||||||||2017-10-10 20:49:30.559478|2017-10-10 20:49:30.559478
NCT03237923|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-31|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||Evaluation of the EasySense System in Congestive Heart Failure|Evaluation of the EasySense System in Congestive Heart Failure|Recruiting||N/A|75|Anticipated|Ohio State University|||1||f||||f|f|f||||||||2017-10-10 20:49:31.222835|2017-10-10 20:49:31.222835
NCT03025360|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-16||||||January 2017|2017-01-01||||||||Expanded Access|||Expanded Access to Provide Larotrectinib (LOXO-101) for the Treatment of Cancers With a NTRK Gene Fusion|Expanded Access to Provide Larotrectinib (LOXO-101) for the Treatment of Cancers With a NTRK Gene Fusion|Available||N/A|||Loxo Oncology, Inc.|||||||||||||||||||2017-10-10 21:26:41.392666|2017-10-10 21:26:41.392666
NCT03237910|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-03|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 31, 2020|Anticipated|2020-03-31|September 30, 2019|Anticipated|2019-09-30||Interventional|AMSA||Real Time Amplitude Spectrum Area to Guide Defibrillation|AMplitude Spectrum Area to Guide Defibrillation During Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest Patients|Not yet recruiting||N/A|412|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:49:31.305522|2017-10-10 20:49:31.305522
NCT03237897|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-07-31|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|October 2019|Anticipated|2019-10-01||Observational|||Evaluation of a Preoperative Education Class for Colorectal Surgery Patients|Evaluation of a Preoperative Education Class for Colorectal Surgery Patients|Not yet recruiting||N/A|240|Anticipated|Carolinas Healthcare System|||2||f||||f|f|f||||||||2017-10-10 20:49:31.549402|2017-10-10 20:49:31.549402
NCT03237884|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-07-31|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|IZERZO||Romanian-Swiss Research Programme IZERZO|Reality Map of Integrated Oncology and Palliative Care in Romanian and Swiss Cancer Centres|Completed||N/A|308|Actual|Cantonal Hospital of St. Gallen|||1||f||||t||||||||||2017-10-10 20:49:31.648304|2017-10-10 20:49:31.648304
NCT03237871|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-31|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 29, 2017|Anticipated|2017-09-29|September 6, 2017|Anticipated|2017-09-06||Interventional|||The EMERGE Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Young Adults|The Engaging Microenterprise for Resource Generation and Health Empowerment (EMERGE) Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Homeless Young Adults|Recruiting||N/A|20|Anticipated|Johns Hopkins Bloomberg School of Public Health||1|||f||||f|f|f||||||||2017-10-10 20:49:31.719056|2017-10-10 20:49:31.719056
NCT03237858|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-31|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 2025|Anticipated|2025-01-01|October 2024|Anticipated|2024-10-01||Interventional|MANAGE-HF||Multiple Cardiac Sensors for the Management of Heart Failure|Multiple Cardiac Sensors for the Management of Heart Failure|Not yet recruiting||N/A|2700|Anticipated|Boston Scientific Corporation||2|||f||||t|f|t|f||t|||||2017-10-10 20:49:31.804312|2017-10-10 20:49:31.804312
NCT03237832|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-02|||May 16, 2016|Actual|2016-05-16|August 2017|2017-08-01|February 2017|Actual|2017-02-01|October 6, 2016|Actual|2016-10-06||Interventional|ARN-6039||A Phase 1 Study of ARN-6039|A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Oral Doses of ARN-6039 in Healthy Adult Subjects.|Completed||Phase 1|60|Actual|Arrien Pharmaceuticals||5|||f||||t|t|f||||||||2017-10-10 20:49:32.167428|2017-10-10 20:49:32.167428
NCT03237819|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-11|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|MAGMAT||Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care|Interest of Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care: Multicentric Randomized Controlled Trial|Not yet recruiting||Phase 3|74|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||||2017-10-10 20:49:32.27215|2017-10-10 20:49:32.27215
NCT03237806|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-07-30|||May 31, 2015|Actual|2015-05-31|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|ARDS||Effects of Sedation on Transpulmonary Pressure and Lung Homogenous|Effects of Sedation on Transpulmonary Pressure and Lung Homogenous of ARDS Patients|Recruiting||N/A|24|Anticipated|Southeast University, China||3|||f||||t|f|f|||f|||||2017-10-10 20:49:32.381798|2017-10-10 20:49:32.381798
NCT03237793|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-07|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Treatment of Hypersensitivity Using Diode Laser and Desensitising Agent on Fluorosed and Non-fluorosed Teeth|Treatment of Hypersensitivity Using Diode Laser and Potassium Nitrate Desensitising Agent- a Comparison of Treatment Effects on Fluorosed and Non-fluorosed Teeth- an in Vivo Randomised Controlled Trial|Completed||N/A|90|Actual|Krishnadevaraya College of Dental Sciences & Hospital||2|||f||||f|f|f||||||||2017-10-10 20:49:32.482444|2017-10-10 20:49:32.482444
NCT03237780|ClinicalTrials.gov processed this data on October 10, 2017|2017-08-02|2017-09-04|||January 19, 2018|Anticipated|2018-01-19|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer|A Randomized, Phase 2 Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination With Atezolizumab Compared to Atezolizumab Alone in Subjects With Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where Platinum-Based Treatment is Not an Option|Not yet recruiting||Phase 2|78|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 20:49:32.570379|2017-10-10 20:49:32.570379
NCT03237767|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-28|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||A CFit Study - Acute Exercise|A CFit Study: To What Extent Does a Single Session of Exercise Training Influence Measures of Inflammation, Oxidative Stress, Nitric Oxide Bioavailability, Microvascular Endothelial Function and Dysglycaemia in Patients With Cystic Fibrosis?|Not yet recruiting||N/A|16|Anticipated|University of Portsmouth||2|||f||||t|f|f||||||||2017-10-10 20:49:32.697086|2017-10-10 20:49:32.697086
NCT03237754|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||October 1, 2016|Actual|2016-10-01|October 2016|2016-10-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Neurostimulation in Chronic and Episodic Migraine|Clinical and Neuronal Changes in Chronic and Episodic Migraine Patients After Neurostimulation|Recruiting||N/A|150|Anticipated|University of Zurich||2|||f||||f|f|f||||||||2017-10-10 20:49:32.803179|2017-10-10 20:49:32.803179
NCT03237741|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-10-02|||August 7, 2017|Actual|2017-08-07|October 2017|2017-10-01|December 14, 2017|Anticipated|2017-12-14|December 14, 2017|Anticipated|2017-12-14||Interventional|||Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants|A Phase I Open-Label Study to Determine the Relative Bioavailability of GDC-0134 and to Investigate the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Subjects of Non-childbearing Potential|Recruiting||Phase 1|24|Anticipated|Genentech, Inc.||4|||f|||||f|f||||||||2017-10-10 20:49:32.909505|2017-10-10 20:49:32.909505
NCT03237728|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||July 28, 2017|Actual|2017-07-28|July 2017|2017-07-01|July 17, 2018|Anticipated|2018-07-17|April 5, 2018|Anticipated|2018-04-05||Interventional|||Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients|Randomized, Double-blind Placebo-controlled Clinical Study to Assess Safety, Tolerance, Pharmacokinetics, Pharmacodynamic of Multiple-dose Kukoamine B Mesilate in Sepsis Patients|Recruiting||Phase 1|44|Anticipated|Tianjin Chasesun Pharmaceutical Co., LTD||4|||f|||||f|f||||||||2017-10-10 20:49:33.017949|2017-10-10 20:49:33.017949
NCT03237715|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants|Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants|Recruiting||N/A|180|Anticipated|Rutgers University|||2||f||||f|f|f||||||||2017-10-10 20:49:33.108501|2017-10-10 20:49:33.108501
NCT03237702|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||July 31, 2017|Anticipated|2017-07-31|July 2017|2017-07-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Decipher Lethal Prostate Cancer Biology - Urine Metabolomics|Decipher the Biology of Lethal Prostate Cancer - Urine Metabolomics Profiling in Men Receiving Prostate Biopsy and Men With Diagnosed Prostate Cancer Receiving MCS Supplementation|Recruiting||Early Phase 1|750|Anticipated|National Taiwan University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:49:33.181387|2017-10-10 20:49:33.181387
NCT03237689|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 31, 2022|Anticipated|2022-08-31|May 31, 2022|Anticipated|2022-05-31||Interventional|MsSCORE||Effects of Glucocorticoids on Cognition in HIV-infected Women|Effects of Glucocorticoids on Cognition in HIV-infected Women|Not yet recruiting||Early Phase 1|148|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||||2017-10-10 20:49:33.264833|2017-10-10 20:49:33.264833
NCT03237676|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-16|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|October 30, 2019|Anticipated|2019-10-30||Interventional|||The Effect of Cognitive Rehabilitation Therapy in Improving Cognitive Function of Attention Following Mild Traumatic Brain Injury|The Effect of Cognitive Rehabilitation Therapy in Improving Cognitive Function of Attention Following Mild Traumatic Brain Injury|Recruiting||N/A|100|Anticipated|University of Malaya||2|||f||||t|f|f||||||||2017-10-10 20:49:33.358075|2017-10-10 20:49:33.358075
NCT03237663|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||March 30, 2015|Actual|2015-03-30|August 2017|2017-08-01|June 23, 2017|Actual|2017-06-23|November 5, 2016|Actual|2016-11-05||Interventional|||Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules)|Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules) Through Phase I Clinical Trial in China|Completed||Phase 1|60|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f|||||f|f||||||||2017-10-10 20:49:33.477224|2017-10-10 20:49:33.477224
NCT03237650|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-07-30|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Conditioned Pain Modulation Using Painful Cutaneous Electrical Stimulation or Simply Habituation?|Conditioned Pain Modulation Using Painful Cutaneous Electrical Stimulation or Simply Habituation?|Completed||N/A|33|Actual|Ruhr University of Bochum|||1||f||||f|f|f||||||||2017-10-10 20:49:33.537004|2017-10-10 20:49:33.537004
NCT03237637|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-01|||March 24, 2017|Actual|2017-03-24|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas|Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas|Recruiting||Phase 3|60|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f|f|f||||||||2017-10-10 20:49:33.593125|2017-10-10 20:49:33.593125
NCT03237624|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Functional Chewing Gum in Reduction of Gingival Inflammation|Use of a Functional Chewing Gum in Reduction of Gingival Inflammation|Not yet recruiting||N/A|36|Anticipated|University of Maryland Baltimore Dental School||2|||f||||t|f|f||||||||2017-10-10 20:49:33.675663|2017-10-10 20:49:33.675663
NCT03237611|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-12|||September 18, 2017|Anticipated|2017-09-18|August 2017|2017-08-01|September 18, 2018|Anticipated|2018-09-18|September 18, 2018|Anticipated|2018-09-18||Interventional|||Low Dose Aprepitant for Patients Receiving Carboplatin|Phase II Trial Testing the Antiemetic Efficacy of a Single-day Low Dose Aprepitant (or Fosaprepitant) Added to a 5-HT3 Receptor Antagonist Plus Dexamethasone in Patients Receiving Carboplatin|Not yet recruiting||Phase 2|50|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t|f|f|||f|||||2017-10-10 20:49:33.763671|2017-10-10 20:49:33.763671
NCT03237598|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-01|||January 1, 2009|Actual|2009-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|December 31, 2009|Actual|2009-12-31||Observational|||Gender Difference of Metabolic Syndrome and Its Association Between Dietary Diversity at Different Ages|China Nutrition and Health Survey|Completed||N/A|4308|Actual|Nanjing Medical University|||2||f|||||f|f||||||||2017-10-10 20:49:33.853547|2017-10-10 20:49:33.853547
NCT03237585|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-30|||October 1, 2015|Actual|2015-10-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 1, 2018|Anticipated|2018-06-01||Interventional|GhanaCHiPS||Impact Assessment of the Rural Response System to Reduce Violence Against Women in Ghana|Impact Assessment of the Rural Response System to Reduce Violence Against Women in Ghana|Recruiting||N/A|3280|Anticipated|Medical Research Council, South Africa||2|||f||||f|f|f||||||||2017-10-10 20:49:34.01457|2017-10-10 20:49:34.01457
NCT03237572|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-25|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|November 25, 2021|Anticipated|2021-11-25|September 16, 2019|Anticipated|2019-09-16||Interventional|Breast-48||Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer|Focused Ultrasound Therapy to Augment Antigen Presentation and Immune-Specificity of Checkpoint Inhibitor Therapy With Pembrolizumab in Metastatic Breast Cancer|Recruiting||Phase 1|15|Anticipated|University of Virginia||2|||f||||t|t|t|t|||||||2017-10-10 20:49:34.119088|2017-10-10 20:49:34.119088
NCT03237559|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-01|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Observational|||Assessment of Knowledge, Attitude and Practice of Eligible Couples Regarding Eugenics|A Descriptive Comparative Study to Assess Knowledge, Attitude and Practice Regarding Eugenics Among Eligible Couples of Selected Area of Ambala, Haryana (India)|Completed||N/A|318|Actual|Maharishi Markendeswar University|||1||f||||t|f|f||||||||2017-10-10 20:49:34.225221|2017-10-10 20:49:34.225221
NCT03237546|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-07|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Use of Serratus Block for Cardiac Surgery|The Use of Serratus Block for Cardiac Surgery|Recruiting||N/A|128|Anticipated|New York University School of Medicine||2|||f||||f|f|f|||f|||||2017-10-10 20:49:34.294241|2017-10-10 20:49:34.294241
NCT03237533|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-07-29|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 1, 2017|Anticipated|2017-12-01||Interventional|OLP||Treatment Modalities of Oral Lichen Planus|Comparative Efficacy of Dexamethasone, Doxycycline, Nystatin and Promethazine With Triamcinolone in Orabase as Symptomatic Treatment of Oral Lichen Planus, A Randomized Controlled Trial|Recruiting||Early Phase 1|32|Anticipated|University of Faisalabad||2|||f||||f|f|f||||||||2017-10-10 20:49:34.393876|2017-10-10 20:49:34.393876
NCT03237520|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparing Virtual Reality Therapy With Modified-CIMT Versus Modified-CIMT Alone in Hemiparetic Children|Comparing Efficacy of Virtual Reality Therapy With Modified Constraint Induced Movement Therapy (mCIMT) Versus mCIMT Alone, for 5-18 Years Children With Hemiparetic Cerebral Palsy - An Open Label, Randomized Controlled, Superiority Trial|Not yet recruiting||N/A|60|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f|f|f||||||||2017-10-10 20:49:34.511662|2017-10-10 20:49:34.511662
NCT03237507|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer|Prospective and Non-interventional Study on Peritoneal Metastasis of Stage IV Gastric Cancer|Active, not recruiting||N/A|110|Anticipated|Harbin Medical University|||2||f|||||t|f||||||||2017-10-10 20:49:34.594327|2017-10-10 20:49:34.594327
NCT03237494|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-02|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Observational|TRAM||Screening for Hereditary Transthyretin Related Amyloidosis-an Nationales, Multicentre, Epidemiological Protocol|TTR Screening - Screening for Hereditary Transthyretin Related Amyloidosis-an Nationales, Multicentre, Epidemiological Protocol|Recruiting||N/A|5000|Anticipated|University of Rostock|||1||f||||t|f|f||||Samples With DNA|"     For the molecular genetic diagnosis of the TTR based disease a NGS-Based sequencing of the     entire TTR gene in all patients will be performed. Dried blood spots will be used for this     procedure.   "|||2017-10-10 20:49:34.692032|2017-10-10 20:49:34.692032
NCT03237481|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)|A Phase 3, Randomized, Double Blind, Saline Placebo and Active Controlled, Multicenter Study of HTX 011 Via Local Administration for Postoperative Analgesia and Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy|Recruiting||Phase 3|400|Anticipated|Heron Therapeutics||3|||f|||||t|t|t|f||||||2017-10-10 20:49:34.778185|2017-10-10 20:49:34.778185
NCT03237468|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-13|||August 11, 2017|Actual|2017-08-11|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|August 30, 2018|Anticipated|2018-08-30||Interventional|PCONS||Neck Strengthening Program for the Prevention or Mitigation of Sports Concussion|Effectiveness of a Neck Strengthening Program for the Prevention or Mitigation of Sports Concussion Injuries in Student Athletes|Recruiting||N/A|1500|Anticipated|Minneapolis Medical Research Foundation||1|||f||||f|f|f||||||||2017-10-10 20:49:34.878743|2017-10-10 20:49:34.878743
NCT03237455|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-04|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Magnetic Resonance Imaging in High Risk Patients for the Development of Diffuse Idiopathic Skeletal Hyperostosis (DISH)|Magnetic Resonance Imaging in High Risk Patients for the Development of Diffuse Idiopathic Skeletal Hyperostosis (DISH)|Not yet recruiting||N/A|30|Anticipated|HaEmek Medical Center, Israel||2|||f|||||f|f||||||||2017-10-10 20:49:34.982889|2017-10-10 20:49:34.982889
NCT03237442|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-08-01|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn|Placebo-Controlled,Randomized,Double-blind Trial of Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|Guangzhou Saliai Stem Cell Science and Technology Co. Ltd.||2|||f|||||f|f||||||||2017-10-10 20:49:35.145665|2017-10-10 20:49:35.145665
NCT03237429|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-07-30|||January 3, 2017|Actual|2017-01-03|July 2017|2017-07-01|January 1, 2019|Anticipated|2019-01-01|March 1, 2018|Anticipated|2018-03-01||Observational|BIS anesthesia||Bioimpedance, Arterial Stiffness and Hemodynamic Instability During Induction of General Anesthesia|The Relationship Between Volemic Status as Assessed by Bioimpedance Spectroscopy, Arterial Stiffness and Hemodynamic Instability During Induction of General Anesthesia|Recruiting||N/A|150|Anticipated|Grigore T. Popa University of Medicine and Pharmacy|||2||f||||f|f|f||||||||2017-10-10 20:49:35.230494|2017-10-10 20:49:35.230494
NCT03237416|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-14|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|October 20, 2017|Anticipated|2017-10-20|September 22, 2017|Anticipated|2017-09-22||Interventional|||Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers|A Phase I, Non-randomized, Open-label, Fixed-sequence Study to Investigate the Effect of Darolutamide (ODM-201) on the Pharmacokinetics of a Probe Substrate of CYP3A4 and P-gp in Healthy Male Volunteers|Active, not recruiting||Phase 1|15|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 20:49:35.322602|2017-10-10 20:49:35.322602
NCT03237403|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Hospital Orientation Since SAMU Regulation Centre Call|Study of Association Between Clinical Criteria Collected at the SAMU Regulation Centre Call and the Hospital Orientation of Patients With Suspected Sepsis State|Recruiting||N/A|1000|Anticipated|Hôpital Necker-Enfants Malades|||1||f||||f|f|f||||||||2017-10-10 20:49:35.433949|2017-10-10 20:49:35.433949
NCT03237390|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-27|||September 27, 2017|Actual|2017-09-27|July 2017|2017-07-01|August 9, 2020|Anticipated|2020-08-09|August 9, 2020|Anticipated|2020-08-09||Interventional|||Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors|Phase I Study of CDK4/6 Inhibitor Ribociclib (LEE011) Combined With Gemcitabine in Patients With Advanced Solid Tumors|Recruiting||Phase 1|49|Anticipated|Mayo Clinic||1|||||||t|t|f||||||||2017-10-10 20:49:35.519819|2017-10-10 20:49:35.519819
NCT03237377|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-14|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer|Neoadjuvant Immunoradiation for Stage IIIA Resectable Non-Small Cell Lung|Not yet recruiting||Phase 2|32|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-10 20:49:35.644002|2017-10-10 20:49:35.644002
NCT03237364|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||October 10, 2017|Anticipated|2017-10-10|August 2017|2017-08-01|October 10, 2018|Anticipated|2018-10-10|October 10, 2018|Anticipated|2018-10-10||Interventional|||Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)|Evaluation of Regional Lung Function in U.S. Soldiers With Suspected Iraq-Afghanistan War Lung Injury Using 19F MRI|Not yet recruiting||Early Phase 1|10|Anticipated|Duke University||1|||f||||t|t|f||||||||2017-10-10 20:49:35.723577|2017-10-10 20:49:35.723577
NCT03237351|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-30|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|July 31, 2018|Anticipated|2018-07-31||Interventional|||Goal Directed Fluid Therapy Guided Fluid Management in Pneumoresection|Goal Directed Fluid Therapy Guided Fluid Management in Pneumoresection: a Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Shenzhen Second People's Hospital||3|||f||||f|f|f||||||||2017-10-10 20:49:35.809264|2017-10-10 20:49:35.809264
NCT03237338|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-30|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|August 20, 2019|Anticipated|2019-08-20||Interventional|||The Study of Mechanism of Chronic Insomnia Disorder Using Acupuncture Based on Changes of Brain GABA and fMRI|"The Study of Brain GABA and Brain Functional Modulatory Mechanism of Chronic Insomnia Disorder Using Acupuncture at Combined Magical-door Acupoints"|Not yet recruiting||N/A|60|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||2|||f||||t|f|f||||||||2017-10-10 20:49:35.90142|2017-10-10 20:49:35.90142
NCT03237325|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-28|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer|A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 3|190|Anticipated|Soligenix||2|||f||||t|t|f||||||||2017-10-10 20:49:35.982908|2017-10-10 20:49:35.982908
NCT03237312|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-07-30|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|November 30, 2016|Actual|2016-11-30|September 30, 2016|Actual|2016-09-30||Interventional|||Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome|The Impact of Serum Antimullerian Hormone Level on Adjusting the Number of Ovarian Drills in Polycystic Ovarian Syndrome|Completed||Phase 2|50|Actual|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:49:36.087046|2017-10-10 20:49:36.087046
NCT03237299|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|CAPE||Loco-regional Complications of Pharyngitis in Children: a National Case-Control Study|Loco-regional Complications of Pharyngitis in Children: a National Case-Control Study|Not yet recruiting||N/A|525|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f|f|f||||||||2017-10-10 20:49:36.164763|2017-10-10 20:49:36.164763
NCT03237286|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|October 2023|Anticipated|2023-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Intravenous Ketamine Plus Neurocognitive Training for Depression|Testing a Synergistic, Neuroplasticity-Based Intervention for Depressive Neurocognition|Not yet recruiting||Phase 1/Phase 2|150|Anticipated|University of Pittsburgh||3|||f||||t|t|f||||||||2017-10-10 20:49:36.249771|2017-10-10 20:49:36.249771
NCT03237273|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||December 2015||2015-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound|HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound on Disease Management and Treatment Decision-making in Moderate and Severe Haemophilia|Not yet recruiting||N/A|200|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 20:49:36.358142|2017-10-10 20:49:36.358142
NCT03237260|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-28|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis|An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis|Recruiting||Phase 4|14|Anticipated|University of Pennsylvania||1|||f||||f|t|f|||t|||||2017-10-10 20:49:36.449199|2017-10-10 20:49:36.449199
NCT03237247|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-08-07|||March 1, 2016|Actual|2016-03-01|August 2017|2017-08-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|||Role of Complete Blood Picture in Predicting the Etiology of Extrahepatic Cholestasis|Role of Complete Blood Picture in Predicting the Etiology of Extrahepatic Cholestasis|Completed||N/A|38|Actual|Assiut University|||5||f||||t||||||||||2017-10-10 20:49:36.537273|2017-10-10 20:49:36.537273
NCT03237234|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-28|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|March 1, 2021|Anticipated|2021-03-01|November 1, 2020|Anticipated|2020-11-01||Interventional|||Enhancing Corticospinal Activation for Improved Walking Function|SCIMS Project 1: Enhancing Corticospinal Activation for Improved Walking Function|Recruiting||N/A|35|Anticipated|Shepherd Center, Atlanta GA||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:49:36.599644|2017-10-10 20:49:36.599644
NCT03237221|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-01|||March 1, 2015|Actual|2015-03-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 12, 2017|Anticipated|2017-12-12||Observational|||Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma|Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma|Recruiting||N/A|300|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University|||1||f||||t|f|f||||||||2017-10-10 20:49:36.686665|2017-10-10 20:49:36.686665
NCT03237208|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-08|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|August 20, 2017|Actual|2017-08-20|August 12, 2017|Actual|2017-08-12||Interventional|||Transcutaneous Electrical Nerve Stimulation Treatment of Renal Colic|Patients Undergoing Routine Transcutaneous Electrical Nerve Stimulation Treatment in Patients With Renal Colic Who Admitted to the Emergency Department: A Randomized Double Blind Placebo-controlled Trial|Completed||N/A|100|Actual|Adiyaman University Research Hospital||2|||f||||t|f|f||||||||2017-10-10 20:49:36.811095|2017-10-10 20:49:36.811095
NCT03237195|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|December 5, 2017|Anticipated|2017-12-05|December 31, 2016|Actual|2016-12-31||Observational|||Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection.|Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection Specimen in Its Entirety.|Active, not recruiting||N/A|200|Anticipated|University of Mississippi Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:49:36.892724|2017-10-10 20:49:36.892724
NCT03237182|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-04|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|InDEX||The Individualized M(X) Drug-resistant TB Treatment Strategy Study|The Individualized M(X) Drug-resistant TB Treatment Strategy Study A Strategy to Improve Treatment Outcomes in Patients With Drug-resistant TB|Recruiting||Phase 4|300|Anticipated|Centre for the AIDS Programme of Research in South Africa||2|||f||||t|f|f||||||||2017-10-10 20:49:36.959705|2017-10-10 20:49:36.959705
NCT03237169|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||October 28, 2016|Actual|2016-10-28|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|PREDICT||Performance of a New REsting Pressure Index During Invasive Angiography Compared To Adenosine Hyperemic FFR|Performance of a New REsting Pressure Index During Invasive Angiography Compared To Adenosine Hyperemic FFR|Recruiting||N/A|100|Anticipated|Centro Hospitalar Lisboa Ocidental|||1||f||||f|f|f||||||||2017-10-10 20:49:37.080929|2017-10-10 20:49:37.080929
NCT03237156|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-28|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Interventional|||Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-906 in Japanese Healthy Male Subjects|Recruiting||Phase 1|24|Anticipated|Takeda||6|||f||||f|f|f||||||||2017-10-10 20:49:37.186588|2017-10-10 20:49:37.186588
NCT03237143|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-08|||June 1, 2015|Actual|2015-06-01|August 2017|2017-08-01|June 30, 2016|Actual|2016-06-30|January 30, 2016|Actual|2016-01-30||Observational|||Low-intensity Extracorporeal Shock Wave for Erectile Disfunction|Quality of Erections After Completing a Low-intensity Extracorporeal Shock Wave Treatment Cycle|Completed||N/A|710|Actual|Boston Medical Group|||1||f||||f|f|f||||||||2017-10-10 20:49:37.281432|2017-10-10 20:49:37.281432
NCT03237130|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||February 15, 2017|Actual|2017-02-15|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Observational|||Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics|Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics|Recruiting||N/A|120|Anticipated|Beijing Cancer Hospital|||1||f||||t|f|f||||||||2017-10-10 20:49:37.453766|2017-10-10 20:49:37.453766
NCT03237117|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||January 1, 2010|Actual|2010-01-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program|Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program: a Randomized Controlled Trial|Recruiting||Early Phase 1|105|Anticipated|Competence Centre on Health Technologies||3|||f||||f|f|f||||||||2017-10-10 20:49:37.534688|2017-10-10 20:49:37.534688
NCT03237104|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-08-01|||July 31, 2017|Anticipated|2017-07-31|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|||Back in the Game: An Immediate Functional Progression Program in Athletes With a Spondylolysis.|Back in the Game: A Pilot Study Assessing an Immediate Functional Progression Program in Athletes With a Spondylolysis.|Not yet recruiting||N/A|12|Anticipated|Nationwide Children's Hospital|||1||f||||f|f|f||||||||2017-10-10 20:49:37.635849|2017-10-10 20:49:37.635849
NCT03237091|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Enhancing Corticospinal Excitability to Improve Functional Recovery|Enhancing Corticospinal Excitability to Improve Functional Recovery|Not yet recruiting||N/A|19|Anticipated|Shepherd Center, Atlanta GA||5|||f|||||f|f||||||||2017-10-10 20:49:37.746224|2017-10-10 20:49:37.746224
NCT03237078|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-29|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Lactobacillus Plantarum PS128 in Patients With Major Depressive Disorder and High Level of Inflammation|Psychophysiological Effects of Lactobacillus Plantarum PS128 in Patients With Major Depressive Disorder and High Level of Inflammation: a Pilot Study of 8-week Open Trial|Not yet recruiting||N/A|40|Anticipated|Taipei Medical University WanFang Hospital||1|||f||||f|f|f||||||||2017-10-10 20:49:37.83571|2017-10-10 20:49:37.83571
NCT03237065|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-01|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|||A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-05)|A Randomized, Open-label, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-05)|Not yet recruiting||Phase 3|120|Anticipated|Pharmacosmos A/S||2|||f|||||t|f||||||||2017-10-10 20:49:37.919759|2017-10-10 20:49:37.919759
NCT03237039|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-01|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|April 3, 2019|Anticipated|2019-04-03|April 3, 2019|Anticipated|2019-04-03||Interventional|EOS60||Classification of the Sagittal Profile of the Spine in Asymptomatic Elderly Subjects|Classification of the Sagittal Profile of the Spine in Asymptomatic Elderly Subjects|Recruiting||N/A|160|Anticipated|Istituto Ortopedico Galeazzi||1|||f||||t|f|f||||||||2017-10-10 20:49:38.094276|2017-10-10 20:49:38.094276
NCT03237026|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-07-30|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 31, 2022|Anticipated|2022-07-31|July 31, 2021|Anticipated|2021-07-31||Observational|||Decipher the Biology of Lethal Prostate Cancer—Using Urine Metabolomics Profiling to Search for Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients|Decipher the Biology of Lethal Prostate Cancer—Using Urine Metabolomics Profiling to Search for Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients|Not yet recruiting||N/A|360|Anticipated|National Taiwan University Hospital|||2||f|||||f|f||||||||2017-10-10 20:49:38.228685|2017-10-10 20:49:38.228685
NCT03237013|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-01|||February 18, 2016|Actual|2016-02-18|August 2017|2017-08-01|January 14, 2017|Actual|2017-01-14|December 14, 2016|Actual|2016-12-14||Interventional|||Strategies to Promote Skin Health|Strategies to Promote Skin Health|Completed||N/A|219|Actual|San Diego State University||3|||f||||f|f|f||||||||2017-10-10 20:49:38.301059|2017-10-10 20:49:38.301059
NCT03237000|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients|Effect of Administering Intravenous Magnesium Sulfate Heptahydrate (MgSO4•7H2O) on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients in 3rd Trimester of Pregnancy|Not yet recruiting||Phase 4|100|Anticipated|Cairo University||1|||f||||t|f|f|||f|||||2017-10-10 20:49:38.403038|2017-10-10 20:49:38.403038
NCT03236987|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-01|||September 20, 2017|Anticipated|2017-09-20|August 2017|2017-08-01|September 20, 2022|Anticipated|2022-09-20|September 20, 2022|Anticipated|2022-09-20||Interventional|CLAZI||CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections|CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections|Not yet recruiting||Phase 3|424|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 20:49:38.488339|2017-10-10 20:49:38.488339
NCT03236961|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-02|||April 3, 2017|Actual|2017-04-03|August 2017|2017-08-01|April 1, 2029|Anticipated|2029-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|APPACII||Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis|Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis: a Prospective Randomised Multicenter Study (The APPAC II Study)|Recruiting||N/A|552|Anticipated|Turku University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:49:38.800019|2017-10-10 20:49:38.800019
NCT03236948|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||RCT of the Effectiveness of the WfWI Intervention in Afghanistan|Individually Randomised Control Trial Evaluation of the Effectiveness of the Women for Women International (WfWI) Intervention in Afghanistan for Intimate Partner Violence Prevention Among Married Women|Active, not recruiting||Phase 3|1461|Actual|Medical Research Council, South Africa||2|||f||||f|f|f||||||||2017-10-10 20:49:38.923785|2017-10-10 20:49:38.923785
NCT03236935|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Phase Ib of L-NMMA and Pembrolizumab|Phase Ib Trial of L-NMMA in Combination With Pembrolizumab in Patients With Melanoma, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Classical Hodgkin Lymphoma, Urothelial Carcinoma, or Microsatellite Instability-High/Mismatch Repair Deficient Cancer|Not yet recruiting||Phase 1|12|Anticipated|The Methodist Hospital System||1|||f||||f|t|f||||||||2017-10-10 20:49:39.018788|2017-10-10 20:49:39.018788
NCT03236922|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-07-29|||June 2016||2016-06-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Autologous Slings With Vesico-Vaginal Fistula Repair|Pubococcygeus Versus Rectus Sheath Sling for Goh Class 3 and 4 Vesico-vaginal Fistulas: a Randomized Controlled Trial|Active, not recruiting||N/A|22|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 20:49:39.140115|2017-10-10 20:49:39.140115
NCT03236909|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-26|||October 2017||2017-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:49:39.259021|2017-10-10 20:49:39.259021
NCT03236896|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-01|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|June 30, 2017|Actual|2017-06-30||Interventional|||Studying the Impact of Exercise on Hot Flashes|Studying the Impact of Exercise on Hot Flashes Using Mobile Fitbit Flex, MENQOL Scale and Hot Flash Diary|Active, not recruiting||N/A|35|Actual|Texas Tech University Health Sciences Center, El Paso||2|||f||||f|f|f||||||||2017-10-10 20:49:39.311956|2017-10-10 20:49:39.311956
NCT03236883|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-28|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|HST||Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer|Phase I Study of Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer|Recruiting||Phase 1|30|Anticipated|Tianjin Medical University Cancer Institute and Hospital||3|||f||||t||||||||||2017-10-10 20:49:39.414757|2017-10-10 20:49:39.414757
NCT03236870|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-10-05|||September 8, 2017|Actual|2017-09-08|October 2017|2017-10-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|ADAPT||A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China|Postmarketing Observational Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China|Recruiting||N/A|310|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 20:49:39.517869|2017-10-10 20:49:39.517869
NCT03236857|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-07-31|||September 4, 2017|Anticipated|2017-09-04|July 2017|2017-07-01|December 6, 2021|Anticipated|2021-12-06|April 25, 2021|Anticipated|2021-04-25||Interventional|||A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies|A Phase 1 Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies|Not yet recruiting||Phase 1|135|Anticipated|AbbVie||1|||f||||t|t|f||||||||2017-10-10 20:49:39.615855|2017-10-10 20:49:39.615855
NCT03236844|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-31|2017-09-11|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 27, 2017|Anticipated|2017-12-27|December 27, 2017|Anticipated|2017-12-27||Interventional|||Relative Bioavailability of Gantenerumab Produced by G4 Process Versus G3 Process Following Subcutaneous (SC) Injection in Healthy Participants|A Multi-Center, Randomized, Open-Label, Single-Dose, Parallel Group Study to Investigate the Relative Bioavailability of Gantenerumab Produced With the G4 Process in Comparison to Gantenerumab Produced With the G3 Process Following Administration by Subcutaneous Injection in Healthy Volunteers|Recruiting||Phase 1|114|Anticipated|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 20:49:39.735786|2017-10-10 20:49:39.735786
NCT03236831|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||AKI Prevention and Early Intervention in Patients Undergoing VAD Placement|AKI Prevention and Early Intervention in Patients Undergoing VAD Placement|Not yet recruiting||N/A|210|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 20:49:39.830923|2017-10-10 20:49:39.830923
NCT03236818|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-08-01|||May 2013||2013-05-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|GOSPEL||Goal Oriented Strategy to Preserve Ejection Fraction Trial|Raising the Bars in the Treatment of Pulmonary Arterial Hypertension: Goal Oriented Strategy to Preserve Ejection Fraction Trial|Active, not recruiting||Phase 4|30|Anticipated|VU University Medical Center||1|||f||||f||||||||||2017-10-10 20:49:39.962088|2017-10-10 20:49:39.962088
NCT03236805|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-14|||September 16, 2017|Anticipated|2017-09-16|July 2017|2017-07-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|KETAMORPH||Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia|Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia a Randomized Controlled Trial|Not yet recruiting||Phase 3|496|Anticipated|Nantes University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:49:40.097272|2017-10-10 20:49:40.097272
NCT03236792|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-28|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis|Phase 1/2 Study Of Ixazomib In Combination With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Immunoglobulin Light Chain AL Amyloidosis|Recruiting||Phase 1/Phase 2|30|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|t|f||||||||2017-10-10 20:49:40.222734|2017-10-10 20:49:40.222734
NCT03236779|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-01|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|May 30, 2018|Anticipated|2018-05-30|February 25, 2018|Anticipated|2018-02-25||Interventional|||A Comparative Study of Two Dry Needling Interventions for Plantar Heel Pain|A Comparative Study of Two Dry Needling Interventions for Plantar Heel Pain: A Randomized Clinical Trial|Not yet recruiting||N/A|94|Anticipated|Universidad de Zaragoza||2|||f||||f|f|f||||||||2017-10-10 20:49:40.332282|2017-10-10 20:49:40.332282
NCT03236766|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-28|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|March 30, 2019|Anticipated|2019-03-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Engaging Pacific Islander Perspectives on Mental Illness and Mental Health Services|Engaging Pacific Islander Perspectives on Mental Illness and Mental Health Services|Not yet recruiting||N/A|200|Anticipated|University of California, Riverside||1|||f||||f|f|f||||||||2017-10-10 20:49:40.416188|2017-10-10 20:49:40.416188
NCT03236753|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-17|||August 11, 2017|Actual|2017-08-11|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Clinical Research on the Efficacy of Thread-embedding Acupuncture on Herniated Intervertebral Disc of Lumbar Spine|Clinical Research on the Efficacy and Safety of Thread-embedding Acupuncture on Herniated Intervertebral Disc of Lumbar Spine; A Multicenter, Randomized, Patient-assessor Blinded, Controlled, Parallel Clinical Trial|Recruiting||N/A|70|Anticipated|Kyunghee University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:49:40.471915|2017-10-10 20:49:40.471915
NCT03236740|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-29|2017-08-02|||August 1, 2017|Actual|2017-08-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS|Doppler Analysis of Ovarian Stromal Blood Flow Changes After Treatment With Metformin Versus Ethinylestradiol-cyproterone Acetate in Women With Polycystic Ovarian Syndrome|Recruiting||Phase 4|100|Anticipated|S.C.B. Medical College and Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:49:40.571527|2017-10-10 20:49:40.571527
NCT03236727|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-01|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||SSEP Fluctuations Due to Dexmedetomidine During Posterior Spine Fusion|SSEP Fluctuations Due to Dexmedetomidine During Posterior Spine Fusion|Completed||Phase 3|25|Actual|George Papanicolaou Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:49:40.656219|2017-10-10 20:49:40.656219
NCT03236714|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-28|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|September 5, 2017|Anticipated|2017-09-05|September 1, 2017|Anticipated|2017-09-01||Observational|||Awareness and Compliance Among Health Professionals of the Preoperative Fasting Period|Awareness and Compliance Among Health Professionals of the Preoperative|Recruiting||N/A|300|Anticipated|Tokat Gaziosmanpasa University|||1||f||||t|f|f||||||||2017-10-10 20:49:40.723798|2017-10-10 20:49:40.723798
NCT03236701|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-14|||June 15, 2017|Actual|2017-06-15|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|November 2017|Anticipated|2017-11-01||Interventional|UAUDIPE||Egg White for Phosphorus Control in Haemodialysis Patients|The Impact of a Nutritional Intervention Based on Egg White for Phosphorus Control in Haemodialysis Patients|Active, not recruiting||N/A|20|Anticipated|Federico II University||2|||f||||f|f|f||||||||2017-10-10 20:49:40.788037|2017-10-10 20:49:40.788037
NCT03236688|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-28|||February 2016||2016-02-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|||Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)|Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)|Recruiting||N/A|30|Anticipated|Exosome Diagnostics, Inc.|||1||f||||f||||||Samples Without DNA|"     10-20 mL of whole blood collected in K2EDTA Plasma Preparation Tubes (PPT) will be acquired     via standard venipuncture and processed to plasma.   "|||2017-10-10 20:49:40.86259|2017-10-10 20:49:40.86259
NCT03236675|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-07-28|||March 2015||2015-03-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|||Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients|Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients|Recruiting||N/A|60|Anticipated|Exosome Diagnostics, Inc.|||2||f||||f||||||Samples Without DNA|"     10-20 mL of whole blood collected in K2EDTA Plasma Preparation Tubes (PPT) will be acquired     via standard venipuncture.      This will be an observational study as subjects will only provide plasma specimens at     different time points and no therapeutic or intervention will be received outside of their     normal standard of care.   "|||2017-10-10 20:49:40.935254|2017-10-10 20:49:40.935254
NCT03236662|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-28|||November 2016||2016-11-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||(-)- Epicatechin Becker Muscular Dystrophy|UCD0115B: An Open-label Extension Study of Purified Epicatechin to Improve Mitochondrial Function, Strength and Skeletal Muscle Exercise Response in Becker Muscular Dystrophy|Recruiting||Phase 2|10|Anticipated|University of California, Davis||1|||f||||f||||||||||2017-10-10 20:49:41.007257|2017-10-10 20:49:41.007257
NCT03234621|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|October 12, 2017|Anticipated|2017-10-12||Interventional|||Protective Ventilation Strategy|Protective Ventilation Strategy During One-lung Ventilation: Effect on Postoperative Pulmonary Complications|Recruiting||N/A|87|Anticipated|Seoul National University Hospital||3|||f|||||f|f||||||||2017-10-10 20:49:59.384777|2017-10-10 20:49:59.384777
NCT03236649|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-28|||August 30, 2017|Anticipated|2017-08-30|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects|Comparison of Efficacy and Safety of Icaritin Versus Sorafenib in First-line Treatment of PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects: a Multicenter, Randomized, Opened Phase III Clinical Trial|Not yet recruiting||Phase 3|200|Anticipated|Beijing Shenogen Biomedical Co., Ltd||2|||f||||f|f|f||||||||2017-10-10 20:49:41.083234|2017-10-10 20:49:41.083234
NCT03236636|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-28|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects|Comparison of Efficacy and Safety of Icaritin Versus Cinobufotalin in First-line Treatment of Advanced Hepatocellular Carcinoma Subjects: a Multicenter, Randomized, Double-blind, Double-dummy Phase III Clinical Trial|Not yet recruiting||Phase 3|280|Anticipated|Beijing Shenogen Biomedical Co., Ltd||2|||f||||f|f|f||||||||2017-10-10 20:49:41.174553|2017-10-10 20:49:41.174553
NCT03236623|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||May 10, 2017|Actual|2017-05-10|July 2017|2017-07-01|November 26, 2017|Anticipated|2017-11-26|September 26, 2017|Anticipated|2017-09-26||Interventional|||Menthol Popsicle to Manage the Patient's Seat in the Preoperative Period.|The Use of the Menthol Popsicle to Manage the Patient's Seat in the Preoperative Period: a Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||||2017-10-10 20:49:41.26945|2017-10-10 20:49:41.26945
NCT03236610|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir|Investigation of Efficacy of Tenofovir Monotherapy in Comparison With Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir Combination Therapy-Multicenter Randomized Open-label Controlled Trial|Recruiting||Phase 3|112|Anticipated|Uijeongbu St. Mary Hospital||2|||f|||||f|f||||||||2017-10-10 20:49:41.344142|2017-10-10 20:49:41.344142
NCT03236597|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Assessing the Effects Of Treadmill And Sit-To-Stand Desks On LPA, Sitting Time, and Cardio-metabolic Risk|Assessing the Effects Of Treadmill And Sit-To-Stand Desks On Light Physical Activity, Sitting Time, And Cardio-metabolic Risk|Not yet recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|f||||||||2017-10-10 20:49:41.414672|2017-10-10 20:49:41.414672
NCT03236584|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||September 1, 2015|Actual|2015-09-01|July 2017|2017-07-01|March 30, 2019|Anticipated|2019-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir|Investigation of Efficacy of Tenofovir Monotherapy in Comparison With Lamivudine Plus Adefovir in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir Combination Therapy - Multicenter Randomized Open-label Controlled Trial|Active, not recruiting||Phase 3|76|Actual|Uijeongbu St. Mary Hospital||2|||f|||||f|f||||||||2017-10-10 20:49:41.482662|2017-10-10 20:49:41.482662
NCT03236571|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-21|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|Marfanpower||Cardiorespiratory and Muscular Rehabilitation of Children and Young Adults With Marfan Syndrome.|Cardiorespiratory and Muscular Rehabilitation of Children and Young Adults With Marfan Syndrome: an Interventional, Prospective, Monocentric Study.|Not yet recruiting||N/A|30|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||||2017-10-10 20:49:41.649977|2017-10-10 20:49:41.649977
NCT03236558|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-21|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|TregDiab||The Role of the Thymus in Type I Diabetes.|Thymic Generation of Regulatory T Lymphocytes in Type I Diabetes Patients.|Not yet recruiting||N/A|30|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||||2017-10-10 20:49:41.775367|2017-10-10 20:49:41.775367
NCT03236545|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Menopause Effects on Vascular Function|Mechanisms of Vascular Dysfunction in Women: Role of Estradiol|Recruiting||N/A|50|Anticipated|University of Delaware||2|||f||||f|f|f|||t|||||2017-10-10 20:49:41.89649|2017-10-10 20:49:41.89649
NCT03236532|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-17|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Supplementation With Glutamine and Exercise in Women With HIV/AIDS|Impact of Physical Exercise Associated With Glutamine Supplementation in Health Indicators of People Living With HIV/AIDS|Completed||N/A|14|Actual|State University of Maringá||2|||f|||||f|f||||||||2017-10-10 20:49:42.043996|2017-10-10 20:49:42.043996
NCT03236519|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-03|||July 25, 2017||2017-07-25||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:49:42.139349|2017-10-10 20:49:42.139349
NCT03236506|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-27|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|ADVANCE||A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study|A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study|Not yet recruiting||Phase 2|135|Anticipated|University of Dundee||3|||f||||f|t|f|||t|||||2017-10-10 20:49:42.190315|2017-10-10 20:49:42.190315
NCT03236493|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-25|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|October 12, 2017|Anticipated|2017-10-12|September 17, 2017|Actual|2017-09-17||Interventional|||Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers|A Phase 1, Randomized, Double-blind, Third-party Open, Placebo-controlled Study To Evaluate The Safety, Tolerability, And Pharmacokinetics After Multiple Oral Doses Of Pf-06700841 In Healthy Japanese Subjects|Recruiting||Phase 1|8|Anticipated|Pfizer||2|||f||||f|f|f||||||||2017-10-10 20:49:42.294069|2017-10-10 20:49:42.294069
NCT03236142|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-28|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||DS vs SIPS-Bariatric Surgery Comparasion|The Single Anastomosis, 300 cm Loop, Duodenal Switch (SIPS) Results in Less Nutritional Deficiencies Than the Standard Duodenal Switch (DS) Operation: A Multicenter, Randomized Controlled Trial|Recruiting||N/A|110|Anticipated|Reading Health System||2|||f||||t|f|f||||||||2017-10-10 20:49:44.954235|2017-10-10 20:49:44.954235
NCT03236480|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|January 1, 2019|Anticipated|2019-01-01|July 1, 2018|Anticipated|2018-07-01||Observational|||The Gut-lung Axis in Chronic Obstructive Pulmonary Disease|Dynamic Changes of the Respiratory Microbiota and Its Relationship to Fecal Microbiota in Chronic Obstructive Pulmonary Disease|Recruiting||N/A|100|Anticipated|Peking University People's Hospital|||2||f||||f|f|f||||Samples With DNA|"     1.Lower respiratory tract specimens including sputum, endotracheal aspiration and     bronchoalveolar lavage fluid. 2.Peripheral whole blood samples 3.fecal samples   "|||2017-10-10 20:49:42.408908|2017-10-10 20:49:42.408908
NCT03236467|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||October 2, 2017|Anticipated|2017-10-02|July 2017|2017-07-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|EXFMPTSD||Neurohormonal Benefits of Exercise in Fibromyalgia and PTSD|Neurobiological and Psychological Benefits of Exercise in Fibromyalgia and PTSD|Not yet recruiting||Early Phase 1|36|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 20:49:42.506814|2017-10-10 20:49:42.506814
NCT03236454|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-16|||May 11, 2017|Actual|2017-05-11|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||tDCS-enhanced Working Memory Training in Subjective Cognitive Decline|Effects and Mechanisms of Cognitive Control Training Combined With Transcranial Direct Current Stimulation (tDCS) in Subjective Cognitive Decline.|Recruiting||N/A|30|Anticipated|University Hospital Tuebingen||2|||f||||f|f|f||||||||2017-10-10 20:49:42.611783|2017-10-10 20:49:42.611783
NCT03236441|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|August 30, 2020|Anticipated|2020-08-30|August 30, 2020|Anticipated|2020-08-30||Interventional|BRICK||Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury|Biochemical and Reno-protective Effects of Remote Ischemic Pre-conditioning on Contrast-induced Acute Kidney Injury|Not yet recruiting||N/A|110|Anticipated|University of Pittsburgh||2|||f||||t|f|t|f|f||||||2017-10-10 20:49:42.716182|2017-10-10 20:49:42.716182
NCT03236415|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-20|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES|Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES|Not yet recruiting||N/A|52|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f|f|t|f||t|||||2017-10-10 20:49:42.966934|2017-10-10 20:49:42.966934
NCT03236402|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-31|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||"A Study to Assess Knowledge and Opinion Regarding Adoption Among Adults Residing in Rural and Urban Area"|"A Cross-sectional Comparative Study to Assess Knowledge and Opinion Regarding Adoption Among Adults Residing in Rural and Urban Area of Ambala, Haryana"|Completed||N/A|400|Actual|Maharishi Markendeswar University|||4||f||||t|f|f||||||||2017-10-10 20:49:43.055786|2017-10-10 20:49:43.055786
NCT03236389|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-31|||September 2016||2016-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Brain Dynamics in Response to Jugular Vein Compression|Brain Dynamics in Response to Jugular Vein Compression|Recruiting||N/A|40|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-10 20:49:43.136887|2017-10-10 20:49:43.136887
NCT03236376|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-31|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|January 2020|Anticipated|2020-01-01||Interventional|||Brain-behavior Associations of Sensorimotor Therapy Post Stroke|Behavioral and Brain Connectivity Analysis of Upper Limb Sensorimotor Rehabilitation Post Stroke: a Randomized Controlled Trial|Not yet recruiting||N/A|80|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f|f|f||||||||2017-10-10 20:49:43.223355|2017-10-10 20:49:43.223355
NCT03236363|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-31|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|MOVI-da10!||Effectiveness of MOVI Interventions on Adiposity, Cognition and Motor Competence: MOVI-da10!|Effectiveness of MOVI Interventions on Improving Adiposity, Cognition and Motor Competence by Increasing Aerobic Cardiorespiratory Fitness: MOVI-da10!|Not yet recruiting||N/A|540|Anticipated|University of Castilla-La Mancha||3|||f||||t|f|f||||||||2017-10-10 20:49:43.324|2017-10-10 20:49:43.324
NCT03236350|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-02|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|ERIC-BP-CKD||Remote Ischaemic Conditioning on Blood Pressure Control in Chronic Kidney Disease Patients|The Effect of Remote Ischaemic Conditioning on Blood Pressure Control in Patients With Chronic Kidney Disease - the ERIC-BP-CKD Trial|Not yet recruiting||N/A|85|Anticipated|Singapore General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:49:43.425932|2017-10-10 20:49:43.425932
NCT03236337|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-01|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effectiveness of MOVI Interventions on Adiposity, Cognition and Subclinical Atherosclerosis: MOVI-daFit!|Effectiveness of MOVI Interventions on Improving Adiposity, Cognition and Subclinical Atherosclerosis by Increasing Aerobic Cardiorespiratory Fitness: MOVI-daFit|Not yet recruiting||N/A|1000|Anticipated|University of Castilla-La Mancha||2|||f||||t|f|f||||||||2017-10-10 20:49:43.533048|2017-10-10 20:49:43.533048
NCT03236324|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-22|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|September 22, 2018|Anticipated|2018-09-22||Interventional|||Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery|Efficacy of Ultrasound-guided Transversalis Fascia Plane Blocks for Post-cesarean Section Analgesia: a Randomized Double Blinded Control Study|Recruiting||Phase 2|104|Anticipated|University of Calgary||2|||f|||||f|f||||||||2017-10-10 20:49:43.652141|2017-10-10 20:49:43.652141
NCT03236129|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-28|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|DLI-Boost||Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells|Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells: A Confirmatory, Randomized, Double Blinded Trial|Not yet recruiting||Phase 3|52|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||||2017-10-10 20:49:45.037806|2017-10-10 20:49:45.037806
NCT03236298|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: Comparing 125 mL/h Versus 250 mL/h Bolus Delivery Flow|Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: a RCT Comparing 125 mL/h Versus 250 mL/h Bolus Delivery Flow|Recruiting||N/A|90|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f|f|f||||||||2017-10-10 20:49:43.858439|2017-10-10 20:49:43.858439
NCT03236285|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|HIIT-FAST||Microvascular and Metabolic Effects of High-intensity Interval Exercise Training|Microvascular and Metabolic Effects of High-intensity Interval Training (HIIT) and Intermittent Fasting (FAST) in Overweight or Obese, Sedentary Women With Cardiometabolic Risk Factors: HIIT-FAST, a Randomized Clinical Trial|Not yet recruiting||N/A|60|Anticipated|National Institute of Cardiology, Laranjeiras, Brazil||4|||f||||f|f|f||||||||2017-10-10 20:49:43.954193|2017-10-10 20:49:43.954193
NCT03236272|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-02|||August 1, 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|August 30, 2019|Anticipated|2019-08-30||Observational|||Establishment of a Biomarkers-based Early Warning System of Acute Respiratory Distress Syndrome (ARDS)|Establishment of a Biomarkers-based Early Warning System of Acute Respiratory Distress Syndrome (ARDS)|Not yet recruiting||N/A|376|Anticipated|Third Military Medical University|||2||f||||f|f|f||||Samples With DNA|"     whole blood ,plasma,bronchoalveolar lavage fluid   "|||2017-10-10 20:49:44.037392|2017-10-10 20:49:44.037392
NCT03236259|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-31|||February 21, 2017|Actual|2017-02-21|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Berry Extract Administration on Cognitive Health|The Effect of Berry Extract Administration on Cognitive Health|Recruiting||Phase 2|102|Anticipated|Maastricht University Medical Center||3|||f||||t|f|f||||||||2017-10-10 20:49:44.105507|2017-10-10 20:49:44.105507
NCT03236233|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-27|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|December 8, 2017|Anticipated|2017-12-08|December 8, 2017|Anticipated|2017-12-08||Interventional|||A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786|A Randomised, Single-blind, Placebo-controlled, Dose-escalation Study to Assess the Safety and Tolerability of Single and Repeat, Inhaled Doses of PC786 in Healthy Subjects Combined With a Randomised, Single-blind, Placebo-controlled, Parallel Group to Assess the Safety and Tolerability of a Single Dose of Inhaled PC786 in Subjects With Mild Asthma|Recruiting||Phase 1|38|Anticipated|Pulmocide Ltd||3|||f||||f|f|f||||||||2017-10-10 20:49:44.317922|2017-10-10 20:49:44.317922
NCT03236220|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation|Effect of the Prophylactic Intervention of N-acetyl-L-cysteine (NAC) on the Incidence of Poor Graft Function and Prolonged Isolated Thrombocytopenia in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|30|Anticipated|Peking University People's Hospital||1|||f||||t|f|f||||||||2017-10-10 20:49:44.402923|2017-10-10 20:49:44.402923
NCT03236207|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-27|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula|Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula|Recruiting||N/A|83|Anticipated|Nestlé||2|||f||||f|f|f||||||||2017-10-10 20:49:44.500469|2017-10-10 20:49:44.500469
NCT03236194|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|August 17, 2018|Anticipated|2018-08-17|December 31, 2017|Anticipated|2017-12-31||Observational|||Ancillary Microbiome Collection From Mother/Infant Pairs During First Year of Life|Ancillary Microbiome Collection From Mother/Infant Pairs During First Year of Life|Recruiting||N/A|80|Anticipated|Milton S. Hershey Medical Center|||1||f||||f|f|f||||Samples With DNA|"     microbiome samples from mother and infant   "|||2017-10-10 20:49:44.647598|2017-10-10 20:49:44.647598
NCT03236181|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-10-04|||October 3, 2017|Actual|2017-10-03|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Chronic Effects of Fats on Satiety & Energy Needs|Chronic Effects of Fats on Satiety and Energy Expenditure|Recruiting||N/A|23|Anticipated|USDA Grand Forks Human Nutrition Research Center||4|||f||||f|f|f||||||||2017-10-10 20:49:44.712587|2017-10-10 20:49:44.712587
NCT03236155|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-31|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Comparing Opioid Prescription Patterns in Total Joint Arthroplasty Patients|Comparing Opioid Prescription Patterns in Total Joint Arthroplasty Patients: A Randomized Controlled Trial|Recruiting||Phase 4|310|Anticipated|Rush University Medical Center||2|||f||||f|t|f|||f|||||2017-10-10 20:49:44.867289|2017-10-10 20:49:44.867289
NCT03236103|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.|AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.|Not yet recruiting||N/A|900|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 20:49:45.206576|2017-10-10 20:49:45.206576
NCT03236090|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-31|||July 15, 2017|Actual|2017-07-15|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|July 1, 2018|Anticipated|2018-07-01||Interventional|||Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis|Study of the Effect of Vivomixx® on Neuroinflammation Ans Systemic Inflammatory Response in Patients With Cirrhosis|Recruiting||N/A|50|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f|f|f|||f|||||2017-10-10 20:49:45.279095|2017-10-10 20:49:45.279095
NCT03236077|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Increasing Exercise Enjoyment and Outcome Expectations Among Women With Obesity|Increasing Exercise Enjoyment and Outcome Expectations Among Women With Obesity|Completed||Phase 1|51|Actual|University at Buffalo||2|||f||||f|f|f||||||||2017-10-10 20:49:46.880946|2017-10-10 20:49:46.880946
NCT03236064|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-22|||May 2016||2016-05-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|May 2021|Anticipated|2021-05-01||Interventional|||Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury|Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury|Recruiting||Phase 1|10|Anticipated|WellSpan Health||1|||f||||f||||||||||2017-10-10 20:49:47.005912|2017-10-10 20:49:47.005912
NCT03236051|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-27|||February 10, 2017|Actual|2017-02-10|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study|Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study|Recruiting||N/A|156|Anticipated|Jinling Hospital, China||2|||f||||t|f|f||||||||2017-10-10 20:49:47.085755|2017-10-10 20:49:47.085755
NCT03236038|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-28|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 1, 2020|Anticipated|2020-03-01|October 1, 2019|Anticipated|2019-10-01|2 Years|Observational [Patient Registry]|(EPIIHC)||Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis|Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis|Not yet recruiting||N/A|56|Anticipated|Corporacion Parc Tauli|||1||f||||f|f|f||||||||2017-10-10 20:49:47.24412|2017-10-10 20:49:47.24412
NCT03236025|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-07|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Video-led Smoking Cessation Intervention in Helping Male Smokers Who is Planning to Have A Baby to Quit|The Effectiveness of a Video-led Smoking Cessation Intervention in Helping Male Smokers in Mainland China Who is Planning to Have a Baby to Quit: A Randomized Control Trial|Recruiting||N/A|888|Anticipated|The University of Hong Kong||3|||f||||t|f|f||||||||2017-10-10 20:49:47.350965|2017-10-10 20:49:47.350965
NCT03236012|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||October 15, 2017|Anticipated|2017-10-15|July 2017|2017-07-01|October 15, 2021|Anticipated|2021-10-15|October 15, 2020|Anticipated|2020-10-15||Interventional|||Hyperhidrosis in Patients With Amputations|Hyperhidrosis of the Residual Limb in Patients With Amputations: Developing a Treatment Approach|Not yet recruiting||Phase 1|75|Anticipated|University of Utah||3|||f||||t|t|f||||||||2017-10-10 20:49:47.488766|2017-10-10 20:49:47.488766
NCT03235999|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-31|||July 2016||2016-07-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Observational|||The Experiences of Patients Living With Malignant Pleural Effusions|The Experiences of Patients Living With Malignant Pleural Effusions|Recruiting||N/A|20|Anticipated|Gloucestershire Hospitals NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 20:49:47.600171|2017-10-10 20:49:47.600171
NCT03235973|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-01|||September 2018|Anticipated|2018-09-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|CEREAL||Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes|Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes|Not yet recruiting||Phase 1|29|Anticipated|Institut Paoli-Calmettes||1|||f||||t|f|f||||||||2017-10-10 20:49:47.770234|2017-10-10 20:49:47.770234
NCT03235960|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-31|||January 1, 2004|Actual|2004-01-01|July 2017|2017-07-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Observational|||Efficacy of Glass-ionomer Fissure Sealants|Clinical Efficacy of Glass-ionomer Fissure Sealants|Active, not recruiting||N/A|500|Anticipated|Association of Paediatric and Preventive Dentists of Serbia|||1||f||||t||||||||||2017-10-10 20:49:47.858506|2017-10-10 20:49:47.858506
NCT03235947|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-31|||September 7, 2016|Actual|2016-09-07|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|PERIFOS||Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients|Perioperative Disodium Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients. Controlled Clinical Trial (PERIFOS Trial)|Recruiting||Phase 4|80|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f|f|f|||f|||||2017-10-10 20:49:48.040705|2017-10-10 20:49:48.040705
NCT03235934|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-19|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|||Glycemic Impact on Glioblastoma Outcomes|Glycemic Impact on Glioblastoma Outcomes|Not yet recruiting||N/A|30|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||||2017-10-10 20:49:48.167046|2017-10-10 20:49:48.167046
NCT03230903|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-26|||October 2016||2016-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Physical Telerehabilitation in Multiple Sclerosis|Physical Telerehabilitation in Patients With Multiple Sclerosis With Significant Mobility Impairment|Recruiting||N/A|78|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-10 20:50:31.821948|2017-10-10 20:50:31.821948
NCT03235921|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-07-31|||March 2016||2016-03-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock|Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock|Recruiting||Phase 2|100|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 20:49:48.241532|2017-10-10 20:49:48.241532
NCT03235908|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Observational|CoPsych||Copeptin in Outcome Prediction of an Acute Psychotic Episode|Copeptin - A Biomarker to Improve Outcome Prediction in Patients With an Acute Psychotic Episode|Recruiting||N/A|80|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f|f|f||||Samples Without DNA|"     Copeptin, Cortisol, Serum Sodium, Urinary sodium and urinary osmolality in case   "|||2017-10-10 20:49:48.375253|2017-10-10 20:49:48.375253
NCT03235895|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-30|||September 25, 2017|Anticipated|2017-09-25|July 2017|2017-07-01|December 10, 2017|Anticipated|2017-12-10|November 25, 2017|Anticipated|2017-11-25||Interventional|||Evaluation of Internet-Based CME for Wet-cupping Providers|Evaluation of Internet-Based CME for Wet-cupping Providers: Randomized Controlled Trial|Not yet recruiting||N/A|90|Anticipated|National Center for Complementary and Alternative Medicine, Saudi Arabia||3|||f||||f|f|f||||||||2017-10-10 20:49:48.49501|2017-10-10 20:49:48.49501
NCT03235882|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-30|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 15, 2020|Anticipated|2020-08-15|August 15, 2019|Anticipated|2019-08-15||Observational|FAST||Fast Assessment of Surfactant Deficiency to Speed up Treatment|Fast Assessment of Surfactant Deficiency to Speed up Treatment: Assessment of Lung Maturity and Prediction of RDS by Determination of L/S-ratio in Fresh Gastric Aspirates by FTIR Spectroscopy|Recruiting||N/A|70|Anticipated|Rigshospitalet, Denmark|||1||f||||f|f|f||||||||2017-10-10 20:49:48.577387|2017-10-10 20:49:48.577387
NCT03235869|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-06|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 1, 2023|Anticipated|2023-03-01|March 1, 2023|Anticipated|2023-03-01||Interventional|||Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma|A Single Arm Pilot Study of Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma|Not yet recruiting||Early Phase 1|19|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f|||t|||||2017-10-10 20:49:48.672134|2017-10-10 20:49:48.672134
NCT03235856|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 1, 2019|Anticipated|2019-01-01|December 31, 2017|Anticipated|2017-12-31||Observational|REDCAKE||Retrospective Digital Computer Analysis of Keratoconus Evolution - REDCAKE|Retrospective Digital Computer Analysis of Keratoconus Evolution - REDCAKE|Not yet recruiting||N/A|1500|Anticipated|University Hospital, Antwerp|||1||f||||f|f|f||||||||2017-10-10 20:49:48.762586|2017-10-10 20:49:48.762586
NCT03235843|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|August 1, 2019|Anticipated|2019-08-01||Interventional|ADAPTION||Rate Adaptive Atrial Pacing in Heart Failure|Rate Adaptive Atrial Pacing in Heart Failure Patients With Chronotropic Incompetence|Recruiting||N/A|65|Anticipated|VU University Medical Center||2|||f||||t|f|f|||f|||||2017-10-10 20:49:48.833865|2017-10-10 20:49:48.833865
NCT03235830|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-30|2017-07-31|||January 28, 2015|Actual|2015-01-28|July 2017|2017-07-01|August 5, 2016|Actual|2016-08-05|August 5, 2016|Actual|2016-08-05||Interventional|||Text Messaging in Healthcare Utilization|Evaluation of Text Messaging as an Educational Method to Improve Healthcare Utilization|Completed||N/A|231|Actual|St. Louis University||2|||f||||f|f|f||||||||2017-10-10 20:49:48.937076|2017-10-10 20:49:48.937076
NCT03235817|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-07-31|||December 2009||2009-12-01|July 2017|2017-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Comparison of Different Ventilation Strategies in Infants Using the PLMA™|A Comparison of Different Ventilation Strategies in Infants Using the Proseal™ Laryngeal Mask Airway|Completed||N/A|39|Actual|Wake Forest University Health Sciences||3|||f||||f|f|t|f|f||||||2017-10-10 20:49:49.016517|2017-10-10 20:49:49.016517
NCT03235804|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-16|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|PREMIUM||The Impact of a High-protein Diet on Metabolism and Gut Microbiome|The Impact of a High-protein Diet on Metabolism and Gut Microbiome: a 12-week Study in Individuals With Excessive Body Weight|Not yet recruiting||N/A|72|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 20:49:49.101714|2017-10-10 20:49:49.101714
NCT03235791|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-07-27|||January 2015||2015-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:49:49.196821|2017-10-10 20:49:49.196821
NCT03235778|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-31|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|December 30, 2017|Anticipated|2017-12-30||Interventional|||A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China|A Randomized, Double-blind, Placebo-controlled, Single-dose, Dose-escalated Phase I Clinical Study Trial to Evaluate the Tolerance and Pharmacokinetics of Felbinac Trometamol Injection in Healthy Subjects|Recruiting||Phase 1|58|Anticipated|Yiling Pharmaceutical Inc.||7|||f||||f|f|f||||||||2017-10-10 20:49:49.238773|2017-10-10 20:49:49.238773
NCT03235765|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||March 10, 2017|Actual|2017-03-10|July 2017|2017-07-01|March 10, 2020|Anticipated|2020-03-10|March 10, 2018|Anticipated|2018-03-10|3 Years|Observational [Patient Registry]|CAPABLE||Cancer Panel From Blood of Lung Cancer Patients|Clinical Validity of Oncogenic Driver Genes Detected From Circulating Tumor DNA in Blood of Lung Cancer Patients|Recruiting||N/A|200|Anticipated|Seoul National University Hospital|||2||f||||f|f|f||||Samples With DNA|"     Cancer panel analysis will be done with patients tumro tissue and ctDNA   "|||2017-10-10 20:49:49.340219|2017-10-10 20:49:49.340219
NCT03235752|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|August 30, 2020|Anticipated|2020-08-30|March 30, 2020|Anticipated|2020-03-30||Interventional|||Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis|A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TJ301 (FE 999301) Administered Intravenously in Patients With Active Ulcerative Colitis|Not yet recruiting||Phase 2|90|Anticipated|Leading Biopharm Limited||3|||f||||t|f|f||||||||2017-10-10 20:49:49.435514|2017-10-10 20:49:49.435514
NCT03235739|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-28|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Ancillary Effects of Oral Naloxegol (Movantik)|Ancillary Effects of Oral Naloxegol (Movantik)|Not yet recruiting||Phase 4|129|Anticipated|The Cleveland Clinic||2|||f||||t|t|f||||||||2017-10-10 20:49:49.535475|2017-10-10 20:49:49.535475
NCT03235726|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-17|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|March 22, 2018|Anticipated|2018-03-22|March 22, 2018|Anticipated|2018-03-22||Interventional|||Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug|A Double-blind (Sponsor Unblind), Randomized, Placebo-controlled, Single and Repeat Escalating Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CCI15106 Inhalation Powder in Healthy Participants and Participants With Moderate Chronic Obstructive Pulmonary Disease (COPD) Including Evaluation of Environmental and Healthy By-stander Exposure Levels During Dosing|Recruiting||Phase 1|58|Anticipated|GlaxoSmithKline||9|||f||||f|f|f||||||||2017-10-10 20:49:49.623462|2017-10-10 20:49:49.623462
NCT03235713|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-07|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||EMA for Tobacco Control Policy Research|Ecological Momentary Assessments for the Evaluation of Tobacco Health Warnings, Point-of-sale Tobacco Displays and Smoking Hotspots: a Pilot Study|Not yet recruiting||N/A|300|Anticipated|The University of Hong Kong|||1||f||||f|f|f||||||||2017-10-10 20:49:49.864478|2017-10-10 20:49:49.864478
NCT03235700|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|HF-FFR||Hyperemic Efficacy of IV Adenosine in HFrEF|Hyperemic Efficacy of Intravenous Infusion of Adenosine in Heart Failure With Reduced Ejection Fraction|Recruiting||N/A|125|Anticipated|Sejong General Hospital||2|||f|||||f|f||||||||2017-10-10 20:49:49.928701|2017-10-10 20:49:49.928701
NCT03235687|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|December 1, 2017|Anticipated|2017-12-01||Interventional|||Decision Impact Trial of the ExoDx Prostate (IntelliScore)|A Prospective, Randomized Blinded, Shared Decision Impact Trial of the ExoDx Prostate (IntelliScore), EPI Test, in Men Presenting for Initial Biopsy.|Recruiting||N/A|1000|Anticipated|Exosome Diagnostics, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:49:50.025488|2017-10-10 20:49:50.025488
NCT03235674|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-01|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|SCORE||Stair Climbing Outcomes in Cardiac Rehabilitation Exercise|A Feasible High Intensity Interval Exercise Training Intervention in Phase II Cardiac Rehabilitation|Not yet recruiting||N/A|40|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:49:50.123417|2017-10-10 20:49:50.123417
NCT03235661|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|August 15, 2020|Anticipated|2020-08-15|August 15, 2020|Anticipated|2020-08-15||Interventional|||Bi-level Positive Airway Pressure for Respiratory Distress Syndrome in Twins Infants|Bi-level Positive Airway Pressure for Respiratory Distress Syndrome in Twins:A Randomized Controlled Trials|Recruiting||N/A|300|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t|f|f||||||||2017-10-10 20:49:50.204934|2017-10-10 20:49:50.204934
NCT03235648|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-30|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|June 1, 2023|Anticipated|2023-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer|Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer|Recruiting||N/A|25|Anticipated|Mansoura University||1|||f||||t|f|f||||||||2017-10-10 20:49:50.30384|2017-10-10 20:49:50.30384
NCT03235635|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-29|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Observational|MAGMP||Metagenomic Analysis of Gut Microbiome in Preterm|Metagenome Analysis of Intestinal Microbiome in Mortality and Morbidity of Preterm Infants|Recruiting||N/A|120|Anticipated|Wonju Severance Christian Hospital|||3||f||||t|f|f||||Samples Without DNA|"     extraction microbiome DNA from stool of newborns   "|||2017-10-10 20:49:50.419494|2017-10-10 20:49:50.419494
NCT03235622|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-29|||March 2011|Actual|2011-03-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|February 2013|Actual|2013-02-01||Observational|BBC||Women Health Cohort for Breast, Bone and Coronary Artery Disease|Women Health Cohort for Breast, Bone and Coronary Artery Disease|Completed||N/A|2100|Actual|Seoul National University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:49:50.550384|2017-10-10 20:49:50.550384
NCT03235609|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-01|||August 16, 2017|Anticipated|2017-08-16|August 2017|2017-08-01|August 15, 2018|Anticipated|2018-08-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Sedation During Pediatric Diagnostic Gastrointestinal Endoscopy Gastrointestinal Endoscopy|Propofol-Ketamine vs. Propofol-Fentanyl for Sedation During Pediatric Diagnostic Gastrointestinal Endoscopy|Not yet recruiting||N/A|60|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:49:50.636634|2017-10-10 20:49:50.636634
NCT03235596|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-31|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|TRANSFEX||Effects of Cathodal tDCS on Executive Functions in Autism|Pilot Study Investigating the Effects of Cathodal Transcranial Direct Current Stimulation (tDCS) on Executive Functions of Patients With Autism Without Mental Retardation. TRANSFEX Study|Recruiting||N/A|22|Anticipated|Centre Hospitalier du Rouvray||1|||f||||f|f|f||||||||2017-10-10 20:49:50.7324|2017-10-10 20:49:50.7324
NCT03235583|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-03|||April 2, 2012|Actual|2012-04-02|July 2017|2017-07-01|October 11, 2013|Actual|2013-10-11|October 11, 2013|Actual|2013-10-11||Interventional|||MOTIONPODTM Validation in Free-living Conditio|Validation of MotionPODTM a Device for Measuring Physical Activity, in Free-living Conditions|Completed||N/A|128|Actual|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 20:49:50.828002|2017-10-10 20:49:50.828002
NCT03235570|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-02|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||A Safety and Tolerability Study of INCB054828 in Japanese Subjects With Advanced Malignancies|A Phase 1, Open-Label, Dose-Escalation, Dose-Expansion, Safety and Tolerability Study of INCB054828 in Japanese Subjects With Advanced Malignancies|Recruiting||Phase 1|54|Anticipated|Incyte Corporation||1|||f||||t|t|f|||t|||||2017-10-10 20:49:50.918699|2017-10-10 20:49:50.918699
NCT03235557|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-07-27|||October 2014||2014-10-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|October 2018|Anticipated|2018-10-01|3 Years|Observational [Patient Registry]|ProRobot||CyberKnife for Prostate Cancer Patients Aged 70 y or More|Robotic Radiation Treatment of Prostate Cancer Patients Aged 70 y or More|Recruiting||N/A|60|Anticipated|Centre Francois Baclesse, Luxembourg|||1||f||||t||||||||||2017-10-10 20:49:51.018683|2017-10-10 20:49:51.018683
NCT03235544|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|July 2020|Anticipated|2020-07-01||Interventional|||A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a BTK Inhibitor (CITADEL-205)|A Phase 2, Open-Label, 2-Cohort, Multicenter Study of INCB050465, a PI3Kδ Inhibitor, in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a BTK Inhibitor (CITADEL-205)|Not yet recruiting||Phase 2|120|Anticipated|Incyte Corporation||2|||f||||t|t|f||||||||2017-10-10 20:49:51.104783|2017-10-10 20:49:51.104783
NCT03235531|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-27|||July 11, 2017|Actual|2017-07-11|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|July 11, 2019|Anticipated|2019-07-11||Interventional|PAVE||Assessment of Valproate on Ethanol Withdrawal|Prospective Assessment of Valproate on Ethanol Withdrawal|Recruiting||Phase 4|210|Anticipated|CAMC Health System||2|||f||||f|t|f|||t|||||2017-10-10 20:49:51.199395|2017-10-10 20:49:51.199395
NCT03235518|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|December 28, 2017|Anticipated|2017-12-28||Observational|IPrEP||A Combination HIV Prevention Strategy for Young Women at Risk for HIV|A Combination HIV Prevention Strategy for Young Women at Risk for HIV|Recruiting||N/A|340|Anticipated|Columbia University|||5||f|||||f|f||||||||2017-10-10 20:49:51.352122|2017-10-10 20:49:51.352122
NCT03235505|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-28|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|EFFECT||Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers|Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers|Not yet recruiting||Phase 4|450|Anticipated|University of Oulu||3|||f|||||f|f||||||||2017-10-10 20:49:51.442398|2017-10-10 20:49:51.442398
NCT03235492|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-29|||August 24, 2017|Actual|2017-08-24|August 2017|2017-08-01|August 15, 2018|Anticipated|2018-08-15|August 15, 2018|Anticipated|2018-08-15||Interventional|||Salivary Glycated Albumin|Clinical Study of Salivary Glycated Albumin|Recruiting||N/A|176|Anticipated|University of Maryland||1|||f||||f|f|f|||f|||||2017-10-10 20:49:51.532088|2017-10-10 20:49:51.532088
NCT03235466|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-28|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||A Prospective Trial of Behavioral Therapy for Chronic Cough|A Prospective Trial of Behavioral Therapy for Chronic Cough|Not yet recruiting||N/A|45|Anticipated|University of California, San Diego||3|||f|||||f|f||||||||2017-10-10 20:49:51.87863|2017-10-10 20:49:51.87863
NCT03235453|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-02|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|December 20, 2019|Anticipated|2019-12-20|December 30, 2017|Anticipated|2017-12-30||Interventional|||Dance for People With Parkinson's Disease|Influence of Binary and Quaternary Rhythm in Motor Symptoms, Sleep, Failure and Quality of Living in People With Parkinson Disease: a Randomized Clinical Trial|Not yet recruiting||N/A|60|Anticipated|Laboratório de Pesquisa em Lazer e Atividade Física||2|||f||||t|f|f||||||||2017-10-10 20:49:51.958813|2017-10-10 20:49:51.958813
NCT03235440|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-26|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Observational|CampPowerUp||Feasibility of the Camp Power Up Program on Children's Body Weight and Quality of Life|Examination of the Acceptance and Feasibility of Implementing the American Diabetes Association's Camp Power Up Program on Changes in Body Weight and Quality of Life Measures in Children|Completed||N/A|14|Actual|Pennington Biomedical Research Center|||1||f||||f|f|f||||||||2017-10-10 20:49:52.050334|2017-10-10 20:49:52.050334
NCT03235427|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-02|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|March 15, 2018|Anticipated|2018-03-15||Observational|CAROLE||The CAROLE (CArdiac Related Oncologic Late Effects) Study|The CAROLE (CArdiac Related Oncologic Late Effects) Study|Recruiting||N/A|200|Anticipated|Northwell Health|||2||f||||f|f|f||||||||2017-10-10 20:49:52.14013|2017-10-10 20:49:52.14013
NCT03235414|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-31|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Normal Liver Stiffness by MRE|Determination of Normal Liver Stiffness by MR Elastography in Children|Not yet recruiting||N/A|96|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f|f|f||||||||2017-10-10 20:49:52.241302|2017-10-10 20:49:52.241302
NCT03235401|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 16, 2017|Anticipated|2017-12-16||Observational|PAH-DBoQ||The PAH Disability and Bothersomeness Questionnaire|"Validation of a Questionnaire Assessing Disability and Bothersomeness in Pulmonary Arterial Hypertension (PAH): The PAH Disability and Bothersomeness Questionnaire"|Recruiting||N/A|120|Anticipated|Association de Recherche en Physiopathologie Respiratoire|||1||f||||f|f|f||||||||2017-10-10 20:49:52.304361|2017-10-10 20:49:52.304361
NCT03235388|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-28|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|March 2021|Anticipated|2021-03-01||Interventional|TAFT||The Trauma Audit Filters Trial|The Trauma Audit Filters Trial: Does Institutional Implementation of Audit Filters Reduce Mortality in Adult Trauma Patients?|Not yet recruiting||N/A|8400|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 20:49:52.579428|2017-10-10 20:49:52.579428
NCT03235375|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-23|||September 13, 2017|Anticipated|2017-09-13|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects|A Phase 1, Open-Label, Single Dose, Parallel-Group Study to Evaluate the Pharmacokinetics, Safety and Tolerability of MEDI0382 in Subjects With Renal Impairment|Not yet recruiting||Phase 1|24|Anticipated|MedImmune LLC||3|||f||||f|f|f||||||||2017-10-10 20:49:52.679296|2017-10-10 20:49:52.679296
NCT03235362|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706|A Phase 1, Randomized, Open-label, Multiple-dose, 3-treatment, 6-sequence, 3-period Crossover Clinical Trial to Investigate the Safety and Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706 in Healthy Volunteers|Not yet recruiting||Phase 1|30|Anticipated|Yuhan Corporation||6|||f||||f|f|f||||||||2017-10-10 20:49:52.761533|2017-10-10 20:49:52.761533
NCT03235336|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||January 1989|Actual|1989-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Associations Between Tea and Sweetened Beverage Consumptions and Hyperuricemia: The China Health and Nutrition Survey|The China Health and Nutrition Survey|Recruiting||N/A|5547|Anticipated|The Hong Kong Polytechnic University|||1||f||||t|f|f||||||||2017-10-10 20:49:53.009426|2017-10-10 20:49:53.009426
NCT03235323|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-04|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|August 7, 2021|Anticipated|2021-08-07|August 7, 2020|Anticipated|2020-08-07||Interventional|SEECABG||Efficacy of External CounterPulsation for Postoperative Coronary Artery Bypass Grafting Patients|Study of Efficacy of External CounterPulsation on Reducing the Prevalence of Vein Graft Failure and Improving Cardiac Function for Postoperative Coronary Artery Bypass Grafting Patients|Recruiting||N/A|120|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f|f|f||||||||2017-10-10 20:49:53.100956|2017-10-10 20:49:53.100956
NCT03235310|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-07-27|||July 1997||1997-07-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|EPF||Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention|ANRS CO1 EPF Prospective Observational Cohort Study on Mother-to-child Transmission HIV1 and/or HIV2 and Prevention|Recruiting||N/A|18200|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f||||||Samples Without DNA|"     3 mL whole blood 3mL plasma   "|||2017-10-10 20:49:53.229813|2017-10-10 20:49:53.229813
NCT03235297|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Observational|DLCO||Effects of Altitude on Single-Breath Diffusing Capacity for Carbon Monoxide|Effects of Altitude on Single-Breath Diffusing Capacity for Carbon Monoxide in Normal Subjects and Chronic Obstructive Pulmonary Disease|Not yet recruiting||N/A|20|Anticipated|Intermountain Health Care, Inc.|||2||f||||f|f|f||||||||2017-10-10 20:49:53.507965|2017-10-10 20:49:53.507965
NCT03235284|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||July 1, 2015|Actual|2015-07-01|July 2017|2017-07-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Kinesitherapy and Nintendo WII® in Balance Rehabilitation of Individuals With Parkinson's Disease|Efficacy of Kinesitherapy and Nintendo WII® in Balance Rehabilitation of Individuals With Parkinson's Disease: Randomized Clinical Trial|Recruiting||N/A|36|Anticipated|Federal University of Bahia||3|||f||||t|f|f||||||||2017-10-10 20:49:53.608492|2017-10-10 20:49:53.608492
NCT03235271|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-09|||August 10, 2017|Anticipated|2017-08-10|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|February 10, 2018|Anticipated|2018-02-10||Observational|||Pilot Study of Acute Stroke Using the Brainpulse™|Non-Blinded Data Collection Pilot Study of Acute Stroke Using the Brainpulse™|Not yet recruiting||N/A|140|Anticipated|Jan Medical, Inc.|||4||f||||f|f|f||||||||2017-10-10 20:49:53.6957|2017-10-10 20:49:53.6957
NCT03235258|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-07-27|||July 2004||2004-07-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|EPF||Cohort of HIV-infected Children|ANRS CO10 EPF - Cohort of HIV-infected Children|Recruiting||N/A|400|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f||||||Samples Without DNA|"     1 to 3 mL whole blood - 1 to 3mL plasma   "|||2017-10-10 20:49:53.774259|2017-10-10 20:49:53.774259
NCT03235245|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-01|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2024|Anticipated|2024-02-01|April 2022|Anticipated|2022-04-01||Interventional|EBIN||Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib|Combination of Targeted Therapy (Encorafenib and Binimetinib) Followed by Combination of Immunotherapy (Ipilimumab and Nivolumab) vs Immediate Combination of Immunotherapy in Patients With Unresectable or Metastatic Melanoma With BRAF V600 Mutation : an EORTC Randomized Phase II Study (EBIN)|Not yet recruiting||Phase 2|270|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t|f|f||||||||2017-10-10 20:49:53.962294|2017-10-10 20:49:53.962294
NCT03235232|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-03|||May 2018|Anticipated|2018-05-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||BREMEN Eye Drops Versus Combigan and Azopt for Open-angle Glaucoma or Intraocular Hypertension|Randomized Clinical Trial to Compare the Efficacy and Safety of BREMEN Eye Drops Versus Combigan and Azopt in Subjects With Open Angle Glaucoma or Ocular Hypertension|Not yet recruiting||Phase 3|266|Anticipated|EMS||2|||f||||f|f|f||||||||2017-10-10 20:49:54.056866|2017-10-10 20:49:54.056866
NCT03235219|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-22|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|January 5, 2018|Anticipated|2018-01-05|January 5, 2018|Anticipated|2018-01-05||Interventional|||A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus|A Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Men and Women With Type 2 Diabetes Mellitus|Recruiting||Phase 1|56|Anticipated|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 20:49:54.133604|2017-10-10 20:49:54.133604
NCT03235206|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-31|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Massage Therapy and the Well-Being of Police Officers|Massage Therapy and the Well-Being of Police Officers|Not yet recruiting||N/A|6|Anticipated|Academy Canada||1|||f|||||f|f||||||||2017-10-10 20:49:54.25656|2017-10-10 20:49:54.25656
NCT03235193|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-02|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PREVISE||Predictive algoRithm for EValuation and Intervention in SEpsis|Prediction of Severe Sepsis Using a Machine Learning Algorithm|Recruiting||N/A|1241|Anticipated|Dascena||2|||f|||||f|f||||||||2017-10-10 20:49:54.319748|2017-10-10 20:49:54.319748
NCT03235167|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy|Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy|Not yet recruiting||Phase 1|100|Anticipated|Dalian University||2|||f|||||f|f||||||||2017-10-10 20:49:54.48192|2017-10-10 20:49:54.48192
NCT03235154|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-24|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic|Bridging Care to HCV Treatment Among Opiate Dependent Patients on Buprenorphine/Naloxone Maintenance Therapy: A Pilot Study of Treating HCV With Epclusa at a Psychiatrist-staffed Outpatient Addiction Clinic|Not yet recruiting||Phase 4|20|Anticipated|Community Research Initiative of New England||1|||f||||f|t|f||||||||2017-10-10 20:49:54.553316|2017-10-10 20:49:54.553316
NCT03235141|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-27|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers|Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers|Recruiting||Phase 1|56|Anticipated|Beijing Tongren Hospital||2|||f||||f|t|f|||t|||||2017-10-10 20:49:54.659892|2017-10-10 20:49:54.659892
NCT03235128|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-08-01|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome|Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome|Not yet recruiting||N/A|50|Anticipated|Assiut University|||5||f||||f|f|f||||||||2017-10-10 20:49:54.763608|2017-10-10 20:49:54.763608
NCT03235115|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||June 23, 2017|Actual|2017-06-23|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|September 20, 2017|Anticipated|2017-09-20||Interventional|||Fitting Evaluation of Hydrogel and Silicone Hydrogel Spherical Contact Lenses|Fitting Evaluation of Hydrogel and Silicone Hydrogel Spherical Contact Lenses|Recruiting||N/A|40|Anticipated|Coopervision, Inc.||3|||f||||f|f|t|f|f|t|||||2017-10-10 20:49:54.83642|2017-10-10 20:49:54.83642
NCT03235102|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-23|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|September 22, 2017|Anticipated|2017-09-22|September 22, 2017|Anticipated|2017-09-22||Observational|||Awareness, Care and Treatment in Obesity Management|Obesity ACTION Study in Canada|Enrolling by invitation||N/A|2530|Anticipated|Novo Nordisk A/S|||3||f||||f|f|f||||||||2017-10-10 20:49:54.918903|2017-10-10 20:49:54.918903
NCT03235089|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-03|||July 25, 2017||2017-07-25||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:49:54.977327|2017-10-10 20:49:54.977327
NCT03235076|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-25|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|August 22, 2018|Anticipated|2018-08-22|May 31, 2018|Anticipated|2018-05-31||Interventional|||Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects|Investigation of Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 MR Tablet Dose in Male and Female Subjects With Renal Impairment and in Age-, Gender-, and Weight- Matched Healthy Subjects in a Single Center, Non-controlled, Open-label, Observational Design|Recruiting||Phase 1|36|Anticipated|Bayer||4|||f||||f|f|f||||||||2017-10-10 20:49:55.016469|2017-10-10 20:49:55.016469
NCT03235063|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-23|||January 2, 2013|Actual|2013-01-02|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|January 2, 2018|Anticipated|2018-01-02|1 Year|Observational [Patient Registry]|||Pregnancy and Dilated Cardiomyopathy|Registry of Pregnancy Follow-up in Patients With Dilated Cardiomyopathy|Recruiting||N/A|100|Anticipated|Nantes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:49:55.092694|2017-10-10 20:49:55.092694
NCT03235050|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-10-04|||August 2, 2017|Actual|2017-08-02|October 2017|2017-10-01|April 27, 2020|Anticipated|2020-04-27|August 20, 2018|Anticipated|2018-08-20||Interventional|||A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes|A Phase IIb, Randomised, Parallel, Double-Blind Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes Mellitus|Recruiting||Phase 2|750|Anticipated|AstraZeneca||5|||f||||f|t|f||||||||2017-10-10 20:49:55.268773|2017-10-10 20:49:55.268773
NCT03235037|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-07-28|||November 26, 2013|Actual|2013-11-26|July 2017|2017-07-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome|Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome|Enrolling by invitation||N/A|15|Anticipated|Children's Research Institute||1|||f||||t|f|f|||f|||||2017-10-10 20:49:55.7141|2017-10-10 20:49:55.7141
NCT03235024|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-31|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis|A Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Mild to Moderate Atopic Dermatitis|Not yet recruiting||Phase 2|130|Anticipated|AOBiome LLC||2|||||||f|t|f||||||||2017-10-10 20:49:55.795168|2017-10-10 20:49:55.795168
NCT03235011|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||March 10, 2017|Actual|2017-03-10|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|SEXODREP||Evaluation of Knowledge Among Adolescents With Sickle Cell Disease.|Evaluation of Knowledge and Practices About Contraception, Sexuality and Transmission Among Adolescents With Sickle Cell Disease.|Recruiting||N/A|100|Anticipated|Centre Hospitalier Intercommunal Creteil|||1||f|||||f|f||||||||2017-10-10 20:49:55.884554|2017-10-10 20:49:55.884554
NCT03234998|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Comparative Efficacy of Two Different Dual-task Balance Interventions|Comparative Efficacy of Two Different Dual-task Balance Interventions on Balance, Gait, and Cognitive Performance Under Single- and Dual-task Conditions in Stroke Patients and Older Adults|Not yet recruiting||N/A|50|Anticipated|Chang Gung University||2|||f||||f|f|f||||||||2017-10-10 20:49:55.971404|2017-10-10 20:49:55.971404
NCT03234985|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|NUCLARA||Study of Intracellular Nucleotide Pools Determination as Biomarker of the Efficacy of the Induction Treatment in Acute Myeloid Leukemia|Study of Intracellular Nucleotide Pools Determination as Biomarker of the Efficacy of the Induction Treatment in Acute Myeloid Leukemia|Recruiting||N/A|44|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:49:56.085286|2017-10-10 20:49:56.085286
NCT03234972|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-21|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|August 31, 2022|Anticipated|2022-08-31|March 21, 2020|Anticipated|2020-03-21||Interventional|||A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma|A Randomized, Multicenter, Open-label, Phase 3 Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Subjects With Relapsed or Refractory Multiple Myeloma|Not yet recruiting||Phase 3|210|Anticipated|Janssen Research & Development, LLC||2|||f||||t|f|f|||f|||||2017-10-10 20:49:56.179766|2017-10-10 20:49:56.179766
NCT03234959|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2019|Anticipated|2019-07-30||Interventional|||CareToy Early Intervention in Infants at Risk for Cerebral Palsy|CareToy: a Smart System for Early Home-based Intervention in Infants at High Risk for Cerebral Palsy|Not yet recruiting||N/A|38|Anticipated|IRCCS Fondazione Stella Maris||2|||f||||t|f|f||||||||2017-10-10 20:49:56.330438|2017-10-10 20:49:56.330438
NCT03234946|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-09-21|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|June 19, 2021|Anticipated|2021-06-19|June 19, 2021|Anticipated|2021-06-19||Interventional|CAIPaDi||Effect of the CAIPaDi Care Model in Relatives of Patients With Type 2 Diabetes Mellitus|Effect of the CAIPaDi Care Model in Relatives of Patients With Type 2 Diabetes Mellitus|Recruiting||N/A|960|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t|f|f||||||||2017-10-10 20:49:56.433868|2017-10-10 20:49:56.433868
NCT03234933|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||August 31, 2017|Anticipated|2017-08-31|July 2017|2017-07-01|August 31, 2023|Anticipated|2023-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Post-Operative Ambulatory Challenge and Exercise (PACE) Trial|Post-Operative Ambulatory Challenge and Exercise (PACE) Trial|Not yet recruiting||N/A|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|f|t|f|||||||2017-10-10 20:49:56.57768|2017-10-10 20:49:56.57768
NCT03234920|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-26|||September 25, 2015|Actual|2015-09-25|July 2017|2017-07-01|December 10, 2017|Anticipated|2017-12-10|December 10, 2017|Anticipated|2017-12-10||Interventional|HMB||Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation|Effects of Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation After Liver Transplantation: Randomized and Controlled Pilot Study|Recruiting||N/A|24|Anticipated|University of Roma La Sapienza||2|||f||||t|f|f||||||||2017-10-10 20:49:56.689719|2017-10-10 20:49:56.689719
NCT03234907|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||August 2, 2017|Anticipated|2017-08-02|July 2017|2017-07-01|April 29, 2020|Anticipated|2020-04-29|January 7, 2020|Anticipated|2020-01-07||Interventional|||Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Chinese Subjects With Moderately to Severely Active Crohn's Disease|Not yet recruiting||Phase 3|300|Anticipated|Takeda||5|||f||||f|f|f||||||||2017-10-10 20:49:56.816402|2017-10-10 20:49:56.816402
NCT03232840|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-02|||July 31, 2017|Actual|2017-07-31|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|June 1, 2018|Anticipated|2018-06-01||Observational|ELPSite||E-learning to Prevent Wrong Site Surgery in Anesthesia|Evaluation of an E-learning to Prevent Wrong Site Surgery in Anesthesia.|Recruiting||N/A|100|Anticipated|University Hospital, Montpellier|||1||f||||f|f|f||||||||2017-10-10 20:49:56.910672|2017-10-10 20:49:56.910672
NCT03232827|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-25|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||The Impact of Waterpipe Tobacco Flavors on Waterpipe Smoking Intentions, Perceptions, Patterns, and Toxicant Exposure|The Impact of Waterpipe Tobacco Flavors on Waterpipe Smoking Intentions, Perceptions, Patterns, and Toxicant Exposure|Recruiting||N/A|76|Anticipated|University of Oklahoma||3|||f|||||f|f||||||||2017-10-10 20:49:56.993052|2017-10-10 20:49:56.993052
NCT03234894|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-26|||April 1, 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:49:57.108823|2017-10-10 20:49:57.108823
NCT03234881|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-26|||October 2, 2017|Anticipated|2017-10-02|July 2017|2017-07-01|August 2, 2021|Anticipated|2021-08-02|August 2, 2020|Anticipated|2020-08-02||Interventional|||Weight Loss Treatment for Veterans With Binge Eating|Weight Loss Treatment and CBT for Veterans With Binge Eating|Not yet recruiting||N/A|108|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 20:49:57.17109|2017-10-10 20:49:57.17109
NCT03234868|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-26|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Benefit of the Digital Workflow for Screw-retained Single Implant Restorations|Benefit of the Digital Workflow for Screw-retained Single Implant Restorations|Completed||Phase 4|34|Actual|University Hospital of Liege||4|||f|||||f|f||||||||2017-10-10 20:49:57.318287|2017-10-10 20:49:57.318287
NCT03234855|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|LMD-1||Laparoscopic Measuring Device Study|Laparoscopic Measuring Device Usability Study|Not yet recruiting||N/A|50|Anticipated|Boehringer Labs LLC|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:49:57.411581|2017-10-10 20:49:57.411581
NCT03234842|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-10|||December 17, 2017|Anticipated|2017-12-17|August 2017|2017-08-01|December 17, 2022|Anticipated|2022-12-17|December 17, 2022|Anticipated|2022-12-17||Interventional|ES01||Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer|A Phase II Trial of Dose Escalated Proton Beam Therapy or Photon Therapy for Resectable and Unresectable Esophageal Cancer|Not yet recruiting||Phase 2|90|Anticipated|University of Florida||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:49:57.509342|2017-10-10 20:49:57.509342
NCT03234829|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-28|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Determination of Teeth Size in a Group of Egyptian Children. A Cross Sectional Study|Determination of The Combined Mesio-Distal Widths of The Permanent Mandibular Incisors and That of The Maxillary and Mandibular Canines and Premolars in a Group of Egyptian Children in Rural Areas of Sohag Governorate: A Cross Sectional Study|Enrolling by invitation||N/A|270|Anticipated|Cairo University|||1||f||||f|f|f||||||||2017-10-10 20:49:57.669455|2017-10-10 20:49:57.669455
NCT03234803|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-27|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Measuring Quality of Life of Poly-amide Complete Dentures|Metal-reinforced Flexible Poly-amide Complete Denture Versus Heat-cured Poly-methyl Methacrylate in Terms of Oral Health Related Quality of Life; Randomized Clinical Trial|Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:49:57.894109|2017-10-10 20:49:57.894109
NCT03234790|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-27|||September 27, 2017|Actual|2017-09-27|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|DICE||Human Study to Develop a Signature of Occupational Diesel Exhaust Exposure|A Controlled Dose-Response Human Study to Develop a Signature of Occupational Diesel Exhaust Exposure|Recruiting||N/A|20|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 20:49:57.998412|2017-10-10 20:49:57.998412
NCT03234777|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-19|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|April 30, 2018|Anticipated|2018-04-30||Interventional|||Evaluating a Knowledge Translation Tool for Parents|Evaluating a Knowledge Translation Tool for Parents: A Pilot Randomized Trial|Not yet recruiting||N/A|200|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 20:49:58.137917|2017-10-10 20:49:58.137917
NCT03234764|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|February 26, 2026|Anticipated|2026-02-26|February 26, 2026|Anticipated|2026-02-26||Observational|||Longitudinal Follow-up Study for Food Allergies|Longitudinal Follow-up Study for Food Allergies|Enrolling by invitation||N/A|1200|Anticipated|Stanford University|||1||f||||f||||||Samples With DNA|"     Blood Sputum Buccal swab Saliva Urine Stool   "|||2017-10-10 20:49:58.284157|2017-10-10 20:49:58.284157
NCT03234751|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-19|||July 13, 2017|Actual|2017-07-13|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|March 2018|Anticipated|2018-03-01||Interventional|BNP3||Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects|Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects|Recruiting||Phase 1|8|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida||2|||f||||t|t|f|||f|||||2017-10-10 20:49:58.375096|2017-10-10 20:49:58.375096
NCT03234738|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-06|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||A Phase 1 Safety and PK Study of IV TP-271|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous TP-271 in Healthy Adult Subjects|Recruiting||Phase 1|40|Anticipated|Tetraphase Pharmaceuticals, Inc.||5|||f||||t|t|f||||||||2017-10-10 20:49:58.529265|2017-10-10 20:49:58.529265
NCT03234725|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-08-03|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|ELUFIBLI||Analysis of New Endoscopic Features and Variable Stiffness in Colonoscopy: Prospective Randomised Trial|Prospective Randomised Trial to Analyse the Advantages of the New Virtual Chromoendoscopy Features and the Variable Stiffness in Connection With Our Colonoscopic Examinations|Recruiting||N/A|1000|Anticipated|Bács-Kiskun County Teaching Hospital|||2||f||||t|f|f||||||||2017-10-10 20:49:58.677813|2017-10-10 20:49:58.677813
NCT03234712|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-31|||September 23, 2017|Anticipated|2017-09-23|July 2017|2017-07-01|May 3, 2019|Anticipated|2019-05-03|March 1, 2019|Anticipated|2019-03-01||Interventional|||A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR) or Its Ligands|A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR) or Its Ligands|Not yet recruiting||Phase 1|80|Anticipated|AbbVie||1|||f||||f|t|f|||t|||||2017-10-10 20:49:58.817449|2017-10-10 20:49:58.817449
NCT03234699|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-07|||February 22, 2017|Actual|2017-02-22|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 3, 2017|Actual|2017-07-03||Interventional|||Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs as a Means of Predicting Drug-drug Interactions|The Effect of Multiple Doses of Cenobamate (YKP3089) on the Single Dose Pharmacokinetics of Cytochrome P450 Substrates (Midazolam, Warfarin, Omeprazole and Bupropion) Administered Orally in an Open-label, One-sequence Study in Healthy Subjects|Completed||Phase 1|24|Actual|SK Life Science||1|||f||||f|t|f||||||||2017-10-10 20:49:58.91909|2017-10-10 20:49:58.91909
NCT03234686|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-09-10|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|||Deferiprone to Delay Dementia (The 3D Study)|Deferiprone to Delay Dementia (The 3D Study): a Clinical Proof of Concept Study|Not yet recruiting||Phase 2|171|Anticipated|Neuroscience Trials Australia||2|||f|||||f|f||||||||2017-10-10 20:49:59.02413|2017-10-10 20:49:59.02413
NCT03234673|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-27|2017-07-30|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo|The Effect of Preceding Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or With NB-UVB in the Treatment of Stable Generalized Vitiligo|Not yet recruiting||Phase 1|30|Anticipated|Assiut University||3|||f||||f|f|f||||||||2017-10-10 20:49:59.108|2017-10-10 20:49:59.108
NCT03234660|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-07|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|October 10, 2018|Anticipated|2018-10-10|August 5, 2018|Anticipated|2018-08-05||Interventional|||Dexmedetomidine and Neuroprotection in Children Undergoing General Anesthesia|The Effects of Dexmedetomidine on the Neurotoxicity From General Anesthesia Assessed by Plasma Glial Fibrillary Acidic Protein|Not yet recruiting||N/A|60|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 20:49:59.182568|2017-10-10 20:49:59.182568
NCT03234647|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-26|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||First In Human Study of the Doraya Catheter for the Treatment of AHF Patients|First In Human Study of the Doraya Catheter for the Treatment of AHF Patients|Not yet recruiting||N/A|15|Anticipated|Revamp Medical Ltd.||1|||f|||||f|f||||||||2017-10-10 20:49:59.246158|2017-10-10 20:49:59.246158
NCT03234634|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-17|||July 30, 2017|Actual|2017-07-30|July 2017|2017-07-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||Collateral-based reSetting of Endovascular Treatment Time Window for Stroke (CoSETS)|Collateral-based reSetting of Endovascular Treatment Time Window for Stroke (CoSETS)|Recruiting||N/A|309|Anticipated|Yonsei University||3|||f||||f|f|f||||||||2017-10-10 20:49:59.308366|2017-10-10 20:49:59.308366
NCT03234608|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-10-02|||August 24, 2017|Actual|2017-08-24|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Health System Integration of Tools to Improve Primary Care for Autistic Adults|Health System Integration of Tools to Improve Primary Care for Autistic Adults|Recruiting||N/A|250|Anticipated|Portland State University||2|||f||||f|f|f||||||||2017-10-10 20:49:59.483001|2017-10-10 20:49:59.483001
NCT03234595|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-20|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma|Everfront Biotech Co., Ltd.|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|Everfront Biotech Co., Ltd.||1|||f||||t|t|f||||||||2017-10-10 20:49:59.590557|2017-10-10 20:49:59.590557
NCT03234582|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-26|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|August 1, 2018|Anticipated|2018-08-01||Observational|||Comparison of RVOT Gradient Under Anaesthesia With Post-operative Gradient in Patients Undergoing TOF Repair|Comparison of Right Ventricular Outflow Tract Gradient Under Anaesthesia With Post-operative Gradient in Patients Undergoing Tetralogy of Fallot Repair|Enrolling by invitation||N/A|20|Anticipated|Postgraduate Institute of Medical Education and Research|||1||f||||f|f|f||||||||2017-10-10 20:49:59.664881|2017-10-10 20:49:59.664881
NCT03234556|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-10-02|||September 25, 2017|Actual|2017-09-25|October 2017|2017-10-01|September 25, 2021|Anticipated|2021-09-25|September 25, 2020|Anticipated|2020-09-25||Interventional|||Systematic Random Biopsy or MRI-US Fusion Biopsy in Diagnosing Prostate Cancer in Patients With PSA Progression|Diagnosing Clinically Significant Prostate Cancer in African American and White Men Phase II, Randomized Clinical Trial, Multi-center, MR-Guided vs. 12-core Systematic Random Biopsy, Localized Prostate Cancer|Recruiting||N/A|400|Anticipated|University of Southern California||2|||f||||t|f|t|f||t|||||2017-10-10 20:49:59.976445|2017-10-10 20:49:59.976445
NCT03234543|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-10-03|||October 8, 2017|Anticipated|2017-10-08|September 2017|2017-09-01|June 15, 2020|Anticipated|2020-06-15|June 15, 2019|Anticipated|2019-06-15||Interventional|||Remote Ischemic Conditioning in Abdominal Surgery|Remote Ischemic Conditioning (RIC) to Decrease Post-Operative Complications After Major Abdominal Surgery - A Phase IIa Trial|Not yet recruiting||N/A|100|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||||2017-10-10 20:50:00.208316|2017-10-10 20:50:00.208316
NCT03234517|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-29|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis|Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis Continuous Versus Interrupted Use. a Randomized Controlled Study|Recruiting||Phase 2|200|Anticipated|Zagazig University||2|||f|||||f|f|||f|||||2017-10-10 20:50:00.488227|2017-10-10 20:50:00.488227
NCT03234504|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|October 24, 2017|Anticipated|2017-10-24|October 24, 2017|Anticipated|2017-10-24||Observational|||Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display|Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display|Recruiting||N/A|30|Anticipated|Yonsei University|||1||f||||f|f|f||||||||2017-10-10 20:50:00.591928|2017-10-10 20:50:00.591928
NCT03234478|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-28|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2020|Anticipated|2020-06-30||Observational|||Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers|Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers|Recruiting||N/A|262|Anticipated|Rush University Medical Center|||4||f||||f|f|f||||Samples With DNA|"     blood will be retained for analysis of GBA metabolites.   "|||2017-10-10 20:50:00.80513|2017-10-10 20:50:00.80513
NCT03234465|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-25|||July 18, 2017|Actual|2017-07-18|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Determination of Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day|A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Topically-applied AG013 for the Attenuation of Oral Mucositis in Subjects With Cancers of the Head and Neck Receiving Concomitant Chemoradiation Therapy|Recruiting||Phase 2|200|Anticipated|Oragenics, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:50:00.945281|2017-10-10 20:50:00.945281
NCT03234452|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||March 23, 2016|Actual|2016-03-23|July 2017|2017-07-01|April 18, 2017|Actual|2017-04-18|July 21, 2016|Actual|2016-07-21||Interventional|||Evaluation of the Beneficial Effects of a Probiotic Product in Healthy Adult Subjects.|Evaluation of the Beneficial Effects of a Probiotic Product (Lactoflorene Plus) in Healthy Adult Subjects in Particular Psychological Stress Conditions.|Completed||N/A|50|Actual|Montefarmaco OTC SpA||2|||f||||f|f|f||||||||2017-10-10 20:50:01.103731|2017-10-10 20:50:01.103731
NCT03234439|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-28|||September 5, 2017|Anticipated|2017-09-05|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||Digital Tools for Coping With Chronic Pain|Digital Tools for Coping With Chronic Pain|Not yet recruiting||N/A|200|Anticipated|MyStrength, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:50:01.20059|2017-10-10 20:50:01.20059
NCT03230877|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||September 2, 2017||2017-09-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:50:32.1133|2017-10-10 20:50:32.1133
NCT03234426|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-07-26|||January 2014||2014-01-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|perturbation||Effectiveness of Perturbations Exercises in Improving Balance, Function and Mobility in Stroke Patients|Effectiveness of Perturbations Exercises in Improving Balance, Function and Mobility in Stroke Patients.|Completed||N/A|30|Actual|Mahatma Gandhi Institute of Medical Sciences||2|||f||||t||||||||||2017-10-10 20:50:01.297478|2017-10-10 20:50:01.297478
NCT03234413|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-28|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Safety on Switching Between Different Botulinum Toxin-A|Switching Between Different Types of Botulinum Toxin-A in Children With Cerebral Palsy Treated for Spasticity: a Safety Retrospective Evaluation|Recruiting||N/A|130|Anticipated|Kocaeli University|||1||f||||f|t|f|||f|||||2017-10-10 20:50:01.406199|2017-10-10 20:50:01.406199
NCT03234400|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings|A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings|Not yet recruiting||Phase 1|48|Anticipated|International Partnership for Microbicides, Inc.||3|||||||f|t|t|t|f||||||2017-10-10 20:50:01.538596|2017-10-10 20:50:01.538596
NCT03234387|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|||A CFit Study - Baseline|A CFit Study: To What Extent Does Inflammation, Oxidative Stress, Nitric Oxide Bioavailability and Microvascular Endothelial Dysfunction Influence the Aerobic Exercise Function of Individuals With Cystic Fibrosis, With and Without Established Diabetes?|Not yet recruiting||N/A|45|Anticipated|University of Portsmouth|||3||f||||t|f|f||||Samples Without DNA|"     Acellular plasma will be stored at - 80 degrees   "|||2017-10-10 20:50:01.656528|2017-10-10 20:50:01.656528
NCT03234374|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-10-04|||June 2, 2017|Actual|2017-06-02|October 2017|2017-10-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty|A Randomized, Single Blind Study to Investigate the PK, Relative Bioavailability and Safety of INL-001 Bupivacaine HCl Collagen-Matrix Implant 300 mg Compared to Marcaine™ 0.25% (Bupivacaine HCl) 175 mg Infiltration After Open Hernioplasty|Completed||Phase 2|52|Actual|Innocoll||2||||||||t|f||||||||2017-10-10 20:50:01.846668|2017-10-10 20:50:01.846668
NCT03234361|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Preventing Hypertension and Sympathetic Overactivation by Targeting Phosphate|Preventing Hypertension and Sympathetic Overactivation by Targeting Phosphate|Not yet recruiting||N/A|114|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:50:02.015204|2017-10-10 20:50:02.015204
NCT03234348|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-26|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|MAGSTEMI||MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction|MAGnesium-based Bioresorbable Scaffold and Vasomotor Function in Patients With Acute ST Segment Elevation Myocardial Infarction|Recruiting||Phase 2/Phase 3|148|Anticipated|Hospital Clinic of Barcelona||2|||f||||t|f|f||||||||2017-10-10 20:50:02.160127|2017-10-10 20:50:02.160127
NCT03234335|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-01|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2019|Anticipated|2019-09-01|2 Years|Observational [Patient Registry]|IRMYG||High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment|A Prospective, Non-interventional, Multinational Study Evaluating the Efficacy and the Safety of High Dose Therapy Followed by Autologous Hematopoietic Stem Cell Transplantation as a Frontline Therapy for Myeloma Patients With Severe Renal Impairment (IRMYG Study)|Not yet recruiting||N/A|150|Anticipated|Institut de Cancérologie de la Loire|||1||f||||f|f|f||||||||2017-10-10 20:50:02.301146|2017-10-10 20:50:02.301146
NCT03234322|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-14|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||The Impact of a Diabetes Risk Prediction Model in Primary Care.|A Cluster Randomized Trial to Investigate the Impact of a Type 2 Diabetes Risk Prediction Model on Change in Physical Activity Within Routine Health Checks in Primary Care.|Enrolling by invitation||N/A|300|Anticipated|German Diabetes Center||2|||f||||f|f|f||||||||2017-10-10 20:50:02.494841|2017-10-10 20:50:02.494841
NCT03234309|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 14, 2022|Anticipated|2022-04-14|April 14, 2021|Anticipated|2021-04-14||Interventional|||Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors|High Resolution Steady State Blood Volume Maps in Pediatric Brain Tumors Using MRI|Not yet recruiting||Phase 2|100|Anticipated|OHSU Knight Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 20:50:02.594585|2017-10-10 20:50:02.594585
NCT03234296|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-09|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|August 30, 2028|Anticipated|2028-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|APPACIII||Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis|Antibiotic Therapy vs. Placebo in the Treatment of Acute Uncomplicated Appendicitis: a Randomized Double-blinded Placebo-controlled Trial - APPAC III Study|Enrolling by invitation||N/A|147|Anticipated|Turku University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:50:02.708923|2017-10-10 20:50:02.708923
NCT03234283|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-28|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|IRRIS||"Visualization of the Intubation Pathway With the IRRIS-Device"|"Video-laryngoscopic Visualization of the Intubation Pathway With the IRRIS-Device. A Clinical Safety and Proof of Concept Study"|Recruiting||N/A|40|Anticipated|University of Zurich||1|||f||||f|f|f||||||||2017-10-10 20:50:02.805036|2017-10-10 20:50:02.805036
NCT03234270|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Changes in Aviators' Body Core Temperature Measurements at F-35|Changes in Aviators' Body Core Temperature Measurements at F-35|Not yet recruiting||N/A|10|Anticipated|Israeli Air Force Aeromedical Center||2|||f||||t|f|f||||||||2017-10-10 20:50:02.895383|2017-10-10 20:50:02.895383
NCT03234257|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|UF-Plaques||Evaluation of the Carotid Plaque Stability by Ultrafast-ultrasound Imaging (UF)|Evaluation of the Carotid Plaque Stability by Ultrafast-ultrasound Imaging (UF)|Not yet recruiting||N/A|55|Anticipated|French Cardiology Society||1|||f||||f|f|f||||||||2017-10-10 20:50:02.960899|2017-10-10 20:50:02.960899
NCT03234244|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||HDDO-1614 Intervention Trial|A Randomized, Open-label, Single-dose Study to Evaluate the Safety and the Pharmacokinetics After Oral Concurrent Administration of HDDO-16141 and HDDO-16142 in Healthy Adult Subjects|Active, not recruiting||Phase 1|37|Actual|Hyundai Pharmaceutical Co., LTD.||3|||f||||f|f|f||||||||2017-10-10 20:50:03.045659|2017-10-10 20:50:03.045659
NCT03234231|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-28|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Supervised Brushing Programme for Intellectual Disabled Students|Supervised Toothbrushing Programme and Oral Health Education for Intellectual Disabled Students: A Cluster Randomised Controlled Trial|Not yet recruiting||N/A|602|Anticipated|MD Equation||2|||f|||||f|f||||||||2017-10-10 20:50:03.156444|2017-10-10 20:50:03.156444
NCT03234218|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-28|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Observational|D-LIVER-X||Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study|Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study|Recruiting||N/A|60|Anticipated|The Mediterranean Institute for Transplantation and Advanced Specialized Therapies|||1||f||||t|f|f||||||||2017-10-10 20:50:03.244881|2017-10-10 20:50:03.244881
NCT03234205|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-02|||August 31, 2011|Actual|2011-08-31|July 2017|2017-07-01|December 19, 2012|Actual|2012-12-19|December 19, 2012|Actual|2012-12-19||Interventional|ARTEMIS||Measurements of Myocardial Relaxation Time by MRI During Respiration|Measurements of Myocardial Relaxation Time by MRI During Respiration|Completed||N/A|9|Actual|Central Hospital, Nancy, France||1|||f||||f|f|f||||||||2017-10-10 20:50:03.322808|2017-10-10 20:50:03.322808
NCT03234192|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-09-08|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of the Astym Technique, the Graston Technique, and Therapeutic Ultrasound in the Treatment of Lateral Epicondylosis.|A Randomized Clinical Controlled Study Comparing the Effectiveness of the Astym Technique, the Graston Technique, and Therapeutic Ultrasound in the Treatment of Lateral Epicondylosis.|Not yet recruiting||N/A|36|Anticipated|New York University School of Medicine||3|||f||||f|f|f||||||||2017-10-10 20:50:03.3811|2017-10-10 20:50:03.3811
NCT03234179|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-30|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2037|Anticipated|2037-08-01|August 1, 2020|Anticipated|2020-08-01||Observational|||A Prognosis and Predicting Genetic Study of Lung Cancer|A Prognosis and Predicting Genetic Study of Lung Cancer|Not yet recruiting||N/A|500|Anticipated|National Taiwan University Hospital|||1||f||||t|f|f||||Samples With DNA|"     The samples are stored at the lab of NTUH hospital with protected of security. The     information of the study subjects will be reached only by investigator of this study.   "|||2017-10-10 20:50:03.474512|2017-10-10 20:50:03.474512
NCT03234166|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|PANIC||Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis|Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis: Can we Predict Primary Drainage Failure?|Not yet recruiting||N/A|130|Anticipated|Nantes University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:50:03.531191|2017-10-10 20:50:03.531191
NCT03234153|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-14|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|March 2027|Anticipated|2027-03-01|December 2026|Anticipated|2026-12-01||Interventional|NITIMIB||Neoadjuvant Immunotherapy With Durvalumab and Tremelimumab for Bladder Cancer Patients Ineligible for Cisplatin|Neoadjuvant Immunotherapy With Durvalumab in Combination With Tremelimumab in Patients With Muscle-invasive Bladder Cancer Ineligible for Cisplatin-based Chemotherapy.|Not yet recruiting||Phase 2|68|Anticipated|University Hospital Inselspital, Berne||1|||f||||f|f|f||||||||2017-10-10 20:50:03.621737|2017-10-10 20:50:03.621737
NCT03234140|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|July 2019|Anticipated|2019-07-01||Observational|CONPIL||Constitutional Genetics in Follicular Lymphoma|Constitutional Genetics to Predict Prognostic and Somatic Alterations in Follicular Lymphoma|Not yet recruiting||N/A|1883|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||Samples With DNA|"     Peripheral blood   "|||2017-10-10 20:50:03.699739|2017-10-10 20:50:03.699739
NCT03234127|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-10-04|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|April 30, 2019|Anticipated|2019-04-30||Interventional|SAFIR||Study of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemia|Study of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemia|Not yet recruiting||N/A|800|Anticipated|Nantes University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:50:03.773316|2017-10-10 20:50:03.773316
NCT03234114|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|June 30, 2020|Anticipated|2020-06-30||Interventional|||Optimal Antithrombotic Therapy for Acute Coronary Syndrome Patients Concomitant Atrial Fibrillation Undergoing Polymer-free Drug Eluting Stent Implantation|Optimal Antithrombotic Therapy for ACS Patients Concomitant AF Undergoing Polymer-free DES Implantation|Not yet recruiting||Phase 4|930|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||f|f|f||||||||2017-10-10 20:50:03.904515|2017-10-10 20:50:03.904515
NCT03234101|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-01|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Meta-Analyses of Low-risk Lifestyle Behaviours and Patient Important Outcomes|Relation of Low-risk Lifestyle Behaviours With Cardiovascular Disease, Diabetes, Cancer and All-Cause Mortality: A Series of Systematic Reviews and Meta-analyses of Prospective Cohort Studies|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f|f|f||||||||2017-10-10 20:50:05.577891|2017-10-10 20:50:05.577891
NCT03234088|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-21|2017-07-27|||April 2011||2011-04-01|July 2017|2017-07-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|CHF||Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring|Home Based Health Monitoring for Congestive Heart Failure Pilot|Completed||N/A|13|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 20:50:05.666751|2017-10-10 20:50:05.666751
NCT03234075|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|November 2021|Anticipated|2021-11-01||Observational|TRACE||Evaluation of a New Regional Organization to Promote Access to Renal Transplantation|Promoting Access to Renal Transplantation: Impact of a Patient-centered Regional Organization|Not yet recruiting||N/A|4000|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 20:50:05.749125|2017-10-10 20:50:05.749125
NCT03234062|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Developing a Biomarker Panel to Assess Choline Nutritional Status|Developing a Biomarker Panel to Assess Choline Nutritional Status|Not yet recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f|f|f||||||||2017-10-10 20:50:05.830931|2017-10-10 20:50:05.830931
NCT03234049|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-07-28|||November 2016||2016-11-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The Use of a Pediatric Trauma Checklist to Improve Clinical Performance in a Simulated Trauma Resuscitation|The Use of a Pediatric Trauma Checklist to Improve Clinical Performance in a Simulated Trauma Resuscitation: a Randomized Trial|Completed||N/A|56|Actual|Express Collaborative||2|||f||||f||||||||||2017-10-10 20:50:05.915486|2017-10-10 20:50:05.915486
NCT03234036|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-17|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|November 17, 2017|Anticipated|2017-11-17|November 17, 2017|Anticipated|2017-11-17||Interventional|||A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir|A Two Part Study to Assess i) the Relative Bioavailability and Food Effect of a Novel Tablet Formulation of Boosted-GSK2838232 Compared to Capsule and ii) the Safety and Pharmacokinetics of Repeated Once-Daily Doses of Non-boosted GSK2838232|Recruiting||Phase 1|20|Anticipated|GlaxoSmithKline||4|||f||||f|t|f||||||||2017-10-10 20:50:06.009444|2017-10-10 20:50:06.009444
NCT03234023|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-21|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|SPRING||Secondary PRevention Intervention by a Nursing Guide Program (SPRING)|Secondary PRevention Intervention by a Nursing Guide Program|Active, not recruiting||N/A|484|Actual|University Hospital A Coruña||2|||f||||t|f|f||||||||2017-10-10 20:50:06.1884|2017-10-10 20:50:06.1884
NCT03234010|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||CSD170303: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes|CSD170303: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes|Recruiting||N/A|140|Anticipated|RAI Services Company||4|||f||||f|f|f||||||||2017-10-10 20:50:06.256131|2017-10-10 20:50:06.256131
NCT03233997|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|August 18, 2017|Anticipated|2017-08-18|August 18, 2017|Anticipated|2017-08-18||Interventional|||CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes|CSD170302: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes|Recruiting||N/A|140|Anticipated|RAI Services Company||4|||f||||f|f|f||||||||2017-10-10 20:50:06.440465|2017-10-10 20:50:06.440465
NCT03233984|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-27|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|April 18, 2018|Anticipated|2018-04-18|April 18, 2018|Anticipated|2018-04-18||Interventional|||Effect of an Environmental Health Education Program on Pregnant Women in Order to Reduce Endocrine Disruptor Exposition|Effect of an Environmental Health Education Program on Pregnant Women in Order to Reduce Endocrine Disruptor Exposition : Controled Randomized Trial on Primary Prevention|Recruiting||N/A|210|Anticipated|Poitiers University Hospital||3|||f|||||f|f||||||||2017-10-10 20:50:06.542312|2017-10-10 20:50:06.542312
NCT03233971|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-27|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|December 30, 2017|Anticipated|2017-12-30||Observational|||How do Older Adults and Caregivers Feel About Their Medications?|Patients' and Caregivers' Attitudes Towards Deprescribing in the Asian Community Setting|Recruiting||N/A|1000|Anticipated|Monash University|||2||f|||||f|f||||||||2017-10-10 20:50:06.629461|2017-10-10 20:50:06.629461
NCT03233958|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Observational|||The Psychosocial Effects of Systemic / Family Constellation|The Psychosocial Effects of Systemic / Family Constellation: An Observational Follow-up Study|Recruiting||N/A|200|Anticipated|Károli Gáspár University of the Reformed Church in Hungary|||1||f||||f|f|f||||||||2017-10-10 20:50:06.70929|2017-10-10 20:50:06.70929
NCT03232801|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-25|||September 2018|Anticipated|2018-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Mindfulness-based Intervention for Older Women With Low Sexual Desire|A Mindfulness-based Intervention for Older Women With Low Sexual Desire|Not yet recruiting||N/A|50|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||||2017-10-10 20:50:06.910365|2017-10-10 20:50:06.910365
NCT03232788|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-25|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Use of Scaffolds for Treatment of Gingival Recession Associated With Interproximal Tissue Deficiency|Use of Computer Aided Design-Computer Aided Manufacturing and Additively Manufactured Scaffolds for Treatment of Gingival Recession Associated With Interproximal Tissue Deficiency|Recruiting||N/A|20|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:50:06.993055|2017-10-10 20:50:06.993055
NCT03232775|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-25|||September 2007|Actual|2007-09-01|July 2017|2017-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Use of a Visual Pedagogy and Structure With Children With Autism for Routine Physical Exams|Evaluating the Effects of a Visual Pedagogy and Structure on the Successful Completion of the Medical Office Visit and Physical Examination With Pre-pubescent Children With Autism|Completed||N/A|18|Actual|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:50:07.105482|2017-10-10 20:50:07.105482
NCT03232762|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Diet on Pregnancy Outcome and Child Obesity|Effects of Diet on Pregnancy Outcome and Child Obesity|Not yet recruiting||N/A|300|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:50:07.191566|2017-10-10 20:50:07.191566
NCT03230136|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|ProCCard||Protection During Cardiac Surgery.|Protection During Cardiac Surgery.|Not yet recruiting||Phase 2|210|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 20:50:37.345202|2017-10-10 20:50:37.345202
NCT03232749|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-18|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|July 15, 2022|Anticipated|2022-07-15|July 15, 2022|Anticipated|2022-07-15||Interventional|||Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint|Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint|Not yet recruiting||N/A|500|Anticipated|University of Florida||1|||f||||f|f|f|||t|||||2017-10-10 20:50:07.291341|2017-10-10 20:50:07.291341
NCT03232736|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-22|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|ROBIN||InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's|Randomized interventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With mechaNical Circulatory Support Devices|Not yet recruiting||N/A|25|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||||2017-10-10 20:50:07.381764|2017-10-10 20:50:07.381764
NCT03232723|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-07|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|September 7, 2017|Actual|2017-09-07|September 7, 2017|Actual|2017-09-07||Interventional|BODMEG||Imaging Non-brain Electromagnetic Activity in Healthy Adults Using MEG|Imaging Non-brain Electromagnetic Activity in Healthy Adults Using MEG|Completed||N/A|10|Actual|New York University School of Medicine||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:50:07.458885|2017-10-10 20:50:07.458885
NCT03232710|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-27|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition|A Single-dose, Two-treatment, Two-sequence, Two-period, Two Way Crossover Bioequivalence Study of Bosiqing Aripiprazole Orally Disintegrating Tablets and ABILIFY Under Fasting/Fed Condition|Recruiting||N/A|66|Anticipated|Chengdu Kanghong Pharmaceutical Group Co., Ltd.||5|||f|||||f|f||||||||2017-10-10 20:50:07.534086|2017-10-10 20:50:07.534086
NCT03232697|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-25|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|MoCATEL||French Language Validation of the 5-minutes Montreal Cognitive Assessment (MoCA)|French Language Validation of the Phone Version of the Montreal Cognitive Assessment (MoCA)|Recruiting||N/A|240|Anticipated|University Hospital, Lille||4|||f||||f|f|f||||||||2017-10-10 20:50:07.613065|2017-10-10 20:50:07.613065
NCT03232684|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-27|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|January 30, 2019|Anticipated|2019-01-30|December 31, 2018|Anticipated|2018-12-31||Observational|||Rapid On-site Evaluation of Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Samples by Pulmonologists|Rapid On-site Evaluation of EBUS-TBNA Samples From Intrathoracic Lymphadenopathy; Can it be Reliably Performed by a Pulmonologist?|Recruiting||N/A|200|Anticipated|Maggiore Bellaria Hospital, Bologna|||1||f||||f|f|f||||||||2017-10-10 20:50:07.698787|2017-10-10 20:50:07.698787
NCT03233932|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-07-26|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||CKD-841 Pharmacokinetic/Pharmacodynamic Study|Clinical Trial to Investigate the Safety and Pharmacokinetics/Pharmacodynamics of CKD-841 After Subcutaneous Injection in Postmenopausal Female|Completed||Phase 1|13|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 20:50:07.811861|2017-10-10 20:50:07.811861
NCT03233919|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-04|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|January 30, 2020|Anticipated|2020-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|CORIC-MI||COmprehensive Remote Ischemic Conditioning in Myocardial Infarction|Evaluation of Comprehensive Remote Ischemic Conditioning in ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Recruiting||N/A|200|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t|f|f||||||||2017-10-10 20:50:07.899779|2017-10-10 20:50:07.899779
NCT03233906|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-27|||May 20, 2017|Actual|2017-05-20|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effects of Chia on Overweight/Obese Women|Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females|Recruiting||N/A|60|Anticipated|California State Polytechnic University, Pomona||2|||f||||f|f|f||||||||2017-10-10 20:50:07.996052|2017-10-10 20:50:07.996052
NCT03233893|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-29|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Radiographic Assessment of Calcific Bridge Formation by Light Activated Calcium Silicate Versus Calcium Hydroxide for Deep Caries|Radiographic Assessment of Calcific Bridge Formation by Light Activated Calcium Silicate Versus Light Activated Calcium Hydroxide in Management of Simple Deeply Seated Carious Lesions With Partial Caries Removal|Not yet recruiting||N/A|60|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:50:08.300338|2017-10-10 20:50:08.300338
NCT03233880|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-27|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Impact of Antichlamydial Treatment on the Rate of Preeclampsia|Impact of Antichlamydial Treatment on the Rate of Preeclampsia Among Egyptian Primigravidae: a Randomized Controlled Trial|Recruiting||Phase 4|1200|Anticipated|Ain Shams Maternity Hospital||2|||f||||t|f|f||||||||2017-10-10 20:50:08.381549|2017-10-10 20:50:08.381549
NCT03233867|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-14|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations|A Non-interventional Study to Identify Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Involved in Glutamatergic Signaling and Neuronal Connectivity|Recruiting||N/A|5000|Anticipated|Aevi Genomic Medicine|||1||f||||f|f|f||||Samples With DNA|"     Saliva   "|||2017-10-10 20:50:08.467259|2017-10-10 20:50:08.467259
NCT03233854|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2035|Anticipated|2035-08-01|August 1, 2025|Anticipated|2025-08-01||Interventional|||CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Patients With Recurrent or Refractory CD19 Positive Diffuse Large B-Cell Lymphoma or B Acute Lymphoblastic Leukemia|Phase I Dose Escalation Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Adults With Recurrent or Refractory B Cell Malignancies|Not yet recruiting||Phase 1|57|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 20:50:08.528627|2017-10-10 20:50:08.528627
NCT03233828|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-27|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|IL-2||Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2|Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2|Not yet recruiting||Phase 2|60|Anticipated|Nova Scotia Health Authority||2|||f||||f|t|f|||t|||||2017-10-10 20:50:08.749183|2017-10-10 20:50:08.749183
NCT03233815|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Benefits of Total Intravenous Anesthesia Compared With Inhaled Anesthesia in Cardiovascular Surgery|Benefits of Total Intravenous Anesthesia Compared With Inhaled Anesthesia in Cardiovascular Surgery|Not yet recruiting||N/A|40|Anticipated|Coordinación de Investigación en Salud, Mexico|||2||f||||f|f|f||||||||2017-10-10 20:50:08.853433|2017-10-10 20:50:08.853433
NCT03233802|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-31|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|IATP2||Individualized Assessment and Treatment for Alcoholism II|Individualized Assessment and Treatment for Alcoholism: Treatment and Mechanisms|Recruiting||N/A|207|Anticipated|UConn Health||3|||f||||f|f|f||||||||2017-10-10 20:50:08.937996|2017-10-10 20:50:08.937996
NCT03233789|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-26|||November 1, 2015|Actual|2015-11-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|February 24, 2017|Actual|2017-02-24||Observational|EVA||Development and Validation of an ADL-score Based on FIM and EBI|Entwicklung Und Validierung Eines ADL-Scores (Activities of Daily Life) Auf Basis Von FIM (Functional Independence Measure) Und EBI (Erweiterter Barthel-Index)|Active, not recruiting||N/A|265|Actual|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:50:09.027506|2017-10-10 20:50:09.027506
NCT03233776|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-26|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|AFFECT-1||Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT|Safety and Efficacy of Interleukin-1 Inhibitor Anakinra for the Amelioration of Fever During Neutropenia and Mucositis in Patients With Multiple Myeloma Receiving an Autologous Stem Cell Transplantation After High-dose Melphalan|Not yet recruiting||Phase 2|18|Anticipated|Radboud University||1|||f||||t|f|f|||f|||||2017-10-10 20:50:09.101472|2017-10-10 20:50:09.101472
NCT03233763|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-26|||April 24, 2017|Actual|2017-04-24|July 2017|2017-07-01|February 1, 2021|Anticipated|2021-02-01|February 1, 2021|Anticipated|2021-02-01||Observational|||Laboratory Studies Into the Pathology of Leukaemia|Laboratory Studies Into the Pathology of Leukaemia|Recruiting||N/A|500|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f|f|f||||Samples Without DNA|"     Bone Marrow and blood   "|||2017-10-10 20:50:09.209448|2017-10-10 20:50:09.209448
NCT03233750|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-20|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Simulation-Based Stress Inoculation Training|Preparing for High Acuity Events: Simulation-Based Stress Inoculation Training|Recruiting||N/A|40|Anticipated|Ottawa Hospital Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:50:09.307085|2017-10-10 20:50:09.307085
NCT03233737|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Experimental Pain Study to Assess Local Anesthetic Efficacy and Safety of CTY-5339 on Gingival Mucosal Tissue in Normal Volunteers|A Double-blind, Cross-over, Incomplete Factorial Study to Assess the Local Anesthetic Efficacy and Safety of CTY-5339 Anesthetic Spray (CTY-5339A) When Applied to the Gingival Mucosal Tissue in Normal Volunteers|Recruiting||Phase 2|50|Anticipated|Cetylite Industries||2|||f||||f|t|f||||||||2017-10-10 20:50:09.40084|2017-10-10 20:50:09.40084
NCT03233711|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-28|2017-09-04|||April 18, 2018|Anticipated|2018-04-18|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer|A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer|Not yet recruiting||Phase 2|200|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 20:50:09.611475|2017-10-10 20:50:09.611475
NCT03233685|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-10-03|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|January 31, 2018|Anticipated|2018-01-31|October 2, 2017|Actual|2017-10-02||Interventional|||Visual Training and and Reaction Time in Tennis|Effect of Visual Training on Reaction Time and Timing in Tennis Players|Active, not recruiting||N/A|30|Actual|University of Milan||2|||f||||t|f|f||||||||2017-10-10 20:50:09.709391|2017-10-10 20:50:09.709391
NCT03233672|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||September 18, 2007|Actual|2007-09-18|July 2017|2017-07-01|September 18, 2014|Actual|2014-09-18|September 18, 2010|Actual|2010-09-18||Interventional|||Hypo-fractionated Postoperative IMRT in Prostate Cancer|HYPOFRACTIONATED POST-OPERATIVE IMRT IN PROSTATE CARCINOMA: A PHASE I/II STUDY|Completed||N/A|124|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||t||||||||||2017-10-10 20:50:09.774705|2017-10-10 20:50:09.774705
NCT03233659|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||August 12, 2014|Actual|2014-08-12|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation|Study of the Function of Immune System in Patients Undergoing Allogeneic Stem Cell Transplantation|Recruiting||N/A|300|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||t|f|f||||Samples With DNA|"     Samples of serum and PBMC   "|||2017-10-10 20:50:09.843301|2017-10-10 20:50:09.843301
NCT03233646|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||OCTA in Mild Cognitive Impairment and Alzheimer's Disease|Evaluating the Retinal Microvasculature in Mild Cognitive Impairment and Alzheimer's Disease Using Optical Coherence Tomography Angiography|Recruiting||N/A|200|Anticipated|Duke University||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:50:09.907339|2017-10-10 20:50:09.907339
NCT03233633|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-29|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Marijuana in Combination With Opioids in Palliative and Hospice Patients|Marijuana in Combination With Opioids for Pain and Symptom Control in Hospice Patients|Enrolling by invitation||Phase 1|66|Anticipated|The Connecticut Hospice Inc.||1|||f||||f|t|f||||||||2017-10-10 20:50:09.98169|2017-10-10 20:50:09.98169
NCT03233620|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-27|||March 1, 2012|Actual|2012-03-01|July 2017|2017-07-01|November 1, 2016|Actual|2016-11-01|October 30, 2014|Actual|2014-10-30||Interventional|||Effectiveness of Contemporary Knee Arthroplasty in Working-age Patients|Effectiveness of Contemporary Knee Arthroplasty in Working-age Patients: a Prospective Study With 2-year Follow-up|Completed||N/A|250|Actual|Coxa, Hospital for Joint Replacement||1|||f|||||f|f||||||||2017-10-10 20:50:10.057253|2017-10-10 20:50:10.057253
NCT03233607|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|QUOTABL||Time of Postpartum Hemoglobin Assessment , Blood Loss and Noninvasive Hemoglobin Spot Check|Optimal Time for Postpartum Hemoglobin Assessment and Its Correlation With Estimated Blood Loss (EBL)/Quantitative Blood Loss (QBL) and Noninvasive Hemoglobin Spot Check|Not yet recruiting||N/A|50|Anticipated|Columbia University|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:50:10.112578|2017-10-10 20:50:10.112578
NCT03233594|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-25|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|June 6, 2020|Anticipated|2020-06-06|June 6, 2019|Anticipated|2019-06-06||Observational|||PET Imaging of Chronic Pain Syndromes|PET Imaging of Chronic Pain Syndromes|Recruiting||N/A|32|Anticipated|Thomas Jefferson University|||1||f||||f|f|f||||||||2017-10-10 20:50:10.187926|2017-10-10 20:50:10.187926
NCT03233581|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-14|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Improving Physical Activity in Young Adult Cancer Survivors|Improving Physical Activity in Young Adult Cancer Survivors|Enrolling by invitation||N/A|50|Anticipated|Seattle Children's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:50:10.27929|2017-10-10 20:50:10.27929
NCT03233568|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-27|||April 1, 2012|Actual|2012-04-01|July 2017|2017-07-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|||Use of Indirect Calorimetry in Obesity|Use of Indirect Calorimetry in Dietary Setting in Obese Subjects: Retrospective Observational Study|Completed||N/A|355|Actual|Ospedale San Donato|||2||f|||||f|f||||||||2017-10-10 20:50:10.343982|2017-10-10 20:50:10.343982
NCT03233555|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-01|||September 3, 2013|Actual|2013-09-03|August 2017|2017-08-01|July 31, 2022|Anticipated|2022-07-31|July 31, 2022|Anticipated|2022-07-31||Interventional|||Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer|Extended Cancer Education for Longer-Term Survivors (EXCELS) In Primary Care|Recruiting||N/A|535|Anticipated|Rutgers, The State University of New Jersey||4|||f||||t||||||||||2017-10-10 20:50:10.420853|2017-10-10 20:50:10.420853
NCT03233542|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-09-26|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Association Between Physical Sensations and Thinking Styles|The Association Between Physical Sensations and Thinking Styles [Der Zusammenhang Zwischen körperlichem Empfinden Und Denkstilen]|Recruiting||N/A|114|Anticipated|Ruhr University of Bochum||3|||f||||f|f|f||||||||2017-10-10 20:50:10.523935|2017-10-10 20:50:10.523935
NCT03233516|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-03|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01|10 Years|Observational [Patient Registry]|TREND||Trial of Respiratory Infections in Children for Enhanced Diagnostics|Trial of Respiratory Infections in Children for Enhanced Diagnostics|Not yet recruiting||N/A|419|Anticipated|Karolinska Institutet|||2||f||||f|f|f||||Samples Without DNA|"     -  capillary lithium-heparin tube (will be separated into two aliquots and diluted in a          commercial buffer)        -  capillary point-of-care test CRP        -  nasopharyngeal swab for Mari-POC (diluted in 1.3ml MariPOC RTI buffer)        -  nasopharyngeal aspirate (diluted into 1.3ml saline) divided into three aliquots:             1. Real-time PCR-analysis of respiratory agents (400μl)             2. Frozen down at -80°C for study IV (400μl)             3. Available for routine microbiological testing as ordered by the attending               physician. If not used, frozen down at -80°C for potential reanalyses. (500μl)      All samples will be taken within 24h from arrival at the emergency unit and time for both     blood and nasopharynx samples will be registered. It will also be noted if antibiotics have     been given before samples taken.   "|||2017-10-10 20:50:10.830148|2017-10-10 20:50:10.830148
NCT03233503|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-28|||March 13, 2014|Actual|2014-03-13|July 2017|2017-07-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Observational|||Taste, Fat Sensation and Texture Study|Taste, Fat Sensation and Texture Study of Dutch and Malaysian Diets|Completed||N/A|35|Actual|Wageningen University|||2||f||||||||||||||2017-10-10 20:50:10.946219|2017-10-10 20:50:10.946219
NCT03233490|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-15|||December 16, 2013|Actual|2013-12-16|August 2017|2017-08-01|October 22, 2014|Actual|2014-10-22|October 22, 2014|Actual|2014-10-22||Interventional|||CPR Training in Students to Increase Bystander Intervention in Out-of-hospital Cardiac Arrest.|CPR Training in Students to Increase Bystander Intervention in Out-of-hospital Cardiac Arrest.|Completed||N/A|1547|Actual|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 20:50:11.021319|2017-10-10 20:50:11.021319
NCT03233477|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-07-27|||July 2014||2014-07-01|July 2017|2017-07-01|July 31, 2029|Anticipated|2029-07-31|July 31, 2019|Anticipated|2019-07-31|10 Years|Observational [Patient Registry]|||Patient Registry of Posner-Schlossman Syndrome|Patient Registry of Posner-Schlossman Syndrome|Recruiting||N/A|180|Anticipated|Peking University|||3||f|||||f|f||||Samples With DNA|"     serum, aqueous humor，iris，trabecular meshwork   "|||2017-10-10 20:50:11.107021|2017-10-10 20:50:11.107021
NCT03233464|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-26|||May 2018|Anticipated|2018-05-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01|1 Day|Observational [Patient Registry]|MIH||Prevalence of Molar Incisor Hypomineralization Among a Group of Egyptian Children in Giza Governorate|Prevalence of Molar Incisor Hypomineralization Among a Group of Egyptian Children in Giza Governorate: A Cross Sectional Study|Enrolling by invitation||N/A|374|Actual|Cairo University|||1||f||||||||||||||2017-10-10 20:50:11.189144|2017-10-10 20:50:11.189144
NCT03233451|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-15|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||Psycho-behavioral Intervention for Depression in Chronic Heart Failure|Effect of Psycho-behavioral Intervention on the Depression, Cardiac Function and Quality of Life in Older Adults With Chronic Heart Failure|Recruiting||N/A|236|Anticipated|Peking University||2|||f||||t|f|f||||||||2017-10-10 20:50:11.258832|2017-10-10 20:50:11.258832
NCT03233438|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-21|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)|Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections|Recruiting||Phase 4|86|Anticipated|Allergan||2|||f|||||t|f||||||||2017-10-10 20:50:11.407805|2017-10-10 20:50:11.407805
NCT03233425|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-25|||January 2009||2009-01-01|July 2017|2017-07-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|KIDSSTEP||Evaluation of Multiprofessional Group Programs for Paediatric Obesity Therapy|Evaluation of Therapy for Overweight Children and Adolescents in Switzerland: Therapy in Multiprofessional Group Programs - Part 2, Collection and Analysis of Data|Completed||N/A|1152|Actual|Ostschweizer Kinderspital|||1||f||||f||||||||||2017-10-10 20:50:11.522108|2017-10-10 20:50:11.522108
NCT03233412|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-26|||August 7, 2017|Anticipated|2017-08-07|June 2017|2017-06-01|August 7, 2019|Anticipated|2019-08-07|January 31, 2019|Anticipated|2019-01-31||Interventional|||Evaluating the Efficacy of Immunomodulatory Topical Treatment of Cervical High-grade Intraepithelial Lesions|Ensaio clínico Randomizado Avaliando a eficácia do Tratamento tópico Imunomodulador de lesões Intraepiteliais Cervicais de Alto Grau|Not yet recruiting||Phase 2|84|Anticipated|Barretos Cancer Hospital||2|||f||||t|f|f||||||||2017-10-10 20:50:11.60694|2017-10-10 20:50:11.60694
NCT03233399|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Modulating Movement Intention|Modulating Movement Intention Via Cortical Stimulation in Healthy Subjects and Patients With Psychogenic Movement Disorders and Non-epileptic Seizures|Recruiting||N/A|80|Anticipated|New York University School of Medicine||2|||f||||f|f|t|f|f||||||2017-10-10 20:50:11.713114|2017-10-10 20:50:11.713114
NCT03233386|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-26|||September 15, 2015|Actual|2015-09-15|July 2017|2017-07-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Observational|||'Keepin' It REAL in Mexico: An Adaptation and Multisite RCT Implementation of a Substance Abuse Prevention Curriculum for Adolescents in Three Mexico Cities.|'Keepin' It REAL in Mexico: An Adaptation and Multisite RCT|Recruiting||N/A|7768|Anticipated|Arizona State University|||3||f||||t|f|f||||||||2017-10-10 20:50:11.86141|2017-10-10 20:50:11.86141
NCT03233373|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-04|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Thermal Imaging as a Diagnostic Tool of Nasal Airflow|Thermal Imaging as a Diagnostic Tool of Nasal Airflow|Not yet recruiting||N/A|40|Anticipated|New York City Health and Hospitals Corporation|||1||f|||||f|f||||||||2017-10-10 20:50:11.959762|2017-10-10 20:50:11.959762
NCT03233360|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-25|||April 17, 2017|Actual|2017-04-17|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 2019|Anticipated|2019-12-01||Observational|||Hepatocellular Carcinoma Registry in Asia|Hepatocellular Carcinoma Registry in Asia|Recruiting||N/A|2500|Anticipated|National Cancer Centre, Singapore|||1||f||||f||||||||||2017-10-10 20:50:12.082767|2017-10-10 20:50:12.082767
NCT03233347|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||August 18, 2017|Anticipated|2017-08-18|July 2017|2017-07-01|August 1, 2025|Anticipated|2025-08-01|August 1, 2023|Anticipated|2023-08-01||Interventional|||Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma|A Phase II Trial of PET-Directed Therapy Using AVD (Doxorubicin, Vinblastine, and Dacarbazine) Plus Brentuximab Vedotin Induction Chemotherapy, With or Without Brentuximab Vedotin Plus Nivolumab, Followed by Nivolumab Consolidation for Patients With Previously Untreated Non-bulky Limited Stage Hodgkin Lymphoma|Not yet recruiting||Phase 2|85|Anticipated|Academic and Community Cancer Research United||1|||f||||t|t|f||||||||2017-10-10 20:50:12.302244|2017-10-10 20:50:12.302244
NCT03233334|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-08|||August 1, 2017|Actual|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study)|Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study)|Recruiting||N/A|15|Anticipated|Allina Health System||1|||f||||f|f|f||||||||2017-10-10 20:50:12.480854|2017-10-10 20:50:12.480854
NCT03233321|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-27|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||Effectiveness of Dry Cold Application on Pain and Bruise at the Subcutaneous Injection Site Among Patients Admitted in ICU|A Study to Assess the Effectiveness of Dry Cold Application on Pain Intensity and Bruise at the Subcutaneous Injection Site Among Patients Admitted in Selected Hospital|Completed||N/A|60|Actual|Maharishi Markendeswar University||2|||f||||t|f|f||||||||2017-10-10 20:50:12.565665|2017-10-10 20:50:12.565665
NCT03233308|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Double-Masked Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)|A Double-Masked, Randomized, Placebo-Controlled Study of Trabecular Outflow Facility Following Treatment With Netarsudil Ophthalmic Solution 0.02% (AR-13324) in Subjects With Elevated Intraocular Pressure|Not yet recruiting||Phase 2|20|Anticipated|Aerie Pharmaceuticals||2|||f|||||t|f||||||||2017-10-10 20:50:12.647665|2017-10-10 20:50:12.647665
NCT03233295|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||October 23, 2014|Actual|2014-10-23|July 2017|2017-07-01|August 27, 2016|Actual|2016-08-27|August 27, 2016|Actual|2016-08-27||Interventional|||A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency|A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency|Completed||Phase 4|108|Actual|Kwang Dong Pharmaceutical co., ltd.||1|||f||||f|f|f||||||||2017-10-10 20:50:12.72264|2017-10-10 20:50:12.72264
NCT03233282|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-25|||May 30, 2013|Actual|2013-05-30|July 2017|2017-07-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|MEEGAPERF||EEG Monitoring for PERFormance Anticipation|Electrophysiological and Bioenergetic Study of Variations in Cognitive and Physical Performance in Healthy Humans: EEG Monitoring for PERFormance Anticipation|Recruiting||N/A|250|Anticipated|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 20:50:12.790036|2017-10-10 20:50:12.790036
NCT03233269|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|September 6, 2018|Anticipated|2018-09-06||Interventional|||BEATS 2: Music Therapy in Sickle Cell|BEATS 2: The Effects of Music Therapy on Young Adults With Sickle Cell Disease|Recruiting||N/A|50|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:50:12.890415|2017-10-10 20:50:12.890415
NCT03233256|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Measurements of Water in Breath and Saliva|Rapid Measurements of Water Isotopes in Human Breath and Saliva for Doubly Labeled Water Analysis|Not yet recruiting||N/A|60|Anticipated|University of Colorado, Denver||1|||f||||f|f|f||||||||2017-10-10 20:50:12.970738|2017-10-10 20:50:12.970738
NCT03233243|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-28|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|ROPPET-NAF||Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT|Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT|Not yet recruiting||Phase 4|43|Anticipated|University of Coimbra||2|||f||||f|t|f|||f|||||2017-10-10 20:50:13.041463|2017-10-10 20:50:13.041463
NCT03233217|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-15|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years|Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular or Subcutaneous Route in Participants Aged 65 Years and Older in Japan|Recruiting||Phase 1/Phase 2|175|Anticipated|Sanofi||5|||f||||f|t|f|||t|||||2017-10-10 20:50:13.252469|2017-10-10 20:50:13.252469
NCT03233191|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-10-03|||July 6, 2017|Actual|2017-07-06|October 2017|2017-10-01|August 1, 2030|Anticipated|2030-08-01|August 1, 2030|Anticipated|2030-08-01||Interventional|||Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer|Tomosynthesis Mammographic Imaging Screening Trial (TMIST)|Recruiting||Phase 3|164946|Anticipated|Eastern Cooperative Oncology Group||2|||f||||t|f|f||||||||2017-10-10 20:50:13.520852|2017-10-10 20:50:13.520852
NCT03233178|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-27|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|ALT||Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study|Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study|Completed||N/A|4000|Actual|LMC Diabetes & Endocrinology Ltd.|||4||f||||f|f|f||||||||2017-10-10 20:50:13.653262|2017-10-10 20:50:13.653262
NCT03233165|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-25|||February 20, 2015|Actual|2015-02-20|July 2017|2017-07-01|March 20, 2017|Actual|2017-03-20|February 20, 2017|Actual|2017-02-20||Interventional|||Comparison Between Two Different High Power Ablative Lasers in the Treatment of Oral Leukoplakia|Comparison Between Two Different High Power Ablative Lasers in the Treatment of Oral Leukoplakia|Completed||N/A|54|Actual|University of Zagreb||2|||f||||t|f|f||||||||2017-10-10 20:50:13.73461|2017-10-10 20:50:13.73461
NCT03233152|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-25|||November 17, 2016|Actual|2016-11-17|May 2017|2017-05-01|November 17, 2019|Anticipated|2019-11-17|November 17, 2018|Anticipated|2018-11-17||Interventional|GlitIpNi||Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma|Phase I Clinical Trial on Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma|Recruiting||Phase 1|6|Anticipated|Universitair Ziekenhuis Brussel||1|||f|||||f|f|||f|||||2017-10-10 20:50:13.919595|2017-10-10 20:50:13.919595
NCT03233139|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|August 27, 2019|Anticipated|2019-08-27|August 27, 2019|Anticipated|2019-08-27||Interventional|||Safety and Pharmacokinetics of REGN2810 (Anti-PD-1) in Japanese Patients With Advanced Malignancies|Phase 1 Study To Investigate The Safety And Pharmacokinetics Of REGN2810 (Anti-PD-1) In Japanese Patients With Advanced Malignancies|Recruiting||Phase 1|6|Anticipated|Regeneron Pharmaceuticals||1|||f||||f|t|f|||t|||||2017-10-10 20:50:14.022852|2017-10-10 20:50:14.022852
NCT03233113|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||September 20, 2016|Actual|2016-09-20|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effects of Safety Seeking Behaviors During Exposure Therapy for Adults With Spider Phobia|"Response Prevention or Response Permission? A Randomized Controlled Trial of the Judicious Use of Safety Behaviors During Exposure Therapy (Institutional Review Board Title: Overcome Your Spider Phobia)"|Recruiting||N/A|70|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 20:50:14.220656|2017-10-10 20:50:14.220656
NCT03233100|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-07-25|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||FMT Treating Constipation Patients With Depression and/or Anxiety Symptoms - Clinical Efficacy and Potential Mechanisms|FMT Treating Constipation Patients With Depression and/or Anxiety Symptoms - Clinical Efficacy and Potential Mechanisms|Recruiting||N/A|40|Anticipated|Jinling Hospital, China||1|||f||||t|f|f||||||||2017-10-10 20:50:14.331799|2017-10-10 20:50:14.331799
NCT03233087|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-04|||August 8, 2017|Anticipated|2017-08-08|June 2017|2017-06-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|||Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study|Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen|Not yet recruiting||N/A|1500|Anticipated|Beijing Institute of Heart, Lung and Blood Vessel Diseases|||3||f|||||f|f||||||||2017-10-10 20:50:14.423923|2017-10-10 20:50:14.423923
NCT03233074|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-25|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|COSMOS||Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors|Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)|Not yet recruiting||N/A|150|Anticipated|Institut de Cancérologie de la Loire|||2||f||||f|f|f||||Samples With DNA|"     Bone marrow   "|||2017-10-10 20:50:14.506254|2017-10-10 20:50:14.506254
NCT03233061|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-29|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|March 28, 2017|Actual|2017-03-28||Interventional|ACTIVOB||Does Obesity Influence Women Cardiorespiratory Fitness and Daily Physical Activities? (ACTIVOB)|Does Obesity Influence Women Cardiorespiratory Fitness and Daily Physical Activities?|Completed||N/A|48|Actual|Laboratory of Movement, Condorcet, Tournai, Belgium||2|||f||||f|f|f||||||||2017-10-10 20:50:14.618914|2017-10-10 20:50:14.618914
NCT03233035|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-07-25|||October 1, 2016|Actual|2016-10-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|January 1, 2018|Anticipated|2018-01-01||Interventional|Ket||Ketamine Intra Nasal Traumatology|Intranasal Ketamine for Treatment of Acute Pain in the Emergency Department : A Randomized Controlled Trial|Recruiting||Phase 2|1000|Anticipated|University of Monastir||2|||f||||t|f|f|||f|||||2017-10-10 20:50:14.802937|2017-10-10 20:50:14.802937
NCT03233022|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-30|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||An Online Trial of Five Well-being Programs|A Randomized Trial Examining the Impact of Five 8-week Online Well-being Programs on Mood and Well-being|Active, not recruiting||N/A|6000|Anticipated|Happify Inc.||5|||f||||f||||||||||2017-10-10 20:50:14.902513|2017-10-10 20:50:14.902513
NCT03233009|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-25|||May 22, 2017|Actual|2017-05-22|July 2017|2017-07-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test|A Human Subject 24 Hour Patch Test to Assess the Irritation Potential of Four Skin Serum Products|Completed||N/A|43|Actual|GlaxoSmithKline||5|||f||||f|f|f||||||||2017-10-10 20:50:14.982411|2017-10-10 20:50:14.982411
NCT03232996|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease.|Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease.|Not yet recruiting||N/A|30|Anticipated|University of Manitoba||1|||f|||||f|f||||||||2017-10-10 20:50:15.089411|2017-10-10 20:50:15.089411
NCT03232983|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-10-02|||August 14, 2017|Actual|2017-08-14|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants|Effect of Injection Site on the Relative and Absolute Bioavailability of Single Dose of LY900014 in Healthy Subjects|Recruiting||Phase 1|28|Anticipated|Eli Lilly and Company||4|||f||||f|t|f|||t|||||2017-10-10 20:50:15.199097|2017-10-10 20:50:15.199097
NCT03232970|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-27|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|September 15, 2017|Anticipated|2017-09-15||Interventional|FPDCT||Full Plate Diet Study|Full Plate Diet Clinical Trial|Not yet recruiting||N/A|40|Anticipated|Loma Linda University||2|||f||||f|f|f||||||||2017-10-10 20:50:15.294217|2017-10-10 20:50:15.294217
NCT03232957|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-08-03|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Intrathecal Morphine for Unilateral Total Knee Arthroplasty|Efficacy and Side Effects of Intrathecal Morphine in Multimodal Analgesia for Unilateral Total Knee Arthroplasty|Not yet recruiting||N/A|120|Anticipated|Mahidol University||3|||f||||f|f|f||||||||2017-10-10 20:50:15.375553|2017-10-10 20:50:15.375553
NCT03232944|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|July 5, 2020|Anticipated|2020-07-05|July 5, 2020|Anticipated|2020-07-05|3 Years|Observational [Patient Registry]|||Personalized CRT - MPP Post Approval Study|Personalized CRT - Multiple Point Pacing Post Approval Study|Recruiting||N/A|1250|Anticipated|Medtronic|||1||f|||||f|f||||||||2017-10-10 20:50:15.480583|2017-10-10 20:50:15.480583
NCT03232931|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-07-25|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Randomized Controlled Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants|Randomized Controlled Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants|Not yet recruiting||N/A|200|Anticipated|Nationwide Children's Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:50:15.574407|2017-10-10 20:50:15.574407
NCT03232918|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Oxytocin and Fetal Heart Rate Changes|A Randomized Controlled Trial Evaluating the Effect of the Oxytocin Infusion Rate on Fetal Heart Rate Changes and Maternal-Fetal Outcomes During the Initiation of Combined Spinal-Epidural Labor Analgesia|Not yet recruiting||Phase 4|730|Anticipated|University of Iowa||2|||f|||||t|f|||f|||||2017-10-10 20:50:15.66099|2017-10-10 20:50:15.66099
NCT03232905|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-10-03|||August 30, 2017|Actual|2017-08-30|October 2017|2017-10-01|November 22, 2017|Anticipated|2017-11-22|October 27, 2017|Anticipated|2017-10-27||Interventional|||Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers|A Phase 1, Randomized, Double-blind, Third-party Open, Placebo-controlled Study To Evaluate The Safety, Tolerability, And Pharmacokinetics After Multiple Oral Doses Of Pf-06651600 In Healthy Japanese Subjects|Recruiting||Phase 1|8|Anticipated|Pfizer||2|||f||||f|f|f||||||||2017-10-10 20:50:15.761453|2017-10-10 20:50:15.761453
NCT03232892|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-25|||September 22, 2017|Anticipated|2017-09-22|July 2017|2017-07-01|September 22, 2021|Anticipated|2021-09-22|September 22, 2019|Anticipated|2019-09-22||Interventional|||Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer|Phase II Trial to Evaluate Trametinib in Patients With Advanced NF1-mutant Non-small Cell Lung Cancer|Not yet recruiting||Phase 2|27|Anticipated|University of California, San Francisco||1|||f||||t|t|f|||t|||||2017-10-10 20:50:15.850776|2017-10-10 20:50:15.850776
NCT03232879|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-29|||January 30, 2017|Actual|2017-01-30|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|April 10, 2017|Actual|2017-04-10||Interventional|||Evaluation of the Excitatory Sympathetic Autonomic Nervous System in the Motor Imagery and Action Observation Training.|Evaluation of the Excitatory Sympathetic Autonomic Nervous System in the Motor Imagery and Action Observation Training. A Randomized Controlled Trial.|Completed||N/A|45|Actual|Universidad Autonoma de Madrid||3|||f|||||f|f||||||||2017-10-10 20:50:15.941855|2017-10-10 20:50:15.941855
NCT03232866|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Effects of Load Monitoring on Pilates Training|Effects of Load Monitoring on Pilates Training: a Randomized Clinical Trial|Not yet recruiting||N/A|40|Anticipated|Paulista University||2|||f||||t|f|f||||||||2017-10-10 20:50:16.024843|2017-10-10 20:50:16.024843
NCT03232853|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-02|||July 31, 2017|Actual|2017-07-31|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|June 1, 2018|Anticipated|2018-06-01||Observational|ELPdrug||E-learning to Prevent Drug Errors in Anesthesia|Evaluation of an E-learning to Prevent Drug Errors in Anesthesia.|Recruiting||N/A|100|Anticipated|University Hospital, Montpellier|||1||f||||f|f|f||||||||2017-10-10 20:50:16.092838|2017-10-10 20:50:16.092838
NCT03232671|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-29|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|April 2017|Actual|2017-04-01||Observational|||Role of Macrophage Migration Inhibitory Factor (MIF) in Heart Failure|Role of Macrophage Migration Inhibitory Factor (MIF) in Heart Failure|Recruiting||N/A|180|Anticipated|University Hospital, Essen|||1||f||||f|f|f||||||||2017-10-10 20:50:16.171668|2017-10-10 20:50:16.171668
NCT03232658|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-30|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea|The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea - Towards Enhanced And Individualized Estimation Of OSA Severity|Not yet recruiting||N/A|10000|Anticipated|Loewenstein Hospital|||1||f||||f|f|f||||||||2017-10-10 20:50:16.246026|2017-10-10 20:50:16.246026
NCT03232645|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-25|||November 15, 2017|Anticipated|2017-11-15|July 2017|2017-07-01|August 15, 2018|Anticipated|2018-08-15|August 15, 2018|Anticipated|2018-08-15||Interventional|LOCALIZE||Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial Fibrillation|ELectrical COupling Information From The Rhythmia HDx Mapping System And DireCtSense Technology In The Treatment Of Paroxysmal AtriaL FibrIllation- A Non-RandomiZed, ProspEctive Study|Not yet recruiting||N/A|60|Anticipated|Boston Scientific Corporation||1|||f|||||f|f||||||||2017-10-10 20:50:16.342645|2017-10-10 20:50:16.342645
NCT03232632|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-07-27|||March 15, 2017|Actual|2017-03-15|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|AMYLCAR||Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries.|Assessment of Cardiac Fixation During Positron Emission Tomography (PET) Examination Using 18F-Flutemetamol (Vizamyl ®) Within Amyloid Cardiac Injuries.|Recruiting||Early Phase 1|15|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||||2017-10-10 20:50:16.4111|2017-10-10 20:50:16.4111
NCT03232619|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-25|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||CD19-CART Treatment for ALL|Safety and Efficacy Evaluation of CD19-CART Treatment for Refractory or Recurrent ALL|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Shanghai Bioray Laboratory Inc.||2|||f||||f|f|f|||f|||||2017-10-10 20:50:16.493031|2017-10-10 20:50:16.493031
NCT03232606|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-02|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|November 15, 2017|Anticipated|2017-11-15|October 15, 2017|Anticipated|2017-10-15||Observational|Asthmeact||Physical Activity of Asthmatic Children|Physical Activity of Asthmatic School Children and Teenagers: Evaluation and Perspectives|Not yet recruiting||N/A|60|Anticipated|Central Hospital, Nancy, France|||1||f||||f|f|f||||||||2017-10-10 20:50:16.588807|2017-10-10 20:50:16.588807
NCT03232593|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-26|2017-07-26|||September 4, 2017|Anticipated|2017-09-04|July 2017|2017-07-01|January 11, 2023|Anticipated|2023-01-11|January 11, 2023|Anticipated|2023-01-11||Observational|||A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)|Post-Marketing Surveillance of Tecentriq in MFDS-Approved Indication(s)|Not yet recruiting||N/A|3000|Anticipated|Hoffmann-La Roche|||1||f|||||t|f|||t|||||2017-10-10 20:50:16.652971|2017-10-10 20:50:16.652971
NCT03232580|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-27|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis|Phase II Study of 99mTc-rhAnnexin V-128 Radionuclide Imaging in Patients With Clinical Suspicion or Confirmed Diagnosis of Spondyloarthritis (SpA)|Not yet recruiting||Phase 2|20|Anticipated|Advanced Accelerator Applications||1|||f||||t|t|f||||||||2017-10-10 20:50:16.727565|2017-10-10 20:50:16.727565
NCT03232567|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-20|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX|Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX|Recruiting||Phase 2|60|Anticipated|Altimmune, Inc.||3|||f|||||t|f||||||||2017-10-10 20:50:16.792292|2017-10-10 20:50:16.792292
NCT03232554|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-26|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|January 30, 2018|Anticipated|2018-01-30|December 31, 2017|Anticipated|2017-12-31||Interventional|BXYMIDA||Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia|Clinical Observation of The Gynecological Iron-Deficiency Anemia Treated With Buxue Yimu Pills|Recruiting||Phase 2|180|Anticipated|Peking Union Medical College Hospital||3|||f||||t|f|f|||f|||||2017-10-10 20:50:16.877126|2017-10-10 20:50:16.877126
NCT03232541|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-27|||July 28, 2017|Anticipated|2017-07-28|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||The Effects of Acupuncture and the Therapist´s Communication on Chemo-therapy Induced Nausea and Vomiting|The Effects of Acupuncture and the Therapist´s Communication on Chemo-therapy Induced Nausea and Vomiting: a Randomized, Sham-controlled Trial|Not yet recruiting||N/A|288|Anticipated|University Hospital, Linkoeping||3|||f|||||f|f||||||||2017-10-10 20:50:16.986039|2017-10-10 20:50:16.986039
NCT03232528|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-27|||November 1, 2016|Actual|2016-11-01|November 2016|2016-11-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||The Promotion Plan of Moxibustion on Ulcerate Colitis|A Study on the Promotion Plan of the Moxibustion Treatment of Ulcerate Colitis|Recruiting||N/A|128|Anticipated|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||||||||||||2017-10-10 20:50:17.075859|2017-10-10 20:50:17.075859
NCT03232515|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-17|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|August 7, 2018|Anticipated|2018-08-07|February 7, 2018|Anticipated|2018-02-07||Interventional|||The Use of Electrical Bioimpedance to Evaluate Dry Weight in Patients With Chronic Renal Failure in Hemodialysis|The Use of Electrical Bioimpedance to Evaluate Dry Weight in Patients With Chronic Renal Failure in Hemodialysis|Recruiting||N/A|38|Anticipated|Universidad de Sonora||1|||f||||t|f|f||||||||2017-10-10 20:50:17.160587|2017-10-10 20:50:17.160587
NCT03232502|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-26|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|January 15, 2018|Anticipated|2018-01-15||Interventional|||Pharmacogenetics in Primary Care Psychotropics|Pharmacogenetics in Primary Care Psychotropics|Not yet recruiting||Phase 3|130|Anticipated|University of Arizona||2|||f|||||f|f|||f|||||2017-10-10 20:50:17.279859|2017-10-10 20:50:17.279859
NCT03232489|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-26|||July 2016||2016-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Pediatric Clinical Practice|Open Label Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Pediatric Clinical Practice|Recruiting||N/A|200|Anticipated|Neurological Associates of West Los Angeles|||1||f||||f||||||||||2017-10-10 20:50:17.34789|2017-10-10 20:50:17.34789
NCT03232476|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of Mechanical Loading With PTH on Cortical Bone|Effect of Mechanical Loading With PTH on Cortical Bone|Not yet recruiting||Phase 4|18|Anticipated|Massachusetts General Hospital||1|||f||||t|f|f||||||||2017-10-10 20:50:17.418902|2017-10-10 20:50:17.418902
NCT03232463|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-26|||June 14, 2016|Actual|2016-06-14|July 2017|2017-07-01|March 7, 2018|Anticipated|2018-03-07|March 7, 2018|Anticipated|2018-03-07||Observational|||Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Clinical Practice|Open Label Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Clinical Practice|Recruiting||N/A|2000|Anticipated|Neurological Associates of West Los Angeles|||1||f||||f|f|f||||||||2017-10-10 20:50:17.489871|2017-10-10 20:50:17.489871
NCT03232450|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|PFOCUS||Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation|PFOCUS Pilot Trial- A Prospective Pilot Trial for PFO ClosUre at the Time of endovaScular Cardiac Electronic Device Implantation|Not yet recruiting||N/A|44|Anticipated|Mayo Clinic||2|||f||||f|f|t|f|f||||||2017-10-10 20:50:17.5665|2017-10-10 20:50:17.5665
NCT03232437|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-26|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Observational|||Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System|A Multicenter Study to Evaluate the External Precision of the Aina HbA1c Monitoring System in Quantitative Measurement of Glycosylated Hemoglobin (HbA1c)|Completed||N/A|6|Actual|Jana Care|||1||f||||f|f|t|t|f|f|Samples With DNA|"     Blood collected in EDTA vacutainers, aliquoted into smaller vials for shipment.   "|||2017-10-10 20:50:17.652905|2017-10-10 20:50:17.652905
NCT03232424|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-27|||July 26, 2017|Actual|2017-07-26|July 2017|2017-07-01|July 2027|Anticipated|2027-07-01|July 2027|Anticipated|2027-07-01||Interventional|||NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma|Pilot Study of Concomitant NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma|Recruiting||Phase 1|10|Anticipated|Hackensack University Medical Center||1|||f||||t|f|t|f|||||||2017-10-10 20:50:17.717639|2017-10-10 20:50:17.717639
NCT03232411|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-25|||February 6, 2017|Actual|2017-02-06|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|||Biobank for African American Prostate Cancer Research in Florida|Biobank for African American Prostate Cancer Research in Florida|Recruiting||N/A|2700|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||1||f||||f|f|f||||Samples With DNA|"     Saliva samples and tumor tissue samples.   "|||2017-10-10 20:50:17.942728|2017-10-10 20:50:17.942728
NCT03232398|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-25|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 31, 2019|Anticipated|2019-10-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus|Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus|Not yet recruiting||Phase 3|50|Anticipated|Hadassah Medical Organization||2|||f||||f|f|f||||||||2017-10-10 20:50:18.054546|2017-10-10 20:50:18.054546
NCT03232385|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-07-25|||April 1, 2018|Anticipated|2018-04-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|MANIFOLD I||Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/MR)|Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/MR)|Withdrawn||N/A|0|Actual|Clear Guide Medical||2||Lack of funding|f||||f|f|t|f||t|||||2017-10-10 20:50:18.219067|2017-10-10 20:50:18.219067
NCT03232372|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-27|||May 8, 2017|Actual|2017-05-08|July 2017|2017-07-01|September 17, 2018|Anticipated|2018-09-17|December 15, 2017|Anticipated|2017-12-15||Interventional|BL-Implants||The Marginal Bone Loss in Dental Implants|The Marginal Bone Loss in Implants of External Connection Versus Internal Connection and Submerged Implants Versus Non-submerged Implants|Recruiting||N/A|6|Anticipated|Hospital Universitari de Bellvitge||3|||f||||t|f|f||||||||2017-10-10 20:50:18.32984|2017-10-10 20:50:18.32984
NCT03232359|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-26|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|June 1, 2016|Actual|2016-06-01|December 1, 2015|Actual|2015-12-01|3 Weeks|Observational [Patient Registry]|||Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome|Assessment of Immature Platelet Fraction in Pregnancy-Associated Thrombotic Microangiopathy|Completed||N/A|57|Actual|Ain Shams Maternity Hospital|||3||f||||f|f|f||||||||2017-10-10 20:50:18.435929|2017-10-10 20:50:18.435929
NCT03232346|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders|A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders|Recruiting||Phase 3|60|Anticipated|New York State Psychiatric Institute||2|||f||||t|t|f|||f|||||2017-10-10 20:50:18.517806|2017-10-10 20:50:18.517806
NCT03232333|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15||Observational|H2H DFU||MIRODERM H2H DFU Study|Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers|Recruiting||N/A|50|Anticipated|Miromatrix Medical Inc.|||1||f||||f|f|t|f|f|f|Samples With DNA|"     Debridement waste   "|||2017-10-10 20:50:18.635376|2017-10-10 20:50:18.635376
NCT03232320|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-07|||July 6, 2017|Actual|2017-07-06|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Meditoxin® Treatment in Patients With Cervical Dystonia|A Prospective, Randomized, Multi-center, Phase III, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Cervical Dystonia|Recruiting||Phase 3|66|Anticipated|Medy-Tox||2|||f|||||f|f||||||||2017-10-10 20:50:18.765574|2017-10-10 20:50:18.765574
NCT03232307|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-05|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Ibrutinib Plus Rituximab and Lenalidomide in Elderly Patients With Newly Diagnosed Mantle Cell Lymphoma (MCL)|A Phase II Study of Ibrutinib Plus Rituximab and Lenalidomide in Elderly Patients With Newly Diagnosed Mantle Cell Lymphoma (MCL)|Not yet recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:50:18.86977|2017-10-10 20:50:18.86977
NCT03232294|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|April 1, 2017|Actual|2017-04-01|12 Months|Observational [Patient Registry]|||Fetal Front-abdominal Wall Thickness and Perinatal Outcome|Effect of Fetal Front-abdominal Wall Thickness on Birth Weight and Perinatal Outcome at 24-26. Gestational Weeks|Completed||N/A|96|Actual|Kayseri Education and Research Hospital|||1||f|||||f|f||||||||2017-10-10 20:50:19.001755|2017-10-10 20:50:19.001755
NCT03232281|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-28|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis|A Phase III, Multicentre, Randomised, Open-label, Parallel, Active-controlled Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis|Recruiting||Phase 3|300|Anticipated|Ipsen||2|||f||||f|f|f||||||||2017-10-10 20:50:19.07942|2017-10-10 20:50:19.07942
NCT03232268|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|November 2023|Anticipated|2023-11-01|November 2019|Anticipated|2019-11-01||Interventional|MICROSTEM||HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies|HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies|Not yet recruiting||Phase 1|32|Anticipated|Institut Paoli-Calmettes||1|||f||||t|f|f||||||||2017-10-10 20:50:19.252217|2017-10-10 20:50:19.252217
NCT03232255|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-28|||August 25, 2017|Actual|2017-08-25|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity|Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity|Recruiting||N/A|30|Anticipated|InQpharm Group||1|||f||||f|f|f||||||||2017-10-10 20:50:19.372158|2017-10-10 20:50:19.372158
NCT03232242|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|July 31, 2020|Anticipated|2020-07-31||Observational|||Application of NGS Technique in Precise Diagnosis of Infectious Diseases|Application of Next Generation Sequencing Technique in Precise Diagnosis of Infectious Diseases|Recruiting||N/A|1500|Anticipated|Huashan Hospital|||1||f||||t|f|f||||||||2017-10-10 20:50:19.45723|2017-10-10 20:50:19.45723
NCT03232229|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|September 30, 2018|Anticipated|2018-09-30||Observational|||Supplementation in Tennis|Supplementation in Tennis: an Observational Study|Not yet recruiting||N/A|200|Anticipated|Vrije Universiteit Brussel|||1||f|||||f|f||||||||2017-10-10 20:50:19.537741|2017-10-10 20:50:19.537741
NCT03232216|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||August 18, 2017|Anticipated|2017-08-18|July 2017|2017-07-01|August 18, 2022|Anticipated|2022-08-18|August 18, 2020|Anticipated|2020-08-18||Interventional|ViDco||Vitamin D Supplementation and Tibia Fracture. Does it Improve Healing Rate?|Vitamin D Supplementation in Patients With Operated Tibia Fracture and Low Vitamin D. Does it Improve Healing Rate?. Randomized Controlled Trial|Not yet recruiting||N/A|682|Anticipated|Hospital del Trabajador de Santiago||4|||f||||t|f|f||||||||2017-10-10 20:50:19.60146|2017-10-10 20:50:19.60146
NCT03232203|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-20|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30|2 Years|Observational [Patient Registry]|||Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)|Evaluation of Referring HCPs' and Parents'/Carers' Understanding of Specific Risks Associated With Strimvelis™ Treatment|Not yet recruiting||N/A|1|Anticipated|GlaxoSmithKline|||2||f||||f|f|f||||||||2017-10-10 20:50:19.723923|2017-10-10 20:50:19.723923
NCT03232190|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-07-26|||January 2014||2014-01-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||The Use of an Age-linked App for Parents During and After a NICU Stay|The Use of an Age-linked Web Application for Parents During and After a NICU Stay in Improving Child Development and Parent Empowerment|Recruiting||N/A|180|Anticipated|Ziekenhuis Oost-Limburg||3|||f||||t||||||||||2017-10-10 20:50:19.808656|2017-10-10 20:50:19.808656
NCT03232177|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-24|||June 5, 2017|Actual|2017-06-05|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Anagre Cap. in Patients With High-Risk Essential Thrombocythemia|A Multicenter, Open-label, Clinical Study for Efficacy and Safety Evaluation of Anagrelide in Patients With Treatment-naïve, High-risk Essential Thrombocythemia as a Primary Treatment|Recruiting||Phase 4|70|Anticipated|Yuhan Corporation||1|||f||||f|f|f||||||||2017-10-10 20:50:19.910974|2017-10-10 20:50:19.910974
NCT03232164|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-24|||February 2, 2017|Actual|2017-02-02|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer|PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer|Recruiting||Early Phase 1|36|Anticipated|University of Wisconsin, Madison||1|||f||||t|t|f||||||||2017-10-10 20:50:20.054038|2017-10-10 20:50:20.054038
NCT03232151|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-24|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|May 1, 2022|Anticipated|2022-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||C-arm Cone Beam CT Perfusion Guided Cerebrovascular Interventions|C-arm Cone Beam CT Perfusion Guided Cerebrovascular Interventions Evaluating Predictability and Accuracy for the Treatment of Acute Cerebral Ischemia in the Angiography Suite|Recruiting||N/A|60|Anticipated|University of Wisconsin, Madison||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:50:20.161927|2017-10-10 20:50:20.161927
NCT03232138|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-20|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|||Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers|Randomized Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers|Not yet recruiting||Phase 2|72|Anticipated|University of Pittsburgh||2|||f||||t|t|f||||||||2017-10-10 20:50:20.252066|2017-10-10 20:50:20.252066
NCT03232099|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-26|||August 31, 2016|Actual|2016-08-31|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Red Wine Effects Upon Gut Flora and Plasma Levels of Trimethylamine-N-oxide (TMAO) - WineFlora Study|Evaluation of Red Wine Effects Upon Gut Flora and Plasma Levels of Trimethylamine-N-oxide (TMAO) in Patients With Established Atherosclerotic Disease|Enrolling by invitation||N/A|42|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:50:20.581216|2017-10-10 20:50:20.581216
NCT03232086|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-26|||January 16, 2017|Actual|2017-01-16|July 2017|2017-07-01|January 16, 2019|Anticipated|2019-01-16|October 16, 2018|Anticipated|2018-10-16||Interventional|RECAP||Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults|Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults|Active, not recruiting||N/A|20|Anticipated|Environmental Protection Agency (EPA)||2|||f||||f|f|f||||||||2017-10-10 20:50:20.662589|2017-10-10 20:50:20.662589
NCT03232073|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-26|||July 13, 2017|Actual|2017-07-13|July 2017|2017-07-01|April 6, 2022|Anticipated|2022-04-06|April 6, 2022|Anticipated|2022-04-06||Interventional|OPTIMUM-LT||Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis|Multicenter, Non-comparative Extension to Study AC-058B301, to Investigate the Long-term Safety, Tolerability, and Control of Disease of Ponesimod 20 mg in Subjects With Relapsing Multiple Sclerosis|Enrolling by invitation||Phase 3|800|Anticipated|Actelion||1|||f||||t|t|f||||||||2017-10-10 20:50:20.73307|2017-10-10 20:50:20.73307
NCT03232047|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-08-15|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 1, 2018|Anticipated|2018-12-01||Interventional|||Computerized Cognitive Training for MCI|A Randomized Control Trial on Computerized Cognitive Training for Individuals With Mild Cognitive Impairment|Recruiting||N/A|120|Anticipated|Peking University||2|||f||||t|f|f||||||||2017-10-10 20:50:20.84665|2017-10-10 20:50:20.84665
NCT03232034|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-26|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|November 1, 2017|Anticipated|2017-11-01||Interventional|||Calcium, Protein and Gut Hormones|The Role of Dietary Milk Minerals and Protein in Gut Hormone Secretion|Recruiting||N/A|20|Anticipated|University of Bath||3|||f|||||f|f||||||||2017-10-10 20:50:20.952391|2017-10-10 20:50:20.952391
NCT03232021|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-04|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations|Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations|Recruiting||Phase 2/Phase 3|78|Anticipated|Saint Savvas Anticancer Hospital||3|||f||||f|f|f||||||||2017-10-10 20:50:21.092398|2017-10-10 20:50:21.092398
NCT03232008|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-26|||September 1, 2015|Actual|2015-09-01|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Canderel:Effects on Blood Glucose Concentration and Appetite Scores|The Effects of Canderel (Aspartame and Acesulfame-k Blend) on Blood Glucose Concentration and Appetite Scores in Humans: a Randomised Controlled Trial|Recruiting||N/A|60|Anticipated|King's College London||2|||f||||f|f|f|||f|||||2017-10-10 20:50:21.208756|2017-10-10 20:50:21.208756
NCT03231995|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-27|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|BMIG||Biomarkers for the Prognosis of Influenza in Children|Prospective Multicentre Study to Determine Respiratory Microbiome Biomarkers for the Prognostic of Clinical Course of Influenza in Children|Not yet recruiting||N/A|330|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 20:50:21.288913|2017-10-10 20:50:21.288913
NCT03231982|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||April 17, 2017|Actual|2017-04-17|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|MACH||Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan|A Randomized, Double-blind, Multi-center, Phase Ⅳ Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety Between Amlodipine Besylate/Candesartan Cilexetil Combination Tablets and Co-administration of Amlodipine Besylate and Candesartan Cilexetil in Patients With Essential Hypertension|Recruiting||Phase 4|210|Anticipated|CJ HealthCare Corporation||2|||f||||f|f|f||||||||2017-10-10 20:50:21.360878|2017-10-10 20:50:21.360878
NCT03231969|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-26|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model|A Single-Center, Double-Masked, Randomized, Vehicle-Controlled, Phase 2, Dose Ranging Evaluation of the Effectiveness of Bilastine Ophthalmic Solution (0.2%, 0.4%, and 0.6%) Compared to Vehicle for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (Ora-CAC®) Model|Active, not recruiting||Phase 2|121|Actual|Faes Farma, S.A.||4|||f||||f|t|f||||||||2017-10-10 20:50:21.448361|2017-10-10 20:50:21.448361
NCT03231956|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-26|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|October 15, 2018|Anticipated|2018-10-15|August 30, 2018|Anticipated|2018-08-30||Observational|CLEAR Sepsis||CLEAR Sepsis Clinical Study|Noninvasive Hemodynamic Monitoring Utilizing ClearSight TM System in Suspected Sepsis Patients Presenting to the Emergency Department (CLEAR SEPSIS)|Recruiting||N/A|1250|Anticipated|Edwards Lifesciences|||4||f||||f|f|t|f|f|t|Samples With DNA|"     Laboratory specimens to be collected include blood and will be analyzed for lactate at a     central clinical research laboratory (WSU Integrative Biosciences, Detroit, MI).     Additionally, plasma samples will be obtained for and stored at the WSU Biobank to support     potential future clinical and translational research. Samples for the purpose of the WSU     Biobank are optional to the clinical research participant and will not adversely affect     participation in the clinical trial.   "|||2017-10-10 20:50:21.519101|2017-10-10 20:50:21.519101
NCT03231943|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-31|||September 26, 2017|Anticipated|2017-09-26|August 2017|2017-08-01|July 19, 2018|Anticipated|2018-07-19|July 19, 2018|Anticipated|2018-07-19||Interventional|||GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers|A Double-Blind (Sponsor Unblinded), Randomized, Placebo-Controlled, Single and Repeated Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK3640254 in Healthy Participants|Not yet recruiting||Phase 1|80|Anticipated|ViiV Healthcare||3|||f||||f|f|f||||||||2017-10-10 20:50:21.607952|2017-10-10 20:50:21.607952
NCT03231930|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-08-29|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC)|Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC)|Recruiting||N/A|600|Anticipated|Macfarlane Burnet Institute for Medical Research and Public Health Ltd||1|||f||||t|f|t|t|f|t|||||2017-10-10 20:50:21.70559|2017-10-10 20:50:21.70559
NCT03231917|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Water Immersion and Polyp Detection: A Randomized Controlled Trial|Water Immersion and Polyp Detection: A Randomized Controlled Trial|Recruiting||N/A|124|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f|||||f|f|||f|||||2017-10-10 20:50:21.790848|2017-10-10 20:50:21.790848
NCT03231904|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-08-03|||August 10, 2017|Anticipated|2017-08-10|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Observational|||Maternal and Fetal Adrenocorticotropic Hormone (ACTH) and Leukemia Inhibitory Factor (LIF) and Gestational Age|The Correlation Between Gestational Age and Maternal and Fetal Levels of LIF and ACTH|Not yet recruiting||N/A|50|Anticipated|Rambam Health Care Campus|||1||f||||f|f|f||||Samples Without DNA|"     fetal and maternal blood samples for ACTH and LIF   "|||2017-10-10 20:50:23.419829|2017-10-10 20:50:23.419829
NCT03231891|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|December 2030|Anticipated|2030-12-01|December 2029|Anticipated|2029-12-01|100 Years|Observational [Patient Registry]|ICARE||Inherited CAncer REgistry|Inherited CAncer REgistry (ICARE) Initiative|Recruiting||N/A|5000|Anticipated|Vanderbilt-Ingram Cancer Center|||1||f||||f|f|f||||Samples With DNA|"     Collection of blood, saliva/cheek swab, urine, and/or other biological specimens may be     requested from participants. Tissues saved during previous surgeries as part of the patient's     treatment may be requested.   "|||2017-10-10 20:50:23.529335|2017-10-10 20:50:23.529335
NCT03231878|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-28|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|Advance||A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients.|A Randomized, Double-blind, Placebo-controlled, Multinational, Multicenter Study With Open-label Treatment Extension to Assess the Effect of MIN-102 (IMP) on the Progression of Adrenomyeloneuropathy in Male Patients With X-linked Adrenoleukodystrophy|Not yet recruiting||Phase 2/Phase 3|105|Anticipated|Minoryx Therapeutics, S.L.||2|||f|||||f|f||||||||2017-10-10 20:50:23.591714|2017-10-10 20:50:23.591714
NCT03231865|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-31|||July 27, 2017|Actual|2017-07-27|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Observational|ZnPP||Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX|Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX|Recruiting||N/A|300|Anticipated|University of Zurich|||1||f||||t|f|f||||||||2017-10-10 20:50:23.659269|2017-10-10 20:50:23.659269
NCT03231852|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Patient Perceptions and Willingness to Enroll in Clinical Trials|Patient Perceptions and Willingness to Enroll in Clinical Trials|Recruiting||N/A|166|Anticipated|University of Virginia|||1||f||||f|f|f||||||||2017-10-10 20:50:23.737044|2017-10-10 20:50:23.737044
NCT03231839|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||February 1, 2009|Actual|2009-02-01|July 2017|2017-07-01|July 31, 2016|Actual|2016-07-31|June 30, 2012|Actual|2012-06-30||Interventional|NUPREDM||Nutritional Prevention of Diabetes Mellitus Type 2|Identification of Factors Predicting the Success of a Nutritional Intervention to Decrease the Risk of Type 2 Diabetes|Completed||N/A|132|Actual|University Hospital Tuebingen||3|||f||||f|f|f||||||||2017-10-10 20:50:23.808437|2017-10-10 20:50:23.808437
NCT03231826|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|May 30, 2019|Anticipated|2019-05-30||Observational|||Arrhythmias in Post-Myocardial Infarction Patients|Exploring Arrhythmias After Hospital Discharge in Post-Myocardial Infarction Patients - the MADDEC Project|Recruiting||N/A|800|Anticipated|University of Tampere|||1||f||||f|f|f||||Samples Without DNA|"     Recording of continuous ECG-signals   "|||2017-10-10 20:50:23.894716|2017-10-10 20:50:23.894716
NCT03231813|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-28|||August 29, 2017|Actual|2017-08-29|June 2017|2017-06-01|September 28, 2017|Actual|2017-09-28|September 28, 2017|Actual|2017-09-28||Interventional|||Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery|Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery: A Randomised, Controlled Trial|Completed||N/A|25|Actual|University of Split, School of Medicine||4|||f||||f|f|f||||||||2017-10-10 20:50:23.992148|2017-10-10 20:50:23.992148
NCT03231800|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-01|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.|Dasotraline (2mg) in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD): A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of Efficacy and Safety in a Laboratory Classroom Setting|Recruiting||Phase 3|100|Anticipated|Sunovion||2|||f||||t|t|f||||||||2017-10-10 20:50:24.090138|2017-10-10 20:50:24.090138
NCT03231787|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-28|||September 4, 2017|Anticipated|2017-09-04|July 2017|2017-07-01|December 17, 2019|Anticipated|2019-12-17|December 17, 2018|Anticipated|2018-12-17||Interventional|AFFEcT||Clinical Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery|Randomized Parallel Multicenter Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery (AFFEcT Study)|Not yet recruiting||N/A|156|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f|f|f||||||||2017-10-10 20:50:24.195684|2017-10-10 20:50:24.195684
NCT03231774|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-14|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|||Comparability of Hemodynamic Parameters Measured by Non-invasive Echocardiography and by Right Heart Catheterization|Comparability of Hemodynamic Parameters Measured by Non-invasive Echocardiography and by Right Heart Catheterization|Recruiting||N/A|100|Anticipated|Heart and Diabetes Center North-Rhine Westfalia|||1||f||||f|f|f||||||||2017-10-10 20:50:24.400173|2017-10-10 20:50:24.400173
NCT03231761|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-10-04|||August 21, 2017|Actual|2017-08-21|October 2017|2017-10-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Impact of Video Presentations on Medical Students' Attitudes Toward Mental Illness|A Randomized Controlled Trial of the Impact of Video Presentations on Medical Students' Explicit and Implicit Attitudes Toward Mental Illness in Nepal|Recruiting||N/A|200|Anticipated|George Washington University||3|||f||||t|f|f||||||||2017-10-10 20:50:24.481581|2017-10-10 20:50:24.481581
NCT03231748|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-24|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Observational|ClicAKI||Clearance of Inflammatory Cytokines During Renal Replacement Therapy Using the EMIC®2 Filter|Clearance of Inflammatory Cytokines in Patients With Septic Acute Kidney Injury During Renal Replacement Therapy Using the EMIC®2 Filter|Active, not recruiting||N/A|10|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 20:50:24.58403|2017-10-10 20:50:24.58403
NCT03231735|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-02|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|MIDAS||Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome|A Randomized Controlled Trial of Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome|Recruiting||Phase 2/Phase 3|130|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 20:50:24.649572|2017-10-10 20:50:24.649572
NCT03231722|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-24|||July 25, 2017|Anticipated|2017-07-25|July 2017|2017-07-01|July 15, 2021|Anticipated|2021-07-15|December 15, 2020|Anticipated|2020-12-15||Interventional|TRIPLETE||First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS|The TRIPLETE Study RANDOMIZED PHASE III STUDY OF TRIPLET mFOLFOXIRI PLUS PANITUMUMAB Versus mFOLFOX6 PLUS PANITUMUMAB AS INITIAL THERAPY FOR UNRESECTABLE RAS AND BRAF WILDTYPE METASTATIC COLORECTAL CANCER PATIENTS|Not yet recruiting||Phase 3|432|Anticipated|Gruppo Oncologico del Nord-Ovest||2|||f||||t|f|f|||f|||||2017-10-10 20:50:24.774408|2017-10-10 20:50:24.774408
NCT03231709|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-09-28|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Treatment Preference for Weekly DPP-4 Inhibitors Versus Daily DPP-4 Inhibitors in Patients With Type 2 Diabetes Mellitus|Treatment Preference for Weekly DPP-4 Inhibitors Versus Daily DPP-4 Inhibitors in Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 4|60|Anticipated|Takeda||2|||f||||f|f|f||||||||2017-10-10 20:50:24.892481|2017-10-10 20:50:24.892481
NCT03231696|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||January 2012|Actual|2012-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|Visibility||Visibility - Classification of Sono-visibility of Anatomical Structures in Peripheral Nerve Blocks|Visibility - A Novel Classification Score of Sono-visibility of Anatomical Structures in Peripheral Nerve Blocks|Completed||N/A|1200|Actual|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:50:25.009439|2017-10-10 20:50:25.009439
NCT03231683|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-07-24|||March 2014||2014-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy|The Use of S+Ketamine Versus Placebo During Target-Controlled Intravenous Anaesthesia to Reduce Morphine Consumption and Side Effects After Abdominal Hysterectomy: A Randomized Controlled Trial|Completed||Phase 2|90|Actual|KK Women's and Children's Hospital||2|||f||||f||||||||||2017-10-10 20:50:25.094032|2017-10-10 20:50:25.094032
NCT03231670|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|October 2020|Anticipated|2020-10-01||Observational|ASTRAL||Innate Immune Response of Blood Cells in Patients With Pneumonia|Analysis of Blood Cells Innate Immune Response in Patients With Lobar Pneumonia|Not yet recruiting||N/A|38|Anticipated|Lille Catholic University|||1||f||||f|f|f||||Samples With DNA|"     Blood samples 5ml   "|||2017-10-10 20:50:25.201503|2017-10-10 20:50:25.201503
NCT03231657|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-27|||September 29, 2017|Anticipated|2017-09-29|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|October 31, 2020|Anticipated|2020-10-31||Interventional|EuroPE||Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease|Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease (EuroPE Study)|Not yet recruiting||N/A|2536|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f|||||f|f||||||||2017-10-10 20:50:25.276831|2017-10-10 20:50:25.276831
NCT03231644|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-24|||October 31, 2016|Actual|2016-10-31|July 2017|2017-07-01|October 2026|Anticipated|2026-10-01|October 2026|Anticipated|2026-10-01|2 Years|Observational [Patient Registry]|||Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry|Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry|Recruiting||N/A|600|Anticipated|Fibrous Dysplasia Foundation|||1||f||||t|f|f|||f|||||2017-10-10 20:50:25.36113|2017-10-10 20:50:25.36113
NCT03231631|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-24|||January 10, 2017|Actual|2017-01-10|July 2017|2017-07-01|August 10, 2017|Anticipated|2017-08-10|August 10, 2017|Anticipated|2017-08-10||Interventional|||Efficacy Of An Education Plan And Adherence Follow-Up To The Exercise In Patients With Angioplasty And Stent Coronary|Efficacy Of An Education Plan And Adherence Follow-Up To The Exercise In Patients With Angioplasty And Implantation Of Coronary Stent, Measured With Hdl And Met In A Cardiac Rehabilitation Unit - Random Triple Blind Clinical Trial|Enrolling by invitation||N/A|71|Anticipated|Clínica de Occidente S.A||2|||f||||t|f|f||||||||2017-10-10 20:50:25.437566|2017-10-10 20:50:25.437566
NCT03231618|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||The Intervention Study of Dietary Intake on Energy Expenditure|The Intervention Study of Dietary Intake on Energy Expenditure|Not yet recruiting||N/A|40|Anticipated|Chinese Academy of Sciences||2|||f||||t|f|f||||||||2017-10-10 20:50:25.525707|2017-10-10 20:50:25.525707
NCT03231605|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-30|||July 26, 2017|Actual|2017-07-26|July 2017|2017-07-01|December 29, 2017|Anticipated|2017-12-29|August 31, 2017|Anticipated|2017-08-31||Interventional|||Comparative Immunogenicity Study of Two Hepatitis A Vaccines|Comparative Immunogenicity Study of Two Live Attenuated Hepatitis A Vaccines|Enrolling by invitation||Phase 4|300|Anticipated|China National Biotec Group Company Limited||2|||f|||||f|f||||||||2017-10-10 20:50:25.615958|2017-10-10 20:50:25.615958
NCT03231592|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-24|||May 10, 2017|Actual|2017-05-10|July 2017|2017-07-01|December 20, 2018|Anticipated|2018-12-20|December 20, 2018|Anticipated|2018-12-20||Interventional|||Im(Proving) the CSA Model|Im(Proving) the CSA Model|Recruiting||N/A|120|Anticipated|Community Health Center of Franklin County||2|||f||||f|f|f||||||||2017-10-10 20:50:25.690709|2017-10-10 20:50:25.690709
NCT03231579|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-26|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study|The Roles of Education and Patient Engagement to Improve Symptom Management and the Quality of Life for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia|Recruiting||N/A|200|Anticipated|Carevive Systems, Inc.|||1||f||||f|f|f||||||||2017-10-10 20:50:25.785924|2017-10-10 20:50:25.785924
NCT03231566|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-24|||February 28, 2015|Actual|2015-02-28|July 2017|2017-07-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Interventional|||Pain Neuroscience Education in Total Knee Arthroplasty|A Randomized Clinical Trial of Preoperative Pain Neuroscience Education for Total Knee Arthroplasty|Completed||N/A|120|Actual|University of Nevada, Las Vegas||2|||f||||f|f|f||||||||2017-10-10 20:50:25.853173|2017-10-10 20:50:25.853173
NCT03231553|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-24|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Effectiveness and Cost-effectiveness of a Tailored Text Message Programme (MiQuit) for Smoking Cessation in Pregnancy|RCT and Meta-analysis Testing Effectiveness and Cost-effectiveness of a Tailored Text Message Programme (MiQuit) for Smoking Cessation in Pregnancy|Not yet recruiting||N/A|692|Anticipated|University of Nottingham||2|||f||||f|f|f||||||||2017-10-10 20:50:25.920874|2017-10-10 20:50:25.920874
NCT03231540|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-07-26|||September 2016||2016-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PRESMUS||The PREServation of MUScle Function in Critically Ill Patients (PRESMUS)|Effect of Whey Protein-enriched Enteral Nutrition in Addition to Standardized Exercise Training on the PREServation of MUScle Function in Critically Ill Patients: A Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-10-10 20:50:26.09125|2017-10-10 20:50:26.09125
NCT03231527|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Outcomes of Total Arterial Coronary Artery Bypass Grafting|Multicentric Registry Database of Total Arterial CABG|Not yet recruiting||N/A|5000|Anticipated|University of Glasgow|||2||f||||f|f|f||||||||2017-10-10 20:50:26.188453|2017-10-10 20:50:26.188453
NCT03231514|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-24|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Determining the Ergogenic Effects of Carb10™ Supplementation on Carbohydrate-Rich and Carbohydrate-Restricted Diets|Determining the Ergogenic Effects of Carb10™ Supplementation on Carbohydrate-Rich and Carbohydrate-Restricted Diets|Recruiting||N/A|100|Anticipated|Texas Woman's University||4|||f||||f|f|f||||||||2017-10-10 20:50:26.334541|2017-10-10 20:50:26.334541
NCT03231501|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-24|||August 4, 2017|Anticipated|2017-08-04|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||HMPL-813 in Treating Patients With Glioblastoma|A Phase Ib, Multi-center, Open-label Study of Epitinib Succinate (HMPL-813) in Treating Patients With Glioblastoma|Not yet recruiting||Phase 1|29|Anticipated|Hutchison Medipharma Limited||1|||f||||f|f|f||||||||2017-10-10 20:50:26.465167|2017-10-10 20:50:26.465167
NCT03231488|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-09|||July 31, 2017|Actual|2017-07-31|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Mindfulness on Cognition and Emotion Following Acquired Brain Injury|The Effect of Mindfulness on Stimulus Over-selectivity and Selective Attention to Threat Following Acquired Brain Injury|Recruiting||N/A|46|Anticipated|University of East Anglia||2|||f|||||f|f||||||||2017-10-10 20:50:26.553229|2017-10-10 20:50:26.553229
NCT03231475|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-16|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|April 2019|Anticipated|2019-04-01||Interventional|SPH1188-11||Phase I Study of SPH1188-11 in NSCLC|Phase I, Open-label Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of SPH1188-11 Tablets for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC).|Recruiting||Phase 1|36|Anticipated|Shanghai Pharmaceuticals Holding Co., Ltd||1|||f||||f|f|f|||f|||||2017-10-10 20:50:26.685166|2017-10-10 20:50:26.685166
NCT03231462|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-26|||March 6, 2015|Actual|2015-03-06|July 2017|2017-07-01|February 28, 2023|Anticipated|2023-02-28|March 31, 2018|Anticipated|2018-03-31||Observational|||Impact of Perioperative Physical Activity on Postoperative Pulmonary Complications and Quality of Life Among Esophageal Cancer Patients|Impact of Perioperative Physical Activity on Postoperative Pulmonary Complications and Quality of Life Among Esophageal Cancer Patients: A Prospective Cohort Study|Recruiting||N/A|180|Anticipated|Samsung Medical Center|||1||f|||||f|f||||||||2017-10-10 20:50:26.782489|2017-10-10 20:50:26.782489
NCT03231449|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|December 2017|Anticipated|2017-12-01||Observational|FEVRIER||A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa|A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa|Active, not recruiting||N/A|5000|Anticipated|Cardiologie et Développement|||1||f||||f||||||||||2017-10-10 20:50:26.853318|2017-10-10 20:50:26.853318
NCT03231436|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-27|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|SpinFix-Bupi||Fixed Dose Spinal Bupivacaine for Cesarean Delivery|Fixed Dose Versus Height - Adjusted Dose of Intrathecal Hyperbaric Bupivacaine With Opioid for Cesarean Delivery: a Prospective Double-blinded Randomized Trial|Recruiting||N/A|120|Anticipated|Centre of Postgraduate Medical Education||2|||f|||||f|f||||||||2017-10-10 20:50:27.001409|2017-10-10 20:50:27.001409
NCT03231423|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-26|||December 9, 2016|Actual|2016-12-09|July 2017|2017-07-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||Effect of Drainage on Laparoscopic Gastric Bypass Surgery|Effect of Drain Usage on Patient Comfort on Laparoscopic Gastric Bypass Surgery|Completed||N/A|66|Actual|Inonu University||2|||f||||t|f|f||||||||2017-10-10 20:50:27.095826|2017-10-10 20:50:27.095826
NCT03231410|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-25|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|ROMAVAS||Role of Monocytes Adhesion and Vascular Lesions in Vascular Access Success or Failure in Uremic Patients|Role of Monocytes Adhesion and Vascular Lesions in Vascular Access Success or Failure in Uremic Patients|Recruiting||N/A|30|Anticipated|Wroclaw Medical University|||1||f||||f|f|f||||Samples With DNA|"     Transcripts of genes related to calcification (osteopontin, osteokalcin, RunX2), inflammation     (TNFa, IL6) and atherosclerosis (ACE/ACE2, VCAM-1, ICAM-1) processes will be assessed.   "|||2017-10-10 20:50:27.165897|2017-10-10 20:50:27.165897
NCT03231397|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Predictors of AAA Expansion and/or Rupture|Noninvasive Assessment of Abdominal Aortic Aneurysm (AAA) Wall Structural Integrity and Inflammation as Predictors of Expansion and/or Rupture|Recruiting||N/A|18|Anticipated|Washington University School of Medicine||3|||f||||f|f|f|||f|||||2017-10-10 20:50:27.291571|2017-10-10 20:50:27.291571
NCT03231384|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-24|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Rt-PA Thrombolytic Therapy in Combination With Remote Ischemic Conditioning for Acute Ischemic Stroke|Safety and Feasibility of Rt-PA Thrombolytic Therapy in Combination With Remote Ischemic Conditioning for Acute Ischemic Stroke(rtPA-RIC1)|Recruiting||N/A|30|Anticipated|Capital Medical University||2|||f|||||f|f||||||||2017-10-10 20:50:27.430427|2017-10-10 20:50:27.430427
NCT03231371|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-08-29|2017-08-29||November 2008||2008-11-01|August 2017|2017-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|CFR-OHT||Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients|Early Detection of Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients: A Prospective Assessment Using Coronary Flow Reserve and Contrast-Enhanced Cardiac MRI|Completed||Phase 3|22|Actual|University of Michigan||1|||f|||||t|f||||||||2017-10-10 20:50:27.535135|2017-10-10 20:50:27.535135
NCT03231358|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-26|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 31, 2023|Anticipated|2023-08-31|August 31, 2022|Anticipated|2022-08-31||Interventional|||Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa|Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa|Not yet recruiting||Phase 3|880|Anticipated|Brown University||2|||f||||t|f|f||||||||2017-10-10 20:50:27.880435|2017-10-10 20:50:27.880435
NCT03231345|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-07-26|||August 18, 2016|Actual|2016-08-18|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Ultrasound-guided Peripheral IJ Study|Ultrasound-guided Placement of Peripheral Intravenous Lines in the Internal Jugular Vein.|Recruiting||N/A|50|Anticipated|University Medical Center of Southern Nevada||1|||f||||f|f|t|f||t|||||2017-10-10 20:50:27.981229|2017-10-10 20:50:27.981229
NCT03231332|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-26|||July 29, 2017|Anticipated|2017-07-29|July 2017|2017-07-01|December 31, 2025|Anticipated|2025-12-31|October 29, 2019|Anticipated|2019-10-29|2 Years|Observational [Patient Registry]|||Effects of H.Pylori Eradication on Microbiome|Long Term Effects of H.Pylori Eradication on Microbiome and Adverse Events|Not yet recruiting||N/A|900|Anticipated|University of Latvia|||2||f||||f|f|f||||Samples With DNA|"     Feces   "|||2017-10-10 20:50:28.091234|2017-10-10 20:50:28.091234
NCT03231319|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-25|||July 27, 2017|Anticipated|2017-07-27|July 2017|2017-07-01|April 19, 2018|Anticipated|2018-04-19|April 19, 2018|Anticipated|2018-04-19||Interventional|||Comparison of Different Neural Blockade Techniques in Postoperative Analgesia After Total Hip Arthroplasty|Comparison of Different Neural Blockade Techniques in Postoperative Analgesia After Total Hip Arthroplasty|Recruiting||N/A|90|Anticipated|Taichung Veterans General Hospital||3|||f|||||f|f||||||||2017-10-10 20:50:28.183069|2017-10-10 20:50:28.183069
NCT03231306|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|October 2019|Anticipated|2019-10-01||Interventional|NF108-BINI||Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas|A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)|Not yet recruiting||Phase 2|20|Anticipated|University of Alabama at Birmingham||1|||||||t|t|f||||||||2017-10-10 20:50:28.274474|2017-10-10 20:50:28.274474
NCT03231293|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||July 28, 2016|Actual|2016-07-28|September 2016|2016-09-01|December 30, 2019|Anticipated|2019-12-30|May 30, 2018|Anticipated|2018-05-30||Observational|FABULOUS||Fimasartan Blood Pressure Lowering After Acute Stroke|A Multicenter Longitudinal Observational Study to Assess the Effectiveness of Fimasartan-based Antihypertensive Treatment and Prognosis in Post-Acute Phase of Ischemic Stroke or Transient Ischemic Attack|Recruiting||N/A|1032|Anticipated|Boryung Pharmaceutical Co., Ltd|||1||f||||||||||||||2017-10-10 20:50:28.560488|2017-10-10 20:50:28.560488
NCT03231280|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-25|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|MODIFY2||A Trial of a Single Delivery of SB-061 in Osteoarthritis of the Knee|A Placebo-controlled, Double-blind, Randomized Trial of a Single Intra-articular Delivery of SB-061 for the Treatment of Symptomatic Osteoarthritis of the Knee|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|Symic OA Co.||2|||f||||f|f|f||||||||2017-10-10 20:50:28.643076|2017-10-10 20:50:28.643076
NCT03231267|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-24|||September 15, 2017|Anticipated|2017-09-15|July 2017|2017-07-01|June 15, 2018|Anticipated|2018-06-15|June 15, 2018|Anticipated|2018-06-15||Observational|PHAGO-BMR||Existence in the Human Digestive Flora of Phages Able to Prevent the Acquisition of Multiresistant Enterobacteria|Existence in the Human Digestive Flora of Phages Able to Prevent the Acquisition of Multiresistant Enterobacteria: PHAGO- BMR|Not yet recruiting||N/A|460|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f|f|f||||||||2017-10-10 20:50:28.747113|2017-10-10 20:50:28.747113
NCT03231254|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|October 29, 2017|Anticipated|2017-10-29|October 20, 2017|Anticipated|2017-10-20||Observational|RCMP||Differences in Predicted Therapeutic Outcome of Oral Appliance Determined by RCMP in Quebec Versus Shenyang Patients With OSA.|Differences in Predicted Therapeutic Outcome of Oral Appliance and Optimal Protrusion Position Determined by Remotely Controlled Mandibular Positioner (RCMP) With Overnight PSG in Quebec Versus Shenyang Patients With OSA|Active, not recruiting||N/A|100|Anticipated|First Hospital of China Medical University|||2||f||||t|f|t|f||f|||||2017-10-10 20:50:28.826397|2017-10-10 20:50:28.826397
NCT03231241|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-25|||December 12, 2014|Actual|2014-12-12|July 2017|2017-07-01|May 1, 2021|Anticipated|2021-05-01|August 15, 2020|Anticipated|2020-08-15||Observational|||Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics|SunStar Project to Explore the Chronification Process in Headache Through Functional Imaging, Deep Phenotyping, and Analysis of CSF of Blood Products|Recruiting||N/A|700|Anticipated|Stanford University|||3||f||||f|f|f||||Samples With DNA|"     Cerebrospinal Fluid and Blood are collected and stored for analysis.   "|||2017-10-10 20:50:28.912984|2017-10-10 20:50:28.912984
NCT03231215|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-01|||July 3, 2016|Actual|2016-07-03|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||The Effect of Adding Dexamethasone to Epidural Bupivacaine for Total Knee Replacement Surgery|The Effect of Adding Dexamethasone to Epidural Bupivacaine for Total Knee Replacement Surgery|Completed||N/A|50|Actual|Assiut University||2|||f||||t|f|f|||f|||||2017-10-10 20:50:29.082868|2017-10-10 20:50:29.082868
NCT03231202|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-25|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Splenic Injury Embolization - the Question About NOM (SInE Qua NOM)|A Multi-centre, Prospective, Randomized Controlled Study to Compare Outcomes of Non-operative Management (NOM) With and Without Splenic Arterial Embolization (SAE) in Hemodynamically Stable OIS Grade 4 and 5 Splenic Injuries.|Recruiting||N/A|224|Anticipated|Oslo University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:50:29.179215|2017-10-10 20:50:29.179215
NCT03231189|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-26|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|January 31, 2020|Anticipated|2020-01-31|December 31, 2019|Anticipated|2019-12-31||Observational|CAMAREC||Cardiac MRI in Front Line for the Diagnosis of Coronary Artery Disease as the Etiology of Left Ventricular Dysfunction|Prospective Multicentric Study for the Diagnostic Performance of CArdiac MAgnetic REsonance Imaging Used First for the Diagnosis of Coronary Artery Disease as the Etiology of Left Ventricular Dysfunction|Not yet recruiting||N/A|406|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||||||||||||2017-10-10 20:50:29.336547|2017-10-10 20:50:29.336547
NCT03231176|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-26|||November 15, 2017|Anticipated|2017-11-15|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer|A Phase 2A, Single Arm, Multicentre, Study of Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer Who Progressed on at Least 1 Line of Systemic Therapy|Not yet recruiting||Phase 2|25|Anticipated|Aslan Pharmaceuticals||1|||f||||f|f|f||||||||2017-10-10 20:50:29.423275|2017-10-10 20:50:29.423275
NCT03231163|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-25|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|October 31, 2017|Anticipated|2017-10-31||Interventional|||Physiological and Perceptual Effects of Music on Resting Metabolic Rate (RMR)|Physiological and Perceptual Effects of Music on Resting Metabolic Rate (RMR)|Recruiting||N/A|50|Anticipated|Old Dominion University||3|||f||||f|f|f||||||||2017-10-10 20:50:29.505267|2017-10-10 20:50:29.505267
NCT03231150|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||March 28, 2017|Actual|2017-03-28|July 2017|2017-07-01|August 28, 2019|Anticipated|2019-08-28|March 28, 2019|Anticipated|2019-03-28||Interventional|PF-RCT||Plantar Fasciitis Randomized Clinical Control Trial|Randomized Clinical Study to Evaluate Ultrasound Guided Injection Therapy Versus Topographic Injection Therapy for Plantar Fasciitis|Recruiting||N/A|62|Anticipated|University of Pennsylvania||2|||f||||f|f|f|||f|||||2017-10-10 20:50:29.584887|2017-10-10 20:50:29.584887
NCT03231137|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||June 16, 2012|Actual|2012-06-16|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|March 12, 2017|Actual|2017-03-12||Interventional|||Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination|Socket Augmentation Using Different Platelet Concentrates, Atorvastatin Gel or Combination (Clinical and Histomorphometric Study)|Completed||Phase 4|50|Actual|Ain Shams University||5|||f||||t|f|f|||f|||||2017-10-10 20:50:29.693921|2017-10-10 20:50:29.693921
NCT03231124|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-08-24|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|August 22, 2017|Actual|2017-08-22|August 22, 2017|Actual|2017-08-22||Interventional|||Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.|A Phase 1, Single Centre Randomised, Double-blind Placebo-controlled Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.|Completed||Phase 1|26|Actual|LEO Pharma||2|||f|||||f|f|||f|||||2017-10-10 20:50:29.772959|2017-10-10 20:50:29.772959
NCT03231111|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-25|||July 25, 2017|Anticipated|2017-07-25|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Interventional|||The Effectiveness of Using Preventive Multimedia Teaching Program in Lung Cancer Women Receiving Targeted Therapy on Skin-Related Quality of Life|The Effectiveness of Using Preventive Multimedia Teaching Program in Lung Cancer Women Receiving Targeted Therapy on Skin-Related Quality of Life|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f|||||f|f||||||||2017-10-10 20:50:29.843539|2017-10-10 20:50:29.843539
NCT03231098|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-25|||October 15, 2017|Anticipated|2017-10-15|July 2017|2017-07-01|July 15, 2018|Anticipated|2018-07-15|July 15, 2018|Anticipated|2018-07-15||Observational|||Detection of GABHS in Throat Gargle|A Quantitative and Comparative Study for the Detection of Group A β-Hemolytic Streptococci in Patient Throat Gargle|Not yet recruiting||N/A|150|Anticipated|Gargle Tech|||1||f||||||||||||||2017-10-10 20:50:29.920538|2017-10-10 20:50:29.920538
NCT03231085|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-24|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2017|Anticipated|2017-07-01||Interventional|IRON KID||Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child|Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child|Not yet recruiting||N/A|50|Anticipated|University Hospital, Montpellier||2|||f||||t|f|f||||||||2017-10-10 20:50:29.989831|2017-10-10 20:50:29.989831
NCT03231072|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-25|||January 31, 2017|Actual|2017-01-31|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Pleural Effusion Drainage in Mechanically Ventilated Patients Monitored by EIT|Effects of the Pleural Effusion Drainage in Mechanically Ventilated Patients Monitored by Electrical Impedance Tomography and End-Expiratory Lung Volume|Recruiting||N/A|15|Anticipated|Czech Technical University in Prague||1|||f||||f|f|f||||||||2017-10-10 20:50:30.086156|2017-10-10 20:50:30.086156
NCT03231059|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-08|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Observational|GLASSY||GLOBAL LEADERS Adjudication Sub-Study|GLOBAL LEADERS Adjudication Sub-Study|Active, not recruiting||N/A|7365|Actual|University Hospital Inselspital, Berne|||2||f||||t|f|f||||||||2017-10-10 20:50:30.167049|2017-10-10 20:50:30.167049
NCT03231046|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-07-25|||April 1, 2018|Anticipated|2018-04-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|MANIFOLD II||Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/CBCT)|Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/CBCT)|Withdrawn||N/A|0|Actual|Clear Guide Medical||2||Lack of funding|f||||f|f|t|f||t|||||2017-10-10 20:50:30.290412|2017-10-10 20:50:30.290412
NCT03231020|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-25|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Observational|||Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study|Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study|Enrolling by invitation||N/A|30|Anticipated|Children's Mercy Hospital Kansas City|||2||f||||f|f|f||||||||2017-10-10 20:50:30.440485|2017-10-10 20:50:30.440485
NCT03231007|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-26|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Observational|SPiRE||Saving Babies' Lives Project Impact and Results Evaluation: a Mixed Methodology Study|Saving Babies' Lives Project Impact and Results Evaluation: a Mixed Methodology Study|Recruiting||N/A|4000|Anticipated|University of Manchester|||4||f||||f|f|f||||||||2017-10-10 20:50:30.529108|2017-10-10 20:50:30.529108
NCT03230994|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-27|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|June 30, 2020|Anticipated|2020-06-30|30 Months|Observational [Patient Registry]|CAN||Cooperative Adenomyosis Network|A Study of Cooperative Network of Diagnosis and Treatment of Uterine Adenomyosis.|Recruiting||N/A|5000|Anticipated|Peking Union Medical College Hospital|||1||f||||t|f|f||||||||2017-10-10 20:50:30.716604|2017-10-10 20:50:30.716604
NCT03230981|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-24|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Age-dependency of Cornea Biomechanics Using OCT Vibrography|Age-dependency of Cornea Biomechanics Measured by OCT Vibrography: A Pilot Study|Not yet recruiting||Early Phase 1|50|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||||2017-10-10 20:50:31.317156|2017-10-10 20:50:31.317156
NCT03230968|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-26|||March 2013|Actual|2013-03-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Use of a Respiratory Care Model in Population Older Than 15 Years in Orizaba, Veracruz Mexico|Reduction in Morbidity, Complications and Mortality Caused by Respiratory Diseases Using a Personalized Integral Model of Care.|Completed||N/A|649|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||f|f|f||||||||2017-10-10 20:50:31.400958|2017-10-10 20:50:31.400958
NCT03230955|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-24|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|May 31, 2018|Anticipated|2018-05-31||Interventional|QUITMENTAL||Effectiveness of a Smoking Cessation Quit Line for Mental Health Patients|Effectiveness of a Smoking Cessation Quit Line for Mental Health Patients: Pragmatic Clinical Trial|Recruiting||N/A|1002|Anticipated|Institut Català d'Oncologia||2|||f||||f|f|f||||||||2017-10-10 20:50:31.473214|2017-10-10 20:50:31.473214
NCT03230942|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-03|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Effect of Pre-op Patient Education on Functional Outcomes After TKA|Effect of Pre-operative Patient Education Program on Functional Outcomes After Total Knee Arthroplasty|Not yet recruiting||N/A|50|Anticipated|University of the State of Santa Catarina||2|||f|||||f|f||||||||2017-10-10 20:50:31.589204|2017-10-10 20:50:31.589204
NCT03230929|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-09-19|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effect of Electromyogram (EMG) Activity on Anesthetic Depth Monitoring|The Effect of EMG Activity on Anesthetic Depth Monitoring : Comparison Between Phase Lag Entropy and BIS|Recruiting||N/A|25|Anticipated|Pusan National University Yangsan Hospital||1|||f||||f|f|f||||||||2017-10-10 20:50:31.667124|2017-10-10 20:50:31.667124
NCT03230864|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-25|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|Anew||Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia|Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia|Recruiting||Phase 2|285|Anticipated|H. Lundbeck A/S||2|||f||||f|t|f||||||||2017-10-10 20:50:32.169435|2017-10-10 20:50:32.169435
NCT03230851|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-27|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|August 10, 2018|Anticipated|2018-08-10|July 10, 2018|Anticipated|2018-07-10||Interventional|||the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy|the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy|Not yet recruiting||Phase 4|210|Anticipated|The First Affiliated Hospital with Nanjing Medical University||7|||f||||f|f|f|||f|||||2017-10-10 20:50:32.270817|2017-10-10 20:50:32.270817
NCT03230825|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-06|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products|Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products After a First Trimester Miscarriage: a Randomized Clinical Trial|Not yet recruiting||N/A|100|Anticipated|Meir Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 20:50:32.474264|2017-10-10 20:50:32.474264
NCT03230812|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Carnitine Supplementation in Type 2 Diabetic Patients|Carnitine Supplementation as a Therapy to Improve Insulin Sensitivity in Type 2 Diabetic Patients With Low Carnitine Status|Not yet recruiting||N/A|26|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:50:32.562989|2017-10-10 20:50:32.562989
NCT03230799|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-24|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Minimal Invasive Lens Surgery and Traditional Cataract Surgery|Comparison of Minimal Invasive Lens Surgery and Traditional Cataract Surgery for Treating Congenital Cataracts|Not yet recruiting||N/A|100|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 20:50:32.690362|2017-10-10 20:50:32.690362
NCT03230786|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-31|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes|A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes|Not yet recruiting||Phase 2|240|Anticipated|KeyBioscience AG||4|||f||||t|f|f||||||||2017-10-10 20:50:32.78473|2017-10-10 20:50:32.78473
NCT03230773|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Use of Public Access Defibrillators by Untrained Bystanders|Can Untrained Bystanders Safely and Effectively Use an Automated External Defibrillator (AED) in a Cardiac Arrest Scenario?|Not yet recruiting||N/A|114|Anticipated|University Hospital Southampton NHS Foundation Trust||6|||f||||f|f|f||||||||2017-10-10 20:50:32.879169|2017-10-10 20:50:32.879169
NCT03230760|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-01|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|June 26, 2018|Anticipated|2018-06-26|June 26, 2018|Anticipated|2018-06-26||Interventional|||Acupuncture for Breast Engorgement During Lactation|Acupuncture for Breast Engorgement During Lactation: a Pilot Study.|Recruiting||N/A|60|Anticipated|Taichung Veterans General Hospital||1|||f||||t|f|f||||||||2017-10-10 20:50:32.958698|2017-10-10 20:50:32.958698
NCT03230747|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-05|||November 2017||2017-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:50:33.057874|2017-10-10 20:50:33.057874
NCT03230734|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|RAPSON||Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer|Randomized, Multicentre Phase II Trial of the Sequencing of Radium-223 and Docetaxel Plus Prednisone in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer (mCRPC)|Not yet recruiting||Phase 2|70|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f|f|f||||||||2017-10-10 20:50:33.104597|2017-10-10 20:50:33.104597
NCT03230721|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-26|||January 15, 2015|Actual|2015-01-15|July 2017|2017-07-01|July 21, 2017|Actual|2017-07-21|April 22, 2017|Actual|2017-04-22||Interventional|||ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH|Comparative Analysis of the Efficacy and Safety of Thulium-fiber Laser Enucleation, Ho:YAG Laser Enucleation and Monopolar Enucleation in Management of BPH|Completed||N/A|450|Actual|I.M. Sechenov First Moscow State Medical University||3|||f||||t|f|f||||||||2017-10-10 20:50:33.244097|2017-10-10 20:50:33.244097
NCT03230708|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites|A Phase I/II Clinical Trial Study on Autologous Erythrocytes Derived Microparticles Packaging Methotrexate Peritoneal Perfusion in the Treatment of Malignant Ascites|Recruiting||Phase 1/Phase 2|18|Anticipated|Hubei Cancer Hospital||2|||f|||||f|f||||||||2017-10-10 20:50:33.337993|2017-10-10 20:50:33.337993
NCT03230695|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-13|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Robotic Therapy and Brain Stimulation in the Early Phase After Stroke|Effects of Robotic Therapy and Transcranial Direct Current Stimulation on Motor Performance of the Paretic Upper Limb in the Early Phase After Stroke|Recruiting||N/A|24|Anticipated|University of Sao Paulo General Hospital||2|||f|||||f|f||||||||2017-10-10 20:50:33.426779|2017-10-10 20:50:33.426779
NCT03230682|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||July 25, 2017|Anticipated|2017-07-25|July 2017|2017-07-01|July 11, 2018|Anticipated|2018-07-11|June 11, 2018|Anticipated|2018-06-11|3 Months|Observational [Patient Registry]|||Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder|Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder|Recruiting||N/A|80|Anticipated|Huashan Hospital|||1||f||||t|f|f||||||||2017-10-10 20:50:33.529651|2017-10-10 20:50:33.529651
NCT03230669|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-25|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Computer-assisted Delivery of Cognitive Behavioral Therapy for Mental Health and Addictions in Canada|Computer-assisted Delivery of Cognitive Behavioral Therapy for Mental Health and Addictions in Canada|Recruiting||N/A|240|Anticipated|University of Prince Edward Island||2|||f||||t|f|f||||||||2017-10-10 20:50:33.613246|2017-10-10 20:50:33.613246
NCT03230656|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-25|2017-07-25|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Cognitive-Communication Screening and Early Therapy for Adults With Mild TBI|Cognitive-Communication Screening and Early Therapy for Adults With Concussion/Mild Traumatic Brain Injury|Recruiting||N/A|300|Anticipated|Northern Arizona University||2|||f||||f|f|f||||||||2017-10-10 20:50:33.703406|2017-10-10 20:50:33.703406
NCT03230643|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure|Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure|Recruiting||N/A|200|Anticipated|Heart and Diabetes Center North-Rhine Westfalia|||1||f||||f|f|f||||||||2017-10-10 20:50:33.810915|2017-10-10 20:50:33.810915
NCT03230630|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|January 1, 2017|Actual|2017-01-01|January 1, 2015|Actual|2015-01-01||Observational|||Plasma Melatonin AND Mortality After Acute Myocardial Infarction|Early-morning Plasma Melatonin Levels Predict Cardiovascular Mortality After Acute Myocardial Infarction|Completed||N/A|732|Actual|Chinese PLA General Hospital|||1||f|||||f|f||||||||2017-10-10 20:50:33.893604|2017-10-10 20:50:33.893604
NCT03230617|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|September 1, 2018|Anticipated|2018-09-01||Observational|||Dynamic Hyperinflation In Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients|Evaluation Of Dynamic Hyperinflation In Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients|Not yet recruiting||N/A|100|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:50:33.95348|2017-10-10 20:50:33.95348
NCT03230604|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|December 1, 2021|Anticipated|2021-12-01|July 24, 2017|Actual|2017-07-24||Interventional|||Clinical Performance of Two Bulk-Fill Composite of Posterior Restorations|Clinical Performance of Bulk-fill Resins Composite Restorations on Posterior Tooth of Adults Patients. Randomized Doble-blind Trial|Recruiting||N/A|155|Anticipated|Universidad Nacional Andres Bello||2|||f||||t|f|f||||||||2017-10-10 20:50:34.03447|2017-10-10 20:50:34.03447
NCT03230591|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-23|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Observational|||Impact of Agalsidase Alfa Therapy on Cardiac funcTION in Patients With Fabry's Cardiomyopathy|Impact of Agalsidase Alfa Therapy on Cardiac funcTION in Patients With Fabry's Cardiomyopathy (ACTION-Fabry Trial)|Recruiting||N/A|25|Anticipated|Yonsei University|||1||f|||||f|f||||Samples Without DNA|"     10cc blood   "|||2017-10-10 20:50:34.129343|2017-10-10 20:50:34.129343
NCT03230578|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 16, 2018|Anticipated|2018-07-16|July 16, 2018|Anticipated|2018-07-16||Observational|PHARM||Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans|Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans|Not yet recruiting||N/A|60|Anticipated|University of New Mexico|||2||f||||f|f|f||||||||2017-10-10 20:50:34.229843|2017-10-10 20:50:34.229843
NCT03230565|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-26|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Continuous Infusions vs Scheduled Bolus Infusions|A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion|Not yet recruiting||N/A|120|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 20:50:34.315536|2017-10-10 20:50:34.315536
NCT03230552|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-29|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Effect of Pre-operative Training Using Surgical Videos on Resident Performance of Unilateral Salpigo-oophrectomy|Effect of Pre-operative Training Using Surgical Videos on Resident Performance of Unilateral Salpigo-oophrectomy|Enrolling by invitation||N/A|24|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 20:50:34.405596|2017-10-10 20:50:34.405596
NCT03230539|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-11|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)|A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA) on Ovulation, Endometrial Changes and Bleeding Patterns in Normally Cycling Women|Recruiting||Phase 1|30|Anticipated|Population Council||3|||f||||f|f|f||||||||2017-10-10 20:50:34.480771|2017-10-10 20:50:34.480771
NCT03230526|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-26|||October 2, 2017|Anticipated|2017-10-02|July 2017|2017-07-01|April 2, 2022|Anticipated|2022-04-02|April 2, 2022|Anticipated|2022-04-02||Interventional|GLIAPARK||Identification of a Biomarker Predictive of Evolution of Parkinson Disease|Brain Microglial Activation in the Early Stage of the Parkinson's Disease: a Predictive Biomarker of the Evolution?|Not yet recruiting||Phase 2|64|Anticipated|Nantes University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:50:34.567028|2017-10-10 20:50:34.567028
NCT03230513|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-30|||October 1, 2015|Actual|2015-10-01|July 2017|2017-07-01|May 1, 2017|Actual|2017-05-01|October 31, 2016|Actual|2016-10-31||Interventional|||Comparison of Home-Based Exercise on the Posterior Canal Benign Paroxysmal Positional Vertigo Symptoms|Comparison of Home-Based Modified Self-Epley Manoeuvre and Brandt-Daroff Exercise on the Posterior Canal Benign Paroxysmal Positional Vertigo Symptoms: A Randomized Single-Blind Controlled Trial|Completed||N/A|50|Actual|University of Malaya||2|||f||||f|f|f||||||||2017-10-10 20:50:34.701298|2017-10-10 20:50:34.701298
NCT03230500|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 1, 2020|Anticipated|2020-03-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Computer Guided Versus Free Hand Immediate Implant Placement|Patient Satisfaction and Early Implant Failure of Computer-guided Versus Free- Hand Immediate Implant Placement in Fresh Extraction Sockets in Esthetic Zone, a Randomized Clinical Trial.|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:50:34.776936|2017-10-10 20:50:34.776936
NCT03230487|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-10-02|||August 10, 2017|Actual|2017-08-10|October 2017|2017-10-01|December 11, 2017|Anticipated|2017-12-11|December 11, 2017|Anticipated|2017-12-11||Interventional|||This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body|Safety, Tolerability, and Pharmacokinetics of Single (Part 1) and Multiple Rising Oral Doses (Part 2) of BI 1015550 in Healthy Male Subjects|Recruiting||Phase 1|42|Anticipated|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 20:50:34.842149|2017-10-10 20:50:34.842149
NCT03230474|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-10-02|||May 2016|Actual|2016-05-01|October 2017|2017-10-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||a Small Dose of Naloxone,Minimize Intrathecal Morphine Side Effects|Ultra Small Dose of Intrathecal Naloxone to Minimize Morphine Induced Side- Effects in Patients Undergoing Minor Anal Surgery Under Spinal Anesthesia. A Randomized Double Blind Study|Completed||N/A|100|Actual|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:50:34.920906|2017-10-10 20:50:34.920906
NCT03230461|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-08|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|August 7, 2017|Actual|2017-08-07|August 7, 2017|Actual|2017-08-07||Interventional|||Estimation of CPR Chest Compression Depth|Can Rescuers Accurately Deliver Subtle Changes to Chest Compression Depth if Recommended by Future Guidelines?|Completed||N/A|100|Actual|University Hospital Southampton NHS Foundation Trust||3|||f||||f|f|f||||||||2017-10-10 20:50:34.990386|2017-10-10 20:50:34.990386
NCT03230448|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-30|||May 29, 2017|Actual|2017-05-29|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31|1 Day|Observational [Patient Registry]|ISA||Study of the Links Between Suicidal Intentionality and Acute Alcoholism|Study of the Links Between Suicidal Intentionality and Acute Alcoholism|Completed||N/A|110|Actual|University Hospital, Toulouse|||2||f||||f|f|f||||||||2017-10-10 20:50:35.078839|2017-10-10 20:50:35.078839
NCT03230435|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-25|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|May 31, 2018|Anticipated|2018-05-31||Observational|QOLAN-DK||Health Related Quality of Life for Patients With Anorexia Nervosa in Denmark.|Health Related Quality of Life for Patients With Anorexia Nervosa in Denmark.|Recruiting||N/A|496|Anticipated|Odense University Hospital|||2||f||||f|f|f||||||||2017-10-10 20:50:35.145875|2017-10-10 20:50:35.145875
NCT03230422|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-09-28|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|September 27, 2017|Actual|2017-09-27|July 31, 2017|Actual|2017-07-31||Interventional|Kivi||A Comparison of Video Laryngoscopes and the Direct Laryngoscope in Simulated Normal and Difficult Infant Airway.|A Comparison of the Novel King Vision Pediatric aBlade and the C-MAC Video Laryngoscope to the Direct Laryngoscope in Simulated Normal and Difficult Infant Airway. A Bicentric, Prospective, Randomized Manikin Study|Completed||N/A|80|Actual|Johannes Gutenberg University Mainz||2|||f||||f|f|f||||||||2017-10-10 20:50:35.226919|2017-10-10 20:50:35.226919
NCT03230409|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-25|||January 1, 2014||2014-01-01|July 2017|2017-07-01|January 15, 2017|Actual|2017-01-15|September 30, 2016|Actual|2016-09-30||Interventional|||Impact of Nursing Interventions on Adherence to Treatment With Anti-tuberculosis Drugs in Children and Adolescents|Impact of Nursing Interventions on Adherence to Treatment With Anti-tuberculosis Drugs in Children and Adolescents|Completed||N/A|359|Actual|Hospital Sant Joan de Deu||2|||f||||t|f|f||||||||2017-10-10 20:50:35.296053|2017-10-10 20:50:35.296053
NCT03230396|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-05|||October 13, 2014|Actual|2014-10-13|August 2017|2017-08-01|July 1, 2015|Actual|2015-07-01|July 1, 2015|Actual|2015-07-01||Interventional|||Vitamin Gum Pharmacokinetics|Oral Release and Pharmacokinetics of Vitamins From a Gum-based Delivery System|Completed||N/A|15|Actual|Penn State University||3|||f||||f|f|f||||||||2017-10-10 20:50:35.374688|2017-10-10 20:50:35.374688
NCT03230370|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-25|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 20, 2020|Anticipated|2020-05-20|May 20, 2020|Anticipated|2020-05-20||Interventional|||Does the Enhanced Rehabilitation Programs Facilitate the Motor Recovery After Stroke?|Does the Enhanced Rehabilitation Programs Facilitate the Motor Recovery After Stroke? A Multicenter Randomized Controlled Study (TIARAS Trial)|Not yet recruiting||N/A|150|Anticipated|Taipei Medical University WanFang Hospital||2|||f||||f|f|f||||||||2017-10-10 20:50:35.537414|2017-10-10 20:50:35.537414
NCT03230357|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-25|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|August 2, 2018|Anticipated|2018-08-02|February 2, 2018|Anticipated|2018-02-02||Interventional|||Research on the Localization Accuracy of PICC Guided by EDUG in Real World|Research on the Localization Accuracy of PICC Guided by EDUG in Real World|Active, not recruiting||N/A|1000|Anticipated|Shandong Branden Med.Device Co.,Ltd||1|||f||||t|f|f||||||||2017-10-10 20:50:35.606856|2017-10-10 20:50:35.606856
NCT03230344|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-23|||December 1, 2016|Actual|2016-12-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Periodontal Surgery With Early vs Delayed Endodontic Treatment in Endo-Perio Lesions Without Communication|Surgical Periodontal Intervention With Simultaneous Versus Delayed Endodontic Treatment in Concurrent Endodontic-Periodontal Lesion Without Communication - An Interventional Study|Recruiting||N/A|36|Anticipated|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||||2017-10-10 20:50:35.668454|2017-10-10 20:50:35.668454
NCT03230331|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-26|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|||Follow Up Study for Treatment of Parkinson's Disease With Subthalamic Deep Brain Stimulation|Long Term Study of Subthalamic Deep Brain Stimulation for Parkinson's Disease|Recruiting||N/A|40|Anticipated|Ruijin Hospital|||2||f|||||f|f||||||||2017-10-10 20:50:35.736744|2017-10-10 20:50:35.736744
NCT03230305|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||April 12, 2017|Actual|2017-04-12|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|Quali-SAGE||Elderly CAncer Patient: Qualitative and Quantitative Factors of Inclusion Failure in Clinical Trials|Elderly CAncer Patient: Qualitative and Quantitative Factors of Inclusion Failure in Clinical Trials|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||||2017-10-10 20:50:36.016563|2017-10-10 20:50:36.016563
NCT03230292|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-17|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|April 8, 2019|Anticipated|2019-04-08|April 6, 2019|Anticipated|2019-04-06||Interventional|||This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.|A Multicenter, 48-week, Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis.|Recruiting||Phase 2|45|Anticipated|UCB Pharma||1|||f||||t|t|f||||||||2017-10-10 20:50:36.125899|2017-10-10 20:50:36.125899
NCT03230279|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2023|Anticipated|2023-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Sacroiliac Joint Fusion Comparison Study|Randomized Controlled Trial Of Minimally Invasive Sacroiliac Joint Fusion Compared To Radiofrequency Ablation For Sacroiliac Joint Dysfunction|Not yet recruiting||N/A|84|Anticipated|Ochsner Health System||2|||f||||f|f|f|||f|||||2017-10-10 20:50:36.240013|2017-10-10 20:50:36.240013
NCT03230266|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-21|||May 17, 2017|Actual|2017-05-17|July 2017|2017-07-01|December 17, 2018|Anticipated|2018-12-17|December 17, 2018|Anticipated|2018-12-17||Interventional|CATS||Root Cause Determination of Catheter Obstructions|Determination of the Root Causes of Obstructions of Catheters in Patients With Type 1 Diabetes Treated by Insulin Implanted Pumps|Active, not recruiting||N/A|140|Anticipated|University Hospital, Montpellier||1|||f||||f|f|f||||||||2017-10-10 20:50:36.364835|2017-10-10 20:50:36.364835
NCT03230253|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-25|||September 30, 2017|Anticipated|2017-09-30|May 2017|2017-05-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Effects and Mechanism of Two Hybrid Exercise-cognitive Trainings in Mild Ischemic Stroke With Cognitive Decline|Effects and Mechanism of Two Hybrid Exercise-cognitive Trainings in Mild Ischemic Stroke With Cognitive Decline: fMRI for Brain Plasticity, and Biomarker and Behavioral Analysis|Not yet recruiting||N/A|75|Anticipated|Chang Gung Memorial Hospital||3|||f||||t|f|f||||||||2017-10-10 20:50:36.454322|2017-10-10 20:50:36.454322
NCT03230240|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-07-23|||January 2016||2016-01-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Immunologic Profile of Peritoneal Cancer|Immunologic, Cellular, and Anti-microbial Profiling of Intraperitoneal Chemotherapy|Recruiting||N/A|60|Anticipated|Catholic Health Initiatives|||1||f||||f||||||Samples Without DNA|"     ascites   "|||2017-10-10 20:50:36.569737|2017-10-10 20:50:36.569737
NCT03230227|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-23|||February 2015|Actual|2015-02-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Presternal Magnesium With Bupivacain Versus Bupivacain Only for Postoperative Pain Relief in Open Heart Surgery|Presternal Magnesium With Bupivacain Infusion Versus Bupivacain Only for Postoperative Pain Relief in Open Heart Surgery ; a Randomized Double Blind Study|Completed||N/A|40|Actual|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:50:36.679|2017-10-10 20:50:36.679
NCT03230214|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-09|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Effect of Bacterial Translocation on Haemodynamic and Coagulation Parameters During Liver Transplantation|Effect of Bacterial Translocation on Haemodynamic and Coagulation Parameters During a Liver Transplantation|Recruiting||N/A|30|Anticipated|Alexandria University|||2||f||||||||||||||2017-10-10 20:50:36.771277|2017-10-10 20:50:36.771277
NCT03230201|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-05|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2021|Anticipated|2021-01-01||Interventional|UTUC||Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)|Impact of Lymph Node Dissection in the Management of High-risk Primary Upper Tract Urothelial Carcinoma Patients|Recruiting||N/A|80|Anticipated|Peking University First Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:50:36.862376|2017-10-10 20:50:36.862376
NCT03230188|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-21|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Observational|PANISA||Patterns of Neurocircuitry Activation In Severe Asthma|Patterns of Neurocircuitry Activation In Severe Asthma|Recruiting||N/A|25|Anticipated|University of Wisconsin, Madison|||1||f||||f|f|f||||Samples Without DNA|"     Blood   "|||2017-10-10 20:50:36.957416|2017-10-10 20:50:36.957416
NCT03230162|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-07-23|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment|Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment|Recruiting||Phase 3|100|Anticipated|Ain Shams University||2|||f|||||f|f||||||||2017-10-10 20:50:37.158309|2017-10-10 20:50:37.158309
NCT03230149|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-19|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Observational|FABRY||Prevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber Neuropathy|Prevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber Neuropathy|Not yet recruiting||N/A|1100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||||2017-10-10 20:50:37.262829|2017-10-10 20:50:37.262829
NCT03230123|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||May 2016||2016-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|BIOMEL||Effects of Green Banana BIOmass Consumption in Patients With Pre-diabetes and Diabetes MELlitus (The BIOMEL Study)|Effects of Green Banana BIOmass Consumption in Patients With Pre-diabetes and Diabetes MELlitus (The BIOMEL Study)|Recruiting||N/A|136|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 20:50:37.457451|2017-10-10 20:50:37.457451
NCT03230110|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-24|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Observational|OSA-CHTN||OSA in Pregnant Women With Chronic HTN|Obstructive Sleep Apnea Among Pregnant Women With Chronic Hypertension|Recruiting||N/A|120|Anticipated|Duke University|||2||f||||f|f|f|||f|Samples With DNA|"     Serum   "|||2017-10-10 20:50:37.553298|2017-10-10 20:50:37.553298
NCT03230097|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-10-02|||September 29, 2017|Actual|2017-09-29|October 2017|2017-10-01|May 28, 2021|Anticipated|2021-05-28|March 8, 2021|Anticipated|2021-03-08||Interventional|||This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year|A Phase II Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 52-week Treatment Period as an Early Intervention in Patients With Attenuated Psychosis Syndrome.|Recruiting||Phase 2|300|Anticipated|Boehringer Ingelheim||2|||f||||t|t|f||||||||2017-10-10 20:50:37.645829|2017-10-10 20:50:37.645829
NCT03230084|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-08-28|||August 23, 2017|Actual|2017-08-23|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Use of a Home-based PDG Urine Test to Confirm Ovulation|Use of a Home-based Urinary Pregnanediol 3-glucuronide (PDG) Test to Confirm Ovulation|Recruiting||N/A|25|Anticipated|Bruyere Research Institute||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:50:37.730534|2017-10-10 20:50:37.730534
NCT03230071|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-26|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia|Efficacy and Safety of Twice Daily TMBCZG in Mild to Moderate Vascular Dementia: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Trial|Not yet recruiting||Phase 2|160|Anticipated|Dongzhimen Hospital, Beijing||4|||f||||t|f|f||||||||2017-10-10 20:50:37.844198|2017-10-10 20:50:37.844198
NCT03230058|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-23|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|March 1, 2018|Anticipated|2018-03-01||Interventional|NATA_VORI||Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis|Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis: a Prospective Randomized Double Masked Clinical Trial|Recruiting||Phase 2/Phase 3|55|Anticipated|L.V. Prasad Eye Institute||2|||f||||t|f|f|||f|||||2017-10-10 20:50:37.930778|2017-10-10 20:50:37.930778
NCT03230045|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-26|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|September 10, 2018|Anticipated|2018-09-10|July 10, 2018|Anticipated|2018-07-10||Interventional|DALAS||Dual Acupoints Stimulation Alleviates Pulmonary Complication|Effect of Dual Acupoints Stimulation on Lung Complication After Abdominal Surgery|Recruiting||N/A|280|Anticipated|Fourth Military Medical University||2|||f||||t|f|f||||||||2017-10-10 20:50:38.017496|2017-10-10 20:50:38.017496
NCT03230032|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-25|||June 10, 2017|Actual|2017-06-10|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy|RCT of Feeding Intervention With Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy.|Recruiting||N/A|216|Anticipated|Nationwide Children's Hospital||2|||f||||t|f|t|f||f|||||2017-10-10 20:50:38.113143|2017-10-10 20:50:38.113143
NCT03230019|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-29|||August 14, 2017|Anticipated|2017-08-14|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Two-Lumen Catheterization For Lung Wedge Resection|Two-Lumen Catheterization Versus Chest Tube Placement in Patients With Lung Wedge Resection: A Prospective Randomized Trial|Not yet recruiting||N/A|96|Anticipated|Guangdong Provincial People's Hospital||2|||f|||||f|f||||||||2017-10-10 20:50:38.191437|2017-10-10 20:50:38.191437
NCT03230006|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-07-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders|Efficacy Evaluation of Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders|Not yet recruiting||N/A|60|Anticipated|Boston University Charles River Campus||2|||f||||t|f|f||||||||2017-10-10 20:50:38.267024|2017-10-10 20:50:38.267024
NCT03229993|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-27|||July 28, 2017|Anticipated|2017-07-28|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|July 28, 2017|Anticipated|2017-07-28||Interventional|OCT-borderline||OCT in Borderline Coronary Artery Lesions|The Safety and Efficacy of OCT in the Evaluation and Treatment of Angiographically Borderline Coronary Artery Lesions|Not yet recruiting||N/A|120|Anticipated|The First Affiliated Hospital with Nanjing Medical University||4|||f|||||f|f||||||||2017-10-10 20:50:38.330552|2017-10-10 20:50:38.330552
NCT03229980|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pediatric Myocardial Protection With Potassium Cardioplegia|Pediatric Myocardial Protection; Large Volume Potassium Cardioplegia Advantageous Over Small Volume Potassium Cardioplegia: Where do we Stand?|Not yet recruiting||Phase 2|60|Anticipated|Assiut University||3|||f||||t|f|f||||||||2017-10-10 20:50:38.388221|2017-10-10 20:50:38.388221
NCT03229967|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-24|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|MiBPD||Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary Dysplasia|Gastrointestinal Microbiota Influence on the Pathogenesis of Bronchopulmonary Dysplasia in Very Low Birthweight Neonates|Enrolling by invitation||N/A|200|Anticipated|University of Tennessee|||3||f||||f|f|f||||||||2017-10-10 20:50:38.456167|2017-10-10 20:50:38.456167
NCT03229954|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-28|||August 28, 2017|Actual|2017-08-28|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial|Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial|Recruiting||Phase 4|358|Anticipated|Yonsei University||2|||f||||f|f|f||||||||2017-10-10 20:50:38.523973|2017-10-10 20:50:38.523973
NCT03229941|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-15|||October 2, 2017|Anticipated|2017-10-02|August 2017|2017-08-01|February 28, 2022|Anticipated|2022-02-28|February 28, 2022|Anticipated|2022-02-28||Interventional|TOP||Transfusion Trigger After Operations in High Cardiac Risk Patients|CSP #599 - Transfusion Trigger After Operations in High Cardiac Risk Patients (TOP)|Not yet recruiting||N/A|3070|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 20:50:38.5944|2017-10-10 20:50:38.5944
NCT03229928|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-25|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|MOCHA||Clinical Testing of a Real-Time Behavior Measurement Tool: Measuring Outcomes for CHAnge|Clinical Testing of a Real-Time Behavior Measurement Tool: Measuring Outcomes for CHAnge|Enrolling by invitation||N/A|60|Anticipated|University of North Carolina, Chapel Hill|||3||f||||f|f|t|t|f||||||2017-10-10 20:50:38.701589|2017-10-10 20:50:38.701589
NCT03229915|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||CPT-fMRI Study for PTSD|Identification of Neuroimaging-Based Biomarkers in the Treatment of Posttraumatic Stress Disorder|Not yet recruiting||N/A|60|Anticipated|University of Manitoba||3|||f||||f|f|f||||||||2017-10-10 20:50:38.774465|2017-10-10 20:50:38.774465
NCT03229902|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-15|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|April 18, 2018|Anticipated|2018-04-18|February 14, 2018|Anticipated|2018-02-14||Interventional|||Mantra Meditation in Subjects That Have Chronically Impaired Attention After Stroke|A Non-Concurrent, Multiple-Baseline, Across-Subjects Trial of Mantra Meditation in Subjects That Have Chronically Impaired Attention After Stroke|Recruiting||N/A|4|Anticipated|University of Kentucky||1|||f||||f|f|f||||||||2017-10-10 20:50:38.838879|2017-10-10 20:50:38.838879
NCT03229889|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-24|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment|Medication Facilitated Ureteral Access Sheath Deployment During Ureteroscopy and Endoscopic-Guided Percutaneous Nephrolithotomy: A Randomized Double-Blind Placebo Controlled Trial of Tadalafil, Tamsulosin and Combination|Enrolling by invitation||Phase 4|220|Anticipated|University of California, Irvine||4|||f||||t|t|f|||t|||||2017-10-10 20:50:38.91485|2017-10-10 20:50:38.91485
NCT03229876|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-26|||July 15, 2017|Actual|2017-07-15|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|U-CART||Universal CD19-CART Treating ALL|A Safety and Efficacy Evaluation of Universal CD19-CART in the Treatment of B Cell Acute Leukemia|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Shanghai Bioray Laboratory Inc.||1|||f||||f|f|f||||||||2017-10-10 20:50:39.014237|2017-10-10 20:50:39.014237
NCT03229863|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-24|||April 18, 2017|Actual|2017-04-18|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|IMiND||An Examination of Infants' Microbiome, Nutrition, and Development Study.|The Infant MiND Study: An Examination of Infants' Microbiome, Nutrition, and Development Study.|Recruiting||N/A|120|Anticipated|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 20:50:39.08714|2017-10-10 20:50:39.08714
NCT03229850|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-24|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique|Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique|Not yet recruiting||N/A|10|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 20:50:39.204541|2017-10-10 20:50:39.204541
NCT03229837|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-02|||August 1, 2017|Actual|2017-08-01|July 2017|2017-07-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Observational|||Validation Study of Pediatric Patient-Reported Outcomes|Pediatric Patient-Reported Outcomes (PEPR) for Childhood Cancer Survivors: Clinical Validity Study|Recruiting||N/A|300|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-10 20:50:39.293164|2017-10-10 20:50:39.293164
NCT03229824|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-07-24|||October 3, 2016|Actual|2016-10-03|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|December 30, 2017|Anticipated|2017-12-30||Interventional|||Use of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical Trial|Randomized Controlled Trial to Reduce Surgical Site Infections in Breast Cancer Surgery With Clorhexidine Gluconate Securement Dressing (Tegaderm CHG)|Recruiting||N/A|104|Anticipated|National Institute of Cancerología||2|||f||||f|f|f||||||||2017-10-10 20:50:39.357233|2017-10-10 20:50:39.357233
NCT03229811|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|March 30, 2022|Anticipated|2022-03-30|March 30, 2021|Anticipated|2021-03-30||Interventional|||Integrating Advance Care Planning Into a Pre-Dialysis Educational Program|Integrating Advance Care Planning Into a Pre-Dialysis Educational Program|Recruiting||N/A|100|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:50:41.010674|2017-10-10 20:50:41.010674
NCT03229798|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-15|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|KCC-SMT-002||Sofusa System With Sumatriptan (KC5010) Phase 1 Pharmacokinetics and Safety Study (KCC-SMT-002)|An Open-Label Phase 1 Study to Establish the Pharmacokinetics and Safety of Sumatriptan Succinate Administered Via the Sofusa™ Device at Variable Doses Compared to Oral Imitrex® Single 100 mg Dose in Healthy Subjects|Not yet recruiting||Phase 1|17|Anticipated|Kimberly-Clark Corporation||4|||f|||||t|t|t|f||||||2017-10-10 20:50:41.088236|2017-10-10 20:50:41.088236
NCT03229785|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-27|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|January 31, 2019|Anticipated|2019-01-31||Interventional|||Quality of Life Improvements With Cord Blood Plasma|Determining Overall Improvement in the Quality of Life of Individuals Receiving Human Umbilical Cord Blood Plasma|Not yet recruiting||Phase 1|200|Anticipated|Hexagon Therapies, LLC||1|||f||||t|f|f||||||||2017-10-10 20:50:41.173489|2017-10-10 20:50:41.173489
NCT03229772|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-07-24|||September 2015||2015-09-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||"Demonstration of the SPECT/CT System With CZT Detectors Imaging Performance in a Clinical Setting"|"Demonstration of the SPECT/CT System With CZT Detectors Imaging Performance in a Clinical Setting"|Completed||N/A|19|Actual|GE Healthcare||1|||f||||f|f|f|||f|||||2017-10-10 20:50:41.242493|2017-10-10 20:50:41.242493
NCT03229759|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-22|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|||Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth|A Randomized Single Center Blinded Clinical Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth Compared to Vehicle and 0.9% Saline|Completed||Phase 2|36|Actual|Becton, Dickinson and Company||3|||f||||f|t|f||||||||2017-10-10 20:50:41.304713|2017-10-10 20:50:41.304713
NCT03229746|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-24|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia|Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia|Not yet recruiting||Phase 4|40|Anticipated|Assiut University||3|||f||||t|f|f|||f|||||2017-10-10 20:50:41.385038|2017-10-10 20:50:41.385038
NCT03229733|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-08-22|||November 2015||2015-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Design and Evaluation the Effects of Kinect-based Computer Games for U/E Training in Chronic Stroke Patients|Design and Evaluation the Feasibility, Effects of Kinect-based Computer Games for Rehabilitation Training of Upper Extremity Function in Patients With Chronic Stroke|Active, not recruiting||N/A|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 20:50:41.467163|2017-10-10 20:50:41.467163
NCT03229720|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-24|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Audio-Visual Distraction Technique on Child's Anxiety|Effectiveness of Audio-Visual Distraction Technique Versus Normal Dental Environment for Management of Anxiety in Pediatric Dental Patients, A Randomized Clinical Trial|Not yet recruiting||N/A|42|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:50:41.543908|2017-10-10 20:50:41.543908
NCT03229707|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-28|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Impact Of Digital Photography & Conventional Method On The Accuracy Of Dental Shade Matching In The Esthetic Zone|Impact Of Digital Photography & Conventional Method On The Accuracy Of Shade Matching In The Esthetic Zone|Not yet recruiting||N/A|9|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:50:41.615357|2017-10-10 20:50:41.615357
NCT03229694|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-22|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||the Effect of Tracleer on Tourniquet-associated Hypertension|Effect of Endothelin Receptor Blocker Tracleer on Toruniquet-associated Hypertension During Total Knee Arthroplasty|Not yet recruiting||Phase 4|80|Anticipated|Xuzhou Medical University||2|||f||||f|t|f|||t|||||2017-10-10 20:50:41.684683|2017-10-10 20:50:41.684683
NCT03229681|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-23|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Interventional|BEPCR||Baduanjin Exercise for Patients With Chronic Heart Failure on Phase II Cardiac Rehabilitation|Baduanjin Exercise for Patients With Chronic Heart Failure on Phase II Cardiac Rehabilitation: A Prospective, Randomized, Controlled Clinical Trial|Recruiting||N/A|120|Anticipated|Xiyuan Hospital of China Academy of Chinese Medical Sciences||2|||f|||||f|f||||||||2017-10-10 20:50:41.875275|2017-10-10 20:50:41.875275
NCT03229668|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-03|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Urological Surgical Operations|Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Urological Surgical Operations|Recruiting||Phase 2/Phase 3|78|Anticipated|Saint Savvas Anticancer Hospital||3|||f||||f|f|f||||||||2017-10-10 20:50:41.972366|2017-10-10 20:50:41.972366
NCT03229655|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-24|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Evaluation of Sequential Stent Addition vs. Incremental Dilation & Stent Exchange for Management of Anastomotic Biliary Strictures After Liver Transplantation|Evaluation of Sequential Stent Addition vs. Incremental Dilation & Stent Exchange for Management of Anastomotic Biliary Strictures After Liver Transplantation|Not yet recruiting||N/A|100|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 20:50:42.084488|2017-10-10 20:50:42.084488
NCT03229642|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-22|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use Disorders|The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use Disorders: Analysis of Clinical Outcomes, Functional Magnetic Resonance Imaging, Biomarkers, and Neuropsychological Tests|Not yet recruiting||N/A|60|Anticipated|National Cheng-Kung University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:50:42.156251|2017-10-10 20:50:42.156251
NCT03229629|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-22|||June 25, 2017|Actual|2017-06-25|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||What Promotes Healthy Eating? The Roles of Information,Affordability,Accessibility,Gender, and Peers on Food Consumption|What Promotes Healthy Eating? The Roles of Information, Affordability, Accessibility, Gender, and Peers on Food Consumption|Recruiting||N/A|7200|Anticipated|Cornell University||6|||f||||f|f|f||||||||2017-10-10 20:50:42.25581|2017-10-10 20:50:42.25581
NCT03229603|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-07-20|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|HPV||A Pilot Study on HPV and Cervical Cancer Screening in Mumbai|A Pilot Study on HPV and Cervical Cancer Screening in Mumbai|Not yet recruiting||N/A|227|Anticipated|Tata Memorial Hospital||1|||f||||t|f|f||||||||2017-10-10 20:50:42.468021|2017-10-10 20:50:42.468021
NCT03229590|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-22|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||Slipped Capital Femoral Epiphysis Treatment|Safe Surgical Dislocation in Slipped Capital Femoral Epiphysis|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:50:42.551262|2017-10-10 20:50:42.551262
NCT03229577|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-21|||July 31, 2017|Anticipated|2017-07-31|June 2017|2017-06-01|December 8, 2017|Anticipated|2017-12-08|December 8, 2017|Anticipated|2017-12-08||Interventional|||Yale College Project Randomized Control Trial|Yale College Project Randomized Control Trial|Recruiting||N/A|200|Anticipated|Yale University||4|||f||||f|f|f||||||||2017-10-10 20:50:42.615964|2017-10-10 20:50:42.615964
NCT03229564|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-21|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children|A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Children in Comparison to Autologous Split-thickness Skin Grafts (STSG)|Not yet recruiting||Phase 2/Phase 3|12|Anticipated|University of Zurich||1|||f||||t|f|f||||||||2017-10-10 20:50:42.715477|2017-10-10 20:50:42.715477
NCT03229551|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Xylitol for Chronic Sinusitis|Xylitol Topical Irrigation for Treatment of Recalcitrant Chronic Sinusitis|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Ochsner Health System||2|||f|||||f|f|||f|||||2017-10-10 20:50:42.817529|2017-10-10 20:50:42.817529
NCT03229538|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-29|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2021|Anticipated|2021-02-28||Interventional|STRESS||STeroids to REduce Systemic Inflammation After Neonatal Heart Surgery|STeroids to REduce Systemic Inflammation After Neonatal Heart Surgery (STRESS)|Not yet recruiting||Phase 3|1200|Anticipated|Duke University||2|||||||t|t|f||||||||2017-10-10 20:50:42.890355|2017-10-10 20:50:42.890355
NCT03229525|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|February 2020|Anticipated|2020-02-01||Interventional|||Narrative Exposure Based Intervention For Post-Traumatic Stress Disorder|Narrative Exposure Based Intervention For Post-Traumatic Stress Disorder|Not yet recruiting||N/A|162|Anticipated|University of Texas at Austin||3|||f||||f|f|f||||||||2017-10-10 20:50:42.997224|2017-10-10 20:50:42.997224
NCT03229512|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||April 11, 2017|Actual|2017-04-11|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Topical Sildenafil as Pre-Treatment for Hand-Foot Skin Reaction|An Open Label, Pilot Study Evaluating the Effect of Topical Sildenafil as Pre-Treatment for Hand-Foot Skin Reaction|Recruiting||Early Phase 1|20|Anticipated|Northwestern University||1|||f||||t|f|f||||||||2017-10-10 20:50:43.066186|2017-10-10 20:50:43.066186
NCT03229499|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-10-05|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|PHANTOM||Pulmonary Hypertension and Anastrozole Trial|Pulmonary Hypertension and Anastrozole Trial (PHANTOM)|Recruiting||Phase 2|84|Anticipated|University of Pennsylvania||2|||f||||t|t|f|||t|||||2017-10-10 20:50:43.153083|2017-10-10 20:50:43.153083
NCT03229486|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-19|||October 17, 2017|Anticipated|2017-10-17|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia|A Prospective, Double-blind, Randomized Study to Investigate the Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Emergence Delirium During Sevoflurane-rocuronium Anesthesia in Pediatric Patients|Not yet recruiting||Phase 4|40|Anticipated|Pusan National University Yangsan Hospital||2|||f||||t|t|f|||t|||||2017-10-10 20:50:43.267002|2017-10-10 20:50:43.267002
NCT03229473|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Fall Risk Assessment in COPD|Validity and Reliability of Balance Screening Tests for Fall Risk Assessment in COPD|Not yet recruiting||N/A|120|Anticipated|McMaster University|||1||f||||f|f|f||||||||2017-10-10 20:50:43.338952|2017-10-10 20:50:43.338952
NCT03229460|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-23|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||High Flow Nasal Oxygen Therapy in the Adult With Hypoxemic Respiratory|Hign Flow Nasal Oxygen Therapy in Perioperative Period of the Adult With Hypercapnic and Hypoxemic Respiratory Faliure|Not yet recruiting||N/A|150|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||3|||f||||t|f|t|f|f|t|||||2017-10-10 20:50:43.517601|2017-10-10 20:50:43.517601
NCT03229447|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-21|||April 15, 2016|Actual|2016-04-15|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts|Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts|Recruiting||Phase 1/Phase 2|96|Anticipated|National Development and Research Institutes, Inc.||2|||f||||f|f|f||||||||2017-10-10 20:50:43.589319|2017-10-10 20:50:43.589319
NCT03229434|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||September 29, 2017|Anticipated|2017-09-29|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Mountain Hiking & Environmental Influences|Effects of Mountain Hiking on Physiological and Psychological Health Parameters With Special Focus on the Influence of the Environment|Not yet recruiting||N/A|50|Anticipated|Universitaet Innsbruck||2|||f||||f|f|f||||||||2017-10-10 20:50:43.67658|2017-10-10 20:50:43.67658
NCT03229421|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-21|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|DMZV||Dermatologic Manifestations of Zika Virus|Survey of Symptoms and Dermatologic Characterization Associated With Zika Virus|Enrolling by invitation||N/A|50|Anticipated|Northwestern University|||1||f|||||f|f||||||||2017-10-10 20:50:43.753875|2017-10-10 20:50:43.753875
NCT03229408|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2021|Anticipated|2021-08-31||Interventional|TIN-PCOS-AOD||Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction|Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction|Not yet recruiting||Phase 2|90|Anticipated|University of Illinois at Chicago||6|||f||||t|t|f||||||||2017-10-10 20:50:43.829323|2017-10-10 20:50:43.829323
NCT03229395|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-24|||January 2, 2014|Actual|2014-01-02|December 2016|2016-12-01|July 18, 2017|Actual|2017-07-18|July 13, 2017|Actual|2017-07-13||Observational|MYOSECRET||Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids|Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids|Completed||N/A|35|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||2||f||||f||||||Samples With DNA|"     blood   "|||2017-10-10 20:50:43.941011|2017-10-10 20:50:43.941011
NCT03229213|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-19|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|Igamecf||Interactive Video Game Responses in Cystic Fibrosis|Evaluation of Physiological Responses During the Use of Interactive Video Game and the Cardiopulmonary Exercise Test in Cystic Fibrosis and Healthy Individuals|Enrolling by invitation||N/A|68|Anticipated|Pontificia Universidade Católica do Rio Grande do Sul|||2||f||||f|f|f||||||||2017-10-10 20:50:45.285991|2017-10-10 20:50:45.285991
NCT03229382|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-27|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|November 2024|Anticipated|2024-11-01|July 2023|Anticipated|2023-07-01||Interventional|OPERA PLRG-10||Evaluation of Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse After First Line Immunochemotherapy With Autologous Stem Cell|Evaluation of Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse After First Line Immunochemotherapy With Autologous Stem Cell (ML29157).|Not yet recruiting||Phase 2|60|Anticipated|Polish Lymphoma Research Group||1|||f||||f|f|f|||f|||||2017-10-10 20:50:44.050707|2017-10-10 20:50:44.050707
NCT03229369|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-24|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Association of ALL and ACL Reconstruction Versus Isolated ACL Reconstruction in High-risk Population: a RCT.|Association of Anterolateral Ligament and Anterior Cruciate Ligament Reconstruction Lead to Superior Outcomes and Lower Failure Rates in High-risk Population?: a Randomized Controlled Trial.|Recruiting||N/A|80|Anticipated|Federal University of São Paulo||2|||f||||f|f|f||||||||2017-10-10 20:50:44.154268|2017-10-10 20:50:44.154268
NCT03229356|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-24|||April 18, 2017|Actual|2017-04-18|July 2017|2017-07-01|April 17, 2019|Anticipated|2019-04-17|October 17, 2018|Anticipated|2018-10-17||Interventional|||An EPIC Based BPA to Enhance Quit Line Referral and Use|An EPIC Based BPA to Enhance Quit Line Referral and Use|Enrolling by invitation||N/A|22|Actual|Johns Hopkins University||3|||f||||t|f|f||||||||2017-10-10 20:50:44.271411|2017-10-10 20:50:44.271411
NCT03229343|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-09-29|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|PALIF||Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis.|Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis (IPF). A Randomized Multi-center Trial.|Not yet recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 20:50:44.358504|2017-10-10 20:50:44.358504
NCT03229330|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|LASERUVe||Low-level Light Therapy on Treatment of Venous Ulcers Assesed by Nursing Outcome Classification (NOC)|The Effect of Low-level Light Therapy on Treatment of Venous Ulcers Assessed by Nursing Outcomes Classification (NOC): Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:50:44.442261|2017-10-10 20:50:44.442261
NCT03229317|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-24|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Observational|RESPIFEPED||Respiratory Outcome of Children From the FEPED Cohort|Respiratory Outcome According to Early Maternal Vitamin D Status During Pregnancy in Children Aged 5 to 6 Years Old|Not yet recruiting||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||||2017-10-10 20:50:44.533681|2017-10-10 20:50:44.533681
NCT03229304|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-21|||May 1, 2016|Actual|2016-05-01|April 2017|2017-04-01|June 1, 2017|Actual|2017-06-01|May 1, 2017|Actual|2017-05-01|9 Months|Observational [Patient Registry]|||Prediction of Postpartum Hemorrhage With Uterine Artery Doppler Measurement|The Role of Uterine Artery Doppler Measurement to Predict the Amount of Postpartum Hemorrhage in Low Risk Term Pregnancy|Completed||N/A|800|Actual|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||f|f|f||||||||2017-10-10 20:50:44.637633|2017-10-10 20:50:44.637633
NCT03229291|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-21|||November 3, 2016|Actual|2016-11-03|July 2017|2017-07-01|June 11, 2017|Actual|2017-06-11|June 11, 2017|Actual|2017-06-11||Interventional|||A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects|A Phase 1, Single-Center, Randomized, Single-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects|Completed||Phase 1|24|Actual|Samumed LLC||4|||f||||f|t|f||||||||2017-10-10 20:50:44.701836|2017-10-10 20:50:44.701836
NCT03229278|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-11|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 30, 2019|Anticipated|2019-07-30|July 30, 2019|Anticipated|2019-07-30||Interventional|||Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma|A Phase I Study to Evaluate the Safety of Trigriluzole (FC-4157/BHV-4157) in Combination With PD-1 Blocking Antibodies|Not yet recruiting||Phase 1|27|Anticipated|Rutgers, The State University of New Jersey||1|||||||t|t|f||||||||2017-10-10 20:50:44.799002|2017-10-10 20:50:44.799002
NCT03229265|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-26|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer|Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer|Recruiting||Phase 4|15|Anticipated|The Rogosin Institute||1|||f||||f|t|f|||f|||||2017-10-10 20:50:44.928075|2017-10-10 20:50:44.928075
NCT03229252|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-10-02|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|(HOPE-1)||An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis|A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy and Safety of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis (HOPE-1 Study: Hydration for Optimal Pulmonary Effectiveness)|Recruiting||Phase 2|78|Anticipated|Spyryx Biosciences, Inc.||3|||f||||t|f|f||||||||2017-10-10 20:50:45.012229|2017-10-10 20:50:45.012229
NCT03229239|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-08-22|||August 11, 2017|Actual|2017-08-11|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 11, 2018|Anticipated|2018-08-11||Interventional|||Corneal Stroma Implantation for the Treatment of Keratoconus|Implant the Corneal Stroma to the Diseased Cornea in Order to Cure Keratoconus|Recruiting||N/A|60|Anticipated|Shandong Eye Hospital||1|||f||||f|f|f||||||||2017-10-10 20:50:45.139665|2017-10-10 20:50:45.139665
NCT03229226|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-26|||October 1, 2015|Actual|2015-10-01|July 2017|2017-07-01|May 1, 2016|Actual|2016-05-01|May 1, 2016|Actual|2016-05-01||Observational|OPPE16||Development and Assessment of a Simulation Model of Focused and Ongoing Professional Practice Evaluations|Development and Assessment of a Simulation Model of Focused and Ongoing Professional Practice Evaluations|Completed||N/A|17|Actual|Rush University Medical Center|||1||f||||t|f|f||||||||2017-10-10 20:50:45.216162|2017-10-10 20:50:45.216162
NCT03227952|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Sensory Stimulation in Fibromyalgia|Study of the Effectiveness of Vibrotactile Sensory Stimulation in Fibromyalgia Patients|Not yet recruiting||N/A|60|Anticipated|Neurovoxel SLP||2|||f||||f|f|f||||||||2017-10-10 20:50:54.760175|2017-10-10 20:50:54.760175
NCT03229200|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-29|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.|Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib After Completion of Ibrutinib Clinical Trials.|Recruiting||Phase 4|500|Anticipated|Pharmacyclics Switzerland GmbH||1|||f||||f|t|f||||||||2017-10-10 20:50:45.376181|2017-10-10 20:50:45.376181
NCT03229187|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-24|||May 1, 2016|Actual|2016-05-01|March 2017|2017-03-01|October 30, 2017|Anticipated|2017-10-30|September 30, 2017|Anticipated|2017-09-30|5 Years|Observational [Patient Registry]|||Specific Molecular Signatures Predict Neoadjuvant Chemotherapy Response in Cervical Cancer|Accurate Prediction and Validation of Response to Neoadjuvant Chemotherapy in Cervical Cancer|Recruiting||N/A|100|Anticipated|Huazhong University of Science and Technology|||1||f||||t|f|f|||f|Samples With DNA|"     Samples with DNA from blood and tissues.   "|||2017-10-10 20:50:45.484459|2017-10-10 20:50:45.484459
NCT03229174|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-07-21|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Brain Perfusion & Oxygenation in Parkinson's Disease With NOH|Evaluation of Brain Perfusion and Oxygenation in PD Patients With Neurogenic Orthostatic Hypotension: 4 Week Comparison of Droxidopa Versus Placebo|Not yet recruiting||Phase 4|28|Anticipated|The Methodist Hospital System||2|||f||||f|t|f|||f|||||2017-10-10 20:50:45.546223|2017-10-10 20:50:45.546223
NCT03229161|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-24|||January 3, 2017|Actual|2017-01-03|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Interval Walking Intervention for Pregnant Women Diagnosed With Gestational Diabetes Mellitus|Interval Walking Intervention for Pregnant Women Diagnosed With Gestational Diabetes Mellitus - a Pilot Study|Recruiting||N/A|20|Anticipated|The Danish Center for Strategic Research on Type 2 Diabetes||2|||f||||t|f|f||||||||2017-10-10 20:50:45.622588|2017-10-10 20:50:45.622588
NCT03229148|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-01|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|AMETIS||Anesthesia Management in Endovascular Therapy for Ischemic Stroke|Anesthesia Management in Endovascular Therapy for Ischemic Stroke: A Multicenter Randomised Study|Recruiting||N/A|270|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 20:50:45.696504|2017-10-10 20:50:45.696504
NCT03229135|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||February 1, 2015|Actual|2015-02-01|July 2017|2017-07-01|October 30, 2016|Actual|2016-10-30|August 20, 2016|Actual|2016-08-20||Observational|||Loading Regimen，Serum Trough Concentrations，Efficacy and Safety in Pneumonia Patients With Gram-positive Infections|A Retrospective Study of Relationships Between Loading Regimen，Serum Trough Concentrations，Efficacy and Safety in Pneumonia Patients With Gram-positive Infections Treated With Teicoplanin|Completed||N/A|113|Actual|People's Hospital of Zhengzhou University|||4||f||||t|f|t|f|f||||||2017-10-10 20:50:45.905691|2017-10-10 20:50:45.905691
NCT03229122|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-10-04|||December 26, 2016|Actual|2016-12-26|October 2017|2017-10-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30|1 Day|Observational [Patient Registry]|CHARLOTTE||Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA|Japan CHARLOTTE: Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA|Recruiting||N/A|600|Anticipated|AstraZeneca|||1||f||||f|f|f||||Samples With DNA|"     From all the eligible subjects who have already attached the signature to the written     informed consent, blood samples shall be collected. By using an assigned 10-mL EDTA-added     blood collecting glass tube, 7 mL of the blood is sampled. The blood samples are to be     recovered together with the specified test request form by Myriad and presence or absence of     gBRCAm shall be centrally determined by US Myriad Genetics. Treatments of the samples,     handling procedures and recovery methods are precisely described on the testing manual.      The physician responsible for institutional study has the responsibility to notify the gBRCAm     results to all the patients who underwent the tests. However, this responsibility needs not     to be observed if the patients themselves refuse such a notification about gBRCAm test     results. This responsibility shall be assumed by the physician responsible for institutional     study in each participating institute.      Incidentally, the genetic test results of the patients should   "|||2017-10-10 20:50:45.983059|2017-10-10 20:50:45.983059
NCT03229109|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-28|||May 3, 2017|Actual|2017-05-03|July 2017|2017-07-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27|1 Day|Observational [Patient Registry]|||Analysis of Sweat Secretions and Body Dehydration Monitor|Spectrophon Dehydration Body Monitor Accuracy Study|Completed||N/A|200|Actual|Tirat Carmel Mental Health Center|||2||f||||f|f|f||||||||2017-10-10 20:50:46.113462|2017-10-10 20:50:46.113462
NCT03229096|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-07-22|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|December 1, 2021|Anticipated|2021-12-01|November 1, 2021|Anticipated|2021-11-01||Interventional|||Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer|Apatinib Plus XELOX Regime as Neoadjuvant Therapy in Locally Advanced Gastric Cancer Patients With Lymph Node Metastasis|Recruiting||Phase 2|35|Anticipated|Shanghai Zhongshan Hospital||1|||f||||f|f|f||||||||2017-10-10 20:50:46.202782|2017-10-10 20:50:46.202782
NCT03229070|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-21|||August 26, 2017|Anticipated|2017-08-26|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|December 30, 2017|Anticipated|2017-12-30||Interventional|CE_PTS||Cycle-ergometer in the Postoperative of Thoracic Surgery|Cycle-ergometer in the Postoperative of Thoracic Surgery: A Randomized, Controlled Clinical Trial Comparing the Effect of Interval Training With Continuous Training on Performance in the Six-minute Walk Test|Not yet recruiting||N/A|135|Anticipated|Federal University of Health Science of Porto Alegre||3|||f||||f|f|f||||||||2017-10-10 20:50:46.408502|2017-10-10 20:50:46.408502
NCT03229057|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-12|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2021|Anticipated|2021-04-30||Interventional|COMET-PCOS||Comparing the Effects of Oral Contraceptive Pills Versus Metformin|Comparing the Effects of Oral Contraceptive Pills Versus Metformin in the Medical Management of Overweight/Obese Women With Polycystic Ovary Syndrome|Not yet recruiting||Phase 3|240|Anticipated|University of Pennsylvania||3|||f||||t|t|f|||t|||||2017-10-10 20:50:46.486588|2017-10-10 20:50:46.486588
NCT03229044|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-25|||December 6, 2005|Actual|2005-12-06|December 2005|2005-12-01|December 5, 2008|Actual|2008-12-05|December 5, 2008|Actual|2008-12-05||Observational|||Tetranectin as a Novel Obesity-associated Adipokine for Regulating Lipid Accumulation|Tetranectin as a Novel Obesity-associated Adipokine for Regulating Lipid Accumulation|Completed||N/A|289|Actual|National Taiwan University Hospital|||3||f|||||f|f||||Samples With DNA|"     Adipose tissues from breast were preserve in -80 refrigerator   "|||2017-10-10 20:50:46.589282|2017-10-10 20:50:46.589282
NCT03229031|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-23|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury|A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury|Not yet recruiting||Phase 3|100|Anticipated|Eusol Biotech Co., Ltd.||2|||f||||t|f|f||||||||2017-10-10 20:50:46.659771|2017-10-10 20:50:46.659771
NCT03229018|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-24|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Different Voxel Sizes on Accuracy of CBCT Linear Measurements: Preclinical Study|Effect of Different Voxel Sizes on Accuracy of 2D and 3D Mandibular Linear Measurements Using CRANEX® 3D Cone Beam Computed Tomography Machine: Preclinical Study|Not yet recruiting||N/A|9|Anticipated|Cairo University||1|||f|||||f|f||||||||2017-10-10 20:50:46.718237|2017-10-10 20:50:46.718237
NCT03229005|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-07-22|||May 15, 2017|Actual|2017-05-15|July 2017|2017-07-01|September 15, 2020|Anticipated|2020-09-15|September 15, 2018|Anticipated|2018-09-15||Observational|i-RES||Soft Tissue Width and Abutment Height Influence Peri-implant Bone Resorption|Influence of Soft Tissue Width and Abutment Height on Peri-implant Bone Resorption: a Clinical and Radiographic Multicenter Study|Recruiting||N/A|80|Anticipated|International Piezosurgery Academy|||4||f||||f|f|f||||||||2017-10-10 20:50:46.780887|2017-10-10 20:50:46.780887
NCT03228992|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-08-02|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Ibuprofen Versus Placebo For Muscle Soreness|A DOUBLE-BLIND, REPEAT-DOSE, PARALLEL GROUP, PILOT STUDY COMPARING THE EFFICACY AND SAFETY OF ORALLY ADMINISTERED IBUPROFEN AND PLACEBO IN DELAYED ONSET MUSCLE SORENESS|Completed||Phase 4|31|Actual|Jean Brown Research||2|||f||||f|t|f||||||||2017-10-10 20:50:46.891442|2017-10-10 20:50:46.891442
NCT03228979|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-07-22|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|November 30, 2021|Anticipated|2021-11-30|June 30, 2021|Anticipated|2021-06-30||Interventional|SPRINT||Secondary Prevention By Structured Semi-Interactive Stroke Prevention Package in INDIA (SPRINT INDIA) Study|Secondary Prevention By Structured Semi-Interactive Stroke Prevention Package in INDIA (SPRINT INDIA) Study|Not yet recruiting||N/A|5830|Anticipated|Christian Medical College and Hospital, Ludhiana, India||2|||f||||t|f|f||||||||2017-10-10 20:50:46.966527|2017-10-10 20:50:46.966527
NCT03228966|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-10-02|||September 12, 2017|Actual|2017-09-12|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Ped HIV - Echo Study: Kenya|Evaluating Indicators of Cardiac Function in Children Living With HIV in Western Kenya|Recruiting||N/A|1200|Anticipated|Duke University|||1||f||||f|f|t|f|f|f|Samples Without DNA|"     Plasma for viral load and inflammatory marker testing   "|||2017-10-10 20:50:47.078064|2017-10-10 20:50:47.078064
NCT03228953|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-03|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|May 15, 2021|Anticipated|2021-05-15|May 15, 2021|Anticipated|2021-05-15||Interventional|||Pharmacogenomic Testing in Major Depressive Disorder|Impact of Comprehensive Pharmacogenomic Testing on the Treatment of Major Depressive Disorder|Recruiting||N/A|206|Anticipated|Columbia University||2|||f||||f|f|f|||f|||||2017-10-10 20:50:47.157123|2017-10-10 20:50:47.157123
NCT03228940|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-20|||October 30, 2017|Anticipated|2017-10-30|July 2017|2017-07-01|November 15, 2018|Anticipated|2018-11-15|October 30, 2018|Anticipated|2018-10-30||Interventional|||Safety and Effect of Oral RVX000222 in Subjects With Fabry Disease|An Open-Label Study to Assess the Safety and Effect on Key Biomarkers of Oral RVX000222 in Subjects With Fabry Disease|Not yet recruiting||Phase 1/Phase 2|16|Anticipated|Resverlogix Corp||1|||f|||||t|f|||t|||||2017-10-10 20:50:47.23896|2017-10-10 20:50:47.23896
NCT03228927|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-24|||August 5, 2017|Anticipated|2017-08-05|July 2017|2017-07-01|August 6, 2017|Anticipated|2017-08-06|August 6, 2017|Anticipated|2017-08-06||Observational|||Characterization of the Facial and Gut Microbiome in Rosacea|Characterization of the Facial and Gut Microbiome in Identical and Fraternal Twins With Rosacea; Comparison to Healthy Controls|Not yet recruiting||N/A|150|Anticipated|The Acne Cure Alliance|||2||f||||t|f|f||||Samples Without DNA|"     skin swab and fecal sample   "|||2017-10-10 20:50:47.335277|2017-10-10 20:50:47.335277
NCT03228914|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-21|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery|Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery|Not yet recruiting||Phase 4|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f|||||t|f|||f|||||2017-10-10 20:50:47.398142|2017-10-10 20:50:47.398142
NCT03228901|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-25|||January 2007|Actual|2007-01-01|July 2017|2017-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Oxytocin and Non-verbal Communication|Exploring the Effects of Oxytocin on Non-verbal Communication|Completed||Phase 2|104|Actual|Yale-NUS College||2|||f||||f|f|f||||||||2017-10-10 20:50:47.484313|2017-10-10 20:50:47.484313
NCT03228888|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||November 1, 2014|Actual|2014-11-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|December 31, 2016|Actual|2016-12-31||Interventional|||Effects of Ecological Rythmic-acoustic Stimulation (E-RAS) on Motor Skills in Individuals With Parkinson's Disease|Effects of Ecological Rythmic-acoustic Stimulation (E-RAS) on Motor Skills in Individuals|Completed||N/A|32|Actual|University of Cagliari||2|||f||||f|f|f||||||||2017-10-10 20:50:47.561461|2017-10-10 20:50:47.561461
NCT03228875|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-21|||October 1998|Actual|1998-10-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01|21 Years|Observational [Patient Registry]|||Determinants of Preterm Birth in Boston Birth Cohort|Molecular Epidemiology of Preterm Birth: Environmental and Genetic Interactions Repository|Recruiting||N/A|12000|Anticipated|Johns Hopkins Bloomberg School of Public Health|||1||f||||f|f|f||||Samples With DNA|"     Plasma, red blood cell, placenta, urine, DNA   "|||2017-10-10 20:50:47.636313|2017-10-10 20:50:47.636313
NCT03228862|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults|Optimal Initial and Maintenance Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Thai Adults: A Randomized, Double-blinded Dose-comparison Study|Enrolling by invitation||Phase 4|360|Actual|Chulalongkorn University||3|||f||||t|f|f||||||||2017-10-10 20:50:47.704482|2017-10-10 20:50:47.704482
NCT03228849|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-22|||June 2013|Actual|2013-06-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|June 15, 2015|Actual|2015-06-15||Interventional|||Comparison of New Suture Anchor Technique for Bony Mallet Injury Versus Conservative Treatment|Conservative Management Equally Effective to New Suture Anchor Technique for Acute Mallet Finger Deformity: A Prospective Randomized Clinical Trial|Completed||N/A|29|Actual|Istanbul University||2|||f||||f|f|f||||||||2017-10-10 20:50:47.779452|2017-10-10 20:50:47.779452
NCT03228836|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-22|2017-07-22|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|August 28, 2020|Anticipated|2020-08-28||Interventional|ORIENT-4||Efficacy and Safety Evaluation of IBI308 in Patients With Extranodal NK/T Cell Lymphoma Patients|Efficacy and Safety Evaluation of IBI308 in Patients With Relapsed/Refractory Extranodal NK/T Cell Lymphoma, Nasal Type: a Multicenter, Single Arm, Phase 2 Study (ORIENT-4)|Not yet recruiting||Phase 2|60|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:50:47.876775|2017-10-10 20:50:47.876775
NCT03228823|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-25|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|PAPS||Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)|Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot Study|Not yet recruiting||Phase 4|36|Anticipated|Hunter Holmes Mcguire Veteran Affairs Medical Center||2|||f||||t|t|f|||t|||||2017-10-10 20:50:47.944954|2017-10-10 20:50:47.944954
NCT03228810|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-23|2017-07-23|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Genetic Biomarker Discovery for Metastatic Prostate Cancer|ROR1751: Genetic Biomarker Discovery for Metastatic Prostate Cancer|Recruiting||N/A|10|Anticipated|Mayo Clinic|||1||f|||||f|f||||||||2017-10-10 20:50:48.058837|2017-10-10 20:50:48.058837
NCT03228797|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-24|||February 11, 2015|Actual|2015-02-11|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Comparison of Postoperative Outcomes Provided by a Continuous Preperitoneal Infusion Versus Ultrasound Guided Rectus Sheath Block for Midline Emergency Laparotomy|A Comparison of Postoperative Outcomes Provided by a Continuous Preperitoneal Infusion Versus Ultrasound Guided Transversus Abdominis Plane Block for Abdominoplasty|Completed||N/A|60|Actual|Dubai Health Authority||3|||f||||f|f|f|||t|||||2017-10-10 20:50:48.123331|2017-10-10 20:50:48.123331
NCT03228784|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-22|||June 1, 2013|Actual|2013-06-01|July 2017|2017-07-01|May 1, 2014|Actual|2014-05-01|May 1, 2014|Actual|2014-05-01||Interventional|||The Effect of Ablation Depth on Dry Eye After LASIK Treatment of Myopia|The Effect of Ablation Depth on Dry Eye After LASIK Treatment of Myopia|Completed||N/A|53|Actual|Minia University|||||f||||||||||||||2017-10-10 20:50:48.197522|2017-10-10 20:50:48.197522
NCT03228771|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-07-24|||March 2016||2016-03-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Socket Augmentation Using Atorvastatin With Or Without PRGF (Clinical and Histomorphometric Study)|Socket Augmentation Using Atorvastatin With Or Without PRGF Derived Fibrin Scaffold (Clinical and Histomorphometric Study)|Recruiting||Phase 4|30|Anticipated|Ain Shams University||3|||f||||t||||||||||2017-10-10 20:50:48.250007|2017-10-10 20:50:48.250007
NCT03228758|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-25|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|November 30, 2019|Anticipated|2019-11-30|July 2019|Anticipated|2019-07-01||Interventional|||Anterior Orientation vs Posterior Orientation in Per Oral Endoscopic Myotomy POEM for the Treatment of Achalasia|Efficacy of Anterior Versus Posterior Myotomy Approach in Per Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia - A Single Operator Analysis|Recruiting||N/A|290|Anticipated|Winthrop University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:50:48.324791|2017-10-10 20:50:48.324791
NCT03228745|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-09|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||The Health Impact of Mindfulness Based Stress Reduction on Total Knee Arthroplasty|The Health Impact of Mindfulness Based Stress Reduction on Total Knee Arthroplasty: A Pilot Study|Enrolling by invitation||N/A|45|Anticipated|University of Manitoba||2|||f|||||f|f||||||||2017-10-10 20:50:48.406807|2017-10-10 20:50:48.406807
NCT03228732|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-31|||October 10, 2017|Anticipated|2017-10-10|July 2017|2017-07-01|December 10, 2020|Anticipated|2020-12-10|December 10, 2020|Anticipated|2020-12-10||Interventional|||The Effects of Fluoxetine and/or DHEA|The Effects of the Selective Serotonin Reuptake Inhibitor, Fluoxetine and/or DHEA, on Neuroendocrine, Autonomic Nervous System and Metabolic Counterregulatory Responses During Repeated Hypoglycemia in T1DM Individuals|Not yet recruiting||Early Phase 1|60|Anticipated|University of Maryland||5|||f||||t|t|f||||||||2017-10-10 20:50:48.480159|2017-10-10 20:50:48.480159
NCT03228719|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-27|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|June 2020|Anticipated|2020-06-01||Interventional|||A Physical Therapist Administered Physical Activity Intervention After Total Knee Replacement|A Novel Physical Therapy Administered Physical Activity Intervention After TKR: A Randomized Control Trial|Recruiting||N/A|125|Anticipated|University of Delaware||2|||f||||f|f|f||||||||2017-10-10 20:50:48.556314|2017-10-10 20:50:48.556314
NCT03228706|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-09|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|MedAdh-RCT||Effectiveness of an Intervention in Improving Medication Adherence Among Malay Patients With Underlying Type 2 Diabetes Mellitus in Malaysia|"Effectiveness of a Structured Group-Based Intervention Know Your Medicine - Take It For Health (KYM-TIFH) in Improving Medication Adherence Among Malay Patients With Underlying Type 2 Diabetes Mellitus in the Sarawak State of Malaysia: A Cluster Randomized Controlled Trial"|Active, not recruiting||N/A|112|Actual|Clinical Research Centre, Malaysia||2|||f||||f|f|f||||||||2017-10-10 20:50:48.628152|2017-10-10 20:50:48.628152
NCT03228693|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-11|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Gene Expression and Biomarker Profiling of Keloid Skin|Gene Expression and Biomarker Profiling of Keloid Skin|Recruiting||N/A|130|Anticipated|Northwestern University||6|||f|||||f|f||||||||2017-10-10 20:50:48.724093|2017-10-10 20:50:48.724093
NCT03228680|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-14|||July 29, 2017|Actual|2017-07-29|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|June 11, 2019|Anticipated|2019-06-11||Interventional|||Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women|A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Assessing the Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Undergoing an Assisted Reproductive Technology Programme|Recruiting||Phase 3|328|Anticipated|Ferring Pharmaceuticals||2|||f||||f|f|f||||||||2017-10-10 20:50:48.809355|2017-10-10 20:50:48.809355
NCT03228667|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||QUILT-3.055: A Study of ALT-803 in Combination With Pembrolizumab or Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|QUILT-3.055: A Phase IIb, Single-Arm, Open-Label Study of ALT-803 in Combination With Pembrolizumab or Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Disease Progression Following an Initial Response to Treatment With PD-1 Checkpoint Inhibitor Therapy|Not yet recruiting||Phase 2|105|Anticipated|Altor BioScience||2|||f||||f|t|f||||||||2017-10-10 20:50:49.041802|2017-10-10 20:50:49.041802
NCT03228654|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|February 1, 2019|Anticipated|2019-02-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Electrosurgical Unipolar Vessel Sealing in Vaginal Hysterectomy|Electrosurgical Unipolar Vessel Sealing Versus Purohit Technique in Vaginal Hysterectomy . ( A Pilot Randomized Clinical Trial)|Recruiting||Phase 4|50|Anticipated|Ain Shams University||2|||f||||t|f|f|||f|||||2017-10-10 20:50:49.143165|2017-10-10 20:50:49.143165
NCT03228641|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-08|||June 1, 2016|Actual|2016-06-01|July 2017|2017-07-01|November 30, 2018|Anticipated|2018-11-30|August 31, 2017|Anticipated|2017-08-31||Interventional|AIS||Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity|A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face|Active, not recruiting||N/A|33|Actual|Cytrellis Biosystems, Inc.||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:50:49.251369|2017-10-10 20:50:49.251369
NCT03228628|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|June 6, 2018|Anticipated|2018-06-06||Interventional|NO for LP||Nitrous Oxide for Lumbar Puncture|Impact of 50% Nitrous Oxide Inhalation on Pain and Anxiety Induced by Lumbar Puncture: a Multicenter Double-blind Randomized Controlled Trial|Not yet recruiting||Phase 4|162|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 20:50:49.350813|2017-10-10 20:50:49.350813
NCT03228615|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-21|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||IBD Shared Decision Making Intervention|Pilot Trial of a Multi-Component Decision Making Intervention in IBD|Not yet recruiting||N/A|54|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f|f|f||||||||2017-10-10 20:50:49.464843|2017-10-10 20:50:49.464843
NCT03228602|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-21|||July 11, 2016|Actual|2016-07-11|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PEGASE||Impaired Gustatory Sensory Perception in Obese and Obese Diabetic Persons|Gustatory Evoked Potentials and Cerebral Control of Food Intake in Obese Subjects|Recruiting||N/A|45|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f|||||f|f||||||||2017-10-10 20:50:49.548142|2017-10-10 20:50:49.548142
NCT03228589|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-24|||July 25, 2017|Anticipated|2017-07-25|July 2017|2017-07-01|December 22, 2017|Anticipated|2017-12-22|December 22, 2017|Anticipated|2017-12-22||Interventional|PIP-D||The Effect of Probiotic Bif195 on Aspirin-induced GI Damage.|The Effect of 8 Weeks Intake of Bif195 on a 6 Week Aspirin-induced Intestinal Deterioration Challenge in Healthy Volunteers - a Randomized, Double-blind, Placebo-controlled, Two Armed, Parallel Group Trial.|Not yet recruiting||Phase 2|70|Anticipated|Chr Hansen||2|||f||||f|f|f||||||||2017-10-10 20:50:49.624185|2017-10-10 20:50:49.624185
NCT03228576|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-20|||April 14, 2017|Actual|2017-04-14|June 2017|2017-06-01|April 14, 2020|Anticipated|2020-04-14|April 14, 2019|Anticipated|2019-04-14||Observational|||Prospective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Association|Observationnal Multicenter Study on a Prospective Cohort of Kidney Transplanted Patients Receiving a Year After Transplant an Extended Releasing Tacrolimus-Everolimus Association|Recruiting||N/A|100|Anticipated|Poitiers University Hospital|||1||f|||||f|f||||||||2017-10-10 20:50:49.698014|2017-10-10 20:50:49.698014
NCT03228563|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||May 23, 2017|Actual|2017-05-23|July 2017|2017-07-01|January 8, 2018|Anticipated|2018-01-08|January 8, 2018|Anticipated|2018-01-08||Interventional|||The Effect of Probiotics on Chronic Kidney Disease|The Effect of Probiotics on Chronic Kidney Disease|Recruiting||N/A|40|Anticipated|China Medical University Hospital||1|||f|||||f|f||||||||2017-10-10 20:50:49.787248|2017-10-10 20:50:49.787248
NCT03228550|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-21|||February 26, 2017|Actual|2017-02-26|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|December 31, 2017|Anticipated|2017-12-31||Interventional|MOBILE||Omega-3 Fatty Acids and Exercise on Mobility and Cognition in Older Women|Investigating the Effects of Omega-3 Fatty Acid Multinutrient Supplement and Exercise on Mobility and Cognition in Older Women|Recruiting||Phase 2|100|Anticipated|Bournemouth University||4|||f||||f|f|f||||||||2017-10-10 20:50:49.874265|2017-10-10 20:50:49.874265
NCT03228537|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-24|2017-09-04|||November 3, 2017|Anticipated|2017-11-03|July 2017|2017-07-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma|A Feasibility Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and in Maintenance for Resectable Malignant Pleural Mesothelioma|Not yet recruiting||Phase 1|28|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 20:50:50.002431|2017-10-10 20:50:50.002431
NCT03228524|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-21|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|July 12, 2018|Anticipated|2018-07-12||Interventional|DAsp&TerapEx||D-aspartate and Therapeutic Exercise|Promotion of Synaptic Plasticity With D-Aspartate to Favour Recovery Form Cerebral Damage|Not yet recruiting||Early Phase 1|100|Anticipated|Neuromed IRCCS||2|||f||||f|f|f||||||||2017-10-10 20:50:50.141061|2017-10-10 20:50:50.141061
NCT03228511|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-21|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Interventional|||Endoscopic-assisted Microsurgical Removal of Cerebellopontine Angle Lesions|Evaluation of Endoscopic-assisted Microsurgical Removal of Cerebellopontine Angle Lesions|Not yet recruiting||N/A|1|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 20:50:50.262478|2017-10-10 20:50:50.262478
NCT03228498|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|May 2, 2019|Anticipated|2019-05-02||Interventional|CONIVAD||Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment|Pilot Study on the Association Choline Alphoscerate-Nimodipine in Patients With Subcortical Vascular Cognitive Impairment|Recruiting||Phase 2|68|Anticipated|Azienda Ospedaliero-Universitaria Careggi||2|||f|||||f|f|||f|||||2017-10-10 20:50:50.321931|2017-10-10 20:50:50.321931
NCT03228485|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-10|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Observational|||BPH Mobile Application Pilot|The Feasibility and Acceptability of a (Mobile) Application for Men With LUTS/BPH: a Pilot Study|Not yet recruiting||N/A|200|Anticipated|Société Internationale d'Urologie|||1||f||||f|f|f||||||||2017-10-10 20:50:50.425517|2017-10-10 20:50:50.425517
NCT03228472|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-21|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|July 12, 2018|Anticipated|2018-07-12||Interventional|TrainingNIBS||Noninvasive Brain Stimulation Training|Noninvasive Brain Stimulation Training to Help Recover Brain-related Symptoms|Not yet recruiting||N/A|100|Anticipated|Neuromed IRCCS||2|||f||||f|f|f||||||||2017-10-10 20:50:50.514445|2017-10-10 20:50:50.514445
NCT03228459|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-24|||January 15, 2015|Actual|2015-01-15|July 2017|2017-07-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|ILERVAS||The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease|Randomized Intervention Study to Assess the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease and Its Impact on Morbidity and Mortality: The ILERVAS Project|Recruiting||N/A|14600|Anticipated|Institut de Recerca Biomèdica de Lleida||2|||f||||f|f|f||||||||2017-10-10 20:50:50.605506|2017-10-10 20:50:50.605506
NCT03228446|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-20|||September 26, 2012|Actual|2012-09-26|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|DIIN||The Effects of Attentional Filter Training on Working Memory|Improving Cognitive Functions by Training Distractor Inhibition (DIIN) in Young and Old Healthy Adults|Active, not recruiting||N/A|90|Anticipated|German Center for Neurodegenerative Diseases (DZNE)||2|||f||||f|f|f||||||||2017-10-10 20:50:50.73288|2017-10-10 20:50:50.73288
NCT03228433|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|May 2, 2018|Anticipated|2018-05-02|May 2, 2018|Anticipated|2018-05-02||Interventional|||A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants|A Randomized, Double-Blind, Placebo-Controlled, Ascending Oral Single Dose Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-418 in Healthy Subjects|Recruiting||Phase 1|40|Anticipated|Takeda||6|||f||||f|t|f||||||||2017-10-10 20:50:50.823175|2017-10-10 20:50:50.823175
NCT03228420|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-07|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|January 1, 2019|Anticipated|2019-01-01||Interventional|SENZA-PDN||Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain|A Post-Market, Multicenter, Prospective, Randomized Clinical Trial Comparing 10 kHz Spinal Cord Stimulation (HF10™ Therapy) Combined With Conventional Medical Management to Conventional Medical Management Alone in the Treatment of Chronic, Intractable, Neuropathic Limb Pain|Recruiting||N/A|360|Anticipated|Nevro Corp||2|||f|||||f|t|f|f|f|||||2017-10-10 20:50:50.91652|2017-10-10 20:50:50.91652
NCT03228407|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-20|||April 28, 2017|Actual|2017-04-28|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)|Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)|Recruiting||N/A|36|Anticipated|McGuire Research Institute||3|||f||||t|f|t|f|||||||2017-10-10 20:50:51.023182|2017-10-10 20:50:51.023182
NCT03228394|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-21|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|August 17, 2018|Anticipated|2018-08-17|August 17, 2018|Anticipated|2018-08-17||Interventional|||A Clinical Trial of Intravenous Ganaxolone in Women With Postpartum Depression|A Phase 2A, Double-blind, Placebo-controlled, Multiple-dose Escalation Study to Evaluate Safety, Pharmacokinetics and Efficacy of Intravenously Administered Ganaxolone in Women With Postpartum Depression|Recruiting||Phase 2|30|Anticipated|Marinus Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 20:50:51.123991|2017-10-10 20:50:51.123991
NCT03228381|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-29|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|BOSS||The BOSS Study: An Acute Evaluation of Anatomical and Geometric Changes Using the Bladder on a Stick System (BOSS)|An Acute Evaluation of Anatomical and Geometric Changes Using the Bladder on a Stick System (BOSS)|Recruiting||N/A|10|Anticipated|Mardil Medical||1|||f||||f|f|t|t|f|t|||||2017-10-10 20:50:51.237252|2017-10-10 20:50:51.237252
NCT03228368|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-21|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 1, 2018|Anticipated|2018-12-01|March 1, 2018|Anticipated|2018-03-01||Observational|||The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients|The Predicted Potential of Quantitative T Cell Repertoire(TCR) Analysis Using Next-generation Sequencing (NGS) in Anti-PD-L1 Treatment in Non Small Cell Lung（NSCLC) Cancer Patients|Recruiting||N/A|10|Anticipated|First Affiliated Hospital of Zhejiang University|||1||f|||||t|f|||t|||||2017-10-10 20:50:51.32925|2017-10-10 20:50:51.32925
NCT03228355|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-21|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Headache Inducing Effect of Cromakalim in Migraine Patients|The Effects of Levcromakalim on Cerebral Hemodynamic in Migraine Patients|Recruiting||N/A|12|Anticipated|Danish Headache Center||2|||f||||f|f|f||||||||2017-10-10 20:50:51.409877|2017-10-10 20:50:51.409877
NCT03228342|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-07-21|||May 3, 2017|Actual|2017-05-03|July 2017|2017-07-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|ULTRAPRO||Ultrasound Impact in Rheumatoid Arthritis Patient Reported Outcomes|The Impact of Musculoskeletal Ultrasound-added to Clinical Evaluations- on Patient Reported Outcomes: A Prospective Study of Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity (ULTRAPRO)|Recruiting||N/A|132|Anticipated|Clínica de Artritis Temprana||2|||f||||f|f|f||||||||2017-10-10 20:50:51.494347|2017-10-10 20:50:51.494347
NCT03228329|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-21|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Validation of Cardiometry in Resuscitation of Patients Undergoing Liver Transplantation|Validation of Electrical Cardiometry in Resuscitation of Patients Undergoing Orthotopic Liver Transplantation|Recruiting||N/A|20|Anticipated|Kasr El Aini Hospital||1|||f||||f|f|f||||||||2017-10-10 20:50:51.592563|2017-10-10 20:50:51.592563
NCT03228316|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-21|||October 20, 2017|Anticipated|2017-10-20|July 2017|2017-07-01|December 20, 2020|Anticipated|2020-12-20|June 20, 2020|Anticipated|2020-06-20||Interventional|||Superior Hypogastric Plexus Block Versus Pulsed Radiofrequency for Chronic Pelvic Cancer Pain|Superior Hypogastric Plexus Block and Pulsed Radiofrequency on Dorsal Root Ganglia of Sacral Nerves for Chronic Pelvic Cancer Pain|Not yet recruiting||N/A|40|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:50:51.68188|2017-10-10 20:50:51.68188
NCT03228290|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-07-19|||October 12, 2011|Actual|2011-10-12|July 2017|2017-07-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Observational|FrAILT||Functional Assessment in Liver Transplantation|Functional Assessment in Liver Transplant Candidates (FrAILT) Study|Recruiting||N/A|3000|Anticipated|University of California, San Francisco|||1||f||||f|f|f||||Samples With DNA|"     Sub-group of 1000 patients will have one single blood draw of 2 tablespoons of blood and     provide a urine and stool sample (about 5ml each or 1 teaspoon each), at the time of consent.     If they agree to participate in the DNA genetic testing, then they will have an additional 1     tablespoon drawn during the same venipuncture.      Sub-group of 1000 patients will have adipose, muscle, liver tissue, and blood collected     during the liver transplant surgery.        -  8 cm³ of muscle tissue from the rectus muscle in the abdomen.        -  8 cm³ of adipose tissue from the subcutaneous and visceral adipose tissue of the          abdomen.        -  8 cm³ of liver tissue from the explanted liver        -  4 tablespoons of blood   "|||2017-10-10 20:50:51.823395|2017-10-10 20:50:51.823395
NCT03228277|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA|Phase II, Multicenter, Single-arm, Open-label Study to Evaluate the Efficacy of Olmutinib(Olita®) in Patients With NSCLC Who Harboring T790M Mutation Confirmed Using DNA Extracted From Extracellular Vesicles in Bronchoalveolar Lavage Fluid|Recruiting||Phase 2|25|Anticipated|Konkuk University Medical Center||1|||f||||t|f|f|||f|||||2017-10-10 20:50:51.932499|2017-10-10 20:50:51.932499
NCT03228264|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia.|A Randomized Controlled, Evaluator-blinded, Multi-center Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia.|Not yet recruiting||N/A|100|Anticipated|University of Bern||2|||f||||f|f|f||||||||2017-10-10 20:50:52.019405|2017-10-10 20:50:52.019405
NCT03228251|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-20|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|STREAM||Simulation-based Training of Rapid Evaluation and Management for Acute Stroke (STREAM) Trial|Simulation-based Training of Rapid Evaluation and Management for Acute Stroke (STREAM) - Multicentric Prospective Interventional Study for the Improvement of Acute Stroke Care|Not yet recruiting||N/A|800|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f|f|f||||||||2017-10-10 20:50:52.123413|2017-10-10 20:50:52.123413
NCT03228238|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||September 1, 2014|Actual|2014-09-01|July 2017|2017-07-01|February 28, 2021|Anticipated|2021-02-28|September 1, 2020|Anticipated|2020-09-01||Interventional|||ANti-Oxidant in Variant Angina (ANOVA) Trial|Effects of Long-term Vitamin C+E and Statin Therapy on Vasospasm Improvement and Regression of Atheroma in Patients With Variant Angina|Recruiting||Phase 4|300|Anticipated|Seoul National University Hospital||4|||f|||||f|f||||||||2017-10-10 20:50:52.213945|2017-10-10 20:50:52.213945
NCT03228225|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|June 20, 2018|Anticipated|2018-06-20||Interventional|||Tele - Cardiac Rehabilitation - Providing Secondary Prevention and Supervised Exercise Without Boundaries of Time and Space - PILOT 1|Tele - Cardiac Rehabilitation - Providing Secondary Prevention and Supervised Exercise Without Boundaries of Time and Space - PILOT 1|Recruiting||N/A|20|Anticipated|Sheba Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:50:52.30728|2017-10-10 20:50:52.30728
NCT03228212|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-19|||July 14, 2017||2017-07-14||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:50:52.378904|2017-10-10 20:50:52.378904
NCT03228186|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-06|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer|Phase II Trial of Pevonedistat (TAK-924) Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer|Not yet recruiting||Phase 2|37|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f|||t|||||2017-10-10 20:50:52.502971|2017-10-10 20:50:52.502971
NCT03228173|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-02|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Iron Deficiency in Female State Fair Attendees|Iron Deficiency, Depression, and Other Affective Disorders in Female State Fair Attendees|Completed||N/A|190|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||Samples Without DNA|"     serum from each subject was coded and frozen in a -80 degrees C in a lab at the University of     Minnesota   "|||2017-10-10 20:50:52.572474|2017-10-10 20:50:52.572474
NCT03228160|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-07-19|||October 1, 2016|Actual|2016-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Light Irradiation and Outcome for Neuropathic Pain|Effects of Linearly Polarized Near-Infrared Irradiation in Patients With Sympathetically Maintained Neuropathic Pain Syndrome|Active, not recruiting||N/A|44|Anticipated|Taipei Medical University Shuang Ho Hospital||2|||f||||f||||||||||2017-10-10 20:50:52.62891|2017-10-10 20:50:52.62891
NCT03228147|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-27|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment|Sensory Evaluation of a New Oral Nutrition Supplement in Patients at Risk for Mucositis|Recruiting||N/A|80|Anticipated|Rutgers, The State University of New Jersey||1|||f|||||f|f||||||||2017-10-10 20:50:52.812712|2017-10-10 20:50:52.812712
NCT03228121|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-25|||April 24, 2017|Actual|2017-04-24|July 2017|2017-07-01|November 24, 2018|Anticipated|2018-11-24|May 24, 2018|Anticipated|2018-05-24||Interventional|||Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD|Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD|Enrolling by invitation||N/A|100|Actual|Lung Institute||2|||f||||f|f|f||||||||2017-10-10 20:50:53.065715|2017-10-10 20:50:53.065715
NCT03228108|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|January 2020|Anticipated|2020-01-01||Interventional|pro-SWAP||Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.|The Effect of Rectal Swab Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy on Infectious Complications and Cost of Care: A Randomized Controlled Trial in the Netherlands.|Not yet recruiting||Phase 4|1400|Anticipated|Radboud University||2|||f||||t|f|f|||f|||||2017-10-10 20:50:53.185208|2017-10-10 20:50:53.185208
NCT03228095|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-24|||July 24, 2017|Anticipated|2017-07-24|July 2017|2017-07-01|December 31, 2025|Anticipated|2025-12-31|December 20, 2019|Anticipated|2019-12-20||Observational|Volatolome||Volatiles in Breath and Headspace Analysis - Diagnostic Markers|Volatile Organic Compounds in Breath and Headspace Analysis - Diagnostic and Monitoring Markers for Diseases|Not yet recruiting||N/A|3000|Anticipated|University of Latvia|||17||f||||f|f|f||||Samples With DNA|"     Surgery and biopsy material as well as blood samples will contain himan DNA   "|||2017-10-10 20:50:53.394577|2017-10-10 20:50:53.394577
NCT03228082|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-19|||July 13, 2017|Actual|2017-07-13|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|BP-PRESELF||Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study|Blood Pressure After PREeclampsia/HELLP by SELF Monitoring|Recruiting||N/A|300|Anticipated|Radboud University||2|||f||||t|f|f|||f|||||2017-10-10 20:50:53.654707|2017-10-10 20:50:53.654707
NCT03228069|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-09-18|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults|Humoral and Cell-mediated Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in Previously Rabies Immunized HIV-infected Adults|Recruiting||N/A|40|Anticipated|Queen Saovabha Memorial Institute||2|||f||||f|f|f||||||||2017-10-10 20:50:53.8296|2017-10-10 20:50:53.8296
NCT03228056|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-07-19|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Postoperative Pain After Single Port, Two Ports and Three Ports VATS Lobectomy|Postoperative Pain After Single Port, Two Ports and Three Ports Video-assisted Thoracic Surgery Lobectomy in Cancer Patients: A Randomized Controlled Trial|Recruiting||N/A|90|Anticipated|Pulmonary Hospital Zakopane||3|||f||||f|f|f||||||||2017-10-10 20:50:53.928173|2017-10-10 20:50:53.928173
NCT03228043|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-07-27|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 30, 2023|Anticipated|2023-04-30|April 30, 2022|Anticipated|2022-04-30||Interventional|||Apatinib for Resectable Colorectal Cancer|Apatinib With Postoperative Adjuvant Chemotherapy for Operable Colorectal Cancer|Recruiting||N/A|80|Anticipated|Nanchong Central Hospital||2|||f||||t|f|f||||||||2017-10-10 20:50:54.038895|2017-10-10 20:50:54.038895
NCT03228030|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|THIAMINE-HF||Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial|Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial|Not yet recruiting||Phase 3|24|Anticipated|McMaster University||2|||f||||t|f|f|||f|||||2017-10-10 20:50:54.157837|2017-10-10 20:50:54.157837
NCT03228017|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-04|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Subclinical Cardiovascular Disease in Psoriatic Disease|Subclinical Cardiovascular Disease in Psoriatic Disease|Recruiting||Phase 4|50|Anticipated|New York University School of Medicine||2|||f||||f|t|f||||||||2017-10-10 20:50:54.263971|2017-10-10 20:50:54.263971
NCT03228004|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-21|||July 26, 2017|Actual|2017-07-26|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Interventional|T1D-DATA||Type 1 Diabetes Data Acquisition and Transfer Adherence Study|Type 1 Diabetes Data Acquisition and Transfer Adherence Study|Recruiting||Phase 1|60|Anticipated|University of Florida||1|||f||||f|f|f||||||||2017-10-10 20:50:54.374226|2017-10-10 20:50:54.374226
NCT03227991|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-07-20|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Safety Planning Intervention to Reduce Short Term Risk|Safety Planning Intervention to Reduce Short Term Risk|Not yet recruiting||N/A|500|Anticipated|New York State Psychiatric Institute||2|||f||||t|f|f||||||||2017-10-10 20:50:54.455096|2017-10-10 20:50:54.455096
NCT03227978|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-19|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||PCL (Poly-ε-caprolactone) Mesh Pleurodesis|PCL (Poly-ε-caprolactone) Mesh Pleurodesis in Thoracoscopic Treatment of Primary Spontaneous Pneumothorax|Not yet recruiting||Early Phase 1|10|Anticipated|National Taiwan University Hospital||1|||f||||t|f|f||||||||2017-10-10 20:50:54.567447|2017-10-10 20:50:54.567447
NCT03227965|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-21|||January 13, 2017|Actual|2017-01-13|November 2016|2016-11-01|July 13, 2021|Anticipated|2021-07-13|January 13, 2021|Anticipated|2021-01-13||Interventional|||Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation|Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation|Recruiting||N/A|50|Anticipated|Poitiers University Hospital||1|||f|||||f|f||||||||2017-10-10 20:50:54.662544|2017-10-10 20:50:54.662544
NCT03227939|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-21|||July 25, 2017|Anticipated|2017-07-25|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||Effects of Combined Surgery on Obstructive Sleep Apnea in Obese Patients: an Open-label Randomized Controlled Clinical Trial|Effect of Laparoscopic Sleeve Gastrectomy (LSG) Plus Uvulopalatopharyngoplasty and Adenoidectomy/Tonsillectomy on Severe Obstructive Sleep Apnea & Hyponea Syndromes in Moderate-to-severe Obese Patients: an Open-label Randomized Controlled Clinical Trial|Not yet recruiting||N/A|100|Anticipated|Shanghai 9th People's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:50:54.839066|2017-10-10 20:50:54.839066
NCT03227926|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|CHRONOS||Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance|A Phase II Trial of Rechallenge With Panitumumab Driven by RAS Clonal-mediated Dynamic of Resistance|Not yet recruiting||Phase 2|129|Anticipated|Fondazione del Piemonte per l'Oncologia||2|||f|||||f|f||||||||2017-10-10 20:50:54.924592|2017-10-10 20:50:54.924592
NCT03227913|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-21|||July 28, 2016|Actual|2016-07-28|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|AlimaSSenSLait||Evaluate the Link Between the Characteristics of Oral Physiology and the Formation of the Food Bolus During the Consumption of Dairy Products in Elderly People|Evaluate the Link Between the Characteristics of Oral Physiology and the Formation of the Food Bolus During the Consumption of Cheese Products in Elderly People|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f|||||f|f||||||||2017-10-10 20:50:55.050513|2017-10-10 20:50:55.050513
NCT03227900|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-19|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Lidocaine and Food Intake|The Effect of lidocaïne Infusion on ad Libitum Food Intake and Satiety in Healthy Volunteers|Recruiting||Phase 4|35|Anticipated|Maastricht University Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 20:50:55.146217|2017-10-10 20:50:55.146217
NCT03227887|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-21|||June 6, 2016|Actual|2016-06-06|July 2017|2017-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluate the Link Between the Characteristics of Oral Physiology and the Formation of the Food Bolus During the Consumption of Cereal Products in Elderly People|Evaluation of the Link Between the Characteristics of Oral Physiology and Formation of the Food Bolus During the Consumption of Cereal Products in Elderly People Via a Modelling Approach.|Completed||N/A|20|Actual|Centre Hospitalier Universitaire Dijon||2|||f|||||f|f||||||||2017-10-10 20:50:55.236722|2017-10-10 20:50:55.236722
NCT03227874|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||September 23, 2015|Actual|2015-09-23|July 2017|2017-07-01|January 29, 2016|Actual|2016-01-29|November 6, 2015|Actual|2015-11-06||Interventional|||Effects of Dried Apple on Metabolic Responses|Acute Effects of Dried Apple Consumption on Metabolic Responses in Healthy Individuals|Completed||N/A|21|Actual|San Diego State University||2|||f||||f|f|f||||||||2017-10-10 20:50:55.322387|2017-10-10 20:50:55.322387
NCT03227848|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||January 4, 2017|Actual|2017-01-04|July 2017|2017-07-01|October 30, 2017|Anticipated|2017-10-30|September 30, 2017|Anticipated|2017-09-30|1 Day|Observational [Patient Registry]|||eMurmur Clinical Performance Evaluation|eMurmur Clinical Performance Evaluation|Recruiting||N/A|120|Anticipated|CSD Labs GmbH|||1||f|||||f|f||||||||2017-10-10 20:50:55.526339|2017-10-10 20:50:55.526339
NCT03227835|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|August 1, 2020|Anticipated|2020-08-01|July 6, 2019|Anticipated|2019-07-06||Observational|CINART||Contrast-Induced Nephropathy After Revision of the Prophylaxis Threshold|Contrast-Induced Nephropathy After Revision of the Prophylaxis Threshold|Recruiting||N/A|660|Anticipated|Maastricht University Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:50:55.605065|2017-10-10 20:50:55.605065
NCT03227822|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||July 2013||2013-07-01|July 2017|2017-07-01|February 1, 2015|Actual|2015-02-01|February 1, 2015|Actual|2015-02-01||Interventional|STRONG||Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease|Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease; a Pilot Study|Terminated||N/A|3|Actual|Catharina Ziekenhuis Eindhoven||2||Unable to include the number of patients|f||||f||||||||||2017-10-10 20:50:55.684314|2017-10-10 20:50:55.684314
NCT03227809|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-21|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|September 14, 2021|Anticipated|2021-09-14|April 30, 2020|Anticipated|2020-04-30||Interventional|FYAH:LGSC||First Years Away From Home: Letting Go and Staying Connected|A Randomized Trial of Letting Go and Staying Connected, an Interactive Parenting Intervention to Reduce Risky Behaviors Among Students|Recruiting||N/A|900|Anticipated|Washington State University||3|||f||||f|f|f||||||||2017-10-10 20:50:55.739868|2017-10-10 20:50:55.739868
NCT03227796|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-10-02|||July 28, 2017|Actual|2017-07-28|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Safety, Tolerability & Pharmacokinetics of LEVI-04 in Healthy Volunteers and Patients With Osteoarthritis Knee Pain|A Randomised, Double-blind, Placebo-controlled, Single Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LEVI-04 in Healthy Volunteers and Patients With Pain Attributed to Osteoarthritis of the Knee|Recruiting||Phase 1|56|Anticipated|Levicept||16|||f||||t|f|f|||f|||||2017-10-10 20:50:55.851092|2017-10-10 20:50:55.851092
NCT03227783|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||The Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in PD|The Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in Parkinson's Disease|Recruiting||N/A|26|Anticipated|Inje University||2|||f||||f|f|f||||||||2017-10-10 20:50:56.00718|2017-10-10 20:50:56.00718
NCT03022357|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-12|||June 2016||2016-06-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Observational|N3iPD||Nigrosomal Iron Imaging in Parkinson's Disease|Nigrosomal Iron Imaging in Parkinson's Disease|Recruiting||N/A|145|Anticipated|University of Nottingham|||1||f||||f||||||||No||2017-10-10 21:27:13.418489|2017-10-10 21:27:13.418489
NCT03227770|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-25|||December 1, 2016|Actual|2016-12-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Efficacy of Hemoperfusion Combined With Hemodialysis in Improving the Survival of MHD Patients|The Efficacy of Hemoperfusion Combined With Hemodialysis in Improving the Survival of Maintenance Hemodialysis (MHD) Patients： A Multi-center, Open-label, Randomized, Parallel Group Study|Recruiting||N/A|1364|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:50:56.079286|2017-10-10 20:50:56.079286
NCT03227757|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-19|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|August 2023|Anticipated|2023-08-01|August 2018|Anticipated|2018-08-01||Interventional|TRILUMINATE||Evaluation of Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater Tricuspid Regurgitation (TRILUMINATE)|Trial to Evaluate Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater Tricuspid Regurgitation (TRILUMINATE)|Not yet recruiting||N/A|75|Anticipated|Evalve||1|||f||||t|f|t|t|f||||||2017-10-10 20:50:56.192002|2017-10-10 20:50:56.192002
NCT03227744|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-21|||April 19, 2017|Actual|2017-04-19|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance|A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance|Recruiting||N/A|48|Anticipated|Winthrop University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:50:56.336818|2017-10-10 20:50:56.336818
NCT03227731|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-19|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|PrEP||Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women|Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women An Open-Label Randomised Control Study|Not yet recruiting||Phase 2/Phase 3|842|Anticipated|University of KwaZulu||2|||f||||t|f|f|||f|||||2017-10-10 20:50:56.413821|2017-10-10 20:50:56.413821
NCT03227718|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-07-24|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|September 26, 2017|Anticipated|2017-09-26|September 26, 2017|Anticipated|2017-09-26||Observational|||VOR Suppression in Non-Gymnast Adults|VOR Suppression in Non-Gymnast Adults|Recruiting||N/A|12|Anticipated|Virginia Commonwealth University|||2||f||||f|f|f||||||||2017-10-10 20:50:56.496956|2017-10-10 20:50:56.496956
NCT03227705|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|CAPP||Canadian Study on the Association of Pessary With Progesterone|Canadian Study on the Association of Pessary With Progesterone|Not yet recruiting||N/A|250|Anticipated|Université de Sherbrooke||2|||f||||t|f|f||||||||2017-10-10 20:50:56.568419|2017-10-10 20:50:56.568419
NCT03227692|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-28|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Persona TKA With iASSIST Knee System and iASSIST Knee System|Randomized Controlled Study Comparing iASSIST Knee System Versus Conventional Instrumentation|Recruiting||N/A|100|Anticipated|Zimmer Biomet||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:50:58.011752|2017-10-10 20:50:58.011752
NCT03227679|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-20|||May 18, 2016|Actual|2016-05-18|July 2017|2017-07-01|April 18, 2017|Actual|2017-04-18|October 8, 2016|Actual|2016-10-08||Interventional|||Metabolism-informed Care for Smoking Cessation|Metabolism-informed Care for Smoking Cessation|Completed||N/A|82|Actual|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:50:58.14332|2017-10-10 20:50:58.14332
NCT03227666|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-18|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 12, 2017|Actual|2017-08-12||Interventional|||Improving Balance Through Balance Exercise|The Effect of Progressive Balance Exercise on Postural Sway - a 4 Week Randomized Controlled Trial|Completed||N/A|52|Actual|Västerbotten County Council||2|||f||||f|f|f||||||||2017-10-10 20:50:58.250737|2017-10-10 20:50:58.250737
NCT03227653|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-20|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV|Neuropsychiatric Adverse Effects of Efavirenz in Children Living With HIV in Kilimanjaro, Tanzania|Active, not recruiting||N/A|126|Anticipated|Radboud University|||2||f||||f|t|f|||f|||||2017-10-10 20:50:58.346688|2017-10-10 20:50:58.346688
NCT03227640|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-20|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|August 1, 2017|Anticipated|2017-08-01||Interventional|Laser||The Impact on Ovarian Reserve of Ovarian Cystectomy Versus Laser Vaporization in the Treatment of Ovarian Endometrioma: a Randomized Clinical Trial|The Impact on Ovarian Reserve of Ovarian Cystectomy Versus Laser Vaporization in the Treatment of Ovarian Endometrioma: a Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|Scientific Institute San Raffaele||2|||f|||||f|f||||||||2017-10-10 20:50:58.432408|2017-10-10 20:50:58.432408
NCT03227627|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-19|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Outcomes of Using LNMES on Tracheostomized Children|Outcomes of Using LNMES on Tracheostomized Children|Recruiting||N/A|40|Anticipated|Children's Hospital Los Angeles||2|||f|||||f|t|f|f|t|||||2017-10-10 20:50:58.528316|2017-10-10 20:50:58.528316
NCT03227614|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|FAIR||Friends/Family in the Abortion Procedure Room (FAIR)|Friends/Family in the Abortion Procedure Room (FAIR): Assessing Pain Level, Patient, Staff and Support Person Satisfaction With Support Person in Abortion Procedure Room: A Randomized Controlled Trial|Enrolling by invitation||N/A|410|Anticipated|Planned Parenthood of Southwest and Central Florida||2|||f||||f|f|f||||||||2017-10-10 20:50:58.610812|2017-10-10 20:50:58.610812
NCT03227601|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|October 19, 2017|Anticipated|2017-10-19||Interventional|||Effect of a Posture Adapter for 12 to 24-month Children With Zyka Virus Syndrome|Effect of a Posture Adapter Use on Body Alignment in Standing Position on Children Between 12 and 24 Months Old With Zyka Virys Congenital Syndrome|Recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco||1|||f||||t|f|f||||||||2017-10-10 20:50:58.691248|2017-10-10 20:50:58.691248
NCT03227588|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-19|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|April 10, 2018|Anticipated|2018-04-10|April 10, 2018|Anticipated|2018-04-10|1 Day|Observational [Patient Registry]|||"Evaluation of the Opsens Fractional Flow Reserve (FFR) Wire as a Work Horse Wire"|"Evaluation of the Opsens Fractional Flow Reserve (FFR) Wire as a Work Horse Wire"|Recruiting||N/A|50|Anticipated|Central Arkansas Veterans Healthcare System|||1||f||||f|f|f||||||||2017-10-10 20:50:58.758952|2017-10-10 20:50:58.758952
NCT03227575|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-06|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control|Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control|Recruiting||N/A|33|Anticipated|Plymouth State University||3|||f||||f|f|f||||||||2017-10-10 20:50:58.934266|2017-10-10 20:50:58.934266
NCT03227562|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-03|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 1, 2019|Anticipated|2019-01-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?|Evaluation of Predictability of the Initial Response to a Low Dose of Risperidone on the Middle Term Efficiency in Anxious Subjects|Not yet recruiting||Phase 3|120|Anticipated|Institut de Recherche Biomedicale des Armees||2|||f||||f|f|f||||||||2017-10-10 20:50:59.026645|2017-10-10 20:50:59.026645
NCT03227549|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-19|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Investigating the Direct Superior Approach for Total Hip Arthroplasty as an Effective Alternative to Traditional Posterior Approach|Investigating the Direct Superior Approach for Total Hip Arthroplasty as an Effective Alternative to Traditional Posterior Approach|Not yet recruiting||N/A|80|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||||2017-10-10 20:50:59.115984|2017-10-10 20:50:59.115984
NCT03227536|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-21|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|ABC-NEO||Asphyxia at Birth : Causes and Neonatal Outcome|Asphyxia at Birth : Evolution of Birth Asphyxia Rate, Etiologies and Neonatal Outcome From 2000 to 2016|Completed||N/A|61448|Actual|Hospices Civils de Lyon|||1||f|||||f|f||||||||2017-10-10 20:50:59.194993|2017-10-10 20:50:59.194993
NCT03227523|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-21|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Nonspecific Low Back Pain in Association With Chronic Obstructive Pulmonary Disease|Nonspecific Low Back Pain in Association With Chronic Obstructive Pulmonary Disease: A Descriptive Observational Cross-Sectional Study|Recruiting||N/A|134|Anticipated|University of Alcala|||2||f||||t|f|f||||||||2017-10-10 20:50:59.260443|2017-10-10 20:50:59.260443
NCT03227510|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-22|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Observational|||MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients|Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Among Somali Patients|Not yet recruiting||N/A|126|Anticipated|People's Friendship University of Russia|||3||f||||f|f|f||||Samples Without DNA|"     blood sample from patients with HCC and from chronic liver disease and healthy volunteer     controls   "|||2017-10-10 20:50:59.352358|2017-10-10 20:50:59.352358
NCT03227497|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-21|||April 21, 2017|Actual|2017-04-21|July 2017|2017-07-01|July 15, 2017|Actual|2017-07-15|July 15, 2017|Actual|2017-07-15||Interventional|FitALA||Dietary Intake of Whole Walnuts in Adult Subjects Under Low Cardiovascular Risk|Investigation of Health Effects of Dietary Intake of Whole Walnuts in Adult Subjects Under Low Cardiovascular Risk Towards Established and Molecular Cardiovascular Risk Factors|Completed||N/A|52|Actual|University of Belgrade||2|||f|||||f|f||||||||2017-10-10 20:50:59.42498|2017-10-10 20:50:59.42498
NCT03227484|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-21|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes|A Double-blind Randomized Study to Determine the Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes|Recruiting||Phase 2|40|Anticipated|University Hospital Tuebingen||2|||f||||f|f|f|||f|||||2017-10-10 20:50:59.522725|2017-10-10 20:50:59.522725
NCT03227471|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-22|||January 23, 2017|Actual|2017-01-23|September 2017|2017-09-01|April 6, 2018|Anticipated|2018-04-06|April 6, 2018|Anticipated|2018-04-06||Interventional|||A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis|A Phase 1/2 Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis|Recruiting||Phase 1/Phase 2|224|Anticipated|Vertex Pharmaceuticals Incorporated||16|||||||t|t|f||||||||2017-10-10 20:50:59.632263|2017-10-10 20:50:59.632263
NCT03227458|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|December 2020|Anticipated|2020-12-01||Interventional|||DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women|DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women|Not yet recruiting||N/A|225|Anticipated|University of Colorado, Denver||3|||f||||t|f|f||||||||2017-10-10 20:50:59.803946|2017-10-10 20:50:59.803946
NCT03227432|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-21|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma|An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma|Not yet recruiting||Phase 2|70|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 20:51:00.07427|2017-10-10 20:51:00.07427
NCT03227419|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|November 2022|Anticipated|2022-11-01|September 2021|Anticipated|2021-09-01||Interventional|SUNSTAR||Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders|Abatacept Versus Tocilizumab by Subcutaneous Administration for the Treatment of Rheumatoid Arthritis in TNF Alpha Inhibitor Inadequate Responder Patients: A Randomized, Open-labeled, Superiority Trial|Not yet recruiting||Phase 4|224|Anticipated|Lille Catholic University||2|||f||||f|f|f||||||||2017-10-10 20:51:00.190839|2017-10-10 20:51:00.190839
NCT03227406|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-28|||July 20, 2016|Actual|2016-07-20|July 2017|2017-07-01|June 20, 2020|Anticipated|2020-06-20|June 20, 2020|Anticipated|2020-06-20||Interventional|||The Evolution of Memories Across Wake and Sleep|The Evolution of Memories Across Wake and Sleep|Enrolling by invitation||N/A|1650|Anticipated|Beth Israel Deaconess Medical Center||4|||f||||f|f|f||||||||2017-10-10 20:51:00.290873|2017-10-10 20:51:00.290873
NCT03227393|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||August 31, 2017|Anticipated|2017-08-31|July 2017|2017-07-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG|The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG|Not yet recruiting||N/A|15|Anticipated|University of Cincinnati||2|||f||||f|f|f||||||||2017-10-10 20:51:00.374151|2017-10-10 20:51:00.374151
NCT03227380|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-21|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|February 20, 2018|Anticipated|2018-02-20||Interventional|||Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy|Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy|Recruiting||N/A|40|Anticipated|Institut Mutualiste Montsouris||1|||f||||t|f|f||||||||2017-10-10 20:51:00.570392|2017-10-10 20:51:00.570392
NCT03227367|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-07-24|||March 17, 2014|Actual|2014-03-17|July 2017|2017-07-01|March 18, 2017|Actual|2017-03-18|April 13, 2016|Actual|2016-04-13||Interventional|||Osteoclast Impairment in Chronic Periodontitis by Regenerative Materials.|Platelet Rich Fibrin/Biphasic Calcium Phosphate Impairs Osteoclasts Differentiation and Promotes Apoptosis by the Intrinsic Mitochondrial Pathway in Chronic Periodontitis|Completed||N/A|50|Actual|Meenakshi Ammal Dental College and Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:51:00.654818|2017-10-10 20:51:00.654818
NCT03227354|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Validation of Non-invasive Absolute Intracranial Pressure Monitoring|Open Study on the Validation of Non-invasive Absolute Intracranial Pressure Monitoring in Patients After Traumatic Brain Injury and Subarachnoid Hemorrhage|Not yet recruiting||N/A|25|Anticipated|Kantonsspital Aarau|||1||f||||f|f|f||||||||2017-10-10 20:51:00.749526|2017-10-10 20:51:00.749526
NCT03227341|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-21|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Pulmonary Rehabilitation in Asthma Control|Does Pulmonary Rehabilitation Contribute to Asthma Control?|Completed||N/A|45|Actual|Izmir Katip Celebi University||2|||f||||f|f|f||||||||2017-10-10 20:51:00.8169|2017-10-10 20:51:00.8169
NCT03227328|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-16|||August 2, 2017|Actual|2017-08-02|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|July 2019|Anticipated|2019-07-01||Interventional|CHENDO||CHemo-ENDOcrine Therapy in Advanced Breast Cancer|Randomized Clinical Trial of Concomitant Chemoendocrine Therapy Versus Chemotherapy Followed by Endocrine Therapy as First Line Treatment of Luminal B Metastatic Breast Cancer.|Recruiting||Phase 3|300|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f|f|f||||||||2017-10-10 20:51:00.898565|2017-10-10 20:51:00.898565
NCT03227315|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-21|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|December 10, 2017|Anticipated|2017-12-10|November 20, 2017|Anticipated|2017-11-20||Observational|||Is There a Relationship Between Stress Tolerance and Analgesic Consumption in Obese Patients?|Is There a Relationship Between Stress Tolerance and Analgesic Consumption in Obese Patients?|Recruiting||N/A|69|Anticipated|Tokat Gaziosmanpasa University|||1||f||||t|f|f||||||||2017-10-10 20:51:01.06344|2017-10-10 20:51:01.06344
NCT03227302|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-21|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|July 30, 2018|Anticipated|2018-07-30||Observational|||Associations of the Grades of Doctor and Neonatal Outcomes|Associations of the Grades of Doctor and Neonatal Outcomes: An Observational Prospective Study|Recruiting||N/A|20000|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University|||3||f||||t|f|f||||||||2017-10-10 20:51:01.146978|2017-10-10 20:51:01.146978
NCT03227289|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-18|||August 1, 2015|Actual|2015-08-01|July 2017|2017-07-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2018|Anticipated|2018-07-30||Observational|||Acute Respiratory Distress Syndrome(ARDS) in Neonates|Pregnancy Risk Factors Promote Conversion From Neonatal Respiratory Distress Syndrome(NRDS) to Acute Respiratory Distress Syndrome(ARDS) : a Observational Cohort Study|Recruiting||N/A|200|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University|||2||f||||t|f|f||||||||2017-10-10 20:51:01.256849|2017-10-10 20:51:01.256849
NCT03227276|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy and Safety of Litramine in 1 Year Weight Loss Study|Double-blind, Randomised, Placebo-controlled 1-year Study to Evaluate the Efficacy and Safety of Litramine in Reducing Body Weight in Overweight and Moderately Obese Subjects|Not yet recruiting||N/A|200|Anticipated|InQpharm Group||2|||f||||f|f|f||||||||2017-10-10 20:51:01.378704|2017-10-10 20:51:01.378704
NCT03227263|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|BABH||BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT).|BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). A National, Multicenter Phase III Study|Not yet recruiting||Phase 3|24|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 20:51:01.511917|2017-10-10 20:51:01.511917
NCT03227250|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-26|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PD GPI DBS||Effects of Bilateral GPI DBS on Freezing of Gait in PD|Effects of Bilateral Pallidal Deep Brain Stimulation on Freezing of Gait in Parkinson's Diseases|Recruiting||N/A|50|Anticipated|Ruijin Hospital|||1||f|||||f|f||||||||2017-10-10 20:51:01.667594|2017-10-10 20:51:01.667594
NCT03227237|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||November 30, 2015|Actual|2015-11-30|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Impact of Strained Interpersonal Relationship (IPR) With Parents on Juvenile Delinquency Among Children|"Assess the Impact of Strained Interpersonal Relationship (IPR) With Parents on Juvenile Delinquency Among Children Residing in Selected Delinquent Home Ambala, Haryana"|Completed||N/A|120|Actual|Maharishi Markendeswar University|||2||f||||t|f|f||||||||2017-10-10 20:51:01.794179|2017-10-10 20:51:01.794179
NCT03227224|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-25|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|December 10, 2018|Anticipated|2018-12-10|December 10, 2018|Anticipated|2018-12-10||Interventional|||A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Adaptive Dose-Finding Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy|Recruiting||Phase 2|280|Anticipated|Janssen Research & Development, LLC||2|||f||||t|t|f||||||||2017-10-10 20:51:01.935146|2017-10-10 20:51:01.935146
NCT03227211|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-05|||November 2, 2016|Actual|2016-11-02|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 1, 2018|Anticipated|2018-03-01||Observational|ReCOPD||COPD Readmissions Prediction- ReCOPD Project|Readmissions and Evolution Prediction Models in Patients Admitted to Hospital With COPD Exacerbations - ReCOPD Project|Recruiting||N/A|1500|Anticipated|Hospital Galdakao-Usansolo|||1||f||||t|f|f||||Samples Without DNA|"     In three of the hospital participant a sample of blood has been collected in each index     admission and stored in each Biobank with the purpose of stuying some biomarkers of     inflamation. In these cases, the patient must sign a specific additional informed consent     established by the Biobank. With each Biobank the method will be established for the     recruitment and delivery of samples.   "|||2017-10-10 20:51:02.258577|2017-10-10 20:51:02.258577
NCT03227198|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-09-02|||November 15, 2017|Anticipated|2017-11-15|July 2017|2017-07-01|December 2, 2018|Anticipated|2018-12-02|September 20, 2018|Anticipated|2018-09-20||Interventional|IMMNC-HF||IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients|Evaluation of the Intramyocardial Injection of Autologous Bone Marrow Derived Mononuclear Stem Cells in Heart Failure (HF) Patients|Not yet recruiting||Phase 1/Phase 2|5|Anticipated|SCARM Institute, Tabriz, Iran||2|||f||||t|f|f||||||||2017-10-10 20:51:02.355085|2017-10-10 20:51:02.355085
NCT03227172|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-21|||January 1, 2011|Actual|2011-01-01|July 2017|2017-07-01|December 20, 2016|Actual|2016-12-20|March 1, 2016|Actual|2016-03-01||Observational|||Differential Diagnosis Between Granuloma and Radicular Cyst: Effectiveness of Magnetic Resonance Imaging.|The Accuracy of Magnetic Resonance Imaging in Diagnosing Endodontic Periapical Lesion|Completed||N/A|34|Actual|University of Bologna|||1||f||||f|f|f||||||||2017-10-10 20:51:02.505899|2017-10-10 20:51:02.505899
NCT03227159|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-21|||January 1, 2007|Actual|2007-01-01|July 2017|2017-07-01|December 31, 2008|Actual|2008-12-31|December 31, 2008|Actual|2008-12-31||Observational|stenoCARDIA||Study for Evaluation of Newly Onset Chest Pain and Rapid Diagnosis of Myocardial Necrosis|Study for Evaluation of Newly Onset Chest Pain and Rapid Diagnosis of Myocardial Necrosis (stenoCARDIA)|Completed||N/A|1818|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f|f|f||||Samples With DNA|"     -  A venous blood sample (10 ml EDTA, 10ml Citrate, 10ml Serum) for storage and further          analysis        -  A venous blood sample (10 ml EDTA ) DNA Analysis   "|||2017-10-10 20:51:02.556692|2017-10-10 20:51:02.556692
NCT03227146|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-21|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults|A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Adults in Comparison to Autologous Split-thickness Skin Grafts (STSG)|Not yet recruiting||Phase 2/Phase 3|12|Anticipated|University of Zurich||1|||f||||t|f|f||||||||2017-10-10 20:51:02.616485|2017-10-10 20:51:02.616485
NCT03227133|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||December 23, 2016|Actual|2016-12-23|July 2017|2017-07-01|June 23, 2019|Anticipated|2019-06-23|June 2019|Anticipated|2019-06-01||Interventional|PREDICTage||Oral Fluency and the Response to Antidepressant Therapy in the Elderly With a Unipolar Depressive Episode|An Exploratory Study of the Use of Oral Fluency as a Predictive Tool for the Antidepressant Response of Elderly With Unipolar Depressive Disorder|Recruiting||N/A|42|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f|f|f||||||||2017-10-10 20:51:02.726786|2017-10-10 20:51:02.726786
NCT03227120|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-21|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||The Effects of Prehabilitative Exercise on Functional Recovery Following Total Knee Arthroplasty|The Effects of Prehabilitative Exercise on Functional Recovery Following Total Knee Arthroplasty|Recruiting||N/A|60|Anticipated|Carilion Clinic||2|||f||||t|f|f||||||||2017-10-10 20:51:02.814286|2017-10-10 20:51:02.814286
NCT03227107|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-21|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Observational|||The Evaluation of NETs, Caspase-1 and Cytokines in ARDS Patients|IRF-1 Regulate Alveolar Macrophage Pyroptosis in Acute Lung Injury and of Which Will be Possible Mechanism|Recruiting||N/A|100|Anticipated|Xiangya Hospital of Central South University|||1||f||||f|f|f||||||||2017-10-10 20:51:03.030547|2017-10-10 20:51:03.030547
NCT03227094|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-21|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|August 15, 2018|Anticipated|2018-08-15|June 15, 2018|Anticipated|2018-06-15||Interventional|AtHome||Simplification of CF-related Diabetes Screening at Home|Simplification of CF-related Diabetes Screening by the Use of a Home-based Oral Glucose Tolerance Test (OGTT): A Pilot Study to Evaluate the Validity and Patients' Perceptions|Not yet recruiting||N/A|20|Anticipated|Institut de Recherches Cliniques de Montreal||3|||f||||f|f|f||||||||2017-10-10 20:51:03.092673|2017-10-10 20:51:03.092673
NCT03227081|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-21|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Behavioral Modulation of Intrusive Memories|Behavioral Modulation of Memory Traces: Influence of Sleep on Emotional Regulation and the Consolidation of Intrusive Memories|Recruiting||N/A|100|Anticipated|Charite University, Berlin, Germany||2|||f||||f|f|f||||||||2017-10-10 20:51:03.19231|2017-10-10 20:51:03.19231
NCT03227068|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Parent Educational Discharge Support Strategies|Nurse-Led Parent Educational Discharge Support Strategies (PEDSS) for Children Newly Diagnosed With Cancer|Not yet recruiting||N/A|1000|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 20:51:03.266853|2017-10-10 20:51:03.266853
NCT03227055|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||December 30, 2016|Actual|2016-12-30|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Cardiovascular Comorbidity in Children With Chronic Kidney Disease|Cardiovascular Comorbidity in Children With Chronic Kidney Disease: Identification of Novel Biomarkers and Therapeutic Targets|Recruiting||N/A|155|Anticipated|Chang Gung Memorial Hospital|||1||f||||f|f|f||||Samples With DNA|"     Plasma, urine, and stool   "|||2017-10-10 20:51:03.354096|2017-10-10 20:51:03.354096
NCT03227042|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-19|||July 31, 2017|Anticipated|2017-07-31|July 2017|2017-07-01|November 15, 2022|Anticipated|2022-11-15|July 31, 2022|Anticipated|2022-07-31||Observational|||A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)|A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)|Not yet recruiting||N/A|60|Anticipated|BioMarin Pharmaceutical|||1||f||||t|f|f||||||||2017-10-10 20:51:03.422302|2017-10-10 20:51:03.422302
NCT03227029|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-10-02|||August 4, 2017|Actual|2017-08-04|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Evaluating the Infectivity, Safety, and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age|Randomized Phase I Study of the Infectivity, Safety, and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age|Recruiting||Phase 1|80|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t|t|f||||||||2017-10-10 20:51:03.531357|2017-10-10 20:51:03.531357
NCT03227016|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-07-21|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Study in Patients With SCLC of Veliparib in Combination With Topotecan|Phase I/II Study in Patients With Small Cell Lung Cancer (SCLC) of Veliparib in Combination With Topotecan|Recruiting||Phase 1|30|Anticipated|Central European Society for Anticancer Drug Research||1|||f||||t|f|f|||f|||||2017-10-10 20:51:03.670112|2017-10-10 20:51:03.670112
NCT03227003|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-07-21|||January 1, 2014|Actual|2014-01-01|July 2017|2017-07-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||DNA Methylation and 1-C Metabolism Nutrient Intake|Dietary Intake of One-carbon Metabolism Nutrients and DNA Methylation in Peripheral Blood|Completed||N/A|5983|Actual|Cancer Council Victoria|||1||f||||t|f|f||||||||2017-10-10 20:51:03.762101|2017-10-10 20:51:03.762101
NCT03226990|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-21|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|||Detection of Pressure Areas for Two Elastomeric Impressions|Detection of Pressure Areas for Elastomeric Impressions With and Without Spacer Using Novel Digital Analyzing Software and Its Correlation With Retention.A Randomized Clinical Trial.|Completed||N/A|40|Actual|Cairo University||1|||f||||f|f|f||||||||2017-10-10 20:51:03.814414|2017-10-10 20:51:03.814414
NCT03226977|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-21|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|||Nasal Intermittent Positive Pressure Ventilation(NIPPV) vs Continuous Positive Airway Pressure for Respiratory Distress Syndrome|Nasal Intermittent Positive Pressure Ventilation vs Continuous Positive Airway Pressure for Preterm Infants With Respiratory Distress Syndrome:a Multicenter Randomized Controlled Study|Recruiting||N/A|1000|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t|f|f||||||||2017-10-10 20:51:03.883977|2017-10-10 20:51:03.883977
NCT03226964|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-20|||October 1, 2016|Actual|2016-10-01|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|AHOE||Assessment of High Flow Nasal Cannula Oxygenation in EBUS Bronchoscopy|Assessment of High Flow Nasal Cannula Oxygenation in EBUS Bronchoscopy|Recruiting||N/A|40|Anticipated|University College Hospital Galway||2|||f||||f|f|f||||||||2017-10-10 20:51:03.989921|2017-10-10 20:51:03.989921
NCT03226951|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-21|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|April 1, 2018|Anticipated|2018-04-01|January 31, 2018|Anticipated|2018-01-31||Interventional|||SDM Laser for Non Central Diabetic CSME|Sub Threshold Laser for Non Central Diabetic Clinical Significant Macular Edema|Recruiting||N/A|20|Anticipated|Marashi Eye Clinic||2|||f||||f|f|f||||||||2017-10-10 20:51:04.077662|2017-10-10 20:51:04.077662
NCT03226938|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-01|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Adhering to Dietary Approaches for Personal Taste (ADAPT), Exam 1|Adhering to Dietary Approaches for Personal Taste (ADAPT) Study, Exam 1|Recruiting||N/A|5000|Anticipated|Tufts University|||1||f||||f|f|f||||||||2017-10-10 20:51:04.163536|2017-10-10 20:51:04.163536
NCT03226925|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-20|||June 30, 2017|Actual|2017-06-30|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Mechanically-assisted Ventilation in the Treatment of Moving Tumours With Photon and Proton Therapies|Added Value of Mechanically-assisted Ventilation in the Treatment of Moving Tumours (Thoracic/Upper Abdomen) With Photon and Proton Therapies.|Recruiting||N/A|30|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f||||f|f|f||||||||2017-10-10 20:51:04.255273|2017-10-10 20:51:04.255273
NCT03226912|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|||The PREDICT Study- a Registry in Critically Ill Patients to Determine Predictors of Disability Free Survival|The PREDICT Study- a Registry in Critically Ill Patients to Determine Predictors of Disability Free Survival|Recruiting||N/A|500|Anticipated|Australian and New Zealand Intensive Care Research Centre|||1||f||||f|f|f||||||||2017-10-10 20:51:04.352028|2017-10-10 20:51:04.352028
NCT03226899|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-27|||July 19, 2017|Actual|2017-07-19|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment|A Phase 4, Study to Evaluate the Safety and Efficacy of Lesinurad 200 mg in Combination With a Xanthine Oxidase Inhibitor (XOI), Compared With an XOI Alone, in Subjects With Gout and Estimated Creatinine Clearance (eCrCl) 30 to <60 mL/Min Who Have Not Achieved Target Serum Uric Acid Levels (sUA) on an XOI Alone|Recruiting||Phase 4|600|Anticipated|Ironwood Pharmaceuticals, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:51:04.429355|2017-10-10 20:51:04.429355
NCT03226886|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-31|||February 5, 2012|Actual|2012-02-05|July 2017|2017-07-01|September 1, 2023|Anticipated|2023-09-01|September 1, 2023|Anticipated|2023-09-01||Observational|TRACERxRenal||TRACERx Renal (TRAcking Renal Cell Carcinoma Evolution Through Therapy (Rx))|TRACERx Renal (TRAcking Renal Cell Carcinoma Evolution Through Therapy (Rx))|Recruiting||N/A|360|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f|f|f||||Samples With DNA|"     The Investigators will be collecting Blood, Urine, Core Biopsies and Surgical Samples   "|||2017-10-10 20:51:04.528932|2017-10-10 20:51:04.528932
NCT03226483|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-20|||March 28, 2017|Actual|2017-03-28|July 2017|2017-07-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|INTRAMET||Intraoperative Radiotherapy After the Resection of Brain Metastases|Intraoperative Radiotherapy After the Resection of Brain Metastases - a Phase II Feasibility Study|Recruiting||N/A|50|Anticipated|Universitätsmedizin Mannheim||1|||f||||f|f|f||||||||2017-10-10 20:51:07.168957|2017-10-10 20:51:07.168957
NCT03226873|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-15|||September 2, 2017|Anticipated|2017-09-02|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|March 2, 2018|Anticipated|2018-03-02||Interventional|||Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV|Assessing the Feasibility and Acceptability of a Peer Outreach and Navigation Intervention to Increase Pre-exposure Prophylaxis Uptake Among Women at High Risk for HIV|Not yet recruiting||N/A|50|Anticipated|Montefiore Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:51:04.60639|2017-10-10 20:51:04.60639
NCT03226860|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-20|||August 3, 2015|Actual|2015-08-03|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|August 15, 2016|Actual|2016-08-15||Interventional|||Improving Gait and Balance in Children With Hemiplegic Cerebral Palsy: Gait Myoelectric Stimulator Study|Improving Gait and Balance in Children With Hemiplegic Cerebral Palsy: Gait Myoelectric Stimulator Study|Completed||N/A|15|Actual|MultiCare Health System Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:51:04.673077|2017-10-10 20:51:04.673077
NCT03226847|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-24|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pulmonary Vein Isolation in Athletes|Pulmonary Vein Isolation in Athletes: Effects on Peak Performance and Pulmonary Vein Function|Recruiting||N/A|20|Anticipated|The Cleveland Clinic||1|||f||||f|f|f||||||||2017-10-10 20:51:04.747939|2017-10-10 20:51:04.747939
NCT03226834|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-20|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|MUANX||Efficiency of Favourite Versus Predetermined Musical Sequence on Gynecology Pre-operative Anxiety|Comparison of Musicotherapy Sessions Using Patient Play-list Versus U Sequence Music Care Medical Device on Pre-operative Anxiety in Women Undergoing Gynecological Surgery: a Randomized-control Study|Not yet recruiting||N/A|170|Anticipated|Centre Hospitalier Universitaire de la Réunion||2|||f||||f|f|f||||||||2017-10-10 20:51:04.834578|2017-10-10 20:51:04.834578
NCT03226821|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2021|Anticipated|2021-04-30||Interventional|||Body Composition and Adipose Tissue in HIV|Body Composition and Adipose Tissue in HIV Lipodystrophy: Effects of Tesamorelin Therapy|Recruiting||Phase 4|24|Anticipated|Columbia University||1|||f||||f|t|f|||f|||||2017-10-10 20:51:04.909517|2017-10-10 20:51:04.909517
NCT03226795|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||March 2018|Anticipated|2018-03-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|March 2021|Anticipated|2021-03-01||Interventional|||Improving Therapeutic Adherence With a Co-constructed Program Involving Both Patients and Health Care Professionals|Improving Therapeutic Adherence of Adult Patients With Cystic Fibrosis: Impact of a Co-constructed Program by Patients and Health Caregivers.|Not yet recruiting||N/A|450|Anticipated|Hospices Civils de Lyon||1|||f|||||f|f||||||||2017-10-10 20:51:05.081652|2017-10-10 20:51:05.081652
NCT03226782|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||August 15, 2016|Actual|2016-08-15|July 2017|2017-07-01|February 11, 2017|Actual|2017-02-11|February 11, 2017|Actual|2017-02-11||Interventional|||Physical Exercise in the Quality of Life and Physical Fitness of Elderly Women With Breast Cancer|Comparison of the Effect of Two Household Physical Exercise Protocols in the Quality of Life and Physical Fitness of Elderly Women With Breast Cancer in Hormoniotherapy Treatment: Interventional Study|Completed||N/A|68|Actual|Professor Fernando Figueira Integral Medicine Institute||2|||f||||f|f|f||||||||2017-10-10 20:51:05.170515|2017-10-10 20:51:05.170515
NCT03226769|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-06|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|September 24, 2017|Anticipated|2017-09-24|September 24, 2017|Anticipated|2017-09-24||Interventional|||Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease|Prospective, Open-Label, Randomized, Proof of Concept Study Exploring Application of TrueTear™ for the Treatment of Meibomian Gland Disease|Recruiting||N/A|70|Anticipated|Allergan||2|||f|||||f|t|f||f|||||2017-10-10 20:51:05.238275|2017-10-10 20:51:05.238275
NCT03226756|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-19|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|June 2019|Anticipated|2019-06-01||Interventional|TopNIVO||Nivolumab in Recurrent and/or Metastatic SCCHN|A Safety Study of Nivolumab in Patients With Recurrent and/or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Not yet recruiting||Phase 2|173|Anticipated|UNICANCER||1|||f||||t|f|f||||||||2017-10-10 20:51:05.312096|2017-10-10 20:51:05.312096
NCT03226743|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-19|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|COMET||Collaborative and Stepped Care in Mental Health (COMET)|Collaborative and Stepped Care in Mental Health by Overcoming Treatment Sector Barriers: A Cluster-randomized Controlled Trial (COMET)|Not yet recruiting||N/A|750|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f|||||f|f||||||||2017-10-10 20:51:05.426825|2017-10-10 20:51:05.426825
NCT03226730|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-07-19|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|IMPACT-RMA||Evaluating Household Visits and Small Groups to Increase Contraception Use Among Married Adolescent Girls in Rural Niger|Evaluating Household Visits and Small Groups to Increase Contraception Use Among Married Adolescent Girls in Rural Niger|Active, not recruiting||N/A|2440|Anticipated|University of California, San Diego||4|||f||||f||||||||||2017-10-10 20:51:05.497772|2017-10-10 20:51:05.497772
NCT03226717|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-07-19|||August 10, 2017|Anticipated|2017-08-10|July 2017|2017-07-01|December 10, 2017|Anticipated|2017-12-10|September 10, 2017|Anticipated|2017-09-10||Observational|||Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy|Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||f|f|f|||f|||||2017-10-10 20:51:05.571976|2017-10-10 20:51:05.571976
NCT03226704|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-16|||August 14, 2017|Actual|2017-08-14|August 15, 2017|2017-08-15|July 31, 2022|Anticipated|2022-07-31|May 1, 2022|Anticipated|2022-05-01||Observational|||Leukapheresis for CAR-Therapy Manufacturing|Leukapheresis for CAR-Therapy Manufacturing|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f|||||f|||||||||2017-10-10 20:51:05.640133|2017-10-10 20:51:05.640133
NCT03226691|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-21|2017-08-22|||July 25, 2017|Actual|2017-07-25|August 15, 2017|2017-08-15|February 28, 2027|Anticipated|2027-02-28|February 26, 2027|Anticipated|2027-02-26||Interventional|||Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients|Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients Using Plerixafor|Recruiting||Phase 1|15|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f|||||f|f||||||||2017-10-10 20:51:05.711313|2017-10-10 20:51:05.711313
NCT03226678|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-08|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD|An Open Label, Prospective, Study to Assess the Safety, Tolerability, Efficacy and Pharmacokinetics of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)|Recruiting||Phase 2|12|Anticipated|Apellis Pharmaceuticals, Inc.||2|||||||t|t|f||||||||2017-10-10 20:51:05.780836|2017-10-10 20:51:05.780836
NCT03226665|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-05|||September 2, 2017|Anticipated|2017-09-02|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Observational|USBOW||Ultrasound Emergency Diagnosis of Small Bowel Obstruction|Ultrasound Emergency Diagnosis of Small Bowel Obstruction. An Observational Study|Not yet recruiting||N/A|50|Anticipated|Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele|||1||f||||f|f|f||||||||2017-10-10 20:51:05.960531|2017-10-10 20:51:05.960531
NCT03226652|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-27|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Heart Function in Patients Assessed for Sleep Apnoea|Heart Function in Patients Assessed for Sleep Disordered Breathing (SDB)|Recruiting||N/A|155|Anticipated|Imperial College London|||1||f||||f|f|f||||||||2017-10-10 20:51:06.029525|2017-10-10 20:51:06.029525
NCT03226639|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|VARIABLE||Predictive Value of Aortic Stiffness on Recurrence of Atrial Fibrillation After Disconnection of Pulmonary Veins (VARIABLE).|Predictive Value of Aortic Stiffness on Recurrence of Atrial Fibrillation After Disconnection of Pulmonary Veins.|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:51:06.116691|2017-10-10 20:51:06.116691
NCT03226626|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|January 1, 2021|Anticipated|2021-01-01||Interventional|TAAD||Tumescent Anesthesia Antibiotic Delivery (TAAD)|Tumescent Anesthesia Antibiotic Delivery (TAAD) and SubQKath for Prevention of Surgical Site Infection, Thrombosis and Sepsis|Not yet recruiting||Phase 2/Phase 3|330|Anticipated|HK Surgical, Inc.||2|||||||t|t|t|t|f||||||2017-10-10 20:51:06.191438|2017-10-10 20:51:06.191438
NCT03226613|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-13|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||New Modalities for Detection of Oropharyngeal Cancer|Advancing New Modalities for the Detection of Oropharyngeal Cancer: Transcervical Ultrasound and HPV16 E6 Antibodies|Recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:51:06.297767|2017-10-10 20:51:06.297767
NCT03226600|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-20|||March 26, 2015|Actual|2015-03-26|May 2017|2017-05-01|December 16, 2016|Actual|2016-12-16|June 13, 2016|Actual|2016-06-13||Interventional|||OrACELL™ vs. Connective Tissue in Miller Class 3 Defects|A COMPARATIVE STUDY OF ROOT COVERAGE USING OrACELL™ VERSUS SUBEPITHELIAL CONNECTIVE TISSUE GRAFT: A RANDOMIZED CONTROLLED TRIAL|Completed||N/A|24|Actual|Texas A&M University||2|||f||||f|f|f|||f|||||2017-10-10 20:51:06.404829|2017-10-10 20:51:06.404829
NCT03226587|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-20|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Acute Effects of Whole Body Blue Light Exposure on Blood Pressure|Acute Effects of Whole Body Blue Light Exposure on Blood Pressure, Endothelial Function and Vascular Stiffness|Recruiting||N/A|20|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||f|f|f||||||||2017-10-10 20:51:06.488244|2017-10-10 20:51:06.488244
NCT03226574|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-23|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain|A Multicenter, Open-Label, Phase 1b Study to Assess the Safety and Define the Maximally Tolerated Dose of Epidural Resiniferatoxin Injection for the Treatment of Intractable Pain Associated With Cancer|Recruiting||Phase 1|36|Anticipated|Sorrento Therapeutics, Inc.||1|||f||||t|t|f||||||||2017-10-10 20:51:06.602715|2017-10-10 20:51:06.602715
NCT03226561|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-27|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Assessment of Near Vision Capacity in Different Light Conditions Following Bilateral Trifocal Intraocular Implantation|Assessment of Near Vision Capacity in Different Light Conditions Following Bilateral Trifocal Intraocular Implantation|Recruiting||N/A|80|Anticipated|Democritus University of Thrace||2|||f||||f|f|f||||||||2017-10-10 20:51:06.689177|2017-10-10 20:51:06.689177
NCT03226548|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-20|||September 2018|Anticipated|2018-09-01|July 2017|2017-07-01|November 2021|Anticipated|2021-11-01|September 2020|Anticipated|2020-09-01||Interventional|||Health Outcomes Tied to the Expansion of EITC in Single Adults|The Earned Income Tax Credit (EITC) and the Health of Adults Without Dependent Children: A Randomized Controlled Trial|Not yet recruiting||N/A|4000|Anticipated|Columbia University||2|||f||||f|f|f||||||||2017-10-10 20:51:06.774294|2017-10-10 20:51:06.774294
NCT03226535|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-20|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|June 22, 2018|Anticipated|2018-06-22|June 22, 2018|Anticipated|2018-06-22||Interventional|||Ultrasound-CT Fusion System for Interventional Radiology Procedures|Ultrasound-CT Fusion System for Interventional Radiology Procedures|Recruiting||N/A|20|Anticipated|Clear Guide Medical||2|||f||||f|f|t|f||t|||||2017-10-10 20:51:06.857588|2017-10-10 20:51:06.857588
NCT03226522|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-24|||July 13, 2017|Actual|2017-07-13|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|ADVANCE||Addressing Dementia Via Agitation-Centered Evaluation|A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's Type|Recruiting||Phase 2/Phase 3|435|Anticipated|Axsome Therapeutics, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:51:06.948539|2017-10-10 20:51:06.948539
NCT03226509|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-20|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|March 1, 2020|Anticipated|2020-03-01|September 1, 2019|Anticipated|2019-09-01|3 Years|Observational [Patient Registry]|||Transforming the Cascade Of Hepatitis C Care|Transforming the Cascade of Hepatitis C Care|Recruiting||N/A|300|Anticipated|University of Pittsburgh|||1||f||||f|f|f||||||||2017-10-10 20:51:07.03599|2017-10-10 20:51:07.03599
NCT03226496|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||January 3, 2016|Actual|2016-01-03|July 2017|2017-07-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|||Motivational Interviewing for PrEP Uptake|A Pilot Study Assessing a Single Motivational Interviewing Session to Improve Uptake of PrEP Among Young Black Men Who Have Sex With Men|Completed||N/A|100|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 20:51:07.110249|2017-10-10 20:51:07.110249
NCT03226470|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-05|||January 10, 2018|Anticipated|2018-01-10|July 2017|2017-07-01|January 10, 2019|Anticipated|2019-01-10|November 10, 2018|Anticipated|2018-11-10||Interventional|||Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions|Safety Study of Transcription Activator-like Effector Nucleases T27 and T512 in HPV16-infected Subjects|Not yet recruiting||Phase 1|40|Anticipated|Huazhong University of Science and Technology||3|||f||||t|f|f||||||||2017-10-10 20:51:07.258203|2017-10-10 20:51:07.258203
NCT03226457|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|RECEDE-CHF||SGLT2 Inhibition in Combination With Diuretics in Heart Failure|Renal and Cardiovascular Effect of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibition in Combination With Loop Diuretics in Diabetic Patients With Chronic Heart Failure|Not yet recruiting||Phase 4|34|Anticipated|University of Dundee||2|||f||||t|t|f|||t|||||2017-10-10 20:51:07.349393|2017-10-10 20:51:07.349393
NCT03226444|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome|A Double-Masked, Randomized, Multi-Center Phase 2 Study to Evaluate the Efficacy and Safety of Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome|Recruiting||Phase 1/Phase 2|201|Anticipated|TearSolutions, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:51:07.447883|2017-10-10 20:51:07.447883
NCT03226431|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-24|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0|Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0 at Duke University to Improve FEV1|Not yet recruiting||Phase 1|6|Anticipated|Duke University||1|||f||||f|t|f||||||||2017-10-10 20:51:07.62414|2017-10-10 20:51:07.62414
NCT03226418|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|July 7, 2023|Anticipated|2023-07-07|July 7, 2022|Anticipated|2022-07-07||Interventional|||Cytarabine and Idarubicin or Decitabine in Treating Older Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome|A Phase II Study of the Impact of Clinicogenetic Risk-Stratified Management and Systemic Inflammation on Outcomes of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome in Older Patients|Recruiting||Phase 2|160|Anticipated|University of Nebraska||2|||f||||t|t|f||||||||2017-10-10 20:51:07.694777|2017-10-10 20:51:07.694777
NCT03226405|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-15|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|October 2, 2023|Anticipated|2023-10-02|October 2, 2020|Anticipated|2020-10-02||Interventional|||Patient Navigation to Improve Patient-Centered Cancer Care|Patient Navigation to Improve Patient-Centered Cancer Care|Not yet recruiting||N/A|900|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:07.837413|2017-10-10 20:51:07.837413
NCT03226392|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-20|||November 7, 2017|Anticipated|2017-11-07|July 2017|2017-07-01|June 11, 2019|Anticipated|2019-06-11|June 11, 2019|Anticipated|2019-06-11||Interventional|||A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma.|A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma|Not yet recruiting||Phase 3|650|Anticipated|Novartis||2|||f||||t|t|f||||||||2017-10-10 20:51:07.935544|2017-10-10 20:51:07.935544
NCT03226379|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-20|||April 23, 2016|Actual|2016-04-23|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Observational|DREAMM||Driving Reduced AIDS-associated Meningo-encephalitis Mortality|Integrating the Diagnosis and Management of HIV-associated Central Nervous System (CNS) Infections Into Routine Health Services in Low and Middle Income Countries (LMICs)|Recruiting||N/A|450|Anticipated|St George's, University of London|||1||f||||t|f|f||||||||2017-10-10 20:51:08.010219|2017-10-10 20:51:08.010219
NCT03226366|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||July 21, 2017|Anticipated|2017-07-21|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Observational|||Effect of Emergency Department Care Reorganization on Door-to-antibiotic Times for Sepsis (LDS SWARM)|Effect of Emergency Department Care Reorganization on Door-to-antibiotic Times for Sepsis (LDS SWARM)|Recruiting||N/A|3500|Anticipated|Intermountain Health Care, Inc.|||4||f||||f|f|f||||||||2017-10-10 20:51:08.105121|2017-10-10 20:51:08.105121
NCT03226353|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-15|||July 6, 2017|Actual|2017-07-06|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Performance of Somofilcon A Over One Week in Wearers Adapted to Omafilcon A|Performance of Somofilcon A Over One Week in Wearers Adapted to Omafilcon A|Recruiting||N/A|75|Anticipated|Coopervision, Inc.||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:51:08.214345|2017-10-10 20:51:08.214345
NCT03226340|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||December 2, 2015|Actual|2015-12-02|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension|Evaluation of the Efficacy and Safety of S-amlodipine+Chlorthalidone Combination Therapy and S-amlodipine+Telmisartan Combination Therapy in Hypertensive Patients Inadequately Controlled With Calcium Channel Blocker Monotherapy|Recruiting||Phase 4|170|Anticipated|Seoul National University Bundang Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:08.286465|2017-10-10 20:51:08.286465
NCT03226327|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 10, 2017|Anticipated|2017-10-10|September 15, 2017|Anticipated|2017-09-15||Interventional|||A Preliminary Trial of Safety and Reducing Blood Pressure of Formula Salt With Limited Sodium Named ManLiKang in Hypertension Patients.|A Preliminary Trial of Safety and Reducing Blood Pressure of Formula Salt With Limited Sodium Named ManLiKang in Hypertension Patients.|Not yet recruiting||N/A|90|Anticipated|Peking University||1|||f||||t|f|f||||||||2017-10-10 20:51:08.390833|2017-10-10 20:51:08.390833
NCT03226314|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-07-20|||November 2017|Anticipated|2017-11-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|AB-RUN||Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island|Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae (Prevalence, Resistance Mechanisms and Risk Factors) in Reunion Island|Not yet recruiting||N/A|650|Anticipated|Centre Hospitalier Universitaire de la Réunion|||1||f||||f|f|f||||Samples Without DNA|"     stools samples   "|||2017-10-10 20:51:08.448182|2017-10-10 20:51:08.448182
NCT03226301|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-20|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|July 1, 2027|Anticipated|2027-07-01|July 1, 2027|Anticipated|2027-07-01||Interventional|||A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations|A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations|Recruiting||Phase 2|230|Anticipated|Stichting Hemato-Oncologie voor Volwassenen Nederland||3|||f||||t|f|f||||||||2017-10-10 20:51:08.517169|2017-10-10 20:51:08.517169
NCT03226288|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-23|||February 9, 2017|Actual|2017-02-09|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|September 2017|Anticipated|2017-09-01|3 Months|Observational [Patient Registry]|||Customized Shoe-padding Orthotics for Plantar Fasciitis|Integrated 3D Surface Scanning System Combined With Soft Tissue and Skeleton Information: Customized Shoe-padding Orthotics for Plantar Fasciitis|Recruiting||N/A|10|Anticipated|National Taiwan University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:51:08.602671|2017-10-10 20:51:08.602671
NCT03226275|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-09-25|||August 9, 2017|Actual|2017-08-09|September 2017|2017-09-01|September 9, 2017|Actual|2017-09-09|September 9, 2017|Actual|2017-09-09||Interventional|||Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Subjects|A Randomized, Two-period Crossover Trial Examining Bioequivalence of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablets Versus Bisoprolol 5 mg Tablets and Amlodipine 5 mg Tablets Given Concomitantly in Healthy Subjects in Fasting and Fed State|Completed||Phase 1|32|Anticipated|Merck KGaA||2|||f||||f|f|f||||||||2017-10-10 20:51:08.662914|2017-10-10 20:51:08.662914
NCT03226262|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-20|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|FAST-FFR||FFRangio Accuracy vs. Standard FFR|FFRangio Accuracy vs. Standard FFR|Not yet recruiting||N/A|386|Anticipated|CathWorks Ltd.|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:51:08.742574|2017-10-10 20:51:08.742574
NCT03226249|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma|Phase II Study of PET-Directed Frontline Therapy With Pembrolizumab and AVD for Patients With Classical Hodgkin Lymphoma|Not yet recruiting||Phase 2|30|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 20:51:08.810839|2017-10-10 20:51:08.810839
NCT03226236|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-07-19|||March 2016||2016-03-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|RENALVax-2||Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC|Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC: a Phase II Trial (RENALVax-2)|Recruiting||Phase 2|37|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-10 20:51:08.961877|2017-10-10 20:51:08.961877
NCT03226223|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||September 15, 2016|Actual|2016-09-15|July 2017|2017-07-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2019|Anticipated|2019-07-30||Interventional|||Pharmacogenetics of Naltrexone for Stimulant Abuse|Using Pharmacogenetics to Better Evaluate Naltrexone for Treating Stimulant Abuse|Recruiting||Phase 2|70|Anticipated|New York State Psychiatric Institute||2|||f||||f|t|f||||||||2017-10-10 20:51:09.058937|2017-10-10 20:51:09.058937
NCT03226210|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||February 1, 2015|Actual|2015-02-01|July 2017|2017-07-01|July 1, 2016|Actual|2016-07-01|May 1, 2016|Actual|2016-05-01||Interventional|||Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes|Comparison of Efficacy and Safety of Prandilin and NovoRapid Evaluated by Continuous Glucose Monitoring System in Newly Diagnosed Type 2 Diabetes|Completed||Phase 4|110|Actual|Nanjing First Hospital, Nanjing Medical University||2|||f|||||f|f|||f|||||2017-10-10 20:51:09.136296|2017-10-10 20:51:09.136296
NCT03226197|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-20|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Feasibility and Safety of Delivering a Ketone Drink to Comatose Survivors of Out-of-hospital Cardiac Arrest|Feasibility and Safety of Delivering a Ketone Drink to Comatose Survivors of Out-of-hospital Cardiac Arrest|Not yet recruiting||N/A|10|Anticipated|Barts & The London NHS Trust||1|||f||||t|f|f||||||||2017-10-10 20:51:09.204562|2017-10-10 20:51:09.204562
NCT03226184|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||July 1, 2012|Actual|2012-07-01|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Anticipated|2017-09-01||Observational|||Sterilizing Effects of the Erbium:YAG Laser Upon Metal Implants|Sterilizing Effects of the Erbium:YAG Laser Upon Metal Implants|Recruiting||N/A|50|Anticipated|Medical University of Vienna|||1||f||||f|f|f||||||||2017-10-10 20:51:09.270387|2017-10-10 20:51:09.270387
NCT03226158|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-11|||August 9, 2017|Actual|2017-08-09|July 2017|2017-07-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2020|Anticipated|2020-10-31||Observational|||Next Generation Pathogen Sequencing for Prediction of Adverse Events|Prediction of Adverse Events in Children and Adolescents With Cancer at High Risk of Infection (PREDSEQ)|Recruiting||N/A|200|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     Plasma samples collected but not required for clinical care will undergo next generation     pathogen sequencing.   "|||2017-10-10 20:51:09.389724|2017-10-10 20:51:09.389724
NCT03226145|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-07-24|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|RECLAIM||Reclassifying Constipation Using Imaging and Manometry|Reclassifying Constipation Using Magnetic Resonance Imaging Combined With High Resolution Manometry: A Validation Study And Double-Blind Crossover Trial|Recruiting||N/A|120|Anticipated|University of Nottingham||2|||f||||f|f|f||||||||2017-10-10 20:51:09.601045|2017-10-10 20:51:09.601045
NCT03226132|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-19|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Improving Sleep to Reduce Risk for Substance Use Disorder|Biobehavioral Mechanisms Underlying Improving Sleep to Reduce Risk for Substance Use Disorder|Not yet recruiting||N/A|60|Anticipated|Florida State University||2|||f|||||f|f||||||||2017-10-10 20:51:09.744486|2017-10-10 20:51:09.744486
NCT03226119|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-27|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study|HTLV Blot 2.4 Post-Market Clinical Study of Neurological Disorders and HTLV Positive Specimens|Active, not recruiting||Phase 4|150|Actual|MP Biomedicals, LLC||2|||f||||f|t|t|f|f||||||2017-10-10 20:51:09.830716|2017-10-10 20:51:09.830716
NCT03226106|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-20|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|October 31, 2021|Anticipated|2021-10-31|October 31, 2021|Anticipated|2021-10-31||Interventional|||Optimizing Physical Activity Outcomes After Total Knee Arthroplasty|Optimizing Physical Activity Outcomes for Veterans After Total Knee Arthroplasty|Not yet recruiting||N/A|100|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 20:51:09.932784|2017-10-10 20:51:09.932784
NCT03226093|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|January 1, 2017|Actual|2017-01-01||Interventional|||Safety Analysis of Implantation of Stromal Vascular Fraction|Safety Analysis of Implantation of Stromal Vascular Fraction|Completed||N/A|676|Actual|Bioheart, Inc.||1|||f||||f|f|f||||||||2017-10-10 20:51:10.039323|2017-10-10 20:51:10.039323
NCT03226080|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-20|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||GA/Spinal vs. GA/Spinal/NMB for Operative Repair of Hip Fracture|Combined General and Spinal Anesthesia vs. Combined General and Spinal Anesthesia With Neuromuscular Blockade for Operative Repair of Hip Fractures|Recruiting||Phase 4|84|Anticipated|Loyola University||2|||f||||t|t|f|||f|||||2017-10-10 20:51:10.111052|2017-10-10 20:51:10.111052
NCT03226067|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-29|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|August 20, 2018|Anticipated|2018-08-20|August 20, 2018|Anticipated|2018-08-20||Interventional|||Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid.|A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase|Recruiting||Phase 2|102|Anticipated|Genkyotex SA||3|||||||t|t|f||||||||2017-10-10 20:51:10.244925|2017-10-10 20:51:10.244925
NCT03226054|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Determining Risk Factors for Successful PPI Weaning|Determining Risk Factors for Successful PPI Weaning|Recruiting||N/A|100|Anticipated|Mount Carmel Health System||1|||f||||f|f|f||||||||2017-10-10 20:51:10.545216|2017-10-10 20:51:10.545216
NCT03226041|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-23|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|October 15, 2017|Anticipated|2017-10-15|September 20, 2017|Anticipated|2017-09-20||Interventional|||PTCCO2 Monitoring During Retroperitoneoscopic Urologic Surgery|The Application of Transcutaneous CO2 Partial Pressure Monitoring in the Anesthesia of Patients Undergoing Retroperitoneoscopic Urologic Surgery|Recruiting||N/A|30|Anticipated|The First Affiliated Hospital with Nanjing Medical University||1|||f||||t|f|f||||||||2017-10-10 20:51:10.649454|2017-10-10 20:51:10.649454
NCT03226028|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-21|||May 4, 2017|Actual|2017-05-04|July 2017|2017-07-01|May 4, 2019|Anticipated|2019-05-04|April 1, 2019|Anticipated|2019-04-01||Interventional|||Perioperative Music Listening on Anxiety, Analgesia Use and Patient Satisfaction|The Effect of Perioperative Music Listening on Anxiety, Analgesia Use and Patient Satisfaction|Recruiting||N/A|150|Anticipated|KK Women's and Children's Hospital||1|||f||||t|f|f||||||||2017-10-10 20:51:10.741999|2017-10-10 20:51:10.741999
NCT03226015|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-19|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Observational|||Autologous Oral Mucosa Transplantation for Limbal Stem Cell Deficiency|Autologous Oral Mucosa With Amniotic Membrane Transplantation for Limbal Stem Cell Deficiency: Clinical and Immunohistochemical Study|Completed||N/A|27|Actual|Klinikum Chemnitz gGmbH|||1||f||||f|f|f||||Samples Without DNA|"     oral mucosa tissue   "|||2017-10-10 20:51:10.839416|2017-10-10 20:51:10.839416
NCT03226002|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||April 26, 2017|Actual|2017-04-26|July 2017|2017-07-01|August 1, 2017|Anticipated|2017-08-01|July 26, 2017|Anticipated|2017-07-26||Interventional|||Which Nostril Should be Used for Nasotracheal Intubation With Airtraq NT®: the Right or Left? A Randomized Clinical Trial|Which Nostril Should be Used for Nasotracheal Intubation With Airtraq NT®: the Right or Left? A Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Kocaeli University||2|||f||||f|f|f||||||||2017-10-10 20:51:10.91236|2017-10-10 20:51:10.91236
NCT03225989|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-19|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|November 1, 2020|Anticipated|2020-11-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer|Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Lokon Pharma AB||1|||f||||f|t|f|||t|||||2017-10-10 20:51:11.009884|2017-10-10 20:51:11.009884
NCT03225976|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-25|||August 19, 2017|Anticipated|2017-08-19|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effect of Light-Emitting Diode on the Strenght and Resistence Capacities of Cycling Athletes|Effect of Light-Emitting Diode on the Strenght and Resistence Capacities of Cycling Athletes|Not yet recruiting||N/A|36|Anticipated|University of Sao Paulo||3|||f||||t|f|f||||||||2017-10-10 20:51:11.104438|2017-10-10 20:51:11.104438
NCT03225963|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||August 1, 2015|Actual|2015-08-01|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.|Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.|Recruiting||N/A|60|Anticipated|Taichung Veterans General Hospital|||1||f||||t|f|f||||Samples With DNA|"     DNA of peripheral mononulcear cells.   "|||2017-10-10 20:51:11.210629|2017-10-10 20:51:11.210629
NCT03225950|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-22|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|August 29, 2020|Anticipated|2020-08-29|August 29, 2020|Anticipated|2020-08-29||Observational|||Interaction Between Immune Cells and Bacteria Associated With Periodontitis|Interaction Between Immune Cells and Bacteria Associated With Periodontitis|Recruiting||N/A|170|Anticipated|University of Copenhagen|||3||f||||f|f|f||||Samples With DNA|"     Saliva, whole blood, peripheral mononuclear blood cells, serum, plasma.   "|||2017-10-10 20:51:11.308261|2017-10-10 20:51:11.308261
NCT03225586|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||January 1, 2002|Actual|2002-01-01|July 2017|2017-07-01|December 31, 2030|Anticipated|2030-12-31|December 31, 2030|Anticipated|2030-12-31||Observational|PURE||Prospective Urban Rural Epidemiology Study|Prospective Urban Rural Epidemiology Study|Recruiting||N/A|200000|Anticipated|Population Health Research Institute|||1||f||||f|f|f||||Samples With DNA|"     Whole blood, Serum, Plasma, Urine   "|||2017-10-10 20:51:15.612037|2017-10-10 20:51:15.612037
NCT03225937|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-18|||August 2012||2012-08-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|HERACLES||Evaluation of Trastuzumab in Combination With Lapatinib or Pertuzumab in Combination With Trastuzumab-Emtansine to Treat Patients With HER2-positive Metastatic Colorectal Cancer|Open-Label, Phase II Study of Trastuzumab in Combination With Lapatinib (Cohort A) or Pertuzumab in Combination With Trastuzumab-emtansine (Cohort B) in Patients With HER2-positive Metastatic Colorectal Cancer: the HERACLES (HER2 Amplification for Colo-rectaL Cancer Enhanced Stratification)Trial|Recruiting||Phase 2|54|Anticipated|Fondazione del Piemonte per l'Oncologia||2|||f||||f||||||||||2017-10-10 20:51:11.451913|2017-10-10 20:51:11.451913
NCT03225924|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-08-21|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|September 2023|Anticipated|2023-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by Chemiotherapy|Phase Ib - II Study of Entospletinib (ENTO) in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) Patients With aaIPI>=1 Treated by Rituximab, Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone (R-CHOP)|Recruiting||Phase 1/Phase 2|131|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t|f|f||||||||2017-10-10 20:51:11.561378|2017-10-10 20:51:11.561378
NCT03225911|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||September 25, 2017|Anticipated|2017-09-25|July 2017|2017-07-01|March 25, 2019|Anticipated|2019-03-25|December 25, 2018|Anticipated|2018-12-25||Interventional|||Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis|Effect of a Lateral Wedge Insole and Simple Knee Sleeve as a Single and Combined Treatment on Biomechanical and Clinical Outcomes in Individuals With Knee Osteoarthritis (The IN-SLEEVE Study).|Not yet recruiting||N/A|30|Anticipated|University of Salford||3|||f||||f|f|f||||||||2017-10-10 20:51:11.663985|2017-10-10 20:51:11.663985
NCT03225898|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-20|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|June 13, 2018|Anticipated|2018-06-13|June 13, 2018|Anticipated|2018-06-13||Interventional|||Upper- and Lower-body Resistance Exercise With and Without Blood Flow Restriction on Hemodynamics and Vascular Function|Upper- and Lower-body Resistance Exercise With and Without Blood Flow Restriction on Hemodynamics and Vascular Function|Recruiting||N/A|20|Anticipated|Kent State University||2|||f||||f|f|f||||||||2017-10-10 20:51:11.749856|2017-10-10 20:51:11.749856
NCT03225885|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Counseling for Prematurity Using a Multimedia Education Tool|Effectiveness of Prenatal Counseling for Prematurity Using a Supplementary Multimedia Parent Education Tool|Not yet recruiting||N/A|80|Anticipated|Medical College of Wisconsin||2|||f||||f|f|f||||||||2017-10-10 20:51:11.836639|2017-10-10 20:51:11.836639
NCT03225872|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-21|||January 3, 2017|Actual|2017-01-03|July 2017|2017-07-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|BOOST||Biology of Osteosarcoma (BOOST) Registry and Biobank|Biology of Osteosarcoma (BOOST) Registry and Biobank|Recruiting||N/A|5000|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||Samples With DNA|"     The investigator will collect saliva and if available baby teeth. There will be no cost to     you. If the investigator finds out that your sample doesn't have enough cells to be useful,     the investigator may call you for an additional sample.   "|||2017-10-10 20:51:11.929432|2017-10-10 20:51:11.929432
NCT03225859|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||September 3, 2018|Anticipated|2018-09-03|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|May 31, 2019|Anticipated|2019-05-31||Interventional|EMPOwER||A Self-Management Program for Completers of Trauma-Focused Therapy for PTSD|Pilot Test of a Self-Management Program for Completers of Trauma-Focused Therapy|Not yet recruiting||N/A|12|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 20:51:12.003843|2017-10-10 20:51:12.003843
NCT03225846|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PRECISION-HD2||Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease|Recruiting||Phase 1/Phase 2|48|Anticipated|Wave Life Sciences Ltd.||4|||f||||t|f|f||||||||2017-10-10 20:51:12.078549|2017-10-10 20:51:12.078549
NCT03225833|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PRECISION-HD1||Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease|Recruiting||Phase 1/Phase 2|48|Anticipated|Wave Life Sciences Ltd.||4|||f||||t|f|f||||||||2017-10-10 20:51:12.160032|2017-10-10 20:51:12.160032
NCT03225807|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-04|||March 2016||2016-03-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|IMPROVENT||Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure|Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure|Recruiting||N/A|8000|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-10-10 20:51:12.370215|2017-10-10 20:51:12.370215
NCT03225794|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-18|||November 1, 2010|Actual|2010-11-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Simian Foamy Virus Transmission to Humans|Epidemiological and Molecular Aspects of the Interspecies Transmission of Foamy Viruses From Monkeys to Humans: A Model of the Early Stages of Viral Emergence.|Recruiting||N/A|1600|Anticipated|Institut Pasteur|||2||f||||f|f|f||||Samples With DNA|"     Blood draw into a 5/10 ml EDTA tubes; Oral specimens will be collected by rubbing the inside     of the cheek with a swab and then rinsing the mouth and collecting the rinse liquid in a     sterile bottle.   "|||2017-10-10 20:51:12.447853|2017-10-10 20:51:12.447853
NCT03225781|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer|A Clinical Trial Using Electrochemotherapy With Bleomycin for the Treatment of Non-metastatic Unresectable Pancreatic Cancer|Recruiting||N/A|20|Anticipated|Universita di Verona||1|||f||||f|f|f||||||||2017-10-10 20:51:12.52389|2017-10-10 20:51:12.52389
NCT03225768|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-06|||August 14, 2017|Anticipated|2017-08-14|August 2017|2017-08-01|May 18, 2018|Anticipated|2018-05-18|March 18, 2018|Anticipated|2018-03-18||Interventional|GTPCI||Guided Training for People With Cognitive Impairment|Adopting Guided Training to Improve Participation Performance of Individuals With Cognitive Impairments After Stroke and Traumatic Brain Injury: A Feasibility Study (GTPCI)|Not yet recruiting||N/A|60|Anticipated|Taipei Medical University WanFang Hospital||1|||f|||||f|f||||||||2017-10-10 20:51:12.58782|2017-10-10 20:51:12.58782
NCT03225755|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 30, 2019|Anticipated|2019-07-30|July 30, 2019|Anticipated|2019-07-30||Observational|||Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy|Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy|Recruiting||N/A|12|Anticipated|Columbia University|||1||f||||f|t|f|||f|Samples Without DNA|"     1. Peripheral venous blood        2. Subcutaneous adipose tissue   "|||2017-10-10 20:51:12.64026|2017-10-10 20:51:12.64026
NCT03225742|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-16|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 1, 2018|Anticipated|2018-02-01|August 1, 2017|Actual|2017-08-01||Observational|||The Impact of Postoperative Catheterization Time After Stress Incontinence Surgery to Success of Surgery|The Impact of Postoperative Catheterization Time After Stress Incontinence Surgery to Voiding Dysfunction, Urinary Retention and Success of Surgery|Active, not recruiting||N/A|100|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital|||2||f||||f|f|f||||||||2017-10-10 20:51:12.715506|2017-10-10 20:51:12.715506
NCT03225729|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-21|||October 23, 2017|Anticipated|2017-10-23|July 2017|2017-07-01|January 4, 2018|Anticipated|2018-01-04|December 29, 2017|Anticipated|2017-12-29||Interventional|CBT-EC2||Assessment of CRYOBEAUTY MAINS ET DECOLLETE Versus Liquid Nitrogen Cryotherapy, in the Treatment of Solar Lentigines|"Prospective Clinical Trial to Assess the Performance of a Cyto-selective Cryotherapye CRYOBEAUTY MAINS ET DECOLLETE Compared With Liquid Nitrogen Cryotherapy in the Treatment of Solar Lentigines in 30 Patients"|Not yet recruiting||N/A|30|Anticipated|Cryobeauty||2|||f||||f|f|f|||f|||||2017-10-10 20:51:12.767504|2017-10-10 20:51:12.767504
NCT03225716|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-05|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|January 31, 2025|Anticipated|2025-01-31|January 31, 2021|Anticipated|2021-01-31||Interventional|||A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia|A Phase 1/2 Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia|Not yet recruiting||Phase 1/Phase 2|38|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 20:51:12.828082|2017-10-10 20:51:12.828082
NCT03225703|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-07-18|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women|The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women|Recruiting||N/A|32|Anticipated|Loughborough University||2|||f||||f|f|f||||||||2017-10-10 20:51:12.914143|2017-10-10 20:51:12.914143
NCT03225690|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-19|||July 19, 2017|Anticipated|2017-07-19|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Prevention of Hyperalgesia With Epidural Morphine|Does Preemptive Epidural Morphine Prevent Remifentanil Induced Hyperalgesia|Recruiting||Phase 4|105|Anticipated|Cukurova University||3|||f||||f|f|f|||f|||||2017-10-10 20:51:14.709317|2017-10-10 20:51:14.709317
NCT03225677|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-20|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|July 30, 2021|Anticipated|2021-07-30|July 30, 2021|Anticipated|2021-07-30||Observational|||Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis|Multiple Tracer Using Single Muscle Biopsy Technique in Evaluating Protein Synthesis and Break Down in Muscles of Cirrhotic Patients|Recruiting||N/A|20|Anticipated|The Cleveland Clinic|||2||f|||||f|f||||||||2017-10-10 20:51:14.792755|2017-10-10 20:51:14.792755
NCT03225651|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-19|||January 18, 2017|Actual|2017-01-18|July 2017|2017-07-01|December 18, 2018|Anticipated|2018-12-18|December 18, 2018|Anticipated|2018-12-18||Interventional|ASPRA||Autologous Bone Marrow Stem Cell Therapy Combined With Psychological Therapy and Rehabilitation for Autism|Autologous Bone Marrow Stem Cell Therapy Combined With Psychological Therapy and Rehabilitation for Autism: An Open Label Controlled Clinical Trial|Recruiting||Phase 2|60|Anticipated|Vinmec Research Institute of Stem Cell and Gene Technology||2|||f||||t|f|f||||||||2017-10-10 20:51:15.028955|2017-10-10 20:51:15.028955
NCT03225638|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 29, 2017|Anticipated|2017-12-29|September 30, 2017|Anticipated|2017-09-30||Interventional|||Performance Evaluation by Magnetic Resonance Imaging (MRI) of Intramuscular Thigh Injections With 3 Configurations of Needle-free Injector (ZENEO®)|Performance Evaluation by Magnetic Resonance Imaging (MRI) of Intramuscular Thigh Injections With 3 Configurations of Needle-free Injector (ZENEO®)|Not yet recruiting||N/A|86|Anticipated|Crossject||2|||f||||f|f|f||||||||2017-10-10 20:51:15.118023|2017-10-10 20:51:15.118023
NCT03225625|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-27|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|SciExVR||Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study|Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study|Recruiting||N/A|40|Anticipated|MD Stem Cells||3|||f||||t|f|f||||||||2017-10-10 20:51:15.184237|2017-10-10 20:51:15.184237
NCT03225612|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-12|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|November 2022|Anticipated|2022-11-01|June 2018|Anticipated|2018-06-01||Interventional|SCOUT-II||Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)|Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) for Symptomatic Chronic Functional Tricuspid Regurgitation|Recruiting||N/A|60|Anticipated|Mitralign, Inc.||1|||f||||t|f|t|t|f||||||2017-10-10 20:51:15.288334|2017-10-10 20:51:15.288334
NCT03225573|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-20|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|CBCT||Prevalence of Second Mesiobuccal Canal of Maxillary First and Second Molars Among Egyptian Population|The Prevalence of a Second Mesiobuccal Canal of Maxillary First and Second Molars Using CBCT Among Egyptian Population: A Cross-Sectional Study|Not yet recruiting||N/A|196|Anticipated|Cairo University|||1||f||||f|f|f||||||||2017-10-10 20:51:15.941022|2017-10-10 20:51:15.941022
NCT03225560|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|COLOPREP||Smart Phone App for COLOnoscopic PREParation|A Novel Smart Phone Application for Patients Undergoing COLOnoscopic Bowel PREParation: A Randomized Controlled Trial|Not yet recruiting||N/A|260|Anticipated|Kingston General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:15.998288|2017-10-10 20:51:15.998288
NCT03225534|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-21|||August 31, 2008|Actual|2008-08-31|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|October 31, 2012|Actual|2012-10-31||Observational|||Project 500 CHILD Study|Project 500 CHILD Study|Active, not recruiting||N/A|500|Actual|McMaster University|||1||f||||f|f|f||||Samples Without DNA|"     Cord blood. Child 1 year blood Child 5 year blood. Parental venous blood. Saliva samples.     Urine samples. Stool samples. Breast milk samples. Nasal swabs.   "|||2017-10-10 20:51:16.189666|2017-10-10 20:51:16.189666
NCT03225521|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||July 18, 2015|Actual|2015-07-18|July 2017|2017-07-01|February 1, 2016|Actual|2016-02-01|February 1, 2016|Actual|2016-02-01||Interventional|HS||A Micro-randomized Trial of HeartSteps, an mHealth Intervention for Increasing Physical Activity|HeartSteps: a Just-in-Time Adaptive Intervention for Increasing Physical Activity Amongst Sedentary Adults.|Completed||N/A|44|Actual|University of Michigan||1|||f||||f|f|f||||||||2017-10-10 20:51:16.273589|2017-10-10 20:51:16.273589
NCT03225508|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-26|||August 1, 2017|Anticipated|2017-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Diaphragmatic Motion Using Linear Ultrasound|A Novel Method to Measure Diaphragmatic Motion and Excursion|Recruiting||N/A|175|Anticipated|University Health Network, Toronto|||2||f||||f|f|f||||||||2017-10-10 20:51:16.361629|2017-10-10 20:51:16.361629
NCT03225495|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-20|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Comparison Between Ultra-narrow Diameter Implants (2,75 mm) Without Bone Regeneration Versus Standard Diameter Implants (4,3 mm) in Combination With Bone Regeneration|Éxito a Corto Plazo de Los Implantes Ultra-estrechos (2,75 mm) en comparación Con Implantes de Plataforma Regular (4,3 mm) Que Requieren regeneración ósea Vestibular simultánea. Ensayo clínico Aleatorizado|Recruiting||N/A|40|Anticipated|University of Barcelona||2|||f||||t|f|f||||||||2017-10-10 20:51:16.484811|2017-10-10 20:51:16.484811
NCT03225482|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-18|||April 2, 2018|Anticipated|2018-04-02|July 2017|2017-07-01|December 30, 2022|Anticipated|2022-12-30|March 31, 2022|Anticipated|2022-03-31||Interventional|||Cognitive Rehabilitation Therapy for Mild Cognitive Impairment|Cognitive Rehabilitation for Older Veterans With Mild Cognitive Impairment|Not yet recruiting||N/A|216|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 20:51:16.557132|2017-10-10 20:51:16.557132
NCT03225469|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-08-10|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|April 30, 2018|Anticipated|2018-04-30|March 31, 2018|Anticipated|2018-03-31||Interventional|IERFAOBP||Improving Effect of Reinforced Family Assistance on the Quality of Bowel Preparation for Colonoscopy|Improving Effect of Reinforced Family Member Education on the Quality of Bowel Preparation for Colonoscopy|Not yet recruiting||N/A|552|Anticipated|Wuxi People's Hospital||2|||f||||t|f|f||||||||2017-10-10 20:51:16.661426|2017-10-10 20:51:16.661426
NCT03225456|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Oxytocin and Eating|Exploring the Effects of Oxytocin on Appetite Regulation in Healthy Adult Men|Not yet recruiting||Phase 2|60|Anticipated|Yale-NUS College||2|||f||||f|f|f||||||||2017-10-10 20:51:16.771176|2017-10-10 20:51:16.771176
NCT03225443|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30|3 Years|Observational [Patient Registry]|||Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Particle Radiotherapy Versus Neoadjuvant Chemotherapy|Shanghai First Maternity and Infant Hospital|Not yet recruiting||N/A|50|Anticipated|Shanghai First Maternity and Infant Hospital|||2||f|||||f|f||||||||2017-10-10 20:51:16.853072|2017-10-10 20:51:16.853072
NCT03225430|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-20|||April 21, 2016|Actual|2016-04-21|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Evaluation of a Cognitive Psychophysiological Treatment for Tourette Syndrome and Tic Disorders|Evaluation of a Cognitive Psychophysiological Treatment for Tourette Syndrome and Tic Disorders|Recruiting||N/A|144|Anticipated|Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine||2|||f||||f|f|f||||||||2017-10-10 20:51:16.926896|2017-10-10 20:51:16.926896
NCT03225417|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-18|||May 16, 2017|Actual|2017-05-16|July 2017|2017-07-01|May 27, 2023|Anticipated|2023-05-27|June 27, 2020|Anticipated|2020-06-27||Interventional|||Ixazomib in Combination With Sirolimus and Tacrolimus in the Prophylaxis of Chronic Graft-versus-host Disease.|Phase Ib/II Trial to Evaluate Safety and Efficacy of Oral Ixazomib in Combination With Sirolimus and Tacrolimus in the Prophylaxis of Chronic Graft-versus-host Disease.|Recruiting||Phase 1/Phase 2|154|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f|f|f|||f|||||2017-10-10 20:51:17.075939|2017-10-10 20:51:17.075939
NCT03225404|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-22|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|MRH||Effectiveness of Therapeutic Percutaneous Electrolysis in Persons With the Treatment of Epicondylitis|Clinical Results After Ultrasound-guided Therapeutic Percutaneous Electrolysis (EPTE®) and Eccentric Exercises in the Treatment of Epicondylitis|Not yet recruiting||N/A|32|Anticipated|University of Cadiz||2|||f||||t|f|f||||||||2017-10-10 20:51:17.230916|2017-10-10 20:51:17.230916
NCT03225391|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||June 10, 2015|Actual|2015-06-10|July 2017|2017-07-01|February 10, 2016|Actual|2016-02-10|February 10, 2016|Actual|2016-02-10||Interventional|||Effect of Naps on Decision Making of Residents.|Effect of Programmed Naps on Decision Making of Residents During Working Hours.|Completed||N/A|27|Actual|Instituto Nacional de Enfermedades Respiratorias||2|||f||||f|f|f||||||||2017-10-10 20:51:17.451556|2017-10-10 20:51:17.451556
NCT03225378|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01|1 Day|Observational [Patient Registry]|VPP-ImPRoVE||Changes in PPV Induced by PLR Test to Predict Fluid Responsiveness in ICU|Changes in Pulse Pressure Variations Induced by Passive Leg Raising Test to Predict Fluid Responsiveness in ICU|Not yet recruiting||N/A|536|Anticipated|Centre Hospitalier d'Arras|||1||f||||f|f|f||||||||2017-10-10 20:51:17.555207|2017-10-10 20:51:17.555207
NCT03225365|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|IMMUNONIVO||Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma|Immune Modulation Study in Patients With Metastatic Melanoma Treated With a First Line Therapy of Nivolumab +/- Ipilimumab (IMMUNONIVO/MelpredictPD1).|Not yet recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 20:51:17.701289|2017-10-10 20:51:17.701289
NCT03225352|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-09-20|||August 7, 2017|Actual|2017-08-07|September 2017|2017-09-01|October 26, 2017|Anticipated|2017-10-26|October 12, 2017|Anticipated|2017-10-12||Interventional|||A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets|An Open Label, Randomized, Four-Way Crossover Trial to Assess the Disintegration, Gastric Emptying and Pharmacokinetic Parameters of a New Disintegrating Acetylsalicylic Acid 500 mg, 1000 mg Tablet Formulation and 2 Different Ibuprofen Tablets in Fasted Healthy Male Subjects|Recruiting||Phase 1|12|Anticipated|Bayer||4|||f||||f|f|f||||||||2017-10-10 20:51:17.859412|2017-10-10 20:51:17.859412
NCT03225339|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-24|||July 16, 2017|Actual|2017-07-16|July 2017|2017-07-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|DIADEM-1||Diabetes Intervention Accentuating Diet and Enhancing Metabolism|A Randomised Controlled Trial Assessing the Impact of Low Calorie Diet and Activity on Body Weight and Glycaemia in Diabetes|Recruiting||N/A|138|Anticipated|Weill Cornell Medical College in Qatar||2|||f||||t|f|f||||||||2017-10-10 20:51:18.009866|2017-10-10 20:51:18.009866
NCT03225326|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block for Tooth Extraction|Efficacy of Anterior and Middle Superior Alveolar (AMSA) Nerve Block Anesthesia Obtained by Articaine Computer-controlled and Conventional Delivery|Active, not recruiting||Phase 4|30|Anticipated|University of Belgrade||2|||f|||||||||f|||||2017-10-10 20:51:18.143288|2017-10-10 20:51:18.143288
NCT03225313|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-08-10|||August 20, 2017|Anticipated|2017-08-20|August 2017|2017-08-01|December 20, 2017|Anticipated|2017-12-20|October 20, 2017|Anticipated|2017-10-20||Interventional|||Comparison Between Ultra Sound Guided Rectus Sheath Block and Field Block for Midline Hernia Repair|Ultra Sound Guided Rectus Sheath Block or Field Block for Midline Hernia Repair: A Comparative Study|Recruiting||N/A|75|Anticipated|Theodor Bilharz Research Institute||3|||f|||||f|f|||f|||||2017-10-10 20:51:18.279327|2017-10-10 20:51:18.279327
NCT03225300|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||January 1, 2005|Actual|2005-01-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation|Evaluation the Prognostic Significance of High Radiation Dose in Malignant Glioma Patients Treated With Chemoradiation|Recruiting||N/A|120|Anticipated|Taichung Veterans General Hospital||1|||f||||f|f|f||||||||2017-10-10 20:51:18.421911|2017-10-10 20:51:18.421911
NCT03225287|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-26|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Extension Study of RA101495 for Patients With PNH Who Have Completed a RA101495 Clinical Study|A Multicenter, Open-label, Uncontrolled, Extension Study of RA101495 in Subjects With Paroxysmal Nocturnal Hemoglobinuria Who Have Completed a RA101495 Clinical Study|Recruiting||Phase 2|28|Anticipated|Ra Pharmaceuticals||1|||f|||||t|f||||||||2017-10-10 20:51:18.565212|2017-10-10 20:51:18.565212
NCT03225274|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||Effectiveness of Breathing Exercises as Therapeutic Play on Respiratory Status Among Children With Lower Respiratory Tract Disorders|"A Study to Evaluate the Effectiveness of Breathing Exercises as Therapeutic Play on Respiratory Status Among Children Undergoing Nebulization Therapy With Lower Respiratory Tract Disorders in Selected Hospitals of Haryana."|Completed||N/A|60|Actual|Maharishi Markendeswar University||2|||f||||f|f|f||||||||2017-10-10 20:51:18.739233|2017-10-10 20:51:18.739233
NCT03225261|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||The Effect of Citrus Extract on Gastrointestinal Health|The Effect of Citrus Extract Administration on Gastrointestinal Health|Recruiting||Phase 2|64|Anticipated|Maastricht University Medical Center||4|||f||||f|f|f||||||||2017-10-10 20:51:18.823103|2017-10-10 20:51:18.823103
NCT03225248|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-20|||November 5, 2014|Actual|2014-11-05|July 2017|2017-07-01|October 12, 2015|Actual|2015-10-12|September 5, 2015|Actual|2015-09-05||Interventional|||Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia|Multi-center, Randomized, Active-Controlled, Double-Blind, Non-Inferiority, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia (MARS Study)|Completed||Phase 3|143|Actual|Korea United Pharm. Inc.||2|||f|||||f|f||||||||2017-10-10 20:51:18.936119|2017-10-10 20:51:18.936119
NCT03225235|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-20|||August 26, 2013|Actual|2013-08-26|May 2017|2017-05-01|August 2025|Anticipated|2025-08-01|August 2018|Anticipated|2018-08-01||Interventional|CYBERPROST||Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer|Prospective Evaluation of Hypofractionated Stereotactic RT (SBRT) Using CyberKnife for Patients With Low and Intermediate Risk of Progression Prostate Cancer.|Recruiting||N/A|600|Anticipated|The Greater Poland Cancer Centre||1|||f||||f|f|f||||||||2017-10-10 20:51:19.026809|2017-10-10 20:51:19.026809
NCT03225222|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-20|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 1, 2022|Anticipated|2022-10-01|October 1, 2020|Anticipated|2020-10-01|36 Months|Observational [Patient Registry]|MR-PROPER||MRI in PROstate Cancer Diagnosis With Prior Risk Assessment|MRI in PROstate Cancer Diagnosis With Prior Risk Assessment|Not yet recruiting||N/A|2558|Anticipated|Erasmus Medical Center|||4||f||||f|f|f||||||||2017-10-10 20:51:19.1403|2017-10-10 20:51:19.1403
NCT03225131|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-20|2017-07-20|||June 16, 2017|Actual|2017-06-16|June 15, 2017|2017-06-15|March 28, 2028|Anticipated|2028-03-28|March 28, 2028|Anticipated|2028-03-28||Observational|||Dark Adaptation in Participants With Age-Related Macular Degeneration|A Long-term Follow-up Study of Participants Enrolled in 11-EI-0147: Longitudinal Investigation of Dark Adaptation in Participants With Age-Related Macular Degeneration (DA_AMD)|Enrolling by invitation||N/A|240|Anticipated|National Institutes of Health Clinical Center (CC)|||5||f|||||f|f||||||||2017-10-10 20:51:19.844142|2017-10-10 20:51:19.844142
NCT03225105|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-27|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|October 8, 2019|Anticipated|2019-10-08|April 11, 2019|Anticipated|2019-04-11||Interventional|||M3541 in Combination With Radiotherapy in Subjects With Solid Tumors|A Phase I, Open-label, Uncontrolled, Multicenter, Dose-escalation Study of M3541 in Combination With Palliative Radiotherapy in Subjects With Solid Tumors|Recruiting||Phase 1|30|Anticipated|EMD Serono||1|||f||||t|t|f||||||||2017-10-10 20:51:20.000382|2017-10-10 20:51:20.000382
NCT03225092|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||Platelet-rich Plasma Injections for Persistent Medial Knee Pain After Total Knee Arthroplasty|Efficacy of Platelet-rich Plasma Injections for the Treatment of Persistent Medial Knee Pain After Total Knee Arthroplasty|Enrolling by invitation||Early Phase 1|15|Anticipated|Ohio State University||1|||f||||f|t|f||||||||2017-10-10 20:51:20.121107|2017-10-10 20:51:20.121107
NCT03225079|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-19|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01|6 Months|Observational [Patient Registry]|PERFORM||PERFORM = Pentaglobin® Registry For Outcome Report and Monitoring|PERFORM = Pentaglobin® Registry For Outcome Report and Monitoring, International Registry on the Use of Pentaglobin® in Patients With Severe Bacterial Infections|Not yet recruiting||N/A|400|Anticipated|Jena University Hospital|||1||f||||t|f|f||||||||2017-10-10 20:51:20.190379|2017-10-10 20:51:20.190379
NCT03225066|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-23|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|October 2018|Anticipated|2018-10-01||Interventional|Sculptra||Efficacy and Safety of Poly-L-lactic Acid|A Prospective, Randomized, Multicenter, Self-controlled, Blinded Trial on the Efficacy and Safety of Poly-L-lactic Acid - SCULPTRA - for the Treatment of Corporal Skin Flaccidity.|Not yet recruiting||N/A|70|Anticipated|Galderma Brasil Ltda.||1|||f||||t|f|f||||||||2017-10-10 20:51:20.247819|2017-10-10 20:51:20.247819
NCT03225053|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-07-18|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|January 30, 2018|Anticipated|2018-01-30|December 20, 2017|Anticipated|2017-12-20||Interventional|EMRPMITH||EFFECTS OF MIOFASCIAL RELEASE AND PERCUTANEOUS MICROELETROLYSIS IN TYPE HEADACHE|EFFECTS OF MIOFASCIAL RELEASE AND PERCUTANEOUS MICROELETROLYSIS IN INDIVIDUALS WITH TYPICAL TYPE HEADACHE|Not yet recruiting||N/A|60|Anticipated|Estácio Ponta Negra||1|||f||||t|f|f|||f|||||2017-10-10 20:51:20.435793|2017-10-10 20:51:20.435793
NCT03225040|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-19|||August 3, 2016|Actual|2016-08-03|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Observational|||Bone MicroArchitecture in Acromegaly|Cross-sectional Study of Bone Density, Bone Microarchitecture, Vertebral Fractures and Trabecular Bone Score in Patients With Acromegaly Treated With Pegvisomant Compared to Patients With Untreated Active Acromegaly|Recruiting||N/A|25|Anticipated|Columbia University|||1||f||||f|f|f|||f|Samples Without DNA|"     Peripheral blood specimens   "|||2017-10-10 20:51:20.510198|2017-10-10 20:51:20.510198
NCT03225027|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||November 15, 2016|Actual|2016-11-15|July 2017|2017-07-01|January 15, 2018|Anticipated|2018-01-15|January 15, 2018|Anticipated|2018-01-15||Interventional|SKYPROVERB||Study on Communication Comprehension in the Schizophrenic Spectrum|Study on Communication Comprehension in the Schizophrenic Spectrum|Recruiting||N/A|60|Anticipated|Centre Hospitalier René Dubos||3|||f||||f|f|f||||||||2017-10-10 20:51:20.623845|2017-10-10 20:51:20.623845
NCT03225014|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-07-20|||January 9, 2017|Actual|2017-01-09|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Adolescent Anterior Knee Pain: ARP Wave Therapy vs. Physical Therapy|A Pilot Study in the Management of Adolescent Anterior Knee Pain: Electromyostimulation Compared to Standard Physical Therapy|Recruiting||N/A|20|Anticipated|Rady Children's Hospital, San Diego||2|||f||||f|f|t|f|f||||||2017-10-10 20:51:20.753666|2017-10-10 20:51:20.753666
NCT03225001|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||June 11, 2012|Actual|2012-06-11|July 2017|2017-07-01|December 16, 2020|Anticipated|2020-12-16|December 16, 2016|Actual|2016-12-16||Interventional|PII NR3/ViV||The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve|PARTNER II Nested Registry 3 (NR3)/Valve-in-Valve (ViV) is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN XT THV in Greater-risk Patients With a Failing Aortic Bioprosthetic Valve.|Active, not recruiting||N/A|372|Actual|Edwards Lifesciences||1|||f||||t|f|t|f|f||||||2017-10-10 20:51:20.854687|2017-10-10 20:51:20.854687
NCT03224988|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-18|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|||Bilateral Brain Dynamics in Cognition and Aging|Bilateral Brain Dynamics Supporting Cognition in Normal Aging and Dementia|Not yet recruiting||N/A|60|Anticipated|Duke University|||2||f|||||f|t|f|f||||||2017-10-10 20:51:21.050384|2017-10-10 20:51:21.050384
NCT03224975|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-18|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|October 1, 2019|Anticipated|2019-10-01||Interventional|EXPLO-DMA||Acute Pain Memory Among Former Burned: Exploration of fMRI.|Acute Pain Memory Among Former Burned: Exploration of Functional Magnetic Resonance Imaging (fMRI).|Not yet recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 20:51:21.135761|2017-10-10 20:51:21.135761
NCT03224962|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-24|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Reliability of Fluorescent Camera in Diagnosis of Occlusal Carious Lesion|Reliability of Fluorescent Camera and Caries Detection Dye Versus Visual- Assessment in Diagnosis of Occlusal Carious Lesion in Adult Patients: Invivo Diagnostic Study|Not yet recruiting||N/A|43|Anticipated|Cairo University|||1||f||||t|f|f||||||||2017-10-10 20:51:21.230702|2017-10-10 20:51:21.230702
NCT03224949|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-20|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|July 31, 2022|Anticipated|2022-07-31|July 31, 2021|Anticipated|2021-07-31||Observational|||Comparison of ALD, NASH, and Healthy Control Patients|Comparison of ALD, NASH, and Healthy Control Patients|Recruiting||N/A|500|Anticipated|The Cleveland Clinic|||6||f||||f|f|f||||||||2017-10-10 20:51:21.305311|2017-10-10 20:51:21.305311
NCT03224936|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-23|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|August 30, 2018|Anticipated|2018-08-30||Observational|||Propofolsleep - A Study on Cardiopulmonary and Pharyngeal Reactions While Drug Induced Sleep Endoscopy (DISE)|Propofolsleep - A Observational Study on Cardiopulmonary and Pharyngeal Reactions While Drug Induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea Syndrome Under PSI Monitoring|Recruiting||N/A|20|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:51:21.404986|2017-10-10 20:51:21.404986
NCT03224923|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-28|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|August 2019|Anticipated|2019-08-01||Interventional|||A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND)|Reassessment of Long-Term Dual Anti-Platelet Therapy Using InDividualized Strategies - Using a Novel Combined Demographic and Pharmacogenomic Strategy: The RAPID EXTEND Pilot Study|Recruiting||Phase 4|70|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t|f|f||||||||2017-10-10 20:51:21.529039|2017-10-10 20:51:21.529039
NCT03224910|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|6 Years|Observational [Patient Registry]|||Diagnostic Efficiency of Touch Imprints Versus Smears|Diagnostic Efficiency of Needle Core Biopsy Touch Imprints Versus Fine Needle Aspiration Smears at the Time of Rapid on Site Interpretation|Active, not recruiting||N/A|10000|Anticipated|University of Mississippi Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:51:21.641179|2017-10-10 20:51:21.641179
NCT03224897|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||April 6, 2017|Actual|2017-04-06|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Effects of Transcranial Direct Current Stimulation Over the Left VLPFC on Cognitive Reappraisal|Effects of Transcranial Direct Current Stimulation Over the Left Ventrolateral Prefrontal Cortex on Cognitive Reappraisal|Recruiting||N/A|60|Anticipated|Universidade Federal de Pernambuco||3|||f||||t|f|f||||||||2017-10-10 20:51:21.72526|2017-10-10 20:51:21.72526
NCT03224884|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-01|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|June 17, 2018|Anticipated|2018-06-17|June 17, 2018|Anticipated|2018-06-17||Interventional|||Interscalene Block Versus Supraclavicular Block for Shoulder Surgery|A Randomized Comparison Between Interscalene and Supraclavicular Brachial Plexus Blocks For Arthroscopic Shoulder Surgery|Recruiting||N/A|44|Anticipated|University of Chile||2|||f||||t|f|f||||||||2017-10-10 20:51:21.848244|2017-10-10 20:51:21.848244
NCT03224871|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-29|||August 11, 2017|Actual|2017-08-11|August 2017|2017-08-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|||A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.|A Pilot Study of Interlesional IL-2 and Hypofractionated Radiotherapy in Patients With Metastatic Non-small Cell Lung Cancer Who Are Refractory to PD 1 / PD L1 Blockade.|Recruiting||Early Phase 1|30|Anticipated|University of California, Davis||2|||||||t|t|f||||||||2017-10-10 20:51:21.96256|2017-10-10 20:51:21.96256
NCT03224858|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-19|||September 27, 2016|Actual|2016-09-27|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|November 30, 2018|Anticipated|2018-11-30||Interventional|SUMMIT||Ambulatory ICU Study for Medically and Socially Complex Patients|Does a Clinic Based Complex Care Coordination Intervention Improve Patient Quality Outcomes in an Underserved Clinic Population? The Streamlined, Unified, Meaningfully Managed Interdisciplinary Team (SUMMIT) Ambulatory ICU Study|Recruiting||N/A|200|Anticipated|Oregon Health and Science University||2|||f||||t|f|f||||||||2017-10-10 20:51:22.117004|2017-10-10 20:51:22.117004
NCT03224845|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-24|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|COACH||Courageous Parents, Courageous Children|Transgenerational Prevention of Anxiety in Children at Ultra-high Risk|Not yet recruiting||N/A|88|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||||2017-10-10 20:51:22.251497|2017-10-10 20:51:22.251497
NCT03224832|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-09|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Pancreatoduodenectomy With Mesopancreas Dissection.A Prospective Study Comparing Artery-first Approach Versus Standard Approach|Pancreatoduodenectomy With Mesopancreas Dissection.A Prospective Study Comparing Artery-first Approach Versus Standard Approach|Not yet recruiting||N/A|40|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:51:22.363381|2017-10-10 20:51:22.363381
NCT03224819|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-27|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 1, 2019|Anticipated|2019-07-01||Interventional|||Study of AMG 673 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia|A Phase 1 First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 673 Administered as Short Term Intravenous Infusions in Subjects With Relapsed/Refractory Acute Myeloid Leukemia|Recruiting||Early Phase 1|50|Anticipated|Amgen||2|||f||||f|t|f||||||||2017-10-10 20:51:22.471951|2017-10-10 20:51:22.471951
NCT03224806|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||June 3, 2014|Actual|2014-06-03|July 2017|2017-07-01|June 13, 2014|Actual|2014-06-13|June 13, 2014|Actual|2014-06-13||Interventional|||Effect of Fiber Composite-enriched Breads on Glycemic Responses|Effect of Fiber Composite-enriched Breads on Glycemic Responses|Completed||N/A|10|Actual|Glycemic Index Laboratories, Inc||4|||f||||f|f|f||||||||2017-10-10 20:51:22.563607|2017-10-10 20:51:22.563607
NCT03224793|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-18|||September 26, 2017|Anticipated|2017-09-26|August 2017|2017-08-01|May 29, 2018|Anticipated|2018-05-29|May 29, 2018|Anticipated|2018-05-29||Interventional|||Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects.|A Blinded, Safety, Tolerability, and Pharmacokinetic Study of Single Doses of BIIB059 in Healthy Japanese Subjects|Not yet recruiting||Phase 1|32|Anticipated|Biogen||4|||f||||f|t|f||||||||2017-10-10 20:51:22.659089|2017-10-10 20:51:22.659089
NCT03224780|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Creatine Kinase Versus 3D Doppler for Antenatal Diagnosis of Abnormal Adherent Placenta.|Creatine Kinase Versus 3D Doppler for Antenatal Diagnosis of Morbidly Adherent Placenta|Recruiting||N/A|200|Anticipated|Beni-Suef University|||1||f||||f|f|f||||||||2017-10-10 20:51:22.772154|2017-10-10 20:51:22.772154
NCT03224767|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-04|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|August 2026|Anticipated|2026-08-01|December 2021|Anticipated|2021-12-01||Interventional|||Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma|Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas|Recruiting||Phase 2|36|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f|t|f||||||||2017-10-10 20:51:22.903452|2017-10-10 20:51:22.903452
NCT03224754|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-21|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|6 Years|Observational [Patient Registry]|||Atypia of Undetermined Significance (AUS) / Follicular Lesion of Undetermined Significance (FLUS)|Understanding Management and Clinical Follow-up of Atypia of Undetermined Significance / Follicular Lesion of Undetermined Significance Category in Thyroid Fine Needle Aspiration: A 6 Year-retrospective Study in a Tertiary Care Center.|Active, not recruiting||N/A|5000|Anticipated|University of Mississippi Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:51:23.010739|2017-10-10 20:51:23.010739
NCT03224741|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|October 1, 2017|Anticipated|2017-10-01||Interventional|||Behavioral Economics Field Experiment in HIV Testing|Behavioral Nudges, Information and Incentives for HIV Testing: A Field Experiment in Ecuador|Recruiting||N/A|3000|Anticipated|Johns Hopkins University||3|||f||||f|f|f||||||||2017-10-10 20:51:23.093874|2017-10-10 20:51:23.093874
NCT03224728|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-17|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01|3 Months|Observational [Patient Registry]|||Spherical Aberration on the Optical of Two Different Aspherical Intraocular Lenses|Effect of Spherical Aberration on the Optical Quality After Implantation of Two Different Aspherical Intraocular Lenses|Completed||N/A|60|Actual|Hospital Hietzing|||1||f||||t|f|f||||||||2017-10-10 20:51:23.195713|2017-10-10 20:51:23.195713
NCT03224715|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|December 1, 2017|Anticipated|2017-12-01||Interventional|||Actinic Cheilitis Pre-Treated With DNA Repair Enzyme Cream|Actinic Cheilitis Pre-Treated With DNA Repair Enzyme Cream|Not yet recruiting||N/A|15|Anticipated|Loyola University||1|||f|||||f|f||||||||2017-10-10 20:51:23.267474|2017-10-10 20:51:23.267474
NCT03224702|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-15|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|April 25, 2018|Anticipated|2018-04-25|April 25, 2018|Anticipated|2018-04-25||Interventional|||First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers|A Single-Center, Phase I, Randomized, Double Blind, Placebo-Controlled, First-In-Human Trial to Assess the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Subcutaneous Injected M6495 (Anti-ADAMTS-5 Nanobody) in Healthy Male Subjects|Recruiting||Phase 1|45|Anticipated|Merck KGaA||2|||f||||f|f|f||||||||2017-10-10 20:51:23.336392|2017-10-10 20:51:23.336392
NCT03224676|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||November 30, 2015|Actual|2015-11-30|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Study to Assess the Quality of Sleep and Perceived Sleep Distractors Among the Adult Patients Admitted in Selected Hospital|Study to Assess the Quality of Sleep and Perceived Sleep Distractors Among the Adult Patients Admitted in Selected Hospital|Completed||N/A|150|Actual|Maharishi Markendeswar University|||1||f||||t|f|f||||||||2017-10-10 20:51:23.485046|2017-10-10 20:51:23.485046
NCT03224663|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||November 30, 2015|Actual|2015-11-30|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Effectiveness of Module Based Learning and Mobile Application Based Learning Regarding Facility Based Newborn Care Among Nursing Students|Module Based Learning and Mobile Application Based Learning Regarding Facility Based Newborn Care Among Nursing Students|Completed||N/A|70|Actual|Maharishi Markendeswar University||2|||f||||t|f|f||||||||2017-10-10 20:51:23.535223|2017-10-10 20:51:23.535223
NCT03224650|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-19|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||Validation of Novel Predictive Score for Patients With Spinal Metastases|Validation of Novel Predictive Score for Patients With Spinal Metastases|Recruiting||N/A|190|Anticipated|Brigham and Women's Hospital|||3||f|||||f|f||||||||2017-10-10 20:51:23.603753|2017-10-10 20:51:23.603753
NCT03224637|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-22|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Radiofrequency Neurotomy In Relieving Chronic Knee Pain|Fluoroscopic Guided Radiofrequency of Genicular Nerves for Pain Alleviation in Chronic Knee Osteoarthritis : A Single-blind Randomized Controlled Trial.|Completed||N/A|60|Actual|Assiut University||2|||f||||t|f|f||||||||2017-10-10 20:51:23.713562|2017-10-10 20:51:23.713562
NCT03224624|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-18|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2021|Anticipated|2021-09-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||Self-management of Blood Pressure Medication for Hypertensive Veterans|Self-management of Blood Pressure Medication for Hypertensive Veterans|Not yet recruiting||N/A|400|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 20:51:23.793899|2017-10-10 20:51:23.793899
NCT03224611|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-20|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|April 30, 2018|Anticipated|2018-04-30||Interventional|||Usefulness of Light Wand-guided Insertion of Flexible Reinforced Laryngeal Mask Airway|Usefulness of Light Wand-guided Insertion of Flexible Reinforced Laryngeal Mask Airway: Comparison With Conventional Blind-insertion|Not yet recruiting||N/A|54|Anticipated|Ajou University School of Medicine||2|||f|||||f|f||||||||2017-10-10 20:51:24.026405|2017-10-10 20:51:24.026405
NCT03224598|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-21|||June 26, 2017|Actual|2017-06-26|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra|A Phase 2 Open Label, Single Arm Pilot Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra|Recruiting||Phase 2|12|Anticipated|Aclaris Therapeutics, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:51:24.107197|2017-10-10 20:51:24.107197
NCT03224585|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-15|||November 30, 2017|Anticipated|2017-11-30|August 2017|2017-08-01|November 5, 2018|Anticipated|2018-11-05|November 5, 2018|Anticipated|2018-11-05||Interventional|||Treatment of Acute Pericarditis With Anakinra|Treatment of Acute Pericarditis With Anakinra|Not yet recruiting||Early Phase 1|14|Anticipated|Virginia Commonwealth University||2|||f||||f|t|f|||t|||||2017-10-10 20:51:24.236314|2017-10-10 20:51:24.236314
NCT03224572|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-18|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients|The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:24.344384|2017-10-10 20:51:24.344384
NCT03224546|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-10-02|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|October 14, 2022|Anticipated|2022-10-14|October 14, 2022|Anticipated|2022-10-14||Interventional|RCT (04)||Cocaine Use Reduction and Health|Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use|Recruiting||N/A|250|Anticipated|University of Kentucky||3|||f||||f|f|f||||||||2017-10-10 20:51:24.551698|2017-10-10 20:51:24.551698
NCT03224533|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-19|||June 1, 2015|Actual|2015-06-01|July 2017|2017-07-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Observational|||Walnut Consumption and Diabetes Risk|Association Between Walnut Consumption and Diabetes Risk in NHANES May be Gender Sex Specific|Completed||N/A|34121|Actual|University of California, Los Angeles|||4||f||||f|f|f||||||||2017-10-10 20:51:24.695961|2017-10-10 20:51:24.695961
NCT03224520|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-07|||December 20, 2017|Anticipated|2017-12-20|August 2017|2017-08-01|March 13, 2020|Anticipated|2020-03-13|October 1, 2019|Anticipated|2019-10-01||Interventional|||Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions|Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco|Not yet recruiting||N/A|1200|Anticipated|University of Massachusetts, Worcester||4|||f||||t|f|f||||||||2017-10-10 20:51:24.800219|2017-10-10 20:51:24.800219
NCT03224507|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-19|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|November 1, 2023|Anticipated|2023-11-01|November 1, 2021|Anticipated|2021-11-01||Interventional|MASTER||Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma|Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma - MASTER Trial|Not yet recruiting||Phase 2|82|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f||||||||2017-10-10 20:51:24.914717|2017-10-10 20:51:24.914717
NCT03224494|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-10-03|||August 10, 2017|Actual|2017-08-10|October 2017|2017-10-01|July 15, 2019|Anticipated|2019-07-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||Evaluation of Bowel Sensitivity Threshold in IBS Patients Versus in Healthy Controls Using the Novel Rapid Barostat Bag|Evaluation of Visceral Bowel Sensitivity Threshold in Irritable Bowel Syndrome Patients Versus in Healthy Controls Using the Novel Rapid Barostat Bag|Recruiting||N/A|200|Anticipated|Queen's University||2|||f||||f|f|f||||||||2017-10-10 20:51:25.042771|2017-10-10 20:51:25.042771
NCT03224481|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-19|||September 2017|Anticipated|2017-09-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Tailored Electronic Reminders on Compliance With Removable Orthodontic Retention|Evaluation of the Effect of Tailored Electronic Reminders on Compliance With Removable Orthodontic Retention: A Randomised Controlled Trial|Not yet recruiting||N/A|68|Anticipated|Queen Mary University of London||2|||f||||t|f|f||||||||2017-10-10 20:51:25.149226|2017-10-10 20:51:25.149226
NCT03224468|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-24|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|MMNE||Effect of Medical Marijuana on Neurocognition and Escalation of Use|Effect of Medical Marijuana on Neurocognition and Escalation of Use|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:25.240888|2017-10-10 20:51:25.240888
NCT03223545|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-28|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|||Stress Management to Support Women's Health|Stress Management to Support Women's Health|Not yet recruiting||N/A|132|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:51:36.388672|2017-10-10 20:51:36.388672
NCT03224455|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|May 30, 2021|Anticipated|2021-05-30|December 1, 2020|Anticipated|2020-12-01||Observational|EASY||Environmental Assessment of Sleep in Youth|Environmental Risk Factors for Pediatric Sleep Disordered Breathing|Not yet recruiting||N/A|300|Anticipated|Boston Children’s Hospital|||1||f||||t|f|f||||||||2017-10-10 20:51:25.338028|2017-10-10 20:51:25.338028
NCT03224442|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-19|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Soft Tissue Evaluation Around Implants Using Prf or a Palatal Pedicle|Clinical Evaluation of Peri-Implant Soft Tissue Around Immediately Placed Implants Using PRF Membrane Versus The Palatal Pedicle Soft Tissue Graft: A Randomized Controlled Clinical Trial.|Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:51:25.4313|2017-10-10 20:51:25.4313
NCT03224429|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||May 15, 2014|Actual|2014-05-15|July 2017|2017-07-01|March 31, 2015|Actual|2015-03-31|March 31, 2015|Actual|2015-03-31||Interventional|||Sickle Cell Disease (SCD) Decision Aid|Comparative Effectiveness of a Decision Aid for Therapeutic Options in Sickle Cell Disease|Completed||N/A|222|Actual|Emory University||2|||f||||f|f|f||||||||2017-10-10 20:51:25.511892|2017-10-10 20:51:25.511892
NCT03224416|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-07-19|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Individual and Contextual Factors That Influence Sexual Decisions|Effects of Acute Alcohol on Sex-Specific Delay Discounting and Subsequent Sexual Decision Making Among MSM|Recruiting||N/A|120|Anticipated|Brown University||3|||f||||f|f|f|||f|||||2017-10-10 20:51:25.592245|2017-10-10 20:51:25.592245
NCT03224403|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-08|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|May 25, 2018|Anticipated|2018-05-25|May 16, 2018|Anticipated|2018-05-16||Interventional|||Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain|A Randomized, Double-Blind, Placebo- and Active- Controlled, Single-Dose, Efficacy and Safety Study of a Test Acetaminophen 500 mg Tablet in Postoperative Dental Pain|Recruiting||Phase 3|660|Anticipated|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||f|t|f||||||||2017-10-10 20:51:25.704375|2017-10-10 20:51:25.704375
NCT03224377|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||October 9, 2017|Anticipated|2017-10-09|July 2017|2017-07-01|February 1, 2019|Anticipated|2019-02-01|October 9, 2018|Anticipated|2018-10-09||Observational|||Diagnostic Utility of Anti MCV Antibodies,Anti CCPantibodies and RF in RA|Diagnostic Utility of Anti-mutated Citrullinated Vimentin Antibodies,Anti Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis|Not yet recruiting||N/A|80|Anticipated|Assiut University|||2||f||||f|f|f||||Samples Without DNA|"     Blood and serum sampling separated by centrifugation   "|||2017-10-10 20:51:25.893891|2017-10-10 20:51:25.893891
NCT03224364|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Solo and Non-solo Approach for Laparoscopic Appendectomy (SOLOAP)|A Randomized Controlled Trial Comparing a Solo and Non-solo Approach for Laparoscopic Appendectomy|Not yet recruiting||N/A|150|Anticipated|Daejeon St. Mary's hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:25.982696|2017-10-10 20:51:25.982696
NCT03224351|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-22|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|March 20, 2018|Anticipated|2018-03-20|March 20, 2018|Anticipated|2018-03-20||Interventional|||A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis|A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of VX-659 Combination Therapy in Subjects Aged 18 Years and Older With Cystic Fibrosis|Recruiting||Phase 2|105|Anticipated|Vertex Pharmaceuticals Incorporated||8|||f||||t|t|f||||||||2017-10-10 20:51:26.092086|2017-10-10 20:51:26.092086
NCT03224338|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-18|||April 5, 2017|Actual|2017-04-05|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects|A Phase II, Multicenter, Single-Arm, Open-Label Clinical Trial to Evaluate the Safety and Efficacy of Triple Therapy With Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects|Recruiting||Phase 2|30|Anticipated|Blueclinical, Ltd.||1|||f|||||f|f||||||||2017-10-10 20:51:26.243746|2017-10-10 20:51:26.243746
NCT03224325|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-11|||July 21, 2017|Actual|2017-07-21|September 2017|2017-09-01|February 20, 2018|Anticipated|2018-02-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Participants|A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Subjects|Recruiting||Phase 1|48|Anticipated|Takeda||6|||f||||f|t|f||||||||2017-10-10 20:51:26.347561|2017-10-10 20:51:26.347561
NCT03224312|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||October 1, 2016|Actual|2016-10-01|July 2017|2017-07-01|December 31, 2028|Anticipated|2028-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Chongqing Primary Aldosteronism Study|Chongqing Primary Aldosteronism Study|Recruiting||N/A|880|Anticipated|Chongqing Medical University|||2||f|||||f|f||||Samples With DNA|"     Serum, plasma and complete blood cell.      Application:        1. diagnosis of PA and primary hypertension;        2. differential diagnosis of PA;        3. finding risk factors of CVD in PA   "|||2017-10-10 20:51:26.449497|2017-10-10 20:51:26.449497
NCT03224299|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-10-04|||June 21, 2017|Actual|2017-06-21|October 2017|2017-10-01|October 3, 2017|Actual|2017-10-03|August 24, 2017|Actual|2017-08-24||Interventional|||Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation|Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation|Completed||Phase 2|72|Actual|Becton, Dickinson and Company||3|||f||||f|t|f||||||||2017-10-10 20:51:26.552299|2017-10-10 20:51:26.552299
NCT03224286|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Pressure Sensitive Mats for Patient Monitoring in the NICU|Pressure Sensitive Mats for Patient Monitoring in the NICU|Not yet recruiting||N/A|35|Anticipated|Children's Hospital of Eastern Ontario|||7||f||||f|f|f||||||||2017-10-10 20:51:26.644594|2017-10-10 20:51:26.644594
NCT03224273|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-10|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Assessment of Two Inlay -Retained Bridge Designs|Clinical Assessment of Two Inlay -Retained Bridge Designs (Proximal Box Shaped and Inlay Shaped) in Missing Posterior Teeth Cases|Not yet recruiting||N/A|70|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:51:26.752795|2017-10-10 20:51:26.752795
NCT03224260|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-20|||June 28, 2017|Actual|2017-06-28|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants|Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants|Recruiting||Phase 1|32|Anticipated|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 20:51:26.847354|2017-10-10 20:51:26.847354
NCT03224247|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-19|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Vertical Splitting of Muscle Layer in Lower Segment Cesarean Sections to Avoid Uterine Vessels Injury|Comparison Between Vertical Splitting Versus Transverse Cutting of Muscle Layer in Lower Segment Cesarean Sections to Avoid Uterine Vessels Injury: a Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|Ain Shams University||2|||f||||t|f|f||||||||2017-10-10 20:51:26.948218|2017-10-10 20:51:26.948218
NCT03224221|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||March 23, 2017|Actual|2017-03-23|June 2017|2017-06-01|June 23, 2019|Anticipated|2019-06-23|January 23, 2019|Anticipated|2019-01-23||Interventional|||Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment|Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment|Recruiting||Phase 2|189|Anticipated|The First Affiliated Hospital of Anhui Medical University||2|||f|||||f|f||||||||2017-10-10 20:51:27.20012|2017-10-10 20:51:27.20012
NCT03224208|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|VECODUE||Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients|VECODUE A Phase II Trial of Vemurafenib Plus Cobimetinib in Patients Treated With Prior First-line Systemic Immunotherapy for Inoperable Locally Advanced or Metastatic Melanoma|Not yet recruiting||Phase 2|62|Anticipated|Fondazione Melanoma Onlus||1|||f||||f|f|f||||||||2017-10-10 20:51:27.302792|2017-10-10 20:51:27.302792
NCT03224195|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-31|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Patient Experience of Acute Rehabilitation After Hip Fracture|Patient Experience of Acute Rehabilitation After Hip Fracture|Not yet recruiting||N/A|20|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f|||||f|f||||||||2017-10-10 20:51:27.402328|2017-10-10 20:51:27.402328
NCT03224182|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-08-08|||June 28, 2017|Actual|2017-06-28|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|January 2020|Anticipated|2020-01-01||Interventional|||A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Patients Undergoing TURBT|A Randomized, Single-Dose, Double-Blind, Placebo-CONtrolled Phase 3 Study of Qapzola™ (Apaziquone) as a Chemotherapy Adjuvant to TransUrEthral Resection of Bladder Tumors in Patients With Low- To-Intermediate-Risk NMIBC (CONQUER)|Recruiting||Phase 3|500|Anticipated|Spectrum Pharmaceuticals, Inc||2|||f||||t|t|f||||||||2017-10-10 20:51:27.48029|2017-10-10 20:51:27.48029
NCT03224169|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||July 18, 2017|Anticipated|2017-07-18|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Implementation of Directly Observed Hand Hygiene in Residential Care Home for the Elderly: a Cluster Randomized Trial|Implementation of Directly Observed Hand Hygiene in Residential Care Home for the Elderly: a Cluster Randomized Trial|Recruiting||N/A|200|Anticipated|The University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:51:27.601674|2017-10-10 20:51:27.601674
NCT03224156|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-25|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|PREDICT-DCM||Prediction of Sudden Cardiac Death in Dilated Cardiomyopathy|Prediction of Sudden Cardiac Death in Dilated Cardiomyopathy: The PREDICT-DCM Trial.|Recruiting||N/A|150|Anticipated|University Hospital Heidelberg|||1||f||||f|f|f||||||||2017-10-10 20:51:27.734744|2017-10-10 20:51:27.734744
NCT03224143|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-18|||February 16, 2017|Actual|2017-02-16|July 2017|2017-07-01|February 16, 2020|Anticipated|2020-02-16|February 16, 2020|Anticipated|2020-02-16||Interventional|ADTS||Doll Therapy Efficacy for People With Dementia Living in Nursing Homes: a Randomized Single-blind Controlled Trial|Doll Therapy Efficacy for People With Dementia Living in Nursing Homes: a Randomized Single-blind Controlled Trial|Enrolling by invitation||N/A|128|Anticipated|University of Applied Sciences and Arts of Southern Switzerland||2|||f||||t|f|f||||||||2017-10-10 20:51:27.872254|2017-10-10 20:51:27.872254
NCT03224130|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-07-18|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|Supplement||Supplement to Hospital to Home Outcomes|Supplement to Hospital to Home Outcomes (H2O): A Study to Improve the Fluidity of Transitions Between Hospital and Home|Completed||N/A|1000|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-10 20:51:27.998053|2017-10-10 20:51:27.998053
NCT03224117|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-08-03|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|SMF||Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat|A Randomized, Double-blind, Multi-center, Placebo-controlled, Dose Finding Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat|Not yet recruiting||Phase 2|140|Anticipated|Daewoong Pharmaceutical Co. LTD.||4|||f||||f|f|f||||||||2017-10-10 20:51:28.09071|2017-10-10 20:51:28.09071
NCT03224104|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-20|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|STEAM||Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma|Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study|Not yet recruiting||Phase 1|81|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||3|||f||||t|f|f|||t|||||2017-10-10 20:51:28.182877|2017-10-10 20:51:28.182877
NCT03224091|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-07-18|||January 25, 2016|Actual|2016-01-25|July 2017|2017-07-01|June 30, 2026|Anticipated|2026-06-30|January 31, 2026|Anticipated|2026-01-31||Observational|PROLED||PROspective Longitudinal All-comer Inclusion Study in Eating Disorders|PROspective Longitudinal All-comer Inclusion Study in Eating Disorders|Recruiting||N/A|1000|Anticipated|Mental Health Services in the Capital Region, Denmark|||1||f||||f|f|f||||||||2017-10-10 20:51:28.284122|2017-10-10 20:51:28.284122
NCT03224078|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-19|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Observational|INDEED||Emergency Department Utilization in Germany|Utilization and Trans-sectoral Patterns of Care for Patients Admitted to Emergency Departments in Germany|Recruiting||N/A|680000|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:51:28.362981|2017-10-10 20:51:28.362981
NCT03224065|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-18|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||NTM-LD Treatment Based on GenSeizer Characteristic Gene Capture Strategy|Randomized, Controlled Clinical Study of Non-tuberculosis Mycobacteria Lung Disease Treatment Based on GenSeizer Characteristic Gene Capture Strategy|Not yet recruiting||N/A|246|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||t|f|f||||||||2017-10-10 20:51:28.465342|2017-10-10 20:51:28.465342
NCT03224052|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-18|||May 1, 2016|Actual|2016-05-01|July 2017|2017-07-01|April 1, 2018|Anticipated|2018-04-01|October 31, 2017|Anticipated|2017-10-31||Observational|ANTHEM||Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria|An Observational Trial of Empirical Antibiotic Therapy in Adults Hospitalised With Malaria|Recruiting||N/A|150|Anticipated|Menzies School of Health Research|||2||f||||t||||||Samples With DNA|"     Blood will be stored for analysis of K13 mutations in the Plasmodium falciparum specimens.     Urine will be also be stored for analysis of glycocalyx break down products.   "|||2017-10-10 20:51:28.538881|2017-10-10 20:51:28.538881
NCT03224039|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||January 1, 2017||2017-01-01|July 2017|2017-07-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain|Comparison of Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain|Recruiting||Phase 4|40|Anticipated|The Brooklyn Hospital Center||2|||f||||f|t|f|||f|||||2017-10-10 20:51:28.74006|2017-10-10 20:51:28.74006
NCT03224026|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source|Which Virus Leads to Viremia in Children With Fever Without Source and do New Biomarkers Correlate With Viral and Bacterial Infections?|Recruiting||N/A|200|Anticipated|MeMed Diagnostics Ltd.|||2||f||||f|f|f||||Samples Without DNA|"     Serum, Plasma, whole blood   "|||2017-10-10 20:51:28.869746|2017-10-10 20:51:28.869746
NCT03224013|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-18|||January 18, 2016|Actual|2016-01-18|July 2017|2017-07-01|July 12, 2017|Actual|2017-07-12|May 12, 2017|Actual|2017-05-12||Interventional|||Hyperopic LASIK With Crosslinking Versus Standard LASIK|Hyperopic LASIK With Concurrent Prophylactic High-fluence Cross-linking Versus Standard LASIK Outcomes|Completed||N/A|25|Actual|Minia University||2|||f|||||f|f||||||||2017-10-10 20:51:28.984095|2017-10-10 20:51:28.984095
NCT03224000|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-10-04|||April 2018|Anticipated|2018-04-01|October 2017|2017-10-01|April 2026|Anticipated|2026-04-01|April 2025|Anticipated|2025-04-01||Interventional|||Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer|Bayesian Phase II Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer|Not yet recruiting||Phase 2|75|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|f|f||||||||2017-10-10 20:51:29.098728|2017-10-10 20:51:29.098728
NCT03223987|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-19|||May 11, 2017|Actual|2017-05-11|July 2017|2017-07-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women|Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women|Recruiting||Early Phase 1|25|Anticipated|Bio-Strath AG||1|||f||||f|f|f||||||||2017-10-10 20:51:29.296253|2017-10-10 20:51:29.296253
NCT03223974|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-17|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|February 2022|Anticipated|2022-02-01|February 2020|Anticipated|2020-02-01||Interventional|BJDCB-BIF||Clinical Trial on Safety and Efficacy of Drug-coated Balloon in Treatment of Coronary Bifurcation Lesions|Clinical Trial on Safety and Efficacy of Drug-coated Balloon in Treatment of Coronary Bifurcation Lesions|Not yet recruiting||N/A|80|Anticipated|Beijing Hospital||2|||f||||f|f|f|||t|||||2017-10-10 20:51:29.413036|2017-10-10 20:51:29.413036
NCT03223961|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-18|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|EPO-PRETAR||A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS|A Randomized Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS With Non RBC Transfusion Dependent Anemia and Without Del 5q|Not yet recruiting||Phase 3|124|Anticipated|Groupe Francophone des Myelodysplasies||2|||f||||f|f|f||||||||2017-10-10 20:51:29.541288|2017-10-10 20:51:29.541288
NCT03223948|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-07-17|||May 10, 2017|Actual|2017-05-10|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Frontiers||Flow veRsus OxygeNaTion In acutE ReSpiratory Failure|A Dose Finding Study to Determine the Optimal Flow Rate and Oxygen Concentration Using High Flow Nasal Oxygenation for Patients With Respiratory Failure.|Recruiting||N/A|180|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f|f|f|||f|||||2017-10-10 20:51:29.884809|2017-10-10 20:51:29.884809
NCT03223935|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-19|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Roasted Pulse Snacks, Post-prandial Food Intake, Appetite, and Glycemia|A Comparison of Roasted Pulse Snacks on Post-prandial Food Intake, Appetite, and Glycemic Response in Healthy Young Adults|Not yet recruiting||N/A|30|Anticipated|University of Manitoba||6|||f||||f|f|f||||||||2017-10-10 20:51:29.989012|2017-10-10 20:51:29.989012
NCT03223922|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-15|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|July 21, 2024|Anticipated|2024-07-21|July 21, 2022|Anticipated|2022-07-21||Interventional|||Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases|Preservation of Cognition and Neuropsychiatric Functioning With Corpus Callosum Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases: A Pilot Study|Recruiting||N/A|24|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:51:30.124917|2017-10-10 20:51:30.124917
NCT03223909|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-19|||October 13, 2016|Actual|2016-10-13|July 2017|2017-07-01|December 16, 2017|Anticipated|2017-12-16|November 16, 2017|Anticipated|2017-11-16||Interventional|087LATAMFIV||Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)|Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Systane ® Ultra Preservative Free on Tear Film Dysfunction Syndrome From Mild to Moderate|Recruiting||Phase 4|288|Anticipated|Laboratorios Sophia S.A de C.V.||3|||f||||t|f|f||||||||2017-10-10 20:51:30.243423|2017-10-10 20:51:30.243423
NCT03223896|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-14|||February 14, 2017|Actual|2017-02-14|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|NALPILO||Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray|Pilot Study: Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray|Completed||Phase 2|20|Actual|National Institute for Health and Welfare, Finland||2|||f||||f|t|f|||t|||||2017-10-10 20:51:30.391516|2017-10-10 20:51:30.391516
NCT03223883|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-21|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2021|Anticipated|2021-08-31||Interventional|||Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease|Curcumin Supplementation for Improving Vascular and Cognitive Function in Chronic Kidney Disease|Not yet recruiting||Phase 2|88|Anticipated|University of Colorado, Denver||2|||f||||t|t|f||||||||2017-10-10 20:51:30.504665|2017-10-10 20:51:30.504665
NCT03223870|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-01|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|||Respiratory Rate Accuracy - Healthy Adults|Respiratory Rate Accuracy - Healthy Adults|Completed||N/A|30|Actual|Nonin Medical, Inc|||1||f||||f|f|t|f|f|t|||||2017-10-10 20:51:30.638858|2017-10-10 20:51:30.638858
NCT03223857|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||April 9, 2013|Actual|2013-04-09|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31|3 Months|Observational [Patient Registry]|||To Evaluate the Visual Performance After Bilateral Implantation of Multifocal Intraocular Lenses|Visual Performance of Multifocal Intraocular Lenses Following Removal of the Crystalline Lens|Recruiting||N/A|100|Anticipated|University Clinic Frankfurt|||1||f||||f|f|f||||||||2017-10-10 20:51:30.760112|2017-10-10 20:51:30.760112
NCT03223844|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-14|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release|Disentangling Pre- and Postsynaptic Aspects of Amphetamine-induced Sensitization: a Combined [18F]DOPA / [11C]-(+)-PHNO PET Study|Not yet recruiting||N/A|22|Anticipated|Medical University of Vienna||1|||f||||f|f|f||||||||2017-10-10 20:51:30.940141|2017-10-10 20:51:30.940141
NCT03223831|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-19|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Partially Covered Versus Uncovered Pyloro-duodenal Stents for Unresectable Malignant Gastric Outlet Obstruction. A Double Blinded Randomised Controlled Trial.|Partially Covered Versus Uncovered Pyloro-duodenal Stents for Unresectable Malignant Gastric Outlet Obstruction. A Double Blinded Randomised Controlled Trial.|Not yet recruiting||Phase 3|116|Anticipated|Chinese University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:51:31.602213|2017-10-10 20:51:31.602213
NCT03223818|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-07-18|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|April 1, 2023|Anticipated|2023-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients|The Impact of Fast-track Perioperative Program on the Clinical and Immunological Outcomes After Liver Resection in Hong Kong Chinese Patients: A Prospective Randomized Trial|Recruiting||N/A|94|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:51:31.774652|2017-10-10 20:51:31.774652
NCT03223805|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-18|||April 4, 2017|Actual|2017-04-04|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|RDSI-LC||Respiratory Distress Symptom Intervention (RDSI) Trial|A Randomised Controlled Trial to Determine the Clinical and Cost Effectiveness of the Respiratory Distress Symptom Intervention for People With Lung Cancer|Recruiting||N/A|258|Anticipated|The Christie NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:51:31.918938|2017-10-10 20:51:31.918938
NCT03223792|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-29|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Acceptance Of A Partially-Hydrolyzed Infant Formula|Acceptance Of A Partially-Hydrolyzed Infant Formula|Recruiting||N/A|100|Anticipated|Mead Johnson Nutrition||2|||f||||f|f|f||||||||2017-10-10 20:51:32.062855|2017-10-10 20:51:32.062855
NCT03223779|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-28|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|January 31, 2025|Anticipated|2025-01-31|January 31, 2021|Anticipated|2021-01-31||Interventional|||Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer|Phase Ib/II Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer|Not yet recruiting||Phase 1/Phase 2|56|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 20:51:32.247659|2017-10-10 20:51:32.247659
NCT03223766|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-02|||August 1, 2017|Actual|2017-08-01|July 2017|2017-07-01|July 2037|Anticipated|2037-07-01|July 2037|Anticipated|2037-07-01||Observational|||Evaluation of Proton Therapy in Pediatric Cancer Patients|Phase IV Clinical Trial of Proton Therapy in Pediatric Cancer|Recruiting||N/A|1000|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-10 20:51:32.396521|2017-10-10 20:51:32.396521
NCT03223753|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-15|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2022|Anticipated|2022-01-01||Interventional|||Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission|A Randomized Web-Based Physical Activity Intervention Among Children and Adolescents With Acute Lymphoblastic Leukemia|Recruiting||N/A|384|Anticipated|Children's Oncology Group||2|||f||||f|f|f||||||||2017-10-10 20:51:32.513098|2017-10-10 20:51:32.513098
NCT03223740|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-08-16|||September 2016||2016-09-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|September 2020|Anticipated|2020-09-01||Interventional|President||Preoperative Stomach Cancer Induction Chemotherapy and Radiation Therapy|A Phase III Trial of Preoperative or Postoperative Chemoradiation Therapy for Potentially Resectable Adenocarcinoma of Stomach Cancer|Recruiting||Phase 3|450|Anticipated|Sichuan Provincial People's Hospital||2|||f||||t||||||||||2017-10-10 20:51:32.637069|2017-10-10 20:51:32.637069
NCT03223727|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-21|||October 30, 2015|Actual|2015-10-30|July 2017|2017-07-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30||Observational|ROTOR||Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223|Registry of Treatment Outcomes in a Non-study Population of Symptomatic Metastasized Castration Resistant Prostate Cancer (mCRPC) Patients Treated With Radium-223|Recruiting||N/A|100|Anticipated|The Netherlands Cancer Institute|||1||f||||f|f|f|||f|Samples Without DNA|"     Extra blood will be collected at baseline, 1st, 2nd, 3rd and 6th (or last) Radium‐223     treatment. Changes in serum and blood levels of biomarkers of bone metabolism and levels of     blood osteoclast precursors in Radium-223 treated patients will e evaluated for their     potential to predict treatment outcome.   "|||2017-10-10 20:51:32.753295|2017-10-10 20:51:32.753295
NCT03223714|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-07-18|||May 2016||2016-05-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|CRVO||Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion|An Efficacy and Safety Trial of Intravitreal Injection of Conbercept Ophthalmic Injection in Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion|Recruiting||Phase 3|237|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.||2|||f||||||||||||||2017-10-10 20:51:32.875806|2017-10-10 20:51:32.875806
NCT03223701|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-15|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Efficacy of Using Solum IV and BMC With GFC in TLIF|Efficacy Study Using Solum IV, Bone Marrow Concentrate With General Fluid Concentrate in Transforaminal Lumbar Interbody Fusion|Not yet recruiting||Phase 4|10|Anticipated|Seton Healthcare Family||1|||f||||f|f|t|f|f||||||2017-10-10 20:51:33.00206|2017-10-10 20:51:33.00206
NCT03223688|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-18|||May 12, 2014|Actual|2014-05-12|July 2017|2017-07-01|May 11, 2017|Actual|2017-05-11|May 11, 2017|Actual|2017-05-11||Interventional|||Early Intervention for Developmental Delay|Effectiveness of Adjunctive Sensory Integration Therapy for Children With Developmental Delay in an Early Intervention Program|Completed||N/A|45|Actual|Chang Gung Memorial Hospital||3|||f||||t|f|f||||||||2017-10-10 20:51:33.179128|2017-10-10 20:51:33.179128
NCT03223675|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-18|||April 1, 2016|Actual|2016-04-01|April 2017|2017-04-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Neurocognitive Impact and Dose-Effect Relationship of Hippocampal Avoidance During Whole Brain Radiotherapy Plus Simultaneous Integrated Boost - A Prospective Follow-up Study||Recruiting||Phase 2|100|Anticipated|Chang Gung Memorial Hospital||1|||f||||||||||||||2017-10-10 20:51:33.270006|2017-10-10 20:51:33.270006
NCT03223649|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-09-12|||July 26, 2017|Actual|2017-07-26|September 5, 2017|2017-09-05|June 28, 2020|Anticipated|2020-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|||Break It Up: A Study Evaluating Breaking Up Daily Sedentary Behavior in Youth|Break It Up: A Study Evaluating Breaking up Daily Sedentary Behavior in Youth|Recruiting||Phase 2|150|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f|||||f|f||||||||2017-10-10 20:51:33.497958|2017-10-10 20:51:33.497958
NCT03223636|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-10-04|||October 2, 2017|Actual|2017-10-02|September 25, 2017|2017-09-25|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Measuring the Latency Connectome in the Central Nervous Systems Using Neuroimaging and Neurophysiological Techniques|Measuring the Latency Connectome in the Central Nervous System Using Neuroimaging and Neurophysiological Techniques|Recruiting||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f|||||f|f||||||||2017-10-10 20:51:33.605765|2017-10-10 20:51:33.605765
NCT03223597|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-21|||September 17, 2015|Actual|2015-09-17|July 2017|2017-07-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01|6 Months|Observational [Patient Registry]|ROTOR||Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223|Registry of Treatment Outcomes in a Non-study Population of Symptomatic Metastasized Castration Resistant Prostate Cancer (mCRPC) Patients Treated With Radium-223|Recruiting||N/A|300|Anticipated|The Netherlands Cancer Institute|||1||f||||f|t|f|||f|||||2017-10-10 20:51:33.933755|2017-10-10 20:51:33.933755
NCT03223584|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-07-19|||November 2015||2015-11-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge||Completed||N/A|30|Actual|Katholieke Universiteit Leuven|||6||f||||f||||||||||2017-10-10 20:51:36.018101|2017-10-10 20:51:36.018101
NCT03223571|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-02|||July 30, 2017|Actual|2017-07-30|June 2017|2017-06-01|April 1, 2018|Anticipated|2018-04-01|December 1, 2017|Anticipated|2017-12-01||Observational|MAPPY||Brain Plasticity Mapping Post-stroke|Brain Plasticity in Stroke Patients : Functional and Anatomical Connectivty|Recruiting||N/A|33|Anticipated|University Hospital, Montpellier|||2||f||||t|f|f||||||||2017-10-10 20:51:36.14467|2017-10-10 20:51:36.14467
NCT03223558|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-19|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|June 5, 2020|Anticipated|2020-06-05|June 5, 2020|Anticipated|2020-06-05||Interventional|SCAR||Early Initiation of Post Sternotomy CArdiac Rehabilitation|Early Initiation of Cardiac Rehabilitation Exercise Training After Sternotomy: A Randomised Controlled Trial and Economic Evaluation|Recruiting||N/A|170|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust||2|||f||||f|f|f||||||||2017-10-10 20:51:36.262234|2017-10-10 20:51:36.262234
NCT03223532|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||April 26, 2017|Actual|2017-04-26|July 2017|2017-07-01|August 15, 2017|Anticipated|2017-08-15|August 14, 2017|Anticipated|2017-08-14||Interventional|||Randomized Trial Comparing PrePex Day 7 Foreskin Removal Procedure (FRP) to a Day 0 PrePex FRP .|A Prospective, Randomized, Open Label Trial Comparing PrePex™ Day 7 Foreskin Removal Procedure (FRP) to a PrePex Day 0 FRP of Male Circumcision in Resource Limited Settings|Active, not recruiting||Phase 3|150|Anticipated|Nyanza Reproductive Health Society||2|||f||||f|f|f||||||||2017-10-10 20:51:36.471239|2017-10-10 20:51:36.471239
NCT03223519|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS)|Double-blind, Randomized, Placebo-controlled, Single-center, Exploratory Clinical Trial to Investigate Safety and Efficacy of COMBOPROFEN for Treatment of Muscular Pain Associated With DOMS.|Recruiting||Phase 2|70|Anticipated|Spherium Biomed||5|||f||||f|f|f||||||||2017-10-10 20:51:36.564145|2017-10-10 20:51:36.564145
NCT03223493|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||October 29, 2015|Actual|2015-10-29|July 2017|2017-07-01|November 12, 2015|Actual|2015-11-12|November 12, 2015|Actual|2015-11-12||Observational|ACTION||Awareness, Care & Treatment in Obesity Management (ACTION) Study|Awareness, Care & Treatment in Obesity Management (ACTION) Study|Completed||N/A|3750|Actual|Novo Nordisk A/S|||3||f||||f|f|f||||||||2017-10-10 20:51:36.74672|2017-10-10 20:51:36.74672
NCT03223480|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-19|2017-07-19|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|February 14, 2020|Anticipated|2020-02-14|August 14, 2019|Anticipated|2019-08-14||Interventional|||EUS - Guided Balloon-occluded Gastrojejunostomy Bypass|EUS - Guided Balloon-occluded Gastrojejunostomy Bypass (EPASS) for Unresectable Malignant Gastric Outlet Obstruction.|Not yet recruiting||Phase 2/Phase 3|22|Anticipated|Chinese University of Hong Kong||1|||f||||t|f|f|||t|||||2017-10-10 20:51:36.814319|2017-10-10 20:51:36.814319
NCT03223467|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-19|||January 4, 2012|Actual|2012-01-04|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Obstructive Sleep Apnea, Predictors and Bariatric Surgery|Effect of Bariatric Surgery on Obstructive Sleep Apnea and Predictors for the Severity of Obstructive Sleep Apnea|Active, not recruiting||N/A|86|Actual|Catholic University of the Sacred Heart||4|||f||||f|f|f||||||||2017-10-10 20:51:36.879709|2017-10-10 20:51:36.879709
NCT03223454|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-19|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Human Amniotic Epithelial Cells for Asherman's Syndrome|Safety and Therapeutic Effect of Human Amniotic Epithelial Cells in Severe Refractory Asherman's Syndrome|Not yet recruiting||Phase 1|50|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||5|||f||||t|f|f||||||||2017-10-10 20:51:37.070484|2017-10-10 20:51:37.070484
NCT03223441|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-08-14|||June 2015||2015-06-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Pulse Wave Velocity as a Predictor for Postoperative Cardiovascular Events|Pulse Wave Velocity as a Predictor for Postoperative Cardiovascular Events|Recruiting||N/A|500|Anticipated|University of Iowa|||1||f||||f||||||||||2017-10-10 20:51:37.171798|2017-10-10 20:51:37.171798
NCT03223428|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01|3 Years|Observational [Patient Registry]|RELAX||Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO|An Observational Study to Evaluate the Real-world Experience of Patients Who Are Initiating Treatment With Telotristat Ethyl (XERMELO™)|Recruiting||N/A|643|Anticipated|Lexicon Pharmaceuticals|||1||f|||||t|||||||||2017-10-10 20:51:37.256919|2017-10-10 20:51:37.256919
NCT03223415|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-18|||August 25, 2017|Anticipated|2017-08-25|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|EFFICACI||Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections|Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections; A Cluster Randomized Feasibility Trial|Not yet recruiting||N/A|2000|Anticipated|Jewish General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:37.35036|2017-10-10 20:51:37.35036
NCT03223402|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-07-18|||December 23, 2016||2016-12-23|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Nevirapine + 3TC Based Maintenance Therapy for HIV Infection|NEVIRAPINE Plus LAMIVUDINE (3TC) for HIV Maintenance Therapy - A Single Center Pilot Study|Recruiting||N/A|10|Anticipated|Cantonal Hospital of St. Gallen||1|||f||||f||||||||||2017-10-10 20:51:37.449243|2017-10-10 20:51:37.449243
NCT03223389|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-24|||August 7, 2017|Anticipated|2017-08-07|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Fat Metabolites and Gut Hormones|Effects of Fat Metabolites on Gut Hormone Secretion After Gastric Bypass Surgery|Not yet recruiting||N/A|20|Anticipated|Hvidovre University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:51:37.566074|2017-10-10 20:51:37.566074
NCT03223376|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|August 2019|Anticipated|2019-08-01||Interventional|FRUTIGA||A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)|A Randomized, Double Blind, Placebo Controlled Phase III Study of Fruquitinib in Combination With Paclitaxel in Second Line Gastric Cancer|Not yet recruiting||Phase 3|544|Anticipated|Hutchison Medipharma Limited||2|||f||||t|f|f||||||||2017-10-10 20:51:37.689008|2017-10-10 20:51:37.689008
NCT03223363|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-17|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||A New Birth Weight Prediction in Chinese Population|A New Birth Weight Prediction Based on Ultrasonography in Chinese Population|Recruiting||N/A|10000|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||f|f|f||||||||2017-10-10 20:51:37.793496|2017-10-10 20:51:37.793496
NCT03223350|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-20|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Topical Capsaicin for Cyclical Vomiting|Topical Capsaicin Cream for Treatment of Suspected Cyclical Vomiting Syndromes|Not yet recruiting||Phase 2|20|Anticipated|Henry Ford Health System||2|||f||||f|t|f|||t|||||2017-10-10 20:51:37.931047|2017-10-10 20:51:37.931047
NCT03223337|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-01|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|November 20, 2017|Anticipated|2017-11-20|November 20, 2017|Anticipated|2017-11-20||Interventional|||Daprodustat Hepatic Impairment Study|A Phase 1, Open-label, Non-randomized, Parallel Group, Single-dose Adaptive Study in Adults With Hepatic Impairment and Matched, Healthy Control Participants With Normal Hepatic Function|Recruiting||Phase 1|24|Anticipated|GlaxoSmithKline||4|||f||||f|t|f||||||||2017-10-10 20:51:38.009945|2017-10-10 20:51:38.009945
NCT03223324|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-07-24|||March 2, 2017|Actual|2017-03-02|July 2017|2017-07-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|||Performance of the Monica Novii Wireless Patch System in Threatened and Actual Pre-Term Labour|Performance of the Monica Novii Wireless Patch System in Threatened and Actual Pre-Term Labour|Recruiting||N/A|60|Anticipated|Monica Healthcare Ltd|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:51:38.111223|2017-10-10 20:51:38.111223
NCT03223311|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-30|||August 28, 2017|Actual|2017-08-28|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|January 31, 2020|Anticipated|2020-01-31||Observational|AxA||Evaluation of Upper Extremity Vascular Access in the Endovascular Treatment of Thoracoabdominal Aortic Pathology|Evaluation of Upper Extremity Vascular Access in the Endovascular Treatment of Thoracoabdominal Aortic Pathology|Recruiting||N/A|60|Anticipated|IRCCS San Raffaele|||1||f||||f||||||||||2017-10-10 20:51:38.200997|2017-10-10 20:51:38.200997
NCT03223298|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-18|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles|Comparison of Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles in the Management of Myofascial Pain Disorder: A Randomized Clinical Trial|Not yet recruiting||Phase 3|110|Anticipated|Weill Medical College of Cornell University||2|||f||||t|t|f|||t|||||2017-10-10 20:51:38.27701|2017-10-10 20:51:38.27701
NCT03223285|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-18|||May 16, 2017|Actual|2017-05-16|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|May 16, 2018|Anticipated|2018-05-16||Interventional|||Diaphragm's Manual Therapy in Patients With Chronic Neck Pain|Diaphragm's Manual Therapy Reduce Pain in Patients With Chronic Neck Pain: a Randomised Controlled Trial|Recruiting||N/A|40|Anticipated|Università degli Studi di Ferrara||2|||f|||||f|f||||||||2017-10-10 20:51:38.373814|2017-10-10 20:51:38.373814
NCT03223272|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||July 23, 2015|Actual|2015-07-23|July 2017|2017-07-01|July 30, 2019|Anticipated|2019-07-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Mechanisms of Refractory Hypertension (Reserpine)|Mechanisms of Refractory Hypertension (Reserpine)|Recruiting||Phase 2|100|Anticipated|University of Alabama at Birmingham||1|||f||||t|t|f|||f|||||2017-10-10 20:51:38.454325|2017-10-10 20:51:38.454325
NCT03223259|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Educating the Educator to Reduce Risk of Dance Student Injury|Educating the Educator to Reduce Risk of Dance Student Injury|Recruiting||N/A|30|Anticipated|New York University School of Medicine||1|||f||||f|f|f||||||||2017-10-10 20:51:38.525804|2017-10-10 20:51:38.525804
NCT03223246|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||August 1, 2018|Anticipated|2018-08-01|July 2017|2017-07-01|July 30, 2019|Anticipated|2019-07-30|July 30, 2019|Anticipated|2019-07-30||Interventional|MEDS||Medication Education for Dosing Safety|Medication Education for Dosing Safety|Not yet recruiting||N/A|200|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:38.600215|2017-10-10 20:51:38.600215
NCT03223233|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-29|||May 2, 2017|Actual|2017-05-02|September 2017|2017-09-01|October 8, 2017|Anticipated|2017-10-08|September 29, 2017|Actual|2017-09-29|2 Weeks|Observational [Patient Registry]|||Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels|Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels|Recruiting||N/A|90|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital|||2||f||||f|f|f||||||||2017-10-10 20:51:38.663281|2017-10-10 20:51:38.663281
NCT03223220|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-18|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|August 15, 2019|Anticipated|2019-08-15||Interventional|QUEST-KETA||Quelling of Excitotoxicity in Acute Stroke With Ketamine|Quelling of Excitotoxicity in Acute Stroke With Ketamine|Not yet recruiting||Phase 2/Phase 3|200|Anticipated|Doylestown Health||2|||f||||t|t|f|||f|||||2017-10-10 20:51:38.739688|2017-10-10 20:51:38.739688
NCT03223207|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-07-18|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01|1 Day|Observational [Patient Registry]|CLE||CareLink Express (CLE Research)||Active, not recruiting||N/A|100|Anticipated|Baylor Research Institute|||2||f||||t||||||||||2017-10-10 20:51:38.925378|2017-10-10 20:51:38.925378
NCT03223181|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-18|||June 8, 2015|Actual|2015-06-08|July 2017|2017-07-01|August 17, 2017|Anticipated|2017-08-17|July 25, 2017|Anticipated|2017-07-25||Observational|||Assessment of Cow's Milk-related Symptom Scoring Awareness Tool in Young Turkish Children|Assessment of Cow's Milk-related Symptom Scoring Awareness Tool in Young Turkish Children|Recruiting||N/A|120|Anticipated|Ankara University|||1||f||||f|f|f||||||||2017-10-10 20:51:39.107313|2017-10-10 20:51:39.107313
NCT03223168|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-16|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology|Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology|Recruiting||N/A|10|Anticipated|University of Michigan||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:51:39.195362|2017-10-10 20:51:39.195362
NCT03223155|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-13|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evaluate Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV Non-Small Cell Lung Cancer|A Randomized Phase I Trial to Evaluate Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (COSINR Study)|Recruiting||Phase 1|80|Anticipated|University of Chicago||2|||f||||f|t|f||||||||2017-10-10 20:51:39.281552|2017-10-10 20:51:39.281552
NCT03223142|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||July 2017|Anticipated|2017-07-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|SMTATS||Standardization of Multi-modal Tumor Ablation Therapy System|A Pilot Study of Multi-mode Precision Ablation System for the Treatment of Liver Malignant|Recruiting||N/A|100|Anticipated|Shanghai Zhongshan Hospital||1|||f||||t|f|f||||||||2017-10-10 20:51:39.388839|2017-10-10 20:51:39.388839
NCT03223129|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-19|||January 9, 2014|Actual|2014-01-09|July 2017|2017-07-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion|Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and a Graded Intravenous Infusion in Patients With Normal Glucose Tolerance, Impaired Glucose Tolerance and in Patients With Type 2 Diabetes Mellitus|Completed||N/A|23|Actual|Catholic University of the Sacred Heart||3|||f||||f|f|f||||||||2017-10-10 20:51:39.485311|2017-10-10 20:51:39.485311
NCT03223116|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-18|||July 1, 2015|Actual|2015-07-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease|Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease: A Prospective, Multicenter Clinical Trial From China|Recruiting||N/A|150|Anticipated|Changhai Hospital||1|||f||||t|f|f||||||||2017-10-10 20:51:39.568437|2017-10-10 20:51:39.568437
NCT03223103|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 22, 2020|Anticipated|2020-05-22|May 22, 2019|Anticipated|2019-05-22||Interventional|||Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma|Phase I Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine in Patients With Newly Diagnosed Glioblastoma|Not yet recruiting||Phase 1|20|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f|t|t|f|f||||||2017-10-10 20:51:39.667584|2017-10-10 20:51:39.667584
NCT03223090|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 1, 2023|Anticipated|2023-10-01|October 1, 2023|Anticipated|2023-10-01||Interventional|MOTOLANGUAGE||Motor Language Learning|A Motor Tool for Language Learning|Not yet recruiting||N/A|684|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 20:51:39.779122|2017-10-10 20:51:39.779122
NCT03223077|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||October 31, 2014|Actual|2014-10-31|July 2017|2017-07-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Observational|||Mucosal and Microbiota Changes During Acute Campylobacteriosis|Mucosal and Microbiota Changes During Acute Campylobacteriosis|Recruiting||N/A|150|Anticipated|Mayo Clinic|||1||f||||f|f|f||||Samples With DNA|"     Coded blood, stool (or other tissue) samples   "|||2017-10-10 20:51:39.864424|2017-10-10 20:51:39.864424
NCT03223064|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||December 30, 2016|Actual|2016-12-30|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|MAGNIFY||Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRI|"Accuracy of Lymph Node Imaging in Prostate Cancer: A Prospective Cohort Study to Determine the Concordance Between Two Imaging Modalities, Combidex Magnetic Resonance Imaging (Nano MRI) and 68Ga-PSMA Positron Emission Tomography (PET)"|Recruiting||N/A|40|Anticipated|Radboud University||1|||f||||f|f|f||||||||2017-10-10 20:51:39.946743|2017-10-10 20:51:39.946743
NCT03223051|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2017|Anticipated|2017-07-01||Interventional|ExplorASI||Development of a Space Exploration Assessment for Children With Spinal Muscular Atrophy|Development of a Space Exploration Assessment for Children With Spinal Muscular Atrophy|Not yet recruiting||N/A|30|Anticipated|Centre d'Investigation Clinique et Technologique 805||1|||f||||f|f|f||||||||2017-10-10 20:51:40.279177|2017-10-10 20:51:40.279177
NCT03223038|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||January 10, 2018|Anticipated|2018-01-10|July 2017|2017-07-01|November 1, 2018|Anticipated|2018-11-01|August 1, 2018|Anticipated|2018-08-01||Observational|PINS 2018||Pediatric International Nutrition Study 2018|Pediatric International Nutrition Study - a Prospective, Multicenter Cohort Study of Nutritional Practices and Outcomes in Pediatric Intensive Care Units Around the World|Not yet recruiting||N/A|2000|Anticipated|Boston Children’s Hospital|||1||f||||f|f|f||||||||2017-10-10 20:51:40.385352|2017-10-10 20:51:40.385352
NCT03223025|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-19|||March 9, 2016|Actual|2016-03-09|July 2017|2017-07-01|February 4, 2017|Actual|2017-02-04|February 4, 2017|Actual|2017-02-04||Interventional|||Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone Deficiency|Efficacy and Safety of CinnaGen Recombinant Human Growth Hormone (CinnaTropin®) in Comparison With Novo Nordisk Growth Hormone (Nordilet®) Product in Pre-Pubertal Children With Idiopathic Growth Hormone Deficiency (IGHD)|Completed||Phase 3|30|Actual|Cinnagen||2|||f||||f|f|f||||||||2017-10-10 20:51:40.477579|2017-10-10 20:51:40.477579
NCT03223012|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||July 31, 2017|Anticipated|2017-07-31|July 2017|2017-07-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|IMPROVE||Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Ankylosing Spondylitis, in the Portuguese National Health Service|Post-marketing Prospective, Observational Cohort Study to Evaluate the Impact of AbbVie Care Patient Support Program on Compliance With Adalimumab, Patient Reported Outcomes and Health Resource Utilization in Inflammatory Bowel Diseases, Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis and Psoriasis in Portugal|Not yet recruiting||N/A|288|Anticipated|AbbVie|||2||f||||f|f|f||||||||2017-10-10 20:51:40.578502|2017-10-10 20:51:40.578502
NCT03222999|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-14|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31|6 Months|Observational [Patient Registry]|||Korean Cardiac Arrest Research Consortium|Korean Cardiac Arrest Research Consortium|Recruiting||N/A|5000|Anticipated|Korean Cardiac Arrest Research Consortium|||1||f||||t|f|f||||||||2017-10-10 20:51:40.675308|2017-10-10 20:51:40.675308
NCT03222986|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-20|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|January 20, 2019|Anticipated|2019-01-20|January 19, 2018|Anticipated|2018-01-19||Observational|||Sepsis-damaged Organs-double-markers Identification of Organ Failure Using Fluorescent Nanoparticle Tracking Analysis|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Institutional Review Board|Recruiting||N/A|60|Anticipated|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||2||f|||||f|f||||Samples Without DNA|"     blood, urine   "|||2017-10-10 20:51:40.748867|2017-10-10 20:51:40.748867
NCT02997098|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-05-23|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|May 2037|Anticipated|2037-05-01|May 2037|Anticipated|2037-05-01|10 Years|Observational [Patient Registry]|||Longitudinal Outcomes in Hepatic Resection|Longitudinal Outcomes in Hepatic Resection|Recruiting||N/A|200|Anticipated|Duke University|||1||f||||f||||||||No||2017-10-10 21:31:13.687601|2017-10-10 21:31:13.687601
NCT03222973|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-10-05|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|December 8, 2020|Anticipated|2020-12-08|September 15, 2020|Anticipated|2020-09-15||Interventional|AFFINITY||Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multiple Sclerosis to Evaluate the Efficacy and Safety of BIIB033 as an Add-On Therapy to Anti-Inflammatory Disease-Modifying Therapies|Recruiting||Phase 2|240|Anticipated|Biogen||2|||f||||t|t|f||||||||2017-10-10 20:51:40.830669|2017-10-10 20:51:40.830669
NCT03222960|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-24|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Improving Caries Risk Using Propolis-containing Versus Fluoride-containing Toothpastes in High Caries Risk Patients|Improving Caries Risk Using Propolis-containing Versus Fluoride-containing Toothpastes in High Caries Risk Patients: Randomized Clinical Trial|Not yet recruiting||N/A|40|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:51:40.921061|2017-10-10 20:51:40.921061
NCT03222947|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Observational|NewViTALS||New Variants Involved in Taybi-Linder Syndrome|Identification of New Genes Involved in the Taybi-Linder Syndrome.|Not yet recruiting||N/A|19|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||Samples With DNA|"     Deoxyribonucleic acid of patients obtained either from blood samples (lymphocytes) or foetal     tissue sampling   "|||2017-10-10 20:51:40.990704|2017-10-10 20:51:40.990704
NCT03222934|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|April 1, 2018|Anticipated|2018-04-01||Observational|||A Multislice Computed Tomographic Study of the Sphenoid Sinus|A Multislice Computed Tomographic Study of the Sphenoid Sinus|Not yet recruiting||N/A|90|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:51:41.060397|2017-10-10 20:51:41.060397
NCT03222921|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Observational|HTO||OpenGo Sensor Insole in Open Wedge HTO|OpenGo Sensor Insole in Open Wedge HTO|Not yet recruiting||N/A|40|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f|f|f||||||||2017-10-10 20:51:41.137596|2017-10-10 20:51:41.137596
NCT03222908|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-09-28|||August 15, 2017|Actual|2017-08-15|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 1, 2018|Anticipated|2018-05-01||Interventional|||Perioperative Smoking Cessation Interventions|Evaluation of Surgical Outcomes in Patients Undergoing Pre-commitment and Social Contracting for Smoking Cessation|Recruiting||N/A|200|Anticipated|Duke University||3|||f||||f|f|f||||||||2017-10-10 20:51:41.214234|2017-10-10 20:51:41.214234
NCT03222895|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-24|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2024|Anticipated|2024-09-01|September 2019|Anticipated|2019-09-01|5 Years|Observational [Patient Registry]|TIGER||Distribution of Lymph Node Metastases in Esophageal Carcinoma|Distribution of Lymph Node Metastases in Esophageal Carcinoma|Not yet recruiting||N/A|5000|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f|f|f||||||||2017-10-10 20:51:41.301911|2017-10-10 20:51:41.301911
NCT03222882|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|October 31, 2017|Anticipated|2017-10-31||Interventional|||Transcriptomic Profile of Endometrium in Different Histological Dating of Hormone Replacement Cycle|Transcriptomic Profile of Endometrium in Different Histological Dating of Hormone Replacement Cycle|Recruiting||N/A|30|Anticipated|Reproductive & Genetic Hospital of CITIC-Xiangya||1|||f|||||f|f||||||||2017-10-10 20:51:41.374749|2017-10-10 20:51:41.374749
NCT03222869|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Observational|||Assessment of Primary Oxygenation and Airflow Measurement for Endoscopic Laryngeal Surgery|Assessment of Primary Oxygenation and Airflow Measurement for Endoscopic Laryngeal Surgery|Recruiting||N/A|160|Anticipated|Johns Hopkins University|||1||f|||||f|f||||||||2017-10-10 20:51:41.447279|2017-10-10 20:51:41.447279
NCT03222856|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-20|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|KELLY||Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes|A Phase II Study of Pembrolizumab and Eribulin in Patients With HR-positive/HER2-negative Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes|Not yet recruiting||Phase 2|44|Anticipated|MedSIR||1|||f||||f|f|f||||||||2017-10-10 20:51:41.515041|2017-10-10 20:51:41.515041
NCT03222843|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient|A Phase III,Multicentre, Randomized, Double-Blind and Open-Label Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Patients With Idiopathic Thrombocytopenic Purpura|Recruiting||Phase 3|414|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||4|||f|||||f|f||||||||2017-10-10 20:51:41.62609|2017-10-10 20:51:41.62609
NCT03222830|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|October 31, 2017|Anticipated|2017-10-31||Interventional|||Transcriptomic Profile of Endometrium in Different Histological Dating of Natural Cycle|Transcriptomic Profile of Endometrium in Different Histological Dating of Natural Cycle|Recruiting||N/A|40|Anticipated|Reproductive & Genetic Hospital of CITIC-Xiangya||1|||f|||||f|f||||||||2017-10-10 20:51:41.841715|2017-10-10 20:51:41.841715
NCT03222817|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-21|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals|HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals|Recruiting||N/A|20|Anticipated|University of Miami||1|||f||||f|f|f||||||||2017-10-10 20:51:41.925354|2017-10-10 20:51:41.925354
NCT03222804|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-17|||May 2017|Anticipated|2017-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MOM||Milk Oriented Microbiota|Establishing a Milk Oriented Microbiota in Healthy Term Infants|Withdrawn||N/A|0|Actual|University of California, Davis||3||Withdrawn due to loss of funding|f||||f|f|f||||||||2017-10-10 20:51:42.010776|2017-10-10 20:51:42.010776
NCT03222791|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-18|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Personalized Nutrition for Pre-Diabetes|Personalized Nutrition for Pre-Diabetes|Recruiting||N/A|200|Anticipated|Weizmann Institute of Science||2|||f||||t|f|f||||||||2017-10-10 20:51:42.142181|2017-10-10 20:51:42.142181
NCT03222765|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-18|||March 15, 2015|Actual|2015-03-15|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|ePREDICE||Prevention of Microvascular Complications in Prediabetes e-PREDICE Study|Early Prevention of Diabetes Complications in People With Hyperglycaemia in Europe: e-PREDICE Study|Recruiting||N/A|1000|Anticipated|Evidem Consultores SL||4|||f||||t|f|f||||||||2017-10-10 20:51:42.323084|2017-10-10 20:51:42.323084
NCT03222752|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-31|||June 5, 2017|Actual|2017-06-05|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder|A 6 Week, Randomized, Double-blind, Placebo Controlled Trial of the Efficacy and Tolerability of Cranial Electrotherapy Stimulation for the Treatment of Major Depressive Disorder, With a 2 Week Open Label Extension Phase.|Recruiting||N/A|141|Anticipated|Electromedical Products International, Inc.||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:51:42.442015|2017-10-10 20:51:42.442015
NCT03222739|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-18|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Ultrasound for Scoliosis Diagnostic Evaluation|Slicer+PLUS: Collaborative, Open-source Software for Ultrasound Analysis|Not yet recruiting||N/A|30|Anticipated|Children's Research Institute||1|||f||||f|f|f||||||||2017-10-10 20:51:42.54451|2017-10-10 20:51:42.54451
NCT03222726|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-07-18|||October 6, 2017|Anticipated|2017-10-06|July 2017|2017-07-01|October 1, 2021|Anticipated|2021-10-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||The Study of the Internet Monitoring and Analysis of Exercise to Reduce the Complications of Diabetic Kidney Disease|Chief of Nephrology, Professor, Shanghai Pudong Hospital,|Not yet recruiting||N/A|240|Anticipated|Shanghai Pudong Hospital||2|||f||||t|f|f||||||||2017-10-10 20:51:42.61888|2017-10-10 20:51:42.61888
NCT03222713|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-17|||June 1, 2015|Actual|2015-06-01|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|June 1, 2016|Actual|2016-06-01||Interventional|SRH||School-based Program Promotion of Self-regulation in Eating Healthy and Oral Health|School-based Program of Promotion of Self-regulation for Healthy Eating and Oral Health: Study in the Context of the School Health Program in Brazil|Active, not recruiting||N/A|429|Actual|Federal University of Health Science of Porto Alegre||1|||f||||t|f|f||||||||2017-10-10 20:51:42.730967|2017-10-10 20:51:42.730967
NCT03222700|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-17|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||The Recovery Profiles After Robotic or Open Thyroidectomy|The Recovery Profiles After Robotic or Open Thyroidectomy|Recruiting||N/A|104|Anticipated|Seoul National University Hospital|||2||f|||||f|f||||||||2017-10-10 20:51:42.809693|2017-10-10 20:51:42.809693
NCT03222687|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-17|||September 1, 2015|Actual|2015-09-01|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis|Off-label Use of Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis: Effectiveness and Safety|Completed||Phase 4|25|Actual|Shandong University||1|||f||||t|f|f|||f|||||2017-10-10 20:51:42.89133|2017-10-10 20:51:42.89133
NCT03222674|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-13|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||CAR T in the Treatment of AML|Phase I/II and Multicenter Trial of Chimeric Antigen Receptor-Modified T Cells (CAR-T Cells) in the Treatment of Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|10|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||f|f|f||||||||2017-10-10 20:51:42.975451|2017-10-10 20:51:42.975451
NCT03222661|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-17|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Direct Comparison of SVOne Obtained Refraction to Subjective Manifest Refraction|Direct Comparison of SVOne Obtained Refraction to Subjective Manifest Refraction|Not yet recruiting||N/A|200|Anticipated|Smart Vision Labs|||1||f||||f|f|f||||||||2017-10-10 20:51:43.058291|2017-10-10 20:51:43.058291
NCT03222648|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-10-03|||September 22, 2017|Actual|2017-09-22|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Rehab-IPF||Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis|Investigating the Effects of a Structured Responsive Exercise Training Programme in Idiopathic Pulmonary Fibrosis - a Pilot Study|Recruiting||N/A|10|Anticipated|University Hospital Southampton NHS Foundation Trust||1|||f||||t|f|f||||||||2017-10-10 20:51:43.139196|2017-10-10 20:51:43.139196
NCT03222635|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||July 25, 2017|Anticipated|2017-07-25|July 2017|2017-07-01|July 25, 2024|Anticipated|2024-07-25|July 25, 2024|Anticipated|2024-07-25||Interventional|||Prospective Endoscopic Follow-up of Patients With Submucosal Esophageal Adenocarcinoma (The PREFER Trial)|Endoscopic Management of Patients With T1bN0M0 Esophageal Adenocarcinoma: a Prospective Multicenter Registry.|Recruiting||N/A|141|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t|f|f||||||||2017-10-10 20:51:43.255672|2017-10-10 20:51:43.255672
NCT03222622|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-18|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis|A Multicenter, Randomized, Double-blind, Four-Arm Parallel-Group, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis|Not yet recruiting||Phase 2|260|Anticipated|Betta Pharmaceuticals Co.,Ltd.||4|||f||||f|f|f||||||||2017-10-10 20:51:43.390606|2017-10-10 20:51:43.390606
NCT03222609|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||October 2, 2017|Anticipated|2017-10-02|July 2017|2017-07-01|March 25, 2020|Anticipated|2020-03-25|March 25, 2020|Anticipated|2020-03-25||Interventional|||A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis|A Phase 2 Single-Arm, Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis|Not yet recruiting||Phase 2|34|Anticipated|AbbVie||1|||f||||f|t|f||||||||2017-10-10 20:51:43.483227|2017-10-10 20:51:43.483227
NCT03216785|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2027|Anticipated|2027-07-01|July 1, 2027|Anticipated|2027-07-01|5 Years|Observational [Patient Registry]|||SNUH MICU Cohort Study|Cohort Study of Patients Patients in the Medical Intensive Care Unit|Recruiting||N/A|5000|Anticipated|Seoul National University Hospital|||1||f|||||f|f||||||||2017-10-10 20:52:33.770345|2017-10-10 20:52:33.770345
NCT03222596|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-08-27|||July 14, 2017|Actual|2017-07-14|August 2017|2017-08-01|August 28, 2017|Actual|2017-08-28|August 28, 2017|Actual|2017-08-28||Interventional|||The Impact of Exercise Training on Living Quality in Multiple Sclerosis Individuals|The Impact of 4-weeks Mild Exercise Training on Living Quality in Ambulatory and Non-ambulatory Multiple Sclerosis Individuals (EDSS From 0-8) in Motivational and Social Supporting Environment: a Randomized Controlled Trial|Completed||N/A|40|Actual|University of Rijeka||2|||f||||f|f|f||||||||2017-10-10 20:51:43.569041|2017-10-10 20:51:43.569041
NCT03222583|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-19|||August 29, 2017|Anticipated|2017-08-29|July 2017|2017-07-01|June 7, 2019|Anticipated|2019-06-07|December 7, 2018|Anticipated|2018-12-07||Interventional|||A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection|Not yet recruiting||Phase 3|504|Anticipated|AbbVie||2|||f||||f|f|f||||||||2017-10-10 20:51:43.678706|2017-10-10 20:51:43.678706
NCT03222570|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-20|||March 2018|Anticipated|2018-03-01|July 2017|2017-07-01|October 2022|Anticipated|2022-10-01|March 2022|Anticipated|2022-03-01||Interventional|||An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression|An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression|Not yet recruiting||Phase 2|200|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t|t|f|||t|||||2017-10-10 20:51:43.794161|2017-10-10 20:51:43.794161
NCT03222557|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-10-05|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Electroacupuncture for Postoperative Ileus After Laparoscopic Surgery for Mid and Low Rectal Cancer|Electroacupuncture for Postoperative Ileus After Laparoscopic Surgery for Mid and Low Rectal Cancer: A Prospective, Randomized, Sham-controlled Trial|Recruiting||N/A|164|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:51:43.9028|2017-10-10 20:51:43.9028
NCT03222544|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-29|||October 25, 2017|Anticipated|2017-10-25|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|December 31, 2018|Anticipated|2018-12-31||Interventional|||Clinical Study of Indocyanine Green - Mediated Photodynamic Therapy for Diabetic Lower Limb Ulcer|Efficacy and Safety of Indocyanine Green-mediated Photodynamic Therapy for Diabetic Lower Limb Ulcer : a Single-blind Randomized Controlled Study|Not yet recruiting||N/A|80|Anticipated|Chongqing Medical University||2|||f||||t|f|f||||||||2017-10-10 20:51:44.014949|2017-10-10 20:51:44.014949
NCT03222531|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-11|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Expanding the Pool in Orthotopic Heart Transplantation|Expanding the Pool in Orthotopic Heart Transplantation: The Use of Hepatitis C Positive Donor Hearts in Hepatitis C Negative Recipients|Recruiting||N/A|100|Anticipated|University of Pittsburgh||1|||f||||t|f|f||||||||2017-10-10 20:51:44.141332|2017-10-10 20:51:44.141332
NCT03222518|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-07-16|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management|NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management|Recruiting||Phase 3|1000|Anticipated|University of Monastir||3|||f||||t|f|f|||f|||||2017-10-10 20:51:44.237906|2017-10-10 20:51:44.237906
NCT03222505|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-25|||January 2010||2010-01-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Walk Assist Device to Improve Community Ambulation|Development of Walk Assist Device to Improve Community Ambulation|Completed||N/A|20|Actual|Shirley Ryan AbilityLab||2|||f||||t||||||||||2017-10-10 20:51:44.348329|2017-10-10 20:51:44.348329
NCT03222492|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-20|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|BRAVOS||Brentuximab Vedotin for Systemic Sclerosis|Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)|Recruiting||Phase 1/Phase 2|24|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t|t|f||||||||2017-10-10 20:51:44.432216|2017-10-10 20:51:44.432216
NCT03222479|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-17|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Interventional|||Smartphone-based Stress Management Intervention for Employees|Development of Stress Guide for Employees: Smartphone-based Stress Management Intervention|Completed||N/A|68|Actual|Seoul National University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:51:44.573276|2017-10-10 20:51:44.573276
NCT03222466|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Patient Educational Materials for Prostate Cancer Screening|A Randomized Trial to Assess Whether Co-creating Patient Educational Materials With Patients Has Added Value Over Researchers and Clinicians Developing Patient Education Materials and Engaging Patients During Usability Testing Only.|Not yet recruiting||N/A|422|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 20:51:44.655788|2017-10-10 20:51:44.655788
NCT03222453|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-17|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|June 14, 2016|Actual|2016-06-14||Interventional|||Thalassemia Treatment Based on the Stem Cell Technology|The Third Affiliated Hospital of Guangzhou Medical University|Enrolling by invitation||N/A|2|Actual|The Third Affiliated Hospital of Guangzhou Medical University||2|||f||||f|f|f||||||||2017-10-10 20:51:44.743571|2017-10-10 20:51:44.743571
NCT03222440|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-17|||July 20, 2017|Anticipated|2017-07-20|July 2017|2017-07-01|July 20, 2020|Anticipated|2020-07-20|July 20, 2018|Anticipated|2018-07-20||Interventional|||Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC|A Single Arm Exploratory Study of Radiation Therapy With Anti-PD-1 Antibody SHR-1210 in Treating Patients With Locally Advanced Esophageal Squamous Cell Carcinomas|Recruiting||N/A|20|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t|f|f||||||||2017-10-10 20:51:44.830393|2017-10-10 20:51:44.830393
NCT03222427|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-18|2017-10-02|||November 17, 2017|Anticipated|2017-11-17|October 2017|2017-10-01|December 22, 2017|Anticipated|2017-12-22|December 22, 2017|Anticipated|2017-12-22||Interventional|||A Study of LY3314814 in Healthy Participants|An Absolute Bioavailability Study of LY3314814 in Healthy Subjects Using an Intravenous Tracer Method|Not yet recruiting||Phase 1|8|Anticipated|Eli Lilly and Company||2|||f||||f|t|f||||||||2017-10-10 20:51:44.915257|2017-10-10 20:51:44.915257
NCT03222414|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||May 1, 2015|Actual|2015-05-01|July 2017|2017-07-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Non-invasive Versus Invasive Blood Pressure Measurement in the Super Morbidly Obese Parturient With Severe Preeclampsia|Non-invasive Versus Invasive Blood Pressure Measurement in the Super Morbidly Obese Parturient (BMI >= 40 kg/m2) With Severe Preeclampsia: A Comparison of Direct Arterial Blood Pressure Measurements With Readings Obtained Using Either Large Cylindrical or Novel Conical Bariatric Upper Arm Blood Pressure Cuffs|Recruiting||N/A|25|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:51:45.003057|2017-10-10 20:51:45.003057
NCT03222401|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-21|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With N. Gonorrhoeae in Healthy Males|IGHID 11705 A Randomized, Open-label, Controlled Clinical Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With Neisseria Gonorrhoeae in Healthy Male Subjects|Not yet recruiting||Phase 2|24|Anticipated|Alopexx Pharmaceuticals, LLC||4|||f||||f|t|f||||||||2017-10-10 20:51:45.116374|2017-10-10 20:51:45.116374
NCT03222388|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-10|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|October 14, 2017|Anticipated|2017-10-14|October 1, 2017|Anticipated|2017-10-01||Observational|||Electronic IIEF Validation|Electronic Validation of the International Index of Erectile Function Questionnaire (IIEF) 5 and 15.|Recruiting||N/A|172|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||6||f||||f|f|f||||||||2017-10-10 20:51:45.227305|2017-10-10 20:51:45.227305
NCT03222375|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-26|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|December 2027|Anticipated|2027-12-01|September 2022|Anticipated|2022-09-01||Observational|SQUED™||SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism|The Home-Use of Semiconducting QUantum Excitonic Device: Image Converter/Sound Converter/Electromagnetic Converter to Improve Communicative Efforts, Speech, Language and Related Cognitive Functions in Children With Autism|Recruiting||N/A|80|Anticipated|American Federation of Medical Synergetics|||1||f||||||t|t|f|t|||||2017-10-10 20:51:45.438774|2017-10-10 20:51:45.438774
NCT03222362|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-16|||January 1, 2006|Actual|2006-01-01|July 2017|2017-07-01|December 31, 2015|Actual|2015-12-31|December 31, 2013|Actual|2013-12-31||Observational|PPV||Pars Plana Vitrecromy in Patients Aged 85 Years and Above|Pars Plana Vitrecromy in Patients Aged 85 Years and Above|Completed||N/A|120|Actual|Tel Aviv Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:51:45.583746|2017-10-10 20:51:45.583746
NCT03222349|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-17|||August 31, 2017|Anticipated|2017-08-31|May 2017|2017-05-01|July 31, 2019|Anticipated|2019-07-31|December 31, 2018|Anticipated|2018-12-31||Interventional|DBSF||Assessment of Pharmacokinetics and Safety of Diazepam Buccal Soluble Film in Pediatric Patients|A Multicenter,Open Label Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Pediatric Subjects With Epilepsy|Enrolling by invitation||Phase 2|18|Anticipated|MonoSol Rx||2|||f||||f|t|f||||||||2017-10-10 20:51:45.689143|2017-10-10 20:51:45.689143
NCT03222336|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-16|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 30, 2020|Anticipated|2020-09-30|June 1, 2020|Anticipated|2020-06-01||Observational|||Natural History in Fabry Patients With IVS4+919G>A Mutation|Study of Natural History Among Patients With Chinese Hotspot Late-onset Fabry Mutation IVS4+919G>A Through Family Pedigree Analysis|Not yet recruiting||N/A|80|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||f|f|f||||||||2017-10-10 20:51:45.843443|2017-10-10 20:51:45.843443
NCT03222323|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-26|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|April 1, 2018|Anticipated|2018-04-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Perineural Dexmedetomidine for Ulnar Nerve Block.|Does Perineural Dexmedetomidine Prolong the Duration of an Ulnar Nerve Block When Controlling for Possible Systemic Effects?|Recruiting||Phase 2|22|Anticipated|Zealand University Hospital||4|||f|||||f|f||||||||2017-10-10 20:51:45.9507|2017-10-10 20:51:45.9507
NCT03222310|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-28|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|September 6, 2017|Anticipated|2017-09-06|September 6, 2017|Anticipated|2017-09-06||Interventional|||A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib|Effect of a Potent CYP3A and P-gp Inhibitor (Itraconazole) on Ipatasertib Pharmacokinetics in Healthy Subjects|Recruiting||Phase 1|15|Anticipated|Hoffmann-La Roche||1|||f||||f|t|f||||||||2017-10-10 20:51:46.11256|2017-10-10 20:51:46.11256
NCT03222297|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-16|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Observational|||Effects of Early Skull Repair With Titanium Mesh on Cerebral Blood Flow and Neurological Recovery|Effects of Early Skull Repair With Titanium Mesh on Cerebral Blood Flow and Neurological Recovery: a Randomized Controlled Clinical Trial Based on CT Perfusion Evaluation|Active, not recruiting||N/A|86|Actual|Taihe Hospital|||2||f||||t|f|f||||||||2017-10-10 20:51:46.209451|2017-10-10 20:51:46.209451
NCT03222284|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-25|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App|The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App|Recruiting||N/A|30|Anticipated|Healthcare Innovation Technology Lab||2|||f||||f|f|t|f|||||||2017-10-10 20:51:46.294111|2017-10-10 20:51:46.294111
NCT03222271|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-17|||October 25, 2017|Anticipated|2017-10-25|July 2017|2017-07-01|October 25, 2021|Anticipated|2021-10-25|October 25, 2020|Anticipated|2020-10-25||Interventional|||iVAPS vs. S/T Modes as Non-invasive Weaning Strategy in COPD Patients|Intelligent Volume Assured Pressure Support (iVAPS) vs. Spontaneous/Timed Mode as Noninvasive Modes for Weaning of COPD Patients|Not yet recruiting||N/A|100|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:51:46.406432|2017-10-10 20:51:46.406432
NCT03222258|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-05|||December 17, 2016|Actual|2016-12-17|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients|Change of Quality of Life, Treatment Decision and Utilization of Health Care Depending on the Use of Palliative Care in Adult and Pediatric Patients With Advanced Stage of Cancer: a Prospective Cohort Study|Recruiting||N/A|500|Anticipated|Seoul National University Hospital|||5||f||||t|f|f||||||||2017-10-10 20:51:46.553154|2017-10-10 20:51:46.553154
NCT03222050|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effectiveness of Distraction Techniques on Pain Intensity During Immunization Among Infants|Effectiveness of Distraction Techniques on Pain Intensity During Immunization Among Infants|Completed||N/A|100|Actual|Maharishi Markendeswar University||4|||f||||t|f|f||||||||2017-10-10 20:51:48.465051|2017-10-10 20:51:48.465051
NCT03222245|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-24|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Observational|||The Effect of Injectable Therapies on Quality of Life in Diabetes|The Effect of Injectable Therapies on Health Status, Quality of Life and Treatment Satisfaction in Patients With Type 2 Diabetes: Prospective Observational Cohort Study|Recruiting||N/A|350|Anticipated|Portsmouth Hospitals NHS Trust|||2||f||||f|f|f||||||||2017-10-10 20:51:46.860566|2017-10-10 20:51:46.860566
NCT03222232|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-16|||January 1, 2002|Actual|2002-01-01|July 2017|2017-07-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Catheter Salvage in Intestinal Failure Patients|Catheter-related Bloodstream Infections in Patients With Intestinal Failure Receiving Home Parenteral Support: Risks Related to a Catheter-salvage-strategy.|Completed||N/A|715|Actual|Rigshospitalet, Denmark|||1||f||||f|f|f||||||||2017-10-10 20:51:46.956856|2017-10-10 20:51:46.956856
NCT03222219|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-25|||January 15, 2017|Actual|2017-01-15|July 2017|2017-07-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Observational|TorqueISQ||Implant Insertion Torque and Primary Stability|Influence of the Implant Insertion Torque on the Primary Stability of Tapered Dental Implants With Deep Spires|Recruiting||N/A|60|Anticipated|International Piezosurgery Academy|||3||f||||t|f|f||||||||2017-10-10 20:51:47.088911|2017-10-10 20:51:47.088911
NCT03222206|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-20|||February 23, 2017|Actual|2017-02-23|July 2017|2017-07-01|February 22, 2018|Anticipated|2018-02-22|February 22, 2018|Anticipated|2018-02-22||Interventional|||The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease|The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease: Investigator Initiated Randomized Placebo-controlled Double-blind, Pilot Study|Enrolling by invitation||Phase 4|34|Anticipated|Korea University Guro Hospital||2|||f||||t|f|f||||||||2017-10-10 20:51:47.229124|2017-10-10 20:51:47.229124
NCT03222193|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|September 15, 2018|Anticipated|2018-09-15|November 15, 2017|Anticipated|2017-11-15||Interventional|SCORED||Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring|Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring|Recruiting||N/A|35|Anticipated|Tongue Laboratory||1|||f||||f|f|f||||||||2017-10-10 20:51:47.378989|2017-10-10 20:51:47.378989
NCT03222180|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||January 15, 2018|Anticipated|2018-01-15|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||A Crowdsourced Social Media Portal for Parents of Very Young Children With Type 1 Diabetes|A Crowdsourced Social Media Portal for Parents of Very Young Children With Type 1 Diabetes|Not yet recruiting||N/A|150|Anticipated|Nemours Children's Clinic||2|||f||||t|f|f||||||||2017-10-10 20:51:47.473315|2017-10-10 20:51:47.473315
NCT03222167|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-04|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b|Open-Label Multi-Center Single Arm Clinical Trial to Study the Efficacy and Safety of the Elbasvir/ Grazoprevir 50/100 mg Fixed Dose Combination Once Daily in Patients With Chronic HCV GT1b Infection Associated With Metabolic Syndrome|Not yet recruiting||Phase 3|60|Anticipated|Institute Of Cardiology & Internal Diseases, Kazakhstan||1|||f||||f|f|f||||||||2017-10-10 20:51:47.576272|2017-10-10 20:51:47.576272
NCT03222154|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|October 1, 2016|Actual|2016-10-01||Interventional|||EFFECTS OF SHOCK WAVE THERAPY IN WOMEN WITH PAIN IN TRAPÉZIO MUSCLE|EFFECTS OF SHOCK WAVE THERAPY IN MIOFASCIAL PAIN: RANDOMIZED AND BLIND CLINICAL TEST|Completed||N/A|60|Actual|Estácio Ponta Negra||3|||f||||f|f|f||||||||2017-10-10 20:51:47.674877|2017-10-10 20:51:47.674877
NCT03222141|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||October 2013|Actual|2013-10-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|September 2015|Actual|2015-09-01||Interventional|PII S3HR/NR7||The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - High Risk and Nested Registry 7|Edwards SAPIEN 3 Transcatheter Heart Valve Therapy for High Risk and Inoperable Patients|Active, not recruiting||Phase 3|668|Actual|Edwards Lifesciences||1|||f||||t|f|t|f|||||||2017-10-10 20:51:47.751345|2017-10-10 20:51:47.751345
NCT03222128|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||February 17, 2014|Actual|2014-02-17|July 2017|2017-07-01|November 2024|Anticipated|2024-11-01|November 18, 2015|Actual|2015-11-18||Interventional|PARTNERII S3i||The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - PARTNERII - S3 Intermediate|"The PARTNER II Trial Placement of AoRTic TraNscathetER Valves Trial (PARTNERII S3 Intermediate)"|Active, not recruiting||N/A|1074|Actual|Edwards Lifesciences||1|||f||||t|f|t|f|f||||||2017-10-10 20:51:47.917815|2017-10-10 20:51:47.917815
NCT03222102|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-26|||October 16, 2017|Anticipated|2017-10-16|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Ventral Hernia Prevention After Liver Transplantation|Ventral Hernia Prevention After Liver Transplantation|Not yet recruiting||N/A|194|Anticipated|Medical University of Graz||2|||f||||f|f|f||||||||2017-10-10 20:51:48.120009|2017-10-10 20:51:48.120009
NCT03222089|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-16|||July 20, 2017|Anticipated|2017-07-20|July 2017|2017-07-01|July 20, 2020|Anticipated|2020-07-20|July 20, 2019|Anticipated|2019-07-20||Interventional|||Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC|FOLFOXIRI in Combination With GM-CSF and IL-2 (FOLFOXIGIL) Versus FOLFOXIRI as First-line Treatment for Patients With Metastatic Colorectal Cancer: a Phase II Trial by the FNF Team.|Not yet recruiting||Phase 2|60|Anticipated|Fujian Cancer Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:48.191046|2017-10-10 20:51:48.191046
NCT03222076|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-28|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Study Evaluating Nivolumab (Anti-PD-1 Antibody) Alone Versus Nivolumab Plus Ipilimumab (Anti-CTLA-4 Antibody) in Patients With Resectable and Potentially Resectable Hepatocellular Carcinoma (HCC) (CA209-956)|An Open-Label Preoperative Pilot Study Evaluating Nivolumab (Anti-PD-1 Antibody) Alone Versus Nivolumab Plus Ipilimumab (Anti-CTLA-4 Antibody) in Patients With Resectable and Potentially Resectable Hepatocellular Carcinoma (HCC) (CA209-956)|Recruiting||Phase 2|45|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-10 20:51:48.292476|2017-10-10 20:51:48.292476
NCT03222063|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||Effectiveness of Play Interventions on Anxiety Among Hospitalized Children|A Study to Assess the Effectiveness of Play Interventions on Anxiety Among Hospitalized Children in Selected Hospital of Yamuna Nagar, Haryana|Completed||N/A|60|Actual|Maharishi Markendeswar University||2|||f||||t|f|f||||||||2017-10-10 20:51:48.399771|2017-10-10 20:51:48.399771
NCT03222037|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-08-08|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|||Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers|Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers|Completed||Phase 4|49|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:51:48.529475|2017-10-10 20:51:48.529475
NCT03222024|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-13|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|February 29, 2020|Anticipated|2020-02-29|August 31, 2019|Anticipated|2019-08-31|12 Months|Observational [Patient Registry]|SIS||Cohort Study for Severe Ischaemic Stroke|Clinical Features, Management and Outcomes of Severe Ischaemic Stroke in Tertiary Hospitals in China: a Multi-centre Prospective Observational Study|Recruiting||N/A|2500|Anticipated|West China Hospital|||3||f||||t|f|f||||Samples With DNA|"     We will collect blood samples from patients with their written consent   "|||2017-10-10 20:51:48.596998|2017-10-10 20:51:48.596998
NCT03222011|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-18|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|STRIDENT||Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study|Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study|Not yet recruiting||N/A|30|Anticipated|St Vincent's Hospital Melbourne||2|||f||||t|f|f|||f|||||2017-10-10 20:51:48.703889|2017-10-10 20:51:48.703889
NCT03221998|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-23|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||The Effect of Timing of Intravenous Paracetamol Administration on Post-surgical Pain|The Effect of Timing of Intravenous Paracetamol Administration on Post-surgical Pain and Cytokines Levels Following Laparoscopic Sleeve Gastrectomy|Not yet recruiting||Early Phase 1|126|Anticipated|Soroka University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:51:48.787483|2017-10-10 20:51:48.787483
NCT03221985|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-07-19|||September 2016||2016-09-01|July 2017|2017-07-01|May 15, 2017|Actual|2017-05-15|May 2017|Actual|2017-05-01||Interventional|||ESM Pilot: Mobile Phones and Psychology|Investigating the Relationship Between Mobile Phone Usage and Emotions. A Pilot Study Using the Experienced Sampling Method|Completed||N/A|2|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-10 20:51:48.887956|2017-10-10 20:51:48.887956
NCT03221972|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-18|||January 1, 2010|Actual|2010-01-01|July 2017|2017-07-01|October 30, 2016|Actual|2016-10-30|December 30, 2013|Actual|2013-12-30||Observational|||Vitamin D of Chinese Children and Adolescents|Vitamin D Nutritional Status and Its Related Factors for Chinese Children and Adolescents in 2010-2012|Completed||N/A|15000|Actual|Centers for Disease Control and Prevention, China|||1||f||||t|f|f||||Samples Without DNA|"     2 mL of fasting venous blood was collected and centrifuged at 1500×g for 15 minutes within 30     minutes after blood taken. The upper serum was aliquoted and stored in brown vessel at -20℃     in the laboratory where the investigation point was located. All the serum specimens from all     the 150 investigation points were transported to our laboratory by cold chain. All the     samples were preserved at -70℃ refrigerator before determination.   "|||2017-10-10 20:51:48.963811|2017-10-10 20:51:48.963811
NCT03221959|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-24|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Descompressive Craniectomy.|Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Decompressive Craniectomy|Not yet recruiting||N/A|48|Anticipated|Kantonsspital Aarau|||1||f||||f|f|f||||||||2017-10-10 20:51:49.033875|2017-10-10 20:51:49.033875
NCT03221946|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-18|||January 31, 2016|Actual|2016-01-31|July 2017|2017-07-01|January 15, 2017|Actual|2017-01-15|January 1, 2017|Actual|2017-01-01||Interventional|||A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain|A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain: A Randomized Control Trial|Completed||Phase 4|90|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||3|||f||||t|f|f|||f|||||2017-10-10 20:51:49.105261|2017-10-10 20:51:49.105261
NCT03221933|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-17|||December 2009|Actual|2009-12-01|July 2017|2017-07-01||||December 2014|Actual|2014-12-01||Interventional|||A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA|Phase Ⅱ Clinical Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for Gestational Age(SGA)|Completed||Phase 2|120|Actual|GeneScience Pharmaceuticals Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:51:49.19026|2017-10-10 20:51:49.19026
NCT03221920|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-28|||August 5, 2017|Anticipated|2017-08-05|July 2017|2017-07-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Very Low Carbohydrate Diet Effects to GPS, Serum Lactate and TNF Alpha on Colorectal Cancer|Effect of Very Low Carbohydrate Diet to Glasgow Prognostic Score, Serum Lactate and TNF Alpha on Colorectal Cancer Patients With Best Supportive Care|Not yet recruiting||N/A|26|Anticipated|Dr. Soetomo General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:49.272941|2017-10-10 20:51:49.272941
NCT03221907|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain|A Multi-center, Randomized, Double-blind, Parallel, Active-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' and 'Pregabalin' in Peripheral Neuropathic Pain|Recruiting||Phase 3|344|Anticipated|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 20:51:49.348401|2017-10-10 20:51:49.348401
NCT03221894|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-21|||July 15, 2017|Actual|2017-07-15|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease|A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease|Recruiting||N/A|90|Anticipated|Dongzhimen Hospital, Beijing|||2||f||||f|f|f||||||||2017-10-10 20:51:49.428128|2017-10-10 20:51:49.428128
NCT03221881|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-15|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer|The Effectiveness and Safety of Neoadjuvant Pegylated Liposomal Doxorubicin and Docetaxel in Breast Cancer.|Completed||N/A|100|Actual|Hebei Medical University Fourth Hospital||1|||f||||t|f|f||||||||2017-10-10 20:51:49.511522|2017-10-10 20:51:49.511522
NCT03221868|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-08-25|||August 2016||2016-08-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Effects of a Physical Exercise Program Among Diabetic Women Users of the National Health System|Effects of a Physical Exercise Program Among Diabetic Women Users of the National Health System: a Randomized Clinical Trial|Completed||N/A|120|Actual|Federal University of Pelotas||2|||f||||f||||||||||2017-10-10 20:51:49.579435|2017-10-10 20:51:49.579435
NCT03221855|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-07-17|||March 2013||2013-03-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Use of Domperidone to Increase Milk Production in Mothers With Newborns in Neonatology|Randomized Clinical Trial: Use of Domperidone to Increase Milk Production in Mothers With Newborns Hospitalized in Neonatology|Completed||Early Phase 1|30|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 20:51:49.794071|2017-10-10 20:51:49.794071
NCT03221842|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-07|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|October 16, 2023|Anticipated|2023-10-16|July 16, 2020|Anticipated|2020-07-16||Interventional|||Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients|A Double-blind, Randomized-withdrawal, Placebo-controlled Study to Evaluate the Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection in Adult Renal Transplant Recipients|Recruiting||Phase 3|90|Anticipated|CSL Behring||2|||f||||t|t|f||||||||2017-10-10 20:51:49.909478|2017-10-10 20:51:49.909478
NCT03221829|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-14|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||A Retrospective Analysis of Spinal Anaesthesia for TURBT Procedures in Elderly Patients|A Retrospective Analysis of Spinal Anaesthesia for Transurethral Resection of Bladder Tumour in Elderly Patients: A Single Centre Experience From 2007 to 2017|Recruiting||N/A|2800|Anticipated|Medical University of Warsaw|||1||f||||f|f|f||||||||2017-10-10 20:51:50.043223|2017-10-10 20:51:50.043223
NCT03221816|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-18|||December 2008||2008-12-01|July 2017|2017-07-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial|Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial|Completed||Phase 4|60|Actual|Casa de Saúde santa Marcelina||2|||f||||f||||||||||2017-10-10 20:51:50.138953|2017-10-10 20:51:50.138953
NCT03221803|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Patient Satisfaction and Bone Changes for OT Cap and OT Vertical Attachment|"Patient Satisfaction and Bone Changes in Bilateral Distal Extension Case Using OT Cap Versus OT Vertical Attachment Randomized Clinical Trial"|Not yet recruiting||N/A|14|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:51:50.252144|2017-10-10 20:51:50.252144
NCT03221790|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|February 1, 2019|Anticipated|2019-02-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Effect of FODMAPs on Mucosal Inflammation in IBS Patients|A Study Evaluating the Effects of Low and High FODMAP Diets on Mucosal Protease Nerve Interactions in IBS Patients|Not yet recruiting||N/A|20|Anticipated|Queen's University||1|||f||||f|f|f||||||||2017-10-10 20:51:50.342227|2017-10-10 20:51:50.342227
NCT03221777|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-14|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|AFOTS||Atrial Fibrillation Occurring Transiently With Stress (AFOTS)|Atrial Fibrillation Occurring Transiently With Stress (AFOTS): Understanding the Risks of Recurrent AF. Study in Non-cardiac Surgery and in Medical Illness Patients.|Recruiting||N/A|276|Anticipated|Population Health Research Institute|||4||f||||f|f|t|f||t|||||2017-10-10 20:51:50.46014|2017-10-10 20:51:50.46014
NCT03221764|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-17|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients|The Intra-Operative Application of Amiodarone Releasing Hydrogel to Prevent Postoperative Atrial Fibrillation in Patients Undergoing Lung Transplantation|Not yet recruiting||Phase 2|20|Anticipated|University of Louisville||1|||f|||||t|t|f|||||||2017-10-10 20:51:50.586882|2017-10-10 20:51:50.586882
NCT03221751|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-17|||December 1, 2016|Actual|2016-12-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|PoND||Prazosin and CSF Biomarkers in mTBI|Prazosin and CSF Biomarkers in mTBI|Recruiting||Phase 4|120|Anticipated|VA Office of Research and Development||2|||f||||f|t|f||||||||2017-10-10 20:51:50.686324|2017-10-10 20:51:50.686324
NCT03221725|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-16|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 1, 2018|Anticipated|2018-02-01|August 1, 2017|Actual|2017-08-01||Observational|||The Development of De-novo Stress Urinary Incontinence After Stage II-III Pelvic Organ Prolapse Surgery|The Effect of Sacrospinous Ligament Fixation After Vaginal Hysterectomy to Development of De-novo Stress Urinary Incontinence and Postoperative Vaginal Length in Treating Stage II-III Pelvic Organ Prolapse Patients|Active, not recruiting||N/A|100|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||f|f|f||||||||2017-10-10 20:51:50.886977|2017-10-10 20:51:50.886977
NCT03221712|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-17|||August 31, 2017|Anticipated|2017-08-31|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Observational|||The Registry Study to Compare the Cardiopulmonary Exercise Test Parameters Before and After Cardiac Rehabilitation in Patients With Chronic Total Occlusion of the Coronary Arteries|The Registry Study to Compare the Cardiopulmonary Exercise Test Parameters Before and After Cardiac Rehabilitation in Patients With Chronic Total Occlusion of the Coronary Arteries|Not yet recruiting||N/A|5000|Anticipated|Asan Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:51:50.961272|2017-10-10 20:51:50.961272
NCT03221699|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-14|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|ZINC-ON||Effects of a Zinc Oxide Underarm Formula on Normal and Injured Skin in Healthy Volunteers|Effects of a Zinc Oxide Underarm Formula on Normal and Injured Skin: A Randomized and Double-blind Trial in Healthy Volunteers|Completed||N/A|30|Actual|Bispebjerg Hospital||2|||f||||f|f|f||||||||2017-10-10 20:51:51.048425|2017-10-10 20:51:51.048425
NCT03221686|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-14|||February 2016||2016-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Oral Supplementation of Arginine, Zinc and Vitamin C on Collagen Synthesis in Inguinal Hernia Patients|The Effect of a Pre- and Postoperative Oral Supplement of Arginine, Zinc and Vitamin C on Collagen Synthesis in Surgical Inguinal Hernia Patients: A Randomized Controlled Trial|Recruiting||N/A|32|Anticipated|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-10 20:51:51.134366|2017-10-10 20:51:51.134366
NCT03221673|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-14|||May 18, 2017|Actual|2017-05-18|July 2017|2017-07-01|May 31, 2020|Anticipated|2020-05-31|December 30, 2019|Anticipated|2019-12-30||Observational|AAK||Arkansas Active Kids! -Objective 3|Relationship of Physical Activity and Diet With Socio-demographic, Environmental, and Metabolic Factors in Arkansas Public School Children|Recruiting||N/A|220|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f|f|f||||Samples With DNA|"     Whole blood, serum, stool, saliva, urine   "|||2017-10-10 20:51:51.231359|2017-10-10 20:51:51.231359
NCT03221660|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Clinical Investigation of the F-Composite 2 System in Direct Filling Therapy|Clinical Investigation of the F-Composite 2 System in Direct Filling Therapy|Not yet recruiting||N/A|75|Anticipated|Ivoclar Vivadent AG||1|||f||||f|f|f|||f|||||2017-10-10 20:51:51.318745|2017-10-10 20:51:51.318745
NCT03221647|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-17|||January 10, 2013|Actual|2013-01-10|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01|5 Years|Observational [Patient Registry]|||INF-α Innate Immune Response to Gliadin|A Gliadin Peptide Regulated the INF-α Immune Response in Celiac Small Intestine and in an En-terocyte Cell Line|Completed||N/A|53|Actual|Federico II University|||3||f||||t|f|f||||Samples With DNA|"     Intestinal biopsies from CD patients and controls obtained during routine analysis. Informed     consensus statement obtained from all subjects or their tutors.   "|||2017-10-10 20:51:51.396523|2017-10-10 20:51:51.396523
NCT03221634|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 10, 2021|Anticipated|2021-06-10|March 20, 2019|Anticipated|2019-03-20||Interventional|||Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)|A Phase 2 Study of Pembrolizumab in Combination With Daratumumab (Anti CD38) in Participants With Relapsed Refractory Multiple Myeloma (rrMM)|Not yet recruiting||Phase 2|57|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f|t|f||||||||2017-10-10 20:51:51.482653|2017-10-10 20:51:51.482653
NCT03221621|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-17|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|HS-COST||Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS|Cost-effectiveness of Adalimumab With Adjuvant Surgery Versus Adalimumab Monotherapy in the Treatment of Hidradenitis Suppurativa'|Not yet recruiting||Phase 4|128|Anticipated|Erasmus Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 20:51:51.679248|2017-10-10 20:51:51.679248
NCT03221608|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2024|Anticipated|2024-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|||Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery|Clinical Study of the Impact of Hyperthermic Intraperitoneal Chemotherapy on Peritoneal Recurrence and Prognosis of Patients With Stage T4 Colorectal Cancer After Radical Surgery: A Multicentre Randomised Clinical Trial|Not yet recruiting||Phase 3|300|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 20:51:51.813144|2017-10-10 20:51:51.813144
NCT03221595|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-10-04|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|March 1, 2019|Anticipated|2019-03-01|January 1, 2019|Anticipated|2019-01-01||Interventional|CWISNONFLAIL||Multicenter RCT of SSRF in Non Flail Patients|A Multicenter, Randomized Controlled Trial of Surgical Stabilization of Rib Fractures in Patients With Severe, Non-flail Fracture Patterns|Not yet recruiting||N/A|100|Anticipated|Denver Health and Hospital Authority||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:51:51.909784|2017-10-10 20:51:51.909784
NCT03221582|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-13|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Interventional|HCV||Impact of Hepatitis C Therapy and Bone Health|Impact of HCV Therapy on Cardiovascular Risk and Bone Health|Not yet recruiting||Phase 4|60|Anticipated|Dallas VA Medical Center||2|||f|||||t|f||||||||2017-10-10 20:51:51.996437|2017-10-10 20:51:51.996437
NCT03221569|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||February 1, 2016||2016-02-01|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Ketamine v. Metoclopramide/Diphenhydramine for Acute Management of Migraine in the Emergency Department|Ketamine v. Metoclopramide/Diphenhydramine for Acute Management of Migraine in the Emergency Department|Recruiting||Phase 4|40|Anticipated|The Brooklyn Hospital Center||2|||f||||f|t|f||||||||2017-10-10 20:51:52.087804|2017-10-10 20:51:52.087804
NCT03221556|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-07-17|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Improving Outcomes for Low-Income Mothers With Depression|Improving Outcomes for Low-Income Mothers With Depression: A Comparative Effectiveness Trial of Two Brief Interventions in the Patient-Centered Medical Home.|Not yet recruiting||N/A|230|Anticipated|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:51:52.183736|2017-10-10 20:51:52.183736
NCT03221543|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-01|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|December 1, 2027|Anticipated|2027-12-01|August 1, 2022|Anticipated|2022-08-01||Interventional|||Resting Metabolic Rate Testing in Bariatric Surgery Patients|The Role of Pre-Surgical Metabolic Testing for Procedure Selection in Bariatric Surgery|Recruiting||N/A|50|Anticipated|Baylor Research Institute||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:51:52.295823|2017-10-10 20:51:52.295823
NCT03221530|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-17|||September 1, 2018|Anticipated|2018-09-01|July 2017|2017-07-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2022|Anticipated|2022-08-01||Interventional|||Early Intervention for Suicide Risk Among Immigrant Youth|Early Intervention for Suicide Risk Among Immigrant Youth|Not yet recruiting||N/A|40|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:51:52.368285|2017-10-10 20:51:52.368285
NCT03221504|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-31|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 31, 2020|Anticipated|2020-01-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children|7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children: a Randomized Controlled Trial|Not yet recruiting||N/A|221|Anticipated|Medical University of Warsaw||2|||f||||t|f|f|||f|||||2017-10-10 20:51:52.534823|2017-10-10 20:51:52.534823
NCT03221491|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-18|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Comparison of Patient-Controlled Analgesia With Different Background Infusion|Comparison of Intravenous Patient-Controlled Analgesia With Different Background Infusion After Colorectal Surgery|Completed||N/A|90|Actual|Guangzhou General Hospital of Guangzhou Military Command||3|||f||||f|f|f||||||||2017-10-10 20:51:52.637193|2017-10-10 20:51:52.637193
NCT03221478|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-22|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|August 22, 2017|Actual|2017-08-22|August 22, 2017|Actual|2017-08-22||Interventional|KT-Knee||Effect of Kinesio Taping on the Stability of Knee in Soccer Players|Effect of Kinesio Taping and Proprioceptive Exercise on the Stability of Knee in Amateur Soccer Players|Completed||N/A|46|Actual|University of Valencia||3|||f||||f|f|f||||||||2017-10-10 20:51:52.752519|2017-10-10 20:51:52.752519
NCT03221465|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-14|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|LIFT||Project LIFT - Promoting Healthy Behavior Through a Wearable Fitness Device and Financial Incentives|Project LIFT - Lifestyle Intervention to Promote Fitness in Transplantation|Recruiting||N/A|120|Anticipated|University of Pennsylvania||3|||f|||||f|f||||||||2017-10-10 20:51:52.820226|2017-10-10 20:51:52.820226
NCT03221452|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-14|||September 2, 2016|Actual|2016-09-02|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|June 10, 2017|Actual|2017-06-10||Interventional|||Adaptation of a Cognitive Training Intervention for Diabetes Self-Management|Adaptation of a Cognitive Training Intervention for Diabetes Self-Management|Active, not recruiting||N/A|29|Actual|University of Texas at Austin||1|||f||||f|f|f||||||||2017-10-10 20:51:52.912632|2017-10-10 20:51:52.912632
NCT03221439|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-10-01|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Cognitive Functional Therapy for Chronic Low Back Pain|Cognitive Functional Therapy (CFT) Compared With a Combined Manual Therapy and Motor Control Exercise in Patients With Non-specific Chronic Low Back Pain: a Multicentre Randomized Controlled Trial|Recruiting||N/A|148|Anticipated|Centro Universitário Augusto Motta||2|||f||||f|f|f||||||||2017-10-10 20:51:52.977605|2017-10-10 20:51:52.977605
NCT03221426|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-27|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|July 26, 2023|Anticipated|2023-07-26|July 26, 2023|Anticipated|2023-07-26||Interventional|||Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)|A Phase III, Randomized, Double-Blind, Clinical Trial of Pembrolizumab (MK-3475) Plus Chemotherapy (XP or FP) Versus Placebo Plus Chemotherapy (XP or FP) as Neoadjuvant/Adjuvant Treatment for Subjects With Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma (KEYNOTE-585)|Recruiting||Phase 3|800|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t|t|f||||||||2017-10-10 20:51:53.081765|2017-10-10 20:51:53.081765
NCT03221413|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-07-14|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|tACS_EEG||Transcranial Alternating Current for Oscillopathies|A Translational, Multimodal Approach to Implementing Non-invasive Paradigms for the Treatment of Oscillopathies|Recruiting||N/A|40|Anticipated|University of Padova||2|||f||||||||||||||2017-10-10 20:51:53.180912|2017-10-10 20:51:53.180912
NCT03221400|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-31|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||PEN-866 in Patients With Advanced Solid Malignancies|A Phase 1/2a, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of PEN-866 in Patients With Advanced Solid Malignancies|Recruiting||Phase 1/Phase 2|150|Anticipated|Tarveda Therapeutics||1|||f||||f|t|f||||||||2017-10-10 20:51:53.272165|2017-10-10 20:51:53.272165
NCT03221387|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-11|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients|Feasibility of Using Daily Home HNHF-O2 During Sleep and/or Daytime in Hypercapnic COPD Patients Following Recent (&lt 12 Wks.) Hospitalization for AECOPD for 90 Days|Recruiting||N/A|30|Anticipated|Temple University||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:51:53.348827|2017-10-10 20:51:53.348827
NCT03221374|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-15|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Mind-body Awareness Training and Brain-computer Interface|Mind-body Awareness Training and Brain-computer Interface|Recruiting||N/A|300|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||||2017-10-10 20:51:53.432397|2017-10-10 20:51:53.432397
NCT03221361|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Maximum Biting Force of Inject Able Thermoplastic Resin Versus Conventional Resin in Complete Denture Patients|Maximum Biting Force of Injectable Thermoplastic Resin Versus Conventional Resin in Complete Denture Patients (A Randomized Clinical Trial)|Not yet recruiting||N/A|21|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:51:55.040516|2017-10-10 20:51:55.040516
NCT03221348|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|October 2019|Anticipated|2019-10-01||Interventional|||A Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular Lymphoma|A Phase I Open-label, Multiple Dose Study of CHO-H01 Administered Intravenously as a Single Agent to Subjects With Refractory or Relapsed Follicular Lymphoma|Not yet recruiting||Phase 1|24|Anticipated|Cho Pharma Inc.||1|||f||||f|t|f||||||||2017-10-10 20:51:55.112735|2017-10-10 20:51:55.112735
NCT03221335|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-13|||May 2016||2016-05-01|July 2017|2017-07-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||EUS-guided RFA for Solid Abdominal Neoplasms|Multi-center Prospective Study on EUS-guided Radiofrequency Ablation for Solid Abdominal Neoplasms.|Recruiting||N/A|30|Anticipated|Chinese University of Hong Kong||1|||f||||t||||||||||2017-10-10 20:51:55.181429|2017-10-10 20:51:55.181429
NCT03221322|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-13|||April 6, 2017|Actual|2017-04-06|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||How do Super Lean Subjects Keep Resistant to Body Weight Gain?|The Investigation of Lifestyle and Genetics in Super Lean Subjects That Keep Them Resistant to Weight Gain|Recruiting||N/A|300|Anticipated|Chinese Academy of Medical Sciences|||2||f||||f|f|f||||Samples With DNA|"     9 ml of blood samples will be collected for the biological measurements and DNA extraction     for genotyping.   "|||2017-10-10 20:51:55.274604|2017-10-10 20:51:55.274604
NCT03221309|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-14|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|ANCHOR||Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior|A Novel Model of Hepatitis C Treatment as Anchor to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior|Enrolling by invitation||N/A|200|Anticipated|University of Maryland|||1||f||||f|f|f|||t|Samples With DNA|"     Whole blood   "|||2017-10-10 20:51:55.360177|2017-10-10 20:51:55.360177
NCT03221296|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-14|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|June 27, 2018|Anticipated|2018-06-27|June 27, 2018|Anticipated|2018-06-27||Interventional|||Fall Prevention - Vestibular Rehabilitation|A Feasibility Study on the Effects of Vestibular Training as a Fall Prevention Strategy in the Elderly|Recruiting||N/A|24|Anticipated|University Health Network, Toronto||2|||f||||f|f|f||||||||2017-10-10 20:51:55.442954|2017-10-10 20:51:55.442954
NCT03221283|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-15|||August 30, 2017|Anticipated|2017-08-30|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|September 2017|Anticipated|2017-09-01||Interventional|||The Application of Music Therapy in Female Amphetamine Use Disorder|The Intervention of Group Therapy: Music in Mood Problems of Female Amphetamine Use Disorder|Not yet recruiting||N/A|40|Anticipated|Shanghai Mental Health Center||2|||f||||f|f|f||||||||2017-10-10 20:51:55.545729|2017-10-10 20:51:55.545729
NCT03221270|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-03|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|October 30, 2020|Anticipated|2020-10-30||Interventional|STILL3||Targeting Auditory Hallucinations With Alternating Current Stimulation|Targeting Auditory Hallucinations With Alternating Current Stimulation|Not yet recruiting||N/A|40|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|t|f|f||||||2017-10-10 20:51:55.639967|2017-10-10 20:51:55.639967
NCT03221257|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|April 2021|Anticipated|2021-04-01||Interventional|SLSIII||Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate|Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease|Not yet recruiting||Phase 2|150|Anticipated|University of California, Los Angeles||2|||f||||t|t|f|||f|||||2017-10-10 20:51:55.738202|2017-10-10 20:51:55.738202
NCT03221244|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-04|||June 2, 2016|Actual|2016-06-02|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|VRAM||Virtual Reality Attention Management|Virtual Reality Attention Management Program for Improving Attention in Children|Recruiting||N/A|50|Anticipated|University of California, Davis||2|||f||||t|f|f||||||||2017-10-10 20:51:55.943099|2017-10-10 20:51:55.943099
NCT03221231|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-13|||May 15, 2016|Actual|2016-05-15|June 2017|2017-06-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms|N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms|Recruiting||Phase 4|75|Anticipated|Universitair Ziekenhuis Brussel||3|||f||||f|f|f|||f|||||2017-10-10 20:51:56.102912|2017-10-10 20:51:56.102912
NCT03221218|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-02|||August 9, 2017|Anticipated|2017-08-09|August 2017|2017-08-01|January 15, 2019|Anticipated|2019-01-15|January 15, 2019|Anticipated|2019-01-15||Interventional|||Enhanced Screening for Early Treatment Targets After MTBI|Enhanced Screening for Early Treatment Targets After Mild Traumatic Brain Injury|Recruiting||N/A|120|Anticipated|University of British Columbia||2|||f|||||f|f||||||||2017-10-10 20:51:56.2073|2017-10-10 20:51:56.2073
NCT03221205|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-17|||October 15, 2014|Actual|2014-10-15|July 2017|2017-07-01|November 1, 2017|Anticipated|2017-11-01|October 15, 2017|Anticipated|2017-10-15||Interventional|||Effect of CPAP on Myocardial Dysfunction in Type 2 Diabetes Mellitus and Obstructive Sleep Apnea Patients|Effect of Nasal CPAP on Myocardial Dysfunction and Glycemic Control in Patients With Type 2 Diabetes, Obstructive Sleep Apnea and Obesity|Active, not recruiting||N/A|78|Actual|Instituto Nacional de Enfermedades Respiratorias||2|||f||||f|f|f||||||||2017-10-10 20:51:56.292907|2017-10-10 20:51:56.292907
NCT03221192|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-31|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|October 21, 2017|Anticipated|2017-10-21|October 21, 2017|Anticipated|2017-10-21||Observational|||Qualitative Analysis of Subject Experience of Nasal Polyps|Qualitative Research to Characterize the Patient Experience of Nasal Polyps|Recruiting||N/A|30|Anticipated|GlaxoSmithKline|||2||f||||f|f|f||||||||2017-10-10 20:51:56.400738|2017-10-10 20:51:56.400738
NCT03221179|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-11|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7049665 in Healthy Volunteers|A Randomized, Adaptive, Investigator/ Subject Blind, Single Ascending Dose, Placebo-Controlled Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered RO7049665 in Healthy Volunteers|Recruiting||Phase 1|40|Anticipated|Hoffmann-La Roche||2|||f|||||f|f||||||||2017-10-10 20:51:56.506302|2017-10-10 20:51:56.506302
NCT03221166|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors|Thalidomide, a Novel Immunological Treatment to Modify the Natural History of Paediatric Crohn's Disease: a New Proposal From a Well-established Paediatric Research Network|Not yet recruiting||Phase 3|124|Anticipated|IRCCS Burlo Garofolo||2|||f||||f|f|f||||||||2017-10-10 20:51:56.603173|2017-10-10 20:51:56.603173
NCT03221153|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-14|||August 25, 2016||2016-08-25|July 2017|2017-07-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Patient Safety Skills for Medical Students|Simulation for the Evaluation of General Skills in Patient Safety and Quality in Undergraduate Medical Students|Recruiting||N/A|140|Anticipated|Instituto Tecnologico y de Estudios Superiores de Monterey||2|||f||||t|f|f||||||||2017-10-10 20:51:56.728702|2017-10-10 20:51:56.728702
NCT02997085|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-08-02|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Virtual Reality for Pain Management Study|Virtual Reality for Pain Management Study|Recruiting||N/A|150|Anticipated|University of Texas at Austin||3|||f||||f||||||||||2017-10-10 21:31:13.763883|2017-10-10 21:31:13.763883
NCT03221140|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-22|||January 1, 2014|Actual|2014-01-01|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Outpatient Parenteral Antimicrobial Therapy (OPAT)|Observational Study About the Feasibility, Safety and Efficacy of Outpatient Parenteral Antimicrobial Therapy (OPAT)|Recruiting||N/A|2000|Anticipated|University of Lausanne Hospitals|||1||f||||f|f|f||||||||2017-10-10 20:51:56.811823|2017-10-10 20:51:56.811823
NCT03221127|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-13|||March 1, 1984|Actual|1984-03-01|July 2017|2017-07-01|December 31, 2052|Anticipated|2052-12-31|December 31, 2052|Anticipated|2052-12-31||Observational|||Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component)|Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component)|Active, not recruiting||N/A|2682|Actual|University of Eastern Finland|||1||f||||f|f|f||||Samples With DNA|"     Blood, serum, plasma, urine, hair, nails, DNA   "|||2017-10-10 20:51:56.890871|2017-10-10 20:51:56.890871
NCT03221114|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-13|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|September 2020|Anticipated|2020-09-01||Interventional|||Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease|Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease|Not yet recruiting||N/A|126|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f|f|f||||||||2017-10-10 20:51:56.957589|2017-10-10 20:51:56.957589
NCT03221101|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-19|||December 2011|Actual|2011-12-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2013|Actual|2013-12-01||Interventional|NIVOLD||Home Non Invasive Ventilation for COPD Patients|Home Non Invasive Ventilation Versus Long Term Oxygen Therapy Alone in COPD Survivors After Acute Hypercapnic Respiratory Failure. A French Multicenter Randomized Controlled Trial|Recruiting||N/A|86|Anticipated|University Hospital, Rouen||2|||f||||t|f|f||||||||2017-10-10 20:51:57.031309|2017-10-10 20:51:57.031309
NCT03221088|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-17|||June 2015|Actual|2015-06-01|July 2017|2017-07-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature|Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Idiopathic Short Stature: A Controlled, Prospective, Randomized, Multicenter Phase-II Study With An Untreated Control Group.|Recruiting||Phase 2|360|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||3|||f||||f|f|f||||||||2017-10-10 20:51:57.1202|2017-10-10 20:51:57.1202
NCT03221075|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-13|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|July 1, 2020|Anticipated|2020-07-01|June 1, 2020|Anticipated|2020-06-01|4 Years|Observational [Patient Registry]|CLARITY||Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy|CLARITY - Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy|Recruiting||N/A|220|Anticipated|University Hospital of Cologne|||1||f||||f|f|f||||||||2017-10-10 20:51:57.222666|2017-10-10 20:51:57.222666
NCT03221062|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||"En Bloc Resection of NMIBC: a Prospective， Single Centre，Randomized Study"|Comparison of the Pathological Stage and Clinical Outcome of en Bloc Transurethral Resection by HybridKnife or Laser Versus Conventional Transurethral Resection for NMIBC: a Prospective, Single Centre, Randomized Study|Not yet recruiting||Phase 4|180|Anticipated|Tongji Hospital||3|||f|||||f|f||||||||2017-10-10 20:51:57.30466|2017-10-10 20:51:57.30466
NCT03221049|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-17|||January 1, 2011|Actual|2011-01-01|July 2017|2017-07-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|||Radiomics for Diagnosing Liver Diseases and Evaluating Progression|the Department of Medical Ultrasonics, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, China.|Recruiting||N/A|3000|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||3||f||||f||||||||||2017-10-10 20:51:57.377761|2017-10-10 20:51:57.377761
NCT03221036|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||August 2, 2017|Anticipated|2017-08-02|July 2017|2017-07-01|February 12, 2021|Anticipated|2021-02-12|October 22, 2020|Anticipated|2020-10-22||Interventional|||Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Chinese Subjects With Moderately to Severely Active Ulcerative Colitis|Not yet recruiting||Phase 3|302|Anticipated|Takeda||4|||f||||f|f|f||||||||2017-10-10 20:51:57.45572|2017-10-10 20:51:57.45572
NCT03221023|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||September 15, 2017|Anticipated|2017-09-15|July 2017|2017-07-01|December 15, 2020|Anticipated|2020-12-15|September 15, 2020|Anticipated|2020-09-15||Interventional|IV-DIRT||Intrawound Vacomycin Prophylaxis for Neural Stimulator|Intrawound Vancomycin Prophylaxis During Stimulator Re-Implantation: A Multi-Centre Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|900|Anticipated|University of British Columbia||2|||f||||f|t|f|||t|||||2017-10-10 20:51:57.635373|2017-10-10 20:51:57.635373
NCT03221010|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-16|2017-07-17|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|July 2017|Actual|2017-07-01||Interventional|MITG||Use of the Motivational Interviewing in the Treatment of Smokers in Groups in Primary Health Care|Evaluation of the Effectiveness of the Motivational Interviewing in the Cessation of Smoking in Groups in Primary Health Care Services: a Community Clinical Trial|Recruiting||N/A|600|Anticipated|Hospital Nossa Senhora da Conceicao||2|||f||||f|f|f||||||||2017-10-10 20:51:57.723875|2017-10-10 20:51:57.723875
NCT03220997|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Do Preoperative Carbohydrate Drinks Prevent Preoperative Catabolism in Mothers Undergoing Elective Caesarean Section? A Randomised Controlled Study|Do Preoperative Carbohydrate Drinks Prevent Preoperative Catabolism in Mothers Undergoing Elective Caesarean Section? A Randomised Controlled Study|Not yet recruiting||N/A|200|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||t|f|f||||||||2017-10-10 20:51:57.818392|2017-10-10 20:51:57.818392
NCT03220984|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-18|||March 16, 2017|Actual|2017-03-16|July 2017|2017-07-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||The Safety and Efficacy Test of Immuncell-LC to Treat Refractory Metastatic Colorectal Cancer|Open-label, Single Center, Phase Ⅱ Clinical Trial to Evaluate Safety and Efficacy of Immuncell-LC in the Patients for Refractory Metastatic Colorectal Cancer|Enrolling by invitation||Phase 2|28|Anticipated|Gangnam Severance Hospital||1|||f||||t|f|f||||||||2017-10-10 20:51:57.907157|2017-10-10 20:51:57.907157
NCT03220620|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-10|||July 14, 2017|Actual|2017-07-14|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Observational|||Influence of Perioperative Fluid Therapy on Hemoglobin and Methemoglobin Levels|Influence of Perioperative Fluid Therapy on Hemoglobin and Methemoglobin Levels in Major Abdominal Surgery|Recruiting||N/A|60|Anticipated|University of Rostock|||2||f||||f|f|f||||||||2017-10-10 20:52:00.752666|2017-10-10 20:52:00.752666
NCT03220971|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-13|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Lipoprotein and Apolipoproteins With Metabolic Liver Diseases|Theranostic Translation Applications Against Viral, Metabolic Liver Diseases and Hepatic Oncogenesis: Lipoprotein and Apolipoproteins at a Crossroad|Not yet recruiting||N/A|440|Anticipated|Tainan Municipal Hospital|||2||f|||||f|f||||Samples Without DNA|"     Biochemical blood: GOT, GPT, HDL, LDL, TG, insulin, AC sugar   "|||2017-10-10 20:51:57.994388|2017-10-10 20:51:57.994388
NCT03220958|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-15|||July 18, 2017|Anticipated|2017-07-18|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|||Metoclopramide for Post Traumatic Headache. An RCT|A Randomized Placebo Controlled Trial of IV Metoclopramide for Acute Post-traumatic Headache|Recruiting||Phase 3|162|Anticipated|Montefiore Medical Center||2|||f||||t|t|f|||t|||||2017-10-10 20:51:58.071306|2017-10-10 20:51:58.071306
NCT03220945|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||January 6, 2016|Actual|2016-01-06|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer|A Comprehensive Yoga Program (SKY) as an Adjunct Therapy for Prostate Cancer - A Randomized Pilot Study|Recruiting||N/A|50|Anticipated|Emory University||2|||f||||f|f|f||||||||2017-10-10 20:51:58.177886|2017-10-10 20:51:58.177886
NCT03220932|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-17|||December 31, 2017|Anticipated|2017-12-31|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|HIPOVA-01||Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer|Assessment of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer|Not yet recruiting||Phase 3|220|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 20:51:58.279747|2017-10-10 20:51:58.279747
NCT03220919|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-17|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|WEB-IT||Efﬁcacy and Safety of Weight-Based Insulin Titration Regimen in Hospitalized Patients With Type 2 Diabetes|Efﬁcacy and Safety of Weight-Based Insulin Titration (WEB-IT) Regimen Compared With Glucose Level-based Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Controlled Study|Recruiting||N/A|500|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||2|||f||||f|f|f||||||||2017-10-10 20:51:58.367684|2017-10-10 20:51:58.367684
NCT03220906|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-28|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Comparison of Blood Pressure Measurements in Upper and Lower Extremities in Children Under General Anesthesia|Comparison of Blood Pressure Measurements in Upper and Lower Extremities in Children Under General Anesthesia|Recruiting||N/A|200|Anticipated|Nationwide Children's Hospital|||1||f||||f|f|f||||||||2017-10-10 20:51:58.462683|2017-10-10 20:51:58.462683
NCT03220893|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-15|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|December 30, 2019|Anticipated|2019-12-30||Observational|MBI-DBT||Comparison of Molecular Breast Imaging and Digital Breast Tomosynthesis for Screening in Women With Dense Breasts|Comparison of Molecular Breast Imaging and Digital Breast Tomosynthesis for Screening in Women With Dense Breasts|Recruiting||N/A|3000|Anticipated|Mayo Clinic|||1||f||||f|f|f||||||||2017-10-10 20:51:58.545313|2017-10-10 20:51:58.545313
NCT03220880|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-03|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|November 1, 2018|Anticipated|2018-11-01||Observational|||Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures|Clinical Characteristics of Intranasal Dexmedetomidine for Sedation in Children Undergoing Non-painful Procedures|Not yet recruiting||N/A|2000|Anticipated|Columbia University|||1||f||||f|t|f|||f|||||2017-10-10 20:51:58.631701|2017-10-10 20:51:58.631701
NCT03220867|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-09-22|||December 11, 2017|Anticipated|2017-12-11|September 2017|2017-09-01|April 27, 2018|Anticipated|2018-04-27|April 27, 2018|Anticipated|2018-04-27||Interventional|||Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants|A Single-Dose, Randomized, Open-Label, Two-Treatment, Two-Period, Two-Cohort, Crossover Study to Assess the Bioequivalence of Xian Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Subjects Compared With Gurabo Risperdal Tablets|Not yet recruiting||Phase 1|60|Anticipated|Xian-Janssen Pharmaceutical Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:51:58.781359|2017-10-10 20:51:58.781359
NCT03220841|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|STRIDENT||Stricture Definition and Treatment (STRIDENT) Drug Therapy Study|Stricture Definition and Treatment (STRIDENT) Drug Therapy Study|Not yet recruiting||Phase 4|78|Anticipated|St Vincent's Hospital Melbourne||2|||f||||t|t|f|||f|||||2017-10-10 20:51:58.963608|2017-10-10 20:51:58.963608
NCT03220828|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-21|||May 11, 2017|Actual|2017-05-11|July 2017|2017-07-01|May 11, 2019|Anticipated|2019-05-11|May 11, 2019|Anticipated|2019-05-11||Interventional|||Evaluation of Technology-Based Stress Reduction Techniques Prior to Vascular Access|Evaluation of Technology-Based Stress Reduction Techniques Prior to Vascular Access|Recruiting||N/A|360|Anticipated|Stanford University||3|||f||||f|f|f||||||||2017-10-10 20:51:59.056194|2017-10-10 20:51:59.056194
NCT03220815|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-15|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Low Speed Drilling Versus Conventional Drilling Technique on Crestal Bone Level in Maxilla.(Group A ) A Randomized Controlled Clinical Trial|Clinical Evaluation of the Effect of Low Speed Drilling Versus Conventional Drilling Technique on Crestal Bone Level in Maxilla. A Randomized Controlled Clinical Trial|Active, not recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:51:59.154425|2017-10-10 20:51:59.154425
NCT03220074|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-30|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|June 15, 2021|Anticipated|2021-06-15|December 15, 2020|Anticipated|2020-12-15||Interventional|||Linezolid for Treatment of Nontuberculous Mycobacterial Diseases|Efficacy and Tolerability of Linezolid for Treatment of Nontuberculous Mycobacterial Diseases|Not yet recruiting||Phase 4|50|Anticipated|Mahidol University||1|||f||||f|f|f||||||||2017-10-10 20:52:04.909106|2017-10-10 20:52:04.909106
NCT03220802|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Probiotic Modulation of Intestinal Microbiota in Long-term Intake of Proton Pump Inhibitors|Probiotic Modulation of Intestinal Microbiota in Long-term Intake of Proton Pump Inhibitors: Influence on Intestinal Inflammation and Digestion|Not yet recruiting||N/A|24|Anticipated|Medical University of Graz||1|||f||||f|f|f||||||||2017-10-10 20:51:59.222463|2017-10-10 20:51:59.222463
NCT03220789|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-15|2017-07-15|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Low Speed Drilling Versus Conventional Drilling Technique on Crestal Bone Level in Maxilla.(Group C ) A Randomized Controlled Clinical Trial|Clinical Evaluation of the Effect of Low Speed Drilling Versus Conventional Drilling Technique on Crestal Bone Level in Maxilla. A Randomized Controlled Clinical Trial|Active, not recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:51:59.294354|2017-10-10 20:51:59.294354
NCT03220776|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-09|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|April 30, 2022|Anticipated|2022-04-30|February 1, 2022|Anticipated|2022-02-01||Interventional|||Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics|Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics|Recruiting||Phase 2|81|Anticipated|Medical University of South Carolina||3|||f|||||t|f||||||||2017-10-10 20:51:59.363357|2017-10-10 20:51:59.363357
NCT03220763|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Eating Away From Home and Mortality|Eating Away From Home and Subsequent Risk of All-cause Mortality in the US Population|Active, not recruiting||N/A|9107|Actual|Queens College, The City University of New York|||1||f||||f|f|f||||||||2017-10-10 20:51:59.540061|2017-10-10 20:51:59.540061
NCT03220750|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||March 28, 2017|Actual|2017-03-28|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|UNIHOPE||University Hospital Advanced Age Pregnant Cohort|University Hospital Advanced Age Pregnant Cohort|Recruiting||N/A|22000|Anticipated|Peking University|||1||f||||t|f|f||||||||2017-10-10 20:51:59.605242|2017-10-10 20:51:59.605242
NCT03220724|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-18|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evaluating the Safety and Immunogenicity of EnvSeq-1 Envs Adjuvanted With GLA-SE, Administered Alone or With DNA Mosaic-Tre Env, in Healthy, HIV-Uninfected Adults|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of EnvSeq-1 Envs Adjuvanted With GLA-SE, Administered Alone or With DNA Mosaic-Tre Env, in Healthy, HIV-Uninfected Adult Participants|Recruiting||Phase 1|132|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||9|||f||||t|t|f||||||||2017-10-10 20:51:59.849285|2017-10-10 20:51:59.849285
NCT03220711|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-11|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon|Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon|Recruiting||Phase 1|25|Anticipated|University of Michigan||1|||f||||t|f|f||||||||2017-10-10 20:52:00.135989|2017-10-10 20:52:00.135989
NCT03220698|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Utility of Tracheal Ultrasonography for the Confirmation of the Endotracheal Tube Placement|Utility of Tracheal Ultrasonography for the Confirmation of Endotracheal Tube Placement During Intubation: A Diagnostic Accuracy Study|Completed||N/A|360|Actual|Marmara University|||1||f||||f|f|f||||||||2017-10-10 20:52:00.223758|2017-10-10 20:52:00.223758
NCT03220685|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-17|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Relationship Between Gut Microbiota And Anemia In Chronic Kidney Disease (CKD) Patients|Relationship Between Gut Microbiota And Anemia In Chronic Kidney Disease (CKD) Patients|Not yet recruiting||N/A|100|Anticipated|Assiut University|||3||f||||t|f|f||||||||2017-10-10 20:52:00.28982|2017-10-10 20:52:00.28982
NCT03220672|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-17|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|July 1, 2017|Actual|2017-07-01|June 1, 2017|Actual|2017-06-01||Interventional|MENO_edu||Effectiveness of Assessment and Educational Intervention on Motor Control of the Pelvic Floor Muscle in Women|Effectiveness of a Tailored Assessment and Educational Intervention on Motor Control of the Pelvic Floor Muscle in Menopausal and Peri-menopausal Women|Completed||N/A|120|Actual|University of Malaga||1|||f||||t|f|f||||||||2017-10-10 20:52:00.364332|2017-10-10 20:52:00.364332
NCT03220659|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-17|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|OPT-MPP||Optimising Pacemaker Therapy Using Multi-point Pacing (the OPT-MPP Study)|Optimising Pacemaker Therapy Using Multi-point Pacing (the OPT-MPP Study)|Not yet recruiting||N/A|50|Anticipated|University of Leeds||2|||f||||f|f|f|||f|||||2017-10-10 20:52:00.452253|2017-10-10 20:52:00.452253
NCT03220646|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-07|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||The Purpose of This Study is to Test Any Good and Bad Effects of a Study Drug Called Abemaciclib (LY2835219) in Patients With Recurrent Brain Tumors.|A Phase 2 Study of Abemaciclib in Patients With Recurrent Brain Tumors|Recruiting||Phase 2|78|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f|||||t|f||||||||2017-10-10 20:52:00.548217|2017-10-10 20:52:00.548217
NCT03220633|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-07-17|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects|A Double-Blind, Placebo-Controlled, Phase I Study To Assess Safety, Tolerability And Pharmacokinetics Of Single/Multiple Ascending Doses Of ATB-346 Orally Administrated In Healthy Male And Female Subjects|Completed||Phase 1|84|Actual|Antibe Therapeutics Inc.||2|||f||||t||||||||||2017-10-10 20:52:00.661086|2017-10-10 20:52:00.661086
NCT03215186|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-09|||February 1, 2011|Actual|2011-02-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|February 28, 2018|Anticipated|2018-02-28||Observational|||Non-genetic Risk Factors of Congenital Cataracts|Establishment of the Mathematic Model of Non-genetic Risk Factors of Congenital Cataracts|Recruiting||N/A|2000|Anticipated|Sun Yat-sen University|||2||f||||t||||||||||2017-10-10 20:52:48.095328|2017-10-10 20:52:48.095328
NCT03220607|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-09-02|||October 15, 2016|Actual|2016-10-15|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|August 30, 2017|Actual|2017-08-30|4 Days|Observational [Patient Registry]|||Uterocervical Angle in the Termination of Second Trimester Pregnancy|The Predictive Performance of Uterocervical Angle in the Termination of Second Trimester Pregnancy|Completed||N/A|120|Actual|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||f|f|f||||||||2017-10-10 20:52:00.850147|2017-10-10 20:52:00.850147
NCT03220594|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-09-29|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|September 29, 2017|Actual|2017-09-29|September 20, 2017|Actual|2017-09-20|6 Months|Observational [Patient Registry]|||Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation|Serum Antimullerian Hormone Levels in Patients Who Underwent Hypogastric Artery Ligation|Completed||N/A|90|Actual|Kanuni Sultan Suleyman Training and Research Hospital|||3||f||||f|f|f||||||||2017-10-10 20:52:00.932868|2017-10-10 20:52:00.932868
NCT03220581|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Psychotherapy Development Study for Internet Gaming|A Psychotherapy Development Study for a New Addictive Disorder|Not yet recruiting||N/A|60|Anticipated|UConn Health||2|||f||||t|f|f||||||||2017-10-10 20:52:01.04494|2017-10-10 20:52:01.04494
NCT03220568|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||November 24, 1993|Actual|1993-11-24|July 2017|2017-07-01|November 30, 2009|Actual|2009-11-30|November 30, 2009|Actual|2009-11-30||Observational|||Adipose Tissue Content of Fatty Acids Present in Dairy Fat and Risk of Stroke. The Danish Diet, Cancer and Health Cohort|Adipose Tissue Content of Fatty Acids Present in Dairy Fat and Risk of Stroke. The Danish Diet, Cancer and Health Cohort|Completed||N/A|57053|Actual|University of Aarhus|||1||f||||f|f|f||||Samples With DNA|"     Subcutaneous adipose tissue   "|||2017-10-10 20:52:01.145835|2017-10-10 20:52:01.145835
NCT03220555|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|DOLVAX||Efficacy of the Buzzy® Device on the Prevention of Health Care Induced Pediatric Pain in a Vaccination Center|Efficacy of a Cold, Vibration, and Distraction Based Medical Device on the Prevention of Health Care Induced Pediatric Pain: a Comparative, Controlled, Randomized and Multicentric Study|Not yet recruiting||N/A|220|Anticipated|Nantes University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:52:01.208211|2017-10-10 20:52:01.208211
NCT03220542|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-17|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori|The Effect of Broccoli Sprout Extract and Probiotics on Proton Pump Inhibitor-based Triple Therapy for Eradication of Helicobacter Pylori: a Prospective Randomized Trial|Recruiting||Phase 4|360|Anticipated|Kyunghee University Medical Center||3|||f||||f||||||||||2017-10-10 20:52:01.29545|2017-10-10 20:52:01.29545
NCT03220529|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-07-16|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Test the Potential of Brillouin Microscopy for Biomechanical Properties Measurements in Human Cornea|A Study to Test the Potential of Brillouin Microscopy for Biomechanical Properties Measurements in Human Cornea|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital||5|||f|||||f|f||||||||2017-10-10 20:52:01.406628|2017-10-10 20:52:01.406628
NCT03220516|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-16|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Single-use Digital Flexible Ureteroscope vs Nondisposable Fiber Optic vs Digital Ureteroscope|A Prospective Randomized Study Comparing Single-use Digital Flexible Ureteroscope, Nondisposable Fiber Optic and Digital Ureteroscope in Treatment of Upper Urinary Stone Less Than 2 cm|Not yet recruiting||N/A|450|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||3|||f|||||f|f||||||||2017-10-10 20:52:01.497051|2017-10-10 20:52:01.497051
NCT03220503|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-16|||March 8, 2017|Actual|2017-03-08|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|September 9, 2017|Anticipated|2017-09-09||Interventional|||Effect of Endometrial Injury Before Frozen Embryo Transfer on Pregnancy Rate|Effect of Endometrial Injury Before Frozen Embryo Transfer on Pregnancy Rate|Recruiting||Phase 4|50|Anticipated|Ain Shams Maternity Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:52:01.582816|2017-10-10 20:52:01.582816
NCT03220490|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-15|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops|Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops|Not yet recruiting||N/A|65|Anticipated|Sheba Medical Center||4|||f||||f|f|f||||||||2017-10-10 20:52:01.67315|2017-10-10 20:52:01.67315
NCT03220477|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-08-08|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.|Phase I/Ib Study of Combined Pembrolizumab Plus Guadecitabine and Mocetinostat for Patients With Advanced NSCLC (DOSE SELECTION)|Recruiting||Phase 1|57|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:52:01.763916|2017-10-10 20:52:01.763916
NCT03220464|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-07-18|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT|Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT to Predict Progression to Active Tuberculosis Among Contacts|Recruiting||N/A|116|Anticipated|Seoul National University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:52:01.868824|2017-10-10 20:52:01.868824
NCT03220451|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-27|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients|"Pilot Study on the Use of Adhesive Elastic Taping as add-on Treatment for the Therapy of Medium/Severe Grade Pressure Ulcers in Spinal Cord Injured Patients"|Recruiting||N/A|24|Anticipated|Montecatone Rehabilitation Institute S.p.A.||1|||f||||f|f|f||||||||2017-10-10 20:52:01.976806|2017-10-10 20:52:01.976806
NCT03220425|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-17|||February 1, 2001|Actual|2001-02-01|July 2017|2017-07-01|November 12, 2001|Actual|2001-11-12|November 12, 2001|Actual|2001-11-12||Interventional|||Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.|A Six Month, Multi-centre, Open-label, Parallel Efficacy and Safety Comparison of Insulin Detemir and NPH Insulin in Subjects With Type 1 Diabetes on a Basal-bolus Regimen.|Completed||Phase 3|752|Actual|Novo Nordisk A/S||2|||f||||f|t|f|||t|||||2017-10-10 20:52:02.205637|2017-10-10 20:52:02.205637
NCT03220412|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-17|||July 15, 2015|Actual|2015-07-15|July 2017|2017-07-01|January 1, 2016|Actual|2016-01-01|January 1, 2016|Actual|2016-01-01||Interventional|||Media Violence and Gun Violence - Experiment 3|Exposure to Gun Violence in Movies Increases Interest in Real Guns|Completed||N/A|104|Actual|Ohio State University||2|||f||||f|f|f||||||||2017-10-10 20:52:02.439276|2017-10-10 20:52:02.439276
NCT03220399|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-06|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1603-1 and NVP-1603-2|Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1603-1 and NVP-1603-2 in Healthy Male Volunteers|Not yet recruiting||Phase 1|30|Anticipated|Navipharm Corporation||3|||f||||f|f|f||||||||2017-10-10 20:52:02.496034|2017-10-10 20:52:02.496034
NCT03220386|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-17|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|EPICS-6||Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making|Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making|Recruiting||N/A|1000|Anticipated|Charite University, Berlin, Germany||1|||f||||f|f|f||||||||2017-10-10 20:52:02.561822|2017-10-10 20:52:02.561822
NCT03220373|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-07-31|||March 7, 2017|Actual|2017-03-07|July 2017|2017-07-01|December 31, 2029|Anticipated|2029-12-31|December 31, 2029|Anticipated|2029-12-31|1 Year|Observational [Patient Registry]|||Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients|Predicting Early Treatment Termination (Dropout) and Post-treatment Clinical Outcome From Neuropsychological Functions in Abstinent Substance Use Dependent (SUD) Patients|Recruiting||N/A|200|Anticipated|Oslo University Hospital|||1||f|||||f|f||||||||2017-10-10 20:52:02.642696|2017-10-10 20:52:02.642696
NCT03220360|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||June 1, 2016|Actual|2016-06-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Application of Different Biomaterials in the Preservation of Vital Pulp in Carious Deciduous Teeth|Application of Different Biomaterials in the Preservation of Vital Pulp in Carious Deciduous Teeth: a Prospective, Single-center, Randomized, Controlled Clinical Trial|Active, not recruiting||N/A|165|Actual|Chengdu Maternal and Children's Health Care Hospital||3|||f||||t|f|f||||||||2017-10-10 20:52:02.704776|2017-10-10 20:52:02.704776
NCT03220347|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-09-28|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|April 15, 2022|Anticipated|2022-04-15|May 13, 2020|Anticipated|2020-05-13||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas|A Phase 1, Open-label, Dose-finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas|Recruiting||Phase 1|115|Anticipated|Celgene||1|||f||||f|t|f|||t|||||2017-10-10 20:52:02.764392|2017-10-10 20:52:02.764392
NCT03220334|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-23|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Healing Effects of Autologous Platelet Rich Plasma on Gastric Ulcer Caused by Endoscopic Submucosal Dissection|Healing Effects of Autologous Platelet Rich Plasma on Gastric Ulcer Caused by Endoscopic Submucosal Dissection|Recruiting||Phase 3|10|Anticipated|Keimyung University Dongsan Medical Center||2|||f|||||f|f||||||||2017-10-10 20:52:02.853546|2017-10-10 20:52:02.853546
NCT03220321|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pink and White Esthetic Scores of Polymer-infiltrated-ceramic-network and Lithium Disilicate Implant Hybrid Abutment Crowns|Pink and White Esthetic Scores of Polymer-infiltrated-ceramic-network and Lithium Disilicate Implant Hybrid Abutment Crowns: Randomized Clinical Trial|Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:52:02.927024|2017-10-10 20:52:02.927024
NCT03220308|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-04|||February 18, 2016|Actual|2016-02-18|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|MindChamp||Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting|Mindfulness Training for Children With ADHD and Mindful Parenting|Recruiting||N/A|100|Anticipated|Karakter Kinder- en Jeugdpsychiatrie||2|||f||||t|f|f||||||||2017-10-10 20:52:03.153695|2017-10-10 20:52:03.153695
NCT03220295|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-07|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Putative Cognitive Enhancer VU319|Study of the M1 Positive Allosteric Modulator VU0467319|Recruiting||Phase 1|52|Anticipated|Vanderbilt University Medical Center||14|||||||t|t|f||||||||2017-10-10 20:52:03.297933|2017-10-10 20:52:03.297933
NCT03220282|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-25|||July 24, 2017|Anticipated|2017-07-24|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|December 30, 2017|Anticipated|2017-12-30||Interventional|MGM||The Milk, Growth and Microbiota Study|Milk, Growth and Microbiota: A Randomized, Controlled Trial (RCT) of Donor Milk vs. Formula to Supplement Breastfeeding Late Preterm Newborns|Recruiting||N/A|48|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||||2017-10-10 20:52:03.443224|2017-10-10 20:52:03.443224
NCT03220269|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-13|||October 1, 2014|Actual|2014-10-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30|6 Months|Observational [Patient Registry]|RIAC||RIAC - Registro Italiano Arresti Cardiaci (Italian Registry of Cardiac Arrest)|RIAC - Registro Italiano Arresti Cardiaci. An Observational, Prospective, Multi-centre, Study of Epidemiology, Treatment, and Outcome of Cardiac Arrest|Recruiting||N/A|8000|Anticipated|Italian Resuscitation Council|||2||f||||f|f|f||||||||2017-10-10 20:52:03.556254|2017-10-10 20:52:03.556254
NCT03220256|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-14|||August 2, 2016|Actual|2016-08-02|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients|Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients: A Pilot Study|Recruiting||Phase 2|30|Anticipated|Seoul National University Hospital||1|||f||||t|f|f|||f|||||2017-10-10 20:52:03.663688|2017-10-10 20:52:03.663688
NCT03220230|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-05|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|November 1, 2018|Anticipated|2018-11-01||Observational|NIRVANA||Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.|Non-interventional Multi-center Study For Molecular Diagnostic Technologies Validation In Nsclc Patients Protocol N° X9001083|Recruiting||N/A|6000|Anticipated|Pfizer|||1||f||||f|f|||||Samples With DNA|"     tumor tissue whole blood   "|||2017-10-10 20:52:03.840529|2017-10-10 20:52:03.840529
NCT03220217|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-29|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)|A Multicentre, Randomised, Dose-confirmation, Factorial Phase II Study to Evaluate the Optimal Dose of 68Ga-OPS202 as a PET Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)|Recruiting||Phase 2|25|Anticipated|Ipsen||3|||f|||||t|f||||||||2017-10-10 20:52:03.945554|2017-10-10 20:52:03.945554
NCT03220204|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-10-02|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|REACH III||Researching Emotions And Cardiac Health: Phase III|A Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: a Randomized, Controlled Pilot Trial|Recruiting||N/A|75|Anticipated|Massachusetts General Hospital||3|||f||||t|f|f||||||||2017-10-10 20:52:04.026454|2017-10-10 20:52:04.026454
NCT03220178|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-14|||July 18, 2017|Anticipated|2017-07-18|July 2017|2017-07-01|December 31, 2023|Anticipated|2023-12-31|June 30, 2021|Anticipated|2021-06-30||Interventional|PRECYCLE||Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy|PRECYCLE: Multicenter, Randomized Phase IV Intergroup Trial to Evaluate the Impact of eHealth-based Patient Reported Outcome (PRO) Assessment on Quality of Life in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib and an Aromatase Inhibitor- or Palbociclib and Fulvestrant|Not yet recruiting||Phase 4|960|Anticipated|Palleos Healthcare GmbH||2|||f||||t|f|f||||||||2017-10-10 20:52:04.201134|2017-10-10 20:52:04.201134
NCT03220165|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-09-27|||August 6, 2017|Actual|2017-08-06|September 2017|2017-09-01|September 3, 2017|Actual|2017-09-03|September 3, 2017|Actual|2017-09-03||Interventional|||Radiolabeled Study to Determine the Mass Balance of [14C] MGL-3196|An Open-Label, Single-Radiolabeled Dose, Non-Randomized Study to Determine the Mass Balance of [14C] MGL-3196|Completed||Phase 1|8|Anticipated|Madrigal Pharmaceuticals, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:52:04.340935|2017-10-10 20:52:04.340935
NCT03220152|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-14|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|PrEParadas||Implementation of PrEP to HIV in Brazilian Transgender Women|Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV in Brazilian Transgender Women|Not yet recruiting||Phase 4|120|Anticipated|Oswaldo Cruz Foundation||1|||f||||f|f|f||||||||2017-10-10 20:52:04.417338|2017-10-10 20:52:04.417338
NCT03220139|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-17|||January 1, 1999|Actual|1999-01-01|July 2017|2017-07-01|January 1, 2017|Actual|2017-01-01|January 1, 2011|Actual|2011-01-01|6 Years|Observational [Patient Registry]|||Type of Dietary Fat Intakes in Relation to Mortality in US Adults: An Iso-caloric Substitution Analysis From the American National Health and Nutrition Examination Survey Linked to the US Mortality Registry|Type of Dietary Fat Intakes in Relation to Mortality in US Adults: An Iso-caloric Substitution Analysis From the American National Health and Nutrition Examination Survey Linked to the US Mortality Registry|Completed||N/A|18372|Actual|North-West University, South Africa|||1||f|||||f|f||||||||2017-10-10 20:52:04.485172|2017-10-10 20:52:04.485172
NCT03220126|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-10-02|||July 17, 2017|Actual|2017-07-17|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants|An Assessment of the Absolute and Relative Bioavailability of Subcutaneous Doses of LY3074828 When Coadministered With LY9999QS to Healthy Subjects|Recruiting||Phase 1|72|Anticipated|Eli Lilly and Company||4|||f||||f|t|f|||t|||||2017-10-10 20:52:04.540173|2017-10-10 20:52:04.540173
NCT03220113|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-18|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|Migraine||Treatment of Chronic Migraine Headaches.|Safety and Efficacy of De-Novo Algorithm and Formula in the Treatment of Patients With Intractable Chronic Craniofacial Neuralgia, or Chronic Migraine Headaches.|Recruiting||Phase 1/Phase 2|100|Anticipated|Corona Doctors Medical Clinics, Inc.||1|||f|||||t|f||||||||2017-10-10 20:52:04.619471|2017-10-10 20:52:04.619471
NCT03220100|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-14|||July 31, 2017|Anticipated|2017-07-31|July 2017|2017-07-01|July 31, 2023|Anticipated|2023-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Study of Stepped Palliative Care in Patients With Advanced Lung Cancer DF/HCC SOCIAL-BEHAVIORAL RESERACH PROTOCOL|Pilot Study of Stepped Palliative Care in Patients With Advanced Lung Cancer DF/HCC SOCIAL-BEHAVIORAL RESERACH PROTOCOL|Not yet recruiting||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||||2017-10-10 20:52:04.738412|2017-10-10 20:52:04.738412
NCT03220087|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-28|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|RECOSY||Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain|Study to Evaluate the Use of Resources and the Costs Associated With Controlled or Uncontrolled Carcinoid Syndrome in Patients With Neuroendocrine Tumours (NETs) in Spain|Recruiting||N/A|130|Anticipated|Ipsen|||2||f||||f||||||||||2017-10-10 20:52:04.826827|2017-10-10 20:52:04.826827
NCT03220061|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-14|||December 12, 2016|Actual|2016-12-12|July 2017|2017-07-01|December 12, 2016|Actual|2016-12-12|December 12, 2016|Actual|2016-12-12||Interventional|||Effectiveness of Music Therapy on Blood Pressure and Anxiety Among Patients Undergoing Haemodialysis|Effectiveness of Music Therapy on Blood Pressure and Anxiety Among Patients Undergoing Haemodialysis|Completed||N/A|60|Actual|Maharishi Markendeswar University||2|||f||||t|f|f||||||||2017-10-10 20:52:05.010597|2017-10-10 20:52:05.010597
NCT03220048|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-14|||September 16, 2015|Actual|2015-09-16|July 2017|2017-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study Examining PrEP-001 in Healthy Subjects|A Phase II, Repeated Dose, Double-Blinded, Randomised, Controlled Study to Examine the Prophylactic Efficacy, Safety and Tolerability of PrEP-001 in Healthy Subjects Subsequently Challenged With Influenza A/Perth/16/2009 (H3N2) Virus|Completed||Phase 2|63|Actual|Hvivo||2|||f||||f||||||||||2017-10-10 20:52:05.090766|2017-10-10 20:52:05.090766
NCT03220022|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-04|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas|Phase I and Dose-Expansion Study of Ibrutinib and R-da-EPOCH for Front Line Treatment of AIDS-Related Lymphomas|Not yet recruiting||Phase 1|54|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 20:52:05.404112|2017-10-10 20:52:05.404112
NCT03220009|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-17|2017-09-04|||November 3, 2017|Anticipated|2017-11-03|July 2017|2017-07-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma|A Randomized Phase II Trial of Adjuvant Nivolumab or Expectant Observation Following Neoadjuvant Ipilimumab Plus Nivolumab and Surgical Resection of High-Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma|Not yet recruiting||Phase 2|100|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 20:52:05.660922|2017-10-10 20:52:05.660922
NCT03219996|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-14|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Observational|||Risk Factors for Predictors of In-hospital Death in Acute Fulminant Myocarditis|Risk Factors Influenced Prognosis of Acute Fulminant Myocarditis by Analyzing Clinical Characteristics and Complications, Laboratory Findings, Treatments, and Electrocardiographic and Echocardiographic Data.|Completed||N/A|76|Actual|The First Affiliated Hospital of Soochow University|||2||f||||t|f|f||||||||2017-10-10 20:52:05.863699|2017-10-10 20:52:05.863699
NCT03219983|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-07-14|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|||Pain Management After Total Shoulder Arthroplasty|Pain Management After Total Shoulder Arthroplasty: Continuous Interscalene Block Versus Local Tissue Infiltration With Liposomal Bupivacaine|Recruiting||Phase 4|80|Anticipated|The Christ Hospital||2|||f||||f|t|f||||||||2017-10-10 20:52:05.926499|2017-10-10 20:52:05.926499
NCT03219970|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||October 31, 2017|Anticipated|2017-10-31|July 2017|2017-07-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Observational|||Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting|An Observational, Non-interventional, Multi-center, Chart Review Study Conducted Among Patients Enrolled in an AZD9291 Early Access Program in Hong Kong, With Locally Advanced/Metastatic EGFR T790M Mutation-positive NSCLC and Prior Exposure to EGFR TKI Therapy|Not yet recruiting||N/A|250|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-10 20:52:06.01668|2017-10-10 20:52:06.01668
NCT03219957|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-18|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of AT-527 in Healthy and HCV-Infected Subjects|A Phase I Study Assessing Single and Multiple Doses of AT-527 in Healthy and HCV-Infected Subjects|Recruiting||Phase 1|88|Anticipated|Atea Pharmaceuticals, Inc.||2|||f|||||f|f||||||||2017-10-10 20:52:06.103083|2017-10-10 20:52:06.103083
NCT03219944|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-17|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation|Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation Around Implant in the Aesthetic Zone: A Randomized Control Clinical Trial|Not yet recruiting||N/A|16|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:52:06.182189|2017-10-10 20:52:06.182189
NCT03219931|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||October 1, 2013|Actual|2013-10-01|July 2017|2017-07-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|NEOBIFI||NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants|Effects of an Association of the Two Bifidobacteria Probiotics Bifidobacterium Breve B632 and Bifidobacterium Breve BR03 in Intestinal Bacterial Colonization and in the Prevention and/or Reduction of the Incidence of Colics in Infants|Recruiting||Phase 4|320|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita||4|||f||||t|f|f||||||||2017-10-10 20:52:06.258463|2017-10-10 20:52:06.258463
NCT03219918|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-13|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Adenoma Detection Rate in Colonoscopy Performed With EndoRings|Adenoma Detection Rate in Colonoscopy Performed With EndoRings - a Single-centre Prospective Randomised Clinical Trial|Enrolling by invitation||N/A|400|Anticipated|Zealand University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:52:06.345739|2017-10-10 20:52:06.345739
NCT03219905|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||April 2014|Actual|2014-04-01|July 2017|2017-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||"Does Kinesio-taping Affect Balance in Healthy Individuals?"|"Does Kinesio-taping Affect Standing Balance in Healthy Individuals? A Randomized Controlled Pilot Trial"|Completed||N/A|24|Actual|Ankara University||2|||f||||f|f|f||||||||2017-10-10 20:52:06.409366|2017-10-10 20:52:06.409366
NCT03219892|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-13|||December 1, 2016|Actual|2016-12-01|July 2017|2017-07-01|June 1, 2019|Anticipated|2019-06-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||rTMS for the Treatment of Freezing of Gait in Parkinson's Disease|Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Freezing of Gait in Parkinson's Disease|Recruiting||N/A|30|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t|f|f||||||||2017-10-10 20:52:06.472135|2017-10-10 20:52:06.472135
NCT03219879|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|NaTel||Telephone-administered Relapse Prevention for Depression|Telephone-administered Cognitive-behavioral Relapse Prevention for Patients With Chronic and Recurrent Depression: A Multi-center Randomized Clinical Trial|Recruiting||N/A|218|Anticipated|University of Zurich||2|||f||||t|f|f||||||||2017-10-10 20:52:06.554152|2017-10-10 20:52:06.554152
NCT03219866|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Nebulizer Versus Dry Powdered Inhalers for COPD|Preliminary Study for Comparison of Triple Therapy Nebulizer Versus Dry Powdered Inhaler for Care Transitions in COPD|Not yet recruiting||Phase 4|100|Anticipated|Wake Forest University Health Sciences||2|||f||||f|t|t|f|f|f|||||2017-10-10 20:52:06.65353|2017-10-10 20:52:06.65353
NCT03219853|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-13|||March 22, 2017|Actual|2017-03-22|July 2017|2017-07-01|December 14, 2017|Anticipated|2017-12-14|December 14, 2017|Anticipated|2017-12-14||Interventional|||Investigating the Sensory Effects of Selenium-enriched Parsnips.|Investigating Flavour-nutrient Learning in Humans Using Selenium-enriched Parsnips|Recruiting||N/A|52|Anticipated|Newcastle University||2|||f||||f|f|f||||||||2017-10-10 20:52:06.908008|2017-10-10 20:52:06.908008
NCT03219840|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis|Effects of Cetylpyridium Chloride (CPC) Based Chewing Gum Plus Tooth Brushing on Plaque Formation and Gingivitis: a Randomized, Double-Blind, Crossover, Placebo-controlled Clinical Trial|Not yet recruiting||N/A|73|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|f|||f|||||2017-10-10 20:52:07.028763|2017-10-10 20:52:07.028763
NCT03219827|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-18|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|July 29, 2020|Anticipated|2020-07-29|July 29, 2019|Anticipated|2019-07-29||Interventional|WasPenIP||Pilot Study: Characterization of the Immune Phenotype of Patients Allergic to Wasp Venom or Penicillin|Pilot Study: Characterization of the Immune Phenotype of Patients Allergic to Wasp Venom or Penicillin|Recruiting||N/A|63|Anticipated|Institut Pasteur||2|||f||||f|f|f||||||||2017-10-10 20:52:07.135172|2017-10-10 20:52:07.135172
NCT03219814|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-13|||May 19, 2017|Actual|2017-05-19|July 2017|2017-07-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Cognitive Dissonance and Attentional Biases Related to Body Dissatisfaction|Does a Cognitive Dissonance-Based Eating Disorder Prevention Intervention Reduce Attentional Biases in Body-Dissatisfied Women?|Recruiting||N/A|228|Anticipated|University of Calgary||4|||f||||f|f|f||||||||2017-10-10 20:52:07.240281|2017-10-10 20:52:07.240281
NCT03219801|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-13|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus|Evaluation of Safety and Efficacy in Patients With Systemic Lupus Erythematosus by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells|Not yet recruiting||Early Phase 1|10|Anticipated|Hebei Medical University||1|||f||||f|f|f||||||||2017-10-10 20:52:07.37619|2017-10-10 20:52:07.37619
NCT03219788|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-14|||July 20, 2017|Anticipated|2017-07-20|July 2017|2017-07-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Remifentanil and Desflurane Inhalational Anesthesia in Bariatric Surgeries|The Recovery Profile of Different Doses of Remifentanil After Desflurane Inhalational Anesthesia for Bariatric Surgeries: Two Centers Controlled Prospective Study|Not yet recruiting||Phase 2|120|Anticipated|Assiut University||3|||f||||t|f|f||||||||2017-10-10 20:52:07.47605|2017-10-10 20:52:07.47605
NCT03219775|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-08|||July 6, 2017|Actual|2017-07-06|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TITAN-TCC||Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma|A Phase II Single Arm Clinical Trial of a Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma|Recruiting||Phase 2|250|Anticipated|AIO-Studien-gGmbH||1|||f||||t|f|f||||||||2017-10-10 20:52:07.573472|2017-10-10 20:52:07.573472
NCT03219762|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-24|||February 7, 2017|Actual|2017-02-07|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|Nabster||Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC|Phase II Study of Nab-paclitaxel in Sensitive and Refractory Relapsed Small Cell Lung Cancer (Nabster Study)|Recruiting||Phase 2|65|Anticipated|Gruppo Oncologico Italiano di Ricerca Clinica||1|||f||||t|t|f|||t|||||2017-10-10 20:52:07.703591|2017-10-10 20:52:07.703591
NCT03219749|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-13|||January 15, 2017|Actual|2017-01-15|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|April 1, 2019|Anticipated|2019-04-01||Interventional|||Sleep Apnea, Cardiovascular and Exercise Study|Examining the Effects of Exercise on Vascular Function in Obstructive Sleep Apnea|Recruiting||N/A|60|Anticipated|Towson University||1|||f||||f|f|f||||||||2017-10-10 20:52:07.908238|2017-10-10 20:52:07.908238
NCT03219736|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-07-13|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 1, 2020|Anticipated|2020-12-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||NiPPV in the Treatment of Acute Asthma Exacerbations|A Randomized Controlled Trial of Non-Invasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations|Active, not recruiting||N/A|240|Anticipated|Arkansas Children's Hospital Research Institute||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:52:08.000636|2017-10-10 20:52:08.000636
NCT03219723|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-13|||September 1, 2015|Actual|2015-09-01|July 2017|2017-07-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Observational|||"Drug Use Surveillance of Takecab for Supplement to Helicobacter Pylori Eradication"|"Drug Use Surveillance of Takecab Tablets Supplement to Helicobacter Pylori Eradication"|Completed||N/A|500|Actual|Takeda|||1||f||||f|f|f||||||||2017-10-10 20:52:08.098486|2017-10-10 20:52:08.098486
NCT03219528|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing|A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing|Not yet recruiting||Phase 4|42|Anticipated|University of Michigan||2|||f||||f|t|f|||t|||||2017-10-10 20:52:09.304302|2017-10-10 20:52:09.304302
NCT03219710|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-19|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||"Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)"|"Olanzapine for Prevention of Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC): An Investigator Initiated, Randomized, Open-label Trial"|Not yet recruiting||Phase 3|240|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f|t|f|||f|||||2017-10-10 20:52:08.187874|2017-10-10 20:52:08.187874
NCT03219697|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-13|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|August 1, 2019|Anticipated|2019-08-01||Interventional|PARENT||Preventing and Addressing At-obesity-Risk Early Years iNtervention With Home Visits in Toronto (PARENT): A Pragmatic RCT|Preventing and Addressing At-obesity-Risk Early Years iNtervention With Home Visits in Toronto (PARENT): A Pragmatic RCT|Not yet recruiting||N/A|120|Anticipated|The Hospital for Sick Children||2|||f||||f|f|f||||||||2017-10-10 20:52:08.282055|2017-10-10 20:52:08.282055
NCT03219684|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-13|||April 1, 2018|Anticipated|2018-04-01|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|April 1, 2019|Anticipated|2019-04-01||Observational|||Cyclosporin A Therapy in Childhood Nephrotic Syndrome|A Descriptive Study on the Effectiveness and Safety of Cyclosporin A Therapy in Steroid Dependent and Steroid Resistant Childhood Nephrotic Syndrome|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||f|f|||||||||2017-10-10 20:52:08.357252|2017-10-10 20:52:08.357252
NCT03219671|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-28|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)|A Phase 2 Study of Nivolumab Plus Ipilimumab in Previously Treated Classical Kaposi Sarcoma (CKS)|Not yet recruiting||Phase 2|20|Anticipated|Rabin Medical Center||1|||f||||f|f|f|||t|||||2017-10-10 20:52:08.426447|2017-10-10 20:52:08.426447
NCT03219658|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-14|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|August 1, 2019|Anticipated|2019-08-01||Interventional|STOMP||STOMP Early Years: A Pilot RCT of an Intensive, Family-Centred, Home Visiting Intervention for Young Children With Severe Obesity|STOMP Early Years: A Pilot Randomized Controlled Trial of an Intensive, Family-Centred, Home Visiting Intervention for Young Children With Severe Obesity|Not yet recruiting||N/A|42|Anticipated|The Hospital for Sick Children||2|||f||||f|f|f||||||||2017-10-10 20:52:08.511405|2017-10-10 20:52:08.511405
NCT03219645|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-13|||July 15, 2017|Anticipated|2017-07-15|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|GDPRS||Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke|A Randomized, Active-Controlled，Blinded-Endpoint and Parallel Group Pilot Trial Comparing the Antiplatelet Effects of Ginkgo Diterpene Lactone Meglumine Injection Plus Aspirin Versus Aspirin Alone in Patients With Acute Ischemic Stroke|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|RenJi Hospital||2|||f||||t|f|f||||||||2017-10-10 20:52:08.584133|2017-10-10 20:52:08.584133
NCT03219632|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-14|||June 5, 2012|Actual|2012-06-05|July 2017|2017-07-01|May 30, 2017|Actual|2017-05-30|April 30, 2017|Actual|2017-04-30|1 Year|Observational [Patient Registry]|||Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG|Angiotensin Blocking Effect of Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG: a Prospective, Multicenter, Observational Registry|Completed||N/A|72|Actual|Seoul National University Bundang Hospital|||1||f||||t|f|f||||||||2017-10-10 20:52:08.680491|2017-10-10 20:52:08.680491
NCT03219619|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-18|||July 13, 2017|Actual|2017-07-13|July 2017|2017-07-01|January 20, 2018|Anticipated|2018-01-20|January 20, 2018|Anticipated|2018-01-20||Interventional|||Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla|Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla: a Randomized Non-inferiority Trial|Recruiting||N/A|150|Anticipated|Fourth Military Medical University||2|||f||||t|f|f||||||||2017-10-10 20:52:08.752454|2017-10-10 20:52:08.752454
NCT03219606|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-13|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|October 31, 2017|Anticipated|2017-10-31||Interventional|||Impact of Education and Training of Modified Rodnan Skin Scoring on the Reliability of Test|Impact of Education and Training of Modified Rodnan Skin Scoring on the Reliability of Test|Recruiting||N/A|10|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||||2017-10-10 20:52:08.84654|2017-10-10 20:52:08.84654
NCT03219593|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-07|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|||Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer|A Prospective Study of the Efficacy and Safety of Apatinib Monotherapy as First-Line Treatment in Elderly Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma|Recruiting||Phase 2|30|Anticipated|First Affiliated Hospital Bengbu Medical College||1|||f||||t|f|f||||||||2017-10-10 20:52:08.943433|2017-10-10 20:52:08.943433
NCT03219580|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-18|||May 20, 2017|Actual|2017-05-20|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|April 30, 2018|Anticipated|2018-04-30||Interventional|||The Role of 5-Fluorouracil in Post-Operative Scar Formation Following Direct Brow Ptosis Repair|The Role of 5-Fluorouracil in Post-Operative Scar Formation Following Direct Brow Ptosis Repair|Enrolling by invitation||Phase 3|50|Anticipated|Eyelid and Facial Consultants||2|||f||||f|t|f|||f|||||2017-10-10 20:52:09.033588|2017-10-10 20:52:09.033588
NCT03219567|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||October 9, 2014||2014-10-09||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:52:09.114922|2017-10-10 20:52:09.114922
NCT03219554|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-01|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor|Samsung Medical Center|Not yet recruiting||Phase 2|33|Anticipated|Samsung Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:52:09.150182|2017-10-10 20:52:09.150182
NCT03219541|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-10-05|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Feasibility and Acceptability of a Text Messaging Intervention to Increase Smoking Cessation in Vietnam|Feasibility and Acceptability of a Text Messaging Intervention to Increase Smoking Cessation in Vietnam|Not yet recruiting||N/A|190|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:52:09.219332|2017-10-10 20:52:09.219332
NCT03219515|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-22|||April 1, 2018|Anticipated|2018-04-01|September 2017|2017-09-01|August 30, 2020|Anticipated|2020-08-30|August 30, 2020|Anticipated|2020-08-30||Interventional|GOODNESS||Herbal Medication (Gongjin-dan) for Chronic Dizziness|Safety, Effectiveness, and Cost-effectiveness of an Herbal Medicine, Gongjin-dan, in Subjects With Chronic Dizziness: a Prospective, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Clinical Trial|Not yet recruiting||N/A|78|Anticipated|Kyunghee University||2|||f|||||f|f||||||||2017-10-10 20:52:09.393696|2017-10-10 20:52:09.393696
NCT03219489|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||An Electronic Medical Record Alert of Progesterone|An Electronic Medical Record Best-Practice Alert of Progesterone to Prevent Preterm Birth: A Pragmatic, Pilot, Cluster Randomized Control Trial|Not yet recruiting||N/A|192|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:52:09.598113|2017-10-10 20:52:09.598113
NCT03219476|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-14|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive HER2-Negative Node-Negative Breast Cancer Patients to Assess Responses and Mechanisms of Endocrine Resistance|Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive HER2-Negative Node-Negative Breast Cancer Patients to Assess Responses and Mechanisms of Endocrine Resistance|Not yet recruiting||Phase 2|39|Anticipated|Medical College of Wisconsin||1|||f||||t|f|f|||f|||||2017-10-10 20:52:09.683163|2017-10-10 20:52:09.683163
NCT03219463|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-11|||August 21, 2017|Actual|2017-08-21|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||The Effects of Ginger Supplementation on Inflammation in Exercising Individuals|The Effects of Ginger Supplementation on Inflammation in Exercising Individuals|Recruiting||N/A|20|Anticipated|Loma Linda University||2|||f||||f|f|f||||||||2017-10-10 20:52:09.799651|2017-10-10 20:52:09.799651
NCT03219450|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-13|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|September 30, 2023|Anticipated|2023-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||A Pilot Study of a Personalized Neoantigen Cancer Vaccine With and Without Low-Dose Cyclophosphamide in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated Chronic Lymphocytic Leukemia.|A Pilot Study of a Personalized Neoantigen Cancer Vaccine With and Without Low-Dose Cyclophosphamide in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated Chronic Lymphocytic Leukemia.|Not yet recruiting||Phase 1|10|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 20:52:09.866271|2017-10-10 20:52:09.866271
NCT03219437|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-07-14|||June 4, 2018|Anticipated|2018-06-04|July 2017|2017-07-01|September 16, 2021|Anticipated|2021-09-16|January 21, 2020|Anticipated|2020-01-21||Interventional|||A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis|A Multicenter, Randomized, Double-Blind, Double-Dummy, Active Controlled Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis|Not yet recruiting||Phase 3|100|Anticipated|AbbVie||2|||f||||f|t|f|||t|||||2017-10-10 20:52:09.95287|2017-10-10 20:52:09.95287
NCT03219424|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-21|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|||Predicting the Probability of Return To Work After Injury|Predicting the Probability of Return to Work After Injury in Hong Kong: Prospective Multicentre Cohort Study|Not yet recruiting||N/A|1163|Anticipated|Chinese University of Hong Kong|||1||f||||f|f|f||||||||2017-10-10 20:52:10.032968|2017-10-10 20:52:10.032968
NCT03219411|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-16|||August 24, 2017|Anticipated|2017-08-24|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|Cinnamon||Effects of Cinnamon Supplementation on Glucose Metabolism in Patients With Pre-diabetes|A Multi-National, Double-Blind, Randomized Trial Of The Influence Of Cinnamon Powders In Subjects With Risk For Developing Diabetes|Recruiting||Phase 2|12|Anticipated|Joslin Diabetes Center||2|||f||||t|f|f||||||||2017-10-10 20:52:10.092901|2017-10-10 20:52:10.092901
NCT03219398|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-15|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|July 31, 2018|Anticipated|2018-07-31||Interventional|||The Effect of Lower Intraabdominal Pressure on Syndecan-1, sVEGF-R2, Occludin and KIM-1 on Living Donor Laparoscopic Nephrectomy|Comparison Effect Between Lower Pressure and Standard Pressure Pneumoperitoneum on Sign of Acute Systemic Inflammation, Endothelial Injury, and Acute Kidney Injury: A Randomized Clinical Trial in Living Donor Laparoscopic Nephrectomy|Recruiting||N/A|44|Anticipated|Indonesia University||2|||f|||||f|f||||||||2017-10-10 20:52:10.192151|2017-10-10 20:52:10.192151
NCT03219385|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-26|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|DIANA||Directed Ablation of Uterine Fibroids Using a Noninvasive Approach|Directed Ablation of Uterine Fibroids Using a Noninvasive Approach (DIANA)|Not yet recruiting||N/A|180|Anticipated|Mirabilis Medica, Inc.||1|||f||||f|f|t|t|f||||||2017-10-10 20:52:10.348232|2017-10-10 20:52:10.348232
NCT03219372|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-28|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 1, 2022|Anticipated|2022-12-01|December 1, 2021|Anticipated|2021-12-01||Interventional|||Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence|Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence|Recruiting||Phase 2|180|Anticipated|Cedars-Sinai Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 20:52:10.426824|2017-10-10 20:52:10.426824
NCT03219359|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Autologous Stem Cell Transplant for Crohn's Disease|Maintenance in Autologous Stem Cell Transplant for Crohn's Disease (MASCT - CD)|Recruiting||Phase 2|50|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|t|f||||||||2017-10-10 20:52:12.248485|2017-10-10 20:52:12.248485
NCT03219346|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-15|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|February 14, 2018|Anticipated|2018-02-14|February 10, 2018|Anticipated|2018-02-10||Interventional|||The Effectiveness of Oral Health in Improving Dysphagia of Patients After Stroke of Swallowing Function and Oral Health Quality of Life|The Effectiveness of Oral Health in Improving Dysphagia of Patients After Stroke of Swallowing Function and Oral Health Quality of Life|Recruiting||N/A|100|Anticipated|Chang Gung Memorial Hospital||1|||f|||||f|f||||||||2017-10-10 20:52:12.381579|2017-10-10 20:52:12.381579
NCT03219333|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-10-02|||September 20, 2017|Actual|2017-09-20|October 2017|2017-10-01|March 2024|Anticipated|2024-03-01|September 2019|Anticipated|2019-09-01||Interventional|EV-201||A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer|A Single-arm, Open-label, Multicenter Study of Enfortumab Vedotin (ASG-22CE) for Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Immune Checkpoint Inhibitor (CPI) Therapy|Recruiting||Phase 2|120|Anticipated|Astellas Pharma Inc||1|||f||||t|t|f||||||||2017-10-10 20:52:12.488383|2017-10-10 20:52:12.488383
NCT03219320|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-10-03|||June 27, 2017|Actual|2017-06-27|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|August 30, 2018|Anticipated|2018-08-30||Interventional|DPN||Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|Recruiting||Phase 2|300|Anticipated|Aptinyx||2|||f||||f|t|f||||||||2017-10-10 20:52:12.589878|2017-10-10 20:52:12.589878
NCT03219307|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture|Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture|Not yet recruiting||Phase 3|30|Anticipated|Aesculap Biologics, LLC||1|||f||||t|t|f|||f|||||2017-10-10 20:52:12.726452|2017-10-10 20:52:12.726452
NCT03219294|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-13|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Does Deep Neuromuscular Blockade Improve Operating Conditions During Total Hip Replacements?|Does Deep Neuromuscular Blockade Improve Operating Conditions During Total Hip Replacements?|Recruiting||Phase 4|116|Anticipated|Maine Medical Center||2|||f||||f|t|f|||f|||||2017-10-10 20:52:12.7921|2017-10-10 20:52:12.7921
NCT03219268|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-18|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|February 2020|Anticipated|2020-02-01||Interventional|||A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms|A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A Bispecific DART® Protein Binding PD-1 and LAG-3 in Patients With Unresectable or Metastatic Neoplasms|Recruiting||Phase 1|131|Anticipated|MacroGenics||1|||f||||f|t|f||||||||2017-10-10 20:52:12.884977|2017-10-10 20:52:12.884977
NCT03219255|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-23|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Observational|||RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term)|Relvar 100 Ellipta Special Drug Use Investigation (COPD, Long-term)|Not yet recruiting||N/A|1000|Anticipated|GlaxoSmithKline|||1||f||||f|f|f||||||||2017-10-10 20:52:13.066841|2017-10-10 20:52:13.066841
NCT03219242|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-13|||June 30, 2016|Actual|2016-06-30|July 2017|2017-07-01|July 15, 2017|Anticipated|2017-07-15|July 1, 2016|Actual|2016-07-01||Interventional|CAIMAN||Primary Debulking Surgery Including Bowel Resection in Advanced Stage Ovarian Cancer Using Caiman® Technology|Longitudinal Prospective Study on Primary Debulking Surgery Including Bowel Resection in Advanced Stage Ovarian Cancer Patients Using Caiman® Technology|Enrolling by invitation||N/A|40|Actual|Catholic University of the Sacred Heart||1|||f||||t|f|f|||f|||||2017-10-10 20:52:13.141462|2017-10-10 20:52:13.141462
NCT03219229|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-14|||February 14, 2004|Actual|2004-02-14|July 2017|2017-07-01|February 20, 2007|Actual|2007-02-20|February 20, 2007|Actual|2007-02-20||Observational|||Metabolic Effects of Differential Organ Growth Rates|Metabolic Effects of Differential Organ Growth Rates|Completed||N/A|49|Actual|Columbia University|||1||f||||f|f|f||||||||2017-10-10 20:52:13.219578|2017-10-10 20:52:13.219578
NCT03219216|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-17|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|November 14, 2018|Anticipated|2018-11-14|November 14, 2018|Anticipated|2018-11-14||Interventional|||A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection|A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection|Not yet recruiting||Phase 3|100|Anticipated|AbbVie||2|||f||||f|t|f|||f|||||2017-10-10 20:52:13.305903|2017-10-10 20:52:13.305903
NCT03219203|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-13|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Immunologic Response of Hepatitis B Vaccine|Immunologic Response of Hepatitis B Single Dose Versus 3-dose Series in Previously Vaccinated HIV-infected Adults at Maharaj Nakorn Chiang Mai Hospital: A Randomized Controlled Trial|Recruiting||Phase 4|80|Anticipated|Chiang Mai University||2|||f||||f|f|f||||||||2017-10-10 20:52:13.394666|2017-10-10 20:52:13.394666
NCT03219190|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||A High School Program for Preventing Prescription Drug Abuse|A High School Program for Preventing Prescription Drug Abuse|Active, not recruiting||N/A|3000|Anticipated|National Health Promotion Associates, Inc.||2|||f||||t|f|f||||||||2017-10-10 20:52:13.508159|2017-10-10 20:52:13.508159
NCT03219177|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-14|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Patient Education and Use of Post Operative Pain Medication in Ambulatory Hand Surgery: a Randomized Controlled Trial|Patient Education and Use of Postoperative Pain Medication in Ambulatory Hand Surgery: a Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|Hospital for Special Surgery, New York||2|||f|||||f|f||||||||2017-10-10 20:52:13.585764|2017-10-10 20:52:13.585764
NCT03218787|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-16|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||XIENCE Short Dual Antiplatelet Therapy (DAPT) Study|XIENCE Short DAPT Study|Recruiting||N/A|2000|Anticipated|Abbott Vascular||1|||f||||t|f|t|f|f||||||2017-10-10 20:52:16.456465|2017-10-10 20:52:16.456465
NCT03219151|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-12|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of a Gamified Electronic Medication Administration Record (eMAR) System|A Mixed-methods Evaluation of a Gamified Electronic Medication Administration Record (eMAR) System for Use in the Simulated Nursing Education|Not yet recruiting||N/A|150|Anticipated|Western University, Canada||2|||f||||f|f|f||||||||2017-10-10 20:52:13.764301|2017-10-10 20:52:13.764301
NCT03219138|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-12|||January 8, 2008|Actual|2008-01-08|July 2017|2017-07-01|July 25, 2009|Actual|2009-07-25|July 25, 2009|Actual|2009-07-25||Interventional|||Algorithm of Muscle Function Tests to Detect Residual Neuromuscular Blockade.|Development of an Algorithm Using Clinical Tests to Avoid Post-operative Residual Neuromuscular Block|Completed||N/A|265|Actual|University of Regensburg||2|||f||||t|f|f||||||||2017-10-10 20:52:13.841297|2017-10-10 20:52:13.841297
NCT03219125|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|ADIMOS||Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women|Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women: a Case-control Study|Not yet recruiting||N/A|194|Anticipated|University Hospital, Lille|||2||f||||f|f|f||||||||2017-10-10 20:52:13.924726|2017-10-10 20:52:13.924726
NCT03219112|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-12|||August 25, 2016||2016-08-25|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Training Balance Control in Children With Cerebral Palsy Using Virtual Reality Games|Training Balance Control Using Virtual Reality Games in Children With Cerebral Palsy and Typically Developing Children|Recruiting||N/A|40|Anticipated|University Ghent||2|||f|||||f|f||||||||2017-10-10 20:52:13.993496|2017-10-10 20:52:13.993496
NCT03219099|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-03|||August 14, 2017|Anticipated|2017-08-14|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|NODARATIS||Normative Database for HR-pQCT-Based Radius and Tibia Strength|Population-Based Normative Database for HR-pQCT-Based Distal Radius and Tibia Strength Assessment in Switzerland|Not yet recruiting||N/A|576|Anticipated|University Hospital Inselspital, Berne|||1||f||||f|f|f||||||||2017-10-10 20:52:14.067959|2017-10-10 20:52:14.067959
NCT03219086|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Spinal Prilocaine for Caesarian Sections|A Prospective Randomized Double Blind Comparison of 7,5 mg Hyperbaric Bupivacaine With 2,5mcg Sufentanyl or 50 mg Hyperbaric Prilocaine With 2,5 mcg Sufentanyl for Caesarean Sections|Not yet recruiting||N/A|400|Anticipated|University Hospital, Antwerp||2|||f|||||f|f|||f|||||2017-10-10 20:52:14.136119|2017-10-10 20:52:14.136119
NCT03219073|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-14|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis|Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis: a Mechanistic FDG-PET Study|Not yet recruiting||N/A|16|Anticipated|University of Colorado, Denver||2|||f||||f|f|f|||f|||||2017-10-10 20:52:14.232894|2017-10-10 20:52:14.232894
NCT03219060|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-12|||August 2010|Actual|2010-08-01|July 2017|2017-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Motivational Interviewing for Nurses' Smoking Cessation|Motivational Interviewing as a Smoking Cessation Strategy With Nurses: an Exploratory Randomized Controlled Trial Following the MRC's Framework for Complex Interventions|Completed||N/A|30|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||||||||||||2017-10-10 20:52:14.306121|2017-10-10 20:52:14.306121
NCT03219047|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||The EXPLORE Trial: Study Evaluating Xenografts to Personalize Therapies (PDX) in Relapsed Mantle Cell Lymphoma to Optimize Response|A Pilot Study Evaluating Xenografts to Personalize Therapies (PDX) in Relapsed Mantle Cell Lymphoma to Optimize Response: The EXPLORE Trial|Not yet recruiting||Early Phase 1|50|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f|||f|||||2017-10-10 20:52:14.388644|2017-10-10 20:52:14.388644
NCT03219021|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-17|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Evaluation of Arch Dimensions of Children With Surgically Repaired Unilateral Cleft Lip and Palate|Evaluation of Arch Dimensions of Children With Surgically Repaired Unilateral Cleft Lip and Palate: A Cross Sectional Study|Not yet recruiting||N/A|233|Anticipated|Cairo University|||1||f||||t|f|f||||||||2017-10-10 20:52:14.572061|2017-10-10 20:52:14.572061
NCT03218995|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-09-14|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Study of Eteplirsen in Young Patients With DMD Amenable to Exon 51 Skipping|An Open-label Safety, Tolerability, and Pharmacokinetics Study of Eteplirsen in Young Patients With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping|Recruiting||Phase 2|12|Anticipated|Sarepta Therapeutics||1|||f||||t|t|f|||t|||||2017-10-10 20:52:14.871361|2017-10-10 20:52:14.871361
NCT03218982|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-13|||May 22, 2017|Actual|2017-05-22|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|January 30, 2019|Anticipated|2019-01-30||Interventional|||Vietnamese Caregiver Intervention Study|A Culturally-Relevant Approach to Reducing Dementia Caregiver Stress in an Underserved Population|Recruiting||N/A|24|Anticipated|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 20:52:14.99398|2017-10-10 20:52:14.99398
NCT03218969|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-17|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|October 15, 2018|Anticipated|2018-10-15|September 15, 2018|Anticipated|2018-09-15||Interventional|RLS-Ecopipam||Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist|Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|The Methodist Hospital System||2|||f||||f|t|f||||||||2017-10-10 20:52:15.14259|2017-10-10 20:52:15.14259
NCT03218956|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|May 30, 2019|Anticipated|2019-05-30|May 15, 2019|Anticipated|2019-05-15||Interventional|||Protein Requirement During Lactation|Determination of Dietary Protein Requirements in Healthy Women During Stages of Lactation|Recruiting||N/A|10|Anticipated|University of British Columbia||1|||f||||f|f|f||||||||2017-10-10 20:52:15.254679|2017-10-10 20:52:15.254679
NCT03218943|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-19|||August 25, 2017|Anticipated|2017-08-25|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Physiological Dead Space Measured by Volumetric Capnography in BiPAP and APRV .|Physiological Dead Space Measured by Volumetric Capnography, Is it Different Between the Biphasic Positive Airway Pressure Mode ( BiPAP ) and Airway Pressure Release Ventilation Mode ( APRV ) ? A Randomized Controlled Study.|Recruiting||N/A|60|Anticipated|Kasr El Aini Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:52:15.335501|2017-10-10 20:52:15.335501
NCT03218930|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-12|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Maltese Antibiotic Stewardship Programme in the Community (MASPIC): Antibiotic Prescribing for Acute Respiratory Tract Complaints|Maltese Antibiotic Stewardship Programme in the Community (MASPIC): a Prospective Quasi-experimental Social Marketing Intervention|Active, not recruiting||N/A|33|Actual|Karolinska Institutet||1|||f|||||f|f||||||||2017-10-10 20:52:15.446987|2017-10-10 20:52:15.446987
NCT03218917|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-15|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Assessment of INS1007 in Subjects With Non-Cystic Fibrosis Bronchiectasis|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study|Not yet recruiting||Phase 2|240|Anticipated|Insmed Incorporated||3|||f||||t|t|f||||||||2017-10-10 20:52:15.525879|2017-10-10 20:52:15.525879
NCT03218904|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||March 17, 2017|Actual|2017-03-17|July 2017|2017-07-01|March 17, 2019|Anticipated|2019-03-17|December 31, 2017|Anticipated|2017-12-31||Interventional|||Glycogen Storage Disease Breath Test Study|Application of Novel Techniques to Devise Nutritional Therapies in Subjects With Glycogen Storage Disease Type I|Recruiting||N/A|38|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 20:52:15.618825|2017-10-10 20:52:15.618825
NCT03218891|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-12|||January 1, 2016|Actual|2016-01-01|January 2017|2017-01-01||||June 21, 2017|Actual|2017-06-21||Interventional|||Cardiac Rehabilitation in Patients With Refractory Angina|Cardiac Rehabilitation in Patients With Refractory Angina|Recruiting||N/A|72|Anticipated|Hospital Israelita Albert Einstein||4|||f||||t|f|f||||||||2017-10-10 20:52:15.716294|2017-10-10 20:52:15.716294
NCT03218878|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-21|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|July 2019|Anticipated|2019-07-01||Observational|||Pregnancy Outcomes After Uterine Cavity Expansion|Pregnancy Outcomes Following Hysteroscopic Expansion of the Uterine Cavity for Patients With Small Cavities and Poor Reproductive Outcomes|Recruiting||N/A|100|Anticipated|Reproductive Medicine Associates of New Jersey|||1||f||||f|f|f||||||||2017-10-10 20:52:15.832115|2017-10-10 20:52:15.832115
NCT03218865|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-22|||October 16, 2013|Actual|2013-10-16|August 2017|2017-08-01|December 24, 2018|Anticipated|2018-12-24|June 24, 2018|Anticipated|2018-06-24||Interventional|EVIA||Influence of the Vitamine E Coated Dialyzer on Inflammation and Anemia|Evaluation of the Dialyzer Vitamin E Coated Effect Inflammatory State of Patients in ESRD and Its Clinical Benefits in Terms of Anemia|Recruiting||N/A|120|Anticipated|Hemotech||2|||f||||t|f|f||||||||2017-10-10 20:52:15.918355|2017-10-10 20:52:15.918355
NCT03218852|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-07-12|||December 2016||2016-12-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|e-TOPplus||Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy|An Extended Follow-up of the Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Patients With Advanced Stage IgA Nephropathy|Active, not recruiting||Phase 4|133|Actual|Guangdong General Hospital||2|||f|||||f|f||||||||2017-10-10 20:52:16.024207|2017-10-10 20:52:16.024207
NCT03218839|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-07-11|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males|Evaluation of Safety, Efficacy and Acceptability of the PrePexTM Device for Rapid Scale-up of Adult Male Circumcision Programs in Zimbabwe, Phase III PrePexTM Field Implementation Trial With HIV Positive Adult Males|Completed||N/A|430|Actual|University of Washington||1|||f||||f||||||||||2017-10-10 20:52:16.09649|2017-10-10 20:52:16.09649
NCT03218826|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-14|2017-09-04|||March 16, 2018|Anticipated|2018-03-16|July 2017|2017-07-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery|Phase I Study of AZD8186 in Combination With Docetaxel in Patients With PTEN Mutated or PIK3CB Mutated Advanced Solid Tumors, Potentially Amenable to Docetaxel|Not yet recruiting||Phase 1|58|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 20:52:16.18251|2017-10-10 20:52:16.18251
NCT03218813|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-25|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||A Pharmacist-Led Hospital-Based Intervention to Support Medication Adherence Following Acute Coronary Syndrome|A Pharmacist-Led Hospital-Based Intervention to Support Medication Adherence Following Acute Coronary Syndrome: An Intervention Cohort Study|Not yet recruiting||N/A|132|Anticipated|King's College London||2|||f||||f|f|f||||||||2017-10-10 20:52:16.297114|2017-10-10 20:52:16.297114
NCT03218800|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-14|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Ertapenem Administered Subcutaneously Versus Intravenously|Ertapenem Administered Subcutaneously Versus Intravenously for Urinary Tract Infections in Oncological Palliative Care Patients: a Randomized, Open, Non-inferiority Clinical Trial|Recruiting||Phase 3|106|Anticipated|Instituto Nacional de Cancer, Brazil||2|||f||||t|f|f|||f|||||2017-10-10 20:52:16.367668|2017-10-10 20:52:16.367668
NCT03218774|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-31|||July 26, 2017|Actual|2017-07-26|July 2017|2017-07-01|July 20, 2019|Anticipated|2019-07-20|July 20, 2018|Anticipated|2018-07-20||Interventional|||Supervised Fitness Program for Adults With Cerebral Palsy|Does Participating in a Supervised Fitness Program Extend the Benefits of Episodic Physical Therapy More Than a Home Exercise Program for Adults With Cerebral Palsy?|Recruiting||N/A|30|Anticipated|Virginia Commonwealth University||2|||f|||||f|f||||||||2017-10-10 20:52:16.543731|2017-10-10 20:52:16.543731
NCT03218761|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-16|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31|2 Days|Observational [Patient Registry]|||POTS NET mRNA Functional Correlation With NET Activity|Validation of Norepinephrine Transporter (NET) mRNA as a Measure of Functional NET Expression in Postural Tachycardia Syndrome (POTS)|Enrolling by invitation||N/A|200|Anticipated|Vanderbilt University Medical Center|||2||f||||f|f|f||||Samples Without DNA|"     Plasma samples supine and upright catechol levels Urine for catechol levels PAXgene tubes for     RNA assessment plasma/serum aliquots   "|||2017-10-10 20:52:16.633475|2017-10-10 20:52:16.633475
NCT03218748|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-20|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Honest, Open, Proud for Soldiers With Mental Illness|Adaptation and Evaluation of the Honest, Open, Proud Program for Soldiers With Mental Illness|Not yet recruiting||N/A|100|Anticipated|University of Ulm||2|||f|||||f|f||||||||2017-10-10 20:52:16.721592|2017-10-10 20:52:16.721592
NCT03218735|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|July 1, 2019|Anticipated|2019-07-01||Interventional|TEAM LGA||Early Term Delivery Versus Expectant Management of the Large for Gestational Age Fetus|Early Term Delivery Versus Expectant Management of the Large for Gestational Age Fetus (TEAM LGA Trial)|Recruiting||N/A|200|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|f||||||||2017-10-10 20:52:16.833252|2017-10-10 20:52:16.833252
NCT03218722|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|PROCOAG||Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma|Impact of Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma|Not yet recruiting||Phase 3|350|Anticipated|University Hospital, Grenoble||2|||f||||t|f|f||||||||2017-10-10 20:52:16.934489|2017-10-10 20:52:16.934489
NCT03218709|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-13|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||The Intervention of Multi-vitamin With Minerals to Hyperuricemia|Effect of Multi-vitamins With Minerals on Uric Acid Metabolism in Subjects With Hyperuricemia: A Randomized, Double-blinded, Placebo-controlled Trail|Recruiting||Phase 4|200|Anticipated|Sun Yat-sen University||4|||f||||f|f|f||||||||2017-10-10 20:52:17.058098|2017-10-10 20:52:17.058098
NCT03218696|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-14|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of a Protective Cough Syrup Against Placebo on Night Cough in Children 1-5 Years Coughing Since 1- 2 Days Due to Common Cold|A Randomized, Double-blind Study to Evaluate the Efficacy and Tolerability of a Cough Syrup Containing Specific Plant Extracts (Poliflav M.A.) and Honey Versus Placebo in Cough Due to Upper Respiratory Tract Infection|Not yet recruiting||N/A|80|Anticipated|Clalit Health Services||2|||f||||f|f|f||||||||2017-10-10 20:52:17.284469|2017-10-10 20:52:17.284469
NCT03218683|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-23|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|August 26, 2019|Anticipated|2019-08-26|August 26, 2019|Anticipated|2019-08-26||Interventional|||Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.|A Phase 1, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Ascending Doses of AZD5991 in Subjects With Relapsed or Refractory Haematologic Malignancies|Recruiting||Phase 1|30|Anticipated|AstraZeneca||5|||f||||f|t|f||||||||2017-10-10 20:52:17.410304|2017-10-10 20:52:17.410304
NCT03218670|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-13|||September 1, 2009|Actual|2009-09-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|TS1C||Your Health in On Click|Your Health in On Click : Risk Behavior Among College Students|Recruiting||N/A|6000|Anticipated|University Hospital, Rouen|||1||f||||t|f|f||||||||2017-10-10 20:52:17.533665|2017-10-10 20:52:17.533665
NCT03218657|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-24|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole|A Prospective, Randomized, Controlled Clinical Study of Non Transfusion Dependent Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole Hydrochloride|Recruiting||N/A|248|Anticipated|Zhejiang Provincial Hospital of TCM||2|||f||||f|f|f|||f|||||2017-10-10 20:52:17.626604|2017-10-10 20:52:17.626604
NCT03218644|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-08-15|||July 8, 2017|Actual|2017-07-08|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|PropNeckPain||Effectiveness of Proprioceptive Exercise in Neck Pain|Effectiveness of a Propioceptive Exercise Program in Subjects With Inespecific Neck Pain|Completed||N/A|47|Actual|University of Valencia||2|||f||||f|f|f||||||||2017-10-10 20:52:17.763599|2017-10-10 20:52:17.763599
NCT03218631|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-12|||July 10, 2017|Actual|2017-07-10|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Oxandrolone in Healthy Adults: A Relative Bioavailability Study|Pharmacokinetics of a Medium Chain Triglyceride Oil Oxandrolone Solution vs. Tablets in Healthy Adults: A Relative Bioavailability Study|Recruiting||Phase 1|6|Anticipated|University of Utah||1|||f||||t|t|f|||f|||||2017-10-10 20:52:17.860807|2017-10-10 20:52:17.860807
NCT03218618|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-12|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|CHOP||CHOKing Prevention Project|CHOKing Prevention Project|Not yet recruiting||N/A|1968|Anticipated|University of Padova|||1||f|||||f|f||||||||2017-10-10 20:52:17.970171|2017-10-10 20:52:17.970171
NCT03218605|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-13|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Which Physical Activity Influences Achilles Tendon Blood Flow the Most?|Effect of Warming-up Activities on the Vascularisation of the Achilles Tendon: a Cohort Study|Recruiting||N/A|60|Anticipated|University Ghent||1|||f|||||f|f||||||||2017-10-10 20:52:18.0374|2017-10-10 20:52:18.0374
NCT03218592|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-12|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|March 30, 2019|Anticipated|2019-03-30|December 25, 2018|Anticipated|2018-12-25||Interventional|ENLIGHTEN||ENLIGHTEN: Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence|ENLIGHTEN: Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence|Recruiting||Phase 4|36|Anticipated|University of North Carolina, Chapel Hill||3|||f||||t|t|f|||f|||||2017-10-10 20:52:18.123227|2017-10-10 20:52:18.123227
NCT03218579|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-18|||February 1, 2013|Actual|2013-02-01|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|microbiome||Endoscopic Assessment and Prediction of Microbiome-modifying Interventions|Endoscopic Assessment and Prediction of Microbiome-modifying Interventions|Recruiting||N/A|45|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f|||||f|f||||||||2017-10-10 20:52:18.236985|2017-10-10 20:52:18.236985
NCT03218566|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-24|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|EXTRACT-PE||Evaluating the Safety and Efficacy of the Indigo Aspiration System in Acute Submassive Pulmonary Embolism|A Prospective, Multicenter Trial to Evaluate the Safety and Efficacy of the Indigo Aspiration System in Acute Submassive Pulmonary Embolism|Not yet recruiting||N/A|150|Anticipated|Penumbra Inc.||1|||f||||t|f|t|f|f||||||2017-10-10 20:52:18.352419|2017-10-10 20:52:18.352419
NCT03218553|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-27|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PACMAN||Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery|Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery : a Randomized, Multicentre, Double Blind, Study|Not yet recruiting||Phase 3|1222|Anticipated|Nantes University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:52:18.444217|2017-10-10 20:52:18.444217
NCT03218540|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-15|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Stroke Volume Variation vs Central Venous Pressure Guidance Fluid Management in Endovascular Aortic Repair|Directed Fluid Therapy Based on Stroke Volume Variations Improves Fluid Management in Endovascular Aortic Repair for Aortic Aneurysm Patients: a Randomized Trial|Completed||N/A|40|Actual|Khon Kaen University||2|||f||||f|f|f||||||||2017-10-10 20:52:18.659293|2017-10-10 20:52:18.659293
NCT03218527|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-12|||October 1, 2015||2015-10-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31|1 Year|Observational [Patient Registry]|IMPROVE||Influence of Circulating Endothelial Progenitor Cells and Modifiable Vascular Risk Factors on Carotid Plaque Vulnerability|Influence of Circulating Endothelial Progenitor Cells and Modifiable Vascular Risk Factors on Carotid Plaque Vulnerability|Recruiting||N/A|120|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f|f|f||||||||2017-10-10 20:52:18.741364|2017-10-10 20:52:18.741364
NCT03218514|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-12|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Observational|||Venous Thromboprophylaxis in Bariatric Surgery|Evaluating Body Size Descriptors on Peak Anti-Xa Levels in Bariatric Surgery Obese Patients Receiving Low Molecular Weight Heparin Fixed Doses|Completed||N/A|118|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||||||||||||2017-10-10 20:52:18.808136|2017-10-10 20:52:18.808136
NCT03218501|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-10-03|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus|A Phase II, Double-Blind, Randomized, Placebo-Controlled Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus|Recruiting||Phase 2|270|Anticipated|Sanwa Kagaku Kenkyusho Co., Ltd.||3|||f|||||f|f||||||||2017-10-10 20:52:18.872891|2017-10-10 20:52:18.872891
NCT03218488|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-10-03|||August 29, 2017|Actual|2017-08-29|October 2017|2017-10-01|September 15, 2026|Anticipated|2026-09-15|September 15, 2026|Anticipated|2026-09-15||Observational|||A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 12 Years and Older With Moderate to Severe Plaque Psoriasis|An Observational Post-authorization Safety Study of Ustekinumab in the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate to Severe Plaque Psoriasis|Recruiting||N/A|75|Anticipated|Janssen-Cilag International NV|||1||f||||f|t|f|||f|||||2017-10-10 20:52:18.966729|2017-10-10 20:52:18.966729
NCT03218475|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-07-12|||July 28, 2016|Actual|2016-07-28|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||MRG HIFU With Radiotherapy for Palliation of H&N Cancer|Magnetic Resonance-Guided High Intensity Focused Ultrasound Combined With Radiotherapy for Palliation of Head and Neck Cancer - A Pilot Study|Recruiting||N/A|10|Anticipated|Sunnybrook Health Sciences Centre||1|||f|||||f|f||||||||2017-10-10 20:52:19.098339|2017-10-10 20:52:19.098339
NCT03218462|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-12|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|December 21, 2017|Anticipated|2017-12-21||Interventional|||Effect of Sensory Adapted Dental Environment on Dental Anxiety of Children With Intellectual and Developmental Disabilities|Effect of Sensory Adapted Dental Environment on Dental Anxiety of Children With Intellectual and Developmental Disabilities|Recruiting||N/A|35|Anticipated|Virginia Commonwealth University||2|||f||||t|f|f||||||||2017-10-10 20:52:19.180428|2017-10-10 20:52:19.180428
NCT03218449|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-12|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|October 31, 2017|Anticipated|2017-10-31||Observational|||Inflammatory Markers for Postoperative Complications in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy|The Prognostic Value of Inflammatory Markers for Postoperative Complications in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|Active, not recruiting||N/A|100|Anticipated|Gangnam Severance Hospital|||2||f||||f|f|f||||||||2017-10-10 20:52:19.273603|2017-10-10 20:52:19.273603
NCT03218436|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-31|||August 31, 2017|Actual|2017-08-31|August 2017|2017-08-01|March 1, 2020|Anticipated|2020-03-01|September 1, 2019|Anticipated|2019-09-01||Interventional|CAPCIN||Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia|Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia|Recruiting||N/A|170|Anticipated|University Women's Hospital Tübingen||2|||f||||f|f|f||||||||2017-10-10 20:52:19.339637|2017-10-10 20:52:19.339637
NCT03218423|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-18|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|August 2021|Anticipated|2021-08-01||Observational|PERT||Longitudinal Performance of Epi proColon|Performance of Epi proColon in Repeated Testing in the Intended Use Population (PERT)|Recruiting||N/A|4500|Anticipated|Epigenomics, Inc|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:52:19.422944|2017-10-10 20:52:19.422944
NCT03218410|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-13|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 30, 2020|Anticipated|2020-06-30||Interventional|Lungembolism||Surgical Pulmonary Embolectomy Versus Catheter-directed Thrombolysis in the Treatment of Pulmonary Embolism: A Non-inferiority Study|Surgical Pulmonary Embolectomy Versus Catheter-directed Thrombolysis in the Treatment of Pulmonary Embolism: A Randomized Phase II Non-inferiority Study|Recruiting||N/A|60|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f||||||||2017-10-10 20:52:19.526479|2017-10-10 20:52:19.526479
NCT03218397|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|RAPIDS-GN||Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia|Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN)|Not yet recruiting||N/A|500|Anticipated|Duke University||2|||f||||f|f|t|f|f||||||2017-10-10 20:52:19.620116|2017-10-10 20:52:19.620116
NCT03218384|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-07|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency|Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency|Recruiting||Phase 2|32|Anticipated|New York University School of Medicine||2|||f||||f|t|f|||f|||||2017-10-10 20:52:19.736772|2017-10-10 20:52:19.736772
NCT03218371|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-12|||October 2013|Actual|2013-10-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|January 2016|Actual|2016-01-01||Observational|||Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.|Scleral Self-indentation During Chandelier-assisted Peripheral Vitrectomy Under Air for Rhegmatogenous Retinal Detachment: A Retrospective Cohort Study.|Completed||N/A|130|Actual|Dar El Oyoun Hospital|||2||f||||f|f|f||||||||2017-10-10 20:52:19.821659|2017-10-10 20:52:19.821659
NCT03218358|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-09|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Observational|||Effect of the Intra-abdominal Pressure on the Risk of Delirium in Mechanically Ventilated Patients.|Effect of the Intra-abdominal Pressure on the Risk of Delirium in Mechanically Ventilated Patients.|Completed||N/A|60|Actual|Assiut University|||1||f||||t|f|f||||||||2017-10-10 20:52:19.901159|2017-10-10 20:52:19.901159
NCT03218345|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-14|||August 2016||2016-08-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||EUS-guided RFA for Pancreatic Neoplasms|Multi-center Prospective Study on EUS-guided Radiofrequency Ablation for Solid Pancreatic Neoplasms|Recruiting||N/A|30|Anticipated|Chinese University of Hong Kong||1|||f||||t||||||||||2017-10-10 20:52:19.953914|2017-10-10 20:52:19.953914
NCT03218332|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-12|||July 4, 2011|Actual|2011-07-04|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study|Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study|Recruiting||N/A|150|Anticipated|University Health Network, Toronto|||2||f||||f|f|f||||Samples With DNA|"     Blood and cerebrospinal fluid (CSF) will be collected.   "|||2017-10-10 20:52:20.046024|2017-10-10 20:52:20.046024
NCT03218319|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|VAPANCR||Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer (VAPANCR)|Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer|Not yet recruiting||N/A|200|Anticipated|University Hospital, Angers||1|||f|||||f|f||||||||2017-10-10 20:52:20.12179|2017-10-10 20:52:20.12179
NCT03218306|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-24|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|SPIDER||Surgical Pleth Index (SPI) Versus Standard Clinical Approach Analgesia|Surgical Pleth Index Guided Intraoperative Analgesia Versus Standard Clinical Approach During Desflurane Based General Anesthesia for Thyroidectomy|Not yet recruiting||N/A|198|Anticipated|University of Cagliari||2|||f||||f|f|f|||f|||||2017-10-10 20:52:20.191883|2017-10-10 20:52:20.191883
NCT03218293|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-12|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|tripcais||Thrombolysis and RIPC in Acute Ischemic Stroke|The Recovery of Nerve Function Deficient of Combined Intravenous Thrombolysis and Remote Ischemic Post-conditioning in Acute Ischemic Stroke.|Not yet recruiting||N/A|120|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||t|f|f||||||||2017-10-10 20:52:20.277361|2017-10-10 20:52:20.277361
NCT03218280|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-12|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|OSPOL||Oxidative Stress Expression and Metabolic Imbalance in Critically Ill Polytrauma Patients and the Implications of Antioxidant Therapy on Clinical Outcomes|Oxidative Stress Expression and Metabolic Imbalance in Critically Ill Polytrauma Patients and the Implications of Antioxidant Therapy on Clinical Outcomes|Active, not recruiting||N/A|100|Anticipated|Romanian Society of Anesthesia and Intensive Care||2|||f||||t|f|f||||||||2017-10-10 20:52:20.345046|2017-10-10 20:52:20.345046
NCT03218267|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-12|||September 1, 2014|Actual|2014-09-01|July 2017|2017-07-01|May 1, 2016|Actual|2016-05-01|September 1, 2015|Actual|2015-09-01||Interventional|||The Postural Control in Patients After Total Hip Replacement|Does the Total Hip Replacement Impact of Postural Stability?|Completed||N/A|60|Actual|Poznan University of Medical Sciences||2|||f||||f|f|f||||||||2017-10-10 20:52:20.416208|2017-10-10 20:52:20.416208
NCT03218254|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2021|Anticipated|2021-10-01||Interventional|MICRO||MethylphenIdate for Fatigue in Haematological Cancer|MethylphenIdate for Fatigue in Haematological Cancer. A Randomized, Double-blind, Placebo-controlled, CROssover Trial - the MICRO Trial|Not yet recruiting||Phase 3|150|Anticipated|Odense University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:52:20.650211|2017-10-10 20:52:20.650211
NCT03218241|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2017-07-12|||June 2012||2012-06-01|July 2017|2017-07-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote|A Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously Administered PRT064445, a Factor Xa (fXa) Inhibitor Antidote|Completed||Phase 1|32|Actual|Portola Pharmaceuticals||5|||f||||f||||||||||2017-10-10 20:52:20.753465|2017-10-10 20:52:20.753465
NCT03218228|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-14|||June 10, 2017|Actual|2017-06-10|July 2017|2017-07-01|December 8, 2018|Anticipated|2018-12-08|August 8, 2018|Anticipated|2018-08-08||Interventional|implant||Immediate Implant Placement in Aggressive Periodontitis|Evaluation of the Health of Peri-implant Tissues Around Immediately Placed Dental Implants in Aggressive Periodontitis Patients Versus Periodontally Healthy Individuals in Maxillary Esthetic Zone|Recruiting||N/A|20|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:52:20.851794|2017-10-10 20:52:20.851794
NCT03218215|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-14|||May 1, 2015|Actual|2015-05-01|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 26, 2015|Actual|2015-05-26||Observational|MONICA||Monitoring Mechanical Assisted Cough|Physiological Study About Advantages of Monitoring Mechanical Assisted Cough|Completed||N/A|21|Actual|Corporacion Parc Tauli|||1||f||||f|f|f||||||||2017-10-10 20:52:20.950431|2017-10-10 20:52:20.950431
NCT03218202|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-12|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Observational|STRIDENT||Stricture Definition and Treatment (STRIDENT) Observational Study.|Stricture Definition and Treatment (STRIDENT) Observational Study.|Not yet recruiting||N/A|50|Anticipated|St Vincent's Hospital Melbourne|||1||f||||t|f|f||||Samples With DNA|"     Standard blood tests. Tests for Single Nucleotide Polymorphisms. Stool testing, Tissue     Sampling.   "|||2017-10-10 20:52:21.027389|2017-10-10 20:52:21.027389
NCT03218189|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Differences Between Essential Medicines Lists in 135 Countries and Model List of Essential Medicines|Differences Between Essential Medicines Lists in 135 Countries and the World Health Organization's Model List of Essential Medicines|Recruiting||N/A|135|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f|f|f||||||||2017-10-10 20:52:21.120806|2017-10-10 20:52:21.120806
NCT03218176|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-02|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|GARROTS||Tourniquets Type Combat Application Tourniquet: Proximal or Distal Location, Simple or Staggered on Upper and Lower Limb|Tourniquets Type Combat Application Tourniquet (CAT): Vascular Suffering According to the Proximal or Distal Location, Simple or Staggered. Study to Upper and Lower Limbs|Recruiting||N/A|30|Anticipated|University Hospital, Brest||8|||f||||f|f|f||||||||2017-10-10 20:52:21.197043|2017-10-10 20:52:21.197043
NCT03218163|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-12|||September 22, 2017|Anticipated|2017-09-22|September 2017|2017-09-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2022|Anticipated|2022-08-01||Interventional|||MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma|A Phase II Study of MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Patients With Newly Diagnosed Poor-risk or Relapsed Multiple Myeloma|Not yet recruiting||Phase 2|36|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:52:21.308727|2017-10-10 20:52:21.308727
NCT03218150|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||October 2016||2016-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Observational|||Cranioplasty: Autogenous Bone Graft Versus Artificial Substitutes|Cranioplasty: Autogenous Bone Graft Versus Artificial Substitutes|Active, not recruiting||N/A|1|Actual|Assiut University|||3||f|||||f|f||||||||2017-10-10 20:52:21.375745|2017-10-10 20:52:21.375745
NCT03218137|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-13|||February 13, 2017|Actual|2017-02-13|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions|Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions|Recruiting||Phase 4|20|Anticipated|Weill Medical College of Cornell University||1|||f||||f|t|f|||t|||||2017-10-10 20:52:21.440145|2017-10-10 20:52:21.440145
NCT03218124|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-12|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Interventional|ORCO||Optimal Remifentanil Concentration and Thyroidectomy|Optimal Effect Site Remifentanil Concentration for Smooth Extubation After Thyroid Surgery|Not yet recruiting||N/A|30|Anticipated|University of Cagliari||1|||f||||f|f|f|||f|||||2017-10-10 20:52:21.528375|2017-10-10 20:52:21.528375
NCT03218111|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-11|||February 6, 2017|Actual|2017-02-06|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Glymphatic Kinetics In Healthy Adult Volunteers|Evaluation Of Brain Glymphatic Kinetics Following Intrathecal Administration Of Gadolinium In Healthy Adult Volunteers|Recruiting||N/A|20|Anticipated|Weill Medical College of Cornell University||1|||f||||f|f|f|||f|||||2017-10-10 20:52:21.646996|2017-10-10 20:52:21.646996
NCT03218098|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-11|||January 2014||2014-01-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Post-Operative Pain After Uniportal Vats Lobectomy: Does A Smaller Incision Result In Better Recovery?|Post-Operative Pain After Uniportal Vats Lobectomy: Does A Smaller Incision Result In Better Recovery?|Completed||N/A|44|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-10 20:52:21.753235|2017-10-10 20:52:21.753235
NCT03218085|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-19|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract|Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine|Recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|t|f|||f|||||2017-10-10 20:52:21.847723|2017-10-10 20:52:21.847723
NCT03218072|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-14|||May 4, 2014|Actual|2014-05-04|July 2017|2017-07-01|January 31, 2015|Actual|2015-01-31|January 31, 2015|Actual|2015-01-31||Interventional|||A Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas|A Phase Ia, Multi-centers, Open-label, Dose-escalation Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HLX01 (a Potential Rituximab Biosimilar) in Patients With CD20-positive B-cell Lymphomas|Completed||Phase 1|12|Actual|Shanghai Henlius Biotech||3|||f||||||||||||||2017-10-10 20:52:21.953687|2017-10-10 20:52:21.953687
NCT03218059|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-07-12|||July 15, 2017|Anticipated|2017-07-15|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Outcome After MTX & Transvaginal Surgery or UAE & Uterine Curettage in Patients With Cesarean Scar Pregnancy|Outcome After MTX & Transvaginal Surgery or UAE & Uterine Curettage in Patients With Cesarean Scar Pregnancy|Not yet recruiting||N/A|100|Anticipated|Shanghai First Maternity and Infant Hospital||1|||f|||||f|f||||||||2017-10-10 20:52:22.052802|2017-10-10 20:52:22.052802
NCT03218046|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-07-14|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|October 2, 2018|Anticipated|2018-10-02|April 2018|Anticipated|2018-04-01||Interventional|EMDR||EMDR as a Treatment for Tinnitus|Eye Movement Desensitisation and Reprocessing (EMDR) as a Treatment for Tinnitus: A Feasibility Study|Recruiting||N/A|30|Anticipated|Norfolk and Norwich University Hospitals NHS Foundation Trust||1|||f||||f|f|f||||||||2017-10-10 20:52:22.168368|2017-10-10 20:52:22.168368
NCT03218033|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-12|||May 1, 2014|Actual|2014-05-01|July 2017|2017-07-01|January 31, 2015|Actual|2015-01-31|January 31, 2015|Actual|2015-01-31||Interventional|||Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus|Improvement of Medication Adherence in Adolescents With SLE Using Web-based Education With and Without a Social Media Intervention|Completed||N/A|37|Actual|Milton S. Hershey Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:52:22.292856|2017-10-10 20:52:22.292856
NCT03218020|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-14|||September 1, 1994|Actual|1994-09-01|July 2017|2017-07-01|December 31, 2009|Actual|2009-12-31|December 31, 2009|Actual|2009-12-31||Observational|||Red Meat, Increased Iron Load and CVD Risk|Red Meat Consumption and Risk of Cardiovascular Diseases - is Increased Iron Load a Possible Link?|Completed||N/A|25540|Actual|German Cancer Research Center|||2||f||||f|f|f||||Samples Without DNA|"     Serum samples from baseline examinations stored in the biobank of the study.   "|||2017-10-10 20:52:22.377481|2017-10-10 20:52:22.377481
NCT03218007|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-15|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|||A2 AR as a Novel Biomarkers for Physician Decision-making Improvement Evaluation's Patients With Suspected Acute Coronary Syndrome But Negative Troponin.|A 2A Receptor (A2 AR) as a Novel Biomarkers for Physician Decision-making Improvement Evaluation's Patients With Suspected Acute Coronary Syndrome But Negative Troponin.|Recruiting||N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f|f|f||||||||2017-10-10 20:52:22.479258|2017-10-10 20:52:22.479258
NCT03217994|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Efficacy of a 6% Hydrogen Peroxide Tooth Bleaching Agent|Efficacy of a 6% Hydrogen Peroxide Tooth Bleaching Agent Without Ligth|Completed||N/A|33|Actual|University of Chile||2|||f||||t|f|f||||||||2017-10-10 20:52:22.583666|2017-10-10 20:52:22.583666
NCT03217981|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-02|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|August 8, 2017|Anticipated|2017-08-08|August 5, 2017|Anticipated|2017-08-05||Observational|HUVR||Sepse: Critical Analysis of New Sepse Definitions and Retrospective Evaluation of Sepse Protocol at a Tertiary Hospital in Brazil|Sepse: Critical Analysis of New Sepse Studies and Definitions and Retrospective Evaluation of Sepse Protocol Implementation at Hospital Unimed Volta Redonda|Recruiting||N/A|506|Anticipated|Unimed Volta Redonda|||2||f|||||f|f||||||||2017-10-10 20:52:22.672549|2017-10-10 20:52:22.672549
NCT03217968|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-14|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Abortive Treatment of Migraine With the Cefaly® Abortive Program Device|Abortive Treatment of Migraine With the Cefaly® Abortive Program Device: Pilot Trial|Recruiting||N/A|60|Anticipated|Cefaly Technology||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:52:22.754111|2017-10-10 20:52:22.754111
NCT03217955|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-12|||May 6, 2014|Actual|2014-05-06|July 2017|2017-07-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|Social||Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset Schizophrenia|Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset Schizophrenia|Completed||N/A|98|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f|f|f||||||||2017-10-10 20:52:22.845945|2017-10-10 20:52:22.845945
NCT03217942|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-12|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Spread of Muscle Hyperalgesia and Pain in a Low Dose NGF-induced Pain Model|Spread of Muscle Hyperalgesia and Pain in a Low Dose NGF-induced Pain Model|Recruiting||Early Phase 1|20|Anticipated|Aalborg University||2|||f||||t|f|f|||f|||||2017-10-10 20:52:22.942927|2017-10-10 20:52:22.942927
NCT03217929|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|taVNS||Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Craving in Obese Individuals.|Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Craving in Obese Individuals: a Randomized, Sham-controlled, Double Blind Clinical Trial.|Not yet recruiting||N/A|54|Anticipated|Federal University of São Paulo||2|||f||||t|f|f||||||||2017-10-10 20:52:23.047778|2017-10-10 20:52:23.047778
NCT03217916|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-13|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Observational|||Kidney Injury Biomarkers in Preeclampsia|Evaluation of Kidney Injury Biomarkers in Women Suffering From Preeclampsia|Not yet recruiting||N/A|40|Anticipated|Woman's Health University Hospital, Egypt|||2||f||||t|f|f||||Samples Without DNA|"     urine sample: 40 ml of a freshly obtained urine specimens will be centrifuged at 1,500 rpm     for 10 min within 30 min of collection, aliquoted, and stored at -70°C until assayed   "|||2017-10-10 20:52:23.131291|2017-10-10 20:52:23.131291
NCT03217903|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-10|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|July 17, 2020|Anticipated|2020-07-17|July 17, 2020|Anticipated|2020-07-17||Interventional|MYRAGE||High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)|High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)|Not yet recruiting||N/A|32|Anticipated|Central Hospital, Nancy, France||1|||f||||f|f|f||||||||2017-10-10 20:52:23.209546|2017-10-10 20:52:23.209546
NCT03217890|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||the Relationship Between Cleft Lip and / or Palate (Different Types) and ABO Blood Groups.|Distribution Of ABO Blood Groups In Relation To Cleft Lip And/or Palate .|Not yet recruiting||N/A|376|Anticipated|Cairo University|||1||f||||t|f|f||||||||2017-10-10 20:52:23.281699|2017-10-10 20:52:23.281699
NCT03217877|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-13|||August 31, 2017|Anticipated|2017-08-31|July 2017|2017-07-01|June 30, 2023|Anticipated|2023-06-30|December 31, 2022|Anticipated|2022-12-31||Interventional|POST PCI||Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention|a Multi-center, Open-label, Nationwide Registry-based, Randomized, Pragmatic Trial Comparing 2 Post-PCI Management Strategies in High-risk PCI Patients With Complex Clinical and Lesion Characteristics|Not yet recruiting||N/A|1700|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:52:23.330838|2017-10-10 20:52:23.330838
NCT03217864|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-13|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg|Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg: Observational, Prospective, Monocentric, Non-interventional Study. Advantages, Disadvantages, Limitations|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||||2017-10-10 20:52:23.413746|2017-10-10 20:52:23.413746
NCT03217851|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Prevalence Survey of Antimalarial Drug Resistance Markers|Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers in Greater Mekong Subregion|Not yet recruiting||N/A|2940|Anticipated|University of Oxford|||1||f||||f|f|f||||Samples Without DNA|"     Collect blood for malaria diagnostic testing (blood smear and/or rapid diagnostic test) and     dried blood spot on filter paper   "|||2017-10-10 20:52:23.486728|2017-10-10 20:52:23.486728
NCT03217825|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan|Antihypertensive Effect of Different Doses of ROSTAFUROXIN in Comparison With Losartan, Assessed by Office and Ambulatory Blood Pressure Monitoring in a Hypertensive Population Selected According to a Specific Genetic Profile.|Recruiting||Phase 2|280|Anticipated|Cvie Therapeutics Ltd.||4|||f||||t|f|f||||||||2017-10-10 20:52:23.656677|2017-10-10 20:52:23.656677
NCT03217812|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-08-24|||October 23, 2017|Anticipated|2017-10-23|August 2017|2017-08-01|August 31, 2022|Anticipated|2022-08-31|January 17, 2020|Anticipated|2020-01-17||Interventional|||A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)|A Phase 3, Multicenter, Randomized, Controlled, Open-label Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)|Not yet recruiting||Phase 3|192|Anticipated|Janssen Research & Development, LLC||2|||f||||t|f|f|||f|||||2017-10-10 20:52:23.75206|2017-10-10 20:52:23.75206
NCT03217799|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-07-16|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||Noninvasive Measurement of Blood Coagulation|Noninvasive Measurement of Blood Coagulation|Not yet recruiting||N/A|140|Anticipated|Meir Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:52:23.910044|2017-10-10 20:52:23.910044
NCT03217786|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2024|Anticipated|2024-09-01|January 2024|Anticipated|2024-01-01||Observational|ECAV||Early Post Transplant Cardiac Allograft Vasculopathy|Early Post Transplant Cardiac Allograft Vasculopathy|Not yet recruiting||N/A|80|Anticipated|Ottawa Heart Institute Research Corporation|||1||f||||f|f|f||||Samples Without DNA|"     Specimens will be assessed for potential CAV biomarkers.   "|||2017-10-10 20:52:23.967|2017-10-10 20:52:23.967
NCT03217773|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||ESD Versus TAMIS for Early Rectal Neoplasms|Endoscopic Submucosal Dissection (ESD) Versus Transanal Minimally Invasive Surgery (TAMIS) for Early Rectal Neoplasms: a Prospective Randomized Controlled Trial|Recruiting||N/A|114|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:52:24.036357|2017-10-10 20:52:24.036357
NCT03217760|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-12|||March 28, 2017|Actual|2017-03-28|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28|1 Month|Observational [Patient Registry]|STRESSENDO||Stress Factors Induced by Patient and Young Clinicien During Endodontic Treatment|Patient's Induced Stress and Young Practitioner's Induced Stress During Endodontic Therapy.|Recruiting||N/A|60|Anticipated|University Hospital, Brest|||2||f|||||f|f||||Samples Without DNA|"     Salivary samples are collected during endodontic treatment to measure cortisol production     during endodontic treatment. Cortisol is a hormone secreted from the adrenal cortex and     dispersed to all body fluids (urine, serum, or saliva). A correlation between salivary     cortisol levels and stress in dental procedure is noticed.   "|||2017-10-10 20:52:24.118206|2017-10-10 20:52:24.118206
NCT03217747|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-10|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Study to Evaluate the Safety and Tolerability of Avelumab in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies|Phase I/II Study to Evaluate the Safety and Tolerability of Avelumab in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies|Recruiting||Phase 1/Phase 2|188|Anticipated|M.D. Anderson Cancer Center||7|||||||f|t|f||||||||2017-10-10 20:52:24.225598|2017-10-10 20:52:24.225598
NCT03217734|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-18|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|October 10, 2018|Anticipated|2018-10-10|April 10, 2018|Anticipated|2018-04-10||Interventional|MAP||MAP Study: Methotrexate and Adalimumab in Psoriasis|MAP Study (Methotrexate and Adalimumab in Psoriasis): Adalimumab vs. Combination Adalimumab and Methotrexate in Psoriasis: Efficacy and Anti-Adalimumab Antibody Formation|Recruiting||Phase 2/Phase 3|56|Anticipated|Bakersfield Dermatology & Skin Cancer Medical Group||2|||f||||t|t|f|||t|||||2017-10-10 20:52:24.353174|2017-10-10 20:52:24.353174
NCT03217721|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-29|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|September 19, 2017|Actual|2017-09-19|September 19, 2017|Actual|2017-09-19||Observational|REANEUF||Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit|Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit : New Recommendations do They Change Our Clinical Practice ?|Completed||N/A|100|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 20:52:24.453556|2017-10-10 20:52:24.453556
NCT03217708|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-12|||July 21, 2017|Anticipated|2017-07-21|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|3 Weeks|Observational [Patient Registry]|||Post Discharge Circadian Rhythms Post Adenotonsillectomy|Post Discharge Circadian Dysrhythmias, Sleep Disturbances, and Return to Baseline Activity in Children With Pre-existing Obstructive Sleep Apnea After AT (Adenotonsillectomy).|Not yet recruiting||N/A|15|Anticipated|Baylor College of Medicine|||2||f||||f|f|t|f|f||||||2017-10-10 20:52:24.514818|2017-10-10 20:52:24.514818
NCT03217695|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-12|||April 4, 2016|Actual|2016-04-04|June 2017|2017-06-01|October 7, 2016|Actual|2016-10-07|October 7, 2016|Actual|2016-10-07||Interventional|||A Study on the Effect of Mindfulness-based Yoga on Youth With Persistent Concussion Symptoms|A Pilot Study on the Effect of Mindfulness-based Yoga on Youth With Persistent Concussion Symptoms: Bridging Neurophysiological and Functional Outcomes|Completed||N/A|6|Actual|Holland Bloorview Kids Rehabilitation Hospital||1|||f||||f|f|f||||||||2017-10-10 20:52:24.573443|2017-10-10 20:52:24.573443
NCT03217682|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Impact of Massage Therapy and Music Therapy on the Quality of Life of Hospice Patients|Impact of Massage Therapy and Music Therapy on the Quality of Life of Hospice Patients|Recruiting||N/A|120|Anticipated|Mayo Clinic||2|||f|||||f|f||||||||2017-10-10 20:52:24.660553|2017-10-10 20:52:24.660553
NCT03217669|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-20|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy|Phase I Study of Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy|Not yet recruiting||Phase 1|22|Anticipated|University of Kansas Medical Center||2|||f||||t|t|f||||||||2017-10-10 20:52:24.906076|2017-10-10 20:52:24.906076
NCT03217656|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-07-11|||January 1999|Actual|1999-01-01|June 2017|2017-06-01|January 2029|Anticipated|2029-01-01|January 2019|Anticipated|2019-01-01||Observational|JBC||The Jiaxing Birth Cohort in China|The Jiaxing Birth Cohort in China|Recruiting||N/A|500000|Anticipated|Zhejiang University|||1||f|||||f|f||||||||2017-10-10 20:52:25.024164|2017-10-10 20:52:25.024164
NCT03217643|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|EATL-001||CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.|Phase 2 Study of Brentuximab Vedotin Associated With CHP Followed by Consolidation With High-dose Therapy / Autologous Stem-cell Transplantation as Frontline Treatment of Patients With Enteropathy-associated T-cell Lymphoma Type 1.|Not yet recruiting||Phase 2|25|Anticipated|Imagine Institute||1|||f||||t|f|f|||f|||||2017-10-10 20:52:25.132221|2017-10-10 20:52:25.132221
NCT03217630|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-08-01|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|August 3, 2017|Anticipated|2017-08-03|August 3, 2017|Anticipated|2017-08-03||Observational|||Ultrasound Evaluation of Gastric Emptying in Diabetic Patients: a Comparison With Non-diabetic Controls|A Cohort Study of Ultrasound Evaluation of Gastric Emptying in Diabetic Patients: a Comparison With Non-diabetic Controls|Recruiting||N/A|110|Anticipated|West China Hospital|||2||f|||||f|f||||||||2017-10-10 20:52:25.230673|2017-10-10 20:52:25.230673
NCT03217617|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-29|||July 15, 2017|Actual|2017-07-15|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Gene Transfer for SCID-X1 Using a Self-inactivating Lentiviral Vector|Gene Transfer for X-linked Severe Combined Immunodeficiency (SCID-X1) Using a Self-inactivating Lentiviral Vector|Recruiting||Phase 1/Phase 2|30|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||f|f|f||||||||2017-10-10 20:52:25.337127|2017-10-10 20:52:25.337127
NCT03217604|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-22|||July 13, 2017|Actual|2017-07-13|September 2017|2017-09-01|March 8, 2018|Anticipated|2018-03-08|March 8, 2018|Anticipated|2018-03-08||Interventional|||A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects|A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo-controlled, First-in-human Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Single Ascending Oral Doses Of Pf-06852231 Administered To Healthy Adult Subjects|Recruiting||Phase 1|24|Anticipated|Pfizer||2|||f||||f|f|f||||||||2017-10-10 20:52:25.44576|2017-10-10 20:52:25.44576
NCT03217591|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of IW-1973 in Patients With Type 2 Diabetes With Albuminuria Treated With Renin-Angiotensin System Inhibitors|Not yet recruiting||Phase 2|150|Anticipated|Ironwood Pharmaceuticals, Inc.||3|||f||||f|t|f||||||||2017-10-10 20:52:25.552208|2017-10-10 20:52:25.552208
NCT03217578|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-15|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|SMA||Neonatal Spinal Muscular Atrophy (SMA) Screening|Study on the Neonatal Screening of Spinal Muscular Atrophy|Not yet recruiting||N/A|250000|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f|f|f||||||||2017-10-10 20:52:25.641712|2017-10-10 20:52:25.641712
NCT03217565|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-13|||July 2, 2018|Anticipated|2018-07-02|September 2017|2017-09-01|October 15, 2020|Anticipated|2020-10-15|October 15, 2020|Anticipated|2020-10-15||Interventional|||A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)|A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate (MK-1986) in Inpatients Under 2 Years Old|Not yet recruiting||Phase 1|42|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f|t|f||||||||2017-10-10 20:52:25.718637|2017-10-10 20:52:25.718637
NCT03217552|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Observational|||The Performance of the Mologic Biomarker Panel in Infection|An Observational Study to Evaluate the Diagnostic and Predictive Accuracy of the Mologic Biomarker Panel in Patientsrnwith Severe Infection|Not yet recruiting||N/A|600|Anticipated|Mologic Ltd|||3||f||||f|f|f||||||||2017-10-10 20:52:25.813382|2017-10-10 20:52:25.813382
NCT03217539|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-13|||July 7, 1977|Actual|1977-07-07|July 2017|2017-07-01|December 31, 2015|Actual|2015-12-31|September 9, 1986|Actual|1986-09-09||Interventional|WE||The Swedish Two-County Trial of Mammography Screening|The Two-County Swedish Mammography Screening Trial|Completed||N/A|133065|Actual|Dalarna County Council, Sweden||2|||f||||t|f|f||||||||2017-10-10 20:52:25.888002|2017-10-10 20:52:25.888002
NCT03217526|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Gait Training in Patients With Burn Injury|Investigation of the Effect of Different Gait Training on Physical Functions in Patients With Lower Extremity Burn Injury|Not yet recruiting||N/A|24|Anticipated|Hacettepe University||2|||f||||t|f|f||||||||2017-10-10 20:52:25.959988|2017-10-10 20:52:25.959988
NCT03217513|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Knee Osteoarthritis Outcome Measures in Arthritic Patients With Osteoporosis|Pilot Study to Evaluate Knee Osteoarthritis Outcome Measures in Arthritic Patients Prescribed Forteo or Prolia for Osteoporosis|Not yet recruiting||N/A|20|Anticipated|Milton S. Hershey Medical Center|||2||f||||f|f|f|||f|Samples With DNA|"     blood and urine collected   "|||2017-10-10 20:52:26.042717|2017-10-10 20:52:26.042717
NCT03217500|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-17|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Corneal Epithelial Autograft for Pterygium|A Randomized Controlled Clinical Trial of Corneal Epithelial Autograft for Pterygium|Recruiting||N/A|45|Anticipated|Sun Yat-sen University||3|||f|||||f|f||||||||2017-10-10 20:52:26.127643|2017-10-10 20:52:26.127643
NCT03217487|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-17|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Corneal Epithelial Autograft for LSCD|A Randomized Controlled Clinical Trial of Corneal Epithelial Autograft for the Treatment of Limbal Stem Cell Deficiency|Recruiting||N/A|20|Anticipated|Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 20:52:26.224875|2017-10-10 20:52:26.224875
NCT03217474|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-17|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis|A Randomized Controlled Clinical Trial of Corneal Debridement for the Treatment of Herpes Simplex Epithelial Keratitis|Recruiting||N/A|100|Anticipated|Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 20:52:26.320808|2017-10-10 20:52:26.320808
NCT03217461|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-17|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Corneal Epithelial Autograft for Limbal Dermoid|A Randomized Controlled Clinical Trial of Corneal Epithelial Autograft for Limbal Dermoid|Recruiting||N/A|40|Anticipated|Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 20:52:26.422409|2017-10-10 20:52:26.422409
NCT03217448|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis|The Efficacy and Safety of Dabigatran Etexilate Comparing With Warfarin for the Anticoagulation Treatment of Cerebral Venous Thrombosis :a Pilot Study|Not yet recruiting||Phase 3|80|Anticipated|Capital Medical University||2|||f||||t|f|f||||||||2017-10-10 20:52:26.521738|2017-10-10 20:52:26.521738
NCT03217435|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-17|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Corneal Epithelial Allograft From Living-related Donor for LSCD|A Randomized Controlled Clinical Trial of Epithelial Allograft Transplantation From Living-related Donors for the Treatment of Limbal Stem Cell Deficiency|Recruiting||N/A|20|Anticipated|Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 20:52:26.603341|2017-10-10 20:52:26.603341
NCT03217422|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||December 7, 2017|Anticipated|2017-12-07|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|AMBER||ADCC Mediated B-Cell dEpletion and BAFF-R Blockade|A Two-part Randomized, Double-blind, Placebo-controlled Multicenter Dose Ranging and Confirmatory Study of the Safety and Efficacy of VAY736 in Autoimmune Hepatitis Patients With Incomplete Response to or Intolerance of Standard Therapy|Not yet recruiting||Phase 2/Phase 3|80|Anticipated|Novartis||4|||f||||t|t|f||||||||2017-10-10 20:52:26.718056|2017-10-10 20:52:26.718056
NCT03217409|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia|A Multicenter Clinical Trial to Compare the Efficacy and Safety Between Rosuvastatin/Ezetimibe Combination and Monotherapy of Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia|Not yet recruiting||Phase 4|88|Anticipated|Yuhan Corporation||2|||f||||f|f|f||||||||2017-10-10 20:52:26.835981|2017-10-10 20:52:26.835981
NCT03217396|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-13|||November 1, 2017|Anticipated|2017-11-01|June 2017|2017-06-01|September 30, 2020|Anticipated|2020-09-30|September 1, 2018|Anticipated|2018-09-01||Observational|||Biomarkers of Synaptic Damage in Multiple Sclerosis|Identification of New Biomarkers Useful to Define the Course of Multiple Sclerosis and Study of the Mechanisms That Promote Synaptic Damage|Not yet recruiting||N/A|150|Anticipated|Neuromed IRCCS|||3||f||||t|f|f||||Samples With DNA|"     blood samples   "|||2017-10-10 20:52:26.933896|2017-10-10 20:52:26.933896
NCT03217383|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance Therapy|Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance Therapy|Recruiting||N/A|61|Anticipated|Zephyr Sleep Technologies||1|||f||||t|f|f||||||||2017-10-10 20:52:27.002745|2017-10-10 20:52:27.002745
NCT03217370|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-11|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|||Study on Patient Blood Management in Haematological Patients|Study on Patient Blood Management in Haematological Patients|Not yet recruiting||N/A|500|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f||||||||2017-10-10 20:52:27.07893|2017-10-10 20:52:27.07893
NCT03217357|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-28|||January 5, 2018|Anticipated|2018-01-05|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|3S||tDCS, Stress and Risk for Schizophrenia|Effects of Transcranial Direct Current Stimulation on Stress Reactivity and Decision Making in Unaffected Siblings of Patients With Schizophrenia|Not yet recruiting||N/A|30|Anticipated|Hôpital le Vinatier||2|||f||||f|f|f||||||||2017-10-10 20:52:27.151686|2017-10-10 20:52:27.151686
NCT03217344|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-13|||October 19, 2015|Actual|2015-10-19|July 2017|2017-07-01|December 20, 2018|Anticipated|2018-12-20|December 20, 2018|Anticipated|2018-12-20||Interventional|||Conservative Treatment of Proximal Humeral Fractures|Conservative Treatment of Proximal Humeral Fractures - Immobilization for 1 Week Compared to Three Weeks: Prospective Randomized Study|Recruiting||N/A|130|Anticipated|Hospital del Mar||2|||f||||f|f|f||||||||2017-10-10 20:52:27.231975|2017-10-10 20:52:27.231975
NCT03217331|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-11|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices|CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|Cardiora Pty. Ltd.||1|||f||||f|t|f||||||||2017-10-10 20:52:27.310804|2017-10-10 20:52:27.310804
NCT03217318|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-13|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|July 15, 2019|Anticipated|2019-07-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||Reduction of Stent Associated Morbidity by Minimizing Stent Material.|"Reduction of Stent Associated Morbidity by Minimizing Stent Material: A Prospective Randomized Single-blind Study Assessing a Novel Suture-Stent."|Recruiting||N/A|84|Anticipated|Cantonal Hospital of St. Gallen||2|||f||||t|f|f||||||||2017-10-10 20:52:27.384276|2017-10-10 20:52:27.384276
NCT03217305|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-10-03|||August 30, 2016|Actual|2016-08-30|October 2017|2017-10-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Neurally Adjusted Ventilatory Assist (NAVA) vs Pressure Support Ventilation After Cardiac Surgery|NAVA vs Pressure Support After Cardiac Surgery, a Physiological Study|Recruiting||N/A|20|Anticipated|Sahlgrenska University Hospital, Sweden||1|||f||||f|f|f||||||||2017-10-10 20:52:27.471113|2017-10-10 20:52:27.471113
NCT03217292|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-13|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Serratus Anterior Plane Block for Pain Treatment After Video-Assisted Thoracoscopic Surgery|Evaluation of the Effect of Serratus Anterior Plane Block for Pain Treatment After Video-Assisted Thoracoscopic Surgery|Completed||N/A|40|Actual|Bursa Yüksek İhtisas Education and Research Hospital||2|||f|||||f|f||||||||2017-10-10 20:52:27.549587|2017-10-10 20:52:27.549587
NCT03217279|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-21|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Observational|TYBRA||Needs Assessment and Quality of Life of Stroke Patients and Their Caregivers|Typology of Needs and Quality of Life of Stroke Patients and Their Caregivers|Not yet recruiting||N/A|300|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:52:27.611704|2017-10-10 20:52:27.611704
NCT03217266|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-13|2017-09-04|||October 27, 2017|Anticipated|2017-10-27|July 2017|2017-07-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma|A Phase Ib Trial of Neoadjuvant AMG-232 Concurrent With Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)|Not yet recruiting||Phase 1|80|Anticipated|National Cancer Institute (NCI)||1|||||||f|t|f||||||||2017-10-10 20:52:27.68107|2017-10-10 20:52:27.68107
NCT03217253|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-12|||March 16, 2018|Anticipated|2018-03-16|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction|A Phase I Study of Single Agent Tazemetostat in Subjects With Advanced Solid Tumors and B-Cell Lymphomas With Hepatic Dysfunction|Not yet recruiting||Phase 1|48|Anticipated|National Cancer Institute (NCI)||1|||||||f|t|f||||||||2017-10-10 20:52:27.819776|2017-10-10 20:52:27.819776
NCT03217240|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||June 5, 2017|Actual|2017-06-05|July 2017|2017-07-01|August 30, 2019|Anticipated|2019-08-30|January 2019|Anticipated|2019-01-01||Observational|||Integrated Computational modelIng of Right Heart Mechanics and Blood Flow Dynamics in Congenital Heart Disease|"Integrated Computational modelIing of Right Heart Mechanics and Blood Flow Dynamics in Congenital Heart Disease (INITIATE)"|Recruiting||N/A|400|Anticipated|National Heart Centre Singapore|||2||f||||f|f|f||||Samples Without DNA|"     Serum samples will be obtained before CMR. The sample will be stored at -80 degree until     assay. Investigators will perform various tests related to participants heart function   "|||2017-10-10 20:52:27.916416|2017-10-10 20:52:27.916416
NCT03217227|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||May 1, 2017|Actual|2017-05-01|February 2017|2017-02-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01||Observational|EMPIRE||Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR|Evaluating Myocardial Ischaemia in Chest Pain Using Cardiovascular Magnetic Resonance (CMR) Imaging Exercise Bike|Recruiting||N/A|300|Anticipated|National Heart Centre Singapore|||2||f||||f|f|f||||Samples With DNA|"     Approximately 30mL of blood in total will be drawn, where 25mL (equivalent to 5 teaspoons) of     blood will be drawn before the exercise stress test and 5mL (equivalent to 1 teaspoon) of     blood will be drawn after the exercise stress test.      Blood samples will be collected from all participants.   "|||2017-10-10 20:52:28.041628|2017-10-10 20:52:28.041628
NCT03217214|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|INDICES||Investigation of Contact Based Method for Diagnosis of Cardiovascular Disease|Investigation of a Non-invasive/ Minimally Contact Based Method for Diagnosis of Cardiovascular Disease: Blockage(Stenosis) and Blood Flow|Not yet recruiting||N/A|100|Anticipated|National Heart Centre Singapore|||2||f||||f|f|f||||||||2017-10-10 20:52:28.160326|2017-10-10 20:52:28.160326
NCT03217201|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-06|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2022|Anticipated|2022-04-30||Interventional|||Systematic Light Exposure to Treat Cancer-Related Fatigue|Systematic Light Exposure to Treat Cancer-Related Fatigue in Breast Cancer Patients|Not yet recruiting||N/A|248|Anticipated|Icahn School of Medicine at Mount Sinai||4|||f||||f|f|t|f|||||||2017-10-10 20:52:28.265813|2017-10-10 20:52:28.265813
NCT03217188|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-05|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Proton Re-Irradiation for Recurrent Head and Neck Cancer|A Phase II Study of Proton Re-Irradiation for Recurrent Head and Neck Cancer|Recruiting||Phase 2|88|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||f|t|f||f|||||2017-10-10 20:52:28.35968|2017-10-10 20:52:28.35968
NCT03217175|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-21|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise|Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||2|||f||||t|f|t|t|f||||||2017-10-10 20:52:28.466787|2017-10-10 20:52:28.466787
NCT03217162|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|||Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS)|Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t|f|f||||||||2017-10-10 20:52:28.556216|2017-10-10 20:52:28.556216
NCT03217149|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 30, 2020|Anticipated|2020-08-30|August 30, 2020|Anticipated|2020-08-30||Interventional|||Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)|Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t|f|f||||||||2017-10-10 20:52:28.644443|2017-10-10 20:52:28.644443
NCT03217136|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-09-08|||December 22, 2017|Anticipated|2017-12-22|September 2017|2017-09-01|September 6, 2020|Anticipated|2020-09-06|September 6, 2020|Anticipated|2020-09-06||Interventional|||MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)|A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem in Pediatric Subjects With Complicated Intra-Abdominal Infection|Not yet recruiting||Phase 2|120|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t|t|f||||||||2017-10-10 20:52:30.335738|2017-10-10 20:52:30.335738
NCT03217123|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||January 1, 2011|Actual|2011-01-01|July 2017|2017-07-01|June 30, 2015|Actual|2015-06-30|December 31, 2014|Actual|2014-12-31||Interventional|10/131||Deep-brain Stimulation in Obsessive-compulsive Disorder: Randomized, Double-blinded Clinical Trial|Deep-brain Stimulation in Obsessive-compulsive Disorder|Completed||N/A|7|Actual|Hospital San Carlos, Madrid||1|||f||||f|f|f||||||||2017-10-10 20:52:30.430674|2017-10-10 20:52:30.430674
NCT03217110|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-06|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|||Cerebellar Stimulation and Cognitive Control|Cerebellar Transcranial Magnetic Stimulation and Cognitive Control|Not yet recruiting||N/A|200|Anticipated|University of Iowa||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:52:30.509154|2017-10-10 20:52:30.509154
NCT03217097|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-13|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|October 2020|Anticipated|2020-10-01||Interventional|MGMT-NET||O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents and Interest of Oxaliplatin in Patients With Unmethylated MGMT NET.|O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents and Interest of Oxaliplatin in Patients With Unmethylated MGMT NET. A Randomized Phase II Study.|Not yet recruiting||Phase 2|99|Anticipated|Hospices Civils de Lyon||4|||f||||t|f|f||||||||2017-10-10 20:52:30.612204|2017-10-10 20:52:30.612204
NCT03217084|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Treatment of Postorthodontic White Spot Lesions|Esthetic Effect of Casein Phosphopeptide-Amorphous Calcium Phosphate Varnish Versus Tricalcium Phosphate Varnish on Postorthodontic White Spot Lesions: A Randomized Pilot Study|Not yet recruiting||Phase 4|20|Anticipated|Cairo University||2|||f||||t|t|f|||t|||||2017-10-10 20:52:30.711443|2017-10-10 20:52:30.711443
NCT03217071|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-28|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer|PembroX: Enhancing the Immunogenicity of Non-Small Cell Lung Cancer With Pembrolizumab +/- Stereotactic Radiotherapy Delivered in the Preoperative Window, A Randomized Phase II Study With Correlative Biomarkers|Recruiting||Phase 2|40|Anticipated|University of California, San Francisco||2|||f|||||t|f|||t|||||2017-10-10 20:52:30.788536|2017-10-10 20:52:30.788536
NCT03217058|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-12|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2020|Anticipated|2020-08-01||Observational|PACE||Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care|Implementing Computerized Substance Use and Depression Screening and Evidence-based Treatments in an HIV Primary Care Population|Not yet recruiting||N/A|4600|Anticipated|University of California, San Francisco|||2||f||||f|f|f||||||||2017-10-10 20:52:30.887704|2017-10-10 20:52:30.887704
NCT03217045|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||May 1, 2013|Actual|2013-05-01|July 2017|2017-07-01|April 1, 2017|Actual|2017-04-01|October 31, 2014|Actual|2014-10-31||Observational|Nutriproto||Nutrition Protocol and Premature Infants' Growth|Impact of Introducing a Standardized Nutrition Protocol on Very Premature Infants' Growth and Morbidity|Completed||N/A|158|Actual|Central Hospital, Nancy, France|||2||f||||f|f|f||||||||2017-10-10 20:52:30.976757|2017-10-10 20:52:30.976757
NCT03217032|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-30|||July 15, 2017|Actual|2017-07-15|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Gene Modified autoHST for Type A or B Hemophilia|Gene Modified Autologous Hematopoeitic Stem Cell for Type A or B Hemophilia|Enrolling by invitation||Phase 1/Phase 2|10|Anticipated|Shenzhen Geno-Immune Medical Institute||2|||f||||f|f|f||||||||2017-10-10 20:52:31.045022|2017-10-10 20:52:31.045022
NCT03217019|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-13|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Guidewire-assisted Radial A-line in Neonate and Infant|Comparison of Radial Artery Cannulation Technique in Pediatric Patients: Direct Versus Guidewire-assisted|Not yet recruiting||N/A|90|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 20:52:31.691662|2017-10-10 20:52:31.691662
NCT03217006|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-18|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|March 31, 2022|Anticipated|2022-03-31|November 30, 2021|Anticipated|2021-11-30||Interventional|ROMA||Randomization of Single vs Multiple Arterial Grafts|Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial|Not yet recruiting||N/A|4300|Anticipated|Weill Medical College of Cornell University||2|||f||||t|f|f||||||||2017-10-10 20:52:31.918856|2017-10-10 20:52:31.918856
NCT03216993|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-12|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|October 1, 2021|Anticipated|2021-10-01|December 31, 2020|Anticipated|2020-12-31||Interventional|||An Early Enteral Nutrition Protocol in Shanghai|The Shanghai Protocol for Early Enteral Nutrition in Mechanical Ventilated Patients|Not yet recruiting||N/A|400|Anticipated|Ruijin Hospital||2|||f||||f|f|f||||||||2017-10-10 20:52:32.052368|2017-10-10 20:52:32.052368
NCT03216980|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-11|||May 15, 2017|Actual|2017-05-15|July 2017|2017-07-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2019|Anticipated|2019-05-15||Interventional|||Examining the Effect of Posttraumatic Stress Disorder on Vascular Function and Exercise Tolerance|Examining the Effect of Posttraumatic Stress Disorder on Vascular Function and Exercise Tolerance|Recruiting||N/A|120|Anticipated|Virginia Commonwealth University||4|||f||||t|f|f||||||||2017-10-10 20:52:32.156187|2017-10-10 20:52:32.156187
NCT03216967|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-11|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|December 1, 2022|Anticipated|2022-12-01|July 1, 2021|Anticipated|2021-07-01||Interventional|BK EVER||Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.|Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia After Reduction of Immunosuppression Alone vs. Reduction of Immunosuppression and Replacement of Mycophenolate Mofetil by Everolimus|Not yet recruiting||Phase 4|130|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||||2017-10-10 20:52:32.270826|2017-10-10 20:52:32.270826
NCT03216954|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-10-02|||September 15, 2017|Actual|2017-09-15|October 2017|2017-10-01|December 14, 2019|Anticipated|2019-12-14|September 14, 2019|Anticipated|2019-09-14||Interventional|||Influence of n-Acetylcysteine Maintenance on Alcohol Effects|A Human Laboratory Study of n-Acetylcysteine for Alcohol Use Disorder|Recruiting||Early Phase 1|25|Anticipated|University of Kentucky||3|||f||||f|t|f|||t|||||2017-10-10 20:52:32.348466|2017-10-10 20:52:32.348466
NCT03216941|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-11|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|January 31, 2016|Actual|2016-01-31|January 1, 2016|Actual|2016-01-01||Interventional|IM-OK-FAST||Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward|Prospective Randomised Double Blind Trial of Ketiapine and Olanzapine Comparative Efficacy for Fast Sedation of Severely Agitated Patients in Emergency Psychiatric Ward|Completed||Phase 4|500|Actual|Universidad Nacional de Rosario||2|||f||||t|f|f||||||||2017-10-10 20:52:32.465424|2017-10-10 20:52:32.465424
NCT03216928|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-11|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TNF-RS-PR||A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis|Pilot Study Investigating a New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis|Recruiting||N/A|30|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||||2017-10-10 20:52:32.554453|2017-10-10 20:52:32.554453
NCT03216915|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-12|||June 1, 2013|Actual|2013-06-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|FINGORHYMS||Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis|FINGORHYMS - Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis|Recruiting||N/A|100|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f|f|f||||||||2017-10-10 20:52:32.645942|2017-10-10 20:52:32.645942
NCT03216902|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-03|||July 25, 2017|Actual|2017-07-25|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study|A Phase IIb, Randomized, Observer-Masked, Placebo- and Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-126 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study|Recruiting||Phase 2|220|Anticipated|Santen Inc.||6|||f||||f|t|f||||||||2017-10-10 20:52:32.740731|2017-10-10 20:52:32.740731
NCT03216889|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Cognitive Behavioral Therapy for Insomnia to Address Insomnia Symptoms in People With Multiple Sclerosis|Cognitive Behavioral Therapy for Insomnia to Address Insomnia Symptoms in People With Multiple Sclerosis|Recruiting||N/A|60|Anticipated|University of Kansas Medical Center||2|||f|||||f|f||||||||2017-10-10 20:52:32.911875|2017-10-10 20:52:32.911875
NCT03216876|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study Of Ursolic Acid For Primary Sclerosing Cholangitis|An Open-Label Study Of Ursolic Acid For Primary Sclerosing Cholangitis|Withdrawn||Phase 1|0|Actual|University of California, Davis||3||Lack of feasibility|f||||t|t|f||||||||2017-10-10 20:52:32.989292|2017-10-10 20:52:32.989292
NCT03216863|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||August 3, 2015|Actual|2015-08-03|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Home Respiratory Rehabilitation in Advanced Lung Cancer Chemotherapy Per os|Home Respiratory Rehabilitation in Patients With Lung Cancer Non-small Cell Advanced or Metastatic Treated With Oral Targeted Therapy|Recruiting||N/A|50|Anticipated|University Hospital, Lille||1|||f||||f||||||||||2017-10-10 20:52:33.093321|2017-10-10 20:52:33.093321
NCT03216850|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-14|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Evaluation of Lipid Emulsion on GCX in Critically Ill Patients|Alterations of Glycocalyx in Critical Illness and During Major Surgery and Approaches for Glycocalyx Protection. Effect of Parenteral Nutrition and Plasma Lipidome on GCX|Not yet recruiting||N/A|15|Anticipated|University Hospital Hradec Kralove|||1||f||||f|f|f||||||||2017-10-10 20:52:33.187268|2017-10-10 20:52:33.187268
NCT03216837|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-07-12|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|SPORT||Stimulation for Perinatal Stroke Optimizing Recovery Trajectories|Stimulation for Perinatal Stroke Optimizing Recovery Trajectories|Recruiting||Phase 2/Phase 3|80|Anticipated|University of Calgary||2|||f||||t|f|f||||||||2017-10-10 20:52:33.272076|2017-10-10 20:52:33.272076
NCT03216824|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-15|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||CVAD-Associated Skin Impairment in Allogeneic Stem Cell Transplant Recipients: Dressing vs No-Dressing|CVAD-Associated Skin Impairment: A Pilot Study Comparing Dressing to No-Dressing in Adult Allogeneic Stem Cell Transplant Recipients|Recruiting||N/A|26|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 20:52:33.38508|2017-10-10 20:52:33.38508
NCT03216811|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-12|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|NIRVANA||Nutraceutical in Cardiovascular Primary Prevention|Nutraceutical Compound to Optimize Cholesterol, Endothelial and Inflammatory Parameters in Subjects With Hypercholesterolemia and Low to Moderate Cardiovascular Risk: the NIRVANA Study|Active, not recruiting||Phase 2|52|Anticipated|University Hospital of Ferrara||1|||f||||t|f|f||||||||2017-10-10 20:52:33.495365|2017-10-10 20:52:33.495365
NCT03216798|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-23|||July 15, 2017|Actual|2017-07-15|June 2017|2017-06-01|July 15, 2022|Anticipated|2022-07-15|July 15, 2018|Anticipated|2018-07-15||Observational|||Client and Provider Preferences for HIV Care|Client and Provider Preferences for HIV Care: Implications for Implementing Differentiated Service Delivery in Thailand|Recruiting||N/A|370|Anticipated|Thai Red Cross AIDS Research Centre|||1||f||||t|f|f||||||||2017-10-10 20:52:33.571301|2017-10-10 20:52:33.571301
NCT03216772|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-08-01|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Safety and Efficacy of Using PK Morcellator With Pneumoliner Containment Hysterectomy|Safety and Efficacy of Using PK Morcellator With Pneumoliner Bag for Laparoscopic Morcellation With Laparoscopic Instrument for Tissue Containment and Removal During Laparoscopic Supracervical Hysterectomy or Total Laparoscopic Hysterectomy|Not yet recruiting||N/A|140|Anticipated|Olympus Surgical Technologies Europe||1|||||||t|f|t|f|f||||||2017-10-10 20:52:33.833445|2017-10-10 20:52:33.833445
NCT03216759|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|CIPS||Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal Complications|Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal Complications in Patients Undergoing Laparotomy With General Anesthesia|Not yet recruiting||N/A|182|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t|f|f||||||||2017-10-10 20:52:33.923305|2017-10-10 20:52:33.923305
NCT03216746|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-18|||December 1, 2016|Actual|2016-12-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Oral Health Educational Methods in Adolescence|Educational Methods in Oral Health for Adolescents: Influence on Knowledge and Oral Clinical Conditions|Active, not recruiting||N/A|291|Actual|Universidade Federal do Paraná||4|||f||||t|f|f||||||||2017-10-10 20:52:34.01335|2017-10-10 20:52:34.01335
NCT03216733|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-11|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 31, 2028|Anticipated|2028-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|SORT OUT X||SORT OUT X - Combo Stent Versus ORSIRO Stent|Randomized Clinical Comparison of a Combined Sirolimus Eluting and Endothelial Progenitor Cell COMBO Stent With a Sirolimus-eluting OSIRO Stent in Patients Treated With Percutaneous Coronary Intervention - The SORT-OUT X Study|Recruiting||N/A|3140|Anticipated|Aarhus University Hospital Skejby||2|||f||||t|f|f||||||||2017-10-10 20:52:34.104066|2017-10-10 20:52:34.104066
NCT03216720|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-09-26|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||Miniaturized Extracorporeal Circulation Study|The Impact of Miniaturized Extracorporeal Circulation on Thrombin Generation and Postoperative Blood Loss|Recruiting||N/A|60|Anticipated|Aarhus University Hospital Skejby||2|||f||||f|f|f||||||||2017-10-10 20:52:34.23138|2017-10-10 20:52:34.23138
NCT03216707|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-31|||September 1, 2017|Actual|2017-09-01|August 2017|2017-08-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Interventional|||High Definition Transcranial Direct Current Stimulation Motor Cortex Versus Insula|The Effects of High Definition Transcranial Direct Current Stimulation Over Primary Motor Cortex Versus Insular Cortical Targets on Experimental Capsaicin Induced Hyperalgesia and Pain in Healthy Volunteers|Recruiting||N/A|30|Anticipated|Assiut University||3|||f||||f|f|f|||f|||||2017-10-10 20:52:34.979109|2017-10-10 20:52:34.979109
NCT03216694|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||July 21, 2017|Anticipated|2017-07-21|July 2017|2017-07-01|July 28, 2017|Anticipated|2017-07-28|July 21, 2017|Anticipated|2017-07-21||Observational|||The Association Between Preoperative CPEX and Postoperative Morbidity Following Oesophagectomy|The Association Between Preoperative Cardiopulmonary Exercise Test Variables and Short-term Postoperative Morbidity Following Oesophagectomy: a Hospital-based Cohort Study|Not yet recruiting||N/A|254|Anticipated|University of East Anglia|||1||f||||f|f|f||||||||2017-10-10 20:52:35.17716|2017-10-10 20:52:35.17716
NCT03216681|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-11|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|February 1, 2018|Anticipated|2018-02-01||Observational|||Hoat Huyet Nhat Nhat Versus Tanakan for Treatment of Symptoms Related to the Insufficient Blood Supply to the Brain|An Observational, Open Label, Post Marketing Study to Evaluate the Safety and Effectiveness of Hoat Huyet Nhat Nhat Compared With Gingko Biloba EGb761 (Tanakan 40mg) in Patients With Symptoms Related to the Insufficient Blood Supply to the Brain|Recruiting||N/A|750|Anticipated|Nhat Nhat Pharmaceutical Company|||2||f||||f|f|f||||||||2017-10-10 20:52:35.251604|2017-10-10 20:52:35.251604
NCT03216668|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-11|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||TONKA Versus Legalon for Lowering Hepatic Enzymes in Liver Function Disorder Patients.|A Randomized, Active-Control, Open Label, Phase IIIb Study to Evaluate the Safety and Efficacy of TONKA Compared With Silymarin (Legalon) for Lowering Hepatic Enzymes in Liver Function Disorder Patients With Moderate to High Elevated Liver|Recruiting||Phase 3|140|Anticipated|Nhat Nhat Pharmaceutical Company||2|||f|||||f|f||||||||2017-10-10 20:52:35.367694|2017-10-10 20:52:35.367694
NCT03216655|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-11|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Individual vs Cohort Long Distance Advising for Mental Care for Congenital Cataract Guardians|Comparison of Individual and Cohort Long Distance Advising for Mental Care for Congenital Cataract Guardians|Recruiting||N/A|80|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 20:52:35.512107|2017-10-10 20:52:35.512107
NCT03216642|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-26|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|April 17, 2018|Anticipated|2018-04-17|April 17, 2018|Anticipated|2018-04-17|2 Months|Observational [Patient Registry]|||The Study of Bacteriology and Pathogen Drug Sensitivity of Chronic Dacryocystitis|The Study of Bacteriology and Pathogen Drug Sensitivity of Chronic Dacryocystitis|Recruiting||N/A|100|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     Secretions from the lacrimal punctum   "|||2017-10-10 20:52:35.622822|2017-10-10 20:52:35.622822
NCT03216629|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Sorry Not Sorry: Apologizing and Its Effect on Discomfort During Dressing Removal|Sorry Not Sorry: Apologizing and Its Effect on Discomfort During Dressing Removal|Not yet recruiting||N/A|30|Anticipated|London Health Sciences Centre||2|||f||||f|f|f||||||||2017-10-10 20:52:35.727559|2017-10-10 20:52:35.727559
NCT03216616|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-11|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Guided Self-Management Intervention Targeting Fatigue in Rheumatic Inflammatory Diseases|Guided Self-Management Intervention Targeting Fatigue in Rheumatic Inflammatory Diseases|Completed||N/A|40|Actual|Diakonhjemmet Hospital||1|||f||||f|f|f||||||||2017-10-10 20:52:35.831922|2017-10-10 20:52:35.831922
NCT03214276|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||January 1, 2012|Actual|2012-01-01|July 2017|2017-07-01|July 1, 2012|Actual|2012-07-01|June 1, 2012|Actual|2012-06-01||Interventional|||Effects of Polyphenols Supplementation on Cycling Endurance|Effects of Acute Specific Grape and Apple Polyphenols Supplementation on Cycling Endurance Performance|Completed||N/A|48|Actual|University of Burgundy||2|||f|||||f|f||||||||2017-10-10 20:52:57.852508|2017-10-10 20:52:57.852508
NCT03216603|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-12|||September 4, 2017|Anticipated|2017-09-04|July 2017|2017-07-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Health Literacy in People With Chronic Obstructive Pulmonary Disease|Health Literacy. An Intervention on Organized Information and Health Care for People With Chronic Obstructive Pulmonary Disease (COPD)|Not yet recruiting||N/A|200|Anticipated|Lovisenberg Diakonale Hospital||2|||f||||f|f|f||||||||2017-10-10 20:52:35.922039|2017-10-10 20:52:35.922039
NCT03216590|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-12|||July 20, 2017|Anticipated|2017-07-20|July 2017|2017-07-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20||Interventional|||The Effect of Draping on Swelling in Shoulder Arthroscopy|Can Preoperative Compressive Draping Reduce Soft Tissue Swelling During Shoulder Arthroscopy? A Prospective Randomized Trial|Not yet recruiting||N/A|50|Anticipated|Hillel Yaffe Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:52:36.031411|2017-10-10 20:52:36.031411
NCT03216577|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-27|||July 27, 2017|Actual|2017-07-27|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|December 31, 2017|Anticipated|2017-12-31||Observational|hOPeFUL||Outcomes of Purpura FULminans in Adults - The hOPeFUL Study|Short and Long-term Outcomes of Purpura Fulminans in Adults|Recruiting||N/A|80|Anticipated|Henri Mondor University Hospital|||2||f||||t|f|f||||||||2017-10-10 20:52:36.135433|2017-10-10 20:52:36.135433
NCT03216564|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-13|||May 10, 2017|Actual|2017-05-10|July 2017|2017-07-01|May 10, 2019|Anticipated|2019-05-10|May 10, 2019|Anticipated|2019-05-10||Interventional|IDEAL-2||An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes|Intervention Using Vitamin D for Elevated Urinary ALbumin in Diabetes (IDEAL-2)|Recruiting||Phase 3|320|Anticipated|Hamad Medical Corporation||2|||f||||t|f|f||||||||2017-10-10 20:52:36.851935|2017-10-10 20:52:36.851935
NCT03216551|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-14|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 15, 2019|Anticipated|2019-08-15|July 31, 2019|Anticipated|2019-07-31||Observational|||Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC|Evaluation the Staging Accuracy of a Selective Mediastinal Lymphadenectomy Strategy Based on Frozen Section Diagnosis and Tumor Location in cT1N0M0 Non-small Cell Lung Cancer|Not yet recruiting||N/A|405|Anticipated|Fudan University|||1||f||||f|f|f||||||||2017-10-10 20:52:36.953725|2017-10-10 20:52:36.953725
NCT03216538|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-16|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD)|A Phase I/II, Single-center, Randomized Double Masked Placebo Controlled Study to Evaluate the Safety and Efficacy of Treatment With AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD)|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Feramda||2|||f||||f|f|f||||||||2017-10-10 20:52:37.065597|2017-10-10 20:52:37.065597
NCT03216525|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-07-11|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol|A Randomized, Double-blind, Single-Center Trial of Alvimopan (Entereg) Versus Placebo in Patients Undergoing Radical Cystectomy and Urinary Diversion on an Enhanced Recovery After Surgery ERAS Protocol|Not yet recruiting||Phase 3|136|Anticipated|Brigham and Women's Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:52:37.164192|2017-10-10 20:52:37.164192
NCT03216512|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD|A Randomized, Sham-Controlled, Crossover Study to Evaluate the Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in Children and Adolescents Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)|Not yet recruiting||N/A|30|Anticipated|Duke University||2|||f||||f|f|t|t||f|||||2017-10-10 20:52:37.257894|2017-10-10 20:52:37.257894
NCT03216499|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-28|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|May 31, 2018|Anticipated|2018-05-31||Interventional|PT2385||HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma|Single-Arm, Open-Label Phase II Efficacy Study of First-in-Class HIF2-Alpha Inhibitor, PT2385, for Patients With Recurrent Glioblastoma|Recruiting||Phase 2|35|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 20:52:37.333364|2017-10-10 20:52:37.333364
NCT03216473|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||May 25, 2016|Actual|2016-05-25|July 2017|2017-07-01|July 4, 2017|Actual|2017-07-04|March 17, 2017|Actual|2017-03-17||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm|A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Study to Evaluate the Efficacy and Safety of NEURONOX® vs. BOTOX® in Patients With Essential Blepharospasm|Completed||Phase 3|140|Actual|Medy-Tox||2|||f||||f|f|f||||||||2017-10-10 20:52:37.558251|2017-10-10 20:52:37.558251
NCT03216460|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-24|||July 11, 2017|Actual|2017-07-11|July 2017|2017-07-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Interventional|||Insulet Artificial Pancreas Free-Living IDE3|Evaluating Glucose Control in Patients With Type 1 Diabetes Under Free-living Conditions With the Insulet Automated Glucose Control System: IDE3|Recruiting||N/A|48|Anticipated|Insulet Corporation||1|||f||||f|f|t|t|f||||||2017-10-10 20:52:37.77255|2017-10-10 20:52:37.77255
NCT03216447|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-07|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|August 31, 2019|Anticipated|2019-08-31||Interventional|||A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant|A Prospective, Multi-center, Open-labeled, Randomized Clinical Trial of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant Recipients to Compare QD Early Conversion and BID Tacrolimus Formulation.|Not yet recruiting||Phase 4|150|Anticipated|Chang Gung Memorial Hospital||2|||f||||f|f|f||||||||2017-10-10 20:52:37.897784|2017-10-10 20:52:37.897784
NCT03212859|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-26|||November 6, 2017|Anticipated|2017-11-06|June 2017|2017-06-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Coach2Move: Sustainable in Daily Practice|Coach2Move: Sustainable in Daily Practice|Not yet recruiting||N/A|400|Anticipated|Radboud University||2|||f||||f|f|f||||||||2017-10-10 20:53:11.199383|2017-10-10 20:53:11.199383
NCT03216434|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|August 2019|Anticipated|2019-08-01||Interventional|||Striatal Dopamine Transporter Density in Post-Traumatic Stress Disorder (PTSD)|Striatal Dopamine Transporter Density in Post-Traumatic Stress Disorder (PTSD)|Not yet recruiting||N/A|50|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||t|f|f|||t|||||2017-10-10 20:52:37.983396|2017-10-10 20:52:37.983396
NCT03216421|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||June 6, 2017|Actual|2017-06-06|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Intraoperative Radiation Therapy (IORT) in DCIS|Locoregional Breast Cancer Recurrence Following Targeted Intraoperative Radiotherapy (IORT) for Ductal Carcinoma in Situ (DCIS)|Recruiting||N/A|265|Anticipated|Columbia University||2|||f||||t|f|f||||||||2017-10-10 20:52:38.08567|2017-10-10 20:52:38.08567
NCT03216408|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-12|2017-07-12|||March 30, 2016|Actual|2016-03-30|July 2017|2017-07-01|March 7, 2017|Actual|2017-03-07|November 10, 2016|Actual|2016-11-10||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines|A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Study to Evaluate the Efficacy and Safety of NEURONOX® vs. BOTOX® in Patients With Moderate to Severe Glabellar Lines|Completed||Phase 3|504|Actual|Medy-Tox||2|||f||||f|f|f||||||||2017-10-10 20:52:38.187452|2017-10-10 20:52:38.187452
NCT03216395|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-18|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|January 31, 2020|Anticipated|2020-01-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Over-the-scope Clips and Standard Treatments in Endoscopic Control of Acute Bleeding From Non-variceal Upper GI Causes|Over-the-scope Clips and Standard Treatments in Endoscopic Control of of Acute Bleeding From Non-variceal Upper GI Causes(OTSC Study)|Not yet recruiting||N/A|200|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:52:38.264501|2017-10-10 20:52:38.264501
NCT03216382|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-04|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Impact of the Attention Training Technique on Attention Control and High Worry|The Impact of the Attention Training Technique on Attention Control and High Worry|Recruiting||N/A|100|Anticipated|Ryerson University||2|||f||||f|f|f||||||||2017-10-10 20:52:38.386309|2017-10-10 20:52:38.386309
NCT03216369|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||November 2015||2015-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|1 Year|Observational [Patient Registry]|||Short- and Long-Term Hemodynamic Effects of Carotid Endarterectomy and Carotid Artery Stenting|Short- and Long-Term Hemodynamic Effects Revealed by Arterial Spin Labeling MRI of Carotid Endarterectomy and Carotid Artery Stenting|Recruiting||N/A|150|Anticipated|Chinese PLA General Hospital|||1||f||||||||||||||2017-10-10 20:52:38.500304|2017-10-10 20:52:38.500304
NCT03216356|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-07-12|||September 2016||2016-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD|Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD|Recruiting||Phase 2/Phase 3|60|Anticipated|Boston University Charles River Campus||3|||f||||f||||||||||2017-10-10 20:52:38.587806|2017-10-10 20:52:38.587806
NCT03216343|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-11|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase Ib Study of Chiauranib in Patients With Small Cell Lung Cancer|Efficacy and Safety of Chiauranib in Relapsed/Refractory Small Cell Lung Cancer: a Single-arm, Open-label, Multi-center, Exploratory Phase Ib Study|Not yet recruiting||Phase 1|27|Anticipated|Chipscreen Biosciences, Ltd.||1|||f|||||f|f||||||||2017-10-10 20:52:38.712353|2017-10-10 20:52:38.712353
NCT03216330|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-11|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Dyspareunia and Central Sensitization|Endometriosis Deep Dyspareunia and Central Sensitization|Enrolling by invitation||N/A|50|Anticipated|BC Women's Hospital & Health Centre|||2||f||||f|f|f||||||||2017-10-10 20:52:38.797695|2017-10-10 20:52:38.797695
NCT03216317|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-09|||July 15, 2017|Actual|2017-07-15|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Isometric Training on Blood Pressure and on the Autonomic Modulation of Hypertensive Patients|Effect of Handgrip's Isometric Training on Blood Pressure and on the Autonomic Modulation of Hypertense Individuals at the Basic Health Units: A Multicentric Study|Recruiting||N/A|160|Anticipated|Hospital Israelita Albert Einstein||2|||f||||t|f|f||||||||2017-10-10 20:52:38.896984|2017-10-10 20:52:38.896984
NCT03216304|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-31|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Interventional|||Safinamide Steady State Interaction With Rosuvastatin|Drug Interaction Study of Safinamide and a BCRP Substrate, Rosuvastatin, Concomitantly Administered to Healthy Volunteers|Completed||Phase 1|24|Actual|Cross Research S.A.||2|||f||||f|f|f||||||||2017-10-10 20:52:38.994533|2017-10-10 20:52:38.994533
NCT03216291|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-07-12|||October 2015||2015-10-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Home Versus Office Biofeedback Therapy for Fecal Incontinence|Home Versus Office Biofeedback Therapy for Fecal Incontinence|Recruiting||N/A|30|Anticipated|Augusta University||2|||f||||f||||||||||2017-10-10 20:52:39.097441|2017-10-10 20:52:39.097441
NCT03216278|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-15|||September 26, 2017|Anticipated|2017-09-26|September 2017|2017-09-01|November 16, 2017|Anticipated|2017-11-16|November 16, 2017|Anticipated|2017-11-16||Interventional|||The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions|A Two Part Bioequivalence Study to Compare Two Fixed Dose Combination (FDC) Tablets of Dapagliflozin/Metformin XR 5/500 mg (Part 1) and 10/1000 mg (Part 2) Manufactured at Two Different Plants (Humacao, Puerto Rico and Mount Vernon, US) in Healthy Subjects Under Fasting and Fed Conditions|Not yet recruiting||Phase 1|88|Anticipated|AstraZeneca||8|||f||||f|t|f|||t|||||2017-10-10 20:52:39.194247|2017-10-10 20:52:39.194247
NCT03216265|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||February 23, 2017|Actual|2017-02-23|July 2017|2017-07-01|April 24, 2017|Actual|2017-04-24|April 19, 2017|Actual|2017-04-19||Interventional|||A Proof of Concept Clinical Study to Investigate the Effects of an Experimental Cosmetic Moisturiser on the Barrier Function of Human Skin on the Face and Forearm|A Proof of Concept (POC) Clinical Study to Investigate the Effects of a Developmental Cosmetic Moisturising Cream on the Barrier Function of Human Skin on the Face and Forearm|Completed||N/A|93|Actual|GlaxoSmithKline||3|||f||||f|f|f||||||||2017-10-10 20:52:39.315116|2017-10-10 20:52:39.315116
NCT03216252|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-11|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||DNA QUANTIFICATION TECHNIQUE AS A INTERPRETATION TOOL IN MITOCHONDRIAL DISEASES|IMPLEMENTING A SINGLE MUSCLE FIBER DNA QUANTIFICATION TECHNIQUE AS A INTERPRETATION TOOL FOR THE VARIANTS OF UNKNOWN SERVICE IN MITOCHONDRIAL DISEASES|Not yet recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f|f|f||||||||2017-10-10 20:52:39.412212|2017-10-10 20:52:39.412212
NCT03216239|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||February 24, 2015|Actual|2015-02-24|February 2015|2015-02-01|February 26, 2016|Actual|2016-02-26|February 26, 2016|Actual|2016-02-26||Observational|||SIBO & SIFO After Colectomy|Does Colectomy Predispose to Small Intestinal Bacterial (SIBO) and Fungal Overgrowth (SIFO)|Completed||N/A|100|Actual|Augusta University|||2||f||||f|f|f||||||||2017-10-10 20:52:39.474596|2017-10-10 20:52:39.474596
NCT03216226|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|February 27, 2018|Anticipated|2018-02-27|February 27, 2018|Anticipated|2018-02-27||Interventional|||A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus|A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)|Recruiting||Phase 3|112|Anticipated|Zealand Pharma||2|||f|||||t|f||||||||2017-10-10 20:52:39.529145|2017-10-10 20:52:39.529145
NCT03216213|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-20|||June 2016||2016-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Evaluating Attitudes Towards Organ Donation in Singapore||Recruiting||N/A|1700|Anticipated|Yale-NUS College||5|||f||||f||||||||||2017-10-10 20:52:39.64627|2017-10-10 20:52:39.64627
NCT03216200|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)|A Single Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.|Recruiting||N/A|5|Anticipated|DeviceFarm, Inc.||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:52:39.728567|2017-10-10 20:52:39.728567
NCT03216187|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-10-01|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 1, 2021|Anticipated|2021-11-01|November 1, 2020|Anticipated|2020-11-01||Interventional|PREVENT||Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery|Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery|Not yet recruiting||Phase 3|300|Anticipated|University Hospital, Geneva||2|||f||||t|f|f||||||||2017-10-10 20:52:39.813739|2017-10-10 20:52:39.813739
NCT03216174|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||July 11, 2017|Anticipated|2017-07-11|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Pilot Study of Non-exposure Simple Suturing EFTR With Sentinel Lymph Node Navigation for EGC (Senorita3-pilot)|Pilot Study of Non-exposure Simple Suturing EFTR (NESS-EFTR) With Sentinel Lymph Node Navigation for Early Gastric Cancer (Senorita3-pilot)|Not yet recruiting||N/A|20|Anticipated|National Cancer Center, Korea||1|||f||||f|f|f||||||||2017-10-10 20:52:39.933583|2017-10-10 20:52:39.933583
NCT03216161|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-12|||August 2010|Actual|2010-08-01|July 2017|2017-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Sub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and Diet|Sub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and Diet|Completed||N/A|816|Actual|German Institute of Human Nutrition|||1||f|||||f|f||||||||2017-10-10 20:52:39.999557|2017-10-10 20:52:39.999557
NCT03216148|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-18|||July 2015||2015-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||18F-FET PET in Childhood Brain Tumours|A Prospective, Multicentre Trial on the Value of 18F-FET PET in the Post-therapeutic Evaluation of Childhood Brain Tumours|Recruiting||Phase 2|160|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-10 20:52:40.083132|2017-10-10 20:52:40.083132
NCT03216135|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-11|||July 20, 2017|Anticipated|2017-07-20|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma|Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma|Recruiting||N/A|50|Anticipated|Ochsner Health System|||3||f||||f|f|f||||Samples With DNA|"     Tissue of the esophagus. Bacterial genomic DNA to be extracted from tissue.   "|||2017-10-10 20:52:40.285312|2017-10-10 20:52:40.285312
NCT03216122|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Immediate vs Delayed Loading of Single Tooth Implants|Immediate vs Delayed Loading of Single Tooth Implants: Randomized Clinical Study|Recruiting||N/A|24|Anticipated|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||||2017-10-10 20:52:40.367356|2017-10-10 20:52:40.367356
NCT03216109|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-12|||May 20, 2017|Actual|2017-05-20|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Improving Supportive Care For Patients With Thoracic Malignancies|Improving Supportive Care For Patients With Thoracic Malignancies|Recruiting||N/A|128|Anticipated|Palo Alto Veterans Institute for Research||2|||f||||f|f|f||||||||2017-10-10 20:52:40.470387|2017-10-10 20:52:40.470387
NCT03216096|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-19|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease|A Prospective, Open Label, One-arm, 4-weeks Study Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease －Phase 1 Study in Dry Eye Patients|Recruiting||Phase 1|20|Anticipated|Santen Pharmaceutical Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:52:40.571998|2017-10-10 20:52:40.571998
NCT03216083|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-06|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Does Intravenous Tranexamic Acid Reduce Blood Loss During Vaginectomy?|Does Intravenous Tranexamic Acid Reduce Blood Loss During Vaginectomy? A Double-blind, Placebo-controlled, Randomized Trial|Not yet recruiting||Phase 3|30|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f|f|f|||t|||||2017-10-10 20:52:40.646503|2017-10-10 20:52:40.646503
NCT03216070|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia|Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia|Recruiting||Phase 4|12|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||t|f|f|||f|||||2017-10-10 20:52:40.736419|2017-10-10 20:52:40.736419
NCT03216044|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-10|||January 2013|Actual|2013-01-01|January 2017|2017-01-01|June 27, 2017|Actual|2017-06-27|January 1, 2017|Actual|2017-01-01||Observational|||Chronic Pain After Childbirth - Caesarean Section Compared to Vaginal Delivery and the Impact of Pre-existing Pain|Incidence and Predictors of Chronic Pain After Vaginal Childbirth and C-section - a Prospective Cohort Study|Completed||N/A|355|Actual|University Hospital Tuebingen|||1||f||||f|f|f||||||||2017-10-10 20:52:40.921402|2017-10-10 20:52:40.921402
NCT03216031|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-10|||April 24, 2017|Actual|2017-04-24|July 2017|2017-07-01|October 15, 2017|Anticipated|2017-10-15|September 15, 2017|Anticipated|2017-09-15||Interventional|PGROW||Project Grow: Establishing an Intergenerational Falls Prevention Gardening Programme|Project GROW: Establishing and Testing a New Intergenerational Falls Prevention Gardening Programme to Improve Physical Activity Levels, Health and Wellbeing in Older People at Risk of Falling|Recruiting||N/A|30|Anticipated|University of Roehampton||1|||f||||f|f|f||||||||2017-10-10 20:52:40.989826|2017-10-10 20:52:40.989826
NCT03216018|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-13|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Prevention Program Promoting Self Resilience, Positive Self-Image and Body Image Among Adolescents|"In Favor of Resilient Self- A Prevention Program Promoting Positive Self-Image and Body Image Among Adolescence Aged 15-17"|Enrolling by invitation||N/A|200|Anticipated|Tel Hai College||2|||f||||t|f|f||||||||2017-10-10 20:52:41.249176|2017-10-10 20:52:41.249176
NCT03216005|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|INFINITE-OUS||Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System|Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System|Enrolling by invitation||N/A|15|Anticipated|Intervene, Inc.||1|||f||||f|f|t|t||t|||||2017-10-10 20:52:41.344058|2017-10-10 20:52:41.344058
NCT03215992|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-11|||June 13, 2016|Actual|2016-06-13|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Optical Tomography in Prostate Cancer|Diffuse Optical Tomography in Prostate Cancer Detection and Risk Stratification A Pilot Study|Recruiting||N/A|20|Anticipated|Columbia University||2|||f||||t|f|t|t|f|f|||||2017-10-10 20:52:41.443124|2017-10-10 20:52:41.443124
NCT03215979|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-11|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|November 20, 2017|Anticipated|2017-11-20|September 29, 2017|Anticipated|2017-09-29||Interventional|||Use of Platelet-enriched Plasma During Auricular Reconstruction|Use of Platelet-enriched Plasma to Improve the Percentage of Integration of the Cutaneous Graft During Second Stage of Auricular Reconstruction in Children Aged 8-12 Years; A Controlled Clinical Trial|Recruiting||N/A|36|Anticipated|Hospital General Dr. Manuel Gea González||2|||f||||f|f|f||||||||2017-10-10 20:52:41.538886|2017-10-10 20:52:41.538886
NCT03215966|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-10|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|October 7, 2017|Anticipated|2017-10-07|October 7, 2017|Anticipated|2017-10-07||Interventional|||A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy Subjects|Single-center, Open-label, Single-dose, Two-period, Randomized, Crossover, Phase I Study to Demonstrate Bioequivalence Between a Fixed Dose Combination Product Formulation of Macitentan/Tadalafil (10 mg/40 mg) and the Free Combination of 10 mg Macitentan (Opsumit®) and 40 mg Tadalafil (Adcirca®) in Healthy Male and Female Subjects|Recruiting||Phase 1|38|Anticipated|Actelion||2|||f||||f|f|f||||||||2017-10-10 20:52:41.630055|2017-10-10 20:52:41.630055
NCT03215953|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-12|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Offloading Interventions for Diabetic Foot Problems in Upper Egypt|Offloading Interventions for Diabetic Foot Problems in Upper Egypt|Not yet recruiting||N/A|68|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:52:41.778824|2017-10-10 20:52:41.778824
NCT03215940|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-14|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)|Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC): Effectiveness, Side Effects and Neurobiological Changes|Not yet recruiting||Early Phase 1|75|Anticipated|University of Utah||3|||f||||t|t|f|||f|||||2017-10-10 20:52:41.896445|2017-10-10 20:52:41.896445
NCT03215914|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-24|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|Aim2||Hybrid Closed Loop Insulin Delivery System in Hypoglycemia|Effect of Hybrid Closed-Loop Insulin Delivery on Glucose Counterregulation in Long Standing Type 1 Diabetes: A Proof of Concept, Mechanistic, Single-Arm Clinical Trial|Recruiting||N/A|18|Anticipated|University of Pennsylvania||1|||f||||t|f|t|f|f|t|||||2017-10-10 20:52:42.257859|2017-10-10 20:52:42.257859
NCT03215901|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-19|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 15, 2017|Anticipated|2017-12-15||Interventional|||Life Plans Intervention Study|Life Plans of Young Adults in Rural KwaZulu-Natal: an Intervention Study|Recruiting||N/A|300|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 20:52:42.414499|2017-10-10 20:52:42.414499
NCT03215888|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-13|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Effects of Change in Insulin Resistance and Systemic Inflammation on Brain Structure and Function|Effects of Change in Insulin Resistance and Systemic Inflammation After Bariatric Surgery on Brain Neurochemistry, Neuroinflammation and Cognitive Function|Not yet recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f|f|f||||Samples Without DNA|"     serum sample to measure hormones and inflammatory markers   "|||2017-10-10 20:52:42.525216|2017-10-10 20:52:42.525216
NCT03215875|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-11|||September 10, 2017|Anticipated|2017-09-10|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Food Effect Study of 60mg ER Torsemide|A Randomized, Balanced, Single Dose, Two-treatment (Fed vs. Fasting), Two-period, Two-sequence, Crossover Study to Evaluate the Effects of Food on the Bioavailability of 60 mg ER Torsemide Tablet in Healthy Human Adult Subjects|Not yet recruiting||Phase 1|28|Anticipated|Sarfez Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:52:42.646079|2017-10-10 20:52:42.646079
NCT03215862|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Lactated Ringer's Solution to Prevent Post-ERCP Pancreatitis|The Effect of the Use of Lactated Ringer's Solution During ERCP on Rate of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis|Not yet recruiting||N/A|242|Anticipated|University of South Florida||2|||f|||||f|f|||f|||||2017-10-10 20:52:42.766464|2017-10-10 20:52:42.766464
NCT03215849|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-10|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Pacing in Heart Failure With Preserved LVEF|The Effect of Biventricular Pacing in Heart Failure With Preserved Left Ventricular Ejection Fraction: A Pilot Mechanistic Analysis|Not yet recruiting||N/A|10|Anticipated|University of East Anglia||3|||f||||t|f|f||||||||2017-10-10 20:52:42.878357|2017-10-10 20:52:42.878357
NCT03215836|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-01|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|August 10, 2018|Anticipated|2018-08-10||Interventional|||Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics|Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics|Recruiting||N/A|50|Anticipated|University of Colorado, Denver||4|||f||||f|f|f||||||||2017-10-10 20:52:43.034858|2017-10-10 20:52:43.034858
NCT03215823|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-09-19|||July 18, 2017|Actual|2017-07-18|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|July 2018|Anticipated|2018-07-01||Observational|||Predictive Factors of the Difficult Intubation When Using the Videolaryngoscope|Predictive Factors of the Difficult Intubation When Using the Videolaryngoscope|Recruiting||N/A|800|Anticipated|Yonsei University|||2||f||||t|f|f||||||||2017-10-10 20:52:43.164638|2017-10-10 20:52:43.164638
NCT03215797|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-07-11|||September 2016||2016-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phenylephrine or Norepinephrine for a Better Hemodynamic Stability|Comparison of the Effects of Norepinephrine and Phenylephrine on Tissue Oxygenation and Hemodynamic Stability During an SVV Fluid Guided Therapy in Elderly Undergoing Radical Resection of Colon Cancer Surgery|Completed||Phase 3|40|Actual|The Second Affiliated Hospital of Dalian Medical University||2|||f||||t|f|f||||||||2017-10-10 20:52:43.430903|2017-10-10 20:52:43.430903
NCT03215784|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||March 2015||2015-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|GOPROFIT||Gestational Obesity and Interventions With Probiotics or Fish Oil Trial|Impact of Fish Oil or Probiotic Intake on Maternal Obesity and Molecular Biomarkers in the Placenta|Recruiting||N/A|80|Anticipated|Universidade Federal do Rio de Janeiro||4|||f||||t||||||||||2017-10-10 20:52:43.56652|2017-10-10 20:52:43.56652
NCT03215771|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-10|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Myoelectric Upper Limb Orthosis Use by Persons With Traumatic Brain Injury|Longitudinal Observation of Myoelectric Upper Limb Orthosis Use Among Veterans With Upper Limb Impairment|Recruiting||N/A|15|Anticipated|Northwestern University||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:52:43.724182|2017-10-10 20:52:43.724182
NCT03215758|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-20|||November 7, 2017|Anticipated|2017-11-07|July 2017|2017-07-01|June 11, 2019|Anticipated|2019-06-11|June 11, 2019|Anticipated|2019-06-11||Interventional|||Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma|A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma|Not yet recruiting||Phase 3|650|Anticipated|Novartis||2|||f||||t|t|f||||||||2017-10-10 20:52:43.821018|2017-10-10 20:52:43.821018
NCT03215745|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Interventional|DELA||Delirium Prevention in Patients From the Intensive Care Unit (DELA)|Trial Randomized, Double-blind, Controlled of Delirium Prevention Program in Patients From the Intensive Care Unit Los Comuneros Hospital University of Bucaramanga, Colombia|Not yet recruiting||N/A|200|Anticipated|Universidad de Santander||2|||f||||t|f|f||||||||2017-10-10 20:52:43.908783|2017-10-10 20:52:43.908783
NCT03215732|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-11|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|AMBASS||Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal|Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B Virus Infection in the Rural Area of Niakhar, Senegal|Not yet recruiting||N/A|3200|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||t|f|f||||||||2017-10-10 20:52:43.981817|2017-10-10 20:52:43.981817
NCT03215719|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma|Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma|Recruiting||Phase 2|54|Anticipated|New York University School of Medicine||1|||f||||f|t|f|||f|||||2017-10-10 20:52:44.085546|2017-10-10 20:52:44.085546
NCT03215706|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-28|||July 20, 2017|Actual|2017-07-20|September 2017|2017-09-01|May 20, 2020|Anticipated|2020-05-20|August 25, 2019|Anticipated|2019-08-25||Interventional|CheckMate 9LA||A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy by Itself as the First Treatment Given for Stage IV Non-Small Cell Lung Cancer (NSCLC)|A Study of Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs Chemotherapy Alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 3|420|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 20:52:44.185205|2017-10-10 20:52:44.185205
NCT03215693|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|January 31, 2019|Anticipated|2019-01-31||Interventional|||X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib|A Phase II, Multicenter, Single-arm Study to Evaluate Safety and Efficacy of X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib|Not yet recruiting||Phase 2|144|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t|f|f||||||||2017-10-10 20:52:44.418356|2017-10-10 20:52:44.418356
NCT03215680|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-17|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|LION||Climat Impact on Urinary Iodine Concentration|Assessment of Impact of High Temperature Climate on Urinary Iodine Concentration in Women of Reproductive Age|Recruiting||N/A|300|Anticipated|Swiss Federal Institute of Technology|||2||f||||f|f|f||||Samples Without DNA|"     24h urine samples, spot urine samples, dried blood spots   "|||2017-10-10 20:52:44.518365|2017-10-10 20:52:44.518365
NCT03215667|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites|Ridge Preservation With Hardening Calcium Phosphate Bone Substitutes and Resorbable Membrane for Implant Site Development on Non-containable Extraction Sites: A Clinical and Histological Prospective Case Series in Humans|Recruiting||N/A|20|Anticipated|Sunstar Americas||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:52:44.600285|2017-10-10 20:52:44.600285
NCT03215654|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-10|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||"EspaiJove.Net- a School-based Intervention Program to Promote Mental Health in Adolescent Population"|"EspaiJove.Net- a School-based Intervention Program to Promote Mental Health and Eradicating Stigma in Adolescent Population: a Randomised Controlled Trial"|Not yet recruiting||N/A|408|Anticipated|Centre d'Higiene Mental Les Corts||4|||f|||||f|f||||||||2017-10-10 20:52:44.673863|2017-10-10 20:52:44.673863
NCT03215641|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-15|||August 2015||2015-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Is it Helpful to Use Fitbits in a Family Based Weight Loss Program?|Effect of Personal Activity Trackers on Weight Loss in Children Enrolled in a Comprehensive Behavioral Family Lifestyle Intervention (CBFLI) Program|Enrolling by invitation||N/A|200|Anticipated|Children's Hospital Los Angeles||2|||f||||f||||||||||2017-10-10 20:52:44.764911|2017-10-10 20:52:44.764911
NCT03215628|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-10|||July 4, 2017|Actual|2017-07-04|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|TCEUS||Quantification of Cerebral Perfusion by Contrast-enhanced Ultrasound During Neonatal Heart Surgery|Quantifizierung Der Hirnperfusion Während Kinderherzchirurgischer Operationen Durch Transkraniellen Kontrastmittelverstärkten Ultraschall|Recruiting||N/A|12|Anticipated|University of Erlangen-Nürnberg Medical School||3|||f||||f|f|f|||f|||||2017-10-10 20:52:44.843971|2017-10-10 20:52:44.843971
NCT03215615|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-07-11|||November 2016||2016-11-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Two Resin Composites and Two Adhesives for a Novel Restorative Protocol to Treat Cervical Lesions|Evaluation of Two Resin Composites and Two Adhesives for a Novel Surgical-restorative Protocol for the Treatment of Non-carious Cervical Lesions Associated With Gingival Recession: a Randomized Controlled Clinical Trial|Recruiting||N/A|80|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||4|||f||||f||||||||||2017-10-10 20:52:44.949248|2017-10-10 20:52:44.949248
NCT03215602|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-18|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|EXTRA||EXercise as TReatment for osteoArthritis|EXercise as TReatment for osteoArthritis|Recruiting||N/A|90|Anticipated|Slagelse Hospital||2|||f||||t|f|f||||||||2017-10-10 20:52:45.060082|2017-10-10 20:52:45.060082
NCT03215589|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-10|||July 3, 2017|Actual|2017-07-03|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|July 3, 2018|Anticipated|2018-07-03||Observational|COASTLINE||Assessment of Cerebral Blood Flow Asymmetry in Cardiac Surgery Patients Undergoing Hypothermic Circulatory Arrest|A Prospective Study of Cerebral Oximetry to Assess Symmetry of Cerebral Blood Flow and Clinical Outcomes in Cardiac Surgery Patients Undergoing Hypothermic Circulatory Arrest|Recruiting||N/A|20|Anticipated|University of Manitoba|||1||f||||f|f|f||||||||2017-10-10 20:52:45.173272|2017-10-10 20:52:45.173272
NCT03215563|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-10|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Observational|||PET-MRI Imaging in Patients With Acute Neurovascular Syndrome|Hybrid 18F-Fluoride Positron Emission Tomography-Magnetic Resonance Imaging in Patients With Acute Acute Neurovascular Syndrome|Not yet recruiting||N/A|80|Anticipated|University of Edinburgh|||2||f||||f|f|f||||||||2017-10-10 20:52:45.250991|2017-10-10 20:52:45.250991
NCT03215550|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-10|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Observational|||PET-MRI Imaging in Patients With Symptomatic Carotid Artery Stenosis|Hybrid 18F-fluoride Positron Emission Tomography-Magnetic Resonance Imaging in Patients With Symptomatic Carotid Artery Stenosis|Not yet recruiting||N/A|40|Anticipated|University of Edinburgh|||1||f||||f|f|f||||Samples Without DNA|"     At the time of carotid endarterectomy, which is an established surgical intervention aimed at     reducing the future risk of stroke in symptomatic patients, tissue will be collected, and     lesion integrity and geometry will be preserved as much as possible. Specimens will be     photographed in detail to permit subsequent assessment by independent and blinded reviewers.     The excised tissue will be aligned and labelled to permit orientation in the carotid artery     axis before undertaking 7.4 T magnetic resonance spectroscopy. Subsequently, carotid plaque     will be snap frozen in liquid nitrogen. Cellular content, macrophage infiltration, apoptosis,     and calcification-associated molecules within the plaques will be assessed by RNA analysis,     immunohistochemistry and immunofluorescence using a variety of validated markers.   "|||2017-10-10 20:52:45.316975|2017-10-10 20:52:45.316975
NCT03215537|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-12|||March 2, 2016|Actual|2016-03-02|July 2017|2017-07-01|December 2, 2018|Anticipated|2018-12-02|December 2, 2017|Anticipated|2017-12-02||Interventional|||Development of Patient Tailored Guideline of Physical Activity for Lung Cancer|Development of Patient Tailored Guideline of Physical Activity for Lung Cancer Survivor After Surgery; to Improve the Symptoms, Complications and Quality of Life|Recruiting||N/A|180|Anticipated|Samsung Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:52:45.385251|2017-10-10 20:52:45.385251
NCT03215524|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-28|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|March 2023|Anticipated|2023-03-01|October 2020|Anticipated|2020-10-01||Interventional|DCDP||A Study Of Daratumumab, Low-Dose Oral Dexamethasone and Cyclophosphamide With Or Without Pomalidomide|A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide With or Without Pomalidomide in Patients With Relapsed and Refractory Multiple Myeloma|Not yet recruiting||Phase 2|120|Anticipated|Myeloma Canada Research Network||2|||f||||t|f|f|||f|||||2017-10-10 20:52:45.464871|2017-10-10 20:52:45.464871
NCT03215511|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-24|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusions or Non-fusion NTRK Cancers|A Phase 1/ 2 Study of the TRK Inhibitor LOXO 195 in Adult Subjects With NTRK Fusion (Previously Treated) or Non-Fusion NTRK Altered Cancers|Recruiting||Phase 1/Phase 2|120|Anticipated|Loxo Oncology, Inc.||1|||t||||f|t|f||||||||2017-10-10 20:52:45.537509|2017-10-10 20:52:45.537509
NCT03215498|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-29|||July 3, 2017|Actual|2017-07-03|September 2017|2017-09-01|December 4, 2017|Anticipated|2017-12-04|November 6, 2017|Anticipated|2017-11-06||Interventional|||A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 Diabetes|A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes|Recruiting||Phase 1|56|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f|||t|||||2017-10-10 20:52:45.697587|2017-10-10 20:52:45.697587
NCT03215485|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-11|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|September 2017|Anticipated|2017-09-01||Interventional|||WAVE~Ripples for Change: Obesity Prevention in Active Youth|The WAVE~Ripples for Change: Obesity Prevention in Active Youth in Afterschool Programs Using Virtual- and Real-World Experiential Learning|Enrolling by invitation||N/A|750|Anticipated|Oregon State University||2|||f||||f||||||||||2017-10-10 20:52:45.933904|2017-10-10 20:52:45.933904
NCT03215472|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-08-08|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women|DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women at Risk for Cardiovascular Disease|Recruiting||N/A|50|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 20:52:46.038059|2017-10-10 20:52:46.038059
NCT03215459|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-09|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Observational|CPET-Panc||Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer|CPET-Panc: Exercise Testing in Chemotherapy|Not yet recruiting||N/A|100|Anticipated|The Clatterbridge Cancer Centre NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 20:52:46.162293|2017-10-10 20:52:46.162293
NCT03215446|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-10|||June 13, 2016|Actual|2016-06-13|July 2017|2017-07-01|December 13, 2018|Anticipated|2018-12-13|June 13, 2018|Anticipated|2018-06-13||Interventional|PHAR||Evaluate the Muscle Protection Effect of Sevoflurane Sedation in Vascular Surgery|Evaluation of Total (Pre and Post) Conditioning on Rhabdomyolysis of Sedation With Sevoflurane Versus Propofol in Vascular Surgery With Clamping|Recruiting||Phase 4|164|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f|f|f||||||||2017-10-10 20:52:46.275266|2017-10-10 20:52:46.275266
NCT03215433|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-10|||December 8, 2016|Actual|2016-12-08|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|12 Months|Observational [Patient Registry]|BIOMARBIOT||Study of Biomarkers of the Response to Biotine|Single-centre, Observational Study, Concerning Blood-lipid Biomarkers of the Response to Treatment With Biotine, Prescribed in the Context of a Nominative TAU (Temporary Authorized Use) in Patients With an Inactive Progressive Form of Multiple Sclerosis (MS).|Recruiting||N/A|25|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:52:46.382031|2017-10-10 20:52:46.382031
NCT03215407|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-12|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 3, 2018|Anticipated|2018-03-03|December 12, 2017|Anticipated|2017-12-12||Interventional|||The Comparative Study of Intra-articular Injection of Tocilizumab and Compound Betamethasone|The Comparative Study of Safety and Effectiveness of Intra-articular Injection of Tocilizumab and Compound Betamethasone in Rheumatoid Arthritis of the Knee|Not yet recruiting||Phase 4|60|Anticipated|Chinese PLA General Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:52:46.55557|2017-10-10 20:52:46.55557
NCT03215394|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-12|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Evaluation of Social ABCs With Attention Training Intervention for Toddlers With Suspected Autism|Evaluation of Social ABCs With Attention Training Intervention for Toddlers With Autism|Recruiting||N/A|150|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||3|||f||||f|f|f||||||||2017-10-10 20:52:46.653388|2017-10-10 20:52:46.653388
NCT03215381|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-10|||October 31, 2017|Anticipated|2017-10-31|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||AZD1390 Administration of a Microdose [11C]AZD1390 to Healthy Volunteers|An Open-Label Positron-Emission Tomography (PET) Study to Determine Brain Exposure of AZD1390 After Intravenous Administration of a Microdose [11C]AZD1390 to Healthy Volunteers|Not yet recruiting||Phase 1|12|Anticipated|AstraZeneca||1|||f||||f|f|f||||||||2017-10-10 20:52:46.820831|2017-10-10 20:52:46.820831
NCT03215368|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-11|||May 1, 2013|Actual|2013-05-01|July 2017|2017-07-01|September 30, 2014|Actual|2014-09-30|September 1, 2014|Actual|2014-09-01||Observational|||Serum Cobalt Status During Pregnancy and the Risks of PIH|Serum Cobalt Status During Pregnancy and the Risks of Pregnancy-induced Hypertension Syndrome: a Population-based Birth Cohort Study|Completed||N/A|3474|Actual|Anhui Medical University|||1||f||||f|f|f||||Samples Without DNA|"     maternal blood samples and fetal umbilical cord blood samples were collected   "|||2017-10-10 20:52:46.911731|2017-10-10 20:52:46.911731
NCT03215355|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium|Improving Cone-beam Computed Tomography for Image Guided Stereotactic Body Radiation Therapy of the Liver Using Gadoxetate Disodium|Not yet recruiting||Phase 4|3|Anticipated|Nova Scotia Health Authority||1|||f|||||f|f||||||||2017-10-10 20:52:46.971247|2017-10-10 20:52:46.971247
NCT03215342|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-18|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|CORE-pABI||Cognitive Rehabilitation in Pediatric Acquired Brain Injury|Cognitive Rehabilitation in Pediatric Acquired Brain Injury - a Randomized Controlled Trial|Not yet recruiting||N/A|80|Anticipated|St. Olavs Hospital||2|||f||||t|f|f||||||||2017-10-10 20:52:47.095051|2017-10-10 20:52:47.095051
NCT03215329|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-11|||January 2, 2017|Actual|2017-01-02|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|Hemorecrut||Comparison of Hemodynamic Effect of 2 Methods for Alveolar Recruitment Maneuver in Anesthetized Patients|Comparison of Stroke Volume Variation During Alveolar Recruitment With Stepwise Increase in Positive End Expiratory Pressure and Continuous Positive Airway Pressure (30cmH2O During 30 Seconds) in Anesthetised Patients|Recruiting||N/A|50|Anticipated|University Hospital, Caen|||2||f||||f|f|f||||||||2017-10-10 20:52:47.209282|2017-10-10 20:52:47.209282
NCT03215316|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-11|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|FLOWLY||Screening Expiratory Flow Limitation by Flow-time Curve|Screening Expiratory Flow Limitation by Flow-time Curve|Recruiting||N/A|80|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f|f|f||||||||2017-10-10 20:52:47.295232|2017-10-10 20:52:47.295232
NCT03215303|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-19|||July 25, 2017|Actual|2017-07-25|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|CPAP-STRA||Effects of CPAP in Severe Therapy-resistant Asthma|Effects of Continuous Positive Airway Pressure (CPAP) on Exercise Capacity of Children and Adolescents With Severe Therapy-resistant Asthma|Enrolling by invitation||N/A|18|Anticipated|Pontificia Universidade Católica do Rio Grande do Sul||2|||f||||f|f|f||||||||2017-10-10 20:52:47.369817|2017-10-10 20:52:47.369817
NCT03215290|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-10|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Trans-parenchymal Compressing Suture in Major Liver Resection|Application of Trans-parenchymal Compressing Suture in Major Liver Resection to Decrease Cutting Surface Related Complication.|Completed||N/A|382|Actual|Tongji Hospital||2|||f|||||f|f||||||||2017-10-10 20:52:47.4667|2017-10-10 20:52:47.4667
NCT03215277|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis.|A Multicenter, Phase 2A, Randomized, Investigator-Blind, Subject-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Subjects With Active Ankylosing Spondylitis|Not yet recruiting||Phase 2|60|Anticipated|UCB Pharma||2|||f||||t|t|f|||f|||||2017-10-10 20:52:47.555149|2017-10-10 20:52:47.555149
NCT03215264|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-10-03|||December 10, 2017|Anticipated|2017-12-10|July 2017|2017-07-01|July 10, 2020|Anticipated|2020-07-10|July 10, 2019|Anticipated|2019-07-10||Interventional|||Phase I/II Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer|Phase I/II Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer|Not yet recruiting||Phase 1/Phase 2|44|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t|t|f||||||||2017-10-10 20:52:47.661123|2017-10-10 20:52:47.661123
NCT03215251|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||Effectiveness of an Intervention Bundle on Thirst Intensity and Dry Mouth Among Patients in ICUs|Experimental Study to Evaluate the Effectiveness of an Intervention Bundle on Thirst Intensity and Dry Mouth Among Patients of Selected Units|Completed||N/A|60|Actual|Maharishi Markendeswar University||2|||f||||t|f|f||||||||2017-10-10 20:52:47.749873|2017-10-10 20:52:47.749873
NCT03215238|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-09|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Observational|||Intraoperative Pleth Variability Index (PVI) Variability|Intraoperative Pleth Variability Index (PVI) Variability|Not yet recruiting||N/A|50|Anticipated|University of California, San Francisco|||2||f||||f|f|f|||f|||||2017-10-10 20:52:47.823675|2017-10-10 20:52:47.823675
NCT03215225|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-09|||December 1, 1989|Actual|1989-12-01|July 2017|2017-07-01|June 2, 2017|Actual|2017-06-02|December 20, 2016|Actual|2016-12-20||Observational|ENDOBO20||Endodontic Root-canal Treatments Evaluated After Long-term Time|Long-term Evaluation of Endodontic Root Canal Treatments: Complication, Factors Affecting Failure, New Disease and Success|Completed||N/A|130|Actual|University of Bologna|||1||f||||f|f|f||||||||2017-10-10 20:52:47.877966|2017-10-10 20:52:47.877966
NCT03215212|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-12|||November 30, 2015|Actual|2015-11-30|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Effectiveness of Ear Plug, Eye Mask and Ocean Sound on Sleep Quality Among ICU Patients|A Comparative Study to Assess the Effectiveness of Ear Plug, Eye Mask and Ocean Sound on Sleep Quality Among ICU Patients|Completed||N/A|60|Actual|Maharishi Markendeswar University||3|||f||||t|f|f||||||||2017-10-10 20:52:47.944913|2017-10-10 20:52:47.944913
NCT03215199|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-09|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 15, 2018|Anticipated|2018-10-15|September 15, 2018|Anticipated|2018-09-15||Interventional|NAPT||Northern Alberta Psychosocial Telecare (NAPT) Screening for HNC Patients|Northern Alberta Psychosocial Telecare (NAPT) Screening for Surgical Head and Neck Cancer Patients: a Randomized Controlled Trial|Not yet recruiting||N/A|50|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 20:52:48.026662|2017-10-10 20:52:48.026662
NCT03215173|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-22|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|FAB||Fit After Baby: A Health Intervention to Increase Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease|Fit After Baby: A Randomized Controlled Trial of a Mobile Health Intervention to Increase Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease|Not yet recruiting||N/A|120|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:52:48.177571|2017-10-10 20:52:48.177571
NCT03215160|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-25|||August 22, 2016|Actual|2016-08-22|August 2017|2017-08-01|February 1, 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Using Mobilization Exercises on Total Knee Arthroplasty Rehabilitation|Effectiveness of Mobilization Exercises on Total Knee Arthroplasty Rehabilitation|Active, not recruiting||N/A|42|Anticipated|Istanbul University||2|||f||||f|f|f||||||||2017-10-10 20:52:48.266629|2017-10-10 20:52:48.266629
NCT03215147|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-07-09|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28|4 Years|Observational [Patient Registry]|||Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis|Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis|Recruiting||N/A|100|Anticipated|Seoul National University Hospital|||1||f|||||f|f||||||||2017-10-10 20:52:48.329691|2017-10-10 20:52:48.329691
NCT03215134|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-10|||May 4, 2017|Actual|2017-05-04|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Self-Criticism Pilot Study|A Novel Intervention for Self-criticism in IAPT Services: Pilot Study|Enrolling by invitation||N/A|20|Anticipated|King's College London||1|||f||||f|f|f||||||||2017-10-10 20:52:48.417226|2017-10-10 20:52:48.417226
NCT03215121|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Mask Study: One-handed vs. Two Handed Technique in Children|Comparative Evaluation of One Handed Versus Two Handed Mask Holding Techniques in Children During Induction of Anesthesia|Not yet recruiting||N/A|40|Anticipated|Nemours Children's Clinic||2|||f||||f|f|f||||||||2017-10-10 20:52:48.491674|2017-10-10 20:52:48.491674
NCT03215108|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-09|||July 12, 2017|Anticipated|2017-07-12|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|June 1, 2019|Anticipated|2019-06-01||Interventional|||Comparison Between Novel Flower-type Covered Stent and Conventional Covered Stent|Comparison Between Novel Flower-type Covered Stent and Conventional Covered Stent in Malignant Extrahepatic Biliary Obstruction: Prospective Randomized Multicenter Study|Recruiting||N/A|256|Anticipated|Samsung Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:52:48.589888|2017-10-10 20:52:48.589888
NCT03215095|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-09-29|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers|Radioiodine (RAI) in Combination With Durvalumab (Medi4736) for RAI-avid, Recurrent/Metastatic Thyroid Cancers|Recruiting||Early Phase 1|11|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:52:48.669145|2017-10-10 20:52:48.669145
NCT03215082|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-10|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|SiMPly Rehab||Seeing-Moving-Playing: Early Rehabilitation Utilizing Visual and Vestibular Technology Following Traumatic Brain Injury|Seeing-Moving-Playing: Early Rehabilitation Utilizing Visual and Vestibular Technology Following Traumatic Brain Injury|Not yet recruiting||N/A|465|Anticipated|McGill University Health Center||2|||f||||t|f|f||||||||2017-10-10 20:52:48.756763|2017-10-10 20:52:48.756763
NCT03215069|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|EMPA post-GDM||Empagliflozin and the Preservation of Beta-cell Function in Women With Recent Gestational Diabetes|Empagliflozin and the Preservation of Beta-cell Function in Women With Recent Gestational Diabetes|Not yet recruiting||Phase 3|120|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f|f|f|||f|||||2017-10-10 20:52:48.847755|2017-10-10 20:52:48.847755
NCT03215056|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-09|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|MAGPIE||Methoxyflurane Analgesia for Paediatric Injuries|A Randomised, Double-blind, Multicentre, Placebo Controlled Study to Evaluate the Safety and Efficacy of Methoxyflurane (PENTHROX®) for the Treatment of Acute Pain in Children and Adolescents From 6 to Less Than 18 Years of Age (Presenting to an Emergency Department With Minor Trauma)|Recruiting||Phase 3|220|Anticipated|Medical Developments International Limited||2|||f||||t|f|f||||||||2017-10-10 20:52:48.919149|2017-10-10 20:52:48.919149
NCT03215043|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||July 2, 2017|Actual|2017-07-02|July 2017|2017-07-01|June 28, 2019|Anticipated|2019-06-28|January 8, 2018|Anticipated|2018-01-08||Interventional|||Effect of Eriocitrin Supplementation in Subjects With Intermediate Hyperglycemia|Evaluation of Metabolic Parameters in Subjects With Intermediate Hyperglycemia Supplemented With Eriocitrin: A Parallel, Double-blind, Randomized, Placebo-controlled Clinical Trial|Recruiting||N/A|80|Anticipated|São Paulo State University||4|||f||||f|f|f||||||||2017-10-10 20:52:49.032647|2017-10-10 20:52:49.032647
NCT03215030|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-08-25|||September 21, 2017|Anticipated|2017-09-21|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-573 in Participants With Refractory Multiple Myeloma|A Phase 1/2a Open-label Study to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-573 (Formerly TEV-48573) Administered Intravenously as a Single Agent in Patients With Refractory Multiple Myeloma|Not yet recruiting||Phase 1/Phase 2|69|Anticipated|Takeda||12|||f||||f|t|f||||||||2017-10-10 20:52:49.138806|2017-10-10 20:52:49.138806
NCT03215017|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-09|||May 15, 2017|Actual|2017-05-15|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery|A Randomized Controlled Study of the Effect of Treatment of Low Anterior Resection Syndrome (LARS) After Rectal Cancer Surgery|Recruiting||N/A|100|Anticipated|Karolinska Institutet||2|||f||||f|f|f|||f|||||2017-10-10 20:52:49.253662|2017-10-10 20:52:49.253662
NCT03215004|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-11|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals|Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals|Recruiting||N/A|24|Anticipated|American Gene Technologies International Inc.|||1||f||||f|f|f||||||||2017-10-10 20:52:49.341135|2017-10-10 20:52:49.341135
NCT03214991|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||May 12, 2017|Actual|2017-05-12|July 2017|2017-07-01|March 31, 2021|Anticipated|2021-03-31|September 30, 2020|Anticipated|2020-09-30||Observational|||Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer|Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer|Recruiting||N/A|100|Anticipated|Seoul National University Hospital|||1||f||||f|f|f||||Samples With DNA|"     peripheral blood circulating tumor DNA in patients with pancreatic cancer   "|||2017-10-10 20:52:49.407152|2017-10-10 20:52:49.407152
NCT03214978|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 1, 2017|Anticipated|2017-12-01||Observational|PTC||Targeted-sequencing of PTC in Different Stages|Targeted-sequencing of PTC in Different Stages|Not yet recruiting||N/A|80|Anticipated|Shanghai 6th People's Hospital|||1||f|||||f|f||||||||2017-10-10 20:52:49.494026|2017-10-10 20:52:49.494026
NCT03214965|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-07-18|||January 2016||2016-01-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||The Use of the Social Networking to Promote Educational and Consultative Actions Among Kidney Transplanted Adolescents.|The Use of the Social Networking to Promote Educational and Consultative Actions Among Kidney Transplanted Adolescents. Comparison of the Knowledge, Satisfaction and Self-esteem Between Two Groups: a Randomized Clinical Trial.|Completed||N/A|128|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||t|f|f||||||||2017-10-10 20:52:49.540914|2017-10-10 20:52:49.540914
NCT03214952|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-10|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||"Drug Use Surveillance of Takecab for Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"|"Drug Use Surveillance of Takecab Tablets for Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"|Recruiting||N/A|3000|Anticipated|Takeda|||1||f||||f|f|f||||||||2017-10-10 20:52:51.463075|2017-10-10 20:52:51.463075
NCT03214939|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-11|2017-07-11|||September 27, 2016|Actual|2016-09-27|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer|Investigation of the Clinical and Laboratory Efficacy of Autogemotherapy Based on Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer|Recruiting||Early Phase 1|30|Anticipated|Research Institute of Fundamental and Clinical Immunology||1|||f||||f|f|f||||||||2017-10-10 20:52:51.542512|2017-10-10 20:52:51.542512
NCT03214926|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-14|||October 17, 2016|Actual|2016-10-17|July 2017|2017-07-01|May 28, 2017|Actual|2017-05-28|May 28, 2017|Actual|2017-05-28||Interventional|||Moving Through Glass: An Augmented Reality Device Application for Persons With Parkinson's Disease|A Pilot Study to Evaluate the Augmented Reality-Based Dance Application on Mobility and Balance of Persons With Parkinson's Disease|Completed||N/A|7|Actual|Syracuse University||1|||f||||f|f|f||||||||2017-10-10 20:52:51.61745|2017-10-10 20:52:51.61745
NCT03214913|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-08|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|June 30, 2021|Anticipated|2021-06-30|December 31, 2020|Anticipated|2020-12-31||Interventional|||Controlled Fluid Resuscitation in Sepsis|Controlled Fluid Resuscitation Strategy in Sepsis Patient|Not yet recruiting||N/A|550|Anticipated|Ruijin Hospital||2|||f||||f|f|f||||||||2017-10-10 20:52:51.709687|2017-10-10 20:52:51.709687
NCT03214900|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-07-13|||July 1, 2012|Actual|2012-07-01|July 2017|2017-07-01|December 31, 2016|Actual|2016-12-31|July 1, 2014|Actual|2014-07-01|1 Year|Observational [Patient Registry]|REVER||Evaluation of Vascular Regeneration After a Drug Eluting Stent Implantation|Evaluation of Vascular Regeneration After a Drug Eluting Stent Implantation and the Development of Neointimal Hyperplasia and Stent Restenosis (REVER Trial).|Completed||N/A|20|Actual|Hospital San Carlos, Madrid|||1||f||||t|f|f||||Samples Without DNA|"     blood samples   "|||2017-10-10 20:52:51.797446|2017-10-10 20:52:51.797446
NCT03214887|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||January 17, 2017|Actual|2017-01-17|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Autologous BMMNC Combined With HA Therapy for PAOD|Therapeutic Angiogenesis for Peripheral Artery Occlusive Disease Using Hyaluronan Combined With Autologous Bone Marrow Cell Therapy -- Phase I/II Safety and Efficacy Study|Recruiting||Phase 1/Phase 2|30|Anticipated|Academia Sinica, Taiwan||3|||f||||t|f|f||||||||2017-10-10 20:52:51.854124|2017-10-10 20:52:51.854124
NCT03214874|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-11|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects|Randomized,Open Label,Balanced,Two Treatment, Four Period, Two Sequence, Single Oral Dose, Crossover, Replicate Study Under Fasting Conditions to Test Within Subject Variability of 20mg ER Torsemide and Demadex Tablets in Healthy Adults|Recruiting||Phase 1|24|Anticipated|Sarfez Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:52:51.948751|2017-10-10 20:52:51.948751
NCT03214848|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-18|||September 13, 2017|Actual|2017-09-13|July 2017|2017-07-01|April 2, 2018|Anticipated|2018-04-02|April 2, 2018|Anticipated|2018-04-02||Interventional|||Evaluation of an Intervention to Increase Post-abortion LARC Uptake.|Evaluation of an Intervention to Increase Post-abortion LARC Uptake: A Randomized Controlled Trial of Educational and Financial Counseling Prior to Clinical Presentation.|Recruiting||N/A|516|Anticipated|Emory University||2|||f||||f|f|f||||||||2017-10-10 20:52:52.130256|2017-10-10 20:52:52.130256
NCT03214835|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-18|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions|CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions|Not yet recruiting||N/A|300|Anticipated|CDx Diagnostics||2|||f||||t|f|f||||||||2017-10-10 20:52:52.32086|2017-10-10 20:52:52.32086
NCT03214809|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-07|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|METUS||The Use of a Point-of-care Thoracic Ultrasound Protocol for Hospital Medical Emergency Teams|The Use of a Point-of-care Thoracic Ultrasound Protocol for Hospital Medical Emergency Teams|Not yet recruiting||N/A|200|Anticipated|Rijnstate Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:52:52.522642|2017-10-10 20:52:52.522642
NCT03214796|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-07|||January 3, 2017|Actual|2017-01-03|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|ALB-INFUS||Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status|Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status|Recruiting||N/A|40|Anticipated|Medical University of Graz|||1||f||||f|t|||||Samples Without DNA|"     serum, plasma, neutrophil granulocytes   "|||2017-10-10 20:52:52.6087|2017-10-10 20:52:52.6087
NCT03214783|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-08-15|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||A Case-control Study to Assess the Association Between Facial Characteristics and Coronary Artery Diseases|A Case-control Study to Assess the Association Between Facial Characteristics and Coronary Artery Diseases|Recruiting||N/A|500|Anticipated|China National Center for Cardiovascular Diseases|||2||f|||||f|f||||||||2017-10-10 20:52:52.710309|2017-10-10 20:52:52.710309
NCT03214770|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-13|||August 10, 2017|Anticipated|2017-08-10|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|September 1, 2017|Anticipated|2017-09-01||Interventional|||Antibacterial Effect of Light-activated Calcium Silicate Versus Light-activated Calcium Hydroxide|Antibacterial Effect of Light-activated Calcium Silicate Versus Calcium Hydroxide on Permanent Carious Molars Treated With Step-wise Excavation (A Randomized Clinical Trial)|Not yet recruiting||Phase 1|48|Anticipated|Cairo University||2|||f||||t|t|f|||t|||||2017-10-10 20:52:52.791102|2017-10-10 20:52:52.791102
NCT03214757|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-11|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||A Study of Anemia in Children With Dilated Cardiomyopathy|A Study of Anemia in Children With Dilated Cardiomyopathy|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:52:52.892251|2017-10-10 20:52:52.892251
NCT03214744|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-12|||May 2018|Anticipated|2018-05-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|pretermfood||Rapid Versus Slow Entral Feeding Advancements on Clinical Outcomes of Preterm Infants|Rapid Versus Slow Entral Feeding Advancements on Clinical Outcomes of Preterm Infants|Not yet recruiting||N/A|1|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:52:52.950557|2017-10-10 20:52:52.950557
NCT03214731|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-11|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|AURORA||Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis|A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis: Pilot Study|Not yet recruiting||Phase 4|90|Anticipated|Sun Yat-sen University||3|||f||||t|f|f||||||||2017-10-10 20:52:53.019671|2017-10-10 20:52:53.019671
NCT03214718|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-08|||August 5, 2017|Anticipated|2017-08-05|July 2017|2017-07-01|August 5, 2019|Anticipated|2019-08-05|August 5, 2019|Anticipated|2019-08-05||Interventional|||Myeloid Derived Suppressor Cells and Chronic Myeloid Leukemia|Effect of Tyrosine Kinase Inhibitors on Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia Patients|Not yet recruiting||N/A|50|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:52:53.121361|2017-10-10 20:52:53.121361
NCT03214705|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-20|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01|21 Days|Observational [Patient Registry]|||Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage|Role of Computed Tomography Perfusion in Detection of Patients at Risk for Delayed Cerebral Ischemia After Subarachnoid Hemorrhage|Recruiting||N/A|60|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:52:53.197843|2017-10-10 20:52:53.197843
NCT03214692|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-07-10|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|GA&CRF||Gum Arabic as Antioxidant and Anti-inflammatory in Hemodialysis Patients|Potential Role of Gum Arabic as Antioxidant and Anti-inflammatory Agent in Hemodialysis Patients|Enrolling by invitation||N/A|50|Anticipated|Al-Neelain University||1|||f||||f|f|f||||||||2017-10-10 20:52:53.295965|2017-10-10 20:52:53.295965
NCT03214679|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-07|||July 12, 2017|Anticipated|2017-07-12|July 2017|2017-07-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)|Accessible Care Intervention for Engaging People Who Inject Illicit Drugs in HCV Care|Recruiting||N/A|300|Anticipated|Weill Medical College of Cornell University||2|||f||||t|f|f||||||||2017-10-10 20:52:53.390181|2017-10-10 20:52:53.390181
NCT03214666|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|June 1, 2023|Anticipated|2023-06-01|December 1, 2022|Anticipated|2022-12-01||Interventional|||CD16/IL-15/CD33 Tri-Specific Killer Engagers (TriKes) for CD33+ Hem Malignancies|CD16/IL-15/CD33 (161533) Tri-Specific Killer Engagers (TriKes) for the Treatment of CD33+ Hematopoietic Malignancies|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t|t|f||||||||2017-10-10 20:52:53.502332|2017-10-10 20:52:53.502332
NCT03214653|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|November 30, 2017|Anticipated|2017-11-30||Interventional|||Comparison Between Target-controlled Infusion of Propofol and Sevoflurane as Maintenance of Anesthesia to Hemodynamic Profile of Renal Transplant Recipient|Comparison Between the Effect of Target-controlled Infusion of Propofol and Sevoflurane as Maintenance of Anesthesia to Intraoperative Hemodynamic Profile of Renal Transplant Recipient|Recruiting||N/A|23|Anticipated|Indonesia University||2|||f|||||f|f||||||||2017-10-10 20:52:53.596233|2017-10-10 20:52:53.596233
NCT03214640|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-07|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Rivanna Ultrasound for Neuraxial Block|Evaluation of Success in Neuraxial Block Placement Between Using Palpation of Landmark Versus Pocket-Size Handheld Ultrasound (U/S) Method|Not yet recruiting||N/A|120|Anticipated|Wake Forest University Health Sciences||2|||f||||t|f|t|f||f|||||2017-10-10 20:52:53.69185|2017-10-10 20:52:53.69185
NCT03214627|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-07|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|ANEMEX||Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial|ANEMEX UK Trial: Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial|Not yet recruiting||N/A|240|Anticipated|Vifor Fresenius Medical Care Renal Pharma||1|||f||||t|f|f||||||||2017-10-10 20:52:53.778882|2017-10-10 20:52:53.778882
NCT03214614|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-12|||November 14, 2016|Actual|2016-11-14|September 2017|2017-09-01|August 25, 2017|Actual|2017-08-25|August 25, 2017|Actual|2017-08-25||Interventional|||A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Male Subjects|Assessment of Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of GLPG2451 and of the Combination of GLPG2451 and GLPG2222 in Healthy Male Subjects|Completed||Phase 1|39|Actual|Galapagos NV||4|||f||||f|f|f||||||||2017-10-10 20:52:53.892705|2017-10-10 20:52:53.892705
NCT03214601|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-08-10|||October 17, 2017|Anticipated|2017-10-17|August 2017|2017-08-01|August 31, 2024|Anticipated|2024-08-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||A Early Feasibility Study of the Relay Branch Thoracic Stent-Graft System in Subjects With Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery|A Prospective, Multicenter, Non-Blinded, Non-Randomized Early Feasibility Study of the Relay Branch Thoracic Stent-Graft System in Subjects With Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery|Not yet recruiting||N/A|10|Anticipated|Bolton Medical||1|||f||||t|f|t|t|||||||2017-10-10 20:52:53.986472|2017-10-10 20:52:53.986472
NCT03214588|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||November 3, 2017|Anticipated|2017-11-03|July 2017|2017-07-01|February 27, 2019|Anticipated|2019-02-27|February 27, 2019|Anticipated|2019-02-27||Interventional|||Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adult Subjects With Friedreich Ataxia|Not yet recruiting||Phase 2|65|Anticipated|Takeda||3|||f||||f|t|f||||||||2017-10-10 20:52:54.074302|2017-10-10 20:52:54.074302
NCT03214575|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-10|||February 1, 2016|Actual|2016-02-01|July 2017|2017-07-01|October 31, 2016|Actual|2016-10-31|October 1, 2016|Actual|2016-10-01||Interventional|||Ultrasound Guided Central Venous Vascular Access - Novel Needle Navigation Technology Compared With Conventional Method|Ultrasound Guided Central Venous Vascular Access - Novel Needle Navigation Technology Compared With Conventional Method: A Prospective Randomized Study|Completed||N/A|100|Actual|University of Malaya||2|||f||||t|f|f||||||||2017-10-10 20:52:54.288397|2017-10-10 20:52:54.288397
NCT03214562|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-26|||September 26, 2017|Actual|2017-09-26|September 2017|2017-09-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Interventional|||Study of the BCL-2 Inhibitor Venetoclax in Combination With Standard Intensive Acute Myeloid Leukemia (AML) Induction/Consolidation Therapy With FLAG-IDA in Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML)|A Phase 1b/2 Study of the BCL-2 Inhibitor Venetoclax in Combination With Standard Intensive Acute Myeloid Leukemia (AML) Induction/Consolidation Therapy With FLAG-IDA in Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML)|Recruiting||Phase 1/Phase 2|56|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 20:52:54.39237|2017-10-10 20:52:54.39237
NCT03214549|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-09|||July 13, 2018|Anticipated|2018-07-13|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Comparison in Marginal Adaptation Between Conventional and Gull Wing Preparation in Laminates Veneers|Marginal Adaptation of E.Max Laminate Veneers Prepared With Modified Gull Wing Preparation and Conventional Preparation|Not yet recruiting||N/A|38|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:52:54.568022|2017-10-10 20:52:54.568022
NCT03214536|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||June 25, 2017|Actual|2017-06-25|July 2017|2017-07-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Erector Spine Block for Back Surgery|Erector Spine Block in Patients Undergoing Back Surgery, Observational Feasibility Trial of the Effect on Postoperative Pain-scores and Opioid Consumption|Recruiting||N/A|15|Anticipated|University Hospital, Antwerp||1|||f||||f|f|f||||||||2017-10-10 20:52:54.658966|2017-10-10 20:52:54.658966
NCT03214523|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|FRoSH||Freshman Sleep and Health Project|Freshman Sleep and Health Project|Enrolling by invitation||N/A|100|Actual|University of California, San Diego||2|||f||||f|f|f||||||||2017-10-10 20:52:54.801509|2017-10-10 20:52:54.801509
NCT03214510|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-10-04|||October 4, 2017|Actual|2017-10-04|October 2017|2017-10-01|October 2023|Anticipated|2023-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Trial of Thoracic Epidural Analgesia Versus Four-Quadrant Transversus Abdominus Plane Block in Oncologic Open Liver Surgery|Randomized, Unblinded, Phase III Trial of Thoracic Epidural Analgesia Versus Four-Quadrant Transversus Abdominus Plane Block in Oncologic Open-Incision Liver Surgery|Recruiting||Phase 3|96|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f|||f|||||2017-10-10 20:52:54.904641|2017-10-10 20:52:54.904641
NCT03214497|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-09|||July 12, 2017|Actual|2017-07-12|August 2017|2017-08-01|July 14, 2018|Anticipated|2018-07-14|July 14, 2018|Anticipated|2018-07-14||Interventional|||Protector™ Versus Supreme® Laryngeal Mask Airway|Prospective Randomised Trial of the Protector™ Versus the Supreme® Laryngeal Mask Airway|Recruiting||N/A|96|Anticipated|Schulthess Klinik||2|||f||||f|f|f||||||||2017-10-10 20:52:55.037117|2017-10-10 20:52:55.037117
NCT03214484|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-10|||June 2, 2017|Actual|2017-06-02|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||The Evolution of Visual Acuity Measured by Electronic Tablet / Computer of Exudative AMD Patients|A Prospective Study Comparing the Evolution of Visual Acuity Measured by Electronic Tablet or Computer and the Visual Acuity Measured by ETDRS in Patients Monitored and Treated for Exudative AMD|Recruiting||N/A|80|Anticipated|Hospital St. Joseph, Marseille, France||2|||f||||f|f|f||||||||2017-10-10 20:52:55.16189|2017-10-10 20:52:55.16189
NCT03214471|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Evaluation of a Lifestyle Intervention After Bariatric Surgery|Evaluation of the Effect of a Lifestyle Intervention Compared to Usual Care on Weight Loss and Changes in Body Composition, Physical Activity Levels and Health-related Quality of Life in the First Year Following Bariatric Surgery|Not yet recruiting||N/A|198|Anticipated|University College, London||2|||f||||t|f|f||||||||2017-10-10 20:52:55.285311|2017-10-10 20:52:55.285311
NCT03214458|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-07|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)|Tolerance and Acute Effects of Humidified Nasal High-flow With Oxygen (HNHF-O2) on Gas Exchange in Patients Hospitalized With an Acute Exacerbation of COPD|Recruiting||N/A|10|Anticipated|Temple University||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:52:55.4313|2017-10-10 20:52:55.4313
NCT03214445|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-10|||March 1, 2015|Actual|2015-03-01|July 2017|2017-07-01|May 1, 2017|Actual|2017-05-01|December 1, 2016|Actual|2016-12-01||Interventional|SEAL2||Sealing Defective Margins of Composite Restorations With Fluid Composite Resin Nanofiller Reinforced|Reparación y Sellado de Restauraciones de Amalgama y Resinas Compuestas Para el Incremento de Su Longevidad Repair and Sealing of Amalgam and Composite Resins to Increase of Longevity|Completed||N/A|60|Actual|University of Chile||3|||f||||t|f|f||||||||2017-10-10 20:52:55.549725|2017-10-10 20:52:55.549725
NCT03214432|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||Return to Work After Mild Traumatic Brain Injury|Return to Work After Mild Traumatic Brain Injury|Recruiting||N/A|20000|Anticipated|University of Copenhagen|||2||f||||f|f|f||||||||2017-10-10 20:52:55.643535|2017-10-10 20:52:55.643535
NCT03214419|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|August 1, 2017|Anticipated|2017-08-01|June 1, 2017|Actual|2017-06-01||Observational|Anatobreast||Study First Step to Virtual Breast Cancer Localization|Anatobreast : First Step to Virtual Breast Cancer Localization|Active, not recruiting||N/A|10|Anticipated|University Hospital, Montpellier|||1||f||||f|f|f||||||||2017-10-10 20:52:55.739558|2017-10-10 20:52:55.739558
NCT03214393|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-07-10|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|July 30, 2018|Anticipated|2018-07-30||Observational|||Certain Maternal Antibodies in Relation to Doppler in Hypertension With Pregnancy|Role of Maternal Anticardiolipin and Anti-B2 Glycoprotein I Antibodies in Correlation With Fetal Doppler in Prediction of Adverse Pregnancy Outcome in Patients With Preeclampsia|Not yet recruiting||N/A|100|Anticipated|Cairo University|||1||f|||||f|f||||||||2017-10-10 20:52:55.903901|2017-10-10 20:52:55.903901
NCT03214380|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-09-27|||July 14, 2017|Actual|2017-07-14|September 2017|2017-09-01|February 15, 2019|Anticipated|2019-02-15|August 31, 2018|Anticipated|2018-08-31||Interventional|PRONTO-T2D||A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes|A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D|Recruiting||Phase 3|670|Anticipated|Eli Lilly and Company||2|||f||||f|t|f||||||||2017-10-10 20:52:56.014957|2017-10-10 20:52:56.014957
NCT03214367|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-10|2017-10-03|||July 17, 2017|Actual|2017-07-17|October 2017|2017-10-01|September 26, 2019|Anticipated|2019-09-26|September 6, 2018|Anticipated|2018-09-06||Interventional|PRONTO-T1D||A Study of LY900014 in Participants With Type 1 Diabetes|A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D|Recruiting||Phase 3|1199|Anticipated|Eli Lilly and Company||3|||f||||f|t|f||||||||2017-10-10 20:52:56.509059|2017-10-10 20:52:56.509059
NCT03214354|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|July 2023|Anticipated|2023-07-01|July 2021|Anticipated|2021-07-01||Interventional|Sickle-MAID||Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor|A Phase II Pilot Study of Nonmyeloablative Conditioning Hematopoietic Stem Cell Transplantation in Children With Sickle Cell Disease Who Have a Matched Related Major ABO-Incompatible Donor (Sickle-MAID)|Recruiting||Phase 2|12|Anticipated|University of Calgary||1|||f||||t|f|f|||f|||||2017-10-10 20:52:57.196885|2017-10-10 20:52:57.196885
NCT03214341|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-07-10|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 1, 2019|Anticipated|2019-12-01||Observational|||Assessment of Mediastinal Masses With Diffusion Weighted MR Imaging|Assessment of Mediastinal Masses With Diffusion Weighted MR Imaging|Not yet recruiting||N/A|24|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:52:57.314057|2017-10-10 20:52:57.314057
NCT03214328|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|EMIBICI||Causes of Fetal Death: Comparison of Diagnostic Accuracy Between Extensive and Selective Protocol Testing|Causes of Fetal Death: Comparison of Diagnostic Accuracy Between Extensive and Selective Protocol Testing|Not yet recruiting||N/A|602|Anticipated|University Hospital, Rouen|||1||f||||f|f|f||||||||2017-10-10 20:52:57.398858|2017-10-10 20:52:57.398858
NCT03214315|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-10|||November 11, 2014|Actual|2014-11-11|July 2017|2017-07-01|October 30, 2017|Anticipated|2017-10-30|October 15, 2017|Anticipated|2017-10-15||Observational|RESCAP||Structural Network on Prostate Cancer in the French Greater West Region|Réseau Structurant Sur le Cancer de la Prostate du Grand Ouest|Recruiting||N/A|1000|Anticipated|University Hospital, Tours|||1||f||||f|f|f||||Samples With DNA|"     Sample of visceral adipose tissue   "|||2017-10-10 20:52:57.490109|2017-10-10 20:52:57.490109
NCT03214302|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-11|||January 1, 2017||2017-01-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus Infection|The Incidence of Postpartum Hepatitis in Pregnant Women With High HBVDNA Loads|Recruiting||N/A|560|Anticipated|Beijing Ditan Hospital||2|||f||||||||||||||2017-10-10 20:52:57.624656|2017-10-10 20:52:57.624656
NCT03214289|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-11|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|December 20, 2019|Anticipated|2019-12-20|July 20, 2019|Anticipated|2019-07-20||Interventional|||Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease|Fecal Microbiota Transplantation for Treatment of Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease- a Pilot Study|Recruiting||Phase 1|4|Anticipated|Sheba Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:52:57.747167|2017-10-10 20:52:57.747167
NCT03214263|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-10|||May 2015||2015-05-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01|5 Years|Observational [Patient Registry]|||Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases|Identification of New Biomarkers to Improve Diagnostics or Predict Treatment Responses, Adverse Events or Prognosis in Patients With Inflammatory Rheumatic Disease Followed in the Danish Nationwide Quality Registry, DANBIO|Recruiting||N/A|20000|Anticipated|Rigshospitalet, Denmark|||3||f||||t||||||Samples With DNA|"     EDTA-whole blood, EDTA-plasma, EDTA-buffy coat, serum, synovial fluid, tissue, PAXgene RNA     tubes   "|||2017-10-10 20:52:57.946788|2017-10-10 20:52:57.946788
NCT03214250|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-01|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|September 1, 2022|Anticipated|2022-09-01|July 1, 2022|Anticipated|2022-07-01||Interventional|||Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma|Open-label, Multicenter, Phase 1b/2 Clinical Study to Evaluate the Safety and Efficacy of CD40 Agonistic Monoclonal Antibody (APX005M) Administered Together With Gemcitabine and Nab-Paclitaxel With or Without PD-1 Blocking Antibody (Nivolumab) in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 1/Phase 2|105|Anticipated|Parker Institute for Cancer Immunotherapy||3|||f||||f|t|f||||||||2017-10-10 20:52:58.098421|2017-10-10 20:52:58.098421
NCT03214237|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-07|||July 9, 2017|Anticipated|2017-07-09|July 2017|2017-07-01|August 30, 2017|Anticipated|2017-08-30|July 31, 2017|Anticipated|2017-07-31||Observational|||A Cross-sectional Study of the Oral Health of Elderly Inpatients in Acute and Subacute Hospitals in Northumberland and North Tyneside|A Cross-sectional Study of the Oral Health of Elderly Inpatients in Acute and Subacute Hospitals in Northumberland and North Tyneside|Not yet recruiting||N/A|200|Anticipated|Northumbria Healthcare NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 20:52:58.258196|2017-10-10 20:52:58.258196
NCT03214224|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Remote Pulmonary Function Testing in Amyotrophic Lateral Sclerosis|Remote Pulmonary Function Testing in Amyotrophic Lateral Sclerosis (ALS)|Not yet recruiting||N/A|83|Anticipated|Milton S. Hershey Medical Center||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:52:58.356922|2017-10-10 20:52:58.356922
NCT03214211|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-30|||August 30, 2017|Anticipated|2017-08-30|July 2017|2017-07-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Observational|||Prospective Observational Study of Pravafenix Cap|Assess the Long-term Safety and Efficacy of Pravafenix Cap. in Korean Patients With Dyslipidemia: a Multicenter, Prospective, Observational Study|Not yet recruiting||N/A|3088|Anticipated|Yooyoung Pharmaceutical Co.,Ltd.|||1||f|||||f|f||||||||2017-10-10 20:52:58.462462|2017-10-10 20:52:58.462462
NCT03214198|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-10|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|||"Special dr ug Use Surveillance of Takecab for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term UsePrevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use"|"Special Drug Use Surveillance of Takecab Tablets for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs:Long-term Use"|Recruiting||N/A|1000|Anticipated|Takeda|||1||f||||f|f|f||||||||2017-10-10 20:52:58.54075|2017-10-10 20:52:58.54075
NCT03214185|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-10|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Effects of PGS2.0 in Patients With Unexplained RPL|Effects of Preimplantation Genetic Screening 2.0 on the Clinical Outcomes of Assisted Reproductive Treatment in Patients With Recurrent Pregnancy Loss : A Multi-center-based Prospective Randomized Clinical Trial|Not yet recruiting||N/A|260|Anticipated|ShangHai Ji Ai Genetics & IVF Institute||2|||f||||t|f|f||||||||2017-10-10 20:52:58.662911|2017-10-10 20:52:58.662911
NCT03214172|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-09-27|||July 3, 2017|Actual|2017-07-03|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban|Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban|Active, not recruiting||N/A|1000|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 20:52:58.771352|2017-10-10 20:52:58.771352
NCT03214159|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-09-30|||July 11, 2017|Actual|2017-07-11|July 2017|2017-07-01|September 20, 2017|Actual|2017-09-20|August 31, 2017|Actual|2017-08-31||Interventional|||Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese Subjects|An Open-label, Randomized Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese Subjects|Completed||Phase 1|12|Actual|First Affiliated Hospital of Zhejiang University||2|||f||||f|f|f||||||||2017-10-10 20:52:58.858439|2017-10-10 20:52:58.858439
NCT03214146|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-11|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|November 1, 2018|Anticipated|2018-11-01||Interventional|||Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS|"An Open-label, Phase 1 Trial for Safety and Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell(HYNR-CS-Allo Inj) Treatment in Amyotrophic Lateral Sclerosis(ALS)"|Recruiting||Phase 1|6|Anticipated|Hanyang University Seoul Hospital||1|||f||||f|f|f||||||||2017-10-10 20:52:58.96734|2017-10-10 20:52:58.96734
NCT03214133|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-14|||May 23, 2017|Actual|2017-05-23|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|June 14, 2017|Actual|2017-06-14||Interventional|coca-dose||Effects of Epicatechin-rich Cocoa on Collagen Synthesis|Determining an Optimal Dose of Epicatechin-Rich Chocolate and Its Effect on Performance|Active, not recruiting||N/A|60|Anticipated|University of California, Davis||2|||f||||t|f|f||||||||2017-10-10 20:52:59.090033|2017-10-10 20:52:59.090033
NCT02993458|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||October 2016||2016-10-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|CampDASH||DASH-Sodium Trial in Adolescents|DASH-Sodium Trial in Adolescents|Recruiting||N/A|522|Anticipated|Purdue University||4|||f||||t||||||||Undecided||2017-10-10 21:31:48.340086|2017-10-10 21:31:48.340086
NCT03214107|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-08|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Carbohydrate-based Strategies to Prevent Exercise-induced Hypoglycemia|Comparison of Two Carbohydrate Intake Strategies to Improve Glucose Control During Exercise in Adults With Type 1 Diabetes|Recruiting||N/A|37|Anticipated|Institut de Recherches Cliniques de Montreal||2|||f||||f|f|f||||||||2017-10-10 20:52:59.286465|2017-10-10 20:52:59.286465
NCT03214094|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-09|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|||"Special Drug Use Surveillance of Takecab for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"|"Special Drug Use Surveillance of Takecab Tablets for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"|Recruiting||N/A|1000|Anticipated|Takeda|||1||f||||f|f|f||||||||2017-10-10 20:52:59.387457|2017-10-10 20:52:59.387457
NCT03214068|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|||Evaluation of the Pattern of Thyroid Dysfunctions in Patients With Metabolic Syndrome|Evaluation of the Pattern of Thyroid Dysfunctions in Patients With Metabolic Syndrome|Not yet recruiting||N/A|200|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:52:59.542999|2017-10-10 20:52:59.542999
NCT03214055|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-24|||July 12, 2017|Actual|2017-07-12|August 2017|2017-08-01|August 20, 2017|Actual|2017-08-20|August 14, 2017|Actual|2017-08-14|7 Days|Observational [Patient Registry]|||Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy|Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy: a Prospective Observational Study|Completed||N/A|39|Actual|Asan Medical Center|||1||f|||||f|f||||||||2017-10-10 20:52:59.608148|2017-10-10 20:52:59.608148
NCT03214042|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-09|||March 1, 2013|Actual|2013-03-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Safety of K-rod Dynamic Stabilization System in the Repair of Lumbar Degenerative Diseases|Efficacy and Safety of K-rod Dynamic Stabilization System in the Repair of Lumbar Degenerative Diseases: Study Protocol for a Prospective, Self-controlled, Clinical Trial|Active, not recruiting||N/A|67|Actual|Shenyang Orthopedic Hospital||1|||f||||t|f|f||||||||2017-10-10 20:52:59.674666|2017-10-10 20:52:59.674666
NCT03214029|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CONTRAST||COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial|COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial|Not yet recruiting||N/A|2000|Anticipated|Minneapolis Medical Research Foundation|||1||f|||||f|t|t|||Samples Without DNA|"     Excess blood is biobanked as EDTA-plasma and heparin samples after being used for the     clinical cTnI assay   "|||2017-10-10 20:52:59.742059|2017-10-10 20:52:59.742059
NCT03214016|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-10|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|May 30, 2018|Anticipated|2018-05-30||Interventional|||Effects of Pilates Method and Aerobic Training in Hypertensive Subjects|Effects of Pilates Method and Aerobic Training in Hypertensive Subjects: a Randomized Trial|Not yet recruiting||N/A|30|Anticipated|Universidade Federal de Santa Maria||2|||f|||||f|f||||||||2017-10-10 20:52:59.987566|2017-10-10 20:52:59.987566
NCT03214003|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|August 2025|Anticipated|2025-08-01|May 2020|Anticipated|2020-05-01||Interventional|TRISS||Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC|Twice-daily Radiotherapy by Simultaneous Integrated Boosting Technique Versus Twice-daily Standard Radiotherapy for Patients With Limited-stage Small Cell Lung Cancer: a Multicenter, Randomized, Controlled, Phase III Study|Enrolling by invitation||N/A|326|Anticipated|Beijing Cancer Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:00.10892|2017-10-10 20:53:00.10892
NCT03213990|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-16|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2023|Anticipated|2023-06-01|December 2022|Anticipated|2022-12-01||Interventional|BLING III||Beta-Lactam InfusioN Group Study|A Phase III Randomised Controlled Trial of Continuous Beta-lactam Infusion Compared With Intermittent Beta-lactam Dosing in Critically Ill Patients|Not yet recruiting||N/A|7000|Anticipated|The George Institute||2|||f||||t|f|f||||||||2017-10-10 20:53:00.246547|2017-10-10 20:53:00.246547
NCT03213977|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-11|||February 1, 2017|Actual|2017-02-01|January 2017|2017-01-01|February 1, 2021|Anticipated|2021-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL|A Multicenter,Randomized, Controlled (Comparative), Open, Prospective Study Evaluating an Efficacy of R-DA-EPOCH and R-CEOP90, With or Without Upfront Auto-HSCT，in Newly Diagnosed Young Patients With Intermediate/High-risk DLBCL|Recruiting||Phase 3|475|Anticipated|Fujian Medical University||4|||f|||||f|f||||||||2017-10-10 20:53:00.389867|2017-10-10 20:53:00.389867
NCT03213964|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|April 1, 2020|Anticipated|2020-04-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int|Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Interleukin-2 in Women With Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Not yet recruiting||Phase 1|16|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f||||||||2017-10-10 20:53:00.525131|2017-10-10 20:53:00.525131
NCT03213951|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-08-22|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection|Pilot Ex-Vivo Investigation of an Experimental Beta Probe for Assessment and Guidance of Prostate Cancer Resection|Recruiting||N/A|10|Anticipated|Indiana University|||1||f||||t|f|f||||||||2017-10-10 20:53:00.614811|2017-10-10 20:53:00.614811
NCT03212846|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-09|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Muscle Spasticity Reduction in Children With Cerebral Palsy by Means of Hippotherapy|Muscle Spasticity Reduction in Children With Cerebral Palsy by Means of Hippotherapy: a Randomized Controlled Trial|Completed||N/A|50|Actual|University of Cadiz||2|||f||||f|f|f||||||||2017-10-10 20:53:11.284661|2017-10-10 20:53:11.284661
NCT03213925|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-08|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|July 1, 2025|Anticipated|2025-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer|Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer|Recruiting||Phase 2|1|Anticipated|Instituto do Cancer do Estado de São Paulo||1|||f||||f|f|f||||||||2017-10-10 20:53:00.809894|2017-10-10 20:53:00.809894
NCT03213912|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-22|||January 29, 2016|Actual|2016-01-29|August 2017|2017-08-01|January 28, 2019|Anticipated|2019-01-28|January 28, 2019|Anticipated|2019-01-28||Observational|||EC50 of Anesthetics During Microelectric Recording|Determination of EC50 of Anesthetics During Microelectric Recording in Patients Receiving Deep Brain Stimulation Under Anesthesia|Recruiting||N/A|50|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||f|f|f||||||||2017-10-10 20:53:00.884213|2017-10-10 20:53:00.884213
NCT03213899|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-09|||August 1, 2015|Actual|2015-08-01|July 2017|2017-07-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|||Association Between Malnutrition and Clinical Outcomes in the Intensive Care Unit|Association Between Malnutrition and Hospital Mortality and Duration of Intensive Care Unit Admission in the Critically Ill: a Prospective Singapore Cohort Study|Completed||N/A|503|Actual|JurongHealth|||1||f||||f|f|f||||||||2017-10-10 20:53:01.001552|2017-10-10 20:53:01.001552
NCT03213886|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-11|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|VITAMINA_D||The Effect of Supplementation of Vitamin D Deficiency in Older People With Acute Hip Fracture:|A Prospective Randomized Trial Comparing the Effects of 2 Vitamin D Supplementation Regimens in Elderly People After Hip Fracture Surgery|Not yet recruiting||Phase 4|48|Anticipated|Consorci Sanitari de Terrassa||2|||f||||t|f|f||||||||2017-10-10 20:53:01.081722|2017-10-10 20:53:01.081722
NCT03213873|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|BETA-PD||Neuroplasticity in Parkinson´s Disease After Training|Effects of the HiBalance-program: Linking Clinical Signs and Symptoms to Changes in the Brain in People With Parkinson´s Disease|Not yet recruiting||N/A|100|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 20:53:01.204946|2017-10-10 20:53:01.204946
NCT03213860|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-08-15|||July 15, 2017|Actual|2017-07-15|July 2017|2017-07-01|August 20, 2017|Anticipated|2017-08-20|August 20, 2017|Anticipated|2017-08-20||Interventional|||The Effect of Night Eye Mask on Post-operative Pain in Cardiac Surgery Patients|The Effect of Night Eye Mask on Post-operative Pain in Cardiac Surgery Patients|Active, not recruiting||N/A|80|Actual|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:53:01.322774|2017-10-10 20:53:01.322774
NCT03213834|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-18|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Fibrinolytic Therapy Versus Medical Thoracoscopy|Fibrinolytic Therapy Versus Medical Thoracoscopy for Treatment of Severe Pleural Infection: A Randomized Clinical Trial|Recruiting||Phase 4|80|Anticipated|University of Florida||2|||f||||f|f|f|||f|||||2017-10-10 20:53:01.537177|2017-10-10 20:53:01.537177
NCT03213821|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-10|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|November 30, 2019|Anticipated|2019-11-30||Interventional|GFR||Safety and Efficacy of High Protein Diet Versus GFR Based Protein Diet in Heart Failure Patients With Renal Insufficiency|Safety and Efficacy of High Protein Diet Versus Glomerular Filtration Rate (GFR) Based Protein Diet in Non-obese Advanced Heart Failure (HF) Patients With Renal Insufficiency: Randomized Controlled Trial|Not yet recruiting||N/A|100|Anticipated|Rajaie Cardiovascular Medical and Research Center||2|||f||||t|f|f||||||||2017-10-10 20:53:01.686222|2017-10-10 20:53:01.686222
NCT03213808|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-02|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|AHCIM11||"VALIDATION OF THE CHAPTER ALLERGIES AND HYPERSENSITIVITY OF THE INTERNATIONAL DISEASE CLASSIFICATION (CIM)"|"ANALYSIS OF HEALTH DATA COLLECTED SYSTEMATICALLY BY THREE HOSPITALS FOR THE VALIDATION OF THE CHAPTER ALLERGY AND HYPERSENSITIVITY IN THE FUTURE VERSION 11 OF THE WORLD HEALTH ORGANIZATION (WHO) INTERNATIONAL CLASSIFICATION OF DISEASES (CIM)"|Recruiting||N/A|100|Anticipated|University Hospital, Montpellier|||5||f||||f|f|f||||||||2017-10-10 20:53:01.791879|2017-10-10 20:53:01.791879
NCT03213795|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-18|||April 12, 2017|Actual|2017-04-12|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Observational|TAMBE||Anatomical Feasibility of Multibranched Off-the-shelf Endografts for Thoracoabdominal and Para-renal Aortic Aneurysms (TAMBE Study)|Anatomical Feasibility of Multibranched Off-the-shelf Endografts for Thoracoabdominal and Para-renal Aortic Aneurysms (TAMBE Study)|Recruiting||N/A|562|Anticipated|IRCCS San Raffaele|||1||f||||f||||||||||2017-10-10 20:53:01.923903|2017-10-10 20:53:01.923903
NCT03213782|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-08|||August 1, 2015|Actual|2015-08-01|July 2017|2017-07-01|January 7, 2017|Actual|2017-01-07|January 7, 2017|Actual|2017-01-07||Interventional|||Effect of Nature Based Sounds' Intervention on Agitation and Anxiety of Patients Admitted in Intensive Care Units.|Effect of Nature Based Sounds' Intervention on Agitation and Anxiety of Patients Admitted in Intensive Care Units of MMIMS&R Hospital, Mullana, Ambala|Completed||N/A|60|Actual|Maharishi Markendeswar University||2|||f||||t|f|f||||||||2017-10-10 20:53:02.015601|2017-10-10 20:53:02.015601
NCT03213769|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Evaluation of Topical Coenzyme Q10 in Management of Oral Aphthous Ulcer|Clinical Evaluation of Topical Coenzyme Q10 in Management of Oral Aphthous Ulcer|Not yet recruiting||N/A|52|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:53:02.137641|2017-10-10 20:53:02.137641
NCT03213756|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-28|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|October 5, 2019|Anticipated|2019-10-05|July 5, 2019|Anticipated|2019-07-05||Interventional|PHYSICALFAV||Isometric Preoperative Exercise on Autologous Arteriovenous Fistulas. Randomized Clinical Trial|Effect of Isometric Preoperative Exercise on Vascular Caliber and the Maturation of Autologous Arteriovenous Fistulas. Randomized Clinical Trial|Recruiting||N/A|158|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||t|f|f||||||||2017-10-10 20:53:02.248125|2017-10-10 20:53:02.248125
NCT03213743|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|||Expression Profiling of microRNA Following Administration of Dexmedetomidine|Expression Profiling of microRNA Following Administration of Dexmedetomidine in Patients Undergoing Procedures|Completed||N/A|3|Actual|The First Affiliated Hospital of Kunming Medical College||1|||f||||f|f|f||||||||2017-10-10 20:53:02.364975|2017-10-10 20:53:02.364975
NCT03213730|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-09|2017-07-09|||January 10, 2017|Actual|2017-01-10|July 2017|2017-07-01|July 30, 2019|Anticipated|2019-07-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Perceptual-Cognitive Training After a Mild Traumatic Brain Injury: Towards a Sensitive Marker for Recovery|Perceptual-Cognitive Training After a Mild Traumatic Brain Injury: Towards a Sensitive Marker for Recovery|Recruiting||N/A|90|Anticipated|McGill University Health Center||3|||f|||||f|f||||||||2017-10-10 20:53:02.440827|2017-10-10 20:53:02.440827
NCT03213717|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-07|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|July 30, 2017|Anticipated|2017-07-30||Interventional|EBU||Effect of Body Weight Loading on Urinary Electrolyte Excretion|Effect of Body Weight Loading on Urinary Electrolyte Excretion|Active, not recruiting||N/A|15|Actual|Göteborg University||3|||f||||f|f|f||||||||2017-10-10 20:53:02.535904|2017-10-10 20:53:02.535904
NCT03213639|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial)|Use of Esomeprazole in Treatment of Early Onset Preeclampsia:a Double Blind Randomized, Placebo-controlled Trial|Not yet recruiting||Phase 2/Phase 3|390|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:53:03.478207|2017-10-10 20:53:03.478207
NCT03213626|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-30|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|||Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma|A Phase II Trial of Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma|Not yet recruiting||Phase 2|37|Anticipated|Indiana University||1|||f||||t|t|f||||||||2017-10-10 20:53:03.562873|2017-10-10 20:53:03.562873
NCT03213613|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents|Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents|Not yet recruiting||N/A|40|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||||2017-10-10 20:53:03.654291|2017-10-10 20:53:03.654291
NCT03213600|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||October 2, 2017|Anticipated|2017-10-02|July 2017|2017-07-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|NSOCOG||Neurostimulation-enhanced Behavioral Remediation of Social Cognition in Schizophrenia|Neurostimulation-enhanced Behavioral Remediation of Social Cognition in Schizophrenia|Not yet recruiting||N/A|150|Anticipated|Hôpital le Vinatier||2|||f||||t|f|f||||||||2017-10-10 20:53:03.860424|2017-10-10 20:53:03.860424
NCT03213587|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-07|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)|Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Had Failed Prior Platinum Based Chemotherapy|Recruiting||Phase 2|51|Anticipated|Zhejiang Cancer Hospital||1|||f|||||f|f||||||||2017-10-10 20:53:03.983481|2017-10-10 20:53:03.983481
NCT03213574|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-07|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Impact of GDT in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients|Impact of Goal Directed Fluid Therapy in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients|Suspended||N/A|50|Anticipated|Loma Linda University||2||Principal Investigator is making changes to the protocol.|f||||f|f|f||||||||2017-10-10 20:53:04.073036|2017-10-10 20:53:04.073036
NCT03213561|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-19|||July 11, 2017|Actual|2017-07-11|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Stable and Independent Communication Brain-computer Interfaces|Stable and Independent Non-invasive Communication Brain-computer Interfaces Based on Error-adaptive Decoding Algorithms|Recruiting||N/A|30|Anticipated|University of Geneva, Switzerland||1|||f||||f|f|f||||||||2017-10-10 20:53:04.172257|2017-10-10 20:53:04.172257
NCT03213548|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-07|||September 15, 2017|Anticipated|2017-09-15|July 2017|2017-07-01|September 15, 2020|Anticipated|2020-09-15|September 15, 2019|Anticipated|2019-09-15||Interventional|||Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty|Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty : A Randomized Clinical Trial|Not yet recruiting||N/A|50|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:53:04.265585|2017-10-10 20:53:04.265585
NCT03213535|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-08|2017-07-10|||January 2017||2017-01-01|January 2017|2017-01-01|July 10, 2017|Anticipated|2017-07-10|July 10, 2017|Anticipated|2017-07-10|2 Days|Observational [Patient Registry]|||Urea and Creatinine Level in Vaginal Fluid as a Predicator for Length of Latency Period in Prelabour Membranes Rupture|Urea and Creatinine Level in Vaginal Fluid as a Predicator for Length of Latency Period in Prelabour Membranes Rupture|Recruiting||N/A|60|Anticipated|Ain Shams University|||1||f||||t|f|f||||||||2017-10-10 20:53:04.390922|2017-10-10 20:53:04.390922
NCT03213522|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-07|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|April 9, 2018|Anticipated|2018-04-09|April 9, 2018|Anticipated|2018-04-09||Interventional|||Comparison of Craniosacral Therapy vs Pelvic Floor Physical Therapy|A Comparison of Craniosacral Therapy vs Pelvic Floor Physical Therapy for the Treatment of Lower Urinary Tract Dysfunction in People With Multiple Sclerosis: A Pilot Study|Recruiting||N/A|30|Anticipated|CentraState Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:53:04.48958|2017-10-10 20:53:04.48958
NCT03213509|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-02|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Verbal Autopsy of Maternal Deaths, Stillbirths, and Neonatal Deaths in BetterBirth|Verbal Autopsy of Maternal Deaths, Stillbirths, and Neonatal Deaths in BetterBirth|Enrolling by invitation||N/A|7605|Anticipated|Harvard School of Public Health|||1||f||||f|f|f||||||||2017-10-10 20:53:04.6112|2017-10-10 20:53:04.6112
NCT03213496|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-07|||May 1, 2016|Actual|2016-05-01|July 2017|2017-07-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|PAMP-Phase2||Promotion of Ambulation Before Non-cardiac Surgery|Impact of a Routine of Pre-surgical Walk for Non Cardiac Adult Patients Compared to Conventional Intervention (Not Recommended Exercise) in Reducing the Length of Hospital Stay and the Time of Onset of Ambulation.|Recruiting||N/A|500|Anticipated|Fundación Cardioinfantil Instituto de Cardiología||2|||f||||t||||||||||2017-10-10 20:53:04.70836|2017-10-10 20:53:04.70836
NCT03213483|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-14|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|October 2018|Anticipated|2018-10-01||Interventional|||Soft Tissue Augmentation Using Deepithelialized Free Gingival Graft Compared to Connective Tissue Graft in Management of Miller Class I and II Gingival Recession.|Soft Tissue Augmentation Using Deepithelialized Free Gingival Graft Compared to Connective Tissue Graft in Management of Miller Class I and II Gingival Recession. A Randomized Controlled Clinical Trial|Not yet recruiting||N/A|28|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:53:04.822583|2017-10-10 20:53:04.822583
NCT03213470|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||January 2016||2016-01-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Observation for Serial Changes in Acute Intracranial Artery Dissection Using HR-MRI||Recruiting||N/A|20|Anticipated|Asan Medical Center||1|||f||||||||||||||2017-10-10 20:53:04.927058|2017-10-10 20:53:04.927058
NCT03213457|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-29|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|March 21, 2021|Anticipated|2021-03-21|October 29, 2018|Anticipated|2018-10-29||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain|A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate in Subjects With Moderate to Severe Endometriosis-Associated Pain|Recruiting||Phase 3|700|Anticipated|AbbVie||3|||f||||f|t|f||||||||2017-10-10 20:53:05.052758|2017-10-10 20:53:05.052758
NCT03213444|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-07|||July 2015|Actual|2015-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Actual|2017-07-01||Interventional|||Impact of Adjuvant Chemotherapy in Patients With Colon Cancer|Impact of Adjuvant Chemotherapy in Cardiovascular Autonomic Regulation in Patients With Colon Cancer|Recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:05.475859|2017-10-10 20:53:05.475859
NCT03213431|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-13|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Development of the Pediatric Neurocognitive Functioning Questionnaire|Assessing Patient-Reported Neurocognitive Functioning in Pediatric Oncology: A Pilot Study Toward Developing the Pediatric Neurocognitive Questionnaire (PNCQ)|Recruiting||N/A|120|Anticipated|St. Jude Children's Research Hospital|||2||f||||f|f|f||||||||2017-10-10 20:53:05.577458|2017-10-10 20:53:05.577458
NCT03213418|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-22|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2022|Anticipated|2022-07-01||Interventional|||Electroretinogram: a New Human Biomarker for Smoking Cessation Treatment|Electroretinogram: a New Human Biomarker for Smoking Cessation Treatment|Not yet recruiting||N/A|50|Anticipated|New York State Psychiatric Institute||1|||f||||f|f|f||||||||2017-10-10 20:53:05.657704|2017-10-10 20:53:05.657704
NCT03213405|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-07|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|May 20, 2018|Anticipated|2018-05-20|May 20, 2018|Anticipated|2018-05-20||Interventional|EVA-VRS01||A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV|A Double Blind, Controlled by Conventional BCG, Dose-escalation Phase I Study, to Evaluate Safety, Tolerability and Immunogenicity of a Mycobacterium Bovis BCG (Bacillus Calmette-Guérin) Vaccine, 1331 Danish Strain, Live Attenuated and Recombinant for the Expression of Human Respiratory Syncytial Virus Nucleoprotein (N) in Healthy Males Within 18 and 50 Years of Age|Enrolling by invitation||Phase 1|24|Actual|Pontificia Universidad Catolica de Chile||4|||f||||t|f|f||||||||2017-10-10 20:53:05.714031|2017-10-10 20:53:05.714031
NCT03213392|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-18|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31|1 Month|Observational [Patient Registry]|||Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Hemorrhage|Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Haemorrhage|Completed||N/A|32|Actual|Postgraduate Institute of Medical Education and Research, Chandigarh|||1||f||||f|t|f|||f|Samples Without DNA|"     serum from blood samples and cerebrospinal fluid   "|||2017-10-10 20:53:05.79558|2017-10-10 20:53:05.79558
NCT03213379|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-07|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|September 15, 2018|Anticipated|2018-09-15|September 15, 2018|Anticipated|2018-09-15||Interventional|@ctipark||Assessment of Actigraphy Procedures on the Initiation of an Apomorphine Treatment Delivered Through a Pump to Patients With Parkinson's Disease|Assessment of Actigraphy Procedures on the Initiation of an Apomorphine Treatment Delivered Through a Pump to Patients With Parkinson's Disease|Not yet recruiting||N/A|190|Anticipated|Orkyn'||2|||f||||f|f|f|||f|||||2017-10-10 20:53:05.861187|2017-10-10 20:53:05.861187
NCT03213366|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-07-07|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Social Media Based Peer-Led Intervention for HIV Prevention|Empowering With PrEP Cluster-Randomized Controlled Trial: A Social Media Based Peer-Led Intervention for HIV Prevention|Recruiting||N/A|240|Anticipated|Montefiore Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:53:05.932022|2017-10-10 20:53:05.932022
NCT03213353|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-12|||July 3, 2017|Actual|2017-07-03|September 2017|2017-09-01|July 17, 2017|Actual|2017-07-17|July 17, 2017|Actual|2017-07-17||Interventional|||A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold Symptoms|A Single-Dose, Randomized, Two-Period, Crossover Bioequivalence Study Between a Combination Tablet With Paracetamol, Guaifenesin and Penylephrine Hydrochloride (Wrafton Laboratories Limited, United Kingdom) and Vicks Active SymptoMax Plus, Powder for Oral Solution (Wrafton Laboratories Limited, United Kingdom) in Healthy Adult Volunteers|Completed||N/A|72|Anticipated|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f|f|f||||||||2017-10-10 20:53:06.016209|2017-10-10 20:53:06.016209
NCT03213327|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-10|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|StayOK||StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks|StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks|Recruiting||N/A|350|Anticipated|Zurich University of Applied Sciences||1|||f||||t|f|f||||||||2017-10-10 20:53:06.174992|2017-10-10 20:53:06.174992
NCT03213314|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-22|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2019|Anticipated|2019-08-31||Interventional|Hepatica||HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies|HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies|Recruiting||N/A|200|Anticipated|University of Edinburgh||4|||f||||t|f|f||||||||2017-10-10 20:53:06.268041|2017-10-10 20:53:06.268041
NCT03213301|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-09-28|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|March 1, 2022|Anticipated|2022-03-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.|Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. A Multicenter, Single-arm Phase II Trial|Recruiting||Phase 2|43|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||t|f|f||||||||2017-10-10 20:53:06.389412|2017-10-10 20:53:06.389412
NCT03213288|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-10-05|||September 25, 2017|Actual|2017-09-25|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status|The Effects of Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status in Adults|Enrolling by invitation||N/A|50|Anticipated|Quadram Institute||3|||f||||f|f|f||||||||2017-10-10 20:53:06.565086|2017-10-10 20:53:06.565086
NCT03213262|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-25|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|September 24, 2017|Actual|2017-09-24|September 18, 2017|Actual|2017-09-18||Observational|||Is Anxiety Affect the Anesthesia Type Performed In Patients During Caeserean Section ?|Is Anxiety Affect the Anesthesia Type Performed In Patients During Caeserean Section ?|Completed||N/A|138|Actual|Tokat Gaziosmanpasa University|||2||f||||t|f|f||||||||2017-10-10 20:53:06.747349|2017-10-10 20:53:06.747349
NCT03213249|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-26|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy|Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy|Recruiting||Phase 1|16|Anticipated|Washington University School of Medicine||2|||f||||f|t|f|||f|||||2017-10-10 20:53:06.820797|2017-10-10 20:53:06.820797
NCT03213236|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-10|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OSA+||OSA Homemonitoring|OSA Homemonitoring|Recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f|||f|||||2017-10-10 20:53:06.958719|2017-10-10 20:53:06.958719
NCT03213223|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-07|||November 18, 2016|Actual|2016-11-18|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|July 31, 2017|Anticipated|2017-07-31||Observational|||Retention of Women in the PMTCT (Prevention of Mother-to-child Transmission of HIV)|Retention-in-care of Women in the Elimination of Mother-to-child Transmission of HIV (eMTCT) Option B Plus Program in Mashonaland East, Zimbabwe: a Mixed Method Study|Recruiting||N/A|462|Anticipated|University of Zimbabwe|||1||f||||f|f|f||||||||2017-10-10 20:53:07.036025|2017-10-10 20:53:07.036025
NCT03213210|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-10-03|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Efficacy of Synthetic Bone Graft for Treatment of Peri-implantitis|Clinical Efficacy of Easy-graft CLASSIC for the Treatment of Peri-implantitis|Not yet recruiting||N/A|15|Anticipated|Sunstar Americas||1|||f||||f|f|t|f|f|t|||||2017-10-10 20:53:07.104305|2017-10-10 20:53:07.104305
NCT03213197|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||February 14, 2017|Actual|2017-02-14|July 2017|2017-07-01|December 22, 2017|Anticipated|2017-12-22|December 22, 2017|Anticipated|2017-12-22||Interventional|||Feasibility of a Standardized Video for Patient Education and as a Decision Aid on Code Status for Patients in the Emergency Department Pending Admission to the Hospital|Feasibility of a Standardized Video for Patient Education and as a Decision Aid on Code Status for Patients in the Emergency Department Pending Admission to the Hospital|Recruiting||N/A|50|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 20:53:07.174372|2017-10-10 20:53:07.174372
NCT03213184|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-22|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2022|Anticipated|2022-08-31||Observational|CREW||Children's Respiratory and Environmental Workgroup|Children's Respiratory and Environmental Workgroup (CREW) Phase II|Not yet recruiting||N/A|5667|Anticipated|University of Wisconsin, Madison|||1||f||||f|f|f||||Samples With DNA|"     -  Blood samples separated into plasma/serum aliquots and red blood cell/buffy coat        -  Urine        -  Stool        -  Nasal wash/blow/lavage        -  Nasal Brushing collected cells expanded in cell culture and cryopreserved        -  Baby teeth (dependent on number returned and amount of material needed for assay)        -  Hair and toenail clippings        -  Saliva        -  Home dust samples   "|||2017-10-10 20:53:07.259062|2017-10-10 20:53:07.259062
NCT03213171|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-23|||September 27, 2017|Anticipated|2017-09-27|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Promoting Organ Donor Registration in Family Physician Offices|Promoting Organ and Tissue Donation Registration in Family Physician Offices: a Pragmatic Stepped-wedge Cluster Randomized Controlled Registry Trial (RegisterNow Trial)|Recruiting||N/A|6|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:53:08.955501|2017-10-10 20:53:08.955501
NCT03213158|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-06|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|IXADES||Ixazomib for Desensitization|Ixazomib for Desensitization in Kidney Transplantation|Not yet recruiting||Phase 2|10|Anticipated|University of Wisconsin, Madison||1|||f||||t|t|f||||||||2017-10-10 20:53:09.047348|2017-10-10 20:53:09.047348
NCT03213145|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||July 11, 2017|Anticipated|2017-07-11|July 2017|2017-07-01|August 16, 2017|Anticipated|2017-08-16|August 10, 2017|Anticipated|2017-08-10||Interventional|||Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers|A Non-Randomized, Open-Label, Two-Part, Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics and Safety of EDP-305 in Healthy Volunteers|Recruiting||Phase 1|48|Anticipated|Enanta Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 20:53:09.110972|2017-10-10 20:53:09.110972
NCT03213132|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||January 15, 2018|Anticipated|2018-01-15|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|SHUTiOASIS||Sleep Healthy Using The Internet for Older Adult Sufferers of Insomnia and Sleeplessness|An Insomnia Internet Intervention for Older Adults|Not yet recruiting||N/A|309|Anticipated|University of Virginia||3|||f||||f|f|f||||||||2017-10-10 20:53:09.202075|2017-10-10 20:53:09.202075
NCT03213119|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-10|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|January 2023|Anticipated|2023-01-01|December 2022|Anticipated|2022-12-01||Interventional|BRAVEST||Boosting Reward-based Attention Through VEstibular STimulation|Boosting Reward-based Attention Through VEstibular STimulation|Not yet recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||3|||f||||f|f|f||||||||2017-10-10 20:53:09.285071|2017-10-10 20:53:09.285071
NCT03213106|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-07|||December 1, 2016|Actual|2016-12-01|July 2017|2017-07-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Cerebellar Non-invasive Stimulation in Ataxias|Effects of Cerebellar Transcranial Magnetic Stimulation in Cerebellar Ataxias|Recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:09.367408|2017-10-10 20:53:09.367408
NCT03213093|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-10|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|PIV & MPP||Pressure and Diabetic Foot|Neurovascular Cutaneous Response to Pressure and Risk of Diabetic Foot Ulcer in Patients With Type 2 Diabetes|Not yet recruiting||N/A|200|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 20:53:09.447647|2017-10-10 20:53:09.447647
NCT03213080|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||TLD Registry for Patients With Advanced Stages of COPD|Targeted Lung Denervation (TLD) for Patients With Advanced Stages of COPD|Not yet recruiting||N/A|200|Anticipated|Nuvaira, Inc.|||1||f||||f|f|f||||||||2017-10-10 20:53:09.517949|2017-10-10 20:53:09.517949
NCT03213067|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||April 11, 2017|Actual|2017-04-11|July 2017|2017-07-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01|1 Day|Observational [Patient Registry]|||Mitochondrial and Microbiota Relationship|Can Metagenomic and Metadata be Combined Using Bioinformatics and Computational Biology Methods to Personalise Patient Treatment.|Recruiting||N/A|40|Anticipated|Newcastle University|||2||f||||t|f|f||||Samples With DNA|"     DNA will be extracted from stool samples and the 16S rRNA gene (V4 region) will be sequenced.     The DNA will then be stored in the Newcastle Mitochondrial Research Biobank   "|||2017-10-10 20:53:09.577565|2017-10-10 20:53:09.577565
NCT03213054|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-25|||July 7, 2017|Actual|2017-07-07|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer|A Phase 1 Study to Evaluate the Safety of OBP-301, Telomelysin in Combination With Radiation Therapy in Patients With Esophageal Cancer Not Applicable for Standard Therapy|Recruiting||Phase 1|12|Anticipated|Oncolys BioPharma Inc||1|||f||||t|t|f|||t|||||2017-10-10 20:53:09.650936|2017-10-10 20:53:09.650936
NCT03213041|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-28|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer|I-CURE-1: A Phase II, Single Arm Study of Pembroluzimab Combined With Carboplatin in Patients With Circulating Tumor Cells (CTCs) Positive Her-2 Negative Metastatic Breast Cancer (MBC)|Recruiting||Phase 2|100|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 20:53:09.835818|2017-10-10 20:53:09.835818
NCT03213028|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-28|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy|Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy|Recruiting||N/A|150|Anticipated|University of Pennsylvania||1|||f||||f|f|f||||||||2017-10-10 20:53:09.952302|2017-10-10 20:53:09.952302
NCT03213015|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-10|||January 25, 2017|Actual|2017-01-25|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|March 25, 2017|Actual|2017-03-25||Interventional|||Correlation Between the Amplitude of Ankle Dorsiflexion and Occurrence of Patellofemoral Pain Syndrome|Correlation Between the Amplitude of Ankle Dorsiflexion and Occurrence of Patellofemoral Pain Syndrome|Completed||N/A|67|Actual|Universidade Anhanguera||1|||f||||f|f|f||||||||2017-10-10 20:53:10.039105|2017-10-10 20:53:10.039105
NCT03213002|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|CAPTEM||Phase I/II Study of Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM|Phase I/II Study of Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed Glioblastoma (GBM)|Recruiting||Phase 1/Phase 2|67|Anticipated|Northwell Health||1|||f||||f|t|f|||t|||||2017-10-10 20:53:10.127556|2017-10-10 20:53:10.127556
NCT03212989|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-06|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|XTRA||Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on ART|IGHID 11627 - A Phase I Study to Evaluate the Effects of Vorinostat and HIV-1 Antigen Expanded Specific T Cell Therapy (HXTC) on Persistent HIV-1 Infection in HIV-Infected Individuals Started on Antiretroviral Therapy (The XTRA Study)|Recruiting||Phase 1|12|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t|t|f||||||||2017-10-10 20:53:10.238811|2017-10-10 20:53:10.238811
NCT03212976|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-04|||April 27, 2017|Actual|2017-04-27|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|MR-ICP||Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure|Assessment of the Clinical Efficacy of a Non-Invasive Measurement of Intracranial Pressure by Magnetic Resonance Phase Contrast Imaging|Recruiting||N/A|30|Anticipated|University of Miami||2|||f||||f|f|f||||||||2017-10-10 20:53:10.372804|2017-10-10 20:53:10.372804
NCT03212963|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-10-03|||March 21, 2017|Actual|2017-03-21|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%|An Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol Propionate Lotion, 0.05% in Subjects 12 to 16 Years 11 Months of Age With Plaque Psoriasis Receiving Two Weeks of Treatment|Recruiting||Phase 4|25|Anticipated|Sun Pharmaceutical Industries Limited||1|||f||||f|t|f||||||||2017-10-10 20:53:10.469429|2017-10-10 20:53:10.469429
NCT03212950|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-10-04|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Closed-Loop With Faster Aspart in Young Adults With Type 1 Diabetes|Day and Night Closed-Loop Glycemic Control With Faster-Acting Insulin Aspart in Young Adults With Type 1 Diabetes Using DreaMed Glucositter - The Fast PHYSI-DREAM Study|Active, not recruiting||N/A|20|Actual|University of Ljubljana, Faculty of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:53:10.578292|2017-10-10 20:53:10.578292
NCT03212937|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-06|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) to Treat Peripheral T-cell Lymphoma|A Phase I Investigator Sponsored Trial of Selinexor (KPT-330), a Selective Inhibitor of Nuclear Export / SINE™ Compound and Ifosfamide, Carboplatin, Etoposide (ICE) in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma|Recruiting||Phase 1|23|Anticipated|National Cancer Centre, Singapore||1|||f||||f|f|f||||||||2017-10-10 20:53:10.685695|2017-10-10 20:53:10.685695
NCT03212924|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||July 13, 2017|Anticipated|2017-07-13|July 2017|2017-07-01|July 13, 2018|Anticipated|2018-07-13|July 13, 2018|Anticipated|2018-07-13||Interventional|||Listening Effort in Cochlear Implant Users|Evaluation of Listening Effort With Pupillometry in Cochlear Implant Users|Not yet recruiting||N/A|30|Anticipated|Oticon Medical||1|||f||||f|f|f||||||||2017-10-10 20:53:10.777896|2017-10-10 20:53:10.777896
NCT03212911|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||HBV Vaccination in HIV-infected Adults|Immunogenicity and Safety of 4- vs. 3-standard Doses HBV Vaccination in HIV-infected Adults With Isolated Anti-HBc Antibody|Recruiting||Phase 4|96|Anticipated|Chiang Mai University||2|||f||||f|f|f||||||||2017-10-10 20:53:10.889264|2017-10-10 20:53:10.889264
NCT03212898|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-06|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Pharmacist Interventions in Rural Elderly Warfarin Patients|The Influence of Pharmacist Interventions on the Effectiveness of Warfarin Treatment in Elderly Patients From Rural Areas|Completed||N/A|131|Actual|Slaven Falamić||2|||f||||f|f|f||||||||2017-10-10 20:53:10.974996|2017-10-10 20:53:10.974996
NCT03212885|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-17|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|July 2020|Anticipated|2020-07-01||Interventional|||Stimulation of the Rostral Zona Incerta for Parkinson's Disease|Deep Brain Stimulation (DBS) of the Rostral Zona Incerta (rZI) for Parkinson's Disease (PD): Clinical Efficacy and Evaluation of Adverse Effects|Recruiting||N/A|81|Anticipated|University of Colorado, Denver||2|||f||||f|f|t|f|f||||||2017-10-10 20:53:11.041494|2017-10-10 20:53:11.041494
NCT03212872|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||July 7, 2016|Actual|2016-07-07|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|EV||Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding|Evaluation of Blood Ammonia Level as a Non Invasive Predictor for Presence of Gastroesophageal Varices and Risk of Bleeding|Recruiting||N/A|150|Anticipated|Tanta University||1|||f|||||f|f||||||||2017-10-10 20:53:11.118399|2017-10-10 20:53:11.118399
NCT03212833|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Impact of Insulin Resistance on Therapeutic Response for Oral Treatment of Chronic Hepatitis C Virus Infection|Impact of Insulin Resistance on Therapeutic Response for Oral Treatment of Chronic Hepatitis C Virus Infection|Recruiting||N/A|50|Anticipated|Assiut University|||||f||||t|f|f||||||||2017-10-10 20:53:11.357552|2017-10-10 20:53:11.357552
NCT03212820|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Low Speed Drilling Versus Conventional Drilling Technique on Crestal Bone Level in Maxilla.(Group B ) A Randomized Controlled Clinical Trial|Clinical Evaluation of the Effect of Low Speed Drilling Versus Conventional Drilling Technique on Crestal Bone Level in Maxilla. A Randomized Controlled Clinical Trial|Active, not recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:53:11.422483|2017-10-10 20:53:11.422483
NCT03212807|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-10|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2023|Anticipated|2023-08-01|February 2021|Anticipated|2021-02-01||Interventional|DuRIANS||Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL|Phase II Study Of Durvalumab In Combination With Lenalidomide In Relapsed/Refractory EBV Associated Subtypes Of DLBCL, Primary CNS Lymphoma And Primary Testicular DLBCL - DuRIANS (Durvalumab Revlimid In Aggressive NHL Subtypes)|Not yet recruiting||Phase 2|21|Anticipated|Singapore General Hospital||1|||f||||t|t|f|||t|||||2017-10-10 20:53:11.48141|2017-10-10 20:53:11.48141
NCT03212794|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||July 2018|Anticipated|2018-07-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|January 2021|Anticipated|2021-01-01||Interventional|ISTOP||Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.|Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.|Not yet recruiting||N/A|58|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:11.697341|2017-10-10 20:53:11.697341
NCT03212781|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women|Total Dose Infusion of Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women: a Randomized Controlled Trial|Completed||Phase 3|66|Actual|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:53:11.769076|2017-10-10 20:53:11.769076
NCT03212768|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-08|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Outcome of Low Energy Ankle Fractures|Outcome of Low Energy Ankle Fractures|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:53:11.844769|2017-10-10 20:53:11.844769
NCT03212755|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-07-07|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy|Serum Immunoglobulin (G ) as a Predictive Marker of Early Renal Affection in Type 2 Diabetic Patients|Not yet recruiting||N/A|75|Anticipated|Assiut University||3|||f||||f|f|f||||||||2017-10-10 20:53:11.904642|2017-10-10 20:53:11.904642
NCT03212742|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-18|||September 4, 2017|Actual|2017-09-04|July 2017|2017-07-01|June 30, 2022|Anticipated|2022-06-30|January 31, 2022|Anticipated|2022-01-31||Interventional|OLA-TMZ-RTE-01||Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients|Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients|Recruiting||Phase 1/Phase 2|79|Anticipated|Centre Francois Baclesse||1|||f||||t|f|f||||||||2017-10-10 20:53:11.979974|2017-10-10 20:53:11.979974
NCT03212729|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-07|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Antimicrobial Photodynamic Therapy Associated With the Conventional Endodontic Treatment: A Clinical and Microbiological Study|Antimicrobial Photodynamic Therapy Associated With the Conventional Endodontic Treatment: A Clinical and Molecular Microbiological Study|Completed||N/A|10|Actual|Universidade Federal Fluminense||2|||f|||||f|f||||||||2017-10-10 20:53:12.114965|2017-10-10 20:53:12.114965
NCT03212716|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-06|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|FLUNEXT||Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.|Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.|Not yet recruiting||Phase 2|300|Anticipated|University Hospital, Lille||3|||f||||f|f|f||||||||2017-10-10 20:53:12.195288|2017-10-10 20:53:12.195288
NCT03212703|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-06|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|MBST||Mindfulness for Parents of OCD-affected Children|A Trial of Mindfulness-Based Skills Training Groups Versus a Waiting List Control Period for Parents of Obsessive-Compulsive Disorder (OCD)-Affected Youth|Recruiting||N/A|45|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 20:53:12.290078|2017-10-10 20:53:12.290078
NCT03212690|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-21|||April 2, 2018|Anticipated|2018-04-02|September 2017|2017-09-01|September 16, 2019|Anticipated|2019-09-16|September 16, 2019|Anticipated|2019-09-16||Observational|||Study of Renin-angiotensin System in Mechanically Ventilated Subjects|Study to Elucidate the Association of the Renin-angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients|Not yet recruiting||N/A|150|Anticipated|GlaxoSmithKline|||1||f||||f|f|f||||||||2017-10-10 20:53:12.395056|2017-10-10 20:53:12.395056
NCT03212677|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-06|||May 17, 2017|Actual|2017-05-17|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers|Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers|Recruiting||N/A|224|Anticipated|Tufts University||8|||f||||t|f|f||||||||2017-10-10 20:53:12.484832|2017-10-10 20:53:12.484832
NCT03212664|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||August 5, 2014|Actual|2014-08-05|July 2017|2017-07-01|June 21, 2017|Actual|2017-06-21|March 1, 2017|Actual|2017-03-01||Interventional|||Physical Therapy Exercises in Hyperkyphosis|Effectiveness of Physical Therapy Exercises in Hyperkyphosis|Terminated||N/A|21|Actual|Texas Scottish Rite Hospital for Children||1||participants did not adhere to study protocol|f|||||f|f||||||||2017-10-10 20:53:12.615132|2017-10-10 20:53:12.615132
NCT03212482|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-07|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|July 30, 2019|Anticipated|2019-07-30|July 1, 2019|Anticipated|2019-07-01||Observational|||Patient-ventilator Asynchrony in Patients With Brain Injury|Patient-ventilator Asynchrony in Patients With Brain Injury|Enrolling by invitation||N/A|100|Anticipated|Capital Medical University|||1||f|||||f|f||||||||2017-10-10 20:53:13.845924|2017-10-10 20:53:13.845924
NCT03212651|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|PANDORE||Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab|A Phase II Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab|Recruiting||Phase 2|40|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f|f|f||||||||2017-10-10 20:53:12.678002|2017-10-10 20:53:12.678002
NCT03212638|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-10-02|||June 27, 2017|Actual|2017-06-27|October 2017|2017-10-01|November 1, 2017|Anticipated|2017-11-01|July 31, 2017|Actual|2017-07-31||Interventional|||A Study of Baricitinib in Healthy Participants|A Bioequivalence and Food Effect Study in Healthy Subjects Comparing Baricitinib Suspension and Commercial Tablet Formulations|Recruiting||Phase 1|44|Anticipated|Eli Lilly and Company||5|||f||||f|t|f||||||||2017-10-10 20:53:12.757132|2017-10-10 20:53:12.757132
NCT03212625|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-07|||January 28, 2016|Actual|2016-01-28|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction|The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction in Patients With Korean Hepatocellular Carcinoma Patients: Multicenter, Prospective Randomized Double-Blind Controlled Study|Recruiting||Phase 4|288|Anticipated|Korea University Guro Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:12.856455|2017-10-10 20:53:12.856455
NCT03212612|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||Galectin-3 in Patients With Endometriosis|Galectin-3 in Patients With Endometriosis|Not yet recruiting||N/A|90|Anticipated|Assiut University|||1||f||||t|f|f||||Samples Without DNA|"     Endometrial samples(1-2 gram) will be separated from each women during proliferative     phase(days 5-15) and washed several times with 0.9% sterile saline solution to remove any     blood from the tissues. The tissue samples will homogenized by tissue homogenizer at     40,000rpm. The supernatant extracts will be collected in Ependorf tubes and frozen at -80°C     till analysis by ELISA   "|||2017-10-10 20:53:12.975714|2017-10-10 20:53:12.975714
NCT03212599|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-20|||May 2013||2013-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2016|Actual|2016-06-01||Observational|DIMAP||Disulfiram as a Modulator of Amyloid Precursor Protein-processing|Quantitative Analysis of the Expression of Dementia-relevant Genes by Intake of the Drug Disulfiram|Completed||N/A|17|Actual|Johannes Gutenberg University Mainz|||1||f||||f||||||Samples With DNA|"     blood samples of each participant are retained and stored at -80.   "|||2017-10-10 20:53:13.070364|2017-10-10 20:53:13.070364
NCT03212586|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-29|||July 18, 2017|Actual|2017-07-18|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|January 4, 2018|Anticipated|2018-01-04||Interventional|||First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, and Food Effect of BAY1902607|Randomized, Placebo-controlled, Double-blind, Parallel-group Study to Investigate the Safety, Tolerability and Pharmacokinetics of Increasing Single Oral Doses of BAY1902607 Including the Relative Bioavailability Between Different Pharmaceutical Formulations and the Effect of Food on the Pharmacokinetics of BAY1902607 in Healthy Men|Recruiting||Phase 1|57|Anticipated|Bayer||2|||f||||f|f|f||||||||2017-10-10 20:53:13.138062|2017-10-10 20:53:13.138062
NCT03212573|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-07|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Implementation of an Enhanced Recovery After Surgery Program in Laparoscopic Roux-en-Y Gastric Bypass|Impact of Implementation of an Enhanced Recovery After Surgery Program in Laparoscopic Roux-en-Y Gastric Bypass|Recruiting||Phase 3|180|Anticipated|Hospital General Universitario Elche||2|||f||||t|f|f||||||||2017-10-10 20:53:13.210039|2017-10-10 20:53:13.210039
NCT03212560|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-07|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Observational|||Exercise Capacity and Physical Activity Levels in Newly Diagnosed Hematologic Malignant Patients|Exercise Capacity, Physical Activity Level and Quality of Life in Newly Diagnosed Hematologic Malignant Patients|Recruiting||N/A|30|Anticipated|Gazi University|||2||f||||f||||||||||2017-10-10 20:53:13.297891|2017-10-10 20:53:13.297891
NCT03212547|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-19|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|December 20, 2019|Anticipated|2019-12-20|September 20, 2019|Anticipated|2019-09-20||Interventional|||Effects of Verbal Intervention on Late and Moderately Late Preterm Infants With Sustained Social Withdrawal|A Randomized Clinical Study on the Effects of Verbal Intervention on Late and Moderately Late Preterm Infants With Sustained Social Withdrawal Diagnosed by Means of the Alarm Distress Baby Scale|Not yet recruiting||N/A|140|Anticipated|Clinica Alemana de Santiago||2|||f||||t|f|f||||||||2017-10-10 20:53:13.391122|2017-10-10 20:53:13.391122
NCT03212534|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|IMPACT||Inpatient Mortality Prediction Algorithm Clinical Trial (IMPACT)|A Randomized Clinical Trial of a Mortality Prediction Algorithm|Recruiting||N/A|1024|Anticipated|Dascena||2|||f|||||f|f||||||||2017-10-10 20:53:13.470011|2017-10-10 20:53:13.470011
NCT03212521|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-29|||August 7, 2017|Actual|2017-08-07|September 2017|2017-09-01|July 13, 2018|Anticipated|2018-07-13|July 13, 2018|Anticipated|2018-07-13||Interventional|||A Study to Evaluate Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection, With APRI (a Predictor of Hepatic Fibrosis) ≤ 1, and Have Never Received HCV Treatment|A Single Arm, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotypes 1-6 Infection and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤ 1|Recruiting||Phase 3|230|Anticipated|AbbVie||1|||t||||f|t|f||||||||2017-10-10 20:53:13.570321|2017-10-10 20:53:13.570321
NCT03212508|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Observational|||Comparison of Two Nasal Interface for CPAP in Preterm|Comparison of Two Nasal Interface for Continuous Distending Airway Pressure in Preterm Infants: RAM Nasal Cannula and Hudson Prongs|Completed||N/A|12|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||f|f|t|f|f|t|||||2017-10-10 20:53:13.705747|2017-10-10 20:53:13.705747
NCT03212495|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-08-26|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Intra-articular Dexmedetomidine Versus Neostigmine After Knee Arthroscopy (a Comparative Study)|Comparison Between Intra-articular Dexmedetomidine and Neostigmine as Adjuvant Analgesics After Knee Arthroscopy|Recruiting||Phase 2/Phase 3|100|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:53:13.757864|2017-10-10 20:53:13.757864
NCT03212469|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-06|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|February 2018|Anticipated|2018-02-01||Interventional|ABBIMUNE||A Trial of Durvalumab and Tremelimumab in Comibination With SBRT in Patients With Metastatic Cancer|A Phase I/II Study Evaluating the Safety and Clinical Activity of Anti-PDL1 (Durvalumab [MEDI4736]) + Anti CTLA-4 (Tremelimumab) Antibodies Administrated in Combination With Stereotactic Body Radiotherapy (SBRT) in Patients With Metastatic Squamous Cell Carcinoma of Head and Neck, Lung, or Oesophageus|Recruiting||Phase 1/Phase 2|40|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||3|||f||||f|f|f||||||||2017-10-10 20:53:13.901282|2017-10-10 20:53:13.901282
NCT03212456|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-07|||January 12, 2017|Actual|2017-01-12|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|December 28, 2017|Anticipated|2017-12-28||Interventional|||Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia|Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia|Recruiting||N/A|200|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||t|f|f||||||||2017-10-10 20:53:13.991166|2017-10-10 20:53:13.991166
NCT03212443|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-31|||August 10, 2017|Anticipated|2017-08-10|July 2017|2017-07-01|November 10, 2017|Anticipated|2017-11-10|October 10, 2017|Anticipated|2017-10-10||Interventional|||Combined Suprascapular and Axillary Nerve Blocks for Arthroscopic Shoulder Surgery|Combined Suprascapular and Axillary Nerve Blocks for Sevoflurane Consumption and Postoperative Analgesia in Arthroscopic Shoulder Surgery|Recruiting||N/A|60|Anticipated|Diskapi Teaching and Research Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:53:14.224194|2017-10-10 20:53:14.224194
NCT03212430|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-08|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Effect of Intravenous L-kynurenine (LKYN) on Cerebral Hemodynamics in Healthy Volunteers|The Effect of Intravenous L-kynurenine (LKYN) on Cerebral Hemodynamics in Healthy Volunteers|Recruiting||Phase 1|6|Anticipated|Danish Headache Center||1|||f||||f|f|f||||||||2017-10-10 20:53:14.316978|2017-10-10 20:53:14.316978
NCT03212417|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-06|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Education as an Intervention of Compassion Fatigue|Pilot/Feasibility Study of a Compassion Fatigue Education Intervention in Hematology/Oncology Clinical Research Nurses|Recruiting||N/A|30|Anticipated|City of Hope Medical Center||1|||f||||t|f|f||||||||2017-10-10 20:53:14.397369|2017-10-10 20:53:14.397369
NCT03212404|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-20|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase 1 Study of CK-301 as a Single Agent in Subjects With Advanced Cancers|A Phase 1, Open-label, Multicenter, Dose-escalation Study of CK-301 Administered Intravenously as a Single Agent to Subjects With Advanced Cancers|Recruiting||Phase 1|80|Anticipated|Checkpoint Therapeutics, Inc.||1|||f||||t|t|f|||t|||||2017-10-10 20:53:14.483964|2017-10-10 20:53:14.483964
NCT03212391|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||September 19, 2016|Actual|2016-09-19|July 2017|2017-07-01|July 20, 2018|Anticipated|2018-07-20|January 20, 2018|Anticipated|2018-01-20||Interventional|WAVE||WAVE Study- Walking and Aging in VErona Study|Effect of Diet and Physical Exercise, With or Without Nordic Walking, on Weight Loss, Physical Performance and Cardiovascular Risk Factors in Elderly Overweight and Obese Subjects.|Recruiting||N/A|64|Anticipated|Azienda Ospedaliera Universitaria Integrata Verona||2|||f||||f|f|f||||||||2017-10-10 20:53:14.593448|2017-10-10 20:53:14.593448
NCT03212378|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||August 1, 2015|Actual|2015-08-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|August 1, 2017|Anticipated|2017-08-01||Observational|||"Safety and Efficacy of Standardized CHIP"|"Safety and Efficacy of Standardized Complex High-risk Interventional Procedures - a New Pathway for Protected Percutaneous Coronary Interventions"|Recruiting||N/A|150|Anticipated|University Hospital, Essen|||3||f|||||f|f||||||||2017-10-10 20:53:14.687186|2017-10-10 20:53:14.687186
NCT03212365|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-14|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery|Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery Patients Randomized to Different Postoperative Anticoagulant Regimens|Recruiting||Phase 2|270|Anticipated|University of Utah||2|||f|||||t|f||||||||2017-10-10 20:53:14.76323|2017-10-10 20:53:14.76323
NCT03212352|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-08-29|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|M&M||Comparing Two Medical Treatments for Early Pregnancy Failure.|Mifepristone and Misoprostol Versus Misoprostol Alone for Uterine Evacuation After Early Pregnancy Failure: a Randomized Double Blind Placebo-controlled Comparison (M&M Trial).|Not yet recruiting||Phase 4|460|Anticipated|Radboud University||2|||f||||t|f|f|||f|||||2017-10-10 20:53:14.846184|2017-10-10 20:53:14.846184
NCT03212339|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Project BELONG: Breaking the Cycle of Intergenerational Family Violence and Trauma|Project BELONG: Breaking the Cycle of Intergenerational Family Violence and Trauma: Innovating, Expanding and Sustaining Treatment for Caregivers and Very Young Children|Not yet recruiting||N/A|90|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:53:14.964673|2017-10-10 20:53:14.964673
NCT03212326|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-11|||January 2013|Actual|2013-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Contrast ICE for Myocardial Scar in VT Ablations|Contrast Enhanced Intracardiac Echocardiography (ICE) for Localization of Myocardial Scar During Ablation of Ventricular Tachycardia|Active, not recruiting||N/A|25|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 20:53:15.069919|2017-10-10 20:53:15.069919
NCT03212313|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-10|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant|A Two-Part, Open-Label, Single-Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant|Recruiting||Phase 1|30|Anticipated|Biotie Therapies Inc.||4|||f||||f|t|f||||||||2017-10-10 20:53:15.143469|2017-10-10 20:53:15.143469
NCT03211364|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-31|||May 1, 2016|Actual|2016-05-01|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Comparing Mobilization Techniques for the Hemiplegic Shoulder|Comparing Mobilization Techniques for the Hemiplegic Shoulder|Recruiting||N/A|15|Anticipated|University Ghent||3|||f|||||f|f||||||||2017-10-10 20:53:22.674872|2017-10-10 20:53:22.674872
NCT03212300|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|May 1, 2018|Anticipated|2018-05-01||Interventional|||"Exercise Prehabilitation and Cognitive and Functional Recovery After Surgery in Older Adults"|"Plasticity in Recovery From Surgery: the Effects of Exercise Prehabilitation on Cognitive and Functional Recovery After Surgery in Older Adults"|Recruiting||N/A|80|Anticipated|New York State Psychiatric Institute||2|||f||||f|f|f||||||||2017-10-10 20:53:15.233886|2017-10-10 20:53:15.233886
NCT03212287|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-10-05|||October 31, 2017|Anticipated|2017-10-31|October 2017|2017-10-01|August 28, 2024|Anticipated|2024-08-28|August 28, 2024|Anticipated|2024-08-28||Observational|BRLCEIACS/OMI||Brilinta Clinical Experience Investigation|Brilinta Tablets 60mg/90mg Clinical Experience Investigation|Not yet recruiting||N/A|1750|Anticipated|AstraZeneca|||1||f||||||||||||||2017-10-10 20:53:15.32698|2017-10-10 20:53:15.32698
NCT03212274|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-07|2017-09-12|||March 30, 2018|Anticipated|2018-03-30|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations|A Phase 2 Study of the PARP Inhibitor Olaparib (AZD2281) in IDH1 and IDH2 Mutant Advanced Solid Tumors|Not yet recruiting||Phase 2|75|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 20:53:15.390879|2017-10-10 20:53:15.390879
NCT03212261|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-28|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma|Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||1|||f||||t|f|f||||||||2017-10-10 20:53:15.496038|2017-10-10 20:53:15.496038
NCT03212248|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-08|||January 2, 2016|Actual|2016-01-02|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|April 30, 2016|Actual|2016-04-30||Observational|TUS-STRAT||CRP and Thoracic Emergency Ultrasound in Pneumonia|CRP (C-Reactive-Protein) and Pneumonia Biomarkers Stratification for Selectively Addressing Priorities in Thoracic Emergency Ultrasound in Pneumonia|Completed||N/A|70|Actual|Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele|||1||f||||f|f|f||||||||2017-10-10 20:53:15.584552|2017-10-10 20:53:15.584552
NCT03212235|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-07|||June 5, 2017|Actual|2017-06-05|July 2017|2017-07-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Hypofractionated Radiation Therapy for Glioblastoma|Hypofractionated Radiation Therapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma|Recruiting||Phase 2|58|Anticipated|Instituto do Cancer do Estado de São Paulo||1|||f||||f|f|f||||||||2017-10-10 20:53:15.678068|2017-10-10 20:53:15.678068
NCT03212222|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-13|||August 25, 2017|Actual|2017-08-25|July 2017|2017-07-01|August 3, 2018|Anticipated|2018-08-03|August 3, 2018|Anticipated|2018-08-03||Interventional|||Cell Phone Application for Vision Assessment|How Does Visual Acuity Assessment Using the Peek Acuity Application Compare to the Standard Exam in the Clinic?|Recruiting||N/A|120|Anticipated|Duke University||2|||f|||||f|f||||||||2017-10-10 20:53:15.756307|2017-10-10 20:53:15.756307
NCT03212209|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-07|||April 28, 2017|Actual|2017-04-28|July 2017|2017-07-01|July 16, 2018|Anticipated|2018-07-16|July 14, 2017|Anticipated|2017-07-14||Interventional|||Comparison of CPAP Modalities for OSA Treatment|A Crossover Study Comparing Fixed Continuous Airway Positive Pressure, FLEX- PLUS and Sensawake Modalities for OSA Treatment|Recruiting||N/A|50|Anticipated|Associação Fundo de Incentivo à Pesquisa||3|||f||||t|f|t|f||t|||||2017-10-10 20:53:15.857832|2017-10-10 20:53:15.857832
NCT03212196|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-07-06|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|PREP||Technical Strategies for Pancreatic Fistula Prevention After Pancreaticoduodenectomy in High-risk Pancreatic Remnant|Technical Strategies for Pancreatic Fistula Prevention After Pancreaticoduodenectomy in High-risk Pancreatic Remnant: a Risk-adjusted Randomized Controlled Trial|Recruiting||N/A|72|Anticipated|Azienda Ospedaliera Universitaria Integrata Verona||2|||f||||f|f|f||||||||2017-10-10 20:53:15.949731|2017-10-10 20:53:15.949731
NCT03212183|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-08|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of a Web-based Virtual Nursing Epilepsy Self-Management Intervention|Evaluation of a Web-based Virtual Nursing Intervention to Support Self-Management Among Adults With Epilepsy: A Preliminary Study|Not yet recruiting||N/A|60|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t|f|f||||||||2017-10-10 20:53:16.064389|2017-10-10 20:53:16.064389
NCT03212170|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-17|||July 15, 2017|Actual|2017-07-15|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer|[18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer|Recruiting||Phase 2|28|Anticipated|University of Wisconsin, Madison||1|||f||||t|t|f||||||||2017-10-10 20:53:16.145903|2017-10-10 20:53:16.145903
NCT03212157|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-06|||January 6, 2017|Actual|2017-01-06|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||GlucoCEST MRI in Oncology|Establishment of GlucoCEST MRI as a Biomarker in Cancer Translational Study|Recruiting||N/A|130|Anticipated|University College, London||3|||f||||t|f|f||||||||2017-10-10 20:53:16.240972|2017-10-10 20:53:16.240972
NCT03212144|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-21|||August 20, 2017|Actual|2017-08-20|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Anti-Inflammatory Effects of Exercise and Peanut Consumption|The Anti-Inflammatory Effects of Exercise and Peanut Consumption|Recruiting||N/A|30|Anticipated|New York State Psychiatric Institute||2|||f||||f|f|f||||||||2017-10-10 20:53:16.339713|2017-10-10 20:53:16.339713
NCT03212131|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-06|||July 14, 2017|Anticipated|2017-07-14|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|March 14, 2018|Anticipated|2018-03-14||Interventional|||Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Not yet recruiting||Phase 1|34|Anticipated|Novo Nordisk A/S||3|||f|||||t|f|||t|||||2017-10-10 20:53:16.428252|2017-10-10 20:53:16.428252
NCT03212118|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-29|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|||Effects of Motivational Interviewing for Long-term Sick Absence|Effects of Motivational Interviewing for Long-term Sick Absence: A Randomized Controlled Trial With Mixed Methods|Recruiting||N/A|750|Anticipated|Norwegian University of Science and Technology||3|||f|||||f|f||||||||2017-10-10 20:53:16.49679|2017-10-10 20:53:16.49679
NCT03212105|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-06|||October 14, 2016|Actual|2016-10-14|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A 60-seconds Personalized Mindfulness Video Exercise for Patients With Orthopedic Illness|A 60-seconds Personalized Mindfulness Video Exercise for Patients With Orthopedic Illness|Enrolling by invitation||N/A|220|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:16.602647|2017-10-10 20:53:16.602647
NCT03212092|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-06|||January 15, 2018|Anticipated|2018-01-15|July 2017|2017-07-01|February 1, 2021|Anticipated|2021-02-01|February 3, 2020|Anticipated|2020-02-03||Interventional|PSYVB||Reducing Aggression Among People With an Intellectual Disability|Reducing Aggressive Behaviour Among People With an Intellectual Disability Through Supplementation of Vitamins, Minerals and n-3 Fatty Acids|Not yet recruiting||N/A|200|Anticipated|Leiden University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:53:16.673984|2017-10-10 20:53:16.673984
NCT03212079|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-10|||April 3, 2017|Actual|2017-04-03|July 2017|2017-07-01|March 15, 2018|Anticipated|2018-03-15|September 15, 2017|Anticipated|2017-09-15||Interventional|PATH||Physical Activities by Technology Help (PATH)|Novel Individualized Intervention for Behavioral Change Among High-Risk Group Cancer Survivors : Physical Activities by Technology Help (PATH)|Recruiting||N/A|42|Anticipated|Johns Hopkins University||3|||f||||t|f|f||||||||2017-10-10 20:53:16.756106|2017-10-10 20:53:16.756106
NCT03212066|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-20|||August 14, 2017|Anticipated|2017-08-14|July 2017|2017-07-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|MasterMind||Master Mind Program Evaluation Study|Elementary School Mindfulness-Based Substance Use Prevention Program|Recruiting||N/A|920|Anticipated|Innovation Research & Training||2|||f||||f|f|f||||||||2017-10-10 20:53:16.854842|2017-10-10 20:53:16.854842
NCT03212053|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-08|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|January 15, 2018|Anticipated|2018-01-15|January 15, 2018|Anticipated|2018-01-15||Interventional|THETE||Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET)|Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET)|Not yet recruiting||N/A|50|Anticipated|Hospices Civils de Lyon||1|||f|||||f|f||||||||2017-10-10 20:53:16.936134|2017-10-10 20:53:16.936134
NCT03212040|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-11|||February 10, 2011|Actual|2011-02-10|July 2017|2017-07-01|December 10, 2012|Actual|2012-12-10|March 10, 2012|Actual|2012-03-10||Interventional|||14 g vs. 16 g in Breast Biopsy|Comparison of Needle Gauge 14 vs. Gauge 16 in Breast Biopsy|Completed||N/A|213|Actual|University Women's Hospital Tübingen||2|||f||||f|f|f||||||||2017-10-10 20:53:17.028511|2017-10-10 20:53:17.028511
NCT03212027|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-13|||July 31, 2017|Anticipated|2017-07-31|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging|Preoperative Prediction of the Pathological Classification of Thymic Epithelial Tumors by Apparent Diffusion Coefficient Using Ultra-high B-values|Not yet recruiting||N/A|60|Anticipated|Tang-Du Hospital|||3||f|||||f|f||||||||2017-10-10 20:53:17.087562|2017-10-10 20:53:17.087562
NCT03212014|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Development and Research of an Individualized Intelligent Platform for Rehabilitaion in Parkinson's Disease|Development and Research of an Individualized Intelligent Platform for Rehabilitaion in Patients With Parkinson's Disease|Recruiting||N/A|75|Anticipated|Taipei Veterans General Hospital, Taiwan||3|||f|||||f|f||||||||2017-10-10 20:53:17.144159|2017-10-10 20:53:17.144159
NCT03212001|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-07|||July 2016||2016-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|THRIVE||TeleHomecaRe InterVention Evaluation Study|TeleHomecaRe InterVention Evaluation (THRIVE) Study|Recruiting||N/A|5400|Anticipated|University of Toronto|||7||f||||f||||||||||2017-10-10 20:53:17.243749|2017-10-10 20:53:17.243749
NCT03211988|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-11|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Entinostat Neuroendocrine (NE) Tumor|A Phase 2 Single-Arm Multicenter Study of Entinostat in Patients With Relapsed or Refractory Abdominal Neuroendocrine (NE) Tumors|Not yet recruiting||Phase 2|40|Anticipated|Columbia University||1|||f||||t|t|f||||||||2017-10-10 20:53:17.345515|2017-10-10 20:53:17.345515
NCT03211975|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|February 25, 2032|Anticipated|2032-02-25|February 25, 2032|Anticipated|2032-02-25||Observational|EPEI||Study of the Prognosis of Infectious Endocarditis (EPEI): Prospective and Retrospective Follow-up of a Cohort of Patients Hospitalized for Infectious Endocarditis|Study of the Prognosis of Infectious Endocarditis (EPEI): Prospective and Retrospective Follow-up of a Cohort of Patients Hospitalized for Infectious Endocarditis|Recruiting||N/A|645|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 20:53:17.615907|2017-10-10 20:53:17.615907
NCT03211962|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Observational|ACR-CHECK||Can Urinary Concentrations of TIMP2 and IGFBP7 be Used to Predict Early Acute Renal Failure Following Cardiac Arrest?|Can Urinary Concentrations of TIMP2 and IGFBP7 be Used to Predict Early Acute Renal Failure Following Cardiac Arrest?|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 20:53:17.700972|2017-10-10 20:53:17.700972
NCT03211949|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-07-05|||October 2014||2014-10-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Ultrasound Guided Topographic Mapping of Medial Antebrachial Cutaneous Nerve|Topographic Assessment of the Medial Antebrachial Cutaneous Nerve Variations at the Axilla and Above the Cubital Fossa Using Ultrasonography|Recruiting||N/A|150|Anticipated|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-10 20:53:17.80864|2017-10-10 20:53:17.80864
NCT03211936|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-18|||December 15, 2015|Actual|2015-12-15|September 2017|2017-09-01|April 15, 2017|Actual|2017-04-15|February 15, 2017|Actual|2017-02-15||Interventional|EVALUS||Pulmonary Evaluation With Ultrasound in Different Levels of PEEP|Pulmonary Evaluation at Different Levels of PEEP: Ultrasonography Compared to Electrical Impedance Tomography (TIE) During Intraoperative Elective Surgeries|Completed||N/A|40|Actual|Instituto do Cancer do Estado de São Paulo||2|||f||||t|f|f||||||||2017-10-10 20:53:17.946086|2017-10-10 20:53:17.946086
NCT03211923|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-06|||January 5, 2017|Actual|2017-01-05|April 2017|2017-04-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Observational|||Muscle Relaxation in Myopathies With Positive Muscle Phenomena|Muscle Relaxation Properties in Myopathies With Positive Muscle Phenomena: a Study Using Transcranial Magnetic Stimulation|Enrolling by invitation||N/A|30|Anticipated|Radboud University|||6||f||||t|f|f||||||||2017-10-10 20:53:18.05151|2017-10-10 20:53:18.05151
NCT03211910|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-06|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Sacral Savers: Study of Prevention and Enhanced Healing of Sacral and Trochenteric Ulcers|Sacral Savers: Study of Prevention and Enhanced Healing of Sacral and Trochenteric Ulcers|Recruiting||N/A|30|Anticipated|Richmond University Medical Center||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:53:18.147514|2017-10-10 20:53:18.147514
NCT03211897|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-13|||June 15, 2017|Actual|2017-06-15|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 1, 2017|Anticipated|2017-12-01||Observational|MOHZA||Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation|Prospective Observational Investigation of Olanzapine Versus Haloperidol Versus Ziprasidone Versus Midazolam for the Treatment of Acute Undifferentiated Agitation in the Emergency Department|Recruiting||N/A|800|Anticipated|Minneapolis Medical Research Foundation|||4||f||||f|f|f||||||||2017-10-10 20:53:18.29614|2017-10-10 20:53:18.29614
NCT03211884|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-24|||July 13, 2017|Actual|2017-07-13|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Evidence-Based Mental Health Services for Distressed Post-9/11 Military Family Caregivers|Evidence-Based Mental Health Services for Distressed Post-9/11 Military Family Caregivers|Recruiting||N/A|100|Anticipated|Duquesne University||2|||f||||t|f|f||||||||2017-10-10 20:53:18.436301|2017-10-10 20:53:18.436301
NCT03211871|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-06|||May 1, 2016|Actual|2016-05-01|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Dexmedetomidine Infusion as an Analgesic Adjuvant During Laparoscopic Cholecystectomy|Dexmedetomidine Infusion as an Analgesic Adjuvant During Laparoscopic Cholecystectomy: Randomized Controlled Study|Recruiting||Phase 3|60|Anticipated|Bogomolets National Medical University||2|||f||||f|f|f||||||||2017-10-10 20:53:18.582709|2017-10-10 20:53:18.582709
NCT03211845|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-05|||May 27, 2015|Actual|2015-05-27|July 2017|2017-07-01|November 20, 2015|Actual|2015-11-20|November 20, 2015|Actual|2015-11-20||Interventional|||Feasibility of Nutritional Telemonitoring in Elderly Home Care Patients|Pilot Study to Assess the Feasibility and Potential Impact of Nutritional Telemonitoring in Community Dwelling Elderly People Receiving Home Care|Completed||N/A|20|Actual|Wageningen University||1|||f||||f|f|f||||||||2017-10-10 20:53:18.948456|2017-10-10 20:53:18.948456
NCT03211832|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-02|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Disseminating Public Health Evidence to Support Prevention and Control of Diabetes Among Local Health Departments|Enhancing Evidence-based Diabetes Control Among Local Health Departments|Recruiting||N/A|240|Anticipated|Washington University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:53:19.067399|2017-10-10 20:53:19.067399
NCT03211819|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-09|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 1, 2020|Anticipated|2020-03-01|September 1, 2019|Anticipated|2019-09-01||Interventional|RCT||Computer-guided Versus Free- Hand Immediate Implant Placement|Esthetic Outcome of Computer-guided Versus Free- Hand Immediate Implant Placement in Fresh Extraction Sockets in Esthetic Zone, a Randomized Clinical Trial.|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:53:19.207536|2017-10-10 20:53:19.207536
NCT03211806|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-10-03|||January 2018|Anticipated|2018-01-01|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|DASH||Detecting Activity to Support Healing|Technology to Reduce Sedentary Behavior Before and After Cancer Surgery|Not yet recruiting||N/A|60|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 20:53:19.335325|2017-10-10 20:53:19.335325
NCT03211793|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-05|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|MANUS||Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis|Mesenchymal Stromal Cells for Angiogenesis and Neovascularisation in Digital Ulcers of Systemic Sclerosis: the MANUS Trial|Recruiting||Phase 1/Phase 2|20|Anticipated|UMC Utrecht||2|||f||||t|f|f|||f|||||2017-10-10 20:53:19.449755|2017-10-10 20:53:19.449755
NCT03211780|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of Intra-Operative Shear Wave Ultrasound Vibrometry for Characterization of Esophageal Malignant Tumors|Use of Intra-Operative Shear Wave Ultrasound Vibrometry for Characterization of Esophageal Malignant Tumors|Recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:53:19.603174|2017-10-10 20:53:19.603174
NCT03211767|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-26|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Double-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for Hypertension|Double-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for Hypertension|Recruiting||N/A|40|Anticipated|University of Manitoba||2|||f||||f|f|f||||||||2017-10-10 20:53:19.703153|2017-10-10 20:53:19.703153
NCT03211754|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-06|||January 2013||2013-01-01|July 2017|2017-07-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|||Anthropometric Measures and Anti-inflammatory Markers by a PUFAs Enriched Diet|Changes on Anthropometric Measures and Anti-inflammatory Markers by a PUFAs Enriched Diet in Obese Subjects|Completed||N/A|40|Actual|Universidad de Guanajuato||1|||f||||f||||||||||2017-10-10 20:53:19.81246|2017-10-10 20:53:19.81246
NCT03211741|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-05|||November 22, 2013|Actual|2013-11-22|July 2017|2017-07-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema|Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema|Recruiting||Phase 4|350|Anticipated|University Hospital, Ghent||1|||f||||f|f|f||||||||2017-10-10 20:53:19.906792|2017-10-10 20:53:19.906792
NCT03211351|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-05|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|October 30, 2017|Anticipated|2017-10-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome|Comparison of the Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome|Recruiting||N/A|60|Anticipated|Huaxia Eye Hospital Group||2|||f||||f|f|f|||f|||||2017-10-10 20:53:22.780072|2017-10-10 20:53:22.780072
NCT03211715|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-05|||July 19, 2017|Anticipated|2017-07-19|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|July 19, 2018|Anticipated|2018-07-19||Observational|||Validation of Low Anterior Resection Syndrome Score in Korean Version|Validation of Low Anterior Resection Syndrome Score in Korean Version|Not yet recruiting||N/A|300|Anticipated|Saint Vincent's Hospital, Korea|||1||f||||t|f|f||||||||2017-10-10 20:53:20.10983|2017-10-10 20:53:20.10983
NCT03211702|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-26|||August 25, 2017|Actual|2017-08-25|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Observational|||Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)|Multi-center, Prospective Cohort Study-II to Investigate the Impact of Comprehensive Geriatric Assessments on Survival and Toxicities in Elderly Diffuse Large B-cell Lymphoma Patients Treated With R-CHOP (GERIAD2)|Recruiting||N/A|100|Anticipated|Chonbuk National University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:53:20.175117|2017-10-10 20:53:20.175117
NCT03211689|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease|The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease|Recruiting||N/A|100|Anticipated|Stockton University||2|||f||||f|f|f||||||||2017-10-10 20:53:20.262896|2017-10-10 20:53:20.262896
NCT03211676|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-06|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|December 14, 2017|Anticipated|2017-12-14|December 14, 2017|Anticipated|2017-12-14||Interventional|THERANOVA||Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer|Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer on Removal of Small and Middle Size Molecules, Inflammatory Parameters and Oxidative Stress. An Open Cross Over Randomized Study|Recruiting||N/A|40|Anticipated|Poitiers University Hospital||2|||f|||||f|f||||||||2017-10-10 20:53:20.358099|2017-10-10 20:53:20.358099
NCT03211663|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-27|||October 15, 2017|Anticipated|2017-10-15|June 2017|2017-06-01|December 1, 2025|Anticipated|2025-12-01|August 1, 2025|Anticipated|2025-08-01||Interventional|||Performance of MOTO Medial® Unicompartmental Knee Arthroplasty|A Prospective, Multi-Center Study To Assess Performance of MOTO Medial® in Unicompartmental Knee Arthroplasty (UKA).|Not yet recruiting||N/A|269|Anticipated|Medacta USA||1|||f||||f|f|f||||||||2017-10-10 20:53:20.488402|2017-10-10 20:53:20.488402
NCT03211650|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||October 14, 2016|Actual|2016-10-14|July 2017|2017-07-01|May 30, 2019|Anticipated|2019-05-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Efficacy of Hyaluronic Acid and Platelet-rich Plasma Combination in Knee Osteoarthritis|Efficacy of Intra-articular Injection of Combined Hyaluronic Acid and Platelet-rich Plasma in Knee Degenerative Joint Disease|Recruiting||Phase 4|175|Anticipated|University of Milan||3|||f|||||f|f|||f|||||2017-10-10 20:53:20.592787|2017-10-10 20:53:20.592787
NCT03211637|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-05|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2016|Actual|2016-12-01||Interventional|||Wounds Protocol at Family Health Strategy Units in a Rio Grande do Sul Countryside Town|Implementing and Assessing an Wounds Protocol at Family Health Strategy Units in a Rio Grande do Sul Countryside Town|Active, not recruiting||N/A|20|Actual|Hospital Nossa Senhora da Conceicao||2|||f||||f|f|f||||||||2017-10-10 20:53:20.696877|2017-10-10 20:53:20.696877
NCT03211624|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-06|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|||Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's Syndrome|The Etiology and Extent of Impaired Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's Syndrome - Prospective Studies|Recruiting||N/A|72|Anticipated|Göteborg University|||2||f||||f|f|f||||Samples With DNA|"     Blood samples for DNA and RNA isolation will be collected and stored at −80°C.      Polymorphism in the glucocorticoid (GC) receptor gene, and other genes involved in metabolism     and transport of GCs will be analysed in all subjects at inclusion in the study.      DNA methylation and mRNA will be analyzed at inclusion and 24 months after treatment.   "|||2017-10-10 20:53:20.763045|2017-10-10 20:53:20.763045
NCT03211611|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-02|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|November 1, 2017|Anticipated|2017-11-01|August 31, 2017|Anticipated|2017-08-31||Observational|||Management of Women With BRCA1/2 Mutation|Role of General Practionners in Management of Women With BRCA1/2 Mutation|Active, not recruiting||N/A|600|Anticipated|University Hospital, Montpellier|||2||f||||f|f|f||||||||2017-10-10 20:53:20.842389|2017-10-10 20:53:20.842389
NCT03211598|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-07-06|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Surefire Institutional DEB-TACE|Pilot Trial Assessing the Technical Feasibility and Safety of the Surefire Infusion System for Use in DEB-TACE (Surefire)|Recruiting||N/A|15|Anticipated|Georgetown University||1|||f||||t|f|f||||||||2017-10-10 20:53:20.919229|2017-10-10 20:53:20.919229
NCT03211585|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-09|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA|EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA (FACIAL REDNESS, TELANGIECTASIAS AND PHOTODAMAGE)|Active, not recruiting||N/A|20|Actual|Syneron Medical||1|||f||||f|f||||f|||||2017-10-10 20:53:20.996052|2017-10-10 20:53:20.996052
NCT03211572|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-05|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|OTT 17-01||The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers|Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers: The EMPOwER Study|Not yet recruiting||Phase 2|82|Anticipated|Ottawa Hospital Research Institute||1|||f||||f|f|f||||||||2017-10-10 20:53:21.052853|2017-10-10 20:53:21.052853
NCT02986048|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|December 2027|Anticipated|2027-12-01|December 2027|Anticipated|2027-12-01|10 Years|Observational [Patient Registry]|||Proton Therapy Patient Registry|Proton Therapy Patient Registry|Recruiting||N/A|999|Anticipated|Case Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-10 21:33:04.081776|2017-10-10 21:33:04.081776
NCT03211559|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-07|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|||Clinical Pilates and Aerobic Exercise in Patients With Ankylosing Spondylitis|Investigating the Effectiveness of Clinical Pilates Exercise When Applied Together With Aerobic Exercise in Patients With Ankylosing Spondylitis|Completed||N/A|36|Actual|Eastern Mediterranean University||2|||f||||f||||||||||2017-10-10 20:53:21.12435|2017-10-10 20:53:21.12435
NCT03211546|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-07|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|April 2022|Anticipated|2022-04-01|December 2021|Anticipated|2021-12-01|24 Months|Observational [Patient Registry]|PedFemFx||Pediatric Femur Fracture Registry|A Prospective Multicenter Observational Registry for Femoral Shaft Fractures in Children up to 16 Years of Age|Not yet recruiting||N/A|200|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f|f|f||||||||2017-10-10 20:53:21.220191|2017-10-10 20:53:21.220191
NCT03211533|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-23|||July 22, 2017|Actual|2017-07-22|July 2017|2017-07-01|July 10, 2020|Anticipated|2020-07-10|July 10, 2019|Anticipated|2019-07-10||Observational|||Early Identification of Infants at Risk of Cerebral Palsy|CareToy Observational Study: Early Identification of Infants at Risk of Cerebral Palsy|Recruiting||N/A|80|Anticipated|IRCCS Fondazione Stella Maris|||1||f||||t|f|f||||||||2017-10-10 20:53:21.35826|2017-10-10 20:53:21.35826
NCT03211520|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-07-05|||February 2013||2013-02-01|June 2017|2017-06-01|June 24, 2016|Actual|2016-06-24|June 24, 2016|Actual|2016-06-24||Observational|||Magnetic Resonance Imaging:A Window to Anthracycline Toxicity|Magnetic Resonance Imaging:A Window to Anthracycline Toxicity|Completed||N/A|13|Actual|Connecticut Children's Medical Center|||1||f||||f||||||Samples Without DNA|"     Pending   "|||2017-10-10 20:53:21.426836|2017-10-10 20:53:21.426836
NCT03211507|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-05|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|October 5, 2020|Anticipated|2020-10-05|October 5, 2019|Anticipated|2019-10-05||Observational|IPFJES||Idiopathic Pulmonary Fibrosis Job Exposures Study|Idiopathic Pulmonary Fibrosis Job Exposures Study|Recruiting||N/A|920|Anticipated|Imperial College London|||2||f||||t|f|f||||Samples With DNA|"     blood   "|||2017-10-10 20:53:21.48431|2017-10-10 20:53:21.48431
NCT03211494|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|AiRDRoP||Does Automated Closed-Loop Ventilation Reduce the DRiving Pressure Levels in Patients With ARDS|Does Automated Closed-Loop Ventilation Reduce the DRiving Pressure Levels in Patients With ARDS (AiRDRoP) - a Single-Center Crossover Study and Randomized Controlled Trial|Not yet recruiting||N/A|48|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f|f|f||||||||2017-10-10 20:53:21.564508|2017-10-10 20:53:21.564508
NCT03211481|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-17|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|June 13, 2019|Anticipated|2019-06-13|June 13, 2019|Anticipated|2019-06-13||Observational|||Design of an Intra-operative Blood Conservation Pathway at Open Myomectomy|Design of an Intra-operative Blood Conservation Pathway at Open Myomectomy: a Modified Delphi Consensus Study|Enrolling by invitation||N/A|20|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f|f|f||||||||2017-10-10 20:53:21.657406|2017-10-10 20:53:21.657406
NCT03211468|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-07-05|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Intervention Program to Improve Body Image and Self-Esteem Among Female Athletes.|Effectiveness of an Intervention Program to Improve Body Image and Self-Esteem Among Female Adolescent Aesthetic Athletes.|Enrolling by invitation||N/A|100|Anticipated|Tel Hai College||2|||f||||t|f|f||||||||2017-10-10 20:53:21.717733|2017-10-10 20:53:21.717733
NCT03211455|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-12|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|February 1, 2019|Anticipated|2019-02-01||Interventional|XYLOBAR||Intravenous Lidocaine in Bariatric Surgery.|Effect of Continuous Intravenous Lidocaine on Early Rehabilitation in Bariatric Surgery. A Randomized Double Blind Controlled Study|Not yet recruiting||Phase 3|180|Anticipated|University Hospital, Caen||2|||f||||t|f|f|||f|||||2017-10-10 20:53:21.781958|2017-10-10 20:53:21.781958
NCT03211442|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-06|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|MEDIRAD-BRACE||Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events|Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events (MEDIRAD-BRACE): A Retrospective Cohort Study|Recruiting||N/A|7000|Anticipated|University Medical Center Groningen|||1||f|||||f|f||||||||2017-10-10 20:53:21.858377|2017-10-10 20:53:21.858377
NCT03211429|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-05|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness of Three Interventions to Reduce Fear of Falling and Improve Functionality in the Elderly|Randomized Clinical Trial Evaluating the Effectiveness of Three Interventions Programs to Improve Functionality and Decrease Fear of Falling in the Elderly|Recruiting||N/A|110|Anticipated|Universidad de Caldas||3|||f||||f||||||||||2017-10-10 20:53:21.932446|2017-10-10 20:53:21.932446
NCT03211416|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-15|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|October 11, 2019|Anticipated|2019-10-11|October 11, 2018|Anticipated|2018-10-11||Interventional|||Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer|A Phase Ib/ II Study of Sorafenib and Pembrolizumab in Advanced Hepatocellular Cancer (HCC)|Recruiting||Phase 1/Phase 2|27|Anticipated|Roswell Park Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 20:53:22.20269|2017-10-10 20:53:22.20269
NCT03211403|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-21|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Multiple Doses Study of SHR4640 in Male Subjects With Asymptomatic Hyperuricemia|A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of SHR4640 in Male Subjects With Asymptomatic Hyperuricemia|Not yet recruiting||Phase 1|32|Anticipated|Atridia Pty Ltd.||4|||f||||f|f|f||||||||2017-10-10 20:53:22.332121|2017-10-10 20:53:22.332121
NCT03211390|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-08-08|||August 24, 2017|Anticipated|2017-08-24|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Using Telemedicine to Improve Spasticity Diagnosis Rates|Using Telemedicine to Improve Spasticity Diagnosis Rates|Not yet recruiting||N/A|140|Anticipated|Vanderbilt University Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:53:22.458383|2017-10-10 20:53:22.458383
NCT03211377|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-07|||March 29, 2017|Actual|2017-03-29|June 2017|2017-06-01|April 29, 2021|Anticipated|2021-04-29|March 29, 2019|Anticipated|2019-03-29||Observational|||Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma|Non-interventional Study to Evaluate Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma|Recruiting||N/A|120|Anticipated|Anyang Tumor Hospital|||3||f||||||||||||||2017-10-10 20:53:22.581404|2017-10-10 20:53:22.581404
NCT03211338|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-30|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone|Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone|Recruiting||N/A|400|Anticipated|Hillel Yaffe Medical Center||12|||f||||f|f|f||||||||2017-10-10 20:53:22.886369|2017-10-10 20:53:22.886369
NCT03211325|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-06|||October 18, 2016|Actual|2016-10-18|July 2017|2017-07-01|August 15, 2018|Anticipated|2018-08-15|March 15, 2018|Anticipated|2018-03-15||Interventional|TRP||Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.|Identification of Transient Receptor Potential (TRP) Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.|Recruiting||N/A|60|Anticipated|University Hospital, Grenoble||3|||f||||t|f|f|||f|||||2017-10-10 20:53:23.005016|2017-10-10 20:53:23.005016
NCT03211312|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-19|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Observational|||The Predictive Scoring Systems of Older People With Cardiac Diseases Undergoing Teeth Extraction Surgery|Risk Factors and Prediction Score of Older Patients With Cardiac Diseases Undergoing Teeth Extraction Surgery|Recruiting||N/A|500|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University|||1||f|||||f|f||||||||2017-10-10 20:53:23.142539|2017-10-10 20:53:23.142539
NCT03211299|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Determinants of Liver Fat Composition|Determinants of Liver Fat Composition in Overweight and Obese Humans|Recruiting||N/A|22|Anticipated|Maastricht University Medical Center|||3||f||||t|f|f||||||||2017-10-10 20:53:23.226725|2017-10-10 20:53:23.226725
NCT03211286|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-05|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 30, 2019|Anticipated|2019-03-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients|Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients. A Randomized, Controlled, Double-blind Study|Not yet recruiting||Phase 4|110|Anticipated|Elda University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:23.329827|2017-10-10 20:53:23.329827
NCT03211273|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||March 2018|Anticipated|2018-03-01|July 2017|2017-07-01|June 2024|Anticipated|2024-06-01|June 2020|Anticipated|2020-06-01||Observational|LIFT||Longitudinal Investigation of Cancer-related Fatigue|A Prospective, Observational Study to Investigate Longterm Courses, Patterns, Determinants and State of Treatment of Cancer-related Fatigue in Germany (LIFT)|Not yet recruiting||N/A|2000|Anticipated|German Cancer Research Center|||1||f||||f|f|f||||Samples Without DNA|"     Diurnal saliva samples (5 samples distributed over a day)   "|||2017-10-10 20:53:23.446177|2017-10-10 20:53:23.446177
NCT03211260|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-06|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease|Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease: a Open, Single-arm Trial|Not yet recruiting||N/A|64|Anticipated|ASST Gaetano Pini-CTO||1|||f||||f|f|f||||||||2017-10-10 20:53:23.52586|2017-10-10 20:53:23.52586
NCT03211247|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-07|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|May 30, 2020|Anticipated|2020-05-30|May 30, 2020|Anticipated|2020-05-30||Interventional|EPITOPE||Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age|A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age.|Recruiting||Phase 3|331|Anticipated|DBV Technologies||3|||f||||t|t|f||||||||2017-10-10 20:53:23.627138|2017-10-10 20:53:23.627138
NCT03211234|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-07-11|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|February 2019|Anticipated|2019-02-01||Interventional|||Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects|A Multi-Center, Randomized, Double Masked and Active Controlled Phase II Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Subjects With Wet Age-related Macular Degeneration - AVANTE Study|Recruiting||Phase 2|51|Anticipated|Santen Inc.||3|||f||||t|f|f||||||||2017-10-10 20:53:23.729932|2017-10-10 20:53:23.729932
NCT03211221|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-05|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|December 1, 2019|Anticipated|2019-12-01|March 1, 2019|Anticipated|2019-03-01||Interventional|rTMSOCD||rTMS Over the Supplementary Motor Area for Treatment-resistant Obsessive-compulsive Disorder.|rTMS Over the Supplementary Motor Area for Treatment-resistant Obsessive-compulsive Disorder: a Multicenter, Double-blind, Controlled Trial.|Recruiting||Phase 2|30|Anticipated|CNS Onlus||2|||f||||f|f|f|||f|||||2017-10-10 20:53:23.816343|2017-10-10 20:53:23.816343
NCT03211208|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-05|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|ALISTER||Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients|Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients|Recruiting||N/A|540|Anticipated|University of Edinburgh|||1||f||||f|f|f||||Samples With DNA|"     Plasma, serum and whole blood samples   "|||2017-10-10 20:53:23.906375|2017-10-10 20:53:23.906375
NCT03211195|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-24|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|August 22, 2017|Actual|2017-08-22|August 22, 2017|Actual|2017-08-22||Interventional|||Sotagliflozin Bioequivalence Study|Bioequivalence Study Comparing Sotagliflozin Tablet Commercial Formulation (Test) and Sotagliflozin Tablet Development Formulation (Reference) in Healthy Male and Female Subjects Under Fasted Conditions|Completed||Phase 1|76|Actual|Sanofi||2|||f||||f|t|f||||||||2017-10-10 20:53:23.986477|2017-10-10 20:53:23.986477
NCT03211182|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-05|||March 7, 2012|Actual|2012-03-07|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|March 18, 2013|Actual|2013-03-18||Interventional|||Lifestyle Modification Intervention in Pre-diabetic Subjects|Evaluation on Prevention for Metabolic Syndrome and Diabetes Mellitus Through Lifestyle Modification Intervention in Prediabetic Subjects|Recruiting||N/A|300|Anticipated|Taipei Medical University||2|||f|||||f|f||||||||2017-10-10 20:53:24.075042|2017-10-10 20:53:24.075042
NCT03210805|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-05|||January 9, 2017|Actual|2017-01-09|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|STC||Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation|Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation|Active, not recruiting||N/A|17|Actual|Loughborough University||1|||f|||||f|f||||||||2017-10-10 20:53:28.57598|2017-10-10 20:53:28.57598
NCT03211169|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-28|||July 29, 2017|Anticipated|2017-07-29|July 2017|2017-07-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures|Comparative Efficacy of Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies for Obtaining Diagnostic Tissue From Indeterminate Biliary Strictures|Not yet recruiting||N/A|100|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 20:53:24.181062|2017-10-10 20:53:24.181062
NCT03211156|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-14|||September 21, 2017|Anticipated|2017-09-21|June 28, 2017|2017-06-28|June 4, 2018|Anticipated|2018-06-04|June 4, 2018|Anticipated|2018-06-04||Interventional|||Treatment of Gardnerella Vaginalis Vaginal Colonization With Amoxicillin|A Randomized, Double-Blind, Placebo Controlled, Phase II Study to Assess Treatment of Gardnerella Vaginalis Vaginal Colonization With Amoxicillin|Not yet recruiting||Phase 2|98|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||f|f|||f|||||2017-10-10 20:53:24.25153|2017-10-10 20:53:24.25153
NCT03211143|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-05|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects|A Randomized, Open-label, Multiple-dose, and Crossover Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of CKD-381 and D027 in Healthy Subjects|Recruiting||Phase 1|40|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f|f|f||||||||2017-10-10 20:53:24.329576|2017-10-10 20:53:24.329576
NCT03211130|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-10|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors|Randomized Controlled Pilot Study of a SystemCHANGE™ Medication Adherence Intervention in Older Adult Stroke Survivors|Not yet recruiting||Early Phase 1|30|Anticipated|University of Missouri, Kansas City||2|||f||||t|f|f||||||||2017-10-10 20:53:24.429235|2017-10-10 20:53:24.429235
NCT03211117|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-08-16|||August 14, 2017|Actual|2017-08-14|July 2017|2017-07-01|December 9, 2019|Anticipated|2019-12-09|December 9, 2019|Anticipated|2019-12-09||Interventional|||Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer|Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer|Recruiting||Phase 2|25|Anticipated|Mayo Clinic||2|||||||t|t|f||||||||2017-10-10 20:53:24.505038|2017-10-10 20:53:24.505038
NCT03211104|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-05|||August 30, 2007|Actual|2007-08-30|May 2017|2017-05-01|August 5, 2015|Actual|2015-08-05|August 5, 2015|Actual|2015-08-05||Interventional|||Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy|Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy : a Randomized, Double Blind, Placebo-controlled Trial|Completed||N/A|107|Actual|Samsung Medical Center||2|||f||||||||||||||2017-10-10 20:53:24.617484|2017-10-10 20:53:24.617484
NCT03211091|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-05|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|January 10, 2017|Actual|2017-01-10|2 Years|Observational [Patient Registry]|||Cerebrovascular Registry|Prove/Cerebrovascular Registry|Active, not recruiting||N/A|5000|Anticipated|Isfahan University of Medical Sciences|||1||f||||t|f|f||||||||2017-10-10 20:53:24.682178|2017-10-10 20:53:24.682178
NCT03211078|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-09|||October 14, 2016|Actual|2016-10-14|July 2017|2017-07-01|September 15, 2017|Anticipated|2017-09-15|September 1, 2017|Anticipated|2017-09-01||Interventional|||ENB and Photodynamic Therapy in the Treatment for Early Lung Cancer|The Application of Electro-magnetic Navigation Bronchoscopy (ENB) and Photodynamic Therapy in the Treatment for Early Lung Cancer|Recruiting||N/A|10|Anticipated|National Taiwan University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:53:24.732092|2017-10-10 20:53:24.732092
NCT03211065|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-26|||July 21, 2017|Actual|2017-07-21|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig|The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non Hodgkin's Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab|Recruiting||Phase 2/Phase 3|10|Anticipated|Rochester General Hospital||1|||f|||||t|f|||t|||||2017-10-10 20:53:24.820111|2017-10-10 20:53:24.820111
NCT03211052|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-07-06|||February 18, 2013|Actual|2013-02-18|July 2017|2017-07-01|June 2, 2015|Actual|2015-06-02|June 2, 2015|Actual|2015-06-02||Interventional|NEPTUNE||A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone|A Randomised Phase II Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone in Intermediate and High Risk Clinically Localized Prostate Cancer|Terminated||Phase 2|16|Actual|Queen Mary University of London||2||IMP no longer available|f||||t||||||||||2017-10-10 20:53:24.907579|2017-10-10 20:53:24.907579
NCT03211039|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-07-05|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|NSIGHT2||Perinatal Precision Medicine|Prenatal Precision Medicine (NSIGHT2): A Randomized, Blinded, Prospective Study of the Clinical Utility of Rapid Genomic Sequencing for Infants in the Acute-care Setting|Recruiting||N/A|1000|Anticipated|Rady Pediatric Genomics & Systems Medicine Institute||2|||f||||f|f|t|t|f||||||2017-10-10 20:53:24.98482|2017-10-10 20:53:24.98482
NCT03211026|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-05|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|June 13, 2021|Anticipated|2021-06-13|March 13, 2021|Anticipated|2021-03-13||Observational|URIKIT||Urinary Tract Infections in Kidney Transplant Recipients|Urinary Tract Infections in Kidney Transplant Recipients : an Observational Cohort|Recruiting||N/A|120|Anticipated|Poitiers University Hospital|||1||f||||t|f|f||||||||2017-10-10 20:53:25.128656|2017-10-10 20:53:25.128656
NCT03211013|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-14|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|February 28, 2019|Anticipated|2019-02-28||Interventional|||Study of the Effects of Oxytocin on Attentional Bias and Startle in PTSD|Placebo-Controlled Study of the Effects of Oxytocin on Attentional Bias and Startle in PTSD|Recruiting||Early Phase 1|40|Anticipated|Palo Alto Veterans Institute for Research||2|||f||||f|t|f||||||||2017-10-10 20:53:25.211226|2017-10-10 20:53:25.211226
NCT03211000|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-09-12|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|October 1, 2017|Anticipated|2017-10-01|July 31, 2017|Actual|2017-07-31||Observational|||Autophagy, Oxidative Stress and Hippo Signaling in Human Aortic Aneurysm|Study of the Molecular Mechanisms Associated With the Formation of Human Aortic Aneurysm: a Focus on Autophagy, Oxidative Stress and Hippo Signaling|Active, not recruiting||N/A|30|Actual|Neuromed IRCCS|||1||f||||f|f|f||||Samples With DNA|"     Aortic aneurysm   "|||2017-10-10 20:53:25.309736|2017-10-10 20:53:25.309736
NCT03210987|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-04|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|||Effects of Bedside Compared to Outside the Room Case Presentation|Effect of Bedside Patient Case Presentation Compared to Outside the Room Case Presentation on Patient Perception of Quality of Care and Patient Outcomes: a Randomized-controlled, Multicenter Trial|Recruiting||N/A|760|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f|f|f||||||||2017-10-10 20:53:25.370412|2017-10-10 20:53:25.370412
NCT03210974|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-05|||June 3, 2016|Actual|2016-06-03|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Retrospective Observational Study About the Evolution of Patients With Breast Cancer in Hospitals From the GEICAM Group (2002 - 2005). ALAMO IV|Retrospective Observational Study About the Evolution of Patients With Breast Cancer in Hospitals From the GEICAM Group (2002 - 2005). ALAMO IV|Recruiting||N/A|12000|Anticipated|Spanish Breast Cancer Research Group|||1||f||||f|f|f||||||||2017-10-10 20:53:25.467885|2017-10-10 20:53:25.467885
NCT03210961|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-10-01|||July 14, 2017|Actual|2017-07-14|October 2017|2017-10-01|August 12, 2018|Anticipated|2018-08-12|August 12, 2018|Anticipated|2018-08-12||Interventional|||A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis|A Phase 1, Within Cohort, Randomized, Double Blind, Third-party Open, Placebo-controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06826647 In Healthy Subjects And Subjects With Plaque Psoriasis|Recruiting||Phase 1|90|Anticipated|Pfizer||4|||f||||f|t|f||||||||2017-10-10 20:53:25.641648|2017-10-10 20:53:25.641648
NCT03210948|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-06|||July 20, 2017|Anticipated|2017-07-20|July 2017|2017-07-01|December 20, 2018|Anticipated|2018-12-20|July 20, 2018|Anticipated|2018-07-20||Interventional|||Conventional Versus Elastography Targeted Endoscopic Ultrasound Fine Needle Aspiration of Solid Pancreatic Lesions|Conventional Versus Elastography Targeted Endoscopic Ultrasound Fine Needle Aspiration of Solid Pancreatic Lesions: a Multicenter Randomized Controlled Trial|Not yet recruiting||N/A|280|Anticipated|Ospedali Riuniti di Foggia||2|||f||||f|f|f|||f|||||2017-10-10 20:53:27.482548|2017-10-10 20:53:27.482548
NCT03210935|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||November 24, 2015|Actual|2015-11-24|July 2017|2017-07-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2025|Anticipated|2025-12-31||Observational|CARADERM||French National Database of Rare Dermatological Cancers|French National Database of Rare Dermatological Cancers: Merkel Cell Carcinoma, Inoperable or Metastatic Basal Cell Carcinoma, Cutaneous Adnexal Carcinomas|Recruiting||N/A|9000|Anticipated|University Hospital, Lille|||3||f||||f|f|f||||||||2017-10-10 20:53:27.583176|2017-10-10 20:53:27.583176
NCT03210922|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-22|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|July 18, 2019|Anticipated|2019-07-18|July 18, 2018|Anticipated|2018-07-18||Interventional|||Semirigid Cervical Collar and Nasotracheal Intubation by Glidescope in Cervical Spine Surgery|Effect of Semirigid Cervical Collar During Nasotracheal Intubation by Glidescope in the Elective Cervical Spinal Surgical Patients: a Study of Clinical Predictors and Outcomes|Recruiting||N/A|180|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f|||||f|f||||||||2017-10-10 20:53:27.773044|2017-10-10 20:53:27.773044
NCT03210909|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-28|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants|Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants|Completed||Phase 1|5|Actual|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 20:53:27.847411|2017-10-10 20:53:27.847411
NCT03210896|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-10|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Breath for Better Health Study|Breath for Better Health Study|Recruiting||N/A|120|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust||3|||f|||||f|f||||||||2017-10-10 20:53:27.925508|2017-10-10 20:53:27.925508
NCT03210883|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-19|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|GEHCO||Global Electrical Heterogeneity and Clinical Outcomes|Global Electrical Heterogeneity and Clinical Outcomes|Active, not recruiting||N/A|10000|Actual|Oregon Health and Science University|||1||f||||f|f|f||||||||2017-10-10 20:53:28.01568|2017-10-10 20:53:28.01568
NCT03210870|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-05|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|CAMPS||Clatsop Astoria Maternal Partnership Study (CAMPS) - Healthy Eating in Pregnancy Intervention|Clatsop Astoria Maternal Partnership Study (CAMPS) - Healthy Eating in Pregnancy Intervention|Recruiting||N/A|100|Anticipated|Oregon Health and Science University||2|||f||||f|f|f||||||||2017-10-10 20:53:28.191268|2017-10-10 20:53:28.191268
NCT03210857|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-14|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|APNECK||Effects of Voluntary Neck Extension on Cerebral Blood Flow, in Breath-hold Divers Ending an Apnoea of Two Minutes or More.|Effect of Voluntary Neck Extension in the Occurrence of an Increase in the Pulsatility Index of Right Internal Carotid Artery in the Amateur Diver, Performing an Apnoea of Two Minutes or More: a Prospective, Monocentric, Open Interventional Study|Completed||N/A|15|Actual|Nantes University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:53:28.274569|2017-10-10 20:53:28.274569
NCT03210844|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-07-06|||October 1, 2013|Actual|2013-10-01|June 2017|2017-06-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Observational|||The Clinical Outcomes After Direct Anterior Approach and Microposterior Approach for Total Hip Arthroplasty|The Clinical Outcomes After Mini-incision Direct Anterior Approach and Microposterior Approach for Total Hip Arthroplasty|Active, not recruiting||N/A|141|Anticipated|National Taiwan University Hospital|||2||f||||f|f|f||||||||2017-10-10 20:53:28.355879|2017-10-10 20:53:28.355879
NCT03210831|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-06|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2022|Anticipated|2022-06-01|January 2022|Anticipated|2022-01-01||Observational|||Early Predictors of Necrotizing Enterocolitis in Neonates|Clinical Model for Early Predictors of Necrotizing Enterocolitis in Neonates|Not yet recruiting||N/A|450|Anticipated|Baylor College of Medicine|||1||f||||f|f|f||||||||2017-10-10 20:53:28.44798|2017-10-10 20:53:28.44798
NCT03210818|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-05|||July 5, 2017|Anticipated|2017-07-05|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|March 31, 2019|Anticipated|2019-03-31||Observational|||Effects of Blood Flow of Venoarterial Extracorporeal Membrane Oxygenation Life Support on Microcirculation|Effects of Adjustment of Blood Flow of Venoarterial Extracorporeal Membrane Oxygenation Life Support on Microcirculation|Not yet recruiting||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:53:28.513721|2017-10-10 20:53:28.513721
NCT03210792|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-05|||July 10, 2017|Anticipated|2017-07-10|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|CMRSHRS||Comparison Manufactured Rib Splint With Hand-made Rib Splint|Comparison of the Effectiveness in Pain Reduction Between a Rib Splint Produced in the ER and a Manufactured Rib Splint: Preliminary Clinical Study|Not yet recruiting||N/A|12|Anticipated|Hanyang University||2|||f||||t|f|f||||||||2017-10-10 20:53:28.658711|2017-10-10 20:53:28.658711
NCT03210779|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-04|||December 5, 2016|Actual|2016-12-05|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|PROWOUND||Effect of Probiotics on Oral Wound Healing - Pilot Study|Effect of Probiotic Tablets and Topical Probiotic Oil (Lactobacillus. Reuteri) on Oral Wound Healing (Pilot Study)|Completed||N/A|10|Actual|University of Copenhagen||2|||f||||f|f|f|||f|||||2017-10-10 20:53:28.726498|2017-10-10 20:53:28.726498
NCT03210766|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-05|||September 1, 2014|Actual|2014-09-01|July 2017|2017-07-01|January 31, 2016|Actual|2016-01-31|January 1, 2015|Actual|2015-01-01||Observational|||Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain|Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain|Completed||N/A|20|Actual|"Azienda Ospedaliera Universitaria Policlinico G. Martino"|||2||f||||t|t|f||||||||2017-10-10 20:53:28.808963|2017-10-10 20:53:28.808963
NCT03210753|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-10|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma|Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma|Recruiting||N/A|400|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 20:53:28.939461|2017-10-10 20:53:28.939461
NCT03210740|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-05|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis|A Phase 2, Single-Center, Randomized, Double- Blind, Parallel-Group, Vehicle-Controlled Study Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK) Lesions|Recruiting||Phase 2|40|Anticipated|AmDerma||2||||||||t|f||||||||2017-10-10 20:53:29.01258|2017-10-10 20:53:29.01258
NCT03210727|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-10|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||CAREgiver Study for Patients Undergoing HSCT|A Mixed Methods Descriptive Study Exploring the Needs and Preferences of Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)|Recruiting||N/A|20|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:53:29.098793|2017-10-10 20:53:29.098793
NCT03210714|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-06|2017-09-18|||November 30, 2017|Anticipated|2017-11-30|June 2017|2017-06-01|March 30, 2021|Anticipated|2021-03-30|March 30, 2021|Anticipated|2021-03-30||Interventional|||Pediatric MATCH: Pan-FGFR Tyrosine Kinase Inhibitor JNJ-42756493 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations|NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of JNJ-42756493 (Erdafitinib) in Patients With Tumors Harboring FGFR 1/2/3/4 Alterations|Not yet recruiting||Phase 2|49|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 20:53:29.190586|2017-10-10 20:53:29.190586
NCT03210701|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-23|||February 14, 2017|Actual|2017-02-14|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|APPROACH||A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV|A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV - A Type II Hybrid Implementation-Effectiveness Study|Recruiting||N/A|30|Anticipated|Memorial University of Newfoundland||1|||f||||f|f|f||||||||2017-10-10 20:53:29.315003|2017-10-10 20:53:29.315003
NCT03210688|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-04|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|ADAPTinMCN||Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy|Treatment of Primary Minimal Change Nephropathy: A Randomized Open-labeled Non-inferiority Study on Prednisolone and Vitamin D|Not yet recruiting||Phase 4|96|Anticipated|University of Aarhus||2|||f||||t|f|f|||f|||||2017-10-10 20:53:29.397431|2017-10-10 20:53:29.397431
NCT03210675|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-05|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|RESPIRE21||Early Detection and Treatment of Respiratory Sleep Disorders in Children With Down Syndrome|Early Detection and Treatment of Respiratory Sleep Disorders in Children With Down Syndrome|Recruiting||N/A|80|Anticipated|Institut Jerome Lejeune||2|||f||||f|f|f||||||||2017-10-10 20:53:29.471225|2017-10-10 20:53:29.471225
NCT03210662|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-07-12|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Pembrolizumab and Fractionated External Beam Radiotherapy (EBRT) in Patients With Non-Hodgkin Lymphoma (NHL)|Phase II Study of Pembrolizumab and Fractionated External Beam Radiotherapy in Patients With Relapsed and Refractory Non-Hodgkin Lymphoma|Not yet recruiting||Phase 2|70|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 20:53:29.56464|2017-10-10 20:53:29.56464
NCT03210649|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-06|||March 7, 2017|Actual|2017-03-07|July 2017|2017-07-01|April 24, 2017|Actual|2017-04-24|April 24, 2017|Actual|2017-04-24||Interventional|||Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519|A Randomized, Double-blind, Placebo-controlled, Phase I Clinical Trial to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 After Oral Administration in Healthy Adult Volunteers : Part I- Single Dosing / Part II- Multiple Dosing|Completed||Phase 1|18|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f|f|f||||||||2017-10-10 20:53:29.666435|2017-10-10 20:53:29.666435
NCT03210636|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-07-05|||November 2014|Actual|2014-11-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Looking at Safety and Feasibility of Novel Laparoscopic Device (LapSpace)|Feasibility and Safety Study of LapSpace, A Novel Laparoscopic Surgical Instrument|Completed||N/A|5|Actual|Johns Hopkins University||1|||f||||t|f|t|f|f|t|||||2017-10-10 20:53:29.741985|2017-10-10 20:53:29.741985
NCT03210623|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-12|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Stent Retriever's(TonbridgeMT) Endovascular Therapy for Acute Ischemic Stroke(AIS)|The Efficacy and Safety Study of Stent Retriever's(TonbridgeMT) Endovascular Therapy for Acute Ischemic Stroke|Not yet recruiting||N/A|220|Anticipated|Zhuhai Tonbridge Medical Tech. Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:53:29.918193|2017-10-10 20:53:29.918193
NCT03210610|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-04|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|July 15, 2020|Anticipated|2020-07-15|July 15, 2020|Anticipated|2020-07-15||Observational|||Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients|Measurement of Colchicine Levels in the Serum of FMF Patients|Not yet recruiting||N/A|80|Anticipated|Sheba Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:53:30.096723|2017-10-10 20:53:30.096723
NCT03210597|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-04|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|August 20, 2017|Anticipated|2017-08-20|December 28, 2016|Actual|2016-12-28||Interventional|||Effects of Water-Based Exercise in Women With Metabolic Syndrome|Effects of Water-Based Aerobic Training, Resistance Training and Concurrent Training in Women With Metabolic Syndrome: A Randomized Controlled Trial|Active, not recruiting||N/A|51|Anticipated|Federal University of Rio Grande do Sul||3|||f|||||f|f||||||||2017-10-10 20:53:30.162383|2017-10-10 20:53:30.162383
NCT03210584|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-04|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|January 2017|Actual|2017-01-01||Observational|MULTICART||Multimodal Evaluation of Cartilage Lesions of Patellofemoral Joint|Multimodal Evaluation of Cartilage Lesions of Patellofemoral Joint|Active, not recruiting||N/A|10|Actual|University Hospital, Grenoble|||1||f||||f|f|f||||None Retained|"     cartilage samples undergoing total knee arthroplasty procedure   "|||2017-10-10 20:53:30.239358|2017-10-10 20:53:30.239358
NCT03210571|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-06|||September 4, 2017|Anticipated|2017-09-04|July 2017|2017-07-01|March 4, 2019|Anticipated|2019-03-04|March 4, 2018|Anticipated|2018-03-04||Interventional|||Clinical Investigation of the eyeWatch Glaucoma Drainage Device|Clinical Investigation of the eyeWatch Glaucoma Drainage Device|Not yet recruiting||N/A|30|Anticipated|Rheon Medical SA||1|||f|||||f|f||||||||2017-10-10 20:53:30.323585|2017-10-10 20:53:30.323585
NCT03210558|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-04|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|STAR||Study of Testosterone and Athlete Response|Effects of Moderately Increased Testosterone Concentration on Physical Performance and Behaviour in Healthy Women - a Double-blind, Randomized, Placebo-controlled Study|Recruiting||Phase 2|50|Anticipated|Karolinska University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:30.393803|2017-10-10 20:53:30.393803
NCT03210545|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)|A Dose-response Study of Markers of Glucocorticoid Effects (DOSCORT): A Single-blinded, Randomized, 2-dose, Cross-over Study|Not yet recruiting||Phase 4|30|Anticipated|Göteborg University||2|||f||||f|f|f|||f|||||2017-10-10 20:53:30.510164|2017-10-10 20:53:30.510164
NCT03210532|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-07-04|||October 7, 2016|Actual|2016-10-07|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia||Active, not recruiting||Phase 3|126|Anticipated|Daewon Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-10 20:53:30.613008|2017-10-10 20:53:30.613008
NCT03210519|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-04|||December 9, 2015|Actual|2015-12-09|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||To Evaluate the Efficacy of Eleutherococcus Senticosus for Subjects Under Renal Dialysis|A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy of Eleutherococcus Senticosus for Anti-inflammation and Improvement of Erythropoietin Hyporesponsiveness in Subjects Under Renal Dialysis|Completed||N/A|19|Actual|Chung Shan Medical University||2|||f||||f|f|f||||||||2017-10-10 20:53:30.690069|2017-10-10 20:53:30.690069
NCT03210506|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Changes of Cytokines During Antiviral Therapy|The Changes of Cytokines During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B|Recruiting||N/A|120|Anticipated|Beijing Ditan Hospital||2|||f||||f||||||||||2017-10-10 20:53:30.769265|2017-10-10 20:53:30.769265
NCT03210493|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Changes of Treg Cells Frequency and Function During Antiviral Therapy|The Changes of Treg Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B|Recruiting||N/A|120|Anticipated|Beijing Ditan Hospital||2|||f||||f||||||||||2017-10-10 20:53:30.864922|2017-10-10 20:53:30.864922
NCT03210480|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-06|||March 28, 2017|Actual|2017-03-28|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)|Clinical Evaluation of Switching to Lithiofor® (Lithium Sulphate Slow -Release, Li-SR Tablets) From Carbolithium® (Lithium Carbonate Immediate-Release, Li-IR, Capsules) in Bipolar Patients, Poorly Tolerant to Lithium Immediate-release Treatment.|Recruiting||Phase 4|138|Anticipated|Aziende Chimiche Riunite Angelini Francesco S.p.A||2|||f||||f|f|f||||||||2017-10-10 20:53:30.972279|2017-10-10 20:53:30.972279
NCT03210467|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-04|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Antiviral Therapy|The Changes of Plasmacytoid Dendritic Cells Frequency and Function During Pegylated Interferon α-2a and Entecavir(ETV) Treatment in Patients With Chronic Hepatitis B.|Recruiting||N/A|120|Anticipated|Beijing Ditan Hospital|||2||f||||f||||||||||2017-10-10 20:53:31.114889|2017-10-10 20:53:31.114889
NCT03210454|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-08-21|||April 2, 2016|Actual|2016-04-02|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Evaluation of Marketing Interventions in Colombia|Evaluation Of The Effect Of Marketing Interventions For Women On Economic Empowerment And Risk Of Intimate Partner Violence In Colombia|Completed||N/A|1882|Actual|Emory University||3|||f||||f|f|f||||||||2017-10-10 20:53:31.215262|2017-10-10 20:53:31.215262
NCT03210441|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-04|||May 6, 2014|Actual|2014-05-06|July 2017|2017-07-01|May 6, 2018|Anticipated|2018-05-06|May 6, 2018|Anticipated|2018-05-06||Observational|CHANGE||Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer|Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment: a Prospective Cohort Study on Patients Affected by Breast Cancer|Recruiting||N/A|204|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia|||2||f||||f|f|f||||||||2017-10-10 20:53:31.322063|2017-10-10 20:53:31.322063
NCT03210428|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-04|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2023|Anticipated|2023-09-01|September 2021|Anticipated|2021-09-01||Observational|IQ-EMBRACE||Quantitative MR Imaging in Locally Advanced Cervical Cancer|Quantitative MR Imaging in Locally Advanced Cervical Cancer Sub-study Under the EMBRACE II Protocol|Not yet recruiting||N/A|320|Anticipated|Aarhus University Hospital|||1||f||||t|f|f||||||||2017-10-10 20:53:31.44684|2017-10-10 20:53:31.44684
NCT03210415|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-11|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 30, 2020|Anticipated|2020-12-30|June 30, 2020|Anticipated|2020-06-30||Observational|||Study on Prevention, Treatment and Mechanism of Preterm Labor for Chinese Pregnant Women ≥35 Years Old|Study on Prevention, Treatment and Mechanism of Preterm Labor for Chinese Pregnant Women ≥35 Years Old|Recruiting||N/A|1500|Anticipated|Ministry of Science and Technology of the People´s Republic of China|||2||f||||t|f|f||||Samples With DNA|"     blood, urine, hair, cervical secretion，saliva，amniotic fluid, placenta   "|||2017-10-10 20:53:31.537114|2017-10-10 20:53:31.537114
NCT03210402|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-05|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|REVAMP||REmodeling the Left Ventricle With Atrial Modulated Pacing|REmodeling the Left Ventricle With Atrial Modulated Pacing|Not yet recruiting||N/A|40|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f|f|f||||||||2017-10-10 20:53:31.628428|2017-10-10 20:53:31.628428
NCT03210389|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-05|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.|A Prospective, Single-arm, and Open Clinical Trial of Chemotherapy With Lobaplatin and 5-FU on Efficacy and Safety in Recurrent Local or Distant Advanced NPC.|Not yet recruiting||Phase 2|60|Anticipated|Sun Yat-sen University||1|||f||||t|f|f||||||||2017-10-10 20:53:31.704179|2017-10-10 20:53:31.704179
NCT03210376|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-21|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Neuromuscular Blockade on Shoulder Pain of Elderly|The Effect of Deep Neuromuscular Blockade With Sugammadex Reversal on Shoulder Pain of Elderly Patients Undergoing Robotic Surgery: A Single-Center Double-Blinded Randomized Controlled Trial|Not yet recruiting||Phase 4|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f|||f|||||2017-10-10 20:53:31.785179|2017-10-10 20:53:31.785179
NCT03210363|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-05|||June 9, 2017|Actual|2017-06-09|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|October 30, 2017|Anticipated|2017-10-30||Interventional|EPI-ARBO||Sero-epidemiology of Priority Arboviruses in French Guiana|Sero-epidemiology of Priority Arboviruses in French Guiana|Recruiting||N/A|2500|Anticipated|Institut Pasteur||1|||f||||f|f|f||||||||2017-10-10 20:53:32.502589|2017-10-10 20:53:32.502589
NCT03210350|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-05|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Observational|||Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients|Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients Using Ultrasound Measured Optic Nerve Sheath Diameter: a Pilot Study|Recruiting||N/A|30|Anticipated|Corniche Hospital|||1||f||||f|f|f||||||||2017-10-10 20:53:32.600173|2017-10-10 20:53:32.600173
NCT03210324|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-04|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy|Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy in Open, Multicenter Phase IV Clinical Studies|Recruiting||Phase 4|2200|Anticipated|China Resources Zizhu Pharmaceutical Co., Ltd.||3|||f||||f|f|f||||||||2017-10-10 20:53:32.831188|2017-10-10 20:53:32.831188
NCT03210298|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-10|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01|1 Year|Observational [Patient Registry]|PIPACRegis||International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)|Multicenter, International Online Documentation of Indications and Results of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC Und PITAC) for Treating Malignant Peritoneal and Pleural Diseases|Recruiting||N/A|1000|Anticipated|University of Magdeburg|||1||f||||f|t|f|||f|Samples With DNA|"     Peritoneal samples   "|||2017-10-10 20:53:33.393411|2017-10-10 20:53:33.393411
NCT03210285|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-04|||July 31, 2017|Anticipated|2017-07-31|July 2017|2017-07-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2018|Anticipated|2018-09-01|5 Years|Observational [Patient Registry]|NF2||WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data|Whole Exome Sequencing (WES) of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data|Not yet recruiting||N/A|100|Anticipated|University Hospital Tuebingen|||2||f||||f|f|f||||Samples With DNA|"     Tumor tissue Blood   "|||2017-10-10 20:53:33.573179|2017-10-10 20:53:33.573179
NCT03210272|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-10-03|||July 18, 2017|Actual|2017-07-18|October 2017|2017-10-01|July 9, 2018|Anticipated|2018-07-09|July 9, 2018|Anticipated|2018-07-09||Interventional|||This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1358894 in Healthy Male Subjects (Single-blind, Partially Randomised, Placebo-controlled Parallel Group Design) and Effect of Food on the Relative Bioavailability of BI 1358894 (Open-label, Randomised, Two-way Cross-over)|Recruiting||Phase 1|124|Anticipated|Boehringer Ingelheim||2|||f||||f|t|f||||||||2017-10-10 20:53:33.688149|2017-10-10 20:53:33.688149
NCT03210259|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-05|2017-10-02|||July 10, 2017|Actual|2017-07-10|October 2017|2017-10-01|July 19, 2019|Anticipated|2019-07-19|February 28, 2019|Anticipated|2019-02-28||Interventional|VOLTAIRE-X||This Trial Compares BI 695501 and Humira® in Patients With a Long-term Disease That Causes Red, Scaly Patches on the Skin (Plaque Psoriasis). The Trial Looks at the Way the Body Takes up the Drugs and How Effective and Safe They Are|VOLTAIRE-X: Pharmacokinetics, Safety, Immunogenicity and Efficacy of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis: a Randomized, Double-blind, Parallel-arm, Multiple-dose, Active Comparator Trial|Recruiting||Phase 3|240|Anticipated|Boehringer Ingelheim||2|||f||||f|t|f||||||||2017-10-10 20:53:33.800829|2017-10-10 20:53:33.800829
NCT03210233|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-05|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Development of Diagnostic Pathway for Teicoplanin Allergy|Development of a Novel Diagnostic Pathway for Immediate Type Hypersensitivity Reactions to Teicoplanin, Including Invivo and Ex-vivo Testing Modalities.|Recruiting||N/A|548|Anticipated|The Leeds Teaching Hospitals NHS Trust||3|||f||||f|f|f||||||||2017-10-10 20:53:34.037497|2017-10-10 20:53:34.037497
NCT03210220|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-09-26|||October 29, 2017|Anticipated|2017-10-29|September 2017|2017-09-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Efficacy of Preoperative Pectoral Nerve Block for Intraoperative Opioid Sparing Effect and Postoperative Analgesia|Efficacy of Preoperative Ultrasound Guided Pectoral Nerve Block for Intraoperative Opioid Sparing Effect and Postoperative Analgesia in Patients Undergoing Surgery for Breast Cancer.|Not yet recruiting||N/A|40|Anticipated|Gachon University Gil Medical Center|||2||f||||||||||||||2017-10-10 20:53:34.136098|2017-10-10 20:53:34.136098
NCT03210207|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-09|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Observational|||Gastric Plication in Mexican Patients|Laparoscopic Gastric Plication: 5 Years of Follow-up in Mexican Patients|Completed||N/A|40|Actual|Instituto Mexicano del Seguro Social|||1||f||||t|f|f||||||||2017-10-10 20:53:34.226708|2017-10-10 20:53:34.226708
NCT03210194|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-30|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|August 31, 2018|Anticipated|2018-08-31||Interventional|RCPNEOPERU||Randomized Cluster Trial on Innovative and Standard Strategies for Neonatal Resuscitation Training (RCPNEOPERU Project)|Continuous Training and Certification in Neonatal Resuscitation in Remote Areas Using a Multi-platform Information and Communication Technology Intervention Compared to Standard Training: A Randomized Cluster Trial|Enrolling by invitation||N/A|12|Anticipated|Universidad Peruana Cayetano Heredia||2|||f||||f|f|f||||||||2017-10-10 20:53:34.319312|2017-10-10 20:53:34.319312
NCT03210181|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-06|||July 4, 2017|Actual|2017-07-04|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||Superficial Cervical Plexus Block for Neck and Shoulder Pain|Superficial Cervical Plexus Block for Neck and Shoulder Pain Due to Levator Scapulae Syndrome: a Randomized, Double Blind Clinical Trial|Recruiting||N/A|60|Anticipated|Makassed General Hospital||2|||f|||||f|f||||||||2017-10-10 20:53:34.446233|2017-10-10 20:53:34.446233
NCT03210168|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-19|||July 4, 2017|Actual|2017-07-04|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||BioFe, Medical Food for the Dietary Management of Iron Deficiency|A Clinical Trial of BioFe, Medical Food for the Dietary Management of Iron Deficiency|Recruiting||N/A|40|Anticipated|Sidero Bioscience, LLC||1|||f||||f|f|f||||||||2017-10-10 20:53:34.55983|2017-10-10 20:53:34.55983
NCT03210155|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-08-29|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Efficacy of CES in New Mothers During the Post Partum Period|Effects of Cranial Electrotherapy Stimulation on Psychological Distress and Maternal Functioning in New Mothers During the Postpartum Period|Enrolling by invitation||N/A|50|Anticipated|Murphey, Christina, RN, PhD||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:53:34.684385|2017-10-10 20:53:34.684385
NCT03210142|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-04|||June 23, 2017|Actual|2017-06-23|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|Lingual||Minimally Invasive Hypoglossal Nerve Stimulation Study (Lingual Study)|Minimally Invasive Hypoglossal Nerve Stimulation Study|Recruiting||N/A|26|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f|f|f||||||||2017-10-10 20:53:34.800284|2017-10-10 20:53:34.800284
NCT03210129|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-28|||July 6, 2017|Actual|2017-07-06|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|MIPAClux||Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients|Motivational Interviewing to Increase Physical Activity Behaviour in Breast, Endometrial and Colorectal Cancer Patients in the Grand-Duchy of Luxembourg: a Pilot Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|Luxembourg Institute of Health||2|||f||||f|f|f||||||||2017-10-10 20:53:34.91433|2017-10-10 20:53:34.91433
NCT03210116|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-07-26|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Observational|||Quality Improvement in Palliative Care Consultation in a Medical ICU|Quality Improvement in Palliative Care Consultation in a Medical Intensive Care Unit|Withdrawn||N/A|0|Actual|Washington University School of Medicine|||2|Change of Protocol and IRB resubmission|f|||||f|f||||||||2017-10-10 20:53:35.045515|2017-10-10 20:53:35.045515
NCT03210103|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-04|||August 15, 2017|Anticipated|2017-08-15|June 2017|2017-06-01|August 15, 2028|Anticipated|2028-08-15|August 15, 2028|Anticipated|2028-08-15||Interventional|ORATOR2||Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer|A Randomized Trial of Treatment De-Escalation for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: Radiotherapy vs. Trans-Oral Surgery (ORATOR II)|Not yet recruiting||N/A|120|Anticipated|Lawson Health Research Institute||2|||f||||t|f|f||||||||2017-10-10 20:53:35.128854|2017-10-10 20:53:35.128854
NCT03210090|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-04|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|CYTHEMAT||Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients|Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients|Recruiting||N/A|100|Anticipated|Maimónides Biomedical Research Institute of Córdoba|||1||f||||f|f|f||||Samples With DNA|"     whole blood   "|||2017-10-10 20:53:35.231677|2017-10-10 20:53:35.231677
NCT03210077|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 30, 2019|Anticipated|2019-03-30|December 31, 2018|Anticipated|2018-12-31||Observational|ROEntropy||Romanian Entropy Clinical Study Network|Romanian Entropy Clinical Study Network|Enrolling by invitation||N/A|500|Anticipated|Romanian Society of Anesthesia and Intensive Care|||2||f||||t|f|f||||||||2017-10-10 20:53:35.33095|2017-10-10 20:53:35.33095
NCT03210064|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-04|||May 4, 2017|Actual|2017-05-04|July 2017|2017-07-01|April 24, 2019|Anticipated|2019-04-24|April 24, 2018|Anticipated|2018-04-24||Interventional|||Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients|A Phase II Clinical Trial Study on Apatinib and 5-Fu Combination Regimen in the Treatment of Advanced Colorectal Cancer Patients|Recruiting||Phase 2|42|Anticipated|Hubei Cancer Hospital||2|||f||||t|f|f||||||||2017-10-10 20:53:35.406151|2017-10-10 20:53:35.406151
NCT03210051|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-16|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|December 17, 2017|Anticipated|2017-12-17|September 17, 2017|Actual|2017-09-17||Interventional|||Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke (REVISE-1)|A Pilot Study Assessing the Safety and Feasibility of Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke|Recruiting||Phase 1|20|Anticipated|Capital Medical University||1|||f||||f|f|f||||||||2017-10-10 20:53:35.525969|2017-10-10 20:53:35.525969
NCT03210038|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-07-26|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|May 1, 2019|Anticipated|2019-05-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia?|Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia?|Recruiting||N/A|104|Anticipated|Assaf-Harofeh Medical Center||4|||f||||t|f|f|||f|||||2017-10-10 20:53:35.639373|2017-10-10 20:53:35.639373
NCT03210025|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-13|||October 7, 2017|Anticipated|2017-10-07|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations|Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations|Not yet recruiting||Phase 1|30|Anticipated|Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited||2|||f||||t|f|f||||||||2017-10-10 20:53:35.734003|2017-10-10 20:53:35.734003
NCT03210012|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-22|||June 11, 2017|Actual|2017-06-11|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|July 6, 2017|Actual|2017-07-06||Observational|||Bubbles, Stress, Diastole|Bubbles, Stress, Diastole|Recruiting||N/A|4|Anticipated|Clinica ARS Medica|||1||f||||f|f|f||||Samples Without DNA|"     blood samples for microparticles count   "|||2017-10-10 20:53:35.804845|2017-10-10 20:53:35.804845
NCT03209999|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-05|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|||Maternal Employment in Low and Middle-income Countries and Infant Feeding|Maternal Employment in Low and Middle-income Countries is Associated With Improved Infant and Young Child Feeding in Children|Completed||N/A|39791|Actual|University of Washington|||3||f||||f|f|f||||||||2017-10-10 20:53:35.87859|2017-10-10 20:53:35.87859
NCT03209986|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-05|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis|Randomized Control Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis Resulted From Viral Hepatitis|Recruiting||N/A|200|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||f|f|f||||||||2017-10-10 20:53:35.943506|2017-10-10 20:53:35.943506
NCT03209973|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-04|||April 21, 2017|Actual|2017-04-21|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of BGB-A317 as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma|A Single Arm, Multicenter, Phase 2 Study of BGB-A317 as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma|Recruiting||Phase 2|68|Anticipated|BeiGene||1|||f||||t|f|f||||||||2017-10-10 20:53:36.038578|2017-10-10 20:53:36.038578
NCT03209960|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-08|||August 24, 2017|Anticipated|2017-08-24|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity|Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity|Not yet recruiting||N/A|140|Anticipated|Vanderbilt University Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:53:36.154376|2017-10-10 20:53:36.154376
NCT03209934|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center|Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center|Completed||N/A|43|Actual|Hospices Civils de Lyon|||1||f|||||f|f||||||||2017-10-10 20:53:36.308812|2017-10-10 20:53:36.308812
NCT03209921|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections|Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections|Completed||N/A|23|Actual|Hospices Civils de Lyon|||1||f|||||f|f||||||||2017-10-10 20:53:36.356868|2017-10-10 20:53:36.356868
NCT03209726|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-03|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|EL-SID||Assessment of S-ICD Eligibility With 12-Lead ECG|Assessment of Subcutaneous Implantable Cardioverter Defibrillator Eligibility With 12-lead Electrocardiogram|Enrolling by invitation||N/A|100|Anticipated|Oregon Health and Science University|||1||f||||f|f|f||||||||2017-10-10 20:53:37.687384|2017-10-10 20:53:37.687384
NCT03209908|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-10|||January 1, 2017||2017-01-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Observational|||The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal Time|The Study of Starting to Use Tenofovir Disoproxil Fumarate(TDF) Antiviral Treatment From the 32 Weeks of Gestation to Block Mother-to-child Transmission of Hepatitis B Virus(HBV MTCT) and Withdrawal Time|Recruiting||N/A|380|Anticipated|Beijing Ditan Hospital|||2||f||||||||||Samples With DNA|"     At the age of seven months, we extract venous blood of these children, separate the serums     and collect the PBMC. Then, the serums are applied to test HBsAg, AntiHBs and HBVDNA which we     adopt to analyse HLA classⅠand class Ⅱ gene polymorphism. meanwhile, detect HBVDNA loads of     pregnant women with HBsAg/HBeAg positive and HBV DNA > 106 copies/ml in 32 weeks，36 weeks of     gestation and before delivery.   "|||2017-10-10 20:53:36.403399|2017-10-10 20:53:36.403399
NCT03209895|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-03|||October 8, 2010|Actual|2010-10-08|July 2017|2017-07-01|June 13, 2011|Actual|2011-06-13|June 13, 2011|Actual|2011-06-13||Interventional|||"Study to Evaluate the Safety and Efficacy of a Proprietary Joint Health Dietary Supplement in Subjects With Joint and Connective Tissue Pain"|"A Double-Blinded, Placebo Controlled, Human Clinical Study to Evaluate the Safety and Efficacy of a Proprietary Joint Health Dietary Supplement in Subjects With Joint and Connective Tissue Pain"|Completed||N/A|135|Actual|U.S. Nutraceuticals, LLC||3|||f||||f|f|f||||||||2017-10-10 20:53:36.5826|2017-10-10 20:53:36.5826
NCT03209882|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)|Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Metabolism and Function in Post-traumatic Stress Disorder (PTSD)|Not yet recruiting||N/A|100|Anticipated|The University of Texas at Arlington||2|||f||||t|f|f||||||||2017-10-10 20:53:36.655207|2017-10-10 20:53:36.655207
NCT03209869|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Treatment of Relapsed or Refractory Neuroblastoma With Expanded Haploidentical NK Cells and Hu14.18-IL2|Treatment of Relapsed or Refractory Neuroblastoma With Ex-Vivo Expanded and Activated Haploidentical NK Cells and Hu14.18-IL2|Not yet recruiting||Phase 1|6|Anticipated|University of Wisconsin, Madison||1|||f||||t|t|f||||||||2017-10-10 20:53:36.729258|2017-10-10 20:53:36.729258
NCT03209856|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-06|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|August 20, 2018|Anticipated|2018-08-20|July 20, 2018|Anticipated|2018-07-20||Interventional|||Vitamin D Supplementation in Vitamin Deficient Women Undergoing IVF Cycles: Does it Affect the Fertility Outcome?|Vitamin D Supplementation in Vitamin Deficient Women Undergoing ICSI Cycles: Does it Affect the Fertility Outcome?|Recruiting||Phase 4|402|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:53:36.832051|2017-10-10 20:53:36.832051
NCT03209843|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-20|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 1, 2020|Anticipated|2020-03-01|July 1, 2019|Anticipated|2019-07-01||Interventional|PERFECTO||Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO)|Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure|Not yet recruiting||N/A|150|Anticipated|Poitiers University Hospital||1|||f|||||f|f||||||||2017-10-10 20:53:36.92286|2017-10-10 20:53:36.92286
NCT03209830|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-03|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage|OSU6162 in the Treatment of Fatigue and Other Neuropsychological Sequelae After Aneurysmal Subarachnoid Hemorrhage - A Double-blind, Randomised, Placebo-controlled Study|Not yet recruiting||Phase 2|100|Anticipated|Oslo University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:53:37.000942|2017-10-10 20:53:37.000942
NCT03209817|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-03|||January 23, 2017|Actual|2017-01-23|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Tomato Supplementation and Cardiovascular Health|Effects of Tomato Supplementation on Cardiovascular Health|Recruiting||N/A|30|Anticipated|Northumbria University||3|||f||||f|f|f||||||||2017-10-10 20:53:37.097046|2017-10-10 20:53:37.097046
NCT03209804|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-03|||June 2016||2016-06-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|SMAVMHR||Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room|Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room|Recruiting||N/A|302|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-10-10 20:53:37.183143|2017-10-10 20:53:37.183143
NCT03209791|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-03|||May 18, 2015|Actual|2015-05-18|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Ethanol Induces Skeletal Muscle Autophagy|Mechanisms of Skeletal Muscle Proteolysis With Ethanol Consumption: an Integrated Molecular Metabolic Approach|Recruiting||N/A|40|Anticipated|The Cleveland Clinic|||4||f||||f|f|f||||||||2017-10-10 20:53:37.284719|2017-10-10 20:53:37.284719
NCT03209778|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-11|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2021|Anticipated|2021-10-01||Interventional|||Involuntary Memories Investigation in Schizophrenia|Involuntary Memories Investigation in Schizophrenia|Not yet recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||||2017-10-10 20:53:37.390994|2017-10-10 20:53:37.390994
NCT03209765|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||WhatsApp Reminder on FIT Compliance|Effectiveness of WhatsApp Reminder on Compliance of Colorectal Cancer Screening: a Randomized Controlled Study|Recruiting||N/A|394|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:53:37.460461|2017-10-10 20:53:37.460461
NCT03209752|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Observational|EOSTransfert||"Prediction of 3D Effect of Brace in Idiopathic Scoliosis Treatment Using EOS Imaging System and Anatomic Transfer."|"Prediction of 3D Effect of Brace in Adolescent and Children Idiopathic Scoliosis Treatment Using EOS Imaging System and Anatomic Transfer."|Active, not recruiting||N/A|30|Actual|University Hospital, Grenoble|||1||f||||f|f|f||||||||2017-10-10 20:53:37.534539|2017-10-10 20:53:37.534539
NCT03209739|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||June 2, 2017|Actual|2017-06-02|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||WhatsApp Reminder on Bowel Preparation Level|Can a WhatsApp Reminder Improve the Quality of Screening Colonoscopy? A Randomized Controlled Study|Recruiting||N/A|440|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:53:37.610118|2017-10-10 20:53:37.610118
NCT03209700|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-08|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|July 10, 2020|Anticipated|2020-07-10|July 10, 2019|Anticipated|2019-07-10||Interventional|MSC-AFP||Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas|Re-treatment for Partial or Non-responders for a Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Perianal Fistulas|Enrolling by invitation||Phase 1|10|Anticipated|Mayo Clinic||1|||f||||f|t|f||||||||2017-10-10 20:53:37.844558|2017-10-10 20:53:37.844558
NCT03209687|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-06|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|August 15, 2019|Anticipated|2019-08-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles|Human Menopausal Gonadotropin as a Novel Addition to Luteal Phase Support in Down-regulated ICSI Cycles (RCT)|Recruiting||Phase 4|600|Anticipated|Cairo University||2|||f|||||f|f|||f|||||2017-10-10 20:53:37.945473|2017-10-10 20:53:37.945473
NCT03209674|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-04|||January 1, 2012|Actual|2012-01-01|July 2017|2017-07-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2025|Anticipated|2025-12-31|2 Months|Observational [Patient Registry]|RIPOSTE||Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry|Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry|Recruiting||N/A|8000|Anticipated|CMC Ambroise Paré|||1||f||||f|f|f||||||||2017-10-10 20:53:38.06759|2017-10-10 20:53:38.06759
NCT03209661|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-05|||April 28, 2017|Actual|2017-04-28|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vascular Effects of a Single Bout of Electronic Cigarette Use|Vascular Effects of a Single Bout of Electronic Cigarette Use|Recruiting||Phase 1|35|Anticipated|University of Texas at Austin||3|||f|||||t|f||||||||2017-10-10 20:53:38.16951|2017-10-10 20:53:38.16951
NCT03209648|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-09-22|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 23, 2017|Actual|2017-08-23||Interventional|||A Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects|A Phase 1, Open-Label, Fixed Sequence Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects|Completed||Phase 1|20|Actual|Debiopharm International SA||1|||f|||||f|f||||||||2017-10-10 20:53:38.271401|2017-10-10 20:53:38.271401
NCT03209635|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Interventional|||Weissella Cibaria JW15 Consumption and NK Cell Activity|Weissella Cibaria JW15 Consumption and NK Cell Activity|Completed||N/A|100|Actual|Yonsei University||2|||f|||||f|f||||||||2017-10-10 20:53:38.392944|2017-10-10 20:53:38.392944
NCT03209622|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-05|||January 2, 2015|Actual|2015-01-02|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|November 1, 2017|Anticipated|2017-11-01||Interventional|SCACS||Smoking Cessation After Acute Coronary Syndrome|Nicotine Replacement Therapy After Acute Coronary Syndrome|Recruiting||N/A|89|Anticipated|University of Monastir||2|||f||||t|f|f|||f|||||2017-10-10 20:53:38.468021|2017-10-10 20:53:38.468021
NCT03209609|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Interventional|VEST Pivotal||VEST Venous Graft External Support Pivotal Study|A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support|Not yet recruiting||N/A|224|Anticipated|Vascular Graft Solutions Ltd.||2|||f||||t|f|t|t|f||||||2017-10-10 20:53:38.583671|2017-10-10 20:53:38.583671
NCT03209596|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-05|||October 20, 2013|Actual|2013-10-20|July 2017|2017-07-01|August 29, 2014|Actual|2014-08-29|January 31, 2014|Actual|2014-01-31||Interventional|||Orange Juice Supplementation in Soccer Players|Nutritional and Biochemical Effects of Orange Juice Supplementation in Soccer Players: a Double Blind, Randomized and Controlled Trial|Completed||N/A|30|Actual|University of Sao Paulo||2|||f||||f|f|f||||||||2017-10-10 20:53:38.663018|2017-10-10 20:53:38.663018
NCT03209583|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-03|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2023|Anticipated|2023-08-01|August 1, 2022|Anticipated|2022-08-01||Observational|AT-PATCH||ATrial Tachycardia PAcing Therapy in Congenital Heart|ATrial Tachycardia PAcing Therapy in Congenital Heart|Not yet recruiting||N/A|300|Anticipated|University of Iowa|||1||f||||t|f|t|f|f|f|||||2017-10-10 20:53:38.762341|2017-10-10 20:53:38.762341
NCT03209570|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-17|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting|A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting|Recruiting||N/A|32|Anticipated|Insight Therapeutics, LLC||2|||f||||f|f|f|||f|||||2017-10-10 20:53:38.88543|2017-10-10 20:53:38.88543
NCT03209557|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-27|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pilot Trial of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women|Pilot Trial Testing Feasibility and Effectiveness of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women|Recruiting||N/A|50|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 20:53:39.005257|2017-10-10 20:53:39.005257
NCT03209544|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-05|||April 23, 2015|Actual|2015-04-23|July 2017|2017-07-01|February 24, 2016|Actual|2016-02-24|December 7, 2015|Actual|2015-12-07||Interventional|||Think Life, an Online Self-help Intervention for Coping With Suicidal Ideation|A Randomized Controlled Trial on the Effectiveness of an Online Self-help Intervention for Suicidal Ideation|Completed||N/A|724|Actual|University Ghent||2|||f|||||f|f||||||||2017-10-10 20:53:39.111593|2017-10-10 20:53:39.111593
NCT03209531|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-22|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Conditioning Brain Responses to Improve Thigh Muscle Function After Anterior Cruciate Ligament Reconstruction|Operant Conditioning of Motor Evoked Responses to Improve Quadriceps Function in Individuals With Anterior Cruciate Ligament Reconstruction|Recruiting||N/A|32|Anticipated|University of Michigan||2|||f|||||f|t|f|f|f|||||2017-10-10 20:53:39.183728|2017-10-10 20:53:39.183728
NCT03202277|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-03|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|August 15, 2019|Anticipated|2019-08-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||BeWell24: Smartphone-based Diabetes Prevention in the VA|BeWell24: Smartphone-based Diabetes Prevention in the VA|Not yet recruiting||N/A|120|Anticipated|Arizona State University||2|||f||||t|f|f||||||||2017-10-10 20:54:42.464799|2017-10-10 20:54:42.464799
NCT03209518|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||"Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg in Premenopausal Breast Cancer"|"Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg in Premenopausal Breast Cancer"|Recruiting||N/A|300|Anticipated|Takeda|||1||f||||f|f|f||||||||2017-10-10 20:53:39.27974|2017-10-10 20:53:39.27974
NCT03209505|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Impact of Contact Lens Coefficient of Friction (CoF) on the Development of Lid Wiper Epitheliopathy (LWE)|The Impact of Contact Lens Coefficient of Friction (CoF) on the Development of Lid Wiper Epitheliopathy (LWE)|Not yet recruiting||Phase 4|20|Anticipated|University of Houston||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:53:39.356856|2017-10-10 20:53:39.356856
NCT03209492|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||"Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for Prostate Cancer"|"Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for Prostate Cancer"|Active, not recruiting||N/A|300|Actual|Takeda|||1||f||||f|f|f||||||||2017-10-10 20:53:39.432688|2017-10-10 20:53:39.432688
NCT03209479|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||November 6, 2015|Actual|2015-11-06|July 2017|2017-07-01|March 31, 2025|Anticipated|2025-03-31|March 31, 2025|Anticipated|2025-03-31||Observational|||"Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) Prevention of Relapse of Multiple Sclerosis"|"Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) Prevention of Relapse of Multiple Sclerosis"|Recruiting||N/A|1000|Anticipated|Takeda|||1||f||||f|f|f||||||||2017-10-10 20:53:39.502186|2017-10-10 20:53:39.502186
NCT03209466|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-05|||May 11, 2017|Actual|2017-05-11|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 15, 2017|Anticipated|2017-12-15||Interventional|||Chlorhexidine Gluconate Solution at 0.125% vs Placebo for the Healing of Grade IIB Ulcers of Diabetic Foot|Clinical Trial to Rate the Effectivity of the Standard Management and Chlorhexidine Gluconate Solution at 0.125% in Comparison With the Standard Management and Physiological Saline Sterile Solution for the Healing of Grade IIB Ulcers for Diabetic Foot Syndrome|Recruiting||Phase 4|35|Anticipated|Universidad de Guanajuato||2|||f||||f|f|f|||f|||||2017-10-10 20:53:39.57547|2017-10-10 20:53:39.57547
NCT03209453|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Family Work Shop for Children With Developmental Delays: a Randomized Trial|Therapeutic Effects of Short-term Family-centered Work Shop for Children With Developmental Delays: a Randomized Trial|Not yet recruiting||N/A|24|Anticipated|Taipei Medical University||2|||f||||f|f|f||||||||2017-10-10 20:53:39.661218|2017-10-10 20:53:39.661218
NCT03209440|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-07|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|August 2021|Anticipated|2021-08-01||Interventional|||Palliative Care for Elderly Outpatients|Palliative Care for Elderly Outpatients|Recruiting||N/A|700|Anticipated|University of Florida||3|||f||||t|f|f||||||||2017-10-10 20:53:39.722627|2017-10-10 20:53:39.722627
NCT03209427|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||April 2, 2014|Actual|2014-04-02|July 2017|2017-07-01|September 21, 2016|Actual|2016-09-21|April 30, 2015|Actual|2015-04-30||Interventional|||Serum Serotonin and Pruritus After Intrathecal Morphine in Cesarean Section|Pruritus After Intrathecal Morphine in Cesarean Section: Incidence, Severity and Its Relation to Serum Serotonin Level|Completed||Phase 4|40|Actual|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:53:39.818322|2017-10-10 20:53:39.818322
NCT03209414|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-07-03|||May 17, 2017|Actual|2017-05-17|July 2017|2017-07-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Observational|FRAPICA||Frailty Syndrome in Daily Practice of Interventional Cardiology Ward|Frailty Syndrome in Daily Practice of Interventional Cardiology Ward|Recruiting||N/A|1000|Anticipated|Medical University of Silesia|||4||f||||t|f|f||||Samples Without DNA|"     4 ml of blood plasma is frozen at -80 degrees of Celsius. SST2 will be assayed after     completion of recruitment.   "|||2017-10-10 20:53:39.890967|2017-10-10 20:53:39.890967
NCT03209401|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies|Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies|Not yet recruiting||Phase 1|146|Anticipated|Georgetown University||1|||f||||t|t|f||||||||2017-10-10 20:53:39.975757|2017-10-10 20:53:39.975757
NCT03209375|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-13|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Observational|||Identification of the Sick Patient in the ED|Identification of the Sick Patient in the ED|Completed||N/A|503|Actual|Lancashire Teaching Hospitals NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 20:53:40.119761|2017-10-10 20:53:40.119761
NCT03209362|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||SI-613 Study for Knee Osteoarthritis|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Repeated Intra-Articular Injection of SI-613 in Patients With Osteoarthritis of the Knee|Not yet recruiting||Phase 2|80|Anticipated|Seikagaku Corporation||2|||f||||f|t|f||||||||2017-10-10 20:53:40.172333|2017-10-10 20:53:40.172333
NCT03209349|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-03|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|December 8, 2017|Anticipated|2017-12-08|December 8, 2017|Anticipated|2017-12-08||Interventional|||Investigation of Cecal Intubation Rates and Pain Levels Between Water Exchange and Air Insufflation Flexible Sigmoidoscopy|Investigation of Cecal Intubation Rates and Pain Levels Between Water Exchange and Air Insufflation Flexible Sigmoidoscopy: A Randomized Controlled Study|Recruiting||N/A|200|Anticipated|Kelowna Gastroenterology Associates||2|||f||||t|f|f||||||||2017-10-10 20:53:40.234109|2017-10-10 20:53:40.234109
NCT03209336|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-05|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|IROT||Study of Intraoperative Radiotherapy for Middle and Low Rectal Cancer|Single Center Study of Intraoperative Radiotherapy for Middle and Low Rectal Cancer in the Standard of Peritoneal Inversion Rectal Cancer.|Recruiting||N/A|50|Anticipated|Second Hospital of Jilin University||2|||f||||t|f|f|||f|||||2017-10-10 20:53:40.318697|2017-10-10 20:53:40.318697
NCT03209323|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-07|||January 1, 2007|Actual|2007-01-01|July 2017|2017-07-01|December 13, 2008|Actual|2008-12-13|December 13, 2008|Actual|2008-12-13||Interventional|EEG||Epileptiform EEG Patterns During Induction of General Anaesthesia With Sevoflurane Compared to Those With Propofol|Influence of Volatile Induction of General Anaesthesia With Sevoflurane Using Two Different Techniques and Intravenous Induction Using Propofol on the Epileptiform Electroencephalograph Patterns:|Completed||N/A|60|Actual|Medical University of Silesia||3|||f||||t|f|f||||||||2017-10-10 20:53:40.389481|2017-10-10 20:53:40.389481
NCT03209310|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-06|||October 30, 2016|Actual|2016-10-30|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|April 16, 2017|Actual|2017-04-16|1 Day|Observational [Patient Registry]|||The Effect of Trunk Control on Respiratory Muscle Strength|The Effect of Trunk Control on Respiratory Muscle Strength and Activities of Daily Living in Children With Cerebral Palsy|Completed||N/A|50|Actual|Gazi University|||2||f||||f|f|f||||||||2017-10-10 20:53:40.629326|2017-10-10 20:53:40.629326
NCT03209297|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-03|||March 27, 2017|Actual|2017-03-27|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|January 2020|Anticipated|2020-01-01||Interventional|||Temporomandibular Dysfunction in Patients With Tinnitus: Assessment and Treatment|The Effect of Conservative Treatment of Temporomandibular Disorders on Somatic Tinnitus|Recruiting||N/A|200|Anticipated|Universiteit Antwerpen||2|||f||||f|f|f||||||||2017-10-10 20:53:40.702877|2017-10-10 20:53:40.702877
NCT03209284|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-22|||July 15, 2014|Actual|2014-07-15|July 2017|2017-07-01|February 15, 2017|Actual|2017-02-15|September 15, 2015|Actual|2015-09-15||Observational|SLSS||Influence of Anatomy of Maxillary Sinus on New Bone Formation After Transcrestal Augmentation Procedures|Influence of the Anatomical Variability of the Maxillary Sinus on New Bone Formation After Transcrestal Augmentation Procedures|Completed||N/A|30|Actual|International Piezosurgery Academy|||2||f||||t|f|f||||Samples Without DNA|"     bone biopsies were retrieved at the time of implant placement (after 6 months of regenerative     procedure) and obtained through implant site preparation with trephine bur   "|||2017-10-10 20:53:40.81606|2017-10-10 20:53:40.81606
NCT03209271|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-03|||February 3, 2017|Actual|2017-02-03|July 2017|2017-07-01|May 27, 2017|Actual|2017-05-27|May 27, 2017|Actual|2017-05-27||Interventional|||Hemodynamic Effects of Cold Versus Warm Fluid Bolus|Hemodynamic Effects of Cold Versus Warm Fluid Bolus Infusion in Healthy Volunteers: a Randomized Cross-over Trial|Completed||N/A|21|Actual|Karolinska Institutet||2|||f||||t|f|f|||f|||||2017-10-10 20:53:40.919325|2017-10-10 20:53:40.919325
NCT03209258|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-05|||October 15, 2017|Anticipated|2017-10-15|July 2017|2017-07-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|INTERACT3||The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial|An Investigator Initiated and Conducted, International, Multicenter, Stepped Wedge Cluster Randomized Study of a Care Bundle of Physiological Control Strategies in Acute Intracerebral Hemorrhage|Not yet recruiting||N/A|8621|Anticipated|The George Institute for Global Health, China||2|||f||||t|f|f||||||||2017-10-10 20:53:41.030749|2017-10-10 20:53:41.030749
NCT03209245|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-05|||April 10, 2014|Actual|2014-04-10|July 2017|2017-07-01|April 15, 2017|Actual|2017-04-15|June 20, 2016|Actual|2016-06-20||Interventional|HDMeld||House Dust Mite Injection Immunotherapy in Elderly Patients.|House Dust Mite Injection Immunotherapy: a Double-blind, Placebo Controlled Study in Elderly Patients With Allergic Rhinitis.|Completed||Phase 3|58|Actual|Medical University of Silesia||2|||f||||f|f|f||||||||2017-10-10 20:53:41.185414|2017-10-10 20:53:41.185414
NCT03209232|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|INDUCE||Infliximab Accelerated Induction in Moderate to Severe Pediatric UC|Infliximab Accelerated Induction for Moderate to Severe Ulcerative Colitis in Children (INDUCE) Trial|Not yet recruiting||N/A|84|Anticipated|Schneider Children's Medical Center, Israel||2|||f||||t|f|f|||f|||||2017-10-10 20:53:41.284962|2017-10-10 20:53:41.284962
NCT03209219|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-05|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Interferon α2a Versus Cyclosporine for Refractory Behçet`s Disease Uveitis|Randomized Prospective Comparative Study of Interferon α2a and Cyclosporine in Patients With Refractory Behçet`s Disease Uveitis|Recruiting||Phase 3|36|Anticipated|Peking Union Medical College Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:41.409411|2017-10-10 20:53:41.409411
NCT03209206|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||July 8, 2017|Anticipated|2017-07-08|July 2017|2017-07-01|April 1, 2022|Anticipated|2022-04-01|June 19, 2020|Anticipated|2020-06-19||Interventional|||The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence|The Effectiveness and Safety of Intravesical Docetaxel Instillation After Operation to Prevent Intravesical Recurrence After Radical Nephroureterectomy or Distal Ureterectomy in Upper Urinary Tract Urothelial Carcinoma: A Prospective Study|Not yet recruiting||Phase 2|84|Anticipated|Seoul National University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:53:41.522449|2017-10-10 20:53:41.522449
NCT03209193|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-11|||July 4, 2017|Actual|2017-07-04|September 2017|2017-09-01|June 4, 2018|Anticipated|2018-06-04|June 4, 2018|Anticipated|2018-06-04||Interventional|||Effect of Anesthetics on Microcirculation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery|Effect of Anesthetics on Microcirculation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery|Recruiting||Phase 4|72|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:53:41.630957|2017-10-10 20:53:41.630957
NCT03209180|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-03|||October 27, 2016|Actual|2016-10-27|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|June 25, 2018|Anticipated|2018-06-25||Interventional|SLOW-HF||Immediate Release Versus Slow Release Carvedilol in Heart Failure|Assessment of Clinical Effect and Treatment Quality of Rapid Release Carvedilol Versus SLOW Release Carvedilol-SR in HEART FAILURE Patient (SLOW-HF): A Prospective Randomized, Open-label, Multicenter Study|Recruiting||Phase 4|320|Anticipated|Seoul National University Bundang Hospital||2|||f|||||f|f||||||||2017-10-10 20:53:41.741793|2017-10-10 20:53:41.741793
NCT03209167|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-03|||January 1, 2001|Actual|2001-01-01|July 2017|2017-07-01|December 31, 2004|Actual|2004-12-31|December 31, 2004|Actual|2004-12-31||Observational|||Comparing Patient Satisfaction of the Abdomen After DIEAP Procedure and Conventional Abdominoplasty|Comparing Patient Satisfaction of the Abdomen After DIEAP Procedure and Conventional Abdominoplasty|Completed||N/A|44||Oslo University Hospital|||2||f|||||f|f||||||||2017-10-10 20:53:41.904595|2017-10-10 20:53:41.904595
NCT03207386|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-04|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|May 2020|Anticipated|2020-05-01||Interventional|||Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative|Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative: A Process and Outcome Evaluation|Recruiting||N/A|5500|Anticipated|University of New Hampshire||1|||f||||f|f|f||||||||2017-10-10 20:53:57.617302|2017-10-10 20:53:57.617302
NCT03209154|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-04|2017-07-04|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|February 1, 2020|Anticipated|2020-02-01|November 1, 2019|Anticipated|2019-11-01||Interventional|IDA||An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment|Individualized Blood Pressure Treatment: a Multidisciplinary Approach to Uncontrolled Hypertension in Order to Reduce Morbidity and Mortality|Not yet recruiting||N/A|80|Anticipated|Oslo University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:53:41.973809|2017-10-10 20:53:41.973809
NCT03209141|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||January 2, 2015|Actual|2015-01-02|July 2017|2017-07-01|January 15, 2018|Anticipated|2018-01-15|September 30, 2017|Anticipated|2017-09-30||Observational|IMPEDDANS||Screening of Diastolic Dysfunction With Impedance Cardiography in Hypertensive Patients|Impedance Cardiography in the Evaluation of Left Ventricular Diastolic Dysfunction in Patients With Arterial Hypertension Study (IMPEDDANS)|Recruiting||N/A|154|Anticipated|Centro Hospitalar de Lisboa Central|||2||f||||f||||||||||2017-10-10 20:53:42.059112|2017-10-10 20:53:42.059112
NCT03209128|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|IPC||Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala|Savings of Hippocampus and Amygdala by Archetherapy in Cerebral Prophylactic Irradiation in Patients With Limited and / or Extended, Responsive or Stable Small Cell Lung Cancer (SCLC)|Recruiting||N/A|20|Anticipated|Centre Francois Baclesse, Luxembourg|||1||f||||f|f|f||||||||2017-10-10 20:53:42.193438|2017-10-10 20:53:42.193438
NCT03209115|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-05|||July 8, 2017|Anticipated|2017-07-08|July 2017|2017-07-01|July 8, 2018|Anticipated|2018-07-08|September 8, 2017|Anticipated|2017-09-08||Interventional|med||Influence of Calcium Hydroxide Chlorhexidine Combination vs. Calcium Hydroxide as an Intra Canal Medicaments in Retreatment Cases|Influence of Calcium Hydroxide Chlorhexidine Combination vs. Calcium Hydroxide as an Intra Canal Medicamentson Postoperative Flare -up Following Two-Visit Endodontic Retreatment Cases|Not yet recruiting||Early Phase 1|24|Anticipated|Cairo University||2|||f|||||f|f|||f|||||2017-10-10 20:53:42.275068|2017-10-10 20:53:42.275068
NCT03209102|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-03|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|ADOLIMIS||Emotional Regulation and Impulsivity Among Adolescents With Borderline Personality Disorder|Multimodal Study of the Emotional Regulation and Impulsivity Among Adolescents With Borderline Personality Disorder : Stress Reactivity and Functional Imaging|Not yet recruiting||Phase 2|66|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f|||||f|f||||||||2017-10-10 20:53:42.366371|2017-10-10 20:53:42.366371
NCT03209076|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-03|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 1, 2020|Anticipated|2020-12-01|June 1, 2020|Anticipated|2020-06-01||Interventional|RAR||Robotic Versus Laparoscopic Low Anterior Resection for Rectal Cancer|Robotic Versus Laparoscopic Low Anterior Resection for Rectal Cancer: A Randomized Study|Not yet recruiting||N/A|113|Anticipated|Instituto Nacional de Cancer, Brazil||2|||f||||t|f|f||||||||2017-10-10 20:53:42.550197|2017-10-10 20:53:42.550197
NCT03209063|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-03|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|August 1, 2018|Anticipated|2018-08-01||Observational|||The Role of Prothrombin Gene Polymorphism as a Risk Factor for Recurrent Pregnancy Loss|The Role of Prothrombin Gene Polymorphism as a Risk Factor for Recurrent Pregnancy Loss|Not yet recruiting||N/A|100|Anticipated|Assiut University|||3||f||||f|f|f||||||||2017-10-10 20:53:42.644808|2017-10-10 20:53:42.644808
NCT03209050|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-03|||July 30, 2017|Anticipated|2017-07-30|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|SAVEUS||Evaluation of the Surfacer System Approach to Central Venous Access|Evaluation of the Surfacer System Approach to Central Venous Access|Not yet recruiting||N/A|30|Anticipated|Bluegrass Vascular Technologies||1|||f||||t|f|t|t|||||||2017-10-10 20:53:42.736247|2017-10-10 20:53:42.736247
NCT03209037|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Changes of CD8+T Cells Frequency and Function During Antiviral Therapy|The Changes of CD8+T Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B|Recruiting||Phase 4|100|Anticipated|Beijing Ditan Hospital||2|||f||||f||||||||||2017-10-10 20:53:42.805078|2017-10-10 20:53:42.805078
NCT03209024|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-03|||March 15, 2017|Actual|2017-03-15|July 2017|2017-07-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|ADELPHY||Smartphone App Assisted Home Blood Pressure Monitoring Amongst Hypertensive Patients in Singapore|App Documentation of Electronic BP Readings in Hypertension|Active, not recruiting||N/A|80|Actual|Duke-NUS Graduate Medical School||2|||f||||f|f|f||||||||2017-10-10 20:53:42.909178|2017-10-10 20:53:42.909178
NCT03209011|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Changes of CD4+T Cells Frequency and Function During Antiviral Therapy|The Changes of CD4+T Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B|Recruiting||Phase 4|100|Anticipated|Beijing Ditan Hospital||2|||f||||f||||||||||2017-10-10 20:53:42.998291|2017-10-10 20:53:42.998291
NCT03208998|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Changes of Natural Killer Cells Frequency and Function During Antiviral Therapy|The Changes of Natural Killer Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B.|Recruiting||Phase 4|100|Anticipated|Beijing Ditan Hospital||2|||f||||f||||||||||2017-10-10 20:53:43.086712|2017-10-10 20:53:43.086712
NCT03208985|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-03|||May 23, 2017|Actual|2017-05-23|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|LIBRella||A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions|A Multi-Center, Open-Label Trial Investigating Behavior Related to Ella® Use in a Simulated OTC Environment (LIBRella)|Recruiting||Phase 3|950|Anticipated|HRA Pharma||1|||f|||||t|f||||||||2017-10-10 20:53:43.188904|2017-10-10 20:53:43.188904
NCT03208972|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-07-03|||October 2014||2014-10-01|July 2017|2017-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG|Prospective Randomized Trial Comparing Ovarian Stimulation in IVF-patients With Corifollitropin Alfa in Combination With Hp-FSH Versus Corifollitropin Alfa in Combination With Low Dose hCG|Completed||Phase 4|107|Actual|AZ Jan Palfijn Gent||2|||f||||f||||||||||2017-10-10 20:53:43.369019|2017-10-10 20:53:43.369019
NCT03208959|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-03|||August 30, 2017|Anticipated|2017-08-30|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||A Trial of HTI-1090 in Subjects With Advanced Solid Tumors|A Phase I, Open-Label, Multicenter, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of HTI-1090 in Patients With Advanced Solid Tumors|Not yet recruiting||Phase 1|30|Anticipated|Atridia Pty Ltd.||5|||f|||||t|f||||||||2017-10-10 20:53:43.454295|2017-10-10 20:53:43.454295
NCT03208946|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-11|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|February 15, 2018|Anticipated|2018-02-15|December 10, 2017|Anticipated|2017-12-10||Interventional|||Effects of a High-CML Diet on Absorption and Excretion Levels in Healthy Adults|Effects of a High Carboxymethyl-lysine (CML) Diet on Absorption and Excretion Levels in Healthy Adults|Recruiting||N/A|30|Anticipated|Universidad de Guanajuato||2|||f||||t|f|f||||||||2017-10-10 20:53:43.561078|2017-10-10 20:53:43.561078
NCT03208933|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-10-02|||June 14, 2017|Actual|2017-06-14|October 2017|2017-10-01|June 24, 2019|Anticipated|2019-06-24|June 24, 2019|Anticipated|2019-06-24||Interventional|||Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).|Local Open-label Multicenter Study to Assess the Effectiveness of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis in Russian Clinical Practice|Recruiting||Phase 3|60|Anticipated|Hoffmann-La Roche||1|||f||||t|t|f|||t|||||2017-10-10 20:53:43.639187|2017-10-10 20:53:43.639187
NCT03208920|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-09|||December 2016|Actual|2016-12-01|August 2017|2017-08-01||||November 2017|Anticipated|2017-11-01||Interventional|Omega-EVAR||Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair|THE OMEGA-EVAR TRIAL: USE OF FISH OIL TO REDUCE INFLAMMATION DURING ENDOVASCULAR ABDOMINAL AORTIC REPAIR|Recruiting||Phase 2|30|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 20:53:43.737786|2017-10-10 20:53:43.737786
NCT03208907|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-08|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|CuraVivax||DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil|An Open Label Randomized Comparative Study to Assess the Efficacy and Tolerability of Eurartesim® Versus Chloroquine and Nonrelapse Effect With Primaquine for Uncomplicated Plasmodium Vivax Monoinfection Malaria|Not yet recruiting||Phase 4|460|Anticipated|Fundação de Medicina Tropical Dr. Heitor Vieira Dourado||4|||f||||t|f|f|||f|||||2017-10-10 20:53:43.837021|2017-10-10 20:53:43.837021
NCT03208894|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-05|||November 1, 2016|Actual|2016-11-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|May 30, 2017|Actual|2017-05-30||Interventional|||Role of Salbutamol and Furosemide in TTN|Role of Salbutamol and Furosemide in Transient Tachypnea of Newborn|Completed||Phase 3|100|Actual|Armed Forces Hospital, Pakistan||4|||f|||||f|f|||f|||||2017-10-10 20:53:43.924668|2017-10-10 20:53:43.924668
NCT03208881|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-03|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness|Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness in Obese Subjects Following a Significant Weight Loss|Recruiting||N/A|80|Anticipated|Parker Research Institute|||1||f||||t||||||||||2017-10-10 20:53:43.996656|2017-10-10 20:53:43.996656
NCT03208868|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-03|||August 5, 2013|Actual|2013-08-05|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis|Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis|Recruiting||N/A|32|Anticipated|The Cleveland Clinic||2|||f|||||f|f||||||||2017-10-10 20:53:44.060095|2017-10-10 20:53:44.060095
NCT03208855|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-03|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|gCBTI||Cognitive Behavioral Therapy for Insomnia in Substance Use Disorders|Cognitive Behavioral Therapy for Insomnia in Substance Use Disorders at an Urban Residential Recovery Program|Not yet recruiting||N/A|80|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-10 20:53:44.141588|2017-10-10 20:53:44.141588
NCT03208842|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|August 31, 2018|Anticipated|2018-08-31||Observational|||Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar|Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar With Doppler Assessment of Retro Chorionic Blood Flow|Not yet recruiting||N/A|200|Anticipated|Cairo University|||2||f||||t|f|f||||||||2017-10-10 20:53:44.214338|2017-10-10 20:53:44.214338
NCT03208829|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-03|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|||Exercises in the Post-operative Rehabilitation of THA|Effects of an Exercise Program Based on Muscle Strengthening in the Rehabilitation of Individuals Undergoing Total Hip Arthroplasty: a Randomized Clinical Trial.|Not yet recruiting||N/A|84|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:53:44.285414|2017-10-10 20:53:44.285414
NCT03208816|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-27|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|CLARO||Community-Led Action Research in Oncology: Improving Symptom Management|Community-Led Action Research in Oncology: Improving Symptom Management|Recruiting||N/A|25|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:53:46.007837|2017-10-10 20:53:46.007837
NCT03208803|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-03|||May 2016||2016-05-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Observational|Ruxo-EPO||Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in Myelofibrosis|Patients With Myelofibrosis Treated With Combination of Janus Kinase 2 Inhibitor and Erythropoiesis-stimulating Agent. A French Observational Study.|Active, not recruiting||N/A|65|Actual|Centre Hospitalier de la Région d'Annecy|||1||f||||f||||||||||2017-10-10 20:53:46.116312|2017-10-10 20:53:46.116312
NCT02942108|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Piezoelectric Vibrations and Tissue, Cellular and Molecular Mechanisms of Oral Wound Healing After Third Molar Surgery||Recruiting||Phase 4|40|Anticipated|University of Belgrade||2|||f||||||||||||||2017-10-10 21:40:17.761171|2017-10-10 21:40:17.761171
NCT03208790|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-14|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions.|Clinical And Immunohistochemical Evaluation Of The Cancer Chemopreventive Effect Of Thymoquinone Compared To A Placebo On Oral Potentially Malignant Lesions Among An Egyptian Population : A Randomized Clinical Trial|Not yet recruiting||Phase 2|81|Anticipated|Cairo University||3|||f||||f|f|f||||||||2017-10-10 20:53:46.198449|2017-10-10 20:53:46.198449
NCT03208777|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-05|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Telomeric Abnormalities in Colorectal Diseases by Fluorescent in Situ Hybridization Technique|Telomeric Abnormalities in Benign and Malignant Colorectal Diseases by Fluorescent in Situ Hybridization Technique|Not yet recruiting||N/A|80|Anticipated|Assiut University|||3||f||||f|f|f||||||||2017-10-10 20:53:46.284901|2017-10-10 20:53:46.284901
NCT03208764|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-08-02|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|April 15, 2018|Anticipated|2018-04-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Inhaled Nitric Oxide for Cystic Fibrosis Patients With MABSC|A Prospective, Open Labeled, Multi-Center, Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Cystic Fibrosis Diagnosed With NTM (Specifically MABSC)|Recruiting||Phase 2|10|Anticipated|Advanced Inhalation Therapies Ltd||1|||f|||||f|f||||||||2017-10-10 20:53:46.359037|2017-10-10 20:53:46.359037
NCT03208751|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-02|||April 1, 2011|Actual|2011-04-01|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Sport as Therapy: a 6-months Lifestyle-Intervention for Patients With Coronary Artery Disease and/or Diabetes|A 6-months Lifestyle Intervention With Interval and Resistance Exercise in Patients With Coronary Artery Disease and Diabetes Mellitus in a Community Based Setting|Recruiting||N/A|500|Anticipated|Technische Universität München||1|||f||||f|f|f||||||||2017-10-10 20:53:46.440272|2017-10-10 20:53:46.440272
NCT03208738|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-05|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Pilot Evaluation of the VetChange Mobile App for Veterans With PTSD Who Engage in Problem Drinking|Pilot Evaluation of the VetChange Mobile App for Veterans With PTSD Who Engage in Problem Drinking|Not yet recruiting||N/A|280|Anticipated|VA Palo Alto Health Care System||3|||f||||f|f|f||||||||2017-10-10 20:53:46.54324|2017-10-10 20:53:46.54324
NCT03208725|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-07-03|||November 2016||2016-11-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Observational|CHAIN||Childhood Acute Illness and Nutrition Network|Building the Evidence Base for Appropriate Care of the Sick, Undernourished Child in Limited Resource Settings|Recruiting||N/A|4800|Anticipated|University of Oxford|||2||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, rectal swabs, faeces, urine, peripheral blood mononuclear cells,     bacterial isolates.   "|||2017-10-10 20:53:46.629585|2017-10-10 20:53:46.629585
NCT03208712|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-06|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy|Pilot Trial of Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy|Not yet recruiting||Early Phase 1|22|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 20:53:46.792139|2017-10-10 20:53:46.792139
NCT03208699|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-04|||October 1, 2015|Actual|2015-10-01|July 2017|2017-07-01|December 31, 2015|Actual|2015-12-31|October 1, 2015|Actual|2015-10-01||Observational|EXPALI||EXPert System, ALImentary|Screening and Diagnosis Help of Eating Disorders|Completed||N/A|256|Actual|University Hospital, Rouen|||1||f||||f|f|f||||||||2017-10-10 20:53:47.017222|2017-10-10 20:53:47.017222
NCT03208686|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-03|||July 2018|Anticipated|2018-07-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|MANUP||The Men Are Now United Program|Self-Management of Diabetes in Black Men|Not yet recruiting||N/A|40|Anticipated|Michigan State University||1|||f||||t|f|f||||||||2017-10-10 20:53:47.070396|2017-10-10 20:53:47.070396
NCT03208673|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-26|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Optive Brand For Day And Night Dry Eye Management|Optive Brand For Day And Night Dry Eye Management|Recruiting||N/A|40|Anticipated|Allergan||1|||f|||||f|f||||||||2017-10-10 20:53:47.142745|2017-10-10 20:53:47.142745
NCT03208660|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-19|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Observational|||Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy|A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy|Recruiting||N/A|2000|Anticipated|Eisai Inc.|||1||f||||f|t|f||||||||2017-10-10 20:53:47.239126|2017-10-10 20:53:47.239126
NCT03208647|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-07-03|||January 1, 2003||2003-01-01|July 2017|2017-07-01|January 1, 2014|Actual|2014-01-01|January 1, 2014|Actual|2014-01-01||Observational|MCSAA||Multi Center Case Control Study on Multiple Risk Factors of Aplastic Anemia|Multi Center Case Control Study on Multiple Risk Factors of Aplastic Anemia Based on EDC Data Management Platform|Completed||N/A|1802|Actual|Zhejiang Provincial Hospital of TCM|||2||f||||f|f|f||||||||2017-10-10 20:53:47.399799|2017-10-10 20:53:47.399799
NCT03208634|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-03|||October 2013|Actual|2013-10-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|RehaMSR||Rehabilitation Multi Sensory Room for Robot Assisted Functional Movements in Upper-limb Rehabilitation in Chronic Stroke|La Riabilitazione Robot Assistita Del Paziente Neurologico: l'Elettromiografia Dinamica di Superficie Come Strumento Per la Personalizzazione Del Trattamento|Completed||N/A|21|Actual|Villa Beretta Rehabilitation Center||1|||f||||f|f|f||||||||2017-10-10 20:53:47.481118|2017-10-10 20:53:47.481118
NCT03208621|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2025|Anticipated|2025-08-01|August 1, 2020|Anticipated|2020-08-01|5 Years|Observational [Patient Registry]|PLASTIC||Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer|Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer: a Multicenter Prospective Study|Not yet recruiting||N/A|543|Anticipated|UMC Utrecht|||1||f||||f|f|f||||||||2017-10-10 20:53:47.605363|2017-10-10 20:53:47.605363
NCT03208608|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-03|||November 21, 2016|Actual|2016-11-21|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|RBANS-H_ARHL||The RBANS-H in Older Adults With Normal Hearing or Age-related Hearing Loss|The Repeatable Battery for the Assessment of Neuropsychological Status for Hearing Impaired Individuals (RBANS-H) in Older Adults With Normal Hearing or Age-related Hearing Loss|Recruiting||N/A|80|Anticipated|University Hospital, Antwerp|||1||f||||||||||||||2017-10-10 20:53:47.699086|2017-10-10 20:53:47.699086
NCT03208595|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-03|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2020|Anticipated|2020-08-01||Observational|||Endometrial Flora in Women Undergoing IVF Treatments|Endometrial Flora Sampling in Women Undergoing IVF/PGD Treatments|Not yet recruiting||N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f|f|f||||Samples With DNA|"     Bacterial DNA only   "|||2017-10-10 20:53:47.808086|2017-10-10 20:53:47.808086
NCT03208582|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-03|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|BAMES||Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?|Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?|Recruiting||Phase 2|15|Anticipated|Sheffield Children's NHS Foundation Trust||1|||f||||t|f|f|||f|||||2017-10-10 20:53:47.871995|2017-10-10 20:53:47.871995
NCT03208569|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-14|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Anticholinergic Burden - Treatment Optimization|Treatment Optimization Regarding Anticholinergic Medications Potential Impact on Cognitive Test Performance|Recruiting||N/A|700|Anticipated|Region Skane|||1||f||||f|f|f||||||||2017-10-10 20:53:47.966299|2017-10-10 20:53:47.966299
NCT03208556|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-12|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma|Pilot Study of Autologous Anti-CD19 4-1BB CAR T Cells With Cell-intrinsic PD1 Inhibition in Relapsed or Refractory B-cell Lymphoma|Recruiting||Phase 1|20|Anticipated|Peking University||1|||f||||t|f|f||||||||2017-10-10 20:53:48.044311|2017-10-10 20:53:48.044311
NCT03208543|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-08-29|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|HECT-CL||Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan|Effectiveness, Safety and Feasibility of Thermotherapy With the Hand-held Exothermic Crystallization Thermotherapy for Cutaneous Leishmaniasis (HECT-CL), Device for Cutaneous Leishmaniasis in Quetta, Pakistan|Not yet recruiting||Phase 3|317|Anticipated|Medecins Sans Frontieres, Netherlands||1|||f||||f|f|f||||||||2017-10-10 20:53:48.13933|2017-10-10 20:53:48.13933
NCT03208530|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-20|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Motivational Interview Intervention to Help Patients Formulate Their Goals for Medical Care in the Emergency Department|A Pilot Study to Test the Acceptability and Feasibility of Brief Motivational Interview Intervention to Help Patients Formulate Their Goals for Medical Care in the Emergency Department|Not yet recruiting||N/A|150|Anticipated|Brigham and Women's Hospital||1|||f||||f|f|f||||||||2017-10-10 20:53:48.227564|2017-10-10 20:53:48.227564
NCT03208517|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-27|||May 1, 2016|Actual|2016-05-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 7, 2017|Actual|2017-05-07||Interventional|tEACH||Improving Staff Attitudes and Care for People With Dementia: eLearning|An eLearning Optimized Person Centred Intervention to Improve Staff Attitudes and Quality of Care for People With Dementia Living in Care Homes|Active, not recruiting||N/A|240|Anticipated|King's College London||3|||f||||f||||||||||2017-10-10 20:53:48.294983|2017-10-10 20:53:48.294983
NCT03208504|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-02|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|NexusSB||The Single Branch NEXUS™ Clinical Study|A Multi-center Prospective Open-Label Non-Randomized Clinical Study to Evaluate the Safety and Performance of the Single Branch Nexus™ Aortic Arch Stent Graft System.|Not yet recruiting||N/A|10|Anticipated|Endospan Ltd.||1|||f||||t|f|f||||||||2017-10-10 20:53:48.370551|2017-10-10 20:53:48.370551
NCT03208491|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-03|||September 30, 2017|Anticipated|2017-09-30|May 2017|2017-05-01|December 30, 2018|Anticipated|2018-12-30|March 30, 2018|Anticipated|2018-03-30||Interventional|AZ@GAME-Eco||AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and Related Disorders|AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and Related Disorders|Not yet recruiting||N/A|136|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||||2017-10-10 20:53:48.481478|2017-10-10 20:53:48.481478
NCT03208478|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-10|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Pain Control for Anterior Cruciate Ligament Reconstruction Patients With Adductor Canal or Femoral Perineural Infusions|A Prospective Comparison of Pain and Quality of Recovery in Patients Undergoing Anterior Cruciate Ligament Reconstruction With Adductor Canal or Femoral Perineural Infusions|Not yet recruiting||N/A|50|Anticipated|Stanford University||2|||f||||f|f|f|||t|||||2017-10-10 20:53:48.553824|2017-10-10 20:53:48.553824
NCT03208465|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-03|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|ELITE||Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease|Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery disease_ELITE Trial|Not yet recruiting||Phase 4|100|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:53:48.680486|2017-10-10 20:53:48.680486
NCT03208452|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-26|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation|The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation After Pediatric Ophthalmic Surgery|Recruiting||Phase 4|92|Anticipated|Seoul National University Bundang Hospital||2|||f||||f|f|f|||f|||||2017-10-10 20:53:48.835637|2017-10-10 20:53:48.835637
NCT03208439|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-15|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Neuromuscular Electrical Stimulation Cycling|Interactive Cycling System Using Electromyography (EMG)-Driven Neuromuscular Electrical Stimulation (NMES) for Rehabilitation|Recruiting||N/A|20|Anticipated|Chinese University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 20:53:48.918003|2017-10-10 20:53:48.918003
NCT03208426|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-07-03|||July 10, 2017|Anticipated|2017-07-10|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Sequential Versus Quadruple Therapy in the Second-line Treatment|Comparison of the Efficacy of 14-day Sequential Therapy and 10-day Bismuth Quadruple Therapy in the Second Line Therapy for Helicobacter Pylori Infection: A Multi-center Randomized Trial|Not yet recruiting||Phase 4|240|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:49.001326|2017-10-10 20:53:49.001326
NCT03208413|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-19|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Therapeutic Effect of Thalidomide in RN|The Therapeutic Effect of Thalidomide in Radiation-induced Brain Injury: a Phase II Clinical Trial|Recruiting||Phase 2|58|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||1|||f||||t|f|f||||||||2017-10-10 20:53:49.122433|2017-10-10 20:53:49.122433
NCT03208400|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 28, 2020|Anticipated|2020-02-28|August 31, 2019|Anticipated|2019-08-31||Interventional|||Virtual Reality Exposure in Spider Phobia|Exposure Treatment in Anxiety Disorders: Proof of Principle for an a Priori Response Prediction Approach|Not yet recruiting||N/A|200|Anticipated|Julius-Maximilians University||1|||f||||f|f|f||||||||2017-10-10 20:53:49.224467|2017-10-10 20:53:49.224467
NCT03208387|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-13|||June 28, 2017|Actual|2017-06-28|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Understanding the Late Effects of Surviving a Pediatric Brain Tumor|Biological Substrates of Impaired Neurocognitive Functioning: Understanding the Late Effects of Surviving a Pediatric Brain Tumor|Recruiting||N/A|48|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||f|f|f||||||||2017-10-10 20:53:49.297343|2017-10-10 20:53:49.297343
NCT03208374|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-03|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Observational|||Feasibility Information for Timely Completion of Neuroimaging Data Collection|Feasibility Information for Timely Completion of Neuroimaging Data Collection|Recruiting||N/A|5000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||f|f|f||||||||2017-10-10 20:53:49.421278|2017-10-10 20:53:49.421278
NCT03208361|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-30|||November 5, 2013|Actual|2013-11-05|June 2017|2017-06-01|April 21, 2016|Actual|2016-04-21|March 29, 2016|Actual|2016-03-29||Interventional|PENIPNEUMO||Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia.|Efficacy of High Doses of Oral Penicillin V Versus High Doses of Oral Amoxicillin in the Treatment of Non-severe Community-acquired Pneumonia in Adults|Terminated||Phase 3|43|Actual|Jordi Gol i Gurina Foundation||2||"Lack of financial support to continue with the study recruitment. Independent study financially   supported by a national grant with a 4.5 years duration."|f||||f|f|f|||f|||||2017-10-10 20:53:49.527254|2017-10-10 20:53:49.527254
NCT03208348|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Pilot Study of Virtual Reality for Providing Exposure Therapy to Children|Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders|Not yet recruiting||N/A|20|Anticipated|Minnesota HealthSolutions||1|||f||||f|f|f||||||||2017-10-10 20:53:49.635604|2017-10-10 20:53:49.635604
NCT03208335|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-07-02|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)|A Phase II Trial Of Rh-Endostatin In Combination With Radiotherapy In The Treatment Of Hepatocellular Carcinoma|Recruiting||Phase 2|61|Anticipated|Chinese PLA General Hospital||1|||f|||||f|f||||||||2017-10-10 20:53:49.722865|2017-10-10 20:53:49.722865
NCT03208322|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-09-01|||September 8, 2017|Anticipated|2017-09-08|September 2017|2017-09-01|September 8, 2019|Anticipated|2019-09-08|September 8, 2019|Anticipated|2019-09-08||Observational|||Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults|Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults|Not yet recruiting||N/A|30|Anticipated|Bristol-Myers Squibb|||1||f||||||||||||||2017-10-10 20:53:49.813201|2017-10-10 20:53:49.813201
NCT03208309|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-03|||January 2013||2013-01-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin|Effect of Diacerein in the Metabolic Control of Patients With Diabetes Mellitus Type 2 and Secondary Failure to Metformin|Completed||Phase 2|40|Actual|ANS Pharma||2|||f||||t||||||||||2017-10-10 20:53:49.901412|2017-10-10 20:53:49.901412
NCT03208296|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-02|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)|A Phase 1b/2a Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Ascend Biopharmaceuticals Ltd||3|||||||f|t|f||||||||2017-10-10 20:53:50.000019|2017-10-10 20:53:50.000019
NCT03208283|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-02|||October 28, 2014|Actual|2014-10-28|July 2017|2017-07-01|October 22, 2018|Anticipated|2018-10-22|October 22, 2017|Anticipated|2017-10-22||Interventional|FSW||Evaluation of the Impact of Water Method During Insertion Phase of Flexible Sigmoidoscopy in Training|Evaluation of the Impact of Water Metsertion Phase of Flexible Sigmoidoscopy in the Training of Primary Care Doctors or Nurse Endoscopists for Colorectal Cancer Screening: A Randomized Controlled Study (FSW Study)|Recruiting||N/A|400|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f|||f|||||2017-10-10 20:53:50.107341|2017-10-10 20:53:50.107341
NCT03208270|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-09-29|||July 28, 2017|Actual|2017-07-28|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Antithrombin Supplementation in ECMO|Pilot Study of Antithrombin Supplementation During Extracorporeal Membrane Oxigenation|Recruiting||Phase 3|40|Anticipated|Policlinico Hospital||2|||f||||f|f|f||||||||2017-10-10 20:53:50.213172|2017-10-10 20:53:50.213172
NCT03208257|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-08-15|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ECASSS-R2||Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2|Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2|Recruiting||Phase 2|10|Anticipated|Intermountain Health Care, Inc.||1|||f||||t|t|f|||f|||||2017-10-10 20:53:50.325359|2017-10-10 20:53:50.325359
NCT03208231|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-07|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|May 2019|Anticipated|2019-05-01||Interventional|||Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in HIV-Infected Infants Receiving Combination Antiretroviral Therapy|Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 With Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants|Not yet recruiting||Phase 1/Phase 2|68|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 20:53:50.505252|2017-10-10 20:53:50.505252
NCT03208218|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-07-04|||August 17, 2016|Actual|2016-08-17|July 2017|2017-07-01|October 31, 2016|Actual|2016-10-31|August 25, 2016|Actual|2016-08-25||Interventional|||Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers|An Open-label, Randomized, Single Dose, Crossover Bioequivalent Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap, 25mg in Healthy Male Volunteers|Completed||Phase 1|42|Actual|Samyang Biopharmaceuticals Corporation||2|||f||||f|f|f||||||||2017-10-10 20:53:50.583956|2017-10-10 20:53:50.583956
NCT03208205|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-02|||January 1, 2006|Actual|2006-01-01|July 2017|2017-07-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Observational|||Outcomes of Vitrectomy in Pediatric Retinal Detachment With Proliferative Vitreoretinopathy|Outcomes of Vitrectomy in Pediatric Retinal Detachment With Proliferative Vitreoretinopathy|Completed||N/A|14|Actual|Medical University of Lublin|||1||f||||f|f|f||||||||2017-10-10 20:53:50.66435|2017-10-10 20:53:50.66435
NCT03208192|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-03|||May 20, 2017|Actual|2017-05-20|July 2017|2017-07-01|May 20, 2019|Anticipated|2019-05-20|May 20, 2019|Anticipated|2019-05-20||Interventional|LLS||Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection|Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection|Recruiting||N/A|100|Anticipated|Moscow Clinical Scientific Center||2|||f||||f|f|f||||||||2017-10-10 20:53:50.732012|2017-10-10 20:53:50.732012
NCT03208179|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|IMPROVE||Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa|IPTp With Dihydroartemisinin-piperaquine and Azithromycin for Malaria, Sexually Transmitted and Reproductive Tract Infections in Pregnancy in High Sulphadoxine-pyrimethamine Resistance Areas in Kenya, Malawi and Tanzania: an International Multi-centre 3-arm Placebo-controlled Trial|Not yet recruiting||Phase 3|4680|Anticipated|Liverpool School of Tropical Medicine||3|||f||||t|f|f||||||||2017-10-10 20:53:50.833543|2017-10-10 20:53:50.833543
NCT03208166|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-09|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PICASSO||Pilot Study of Pre-Ischemic Conditioning for Intracranial Atherosclerosis|Pilot Study of Pre-Ischemic Conditioning for Intracranial Atherosclerosis|Recruiting||Early Phase 1|10|Anticipated|Medical University of South Carolina||2|||f||||t|f|t|f|f||||||2017-10-10 20:53:50.976002|2017-10-10 20:53:50.976002
NCT03208153|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|MOSCA-FRAIL||the Invasive and Conservative Strategies in Elderly Frail Patients With Non-ST Elevation Myocardial Infarction (MOSCA-FRAIL)|Randomized Comparison Between the Invasive and Conservative Strategies in Elderly Frail Patients With Non-ST Elevation Myocardial Infarction: The MOSCA-FRAIL Clinical Trial|Recruiting||N/A|178|Anticipated|University of Valencia||2|||f||||t|f|f||||||||2017-10-10 20:53:51.061175|2017-10-10 20:53:51.061175
NCT03208140|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-07-09|||February 1, 2015|Actual|2015-02-01|July 2017|2017-07-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01|1 Day|Observational [Patient Registry]|MULTITOTAL||A Study of Laryngoscopic Vision With the TotalTrack Device Versus Indirect Laryngoscopy|A Prospective, Multicenter Comparative Study of Laryngoscopic Vision With the TotalTrack Device Versus Indirect Laryngoscopy in Patients With an Uncomplicated Airway Scheduled for Surgery in the Context of Routine Anesthetic Practice|Recruiting||N/A|300|Anticipated|Formacion Internacional para la Docencia e Investigación de la Vía Aérea|||1||f||||t|f|f||||||||2017-10-10 20:53:51.163583|2017-10-10 20:53:51.163583
NCT03208127|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-10-04|||December 31, 2017|Anticipated|2017-12-31|October 2017|2017-10-01|September 1, 2020|Anticipated|2020-09-01|December 31, 2019|Anticipated|2019-12-31||Interventional|||DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant|Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Liver Transplant|Not yet recruiting||Phase 4|10|Anticipated|Massachusetts General Hospital||1|||f||||f|t|f|||f|||||2017-10-10 20:53:51.373306|2017-10-10 20:53:51.373306
NCT03208114|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-19|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Information on Breast Milk Substitutes at Hospital Discharge|Does the Information on Breast Milk Substitutes at Hospital Discharge Affect Breastfeeding Behavior at Six Months? A Randomized Controlled Trial|Completed||N/A|802|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f|f|f||||||||2017-10-10 20:53:51.472694|2017-10-10 20:53:51.472694
NCT03208101|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-24|||July 3, 2017|Actual|2017-07-03|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults|A Single-center, Randomized, Active-controlled, Parallel-group, Open-label, Phase I Study to Evaluate Safety and Immunogenicity of Single Injection of LBVD or Eupenta Co-administered With Imovax Polio in Healthy Adults|Active, not recruiting||Phase 1|42|Anticipated|LG Chem||2|||f||||f|f|f||||||||2017-10-10 20:53:51.570509|2017-10-10 20:53:51.570509
NCT03206996|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-20|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Exposure Therapy for Auditory Sensitivity in Autism|Treatment for Auditory Hyper-Reactivity Behavior in Children With Autism Using Exposure and Response Prevention Principles|Not yet recruiting||N/A|5|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 20:53:51.655569|2017-10-10 20:53:51.655569
NCT03206983|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-29|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Efficacy of the Canabrava/s Pupil Expansion Device in Cataract Surgery With Small Pupils: The First 30 Cases|Efficacy of the Canabrava/s Pupil Expansion Device in Cataract Surgery With Small Pupils: The First 30 Cases|Completed||N/A|29|Actual|Santa Casa de Misericórdia de Belo Horizonte||1|||f||||t|f|f||||||||2017-10-10 20:53:51.765166|2017-10-10 20:53:51.765166
NCT03206970|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-03|||February 20, 2017|Actual|2017-02-20|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Study of Evaluate Efficacy and Safety of BGB-3111 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)|A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate Efficacy and Safety of BGB-3111, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Subjects With Refractory or Relapsed Mantle Cell Lymphoma (MCL)|Recruiting||Phase 2|80|Anticipated|BeiGene||1|||||||t|t|f||||||||2017-10-10 20:53:51.848937|2017-10-10 20:53:51.848937
NCT03208088|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-25|||June 12, 2017||2017-06-12||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:53:51.974513|2017-10-10 20:53:51.974513
NCT03208075|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-08-11|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||the Regulation of Phosphorus Homeostasis by Dietary Phosphorus Intake in Normal Men|the Regulation of Phosphorus Homeostasis by Dietary Phosphorus Intake in Normal Men|Completed||N/A|6|Actual|Huashan Hospital||3|||f||||t|f|f||||||||2017-10-10 20:53:52.013656|2017-10-10 20:53:52.013656
NCT03208062|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|May 31, 2022|Anticipated|2022-05-31|May 31, 2022|Anticipated|2022-05-31||Observational|BioBanca||Banca di Materiale Biologico Per lo Studio di Patologie Che Interessano l'Apparato Muscolo-scheletrico|Costituzione di Una Banca di Materiale Biologico da Paziente (Biobanca) Per lo Studio di Patologie Che Interessano l'Apparato Muscolo-scheletrico|Enrolling by invitation||N/A|1500|Anticipated|Istituto Ortopedico Galeazzi|||1||f||||f|f|f||||Samples With DNA|"     Blood, bone, muscles, cartilage, tumor.   "|||2017-10-10 20:53:52.099528|2017-10-10 20:53:52.099528
NCT03208049|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Predictors of Response to Insomnia Treatments for Gulf War Veterans|Predictors of Response to Insomnia Treatments for Gulf War Veterans|Not yet recruiting||N/A|100|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 20:53:52.174125|2017-10-10 20:53:52.174125
NCT03208036|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|September 30, 2021|Anticipated|2021-09-30|January 1, 2021|Anticipated|2021-01-01||Interventional|||Restoration of Cognitive Function With TDCS and Training in Schizophrenia|Restoration of Cognitive Function With TDCS and Training in Schizophrenia|Not yet recruiting||N/A|110|Anticipated|VA Office of Research and Development||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:53:52.275397|2017-10-10 20:53:52.275397
NCT03208023|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|RESIPI||RESIPI for Reducing Perioperative Major Adverse Cardiac Events|RESIPI for Reducing Perioperative Major Adverse Cardiac Events: A Phase II Prospective Randomized Controlled Trial|Not yet recruiting||N/A|300|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 20:53:52.387149|2017-10-10 20:53:52.387149
NCT03208010|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-30|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Diabetes Prevention for Mexican Americans|Diabetes Prevention Culturally Tailored for Mexican Americans|Not yet recruiting||N/A|300|Anticipated|University of Texas at Austin||2|||f||||t|f|f||||||||2017-10-10 20:53:52.498209|2017-10-10 20:53:52.498209
NCT03207997|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-03|2017-07-03|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|IRMSCLERO||MRI Quantification of Pulmonary Fibrosis in Scleroderma Patients|MRI Quantification of Pulmonary Fibrosis in Scleroderma Patients by Using Elastic Registration Method: Feasibility Study|Not yet recruiting||N/A|40|Anticipated|Assistance Publique - Hôpitaux de Paris||4|||f||||f|f|f||||||||2017-10-10 20:53:52.595905|2017-10-10 20:53:52.595905
NCT03207984|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-06|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison Between Connective Graft and Xenogeneic Matrix, in the Aesthetic Area of Patients With Gingival Recessions|Comparative Evaluation of the Xenogenic Matrix and Subepithelial Connective Tissue Graft in the Treatment of Multiple Recessions in Aesthetic Area: a Randomized Clinical Study.|Enrolling by invitation||N/A|40|Actual|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:53:52.700013|2017-10-10 20:53:52.700013
NCT03207971|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||February 3, 2017|Actual|2017-02-03|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||ASSESSMENT OF CLINICAL PARAMETERS AND LASER DOPPLER FLOWMETRY FOR THE TREATMENT OF MULTIPLE GENGIVAL RECESSIONS WITH TWO TYPES OF SUBEPITELIAL CONNECTIVE GRAFT: RANDOMIZED CLINICAL STUDY|ANALISYS OF MULTIPLE GINGIVAL RECESSION TREATMENT WITH SUBEPITHELIAL CONNECTIVE TISSUE GRAFT REMOVED FROM PALATAL AREA WITH PREDOMINANCE OF LAMINA PROPRIA AND PREDOMINANCE OF SUBMUCOSA: CLINICAL EVALUATION AND LASER DOPPLER FLOWMETRY|Recruiting||N/A|20|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:53:52.789439|2017-10-10 20:53:52.789439
NCT03207958|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-30|||September 30, 2017|Anticipated|2017-09-30|June 2017|2017-06-01|September 30, 2020|Anticipated|2020-09-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation|A Pilot Study of Belimumab (Benlysta) for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation|Not yet recruiting||Phase 1|10|Anticipated|Washington University School of Medicine||1|||f||||f|t|f|||f|||||2017-10-10 20:53:52.8945|2017-10-10 20:53:52.8945
NCT03207945|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-30|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|EPIC-HIV||Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)|Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)|Not yet recruiting||Phase 3|140|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||||2017-10-10 20:53:53.007805|2017-10-10 20:53:53.007805
NCT03207932|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-02|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01|2 Years|Observational [Patient Registry]|||Ultrasound Guidance Versus Anatomical Landmarks for CVC Catheterisation:|Ultrasound Guidance Versus Anatomical Landmarks for Succlavic and Femoral Veinvein Catheterisation: an Observational Prospective Study|Not yet recruiting||N/A|346|Anticipated|University of Pisa|||2||f|||||f|f||||||||2017-10-10 20:53:53.12016|2017-10-10 20:53:53.12016
NCT03207919|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-30|||November 4, 2016|Actual|2016-11-04|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||The Lullaby Project: A Musical Intervention for Pregnant Women|The Lullaby Project: A Musical Intervention for Pregnant Women|Active, not recruiting||N/A|25|Anticipated|Virginia Commonwealth University||2|||f|||||f|f||||||||2017-10-10 20:53:53.180083|2017-10-10 20:53:53.180083
NCT03207906|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-03|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients|A Multi-center, Randomized, Double-blind, Vehicle-controlled, Phase-2 Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients|Not yet recruiting||Phase 2|150|Anticipated|Veloce BioPharma LLC||3|||f||||t|t|f||||||||2017-10-10 20:53:53.262772|2017-10-10 20:53:53.262772
NCT03207893|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-06-30|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 Diabetes|Benefits of Adding Continuous Glucose Monitoring to Glycemic Load, Exercise, and Monitoring of Blood Glucose (GEM) for Adults With Type 2 Diabetes - Phase 2|Not yet recruiting||N/A|30|Anticipated|University of Virginia||2|||f||||f|f|f||||||||2017-10-10 20:53:53.339217|2017-10-10 20:53:53.339217
NCT03207880|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services|Piloting an Innovation to Improve the Quality of Remote Abortion Services: Incorporating Use of Multi-Level Pregnancy Tests|Not yet recruiting||N/A|300|Anticipated|Gynuity Health Projects||1|||f|||||f|f||||||||2017-10-10 20:53:53.474836|2017-10-10 20:53:53.474836
NCT03207867|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-16|||September 8, 2017|Anticipated|2017-09-08|August 2017|2017-08-01|January 30, 2021|Anticipated|2021-01-30|January 30, 2021|Anticipated|2021-01-30||Interventional|||A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma|A Phase 2, Multi-center, Open Label Study of NIR178 in Combination With PDR001 in Patients With Selected Advanced Solid Tumors and Non-Hodgkin Lymphoma|Not yet recruiting||Phase 2|260|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 20:53:53.544185|2017-10-10 20:53:53.544185
NCT03207854|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-09-12|||April 12, 2017|Actual|2017-04-12|September 2017|2017-09-01|April 12, 2023|Anticipated|2023-04-12|April 12, 2022|Anticipated|2022-04-12||Observational|||Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers|Protocol for Immunology Specimen Collection From Cancer Patients, Patients With Hematologic Diagnoses, and Healthy Normal Controls|Recruiting||N/A|500|Anticipated|University of Southern California|||1||f||||t|f|f||||Samples With DNA|"     Blood, bone marrow, tissue   "|||2017-10-10 20:53:53.658743|2017-10-10 20:53:53.658743
NCT03207841|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-08|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 1, 2021|Anticipated|2021-10-01|July 31, 2021|Anticipated|2021-07-31||Interventional|||Low Carbohydrate/High Protein Diet to Improve Metabolic Health|Utilizing a Low-Carbohydrate/High-Protein Diet to Improve Metabolic Health in Individuals With Spinal Cord Injury|Not yet recruiting||N/A|100|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f||||||||2017-10-10 20:53:53.745923|2017-10-10 20:53:53.745923
NCT03207828|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-20|||September 9, 2017|Actual|2017-09-09|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|July 27, 2018|Anticipated|2018-07-27||Interventional|||Testing Interventions for Patients With Fibromyalgia and Depression|"Eficacia de la Terapia de activación Conductual Para Pacientes Con Dolor crónico: Ensayo clínico Randomizado"|Recruiting||N/A|90|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f|f|f||||||||2017-10-10 20:53:53.821902|2017-10-10 20:53:53.821902
NCT03207815|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-26|||July 26, 2017|Actual|2017-07-26|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|Uveitis||Efficacy and Safety of Filgotinib in Adults With Active Non-Infectious Uveitis|A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Non-Infectious Uveitis|Recruiting||Phase 2|110|Anticipated|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 20:53:53.967678|2017-10-10 20:53:53.967678
NCT03207802|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Remotely Monitoring Patients With Chronic Conditions in Their Home|Necklace-Shaped Sensor for Non-Invasive Measurement of Vital Signs, Thoracic Impedance, ECG, Skin Temperature and Motion|Enrolling by invitation||N/A|60|Anticipated|toSense, Inc.|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:53:54.069092|2017-10-10 20:53:54.069092
NCT03207789|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||January 1, 2015|Actual|2015-01-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|June 1, 2017|Actual|2017-06-01|5 Years|Observational [Patient Registry]|Tcell-Brazil||T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients|Prospective Collection of Data in Patients With T-cell Lymphomas Distributed in the Five Distinct Macro Regions of Brazil|Enrolling by invitation||N/A|500|Actual|Grupo de Estudos Multicentricos em Onco-Hematologia|||1||f||||f|f|f||||||||2017-10-10 20:53:54.127467|2017-10-10 20:53:54.127467
NCT03207776|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-30|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD|A Cluster Randomized, Stepped-Wedge Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of Chronic Obstructive Pulmonary Disorder (COPD)|Recruiting||N/A|5920|Anticipated|Carolinas Healthcare System||2|||f||||f|f|f||||||||2017-10-10 20:53:54.178899|2017-10-10 20:53:54.178899
NCT03207763|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-05|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Microneedle Patch Study in Healthy Infants/Young Children|A Study to Evaluate the Safety, Reactogenicity, and Acceptability of a Placebo Microneedle Patch in Healthy Infants and Young Children|Recruiting||N/A|50|Anticipated|Emory University||2|||f||||f|f|t|t|f|f|||||2017-10-10 20:53:54.289828|2017-10-10 20:53:54.289828
NCT03207750|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-10|||July 31, 2017|Anticipated|2017-07-31|July 2017|2017-07-01|August 11, 2019|Anticipated|2019-08-11|March 4, 2019|Anticipated|2019-03-04||Interventional|||This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine|Immunogenicity, Reactogenicity and Safety Study of Pediarix®, Hiberix® and Prevenar 13® Co-administered With Two Different Formulations of GSK Biologicals' HRV Vaccine (444563) in Healthy Infants 6-12 Weeks of Age|Not yet recruiting||Phase 3|1280|Anticipated|GlaxoSmithKline||2|||f|||||t|f||||||||2017-10-10 20:53:54.369494|2017-10-10 20:53:54.369494
NCT03207737|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-12|||September 1, 2017|Actual|2017-09-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|MENTOR||Mindfulness, Exercise and Nutrition To Optimize Resilience for Individuals With a Spinal Cord Injury.|A Blended Residential/Telehealth Lifestyle Intervention to Improve Cardiovascular Health and Manage Pain in Adults With Spinal Cord Injury.|Recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 20:53:54.591309|2017-10-10 20:53:54.591309
NCT03207724|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-06|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|OnFX||Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia|A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia|Not yet recruiting||Phase 1|16|Anticipated|Cedars-Sinai Medical Center||1|||f||||t|t|f||||||||2017-10-10 20:53:54.676145|2017-10-10 20:53:54.676145
NCT03207711|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-30|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|Delish||Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger|Optimizing Lifestyle Interventions With Mindfulness-based Strategies in Type 2 Diabetes|Recruiting||N/A|180|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||||2017-10-10 20:53:54.789718|2017-10-10 20:53:54.789718
NCT03207698|ClinicalTrials.gov processed this data on October 10, 2017|2017-07-01|2017-07-01|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||PRF+1% MF for Class II Mandibular Furcation Defects|Evaluation of Adjunctive Effect of 1% Metformin To Platelet Rich Fibrin For Mandibular Class II Furcation Defects: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|75|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||f|f|f||||||||2017-10-10 20:53:54.901839|2017-10-10 20:53:54.901839
NCT03207685|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-30|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System|Characterizing Generalized Seizure Detection And Alerting In The Epilepsy Monitoring Unit With The Empatica Embrace Watch And Smartphone-Based Alert System|Not yet recruiting||N/A|100|Anticipated|Empatica, Inc.||1|||f||||f|f|t|t|f|f|||||2017-10-10 20:53:54.998356|2017-10-10 20:53:54.998356
NCT03207672|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-30|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of E7389 Liposomal Formulation in Subjects With Solid Tumor|An Open-label Phase 1 Study of E7389 Liposomal Formulation in Subjects With Solid Tumor|Not yet recruiting||Phase 1|67|Anticipated|Eisai Inc.||2|||f|||||f|f||||||||2017-10-10 20:53:55.088692|2017-10-10 20:53:55.088692
NCT03207659|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-07-17|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Dusting vs Fragmenting in RIRS: a Multicenter Prospective Randomised Trial|Dusting vs Basketing in RIRS: a Multicenter Prospective Randomised Trial|Not yet recruiting||N/A|300|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t|f|f||||||||2017-10-10 20:53:55.177003|2017-10-10 20:53:55.177003
NCT03207646|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-30|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|smartGUIDE||Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease|Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease (smartGUIDE)|Not yet recruiting||N/A|150|Anticipated|Stanford University||2|||f||||f|f|f|||f|||||2017-10-10 20:53:55.25668|2017-10-10 20:53:55.25668
NCT03207633|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-07-01|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Low Frequency TMS on DLPFC and OFC in OCD Patients|Comparative Study of the Therapeutic Effect of Low Frequency TMS on DLPFC and OFC in OCD Patients|Not yet recruiting||N/A|60|Anticipated|Assiut University||3|||f||||f|f|f||||||||2017-10-10 20:53:55.355075|2017-10-10 20:53:55.355075
NCT03207620|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-03|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Interrelation Between Bronchial Asthma and Smoking|Interrelation Between Bronchial Asthma and Smoking|Not yet recruiting||Phase 3|104|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:53:55.4538|2017-10-10 20:53:55.4538
NCT03207607|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-03|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Mid-morning Gel Snacks on Subjective Appetite, Glycemic and Insulin Responses, and Food Intake|The Effect of Mid-Morning Gel Snacks on Subjective Appetite, Glycemic and Insulin Responses, and Food Intake in Healthy Adults|Completed||N/A|23|Actual|Ryerson University||6|||f|||||f|f|||f|||||2017-10-10 20:53:55.549068|2017-10-10 20:53:55.549068
NCT03207594|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-06-30|||June 2016||2016-06-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Improving Evidence-Based Care for Cancer Patients|Improving Evidence-Based Care for Cancer Patients|Recruiting||N/A|276|Anticipated|Medical University of South Carolina|||3||f||||t||||||||||2017-10-10 20:53:55.647524|2017-10-10 20:53:55.647524
NCT03207581|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-03|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|October 30, 2018|Anticipated|2018-10-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Effect of Coaching on Mid-Career Physician Well-Being, Job Satisfaction, and Fulfillment|RCT: Effect of Coaching on Mid-Career Physician Well-Being, Job Satisfaction, and Fulfillment|Recruiting||N/A|80|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 20:53:55.744166|2017-10-10 20:53:55.744166
NCT03206788|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-06|||April 20, 2018|Anticipated|2018-04-20|September 2017|2017-09-01|August 10, 2020|Anticipated|2020-08-10|August 10, 2019|Anticipated|2019-08-10||Interventional|||Losartan and Inflammation in Cystic Fibrosis|Losartan as Anti-inflammatory Therapy to Augment F508del Cystic Fibrosis Transmembrane (CFTR) Recovery|Not yet recruiting||Phase 2|36|Anticipated|University of Miami||2|||f||||t|t|f|||f|||||2017-10-10 20:54:01.985895|2017-10-10 20:54:01.985895
NCT03207568|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||October 25, 2014|Actual|2014-10-25|June 2017|2017-06-01|April 30, 2016|Actual|2016-04-30|April 14, 2016|Actual|2016-04-14||Interventional|RE-GENERATION||RE-GENERATION: The Safety and Performance of the Relay Pro and Relay NBS Pro Stent-graft Devices in the European Union (EU)|RE-GENERATION: An EU Clinical Study to Evaluate the Safety and Performance of the Relay Pro and Relay Non Bare Stent (NBS) Pro Stent-graft Devices in Patients With Thoracic Aortic Pathologies|Completed||N/A|30|Actual|Bolton Medical||1|||f||||f|f|f||||||||2017-10-10 20:53:55.840778|2017-10-10 20:53:55.840778
NCT03207555|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-07|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|||Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)|Ibrutinib Monotherapy in Early Stage Chronic Lymphocytic Leukemia (CLL) Without IWCLL/NCI-WG 2008 Treatment Indications But With High-Risk Features for Disease Progression|Not yet recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:53:55.922898|2017-10-10 20:53:55.922898
NCT03207542|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-07|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)|An Open-label Phase 2 Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)|Not yet recruiting||Phase 2|72|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 20:53:56.034121|2017-10-10 20:53:56.034121
NCT03207529|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-12|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of BYL719 (Alpelisib) in Combination With Androgen Receptor Inhibitor (Enzalutamide) in Patients With Androgen Receptor (AR)-Positive and PTEN Positive Metastatic Breast Cancer|Phase Ib Study of BYL719 (Alpelisib) in Combination With Androgen Receptor Inhibitor (Enzalutamide) in Patients With Androgen Receptor (AR)-Positive and PTEN Positive Metastatic Breast Cancer|Not yet recruiting||Phase 1|28|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:53:56.145713|2017-10-10 20:53:56.145713
NCT03207516|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-30|||July 22, 2014|Actual|2014-07-22|June 2017|2017-06-01|April 28, 2015|Actual|2015-04-28|April 28, 2015|Actual|2015-04-28||Interventional|Digeribilità||Sourdough Bakery Products and Digestive Function|Impact of Bakery Products With Sourdough or Brewer's Yeast on Digestive Function: a Double Blind Randomised Study in Healthy Subjects|Completed||N/A|17|Actual|Irccs Sdn||2|||f||||f|f|f||||||||2017-10-10 20:53:56.254963|2017-10-10 20:53:56.254963
NCT03207503|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-19|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|Lifespan||Neurobehavioral Mechanisms of Emotion Regulation in Depression Across the Adult Lifespan|Neurobehavioral Mechanisms of Emotion Regulation in Depression Across the Adult Lifespan|Not yet recruiting||N/A|240|Anticipated|Duke University|||2||f||||f|f|f||||||||2017-10-10 20:53:56.336037|2017-10-10 20:53:56.336037
NCT03207490|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-30|||July 2014||2014-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|sERF||Robotics for Rehabilitation of Hand and Fingers After Stroke|sEMG Based-Rehabilitation of Hand and Fingers After Stroke|Recruiting||Early Phase 1|40|Anticipated|IRCCS San Camillo, Venezia, Italy||1|||f||||f||||||||||2017-10-10 20:53:56.427091|2017-10-10 20:53:56.427091
NCT03207477|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2026|Anticipated|2026-09-01|September 2024|Anticipated|2024-09-01||Interventional|PremavionSuivi||Premavision Cohort Follow-up|Visual Maturation in Prematurely Born Infants According to Factors Influencing Its Development. Premavision Follow-up at 18 Months Corrected Age, 4 and 7 Years of Age.|Not yet recruiting||N/A|108|Anticipated|Central Hospital, Nancy, France||2|||f||||f|f|f||||||||2017-10-10 20:53:56.54467|2017-10-10 20:53:56.54467
NCT03207464|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Molecular Imaging of Norepinephrine Transporter (NET) Using [C-11]Methylreboxetine PET in Multiple Sclerosis|Molecular Imaging of Norepinephrine Transporter (NET) Using [C-11]Methylreboxetine PET in Multiple Sclerosis|Not yet recruiting||Phase 1/Phase 2|8|Anticipated|Brigham and Women's Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:53:56.624791|2017-10-10 20:53:56.624791
NCT03207451|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-06-30|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Influence of Vorapaxar on Thrombin Generation and Coagulability||Recruiting||Phase 4|100|Anticipated|Inova Health Care Services||4|||f||||||||||||||2017-10-10 20:53:56.70957|2017-10-10 20:53:56.70957
NCT03207438|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-04|||April 2006|Actual|2006-04-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|July 2007|Actual|2007-07-01||Interventional|||Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression|Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression|Active, not recruiting||Phase 4|1570|Actual|University of Saskatchewan||4|||f||||f|t|f|||t|||||2017-10-10 20:53:56.831512|2017-10-10 20:53:56.831512
NCT03207425|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|August 24, 2017|Anticipated|2017-08-24|August 20, 2017|Anticipated|2017-08-20||Interventional|||A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers|A Phase 1, Open-Label, Parallel Group, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of EDP 305 in Subjects With Varying Degrees of Hepatic Function|Recruiting||Phase 1|30|Anticipated|Enanta Pharmaceuticals||3|||f|||||t|f||||||||2017-10-10 20:53:56.931279|2017-10-10 20:53:56.931279
NCT03207412|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||December 22, 2017|Anticipated|2017-12-22|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|July 1, 2019|Anticipated|2019-07-01||Interventional|||Human Amniotic Epithelial Cells Treatment for Ovarian Insufficiency|Clinical Study of Minimally Invasive Implantation of Human Amniotic Epithelial Cells in the Treatment of Premature Ovarian Insufficiency|Not yet recruiting||N/A|20|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t|f|f||||||||2017-10-10 20:53:57.451497|2017-10-10 20:53:57.451497
NCT03207399|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-05|||September 9, 2017|Anticipated|2017-09-09|July 2017|2017-07-01|September 9, 2019|Anticipated|2019-09-09|September 9, 2019|Anticipated|2019-09-09||Interventional|||Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment|Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment: A Pilot Feasibility and Efficacy Study|Not yet recruiting||Phase 4|10|Anticipated|Duke University||1|||f||||f|t|f|||f|||||2017-10-10 20:53:57.547931|2017-10-10 20:53:57.547931
NCT03207373|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-29|||April 13, 2017|Actual|2017-04-13|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|February 2021|Anticipated|2021-02-01||Interventional|||Stress ECG Test for the Evaluation of the Risk of Sudden Cardiac Death in a Paediatric Cohort With WPW Pattern|Reproducibility and Validity of the Stress ECG Test for the Evaluation of the Risk of Sudden Cardiac Death in a Paediatric Cohort With Preexcitation (WPW Pattern)|Enrolling by invitation||N/A|20|Anticipated|University Children's Hospital, Zurich||1|||f||||f|f|f|||f|||No||2017-10-10 20:53:57.694937|2017-10-10 20:53:57.694937
NCT03207360|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Pain Coping Skills and Meaning-Centered Intervention|Pain Coping Skills Training and Meaning-Centered Intervention for Cancer Pain|Not yet recruiting||N/A|50|Anticipated|Duke University||1|||f||||f|f|f||||||||2017-10-10 20:53:57.78647|2017-10-10 20:53:57.78647
NCT03207347|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-10-04|||January 2018|Anticipated|2018-01-01|October 2017|2017-10-01|January 2024|Anticipated|2024-01-01|January 2021|Anticipated|2021-01-01||Interventional|||A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)|A Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response (DDR) Pathway Deficient Neoplasms (UF-STO-ETI-001)|Not yet recruiting||Phase 2|47|Anticipated|University of Florida||2|||f||||t|t|f|||f|||||2017-10-10 20:53:57.862869|2017-10-10 20:53:57.862869
NCT03207334|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-10-04|||January 2018|Anticipated|2018-01-01|October 2017|2017-10-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-BMT-AML-001)|A Phase II, Open-Label Study Defining Genomic Signatures That Correlate With Midostaurin Response in Relapsed or Refractory Acute Myeloid Leukemia (AML)|Not yet recruiting||Phase 2|20|Anticipated|University of Florida||1|||f||||t|t|f|||f|||||2017-10-10 20:53:57.968079|2017-10-10 20:53:57.968079
NCT03207321|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-05|||January 1, 1987|Actual|1987-01-01|July 2017|2017-07-01|December 31, 2012|Actual|2012-12-31|December 31, 1990|Actual|1990-12-31||Observational|||Early Childhood Nutrition and Adult Outcomes in India|Analysis of the Association Between Early Childhood Nutrition and Adult Outcomes Using Andhra Pradesh Children and Parents Study (APCAPS) Data|Completed||N/A|1360|Actual|University of Chicago|||2||f||||f|f|f||||||||2017-10-10 20:53:58.07544|2017-10-10 20:53:58.07544
NCT03207308|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-29|||February 3, 2017|Actual|2017-02-03|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Vitamin A Total Body Stores of Senegalese Children in Relation to Their Infectious Status|Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection in Senegal|Recruiting||N/A|55|Anticipated|Cheikh Anta Diop University, Senegal||1|||f||||f|f|f|||f|||||2017-10-10 20:53:58.158033|2017-10-10 20:53:58.158033
NCT03207295|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-05|||July 5, 2017|Actual|2017-07-05|June 2017|2017-06-01|December 1, 2020|Anticipated|2020-12-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children|A Randomized, Single-Blind, Placebo-Controlled, Single-Center Clinical Study of the Efficacy and Safety of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children|Recruiting||N/A|108|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t|f|f|||f|||||2017-10-10 20:53:58.254803|2017-10-10 20:53:58.254803
NCT03207269|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-01|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|July 31, 2019|Anticipated|2019-07-31|July 1, 2019|Anticipated|2019-07-01||Interventional|||Impact of Bedtime Snacks on Glucose Control in Type 2 Diabetes|A High-protein Bedtime Snack to Control Morning Blood Glucose|Recruiting||N/A|15|Anticipated|University of British Columbia||3|||f||||f|f|f||||||||2017-10-10 20:53:58.419515|2017-10-10 20:53:58.419515
NCT03207256|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|December 2024|Anticipated|2024-12-01|November 2024|Anticipated|2024-11-01||Interventional|||Compassionate Use Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials|An Open Label Compassionate Use Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials With B-cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Enrolling by invitation||Phase 2|50|Anticipated|TG Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:53:58.491772|2017-10-10 20:53:58.491772
NCT03207243|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-06|||September 8, 2017|Anticipated|2017-09-08|September 2017|2017-09-01|November 8, 2018|Anticipated|2018-11-08|August 16, 2018|Anticipated|2018-08-16||Interventional|||Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma|A Randomized, Double-blind, Parallel Group, Multicenter, Stratified Study Evaluating the Efficacy and Safety of Repeat Doses of GSK3772847 Compared With Placebo in Participants With Moderately Severe Asthma|Not yet recruiting||Phase 2|148|Anticipated|GlaxoSmithKline||2|||f||||f|t|f||||||||2017-10-10 20:53:58.563083|2017-10-10 20:53:58.563083
NCT03207230|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-08|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MESA-DCM||Multicenter Exploratory Study of Accelerometry in Dilated Cardiomyopathy|A Multicenter Exploratory Study of Accelerometry Measurements in Dilated Cardiomyopathy Patients|Not yet recruiting||N/A|50|Anticipated|Stanford University||1|||f||||f|f|f|||f|||||2017-10-10 20:53:58.680517|2017-10-10 20:53:58.680517
NCT03207217|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Virtual Training Role-Plays to Improve Patient Suicide Outcomes in Primary Care Settings|Virtual Training Role-Plays to Improve Patient Suicide Outcomes in Primary Care Settings|Not yet recruiting||N/A|91|Anticipated|SIMmersion, LLC||3|||f||||f|f|f||||||||2017-10-10 20:53:58.759808|2017-10-10 20:53:58.759808
NCT03207204|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-30|||July 2, 2017|Anticipated|2017-07-02|June 2017|2017-06-01|July 2, 2020|Anticipated|2020-07-02|December 2, 2017|Anticipated|2017-12-02||Interventional|||In-office Bleaching Using a Violet Light|Long-term Clinical Evaluation of In-office Dental Bleaching Using a Violet Light (405-410 nm)|Not yet recruiting||N/A|200|Anticipated|University of Sao Paulo||8|||f||||t|f|f||||||||2017-10-10 20:53:58.825438|2017-10-10 20:53:58.825438
NCT03207191|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-06-30|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|PHIBI||Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation|A Phase I Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With the Anti-CD33 Antibody BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 1|52|Anticipated|Philogen S.p.A.||1|||f||||t||||||||||2017-10-10 20:53:59.092992|2017-10-10 20:53:59.092992
NCT03207178|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-29|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma|Sequential Infusion of Anti-CD19 and Anti-CD20 Chimeric Antigen Receptor(CAR) T Cells Against Relapsed and Refractory B-cell Lymphoma|Recruiting||Phase 1/Phase 2|20|Anticipated|Shanghai Longyao Biotechnology Inc., Ltd.||1|||f||||t|f|f||||||No||2017-10-10 20:53:59.226851|2017-10-10 20:53:59.226851
NCT03207165|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-08|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Milrinone Versus Dobutamine in Critically Ill Patients|Comparison of Milrinone Versus Dobutamine in a Heterogeneous Population of Critically Ill Patients|Recruiting||Phase 4|192|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t|f|f|||f|||||2017-10-10 20:53:59.352579|2017-10-10 20:53:59.352579
NCT03207152|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-10-02|||September 11, 2017|Actual|2017-09-11|June 2017|2017-06-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|PRESAGE||Biomarkers Predicting Infectivity in an Experimental Human Influenza Model|Biomarkers Predicting Infectivity in an Experimental Human Influenza Model|Enrolling by invitation||Phase 1|50|Anticipated|Duke University||1|||f||||f|t|f|||t|||||2017-10-10 20:53:59.519652|2017-10-10 20:53:59.519652
NCT03207139|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer|Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer|Recruiting||N/A|73|Anticipated|Chang Gung Memorial Hospital||1|||f||||t|f|f||||||||2017-10-10 20:53:59.621666|2017-10-10 20:53:59.621666
NCT03207126|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|January 20, 2019|Anticipated|2019-01-20|December 20, 2018|Anticipated|2018-12-20||Interventional|||Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?|Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy in the Detection of Endometrial Cancer?|Not yet recruiting||N/A|50|Anticipated|Imperial College London||1|||f||||f|f|f||||||||2017-10-10 20:53:59.713869|2017-10-10 20:53:59.713869
NCT03207100|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-22|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|||Effect of an Analgo-sedation Protocol for Patients With Spontaneous Intracerebral Hemorrhage|Effect of an Analgo-sedation Protocol for Patients With Spontaneous Intracerebral Hemorrhage: Study Protocol for a Randomized Controlled Clinical Trial|Not yet recruiting||N/A|346|Anticipated|The Third Affiliated Hospital of Southern Medical University||3|||f|||||f|f||||||||2017-10-10 20:53:59.921602|2017-10-10 20:53:59.921602
NCT03207087|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-02|||June 23, 2017|Actual|2017-06-23|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|WEB-IT China||The WEB®-IT China Clinical Study|WEB® Intrasaccular Therapy Study China Clinical Trial Protocol|Recruiting||N/A|150|Anticipated|Sequent Medical, Inc||1|||f|||||f|t|t||t|||||2017-10-10 20:54:00.055451|2017-10-10 20:54:00.055451
NCT03207074|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||June 30, 2017|Anticipated|2017-06-30|May 2017|2017-05-01|October 20, 2019|Anticipated|2019-10-20|June 20, 2019|Anticipated|2019-06-20||Interventional|||Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?|Pilot Study: Can the iKnife (Rapid Evaporative Ionisation Mass Spectrometry) Distinguish Between Normal and Malignant Endometrial Tissue?|Not yet recruiting||N/A|50|Anticipated|Imperial College London||1|||f||||f|f|f||||||||2017-10-10 20:54:00.162539|2017-10-10 20:54:00.162539
NCT03207061|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|January 20, 2019|Anticipated|2019-01-20|December 20, 2018|Anticipated|2018-12-20||Interventional|||Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?|Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?|Not yet recruiting||N/A|500|Anticipated|Imperial College London||1|||f||||f|f|f||||||||2017-10-10 20:54:00.263918|2017-10-10 20:54:00.263918
NCT03207048|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-10|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients|Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Cognitive Function and Prevent Relapses in Bipolar Patients|Recruiting||N/A|74|Anticipated|Guangzhou Psychiatric Hospital||2|||f||||t|f|f||||||||2017-10-10 20:54:00.35619|2017-10-10 20:54:00.35619
NCT03207035|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-06-30|||October 15, 2014|Actual|2014-10-15|June 2017|2017-06-01|March 14, 2016|Actual|2016-03-14|March 14, 2016|Actual|2016-03-14||Interventional|||Effect of Local Anaesthetic Dilution on the Characteristics of Ultrasound Guided Axillary Brachial Plexus Block|Effect of Local Anaesthetic Dilution on the Characteristics of Ultrasound Guided Axillary Brachial Plexus Block|Completed||N/A|20|Actual|Cork University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:54:00.466824|2017-10-10 20:54:00.466824
NCT03207022|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-06-30|||June 11, 2014|Actual|2014-06-11|June 2017|2017-06-01|July 14, 2016|Actual|2016-07-14|July 14, 2016|Actual|2016-07-14||Interventional|||Comparison Between Epinephrine and Clonidine as Adjuvants to Lidocaine in Axillary Brachial Plexus Block.|Comparison Between Epinephrine and Clonidine as Adjuvants to Lidocaine in Ultrasound Guided Axillary Brachial Plexus Block.|Completed||N/A|24|Actual|Cork University Hospital||2|||f||||f|f|f||||||||2017-10-10 20:54:00.551226|2017-10-10 20:54:00.551226
NCT03207009|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-03|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia, Who Have a β0/β0 Genotype|A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects With Transfusion-dependent β-Thalassemia, Who Have a β0/β0 Genotype, by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral βA-T87Q-Globin Vector in Subjects ≥12 and ≤50 Years of Age|Recruiting||Phase 3|15|Anticipated|bluebird bio||1|||f||||t|t|f||||||||2017-10-10 20:54:00.630509|2017-10-10 20:54:00.630509
NCT03206957|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-30|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|DOPANUR||Correlation Between Optic Nerve Vessel Anomalies, Serum Angiogenic Factors and Renal Anomalies in Down Syndrome Children|Interventional Controlled Cross-sectional Study Assessing the Correlation Between Optic Nerve Vessels Anomalies, Serum Angiogenic Factors and Renal Anomalies in Children With Down Syndrome.|Not yet recruiting||N/A|200|Anticipated|Queen Fabiola Children's University Hospital||4|||f||||f|f|f||||||||2017-10-10 20:54:00.763072|2017-10-10 20:54:00.763072
NCT03206944|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-29|||July 1, 2015|Actual|2015-07-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|January 1, 2017|Actual|2017-01-01||Interventional|||Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects|Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects at High Estimated Cardiovascular Risk|Completed||Phase 4|82|Actual|Poznan University of Medical Sciences||2|||f||||f|f|f|||f|||No||2017-10-10 20:54:00.893166|2017-10-10 20:54:00.893166
NCT03206931|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-10||||||July 2017|2017-07-01||||||||Expanded Access|||Expanded Access to Provide LOXO-195 for the Treatment of Cancers With a NTRK Gene Fusion|Expanded Access to Provide LOXO-195 for the Treatment of Cancers With a NTRK Gene Fusion|Available||N/A|||Loxo Oncology, Inc.||||||t|||||||||||||2017-10-10 20:54:00.991199|2017-10-10 20:54:00.991199
NCT03206918|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of BGB-3111 in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate Safety and Efficacy of BGB-3111, a Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|Recruiting||Phase 2|80|Anticipated|BeiGene||1|||||||t|t|f||||||||2017-10-10 20:54:01.05068|2017-10-10 20:54:01.05068
NCT03206905|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Safety, Tolerability, and Sustained Weight Loss of Endoscopic Sleeve Gastroplasty With Diet Modification and Exercise|Safety, Tolerability and Sustained Weight Loss of Immediate Endoscopic Sleeve Gastroplasty (ESG) With Diet Modification and Exercise vs. Early Diet Modification and Exercise and Delayed ESG for the Treatment of Obesity|Recruiting||N/A|34|Anticipated|Weill Medical College of Cornell University||2|||f||||t|f|f||||||||2017-10-10 20:54:01.18704|2017-10-10 20:54:01.18704
NCT03206892|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-11|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||LESS Surgery Versus Conventional Multiport Laparoscopy in Ovarian Drilling|Laparoendoscopic Single-site Surgery Versus Conventional Multi-port Laparoscopy in Ovarian Drilling: A Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Ain Shams Maternity Hospital||2|||f|||||f|f||||||||2017-10-10 20:54:01.282534|2017-10-10 20:54:01.282534
NCT03206879|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||Fecal ESBL Resurgence During Antibiotic Treatment|Fecal ESBL Resurgence During Antibiotic Treatment|Enrolling by invitation||N/A|150|Anticipated|University Hospital, Akershus|||1||f||||f|f|f||||Samples With DNA|"     Bacterial fecal isolates.   "|||2017-10-10 20:54:01.381115|2017-10-10 20:54:01.381115
NCT03206866|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||December 30, 2016|Actual|2016-12-30|June 2017|2017-06-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30|1 Year|Observational [Patient Registry]|||Role of Serum Regucalcin in Diagnosis of Hepatocellular Carcinoma|Role of Serum Regucalcin in Diagnosis of Hepatocellular Carcinoma|Recruiting||N/A|96|Anticipated|Mansoura University|||3||f||||t|f|f||||||No||2017-10-10 20:54:01.442933|2017-10-10 20:54:01.442933
NCT03206853|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-29|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|CIA-HOTs||Surgical Management of Complex Intracranial Aneurysms With Hybrid Operating Techniques|Clinical Trail of Hybrid Operating Technique in Management of Complex Intracranial Aneurysms With Coexistence of Multiple Risk Factors|Recruiting||N/A|258|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t|f|f||||||||2017-10-10 20:54:01.51981|2017-10-10 20:54:01.51981
NCT03206827|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-08|||November 29, 2016|Actual|2016-11-29|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2017|Actual|2017-06-30||Interventional|ScenoProt||Effect of Plant and Animal Proteins on Biomarkers of Colorectal Cancer and Type 2 Diabetes in Healthy Adults (ScenoProt)|Effects of Dietary Plant and Animal Proteins on Biomarkers of Colorectal Cancer and Type 2 Diabetes in Healthy Adults|Active, not recruiting||N/A|147|Actual|Helsinki University||3|||f||||f|f|f||||||||2017-10-10 20:54:01.712706|2017-10-10 20:54:01.712706
NCT03206814|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|CHARGE-APP||Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System|Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System|Not yet recruiting||N/A|480|Anticipated|Istituto Auxologico Italiano||2|||f||||f|f|f||||||||2017-10-10 20:54:01.819715|2017-10-10 20:54:01.819715
NCT03206801|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Urine CXCL10 Monitoring Trial in Kidney Transplant|A Randomized Controlled Trial of Urine CXCL10 Chemokine Monitoring Post-renal Transplant|Not yet recruiting||Phase 2/Phase 3|420|Anticipated|University of Manitoba||2|||f||||t|f|f||||||||2017-10-10 20:54:01.89902|2017-10-10 20:54:01.89902
NCT03206775|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-22|||June 6, 2017|Actual|2017-06-06|August 2017|2017-08-01|September 15, 2018|Anticipated|2018-09-15|September 15, 2017|Anticipated|2017-09-15||Observational|||D2D Normative Data for Remote Assessments|Collection of Normative Data for iPad-Based Cognitive Assessment Tools: Phase 1|Active, not recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||||||2017-10-10 20:54:02.083522|2017-10-10 20:54:02.083522
NCT03206762|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||JET-PCB Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon|JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon in Treating Complex Denovo Femoropopliteal Arterial Disease|Not yet recruiting||N/A|250|Anticipated|Midwest Cardiovascular Research Foundation||2|||f||||t|f|t|f|f||||||2017-10-10 20:54:02.191455|2017-10-10 20:54:02.191455
NCT03206749|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-15|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|October 12, 2017|Anticipated|2017-10-12|October 5, 2017|Anticipated|2017-10-05||Interventional|||A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy|A Phase 2 Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-design Study of the Efficacy and Safety of VX-150 for Acute Pain Following Bunionectomy|Recruiting||Phase 2|240|Anticipated|Vertex Pharmaceuticals Incorporated||3|||||||t|t|f||||||||2017-10-10 20:54:02.260534|2017-10-10 20:54:02.260534
NCT03206736|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-21|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Loop Duodenal Switch: Outcomes at One Year|The Effect of Loop Duodenal Switch Surgery in Morbidly Obese Patients on Weight Los at One Year.|Not yet recruiting||N/A|63|Anticipated|University of Nebraska||1|||f||||f|f|f||||||||2017-10-10 20:54:02.346498|2017-10-10 20:54:02.346498
NCT03206723|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-22|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Bandage Contact Lenses for Corneal Abrasions|Bandage Contact Lenses to Decrease Pain and Improve Healing in Emergency Department Subjects Presenting With Corneal Abrasions|Recruiting||Phase 2|60|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||t|t|t|f|f|f|||||2017-10-10 20:54:02.41426|2017-10-10 20:54:02.41426
NCT03206710|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-03|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2023|Anticipated|2023-12-01||Observational|VCSIP-ECHO||Vitamin C Supplementation to Pregnant Smokers: Follow-up of 2 Randomized Trials Plus Changes in DNA Methylation|Maternal Vitamin C Supplementation to Decrease Effects of Smoking During Pregnancy on Infant Lung Function and Health: Follow-up of 2 Randomized Trials and Association With Changes in DNA Methylation|Recruiting||N/A|420|Anticipated|Oregon Health and Science University|||3||f||||t|f|f||||Samples With DNA|"     buccal swabs, hair, blood, and urine   "|||2017-10-10 20:54:02.508674|2017-10-10 20:54:02.508674
NCT03206697|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-07|||June 30, 2017|Actual|2017-06-30|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Observational|||mtDNA and Embryo Metabolism|Definition: Evaluation of Mitichondrial Values and it Relationship With Embryo Metabolism and Mitochondrial Homeostasis.|Recruiting||N/A|171|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA|||1||f|||||f|f||||||||2017-10-10 20:54:02.592375|2017-10-10 20:54:02.592375
NCT03206684|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-25|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer|A Prospective, Open, Randomized, Controlled Clinical Study to Evaluate the Efficacy and Safety of PEG-rhG-CSF in Reducing Neutropenia in Patients With Cervical Cancer|Not yet recruiting||Phase 4|20|Anticipated|Fourth Military Medical University||2|||f|||||f|f||||||||2017-10-10 20:54:02.656209|2017-10-10 20:54:02.656209
NCT03206671|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-10-05|||August 3, 2017|Actual|2017-08-03|October 2017|2017-10-01|August 2024|Anticipated|2024-08-01|August 2024|Anticipated|2024-08-01||Interventional|B-NHL 2013||Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents|B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents|Recruiting||Phase 3|650|Anticipated|University Hospital Muenster||5|||f||||t|f|f||||||||2017-10-10 20:54:02.7331|2017-10-10 20:54:02.7331
NCT03206658|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-03|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Spironolactone on Acute Kidney Injury in Critically Ill Patients|Usefulness of Spironolactone for the Prevention of Acute Kidney Injury in Critically Ill Patients With Invasive Mechanical Ventilation|Not yet recruiting||Phase 3|90|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t|f|f||||||||2017-10-10 20:54:04.715334|2017-10-10 20:54:04.715334
NCT03206645|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-25|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||PTC-596 in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy|Phase IB Study of Weekly Paclitaxel + Carboplatin With the BMI-1 Inhibitor PTC596 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy|Recruiting||Phase 1|27|Anticipated|University of Oklahoma||1|||f||||t|t|f||||||||2017-10-10 20:54:04.807936|2017-10-10 20:54:04.807936
NCT03206619|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-07-02|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme|Study on Patient Acceptance and Engagement of Timely Tailored Motivational Messages Sent by a Health Recommender System and Delivered Via a Mobile App for Smoking Cessation|Recruiting||N/A|120|Anticipated|University of Seville|||1||f||||t|f|f||||||||2017-10-10 20:54:04.965893|2017-10-10 20:54:04.965893
NCT03206606|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-17|||October 1, 2016|Actual|2016-10-01|July 2017|2017-07-01|December 20, 2017|Anticipated|2017-12-20|July 7, 2017|Actual|2017-07-07||Observational|||Evaluation of a Mobile Application to Facilitate the Interpretation of Spirometry by Family Physicians and Residents|Evaluation of a Mobile Application to Facilitate the Interpretation of the Spirometry Test by Family Physicians and Family Medicine Residents: Impact on Prescription and Interpretation of This Test|Active, not recruiting||N/A|104|Actual|Laval University|||2||f||||f|f|f||||||||2017-10-10 20:54:05.064547|2017-10-10 20:54:05.064547
NCT03206593|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31|12 Months|Observational [Patient Registry]|||Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure|Fasting Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure|Recruiting||N/A|2000|Anticipated|Guangdong General Hospital|||1||f|||||f|f||||||||2017-10-10 20:54:05.155846|2017-10-10 20:54:05.155846
NCT03206580|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-29|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 31, 2019|Anticipated|2019-01-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Functional Mobility in the Elderly: Influence of Morphological, Neuromuscular and Training Parameters|Functional Mobility in the Elderly: Influence of Morphological, Neuromuscular and Training|Not yet recruiting||N/A|36|Anticipated|Federal University of Rio Grande do Sul||2|||f||||t|f|f||||||||2017-10-10 20:54:05.219575|2017-10-10 20:54:05.219575
NCT03206567|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||May 4, 2017|Actual|2017-05-04|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair|A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability and Safety of a Nutraceutical Supplement With Standardized Botanicals to Promote Hair Growth in Women With Self-Perceived Thinning Hair|Recruiting||N/A|40|Anticipated|Ablon Skin Institute Research Center||2|||f||||f|f|f|||t|||||2017-10-10 20:54:05.406961|2017-10-10 20:54:05.406961
NCT03206554|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-30|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Local Infiltration Analgesia in Total Knee Arthroplasty|Local Infiltration Analgesia in Total Knee Arthroplasty: A Randomized, Prospective, Placebo Controlled, Double Blinded Study.|Completed||Phase 2|40|Actual|Asklepieion Voulas General Hospital||2|||f||||f|f|f||||||||2017-10-10 20:54:05.504139|2017-10-10 20:54:05.504139
NCT03206541|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-29|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|4 Weeks|Observational [Patient Registry]|||Neurologic Manifestations of the Arbovirus Infection in Colombia|Neurovirus Emerging in the Americas Study (NEAS): Neurologic Manifestations of the Arbovirus Dengue, Chikungunya and Zika Infections in Colombia|Recruiting||N/A|150|Anticipated|Johns Hopkins University|||2||f||||f|f|f||||Samples With DNA|"     The study will retain blood (serum and plasma), urine, spinal fluid and saliva for cases and     controls according to the protocol. The samples will remain in the core laboratory at UV and     some of them will be shared with the JHU team.   "|||2017-10-10 20:54:05.585126|2017-10-10 20:54:05.585126
NCT03206528|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-29|||April 25, 2017|Actual|2017-04-25|June 2017|2017-06-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Observational|||Clinical Evaluation of the Vital Signs Monitoring System (VSMS)|Clinical Evaluation of the Vital Signs Monitoring System (VSMS)|Recruiting||N/A|100|Anticipated|G Medical Innovations Ltd.|||2||f||||f|f|t|t|f|f|||||2017-10-10 20:54:05.708185|2017-10-10 20:54:05.708185
NCT03206515|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-06-29|||January 2016||2016-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones|The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones: A Randomized Controlled Trial|Recruiting||N/A|86|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||||||||||||2017-10-10 20:54:05.794142|2017-10-10 20:54:05.794142
NCT03206502|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-06-29|||May 2016||2016-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:54:05.875825|2017-10-10 20:54:05.875825
NCT03206489|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-21|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Nasal High Frequency Oscillation for Respiratory Distress Syndrome in Twins Infants|Nasal High Frequency Oscillation for Respiratory Distress Syndrome in Preterm Twins Infants|Recruiting||N/A|200|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t|f|f||||||||2017-10-10 20:54:05.916277|2017-10-10 20:54:05.916277
NCT03206476|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-30|||February 1, 2016|Actual|2016-02-01|June 2017|2017-06-01|September 30, 2016|Actual|2016-09-30|June 30, 2016|Actual|2016-06-30||Interventional|||Modifications in the Eating Habits of Adolescents of Secondary Education as a Result of a Nutritional Intervention|Modifications in the Eating Habits of Secondary Education Adolescents, as a Result of a Nutritional Intervention Based on the Social Cognitive Theory and the Transtheoric Model.|Completed||N/A|107|Actual|Centro Universitario de Ciencias de la Salud, Mexico||2|||f||||f|f|f||||||||2017-10-10 20:54:06.008609|2017-10-10 20:54:06.008609
NCT03206463|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-28|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|THC-BD||Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder|Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder|Not yet recruiting||Phase 1|40|Anticipated|Yale University||3|||f||||t|t|f||||||||2017-10-10 20:54:06.106119|2017-10-10 20:54:06.106119
NCT03206424|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-29|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||Patterns of Complementary Feeding in Infancy|Pattern of Complementary Feeding and Its Impact on Growth Parameters of Infants Under the Age of 2 Years in Assiut Governorate|Not yet recruiting||N/A|1000|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:54:06.382524|2017-10-10 20:54:06.382524
NCT03206411|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|||Assessment of Severity and Outcome of Addicted Cases.|Assessment of Severity and Outcome of Addicted Cases Admitted to Neurology and Psychiatry Hospital in Assiut University.|Recruiting||N/A|80|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:54:06.447093|2017-10-10 20:54:06.447093
NCT03206398|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||May 1, 2015|Actual|2015-05-01|June 2017|2017-06-01|February 1, 2016|Actual|2016-02-01|December 1, 2015|Actual|2015-12-01||Interventional|||Influence of an Anti-gravity Treadmill on Functional Outcome in Non-operatively Treated Pelvic Fractures - a Pilot Study|Influence of an Anti-gravity Treadmill on Functional Outcome in Non-operatively Treated Pelvic Fractures - a Pilot Study|Completed||N/A|9|Actual|University of Leipzig||1|||f||||f|f|f||||||||2017-10-10 20:54:06.513216|2017-10-10 20:54:06.513216
NCT03206385|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31|3 Years|Observational [Patient Registry]|Boost_Pelvis||IMRT Followed by CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume|Intensity Modulated Radiation Treatments Followed by A Stereotactic CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume|Recruiting||N/A|120|Anticipated|Centre Francois Baclesse, Luxembourg|||1||f||||f|f|f||||||||2017-10-10 20:54:06.579557|2017-10-10 20:54:06.579557
NCT03206359|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-07-03|||January 25, 2012|Actual|2012-01-25|June 2017|2017-06-01|April 3, 2015|Actual|2015-04-03|April 3, 2015|Actual|2015-04-03||Observational|GADD34-IFN||GADD34 and Type I IFN Response Genes in SLE|Evaluation of GADD34 and Type I IFN Response Gene Expression in Patients Suffering From Systemic Lupus Erythematosus|Completed||N/A|90|Actual|University Hospital, Grenoble|||2||f||||f|f|f||||||||2017-10-10 20:54:06.729565|2017-10-10 20:54:06.729565
NCT03206346|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-30|||January 2012|Actual|2012-01-01|June 2017|2017-06-01|August 2013|Actual|2013-08-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.|Randomised Double-blind Placebo Controlled Multicenter Clinical Trial of Efficacy and Safety of Ingavirin® Capsules 30mg, in Daily Dose 60mg for the Treatment of Influenza and Other Acute Respiratory Viral Infections at Patients 13-18 y.o.|Completed||Phase 3|161|Actual|Valenta Pharm JSC||2|||f||||f|f|f||||||||2017-10-10 20:54:06.794105|2017-10-10 20:54:06.794105
NCT03206333|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-30|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01||Observational|||Automated Quantification of Coronary Artery Calcifications on Radiotherapy Planning CTs for Cardiovascular Risk Prediction in Breast Cancer Patients: the BRAGATSTON Study|Automated Quantification of Coronary Artery Calcifications on Radiotherapy Planning CTs for Cardiovascular Risk Prediction in Breast Cancer Patients: the BRAGATSTON Study|Active, not recruiting||N/A|16000|Anticipated|UMC Utrecht|||1||f||||f|f|f||||||||2017-10-10 20:54:07.003769|2017-10-10 20:54:07.003769
NCT03206320|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-26|||December 5, 2016|Actual|2016-12-05|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|July 31, 2017|Actual|2017-07-31||Interventional|||Topical Lidocaine for Needle Insertion and Injection Pain|Topical Lidocaine 2% Gel for Analgesia and Patient Comfort During Interscalene Brachial Plexus and Axillary Blocks: A Noninferiority Randomized Trial|Active, not recruiting||N/A|30|Actual|New York School of Regional Anesthesia||3|||f||||f|f|f||||||||2017-10-10 20:54:07.080855|2017-10-10 20:54:07.080855
NCT03206307|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-30|||October 1, 2016|Actual|2016-10-01|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|July 31, 2018|Anticipated|2018-07-31||Observational|SPIRO||Spiroergometric and Psychological Measurements to Predict Return to Work After 18 and 36 Months After Medical Rehab|Spiroergometrische Und Psychologische Messungen Zur Vorhersage Der Erwerbsfähigkeit Und Rückkehr Zur Arbeit Nach 18 Und 36 Monaten Nach Der Medizinischen Rehabilitation|Active, not recruiting||N/A|250|Anticipated|Jacobs University Bremen gGmbH|||2||f||||f|f|f||||||||2017-10-10 20:54:07.165836|2017-10-10 20:54:07.165836
NCT03206294|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-24|||March 8, 2017|Actual|2017-03-08|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|April 28, 2017|Actual|2017-04-28||Interventional|||Impact of Pharmacist in Cardiology Service on Diabetic Patient's Care Management|Impact of Pharmacist in Cardiology Service on Diabetic Patient's Care Management|Active, not recruiting||N/A|44|Actual|Groupe Hospitalier Paris Saint Joseph||1|||f||||f|f|f||||||||2017-10-10 20:54:07.241112|2017-10-10 20:54:07.241112
NCT03206281|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-30|||July 5, 2017|Anticipated|2017-07-05|June 2017|2017-06-01|September 29, 2018|Anticipated|2018-09-29|August 29, 2018|Anticipated|2018-08-29|1 Year|Observational [Patient Registry]|TSFW||Tall Stature Women Fetal Weight Estimation|Tall Stature Women Fetal Weight Estimation,Clinical Versus Sonographic Estimation|Not yet recruiting||N/A|200|Anticipated|Meir Medical Center|||2||f||||t|f|f||||||||2017-10-10 20:54:07.321905|2017-10-10 20:54:07.321905
NCT03206268|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-06-30|||May 1, 2015|Actual|2015-05-01|April 2017|2017-04-01|October 31, 2015|Actual|2015-10-31|October 31, 2015|Actual|2015-10-31||Observational|Real||RNFL Thickness Measurements Obtained Using SD-OCT and SLP Using GDx Variable Corneal Compensation|Correlation in Retinal Nerve Fiber Layer Thickness in Uveitis and Healthy Eyes Using Scanning Laser Polarimetry and Optical Coherence Tomography|Completed||N/A|54|Actual|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 20:54:07.395634|2017-10-10 20:54:07.395634
NCT03206255|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-06-30|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls|Immuno-persistence Study of A Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Female Subjects Aged 9 to 17 Years|Not yet recruiting||N/A|979|Anticipated|Xiamen University|||3||f||||f||||||||||2017-10-10 20:54:07.48011|2017-10-10 20:54:07.48011
NCT03206229|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-06-30|||February 13, 2017|Actual|2017-02-13|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|July 20, 2017|Anticipated|2017-07-20||Interventional|TPI-120||Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects|A Randomized, Double Blind, Single-Dose, Two-Period Crossover Comparative Pharmacology Study Comparing TPI-120 and Neulasta® Administered Through Subcutaneous Route in Healthy Adult Subjects|Recruiting||Phase 1|122|Anticipated|Adello Biologics, LLC||2|||f||||f|t|f|||f|||||2017-10-10 20:54:07.712815|2017-10-10 20:54:07.712815
NCT03206216|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-08|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|August 4, 2019|Anticipated|2019-08-04|August 4, 2019|Anticipated|2019-08-04||Interventional|||Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN|Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN|Recruiting||N/A|50|Anticipated|Stanford University||1|||f||||t|f|t|f|f|f|||||2017-10-10 20:54:07.8015|2017-10-10 20:54:07.8015
NCT03206203|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-29|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer|A Phase II Trial of Atezolizumab (Anti-PDL1) With Carboplatin in Patients With Metastatic Triple Negative Breast Cancer|Recruiting||Phase 2|185|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t|t|f||||||||2017-10-10 20:54:07.901285|2017-10-10 20:54:07.901285
NCT03206190|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-02|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|May 2029|Anticipated|2029-05-01|May 2027|Anticipated|2027-05-01||Interventional|||The Pre-SPG4 Study|Studying the Presymptomatic and Early Phase of SPG4|Recruiting||N/A|200|Anticipated|University Hospital Tuebingen||3|||f||||f|f|f||||||||2017-10-10 20:54:08.041483|2017-10-10 20:54:08.041483
NCT03206177|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-25|||August 20, 2017|Actual|2017-08-20|September 2017|2017-09-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary|Feasibility IB Trial of Paclitaxel/Carboplatin + Galunisertib (a Small Molecule Inhibitor of the Kinase Domain of Type 1 TGF-B Receptor) in Patients With Newly Diagnosed, Persistent or Recurrent Carcinosarcoma of the Uterus or Ovary|Recruiting||Phase 1|20|Anticipated|University of Oklahoma||1|||f||||t|t|f||||||||2017-10-10 20:54:08.186023|2017-10-10 20:54:08.186023
NCT03206164|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-30|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|HM@24/7||HealthMatters@24/7 eLearning for People Supporting Adults With Intellectual and Developmental Disabilities|HealthMatters@24/7 Asynchronous Health Promotion eLearning for People Supporting Adults With Intellectual and Developmental Disabilities|Active, not recruiting||N/A|60|Anticipated|University of Illinois at Chicago||2|||f||||f|f|f||||||||2017-10-10 20:54:08.279876|2017-10-10 20:54:08.279876
NCT03206138|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-29|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.|A Randomized, Open-label Study to Evaluate the Safety and Efficacy of GX-188E, a DNA Therapeutic Vaccine Administered Intramuscularly by Electroporation, With GX-I7 Intravaginal Application or Imiquimod Topical Application in HPV16 and/or 18 Positive Patients With CIN3.|Recruiting||N/A|50|Anticipated|Seoul St. Mary's Hospital||2|||f||||t|f|f||||||||2017-10-10 20:54:08.465362|2017-10-10 20:54:08.465362
NCT03206112|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-23|||September 20, 2017|Actual|2017-09-20|August 30, 2017|2017-08-30|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Loss of Depotentiation in Focal Dystonia|Loss of Depotentiation in Focal Dystonia|Recruiting||Early Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f|||||f|f||||||||2017-10-10 20:54:08.61838|2017-10-10 20:54:08.61838
NCT03206099|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-08-18|||July 31, 2017|Actual|2017-07-31|July 12, 2017|2017-07-12|December 31, 2032|Anticipated|2032-12-31|December 31, 2030|Anticipated|2030-12-31||Observational|||NIAID Centralized Sequencing Protocol|Centralized Sequencing Protocol|Recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f|||||f|f||||||||2017-10-10 20:54:08.703101|2017-10-10 20:54:08.703101
NCT03206034|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-29|||March 1, 2013|Actual|2013-03-01|June 2017|2017-06-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|SME||Stylistic Memory Enhancement|Stylistic Memory Enhancement|Completed||N/A|20|Actual|Kessler Foundation||2|||f||||f|f|f||||||||2017-10-10 20:54:09.203506|2017-10-10 20:54:09.203506
NCT03206021|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-18|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Treatment of Children With Recurrent Refractory Brain/Solid Tumors and Recurrent Ependymoma|Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain and Solid Tumors|Recruiting||Phase 1|54|Anticipated|The Hospital for Sick Children||3|||f||||t|f|f||||||||2017-10-10 20:54:09.261283|2017-10-10 20:54:09.261283
NCT03206008|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-30|2017-09-26|||November 18, 2016|Actual|2016-11-18|September 2017|2017-09-01|April 4, 2019|Anticipated|2019-04-04|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Effect of Intraoperative Magnesium Sulfate Infusion on the Postoperative Recovery|The Effect of Intraoperative Magnesium Sulfate Infusion on the Postoperative Recovery After Outpatient Surgery|Recruiting||N/A|338|Anticipated|Seoul National University Bundang Hospital||2|||f|||||f|f||||||||2017-10-10 20:54:09.451431|2017-10-10 20:54:09.451431
NCT03205995|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-26|||February 23, 2017|Actual|2017-02-23|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|aHUS||Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome|A Phase 3 Study to Evaluate the Safety and Efficacy of OMS721 for the Treatment of Atypical Hemolytic Uremic Syndrome (aHUS) in Adults and Adolescents|Recruiting||Phase 3|80|Anticipated|Omeros Corporation||1|||t||||t|t|f||||||||2017-10-10 20:54:09.5315|2017-10-10 20:54:09.5315
NCT03205982|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-29|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|WiseApp||The Wise App Trial for Improving Health Outcomes in PLWH|The Wise App Trial for Improving Health Outcomes in People Living With HIV|Not yet recruiting||N/A|200|Anticipated|Columbia University||2|||f||||t|f|f||||||||2017-10-10 20:54:09.626859|2017-10-10 20:54:09.626859
NCT03205969|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||January 5, 2015|Actual|2015-01-05|June 2017|2017-06-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Effects of Mobile Game on Life Quality of Cancer Patients|Pilot Study : Effects of Mobile Game for Chemotherapy Side Effect Education on Life Quality of Cancer Patients|Completed||N/A|60|Actual|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||1|||f|||||f|f||||||||2017-10-10 20:54:09.696127|2017-10-10 20:54:09.696127
NCT03205956|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Observational|MPDP||Measuring Parkinson's Disease Progression|Dopamine Buffering Capacity Measured by phMRI as a Novel Biomarker of Disease Progression in PD|Recruiting||N/A|40|Anticipated|Washington University School of Medicine|||1||f||||f|t|f||||||||2017-10-10 20:54:09.767079|2017-10-10 20:54:09.767079
NCT03205943|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-06-29|||December 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Use of ICON™ to Detect Hemodynamic Variables During Dexmedetomidine Sedation in Children Undergoing Pulmonary Function Test|Use of a Non-invasive Bio-impedance Cardiac Monitor, ICON™, to Detect and Trend Hemodynamic Variables During Dexmedetomidine Sedation in Children Undergoing Pulmonary Function Testing|Withdrawn||N/A|0|Actual|Boston Children’s Hospital|||1|logistical challenges|f||||f||||||||||2017-10-10 20:54:09.858003|2017-10-10 20:54:09.858003
NCT03205930|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-02|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|October 2019|Anticipated|2019-10-01||Interventional|||Neo-MASCT Immunotherapy for Advanced NSCLC.|A Phase I/Ⅱ Open, Single Center, One-armed Trail, Neo - MASCT Treatment for Advanced NSCLC of the Safety and Efficacy.|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|The First People's Hospital of Lianyungang||1|||f||||f|f|f||||||||2017-10-10 20:54:09.923364|2017-10-10 20:54:09.923364
NCT03205917|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-28|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Clinical Trial of PGDM1400 and PGT121 Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults|A Phase 1 Randomized Placebo-controlled Clinical Trial of the Safety, Pharmacokinetics and Antiviral Activity of PGDM1400 and PGT121 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults|Not yet recruiting||Phase 1|60|Anticipated|International AIDS Vaccine Initiative||8|||||||f|t|f||||||||2017-10-10 20:54:10.003723|2017-10-10 20:54:10.003723
NCT03205904|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-28|||December 12, 2016|Actual|2016-12-12|June 2017|2017-06-01|March 13, 2020|Anticipated|2020-03-13|November 20, 2017|Anticipated|2017-11-20||Interventional|||Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis.|Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis.|Recruiting||N/A|38|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||Undecided||2017-10-10 20:54:10.123857|2017-10-10 20:54:10.123857
NCT03205891|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-07|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell Lymphomas|An Open Label Phase I Study of Brentuximab Vedotin Plus TAK228 for Patients With Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell Lymphomas|Not yet recruiting||Phase 1|18|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:54:10.214866|2017-10-10 20:54:10.214866
NCT03205878|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Telecoaching to Improve Physical Activity in Patients With Obstructive Sleep Apnea|Improving Physical Activity in Obstructive Sleep Apnea Patients Treated With Continuous Positive Airway Pressure|Not yet recruiting||N/A|102|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f|f|f||||||No||2017-10-10 20:54:10.322394|2017-10-10 20:54:10.322394
NCT03205865|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-29|||December 6, 1993|Actual|1993-12-06|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|DAISY||Diabetes Autoimmunity Study in the Young|Natural History of Pre-Diabetic Autoimmunity|Active, not recruiting||N/A|2547|Actual|University of Colorado, Denver|||1||f||||f|f|f||||Samples With DNA|"     Biological samples collected at one or more clinic visits include: whole blood, serum,     plasma, red blood cells, white blood cells (buffy coat), throat swab, rectal swab, urine,     saliva.   "|||2017-10-10 20:54:10.392825|2017-10-10 20:54:10.392825
NCT03205852|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||July 7, 2014|Actual|2014-07-07|June 2017|2017-06-01|December 29, 2014|Actual|2014-12-29|September 5, 2014|Actual|2014-09-05||Observational|||Patients Decision-making in Rotator Cuff Surgery|Do we Really Allow Patient Decision-making in Rotator Cuff Surgery? A Prospective Randomized Study|Completed||N/A|80|Actual|Hospital del Mar|||2||f||||t|f|f||||||Undecided||2017-10-10 20:54:10.450136|2017-10-10 20:54:10.450136
NCT03205839|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-27|||July 27, 2017|Actual|2017-07-27|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|November 27, 2017|Anticipated|2017-11-27||Interventional|||Acceptance-based Self-help for Individuals With Visible Difference and Social Anxiety|Effectiveness of Acceptance-based Self-help for Individuals With Visible Difference and Social Anxiety: a Pilot Randomised Controlled Trial|Recruiting||N/A|128|Anticipated|University of Sheffield||2|||f|||||f|f||||||||2017-10-10 20:54:10.515257|2017-10-10 20:54:10.515257
NCT03205826|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Chartis Collateral Ventilation Measurement: Conscious Sedation Versus General Anesthesia|Measuring Collateral Ventilation Using Chartis® to Select Patients With Severe Emphysema for Endobronchial Valve Treatment: Conscious Sedation Versus General Anesthesia|Not yet recruiting||N/A|50|Anticipated|University Medical Center Groningen||1|||f||||f|f|f||||||No|No plan to share IPD|2017-10-10 20:54:10.602832|2017-10-10 20:54:10.602832
NCT03205813|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-28|||July 11, 2017|Actual|2017-07-11|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|June 30, 2018|Anticipated|2018-06-30||Observational|||Prospective Study of Pain After Spinal Morphine for Cesarean Section and Factors Involved in Moderate to Severe Pain|Prospective Study of Pain After Spinal Morphine for Cesarean Section and Analysis of Factors Involved in Moderate to Severe Pain|Recruiting||N/A|660|Anticipated|Mahidol University|||1||f||||f|f|f||||||||2017-10-10 20:54:10.67819|2017-10-10 20:54:10.67819
NCT03205800|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|TAD||Temporary Anchorage Devices for Ridge Preservation|The Use of Temporary Anchorage Devices for Ridge Preservation After Tooth Extraction|Not yet recruiting||N/A|10|Anticipated|University of Maryland Baltimore Dental School||2|||f||||f|f|f||||||||2017-10-10 20:54:10.767972|2017-10-10 20:54:10.767972
NCT03205787|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-09-22|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Red Clover Botanical Dietary Supplements - Metabolism and Safety in Women|Red Clover Botanical Dietary Supplements - Metabolism and Safety in Women|Recruiting||N/A|20|Anticipated|University of Illinois at Chicago||1|||f||||t|f|f||||||||2017-10-10 20:54:10.839027|2017-10-10 20:54:10.839027
NCT03205774|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-05|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|October 30, 2017|Anticipated|2017-10-30|October 15, 2017|Anticipated|2017-10-15||Interventional|||Positioning and Ultrasound Examination of the Gastric Antrum|Effect of Positioning on Ultrasound Examination of the Gastric Antrum|Recruiting||N/A|25|Anticipated|Hôpital Edouard Herriot||4|||f||||f|f|f||||||||2017-10-10 20:54:10.919421|2017-10-10 20:54:10.919421
NCT03205761|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-10-03|||September 13, 2017|Actual|2017-09-13|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|COMETABreast||Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer|A Phase II Clinical Trial to Analyse Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer (COMETA-Breast Study)|Recruiting||Phase 2|34|Anticipated|Spanish Breast Cancer Research Group||1|||f||||f|f|f|||f|||||2017-10-10 20:54:10.998449|2017-10-10 20:54:10.998449
NCT03205748|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|||Evaluation of Different Etiologies of Obscure Ascites|Evaluation of Different Etiologies of Obscure Ascites: Clinical, Laboratory, and Laparoscopic Study.|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:54:11.112938|2017-10-10 20:54:11.112938
NCT03205735|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-07-05|||June 29, 2017|Actual|2017-06-29|June 2017|2017-06-01|September 29, 2019|Anticipated|2019-09-29|June 29, 2019|Anticipated|2019-06-29|24 Months|Observational [Patient Registry]|DPD DIG||The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line|The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line|Recruiting||N/A|200|Anticipated|Centre Antoine Lacassagne|||2||f|||||f|f||||||||2017-10-10 20:54:11.177685|2017-10-10 20:54:11.177685
NCT03205722|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany|The Effectiveness of Nivolumab (OPDIVO®) Monotherapy as First-Line Therapy in Adults With Advanced (Unresectable or Metastatic) Melanoma: An Early Retrospective, Observational Study in Germany|Not yet recruiting||N/A|100|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 20:54:11.254599|2017-10-10 20:54:11.254599
NCT03205709|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 31, 2022|Anticipated|2022-07-31|July 31, 2022|Anticipated|2022-07-31||Interventional|CogTraining||Cognitive Training and Neuroplasticity in Mild Cognitive Impairment|Cognitive Training and Neuroplasticity in Mild Cognitive Impairment|Not yet recruiting||N/A|100|Anticipated|New York State Psychiatric Institute||2|||f||||t|f|f||||||||2017-10-10 20:54:11.334214|2017-10-10 20:54:11.334214
NCT03205514|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31|1 Year|Observational [Patient Registry]|SHERLOCK||Multimodality Investigation of Intermediate Culprit Lesion With Negative FFR in NSTE-ACS|Multimodality Investigation of Intermediate Culprit Lesion With Negative Fractional Flow Reserve in Patients With no ST-segment Elevation Acute Coronary Syndrome.|Recruiting||N/A|30|Anticipated|University Hospital of Ferrara|||1||f||||t|f|f||||||No||2017-10-10 20:54:12.50217|2017-10-10 20:54:12.50217
NCT03205696|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|June 20, 2019|Anticipated|2019-06-20|June 20, 2019|Anticipated|2019-06-20||Observational|||Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection|A Comprehensive Community-Based Strategy to Optimize the HIV Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection|Recruiting||N/A|72|Anticipated|University of California, Los Angeles|||2||f||||f|f|f||||Samples With DNA|"     Study site staff will store blood specimens collected in this study at least through the end     of the study. In addition, as part of the informed consent process, subjects will be asked to     provide written informed consent for blood specimens to be stored after the end of the study     for possible future testing. The specimens of participants who do not consent to long-term     storage and additional testing will be destroyed at the end of the study   "|No||2017-10-10 20:54:11.4207|2017-10-10 20:54:11.4207
NCT03205683|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Intraneural Facilitation as a Treatment for Carpal Tunnel Syndrome|Intraneural Facilitation as a Treatment for Carpal Tunnel Syndrome|Not yet recruiting||N/A|68|Anticipated|Loma Linda University||2|||f||||f|f|f||||||||2017-10-10 20:54:11.517066|2017-10-10 20:54:11.517066
NCT03205670|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2022|Anticipated|2022-06-01||Interventional|||Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers|An Open Prospective Clinical Study on Safety and Efficacy of Surgical Treatment of Patients With Anterior Urethral Stricture Using a Tissue-engineered Construct Based on Autologous Buccal Mucosa Cells and Matrix From Reconstituted Collagen and Reinforcing Polylactoglycolide Fibers|Recruiting||Early Phase 1|6|Anticipated|I.M. Sechenov First Moscow State Medical University||1|||f||||f|f|f||||||Undecided||2017-10-10 20:54:11.586781|2017-10-10 20:54:11.586781
NCT03205657|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-29|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Auto/Allo Tandem Transplant for Relapsed B-NHL|MAC and autoHSCT, Targeted Immunotherapy and RIC alloHSCT in Children, Adolescents, and Young Adults (CAYA) With Poor-risk Refractory/Relapsed Mature B-NHL: A Retrospective Chart Review|Active, not recruiting||N/A|40|Anticipated|New York Medical College|||1||f||||f|f|f||||||||2017-10-10 20:54:11.66994|2017-10-10 20:54:11.66994
NCT03205631|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment|Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment|Recruiting||N/A|50|Anticipated|IC-IT Sciences Inc.||2|||f||||f|f|f||||||||2017-10-10 20:54:11.721116|2017-10-10 20:54:11.721116
NCT03205605|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Effect of Heat on Oxybutynin Release and Absorption From Oxybutynin Products|Determination of Serum Oxybutynin Levels After Using Oxybutynin Transdermal Delivery System and Transdermal Gel With and Without Standardized Heat Application in Healthy Human Volunteers|Not yet recruiting||Early Phase 1|12|Anticipated|University of Maryland||4|||f||||f|t|f|||f|||||2017-10-10 20:54:11.866382|2017-10-10 20:54:11.866382
NCT03205592|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-05|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|GastrICU||Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients|Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients|Recruiting||N/A|60|Anticipated|Hôpital Edouard Herriot|||1||f||||f|f|f||||||||2017-10-10 20:54:11.935013|2017-10-10 20:54:11.935013
NCT03205579|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Pain Education to Improve Cancer Pain Management Patients: A Randomized Trial|Effectiveness of Pain Education to Improve Cancer Pain Management in Hospitalized Patients: A Randomized Controlled Trial|Not yet recruiting||N/A|70|Anticipated|Mahidol University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:54:12.005292|2017-10-10 20:54:12.005292
NCT03205566|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-29|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|R-PrEP||Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection|The Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection|Not yet recruiting||Phase 4|36|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 20:54:12.064821|2017-10-10 20:54:12.064821
NCT03205553|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-07|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Direct Peritoneal Resuscitation in Gastroschisis|Direct Peritoneal Resuscitation in Gastroschisis|Not yet recruiting||Early Phase 1|48|Anticipated|University of Arkansas||2||||||||t|f||||||||2017-10-10 20:54:12.150732|2017-10-10 20:54:12.150732
NCT03205540|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-06|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Epidural Analgesia vs Adductor Canal Block in Bilateral TKA|Comparison Efficacy of Analgesic Techniques: Continuous Epidural Analgesia Versus Bilateral Single-shot Adductor Canal Blocks in Patients Undergoing Bilateral Total Knee Arthroplasty|Not yet recruiting||N/A|70|Anticipated|Mahidol University||2|||f||||f|f|f||||||||2017-10-10 20:54:12.222052|2017-10-10 20:54:12.222052
NCT03205527|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-29|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Perturbation Training for Fall-risk Reduction Among Stroke Survivors|Perturbation Training for Enhancing Stability and Limb Support Control for Fall-risk Reduction Among Stroke Survivors|Recruiting||N/A|181|Anticipated|University of Illinois at Chicago||4|||f||||t|f|f||||||No||2017-10-10 20:54:12.296371|2017-10-10 20:54:12.296371
NCT03205501|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|EAGLE||Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions|Molecular Fluorescence Endoscopy for the Detection of (Pre)Malignant Lesions in Barrett's Esophagus Using a Fluorescent Tracer 'EMI-137' Targeting c-Met: a Single-center Feasibility and Safety Study|Active, not recruiting||Phase 1|25|Anticipated|University Medical Center Groningen||1|||f||||t|f|f||||||||2017-10-10 20:54:12.608761|2017-10-10 20:54:12.608761
NCT03205488|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-28|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|NILO-PD||Nilotinib in Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease|Not yet recruiting||Phase 2|135|Anticipated|Northwestern University||2|||f||||t|t|f||||||||2017-10-10 20:54:12.693603|2017-10-10 20:54:12.693603
NCT03205475|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||July 30, 2017|Anticipated|2017-07-30|June 2017|2017-06-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||JASPER Implementation in NFLD|JASPER Implementation Cascade: Newfoundland and Labrador|Not yet recruiting||N/A|76|Anticipated|Government of Newfoundland and Labrador||6|||f||||f|f|f||||||No||2017-10-10 20:54:12.804229|2017-10-10 20:54:12.804229
NCT03205462|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-05|||August 10, 2017|Actual|2017-08-10|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers|An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone Used as a Single-Dose Administration or a Treatment Course in Healthy Volunteers|Recruiting||Phase 1|25|Anticipated|Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation||3|||f||||f|f|f||||||||2017-10-10 20:54:12.901344|2017-10-10 20:54:12.901344
NCT03205449|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-29|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|January 31, 2018|Anticipated|2018-01-31||Interventional|PLH-MaPa||Parenting for Lifelong Health (PLH) - Masayang Pamilya (MaPa) Evaluation Study|Parenting for Lifelong Health-Philippines: Randomized Controlled Trial of a Culturally-adapted Parenting Program on Reducing the Risk of Violence Against Children in Low-income Filipino Families With Children Aged 2 to 6 Years in Manila|Recruiting||N/A|120|Anticipated|Ateneo de Manila University||2|||f||||f|f|f||||||No||2017-10-10 20:54:12.999753|2017-10-10 20:54:12.999753
NCT03205436|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Affinity Prospective Diabetic Foot Trial Crossover Group|A Multi-center, Randomized Controlled Clinical Trial Evaluating the Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers: Crossover Group From Standard of Care|Recruiting||N/A|20|Anticipated|SerenaGroup, Inc.||1|||f||||f|f|f||||||No||2017-10-10 20:54:13.14729|2017-10-10 20:54:13.14729
NCT03205423|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-17|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Medication Development for Opioid and Alcohol Abuse|Medication Development for Opioid and Alcohol Abuse: Laboratory Study in Humans|Recruiting||Phase 2|36|Anticipated|New York State Psychiatric Institute||2|||f||||f|t|f|||f|||||2017-10-10 20:54:13.262931|2017-10-10 20:54:13.262931
NCT03205410|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||January 1, 2014|Actual|2014-01-01|June 2017|2017-06-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Interventional|||Remote Ischemic Preconditioning as a New Method of Nephroprotection|Remote Ischemic Preconditioning as a New Method of Nephroprotection in Patients Undergoing Cardiac Surgery|Completed||N/A|50|Actual|Medical Universtity of Lodz||2|||f||||f|f|f||||||||2017-10-10 20:54:13.382824|2017-10-10 20:54:13.382824
NCT03205397|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-30|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|I-PPOP||Impact of a Child-Parent Preoperative Accompanying Procedure on the Anxiety of Children Aged 5 to 12 With Scheduled Surgery|Impact of a Child-Parent Preoperative Accompanying Procedure on the Anxiety of Children Aged 5 to 12 With Scheduled Surgery|Not yet recruiting||N/A|40|Anticipated|University Hospital, Limoges||2|||f||||f|f|f||||||||2017-10-10 20:54:13.494628|2017-10-10 20:54:13.494628
NCT03205384|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-29|||January 2017||2017-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01|2 Years|Observational [Patient Registry]|||Morbimortality in Older People Undergoing Urgent Abdominal Surgery|Analysis of Morbimortality and Functional Status in Older Patients(>65 Years Old) Undergoing Urgent Abdominal Surgery Using CRISTAL Score Modify|Recruiting||N/A|800|Anticipated|Hospital of Navarra|||2||f||||t||||||||||2017-10-10 20:54:13.56942|2017-10-10 20:54:13.56942
NCT03205371|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-29|||November 7, 2016|Actual|2016-11-07|September 2017|2017-09-01|June 12, 2018|Anticipated|2018-06-12|June 12, 2018|Anticipated|2018-06-12||Interventional|||Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers|Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Other Pediatric Vaccines in Healthy Toddlers|Active, not recruiting||Phase 3|1200|Anticipated|Sanofi||9|||f||||f|t|f|||t|||||2017-10-10 20:54:13.704577|2017-10-10 20:54:13.704577
NCT03205358|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-06||2017-09-06|March 31, 2015|Actual|2015-03-31|September 2017|2017-09-01|August 18, 2015|Actual|2015-08-18|August 18, 2015|Actual|2015-08-18||Interventional|||Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers|A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers|Completed||Phase 2|200|Actual|Sanofi||2|||f||||f|t|f|||t|||||2017-10-10 20:54:13.987169|2017-10-10 20:54:13.987169
NCT03205345|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-29|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|ENCORE-LF||Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis|Recruiting||Phase 2|210|Anticipated|Conatus Pharmaceuticals Inc.||3|||f||||t|t|f||||||||2017-10-10 20:54:14.123487|2017-10-10 20:54:14.123487
NCT03205332|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-01|||June 12, 2015|Actual|2015-06-12|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Training Mental Habits Study|An Experimental Investigation of the Effects of Concrete Thinking on Worry, Problem-Solving and Cognitive Processing in Individuals With Generalized Anxiety Disorder|Recruiting||N/A|110|Anticipated|Ryerson University||2|||f||||f|f|f||||||||2017-10-10 20:54:14.29688|2017-10-10 20:54:14.29688
NCT03205319|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-28|||September 18, 2017|Actual|2017-09-18|June 2017|2017-06-01|August 1, 2018|Anticipated|2018-08-01|April 1, 2018|Anticipated|2018-04-01||Interventional|TRIODe||Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia|To Scope or Not to Scope: Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia; a Randomised Controlled Trial|Enrolling by invitation||N/A|400|Anticipated|Radboud University||2|||f||||f|f|f||||||||2017-10-10 20:54:14.444607|2017-10-10 20:54:14.444607
NCT03205306|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-29|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Myasthenia Gravis and Psyche|Myasthenia Gravis and Psyche|Recruiting||N/A|4300|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:54:14.581877|2017-10-10 20:54:14.581877
NCT03205293|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-02|||March 1, 2011|Actual|2011-03-01|July 2017|2017-07-01|December 1, 2020|Anticipated|2020-12-01|April 1, 2013|Actual|2013-04-01||Interventional|||School-Based Intervention Program to Promote Healthy Eating and Physical Activity|School-Based Intervention Program to Promote Healthy Eating and Physical Activity Using Participatory Approach|Enrolling by invitation||N/A|1500|Anticipated|Hadassah Medical Organization||2|||f||||f|f|f||||||||2017-10-10 20:54:14.672581|2017-10-10 20:54:14.672581
NCT03205280|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-30|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01||Observational|POCADIMS||Clinical Decision Support System (CADIMS) for MS Diagnostic|Assessment of a Clinical Decision Support System (CADIMS) for Improving Multiple Sclerosis Diagnostic Accuracy|Not yet recruiting||N/A|200|Anticipated|Rennes University Hospital|||1||f|||||f|f||||||||2017-10-10 20:54:14.785817|2017-10-10 20:54:14.785817
NCT03205267|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-28|||March 2016||2016-03-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|BODO||Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients|Multicenter, Open-label Single Arm Phase II Study Testing the Tolerability and the Efficacy of Bosutinib step-in Dosing in Chronic Phase CML Patients Intolerant or Refractory to Previous Imatinib, Nilotinib or Dasatinib Therapy|Recruiting||Phase 2|127|Anticipated|University of Bonn||1|||f||||t||||||||No||2017-10-10 20:54:14.917207|2017-10-10 20:54:14.917207
NCT03205254|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||March 28, 2016|Actual|2016-03-28|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Effects of Short-term Diet on HDL Composition and Function|Short-term Effects of Mediterranean or Fast Food Diet on HDL Composition and Function|Recruiting||N/A|160|Anticipated|University of California, Davis||2|||f||||f|f|f|||f|||No||2017-10-10 20:54:15.222283|2017-10-10 20:54:15.222283
NCT03205241|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||April 2014|Actual|2014-04-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of 4 Weeks Fish Oil Supplementation on Cycling Performance in Healthy Male Cyclists|Effect of 4 Weeks Fish Oil Supplementation on Cycling Performance or Oxidative and Inflammatory Parameters in Healthy Male Cyclists|Completed||N/A|12|Actual|Loughborough University||2|||f||||f|f|f||||||No||2017-10-10 20:54:15.382926|2017-10-10 20:54:15.382926
NCT03205228|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-10|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|March 30, 2018|Anticipated|2018-03-30||Interventional|||Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump Inhibitors|Treatment Outcomes in Patients With Globus: A Randomized Control Trial of Psychoeducation, Anxiolytics and Proton Pump Inhibitors|Recruiting||Phase 3|50|Anticipated|Mahidol University||3|||f||||f|f|f||||||||2017-10-10 20:54:15.475206|2017-10-10 20:54:15.475206
NCT03205215|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-17|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|June 30, 2020|Anticipated|2020-06-30||Interventional|HBOT for PCS||Hyperbaric Oxygen for Post Concussive Syndrome|Hyperbaric Oxygen for Post Concussive Syndrome|Suspended||N/A|150|Anticipated|University of British Columbia||2||Unable to begin recruiting at this time|f||||f|f|f||||||||2017-10-10 20:54:15.602403|2017-10-10 20:54:15.602403
NCT03205202|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||June 1, 2015|Actual|2015-06-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|March 2020|Anticipated|2020-03-01||Interventional|COSMOS-Eye||Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract|Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract (COSMOS-Eye)|Active, not recruiting||Phase 4|18000|Anticipated|Brigham and Women's Hospital||4|||f||||t|f|f||||||||2017-10-10 20:54:15.710862|2017-10-10 20:54:15.710862
NCT03205189|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-10|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|AMBUPRESS||Comparison Between Pre-operative Prescription Delivered During Anesthesia Consultation or Post-operative Prescription|Comparison Between Pre-operative Prescription Delivered During Anesthesia Consultation or Post-operative Prescription: a Randomized Prospective Trial|Recruiting||N/A|186|Anticipated|University Hospital, Rouen||2|||f||||f|f|f||||||||2017-10-10 20:54:15.798009|2017-10-10 20:54:15.798009
NCT03205176|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-09-26|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|January 3, 2019|Anticipated|2019-01-03|January 3, 2019|Anticipated|2019-01-03||Interventional|||AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas|A Phase I, Multicenter Dose-Escalation Study to Assess the Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of AZD5153 in Patients With Relapsed/Refractory Malignant Solid Tumors, Including Lymphomas|Recruiting||Phase 1|60|Anticipated|AstraZeneca||7|||f||||f|t|f|||f|||||2017-10-10 20:54:15.892708|2017-10-10 20:54:15.892708
NCT03205150|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-24|||September 18, 2017|Anticipated|2017-09-18|July 2017|2017-07-01|April 13, 2019|Anticipated|2019-04-13|April 13, 2019|Anticipated|2019-04-13||Interventional|||Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients|A 12-week Randomized, Patient and Investigator Blinded, Placebo-controlled, Parallel Group Study to Investigate the Efficacy of LIK066 in Obese Patients With Non-alcoholic Steatohepatitis (NASH)|Not yet recruiting||Phase 2|110|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 20:54:16.083005|2017-10-10 20:54:16.083005
NCT03205137|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-10-02|||October 9, 2017|Anticipated|2017-10-09|October 2017|2017-10-01|October 10, 2017|Anticipated|2017-10-10|October 10, 2017|Anticipated|2017-10-10||Observational|||Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice|Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine FDC Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice|Not yet recruiting||N/A|3275|Anticipated|Boehringer Ingelheim|||4||f||||f||||||||||2017-10-10 20:54:16.160491|2017-10-10 20:54:16.160491
NCT03205124|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-28|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 1, 2019|Anticipated|2019-07-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration.|The Effect of Pre-operative and/or Post-operative Electrical Stimulation on Enhancing Regeneration of Peripheral Sensory Nerve Regeneration in Human Hand, a Double Blind Randomized Controlled Study.|Not yet recruiting||Phase 2/Phase 3|66|Anticipated|University of Alberta||3|||f||||t|f|f||||||No|No plan to share individual participant data with other researchers.|2017-10-10 20:54:16.233403|2017-10-10 20:54:16.233403
NCT03205111|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Role of Office Hysteroscope in Premenopausal Uterine Bleeding|Endometrial Characterization Using Office Hysteroscopy in Women Presenting With Abnormal Uterine Bleeding|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||||2017-10-10 20:54:16.342034|2017-10-10 20:54:16.342034
NCT03205098|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-29|||June 19, 2015|Actual|2015-06-19|June 2017|2017-06-01|September 30, 2016|Actual|2016-09-30|June 30, 2015|Actual|2015-06-30||Observational|ISKETRAIL||Evaluation of Biological Markers of Mesenteric Ischemia During an Ultra-trail|Evaluation of Biological Markers of Mesenteric Ischemia During an Ultra-trail|Completed||N/A|200|Actual|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 20:54:16.400917|2017-10-10 20:54:16.400917
NCT03205072|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-29|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01|12 Months|Observational [Patient Registry]|||POCS in Liver Transplantation Patients|Per-Oral Cholangioscopy in Liver Transplantation Patients|Not yet recruiting||N/A|66|Anticipated|Boston Scientific Corporation|||1||f||||f|f|f||||Samples Without DNA|"     Biopsies if needed at the discretion of the PI.   "|||2017-10-10 20:54:16.536266|2017-10-10 20:54:16.536266
NCT03205059|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||An Evidence-based Approach for Bullying Prevention|An Evidence-based Approach for Bullying Prevention|Active, not recruiting||N/A|3000|Anticipated|National Health Promotion Associates, Inc.||2|||f||||t|f|f||||||No||2017-10-10 20:54:16.605779|2017-10-10 20:54:16.605779
NCT03205046|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-29|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies|A Phase 1/2 Proof-of-Concept Study of the Combination of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies|Recruiting||Phase 1/Phase 2|59|Anticipated|Acerta Pharma BV||2|||f|||||t|f||||||||2017-10-10 20:54:16.665579|2017-10-10 20:54:16.665579
NCT03205033|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy|Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy: a Randomized, Double-blind, Placebo-controlled Trial.|Completed||Phase 2|36|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||Undecided||2017-10-10 20:54:16.749165|2017-10-10 20:54:16.749165
NCT03205020|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-30|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|February 1, 2018|Anticipated|2018-02-01|January 1, 2018|Anticipated|2018-01-01|6 Months|Observational [Patient Registry]|||Maternal Serum Amyloid A Levels in Pregnancies Complicated With Preterm Labour.|Maternal Serum Amyloid A Levels in Pregnancies Complicated With Preterm Labour.|Recruiting||N/A|58|Anticipated|Ain Shams University|||2||f|||||f|f||||||||2017-10-10 20:54:17.003869|2017-10-10 20:54:17.003869
NCT03205007|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-05|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|BBHL||Adaptation of a Health Promotion Nutrition Program for Older Adults|Adaptation of a Health Promotion Nutrition Program for Older Adults Entitled:Beneficial Bites for Healthy Living|Recruiting||N/A|40|Anticipated|University of Wisconsin, Madison||1|||f||||f|f|f||||||||2017-10-10 20:54:17.119777|2017-10-10 20:54:17.119777
NCT03204994|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-18|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Fluorescence Targeted Pelvic Lymph Node Mapping|Investigating the Feasibility of Fluorescence Targeted Pelvic Lymph Node Mapping During Rectal Cancer Surgery|Enrolling by invitation||Phase 1/Phase 2|30|Anticipated|Oxford University Hospitals NHS Trust||1|||f||||f|f|f||||||||2017-10-10 20:54:17.234378|2017-10-10 20:54:17.234378
NCT03204981|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-19|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias|Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias|Not yet recruiting||N/A|200|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|f|t|f|f||||||2017-10-10 20:54:17.341218|2017-10-10 20:54:17.341218
NCT03204968|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-30|||December 1, 2015|Actual|2015-12-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 5, 2016|Actual|2016-06-05||Interventional|||The Effect of Vagus Nerve Stimulation on the Inflammatory Response After Lung Lobectomy|The Effect of Vagus Nerve Stimulation on the Inflammatory Response After Lung Lobectomy|Completed||N/A|130|Actual|Otto Wagner Hospital||2|||f|||||f|f||||||||2017-10-10 20:54:17.464637|2017-10-10 20:54:17.464637
NCT03204955|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|ACETATE||A Low ChloridE hyperTonic Solution for Brain Edema|Low-chloride Versus High-chloride Containing Hypertonic Solution for the Treatment of Subarachnoid Hemorrhage-Related Complications|Recruiting||Phase 1|80|Anticipated|Emory University||2|||f||||t|t|f|||f|||||2017-10-10 20:54:17.568214|2017-10-10 20:54:17.568214
NCT03204942|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-08-04|||February 14, 2017|Actual|2017-02-14|August 2017|2017-08-01|July 5, 2018|Anticipated|2018-07-05|January 30, 2018|Anticipated|2018-01-30||Interventional|||Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for Metastatic Pain in Thoracic Vertebral Body|Comparison Between Dorsal Root Ganglion Thermal Radiofrequency Versus Pulsed Radiofrequency for the Management of Intractable Metastatic Pain in Thoracic Vertebral Body|Recruiting||N/A|69|Anticipated|National Cancer Institute, Egypt||3|||f||||f|f|t|f||t|||||2017-10-10 20:54:17.707728|2017-10-10 20:54:17.707728
NCT03204929|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-18|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease|A Phase 1 Dose Escalation Study of Cu(II)ATSM Administered Orally to Patients With Early Idiopathic Parkinson's Disease|Recruiting||Phase 1|38|Anticipated|Collaborative Medicinal Development Pty Limited||1|||f||||t|t|f|||t|||||2017-10-10 20:54:17.844195|2017-10-10 20:54:17.844195
NCT03204916|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-08|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Observational|||Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia|Documentation and Delivery of Guideline-Consistent Treatment in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia (ALL)|Not yet recruiting||N/A|318|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-10 20:54:17.994919|2017-10-10 20:54:17.994919
NCT03204903|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-07-09|||August 1, 2016|Actual|2016-08-01|March 2017|2017-03-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Laser Acupuncture for Dry Eye|Laser Acupuncture Therapy in Patients With Dry Eye: A Two-center Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Chang Gung Memorial Hospital||2|||f||||f|f|f||||||||2017-10-10 20:54:18.131466|2017-10-10 20:54:18.131466
NCT03204890|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||TPTNS for Treating Patients With Premature Ejaculation|Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for Treating Patients With Premature Ejaculation. Phase II Clinical Trial|Recruiting||N/A|26|Anticipated|Boston Medical Group||1|||f||||f|f|f||||||No||2017-10-10 20:54:18.251574|2017-10-10 20:54:18.251574
NCT03204877|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-10|||August 22, 2017|Anticipated|2017-08-22|June 2017|2017-06-01|March 1, 2020|Anticipated|2020-03-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Acute Metabolic Effects of Melatonin Treatment|Acute Metabolic Effects of Melatonin Treatment|Enrolling by invitation||Phase 1/Phase 2|40|Anticipated|University of Aarhus||2|||f||||t|f|f||||||||2017-10-10 20:54:18.394644|2017-10-10 20:54:18.394644
NCT03204864|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||March 1, 2016|Actual|2016-03-01|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|Opsite 2||Optimization of Coronary Sinus Lead Placement Targeted to the Longest Right-to-Left Delay|Optimization of Coronary Sinus Lead Placement Targeted to the Longest Right-to-Left Delay|Recruiting||N/A|300|Anticipated|Ospedale del Tigullio, Polo di Lavagna||2|||f||||f|f|f||||||Undecided||2017-10-10 20:54:18.546901|2017-10-10 20:54:18.546901
NCT03204851|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-11|||October 20, 2016|Actual|2016-10-20|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|December 30, 2017|Anticipated|2017-12-30||Interventional|Microlyte||Microlyte Dressing in the Management of Wounds|An Open-Label Prospective Pilot Study to Evaluate the Efficacy and Tolerability of Microlyte Ag Pre-Dressing in the Management of Complex Skin Wounds.|Recruiting||N/A|100|Anticipated|Mission Health System, Asheville, NC||4|||f||||f|f|t|f|f||||||2017-10-10 20:54:18.710602|2017-10-10 20:54:18.710602
NCT03204838|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-28|||July 10, 2017|Anticipated|2017-07-10|June 2017|2017-06-01|May 5, 2020|Anticipated|2020-05-05|December 31, 2019|Anticipated|2019-12-31|2 Years|Observational [Patient Registry]|||IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients|STUDY TITLE IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients and Myelodysplasticsyndromes, Clinical Response to Treatment|Recruiting||N/A|100|Anticipated|Hospital General de Mexico|||1||f||||t|f|f||||Samples With DNA|"     Retrospective phase clinical and molecular data of patients without treatment with     morphological, genetic, immunophenotype classification. Molecular biology (AML-ETO, PMR-RAR     alpha, Inv 16, FLT 3, CEBP mutation 50 cases , 100 controls. Address Hospital General de     Mexico , Hematology service ( external consult and transfusional area). (Lysis Buffer)   "|No||2017-10-10 20:54:18.851436|2017-10-10 20:54:18.851436
NCT03204825|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-28|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|PrEPAID||Pain Management and Patient Education for Physical Activity in Intermittent Claudication (PrEPAID)|Pain Management and Patient Education for Physical Activity in Intermittent Claudication (PrEPAID): Feasibility Randomised Controlled Trial|Not yet recruiting||N/A|80|Anticipated|Glasgow Caledonian University||4|||f||||t|f|f||||||No||2017-10-10 20:54:18.96759|2017-10-10 20:54:18.96759
NCT03204812|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-08|||July 14, 2017|Actual|2017-07-14|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Tremelimumab + Durvalumab Chemotherapy Naive CRPC|A Pilot Trial to Explore the Link Between Immunological Changes, Efficacy, Safety and Tolerability of Durvalumab (MEDI4736) Plus Tremelimumab in Chemotherapy-naïve Men With Metastatic Castration-resistant Prostate Cancer (CRPC)|Recruiting||Phase 2|27|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:54:19.117771|2017-10-10 20:54:19.117771
NCT03204799|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||December 17, 2016|Actual|2016-12-17|June 2017|2017-06-01|December 16, 2018|Anticipated|2018-12-16|January 1, 2018|Anticipated|2018-01-01||Observational|||Metagenomic Analysis of Human Gut Microbiota in Patients With Metabolic Diseases Including Diabetes|Metagenomic Analysis of Human Gut Microbiota in Patients With Metabolic Diseases Including Diabetes.|Recruiting||N/A|150|Anticipated|Yonsei University|||6||f||||f|f|f||||||No||2017-10-10 20:54:19.222245|2017-10-10 20:54:19.222245
NCT03204786|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2023|Anticipated|2023-02-01|December 2022|Anticipated|2022-12-01||Interventional|||Intranasal Vasopressin Treatment in Children With Autism|Intranasal Vasopressin Treatment in Children With Autism|Not yet recruiting||Phase 2|100|Anticipated|Stanford University||3|||f||||t|t|f||||||||2017-10-10 20:54:19.341567|2017-10-10 20:54:19.341567
NCT03204773|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-29|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Observational|||Studying Non-motor Symptoms in SPG4|Studying Non-motor Symptoms in Patients With Hereditary Spastic Paraplegia (HSP) Type 4 (SPG4) Compared to Healthy Controls|Not yet recruiting||N/A|600|Anticipated|University Hospital Tuebingen|||2||f||||f|f|f||||||No||2017-10-10 20:54:19.498492|2017-10-10 20:54:19.498492
NCT03204760|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-29|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|August 30, 2017|Anticipated|2017-08-30|April 30, 2017|Actual|2017-04-30||Interventional|||Steroids In The Management Of Acute Asthma Exacerbations In Children, Which Form Is More Suitable?|Steroids In The Management Of Acute Asthma Exacerbations In Children, Which Form Is More Suitable?|Active, not recruiting||Phase 2|50|Actual|Assiut University||2|||f||||f|f|f|||f|||No||2017-10-10 20:54:19.647392|2017-10-10 20:54:19.647392
NCT03204747|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||February 27, 2017|Actual|2017-02-27|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Effect of Need to Void on Gait Speed in Multiple Sclerosis|Effect of Need to Void on Gait Speed in Multiple Sclerosis|Recruiting||N/A|67|Anticipated|Pierre and Marie Curie University|||1||f||||f|f|f||||||||2017-10-10 20:54:19.771256|2017-10-10 20:54:19.771256
NCT03204734|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-06-27|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|December 30, 2021|Anticipated|2021-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer|Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After 2nd-line or Over 2nd-line Therapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer|Recruiting||Phase 2|132|Anticipated|Zhejiang Cancer Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:54:19.877235|2017-10-10 20:54:19.877235
NCT03204721|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-28|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|GVHD||Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis|Prevention of Graft-versus-host Disease in Patients Treated With Allogeneic Stem Cell Transplantation: Possible Role of Extracorporeal Photophoresis|Recruiting||N/A|156|Anticipated|Oslo University Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:54:19.976183|2017-10-10 20:54:19.976183
NCT03204708|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-28|||April 15, 2016|Actual|2016-04-15|June 2017|2017-06-01|February 28, 2017|Actual|2017-02-28|February 15, 2017|Actual|2017-02-15||Interventional|||Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy|Evaluation of the Postoperative Analgesic Efficacy of Catheter Placed Interpectoral Region Via Open Technique in Patients Undergoing Modified Radical Mastectomy|Terminated||N/A|86|Actual|Istanbul University||2||didn't have catheters in the hospital at the time of ethics committe approval.|f||||f|f|f||||||No||2017-10-10 20:54:20.082904|2017-10-10 20:54:20.082904
NCT03204695|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-04|||May 29, 2017|Actual|2017-05-29|July 2017|2017-07-01|August 13, 2018|Anticipated|2018-08-13|July 13, 2018|Anticipated|2018-07-13||Interventional|||WAVECREST Post Market Clinical Follow-Up (PMCF) Study|A Prospective, Multicenter, Non-randomized, Post-market Clinical Follow-up Study to Confirm Safety and Performance of the Coherex WaveCrest® Left Atrial Appendage Occlusion System in Patients With Non-valvular Atrial Fibrillation|Recruiting||Phase 3|65|Anticipated|Coherex Medical||1|||f||||t|f|f||||||||2017-10-10 20:54:20.155408|2017-10-10 20:54:20.155408
NCT03204682|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||April 13, 2016|Actual|2016-04-13|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|ENDOSTIM||Repetitive Transcranial Magnetic Stimulation as an Analgesic Treatment in Endometriosis Chronic Pain : Feasibility|Repetitive Transcranial Magnetic Stimulation as an Analgesic Treatment in Endometriosis Chronic Pain : Feasibility Study|Recruiting||N/A|24|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 20:54:20.231896|2017-10-10 20:54:20.231896
NCT03204669|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||June 1, 1999|Actual|1999-06-01|June 2017|2017-06-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Trace Element Repletion Following Severe Burn Injury|Trace Element Repletion Following Severe Burn Injury|Completed||N/A|139|Actual|Centre Hospitalier Universitaire Vaudois|||1||f||||f|f|f||||||No||2017-10-10 20:54:20.318507|2017-10-10 20:54:20.318507
NCT03204656|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-06-28|||February 20, 2017|Actual|2017-02-20|May 2017|2017-05-01|May 20, 2017|Actual|2017-05-20|May 20, 2017|Actual|2017-05-20||Observational|SBI||Selective Bronchial Intubation (SBI)|Selective Bronchial Intubation (SBI) at Marie Lannelongue Hospital (HML) : Epidemiology of Expected and Unexpected Difficult Intubations.|Completed||N/A|200|Actual|Centre Chirurgical Marie Lannelongue|||1||f||||f|f|f||||||No||2017-10-10 20:54:20.395382|2017-10-10 20:54:20.395382
NCT03204643|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Evaluation of Behavioral Health-Virtual Patient Navigation Team (BH-VPN)|An Evaluation of ED to Admission Conversion Among Patients With a Telepsychiatric Consult Who Are Followed by a Behavioral Health - Virtual Patient Navigation Team|Recruiting||N/A|460|Anticipated|Carolinas Healthcare System||2|||f||||t|f|f||||||No||2017-10-10 20:54:20.454966|2017-10-10 20:54:20.454966
NCT03204630|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-06-28|||January 2011||2011-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional|||Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk|Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk|Completed||N/A|236|Actual|Biosearch S.A.||3|||f||||f||||||||||2017-10-10 20:54:20.582798|2017-10-10 20:54:20.582798
NCT03204617|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-10-05|||July 7, 2017|Actual|2017-07-07|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Safety and Immunogenicity Study of DNA.HTI and MVA.HTI in HIV-1-positive Patients(AELIX-002)|A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines DNA.HTI and MVA.HTI in Early Treated HIV-1 Positive Individuals|Active, not recruiting||Phase 1|15|Anticipated|Aelix Therapeutics||2|||f||||f|f|f||||||||2017-10-10 20:54:20.664774|2017-10-10 20:54:20.664774
NCT03204604|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-27|||August 8, 2016|Actual|2016-08-08|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Brain Ketone Body Challenge Imaging Study|The Brain Ketone Body Challenge Imaging Study|Recruiting||N/A|20|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||No||2017-10-10 20:54:20.749311|2017-10-10 20:54:20.749311
NCT03204591|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-29|||July 20, 2017|Anticipated|2017-07-20|June 2017|2017-06-01|January 18, 2019|Anticipated|2019-01-18|October 18, 2018|Anticipated|2018-10-18||Observational|||Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury|Risk of Bacterial Infection in Cirrhotic Patients With Acute Severe Liver Injury: a Multicenter,Prospective, Observational Study|Not yet recruiting||N/A|500|Anticipated|The Zhejiang Study Group for Organ Failure in Cirrhosis|||1||f||||t|f|f||||||No||2017-10-10 20:54:20.843018|2017-10-10 20:54:20.843018
NCT03204578|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-30|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PiSA||Physiological Study of the Human CYP3A Activity (PiSA)|Physiological Study of the Human CYP3A Activity (PiSA)|Recruiting||Phase 4|12|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f|f|f||||||||2017-10-10 20:54:20.914403|2017-10-10 20:54:20.914403
NCT03204565|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-27|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|April 24, 2017|Actual|2017-04-24|April 3, 2017|Actual|2017-04-03||Interventional|||Effectiveness of Adjunctive Hyaluronic Acid Application in Coronally Advanced Flap in Single Gingival Recession Sites|Effectiveness of Adjunctive Hyaluronic Acid Application in Coronally Advanced Flap in Miller Class I Single Gingival Recession Sites|Completed||N/A|30|Actual|University of Roma La Sapienza||2|||f||||f|||||f|||No||2017-10-10 20:54:21.037537|2017-10-10 20:54:21.037537
NCT03204552|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-29|||October 15, 2007|Actual|2007-10-15|June 2017|2017-06-01|December 2027|Anticipated|2027-12-01|December 2027|Anticipated|2027-12-01||Observational|TCHS||Tzu Chi Health Study (Diabetes and Cardiometabolic Health Components)|Dalin Tzu Chi General Hospital|Active, not recruiting||N/A|6002|Actual|Dalin Tzu Chi General Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 20:54:21.146174|2017-10-10 20:54:21.146174
NCT03204539|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-26|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 1, 2022|Anticipated|2022-12-01|December 1, 2022|Anticipated|2022-12-01||Interventional|INITIATE||INdividualized ITI Based on Fviii(ATE) Protection by VWF|INdividualized ITI Based on Fviii(ATE) Protection by VWF (INITIATE)|Recruiting||Phase 4|120|Anticipated|University of California, Davis||2|||f||||t|t|f||||||||2017-10-10 20:54:21.239145|2017-10-10 20:54:21.239145
NCT03204526|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-08-10|||June 2015||2015-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease|Safety and Feasibility of Using Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus to Improve Cognitive Performance in Patients With Parkinson's Disease|Recruiting||Phase 2|20|Anticipated|University of California, Davis||1|||f||||||||||||||2017-10-10 20:54:21.339873|2017-10-10 20:54:21.339873
NCT03204513|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-27|||December 2016||2016-12-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Impact of Powered Knee-Ankle Prosthesis Leg on Everyday Community Mobility and Social Interaction|Impact of Powered Knee-Ankle Prosthesis Leg on Everyday Community Mobility and Social Interaction|Recruiting||N/A|15|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||No||2017-10-10 20:54:21.404723|2017-10-10 20:54:21.404723
NCT03204500|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-30|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Dual Treatment With Lithium and Valproate in ALS.|A Randomized Clinical Trial, Double Blind, Placebo-controlled of Lithium and Valproate in Amyotrophic Lateral Sclerosis.|Recruiting||Phase 2|40|Anticipated|El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez||2|||f||||f|f|f|||f|||||2017-10-10 20:54:23.19459|2017-10-10 20:54:23.19459
NCT03204487|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-22|||May 10, 2016|Actual|2016-05-10|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|April 25, 2017|Actual|2017-04-25||Interventional|||A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness|An Open, Non-randomized Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma on Tear Film Thickness|Completed||Phase 4|30|Actual|Ordination Dr. Hommer||1|||f||||t|f|f||||||||2017-10-10 20:54:23.319671|2017-10-10 20:54:23.319671
NCT03204474|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-08-01|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|||A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male Subjects|A Randomized, Open-Label, Single-Dose, 2-Way Crossover Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male Subjects|Completed||Phase 1|30|Actual|UCB Pharma||2|||f||||f|f|f|||f|||||2017-10-10 20:54:23.401868|2017-10-10 20:54:23.401868
NCT03204461|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-27|||December 3, 2012|Actual|2012-12-03|June 2017|2017-06-01|July 30, 2015|Actual|2015-07-30|July 9, 2015|Actual|2015-07-09||Observational|||Glucose Metabolism in Different PCOS Phenotypes|Associatons of PCOS Phenotypes With Ectopic Lipids, Adipocytokines and Parameters of Insulin Resistance|Completed||N/A|73|Actual|Medical University of Vienna|||3||f|||||f|f||||||||2017-10-10 20:54:23.494407|2017-10-10 20:54:23.494407
NCT03204448|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|May 7, 2018|Anticipated|2018-05-07|May 7, 2018|Anticipated|2018-05-07||Observational|||Clinical Performance of BioCLIA Ro60|Evaluation of Clinical Performance of Serologic Anti-Ro60 Autoantibody Detection Kit on BioCLIA Platform|Enrolling by invitation||N/A|500|Anticipated|HOB Biotech Group|||2||f||||f|f|t|t|f|f|Samples Without DNA|"     Clinically leftover plasma/serum   "|||2017-10-10 20:54:23.577795|2017-10-10 20:54:23.577795
NCT03204435|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|HOT-CIACS||Hybrid Operating Treatment of Coexistence of Intracranial Aneurysms and Cerebrovascular Stenosis|Clinical Trail of Hybrid Operating Technique in Management of Intracranial Aneurysms With Coexistence of Atherosclerotic Intracranial Arterial Stenosis|Recruiting||N/A|196|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t|f|f||||||Undecided|the IPD will be open to public researchers in 6 months after the study closed|2017-10-10 20:54:23.647261|2017-10-10 20:54:23.647261
NCT03204422|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-29|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Estimation Method of 24-hour Urinary Sodium Excretion by Using Spot Urine for Chinese Population|The Exploratory and Validation Study of Estimation Method of 24-hour Urinary Sodium Excretion by Using Spot Urine for Chinese Children and Adults|Recruiting||N/A|400|Anticipated|Beijing Children's Hospital|||2||f||||t|f|f||||Samples Without DNA|"     the 24-h urine sample and the spot urine samples will be required collected and be retained.   "|No||2017-10-10 20:54:23.748662|2017-10-10 20:54:23.748662
NCT03204409|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-30|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 3, 2019|Anticipated|2019-09-03|December 31, 2018|Anticipated|2018-12-31||Observational|ZIKAllianceNH||ZIKAlliance Natural History Study|Longitudinal Clinical and Virological Study Among Symptomatic Patients With Zika Virus Infection in the City of Sao Paulo, Brazil|Not yet recruiting||N/A|1000|Anticipated|University of Heidelberg Medical Center|||1||f||||f|f|f||||Samples With DNA|"     blood, saliva, urine and genital fluid samples   "|||2017-10-10 20:54:23.827565|2017-10-10 20:54:23.827565
NCT03204396|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-29|2017-06-29|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|SKIP||Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues|Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues - a Randomized, Double-blind, Placebo-controlled Trial|Recruiting||Phase 2|256|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f|||f|||No||2017-10-10 20:54:23.899397|2017-10-10 20:54:23.899397
NCT03204370|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-29|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2019|Anticipated|2019-07-01||Observational|||Natural History of Atypical Morquio A Disease|Natural History of Atypical Morquio A Disease: a 5-years Prospective Study in a Series of 9 Adult Patients Followed in a Single Expert Center|Not yet recruiting||N/A|9|Anticipated|Association Aquitaine de Recherche Clinique en Rhumatologie|||1||f|||||t|f||||||||2017-10-10 20:54:24.099543|2017-10-10 20:54:24.099543
NCT03204357|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-29|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|July 2020|Anticipated|2020-07-01||Interventional|||Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass|Targeted Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass: a Prospective Randomized Controlled Trial.|Not yet recruiting||N/A|70|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:54:24.170465|2017-10-10 20:54:24.170465
NCT03204344|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-18|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Preoperative Oral Carbohydrate and Postoperative Recovery in Diabetic Patients|Impact of Preoperative Oral Carbohydrate on Recovery in Diabetic Patients After Gastrointestinal Surgery: a Pilot Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Peking University First Hospital||2|||f||||t|f|f|||f|||||2017-10-10 20:54:24.310309|2017-10-10 20:54:24.310309
NCT03204331|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-10-05|||August 30, 2017|Actual|2017-08-30|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain|SPIRIT 2: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Administered With and Without Low-Dose Estradiol and Norethindrone Acetate in Women With Endometriosis-Associated Pain|Recruiting||Phase 3|600|Anticipated|Myovant Sciences GmbH||3|||f||||t|t|f||||||||2017-10-10 20:54:24.451274|2017-10-10 20:54:24.451274
NCT03204318|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-10-05|||June 27, 2017|Actual|2017-06-27|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain|SPIRIT 1: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Administered With and Without Low-Dose Estradiol and Norethindrone Acetate in Women With Endometriosis-Associated Pain|Recruiting||Phase 3|600|Anticipated|Myovant Sciences GmbH||3|||f||||t|t|f||||||||2017-10-10 20:54:24.583378|2017-10-10 20:54:24.583378
NCT03204305|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-20|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Brain Imaging of Cannabinoid Receptors|Brain Imaging of Cannabinoid Receptors in Women|Recruiting||Early Phase 1|20|Anticipated|Johns Hopkins University||2|||f||||f|t|f||||||||2017-10-10 20:54:24.710731|2017-10-10 20:54:24.710731
NCT03204292|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-06-28|||July 2015||2015-07-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Evaluating the Fluid Balance of Mechanically Ventilated Patients by Ultrasonography|Measurement of the Inferior Vena Cava as a Method of Evaluating the Fluid Balance of Mechanically Ventilated Patients|Completed||N/A|57|Actual|Jagiellonian University|||1||f||||f||||||||No|The assessment of the width of the abdominal aorta was performed above arise of the celiac trunk, at the height of the vein of the lower vena cava. The width of the inferior vena cava and the abdominal aorta was assessed using transthoracic ultrasound for the following five days. Daily differences in the amount of fluid intake and lost was recorded. CVP measurement was performed.|2017-10-10 20:54:24.826643|2017-10-10 20:54:24.826643
NCT03204279|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-20|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CINV||PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting|A Multicenter Multinational Randomized Double Blind PK/PD Dose-finding Study of Oral Netupitant Given With Oral Palonosetron in Pediatric Cancer Patients for Prevention of Nausea and Vomiting Associated With Emetogenic Chemotherapy|Recruiting||Phase 2|92|Anticipated|Helsinn Healthcare SA||2|||f||||t|t|f||||||||2017-10-10 20:54:24.90786|2017-10-10 20:54:24.90786
NCT03204266|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-17|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Oral Supplementation to Enhance Recovery Pilot Study|Oral Supplementation to Enhance Recovery Pilot Study|Recruiting||Early Phase 1|46|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 20:54:25.053293|2017-10-10 20:54:25.053293
NCT03204253|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-06-28|||January 2016||2016-01-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|late-rLH||Effects of Recombinant LH in Patients With Repeated Implantation Failure|Effects of Recombinant LH in Late Phase of Ovarian Stimulation in Patients With Repeated Implantation Failure, Clinical Results|Completed||N/A|60|Actual|University of Roma La Sapienza||2|||f||||f|f|f||||||No||2017-10-10 20:54:25.145144|2017-10-10 20:54:25.145144
NCT03204240|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-23|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|August 2021|Anticipated|2021-08-01||Interventional|SCI||Metabolic Health in Individuals With Spinal Cord Injury (SCI)|Targeting Skeletal Muscle to Improve Metabolic Health in Individuals With Spinal Cord Injury (SCI)|Not yet recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f||||||||2017-10-10 20:54:25.211921|2017-10-10 20:54:25.211921
NCT03200418|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-18|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|October 3, 2017|Anticipated|2017-10-03|September 28, 2017|Anticipated|2017-09-28||Interventional|||Evaluation of the Effect of Output on Newly Developed Adhesives|Evaluation of the Effect of Output on Newly Developed Adhesives|Recruiting||N/A|6|Anticipated|Coloplast A/S||1|||f||||f|f|f||||||||2017-10-10 20:54:57.971691|2017-10-10 20:54:57.971691
NCT03204227|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-14|||June 2, 2017|Actual|2017-06-02|September 2017|2017-09-01|September 6, 2017|Actual|2017-09-06|August 12, 2017|Actual|2017-08-12||Interventional|JECEVAX-2B||Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age|Evaluate the Safety of a Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) Produced by The Company for Vaccine and Biological Production No.1 in Vietnamese Children Aged 9-24 Months|Completed||Phase 2|220|Actual|National Institute of Hygiene and Epidemiology, Vietnam||2|||f||||t|f|f||||||||2017-10-10 20:54:25.300291|2017-10-10 20:54:25.300291
NCT03204214|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-11|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|BACH||Binge Drinking And Addiction : Case-Control Study in Hospital|Binge Drinking And Addiction : Case-Control Study in Hospital|Recruiting||N/A|252|Anticipated|University Hospital, Rouen|||1||f||||f|f|f||||||||2017-10-10 20:54:25.384832|2017-10-10 20:54:25.384832
NCT03204201|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-11|||July 11, 2017|Actual|2017-07-11|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Validation of ICG to Identify the Urethra During Rectal Surgery|Validation of ICG to Identify the Urethra During Rectal Surgery|Enrolling by invitation||Phase 1/Phase 2|30|Anticipated|Oxford University Hospitals NHS Trust||1|||f||||f|f|f||||||||2017-10-10 20:54:25.448321|2017-10-10 20:54:25.448321
NCT03204188|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-09-23|||September 22, 2017|Actual|2017-09-22|September 22, 2017|2017-09-22|March 30, 2027|Anticipated|2027-03-30|March 30, 2027|Anticipated|2027-03-30||Interventional|||Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|A Phase II Study Of Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|Recruiting||Phase 2|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||t|||||t|f||||||||2017-10-10 20:54:25.513193|2017-10-10 20:54:25.513193
NCT03204175|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-08-23|||July 10, 2017|Actual|2017-07-10|June 2017|2017-06-01|December 10, 2017|Anticipated|2017-12-10|December 10, 2017|Anticipated|2017-12-10||Interventional|||Fit Plus: Assessing the Impact of a School-based Intervention on Toilet Quality|A Randomised Control Trial of a Sanitation Operation and Management Intervention in Elementary Schools in the Philippines (Fit for School Plus)|Enrolling by invitation||N/A|8000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f|f|f||||||||2017-10-10 20:54:25.607821|2017-10-10 20:54:25.607821
NCT03204162|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-28|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Optimizing Integration of CPR Feedback Technology With CPR Coaching for Cardiac Arrest|Optimizing Integration of CPR Feedback Technology With CPR Coaching for Cardiac Arrest|Not yet recruiting||N/A|180|Anticipated|Express Collaborative||2|||f||||f|f|f||||||No||2017-10-10 20:54:25.675476|2017-10-10 20:54:25.675476
NCT03204149|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-07-02|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Safety of Low Level Laser Device Treatment in Chronic Wounds|Evaluation of Safety of Low Level Laser MC-8XL Device Treatment in Chronic Wounds|Recruiting||Phase 1|15|Anticipated|Medical Coherence LLC||2|||f|||||f|f||||||||2017-10-10 20:54:25.899414|2017-10-10 20:54:25.899414
NCT03204136|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-27|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|April 1, 2019|Anticipated|2019-04-01||Observational|||Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease|Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease: an Open-label, Retrospective Study|Not yet recruiting||N/A|60|Anticipated|Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, China|||2||f|||||f|f||||||||2017-10-10 20:54:25.980346|2017-10-10 20:54:25.980346
NCT03204123|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of PET/CT Scan With 68Ga-labeled PSMA Ligand to Evaluate Prostate Cancer After Radical Prostatectomy|PSMA PET Imaging of Recurrent Prostate Cancer|Recruiting||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center||2||||||||t|f||||||||2017-10-10 20:54:26.058313|2017-10-10 20:54:26.058313
NCT03204110|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-06-27|||March 6, 2012|Actual|2012-03-06|June 2017|2017-06-01|August 23, 2016|Actual|2016-08-23|July 11, 2016|Actual|2016-07-11||Observational|SVC-2R||Retinal Patterns in Reversible Cerebral Vasoconstriction Syndrome|Non Invasive Assessment of Morphological and Functional Retinal Patterns in Reversible Cerebral Vasoconstriction Syndrome Using Transorbital Echotomography Doppler, Retinography and Retinal Vessel Analyser|Completed||N/A|23|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 20:54:26.173493|2017-10-10 20:54:26.173493
NCT03204097|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Local Host Modulating Agents Alendronate & Aloe Vera for Treatment of Furcation Defects in Chronic Periodontitis|1% Alendronate and Aloevera Gel Local Host Modulating Agents in Chronic Periodontitis Subjects With Class II Furcation Defects: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|90|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||||||||||||2017-10-10 20:54:26.253409|2017-10-10 20:54:26.253409
NCT03204084|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-26|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Observational|||Assessment of Low-temperature Plasma Surgery System in Pterygium With Fibrin Glue and Conjunctival Autografts|Assessment of Low-temperature Plasma Surgery System in Pterygium With Fibrin Glue and Conjunctival Autografts|Completed||N/A|56|Actual|Zhongshan Ophthalmic Center, Sun Yet-sen University|||2||f|||||f|f||||||Undecided||2017-10-10 20:54:26.343462|2017-10-10 20:54:26.343462
NCT03204071|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Locally Delivered Metformin and Aloe Vera for Treatment of Intrabody Defects in Chronic Periodontitis|COMPARATIVE EVALUATION OF SUBGINGIVALLY DELIVERED 1% METFORMIN AND ALOE VERA GEL IN TREATMENT OF INTRABODY DEFECTS IN CHRONIC PERIODONTITIS SUBJECTS: A RANDOMIZED CONTROLLED CLINICAL TRIAL|Completed||Phase 2/Phase 3|90|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||||||||||||2017-10-10 20:54:26.435498|2017-10-10 20:54:26.435498
NCT03204058|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||February 10, 2016|Actual|2016-02-10|June 2017|2017-06-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||Locally Delivered Metformin & Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis|Comparative Evaluation of Locally Delivered 1% Metformin and 1.2% Rosuvastatin Gel in Treatment of Intrabony Defects in Chronic Periodontitis Subjects: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|90|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||f||||||||||2017-10-10 20:54:26.53488|2017-10-10 20:54:26.53488
NCT03204045|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-05|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|June 5, 2017|Actual|2017-06-05|May 5, 2017|Actual|2017-05-05||Interventional|||Comparison of the Effects of Oxycodone Versus Fentanyl on Airway Reflex to Tracheal Extubation and Postoperative Pain|Comparison of the Effects of Oxycodone Versus Fentanyl on Airway Reflex to Tracheal Extubation and Postoperative Pain During Recovery of Anesthesia After Laparoscopic Cholecystectomy|Completed||N/A|90|Actual|Yeungnam University College of Medicine||3|||f||||t|f|f||||||||2017-10-10 20:54:26.626223|2017-10-10 20:54:26.626223
NCT03204032|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor|A Phase II Randomized,Controlled,Open Label,Multicentre Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor|Recruiting||Phase 2|60|Anticipated|Chinese Academy of Medical Sciences||2|||f|||||f|f||||||||2017-10-10 20:54:26.718544|2017-10-10 20:54:26.718544
NCT03204019|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor|A Phase II Randomized,Controlled,Open Label,Multicentre Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor|Recruiting||Phase 2|60|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f|f|f|||f|||||2017-10-10 20:54:26.813638|2017-10-10 20:54:26.813638
NCT03204006|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.|Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients|Recruiting||N/A|70|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:54:26.904236|2017-10-10 20:54:26.904236
NCT03203993|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-27|||September 30, 2017|Anticipated|2017-09-30|June 2017|2017-06-01|March 31, 2024|Anticipated|2024-03-31|March 31, 2024|Anticipated|2024-03-31||Observational|CRONUS||China Ovarian Cancer BRCA Testing Study|China Local BRCA Testing and Exploration of Ovarian Cancer Treatment Outcomes of Different BRCA Status in Newly Diagnosed Epithelial Ovarian Cancer Patients|Not yet recruiting||N/A|900|Anticipated|AstraZeneca|||1||f||||f|f|f||||Samples With DNA|"     Whole blood, tumor tissue   "|No||2017-10-10 20:54:26.981942|2017-10-10 20:54:26.981942
NCT03203980|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-06|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|July 15, 2018|Anticipated|2018-07-15|January 15, 2018|Anticipated|2018-01-15||Observational|HEMOTRI||Bleeding Events After Triple Antithrombotic Therapy Initiation.|Bleeding Events After Triple Antithrombotic Therapy Initiation: a Prospective Observational Study in Real Life|Not yet recruiting||N/A|200|Anticipated|Central Hospital, Nancy, France|||1||f||||t|f|f||||||||2017-10-10 20:54:27.047269|2017-10-10 20:54:27.047269
NCT03203967|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-28|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|May 30, 2018|Anticipated|2018-05-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty|Effect of Low-dose Epidural Morphine Combined With Single-injection Femoral Nerve Block on Postoperative Analgesia in Patients After Total Knee Arthroplasty|Recruiting||N/A|110|Anticipated|Peking University First Hospital||2|||f||||t|f|f|||f|||Yes||2017-10-10 20:54:27.106083|2017-10-10 20:54:27.106083
NCT03203954|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-28|||May 1, 2016|Actual|2016-05-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Testing the Neuroscience of Guided Learning in Depression|Neural Substrates of Reinforcement Learning and Its Training in Major Depression|Recruiting||N/A|216|Anticipated|Virginia Polytechnic Institute and State University||3|||f||||f|f|f||||||Yes|following study completion, de-identified data will be made available to approved researchers and may be requested from the principal investigator|2017-10-10 20:54:27.231152|2017-10-10 20:54:27.231152
NCT03203941|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-26||||||June 2017|2017-06-01||||||||Expanded Access|||ACT for CP Individual Patient Expanded Access IND Protocol|Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP) Individual Patient Expanded Access IND Protocol|No longer available||N/A|||The University of Texas Health Science Center, Houston||||||t||t|||||||||||2017-10-10 20:54:27.330058|2017-10-10 20:54:27.330058
NCT03203928|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|June 23, 2018|Anticipated|2018-06-23||Interventional|||Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD|Effectiveness of a Tailored Occupational Therapy Intervention for Women With Attention-Deficit/Hyperactivity Disorder (ADHD)|Not yet recruiting||N/A|24|Anticipated|Columbia University||2|||f||||t|f|f||||||No||2017-10-10 20:54:27.400243|2017-10-10 20:54:27.400243
NCT03203915|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Metabolic Response to Chardonnay Grape Pomace Powder|Metabolic Response to Chardonnay Grape Pomace Powder|Recruiting||N/A|32|Anticipated|USDA, Western Human Nutrition Research Center||6|||f||||f|f|f||||||||2017-10-10 20:54:27.48543|2017-10-10 20:54:27.48543
NCT03203902|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparative Effectiveness of Stress Management|Comparative Effectiveness of Stress Management Using Psychoeducation Versus Therapeutic Touch for Formerly Homeless Adults With Mental Illness and Substance Use Histories|Not yet recruiting||N/A|30|Anticipated|Columbia University||3|||f||||t|f|f||||||No||2017-10-10 20:54:27.590553|2017-10-10 20:54:27.590553
NCT03203889|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||June 27, 2017|Actual|2017-06-27|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|CRAFT-AI||Testing Effectiveness of the Community Reinforcement Approach and Family Training (CRAFT) With American Indians|Randomized Controlled Trial of CRAFT With American Indians|Recruiting||N/A|40|Anticipated|University of New Mexico||2|||f||||t|f|f||||||No|Sharing of these data will have to be negotiated with tribal partner.|2017-10-10 20:54:27.676024|2017-10-10 20:54:27.676024
NCT03203720|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-30|||July 11, 2011|Actual|2011-07-11|June 2017|2017-06-01|December 30, 2014|Actual|2014-12-30|December 30, 2014|Actual|2014-12-30||Interventional|BMI||Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder|Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder|Completed||N/A|45|Actual|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 20:54:29.345228|2017-10-10 20:54:29.345228
NCT03203876|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-10-02|||July 5, 2017|Actual|2017-07-05|September 2017|2017-09-01|October 17, 2018|Anticipated|2018-10-17|October 16, 2018|Anticipated|2018-10-16||Interventional|||A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors|A Phase 1 Study of the Safety and Pharmacokinetics of Anti-KIR Monoclonal Antibody (Lirilumab, BMS-986015) in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab,BMS-936558) or in Combination With Nivolumab and Anti-CTLA-4 Monoclonal Antibody (Ipilimumab, BMS-734016) in Advanced and/or Metastatic Solid Tumors|Recruiting||Phase 1|21|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f|||t|||||2017-10-10 20:54:27.766758|2017-10-10 20:54:27.766758
NCT03203863|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-28|||April 1, 2009|Actual|2009-04-01|June 2017|2017-06-01|April 30, 2012|Actual|2012-04-30|December 24, 2011|Actual|2011-12-24||Observational|||Metabolic Syndrome in Children and Adolescents|Metabolic Syndrome in Adolescents. Associations With Endothelial Dysfunction and Early Programming Influences|Completed||N/A|3325|Actual|Pontificia Universidad Catolica de Chile|||1||f||||f||||||||No||2017-10-10 20:54:27.891318|2017-10-10 20:54:27.891318
NCT03203850|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-28|||October 3, 2017|Anticipated|2017-10-03|June 2017|2017-06-01|November 24, 2020|Anticipated|2020-11-24|November 24, 2020|Anticipated|2020-11-24||Interventional|||A Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis.|A Phase II, Multicenter, Open-label, Randomized Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis.|Not yet recruiting||Phase 2|150|Anticipated|Novartis||2|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 20:54:27.970567|2017-10-10 20:54:27.970567
NCT03203837|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-12|||July 5, 2017|Actual|2017-07-05|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®|Biomarker Analyses in Hepatocellular Carcinoma Patients Treated With Therasphere®|Recruiting||N/A|25|Anticipated|Northwestern University|||1||f||||f|f|f||||Samples With DNA|"     Any leftover patient plasma samples collected for this study will be retained for future     research which may or may not involve genetic testing.   "|||2017-10-10 20:54:28.066966|2017-10-10 20:54:28.066966
NCT03203824|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-27|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals|The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals|Recruiting||N/A|10|Anticipated|Loma Linda University||2|||f||||f|f|f||||||||2017-10-10 20:54:28.221289|2017-10-10 20:54:28.221289
NCT03203811|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-08|||February 17, 2017|Actual|2017-02-17|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 1, Study to Evaluate HTI-2088 Tablet|A Phase 1, Double-blind, Placebo-Controlled, Single Oral Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTI-2088 Tablet in Healthy Adult Subjects|Recruiting||Phase 1|40|Anticipated|Hengrui Therapeutics, Inc.||3|||f||||t|t|f||||||||2017-10-10 20:54:28.329492|2017-10-10 20:54:28.329492
NCT03203798|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||September 1, 2016|Actual|2016-09-01|June 2017|2017-06-01|December 26, 2017|Anticipated|2017-12-26|September 26, 2017|Anticipated|2017-09-26||Interventional|||Effects of Training of Pelvic Floor Muscles (MAP) on Stress Urinary Incontinence|Effects of Pelvic Floor Muscle Training or Hipopressive Abdominal Gymnastics in the Treatment of Women's Stress Urinary Incontinence: a Prospective, Randomized, Controlled Study|Recruiting||N/A|42|Anticipated|Federal University of Uberlandia||2|||f||||t|f|f||||||No||2017-10-10 20:54:28.537301|2017-10-10 20:54:28.537301
NCT03203785|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Effect of Carbohydrate Consumption on Fatigue and Muscle Damage in Jiu-Jitsu Athletes|Effect of Carbohydrate Consumption on Fatigue and Muscle Damage in Jiu-Jitsu Athletes: A Randomized Clinical Trial|Recruiting||N/A|16|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t|f|f||||||Undecided||2017-10-10 20:54:28.655892|2017-10-10 20:54:28.655892
NCT03203772|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-12|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Immersive Virtual Reality for Neuropathic Pain|Management of Pain in Limb Neuropathic Conditions Through Immersive Virtual Reality|Recruiting||N/A|20|Anticipated|Loma Linda University||1|||f|||||f|f||||||||2017-10-10 20:54:28.807499|2017-10-10 20:54:28.807499
NCT03203759|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-07|||June 6, 2017|Actual|2017-06-06|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Hospital-Level Care at Home for Acutely Ill Adults|Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial|Recruiting||N/A|90|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:54:28.921142|2017-10-10 20:54:28.921142
NCT03203746|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-06-28|||September 28, 2015|Actual|2015-09-28|June 2017|2017-06-01|December 14, 2016|Actual|2016-12-14|November 10, 2016|Actual|2016-11-10||Interventional|||Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis|Gingival Crevicular Fluid Levels of Protein Carbonyl Oxidative Stress Biomarker Following the Use of Locally Delivered Lycopene Antioxidants in Patients With Chronic Periodontitis - Randomized Clinical Trial|Completed||Phase 1/Phase 2|24|Actual|Ain Shams University||3|||f||||f||||||||No||2017-10-10 20:54:29.133712|2017-10-10 20:54:29.133712
NCT03203733|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-24|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cryoprotection of Chemotherapy-induced Oral Mucositis After Autologous Stem Cell Transplantation, a Randomized Study|Cryoprotection of Chemotherapy-induced Oral Mucositis After Autologous Stem Cell Transplantation, a Randomized Study|Not yet recruiting||N/A|180|Anticipated|Uppsala University||2|||f|||||f|f||||||||2017-10-10 20:54:29.231019|2017-10-10 20:54:29.231019
NCT03203707|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-26|||April 1, 2011|Actual|2011-04-01|June 2017|2017-06-01|February 28, 2015|Actual|2015-02-28|February 28, 2015|Actual|2015-02-28||Interventional|||Early Assessment and Intervention for Adolescents at Risk for Bipolar Disorder|Early Assessment and Intervention for Adolescents at Risk for Bipolar Disorder|Completed||N/A|50|Actual|University of Pittsburgh||2|||f||||f|f|f||||||No||2017-10-10 20:54:29.435511|2017-10-10 20:54:29.435511
NCT03203694|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-10-03|||January 1, 2018|Anticipated|2018-01-01|October 2017|2017-10-01|June 1, 2022|Anticipated|2022-06-01|January 1, 2022|Anticipated|2022-01-01||Interventional|||Effects of Walking on Vascular Function in Diabetic Patients|Restoring Vasodilator Actions of Insulin in Patients With Type 2 Diabetes|Not yet recruiting||N/A|30|Anticipated|University of Missouri-Columbia||2|||f||||t|f|f||||||||2017-10-10 20:54:29.530606|2017-10-10 20:54:29.530606
NCT03203681|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-25|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters|Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters|Not yet recruiting||Phase 4|40|Anticipated|University of Miami||1|||||||t|t|f|||f|||||2017-10-10 20:54:29.608661|2017-10-10 20:54:29.608661
NCT03203668|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-30|||January 1, 2013|Actual|2013-01-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||18F-fluorocholine PET/CT Imaging in Hyperparathyroidism|Diagnostic Value of 18F-fluorocholine PET/CT Imaging in Localization of Hyperfunctioning Parathyroid Tissue in Hyperparathyroidism|Recruiting||N/A|1000|Anticipated|University Medical Centre Ljubljana||1|||f||||f|f|f||||||||2017-10-10 20:54:29.708046|2017-10-10 20:54:29.708046
NCT03203655|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Text Based Mobile Technology and Weight Loss|Efficacy of a Culturally Sensitive and Linguistically Appropriate Internet and Mobile-based Weight Loss Therapy in Obese Hispanic/Latino Adult Women|Not yet recruiting||N/A|40|Anticipated|Washington University School of Medicine||2|||f||||f|f|f||||||No||2017-10-10 20:54:29.80961|2017-10-10 20:54:29.80961
NCT03203629|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-27|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01|3 Months|Observational [Patient Registry]|HEARIT-Reg||Heart Sounds Registry|Heart Sounds Registry In Patients Using The Wearable Cardioverter Defibrillator (HEARIT-Registry) Study Protocol|Recruiting||N/A|300|Anticipated|Zoll Medical Corporation|||1||f||||f|f|t|f|f|t|||No||2017-10-10 20:54:30.087993|2017-10-10 20:54:30.087993
NCT03203616|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-27|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|KIARA||Kadcyla In pAtients With bRAin Metastasis|Multicenter, Non-randomised, Open-label, Single Agent Phase II Study to Determine the Clinical Benefit of Trastuzumab Emtansine (T-DM1) in HER2-positive Metastatic Breast Cancer Patients With Brain Metastasis|Not yet recruiting||Phase 2|97|Anticipated|Jules Bordet Institute||1|||f|||||f|f||||||No||2017-10-10 20:54:30.188475|2017-10-10 20:54:30.188475
NCT03203603|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-07|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Observational|VCSIPRenewal||VCSIP Follow-up Study|Vitamin C to Decrease the Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP): Follow-up of a Randomized Trial|Recruiting||N/A|240|Anticipated|Oregon Health and Science University|||3||f||||t|f|f||||Samples With DNA|"     buccal swabs, hair, blood and urine will be collected.   "|||2017-10-10 20:54:30.299024|2017-10-10 20:54:30.299024
NCT03203590|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-28|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01||Interventional|||Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC Patients|Oral Navelbine Carboplatin Versus Gefitinib Neoadjuvant Therapy for Resectable EGFR Mutation Positive Stage Ⅱ-ⅢA NSCLC, Prospective, Randomized, Multicenter, Phase Ⅲ Clinical Trial|Not yet recruiting||Phase 3|590|Anticipated|Sun Yat-sen University||2|||f||||t|f|f|||f|||Yes||2017-10-10 20:54:30.423326|2017-10-10 20:54:30.423326
NCT03203577|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-26|||July 2015||2015-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|Homerun||Initiation of Home Mechanical Ventilation at Home in Patients With Chronic Hypercapnic Respiratory Failure|Initiation of Home Mechanical Ventilation at Home in a Selectve Group of Patients With Chronic Hypercapnic Respiratory Failure in the Netherlands|Recruiting||N/A|96|Anticipated|University Medical Center Groningen||2|||f||||t||||||||No||2017-10-10 20:54:30.557213|2017-10-10 20:54:30.557213
NCT03203551|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-29|||September 1, 2014|Actual|2014-09-01|June 2017|2017-06-01|July 1, 2016|Actual|2016-07-01|January 1, 2016|Actual|2016-01-01||Interventional|||Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous.|Clinical and Laboratorial Evaluation of the Effect of Sodium Hypochlorite, Chloramine T and Ricinus Communis Solutions in Candida Species Identified in the Biofilm of Total Prostheses and Palate of Total Edentulous Individuals.|Completed||N/A|108|Actual|University of Sao Paulo||4|||f||||t|f|f||||||||2017-10-10 20:54:30.758904|2017-10-10 20:54:30.758904
NCT03203538|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-05|||August 25, 2017|Actual|2017-08-25|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Light Intervention for Adaptation to Night Work|Effects of Bright Light Intervention for Adaptation to Night Work: Shift Work Simulation Experiments|Enrolling by invitation||N/A|102|Anticipated|University of Bergen||6|||f||||f|f|f||||||||2017-10-10 20:54:30.847844|2017-10-10 20:54:30.847844
NCT03203525|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Study of the NovoTTF-100L System to Enhance Antitumor Activity in Patients With Predominant Hepatic Metastatic Cancer|A Phase I Study of the NovoTTF-100L System to Enhance Antitumor Activity in Patients With Predominant Hepatic Metastatic Cancer|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||2||IND not received|f||||f|t|t|f|||||||2017-10-10 20:54:30.964822|2017-10-10 20:54:30.964822
NCT03203512|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-27|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HI-FIVE||Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles|Effects of Fish Oil-derived N-3 Polyunsaturated Fatty Acids on the Generation and Functional Activities of Extracellular Vesicles|Not yet recruiting||N/A|40|Anticipated|University of Reading||2|||f||||t|f|f||||||||2017-10-10 20:54:31.073408|2017-10-10 20:54:31.073408
NCT03203499|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-07-27|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol|A Phase 1b, Proof of Concept, Dose-Ranging Study to Evaluate the Safety of the Coadministration of Ascending Doses of ANS-6637 and Ethanol in Healthy Male Moderate Drinkers|Recruiting||Phase 1|48|Anticipated|Amygdala Neurosciences, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:54:31.156233|2017-10-10 20:54:31.156233
NCT03203486|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-27|||April 2014|Actual|2014-04-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Response of NAFLD Patients to Mediterranean Diet|The Effectiveness of a Mediterranean Diet Intervention in NAFLD Clinical Course|Completed||N/A|44|Actual|Harokopio University||1|||f||||f|f|f||||||No||2017-10-10 20:54:31.235478|2017-10-10 20:54:31.235478
NCT03203460|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-28|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2018|Anticipated|2018-12-15||Interventional|ERASE||Exercise During Active Surveillance for Prostate Cancer|A Phase II Randomized Controlled Trial of Exercise in Prostate Cancer Patients Undergoing Active Surveillance|Not yet recruiting||N/A|66|Anticipated|University of Alberta||2|||f||||f|f|f||||||No||2017-10-10 20:54:31.428392|2017-10-10 20:54:31.428392
NCT03203447|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-28|2017-06-28|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|TOPAZ||Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO|A Randomized, Masked, Controlled Trial to Study the Safety and Efficacy of Suprachoroidal CLS-TA With Intravitreal Aflibercept in Subjects With Retinal Vein Occlusion|Not yet recruiting||Phase 3|460|Anticipated|Clearside Biomedical, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:54:31.549399|2017-10-10 20:54:31.549399
NCT03203434|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||January 1, 2015|Actual|2015-01-01|June 2017|2017-06-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01|30 Days|Observational [Patient Registry]|||Non-invasive Detection of Anastomotic Leakage|Non-invasive Detection of Anastomotic Leakage Following Esophageal and Pancreatic Surgery by Urinary Analysis|Completed||N/A|66|Actual|VU University Medical Center|||4||f||||f|f|f||||Samples Without DNA|"     Urine samples   "|No||2017-10-10 20:54:31.67234|2017-10-10 20:54:31.67234
NCT03203421|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-01|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2|A Phase I/II Study to Assess the Safety, Immunogenicity and Protective Efficacy of Novel Malaria Vaccine Candidates ChAdOx1 LS2 and MVA LS2 in Healthy UK Adults|Recruiting||Phase 1/Phase 2|31|Anticipated|University of Oxford||4|||f|||||f|f||||||||2017-10-10 20:54:31.777925|2017-10-10 20:54:31.777925
NCT03203395|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-27|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|January 1, 2018|Anticipated|2018-01-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Screening for Depression and Anxiety in Patients With Heart Disease|Screening for Depression and Anxiety in Patients With Heart Disease|Enrolling by invitation||N/A|200|Anticipated|Diakonhjemmet Hospital||1|||f||||f|f|f||||||No||2017-10-10 20:54:31.963367|2017-10-10 20:54:31.963367
NCT03203382|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-06-27|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Corneal Nerve Structure in Sjogren's||Completed||N/A|100|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 20:54:32.039587|2017-10-10 20:54:32.039587
NCT03203369|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-13|||June 28, 2017|Actual|2017-06-28|September 2017|2017-09-01|June 15, 2022|Anticipated|2022-06-15|December 15, 2021|Anticipated|2021-12-15||Interventional|ABC123||Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN|Phase 1, Open-label Dose-escalation and Dose-expansion Study to Evaluate the Safety, Expansion, Persistence and Clinical Activity of a Single Dose of UCART123 (Allogeneic Engineered T-cells Expressing Anti-CD123 Chimeric Antigen Receptor), Administered in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)|Suspended||Phase 1|72|Anticipated|Cellectis S.A.||2||The protocol is being revised; the trial will resume once revisions are made.|f||||t|t|f||||||||2017-10-10 20:54:32.786216|2017-10-10 20:54:32.786216
NCT03203356|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-27|||May 30, 2016|Actual|2016-05-30|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|May 1, 2017|Actual|2017-05-01||Observational|||Adrenal Function in GHD Children|Evaluation of Adrenal Function Before and After GH Treatment in GHD Affected by GH Deficiency|Completed||N/A|30|Actual|University of Palermo|||2||f||||t|f|f||||||No|IPD will be available just for our study|2017-10-10 20:54:32.869679|2017-10-10 20:54:32.869679
NCT03203343|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-27|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 25, 2018|Anticipated|2018-12-25|December 1, 2018|Anticipated|2018-12-01||Interventional|||Inflammatory Stress Response in Pediatric Inguinal Hernia Repair|Comparison of Inflammatory Stress Response Between Laparoscopic and Open Approach for Pediatric Inguinal Hernia Repair|Recruiting||N/A|60|Anticipated|University Hospital of Split||2|||f||||f|f|f||||||Yes|Just investigators have insight in patient data, no such data (names and private data) would be written in the study for publishing|2017-10-10 20:54:32.953444|2017-10-10 20:54:32.953444
NCT03203330|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||April 1, 2018|Anticipated|2018-04-01|June 2017|2017-06-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade (KLG) 2 or 3 Osteoarthritis of the Knee|Not yet recruiting||Phase 3|510|Anticipated|TissueGene, Inc.||2|||f||||t|t|f||||||No||2017-10-10 20:54:33.07593|2017-10-10 20:54:33.07593
NCT03203317|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-29|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|July 26, 2017|Actual|2017-07-26|July 26, 2017|Actual|2017-07-26||Interventional|||Myocellular Signalling in Skeletal Muscle|Insulin-dependent and Exercise-induced Myocellular Signalling in Skeletal Muscle|Completed||N/A|8|Actual|University of Copenhagen||2|||f||||t|f|f||||||||2017-10-10 20:54:33.1872|2017-10-10 20:54:33.1872
NCT03203304|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-08|||August 25, 2017|Actual|2017-08-25|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Study of Stereotactic Body Radiotherapy (SBRT) Followed by Nivolumab or Ipilimumab With Nivolumab in Unresectable Hepatocellular Carcinoma|Phase I Study of Stereotactic Body Radiotherapy (SBRT) Followed by Nivolumab or Ipilimumab With Nivolumab in Unresectable Hepatocellular Carcinoma|Recruiting||Phase 1|50|Anticipated|University of Chicago||2|||f||||t|t|f|||f|||||2017-10-10 20:54:33.295887|2017-10-10 20:54:33.295887
NCT03203291|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-06-28|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|April 1, 2018|Anticipated|2018-04-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Reducing Assymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients|The Integration of Motor Learning Principles to Reduce Load Asymmetry Using a Novel Robotic Device in Individuals Chronically Post-Stroke|Recruiting||N/A|12|Anticipated|Columbia University||1|||f||||f|f|f||||||No||2017-10-10 20:54:33.40461|2017-10-10 20:54:33.40461
NCT03203278|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-16|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Web-based Exercise for South Asian People With Type 2 Diabetes|Web-based Exercise Intervention for South Asian People With Type 2 Diabetes: a Randomised Controlled Trial|Not yet recruiting||N/A|40|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f|f|f||||||||2017-10-10 20:54:33.49872|2017-10-10 20:54:33.49872
NCT03203265|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-26|||April 6, 2015|Actual|2015-04-06|July 2017|2017-07-01|December 1, 2022|Anticipated|2022-12-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Innovative Strategy to Offer Online Test and Treat for Thai MSM/TG|Thai Red Cross AIDS Research Centre (TRCARC)|Recruiting||N/A|600|Anticipated|Thai Red Cross AIDS Research Centre||3|||f||||t|f|f||||||||2017-10-10 20:54:33.605581|2017-10-10 20:54:33.605581
NCT03203252|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-28|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Observational|3D-SI||Pilot Study for 3-Dimensional Surface Imaging in Implant-based Breast Reconstruction|Pilot Study Towards Development of an Objective Evaluation of Outcome After Implant-based Breast Reconstruction, Using 3D-surface Imaging (3D-SI) and the Feasibility of a Novel Online Research Tool.|Recruiting||N/A|50|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f|f|f||||||No||2017-10-10 20:54:33.699067|2017-10-10 20:54:33.699067
NCT03203239|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Red Light Treatment in Peripheral Artery Disease|Vasodilatory Effects of Light on Peripheral Artery Disease|Not yet recruiting||N/A|40|Anticipated|Medical College of Wisconsin||1|||f||||f|f|f|||f|||No||2017-10-10 20:54:33.794524|2017-10-10 20:54:33.794524
NCT03203226|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-29|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|January 30, 2017|Actual|2017-01-30|December 28, 2016|Actual|2016-12-28||Interventional|||The Feldenkrais Method for People With Intellectual Disability|The Feldenkrais Method for Improving Functioning and Body Balance in People With Intellectual Disability: a Randomized Clinical Trial|Completed||N/A|60|Actual|Basque Country University||2|||f||||t|f|f||||||No||2017-10-10 20:54:33.875305|2017-10-10 20:54:33.875305
NCT03203213|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-12|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Interventional|Musitox®||Musitox® Project: Consumption of Psychoactive Substances at Music Festivals in Aquitaine|Musitox® Project: Consumption of Psychoactive Substances at Music Festivals in Aquitaine|Completed||N/A|25|Actual|University Hospital, Bordeaux||1|||f||||f|f|f||||||||2017-10-10 20:54:33.957182|2017-10-10 20:54:33.957182
NCT03203200|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-06-27|||August 2015||2015-08-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ZETRA||A Cognitive Behavioral And Structural HIV Prevention Intervention for Young Ugandan Sex Workers|A Cognitive Behavioral And Structural HIV Prevention Intervention for Young Ugandan Women Engaging in High Risk Sexual Behavior|Recruiting||N/A|450|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 20:54:34.036867|2017-10-10 20:54:34.036867
NCT03203187|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-10|||October 2, 2016|Actual|2016-10-02|August 2017|2017-08-01|August 14, 2026|Anticipated|2026-08-14|July 14, 2026|Anticipated|2026-07-14||Interventional|||The Effect of Daily Mango Intake on Cardiovascular Health|The Effect of Daily Mango Intake (Mangifera Indica L.) on Cardiovascular Health|Recruiting||N/A|25|Anticipated|University of California, Davis||2|||f|||||f|f||||||||2017-10-10 20:54:34.114546|2017-10-10 20:54:34.114546
NCT03203174|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-14|||January 2015||2015-01-01|July 2017|2017-07-01|August 2, 2016|Actual|2016-08-02|August 2, 2016|Actual|2016-08-02||Interventional|||The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis|The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis|Completed||Phase 1|13|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 20:54:34.196743|2017-10-10 20:54:34.196743
NCT03203161|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-21|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|July 2027|Anticipated|2027-07-01|July 2027|Anticipated|2027-07-01||Observational|ROSA||Registry on Obesity Surgery in Adolescents|A Prospective Observational Cohort Study Collecting Coordinated Clinical, Epidemiological, and Behavioural Data to Assess Safety and Efficacy of Surgical Treatment in Adolescent Morbid Obese Patients|Not yet recruiting||N/A|50|Anticipated|Queen Fabiola Children's University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:54:34.287227|2017-10-10 20:54:34.287227
NCT03203148|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-28|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Observational|||Two Monitors for Measuring the Activated Clotting Time: A Comparison|Comparison of Two Point of Care Techniques Mechanical Versus Biochemical Activated Clotting Time|Recruiting||N/A|20|Anticipated|Umeå University|||1||f||||f|f|f||||||No||2017-10-10 20:54:34.41037|2017-10-10 20:54:34.41037
NCT03203135|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-28|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|March 30, 2019|Anticipated|2019-03-30|September 30, 2018|Anticipated|2018-09-30||Interventional|PREV'HODE||Assesment of the Impact of a Nutritional Prevention Programme for Employees in Staggered Hours.|Assesment of the Impact of a Nutritional Prevention Programme for Employees in Staggered Hours.|Recruiting||N/A|185|Anticipated|Institut Pasteur de Lille||2|||f|||||f|f||||||||2017-10-10 20:54:34.50609|2017-10-10 20:54:34.50609
NCT03203122|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||August 7, 2017|Anticipated|2017-08-07|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa|The Effect of Intense Pulsed Light Assisted Hair Removal Therapy on Mild and Moderate Cases of Hidrosadenitis Suppurativa|Recruiting||N/A|20|Anticipated|Zealand University Hospital||2|||f||||t|f|f||||||No|Will not be shared|2017-10-10 20:54:34.594919|2017-10-10 20:54:34.594919
NCT03203109|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-21|||January 2012|Actual|2012-01-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Observational|DOBRAS-R||Determinants of Balance Recovery After Stroke - Retrospective Study|Determinants of Balance Recovery After Stroke|Completed||N/A|300|Actual|University Hospital, Grenoble|||1||f||||f|f|f||||||||2017-10-10 20:54:34.68087|2017-10-10 20:54:34.68087
NCT03203096|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-26|||January 15, 2017|Actual|2017-01-15|June 2017|2017-06-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Interventional|||Magnesium Supplementation in Stress Conditions|Randomized, Double-blind, Placebo-controlled Intervention Study About the Effects of Magnesium Supplementation Using Nutritional Supplements on the Stress Parameters of Students Preparing for Examination|Completed||N/A|70|Actual|Protina Pharmazeutische GmbH||2|||f||||f|f|f||||||No||2017-10-10 20:54:34.762601|2017-10-10 20:54:34.762601
NCT03203083|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-28|||March 19, 2014|Actual|2014-03-19|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 3, 2014|Actual|2014-07-03||Observational|||Single Leg Squat Performance in Physically and Non-physically Active Individuals|Single Leg Squat Performance in Physically and Non-physically Active Individuals: a Cross-sectional Study|Completed||N/A|72|Actual|Istituto Ortopedico Galeazzi|||2||f|||||f|f||||||||2017-10-10 20:54:34.838215|2017-10-10 20:54:34.838215
NCT03203070|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-28|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Laparoscopic-guided TAP Block in Patients Undergoing Gastric Bypass|Laparoscopic-guided Transversus Abdominis Plane (TAP) Block for Postoperative Pain Control in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass|Recruiting||Phase 3|200|Anticipated|Hospital General Universitario Elche||2|||f||||t|f|f||||||||2017-10-10 20:54:34.903084|2017-10-10 20:54:34.903084
NCT03203057|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-13|||October 5, 2016|Actual|2016-10-05|July 2017|2017-07-01|November 1, 2017|Anticipated|2017-11-01|September 30, 2017|Anticipated|2017-09-30||Observational|ICE-land||Induced Myocardial Ischemia: a Serial Troponin T and Troponin I Measurements|Serial Measurements of High-sensitivity Cardiac Troponin T and Troponin I After Short, Controlled Induced Cardiac Ischemia|Recruiting||N/A|40|Anticipated|Herlev Hospital|||4||f||||f|f|f||||Samples Without DNA|"     Serum and plasma   "|||2017-10-10 20:54:34.987509|2017-10-10 20:54:34.987509
NCT03203044|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||October 10, 2016|Actual|2016-10-10|June 2017|2017-06-01|November 16, 2016|Actual|2016-11-16|November 16, 2016|Actual|2016-11-16||Interventional|||Impact of Soylent Consumption on Human Microbiome Composition|Impact of Soylent Consumption on Human Microbiome Composition|Completed||N/A|14|Actual|University of California, Berkeley||2|||f||||f|f|f||||||Yes|Bacterial DNA sequencing data from collected fecal samples will be shared in a public repository. Sample labels will be deidentified.|2017-10-10 20:54:35.070512|2017-10-10 20:54:35.070512
NCT03203031|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-28|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|October 1, 2018|Anticipated|2018-10-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Postoperative Pain in Neonates After Abdominal Surgery Using Quadratus Lumborum Block|Postoperative Pain in Neonates After Abdominal Surgery Using Ultrasound Guided Quadratus Lumborum Block Performed at the Beginning of the Procedure|Not yet recruiting||N/A|20|Anticipated|Hôpital Armand Trousseau|||1||f||||f|f|f||||||Undecided||2017-10-10 20:54:35.151403|2017-10-10 20:54:35.151403
NCT03203018|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Health Literacy and Cardiovascular Knowledge Workshop in Women From Disadvantaged Communities|Health Literacy and Cardiovascular Knowledge Workshop in Women From Disadvantaged Communities|Recruiting||N/A|300|Anticipated|Hadassah Medical Organization||1|||f||||f|f|f||||||No||2017-10-10 20:54:35.233123|2017-10-10 20:54:35.233123
NCT03203005|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-20|||September 18, 2017|Actual|2017-09-18|June 2017|2017-06-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|||IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients|A Phase I/II Trial of IMA970A Plus CV8102 Following a Single Pre-vaccination Infusion of Cyclophosphamide in Patients With Very Early, Early and Intermediate Stage of Hepatocellular Carcinoma After Any Standard Treatments|Recruiting||Phase 1/Phase 2|40|Anticipated|National Cancer Institute, Naples||1|||f||||t|f|f||||||||2017-10-10 20:54:35.321259|2017-10-10 20:54:35.321259
NCT03202979|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-27|||May 16, 2017|Actual|2017-05-16|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trazodone in Painful Diabetic Neuropathy|Efficacy and Safety of Low Doses of Trazodone in Patients Affected by Painful Diabetic Neuropathy: Randomized, Controlled, Pilot Study.|Recruiting||Phase 2|120|Anticipated|Aziende Chimiche Riunite Angelini Francesco S.p.A||3|||f||||f|f|f||||||No||2017-10-10 20:54:35.533642|2017-10-10 20:54:35.533642
NCT03202966|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-08-15|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|August 2019|Anticipated|2019-08-01||Interventional|||Early Intervention Therapy for Children With Delayed Development: Enabling Access in India's Rural Communities|Early Intervention Therapy for Children With Delayed Development: Enabling Access in India's Rural Communities|Recruiting||N/A|700|Anticipated|Amar Seva Sangam||1|||f||||f|f|f||||||||2017-10-10 20:54:35.71223|2017-10-10 20:54:35.71223
NCT03202953|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-27|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Comparison of Volume Controlled Ventilation With 1:1 Inspiratory to Expiratory Ratio and Autoflow-volume Controlled Ventilation in Robot-assisted Laparoscopic Radical Prostatectomy With Steep Trendelenburg Position and Pneumoperitoneum|Comparison of Volume Controlled Ventilation With 1:1 Inspiratory to Expiratory Ratio and Autoflow-volume Controlled Ventilation in Robot-assisted Laparoscopic Radical Prostatectomy With Steep Trendelenburg Position and Pneumoperitoneum|Not yet recruiting||N/A|80|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 20:54:35.793064|2017-10-10 20:54:35.793064
NCT03202940|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-10-04|||September 14, 2017|Actual|2017-09-14|October 2017|2017-10-01|August 30, 2020|Anticipated|2020-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|||A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC|A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC|Recruiting||Phase 1/Phase 2|31|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 20:54:35.870243|2017-10-10 20:54:35.870243
NCT03202927|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-30|||March 25, 2017|Actual|2017-03-25|June 2017|2017-06-01|August 22, 2017|Anticipated|2017-08-22|July 15, 2017|Anticipated|2017-07-15||Interventional|TPI-120||Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects|A Randomized, Single Blind, Repeat-dose, Two Cycle, Parallel-Arm Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects|Recruiting||Phase 1|102|Anticipated|Adello Biologics, LLC||2|||f||||f|t|f|||f|||||2017-10-10 20:54:35.952911|2017-10-10 20:54:35.952911
NCT03202914|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||October 1988|Actual|1988-10-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|May 1993|Actual|1993-05-01||Interventional|MDRD||Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression|Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression: A Secondary Data Analysis of the Modification of Diet in Renal Disease (MDRD) Study|Completed||N/A|840|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||f|f|f||||||No||2017-10-10 20:54:36.03955|2017-10-10 20:54:36.03955
NCT03202901|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-07-12|||July 24, 2017|Anticipated|2017-07-24|June 2017|2017-06-01|March 21, 2018|Anticipated|2018-03-21|November 21, 2017|Anticipated|2017-11-21||Interventional|TURMACTIVE||Accute Effect of B-Turmactive Both on Mild and Moderate Knee Pain on Healthy Volunteers|Accute Effect of B-Turmactive Both on Mild and Moderate Knee Pain on Healthy Volunteers: a Pilot, Randomised, Parallel and Double Blind Pilot Trial|Not yet recruiting||N/A|64|Anticipated|Technological Centre of Nutrition and Health, Spain||2|||f||||f|f|f||||||||2017-10-10 20:54:36.123212|2017-10-10 20:54:36.123212
NCT03202888|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-30|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|FIQS||Family Input for Quality and Safety|Novel IT to Create Patient-Integrated Hospital QI and Improve Patient Safety|Not yet recruiting||N/A|435|Anticipated|University of California, San Francisco||1|||f||||f|f|f||||||||2017-10-10 20:54:36.201524|2017-10-10 20:54:36.201524
NCT03202875|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||November 14, 2012|Actual|2012-11-14|June 2017|2017-06-01|December 28, 2012|Actual|2012-12-28|December 28, 2012|Actual|2012-12-28||Interventional|||A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus|A Randomized, Double-Blind, Controlled, Single-Dose, 3-Treatment, 3-Period, 6-Sequence Crossover Study to Compare Exposure and Activity of SAR341402 to NovoRapid® and NovoLog® Using the Euglycemic Clamp Technique, in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|30|Actual|Sanofi||3|||f||||f|f|f|||f|||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 20:54:36.276999|2017-10-10 20:54:36.276999
NCT03202862|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-27|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer|An Open-Label, Single Arm, Phase II Trial to Evaluate the Efficacy of 500mg Fulvestrant (Faslodex) in ESR1 Mutated Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer After Previous Aromatase Inhibitor Treatment|Not yet recruiting||Phase 2|50|Anticipated|Fudan University||1|||f|||||f|f|||f|||||2017-10-10 20:54:36.360398|2017-10-10 20:54:36.360398
NCT03202849|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||A Randomized Trial of Vitamin D Supplementation With or Without Vitamin A in Stem Cell Transplantation|A Randomized Double Blinded Trial of Vitamin D Supplementation With or Without Vitamin A Supplementation in Allogeneic Stem Cell Transplantation|Recruiting||N/A|100|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f|f|f||||||No||2017-10-10 20:54:36.423236|2017-10-10 20:54:36.423236
NCT03202836|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-08-02|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|March 29, 2018|Anticipated|2018-03-29||Interventional|||Vaginal Progesterone Supplementation in the Management of Preterm Labor|Vaginal Progesterone Supplementation in the Management of Preterm Labor: A Randomized, Double Blind, Controlled Trial|Recruiting||N/A|86|Anticipated|Chulalongkorn University||2|||f||||t|f|f||||||||2017-10-10 20:54:36.505401|2017-10-10 20:54:36.505401
NCT03202823|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||April 13, 2017|Actual|2017-04-13|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Observational|MASCADI||Arachidonic Acid Metabolism in Carotid Stenosis Plaque in Diabetic Patients|Arachidonic Acid Metabolism in Carotid Stenosis Plaque in Diabetic Patients|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f|||||f|f||||||||2017-10-10 20:54:36.587839|2017-10-10 20:54:36.587839
NCT03202810|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||November 15, 2011|Actual|2011-11-15|June 2017|2017-06-01|November 14, 2022|Anticipated|2022-11-14|November 14, 2021|Anticipated|2021-11-14|10 Years|Observational [Patient Registry]|iTOP||Innovative Approach to Triage Oral Precancer|Biomarker-driven Approach to Develop Population-wide Cost-effective Prevention Strategies for High-risk Oral Premalignancies|Recruiting||N/A|360|Anticipated|British Columbia Cancer Agency|||1||f||||f|f|f||||Samples With DNA|"     Formalin-fixed paraffin-embeded biopsy specimens, blood samples for serum, plasma, and DNA;     fresh frozen tissue of biopsy specimens; exfoliated cells.   "|Undecided|Undecided|2017-10-10 20:54:36.776693|2017-10-10 20:54:36.776693
NCT03202797|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-22|||March 17, 2017|Actual|2017-03-17|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Observational|BIMODALITE||Optimizing Regulation of a Cochlear Implant in Patients With Functional Contralateral Audition.|Optimizing Regulation of a Cochlear Implant in Patients With Functional Contralateral Audition Using an Evolutionary Algorithm.|Recruiting||N/A|14|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:54:36.86064|2017-10-10 20:54:36.86064
NCT03202784|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-10|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|August 1, 2017|Anticipated|2017-08-01||Interventional|||A Relative Bioavailability Study of Two Formulations of BCX7353|A Phase 1, Single-Dose, 3-Period Crossover Study to Evaluate the Relative Bioavailability of Two BCX7353 Capsule Formulations and to Evaluate the Effect of Food on BCX7353 Pharmacokinetics in Healthy Subjects|Active, not recruiting||Phase 1|24|Anticipated|BioCryst Pharmaceuticals||3|||f||||f|f|f||||||||2017-10-10 20:54:36.949307|2017-10-10 20:54:36.949307
NCT03202771|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||February 2007|Actual|2007-02-01|June 2017|2017-06-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||RCT of Home Versus Office Biofeedback for Constipation|Home Versus Office Biofeedback Training for Dyssynergic Defecation|Completed||N/A|100|Actual|Augusta University||2|||f||||t|f|f||||||No||2017-10-10 20:54:37.047458|2017-10-10 20:54:37.047458
NCT03202758|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-15|||August 29, 2017|Actual|2017-08-29|September 2017|2017-09-01|August 29, 2020|Anticipated|2020-08-29|August 29, 2019|Anticipated|2019-08-29||Interventional|MEDITREME||Evaluation of the Safety and the Tolerability of Durvalumab Plus Tremelimumab Combined With FOLFOX in mCRC|Phase Ib/II Trial Evaluating the Safety, Tolerability and Immunological Activity of Durvalumab (MEDI4736) (Anti-PD-L1) Plus Tremelimumab (Anti-CTLA-4) Combined With FOLFOX in Patients With Metastatic Colorectal Cancer|Recruiting||Phase 1/Phase 2|48|Anticipated|Centre Georges Francois Leclerc||1|||f|||||f|f||||||||2017-10-10 20:54:37.134498|2017-10-10 20:54:37.134498
NCT03202745|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||January 2017||2017-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Informative Letters on the Prescription and Receipt of Opioids|The Effect of Informative Letters on the Prescription and Receipt of Opioids|Active, not recruiting||N/A|9518|Actual|Abdul Latif Jameel Poverty Action Lab||3|||f||||t||||||||Undecided||2017-10-10 20:54:37.253426|2017-10-10 20:54:37.253426
NCT03202732|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-03|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|February 1, 2020|Anticipated|2020-02-01|February 20, 2018|Anticipated|2018-02-20||Interventional|||DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes|DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes: A Randomised Controlled Trial and Interview Study|Not yet recruiting||N/A|400|Anticipated|Aarhus University Hospital||2|||f|||||f|f||||||||2017-10-10 20:54:37.345256|2017-10-10 20:54:37.345256
NCT03202719|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||July 31, 2017|Anticipated|2017-07-31|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Duration of IPV Priming and Antibody Decay|Duration of Priming and Antibody Decay With Full-dose Inactivated Poliovirus Vaccine (IPV) Administered With or Without Bivalent Oral Poliovirus Vaccine (bOPV)|Not yet recruiting||Phase 4|1645|Anticipated|Centers for Disease Control and Prevention||5|||f||||t|f|f||||||No|Summary tables to be shared December 2019|2017-10-10 20:54:37.460932|2017-10-10 20:54:37.460932
NCT03202706|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||February 24, 2016|Actual|2016-02-24|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Observational|CB1R||Use of Biopsies of Abdominal Subcutaneous Fat to Study the Role of the Activation of Endocannabinoid 1 Receptors (CB1R) on Adipocyte Glucolipid Metabolism|Use of Biopsies of Abdominal Subcutaneous Fat to Study the Role of the Activation of Endocannabinoid 1 Receptors (CB1R) on Adipocyte Glucolipid Metabolism|Recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:54:37.588822|2017-10-10 20:54:37.588822
NCT03202693|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-27|||March 2006||2006-03-01|February 2014|2014-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|CL-004||A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects.|A Phase 1, Open-Label, Single-Dose Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of [14C]-PA 824 in Healthy Adult Male Subjects.|Completed||Phase 1|6|Actual|Global Alliance for TB Drug Development||1|||f||||f||||||||||2017-10-10 20:54:37.679401|2017-10-10 20:54:37.679401
NCT03202680|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-11|||July 6, 2017|Actual|2017-07-06|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Lean Beef Consumption and Insulin Sensitivity in Men and Women With Risk Factors for Diabetes|A Randomized, Controlled-Feeding, Crossover Trial to Assess the Effects of Increasing Lean Beef Consumption Within a Healthy Dietary Pattern on Insulin Sensitivity in Men and Women With Risk Factors for Diabetes Mellitus.|Recruiting||N/A|40|Anticipated|Midwest Center for Metabolic and Cardiovascular Research||2|||f||||f|f|f||||||||2017-10-10 20:54:37.76405|2017-10-10 20:54:37.76405
NCT03202667|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SANDx||Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study|Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study|Recruiting||Phase 2/Phase 3|16|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f||||||||2017-10-10 20:54:37.881886|2017-10-10 20:54:37.881886
NCT03202654|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-28|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Effects of Corn and Coconut Oils on Lipoprotein Lipids, Insulin Sensitivity and Inflammation|A Randomized, Double-Blind, Controlled, Crossover, Pilot Trial Comparing the Effects of Corn and Coconut Oils on Fasting Lipoprotein Lipids and Markers of Insulin Sensitivity and Inflammation in Men and Women|Active, not recruiting||N/A|24|Anticipated|Midwest Center for Metabolic and Cardiovascular Research||2|||f|||||f|f||||||||2017-10-10 20:54:38.043298|2017-10-10 20:54:38.043298
NCT03202641|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-28|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients|Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients: an Open Lung is a Better Heart|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||||2017-10-10 20:54:38.139482|2017-10-10 20:54:38.139482
NCT02911181|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-09-20|||February 2016||2016-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|||Quality Project Malnutrition Intensive Care|Quality Project Malnutrition Intensive Care|Completed||N/A|300|Actual|Medical Centre Leeuwarden|||1||f||||f||||||||No||2017-10-10 21:47:20.616413|2017-10-10 21:47:20.616413
NCT03202628|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-04|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|July 24, 2022|Anticipated|2022-07-24|July 24, 2022|Anticipated|2022-07-24||Interventional|||Ixazomib Citrate, Pomalidomide, Dexamethasone, and Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Multiple Myeloma|Phase 2 Trial of Induction With Ixazomib, Pomalidomide, Dexamethasone Prior to Salvage Autologous Stem Cell Transplantation Followed by Consolidation With Ixazomib, Pomalidomide, and Dexamethasone and Ixazomib Maintenance in Multiple Myeloma|Recruiting||Phase 2|25|Anticipated|Mayo Clinic||1|||||||t|t|f||||||||2017-10-10 20:54:38.26139|2017-10-10 20:54:38.26139
NCT03202615|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-08-25|||September 2015||2015-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During Pregnancy|Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During Pregnancy: A Randomized Controlled Trial|Recruiting||Phase 4|130|Anticipated|Abdelwahed, Mai Mahmoud Mohamed, M.D.||2|||f||||t|t|f|||t|||||2017-10-10 20:54:38.405774|2017-10-10 20:54:38.405774
NCT03202602|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-10-04|||August 15, 2017|Actual|2017-08-15|October 2017|2017-10-01|June 30, 2019|Anticipated|2019-06-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Benefits of Telemedicine in CPAP Treatment|The Benefits of Telemedicine in CPAP Treatment of Obstructive Sleep Apnea Syndrome (OSAS)|Enrolling by invitation||N/A|200|Anticipated|Uppsala University|||2||f||||f|f|f||||||||2017-10-10 20:54:38.514273|2017-10-10 20:54:38.514273
NCT03202589|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-27|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|October 1, 2018|Anticipated|2018-10-01||Observational|PAGET||Assessment for GEriatric Trauma Patients|The PAGET Survey : Pre-operative Assessment for GEriatric Trauma Patients|Recruiting||N/A|2000|Anticipated|University Hospital, Montpellier|||1||f||||t|f|f||||||Undecided|nc|2017-10-10 20:54:38.593521|2017-10-10 20:54:38.593521
NCT03202576|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 20, 2019|Anticipated|2019-06-20|December 30, 2018|Anticipated|2018-12-30||Interventional|NTSNB||Nasogastric Tube Securement Comparison Study|Nasogastric Tube Securement: Comparison of Standard Practice Versus Nasal Bridle for Pediatric Hospitalized Patients|Not yet recruiting||N/A|172|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 20:54:38.673544|2017-10-10 20:54:38.673544
NCT03202563|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||June 28, 2017|Anticipated|2017-06-28|June 2017|2017-06-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)|A Multicenter, Randomized, Active-controlled, Parallel Group, Open-label, Phase 4 Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin 50mg q.d., Versus Dapagliflozin 10mg q.d. Added to Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone or Diabetes Medication Naïve Patient|Not yet recruiting||Phase 4|70|Anticipated|LG Chem||2|||f||||t|f|f||||||Undecided||2017-10-10 20:54:38.761872|2017-10-10 20:54:38.761872
NCT03202550|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-10|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|February 1, 2018|Anticipated|2018-02-01||Interventional|OSDI||Oral Sedation During Cervical Dilator Placement|Oral Sedation During Cervical Dilator Placement: A Randomized Controlled Trial|Recruiting||Phase 4|60|Anticipated|Johns Hopkins University||2|||f||||f|t|f|||t|||||2017-10-10 20:54:38.849535|2017-10-10 20:54:38.849535
NCT03202537|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-18|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|March 31, 2022|Anticipated|2022-03-31|October 1, 2021|Anticipated|2021-10-01||Interventional|||Effectiveness of Physiologic Testing in PPI Non-Responders|Effectiveness of Physiologic Testing in PPI Non-Responders|Enrolling by invitation||Early Phase 1|240|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 20:54:38.935444|2017-10-10 20:54:38.935444
NCT03202524|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-27|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis|Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis|Not yet recruiting||Phase 4|100|Anticipated|Montefiore Medical Center||2|||f||||f|t|f|||t|||No|Data collected during the study will only be shared with researchers approved to key-personnel on the study protocol.|2017-10-10 20:54:39.00745|2017-10-10 20:54:39.00745
NCT03202511|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-27|||June 23, 2017|Actual|2017-06-23|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||"Assessment of a New Boosting Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers"|"Assessment of a New Boosting Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers"|Recruiting||Early Phase 1|16|Anticipated|Indiana University||2|||f||||t|t|f|||f|||No|We do not plan to share IPD with other researchers.|2017-10-10 20:54:39.076605|2017-10-10 20:54:39.076605
NCT03202498|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-27|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Safety and Tolerability of Yaq-001 in Patients With Cirrhosis|"Safety and Tolerability of Yaq-001 in Patients With Cirrhosis (CARBALIVE-SAFETY)"|Not yet recruiting||N/A|56|Anticipated|Yaqrit Ltd||4|||f||||f|f|f||||||No||2017-10-10 20:54:39.160703|2017-10-10 20:54:39.160703
NCT03202485|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-27|||March 3, 2014|Actual|2014-03-03|June 2017|2017-06-01|January 1, 2017|Actual|2017-01-01|March 2, 2015|Actual|2015-03-02||Interventional|||Comparison Between TICL and ICL+AK for High Myopic Astigmatism|Comparison Between Toric and Spherical Implantable Collamer Lens Combined With Astigmatic Keratotomy for High Myopic Astigmatism|Completed||N/A|62|Actual|Wenzhou Medical University||2|||f||||f|f|f||||||No||2017-10-10 20:54:39.302365|2017-10-10 20:54:39.302365
NCT03202472|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-12|||August 3, 2017|Actual|2017-08-03|June 2017|2017-06-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery|Pilot Trial Evaluating a Miniature Radiofrequency Tag for Localization of Non-palpable Breast Lesions for Surgery|Recruiting||N/A|50|Anticipated|Jonsson Comprehensive Cancer Center||1|||f|||||f|t|f|||||||2017-10-10 20:54:39.369552|2017-10-10 20:54:39.369552
NCT03202459|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-27|||March 2, 2017|Actual|2017-03-02|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Prophylaxy of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery|Prophylaxy of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery|Recruiting||N/A|60|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||3|||f||||f|f|f||||||No||2017-10-10 20:54:39.471674|2017-10-10 20:54:39.471674
NCT03202446|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-27|||June 13, 2016|Actual|2016-06-13|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer|Phase 3 Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT) System in Advanced Breast Cancer|Recruiting||Phase 3|246|Anticipated|Eske Corporation S.A.C||3|||f||||t|f|f||||||Undecided||2017-10-10 20:54:39.604166|2017-10-10 20:54:39.604166
NCT03202433|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-27|||December 30, 2016|Actual|2016-12-30|June 2017|2017-06-01|August 1, 2017|Anticipated|2017-08-01|July 29, 2017|Anticipated|2017-07-29||Interventional|||Reduce Stress Associated With Needle Aspiration, in Voluntary and Replacement Blood Donors|Use of Virtual Reality in Blood Donors, an Innovative Tool|Recruiting||N/A|240|Anticipated|Center for Blood and Tissues IV and V Region, Chile||2|||f||||t|f|f||||||No||2017-10-10 20:54:39.705152|2017-10-10 20:54:39.705152
NCT03202420|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-23|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|TOPS at DOC||Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic|Pilot Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic|Not yet recruiting||N/A|35|Anticipated|Duke University||1|||f|||||f|f||||||||2017-10-10 20:54:39.778329|2017-10-10 20:54:39.778329
NCT03202407|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-27|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Hyperphosphatemia in Children With Chronic Kidney Disease|Effect of Non-calcium Phosphate Binders Versus Calcium Based Binders on Chronic Kidney Disease -Mineral and Bone Disorder in Children on Regular Hemodialysis|Not yet recruiting||Phase 3|40|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:54:39.84416|2017-10-10 20:54:39.84416
NCT03202394|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-02|||August 5, 2017|Actual|2017-08-05|October 2017|2017-10-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS|A Phase IIa, Placebo Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO-11006 Inhalation Solution in Patients With Acute Respiratory Distress Syndrome|Recruiting||Phase 2|60|Anticipated|BioMarck Pharmaceuticals, Ltd.||2|||f||||t|t|f||||||||2017-10-10 20:54:39.903373|2017-10-10 20:54:39.903373
NCT03202381|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-27|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|BLADE||Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix|A Pilot Phase IV Study to Evaluate Variation in Bone Mineral Density, Lean and Fat Body Mass Index Measured by Dual-energy X-ray Absorptiometry in Patients With Prostate Cancer Without Bone Metastasis Treated With Degarelix|Recruiting||Phase 4|35|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||1|||f|||||f|f|||f|||||2017-10-10 20:54:39.98747|2017-10-10 20:54:39.98747
NCT03202368|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-28|||August 2, 2017|Anticipated|2017-08-02|July 2017|2017-07-01|December 20, 2018|Anticipated|2018-12-20|December 20, 2018|Anticipated|2018-12-20||Interventional|||An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)|An Extension Study to Evaluate Long Term Safety of Subcutaneous Tocilizumab in Patients With Giant Cell Arteritis Who Have Completed WA28119 Core Study in France, and Subsequently Having Flare or Persisting Disease Activity.|Not yet recruiting||Phase 3|11|Anticipated|Hoffmann-La Roche||1|||f|||||f|f||||||||2017-10-10 20:54:40.105295|2017-10-10 20:54:40.105295
NCT03202355|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-28|||June 5, 2017|Actual|2017-06-05|August 2017|2017-08-01|June 5, 2018|Anticipated|2018-06-05|June 5, 2018|Anticipated|2018-06-05||Interventional|||The Effect of OrthoPulse Photobiomodulation on the Rate of Tooth Movement During Alignment With Fixed Appliances|The Effect of OrthoPulse Photobiomodulation on the Rate of Tooth Movement During Alignment With Fixed Appliances|Recruiting||N/A|50|Anticipated|Biolux Research Ltd.||2|||f||||f|f|t|f||f|||||2017-10-10 20:54:40.186463|2017-10-10 20:54:40.186463
NCT03202342|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||November 11, 2013|Actual|2013-11-11|June 2017|2017-06-01|October 30, 2014|Actual|2014-10-30|October 30, 2014|Actual|2014-10-30||Interventional|COLD-2||fMRI of Hypothalamic Responses to Taste, Temperature and Glucose|Functional Magnetic Resonance Imaging of Human Hypothalamic Responses to Taste, Temperature and Glucose Sensing|Completed||N/A|16|Actual|Unilever R&D||10|||f||||f|f|f||||||No||2017-10-10 20:54:40.290121|2017-10-10 20:54:40.290121
NCT03202329|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|June 1, 2019|Anticipated|2019-06-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Post-operative, Nurse-based Heart Failure Care in Non-cardiac Surgery|Evaluation of Post-operative, Nurse-based Heart Failure Care Compared to Standard Treatment in Patients With Heart Failure Undergoing Non-cardiac Surgery|Not yet recruiting||N/A|525|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 20:54:42.12193|2017-10-10 20:54:42.12193
NCT03202316|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-16|||August 11, 2017|Actual|2017-08-11|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Study of Triple Combination of Atezolizumab + Cobimetinib + Eribulin (ACE) in Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer|A Phase II Study of Triple Combination of Atezolizumab + Cobimetinib + Eribulin (ACE) in Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer|Recruiting||Phase 2|33|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:54:42.203184|2017-10-10 20:54:42.203184
NCT03202303|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-15|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|September 30, 2021|Anticipated|2021-09-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)|Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)|Not yet recruiting||Phase 2|100|Anticipated|Montefiore Medical Center||2|||f|||||f|f||||||||2017-10-10 20:54:42.312855|2017-10-10 20:54:42.312855
NCT03202290|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|BANCO||BANCO Study: Behavioral Addictions and Related NeuroCOgnitive Aspects: A Monocentric, Prospective, Controlled, Open-label Study of a Sample of Patients With Gambling Disorder|BANCO Study: Behavioral Addictions and Related NeuroCOgnitive Aspects: A Monocentric, Prospective, Controlled, Open-label Study of a Sample of Patients With Gambling Disorder|Not yet recruiting||N/A|60|Anticipated|Nantes University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 20:54:42.390583|2017-10-10 20:54:42.390583
NCT02910713|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-25|||September 2016||2016-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:47:24.915922|2017-10-10 21:47:24.915922
NCT03202264|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-28|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|February 20, 2018|Anticipated|2018-02-20|December 31, 2017|Anticipated|2017-12-31||Observational|||Team Approach to Polypharmacy Reduction to Improve Mobility Long-Term Care|Team Approach to Polypharmacy Reduction to Improve Mobility (TAPER-Mobility): A Pilot Feasibility Study in a Long-Term Care Setting|Recruiting||N/A|80|Anticipated|McMaster University|||1||f||||f|f|f||||||||2017-10-10 20:54:42.542371|2017-10-10 20:54:42.542371
NCT03202251|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-26|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|April 10, 2020|Anticipated|2020-04-10|April 10, 2020|Anticipated|2020-04-10||Observational|||Deep Brain Stimulation in Patients With LUTS|The Impact of Deep Brain Stimulation in Patients With Lower Urinary Tract Symptoms: A Prospective, Observational, Cohort Study|Recruiting||N/A|36|Anticipated|The Methodist Hospital System|||1||f||||f|f|f||||||Undecided|To be determined|2017-10-10 20:54:42.633914|2017-10-10 20:54:42.633914
NCT03202238|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-06-26|||June 25, 2017|Actual|2017-06-25|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||FireFly Vein Finder: Venepuncture Made Easy|FireFly Vein Finder: Venepuncture Made Easy|Active, not recruiting||N/A|240|Actual|National University Hospital, Singapore||4|||f|||||f|f||||||No||2017-10-10 20:54:42.710894|2017-10-10 20:54:42.710894
NCT03202225|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-26|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Observational|||Primary Constrained Condylar Knee Arthroplasty Without Stem Extensions: Prevalence and Risk Factors|Primary Constrained Condylar Knee Arthroplasty Without Stem Extensions: Prevalence and Risk Factors|Enrolling by invitation||N/A|246|Anticipated|Navamindradhiraj University|||1||f||||t|f|t|f|f|t|||No||2017-10-10 20:54:42.807687|2017-10-10 20:54:42.807687
NCT03202212|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-27|||February 3, 2014|Actual|2014-02-03|June 2017|2017-06-01|November 11, 2014|Actual|2014-11-11|February 10, 2014|Actual|2014-02-10||Interventional|||Effect of Mixed On-line Hemodiafiltration on Circulating Markers of Inflammation and Vascular Dysfunction|Effect of Mixed On-line Hemodiafiltration on Circulating Markers of Inflammation and Vascular Dysfunction|Completed||Phase 1/Phase 2|30|Actual|Azienda Ospedaliera Città della Salute e della Scienza di Torino||2|||f||||f|f|f||||||Yes|At the time of registration the study was already completed. IPD data will be available upon request till the study publication, then data will be enclosed within the publication as supplementary material.|2017-10-10 20:54:42.864733|2017-10-10 20:54:42.864733
NCT03202199|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-24|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|July 1, 2021|Anticipated|2021-07-01|January 1, 2020|Anticipated|2020-01-01||Interventional|PACMI||Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.|Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma. PACMI (Pancreatic AdenoCarcinoma Multimodality Imaging)|Recruiting||N/A|125|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||||2017-10-10 20:54:43.062162|2017-10-10 20:54:43.062162
NCT03202186|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-13|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|PROGEST||Study of Progesterone in Treatment of Vasomotor Symptoms|Double-Blind Trial Investigating the Efficacy of Different Doses of Progesterone Compared With Placebo for Treatment of Vasomotor Symptoms|Recruiting||Phase 3|304|Anticipated|BHR Pharma, LLC||4|||f||||f|f|f||||||||2017-10-10 20:54:43.151746|2017-10-10 20:54:43.151746
NCT03202173|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-12|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 27, 2017|Actual|2017-06-27||Interventional|||The Diagnosis of Nasopharyngeal Carcinomas Through the Probe-based Confocal Laser Endomicroscopy|The Diagnosis of the Squamous Cell Carcinoma of the Head and Neck by Using the Probe-based Confocal Laser Endomicroscopy|Recruiting||N/A|15|Anticipated|Eye & ENT Hospital of Fudan University||3|||f||||t|f|f||||||||2017-10-10 20:54:43.257905|2017-10-10 20:54:43.257905
NCT03202160|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||April 15, 2018|Anticipated|2018-04-15|June 2017|2017-06-01|September 15, 2019|Anticipated|2019-09-15|April 15, 2019|Anticipated|2019-04-15||Observational|||Causes of Goiter in Children Attending Assiut University Children Hospital|Cases of Goiter in Children Attending Assiut University Children Hospital|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 20:54:43.359266|2017-10-10 20:54:43.359266
NCT03202147|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||July 2016||2016-07-01|June 2017|2017-06-01|November 2017||2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)|A Phase II Safety and Efficacy Study of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)|Suspended||Phase 2|500|Anticipated|AZTherapies, Inc.||2||Study halted prematurely prior to initiation but potentially will resume|f||||f||||||||No||2017-10-10 20:54:43.435289|2017-10-10 20:54:43.435289
NCT03202134|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||January 2014|Actual|2014-01-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|1 Month|Observational [Patient Registry]|DIEPflap||Prospective Study Evaluating Impact of Anesthesia on Outcome After Diepflap Surgery|Impact of Opioid and Non Opioid Anesthesia on Quality of Recovery|Recruiting||N/A|500|Anticipated|AZ Sint-Jan AV|||1||f||||f|f|f||||||No||2017-10-10 20:54:43.532213|2017-10-10 20:54:43.532213
NCT03202121|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-27|||July 1, 2011|Actual|2011-07-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Relationship of Nocturnal Concentrations of Melatonin, γ-aminobutyric Acid and Total Antioxidants With Insomnia|Relationship of Nocturnal Concentrations of Melatonin, γ-aminobutyric Acid and Total Antioxidants in Peripheral Blood With Insomnia After Stroke: Study Protocol for a Prospective Single-center Randomized Controlled Clinical Trial|Active, not recruiting||N/A|75|Actual|China Rehabilitation Research Center|||3||f||||t|f|f||||||Undecided||2017-10-10 20:54:43.627779|2017-10-10 20:54:43.627779
NCT03202108|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-04|||August 3, 2017|Anticipated|2017-08-03|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 15, 2017|Anticipated|2017-09-15||Interventional|Krio||Evaluation of Krio in Children and Adults With Epilepsy|A Feasibility Study to Evaluate the Acceptability of Krio, a Food for Special Medical Purposes (FSMP) for Use in the Ketogenic Diet (KD) With Regard to Product Tolerance, Compliance and Acceptability|Not yet recruiting||N/A|15|Anticipated|Vitaflo International, Ltd||1|||f||||f|f|f||||||||2017-10-10 20:54:43.719854|2017-10-10 20:54:43.719854
NCT03202095|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-22|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Creatine for Treatment of Depression Associated With Type 2 Diabetes|Creatine for Treatment of Depression Associated With Type 2 Diabetes|Recruiting||Phase 4|15|Anticipated|University of Utah||1|||f||||t|t|f||||||||2017-10-10 20:54:43.82698|2017-10-10 20:54:43.82698
NCT03202082|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||July 1, 2015|Actual|2015-07-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Impact of Neuropsychological Evaluation on Epilepsy Treatment|Impact of Neuropsychological Evaluation on Epilepsy Treatment|Recruiting||Phase 2|100|Anticipated|University of South Florida||2|||f||||f|f|f||||||No||2017-10-10 20:54:43.932853|2017-10-10 20:54:43.932853
NCT03202069|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-10-04|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Protein Eating Patterns and Weight Loss|Effect of Daily Protein Intake Patterns During Weight Loss on Dietary Adherence and Body Composition in Women|Recruiting||N/A|46|Anticipated|USDA Grand Forks Human Nutrition Research Center||2|||f||||f|f|f||||||||2017-10-10 20:54:44.01206|2017-10-10 20:54:44.01206
NCT03202056|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-25|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effects of Dry Needling Technique in Hip Abductor Muscles in Subjects With Grade I-III Hip Osteoarthritis|Effects of Dry Needling Technique in Hip Abductor Muscles in Subjects With Grade I-III Hip Osteoarthritis|Not yet recruiting||N/A|60|Anticipated|Universidad de Zaragoza||3|||f||||t|f|f||||||No|The patient data were confidential and were assigned a number to each patient to maintain confidentiality|2017-10-10 20:54:44.105195|2017-10-10 20:54:44.105195
NCT03202043|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-22|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Juice Study: Sensitivity of Skin Carotenoid Status to Detect Change in Intake|Sensitivity of Skin Carotenoid Status to Detect Changes in Intake of Varying Levels of Vegetables|Recruiting||N/A|80|Anticipated|USDA Grand Forks Human Nutrition Research Center||4|||f||||f|f|f||||||||2017-10-10 20:54:44.194437|2017-10-10 20:54:44.194437
NCT03202030|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||January 2016||2016-01-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|IDRBio-oss||Immediate Dentoalveolar Restoration Compared to Bio-oss|Immediate Dentoalveolar Restoration Compared to Demineralized Bovine Bone in Immediate Implants Placed in Fresh Sockets With Buccal Bone Resorption: 18-months Randomized Controlled Trial|Recruiting||N/A|34|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||No||2017-10-10 20:54:44.293537|2017-10-10 20:54:44.293537
NCT03202017|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Lung Volume Recruitment Combined With Expiratory Muscle Strength Training in ALS|A Pilot Study of Lung Volume Recruitment Combined With Expiratory Muscle Strength Training in ALS|Not yet recruiting||N/A|24|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|f||||||||2017-10-10 20:54:44.374765|2017-10-10 20:54:44.374765
NCT03202004|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-25|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|September 28, 2018|Anticipated|2018-09-28|April 26, 2018|Anticipated|2018-04-26||Interventional|||GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis|A Double-Blind Safety and Efficacy Study of GSK2894512 Cream Versus Vehicle in the Treatment of Adult Plaque Psoriasis|Not yet recruiting||Phase 3|120|Anticipated|GlaxoSmithKline||2|||f||||f|t|f||||||||2017-10-10 20:54:44.476766|2017-10-10 20:54:44.476766
NCT03201991|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|ADVANCE||ALS Study Determining Various Biomarkers and Strength Comparison After Exercise|ALS Study Determining Various Biomarkers and Strength Comparison After Exercise|Recruiting||N/A|7|Anticipated|University of Kansas Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:54:44.555431|2017-10-10 20:54:44.555431
NCT03201978|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-05|||December 14, 2017|Anticipated|2017-12-14|September 2017|2017-09-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects|A Randomized, Double-Blind, Vehicle-Controlled, 3-Period, Sequential Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Repeat Topical Applications of GSK2894512 Cream in Healthy Adult Participants|Not yet recruiting||Phase 1|26|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 20:54:44.641816|2017-10-10 20:54:44.641816
NCT03201965|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-27|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|October 30, 2025|Anticipated|2025-10-30|January 22, 2021|Anticipated|2021-01-22||Interventional|||A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis|A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis|Not yet recruiting||Phase 3|370|Anticipated|Janssen Research & Development, LLC||2|||f||||t|t|f||||||||2017-10-10 20:54:44.748187|2017-10-10 20:54:44.748187
NCT03201952|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-13|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans|Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans|Recruiting||Phase 1|16|Anticipated|Vanderbilt University Medical Center||2|||f||||t|t|f||||||||2017-10-10 20:54:45.090512|2017-10-10 20:54:45.090512
NCT03201939|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-26|||November 1, 2017|Anticipated|2017-11-01|June 2017|2017-06-01|October 1, 2022|Anticipated|2022-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria|Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria|Not yet recruiting||Phase 2|200|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||Yes|Investigative team will work with study biostatisticians, DSMB members, and collaborators to release analysis scripts (with publications) and devise an IPD sharing plan at/near study completion.|2017-10-10 20:54:45.188979|2017-10-10 20:54:45.188979
NCT03201926|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-19|||June 26, 2017|Actual|2017-06-26|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||Development and Clinical Application of Invalid Foods Using Mealworms|Development and Clinical Application of Invalid Foods Using Mealworms|Recruiting||N/A|168|Anticipated|Yonsei University||2|||f||||t|f|f||||||||2017-10-10 20:54:45.28512|2017-10-10 20:54:45.28512
NCT03201549|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-08-11|||July 30, 2017|Actual|2017-07-30|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|E228||The Effects of Increased Fructose Ingestion on FGF-21 Levels in Humans|The Effects of Increased Fructose Ingestion on FGF-21 Levels in Humans|Recruiting||N/A|15|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:54:48.261094|2017-10-10 20:54:48.261094
NCT03201900|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-19|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Patients With Partial Onset Seizures (Including Secondarily Generalized Seizures)|A Multicenter, Uncontrolled, Open-label Study and Extension Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Patients With Partial Onset Seizures (Including Secondarily Generalized Seizures)|Recruiting||Phase 3|80|Anticipated|Eisai Inc.||1|||f||||f|t|f|||t|||||2017-10-10 20:54:45.471665|2017-10-10 20:54:45.471665
NCT03201887|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-26|||July 1, 2017|Anticipated|2017-07-01|January 2017|2017-01-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Detecting Malingering Detection Using Eye Movements and Response Time (MDER)|Detecting Malingering Detection Using Eye Movements and Response Time|Not yet recruiting||N/A|120|Anticipated|Loewenstein Hospital||4|||f||||t|f|f||||||No|We do not plan to share IPD|2017-10-10 20:54:45.562962|2017-10-10 20:54:45.562962
NCT03201874|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||iCanCope With Sickle Cell Pain|iCanCope With Sickle Cell Disease: A Mobile Pain Management Intervention for Adolescents|Not yet recruiting||N/A|160|Anticipated|Seattle Children's Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:54:45.646529|2017-10-10 20:54:45.646529
NCT03201861|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-25|||July 20, 2017|Anticipated|2017-07-20|June 2017|2017-06-01|December 31, 2021|Anticipated|2021-12-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women|Phase 2 Study of Weekly Paclitaxel in Combination With Cisplatin as Adjuvant Chemotherapy for Early Stage Human Epidermal Growth Factor Receptor-2 (HER2) Negative Breast Cancer in High-risk Women|Not yet recruiting||Phase 2|762|Anticipated|RenJi Hospital||2|||f|||||f|f|||f|||No||2017-10-10 20:54:45.7548|2017-10-10 20:54:45.7548
NCT03201848|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-07-11|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|ITP||The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia|A Multisite, Randomized, Double-Blind, Placebo-Controlled, and Parallel Study to Evaluate the Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (Qi Yin Deficiency)|Recruiting||Phase 4|216|Anticipated|Qidong Gaitianli Medicines Co., Ltd||2|||f||||t|f|f||||||||2017-10-10 20:54:45.844921|2017-10-10 20:54:45.844921
NCT03201835|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-19|||September 24, 2015|Actual|2015-09-24|September 2017|2017-09-01|June 6, 2016|Actual|2016-06-06|December 6, 2015|Actual|2015-12-06||Interventional|||5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers|A Single-Center, Randomized, 5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers|Completed||Phase 1|15|Actual|PhytoTech Therapeutics, Ltd.||5|||f|||||f|f||||||||2017-10-10 20:54:45.941316|2017-10-10 20:54:45.941316
NCT03201822|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-26|||April 1, 2013|Actual|2013-04-01|June 2017|2017-06-01|May 25, 2013|Actual|2013-05-25|May 25, 2013|Actual|2013-05-25||Interventional|||Intake-dependent Effect of Cocoa Flavanol Absorption, Metabolism and Excretion in Humans|Intake-dependent Effect of Cocoa Flavanol Absorption, Metabolism and Excretion in Humans|Completed||N/A|14|Actual|University of California, Davis||4|||f||||f|f|f||||||Yes|Only researchers listed in the protocol and approved by the IRB will have access to IPD.|2017-10-10 20:54:46.040143|2017-10-10 20:54:46.040143
NCT03201809|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-06|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial|Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial|Recruiting||N/A|252|Anticipated|University of California, Davis||2|||f||||f|f|t|f||f|||||2017-10-10 20:54:46.147051|2017-10-10 20:54:46.147051
NCT03201796|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||February 2, 2016|Actual|2016-02-02|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Prulifloxacin in Chronic Bacterial Prostatitis (CBP)|Evaluation of the Efficacy and Safety of Prulifloxacin vs Levofloxacin in the Treatment of Chronic Bacterial Prostatitis.|Recruiting||Phase 2|148|Anticipated|Aziende Chimiche Riunite Angelini Francesco S.p.A||2|||f||||f|f|f||||||No||2017-10-10 20:54:46.246327|2017-10-10 20:54:46.246327
NCT03201783|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-08|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Immediate Versus Delayed FET Following a Stimulated IVF Cycle|A Randomized Trial Comparing the Effect of Immediate Versus Delayed Frozen-thawed Embryo Transfer Following a Stimulated IVF Cycle|Recruiting||N/A|724|Anticipated|ShangHai Ji Ai Genetics & IVF Institute||2|||f|||||f|f||||||||2017-10-10 20:54:46.419629|2017-10-10 20:54:46.419629
NCT03201770|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-05|||June 22, 2017|Actual|2017-06-22|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Cohort Event Monitoring Study of Pyramax®|Phase IIIb/IV Cohort Event Monitoring Study To Evaluate, In Real Life Setting, The Safety And Tolerability In Malaria Patients Of The Fixed-Dose Artemisinin-Based Combination Therapy Pyramax®|Recruiting||Phase 4|8572|Anticipated|Shin Poong Pharmaceutical Co. Ltd.||1|||f||||t|f|f||||||||2017-10-10 20:54:46.523996|2017-10-10 20:54:46.523996
NCT03201757|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-16|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831|A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder|Enrolling by invitation||Phase 3|500|Anticipated|Alkermes, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:54:46.618705|2017-10-10 20:54:46.618705
NCT03201744|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-26|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Prospective Randomized Trial of Moderate vs Deep Neuromuscular Blockade During Laparoscopic Ventral Hernia Repair|Prospective Randomized Trial of Moderate vs Deep Neuromuscular Blockade During Laparoscopic Ventral Hernia Repair|Not yet recruiting||N/A|34|Anticipated|Stony Brook University||2|||f|||||f|f|||f|||||2017-10-10 20:54:46.699774|2017-10-10 20:54:46.699774
NCT03201731|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-03|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Social Isolation and Loneliness in Older People|Social Isolation and Loneliness in Very Late-onset Schizophrenia-like Psychosis: A Case-control Study|Not yet recruiting||N/A|66|Anticipated|University College, London|||2||f|||||f|f||||||||2017-10-10 20:54:46.77784|2017-10-10 20:54:46.77784
NCT03201718|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-12|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|HCV PMS||A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs|"Post-marketing Surveillance Study of Viekira/ Exviera Tablets for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs"|Recruiting||N/A|3000|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 20:54:46.83197|2017-10-10 20:54:46.83197
NCT03201705|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-10-01|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||A Novel Approach in Spinal Cord Stimulation: a Combination of Burst and Tonic Waveforms.|A Novel Approach in Spinal Cord Stimulation: a Combination of Burst and Tonic Waveforms.|Not yet recruiting||N/A|10|Anticipated|Ospedale Santa Maria delle Croci||1|||f||||f|f|f||||||||2017-10-10 20:54:46.964245|2017-10-10 20:54:46.964245
NCT03201692|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-07-25|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|April 10, 2019|Anticipated|2019-04-10|April 10, 2019|Anticipated|2019-04-10||Interventional|||Improving Dynamic Balance and Gait Adaptability Using Treadmill Training|Improving Dynamic Balance and Gait Adaptability Using Treadmill Training With Visual Cues in Subjects With Neurological Disorders: Design of a Pilot Study|Recruiting||N/A|48|Anticipated|Fondazione Don Carlo Gnocchi Onlus||2|||f|||||f|f|||f|||||2017-10-10 20:54:47.039601|2017-10-10 20:54:47.039601
NCT03201679|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-06-28|||January 1, 2014|Actual|2014-01-01|June 2017|2017-06-01|August 1, 2017|Anticipated|2017-08-01|January 30, 2015|Actual|2015-01-30||Observational|||The Association Between Preoperative Sepsis and the Mortality After Hip Fracture Surgery|The Association Between Preoperative Sepsis and the Mortality After Hip Fracture Surgery|Active, not recruiting||N/A|1967|Actual|Bispebjerg Hospital|||2||f|||||f|f||||||||2017-10-10 20:54:47.116387|2017-10-10 20:54:47.116387
NCT03201666|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||July 1, 2016|Actual|2016-07-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|July 1, 2017|Anticipated|2017-07-01||Observational|||Comparison of Karyotyping, CMA and NIPT for Prenatal Diagnosing Chromosomal Anomalies|Comparison of Karyotyping, CMA and NIPT for Prenatal Diagnosing Chromosomal Anomalies|Recruiting||N/A|1000|Anticipated|Taizhou Hospital|||1||f||||f|f|f||||Samples With DNA|"     Sample1.maternal peripheral blood，which used for extracted fetal free DNA for NIPT     examination Sample2.amniotic fluid, which used for karyotyping and CMA analysis.   "|No||2017-10-10 20:54:47.186091|2017-10-10 20:54:47.186091
NCT03201653|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-06-25|||July 2017|Anticipated|2017-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||A Prospective Randomized Trial of Efficacy of Stump Closure for Distal Pancreatectomy|A Prospective Randomized Trial of Efficacy of Stump Closure for Distal Pancreatectomy|Recruiting||N/A|84|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:54:47.384747|2017-10-10 20:54:47.384747
NCT03201640|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-19|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||VR for Preoperative Anxiety in Children|Virtual Reality for Educating and Reducing Preoperative Anxiety in Children - A Randomised Control Trial|Recruiting||N/A|240|Anticipated|The Hospital for Sick Children||2|||f||||f|f|f||||||||2017-10-10 20:54:47.499845|2017-10-10 20:54:47.499845
NCT03201627|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 30, 2018|Anticipated|2018-12-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Study of Lithium Carbonate to Treat Niemann-Pick Type C1 Disease|a Single-center, Prospective, Open, and Non-randomized Case-control Study of Lithium Carbonate Effect on Niemann Disease C1 Type|Recruiting||Phase 1/Phase 2|7|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||f|f|f||||||No||2017-10-10 20:54:47.606696|2017-10-10 20:54:47.606696
NCT03201614|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-26|||November 15, 2017||2017-11-15||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:54:47.698867|2017-10-10 20:54:47.698867
NCT03201601|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-10-03|||February 2016||2016-02-01|October 2016|2016-10-01|October 31, 2017|Anticipated|2017-10-31|May 2017|Actual|2017-05-01||Interventional|||Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome|Comparison of the Effect of a Combination of Myoinositol:D-chiro-inositol With Low Proportion of DCI (40:1) Versus a Combination With a Higher Proportion of DCI (3.6:1) in the Oocyte Quality and Pregnancy Rates in Women With PCOS|Active, not recruiting||Phase 2/Phase 3|60|Anticipated|Biosearch S.A.||2|||f||||t||||||||||2017-10-10 20:54:47.740717|2017-10-10 20:54:47.740717
NCT03201588|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-28|||December 15, 2016|Actual|2016-12-15|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|May 1, 2018|Anticipated|2018-05-01||Interventional|MDM||Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM)|A Randomized Intervention, Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM)|Recruiting||N/A|210|Anticipated|Göteborg University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:54:47.848016|2017-10-10 20:54:47.848016
NCT03201575|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|RECO-Sepsis||REmote Ischemic COnditioning in Septic Shock|REmote Ischemic COnditioning in Septic Shock: The RECO-Sepsis Study|Not yet recruiting||N/A|180|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||No||2017-10-10 20:54:48.000916|2017-10-10 20:54:48.000916
NCT03201562|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-30|||April 30, 2017|Actual|2017-04-30|June 2017|2017-06-01|November 2, 2017|Anticipated|2017-11-02|October 2, 2017|Anticipated|2017-10-02||Interventional|||A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia|A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia|Recruiting||Phase 2|34|Anticipated|Presbyopia Therapies, LLC||3|||f|||||t|f||||||||2017-10-10 20:54:48.172462|2017-10-10 20:54:48.172462
NCT03201536|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-06-26|||October 2012||2012-10-01|June 2017|2017-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|ZIPS3||ZipLine Incision Approximation Verses Suture:ZIPS3 Physician Preference Study|ZipLine Incision Approzimation Vs. Suture:Zips3 Physician Preference Study|Withdrawn||N/A|0|Actual|ZipLine Medical Inc.||2||Lack of enrollment|f||||f||||||||||2017-10-10 20:54:48.350147|2017-10-10 20:54:48.350147
NCT03201523|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-25|||November 1, 2013|Actual|2013-11-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of a Socio-ecological Cardiovascular Disease Prevention Intervention for Ultra-Orthodox Jewish Hasidic Women|Evaluation of a Socio-ecological Cardiovascular Disease Prevention Intervention for Ultra-Orthodox Jewish Hasidic Women Using a Participatory Approach|Enrolling by invitation||N/A|239|Anticipated|Hadassah Medical Organization||1|||f||||f|f|f||||||Undecided||2017-10-10 20:54:48.442803|2017-10-10 20:54:48.442803
NCT03201510|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Observational|||Feasibility of HIV Prevention Cohort Studies Among Men Who Have Sex With Men in Sub-Saharan Africa|HPTN 075: Feasibility of HIV Prevention Cohort Studies Among Men Who Have Sex With Men in Sub-Saharan Africa|Active, not recruiting||N/A|401|Actual|HIV Prevention Trials Network|||1||f||||t||||||Samples Without DNA|"     Plasma samples will be stored from each study visit   "|No||2017-10-10 20:54:48.56434|2017-10-10 20:54:48.56434
NCT03201497|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|July 1, 2019|Anticipated|2019-07-01|1 Year|Observational [Patient Registry]|||Prospective Registration of Severe Pneumocystis Jiroveci Pneumonia Requiring ICU Admission|Prospective Registration of Severe Pneumocystis Jiroveci Pneumonia Requiring ICU|Not yet recruiting||N/A|300|Anticipated|Peking Union Medical College Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 20:54:48.72105|2017-10-10 20:54:48.72105
NCT03201484|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-27|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Observational|||Patient Reported Outcomes Following Parotid Resections|Patient Reported Outcomes Following Parotid Resections: Version 2|Not yet recruiting||N/A|50|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||||||||||||2017-10-10 20:54:48.814562|2017-10-10 20:54:48.814562
NCT03201471|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-20|||August 20, 2017|Actual|2017-08-20|June 2017|2017-06-01|February 5, 2020|Anticipated|2020-02-05|December 30, 2019|Anticipated|2019-12-30||Interventional|DLBCL||Chidamide With R-CHOP Regimen for DLBCL Patients|Chidamide With R-CHOP Regimen for de Novo, High Risk Diffuse Large B Cell Lymphoma (DLBCL): A Prospective, Signal Arm, Open Label Clinical Trial|Recruiting||Phase 2|39|Anticipated|First Affiliated Hospital of Zhejiang University||1|||f||||t|f|f||||||||2017-10-10 20:54:48.893408|2017-10-10 20:54:48.893408
NCT03201458|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-27|2017-09-04|||April 20, 2018|Anticipated|2018-04-20|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery|A Randomized Phase 2 Study of Atezolizumab in Combination With Cobimetinib Versus Atezolizumab Monotherapy in Participants With Unresectable Cholangiocarcinoma|Not yet recruiting||Phase 2|82|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 20:54:48.999607|2017-10-10 20:54:48.999607
NCT03201445|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-10-02|||July 11, 2017|Actual|2017-07-11|October 2017|2017-10-01|September 2022|Anticipated|2022-09-01|June 2019|Anticipated|2019-06-01||Interventional|MANTA||Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Ulcerative Colitis|A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Ulcerative Colitis|Recruiting||Phase 2|250|Anticipated|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 20:54:49.154384|2017-10-10 20:54:49.154384
NCT03201432|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-06-25|||May 2014||2014-05-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis|A Randomized Trial for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis: Drug Eluting Stents Versus Bare Metal Stents|Completed||Phase 2/Phase 3|160|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:54:49.313509|2017-10-10 20:54:49.313509
NCT03201406|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-28|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Observational|||Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease|Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease|Recruiting||N/A|837|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 20:54:49.729491|2017-10-10 20:54:49.729491
NCT03201393|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-17|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Twice Daily Oral ALLOD-2 vs. Placebo in the Treatment of Chronic Low Back Pain (ANODYNE-4)|A Single Center, Phase 2B, Randomized, Double Blind, Study to Assess the Efficacy, Safety, and Tolerability of Twice Daily Oral ALLOD-2 vs. Placebo in the Treatment of Chronic Low Back Pain (ANODYNE-4)|Recruiting||Phase 2/Phase 3|48|Anticipated|Allodynic Therapeutics, LLC||2|||f||||f|t|f|||f|||||2017-10-10 20:54:49.851385|2017-10-10 20:54:49.851385
NCT03201380|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-27|||November 1, 2014|Actual|2014-11-01|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2015|Actual|2015-11-01||Observational|TEPCholine||Evaluation of the Practice of the TEP Choline at Patients With Prostate Cancer|Evaluation of the Practice of the TEP Choline in Provence - Alps and Côte d'Azur at Patients With Prostate Cancer - Multicentre Retrospective Study.|Active, not recruiting||N/A|300|Actual|Institut Paoli-Calmettes|||1||f||||f|f|f||||||No||2017-10-10 20:54:50.007382|2017-10-10 20:54:50.007382
NCT03200444|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|August 30, 2017|Anticipated|2017-08-30|July 15, 2017|Anticipated|2017-07-15||Interventional|||Evaluation of the Peel Force of New Adhesives From the Skin|Evaluation of the Peel Force of New Adhesives From the Skin|Recruiting||N/A|6|Anticipated|Coloplast A/S||1|||f||||f|f|f||||||No||2017-10-10 20:54:57.819141|2017-10-10 20:54:57.819141
NCT03201367|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-27|||May 1, 2014|Actual|2014-05-01|June 2017|2017-06-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV|Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic Portal Vein Thrombosis in HCV Related Compensated Cirrhosis|Completed||N/A|40|Actual|Zagazig University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:54:50.109007|2017-10-10 20:54:50.109007
NCT03201354|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-06-26|||February 2012||2012-02-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery|Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery: Prospective, Multi-center, Comparative Study|Completed||N/A|98|Actual|Institut Catala de Retina||2|||f||||f||||||||||2017-10-10 20:54:50.212543|2017-10-10 20:54:50.212543
NCT03201341|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-04|||July 11, 2011|Actual|2011-07-11|September 2017|2017-09-01|July 11, 2019|Anticipated|2019-07-11|June 11, 2019|Anticipated|2019-06-11||Interventional|||Multisensory Body and Space Representations (BASES-EXTINCTION)|Cerebral Bases of Multisensory Perception of the Body and Its Action Space|Recruiting||N/A|1040|Anticipated|Hospices Civils de Lyon||5|||f|||||f|f||||||||2017-10-10 20:54:50.333283|2017-10-10 20:54:50.333283
NCT03201328|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Interventional|AUDIPIC||Impact of Binaural Audition on Postural Performance and Orientation|Prospective, Single Centre Cohort Study on the Impact of Binaural Audition on Postural Performance and Orientation in Healthy Subjects and Patients With Cochlear Implants.|Completed||N/A|15|Actual|Centre Hospitalier Universitaire Dijon||3|||f|||||f|f||||||||2017-10-10 20:54:50.495505|2017-10-10 20:54:50.495505
NCT03201315|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-27|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Observational|||The Incremental Risk of Intraoperative Fentanyl on PONV|The Incremental Risk of Intraoperative Fentanyl on PONV: A Modifiable Risk Without Drawbacks?|Recruiting||N/A|500|Anticipated|University Hospital, Basel, Switzerland|||1||f|||||f|f||||||Undecided||2017-10-10 20:54:50.592279|2017-10-10 20:54:50.592279
NCT03201302|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-06-27|||April 2013||2013-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 2014|Actual|2014-06-01||Interventional|KOMO-BONE||The KOMOtini BONE Study: Evaluation of the Osteogenic Potential of Sports|The KOMOtini BONE Study: Evaluation of Sports-Related Osteogenic Potential in School-Aged Children|Active, not recruiting||N/A|335|Actual|University of Thessaly||16|||f||||f||||||||No||2017-10-10 20:54:50.689183|2017-10-10 20:54:50.689183
NCT03201289|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-27|||January 2013|Actual|2013-01-01|June 2017|2017-06-01|December 29, 2016|Actual|2016-12-29|December 29, 2016|Actual|2016-12-29||Observational|||Microvolt T-wave Alternans in Cardiac Surgery Patients|Microvolt T-wave Alternans in Cardiac Surgery Patients|Completed||N/A|224|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-10 20:54:50.843822|2017-10-10 20:54:50.843822
NCT03201276|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-03|||July 2, 2017|Anticipated|2017-07-02|July 2017|2017-07-01|October 1, 2019|Anticipated|2019-10-01|July 1, 2019|Anticipated|2019-07-01||Observational|||Individual Differences in Glucosamine Sulfate Exposure Levels|Individual Differences in Glucosamine Sulfate Exposure Levels and Related Gene Polymorphism Research|Not yet recruiting||N/A|400|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|||1||f|||||t|f|||f|||||2017-10-10 20:54:50.927158|2017-10-10 20:54:50.927158
NCT03201263|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-30|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|PROTECTION||Sigh in Acute Hypoxemic Respiratory Failure|PRessure suppOrT vEntilation + Sigh in aCuTe hypoxemIc respiratOry Failure patieNts (PROTECTION): a Pilot Randomized Controlled Trial|Recruiting||N/A|258|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f|||||f|f||||||||2017-10-10 20:54:51.065489|2017-10-10 20:54:51.065489
NCT03201250|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma|A Phase I/II Study of the c-Met Inhibitor Cabozantinib as a Targeted Strategy to Reverse Resistance to the Proteasome Inhibitor Carfilzomib in Refractory Multiple Myeloma|Not yet recruiting||Phase 1/Phase 2|32|Anticipated|University of Nebraska||1|||||||t|t|f||||||||2017-10-10 20:54:51.230038|2017-10-10 20:54:51.230038
NCT03201237|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-27|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Comparison of Short- and Long-time Action Observation Training on Upper Limb Function in Children With Cerebral Palsy|Main Researcher for Action Observation Training (AOT)|Completed||N/A|10|Actual|Inje University||2|||f|||||f|f||||||||2017-10-10 20:54:51.49498|2017-10-10 20:54:51.49498
NCT03201224|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-27|||January 1, 2014|Actual|2014-01-01|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|January 1, 2019|Anticipated|2019-01-01|1 Day|Observational [Patient Registry]|||Image Transmission Applied to Organ Transplant: Before-after Study of the Effectiveness of the Device|Image Transmission Applied to Organ Transplant: Before-after Study of the Device of the Effectiveness|Recruiting||N/A|20000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f|f|f||||||||2017-10-10 20:54:51.585392|2017-10-10 20:54:51.585392
NCT03201198|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-17|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|ActiveCOPD||Active for Life: Chronic Obstructive Pulmonary Disease|Active for Life: Chronic Obstructive Pulmonary Disease|Recruiting||N/A|183|Anticipated|University of Michigan||2|||f||||t|f|f||||||||2017-10-10 20:54:51.854413|2017-10-10 20:54:51.854413
NCT03201185|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-27|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|RASTAVI||Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)|Beneficio Del Bloqueo Del Sistema Renina-angiotensina Sobre la evolución clínica y el Remodelado Ventricular Tras la colocación de Una prótesis percutánea aórtica (RASTAVI)|Not yet recruiting||Phase 4|336|Anticipated|Hospital Clínico Universitario de Valladolid||2|||f||||t|t|f|||f|||||2017-10-10 20:54:51.982479|2017-10-10 20:54:51.982479
NCT03201172|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-06|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Univation® X Follow-Up Study|Prospective Observational 2 Year Follow-up on a Retrospective Cohort of Primary Unicompartmental Knee Arthroplasty (UKA) Patients Treated With Univation® X or iUni®.|Enrolling by invitation||N/A|80|Anticipated|Aesculap AG|||2||f||||f|f|f||||||||2017-10-10 20:54:52.080085|2017-10-10 20:54:52.080085
NCT03201159|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-28|||June 25, 2017|Actual|2017-06-25|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis|A Pilot, Exploratory Dose Escalating Study on the Safety, Pharmacodynamics and Preliminary Efficacy of VLX103 in the Treatment of Moderate Alcoholic Steatohepatitis|Recruiting||Phase 1|18|Anticipated|University of Massachusetts, Worcester||3|||f||||t|t|f||||||Yes|Data will be filtered through Data Coordinating Center|2017-10-10 20:54:52.158583|2017-10-10 20:54:52.158583
NCT03201146|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-07-11|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|August 1, 2020|Anticipated|2020-08-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Apatinib Combine With Platinum‐Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC|A Phase 1/2 Study of Apatinib in Combination With AP(Pemetrexed/Cisplatin) or AC(Pemetrexed/Carboplatin) as First-line Chemotherapy for Advanced Epidermal Growth Factor Receptor(EGFR) Wild Type Non-squamous Non-small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|48|Anticipated|West China Hospital||5|||f||||f|f|f||||||||2017-10-10 20:54:52.275487|2017-10-10 20:54:52.275487
NCT03201133|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-29|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2018|Anticipated|2018-08-01|December 19, 2017|Anticipated|2017-12-19||Observational|||Clinical Subgroups in Patellofemoral Pain Syndrome|Clinical Subgroups Identification in Patellofemoral Pain Syndrome Patients|Not yet recruiting||N/A|45|Anticipated|Federal University of Rio Grande do Sul|||3||f|||||f|f||||||||2017-10-10 20:54:52.410086|2017-10-10 20:54:52.410086
NCT03201120|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||March 29, 2017|Actual|2017-03-29|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing|Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing|Recruiting||N/A|180|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||No||2017-10-10 20:54:52.486944|2017-10-10 20:54:52.486944
NCT03201107|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-10-03|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Obesity, Sarcopenic, Risk of Falls in Spanish Postmenopausal Women|Effects of a Program of Pilates Exercises on Obesity, Sarcopenic, Risk of Falls and Health in Spanish Postmenopausal Women|Recruiting||N/A|105|Anticipated|University of Jaén||2|||f||||f|f|f||||||||2017-10-10 20:54:52.59011|2017-10-10 20:54:52.59011
NCT03201094|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|INSPIRE||Impact of NMES and HPRO on Recovery After SAH|Impact of Neuromuscular Stimulation and High Protein Nutritional Supplementation on Long-term Recovery After Aneurysmal Subarachnoid Hemorrhage.|Not yet recruiting||N/A|30|Anticipated|University of Maryland||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:54:52.726396|2017-10-10 20:54:52.726396
NCT03201081|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-26|||January 15, 2017|Actual|2017-01-15|June 2017|2017-06-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Motivational Resistance-training Program on Adherence and Body Composition in Elderly|Impact of a Motivational Resistance-training Program on Adherence and Body Composition in Elderly|Completed||N/A|47|Actual|Universidad Católica San Antonio de Murcia||2|||f||||f|f|f||||||No||2017-10-10 20:54:52.811785|2017-10-10 20:54:52.811785
NCT03201068|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-09-24|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome|Impact of a Probiotic Supplement on the Microbiome, Immune System, and Metabolic Syndrome|Recruiting||N/A|45|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 20:54:52.90513|2017-10-10 20:54:52.90513
NCT03201055|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-26|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Snore Positive Airway Pressure Trial|Assessment of Performance, Usability and Acceptance of a Continuous Positive Airway Pressure System to Alleviate Self-reported Snore in Non-apnoeic Participants|Not yet recruiting||N/A|20|Anticipated|ResMed||1|||f||||f|f|f||||||||2017-10-10 20:54:53.001758|2017-10-10 20:54:53.001758
NCT03201042|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-18|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Observational|LyTIC||Lyme Test Indication Combinations (LyTIC) Study|Lyme Test Indication Combinations (LyTIC) Study|Recruiting||N/A|500|Anticipated|Oxford Immunotec|||3||f||||f|f|t|f|f|f|Samples Without DNA|"     whole blood serum   "|||2017-10-10 20:54:53.076352|2017-10-10 20:54:53.076352
NCT03201016|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-26|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2017|Actual|2017-06-01|6 Months|Observational [Patient Registry]|POC||Prevalence of Osteoporosis and Fractures in Patients With Hepatic Cirrhosis and Investigation of the Associated Factors|Prevalence of Osteoporosis and Fractures in Patients With Hepatic Cirrhosis and Investigation of the Associated Factors|Recruiting||N/A|110|Anticipated|Corporacion Parc Tauli|||1||f||||t|f|f||||||No||2017-10-10 20:54:53.481222|2017-10-10 20:54:53.481222
NCT03201003|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-28|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|ARTEMIS||ARTEMIS Peanut Allergy In Children|AR101 Trial in Europe Measuring Oral Immunotherapy Success in Peanut Allergic Children (ARTEMIS)|Recruiting||Phase 3|160|Anticipated|Aimmune Therapeutics, Inc.||2|||f||||t|t|f|||t|||||2017-10-10 20:54:53.558376|2017-10-10 20:54:53.558376
NCT03200990|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-07-03|||December 2016||2016-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PULSE||PULsecath mechanicaL Support Evaluation|PULsecath mechanicaL Support Evaluation (PULSE) - Trial|Enrolling by invitation||N/A|40|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 20:54:53.64109|2017-10-10 20:54:53.64109
NCT03200977|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||March 31, 2017|Actual|2017-03-31|June 2017|2017-06-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2022|Anticipated|2022-12-30||Observational|||Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab|Observational Cohort Study to Characterize the Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab|Recruiting||N/A|90|Anticipated|Bristol-Myers Squibb|||2||f||||||||||||||2017-10-10 20:54:53.763429|2017-10-10 20:54:53.763429
NCT03200964|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-29|||January 2004|Actual|2004-01-01|September 2017|2017-09-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|1 Month|Observational [Patient Registry]|||Anesthesia Followup of All Bariatric Procedures at One Hospital|Retrospective Analysis of Anesthesia Delivering for Bariatric Surgery|Recruiting||N/A|20000|Anticipated|AZ Sint-Jan AV|||1||f||||f|f|f||||||||2017-10-10 20:54:53.871001|2017-10-10 20:54:53.871001
NCT03200951|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-26|||July 1, 2017|Actual|2017-07-01|June 2017|2017-06-01|May 30, 2019|Anticipated|2019-05-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||The Effect of Epidural Analgesia on Intracranial Pressure by Measuring the Optic Nerve Sheath Diameter Using Ultrasound in Pediatric Patients With Cerebral Palsy|The Effect of Epidural Analgesia on Intracranial Pressure by Measuring the Optic Nerve Sheath Diameter Using Ultrasound in Pediatric Patients With Cerebral Palsy|Recruiting||N/A|40|Anticipated|Yonsei University||2|||f||||f|f|f||||||||2017-10-10 20:54:53.953673|2017-10-10 20:54:53.953673
NCT03200938|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-06-29|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Clinical Applicability of PBS® CIMMO Cement in Pulpotomies|Clinical Applicability of PBS® CIMMO Cement in Decoded Teeth Pulpotomies as Base and Restoration|Recruiting||N/A|30|Anticipated|Universidade do Vale do Sapucai||2|||f||||f|f|f||||||No||2017-10-10 20:54:54.045583|2017-10-10 20:54:54.045583
NCT03200925|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-27|||June 23, 2017|Actual|2017-06-23|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effect of Video Education on Skin-to-Skin at the Time of Delivery|The Effect of Video Education on Skin-to-Skin at the Time of Delivery|Enrolling by invitation||N/A|240|Anticipated|Kettering Health Network||2|||f||||f|f|f||||||No||2017-10-10 20:54:54.13783|2017-10-10 20:54:54.13783
NCT03200912|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-26|||August 19, 2016|Actual|2016-08-19|June 2017|2017-06-01|March 22, 2017|Actual|2017-03-22|March 7, 2017|Actual|2017-03-07||Interventional|||An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis|A Multicenter Randomized Doubleblind Vehicle-controlled Parallel Comparison Study to Determine Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.015% and Picato® Gel 0.015% in Subjects With Actinic Keratosis on the Face or Scalp|Completed||Phase 3|507|Actual|Actavis Inc.||3|||f||||f|t|f|||f|||No||2017-10-10 20:54:54.224523|2017-10-10 20:54:54.224523
NCT03200899|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||January 2014|Actual|2014-01-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis|Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis|Recruiting||N/A|220|Anticipated|University of Texas at Austin||2|||f||||t|f|f||||||Yes|Data files will be de-identified and data will be available on request to the investigators - estimated availability 2020|2017-10-10 20:54:54.355996|2017-10-10 20:54:54.355996
NCT03200886|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-26|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|June 30, 2017|Anticipated|2017-06-30|May 31, 2017|Actual|2017-05-31||Observational|||Comparison of the Efficacy of Intra-articular Hybrid Hyaluronic Acid and Steroid in Patients With Rizoarthrosis|Comparison of the Efficacy of Intra-articular Hybrid Hyaluronic Acid and Steroid in Patients With Rizoarthrosis|Active, not recruiting||N/A|100|Actual|University of Siena|||2||f||||t|t|f|||f|||||2017-10-10 20:54:54.452717|2017-10-10 20:54:54.452717
NCT03200873|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-06|||May 17, 2017|Actual|2017-05-17|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Effects of rTMS on Impulsivity and Empathy|Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Impulsivity and Empathy in a Non-clinical Population|Recruiting||N/A|54|Anticipated|University of Nottingham||2|||f||||t|f|f||||||||2017-10-10 20:54:54.543877|2017-10-10 20:54:54.543877
NCT03200860|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||December 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|EMPA-RESPONSE||Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure|Randomized, Double Blind, Placebo Controlled, Multicenter Pilot Study on the Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure (EMPA-RESPONSE-AHF)|Not yet recruiting||Phase 2|80|Anticipated|University Medical Center Groningen||2|||f||||t|f|f|||f|||No||2017-10-10 20:54:54.639607|2017-10-10 20:54:54.639607
NCT03200834|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-06-26|||January 25, 2017|Actual|2017-01-25|June 2017|2017-06-01|January 25, 2025|Anticipated|2025-01-25|January 25, 2022|Anticipated|2022-01-25||Interventional|||Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON)|Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON)|Recruiting||N/A|200|Anticipated|G.V. Bondar Republican Cancer Center||2|||f|||||f|f||||||Undecided||2017-10-10 20:54:54.852889|2017-10-10 20:54:54.852889
NCT03200821|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-26|||August 14, 2000|Actual|2000-08-14|June 2017|2017-06-01|September 19, 2002|Actual|2002-09-19|September 24, 2001|Actual|2001-09-24||Interventional|||An Open Label Study to Evaluate G17DT Compared to Gemcitabine|A Phase 3 Study to Evaluate the Efficacy and Safety of 250 µg G17DT or 1000 µg/m^2 Gemcitabine in Subjects With Advanced Pancreatic Cancer|Completed||Phase 3|103|Actual|Cancer Advances Inc.||2|||f||||f|t|f||||||No||2017-10-10 20:54:54.926011|2017-10-10 20:54:54.926011
NCT03200808|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-27|||October 2013||2013-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|NNEDsMB||Methylene Blue Injection for Nonneoplastic Epithelial Disorders of Vulva|Evaluation of the Efficacy of Mixed Methylene Blue Compound Injection for the Treatment of Nonneoplastic Epithelial Disorders of Vulva.|Active, not recruiting||Phase 1|118|Actual|Maternal and Child Health Hospital of Hubei Province||1|||f||||t|f|f|||f|||No||2017-10-10 20:54:54.989933|2017-10-10 20:54:54.989933
NCT03200795|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-26|||August 15, 2017|Anticipated|2017-08-15|June 2017|2017-06-01|October 20, 2018|Anticipated|2018-10-20|August 20, 2018|Anticipated|2018-08-20||Interventional|||Effect of Different Exercises on Musculoskeletal Pain,Glucose Level and Quality of Life Among Patients With Diabetes|Effect of Rebound Exercises and Circuit Training on Musculoskeletal Pain, Selected Biochemical and Psychosocial Parameters Among Individuals With Type 2 Diabetics|Not yet recruiting||N/A|90|Anticipated|University of KwaZulu||2|||f||||f|f|f||||||No||2017-10-10 20:54:55.068859|2017-10-10 20:54:55.068859
NCT03200782|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-26|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|July 30, 2018|Anticipated|2018-07-30|June 30, 2018|Anticipated|2018-06-30||Interventional|Hypo-BEAR||Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study|Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study|Recruiting||N/A|12|Anticipated|University Hospital, Basel, Switzerland||3|||f||||t|f|f||||||No||2017-10-10 20:54:55.147674|2017-10-10 20:54:55.147674
NCT03200769|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-26|||July 2014||2014-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|SASER||Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy|Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy|Recruiting||N/A|408|Anticipated|University Hospital, Lille||4|||f||||t||||||||||2017-10-10 20:54:55.247511|2017-10-10 20:54:55.247511
NCT03200756|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Rest-CR||Cardiac Rehabilitation and Sedentary Behavior|The Effect of Cardiac Rehabilitation on Sedentary Behavior|Recruiting||N/A|20|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||No||2017-10-10 20:54:55.331395|2017-10-10 20:54:55.331395
NCT03200743|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-26|||May 14, 2017|Actual|2017-05-14|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|18 Years|Observational [Patient Registry]|||Catestatin and Hypertension in Pregnancy|Relationship Between Catestatin and Pregnant Hypertensive Disorders|Recruiting||N/A|400|Anticipated|Peking University Third Hospital|||2||f||||t|f|f||||None Retained|"     Plasma   "|Undecided||2017-10-10 20:54:55.532128|2017-10-10 20:54:55.532128
NCT03200730|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-06-26|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|FDI||A Novel Family Dignity Intervention (FDI) for Asian Palliative Care|A Multicenter Randomized Controlled Trial of a Novel Family Dignity Intervention (FDI) for Asian Palliative Care|Recruiting||N/A|252|Anticipated|Nanyang Technological University||2|||f||||t|f|f||||||No||2017-10-10 20:54:55.656218|2017-10-10 20:54:55.656218
NCT03200717|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-03|||October 16, 2017|Anticipated|2017-10-16|October 2017|2017-10-01|November 2, 2020|Anticipated|2020-11-02|November 2, 2020|Anticipated|2020-11-02||Interventional|IO-PAZ||Study of Efficacy and Safety of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment|A Prospective International Multicenter Phase II Study to Evaluate the Efficacy, Safety and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Previous Therapy With Checkpoint Inhibitor Treatment|Not yet recruiting||Phase 2|140|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 20:54:55.782265|2017-10-10 20:54:55.782265
NCT03200704|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|FILM-B||A Study Assessing the Safety and Utility of IC2000 and SPY Fluorescence Imaging Systems in the Identification of Lymph Nodes During Lymphatic Mapping in Subjects With Breast Cancer|A Randomized, Prospective, Open Label, Multicenter Study Assessing the Safety and Utility of IC2000 and SPY Fluorescence Imaging Systems in the Identification of Lymph Nodes During Lymphatic Mapping in Subjects With Breast Cancer|Not yet recruiting||Phase 3|110|Anticipated|Novadaq Technologies Inc.||2|||f||||t|t|t|f|||||||2017-10-10 20:54:55.869834|2017-10-10 20:54:55.869834
NCT03200691|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-03|||August 10, 2017|Anticipated|2017-08-10|August 2017|2017-08-01|July 1, 2020|Anticipated|2020-07-01|June 30, 2018|Anticipated|2018-06-30||Interventional|||Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma|Phase II Study of Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma|Recruiting||Phase 2|21|Anticipated|Hangzhou Cancer Hospital||1|||f||||t|f|f||||||||2017-10-10 20:54:55.969088|2017-10-10 20:54:55.969088
NCT03200678|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-06|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|WEAKNESS||WEakness and Atrophy: isoKinetic With Surface Electromyography Assessment in ACL Surgery|Motor Unit Recruitment Study With Fatigue Testing: 9 Months Following up After Anterior Cruciate Ligament Surgery.|Not yet recruiting||N/A|80|Anticipated|Direction Centrale du Service de Santé des Armées||2|||f||||f|f|f||||||||2017-10-10 20:54:56.071111|2017-10-10 20:54:56.071111
NCT03200665|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-06-26|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Sonographic Evaluation of Fetal Growth in the Third Trimester of Low-risk Pregnancy: a Randomized Trial|Sonographic Evaluation of Fetal Growth in the Third Trimester of Low-risk Pregnancy: a Randomized Trial|Recruiting||N/A|2700|Anticipated|Hospital de Santa Maria, Portugal||2|||f||||f|f|f||||||Undecided||2017-10-10 20:54:56.191857|2017-10-10 20:54:56.191857
NCT03200652|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Metabolic Availability of Lysine From Wheat in Adult Men|Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Lysine From Indian Wheat, in Healthy Young Adult Men|Recruiting||N/A|5|Anticipated|The Hospital for Sick Children||1|||f||||f|f|f||||||No||2017-10-10 20:54:56.285481|2017-10-10 20:54:56.285481
NCT03200639|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||May 30, 2015|Actual|2015-05-30|June 2017|2017-06-01|December 10, 2015|Actual|2015-12-10|December 1, 2015|Actual|2015-12-01||Interventional|||Cachexia in Gynecological Cancer and the Preventive Role of Weight Training|Comparison of High Intensity Interval Body Weight Training Versus Combined Training on Body Composition, Physical Function, Metabolic Risk and Inflammation in Postmenopausal Women With and Without Gynecological Cancer|Completed||N/A|38|Actual|Universidade Federal do Triangulo Mineiro||4|||f||||f|f|f||||||No||2017-10-10 20:54:56.390779|2017-10-10 20:54:56.390779
NCT03200431|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-18|||June 26, 2017|Actual|2017-06-26|August 2017|2017-08-01|September 10, 2017|Anticipated|2017-09-10|September 10, 2017|Anticipated|2017-09-10||Interventional|||Evaluation of the Influence of Output on Skin Wearing a New Adhesive|Evaluation of the Influence of Output in Skin Covered by Newly Developed Adhesives|Recruiting||N/A|4|Anticipated|Coloplast A/S||1|||f||||f|f|f||||||||2017-10-10 20:54:57.89806|2017-10-10 20:54:57.89806
NCT03200626|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-23|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|July 1, 2020|Anticipated|2020-07-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma|A Prospective, Multicenter, Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||N/A|750|Anticipated|Medical College of Wisconsin|||3||f||||f|f|f||||||No|No IPD to be shared|2017-10-10 20:54:56.535338|2017-10-10 20:54:56.535338
NCT03200613|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-23|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|November 1, 2019|Anticipated|2019-11-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury|Apixaban Versus Low-Molecular Weight Heparin For Thromboprophylaxis In Patients With Acute Spinal Cord Injury: A Pilot Study|Not yet recruiting||Phase 2|40|Anticipated|McMaster University||2|||f||||t|f|f||||||No||2017-10-10 20:54:56.621669|2017-10-10 20:54:56.621669
NCT03200600|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-08-03|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|July 1, 2022|Anticipated|2022-07-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery|Impact of Perioperative Dexamethasone and Flurbiprofen Axetil on Delirium After Surgery for Non-small Cell Lung Cancer: A 2x2 Factorial Randomized Controlled Trial|Recruiting||Phase 4|844|Anticipated|Peking University First Hospital||4|||f||||t|f|f|||f|||||2017-10-10 20:54:56.723812|2017-10-10 20:54:56.723812
NCT03200587|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)|A Phase 1B, Open Label, Dose-finding Study to Evaluate the Safety and Tolerability of Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)|Not yet recruiting||Phase 1|20|Anticipated|University of Utah||1|||f||||t|t|f||||||No||2017-10-10 20:54:56.859447|2017-10-10 20:54:56.859447
NCT03200574|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-26|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|August 2020|Anticipated|2020-08-01||Interventional|BELIEVE||Behavior of Valve Leaflets|Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant|Not yet recruiting||N/A|230|Anticipated|LivaNova||1|||f||||t|f|t|f|f|t|||No||2017-10-10 20:54:56.934493|2017-10-10 20:54:56.934493
NCT03200561|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-26|||October 17, 2013|Actual|2013-10-17|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|RAST||A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)|A Randomized Open-label Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)|Recruiting||Phase 3|100|Anticipated|National Taiwan University Hospital||2|||f|||||f|f||||||||2017-10-10 20:54:57.037404|2017-10-10 20:54:57.037404
NCT03200548|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-16|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|AcuSLE||Acupressure for Fatigue in Systemic Lupus Erythematosus|Acupressure for Persistent Fatigue in Systemic Lupus Erythematosus Patients|Recruiting||N/A|72|Anticipated|University of Michigan||4|||f||||f|f|f||||||||2017-10-10 20:54:57.138532|2017-10-10 20:54:57.138532
NCT03200535|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-28|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs|Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs|Enrolling by invitation||N/A|6600|Anticipated|Kaiser Permanente||4|||f||||f|f|f||||||No||2017-10-10 20:54:57.244828|2017-10-10 20:54:57.244828
NCT03200522|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-23|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||BREATHE-Easy Trial|Western Versus Prudent Diet Feeding Study in Adult Women With Asthma|Not yet recruiting||N/A|12|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||No||2017-10-10 20:54:57.329878|2017-10-10 20:54:57.329878
NCT03200509|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-26|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|PAyBACK||Efficacy of a Multimodal Physical Activity Intervention in Patients With Chronic Nonspecific Low Back Pain|Efficacy of a Multimodal Physical Activity Intervention With Supervised Exercises, Health Coaching and an Activity Monitor on Physical Activity Levels of Patients With Chronic Nonspecific Low Back Pain: PAyBACK Trial|Not yet recruiting||N/A|160|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f|||||f|f||||||||2017-10-10 20:54:57.44403|2017-10-10 20:54:57.44403
NCT03200496|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-07-06|||May 29, 2017|Actual|2017-05-29|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male Subjects|Comparisons of Pharmacokinetics and Safety/Tolerability Profiles Between DA-5206 and Talion® Under Fasting and Fed States in Healthy Male Subjects|Completed||Phase 1|30|Actual|Dong-A ST Co., Ltd.||3|||f|||||f|f||||||||2017-10-10 20:54:57.54313|2017-10-10 20:54:57.54313
NCT03200483|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||March 2014||2014-03-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|||Musical Auditory Stimulation and Exercise|Effects of Musical Auditory Stimulation on Autonomic Cardiac Response and Cardiorespiratory Parameters During and After Long-term Submaximal Aerobic Exercise|Completed||N/A|35|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||||||||||||2017-10-10 20:54:57.613223|2017-10-10 20:54:57.613223
NCT03200457|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-22|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|July 1, 2019|Anticipated|2019-07-01|January 1, 2019|Anticipated|2019-01-01||Interventional|HEMOCOMPARE||Comparison of the Variability of Hepatic Load Quantification in Iron and Fat Estimated by MRI at 1.5 and 3 Tesla|Comparison of the Variability of Hepatic Load Quantification in Iron and Fat Estimated by MRI at 1.5 and 3 Tesla|Not yet recruiting||N/A|80|Anticipated|Rennes University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:54:57.742161|2017-10-10 20:54:57.742161
NCT03200405|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-24|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|NANEP||Visible vs. Non-Visible Mesh in Underlay Positon After Repair of Umbilical Hernias|Morphological Imaging of Meshes in Underlay Position After Treatment of Primary Umbilical Hernias: a Randomised Controlled Trial|Active, not recruiting||N/A|31|Actual|Wuerzburg University Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 20:54:58.044818|2017-10-10 20:54:58.044818
NCT03200392|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-04|||February 2015|Actual|2015-02-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Er,Cr:YSGG Laser For Recipient Bed Bio-modification And Connective Tissue Harvesting in Treatment of Gingival Recession|The Use Of Er,Cr:YSGG Laser For Recipient Bed Bio-modification And De-epithelialized Palatal Graft Harvesting In The Treatment of Gingival Recession Defects -(Randomized Clinical Trial)|Completed||N/A|24|Actual|Misr International University||3|||f||||f||||||||||2017-10-10 20:54:58.122516|2017-10-10 20:54:58.122516
NCT03200379|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-26|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|June 15, 2037|Anticipated|2037-06-15|June 15, 2037|Anticipated|2037-06-15||Observational|||Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan|Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan|Recruiting||N/A|150000|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f|f|f||||Samples With DNA|"     host genetic associated HCV related outcomes would be retrived provided by patient consents   "|No||2017-10-10 20:54:58.208161|2017-10-10 20:54:58.208161
NCT03200366|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-10|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Comparing Interventions to Increase Colorectal Cancer Screening|Comparing Interventions to Increase Colorectal Cancer Screening in Low-Income and Minority Patients|Enrolling by invitation||N/A|750|Anticipated|Indiana University||3|||f||||t|f|f||||||||2017-10-10 20:54:58.286123|2017-10-10 20:54:58.286123
NCT03200353|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-28|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|April 10, 2017|Actual|2017-04-10||Interventional|||Sores Treatment by Oxygenotherapy|Evaluation Ofsores Treatment by Oxygenotherapy|Recruiting||N/A|30|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||f|f|f||||||No||2017-10-10 20:54:58.417854|2017-10-10 20:54:58.417854
NCT03200340|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-21|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 20, 2019|Anticipated|2019-06-20|June 20, 2019|Anticipated|2019-06-20||Interventional|||EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation|Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation for Cancers of the Mouth, Oropharynx, Hypopharynx and Nasopharynx|Not yet recruiting||Phase 2|84|Anticipated|Enzychem Lifesciences Corporation||4|||f||||t|t|f||||||||2017-10-10 20:54:58.506547|2017-10-10 20:54:58.506547
NCT03200327|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|SAPPRO||Comparison of Anterior Prosthetic Vaginal Sacrospinofixation With Laparoscopic Promontofixation for the Treatment of Anterior and Apical Genitourinary Prolapse|Comparison of Anterior Prosthetic Vaginal Sacrospinofixation With Laparoscopic Promontofixation for the Treatment of Anterior and Apical Genitourinary Prolapse|Not yet recruiting||N/A|156|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f|||||f|f||||||||2017-10-10 20:54:58.589872|2017-10-10 20:54:58.589872
NCT03200314|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-08-16|||August 13, 2017|Actual|2017-08-13|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||Blood Recirculation and vvECMO|Measurment of Blood Recirculation and Adjustment of vvECMO Blood Flow During Veno-venous Extracoporeal Membrane Oxygenation|Recruiting||N/A|25|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:54:58.705074|2017-10-10 20:54:58.705074
NCT03200301|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-28|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|Cord Milking||Effect of Intact Umbilical Cord Milking on Neonatal and First Year Neurodevelopmental Outcomes in Very Preterm Infants.|Effect of Intact Umbilical Cord Milking Versus Immediate Cord Clamping on Neonatal Outcomes and First Year Neurodevelopmental Outcomes in Very Preterm Infants - A Randomised Controlled Trial|Not yet recruiting||N/A|250|Anticipated|Jubilee Mission Medical College and Research Institute||2|||f||||t|f|f||||||Undecided||2017-10-10 20:54:58.772922|2017-10-10 20:54:58.772922
NCT03200288|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-03|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis|A Phase 3,Randomized,Double-blind,Placebo-controlled Study to Evaluate the Clinical Performance and Safety of an Intra-articular Solution of High and Low Molecular Weight Hyaluronic Acid (HL-01) in the Treatment of Symptomatic Knee Osteoarthritis|Recruiting||Phase 3|720|Anticipated|IBSA Institut Biochimique SA||2|||f|||||f|f|||f|||||2017-10-10 20:54:58.85928|2017-10-10 20:54:58.85928
NCT03200275|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-06-26|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Impact of Legionella Urine Antigen Testing (LUAT) on the Local Epidemiology and Diagnosis of Legionella Pneumonia|The Impact of Legionella Urine Antigen Testing (LUAT) on the Local Epidemiology and Diagnosis of Legionella Pneumonia - A Hospital Based Study in Malaysia|Not yet recruiting||N/A|503|Anticipated|Ministry of Health, Malaysia|||1||f||||t|f|f||||||No||2017-10-10 20:54:58.958057|2017-10-10 20:54:58.958057
NCT03200262|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|TRILLARTHRO||Analytic and Functional Evaluation After Surgical Treatment Using an Original Arthroscopic Trillat Technique in Patients With Chronic Anterior Shoulder Instability|Analytic and Functional Evaluation After Surgical Treatment Using an Original Arthroscopic Trillat Technique in Patients With Chronic Anterior Shoulder Instability|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f|||||f|f||||||||2017-10-10 20:54:59.044122|2017-10-10 20:54:59.044122
NCT03200249|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-26|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|RADICAL||Preoperative Chemo-radiation With IG-IMRT Dose Escalation for Locally Advanced Rectal Cancers|Preoperative Chemo-radiation With IG-IMRT Dose Escalation for Locally Advanced Rectal Cancers: Phase 2 Study (RADICAL)|Recruiting||N/A|51|Anticipated|Centre Georges Francois Leclerc||1|||f||||t|f|f|||f|||No||2017-10-10 20:55:00.665201|2017-10-10 20:55:00.665201
NCT03200236|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-17|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||The Lung Screening, Tobacco and Health Project|Integrating Evidence-Based Smoking Cessation Interventions Into Lung Cancer Screening Programs: A Randomized Trial|Recruiting||Phase 3|1330|Anticipated|Georgetown University||2|||f||||t|f|f|||f|||||2017-10-10 20:55:00.781799|2017-10-10 20:55:00.781799
NCT03200223|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-25|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|June 22, 2018|Anticipated|2018-06-22||Interventional|||Lifestyle Related Disease Management With Wearable Device and Mobile Application|A Study of the Management of the Patient's Disease Based on the Life Log Data of Patient With Lifestyle-related Diseases Through a Wearable Device and Mobile App|Recruiting||N/A|60|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:55:00.898825|2017-10-10 20:55:00.898825
NCT03200210|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-25|2017-06-26|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|LUMINA||Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients|Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective, Multicenter, Double-Blinded, Randomized Controlled Trial|Not yet recruiting||Phase 4|548|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||No||2017-10-10 20:55:00.971036|2017-10-10 20:55:00.971036
NCT03200197|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-25|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effectiveness of Menthol Chewing Gum in the Management of Thirst|Effectiveness of Menthol Chewing Gum in the Management of Preoperative Thirst: Randomized Clinical Trial|Completed||N/A|102|Actual|Universidade Estadual de Londrina||2|||f||||f|f|f||||||Undecided||2017-10-10 20:55:01.052558|2017-10-10 20:55:01.052558
NCT03200184|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-09-18|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2018|Anticipated|2018-03-01||Interventional|SD1000||Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients||Active, not recruiting||Phase 4|1448|Actual|Tehran University of Medical Sciences||1|||f||||f|f|f||||||||2017-10-10 20:55:01.128594|2017-10-10 20:55:01.128594
NCT03200171|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-24|2017-06-28|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||Effect of DAAs on Behavior of HCC in HCV Patients|Effect of Direct Acting Antiviral Agents on Behavior of Hepatocellular Carcinoma and Overall Survival in Patients With Chronic Hepatitis C|Not yet recruiting||N/A|300|Anticipated|Al-Azhar University|||2||f||||f|f|f||||||No||2017-10-10 20:55:01.226421|2017-10-10 20:55:01.226421
NCT03200158|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-25|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Study on Correlated Factors of Barrier and Immune Function in Stress Related Mucosal Disease (SRMD)|Study on Changes of Barrier and Immune Function in Stress Related Mucosal Disease (SRMD)|Completed||N/A|53|Actual|Shandong University||1|||f||||f|f|f||||||No||2017-10-10 20:55:01.345223|2017-10-10 20:55:01.345223
NCT03200145|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-26|||June 27, 2017|Anticipated|2017-06-27|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|RECENPE||Person Centered Nursing Homes: Impact Assessment Of Centered Person Care In Nursing Homes|Residències Centrades en Les Persones (RECENPE): avaluació de l'Impacte d'un Model d'ACP en residències Per Persones Grans|Not yet recruiting||N/A|170|Anticipated|Fundacio Salut i Envelliment UAB|||1||f||||f|f|f||||||Undecided||2017-10-10 20:55:01.476589|2017-10-10 20:55:01.476589
NCT03200132|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|December 25, 2017|Anticipated|2017-12-25|December 25, 2017|Anticipated|2017-12-25||Observational|||Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)|Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)|Recruiting||N/A|15|Anticipated|Maastricht University Medical Center|||1||f|||||f|f||||||||2017-10-10 20:55:01.580811|2017-10-10 20:55:01.580811
NCT03200119|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-25|||June 20, 2016|Actual|2016-06-20|June 2017|2017-06-01|November 18, 2016|Actual|2016-11-18|July 26, 2016|Actual|2016-07-26||Interventional|||MyHealthKeeper: Clinical Trial Study Based on Personal Health Record Healthcare Management|A Study of the Management of the Patient's Disease Based on the Life Log Data of Patients With Lifestyle-related Diseases Through a Wearable Device|Completed||N/A|68|Actual|Seoul National University Hospital||2|||f||||t|f|f||||||No|patient personal information is confidential according to the hospital's data protection policy|2017-10-10 20:55:01.777906|2017-10-10 20:55:01.777906
NCT03200106|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites|Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites|Not yet recruiting||N/A|20|Anticipated|Sequana Medical AG|||1||f||||f|f|f||||||Undecided||2017-10-10 20:55:01.893769|2017-10-10 20:55:01.893769
NCT03200093|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Oral Vancomycin for Preventing Clostridium Difficile Recurrence|Secondary Prophylaxis With Oral Vancomycin for Clostridium Difficile Recurrence: A Randomized Control Study|Recruiting||Phase 4|240|Anticipated|Rochester General Hospital||2|||f||||t|t|f|||f|||No||2017-10-10 20:55:02.040909|2017-10-10 20:55:02.040909
NCT03200067|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-25|||June 3, 2017|Actual|2017-06-03|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects on the Personalized Rehabilitation Service in Patients With Cancer|Effects on the Personalized Rehabilitation Service in Patients With Cancer|Recruiting||N/A|200|Anticipated|Seoul National University Bundang Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:55:02.344028|2017-10-10 20:55:02.344028
NCT02896738|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-02-09|||September 2015|Actual|2015-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Observational|DIMAVE||MRI Screening for Auditory Pathway Malformations in Visually Impaired Children||Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:49:34.086083|2017-10-10 21:49:34.086083
NCT03200054|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-07-05|||January 2016||2016-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|PACART||Postpartum Adherence Clubs for Antiretroviral Therapy|Postpartum Adherence Clubs for Antiretroviral Therapy: a Randomised Controlled Trial|Recruiting||N/A|388|Anticipated|University of Cape Town||2|||f||||t||||||||||2017-10-10 20:55:02.439309|2017-10-10 20:55:02.439309
NCT03200041|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-06-23|||February 2016||2016-02-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|TWIN||Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin Pregnancies|Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin Pregnancies|Recruiting||N/A|1000|Anticipated|Premaitha Health||2|||f||||f||||||||Yes|IONA Test results being given to patients|2017-10-10 20:55:02.549081|2017-10-10 20:55:02.549081
NCT03200028|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||CCTAP: Cognitive Control Training for Treatment of AUD-PTSD|CCTAP: Cognitive Control Training for Treatment of AUD-PTSD|Not yet recruiting||N/A|15|Anticipated|Posit Science Corporation||1|||f|||||f|f||||||||2017-10-10 20:55:02.655676|2017-10-10 20:55:02.655676
NCT03200015|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-27|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma|Effect of Metformin in Combination With R-CHOP for the First Line Treatment of Patients With Diffuse Large B-cell Lymphoma|Recruiting||Phase 2|50|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||f|f|f|||f|||||2017-10-10 20:55:02.744843|2017-10-10 20:55:02.744843
NCT03200002|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-26|||January 1, 2014|Actual|2014-01-01|June 2017|2017-06-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Interventional|||Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis|Effect of Cyclophosphamide Versus Mycophenolate Mofetil in Induction Therapy of Lupus Nephritis in Nepalese Population|Completed||Phase 2|49|Actual|Chitwan Medical College||2|||f||||f|f|f|||f|||Undecided||2017-10-10 20:55:02.85153|2017-10-10 20:55:02.85153
NCT03199989|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-25|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|July 31, 2024|Anticipated|2024-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|EPAC1||Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)|Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)|Recruiting||Phase 3|1254|Anticipated|Beijing Cancer Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:55:02.934145|2017-10-10 20:55:02.934145
NCT03199976|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-06-26|||April 20, 2016|Actual|2016-04-20|June 2017|2017-06-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Efficacy of Intermittent Tiotropium in Early Childhood Wheezing|Efficacy of Intermittent Tiotropium in Early Childhood Wheezing|Recruiting||Phase 4|195|Anticipated|Helsinki University Central Hospital||3|||f||||t|f|f||||||Undecided||2017-10-10 20:55:03.043688|2017-10-10 20:55:03.043688
NCT03199963|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-24|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|October 30, 2020|Anticipated|2020-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|4WARD||Trial of 4-OHT Gel in Women Aimed at Reducing Dense Breast Tissue|A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women With BI-RADS Breast Density Categories C or D|Recruiting||Phase 3|330|Anticipated|BHR Pharma, LLC||2|||f||||t|t|f||||||||2017-10-10 20:55:03.144718|2017-10-10 20:55:03.144718
NCT03199950|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-26|||June 23, 2017|Actual|2017-06-23|June 2017|2017-06-01|November 23, 2018|Anticipated|2018-11-23|November 23, 2018|Anticipated|2018-11-23||Interventional|PRODEO||PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel|Delirium: Is Prophylactic Drug Therapy Useful in High Risk Patients as Defined by the Delirium Risk Prediction Model?|Recruiting||Phase 4|1366|Anticipated|Zuyderland Medisch Centrum||2|||f||||t|f|f||||||Undecided||2017-10-10 20:55:03.258465|2017-10-10 20:55:03.258465
NCT03199937|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-18|||July 11, 2015|Actual|2015-07-11|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Executive Function Intervention for High School Students With ASD|Behavioral and Neural Outcomes of a New Executive Function Treatment for Transition-age Youth With ASD|Enrolling by invitation||N/A|76|Anticipated|Children's Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:55:03.379739|2017-10-10 20:55:03.379739
NCT03199924|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-06-24|||July 1, 2016|Actual|2016-07-01|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Treatment of Renal Colic in the Emergency Departement (ED).|Intravenous Magnesium Sulfate Combined to Diclofenac Versus Intravenous Lidocaine Combined to Diclofenac Versus Diclofenac Alone in the ED Treatment of Renal Colic. A Randomized Double Blind Study.|Recruiting||Phase 2|600|Anticipated|University of Monastir||3|||f||||t|f|f||||||No||2017-10-10 20:55:03.514763|2017-10-10 20:55:03.514763
NCT03199911|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-29|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||Topical Antibiotic Prophylaxis for Eyelids|The Role of Topical Antibiotic Prophylaxis in Eyelid Surgery|Recruiting||Phase 4|400|Anticipated|University of California, San Francisco||2|||f||||f|t|f||||||||2017-10-10 20:55:03.601528|2017-10-10 20:55:03.601528
NCT03199898|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-10|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Reliability Testing of Silverman-Andersen Retraction Score in Preterm Infants|Reliability Testing of Silverman-Andersen Retraction Score in Preterm Infants|Recruiting||N/A|40|Anticipated|St. Olavs Hospital|||3||f||||f|f|f||||||||2017-10-10 20:55:03.833857|2017-10-10 20:55:03.833857
NCT03199885|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-26|2017-09-04|||July 11, 2018|Anticipated|2018-07-11|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Paclitaxel, Trastuzumab, and Pertuzumab With or Without Pembrolizumab in Treating Patients With Metastatic Breast Cancer|A Randomized Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab Compared to Paclitaxel/Trastuzumab/Pertuzumab/Pembrolizumab in First-Line HER2-Positive Metastatic Breast Cancer|Not yet recruiting||Phase 3|480|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 20:55:03.934841|2017-10-10 20:55:03.934841
NCT03199872|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-02|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours|A Phase I/II Study of RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours|Active, not recruiting||Phase 1/Phase 2|25|Anticipated|RhoVac APS||1|||f||||f|f|f||||||||2017-10-10 20:55:04.111589|2017-10-10 20:55:04.111589
NCT03199859|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-23|||May 17, 2016|Actual|2016-05-17|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2017|Anticipated|2017-08-31|12 Months|Observational [Patient Registry]|||Early Diagnosis and Treatment Standardization of Delirium|Early Diagnosis and Treatment Standardization of Delirium|Recruiting||N/A|250|Anticipated|Seoul National University Hospital|||||f||||f|f|f||||||No||2017-10-10 20:55:04.202564|2017-10-10 20:55:04.202564
NCT03199846|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-09-26|||October 25, 2016|Actual|2016-10-25|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States|Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States|Active, not recruiting||N/A|650|Anticipated|Bristol-Myers Squibb|||6||f||||f||||||||||2017-10-10 20:55:04.292527|2017-10-10 20:55:04.292527
NCT03199833|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||November 10, 2016|Actual|2016-11-10|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|RETRAINER-S2||Reaching Training Based on Robotic Hybrid Assistance for Stroke Patients ( RETRAINER-S2 )|Reaching Training Based on Robotic Hybrid Assistance for Stroke Patients|Recruiting||N/A|68|Anticipated|Villa Beretta Rehabilitation Center||2|||f||||f|f|f||||||No||2017-10-10 20:55:04.412712|2017-10-10 20:55:04.412712
NCT03199820|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-23|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Interventional|PROBIT-F||Balloon Catheter Versus Propess for Labour Induction|Prostaglandin Insert (Propess) Versus Trans-cervical Balloon Catheter for Out-patient Labour Induction: A Randomised Controlled Trial of Feasibility|Not yet recruiting||Phase 4|120|Anticipated|St George's, University of London||2|||f||||t|f|f|||f|||Undecided||2017-10-10 20:55:04.549826|2017-10-10 20:55:04.549826
NCT03199807|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-24|||July 20, 2017|Anticipated|2017-07-20|June 2017|2017-06-01|July 20, 2021|Anticipated|2021-07-20|July 20, 2020|Anticipated|2020-07-20||Interventional|LCRAI-1||Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC|Phase IB/II Study of Personalized New Antigen Reactive Immune Cells (NRT) Combined With Radiotherapy for Advanced Hepatocellular Carcinoma Patients|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||t|f|f||||||Undecided||2017-10-10 20:55:04.681604|2017-10-10 20:55:04.681604
NCT03199794|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-19|||December 14, 2016|Actual|2016-12-14|July 2017|2017-07-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Observational|||Prospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice|Prospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice|Recruiting||N/A|50|Anticipated|Baxalta US Inc.|||1||f||||f||||||||||2017-10-10 20:55:04.77456|2017-10-10 20:55:04.77456
NCT03199781|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-24|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|September 15, 2017|Anticipated|2017-09-15|August 20, 2017|Anticipated|2017-08-20||Interventional|||Motorized Mechanical Massage Associated With Cosmetics in Improving Body Contour and Appearance of Gynoid Lipodystrophy|Motorized Mechanical Massage Associated With Cosmetics in Improving Body Contour and Appearance of Gynoid Lipodystrophy|Recruiting||N/A|30|Anticipated|Indústria Brasileira Equipamentos Médicos - IBRAMED||1|||f||||f|f|f||||||Yes||2017-10-10 20:55:04.880365|2017-10-10 20:55:04.880365
NCT03199768|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-23|||September 15, 2016|Actual|2016-09-15|September 2016|2016-09-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Observational|||Delirium in Geriatric Hospital Single-bed and Multibed Rooms|Can the Hospital's Architectural Design Affect the Incidence and Treatment of Delirium in Geriatric Patients? A Comparison Between Single-bed and Multibed Rooms|Recruiting||N/A|640|Anticipated|University of Aarhus|||2||f||||t|f|f||||||No||2017-10-10 20:55:04.991847|2017-10-10 20:55:04.991847
NCT03199755|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-27|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Dried Leaf Artemisia (DLA) Compared to Artemisinin Combination Therapy (ACT) vs Malaria|Efficacy of Dried Leaf Artemisia (DLA) Versus Coartem (ACT): A Randomized Controlled Clinical Trial for Comparing DLA vs. ACT to Treat Malaria|Not yet recruiting||Phase 2|600|Anticipated|Worcester Polytechnic Institute||3|||f||||f|f|f||||||Undecided||2017-10-10 20:55:05.123973|2017-10-10 20:55:05.123973
NCT03199742|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Evaluation of a Mobile Phone App for Veterans With PTSD|Evaluation of a Mobile Phone App for Veterans With PTSD|Recruiting||N/A|600|Anticipated|VA Palo Alto Health Care System||4|||f||||f|f|f||||||No||2017-10-10 20:55:05.233149|2017-10-10 20:55:05.233149
NCT03199729|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-23|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Aging and Mixed Perturbation Training to Reduce Falls in Locomotion|Aging and Mixed Perturbation Training to Reduce Falls in Locomotion|Not yet recruiting||N/A|420|Anticipated|University of Illinois at Chicago||4|||f||||f|f|f||||||No||2017-10-10 20:55:05.349876|2017-10-10 20:55:05.349876
NCT03199716|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-06-23|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents|Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents|Recruiting||N/A|66|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-10-10 20:55:05.469824|2017-10-10 20:55:05.469824
NCT03199703|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-23|||January 17, 2017|Actual|2017-01-17|June 2017|2017-06-01|August 17, 2020|Anticipated|2020-08-17|January 17, 2020|Anticipated|2020-01-17||Interventional|CRYO-LATS||Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation|Randomized Trial of Conventional Versus Radiofrequency Needle Transseptal Puncture for Cryoballoon Ablation|Recruiting||N/A|150|Anticipated|University of British Columbia||2|||f||||f|f|f||||||Undecided||2017-10-10 20:55:05.584496|2017-10-10 20:55:05.584496
NCT03199690|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RADIO||A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers|Phase One, Open Lab Study to Investigate the Impact of Rifampicin Administration on the PK of Dolutegravir When Dosed Once Daily at 50 or 100 mg in Healthy Volunteers|Not yet recruiting||Phase 1|16|Anticipated|St Stephens Aids Trust||1|||f||||f|f|f|||f|||No||2017-10-10 20:55:05.702882|2017-10-10 20:55:05.702882
NCT02895971|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-07-03|||March 4, 2013|Actual|2013-03-04|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|EPIGETBO III||Incidence of Venous Thromboembolism and Professional Practices in Brest Area||Completed||N/A|1416|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:49:40.304194|2017-10-10 21:49:40.304194
NCT03199677|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-29|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer|An Exploratory Single-center, Open-label , Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer|Recruiting||Phase 2|40|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f|f|f|||f|||Undecided||2017-10-10 20:55:05.788577|2017-10-10 20:55:05.788577
NCT03199664|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-24|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo|Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo|Recruiting||Phase 4|100|Anticipated|South Valley University||2|||f||||t|f|f|||t|||||2017-10-10 20:55:05.874925|2017-10-10 20:55:05.874925
NCT03199651|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-24|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|BLCIO||Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer|Beating Lung Cancer in Ohio (BLCIO) Protocol|Recruiting||N/A|2994|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t|f|f||||||||2017-10-10 20:55:05.956764|2017-10-10 20:55:05.956764
NCT03199638|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||April 2016||2016-04-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes|Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes|Recruiting||N/A|24|Anticipated|Nemours Children's Clinic||3|||f||||f||||||||No||2017-10-10 20:55:06.07127|2017-10-10 20:55:06.07127
NCT03199625|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||January 2016||2016-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Different Neural Circuit Mechanisms Between Cognitive Therapy and Behavior Therapy for Patients With Panic Disorder: a Dynamic Research|Different Neural Circuit Mechanisms Between Cognitive Therapy and Behavior Therapy for Patients With Panic Disorder: a Dynamic Research|Recruiting||Phase 2|96|Anticipated|Nanjing Medical University||3|||f||||||||||||||2017-10-10 20:55:06.203847|2017-10-10 20:55:06.203847
NCT03199612|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-23|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 30, 2022|Anticipated|2022-08-30|June 30, 2022|Anticipated|2022-06-30||Interventional|||Hemolysis With Continuous Flow Pumps|The Role of Hemolysis in Promoting Thrombosis During Mechanical Circulatory Support With Continuous Flow Pumps (Aim 2)|Not yet recruiting||Early Phase 1|44|Anticipated|Montefiore Medical Center||2|||f||||t|t|f|||t|||No||2017-10-10 20:55:06.291397|2017-10-10 20:55:06.291397
NCT03199586|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-09-29|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)|First-in-Human, Dose Finding, Open Label Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)|Not yet recruiting||Phase 1|60|Anticipated|Novita Pharmaceuticals, Inc.||1|||f||||f|t|f||||||||2017-10-10 20:55:06.434357|2017-10-10 20:55:06.434357
NCT03199573|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-08-17|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Observational|||Hats on Head Start: A A Survey of Sun Protection Behaviors in Head Start and Other Early Childhood Education Programs|Hats on Head Start: A Survey of Sun Protection Behaviors in Head Start and Other Early Childhood Education Programs|Completed||N/A|202|Actual|Northwestern University|||1||f||||f|f|f||||||||2017-10-10 20:55:06.501784|2017-10-10 20:55:06.501784
NCT03199560|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|August 22, 2019|Anticipated|2019-08-22|June 22, 2019|Anticipated|2019-06-22||Interventional|||Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy|A Randomized Controlled Double-blinded Study Comparing the Intraoperative Injection of Lymphatic Mapping Agents Tc 99m Tilmanocept to Tc 99m Filtered Sulfur Colloid in Breast Cancer Patients Undergoing Breast Conservation and Sentinel Lymph Node Biopsy|Recruiting||Phase 4|86|Anticipated|Memorial Health University Medical Center||2|||f||||f|t|f|||f|||No||2017-10-10 20:55:06.627794|2017-10-10 20:55:06.627794
NCT03199547|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-07-14|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|August 2020|Anticipated|2020-08-01||Interventional|PregnAnZI-2||Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death|Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis and Death: a Phase III Double-blind Randomized Clinical Trial|Not yet recruiting||Phase 3|12500|Anticipated|Medical Research Council Unit, The Gambia||2|||f||||t|f|f||||||||2017-10-10 20:55:06.808777|2017-10-10 20:55:06.808777
NCT03199534|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-23|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|||A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction|A Prospective Cohort Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction|Recruiting||Phase 4|40|Anticipated|EvergreenHealth||2|||f||||f|t|f|||t|||No|There is no plan to share individual participant data.|2017-10-10 20:55:06.911159|2017-10-10 20:55:06.911159
NCT03199521|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-23|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|May 2018|Anticipated|2018-05-01||Observational|||Assessment of The Effect of Apixaban in AF|Assessing The Effect of Apixaban on Endogenous Fibrinolysis in Patients With Non-Valvular Atrial Fibrillation|Not yet recruiting||N/A|200|Anticipated|East and North Hertfordshire NHS Trust|||3||f||||t||||||Samples Without DNA|"     plasma   "|Yes||2017-10-10 20:55:07.023681|2017-10-10 20:55:07.023681
NCT03199508|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-24|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Clinical Values of Voiding Diary for Diagnosis and Treatment for Monosymptomatic Enuresis in Children|Prospective, Randomized, Controlled, Multicenter Clinical Trial of Voiding Diary for Diagnosis and Treatment for Monosymptomatic Enuresis in Children|Recruiting||N/A|800|Anticipated|The Children's Hospital of Zhejiang University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:55:07.14166|2017-10-10 20:55:07.14166
NCT03199495|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-23|||April 17, 2017|Actual|2017-04-17|June 2017|2017-06-01|April 16, 2018|Anticipated|2018-04-16|April 16, 2018|Anticipated|2018-04-16||Interventional|||Efficacy of Electroacupuncture on Acute Abdomen Emergency Care|Efficacy of Electroacupuncture on Acute Abdomen Emergency Care|Recruiting||N/A|60|Anticipated|Changhua Christian Hospital||2|||f|||||f|f||||||||2017-10-10 20:55:07.243337|2017-10-10 20:55:07.243337
NCT03199482|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-23|||July 12, 2017|Anticipated|2017-07-12|June 2017|2017-06-01|July 7, 2018|Anticipated|2018-07-07|October 12, 2017|Anticipated|2017-10-12||Interventional|||Effect of Pretreatment Dexamethazone on Pain and Success of Nerve Block|A Comparative Evaluation of Effect of Dexamethazone on Postendodontic Pain and Success of Inferior Alveolar Nerve Block in Mandibular Molars With Symptomatic Irreversible Pulpitis|Not yet recruiting||Early Phase 1|32|Anticipated|Cairo University||2|||f||||t|t|f|||t|||No||2017-10-10 20:55:07.326437|2017-10-10 20:55:07.326437
NCT03199469|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-12|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|March 2025|Anticipated|2025-03-01|March 2019|Anticipated|2019-03-01||Interventional|ASPIRO||Gene Transfer Clinical Study in X-Linked Myotubular Myopathy|ASPIRO: A Phase 1/2, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT132, an AAV8-Delivered Gene Therapy in X-Linked Myotubular Myopathy (XLMTM) Patients|Recruiting||Phase 1/Phase 2|12|Anticipated|Audentes Therapeutics||4|||f||||t|t|f||||||||2017-10-10 20:55:07.419325|2017-10-10 20:55:07.419325
NCT03199456|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-22|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||A Randomized Post-market Study to Evaluate Zip Device Compared to Sutures for Laceration Repair in Pediatrics|A Randomized, Controlled, Post-market Clinical Investigation to Evaluate Zip Surgical Skin Closure Device in Comparison of Using Standard of Care Sutures for Laceration Repair in Pediatrics in an Accident and Emergency Department|Recruiting||N/A|26|Anticipated|ZipLine Medical Inc.||2|||f||||f|f|t|f|f|t|||No||2017-10-10 20:55:07.523935|2017-10-10 20:55:07.523935
NCT03199443|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-20|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||Standardization of Lead Placement for Sacral Neuromodulation Part 2|Pelvic Floor Electromyography Monitoring as Tool to Improve Patient Selection and Outcome - Standardization of Lead Placement for Sacral Neuromodulation.|Not yet recruiting||N/A|60|Anticipated|Universiteit Antwerpen|||2||f||||f|f|f||||||||2017-10-10 20:55:07.612319|2017-10-10 20:55:07.612319
NCT03199430|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-06-22|||September 2015||2015-09-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism.|The Polyphenol Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism During Graded Exercise in Man.|Completed||Phase 4|8|Actual|Swansea University||2|||f||||f||||||||||2017-10-10 20:55:07.699328|2017-10-10 20:55:07.699328
NCT03199417|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-23|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|TOPICAL||Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL)|Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL)|Recruiting||Phase 2/Phase 3|186|Anticipated|University of Michigan||2|||f||||t|f|f||||||Undecided||2017-10-10 20:55:07.79382|2017-10-10 20:55:07.79382
NCT03199404|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-25|||June 6, 2017|Actual|2017-06-06|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|July 30, 2018|Anticipated|2018-07-30|3 Months|Observational [Patient Registry]|TRAP||Trevo Aspiration Proximal Flow Control Registry|TRevo Aspiration Proximal Flow Control for Endovascular Stroke Intervention Data Registry|Enrolling by invitation||N/A|130|Anticipated|University of Massachusetts, Worcester|||1||f||||f|f|f||||||||2017-10-10 20:55:07.888286|2017-10-10 20:55:07.888286
NCT03199391|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||April 26, 2017|Actual|2017-04-26|June 2017|2017-06-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Observational|||BioWick SureLock Clinical Outcomes Study|Efficacy of the BioWick SureLock Implant for the Reattachment of Soft Tissue to Bone in Subjects Undergoing Rotator Cuff Repairs|Enrolling by invitation||N/A|83|Anticipated|Zimmer Biomet|||1||f||||f|f|t|f|f|t|||No||2017-10-10 20:55:07.975985|2017-10-10 20:55:07.975985
NCT03199378|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||June 3, 2016|Actual|2016-06-03|June 2017|2017-06-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Observational|||Neuropsychological Norms for Ethnically Diverse Florida Elders|Neuropsychological Norms for Ethnically Diverse Florida Elders|Recruiting||N/A|350|Anticipated|University of South Florida|||3||f|||||f|f||||||||2017-10-10 20:55:08.059425|2017-10-10 20:55:08.059425
NCT03199365|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-28|||June 10, 2016|Actual|2016-06-10|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Reaching Latino Family Dyads to Increase Physical Activity and Healthy Eating|Tu Salud ¡Si Cuenta! Reaching Latino Family Dyads to Increase Physical Activity and Healthy Eating|Recruiting||N/A|120|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 20:55:08.153484|2017-10-10 20:55:08.153484
NCT03199352|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-21|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Observational|||Hand-sewn and Linear-stapled Roux-en-Y Gastric Bypass: Outcomes|Comparison of Hand-sewn and Linear-stapled Roux-en-Y Gastric Bypass: Outcomes in Stricture, Ulceration, and Gastritis|Not yet recruiting||N/A|63|Anticipated|University of Nebraska|||2||f||||f|f|f||||||||2017-10-10 20:55:08.273084|2017-10-10 20:55:08.273084
NCT03199339|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-10-03|||August 29, 2017|Actual|2017-08-29|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371|A Phase 1, Partially-Blind, Placebo Controlled, Randomized, Combined Single Ascending Dose With a Food Effect Cohort and Multiple Ascending Dose and a Drug-Drug Interaction Study to Evaluate the Safety, Tolerability, Pharmacokinetics and the Pharmacokinetic Interaction Between TBA-7371 With Midazolam and Bupropion in Healthy Adult Subjects.|Recruiting||Phase 1|92|Anticipated|Global Alliance for TB Drug Development||19|||||||f|t|f||||||||2017-10-10 20:55:08.344785|2017-10-10 20:55:08.344785
NCT03199326|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-10|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|CCIR||Collaborative Care for Infants at Risk|Collaborative Care for Infants at Risk|Not yet recruiting||N/A|850|Anticipated|University of Utah||2|||f||||f|f|f||||||||2017-10-10 20:55:08.483373|2017-10-10 20:55:08.483373
NCT02889640|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||September 2016||2016-09-01|August 2016|2016-08-01||||June 2017|Anticipated|2017-06-01||Interventional|||Increasing the Reach of Promising Dropout Prevention Programs: Examining the Trade-offs Between Scale and Effectiveness||Enrolling by invitation||N/A|2800|Anticipated|University of Chicago||3|||f||||f||||||||||2017-10-10 21:50:48.79371|2017-10-10 21:50:48.79371
NCT03199313|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-09-27|||September 26, 2017|Actual|2017-09-26|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects|Recruiting||Phase 1|32|Anticipated|Global Alliance for TB Drug Development||10|||||||f|t|f||||||||2017-10-10 20:55:08.566682|2017-10-10 20:55:08.566682
NCT03199300|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Observational|InvestiCAT||Investigating Cardiovascular Adverse Events Related to Cancer Treatment|Investigating Cardiovascular Adverse Events Related to Cancer Treatment: a Study of Extreme Toxicity Using Induced Pluripotent Stem Cells|Not yet recruiting||N/A|48|Anticipated|University Medical Center Groningen|||8||f||||f|f|f||||Samples With DNA|"     Urine sample, blood sample, germline DNA, skin fibroblasts.   "|No||2017-10-10 20:55:08.669058|2017-10-10 20:55:08.669058
NCT03199287|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|Meta-ENDO||Clinical Metagenomics of Infective Endocarditis|Clinical Metagenomics of Infective Endocarditis|Recruiting||N/A|100|Anticipated|University Hospital, Geneva|||1||f||||f|f|f||||||No||2017-10-10 20:55:08.78814|2017-10-10 20:55:08.78814
NCT03199274|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-19|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|December 12, 2019|Anticipated|2019-12-12||Interventional|||Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer|Ultrasound Microbubble Destruction and Perfusion Quantification for Improving Radioembolization Therapy of Hepatocellular Carcinoma|Recruiting||Early Phase 1|52|Anticipated|Thomas Jefferson University||2|||||||t|t|f||||||||2017-10-10 20:55:08.872905|2017-10-10 20:55:08.872905
NCT03199261|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-23|||December 23, 2016||2016-12-23|December 2016|2016-12-01|January 21, 2017|Actual|2017-01-21|January 21, 2017|Actual|2017-01-21||Interventional|||A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects|The Pharmacokinetic Comparison and Bioequivalence Evaluation of Two 10-µg Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects|Completed||Phase 1|24|Actual|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||2|||f||||f||||||||No||2017-10-10 20:55:08.972535|2017-10-10 20:55:08.972535
NCT03199248|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-13|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Observational|||"A New Surgical Treatment Technique Aspiration and Percutaneous Capsulotomy for Digital Mucous Cyst"|"A New Surgical Treatment Technique Aspiration and Percutaneous Capsulotomy for Digital Mucous Cyst"|Recruiting||N/A|50|Anticipated|Taipei Veterans General Hospital, Taiwan|||2||f|||||f|f||||||||2017-10-10 20:55:09.052023|2017-10-10 20:55:09.052023
NCT03199235|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-26|||February 20, 2017|Actual|2017-02-20|June 2017|2017-06-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Iron Fish in Dominican Republic (DR) Children|Cooking With Iron Ingots: Assessing Feasibility and Natural History of Iron-deficiency Anemia Among Preschool-aged Children in Resource-limited Settings|Recruiting||N/A|40|Anticipated|Children's Hospital of Philadelphia||2|||f||||t|f|f||||||||2017-10-10 20:55:09.147035|2017-10-10 20:55:09.147035
NCT03199222|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-03|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Prosthetic Smart Socket Technology to Improve Patient Interaction, Usability, Comfort, Fit, and Function.|Prosthetic Smart Socket Technology to Improve Patient Interaction, Usability, Comfort, Fit, and Function.|Not yet recruiting||N/A|60|Anticipated|University of South Florida||2|||f||||f|f|f||||||||2017-10-10 20:55:09.250816|2017-10-10 20:55:09.250816
NCT03199209|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-07|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Promoting Healthy Lifestyles in Latino Family Dyads|Tu Salud ¡Si Cuenta! Promoting Healthy Lifestyles in Latino Family Dyads|Not yet recruiting||N/A|600|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 20:55:09.331525|2017-10-10 20:55:09.331525
NCT03199196|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||May 2, 2014|Actual|2014-05-02|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Social Networks to Promote Physical Activity|Using Social Networks to Promote Physical Activity in African American and Hispanic Women|Active, not recruiting||N/A|101|Actual|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 20:55:09.430896|2017-10-10 20:55:09.430896
NCT03199183|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01|12 Months|Observational [Patient Registry]|TA-China||Registration Study of Takayasu's Arteritis in China|Registration Study of Takayasu's Arteritis in China|Not yet recruiting||N/A|1067|Anticipated|China National Center for Cardiovascular Diseases|||1||f||||t|f|f||||Samples With DNA|"     All participants will have samples with DNA taken for laboratory biomarker analysis or     genetic sequencing.   "|Undecided|Consent for sharing of non identifiable study data for regulatory authorities.|2017-10-10 20:55:09.538742|2017-10-10 20:55:09.538742
NCT03199170|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-31|||September 1, 2017|Actual|2017-09-01|August 2017|2017-08-01|January 30, 2019|Anticipated|2019-01-30|July 1, 2018|Anticipated|2018-07-01||Interventional|||Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section|Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section|Enrolling by invitation||N/A|120|Anticipated|Mahidol University||3|||f||||t|f|f||||||||2017-10-10 20:55:09.637926|2017-10-10 20:55:09.637926
NCT03199157|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||March 2015|Actual|2015-03-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Fentanyl 12 Mcg Transdermal Patch For Postoperative Pain|The Effect Of Fentanyl 12 Mcg Transdermal Patch On Postoperative Pain Following Unilateral, Single-Level Laminectomy/Discectomy: A Randomized, Controlled, Double-Blind Study|Completed||Phase 4|78|Actual|Baskent University||2|||f||||t||||||||||2017-10-10 20:55:09.732246|2017-10-10 20:55:09.732246
NCT03199144|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-29|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|CKPancreas||Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer|Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Borderline Resectable Pancreatic Cancer : Phase II Study|Recruiting||Phase 2|70|Anticipated|Centre Francois Baclesse, Luxembourg||1|||f|||||f|f||||||No||2017-10-10 20:55:09.803052|2017-10-10 20:55:09.803052
NCT03199131|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-26|||February 20, 2017|Actual|2017-02-20|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|MVD||The Right Ventricle in Chronic Pressure Overload: Identifying Novel Molecular Targets for Functional Imaging|The Right Ventricle in Chronic Pressure Overload: Identifying Novel Molecular Targets for Functional Imaging|Recruiting||N/A|20|Anticipated|Centre Chirurgical Marie Lannelongue||2|||f||||t|f|f||||||||2017-10-10 20:55:09.887548|2017-10-10 20:55:09.887548
NCT03199118|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-24|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Use of Platelet Rich Fibrin in Addition to CAF and SCTG for Treatment of Gingival Recession|The Use of Coronally Advanced Flap and Subepithelial Connective Tissue Graft With or Without Platelet Rich Fibrin in the Treatment of Miller Class I or II Gingival Recession: a Randomized Clinical Trial|Not yet recruiting||N/A|34|Anticipated|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 20:55:09.965645|2017-10-10 20:55:09.965645
NCT03199105|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||May 1, 2015|Actual|2015-05-01|June 2017|2017-06-01|July 20, 2017|Anticipated|2017-07-20|July 20, 2017|Anticipated|2017-07-20||Interventional|||Preoperative Education With Illustrations Enhances Effect of Tetracaine Mucilage in Alleviating Postoperative CRBD|Preoperative Education With Cartoon Illustrations Enhances the Effect of Tetracaine Mucilage in Alleviating Postoperative Catheter-related Bladder Discomfort: a Prospective, Randomized, Controlled Study|Recruiting||N/A|150|Anticipated|West China Hospital||4|||f|||||f|f||||||||2017-10-10 20:55:10.072463|2017-10-10 20:55:10.072463
NCT03199092|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||June 26, 2017|Anticipated|2017-06-26|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Rhythmic Reading Training Compared to 'Abilmente' Method|Effectiveness of Intervention for Developmental Dyslexia: Rhythmic Reading Training Compared to 'Abilmente' Method|Recruiting||N/A|32|Anticipated|Catholic University of the Sacred Heart||2|||f|||||f|f||||||||2017-10-10 20:55:10.159186|2017-10-10 20:55:10.159186
NCT03199079|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-22|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|October 25, 2017|Anticipated|2017-10-25|September 25, 2017|Anticipated|2017-09-25||Observational|||Cervix Monitor for Elasticity and Length Measurements|Cervix Monitor for Risk Assessment of Spontaneous Preterm Delivery|Enrolling by invitation||N/A|20|Anticipated|Advanced Tactile Imaging, Inc.|||2||f||||f|f|t|t|||||Yes||2017-10-10 20:55:10.381013|2017-10-10 20:55:10.381013
NCT03199066|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-21|||January 1, 1999|Actual|1999-01-01|June 2017|2017-06-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2020|Anticipated|2020-12-31|10 Years|Observational [Patient Registry]|||Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL)|The Incidence, Epidemiology, Clinical Characteristic, Prognostic Factors, Therapy and Outcome of Non-Hodgkin Lymphoma Patients in the Czech Republic. NiHiL- Longitudinal Observational Study of Czech Lymphoma Study Group (CLSG)|Recruiting||N/A|20000|Anticipated|Czech Lymphoma Study Group|||8||f||||f|f|f||||||No|Individual participant data are available only for reasearchers in CLSG.|2017-10-10 20:55:10.466843|2017-10-10 20:55:10.466843
NCT03199053|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-10-05|||October 31, 2017|Anticipated|2017-10-31|October 2017|2017-10-01|November 22, 2021|Anticipated|2021-11-22|December 21, 2020|Anticipated|2020-12-21||Interventional|||Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old|A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, and Saxagliptin 2.5 and 5 mg in Pediatric Patients With Type 2 Diabetes Mellitus Who Are Between 10 and Below 18 Years of Age|Not yet recruiting||Phase 3|243|Anticipated|AstraZeneca||5|||f||||t|f|f||||||||2017-10-10 20:55:10.58976|2017-10-10 20:55:10.58976
NCT03199040|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||September 30, 2017|Anticipated|2017-09-30|June 2017|2017-06-01|September 30, 2020|Anticipated|2020-09-30|March 31, 2020|Anticipated|2020-03-31||Interventional|||Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy|A Randomized Phase 1 Trial of Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy|Not yet recruiting||Phase 1|24|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||No||2017-10-10 20:55:11.006008|2017-10-10 20:55:11.006008
NCT03199027|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||January 18, 2017|Actual|2017-01-18|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|TRAC||Timing of Referral to Adherence Clubs for Antiretroviral Therapy|Timing of Referral to Adherence Clubs for Antiretroviral Therapy - a Randomised Controlled Trial|Recruiting||N/A|214|Anticipated|University of Cape Town||2|||f||||t|f|f||||||No||2017-10-10 20:55:11.139389|2017-10-10 20:55:11.139389
NCT03199014|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-07-04|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||the Effect of Prolonged Inflation Time During Stents Deployment for ST-elevation Myocardial Infarction|the Effect of Prolonged Inflation Time During Drug-eluting Stents Deployment Compared With Conventional Method for ST-elevation Myocardial Infarction|Recruiting||N/A|60|Anticipated|West China Hospital||2|||f||||f||||||||||2017-10-10 20:55:11.236305|2017-10-10 20:55:11.236305
NCT03199001|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-23|||February 19, 2015|Actual|2015-02-19|June 2017|2017-06-01|February 19, 2019|Anticipated|2019-02-19|August 19, 2018|Anticipated|2018-08-19||Observational|FABRY400||Native T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Rare Diseases|Native T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Rare Diseases- A New Method to Improve Patient Care|Recruiting||N/A|400|Anticipated|University College, London|||1||f||||t|f|f||||Samples With DNA|"     Serum, plasma and urine samples   "|No||2017-10-10 20:55:11.347434|2017-10-10 20:55:11.347434
NCT03198988|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-24|||October 3, 2017||2017-10-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:55:11.4459|2017-10-10 20:55:11.4459
NCT03198975|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||June 23, 2017|Actual|2017-06-23|June 2017|2017-06-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Observational|||Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma|Development of a Machine Learning-based Model for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma|Recruiting||N/A|40|Anticipated|Sun Yat-sen University|||1||f||||f|f|f||||Samples With DNA|"     serum,tumor tissue   "|No||2017-10-10 20:55:11.490716|2017-10-10 20:55:11.490716
NCT03190317|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|August 2018|Anticipated|2018-08-01||Observational|HI-FIV||Health Information for Infected Veterans|Health Information for Infected Veterans|Not yet recruiting||N/A|2592|Anticipated|VA Palo Alto Health Care System|||2||f||||f|f|f||||||No||2017-10-10 20:56:32.596737|2017-10-10 20:56:32.596737
NCT03198962|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-16|||November 15, 2016|Actual|2016-11-15|June 2017|2017-06-01|December 20, 2022|Anticipated|2022-12-20|November 15, 2020|Anticipated|2020-11-15||Observational|||Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TG|Use of Amphetamine-type Stimulants and Its Relationship With HIV Incidence and Antiretroviral Adherence Among Thai Men Who Have Sex With Men and Transgender Women|Recruiting||N/A|510|Anticipated|Thai Red Cross AIDS Research Centre|||4||f||||t|f|f||||||||2017-10-10 20:55:11.589024|2017-10-10 20:55:11.589024
NCT03198949|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-22|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)|A Prospective, Randomized, Double-blind, Placebo-controlled Cross Over Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)|Not yet recruiting||Phase 3|26|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 20:55:11.675825|2017-10-10 20:55:11.675825
NCT03198936|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-06-26|||April 11, 2017|Actual|2017-04-11|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||To Access the Effect of Brain Pill™ on Working Memory Capacity and Mood Behaviour.|Effect of Brain Pill™ on Working Memory Capacity and Mood Behaviour in Healthy Adults With Subjective Memory Complains and Mild Mood Disturbances.|Recruiting||N/A|80|Anticipated|Vedic Lifesciences Pvt. Ltd.||2|||f||||f|f|f||||||No||2017-10-10 20:55:11.759584|2017-10-10 20:55:11.759584
NCT03198923|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-21|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer|A Phase 1/2 Safety and Efficacy Study of Natural Killer and Natural Killer T Cell Immunotherapy in Patients With Non Small Cell Lung Cancer|Recruiting||Phase 1|30|Anticipated|Hunan Province Tumor Hospital||1|||f|||||f|f||||||||2017-10-10 20:55:11.857003|2017-10-10 20:55:11.857003
NCT03198910|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Retrospective Data Analysis of Data From the Zurich PH Registry|Efficacy of Medical Therapy for Pulmonary Arterial and Inoperable Chronic Thromboembolic Pulmonary Hypertension in a Real Life Setting|Recruiting||N/A|200|Anticipated|University of Zurich|||2||f||||f|f|f||||||No||2017-10-10 20:55:11.942694|2017-10-10 20:55:11.942694
NCT03198897|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-24|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Observational|BioHoFH||Biomarker for Homozygous Familial Hypercholesterolemia|BioHoFH - Biomarker for Homozygous Familial Hypercholesterolemia AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|20|Anticipated|University of Rostock|||1||f||||t|f|f||||Samples With DNA|"     For the development of the new biomarker using the technique of Mass-spectometry a dry blood     spot filter card are taken. To prove the correct diagnosis in those patients where up to the     enrollment in the study no genetic testing has been done, sequencing will be done. The     analyses are done in the Centogene AG, Schillingallee 68, 18055 Rostock (Germany)   "|||2017-10-10 20:55:12.037747|2017-10-10 20:55:12.037747
NCT03198871|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-20|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|October 15, 2018|Anticipated|2018-10-15|October 15, 2018|Anticipated|2018-10-15||Interventional|||IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population|Role of Scheduled Intravenous Acetaminophen for Postoperative Pain Management in an Enhanced Recovery After Surgery (ERAS) Population: A Prospective, Randomized and Placebo-Controlled Clinical Trial|Not yet recruiting||Phase 3|154|Anticipated|University of Pittsburgh||2|||f||||t|t|f|||t|||||2017-10-10 20:55:12.184982|2017-10-10 20:55:12.184982
NCT03198858|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-22|||April 2016||2016-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|CAPA-VU||CAPA-VU Trial Catheter Ablation in Paroxymal Atrial Fibrillation Based on UNIVU|CAPA-VU Trial Catheter Ablation in Paroxymal Atrial Fibrillation Based on UNIVU|Recruiting||N/A|100|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||Undecided||2017-10-10 20:55:12.303504|2017-10-10 20:55:12.303504
NCT03198845|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-23|2017-06-23|||August 1, 2014|Actual|2014-08-01|June 2017|2017-06-01|July 31, 2015|Actual|2015-07-31|July 31, 2015|Actual|2015-07-31||Interventional|||Effects of Video Game on Patients With Knee Osteoarthritis|Therapeutic Effects Video Game Play Therapy on Patients With Knee Osteoarthritis: a Single Blind, Randomized-controlled Clinical Trial|Completed||N/A|80|Actual|Taipei Medical University||2|||f||||f|f|f||||||No||2017-10-10 20:55:12.402334|2017-10-10 20:55:12.402334
NCT03198832|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-22|||May 2, 2016|Actual|2016-05-02|June 2017|2017-06-01|January 28, 2017|Actual|2017-01-28|August 26, 2016|Actual|2016-08-26||Interventional|||oxLDL in Diabetes Mellitus Patients and Disease Periodontal|Disease Periodontal Influence on Markers of Cardiovascular in Diabetes Mellitus Patients|Completed||N/A|44|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f|f|f||||||No||2017-10-10 20:55:12.500413|2017-10-10 20:55:12.500413
NCT03198819|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-06-20|||August 2016||2016-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Powder Topical Rifampicin on Reducing Infections After Neural Tube Defect Surgery in Infants|Powder Topical Rifampicin on Reducing Infections After Neural Tube Defect Surgery in Infants|Recruiting||N/A|30|Anticipated|Yuzuncu Yıl University|||2||f||||t|t|f|||f|||Yes||2017-10-10 20:55:12.581499|2017-10-10 20:55:12.581499
NCT03198806|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-25|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Water Intake Associated With Aerobic Exercise in Coronary|Influence of Hydration on Autonomic Behavior and Cardiorespiratory Parameters of Coronaropathy Submitted to Aerobic Exercise|Recruiting||N/A|31|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||4|||f||||t|f|f||||||||2017-10-10 20:55:12.680142|2017-10-10 20:55:12.680142
NCT03198793|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|NEW-HOPE||Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins|A Phase 2, Open-Label, Dose-Titrating Safety and Efficacy Study of QGC001 Administered Orally, Twice Daily, Over 8 Weeks in Hypertensive Overweight Subjects of Multiple Ethnic and Racial Groups in the United States|Not yet recruiting||Phase 2|250|Anticipated|Quantum Genomics SA||1|||f||||f|f|f||||||||2017-10-10 20:55:12.767969|2017-10-10 20:55:12.767969
NCT03198780|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-23|||March 1, 2018|Anticipated|2018-03-01|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Mindful Breathing Awareness Through Pursed-Lip Breathing Training|A Home-based Intervention to Promote Mindful Breathing Awareness Through Pursed-lip Breathing Training for COPD Patients|Not yet recruiting||N/A|10|Anticipated|Minnesota HealthSolutions||1|||f|||||f|f|||f|||No||2017-10-10 20:55:12.841335|2017-10-10 20:55:12.841335
NCT03198767|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-09|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|September 20, 2017|Anticipated|2017-09-20|September 20, 2017|Anticipated|2017-09-20||Interventional|||Effects of Carbohydrate in Diet and Supplements on the GI Tolerability of LIK066|A Randomized, Open Label, Two-part, Three-period, Cross Over Study to Investigate the Effects of Carbohydrate in Diet and to Evaluate Supplements on the Gastrointestinal Tolerability of LIK066 in Overweight or Obese Subjects|Recruiting||Phase 2|48|Anticipated|Novartis||6|||f||||f|t|f||||||||2017-10-10 20:55:12.909447|2017-10-10 20:55:12.909447
NCT03198754|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-28|||July 22, 2016|Actual|2016-07-22|June 2017|2017-06-01|July 22, 2018|Anticipated|2018-07-22|July 22, 2018|Anticipated|2018-07-22||Interventional|||Systematic Programmed Illumination (sPI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue|Systematic Programmed Illumination (sPI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue During Hematopoetic Stem Cell Transplantation for Multiple Myeloma|Recruiting||N/A|60|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|t|f|||||Undecided||2017-10-10 20:55:13.000863|2017-10-10 20:55:13.000863
NCT03198741|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-22|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|OPT-PEACE||Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation|COmparison of Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation for Prevention of Gastrointestinal Injury Evaluated by Ankon Magnetically Controlled Capsule Endoscopy|Not yet recruiting||Phase 4|593|Anticipated|Shenyang Northern Hospital||3|||f||||t|f|f||||||No||2017-10-10 20:55:13.110078|2017-10-10 20:55:13.110078
NCT03198728|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-14|||July 5, 2017|Actual|2017-07-05|June 2017|2017-06-01|January 20, 2019|Anticipated|2019-01-20|February 11, 2018|Anticipated|2018-02-11||Interventional|||Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men|A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)|Recruiting||Phase 3|300|Anticipated|Marius Pharmaceuticals||2|||f|||||t|f||||||||2017-10-10 20:55:13.226221|2017-10-10 20:55:13.226221
NCT03198702|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-04|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|POPB-TOX||Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy|Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy|Not yet recruiting||Phase 3|62|Anticipated|University Hospital, Brest||2|||f||||f|f|f||||||||2017-10-10 20:55:13.576816|2017-10-10 20:55:13.576816
NCT03198689|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-01|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis|A Pilot Study of Adcetris Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Scleroderma)|Not yet recruiting||Phase 2|10|Anticipated|Lawson Health Research Institute||1|||f||||f|t|f|||t|||||2017-10-10 20:55:13.697155|2017-10-10 20:55:13.697155
NCT03198676|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-30|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|May 24, 2017|Actual|2017-05-24|May 24, 2017|Actual|2017-05-24||Interventional|||A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production|A Single Centre, Partially Blinded, Randomised Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production in Healthy Human Volunteers|Completed||Phase 1|20|Actual|Prep Biopharm Limited||4|||f||||f|t|f||||||||2017-10-10 20:55:13.805918|2017-10-10 20:55:13.805918
NCT03198663|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-22|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|December 2018|Anticipated|2018-12-01||Interventional|||POSSE Project: A Community-Level Intervention for Black YMSM|POSSE Project: A Community-Level Intervention for Black YMSM|Recruiting||N/A|1000|Anticipated|John H. Stroger Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:55:13.892126|2017-10-10 20:55:13.892126
NCT03198650|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-25|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|January 27, 2021|Anticipated|2021-01-27|January 27, 2021|Anticipated|2021-01-27||Interventional|||A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies|A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Acalabrutinib, a Selective and Irreversible Bruton's Tyrosine Kinase Inhibitor, in Japanese Adult Patients With Advanced B-cell Malignancies|Recruiting||Phase 1|28|Anticipated|AstraZeneca||1|||f|||||f|f||||||||2017-10-10 20:55:14.103834|2017-10-10 20:55:14.103834
NCT03198637|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-07-19|||April 2013||2013-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Neuromuscular Blockade's Monitoring and Clinical Assessment During Cisatracurium Paralysis in Critically Ill Patients||Recruiting||Phase 3|50|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 20:55:14.209146|2017-10-10 20:55:14.209146
NCT03189420|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-20|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01|3 Months|Observational [Patient Registry]|||Glioma Microenvironment an Exploratory Study|Glioma Microenvironment an Exploratory Study|Recruiting||N/A|30|Anticipated|Hospital Sirio-Libanes|||2||f|||||f|f||||||||2017-10-10 20:56:40.620811|2017-10-10 20:56:40.620811
NCT03198624|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-06|||May 16, 2017|Actual|2017-05-16|September 2017|2017-09-01|August 20, 2017|Actual|2017-08-20|August 20, 2017|Actual|2017-08-20||Interventional|HTL0018318||Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects|A Two-part, Single and Multiple Dose, Parallel Group Study to Assess Safety and Pharmacokinetics of Oral HTL0018318 in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|54|Actual|Heptares Therapeutics Limited||6|||f|||||f|f||||||||2017-10-10 20:55:14.324489|2017-10-10 20:55:14.324489
NCT03198611|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-22|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|December 1, 2018|Anticipated|2018-12-01||Observational|REPRISS||Reversibility of Diastolic Disfunction in Septic Shock|Early Reversibility of Diastolic Disfunction as a Prognostic Factor in Septic Shock|Not yet recruiting||N/A|350|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||4||f|||||f|f||||||||2017-10-10 20:55:14.450433|2017-10-10 20:55:14.450433
NCT03198598|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-22|||June 19, 2017|Actual|2017-06-19|April 2017|2017-04-01|June 26, 2019|Anticipated|2019-06-26|June 26, 2018|Anticipated|2018-06-26||Interventional|||Effects of Yoga Practice in Multiple Sclerosis Patients: a Multidimensional Approach|Effects of Yoga Practice in Multiple Sclerosis Patients: a Multidimensional Approach|Recruiting||N/A|130|Anticipated|Hospital Israelita Albert Einstein||5|||f||||t|f|f||||||No||2017-10-10 20:55:14.553171|2017-10-10 20:55:14.553171
NCT03198585|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-29|||June 29, 2017|Actual|2017-06-29|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|Empire HF||Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction|Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction: A Randomized Clinical Trial (Empire HF)|Recruiting||Phase 2|189|Anticipated|Herlev and Gentofte Hospital||2|||f||||f|f|f|||t|||||2017-10-10 20:55:14.675538|2017-10-10 20:55:14.675538
NCT03198572|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-22|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|EASYBEinNASH||Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis|Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis: a Multicentre, Randomised, Placebo-controlled Trial|Not yet recruiting||Phase 4|120|Anticipated|Fudan University||2|||f||||f|f|f|||f|||No||2017-10-10 20:55:14.804083|2017-10-10 20:55:14.804083
NCT03198546|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-21|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||GPC3-T2-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression|CAR-T Cell Targeting GPC3 for Immunotherapy of Hepatocellular Carcinoma: Phase I Clinical Trial|Recruiting||Phase 1|30|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||1|||f||||f|f|f||||||||2017-10-10 20:55:15.159448|2017-10-10 20:55:15.159448
NCT03198533|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-23|||July 10, 2007|Actual|2007-07-10|May 2017|2017-05-01|February 11, 2018|Anticipated|2018-02-11|February 11, 2018|Anticipated|2018-02-11||Interventional|TriathlonRSA||Evaluation of Triathlon - A New Total Knee Prosthesis System - Triathlon PA vs. Triathlon Pressfit|Evaluation of Triathlon - A New Total Knee Prosthesis System - Triathlon PA vs. Triathlon Pressfit|Active, not recruiting||N/A|60|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-10-10 20:55:15.280679|2017-10-10 20:55:15.280679
NCT03198520|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-26|||June 6, 2017|Actual|2017-06-06|July 2017|2017-07-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||REFRAME RPD Post-Market Clinical Study|REFRAME RPD Post-Market Clinical Study|Recruiting||N/A|40|Anticipated|Solvay Dental 360||1|||f||||f|f|f|||f|||||2017-10-10 20:55:15.379431|2017-10-10 20:55:15.379431
NCT03198507|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-27|||June 18, 2017|Actual|2017-06-18|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|ERADICATE Hp2||ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator|A Randomized Double Blind Active Comparator Controlled Phase III Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection|Recruiting||Phase 3|444|Anticipated|RedHill Biopharma Limited||2|||f||||f|t|f||||||No||2017-10-10 20:55:15.50045|2017-10-10 20:55:15.50045
NCT03198481|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-21|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|June 28, 2019|Anticipated|2019-06-28|February 28, 2019|Anticipated|2019-02-28||Interventional|MUVi||Patient-Centered Versus Physician-Centered Counseling MidUrethral Sling Videos|Protocol for Patient-Centered Versus Physician-Centered Counseling Video for Midurethral Slings an RCT|Recruiting||N/A|60|Anticipated|University of New Mexico||2|||f||||f|f|f||||||||2017-10-10 20:55:15.713278|2017-10-10 20:55:15.713278
NCT03198468|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-23|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|VAPORIZE||Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)|Vapor Ablation for Localized Cancer Lesions of the Lung - A Clinical Feasibility Treat-and Resect Study (VAPORIZE)|Not yet recruiting||N/A|8|Anticipated|Uptake Medical Technology, Inc.||1|||f||||t|f|f||||||No||2017-10-10 20:55:15.840589|2017-10-10 20:55:15.840589
NCT03198455|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-06-22|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Does Medicinal Mushroom Agaricus Blazei Protect Against Allergy and Asthma?|Does Medicinal Mushroom Agaricus Blazei Protect Against Allergy and Asthma?|Completed||N/A|60|Actual|Oslo University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:55:15.948287|2017-10-10 20:55:15.948287
NCT03198299|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-22|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Therapeutic Effects of Arch Support Insoles on Children|Therapeutic Effects of Physical Function and Balance of Arch Support Insoles on Children|Completed||N/A|45|Actual|Taipei Medical University||2|||f||||f|f|f||||||No||2017-10-10 20:55:17.031003|2017-10-10 20:55:17.031003
NCT03198442|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-21|||October 5, 2016|Actual|2016-10-05|February 2017|2017-02-01|December 21, 2018|Anticipated|2018-12-21|October 5, 2018|Anticipated|2018-10-05||Interventional|Breast PET||Breast PET Feasibility|Role of Dedicated Breast PET in the Characterisation of Indeterminate Breast Lesions on MRI Requiring a Second-look Ultrasound - a Feasibility Study|Recruiting||N/A|20|Anticipated|University College, London||1|||f||||f|f|f||||||Yes|All requests for data sharing will adhere to the UCL Surgical & Interventional Trials Unit (SITU) data sharing agreement policy. UCL Medical School is supportive of data sharing and will endeavour to assist in requests for data sharing. These data will be held on secure servers and will not be released to any third parties until all the main outputs from the studies have been published. All requests for access to the data will be formally requested through the use of a SITU data request form which will state the purpose, analysis and publication plans together with the named collaborators. All requests are dealt with on a case by case basis by SITU and the Chief Investigator. All requests will be logged and those successful will have a data transfer agreement which will specify appropriate acknowledgement of the Chief Investigator and study group, the sponsor, and funders.|2017-10-10 20:55:16.036871|2017-10-10 20:55:16.036871
NCT03198429|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-22|||October 31, 2016|Actual|2016-10-31|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|SafeUnderstood||Cluster RCT of Embedded Parenting Intervention to Prevent Recurrence and Reduce Impairment in Young Children Exposed to Domestic Violence|Cluster Randomized Trial of Embedded Dyadic Mother-child and Father-focused Intervention for Preventing Recurrence of Maltreatment and Reducing Impairment in Young Children Exposed to Domestic Violence|Recruiting||N/A|200|Anticipated|University of Toronto||4|||f||||t|f|f||||||No||2017-10-10 20:55:16.140331|2017-10-10 20:55:16.140331
NCT03198416|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-09-13|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pharyngeal Anatomy In Obstructive Sleep Apnea With HRM|Assessment Of Pharyngeal Anatomy In Obstructive Sleep Apnea With High Resolution Manometry|Not yet recruiting||N/A|75|Anticipated|Vanderbilt University Medical Center||1|||f||||f|f|t|f||f|||||2017-10-10 20:55:16.2456|2017-10-10 20:55:16.2456
NCT03198403|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-28|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|September 28, 2017|Actual|2017-09-28|September 26, 2017|Actual|2017-09-26||Interventional|||The Effect of Popliteal Plexus Block on Pain After Total Knee Arthroplasty|The Effect of Popliteal Plexus Block on Postoperative Pain After Total Knee Arthroplasty|Completed||Phase 4|17|Actual|Regionshospitalet Silkeborg||2|||f||||t|f|f|||f|||||2017-10-10 20:55:16.323253|2017-10-10 20:55:16.323253
NCT03198390|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-29|||August 4, 2017|Actual|2017-08-04|June 2017|2017-06-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2019|Anticipated|2019-07-01||Observational|||Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Atopic Dermatitis|Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Atopic Dermatitis|Recruiting||N/A|300|Anticipated|University of Arizona|||2||f||||f|f|f||||||||2017-10-10 20:55:16.405681|2017-10-10 20:55:16.405681
NCT03198377|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-03|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 5, 2017|Anticipated|2017-09-05||Interventional|||The Effect of Frequency Modulation in TENS on Habituation and Pain Threshold|The Effect of Frequency Modulation in Transcutaneous Electrical Nerve Stimulation (TENS) on Habituation and Pain Threshold: a Randomized, Double Blind, Controlled Cross-over|Recruiting||N/A|35|Anticipated|University of Castilla-La Mancha||4|||f||||t|f|f||||||||2017-10-10 20:55:16.482332|2017-10-10 20:55:16.482332
NCT03198364|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2020|Anticipated|2020-06-30|May 31, 2020|Anticipated|2020-05-31||Interventional|||Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI|Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI Accessing Community Care|Not yet recruiting||Phase 2|70|Anticipated|University of California, San Diego||2|||f||||t|f|f||||||No||2017-10-10 20:55:16.608362|2017-10-10 20:55:16.608362
NCT03198351|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||April 2013||2013-04-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|2 Years|Observational [Patient Registry]|||An Observational Study on Teriflunomide-exposed Pregnancies|Teriflunomide Pregnancy Outcome Exposure Registry: An OTIS Autoimmune Diseases in Pregnancy Project|Recruiting||N/A|325|Anticipated|Sanofi|||4||f||||f|t|f||||||Yes|"Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications.
Patient level data will be anonymized and study documents will be redacted to protect the privacy of our trial participants.
Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://www.clinicalstudydatarequest.com/"|2017-10-10 20:55:16.693533|2017-10-10 20:55:16.693533
NCT03198338|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ultrasound Guided Transversus Abdominis Plane(TAP) Block in Intensive Care Unit|Ultrasound Guided Transversus Abdominis Plane(TAP) Block in Intensive Care Unit(ICU) for Postoperative Analgesia After Open Colon Resection: a Double Blind Randomized Controlled Trial|Recruiting||N/A|46|Anticipated|Seoul National University Bundang Hospital||2|||f||||t|f|f||||||Yes|It can be shared after request to principal investigator (T.K Oh or I.A Song)|2017-10-10 20:55:16.770931|2017-10-10 20:55:16.770931
NCT03198325|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-22|||July 27, 2016|Actual|2016-07-27|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|APACHE||Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed Viremia|Monitored Antiretroviral Pause in Chronic HIV-Infected Subjects With Long-Lasting Suppressed Viremia (APACHE Study)|Recruiting||N/A|30|Anticipated|Ospedale San Raffaele||1|||f||||t|f|f||||||Yes|Congress and scientific pubblications|2017-10-10 20:55:16.856242|2017-10-10 20:55:16.856242
NCT03198312|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-22|||October 20, 2016|Actual|2016-10-20|June 2017|2017-06-01|January 20, 2018|Anticipated|2018-01-20|October 20, 2017|Anticipated|2017-10-20||Interventional|||CathiportTM Clinical Efficacy and Safety Evaluation|a Prospective, Multicenter, Randomized, Open, Parallel Controlled Noninferiority Clinical Study to Evaluate the Efficacy and Safety of CathiportTM Implantable Drug Delivery Device|Active, not recruiting||N/A|220|Actual|Shandong Branden Med.Device Co.,Ltd||2|||f|||||f|f||||||||2017-10-10 20:55:16.955378|2017-10-10 20:55:16.955378
NCT03198286|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-05|||August 1, 2015|Actual|2015-08-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 27, 2016|Actual|2016-10-27||Interventional|||Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors|A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System|Active, not recruiting||N/A|40|Actual|Thomas Jefferson University||1|||f||||t|f|f||||||||2017-10-10 20:55:17.139032|2017-10-10 20:55:17.139032
NCT03198273|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-22|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||The Efficacy of Clinical Pilates Exercises on Individuals With Lumbar Disc Herniation|The Efficacy of Clinical Pilates Exercises on Individuals With Lumbar Disc Herniation|Recruiting||N/A|88|Anticipated|Eastern Mediterranean University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:55:17.229676|2017-10-10 20:55:17.229676
NCT03198260|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-27|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|June 27, 2017|Actual|2017-06-27|June 27, 2017|Actual|2017-06-27||Interventional|MTSS||Observing the Effect of Fascial Manipulation in Athletes With Shin Splits.Tibial Stress Syndrome.|Influence of Fascial Manipulation on Running Kinematics Among Athletes With Medial Tibial Stress Syndrome.|Completed||N/A|10|Actual|Manipal University||2|||f||||f|f|f||||||No||2017-10-10 20:55:17.328286|2017-10-10 20:55:17.328286
NCT03198247|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Physiotherapy and Therapeutic Education After Total Knee Arthroplasty.|Physiotherapy and Therapeutic Education in Patients With Pain Catastrophizing After a Total Knee Arthroplasty. Randomized Clinical Trial|Not yet recruiting||N/A|60|Anticipated|Centro Universitario La Salle||2|||f||||f|f|f||||||No||2017-10-10 20:55:17.409571|2017-10-10 20:55:17.409571
NCT03198234|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-19|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|T-allo10||Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders|Use of T-allo10 Cell Infusions Combined With Mismatched Related or Mismatched Unrelated Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies|Recruiting||Phase 1|30|Anticipated|Stanford University||3|||f||||t|t|f||||||||2017-10-10 20:55:17.499113|2017-10-10 20:55:17.499113
NCT03198221|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-23|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparison of Prepopik vs Golytely Bowel Preparation|Randomized Comparison of the Impact of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Versus Polyethylene Glycol Bowel Preparation on Inpatient Colonoscopy Quality Parameters|Not yet recruiting||Phase 4|1000|Anticipated|The Cleveland Clinic||4|||f||||f|t|f|||f|||||2017-10-10 20:55:17.593485|2017-10-10 20:55:17.593485
NCT03198208|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-23|||January 1, 2007|Actual|2007-01-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2015|Actual|2015-12-31|30 Days|Observational [Patient Registry]|||Intraoperative Fentanyl Dose on Respiratory Complications|Effects of Intraoperative Fentanyl Dose on Postoperative Respiratory Complications|Active, not recruiting||N/A|183396|Actual|Massachusetts General Hospital|||2||f||||f|f|f||||||No||2017-10-10 20:55:17.671472|2017-10-10 20:55:17.671472
NCT03198195|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-26|||March 10, 2015|Actual|2015-03-10|June 2017|2017-06-01|July 10, 2020|Anticipated|2020-07-10|March 10, 2017|Actual|2017-03-10|5 Years|Observational [Patient Registry]|||Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome|Post-transplant Cyclophosphamide for HLA-haploidentical Transplantation in Wiskott-Aldrich Syndrome|Enrolling by invitation||N/A|5|Actual|Capital Research Institute of Pediatrics|||1||f||||t|f|f||||||No||2017-10-10 20:55:17.74102|2017-10-10 20:55:17.74102
NCT03198182|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-10-05|||June 28, 2017|Actual|2017-06-28|October 2017|2017-10-01|September 22, 2017|Actual|2017-09-22|September 22, 2017|Actual|2017-09-22||Interventional|||A Study to Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese Subjects|A Randomized, Parallel, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986036 in Healthy Japanese and Non-Japanese Subjects|Completed||Phase 1|63|Actual|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 20:55:17.790665|2017-10-10 20:55:17.790665
NCT03198169|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-05|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Study to Investigate Two Atteris Antimicrobial Products on Chronic Wound Healing.|2-part, Randomized, Double Blind, Prospective, Single Center, Controlled Trial to Investigate an Antimicrobial Skin and Wound Cleanser and an Antimicrobial Barrier Film Dressing on the Rates of Healing for Chronic Wounds|Enrolling by invitation||N/A|100|Anticipated|Atteris Healthcare, LLC||4|||f||||f|f|t|f|f|t|||||2017-10-10 20:55:17.862295|2017-10-10 20:55:17.862295
NCT03198156|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-08|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|tDCS||Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy|Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy|Recruiting||N/A|60|Anticipated|Ohio State University||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:55:19.60441|2017-10-10 20:55:19.60441
NCT03198143|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-08-01|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effect of Ghrelin on Decision-Making|Effect of Ghrelin on Nutritional and Financial Decision-Making|Not yet recruiting||Phase 1|50|Anticipated|Duke University||4|||f|||||t|f||||||||2017-10-10 20:55:19.691335|2017-10-10 20:55:19.691335
NCT03198130|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-16|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|August 23, 2019|Anticipated|2019-08-23|August 23, 2019|Anticipated|2019-08-23||Interventional|||An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)|An Exploratory Tumor Biopsy-Driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Immunomodulatory Treatment-Naïve Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck Receiving REGN2810 (Anti-PD-1)|Recruiting||Phase 1|30|Anticipated|Regeneron Pharmaceuticals||1|||f||||t|t|f|||t|||||2017-10-10 20:55:19.782318|2017-10-10 20:55:19.782318
NCT03198117|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-21|||April 25, 2017|Actual|2017-04-25|May 2017|2017-05-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC)|Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III NSCLC After Postoperative Adjuvant Chemotherapy: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial, Along With a Registration Study|Active, not recruiting||N/A|798|Anticipated|Qidong Gaitianli Medicines Co., Ltd||3|||f||||t|f|f||||||No||2017-10-10 20:55:19.877239|2017-10-10 20:55:19.877239
NCT03198104|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-21|||April 1, 2016|Actual|2016-04-01|June 2017|2017-06-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|Kids4LIFe||Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI|Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI|Recruiting||N/A|100|Anticipated|Perspectum Diagnostics Ltd|||3||f||||f|f|f||||Samples Without DNA|"     Liver biopsy and histology.   "|No|All data stored from patients (including MRI data files) will be anonymised during upload to the custom-built data management system that is being designed specifically for this study. No project partner will be able to access identifiable information (with the exception of the medical team who will upload the data).|2017-10-10 20:55:19.960429|2017-10-10 20:55:19.960429
NCT03198091|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-21|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|June 1, 2018|Anticipated|2018-06-01||Interventional|||Efficacy of Dun Ye Guan Xin Ning Tablet in Patients With Stable Angina Pectoris|An Open Label, Single Arm, Multiple Center Study Observing the Efficacy of Dun Ye Guan Xin Ning Tablet in Patients With Coronary Artery Disease of Angina Pectoris|Recruiting||N/A|1000|Anticipated|Peking University First Hospital||1|||f||||f|f|f||||||No||2017-10-10 20:55:20.095137|2017-10-10 20:55:20.095137
NCT03198078|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-13|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Trial to Evaluate the Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia|A Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial to Evaluate the Efficacy of Brexpiprazole Monotherapy for the Treatment in Adolescents (13-17 Years Old) With Schizophrenia|Recruiting||Phase 3|387|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f|||||t|f||||||||2017-10-10 20:55:20.215652|2017-10-10 20:55:20.215652
NCT03198065|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-21|||June 17, 2017|Actual|2017-06-17|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|||Single-incision Laparoscopic Surgery in Acute Abdomen|The Application of Minimally Invasive Single-incision Laparoscopic Surgery in Acute Abdomen|Recruiting||N/A|30|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:55:20.338345|2017-10-10 20:55:20.338345
NCT03198052|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-21|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|August 1, 2023|Anticipated|2023-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||PSCA/MUC1/PD-L1/CD80/86-CAR-T Cells Immunotherapy Against Cancers|CAR-T Cells Targeting PSCA, MUC1, PD-L1, or CD80/86 for Immunotherapy of Lung Cancer: Phase I Clinical Trial|Recruiting||Phase 1|30|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||1|||f||||f|f|f||||||||2017-10-10 20:55:20.432828|2017-10-10 20:55:20.432828
NCT03198039|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-08-29|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Guided Meditation as an Adjunct to Enhance Postoperative Recovery|Guided Meditation as an Adjunct to Enhance Postoperative Recovery: A Feasibility Study|Not yet recruiting||N/A|30|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||f|f|f||||||||2017-10-10 20:55:20.653009|2017-10-10 20:55:20.653009
NCT03198026|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|January 2022|Anticipated|2022-01-01|November 2021|Anticipated|2021-11-01||Interventional|||Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas|Phase II, Single Arm, Open Label Multi-center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent Non-Hodgkin's Lymphomas|Not yet recruiting||Phase 2|30|Anticipated|Thomas Jefferson University||1|||||||t|t|f||||||||2017-10-10 20:55:20.749801|2017-10-10 20:55:20.749801
NCT03198013|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||November 11, 2008|Actual|2008-11-11|June 2017|2017-06-01|May 18, 2009|Actual|2009-05-18|May 18, 2009|Actual|2009-05-18||Interventional|||A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males|Placebo-Controlled, Double-Blind, Ascending Single and Multiple Oral Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-791826 and to Assess Its Marker Specific Pharmacodynamics in Relation to Prednisolone in Healthy Males|Completed||Phase 1|120|Actual|Bristol-Myers Squibb||2|||f||||t|t|f|||t|||||2017-10-10 20:55:20.858575|2017-10-10 20:55:20.858575
NCT03198000|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-10|||June 28, 2017|Actual|2017-06-28|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||A Study to Evaluate the Efficacy of Investigational OTC Eye Drops|A Single-Center, Randomized, Controlled Study to Evaluate the Efficacy of Two Investigational OTC Eye Drops in Healthy Adults With Red Eye|Completed||Phase 3|120|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f|t|f|||f|||||2017-10-10 20:55:20.956481|2017-10-10 20:55:20.956481
NCT03197987|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|January 30, 2018|Anticipated|2018-01-30|January 1, 2018|Anticipated|2018-01-01||Interventional|COLONAUX||Comparison of Two Devices During Colonoscopy|Endocuff vs Transparent Cap To Increase Adenoma Detection Rate During Colonoscopy|Recruiting||N/A|644|Anticipated|Hospital General Universitario Elche||2|||f||||f|f|f||||||No||2017-10-10 20:55:21.074927|2017-10-10 20:55:21.074927
NCT03197974|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-14|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|ORBIT||RCT of a Web-based Intervention to Improve Quality of Life in Late Stage Bipolar Disorder (ORBIT)|Web-based Intervention With Email Support to Improve Quality of Life in Late Stage Bipolar Disorder (ORBIT): Randomised Controlled Trial|Recruiting||N/A|300|Anticipated|Swinburne University of Technology||2|||f||||f|f|f||||||||2017-10-10 20:55:21.225468|2017-10-10 20:55:21.225468
NCT03197961|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-04|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Interventional|DynamoPrEP||Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP|The Pharmacokinetic and Pharmacodynamic Impacts of Depot Medroxyprogesterone Acetate on HIV Pre-exposure Prophylaxis (PrEP)|Not yet recruiting||Early Phase 1|14|Anticipated|University of Pittsburgh||1|||f||||f|t|f|||f|||||2017-10-10 20:55:21.376364|2017-10-10 20:55:21.376364
NCT03197948|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-09-15|||July 28, 2016|Actual|2016-07-28|September 2017|2017-09-01|January 1, 2021|Anticipated|2021-01-01|November 12, 2020|Anticipated|2020-11-12||Observational|||Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment|A Pilot Feasibility Trial Examining the Use of Electronic Patient-Reported Outcomes in Prostate Cancer Patients With Apple ResearchKit Smartphone Application|Recruiting||N/A|60|Anticipated|Thomas Jefferson University|||1||f||||f|f|f||||||||2017-10-10 20:55:21.478163|2017-10-10 20:55:21.478163
NCT03197935|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-01|||July 31, 2017|Anticipated|2017-07-31|August 2017|2017-08-01|September 26, 2021|Anticipated|2021-09-26|March 19, 2019|Anticipated|2019-03-19||Interventional|IMpassion031||A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer|A Phase III Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Neoadjuvant Anthracycline/Nab-Paclitaxel-Based Chemotherapy Compared With Placebo and Chemotherapy in Patients With Primary Invasive Triple-Negative Breast Cancer|Recruiting||Phase 3|204|Anticipated|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 20:55:21.600881|2017-10-10 20:55:21.600881
NCT03197909|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-02|||July 6, 2017|Actual|2017-07-06|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Involvement of Plasmatic Factors in the Peripheral Muscle Dysfunction of COPD Patients - In Vitro Study|Involvement of Plasmatic Factors in the Peripheral Muscle Dysfunction of COPD Patients - In Vitro Study|Recruiting||N/A|18|Anticipated|University Hospital, Montpellier|||2||f||||f|f|f||||||||2017-10-10 20:55:21.953336|2017-10-10 20:55:21.953336
NCT03197896|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-31|||September 29, 2016|Actual|2016-09-29|July 2017|2017-07-01|May 1, 2021|Anticipated|2021-05-01|May 12, 2020|Anticipated|2020-05-12||Interventional|||Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods|A Neighborhood-Based Intervention to Reduce Prostate Cancer Disparities|Recruiting||N/A|240|Anticipated|Thomas Jefferson University||2|||f||||f|f|f||||||||2017-10-10 20:55:22.049253|2017-10-10 20:55:22.049253
NCT03197870|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-24|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|TIME-2b||The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)|Phase 2 Double-Masked, Placebo-Controlled Study to Assess the Safety and Efficacy of Subcutaneously Administered AKB-9778 15mg Once Daily or 15mg Twice Daily for 12 Months in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy|Recruiting||Phase 2|150|Anticipated|Aerpio Therapeutics||3|||f||||t|t|f||||||||2017-10-10 20:55:22.24777|2017-10-10 20:55:22.24777
NCT03197857|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-21|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 2023|Anticipated|2023-10-01|May 2023|Anticipated|2023-05-01||Interventional|CaPaCITy||Physical Condition and Bariatric Surgery|Determination of Factors Influencing the Physical Condition of Obese Patients Following Bariatric Surgery. Randomized Controlled Trial|Not yet recruiting||N/A|150|Anticipated|University Hospital, Clermont-Ferrand||6|||f|||||f|f||||||||2017-10-10 20:55:22.514107|2017-10-10 20:55:22.514107
NCT03197844|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-21|||June 23, 2017|Anticipated|2017-06-23|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|June 23, 2017|Anticipated|2017-06-23||Observational|||Study on Registration of Xinyuan Capsule|Study on Registration of Xinyuan Capsule|Not yet recruiting||N/A|3000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t|f|f||||||No||2017-10-10 20:55:22.632959|2017-10-10 20:55:22.632959
NCT03197831|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-27|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Impact of Medicaid Expansion on Healthcare Utilization|Impact of Medicaid Expansion Under ACA on Inpatient and Emergency Room Utilization and Substance Use Disorder Treatment|Enrolling by invitation||N/A|177|Actual|University of Arkansas|||4||f||||f|f|f||||||No||2017-10-10 20:55:22.701012|2017-10-10 20:55:22.701012
NCT03197818|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-22|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TRIVERSYTI||Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)|A 24-week, Double Blind, Double Dummy, Randomized, Multinational, Multicentre, 2-arm Parallel Group,Active Controlled Clinical Trial of Fixed Combination of Beclometasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrronium Bromide Administered Via pMDI (CHF 5993) Versus the Fixed Combination of Budesonide Plus Formoterol Fumarate (Symbicort® Turbuhaler®) in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||Phase 3|990|Anticipated|Chiesi Farmaceutici S.p.A.||2|||f||||f|f|f||||||No||2017-10-10 20:55:22.795126|2017-10-10 20:55:22.795126
NCT03197805|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-22|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|EQUIVOK||Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients|Prospective Study Assessing the Impact of RNA Genomic Profile Defined by a Genomic Test on Treatment Decision-making in Breast Cancer Patients With an ISH Equivocal HER2 Status- EQUIVOK Study|Not yet recruiting||N/A|260|Anticipated|Centre Jean Perrin||1|||f||||f|f|f||||||No||2017-10-10 20:55:23.015964|2017-10-10 20:55:23.015964
NCT03197792|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-22|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|May 24, 2019|Anticipated|2019-05-24|May 24, 2018|Anticipated|2018-05-24||Interventional|PVP-ETO-CPC||Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy|Perioperative Transesophageal Portal Vein Pulsatility as a Predictor of Persistent Organ Dysfunction Plus Death 7 Days After Pulmonary Endarterectomy|Recruiting||N/A|39|Anticipated|Centre Chirurgical Marie Lannelongue||1|||f||||f|f|f||||||No||2017-10-10 20:55:23.20512|2017-10-10 20:55:23.20512
NCT03197428|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-21|||July 5, 2016|Actual|2016-07-05|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Platelet-rich Plasma for Chronic Lateral Ankle Instability|Efficacy of Platelet-rich Plasma in the Treatment of Chronic Lateral Ankle Instability|Recruiting||N/A|30|Anticipated|Show Chwan Memorial Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:55:26.029806|2017-10-10 20:55:26.029806
NCT03197779|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-28|||November 18, 2013|Actual|2013-11-18|June 2017|2017-06-01|January 24, 2017|Actual|2017-01-24|February 2, 2016|Actual|2016-02-02||Interventional|||A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS- 962212 in Healthy Subjects|Completed||Phase 1|691|Actual|Bristol-Myers Squibb||5|||f||||f|t|f||||||||2017-10-10 20:55:23.331492|2017-10-10 20:55:23.331492
NCT03197766|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-21|||December 12, 2016|Actual|2016-12-12|June 2017|2017-06-01||||October 2019|Anticipated|2019-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia|A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia|Enrolling by invitation||Phase 3|110|Anticipated|BioMarin Pharmaceutical||2|||f||||t||f||||||Undecided||2017-10-10 20:55:23.451048|2017-10-10 20:55:23.451048
NCT03197753|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-08-15|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|August 1, 2017|Actual|2017-08-01||Interventional|||Postoperative Discomfort After Dental General Anesthesia|Postoperative Discomfort and Emergence Delirium In Children Receiving Dental Treatment Under General Anesthesia: Comparison Of Nasal Tracheal Intubation and Laryngeal Mask Airway|Completed||N/A|70|Actual|Adnan Menderes University||2|||f||||f|f|f||||||||2017-10-10 20:55:23.561146|2017-10-10 20:55:23.561146
NCT03197740|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||July 7, 2017|Anticipated|2017-07-07|June 2017|2017-06-01|April 30, 2019|Anticipated|2019-04-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease|A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease|Not yet recruiting||Phase 3|588|Anticipated|Icure Pharmaceutical Inc.||8|||f|||||f|f||||||||2017-10-10 20:55:23.650968|2017-10-10 20:55:23.650968
NCT03197727|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||November 28, 2014|Actual|2014-11-28|June 2017|2017-06-01|January 18, 2016|Actual|2016-01-18|June 30, 2015|Actual|2015-06-30||Interventional|||Tooth Wear and Associated Risk Factors|Evaluation of Tooth Wear and Associated Risk Factors: a Matched Case-control Study|Completed||N/A|100|Actual|Hacettepe University||1|||f||||t|f|f||||||No||2017-10-10 20:55:23.726405|2017-10-10 20:55:23.726405
NCT03197701|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-07-13|||September 2015||2015-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|||Maximal Effort-dependent Respiratory Flow Rates|Maximal Effort-dependent Respiratory Flow Rates: Reproducibility and Reference Values|Recruiting||N/A|300|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||f||||||||||2017-10-10 20:55:23.892919|2017-10-10 20:55:23.892919
NCT03197688|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-08-22|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|OrPHeUS||Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States|Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States|Active, not recruiting||N/A|2200|Anticipated|Actelion|||1||f||||f|t|f|||f|||||2017-10-10 20:55:23.962222|2017-10-10 20:55:23.962222
NCT03197675|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-26|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||Acupuncture in Spinal Cord Injury Subjects|The Use of Acupuncture in Potentiating Functional Recovery in Spinal Cord Injury Subjects|Not yet recruiting||N/A|100|Anticipated|University of Maryland||2|||f||||t|f|f||||||No||2017-10-10 20:55:24.049919|2017-10-10 20:55:24.049919
NCT03197662|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-13|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|February 2020|Anticipated|2020-02-01||Interventional|||Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome|Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Children and Adolescents With Prader-Willi Syndrome|Not yet recruiting||Phase 2|50|Anticipated|Montefiore Medical Center||2|||f||||t|t|f||||||||2017-10-10 20:55:24.126042|2017-10-10 20:55:24.126042
NCT03197649|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-23|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|May 2023|Anticipated|2023-05-01|May 2022|Anticipated|2022-05-01||Interventional|||CO2 Laser Phototherapy for Management of Mature Burn Scars|Randomized, Prospective, Split Scar Pilot Study to Evaluate the Efficacy of CO2 Laser Phototherapy for Management of Mature Burn Scars|Recruiting||N/A|50|Anticipated|University of California, Davis||2|||f||||f|f|f||||||No|No plan|2017-10-10 20:55:24.208155|2017-10-10 20:55:24.208155
NCT03197636|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-22|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients|An Observational Study Design to Detect if Co-stimulatory Markers and Vitamin D Status in Anti-PD-1 Treated Advanced Melanoma Patients Can Predict Treatment Outcome|Enrolling by invitation||N/A|40|Anticipated|Aarhus University Hospital|||2||f||||||||||||||2017-10-10 20:55:24.296097|2017-10-10 20:55:24.296097
NCT03197623|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-21|||October 14, 2016|Actual|2016-10-14|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of the Safety and Tolerability of Intravenous LLP2A-Alendronate in Adult Men and Women With Osteopenia Secondary to Glucocorticoids|Recruiting||Phase 1|50|Anticipated|University of California, Davis||2|||f||||t|t|f||||||Undecided||2017-10-10 20:55:24.370579|2017-10-10 20:55:24.370579
NCT03197610|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-20|||January 1, 2015|Actual|2015-01-01|June 2017|2017-06-01|September 1, 2016|Actual|2016-09-01|July 1, 2016|Actual|2016-07-01||Interventional|||The Effect of Enamel Matrix Derivatives on Root Coverage Esthetic Score|The Effect of Enamel Matrix Derivatives on Root Coverage Esthetic Score|Completed||N/A|19|Actual|Yuzuncu Yıl University||2|||f||||f|f|f||||||Yes||2017-10-10 20:55:24.481649|2017-10-10 20:55:24.481649
NCT03197584|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|||QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy|NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy|Not yet recruiting||Phase 1/Phase 2|67|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||No||2017-10-10 20:55:24.76645|2017-10-10 20:55:24.76645
NCT03197571|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy|QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and Anti-programmed Cell Death Protein 1 (PD-1)/Programmed Death-ligand 1 (PD-L1) Therapy|Not yet recruiting||Phase 1/Phase 2|113|Anticipated|NantCell, Inc.||1|||f||||f|t|f||||||No||2017-10-10 20:55:24.902947|2017-10-10 20:55:24.902947
NCT03197558|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-24|||June 27, 2017||2017-06-27||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:55:25.034502|2017-10-10 20:55:25.034502
NCT03197545|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-21|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|January 2019|Anticipated|2019-01-01||Observational|||Determining the Risk of Stress Fracture in IDF Soldiers Based on SNPs Identified for Osteoporosis|Determining the Risk of Stress Fracture in IDF Soldiers Based on SNPs Identified for Osteoporosis|Recruiting||N/A|440|Anticipated|Medical Corps, Israel Defense Force|||3||f||||f||||||Samples With DNA|"     DNA samples will be taken by a sample of the patient's saliva from the inside of the cheek by     a sterile specific kit designed for the preservation and subsequent production of DNA from     the kit (FTA card).   "|No|Data will be published after statistical analysis only.|2017-10-10 20:55:25.078906|2017-10-10 20:55:25.078906
NCT03197532|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-06-22|||January 2011||2011-01-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|AUHS||Assessing Urinary Hormones in Female Cancer Survivors|Follicular and Luteal Dysfunction in Cancer Survivors|Active, not recruiting||N/A|60|Anticipated|University of Pennsylvania|||3||f||||f||||||Samples Without DNA|"     daily urinary collections for 2 menstrual cycles   "|No||2017-10-10 20:55:25.172488|2017-10-10 20:55:25.172488
NCT03197519|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-20|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Evaluation of a Program for Eating Disorders That Combines Cognitive-behavioral Therapy With Online Psychological Treatment|Evaluation of a Treatment Program for Eating Disorders That Combines Face-to-face Cognitive Behavioural Treatment With an Online Intervention Using the TCapp Application, Within the Framework of Broader Research Project Entitled mHealth: Challenges and Opportunities for Health Systems|Not yet recruiting||N/A|250|Anticipated|Universitat Oberta de Catalunya||2|||f||||f|f|f||||||No||2017-10-10 20:55:25.270435|2017-10-10 20:55:25.270435
NCT03197506|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-18|||September 15, 2017|Actual|2017-09-15|June 2017|2017-06-01|July 31, 2022|Anticipated|2022-07-31|July 31, 2022|Anticipated|2022-07-31||Interventional|||Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma|Phase II Study of Pembrolizumab (MK-3475) in Combination With Standard Therapy for Newly Diagnosed Glioblastoma|Recruiting||Phase 2|90|Anticipated|Mayo Clinic||1|||||||t|t|f||||||||2017-10-10 20:55:25.420527|2017-10-10 20:55:25.420527
NCT03197493|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-21|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Extension, Carbidopa-levodopa in Neovascular AMD|Extension of Protocol 002, Carbidopa-levodopa in Neovascular Extension of Protocol 002, Carbidopa-levodopa in Neovascular AMD|Not yet recruiting||Phase 2|52|Anticipated|Snyder, Robert W., M.D., Ph.D., P.C.||2|||f||||f|t|f||||||No||2017-10-10 20:55:25.559754|2017-10-10 20:55:25.559754
NCT03197480|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-07|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Ocular and Systemic Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME|Identifying Ocular and Systemic Biomarkers for Response to Aflibercept in Asian Patients With Centre Involving Diabetic Macular Edema: A Prospective Interventional Trial|Not yet recruiting||Phase 4|100|Anticipated|Singapore National Eye Centre||2|||f||||t|t|f|||t|||||2017-10-10 20:55:25.643223|2017-10-10 20:55:25.643223
NCT03197467|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-22|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|NEOMUN||Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer|Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer [NEOMUN]|Not yet recruiting||Phase 2|30|Anticipated|AIO-Studien-gGmbH||1|||f||||f|f|f||||||No||2017-10-10 20:55:25.756148|2017-10-10 20:55:25.756148
NCT03197454|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-26|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|PACR-AD||Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease (PACR-AD)|Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease (PACR-AD) Phase II|Not yet recruiting||N/A|120|Anticipated|Posit Science Corporation||2|||f|||||f|f||||||||2017-10-10 20:55:25.853304|2017-10-10 20:55:25.853304
NCT03197441|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-21|||August 29, 2016|Actual|2016-08-29|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Platelet Rich Plasma for Knee Osteoarthritis|Intraoperative Platelet Rich Plasma Injection in Arthroscopic Surgery for Osteoarthritis of the Knee|Recruiting||N/A|30|Anticipated|Show Chwan Memorial Hospital||1|||f||||t|f|f||||||No||2017-10-10 20:55:25.929668|2017-10-10 20:55:25.929668
NCT03197415|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-21|||April 22, 2016|Actual|2016-04-22|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Platelet-rich Plasma for Low Back Pain|Intradiscal Injection of Platelet-rich Plasma for Discogenic Pain in L-spine|Recruiting||N/A|30|Anticipated|Show Chwan Memorial Hospital||1|||f||||t|f|f||||||No||2017-10-10 20:55:26.127418|2017-10-10 20:55:26.127418
NCT03197402|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Leucine-enriched Nutraceutical and Attenuating Muscle Loss|Efficacy of a High Quality Protein Leucine-enriched Nutraceutical in Attenuating Inactivity- and Hypo-energetic Diet-induced Muscle Loss in Older Women|Not yet recruiting||N/A|20|Anticipated|McMaster University||2|||f||||f|f|f||||||No|These data will not be shared with other researchers|2017-10-10 20:55:26.210105|2017-10-10 20:55:26.210105
NCT03197389|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-22|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early ER/PR Negative Breast Cancer.|Effect of Pembrolizumab (Keytruda®) on Biomarkers Related to Intratumoral Immunity, Proliferation and Apoptosis in Early ER/PR Negative Breast Cancer.|Not yet recruiting||Early Phase 1|34|Anticipated|Universitaire Ziekenhuizen Leuven||4|||f||||t|f|f|||f|||No||2017-10-10 20:55:26.304988|2017-10-10 20:55:26.304988
NCT03197376|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-28|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants|A Phase 3, Randomized, Double-Blind Study of the Safety, Tolerability, Lot-to-Lot Consistency, Immunogenicity & Non-Interference With Concomitant Vaccinations of Serum Institute of PNEUMOSIL in Healthy Infants in The Gambia|Recruiting||Phase 3|2250|Anticipated|PATH||4|||f||||t|f|f||||||||2017-10-10 20:55:26.386191|2017-10-10 20:55:26.386191
NCT03197363|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-13|||July 11, 2017|Actual|2017-07-11|June 2017|2017-06-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Observational|Bialystok+||Białystok PLUS - Polish Longitudinal University Study|Bialystok PLUS - Polish Longitudinal University Study|Enrolling by invitation||N/A|10000|Anticipated|Medical University of Bialystok|||1||f||||t|f|f||||Samples With DNA|"     Blood samples: Serum, plasma (will be collected from fasting blood samples) In this study we     will be isolated Peripheral Blood Mononuclear Cells (PBMC) from fresh blood sampled on EDTA     as anticoagulant.      Saliva samples (unstimulated and stimulated) Urine samples Stool samples (for analysis     intestinal microbiome)   "|||2017-10-10 20:55:26.483892|2017-10-10 20:55:26.483892
NCT03197350|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Characterization of Heart Failure With Preserved Ejection Fraction|Characterization of Heart Failure With Preserved Ejection Fraction|Recruiting||N/A|200|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f|||||f|f||||||||2017-10-10 20:55:26.561584|2017-10-10 20:55:26.561584
NCT03197337|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-22|2017-06-22|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Is Localized Provoked Vulvodynia Caused by Laxity of the Utero-Sacral Ligaments?|Is Localized Provoked Vulvodynia Caused by Laxity of the Utero-Sacral Ligaments?|Not yet recruiting||N/A|30|Anticipated|Western Galilee Hospital-Nahariya||2|||f|||||f|f||||||||2017-10-10 20:55:26.651538|2017-10-10 20:55:26.651538
NCT03197324|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-21|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|September 17, 2017|Actual|2017-09-17|September 17, 2017|Actual|2017-09-17||Interventional|||Bexagliflozin Drug/Drug Interaction Study With Digoxin|A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effect of Bexagliflozin on the Pharmacokinetics of Digoxin in Healthy Subjects|Completed||Phase 1|20|Actual|Theracos||2|||f||||t|t|f||||||||2017-10-10 20:55:26.741847|2017-10-10 20:55:26.741847
NCT03197311|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-06|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Mobile Application for Post-op Analgesic Consumption|A Mobile Application to Monitor Patient's Analgesic Consumption After Minor Oral Surgery.|Not yet recruiting||N/A|20|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 20:55:26.81472|2017-10-10 20:55:26.81472
NCT03197298|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-22|||December 21, 2012|Actual|2012-12-21|June 2017|2017-06-01|July 25, 2016|Actual|2016-07-25|July 25, 2016|Actual|2016-07-25|1 Year|Observational [Patient Registry]|CHANGE DAPT||Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome|Clopidogrel or Ticagrelor in Acute Coronary Syndrome Patients Treated With Newer-Generation Drug-Eluting Stents: CHANGE DAPT|Completed||N/A|2062|Actual|Thorax Centrum Twente|||2||f||||||||||||||2017-10-10 20:55:26.905295|2017-10-10 20:55:26.905295
NCT03197285|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-22|||June 2012|Actual|2012-06-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|November 2013|Actual|2013-11-01||Interventional|||Effectiveness of an Eye-Cervical Re-education Program in Chronic Neck Pain|Effectiveness of an Eye-Cervical Re-education Program (ECRP) to Decrease Pain and Increase Mobility in the Cervical Area Compared to a Combined Physiotherapy Protocol (CPP) in Patients With Chronic Neck Pain Symptoms.|Completed||N/A|44|Actual|University of Cadiz||2|||f||||f|f|f||||||No||2017-10-10 20:55:27.001334|2017-10-10 20:55:27.001334
NCT03197272|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||April 21, 2016|Actual|2016-04-21|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|PiXLO2||Advanced Cross Linking for Low-grade Myopia|Non-invasive Phototherapeutic Intrastromal Corneal Collagen Crosslinking (PiXL) for Low-grade Myopia|Recruiting||N/A|120|Anticipated|Umeå University||2|||f||||f|f|f|||f|||No||2017-10-10 20:55:27.073305|2017-10-10 20:55:27.073305
NCT03197259|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-08|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|August 1, 2020|Anticipated|2020-08-01|January 1, 2020|Anticipated|2020-01-01|3 Years|Observational [Patient Registry]|CLLTRegistry||Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study|Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study|Recruiting||N/A|1000|Anticipated|Izmir Hematologic Diseases and Cancer Research Help Association|||1||f||||f|f|f||||||||2017-10-10 20:55:27.147022|2017-10-10 20:55:27.147022
NCT03197246|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-14|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Interventional|IVEKG||Intravascular ECG During Insertion of Peripheral Inserted Central-venous Catheters: Replacement for Chest X-ray?|May Intravascular Electrocardiography (IVECG) During Insertion of Peripheral Inserted Central-venous Catheters (PICC-line) Replace Chest X-ray?|Recruiting||N/A|92|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 20:55:27.213042|2017-10-10 20:55:27.213042
NCT03197233|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-23|||January 1999|Actual|1999-01-01|June 2017|2017-06-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Observational|||Vitamin A and D Intake in Pregnancy, Infant Supplementation and Asthma Development|Norwegian Mother and Child Study - Causal Pathways for Asthma (CASPAR)|Completed||N/A|61676|Actual|Norwegian Institute of Public Health|||1||f||||f|f|f||||||Yes|Data have been shared with collaborators.|2017-10-10 20:55:27.284071|2017-10-10 20:55:27.284071
NCT03197220|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-06-21|||November 22, 2015|Actual|2015-11-22|March 2017|2017-03-01|January 20, 2017|Actual|2017-01-20|November 21, 2016|Actual|2016-11-21||Interventional|||Omega-3 and Cardiovascular Risk Factors|The Impact of Fish and Walnut Consumption on Cardiovascular Risk Factors in Overweight and Obese Females: A Randomized Clinical Trial|Completed||N/A|99|Actual|Isfahan University of Medical Sciences||3|||f|||||f|f||||||||2017-10-10 20:55:27.345755|2017-10-10 20:55:27.345755
NCT03197207|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-22|||June 3, 2016|Actual|2016-06-03|May 2017|2017-05-01|December 30, 2016|Actual|2016-12-30|August 25, 2016|Actual|2016-08-25||Interventional|||Quantitative Analysis of Different Acupuncture Needle Manipulation to Treat Chronic Shoulder Pain|Quantitative Analysis of Different Acupuncture Needle Manipulation to Treat Chronic Shoulder Pain|Completed||N/A|60|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-10 20:55:27.409389|2017-10-10 20:55:27.409389
NCT03197194|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-28|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|THEIA||A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion|A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion|Not yet recruiting||Phase 3|70|Anticipated|Nantes University Hospital||2|||f||||t|f|f|||f|||Undecided||2017-10-10 20:55:27.479874|2017-10-10 20:55:27.479874
NCT03197181|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Frontopolar Cortex and Motivation in Healthy Older Adults|Causal Role of Frontopolar Cortex for Motivation in Healthy Older Adults: a Transcranial Direct Current Stimulation Study|Not yet recruiting||N/A|120|Anticipated|University of Zurich||2|||f||||t|f|f||||||No||2017-10-10 20:55:27.654605|2017-10-10 20:55:27.654605
NCT03197168|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-06-22|||March 2014||2014-03-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|August 2015|Actual|2015-08-01||Interventional|||Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile|Implementing a Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among Mental Health Outpatients in Chile: a Pilot Randomized Controlled Trial|Completed||N/A|76|Actual|University of Chile||2|||f||||f||||||||No||2017-10-10 20:55:27.863598|2017-10-10 20:55:27.863598
NCT03197155|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-21|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|January 31, 2017|Actual|2017-01-31||Observational|RECAR||Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence|Direct-acting Antiviral Therapy Decreases Hepatocellular Carcinoma Recurrence Rate in Cirrhotic Patients With Chronic Hepatitis C|Completed||N/A|68|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 20:55:27.98319|2017-10-10 20:55:27.98319
NCT03197142|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-21|||October 1, 2014|Actual|2014-10-01|June 2017|2017-06-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01|5 Years|Observational [Patient Registry]|Pavia CARe||Cardiac Arrest Registry of the Province of Pavia (Pavia CARe)|Cardiac Arrest Registry of the Province of Pavia (Pavia CARe)|Recruiting||N/A|5000|Anticipated|IRCCS Policlinico S. Matteo|||1||f||||f|f|f||||||No||2017-10-10 20:55:28.069758|2017-10-10 20:55:28.069758
NCT03197129|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Waiting Room's Environment and Children Anxiety Prior Dental Treatment|The Effect of Waiting Room's Environment on the Levels of Anxiety Experienced by Children Prior Dental Treatment|Not yet recruiting||N/A|100|Anticipated|Hadassah Medical Organization||2|||f|||||f|f||||||No||2017-10-10 20:55:28.20381|2017-10-10 20:55:28.20381
NCT03197116|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-08-14|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lay Tel Compliance Study|The Effectiveness of Telephone Reminders by a Layperson on Compliance With Colorectal Cancer Screening: an Open-label, Randomized Controlled Trial|Recruiting||N/A|500|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 20:55:28.302794|2017-10-10 20:55:28.302794
NCT03197103|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-04|||July 4, 2017|Actual|2017-07-04|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction|The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction|Active, not recruiting||Phase 4|15|Actual|Centre of Postgraduate Medical Education||2|||f||||f|f|f||||||||2017-10-10 20:55:28.402069|2017-10-10 20:55:28.402069
NCT03197090|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-21|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|May 1, 2018|Anticipated|2018-05-01|February 28, 2018|Anticipated|2018-02-28||Interventional|||Detection of Atrial Fibrillation in the Hospital Setting by Use of a Handheld ECG Recording Device|Detection of Atrial Fibrillation in the Hospital Setting by Use of a Handheld ECG Recording Device - The DETECT-AF Trial|Not yet recruiting||N/A|1600|Anticipated|University of Freiburg||2|||f||||f|f|f||||||No||2017-10-10 20:55:28.516467|2017-10-10 20:55:28.516467
NCT03197077|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|June 1, 2018|Anticipated|2018-06-01||Interventional|Elonva_IVM||Optimisation of Follicular Recruitment in IVM Cycles|A Comparison Between Corifollitropin Alfa and Recombinant FSH for Follicular Recruitment in Women With Polycystic Ovaries Who Undergo IVM Treatment|Not yet recruiting||Phase 3|145|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f|f|f||||||||2017-10-10 20:55:28.616342|2017-10-10 20:55:28.616342
NCT03197064|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia|Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked|Not yet recruiting||Phase 4|50|Anticipated|Stanford University||1|||f||||t|t|f|||t|||Yes|There is a plan to make IPD available only to members of the research team involved in this project. All patient identifying information will be removed from all data as it is collected to protect patient privacy.|2017-10-10 20:55:28.72622|2017-10-10 20:55:28.72622
NCT03197051|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||June 26, 2017|Anticipated|2017-06-26|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|May 29, 2019|Anticipated|2019-05-29||Observational|||Impact of Perioperative Shedding of the Endothelial Glycocalyx on the Incidence of Postoperative Acute Kidney Injury in Patients Undergoing Valvular Heart Surgery.|Impact of Perioperative Shedding of the Endothelial Glycocalyx on the Incidence of Postoperative Acute Kidney Injury in Patients Undergoing Valvular Heart Surgery.|Not yet recruiting||N/A|250|Anticipated|Yonsei University|||4||f||||f|f|f||||||No||2017-10-10 20:55:28.836835|2017-10-10 20:55:28.836835
NCT03197038|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-21|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Exercise Training and Cognitive Function in Kidney Disease|Exercise Training and Cognitive Function in Kidney Disease|Not yet recruiting||N/A|30|Anticipated|University of Illinois at Chicago||2|||f||||t|f|f||||||Undecided||2017-10-10 20:55:28.962663|2017-10-10 20:55:28.962663
NCT03197012|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-28|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor|Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor|Recruiting||Early Phase 1|32|Anticipated|University of California, San Francisco||2|||f|||||t|f||||||||2017-10-10 20:55:29.174279|2017-10-10 20:55:29.174279
NCT03196999|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-25|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Remotely Resolving Psychological Stress (Remote RePS)|"Remote RePS: An Entirely Remote Study of an Attention Bias Modification Training App for Posttraumatic Stress Disorder"|Not yet recruiting||N/A|68|Anticipated|University of California, San Francisco||3|||f|||||f|f||||||||2017-10-10 20:55:29.292014|2017-10-10 20:55:29.292014
NCT03196986|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-21|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|||MIL60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer|Efficacy and Safety of First-line MIL60 Plus Paclitaxel/Carboplatin Versus Bevacizumab Plus Paclitaxel/Carboplatin in Patients With Advanced and Recurrent Non-squamous Non-small Cell Lung Cancer: a Randomized, Double-blind, Phase 3 Study|Not yet recruiting||Phase 3|436|Anticipated|Beijing Mabworks Biotech Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 20:55:29.392801|2017-10-10 20:55:29.392801
NCT03196973|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-12|||July 22, 2017|Actual|2017-07-22|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa|A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Externa (AOE)|Recruiting||Phase 3|500|Anticipated|Salvat||3|||f||||f|t|f||||||||2017-10-10 20:55:29.482191|2017-10-10 20:55:29.482191
NCT03196960|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-22|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|MQS||Effects of Mobility Dose in Surgical Intensive Care Unit Patients|Effects of Mobility Dose in Surgical Intensive Care Unit Patients on Adverse Discharge Disposition|Recruiting||N/A|150|Anticipated|Massachusetts General Hospital|||1||f||||f|f|f||||||No||2017-10-10 20:55:29.594994|2017-10-10 20:55:29.594994
NCT03196947|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-20|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|SMR-3184||Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP|Phase I, Open Label, Dose Escalation Study to Investigate the Tolerability and Efficacy of APO010 in Patients With Relapsed/Refractory Multiple Myeloma Selected by Drug Response Predictor (DRP)|Recruiting||Phase 1/Phase 2|35|Anticipated|Oncology Venture||1|||f||||t|f|f||||||||2017-10-10 20:55:29.723141|2017-10-10 20:55:29.723141
NCT03196934|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-06-20||||||June 2017|2017-06-01||||||||Expanded Access|||Expanded Use of Cannabidiol Oral Solution|A Multicenter, Open-label, Flexible Dose Study to Assess the Long-term Safety of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Treatment for Pediatric Subjects With a Treatment-resistant Seizure Disorder Who Complete INS011-14-029 or Part A of INS011-15-054|Available||N/A|||MultiCare Health System Research Institute|||||||t||||||||||||2017-10-10 20:55:29.859532|2017-10-10 20:55:29.859532
NCT03196921|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|March 1, 2019|Anticipated|2019-03-01|October 1, 2018|Anticipated|2018-10-01||Interventional|ORACLE||Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection|A Prospective Cohort to Evaluate the Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB/MAT2203) for the Treatment of Cryptococcal Infection|Not yet recruiting||Phase 1/Phase 2|80|Anticipated|Matinas BioPharma Nanotechnologies, Inc.||2|||f||||f|t|f||||||No||2017-10-10 20:55:29.922096|2017-10-10 20:55:29.922096
NCT03196908|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||June 23, 2017|Anticipated|2017-06-23|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Impact of Energy Drink Brands on Heart Rhythm|Impact of Energy Drink Brands on Heart Rhythm in Healthy Volunteers: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|University of the Pacific||3|||f||||f|f|f||||||No||2017-10-10 20:55:30.036105|2017-10-10 20:55:30.036105
NCT03196895|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-06-21|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|August 2021|Anticipated|2021-08-01|June 2021|Anticipated|2021-06-01||Interventional|||Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification|Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification|Recruiting||N/A|200|Anticipated|University of Virginia||4|||f||||f|f|f||||||Undecided||2017-10-10 20:55:30.180324|2017-10-10 20:55:30.180324
NCT03196882|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-22|||July 10, 2013|Actual|2013-07-10|June 2017|2017-06-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|(ECLIPSES)||Effectiveness of Adaptation of the Dose of Iron Supplementation in Pregnancy on Maternal-child Health. (ECLIPSES)|Effectiveness of Adaptation of the Dose of Iron Supplementation in Pregnancy on Maternal-child Health. Randomized Clinical Trial (ECLIPSES)|Completed||Phase 4|704|Actual|Jordi Gol i Gurina Foundation||4|||f||||t|f|f||||||No||2017-10-10 20:55:30.340461|2017-10-10 20:55:30.340461
NCT03196869|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-21|||April 7, 2017|Actual|2017-04-07|June 2017|2017-06-01|August 12, 2022|Anticipated|2022-08-12|April 12, 2019|Anticipated|2019-04-12||Interventional|||the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer|Phase II Clinical Randomized Study of the Effect of Chronomodulated Chemotherapy Followed by Concurrent IMRT Chemo-radiotherapy on the Dendritic Cells Subsets and Immunity in the Treatment of Advanced Nasopharyngeal Cancer|Recruiting||Phase 2|128|Anticipated|Guiyang Medical University||2|||f||||t|f|f||||||No||2017-10-10 20:55:30.453741|2017-10-10 20:55:30.453741
NCT03196856|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-21|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|BEAST||Brock Exercise And Supplement Trials|Effects of Greek Yogurt and Exercise on Muscle Size, Body Composition and Bone Health in Untrained, University-aged Males|Not yet recruiting||N/A|40|Anticipated|Brock University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:55:30.571777|2017-10-10 20:55:30.571777
NCT03196843|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-27|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 2022|Anticipated|2022-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.|Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With Head and Neck Squamous Cell Carcinoma: a Prospective Randomized Controlled Trial|Not yet recruiting||Phase 4|202|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f|||||f|f|||f|||No||2017-10-10 20:55:30.660503|2017-10-10 20:55:30.660503
NCT03196830|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||CAR-T for R/R B-NHL|Safety and Efficacy of Chimeric Antigen Receptor T Cell (CAR-T) Treating Relaspe/Refractory CD19/CD20/CD22/CD30 Postive Non-Hodgkin Lymphoma|Recruiting||Phase 2|10|Anticipated|The First Affiliated Hospital of Soochow University||1|||f||||f|f|f||||||No||2017-10-10 20:55:30.746882|2017-10-10 20:55:30.746882
NCT03196817|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-10|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 1, 2017|Actual|2017-05-01||Interventional|||Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration|Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration: Clinical Randomized Trial|Active, not recruiting||Phase 4|84|Actual|Hospital Alvorada||2|||f||||t||||||||||2017-10-10 20:55:30.843552|2017-10-10 20:55:30.843552
NCT03196804|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-23|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126.|A Dose Blocked-randomized, Double-blind, Placebo-controlled, Multiple Dosing and Dose-escalation Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects|Recruiting||Phase 1|32|Anticipated|LG Chem||2|||f||||f|f|f||||||No||2017-10-10 20:55:30.946255|2017-10-10 20:55:30.946255
NCT03196791|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-08-21|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|August 30, 2019|Anticipated|2019-08-30|January 1, 2019|Anticipated|2019-01-01||Interventional|||Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient|A Double-blind, Randomized and Controlled Trial to Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient|Recruiting||N/A|196|Anticipated|Korea University Anam Hospital||2|||f||||f|f|f||||||||2017-10-10 20:55:31.04085|2017-10-10 20:55:31.04085
NCT03196778|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Low Dose Hemi-body Radiation For Recurrent Prostate Cancer|Non-Targeted Low Dose Radiotherapy For Recurrent Prostate Cancer|Not yet recruiting||Phase 2|21|Anticipated|Juravinski Cancer Center||1|||f||||t|f|f||||||No|No plan to share IPD. Results to be reported as aggregate outcomes for the group.|2017-10-10 20:55:31.134592|2017-10-10 20:55:31.134592
NCT03196752|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-22|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Interventional|||Laryngeal Handshake for Identifying the Cricothyroid Membrane|Utility of the Laryngeal Handshake Method for Identifying the Cricothyroid Membrane|Recruiting||N/A|123|Anticipated|Seoul National University Hospital||1|||f||||f|f|f||||||No||2017-10-10 20:55:31.292236|2017-10-10 20:55:31.292236
NCT03196739|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-04|||June 20, 2017|Actual|2017-06-20|October 2017|2017-10-01|March 30, 2018|Anticipated|2018-03-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Feasibility of Virtual Reality Games Using Head-mounted Display on Patients With Brain Disorders|Feasibility of Virtual Reality Games Using Head-mounted Display on Patients With Brain Disorders|Recruiting||N/A|12|Anticipated|Seoul National University Hospital||1|||f|||||f|f||||||||2017-10-10 20:55:31.361898|2017-10-10 20:55:31.361898
NCT03196726|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||March 2, 2017|Actual|2017-03-02|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Behavioural Interventions for Postnatal Depression: a RCT Study|POSTNATAL DEPRESSION: Malaysia ASPIRE* Project PHASE 2|Recruiting||N/A|54|Anticipated|Ministry of Health, Malaysia||2|||f||||t|f|f||||||No|data sharing must be requested from Director General of Health Malaysia|2017-10-10 20:55:31.446311|2017-10-10 20:55:31.446311
NCT03196713|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||April 1, 2013|Actual|2013-04-01|June 2017|2017-06-01|October 27, 2017|Anticipated|2017-10-27|August 31, 2017|Anticipated|2017-08-31||Interventional|||Early Intervention, Supervision, Quality and Outcome in ASD|Quality and Efficacy of Early Intensive Autism Intervention: a Matter of Trust, Knowledge, and Supervision?|Active, not recruiting||N/A|34|Actual|Karolinska Institutet||2|||f||||f|f|f||||||No||2017-10-10 20:55:31.540678|2017-10-10 20:55:31.540678
NCT03196700|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||January 1, 2009|Actual|2009-01-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|January 1, 2017|Actual|2017-01-01||Interventional|||Short Course Radiation Therapy in Palliative Treatment|Short Course Accelerated Radiation Therapy in Palliative Treatment of Advanced Head and Neck Malignancies|Completed||N/A|48|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||t|f|f||||||Undecided||2017-10-10 20:55:31.607871|2017-10-10 20:55:31.607871
NCT03196687|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-06-22|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Frequency of Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetes Mellitus Type 2|Frequency of Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetes Mellitus Type 2|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||Undecided|This study will assess the prevelancea and frequency of diastolic dysfunction of the left ventricle in patients with asymptomatic type 2 DM and to explore its relation to other parameters, including patients' age, sex, the duration of diabetes and glycemic control.|2017-10-10 20:55:31.673687|2017-10-10 20:55:31.673687
NCT03196674|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-08|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Controlled Feedback on the Rehabilitation of Individuals With Disability Due to Stiff Shoulder Following Trauma|The Effect of Controlled Feedback on the Rehabilitation of Individuals With Disability Due to Stiff Shoulder Following Trauma|Not yet recruiting||N/A|30|Anticipated|Hadassah Medical Organization||2|||f|||||f|f||||||||2017-10-10 20:55:31.731233|2017-10-10 20:55:31.731233
NCT03196661|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-20|||November 6, 2015|Actual|2015-11-06|May 2017|2017-05-01|March 23, 2017|Actual|2017-03-23|July 5, 2016|Actual|2016-07-05||Interventional|||Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population|Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population|Completed||Phase 1|588|Actual|Hualan Biological Bacterin Co. Ltd.||4|||f||||f|f|f||||||||2017-10-10 20:55:31.805741|2017-10-10 20:55:31.805741
NCT03196648|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||May 1, 2015|Actual|2015-05-01|June 2017|2017-06-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Randomized Trial of a Gum Health Formulation|A Randomized Trial Evaluating the Efficacy of a Gum Health Formulation on Gingival Inflammation, Oral Malodor and Tooth Whitening|Completed||N/A|39|Actual|Glo Science, Inc.||3|||f||||f|f|f|||f|||No||2017-10-10 20:55:31.873406|2017-10-10 20:55:31.873406
NCT03196622|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-25|||July 11, 2017|Actual|2017-07-11|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|SARCSA||Validation of a Screening Test for Sarcopenia in Older People|Validation of a Screening Test of Sarcopenia in the Elderly People at Hospital and in Retirement Houses|Recruiting||N/A|1300|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 20:55:32.017593|2017-10-10 20:55:32.017593
NCT03196609|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-08-30|||February 6, 2017|Actual|2017-02-06|June 2017|2017-06-01|March 6, 2018|Anticipated|2018-03-06|February 6, 2018|Anticipated|2018-02-06||Interventional|Catalogue-Onco||Characteristics of the Intestinal Microbiota in Patients With Cancer|Characteristics of the Intestinal Microbiota in Patients With Cancer (Catalogue-Onco)|Recruiting||N/A|55|Anticipated|Centre Georges Francois Leclerc||1|||f|||||f|f||||||||2017-10-10 20:55:32.115285|2017-10-10 20:55:32.115285
NCT03196596|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-20|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|TAVIguide||Added Value of Patient-specific Computer Simulation in Transcatheter Aortic Valve Implantation (TAVI)|The Value of Patient-specific Computer Simulation in the Planning of TAVI With the Self-expanding Evolut R Valve|Recruiting||N/A|120|Anticipated|Erasmus Medical Center|||2||f||||f|f|f||||||No||2017-10-10 20:55:32.43571|2017-10-10 20:55:32.43571
NCT03196583|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|BVL Project||Efficacy of a Novel MAD in OSA|Open Label Pilot Exploratory Study of a New Mandibular Oral Device for Mild to Moderate Obstructive Sleep Apnea: The BVL Project|Recruiting||N/A|20|Anticipated|Ente Ospedaliero Cantonale, Bellinzona||1|||f||||t|f|f||||||No|IPD will not be made available to researchers not pertaining to this project.|2017-10-10 20:55:32.911327|2017-10-10 20:55:32.911327
NCT03196570|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-20|||October 15, 2017|Anticipated|2017-10-15|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|April 1, 2019|Anticipated|2019-04-01||Interventional|||Increasing Physical Activity in Latino Men|Increasing Physical Activity in Latino Men Through Tailoring|Not yet recruiting||N/A|50|Anticipated|University of Connecticut||2|||f||||f|f|f||||||Undecided||2017-10-10 20:55:33.087044|2017-10-10 20:55:33.087044
NCT03196557|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-21|||March 31, 2008|Actual|2008-03-31|June 2017|2017-06-01|May 5, 2008|Actual|2008-05-05|May 5, 2008|Actual|2008-05-05||Interventional|||A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject|An Experimental Medicine Study to Assess the Pharmacodynamics Following Administration of Multiple Doses of Prednisolone to Healthy Male Subjects|Completed||Phase 1|24|Actual|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 20:55:33.181322|2017-10-10 20:55:33.181322
NCT03196544|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Novel Behavioral Intervention to Enhance Social Connections in Anxiety and Depression|Novel Behavioral Intervention to Target Social Reward Sensitivity and Attachment|Not yet recruiting||N/A|60|Anticipated|University of California, San Diego||3|||f||||t|f|f||||||Yes||2017-10-10 20:55:33.31974|2017-10-10 20:55:33.31974
NCT03196518|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-21|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer|PET Imaging of Thyroid Tissue Expressing Sodium-iodine Symporter Using the New Tracer 18F-tetrafluoroborate (18F-TFB)|Recruiting||N/A|5|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||f|f|||f|||||2017-10-10 20:55:33.556066|2017-10-10 20:55:33.556066
NCT03196505|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-24|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|Exparel||The Effect of Liposomal Bupivacaine on Post Operative Pain and Narcotic Use After Bariatric Surgery|The Effect of Liposomal Bupivacaine on Post Operative Pain and Narcotic Use After Bariatric Surgery|Not yet recruiting||Phase 4|200|Anticipated|University of California, San Francisco||2|||f||||t|t|f|||f|||||2017-10-10 20:55:33.683031|2017-10-10 20:55:33.683031
NCT03196492|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-27|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|June 14, 2019|Anticipated|2019-06-14|June 14, 2019|Anticipated|2019-06-14||Observational|AIMS||Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women|Effect of Injectable Contraceptives on Inflammation, Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women|Recruiting||N/A|80|Anticipated|Johns Hopkins University|||2||f||||f|f|f||||||No||2017-10-10 20:55:33.8119|2017-10-10 20:55:33.8119
NCT03196479|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-04|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|June 30, 2017|Actual|2017-06-30||Interventional|||Comparison Between Efficacy of Ketamine and Propofol Mixture With 1:6 Ratio and 1:4 Ratio for Endoscopic Retrograde Procedure Sedation|Comparison Between Efficacy of Ketamine and Propofol Mixture With 1:6 Ratio and 1:4 Ratio for Endoscopic Retrograde Procedure Sedation|Completed||N/A|58|Actual|Indonesia University||2|||f|||||f|f||||||||2017-10-10 20:55:33.910443|2017-10-10 20:55:33.910443
NCT03196466|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-03|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|EPIPOP||Population Pharmacokinetics of Antiepileptic in Pediatrics|Population Pharmacokinetics of Antiepileptic in Pediatrics|Recruiting||N/A|1000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||||2017-10-10 20:55:34.037774|2017-10-10 20:55:34.037774
NCT03196453|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|FITCHI||Fit Child - Clinical Study on Weight Control|Sopusuhtainen Lapsi - Kliininen Tutkimus Painonhallinnasta|Not yet recruiting||N/A|45|Anticipated|Turku University Hospital||3|||f||||t|f|f||||||No|IPD will be shared once the study has been completed and analysed|2017-10-10 20:55:34.172872|2017-10-10 20:55:34.172872
NCT03196440|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-03|||July 7, 2015|Actual|2015-07-07|July 2016|2016-07-01|July 9, 2018|Anticipated|2018-07-09|January 31, 2018|Anticipated|2018-01-31||Observational|TASTE||Sensitivity of Basic Taste in Elderly|Thresholds Analysis of Five Basic Tastes in the Elderly Population|Recruiting||N/A|300|Anticipated|Hospital Israelita Albert Einstein|||1||f||||t|f|f||||||||2017-10-10 20:55:34.307138|2017-10-10 20:55:34.307138
NCT03196427|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||November 10, 2017|Anticipated|2017-11-10|June 2017|2017-06-01|June 14, 2025|Anticipated|2025-06-14|February 8, 2025|Anticipated|2025-02-08||Interventional|||Long-term Safety With Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease|A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease|Not yet recruiting||Phase 2|80|Anticipated|Takeda||2|||f||||t|t|f||||||||2017-10-10 20:55:34.42505|2017-10-10 20:55:34.42505
NCT03196414|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-06-21|||September 2016||2016-09-01|September 2016|2016-09-01|December 2026|Anticipated|2026-12-01|September 2026|Anticipated|2026-09-01||Interventional|||Study of CART-138/BCMA Therapy for R/R Multiple Myeloma|Study of T Cells Targeting CD138/BCMA (CART-138/BCMA) for Chemotherapy Refractory and Relapsed Multiple Myeloma|Recruiting||Phase 1/Phase 2|10|Anticipated|The First Affiliated Hospital of Soochow University||1|||f||||f||||||||No||2017-10-10 20:55:34.531378|2017-10-10 20:55:34.531378
NCT03196401|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-18|||July 27, 2017|Actual|2017-07-27|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma|A Pilot Study to Evaluate for the Abscopal Effect of Durvalumab (Anti-PD-L1) in Combination With Definitive Radiation Therapy in Solitary Bone Plasmacytoma With Limited Clonal Bone Marrow Plasmacytosis|Suspended||Phase 1|20|Anticipated|Memorial Sloan Kettering Cancer Center||1||FDA recommendation|f|||||t|f||||||||2017-10-10 20:55:34.61877|2017-10-10 20:55:34.61877
NCT03196388|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||June 2017|Anticipated|2017-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ENZART||Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer|Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer|Not yet recruiting||Phase 2|70|Anticipated|Fundación Canaria de Investigación Sanitaria||1|||f||||t|f|f||||||||2017-10-10 20:55:34.728787|2017-10-10 20:55:34.728787
NCT03196362|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes|Impacts of Sequential Treatment Using Fixed Dose Pioglitazone/Metformin Combination Following Short-term Intensive Insulin Treatment on Long-term Blood Glucose Control and β-Cell Function in Patients With Newly Diagnosed Type 2 Diabetes|Recruiting||Phase 4|50|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||No||2017-10-10 20:55:34.951751|2017-10-10 20:55:34.951751
NCT03196349|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 1, 2021|Anticipated|2021-10-01|July 1, 2021|Anticipated|2021-07-01||Interventional|COVET||Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism|Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism (COVET)|Not yet recruiting||Phase 3|3165|Anticipated|Duke University||3|||f||||t|t|f|||f|||Undecided||2017-10-10 20:55:35.06306|2017-10-10 20:55:35.06306
NCT03196336|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-06-26|||March 2015||2015-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Pharmacotherapy Follow-up Care in Outpatients With Type 2 Diabetes Mellitus|Effectiveness of Pharmacotherapy Follow-up Care in Outpatients With Type 2 Diabetes Mellitus: Randomized Clinical Trial|Active, not recruiting||N/A|60|Actual|University of Sorocaba||2|||f||||f||||||||No|not applied|2017-10-10 20:55:35.141122|2017-10-10 20:55:35.141122
NCT03196323|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-23|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Development of a Behavioral Outcome Measure for Rett Syndrome (RettBe)|Development of a Behavioral Outcome Measure for Rett Syndrome (RettBe)|Recruiting||N/A|400|Anticipated|University of South Florida|||2||f||||t|f|f||||||No||2017-10-10 20:55:35.211842|2017-10-10 20:55:35.211842
NCT03196310|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-21|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Single Blinded First CMC Osteoarthritis Treatment|Randomized Single Blinded First CMC Osteoarthritis Treatment: Therapy and Bracing Alone vs. Intra-Articular Corticosteroid Injection vs Intra-Articular Leukocyte Depleted Platelet Rich Plasma|Not yet recruiting||N/A|150|Anticipated|Kettering Health Network||3|||f|||||f|f||||||||2017-10-10 20:55:35.289437|2017-10-10 20:55:35.289437
NCT03196297|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-28|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|August 9, 2019|Anticipated|2019-08-09|June 15, 2018|Anticipated|2018-06-15||Interventional|explorer™5||A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors|A Multi-Centre Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors|Recruiting||Phase 2|33|Anticipated|Novo Nordisk A/S||1|||f||||t|t|f||||||||2017-10-10 20:55:35.362125|2017-10-10 20:55:35.362125
NCT03196284|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-28|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|October 23, 2019|Anticipated|2019-10-23|August 29, 2018|Anticipated|2018-08-29||Interventional|explorer™4||A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors|A Multi-Centre, Randomised, Open-Label, Controlled Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors|Recruiting||Phase 2|26|Anticipated|Novo Nordisk A/S||2|||f||||t|t|f||||||||2017-10-10 20:55:35.49663|2017-10-10 20:55:35.49663
NCT03196271|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-20|||January 4, 2017|Actual|2017-01-04|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ketogenic Diet Drink Study|Evaluating the Tolerance, Compliance, Acceptability and Safety of Ketocal 2.5:1 LQ, a Nutritionally Complete Liquid Feed for Use as Part of the Ketogenic Diet (KD) in Children 8+ Years, Adolescents and Adults With Intractable Epilepsy or Other Disorders Where the KD is Indicated|Recruiting||N/A|40|Anticipated|Nutricia UK Ltd||1|||f||||f|f|f||||||No||2017-10-10 20:55:35.625386|2017-10-10 20:55:35.625386
NCT03196258|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-20|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|SPOC_CBT||Cognitive Behavioural Therapy to Reduce Persistent Post-Surgical Pain After Fracture|Cognitive Behavioural Therapy to Reduce Persistent Post-Surgical Pain Following Internal Fixation of Extremity Fractures: A Randomized Controlled Trial (SPOC-CBT)|Not yet recruiting||N/A|40|Anticipated|McMaster University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:55:35.761877|2017-10-10 20:55:35.761877
NCT03196245|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-03|||August 14, 2012|Actual|2012-08-14|October 2017|2017-10-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|Flu vaccine||NK Cell Mediated Influenza Immunity During Pregnancy|NK Cell Mediated Influenza Immunity During Pregnancy|Active, not recruiting||N/A|94|Actual|Stanford University|||1||f||||f|f|f||||Samples Without DNA|"     We have peripheral blood mononuclear cells and plasma from a small number of subjects banked     for future assessment of immunologic function, as specified in our consent.   "|||2017-10-10 20:55:35.877915|2017-10-10 20:55:35.877915
NCT03196232|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer|Phase II Study of Epacadostat (INCB024360) With Pembrolizumab (MK3475) in Metastatic or Unresectable Gastroesophageal Junction and Gastric Adenocarcinoma Requiring Paired Biopsies|Recruiting||Phase 2|30|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 20:55:35.94884|2017-10-10 20:55:35.94884
NCT03196219|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-07-17|||July 7, 2017|Actual|2017-07-07|June 2017|2017-06-01|December 22, 2017|Anticipated|2017-12-22|December 22, 2017|Anticipated|2017-12-22||Interventional|C3J17-206-00||A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects|A Phase 2, Open-label and Single-Blind Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects|Recruiting||Phase 2|26|Anticipated|C3 Jian, LLC||3|||f||||f|t|f||||||||2017-10-10 20:55:36.043714|2017-10-10 20:55:36.043714
NCT03196206|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-21|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment|An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of BMS- 986177 in Participants With Normal Renal Function and Participants With Moderate and Severe Renal Impairment|Not yet recruiting||Phase 1|24|Anticipated|Bristol-Myers Squibb||3|||f|||||t|f||||||||2017-10-10 20:55:36.12548|2017-10-10 20:55:36.12548
NCT03196193|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-25|||March 21, 2017|Actual|2017-03-21|June 2017|2017-06-01|January 31, 2019|Anticipated|2019-01-31|October 15, 2018|Anticipated|2018-10-15||Interventional|||CM Asia Nail With AS2 Without AS2 （AS2 Study）|Randomized Controlled Study Comparing Zimmer Natural Nail System Cephalomedullary Asia Nail With Anterior Support Screw (AS2) Versus Conventional Technique|Recruiting||N/A|240|Anticipated|Zimmer Biomet||2|||f||||f|f|t|f|f|t|||No||2017-10-10 20:55:36.20693|2017-10-10 20:55:36.20693
NCT03196180|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-09-25|||October 15, 2017|Anticipated|2017-10-15|June 2017|2017-06-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia|A Phase I Safety and Dose-Finding Trial of Alternate-Weekly, Self-Administered, Intravaginal Application of 5-Fluorouracil and Imiquimod for Treatment of High-Grade Cervical Intraepithelial Lesions|Not yet recruiting||Phase 1|34|Anticipated|National Cancer Institute (NCI)||1|||f||||t|t|f||||||||2017-10-10 20:55:36.300709|2017-10-10 20:55:36.300709
NCT03196167|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-26|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Sugammadex and Decreased Time to Extubation|Efficacy and Safety of Sugammadex to Shorten Time-to-extubation Among Postoperative ICU Patients Following Isolated CABG Surgery: A Prospective Randomized Placebo-controlled Trial|Not yet recruiting||Phase 4|110|Anticipated|Yale University||2|||f||||t|t|f|||t|||Undecided||2017-10-10 20:55:36.384047|2017-10-10 20:55:36.384047
NCT03196154|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-06|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|InsuReB||Association Between Insulin Resistance and Beta Cell Function With HbA1C in Diabetics|Cross-Sectional Study on Association Between the Estimation of Insulin Resistance and Beta Cell Function Through Homeostasis Model Assessment With HbA1C Among Oral Anti-Diabetics Treatment Non-Responders|Recruiting||N/A|250|Anticipated|Clinical Research Centre, Malaysia|||2||f||||f|f|f||||Samples Without DNA|"     Blood plasma serum   "|||2017-10-10 20:55:38.148258|2017-10-10 20:55:38.148258
NCT02889263|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-02||||||August 2016|2016-08-01||||September 2014|Actual|2014-09-01||Observational|REHOSP||Comparison of Rehospitalization Rates in France and the United States|Comparison of Rehospitalization Rates in France and the United States|Completed||N/A|1944566|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||f||||||||||2017-10-10 21:50:53.444555|2017-10-10 21:50:53.444555
NCT03196141|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||February 27, 2017|Actual|2017-02-27|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Utilization of Somatic Tissue Oxygen Saturation Monitoring in Pregnant Women|Perioperative Clinical Utilization of Somatic Tissue Oxygen Saturation Monitoring in Pregnant Women|Recruiting||N/A|35|Anticipated|Yale University||3|||f||||f|f|t|f|f|t|||No||2017-10-10 20:55:38.276328|2017-10-10 20:55:38.276328
NCT03196128|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 30, 2018|Anticipated|2018-01-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Early Intervention Psychosis Communication and Engagement Trial|Digital Media Versus Standard Method of Communication to Examine Engagement of Patients in Community Early Intervention Psychosis (EIP) Services|Recruiting||N/A|40|Anticipated|South London and Maudsley NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 20:55:38.397108|2017-10-10 20:55:38.397108
NCT03196115|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-03|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Observational|BioHFS||BioHFS - Biomarker for Hyaline Fibromatosis Syndrome|Biomarker for Hyaline Fibromatosis Syndrome - An International, Multicenter, Epidemiological Protocol - BioHFS|Recruiting||N/A|20|Anticipated|University of Rostock|||1||f||||t|f|f||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectrometry 7,5 ml     EDTA blood and/or a dry blood spot filter card are taken. To proof the correct diagnosis in     those patients where up to the enrollment in the study no genetic testing has been done,     sequencing of Hyaline fibromatosis syndrome will be done.   "|||2017-10-10 20:55:38.468822|2017-10-10 20:55:38.468822
NCT03196102|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||April 5, 2017|Actual|2017-04-05|June 2017|2017-06-01|May 5, 2018|Anticipated|2018-05-05|April 5, 2018|Anticipated|2018-04-05||Interventional|||Evaluation of a Brief Tobacco Intervention in the US Military|Evaluation of a Brief Tobacco Intervention in the US Military|Recruiting||N/A|3000|Anticipated|University of Tennessee||3|||f||||f|f|f||||||No||2017-10-10 20:55:38.549082|2017-10-10 20:55:38.549082
NCT03196089|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Short-term Oxygen During CPET in COPD|Effect of Short-term Oxygen Therapy on Cardiopulmonary Exercise (CPET) Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 2|20|Anticipated|University of Zurich||2|||f||||f|f|f||||||No||2017-10-10 20:55:38.677925|2017-10-10 20:55:38.677925
NCT03196076|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-13|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|December 3, 2018|Anticipated|2018-12-03|August 3, 2018|Anticipated|2018-08-03||Interventional|CEUS-CKDx||Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension|Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension (CEUS CKDx)|Recruiting||Phase 2|28|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f|t|f||||||||2017-10-10 20:55:38.769949|2017-10-10 20:55:38.769949
NCT03196063|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-08-21|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Effectiveness of Two Exercise Protocols in the Treatment of Patients With Patellar Tendinopathy|Effectiveness of Two Exercise Protocols in the Treatment of Patients With Patellar Tendinopathy: a Randomized Controlled Trial|Recruiting||N/A|68|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:55:38.863088|2017-10-10 20:55:38.863088
NCT03196050|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Telemonitoring of Geriatric Cancer Patients Using Handheld Devices|Telemonitoring of Geriatric Cancer Patients Using Handheld Devices (TeleGraPH)|Recruiting||N/A|50|Anticipated|Universitätsmedizin Mannheim||1|||f||||f|f|f||||||No||2017-10-10 20:55:38.962693|2017-10-10 20:55:38.962693
NCT03196037|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors|Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors|Not yet recruiting||N/A|15|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-10 20:55:39.042391|2017-10-10 20:55:39.042391
NCT03196024|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Corazon de la Familia (Heart of the Family)|A Randomized Controlled Trial to Examine a Healthy Lifestyle Intervention With Families to Prevent Cardiovascular Disease and Type 2 Diabetes in Hispanics/Latinos|Not yet recruiting||N/A|440|Anticipated|University of Kentucky||2|||f||||f|f|f||||||Yes|De-identified data from this study will be made available after completion of analyses for primary and secondary outcomes, and publications and research presentations that address the specific aims and major secondary analyses of the study. Data will be submitted to the Inter-university Consortium for Political and Social Research (ICPSR), a unit of the Institute for Social Research at the University of Michigan. The PI will remove all direct and indirect identifiers from the study data before submitting data to ICPSR. The ICPSR also carefully reviews submitted datasets to assure confidentiality of human subjects is preserved. All de-identified data housed by ICPSR are available to over 759 member institutions as well as to other institutions and individuals. Should access to data from this study be restricted to member institutions, the PI will, on request, provide the de-identified dataset and accompanying documentation to requesters.|2017-10-10 20:55:39.237272|2017-10-10 20:55:39.237272
NCT03196011|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-07-03|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2024|Anticipated|2024-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Traditional Versus Alternative Alignment in TKR|A Prospective, Randomised, Controlled Study of the Outcomes and Cost Effectiveness of Triathlon CR Knee Replacement System: Traditional Instruments Versus Alternative Alignment Manual Instruments.|Not yet recruiting||N/A|126|Anticipated|Royal Devon and Exeter NHS Foundation Trust||2|||f||||t|f|f||||||||2017-10-10 20:55:39.360836|2017-10-10 20:55:39.360836
NCT03195998|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Observational|TcB||Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants|Determining the Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants With a Gestational Age of 23 0/7 - 34 6/7 Weeks|Not yet recruiting||N/A|60|Anticipated|Mednax Center for Research, Education and Quality|||2||f|||||f|f||||||No||2017-10-10 20:55:39.520951|2017-10-10 20:55:39.520951
NCT03195985|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-06-20|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Mindfulness in Old Adults With Subjective Cognitive Complaints|Managing Stress and Cognitive Difficulties With a Short Mindfulness-based Intervention in Old Adults With Subjective Cognitive Complaints|Not yet recruiting||N/A|20|Anticipated|Chelsea and Westminster NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 20:55:39.621202|2017-10-10 20:55:39.621202
NCT03195972|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-20|||December 23, 2016|Actual|2016-12-23|June 2017|2017-06-01|March 23, 2018|Anticipated|2018-03-23|December 23, 2017|Anticipated|2017-12-23|3 Months|Observational [Patient Registry]|ObservAG||Observational Study to Assess Adherence Oral Anticancer Therapies|Observational Study to Assess Adherence of Oral Anticancer Therapies|Recruiting||N/A|200|Anticipated|Centre Georges Francois Leclerc|||1||f||||f|f|f||||||No||2017-10-10 20:55:39.708526|2017-10-10 20:55:39.708526
NCT03195959|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-22|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension|Effect of Normobaric Hypoxia and Hyperoxia on Pulmonary Hemodynamics in Patients With Pulmonary Hypertension|Recruiting||N/A|50|Anticipated|University of Zurich|||2||f||||f|f|f||||||No||2017-10-10 20:55:39.783234|2017-10-10 20:55:39.783234
NCT03195946|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes|Interventional, Open-label, Multiple-dose Study to Investigate the Effects of Multiple Doses of Lu AF35700 on the Pharmacokinetics of Cytochrome P450 (CYP450) Substrates Dextromethorphan (CYP2D6), Caffeine (CYP1A2), Omeprazole (CYP2C19), and Midazolam (CYP3A4/5) in Healthy Young Adults|Recruiting||Phase 1|24|Anticipated|H. Lundbeck A/S||1|||f||||f|f|f||||||No||2017-10-10 20:55:39.876872|2017-10-10 20:55:39.876872
NCT03195933|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-21|||July 31, 2013|Actual|2013-07-31|June 2017|2017-06-01|May 19, 2016|Actual|2016-05-19|May 19, 2016|Actual|2016-05-19||Interventional|DASH||Depression, Adversity, and Stress Hormones (DASH) Study|Learning, Neural Signaling of Cortisol, and Early Adversity in Depression|Completed||N/A|85|Actual|University of Wisconsin, Madison||2|||f||||f|f|f|||f|||Yes|We will make our data publicly available on a password protected website after the data are collected and analyzed, and manuscripts presenting data testing our hypotheses are accepted for publication. These data will be thoroughly de-identified. Several classes of data will be made available, including self-report, behavioral, diagnostic, hormonal, and summary data from our physiological and imaging datasets.|2017-10-10 20:55:39.971357|2017-10-10 20:55:39.971357
NCT03195920|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease|Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease|Recruiting||N/A|40|Anticipated|Applaud Medical, Inc.||1|||f||||f|f|f||||||Undecided||2017-10-10 20:55:40.077958|2017-10-10 20:55:40.077958
NCT03195907|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||February 1, 2015|Actual|2015-02-01|June 2017|2017-06-01|January 1, 2016|Actual|2016-01-01|January 1, 2016|Actual|2016-01-01||Observational|||Pulmonary Physiotherapy for Ischemic Stroke|Predictors of Intensive Care Unit Admission and Mortality in Patients With Ischemic Stroke: Investigating the Effects of a Pulmonary Rehabilitation Program|Completed||N/A|181|Actual|Bezmialem Vakif University|||2||f||||f|f|f||||||No|The datasets during and/or analysed during the current study available from the corresponding author on reasonable request.|2017-10-10 20:55:40.169566|2017-10-10 20:55:40.169566
NCT03195894|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-21|||November 8, 2015|Actual|2015-11-08|June 2017|2017-06-01|January 15, 2018|Anticipated|2018-01-15|August 15, 2017|Anticipated|2017-08-15||Interventional|||Clinical Study of TripleA for Treatment of Alcohol Addiction in Outpatient Care|Clinical Study of TripleA Connected to Diagnosis, Care and Aftercare of Alcohol Addiction in Outpatient Care|Active, not recruiting||N/A|210|Anticipated|Kontigo Care AB||2|||f||||f|f|f||||||No||2017-10-10 20:55:40.254846|2017-10-10 20:55:40.254846
NCT03195881|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-21|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|PANDORA||Neuroprognostication Using Optic Nerve Sheath Diameter|Post Cardiac Arrest Neuroprognostication Using the Diameter of Optic Nerve Sheath Via Ocular ultRAsound|Recruiting||N/A|62|Anticipated|TriHealth Inc.|||1||f||||f|f|f||||||No||2017-10-10 20:55:40.347592|2017-10-10 20:55:40.347592
NCT03195868|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-20|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy|A Comparative Analysis of Changes in Peripheral Nerve Density and Structure Following Photobiomodulation Therapy Using the REALief Therapy System for Patients With Diabetic or Chemotherapy-associated Neuropathy|Not yet recruiting||N/A|44|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f|f|f|||f|||||2017-10-10 20:55:40.447135|2017-10-10 20:55:40.447135
NCT03195855|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-22|||November 1, 2017|Anticipated|2017-11-01|June 2017|2017-06-01|January 2, 2020|Anticipated|2020-01-02|November 1, 2019|Anticipated|2019-11-01||Interventional|||Foot and Ankle Mobilisation in Diabetic Peripheral Neuropathy|The Effects of Foot and Ankle Joint Mobilisation Combined With a Home Programme of Ankle Stretches on Joint Range of Motion and Forefoot Peak Plantar Pressures in People With Diabetic Peripheral Neuropathy: a Randomized Controlled Trial|Not yet recruiting||N/A|58|Anticipated|University of Plymouth||2|||f||||t|f|f||||||No||2017-10-10 20:55:40.529344|2017-10-10 20:55:40.529344
NCT03195842|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||March 10, 2016|Actual|2016-03-10|June 2017|2017-06-01|September 26, 2016|Actual|2016-09-26|September 26, 2016|Actual|2016-09-26||Interventional|||Audio-Recorded Discharge Instructions for LEP Parents|Impact of Audio-Recorded Discharge Instructions on Confidence and Comprehension Among Limited English Proficient Parents: A Pilot Randomized Trial|Completed||N/A|83|Actual|Seattle Children's Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:55:40.606674|2017-10-10 20:55:40.606674
NCT03195829|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-20|||December 2015||2015-12-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PSCogStim||Feasibility Study of a Computerized Cognitive Stimulation|A Computerized Cognitive Stimulation Program in Elderly With Mild Cognitive Impairment: A Feasibility Study|Completed||N/A|20|Actual|Broca Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:55:40.670604|2017-10-10 20:55:40.670604
NCT03186469|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-13|||October 7, 2014|Actual|2014-10-07|July 2017|2017-07-01|October 31, 2019|Anticipated|2019-10-31|April 30, 2019|Anticipated|2019-04-30||Interventional|GIFTSS||Generations in Families Talking Safe Sleep|Generations in Families Talking Safe Sleep|Recruiting||N/A|387|Anticipated|Arkansas Children's Hospital Research Institute||3|||f||||f|f|f||||||||2017-10-10 20:57:06.291535|2017-10-10 20:57:06.291535
NCT03195816|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-20|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||A Computer-based Cognitive Stimulation in Mild Cognitive Impairment With White Matter Hyperintensities|Effects of a Computer-based Cognitive Stimulation on the Verbal Learning and the Progression of White Matter Hyperintensities in Mild Cognitive Impairment: A Protocol for a Randomized Controlled Trial.|Not yet recruiting||N/A|90|Anticipated|Broca Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:55:40.74166|2017-10-10 20:55:40.74166
NCT03195803|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-20|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Cognitive Intervention in Mild Cognitive Impairment With or Without White Matter Hyperintensities|Evaluation of Differential Effects of a Computer-based-cognitive Intervention on Cognition Among Elderly With Mild Cognitive Impairment With and Without White Matter Hyperintensities: A Comparative Study.|Completed||N/A|51|Actual|Broca Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:55:40.809583|2017-10-10 20:55:40.809583
NCT03195790|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-08-08|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|CHECK||Creating Healthy Environments for Chicago Kids|Value and Mechanisms of Home Visitation in Obesity Interventions for Low-income Children|Recruiting||N/A|266|Anticipated|Rush University Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:55:40.889323|2017-10-10 20:55:40.889323
NCT03195777|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-08-28|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|June 30, 2022|Anticipated|2022-06-30|March 31, 2022|Anticipated|2022-03-31||Interventional|||Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT|Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT|Not yet recruiting||N/A|80|Anticipated|Massachusetts General Hospital||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:55:41.011812|2017-10-10 20:55:41.011812
NCT03195764|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-18|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors|A Phase I Safety and Tolerability Study of T-1101 (Tosylate) as a Oral Powder for Constitution (OPC) in Patients With Advanced Refractory Solid Tumors|Enrolling by invitation||Phase 1|40|Anticipated|Taivex Therapeutics Corporation||1|||f|||||f|f||||||||2017-10-10 20:55:41.160049|2017-10-10 20:55:41.160049
NCT03195751|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-05|||September 13, 2017|Actual|2017-09-13|October 2017|2017-10-01|September 23, 2017|Actual|2017-09-23|September 23, 2017|Actual|2017-09-23||Observational|||Wearable Technology in Shoulder Range of Motion|Wearable Technology in Shoulder Range of Motion: Validation of a Motion-Based Software Development Kit|Completed||N/A|10|Actual|The Cleveland Clinic|||2||f|||||f|f||||||||2017-10-10 20:55:41.238734|2017-10-10 20:55:41.238734
NCT03195738|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-22|||July 25, 2014|Actual|2014-07-25|June 2017|2017-06-01|July 1, 2016|Actual|2016-07-01|March 30, 2016|Actual|2016-03-30||Interventional|||Feasibility of a Cognitive Intervention for Youth Post Concussion|Feasibility and Effects of the CO-OP Approach for Post-concussion Rehabilitation|Completed||N/A|3|Actual|Holland Bloorview Kids Rehabilitation Hospital||1|||f||||f|f|f||||||No||2017-10-10 20:55:41.318064|2017-10-10 20:55:41.318064
NCT03195725|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||How is the Term 'Harm' Being Interpreted and Documented on Hospice DNACPR Forms Following the Tracey Judgement?|How is the Term 'Harm' Being Interpreted and Documented on Hospice DNACPR Forms Following the Tracey Judgement?|Not yet recruiting||N/A|300|Anticipated|The Royal Wolverhampton Hospitals NHS Trust|||2||f||||f|f|f||||||No||2017-10-10 20:55:41.400607|2017-10-10 20:55:41.400607
NCT03195712|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-19|||September 4, 2012|Actual|2012-09-04|June 2017|2017-06-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Observational|||Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers|Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers in Class II and III Obesity|Completed||N/A|691|Actual|St. Luke's-Roosevelt Hospital Center|||1||f|||||f|f||||||||2017-10-10 20:55:41.478079|2017-10-10 20:55:41.478079
NCT03195686|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-09-13|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 29, 2018|Anticipated|2018-06-29||Observational|||Efficacy of PLEM100(Inbody®) in Children|Efficacy of PLEM100(Inbody®) to Measure the the Sedation Level in Pediatric Patients|Recruiting||N/A|30|Anticipated|Seoul National University Hospital|||1||f||||f|f|f||||||||2017-10-10 20:55:41.660114|2017-10-10 20:55:41.660114
NCT03195673|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 15, 2019|Anticipated|2019-07-15|July 15, 2018|Anticipated|2018-07-15||Interventional|TZ-CAS||Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting|A Pilot Study Assessing the Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting|Not yet recruiting||Phase 2|60|Anticipated|Capital Medical University||2|||f||||t|f|f||||||Yes||2017-10-10 20:55:41.739034|2017-10-10 20:55:41.739034
NCT03195660|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-08|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|CAT-PEF||Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study|Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study|Active, not recruiting||N/A|2|Actual|ResMed||1|||f||||f|f|t|f|f|f|||||2017-10-10 20:55:41.831243|2017-10-10 20:55:41.831243
NCT03195647|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-19|||August 1, 2017|Anticipated|2017-08-01|March 2017|2017-03-01|February 28, 2018|Anticipated|2018-02-28|January 30, 2018|Anticipated|2018-01-30||Interventional|TightK||Pilot Study for the Tight K Study|PILOT STUDY for the Tight K TRIAL. Arrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter?|Not yet recruiting||Phase 3|160|Anticipated|Queen Mary University of London||2|||f||||t|f|f|||f|||Undecided||2017-10-10 20:55:41.917813|2017-10-10 20:55:41.917813
NCT03195634|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-21|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|||WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver Cirrhosis|WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver Cirrhosis|Not yet recruiting||N/A|80|Anticipated|Shanghai Changzheng Hospital|||1||f||||t|f|f||||Samples Without DNA|"     serum   "|No||2017-10-10 20:55:42.015767|2017-10-10 20:55:42.015767
NCT03195621|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-21|2017-06-21|||July 1, 2016|Actual|2016-07-01|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|CTCAD||Critical Treatment of Coronary Artery Disease|Treatment Strategy for Critical Lesions of Coronary Artery Disease|Recruiting||N/A|200|Anticipated|Southeast University, China||2|||f||||t|f|f||||||Undecided|We do not decide whether to share individual participant data|2017-10-10 20:55:42.091024|2017-10-10 20:55:42.091024
NCT03195608|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|February 20, 2018|Anticipated|2018-02-20|December 31, 2017|Anticipated|2017-12-31||Interventional|||Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disease|Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disease|Not yet recruiting||N/A|20|Anticipated|Western University, Canada||1|||f||||f|f|f||||||No||2017-10-10 20:55:42.174682|2017-10-10 20:55:42.174682
NCT03195595|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-21|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|||Minimal Invasive Mitral Valve Replacement Versus Conventional Median Sternotomy Approach|Minimal Invasive Mitral Valve Replacement Versus Conventional Median Sternotomy Approach|Recruiting||N/A|30|Anticipated|Assiut University|||2||f|||||f|f||||||No||2017-10-10 20:55:42.247603|2017-10-10 20:55:42.247603
NCT03195582|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Chlorohexidine Gel on Tissue Healing Following Surgical Exposure of Dental Implants|The Effect of Chlorohexidine Gel on Tissue Healing Following Surgical Exposure of Dental Implants|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Rambam Health Care Campus||2|||f|||||f|f||||||No||2017-10-10 20:55:42.326785|2017-10-10 20:55:42.326785
NCT03195569|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|December 10, 2018|Anticipated|2018-12-10|June 12, 2018|Anticipated|2018-06-12|1 Year|Observational [Patient Registry]|||To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer|To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer|Recruiting||N/A|15|Anticipated|Qilu Pharmaceutical Co., Ltd.|||2||f||||f|t|f|||f|||||2017-10-10 20:55:42.404298|2017-10-10 20:55:42.404298
NCT03195556|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Augmentation of Limb Perfusion With Contrast Ultrasound|Augmentation of Limb Perfusion With Contrast Ultrasound|Not yet recruiting||N/A|30|Anticipated|Oregon Health and Science University||2|||f||||t|f|f|||f|||No||2017-10-10 20:55:42.518639|2017-10-10 20:55:42.518639
NCT03195543|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-19|||March 12, 2015|Actual|2015-03-12|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension|Assessment of Blood Coagulation Disorders in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.|Recruiting||N/A|60|Anticipated|National and Kapodistrian University of Athens|||2||f|||||f|f||||||No||2017-10-10 20:55:42.610138|2017-10-10 20:55:42.610138
NCT03195530|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Bispectral Index (BIS) Values Required for an Adequate Depth of Anesthesia in Elderly Patients Using Propofol|Bispectral Index (BIS) Values Required for an Adequate Depth of Anesthesia in Elderly Patients Using Propofol, According to the Caracteristic Electroencephalographic Pattern|Not yet recruiting||N/A|19|Anticipated|Pontificia Universidad Catolica de Chile|||1||f||||t|f|f||||||No||2017-10-10 20:55:42.749103|2017-10-10 20:55:42.749103
NCT03195517|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-22|||May 2015||2015-05-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Physical Training on Bone Turnover and Quality of Life in Osteopenic Postmenopausal Women.||Completed||N/A|33|Actual|University Of Perugia||2|||f||||||||||||||2017-10-10 20:55:42.823757|2017-10-10 20:55:42.823757
NCT03195504|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-19|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||High-flow Nasal Oxygenation in Obese Patients During Apnea|Effectiveness of Apneic Oxygenation Using High-flow Nasal Cannula in Morbidly Obese Patients Undergoing General Anesthesia|Not yet recruiting||N/A|40|Anticipated|University Health Network, Toronto||2|||f||||f|f|f||||||Undecided||2017-10-10 20:55:42.893815|2017-10-10 20:55:42.893815
NCT03195491|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-03|||October 26, 2017|Anticipated|2017-10-26|October 2017|2017-10-01|July 30, 2020|Anticipated|2020-07-30|July 29, 2020|Anticipated|2020-07-29||Interventional|CheckMate870||A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia|An Open Label, Safety Study of Participants With Non-Small Cell Lung Cancer Receiving Second-Line Nivolumab Monotherapy in Asia|Not yet recruiting||Phase 3|400|Anticipated|Bristol-Myers Squibb||1|||f||||f|f|f||||||||2017-10-10 20:55:42.977647|2017-10-10 20:55:42.977647
NCT03195478|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-26|||July 27, 2017|Actual|2017-07-27|September 2017|2017-09-01|June 25, 2020|Anticipated|2020-06-25|November 26, 2019|Anticipated|2019-11-26||Interventional|||Study of Nivolumab in Combination With Ipilimumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors|A Phase 1 Study of Nivolumab (BMS-936558) in Combination With Ipilimumab (BMS-734016) in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors|Recruiting||Phase 1|27|Anticipated|Bristol-Myers Squibb||3|||f||||f|t|f|||t|||||2017-10-10 20:55:43.130541|2017-10-10 20:55:43.130541
NCT03195465|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder|The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder|Recruiting||N/A|23|Anticipated|Loma Linda University||1|||f||||f|f|f||||||||2017-10-10 20:55:43.22872|2017-10-10 20:55:43.22872
NCT03195452|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 1, 2020|Anticipated|2020-05-01|October 7, 2019|Anticipated|2019-10-07||Interventional|||QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient|QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient|Recruiting||Phase 2|100|Anticipated|Nantes University Hospital||1|||f|||||f|f||||||||2017-10-10 20:55:43.312381|2017-10-10 20:55:43.312381
NCT03195439|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-19|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|TTP||Temple Touch Pro (TTP) Non-Invasive Core Temperature Monitoring as a Measure for Early Detection of Fever Related Infections, Including Sepsis.|Temple Touch Pro (TTP) Non-Invasive Core Temperature Monitoring as a Measure for Early Detection of Fever Related Infections, Including Sepsis.|Not yet recruiting||N/A|600|Anticipated|Medisim Ltd||1|||f|||||f|f|||f|||No||2017-10-10 20:55:43.391911|2017-10-10 20:55:43.391911
NCT03195426|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-10|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|June 22, 2017|Actual|2017-06-22||Interventional|||A Diaphragm-Sparing Nerve Block for Arthroscopic Shoulder Surgery?|Is There a Real Diaphragm-Sparing Nerve Block for Arthroscopic Shoulder Surgery?|Completed||N/A|10|Actual|Clinique Medipole Garonne||1|||f||||t|f|f||||||||2017-10-10 20:55:43.46068|2017-10-10 20:55:43.46068
NCT03195413|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-29|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Early Ultrasound-guided Nerve Block for Painful Hand Injuries in the Emergency Department|Early Ultrasound-guided Nerve Block for Painful Hand Injuries in the Emergency Department|Not yet recruiting||N/A|50|Anticipated|University of Washington||2|||f||||t|f|f|||f|||||2017-10-10 20:55:43.619197|2017-10-10 20:55:43.619197
NCT03195400|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-06-21|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2021|Anticipated|2021-12-31|August 31, 2021|Anticipated|2021-08-31||Observational|||Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes|Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes|Recruiting||N/A|100|Anticipated|Yale University|||2||f||||t|f|f||||Samples With DNA|"     DNA will be extracted from whole blood with the use of a Flexigene Kit (Qiagen) and     genotyping will be performed using a matrix assisted based laser desorption-ionization time     of flight mass spectrometry on the MassARRAY platform (Sequenom). DNA sample is obtained with     fasting samples during the OGTT.   "|Undecided||2017-10-10 20:55:43.729906|2017-10-10 20:55:43.729906
NCT03195387|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-18|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model|A Single Site, Randomized, Double-blind, Placebo-controlled Phase Ib Study, to Evaluate the Chemoprotective Activity of a Single Dose of MMV390048 in a Controlled P. Falciparum Sporozoite Infection Model in Non-immune Healthy Volunteers|Not yet recruiting||Phase 1|36|Anticipated|Medicines for Malaria Venture||4|||f||||f|f|f||||||||2017-10-10 20:55:43.842031|2017-10-10 20:55:43.842031
NCT03195374|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-21|||February 2018|Anticipated|2018-02-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|POMA 4||Prescription Opioid Misuse Assessment|Assessment of the Prevalence of Analgesics Opioid Misuse in Chronic Non-cancer Pain Patients|Not yet recruiting||N/A|1068|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 20:55:43.96045|2017-10-10 20:55:43.96045
NCT03195361|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-06-19|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Multicenter, Prospective, Non-randomized, Single-arm, Interventional Study for the Evaluation of the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse||Recruiting||N/A|50|Anticipated|Lyra Medical Ltd.||1|||f|||||f|f||||||||2017-10-10 20:55:44.066241|2017-10-10 20:55:44.066241
NCT03195348|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-19|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||The Effects of Whole Body Unloading on Physiological Function|The Effects of Whole Body Unloading on Physiological Function|Recruiting||N/A|16|Anticipated|King's College London||1|||f||||f|f|f||||||No||2017-10-10 20:55:44.158811|2017-10-10 20:55:44.158811
NCT03195335|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-21|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2018|Anticipated|2018-08-01|May 1, 2018|Anticipated|2018-05-01|1 Week|Observational [Patient Registry]|TVoLHA||Turkish Version of LIFE Habits Assessment|Validity and Reliability of Turkish Version of LIFE Habits (Life-H) Assessment for Children With Cerebral Palsy|Not yet recruiting||N/A|450|Anticipated|Hacettepe University|||1||f||||f|f|f||||||Undecided||2017-10-10 20:55:44.263725|2017-10-10 20:55:44.263725
NCT03195322|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-10-04|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|August 1, 2018|Anticipated|2018-08-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Pre-pectoral AlloDerm® to Reinforce Tissues in Tissue Expander Breast Reconstruction|The Use of Complete AlloDerm® Coverage in Two-stage Tissue Expansion and Implant Placement in the Subcutaneous (Pre-pectoral) Plane: a Prospective Pilot|Recruiting||N/A|20|Anticipated|Johns Hopkins University||1|||f||||t|f|f|||t|||||2017-10-10 20:55:44.353887|2017-10-10 20:55:44.353887
NCT03195309|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-21|||January 20, 2017|Actual|2017-01-20|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|PCEA||A Comparison of Different Concentration Ropivacaine for Patient-controlled Epidural Analgesia|A Comparison of Different Concentration Ropivacaine Combination With Fentanyl for Patient-controlled Epidural Analgesia After Cesarean Delivery|Active, not recruiting||Phase 1/Phase 2|120|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||t|f|f|||f|||No||2017-10-10 20:55:44.489402|2017-10-10 20:55:44.489402
NCT03195296|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-21|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|LYMPHGO||T and B Cells in Graves' Orbitopathy|T and B Cells Infiltrating Orbital Tissues in Graves' Orbitopathy (GO) and Their Relation With GO Features|Completed||N/A|20|Actual|University of Pisa|||1||f||||f|f|f||||Samples Without DNA|"     Fibroadipose orbital tissue samples   "|No||2017-10-10 20:55:44.595475|2017-10-10 20:55:44.595475
NCT03195283|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-21|||July 28, 2015|Actual|2015-07-28|May 2017|2017-05-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Observational|||Novel Meal Service Improves Nutritional Intake|A Novel In-hospital Meal Service Improves Protein and Energy Intake|Completed||N/A|637|Actual|Radboud University|||2||f||||f||||||||No||2017-10-10 20:55:44.668683|2017-10-10 20:55:44.668683
NCT03195270|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||November 24, 2014|Actual|2014-11-24|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Use of PET/MR Imaging in Chronic Pain|Use of [18F]FDG PET/MRI in the Diagnosis of Pain Generators and/or Sites of Inflammation and to Monitor Treatment Effects in Patients With Chronic Pain|Recruiting||Phase 1|60|Anticipated|Stanford University||1|||f|||||||||f|||No|There is currently no plan to share the individual participant data with other researchers outside our group of researchers or referring physicians.|2017-10-10 20:55:44.759579|2017-10-10 20:55:44.759579
NCT03195257|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-21|||November 17, 2012|Actual|2012-11-17|June 2017|2017-06-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes|Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes|Completed||N/A|10|Actual|University Hospital, Gentofte, Copenhagen||5|||f||||t|f|f||||||No||2017-10-10 20:55:44.870659|2017-10-10 20:55:44.870659
NCT03195244|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-22|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|February 12, 2018|Anticipated|2018-02-12|February 12, 2018|Anticipated|2018-02-12||Interventional|AT&ASD||Aquatic Therapy and Autism Spectrum Disorders|Aquatic Therapy and Autism Spectrum Disorders|Recruiting||N/A|100|Anticipated|Panhandle Eye Group, LLP||3|||f||||f|f|f||||||No||2017-10-10 20:55:44.951913|2017-10-10 20:55:44.951913
NCT03195231|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-20|||June 25, 2017|Anticipated|2017-06-25|June 2017|2017-06-01|January 15, 2020|Anticipated|2020-01-15|December 15, 2019|Anticipated|2019-12-15||Interventional|||Wuling Powder for the Treatment and Underlying Mechanism of Depressive Symptoms in Patients With Parkinson's Disease|Wuling Powder for the Treatment and Underlying Mechanism of Depressive Symptoms in Patients With Parkinson's Disease: a Randomised, Double-blind, Placebo-controlled Trial.|Not yet recruiting||Phase 4|120|Anticipated|Beijing Hospital||2|||f|||||f|f||||||||2017-10-10 20:55:45.054837|2017-10-10 20:55:45.054837
NCT03195218|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|UH3||HRME in the Screening of Cervical Cancer Precursor Lesions in Brazil (UH3 - Brazil)|Validation of High Resolution Microendoscope in the Screening of Cervical Cancer Precursor Lesions in Brazil (UH3 - Brazil)|Recruiting||N/A|1780|Anticipated|Barretos Cancer Hospital||1|||f||||f|f|f|||f|||Yes|RedCap Platform will be used to share data.|2017-10-10 20:55:45.138083|2017-10-10 20:55:45.138083
NCT03195205|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-19|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Identification to Elimination in HCV-Infected Individuals|A Novel Approach Continuum to Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk Populations|Recruiting||Early Phase 1|3000|Anticipated|TruCare Internal Medicine & Infectious Disease||1|||f|||||t|f||||||Undecided||2017-10-10 20:55:45.252494|2017-10-10 20:55:45.252494
NCT03195192|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-18|||March 9, 2017|Actual|2017-03-09|September 2017|2017-09-01|June 9, 2019|Anticipated|2019-06-09|March 9, 2019|Anticipated|2019-03-09||Interventional|||Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer|Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer|Recruiting||N/A|100|Anticipated|Translational Drug Development||1|||f||||f|f|f||||||||2017-10-10 20:55:45.366272|2017-10-10 20:55:45.366272
NCT03195179|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury|The Outcomes of Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury|Recruiting||N/A|100|Anticipated|University of Utah|||2||f||||f|f|f||||||No||2017-10-10 20:55:45.505684|2017-10-10 20:55:45.505684
NCT03195166|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-27|||July 3, 2017|Anticipated|2017-07-03|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Hemodynamic Effects of Continuous Spinal Anesthesia in Patient Aged Over 65 Years|Hemodynamic Effects of Continuous Spinal Anesthesia in Patient Aged Over 65 Years Undergoing Total Knee Arthroplasty|Not yet recruiting||N/A|20|Anticipated|University Tunis El Manar||1|||f||||f|f|f||||||No||2017-10-10 20:55:45.633217|2017-10-10 20:55:45.633217
NCT03195153|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-19|||March 28, 2017|Actual|2017-03-28|June 2017|2017-06-01|July 15, 2017|Anticipated|2017-07-15|June 23, 2017|Anticipated|2017-06-23||Interventional|||Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin|Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin|Recruiting||Phase 4|200|Anticipated|University of Roma La Sapienza||3|||f||||f|f|f|||f|||||2017-10-10 20:55:45.713756|2017-10-10 20:55:45.713756
NCT03195140|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-31|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial|Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes|Recruiting||N/A|90|Anticipated|Tandem Diabetes Care, Inc.||2|||f||||f|f|t|t|f||||||2017-10-10 20:55:45.80632|2017-10-10 20:55:45.80632
NCT03195127|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-20|||June 28, 2011|Actual|2011-06-28|June 2017|2017-06-01|February 1, 2017|Actual|2017-02-01|July 31, 2015|Actual|2015-07-31||Interventional|||Development of a Rehabilitation Strengthening and Mobility Program for Ventilator Dependent Older Patients|Development of a Rehabilitation Strengthening and Mobility Program for Ventilator Dependent Older Patients|Completed||N/A|40|Actual|University of Maryland||2|||f||||f|f|f||||||No||2017-10-10 20:55:45.924731|2017-10-10 20:55:45.924731
NCT03195114|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-06-21|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|December 1, 2023|Anticipated|2023-12-01|December 1, 2023|Anticipated|2023-12-01||Observational|Class-CMR||Cardiac MRI for Post-TAVR Paravalvular Leak Assessment|Multicenter Prospective CoreValve Study Using Cardiac MRI for Assessment of Paravalvular Aortic Regurgitation and Its Impact on LV Reverse Remodeling and Cardiovascular Outcomes|Recruiting||N/A|55|Anticipated|University of Pittsburgh|||1||f||||t|f|f||||None Retained|"     Samples for future   "|No||2017-10-10 20:55:46.013181|2017-10-10 20:55:46.013181
NCT03195101|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-06-21|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 1, 2021|Anticipated|2021-01-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Evaluation of Transconjunctival Approach in Management of Orbital Tumors|Evaluation of Transconjunctival Approach in Management of Orbital Tumors|Not yet recruiting||N/A|30|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 20:55:46.101672|2017-10-10 20:55:46.101672
NCT03195088|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-10-03|||July 27, 2017|Actual|2017-07-27|October 2017|2017-10-01|June 25, 2018|Anticipated|2018-06-25|June 25, 2018|Anticipated|2018-06-25||Interventional|||Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Subcutaneous Doses of BI 473494 in Healthy Male Subjects (Single-blind, Partially Randomised, Placebo-controlled Parallel Group Design)|Recruiting||Phase 1|88|Anticipated|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 20:55:46.169294|2017-10-10 20:55:46.169294
NCT03195075|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-21|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|January 2020|Anticipated|2020-01-01||Interventional|||Endoscopic Ultrasonography Guided Biliary Drainage|Endoscopic Ultrasonography-Guided Biliary Drainage Versus Percutaneous Trans-hepatic Biliary Drainage for Malignant Biliary Obstruction After Failed Endoscopic Retrograde Cholangio-pancreaticography|Not yet recruiting||N/A|40|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:55:46.255188|2017-10-10 20:55:46.255188
NCT03195062|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-19|||March 23, 2017|Actual|2017-03-23|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|FruPP||Fructose Extra-splanchnic Metabolism and Its Effects on Systemic Flux of Substrates (FruPP)|Fructose Extra-splanchnic Metabolism and Its Effects on Systemic Flux of Substrates (FruPP)|Recruiting||N/A|12|Anticipated|University of Lausanne||1|||f||||t|f|f||||||No||2017-10-10 20:55:46.335885|2017-10-10 20:55:46.335885
NCT03195049|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-21|||April 15, 2018|Anticipated|2018-04-15|June 2017|2017-06-01|September 15, 2019|Anticipated|2019-09-15|April 15, 2019|Anticipated|2019-04-15||Interventional|COET||Complications of Exchange Transfusion in Neonates|Complications of Exchange Transfusion in Neonates|Not yet recruiting||N/A|50|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 20:55:46.407972|2017-10-10 20:55:46.407972
NCT03195036|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-20|||April 17, 2017|Actual|2017-04-17|June 2017|2017-06-01|July 17, 2019|Anticipated|2019-07-17|April 17, 2019|Anticipated|2019-04-17||Interventional|||Evaluation of an Early Childhood Development Intervention for HIV-Exposed Children in Cameroon|Evaluation of an Early Childhood Development Intervention for HIV-Exposed Children in Cameroon|Recruiting||N/A|200|Anticipated|Duke University||2|||f||||f|f|f||||||No||2017-10-10 20:55:46.486035|2017-10-10 20:55:46.486035
NCT03195023|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-19|||June 2015||2015-06-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Interventional|PROERCAN01||Effect of RAS Blockers on Chronic Kidney Disease Progression in Elderly Patients With Non Proteinuric Nephropathies|Effect of Renin-angiotensin System Blocker Drugs on Chronic Kidney Disease Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)|Recruiting||Phase 4|106|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||||||||||||2017-10-10 20:55:46.56285|2017-10-10 20:55:46.56285
NCT03195010|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-21|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|October 5, 2018|Anticipated|2018-10-05|October 5, 2018|Anticipated|2018-10-05||Interventional|||Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia|Management of Acute Venous Thromboembolic Events (VTE) in Patients With Hematologic Disorders and Treatment-Induced Thrombocytopenia: A Pilot Study|Enrolling by invitation||Phase 2|12|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t|t|f||||||||2017-10-10 20:55:46.665729|2017-10-10 20:55:46.665729
NCT03194997|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-12|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Pilates and Dance to Breast Cancer Patients Undergoing Treatment|Pilates and Dance to Breast Cancer Patients Undergoing Treatment: MoveMama Project|Not yet recruiting||N/A|201|Anticipated|Laboratório de Pesquisa em Lazer e Atividade Física||3|||f||||t|f|f||||||||2017-10-10 20:55:46.756435|2017-10-10 20:55:46.756435
NCT03194984|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-19|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 20, 2017|Anticipated|2017-12-20|August 20, 2017|Anticipated|2017-08-20||Interventional|||Effectiveness of Office Bleaching Agents in Patients of Different Age Group|Randomized Clinical Trial Comparing the Effectiveness of Office Bleaching Agents in Patients of Different Age Group|Recruiting||N/A|56|Anticipated|Federal University of Uberlandia||2|||f||||f|f|f||||||No||2017-10-10 20:55:46.854347|2017-10-10 20:55:46.854347
NCT03194971|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-19|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|May 31, 2022|Anticipated|2022-05-31|May 31, 2021|Anticipated|2021-05-31||Observational|||NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy|NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy|Recruiting||N/A|20|Anticipated|Medical College of Wisconsin|||2||f||||f|f|||||Samples Without DNA|"     Samples are obtained from regions suspicious for tumor.   "|Undecided||2017-10-10 20:55:46.951497|2017-10-10 20:55:46.951497
NCT03194958|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-06|||June 5, 2017|Actual|2017-06-05|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Helping Poor Smokers Quit|Helping the Poor Quit Smoking: Specialized Quitlines and Meeting Basic Needs|Recruiting||N/A|2000|Anticipated|Washington University School of Medicine||4|||f||||f|f|f||||||||2017-10-10 20:55:47.291896|2017-10-10 20:55:47.291896
NCT03194945|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-19|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes|Effects of Linagliptin and Metformin Monotherapy or Combined Sequential Treatment After Early Short-term Intensive Insulin Treatment on Long-term Blood Glucose Control and Function of β Cells in Patients With Type 2 Diabetes|Not yet recruiting||Phase 4|448|Anticipated|Sun Yat-sen University||4|||f||||t|f|f|||f|||Undecided||2017-10-10 20:55:47.503578|2017-10-10 20:55:47.503578
NCT03194932|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-12|||July 11, 2017|Actual|2017-07-11|June 2017|2017-06-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia|A Phase I and Expansion Cohort Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia|Recruiting||Phase 1|54|Anticipated|St. Jude Children's Research Hospital||1|||||||f|t|f||||||||2017-10-10 20:55:47.621442|2017-10-10 20:55:47.621442
NCT03194919|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-12|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Negotiating a Quit Date or Not in Online Interventions|The Effect of Negotiating a Quit Date on Attempting to Quit Smoking|Recruiting||N/A|1500|Anticipated|University of Oslo||2|||f||||f|f|f||||||||2017-10-10 20:55:47.728057|2017-10-10 20:55:47.728057
NCT03194906|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Low Grade Glioma|Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Low Grade Glioma: A Pilot Study|Recruiting||Phase 2|50|Anticipated|St. Jude Children's Research Hospital||2|||||||t|t|f||||||||2017-10-10 20:55:47.820238|2017-10-10 20:55:47.820238
NCT03194893|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-20|2017-09-25|||July 5, 2017|Actual|2017-07-05|September 2017|2017-09-01|June 12, 2024|Anticipated|2024-06-12|June 12, 2024|Anticipated|2024-06-12||Interventional|||A Roll Over Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer|A Multicenter, International, Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer|Recruiting||Phase 3|200|Anticipated|Hoffmann-La Roche||2|||f||||f|t|f||||||||2017-10-10 20:55:47.930988|2017-10-10 20:55:47.930988
NCT03194880|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-22|||December 8, 2016|Actual|2016-12-08|June 2017|2017-06-01|December 10, 2020|Anticipated|2020-12-10|December 8, 2018|Anticipated|2018-12-08||Observational|||Alere COMBO and Alere q Detect in an HIV PrEP Program in Thailand|Performance Characteristics of AlereCOMBO and Alere q Detect in an HIV PrEP Program in Thailand|Recruiting||N/A|150|Anticipated|Thai Red Cross AIDS Research Centre|||1||f||||t|f|f||||||||2017-10-10 20:55:48.063423|2017-10-10 20:55:48.063423
NCT03194854|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-28|||March 5, 2018|Anticipated|2018-03-05|August 2017|2017-08-01|June 4, 2018|Anticipated|2018-06-04|June 4, 2018|Anticipated|2018-06-04||Interventional|||Fun For Wellness: Online Well-Being Promotion Intervention in a Health System Patient Sample|Fun For Wellness: Online Well-Being Promotion Intervention in a Health System Patient Sample|Suspended||N/A|500|Anticipated|University of Miami||2||Data broker not releasing email addresses to recruit participants.|f||||f|f|f||||||||2017-10-10 20:55:48.251808|2017-10-10 20:55:48.251808
NCT03194841|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||August 22, 2016|Actual|2016-08-22|June 2017|2017-06-01|January 6, 2017|Actual|2017-01-06|January 6, 2017|Actual|2017-01-06||Interventional|HFSC||Heart Failure Self-care With the Aid of a Smartphone Application|Heart Failure Self-care With the Aid of a Smartphone Application|Completed||N/A|10|Actual|University of Massachusetts, Worcester||1|||f||||f|f|f||||||No||2017-10-10 20:55:48.361277|2017-10-10 20:55:48.361277
NCT03194828|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-19|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Real-time Glaucoma Medication Adherence|Leveraging Real-Time Medication Use Monitoring to Improve Adherence in Adults With Glaucoma|Recruiting||N/A|80|Anticipated|University of Tennessee||2|||f||||f|f|f||||||No|No IPD|2017-10-10 20:55:48.427808|2017-10-10 20:55:48.427808
NCT03194815|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-06-23|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|SINAPPS2||IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2|A Randomised Phase II Double-blinded Placebo-controlled Trial of Intravenous Immunoglobulins and Rituximab in Patients With Antibody-associated Psychosis (SINAPPS2)|Not yet recruiting||Phase 2|80|Anticipated|University of Cambridge||2|||f||||t|f|f||||||Undecided||2017-10-10 20:55:48.550978|2017-10-10 20:55:48.550978
NCT03194802|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|March 27, 2018|Anticipated|2018-03-27|August 6, 2017|Anticipated|2017-08-06||Interventional|||Efficacy of Sleeping Without Pills (SWOP), an Online Drug Tapering Program|Efficacy of Sleeping Without Pills (SWOP), an Online Drug Tapering Program|Recruiting||N/A|80|Anticipated|University of Manitoba||2|||f|||||f|f||||||||2017-10-10 20:55:48.679561|2017-10-10 20:55:48.679561
NCT03194789|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-29|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SUI||The Effect of Footwear Generated Biomechanical Manipulation on Symptoms of Stress Urinary Incontinence|The Effect of Footwear Generated Biomechanical Manipulation on Symptoms of Stress Urinary Incontinence|Not yet recruiting||N/A|64|Anticipated|Montefiore Medical Center||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:55:48.774594|2017-10-10 20:55:48.774594
NCT03194776|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-26|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|January 18, 2019|Anticipated|2019-01-18|January 18, 2019|Anticipated|2019-01-18||Interventional|||Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication|A Patient and Investigator-blinded, Randomized, Placebo Controlled Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication|Recruiting||Phase 2|40|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 20:55:48.907564|2017-10-10 20:55:48.907564
NCT03194763|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-22|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Observational|COROPEDIA||Observational Study for Feasibility and Performance of Sub-millisievert Coronary Computed Tomography Angiography (CCTA) for Coronary Artery Anomalies (CAA) in Paediatric Patients|Observational Study for Feasibility and Performance of Sub-millisievert Coronary Computed Tomography Angiography (CCTA) for Coronary Artery Anomalies (CAA) in Paediatric Patients|Not yet recruiting||N/A|50|Anticipated|University Hospital, Montpellier|||1||f||||f|f|f||||||No||2017-10-10 20:55:48.996634|2017-10-10 20:55:48.996634
NCT03194750|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-20|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|||Ultrasound Assessment of Volume in Patients on Continuous Dialysis|Ultrasound Assessment of Volume in Patients on Continuous Dialysis|Recruiting||N/A|20|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f||||||No||2017-10-10 20:55:49.08425|2017-10-10 20:55:49.08425
NCT03194737|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-28|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Prostatic Urethral Lift in Subject With Acute Urinary Retention|Prostatic Urethral Lift in Subject With Acute Urinary Retention|Not yet recruiting||N/A|50|Anticipated|NeoTract, Inc.||2|||f||||t|f|t|f||t|||No||2017-10-10 20:55:49.198992|2017-10-10 20:55:49.198992
NCT03194724|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-19|||April 30, 2016|Actual|2016-04-30|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Using Stable Isotope Techniques to Monitor & Assess the Vitamin A Status of Children Susceptible to Infection|Using Stable Isotope Techniques to Monitor & Assess the Vitamin A Status of Children Susceptible to Infection|Active, not recruiting||N/A|120|Anticipated|National Food Technology Research Centre, Botswana|||2||f||||f|f|f||||||Yes|Data will be shared for pooling purposes as this study is part of a regional project|2017-10-10 20:55:49.282818|2017-10-10 20:55:49.282818
NCT03194711|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-19|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|May 29, 2018|Anticipated|2018-05-29|May 29, 2018|Anticipated|2018-05-29||Observational|||BVS-OCT Imaging Study|Bioabsorbable Drug-eluting Scaffolds (BVS)-Optical Coherence Tomography (OCT) Imaging Study|Active, not recruiting||N/A|50|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||f|f|f||||||No||2017-10-10 20:55:49.362971|2017-10-10 20:55:49.362971
NCT03194698|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-20|||August 17, 2017|Anticipated|2017-08-17|June 2017|2017-06-01|December 17, 2018|Anticipated|2018-12-17|December 17, 2018|Anticipated|2018-12-17||Interventional|||Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea|Pilot Study to Examine Efficacy and Cytokines Levels After Meibomian Gland Expression (MGX) With and Without Intense Pulsed Light Treatment (IPL)|Enrolling by invitation||N/A|20|Anticipated|Mayo Clinic||2|||f||||f|f|t|f|f|f|||No||2017-10-10 20:55:49.4705|2017-10-10 20:55:49.4705
NCT03194685|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-11|||May 5, 2017|Actual|2017-05-05|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia|A First-in-Human Phase 1/2a Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of FF-10101-01 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|99|Anticipated|Fujifilm Pharmaceuticals U.S.A., Inc.||12|||f||||t|t|f||||||||2017-10-10 20:55:49.547512|2017-10-10 20:55:49.547512
NCT03194672|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-14|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|November 2020|Anticipated|2020-11-01||Interventional|HAT||Healthy Adolescent Transitions (HAT)|Healthy Adolescent Transitions (HAT): A Comprehensive Approach to Targeting Adolescent Mothers|Recruiting||Phase 2|500|Anticipated|Nationwide Children's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:55:49.672794|2017-10-10 20:55:49.672794
NCT03194659|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Synergy Between Choline and DHA|Maternal Choline Supplementation and Its Impact on Docosahexaenoic Acid Supply in Human Pregnancy|Recruiting||N/A|40|Anticipated|Cornell University||2|||f||||f|f|f||||||||2017-10-10 20:55:49.768349|2017-10-10 20:55:49.768349
NCT03194620|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-21|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|January 12, 2017|Actual|2017-01-12|January 12, 2017|Actual|2017-01-12||Interventional|||Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans|Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans|Completed||N/A|12|Actual|University of California, Davis||8|||f||||f|f|f||||||||2017-10-10 20:55:50.683119|2017-10-10 20:55:50.683119
NCT03194607|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-19|||September 20, 2016|Actual|2016-09-20|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Observational|SPEED||Quantitative Evaluation of Motor Function Before and After Surgery for Degenerative Lumbar Spinal Stenosis|Quantitative Evaluation of Motor Function Before and After Surgery for Degenerative Lumbar Spinal Stenosis|Recruiting||N/A|55|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 20:55:50.806646|2017-10-10 20:55:50.806646
NCT03194594|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-18|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|June 12, 2017|Actual|2017-06-12|June 1, 2017|Actual|2017-06-01||Interventional|||Dexamethasone and Ketamine on Change of Postoperative Mood|The Effects of Combination of Intravenous Dexamethasone and Ketamine on Change of Postoperative Mood in Patients Undergoing Laparoscopically Assisted Gynecologic Surgery.|Completed||Phase 4|93|Actual|Wonkwang University Hospital||3|||f||||t|f|f||||||Undecided||2017-10-10 20:55:50.914881|2017-10-10 20:55:50.914881
NCT03194581|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-18|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Observational|||Normoxic Challenges Utility to Evaluate Blood Loss|Normoxic Challenges Utility to Evaluate Blood Loss Through Cerebral Oxygenation|Not yet recruiting||N/A|20|Anticipated|Centro Hospitalar do Tâmega e Sousa|||1||f|||||f|f||||||||2017-10-10 20:55:51.015674|2017-10-10 20:55:51.015674
NCT03194568|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-05|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|July 2023|Anticipated|2023-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Vertebral Body Tethering Outcomes for Pediatric Idiopathic Scoliosis|Safety and Feasibility of a Vertebral Body Tethering Technique for Pediatric Idiopathic Scoliosis|Active, not recruiting||N/A|4|Actual|Children's Hospital of Philadelphia||1|||f||||t|f|t|f|f||||||2017-10-10 20:55:51.089964|2017-10-10 20:55:51.089964
NCT03194555|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-03|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy, Safety, and Tolerability of Twice Daily Oral ALLOD-2 vs. Placebo in Episodic Migraine Prevention (ANODYNE-3)|A Single Center, Phase 2B, Randomized, Double Blind, Study to Assess the Efficacy, Safety, and Tolerability of ALLOD-2 vs. Placebo in the Prevention of Episodic Migraine in Adults (ANODYNE-3)|Recruiting||Phase 2/Phase 3|48|Anticipated|Allodynic Therapeutics, LLC||2|||f||||f|t|f|||f|||||2017-10-10 20:55:51.188041|2017-10-10 20:55:51.188041
NCT03194542|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-08|||October 18, 2017|Anticipated|2017-10-18|September 2017|2017-09-01|June 29, 2019|Anticipated|2019-06-29|June 8, 2019|Anticipated|2019-06-08||Interventional|||A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence|A Phase-2 Study To Determine Efficacy and Safety of Luspatercept in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia With or Without Red Blood Cell-Transfusion Dependence|Not yet recruiting||Phase 2|70|Anticipated|Celgene||1|||f||||f|t|f||||||||2017-10-10 20:55:51.310268|2017-10-10 20:55:51.310268
NCT03194529|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|June 30, 2022|Anticipated|2022-06-30||Interventional|FMTPCD||FMT in Pediatric Crohn's Disease|Safety of FMT in Maintenance of Pediatric Crohn's Disease|Recruiting||Phase 1/Phase 2|10|Anticipated|Children's Hospital Los Angeles||1|||f||||t|t|f||||||||2017-10-10 20:55:51.499796|2017-10-10 20:55:51.499796
NCT03194516|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-07-28|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Observational|GCC 1717||Ketogenic Diet and Prostate Cancer Surveillance Pilot|A Ketogenic Diet Pilot Study for Overweight Prostate Cancer Patients on Active Surveillance|Enrolling by invitation||N/A|12|Anticipated|University of Maryland|||1||f||||t|f|f||||Samples With DNA|"     Prostate biopsy   "|||2017-10-10 20:55:51.620374|2017-10-10 20:55:51.620374
NCT03194503|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-19|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|||Tracheal Intubation Coaching in NICUs|Improving Safety and Quality of Tracheal Intubations in Neonatal ICUs|Not yet recruiting||N/A|2300|Anticipated|Children's Hospital of Philadelphia||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:55:51.712953|2017-10-10 20:55:51.712953
NCT03194490|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-20|||August 24, 2016|Actual|2016-08-24|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Benefit of Adding Stretching to Standard Intervention For Patients With Nonspecific Mechanical Neck Pain|Benefit of Adding Stretching to Standard Intervention For Patients With Nonspecific Mechanical Neck Pain|Active, not recruiting||N/A|32|Anticipated|Loma Linda University||2|||f||||f|f|f||||||No||2017-10-10 20:55:51.864861|2017-10-10 20:55:51.864861
NCT03194477|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Young Black Men's Sexual Health Study|Identifying and Engaging Urban HIV Infected and Uninfected YBMSM in Care|Recruiting||N/A|465|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t|f|f||||||||2017-10-10 20:55:51.964764|2017-10-10 20:55:51.964764
NCT03194464|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-06-20|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|||Interlimb Transfer Post-stroke|Neural Mechanisms Mediating Interlimb Transfer Following Stroke|Recruiting||N/A|24|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|||No||2017-10-10 20:55:52.088162|2017-10-10 20:55:52.088162
NCT03194451|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-22|||July 10, 2017|Anticipated|2017-07-10|June 2017|2017-06-01|July 10, 2019|Anticipated|2019-07-10|August 20, 2017|Anticipated|2017-08-20||Observational|CELSORDINO||Dental Stem Cells and Bone Tissue Engineering (CELSORDINO)|Dental Stem Cells and Bone Tissue Engineering|Not yet recruiting||N/A|40|Anticipated|Central Hospital, Nancy, France|||1||f||||t|f|f||||Samples Without DNA|"     teeth   "|No||2017-10-10 20:55:52.204755|2017-10-10 20:55:52.204755
NCT03194438|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-10-03|||June 19, 2017|Actual|2017-06-19|October 2017|2017-10-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Urban Zen Integrative Therapy for Persons With Pulmonary Hypertension|Feasibility and Acceptability of an Integrative Therapy for Symptom Management in Persons With Pulmonary Hypertension|Recruiting||N/A|20|Anticipated|Ohio State University||1|||f||||t|f|f||||||||2017-10-10 20:55:52.285819|2017-10-10 20:55:52.285819
NCT03194425|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-20|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Standardization of Lead Placement for Sacral Neuromodulation. Part 1|Pelvic Floor EMG Monitoring as Tool to Improve Patient Selection and Outcome - Standardization of Lead Placement for Sacral Neuromodulation.|Recruiting||N/A|60|Anticipated|Universiteit Antwerpen||2|||f||||f|f|f||||||||2017-10-10 20:55:52.377776|2017-10-10 20:55:52.377776
NCT03194412|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-20|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|FOCUS-WMU||FOCUS- Frailty Management Optimization Through EIP AHA Commitments and Utilization of Stakeholders Input|FOCUS- Frailty Management Optimization Through EIP AHA Commitments and Utilization of Stakeholders Input (WP7-WMU)|Recruiting||N/A|270|Anticipated|Wroclaw Medical University||5|||f||||t|f|f||||||No||2017-10-10 20:55:52.463698|2017-10-10 20:55:52.463698
NCT03194399|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-20|||November 27, 2015|Actual|2015-11-27|June 2017|2017-06-01|February 22, 2016|Actual|2016-02-22|February 15, 2016|Actual|2016-02-15||Interventional|||Development of Personalized Health Care Service in Patients With Breast Cancer|Development of Personalized Health Care Service in Patients With Breast Cancer|Completed||N/A|11|Actual|Seoul National University Bundang Hospital||1|||f||||t|f|f||||||No||2017-10-10 20:55:52.577721|2017-10-10 20:55:52.577721
NCT03194386|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-20|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|EMDR-ED||Eye-Movement Desensitization and Reprocessing in the ED and Post-Traumatic Syndrome|Feasibility and Interest of Early Eye-Movement Desensitization and Reprocessing Provided in the Emergency Department for Patients With High Risk of Post Traumatic Syndrome|Completed||N/A|110|Actual|University Hospital, Bordeaux||3|||f||||f|f|f||||||Yes||2017-10-10 20:55:52.643424|2017-10-10 20:55:52.643424
NCT03194373|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-21|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|July 3, 2021|Anticipated|2021-07-03|July 3, 2020|Anticipated|2020-07-03||Interventional|||Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma|A Multi-Center Open Label Single Arm Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 2|40|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 20:55:52.716435|2017-10-10 20:55:52.716435
NCT03194360|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-20|||December 1, 2015|Actual|2015-12-01|June 2017|2017-06-01|January 15, 2017|Actual|2017-01-15|January 15, 2017|Actual|2017-01-15||Observational|||Risk Factors of Delirium in Sequential Sedation Patients in Intensive Care Unit|Risk Factors of Delirium in Sequential Sedation Patients in Intensive Care Unit|Completed||N/A|141|Actual|West China Hospital|||2||f||||t|f|f|||f|||No||2017-10-10 20:55:52.791545|2017-10-10 20:55:52.791545
NCT03194347|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-23|||May 29, 2017|Actual|2017-05-29|June 2017|2017-06-01|May 31, 2021|Anticipated|2021-05-31|May 29, 2020|Anticipated|2020-05-29||Observational|MAGynMA||Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas|Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas|Recruiting||N/A|300|Anticipated|University Women's Hospital Tübingen|||1||f|||||f|f||||Samples With DNA|"     blood   "|||2017-10-10 20:55:52.856365|2017-10-10 20:55:52.856365
NCT03194321|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-19|||May 9, 2017|Actual|2017-05-09|June 2017|2017-06-01|May 9, 2021|Anticipated|2021-05-09|May 9, 2020|Anticipated|2020-05-09||Interventional|||Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in HLA Sensitized Kidney Transplant Recipients|A Prospective, Pilot Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in HLA Sensitized Kidney Transplant Recipients|Recruiting||Phase 4|10|Anticipated|Cedars-Sinai Medical Center||1|||f||||t|t|f||||||||2017-10-10 20:55:52.997114|2017-10-10 20:55:52.997114
NCT03194308|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-19|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Observational|||Safer Conception for Women|Safer Conception for Women: PrEP Uptake/Adherence to Reduce Periconception HIV Risk for South African Women|Not yet recruiting||N/A|350|Anticipated|Massachusetts General Hospital|||1||f||||t|f|f|||t|||Undecided||2017-10-10 20:55:53.067152|2017-10-10 20:55:53.067152
NCT03194295|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-14|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Activating Community Support for Substance Users|Activating Personal Network Support in Treatment Seeking Substance Users|Not yet recruiting||N/A|136|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-10 20:55:53.180259|2017-10-10 20:55:53.180259
NCT03194282|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-19|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Effects of the Insole on Balance Capacity in Chronic Stroke|Effects of the Insole on Balance Capacity in Chronic Stroke|Not yet recruiting||N/A|30|Anticipated|Taipei Medical University WanFang Hospital||2|||f|||||f|f||||||||2017-10-10 20:55:53.262473|2017-10-10 20:55:53.262473
NCT03194269|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-21|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|October 28, 2020|Anticipated|2020-10-28|October 28, 2020|Anticipated|2020-10-28||Interventional|FOLD||Long Term Prospective Uncontrolled Study Of Earfold™ For The Treatment Of Prominent Ears|FOLD: Long Term Prospective Uncontrolled Study Of Earfold™ For The Treatment Of Prominent Ears|Recruiting||N/A|100|Anticipated|Allergan||1|||f|||||f|f||||||||2017-10-10 20:55:53.324718|2017-10-10 20:55:53.324718
NCT03194256|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-19|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|February 28, 2022|Anticipated|2022-02-28|February 28, 2022|Anticipated|2022-02-28||Interventional|CENIC2-P3||Evaluating New Nicotine Standards for Cigarettes - Project 3|Effects of Very Low Nicotine Content Cigarettes and E-cigarette Characteristics on Smoking in Adolescents|Not yet recruiting||N/A|120|Anticipated|Brown University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:55:53.411483|2017-10-10 20:55:53.411483
NCT03194230|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||October 2, 2017|Anticipated|2017-10-02|June 2017|2017-06-01|February 2, 2021|Anticipated|2021-02-02|August 2, 2020|Anticipated|2020-08-02||Interventional|DILATOP||Interest of Cervical Dilators in Second Trimester Termination of Pregnancy|Interest of Cervical Dilators in the Induction of Labor in Second Trimester Medical Termination of Pregnancy.|Not yet recruiting||N/A|280|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 20:55:53.652159|2017-10-10 20:55:53.652159
NCT03194217|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|June 30, 2018|Anticipated|2018-06-30||Interventional|CASPAR||BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness|Dose Finding Phase IIb Study of Bavisant to Evaluate Its Safety and effiCacy in treAtment of exceSsive Daytime sleePiness (EDS) in PARkinson's Disease (PD).|Not yet recruiting||Phase 2|230|Anticipated|BenevolentAI Bio||4|||f||||f|t|f||||||No||2017-10-10 20:55:53.754097|2017-10-10 20:55:53.754097
NCT03194204|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-20|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 1, 2019|Anticipated|2019-10-01||Observational|||MMP-3 and 9 in RA and Their Relation to Cardiovascular Affection , Disease Activity and Treatment Response|Matrix Metalloproteinase- 3 and 9 in Rheumatoid Arthritis and Their Relation to Cardiovascular Affection , Disease Activity and Treatment Response|Not yet recruiting||N/A|120|Anticipated|Assiut University|||2||f||||f|f|f|||f|Samples Without DNA|"     blood and serum samples separated br centrifugation   "|No||2017-10-10 20:55:53.826898|2017-10-10 20:55:53.826898
NCT03194191|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-27|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|GAS||Pregnancy With Insomnia: a Trial of Acupuncture|Pregnancy With Insomnia: a Trial of Acupuncture|Not yet recruiting||N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 20:55:53.944217|2017-10-10 20:55:53.944217
NCT03194178|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-24|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|ADOROBIN||Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence|Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence|Recruiting||N/A|100|Anticipated|Imagine Institute|||1||f||||f|f|f||||||||2017-10-10 20:55:55.694325|2017-10-10 20:55:55.694325
NCT03194165|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-03|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|POPARV||Population Pharmacokinetics of Antiretroviral in Children|Population Pharmacokinetics of Antiretroviral in Children|Recruiting||N/A|700|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||||2017-10-10 20:55:55.792175|2017-10-10 20:55:55.792175
NCT03194152|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-14|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Peanut Consumption and Cardiovascular Disease Risk in a Chinese Population|Effects of Peanut Consumption on Cardiovascular Disease Risk Factors and Gut Microbiota Among Adults in China: A Randomized Controlled Trial|Recruiting||N/A|250|Anticipated|Harvard School of Public Health||2|||f|||||f|f||||||||2017-10-10 20:55:55.899082|2017-10-10 20:55:55.899082
NCT03194139|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study Designed to Compare the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 and GC4419 in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Crossover, Single Dose Study Designed to Compare the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 and GC4419 in Healthy Volunteers|Not yet recruiting||Phase 1|36|Anticipated|Galera Therapeutics, Inc.||2|||f||||f|t|f||||||No||2017-10-10 20:55:55.991645|2017-10-10 20:55:55.991645
NCT03194126|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-21|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|IMEGYN||Evaluation of Efficacy of Two Therapeutic Strategies for Cervical Maturation Before Medical Termination|Evaluation of Efficacy of Two Therapeutic Strategies for Cervical Maturation Before Medical Termination: Mechanical Plus Medicinal Maturation vs Medicinal Maturation Alone|Not yet recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f|f|f||||||No||2017-10-10 20:55:56.093879|2017-10-10 20:55:56.093879
NCT03194113|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-21|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|IMPACT||Improving PTSD Treatments for Adults With Childhood Trauma|Improving PTSD Treatments for Adults With Childhood Trauma|Recruiting||N/A|150|Anticipated|Leiden University Medical Center||3|||f||||f||||||||Undecided||2017-10-10 20:55:56.196323|2017-10-10 20:55:56.196323
NCT03194100|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-20|||January 1, 2014|Actual|2014-01-01|June 2017|2017-06-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Observational|||Serum METRNL Concentration in Type 2 Diabetes|Comparison of Serum METRNL Concentration Between Type 2 Diabetes and Normal Glucose Tolerance|Completed||N/A|125|Actual|Chungnam National University Hospital|||3||f|||||f|f||||||||2017-10-10 20:55:56.313091|2017-10-10 20:55:56.313091
NCT03194087|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-20|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||the Study on Prognostic for Hemodialysis Patients|the Study on Difference Prognostic for Low Parathyroid Hormone Levels and Severe Secondary Hyperparathyroidism in Hemodialysis Patients|Recruiting||N/A|827|Anticipated|Beijing Friendship Hospital|||1||f||||t|f|f||||||No||2017-10-10 20:55:56.403255|2017-10-10 20:55:56.403255
NCT03194074|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-08-01|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|POCDLLS||Early Cognitive Function in Elderly Patients After Laser Laryngeal Surgery: Des vs Prop|Early Cognitive Function and Recovery in Elderly Patients After Laser Laryngeal Surgery: Desflurane-based vs Propofol-based Anesthesia|Not yet recruiting||Phase 4|70|Anticipated|Eye & ENT Hospital of Fudan University||2|||f||||f|f|f|||f|||||2017-10-10 20:55:56.477358|2017-10-10 20:55:56.477358
NCT03194061|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-11|||January 1, 2015|Actual|2015-01-01|June 2017|2017-06-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2016|Actual|2016-08-31||Interventional|HIPOCP||Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer|Hypofractionated Radiotherapy and Concurrent Cisplatin for Locally Advanced Head and Neck Cancer: A Feasibility Trial|Active, not recruiting||N/A|20|Actual|Barretos Cancer Hospital||1|||f||||t|f|f||||||||2017-10-10 20:55:56.698341|2017-10-10 20:55:56.698341
NCT03194048|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||December 16, 2015|Actual|2015-12-16|June 2017|2017-06-01|April 1, 2016|Actual|2016-04-01|December 20, 2015|Actual|2015-12-20||Interventional|||Effect of Functional Chewing Training on Tongue Thrust and Drooling in Children With Cerebral Palsy|Effect of Functional Chewing Training on Tongue Thrust and Drooling in Children With Cerebral Palsy: A Randomised Controlled Trial|Completed||N/A|32|Actual|Hacettepe University||2|||f|||||f|f||||||Undecided||2017-10-10 20:55:56.785061|2017-10-10 20:55:56.785061
NCT03194035|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-20|||October 6, 2017|Anticipated|2017-10-06|June 2017|2017-06-01|October 13, 2017|Anticipated|2017-10-13|October 13, 2017|Anticipated|2017-10-13||Observational|TRAIL-INFLA||Inflammation in an Ultra Endurance Race|Per Effort Study of Inflammatory Consequences of an Ultra Endurance Race (165km)|Not yet recruiting||N/A|25|Anticipated|Hôpital Necker-Enfants Malades|||1||f||||f|f|f||||||No||2017-10-10 20:55:56.87288|2017-10-10 20:55:56.87288
NCT03194022|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||October 6, 2017|Anticipated|2017-10-06|June 2017|2017-06-01|October 13, 2017|Anticipated|2017-10-13|October 6, 2017|Anticipated|2017-10-06||Observational|TRAIL-BIO||Biological Consequences of an Ultra Endurance Race|Per Effort Study of Biological Consequences of an Ultra Endurance Race (165km)|Not yet recruiting||N/A|25|Anticipated|Hôpital Necker-Enfants Malades|||1||f||||f|f|f||||Samples Without DNA|"     blood electrolytes   "|Undecided||2017-10-10 20:55:56.952601|2017-10-10 20:55:56.952601
NCT03194009|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-15|||August 10, 2017|Actual|2017-08-10|June 2017|2017-06-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|PRuDENTE||PRuDENTE; Diabetes Prevention Via Exercise, Nutrition and Treatment|PRuDENTE; Diabetes Prevention Via Exercise, Nutrition and Treatment|Recruiting||N/A|3060|Anticipated|Instituto Nacional de Salud Publica, Mexico||2|||f||||t|f|f|||f|||||2017-10-10 20:55:57.019959|2017-10-10 20:55:57.019959
NCT03193996|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-19|||August 15, 2017|Anticipated|2017-08-15|June 2017|2017-06-01|February 28, 2022|Anticipated|2022-02-28|August 15, 2020|Anticipated|2020-08-15||Interventional|4DCT||4DCT Imaging for Improved Diagnosis and Treatment of Wrist Ligament Injuries|4DCT Imaging for Improved Diagnosis and Treatment of Wrist Ligament Injuries|Not yet recruiting||N/A|60|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|f|f|||No||2017-10-10 20:55:57.126839|2017-10-10 20:55:57.126839
NCT03193983|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-19|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Flaps Coverage Versus Occlusive Dressing in Treating Fingertip Injuries With Exposed Bone|Flaps Coverage Versus Occlusive Dressing in Treating Fingertip Injuries With Exposed Bone|Recruiting||N/A|60|Anticipated|Assiut University||2|||f||||f|f|f||||||Yes|whole study data and results will be available|2017-10-10 20:55:57.224979|2017-10-10 20:55:57.224979
NCT03193970|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||April 30, 2015|Actual|2015-04-30|June 2017|2017-06-01|December 2034|Anticipated|2034-12-01|December 2034|Anticipated|2034-12-01|3 Months|Observational [Patient Registry]|||Measuring Surgical Recovery After Radical Cystectomy|Measuring Surgical Recovery After Radical Cystectomy|Recruiting||N/A|20000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||||||2017-10-10 20:55:57.32244|2017-10-10 20:55:57.32244
NCT03193450|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-17|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Telephone-Based Re-education for Hp Eradication|Telephone-Based Re-Education of Drug Administration for Helicobacter Pylori Eradication: a Multi-Center Randomized, Controlled Study|Not yet recruiting||N/A|162|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f|f|f||||||No||2017-10-10 20:56:01.431013|2017-10-10 20:56:01.431013
NCT03193944|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-20|||February 10, 2017|Actual|2017-02-10|June 2017|2017-06-01|July 10, 2017|Anticipated|2017-07-10|May 10, 2017|Actual|2017-05-10||Interventional|||Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran|Vitamin D Supplementation on Metabolic Syndrome Indicators Among Food Insecure, Vitamin D Deficient Older Adults in Karaj City, Alborz Province, Iran;|Enrolling by invitation||Phase 2|120|Anticipated|Alborz Medical University||2|||f||||t|f|f||||||Yes||2017-10-10 20:55:57.519279|2017-10-10 20:55:57.519279
NCT03193931|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-08|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|September 1, 2023|Anticipated|2023-09-01|December 30, 2021|Anticipated|2021-12-30||Interventional|ELDORANDO||Study Comparing Pembrolizumab With Methotrexate in Elderly, Frail or Cisplatin-ineligible Patients With Head and Neck Cancers|A Randomized Phase II Study Comparing Pembrolizumab With Methotrexate in Elderly, Frail or Cisplatin-ineligible Patients With Head and Neck Cancers|Not yet recruiting||Phase 2|100|Anticipated|AIO-Studien-gGmbH||2|||f||||t|f|f||||||||2017-10-10 20:55:57.610227|2017-10-10 20:55:57.610227
NCT03193918|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-19|||April 14, 2017|Actual|2017-04-14|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma|Phase I/Ib Study of Crenolanib With Ramucirumab and Paclitaxel as Second Line Therapy for Advanced Esophagogastric Adenocarcinoma|Recruiting||Phase 1|34|Anticipated|Arog Pharmaceuticals, Inc.||1|||f|||||t|f||||||||2017-10-10 20:55:57.702163|2017-10-10 20:55:57.702163
NCT03193905|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-06-19|||November 2015||2015-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Preventing Inadvertent Hypothermia in Patients Undergoing Major Spinal Surgery|Preventing Inadvertent Hypothermia in Patients Undergoing Major Spinal Surgery|Completed||N/A|60|Actual|Aalborg Universitetshospital||2|||f||||f||||||||No||2017-10-10 20:55:57.782238|2017-10-10 20:55:57.782238
NCT03193892|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-18|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|3 Years|Observational [Patient Registry]|||A National Registry on Chinese Patients With Lymphangioleiomyomatosis|A National Registry on Clinical Manifestations, Genetics, Interventions, and Outcomes in Chinese Patients With Lymphangioleiomyomatosis (LAM-CHINA)|Recruiting||N/A|800|Anticipated|Peking Union Medical College Hospital|||1||f||||t|f|f||||Samples With DNA|"     Biological specimens are preserved in serum, plasma, and leukocytes   "|No|Currently, there is no such a plan to share IPD to other researchers|2017-10-10 20:55:57.859893|2017-10-10 20:55:57.859893
NCT03193879|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-26|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01|2 Years|Observational [Patient Registry]|||Effects of Particulate Matter on the Pulmonary Function and Acute Exacerbation of COPD and Asthma|Effects of Particulate Matter on the Lung Function and Acute Exacerbation of COPD and Asthma Patients－－A Multi-center Cohort Study|Recruiting||N/A|500|Anticipated|Peking Union Medical College Hospital|||3||f||||t|f|f||||Samples With DNA|"     Biological specimens are preserved in serum, plasma, and leukocytes   "|Undecided||2017-10-10 20:55:57.944056|2017-10-10 20:55:57.944056
NCT03193866|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-18|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01|3 Years|Observational [Patient Registry]|COMBAT-MS||COMparison Between All immunoTherapies for Multiple Sclerosis.|COMparison Between All immunoTherapies for Multiple Sclerosis. An Observational Long-term Prospective Cohort Study of Safety, Efficacy and Patient's Satisfaction of MS Disease Modulatory Treatments in Relapsing-remitting Multiple Sclerosis|Recruiting||N/A|3700|Anticipated|Karolinska Institutet|||1||f||||t|t|f|||f|Samples Without DNA|"     Serum samples will be taken yearly for analysis of anti-drug antibodies. These samples will     be saved in biobank.   "|No||2017-10-10 20:55:58.067458|2017-10-10 20:55:58.067458
NCT03193853|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-19|||July 5, 2017|Anticipated|2017-07-05|June 2017|2017-06-01|June 9, 2022|Anticipated|2022-06-09|June 9, 2021|Anticipated|2021-06-09||Interventional|||TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer|Phase II Clinical Trial of Treatment With TAK-228 and TAK-117 to Inhibit Homologous Recombination (HR) Followed by Cisplatin and Nab Paclitaxel in Patients With Chemotherapy-pretreated Metastatic Triple Negative Breast Cancer|Recruiting||Phase 2|20|Anticipated|Baylor Research Institute||1|||f||||f|t|f||||||Yes|The Investigators will share de-identified data with Takeda for information/publication purposes|2017-10-10 20:55:58.195323|2017-10-10 20:55:58.195323
NCT03193840|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-22|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|osteotomy||Posterior Wall Osteotomy for Old Acetabular Fracture|Surgical Treatment of Old Acetabular Fracture With Posterior Wall Osteotomy|Recruiting||N/A|40|Anticipated|Hebei Medical University Third Hospital||1|||f||||t|f|f||||||No||2017-10-10 20:55:58.281474|2017-10-10 20:55:58.281474
NCT03193827|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-18|||November 1, 2016|Actual|2016-11-01|June 2017|2017-06-01|June 10, 2017|Actual|2017-06-10|June 1, 2017|Actual|2017-06-01||Interventional|||In-line Filtration Reduces Postoperative Phlebitis.|In-line Filtration Reduces Postoperative Venous Peripheral Phlebitis Associated With Cannulation: a Randomised Clinical Trial|Completed||N/A|268|Actual|Careggi Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:55:58.360546|2017-10-10 20:55:58.360546
NCT03193814|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-20|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|XHZL||Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal Cancer|Study Evaluating the Safety and Efficacy of FOLFOX Plus Apatinib or FOLFIRI Plus Apatinib as Second-line Therapy in Metastatic Colorectal Cancer|Not yet recruiting||Phase 2|50|Anticipated|Wuhan Union Hospital, China||1|||f|||||f|f||||||||2017-10-10 20:55:58.545527|2017-10-10 20:55:58.545527
NCT03193632|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Observational|||The Effect of LBM Evaluated by US on REE Measured by Indirect Calorimetry|The Effect of Lean Body Mass Evaluated by Musculoskeletal Ultrasound on Resting Energy Expenditure Measured by Indirect Calorimetry: Prospective Observational Study|Recruiting||N/A|40|Anticipated|Cairo University|||1||f||||||||||||Undecided||2017-10-10 20:56:00.003757|2017-10-10 20:56:00.003757
NCT03193801|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 1, 2024|Anticipated|2024-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||PARTNER 3 Trial - Mitral Valve in Valve|PARTNER 3 Trial - Mitral Valve in Valve is a Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3 Transcatheter Heart Valve Implantation in Patients With a Failing Mitral Bioprosthetic Valve|Not yet recruiting||N/A|50|Anticipated|Edwards Lifesciences||1|||f||||t|f|t|t|f||||||2017-10-10 20:55:58.6251|2017-10-10 20:55:58.6251
NCT03193788|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-13|2017-06-18|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|PREMIER||Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy|A Prospective Randomized Phase III Trial of Maintenance Pemetrexed Versus Observation in Patients With Recurrent or Metastatic Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy Without Disease Progression|Recruiting||Phase 3|74|Anticipated|Asan Medical Center||2|||f||||f||||||||Undecided||2017-10-10 20:55:58.722164|2017-10-10 20:55:58.722164
NCT03193775|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-20|||August 1, 2011|Actual|2011-08-01|June 2017|2017-06-01|October 1, 2015|Actual|2015-10-01|October 1, 2015|Actual|2015-10-01||Interventional|||Impact of Hepatitis B Vaccination on HBs Antigenemia|Impact of Hepatitis B Vaccination on HBsAg Kinetics, Interferon-inducible Protein 10 Level and Recurrence of Viremia|Completed||N/A|220|Actual|Zagazig University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:55:58.915262|2017-10-10 20:55:58.915262
NCT03193762|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-22|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|June 1, 2018|Anticipated|2018-06-01||Observational|EVANX||Usefulness of a Visual Analogue Scale to Evaluate Anxiety in the Painful Hospitalized Patient|Usefulness of a Visual Analogue Scale to Evaluate Anxiety in the Painful Hospitalized Patient|Recruiting||N/A|404|Anticipated|Lille Catholic University|||1||f||||f|f|f||||||||2017-10-10 20:55:58.985119|2017-10-10 20:55:58.985119
NCT03193749|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|ATTACH||A Trial Testing Amiodarone in Chagas Cardiomiopathy|A Trial Testing Amiodarone in Chagas Cardiomyopathy (ATTACH)|Recruiting||Phase 3|200|Anticipated|Fundación Cardioinfantil Instituto de Cardiología||2|||f||||f|f|f|||f|||Yes|Upon submission of primary results, following requests of editors, by request to the steering committee|2017-10-10 20:55:59.106116|2017-10-10 20:55:59.106116
NCT03193736|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-27|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|November 30, 2019|Anticipated|2019-11-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications|A Prospective, Open, Multicenter Clinical Trial With One Cohort Analysing the Efficacy and Safety of MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications|Recruiting||N/A|25|Anticipated|iSTAR Medical||1|||f||||t|f|f||||||||2017-10-10 20:55:59.223045|2017-10-10 20:55:59.223045
NCT03193723|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||October 1, 2016|Actual|2016-10-01|June 2017|2017-06-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Ultrasound Guided Local Anesthetic Field Block (A Five Step Procedure) for Open Inguinal Hernia Repair|Efficacy of Ultrasound Guided Local Anesthetic Field Block (A Five Step Procedure) as a Sole Anesthetic for Open Inguinal Hernia Repair Versus Spinal Anesthesia: A Randomized Controlled Study.|Recruiting||N/A|86|Anticipated|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 20:55:59.314192|2017-10-10 20:55:59.314192
NCT03193710|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-03|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|October 2023|Anticipated|2023-10-01|October 2018|Anticipated|2018-10-01||Observational|||The Effects of General Anesthetics on Lymphocytes in Patients Undergoing Colorectal Cancer Resection and Mechanism Involved|Comparison of the Effects of Total Intravenous Anesthesia and Inhalation Anesthesia on Lymphocytes in Patients Undergoing Colorectal Cancer Resection and the Mechanism Involved: a Single-center, Randomized, Prospective Study|Not yet recruiting||N/A|260|Anticipated|West China Hospital|||2||f||||t||||||Samples Without DNA|"     Blood of the enrolled patients will be sampled at different time-points for examination of     lymphocytes.   "|||2017-10-10 20:55:59.429435|2017-10-10 20:55:59.429435
NCT03193697|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-19|||January 1, 2014|Actual|2014-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 1, 2016|Actual|2016-06-01||Interventional|||Efficacy and Safety of Cemented and Cementless Prostheses for Unstable Intertrochanteric Fractures in the Elderly|Efficacy and Safety of Cemented and Cementless Prostheses in the Repair of Unstable Intertrochanteric Fractures in the Elderly: a Prospective, Single-center, Non-randomized, Controlled, Clinical Trial With 6-month Follow-up|Active, not recruiting||N/A|86|Anticipated|Harrison International Peace Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:55:59.562778|2017-10-10 20:55:59.562778
NCT03193684|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-17|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 31, 2022|Anticipated|2022-08-31|January 31, 2022|Anticipated|2022-01-31||Interventional|||Dapagliflozin and Hepatic Glucose Metabolism|Effect of Dapagliflozin on Hepatic Glucose Metabolism: Role of Autonomic Nervous System|Not yet recruiting||Phase 4|108|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f|t|f|||t|||No||2017-10-10 20:55:59.643128|2017-10-10 20:55:59.643128
NCT03193671|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-28|||September 1, 2013|Actual|2013-09-01|August 2017|2017-08-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29|12 Weeks|Observational [Patient Registry]|||Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis|Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis|Completed||N/A|684|Actual|Göteborg University|||4||f||||t|f|f||||Samples With DNA|"     Serum samples   "|||2017-10-10 20:55:59.739033|2017-10-10 20:55:59.739033
NCT03193658|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-20|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||USG Thoracolumbar Interfascial Plane (TLIP) in Lumbar Spine Surgeries|Effect of Ultrasound Guided Bilateral Thoracolumbar Interfascial Plane (TLIP) Block on Post-operative Opioid Consumption After Lumbar Spine Surgeries. A Randomized Double Blinded Study.|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f|||||f|f||||||Undecided||2017-10-10 20:55:59.819985|2017-10-10 20:55:59.819985
NCT03193619|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-28|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|1 Year|Observational [Patient Registry]|||Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon|A Prospective, Multi-Center, Single-Arm, Real-World Study Assessing the Clinical Use of the Bard® UltraScore™ Focused Force PTA Balloon|Not yet recruiting||N/A|350|Anticipated|C. R. Bard|||1||f||||f|f|t|f|f|t|||||2017-10-10 20:56:00.110847|2017-10-10 20:56:00.110847
NCT03193606|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-03|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Radiographic Assessment of Glass Ionomer Restorations With and Without Prior Application of Nano Silver Fluoride in Occlusal Carious Molars Treated With Partial Caries Removal Technique|Radiographic Assessment of Glass Ionomer Restorations With and Without Prior Application of Nano Silver Fluoride in Occlusal Carious Molars Treated With Partial Caries Removal Technique (Randomized Clinical Trial)|Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:56:00.329037|2017-10-10 20:56:00.329037
NCT03193593|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-06|||August 29, 2017|Actual|2017-08-29|September 2017|2017-09-01|February 15, 2018|Anticipated|2018-02-15|November 30, 2017|Anticipated|2017-11-30||Interventional|||Study to Evaluate EB-001 in Reducing Musculoskeletal Pain|Phase 2 Placebo-Controlled, Double Blind, Ascending Dose Cohort Study to Evaluate Safety and Efficacy of EB-001 IM Injections in Reducing Musculoskeletal Pain in Subjects Undergoing Elective Augmentation Mammoplasty (Breast Augmentation)|Recruiting||Phase 2|64|Anticipated|Bonti, Inc.||2|||f||||t|t|f||||||||2017-10-10 20:56:00.396866|2017-10-10 20:56:00.396866
NCT03193580|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-06-18|||June 20, 2017|Anticipated|2017-06-20|June 2017|2017-06-01|August 30, 2018|Anticipated|2018-08-30|July 1, 2018|Anticipated|2018-07-01||Interventional|AMPED||Accelerating Motor Learning in Pediatrics|Accelerating Motor Learning in Pediatrics|Not yet recruiting||N/A|24|Anticipated|University of Calgary||3|||f||||f|f|f||||||No||2017-10-10 20:56:00.468089|2017-10-10 20:56:00.468089
NCT03193567|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-18|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Study of High Efficient Killing Cell Therapy for Advanced NSCLC|Phase I Study of High Efficient Killing Cell Therapy for Advanced Non Small Cell Lung Cancer|Not yet recruiting||Phase 1|15|Anticipated|Ruijin Hospital||1|||f||||t|f|f||||||||2017-10-10 20:56:00.569885|2017-10-10 20:56:00.569885
NCT03193554|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-18|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 30, 2019|Anticipated|2019-12-30|June 30, 2019|Anticipated|2019-06-30|3 Months|Observational [Patient Registry]|||Diagnostic Value of MicroRNA 210 In Preeclampsia|Diagnostic Value of microRNA 210 In Preeclampsia|Not yet recruiting||N/A|60|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 20:56:00.636883|2017-10-10 20:56:00.636883
NCT03193541|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-17|||December 30, 2016|Actual|2016-12-30|June 2017|2017-06-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2021|Anticipated|2021-12-30||Observational|||A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer|A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer|Recruiting||N/A|1200|Anticipated|University of Hawaii|||1||f||||t|f|f||||Samples With DNA|"     Urine collection (minimal 50 mL) and cystoscopy (+ biopsy w/in 4 weeks, if abnormal noted)   "|No||2017-10-10 20:56:00.69904|2017-10-10 20:56:00.69904
NCT03193528|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-17|||December 30, 2016|Actual|2016-12-30|June 2017|2017-06-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2021|Anticipated|2021-12-30||Observational|||A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer|A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer|Recruiting||N/A|450|Anticipated|University of Hawaii|||1||f||||t|f|f||||Samples With DNA|"     Urine collection (minimal 50 mL) and cystoscopy (+ biopsy w/in 4 weeks, if abnormal noted)   "|No||2017-10-10 20:56:00.759344|2017-10-10 20:56:00.759344
NCT03193515|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-17|||December 30, 2016|Actual|2016-12-30|June 2017|2017-06-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2021|Anticipated|2021-12-30||Observational|||A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer|A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer|Recruiting||N/A|300|Anticipated|University of Hawaii|||1||f||||t|f|f||||Samples With DNA|"     Urine collection (minimal 50 mL) and cystoscopy (+ biopsy w/in 4 weeks, if abnormal noted)   "|No||2017-10-10 20:56:00.835225|2017-10-10 20:56:00.835225
NCT03193489|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-17|||May 11, 2015|Actual|2015-05-11|June 2017|2017-06-01|June 30, 2017|Anticipated|2017-06-30|May 31, 2017|Actual|2017-05-31||Interventional|||Two-year Follow-up to High-intensity Multi-component Agility Intervention That Improves Clinical and Motor Symptoms of Parkinson's Disease|A High-intensity Multi-component Agility Intervention in Parkinson's Patients: Two-year Follow-up|Active, not recruiting||N/A|3|Actual|Somogy Megyei Kaposi Mór Teaching Hospital||1|||f||||t|f|f||||||No||2017-10-10 20:56:01.125604|2017-10-10 20:56:01.125604
NCT03193476|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 1, 2022|Anticipated|2022-12-01|September 1, 2022|Anticipated|2022-09-01|5 Years|Observational [Patient Registry]|XLHRegistry||Registry for Patients With X-linked Hypophosphatemia|An International, Multicentre, Prospective, Non-interventional Observational Registry for Patients With X-linked Hypophosphatemia (XLH)|Not yet recruiting||N/A|1200|Anticipated|Kyowa Kirin Pharmaceutical Development Ltd|||1||f|||||f|f||||||||2017-10-10 20:56:01.202496|2017-10-10 20:56:01.202496
NCT03193463|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-18|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy|Pilot Trial of Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive World Health Organization (WHO) Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy (IND 117,240)|Recruiting||Early Phase 1|30|Anticipated|Case Comprehensive Cancer Center||3|||f||||t|t|t|f|f||||||2017-10-10 20:56:01.271592|2017-10-10 20:56:01.271592
NCT02881788|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-06-26|||August 2016||2016-08-01|December 2016|2016-12-01|December 31, 2017|Anticipated|2017-12-31|September 2017|Anticipated|2017-09-01|1 Year|Observational [Patient Registry]|||Minnesota Healthy Brain Initiative||Active, not recruiting||N/A|2000|Anticipated|Minneapolis Medical Research Foundation|||3||f||||||||||||||2017-10-10 21:52:01.421342|2017-10-10 21:52:01.421342
NCT03193437|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-19|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|SELECT||Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy|A Phase 2, Open-label Study of Selinexor (KPT-330) in Patients With Advanced Thymic Epithelial Tumor (TET) Progressing After Primary Chemotherapy (SELECT)|Not yet recruiting||Phase 2|25|Anticipated|Georgetown University||1|||f||||t|t|f||||||No||2017-10-10 20:56:01.551376|2017-10-10 20:56:01.551376
NCT03193424|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-17|2017-06-19|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma|A Prospective, Open-label, Randomized Controlled Clinical Study of Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma|Recruiting||Phase 2|120|Anticipated|The First Affiliated Hospital of Zhengzhou University||2|||f||||f|f|f||||||No||2017-10-10 20:56:01.643981|2017-10-10 20:56:01.643981
NCT03193411|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-17|||January 2014|Actual|2014-01-01|June 2017|2017-06-01|June 2014|Actual|2014-06-01|May 29, 2014|Actual|2014-05-29||Interventional|||Visumax Femtolasik Versus Moria M2 Microkeratome in Myopia|Visumax Femtolasik Versus Moria M2 Microkeratome in Mild to Moderate Myopia: Efficacy, Safety, Predictability, Aberrometric Changes and Flap Thickness Predictability|Completed||N/A|30|Actual|Dar Al Shifa Hospital||2|||f|||||f|f||||||No||2017-10-10 20:56:01.73906|2017-10-10 20:56:01.73906
NCT03193398|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-26|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy And Safety Study Of BTRX-246040 Administered Once Daily In Patients With Major Depressive Disorder With Or Without Anhedonia|Recruiting||Phase 2|100|Anticipated|BlackThorn Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:56:01.815991|2017-10-10 20:56:01.815991
NCT03193385|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-17|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Observational|||Treatment of Developmental Dysplasia of the HIp|Evaluation of Closed Reduction for Treatment of Developmental Dysplasia of the Hip in Children|Not yet recruiting||N/A|20|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 20:56:01.94527|2017-10-10 20:56:01.94527
NCT03193372|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-31|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|August 8, 2017|Actual|2017-08-08||Observational|||A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea|A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea|Active, not recruiting||N/A|2200|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 20:56:02.026772|2017-10-10 20:56:02.026772
NCT03193359|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-12|||January 15, 2018|Anticipated|2018-01-15|July 2017|2017-07-01|September 9, 2021|Anticipated|2021-09-09|September 9, 2021|Anticipated|2021-09-09||Interventional|||Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine|A Multicenter, Open-label, Safety, Tolerability and Efficacy Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine|Withdrawn||Phase 3|0|Actual|Allergan||1||Corporate Decision|f||||f|f|f||||||||2017-10-10 20:56:02.11461|2017-10-10 20:56:02.11461
NCT03193346|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-12|||July 3, 2017|Anticipated|2017-07-03|July 2017|2017-07-01|March 25, 2021|Anticipated|2021-03-25|March 25, 2021|Anticipated|2021-03-25||Interventional|||BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine|Withdrawn||Phase 3|0|Actual|Allergan||2||Corporation Decision|f||||f|f|f||||||||2017-10-10 20:56:02.201052|2017-10-10 20:56:02.201052
NCT03193333|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-18|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|December 16, 2018|Anticipated|2018-12-16|October 31, 2018|Anticipated|2018-10-31||Interventional|PRO-122LATAM||PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)|A Non-inferiority in the Intraocular Pressure Decrease of the Preservative-free Ophthalmic Solution PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma|Recruiting||Phase 3|51|Anticipated|Laboratorios Sophia S.A de C.V.||3|||f||||t|f|f||||||||2017-10-10 20:56:02.28996|2017-10-10 20:56:02.28996
NCT03193320|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-16|||July 17, 2017|Anticipated|2017-07-17|June 2017|2017-06-01|December 17, 2017|Anticipated|2017-12-17|December 17, 2017|Anticipated|2017-12-17||Interventional|MIFAS||Management of Intraoperative Fluids in Ambulatory Surgery|Intraoperative Fluid Therapy Management in Low-risk Patients Under General Anesthesia— a Randomized Controlled Trial Comparing Liberal, Restrictive and Pleth Variability Index (PVI)-Guided Fluid Administration in a Day Surgery Setting|Not yet recruiting||N/A|243|Anticipated|Policlinica Metropolitana||3|||f||||f|f|f||||||Undecided||2017-10-10 20:56:02.406141|2017-10-10 20:56:02.406141
NCT03193307|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-10-03|||June 29, 2017|Actual|2017-06-29|October 2017|2017-10-01|October 20, 2017|Anticipated|2017-10-20|October 13, 2017|Anticipated|2017-10-13||Interventional|||This Study Tests in Healthy Korean Women Which Effects BI 409306 and a Birth-control Pill Have on Each Other|A Study to Investigate the Pharmacokinetic Drug-drug Interaction Following Oral Administration of Ethinylestradiol/Levonorgestrel (Microgynon®) and BI 409306 in Healthy Korean Premenopausal Female Subjects (an Open-label, Two-period, Fixed-sequence Study)|Recruiting||Phase 1|16|Anticipated|Boehringer Ingelheim||1|||f||||f|f|f||||||||2017-10-10 20:56:02.50622|2017-10-10 20:56:02.50622
NCT03193294|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||November 7, 2016||2016-11-07|June 2017|2017-06-01|November 6, 2019|Anticipated|2019-11-06|January 31, 2018|Anticipated|2018-01-31||Interventional|CorMicA||CORonary MICrovascular Angina (CorMicA)|CORonary MICrovascular Angina (CorMicA): a Randomised, Controlled, Pilot Trial|Recruiting||N/A|150|Anticipated|NHS National Waiting Times Centre Board||2|||f||||f|f|f||||||Undecided|Data access may be possible pending Sponsor approval|2017-10-10 20:56:02.594469|2017-10-10 20:56:02.594469
NCT03193281|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-20|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Interventional|KISS||KISS Study: Kinase Inhibition With Sprycel Start up|KISS Study: A Phase II Study of Dasatinib Followed by Imatinib in Newly Diagnosed, Previously Untreated Patients With Chronic Phase CML|Recruiting||Phase 2|100|Anticipated|University of Auckland, New Zealand||1|||f||||t|t|f|||t|||||2017-10-10 20:56:02.749282|2017-10-10 20:56:02.749282
NCT03193268|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-10-03|||October 15, 2017|Anticipated|2017-10-15|July 2017|2017-07-01|November 21, 2017|Anticipated|2017-11-21|November 21, 2017|Anticipated|2017-11-21||Interventional|||Effects of Intensity-matched Agility and Cycling Exercise Training on PD Patients' Clinical Symptoms, Posture, and Mobility|Effects of Intensity-matched Agility and Cycling Exercise Training on PD Patients' Clinical Symptoms, Posture, and Mobility|Enrolling by invitation||N/A|2|Actual|Somogy Megyei Kaposi Mór Teaching Hospital||3|||f||||t|f|f||||||||2017-10-10 20:56:02.871187|2017-10-10 20:56:02.871187
NCT03193255|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-20|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy and Safety of cleadewGP for Rigid Contact Lenses|Efficacy and Safety of Povidone Iodine-based Disinfecting Solution (cleadewGP) for Rigid Contact Lenses|Recruiting||N/A|80|Anticipated|The Hong Kong Polytechnic University||4|||f||||f|f|f||||||Undecided||2017-10-10 20:56:02.954547|2017-10-10 20:56:02.954547
NCT03193242|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-19|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|eAMS||The Electronic Asthma Management System|eAMS: The Electronic Asthma Management System|Not yet recruiting||N/A|50|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 20:56:03.047864|2017-10-10 20:56:03.047864
NCT03193229|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes|MapTrek, an Interactive, m-Health Intervention to Increase Activity Among Patients at Risk for Type 2 Diabetes|Recruiting||N/A|430|Anticipated|University of Iowa||2|||f||||f|f|f||||||No||2017-10-10 20:56:03.136598|2017-10-10 20:56:03.136598
NCT03193216|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-20|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus|The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus: A Pilot Study|Not yet recruiting||Phase 2|20|Anticipated|Medical University of South Carolina||1|||f||||t|t|f||||||No||2017-10-10 20:56:03.222022|2017-10-10 20:56:03.222022
NCT03193203|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-09-26|||March 24, 2017|Actual|2017-03-24|June 2017|2017-06-01|August 7, 2017|Actual|2017-08-07|August 7, 2017|Actual|2017-08-07||Interventional|||Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects|A Randomised, Open-label, Two-period, Two-sequence, Single-dose, Cross-over Study to Compare the Pharmacokinetics, Safety, and Tolerability of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects|Completed||Phase 1|50|Actual|Samsung Bioepis Co., Ltd.||2|||f|||||f|f||||||||2017-10-10 20:56:03.290974|2017-10-10 20:56:03.290974
NCT03193190|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-01|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|April 4, 2020|Anticipated|2020-04-04|November 16, 2019|Anticipated|2019-11-16||Interventional|||A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)|A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)|Recruiting||Phase 1/Phase 2|185|Anticipated|Hoffmann-La Roche||4|||f||||t|t|f||||||||2017-10-10 20:56:03.367778|2017-10-10 20:56:03.367778
NCT03193177|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-26|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Safety and Clinical Efficiency of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases|An Open Label, Phase I/II Clinical Trial of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases|Recruiting||Phase 1/Phase 2|50|Anticipated|Tsinghua University||1|||f||||t|f|f||||||Yes||2017-10-10 20:56:03.497961|2017-10-10 20:56:03.497961
NCT03193151|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|August 2019|Anticipated|2019-08-01||Observational|INTERLIVER||Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation|Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation, a Multicenter Study|Not yet recruiting||N/A|300|Anticipated|University of Alberta|||1||f||||f|f|f||||Samples Without DNA|"     Biopsy extract containing RNA   "|No||2017-10-10 20:56:03.6688|2017-10-10 20:56:03.6688
NCT03193138|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-10|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Observational|TORNICS||CardioTOxicity Induced by andRogeNICS and Their Antagonists (TORNICS)|Cardiotoxicity of Androgenic Agonists and Antagonists in the National French Pharmacovigilance Database and EudraCT Database|Completed||N/A|3096|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||f|f|f||||||||2017-10-10 20:56:03.751366|2017-10-10 20:56:03.751366
NCT03193125|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|June 4, 2018|Anticipated|2018-06-04|June 4, 2018|Anticipated|2018-06-04||Interventional|||Carnitine and Liver Mitochondria Fatty Acid Processing|Effects of Carnitine Supplementation on Liver Mitochondria Fatty Acid Processing|Recruiting||N/A|24|Anticipated|Pennington Biomedical Research Center||2|||f||||f|f|f||||||Yes|Anonymized blood assay results, MRI data, and other de-identified clinical lab data will be shared with other researchers beginning 6 months after study completion. It may be obtained through a written request to the PI.|2017-10-10 20:56:03.822062|2017-10-10 20:56:03.822062
NCT03193112|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|November 15, 2018|Anticipated|2018-11-15|October 15, 2017|Anticipated|2017-10-15||Observational|||Melatonin Decreases Eye Pressure in Normotensive Patients|Melatonin Decreases Eye Pressure in Depressive Patients With Normal Intraocular Pressure|Recruiting||N/A|25|Anticipated|Kahramanmaras Sutcu Imam University|||1||f||||f|||||t|||No||2017-10-10 20:56:03.893781|2017-10-10 20:56:03.893781
NCT03193099|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-28|||July 11, 2017|Actual|2017-07-11|May 2017|2017-05-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|Win-HD||Decoding Presymptomatic White Matter Changes in Huntington Disease|Decoding Presymptomatic White Matter Changes in Huntington Disease|Recruiting||N/A|40|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f|f|f||||||||2017-10-10 20:56:03.966331|2017-10-10 20:56:03.966331
NCT03193086|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-16|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Observational|||The Effect of Alemtuzumab on the Blood-brain-barrier and the Brain's Metabolism in Multiple Sclerosis Patients|The Effect of Alemtuzumab on the Blood-brain-barrier and Cerebral Metabolism in Multiple Sclerosis Patients; a New MRI Method for Treatment Response Evaluation in Multiple Sclerosis|Recruiting||N/A|35|Anticipated|Glostrup University Hospital, Copenhagen|||1||f||||f|t|f|||f|Samples Without DNA|"     plasma, urine   "|No||2017-10-10 20:56:04.050585|2017-10-10 20:56:04.050585
NCT03193073|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-19|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient|Impact of Anemia Correction and Fibroblast Growth Factor 23 Levels in Left Ventricular Hypertrophy, and Early Endothelial Dysfunction in Chronic Kidney Disease, and Renal Transplant Patient|Not yet recruiting||N/A|80|Anticipated|Assiut University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:56:04.150077|2017-10-10 20:56:04.150077
NCT03193047|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-06-19|||April 7, 2017|Actual|2017-04-07|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy|A Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg QD When Added to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Inhibitor Therapy|Recruiting||Phase 2|130|Anticipated|Esperion Therapeutics||2|||f||||t|t|f||||||No||2017-10-10 20:56:04.419672|2017-10-10 20:56:04.419672
NCT03193034|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-08-14|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||DSJ-2016-07 ATTUNE® Cementless CR RP Japan|Multi-Center Clinical Evaluation of the ATTUNE® Cementless Rotating Platform Total Knee Arthroplasty in the Japanese Patient Population|Recruiting||Phase 4|80|Anticipated|DePuy Orthopaedics||1|||f||||f|f|f||||||||2017-10-10 20:56:04.515846|2017-10-10 20:56:04.515846
NCT03193021|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-28|||September 20, 2017||2017-09-20||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:56:04.632823|2017-10-10 20:56:04.632823
NCT03193008|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-19|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|July 15, 2017|Anticipated|2017-07-15|July 15, 2017|Anticipated|2017-07-15||Observational|||Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?|Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?|Active, not recruiting||N/A|1400|Anticipated|Corporacion Parc Tauli|||1||f||||f|f|f||||||No||2017-10-10 20:56:04.676165|2017-10-10 20:56:04.676165
NCT03192995|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-08|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|June 2019|Anticipated|2019-06-01||Interventional|TLC||Treatment With Lorcaserin for Cocaine Use: The TLC Study|Treatment With Lorcaserin for Cocaine Use: The TLC Study|Not yet recruiting||Phase 2|45|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||||2017-10-10 20:56:04.74745|2017-10-10 20:56:04.74745
NCT03192982|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 1, 2020|Anticipated|2020-08-01|January 1, 2019|Anticipated|2019-01-01||Interventional|50506||Post-operative Complication, Impulsive Compression, in Situ Bypass|Impact on Expected Post-operative Complications With Impulsive Compression of Vein Complexes in Foot of Patients Operated on With In-situ Bypass for Acute/Chronic Leg Ischemia|Not yet recruiting||N/A|100|Anticipated|Vejle Hospital||2|||f||||f|f|f||||||||2017-10-10 20:56:04.832095|2017-10-10 20:56:04.832095
NCT03192969|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-10|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|November 23, 2021|Anticipated|2021-11-23|June 7, 2020|Anticipated|2020-06-07||Interventional|||A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)|A Phase III Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Combination With Glucocorticoid Treatment Compared to Glucocorticoid Monotherapy in Adults With Giant Cell Arteritis|Withdrawn||Phase 3|0|Actual|Bristol-Myers Squibb||3||Business objectives have changed|f||||t|t|f||||||||2017-10-10 20:56:04.944685|2017-10-10 20:56:04.944685
NCT03192956|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-16|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|January 1, 2022|Anticipated|2022-01-01|July 1, 2021|Anticipated|2021-07-01||Observational|DCS NEURO||Markers of Central Nervous System Injury in Decompression Sickness|Neuroskademarkörer Vid Dykarsjuka|Recruiting||N/A|40|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||f|f|f||||Samples Without DNA|"     Serum. Plasma.   "|No||2017-10-10 20:56:05.256133|2017-10-10 20:56:05.256133
NCT03192943|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-15|||June 23, 2017|Actual|2017-06-23|September 2017|2017-09-01|July 21, 2019|Anticipated|2019-07-21|July 21, 2019|Anticipated|2019-07-21||Interventional|||A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors|A Phase 1 Study for Safety and Tolerability of BMS-986205 Administered in Combination With Nivolumab (BMS-936558) in Advanced Malignant Tumors|Recruiting||Phase 1|18|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f|||t|||||2017-10-10 20:56:05.339031|2017-10-10 20:56:05.339031
NCT03192930|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-16|||March 17, 2017|Actual|2017-03-17|June 2017|2017-06-01|December 17, 2017|Anticipated|2017-12-17|December 17, 2017|Anticipated|2017-12-17||Observational|Mättnad 2017||Inflammatory and Cerebrospinal Biochemical Markers in Blood During Prolonged Hyperbaric Exposure|Inflammatoriska Och Neurokemiska förändringar Vid ökat Omgivningstryck|Recruiting||N/A|20|Anticipated|Sahlgrenska University Hospital, Sweden|||2||f||||f|f|f||||Samples Without DNA|"     Serum. Plasma.   "|No||2017-10-10 20:56:05.443256|2017-10-10 20:56:05.443256
NCT03192917|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-18|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 1, 2018|Anticipated|2018-09-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy|A Prospective Randomized Study Whether Low-energy Extracorporeal Shockwave Therapy (LI-ESWT) Can Increase Erectile Function in Patients After Radical Prostatectomy|Not yet recruiting||N/A|70|Anticipated|University of Southern Denmark||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:05.530693|2017-10-10 20:56:05.530693
NCT03192904|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-16|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 1, 2024|Anticipated|2024-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in Segmentectomy|Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial|Recruiting||N/A|136|Anticipated|Ruijin Hospital||2|||f||||f|f|f||||||||2017-10-10 20:56:05.644602|2017-10-10 20:56:05.644602
NCT03192891|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-28|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|November 30, 2018|Anticipated|2018-11-30|March 31, 2018|Anticipated|2018-03-31||Observational|SPINS||Clinical Impact of Stress CMR Perfusion Imaging|The Clinical Impact of Stress CMR Perfusion Imaging in the United States (SPINS): A Global CMR Registry Substudy|Active, not recruiting||N/A|2200|Anticipated|Society for Cardiovascular Magnetic Resonance|||1||f||||f|f|f||||||Undecided||2017-10-10 20:56:05.753924|2017-10-10 20:56:05.753924
NCT03192878|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-16|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|February 2019|Anticipated|2019-02-01||Observational|TAKASIM||Infliximab Biosimilar in Takayasu's Arteritis|A Prospective Observational Study of Infliximab Biosimilar in the Treatment of Takayasu's Arteritis Resistant to Corticosteroids and Conventional Immune-suppressive Treatments|Recruiting||N/A|30|Anticipated|Ospedale San Raffaele|||2||f||||f|f|f||||Samples Without DNA|"     serum, plasma   "|Undecided||2017-10-10 20:56:05.847466|2017-10-10 20:56:05.847466
NCT03192865|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-10|||October 1, 2014|Actual|2014-10-01|July 2017|2017-07-01|October 30, 2015|Actual|2015-10-30|October 2, 2014|Actual|2014-10-02||Observational|||Diaphragmatic Paralysis in Arthroscopic Shoulder Surgery|Diaphragmatic Paralysis in Arthroscopic Shoulder Surgery: Consequences and Causes|Completed||N/A|82|Actual|Clinique Medipole Garonne|||2||f||||t|f|f||||||||2017-10-10 20:56:05.973687|2017-10-10 20:56:05.973687
NCT03192852|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-21|||December 12, 2017|Anticipated|2017-12-12|June 2017|2017-06-01|April 17, 2019|Anticipated|2019-04-17|January 17, 2019|Anticipated|2019-01-17||Interventional|Bleaching||Evaluation of Dental Bleaching In-office|Evaluation of Bleaching In-office With Violet LEd Light (405 nm): Randomized, Controlled Double Blind and Clinical Trial|Not yet recruiting||N/A|80|Anticipated|University of Nove de Julho||4|||f||||t|f|f||||||Yes|After completing the data search, it is published in indexed journals with high impact factor|2017-10-10 20:56:06.060957|2017-10-10 20:56:06.060957
NCT03192839|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-19|2017-07-19|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Early DHA Supplementation in Very Low Birth Weight Infants|Early DHA Supplementation in Very Low Birth Weight Infants|Recruiting||N/A|20|Anticipated|Mead Johnson Nutrition||3|||f||||t|f|f||||||||2017-10-10 20:56:06.164304|2017-10-10 20:56:06.164304
NCT03192826|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-07-08|||June 20, 2016|Actual|2016-06-20|June 2017|2017-06-01|July 8, 2017|Actual|2017-07-08|July 8, 2017|Actual|2017-07-08||Interventional|||Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy|Study of the Efficacy of Brinzolamide 1% Plus Brimonidine 0.2% Versus Brimonidine 0.2% in the Prevention of Intraocular Pressure Rise After Nd-YAG Laser Capsulotomy|Completed||Phase 4|79|Actual|University Hospital of Patras||3|||f|||||t|f|||t|||||2017-10-10 20:56:06.25547|2017-10-10 20:56:06.25547
NCT03192813|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-06-16|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Observational|SCOPE II||Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation II|Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation II: A Randomized, Controlled, Non-inferiority Trial Evaluating Safety and Clinical Efficacy of the Symetis ACURATE Neo Compared to the Medtronic Evolut R Bioprosthesis in Transfemoral Transcatheter Aortic Valve Implantation|Recruiting||N/A|764|Anticipated|Ceric Sàrl|||2||f||||f|f|f||||||No||2017-10-10 20:56:06.350122|2017-10-10 20:56:06.350122
NCT03192800|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-18|||March 1, 2013|Actual|2013-03-01|March 2017|2017-03-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|COPSDAVF||Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas (COPSDAVF)|Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas|Recruiting||N/A|300|Anticipated|Xuanwu Hospital, Beijing|||1||f||||t|f|f||||||Undecided||2017-10-10 20:56:06.515921|2017-10-10 20:56:06.515921
NCT03192787|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-18|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|June 19, 2017|Anticipated|2017-06-19||Observational|||A Registry Study of Sanwujiaowan Capsule Used in Clinical Real World|A Registry Study of Sanwujiaowan Capsule Used in Clinical Real World|Not yet recruiting||N/A|3000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t|f|f||||||No||2017-10-10 20:56:06.604754|2017-10-10 20:56:06.604754
NCT03192774|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-18|||September 2007|Actual|2007-09-01|June 2017|2017-06-01||||December 2022|Anticipated|2022-12-01|10 Years|Observational [Patient Registry]|POST-TAVI||The Prospective Segeberg TAVI Registry|A Prospective Follow-up Assessment of Transcatheter Aortic Valve Implantation in Bad Segeberg|Recruiting||N/A|2000|Anticipated|Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH|||1||f||||f|f|t|f|f|f|||No||2017-10-10 20:56:06.661256|2017-10-10 20:56:06.661256
NCT03192761|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-19|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Best Method for ACL Reconstruction.|The Best Method for ACL Reconstruction. A Study Comparing Reconstructions of Anterior Cruciate Ligament Using Grafts Taken From Three Different Anatomical Locations at the Knee and Thigh. A Randomized Clinical Trial|Recruiting||N/A|90|Anticipated|Bispebjerg Hospital||3|||f||||t|f|f||||||Undecided||2017-10-10 20:56:06.726686|2017-10-10 20:56:06.726686
NCT03192748|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-18|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 19, 2017|Anticipated|2017-06-19||Observational|||A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World|A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World|Not yet recruiting||N/A|3000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t|f|f||||||No||2017-10-10 20:56:06.819385|2017-10-10 20:56:06.819385
NCT03192735|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-19|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2024|Anticipated|2024-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Apatinib Combined With SOX Neoadjuvant Chemotherapy for Locally Advanced Gastric Cance|Apatinib Combined With Oxaliplatin and Gimeracil and Oteracil Porassium Capsules Neoadjuvant Chemotherapy for Locally Advanced Gastric Cance: A Multicentre, One-armed, Clinical Pilot Trial|Recruiting||Phase 2|50|Anticipated|Fujian Medical University||1|||f|||||f|f|||f|||||2017-10-10 20:56:06.870285|2017-10-10 20:56:06.870285
NCT03192722|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-18|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2|Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2|Recruiting||N/A|20|Anticipated|Nova Southeastern University||2|||f|||||f|f||||||||2017-10-10 20:56:06.950043|2017-10-10 20:56:06.950043
NCT03192709|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-06-18|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Sildenafil and Outcome of IVF/ICSI Cycles|The Effect of Vaginal Sildenafil on the Outcome of IVF/ICSI Cycles in Patients With Repeated IVF/ICSI Failure: a Pilot Study|Recruiting||Phase 1/Phase 2|60|Anticipated|Royan Institute||3|||f||||t|f|f||||||No||2017-10-10 20:56:07.034609|2017-10-10 20:56:07.034609
NCT03192696|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-16|||July 2017||2017-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:56:07.136933|2017-10-10 20:56:07.136933
NCT03192683|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-18|2017-06-19|||April 1, 2016|Actual|2016-04-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||"Modified Providence Pedi Cast-Sling vs.Cast and Sling"|Patient and Parent Satisfaction With Sling Use After Pediatric Upper Extremity Fractures: A Randomized Controlled Trial|Completed||N/A|71|Actual|Lifespan||2|||f||||f|f|f||||||No||2017-10-10 20:56:07.170543|2017-10-10 20:56:07.170543
NCT03192670|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-18|||June 20, 2017|Anticipated|2017-06-20|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Study of Low-level Light Therapy Using Photo-activated Modulation Ameliorates Cognitive Deficits|A Study of Low-level Light Therapy Using Photo-activated Modulation Ameliorates Cognitive Deficits by Enhancing Cerebral Blow Flow|Not yet recruiting||N/A|168|Anticipated|Pusan National University||4|||f|||||f|f||||||No||2017-10-10 20:56:07.236129|2017-10-10 20:56:07.236129
NCT03192657|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-18|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Basiliximab Treating Interstitial Pneumonia of CADM|Basiliximab as a Treatment of Interstitial Pneumonia in Clinical Amyopathic Dermatomyositis Patients|Not yet recruiting||Phase 2|100|Anticipated|RenJi Hospital||2|||f|||||f|f||||||||2017-10-10 20:56:07.332193|2017-10-10 20:56:07.332193
NCT03192644|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||July 1, 2017|Anticipated|2017-07-01|January 2017|2017-01-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.|The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.|Recruiting||Phase 3|162|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:07.42084|2017-10-10 20:56:07.42084
NCT03192631|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-18|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Financial Incentives to Improve Acceptance of Antipsychotic Injections|Financial Incentives to Improve Acceptance and Adherence to Depot Injection Anti-psychotic Medication in Treatment Avoidant and Non-adherent Patients - a Pilot Study|Not yet recruiting||N/A|20|Anticipated|Focus Community Mental Health Team||2|||f||||f|f|f||||||No||2017-10-10 20:56:07.506792|2017-10-10 20:56:07.506792
NCT03192618|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.|The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.|Recruiting||Phase 3|290|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:07.589673|2017-10-10 20:56:07.589673
NCT03192605|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-19|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|||The Effect of Wild Blueberry Consumption on Glucose Regulation in Healthy Adults|The Effect of Wild Blueberry Consumption on Diabetes: Evaluation of Glucose Regulation, Gastrointestinal Hormones and Satiety in Healthy Adults|Completed||N/A|17|Actual|University of Prince Edward Island||2|||f||||f|f|f||||||Yes|Data will be shared as requested by other researchers. It may be made available by June 2018.|2017-10-10 20:56:07.665914|2017-10-10 20:56:07.665914
NCT03192592|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-27|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|July 28, 2017|Anticipated|2017-07-28|June 26, 2017|Actual|2017-06-26||Interventional|Apotech||Safety and Effectiveness Evaluation of the Apotech® Diabetic Body Moisturizer|Safety and Effectiveness Evaluation of a New Moisturizer Formulation With Antioxidant, Anti-inflammatory and Anti-microbial Effects in the Prevention of a Diabetic Skin Dryness and Complications|Active, not recruiting||N/A|36|Actual|ANS Pharma||1|||f||||t|f|f||||||Undecided||2017-10-10 20:56:07.731035|2017-10-10 20:56:07.731035
NCT03192579|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-21|||July 26, 2013|Actual|2013-07-26|August 2017|2017-08-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|||Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial|Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial|Completed||Phase 4|50|Actual|Kobe University||2|||f||||t|f|f||||||||2017-10-10 20:56:07.812394|2017-10-10 20:56:07.812394
NCT03192566|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-17|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Acetaminophen Dosing in Obese Adolescents|The Pharmacokinetics of Intravenous Acetaminophen and Its Metabolites in Obese Children and Adolescents|Recruiting||Phase 3|6|Anticipated|Children's Research Institute||1|||f||||f|t|f|||f|||No||2017-10-10 20:56:07.879794|2017-10-10 20:56:07.879794
NCT03192553|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-22|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Alternative Doffing Strategies to Prevent Healthcare Worker Self-Contamination When Using Personal Protective Equipment (PPE)|Alternative Doffing Strategies to Prevent Healthcare Worker Self-Contamination When Using Personal Protective Equipment (PPE)|Enrolling by invitation||N/A|100|Anticipated|Virginia Commonwealth University||4|||f|||||f|f||||||||2017-10-10 20:56:08.102254|2017-10-10 20:56:08.102254
NCT03192540|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-16|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|DSFIT||The Impact of an 8-week Supported Exercise Program on Fitness and Symptoms in Adolescents With Down Syndrome|The Impact of an 8-week Supported Exercise Program on Fitness and Symptoms of Anxiety and Depression in Adolescents With Down Syndrome|Not yet recruiting||N/A|8|Anticipated|Boston Children’s Hospital||1|||f||||f|f|f||||||No||2017-10-10 20:56:08.212003|2017-10-10 20:56:08.212003
NCT03192527|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-19|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Single Dose Recombinant Human Follicle Stimulating Hormone Fc Husion Protein (KN015) in Healthy Volunteers|A Phase I, Randomized, Placebo Controlled, Single Ascending Dose (SAD) Study of Recombinant Human Follicle Stimulating Hormone Fc Fusion Protein (KN015) in Healthy Female Volunteers|Recruiting||Phase 1|50|Anticipated|Alphamab Jilin Co., Ltd.||2|||f||||t|f|f||||||No||2017-10-10 20:56:08.294144|2017-10-10 20:56:08.294144
NCT03192514|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||October 2, 2017|Anticipated|2017-10-02|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Electronic Deprescribing Tool for the Prevention of PIP|Electronic Deprescribing Tool for the Prevention of Potentially Inappropriate Prescribing for Older Patients: A Protocol for a Cluster Randomized Trial|Not yet recruiting||N/A|280|Anticipated|University of Beira Interior||2|||f||||t|f|f||||||No||2017-10-10 20:56:08.416984|2017-10-10 20:56:08.416984
NCT03192501|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-03|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Observational|||iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care|Multicentre Perspective Non-interventional Study of Survival Benefits of iCAGES-guided Therapy in Contrast to Standard Therapy for Advanced Cancers|Recruiting||N/A|250|Anticipated|Second Affiliated Hospital of Guangzhou Medical University|||2||f||||t|f|f|||t|Samples With DNA|"     cancer biopsy samples   "|||2017-10-10 20:56:08.527527|2017-10-10 20:56:08.527527
NCT03192488|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-15|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia|Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia|Recruiting||Phase 4|15|Anticipated|Indiana University||2|||f||||t|t|f|||t|||||2017-10-10 20:56:08.648737|2017-10-10 20:56:08.648737
NCT03192475|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-16|||January 28, 2013|Actual|2013-01-28|June 2017|2017-06-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|PRS||The Pitt Retiree Study: A Diabetes Prevention Program for Medicare Eligible Older Adults|Dissemination of a Diabetes Prevention Program Among Medicare Eligible Older Adults|Completed||N/A|322|Actual|University of Pittsburgh||2|||f||||t|f|f||||||Yes|At the time of application in 2011 no formal data sharing plan was proposed, no designated funds were requested for archiving with a repository, and the R18 application was less than the $500,000 per year threshold set for data sharing. However, under my own auspices (as PI) I do plan to share the final research data with colleagues (post-doctoral students and junior faculty, co-investigators at my institution across several departments including Medicine, Psychiatry, Epidemiology/Public Health). All data is de-identified per the original Data Safety and Monitoring Plan. All safeguards will be taken to ensure confidentiality and privacy of participants. I will not place limits on questions or methods of those sharing data files and only require that the Pitt Retiree Study participants be acknowledged on all abstracts and manuscript publications resulting from the final data set.|2017-10-10 20:56:08.764678|2017-10-10 20:56:08.764678
NCT03192462|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-16|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2025|Anticipated|2025-08-01|March 1, 2021|Anticipated|2021-03-01||Interventional|TACTOPS||TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer|Tumor-Associated Antigen (TAA) Specific Cytotoxic T Lymphocytes Administered in Patients With Pancreatic Cancer|Not yet recruiting||Phase 1/Phase 2|45|Anticipated|Baylor College of Medicine||3|||f||||t|t|f||||||||2017-10-10 20:56:08.872048|2017-10-10 20:56:08.872048
NCT03192449|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-20|||November 21, 2016|Actual|2016-11-21|June 2017|2017-06-01|January 20, 2017|Actual|2017-01-20|December 15, 2016|Actual|2016-12-15||Interventional|||Serum Pharmacokinetic Disposition and Urinary Excretion of Albendazole|Serum Pharmacokinetic Disposition and Urinary Excretion of Albendazole and Its Metabolites in Non-infected Human Volunteers.|Completed||Phase 1|8|Actual|Universidad Nacional de Salta||1|||f||||f|f|f||||||Yes|Publication in peer review journal|2017-10-10 20:56:09.028458|2017-10-10 20:56:09.028458
NCT03192423|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||December 12, 2016|Actual|2016-12-12|June 2017|2017-06-01|August 1, 2017|Anticipated|2017-08-01|July 1, 2017|Anticipated|2017-07-01||Observational|||Acute Mental Stress During Lumbar Puncture|Acute Mental Stress Among the Physician and Patient During Lumbar Puncture, and Its Impact on Performance and Patient Related Outcomes|Recruiting||N/A|50|Anticipated|Rigshospitalet, Denmark|||3||f||||f|f|f||||||No||2017-10-10 20:56:09.193759|2017-10-10 20:56:09.193759
NCT03192410|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-15|||April 2002|Actual|2002-04-01|June 2017|2017-06-01|January 2040|Anticipated|2040-01-01|January 2040|Anticipated|2040-01-01||Observational|||Prospective Cohort Study of 4,837 Post-myocardial Infarction Patients (Alpha Omega Cohort)|Prospective Cohort Study of 4,837 Post-myocardial Infarction Patients (Alpha Omega Cohort)|Active, not recruiting||N/A|4837|Actual|Wageningen University|||1||f||||t|f|f||||Samples With DNA|"     Non-fasting venous blood samples were taken in 4785 patients at baseline, in 810 patients     after 20 months and in 2503 patients after 40 months of follow-up. DNA has been extracted for     genotyping.   "|Undecided||2017-10-10 20:56:09.306986|2017-10-10 20:56:09.306986
NCT03192397|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-08|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant|A Phase II Trial of Fludarabine/Melphalan/Total Body Irradiation With Post Transplant Cyclophosphamide as Graft Versus Host Disease Prophylaxis in Matched-Related and Matched-Unrelated Allogeneic Hematopoietic Cell Transplantation|Recruiting||Phase 2|30|Anticipated|Roswell Park Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 20:56:09.429127|2017-10-10 20:56:09.429127
NCT03192384|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-15|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|||A Service Intervention to Reduce Falls in Hospital|Step Wedge Cluster Randomised Trial of a Service Intervention to Reduce Falls in Hospital|Active, not recruiting||N/A|9|Actual|University of Warwick|||2||f|||||f|f||||||||2017-10-10 20:56:09.59204|2017-10-10 20:56:09.59204
NCT03192371|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-27|||February 15, 2018|Anticipated|2018-02-15|July 2017|2017-07-01|May 12, 2019|Anticipated|2019-05-12|May 12, 2019|Anticipated|2019-05-12||Interventional|||A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children|A Phase IV, Randomized, Open-label Study to Evaluate One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens (Zagreb 2-1-1 and Essen 1-1-1-1-1) in Chinese Children|Not yet recruiting||Phase 4|250|Anticipated|GlaxoSmithKline||2|||f|||||f|f||||||||2017-10-10 20:56:09.680645|2017-10-10 20:56:09.680645
NCT03192358|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-22|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|February 28, 2021|Anticipated|2021-02-28|August 2019|Anticipated|2019-08-01||Observational|||Physiological Flow of Liquids Used in Dysphagia Management|Physiological Flow of Liquids Used in Dysphagia Management (Previously Tongue-Pressure Timing for Liquid Flow Detection and Control in Swallowing)|Not yet recruiting||N/A|40|Anticipated|University Health Network, Toronto|||2||f||||f|f|f||||||No||2017-10-10 20:56:09.78693|2017-10-10 20:56:09.78693
NCT03192319|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-18|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell Transplantation|Comparison of Change in Humoral and Cellular Immunity Induced by Zoster Vaccine According to the Timing of Vaccination After Hematopoietic Stem Cell Transplantation|Recruiting||N/A|60|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:56:10.155096|2017-10-10 20:56:10.155096
NCT03192306|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-07|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores|A Multicenter, Placebo-Controlled, Randomized, Double-Blind Study of the Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Episodic Treatment of Recurrent Herpes Labialis|Recruiting||Phase 2|450|Anticipated|Topical Remedy||2|||f||||f|t|f||||||||2017-10-10 20:56:10.248419|2017-10-10 20:56:10.248419
NCT03192293|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-16|||January 20, 2017|Actual|2017-01-20|January 2017|2017-01-01|January 20, 2019|Anticipated|2019-01-20|January 20, 2019|Anticipated|2019-01-20||Interventional|||Metformin and Simvastatin in Addition to Fulvestrant|Single Arm Phase 2 Study of Metformin and Simvastatin in Addition to Fulvestrant in Metastatic Estrogen Receptor Positive Breast Cancer|Recruiting||Phase 2|28|Anticipated|National University Hospital, Singapore||1|||f||||f|f|f||||||No||2017-10-10 20:56:10.366527|2017-10-10 20:56:10.366527
NCT03192280|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-10|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Interventional|||Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response|Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response|Completed||N/A|12|Actual|LEO Pharma||1|||f|||||f|f|||t|||||2017-10-10 20:56:10.455999|2017-10-10 20:56:10.455999
NCT03192267|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-16|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|November 2027|Anticipated|2027-11-01|October 2026|Anticipated|2026-10-01|10 Years|Observational [Patient Registry]|||Prospective Observational Study of RA Patients|Prospective Observational Study of Newly Diagnosed Rheumatoid Arthritis Patients|Recruiting||N/A|100|Anticipated|University of Nebraska|||1||f||||f|f|f||||Samples With DNA|"     serum, plasma, whole blood for RNA/DNA isolation   "|No||2017-10-10 20:56:10.560487|2017-10-10 20:56:10.560487
NCT03192254|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-16|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Understanding Mechanisms of Health Behavior Change|Understanding Mechanisms of Health Behavior Change|Recruiting||N/A|72|Anticipated|University of Colorado, Boulder||3|||f||||f|f|f||||||No||2017-10-10 20:56:10.653141|2017-10-10 20:56:10.653141
NCT03192241|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-23|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PUMP||PUMP (Providing the Underprivileged With Manual Pumps): An RCT|PUMP (Providing the Underprivileged With Manual Pumps): A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|University of California, Davis||2|||f||||f|f|f||||||No||2017-10-10 20:56:10.765676|2017-10-10 20:56:10.765676
NCT03192228|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-16|||July 2011|Actual|2011-07-01|June 2017|2017-06-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Observational|||Impact of a Multidisciplinary Therapeutic Education Program Being Set up for Patients With Type 2 Diabetes Mellitus|Evaluation of a Multidisciplinary Program of Therapeutic Education in Type 2 Diabetes Mellitus Diabetes in Order to Fix Individualized Objectives|Completed||N/A|120|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||f|f|f||||||No||2017-10-10 20:56:10.852958|2017-10-10 20:56:10.852958
NCT03192215|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-16|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|April 30, 2022|Anticipated|2022-04-30|October 31, 2021|Anticipated|2021-10-31||Interventional|ARCADIA||AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke|AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke|Not yet recruiting||Phase 3|1100|Anticipated|Columbia University||2|||f||||t|t|f|||f|||Undecided||2017-10-10 20:56:10.941571|2017-10-10 20:56:10.941571
NCT03192202|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-09|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||AFM13 in Relapsed/Refractory Cutaneous Lymphomas|Clinical and Biological Evaluation of the Novel CD30/CD16A Tetravalent Bispecific Antibody (AFM13) in Relapsed or Refractory CD30-Positive Lymphoma With Cutaneous Presentation: A Biomarker Phase Ib/IIa Study|Recruiting||Phase 1/Phase 2|18|Anticipated|Columbia University||6|||f||||t|t|f||||||||2017-10-10 20:56:11.43289|2017-10-10 20:56:11.43289
NCT03192189|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-16|||August 20, 2016|Actual|2016-08-20|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|IRA Cible||Development of a Decision-making Aid for Referring Kidney Injury Patients in Need of Dialysis for Nephrology Consultations|Development of a Decision-making Aid for Referring Kidney Injury Patients in Need of Dialysis for Nephrology Consultations|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f|f|f||||||No||2017-10-10 20:56:11.524728|2017-10-10 20:56:11.524728
NCT03192176|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-28|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|August 19, 2018|Anticipated|2018-08-19|July 19, 2018|Anticipated|2018-07-19||Interventional|||A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)|A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)|Recruiting||Phase 2|352|Anticipated|Ogeda S.A.||8|||f||||f|t|f||||||||2017-10-10 20:56:13.289487|2017-10-10 20:56:13.289487
NCT03192163|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-17|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|CDTPPA||Cultural Differences in Treatment Preferences and Perceptions of Acne|Cultural, Racial, and Ethnic Differences in Treatment Preferences and Perceptions of Acne Vulgaris|Recruiting||N/A|100|Anticipated|Northwestern University|||2||f||||f|f|f||||||||2017-10-10 20:56:13.494074|2017-10-10 20:56:13.494074
NCT03192150|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-22|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|ISV-305||Independent Comparative Study to Evaluate ISV-305 Compared to Vehicle for the Treatment of Inflammation and Pain Associated With Cataract Surgery|A Phase 3, Randomized, Multicenter, Double-masked Study to Compare the Ocular Safety, Tolerability, and Efficacy of ISV-305 (0.1% Dexamethasone in DuraSite® 2) to DuraSite 2 Vehicle for the Treatment of Inflammation and Pain Associated With Cataract Surgery|Not yet recruiting||Phase 3|240|Anticipated|InSite Vision||2|||f||||f|t|f|||f|||||2017-10-10 20:56:13.582357|2017-10-10 20:56:13.582357
NCT03192137|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-22|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|ISV-305||Comparative Study to Evaluate ISV-305 Compared to Vehicle for the Treatment of Inflammation and Pain Associated With Cataract Surgery|A Phase 3, Randomized, Multicenter, Double-masked Study to Compare the Ocular Safety, Tolerability, and Efficacy of ISV-305 (0.1% Dexamethasone in DuraSite® 2) to DuraSite 2 Vehicle for the Treatment of Inflammation and Pain Associated With Cataract Surgery|Not yet recruiting||Phase 3|240|Anticipated|InSite Vision||2|||f||||f|t|f||||||||2017-10-10 20:56:13.656366|2017-10-10 20:56:13.656366
NCT03192124|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-07|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|July 30, 2018|Anticipated|2018-07-30||Observational|||Evaluating Bactisure Wound Lavage in Orthopedic Wounds|Evaluating Bactisure Wound Lavage in Cleansing Orthopedic Surgical Wounds|Recruiting||N/A|40|Anticipated|Zimmer Biomet|||1||f||||f|f|t|f|f|f|Samples With DNA|"     Level 1 Panel is a quantitative real-time PCR test to detect 12 microbial organisms that may     be present in patient specimen (bacteria and fungi) and includes test for resistance factors     to vancomycin and methicillin.      Microbial DNA in each sample will be sequenced using the Ion Torrent PGM sequencer in order     to establish what type of bacterial and fungal species are present.   "|||2017-10-10 20:56:13.734787|2017-10-10 20:56:13.734787
NCT03192111|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-07|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function|A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function|Recruiting||Phase 1|40|Anticipated|Syndax Pharmaceuticals||4|||f||||f|t|f||||||||2017-10-10 20:56:13.834814|2017-10-10 20:56:13.834814
NCT03192098|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-15|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|November 1, 2018|Anticipated|2018-11-01||Interventional|DILATE||Progressive Esophageal Dilation for Benign Strictures: a Randomized Controlled Trial|Progressive Versus Conservative Dilation Strategy for Benign Esophageal Strictures: a Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Radboud University||2|||f||||t|f|f||||||No||2017-10-10 20:56:13.946287|2017-10-10 20:56:13.946287
NCT03192085|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-15|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparison of SITA-Standard Compared to SITA-Fast Visual Fields.|Specificity and Patient Perception of SITA-Standard Compared to SITA-Fast Visual Fields in Patients Suspected of Having Glaucoma|Not yet recruiting||N/A|150|Anticipated|Royal Devon and Exeter NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 20:56:14.072259|2017-10-10 20:56:14.072259
NCT03192072|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-23|||July 17, 2017||2017-07-17||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:56:14.247913|2017-10-10 20:56:14.247913
NCT03192059|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-10|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 2022|Anticipated|2022-06-01|June 2021|Anticipated|2021-06-01||Interventional|PRIMMO||Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer|A Phase II Investigation of Pembrolizumab (Keytruda) in Combination With Radiation and an Immune Modulatory Cocktail in Patients With Cervical and Uterine Cancer (PRIMMO Trial)|Recruiting||Phase 2|43|Anticipated|University Hospital, Ghent||1|||f||||t|f|f|||f|||||2017-10-10 20:56:14.306445|2017-10-10 20:56:14.306445
NCT03192046|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bracing for Walking in Parkinson's Disease|Impact of Carbon Fiber AFOs on Gait and Resulting Changes in Quality of Life Across Time in Persons With PD|Recruiting||N/A|16|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|f|t|f|f|f|||No||2017-10-10 20:56:14.454032|2017-10-10 20:56:14.454032
NCT03192033|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-16|||July 3, 2017|Anticipated|2017-07-03|June 2017|2017-06-01|April 3, 2019|Anticipated|2019-04-03|March 3, 2019|Anticipated|2019-03-03||Interventional|STEP||STEP: Proglide® Versus Femoseal®: A Trial to Compare the Efficacy of Arterial Closure Devices Following Endovascular Peripheral Arterial Procedures|STEP: Proglide® Versus Femoseal®: A Randomized Controlled Trial to Compare the Efficacy of Arterial Closure Devices Following Endovascular Peripheral Arterial Procedures|Not yet recruiting||N/A|230|Anticipated|Nantes University Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:56:14.555414|2017-10-10 20:56:14.555414
NCT03192020|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-25|||August 14, 2017|Anticipated|2017-08-14|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|DETECT||Trial Comparing Treatment Strategies in Dupuytren's Contracture|DupuytrEn Treatment EffeCtiveness Trial (DETECT): Prospective, Randomized, Controlled, Outcome Assessor-blinded, Three Armed Parallel 1:1:1, Multicenter Trial Comparing Efficacy and Cost Effectiveness of Collagenase Clostridium Histolyticum, Percutaneous Needle Fasciotomy and Limited Fasciectomy as a Short and Long Term Treatment Strategy in Mild or Moderate Dupuytren's Contracture|Not yet recruiting||Phase 4|278|Anticipated|University of Tampere||3|||f||||t|t|f|||t|||Yes|All the IPD will be shared with other researchers by request.|2017-10-10 20:56:14.692351|2017-10-10 20:56:14.692351
NCT03192007|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-10-04|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2022|Anticipated|2022-08-31||Observational|||Multi-Parametric MRI for Renal Transplantation|Multi-Parametric MRI for Renal Transplantation|Not yet recruiting||N/A|140|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f|f|t|f|f|f|||||2017-10-10 20:56:14.857482|2017-10-10 20:56:14.857482
NCT03191994|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-16|||January 2, 2014||2014-01-02|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of an Eight Week Exercise Intervention in Treating Major Depressive Disorder|Exercise Promotes Neuroplasticity in Depressed and Healthy Brains: An fMRI Pilot Study|Recruiting||N/A|40|Anticipated|University of Ontario Institute of Technology||4|||f||||f|f|f||||||No||2017-10-10 20:56:14.945565|2017-10-10 20:56:14.945565
NCT03191981|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-22|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|MUKfourteen||Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma|A Phase I/II Trial Investigating the Combination of Pembrolizumab (Keytruda) With Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma|Withdrawn||Phase 1/Phase 2|0|Actual|University of Leeds||1||Withdrawal of pharma support prior to opening to recruitment|f||||t|f|f||||||||2017-10-10 20:56:15.059932|2017-10-10 20:56:15.059932
NCT03191968|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-14|||July 6, 2017|Actual|2017-07-06|April 2017|2017-04-01|September 26, 2018|Anticipated|2018-09-26|June 30, 2018|Anticipated|2018-06-30||Interventional|BOOST||Prostate Cancer Survivors and Exercise and Behavioral Counseling|A Pilot, Randomized Controlled Trial Adding Behavioral Counseling to Supervised Physical Activity in Prostate Cancer Survivors|Recruiting||Phase 2|50|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f|f|f||||||||2017-10-10 20:56:15.163273|2017-10-10 20:56:15.163273
NCT03191955|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-20|||November 2015||2015-11-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2017|Anticipated|2017-08-01||Observational|MWIC||Muscle Wasting in Cancer (MWIC)|Biochemical and Functional Biomarkers of Cachexia in Cancer Patients|Recruiting||N/A|120|Anticipated|University of Edinburgh|||2||f||||t||||||Samples With DNA|"     Rectus Muscle Quadriceps Femoris Muscle Tumour Subcutaneous fat Intra-abdominal fat Blood     Urine   "|Yes|Anonymised individual participant data (IPD), including phenotypic data but not including patient identifiable data will be shared with other researchers in collaboration with our research group. Interested parties may contact the lead researcher with data requests.|2017-10-10 20:56:15.303734|2017-10-10 20:56:15.303734
NCT03191942|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-20|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|June 2020|Anticipated|2020-06-01||Interventional|||Variation of Orthokeratology Lens Treatment Zone (VOLTZ) Study|Variation of Orthokeratology Lens Treatment Zone (VOLTZ) Study|Recruiting||N/A|60|Anticipated|The Hong Kong Polytechnic University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:15.416972|2017-10-10 20:56:15.416972
NCT03191929|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-14|||August 2011||2011-08-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Depression Screening in Primary Care: Using HIT for Patients With Limited English|Depression Screening in Primary Care: Using HIT for Patients With Limited English|Completed||N/A|410|Actual|University of California, Irvine||2|||f||||f|f|f||||||No||2017-10-10 20:56:15.521356|2017-10-10 20:56:15.521356
NCT03191916|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-21|||October 19, 2015|Actual|2015-10-19|April 2017|2017-04-01|February 27, 2018|Anticipated|2018-02-27|February 27, 2018|Anticipated|2018-02-27||Interventional|tDCS||Transcranial Direct Current Stimulation for Cognitive Improvement in Parkinson's Mild Cognitive Impairment (tDCS)|Transcranial Direct Current Stimulation (tDCS) to Improve Cognitive Function and Cognitive Fatigue in Parkinson's Patient Mild Cognitive Impairment (MCI)|Recruiting||N/A|40|Anticipated|Sanford Health||2|||f||||f|f|t|t|f|f|||||2017-10-10 20:56:15.604944|2017-10-10 20:56:15.604944
NCT03191903|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-10-02|||May 25, 2017|Actual|2017-05-25|October 2017|2017-10-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide|Randomized, Double-Blind, Active Comparator Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal™) to Provide Symptomatic Relief of Osteoarthritis of the Knee|Recruiting||Phase 3|576|Anticipated|Anika Therapeutics, Inc.||3|||f||||t|t|f||||||||2017-10-10 20:56:15.710986|2017-10-10 20:56:15.710986
NCT03191890|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-16|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|June 15, 2022|Anticipated|2022-06-15|June 15, 2022|Anticipated|2022-06-15|9 Weeks|Observational [Patient Registry]|||Observational, Non-Interventional, Prospective, Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the Performance of the Anecova Intra Uterine Culture Device|Observational, Non-Interventional, Prospective, Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the Performance of the Anecova Intra Uterine Culture Device for Participants With Subfertility Issue Undergoing Assisted Reproductive Medical Treatment in Routine Clinical Practice|Recruiting||N/A|600|Anticipated|Anecova SA|||1||f||||t|f|f||||||Undecided||2017-10-10 20:56:16.014129|2017-10-10 20:56:16.014129
NCT03191877|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-16|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 30, 2018|Anticipated|2018-01-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Effect of Coffee Consumption on Intestinal Motility|Effect of Coffee Consumption on Intestinal Motility After Caesarean Sections; Randomized Controlled Trial|Not yet recruiting||N/A|600|Anticipated|Armed Forces Hospitals, Southern Region, Saudi Arabia||3|||f||||f|f|f||||||Undecided||2017-10-10 20:56:16.103023|2017-10-10 20:56:16.103023
NCT03191851|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-16|||January 4, 2016|Actual|2016-01-04|December 2016|2016-12-01|January 31, 2018|Anticipated|2018-01-31|July 2017|Anticipated|2017-07-01||Interventional|EMPATHY||Evaluation of 'Melody' Paracentesis Device for Ascites Therapy|Evaluation of 'Melody' Paracentesis Device for Ascites Therapy in Patients With Cirrhosis (EMPATHY)|Recruiting||N/A|112|Anticipated|University of Nottingham||3|||f||||t||||||||No||2017-10-10 20:56:16.515751|2017-10-10 20:56:16.515751
NCT03191838|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-16|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Audiovisual Distraction for Patients Undergoing Total Knee or Hip Replacement Surgery|Audiovisual Distraction Versus Propofol Sedation for Patients Undergoing Total Knee or Hip Replacement Surgery Under Spinal Anesthesia|Not yet recruiting||N/A|50|Anticipated|University of Utah||2|||f||||t|f|f||||||No|No IPD will be shared with other researchers|2017-10-10 20:56:16.627805|2017-10-10 20:56:16.627805
NCT03191825|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-12|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Online Lapse Management Intervention|Testing the Efficacy of a Lapse Management System in an Online Smoking Cessation|Recruiting||N/A|1500|Anticipated|University of Oslo||3|||f||||f|f|f||||||||2017-10-10 20:56:16.720988|2017-10-10 20:56:16.720988
NCT03191812|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-19|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|May 26, 2019|Anticipated|2019-05-26|November 26, 2018|Anticipated|2018-11-26||Interventional|||The Short-term Effects of Noninvasive Electrical Brain Stimulation on Dual Tasking in Older Adults|Optimization of Transcranial Direct Current Stimulation (tDCS) for Dual Task Performance in Older Adults With and Without a History of Falls|Recruiting||N/A|40|Anticipated|Hebrew Rehabilitation Center, Boston||4|||f||||t|f|f||||||No||2017-10-10 20:56:16.826088|2017-10-10 20:56:16.826088
NCT03191786|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-25|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 20, 2021|Anticipated|2021-01-20|January 20, 2021|Anticipated|2021-01-20||Interventional|||A Study of Atezolizumab Compared With Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Containing Therapy|A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab Compared With Chemotherapy in Patients With Treatment Naïve Advanced or Recurrent (Stage IIIb Not Amenable for Multimodality Treatment) or Metastatic (Stage IV) Non-Small Cell Lung Cancer Who Are Deemed Unsuitable for Platinum-Containing Therapy|Recruiting||Phase 3|441|Anticipated|Hoffmann-La Roche||2|||f||||t|f|f||||||||2017-10-10 20:56:17.205202|2017-10-10 20:56:17.205202
NCT03191773|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-17|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies|A Prospective, Multicenter, Single-Arm Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies|Recruiting||Phase 1/Phase 2|100|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||1|||f|||||f|f|||f|||No||2017-10-10 20:56:17.454231|2017-10-10 20:56:17.454231
NCT03191760|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-10-05|||June 8, 2017|Actual|2017-06-08|October 2017|2017-10-01|July 8, 2018|Anticipated|2018-07-08|June 8, 2018|Anticipated|2018-06-08||Interventional|PTSD||Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)|Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)|Recruiting||N/A|15|Anticipated|Seattle Institute for Biomedical and Clinical Research||1|||f||||f|f|f||||||||2017-10-10 20:56:17.57588|2017-10-10 20:56:17.57588
NCT03191747|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-16|||June 9, 2017|Actual|2017-06-09|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Masculine Norms and Skin Care Knowledge, Attitudes, and Behaviors|Examining the Association Between Adherence to Masculine Norms and Skin Care Knowledge, Attitudes, and Behaviors in Adult Men|Active, not recruiting||N/A|991|Actual|Northwestern University|||1||f|||||f|f||||||||2017-10-10 20:56:17.667078|2017-10-10 20:56:17.667078
NCT03191734|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-30|||September 13, 2017|Anticipated|2017-09-13|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue|French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue|Recruiting||N/A|30|Anticipated|PROCEPT BioRobotics||1|||f||||f|f|f||||||||2017-10-10 20:56:17.730863|2017-10-10 20:56:17.730863
NCT03191721|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-16|||June 2010|Actual|2010-06-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|December 2014|Actual|2014-12-01||Interventional|||Triclosan Toothpaste in the Maintenance Phase of Peri-implantitis Treatment.|Effects of a Toothpaste Containing 0.3% Triclosan in the Maintenance Phase of Peri-implantitis Treatment.|Completed||Phase 3|102|Actual|University of Guarulhos||2|||f||||f|f|f||||||Yes|March 2017|2017-10-10 20:56:17.824313|2017-10-10 20:56:17.824313
NCT03191708|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-07-25|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Observational|||The FAVOR II China Study|Functional Diagnostic Accuracy of Quantitative Flow Ratio in On-line Assessment of Coronary Stenosis (The FAVOR II China Study)|Completed||N/A|308|Actual|China National Center for Cardiovascular Diseases|||1||f|||||f|f||||||||2017-10-10 20:56:17.983672|2017-10-10 20:56:17.983672
NCT03191695|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-06-20|||February 2018|Anticipated|2018-02-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|October 2018|Anticipated|2018-10-01|1 Day|Observational [Patient Registry]|PLCC||Participation to Life of Children With Cerebral Palsy|The Investigation of Necessity, Participation to Life of Children With Cerebral Palsy and Their Families|Not yet recruiting||N/A|500|Anticipated|Hacettepe University|||1||f||||t|f|f||||||No||2017-10-10 20:56:18.160353|2017-10-10 20:56:18.160353
NCT03191682|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-06-16|||February 20, 2017|Actual|2017-02-20|February 2017|2017-02-01|February 20, 2019|Anticipated|2019-02-20|February 20, 2019|Anticipated|2019-02-20||Interventional|||A First-in-Human Study of PRL3-ZUMAB|A Phase I, First-in-Human Study of PRL3-ZUMAB In Advanced, Solid Tumors|Recruiting||Phase 1|38|Anticipated|National University Hospital, Singapore||1|||f||||f|f|f||||||No||2017-10-10 20:56:18.288059|2017-10-10 20:56:18.288059
NCT03191669|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-08-21|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Vaccine Exposure in Patients With MS|Vaccine Exposure in Patients With Multiple Sclerosis in the Auvergne-Rhone-Alpes Region|Recruiting||N/A|500|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:56:18.396046|2017-10-10 20:56:18.396046
NCT03191656|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-18|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Observational|REDUCELAPHFIII||REDUCE LAP-HF III Corvia Protocol 1701|A Post-Market Clinical Follow-up Study to Evaluate the Corvia Medical, Inc. InterAtrial Shunt Device - IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure|Recruiting||N/A|100|Anticipated|Corvia Medical|||1||f||||f||t|t|f||||||2017-10-10 20:56:18.507561|2017-10-10 20:56:18.507561
NCT03191643|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-16|||October 1, 2011|Actual|2011-10-01|June 2017|2017-06-01|January 31, 2016|Actual|2016-01-31|January 31, 2016|Actual|2016-01-31||Observational|||PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer|18F-FDG PET-guided External Beam Radiotherapy in Iodine-refractory Differentiated Thyroid Cancer|Completed||N/A|16|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f|||||f|f||||||Undecided||2017-10-10 20:56:18.614124|2017-10-10 20:56:18.614124
NCT03191630|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|March 30, 2019|Anticipated|2019-03-30|February 28, 2018|Anticipated|2018-02-28||Interventional|CHANGE||Increasing Activity Post-Kidney Transplant With SystemCHANGE|Increasing Activity Post-Kidney Transplant With SystemCHANGE|Not yet recruiting||N/A|60|Anticipated|Ohio State University||2|||f||||f|f|f||||||No||2017-10-10 20:56:18.703235|2017-10-10 20:56:18.703235
NCT03191617|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-06-15|||September 2015||2015-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|EFORT-LM||Nutrition of Premature Infants With Human Breastmilk Fortifier|Nutrition of Premature Infants With Human Breastmilk Fortifier With Higher Protein Content and Long Chain Poli- Unsaturated Fatty Acids (LCPUFA)|Recruiting||N/A|160|Anticipated|NEOCOSUR||2|||f||||t||||||||Undecided||2017-10-10 20:56:18.819669|2017-10-10 20:56:18.819669
NCT03191604|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy|A Multicenter Study Evaluating the Impact of NBI on Patients With Barrett's Esophagus Associated Neoplasia Undergoing Endoscopic Eradication Therapy (EET)|Recruiting||N/A|100|Anticipated|Northwestern University|||1||f||||f|f|f||||||||2017-10-10 20:56:18.913491|2017-10-10 20:56:18.913491
NCT03191591|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-15|||August 9, 2016|Actual|2016-08-09|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||The First 1,000 Days Program: Maternal-Child Obesity Prevention in Early Life|The First 1,000 Days Program: Maternal-Child Obesity Prevention in Early Life|Enrolling by invitation||N/A|2000|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||No||2017-10-10 20:56:19.044714|2017-10-10 20:56:19.044714
NCT03191578|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-20|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|August 31, 2019|Anticipated|2019-08-31|May 8, 2019|Anticipated|2019-05-08||Interventional|RUTIVAC-1||Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI®|A Randomized, Double-Blind, Placebo-Controlled Phase I Trial to Evaluate the Immunomodulatory Effect of RUTI® in Individuals With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Treated With Intravesical Bacillus Calmette-Guerin (BCG)|Recruiting||Phase 1|40|Anticipated|Archivel Farma S.L.||2|||f||||f|f|f||||||||2017-10-10 20:56:19.150968|2017-10-10 20:56:19.150968
NCT03191565|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-14|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|mDIARY||Using Smartphones for Selfmonitoring of Skill-use i Dialectical Behavior Therapy|The mDIARY Study: Using Smartphones for Daily Selfmonitoring of Skilluse and Outcome in Dialectical Behavior Therapy With Borderline Personality Disorder: A Combined RCT and Timeseries Study|Recruiting||N/A|100|Anticipated|Region of Southern Denmark||2|||f||||t|f|f||||||Yes|After receiving permission from the participants, individual data will be shared with the individual therapist who is treating the patient, but only data regarding for their own clients, so they can follow therapy-progress. De-identified data will be shared with researcher doing the economic evaluation, August 2019. According to danish data protection law this researcher will need a Data processor approval through The danish Data protection agency.|2017-10-10 20:56:19.26495|2017-10-10 20:56:19.26495
NCT03191539|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-20|||August 14, 2017|Anticipated|2017-08-14|June 2017|2017-06-01|June 14, 2019|Anticipated|2019-06-14|June 14, 2019|Anticipated|2019-06-14||Interventional|APREMILAST||Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis|Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis|Not yet recruiting||Phase 3|56|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||f|f|f||||||No||2017-10-10 20:56:19.551749|2017-10-10 20:56:19.551749
NCT03191526|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-25|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)|A Phase 3 Multicenter, Randomized, Double-Blind and Placebo-Controlled Study, and Open Study of KW-0761 in Patients With HTLV-1 Associated Myelopathy (HAM)|Recruiting||Phase 3|52|Anticipated|Kyowa Hakko Kirin Co., Ltd||2|||f||||f|f|f||||||No||2017-10-10 20:56:19.634229|2017-10-10 20:56:19.634229
NCT03191513|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-14|||June 12, 2017|Actual|2017-06-12|May 2017|2017-05-01|February 27, 2018|Anticipated|2018-02-27|October 15, 2017|Anticipated|2017-10-15||Interventional|INTERMET||The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Fat Metabolism|The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Fat Metabolism|Recruiting||N/A|24|Anticipated|King's College London||3|||f||||f|f|f||||||No||2017-10-10 20:56:19.758081|2017-10-10 20:56:19.758081
NCT03191500|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-16|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|November 1, 2017|Anticipated|2017-11-01||Interventional|||Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access|Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access : a Prospective, Muti-center, Single-arm Study|Not yet recruiting||N/A|68|Anticipated|Hangzhou Wei Qiang Medical Technology Co., Ltd.||1|||f|||||f|f||||||No||2017-10-10 20:56:19.862995|2017-10-10 20:56:19.862995
NCT03191487|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||April 2018|Anticipated|2018-04-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|ChimioPal||Evaluation of a New Organization for Collecting Pre-chemotherapy Session Information|Evaluation of a New Organization for Collecting Pre-chemotherapy Session Information: a Multicenter, Open, Randomized Trial|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes||2||no Financial agreement|f||||f|f|f||||||||2017-10-10 20:56:19.93621|2017-10-10 20:56:19.93621
NCT03191474|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-16|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|April 6, 2021|Anticipated|2021-04-06|April 6, 2020|Anticipated|2020-04-06||Interventional|||Linkage of Transgender Individuals to PrEP|CCTG 602: Linkage of Transgender Individuals to PrEP, A Multicenter Trial of the California Collaborative Treatment Group (CCTG)|Recruiting||N/A|500|Anticipated|California Collaborative Treatment Group||2|||f||||f|f|f||||||||2017-10-10 20:56:20.068844|2017-10-10 20:56:20.068844
NCT03191461|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Observational|||Myocardial Perfusion and Fibrosis in Cancer Survivors|Myocardial Perfusion and Fibrosis in Cancer Survivors|Not yet recruiting||N/A|16|Anticipated|Wake Forest University Health Sciences|||2||f||||f|f|f||||||||2017-10-10 20:56:20.188206|2017-10-10 20:56:20.188206
NCT03191448|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-16|||November 11, 2015|Actual|2015-11-11|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Ridge Preservation Using FDBA and a Collagen Wound Dressing in Molar Sites|Evaluation of Healing at Molar Extraction Sites With Ridge Preservation Using Freeze Dried Bone Allograft and a Collagen Wound Dressing|Active, not recruiting||N/A|40|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||f|f|f||||||No||2017-10-10 20:56:20.276038|2017-10-10 20:56:20.276038
NCT03191435|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-11|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Inspiratory Muscle Training on Glycemic Control in Individuals With Type 2 Diabetes|Effect of Inspiratory Muscle Training on Glycemic Control in Individuals With Type 2 Diabetes:Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 20:56:20.350263|2017-10-10 20:56:20.350263
NCT03191422|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-23|||July 4, 2016|Actual|2016-07-04|June 2017|2017-06-01|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Interventional|||LSVT BIG for Chronic Stroke Rehabilitation|LSVT BIG for Chronic Stroke Rehabilitation: a Single-Case Experimental Design|Completed||N/A|2|Actual|University of Ottawa||1|||f||||f|f|f||||||No|No plan to share data.|2017-10-10 20:56:20.462477|2017-10-10 20:56:20.462477
NCT03191409|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-07-12|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 15, 2019|Anticipated|2019-06-15||Observational|||Interaction Research on Cognitive Impairment and Emotional Disorder in End-stage Renal Disease|Interaction Research on Cognitive Impairment and Emotional Disorder in End-stage Renal Disease|Recruiting||N/A|50|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||f||||||||||2017-10-10 20:56:20.54574|2017-10-10 20:56:20.54574
NCT03191396|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-10-02|||June 27, 2017|Actual|2017-06-27|October 2017|2017-10-01|August 14, 2018|Anticipated|2018-08-14|June 10, 2018|Anticipated|2018-06-10||Interventional|SUSTAIN 10||Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes|Efficacy and Safety of Semaglutide 1.0 mg Once-weekly Versus Liraglutide 1.2 mg Once-daily as add-on to 1-3 Oral Anti-diabetic Drugs (OADs) in Subjects With Type 2 Diabetes|Recruiting||Phase 3|576|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f|||t|||||2017-10-10 20:56:20.635568|2017-10-10 20:56:20.635568
NCT03191370|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-15|||July 20, 2017|Anticipated|2017-07-20|June 2017|2017-06-01|September 20, 2017|Anticipated|2017-09-20|September 20, 2017|Anticipated|2017-09-20||Interventional|||Distraction Technique to Reduce Discomfort of Transnasal Fiberoptic Laryngoscopy|Pragmatic Randomised Controlled Trial Assessing the Use of a Simple Distraction Technique to Reduce Discomfort When Performing Transnasal Fiberoptic Laryngoscopy in the ENT Outpatient Clinic|Not yet recruiting||N/A|40|Anticipated|United Lincolnshire Hospitals NHS Trust||4|||f||||f|f|f||||||No||2017-10-10 20:56:21.156867|2017-10-10 20:56:21.156867
NCT03191357|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-15|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Observational|MRP||Evaluation of Military Service and Family Members for Post Concussive and Posttraumatic Stress Symptoms|Evaluation of Military Service and Family Members for Post Concussive and Posttraumatic Stress Symptoms|Recruiting||N/A|2000|Anticipated|Uniformed Services University of the Health Sciences|||4||f||||f|f|f||||Samples With DNA|"     During this study, no more than 40 mL or one ounce, of blood will be drawn. Participants may     decline the blood draw and still participate in other study procedures. A phlebotomist,     research nurse, or trained and credentialed study team member will draw samples. The samples     sent directly to the CNRM Biospecimen Repository. WRNMMC samples will be transported by     Runners Courier services. The FBCH samples will be packaged and shipped overnight FedEx     directly to the Biospecimen Repository.   "|Yes|Information to be shared via Fitbir|2017-10-10 20:56:21.263376|2017-10-10 20:56:21.263376
NCT03191344|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-29|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|IPSS||Extended Application of Intraoperative Parathyroid Scores System(IPSS) in Thyroidectomy|Extended Application of Intraoperative Parathyroid Scores System(IPSS) in Thyroidectomy|Recruiting||N/A|300|Anticipated|Fujian Medical University|||2||f||||f|f|f||||||||2017-10-10 20:56:21.372035|2017-10-10 20:56:21.372035
NCT03191331|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-22|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 1, 2018|Anticipated|2018-05-01||Interventional|||Dietary Intervention, Gestational Weight Gain and Gestational Diabetes.|Intervention Study on Dietary Changes in Relation to Weight Gain and Prevalence of Gestational Diabetes During Pregnancy|Recruiting||N/A|30|Anticipated|University of Eastern Finland||2|||f||||f|f|f||||||No||2017-10-10 20:56:21.476716|2017-10-10 20:56:21.476716
NCT03191318|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-29|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|BARI-ERAS||Comparison of Enhanced Recovery After Surgery (ERAS) Pathway With Conventional Pathway After Laparoscopic Sleeve Gastrectomy|Randomized Control Trial to Compare the Outcomes of Enhanced Recovery After Surgery (ERAS) Pathway and Standard Recovery Pathway After Laparoscopic Sleeve Gastrectomy|Recruiting||N/A|60|Anticipated|GEM Hospital & Research Center||2|||f||||t|f|f||||||||2017-10-10 20:56:21.607735|2017-10-10 20:56:21.607735
NCT03191305|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CVT||Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous Thrombosis|Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous Thrombosis|Not yet recruiting||N/A|50|Anticipated|Foundation University Islamabad||2|||f||||t|f|f|||f|||No||2017-10-10 20:56:21.725395|2017-10-10 20:56:21.725395
NCT03191292|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-23|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Observational|||Bacterial Epidemiology and Empirical Antibiotherapy in Patients With Prosthetic Joint Infection|Bacterial Epidemiology and Empirical Antibiotherapy in Patients With Prosthetic Joint Infection|Completed||N/A|567|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:56:21.821541|2017-10-10 20:56:21.821541
NCT03191279|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-06-15|||August 2018|Anticipated|2018-08-01|June 2017|2017-06-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Observational|||First Aid by Laypersons - Effect on Mortality and Length of Stay|Førstehjelp Gjort av Lekfolk-effekt på dødelighet og behandlingsforløp (First Aid by Laypersons - Effect on Mortality and Length of Stay)|Not yet recruiting||N/A|1400|Anticipated|University of Tromso|||3||f||||f|f|f||||||No|No plan of sharing IDP|2017-10-10 20:56:21.898821|2017-10-10 20:56:21.898821
NCT03191266|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-15|||November 1, 2017|Anticipated|2017-11-01|June 2017|2017-06-01|October 31, 2021|Anticipated|2021-10-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Transcranial Magnetic Stimulation for the Treatment of Veterans With Alcohol Use Disorders|Transcranial Magnetic Stimulation for the Treatment of Veterans With Alcohol Use Disorders|Not yet recruiting||N/A|100|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|f|||Yes|Final datasets in machine-readable format will be submitted to PubMed Central, which will permit the easiest access All participants will be assigned a subject code, which will have no relationship to any aspect of identifiable private information. Therefore, the data associated with each participant will be completely de-identified. There will be no mechanism by which public users will be able to re-identify participant data (e.g., name, address) with the subject code.|2017-10-10 20:56:21.99683|2017-10-10 20:56:21.99683
NCT03191253|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-15|||July 6, 2016|Actual|2016-07-06|June 2017|2017-06-01|October 28, 2017|Anticipated|2017-10-28|October 28, 2017|Anticipated|2017-10-28||Interventional|CHEFS||Changing Health Through Food Support (CHEFS) Program|Changing Health Through Food Support (CHEFS): Pilot RCT to Identify Potential Health Impacts of Providing Comprehensive, Medically-appropriate Food Support to Low-income Urban Adults Living With HIV (PLHIV)|Active, not recruiting||N/A|200|Anticipated|University of California, San Francisco||2|||f|||||f|f||||||No|We do not plan to share individual participant data.|2017-10-10 20:56:22.119986|2017-10-10 20:56:22.119986
NCT03191240|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-16|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 30, 2018|Anticipated|2018-07-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA|AMCPR (Augmented-Medication CardioPulmonary Resuscitation) for Improving Outcome in Patient With Cardiac Arrest: Multi-center, Double-blind, Prospective Randomized Clinical Trial.|Not yet recruiting||Phase 2|110|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:22.21839|2017-10-10 20:56:22.21839
NCT03191227|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-15|||April 2010|Actual|2010-04-01|June 2017|2017-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01|6 Years|Observational [Patient Registry]|Mitchelstown||The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort|The Cork and Kerry Diabetes and Heart Disease Study (Phase II)|Completed||N/A|2047|Actual|University College Cork|||1||f||||f|f|f||||Samples Without DNA|"     Plasma   "|No|All collected source data are maintained and stored at the study research office, in the Department of Epidemiology and Public Health, University College Cork. Specific proposals for future collaboration would be welcomed. Further information can be found on the research centre website, http://www.hrbchdr.com/ or through email to patricia.kearney@ucc.ie.|2017-10-10 20:56:22.323827|2017-10-10 20:56:22.323827
NCT03191214|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||July 21, 2017|Anticipated|2017-07-21|June 2017|2017-06-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Observational|||Impact of Forced Air Warming on Perioperative Thermodynamics|An Observational Thermography Study of the Core-peripheral Temperature Gradient as a Function of Vascular Resistance During the Redistribution Phase Following the Induction of General Anaesthesia in Warmed and Non-warmed Patients|Not yet recruiting||N/A|24|Anticipated|University College, London|||2||f||||f|f|t|f|f|f|||No||2017-10-10 20:56:22.405609|2017-10-10 20:56:22.405609
NCT03191201|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-15|||June 21, 2017|Anticipated|2017-06-21|June 2017|2017-06-01|April 20, 2021|Anticipated|2021-04-20|May 12, 2020|Anticipated|2020-05-12||Interventional|DIAFER||A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.|A Double Blind Randomised Placebo-controlled Trial to Assess the Effect of a Single Administration of Ferric Carboxymaltose of 1000 mg Iron on Glucose Homeostasis, in Iron-deficient Non-anaemic Women of Childbearing Age.|Recruiting||Phase 4|38|Anticipated|University of Lausanne||2|||f||||t|f|f|||f|||No||2017-10-10 20:56:22.501886|2017-10-10 20:56:22.501886
NCT03191188|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-16|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients|A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients|Not yet recruiting||N/A|96|Anticipated|University of California, Irvine||2|||f||||t|f|f||||||No||2017-10-10 20:56:22.631889|2017-10-10 20:56:22.631889
NCT03191175|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-06|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|InflammoVIH||Inflammasome Activation Via Circulating Metabolites|Residual Immune Activation in HIV-infected Patients on Successful cART: Association Between Inflammasome Activation in Monocytes by Circulating Metabolites and Non AIDS Defining Comorbidities|Recruiting||N/A|50|Anticipated|University Hospital, Bordeaux|||2||f||||f|f|f||||Samples With DNA|"     Blood sampling   "|||2017-10-10 20:56:22.741159|2017-10-10 20:56:22.741159
NCT03191162|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-16|||April 21, 2017|Actual|2017-04-21|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|MULTIBENZ||Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.|Phase II Clinical Trial for the Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease in Adult Patients. Berenice Project|Recruiting||Phase 2|240|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||f|f|f||||||Undecided||2017-10-10 20:56:22.876868|2017-10-10 20:56:22.876868
NCT03191149|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-12|||May 11, 2018|Anticipated|2018-05-11|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations|Phase II Study of Osimertinib in Advanced NSCLC Patients With Exon 20 Insertion Mutations in EGFR|Not yet recruiting||Phase 2|20|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 20:56:22.99472|2017-10-10 20:56:22.99472
NCT03191136|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-26|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|October 30, 2017|Anticipated|2017-10-30|June 27, 2017|Actual|2017-06-27||Interventional|||Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers|A Open-label, Randomized, Single Dose, Crossover Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Male Volunteers|Recruiting||Phase 1|24|Anticipated|Yuhan Corporation||2|||f||||f|f|f||||||No||2017-10-10 20:56:23.099302|2017-10-10 20:56:23.099302
NCT03191123|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-18|||July 5, 2016|Actual|2016-07-05|June 2017|2017-06-01|July 5, 2019|Anticipated|2019-07-05|July 5, 2017|Anticipated|2017-07-05||Interventional|||Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor|Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor: a Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Huazhong University of Science and Technology||2|||f||||t|f|f||||||No||2017-10-10 20:56:23.189712|2017-10-10 20:56:23.189712
NCT03191110|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-15|||August 3, 2010|Actual|2010-08-03|June 2017|2017-06-01||||December 2030|Anticipated|2030-12-01||Observational|COLON||The COLON Study: Colorectal Cancer Cohort|The COLON Study: Colorectal Cancer: Longitudinal, Observational Study on Nutritional and Lifestyle Factors That May Influence Colorectal Tumour Recurrence, Survival and Quality of Life|Recruiting||N/A|2000|Anticipated|Wageningen University|||1||f||||f|f|f||||Samples With DNA|"     Blood samples will be collected for all participants. Stool samples will be collected in a     subgroup of colon cancer patients.   "|||2017-10-10 20:56:23.304835|2017-10-10 20:56:23.304835
NCT03191097|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||August 2014|Actual|2014-08-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.|Randomised Double-blind Placebo Controlled Multicenter Clinical Trial of Efficacy and Safety of Ingavirin® Capsules 30mg, in Daily Dose 60mg for the Treatment of Influenza and Other Acute Respiratory Viral Infections at Children 7-12 y.o.|Completed||Phase 3|310|Actual|Valenta Pharm JSC||2|||f||||f|f|f||||||No||2017-10-10 20:56:23.417773|2017-10-10 20:56:23.417773
NCT03191084|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-16|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations|Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations|Recruiting||Early Phase 1|28|Anticipated|Yale University||2|||f||||t|t|f||||||||2017-10-10 20:56:23.528948|2017-10-10 20:56:23.528948
NCT03190876|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|September 1, 2019|Anticipated|2019-09-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Seroma Prevention After Body Contouring Procedures|Prevention of Seroma Formation After Body Contouring Procedures|Recruiting||N/A|100|Anticipated|University of Regensburg||3|||f||||f|f|f||||||No||2017-10-10 20:56:25.207329|2017-10-10 20:56:25.207329
NCT03191071|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-19|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|March 1, 2019|Anticipated|2019-03-01||Interventional|UltraPro||An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care|Procalcitonin and Lung Ultrasonography Point-of-care Testing to Decide on Antibiotic Prescription in Patients With Lower Respiratory Tract Infection at Primary Care Level: Pragmatic Cluster Randomized Trial|Not yet recruiting||N/A|630|Anticipated|Centre Hospitalier Universitaire Vaudois||3|||f||||t|f|f||||||Undecided|Only coded and anonymous data will be made available to protect patients right to privacy|2017-10-10 20:56:23.649805|2017-10-10 20:56:23.649805
NCT03191058|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-16|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|CREST-MST||Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression|Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST - MST)|Not yet recruiting||N/A|130|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t|f|t|t|||||No||2017-10-10 20:56:23.772654|2017-10-10 20:56:23.772654
NCT03191045|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-19|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|January 28, 2018|Anticipated|2018-01-28||Observational|iPD1||In Vivo Predictive Dissolution 1|Development of MRI Protocols to Assess Gastrointestinal Motility With Concomitant Perfused Manometry Validation in Healthy Volunteers|Recruiting||N/A|21|Anticipated|University of Nottingham|||1||f||||f|f|f||||||||2017-10-10 20:56:23.838928|2017-10-10 20:56:23.838928
NCT03191032|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-19|||March 2013|Actual|2013-03-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Early Sensory Re-education of the Hand With a Sensor Glove Model|Cortical and Functional Responses to an Early Protocol of Sensory Re-education of the Hand Using Audio-tactile Interaction|Completed||N/A|17|Actual|University of Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 20:56:23.931408|2017-10-10 20:56:23.931408
NCT03191019|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-21|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Mobile-phone Based Intervention to Support Smoking Cessation Among Chilean Women|Design and Evaluation of a Mobile-phone Based Intervention to Support Smoking Cessation Among Chilean Women Aged 18 to 44 Years in the Metropolitan Region|Not yet recruiting||N/A|400|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f|f|f||||||No||2017-10-10 20:56:24.004473|2017-10-10 20:56:24.004473
NCT03191006|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-22|||June 24, 2017|Anticipated|2017-06-24|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effects of Insoles on Children With Developmental Delays|Therapeutic Effects of Physical Function and Balance of Customized Insoles on Children With Developmental Delays|Not yet recruiting||N/A|52|Anticipated|Taipei Medical University||2|||f||||f|f|f||||||No||2017-10-10 20:56:24.094962|2017-10-10 20:56:24.094962
NCT03190993|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-11|||July 20, 2017|Anticipated|2017-07-20|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|DEB Pilot||The DEB Pilot Study|The Diet Composition and Energy Balance Pilot Study|Recruiting||N/A|20|Anticipated|Pennington Biomedical Research Center||2|||f||||f|f|f||||||||2017-10-10 20:56:24.172512|2017-10-10 20:56:24.172512
NCT03190980|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-17|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Oral Glucose in Pain Alleviation Among Term Neonates|Efficacy and Safety of Oral Glucose in Pain Alleviation Among Healthy Term Neonates|Recruiting||N/A|360|Anticipated|Makassed General Hospital||3|||f|||||f|f||||||||2017-10-10 20:56:24.251901|2017-10-10 20:56:24.251901
NCT03190954|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-16|2017-09-12|||August 17, 2017|Actual|2017-08-17|September 6, 2017|2017-09-06|December 31, 2024|Anticipated|2024-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Brain Dopaminergic Signaling in Opioid Use Disorders|Brain Dopaminergic Signaling in Opioid Use Disorders (OUD)|Recruiting||Early Phase 1|180|Anticipated|National Institutes of Health Clinical Center (CC)||1|||t|||||t|f||||||||2017-10-10 20:56:24.415356|2017-10-10 20:56:24.415356
NCT03190902|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||September 15, 2015||2015-09-15|June 2017|2017-06-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Interventional|||Cognitive Impairment in Pediatric Onset Multiple Sclerosis|Cognitive Impairment in Pediatric Onset Multiple Sclerosis: Research of Biomarkers Predictive of Cognitive Impairment Progression|Completed||N/A|36|Actual|University of Bari||4|||f||||f|f|f||||||No||2017-10-10 20:56:24.927943|2017-10-10 20:56:24.927943
NCT03190863|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-06|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TETRAMINF||Grasping Rehabilitation Using Motor Imagery With or With no Neurofeedback After Tetraplegia|Investigating the Effect of Motor Imagery With or With no Visual Neurofeedback on Grasping Capabilities After C6-C7 Tetraplegia: a Multicentric Randomized Controlled Trial.|Not yet recruiting||N/A|21|Anticipated|Hospices Civils de Lyon||3|||f|||||f|f||||||||2017-10-10 20:56:25.338742|2017-10-10 20:56:25.338742
NCT03190850|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-15|||April 5, 2016|Actual|2016-04-05|June 2017|2017-06-01|May 10, 2018|Anticipated|2018-05-10|March 9, 2018|Anticipated|2018-03-09||Interventional|MARITSA||Effect of Inspiratory Muscle Training|Effect of Inspiratory Muscle Training in Sleep Apnea of Elderly|Recruiting||N/A|30|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||Undecided||2017-10-10 20:56:25.530831|2017-10-10 20:56:25.530831
NCT03190837|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-25|||June 12, 2017|Actual|2017-06-12|May 2017|2017-05-01|January 2027|Anticipated|2027-01-01|January 2027|Anticipated|2027-01-01||Observational|||A Long-term Follow-up Study of Gaucher Disease|A Long-term Follow-up Study of Gaucher Disease|Recruiting||N/A|200|Anticipated|Duke University|||1||f||||f|f|f||||||||2017-10-10 20:56:25.677184|2017-10-10 20:56:25.677184
NCT03190824|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-15|||December 22, 2016|Actual|2016-12-22|June 2017|2017-06-01|October 31, 2018|Anticipated|2018-10-31|June 24, 2018|Anticipated|2018-06-24||Interventional|||Study to Evaluate the Efficacy, Safety, and Immunological Response of OBP-301|Open-label, Multi-center Phase IIa Study to Evaluate the Efficacy, Safety, and Immunological Response of OBP-301, Telomerase Specific Replication-competent Oncolytic Adenovirus in Patients With Unresectable Metastatic Melanoma|Recruiting||Phase 2|50|Anticipated|INC Research||1|||||||f|t|f||||||No||2017-10-10 20:56:25.83142|2017-10-10 20:56:25.83142
NCT03190811|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-18|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors|A Prospective Study of Anti-PD-1 Alone or Combined Wih Autologous DC-CIK Cell Therapy in Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|100|Anticipated|Capital Medical University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:56:26.010684|2017-10-10 20:56:26.010684
NCT03190785|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Benzoates - an Obesogenic Endocrine Disrupting Chemical|Benzoic Acid in Beverages: Establishing a Link Between Urinary Metabolites, Metabolic Dysregulation and Weight Loss Failure|Recruiting||N/A|20|Anticipated|East Carolina University||1|||f||||f|f|f||||||No||2017-10-10 20:56:26.315301|2017-10-10 20:56:26.315301
NCT03190772|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation|The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation|Not yet recruiting||N/A|96|Anticipated|Philipps University Marburg Medical Center||3|||f||||f|f|f||||||No||2017-10-10 20:56:26.469143|2017-10-10 20:56:26.469143
NCT03190759|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-15|||November 11, 2017|Anticipated|2017-11-11|June 2017|2017-06-01|October 20, 2018|Anticipated|2018-10-20|December 22, 2017|Anticipated|2017-12-22||Observational|||Assessment of Asthma Exacerbation in Children by Modified Pulmonary Index Score|Assessment of the Severity of Acute Asthma Exacerbation in Children Attending the Emergency Departments to Predict Outcomes by Modified Pulmonary Index Score|Not yet recruiting||N/A|1|Anticipated|Assiut University|||1||f|||||f|f||||||Yes||2017-10-10 20:56:26.598444|2017-10-10 20:56:26.598444
NCT03190746|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-14|||June 1, 2015|Actual|2015-06-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|||Relationship of YWHAH Polymorphisms to Rheumatoid Arthritis Disease Severity|Relationship of YWHAH Polymorphisms to Rheumatoid Arthritis Disease Severity|Completed||N/A|71|Actual|Keesler Air Force Base Medical Center|||2||f||||f|f|f||||||No|Small pilot trial with limited data|2017-10-10 20:56:26.699339|2017-10-10 20:56:26.699339
NCT03190733|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||August 30, 2017|Anticipated|2017-08-30|December 2016|2016-12-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT|A Randomized,Open,Multicenter and Prospective Study of the Optimized Dose of Anti-Thymoglobuline in Haploidentical Allogeneic Stem Cell Transplantation|Not yet recruiting||Phase 4|192|Anticipated|Zhujiang Hospital||2|||f||||t|f|f|||f|||Yes|individual participant data are to be shared with other researchers, when it will be available and be obtained by web.|2017-10-10 20:56:26.807214|2017-10-10 20:56:26.807214
NCT03190720|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-19|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Development of Exercise Promotion Program Using a Mobile Community|Development of Exercise Promotion Program Using a Mobile Community Based on a Smart Phone Application in Breast Cancer Survivors|Not yet recruiting||N/A|50|Anticipated|Asan Medical Center||2|||f||||f|f|f||||||No||2017-10-10 20:56:26.95876|2017-10-10 20:56:26.95876
NCT03190707|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-22|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||A Good Start to Life - an Early Cross-sectorial Intervention|Early Prevention of Social Inequality in Health - an Interdisciplinary and Cross-sectorial Intervention for Vulnerable Pregnant Women|Enrolling by invitation||N/A|100|Anticipated|Intersectoral Research Unit for Health Services||2|||f||||t|f|f||||||No|Due to individual data protection we will not be able to share individual participant data (IPD).|2017-10-10 20:56:27.06166|2017-10-10 20:56:27.06166
NCT03190694|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-16|||October 12, 2017|Anticipated|2017-10-12|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|July 16, 2019|Anticipated|2019-07-16||Interventional|DIAMOND||Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria|A Study to Assess the Renoprotective Effects of the SGLT2 Inhibitor Dapagliflozin in Non-Diabetic Patients With Proteinuria: a Randomized Double Blind 6-Weeks Cross-Over Trial|Not yet recruiting||Phase 2|50|Anticipated|University Medical Center Groningen||2|||f||||f|f|f|||f|||Undecided||2017-10-10 20:56:27.223962|2017-10-10 20:56:27.223962
NCT03190681|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-14|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|MBB_MPH||Motivation and Methylphenidate|Etude Comparative Monocentrique, randomisée, en Cross-over, en Double Aveugle, Contre Placebo, de l'Action du méthylphénidate Sur Les paramètres Cognitifs de la Motivation|Not yet recruiting||Early Phase 1|24|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f|f|f|||f|||No||2017-10-10 20:56:27.362828|2017-10-10 20:56:27.362828
NCT03190668|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Skeletal Muscle and Adipose Tissue Study|Skeletal Muscle and Adipose Tissue Concentrations of Cefazolin Comparing Two Different Dosing Regimens During Pediatric Posterior Spinal Fusion Surgery|Not yet recruiting||N/A|20|Anticipated|University of Florida||2|||f||||t|f|f|||f|||||2017-10-10 20:56:27.457312|2017-10-10 20:56:27.457312
NCT03190655|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-14|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings|Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings in the Treatment of Partial Thickness Burns|Recruiting||N/A|72|Anticipated|Indonesia University||2|||f||||f|f|f||||||No||2017-10-10 20:56:27.614602|2017-10-10 20:56:27.614602
NCT03190642|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-07-26|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|July 1, 2019|Anticipated|2019-07-01||Interventional|||Prospective Evaluation of Perioperative Steroid Dosing on Postsurgical Edema in Orthognathic Surgery|Prospective Evaluation of Perioperative Steroid Dosing on Postsurgical Edema in Orthognathic Surgery|Not yet recruiting||Phase 4|180|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||||2017-10-10 20:56:27.742817|2017-10-10 20:56:27.742817
NCT03190629|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-16|||April 1, 2012|Actual|2012-04-01|June 2017|2017-06-01|March 31, 2013|Actual|2013-03-31|March 31, 2013|Actual|2013-03-31||Interventional|||The Effect of On-line Hemodiafiltratrion on Nutritional Status and Body Composition|The Effect of On-line Hemodiafiltratrion on Nutritional Status and Body Composition: A Prospective, Controlled, Pilot Study|Completed||N/A|33|Actual|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||f|f|f||||||No||2017-10-10 20:56:27.902169|2017-10-10 20:56:27.902169
NCT03190616|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-06-14|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 30, 2019|Anticipated|2019-12-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Apatinib in Refractory Colorectal Cancer|A Single Arm, Open Label, Multicenter Exploratory Study of Apatinib in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Second Line Therapy|Recruiting||Phase 2|54|Anticipated|The First Affiliated Hospital with Nanjing Medical University||1|||f||||t|f|f||||||No||2017-10-10 20:56:28.002046|2017-10-10 20:56:28.002046
NCT03190603|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||June 20, 2017|Anticipated|2017-06-20|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis|Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis Results From MRI Finding|Not yet recruiting||Phase 4|50|Anticipated|Armed Forces Capital Hospital, Republic of Korea||1|||f||||t|f|f||||||No||2017-10-10 20:56:28.115054|2017-10-10 20:56:28.115054
NCT03190590|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 1, 2021|Anticipated|2021-12-01|March 2, 2021|Anticipated|2021-03-02||Interventional|||Neurophysiological and Functional Mechanisms of Motor Control and Learning|Neurophysiological and Functional Mechanisms of Motor Control and Learning|Not yet recruiting||N/A|462|Anticipated|New York University School of Medicine||3|||f||||f|f|t|f|f|t|||||2017-10-10 20:56:28.215908|2017-10-10 20:56:28.215908
NCT03190577|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|January 30, 2021|Anticipated|2021-01-30|January 30, 2021|Anticipated|2021-01-30||Interventional|PRE-TRANS||Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology|Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology|Not yet recruiting||N/A|400|Anticipated|Nantes University Hospital||1|||f||||f|f|f||||||No||2017-10-10 20:56:28.32515|2017-10-10 20:56:28.32515
NCT03190564|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||July 2017||2017-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:56:28.429597|2017-10-10 20:56:28.429597
NCT03190551|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-15|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Retroclavicular Versus Costoclavicular Approach for Infraclavicular Brachial Plexus Block|A Randomized Controlled Trial Comparing Retroclavicular and Costoclavicular Approach for Infraclavicular Brachial Plexus Block|Completed||N/A|60|Actual|Antalya Training and Research Hospital||2|||f||||f||||||||No||2017-10-10 20:56:28.467588|2017-10-10 20:56:28.467588
NCT03190538|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-14|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|May 31, 2028|Anticipated|2028-05-31|May 31, 2027|Anticipated|2027-05-31||Observational|||Nonalcoholic Steatohepatitis in Chinese Children|Nonalcoholic Steatohepatitis in Chinese Children: a Long Term Follow-up|Recruiting||N/A|400|Anticipated|Humanity and Health Research Centre|||1||f||||f|f|f||||Samples With DNA|"     Liver-biopsy will be collected and to be used as the diagnosis of NASH.   "|Undecided||2017-10-10 20:56:28.545437|2017-10-10 20:56:28.545437
NCT03190525|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|CLARITY||Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma|CLinical Decision-making, Prognosis, quAlity of Life and Satisfaction With caRe in patIents With Relapsed/refracTory Multiple mYeloma (CLARITY)|Not yet recruiting||N/A|312|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f|f|f||||||||2017-10-10 20:56:28.660907|2017-10-10 20:56:28.660907
NCT03190512|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-15|||May 4, 2015|Actual|2015-05-04|June 2017|2017-06-01|September 1, 2016|Actual|2016-09-01|March 31, 2016|Actual|2016-03-31||Interventional|||Periodontal Treatment and Psychology|The Effect of Periodontal Treatment on Depression, Body Image, Self-Esteem and Anxiety in Depressed Patients: A Randomized Controlled Clinical Trial|Completed||N/A|184|Actual|Tokat Gaziosmanpasa University||2|||f||||f|f|f||||||No||2017-10-10 20:56:29.013031|2017-10-10 20:56:29.013031
NCT02858661|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||February 2013||2013-02-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Improving the Diagnosis of Meningitis in Emergency Rooms||Recruiting||N/A|2250|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:55:45.91392|2017-10-10 21:55:45.91392
NCT03190499|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|August 1, 2018|Anticipated|2018-08-01||Observational|sıcc||Quality of Life in Children With Cancer|The Relationship Between Sleep, Fatigue, Quality of Life and Family Impact in Children With Cancer|Not yet recruiting||N/A|100|Anticipated|Cumhuriyet University|||1||f||||f|f|f||||||No||2017-10-10 20:56:29.111671|2017-10-10 20:56:29.111671
NCT03190486|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-10|||July 10, 2017|Actual|2017-07-10|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Perception of Baby's Painful Cry in fMRI|Perception of Baby's Painful Cry: Investigation in fMRI to Neuronal Activity Related to Empathy in Adults|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 20:56:29.201704|2017-10-10 20:56:29.201704
NCT03190473|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-10-04|||January 2, 2018|Anticipated|2018-01-02|October 2017|2017-10-01|February 28, 2023|Anticipated|2023-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|OPTIMIZE||OPTIMIZE IDE for the Treatment of ACS|The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study|Not yet recruiting||N/A|1630|Anticipated|Svelte Medical Systems, Inc.||2|||f||||t|f|t|t|f||||||2017-10-10 20:56:29.293668|2017-10-10 20:56:29.293668
NCT03190460|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||February 15, 2017|Actual|2017-02-15|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|FaCT2||Evaluating Technology-Based Fall Prevention Interventions|Influence of Cognitive Training on Fall Prevention in At Risk Older Adults|Recruiting||N/A|60|Anticipated|University of Washington||2|||f||||f|f|f||||||No||2017-10-10 20:56:29.393603|2017-10-10 20:56:29.393603
NCT03190447|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-14|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|May 30, 2020|Anticipated|2020-05-30||Interventional|||Wich is the Best Dressing in Wounds by Primary Surgery of THA and / or TKA?|Randomized Clinical Trial Comparing 5 Types Dressings in Wounds by Primary Orthopedic Surgery of Total Hip Arthroplasty and / or Knee|Recruiting||N/A|550|Anticipated|Corporacion Parc Tauli||5|||f|||||f|f||||||No||2017-10-10 20:56:31.56337|2017-10-10 20:56:31.56337
NCT03190434|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-14|||May 2006||2006-05-01|August 2006|2006-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Pivotal Study of the AL-SENSE in Diagnosis Amniotic Fluid Leakage|Pivotal Study of the AL-SENSE in Diagnosis Amniotic Fluid Leakage|Completed||N/A|340|Actual|Common Sense|||1||f||||t||||||Samples Without DNA|"     vaginal fluids   "|No||2017-10-10 20:56:31.669558|2017-10-10 20:56:31.669558
NCT03190421|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-27|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Expanded Quantitative Urinary Culture (EQUC) vs Standard Culture (SUC) Techniques in the Clinical Care|The Use of Expanded Quantitative Urinary Culture (EQUC) Versus Standard Culture (SUC) Techniques in the Clinical Care of Women With Symptoms of Urinary Tract Infections.|Recruiting||N/A|225|Anticipated|Loyola University||2|||f||||t|f|f||||||||2017-10-10 20:56:31.738663|2017-10-10 20:56:31.738663
NCT03190408|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|VOLUME||Variation in Fluids Administered in Shock|Observation of Variation in Fluids Administered and Characterization of Vasopressor Requirements in Shock|Not yet recruiting||N/A|500|Anticipated|Montefiore Medical Center|||1||f||||f|f|f||||||||2017-10-10 20:56:31.858359|2017-10-10 20:56:31.858359
NCT03190395|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-26|||September 30, 2017|Anticipated|2017-09-30|September 2016|2016-09-01|August 31, 2021|Anticipated|2021-08-31|September 1, 2018|Anticipated|2018-09-01||Interventional|||Compared With 2 Different Ablation Strategies Clinical Outcome for Treating Patients With Paroxysmal Atrial Fibrillation|Compared to the Long-term Clinical Outcome of Circumferential Pulmonary Vein Isolation(CPVI) and CPVI Combine With Left Atrial Roofline Ablation(CVPI+LARA) for Treating Patients With Paroxysmal Atrial Fibrillation Prospective Randomised Study|Recruiting||N/A|120|Anticipated|Zhujiang Hospital||2|||f||||t|f|f||||||||2017-10-10 20:56:31.947251|2017-10-10 20:56:31.947251
NCT03190382|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||June 24, 2017|Anticipated|2017-06-24|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||SHOWME-PAD (Peripheral Artery Disease)|SHOW-ME PAD (Peripheral Artery Disease)|Not yet recruiting||N/A|72|Anticipated|Saint Luke's Health System||1|||f||||f|f|f||||||Undecided||2017-10-10 20:56:32.039846|2017-10-10 20:56:32.039846
NCT03190356|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-22|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Observational|||Soberlink - MAP Outcomes Study Protocol|Soberlink - MAP Outcomes Study Protocol|Recruiting||N/A|30|Anticipated|Soberlink Healthcare LLC|||2||f||||f|f|t|f|f|f|||||2017-10-10 20:56:32.212707|2017-10-10 20:56:32.212707
NCT03190343|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||November 2016||2016-11-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01|12 Months|Observational [Patient Registry]|||Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases|"Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases Trial  EASYSPY "|Recruiting||N/A|60|Anticipated|Hospital St. Joseph, Marseille, France|||1||f||||f||||||||No||2017-10-10 20:56:32.317557|2017-10-10 20:56:32.317557
NCT03190330|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-24|||January 15, 2018|Anticipated|2018-01-15|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|November 29, 2019|Anticipated|2019-11-29||Interventional|||A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion|A Prospective, Multicenter, Open Label Single Arm Phase IV Clinical Trial to Assess Safety of ImbruvicaTM (Ibrutinib Capsules 140 mg) in Indian Patients With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion|Not yet recruiting||Phase 4|40|Anticipated|Johnson & Johnson Private Limited||1|||f||||f|t|f|||t|||||2017-10-10 20:56:32.408223|2017-10-10 20:56:32.408223
NCT03190304|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|December 14, 2018|Anticipated|2018-12-14|July 14, 2018|Anticipated|2018-07-14||Interventional|NEPRIExTol||The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure|The Effect of NEPRIlysin (LCZ696) on EXercise TOLerance, Muscle Vasodilatation, Muscle Strength and Body Composition in Patients With Heart Failure - NEPRIExTol-HF Trial|Recruiting||Phase 4|52|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 20:56:32.692197|2017-10-10 20:56:32.692197
NCT03190291|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-25|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|February 1, 2020|Anticipated|2020-02-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||A Stepped-Care Telehealth Approach To Treat Distress In Rural Cancer Survivors|A Stepped-Care Telehealth Approach To Treat Distress In Rural Cancer Survivors|Not yet recruiting||N/A|90|Anticipated|Wake Forest University Health Sciences||3|||f||||t|f|f||||||||2017-10-10 20:56:32.80965|2017-10-10 20:56:32.80965
NCT03190278|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-13|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|December 15, 2021|Anticipated|2021-12-15|June 15, 2021|Anticipated|2021-06-15||Interventional|AML123||Study Evaluating Safety and Efficacy of UCART123 in Patients With Acute Myeloid Leukemia|Phase I, Open Label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Expansion, Persistence, and Clinical Activity of a Single Dose of UCART123 (Allogeneic Engineered T Cells Expressing Anti-CD123 Chimeric Antigen Receptor), Administered in Patients With Relapsed/Refractory Acute Myeloid Leukemia, and Patients With Newly Diagnosed High-risk Acute Myeloid Leukemia|Suspended||Phase 1|156|Anticipated|Cellectis S.A.||2||The protocol is being revised; the trial will resume once revisions are made.|f||||t|t|f||||||||2017-10-10 20:56:32.936657|2017-10-10 20:56:32.936657
NCT03190265|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer|A Randomized Phase 2 Study of the Safety, Efficacy, and Immune Response of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cyclophosphamide) in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma|Not yet recruiting||Phase 2|63|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t|t|f||||||Undecided||2017-10-10 20:56:33.710062|2017-10-10 20:56:33.710062
NCT03190252|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-16|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Observational|TriMix17-18||Inflammatory and Cerebrospinal Biochemical Markers in Blood After Trimix Diving|Biokemiska förändringar Vid förhöjt Partialtryck för Syrgas|Recruiting||N/A|32|Anticipated|Sahlgrenska University Hospital, Sweden|||2||f||||f|f|f||||Samples Without DNA|"     Plasma, Serum.   "|No||2017-10-10 20:56:33.844107|2017-10-10 20:56:33.844107
NCT03190239|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-15|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer Patients|Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed After First - Line Induction Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer: A Prospective, Open, Single Arm Clinical Study|Not yet recruiting||Phase 2|20|Anticipated|Xinqiao Hospital of Chongqing||1|||f|||||f|f||||||||2017-10-10 20:56:33.957281|2017-10-10 20:56:33.957281
NCT03190226|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-19|||May 1, 2016|Actual|2016-05-01|May 2016|2016-05-01|May 27, 2017|Actual|2017-05-27|May 27, 2017|Actual|2017-05-27||Interventional|||L-PRF for Increasing Keratinised Mucosa Around Implants|L-PRF Membranes for Increasing the Width of Keratinised Mucosa Around Implants: A Split-mouth, Randomized, Controlled Pilot Clinical Trial|Completed||Phase 4|8|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f|t|t|f|f|f|||No||2017-10-10 20:56:34.082047|2017-10-10 20:56:34.082047
NCT03190213|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|Pembro NEC||Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma|Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma|Not yet recruiting||Phase 2|40|Anticipated|University of Utah||1|||f||||t|t|f||||||No||2017-10-10 20:56:34.199964|2017-10-10 20:56:34.199964
NCT03190187|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-06-15|||February 20, 2018|Anticipated|2018-02-20|June 2017|2017-06-01|November 1, 2018|Anticipated|2018-11-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Spinal Manipulation Effectiveness in Spinal Disorders|Spinal Manipulation Effectiveness in Pain, Disability and Range of Motion.|Not yet recruiting||N/A|98|Anticipated|University of Jaén||2|||f||||f|f|f||||||No|There is no intention to share the plan|2017-10-10 20:56:34.355157|2017-10-10 20:56:34.355157
NCT03190174|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-24|||August 24, 2017|Actual|2017-08-24|June 2017|2017-06-01|April 1, 2020|Anticipated|2020-04-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma|A Phase 1b Single Center Investigation of Safety/Efficacy of Nivolumab (Opdivo®) and ABI-009 (Nab-rapamycin) in Patients With Advanced Undifferentiated Pleomorphic Sarcoma, Liposarcoma, Chondrosarcoma, Osteosarcoma and Ewing Sarcoma|Recruiting||Phase 1/Phase 2|40|Anticipated|Sarcoma Oncology Research Center, LLC||1|||f||||t|t|f|||f|||||2017-10-10 20:56:34.453279|2017-10-10 20:56:34.453279
NCT03190161|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-08|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||Music to Reduce Use of Smoking in Patients With Schizophrenia|Music to Reduce Use of Smoking in Patients With Schizophrenia|Not yet recruiting||N/A|5|Anticipated|New York University School of Medicine||1|||f||||f|f|f||||||||2017-10-10 20:56:34.586115|2017-10-10 20:56:34.586115
NCT03190148|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-15|||February 13, 2014|Actual|2014-02-13|June 2017|2017-06-01|May 1, 2016|Actual|2016-05-01|April 21, 2016|Actual|2016-04-21||Interventional|||Glucose Metabolism in Pregnant Women With a History of Bariatric Surgery, as Well as Three to Six Months After Delivery.|Explorative Study: Diagnosis and Medical Care of Disturbances of Glucose Metabolism in Pregnant Women With a History of Bariatric Surgery, Normal Weight and Obese Pregnant Women|Completed||N/A|64|Actual|Medical University of Vienna||3|||f|||||f|f||||||||2017-10-10 20:56:34.692505|2017-10-10 20:56:34.692505
NCT03190135|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-15|||September 1, 2015|Actual|2015-09-01|June 2017|2017-06-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Interventional|||Evaluation of the BOKS Before-school Physical Activity Program|Evaluation of the Build Our Kids' Success (BOKS) Before-school Physical Activity Program|Completed||N/A|1250|Actual|Massachusetts General Hospital||3|||f||||f|f|f||||||No||2017-10-10 20:56:34.786067|2017-10-10 20:56:34.786067
NCT03190122|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-06-15|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.|Neurocognitive Outcome Assessment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.|Not yet recruiting||Phase 4|90|Anticipated|Kasr El Aini Hospital||2|||f|||||f|f||||||||2017-10-10 20:56:34.895522|2017-10-10 20:56:34.895522
NCT03190109|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-15|||October 13, 2016|Actual|2016-10-13|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|||Bone Age Determined by Ultrasound (BAUS) in Brazilian Control Children|Analyses of Bone Age Determined by Ultrasound in a Cohort of Brazilian Control Children and Adolescents: Comparison With Conventional Bone Age Determined by X-Ray|Recruiting||N/A|500|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo|||1||f||||f|f|f||||||No||2017-10-10 20:56:34.956647|2017-10-10 20:56:34.956647
NCT03190096|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-15|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|SAFE-SVC||Safety and Feasibility of Electrical Isolation of the Superior Vena Cava for Paroxysmal Atrial Fibrillation|Safety and Feasibility of Electrical Isolation of the Superior Vena Cava in Addition to Pulmonary Vein Ablation for Paroxysmal Atrial Fibrillation Using the Cryoballoon: the SAFE-SVC Study.|Recruiting||N/A|120|Anticipated|Ettore Sansavini Health Science Foundation|||1||f||||t|f|f||||||No||2017-10-10 20:56:35.064778|2017-10-10 20:56:35.064778
NCT03190083|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-15|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer|Efficacy of Digital Breast Tomosynthesis (DBT) in Addition to Standard 2- Dimensional Mammography in Evaluating Extent of Disease in Newly Diagnosed Breast Cancer Patients|Not yet recruiting||N/A|150|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f||||||2017-10-10 20:56:35.155435|2017-10-10 20:56:35.155435
NCT03190070|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-20|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Measurement of Renal Functional Reserve|Measurement of Renal Functional Reserve With Urinary Clearance of Cold Iothalamate Before and After an Oral Protein Load|Recruiting||N/A|30|Anticipated|Brigham and Women's Hospital||1|||f||||f|f|f||||||||2017-10-10 20:56:35.405037|2017-10-10 20:56:35.405037
NCT03190057|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|IRISBioFreedom||IRIS-BioFreedom Cohort in the IRIS-DES Registry|Evaluation of Effectiveness and Safety of BioFreedom® Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Not yet recruiting||N/A|1000|Anticipated|Asan Medical Center|||1||f||||f|f|f||||||Undecided||2017-10-10 20:56:35.490761|2017-10-10 20:56:35.490761
NCT03190044|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-15|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|ParMig||Magnesium, Partenium, Andrographis, Co-enzyme Q10 and Riboflavin (PACR) in Migraine Prophylaxis|A Fixed Combination of Magnesium, Partenium, Andrographis, Co-enzyme Q10 and Riboflavin (PACR) as Prophylactic Treatment for Migraine: a Randomized Controlled Double Blind Study (ParMig Study)|Recruiting||N/A|82|Anticipated|University of Roma La Sapienza||2|||f||||f|f|f||||||No||2017-10-10 20:56:35.581649|2017-10-10 20:56:35.581649
NCT03190031|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-15|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|MUCOMUREE||Respiratory Muscle Training in CF Patients|Respiratory Muscle Training in Patients With Cystic Fibrosis|Recruiting||N/A|30|Anticipated|University Hospital, Grenoble||2|||f||||f|f|f||||||No||2017-10-10 20:56:35.666792|2017-10-10 20:56:35.666792
NCT03190018|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-06-15|||June 19, 2017|Anticipated|2017-06-19|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.|A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.|Recruiting||N/A|8|Anticipated|Triomed AB||1|||f||||f|f|f||||||No||2017-10-10 20:56:35.778864|2017-10-10 20:56:35.778864
NCT03189992|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-15|||January 2014||2014-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of TCM Syndrome of Hepatocellular Carcinoma and Colorectal Cancer Based on System Science|"Study of Same TCM Syndrome for Different Diseases and Same Treatment for Different Diseases of Primary Hepatocellular Carcinoma and Colorectal Cancer Under the Perspective of System Science"|Recruiting||Phase 1|320|Anticipated|Shanghai University of Traditional Chinese Medicine||4|||f||||t||||||||Undecided||2017-10-10 20:56:35.973523|2017-10-10 20:56:35.973523
NCT03189979|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Club Fit: Physical Activity and Healthy Eating at an After School Program|Club Fit: Pilot Testing of a Physical Activity and Healthy Eating Intervention at a Boys & Girls Club After School Program|Completed||N/A|61|Actual|Mayo Clinic||1|||f||||f|f|f||||||No|Individual participant data will not be shared.|2017-10-10 20:56:36.077507|2017-10-10 20:56:36.077507
NCT03189966|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-16|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Truncal Blocks for Pediatric With Developmental Dysplasia of the Hip Undergoing Open Reduction|Effect of Different Truncal Blocks Under Ultrasound-Guidance on Pain Management After Open Reduction of Pediatric Developmental Dysplasia of the Hip: a Randomized Trial|Recruiting||N/A|90|Anticipated|Second Affiliated Hospital of Wenzhou Medical University||3|||f||||f|f|f||||||||2017-10-10 20:56:36.170975|2017-10-10 20:56:36.170975
NCT03189953|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-06-15|||April 2015||2015-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|GLP-1-AHH||68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH|68Ga-NODAGA-exendin-4 PET/CT in Patients With AHH - a Prospective Comparative Evaluation of Preoperative Imaging|Enrolling by invitation||Phase 1/Phase 2|56|Anticipated|Radboud University||1|||f||||f||||||||||2017-10-10 20:56:36.305712|2017-10-10 20:56:36.305712
NCT03189940|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-13|||June 20, 2016|Actual|2016-06-20|June 2017|2017-06-01|November 18, 2016|Actual|2016-11-18|July 26, 2016|Actual|2016-07-26||Interventional|||Lifestyle Modification Using an App in OSA|Effect of Lifestyle Modification Using Smartphone Application on Weight Reduction and Obstructive Sleep Apnea|Completed||N/A|59|Actual|Seoul National University Hospital||2|||f||||t|f|f|||f|||No|the individual data is confidential according to the hospital's policy|2017-10-10 20:56:36.406276|2017-10-10 20:56:36.406276
NCT03189927|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-15|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 1, 2019|Anticipated|2019-01-01|July 1, 2018|Anticipated|2018-07-01||Interventional|BIDARCA||BD-Covered Stent for Benign Esophageal Strictures: a Safety and Feasibility Study|BD-Covered Stent for Benign Esophageal Strictures: a Safety and Feasibility Study|Not yet recruiting||N/A|15|Anticipated|Radboud University||1|||f||||t|f|f||||||No||2017-10-10 20:56:36.49185|2017-10-10 20:56:36.49185
NCT03189888|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||January 2013|Actual|2013-01-01|June 2017|2017-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Granulocyte-monocyte Apheresis in Ulcerative Colitis|Granulocyte-monocyte Apheresis in Steroid-dependent, Azathioprine-intolerant/Resistant Moderate Ulcerative Colitis: a Prospective Multicentre Study|Completed||N/A|33|Actual|Valduce Hospital||1|||f||||f|f|f||||||||2017-10-10 20:56:36.765824|2017-10-10 20:56:36.765824
NCT03189849|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-14|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FAARM||Farms, Animals and Adolescents: Reinforcing the Microbiome|Farms, Animals and Adolescents: Reinforcing the Microbiome|Enrolling by invitation||N/A|40|Anticipated|University of Wisconsin, Madison|||1||f||||f|f|f||||||No||2017-10-10 20:56:37.178771|2017-10-10 20:56:37.178771
NCT03189836|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Interventional|||Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma|Phase 1 Study of ACTR707, an Autologous T Cell Product, in Combination With Rituximab, in Subjects With Relapsed or Refractory CD20+ B Cell Lymphoma|Recruiting||Phase 1|40|Anticipated|Unum Therapeutics Inc.||1|||f||||f|t|f||||||||2017-10-10 20:56:37.297742|2017-10-10 20:56:37.297742
NCT03189823|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-15|||January 1, 2003|Actual|2003-01-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|MCSNL||Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain|Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain|Completed||N/A|17|Actual|Radboud University|||1||f||||t|f|t|t|f|f|||Yes|An anominized excel file, compatible with SPSS will be attached to the submitted manuscript|2017-10-10 20:56:37.441404|2017-10-10 20:56:37.441404
NCT03189810|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-05|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|rTMSCANSZ||Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia|Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia|Recruiting||N/A|40|Anticipated|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||||2017-10-10 20:56:37.526166|2017-10-10 20:56:37.526166
NCT03189797|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-14|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Effect of Tailored Preventive Program on Caires Incidence Using International Caries Classification and Management System (ICCMS) A Randomized Clinical Trial|Effect of Tailored Preventive Program on Caires Incidence Using International Caries Classification and Management System (ICCMS) A Randomized Clinical Trial|Not yet recruiting||N/A|40|Anticipated|Cairo University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:37.644952|2017-10-10 20:56:37.644952
NCT03189784|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|November 30, 2017|Anticipated|2017-11-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Ankle Instability Treatment in Patients With Chronic Ankle Instability|Mobilization With Movement Treatment in Patients With Chronic Ankle Instability|Not yet recruiting||N/A|80|Anticipated|University of Jaén||2|||f||||f|f|f||||||No||2017-10-10 20:56:37.727156|2017-10-10 20:56:37.727156
NCT03189771|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-15|||June 27, 2017|Anticipated|2017-06-27|June 2017|2017-06-01|July 30, 2018|Anticipated|2018-07-30|July 1, 2018|Anticipated|2018-07-01||Interventional|||Effect of Occlusal Reduction on Post-operative Pain|Effect of Occlusal Reduction on Post-operative Pain in Patients With Irreversible Pulpitis and Symptomatic Apical Periodontitis Treated in a Single-visit: A Randomized Clinical Trial|Not yet recruiting||N/A|52|Anticipated|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 20:56:37.826816|2017-10-10 20:56:37.826816
NCT03189758|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|DSMRI||Dietary Sodium (DS) Intervention to Reduce Tissue Sodium in Magnetic Resonance Imaging (MRI) for Hemodialysis (HD) Patients|Dietary Sodium (DS) Intervention to Reduce Tissue Sodium in Magnetic Resonance Imaging (MRI) for Hemodialysis (HD) Patients|Not yet recruiting||N/A|20|Anticipated|University of Illinois at Urbana-Champaign||1|||f||||f|f|f|||f|||Undecided||2017-10-10 20:56:37.891593|2017-10-10 20:56:37.891593
NCT03189732|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-14|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Metformin on Exercise-induced Lipolysis|New Electrophoretic Approaches in Studies of Obesity and Diabetes|Active, not recruiting||N/A|10|Actual|Charles University, Czech Republic||3|||f||||f|f|f|||f|||No||2017-10-10 20:56:38.188506|2017-10-10 20:56:38.188506
NCT03189706|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-17|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Pilot Study of Chemoimmunotherapy for High-Risk Neuroblastoma|Pilot Study of Hu3F8, Irinotecan/Temozolomide and Sargramostim (HITS) Chemoimmunotherapy for High-Risk Neuroblastoma|Recruiting||Early Phase 1|10|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:56:38.578933|2017-10-10 20:56:38.578933
NCT03189693|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-17|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Paravertebral Block for Pain Management After Appendectomy|Paravertebral Block for Postoperative Pain Management in Adult Patients Undergoing Appendectomy|Recruiting||N/A|60|Anticipated|Makassed General Hospital||2|||f|||||f|f||||||||2017-10-10 20:56:38.686177|2017-10-10 20:56:38.686177
NCT03189680|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-17|||May 11, 2015|Actual|2015-05-11|June 2017|2017-06-01|June 30, 2017|Anticipated|2017-06-30|May 31, 2017|Actual|2017-05-31||Interventional|||Agility Training in Parkinson's Disease|A High-Intensity Multi-Component Agility Intervention Improves Parkinson's Patients' Clinical and Motor Symptoms|Enrolling by invitation||N/A|3|Actual|Somogy Megyei Kaposi Mór Teaching Hospital||3|||f||||t|f|f||||||No||2017-10-10 20:56:38.775285|2017-10-10 20:56:38.775285
NCT03189667|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-20|||October 5, 2017|Anticipated|2017-10-05|June 2017|2017-06-01|January 5, 2019|Anticipated|2019-01-05|January 5, 2019|Anticipated|2019-01-05||Interventional|||Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula|Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula|Not yet recruiting||N/A|92|Anticipated|King Abdullah International Medical Research Center||2|||f||||t|f|t|f||t|||||2017-10-10 20:56:38.867516|2017-10-10 20:56:38.867516
NCT03189654|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-20|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01|5 Days|Observational [Patient Registry]|||Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients With Heart Failure|Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients With Heart Failure|Recruiting||N/A|30|Anticipated|Heart and Diabetes Center North-Rhine Westfalia|||2||f||||f|f|f||||||||2017-10-10 20:56:38.960599|2017-10-10 20:56:38.960599
NCT03189641|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-21|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|December 31, 2022|Anticipated|2022-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions|An Exploratory Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions|Recruiting||N/A|30|Anticipated|JIMRO Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 20:56:39.066724|2017-10-10 20:56:39.066724
NCT03189628|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-14|||March 13, 2017|Actual|2017-03-13|June 2017|2017-06-01|March 13, 2018|Anticipated|2018-03-13|August 25, 2017|Anticipated|2017-08-25||Interventional|||The Effect of Autologous Stromal Vascular Fractions on Skin Regeneration|Study of Autologous Stromal Vascular Fraction From Adipose Tissue in Promoting Skin Regeneration|Recruiting||Phase 1/Phase 2|30|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:56:39.169802|2017-10-10 20:56:39.169802
NCT03189615|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||May 14, 2017|Actual|2017-05-14|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy Subjects|Interventional, Open-label, Three-group, Single-dose Study Investigating the Pharmacokinetic Properties of Lu AF35700 in Subjects With Hepatic Impairment (Mild or Moderate) and in Healthy Subjects|Recruiting||Phase 1|24|Anticipated|H. Lundbeck A/S||3|||f||||f|f|f|||f|||||2017-10-10 20:56:39.274106|2017-10-10 20:56:39.274106
NCT03189602|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-06-15|||January 1, 2014|Actual|2014-01-01|June 2017|2017-06-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Pulmonary Artery Involvement in Takayasu's Arteritis|Pulmonary Artery Involvement in Takayasu's Arteritis: a Retrospective Study in China|Completed||N/A|51|Actual|Peking Union Medical College Hospital|||1||f||||t|f|f||||Samples Without DNA|"     serum   "|Yes||2017-10-10 20:56:39.353632|2017-10-10 20:56:39.353632
NCT03189589|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-04|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|||Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects|A Randomised, Double-blind, Parallel Group Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Single Dose of GSK2269557 Administered Via the ELLIPTA™ Dry Powder Inhaler to Healthy Participants|Completed||Phase 1|12|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 20:56:39.422949|2017-10-10 20:56:39.422949
NCT03189576|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|August 30, 2021|Anticipated|2021-08-30|August 30, 2021|Anticipated|2021-08-30||Interventional|||Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases|Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases|Recruiting||N/A|37|Anticipated|Tampere University Hospital||1|||f||||f|f|f||||||No||2017-10-10 20:56:39.513098|2017-10-10 20:56:39.513098
NCT03189563|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Efficacy of DA-9805 for Parkinson's Disease|A Phase IIa, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of DA-9805 in Subjects With Parkinson's Disease|Not yet recruiting||Phase 2|60|Anticipated|Dong-A ST Co., Ltd.||3|||f||||t|t|f||||||||2017-10-10 20:56:39.608168|2017-10-10 20:56:39.608168
NCT03189550|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-06-13|||July 1, 2014|Actual|2014-07-01|June 2017|2017-06-01|February 17, 2017|Actual|2017-02-17|February 15, 2017|Actual|2017-02-15||Observational|ERAS||Enhanced Recovery After Surgery in Colorectal Surgery: A Large-Scale Quality Improvement Project|Enhanced Recovery After Surgery in Colorectal Surgery: A Large-Scale Quality Improvement Project|Completed||N/A|664|Actual|Vanderbilt University Medical Center|||3||f||||f|f|f||||||No||2017-10-10 20:56:39.710124|2017-10-10 20:56:39.710124
NCT03189537|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-15|||October 3, 2010|Actual|2010-10-03|June 2017|2017-06-01|October 10, 2011|Actual|2011-10-10|April 19, 2011|Actual|2011-04-19||Interventional|||Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections|Double Blind Randomised Placebo Controlled Trial for Evaluation of Efficacy and Safety of Ingavirin® for Post-exposure Profilaxis During Rise in the Incidence of Influenza and Other Acute Respiratory Viral Infections in Adults|Completed||Phase 3|400|Actual|Valenta Pharm JSC||2|||f||||f|f|f||||||No||2017-10-10 20:56:39.806263|2017-10-10 20:56:39.806263
NCT03189524|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||July 5, 2016|Actual|2016-07-05|June 2017|2017-06-01|June 30, 2021|Anticipated|2021-06-30|January 31, 2021|Anticipated|2021-01-31||Interventional|||A Study to Investigate BGB-3111 in Chinese Patients With B-cell Lymphoma|A Phase I Clinical Study to Investigate the Safety, Tolerability and Pharmacokinetics/ Pharmacodynamics of BTK Inhibitor BGB-3111 in Chinese Patients With B-cell Lymphoma|Recruiting||Phase 1|41|Anticipated|BeiGene||1|||||||||||||||||2017-10-10 20:56:39.8953|2017-10-10 20:56:39.8953
NCT03189511|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-13|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|May 30, 2018|Anticipated|2018-05-30|April 30, 2018|Anticipated|2018-04-30||Interventional|FluvaBAT||Effect of Fluvastatin on Brown Fat Activity|Short Term Effect of Fluvastatin on Brown Adipose Tissue Thermogenesis and Activity in Humans|Recruiting||Phase 4|16|Anticipated|University of Zurich||1|||f||||t|f|f|||f|||Undecided||2017-10-10 20:56:39.976651|2017-10-10 20:56:39.976651
NCT03189498|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-09-22|||June 28, 2017|Actual|2017-06-28|September 2017|2017-09-01|December 22, 2017|Anticipated|2017-12-22|December 21, 2017|Anticipated|2017-12-21||Interventional|||A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal Function|A Phase 1, Open-label, Single-dose, Parallel-group Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Subjects With Various Degrees of Renal Function|Recruiting||Phase 1|42|Anticipated|Janssen Pharmaceutica N.V., Belgium||5|||f||||f|f|f||||||||2017-10-10 20:56:40.11681|2017-10-10 20:56:40.11681
NCT03189485|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-15|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|May 31, 2022|Anticipated|2022-05-31|May 31, 2022|Anticipated|2022-05-31||Interventional|TPI||Tau PET Imaging in the NACC Study Cohort|Tau PET Imaging in the NACC Study Cohort: Modulators of MTL Subregion Structure and Function in Normal and Pathological Aging|Enrolling by invitation||Early Phase 1|100|Anticipated|University of Pennsylvania||1|||f||||f|t|f||||||||2017-10-10 20:56:40.206239|2017-10-10 20:56:40.206239
NCT03189472|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-05|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Remotely-supervised Transcranial Direct Current Stimulation (tDCS) for At-home Treatment of Fatigue and Cognitive Slowing in Parkinson's Disease|Remotely-supervised Transcranial Direct Current Stimulation (tDCS) for At-home Treatment of Fatigue and Cognitive Slowing in Parkinson's Disease|Recruiting||N/A|24|Anticipated|New York University School of Medicine||2|||f||||f|f|f|||f|||||2017-10-10 20:56:40.288501|2017-10-10 20:56:40.288501
NCT03189459|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-14|||December 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||IN-HOME-Parkinson's Disease|Reaching the Most Vulnerable: A Novel Model of Care in Advanced Parkinson's Disease|Not yet recruiting||N/A|156|Anticipated|New York University School of Medicine||3|||f||||f|f|f||||||||2017-10-10 20:56:40.37892|2017-10-10 20:56:40.37892
NCT03189446|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-25|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer|Phase II Trial of Vaginal Cuff Brachytherapy Followed by Adjuvant Chemotherapy With Carboplatin and Dose Dense Paclitaxel in Patients With High-Risk Endometrial Cancer|Not yet recruiting||Phase 2|50|Anticipated|University of Oklahoma||1|||f||||t|t|f|||f|||||2017-10-10 20:56:40.462416|2017-10-10 20:56:40.462416
NCT03189433|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-15|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)|Phase 2, Multiple-Site, Open-Label, Randomized, 2-Group, Parallel Study to Assess the Efficacy and Safety of Ryanodex(R) (EGL-4101)as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)|Not yet recruiting||Phase 2|100|Anticipated|Eagle Pharmaceuticals, Inc.||2|||f||||f|t|f|||f|||No||2017-10-10 20:56:40.549854|2017-10-10 20:56:40.549854
NCT03189407|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-13|||March 1, 2016|Actual|2016-03-01|June 2017|2017-06-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Interventional|||Effect of Moringa Oleifera on Metformin Plasma Level in Type 2 Diabetes Mellitus Patients|Evaluation of the Effect of Moringa Oleifera Tea on Metformin Steady State Plasma Level in Type 2 Diabetes Mellitus Patients - a Pre and Post Non-randomised Trial|Completed||N/A|25|Actual|University of Ibadan||1|||f||||f|f|f||||||No|The data will only be made public as a publication in a peer-reviewed journal. Also, the Endocrinologist in the team is aware of the results obtained and the implications of using Moringa tea on therapy outcome for a patient on metformin|2017-10-10 20:56:40.700444|2017-10-10 20:56:40.700444
NCT03189381|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases|A Pilot Phase 2 Study Evaluating Dose De-escalation in Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases|Not yet recruiting||Phase 2|50|Anticipated|Indiana University||2|||f||||t|f|f||||||No||2017-10-10 20:56:40.869458|2017-10-10 20:56:40.869458
NCT03189368|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-14|||September 18, 2017|Anticipated|2017-09-18|September 2017|2017-09-01|November 1, 2020|Anticipated|2020-11-01|September 30, 2019|Anticipated|2019-09-30||Observational|HUMVEE||Heart Failure Study of Multi-site Pacing Effects on Ventriculoarterial Coupling|Heart Failure Study of Multi-site Pacing Effects on Ventriculoarterial Coupling|Not yet recruiting||N/A|73|Anticipated|National and Kapodistrian University of Athens|||1||f||||f|f|t|f|f|t|||||2017-10-10 20:56:40.961747|2017-10-10 20:56:40.961747
NCT03189355|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-10|||January 9, 2017|Actual|2017-01-09|July 2017|2017-07-01|February 9, 2019|Anticipated|2019-02-09|January 9, 2019|Anticipated|2019-01-09||Interventional|Coc-SEPP1B||Expression of Protein Tyrosine Phosphatase 1B (PTP1B) and Body Composition Modification in Patients With Septic Shock|Expression of Protein Tyrosine Phosphatase 1B (PTP1B) and Body Composition Modification in Patients With Septic Shock|Recruiting||N/A|52|Anticipated|University Hospital, Rouen||1|||f||||f|f|f||||||||2017-10-10 20:56:41.050644|2017-10-10 20:56:41.050644
NCT03189342|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-15|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Effects of Training on Fall Risk and Balance Performances|Effects of Dual-Task Training and Exercise-Cognitive Activity Combined Training on Fall Risk and Balance Performance in Elderly at Risk of Falls: A Randomised Controlled Trial Study|Completed||N/A|45|Actual|Istanbul Medipol University Hospital||3|||f||||t|f|f||||||No|There is no plan to share data for other researches|2017-10-10 20:56:41.126878|2017-10-10 20:56:41.126878
NCT03189329|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-14|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Effect of Retrobulbar Block for Eye Surgery on Brain Oxygenation and Cognitive Functions in Elderly Patients|The Effect of Retrobulbar Block on Bi-Hemispheric Cerebral Oxygen Saturation and Early Period Postoperative Cognitive Functions With Lidocaine and Levobupivacaine in Elderly Patients With Ophthalmic Surgery|Completed||Phase 4|66|Actual|Ondokuz Mayıs University||2|||f||||f|f|f||||||No||2017-10-10 20:56:41.222808|2017-10-10 20:56:41.222808
NCT03189316|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-13|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||Anti-inflammatory Cells in Peritoneal Cavity|Can the Peritoneal Cavity be a Source of Regulatory B Cells to Treat Auto-immune Disease?|Not yet recruiting||N/A|45|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f||||||Undecided||2017-10-10 20:56:41.319899|2017-10-10 20:56:41.319899
NCT03189303|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-07-19|||August 30, 2017|Anticipated|2017-08-30|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Observational|||Cup Position in THA With Standard Instruments|Planned vs. Actual Acetabular Cup Position in Total Hip Arthroplasty With Standard Instrumentation and Technique|Not yet recruiting||N/A|176|Anticipated|DePuy Orthopaedics|||1||f||||f|f|t|f|f||||||2017-10-10 20:56:41.540951|2017-10-10 20:56:41.540951
NCT03189290|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-06-13|||July 22, 2017|Anticipated|2017-07-22|June 2017|2017-06-01|July 22, 2019|Anticipated|2019-07-22|July 22, 2019|Anticipated|2019-07-22||Interventional|SQUARE||Study of the QUadratus Lumborum Bloc in Total Hip ARthroplasty: Efficacy and Safety|Study of the QUadratus Lumborum Bloc in Total Hip ARthroplasty: Efficacy and Safety|Not yet recruiting||N/A|100|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f|||f|||||2017-10-10 20:56:41.612528|2017-10-10 20:56:41.612528
NCT03189277|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-15|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||A Hospital Based Survey on Lung Cancer Related-pain in Northern China|Clinical Characteristics, Evaluation and Management of Lung Cancer Related-pain in Northern China: a Hospital-based Cross-sectional Study|Not yet recruiting||N/A|2000|Anticipated|Chinese Academy of Medical Sciences|||1||f||||f|f|f||||||No||2017-10-10 20:56:41.711595|2017-10-10 20:56:41.711595
NCT03189264|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-14|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||Percutaneous Nephrolithotomy for Treatment of Kidney Stones Greater Than 2 cm|Percutaneous Nephrolithotomy With Coaxial Dilatation vs Pneumatic Balloon for Treatment of Kidney Stones Greater Than 2 cm|Active, not recruiting||N/A|70|Anticipated|Los Comuneros Hospital Universitario Bucaramanga||2|||f||||t|f|t|f|f|t|||No||2017-10-10 20:56:41.801375|2017-10-10 20:56:41.801375
NCT03189251|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||June 1971|Actual|1971-06-01|June 2017|2017-06-01||||June 2001|Actual|2001-06-01||Observational|||HFCS, Apple Juice, Excess Free Fructose & asthma-the FHS-OS|Moderate Intake of High Fructose Corn Syrup Sweetened Soft Drinks, Fruit Drinks and Apple Juice Increases Asthma Risk - the Framingham Offspring Cohort|Completed||N/A|2657|Actual|DeChristopher, Luanne R.|||1||f||||f|f|f||||||No||2017-10-10 20:56:41.930852|2017-10-10 20:56:41.930852
NCT03189238|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-23|||June 28, 2017|Anticipated|2017-06-28|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|PRP||Platelet Rich Plasma (PRP) Peri-urethral and Clitoral Injections for the Treatment of Female Orgasmic Disorder|A Double Blind Placebo Controlled Trial of Autologous Platelet Rich Plasma (PRP) Peri-urethral and Clitoral Injections for the Treatment of Female Orgasmic Disorder|Recruiting||Phase 2|40|Anticipated|Center for Vulvovaginal Disorders||2|||f||||t|t|f|||f|||No||2017-10-10 20:56:41.998444|2017-10-10 20:56:41.998444
NCT03189225|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-06-14|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Interventional|CAVALRY||Capillary And Venous Accuracy: LifeScan Products vs Hospital Reference and YSI|Capillary And Venous Accuracy: LifeScan Products vs Hospital Reference and YSI|Completed||N/A|120|Actual|LifeScan||1|||f||||f|f|f||||||No||2017-10-10 20:56:42.091486|2017-10-10 20:56:42.091486
NCT03189212|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-10-05|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation|Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation|Recruiting||N/A|45|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:56:42.194863|2017-10-10 20:56:42.194863
NCT03189199|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-18|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|July 19, 2017|Anticipated|2017-07-19||Observational|||A Registry Study on Safety Surveillance of Dazhuhongjingtian (a Chinese Medicine Injection) Used in China|A Registry Study on Safety Surveillance of Dazhuhongjingtian (a Chinese Medicine|Not yet recruiting||N/A|3000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t|f|f||||||Yes||2017-10-10 20:56:42.327538|2017-10-10 20:56:42.327538
NCT03189186|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-14|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2022|Anticipated|2022-07-01||Interventional|||Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas|Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas|Recruiting||Phase 1|21|Anticipated|University of California, Irvine||1|||f||||t|t|f||||||||2017-10-10 20:56:42.403795|2017-10-10 20:56:42.403795
NCT03189173|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea|Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea|Not yet recruiting||Phase 2|40|Anticipated|Brigham and Women's Hospital||1|||f||||f|t|t|f|f|f|||Yes|Fully-deidentified subject data will be shared via an online repository.|2017-10-10 20:56:42.517471|2017-10-10 20:56:42.517471
NCT03189160|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-16|||March 2016||2016-03-01|June 2017|2017-06-01||||March 2018|Anticipated|2018-03-01||Interventional|||A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome|A Phase 2 Study of Pegylated Recombinant Human Growth Hormone Injection to Treat Children of Turner Syndrome|Recruiting||Phase 2|180|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||3|||f||||f|f|||||||||2017-10-10 20:56:42.631649|2017-10-10 20:56:42.631649
NCT03189147|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-15|||August 16, 2017|Anticipated|2017-08-16|June 2017|2017-06-01|December 31, 2021|Anticipated|2021-12-31|August 16, 2021|Anticipated|2021-08-16||Interventional|||BicepsTenodesis vs. Biceps Debridement in Combined RC Tears and SLAP Lesions|BicepsTenodesis vs. Biceps Debridement in Combined Rotator Cuff (RC) Tears and Superior Labral Anterior to Posterior (SLAP) Lesions: A Randomized Trial|Not yet recruiting||N/A|100|Anticipated|Shoulder & Upper Extremity Research Group of Edmonton||2|||f|||||f|f||||||||2017-10-10 20:56:42.754609|2017-10-10 20:56:42.754609
NCT03189134|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Utilization of Confocal Microscopy During Cardiac Surgery|Utilization of Confocal Microscopy During Cardiac Surgery|Not yet recruiting||Phase 1|6|Anticipated|Boston Children’s Hospital||1|||f||||t|t|t|f|||||||2017-10-10 20:56:42.839312|2017-10-10 20:56:42.839312
NCT03189108|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-15|2017-07-12|||May 22, 2017|Actual|2017-05-22|June 5, 2017|2017-06-05|January 4, 2028|Anticipated|2028-01-04|January 4, 2027|Anticipated|2027-01-04||Observational|||Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors|Collection of Malignant Ascites, Pleural Fluid, and Blood From Patients With Solid Tumors|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f|||||f|f||||||||2017-10-10 20:56:43.019228|2017-10-10 20:56:43.019228
NCT03189095|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-14|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Workout on Wheels Internet Intervention (WOWii)|Project Workout on Wheels Internet Intervention (WOWii): Summative Evaluation With Randomized Clinical Trial|Recruiting||N/A|140|Anticipated|Baylor Research Institute||2|||f||||f|f|f||||||No||2017-10-10 20:56:43.107184|2017-10-10 20:56:43.107184
NCT03189082|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-10-05|||August 10, 2017|Actual|2017-08-10|October 2017|2017-10-01|October 4, 2017|Actual|2017-10-04|September 10, 2017|Actual|2017-09-10||Interventional|||Microbotox for Lower Face Rejuvenation|"Microbotox Versus Intramuscular Botulinum Toxin in Lower Face Rejuvenation: A Crossover Clinical Trial"|Completed||N/A|15|Actual|St Joseph University, Beirut, Lebanon||1|||f||||f|f|f|||f|||||2017-10-10 20:56:43.214274|2017-10-10 20:56:43.214274
NCT03189069|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-18|||October 6, 2016|Actual|2016-10-06|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|||A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage|Real-World Comparisons of Bleeding Among Novel Oral Anticoagulant (NOAC)-Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage, Who Newly Initiated Novel Oral Anticoagulation Therapies or Were Treated With Warfarin|Completed||N/A|36000|Actual|Bristol-Myers Squibb|||4||f||||f||||||||||2017-10-10 20:56:43.301272|2017-10-10 20:56:43.301272
NCT03189056|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-07-19|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Observational|||Lower Urinary Tract Dysfunction in Chronic Chagas' Disease : Clinical and Urodynamic Presentation|Lower Urinary Tract Dysfunction in Chronic Chagas' Disease : Clinical and Urodynamic Presentation|Recruiting||N/A|200|Anticipated|Institut de Recherche pour le Developpement|||1||f||||f|f|f||||||||2017-10-10 20:56:43.388142|2017-10-10 20:56:43.388142
NCT03188887|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-13|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|TIGER||Treatment of IgA Nephropathy According to Renal Lesions|Treatment of IgA Nephropathy According to Renal Lesions|Not yet recruiting||Phase 3|122|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 20:56:44.58908|2017-10-10 20:56:44.58908
NCT03189043|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-14|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections|Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections|Not yet recruiting||Phase 2|10000|Anticipated|Aionx, Inc.||2|||f||||f|f|f||||||No||2017-10-10 20:56:43.492749|2017-10-10 20:56:43.492749
NCT03189030|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-15|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer|A Phase 1 Safety and Tolerability Study of Personalized Live, Attenuated, Double-Deleted Listeria Monocytogenes (pLADD) Immunotherapy in Adults With Metastatic Colorectal Cancer|Recruiting||Phase 1|10|Anticipated|Aduro Biotech, Inc.||1|||f|||||t|f||||||||2017-10-10 20:56:43.559591|2017-10-10 20:56:43.559591
NCT03189017|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-03|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|October 24, 2017|Anticipated|2017-10-24|October 10, 2017|Anticipated|2017-10-10||Interventional|||A Phase I Study of ICP-022 in Subjects|A Phase I Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ICP-022 Following Single and Multiple Escalating Dose|Recruiting||Phase 1|64|Anticipated|Innocare Pharma Australia Pty Ltd||2|||f||||t|f|f|||f|||||2017-10-10 20:56:43.633529|2017-10-10 20:56:43.633529
NCT03189004|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-18|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Assessing the Impact of Mobile Phone Technology to Improve Health Nutrition and Population (HNP) Service Utilization in Rural Bangladesh Through Pilot Intervention|Assessing the Impact of Mobile Phone Technology to Improve Health Nutrition and Population (HNP) Service Utilization in Rural Bangladesh Through Pilot Intervention|Recruiting||N/A|5280|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||6|||f|||||f|f||||||||2017-10-10 20:56:43.726582|2017-10-10 20:56:43.726582
NCT03188991|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms|Phase 2a Trial Evaluating the Safety of Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms|Recruiting||Phase 2|30|Anticipated|NanOlogy, LLC||3|||||||t|t|f||||||||2017-10-10 20:56:43.815418|2017-10-10 20:56:43.815418
NCT03188965|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-19|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|January 24, 2020|Anticipated|2020-01-24|December 23, 2019|Anticipated|2019-12-23||Interventional|||First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas|An Open-label, First-in-human, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Maximum Tolerated Dose and / or Recommended Phase II Dose of the ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas|Recruiting||Phase 1|210|Anticipated|Bayer||1|||f||||f|t|f||||||||2017-10-10 20:56:44.001435|2017-10-10 20:56:44.001435
NCT03188952|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-13|||July 3, 2017|Anticipated|2017-07-03|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 1, 2018|Anticipated|2018-06-01||Interventional|||Validity of ICDAS Versus ICCMS|Validity of International Caries Classification and Management System (ICCMS) Versus International Caries Detection and Assessment System (ICDAS ) in Caries Assessment : Invivo Diagnostic Study|Not yet recruiting||N/A|40|Anticipated|Cairo University||2|||f||||t|f|f||||||Yes||2017-10-10 20:56:44.099973|2017-10-10 20:56:44.099973
NCT03188939|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-15|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparative Study Between Single , Intra- Cluster and Double-injection Ultrasound-guided Supraclavicular Block of Brachial Plexus|Randomized Comparative Study Between Single-injection , Intra- Cluster -Injection and Double-injection Ultrasound-guided Supraclavicular Block of Brachial Plexus|Enrolling by invitation||Phase 4|36|Anticipated|Cairo University||3|||f||||f|f|f||||||||2017-10-10 20:56:44.186439|2017-10-10 20:56:44.186439
NCT03188926|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-13|||January 4, 2016|Actual|2016-01-04|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|12 Months|Observational [Patient Registry]|MTC||Surgical Treatment of Long Bone Metastases|Surgical Treatment for Long Bone Metastases With Intramedullary Nail or Endoprosthetic Reconstruction|Recruiting||N/A|120|Anticipated|Istituto Ortopedico Rizzoli|||1||f||||t|f|f||||||Yes|publish a manuscript in international journal|2017-10-10 20:56:44.26038|2017-10-10 20:56:44.26038
NCT03188913|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-15|||June 19, 2017|Anticipated|2017-06-19|May 2017|2017-05-01|July 21, 2019|Anticipated|2019-07-21|June 19, 2019|Anticipated|2019-06-19||Observational|||Factor XIII in Major Burns Coagulation|Major Burns Coagulation and the Role of Factor XIII: A Descriptive Study|Not yet recruiting||N/A|20|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||1||f||||f|f|f||||Samples Without DNA|"     Blood   "|No||2017-10-10 20:56:44.347715|2017-10-10 20:56:44.347715
NCT03188900|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-19|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|April 12, 2020|Anticipated|2020-04-12|October 12, 2019|Anticipated|2019-10-12|22 Weeks|Observational [Patient Registry]|APHERESE||Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia|New Therapeutic Strategy Against Preeclampsia: Angiogenic Switch to Physiological State by Extracorporeal Removal of sFlt-1|Recruiting||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f|f|f||||Samples Without DNA|"     Blood   "|No||2017-10-10 20:56:44.499095|2017-10-10 20:56:44.499095
NCT03188874|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-06-13|||September 2010||2010-09-01|June 2017|2017-06-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01|10 Years|Observational [Patient Registry]|||Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)|Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)|Recruiting||N/A|5500|Anticipated|Technische Universität Dresden|||1||f||||f|f|f||||Samples Without DNA|"     bone marrow pheripher blood   "|No||2017-10-10 20:56:44.69073|2017-10-10 20:56:44.69073
NCT03188861|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-13|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|April 30, 2019|Anticipated|2019-04-30|August 31, 2018|Anticipated|2018-08-31||Observational|EMASPOT||Systematic Screening for Comorbid Psychological Conditions in Cardiac ACSC Patients With Multimorbidity in the ED|Systematic Screening for Comorbid Psychological Conditions in Cardiac Ambulatory Care Sensitive Conditions (ACSC) Patients With Multimorbidity in the Emergency Departments (ED)|Recruiting||N/A|650|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||No||2017-10-10 20:56:44.858415|2017-10-10 20:56:44.858415
NCT03188848|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-07-12|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Dose Escalating Study of BPI-3016 in Healthy Subjects|A Randomized, Double-blind, Placebo Controlled, Dose Finding Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BPI-3016 in Healthy Subjects|Not yet recruiting||Phase 1|63|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||f|f|f||||||||2017-10-10 20:56:44.93137|2017-10-10 20:56:44.93137
NCT03188835|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|GB7||Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)|Brown Fat Energy Metabolism During Cold Exposure: Effects of Fructose- or Glucose-rich Diet in Healthy Subjects|Recruiting||N/A|15|Anticipated|Université de Sherbrooke||3|||f||||f|f|f||||||No||2017-10-10 20:56:45.029087|2017-10-10 20:56:45.029087
NCT03188822|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing|A Prospective, Randomized, Controlled Trial of Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Steroid Releasing Implant vs. a Bioabsorbable Nasal Dressing With Added Steroid|Not yet recruiting||N/A|30|Anticipated|University of Rochester||2|||f|||||f|t|f|f|t|||No||2017-10-10 20:56:45.167274|2017-10-10 20:56:45.167274
NCT03188809|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-28|||April 5, 2017|Actual|2017-04-05|July 2017|2017-07-01|October 2, 2017|Anticipated|2017-10-02|October 1, 2017|Anticipated|2017-10-01||Interventional|||Adductor Canal Block Versus Femoral Nerve Block With Repeated Bolus Doses Arthroplasty|Adductor Canal Block Versus Femoral Nerve Block With Repeated Bolus Doses: Postoperative Analgesia and Functional Outcomes After Total Knee Arthroplasty|Recruiting||N/A|42|Anticipated|Kecioren Education and Training Hospital||2|||f||||f|f|f||||||||2017-10-10 20:56:45.264536|2017-10-10 20:56:45.264536
NCT03188796|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||October 2017|Anticipated|2017-10-01|October 2016|2016-10-01|February 2021|Anticipated|2021-02-01|December 2020|Anticipated|2020-12-01||Interventional|VITDALIZE||The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients|The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients With Severe Vitamin D Deficiency: a Multicenter, Placebo-controlled Double-blind Phase III Randomized Controlled Trial (RCT)|Not yet recruiting||Phase 3|2400|Anticipated|Medical University of Graz||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:45.362086|2017-10-10 20:56:45.362086
NCT03188783|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-08-14|||January 24, 2017|Actual|2017-01-24|August 2017|2017-08-01|August 9, 2017|Actual|2017-08-09|August 9, 2017|Actual|2017-08-09||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants|A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|32|Actual|Hoffmann-La Roche||4|||f||||f|t|f||||||||2017-10-10 20:56:45.448788|2017-10-10 20:56:45.448788
NCT03188770|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-14|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PRoVENT-iMIC||Practice of Ventilation in Middle-Income Countries|PRactice of VENTilation in Critically Ill Patients in Middle-Income Countries (PRoVENT-iMIC) - an International Multicenter Service Review Focusing on ICUs in Asia|Not yet recruiting||N/A|3000|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f|f|f||||||No||2017-10-10 20:56:45.660247|2017-10-10 20:56:45.660247
NCT03188757|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-26|||July 13, 2017|Actual|2017-07-13|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Influence of Acute Hyperglycaemia on Brain in T1D|The Influence of Acute Hyperglycaemia on Oxidative Stress, Inflammation, Neurochemical Profile in Brain and Executive Functions of Adolescents With Type 1 Diabetes Mellitus|Recruiting||N/A|20|Anticipated|University of Ljubljana, Faculty of Medicine||1|||f||||t|f|f|||f|||||2017-10-10 20:56:45.832201|2017-10-10 20:56:45.832201
NCT03188744|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-07|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Evaluation of the Late Impact on the Women's Health Undergoing to Treatment for Cervical Cancer|Evaluation of the Late Impact on the Women's Health Undergoing to Treatment for Cervical Cancer|Recruiting||N/A|100|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:56:45.947352|2017-10-10 20:56:45.947352
NCT03188731|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|September 30, 2019|Anticipated|2019-09-30|December 31, 2018|Anticipated|2018-12-31||Observational|ZIKAlliancePW||ZIKAlliance Pregnant Women Cohort|Pregnant Women (PW) Cohort for Evaluation of Risks of Congenital Malformations and Other Adverse Pregnancy Outcomes After Zika Virus Infection (Part of ZIKAlliance)|Recruiting||N/A|5000|Anticipated|University of Heidelberg Medical Center|||1||f||||t|f|f||||Samples With DNA|"     Blood, Hair, Urine, Vaginal fluids, Saliva, Semen   "|Yes|IPD meta-analysis moderated by WHO. Data will be shared after individual cohort data is analyzed and published.|2017-10-10 20:56:46.082423|2017-10-10 20:56:46.082423
NCT03188718|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|WPAT||WatchPAT Device Validation Study Compared to Polysomnography|Validation Study of the WatchPAT 200 in the Diagnosis of Obstructive Sleep Apnea in Children 4-12 Years of Age|Not yet recruiting||N/A|60|Anticipated|University of Colorado, Denver||1|||f||||f|f|f|||f|||||2017-10-10 20:56:46.226959|2017-10-10 20:56:46.226959
NCT03188705|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-06-15|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||CES1 Carriers in the PAPI Study|Enrichment of CES1 Carriers in the Pharmacogenomics Anti-Platelet Intervention Study|Not yet recruiting||Phase 4|50|Anticipated|University of Maryland||1|||f||||f|t|f|||f|||Yes|"Yes
It is possible that deidentified data will be deposited into large public databases as per NIH data sharing policies (e.g. dbGAP, PharmGKB). Data to be shared would include, but not limited to, anthropometric data, study outcome data, and relevant covariate data used in statistical models of association. It is anticipated that data would be available after the completion of the trial. The data will be obtained from the participants and the study-related research procedures."|2017-10-10 20:56:46.329923|2017-10-10 20:56:46.329923
NCT03188692|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-25|||June 23, 2017|Actual|2017-06-23|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants|Phase 3 Study of BK1310 Intramuscular Injection in Healthy Infants|Active, not recruiting||Phase 3|33|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f|f|f||||||||2017-10-10 20:56:46.432906|2017-10-10 20:56:46.432906
NCT03188679|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-13|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Development of Potential Biomarkers for Foetal Brain Development After Congenital CMV Infection|Development of Potential Biomarkers for Foetal Brain Development After Congenital CMV Infection|Not yet recruiting||N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f||||||Yes|Data on pregnancy outcome (birth weight, gestational age at birth, Apgar score) and neonatal development in relation to CMV infection (clinical signs relevant to neonatal CMV infection: jaundice, petechia, hepatosplenomegaly, neurological impairment, hearing deficit, visual impairment) will be recorded. Dat will be availabe within six months after delivery. Data will be obtained from the digitalised patient records.|2017-10-10 20:56:46.543974|2017-10-10 20:56:46.543974
NCT03188666|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||October 9, 2017|Anticipated|2017-10-09|June 2017|2017-06-01|April 9, 2020|Anticipated|2020-04-09|May 9, 2019|Anticipated|2019-05-09||Interventional|LUMINA-1||A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva|A Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effects on Heterotopic Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva|Not yet recruiting||Phase 2|40|Anticipated|Regeneron Pharmaceuticals||2|||f||||t|t|f|||t|||||2017-10-10 20:56:46.633808|2017-10-10 20:56:46.633808
NCT03188653|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-27|||May 31, 2017|Actual|2017-05-31|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Evaluating the Effects of Cleansers on the Skin|Evaluating the Effects of Cleansers on the Skin|Recruiting||N/A|50|Anticipated|University of Arizona||7|||f||||f|f|f||||||No||2017-10-10 20:56:46.726811|2017-10-10 20:56:46.726811
NCT03188640|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||March 1, 2014|Actual|2014-03-01|June 2017|2017-06-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Interventional|OBLIV||Bariatric Surgery, Hormones, and Quality of Life|Health-related Quality of Life, Sexuality and Hormone Status After Bariatric Surgery|Completed||N/A|68|Actual|Linkoeping University||1|||f|||||f|f||||||No|De-indentified individual participant data can be made available for primary and secondary outcomes, upon request, after study completion and manuscript publication.|2017-10-10 20:56:46.854209|2017-10-10 20:56:46.854209
NCT03188627|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|February 18, 2019|Anticipated|2019-02-18||Interventional|||Autologous Bronchial Basal Cell Transplantation for Treatment of COPD|A Single-centered, Non-randomized, Concurrent Control Study on Autologous Bronchial Basal Cell Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 1/Phase 2|20|Anticipated|Regend Therapeutics||2|||f||||f|f|f||||||No||2017-10-10 20:56:46.970308|2017-10-10 20:56:46.970308
NCT03188614|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-14|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|October 1, 2018|Anticipated|2018-10-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Crystalloids for AKI in Shock Patients|Different Crystalloids on the Incidence of Acute Kidney Injury in Shock Patients|Not yet recruiting||N/A|40|Anticipated|Southeast University, China||2|||f||||f|f|f||||||No||2017-10-10 20:56:47.08817|2017-10-10 20:56:47.08817
NCT03188601|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01|1 Year|Observational [Patient Registry]|AATGVHD-MARK||α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD|Relative Inactivity of Alpha-1-antitrypsin After Bone Marrow Transplantation as a Dynamic Biomarker for GVHD and Prognosis: a Prospective Cohort Study|Not yet recruiting||N/A|150|Anticipated|Rambam Health Care Campus|||4||f||||t|f|f||||Samples Without DNA|"     Serum samples and peripheral blood mononuclear cells' RNA extracts   "|||2017-10-10 20:56:47.180436|2017-10-10 20:56:47.180436
NCT03188588|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-13|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Observational|ObsO2||Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients|Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients|Recruiting||N/A|120|Anticipated|SOS Oxygene Mediterranee|||1||f||||f|f|f||||||No||2017-10-10 20:56:47.279168|2017-10-10 20:56:47.279168
NCT03188575|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-18|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|July 25, 2018|Anticipated|2018-07-25||Interventional|D-IAPT||Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in IAPT|Digital IAPT: The Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in the Improving Access to Psychological Therapies Programme|Recruiting||N/A|360|Anticipated|Silver Cloud Health||2|||f||||t|f|f||||||||2017-10-10 20:56:47.36767|2017-10-10 20:56:47.36767
NCT03188562|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||May 2011||2011-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC. A Randomised Controlled Trial|Comparison of Diagnostic and Therapeutic Efficacy of Transbronchial and Transoesophageal Endoscopic Ultrasound Guided Needle Aspiration and Transcervical Extended Mediastinal Lymphadenectomy (TEMLA) in Operable Non-small-cell Lung Cancer. A Randomised Controlled Trial|Recruiting||N/A|200|Anticipated|Pulmonary Hospital Zakopane||2|||f||||f||||||||Undecided||2017-10-10 20:56:47.488141|2017-10-10 20:56:47.488141
NCT03188549|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-13|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|January 15, 2019|Anticipated|2019-01-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Magen Haim Project - Assessing Hand Hygiene Formulas|Magen Haim Project - Assessing Hand Hygiene Formulas|Not yet recruiting||Phase 4|1505|Anticipated|Sheba Medical Center||3|||f||||t|t|f|||t|||No||2017-10-10 20:56:47.602745|2017-10-10 20:56:47.602745
NCT03188536|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-03|||July 25, 2017|Anticipated|2017-07-25|July 2017|2017-07-01|September 28, 2018|Anticipated|2018-09-28|May 31, 2018|Anticipated|2018-05-31||Observational|||Clinical and Sociodemographic Characterization of Multiple Myeloma Patients With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)|Clinical and Sociodemographic Characterization of Multiple Myeloma Patients With Symptomatic Relapse and/or Refractory Disease in Spain|Not yet recruiting||N/A|350|Anticipated|Takeda|||1||f||||f|f|f||||||||2017-10-10 20:56:47.710307|2017-10-10 20:56:47.710307
NCT03188523|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-14|2017-09-13|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|May 25, 2018|Anticipated|2018-05-25|May 25, 2018|Anticipated|2018-05-25||Interventional|||Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002)|A Single-Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8504 Monotherapy in Anti-Retroviral Therapy (ART)-Naïve, HIV-1 Infected Patients|Recruiting||Phase 1|24|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||f|f|f||||||||2017-10-10 20:56:47.7936|2017-10-10 20:56:47.7936
NCT03188510|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-10-02|||June 30, 2017|Actual|2017-06-30|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Two Different Formulations of LY3074828 in Healthy Participants|Relative Bioavailability of LY3074828 Solution Formulation in Pre-Filled Syringes Compared to Lyophilized Formulation After Single Subcutaneous Administration|Active, not recruiting||Phase 1|54|Actual|Eli Lilly and Company||3|||f||||f|t|f||||||||2017-10-10 20:56:47.887115|2017-10-10 20:56:47.887115
NCT03188497|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-13|||February 2, 2017|Actual|2017-02-02|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Clinical Study of Concurrent Radiotherapy With Concurrent Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma|Clinical Study of Concurrent Radiotherapy With Concurrent Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 1|18|Anticipated|Fifth Affiliated Hospital, Sun Yat-Sen University||6|||f|||||f|f||||||||2017-10-10 20:56:47.956891|2017-10-10 20:56:47.956891
NCT03188484|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-23|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|April 2017|Actual|2017-04-01|2 Years|Observational [Patient Registry]|AFRICAT||Atrial Fibrillation Research In CATalonia|Stepwise High Risk Individuals Screening for Atrial Fibrillation Using Sequential Clinical-electro-biological Register: the AFRICAT Study (Atrial Fibrillation Research In CATalonia)|Active, not recruiting||N/A|5000|Actual|Jordi Gol i Gurina Foundation|||1||f||||t|f|f||||Samples Without DNA|"     A blood sample of 32 cc divided into two serum tubes (8.5 cc), two plasma EDTA tubes (6 cc)     and one TempusTM RNA tube (3 cc). Samples will be processed and stored at -20 ºC at the     recruiting centre until shipment to Neurovascular Research Laboratory, where the sample bank     will be set up.      Biomarker discovery study will be performed by exploration with a multiple screening platform     with 1,310 different proteins, based on DNA aptamer technology (SOMAscan, Somalogic). These     aptamers have been modified in their lateral chains, increasing their chemical diversity and,     therefore, the number of targets. The whole library will be explored and, after the     statistical analyses, the best candidates will be chosen for replication by simple ELISA.   "|Yes||2017-10-10 20:56:48.056586|2017-10-10 20:56:48.056586
NCT03188471|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-14|||January 2017||2017-01-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Preventive Application of GnRH Antagonist on Early OHSS|Preventive Application of GnRH Antagonist on Early Ovarian Hyperstimulation Syndrome in High-risk Women: A Prospective Randomized Trial|Recruiting||Phase 4|175|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f|||||f|f||||||No||2017-10-10 20:56:48.117536|2017-10-10 20:56:48.117536
NCT03188458|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-13|||November 6, 2017|Anticipated|2017-11-06|June 2017|2017-06-01|October 8, 2018|Anticipated|2018-10-08|October 8, 2018|Anticipated|2018-10-08||Interventional|||Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia|Immunogenicity of a Single Dose of GSK Biologicals' Diphtheria, Tetanus and Acellular Pertussis (dTpa) Booster Vaccine (Boostrix™ [263855]) in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia|Not yet recruiting||Phase 4|276|Anticipated|GlaxoSmithKline||1|||f|||||f|f||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 20:56:48.219442|2017-10-10 20:56:48.219442
NCT03188445|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|December 30, 2018|Anticipated|2018-12-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency Anaemia in Pregnancy.|Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency Anaemia in Pregnancy: a Randomised, Comparative, Open-label Trial|Not yet recruiting||Phase 4|140|Anticipated|Pharmacosmos A/S||2|||f||||f|f|f||||||No||2017-10-10 20:56:48.299841|2017-10-10 20:56:48.299841
NCT03188393|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-26|||April 13, 2017|Actual|2017-04-13|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery|A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients With Clinical/Radiologic Complete Response After Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment Without Surgery|Recruiting||Phase 2|175|Anticipated|NRG Oncology||1|||f||||f|f|f||||||No||2017-10-10 20:56:48.706447|2017-10-10 20:56:48.706447
NCT03188380|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-13|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Imaging Modalities in Diagnosing Necrotizing Enterocolitis in Preterm Infants.|The Use of Different Imaging Modalities in Diagnosing Necrotizing Enterocolitis in Preterm Infants.|Not yet recruiting||N/A|200|Anticipated|Princess Anna Mazowiecka Hospital, Warsaw, Poland|||2||f||||f|f|f||||||Undecided||2017-10-10 20:56:48.831729|2017-10-10 20:56:48.831729
NCT03188367|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|June 13, 2019|Anticipated|2019-06-13|June 13, 2017|Actual|2017-06-13||Interventional|RAPLAGE||Dose-finding Gluten Challenge Trial in Nonceliac Gluten-sensitivity|Randomized, Dose-finding, Double-blind, Placebo-controlled, Crossover Gluten Challenge Trial in Subjects With Nonceliac Gluten-sensitivity|Active, not recruiting||N/A|840|Actual|IRCCS Policlinico S. Matteo||12|||f||||t|f|f||||||No||2017-10-10 20:56:48.914538|2017-10-10 20:56:48.914538
NCT03188354|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-10-05|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma|Diagnostic Assessment of 18F-fluciclovine and 18F-FDG - PET/MRI of Primary Central Nervous System Lymphoma|Recruiting||N/A|10|Anticipated|Norwegian University of Science and Technology||1|||f||||t|f|f||||||||2017-10-10 20:56:48.998416|2017-10-10 20:56:48.998416
NCT03188341|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-13|||December 2010|Actual|2010-12-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Observational|CCVS||Cardiac Complication After Vascular Surgery|The Reasons of Repolarization Disturbances Disclosure in Vascular Surgery|Completed||N/A|100|Actual|Pomeranian Medical University Szczecin|||1||f||||f|f|f||||Samples With DNA|"     Metabolic monitoring consisted of electrolytes and arterial blood gas analysis prior to     anesthesia induction and at the end of the procedure.      Blood was drawn into anticoagulant for genetic studies. Genomic DNA was isolated from     peripheral blood leukocytes to investigate rs203462 AKAP10 polymorphism in the study     population.   "|No||2017-10-10 20:56:49.094427|2017-10-10 20:56:49.094427
NCT03188328|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety, Tolerability, PK, Dosimetry, MTD and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by IV Escalating Doses of [177Lu]DOTA-biotin in Pts With Injectable Solid Tumors or Lymphomas|A Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, Dosimetry, Maximum Tolerated Dose and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by Systemic IV Administration of Escalating Doses of [177Lu]DOTA-biotin in Patients With Solid Tumors or Lymphomas With Injectable Neoplastic Lesions.|Recruiting||Phase 1|24|Anticipated|sigma-tau i.f.r. S.p.A.||1|||f||||t|t|f||||||Undecided||2017-10-10 20:56:49.163718|2017-10-10 20:56:49.163718
NCT03188315|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Studies of Small DNA Virus Encoded Oncogenes in Viral Carcinogenesis Using Laboratory Model Systems|Studies of Small DNA Virus Encoded Oncogenes in Viral Carcinogenesis Using Laboratory Model Systems|Not yet recruiting||N/A|40|Anticipated|Assiut University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:56:49.244507|2017-10-10 20:56:49.244507
NCT03188302|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-14|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|July 14, 2017|Anticipated|2017-07-14||Interventional|||Evaluation of New Method for Measuring Stool Consistency|Evaluation of a New Method for Measuring Stool Consistency, Using a Texture Analyser (TA.XT Express Texture Analyser)|Enrolling by invitation||N/A|40|Anticipated|Yakult Honsha European Research Center, ESV||1|||f||||f|f|f||||||No||2017-10-10 20:56:49.308567|2017-10-10 20:56:49.308567
NCT03188289|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-14|||January 20, 2014|Actual|2014-01-20|June 2017|2017-06-01|September 10, 2014|Actual|2014-09-10|July 15, 2014|Actual|2014-07-15||Interventional|||Microbial Growth in the Suture Thread, After Application of Different Antiseptic Gels in Mandibular Third Molars Extraction|Randomized Clinical Trial of Microbial Growth in the Suture Thread, After the Post-surgical Application of Different Antiseptic Gels in Mandibular Third Molars Extraction|Completed||Phase 4|21|Actual|University of Santiago de Compostela||4|||f||||t|f|f||||||No||2017-10-10 20:56:49.383752|2017-10-10 20:56:49.383752
NCT03188276|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-14|||February 1, 2016|Actual|2016-02-01|June 2017|2017-06-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs|The Relationship Between Direct Acting Antiviral Treatment Effect and Myeloid-Derived Suppressor Cells and NK Cells Activity in Chronic Hepatitis C|Completed||Early Phase 1|52|Actual|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t|f|f||||||No|Individual participant data (IPD) is not available to other researchers|2017-10-10 20:56:49.469905|2017-10-10 20:56:49.469905
NCT03188263|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-21|||July 17, 2017|Anticipated|2017-07-17|June 2017|2017-06-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|ML||Morning Light Treatment to Improve Glucose Metabolism|Morning Light Treatment at Home to Improve Glucose Metabolism in People at Increased Risk for Type 2 Diabetes|Not yet recruiting||N/A|34|Anticipated|Northwestern University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:51.12774|2017-10-10 20:56:51.12774
NCT03188250|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-14|||September 2012|Actual|2012-09-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2014|Actual|2014-06-01||Interventional|||Chama Cha MamaToto: a Pilot Study of Peer Support Groups in Kenya|Increasing Pregnancy Health Services Uptake Through Integrated Peer Support Groups in Kenya: A Prospective Cohort Study|Completed||N/A|515|Actual|Moi University||2|||f||||f|f|f||||||No||2017-10-10 20:56:51.208594|2017-10-10 20:56:51.208594
NCT03188237|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-14|||January 2012|Actual|2012-01-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||AfyaJamii (Parenting Well): Evaluating the Feasibility of a Group Antenatal/Well-child Care Model in Pregnancy in Kenya|AfyaJamii (Parenting Well): Evaluating the Feasibility of a Group Antenatal and Well-child Care Model in Pregnancy in Kenya|Completed||N/A|15|Actual|Moi University||2|||f||||f|f|f||||||No||2017-10-10 20:56:51.277021|2017-10-10 20:56:51.277021
NCT03188224|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-06|||September 24, 2017|Anticipated|2017-09-24|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|December 1, 2018|Anticipated|2018-12-01||Interventional|ApplyIT||Apply the (MyTransition) App In Transition|An App-based Transition Toolkit Targeting Youth With Chronic Health Conditions: A Randomized Trial as a Foundation to Improve Healthcare Transition and Outcomes|Not yet recruiting||N/A|100|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:56:51.343764|2017-10-10 20:56:51.343764
NCT03188211|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-14|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|December 30, 2017|Anticipated|2017-12-30||Interventional|SIM-AF||E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF|Simulation-based Technologies to Improve the Appropriate Use of Oral Anticoagulants in Hospitalized Elderly Patients With Atrial Fibrillation|Active, not recruiting||N/A|240|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||t|f|f||||||Undecided||2017-10-10 20:56:51.414827|2017-10-10 20:56:51.414827
NCT03188198|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-07-03|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Risk Adapted Therapy in Diffuse Large B Cell Lymphoma|Phase II Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R in Untreated De Novo Diffuse Large B-Cell Lymphomas|Recruiting||Phase 2|60|Anticipated|Mansoura University||2|||f||||f|f|f|||f|||||2017-10-10 20:56:51.53076|2017-10-10 20:56:51.53076
NCT03188185|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-15|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)|A Phase 3b Efficacy and Safety Study of Adjunctive ALKS 5461 in Treatment Refractory Major Depressive Disorder|Recruiting||Phase 3|325|Anticipated|Alkermes, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:56:51.626705|2017-10-10 20:56:51.626705
NCT03188172|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-16|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|October 1, 2020|Anticipated|2020-10-01||Interventional|MUKnineb||MUK Nine b: OPTIMUM Treatment Protocol|MUK Nine b: OPTIMUM. A Phase II Study Evaluating Optimised Combination of Biological Therapy in Newly Diagnosed High Risk Multiple Myeloma and Plasma Cell Leukaemia.|Not yet recruiting||Phase 2|95|Anticipated|University of Leeds||1|||f||||t|f|f||||||||2017-10-10 20:56:51.900032|2017-10-10 20:56:51.900032
NCT03188159|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-14|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer|Phase II Study of Intravenous Vinorelbine in Patients With Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer (VIP)|Not yet recruiting||Phase 2|36|Anticipated|National University Hospital, Singapore||1|||f||||f|f|f||||||No||2017-10-10 20:56:52.04658|2017-10-10 20:56:52.04658
NCT03188146|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-14|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|May 1, 2028|Anticipated|2028-05-01|May 1, 2027|Anticipated|2027-05-01||Observational|||Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid|Performance of Biochemical Response Criteria and Risk Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid|Recruiting||N/A|500|Anticipated|Humanity and Health Research Centre|||1||f||||f|t|f|||f|||Undecided||2017-10-10 20:56:52.149722|2017-10-10 20:56:52.149722
NCT03188120|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-21|||July 4, 2017|Actual|2017-07-04|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Specific Use-Result of Spiriva Respimat® in Asthmatics|Specific Use-Result Surveillance of Spiriva Respimat in Asthmatics (Patients With Mild and Moderate Persistent Asthma)|Recruiting||N/A|180|Anticipated|Boehringer Ingelheim|||1||f|||||f|f||||||||2017-10-10 20:56:52.343741|2017-10-10 20:56:52.343741
NCT03188107|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-15|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01|3 Months|Observational [Patient Registry]|IMP||Interrater Reliability of Infant Motor Profile|Interrater and Intrarater Reliability of Infant Motor Profile: Assessing Motor Profiles of Risky Infants|Not yet recruiting||N/A|40|Anticipated|Abant Izzet Baysal University|||2||f||||f||||||||Undecided||2017-10-10 20:56:52.429774|2017-10-10 20:56:52.429774
NCT03188081|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-26|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Observational|TIGHT||A Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous (SC) Abatacept|A Prospective, Multicentric, Observational Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life RA Patients Treated With Abatacept SC|Active, not recruiting||N/A|300|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 20:56:52.628318|2017-10-10 20:56:52.628318
NCT03188068|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-15|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome|Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome|Recruiting||Phase 2|30|Anticipated|West China Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 20:56:52.74457|2017-10-10 20:56:52.74457
NCT03188055|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-18|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||A Communication Tool to Assist Severely Injured Older Adults|Best Case/Worst Case Trauma Study: A Communication Tool to Assist Severely Injured Older Adults|Enrolling by invitation||N/A|410|Anticipated|University of Wisconsin, Madison||2|||f||||t|f|f||||||||2017-10-10 20:56:52.87171|2017-10-10 20:56:52.87171
NCT03188029|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-15|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Cortisol Level After Repeated Doses of Etomidate|Effect of Repeated Doses of Etomidate on the Adrenocortical Function|Not yet recruiting||N/A|30|Anticipated|University Tunis El Manar||1|||f|||||f|f||||||Undecided||2017-10-10 20:56:53.036536|2017-10-10 20:56:53.036536
NCT03188016|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-07-05|||October 23, 2017|Anticipated|2017-10-23|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|March 2, 2018|Anticipated|2018-03-02||Interventional|||Improvised Music to Enhance Intensive Interaction Version 1|Feasibility Study: Improvised Music to Enhance the Effectiveness of Intensive Interaction in Developing Interpersonal Communication of Profoundly Intellectually Disabled Children and Young People|Not yet recruiting||N/A|6|Anticipated|Beacon Hill Academy||2|||f||||f|f|f||||||||2017-10-10 20:56:53.116299|2017-10-10 20:56:53.116299
NCT03187990|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||March 3, 2017|Actual|2017-03-03|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA|Single-center Study for Biopsy Guidance Using Gallium-68 Labeled Prostate-specific Membrane Antigen (PSMA) PET/MRI in Patients With Elevated PSA Eligible for Prostate Biopsy in Comparison to Multiparametric MRI.|Recruiting||N/A|40|Anticipated|University of Zurich||2|||f||||t|f|f||||||No||2017-10-10 20:56:53.315322|2017-10-10 20:56:53.315322
NCT03187977|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-09-28|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI|Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI: A Pilot Study|Recruiting||N/A|77|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|f|f||||||||2017-10-10 20:56:53.398573|2017-10-10 20:56:53.398573
NCT03187964|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-18|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|UltraHIV||Xpert Ultra and Xpert HIV-VL in People Living With HIV|Feasibility, Accuracy, and Effect of Polyvalent Point-of-care Xpert MTB/RIF Ultra and Xpert HIV-1 Viral Load Testing in HIV-positive Patients Initiating ART: a Randomised Controlled Trial|Not yet recruiting||N/A|1500|Anticipated|University of Stellenbosch|||4||f||||f|f|f||||Samples With DNA|"     Blood and urine collected for bio-banking for use in future diagnostic studies.   "|||2017-10-10 20:56:53.487024|2017-10-10 20:56:53.487024
NCT03187951|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-04|||June 13, 2017|Actual|2017-06-13|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer|PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer: A Randomized Trial Testing Effects on Fitness, Health-Related Quality of Life, and Tumor Vasculature|Recruiting||N/A|128|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 20:56:53.69988|2017-10-10 20:56:53.69988
NCT03187938|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-21|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight|Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight|Recruiting||N/A|350|Anticipated|TriHealth Inc.|||1||f||||f|f|f||||||No||2017-10-10 20:56:53.817404|2017-10-10 20:56:53.817404
NCT03187925|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-21|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01|5 Years|Observational [Patient Registry]|||Cricopharyngeal Dysfunction and Esophageal Diverticulum|A Complete Title Used for Approval Letters. Cervical Diverticulum Prospective, Multi-Institutional Study Proposal|Recruiting||N/A|500|Anticipated|University of Cincinnati|||1||f|||||f|t|f|f|f|||||2017-10-10 20:56:53.90717|2017-10-10 20:56:53.90717
NCT03187912|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-14|||September 19, 2016|Actual|2016-09-19|June 2017|2017-06-01||||September 30, 2018|Anticipated|2018-09-30||Interventional|||Accelerated Corneal Cross-linking With Different Riboflavin Solutions|Effect-evaluation of an Accelerated Corneal Cross-linking Protocol With Different Riboflavin Solutions|Recruiting||Phase 3|60|Anticipated|Medical University of Vienna||2|||f|||||f|f|||f|||||2017-10-10 20:56:54.012261|2017-10-10 20:56:54.012261
NCT03187899|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-10|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Superficial Cervical Plexus Blockade for Clavicle Fracture Analgesia|Superficial Cervical Plexus Blockade for Clavicle Fracture Analgesia|Not yet recruiting||Phase 3|40|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||t|||||2017-10-10 20:56:54.113037|2017-10-10 20:56:54.113037
NCT03187886|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|July 31, 2017|Anticipated|2017-07-31|June 12, 2017|Actual|2017-06-12||Observational|||Use Lay Language. CAA-ri : a Series of 28 Patients|A Clinico-radiological Reappraisal of Cerebral Amyloid Angiopathy-related Inflammation in a Series of 28 Patients.|Terminated||N/A|28|Actual|University Hospital, Montpellier|||1||f||||f|f|f||||||Undecided|NC|2017-10-10 20:56:54.232987|2017-10-10 20:56:54.232987
NCT03187873|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-13|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Chamas for Change Validation|Chamas for Change: Validating an Integrated Community-based Strategy of Peer Support in Pregnancy and Infancy in Kenya|Recruiting||N/A|3040|Anticipated|Moi University||2|||f||||f|f|f||||||No||2017-10-10 20:56:54.31873|2017-10-10 20:56:54.31873
NCT03186105|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 2, 2018|Anticipated|2018-12-02|December 2, 2018|Anticipated|2018-12-02||Interventional|||Feasability of Ambulatory Appendicectomy|EVALUATION OF THE AMBULATORY FEASIBILITY OF APPENDICECTOMY FOR ACUTE APPENDICITIS IN CHILDREN 6 TO 17 YEARS|Recruiting||N/A|50|Anticipated|Fondation Lenval||1|||f||||f|f|f||||||No||2017-10-10 20:57:10.961697|2017-10-10 20:57:10.961697
NCT03187860|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-14|||November 15, 2017|Anticipated|2017-11-15|June 2017|2017-06-01|November 15, 2019|Anticipated|2019-11-15|November 15, 2019|Anticipated|2019-11-15||Observational|RhéMuc||Ciliation and Mucus Rheology Parameters Determined Via Air-liquid-interface Cell Cultures in Non-smoking, Smoking, COPD and Asthmatic Patients|Ciliation and Mucus Rheology Parameters Determined Via Air-liquid-interface Cell Cultures in Non-smoking, Smoking, COPD and Asthmatic Patients|Not yet recruiting||N/A|40|Anticipated|University Hospital, Montpellier|||4||f||||f|f|f||||Samples Without DNA|"     Bronchial biopsies will be used to derive air-liquid-interface cell cultures. We expect     several replicate cell cultures per biopsy.   "|||2017-10-10 20:56:54.465533|2017-10-10 20:56:54.465533
NCT03187847|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-24|||August 27, 2017|Anticipated|2017-08-27|June 2017|2017-06-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Observational|||Rehabilitation in Multiple Sclerosis - Sometimes Too Much?|Changes in Perceived Fatigue and Physical Activity in People With MS Before and After the Rehabilitation - an Observational Study|Not yet recruiting||N/A|50|Anticipated|Klinik Valens|||1||f||||f|f|f||||||No||2017-10-10 20:56:54.595706|2017-10-10 20:56:54.595706
NCT03187834|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-14|||July 4, 2017|Actual|2017-07-04|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|ARMCA||Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso|Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso|Active, not recruiting||Phase 4|252|Actual|University of California, San Francisco||4|||f||||f|t|f|||f|||||2017-10-10 20:56:54.681767|2017-10-10 20:56:54.681767
NCT03187821|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-14|||September 2012||2012-09-01|June 2017|2017-06-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure|Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure|Completed||N/A|1000|Actual|Aravind Eye Care System||2|||f||||t||||||||Undecided||2017-10-10 20:56:54.788238|2017-10-10 20:56:54.788238
NCT03187808|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-06-13|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Effects of Single Thoracic Manipulation and Special Massage Technique (RT Technique) on Chronic Mechanical Neck Pain|The Effect of Single Thoracic Manipulation Combined With Special Massage Technique on Mechanical Neck Pain: A Randomized Controlled Trial|Completed||N/A|30|Actual|Khon Kaen University||2|||f||||t||||||||No|The participants' data and documents in this study will not be shared to other researchers.|2017-10-10 20:56:54.881338|2017-10-10 20:56:54.881338
NCT03187795|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-16|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|March 30, 2022|Anticipated|2022-03-30|September 30, 2021|Anticipated|2021-09-30||Interventional|MOSET-SCI||Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury|Efficacy and Tolerability of Mirabegron Compared to Oxybutynin Chloride Immediate Release for Neurogenic Detrusor Overactivity in Persons With Chronic Spinal Cord Injury: A Randomized, Double-Blind, Controlled, Cross-Over Clinical Trial|Not yet recruiting||Phase 2|62|Anticipated|Kessler Foundation||2|||f||||t|t|f|||t|||||2017-10-10 20:56:54.964866|2017-10-10 20:56:54.964866
NCT03187782|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-13|||February 2014|Actual|2014-02-01|June 2017|2017-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Pulse Diagnoses in Patients While Dysmenorrhea is Attacking|The Effect of Acupuncture Treatment of Acupoint San Yin Jiao on the Pulse Diagnoses in Patients While Dysmenorrhea is Attacking|Completed||N/A|15|Actual|Taipei Hospital, Taiwan|||1||f||||||||||||Undecided||2017-10-10 20:56:55.121359|2017-10-10 20:56:55.121359
NCT03187769|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-16|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder|A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults With Schizophrenia, Schizophreniform, or Bipolar I Disorder Who Are Early in Their Illness|Recruiting||Phase 3|250|Anticipated|Alkermes, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:56:55.183927|2017-10-10 20:56:55.183927
NCT03187756|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-08|||June 2, 2017|Actual|2017-06-02|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft|Phase II Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft|Recruiting||Phase 2|15|Anticipated|New York University School of Medicine||1|||f||||f|t|f|||t|||||2017-10-10 20:56:55.307987|2017-10-10 20:56:55.307987
NCT03187743|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|October 2020|Anticipated|2020-10-01||Interventional|DECOR||Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone|Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone|Not yet recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||No||2017-10-10 20:56:55.402778|2017-10-10 20:56:55.402778
NCT03187730|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants|Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants|Not yet recruiting||N/A|600|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:56:55.505788|2017-10-10 20:56:55.505788
NCT03187717|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-13|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|February 1, 2017|Actual|2017-02-01|January 1, 2017|Actual|2017-01-01||Observational|||Total Intravenous Anesthesia and Inhalation Anesthesia|The Comparison of Total Intravenous Anesthesia and Inhalation Anesthesia Procedures Used in Oral and Maxillofacial Surgeries in View of Postoperative Complications and the Recovery Period|Completed||N/A|583|Actual|Adnan Menderes University|||2||f||||t|f|f||||||No||2017-10-10 20:56:55.574672|2017-10-10 20:56:55.574672
NCT03187704|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||May 1, 2012|Actual|2012-05-01|June 2017|2017-06-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Interventional|||Boston Puerto Rican Health Study|Boston Puerto Rican Health Study - Project 4|Completed||N/A|23|Actual|Tufts University||2|||f||||f|f|f||||||No|We do not plan to share individual participant data|2017-10-10 20:56:55.64235|2017-10-10 20:56:55.64235
NCT03187691|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-13|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia|An Open Label Phase II Clinical Study to Evaluate the Safety and Pharmacokinetics of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous (AML) and Lymphoblastic Leukaemia (ALL)|Not yet recruiting||Phase 2|30|Anticipated|Matinas BioPharma Nanotechnologies, Inc.||2|||||||f|t|f||||||No||2017-10-10 20:56:55.725956|2017-10-10 20:56:55.725956
NCT03187678|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-27|||December 21, 2017|Anticipated|2017-12-21|September 2017|2017-09-01|July 9, 2018|Anticipated|2018-07-09|July 9, 2018|Anticipated|2018-07-09||Interventional|||Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension|A Multicenter, Open-label, Single-sequence Cross-over Study to Assess Safety, Tolerability, and Pharmacokinetics of Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension Switching From an Oral Stable Dose of Selexipag|Not yet recruiting||Phase 3|20|Anticipated|Actelion||1|||f||||f|t|f||||||||2017-10-10 20:56:55.805568|2017-10-10 20:56:55.805568
NCT03187665|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-09|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Observational|||Alarms Due to Loss of Signal Integrity in Partially Wireless Versus Traditional Pulse Oximetry in Pediatric Patients|The Ties That Bind: Evaluation of a Patient-worn Pulse Oximeter Compared to Traditional Pulse Oximetry on Loss of Signal Integrity in Pediatric Patients|Recruiting||N/A|48|Anticipated|Medical College of Wisconsin|||4||f||||f|f|t|f|f|f|||||2017-10-10 20:56:55.902093|2017-10-10 20:56:55.902093
NCT03187652|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-19|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|||A Prospective Study on the Long-Term Vascular Burden in TTP Patients|A Prospective Study on the Long-Term Vascular Burden in TTP Patients|Recruiting||N/A|15|Anticipated|Lawson Health Research Institute|||1||f||||f|f|f||||||No||2017-10-10 20:56:56.022165|2017-10-10 20:56:56.022165
NCT03187639|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|FORECAST||Fractional Flow Reserve Derived From Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain|Fractional Flow Reserve Derived From Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain|Not yet recruiting||Phase 3|1400|Anticipated|University Hospital Southampton NHS Foundation Trust||2|||f||||t|f|f||||||No||2017-10-10 20:56:56.095639|2017-10-10 20:56:56.095639
NCT03187626|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-02|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|RHIBOT||Efficacy of an Intra-articular Injection of Botulinum Toxin A Associated With Splinting for Base-of-thumb Osteoarthritis|Short-term Efficacy of a Single Ultrasound-guided Intra-articular Injection of Botulinum Toxin A Associated With Splinting for Base-of-thumb Osteoarthritis: a Randomized Controlled Double-blind Pilot Study|Not yet recruiting||Phase 2/Phase 3|60|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f|||||f|f||||||||2017-10-10 20:56:56.191228|2017-10-10 20:56:56.191228
NCT03187613|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-22|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2021|Anticipated|2021-07-01||Observational|||Correlation of Metamorphopsia and Aniseikonia to Retinal Shift Following Retinal Detachment Surgery|Correlation of Metamorphopsia and Aniseikonia to Retinal Shift Following Retinal Detachment Surgery|Recruiting||N/A|30|Anticipated|Helse Stavanger HF|||1||f||||f|f|f||||||Undecided||2017-10-10 20:56:56.423232|2017-10-10 20:56:56.423232
NCT03187600|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-08-23|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|June 10, 2020|Anticipated|2020-06-10|June 10, 2020|Anticipated|2020-06-10||Interventional|||Submucosa/Mucosal Pharyngeal Flap Trial|Single Blinded Randomized Controlled Trial Comparing Muscular Pharyngeal Flap to Mucosal/Submucosal Pharyngeal Flap Surgical Technique for the Treatment of Velopharyngeal Dysfunction|Recruiting||N/A|20|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:56:56.509471|2017-10-10 20:56:56.509471
NCT03187587|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-14|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Percutaneous Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer|An Open-Label, Comparative Trial to Evaluate the Effect of imILT in Patients With Advanced Disease or Stage IV Pancreatic Carcinoma|Recruiting||N/A|20|Anticipated|Clinical Laserthermia Systems AB||2|||f||||f|f|f||||||No||2017-10-10 20:56:56.616779|2017-10-10 20:56:56.616779
NCT03187574|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-16|||May 2009|Actual|2009-05-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|January 2015|Actual|2015-01-01||Observational|ELEPE||Comparison of Two Vaginal Mesh Kits in the Management of Vaginal Prolapse|A Prospective Comparison of Two Vaginal Mesh Kits in the Management of Anterior and Apical Vaginal Prolapse: Long Term-results for Apical Fixation and Quality of Life|Completed||N/A|126|Actual|Hospices Civils de Lyon|||2||f||||f|f|f||||||No||2017-10-10 20:56:56.707637|2017-10-10 20:56:56.707637
NCT03187561|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-12|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|February 28, 2022|Anticipated|2022-02-28|February 28, 2021|Anticipated|2021-02-28||Interventional|SIESTA-FF||Coparenting, Infant Sleep, and Infant Development|Coparenting, Infant Sleep, and Infant Development|Not yet recruiting||N/A|216|Anticipated|Penn State University||3|||f||||t|f|f||||||No||2017-10-10 20:56:56.789146|2017-10-10 20:56:56.789146
NCT03187548|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of CPP-ACP Prophylactic Effect on Enamel Surface During Orthodontic Treatment|Evaluation of the Demineralizing Effect on Enamel Surface During Orthodontic Treatment With and Without the Addition of Casein Phosphopeptides-Amorphous Calcium Phosphate (CPP-ACP) on: A Randomized Clinical Trial, Split Mouth Design|Not yet recruiting||Phase 1|45|Anticipated|Cairo University||1|||f||||t|t|f|||t|||No||2017-10-10 20:56:56.874582|2017-10-10 20:56:56.874582
NCT03187535|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-18|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effect of TEAS on PONV After Spinal Surgery|The Effect of Transcutaneous Electric Acupoint Stimulation on Post-operative Nausea and Vomiting After Spinal Surgery|Not yet recruiting||N/A|72|Anticipated|Ohio State University||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:56:56.976524|2017-10-10 20:56:56.976524
NCT03187522|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-13|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|February 2024|Anticipated|2024-02-01|December 2019|Anticipated|2019-12-01||Interventional|||An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft|An EU Post-Approval Registry of the TREO® Stent-Graft for Patients With Infrarenal Abdominal Aortic Aneurysms|Recruiting||N/A|600|Anticipated|Bolton Medical||1|||f||||f|f|f||||||No||2017-10-10 20:56:57.092127|2017-10-10 20:56:57.092127
NCT03187509|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-12|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Weight-Based Torsemide Dosing in Subjects With Heart Failure|Weight-Based Torsemide Dosing vs. Standard Outpatient Management in Subjects With Heart Failure: A Randomized Open-Label Pilot Study|Not yet recruiting||N/A|40|Anticipated|New York City Health and Hospitals Corporation||2|||f||||t|f|f|||f|||||2017-10-10 20:56:57.250272|2017-10-10 20:56:57.250272
NCT03187496|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-16|||May 11, 2017|Actual|2017-05-11|August 2017|2017-08-01|June 14, 2017|Actual|2017-06-14|June 1, 2017|Actual|2017-06-01||Interventional|||Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.|A Non-Randomized, Multiple-Dose, Open-Label, Single Sequence Study to Evaluate the Effect of Concomitant Administration of EDP-305 on the Pharmacokinetics and Safety of Midazolam, Caffeine, and Rosuvastatin in Healthy Human Volunteers|Completed||Phase 1|24|Actual|Enanta Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 20:56:57.339675|2017-10-10 20:56:57.339675
NCT03187483|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-12|||January 2014|Actual|2014-01-01|June 2017|2017-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Flash-free Brackets and Dental Plaque|Do Adhesive Flash-free Brackets Affect Bacterial Plaque? A Randomized Controlled Clinical and Microbiological Assessment|Completed||N/A|45|Actual|Ege University||2|||f||||t|f|f||||||No||2017-10-10 20:56:57.461378|2017-10-10 20:56:57.461378
NCT03187470|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-12|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Left Ventricular Dyssynchrony in Multipole Pacing|The Impact of Multipole Pacing (MPP) on Left Ventricular Dyssynchrony in Patients With Cardiac Resynchronization Therapy (CRT) - a Real-Time Three Dimensional Echocardiography Approach|Recruiting||N/A|40|Anticipated|Deutsches Herzzentrum Muenchen||1|||f||||f|f|f||||||No||2017-10-10 20:56:57.530043|2017-10-10 20:56:57.530043
NCT03187457|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-13|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PreFem||"PreFem: What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"|"PreFem: What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"|Recruiting||N/A|60|Anticipated|Danisco||2|||f||||f|f|f||||||||2017-10-10 20:56:57.652042|2017-10-10 20:56:57.652042
NCT03187444|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-12|||April 24, 2015|Actual|2015-04-24|June 2017|2017-06-01|April 4, 2037|Anticipated|2037-04-04|October 24, 2036|Anticipated|2036-10-24||Interventional|RCVRIC||Cardiovascular Risk and Chronic Inflammatory Rheumatism|Cardiovascular Risk and Chronic Inflammatory Rheumatism|Recruiting||N/A|200|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 20:56:57.746666|2017-10-10 20:56:57.746666
NCT03187431|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-06-13|||December 11, 2017|Anticipated|2017-12-11|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Role of Stem Cell Therapy in Interstitial Pulmonary Fibrosis|Mesenchymal Stem Cell as Therapeutic Modality in Interstitial Pulmonary Fibrosis|Not yet recruiting||Phase 1|12|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 20:56:57.877421|2017-10-10 20:56:57.877421
NCT03187418|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-30|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma|Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation (mTSCPC) in Uncontrolled Glaucoma at the University of Montreal Hospital Center (CHUM)|Recruiting||N/A|50|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t|f|t|f|f|t|||||2017-10-10 20:56:57.96553|2017-10-10 20:56:57.96553
NCT03187405|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-05|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|October 2021|Anticipated|2021-10-01||Interventional|FIVHeMA||Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage.|Intraventricular Fibrinolysis Versus External Ventricular Drainage Alone in Aneurysmal Subarachnoid Hemorrhage: a Randomized Controlled Trial.|Not yet recruiting||Phase 3|440|Anticipated|University Hospital, Caen||2|||f||||t|f|f||||||||2017-10-10 20:56:58.127406|2017-10-10 20:56:58.127406
NCT03187392|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|September 18, 2017|Anticipated|2017-09-18|September 16, 2017|Anticipated|2017-09-16||Interventional|||Pain Relief for Birth Control Implants Insertion|Topical Lidocaine-prilocaine Cream Versus Lidocaine Infiltration for Pain Relief During Insertion of Subcutaneous Birth Control Implants : A Randomized Controlled Trial|Recruiting||Phase 3|144|Anticipated|Assiut University||2|||f||||t|f|f||||||No||2017-10-10 20:56:58.278258|2017-10-10 20:56:58.278258
NCT03187379|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-12|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Efficacy of Exparel (TM) on Post-operative Pain After Laparoscopic Gastric Bypass Using Circular EEA Stapler|Efficacy of Exparel (TM) on Post-operative Pain After Laparoscopic Gastric Bypass Using Circular EEA Stapler|Recruiting||Phase 4|150|Anticipated|The Cleveland Clinic||2|||f||||f|t|f|||f|||No||2017-10-10 20:56:58.376221|2017-10-10 20:56:58.376221
NCT03187366|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||February 2018|Anticipated|2018-02-01|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|February 2021|Anticipated|2021-02-01||Interventional|||Schistosomiasis in Senegal|EID: Using Community Ecology Theory to Predict the Effects of Agricultural Expansion and Intensification on Infections of Humans: Implications for Sustainable Agriculture|Recruiting||N/A|1000|Anticipated|University of South Florida||3|||f||||f|f|f||||||Undecided||2017-10-10 20:56:58.479826|2017-10-10 20:56:58.479826
NCT03187353|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-22|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2022|Anticipated|2022-07-01||Interventional|IMPRES||IMProving Executive Function Study|Multi-Modal Imaging of Psychostimulant Effects on Executive Function Post-RRSO|Recruiting||Phase 4|100|Anticipated|University of Pennsylvania||2|||f||||t|t|f|||f|||||2017-10-10 20:56:58.584308|2017-10-10 20:56:58.584308
NCT03187327|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||September 2013|Actual|2013-09-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Observational|FPS||Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology|Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology and Evaluation of Occult Tubal Lesions Prevalence: Preliminary Study|Completed||N/A|69|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 20:56:58.800802|2017-10-10 20:56:58.800802
NCT03187314|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-03|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer|Phase II Study of Radiation Therapy With Anti-PD-1 Antibody SHR-1210 in Treating Patients With Unresectable Esophageal Cancer|Recruiting||Phase 2|21|Anticipated|Hangzhou Cancer Hospital||1|||f||||t|f|f||||||||2017-10-10 20:56:58.893023|2017-10-10 20:56:58.893023
NCT03187288|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-08|||September 25, 2017|Anticipated|2017-09-25|August 2017|2017-08-01|September 25, 2024|Anticipated|2024-09-25|September 25, 2022|Anticipated|2022-09-25||Interventional|||A Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome|An Open-Label, Dose Escalation, Safety and Pharmacokinetic Study of CFI-400945 Fumarate Administered Orally to Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome|Not yet recruiting||Phase 1|48|Anticipated|University Health Network, Toronto||1|||f||||t|f|f||||||||2017-10-10 20:56:59.147267|2017-10-10 20:56:59.147267
NCT03187275|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-08-13|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|mProstate||Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer Survivors|Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer Survivors|Recruiting||N/A|15|Anticipated|Emory University||2|||f||||t|f|f||||||||2017-10-10 20:56:59.236773|2017-10-10 20:56:59.236773
NCT03187262|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||July 31, 2017|Anticipated|2017-07-31|June 2017|2017-06-01|January 31, 2025|Anticipated|2025-01-31|January 31, 2021|Anticipated|2021-01-31||Interventional|||A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia|A Phase 2 Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia|Not yet recruiting||Phase 2|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 20:56:59.343132|2017-10-10 20:56:59.343132
NCT03187249|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Intervention Strategy in Chronic Obstructive Pulmonary Disease With Anxiety and Depression|Intervention Strategy in Chronic Obstructive Pulmonary Disease With Anxiety and Depression|Recruiting||N/A|500|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||4|||f||||t|f|f||||||Undecided||2017-10-10 20:56:59.432146|2017-10-10 20:56:59.432146
NCT03187236|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-06-13|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|3 Years|Observational [Patient Registry]|||Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China|The Early Detection, Clinical Course and Prognosis of Anxiety and Depression in Chronic Obstructive Pulmonary Disease|Recruiting||N/A|1906|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t|f|f||||Samples With DNA|"     Serum and blood cells   "|Undecided||2017-10-10 20:56:59.519245|2017-10-10 20:56:59.519245
NCT03187223|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-13|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|October 2020|Anticipated|2020-10-01||Interventional|BEB-2||Bendamustine and Melphalan in Myeloma|A Randomized Phase II Trial Comparing Bendamustine and Melphalan With Melphalan Alone as Conditioning Regimen for Autologous Stem Cell Transplantation (ASCT) in Myeloma Patients|Recruiting||Phase 2|120|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f|||f|||||2017-10-10 20:56:59.576927|2017-10-10 20:56:59.576927
NCT03187210|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-13|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2022|Anticipated|2022-06-01|June 2021|Anticipated|2021-06-01||Interventional|BAL||Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas|Brentuximab Vedotin and BeEAM High-dose Chemotherapy (B-BeEAM) With Autologous Stem Cell Transplantation for CD30+ Lymphomas, a Phase I/II Study|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|University Hospital Inselspital, Berne||3|||f||||f|f|f||||||||2017-10-10 20:56:59.663819|2017-10-10 20:56:59.663819
NCT03187197|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-13|2017-10-03|||June 20, 2017|Actual|2017-06-20|October 2017|2017-10-01|March 29, 2019|Anticipated|2019-03-29|August 9, 2018|Anticipated|2018-08-09||Observational|||Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation|Patients Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation Impact of Conventional Oral Anticoagulant (OAC) Compared With Novel Oral Anticoagulant (NOAC)|Recruiting||N/A|1400|Anticipated|Boehringer Ingelheim|||2||f||||f|f|f||||||||2017-10-10 20:56:59.742807|2017-10-10 20:56:59.742807
NCT03187171|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-25|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||ACDF Comparison Trial|Comparison of Outcomes After ACDF Using Allograft Fusion Versus PEEK Fusion: a Prospective Clinical Trial|Not yet recruiting||N/A|96|Anticipated|Duke University||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:57:00.245576|2017-10-10 20:57:00.245576
NCT03182283|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-09|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|PCPC||Person-Centered Psychosis Care: An Educational Intervention|Person-Centered Psychosis Care: An Educational Intervention for Inpatient Staff|Recruiting||N/A|100|Anticipated|Göteborg University||2|||f||||f|f|f||||||No||2017-10-10 20:57:47.895101|2017-10-10 20:57:47.895101
NCT03187158|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-14|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|August 15, 2019|Anticipated|2019-08-15|July 15, 2019|Anticipated|2019-07-15||Observational|FEAL||Factors Affecting Early Adult Lung Function|Factors Affecting Early Adult Lung Function|Enrolling by invitation||N/A|500|Anticipated|Council of Scientific and Industrial Research, India|||2||f||||t|f|f||||||Yes|Participant data sets and/or documents to be shared : Lung function data, biomarker data, retrospective maternal anthropometry data will be shared as a complete dataset, but with a participant ID which will be delinked from actual participant identity. The ID will only be linked to the participant in the event that an abnormality is detected and the participant may require intervention. Data will be shared via a common excel sheet available to all investigators.|2017-10-10 20:57:00.354659|2017-10-10 20:57:00.354659
NCT03187145|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-09|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|August 30, 2017|Anticipated|2017-08-30|July 30, 2017|Anticipated|2017-07-30||Observational|||Ultrasound Evaluation of Gastric Emptying in Diabetic Patients|A Cohort Study of Ultrasound Evaluation of Gastric Emptying in Diabetic Patients: a Comparison With Healthy Controls|Recruiting||N/A|100|Anticipated|West China Hospital|||2||f||||f|f|f||||||||2017-10-10 20:57:00.465153|2017-10-10 20:57:00.465153
NCT03187132|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-07-18|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Development and Validation of a Digital Pain-reduction Kit for Orthopedic Injuries|Development and Validation of a Digital Pain-reduction Kit for Orthopedic Injuries|Not yet recruiting||N/A|140|Anticipated|Cedars-Sinai Medical Center||2|||f||||f|f|t|f|f|f|||||2017-10-10 20:57:00.561909|2017-10-10 20:57:00.561909
NCT03187119|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-12|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|July 31, 2018|Anticipated|2018-07-31|June 30, 2018|Anticipated|2018-06-30||Interventional|TAAC||Investigation of the Role of Pictorial Asthma Action Plans to Promote Self-management in Rural Youth With Asthma|Take Action for Asthma Control Study - Pilot Randomized Controlled Trial of Pictorial Asthma Action Plans to Promote Self-management and Health in Rural Youth With Asthma|Recruiting||N/A|60|Anticipated|West Virginia University||2|||f||||t|f|f||||||No||2017-10-10 20:57:00.672996|2017-10-10 20:57:00.672996
NCT03187106|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-16|||June 27, 2017|Anticipated|2017-06-27|June 2017|2017-06-01|June 5, 2019|Anticipated|2019-06-05|June 5, 2019|Anticipated|2019-06-05||Interventional|PAC||Prophylactic Antibiotics After Cesarean|Prophylactic Antibiotics After Cesarean|Not yet recruiting||Phase 1|332|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t|t|f|||t|||No||2017-10-10 20:57:00.811202|2017-10-10 20:57:00.811202
NCT03187093|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-14|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Cognitive Dysfunction in MDD Patients|Cognitive Dysfunction in Patients With Major Depressive Disorder, Clinical Peculiarities, Biological Markers, and Treatment Efficacy|Recruiting||Phase 4|150|Anticipated|State Institution, Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine||2|||f||||f|t|f|||t|||Undecided||2017-10-10 20:57:00.924578|2017-10-10 20:57:00.924578
NCT03187080|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-31|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 30, 2021|Anticipated|2021-12-30|September 1, 2021|Anticipated|2021-09-01||Interventional|||Enhanced Recovery Strategies in Elective Breast Surgery|Evaluating the Use of Enhanced Recovery Strategies and Paravertebral Block in Elective Breast Reduction and Breast Augmentation|Recruiting||Phase 4|296|Anticipated|University of Wisconsin, Madison||8|||f||||f|t|f|||f|||||2017-10-10 20:57:01.052258|2017-10-10 20:57:01.052258
NCT03187067|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|PLUS||Pediatric Pneumonia Lung Ultrasound|Evaluation of Impact of Lung Ultrasound (LUS) on Management of Pneumonia in Low-resource Settings|Not yet recruiting||N/A|240|Anticipated|Save the Children|||4||f||||f|f|t|f|f|t|Samples Without DNA|"     Respiratory and blood samples   "|No|There is no plan to make individual participant data (IPD) available to other researchers.|2017-10-10 20:57:01.204194|2017-10-10 20:57:01.204194
NCT03187054|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-20|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||POPQ Versus Simulated Apical Support as a Guideline for Anterior or Posterior Repair During Vaginal Reconstruction|Preoperative POPQ Versus Simulated Apical Support as a Guideline for Anterior or Posterior Repair at the Time of Transvaginal Apical Suspension|Recruiting||N/A|332|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 20:57:01.317793|2017-10-10 20:57:01.317793
NCT03187041|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-13|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Sensation and Skin Pressures Under Blood-Draw Tourniquets|Skin Surface Pressures Under Blood-Draw Tourniquets|Active, not recruiting||N/A|20|Anticipated|University of California, San Diego||1|||f||||f|f|f||||||No|Individual Participant Data will not be shared.|2017-10-10 20:57:01.4287|2017-10-10 20:57:01.4287
NCT03187028|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-21|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|PACE||Diet and Exercise After Pancreatic Cancer|Diet and Exercise After Pancreatic Cancer: Clinical and Functional Outcomes (Non Canonical WNT Signaling in Colorectal Cancer)|Recruiting||N/A|50|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 20:57:01.524893|2017-10-10 20:57:01.524893
NCT03187015|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-08-07|||June 2, 2017|Actual|2017-06-02|August 2017|2017-08-01|June 25, 2017|Actual|2017-06-25|June 25, 2017|Actual|2017-06-25||Interventional|||A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects|An Open Label, 2-Period Study to Assess the Effect of Entinostat on the Pharmacokinetics of Midazolam in Healthy Adult Subjects|Completed||Phase 1|26|Actual|Syndax Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 20:57:01.649045|2017-10-10 20:57:01.649045
NCT03187002|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-13|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion|Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion: A Blinded Randomized Controlled Trial|Not yet recruiting||N/A|142|Anticipated|Stanford University||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:57:01.756378|2017-10-10 20:57:01.756378
NCT03186638|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-12|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|March 1, 2020|Anticipated|2020-03-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Exercise and Low-Dose Ibuprofen for Cognitive Impairment in Colorectal Cancer Patients Receiving Chemotherapy|Phase II Study of Exercise and Low-Dose Ibuprofen for Cognitive Impairment in Colorectal Cancer Patients Receiving Chemotherapy|Recruiting||Phase 2|140|Anticipated|University of Rochester||4|||f||||t|t|f|||f|||No||2017-10-10 20:57:04.62096|2017-10-10 20:57:04.62096
NCT03186989|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-28|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|February 29, 2020|Anticipated|2020-02-29|January 31, 2020|Anticipated|2020-01-31||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease|Recruiting||Phase 1/Phase 2|44|Anticipated|Ionis Pharmaceuticals, Inc.||2|||f||||t|f|f||||||||2017-10-10 20:57:01.842931|2017-10-10 20:57:01.842931
NCT03186976|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-13|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|RASTA-AF||Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study|Reversal of Atrial Substrate to Prevent Atrial Fibrillation - A Pilot Study|Not yet recruiting||N/A|50|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||No||2017-10-10 20:57:02.009464|2017-10-10 20:57:02.009464
NCT03186963|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-08|||May 2013||2013-05-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|June 2017|Actual|2017-06-01||Interventional|||Effectiveness of Immobilization in the Postoperative Analgesia of Surgically Treated Distal Radius Fractures|Effectiveness of Immobilization in the Postoperative Analgesia of Patients With Distal Radius Fracture Treated With Volar Locking Plating: a Prospective, Randomized Clinical Trial|Active, not recruiting||N/A|39|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 20:57:02.185042|2017-10-10 20:57:02.185042
NCT03186950|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-14|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Stainless Steel Crowns Versus Bulkfill Composite Resin for Restoring Primary Molars After Endodontic Treatment|Stainless Steel Crowns Versus Bulkfill Composite Resin for Restoring Primary Molars After Endodontic Treatment: Randomized Clinical Trial|Active, not recruiting||N/A|90|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 20:57:02.341429|2017-10-10 20:57:02.341429
NCT03186937|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-01|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer|A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer|Recruiting||Phase 2|25|Anticipated|University of Wisconsin, Madison||1|||f|||||f|f||||||||2017-10-10 20:57:02.475848|2017-10-10 20:57:02.475848
NCT03186924|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-12|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|June 8, 2020|Anticipated|2020-06-08|June 8, 2020|Anticipated|2020-06-08||Interventional|||Reducing Sedentary Time in Rheumatoid Arthritis: The Take a STAND for Health Study|Reducing Sedentary Time in Rheumatoid Arthritis: The Take a STAND for Health Study|Recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 20:57:02.601406|2017-10-10 20:57:02.601406
NCT03186898|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-22|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|August 31, 2027|Anticipated|2027-08-31|August 1, 2022|Anticipated|2022-08-01||Interventional|||Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer|A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma|Recruiting||N/A|186|Anticipated|NRG Oncology||2|||f||||f|f|f||||||No||2017-10-10 20:57:02.766175|2017-10-10 20:57:02.766175
NCT03186885|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-13|||October 16, 2017|Anticipated|2017-10-16|June 2017|2017-06-01|July 31, 2021|Anticipated|2021-07-31|February 1, 2021|Anticipated|2021-02-01||Interventional|||Healthy Frio: A Rural Community Partnership to Advance Latino Obesity Research|Healthy Frio: A Rural Community Partnership to Advance Latino Obesity Research|Not yet recruiting||N/A|540|Anticipated|University of Texas at Austin||3|||f||||f|f|f||||||No||2017-10-10 20:57:02.882229|2017-10-10 20:57:02.882229
NCT03186872|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-13|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Improving Quality of Care With a Digital Behavioral Program in IBD Patient Centered Medical Home|Improving Quality of Care With a Digital Behavioral Program in IBD Patient Centered Medical Home|Recruiting||N/A|150|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||No|IPD data will not be shared. Data is shared at the aggregate level.|2017-10-10 20:57:02.975878|2017-10-10 20:57:02.975878
NCT03186859|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-13|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|EDISON||Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease)|Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease)|Recruiting||N/A|32|Anticipated|University of Oxford||2|||f||||f|f|f||||||No||2017-10-10 20:57:03.074538|2017-10-10 20:57:03.074538
NCT03186846|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-13|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Volume Optimisation and Cognitive Function in Major Abdominal Surgery|Influence of Volume Optimisation on Cognitive Function in Major Abdominal Surgery|Not yet recruiting||N/A|30|Anticipated|University Medical Centre Ljubljana||2|||f|||||f|f||||||||2017-10-10 20:57:03.203962|2017-10-10 20:57:03.203962
NCT03186833|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-13|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Observational|IDENTIFY-HF||The Heart Failure With Preserved Ejection Fraction (HFpEF) Pathophysiology Study.|The Heart Failure With Preserved Ejection Fraction (HFpEF) Pathophysiology Study. Does Ageing Coupled With Vascular Effects of Comorbidities Lead to HFpEF? An In-depth Understanding From a Tertiary Centre|Recruiting||N/A|95|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust|||5||f||||f|f|f||||Samples Without DNA|"     Serum analysis for galectin-3   "|No||2017-10-10 20:57:03.299906|2017-10-10 20:57:03.299906
NCT03186820|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-21|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|November 15, 2018|Anticipated|2018-11-15|June 15, 2018|Anticipated|2018-06-15||Interventional|EndoSWI||Exploratory Study of the Interest of MRI Susceptibility Weighted Imaging for the Pre-operative Assessment of Pelvic Endometriosis Extent|Exploratory Study of the Interest of MRI Susceptibility Weighted Imaging for the Pre-operative Assessment of Pelvic Endometriosis Extent|Recruiting||N/A|60|Anticipated|University Hospital, Bordeaux||1|||f||||f|f|f||||||No||2017-10-10 20:57:03.387959|2017-10-10 20:57:03.387959
NCT03186807|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-13|||June 20, 2017|Anticipated|2017-06-20|June 2017|2017-06-01|June 20, 2020|Anticipated|2020-06-20|June 20, 2019|Anticipated|2019-06-20||Observational|||Evaluation of Brain Volume and Dimensions in Healthy Fetuses Using Obstetrics Ultrasound Examination at 14-34 Weeks of Pregnancy.|Evaluation of Brain Volume and Dimensions in Healthy Fetuses Using Obstetrics Ultrasound Examination at 14-34 Weeks of Pregnancy.|Not yet recruiting||N/A|500|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t|f|f||||||No|This is a prospective study that evaluates normal fetal brain cortex development from 14 to 34 WG using 2D and 3D ultrasound in singleton low risk pregnancies with unknown obstetrical complications. Recruitment at time of visit to our hospital emergency room, outpatient clinic, and hospitalized patient. Each participating women can take part in a single Ultrasonographical scan related to our study objective. The clinical and obstetrical data will be obtained prior to the US evaluation; and will include maternal medical and obstetrical data and confirmation of fetal gestational age based on first day of the last menstrual cycle (LMP) supported by CRL|2017-10-10 20:57:03.494937|2017-10-10 20:57:03.494937
NCT03186768|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-10-03|||June 12, 2017|Actual|2017-06-12|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Actual|2017-09-30||Interventional|||Soap on a Rope Trial|Evaluation of Soap on a Rope Hall Pass Behavior Intervention: a School-randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Syracuse University||2|||f||||f|f|f||||||||2017-10-10 20:57:03.779858|2017-10-10 20:57:03.779858
NCT03186755|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-13|||June 11, 2017|Actual|2017-06-11|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis|Randomized Controlled Trial Comparing Olopatadine 0.1% Ophthalmic Solution With Hylo-Dual Ophthalmic Preparation in Children With Seasonal Allergic Conjunctivitis|Recruiting||Phase 4|42|Anticipated|St. Justine's Hospital||2|||f||||t|t|f|||t|||No||2017-10-10 20:57:03.85744|2017-10-10 20:57:03.85744
NCT03186742|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-13|||July 1, 2014|Actual|2014-07-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|January 1, 2017|Actual|2017-01-01||Interventional|||Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy|Effects of Eplerenone on Left Ventricular Hypertrophy in Patients With Resistant Hypertension and Obstructive Sleep Apnoea|Completed||Phase 4|125|Actual|Poznan University of Medical Sciences||2|||f||||f|f|f|||f|||No||2017-10-10 20:57:03.978956|2017-10-10 20:57:03.978956
NCT03186729|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-13|||June 23, 2017|Anticipated|2017-06-23|June 2017|2017-06-01|June 2031|Anticipated|2031-06-01|June 2021|Anticipated|2021-06-01||Interventional|STATICH||Study of Antithrombotic Treatment After Intracerebral Haemorrhage|Study of Antithrombotic Treatment After Intracerebral Haemorrhage|Not yet recruiting||Phase 4|500|Anticipated|Oslo University Hospital||2|||f||||t|t|f|||t|||Yes||2017-10-10 20:57:04.060294|2017-10-10 20:57:04.060294
NCT03186716|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-17|||June 11, 2017|Actual|2017-06-11|June 2017|2017-06-01|November 25, 2017|Anticipated|2017-11-25|November 25, 2017|Anticipated|2017-11-25||Interventional|||A Trial of Enteral Colostrum on Intestinal Permeability in Critically Ill Patients|Effects of Colostrum Supplement on Intestinal Permeability in Hospitalized Patients With Enteral Feeding in Intensive Care Unit|Recruiting||N/A|70|Anticipated|National Nutrition and Food Technology Institute||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:04.14399|2017-10-10 20:57:04.14399
NCT03186703|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|January 1, 2018|Anticipated|2018-01-01||Interventional|||Evaluating the Impact of the McMaster Optimal Aging Portal on Cancer Prevention Behaviours in Underserved Populations|Evaluating the Impact of the McMaster Optimal Aging Portal on Knowledge, Behavioural Intentions and Health Behaviours Related to Cancer Risk in Underserved Populations.|Not yet recruiting||N/A|466|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 20:57:04.226946|2017-10-10 20:57:04.226946
NCT03186690|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-06-13|||July 4, 2013|Actual|2013-07-04|June 2017|2017-06-01|December 22, 2015|Actual|2015-12-22|July 4, 2015|Actual|2015-07-04||Interventional|||Similar Outcomes of Vital Pulp Therapy Using Mineral Trioxide Aggregate or Biodentine™|154/2013 Grant for Mineral Trioxide Aggregate and Biodentine for Vital Pulp Therapy|Completed||N/A|50|Actual|Jordan University of Science and Technology||2|||f||||f|f|f||||||No||2017-10-10 20:57:04.302933|2017-10-10 20:57:04.302933
NCT03186677|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-27|||June 3, 2017|Actual|2017-06-03|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|March 2, 2018|Anticipated|2018-03-02||Interventional|||Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients|A Phase 1, Open-label, Multi-center, Dose-escalation Study to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of ISU304 in Previously Treated Hemophilia B Patients|Recruiting||Phase 1|12|Anticipated|ISU Abxis Co., Ltd.||5|||f||||t|f|f||||||||2017-10-10 20:57:04.374529|2017-10-10 20:57:04.374529
NCT03186664|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-13|||December 28, 2016|Actual|2016-12-28|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|SARR||The Role of SAtivex® in Robotic-Rehabilitation|The Role of SAtivex® Associated With Robotic-Rehabilitation in Improving the Motor Performances of Multiple Sclerosis Patients (SARR)|Recruiting||N/A|40|Anticipated|"IRCCS Centro Neurolesi Bonino-Pulejo"||2|||f||||f|f|f||||||No||2017-10-10 20:57:04.468029|2017-10-10 20:57:04.468029
NCT03186651|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-13|||March 7, 2017|Actual|2017-03-07|June 2017|2017-06-01|November 30, 2017|Anticipated|2017-11-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||An Investigation With an Intra-vaginal Device for Stress Urinary Incontinence|An Open Randomized Controlled Multicenter Clinical Investigation With an Intra-vaginal Device for Stress Urinary Incontinence in Comparison to Using Standard of Care|Recruiting||N/A|96|Anticipated|Invent Medic Sweden AB||2|||f||||t|f|f||||||No||2017-10-10 20:57:04.539322|2017-10-10 20:57:04.539322
NCT03186625|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-29|||August 10, 2017|Anticipated|2017-08-10|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|May 31, 2018|Anticipated|2018-05-31||Interventional|TCM-TMAO||Impact of Traditional Chinese Medicine on the Gut Microbiota-dependent Trimethylamine N-oxide|Impact of Traditional Chinese Medicine on the Gut Microbiota-dependent Trimethylamine N-oxide in Acute Coronary Syndromes : A Randomized Placebo Controlled Trial|Not yet recruiting||N/A|80|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f|||||f|f||||||||2017-10-10 20:57:04.863173|2017-10-10 20:57:04.863173
NCT03186612|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-14|||March 2, 2016|Actual|2016-03-02|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 2, 2017|Anticipated|2017-12-02||Interventional|||Virtual Reality and Manual Dexterity in in Patients With Multiple Sclerosis|Effects of a Game-based Virtual Reality Video Capture Training Program Plus Occupational Therapy on Manual Dexterity in Patients With Multiple Sclerosis: a Randomizaed Controlled Trial|Recruiting||N/A|26|Anticipated|Universidad Rey Juan Carlos||2|||f||||t|f|f||||||No||2017-10-10 20:57:04.980171|2017-10-10 20:57:04.980171
NCT03186599|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-13|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer|Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer|Recruiting||N/A|200|Anticipated|Gachon University||3|||f||||f|f|f||||||Undecided||2017-10-10 20:57:05.116569|2017-10-10 20:57:05.116569
NCT03186586|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-07-03|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 30, 2018|Anticipated|2018-03-30||Interventional|||Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena|Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena, a Randomized Clinical Trial|Recruiting||Phase 4|32|Anticipated|University of Campinas, Brazil||2|||f||||f|f|f||||||||2017-10-10 20:57:05.249567|2017-10-10 20:57:05.249567
NCT03186573|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-09-08|||May 11, 2017|Actual|2017-05-11|September 2017|2017-09-01|August 17, 2017|Actual|2017-08-17|June 22, 2017|Actual|2017-06-22||Interventional|||Effect of Grape Juice Consumption on the Parameters of Oxidative Stress and Muscle Fatigue in Judo Athletes|Effect of Grape Juice Consumption on the Parameters of Oxidative Stress and Muscle Fatigue in Judo Athletes: A Randomized Clinical Trial|Completed||N/A|12|Actual|Federal University of Health Science of Porto Alegre||3|||f||||t|f|f||||||||2017-10-10 20:57:05.369364|2017-10-10 20:57:05.369364
NCT03186560|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-06|||October 20, 2017|Anticipated|2017-10-20|June 2017|2017-06-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20||Interventional|||Speckle Study: In Arterial, Mixed and Diabetic Foot Ulcers|A Single Centre Open Label Study Measuring Microcirculatory Flux Using Speckle Imaging Device, in Patients With Arterial, Mixed and Diabetic Foot Ulcers Using gekoTM Neuromuscular Electrostimulation (NMES)|Not yet recruiting||N/A|40|Anticipated|Firstkind Ltd||4|||f||||f|f|f||||||||2017-10-10 20:57:05.491528|2017-10-10 20:57:05.491528
NCT03186547|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-19|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Satisfaction Of Adult Patients With Gummy Smile Treated By Botulinum Toxin A Injection|Satisfaction Of Adult Patients With Gummy Smile Treated By Botulinum Toxin A Injection Versus Modified Lip Repositioning Surgery : A Randomized Clinical Trial|Not yet recruiting||Early Phase 1|22|Anticipated|Cairo University||2|||f||||t|t|f|||t|||Yes||2017-10-10 20:57:05.593812|2017-10-10 20:57:05.593812
NCT03186534|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-13|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|2GETHER||Randomized Trial of an HIV Prevention and Relationship Education Program for Young Male Couples|Efficacy of Couples-Based HIV Prevention in Vulnerable Young Men|Not yet recruiting||Phase 3|400|Anticipated|Northwestern University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:05.69903|2017-10-10 20:57:05.69903
NCT03186521|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-13|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|ALGOSEDA||Impact of a Nurse Implemented Sedation and Analgesia Algorithm in Surgical Intensive Care Unit|Impact of a Nurse Implemented Sedation and Analgesia Algorithm on Complications of Critical Illness and Outcome of Surgical Intensive Care Patients|Recruiting||N/A|200|Anticipated|University Hospital, Caen|||1||f||||f|f|f||||||No||2017-10-10 20:57:05.824197|2017-10-10 20:57:05.824197
NCT03186495|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-22|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|May 16, 2018|Anticipated|2018-05-16|April 25, 2018|Anticipated|2018-04-25||Interventional|||Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function|Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function|Recruiting||Phase 1|48|Anticipated|Novo Nordisk A/S||5|||f||||f|t|f|||t|||Yes|According to the Novo Nordisk disclosure commitment on novonordisk-trials.com|2017-10-10 20:57:06.068781|2017-10-10 20:57:06.068781
NCT03186482|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-06-12|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|RIFT||RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP|The Effect of Rifampicin on the Plasma Pharmacokinetics of Emtricitabine (FTC) and Tenofovir Alafenamide Fumarate (TAF) and Intracellular Tenofovir-diphosphate (TFV-DP) and FTC-triphosphate (FTC-TP)|Recruiting||Phase 1|20|Anticipated|St Stephens Aids Trust||3|||f||||f|f|f||||||Yes|Only authorised representatives of the sponsor (such as monitors and auditors) and individuals who are authorised on the signature and delegation log will have access to the participants' personal data. This could typically be: doctors, nurses, pharmacists, laboratory staff and data manager within the Trust/Care organisation. It is also possible that the regulatory authorities may wish to access this data. The access given to participants' data is explained in the participant information sheet, so consent will have been given to these individuals outside the care organisation.|2017-10-10 20:57:06.177099|2017-10-10 20:57:06.177099
NCT03186456|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-12|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Acute Cerebral Infarction|Study the Safety and Efficacy of Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Acute Cerebral Infarction|Not yet recruiting||Phase 1|40|Anticipated|Sclnow Biotechnology Co., Ltd.||2|||f|||||f|f|||f|||Undecided||2017-10-10 20:57:06.402776|2017-10-10 20:57:06.402776
NCT03186443|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-13|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Pregabalin Treatment and Prevention Post-herpetic Neuralgia|Prevention Effect of Pregabalin on Postherpetic Neuralgia: A Multicenter, Randomized, Double-blind, Controlled Trial|Not yet recruiting||Phase 3|342|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||2|||f||||t|t|f|||t|||No||2017-10-10 20:57:06.533069|2017-10-10 20:57:06.533069
NCT03186430|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-21|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||PreTeenVax Evaluation|A Practice-Provider-Parent-Adolescent Intervention to Increase HPV Vaccination|Recruiting||N/A|400|Anticipated|Emory University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:57:06.64465|2017-10-10 20:57:06.64465
NCT03186417|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Mesenchymal Stem Cells in Early Rheumatoid Arthritis|Cell-Based Therapy in Rheumatoid Arthritis: Proof of Concept Phase 1 Trial|Not yet recruiting||Phase 1|20|Anticipated|MetroHealth Medical Center||3|||f||||f|t|f||||||||2017-10-10 20:57:06.776494|2017-10-10 20:57:06.776494
NCT03186404|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-14|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|SPARE-HF||Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study|Randomized Double Blind Placebo Controlled Trial of Statins for the Primary pREvention of Heart Failure in Patients With Cancer Receiving Anthracycline Based Chemotherapy|Not yet recruiting||Phase 2|100|Anticipated|University Health Network, Toronto||2|||f||||t|f|f|||f|||No||2017-10-10 20:57:06.897866|2017-10-10 20:57:06.897866
NCT03186391|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-12|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|ExercisePAD||Exercise Testing in Peripheral Artery Disease Patients|Sensitivity and Specificity of the AHA Post-exercise ABI Criteria|Recruiting||N/A|1500|Anticipated|Rennes University Hospital|||1||f||||f|f|f||||||No||2017-10-10 20:57:07.017668|2017-10-10 20:57:07.017668
NCT03186378|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-13|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|January 31, 2018|Anticipated|2018-01-31||Interventional|||Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.|A Phase 2, Open-Label Study to Evaluate the Safety, Efficacy and Systemic Exposure of VP-102 Topical Film Forming Solution [0.7% (w/v) in Subjects (2 Years and Older) With Molluscum Contagiosum|Recruiting||Phase 2|30|Anticipated|Verrica Pharmaceuticals Inc.||2|||f||||t|t|t|t|f|t|||No||2017-10-10 20:57:07.104476|2017-10-10 20:57:07.104476
NCT03186365|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-13|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis|Efficacy of 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve Chronic Hepatitis C Genotype 1b Patients With Mild Fibrosis: an Open-label, Randomized, Active Control Trial (EGALITE)|Recruiting||Phase 3|82|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 20:57:07.211674|2017-10-10 20:57:07.211674
NCT03186352|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-03|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|PAD||Clinical Effect of Photoactivated Disinfection on Primary Root Carious Lesions After Partial Caries Removal|Clinical Effect of Photoactivated Disinfection on Primary Root Carious Lesions After Partial Caries Removal|Recruiting||N/A|15|Anticipated|Medical University of Warsaw||1|||f|||||f|f||||||||2017-10-10 20:57:07.313665|2017-10-10 20:57:07.313665
NCT03186326|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-10|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|March 31, 2025|Anticipated|2025-03-31|February 28, 2024|Anticipated|2024-02-28||Interventional|SAMCO||Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer|Multicenter Randomized Phase II Study Comparing the Effectiveness and Tolerance of Avelumab Versus Standard 2nd Line Treatment Chemotherapy in Patients With Colorectal Metastatic Cancer With Microsatellite Instability (MSI)|Not yet recruiting||Phase 2|118|Anticipated|Federation Francophone de Cancerologie Digestive||2|||f||||t|f|f||||||||2017-10-10 20:57:07.507502|2017-10-10 20:57:07.507502
NCT03186313|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-13|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||A Phase 3 Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection.|A Phase 3 Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus (EPGCG, Sofosbuvir , Daclatasvir & Ribavirin) Versus Sofosbuvir + Daclatasvir + Ribavirin (Part A) and a Single Dose of Dactavira (EPGCG, Sofosbuvir & Daclatasvir) Versus Sofosbuvir + Daclatasvir (Part B) in Egyptian Adults With Chronic Genotype 4 HCV Infection.|Completed||Phase 3|72|Actual|Egyptian Liver Hospital||4|||f||||||||||||||2017-10-10 20:57:07.583044|2017-10-10 20:57:07.583044
NCT03186300|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-01|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|PEPPER||Patient Empowerment Through Predictive Personalised Decision Support (PEPPER)|Patient Empowerment Through Predictive Personalised Decision Support (PEPPER)|Enrolling by invitation||N/A|20|Anticipated|Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta||1|||f||||t|f|f||||||||2017-10-10 20:57:07.671329|2017-10-10 20:57:07.671329
NCT03186287|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Effectiveness of Eccentric and Concentric Strength Training in Patients With Subacromial Impingement Syndrome|Effectiveness of Eccentric and Concentric Strength Training in Patients With Subacromial Impingement Syndrome: A Randomized Controlled Trial|Not yet recruiting||N/A|78|Anticipated|Dokuz Eylul University||3|||f||||t|f|f||||||||2017-10-10 20:57:07.784876|2017-10-10 20:57:07.784876
NCT03186274|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-13|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Discussing Death and Dying: An End of Life Curriculum to Empower Residents|Discussing Death and Dying: An End of Life Curriculum to Empower Residents|Recruiting||N/A|36|Anticipated|Vanderbilt University Medical Center||3|||f||||f|f|f||||||||2017-10-10 20:57:07.861371|2017-10-10 20:57:07.861371
NCT03186261|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-13|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|January 31, 2018|Anticipated|2018-01-31||Interventional|||Antibacterial Effect of Nano Silver Fluoride vs Chlorhexidine on Occlusal Carious Molars Treated With Partial Caries Removal Technique|Evaluation of the Antibacterial Effect of Nano Silver Fluoride Versus Chlorhexidine on Occlusal Carious Molars Treated With Partial Caries Removal Technique: A Randomized Clinical Trial|Not yet recruiting||Phase 3|44|Anticipated|Cairo University||2|||f||||t|t|f|||t|||Yes||2017-10-10 20:57:07.958916|2017-10-10 20:57:07.958916
NCT03186248|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-12|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|August 20, 2018|Anticipated|2018-08-20|July 15, 2018|Anticipated|2018-07-15||Interventional|||Randomized Clinical Trial Comparing Short Versus Long Oesophageal Myotomy in POEM for Achalasia Cardia.|Double Blind Randomized Clinical Trial Comparing Short Versus Long Esophageal Myotomy in Per Oral Endoscopic Myotomy for Achalasia Cardia|Not yet recruiting||N/A|68|Anticipated|Asian Institute of Gastroenterology, India||2|||f||||t|f|f||||||No||2017-10-10 20:57:08.042958|2017-10-10 20:57:08.042958
NCT03186235|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-13|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|February 15, 2019|Anticipated|2019-02-15|November 1, 2018|Anticipated|2018-11-01||Observational|||T Regulatory Cells in Hepatitis c Infected Patients|Regulatory T Cells and Their Cytokines Profile in Different Groups of Hepatitis c Infected Patients: Across Sectional Study|Not yet recruiting||N/A|120|Anticipated|Assiut University|||6||f||||f|f|f||||||No||2017-10-10 20:57:08.13097|2017-10-10 20:57:08.13097
NCT03186222|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-12|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|||Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris.|Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris.|Not yet recruiting||N/A|200|Anticipated|Assiut University|||2||f||||f|f|f||||||No||2017-10-10 20:57:08.250153|2017-10-10 20:57:08.250153
NCT03186209|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-15|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|February 26, 2021|Anticipated|2021-02-26|February 26, 2021|Anticipated|2021-02-26||Interventional|||Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)|A Multicentre, Randomised, Double-blind, Parallel Group, Placebocontrolled, Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma.|Recruiting||Phase 3|834|Anticipated|AstraZeneca||2|||f||||f|t|f|||t|||||2017-10-10 20:57:08.360295|2017-10-10 20:57:08.360295
NCT03186196|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-12|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|May 1, 2017|Actual|2017-05-01|December 1, 2016|Actual|2016-12-01||Interventional|||Polymorphism C677T MTHFR and Folate Intake in Inflammatory Biomarkers|Influence of Polymorphism C677T MTHFR and Folate Intake in Interleukins, Homocysteine and TNF-α|Completed||N/A|48|Actual|Federal University of Paraíba||2|||f||||t||||||||Yes|The data of the participants are in the excel database|2017-10-10 20:57:08.560744|2017-10-10 20:57:08.560744
NCT03186183|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-26|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men|GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men|Recruiting||N/A|50|Anticipated|Ryerson University||1|||f||||f|f|f||||||||2017-10-10 20:57:08.647077|2017-10-10 20:57:08.647077
NCT03186170|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-23|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|July 15, 2017|Actual|2017-07-15|July 15, 2017|Actual|2017-07-15||Interventional|||Comparison of in Vitro Fertilization Rates of Oocytes and Embryo Development Using Two Techniques of Semen Processing|Comparison of in Vitro Fertilization Rates of Oocytes and Embryo Development Using Two Techniques of Semen Processing|Completed||N/A|30|Actual|University of Campinas, Brazil||2|||f|||||f|f||||||||2017-10-10 20:57:08.764221|2017-10-10 20:57:08.764221
NCT03186157|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-13|||February 1, 2012|Actual|2012-02-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|TS||Prevalence of Trephined Syndrome After Decompressive Craniectomy|A Prospective Observational Study on Risk Factors of Developing and Prevalence of Trephined Syndrome in Patients After Hemispheric Decompressive Craniectomy and Effect of Cranioplasty on Functional and Cognitive Recovery|Recruiting||N/A|60|Anticipated|University Hospital, Geneva|||1||f||||t|f|f||||||No||2017-10-10 20:57:10.538729|2017-10-10 20:57:10.538729
NCT03186144|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-06-13|||February 2012|Actual|2012-02-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|CHARGE||Clinical and Molecular Study of CHARGE Syndrom||Completed||N/A|141|Actual|Poitiers University Hospital||1|||f||||||||||||||2017-10-10 20:57:10.66655|2017-10-10 20:57:10.66655
NCT03186118|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-03|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|July 2032|Anticipated|2032-07-01|August 2020|Anticipated|2020-08-01||Interventional|||Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia|A Pilot Feasibility and Safety Study of CD19t T-Antigen Presenting Cells (T-APCs) Following CAR T Cell Immunotherapy for CD19+ Leukemia|Recruiting||Phase 1|30|Anticipated|Seattle Children's Hospital||3|||f||||t|t|f||||||||2017-10-10 20:57:10.857354|2017-10-10 20:57:10.857354
NCT03186092|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-22|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Effects of Respiratory Muscle Training on Respiratory Muscle Strength, Functional Capacity and Quality of Life in Pulmonary Hypertension|Effects of Respiratory Muscle Training on Respiratory Muscle Strength, Functional Capacity and Quality of Life in Pulmonary Hypertension|Not yet recruiting||N/A|24|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:11.065176|2017-10-10 20:57:11.065176
NCT03186079|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-07-12|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Constipation|Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Functional Constipation: a Double Blind, Randomized and Placebo-controlled Trial|Recruiting||N/A|200|Anticipated|Shengjing Hospital||2|||f||||t|f|f||||||||2017-10-10 20:57:11.154357|2017-10-10 20:57:11.154357
NCT03186066|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-11|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|ESCAPE||Endoscopic Treatment of the Buried Bumper Syndrome: Comparison of the Flamingo Device Versus Standard Therapy|A Prospective Randomized Controlled Multicenter Trial for Evaluation of the Flamingo Device in Endoscopic Treatment of the Buried Bumper Syndrome.|Recruiting||N/A|64|Anticipated|Kliniken Ludwigsburg-Bietigheim gGmbH||2|||f||||f|f|f||||||No||2017-10-10 20:57:11.25722|2017-10-10 20:57:11.25722
NCT03186053|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-10|||April 7, 2017|Actual|2017-04-07|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Interventional|||Sodium Creatine Phosphate in Heart Valve Surgery|Cardioprotective Effects of Sodium Creatine Phosphate in Valve Surgery: A Prospective Randomized Controlled Study|Recruiting||N/A|250|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:57:11.34089|2017-10-10 20:57:11.34089
NCT03186040|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-10|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|May 31, 2020|Anticipated|2020-05-31|April 30, 2020|Anticipated|2020-04-30||Interventional|||Open-label Clinical Trial of Lacosamide in ALS|Open-label Clinical Trial: Safety of Lacosamide in Patients With Amyotrophic Lateral Sclerosis|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Chiba University||1|||f||||t|f|f|||f|||||2017-10-10 20:57:11.448153|2017-10-10 20:57:11.448153
NCT03186027|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-28|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|CONNeCT||Coenzyme Q10 Plus NADH Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|Effect of Coenzyme Q10 Plus NADH Supplementation on the Changes in Fatigue Perception, Sleep Disturbances, Autonomic Function and Health-related Quality of Life in CFS/ME - A Randomized, Placebo-controlled, Double-blind Trial.|Recruiting||N/A|282|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f|f|f||||||No||2017-10-10 20:57:11.668299|2017-10-10 20:57:11.668299
NCT03186014|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-09|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Fully Covered Irradiation Stent for the Palliation of Malignant Dysphagia|A Novel Fully Covered Segmented Irradiation Stent Loaded With 125I Seeds for the Palliation of Malignant Dysphagia：a Prospective Pilot Study|Recruiting||N/A|38|Anticipated|Zhongda Hospital||1|||f||||f|f|f||||||||2017-10-10 20:57:11.804773|2017-10-10 20:57:11.804773
NCT03186001|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Frontalis Botulinum Toxin|The Impact of Botulinum Toxin Injection in the Frontalis on Brow Height and Morphology: A Randomized Trial|Not yet recruiting||Phase 4|30|Anticipated|St Joseph University, Beirut, Lebanon||3|||f||||f|f|f||||||No||2017-10-10 20:57:11.902453|2017-10-10 20:57:11.902453
NCT03185988|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-12|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|July 2021|Anticipated|2021-07-01||Interventional|||Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System|Multicenter, Phase II Study of Chemotherapy in Combination With Trastuzumab in Patients of Pretreated, HER2 Positive, Relapse or Metastatic Carcinoma of Digestive System|Not yet recruiting||Phase 2|75|Anticipated|Peking University||3|||f||||t|f|f|||f|||No||2017-10-10 20:57:12.001944|2017-10-10 20:57:12.001944
NCT03185975|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-07-06|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Providing Online Counseling for Home-Based HIV Testing With Transgender Youth|Providing Online Counseling for Home-Based HIV Testing With Transgender Youth|Recruiting||N/A|200|Anticipated|University of Michigan||2|||f||||t|f|f||||||||2017-10-10 20:57:12.120435|2017-10-10 20:57:12.120435
NCT03185962|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-12|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Observational|POSE||Predictors Of Successful Extubation in Critically Ill Patients: Multicentre Observational Study|Predictors Of Successful Extubation in Critically Ill Patients: Multicentre Observational Study|Recruiting||N/A|2500|Anticipated|Osaka University|||3||f||||f|f|f||||||No||2017-10-10 20:57:12.237328|2017-10-10 20:57:12.237328
NCT03185949|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-11|||February 8, 2017||2017-02-08||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:57:12.340403|2017-10-10 20:57:12.340403
NCT03185936|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||March 1, 2011|Actual|2011-03-01|June 2017|2017-06-01|April 1, 2017|Actual|2017-04-01|April 1, 2016|Actual|2016-04-01||Interventional|||Surgical Management of Optic Disc Pit Maculaopathy|Pars Plana Vitrectomy With Internal Limiting Membrane Peeling in Optic Disc Pit Maculopathy|Completed||N/A|9|Actual|Minia University||1|||f||||t|f|f||||||No|Can not be shared|2017-10-10 20:57:12.405333|2017-10-10 20:57:12.405333
NCT03185923|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-11|||June 20, 2017|Anticipated|2017-06-20|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia|A Randomized Controlled Trial of Integrated Traditional Chinese and Western Medicine in the Treatment of Severe Community Acquired Pneumonia|Not yet recruiting||Phase 3|198|Anticipated|Henan University of Traditional Chinese Medicine||2|||f||||t|f|f||||||No||2017-10-10 20:57:12.492846|2017-10-10 20:57:12.492846
NCT03181919|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|March 1, 2017|Actual|2017-03-01|January 1, 2017|Actual|2017-01-01||Interventional|||Letrozole Step-up Protocol for Ovulation Induction in Infertile Women With PCOS|Letrozole Step-up Protocol for Ovulation Induction in Infertile Women With PCOS|Completed||N/A|90|Actual|Benha University||2|||f||||t|f|f||||||Yes|Publish a manuscript|2017-10-10 20:57:51.020985|2017-10-10 20:57:51.020985
NCT03185910|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-06-10|||February 3, 2016|Actual|2016-02-03|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|December 2, 2017|Anticipated|2017-12-02||Interventional|||Mindfulness-Based Childbirth and Parenting Education on Pregnant Women|The Efficacy of a Mindfulness-Based Childbirth and Parenting Education on Pregnant Women's Childbirth Self-efficacy, Psychological Health and Maternal Outcomes: A Randomized Controlled Trial|Active, not recruiting||N/A|104|Actual|National Taiwan University of Nursing and Health Sciences||2|||f||||t|f|f||||||No||2017-10-10 20:57:12.586115|2017-10-10 20:57:12.586115
NCT03185897|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-07|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2022|Anticipated|2022-04-30||Observational|||Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia|A Global Epidemiologic Study to Determine the Prevalence of Neutralizing Antibodies and Related Adaptive Immune Responses to Adeno-Associated Virus (AAV) in Adults With Hemophilia|Recruiting||N/A|250|Anticipated|Baxalta US Inc.|||2||f||||f|f|f||||||||2017-10-10 20:57:12.658072|2017-10-10 20:57:12.658072
NCT03185884|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-08-31|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|August 12, 2017|Actual|2017-08-12|August 12, 2017|Actual|2017-08-12||Interventional|||Carbohydrates and Children|An Evaluation of Carbohydrates and Children|Completed||N/A|20|Actual|Abbott Nutrition||2|||f||||f|f|f||||||||2017-10-10 20:57:12.737493|2017-10-10 20:57:12.737493
NCT03185871|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-06|||October 30, 2017|Anticipated|2017-10-30|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses|Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses|Not yet recruiting||Phase 2|45|Anticipated|University of Wisconsin, Madison||1|||f|||||t|f|||t|||||2017-10-10 20:57:12.818284|2017-10-10 20:57:12.818284
NCT03185858|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|SINEMA||SINEMA Model of Care to Improve the Health of Stroke Patients in Rural China|System-integrated Technology-enabled Model of Care to Improve the Health of Stroke Patients in Rural China|Not yet recruiting||N/A|1250|Anticipated|Duke Kunshan University||2|||f||||f|f|f||||||No|We will not share the individual participant data. But other researchers could contact PI if there is special inquiry.|2017-10-10 20:57:12.934716|2017-10-10 20:57:12.934716
NCT03185845|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism|The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism—— A National Multicenter, Prospective, Randomized, Controlled Clinical Trial|Recruiting||N/A|392|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:13.032581|2017-10-10 20:57:13.032581
NCT03185832|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-09|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|HINODE||Heart Failure and Sudden Cardiac Death Japan Registry|Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan|Recruiting||N/A|900|Anticipated|Boston Scientific Corporation|||4||f||||f|f|t|f|f|t|||||2017-10-10 20:57:13.11945|2017-10-10 20:57:13.11945
NCT03185819|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-09-22|||September 29, 2017|Anticipated|2017-09-29|September 2017|2017-09-01|February 4, 2022|Anticipated|2022-02-04|October 7, 2021|Anticipated|2021-10-07||Interventional|||Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide|A Double-blind, Randomized, Psychoactive Placebo-controlled, Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Subjects Assessed to be at Imminent Risk for Suicide|Not yet recruiting||Phase 2|145|Anticipated|Janssen Research & Development, LLC||4|||f||||t|t|f||||||||2017-10-10 20:57:13.280403|2017-10-10 20:57:13.280403
NCT03185793|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-18|||May 11, 2017|Actual|2017-05-11|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|April 1, 2018|Anticipated|2018-04-01||Interventional|||Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia|Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia (Asymptomatic and Gout)|Recruiting||Phase 2|200|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||t|f|f||||||No||2017-10-10 20:57:13.677038|2017-10-10 20:57:13.677038
NCT03185780|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-11|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Complementary/Integrative Medicine for Brain Cancer Patients|Impact of Complementary/Integrative Medicine Treatments on Patients With Brain Cancer: A Pilot Study|Not yet recruiting||N/A|40|Anticipated|The Chaim Sheba Medical Center||1|||f||||f|f|f||||||Undecided||2017-10-10 20:57:13.787858|2017-10-10 20:57:13.787858
NCT03185767|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-11|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|July 1, 2017|Anticipated|2017-07-01|June 30, 2017|Anticipated|2017-06-30||Interventional|||Long Non Coding RNA in Complications of Systemic Lupus|Long Non Coding RNA IN Systemic Lupus|Recruiting||N/A|100|Anticipated|Cairo University||2|||f||||t|f|f||||||No||2017-10-10 20:57:13.873427|2017-10-10 20:57:13.873427
NCT03185754|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-06-19|||June 12, 2013|Actual|2013-06-12|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|November 15, 2018|Anticipated|2018-11-15||Interventional|||Comparison of Sublobar Resection and Lobectomy to Treat Lung Cancer|Comparison of Sublobar Resection and Lobectomy to Treat Lung Cancer|Recruiting||N/A|400|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||No||2017-10-10 20:57:13.950462|2017-10-10 20:57:13.950462
NCT03185741|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-12|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|July 31, 2021|Anticipated|2021-07-31|January 31, 2021|Anticipated|2021-01-31||Interventional|||EHR-based Universal Medication Schedule to Improve Adherence to Complex Regimens|EHR-based Universal Medication Schedule to Improve Adherence to Complex Regimens|Not yet recruiting||N/A|1200|Anticipated|Northwestern University||3|||f||||t|f|f||||||No||2017-10-10 20:57:14.073296|2017-10-10 20:57:14.073296
NCT03185728|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-09|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|iLookOut||iLook Out for Child Abuse: An Innovative Learning Module for Childcare Providers|iLook Out for Child Abuse: An Innovative Learning Module for Childcare Providers|Not yet recruiting||N/A|9000|Anticipated|Milton S. Hershey Medical Center||3|||f||||f|f|f||||||No||2017-10-10 20:57:14.183194|2017-10-10 20:57:14.183194
NCT03185715|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-12|||October 2014|Actual|2014-10-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Oocyte Recipient's Decision in the Number of Embryos to be Transferred|Single or Double Embryo Transfer? Decision-making Process in Patients Participating in an Oocyte Donation Program|Completed||N/A|100|Actual|Institut Universitari Dexeus||1|||f||||f|f|f||||||No||2017-10-10 20:57:14.27979|2017-10-10 20:57:14.27979
NCT03185702|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-12|||August 28, 2015|Actual|2015-08-28|June 2017|2017-06-01|January 1, 2030|Anticipated|2030-01-01|January 1, 2025|Anticipated|2025-01-01|10 Years|Observational [Patient Registry]|TRN||Turner Syndrome Research Network Registry|Turner Syndrome Research Network Registry|Recruiting||N/A|200|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||f|f|f||||Samples With DNA|"     Saliva, blood, and tissue samples   "|Yes|De-identified genetic and clinical IPD data will be shared with approved researchers with local IRB approval after authorization from the UTHouston study team. Aggregate data will be made available to the general research community through NIH databases.|2017-10-10 20:57:14.361075|2017-10-10 20:57:14.361075
NCT03185676|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance|The Long Term Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance as Compared to a Control.|Recruiting||N/A|32|Anticipated|Lund University||2|||f||||f|f|f||||||No||2017-10-10 20:57:14.569629|2017-10-10 20:57:14.569629
NCT03185663|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-06-12|||August 2017|Anticipated|2017-08-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|ALGOFRACT||Pilot Study Comparing Two Techniques of Taking Care Analgesic in Patients 70 and Older, Awaiting Surgery After Extracapsular Fracture of the Proximal Femur|Pilot Study Comparing Two Techniques of Taking Care Analgesic in Patients 70 and Older, Awaiting Surgery After Extracapsular Fracture of the Proximal Femur|Not yet recruiting||N/A|40|Anticipated|University Hospital, Limoges||2|||f||||f|f|f||||||No||2017-10-10 20:57:14.65871|2017-10-10 20:57:14.65871
NCT03185650|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Regional Lung Deposition of Inhaled Saline Using the tPAD Device|Evaluation of Regional Lung Deposition of Inhaled Saline Using the Trans-Nasal Pulmonary Aerosol Delivery Device in Healthy, Non-Smoking Adult Subjects|Not yet recruiting||N/A|10|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|t|t||f|||No||2017-10-10 20:57:14.747102|2017-10-10 20:57:14.747102
NCT03185637|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-12|2017-08-16|||October 1, 2016|Actual|2016-10-01|June 2017|2017-06-01|June 30, 2017|Actual|2017-06-30|May 31, 2017|Actual|2017-05-31|30 Days|Observational [Patient Registry]|PaedSurgAfrica||Children's Surgery in Sub-Saharan Africa|Paediatric Surgery Across Sub-Saharan Africa: A Multi-Centre Prospective Cohort Study|Completed||N/A|1407|Actual|King's College London|||5||f||||f|f|f||||||||2017-10-10 20:57:14.892805|2017-10-10 20:57:14.892805
NCT03185624|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-07-18|||July 25, 2017|Anticipated|2017-07-25|June 2017|2017-06-01|July 31, 2018|Anticipated|2018-07-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease|Effectiveness of Rifaximin on Preventing Postoperative Endoscopic Recurrence in Crohn's Disease Patients Without Risk Factor for Recurrence: A Multicenter Randomized Controlled Trial|Not yet recruiting||Phase 3|80|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 20:57:15.108743|2017-10-10 20:57:15.108743
NCT03185611|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-12|||May 18, 2017|Actual|2017-05-18|June 2017|2017-06-01|July 31, 2018|Anticipated|2018-07-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease|Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Endoscopic Recurrence in Crohn's Disease Patients With Risk Factor for Recurrence: A Multicenter Randomized Controlled Trial|Recruiting||Phase 3|120|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 20:57:15.205834|2017-10-10 20:57:15.205834
NCT03185598|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-11|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|March 1, 2017|Actual|2017-03-01||Observational|||MACE and First Operating Room Systolic Blood Pressure in Patients Undergoing Non-cardiac Surgery Implications for the Hypertension Threshold|MACE and First Operating Room Systolic Blood Pressure in Patients Undergoing Non-cardiac Surgery Implications for the Hypertension Threshold|Completed||N/A|18211|Actual|Peking University First Hospital|||2||f||||f|f|f||||||No||2017-10-10 20:57:15.315406|2017-10-10 20:57:15.315406
NCT03185585|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-19|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|COAST||Validation of a Comprehensive Older Adult Screening Tool (COAST)|Development and Validation of a Comprehensive Older Adult Screening Tool (COAST)|Recruiting||N/A|300|Anticipated|University of Florida|||1||f||||f|f|f||||||No||2017-10-10 20:57:15.40422|2017-10-10 20:57:15.40422
NCT03185572|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-13|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|3 Years|Observational [Patient Registry]|||Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Hypertension in China|The Prevalence, Disease Course, Prognosis and Interaction of Chronic Obstructive Pulmonary Disease With Pulmonary Hypertension|Recruiting||N/A|1708|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t|f|f||||Samples With DNA|"     serum and blood cells   "|Undecided||2017-10-10 20:57:15.523879|2017-10-10 20:57:15.523879
NCT03185559|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-11|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.|A Prospective, Randomized, Double-blind, Parallel-group, Sham Controlled Single-center Pivotal Clinical Investigation to Evaluate the Clinical Safety and Performance of Self-administered Home-use Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation Device (Relievion™) in Treating Migraine.|Not yet recruiting||N/A|86|Anticipated|Neurolief Ltd.||2|||f||||f|f|f||||||No||2017-10-10 20:57:15.633986|2017-10-10 20:57:15.633986
NCT03185533|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-10|||January 1, 2015|Actual|2015-01-01|June 2017|2017-06-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Reducing Length of Stay in the Emergency Department|Reducing Length of Stay in the Emergency Department: Analyzing the Factors and Quality Improvement Interventions|Completed||N/A|72000|Actual|National Taiwan University Hospital Hsin-Chu Branch|||1||f||||t|f|f||||||Yes||2017-10-10 20:57:15.971102|2017-10-10 20:57:15.971102
NCT03185520|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||February 15, 2017|Actual|2017-02-15|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|18 Months|Observational [Patient Registry]|Y-ESUS||Young ESUS Patient Registry|Longitudinal Study of Young Patients With Embolic Stroke of Undetermined Source (ESUS)|Recruiting||N/A|1000|Anticipated|Population Health Research Institute|||1||f||||f|f|f||||||No||2017-10-10 20:57:16.06478|2017-10-10 20:57:16.06478
NCT03185507|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-07-12|||March 22, 2017|Actual|2017-03-22|July 2017|2017-07-01|March 13, 2018|Anticipated|2018-03-13|May 1, 2017|Actual|2017-05-01||Interventional|||The Effect of Cryotherapy on Cerebral Hemodynamics Within Healthy Subjects|The Effect of Cryotherapy on Cerebral Hemodynamics Within Healthy Subjects|Active, not recruiting||Phase 1|34|Actual|University of Virginia||2|||f||||f|f|f||||||||2017-10-10 20:57:16.171691|2017-10-10 20:57:16.171691
NCT03185494|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-10|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22|Clinical Study of CD19/CD20 Tan CAR T Cells in Relapsed and/or Chemotherapy Refractory B-cell Leukemias and Lymphomas|Recruiting||Phase 1/Phase 2|30|Anticipated|Chinese PLA General Hospital||1|||f||||t|f|f||||||Yes||2017-10-10 20:57:16.280869|2017-10-10 20:57:16.280869
NCT03185481|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-10-03|||July 6, 2017|Actual|2017-07-06|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations|A Phase 2, Open Label Extension Study To Investigate The Long Term Safety And Tolerability Of Pf-06649751 In Subjects With Motor Fluctuations Due To Parkinson's Disease|Recruiting||Phase 2|198|Anticipated|Pfizer||8|||f||||t|t|f||||||||2017-10-10 20:57:16.408691|2017-10-10 20:57:16.408691
NCT03185468|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-22|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Intervention of Bladder Cancer by CAR-T|Intervention of Advanced or Metastatic Urothelial Bladder Cancer by 4SCAR-T Cell Therapies|Recruiting||Phase 1/Phase 2|20|Anticipated|Shenzhen Geno-Immune Medical Institute||2|||f||||f|f|f||||||No||2017-10-10 20:57:16.855595|2017-10-10 20:57:16.855595
NCT03185455|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-12|||August 22, 2016|Actual|2016-08-22|June 2017|2017-06-01|January 23, 2017|Actual|2017-01-23|January 20, 2017|Actual|2017-01-20||Interventional|TextBP||Remote Surveillance of Postpartum Hypertension|Remote Surveillance of Postpartum Hypertension|Completed||N/A|206|Actual|University of Pennsylvania||2|||f||||f|f|f||||||No||2017-10-10 20:57:16.998668|2017-10-10 20:57:16.998668
NCT03185442|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-08-24|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Cerebral Effects of Pulsed Radiofrequency on the Lumbar Dorsal Root Ganglion With Functional Magnetic Resonance Imaging.|Evaluation of Central Cerebral Effects of Pulsed Dosed Radiofrequency (PRF) on the Lumbar Dorsal Root Ganglion (DRG) Using Functional Magnetic Resonance Imaging (fMRI).|Not yet recruiting||N/A|25|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f|f|f||||||||2017-10-10 20:57:17.118948|2017-10-10 20:57:17.118948
NCT03185429|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-08-11|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor|Study of DC Vaccine Loaded Tumor Specific Antigen in Treating Patients With Gastrointestinal Solid Tumor|Not yet recruiting||N/A|20|Anticipated|BGI, China||1|||f||||f|f|f||||||||2017-10-10 20:57:17.213764|2017-10-10 20:57:17.213764
NCT03185416|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-09-21|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|EPIICC||Early Palliative Care Integration in Interventional Cancer Care|Early Palliative Care Integration in Interventional Cancer Care|Not yet recruiting||N/A|60|Anticipated|University of Miami||2|||f||||f|f|f||||||||2017-10-10 20:57:17.323564|2017-10-10 20:57:17.323564
NCT03185403|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-12|||December 2013|Actual|2013-12-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|HEMOBLOC||The Hemodynamic Effect Between Two Types of Anesthesia in Esophageal Surgery|Comparison of the Hemodynamic Effect Between the Paravertebral Block and Thoracic Epidural in Esophageal Surgery With Thoracotomy .|Completed||N/A|54|Actual|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 20:57:17.425194|2017-10-10 20:57:17.425194
NCT03185390|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-07-08|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|July 15, 2018|Anticipated|2018-07-15||Interventional|||Periampullary Lesions Via ERCP in Assuit University Hospital|Periampullary Lesions Via ERCP in Assuit University Hospital|Recruiting||N/A|100|Anticipated|Assiut University||1|||f||||t|f|f||||||||2017-10-10 20:57:17.554414|2017-10-10 20:57:17.554414
NCT03185195|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-09|||November 22, 2016|Actual|2016-11-22|June 2017|2017-06-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Interventional|ADME||Phase 1 Absorption Distribution Metabolism and Excretion of AQX-1125|An Open-Label,2-Part Sequential Dose Study Designed to Assess the Absolute Bioavailability, Mass Balance Recovery, Metabolite Profile and Identification of Metabolite Structure for [14C]-AQX-1125 in Healthy Subjects|Completed||Phase 1|9|Actual|Aquinox Pharmaceuticals (Canada) Inc.||3|||f||||f|||||f|||No||2017-10-10 20:57:19.163121|2017-10-10 20:57:19.163121
NCT03185377|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-13|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|3 Years|Observational [Patient Registry]|||Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China|The Study of Early Detection, Disease Course and Prognosis of Pulmonary Thromboembolism in Chronic Pulmonary Hypertension|Recruiting||N/A|1708|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t|f|f||||Samples With DNA|"     Serum and blood cell   "|Undecided||2017-10-10 20:57:17.66455|2017-10-10 20:57:17.66455
NCT03185364|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-11|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD|The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD|Recruiting||N/A|46|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:17.7389|2017-10-10 20:57:17.7389
NCT03185351|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-14|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Midazolam in Supraclavicular Brachial Plexus Block|Perineural Versus Intravenous Midazolam in Patients Undergoing Forearm Orthopedic Surgeries Using Supraclavicular Brachial Plexus Block|Recruiting||Phase 2|90|Anticipated|Assiut University||3|||f||||f|f|f||||||Undecided||2017-10-10 20:57:17.830262|2017-10-10 20:57:17.830262
NCT03185338|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-12|||January 9, 2018|Anticipated|2018-01-09|June 2017|2017-06-01|October 22, 2019|Anticipated|2019-10-22|January 17, 2018|Anticipated|2018-01-17||Interventional|PREVIENE||A School-based Physical Activity Promotion Intervention in Children. PREVIENE Project|A School-based Physical Activity Promotion Intervention in Children: Rationale and Study Protocol for the PREVIENE Project|Not yet recruiting||N/A|300|Anticipated|Universidad de Granada||6|||f||||f|f|f||||||Undecided||2017-10-10 20:57:17.937502|2017-10-10 20:57:17.937502
NCT03185325|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-06-21|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|September 1, 2019|Anticipated|2019-09-01||Observational|||Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma|Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma|Not yet recruiting||N/A|50|Anticipated|Assiut University|||2||f||||f|f|f||||Samples With DNA|"     Peripheral blood and bone marrow samples for micro ribonucleic acid 155 extraction   "|No||2017-10-10 20:57:18.066424|2017-10-10 20:57:18.066424
NCT03185312|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-11|2017-06-11|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|||Cutaneous JAK in Vitiligo and Acne Vulgaris.|Cutaneous JAK Expression in Vitiligo and Acne Vulgaris.|Not yet recruiting||N/A|60|Anticipated|Assiut University|||3||f||||f|f|f||||||No||2017-10-10 20:57:18.163144|2017-10-10 20:57:18.163144
NCT03185299|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-06-09|||July 4, 2017|Anticipated|2017-07-04|June 2017|2017-06-01|August 4, 2018|Anticipated|2018-08-04|June 4, 2018|Anticipated|2018-06-04||Interventional|||Impact of Reinforced Education by Video on the Quality of Bowel Preparation|Impact of Reinforced Education by Video on the Quality of Bowel Preparation|Not yet recruiting||N/A|300|Anticipated|Changhai Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:18.285826|2017-10-10 20:57:18.285826
NCT03185286|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-12|||December 31, 2015|Actual|2015-12-31|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||3D-Printed Personalized Metal Implant in Surgical Treatment of Ankle Bone Defects|3D-Printed Personalized Metal Implant in Surgical Treatment of Ankle Bone Defects|Recruiting||N/A|40|Anticipated|Southwest Hospital, China||1|||f|||||f|f||||||No||2017-10-10 20:57:18.392935|2017-10-10 20:57:18.392935
NCT03185273|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-09|||March 9, 2016|Actual|2016-03-09|June 2017|2017-06-01|June 9, 2020|Anticipated|2020-06-09|January 9, 2020|Anticipated|2020-01-09||Observational|||Parent-child Relationship Among Low-income Families in Hong Kong|In-depth Exploration of a Bidirectional Parent-child Relationship and Its Mediating and Moderating Factors Among Low-income Families in Hong Kong|Recruiting||N/A|220|Anticipated|The University of Hong Kong|||1||f|||||f|f||||Samples With DNA|"     DNA will be extracted from buccal epithelial cells. Telomere length will be measured by the     method adapted from that originally published by Cawthon. For each sample, the telomere     length will be represented by the relative ratio of the telomere repeat copy number (T) to     the single copy gene 36BA copy number (S). The T/S ratio will be determined by quantitative     polymerase chain reaction (qPcR) using a 7900HT Thermocycler (Applied Biosystems).   "|No||2017-10-10 20:57:18.48891|2017-10-10 20:57:18.48891
NCT03185260|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-12|||May 1, 2016|Actual|2016-05-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|1 Day|Observational [Patient Registry]|||Registry of Laypeople's CPR Performance|International Registry of Laypeople's CPR Performance After Training With Feedback Devices|Recruiting||N/A|10000|Anticipated|Pavia nel Cuore|||1||f|||||f|f||||||||2017-10-10 20:57:18.584853|2017-10-10 20:57:18.584853
NCT03185247|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Implementation of Transdx Group for POTS|Implementation of a Transdiagnostic Psychological Group Intervention for Pediatric Autonomic Dysfunction|Recruiting||N/A|20|Anticipated|University of Colorado, Denver||1|||f||||f|f|f||||||No||2017-10-10 20:57:18.716722|2017-10-10 20:57:18.716722
NCT03185234|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-13|||June 23, 2017|Actual|2017-06-23|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|RAdiCS||Rehabilitating (Stroke-induced) Apraxia With Direct Current Stimulation|Therapeutischer Einsatz Der Schwachen Gleichstromstimulation (tDCS) Bei Motorisch-kognitiven Defiziten Nach Schlaganfall|Recruiting||N/A|110|Anticipated|University of Cologne||2|||f||||t|f|f||||||||2017-10-10 20:57:18.814553|2017-10-10 20:57:18.814553
NCT03185221|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-12|||June 20, 2013|Actual|2013-06-20|June 2017|2017-06-01|June 20, 2020|Anticipated|2020-06-20|June 20, 2019|Anticipated|2019-06-20||Interventional|||Cordimax China Post Market Surveillance|Comparing the Safety and Efficacy of Cordimax and Xience V Drug-eluting Stents, for the Treatment of Coronary Heart Disease (CHD) in the Clinical Research of Real World|Active, not recruiting||Phase 3|3660|Actual|Shandong Branden Med.Device Co.,Ltd||2|||f||||t|f|f|||f|||No||2017-10-10 20:57:18.944183|2017-10-10 20:57:18.944183
NCT03185208|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-07|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|LATTICE||Lithium As a Treatment to Prevent Impairment of Cognition in Elders|Evaluation of Brain and Cognitive Changes in Older Adults With MCI Taking Lithium to Prevent Alzheimer Type Dementia|Recruiting||Phase 4|80|Anticipated|University of Pittsburgh||2|||f||||t|t|f|||t|||||2017-10-10 20:57:19.04113|2017-10-10 20:57:19.04113
NCT03185182|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-09-26|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|RCCSCAN||Diagnostic Imaging for Clear Cell Renal Cell Carcinoma|"An Exploratory Study Regarding the Use of the Biomarker Dopamine Transporter (DAT) for Image Diagnosis of Clear Cell Renal Cell Carcinoma"|Recruiting||Phase 2|10|Anticipated|Region Skane||1|||f|||||f|f|||f|||||2017-10-10 20:57:19.289127|2017-10-10 20:57:19.289127
NCT03185169|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-09|||November 18, 2016|Actual|2016-11-18|June 2017|2017-06-01|June 18, 2018|Anticipated|2018-06-18|December 18, 2017|Anticipated|2017-12-18||Interventional|GSM||GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors|GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors|Recruiting||Early Phase 1|14|Anticipated|Alta Bates Summit Medical Center||1|||f||||f|t|f|||f|||Undecided||2017-10-10 20:57:19.368002|2017-10-10 20:57:19.368002
NCT03185156|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-09-28|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate|The Preventive Effect of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate|Recruiting||N/A|60|Anticipated|West China Second University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:57:19.474875|2017-10-10 20:57:19.474875
NCT03185143|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-16|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Oral ALLOD-2 vs. Oral Sumatriptan and vs. Placebo in the Acute Treatment of Migraine With Associated Nausea (ANODYNE-2)|Single Center, Phase 2B, Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Single Dose of Oral ALLOD-2 Versus Oral Sumatriptan in the Acute Treatment of Migraine With Associated Nausea in Adults (ANODYNE-2)|Recruiting||Phase 2/Phase 3|90|Anticipated|Allodynic Therapeutics, LLC||3|||||||f|t|f||||||||2017-10-10 20:57:19.584949|2017-10-10 20:57:19.584949
NCT03185130|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-10|2017-07-20|||May 16, 2017|Actual|2017-05-16|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|I-FiBH||Intravenous Fluids in Benign Headaches Trail|Intravenous Fluids in Benign Headaches Trail: A Randomized Single Blind Clinical Trial|Recruiting||Phase 4|90|Anticipated|University Medical Center of Southern Nevada||2|||f||||f|t|f|||f|||||2017-10-10 20:57:19.693735|2017-10-10 20:57:19.693735
NCT03185117|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||September 1, 2016|Actual|2016-09-01|June 2017|2017-06-01|September 5, 2017|Anticipated|2017-09-05|September 5, 2017|Anticipated|2017-09-05||Observational|||Opioid Consumption After Hospital Discharge in Orthopedic Surgery|Opioid Consumption After Hospital Discharge in Orthopedic Surgery|Recruiting||N/A|300|Anticipated|Ohio State University|||1||f||||f|f|f||||||No|Efforts will be made to keep patient information confidential. individual participant data will only be available to researchers who are approved by the Institutional Review Board (IRB) to participate in study enrollment, follow up and data analysis|2017-10-10 20:57:19.859471|2017-10-10 20:57:19.859471
NCT03185104|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-09|||November 1, 2013|Actual|2013-11-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Silver Diamine Fluoride for Caries Prevention in Removable Partial Dentures Wearers|Randomized Double-blind Placebo-controlled Trial of Silver Diamine Fluoride for Caries Prevention in Removable Partial Dentures Wearers|Active, not recruiting||N/A|196|Actual|The University of Hong Kong||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:19.974888|2017-10-10 20:57:19.974888
NCT03185091|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-06-16|||January 14, 2013|Actual|2013-01-14|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|March 22, 2016|Actual|2016-03-22||Interventional|||Neuromonitoring During Rapid Ventricular Pacing in Patients Undergoing Cerebral Aneurysm Surgery|Safety of Rapid Ventricular Pacing During Cerebral Aneurysm Surgery by Multimodal Neuromonitoring|Active, not recruiting||N/A|7|Actual|University Hospital, Antwerp||1|||f||||f||||||||Undecided||2017-10-10 20:57:20.069292|2017-10-10 20:57:20.069292
NCT03185078|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-12|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|RCT||Extracorporeal Shock Wave Therapy on Diabetes Related Frozen Shoulder|Effect of Different Doses of Extracorporeal Shock Wave Therapy on Diabetes Related Frozen Shoulder|Not yet recruiting||N/A|45|Anticipated|Okan University||3|||f||||f|f|f||||||No||2017-10-10 20:57:20.153313|2017-10-10 20:57:20.153313
NCT03185065|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-10-04|||October 4, 2017|Anticipated|2017-10-04|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|July 30, 2019|Anticipated|2019-07-30||Interventional|TRIUMPHANT-MS||Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis|Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis|Recruiting||Phase 3|136|Anticipated|Johns Hopkins University||4|||f||||t|t|f|||f|||||2017-10-10 20:57:20.235116|2017-10-10 20:57:20.235116
NCT03185052|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-10-05|||September 28, 2017|Actual|2017-09-28|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|FREEDOM OP||Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach|Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach|Recruiting||N/A|130|Anticipated|Nantes University Hospital||1|||f||||f|f|f||||||||2017-10-10 20:57:20.344545|2017-10-10 20:57:20.344545
NCT03185039|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-12|||May 29, 2017|Actual|2017-05-29|June 2017|2017-06-01|November 29, 2020|Anticipated|2020-11-29|November 29, 2020|Anticipated|2020-11-29||Interventional|||Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents|Study of the Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents Compared to Patients Not Treated With Antiangiogenic (Localized Kidney Cancer and Oligometastatic)|Recruiting||N/A|50|Anticipated|Institut Paoli-Calmettes||1|||f||||f|f|f||||||No||2017-10-10 20:57:20.584129|2017-10-10 20:57:20.584129
NCT03185026|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-08|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|PEPSUI||Psychoeducation for Suicidal Behavior|Effectiveness of the First French Psychoeducational Program for Suicidal Behavior : a Randomized Controlled Trial|Not yet recruiting||N/A|500|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f||||||No||2017-10-10 20:57:20.685482|2017-10-10 20:57:20.685482
NCT03184480|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-07-06|||August 31, 2017|Anticipated|2017-08-31|July 2017|2017-07-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Observational|||Arnuity® Ellipta® Drug Use Investigation|Arnuity Ellipta Drug Use Investigation|Not yet recruiting||N/A|300|Anticipated|GlaxoSmithKline|||1||f||||f|f|f||||||||2017-10-10 20:57:25.267814|2017-10-10 20:57:25.267814
NCT03185000|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-12|||February 2018|Anticipated|2018-02-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|TRIBUTE||Treg Immunotherapy in Crohn's Disease|A Double-blind, Placebo Controlled, First Into Human Clinical Trial of T Regulatory Cells (TR004) for Inflammatory Bowel Disease Using (ex Vivo) Treg Expansion|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|King's College London||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:21.172692|2017-10-10 20:57:21.172692
NCT03184987|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-14|||June 22, 2017|Actual|2017-06-22|September 2017|2017-09-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma|A Phase III, 52-week, Open-label Study to Evaluate Long-term Safety of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Patients With Asthma|Recruiting||Phase 3|110|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 20:57:21.292786|2017-10-10 20:57:21.292786
NCT03184974|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|November 1, 2016|Actual|2016-11-01|October 1, 2016|Actual|2016-10-01|1 Year|Observational [Patient Registry]|||Open Lung PEEP in Thoracic Surgery|Individualized Open Lung PEEP in Thoracic Surgery: A Prospective Multicenter Observational Study in 17 Spanish Hospitals|Completed||N/A|690|Actual|Fundación para la Investigación del Hospital Clínico de Valencia|||1||f||||f|f|f||||||Undecided||2017-10-10 20:57:21.408756|2017-10-10 20:57:21.408756
NCT03184961|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-14|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||Lung Recruitment Maneuver for Predicting Fluid Responsiveness in Children|Study on Variables Able to Predict Fluid Responsiveness Using Lung Recruitment Maneuver in Pediatric Patients Undergoing General Anesthesia|Recruiting||N/A|30|Anticipated|Seoul National University Hospital||1|||f|||||f|f||||||||2017-10-10 20:57:21.470804|2017-10-10 20:57:21.470804
NCT03184948|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-08|||May 29, 2017|Actual|2017-05-29|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Understanding Neonatal Jaundice in Rwanda|Understanding Neonatal Jaundice in Rwanda|Active, not recruiting||N/A|46|Actual|University of California, Merced||3|||f||||f|f|f||||||Undecided|All IPD collected will be anonymized and aggregated for analysis. The anonymized information will be shared publicly if permission from the Rwandan Ministry of Health is granted.|2017-10-10 20:57:21.546413|2017-10-10 20:57:21.546413
NCT03184935|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-12|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS)|Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS)|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Sclnow Biotechnology Co., Ltd.||2|||f|||||f|f||||||Undecided||2017-10-10 20:57:21.659756|2017-10-10 20:57:21.659756
NCT03184922|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-07-05|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|March 1, 2023|Anticipated|2023-03-01|March 1, 2021|Anticipated|2021-03-01||Interventional|||Fixed Versus Adjustable Loop in ACL Reconstruction|A Prospective, Randomised Study Investigating the Use of a Fixed Loop Versus an Adjustable Suspensory Loop in Anterior Cruciate Ligament Reconstruction - a Comparison of Clinical and Functional Outcome|Recruiting||N/A|150|Anticipated|Royal Devon and Exeter NHS Foundation Trust||2|||f||||t|f|f||||||||2017-10-10 20:57:21.759091|2017-10-10 20:57:21.759091
NCT03184909|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-09-01|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Tulsi Consumption and Its Effects on Cognition, Stress and Anxiety|Consumption of Tulsi and Its Effects on Neurocognition, Stress and Anxiety: A Randomised Controlled Clinical Trial|Not yet recruiting||N/A|30|Anticipated|Organic India||2|||f||||f|f|f||||||||2017-10-10 20:57:21.872073|2017-10-10 20:57:21.872073
NCT03184896|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-11|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|April 30, 2019|Anticipated|2019-04-30|October 31, 2018|Anticipated|2018-10-31||Observational|HiFit||Hip Fracture Observational Study|Prospective Observational Study in Hip Fracture|Not yet recruiting||N/A|700|Anticipated|The George Institute for Global Health, China|||1||f||||f|f|f||||||No||2017-10-10 20:57:21.957442|2017-10-10 20:57:21.957442
NCT03184883|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-19|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Comparative Study Between Acrylic and Flexible Dentures|Comparative Study of Conventional Versus Flexible Mandibular Single Complete Denture|Not yet recruiting||N/A|17|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 20:57:22.043256|2017-10-10 20:57:22.043256
NCT03184870|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-27|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|March 8, 2021|Anticipated|2021-03-08|March 8, 2021|Anticipated|2021-03-08||Interventional|||A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors|A Phase 1b/2 Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|260|Anticipated|Bristol-Myers Squibb||4|||f||||f|t|f||||||||2017-10-10 20:57:22.144732|2017-10-10 20:57:22.144732
NCT03184857|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-18|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Open Maxillary Sinus Augmentation Using Different Types of Bone Particles|Two Stage Sinus Lifting Using Nano Hydroxyapatite Particles [Nanostreams] Versus Deprotenized Bovine Bone Allograft [Tutogen] : Randomized Clinical Trial.|Active, not recruiting||N/A|24|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 20:57:22.359566|2017-10-10 20:57:22.359566
NCT03184844|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-12|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|May 2, 2019|Anticipated|2019-05-02|February 2, 2019|Anticipated|2019-02-02||Interventional|||The Effective and Safety of Thalidomide in TI|The Multi-center Clinical Trials of Thalidomide in TI|Recruiting||Phase 2|100|Anticipated|303rd Hospital of the People's Liberation Army||1|||f|||||f|f||||||Yes|Twenty four months later after the last visit，summery report will be shared with other researchers through database|2017-10-10 20:57:22.42382|2017-10-10 20:57:22.42382
NCT03184831|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||"Comparison of Deproteinized Bovine Bone Mixed With Injectable Platelet Rich Fibrin Versus a Sole Deproteinized Bovine Bone TUTOGEN BONE in Sinus Floor Elevation With Simultaneous Implant Placement. A Randomized Clinical Trial"|"Comparison of Deproteinized Bovine Bone Mixed With Injectable Platelet Rich Fibrin Versus a Sole Deproteinized Bovine Bone TUTOGEN BONE in Sinus Floor Elevation With Simultaneous Implant Placement. A Randomized Clinical Trial."|Active, not recruiting||N/A|28|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 20:57:22.517806|2017-10-10 20:57:22.517806
NCT03184818|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-26|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|2 Weeks|Observational [Patient Registry]|RxOUTMAP||Outcomes of Urinary Tract Infection Management by Pharmacists|Outcomes of Urinary Tract Infection Management by Pharmacists|Recruiting||N/A|750|Anticipated|University of Alberta|||2||f||||f|f|f||||||||2017-10-10 20:57:22.587416|2017-10-10 20:57:22.587416
NCT03184805|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-12|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2021|Anticipated|2021-06-01||Interventional|||STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation|Randomized Controlled Comparison: STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation (STOP-ASP Trial)|Not yet recruiting||N/A|2400|Anticipated|Yonsei University||2|||f||||t|f|f||||||No||2017-10-10 20:57:22.698996|2017-10-10 20:57:22.698996
NCT03184792|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-08|||December 27, 2016|Actual|2016-12-27|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ADDRESS||Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury|Activity Dependent Rehabilitation Via Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury|Recruiting||N/A|10|Anticipated|University of Washington||2|||f||||t|f|f|||f|||No||2017-10-10 20:57:22.809229|2017-10-10 20:57:22.809229
NCT03184779|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-10-04|||July 26, 2016|Actual|2016-07-26|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|March 17, 2017|Actual|2017-03-17||Interventional|||The Effect of a Safety Video on Ski and Snowboard School Program Participants in Calgary, Alberta|Ski and Snowboard School Programs: Assessing the Effect of a Safety Video Intervention on Knowledge, Behaviour and Injury Risk in Youth Skiing and Snowboarding|Active, not recruiting||N/A|2348|Actual|Sport Injury Prevention Research Centre||2|||f||||f|f|f||||||||2017-10-10 20:57:22.900237|2017-10-10 20:57:22.900237
NCT03184766|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-08|||August 10, 2016|Actual|2016-08-10|April 2017|2017-04-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||Ibuprofen and Pseudoephedrine Comparative Pharmacokinetic Study|An Open-label, Randomised, Three-way Cross-over, Single Dose, Single Centre, Comparative Pharmacokinetic Study Between Ibuprofen and Pseudoephedrine Liquid Capsules (2x 200 mg Ibuprofen & 30 mg Pseudoephedrine) (Test), Ibuprofen and Pseudoephedrine Tablets (2x 200 mg Ibuprofen & 30 mg Pseudoephedrine) (Comparator 1), and Ibuprofen Liquid Capsules (2x 200 mg Solubilised Ibuprofen) (Comparator 2)|Completed||Phase 1|55|Actual|Reckitt Benckiser Healthcare (UK) Limited||6|||f||||f|f|f||||||No||2017-10-10 20:57:22.974888|2017-10-10 20:57:22.974888
NCT03184753|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-10|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Intervention of IgT Against Ovarian Cancer|Interventional Treatment of Ovarian Cancer (OC) With OC Immunogene-modified T Cells (OC-IgT)|Recruiting||Phase 1/Phase 2|100|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||f|f|f||||||No||2017-10-10 20:57:23.078397|2017-10-10 20:57:23.078397
NCT03184740|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-09|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|July 31, 2017|Actual|2017-07-31||Interventional|||Physical Performance and Analgesic Effects of tDCS in Primary Dysmenorrhea|Physical Performance and Analgesic Effects of tDCS in Primary Dysmenorrhea: A Randomized, Double Blind Clinical Trial|Completed||N/A|20|Actual|Universidade Federal do Rio Grande do Norte||2|||f|||||f|f||||||||2017-10-10 20:57:23.177155|2017-10-10 20:57:23.177155
NCT03184727|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-13|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Pulmonary Vasculature and Right Heart Dysfunction in Chronic Obstructive Pulmonay Disease|Pulmonary Vasculature and Right Heart Dysfunction in Chronic Obstructive Pulmonay Disease|Recruiting||N/A|600|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t|f|f||||Samples With DNA|"     serum and blood cells   "|Undecided||2017-10-10 20:57:23.259532|2017-10-10 20:57:23.259532
NCT03184714|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-10|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Noninvasive Positive Pressure Ventilation in Overlap Syndrome|The Effectiveness of Noninvasive Positive Pressure Ventilation Treatment in Overlap Syndrome|Recruiting||N/A|292|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:23.32834|2017-10-10 20:57:23.32834
NCT03184701|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-06-10|||April 2016||2016-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Monitoring of Symptoms and Cognitive Function Using Telehealth|Remote Monitoring of Symptoms and Cognitive Function Using Telehealth|Recruiting||N/A|80|Anticipated|Albert Einstein Healthcare Network||1|||f||||f||||||||No||2017-10-10 20:57:23.406123|2017-10-10 20:57:23.406123
NCT03184688|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-08|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|||Platelet Rich Plasma for Carpal Tunnel Syndrome|The Long-term Effect of Platelet-rich Plasma in Patients With Carpal Tunnel Syndrome: a Prospective Randomized Double-blind Controlled Trial|Recruiting||N/A|30|Anticipated|Tri-Service General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:57:23.503744|2017-10-10 20:57:23.503744
NCT03184675|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Interventional|||The Effects of Functional Action-Observation Training on Gait Ability in Patients With Chronic Stroke|Main Researcher for the Effects of Functional Action-observation Training on Gait Ability|Not yet recruiting||N/A|40|Anticipated|Inje University||2|||f|||||f|f||||||||2017-10-10 20:57:23.596906|2017-10-10 20:57:23.596906
NCT03184649|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-11|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection (RCT)|The Effect of Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection and Following Dental Extraction in Primary Molars: A Randomized Clinical Trial|Enrolling by invitation||Phase 1/Phase 2|52|Anticipated|Cairo University||3|||f||||f|f|f||||||No|i will be available after finished|2017-10-10 20:57:23.765517|2017-10-10 20:57:23.765517
NCT03184636|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-26|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|December 30, 2017|Anticipated|2017-12-30||Observational|ACLF||Prevalence of Acute-On-Chronic Liver Failure in Zagazig University Hospitals|ACLF in Zagazig University Hospitals|Recruiting||N/A|100|Anticipated|Zagazig University|||1||f||||f|f|f||||||No||2017-10-10 20:57:23.865496|2017-10-10 20:57:23.865496
NCT03184623|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-05|||June 9, 2017|Actual|2017-06-09|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|September 5, 2017|Actual|2017-09-05||Observational|||Muscle Mass and Body Composition|Time Course of Changes in Muscle Mass and Body Composition During ICU Admission|Completed||N/A|23|Actual|Medical Centre Leeuwarden|||1||f||||f|f|f||||||||2017-10-10 20:57:23.94254|2017-10-10 20:57:23.94254
NCT03184610|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||December 2014|Actual|2014-12-01|June 2017|2017-06-01||||June 2017|Actual|2017-06-01||Observational|||Distinguishing Healthy and Keratoconic Eyes Using Ultrahigh-Resolution OCT|Distinguishing Healthy and Keratoconic Eyes Using Ultrahigh-Resolution Optical Coherence Tomography (UHR-OCT) Based Corneal Epithelium Thickness Mapping|Completed||N/A|60|Actual|Medical University of Vienna|||2||f||||t|f|f||||||No||2017-10-10 20:57:23.998662|2017-10-10 20:57:23.998662
NCT03184597|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-11|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions|HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions: a Multicenter Clinical Study|Not yet recruiting||N/A|4000|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||4|||f||||t|f|f||||||Yes|The clinical data and HLA genotype of the participant will be shared in the collaborators|2017-10-10 20:57:24.08381|2017-10-10 20:57:24.08381
NCT03184584|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|July 2020|Anticipated|2020-07-01||Interventional|||Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome|An Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome|Not yet recruiting||Phase 2/Phase 3|20|Anticipated|ProMetic BioSciences Inc.||1|||f||||t|f|f||||||||2017-10-10 20:57:24.190049|2017-10-10 20:57:24.190049
NCT03184545|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-07-28|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome|A Prospective Randomized Study Comparing the Outcome of Electrical Stimulation of Vastus Medialis Obliquus Muscle and Physical Therapy vs Only Physical Therapy But no Electrical Stimulation in Patients With Patellofemoral Pain Syndrome|Recruiting||Phase 3|92|Anticipated|Northwell Health||2|||f||||t|f|t|f|f|f|||||2017-10-10 20:57:24.557079|2017-10-10 20:57:24.557079
NCT03184532|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 15, 2017|Anticipated|2017-12-15||Observational|gastric US||Bedside Gastric Ultrasound for Assessment of ASA Preoperative Starving Guidelines Accuracy: Diabetic vs Non Diabetic Patients|Bedside Gastric Ultrasound for Assessment of ASA Preoperative Starving Guidelines Accuracy: Diabetic vs Non Diabetic Patients|Not yet recruiting||N/A|100|Anticipated|Healthpoint Hospital|||2||f|||||f|f||||||||2017-10-10 20:57:24.810247|2017-10-10 20:57:24.810247
NCT03184519|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-08-22|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|hyperPOC||Comparison of hhCG With hCG+ß|Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy After In-vitro Fertilization and Embryo Transfer.|Recruiting||N/A|136|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||1|||f||||f|f|f||||||||2017-10-10 20:57:24.887832|2017-10-10 20:57:24.887832
NCT03184506|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-08|||June 12, 2017|Anticipated|2017-06-12|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Pre-warming on Perioperative Hypothermia During HoLEPunder Spinal Anesthesia|Effect of Pre-warming on Perioperative Hypothermia and Shivering During Holmium Laser Enucleation of the Prostate (HoLEP) Under Spinal Anesthesia|Not yet recruiting||N/A|50|Anticipated|Hallym University Kangnam Sacred Heart Hospital||2|||f||||f|f|f||||||||2017-10-10 20:57:24.989238|2017-10-10 20:57:24.989238
NCT03184493|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|XBD||Celebrex and Metformin for Postoperative Hepatocellular Carcinoma|Celebrex and Metformin for Postoperative Hepatocellular Carcinoma|Recruiting||Phase 3|200|Anticipated|Guangxi Medical University||4|||f||||t|f|f||||||Undecided||2017-10-10 20:57:25.112054|2017-10-10 20:57:25.112054
NCT03184467|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Design, Prospective, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Donepezil and Combined With GV1001 in Alzheimer Patients|Recruiting||Phase 2|90|Anticipated|GemVax & Kael||3|||f||||f|f|f||||||Undecided||2017-10-10 20:57:25.406105|2017-10-10 20:57:25.406105
NCT03184454|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||October 2016||2016-10-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Combined Cortical/Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder|Combined Cortical and Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder|Recruiting||Phase 2|5|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||Yes||2017-10-10 20:57:25.582579|2017-10-10 20:57:25.582579
NCT03184441|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-10-03|||June 2015||2015-06-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|August 2016|Actual|2016-08-01||Interventional|||Premie Pouch to Manage Deformational Plagiocephaly in Very Low Birth Weight Infants|Premie Pouch to Manage Deformational Plagiocephaly in Very Low Birth Weight Infants|Active, not recruiting||N/A|10|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-10 20:57:25.737597|2017-10-10 20:57:25.737597
NCT03184428|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-15|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Observational|||Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313|Retro- and Prospective Monocentric Study to Evaluate the Rate of Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS (Micro Incision Cataract Surgery) -IOL (Intraocular Lens) L313|Recruiting||N/A|2775|Anticipated|Dietrich-Bonhoeffer-Klinikum|||1||f||||f|f|f||||||Yes|results will be published in ophthalmological journals|2017-10-10 20:57:25.886948|2017-10-10 20:57:25.886948
NCT03184415|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-11|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis|A Multi-Center, Randomized, Parallel, Double-Blind, Phase III Clinical Trial to Compare the Efficacy and Safety of DWC20155/DWC20156 Combination Therapy With DWC20155 or DWC20156 Monotherapy in Patients With Gastritis|Not yet recruiting||Phase 3|369|Anticipated|Daewoong Pharmaceutical Co. LTD.||3|||f||||t|f|f||||||||2017-10-10 20:57:26.073364|2017-10-10 20:57:26.073364
NCT03184402|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-11|||April 18, 2017|Actual|2017-04-18|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)|Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study (PART 2)|Recruiting||Phase 3|124|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||t|f|f||||||No||2017-10-10 20:57:26.200118|2017-10-10 20:57:26.200118
NCT03184389|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-07-20|||June 23, 2017|Actual|2017-06-23|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Sense2Stop:Mobile Sensor Data to Knowledge|Sense2Stop Mobile Sensor Data to Knowledge: Preliminary Study of the Effects of Wearable Sensors and Smartphone Apps on Real Time Stress and Smoking in Recently Quit Smokers|Recruiting||N/A|75|Anticipated|Northwestern University||1|||f||||f|f|f||||||||2017-10-10 20:57:26.342365|2017-10-10 20:57:26.342365
NCT03184376|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||February 28, 2012|Actual|2012-02-28|June 2017|2017-06-01|May 30, 2016|Actual|2016-05-30|December 16, 2015|Actual|2015-12-16||Interventional|||Histological Improvement of NASH With Prebiotic|Histological Improvement of Non-alcoholic Steatohepatitis With a Prebiotic: a Pilot Clinical Trial|Completed||N/A|14|Actual|University of Calgary||2|||f||||f|f|f||||||Undecided|Other researchers would need to make an individual inquiry.|2017-10-10 20:57:26.488493|2017-10-10 20:57:26.488493
NCT03184363|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)|Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines: Multi-center, Single Arm, Open, Extension Study|Not yet recruiting||Phase 3|102|Anticipated|Daewoong Pharmaceutical Co. LTD.||1|||f|||||f|f||||||Undecided||2017-10-10 20:57:26.59223|2017-10-10 20:57:26.59223
NCT03184350|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-09|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|APROVE||Adjuvant Protontherapy of Cervical and Endometrial Carcinomas|Adjuvant Protontherapy of Cervical and Endometrial Carcinomas - A Phase-II-study|Recruiting||N/A|25|Anticipated|Heidelberg University||1|||f||||f|f|f||||||No||2017-10-10 20:57:26.673644|2017-10-10 20:57:26.673644
NCT03184337|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-20|||April 24, 2017|Actual|2017-04-24|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|LB||Women's Lifestyle Balance Study|Women's Lifestyle and Sleep Intervention for Prediabetes and Metabolic Syndrome|Active, not recruiting||N/A|24|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||No||2017-10-10 20:57:26.781716|2017-10-10 20:57:26.781716
NCT03184324|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-22|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)|A Multi-Center, Randomized, Double-Blind, Active-controlled, Phase 2, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease.|Recruiting||Phase 2|208|Anticipated|Daewoong Pharmaceutical Co. LTD.||4|||f||||f|f|f||||||||2017-10-10 20:57:26.899608|2017-10-10 20:57:26.899608
NCT03184311|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-09|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|HIT-HF||High-intensity Interval Training in Heart Failure Patients With Preserved Ejection Fraction|High-intensity Interval Training as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction: A Prospective, Single-blind, Randomized Controlled Trial|Not yet recruiting||N/A|98|Anticipated|Cantonal Hosptal, Baselland||2|||f||||t|f|f||||||Yes|Patient-level anonymised datasets can be requested after completion of all planned analyses and publications from the study centre (anticipated by the end of 2020). Public access to the study protocol will be granted by publishing it in a scientific journal. Blood sample results will be shared on the Swiss Biobanking Platform.|2017-10-10 20:57:27.016589|2017-10-10 20:57:27.016589
NCT03184298|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-09|||May 11, 2016|Actual|2016-05-11|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Perceptions of Male Soldiers on Sex, Dating, and Alcohol-Use at Fort Bragg|Perceptions of Male Soldiers on Sex, Dating, and Alcohol-Use at Fort Bragg|Recruiting||N/A|290|Anticipated|Womack Army Medical Center||3|||f||||t|f|f||||||No|Individual participant data will be housed on a secure server in the Department of Clinical Investigation at Womack Army Medical Center. All information will be treated as confidential material and access will be restricted to research staff.|2017-10-10 20:57:27.126796|2017-10-10 20:57:27.126796
NCT03184285|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-09|||June 1, 2015|Actual|2015-06-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Continuous Non-invasive Assessment of Blood Pressure in Bariatric Surgery|Continuous Non-invasive Assessment of Blood Pressure in Comparison to the Invasive Gold-standard and to the Sphygmomanometer.|Completed||N/A|50|Actual|University of Schleswig-Holstein||1|||f||||f|f|f||||||No||2017-10-10 20:57:27.242018|2017-10-10 20:57:27.242018
NCT03184272|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-09|||June 1, 2015|Actual|2015-06-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Non-invasive Assessment of Cardiac Output and Fluid Responsiveness in Bariatric Surgery|Accuracy of Non-invasive Assessment of Cardiac Output and Fluid Responsiveness in Patients Undergoing Bariatric Procedures.|Completed||N/A|50|Actual|University of Schleswig-Holstein||1|||f||||f|f|f||||||No||2017-10-10 20:57:27.374574|2017-10-10 20:57:27.374574
NCT03184259|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-09-15|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Interactive Exoskeleton Robot for Walking|Wearable Interactive Lower-limb Exoskeleton Robotic Device for Gait Training of Post-stroke Patients on Different Walking Conditions|Recruiting||N/A|64|Anticipated|Chinese University of Hong Kong||4|||f||||f|f|f||||||||2017-10-10 20:57:27.495813|2017-10-10 20:57:27.495813
NCT03184246|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|January 30, 2019|Anticipated|2019-01-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Depth of Endotracheal Tube Insertion|The Depth of Endotracheal Tube Insertion - Use of Direct Laryngoscopy and Videolaryngoscopy (GlideScope), Comparison of Methods|Not yet recruiting||N/A|100|Anticipated|University Hospital Hradec Kralove||2|||f||||f|f|f||||||No||2017-10-10 20:57:27.589777|2017-10-10 20:57:27.589777
NCT03184233|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-31|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|June 3, 2019|Anticipated|2019-06-03||Interventional|||Rapid Ventricular Pacing During Cerebral Aneurysm Surgery: a Study Concerning the Safety for Heart and Brain|Rapid Ventricular Pacing During Cerebral Aneurysm Surgery: a Study Concerning the Safety for Heart and Brain|Recruiting||N/A|66|Anticipated|University Hospital, Antwerp||2|||f||||t|f|f||||||||2017-10-10 20:57:27.682934|2017-10-10 20:57:27.682934
NCT03184220|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-10|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|MRH||Treatment of Cervical Syndrome With Myofascial Therapies|Treatment of Cervical Syndrome With Myofascial Therapies|Recruiting||N/A|54|Anticipated|University of Cadiz||2|||f||||t|f|f||||||No||2017-10-10 20:57:27.803532|2017-10-10 20:57:27.803532
NCT03184207|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-28|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|June 21, 2019|Anticipated|2019-06-21|June 21, 2019|Anticipated|2019-06-21||Observational|EPIC||A Systematic Echography During Intubation Procedure to Predict Cardiovascular Collapse|A Systematic Ultrasound Assessment During Intubation Procedure to Predict Cardiovascular Collapse Related to Intubation in the Intensive Care Unit: a Prospective, Multiple-center Study|Recruiting||N/A|70|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 20:57:27.910248|2017-10-10 20:57:27.910248
NCT03184194|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-08|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|July 15, 2020|Anticipated|2020-07-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||Nivolumab Combined With Daratumumab With or Without Lenalidomide|A Phase 2 Study of Nivolumab Combined With Daratumumab With or Without Lenalidomide-dexamethasone in Relapsed/Refractory Multiple Myeloma|Not yet recruiting||Phase 2|60|Anticipated|VU University Medical Center||2|||f||||t|f|f|||f|||Undecided||2017-10-10 20:57:27.990938|2017-10-10 20:57:27.990938
NCT03184181|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-10|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|August 1, 2017|Anticipated|2017-08-01||Interventional|MRH-EPTE||Effectiveness of Therapeutic Percutaneous Electrolysis in Persons With the Treatment of Supraspinatus Tendinopathy|Clinical Results After Ultrasound-guided Therapeutic Percutaneous Electrolysis (EPTE®) and Eccentric Exercises in the Treatment of Supraspinatus Tendynopathy|Recruiting||N/A|32|Anticipated|University of Cadiz||2|||f||||t|f|f||||||No||2017-10-10 20:57:28.185911|2017-10-10 20:57:28.185911
NCT03184168|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-11|||July 5, 2017|Actual|2017-07-05|September 2017|2017-09-01|August 25, 2017|Actual|2017-08-25|August 7, 2017|Actual|2017-08-07||Interventional|||Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers|A Phase 1 Open-label, Radiolabeled, Single-dose Study To Investigate The Metabolism Of [14c]Lorlatinib (Pf-06463922) In Healthy Male Volunteers|Completed||Phase 1|6|Actual|Pfizer||1|||t||||f|t|f||||||||2017-10-10 20:57:28.349174|2017-10-10 20:57:28.349174
NCT03184155|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-09|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine|Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine|Not yet recruiting||Early Phase 1|50|Anticipated|Thomas Jefferson University||2|||f||||f|t|f|||t|||No||2017-10-10 20:57:28.457719|2017-10-10 20:57:28.457719
NCT03184142|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-07-23|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Increasing Reporting of Intimidation of Medical Students With Simulation|Increasing Reporting of Intimidation of Medical Students With Simulation: a Randomised Controlled Trial|Recruiting||N/A|150|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||3|||f||||f|f|f||||||||2017-10-10 20:57:28.553887|2017-10-10 20:57:28.553887
NCT03184129|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Efficacy of Newly Developed Knee Prosthesis for Knee Arthroplasty|Safety and Efficacy of Newly Developed Knee Prosthesis for Knee Arthroplasty: a Prospective, Single-center, Randomized, Positive Parallel Controlled, Non-inferiority Clinical Trial|Recruiting||N/A|72|Anticipated|Taihe Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:28.650604|2017-10-10 20:57:28.650604
NCT03184116|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-09|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Individual Intervention for Men in Focused Deterrence Program|Reducing Violence Among High Risk African American Men in Focused Deterrence Program Through Individual Support|Not yet recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f||||||||2017-10-10 20:57:28.737158|2017-10-10 20:57:28.737158
NCT03184103|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-13|||June 27, 2017|Anticipated|2017-06-27|June 2017|2017-06-01|December 27, 2019|Anticipated|2019-12-27|June 27, 2019|Anticipated|2019-06-27||Observational|||Acute Post Streptococcal Glomerulonephritis|Clinical Spectrum and Outcome of Acute Post Streptococcal Glomerulonephritis in Children .|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 20:57:28.801739|2017-10-10 20:57:28.801739
NCT03184090|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-28|||June 28, 2017|Actual|2017-06-28|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|BioPER||Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC|A Multicentre, International, Non-controlled Phase II Trial to Identify the Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge Upon Progression to a Palbociclib Combination in ER-positive Metastatic Breast Cancer Patients (BioPER)|Recruiting||Phase 2|33|Anticipated|MedSIR||1|||f||||f|f|f|||f|||||2017-10-10 20:57:28.880765|2017-10-10 20:57:28.880765
NCT03184077|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-28|||September 2, 2014|Actual|2014-09-02|July 2017|2017-07-01|September 26, 2017|Anticipated|2017-09-26|September 26, 2017|Anticipated|2017-09-26||Interventional|||Rapidly Absorbing Polyglactin 910 Versus Monocryl for Laceration Repair|Rapidly Absorbing Polyglactin 910 Versus Monocryl for Laceration Repair: A Randomized Controlled Trial|Active, not recruiting||N/A|350|Anticipated|Virginia Commonwealth University||2|||f||||f|f|t|f|f||||||2017-10-10 20:57:29.0491|2017-10-10 20:57:29.0491
NCT03184064|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-08|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|April 1, 2018|Anticipated|2018-04-01|January 1, 2018|Anticipated|2018-01-01||Interventional|Glu-FX||Acute Effects of Blackcurrant and Citrus Polyphenol Extracts on Postprandial Glycaemia|Acute Effects of Blackcurrant and Citrus Polyphenol Extracts on Postprandial Glycaemia: The Glu-FX Study|Recruiting||N/A|32|Anticipated|Lucozade Ribena Suntory||4|||f||||f|f|f||||||No||2017-10-10 20:57:29.147343|2017-10-10 20:57:29.147343
NCT03184051|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-07-06|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|CARTILAGE||Diagnostic Performance of Ultrasound Imaging Technique for Femoral Condyle Cartilage Evaluation and Osteoarthritis|Qualification of Ultrasound Imaging Technique in the Quantitative Evaluation of Cartilaginous Tissue of Femoral Condyle Articulation and Osteoarthritis|Recruiting||N/A|16|Anticipated|University Hospital, Grenoble|||1||f||||f|f|f||||||||2017-10-10 20:57:31.235105|2017-10-10 20:57:31.235105
NCT03184038|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-05|||February 21, 2017|Actual|2017-02-21|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Assessment of Neurocognitive Function in Patients With Multiple Brain Metastases Undergoing Stereotactic Radiosurgery or Stereotactic Body Radiation Therapy|Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery: A Phase II Study|Recruiting||Phase 2|360|Anticipated|Thomas Jefferson University||1|||f||||t|f|f||||||||2017-10-10 20:57:31.362956|2017-10-10 20:57:31.362956
NCT03184025|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-09|||July 1, 2014|Actual|2014-07-01|June 2017|2017-06-01|December 29, 2020|Anticipated|2020-12-29|December 29, 2014|Actual|2014-12-29||Interventional|||Effect of Surface Sealant Application on Clinical Performance Occlusal Restorations|Effect of Surface Sealant Application on Clinical Performance of HEMA Containing and HEMA-free Self-Etch Adhesives|Active, not recruiting||N/A|40|Actual|Kocaeli University||1|||f|||||f|f||||||||2017-10-10 20:57:31.469773|2017-10-10 20:57:31.469773
NCT03184012|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-08|||November 1, 2015|Actual|2015-11-01|June 2017|2017-06-01|January 30, 2017|Actual|2017-01-30|November 1, 2016|Actual|2016-11-01||Interventional|||Clinical Evaluation of Zirconia Crowns and Anterior Strip Crowns|Clinical Comparison Between Zirconia Crowns Versus Anterior Strip Crowns|Completed||N/A|120|Actual|King Abdulaziz University||2|||f||||t|f|t|f|f|t|||No||2017-10-10 20:57:31.530255|2017-10-10 20:57:31.530255
NCT03183999|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-09|||January 26, 2017|Actual|2017-01-26|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 1, 2017|Anticipated|2017-12-01||Interventional|||Effect of Fermented Ginseng (GINST) on Sperm Motility|Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Evaluation of Sperm Motility Improvement Effect of Fermented Ginseng(GINST)|Recruiting||N/A|60|Anticipated|Severance Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:31.610821|2017-10-10 20:57:31.610821
NCT03183986|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-19|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Comparison of the Efficacy of Phototherapy Using Blue LED's With Wavelength 478 vs. 459 nm.|Comparison of the Efficacy of Phototherapy With Wavelength 478 vs. 459 nm for Treatment of Neonatal Jaundice Using Blue LED's.|Recruiting||N/A|100|Anticipated|University of Aarhus||2|||f||||t|f|f||||||No||2017-10-10 20:57:31.712179|2017-10-10 20:57:31.712179
NCT03183960|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-10|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|June 15, 2019|Anticipated|2019-06-15||Interventional|Stroke65+||Stroke - 65 Plus. Continued Active Life.|Stroke - 65 Plus. Continued Active Life. A Randomised Controlled Trial of the Effect of a Novel Self-management Intervention Supporting Older Adults After Stroke|Not yet recruiting||Phase 2|60|Anticipated|Central Jutland Regional Hospital||2|||f||||f|f|f||||||||2017-10-10 20:57:31.919385|2017-10-10 20:57:31.919385
NCT03183947|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-09|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|APIC-II||Symptom Based Treatment Affects Brain Plasticity - Cognitive Training in Patients With Affective Symptoms|Symptom Based Treatment Affects Brain Plasticity - Cognitive Training in Patients With Affective Symptoms|Not yet recruiting||N/A|120|Anticipated|RWTH Aachen University||2|||f||||f|f|f||||||||2017-10-10 20:57:32.021495|2017-10-10 20:57:32.021495
NCT02856958|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||July 2016||2016-07-01|August 2016|2016-08-01||||July 2018|Anticipated|2018-07-01||Interventional|||Acute Nerve Decompression Versus Non-operative Treatment for Peroneal Nerve Palsy Following Primary Total Knee Arthroplasty||Recruiting||N/A|100|Anticipated|Rush University Medical Center||2|||f||||||||||||||2017-10-10 21:56:01.387409|2017-10-10 21:56:01.387409
NCT03183934|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|||A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial|A Follow-up Study to Evaluate the Efficacy and Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 1/2 Clinical Trial of ALLO-ASC-EB-101|Not yet recruiting||N/A|5|Anticipated|Anterogen Co., Ltd.|||1||f||||f||||||||No||2017-10-10 20:57:32.337885|2017-10-10 20:57:32.337885
NCT03183921|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-09|||September 1, 2016|Actual|2016-09-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|September 1, 2018|Anticipated|2018-09-01|4 Weeks|Observational [Patient Registry]|ENIRRIs||Study on ICU Patients With Nosocomial Lower Respiratory Tract Infections|Epidemiological, Microbiological and Clinical Profile of Ice Patients With Nosocomial Lower Respiratory Tract Infections|Recruiting||N/A|600|Anticipated|Policlinico Universitario Agostino Gemelli|||1||f||||f|f|f||||||Undecided||2017-10-10 20:57:32.423445|2017-10-10 20:57:32.423445
NCT03183908|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-25|||August 28, 2017|Actual|2017-08-28|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||FLUAD vs. Fluzone High-Dose Study|Safety and Immunogenicity of Adjuvanted Versus High-Dose Inactivated Influenza Vaccines in Older Adults|Recruiting||Phase 4|900|Anticipated|Duke University||2|||f||||f|t|f|||t|||||2017-10-10 20:57:32.522115|2017-10-10 20:57:32.522115
NCT03183895|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-09|||August 2017||2017-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:57:32.678879|2017-10-10 20:57:32.678879
NCT03183882|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-08-07|||August 7, 2017|Anticipated|2017-08-07|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Peer Comparison Feedback on Opioid Prescribing|Effect of Peer Comparison Feedback on Opioid Prescribing by Emergency Medicine Providers|Not yet recruiting||N/A|190|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||||2017-10-10 20:57:32.721332|2017-10-10 20:57:32.721332
NCT03183869|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-22|||August 24, 2017|Actual|2017-08-24|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients|Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients|Recruiting||Phase 2|40|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:57:32.795958|2017-10-10 20:57:32.795958
NCT03183856|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-25|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|May 14, 2018|Anticipated|2018-05-14|May 14, 2018|Anticipated|2018-05-14||Interventional|||Comparison of Ambulatory and Functional Improvement by Morning Walk|Comparison of Clinical Efficacy and Safety for Ambulatory and Functional Improvement in Patients After Total Knee Arthroplasty With Morning Walk|Recruiting||N/A|60|Anticipated|Ulsan University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:57:32.914129|2017-10-10 20:57:32.914129
NCT03183843|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||June 29, 2016|Actual|2016-06-29|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|June 30, 2018|Anticipated|2018-06-30||Interventional|||Dabigatran in Patients With Atrial Fibrillation and Mitral Biological Prostheses|The Use of Dabigatran Etexilate in Patients With Atrial Fibrillation After Mitral Valve Prosthetic Replacement|Enrolling by invitation||Phase 4|40|Actual|Research Institute for Complex Problems of Cardiovascular Diseases, Russia||2|||f||||f|f|f|||f|||No||2017-10-10 20:57:33.008498|2017-10-10 20:57:33.008498
NCT03183830|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||February 2, 2017|Actual|2017-02-02|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Influence of Dietary Nitrate on Skin Inflammation|A Double-blind, Randomised, Placebo-controlled Parallel Study to Investigate the Influence of Dietary Nitrate on Skin Inflammation in Healthy Volunteers|Recruiting||Phase 1|24|Anticipated|Queen Mary University of London||2|||f||||t|f|f||||||No|N/A - no plan to make IPD available to others|2017-10-10 20:57:33.1385|2017-10-10 20:57:33.1385
NCT03183817|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|June 12, 2019|Anticipated|2019-06-12||Interventional|PROTECT||Person-centred Care at Distance|Person-centred Care at Distance for Persons With COPD and/or Heart Failure|Not yet recruiting||N/A|240|Anticipated|Göteborg University||2|||f||||f|f|f||||||||2017-10-10 20:57:33.321962|2017-10-10 20:57:33.321962
NCT03183804|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||April 24, 2016|Actual|2016-04-24|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|August 17, 2018|Anticipated|2018-08-17||Observational|||A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial|A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 2 Clinical Trial of ALLO-ASC-DFU-201|Enrolling by invitation||N/A|54|Anticipated|Anterogen Co., Ltd.|||2||f||||f||||||||Undecided||2017-10-10 20:57:33.995342|2017-10-10 20:57:33.995342
NCT03183765|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-09|2017-06-10|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts|Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts : a Randomized Controlled Trial|Not yet recruiting||Phase 4|30|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 20:57:35.556285|2017-10-10 20:57:35.556285
NCT03183752|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||August 13, 2015||2015-08-13|June 2017|2017-06-01|July 10, 2018|Anticipated|2018-07-10|July 10, 2018|Anticipated|2018-07-10||Interventional|||Insulin Resistance and Metformin Use on Volume of Benign Thyroid Nodules|The Role of Insulin Resistance and the Effect of Metformin Use on Volume of Benign Thyroid Nodules|Recruiting||N/A|30|Anticipated|Hospital Universitário Clementino Fraga Filho||2|||f||||f|f|f||||||No||2017-10-10 20:57:35.656684|2017-10-10 20:57:35.656684
NCT03183726|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||January 11, 2016|Actual|2016-01-11|June 2017|2017-06-01|July 31, 2017|Anticipated|2017-07-31|June 30, 2017|Anticipated|2017-06-30||Observational|||A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial|A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 1 Clinical Trial of ALLO-ASC-DFU-101|Enrolling by invitation||N/A|4|Anticipated|Anterogen Co., Ltd.|||1||f||||t||||||||No||2017-10-10 20:57:35.881165|2017-10-10 20:57:35.881165
NCT03183713|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Confounding Burden of Psychological Impairments in Cervical Spine Surgery|The Confounding Burden of Psychological Impairments in Cervical Spine Surgery|Recruiting||N/A|60|Anticipated|New York University School of Medicine||3|||f||||f|f|f||||||||2017-10-10 20:57:35.979409|2017-10-10 20:57:35.979409
NCT03183700|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-08|||August 9, 2016||2016-08-09|June 2017|2017-06-01|August 9, 2018|Anticipated|2018-08-09|August 9, 2017|Anticipated|2017-08-09||Interventional|||Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women|The Value of HPV DNA Testing Using Self-collected Sampling in Non Attendees Cervical Cancer Screening and Molecular Triage Strategies on Self-sampled Material for HPV Positive Women.|Recruiting||N/A|8000|Anticipated|Cancer Prevention and Research Institute, Italy||3|||f||||t||||||||||2017-10-10 20:57:36.121937|2017-10-10 20:57:36.121937
NCT03183687|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-09|||June 20, 2017|Anticipated|2017-06-20|June 2017|2017-06-01|July 31, 2023|Anticipated|2023-07-31|July 31, 2019|Anticipated|2019-07-31||Observational|||Resident Wellness Initiative: Improving Physical Activity, Nutrition Education and Mental Health of Residents|Resident Wellness Initiative: Improving Physical Activity, Nutrition Education and Mental Health of Residents|Enrolling by invitation||N/A|20|Anticipated|University of Wisconsin, Madison|||1||f||||f|f|f||||||Undecided||2017-10-10 20:57:36.997211|2017-10-10 20:57:36.997211
NCT03183674|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-09|||July 15, 2016|Actual|2016-07-15|June 2017|2017-06-01|July 29, 2017|Anticipated|2017-07-29|July 20, 2017|Anticipated|2017-07-20||Interventional|OxytocinASD||Oxytocin in Spectrum Autism Disorders|Oxytocin in Individuals With Spectrum Autism Disorders|Recruiting||Phase 1|80|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|f|||f|||Yes|The investigators intend to share research information, such as, harms and benefits|2017-10-10 20:57:37.111388|2017-10-10 20:57:37.111388
NCT03183661|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||November 16, 2016|Actual|2016-11-16|June 2017|2017-06-01|April 30, 2021|Anticipated|2021-04-30|March 31, 2021|Anticipated|2021-03-31||Observational|||A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial|Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in the Subjects With Crohn´s Disease(ALLO-ASC-CD-101)|Enrolling by invitation||N/A|9|Anticipated|Anterogen Co., Ltd.|||1||f||||f||||||||Undecided||2017-10-10 20:57:37.236686|2017-10-10 20:57:37.236686
NCT03183648|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-11|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Observational|||A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial|A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 2 Clinical Trial of ALLO-ASC-BI-201|Enrolling by invitation||N/A|30|Anticipated|Anterogen Co., Ltd.|||1||f||||t|f|f||||||No||2017-10-10 20:57:37.338781|2017-10-10 20:57:37.338781
NCT03183635|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-15|||November 4, 2016|Actual|2016-11-04|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Rapid Movement Therapy for Stroke Rehabilitation|A Randomized Controlled Trial of Rapid Movement Therapy With Real-time Feedback to Improve Balance Recovery for Fall Prevention After Stroke|Recruiting||N/A|40|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 20:57:37.423562|2017-10-10 20:57:37.423562
NCT03183622|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-11|||November 2015|Actual|2015-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|||A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial|A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 1 Clinical Trial of ALLO-ASC-BI-101|Active, not recruiting||N/A|5|Actual|Anterogen Co., Ltd.|||1||f||||t|f|f||||||No||2017-10-10 20:57:37.545806|2017-10-10 20:57:37.545806
NCT03183609|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-24|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|July 30, 2025|Anticipated|2025-07-30|July 30, 2022|Anticipated|2022-07-30||Interventional|||Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)|Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)|Recruiting||N/A|40|Anticipated|University of Maryland||2|||f||||t|f|f||||||||2017-10-10 20:57:37.662934|2017-10-10 20:57:37.662934
NCT03183596|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-07|||December 2017|Anticipated|2017-12-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|August 2019|Anticipated|2019-08-01||Interventional|||Optimal Injection Site for Serratus Anterior Plane Block in Reconstructive Breast Surgery|Optimal Injection Site for Serratus Anterior Plane Block in Reconstructive Breast Surgery (Randomized, Pilot Study)|Not yet recruiting||Phase 3|40|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||t|||||2017-10-10 20:57:37.843148|2017-10-10 20:57:37.843148
NCT03183583|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||January 23, 2017|Actual|2017-01-23|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|January 23, 2018|Anticipated|2018-01-23||Observational|||Tissue Adhesive in Hip and Knee Arthroplasty, A Cost -Effectiveness Analysis|Tissue Adhesive in Hip and Knee Arthroplasty, A Cost -Effectiveness Analysis|Recruiting||N/A|980|Anticipated|Amphia Hospital|||1||f||||f||||||||No||2017-10-10 20:57:37.984643|2017-10-10 20:57:37.984643
NCT03183570|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-24|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis Using PET/CT|Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis With [18F]FP-R01-MG-F2 PET/CT|Recruiting||Early Phase 1|10|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 20:57:38.099535|2017-10-10 20:57:38.099535
NCT03183544|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-10|||August 10, 2017|Actual|2017-08-10|June 2017|2017-06-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|PSMA||Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit|Kinetics, Biodistribution, Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit, in Healthy Male Volunteers and Patients With Limited Recurrent Prostate Cancer|Withdrawn||Phase 1|0|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1||The Ethics Committee did not approved the start of the study|f||||f|f|f||||||||2017-10-10 20:57:38.433694|2017-10-10 20:57:38.433694
NCT03183531|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||January 1, 2011|Actual|2011-01-01|June 2017|2017-06-01|March 31, 2016|Actual|2016-03-31|December 31, 2015|Actual|2015-12-31||Observational|||New Protocol for Febrile Neonate Management|New Protocol for Identification of Serious Bacterial Infection in Febrile Newborn|Completed||N/A|328|Actual|Sisli Etfal Training & Research Hospital|||1||f|||||f|f||||||||2017-10-10 20:57:38.571438|2017-10-10 20:57:38.571438
NCT03183518|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-08|||March 27, 2017|Actual|2017-03-27|June 2017|2017-06-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||To Assess the Photosensitisation and Photoallergy Potential of a Cosmetic Facial Product in Healthy Participants|A Clinical Study to Assess the Photosensitisation and Photoallergy Potential of a Cosmetic Facial Product in Healthy Subjects|Completed||N/A|49|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 20:57:38.657365|2017-10-10 20:57:38.657365
NCT03183505|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-03|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb|Safety and Efficacy Study of Anyu Peibo in the Treatment of Major Depressive Disorder(MDD): a Ⅱb Stratified Randomized, Double-Blind, Placebo-Paralleled, Multicenter Clinical Trial|Recruiting||Phase 2|172|Anticipated|Shanghai Mental Health Center||2|||f||||f|f|f||||||||2017-10-10 20:57:38.754435|2017-10-10 20:57:38.754435
NCT03183479|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-08|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery|The Effects of Fibrinogen Concentrate Infusion on Perioperative Blood Loss and Allogeneic Blood Conservation in Patients Undergoing Scoliosis Surgery|Recruiting||Phase 3|104|Anticipated|Peking Union Medical College Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:38.988203|2017-10-10 20:57:38.988203
NCT03183466|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-08|||December 1, 2011|Actual|2011-12-01|May 2017|2017-05-01|July 1, 2017|Anticipated|2017-07-01|November 30, 2014|Actual|2014-11-30||Interventional|||Do You Arthroscopic Repair for Subscapularis Tendon Tear, Which Accounts for More Than Half of the 1st Facet? Or do You Perform Debridement?|Prospective Randomized Clinical Trial of Arthroscopic Repair Versus Debridement for Subscapularis Tendon Tear More Than 1/2 to Entire 1st Facet (Representing 1/3 to More Than 1/3 Tear of Subscapularis Entire Footprint)|Active, not recruiting||N/A|80|Actual|Samsung Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:57:39.131044|2017-10-10 20:57:39.131044
NCT03183453|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-08|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Neuropsychological Rehabilitation of Spontaneous Confabulation: a Replica Study|Replica Study of a Neuropsychological Treatment for Patients Who Show Spontaneous Confabulation After Acquired Brain Injury|Recruiting||N/A|50|Anticipated|San Rafael University Hospital, Granada, Spain||4|||f||||f||||||||||2017-10-10 20:57:39.212978|2017-10-10 20:57:39.212978
NCT03183440|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|PREGRALL||Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children|A Multicenter Clinical Trial To Assess The Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children.|Not yet recruiting||N/A|376|Anticipated|Nantes University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:39.312374|2017-10-10 20:57:39.312374
NCT03183427|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-10|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Observational|||Corpus Callosum Size in Patients With Pineal Cyst|Corpus Callosum Size in Patients With Pineal Cyst|Not yet recruiting||N/A|200|Anticipated|Military University Hospital, Prague|||2||f||||f|f|f||||||No||2017-10-10 20:57:39.4096|2017-10-10 20:57:39.4096
NCT03183414|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|December 20, 2017|Anticipated|2017-12-20||Observational|||Right Ventricular Dysfunction in Cardiac Surgery Patients|Right Ventricular Dysfunction in Cardiac Surgery|Not yet recruiting||N/A|15|Anticipated|Medical Centre Leeuwarden|||1||f||||f|f|f||||||No|not available, patient data is anonym|2017-10-10 20:57:39.473583|2017-10-10 20:57:39.473583
NCT03183401|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-20|||July 9, 2017|Anticipated|2017-07-09|June 2017|2017-06-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Observational|DENACAPST||National Breast and Thyroid Screening After a Treatment Received Against a Cancer During Childhood|National Breast and Thyroid Screening After a Treatment Received Against a Cancer During Childhood|Recruiting||N/A|2000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f|f|f||||||No||2017-10-10 20:57:39.555882|2017-10-10 20:57:39.555882
NCT03183388|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|BE-SMART||Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)|Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)|Recruiting||N/A|52|Anticipated|Yale University||1|||f||||f|f|f||||||No||2017-10-10 20:57:39.632019|2017-10-10 20:57:39.632019
NCT03183375|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-19|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan|An Open Label Randomized Controlled Trial to Evaluate the Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan|Recruiting||Phase 2|100|Anticipated|Omair Sana Foundation||2|||f||||t|f|f||||||||2017-10-10 20:57:39.712724|2017-10-10 20:57:39.712724
NCT03183362|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-12|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section|Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section; a Randomized Controlled Study|Not yet recruiting||N/A|110|Anticipated|Cairo University||2|||f||||t|f|f||||||No||2017-10-10 20:57:39.795425|2017-10-10 20:57:39.795425
NCT03183349|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-10|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Immediate Implant Placement With Platlet Rich Fibrin as Space Filling Material Versus the Use of Deprotienized Bovine Bone (Tutogen) in Maxillary Premolars.|Immediate Implant Placement With Platlet Rich Fibrin as Space Filling Material Versus the Use of Deprotienized Bovine Bone (Tutogen) in Maxillary Premolars. A Randomized Controlled Clinical Trial|Active, not recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||Yes||2017-10-10 20:57:39.871698|2017-10-10 20:57:39.871698
NCT03183336|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-06|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Horizontal Ridge Augmentation of the Mandible Autogenous Block Grafts|Horizontal Ridge Augmentation of the Mandible Using Interpositional Autogenous Block Grafts Versus Onlay Block Grafts; Randomized Controlled Clinical Trial|Active, not recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:57:39.941213|2017-10-10 20:57:39.941213
NCT03183323|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-09|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|May 11, 2018|Anticipated|2018-05-11||Interventional|ITISHOPE4HF||Implementation of Telerehabilitation In Support of HOme-based Physical Exercise for Heart Failure|Implementation of Telerehabilitation In Support of HOme-based Physical Exercise for Heart Failure|Recruiting||N/A|70|Anticipated|Levanger Hospital||2|||f||||t|f|f||||||||2017-10-10 20:57:39.997566|2017-10-10 20:57:39.997566
NCT03183310|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-07|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||The Effect of Chlorpromazine on Esophageal Sensitivity in Healthy Volunteers.|The Effect of Chlorpromazine (Largactil®), a Dopamine Receptor Antagonist, on Esophageal Sensitivity in Healthy Volunteers: a Randomized, Double-blind, Placebo-controlled Study.|Not yet recruiting||N/A|14|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f|f|f|||f|||No||2017-10-10 20:57:40.11374|2017-10-10 20:57:40.11374
NCT03183297|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Evaluate the Pharmacokinetics and Pharmacodynamics of JMI-001|A Double-Blind, Placebo-Controlled, 4-Way Crossover Study to Evaluate the Pharmacokinetics and Pharmacodynamics at Two Dose Levels of JMI-001 in Comparison With Fexofenadine and Naproxen Administered in Conjunction With Alcohol.|Not yet recruiting||Phase 1|48|Anticipated|JMI Capital Group||4|||f||||f|t|f||||||No||2017-10-10 20:57:40.296065|2017-10-10 20:57:40.296065
NCT03183284|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-06-08|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|June 30, 2017|Anticipated|2017-06-30||Observational|||Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra|Comparison Study of Methyl Prdnisolone Versus Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||No||2017-10-10 20:57:40.394479|2017-10-10 20:57:40.394479
NCT03183271|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-13|||July 16, 2012|Actual|2012-07-16|June 2017|2017-06-01|September 30, 2016|Actual|2016-09-30|March 30, 2015|Actual|2015-03-30||Interventional|||Proton Boost for Locally Advanced HEAD AND NECK TUMORS|Phase II Clinical Study on Proton Therapy Boost (Hadrontherapy) for Locally Advanced HEAD AND NECK TUMORS|Completed||N/A|20|Actual|CNAO National Center of Oncological Hadrontherapy||1|||f||||f|f|f||||||||2017-10-10 20:57:40.455736|2017-10-10 20:57:40.455736
NCT03183258|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-07|||May 19, 2016|Actual|2016-05-19|June 2017|2017-06-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Vascularised Sentinel Skin Flaps to Detect Rejection in Pancreas Transplantation|Vascularised Sentinel Skin Flaps to Detect Rejection in Pancreas Transplantation|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Oxford||1|||f|||||f|f||||||||2017-10-10 20:57:40.550045|2017-10-10 20:57:40.550045
NCT03183245|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2023|Anticipated|2023-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis|A Phase 3 Study to Compare the Efficacy and Safety of Humacyte's Human Acellular Vessel With That of an Autologous Arteriovenous Fistula in Subjects With End Stage Renal Disease|Not yet recruiting||Phase 3|240|Anticipated|Humacyte, Inc.||2|||f||||t|t|f||||||No||2017-10-10 20:57:40.642377|2017-10-10 20:57:40.642377
NCT03183232|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|June 15, 2020|Anticipated|2020-06-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Safety and Efficiency of γδ T Cell Against Lung Cancer|γδ T Cell Immunotherapy for Treatment of Lung Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||3|||f||||t|f|f||||||||2017-10-10 20:57:40.751516|2017-10-10 20:57:40.751516
NCT03183219|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|June 15, 2020|Anticipated|2020-06-15|January 15, 2018|Anticipated|2018-01-15||Interventional|||Safety and Efficiency of γδ T Cell Against Liver Cancer|γδ T Cell Immunotherapy for Treatment of Liver Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||3|||f||||t|f|f||||||||2017-10-10 20:57:40.845121|2017-10-10 20:57:40.845121
NCT03183206|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|June 15, 2020|Anticipated|2020-06-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Safety and Efficiency of γδ T Cell Against Breast Cancer|γδ T Cell Immunotherapy for Treatment of Breast Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||3|||f||||t|f|f||||||||2017-10-10 20:57:40.956721|2017-10-10 20:57:40.956721
NCT03183193|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-07|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|FLiO||Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)|Non-alcoholic Fatty Liver Disease (NAFLD) in Overweight and Obese People Under Nutritional and Lifestyle Follow-up: a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||t||||||||Undecided||2017-10-10 20:57:41.122222|2017-10-10 20:57:41.122222
NCT03168191|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-24|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2|Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2|Recruiting||Phase 1|50|Anticipated|Yale University||3|||f||||f|t|f||||||||2017-10-10 21:01:41.162879|2017-10-10 21:01:41.162879
NCT03183180|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-08|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01||Observational|||Prevalence of Secondary Cardiac Damage in Rheumatic Fever Patients and Penicillin Secondary Prophylaxis|Prevalence of Secondary Cardiac Damage in Rheumatic Fever Patients and Adherence to Penicillin Secondary Prophylaxis|Not yet recruiting||N/A|100|Anticipated|Assuta Hospital Systems|||1||f||||f|f|f||||||Undecided||2017-10-10 20:57:41.420034|2017-10-10 20:57:41.420034
NCT03183167|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||January 1, 2006|Actual|2006-01-01|June 2017|2017-06-01|April 1, 2017|Actual|2017-04-01|December 31, 2016|Actual|2016-12-31||Observational|UKER-ICH||Longitudinal Cohort Study on ICH Care|Universitätsklinikum Erlangen Cohort of Patients With Spontaneous Intracerebral Hemorrhage|Completed||N/A|1076|Actual|University of Erlangen-Nürnberg Medical School|||1||f||||f|f|f||||||No||2017-10-10 20:57:41.492677|2017-10-10 20:57:41.492677
NCT03183154|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|MIAMI||Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected|Mathematical Modeling of the HIV Transmission Risk During the First 24 Weeks After Initiation of Antiretroviral Therapy in naïve HIV-infected MSM: Comparison of INSTI-based Regimens vs. nnRTI and PI Based Regimens.|Recruiting||N/A|1831|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||f|f|f||||||No||2017-10-10 20:57:41.574697|2017-10-10 20:57:41.574697
NCT03183141|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-12|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|ECOSPORIV||ECOSPOR IV: An Open-Label Extension of Study SERES 0012 Evaluating SER-109 in Subjects With Recurrent Clostridium Difficile Infection|ECOSPOR IV: An Open-Label Extension of Study SERES 0012 Evaluating SER-109 in Subjects With Recurrent Clostridium Difficile Infection|Recruiting||Phase 3|100|Anticipated|Seres Therapeutics, Inc.||1|||f||||f|t|f||||||No||2017-10-10 20:57:41.653442|2017-10-10 20:57:41.653442
NCT03183128|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-12|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|ECOSPORIII||ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection|A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults|Recruiting||Phase 3|320|Anticipated|Seres Therapeutics, Inc.||2|||f||||t|t|f||||||No||2017-10-10 20:57:41.753731|2017-10-10 20:57:41.753731
NCT03183115|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-08|||April 18, 2016|Actual|2016-04-18|June 2017|2017-06-01|December 30, 2026|Anticipated|2026-12-30|April 30, 2021|Anticipated|2021-04-30||Interventional|||RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection|Preemptive Radiofrequency Ablation for Esophageal Speckled Lugol Background Mucosa to Prevent Metachronous Neoplastic Recurrence After Complete Endoscopic Submucosal Dissection ~A Randomized Controlled Study|Recruiting||N/A|100|Anticipated|E-DA Hospital||2|||f||||t|f|f||||||Undecided|The initial outcome and the data of adverse events will be shared with other researchers, by mail, when they are available.|2017-10-10 20:57:41.846285|2017-10-10 20:57:41.846285
NCT03183102|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.|The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.|Not yet recruiting||N/A|30|Anticipated|Colorado State University||2|||f||||f|f|f||||||||2017-10-10 20:57:41.951899|2017-10-10 20:57:41.951899
NCT03183089|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||December 3, 2015|Actual|2015-12-03|June 2017|2017-06-01|January 4, 2016|Actual|2016-01-04|January 4, 2016|Actual|2016-01-04||Interventional|||Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye|A Randomized, Single-Center, Comparative Study of Rohto Dry-Aid® and Systane® Ultra in the Management of Tear Film Stability and Visual Function in Patients With Dry Eye|Completed||Phase 4|80|Actual|The Mentholatum Company||2|||f||||f|t|f|||f|||No||2017-10-10 20:57:42.02581|2017-10-10 20:57:42.02581
NCT03183076|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-08|||September 1, 2015|Actual|2015-09-01|May 2017|2017-05-01|December 30, 2016|Actual|2016-12-30|April 30, 2016|Actual|2016-04-30||Interventional|||Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy|Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy in Adults Patients|Completed||N/A|14|Actual|Instituto Mexicano del Seguro Social||2|||f||||t|f|f||||||No||2017-10-10 20:57:42.116687|2017-10-10 20:57:42.116687
NCT03183063|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-09|||April 12, 2017|Actual|2017-04-12|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events|A Novel Method to Detect Pulmonary Thromboembolic Events With Non-Contrast 4DCT|Enrolling by invitation||N/A|20|Anticipated|William Beaumont Hospitals|||1||f||||f|f|t|f|f|f|||No|Information gathered for this study will not be disclosed to any other person or entity, or for other research.|2017-10-10 20:57:42.228486|2017-10-10 20:57:42.228486
NCT03183050|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-08|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|MEND2||MEND 2: Making Treatment Decisions Using Genomic Testing|MEND 2: Making Treatment Decisions Using Genomic Testing|Recruiting||N/A|135|Anticipated|Georgetown University||1|||f||||f|f|f||||||Yes|Data will include self-reported survey data, data obtained from chart review and audio recorded encounters. We will make de-identified data available by request to investigators not associated with the study. Priority for sharing of data will be given to junior faculty and/or faculty interested in questions related to translational science. Any requests for data from non-study investigators will be reviewed by the investigative team to ensure that it does not conflict with planned analyses, is otherwise respectful of the study participants, and complies with all relevant IRB and HIPAA regulations.|2017-10-10 20:57:42.303356|2017-10-10 20:57:42.303356
NCT03183037|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Acupuncture for Symptoms of Nerve Damage|Acupuncture for Persistent Chemotherapy-induced Peripheral Neuropathy Symptoms in Solid Tumor Survivors: A Pilot Study|Recruiting||N/A|75|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f|||||f|f||||||Undecided||2017-10-10 20:57:42.393585|2017-10-10 20:57:42.393585
NCT03182296|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-08|||November 10, 2016|Actual|2016-11-10|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Visualizing Beta Cells in Patients With a History of Gestational Diabetes|Visualizing Beta Cells in Patients With a History of Gestational Diabetes|Recruiting||N/A|24|Anticipated|Radboud University||2|||f||||f|f|f||||||No||2017-10-10 20:57:47.827172|2017-10-10 20:57:47.827172
NCT03183024|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-11|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|June 15, 2018|Anticipated|2018-06-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody|Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monocloncal Antibody|Not yet recruiting||Phase 4|12|Anticipated|Bernstein Clinical Research Center||2|||f||||t|t|f||||||||2017-10-10 20:57:42.48829|2017-10-10 20:57:42.48829
NCT03183011|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-08|||November 1, 2016|Actual|2016-11-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Cardiac Magnetic Resonance Imaging After Cardiac Resynchronization Therapy|Cardiac Magnetic Resonance Imaging After Cardiac Resynchronization Therapy|Recruiting||N/A|40|Anticipated|University of Virginia||1|||f||||t|f|f||||||No||2017-10-10 20:57:42.582253|2017-10-10 20:57:42.582253
NCT03182998|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-09-01|||July 14, 2017|Actual|2017-07-14|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Decision Aids to Improve Knowledge in Patients With Prostate Cancer|Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men|Recruiting||N/A|100|Anticipated|Mayo Clinic||3|||f||||t|f|f||||||||2017-10-10 20:57:42.663539|2017-10-10 20:57:42.663539
NCT03182985|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-21|||June 22, 2017|Anticipated|2017-06-22|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Impact of Time Restricted Feeding (TRF) in Improving the Health of Patients With Metabolic Syndrome|The Impact of Time Restricted Feeding (TRF) in Improving the Health of Patients With Metabolic Syndrome|Recruiting||N/A|100|Anticipated|University of California, San Diego||1|||f||||f|f|f|||f|||No||2017-10-10 20:57:42.788633|2017-10-10 20:57:42.788633
NCT03182972|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||August 2, 2016|Actual|2016-08-02|June 2017|2017-06-01|April 2, 2018|Anticipated|2018-04-02|March 2, 2018|Anticipated|2018-03-02||Interventional|||Implementation Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Southwestern Nigeria|Implementation Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Southwestern Nigeria|Recruiting||N/A|300|Anticipated|University of Ibadan||1|||f||||t|f|f||||||Yes||2017-10-10 20:57:42.882505|2017-10-10 20:57:42.882505
NCT03182959|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-07|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer|A Phase 0 Study Evaluating the Systemic Bioavailability and Pharmacodynamic Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer|Not yet recruiting||Early Phase 1|36|Anticipated|University of Arizona||2|||f||||t|t|f|||f|||Undecided||2017-10-10 20:57:42.96159|2017-10-10 20:57:42.96159
NCT03182946|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Observational|||Correcting Platelet Dysfunction After Traumatic Brain Injury|Correction of Platelet Dysfunction Following Traumatic Brain Injury in Geriatric Patients|Not yet recruiting||N/A|130|Anticipated|Carolinas Healthcare System|||1||f||||t|f|f||||Samples With DNA|"     Blood samples from which platelet function and platelet mitochondrial function will be     analyzed, as well as serum markers for mitochondrial function   "|No|Only collaborators will have patient names for data acquisition.|2017-10-10 20:57:43.059509|2017-10-10 20:57:43.059509
NCT03182933|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-08|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty|Impact of Liposomal Bupivacaine Injected for Adductor Canal Block on Recovery Profile and Block Characteristics Following Total Knee Arthroplasty.|Recruiting||Phase 4|70|Anticipated|University of Wisconsin, Madison||2|||f||||t|t|f|||f|||No||2017-10-10 20:57:43.134412|2017-10-10 20:57:43.134412
NCT03182920|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-10-02|||June 16, 2017|Actual|2017-06-16|October 2017|2017-10-01|August 14, 2017|Actual|2017-08-14|August 14, 2017|Actual|2017-08-14||Interventional|||A Study of Lasmiditan in Healthy Participants|Effect of Age on the Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Healthy Subjects|Completed||Phase 1|36|Actual|Eli Lilly and Company||3|||f||||f|t|f||||||||2017-10-10 20:57:43.222999|2017-10-10 20:57:43.222999
NCT03182881|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-08-07|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|June 20, 2017|Actual|2017-06-20||Interventional|MRvsMLD||Effectiveness of Myofascial Release Versus Manual Lymphatic Drainage After Breast Cancer Surgery|Effectiveness of Myofascial Release Versus Manual Lymphatic Drainage After Breast Cancer Surgery In Women Undergoing Conservative Surgery and Radiotherapy. Randomized Clinical Trial|Completed||N/A|30|Actual|University of Valencia||2|||f||||f|f|f||||||||2017-10-10 20:57:43.450149|2017-10-10 20:57:43.450149
NCT03182868|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-20|||June 21, 2016||2016-06-21||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:57:43.52125|2017-10-10 20:57:43.52125
NCT03182855|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-14|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|June 1, 2018|Anticipated|2018-06-01||Interventional|CanTi||Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI|Cangrelor vs. Ticagrelor for Early Platelet Inhibition in ST-elevation Myocardial Infarction|Not yet recruiting||Phase 4|80|Anticipated|University of Aarhus||2|||f||||t|f|f|||f|||||2017-10-10 20:57:43.567301|2017-10-10 20:57:43.567301
NCT03182842|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-03|||June 17, 2017|Actual|2017-06-17|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|||FreeStyle Libre FGM During Summer Camp for Children With Type 1 Diabetes|Evaluation of FreeStyle Libre Flash Glucose Monitoring System During a Children With Type 1 Diabetes Summer Camp - The Free Summer Study|Completed||N/A|45|Actual|University of Ljubljana, Faculty of Medicine||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:57:43.800916|2017-10-10 20:57:43.800916
NCT03182829|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-09|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|PADOASU||Performance Assessment of an in Vitro Diagnostic Test for DOAC in Urine|Performance Assessment of an in Vitro Diagnostic Test for Direct Oral Anticoagulants (Apixaban, Edoxaban, Rivaroxaban, Dabigatran) in Urine|Not yet recruiting||N/A|880|Anticipated|Doasense GmbH|||2||f||||t|f|f||||Samples Without DNA|"     urine sample, spontaneously collected from patients   "|Yes|Individual data of patients are collected during the study and stored centrally at clinical research services Mannheim. They will be shared with other researchers upon request.|2017-10-10 20:57:43.896513|2017-10-10 20:57:43.896513
NCT03182816|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-07|||June 7, 2017|Anticipated|2017-06-07|June 2017|2017-06-01|April 20, 2019|Anticipated|2019-04-20|January 20, 2019|Anticipated|2019-01-20||Interventional|||CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor|A Clinical Study of CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for Patients With EGFR Positive Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|40|Anticipated|Shanghai Cell Therapy Research Institute||1|||f||||f|f|f||||||No||2017-10-10 20:57:43.991236|2017-10-10 20:57:43.991236
NCT03182803|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-07|||June 7, 2017|Anticipated|2017-06-07|June 2017|2017-06-01|April 20, 2019|Anticipated|2019-04-20|January 20, 2019|Anticipated|2019-01-20||Interventional|||CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor|A Clinical Study of CTL-A4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Patients With Mesothelin Positive Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|40|Anticipated|Shanghai Cell Therapy Research Institute||1|||f||||f|f|f||||||No||2017-10-10 20:57:44.104848|2017-10-10 20:57:44.104848
NCT03182790|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-20|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||"Promoting Smoking Cessation in the Community Via Quit to Win Contest 2017"|"Building Capacity and Promoting Smoking Cessation in the Community Via Quit to Win Contest 2017: a Single-blind Cluster Randomized Controlled Trial on a Combined Cocktail Intervention of Brief Advice, Instant Messaging and Active Referral (AIR) to Increase Abstinence"|Not yet recruiting||N/A|1200|Anticipated|The University of Hong Kong||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:44.217131|2017-10-10 20:57:44.217131
NCT03182777|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-06-07|||May 2015||2015-05-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|December 2017|Anticipated|2017-12-01||Interventional|SLDAPCC||Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies|Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies|Recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Yes|After thesis defense, the IPD will be available on the Portal Digital Library of Theses and Dissertations of the University of São Paulo (http://www.teses.usp.br/index.php?option=com_jumi&fileid=12&Itemid=77&lang=pt-br), in a PDF file.|2017-10-10 20:57:44.364827|2017-10-10 20:57:44.364827
NCT03182764|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||April 28, 2017|Actual|2017-04-28|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Observational|||Tobacco Control-Related Policy Survey|Policy-Related Survey - Territory-wide Telephone Survey on Tobacco Control|Recruiting||N/A|5104|Anticipated|The University of Hong Kong|||3||f|||||f|f||||||||2017-10-10 20:57:44.488766|2017-10-10 20:57:44.488766
NCT03182751|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement|Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement in Low Energy Hip Fracture Patients?|Recruiting||Phase 2|156|Anticipated|Mayo Clinic||2|||f||||t|t|f|||f|||||2017-10-10 20:57:44.575602|2017-10-10 20:57:44.575602
NCT03182738|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-08|||February 2016||2016-02-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|January 2020|Anticipated|2020-01-01||Interventional|VIP-HANA||Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms|Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms|Recruiting||N/A|100|Anticipated|Columbia University||2|||f||||f||||||||No||2017-10-10 20:57:44.69445|2017-10-10 20:57:44.69445
NCT03182725|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-20|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|POTS||Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome|Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome (a Double-blind Placebo-parallel Group Trial)|Recruiting||Phase 3|20|Anticipated|University of California, San Diego||2|||f|||||t|f||||||||2017-10-10 20:57:44.802047|2017-10-10 20:57:44.802047
NCT03182712|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-07|||February 2007||2007-02-01|June 2017|2017-06-01|March 15, 2008|Actual|2008-03-15|February 10, 2008|Actual|2008-02-10||Interventional|||n-3 Fatty Acid Effects in T2DM After Acute High Intensity Exercise|Effects of n-3 Fatty Acids and Vitamin E Supplementation Upon Oxidative Stress, Inflammation and Metabolic Parameters in Type 2 Diabetic Subjects at Rest and After an Acute High Intensity Exercise Bout|Completed||N/A|30|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||Yes|All data, including body composition, inflammatory and oxidative stress markers and metabolites.|2017-10-10 20:57:44.902256|2017-10-10 20:57:44.902256
NCT03182699|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-07|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 1, 2020|Anticipated|2020-12-01|November 1, 2019|Anticipated|2019-11-01||Interventional|EtECAR-HD||Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients|Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients: A Randomized Controlled Trial|Not yet recruiting||Phase 4|62|Anticipated|Medical University of Vienna||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:44.99874|2017-10-10 20:57:44.99874
NCT03182673|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-17|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||The Study of SHR7390 in Combination With SHR-1210 in Patients With Advanced Solid Tumors|A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR7390 Combined With SHR-1210 in Patients With Advanced Solid Tumors|Not yet recruiting||Phase 1|60|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:57:45.291848|2017-10-10 20:57:45.291848
NCT03182660|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-21|||June 12, 2017||2017-06-12||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 20:57:45.394782|2017-10-10 20:57:45.394782
NCT03182647|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-30|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|ACLLTFU||Long-term Follow-up of Anterior Cruciate Ligament Injury|Long-term Follow-up of Anterior Cruciate Ligament Injury|Recruiting||N/A|300|Anticipated|Linkoeping University|||2||f||||f|f|f||||||||2017-10-10 20:57:45.43588|2017-10-10 20:57:45.43588
NCT03182634|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-06-09|||December 15, 2016|Actual|2016-12-15|June 2017|2017-06-01|November 2023|Anticipated|2023-11-01|November 2022|Anticipated|2022-11-01||Interventional|plasmaMATCH||The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial|A Multiple Parallel Cohort, Multi-centre Phase IIa Trial Aiming to Provide Proof of Principle Efficacy for Designated Targeted Therapies in Patients With Advanced Breast Cancer Where the Targetable Mutation is Identified Through ctDNA|Recruiting||Phase 2|1000|Anticipated|Institute of Cancer Research, United Kingdom||4|||f||||t|f|f||||||||2017-10-10 20:57:45.537925|2017-10-10 20:57:45.537925
NCT03182621|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-07|||January 2014|Actual|2014-01-01|June 2017|2017-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comprehensive Versus Traditional Lifestyle Program|THINK (Translational Health in Nutrition and Kinesiology) Junior Edition|Completed||N/A|105|Actual|University of Miami||2|||f||||t|f|f||||||Yes|Only the study investigators and/or sponsor will monitor the plan for data and safety monitoring for this study. Shared data will be done through encrypted files and file management platform OneDrive.|2017-10-10 20:57:45.650682|2017-10-10 20:57:45.650682
NCT03182608|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-19|||June 9, 2017|Actual|2017-06-09|July 2017|2017-07-01|March 25, 2018|Anticipated|2018-03-25|March 25, 2018|Anticipated|2018-03-25||Interventional|||Ultrasound Assessment of the Anatomic Landmarks for Spinal Anesthesia in Patients With Hip Fracture|Ultrasound Assessment of the Anatomic Landmarks for Spinal Anesthesia in Patients With Hip Fracture|Recruiting||N/A|54|Anticipated|SMG-SNU Boramae Medical Center||2|||f|||||f|f||||||||2017-10-10 20:57:45.729272|2017-10-10 20:57:45.729272
NCT03182595|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-07|||March 17, 2017|Actual|2017-03-17|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Variability of Sulfotransferase 1A1 Activity in Humans: an Approach to Improve Predictive Drug Response - Part I: Analysis of Intraindividual Variation in Healthy Adults|Variability of Sulfotransferase 1A1 Activity in Humans: an Approach to Improve Predictive Drug Response - Part I: Analysis of Intraindividual Variation in Healthy Adults|Recruiting||Phase 1|36|Anticipated|Hospital da Luz, Portugal||1|||f||||f|f|f|||f|||No||2017-10-10 20:57:45.816395|2017-10-10 20:57:45.816395
NCT03182582|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-15|||January 5, 2017|Actual|2017-01-05|June 2017|2017-06-01|March 17, 2017|Actual|2017-03-17|March 17, 2017|Actual|2017-03-17||Interventional|||Efficacy of Laser Debridement on Pain and Bacterial Load in Chronic Wounds|Efficacy of the Er:YAG Laser Debridement on Patient-Reported Pain and Bacterial Load in Chronic Wounds|Completed||N/A|22|Actual|Stanford University||2|||f||||f|f|t|f|f|t|||No||2017-10-10 20:57:45.898184|2017-10-10 20:57:45.898184
NCT03182569|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-07|||December 11, 2016|Actual|2016-12-11|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Flexible Catheter for Insulin in Diabetes|Use of a Flexible Catheter for the Administration of Subcutaneous Insulin in Diabetic Ketoacidosis|Recruiting||N/A|20|Anticipated|Hospital General de Niños Pedro de Elizalde||2|||f||||t||||||||Undecided||2017-10-10 20:57:46.007321|2017-10-10 20:57:46.007321
NCT03182556|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-07|||May 11, 2012|Actual|2012-05-11|June 2017|2017-06-01|September 10, 2016|Actual|2016-09-10|April 17, 2013|Actual|2013-04-17||Interventional|||Efficacy of Electromyographic Biofeedback, Aerobic Exercise and Stretching in Fibromyalgia.|Comparison of the Efficacy of Electromyographic Biofeedback, Aerobic Exercise (Biodanza) and Stretching in Patients With Fibromyalgia.|Completed||N/A|89|Actual|Universidad de Almeria||3|||f||||f|f|f||||||No||2017-10-10 20:57:46.097702|2017-10-10 20:57:46.097702
NCT03182543|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-07|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|April 30, 2017|Actual|2017-04-30|February 28, 2017|Actual|2017-02-28||Interventional|||Physiological Effect of Ataulfo Mango (Manguifera Indica) Beverage in Exercise|Physiological Response to Ataulfo Mango Pulp and Peel Beverages in Exercise|Completed||N/A|19|Actual|Universidad Autonoma de Ciudad Juarez||3|||f||||t|f|f||||||No||2017-10-10 20:57:46.18526|2017-10-10 20:57:46.18526
NCT03182530|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Prevention of Radial Artery Occlusion After Trans-radial Cardiac Catheterization|Prevention of Radial Artery Occlusion After Trans-radial Cardiac Catheterization. Randomized Duplex Follow-up Study.|Not yet recruiting||N/A|600|Anticipated|Assiut University||3|||f||||f|f|f||||||No||2017-10-10 20:57:46.27614|2017-10-10 20:57:46.27614
NCT03182517|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-07-11|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|||Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.|Correlation of Parathyroid Hyperplasia by Ultrasound With Clinical and Laboratory Findings in Patients With Chronic Kidney Disease.|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 20:57:46.356983|2017-10-10 20:57:46.356983
NCT03182504|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-14|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|September 18, 2017|Anticipated|2017-09-18|August 20, 2017|Anticipated|2017-08-20||Interventional|||A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants|A Non-Randomized, Open Label, One Treatment, One Group Study to Investigate the Intrapulmonary Lung Penetration of RO7079901 in Healthy Volunteers|Active, not recruiting||Phase 1|20|Anticipated|Hoffmann-La Roche||1|||f||||f|t|f||||||||2017-10-10 20:57:46.415816|2017-10-10 20:57:46.415816
NCT03182491|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-14|||April 28, 2017|Actual|2017-04-28|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01|2 Days|Observational [Patient Registry]|ANAMEK||Mechanisms of Anaphylaxis|Mechanisms of Anaphylaxis|Recruiting||N/A|40|Anticipated|Haukeland University Hospital|||4||f|||||f|f||||Samples With DNA|"     Serum samples, plasma samples, full blood-samples   "|||2017-10-10 20:57:46.515441|2017-10-10 20:57:46.515441
NCT03182478|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-08|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Treating Skin Picking With Cognitive-Behavioral Protocol in Individual and Group Format.|Improving Skin Picking Treatment Using a Cognitive-Behavioral Protocol in Individual and Group Format: a Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:46.632583|2017-10-10 20:57:46.632583
NCT03182465|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-10-04|||October 4, 2017|Actual|2017-10-04|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|CALIF||Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia|Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia According to the MASCC Score: a Prospective, Monocentric Observational Study (CALIF)|Recruiting||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f|f|f||||||||2017-10-10 20:57:46.760232|2017-10-10 20:57:46.760232
NCT03182452|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-06-08|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (Europe)|Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (Europe)|Active, not recruiting||N/A|600|Anticipated|Philips Healthcare|||2||f|||||f|||||||No||2017-10-10 20:57:46.840391|2017-10-10 20:57:46.840391
NCT03182439|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-23|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Accuracy of Commercially Available Heart Rate Monitors III|Accuracy of Commercially Available Heart Rate Monitors in Cardiac Rehabilitation Patients: A Prospective, Randomized Study|Recruiting||N/A|80|Anticipated|The Cleveland Clinic||4|||f||||f|f|f||||||No||2017-10-10 20:57:46.902955|2017-10-10 20:57:46.902955
NCT03182426|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-07|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2021|Anticipated|2021-12-31|June 30, 2021|Anticipated|2021-06-30||Interventional|||Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)|Autologous Hematopoietic Stem Cell Mobilization (Plerixafor) and Immunologic Reset in New Onset Type 1 Diabetes Mellitus|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|University of Alberta||2|||f||||t|f|f|||f|||Undecided||2017-10-10 20:57:46.989894|2017-10-10 20:57:46.989894
NCT03182413|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||September 2015||2015-09-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation|Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects|Completed||Phase 1|20|Actual|Theranexus||5|||f||||t||||||||Undecided||2017-10-10 20:57:47.102216|2017-10-10 20:57:47.102216
NCT03182400|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-19|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|PROSCEA||Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults|Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults|Recruiting||N/A|450|Anticipated|University Hospital, Tours||1|||f||||f|f|f||||||Undecided||2017-10-10 20:57:47.192169|2017-10-10 20:57:47.192169
NCT03182387|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|July 15, 2019|Anticipated|2019-07-15|July 15, 2019|Anticipated|2019-07-15||Observational|KIDNAP||Key to Improve DiagNosis in Aspiration Pneumonia|Evaluation du Dosage de l'Amylase Dans le Liquide Broncho Alveolaire Dans le Diagnostic précoce de la Pneumopathie d'Inhalation Infectieuse du Sujet Comateux intubé-ventilé.|Not yet recruiting||N/A|60|Anticipated|University Hospital, Bordeaux|||1||f||||f|f|f||||Samples Without DNA|"     bronchoalveolar fluid.   "|No||2017-10-10 20:57:47.265528|2017-10-10 20:57:47.265528
NCT03182361|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-07|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Implant Survival and Peri-abutment Tissue Reactions of Extra-oral Implants: An Interventional Study of 10 Patients|Implant Survival and Peri-abutment Tissue Reactions of Extra-oral Implants: An Interventional Study of 10 Patients|Enrolling by invitation||N/A|10|Actual|University Hospital, Ghent||1|||f|||||f|f||||||||2017-10-10 20:57:47.425485|2017-10-10 20:57:47.425485
NCT03182348|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-06-08|||September 2012|Actual|2012-09-01|May 2017|2017-05-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|||Does OCT Imaging Allow us to See Blood Vessel Development in and Around Deposits of Fat and Calcium Inside Blood Vessels|Coronary Optical Coherence Tomography Correlation and Strain Mapping to Investigate Human Atherosclerosis: a Feasibility Study|Recruiting||N/A|30|Anticipated|University of Leicester|||1||f||||f|f|f||||||No||2017-10-10 20:57:47.51449|2017-10-10 20:57:47.51449
NCT03182335|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-13|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|||Vasopressor SAT Study|An Assessment of Vasoactive Medication Dose in Mechanically Ventilated Patients Undergoing Daily Sedation Awakening Trial (SAT)|Recruiting||N/A|24|Anticipated|University of Chicago|||1||f||||f|t|f|||f|||||2017-10-10 20:57:47.59466|2017-10-10 20:57:47.59466
NCT03182322|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-19|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||PINIT Study: Primary Intranasal Insulin Trial|An Immune Efficacy Study for Primary Prevention Using Intranasal Insulin Therapy in Islet Autoantibody Negative Children at High Genetic Risk for Type 1 Diabetes|Not yet recruiting||Phase 2|38|Anticipated|Technische Universität München||2|||f||||t|f|f||||||||2017-10-10 20:57:47.680112|2017-10-10 20:57:47.680112
NCT03182309|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|3 Years|Observational [Patient Registry]|||Registry for Chronic Obstructive Pulmonary Disease With Sleep Apnea Hypopnea Syndrome in China|The Prevalence, Disease Course, Prognosis and Interaction of Chronic Obstructive Pulmonary Disease With Sleep Apnea Hypopnea Syndrome|Recruiting||N/A|3502|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t|f|f||||Samples With DNA|"     Serum and blood cells   "|Undecided||2017-10-10 20:57:47.772831|2017-10-10 20:57:47.772831
NCT03182270|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-08|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in Cystic Tumors of the Pancreas|Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in Cystic Tumors of the Pancreas|Recruiting||N/A|40|Anticipated|Peking Union Medical College Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 20:57:48.104031|2017-10-10 20:57:48.104031
NCT03182257|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-21|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|ONTRK||Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors|An Open-label, Multi-center, Dose-escalation and Expansion Study to Evaluate the Safety and Efficacy of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|65|Anticipated|Ono Pharmaceutical Co. Ltd||2|||f||||f|t|f||||||||2017-10-10 20:57:48.205403|2017-10-10 20:57:48.205403
NCT03182231|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-15|||October 7, 2016|Actual|2016-10-07|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||GLP1-imaging Before and After Bariatric Surgery|Visualizing Beta Cells in Patients With T2D Before and After Bariatric Surgery|Recruiting||Phase 1/Phase 2|12|Anticipated|Radboud University||1|||f||||f|f|f||||||No||2017-10-10 20:57:48.51681|2017-10-10 20:57:48.51681
NCT03182218|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|RA-ACOD||Periprocedural Direct Oral Anticoagulant Management|Prospective Observational Study of the Direct Oral Anticoagulants Periprocedural Management|Recruiting||N/A|1100|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia|||1||f||||t|f|f||||||No|There is no plan to share individual participant data|2017-10-10 20:57:48.635906|2017-10-10 20:57:48.635906
NCT03182205|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-06|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 26, 2018|Anticipated|2018-06-26||Interventional|||Autonomic and Hemodynamic Responses to Inspiratory Muscle Exercise in Pre Hypertensive and Hypertensive Individuals|Autonomic and Hemodynamic Responses to Inspiratory Muscle Exercise in Pre Hypertensive and Hypertensive Individuals: a Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Federal University of Juiz de Fora||2|||f||||f|f|f||||||||2017-10-10 20:57:48.867015|2017-10-10 20:57:48.867015
NCT03182192|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-15|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||GLP1R-imaging in Hypoglycemia|Visualizing Beta Cells in Patients With Hyperinsulinemic Hypoglycemia After Bariatric Surgery|Recruiting||Phase 1|12|Anticipated|Radboud University||2|||f||||f|f|f||||||No||2017-10-10 20:57:48.990754|2017-10-10 20:57:48.990754
NCT03182179|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-08|||November 1, 2016|Actual|2016-11-01|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|Hodolar||Efficacy of Ondansetron in LARS Treatment|Efficacy of Ondansetron in the Treatment of Low Anterior Resection Syndrome (LARS): a Double Blind, Randomized, Placebo-controlled Study|Recruiting||N/A|46|Anticipated|Ente Ospedaliero Cantonale, Bellinzona||2|||f||||f|f|f||||||Undecided||2017-10-10 20:57:49.09465|2017-10-10 20:57:49.09465
NCT03182166|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 31, 2019|Anticipated|2019-01-31|August 31, 2018|Anticipated|2018-08-31||Interventional|GOLILOR||Golimumab in Ulcerative Colitis (UC) Patients With Secondary Loss of Response (LOR) to Maintenance Therapy Followed by Dose Optimization|Pharmacokinetic and Pharmacodynamic Study of Golimumab in Ulcerative Colitis (UC) Patients With Secondary Loss of Response (LOR) to Maintenance Therapy Followed by Dose Optimization|Not yet recruiting||Phase 2|80|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 20:57:49.186189|2017-10-10 20:57:49.186189
NCT03182153|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-08|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy|Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy|Recruiting||N/A|100|Anticipated|Atlantic Health System|||1||f||||f|f|t|f|f|t|||No||2017-10-10 20:57:49.301228|2017-10-10 20:57:49.301228
NCT03182127|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-09|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Role of MRI in Evaluation of Non-traumatic Causes of Painful Elbow|Role of Magnetic Resonance Imaging in Evaluation of Non-traumatic Causes of Painful Elbow Joint|Not yet recruiting||N/A|46|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:57:49.510872|2017-10-10 20:57:49.510872
NCT03182114|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-07|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 15, 2017|Anticipated|2017-09-15||Interventional|||Supine Versus Left Lateral Tilted Position During Cesarean Delivery|Hemodynamic Effects of Supine Position Versus Left Lateral Tilted Position During Cesarean Delivery: a Randomized Controlled Trial.|Recruiting||Phase 4|450|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 20:57:49.612377|2017-10-10 20:57:49.612377
NCT03182101|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-07|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|September 2020|Anticipated|2020-09-01||Interventional|||Quality Assessment in Exposure Therapy|Quality Assessment in Exposure Therapy|Not yet recruiting||N/A|300|Anticipated|Rhode Island Hospital||1|||f||||t|f|f||||||Yes|Twice yearly data sharing through NDCT|2017-10-10 20:57:49.724845|2017-10-10 20:57:49.724845
NCT03182088|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-09-07|||June 15, 2017|Actual|2017-06-15|September 2017|2017-09-01|October 1, 2017|Anticipated|2017-10-01|September 15, 2017|Anticipated|2017-09-15||Interventional|||Norepinephrine Infusion Different Doses in Cesarean Delivery|Norepinephrine Infusion for Prevention of Post-spinal Hypotension During Cesarean Delivery: A Randomized Controlled Dose Finding Trial.|Recruiting||Phase 4|255|Anticipated|Cairo University||3|||f||||t|f|f|||f|||||2017-10-10 20:57:49.806499|2017-10-10 20:57:49.806499
NCT03182062|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-07|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|iPROVE-OLV||Individualized Perioperative Open-Lung Ventilatory Strategy During One-Lung Ventilation|Postoperative Complication and Hospital Stay Reduction With a Individualized Perioperative Lung Protective Ventilation During One-lung Ventilation: A Prospective, Multicenter, Randomized Trial|Not yet recruiting||N/A|910|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:50.045085|2017-10-10 20:57:50.045085
NCT03182049|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-13|||October 2018|Anticipated|2018-10-01|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Observational|NoAAC PR-03||Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 Study|Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease: North American Airway Collaborative (NoAAC) PR-03 Study|Not yet recruiting||N/A|100|Anticipated|Vanderbilt University Medical Center|||1||f||||t|f|f||||Samples With DNA|"     We plan to obtain a small amount of blood at a time when other medically indicated labs,     operative or office-based procedures occur.      Excess tissue obtained at standard of care surgical biopsy will be preserved for molecular     study.   "|||2017-10-10 20:57:50.130181|2017-10-10 20:57:50.130181
NCT03182036|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-07|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Portable Oxygen Concentrator Signal Capture Study|Portable Oxygen Concentrator Signal Capture Study|Recruiting||N/A|20|Anticipated|ResMed||1|||f||||f|f|t|f|f|t|||No||2017-10-10 20:57:50.240519|2017-10-10 20:57:50.240519
NCT03182023|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-07-30|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||Long-term Outcome of Patients Treated With Extracorporeal Membrane Oxygenation|Outcomes and Long-term Quality-of-life of Patients Treated With Extracorporeal Membrane Oxygenation|Not yet recruiting||N/A|83|Anticipated|Southeast University, China|||1||f||||f|f|f|||f|||||2017-10-10 20:57:50.334049|2017-10-10 20:57:50.334049
NCT03182010|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-12|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Ultrasound Evaluation of Cesarean Scar After Uterotomy Closure With Barbed and Conventional Sutures|Ultrasound Evaluation of Cesarean Scar After Uterotomy Closure With Barbed and Conventional Sutures ; a Randomized Controlled Study|Not yet recruiting||N/A|110|Anticipated|Cairo University||2|||f||||t|f|f||||||No||2017-10-10 20:57:50.414197|2017-10-10 20:57:50.414197
NCT03181997|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-26|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01|2 Years|Observational [Patient Registry]|TOP-AS||Outcomes of Transcatheter Aortic Valve Implantation in Oncology Patients With Severe Aortic Stenosis|TOP-AS Registry: Transcatheter Aortic Valve Implantation in Oncology Patients With Severe Aortic Stenosis|Enrolling by invitation||N/A|168|Actual|Rabin Medical Center|||1||f||||f|f|t|f|f|f|||||2017-10-10 20:57:50.492165|2017-10-10 20:57:50.492165
NCT03181984|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-21|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain|Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain|Recruiting||Phase 4|1500|Anticipated|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||1|||f||||f|f|f||||||||2017-10-10 20:57:50.574746|2017-10-10 20:57:50.574746
NCT03181971|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-08|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||School Water Access, Food and Beverage Intake, and Obesity|The Impact of the School Water Access on Child Food and Beverage Intake and Obesity|Recruiting||N/A|1742|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||No||2017-10-10 20:57:50.655689|2017-10-10 20:57:50.655689
NCT03181945|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||May 1, 2016|Actual|2016-05-01|June 2017|2017-06-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome|Comparison of 4 Weeks Versus 12 Weeks Anti-convulsant Therapy for Acute Symptomatic Seizure in Children With Acute Encephalitis Syndrome- Open Label, Randomized Controlled Trial|Active, not recruiting||N/A|60|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t|f|f||||||Undecided||2017-10-10 20:57:50.877286|2017-10-10 20:57:50.877286
NCT03181932|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-25|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 15, 2019|Anticipated|2019-12-15|June 15, 2019|Anticipated|2019-06-15||Interventional|||A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients|A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients|Recruiting||Phase 3|200|Anticipated|Savara Inc.||2|||f||||t|t|f||||||||2017-10-10 20:57:50.939337|2017-10-10 20:57:50.939337
NCT03181906|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||March 11, 2016|Actual|2016-03-11|June 2017|2017-06-01|April 30, 2017|Actual|2017-04-30|February 28, 2017|Actual|2017-02-28||Interventional|||Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting|Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting- A Randomised Controlled Trial|Completed||N/A|200|Actual|National Healthcare Group, Singapore||2|||f|||||f|f||||||Undecided||2017-10-10 20:57:51.07872|2017-10-10 20:57:51.07872
NCT03181880|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-06-30|||December 4, 2017|Anticipated|2017-12-04|June 2017|2017-06-01|December 3, 2018|Anticipated|2018-12-03|December 3, 2018|Anticipated|2018-12-03||Interventional|ASTUTE||To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease|To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease|Withdrawn||Phase 4|0|Actual|AstraZeneca||2||"Study stopped early as AZ have re-prioritised to focus on research to help bring existing and   innovative medicines to more patients with asthma and COPD."|f||||f|f|f|||f|||||2017-10-10 20:57:51.264715|2017-10-10 20:57:51.264715
NCT03181867|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-08|2017-09-12|||August 3, 2017|Actual|2017-08-03|August 24, 2017|2017-08-24|October 1, 2020|Anticipated|2020-10-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer|(18)F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer|Recruiting||Phase 2|330|Anticipated|National Institutes of Health Clinical Center (CC)||2|||t|||||t|f||||||||2017-10-10 20:57:51.359643|2017-10-10 20:57:51.359643
NCT03181854|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Randomized Controlled Trial of Integrated Early Palliative Care|Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Cancer Patients|Not yet recruiting||N/A|232|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||||2017-10-10 20:57:51.439588|2017-10-10 20:57:51.439588
NCT03181841|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-08|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals|Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals: a Mono-center, Randomized, Placebo Controlled, Double-blind Study (Phase I)|Enrolling by invitation||Phase 1|120|Anticipated|University of Zurich||4|||f||||f|f|f||||||||2017-10-10 20:57:51.528392|2017-10-10 20:57:51.528392
NCT03181828|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-07|||March 24, 2017|Actual|2017-03-24|June 2017|2017-06-01|April 30, 2019|Anticipated|2019-04-30|March 31, 2019|Anticipated|2019-03-31||Interventional|||Manipulating the Gut Microbiome Study|Manipulating the Gut Microbiome Study|Recruiting||Phase 1/Phase 2|16|Anticipated|Children's Research Institute||2|||f||||f|t|f||||||||2017-10-10 20:57:51.59913|2017-10-10 20:57:51.59913
NCT03181815|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-09|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|May 1, 2019|Anticipated|2019-05-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia|Efficacy and Safety of Cladribine in Combination With G-CSF, Low-dose Cytarabine and Aclarubicin in Patients With Refractory/Relapsed Acute Myeloid Leukemia: a Phase 2 Clinical Trial|Recruiting||Phase 2|48|Anticipated|Sun Yat-sen University||1|||f||||f|f|f||||||Undecided||2017-10-10 20:57:51.67965|2017-10-10 20:57:51.67965
NCT03181802|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-08|||November 18, 2003|Actual|2003-11-18|May 2017|2017-05-01|May 8, 2005|Actual|2005-05-08|May 5, 2005|Actual|2005-05-05||Interventional|BoNT-A||Are Paraspinous Intramuscular Injections of Botulinum Toxin A (BoNT-A) Efficient in the Treatment of Chronic Low-back Pain (LBP)?|Are Paraspinous Intramuscular Injections of Botulinum Toxin A (BoNT-A) Efficient in the Treatment of Chronic Low-back Pain?|Completed||Phase 3|19|Actual|University Hospital, Bordeaux||2|||f||||f|f|f||||||No||2017-10-10 20:57:51.770756|2017-10-10 20:57:51.770756
NCT03181789|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|HVTN 119||Evaluating the Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA by Intramuscular Electroporation, in Healthy, HIV-Uninfected Adults|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA by Intramuscular Electroporation, in Healthy, HIV-Uninfected Adult Participants|Not yet recruiting||Phase 1|56|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t|t|t|f|||||||2017-10-10 20:57:51.849447|2017-10-10 20:57:51.849447
NCT03181776|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-28|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|October 15, 2017|Anticipated|2017-10-15|September 30, 2017|Anticipated|2017-09-30||Interventional|||Hemodynamic Effect of Left Tilting in Cesarean Delivery|Hemodynamic Effect of Three Randomized Angles of Left Tilting After Spinal Anesthesia for Cesarean Delivery|Recruiting||N/A|61|Anticipated|Cairo University||1|||f||||f|f|f||||||||2017-10-10 20:57:53.775354|2017-10-10 20:57:53.775354
NCT03181763|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-21|||September 21, 2017|Actual|2017-09-21|May 2017|2017-05-01|September 10, 2018|Anticipated|2018-09-10|August 10, 2018|Anticipated|2018-08-10||Interventional|||"Evaluation of MDMA on Starle Response"|Evaluation of 3,4-methylenedioxymethamphetamine (MDMA) on Startle Response|Recruiting||Phase 1|30|Anticipated|Multidisciplinary Association for Psychedelic Studies||2|||f||||f|t|f||||||||2017-10-10 20:57:53.912205|2017-10-10 20:57:53.912205
NCT03181750|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-12|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|May 2021|Anticipated|2021-05-01||Interventional|||Apoyo Con Carino: Patient Navigation for Palliative Care for Non-Cancer Illness|Apoyo Con Carino: (Support With Caring) Improving Palliative Care Outcomes for Latinos With Advanced Medical Illness|Recruiting||N/A|340|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||No||2017-10-10 20:57:54.045416|2017-10-10 20:57:54.045416
NCT03181555|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Pilot Study: Identification of a Multi-omic Predictive Signature for Preterm Birth in Obese African American Women|Pilot Study: Identification of a Multi-omic Predictive Signature for Preterm Birth in Obese African American Women|Completed||N/A|25|Actual|Baylor University||1|||f||||f||||||||||2017-10-10 20:57:55.664197|2017-10-10 20:57:55.664197
NCT03181737|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-03|||August 3, 2017|Actual|2017-08-03|June 2017|2017-06-01|April 1, 2019|Anticipated|2019-04-01|October 1, 2018|Anticipated|2018-10-01||Interventional|ONSIDE||Psychological Online-training to Optimize Adherence in Patients With Type-II Diabetes|Psychological Online-training to Optimize Adherence in Patients With Type-II Diabetes a Randomized Controlled Trial (ONSIDE-study)|Recruiting||N/A|300|Anticipated|Philipps University Marburg Medical Center||3|||f||||f|f|f||||||||2017-10-10 20:57:54.173443|2017-10-10 20:57:54.173443
NCT03181724|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||May 13, 2016|Actual|2016-05-13|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Effect of Review of a Decision Aid Prior to the Appointment on Decisional Conflict Compared to Usual Care in the Treatment of Trapeziometacarpal (TMC) Arthritis|A Randomized Trial Measuring the Effect of Review of a Decision Aid Prior to the Appointment on Decisional Conflict Compared to Usual Care in the Treatment of Trapeziometacarpal (TMC) Arthritis|Enrolling by invitation||N/A|110|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:57:54.277947|2017-10-10 20:57:54.277947
NCT03181711|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-07|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|Diagncamera||Is DIAGNOcam Comparable to Bitewing Radiographs as a Diagnostic Method for Approximal Caries in Primary Teeth?|A Comparison Between DIAGNOcam and Bitewing Radiographs as Diagnostic Methods for Approximal Caries in Primary Teeth.|Recruiting||N/A|50|Anticipated|Malmö University|||1||f||||f|f|f||||||No||2017-10-10 20:57:54.355382|2017-10-10 20:57:54.355382
NCT03181698|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-25|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Brain Morphometry in Bipolar Mania|Voxel-based Morphometric Study of Different Brain Structures in Patients With Mood Disorder Bipolar Mania|Recruiting||N/A|60|Anticipated|Assiut University|||3||f||||f|f|f||||||||2017-10-10 20:57:54.424606|2017-10-10 20:57:54.424606
NCT03181685|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-07|||December 20, 2016|Actual|2016-12-20|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles|Subcutaneous Versus Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles: Which is the Preference Expressed by the Patients?|Recruiting||Phase 4|60|Anticipated|Andros Day Surgery Clinic||2|||f|||||f|f|||f|||No||2017-10-10 20:57:54.506905|2017-10-10 20:57:54.506905
NCT03181672|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-07|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Stellate Ganglion Block on Tourniquet Response|Influence of Stellate Ganglion Block on Tourniquet Response in Lower Limbs.|Recruiting||N/A|100|Anticipated|The Affiliated Hospital of Xuzhou Medical University||2|||f||||t|f|f||||||No|IPD will be available when this trial is finished and the article have been published.|2017-10-10 20:57:54.615022|2017-10-10 20:57:54.615022
NCT03181659|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-02|||September 29, 2017|Anticipated|2017-09-29|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|June 29, 2018|Anticipated|2018-06-29||Interventional|||Therapeutic Exercise and Therapeutic Patient Education With or Without Manual Therapy for Chronic Nonspecific Low Back Pain.|Therapeutic Exercise and Therapeutic Patient Education With or Without Manual Therapy for Chronic Nonspecific Low Back Pain: a Randomized Control Trial.|Recruiting||N/A|60|Anticipated|Universidad Autonoma de Madrid||2|||f||||t|f|f||||||||2017-10-10 20:57:54.846318|2017-10-10 20:57:54.846318
NCT03181646|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-07|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|citicoline||Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy|Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy|Recruiting||Phase 3|50|Anticipated|Armed Forces Hospital, Pakistan||2|||f|||||f|f||||||||2017-10-10 20:57:54.980883|2017-10-10 20:57:54.980883
NCT03181633|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-29|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Long-term Treatment Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)|An Open-Label Study to Evaluate Efficacy and Safety of Long-term Treatment With ACH-0144471 in Patients Who Completed Clinical Study ACH471-100|Recruiting||Phase 2|12|Anticipated|Achillion Pharmaceuticals||1|||f|||||t|f|||t|||||2017-10-10 20:57:55.082667|2017-10-10 20:57:55.082667
NCT03181620|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-07|||September 8, 2016|Actual|2016-09-08|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|SATIRE||Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation|Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation (SATIRE Trial): A Prospective, Randomized Cohort Study|Recruiting||N/A|200|Anticipated|Abington Memorial Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:57:55.174224|2017-10-10 20:57:55.174224
NCT03181607|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-11|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|May 2022|Anticipated|2022-05-01|December 2018|Anticipated|2018-12-01||Observational|||Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV|The 3rd Affiliated Hospital, Guangzhou Medical University|Recruiting||N/A|800|Anticipated|The Third Affiliated Hospital of Guangzhou Medical University|||1||f|||||f|f||||||||2017-10-10 20:57:55.289952|2017-10-10 20:57:55.289952
NCT03181594|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||March 2, 2017|Actual|2017-03-02|June 2017|2017-06-01|July 31, 2018|Anticipated|2018-07-31|October 31, 2017|Anticipated|2017-10-31||Interventional|FROST||Evaluation of the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis|Clinical Evaluation of Safety and Efficacy for the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis|Recruiting||N/A|75|Anticipated|Arrinex, Inc.||1|||f|||||f|t|f|f|f|||||2017-10-10 20:57:55.365416|2017-10-10 20:57:55.365416
NCT03181581|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-08|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Improving Ultrasound Images in Brain Tumour Surgery With the Use of an Acoustic Coupling Fluid Mimicking Brain Tissue.|Improving Ultrasound Images in Brain Tumour Surgery With the Use of an Acoustic Coupling Fluid Mimicking Brain Tissue: a Phase II Technical and Safety Study|Recruiting||Phase 2|74|Anticipated|St. Olavs Hospital||4|||f||||t|f|f||||||||2017-10-10 20:57:55.463756|2017-10-10 20:57:55.463756
NCT03181568|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-07|||July 10, 2017|Anticipated|2017-07-10|June 2017|2017-06-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Interventional|||Evaluating Surface Area Reduction Using MolecuLight Imaging Device|A 12-week, Single-blind, Prospective, Randomized, Controlled, Pilot Clinical Trial to Evaluate Surface Area Reduction With Use of the MolecuLight i:X™ Imaging Device Compared to Standard Treatment of Chronic Wounds|Not yet recruiting||N/A|80|Anticipated|Bradford Teaching Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 20:57:55.575953|2017-10-10 20:57:55.575953
NCT03181542|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-01|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Infra Red Vein Visualization: Efficacy vs. Standard Technique|A Randomized Controlled Study of Efficacy of Infra Red Vein Illumination Versus Standard Technique|Recruiting||N/A|139|Anticipated|Milton S. Hershey Medical Center||2|||f||||f|f|t|f|f|t|||||2017-10-10 20:57:55.729687|2017-10-10 20:57:55.729687
NCT03181529|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-08-15|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|October 2018|Anticipated|2018-10-01||Interventional|||Effects of Psilocybin in Major Depressive Disorder|Effects of Psilocybin in Major Depressive Disorder|Recruiting||Phase 2|24|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||||2017-10-10 20:57:55.817052|2017-10-10 20:57:55.817052
NCT03181516|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|January 2022|Anticipated|2022-01-01|August 2021|Anticipated|2021-08-01||Interventional|PLAY ON||Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics|Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics|Not yet recruiting||Phase 2|300|Anticipated|Georgetown University||2|||f||||t|t|f||||||No||2017-10-10 20:57:55.893238|2017-10-10 20:57:55.893238
NCT03181503|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||August 28, 2017|Anticipated|2017-08-28|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|June 4, 2018|Anticipated|2018-06-04||Interventional|||Safety and Efficacy of Nemolizumab in PN|A Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis (PN)|Not yet recruiting||Phase 2|100|Anticipated|Galderma R&D||2|||||||f|t|f||||||No||2017-10-10 20:57:55.954334|2017-10-10 20:57:55.954334
NCT03181490|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|||Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules|Targeted High-throughput DNA Methylation Sequencing of Circulating Tumor DNA to Differentiate Benign and Malignant Pulmonary Nodules|Not yet recruiting||N/A|1230|Anticipated|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||t|f|f||||Samples With DNA|"     whole blood   "|||2017-10-10 20:57:56.009601|2017-10-10 20:57:56.009601
NCT03181477|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-09|||April 7, 2017|Actual|2017-04-07|March 2017|2017-03-01|December 7, 2021|Anticipated|2021-12-07|April 7, 2019|Anticipated|2019-04-07||Interventional|Glio-SIB-Up||Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas|Multicenter Phase II Study Evaluating the Efficacy of Radiotherapy With Modulation Intensity and Integrated Boost (SIB-IMRT) at the Dose of 80Gy, Associated With Chemotherapy by Temozolomide in the Treatment of Adult Glioblastomas|Recruiting||N/A|67|Anticipated|Centre Georges Francois Leclerc||1|||f||||f|f|f||||||No||2017-10-10 20:57:56.081449|2017-10-10 20:57:56.081449
NCT03181464|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-26|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|SNoB||Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics|Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics|Recruiting||Phase 4|50|Anticipated|Washington University School of Medicine||2|||f||||f|t|f|||f|||||2017-10-10 20:57:56.170723|2017-10-10 20:57:56.170723
NCT03181451|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-07|||March 14, 2017|Actual|2017-03-14|June 2017|2017-06-01|December 28, 2017|Anticipated|2017-12-28|September 28, 2017|Anticipated|2017-09-28||Interventional|||Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency|A Phase 1, Open-Label, Randomised, Repeat Dose, Parallel Group Study to Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects Aged 10-17 Years of Age With Iron Deficiency|Recruiting||Phase 1|36|Anticipated|Shield Therapeutics||3|||f||||f|f|f||||||No||2017-10-10 20:57:56.260233|2017-10-10 20:57:56.260233
NCT03181438|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-07|||June 3, 2017|Actual|2017-06-03|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy Transverse Abdominal Plane (TAP) Block Renal Transplant Surgery|Efficacy of Ultrasound-guided Transverse Abdominal Plane Block for Analgesia in Renal Transplantation|Recruiting||N/A|42|Anticipated|Federal University of São Paulo||2|||f|||||f|f||||||No||2017-10-10 20:57:56.499762|2017-10-10 20:57:56.499762
NCT03181425|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-04|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Observational|TRACTILAGE||Magnetic Resonance Imaging Diffusion Tensor Tractography for Early Osteoarthritis Assessment|Evaluation of Magnetic Resonance Imaging Diffusion Tensor and Knee Cartilage Tractography Reconstructions for the Study of Early Osteoarthritis|Completed||N/A|8|Actual|University Hospital, Grenoble|||1||f||||f|f|f||||||||2017-10-10 20:57:56.601269|2017-10-10 20:57:56.601269
NCT03181412|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|SCENE||Stroke Cincinnati Prehospital Stroke Severity Scale Evaluation iN prEhospital|Evaluation of the Performances of the Cincinnati Prehospital Stroke Severity Scale Realized During Telephone Call With Emergency Department Physicians to Predict Large-vessel Occlusion|Not yet recruiting||N/A|1220|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 20:57:56.677585|2017-10-10 20:57:56.677585
NCT03181399|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-06|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)|Dietary Treatment of Glucose Transporter Type 1 Deficiency (G1D)|Not yet recruiting||Phase 2|45|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t|t|f||||||No||2017-10-10 20:57:56.756786|2017-10-10 20:57:56.756786
NCT03181386|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|April 30, 2021|Anticipated|2021-04-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants|Prospective Study of the Assessment of the Dental Protocol for Tooth Extraction in Patients With Atrial Fibrillation in Continuous Use of New Oral Anticoagulants: A Pilot Study|Recruiting||N/A|60|Anticipated|University of Sao Paulo General Hospital||3|||f||||t|f|f||||||Yes|After thesis defense, the IPD will be available on the Portal Digital Library of Theses and Dissertations of the University of São Paulo (http://www.teses.usp.br/index.php?option=com_jumi&fileid=12&Itemid=77&lang=ptbr), in a PDF file.|2017-10-10 20:57:56.853183|2017-10-10 20:57:56.853183
NCT03181373|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-07|||September 26, 2014|Actual|2014-09-26|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||IRM Cognition in Patients With Head Trauma|Longitudinal Descriptive Study of the Correlation Between Cognitive Functions, White Matter Anatomical Pathways and Functional Magnetic Resonance Imaging Activations in Patients With Moderate to Severe Head Trauma.|Active, not recruiting||N/A|20|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 20:57:56.973801|2017-10-10 20:57:56.973801
NCT03181360|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-14|||June 12, 2017|Actual|2017-06-12|April 2017|2017-04-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|TWIST||Tenecteplase in Wake-up Ischaemic Stroke Trial|Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST). A Randomised-controlled Trial of Thrombolytic Treatment With Tenecteplase for Acute Ischaemic Stroke Upon Awakening|Recruiting||Phase 3|500|Anticipated|University Hospital of North Norway||2|||f||||t|f|f||||||||2017-10-10 20:57:57.070434|2017-10-10 20:57:57.070434
NCT03181347|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-06|||July 3, 2017|Anticipated|2017-07-03|June 2017|2017-06-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|||The Microbiology of Bariatric Surgery|The Microbiology of Bariatric Surgery|Not yet recruiting||N/A|90|Anticipated|University of Alberta||3|||f|||||f|f||||||||2017-10-10 20:57:57.343452|2017-10-10 20:57:57.343452
NCT03181334|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-28|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|C-SPAN||The C-SPAN Coalition: Colorectal Cancer Screening and Navigation|The C-SPAN Coalition: Colorectal Cancer Screening and Navigation|Enrolling by invitation||N/A|165000|Anticipated|University of Texas Southwestern Medical Center||5|||f||||f|f|f||||||||2017-10-10 20:57:57.44852|2017-10-10 20:57:57.44852
NCT03181321|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-07|||November 1, 2014|Actual|2014-11-01|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|June 1, 2017|Actual|2017-06-01||Interventional|||The First Twenty for Volunteer Firefighters|The First Twenty for Volunteer Firefighters|Active, not recruiting||N/A|419|Actual|The University of Texas Health Science Center, Houston||2|||f|||||f|f||||||No||2017-10-10 20:57:57.549392|2017-10-10 20:57:57.549392
NCT03181295|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-06|||February 21, 2017|Actual|2017-02-21|June 2017|2017-06-01|February 2, 2018|Anticipated|2018-02-02|February 2, 2018|Anticipated|2018-02-02||Interventional|SWYW||Screening While You Wait: An Intervention to Facilitate Exercise in Primary Care|Screening While You Wait: A Technology-based Intervention to Facilitate Actionable Exercise Prescriptions in Primary Care|Recruiting||N/A|500|Anticipated|Women's College Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:57:57.719465|2017-10-10 20:57:57.719465
NCT03181282|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-06|||June 22, 2017|Anticipated|2017-06-22|June 2017|2017-06-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|PTDBS||Physical Therapy and Deep Brain Stimulation in Parkinson Disease|Physical Therapy and Deep Brain Stimulation in Parkinson Disease|Recruiting||Phase 1|34|Anticipated|Washington University School of Medicine||2|||f||||t|f|f||||||No||2017-10-10 20:57:57.826244|2017-10-10 20:57:57.826244
NCT03181269|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-22|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Human Milk and Infant Intestinal Microbiome Study|Human Milk and Infant Intestinal Microbiome Study|Recruiting||N/A|88|Anticipated|University of Virginia||2|||f||||f|f|f||||||||2017-10-10 20:57:57.925919|2017-10-10 20:57:57.925919
NCT03181256|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 30, 2027|Anticipated|2027-07-30|July 30, 2026|Anticipated|2026-07-30||Observational|||Early Detection of Lung Cancer|Early Detection of Lung Cancer in the Medically Underserved Population|Not yet recruiting||N/A|154|Anticipated|Vanderbilt-Ingram Cancer Center|||1||f||||t|f|f||||Samples With DNA|"     Sputum, nasal epithelium, buccal epithelium, blood, urine   "|||2017-10-10 20:57:58.033296|2017-10-10 20:57:58.033296
NCT03181230|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-10-04|||May 26, 2017|Actual|2017-05-26|October 2017|2017-10-01|June 30, 2022|Anticipated|2022-06-30|May 31, 2018|Anticipated|2018-05-31||Observational|||Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome|Pilot Study of Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome|Recruiting||N/A|60|Anticipated|University of Colorado, Denver|||2||f||||f|f|f||||Samples Without DNA|"     Blood (serum and plasma)   "|||2017-10-10 20:57:58.237525|2017-10-10 20:57:58.237525
NCT03181217|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||January 28, 2013|Actual|2013-01-28|June 2017|2017-06-01|May 23, 2013|Actual|2013-05-23|May 23, 2013|Actual|2013-05-23||Interventional|COLD||Functional Magnetic Resonance Imaging of Human Hypothalamic Responses to Oral Temperature and Glucose Sensing|Functional Magnetic Resonance Imaging of Human Hypothalamic Responses to Oral Temperature and Glucose Sensing|Completed||N/A|16|Actual|Unilever R&D||4|||f||||f|f|f||||||No||2017-10-10 20:57:58.347557|2017-10-10 20:57:58.347557
NCT03181204|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|June 15, 2018|Anticipated|2018-06-15|June 15, 2018|Anticipated|2018-06-15||Observational|INVECCO||Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS|Modeling Bronchial Epithelia Modifications Associated With Chronic Obstructive Pulmonary Disease (COPD) Using Induced Pluripotent Stemcells (iPS)|Not yet recruiting||N/A|16|Anticipated|University Hospital, Montpellier|||2||f||||f|f|f||||Samples Without DNA|"     This study will general cell cultures.   "|||2017-10-10 20:57:58.463849|2017-10-10 20:57:58.463849
NCT03181191|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-09|||April 27, 2017|Actual|2017-04-27|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion|The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion|Recruiting||N/A|24|Anticipated|University Hospital, Gentofte, Copenhagen||3|||f||||t|f|f||||||No||2017-10-10 20:57:58.586075|2017-10-10 20:57:58.586075
NCT03181178|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-07|||February 2013|Actual|2013-02-01|June 2017|2017-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TRIUMF||Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants|Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants (6 to 18 Months)|Completed||N/A|1204|Actual|Nevin Scrimshaw International Nutrition Foundation||4|||f||||t|f|f||||||No|There is no plan to share individual participant data to other researchers|2017-10-10 20:57:58.706815|2017-10-10 20:57:58.706815
NCT03181165|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-01|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Pharmacist-led Therapeutic Nutritional Intervention in Type 2 Diabetes|Impact of a Pharmacist-led Therapeutic Nutritional Intervention on Medications and Glucose Control in Type 2 Diabetes|Recruiting||N/A|200|Anticipated|University of British Columbia||2|||f||||t|f|f||||||||2017-10-10 20:57:58.85286|2017-10-10 20:57:58.85286
NCT03181152|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-06|||June 10, 2017|Anticipated|2017-06-10|March 2017|2017-03-01|October 30, 2018|Anticipated|2018-10-30|August 30, 2018|Anticipated|2018-08-30||Observational|||The Application of Impulse Oscillometry on the Diagnosis of ACOS,Asthma and COPD.|The Application of Impulse Oscillometry on the Differential Diagnosis of ACOS,Asthma and COPD.|Recruiting||N/A|100|Anticipated|Shengjing Hospital|||3||f|||||f|f||||||No||2017-10-10 20:57:58.981863|2017-10-10 20:57:58.981863
NCT03181139|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-06|||July 1, 2013|Actual|2013-07-01|June 2017|2017-06-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Observational|ERAS_Breast||Efficacy of Enhanced Recovery After Surgery Pathway for Total Mastectomy|Efficacy of Enhanced Recovery After Surgery Pathway for Total Mastectomy|Completed||N/A|386|Actual|University of California, San Francisco|||2||f||||f|f|f||||||No||2017-10-10 20:57:59.110572|2017-10-10 20:57:59.110572
NCT03181126|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-31|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|April 12, 2020|Anticipated|2020-04-12|March 7, 2020|Anticipated|2020-03-07||Interventional|||A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed Acute Lymphoblastic Leukemia|A Phase 1 Dose Escalation, Open-Label Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed Acute Lymphoblastic Leukemia|Not yet recruiting||Phase 1|42|Anticipated|AbbVie||1|||f||||f|t|f||||||||2017-10-10 20:57:59.381381|2017-10-10 20:57:59.381381
NCT03181113|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-07|||May 18, 2016|Actual|2016-05-18|June 2017|2017-06-01|January 30, 2020|Anticipated|2020-01-30|January 30, 2020|Anticipated|2020-01-30||Observational|||Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy|A Multi-center, Prospective Study to Acess Long-term Benefit in HBeAg Positive Chronic Hepatitis B Patients Who Previously Received Standard Peginterferon Alfa Therapy|Recruiting||N/A|775|Anticipated|Xiamen Amoytop Biotech Co., Ltd.|||2||f||||f|f|f||||Samples With DNA|"     plasma, hemocyte   "|No||2017-10-10 20:57:59.552542|2017-10-10 20:57:59.552542
NCT03181100|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-10-05|||July 27, 2017|Actual|2017-07-27|October 2017|2017-10-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|||Atezolizumab Combinations With Chemotherapy for Anaplastic and Poorly Differentiated Thyroid Carcinomas|Atezolizumab Combinations With Chemotherapy for Anaplastic and Poorly Differentiated Thyroid Carcinomas|Recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||5|||f|||||t|f||||||||2017-10-10 20:57:59.856834|2017-10-10 20:57:59.856834
NCT03181087|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-06-07|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|January 31, 2018|Anticipated|2018-01-31||Interventional|||Safety of Umbilical Cord Mesenchyme Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars|A Phase I, Single-arm, Open Study of the Safety of Umbilical Cord Mesenchyme Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars|Recruiting||Phase 1|10|Anticipated|Maternal and Child Health Hospital of Foshan||1|||f||||t|f|f||||||Undecided||2017-10-10 20:58:00.113406|2017-10-10 20:58:00.113406
NCT03181074|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-07|2017-10-03|||October 21, 2015|Actual|2015-10-21|October 2017|2017-10-01|April 11, 2019|Anticipated|2019-04-11|April 11, 2019|Anticipated|2019-04-11||Observational|||Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults|Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults|Recruiting||N/A|10|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 20:58:00.26509|2017-10-10 20:58:00.26509
NCT03181061|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-06|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Observational|FAB||Determinants of Success, Characterizing the Facilitators of Integrated Abortion Provision|Determinants of Success, Characterizing the Facilitators of Integrated Abortion Provision|Enrolling by invitation||N/A|40|Anticipated|University of New Mexico|||1||f||||f|f|f||||||No||2017-10-10 20:58:00.403138|2017-10-10 20:58:00.403138
NCT03181048|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-28|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Clinical Trial of Concomitant Hip Arthroscopy During PAO|Single-Blind Randomized Clinical Trial of Concomitant Hip Arthroscopy During Periacetabular Osteotomy for the Management of Hip Dysplasia|Recruiting||N/A|106|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 20:58:00.46778|2017-10-10 20:58:00.46778
NCT03181035|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|FAITH||Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer|Defining a Personalized Hypoxic Radiation Target Through Correlation of Functional F18-FAZA PET Imaging to Pimonidazole-stained 3D Whole-mounted Histological Specimen|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f|f|f||||||||2017-10-10 20:58:00.590406|2017-10-10 20:58:00.590406
NCT03181022|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-07|||December 8, 2015|Actual|2015-12-08|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|TMI Project||The Tailored-Motivational Interviewing Project|Development of an MI Implementation Intervention in Adolescent HIV Care Settings|Active, not recruiting||N/A|110|Anticipated|Wayne State University||4|||f|||||f|f||||||||2017-10-10 20:58:00.691637|2017-10-10 20:58:00.691637
NCT03181009|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-17|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 1, 2018|Anticipated|2018-07-01||Interventional|||Multi OIT to Test Immune Markers After Minimum Maintenance Dose|A Phase 2 Study Multi Oral Immunotherapy in Multi Food Allergic Patients to Test Immune Markers After Minimum Maintenance Dose|Recruiting||Phase 2|60|Anticipated|Stanford University||2|||f||||t|t|f||||||||2017-10-10 20:58:00.779937|2017-10-10 20:58:00.779937
NCT03177967|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-12|||April 24, 2017|Actual|2017-04-24|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|Stå Opp||"Get up - The Sleep Study in Oppegard"|"Get up - The Sleep Study in Oppegard (Stå Opp - Søvnstudien i Oppegård)"|Active, not recruiting||N/A|38|Actual|Norwegian Institute of Public Health||3|||f||||f|f|f||||||No||2017-10-10 20:58:25.350866|2017-10-10 20:58:25.350866
NCT03180983|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-25|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|February 28, 2019|Anticipated|2019-02-28|December 31, 2018|Anticipated|2018-12-31||Interventional|||Antibiotic Use in French Nursing Home|Effect of a Nurse-centered Multimodal Intervention on Prescribing Antibiotics in Nursing Home: A Randomized Cluster Study|Not yet recruiting||N/A|40|Anticipated|University of Paris 13||2|||f||||f|f|f||||||||2017-10-10 20:58:00.992868|2017-10-10 20:58:00.992868
NCT03180970|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-07|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Different Lugol's Solution Concentration for Image Quality of Esophageal Lesions in Chromoendoscopy With Iodine Staining|Different Lugol's Solution Concentration for Image Quality of Early Esophageal Squamous Neoplasia in Chromoendoscopy With Iodine Staining|Not yet recruiting||Phase 4|50|Anticipated|Shandong University||5|||f||||t|f|f||||||||2017-10-10 20:58:01.093897|2017-10-10 20:58:01.093897
NCT03180957|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-07|||March 2, 2016|Actual|2016-03-02|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|RIDD||Repurposing Anti-TNF for Treating Dupuytren's Disease|A Multi-centre, Double Blind, Randomised, Placebo-controlled, Parallel Group, Phase II Trial to Determine the Efficacy of Intra-nodular Injection of Anti-TNF to Control Disease Progression in Early Dupuytren's Disease, With a Dose Response.|Recruiting||Phase 2|178|Anticipated|University of Oxford||2|||f||||t|f|f||||||No||2017-10-10 20:58:01.211934|2017-10-10 20:58:01.211934
NCT03180944|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-06|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lower Lugol's Solution Concentration on Reducing the Adverse Symptoms of Chromoendoscopy With Iodine Staining|Lower Lugol's Solution Concentration on Reducing the Adverse Symptoms of Chromoendoscopy With Iodine Staining|Not yet recruiting||Phase 2|200|Anticipated|Shandong University||5|||f||||t|f|f||||||||2017-10-10 20:58:01.32801|2017-10-10 20:58:01.32801
NCT03180931|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-07|||December 2, 2016|Actual|2016-12-02|June 2017|2017-06-01|August 31, 2017|Anticipated|2017-08-31|May 31, 2017|Actual|2017-05-31|1 Day|Observational [Patient Registry]|INVEST||Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis|Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography: Insights From the International INVEST Registry|Active, not recruiting||N/A|36|Anticipated|University Hospital Inselspital, Berne|||1||f||||f|f|t|f||f|||No||2017-10-10 20:58:01.436062|2017-10-10 20:58:01.436062
NCT03180918|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-07|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|January 2100|Anticipated|2100-01-01|January 2100|Anticipated|2100-01-01||Interventional|||Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment|Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment|Recruiting||N/A|100|Anticipated|University Hospital, Geneva||1|||f||||f|f|f||||||||2017-10-10 20:58:01.552804|2017-10-10 20:58:01.552804
NCT03180905|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||ImPACT Normative Extension|ImPACT Normative Extension|Recruiting||N/A|800|Anticipated|ImPACT Applications, Inc.||2|||f||||f|f|t|f|f|f|||No||2017-10-10 20:58:01.622471|2017-10-10 20:58:01.622471
NCT03180892|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||January 1, 2013|Actual|2013-01-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|1 Year|Observational [Patient Registry]|||Non-immune Related Hypothyroidism in Iodine Sufficient Area|Non-immune Related Hypothyroidism in Iodine Sufficient Area|Completed||N/A|6564|Actual|Samsung Medical Center|||1||f||||f|f|f||||||Yes|This data is national data of Korea. It is already possible to use the data freely only for the purpose of academic research and the like.|2017-10-10 20:58:01.694145|2017-10-10 20:58:01.694145
NCT03180879|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-10-04|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Interventional|||Ibuprofen Bioavailability Study|An Open Label, Randomised, Single Dose, Three-way Crossover Study to Compare the Bioavailability of 400 mg Ibuprofen From 2 x 200 mg Ibuprofen Acid Orodispersable Tablets, 2x 200 mg Ibuprofen Acid Tablets and 2 x 342 mg Ibuprofen Lysine Tablets in Fasted Healthy Volunteers|Completed||Phase 1|36|Actual|Reckitt Benckiser Healthcare (UK) Limited||6|||f||||f|f|f||||||||2017-10-10 20:58:01.749702|2017-10-10 20:58:01.749702
NCT03180866|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-07|||December 2016||2016-12-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis|Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis|Recruiting||N/A|32|Anticipated|Illumicure Inc||2|||f||||t||||||||No||2017-10-10 20:58:01.856234|2017-10-10 20:58:01.856234
NCT03180853|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||May 5, 2017|Actual|2017-05-05|June 2017|2017-06-01|April 25, 2022|Anticipated|2022-04-25|April 21, 2022|Anticipated|2022-04-21||Observational|||Multiple Myeloma Patient Registry|Multiple Myeloma Patient Registry|Recruiting||N/A|1000|Anticipated|Janssen Scientific Affairs, LLC|||1||f||||f|f|f|||t|||||2017-10-10 20:58:01.961049|2017-10-10 20:58:01.961049
NCT03180840|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-07|||December 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|BRIGHT||Study of the Safety, Efficacy, & PK of Pegunigalsidase Alfa (PRX-102) 2 mg/kg IV Administered Every 4 Weeks in Fabry Disease Patients|Phase 3, Open-Label, Switch Over Study to Assess Safety, Efficacy & PK of Pegunigalsidase Alfa 2 mg/kg Administered Every 4 Weeks for 52 Weeks in Fabry Disease Patients Currently Treated With Enzyme Replacement Therapy: Fabrazyme® (Agalsidase Beta) or Replagal™ (Agalsidase Alfa)|Not yet recruiting||Phase 3|30|Anticipated|Protalix||1|||f||||t|t|f||||||Undecided||2017-10-10 20:58:02.035897|2017-10-10 20:58:02.035897
NCT03180827|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-07|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|January 2100|Anticipated|2100-01-01|January 2100|Anticipated|2100-01-01||Interventional|||Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment|Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment|Recruiting||N/A|100|Anticipated|University Hospital, Geneva||1|||f||||f|f|f||||||||2017-10-10 20:58:02.165719|2017-10-10 20:58:02.165719
NCT03180814|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-06-06|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Whole Body Vibration on Autonomic Function in Healthy Young and Elderly|Acute Effects of Whole Body Vibration on Autonomic Function in Healthy Young and Elderly|Not yet recruiting||N/A|40|Anticipated|Universidade Federal de Pernambuco||2|||f||||f|f|f||||||No||2017-10-10 20:58:02.229691|2017-10-10 20:58:02.229691
NCT03180801|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-06|||August 18, 2016|Actual|2016-08-18|June 2017|2017-06-01|May 25, 2017|Actual|2017-05-25|March 31, 2017|Actual|2017-03-31||Interventional|||Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model|Phase IIb Study of the Efficacy of FLU-v, a Broad Spectrum Influenza Vaccine in an H1N1 Influenza Healthy Human Challenge Model|Completed||Phase 2|123|Actual|PepTcell Limited||3|||f||||f|f|f||||||No||2017-10-10 20:58:02.305123|2017-10-10 20:58:02.305123
NCT03180788|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-11|||July 1, 2017|Actual|2017-07-01|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|December 20, 2017|Anticipated|2017-12-20||Interventional|ESD||The Impact of Traction Assisted ESD on Procedural Time and Outcome|The Impact of Traction Assisted ESD on Procedural Time, En Bloc Resection, Curative Resection and Complication Incidence|Recruiting||N/A|60|Anticipated|Region Skane||2|||f||||f|f|f||||||||2017-10-10 20:58:02.397813|2017-10-10 20:58:02.397813
NCT03180775|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-07|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|May 1, 2018|Anticipated|2018-05-01|December 15, 2017|Anticipated|2017-12-15||Interventional|||Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity|Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity|Not yet recruiting||N/A|110|Anticipated|Rambam Health Care Campus||11|||f||||t|f|f||||||Undecided||2017-10-10 20:58:02.471389|2017-10-10 20:58:02.471389
NCT03180762|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-22|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|November 13, 2017|Anticipated|2017-11-13|November 13, 2017|Anticipated|2017-11-13||Interventional|||A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healthy Participants|A 3-Part, Randomized, Placebo-controlled, Double-blind, Single Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healthy Subjects|Suspended||Phase 1|70|Anticipated|Janssen Research & Development, LLC||8||"Trial on hold: A SAE has occured. As a measure of precaution, the dosing of JNJ-64140284 has   been suspended for all subjects participating in the trial."|f||||f|f|f||||||||2017-10-10 20:58:02.588568|2017-10-10 20:58:02.588568
NCT03180749|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||March 2, 2017|Actual|2017-03-02|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Observational|PMCFU||Post-Marketing Clinical Follow-Up of a Spine Implant|Post-Marketing Clinical Follow-up of an Anular Closure System (Barricaid®) to Confirm Comparability of Outcome Between Devices With Subcomponents From Two Different Suppliers|Recruiting||N/A|250|Anticipated|Intrinsic Therapeutics|||1||f||||t|f|f||||||Undecided||2017-10-10 20:58:02.808878|2017-10-10 20:58:02.808878
NCT03180736|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-28|||June 10, 2017|Actual|2017-06-10|June 2017|2017-06-01|July 1, 2023|Anticipated|2023-07-01|June 1, 2021|Anticipated|2021-06-01||Interventional|EMN14||Compare Progression Free Survival Btw Daratumumab/Pomalidomide/Dexamethasone vs Pomalidomide/Dexamethasone|Phase 3 Study Comparing Pomalidomide and Dexamethasone w/Without Daratumumab in Subjects With Relapsed or Refractory MM Who Received at Least One Prior Line of Therapy With Both Lenalidomide and a Proteasome Inhibitor.|Recruiting||Phase 3|302|Anticipated|European Myeloma Network||2|||f||||t|f|f|||f|||No||2017-10-10 20:58:02.890515|2017-10-10 20:58:02.890515
NCT03180723|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-15|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis|Effect of Rituximab in Treatment of Primary Membranoproliferative Glomerulonephritis|Not yet recruiting||Phase 3|30|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 20:58:02.987164|2017-10-10 20:58:02.987164
NCT03180710|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-07|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes|A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes|Recruiting||Phase 1|32|Anticipated|Adocia||4|||f||||f|f|f||||||No||2017-10-10 20:58:03.099086|2017-10-10 20:58:03.099086
NCT03180697|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-06|||June 3, 2017|Actual|2017-06-03|May 2017|2017-05-01|October 1, 2021|Anticipated|2021-10-01|September 30, 2021|Anticipated|2021-09-30||Observational|APT||The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas|Clinical Study on the Efficacy of Amide Proton Transfer Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas|Recruiting||N/A|100|Anticipated|Zhujiang Hospital|||1||f||||t|f|f|||f|Samples With DNA|"     Biospecimen obtained by sugery or biopsy should be retained and test by pathology   "|No||2017-10-10 20:58:03.258384|2017-10-10 20:58:03.258384
NCT03180684|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-28|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||VGX-3100 Followed by Electroporation Alone or in Combination With Imiquimod for the Treatment of Human Papilloma Virus HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva|A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA® 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva|Recruiting||Phase 2|36|Anticipated|Inovio Pharmaceuticals||2|||f||||t|t|f||||||||2017-10-10 20:58:03.349664|2017-10-10 20:58:03.349664
NCT03180671|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-06|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|May 1, 2019|Anticipated|2019-05-01|January 1, 2019|Anticipated|2019-01-01||Interventional|Deprogrammer||Anterior Deprogrammers for Reducing Pain and Masticatory Muscles Tension|The Effectiveness of Anterior Deprogrammers as a Tool for Reducing Pain and Masticatory Muscles Tension|Recruiting||N/A|80|Anticipated|Wroclaw Medical University||4|||f||||t|f|t|f|f|t|||No||2017-10-10 20:58:03.493843|2017-10-10 20:58:03.493843
NCT03180658|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-07|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|July 1, 2020|Anticipated|2020-07-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Concentrated Growth Factors in Regenerative Therapy in Furcation Involvements in Humans|The Effect of Concentrated Growth Factors in Regenerative Therapy in Furcation Involvements in Humans|Recruiting||N/A|30|Anticipated|Peking University||2|||f||||t|f|f||||||No||2017-10-10 20:58:03.592273|2017-10-10 20:58:03.592273
NCT03180645|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||March 20, 2017|Actual|2017-03-20|June 2017|2017-06-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|||Proof of Concept Anti-ageing Clinical Study in Healthy Subjects|A Proof of Concept (POC) Clinical Study to Evaluate the Appearance of Fine Lines and Wrinkles on a Developmental Cosmetic Moisturising Cream in Healthy Subjects Presenting Visible Signs of Ageing|Completed||N/A|86|Actual|GlaxoSmithKline||3|||f||||f|f|f||||||No||2017-10-10 20:58:03.679751|2017-10-10 20:58:03.679751
NCT03180632|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-06|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|Endo-Lora||Effect of A Single Dose of Lorazepam on Salivary Cortisol Response in Children Undergoing Digestive Endoscopy:|Effect of A Single Dose of Lorazepam on Salivary Cortisol Response in Children Undergoing Digestive Endoscopy: a Randomized Double Blinded Study|Not yet recruiting||Phase 2|96|Anticipated|St. Justine's Hospital||3|||f||||t|f|f|||f|||No||2017-10-10 20:58:03.77148|2017-10-10 20:58:03.77148
NCT03180619|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-27|||June 29, 2017|Actual|2017-06-29|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|April 2019|Anticipated|2019-04-01||Interventional|||Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)|A Phase 2, Open-label Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) in Virologically Suppressed Chronic Hepatitis B Subjects With Renal and/or Hepatic Impairment|Recruiting||Phase 2|120|Anticipated|Gilead Sciences||1|||f||||t|t|f||||||||2017-10-10 20:58:03.861197|2017-10-10 20:58:03.861197
NCT03180606|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-27|||September 27, 2017|Actual|2017-09-27|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Enhanced Primary Care for Elderly|Enhanced Primary Care for Elderly: A Multicenter Pragmatic Clinical Trial Where Older People With Great Needs Are Predicted and Given Personalized Primary Care|Recruiting||N/A|1600|Anticipated|Region Östergötland|||2||f||||f|f|f||||||||2017-10-10 20:58:03.989149|2017-10-10 20:58:03.989149
NCT03180593|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||February 7, 2017|Actual|2017-02-07|June 2017|2017-06-01|September 7, 2017|Anticipated|2017-09-07|August 7, 2017|Anticipated|2017-08-07||Interventional|BVreduce||Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH|A Prospective, Randomized, Open-Label, 13 to 14-week Study of the Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Subjects With Left Ventricular Hypertrophy (LVH)|Recruiting||Phase 4|30|Anticipated|Trinity Hypertension & Metabolic Research Institute||2|||f||||f|t|f|||f|||No||2017-10-10 20:58:04.089104|2017-10-10 20:58:04.089104
NCT03180580|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-06-11|||July 2015||2015-07-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||School Based Childhood Obesity Feasibility Study|"Feasibility and Acceptability of Implementing School Based Healthy Eating and Active Living Intervention to Control Overweight and Obesity Among Children in Urban Area in Bangladesh"|Completed||N/A|831|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||1|||f||||f||||||||No||2017-10-10 20:58:04.186509|2017-10-10 20:58:04.186509
NCT03180567|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer|Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer|Recruiting||N/A|20|Anticipated|Tanta University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:58:04.264226|2017-10-10 20:58:04.264226
NCT03180554|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-19|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Can You Feel the Beat? Vagus Nerve Stimulation and Deep Breathing as Treatments for Chronic Widespread Pain|Can You Feel the Beat? Vagus Nerve Stimulation and Deep Breathing as Treatments for Chronic Widespread Pain|Not yet recruiting||N/A|100|Anticipated|Oslo University Hospital||8|||f||||f|f|f|||f|||||2017-10-10 20:58:04.346774|2017-10-10 20:58:04.346774
NCT03180541|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-07|||December 2013|Actual|2013-12-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluating the Coordinated National Implementation of DBT in Ireland|Evaluation of a Coordinated National Implementation of DBT in Community Mental Health Services in Ireland|Active, not recruiting||N/A|210|Anticipated|Health Service Executive, Ireland||2|||f||||t|f|f||||||No||2017-10-10 20:58:04.448736|2017-10-10 20:58:04.448736
NCT03180528|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-04|||January 29, 2018|Anticipated|2018-01-29|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer|A Phase 2 Open-Label, Single-Arm Trial of the Efficacy of Topical Remetinostat on Basal Cell Carcinoma in Patients|Not yet recruiting||Phase 2|30|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 20:58:04.517303|2017-10-10 20:58:04.517303
NCT03180515|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-07|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation|Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation|Recruiting||N/A|34|Anticipated|Stanford University||1|||f||||t|f|t|f|f||||No||2017-10-10 20:58:04.602006|2017-10-10 20:58:04.602006
NCT03180502|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-06|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|August 31, 2027|Anticipated|2027-08-31|May 15, 2022|Anticipated|2022-05-15||Interventional|||Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma|A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas|Recruiting||Phase 2|120|Anticipated|NRG Oncology||2|||f||||f|t|f||||||||2017-10-10 20:58:04.679049|2017-10-10 20:58:04.679049
NCT03180489|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Does Dapagliflozin Provide Additional Health Benefits To Dietary Counseling For Weight Loss?|Does Dapagliflozin Provide Additional Health Benefits To Dietary Counseling For Weight Loss?|Recruiting||Phase 2|50|Anticipated|Colorado State University||2|||f||||f|t|f|||f|||No||2017-10-10 20:58:04.784351|2017-10-10 20:58:04.784351
NCT03180476|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-12|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|April 1, 2019|Anticipated|2019-04-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma|Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma|Recruiting||Phase 2|24|Anticipated|Sichuan Cancer Hospital and Research Institute||1|||f||||f|f|f||||||Undecided||2017-10-10 20:58:04.880062|2017-10-10 20:58:04.880062
NCT03180463|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells|The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Sclnow Biotechnology Co., Ltd.||2|||f|||||f|f||||||Undecided||2017-10-10 20:58:04.953548|2017-10-10 20:58:04.953548
NCT03180450|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)|The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|Sclnow Biotechnology Co., Ltd.||2|||f|||||f|f||||||Undecided||2017-10-10 20:58:05.032496|2017-10-10 20:58:05.032496
NCT03180437|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-06|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|June 15, 2020|Anticipated|2020-06-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Safety and Efficiency of γδ T Cell Against Pancreatic Cancer|γδ T Cell Immunotherapy for Treatment of Pancreatic Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||3|||f||||t|f|f||||||||2017-10-10 20:58:05.11261|2017-10-10 20:58:05.11261
NCT03180424|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-06|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||Impact on Functional Status in Older Adults Treated With L-Carnitine|Impact on Functional Status in Older Adults Treated With L-Carnitine|Enrolling by invitation||Phase 2/Phase 3|60|Anticipated|Hospital de Clínicas Dr. Manuel Quintela||3|||f||||f|t|f|||t|||Undecided||2017-10-10 20:58:05.188423|2017-10-10 20:58:05.188423
NCT03180411|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-06|||February 14, 2017|Actual|2017-02-14|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Colorectal Cancer (CRC) Surveillance Tool: Cognitive and Pilot Testing|Colorectal Cancer Surveillance Decision Support Tool: Cognitive and Pilot Testing|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center|||2||f||||f|f|f||||||||2017-10-10 20:58:05.261506|2017-10-10 20:58:05.261506
NCT03180398|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-06|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients|Pilot Study of Using Multi-parametric Magnetic Resonance Imaging for Organ Delineation and Tumor Response Assessment of Prostate Cancer Patients Being Treated With Radiation Therapy|Not yet recruiting||N/A|20|Anticipated|Henry Ford Health System||1|||f|||||f|t|f|||||||2017-10-10 20:58:05.366504|2017-10-10 20:58:05.366504
NCT03180385|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|NAVA||NAVA Versus BiPAP Non-Invasive Respiratory Support in Infants Following Congenital Heart Surgery|Neurally Adjusted Ventilatory Assist (NAVA) Versus Conventional Biphasic Positive End Expiratory Pressure (BiPAP) Non-Invasive Respiratory Support in Infants Following Congenital Heart Surgery|Recruiting||N/A|40|Anticipated|Children's Hospitals and Clinics of Minnesota||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:58:05.445654|2017-10-10 20:58:05.445654
NCT03180372|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-25|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|November 30, 2018|Anticipated|2018-11-30|November 23, 2018|Anticipated|2018-11-23||Interventional|||Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence|Safety and Efficacy of Hybrid Fractional Laser diVa Treatment for Symptoms of Urinary Incontinence|Recruiting||N/A|60|Anticipated|Sciton||1|||f||||f|f|t|f|||||||2017-10-10 20:58:05.530986|2017-10-10 20:58:05.530986
NCT03180359|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-06|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2021|Anticipated|2021-01-01||Interventional|COVAGREF||Vaccines Immunogenicity in Renal, Hepatic, Cardiac or Pulmonary Transplanted Children|Vaccines Immunogenicity in Children Transplanted or Candidate for a Renal, Hepatic, Cardiac or Pulmonary Transplantation, Followed in the Rhône-Alpes Region. A Descriptive and Prospective Monocentric Cohort Study|Recruiting||N/A|341|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||No||2017-10-10 20:58:05.635587|2017-10-10 20:58:05.635587
NCT03180346|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||March 21, 2017|Actual|2017-03-21|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Prospective, Randomized, Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO) or Standard Care Dressings (AQUACEL Ag SURGICAL Dressing).|A Prospective, Randomized, Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO) or Standard Care Dressings (AQUACEL Ag SURGICAL Dressing).|Enrolling by invitation||N/A|494|Anticipated|Rothman Institute Orthopaedics||2|||f|||||f|f||||||||2017-10-10 20:58:05.744017|2017-10-10 20:58:05.744017
NCT03180333|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-07|||March 2012||2012-03-01|May 2017|2017-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers|The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers|Completed||Phase 1|16|Actual|Guangzhou Yipinhong Pharmaceutical CO.,LTD||5|||f||||f||||||||No||2017-10-10 20:58:05.818551|2017-10-10 20:58:05.818551
NCT03180320|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-06|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|BESMILE-HF||Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)|Effect of an Exercise-based Cardiac Rehabilitation Program 'Baduanjin-eight-silken-movement With Self-efficacy Building' for Patients With Chronic Heart Failure in Guangzhou, China (BESMILE-HF Study)|Not yet recruiting||N/A|200|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||t|f|f||||||No||2017-10-10 20:58:05.899418|2017-10-10 20:58:05.899418
NCT03180307|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-08|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer|A Phase 3, Randomized, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer|Not yet recruiting||Phase 3|147|Anticipated|On Target Laboratories, LLC||2|||f||||f|t|t|f|f||||No||2017-10-10 20:58:05.981761|2017-10-10 20:58:05.981761
NCT03180294|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|May 31, 2027|Anticipated|2027-05-31|October 30, 2019|Anticipated|2019-10-30||Interventional|||Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer|Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer|Recruiting||Phase 2|234|Anticipated|NRG Oncology||3|||f||||t|t|f||||||No||2017-10-10 20:58:06.056075|2017-10-10 20:58:06.056075
NCT02856360|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-17|||July 2016||2016-07-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|July 2019|Anticipated|2019-07-01||Interventional|||Changes in Footwear Comfort and Performance in High School Football Players||Enrolling by invitation||N/A|100|Anticipated|High Point University||2|||f||||f||||||||||2017-10-10 21:56:06.57649|2017-10-10 21:56:06.57649
NCT03180281|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-06-06|||July 1, 2017|Anticipated|2017-07-01|January 2017|2017-01-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|TOND||Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell|Exploring Effective and Safety Therapies Which Protect Islet β Cell on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity|Not yet recruiting||N/A|135|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||3|||f||||f|f|f||||||No||2017-10-10 20:58:06.145658|2017-10-10 20:58:06.145658
NCT03180268|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-15|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|August 31, 2027|Anticipated|2027-08-31|June 15, 2027|Anticipated|2027-06-15||Interventional|||Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery|Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma|Recruiting||N/A|148|Anticipated|NRG Oncology||2|||f||||f|f|f||||||No||2017-10-10 20:58:06.226283|2017-10-10 20:58:06.226283
NCT03180255|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-02|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery|Multi-Center, Double-Masked, Randomized, Placebo-Controlled Phase 2b Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Having Undergone Cataract Surgery With Implantation of a Posterior Chamber Intraocular Lens (IOL)|Recruiting||Phase 2|100|Anticipated|Eyegate Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:58:06.315594|2017-10-10 20:58:06.315594
NCT03180242|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-06|||March 22, 2016|Actual|2016-03-22|June 2017|2017-06-01|August 22, 2016|Actual|2016-08-22|August 22, 2016|Actual|2016-08-22||Interventional|||A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers|Phase 1, Double-Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Two-Stage, Comparative Pharmacokinetic Study of EirGenix' Trastuzumab and Herceptin® (Trastuzumab) Sourced From US and EU Administered to Healthy Male Volunteers|Completed||Phase 1|84|Actual|EirGenix, Inc.||3|||f||||f||||||||||2017-10-10 20:58:06.393019|2017-10-10 20:58:06.393019
NCT03180229|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-14|||May 29, 2017|Actual|2017-05-29|September 2017|2017-09-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Actual|2017-09-01||Interventional|lap||Granisetron Effect on Hemodynamic Changes in Laparoscopic Cholecystectomy|Granisetron Effect on Hemodynamic Changes and Intubation Condition During Anesthesia Induction in Laparoscopic Cholecystectomy|Recruiting||Phase 4|120|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||2|||f|||||f|f||||||||2017-10-10 20:58:06.574729|2017-10-10 20:58:06.574729
NCT03180216|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-17|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|July 2020|Anticipated|2020-07-01||Interventional|NATS||T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation|Novel Antigens Targeted by ex Vivo Expanded T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation|Recruiting||Phase 1|32|Anticipated|Children's Research Institute||1|||f||||t|t|f||||||||2017-10-10 20:58:06.688106|2017-10-10 20:58:06.688106
NCT03180203|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-06|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|POSITiVE||Postoperative INTELLiVENT-ASV Ventilation.|The Full Closed Loop Ventilation Mode INTELLiVENT-ASV: User-friendly and Effective Mechanical Ventilation in High Risk Postoperative Patient on the Intensive Care Unit.|Recruiting||N/A|250|Anticipated|Catharina Ziekenhuis Eindhoven||2|||f||||f|f|f||||||No||2017-10-10 20:58:06.823005|2017-10-10 20:58:06.823005
NCT03180190|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-07|||June 28, 2017|Anticipated|2017-06-28|June 2017|2017-06-01|July 28, 2018|Anticipated|2018-07-28|June 28, 2018|Anticipated|2018-06-28|1 Year|Observational [Patient Registry]|HCQ||Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine)|Cytochrome P450 and ATP-Binding Cassette C C (ABCC) Variants in Egyptian Patients Receiving Hydroxychloroquine and Their Association With Efficacy and Toxicity|Not yet recruiting||N/A|50|Anticipated|Assiut University|||2||f||||f|f|f||||Samples Without DNA|"     5 ml of blood will be collected into tubes containing EDTA, and stored immediately at −80 for     genomic DNA extraction and genotyping using real time PCR (Taqman discrimination assay) for     study frequency of single nucleotide polymorphisms (SNPs)of CYP2C19, CYP1A2, and ABCG2.   "|No||2017-10-10 20:58:06.941784|2017-10-10 20:58:06.941784
NCT03180177|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-29|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer|A Phase III Multicenter Prospective Randomized Controlled Clinical Trial of HIPEC as NACT and Postoperative Chemotherapy After Interval Debulking Surgery in the Treatment of Advanced-Stage Epithelial Ovarian Cancer|Not yet recruiting||Phase 3|184|Anticipated|Affiliated Tumor Hospital of Guangzhou Medical University||2|||f||||t|f|f||||||||2017-10-10 20:58:07.025211|2017-10-10 20:58:07.025211
NCT03180164|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-06|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Depression in Chronic Airways Diseases|Anxiety and Depression in Chronic Airways Diseases|Not yet recruiting||N/A|1|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 20:58:07.170739|2017-10-10 20:58:07.170739
NCT03180151|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|December 30, 2019|Anticipated|2019-12-30|March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Corticotomy in En-mass Retraction||Active, not recruiting||N/A|30|Anticipated|King Abdulaziz University||2|||f||||f|f|f||||||||2017-10-10 20:58:07.25061|2017-10-10 20:58:07.25061
NCT03180138|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-22|||July 11, 2016|Actual|2016-07-11|August 2017|2017-08-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||Enhancing Health Care Access With Cellular Technology|Enhancing Health Care Access With Cellular Technology: Networked and Mobile Technologies to Improve Uptake and Coverage of Vaccinations|Completed||N/A|832|Actual|Johns Hopkins University||3|||f||||f|f|f||||||||2017-10-10 20:58:07.330259|2017-10-10 20:58:07.330259
NCT03180125|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-06-06|||August 15, 2017|Anticipated|2017-08-15|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Hyaluronic Acid Hydro-dissection Use in Idiopathic Carpal Tunnel Syndrome Guided by Ultrasonic Study|Use of Hyaluronic Acid Injection in Treatment of Idiopathic Carpal Tunnel Syndrome Versus Corticosteroid Injection Sonographically Guided|Not yet recruiting||Phase 1|50|Anticipated|Assiut University||2|||f||||t|t|t|f|f|t|||Yes||2017-10-10 20:58:07.415662|2017-10-10 20:58:07.415662
NCT03180112|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-06|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|February 1, 2019|Anticipated|2019-02-01|August 1, 2018|Anticipated|2018-08-01||Observational|||The Association Between Herpes Simplex Viruses and Autism|The Association Between Herpes Simplex Viruses (Type One and Two) and Autism Spectrum Disorders|Not yet recruiting||N/A|80|Anticipated|Assiut University|||2||f||||f|f|f||||Samples With DNA|"     quantitative polymerase chain reaction.   "|No||2017-10-10 20:58:07.517789|2017-10-10 20:58:07.517789
NCT03180099|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-06-06|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|August 15, 2017|Anticipated|2017-08-15|July 30, 2017|Anticipated|2017-07-30||Interventional|||Efficiency of Thoracolumbar Interfascial Plane Block in Lumbar Disk Surgery|Efficiency of Thoracolumbar Interfascial Plane Block in Lumbar Disk Surgery|Recruiting||Phase 4|50|Anticipated|Erzurum Palandöken State Hospital||2|||f|||||f|f|||f|||||2017-10-10 20:58:07.635231|2017-10-10 20:58:07.635231
NCT03180086|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-11|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Breast Cancer Risk Assessment in Women Aged 40-49|Breast Cancer Risk Assessment in Women Aged 40-49|Recruiting||N/A|445|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f|f|f||||||||2017-10-10 20:58:07.754074|2017-10-10 20:58:07.754074
NCT03180073|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-07|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement|Prevalence and Significance of Bradycardic Arrhythmias and Conduction Abnormalities Among Patients With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement Using Extended Heart Rhythm Recording (Brady-TAVR Study)|Recruiting||N/A|100|Anticipated|The Cleveland Clinic|||1||f||||f|f|f||||||No||2017-10-10 20:58:07.869061|2017-10-10 20:58:07.869061
NCT03180060|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||August 3, 2015|Actual|2015-08-03|June 2017|2017-06-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|||Meta-Analysis of Stress Myocardial Perfusion Imaging|Accuracy and Heterogeneity of Stress Imaging for Detecting Coronary Artery Disease: A Systematic Review and Meta-Analysis Using HSROC Methods in 23,051 Patients.|Completed||N/A|23051|Actual|American British Cowdray Medical Center|||5||f||||f|f|f||||||Yes|We are intended to publish the corresponding paper in a high-impact journal, with all information available to other researchers in the corresponding appendix.|2017-10-10 20:58:07.962162|2017-10-10 20:58:07.962162
NCT03180021|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|DIVINE||Dynamic Imaging of Variation in Lupus Nephritis|Dynamic Imaging of Variation in Lupus Nephritis|Recruiting||N/A|30|Anticipated|RILITE Foundation|||2||f||||f|f|f||||Samples With DNA|"     To collect blood and urine samples for future research to identify biomarkers specific to     systemic lupus erythematosus and to LN.   "|||2017-10-10 20:58:08.218082|2017-10-10 20:58:08.218082
NCT03180008|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-06|||December 2012|Actual|2012-12-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Fit and Strong! Plus Comparative Effectiveness Trial|Comparative Effectiveness of Customary Fit and Strong! vs. Fit and Strong Plus!|Active, not recruiting||N/A|413|Actual|University of Illinois at Chicago||2|||f||||t|f|f||||||No||2017-10-10 20:58:08.380817|2017-10-10 20:58:08.380817
NCT03179995|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-25|||July 7, 2017|Actual|2017-07-07|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|June 18, 2018|Anticipated|2018-06-18||Interventional|||Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy|GI-072: Randomized Controlled Trial of the Use of Octreotide to Enhance Liver Recovery After Major Hepatectomy|Recruiting||Phase 2|80|Anticipated|Fox Chase Cancer Center||2|||f||||t|t|f|||f|||||2017-10-10 20:58:08.489379|2017-10-10 20:58:08.489379
NCT03179982|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-06|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Integrated Prevention of HIV Risk and Intimate Partner Violence Among Adolescents in South Africa|Integrated Prevention of HIV Risk and Intimate Partner Violence Among Adolescents in South Africa|Not yet recruiting||N/A|60|Anticipated|Brown University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:58:08.605897|2017-10-10 20:58:08.605897
NCT03179969|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|December 2019|Anticipated|2019-12-01||Observational|PLUG||The German Plug - Registry|Interventional Therapy of Paravalvular Post-surgical or Post-interventional Valve Replacement Leaks With Plug Devices: The German Plug - Registry|Active, not recruiting||N/A|200|Anticipated|Stiftung Institut fuer Herzinfarktforschung|||1||f||||f|f|f||||||No||2017-10-10 20:58:08.702593|2017-10-10 20:58:08.702593
NCT03179956|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Ribociclib on Head and Neck Squamous Cell Cancer|Biomarker Window of Opportunity Study to Evaluate the Impact of Ribociclib on Head and Neck Squamous Cell Cancer|Not yet recruiting||Early Phase 1|29|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|f||||||No||2017-10-10 20:58:08.783032|2017-10-10 20:58:08.783032
NCT03179930|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-08-07|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas|A Phase II Study of Pembrolizumab and Entinostat in Patients With Relapsed and Refractory Lymphomas|Recruiting||Phase 2|78|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 20:58:08.965532|2017-10-10 20:58:08.965532
NCT03175822|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-01|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Effects of Visual Art Training on Dementia|Effects of Visual Art Training on Dementia|Not yet recruiting||N/A|100|Anticipated|York University||2|||f|||||f|f||||||Undecided||2017-10-10 21:00:29.683944|2017-10-10 21:00:29.683944
NCT03179917|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-09|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma|Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma|Recruiting||Phase 2|22|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||Undecided||2017-10-10 20:58:09.111912|2017-10-10 20:58:09.111912
NCT03179904|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-26|||September 25, 2017|Actual|2017-09-25|June 2017|2017-06-01|July 30, 2021|Anticipated|2021-07-30|July 30, 2021|Anticipated|2021-07-30||Interventional|||FASN Inhibitor TVB-2640, Paclitaxel, and Trastuzumab in Treating Patients With HER2 Positive Advanced Breast Cancer|Phase II Trial to Evaluate the Efficacy of the FASN Inhibitor, TVB-2640, in Combination With Paclitaxel and Trastuzumab in Patients With HER2+ Metastatic Breast Cancer Resistant to Trastuzumab and Taxane-Based Therapy|Recruiting||Phase 2|80|Anticipated|Mayo Clinic||1|||||||t|t|f||||||||2017-10-10 20:58:09.247525|2017-10-10 20:58:09.247525
NCT03179891|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-08-25|||August 31, 2017|Anticipated|2017-08-31|June 2017|2017-06-01|October 20, 2017|Anticipated|2017-10-20|September 29, 2017|Anticipated|2017-09-29||Interventional|||Study to Assess the Pharmacokinetics and Safety of DBSF in Adult Subjects With Epilepsy|A Multi-Center, Open Label, Cross-Over Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy|Enrolling by invitation||Phase 2|40|Anticipated|MonoSol Rx||2|||f||||f|t|f||||||||2017-10-10 20:58:09.383117|2017-10-10 20:58:09.383117
NCT03179878|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-10-03|||June 16, 2017|Actual|2017-06-16|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|SYNB1020CP001||Safety and Tolerability of SYNB1020-CP-001|A Phase 1, First-in-human, Oral Single and Multiple Dose-Escalation, Randomized, Double-blinded, Placebo-controlled Study of SYNB1020 in Healthy Adult Volunteers to Evaluate Safety, Tolerability, Dosing, and Pharmacodynamics|Active, not recruiting||Phase 1|52|Actual|Synlogic||2|||f||||f|t|f||||||||2017-10-10 20:58:09.465583|2017-10-10 20:58:09.465583
NCT03179865|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-05|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of PUCAI Score at Assessment for Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis|Evaluation of PUCAI Score at Assessment for Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis|Recruiting||N/A|25|Anticipated|Wolfson Medical Center|||1||f|||||f|||||||||2017-10-10 20:58:09.543966|2017-10-10 20:58:09.543966
NCT03179852|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-06|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Nutrition Education on 3rd and 5th Grade Student's Fruit and Vegetable Consumption and Knowledge|Effects of Nutrition Education on 3rd and 5th Grade Student's Fruit and Vegetable Consumption and Knowledge|Active, not recruiting||Phase 2|150|Anticipated|Central Washington University||1|||f||||f|f|f||||||No||2017-10-10 20:58:09.613758|2017-10-10 20:58:09.613758
NCT03179839|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-06-29|||January 20, 2017|Actual|2017-01-20|June 2017|2017-06-01|February 20, 2019|Anticipated|2019-02-20|December 1, 2018|Anticipated|2018-12-01||Interventional|||The Study of Mindfulness Based Cognitive Therapy and Obsessive-Compulsive Disorder|The Study of Mindfulness Based Cognitive Therapy and Obsessive-Compulsive Disorder|Recruiting||N/A|120|Anticipated|Shanghai Mental Health Center||3|||f||||f|f|f||||||No||2017-10-10 20:58:09.674641|2017-10-10 20:58:09.674641
NCT03179826|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Observational|COMEGE||Analysis of Inhaled Corticoid Prescriptions in General Medicine|Analysis of Inhaled Corticoid Prescriptions in General Medicine|Not yet recruiting||N/A|80|Anticipated|University Hospital, Montpellier|||1||f||||f|f|f||||||||2017-10-10 20:58:09.772073|2017-10-10 20:58:09.772073
NCT03179813|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-11|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|December 7, 2017|Anticipated|2017-12-07|October 3, 2017|Anticipated|2017-10-03||Interventional|||Topical Hydrocortisone for Pain and Edema Control After Third Molar Surgery|Topical Hydrocortisone for Pain and Edema Control After Third Molar Surgery: a Clinical, Crossover, Randomized, Double-blind, Controlled Study|Active, not recruiting||Phase 4|40|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 20:58:09.900943|2017-10-10 20:58:09.900943
NCT03179800|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2026|Anticipated|2026-01-01|May 2020|Anticipated|2020-05-01||Interventional|CALM-2||CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™|CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™|Not yet recruiting||N/A|300|Anticipated|Vascular Dynamics, Inc.||2|||f||||t|f|t|t|f||||||2017-10-10 20:58:09.976014|2017-10-10 20:58:09.976014
NCT03179787|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-06|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism|Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism|Recruiting||N/A|300|Anticipated|Otsuka Pharmaceutical Co., Ltd.|||1||f|||||f|f||||||||2017-10-10 20:58:10.058755|2017-10-10 20:58:10.058755
NCT03179774|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-06|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|ERCAO||Endovascular Revascularization for Chronic Carotid Artery Occlusion Trial|Endovascular Revascularization for Chronic Carotid Artery Occlusion Trial (ERCAO Trial) Part 1: Prospective Clinical Registry Study Part 2: Prospective Randomized Control Trial Study|Not yet recruiting||N/A|200|Anticipated|National Taiwan University Hospital||4|||f||||t|f|f||||||||2017-10-10 20:58:10.125555|2017-10-10 20:58:10.125555
NCT03179761|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-08|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients|High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients|Not yet recruiting||Phase 2|138|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t|t|f||||||||2017-10-10 20:58:10.228986|2017-10-10 20:58:10.228986
NCT03179748|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-02|||December 5, 2017|Anticipated|2017-12-05|October 2017|2017-10-01|June 1, 2020|Anticipated|2020-06-01|May 31, 2020|Anticipated|2020-05-31||Observational|||Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients|Non-interventional, Multi-Centre, Post-Authorisation Safety Study With Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients|Not yet recruiting||N/A|8|Anticipated|Novo Nordisk A/S|||1||f||||||||||||||2017-10-10 20:58:10.3535|2017-10-10 20:58:10.3535
NCT03179735|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-05|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|July 10, 2018|Anticipated|2018-07-10|March 10, 2018|Anticipated|2018-03-10||Interventional|MOUORT||Mouthwashes During Orthodontic Treatment|Mouthwashes as Positive Modulators of Periodontal Response During Orthodontic Treatment: a 6-month Randomized Placebo Controlled Clinical Trial|Enrolling by invitation||Phase 4|60|Anticipated|University of Taubate||3|||f||||t|f|f||||||No|No individual participant data will be shared.|2017-10-10 20:58:10.445265|2017-10-10 20:58:10.445265
NCT03179722|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-06|||November 8, 2016|Actual|2016-11-08|June 2017|2017-06-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|SIMENON||Studying the Impact of a Medication Use Evaluation by the Community Pharmacist|Studying the Impact of a Medication Use Evaluation by the Community Pharmacist|Active, not recruiting||N/A|900|Anticipated|Katholieke Universiteit Leuven||2|||f||||f|f|f||||||No||2017-10-10 20:58:10.542971|2017-10-10 20:58:10.542971
NCT03179709|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-24|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Provider Perceptions of Neuromuscular Blockade in ARDS|Provider Perceptions of Neuromuscular Blockade in ARDS|Enrolling by invitation||N/A|90|Anticipated|University of Pittsburgh|||3||f||||f|f|f||||||||2017-10-10 20:58:10.627505|2017-10-10 20:58:10.627505
NCT03179696|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-05|||August 15, 2016|Actual|2016-08-15|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|mCBTn||Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia|Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia|Enrolling by invitation||N/A|40|Anticipated|University of California, San Diego||1|||f||||t|f|f||||||Undecided||2017-10-10 20:58:12.424865|2017-10-10 20:58:12.424865
NCT03179683|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-06|||October 2011|Actual|2011-10-01|June 2017|2017-06-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Low Level Laser Teraphy on Bone Regeneration|Radiographic Evaluation of Low Level Laser Therapy Enhanced Maxillary Sinus Augmentation With Simultaneous Implant Placement|Completed||N/A|12|Actual|Bulent Ecevit University||2|||f||||f|f|f||||||No||2017-10-10 20:58:12.556656|2017-10-10 20:58:12.556656
NCT03179670|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-06|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|October 30, 2017|Anticipated|2017-10-30||Observational|UROEVAL||Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH|Interest of a Systematic Assessment of the Treatment of Lower Urinary Tract Symptoms (LUTS) in the Management of Benign Prostatic Hyperplasia (BPH) in Urology|Not yet recruiting||N/A|1000|Anticipated|Laboratoires Bouchara-Recordati|||1||f||||f||||||||No||2017-10-10 20:58:12.625317|2017-10-10 20:58:12.625317
NCT03179657|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-05|||July 1, 2008|Actual|2008-07-01|June 2017|2017-06-01|December 2027|Anticipated|2027-12-01|December 2023|Anticipated|2023-12-01||Observational|GNHS||Guangzhou Nutrition and Health Study (GNHS)|Guangzhou Nutrition and Health Study (GNHS): a Community-based Prospective Cohort Study in Guangzhou Residents|Active, not recruiting||N/A|4540|Actual|Sun Yat-sen University|||1||f|||||f|f||||Samples With DNA|"     12-h fasting venous blood, urine and faeces was/will be collected at baseline and follow-ups.   "|No||2017-10-10 20:58:12.677874|2017-10-10 20:58:12.677874
NCT03179644|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-06|||July 8, 2016|Actual|2016-07-08|May 2017|2017-05-01|July 8, 2018|Anticipated|2018-07-08|July 8, 2018|Anticipated|2018-07-08||Interventional|||Study of Variations of Pleural and Esophageal Pressures Under Mechanical Ventilation After Lung Transplantation|Study of Variations of Pleural and Esophageal Pressures Under Mechanical Ventilation After Lung Transplantation|Recruiting||N/A|45|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f|f|f||||||||2017-10-10 20:58:12.753863|2017-10-10 20:58:12.753863
NCT03179631|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-11|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|March 2020|Anticipated|2020-03-01||Interventional|||Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy|A Phase 3 Randomized Double Blind Placebo Controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) and Open Label Extension|Recruiting||Phase 3|250|Anticipated|PTC Therapeutics||2|||f|||||t|f||||||||2017-10-10 20:58:12.828344|2017-10-10 20:58:12.828344
NCT03179618|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.|Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.|Not yet recruiting||Phase 4|120|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||Undecided||2017-10-10 20:58:12.957522|2017-10-10 20:58:12.957522
NCT03179605|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-05|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06|An Open Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 in Pediatric Subjects With Moderate to Severe Plaque Psoriasis|Recruiting||Phase 2|50|Anticipated|Promius Pharma, LLC||1|||f||||f|t|f||||||No||2017-10-10 20:58:13.046941|2017-10-10 20:58:13.046941
NCT03179592|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-05|||March 22, 2017|Actual|2017-03-22|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|VOLCANIC-CTA||VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography|VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography (VOLCANIC-CTA): A Prospective Trial|Recruiting||Phase 3|140|Anticipated|Medical University of South Carolina||1|||f|||||t|f|||f|||No||2017-10-10 20:58:13.133352|2017-10-10 20:58:13.133352
NCT03179579|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2021|Anticipated|2021-08-01||Interventional|||Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer|A Phase III Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined With Systemic Chemotherapy And Cytoreductive Surgery (CRS) in the Treatment of Peritoneal Carcinomatosis From Gastric Cancer|Not yet recruiting||Phase 3|88|Anticipated|Affiliated Tumor Hospital of Guangzhou Medical University||2|||f||||t|f|f||||||No||2017-10-10 20:58:13.231995|2017-10-10 20:58:13.231995
NCT03179566|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-08|||June 6, 2017|Actual|2017-06-06|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|September 1, 2017|Actual|2017-09-01||Interventional|SODAS||Pain and Medication Use Following Surgery|Safe Opioid Disposal After Surgery Trial|Completed||N/A|391|Actual|University of Michigan||3|||f||||f|f|f||||||||2017-10-10 20:58:13.343192|2017-10-10 20:58:13.343192
NCT03179553|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Observational|HeartBeat||Heart Beat Variability in Neonatal Encephalopathy|Improving Early Decisions in Neonatal Encephalopathy by Monitoring Heartbeat Variability|Not yet recruiting||N/A|210|Anticipated|Thayyil, Sudhin|||2||f||||f|f|f||||Samples With DNA|"     salivary swabs for cortisol measurements.   "|No||2017-10-10 20:58:13.542139|2017-10-10 20:58:13.542139
NCT03179540|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-08-29|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|January 2021|Anticipated|2021-01-01||Interventional|NOM||Non-operative Management for Locally Advanced Rectal Cancer|Phase II Study to Assess the Safety of Non-operative Management for Low Rectal Cancer|Not yet recruiting||N/A|90|Anticipated|Mount Sinai Hospital, Canada||1|||f||||t|f|f||||||||2017-10-10 20:58:13.635819|2017-10-10 20:58:13.635819
NCT03179527|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.|Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.|Not yet recruiting||Phase 4|120|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||Undecided||2017-10-10 20:58:13.71549|2017-10-10 20:58:13.71549
NCT03179514|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.|Research on the Clinical Effect of Gualou Xiebai Banxia Decoction Compounded With Danshen Decoction in Treating Unstable Angina.|Not yet recruiting||Phase 4|120|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||Undecided||2017-10-10 20:58:13.835955|2017-10-10 20:58:13.835955
NCT03179501|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-10-02|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||NP001, Alzheimer's Disease, and Blood Markers of Inflammation|Effect of Single Dose NP001 on Blood Markers of Inflammation in Individuals With Mild-to-Moderate Alzheimer's Disease|Recruiting||Phase 1|14|Anticipated|University of Hawaii||2|||f||||f|t|f||||||||2017-10-10 20:58:13.943906|2017-10-10 20:58:13.943906
NCT03179488|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-03|||July 3, 2017|Actual|2017-07-03|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Therapist-dependent Dose of Spinal TENS|Intensity Matters: Therapist-dependent Dose of Spinal Transcutaneous Electrical Nerve Stimulation|Recruiting||N/A|20|Anticipated|University of Castilla-La Mancha||2|||f||||f|f|f||||||||2017-10-10 20:58:14.039443|2017-10-10 20:58:14.039443
NCT03179475|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-06-05|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|June 1, 2019|Anticipated|2019-06-01||Interventional|||Targin® for Chronic Pain Management in Patients With Spinal Cord Injury|An Open-label, Single Centre Prospective Cohort Study to Determine the Effectiveness and Safety of Targin® for Pain Management and Opioid-induced Constipation in Patients With Spinal Cord Injury: Can we Improve Pain and Ameliorate Secondary Complications of Opioid Treatment?|Not yet recruiting||Phase 3|20|Anticipated|University of British Columbia||1|||f||||t|f|f||||||Undecided|Undecided Data collected during the study will be used by the investigator to communicate results of the study to the research community. Data will mostly be communicated as a pooled data set; in the event that individual participant data is communicated, it will be represented with the unique study identifier which does not identify the individual participant.|2017-10-10 20:58:14.148382|2017-10-10 20:58:14.148382
NCT03179462|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-30|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||"Ounce-equivalents in the Protein Foods Group: Benefits of Quality"|"Ounce-equivalents in the Protein Foods Group: Benefits of Quality"|Recruiting||N/A|30|Anticipated|University of Arkansas||3|||f||||f|f|f||||||||2017-10-10 20:58:14.271035|2017-10-10 20:58:14.271035
NCT03179449|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-14|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI|MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI (Pediatric Brain Tumor Protocol)|Recruiting||Early Phase 1|10|Anticipated|Stanford University||1|||||||t|t|f||||||||2017-10-10 20:58:14.365533|2017-10-10 20:58:14.365533
NCT03179436|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-28|||July 2, 2017|Actual|2017-07-02|September 2017|2017-09-01|March 4, 2019|Anticipated|2019-03-04|March 4, 2019|Anticipated|2019-03-04||Interventional|||Safety, Pharmacokinetics (PK), and Efficacy of MK-1308 in Combination With Pembrolizumab in Advanced Solid Tumors (MK-1308-001)|A Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-1308 in Combination With Pembrolizumab for Subjects With Advanced Solid Tumors|Recruiting||Phase 1|148|Anticipated|Merck Sharp & Dohme Corp.||6|||f||||f|t|f||||||||2017-10-10 20:58:14.463044|2017-10-10 20:58:14.463044
NCT03179423|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-19|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|RAINBOW-T1D||Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years|Randomised, Double-Blind, Placebo-Controlled Study to Investigate GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years|Recruiting||Phase 2|60|Anticipated|GeNeuro Australia PTY Ltd||2|||f||||t|f|f||||||||2017-10-10 20:58:14.582993|2017-10-10 20:58:14.582993
NCT03179410|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-10-02|||October 31, 2017|Anticipated|2017-10-31|October 2017|2017-10-01|October 31, 2022|Anticipated|2022-10-31|April 30, 2020|Anticipated|2020-04-30||Interventional|PICK-NEPC||PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer|PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer|Not yet recruiting||Phase 2|18|Anticipated|Duke University||1|||f||||f|t|f||||||||2017-10-10 20:58:14.706316|2017-10-10 20:58:14.706316
NCT03179397|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-06|||May 31, 2017|Actual|2017-05-31|May 2017|2017-05-01|May 1, 2021|Anticipated|2021-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Clinical Trial to Evaluate the Model SC9 IOL Compared to the Model LI61SE IOL (Bausch & Lomb)|A Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Silicone IOL for the Visual Correction of Aphakia Secondary to the Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia|Recruiting||N/A|500|Anticipated|CORD, LLC||2|||f||||f|f|t|t|f||||No||2017-10-10 20:58:14.788653|2017-10-10 20:58:14.788653
NCT03146429|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-07|||January 1, 2017||2017-01-01|May 2017|2017-05-01|April 15, 2017|Actual|2017-04-15|April 15, 2017|Actual|2017-04-15||Observational|||Prediction of Future Weight Change With Dopamine Transporter|Prediction of Future Weight Change With Dopamine Transporter|Completed||N/A|200|Actual|Pusan National University Hospital|||1||f|||||f|f||||||||2017-10-10 21:05:16.530477|2017-10-10 21:05:16.530477
NCT03179384|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-28|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|CEFIMPACT||Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis|Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis|Not yet recruiting||Phase 4|100|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f|f|f||||||||2017-10-10 20:58:14.900392|2017-10-10 20:58:14.900392
NCT03179371|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-06|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|July 2017|Anticipated|2017-07-01||Observational|pro-CDH||Proteomic Profiling for Congenital Diaphragmatic Hernia|Proteomic Analysis of Amniotic Fluid in the Case of Diaphragmatic Hernia: Search for Prognostic Expression Profiles|Recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f|f|f||||||No||2017-10-10 20:58:14.976246|2017-10-10 20:58:14.976246
NCT03179358|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-06|||October 21, 2016|Actual|2016-10-21|June 2017|2017-06-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC|A Prospective, Non-randomized Multicenter Study Verifying C-REX LapAid and C-REX DMH/DMHC|Recruiting||N/A|20|Anticipated|Carponovum AB||1|||f||||f|f|f||||||No||2017-10-10 20:58:15.059628|2017-10-10 20:58:15.059628
NCT03179345|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||September 24, 2015|Actual|2015-09-24|June 2017|2017-06-01|November 20, 2015|Actual|2015-11-20|November 20, 2015|Actual|2015-11-20||Interventional|||Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica|A Phase 4, Double-Blind, Placebo-Controlled, Crossover Study Comparing Simulated Driving Performance, Daytime Sedation, and Cognition in Healthy Volunteers Taking Therapeutic Doses of Gralise®, Neurontin®, or Lyrica®|Completed||Phase 4|32|Actual|Depomed||4|||f||||||||||||||2017-10-10 20:58:15.147011|2017-10-10 20:58:15.147011
NCT03179332|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-06|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump|A Euglycaemic Clamp Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of a Bolus Dose of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® by an Insulin Pump|Recruiting||Phase 1|42|Anticipated|Adocia||3|||f||||f|f|f||||||No||2017-10-10 20:58:15.348287|2017-10-10 20:58:15.348287
NCT03179319|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-11|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||"Mobile-Based Application MyChoices"|"Mobile-Based Application MyChoices to Increase Uptake of HIV Testing, Detection of New HIV Infections, and Linkage to Care and Prevention Services by Young Men Who Have Sex With Men"|Recruiting||N/A|60|Anticipated|Brown University||2|||f||||f|f|f||||||||2017-10-10 20:58:15.464278|2017-10-10 20:58:15.464278
NCT03179306|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-30|||May 15, 2017|Actual|2017-05-15|May 8, 2017|2017-05-08|March 2, 2022|Anticipated|2022-03-02|March 2, 2022|Anticipated|2022-03-02||Observational|||Cervix Image Sharing Protocol (CISP)|Cervix Image Sharing Protocol (CISP)|Active, not recruiting||N/A|27084|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f||||||||||||||2017-10-10 20:58:15.583704|2017-10-10 20:58:15.583704
NCT03179293|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-07-10|||July 1, 2017|Actual|2017-07-01|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Transition to Propofol After Sevoflurane Anaesthesia to Prevent Emergence Agitation|Transition to Propofol After Sevoflurane Anaesthesia to Prevent Emergence Agitation in Genito-urinary Paediatric Surgeries|Recruiting||Phase 4|64|Anticipated|Assiut University||2|||f|||||f|f|||f|||||2017-10-10 20:58:15.653168|2017-10-10 20:58:15.653168
NCT03179280|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-06|||March 2011|Actual|2011-03-01|June 2017|2017-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia|Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia According to the Composition of the Meal in Adolescents With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion|Completed||N/A|10|Actual|Aristotle University Of Thessaloniki||2|||f||||f|f|f|||f|||No||2017-10-10 20:58:15.74425|2017-10-10 20:58:15.74425
NCT03179254|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-08|||March 22, 2010|Actual|2010-03-22|June 2017|2017-06-01|August 26, 2014|Actual|2014-08-26|January 10, 2014|Actual|2014-01-10||Interventional|Diabetes||Type 2 Diabetes and Ambulatory Surgery Patients|Oral Hypoglycemic Agent Continuation Versus Interruption in Type 2 Diabetic Patients Undergoing Ambulatory Surgery|Completed||Phase 4|160|Actual|University of Texas Southwestern Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:15.933663|2017-10-10 20:58:15.933663
NCT03179241|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-30|||August 10, 2017|Anticipated|2017-08-10|July 2017|2017-07-01|December 1, 2021|Anticipated|2021-12-01|October 1, 2021|Anticipated|2021-10-01||Observational|||Outcome After Selective Dorsal Rhizothomy Concerning Life Quality, Cerebral Imaging and Cognition|SDR-Auswertung, Unterteil Kognition, Bildgebung, Lebensqualität|Recruiting||N/A|180|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 20:58:16.010686|2017-10-10 20:58:16.010686
NCT03179228|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-05|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 1, 2028|Anticipated|2028-06-01|June 1, 2023|Anticipated|2023-06-01||Interventional|||Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia|Phase II, Single Arm Prospective Study To Evaluate Safety And Efficacy Of Prostate Artery Embolization In Patients With Lower Urinary Tract Symptoms Due To Benign Prostatic Hyperplasia|Not yet recruiting||Phase 2|20|Anticipated|Stanford University||1|||f||||f|f|t|f|f||||Undecided||2017-10-10 20:58:16.088645|2017-10-10 20:58:16.088645
NCT03179215|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||March 5, 2017|Actual|2017-03-05|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|August 2017|Anticipated|2017-08-01||Observational|||Dynamic Arterial Elastance as a Predictor of Arterial Blood Pressure Response to Fluid Administration in Septic Patients|Dynamic Arterial Elastance as a Predictor of Arterial Blood Pressure Response to Fluid Administration in Septic Patients|Recruiting||N/A|50|Anticipated|Cairo University|||1||f||||t|f|f||||||Undecided||2017-10-10 20:58:16.215819|2017-10-10 20:58:16.215819
NCT02834871|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-03-27|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|STAC2||Integration of the Cervical Proprioceptive Signals in Patients With Cervical Dystonia||Completed||N/A|40|Actual|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f||||||||||2017-10-10 21:59:30.798993|2017-10-10 21:59:30.798993
NCT03179202|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-26|||June 23, 2017|Actual|2017-06-23|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS)|A Study of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain|Recruiting||N/A|50|Anticipated|SPR Therapeutics, LLC||1|||f|||||f|t|f|f||||||2017-10-10 20:58:16.298822|2017-10-10 20:58:16.298822
NCT03179189|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-09-27|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|November 1, 2017|Anticipated|2017-11-01|6 Months|Observational [Patient Registry]|||Investigation of The Prevalence of Sepsis in Adults in Multicenter Intensive Care Unıts in Turkey|Investigation of The Prevalence of Sepsis in Adults in Multicenter Intensive Care Unıts in Turkey|Recruiting||N/A|1000|Anticipated|Izmir Ataturk Training and Research Hospital|||1||f||||f|f|f||||||||2017-10-10 20:58:16.413797|2017-10-10 20:58:16.413797
NCT03179176|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-06|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|EUHF_PRC||Evaluation of the Interest of Ultra-high Frequency Doppler Ultrasound (UFDU) in the Surgical Management of Patients Operated in an Awake Condition for a Cerebral Tumor|Evaluation of the Interest of Ultra-high Frequency Doppler Ultrasound (UFDU) in the Surgical Management of Patients Operated in an Awake Condition for a Cerebral Tumor|Recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f|f|f||||||||2017-10-10 20:58:16.478874|2017-10-10 20:58:16.478874
NCT03179163|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-05|||July 20, 2016|Actual|2016-07-20|June 2017|2017-06-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|H2SPharm||Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans|Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvascular Function and Vessel Remodeling in Hypertensive Humans|Recruiting||Phase 1/Phase 2|70|Anticipated|Penn State University||4|||f||||f|t|f||||||No||2017-10-10 20:58:16.556432|2017-10-10 20:58:16.556432
NCT03179150|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||September 1, 2015|Actual|2015-09-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|March 30, 2016|Actual|2016-03-30||Observational|||Clinical Validation of the M5L Lung CAD|Clinical Validation of a CAD System for the Automated Identification of Pulmonary Metastases in Oncological Patients - CADM5L|Completed||N/A|237|Actual|Candiolo Cancer Institute - IRCCS|||1||f||||t|f|f||||||No||2017-10-10 20:58:16.668222|2017-10-10 20:58:16.668222
NCT03179137|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-05|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2019|Anticipated|2019-10-01||Observational|||Mitochondrial Bioenergetics and Role in Cellular Damage in Ischemic Myocardium|Pathophysiological Mechanisms Elicited by Ischemia and Metabolic Co-morbidities in Myocardium of Patients With Coronary Artery Disease|Recruiting||N/A|80|Anticipated|University of Split, School of Medicine|||1||f||||f|f|f||||Samples With DNA|"     Human myocardial tissue, atrial and ventricular   "|No||2017-10-10 20:58:16.753691|2017-10-10 20:58:16.753691
NCT03179124|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||June 20, 2016|Actual|2016-06-20|June 2017|2017-06-01|May 20, 2017|Actual|2017-05-20|April 20, 2017|Actual|2017-04-20|1 Day|Observational [Patient Registry]|||Upper Extremity Function In Cerebral Palsy And Its Association With Balance And Trunk Control|Upper Extremity Function In Cerebral Palsy And Its Association With Balance And Trunk Control|Completed||N/A|62|Actual|Gazi University|||2||f||||f|f|f||||||No||2017-10-10 20:58:16.845635|2017-10-10 20:58:16.845635
NCT03179098|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-06-06|||July 30, 2017|Anticipated|2017-07-30|June 2017|2017-06-01|March 30, 2019|Anticipated|2019-03-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Immediate Effects of Superficial Heat Associated With Elongation in the Posttraumatic Elbow Contracture|Immediate Effects of Superficial Heat Associated With Sustained Stretching on Post-traumatic Elbow Contracture: a Randomized Clinical Trial|Not yet recruiting||N/A|20|Anticipated|University of Sao Paulo||2|||f|||||f|f||||||||2017-10-10 20:58:17.03581|2017-10-10 20:58:17.03581
NCT03179085|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Home-Based Kidney Care in Native American's of New Mexico (HBKC)|Home-Based Chronic Kidney Disease (CKD) Care in Native American's of New Mexico- A Disruptive Innovation|Not yet recruiting||N/A|240|Anticipated|University of New Mexico||2|||f||||f|f|f||||||Undecided|Anonymized data will be available to share once the tribal leadership approves it.|2017-10-10 20:58:17.115327|2017-10-10 20:58:17.115327
NCT03179072|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-26|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Dehydr8 and Deactiv8|The Impact of a Typical 8 Day Course of 'Target Weight' Driven Haemodialysis on the Hydration Status, Physical and Cognitive Function, Physical Activity and Quality of Life of Adults With End-stage Renal Disease.|Recruiting||N/A|120|Anticipated|University of Portsmouth|||1||f||||t|f|f||||||||2017-10-10 20:58:17.202354|2017-10-10 20:58:17.202354
NCT03179046|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|August 2018|Anticipated|2018-08-01||Observational|||Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus|Association of Heart Structure and Function Abnormalities With Laboratory Findings in Patients With Systemic Lupus Erythematosus|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f|f|f|||f|||No||2017-10-10 20:58:17.379833|2017-10-10 20:58:17.379833
NCT03179033|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||October 19, 2016|Actual|2016-10-19|June 2017|2017-06-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20|2 Weeks|Observational [Patient Registry]|||Impact of Fluid and Passive Leg Raising on Cardiac Output in Patients Undergoing Cardiac Surgery|Impact of Fluid and Passive Leg Raising on Cardiac Output in Patients Undergoing Cardiac Surgery|Recruiting||N/A|20|Anticipated|Sheba Medical Center|||1||f|||||f|f||||||||2017-10-10 20:58:17.439239|2017-10-10 20:58:17.439239
NCT03179020|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-05|||May 28, 2017|Actual|2017-05-28|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|DONORS||Donation Network to Optimize Organ Recovery Study|Cluster Randomized Trial Evaluating the Implementation of a Evidence Based Checklist for the Management of Potential Organ Donors|Recruiting||N/A|1200|Anticipated|Hospital Moinhos de Vento||2|||f||||f|f|f||||||No||2017-10-10 20:58:17.495719|2017-10-10 20:58:17.495719
NCT03179007|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||June 7, 2017|Anticipated|2017-06-07|June 2017|2017-06-01|April 20, 2019|Anticipated|2019-04-20|January 20, 2019|Anticipated|2019-01-20||Interventional|||CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor|A Clinical Study of CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for Patients With MUC1 Positive Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|40|Anticipated|Shanghai Cell Therapy Research Institute||1|||f||||f|f|f||||||No||2017-10-10 20:58:17.581847|2017-10-10 20:58:17.581847
NCT03178994|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 15, 2017|Anticipated|2017-12-15||Interventional|||The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne|The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne|Not yet recruiting||Phase 3|42|Anticipated|Chulalongkorn University||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:17.664553|2017-10-10 20:58:17.664553
NCT03178981|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-12|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|October 31, 2017|Anticipated|2017-10-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||E-cigarette Nicotine Pharmacokinetic Study|A Pharmacokinetic Study to Examine Nicotine Delivery From E-cigarettes and a Conventional Cigarette in Healthy Subjects During a Brief Period of ad Libitum Use|Active, not recruiting||N/A|18|Actual|British American Tobacco (Investments) Limited||6|||f||||f|f|f||||||||2017-10-10 20:58:17.730804|2017-10-10 20:58:17.730804
NCT03178968|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-05|||January 10, 2017|Actual|2017-01-10|May 2017|2017-05-01|May 29, 2017|Actual|2017-05-29|May 29, 2017|Actual|2017-05-29||Interventional|||Can Surface Roughness Predict Progression of Tooth Wear?|Can Surface Roughness Predict Progression of Tooth Wear in Participants With Dietary Origins of Acid?|Completed||N/A|30|Actual|King's College London||3|||f|||||f|f||||||No||2017-10-10 20:58:17.809668|2017-10-10 20:58:17.809668
NCT03178955|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-07|||March 27, 2017|Actual|2017-03-27|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Observational|||Circadian RA Study in Rheumatoid Arthritis Subjects|The Effects of Biologic Therapy With Disease Activity and Circadian Rhythm|Recruiting||N/A|30|Anticipated|University of California, Davis|||1||f||||f|t|f|||t|Samples With DNA|"     Serum specimens collected for this study will be immediately sent to the UC Davis clinical     laboratory for analysis of RH and CRP. From each study visit, 0.5 ml serum will also be     stored to potentially use for analyses of additional markers of inflammation such as     interleukin-6 (IL-6). Serum samples will be de-identified; therefore only subject ID numbers     will be labeled on the vials of serum.   "|||2017-10-10 20:58:18.015149|2017-10-10 20:58:18.015149
NCT03178929|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 31, 2020|Anticipated|2020-08-31|July 1, 2020|Anticipated|2020-07-01||Interventional|||Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma|A Randomized Controlled Study on the Effect of S-Adenosyl Methionine Treatment on Anti-tumor Recurrence After Radical Treatment of Primary Hepatic Carcinoma|Not yet recruiting||N/A|207|Anticipated|Beijing Insight Science & Technology Co. Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:18.244843|2017-10-10 20:58:18.244843
NCT03178916|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-07-11|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Observational|||Breast Feeding Practice in High Risk Pregnant Women|Breast Feeding Practice in High Risk Pregnant Women|Recruiting||N/A|140|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 20:58:18.348015|2017-10-10 20:58:18.348015
NCT03178903|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-06-05|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|StRIDE||tDCS for Increasing Exercise Adherence in Depressed Individuals|tDCS for Increasing Exercise Adherence in Individuals With Elevated Depressive Symptoms|Recruiting||N/A|72|Anticipated|Butler Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:58:18.422251|2017-10-10 20:58:18.422251
NCT03178890|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-05|||September 26, 2016|Actual|2016-09-26|June 2017|2017-06-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|OHMG||Osseointegrated Human-Machine Gateway|The Osseointegrated Human-machine Gateway|Recruiting||N/A|18|Anticipated|Integrum||1|||f||||f|f|f||||||No||2017-10-10 20:58:18.50914|2017-10-10 20:58:18.50914
NCT03178877|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-05|||November 1, 2016|Actual|2016-11-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|1 Day|Observational [Patient Registry]|IBS||The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors|The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors|Completed||N/A|350|Actual|Indonesia University|||2||f||||f|f|f||||||No|Not available to other researcher|2017-10-10 20:58:18.594213|2017-10-10 20:58:18.594213
NCT03178708|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-05|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients|The Implications of Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients as Regard Its Effect on the Duration of Wake up Test and Postoperative Opioid Consumption|Recruiting||Phase 2/Phase 3|40|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 20:58:19.825498|2017-10-10 20:58:19.825498
NCT03178695|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-10-03|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|November 25, 2018|Anticipated|2018-11-25|August 1, 2018|Anticipated|2018-08-01||Interventional|||Inovium Ovarian Rejuvenation Trials|Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation|Recruiting||Phase 1|50|Anticipated|Ascendance Biomedical||2|||f||||t|f|f||||||||2017-10-10 20:58:19.911475|2017-10-10 20:58:19.911475
NCT03178864|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-05|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|SECRET||Study of Rivaroxaban for CeREbral Venous Thrombosis|Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Early Anticoagulation With Rivaroxaban Versus Standard of Care in Determining Safety at 365 Days in Symptomatic Cerebral Venous Thrombosis|Not yet recruiting||Phase 2|384|Anticipated|University of British Columbia||2|||f||||t|f|f|||f|||Yes|"Upon completion of the SECRET Trial, a public use database will be prepared by stripping any and all personal identifiers. The public use database, consisting of several data files, should contain: (1) baseline and demographic characteristics; (2) outcomes assessments; (3) CT/MRI data; (4) concomitant medications and procedures; and (5) adverse events. Each data file is made available as a formatted SAS dataset or other electronic format. The data files are distributed along with the data dictionary and a brief instruction (Readme) file. These data files will be made available to the public only after all major manuscripts (including secondary analysis papers) of the Trial are accepted for publication in peer-reviewed journals."|2017-10-10 20:58:18.676493|2017-10-10 20:58:18.676493
NCT03178851|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-26|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma|A Phase Ib Study Evaluating Cobimetinib Plus Atezolizumab in Patients With Advanced BRAF V600 Wild-Type Melanoma Who Have Progressed During or After Treatment With Anti−PD-1 Therapy and Atezolizumab Monotherapy in Patients With Previously Untreated Advanced BRAF V600 Wild-Type Melanoma|Recruiting||Phase 1|92|Anticipated|Hoffmann-La Roche||3|||f||||f|t|f||||||||2017-10-10 20:58:18.785538|2017-10-10 20:58:18.785538
NCT03178838|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-06|2017-06-06|||December 3, 2013|Actual|2013-12-03|June 2017|2017-06-01|November 11, 2014|Actual|2014-11-11|November 11, 2014|Actual|2014-11-11||Observational|Paro-Proto||Clinical Study of the Presence of Trichomonas Tenax and Entamoeba Gingivalis in Patients With Periodontitis|Preliminary Clinical Study of the Presence of Trichomonas Tenax and Entamoeba Gingivalis in Patients With Periodontitis Consulting to CHU of Nancy, in Periodontal Department.|Completed||N/A|50|Actual|Central Hospital, Nancy, France|||1||f||||t|f|f||||||No|Commission Nationale de l'Informatique et des libertés|2017-10-10 20:58:18.940279|2017-10-10 20:58:18.940279
NCT03178825|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-25|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|October 30, 2018|Anticipated|2018-10-30|October 21, 2018|Anticipated|2018-10-21||Interventional|||Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause|Safety and Efficacy of Hybrid Fractional Laser Treatment for Symptoms of Genitourinary Syndrome of Menopause|Recruiting||N/A|60|Anticipated|Sciton||1|||f||||f|f|t|f|||||||2017-10-10 20:58:19.000818|2017-10-10 20:58:19.000818
NCT03178812|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-06-05|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)|The Role of the Cystic Fluid Interleukins 1,8, & 10 and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)|Not yet recruiting||N/A|30|Anticipated|Hillel Yaffe Medical Center||2|||f||||t|f|f||||||No||2017-10-10 20:58:19.111074|2017-10-10 20:58:19.111074
NCT03178799|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-27|||June 23, 2017|Actual|2017-06-23|June 2017|2017-06-01|December 31, 2028|Anticipated|2028-12-31|December 31, 2028|Anticipated|2028-12-31||Interventional|||Randomized Fracture Liaison Services|Fracture Liaison Service：A Randomized Control Trial|Enrolling by invitation||N/A|400|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:19.201295|2017-10-10 20:58:19.201295
NCT03178786|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-01|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|ExplorArtPD||Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease|Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 20:58:19.276582|2017-10-10 20:58:19.276582
NCT03178773|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-21|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|January 15, 2019|Anticipated|2019-01-15|January 15, 2019|Anticipated|2019-01-15||Interventional|TExTMED+FANSII||TExT-MED + FANS Full Trial|Trial to EXamine Text Messaging for Diabetes in ED Patients Incorporating Social Support - Intervention With Washout|Recruiting||Phase 2|166|Anticipated|University of Southern California||2|||f||||f|f|f||||||||2017-10-10 20:58:19.371261|2017-10-10 20:58:19.371261
NCT03178760|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-05|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|December 15, 2017|Anticipated|2017-12-15|September 15, 2017|Anticipated|2017-09-15||Observational|||Measurement of Optic Nerve Sheath Diameter in Children Without the Increased Intracranial Pressure|Measurement of Optic Nerve Sheath Diameter in Children Without the Increased Intracranial Pressure|Recruiting||N/A|200|Anticipated|Cukurova University|||1||f||||t|f|f||||||Undecided||2017-10-10 20:58:19.498733|2017-10-10 20:58:19.498733
NCT03178747|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-03|||March 7, 2017|Actual|2017-03-07|August 2017|2017-08-01|March 6, 2018|Anticipated|2018-03-06|December 7, 2017|Anticipated|2017-12-07||Interventional|||Tzanck Smear With Methylene Blue Stain for Herpes|A Comparative Study of Tzanck Smear With Methylene Blue Versus Giemsa Stain to Diagnose Herpes Simplex, Herpes Zoster and Varicella Zoster Skin Infections|Recruiting||Phase 3|150|Anticipated|Chulalongkorn University||2|||f||||f|f|f||||||||2017-10-10 20:58:19.568982|2017-10-10 20:58:19.568982
NCT03178734|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-05|||July 22, 2016|Actual|2016-07-22|June 2017|2017-06-01||||September 1, 2019|Anticipated|2019-09-01||Interventional|||Foley Catheter vs a Self-contained Valved Urinary Catheter|Foley Catheter vs a Self-contained Valved Urinary Catheter for Patients Who Cannot Void Spontaneously Immediately After Urogynecologic Procedures|Recruiting||N/A|100|Anticipated|Atlantic Health System||2|||f||||t|f|t|f|f|f|||No||2017-10-10 20:58:19.666206|2017-10-10 20:58:19.666206
NCT03178721|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-05|||June 25, 2017|Anticipated|2017-06-25|May 2017|2017-05-01|July 25, 2018|Anticipated|2018-07-25|June 25, 2018|Anticipated|2018-06-25|1 Year|Observational [Patient Registry]|||Regulatory BCells in Systemic Lupus Erythematosus|Regulatory BCells in Systemic Lupus Erythematosus and Its Relation to Atherosclerosis and Disease Activity|Not yet recruiting||N/A|40|Anticipated|Assiut University|||2||f||||f|f|f||||Samples Without DNA|"     1- 5ml fresh human peripheral whole blood was layered over a ficoll density gradient to     isolate PBMCs. Breg cells will be sorted by fluorescently labelling PBMCs to identify Breg     cells Quantification of the percentage of specific phenotype CD19+ CD38hi CD24hi of B-reg by     using flow cytometry.   "|No||2017-10-10 20:58:19.757684|2017-10-10 20:58:19.757684
NCT03178682|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-05|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|July 1, 2017|Anticipated|2017-07-01||Observational|||Ultrasound Predictors of Early Pregnancy Failure in Patients With Recurrent Pregnancy Loss|Ultrasound Predictors of Early Pregnancy Failure in Patients With Recurrent Pregnancy Loss|Recruiting||N/A|90|Anticipated|Ain Shams University|||1||f|||||f|f||||||Undecided||2017-10-10 20:58:20.003704|2017-10-10 20:58:20.003704
NCT03178669|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-08-21|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|CONDUCT||The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis|A Randomised Dose-Optimisation Study to Evaluate the Efficacy and Safety of Cobitolimod in Moderate to Severe Active Ulcerative Colitis Patients|Recruiting||Phase 2|215|Anticipated|InDex Pharmaceuticals||5|||f||||t|f|f||||||||2017-10-10 20:58:20.088363|2017-10-10 20:58:20.088363
NCT03178656|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-06|||December 15, 2016|Actual|2016-12-15|June 2017|2017-06-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis|RCT Research: the Treatment of Hepatic Carcinoma With Portal Vein Branch Tumor Thrombosis (Resection or Sorafenib)|Recruiting||Phase 4|54|Anticipated|Huazhong University of Science and Technology||2|||f||||t|f|f||||||No||2017-10-10 20:58:20.196285|2017-10-10 20:58:20.196285
NCT03178643|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-05|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|EPiTOMISE||Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)|Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)|Not yet recruiting||Phase 4|246|Anticipated|Duke University||3|||f||||t|f|f|||f|||Undecided||2017-10-10 20:58:20.288999|2017-10-10 20:58:20.288999
NCT03178630|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-21|||February 20, 2017|Actual|2017-02-20|August 2017|2017-08-01|February 2031|Anticipated|2031-02-01|February 2030|Anticipated|2030-02-01||Observational|||MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease|Longitudinal Study for the Assessment of MRI Based Biomarkers as a Predictors of Clinical Endpoints in Pediatric Onset Autoimmune Liver Disease|Recruiting||N/A|115|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f|f|f||||Samples With DNA|"     Plasma and serum samples.   "|||2017-10-10 20:58:20.370037|2017-10-10 20:58:20.370037
NCT03178617|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-18|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|May 19, 2021|Anticipated|2021-05-19|May 19, 2021|Anticipated|2021-05-19||Interventional|||High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Lymphoblastic Lymphoma|Improving Learning and School Functioning in Latino Children With Cancer|Recruiting||N/A|276|Anticipated|City of Hope Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:58:20.453021|2017-10-10 20:58:20.453021
NCT03178604|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-08-02|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|August 2, 2017|Actual|2017-08-02|June 30, 2017|Actual|2017-06-30||Interventional|MChHams||Effectiveness of a Massage Protocol Versus Muscle Chain for Hamstring|Effectiveness of a Massage Protocol Versus Muscle Chain Method for Hamstring Shortening. Randomized Clinical Trial|Completed||N/A|30|Actual|University of Valencia||3|||f||||f|f|f||||||||2017-10-10 20:58:20.559399|2017-10-10 20:58:20.559399
NCT03178591|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-06-05|||October 2014||2014-10-01|January 2017|2017-01-01||||October 2017|Anticipated|2017-10-01||Interventional|||Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor|Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor on Ischemic Burden in Stable Ischemic Heart Disease Patients|Recruiting||Phase 4|100|Anticipated|Chiang Mai University||2|||f||||t||||||||||2017-10-10 20:58:20.643641|2017-10-10 20:58:20.643641
NCT03178578|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-06-03|||May 18, 2017|Actual|2017-05-18|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Prospective Observational Study of the Expectations and Physiological Effects of Fluid Bolus Therapy|A Prospective Observational Study of the Expectations and Physiological Effects of Fluid Bolus Therapy in the Intensive Care Unit|Recruiting||N/A|100|Anticipated|Karolinska Institutet|||1||f||||f|f|f||||||No||2017-10-10 20:58:20.724426|2017-10-10 20:58:20.724426
NCT03178565|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-06-03|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Effects of Mechanical Insufflation-exsufflation on Airway Mucus Clearance in the ICU|The Effects of Mechanical Insufflation-exsufflation for Airway Mucus Clearance Among Mechanically Ventilated ICU Patients: a Randomized Trial|Recruiting||N/A|170|Anticipated|Hospital Moinhos de Vento||2|||f||||f||||||||No||2017-10-10 20:58:20.813212|2017-10-10 20:58:20.813212
NCT03178539|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-09|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|July 30, 2018|Anticipated|2018-07-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||Comparative Study Between the Effect of Diclofanic and Ketorolac in Post Tonsillectomy Pain Management|Comparative Study Between the Effect of Diclofanic and Ketorolac in Post Tonsillectomy Pain Management|Recruiting||Phase 2/Phase 3|100|Anticipated|Assiut University||2|||f||||t|f|f|||f|||No||2017-10-10 20:58:21.268347|2017-10-10 20:58:21.268347
NCT03178526|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-06|||December 24, 2015|Actual|2015-12-24|June 2017|2017-06-01|February 13, 2016|Actual|2016-02-13|January 13, 2016|Actual|2016-01-13||Interventional|||The Effect of Lovastatin Gel in the Treatment of Chronic Periodontitis|The Effect of Lovastatin Gel in the Treatment of Chronic Periodontitis Randomized Controlled Trial Split-mouth|Completed||Phase 2/Phase 3|15|Actual|Islamic Azad University, Tehran||2|||f||||t|f|f||||||No||2017-10-10 20:58:21.384506|2017-10-10 20:58:21.384506
NCT03178513|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-07-07|||June 6, 2017|Actual|2017-06-06|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Post-Acute Physician Home Visit Program|Post-Acute Physician Home Visits: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||||2017-10-10 20:58:21.469342|2017-10-10 20:58:21.469342
NCT03178500|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Clomiphene Citrate Stair-Step Protocol|Clomiphene Citrate Stair-step Protocol for Ovulation Induction in Women With Polycystic Ovarian Syndrome: A Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|Ain Shams Maternity Hospital||2|||f||||f|f|f|||f|||Undecided||2017-10-10 20:58:21.605832|2017-10-10 20:58:21.605832
NCT03178487|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-09-01|||October 25, 2017|Anticipated|2017-10-25|September 2017|2017-09-01|September 27, 2020|Anticipated|2020-09-27|November 5, 2018|Anticipated|2018-11-05||Interventional|SELECT Axis 1||A Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis|Not yet recruiting||Phase 2|228|Anticipated|AbbVie||3|||f||||t|t|f||||||||2017-10-10 20:58:21.703606|2017-10-10 20:58:21.703606
NCT03178474|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-09-14|||December 1, 2015|Actual|2015-12-01|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|June 30, 2017|Actual|2017-06-30||Interventional|||Efficacy of JINLINGGUAN and TOFER Formula in Formula-fed Chinese Term Infants|Efficacy of JINLINGGUAN and TOFER Formula in Formula-fed Chinese Term Infants: A Controlled Trial|Recruiting||N/A|180|Anticipated|Sun Yat-sen University||3|||f||||f|f|f||||||||2017-10-10 20:58:21.809759|2017-10-10 20:58:21.809759
NCT03178461|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-28|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||The Effect of Warmed Parenteral Fluids During Delivery|The Effect of Warmed Parenteral Fluids During Vaginal Delivery and Cesarean Section|Recruiting||N/A|7000|Anticipated|Meir Medical Center||2|||f||||t|f|f||||||||2017-10-10 20:58:21.924374|2017-10-10 20:58:21.924374
NCT03178448|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-04|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2022|Anticipated|2022-12-30||Observational|PRECISE||PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events|PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE)|Recruiting||N/A|2000|Anticipated|Ministry of Science and Technology of the People´s Republic of China|||1||f||||t|f|f||||Samples With DNA|"     Blood and urine samples will also be collected at baseline to test genetic and metabolomic     markers.   "|Yes|The data can be requested through the website of the data management system (http://mrms.trials.com.cn/secure/login) or by sending email to the principal investigators.|2017-10-10 20:58:22.019595|2017-10-10 20:58:22.019595
NCT03178422|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-24|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 23, 2017|Anticipated|2017-10-23||Interventional|||Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects|Open-Label, Multicenter Study Evaluating the Safety and Efficacy of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2) System (21mg) Compared to the NicoDerm® CQ® Patch (21mg) for Smoking Cessation in Treatment Seeking Subjects|Recruiting||Phase 2|220|Anticipated|Chrono Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 20:58:22.222278|2017-10-10 20:58:22.222278
NCT03178409|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-05|||January 1, 2004|Actual|2004-01-01|June 2017|2017-06-01|May 15, 2017|Actual|2017-05-15|December 31, 2014|Actual|2014-12-31||Observational|||Combined HCC-MFCCC|Survival After Hepatectomy for Combined Hepatocellular Cholagiocarcinoma|Completed||N/A|100|Actual|University of Milan|||3||f||||f|f|f||||||No||2017-10-10 20:58:22.38784|2017-10-10 20:58:22.38784
NCT03178396|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-06|||December 7, 2015|Actual|2015-12-07|June 2017|2017-06-01|August 9, 2016|Actual|2016-08-09|August 9, 2016|Actual|2016-08-09||Interventional|||Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets|Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets|Completed||N/A|31|Actual|Thomas Jefferson University||4|||f||||t|f|f||||||Yes|Summarized data, available immediately by contacting PI|2017-10-10 20:58:22.456378|2017-10-10 20:58:22.456378
NCT03178383|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-05|||July 1, 2016|Actual|2016-07-01|June 2017|2017-06-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Integration of Cancer Health Activities Into African American Churches|Integration of Cancer Health Activities Into African American Churches|Recruiting||N/A|642|Anticipated|University of Maryland||2|||f|||||f|f||||||||2017-10-10 20:58:22.546805|2017-10-10 20:58:22.546805
NCT03178370|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-05|||March 6, 2014|Actual|2014-03-06|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|December 31, 2017|Anticipated|2017-12-31||Observational|||Gastroparesis Syndromes: Pathophysiology and Response to Electrical Stimulation|Autonomic Dysregulation and Enteric Nerve Changes in the Pathophysiology of Diabetic Gastroparesis|Active, not recruiting||N/A|43|Actual|University of Louisville|||2||f||||f|f|t|f|f|t|Samples Without DNA|"     Serum   "|Undecided|No plan in place.|2017-10-10 20:58:22.637053|2017-10-10 20:58:22.637053
NCT03178357|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-05|2017-06-05|||June 6, 2017|Anticipated|2017-06-06|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Cardiac Rehabilitation in Patients With HCM Without LV Outflow Tract Obstruction With Preserved EF - Pilot Study|"Efficacy and Safety of Cardiac Rehabilitation in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction With Preserved Systolic Function - Pilot Study"|Not yet recruiting||N/A|30|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||t|f|f||||||No||2017-10-10 20:58:22.711411|2017-10-10 20:58:22.711411
NCT03178344|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-29|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|AIMS1||Effect of tACS Stimulation on Alpha Oscillations|Rational Optimization of tACS for Targeting Thalamo-Cortical Oscillations (Experiment 2)|Recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|t|t|f|f|||||2017-10-10 20:58:22.79281|2017-10-10 20:58:22.79281
NCT03178331|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-18|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31|12 Months|Observational [Patient Registry]|||Who Needs a School Doctor's Health Check?|Who Needs a School Doctor's Health Check: an Observational Study of a Screening Method in Finland|Recruiting||N/A|1050|Anticipated|Helsinki University|||2||f||||f|f|f||||||||2017-10-10 20:58:22.895173|2017-10-10 20:58:22.895173
NCT03178318|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-05|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|ULOC||Study Assessing the Position of Cricothyroid Membrane in Relation to Movement of Neck From Neutral to Extended Position|An Observational Study Assessing the Position of Cricothyroid Membrane in Relation to Movement of Neck From Neutral to Extended Position|Not yet recruiting||N/A|20|Anticipated|Northampton General Hospital NHS Trust||1|||f||||f|f|f||||||No||2017-10-10 20:58:22.989825|2017-10-10 20:58:22.989825
NCT03178305|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-05|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|November 1, 2017|Anticipated|2017-11-01||Interventional|Do CHANGE-2||Do Cardiac Health: Advanced New Generation Ecosystem - Phase 2|Do Cardiac Health: Advanced New Generation Ecosystem - Phase 2|Not yet recruiting||N/A|250|Anticipated|Elisabeth-TweeSteden Ziekenhuis||2|||f||||t|f|f||||||No||2017-10-10 20:58:23.062104|2017-10-10 20:58:23.062104
NCT03178292|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-05|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|June 15, 2017|Anticipated|2017-06-15|June 15, 2017|Anticipated|2017-06-15||Interventional|||Conventional Antibiotic Prophylaxis Versus Add-On 5 Days Levofloxacin Before Percutaneous Nephrolithotomy|Conventional Antibiotic Prophylaxis Versus Add-On 5 Days Levofloxacin Before Percutaneous Nephrolithotomy (PCNL)|Not yet recruiting||N/A|300|Anticipated|Mansoura University||2|||f||||t|f|f|||f|||Yes|Yes meta-analyses by contact the Prof. Ahmed Shoma, MD, Phd (Study Chair)|2017-10-10 20:58:23.165547|2017-10-10 20:58:23.165547
NCT03178279|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-15|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||The Evaluation of the Use of a New Physical Health Plan|An Evaluation of the Use of a Physical Health Plan With People With Psychosis|Not yet recruiting||N/A|300|Anticipated|King's College London||1|||f||||f|f|f||||||||2017-10-10 20:58:23.248866|2017-10-10 20:58:23.248866
NCT03178266|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-02|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 15, 2018|Anticipated|2018-01-15|December 31, 2017|Anticipated|2017-12-31||Observational|ZAPS||Zip Arthroplasty Patient Satisfaction Evaluation|Zip Arthroplasty Patient Satisfaction Evaluation|Not yet recruiting||N/A|40|Anticipated|ZipLine Medical Inc.|||2||f||||f|f|f||||||||2017-10-10 20:58:23.321971|2017-10-10 20:58:23.321971
NCT03178253|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-06|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy|Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy|Enrolling by invitation||N/A|100|Anticipated|Assiut University|||1||f||||f|f|f||||||Undecided||2017-10-10 20:58:23.397283|2017-10-10 20:58:23.397283
NCT03178240|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||February 1, 2018|Anticipated|2018-02-01|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Sunface Mirroring RCT in Brazil|Randomized Trial of a Photoaging Mirroring Intervention for Skin Cancer Prevention in Secondary Schools in Brazil - Study Protocol|Not yet recruiting||N/A|1000|Anticipated|University of Giessen||2|||f||||f|f|f||||||No||2017-10-10 20:58:23.456854|2017-10-10 20:58:23.456854
NCT03178227|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||February 1, 2018|Anticipated|2018-02-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Smokerface Mirroring in Brazil RCT|Randomized Trial of a Photoaging Mirroring Intervention to Prevent Smoking in Secondary Schools in Brazil - Study Protocol|Not yet recruiting||N/A|1000|Anticipated|University of Giessen||2|||f|||||f|f||||||||2017-10-10 20:58:23.513147|2017-10-10 20:58:23.513147
NCT03178214|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-06-05|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration|A Single Centre, Open-label, Randomised, Single Dose, Three-period, Crossover Study to Evaluate the Bioavailability of Infacort Administered as Sprinkles With Soft Food and Yoghurt Compared With Direct Administration to the Back of the Tongue in Dexamethasone-suppressed Healthy Adult Male Subjects|Recruiting||Phase 1|18|Anticipated|Diurnal Limited||3|||f||||f|f|f|||f|||No||2017-10-10 20:58:23.590332|2017-10-10 20:58:23.590332
NCT03178201|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-07|||July 5, 2017|Anticipated|2017-07-05|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||TGR1202 in Relapsed and Refractory Follicular Lymphoma|Phase II Study of the Phosphoinositide-3-Kinase-Delta Inhibitor TGR-1202 in Patients With Relapsed or Refractory Follicular Lymphoma|Recruiting||Phase 2|20|Anticipated|Columbia University||1|||f||||t|t|f||||||No||2017-10-10 20:58:23.676596|2017-10-10 20:58:23.676596
NCT03178188|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-05|||December 15, 2016|Actual|2016-12-15|June 2017|2017-06-01|December 14, 2017|Anticipated|2017-12-14|December 14, 2017|Anticipated|2017-12-14||Interventional|||Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus Erythematosus|Efficacy of 595 nm Pulsed-dye Laser as an Adjunctive Treatment of Discoid Lupus Erythematosus, A Randomized, Patient/Assessor Blinded Placebo Control Trial|Recruiting||Phase 2/Phase 3|24|Anticipated|Chulalongkorn University||2|||f||||f|f|f||||||No||2017-10-10 20:58:23.758104|2017-10-10 20:58:23.758104
NCT03178175|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-05|||December 29, 2016|Actual|2016-12-29|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Acupuncture for Management of Balance Impairment in Patients With Parkinson's Disease|Acupuncture for Management of Balance Impairment in Patients With Parkinson's Disease: A Single Blinded Randomised Controlled Study|Recruiting||N/A|26|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:58:23.829751|2017-10-10 20:58:23.829751
NCT03178162|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-03|||December 1, 2015|Actual|2015-12-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|||Evaluation of a Non-invasive Cardiac Output Monitoring System.|Evaluation of a Non-invasive Cardiac Output Monitoring System in Comparison to the Semi-invasive Monitoring System FloTrac VigileoTechnology in Elderly Patients.|Completed||N/A|60|Actual|University of Schleswig-Holstein|||1||f||||f|f|f||||||No||2017-10-10 20:58:23.908396|2017-10-10 20:58:23.908396
NCT03178149|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-19|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|October 2026|Anticipated|2026-10-01|April 2021|Anticipated|2021-04-01||Interventional|||A Phase 1b Dose Escalation Evaluation of Safety and Tolerability and a Phase 2 Proof of Concept Investigation of Efficacy and Safety of ASP7317 for Atrophy Secondary to Age-related Macular Degeneration|A Staged Study Incorporating a Phase 1b, Multicenter, Unmasked, Dose Escalation Evaluation of Safety and Tolerability and a Phase 2, Multicenter, Unmasked, Randomized, Parallel Group, Controlled, Proof of Concept Investigation of Efficacy and Safety of ASP7317 for Atrophy Secondary to Age-related Macular Degeneration|Not yet recruiting||Phase 1/Phase 2|150|Anticipated|Astellas Pharma Inc||6|||f||||t|t|f||||||||2017-10-10 20:58:23.962854|2017-10-10 20:58:23.962854
NCT03178136|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-06-04|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2018|Anticipated|2018-06-01||Observational|||HR-HPV Multi-site Opportunistic Screening in Liaoning, China|HR-HPV Multi-site Opportunistic Screening in Liaoning, China|Not yet recruiting||N/A|10000|Anticipated|Shengjing Hospital|||2||f||||t|f|f||||Samples With DNA|"     blood, cervical cell   "|No||2017-10-10 20:58:24.079378|2017-10-10 20:58:24.079378
NCT03178123|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-06-04|||May 31, 2017|Actual|2017-05-31|May 2017|2017-05-01|April 30, 2025|Anticipated|2025-04-30|April 30, 2022|Anticipated|2022-04-30||Interventional|||The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery|A Phase II Randomized, Control, Multi-center Study of Recombinant Humanized Anti-PD-1 mAb for Injection Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery|Recruiting||Phase 2|220|Anticipated|Shanghai Junshi Bioscience Co.,Ltd.||2|||f||||t|f|f||||||Yes||2017-10-10 20:58:24.168669|2017-10-10 20:58:24.168669
NCT03178110|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer|Effectiveness of Manual Therapy in Combination With a Dynamic Splint (Dynasplint) in the Treatment of Trismus in Patients With Head and Neck Cancer: A Pilot Study|Not yet recruiting||N/A|10|Anticipated|University of Alberta||1|||f||||f|f|f||||||Undecided|No plan in place at this time.|2017-10-10 20:58:24.275892|2017-10-10 20:58:24.275892
NCT03178097|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-03|||December 1, 2015|Actual|2015-12-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|||Evaluation of a Non-invasive Cardiac Output Monitoring System.|Evaluation of a Non-invasive Cardiac Output Monitoring System in Comparison to the Semi-invasive Monitoring System FloTrac VigileoTechnology in Elderly Patients.|Completed||N/A|60|Actual|University of Schleswig-Holstein|||1||f||||f|f|f||||||No||2017-10-10 20:58:24.361014|2017-10-10 20:58:24.361014
NCT03178084|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-06-05|||October 15, 2014|Actual|2014-10-15|June 2017|2017-06-01|March 7, 2017|Actual|2017-03-07|November 5, 2016|Actual|2016-11-05||Interventional|MeritRate||Effects of Maraviroc vs. Efavirenz on CD4/CD8 Ratio|The Effects of Maraviroc Versus Efavirenz in Combination With Zidovudine/Abacavir on the CD4/CD8 Ratio in Treatment-naïve HIV-infected Individuals|Completed||Phase 3|721|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||3|||f||||t|t|f|||t|||No||2017-10-10 20:58:24.420943|2017-10-10 20:58:24.420943
NCT03178071|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-10-04||||||October 2017|2017-10-01||||||||Expanded Access|||Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer Harboring Specific Molecular Alterations|An Expanded Access Protocol For Lorlatinib For Treatment Of Patients With Advanced Non-small Cell Lung Cancer Harboring Specific Molecular Alterations|Available||N/A|||Pfizer||||||t|||||||||||||2017-10-10 20:58:24.494948|2017-10-10 20:58:24.494948
NCT03178058|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-05|||October 2016||2016-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Risk Factors for Postoperative Nausea, Vomiting and Pruritus|Risk Factors for Nausea, Vomiting and Pruritus After Neuraxial Morphine for Cesarean Section|Recruiting||N/A|100|Anticipated|Rabin Medical Center|||1||f||||f||||||||||2017-10-10 20:58:24.5574|2017-10-10 20:58:24.5574
NCT03178045|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-26|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients|Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients|Recruiting||N/A|1700|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f|||||f|f||||||||2017-10-10 20:58:24.636316|2017-10-10 20:58:24.636316
NCT03178032|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-03|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|December 30, 2019|Anticipated|2019-12-30|August 30, 2019|Anticipated|2019-08-30||Interventional|||Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas|Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.|Recruiting||Phase 1|12|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||t|t|f|||t|||Yes|During the trail the results will be presented in scientific meetings. After the trial, a paper will be published by the IP|2017-10-10 20:58:24.720756|2017-10-10 20:58:24.720756
NCT03178019|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-06|||February 1, 2014|Actual|2014-02-01|June 2017|2017-06-01|December 1, 2016|Actual|2016-12-01|December 1, 2015|Actual|2015-12-01||Observational|DPP4||DPP4 Activity, Microvascular Reactivity and Inflammation|Dipeptidyl Peptidase 4 (DPP4) Activity and Its Associations With Endothelial Dysfunction, Inflammatory and Metabolic Markers, Heart Rate and Blood Pressure Variability, and Measures of Adiposity in Subjects With Different Grades of Glucose Tolerance|Completed||N/A|52|Actual|Rio de Janeiro State University|||3||f||||f|f|f||||||No||2017-10-10 20:58:24.819644|2017-10-10 20:58:24.819644
NCT03178006|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-06|||January 5, 2015|Actual|2015-01-05|June 2017|2017-06-01|November 4, 2016|Actual|2016-11-04|November 4, 2016|Actual|2016-11-04||Observational|||Correlation Between Intestinal Microbiota, Inflamatory Biomarkers, Intestinal Morphology, Hepatic Fibrosis Degree and Vascular Reactivity.|Correlation Between Intestinal Microbiota, Inflamatory Biomarkers, Intestinal Morphology, Hepatic Fibrosis Degree and Vascular Reactivity in Patients With Different Degrees of Glucose Tolerance and Body Adiposity.|Completed||N/A|47|Actual|Rio de Janeiro State University|||3||f|||||f|f||||||||2017-10-10 20:58:24.900176|2017-10-10 20:58:24.900176
NCT03177993|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-13|||July 13, 2017|Actual|2017-07-13|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|FIT||Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji|Community Based Safety Study of 2-drug (Diethylcarbamazine and Albendazole) Versus 3-drug (Ivermectin, Diethylcarbamazine and Albendazole) Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji|Recruiting||N/A|4000|Anticipated|Washington University School of Medicine||3|||f||||t|f|f||||||||2017-10-10 20:58:24.950305|2017-10-10 20:58:24.950305
NCT03177980|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-06-02|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|November 30, 2019|Anticipated|2019-11-30||Observational|||Fentanyl and Clonidine for Analgesia During Hypothermia in Term Asphyxiated Infants|Fentanyl and Clonidine for Analgesia During Hypothermia in Term Asphyxiated Infants - a Prospective Pharmacokinetic/Pharmacodynamic/Pharmacogenetic Observational Study. Cohort 1 in The SANNI Project.|Recruiting||N/A|50|Anticipated|Region Skane|||2||f||||f|f|f|||f|Samples With DNA|"     Whole blood   "|No||2017-10-10 20:58:25.196257|2017-10-10 20:58:25.196257
NCT03145545|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05||||||May 2017|2017-05-01||||||||Expanded Access|||Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC|Expanded Access Protocol Using TCR Alpha/Beta T Cell/CD19+ Depleted Unrelated Donor or Partially Matched Related Donor Peripheral Stem Cells|Available||N/A|||Children's Hospital of Philadelphia||||||||t|||||||||||2017-10-10 21:05:24.64583|2017-10-10 21:05:24.64583
NCT03177954|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Developing a Patient Oriented Discharge Summary for Stroke Inpatients|Developing and Piloting a Patient Oriented Discharge Summary (PODS) Program to Facilitate a Successful Transition From Inpatient Stroke Rehab to Home|Not yet recruiting||N/A|20|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f|f|f||||||No||2017-10-10 20:58:25.468808|2017-10-10 20:58:25.468808
NCT03177941|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Teaching Skin Self-Examination to First-degree Relatives of Melanoma Patients Using Mobile App Technology|Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention (SBIR Topic 342, Direct to Phase II- Vignet, Inc.)|Not yet recruiting||N/A|600|Anticipated|Northwestern University||2|||f||||t|f|f||||||Yes|Publish results|2017-10-10 20:58:25.557669|2017-10-10 20:58:25.557669
NCT03177928|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-05|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|February 28, 2019|Anticipated|2019-02-28|August 31, 2018|Anticipated|2018-08-31||Interventional|||Cardiac Changes in Myeloproliferative Neoplasms|Functional and Morphological Cardiac Changes in Myeloproliferative Neoplasms|Not yet recruiting||N/A|40|Anticipated|Assiut University||3|||f||||f|f|f||||||No||2017-10-10 20:58:25.668065|2017-10-10 20:58:25.668065
NCT03177915|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-05|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Median Nerve Hydro-dissection Using Single Injection of Hyaluronic Acid as a Novel Treatment of Carpal Tunnel Syndrome|Median Nerve Hydro-dissection Using Single Injection of Hyaluronic Acid as a Novel Treatment of Carpal Tunnel Syndrome: Double Blind Randomized Clinical Trial|Completed||N/A|60|Actual|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 20:58:25.759393|2017-10-10 20:58:25.759393
NCT03177902|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-06|||June 4, 2017|Actual|2017-06-04|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Observational|||Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer|A Prospective Study to Assess Both Thyroid Abnormity Incidence In Chinese Women With Newly Diagnosed Breast Cancer and Thyroid Toxicity of Breast Cancer Patients Undergoing Chemotherapy|Recruiting||N/A|400|Anticipated|First Affiliated Hospital Bengbu Medical College|||2||f||||t|f|f||||||||2017-10-10 20:58:25.88027|2017-10-10 20:58:25.88027
NCT03177889|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-05|||July 31, 2018|Anticipated|2018-07-31|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2019|Anticipated|2019-08-31||Interventional|LUNG-CLEAR||Lung Dispersing, Turbid Descending and Gut Clearing Decoction for Bronchiectasis|Efficacy and Safety of Lung Dispersing, Turbid Descending and Gut Clearing Decoction on Clinically Stable Bronchiectasis (LUNG-CLEAR): A Multicenter, Randomized, Cross-over Trial|Not yet recruiting||N/A|80|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||t|f|f||||||Yes||2017-10-10 20:58:25.975682|2017-10-10 20:58:25.975682
NCT03177876|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-05|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Sinus Lift With Hydroxyapatite Nano Particles Versus Tenting Technique|Schneiderian Membrane Elevation and Augmentation With Hydroxyapatite Nano Particles [ Nano Streams ] Versus Graft Less Tenting Technique With Simultaneous Implant Placement: Randomized Clinical Trial|Active, not recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||Yes||2017-10-10 20:58:26.088301|2017-10-10 20:58:26.088301
NCT03177863|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-12|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|EXCIN2||Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age|Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age. A Multicenter Clinical Study|Recruiting||N/A|160|Anticipated|Sahlgrenska University Hospital, Sweden||1|||f||||f|f|f||||||No||2017-10-10 20:58:26.16815|2017-10-10 20:58:26.16815
NCT03177850|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-05|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Respiratory Disease at Altitude|Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Chronic Obstructive Pulmonary Disease at Altitude, Assessed by Respiratory Polygraphy: A Randomized, Placebo-controlled, Double-blind Parallel Trial|Recruiting||Phase 4|180|Anticipated|University of Zurich||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:26.287656|2017-10-10 20:58:26.287656
NCT03177837|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-05|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Acetazolamide on Exercise Performance in Patients With Respiratory Disease at Altitude|Effect of Acetazolamide on Exercise Performance in Patients With Chronic Obstructive Pulmonary Disease at Altitude, Assessed by Maximal Cycling Spiroergometry: A Randomized, Placebo-controlled, Double-blind Parallel Trial|Recruiting||Phase 4|100|Anticipated|University of Zurich||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:26.393303|2017-10-10 20:58:26.393303
NCT03177824|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-06-08|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|September 30, 2017|Anticipated|2017-09-30||Interventional|||Sildenafil Citrate for Treatment of Growth-restricted Fetuses|Sildenafil Citrate for Treatment of Growth-restricted Fetuses|Recruiting||Phase 3|60|Anticipated|Ain Shams University||2|||f|||||f|f|||f|||||2017-10-10 20:58:26.508686|2017-10-10 20:58:26.508686
NCT03177811|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-05|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Acetazolamide on Postural Control in Patients With Respiratory Disease at Altitude|Effect of Acetazolamide on Postural Control in Patients With Chronic Obstructive Pulmonary Disease at Altitude: A Randomized, Placebo-controlled, Double-blind Parallel Trial|Recruiting||Phase 4|100|Anticipated|University of Zurich||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:26.610558|2017-10-10 20:58:26.610558
NCT03177798|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|MitoCKD||Mitochondria and Chronic Kidney Disease|Mitochondrial Dysfunction in Chronic Kidney Disease|Active, not recruiting||Phase 2|11|Anticipated|Vanderbilt University Medical Center||2|||f||||t|t|f||||||||2017-10-10 20:58:26.712568|2017-10-10 20:58:26.712568
NCT03177785|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-06-02|||August 4, 2016|Actual|2016-08-04|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Testing a Resilience Intervention for Individuals Aging With Multiple Sclerosis (MS)|Testing a Resilience Intervention for Individuals Aging With Multiple Sclerosis (MS)|Completed||N/A|31|Actual|University of Washington||2|||f||||||||||||No||2017-10-10 20:58:26.796498|2017-10-10 20:58:26.796498
NCT03177772|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-05|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|June 2020|Anticipated|2020-06-01||Observational|PLGT||Group Therapy For Dementia Caregivers At Risk For Complicated Grief|Group Therapy For Dementia Caregivers At Risk For Complicated Grief|Not yet recruiting||N/A|80|Anticipated|University of Utah|||3||f||||f|f|f||||||Undecided|Research protocol is registered in Open Science Framework. Individual de-identified participant data available only through direct request to PI.|2017-10-10 20:58:26.872867|2017-10-10 20:58:26.872867
NCT03177759|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-02|||September 9, 2016|Actual|2016-09-09|June 2017|2017-06-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Observational|LPC||Living With Prostate Cancer (LPC)|Evaluating a Group Therapy Intervention to Alleviate Psychological Distress in Men With Prostate Cancer: An Assessment of a Group Therapy Program From Vancouver's Prostate Cancer Supportive Care (PCSC) Program|Recruiting||N/A|72|Anticipated|Vancouver Prostate Centre|||1||f||||f|f|f||||||No||2017-10-10 20:58:26.95306|2017-10-10 20:58:26.95306
NCT03177746|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-23|||June 23, 2017|Actual|2017-06-23|June 2017|2017-06-01|December 3, 2017|Anticipated|2017-12-03|November 3, 2017|Anticipated|2017-11-03||Interventional|||The Safety of Dapoxetine/Tadalafil Combination Therapy|The Safety of Dapoxetine/Tadalafil Combination Therapy in Treatment of Men With Premature Ejaculation and Erectile Dysfunction|Active, not recruiting||Phase 4|40|Anticipated|Neutec Ar-Ge San ve Tic A.Ş||1|||f||||f|f|f||||||Undecided||2017-10-10 20:58:27.038682|2017-10-10 20:58:27.038682
NCT03177733|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-28|||June 10, 2017|Actual|2017-06-10|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Evaluation of a Breast Double Block Analgesia for the Mastectomy With Radical Axillary Lymphadenectomy Surgery|Evaluation of a Breast Double Block Analgesia for the Mastectomy With Radical Axillary Lymphadenectomy Surgery|Recruiting||N/A|8|Anticipated|Maison de Santé Prostestante de Bordeaux Bagatelle|||1||f||||f|f|f||||||||2017-10-10 20:58:27.125898|2017-10-10 20:58:27.125898
NCT03177720|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-02|||May 29, 2016|Actual|2016-05-29|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Evaluation of Innovative Tools in Development of Antibiotics|Determination of Single-dose Intrapulmonary Pharmacokinetics of Ciprofloxacin and Imipenem in Healthy Subjects and Intubated Patients Suffering From Pneumonia Using Bronchoalveolar Lavage|Recruiting||Phase 1|42|Anticipated|Medical University of Vienna||2|||f|||||f|f||||||||2017-10-10 20:58:27.242655|2017-10-10 20:58:27.242655
NCT03177707|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-02|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|IMPPACT||Intimacy and Mindfulness Post-Prostate Cancer Treatment|Mindfulness-based Therapy Group Intervention for Couple's Dealing With Sexual Dysfunction After Prostate-cancer Treatment|Recruiting||N/A|84|Anticipated|Vancouver Prostate Centre||2|||f||||f|f|f||||||No||2017-10-10 20:58:27.349212|2017-10-10 20:58:27.349212
NCT03177694|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-02|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|"MoniToux"||A Wireless Bed Sensor for Monitoring Coughs|A Prospective Observational Pilot Study to Evaluate the Reliability and Usability of a Wireless Bed Sensor Connected to a Medical Data Analysis Platform to Monitor Coughs in Hospitalized Patients Suffering From Respiratory Diseases|Not yet recruiting||N/A|20|Anticipated|Ligue Pulmonaire Neuchâteloise|||1||f|||||f|f||||||Undecided||2017-10-10 20:58:27.448267|2017-10-10 20:58:27.448267
NCT03177681|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-09-07|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms|The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms|Not yet recruiting||N/A|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 20:58:27.515332|2017-10-10 20:58:27.515332
NCT03177668|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-02|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma|Phase I/II Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma|Recruiting||Phase 1/Phase 2|48|Anticipated|Kissei Pharmaceutical Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 20:58:27.61418|2017-10-10 20:58:27.61418
NCT03177655|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-05|||March 1, 2012|Actual|2012-03-01|June 2017|2017-06-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|HLGI||Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis|Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis|Completed||N/A|20|Actual|University of California, San Diego||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:27.686895|2017-10-10 20:58:27.686895
NCT03177642|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||April 18, 2017|Actual|2017-04-18|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Orthopaedic Hand and Upper Extremity Data Repository|Orthopaedic Hand and Upper Extremity Data Repository|Enrolling by invitation||N/A|3000|Anticipated|Massachusetts General Hospital|||1||f||||f|f|f||||||No||2017-10-10 20:58:27.752643|2017-10-10 20:58:27.752643
NCT03177629|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-06|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||H. Pylori Eradication for Moderate ITP|Efficacy of Helicobacter Pylori Eradication for the Treatment of Chronic or Persistent Immune Thrombocytopenic Purpura Patients With Moderate Thrombocytopenia: Multicenter Prospective Randomized Phase 3 Study|Recruiting||Phase 3|54|Anticipated|Seoul National University Hospital||3|||f|||||f|f||||||No||2017-10-10 20:58:27.806653|2017-10-10 20:58:27.806653
NCT03177616|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-03|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|IMPACT||Integrative Migraine Pain Alleviation Through Chiropractic Therapy|Integrative Migraine Pain Alleviation Through Chiropractic Therapy|Recruiting||N/A|60|Anticipated|Harvard University Faculty of Medicine||2|||f||||t|f|f||||||||2017-10-10 20:58:27.90502|2017-10-10 20:58:27.90502
NCT03177603|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-10-05|||February 21, 2018|Anticipated|2018-02-21|October 2017|2017-10-01|October 28, 2019|Anticipated|2019-10-28|October 28, 2019|Anticipated|2019-10-28||Interventional|||A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)|An Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2586881 in Participants With Pulmonary Arterial Hypertension|Not yet recruiting||Phase 2|25|Anticipated|GlaxoSmithKline||4|||f||||f|t|f||||||||2017-10-10 20:58:28.002976|2017-10-10 20:58:28.002976
NCT03144817|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-25|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|DeSaLT||Dialysate Sodium Lowering Trial|Dialysate Sodium Lowering Trial|Recruiting||Phase 2|40|Anticipated|Tufts Medical Center||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:05:33.516381|2017-10-10 21:05:33.516381
NCT03177590|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-02|||May 10, 2016|Actual|2016-05-10|June 2017|2017-06-01|July 10, 2017|Anticipated|2017-07-10|July 10, 2017|Anticipated|2017-07-10||Interventional|||Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project|Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project|Recruiting||N/A|30|Anticipated|Fondation Lenval||1|||f||||f|f|f||||||No||2017-10-10 20:58:28.098309|2017-10-10 20:58:28.098309
NCT03177577|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-07|||December 29, 2016|Actual|2016-12-29|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Strengthening of the First Dorsal Interosseous for Thumb Carpometacarpal Osteoarthritis|Strengthening of the First Dorsal Interosseous for Thumb Carpometacarpal Osteoarthritis|Enrolling by invitation||N/A|30|Anticipated|Massachusetts General Hospital||2|||f||||f|f|||||||No||2017-10-10 20:58:28.228567|2017-10-10 20:58:28.228567
NCT03177564|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-05|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|June 10, 2018|Anticipated|2018-06-10|June 10, 2018|Anticipated|2018-06-10||Interventional|||Driving Pressure Limited Ventilation During Video-assisted Thoracoscopic Lobectomy|A Randomized Controlled Trial to Assess the Feasiblity of a Driving Pressure Limited Ventilation vs.Standard Strategy During Video-assisted Thoracoscopic Lobectomy|Recruiting||N/A|90|Anticipated|The Affiliated Hospital of Xuzhou Medical University||3|||f||||t|f|f||||||No||2017-10-10 20:58:28.304986|2017-10-10 20:58:28.304986
NCT03177551|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-02|||May 4, 2017|Actual|2017-05-04|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Observational|CRPC-PN||Predictive Nomogram of CRPC|Development and Validation of Predictive Nomogram for Castration Resistant to Androgen Deprivation Therapy in Patients With Advanced Prostate Cancer|Recruiting||N/A|300|Anticipated|Tianjin Medical University Second Hospital|||2||f||||t|f|f||||||Yes|IPD could be got by contacting researchers.|2017-10-10 20:58:28.405496|2017-10-10 20:58:28.405496
NCT03177538|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-19|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|TEMPER||Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders|Open Randomized Study Comparing Clinical Efficacy of Corifollitropin Alfa (Elonva) in Combination With Menotropin (Merional) With Follitropin and Lutropin Alfa (Pergoveris) for Ovarian Stimulation in Expected Suboptimal Responders|Recruiting||Phase 4|40|Anticipated|D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology||2|||f|||||f|f||||||||2017-10-10 20:58:28.477848|2017-10-10 20:58:28.477848
NCT03177525|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-13|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Parent Training to Enhance Social Success for Children With Autism Spectrum Disorder|Parent Training to Enhance Social Success for Children With Autism Spectrum Disorder|Recruiting||N/A|50|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 20:58:28.578121|2017-10-10 20:58:28.578121
NCT03177512|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-06-02|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing and Pre-exposure Prophylaxis (PrEP) for Young Men Who Have Sex With Men|LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing and Pre-exposure Prophylaxis (PrEP) for Young Men Who Have Sex With Men|Not yet recruiting||N/A|60|Anticipated|Public Health Foundation Enterprises, Inc.||2|||f||||f|f|f||||||No||2017-10-10 20:58:28.665442|2017-10-10 20:58:28.665442
NCT03177499|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-10-03|||August 24, 2017|Actual|2017-08-24|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|vePPG||Virtual Imaging-based Early Portal Pressure Gradient (vePPG) (CHESS1702)|Virtual Imaging-based Early Portal Pressure Gradient (vePPG) After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension|Recruiting||N/A|80|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t|f|f||||||||2017-10-10 20:58:28.790197|2017-10-10 20:58:28.790197
NCT03177486|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-05|||December 1, 2015|Actual|2015-12-01|June 2017|2017-06-01|November 18, 2016|Actual|2016-11-18|November 18, 2016|Actual|2016-11-18||Observational|||Frank Score and Coronary Artery Disease|Frank Score and Its Guidance Significance of Making Treatment Strategy in Coronary Artery Disease|Completed||N/A|364|Actual|Shaanxi Provincial People's Hospital|||1||f|||||f|f||||||||2017-10-10 20:58:28.921112|2017-10-10 20:58:28.921112
NCT03177473|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-27|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|May 15, 2020|Anticipated|2020-05-15|May 15, 2019|Anticipated|2019-05-15|12 Months|Observational [Patient Registry]|||Study Using the CervicalStim Device Following Cervical Fusion|A Multi-Center, Open-Label, Prospective Study of CervicalStim Device™ as Adjunctive Care Following Cervical Fusion|Enrolling by invitation||N/A|500|Anticipated|Orthofix Inc.|||1||f||||f|f|t|f|f|f|||Undecided|if we decide to share, we will share only deidentified summary data|2017-10-10 20:58:28.996136|2017-10-10 20:58:28.996136
NCT03177460|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-13|||June 7, 2017|Actual|2017-06-07|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Pilot Presurgical Study of Daratumumab in Men With High-Risk Localized Prostate Cancer|A Pilot Presurgical Study of Daratumumab (CD38 Antagonist) in Men With High-Risk Localized Prostate Cancer Followed by Radical Prostatectomy|Recruiting||Phase 1|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 20:58:30.91153|2017-10-10 20:58:30.91153
NCT03177447|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-05|||July 1, 2013|Actual|2013-07-01|June 2017|2017-06-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||ENABLE: CHF-PC (Comprehensive Heartcare For Patients and Caregivers)|ENABLE: CHF-PC (Educate, Nurture, Advise, Before Life Ends: Comprehensive Heartcare for Patients and Caregivers)|Completed||N/A|62|Actual|University of Alabama at Birmingham||1|||f||||f|f|f||||||No|There is no plan to make individual participant data (IPD) available to other researchers.|2017-10-10 20:58:31.014416|2017-10-10 20:58:31.014416
NCT03177434|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-06-04|||February 2016||2016-02-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years.|Multicenter Study Evaluating the Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years. A Prospective, Randomized Study.|Recruiting||Phase 4|102|Anticipated|Children's Memorial Health Institute, Poland||2|||f||||t||||||||Yes|publication|2017-10-10 20:58:31.095202|2017-10-10 20:58:31.095202
NCT03177421|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-15|||June 13, 2017|Actual|2017-06-13|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Health Information Technology to Improve Bedtime Media Use in Children|Improving Bedtime Media Use and Sleep Through Health Information Technology|Enrolling by invitation||N/A|60100|Anticipated|Indiana University||2|||f||||f|f|f||||||||2017-10-10 20:58:31.201768|2017-10-10 20:58:31.201768
NCT03177408|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-06-04|||August 15, 2017|Anticipated|2017-08-15|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Impact of HMGB1 on Diastolic Dysfunction in Hypertensive Patients|Impact of HMGB1 on Diastolic Dysfunction in Hypertensive Patients|Not yet recruiting||N/A|100|Anticipated|Affiliated Hospital of Hebei University|||1||f||||t|f|f||||||No||2017-10-10 20:58:31.293818|2017-10-10 20:58:31.293818
NCT03177395|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-12|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|POP||PP100-01 (Calmangafodipir) for Overdose of Paracetamol|A Randomised Open Label Exploratory, Safety and Tolerability Study With PP100-01 in Patients Treated With the 12-hour Regimen of N-Acetylcysteine for Paracetamol/Acetaminophen Overdose (The POP Trial)|Enrolling by invitation||Phase 1|24|Anticipated|PledPharma AB||2|||f||||t|f|f|||f|||No||2017-10-10 20:58:31.356774|2017-10-10 20:58:31.356774
NCT03177382|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-05|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|May 30, 2023|Anticipated|2023-05-30|May 30, 2021|Anticipated|2021-05-30||Interventional|TNTCRT||Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors|Total Neoadjuvant Treatment Versus Conventional Neo-chemoradiotherapy in Locally Advanced Rectal Cancer With High Risk Factors: a Multicenter Randomized Phase III Clinical Study.|Recruiting||Phase 3|458|Anticipated|West China Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 20:58:31.568583|2017-10-10 20:58:31.568583
NCT03177369|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration|Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration|Completed||N/A|60|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:58:31.69164|2017-10-10 20:58:31.69164
NCT03177356|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-03|2017-06-05|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Implant Placement in Mandibular Molar Xenograft Versus PRF|Immediate Implant Placement With Deproteinized Bovine Bone (Tutogen) Versus Placement of Platelet-rich Fibrin as a Space Filling Material in Mandibular Molars. Randomized Clinical Trial.|Active, not recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 20:58:31.854787|2017-10-10 20:58:31.854787
NCT03177343|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Pristinamycin in the Treatment of MSSA Bone and Joint Infection|Pristinamycin in the Treatment of MSSA Bone and Joint Infection|Completed||N/A|102|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 20:58:31.926049|2017-10-10 20:58:31.926049
NCT03177330|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-05|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Safety and Efficacy of Heparin Dosing Score Protocol for Polymyxin-B Hemoperfusion|Safety and Efficacy of Heparin Dosing Score Protocol for Anticoagulation During Polymyxin-B Hemoperfusion: a Retrospective Study|Recruiting||N/A|30|Anticipated|National Taiwan University Hospital|||1||f|||||f|f||||||||2017-10-10 20:58:31.994914|2017-10-10 20:58:31.994914
NCT03177317|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-06-04|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy|A Feasibility Study of Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapies|Recruiting||N/A|50|Anticipated|Seoul National University Bundang Hospital||1|||f||||t|f|f||||||No||2017-10-10 20:58:32.071444|2017-10-10 20:58:32.071444
NCT03177304|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-02|||December 1, 2014|Actual|2014-12-01|June 2017|2017-06-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Web Based Therapist Training in Interpersonal Psychotherapy for Depression|Web Based Therapist Training in Interpersonal Psychotherapy for Depression|Completed||N/A|26|Actual|Center for Psychological Consultation||1|||f||||f|f|f||||||No||2017-10-10 20:58:32.157328|2017-10-10 20:58:32.157328
NCT03177291|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-09-20|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC|A Phase I/Ib Trial of Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC|Recruiting||Phase 1|66|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||2|||||||f|t|f||||||||2017-10-10 20:58:32.236741|2017-10-10 20:58:32.236741
NCT03177278|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-07-11|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|||A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin|A Phase 1, Open-Label Study to Assess the Metabolism, Excretion, and Mass Balance of [14C]-Plazomicin Following a Single IV Infusion in Healthy Adult Male Subjects|Completed||Phase 1|6|Actual|Achaogen, Inc.||1|||f|||||t|f||||||||2017-10-10 20:58:32.371409|2017-10-10 20:58:32.371409
NCT03177265|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-02|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|July 1, 2020|Anticipated|2020-07-01|August 30, 2019|Anticipated|2019-08-30||Interventional|TiMES||Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling|Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling|Not yet recruiting||N/A|3600|Anticipated|VA Office of Research and Development||4|||f||||t|f|f|||f|||No||2017-10-10 20:58:32.458006|2017-10-10 20:58:32.458006
NCT03177239|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-04|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|UNISoN||UNISoN: anzUp Nivo Then Ipi+Nivo in Sequential Non-clear Cell.|A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602).|Not yet recruiting||Phase 2|85|Anticipated|Australian and New Zealand Urogenital and Prostate Cancer Trials Group||1|||f||||t|t|f|||t|||||2017-10-10 20:58:32.782635|2017-10-10 20:58:32.782635
NCT03177226|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-01|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation|Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation|Recruiting||N/A|30|Anticipated|Virility Medical Ltd.||2|||f||||f|f|f||||||No||2017-10-10 20:58:32.953282|2017-10-10 20:58:32.953282
NCT03177213|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-04|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Serum IL-21 Levels in Patients With Pemphigus Vulgaris|Serum IL-21 Levels in Patients With Pemphigus Vulgaris|Not yet recruiting||N/A|20|Anticipated|Assiut University|||2||f||||f|f|f||||Samples Without DNA|"     Blood sample   "|No||2017-10-10 20:58:33.041389|2017-10-10 20:58:33.041389
NCT03177200|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-02|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|March 2018|Anticipated|2018-03-01||Observational|||Defining and Evaluating Norms for Health and Social Service (HASS) Use|Defining and Evaluating Norms for Health and Social Service (HASS) Use for Population Health Segments|Not yet recruiting||N/A|1007|Anticipated|National University, Singapore|||1||f||||f|f|f||||||Undecided||2017-10-10 20:58:33.11211|2017-10-10 20:58:33.11211
NCT03177187|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-01|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|ACE||Combination Study of AZD5069 and Enzalutamide.|ACE: Proof of Concept Phase I/II Trial of the CXCR2 Antagonist AZD5069, Administered in Combination With Enzalutamide, in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)|Not yet recruiting||Phase 1/Phase 2|49|Anticipated|Institute of Cancer Research, United Kingdom||2|||f|||||f|f||||||||2017-10-10 20:58:33.181374|2017-10-10 20:58:33.181374
NCT03177174|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-06-25|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|June 1, 2020|Anticipated|2020-06-01|May 31, 2020|Anticipated|2020-05-31||Interventional|||Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma|the General Hospital of PLA|Recruiting||N/A|150|Anticipated|Chinese PLA General Hospital||3|||f||||t|f|f|||f|||No||2017-10-10 20:58:33.275979|2017-10-10 20:58:33.275979
NCT03177161|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-05|||June 12, 2017|Anticipated|2017-06-12|June 2017|2017-06-01|January 15, 2018|Anticipated|2018-01-15|January 15, 2018|Anticipated|2018-01-15||Interventional|||Assessment of Patient Reported Health Status Questions Via Four Different Methods of Administration, in Stroke Survivors.|Assessment of Patient Reported Health Status Questions Via Four Different Methods of Administration, in Stroke Survivors. A Randomised Controlled Trial. A Non-inferiority Study of the Response Rate for Four Alternative Methods of Administration of 15 Patient Reported Health Status Questions in Stroke Survivors.|Recruiting||N/A|808|Anticipated|Aneurin Bevan University Health Board||4|||f||||t|f|f||||||No||2017-10-10 20:58:33.373936|2017-10-10 20:58:33.373936
NCT03177148|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-12|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|May 31, 2021|Anticipated|2021-05-31|September 30, 2020|Anticipated|2020-09-30||Interventional|BMi2+||Population Effects of MI on Pediatric Obesity in Primary Care|Population Effects of Motivational Interviewing on Pediatric Obesity in Primary Care|Recruiting||N/A|316|Anticipated|University of Michigan||2|||f||||t|f|f||||||||2017-10-10 20:58:33.490846|2017-10-10 20:58:33.490846
NCT03177135|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-01|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||PROOF OF AMNIOSENSE BLUE IN HOME USAGE AND HOSPITAL|PROOF OF AMNIOSENSE BLUE IN HOME USAGE AND AS A HOSPITAL STANDARD OF CARE FOR AMNIOTIC FLUID LEAK DETECTION|Not yet recruiting||N/A|200|Anticipated|Common Sense||1|||f||||f|f|f||||||No||2017-10-10 20:58:33.609268|2017-10-10 20:58:33.609268
NCT03177122|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-02|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Myo-Inositol- Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology|Effect of Myo-Inositol- Based Co-treatment on Oocyte Quality in Women With Polycystic Ovarian Syndrome Undergoing Assisted Reproductive Technology|Recruiting||Phase 4|100|Anticipated|American University of Beirut Medical Center||2|||f|||||f|f|||f|||No||2017-10-10 20:58:34.281921|2017-10-10 20:58:34.281921
NCT03177109|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-06|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|May 3, 2018|Anticipated|2018-05-03|May 3, 2018|Anticipated|2018-05-03||Interventional|||Comparison of Different Desensitizers in Reducing Dentinal Hypersensitivity|Comparison of Fluoride Varnish With Two Different Desensitizers in Reducing Dentinal Hypersensitivity|Recruiting||Phase 3|60|Anticipated|Aga Khan University||3|||f||||t|f|f|||t|||No||2017-10-10 20:58:34.405002|2017-10-10 20:58:34.405002
NCT03177096|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-07-31|||September 20, 2016|Actual|2016-09-20|July 2017|2017-07-01|August 15, 2017|Anticipated|2017-08-15|June 28, 2017|Actual|2017-06-28||Interventional|IM-CAPT||Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes|Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes. A French Monocentric Prospective Study (IM-CAPT)|Active, not recruiting||N/A|14|Actual|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace||1|||f||||f|f|f||||||||2017-10-10 20:58:34.539589|2017-10-10 20:58:34.539589
NCT03177083|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-06-01|||January 30, 2017|Actual|2017-01-30|June 2017|2017-06-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|PLENO||Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy|Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients With Relapsing Remitting Multiple Sclerosis (MS) Transitioning From Current Subcutaneous Interferon Therapy to Peginterferon Beta 1a (PLEGRIDY™)|Recruiting||Phase 4|140|Anticipated|Biogen||2|||f||||f|f|f||||||||2017-10-10 20:58:34.64548|2017-10-10 20:58:34.64548
NCT03177070|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-02|||May 9, 2016|Actual|2016-05-09|June 2017|2017-06-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|||Fluorescent Imaging & Methylene Blue: Ureter Study|Investigating the Use of Fluorescent Imaging and Methylene Blue to Identify and Prevent Ureteric Injuries During Laparoscopic and Open Colorectal Surgery|Completed||Phase 2|50|Actual|University of Oxford||1|||f||||f|f|f||||||No|No plan to share IPD|2017-10-10 20:58:34.78755|2017-10-10 20:58:34.78755
NCT03177057|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||April 23, 2013|Actual|2013-04-23|June 2017|2017-06-01||||July 30, 2014|Actual|2014-07-30||Interventional|SMART||SMART Project in Preventing Skin Cancer|Self-Monitoring and Readiness Texting Project (SMART)|Active, not recruiting||N/A|114|Actual|Fox Chase Cancer Center||4|||f||||||||||||||2017-10-10 20:58:34.866579|2017-10-10 20:58:34.866579
NCT03177044|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-02|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|LIBERATE||Behavioural Treatment for Functional Bowel Symptoms in Inflammatory Bowel Disease|Behavioural Treatment for Functional Bowel Symptoms in Inflammatory Bowel Disease|Recruiting||N/A|35|Anticipated|St Vincent's Hospital Melbourne||1|||f||||t|f|f||||||No||2017-10-10 20:58:34.969252|2017-10-10 20:58:34.969252
NCT03177031|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-02|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|CAPD-3||Clinical Performance and Safety Comparison of Stay Safe Link® With Stay Safe® in Patient on CAPD (CAPD-3)|A Randomised, Open-label, Parallel Group, Multi-centre Controlled Study to Evaluate the Clinical Performance and Safety of Stay Safe Link® Compared With Stay Safe® in Patients With End-stage Kidney Disease on Continuous Ambulatory Peritoneal Dialysis|Not yet recruiting||N/A|434|Anticipated|Penang Hospital, Malaysia||2|||f||||t|f|f||||||No|There is no plan to share individual participant data with other researchers|2017-10-10 20:58:35.131903|2017-10-10 20:58:35.131903
NCT03177018|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||September 13, 2016|Actual|2016-09-13|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|FA2CM-DVDA||DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia|Feasibility of DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia|Recruiting||N/A|30|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||No||2017-10-10 20:58:35.227644|2017-10-10 20:58:35.227644
NCT03177005|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-27||||||July 2017|2017-07-01||||||||Expanded Access|||Expanded Access for Hereditary Angioedema (HAE)||Approved for marketing||N/A|||CSL Behring||||||t|||||||||||||2017-10-10 20:58:35.325316|2017-10-10 20:58:35.325316
NCT03176992|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-05|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Surgicel® & Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding|Surgicel® Versus Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding (HMB): Randomised Controlled Trial|Recruiting||Phase 2|240|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 20:58:35.397103|2017-10-10 20:58:35.397103
NCT03176979|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||April 21, 2017|Actual|2017-04-21|June 2017|2017-06-01|April 21, 2019|Anticipated|2019-04-21|April 21, 2018|Anticipated|2018-04-21||Interventional|||Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer|Emerging Tools in the Detection of Breast Cancer: Comparison of Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis to Conventional Imaging Techniques Including Contrast Enhanced Magnetic Resonance Imaging and 2D Mammography With or Without Targeted Ultrasound|Recruiting||N/A|40|Anticipated|University of Southern California||1|||f||||t|f|f|||f|||||2017-10-10 20:58:35.529576|2017-10-10 20:58:35.529576
NCT03176966|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-29|||September 2, 2016|Actual|2016-09-02|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis|Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis|Enrolling by invitation||Phase 4|60|Anticipated|Vanderbilt University Medical Center||2|||f||||f|t|f||||||||2017-10-10 20:58:35.667004|2017-10-10 20:58:35.667004
NCT03176953|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||November 1, 2017|Anticipated|2017-11-01|June 2017|2017-06-01|October 31, 2021|Anticipated|2021-10-31|October 31, 2021|Anticipated|2021-10-31||Interventional|TOP||Topiramate and Prolonged Exposure|Combining Topiramate and Prolonged Exposure for PTSD and Alcohol Use Disorder|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||t|||No||2017-10-10 20:58:35.786673|2017-10-10 20:58:35.786673
NCT03176940|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-05|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|2-HOBA||2-HOBA: Initial Evaluation in Humans|2-Hydroxybenzylamine: Initial Evaluation in Humans|Recruiting||N/A|28|Anticipated|Metabolic Technologies Inc.||6|||f||||t|f|f||||||||2017-10-10 20:58:35.934321|2017-10-10 20:58:35.934321
NCT03176927|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-01|||December 2012||2012-12-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Biomagnetic Characterization of Gastric Dysrhythmias III|Biomagnetic Characterization of Gastric Dysrhythmias III|Enrolling by invitation||N/A|150|Anticipated|Vanderbilt University Medical Center||5|||f||||t||||||||No||2017-10-10 20:58:36.058447|2017-10-10 20:58:36.058447
NCT03176914|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-01|||January 19, 2017|Actual|2017-01-19|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Testing the Effectiveness of a Modified Community Model in Improving Child Health Outcomes in Mashonaland East, Zimbabwe|Testing the Effectiveness of a Modified Care Group Model in Improving Child Health Outcomes in Mashonaland East, Zimbabwe|Recruiting||N/A|750|Anticipated|University of Zimbabwe||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:36.172539|2017-10-10 20:58:36.172539
NCT03176901|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-01|||February 3, 2017|Actual|2017-02-03|June 2017|2017-06-01|August 25, 2018|Anticipated|2018-08-25|November 25, 2017|Anticipated|2017-11-25||Interventional|SHUW||Comparing Approaches to Treat Older Adult Women's Urge Incontinence: Pilot Feasibility and Randomized Controlled Trial|Comparing Mindfulness-Based Stress Reduction With the Health Enhancement Program in the Treatment of Urinary Urge Incontinence in Older Adult Women: A Pilot Feasibility and Randomized Controlled Trial|Active, not recruiting||N/A|25|Actual|University of Utah||2|||f||||f|f|f||||||No||2017-10-10 20:58:36.268629|2017-10-10 20:58:36.268629
NCT03176888|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-01|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Health Benefits of HIT for Breast Cancer Patients|The Efficacy of Reduced-exertion High-intensity Interval Training for Improving Health and Well-being in Newly Diagnosed Female Breast Cancer Patients|Not yet recruiting||N/A|30|Anticipated|University of Stirling||2|||f||||f|f|f||||||No|This is a small study which will generate pilot data for larger trials. Although the investigators will publish group data there is no plan to share individual data with other researchers. However, any requests for anonymised individual data will be considered on a case-by-case basis.|2017-10-10 20:58:36.371974|2017-10-10 20:58:36.371974
NCT03176875|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-06|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease|Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease|Recruiting||N/A|50|Anticipated|University Medical Centre Ljubljana||2|||f||||t|f|f||||||No||2017-10-10 20:58:36.454589|2017-10-10 20:58:36.454589
NCT03176862|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-05|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Observational|FibroCKD||Left Ventricular Fibrosis in Chronic Kidney Disease|Onset and Functional Consequences of Left Ventricular (LV) Fibrosis in Chronic Kidney|Recruiting||N/A|260|Anticipated|University Hospital Birmingham NHS Foundation Trust|||3||f||||t|f|f||||Samples With DNA|"     Blood samples   "|Undecided||2017-10-10 20:58:36.547518|2017-10-10 20:58:36.547518
NCT03176849|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-01|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT|A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 (Stoss Therapy) in Pediatric Patients Undergoing HSCT to Prevent Vitamin D Deficiency and Insufficiency During Transplant|Not yet recruiting||Phase 4|30|Anticipated|Phoenix Children's Hospital||2|||f||||f|f|f|||t|||No||2017-10-10 20:58:36.645068|2017-10-10 20:58:36.645068
NCT03176836|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-01|||June 20, 2016|Actual|2016-06-20|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|July 1, 2019|Anticipated|2019-07-01||Interventional|||Li-Fraumeni Syndrome Imaging Study|Novel Approaches to Molecular and Clinical Surveillance in Li-Fraumeni Syndrome - Pilot Study.|Enrolling by invitation||N/A|30|Anticipated|The Hospital for Sick Children||1|||f||||t|f|f||||||No||2017-10-10 20:58:36.754699|2017-10-10 20:58:36.754699
NCT03176823|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-01|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Remote Ischemic Conditioning as a Treatment for Traumatic Brain Injury|Remote Ischemic Conditioning as a Treatment for Traumatic Brain Injury: a Prospective Randomized Controlled Trial.|Not yet recruiting||N/A|40|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||No||2017-10-10 20:58:36.820379|2017-10-10 20:58:36.820379
NCT03176810|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|COCOA||Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention|Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention|Active, not recruiting||N/A|550|Actual|Wakayama Medical University||2|||f||||t|f|f||||||Undecided||2017-10-10 20:58:36.944875|2017-10-10 20:58:36.944875
NCT03176797|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI|Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI|Enrolling by invitation||N/A|300|Anticipated|Zhujiang Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 20:58:37.152379|2017-10-10 20:58:37.152379
NCT03176771|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-08-08|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Fixed-Dose Study to Evaluate the Efficacy and Safety of MT-5199 for the Treatment in Patients With Tardive Dyskinesia (J-KINECT)|Recruiting||Phase 2/Phase 3|240|Anticipated|Mitsubishi Tanabe Pharma Corporation||5|||f|||||f|f||||||||2017-10-10 20:58:37.382659|2017-10-10 20:58:37.382659
NCT03176758|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-02|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Postoperative Pain in Total Knee Arthroplasty: a Comparison Between General and Spinal Anesthesia|Postoperative Pain in Total Knee Arthroplasty: a Comparison Between General and Spinal Anesthesia|Not yet recruiting||Phase 4|60|Anticipated|Meir Medical Center||2|||f||||f|t|f|||t|||No|Participant's data will be collectively statistically analyzed, The results will be available as part of the researches findings while the participant's information will not be shared.|2017-10-10 20:58:37.52666|2017-10-10 20:58:37.52666
NCT03176745|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||July 1, 2015|Actual|2015-07-01|June 2017|2017-06-01|January 15, 2017|Actual|2017-01-15|June 30, 2016|Actual|2016-06-30||Observational|||Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls|Determination of the Optimal Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls|Completed||N/A|153|Actual|Universitätsmedizin Mannheim|||4||f||||t|f|f||||||No||2017-10-10 20:58:37.611267|2017-10-10 20:58:37.611267
NCT03176732|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-07|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Observational|PISA-BP||Mechanisms for Individual Differences in Hypertension in Obstructive Sleep|Mechanisms for Individual Differences in Hypertension in Obstructive Sleep|Recruiting||N/A|200|Anticipated|University of Pennsylvania|||4||f||||f|f|f||||Samples With DNA|"     As a part of the research protocol, we intend to draw from each participant at baseline and     following 4 months of PAP therapy. All samples will be processed according to the recommended     procedures for the different analyses we intend to measure and stored at -80°C until     analysis.   "|No||2017-10-10 20:58:37.681794|2017-10-10 20:58:37.681794
NCT03176706|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Observational|STRIPE||Assessment of Dried Blood Spot Thyroglobulin and Urinary Iodine Concentration in Pregnant Women|Assessment of Dried Blood Spot Thyroglobulin in Pregnant Women to Redefine the Range of Median Urinary Iodine Concentration That Indicates Adequate Iodine Intake|Not yet recruiting||N/A|3000|Anticipated|Swiss Federal Institute of Technology|||6||f|||||f|f||||||||2017-10-10 20:58:37.923436|2017-10-10 20:58:37.923436
NCT03176693|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-03|||May 5, 2017|Actual|2017-05-05|June 2017|2017-06-01|May 2024|Anticipated|2024-05-01|May 2023|Anticipated|2023-05-01||Interventional|||Preoperative Alpha Blockade for Pheochromocytoma|Randomized Controlled Trial of Preoperative Alpha Blockade for Pheochromocytoma|Recruiting||Phase 3|60|Anticipated|University of California, Los Angeles||2|||f||||f|t|f|||f|||No||2017-10-10 20:58:38.006098|2017-10-10 20:58:38.006098
NCT03176680|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-02|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|ERAS||The Effects on Major Organ Complications on Esophagectomy of New Anesthetic ERAS Strategy: a Prospective Investigation|The Effects on Major Organ Complications on Esophagectomy of New Anesthetic ERAS (Enhanced Recovery After Surgery) Strategy: a Prospective Investigation|Not yet recruiting||N/A|120|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:38.127957|2017-10-10 20:58:38.127957
NCT03176667|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-02|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Ultrasound Guided Erector Spinae Plane Block in Patients Undergoing VATS Lobectomy|Ultrasound Guided Erector Spinae Plane Block in Patients Undergoing Video-assisted Thoracoscopic Surgery (VATS) Lobectomy or Wedge Resections - a Pilot Randomized Control Trial|Not yet recruiting||N/A|20|Anticipated|McMaster University||2|||f||||f|f|f||||||No||2017-10-10 20:58:38.225552|2017-10-10 20:58:38.225552
NCT03176654|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-13|||August 15, 2016|Actual|2016-08-15|June 2017|2017-06-01|September 20, 2016|Actual|2016-09-20|September 20, 2016|Actual|2016-09-20||Interventional|HVLAT||The Effect of Manipulation of the Cervical Spine on Pain Biomarkers|The Effect of High-Velocity Low-Amplitude Thrust Manipulation of the Cervical Spine on Pain Biomarkers in Females With Non-Specific Mechanical Neck Pain|Completed||N/A|40|Actual|Loma Linda University||2|||f||||f|f|f||||||No||2017-10-10 20:58:38.316386|2017-10-10 20:58:38.316386
NCT03176641|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-02|||August 24, 2016|Actual|2016-08-24|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Platelet-rich Plasma for Meniscus Repair|Efficacy of Platelet-rich Plasma on Meniscus Repair- a Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Show Chwan Memorial Hospital||2|||f||||t|f|f||||||No||2017-10-10 20:58:38.402354|2017-10-10 20:58:38.402354
NCT03176628|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|BAKIS||Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury Study|Randomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics, Pharmacodynamics & Safety of Escalating Doses of Basis (Nicotinamide Riboside and Pterostilbene) in Patients With Acute Kidney Injury (AKI)|Not yet recruiting||N/A|24|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||||2017-10-10 20:58:38.496088|2017-10-10 20:58:38.496088
NCT03176615|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-20|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|June 1, 2020|Anticipated|2020-06-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Meal-induced Thrombin Generation Before and After Gastric Bypass|Meal-induced Thrombin Generation in Obese Women and Men Before and After Gastric Bypass - a Model of Intentional Weight Loss|Recruiting||N/A|30|Anticipated|Hospital of South West Jutland||2|||f||||t|f|f||||||||2017-10-10 20:58:38.607517|2017-10-10 20:58:38.607517
NCT03176602|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||August 1, 2015|Actual|2015-08-01|June 2017|2017-06-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|||Prognostic Value of the SGA and NUTRIC in the ICU|Combining Two Commonly Adopted Nutrition Instruments in the Critical Care Setting is Superior to Administering Either One Alone|Completed||N/A|503|Actual|JurongHealth|||1||f||||f|f|f||||||No||2017-10-10 20:58:38.6962|2017-10-10 20:58:38.6962
NCT03176589|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-16|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|June 7, 2018|Anticipated|2018-06-07|June 7, 2018|Anticipated|2018-06-07||Interventional|||Effect of PEP on Oxygen Saturation and Carbon Dioxide After Abdominal Surgery|Effect of PEP on Oxygen Saturation and Carbon Dioxide After Abdominal Surgery|Recruiting||N/A|65|Anticipated|Umeå University||2|||f||||f|f|f||||||No||2017-10-10 20:58:38.772581|2017-10-10 20:58:38.772581
NCT03176576|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-06|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population|Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population|Recruiting||N/A|60|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|f|f||||||||2017-10-10 20:58:38.870146|2017-10-10 20:58:38.870146
NCT03176563|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-06|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|May 2019|Anticipated|2019-05-01||Observational|REGATTA II||Observational Follow-up Study of REGATTA|Observational Study of Patients With Uncomplicated Urinary Tract Infection Treated With Antibiotics or Herbal Medicinal Product|Recruiting||N/A|430|Anticipated|University Medical Center Goettingen|||2||f||||f|f|f||||||||2017-10-10 20:58:38.989036|2017-10-10 20:58:38.989036
NCT03176550|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-31|||August 1, 2014|Actual|2014-08-01|May 2017|2017-05-01|April 30, 2015|Actual|2015-04-30|April 30, 2015|Actual|2015-04-30||Interventional|||Peripheral Stimulation Neural Response|Effects of Somatosensory Electrical Simulation On Motor Function and Cortical Oscillations|Completed||Early Phase 1|8|Actual|University of California, San Francisco||1|||f||||f|f|t|f||f|||No||2017-10-10 20:58:39.190547|2017-10-10 20:58:39.190547
NCT03176537|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Periodontal Profile of Hypogonadic Men|Clinical, Microbiologic and Immunologic Profile of the Periodontal Condition in Hypogonadic Men|Recruiting||Phase 4|50|Anticipated|Universidade Federal do Paraná||2|||f||||f|f|f|||f|||No||2017-10-10 20:58:39.246527|2017-10-10 20:58:39.246527
NCT03176524|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-06|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM|A Randomised, Double-blind, Three-period Crossover Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With Type 1 Diabetes|Recruiting||Phase 1|27|Anticipated|Adocia||3|||f||||f|f|f||||||No||2017-10-10 20:58:39.350291|2017-10-10 20:58:39.350291
NCT03176511|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 2017|Anticipated|2017-12-01||Interventional|||Fall Prevention in Older Adults Study|Novel Dual-Task Balance Challenge to Prevent Falls in Older Adults|Recruiting||N/A|24|Anticipated|University of Arizona||2|||f||||f|f|f||||||No|There is no plan to make individual participant data (IPD) available to other researchers.|2017-10-10 20:58:39.447746|2017-10-10 20:58:39.447746
NCT03175796|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-30|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|IMH-HV RCT||Infant Mental Health-Home Visiting Randomized Controlled Trial|Infant Mental Health-Home Visiting Randomized Controlled Trial|Not yet recruiting||N/A|144|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 21:00:29.859348|2017-10-10 21:00:29.859348
NCT03176498|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Human Umbilical Cord Mesenchymal Stem Cell Therapy for Cerebral Infarction Patients in Convalescent Period.|The Effects of Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neurological Function for Cerebral Infarction Patients in Convalescent Period.|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Sclnow Biotechnology Co., Ltd.||2|||f|||||f|f||||||Undecided||2017-10-10 20:58:39.535383|2017-10-10 20:58:39.535383
NCT03176485|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||October 17, 2014|Actual|2014-10-17|June 2017|2017-06-01|April 15, 2018|Anticipated|2018-04-15|October 15, 2017|Anticipated|2017-10-15||Interventional|||Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors|Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated Light|Recruiting||N/A|45|Anticipated|University of Arizona||3|||f||||t|f|f||||||Undecided||2017-10-10 20:58:39.623463|2017-10-10 20:58:39.623463
NCT03176472|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-05|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|||Ricolinostat in Patients With Diabetic Neuropathic Pain|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Ricolinostat in Patients With Diabetic Neuropathic Pain|Not yet recruiting||Phase 2|450|Anticipated|Regenacy Pharmaceuticals LLC||2|||f||||t|t|f||||||No||2017-10-10 20:58:39.709229|2017-10-10 20:58:39.709229
NCT03176459|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-03|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|February 1, 2018|Anticipated|2018-02-01||Interventional|C-Section||Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections|A Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the Transversus Abdominis Plane (TAP) Versus Bupivacaine Alone in Subjects Undergoing Elective Cesarean Section|Recruiting||Phase 4|152|Anticipated|Pacira Pharmaceuticals, Inc||2|||f||||t|t|f|||f|||||2017-10-10 20:58:39.773275|2017-10-10 20:58:39.773275
NCT03176446|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|March 1, 2019|Anticipated|2019-03-01|December 20, 2018|Anticipated|2018-12-20||Interventional|||Pain and Anxiety Evaluation in Children Using Different Techniques of Local Anesthesia for Dental Treatment|Pain and Anxiety Evaluation in Children Using Different Techniques of Local Anesthesia for Dental Treatment|Not yet recruiting||Phase 2|240|Anticipated|Universidade Estadual de Ponta Grossa||4|||f|||||f|f|||f|||||2017-10-10 20:58:39.908667|2017-10-10 20:58:39.908667
NCT03176433|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-01|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Post Static Cold Storage Normothermic Machine Liver Perfusion|A Multicentre, Single-arm, Prospective Clinical Trial to Investigate the Safety and Feasibility of Cold Storage Prior to Normothermic Machine Perfusion in Adult Human Liver Transplantation|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Oxford||1|||f|||||f|f||||||||2017-10-10 20:58:40.036035|2017-10-10 20:58:40.036035
NCT03176420|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Endovascular Revascularization of Symptomatic Chronically Occluded Internal Carotid Artery|The Safety and Feasibility of Endovascular Revascularization of Chronically Occluded Cervical Internal Carotid Artery (COICA) Using Newly Suggested Radiographic Classification of COICA: Pilot Study|Not yet recruiting||N/A|50|Anticipated|University of Iowa||1|||f||||f|f|f||||||Yes|After 1 year following completion of the study, data finalization will occur, and the final dataset will be available for access and distribution. The final dataset will be stripped of identifiers prior to release for sharing.disclosure We will make the data and associated documentation available to users only under a data sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.|2017-10-10 20:58:40.125691|2017-10-10 20:58:40.125691
NCT03176407|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-31|||April 11, 2015|Actual|2015-04-11|May 2017|2017-05-01|February 29, 2016|Actual|2016-02-29|February 24, 2016|Actual|2016-02-24||Interventional|DING||Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule [DING]|Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule: A Pilot Study [DING]|Completed||N/A|30|Actual|Ovesco Endoscopy AG||1|||f||||f|f|f||||||Undecided||2017-10-10 20:58:40.186327|2017-10-10 20:58:40.186327
NCT03176394|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-31|||May 24, 2017|Actual|2017-05-24|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy of BLASTX in Catheter Associated Bacteriuria Versus Standard of Care (SOC)|Efficacy of Bladder Catheters Lubricated With a Biofilm Disruptive Gel, in Reducing Catheter-associated Bacteriuria (CAB) Compared to Standard of Care: A PILOT Clinical Trial|Recruiting||N/A|25|Anticipated|Next Science TM||2|||f||||f|f|t|f|f|t|||No||2017-10-10 20:58:40.272748|2017-10-10 20:58:40.272748
NCT03176381|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-07|||May 5, 2017|Actual|2017-05-05|June 2017|2017-06-01|May 5, 2020|Anticipated|2020-05-05|May 5, 2019|Anticipated|2019-05-05||Observational|||Tissue Predictors of Abiraterone Benefit|Development of Tissue Predictors of Abiraterone Benefit in Men With mCRPC|Recruiting||N/A|60|Anticipated|Tianjin Medical University Second Hospital|||1||f||||t|f|f|||t|Samples With DNA|"     mRNA panel with AKR1C3, FKB5 and PCNA would be tested in the tissue specimen.   "|Yes|IPD can be got by contacting researchers|2017-10-10 20:58:40.545334|2017-10-10 20:58:40.545334
NCT03176368|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-06-01|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|September 15, 2018|Anticipated|2018-09-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Coconut Oil: Managing Radiation-Induced Xerostomia|Coconut Oil as a Novel Approach to Managing Radiation-Induced Xerostomia: An Interventional Study|Not yet recruiting||N/A|30|Anticipated|Ottawa Hospital Research Institute||1|||f||||f|f|f||||||No||2017-10-10 20:58:40.660961|2017-10-10 20:58:40.660961
NCT03176355|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-01|||March 23, 2011|Actual|2011-03-23|June 2017|2017-06-01|January 7, 2013|Actual|2013-01-07|January 7, 2012|Actual|2012-01-07||Interventional|||Intraoperative Mitomycin C in Lacrimal Sac Mucocele|Evaluation of Intraoperative Mitomycin C in Surgical Management of Lacrimal Sac Mucocele|Completed||N/A|30|Actual|Minia University||1|||f|||||f|f||||||||2017-10-10 20:58:40.754959|2017-10-10 20:58:40.754959
NCT03175783|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-07-30|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Use of Wearable Activity Tracker in Elderly Undergoing Abdominal Surgery|Use of Wearable Activity Tracker to Monitor and Increase Mobility for Elderly Undergoing Abdominal Surgery: A Randomized Control Trial|Recruiting||N/A|60|Anticipated|University of Malaya||2|||f||||t|f|f||||||||2017-10-10 21:00:32.256833|2017-10-10 21:00:32.256833
NCT03176342|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-03|||August 4, 2016|Actual|2016-08-04|June 2017|2017-06-01|August 3, 2017|Anticipated|2017-08-03|August 3, 2017|Anticipated|2017-08-03||Interventional|||Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)|Drug Patch Tests, Enzyme-linked Immunosorbent Spot Assay (Elispot) and Lymphocyte Transformation Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)|Recruiting||N/A|30|Anticipated|Chulalongkorn University||1|||f|||||f|||||||||2017-10-10 20:58:40.828088|2017-10-10 20:58:40.828088
NCT03176329|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-07-04|||September 19, 2016|Actual|2016-09-19|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|I-Nursing||Closed-loop Versus Conventional Ventilation Mode During Mobilization Period in Critical Care Patients|Closed-loop Versus Conventional Ventilation Mode During Mobilization Period in Critical Care Patients : a Prospective Randomized Crossover Study|Recruiting||N/A|267|Anticipated|Hopital of Melun||2|||f||||f|f|f||||||||2017-10-10 20:58:40.935009|2017-10-10 20:58:40.935009
NCT03176316|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-02|||August 30, 2017|Anticipated|2017-08-30|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|FusionIleus||The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus|The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus|Not yet recruiting||Phase 4|150|Anticipated|Loyola University||1|||f||||f|t|f|||f|||Undecided||2017-10-10 20:58:41.049719|2017-10-10 20:58:41.049719
NCT03176303|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-27|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|December 23, 2019|Anticipated|2019-12-23|July 23, 2019|Anticipated|2019-07-23||Observational|||Study Using the SpinalStim Device Following Lumbar Fusion Surgery|A Multi-Center, Open-Label, Prospective Study of SpinalStim™ (MOP-SS) as Adjunctive Care Following Lumbar Fusion Surgery|Enrolling by invitation||N/A|500|Anticipated|Orthofix Inc.|||1||f||||f|f||||f|||Undecided|if we decide to share, we will only share deidentified summary data|2017-10-10 20:58:41.149201|2017-10-10 20:58:41.149201
NCT03176290|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-02|2017-06-02|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation|Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation: Is There Still a Rolefor Liver Biopsy?|Completed||N/A|31|Actual|Ain Shams University|||1||f||||t|f|f||||||Undecided||2017-10-10 20:58:41.242259|2017-10-10 20:58:41.242259
NCT03176264|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-01|||September 7, 2017|Anticipated|2017-09-07|June 2017|2017-06-01|January 7, 2021|Anticipated|2021-01-07|January 7, 2021|Anticipated|2021-01-07||Interventional|||PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer|ElevatION: CRC-101: A Phase Ib Study of PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer|Not yet recruiting||Phase 1|92|Anticipated|Novartis||1|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent expert panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data is currently available according to the process described on www.clinicalstudydatarequest.com"|2017-10-10 20:58:41.472949|2017-10-10 20:58:41.472949
NCT03176251|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-10-04|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Applying Gamification to Postgraduate Endoscopic Training|Gamification of a Virtual-reality Simulation Curriculum in Endoscopy: Impact on Clinical Performance|Recruiting||N/A|36|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 20:58:41.57237|2017-10-10 20:58:41.57237
NCT03176238|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-16|||March 29, 2013|Actual|2013-03-29|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|EVEREXES||Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer|A Phase IIIb, Multi-center, Open-label Study of RAD001 in Combination With EXemestane in Post-menopausal Women With EStrogen Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 3|236|Actual|Novartis||1|||f||||f|f|f||||||Undecided||2017-10-10 20:58:41.661886|2017-10-10 20:58:41.661886
NCT03176225|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-22|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair|Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair|Recruiting||N/A|144|Anticipated|LeMaitre Vascular||2|||f||||t|f|t|f|f|t|||||2017-10-10 20:58:41.885262|2017-10-10 20:58:41.885262
NCT03176212|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-31|||January 2012||2012-01-01|May 2017|2017-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Milk Fat Globule Membrane (MFGM) on Gut Barrier Protection in Runners|Effect of Milk Fat Globule Membrane (MFGM) on Gut Barrier Protection in Runners|Completed||N/A|14|Actual|Utah State University||2|||f||||f||||||||No||2017-10-10 20:58:41.980114|2017-10-10 20:58:41.980114
NCT03176199|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||September 1, 2016|Actual|2016-09-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain|An Interventional, Open Label, and Randomized Controlled Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Opioid-naive Patients With Moderate to Severe Cancer Pain|Recruiting||Phase 4|80|Anticipated|Taiwan Mundipharma Pharmaceuticals Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 20:58:42.072601|2017-10-10 20:58:42.072601
NCT03175809|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-07-05|||June 9, 2017|Actual|2017-06-09|July 2017|2017-07-01|December 25, 2018|Anticipated|2018-12-25|November 23, 2018|Anticipated|2018-11-23||Interventional|||Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain|Pelvic Floor Muscle Training With or Without Dry Needling for Women With Chronic Pelvic Pain: a Randomized Controlled Trial|Recruiting||N/A|44|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t|f|f||||||||2017-10-10 21:00:29.74813|2017-10-10 21:00:29.74813
NCT03176186|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-06-02|||October 15, 2017|Anticipated|2017-10-15|June 2017|2017-06-01|October 15, 2019|Anticipated|2019-10-15|July 2019|Anticipated|2019-07-01||Interventional|XePOHCAS||Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest|XePOHCAS - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome|Not yet recruiting||Phase 3|1436|Anticipated|NeuroproteXeon, Inc.||2|||f||||t|t|t|t|||||Yes|Authorized representatives of the SITE OF STUDY CONDUCT or other associated health care providers as authorized.|2017-10-10 20:58:42.200004|2017-10-10 20:58:42.200004
NCT03176173|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-29|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|June 28, 2021|Anticipated|2021-06-28|June 28, 2020|Anticipated|2020-06-28||Interventional|||Radical-Dose Image Guided Radiation Therapy in Treating Patients With Metastatic Non-small Cell Lung Cancer Undergoing Immunotherapy|Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)|Recruiting||Phase 2|85|Anticipated|Stanford University||2|||f||||t|t|f||||||||2017-10-10 20:58:42.28509|2017-10-10 20:58:42.28509
NCT03176160|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-28|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|July 2019|Anticipated|2019-07-01||Interventional|LASR||LASR (LITT and Short Course XRT)|LASR: LITT And Short Course Radiation for Patients With GBM Requiring Standard Treatment Alternatives|Not yet recruiting||N/A|20|Anticipated|Duke University||1|||f||||f|f|f|||f|||||2017-10-10 20:58:42.393878|2017-10-10 20:58:42.393878
NCT03176147|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||November 12, 2015|Actual|2015-11-12|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Observational|IMAGE||Iron Metabolism Parameters At First Trimester and preGnancy outcomE|Clinical and Biological Predictive Factors of Iron Deficiency Anemia in the Third Trimester of Pregnancy|Active, not recruiting||N/A|865|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 20:58:42.498482|2017-10-10 20:58:42.498482
NCT03176121|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-01|||October 31, 2016|Actual|2016-10-31|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|STOP Pain||Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain|A Long Term, Open-Label, Multi-Center Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain|Recruiting||Phase 4|200|Anticipated|Taiwan Mundipharma Pharmaceuticals Ltd.||1|||f||||f|f|f||||||Undecided||2017-10-10 20:58:42.671329|2017-10-10 20:58:42.671329
NCT03176108|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-02|||June 20, 2017|Anticipated|2017-06-20|May 2017|2017-05-01|June 20, 2019|Anticipated|2019-06-20|January 20, 2019|Anticipated|2019-01-20||Interventional|DP-KID||Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile|Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile : a Study Prospective, Controlled and Randomized|Not yet recruiting||N/A|68|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f||||||No||2017-10-10 20:58:42.858566|2017-10-10 20:58:42.858566
NCT03176095|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-14|||March 1, 2012|Actual|2012-03-01|June 2017|2017-06-01|August 30, 2015|Actual|2015-08-30|August 30, 2015|Actual|2015-08-30||Interventional|CiPP||Celiac Disease Prevention With Probiotics|Celiac Disease Prevention With Probiotics|Completed||N/A|90|Actual|Lund University||2|||f|||||f|f||||||Undecided||2017-10-10 20:58:42.938232|2017-10-10 20:58:42.938232
NCT03176082|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-31|||October 2016||2016-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|MFIT||Mailed Reminders Plus Fecal Immunochemical Testing|Mailed Reminders Plus Fecal Immunochemical Testing (FIT) to Increase Colorectal Cancer Screening Among Medicaid Beneficiaries in Mecklenburg County|Enrolling by invitation||N/A|2000|Anticipated|UNC Lineberger Comprehensive Cancer Center||2|||f||||f|f|f||||||No||2017-10-10 20:58:43.014801|2017-10-10 20:58:43.014801
NCT03176069|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-01|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation and Comparison of Women Pelvic Floor With and Without Sexual Dysfunction (Vaginismus)|Evaluation and Comparison of Women Pelvic Floor With and Without Sexual Dysfunction (Vaginismus)|Recruiting||N/A|40|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t|f|f||||||No||2017-10-10 20:58:43.08682|2017-10-10 20:58:43.08682
NCT03176056|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||February 2, 2016|Actual|2016-02-02|May 2017|2017-05-01|January 28, 2018|Anticipated|2018-01-28|July 2, 2017|Anticipated|2017-07-02||Interventional|||The Effectiveness of Low Carbohydrate Diet in Reducing Polypharmacy for Patients With Type 2 Diabetes Mellitus|Low Carbohydrate Diet for Type 2 Diabetes Mellitus|Active, not recruiting||N/A|92|Actual|National Taiwan University Hospital||2|||f||||f|f|f||||||No||2017-10-10 20:58:43.197577|2017-10-10 20:58:43.197577
NCT03176043|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-02|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Patient Controlled Fluid Administration|Could Thirst-triggered Self-administration of Intravenous Fluid Lead to More Rapid Rehydration Than Clinician-directed Infusion?|Recruiting||Early Phase 1|16|Anticipated|University College, London||2|||f||||f|f|f||||||No||2017-10-10 20:58:43.268524|2017-10-10 20:58:43.268524
NCT03176030|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-02|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Fortified Foods in Older Inpatients|Can Fortified Foods Improve Energy and Protein Intake in Older People Whilst in Hospital? A Pilot Study|Not yet recruiting||N/A|80|Anticipated|University Hospital Southampton NHS Foundation Trust|||2||f||||f|f|f||||||No|No data will be shared unless requested directly from authors|2017-10-10 21:00:28.34628|2017-10-10 21:00:28.34628
NCT03176017|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-05|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Holmium Laser Ejaculatory Sparing Transurethral Incision Of The Prostate (HoLES-TUIP) Versus Conventional TUIP|Holmium Laser Ejaculatory Sparing Transurethral Incision Of The Prostate (HoLES-TUIP) Versus Conventional TUIP|Not yet recruiting||N/A|40|Anticipated|Mansoura University||2|||f||||t|f|f||||||Yes|Yes meta-analyses by contact the Dr Ahmed Elshal, MD (Study Chair)|2017-10-10 21:00:28.462982|2017-10-10 21:00:28.462982
NCT03176004|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-05|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|September 2019|Anticipated|2019-09-01||Interventional|||Attention Training to Modify Error-related Negativity and Risk for Anxiety in Adolescence|Attention Training to Modify Error-related Negativity and Risk for Anxiety in Adolescence|Recruiting||N/A|600|Anticipated|Florida State University||3|||f||||f|f|f||||||Yes|Data is being uploaded to the Research Domain Criteria Database, and will be available through National Institute of Mental Health Data Archive; the analyzed data yielded in our project, as specified in the same document (i.e., 12 months after accomplishment of each primary aim or objective, or immediately upon publication of the project's primary results, whichever occurs first).|2017-10-10 21:00:28.554466|2017-10-10 21:00:28.554466
NCT03175991|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-13|||July 5, 2017|Anticipated|2017-07-05|June 2017|2017-06-01|August 21, 2018|Anticipated|2018-08-21|May 29, 2018|Anticipated|2018-05-29||Observational|||Gynacological Imaging Reporting and Data System in Ovarian Masses by Ultrasonography|Gynacological Imaging Reporting and Data System in Classifying Ovarian Masses on the Basis of Ultrasonography|Not yet recruiting||N/A|54|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:00:28.629603|2017-10-10 21:00:28.629603
NCT03175978|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-08-23|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Interventional|||IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome|Pilot Study of IGF-Methotrexate Conjugate in the Treatment of Myelodysplastic Syndrome, CMML and Oligoblastic AML|Not yet recruiting||Phase 1/Phase 2|9|Anticipated|IGF Oncology, LLC||1|||f||||t|t|f||||||||2017-10-10 21:00:28.690886|2017-10-10 21:00:28.690886
NCT03175965|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-02|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Prognostic Value of P30 After Cardiac Arrest|Characteristics of the Somatosensory Evoked Potentials Indicating Poor Neurologic Outcome After Cardiac Arrest|Not yet recruiting||N/A|86|Anticipated|Uijeongbu St. Mary Hospital|||1||f||||f|f|t|f||t|||No||2017-10-10 21:00:28.795476|2017-10-10 21:00:28.795476
NCT03175952|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-12|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 1, 2020|Anticipated|2020-05-01|April 30, 2019|Anticipated|2019-04-30||Observational|||Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.|Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.|Recruiting||N/A|120|Anticipated|Tianjin Chest Hospital|||1||f||||f|f|f||||||||2017-10-10 21:00:28.887844|2017-10-10 21:00:28.887844
NCT03175939|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-02|||April 1, 1998|Actual|1998-04-01|June 2017|2017-06-01|December 31, 2014|Actual|2014-12-31|December 31, 2008|Actual|2008-12-31||Interventional|||Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma|Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma After Concomitant Radiotherapy And Chemotherapy|Completed||Phase 2|263|Actual|Sun Yat-sen University||1|||f|||||f|f||||||No||2017-10-10 21:00:28.963209|2017-10-10 21:00:28.963209
NCT03175926|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-31|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|AUDIT||Description of the Ability to Learn How to Handle Inhaler Devices in Asthma|Description of the Ability to Learn How to Handle Inhaler Devices in Asthma - AUDIT|Not yet recruiting||N/A|30|Anticipated|University Hospital, Bordeaux||3|||f||||f|f|f||||||Undecided||2017-10-10 21:00:29.03408|2017-10-10 21:00:29.03408
NCT03175913|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-11|||June 1, 2014|Actual|2014-06-01|June 2017|2017-06-01|December 1, 2015|Actual|2015-12-01|December 1, 2015|Actual|2015-12-01||Interventional|||Vapocoolant Spray for Reducing the Pain of Spinal Needle Insertion|Ocoolant Spray vs Lidocaine Infiltration for Reducing the Pain of Spinal Needle Insertion During the Caudal Epidural Injection|Completed||N/A|66|Actual|The Catholic University of Korea||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:00:29.138965|2017-10-10 21:00:29.138965
NCT03175900|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-27|||June 17, 2017|Actual|2017-06-17|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ENMNM||Effectiveness and Neural Mechanism of Naoandiwan for Migraine|Effectiveness and Neural Mechanism of Naoandiwan for Migraine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Recruiting||Phase 4|34|Anticipated|Dongzhimen Hospital, Beijing||2|||f||||t|f|f||||||||2017-10-10 21:00:29.214564|2017-10-10 21:00:29.214564
NCT03175887|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-07-09|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Investigational TMS Treatment for Depression|Dorsolateral Versus Medial Prefrontal TMS for Depression|Not yet recruiting||N/A|40|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t|f|t|f||t|||||2017-10-10 21:00:29.298226|2017-10-10 21:00:29.298226
NCT03175874|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-02|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|AVP||Autophagy and Pathological Aging|AVP Study: Autophagy and Pathological Aging Human Study in Osteoporosis With or Without Dementia of Alzheimer's Type|Not yet recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f|f|f||||||Undecided||2017-10-10 21:00:29.369653|2017-10-10 21:00:29.369653
NCT03175861|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-06|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Observational|MUMOFRAT||Modeling of the Response to Hypofractionated Stereotactic Pulmonary Irradiation|Multiscale Modeling / Simulation of the Response to Pulmonary Stereotactic Hypofractionated Irradiation|Recruiting||N/A|60|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 21:00:29.441316|2017-10-10 21:00:29.441316
NCT03175848|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-07-18|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer|Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer: A Prospective, Single Arm, Phase II Clinical Trial|Recruiting||N/A|48|Anticipated|Zhejiang Cancer Hospital||1|||f||||t|f|f||||||||2017-10-10 21:00:29.531907|2017-10-10 21:00:29.531907
NCT03175835|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-05|||May 8, 2017|Actual|2017-05-08|April 2017|2017-04-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects|An Open-label, Multiple Dose, Fixed-sequence, 3-period Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects|Completed||Phase 1|30|Actual|Chong Kun Dang Pharmaceutical||1|||f||||f|f|f||||||||2017-10-10 21:00:29.608969|2017-10-10 21:00:29.608969
NCT03175770|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-01|||January 1, 2015|Actual|2015-01-01|June 2017|2017-06-01|June 15, 2017|Anticipated|2017-06-15|June 1, 2017|Anticipated|2017-06-01||Observational|||Feasibility of Radiofrequency Resection in Oropharyngeal Tumor Surgery|Feasibility of Radiofrequency Resection in Oropharyngeal Tumor Surgery|Active, not recruiting||N/A|25|Anticipated|Technische Universität München|||1||f||||t|f|f||||||No|Individual participant data will not be shared with other researchers|2017-10-10 21:00:32.337672|2017-10-10 21:00:32.337672
NCT03175757|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||May 12, 2017|Actual|2017-05-12|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels|A Randomized, Single-blind, Placebo-controlled Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels Among Generally Healthy Participants|Recruiting||N/A|30|Anticipated|Supplement Formulators, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:00:32.423527|2017-10-10 21:00:32.423527
NCT03175744|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-06-01|||May 24, 2017||2017-05-24||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:00:32.543762|2017-10-10 21:00:32.543762
NCT03175731|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-26|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|PPI||PPI and Esophagogastric Variceal Bleeding in Cirrhotic Patients (PPI: Proton Pump Inhibitors)|A Multicentre Randomized Controlled Study on the Effect of PPI on Esophagogastric Variceal Bleeding in Cirrhotic Patients (PPI: Proton Pump Inhibitors)|Recruiting||Phase 4|240|Anticipated|Qilu Hospital of Shandong University||4|||f||||t|f|f||||||||2017-10-10 21:00:32.580088|2017-10-10 21:00:32.580088
NCT03175718|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-09-20|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|February 28, 2021|Anticipated|2021-02-28|February 29, 2020|Anticipated|2020-02-29||Interventional|VAC||INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients|The Effect of INPWT on Wound Complications and Clinical Outcomes Following Lower Extremity Sarcoma Surgery in Patients Treated With Preoperative Radiation Therapy: A Multicentre Randomized Controlled Trial|Not yet recruiting||N/A|291|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:00:32.671475|2017-10-10 21:00:32.671475
NCT03175705|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-01|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC|A Study of Specific HCC Antigens CD8+ T Cells Therapy for Treating Patients With Relapsed/Advanced Hepatocellular Carcinoma (HCC)|Recruiting||Phase 1|18|Anticipated|Beijing YouAn Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:00:32.766941|2017-10-10 21:00:32.766941
NCT03175692|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-15|||June 14, 2017|Actual|2017-06-14|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Observational|||Rapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children|Rapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children|Enrolling by invitation||N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||f|f|f||||Samples With DNA|"     Use blood or DBS to extract DNA   "|No||2017-10-10 21:00:32.857582|2017-10-10 21:00:32.857582
NCT03175679|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-01|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC|A Study of Adoptive Invariant Nature Killer T Cell Therapy for Relapsed/Advanced Hepatocellular Carcinoma (HCC)|Recruiting||Phase 1|18|Anticipated|Beijing YouAn Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:00:32.921367|2017-10-10 21:00:32.921367
NCT03175666|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-19|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy|NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy|Not yet recruiting||Phase 1/Phase 2|79|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||No||2017-10-10 21:00:34.079581|2017-10-10 21:00:34.079581
NCT03175653|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-07-25|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Impact of the Number of Opiates Prescribed on Post Cesarean Pain Control|Assessing the Impact of the Number of Opiates Prescribed on Post Cesarean Pain Control: A Randomized Controlled Trial|Recruiting||N/A|118|Anticipated|Mount Carmel Health System||2|||f||||f|f|f|||f|||||2017-10-10 21:00:34.184195|2017-10-10 21:00:34.184195
NCT03175640|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-02|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PTSL||Prescribe to Save Lives|Implementation to Motivate Physician Response to Opioid Dependence in HIV Settings|Recruiting||N/A|120|Anticipated|Baystate Medical Center||1|||f||||f|f|f||||||Yes|The investigators will make study data available to the community of scientists and the public in keeping with NIDA policies. After all data have been collected and the results of the major papers are in press, de-identified data will be made available to other qualified researchers on request. The request will be evaluated by Dr. Friedmann to ensure that it meets reasonable standards of scientific integrity. Ultimately, it is anticipated that de-identified data and codebooks will be warehoused and available through the ICPSR and SAMHDA websites. This data sharing plan will comply with the requirements of the privacy rule and federal regulations under HIPAA and 42 CFR Part 2 that govern the protection of individually identifiable information.|2017-10-10 21:00:34.28786|2017-10-10 21:00:34.28786
NCT03175627|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Clinical Performance of Posterior Composite Tooth Fillings in Adults|Clinical Investigation Of A Bulk Fill Composite In Class II Restorations In Adult Subjects|Recruiting||N/A|60|Anticipated|Louisiana State University Health Sciences Center in New Orleans||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:00:34.403025|2017-10-10 21:00:34.403025
NCT03175614|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-04|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|EVIDENT3||Effectiveness to Weight Loss in Sedentary and Overweight People Using a Smartphone Application.|EVIDENT3 Study: A Randomized, Controlled Clinical Trial to Reduce Inactivity and Caloric Intake in Sedentary, Overweight People Using a Smartphone Application. Study Protocol.|Recruiting||N/A|700|Anticipated|Fundacion para la Investigacion y Formacion en Ciencias de la Salud||2|||f||||f|f|f|||f|||||2017-10-10 21:00:34.52109|2017-10-10 21:00:34.52109
NCT03175601|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-02|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|SleSOB||Sleep Disturbances and Biomarkers of Sarcopenic OBesity|Sleep Disturbances and Biomarkers of Sarcopenic OBesity: Insight Into Mechanisms of Prefrailty|Not yet recruiting||N/A|100|Anticipated|Istituto di Fisiologia Clinica CNR|||1||f||||f|f|f||||Samples Without DNA|"     Serum, plasma and urine samples   "|No||2017-10-10 21:00:35.752809|2017-10-10 21:00:35.752809
NCT03175588|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-19|||September 11, 2017|Anticipated|2017-09-11|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 11, 2017|Anticipated|2017-12-11||Interventional|||Comparison of Effects of Interactive Video Games in the Elderly|Comparison of Effects of Interactive Video Games and Activity Based Approaches on Mobility and General Well Being in the Elderly|Not yet recruiting||N/A|75|Anticipated|Istanbul University||2|||f||||f|f|f||||||||2017-10-10 21:00:35.837094|2017-10-10 21:00:35.837094
NCT03175575|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||May 1, 2014|Actual|2014-05-01|June 2017|2017-06-01|June 30, 2014|Actual|2014-06-30|June 30, 2014|Actual|2014-06-30||Observational|||Pilot Study on Community Gardens and Food Purchases in Deprived Neighborhood (Marseille, France)|A Pilot Study to Assess How Access to a Community Garden Could Help Instigate the Adoption of Healthier Food Purchase Patterns in Deprived Neighborhood (Marseille, France)|Completed||N/A|21|Actual|Institut National de la Recherche Agronomique|||1||f||||f|f|f||||||No||2017-10-10 21:00:35.938876|2017-10-10 21:00:35.938876
NCT03175562|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||March 27, 2017|Actual|2017-03-27|June 2017|2017-06-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants|A Human Repeat Insult Patch Test (HRIPT) in Healthy Subjects to Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product|Completed||N/A|294|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||No||2017-10-10 21:00:36.010601|2017-10-10 21:00:36.010601
NCT03175549|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-10-03|||October 23, 2017|Anticipated|2017-10-23|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Medication Development in Alcoholism: Apremilast Versus Placebo|Medication Development for Protracted Abstinence in Alcoholism: Apremilast Versus Placebo|Not yet recruiting||Phase 2|50|Anticipated|The Scripps Research Institute||2|||f||||f|t|f|||f|||||2017-10-10 21:00:36.196636|2017-10-10 21:00:36.196636
NCT03175536|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-01|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|October 31, 2020|Anticipated|2020-10-31|April 30, 2020|Anticipated|2020-04-30||Observational|AFFORD||Asthma in Families Facing Out-of-pocket Requirements With Deductibles|Comparing Patient-Centered Outcomes for Adults and Children With Asthma in High-Deductible Health Plans With and Without Preventive Drug Lists|Enrolling by invitation||N/A|111164|Anticipated|Harvard Pilgrim Health Care|||3||f||||f|f|f||||||No||2017-10-10 21:00:36.308042|2017-10-10 21:00:36.308042
NCT03175523|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-13|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|December 31, 2023|Anticipated|2023-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|HOWTO-BRS||HOW To Optimally Implant BioResorbable Scaffold - Intravascular Imaging Versus Quantitative Coronary Angiography Guidance|HOW To Optimally Implant BioResorbable Scaffold - Intravascular Imaging Versus Quantitative Coronary Angiography Guidance|Not yet recruiting||N/A|800|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:00:36.43017|2017-10-10 21:00:36.43017
NCT03175510|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-22|||May 15, 2016|Actual|2016-05-15|June 2017|2017-06-01|September 1, 2017|Actual|2017-09-01|August 1, 2017|Actual|2017-08-01||Observational|||Reliabılıty,Validity Of The Turkish Version Of The Back Pain Function Scale|Reliabılıty,Validity Of The Turkish Version Of The Back Pain Function Scale|Completed||N/A|180|Actual|Gazi University|||1||f||||t|f|f||||||||2017-10-10 21:00:36.529455|2017-10-10 21:00:36.529455
NCT03175497|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors|A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of Telatinib, a Selective Inhibitor of the Vascular Endothelial Growth Factor (VEGF) Receptor, in Adult Chinese Patients With Advanced Solid Tumors|Not yet recruiting||Phase 1|24|Anticipated|EddingPharm Oncology Co., LTD.||1|||f||||f|t|f|||f|||No||2017-10-10 21:00:36.606164|2017-10-10 21:00:36.606164
NCT03175484|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-28|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Simulation to Assess Cognitive Workload and Task Load IndeX (TLX) Performance|The Influence of the Perceived Workload on Performance During High Fidelity Simulation in Surgical Specialty ( Including Anesthesia) and Nurses|Recruiting||N/A|84|Anticipated|Claude Bernard University|||1||f||||f|f|f||||||||2017-10-10 21:00:36.690759|2017-10-10 21:00:36.690759
NCT03175471|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-01|||January 17, 2017|Actual|2017-01-17|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|||MRI Based Biomarkers in Pediatric Autoimmune Liver Disease|Cross-sectional Study for Assessment of MRI Based Biomarkers of Bile Duct Injury and Hepatic Fibrosis in Pediatric Onset Autoimmune Liver Disease|Recruiting||N/A|115|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f|f|f||||Samples With DNA|"     Plasma and serum samples, Liver biopsy tissue samples   "|No||2017-10-10 21:00:36.775069|2017-10-10 21:00:36.775069
NCT03175458|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-01|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Schnederian Membrane Elevation and Augmentation With Deproteinized Bovine Bone [Tutu-gen Bone] Versus Graft Less Tenting Technique With Simultaneous Implant Placement|Schnederian Membrane Elevation and Augmentation With Deproteinized Bovine Bone [Tutu-gen Bone] Versus Graft Less Tenting Technique With Simultaneous Implant Placement: Randomized Clinical Trial|Active, not recruiting||N/A|30|Anticipated|Cairo University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:00:36.900712|2017-10-10 21:00:36.900712
NCT03175445|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||January 30, 2017|Actual|2017-01-30|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|December 30, 2017|Anticipated|2017-12-30||Observational|||Sexual Dimorphism Analysis in Egyptian Population by Locating the Mandibular Canal Using CBCT|Sexual Dimorphism Analysis in Egyptian Population by Locating the Mandibular Canal Using Cone-beam Computed Tomography: an Observational Cross Sectional Study|Enrolling by invitation||N/A|136|Actual|Cairo University|||2||f||||f|f|f||||||Undecided||2017-10-10 21:00:37.008275|2017-10-10 21:00:37.008275
NCT03175068|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-05-31|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response|Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response|Not yet recruiting||N/A|240|Anticipated|University of Illinois at Chicago||2|||f||||t|f|f||||||||2017-10-10 21:00:40.202787|2017-10-10 21:00:40.202787
NCT03175432|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-22|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|BEAT-MBM||Study of BEvacizumab in Combination With ATezolizumab in Patients With Untreated Melanoma Brain Metastases|Phase II Study of BEvacizumab in Combination With ATezolizumab in Patients With Untreated Melanoma Brain Metastases (BEAT-MBM)|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:00:37.095931|2017-10-10 21:00:37.095931
NCT03175419|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||February 16, 2016|Actual|2016-02-16|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|January 2, 2017|Actual|2017-01-02|2 Years|Observational [Patient Registry]|BReLLS||BReLLS: A Prospective Belgian Registry on Laparoscopic Liver Surgery|BReLLS: A Prospective Belgian Registry on Laparoscopic Liver Surgery|Recruiting||N/A|1000|Anticipated|University Hospital, Ghent|||1||f||||t|f|f||||||Yes||2017-10-10 21:00:37.233111|2017-10-10 21:00:37.233111
NCT03175406|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-01|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Observational|||Predicting the Outcomes of Labor Induction|Comparing the Accuracy of Manipal Cervical Scoring System and Modified Bishop Score in Predicting Successful Induction of Labor|Completed||N/A|105|Actual|Ain Shams University|||1||f|||||f|f||||||Undecided||2017-10-10 21:00:37.323175|2017-10-10 21:00:37.323175
NCT03175393|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Relation Between Postprandial Lipogram and Coronary Artery Disease Severity|Relation Between Postprandial Lipogram and Coronary Artery Disease Severity|Recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||No||2017-10-10 21:00:37.397508|2017-10-10 21:00:37.397508
NCT03175367|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||August 28, 2017|Anticipated|2017-08-28|June 2017|2017-06-01|February 12, 2020|Anticipated|2020-02-12|July 16, 2019|Anticipated|2019-07-16||Interventional|||Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia|A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Doses and Dose Regimens of Evinacumab in Patients With Persistent Hypercholesterolemia Despite Maximally Tolerated Lipid Modifying Therapy|Not yet recruiting||Phase 2|252|Anticipated|Regeneron Pharmaceuticals||7|||f||||t|t|f|||t|||||2017-10-10 21:00:37.577631|2017-10-10 21:00:37.577631
NCT03175354|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-26|||April 26, 2017|Actual|2017-04-26|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Study in Subjects With Moderate Atopic Dermatitis|A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis|Recruiting||Phase 2|203|Anticipated|Ralexar Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:00:37.692181|2017-10-10 21:00:37.692181
NCT03175341|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-06-02|||June 5, 2017|Anticipated|2017-06-05|June 2017|2017-06-01|May 6, 2018|Anticipated|2018-05-06|May 6, 2018|Anticipated|2018-05-06||Interventional|||Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer|Phase I/II Randomized Study to Evaluate the Role of Intravenous Ascorbic Acid Supplementation to Conventional Neoadjuvant Chemotherapy in Women With Breast Cancer|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Academic Emergency County Hospital Sibiu||2|||f||||t|f|f||||||No||2017-10-10 21:00:37.814667|2017-10-10 21:00:37.814667
NCT03175328|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|CRTSAKI||CRRT Timing in Sepsis-associated AKI in ICU|The Timing of Continuous Renal Replacement Therapy Initiation in Sepsis-associated Acute Kidney Injury in the Intensive Care Unit|Not yet recruiting||N/A|600|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||2|||f|||||f|f|||f|||No||2017-10-10 21:00:38.022461|2017-10-10 21:00:38.022461
NCT03175315|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-31|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|FLASH||Evaluation of a Treatment and Education Program for Diabetic Patients Who Use Flash Glucose Monitoring|Evaluation of a Newly Developed Psychoeducational Treatment and Education Program for People With Type 1 and Type 2 Diabetes on an Intensified Insulin Therapy Who Use Flash Glucose Monitoring|Recruiting||N/A|216|Anticipated|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||f|f|f||||||No||2017-10-10 21:00:38.14633|2017-10-10 21:00:38.14633
NCT03175302|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-14|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|August 1, 2021|Anticipated|2021-08-01||Observational|PRECEDE||PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing|PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing|Not yet recruiting||N/A|25240|Anticipated|University of Florida|||2||f||||f|f|f||||||||2017-10-10 21:00:38.274094|2017-10-10 21:00:38.274094
NCT03175289|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||September 29, 2016|Actual|2016-09-29|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Expiratory Muscle Strength Training in Improving Bulbar Function and Quality of Life in Patients With Head and Neck Cancer|The Impact of Expiratory Muscle Strength Training on Bulbar Function and Well Being of Individuals With Head and Neck Cancer|Recruiting||N/A|70|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t|f|f||||||||2017-10-10 21:00:38.393727|2017-10-10 21:00:38.393727
NCT03175276|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-06|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Observational|Delirium||Informant Questionaire on Cognitive Decline in the Elderly (IQCODE) and Delirium in Geriatric Patients|Predict IQCODE Delirium in Geriatric Patients|Recruiting||N/A|235|Anticipated|University of Aarhus|||1||f||||f|f|f||||||No||2017-10-10 21:00:38.547277|2017-10-10 21:00:38.547277
NCT03175263|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||September 1, 2008|Actual|2008-09-01|June 2017|2017-06-01|December 30, 2015|Actual|2015-12-30|December 30, 2015|Actual|2015-12-30||Observational|||OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain|OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain : an Observational, Open Label, Real-life Cohort Study.|Completed||N/A|57|Actual|University Hospital, Limoges|||1||f||||f|f|f||||||No||2017-10-10 21:00:38.618875|2017-10-10 21:00:38.618875
NCT03175250|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-02|||October 15, 2013|Actual|2013-10-15|June 2017|2017-06-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Interventional|||Translation of Basic Research in Cognitive Science to HIV Risk|Action Plans & Memory Consolidation: Reducing HIV Risk in Drug Users|Completed||N/A|343|Actual|Claremont Graduate University||3|||f||||t|f|f||||||Yes|Pretest and outcome data will be made available after publication. Data can be obtained from the PI at alan.stacy@cgu.edu|2017-10-10 21:00:38.696482|2017-10-10 21:00:38.696482
NCT03175237|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-08-07|||May 10, 2014|Actual|2014-05-10|August 2017|2017-08-01|September 30, 2015|Actual|2015-09-30|August 15, 2015|Actual|2015-08-15||Interventional|||Mirror Therapy in Pos Stroke Individuals|Mirror Therapy: Technique Benefits in Different Motor Impairment in Post-stroke Subjects|Completed||N/A|27|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f|f|f||||||||2017-10-10 21:00:38.775222|2017-10-10 21:00:38.775222
NCT03175224|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-25|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||CBT-101 Study for Advanced Solid Tumors and c-Met Dysregulation|Phase 1 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of CBT-101 in Subjects With Advanced Solid Tumors and c-Met Dysregulation|Recruiting||Phase 1|68|Anticipated|CBT Pharmaceuticals, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:00:38.84948|2017-10-10 21:00:38.84948
NCT03175211|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-10-03|||June 30, 2017|Actual|2017-06-30|October 2017|2017-10-01|June 4, 2018|Anticipated|2018-06-04|June 4, 2018|Anticipated|2018-06-04||Interventional|||Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Subcutaneous Doses of BI 456906 in Healthy Male Subjects (Single-blind, Partially Randomised, Placebo-controlled Parallel Group Design)|Recruiting||Phase 1|80|Anticipated|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 21:00:38.957275|2017-10-10 21:00:38.957275
NCT03175198|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-09-21|||July 5, 2017|Actual|2017-07-05|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|June 30, 2020|Anticipated|2020-06-30||Observational|||Japanese Pradaxa PMS, Long Term|Post-Marketing Surveillance on the Long-Term Use of Prazaxa® Capsules in Japanese Patients With Nonvalvular Atrial Fibrillation After the Availability of Idarucizumab.|Recruiting||N/A|6000|Anticipated|Boehringer Ingelheim|||1||f|||||t|f||||||||2017-10-10 21:00:39.044277|2017-10-10 21:00:39.044277
NCT03175185|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-06-01|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Observational|||Psychiatric Assessment Of Parents Of Children With ADHD|Psychiatric Assessment Of Parents Of Children With Attention Deficit Hyperactivity Disorder|Not yet recruiting||N/A|200|Anticipated|Assiut University|||2||f||||f|f|f||||||Undecided||2017-10-10 21:00:39.127382|2017-10-10 21:00:39.127382
NCT03175172|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-10-04|||June 15, 2017|Actual|2017-06-15|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM|A Phase 2 Single-arm Study to Evaluate Safety and Efficacy of CRS-207 With Pembrolizumab in Adults With Previously-Treated Malignant Pleural Mesothelioma|Recruiting||Phase 2|35|Anticipated|Aduro Biotech, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:00:39.209432|2017-10-10 21:00:39.209432
NCT03175159|ClinicalTrials.gov processed this data on October 10, 2017|2017-06-01|2017-08-18|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 1, 2022|Anticipated|2022-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|||Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse|Integrated Behavioral Activation and HIV Risk Reduction Counseling for Men Who Have Sex With Men (MSM) With Stimulant Abuse|Not yet recruiting||N/A|286|Anticipated|Brown University||3|||f|||||f|f||||||||2017-10-10 21:00:39.359672|2017-10-10 21:00:39.359672
NCT03175146|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-06-05|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely|Stereotactic Body RadioTherapy (SBRT) for Oligo-metastatic Colo-rectal Cancer With Bio-marker Evaluation for Early Progression|Not yet recruiting||N/A|30|Anticipated|AHS Cancer Control Alberta||1|||f||||t|f|f||||||Yes||2017-10-10 21:00:39.469745|2017-10-10 21:00:39.469745
NCT03175133|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-31|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|June 23, 2018|Anticipated|2018-06-23|May 23, 2018|Anticipated|2018-05-23||Interventional|||Strength Training to Improve Gait in People With Multiple Sclerosis|Targeted Strength Training to Improve Gait in People With Multiple Sclerosis: a Feasibility Study|Recruiting||N/A|10|Anticipated|University of Colorado, Denver||1|||f||||f|f|f||||||No||2017-10-10 21:00:39.569416|2017-10-10 21:00:39.569416
NCT03175120|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-02|||May 25, 2017|Actual|2017-05-25|October 2017|2017-10-01|December 30, 2018|Anticipated|2018-12-30|December 10, 2018|Anticipated|2018-12-10||Interventional|DUAL™ II China||A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)|A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other OAD|Recruiting||Phase 3|450|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f|||t|||||2017-10-10 21:00:39.68077|2017-10-10 21:00:39.68077
NCT03175107|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-31|||November 2, 2015|Actual|2015-11-02|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 23, 2016|Actual|2016-12-23||Interventional|PD_managerSI||Exergaming in Upper Extremities for Persons With Parkinson's Disease|mHealth Platform for Parkinson's Disease Management: Exergaming in Upper Extremities for Persons With Parkinson's Disease|Recruiting||N/A|47|Anticipated|University Rehabilitation Institute, Republic of Slovenia||1|||f||||f|f|f||||||Undecided||2017-10-10 21:00:39.88215|2017-10-10 21:00:39.88215
NCT03175094|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-31|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|November 2016|Actual|2016-11-01||Interventional|||PLUS PINK: HHRP+ Adaptation for Women With HIV Under Community Supervision|PLUS PINK: HHRP+ Adaptation for Women With HIV Under Community Supervision|Active, not recruiting||N/A|48|Actual|Yale University||2|||f||||f|f|f||||||No||2017-10-10 21:00:39.969507|2017-10-10 21:00:39.969507
NCT03175081|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-02|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|April 27, 2018|Anticipated|2018-04-27|February 2018|Anticipated|2018-02-01||Interventional|||Intraperitoneal Local Anesthetic in Bariatric Surgery Study (iLABS Study)|Intraperitoneal Local Anesthetic in Bariatric Surgery: A Double Blind-randomized Controlled Pilot Trial|Recruiting||N/A|54|Anticipated|Universiti Putra Malaysia||2|||f||||t|f|f||||||No||2017-10-10 21:00:40.064122|2017-10-10 21:00:40.064122
NCT03175042|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-05-31|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic|Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic|Not yet recruiting||N/A|100|Anticipated|The University of Texas Medical Branch, Galveston|||1||f||||t|f|t|f|f|t|||No||2017-10-10 21:00:40.368984|2017-10-10 21:00:40.368984
NCT03175029|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.|Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.|Recruiting||Phase 2|75|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 21:00:40.451988|2017-10-10 21:00:40.451988
NCT03175016|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-25|||June 20, 2017|Actual|2017-06-20|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|DEBIRI-CRLM||Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer|Irinotecan-Eluting Bead (DEBIRI) for Unresectable Liver Metastases From Colorectal Cancer After Systemic Chemotherapy Failure|Recruiting||Phase 2/Phase 3|200|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:00:40.561449|2017-10-10 21:00:40.561449
NCT03175003|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-07-06|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|October 31, 2017|Anticipated|2017-10-31||Interventional|||Assessment of a New Food Product in Metabolically at Risk Children|Assessment of Protein Intake and Micronutrient Fortification in Metabolically at Risk Children|Recruiting||N/A|80|Anticipated|University of California, Davis||4|||f||||f|f|f||||||||2017-10-10 21:00:40.813805|2017-10-10 21:00:40.813805
NCT03174990|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-31|||August 31, 2010|Actual|2010-08-31|May 2017|2017-05-01|December 20, 2013|Actual|2013-12-20|May 17, 2013|Actual|2013-05-17||Observational|||Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease|The Effect of Aspirin and Thienopyridine Non-responsiveness on Outcomes in Peripheral Arterial Disease|Completed||N/A|195|Actual|University of California, Davis|||4||f||||f|f|f|||t|Samples With DNA|"     Blood   "|No||2017-10-10 21:00:40.945109|2017-10-10 21:00:40.945109
NCT03174977|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-31|||June 5, 2017|Anticipated|2017-06-05|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics Distribution of Raltegravir by PET/MR|Pharmacokinetics Distribution of Raltegravir Using Radiolabeling in HIV-infected Patients by PET/MR: a Pilot Study.|Recruiting||Early Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||t|t|f|||f|||||2017-10-10 21:00:41.038827|2017-10-10 21:00:41.038827
NCT03174938|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-02|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|December 31, 2028|Anticipated|2028-12-31|December 31, 2028|Anticipated|2028-12-31||Interventional|BioFINDER2||The Swedish BioFINDER 2 Study|The Swedish BioFINDER 2 Study|Recruiting||N/A|1505|Anticipated|Skane University Hospital||5|||f||||t|f|f|||f|||Undecided||2017-10-10 21:00:41.372005|2017-10-10 21:00:41.372005
NCT03174925|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-05|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|August 15, 2020|Anticipated|2020-08-15|August 15, 2020|Anticipated|2020-08-15||Interventional|||Ultrasound Elastography in Imaging Patients With Thyroid Nodules|Elastography in Thyroid Nodule Evaluation|Recruiting||N/A|53|Anticipated|Stanford University||1|||f||||t|f|f||||||||2017-10-10 21:00:41.508401|2017-10-10 21:00:41.508401
NCT03174912|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-31|||January 1, 2007|Actual|2007-01-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?||Completed||Phase 4|400|Actual|Ankara Training and Research Hospital||3|||f||||f|f|f||||||Undecided||2017-10-10 21:00:41.601426|2017-10-10 21:00:41.601426
NCT03174899|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-06|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Diffusion Weighted Magnetic Resonance Imaging in Chronic Kidney Disease|Role of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Chronic Kidney Disease|Not yet recruiting||N/A|31|Anticipated|Assiut University||5|||f|||||f|f||||||||2017-10-10 21:00:41.685508|2017-10-10 21:00:41.685508
NCT03174886|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-28|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|AIDA||A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia|A 24-month Randomised Parallel Group Single-blinded Multi-centre Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia|Recruiting||Phase 1|30|Anticipated|Axon Neuroscience SE||2|||f||||t|f|f||||||||2017-10-10 21:00:41.796953|2017-10-10 21:00:41.796953
NCT03174873|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-31|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|||Tubal Factor in Unexplained Infertility|Laparoscopic Tubal Evaluation in Unexplained Infertility|Recruiting||N/A|100|Anticipated|Assiut University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:00:41.92649|2017-10-10 21:00:41.92649
NCT03174860|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-31|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success|Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success in Mandibular Molars With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|66|Anticipated|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 21:00:41.993693|2017-10-10 21:00:41.993693
NCT03174652|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-23|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 20, 2017|Actual|2017-07-20||Observational|AnPREG||Anemia Pregnancy Outcome on the Thai-Myanmar Border|Causes and Impact of Anemia on Pregnancy Outcome on the Thai-Myanmar Border: Retrospective Analysis|Active, not recruiting||N/A|15548|Anticipated|University of Oxford|||1||f||||f|f|f||||||||2017-10-10 21:00:43.676694|2017-10-10 21:00:43.676694
NCT03174847|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-31|||February 20, 2017|Actual|2017-02-20|May 2017|2017-05-01|January 30, 2020|Anticipated|2020-01-30|January 30, 2019|Anticipated|2019-01-30||Observational|PA_PACES||Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism|Prospective Study Assessing Blood Pressure, Cardiovascular, Endothelial and Other Outcomes poSt-surgical and Medical Treatment in Patients With Primary Aldosteronism|Recruiting||N/A|50|Anticipated|Changi General Hospital|||2||f||||f|f|f||||Samples With DNA|"     Peripheral blood samples Adrenal vein blood samples (during adrenal vein sampling) Adrenal     tissue (post-adrenalectomy)   "|No||2017-10-10 21:00:42.094425|2017-10-10 21:00:42.094425
NCT03174821|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-31|||October 20, 2010|Actual|2010-10-20|May 2017|2017-05-01|May 16, 2014|Actual|2014-05-16|May 16, 2014|Actual|2014-05-16||Interventional|||Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy|The Impact of Insulin Pump Therapy to Oxidative Stress in Patients With Diabetic Nephropathy|Completed||N/A|160|Actual|Chinese PLA General Hospital||2|||f||||f|f|f||||||No|The individual participant data (IPD) was not allowed to use outside this research.|2017-10-10 21:00:42.310776|2017-10-10 21:00:42.310776
NCT03174808|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-23|||August 20, 2017|Actual|2017-08-20|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|October 31, 2017|Anticipated|2017-10-31||Interventional|||Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)|Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)|Recruiting||N/A|15|Anticipated|Yale University||1|||f||||f|f|f||||||||2017-10-10 21:00:42.414844|2017-10-10 21:00:42.414844
NCT03174795|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-25|||July 11, 2017|Actual|2017-07-11|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection|A Non-Randomized, Open-Label, One Treatment, One Group Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Patients With a Complicated Urinary Tract Infection|Recruiting||Phase 1|20|Anticipated|Hoffmann-La Roche||1|||f||||f|t|f||||||||2017-10-10 21:00:42.532274|2017-10-10 21:00:42.532274
NCT03174782|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-05-31|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Regional Nerve Blocks for Major Lower Extremity Amputations|Regional Nerve Blocks for Major Lower Extremity Amputations|Not yet recruiting||Phase 4|300|Anticipated|University of California, San Francisco||2|||f||||t|t|f|||t|||No||2017-10-10 21:00:42.68005|2017-10-10 21:00:42.68005
NCT03174769|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-10-05|||May 1, 2017|Actual|2017-05-01|October 2017|2017-10-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Impact of Protein Quantity Within the USDA Healthy Style Eating Pattern on Sleep|Effects of Higher Consumption of Protein-rich Animal Foods With the USDA Healthy U.S.-Style Eating Pattern on Sleep Quality and Cardio-metabolic Health in Overweight/Obese Adults During Diet-induced Weight Loss|Recruiting||N/A|60|Anticipated|Purdue University||2|||f||||f|f|f||||||||2017-10-10 21:00:42.785666|2017-10-10 21:00:42.785666
NCT03174756|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-05-31|||January 15, 2015|Actual|2015-01-15|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 15, 2016|Actual|2016-11-15||Interventional|HOCl-SAP||HYPOCHLOROUS ACID SUBSTANTIVITY AS ANTIPLAQUE AGENT (HOCl-SAP)|EVALUATION OF THE HYPOCHLOROUS ACID SUBSTANTIVITY AS ANTI-PLAQUE AGENT. A RANDOMIZED CONTROLLED TRIAL|Completed||Phase 2|75|Actual|Universidad El Bosque, Bogotá||5|||f||||f|f|f|||f|||No|No requerid|2017-10-10 21:00:42.900287|2017-10-10 21:00:42.900287
NCT03174743|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-04|||June 2, 2017|Actual|2017-06-02|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Protective Ventilation During Pulmonary Lobectomy|The Effect of Protective Ventilation During Pulmonary Lobectomy|Recruiting||N/A|120|Anticipated|Xuzhou Medical University||4|||f||||t|f|f||||||No|IPD will be available when this trial is finished and the article have been published.|2017-10-10 21:00:43.018366|2017-10-10 21:00:43.018366
NCT03174717|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-31|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluating an Individualized Music Program Intervention in Long-term Care|Evaluating an Individualized Music Program Intervention in Long-term Care|Not yet recruiting||N/A|50|Anticipated|Memorial University of Newfoundland||1|||f||||f|f|f||||||No||2017-10-10 21:00:43.268826|2017-10-10 21:00:43.268826
NCT03174704|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-05-31|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2022|Anticipated|2022-05-01|May 1, 2022|Anticipated|2022-05-01||Observational|MARC||Medication Adherence Research in COPD Patients|Longitudinal Determinants of Medication Adherence in COPD|Recruiting||N/A|360|Anticipated|Johns Hopkins University|||1||f||||f|f|f||||||No|We do not share individual participant data.|2017-10-10 21:00:43.359782|2017-10-10 21:00:43.359782
NCT03174691|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-15|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Interventional|||Early Luteal Progesterone Profile in IVF Patients Triggered With hCG|The Early Luteal Progesterone Profile in IVF Patients Triggered With hCG|Completed||N/A|161|Actual|Vietnam National University||1|||f||||f|f|f|||f|||||2017-10-10 21:00:43.441459|2017-10-10 21:00:43.441459
NCT03174678|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-01|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|May 25, 2017|Actual|2017-05-25|May 1, 2017|Actual|2017-05-01||Interventional|||Dexmedetomidine Premedication in Children|The Effect of Oral Dexmedetomidine Premedication On Preoperative Cooperation and Emergence Delirium In Children Undergoing Dental Treatment|Completed||Phase 4|100|Actual|Adnan Menderes University||2|||f||||f|t|f|||t|||Undecided||2017-10-10 21:00:43.512675|2017-10-10 21:00:43.512675
NCT03174665|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||January 2016||2016-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Chronic Neuropathic Pain After Nerve Repair Hand Surgery|Incidence of Chronic Neuropathic Pain and Sensory Deficits After Nerve Repair Hand Surgery (Correlation With Genetics, Fenotypes and Biomarkers)|Enrolling by invitation||N/A|990|Actual|Uppsala University|||2||f||||f||||||||Yes||2017-10-10 21:00:43.597907|2017-10-10 21:00:43.597907
NCT03174639|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-31|||March 11, 2016|Actual|2016-03-11|May 2017|2017-05-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||High Myopia Macular Hole and Retinal Detachment Treated With Double ILM Flaps|High Myopia Macular Hole and Retinal Detachment Accepted Internal Limiting Membrane Flip Packing and Free Flap Was the Internal Limiting Membrane (ILM Flap Was Double)|Completed||N/A|8|Actual|National Taiwan University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:00:43.73314|2017-10-10 21:00:43.73314
NCT03174626|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-05-31|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Williams LifeSkills - Cancer Caregiver Intervention|A Pilot Study on the Implementation of the WLS-Cancer Care Protocol|Recruiting||N/A|40|Anticipated|Duke University||2|||f||||t|f|f||||||No||2017-10-10 21:00:43.81575|2017-10-10 21:00:43.81575
NCT03174613|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-16|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|November 30, 2018|Anticipated|2018-11-30|July 31, 2018|Anticipated|2018-07-31||Interventional|||A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255|A Dose Blocked-randomized, Double-blind, Placebo Controlled, Single and Multiple Dosing, Dose-escalation Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamics and Food Effect of LC51-0255|Active, not recruiting||Phase 1|110|Anticipated|LG Chem||2|||f||||f|f|f||||||||2017-10-10 21:00:43.91635|2017-10-10 21:00:43.91635
NCT03174600|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Observational|||Impact of Lower Urinary Tract Dysfunction on Clinical Manifestation in Patients With Stroke|The Course of Post-stroke Bladder Problems and Their Relation With Functional, Mental Status and Quality of Life: A Six-month Prospective, Multicenter Study|Completed||N/A|70|Actual|Ege University|||1||f||||f|f|f||||||No||2017-10-10 21:00:44.018947|2017-10-10 21:00:44.018947
NCT03174587|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-06|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis|A Phase 1 Study to Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis.|Enrolling by invitation||Phase 1|6|Anticipated|Corestem, Inc.||1|||f||||t|f|f||||||||2017-10-10 21:00:44.136837|2017-10-10 21:00:44.136837
NCT03174574|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||August 17, 2016|Actual|2016-08-17|June 2017|2017-06-01|July 31, 2021|Anticipated|2021-07-31|May 30, 2018|Anticipated|2018-05-30|3 Months|Observational [Patient Registry]|TCOG||Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.|Two Cancers, One Gene|Recruiting||N/A|500|Anticipated|Mayo Clinic|||1||f||||f|f|f||||Samples With DNA|"     Whole blood, serum, tissue   "|No||2017-10-10 21:00:44.242291|2017-10-10 21:00:44.242291
NCT03174561|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Inuline Supplement in Patients With Irritable Bowel Syndrome|Clinical Assessment of the Benefits of the Combination Inuline, Choline and Silymarin in Mitigating the Symptomatology in Patients With Irritable Bowel Syndrome|Recruiting||N/A|50|Anticipated|SC Fiterman Pharma SRL||2|||f|||||f|f||||||No||2017-10-10 21:00:44.346643|2017-10-10 21:00:44.346643
NCT03174548|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-19|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|September 15, 2017|Actual|2017-09-15||Interventional|||A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects|A Phase 1, Randomized, Single-center, Open-label, Three-sequence, Three-period, Three-treatment Crossover Study to Evaluate the Effect of Food on the Single-dose Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability of Sotagliflozin Oral Tablet to Oral Solution in Healthy Male and Female Subjects|Completed||Phase 1|14|Actual|Sanofi||3|||f||||f|t|f||||||||2017-10-10 21:00:44.591239|2017-10-10 21:00:44.591239
NCT03174535|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-05|||October 15, 2016|Actual|2016-10-15|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31|1 Year|Observational [Patient Registry]|||Risk Assessment Model for Ischemic Stroke Endpoint Events|Risk Assessment Model for Ischemic Stroke Endpoint Events Combining Multi-dimensional Traditional Chinese Medicine(TCM) and Modern Medicine Indicators: a Registry Study|Recruiting||N/A|3000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t|f|f||||Samples With DNA|"     Biospecimen includes serum, blood clots and whole blood.   "|No||2017-10-10 21:00:44.741057|2017-10-10 21:00:44.741057
NCT03174522|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||The Efficacy and Safety of Rexmyelocel-T to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM|The Efficacy and Safety of Intra-arterial Administration of Rexmyelocel-T to Treat Ischemic Ulcers in Subjects With Critical Limb Ischemia (CLI) Rutherford Category 5 and Diabetes Mellitus: A Pivotal, Placebo-controlled, Double-blind, Parallel-group, Adaptive Trial|Recruiting||Phase 3|78|Anticipated|Rexgenero Limited||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:00:44.847163|2017-10-10 21:00:44.847163
NCT03174509|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Is Positive Pressure Extubation a Safe Procedure?|Is Positive Pressure Extubation Safe Procedure? A Randomized Non-inferiority Trial.|Recruiting||N/A|198|Anticipated|Hospital Donación Francisco Santojanni||2|||f||||t|f|f||||||Undecided||2017-10-10 21:00:44.977416|2017-10-10 21:00:44.977416
NCT03174496|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-12|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|May 31, 2018|Anticipated|2018-05-31||Observational|PATIPS||Physical Activity Tracking in Paediatric Elective Tonsillectomy|Physical Activity Tracking in Paediatric Elective Tonsillectomy|Recruiting||N/A|24|Anticipated|University Children's Hospital Basel|||2||f||||f|f|f||||||No||2017-10-10 21:00:45.133487|2017-10-10 21:00:45.133487
NCT03174483|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-05-31|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Radiologic Scoring of Patients With Chronic Sinusitis and Nasal Polyps|Effects of Hypertonic Saline and Fluticasone Nasal Sprays on Radiologic Scoring of Patients With Chronic Sinusitis and Nasal Polyps|Recruiting||N/A|60|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:00:45.241704|2017-10-10 21:00:45.241704
NCT03174470|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-01|||November 2, 2016|Actual|2016-11-02|June 2017|2017-06-01||||June 30, 2017|Anticipated|2017-06-30||Interventional|||Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle|Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle|Active, not recruiting||N/A|20|Actual|Virility Medical Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:00:45.350333|2017-10-10 21:00:45.350333
NCT03174457|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-29|||June 21, 2017|Actual|2017-06-21|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01|4 Weeks|Observational [Patient Registry]|||Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study|Non-interventional Study on the Safety and Efficacy for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study|Recruiting||N/A|120|Anticipated|Astellas Pharma Inc|||1||f||||f|t|f|||t|||||2017-10-10 21:00:45.466098|2017-10-10 21:00:45.466098
NCT03174444|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-10-04|||August 15, 2017|Actual|2017-08-15|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|November 30, 2017|Anticipated|2017-11-30||Interventional|SMILES||Small Media Interventions to Increase Colorectal Cancer Screening Among Chinese Americans|Small Media Interventions to Increase Colorectal Cancer Screening Among Chinese Americans|Recruiting||N/A|2000|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||||2017-10-10 21:00:45.613888|2017-10-10 21:00:45.613888
NCT03174431|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-06-01|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Continence Pessary Versus Disposable Intravaginal Device Trial|A Comparison of Continence Pessary to a Disposable Intravaginal Device in the Management of Stress Urinary Incontinence: A Randomized Controlled Trial|Not yet recruiting||N/A|150|Anticipated|Ohio State University||2|||f||||f|f|f|||f|||No||2017-10-10 21:00:45.73489|2017-10-10 21:00:45.73489
NCT03174418|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|September 2018|Anticipated|2018-09-01||Observational|FORECAST||Fluid-dynamics in Bifurcation PCI|A Multicentre Prospective Study on the Role of Fluid Dynamics OCT-based REconstruction of Coronary Atherosclerosis in bifurcationS to Predict ouTcome|Not yet recruiting||N/A|300|Anticipated|Catholic University of the Sacred Heart|||2||f||||||||||||||2017-10-10 21:00:45.853686|2017-10-10 21:00:45.853686
NCT03174392|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-07|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Multimodal Exercise Training Poststroke|Exercise Training in a Novel Training Environment Compared to Increased Treadmill Speed During Walking With Individuals Poststroke|Recruiting||N/A|16|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 21:00:46.10389|2017-10-10 21:00:46.10389
NCT03174379|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-10-05|||June 5, 2017|Actual|2017-06-05|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Analyze the Effect of Acupuncture on Mobility And Quality of Life in Multiple Sclerosis|A Pilot Study to Analyze the Effect of Acupuncture on Mobility And Quality of Life in Multiple Sclerosis|Recruiting||N/A|30|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:00:46.229683|2017-10-10 21:00:46.229683
NCT03174366|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-30|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|May 16, 2020|Anticipated|2020-05-16|May 16, 2020|Anticipated|2020-05-16||Interventional|||Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy|Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy|Recruiting||Phase 3|7|Anticipated|Western University of Health Sciences||1|||f||||f|t|f|||t|||No||2017-10-10 21:00:46.359861|2017-10-10 21:00:46.359861
NCT03174353|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-01|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula|A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula|Not yet recruiting||Phase 2|123|Anticipated|University of Washington||1|||f||||t|t|f||||||No||2017-10-10 21:00:46.464883|2017-10-10 21:00:46.464883
NCT03174340|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-01|||February 21, 2008|Actual|2008-02-21|June 2017|2017-06-01|June 19, 2013|Actual|2013-06-19|April 25, 2013|Actual|2013-04-25||Interventional|||Evaluation of Exercise, in Addition to Diet, in Women With Gestational Diabetes|Evaluation of Exercise, in Addition to Diet, in Women With Gestational Diabetes|Completed||N/A|109|Actual|University Hospital, Geneva||2|||f||||f|f|f||||||Yes|Meta-analysis with the Cochrane Collaboration, if individual patient data are needed|2017-10-10 21:00:46.572455|2017-10-10 21:00:46.572455
NCT03174327|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-22|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|SUPERSONIC||Evaluation of Hepatic Rigidity by Ultrasonic Impulse Elastography in Liver Transplant Patients|Evaluation of Hepatic Rigidity by Ultrasonic Impulse Elastography in Liver Transplant Patients (SUPERSONIC)|Recruiting||N/A|100|Anticipated|Rennes University Hospital||1|||f||||f|f|f||||||||2017-10-10 21:00:46.662228|2017-10-10 21:00:46.662228
NCT03174301|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|June 2021|Anticipated|2021-06-01||Observational|Pre-Vent||Prematurity-Related Ventilatory Control: Role in Respiratory Outcomes|Prematurity-Related Ventilatory Control: Role in Respiratory Outcomes|Not yet recruiting||N/A|2000|Anticipated|University of Virginia|||1||f||||t|f|f||||||||2017-10-10 21:00:46.922294|2017-10-10 21:00:46.922294
NCT03174288|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-30|||August 2015||2015-08-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|EJB048||The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes|The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes|Recruiting||N/A|60|Anticipated|University of Virginia||3|||f||||f||||||||No||2017-10-10 21:00:47.00665|2017-10-10 21:00:47.00665
NCT03174275|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 1, 2026|Anticipated|2026-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|||Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma|Multimodality Therapy With Induction Carboplatin/Nab-Paclitaxel/Durvalumab Followed by Surgical Resection and Risk-adapted Adjuvant Therapy for the Treatment of Locally-Advanced and Surgically Resectable Squamous Cell Carcinoma of the Head and Neck|Not yet recruiting||Phase 2|39|Anticipated|UNC Lineberger Comprehensive Cancer Center||3|||f||||t|t|f||||||No||2017-10-10 21:00:47.146292|2017-10-10 21:00:47.146292
NCT03174262|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-30|||April 13, 2017|Actual|2017-04-13|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Effects of an OT Workstation Intervention on Knowledge, Self-efficacy, and Habit Formation|Effects of an Occupational Therapy Computer Workstation Intervention on Ergonomic Knowledge, Self-efficacy, and Habit Formation|Recruiting||N/A|30|Anticipated|Virginia Commonwealth University||2|||f||||f|f|f||||||No|No data will be shared with other researchers.|2017-10-10 21:00:47.296051|2017-10-10 21:00:47.296051
NCT03174249|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-30|||September 1, 2012|Actual|2012-09-01|May 2017|2017-05-01|June 1, 2015|Actual|2015-06-01|June 1, 2015|Actual|2015-06-01||Interventional|ETHICS||Exposure Therapy Combined With Cortical Interventions for CRPS-II|Leaving the Wheelchair Behind - Treating CRPS-II With Exposure Therapy Combined With Cortical Interventions: a Series of Case Reports|Completed||N/A|4|Actual|Uppsala University||1|||f||||f|f|f||||||No||2017-10-10 21:00:47.39244|2017-10-10 21:00:47.39244
NCT03174236|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-30|||June 5, 2017|Anticipated|2017-06-05|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|April 30, 2020|Anticipated|2020-04-30||Interventional|FLACSAM||First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition|First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition|Not yet recruiting||Phase 3|2000|Anticipated|University of Oxford||4|||f||||t|f|f|||f|||Yes|Data sharing will be considered by applying to the Data Governance Committee at CGMR,C Kilifi who will manage the process and ensure that appropriate ethical approval is in place and consent has been obtained for uses outside those given in this protocol:DGC@kemri-wellcome.org. Explanation of this eventuality will be included in the participant information and consent form. We intend to share anonymised data with the CHAIN network cohort study (KEMRI/SERU/CGMR-C /054/3318, OxTREC 34-16) which consists of institutions doing studies in malnourished children in Africa and South Asia; to upload anonymised bacterial and resistance sequences on recognised international repositories; and share anonymised bacterial sequence data relating to bacterial resistance with groups working an antimicrobial resistance in Africa and elsewhere.|2017-10-10 21:00:47.47171|2017-10-10 21:00:47.47171
NCT03174223|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Influence of Deep Versus Moderate Neuromuscular Blockade During General Anesthesia on 30-day Readmission Rates|Influence of Deep Versus Moderate Neuromuscular Blockade During General Anesthesia on 30-day Readmission Rates: A Retrospective Analysis of Patient Chart Data|Not yet recruiting||N/A|460|Anticipated|Leiden University Medical Center|||2||f||||f|f|f||||||||2017-10-10 21:00:47.610032|2017-10-10 21:00:47.610032
NCT03174210|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-07|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Supplemental Oxygen Delivered by a Portable Oxygen Concentrator Compared to a Liquid Oxygen Device in COPD|Effects of Supplemental Oxygen Delivered by a Portable Oxygen Concentrator Compared to a Liquid Oxygen Device in Hypoxemic COPD Patients at Rest|Recruiting||N/A|15|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f|f|f||||||Undecided||2017-10-10 21:00:47.674695|2017-10-10 21:00:47.674695
NCT03174184|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-14|||August 23, 2017|Actual|2017-08-23|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB|A Phase 2a Study of the Early Bactericidal Activity of Rifampin (RIF) in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampin-resistant or Rifampin-susceptible Pulmonary Tuberculosis|Recruiting||Phase 2|88|Anticipated|Johns Hopkins University||6|||f||||t|t|f||||||||2017-10-10 21:00:47.883241|2017-10-10 21:00:47.883241
NCT03174171|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-30|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Open-label Study on Treatment of Primary Aldosteronism With Everolimus|Open-label Study on Treatment of Primary Aldosteronism With Everolimus|Recruiting||Phase 2|12|Anticipated|University Hospital, Basel, Switzerland||1|||f||||t|f|f|||f|||No||2017-10-10 21:00:47.995382|2017-10-10 21:00:47.995382
NCT03174158|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-09-29|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|GR2Q||A Text Messaging Program for Smokers in Primary Care|A Text Messaging Intervention for Smoking Cessation Among Community Health Center Patients|Recruiting||Phase 4|206|Anticipated|Massachusetts General Hospital||4|||f||||f|t|f|||f|||||2017-10-10 21:00:48.070534|2017-10-10 21:00:48.070534
NCT03174145|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-26|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain|Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain of Knee or Hip|Recruiting||N/A|78|Anticipated|Tools4Patient||2|||f||||t|f|f||||||||2017-10-10 21:00:48.184736|2017-10-10 21:00:48.184736
NCT03174132|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-10-03|||September 21, 2017|Actual|2017-09-21|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Pain and Safety of Restylane Perlane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds|A Randomised, Multi-center, Subject and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associate With Correction of Moderate to Severe Nasolabial Folds Using Restylane Perlane Lidocaine Compared to Restylane Perlane|Recruiting||N/A|70|Anticipated|Q-Med AB||2|||f||||f|f|f||||||||2017-10-10 21:00:48.278962|2017-10-10 21:00:48.278962
NCT03174119|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-29|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Light Therapy in Disorders of Consciousness: Behavioral, Neuroimaging and (Neuro)Physiological Assessments.|Luminothérapie Chez Les Patients présentant un état de la Conscience altérée: évaluations Comportementale, de Neuroimagerie et (Neuro)Physiologique.|Not yet recruiting||N/A|50|Anticipated|University Hospital of Liege||2|||f||||t|f|f||||||Undecided||2017-10-10 21:00:48.371881|2017-10-10 21:00:48.371881
NCT03174106|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-01|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Longterm Follow-up of Cardiac Patients With an Smartphone-Application|Longterm Follow-up of Cardiac Patients With an Smartphone-Application -A Randomized Clinical Study|Not yet recruiting||N/A|115|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f|f|f||||||Undecided||2017-10-10 21:00:48.457869|2017-10-10 21:00:48.457869
NCT03174093|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-06-01|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|MATCh AFib||Mhealth Application for anTicoagulation Care in Atrial Fibrillation|A Mobile Health Application to Improve Anticoagulation Care in Atrial Fibrillation: Randomized Controlled Trial|Not yet recruiting||N/A|200|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||t|f|f||||||No||2017-10-10 21:00:48.540163|2017-10-10 21:00:48.540163
NCT03174080|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-06-01|||July 16, 2017|Anticipated|2017-07-16|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||PET MRI for Evaluation of Knee Osteoarthritis in Patients With Bilateral Knee OA|PET MRI for Evaluation of Knee Osteoarthritis in Patients With Bilateral Knee OA|Not yet recruiting||N/A|150|Anticipated|Assuta Medical Center|||1||f||||f||||||Samples Without DNA|"     without biospecimen   "|No|IPD|2017-10-10 21:00:48.614452|2017-10-10 21:00:48.614452
NCT03174054|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 1, 2019|Anticipated|2019-06-01|January 1, 2019|Anticipated|2019-01-01||Observational|||The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions|Evaluation of the Added Value of PSMA-PET Compared With Multi-parametric MRI in the Detection and Classification of Prostate Lesions|Not yet recruiting||N/A|70|Anticipated|Assuta Medical Center|||3||f||||f|f|f||||||No||2017-10-10 21:00:48.763035|2017-10-10 21:00:48.763035
NCT03174041|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-25|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Interventional|||A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin|A 4-Part Phase 1 Study to Evaluate the Effect of GDC-0853 on the Pharmacokinetics of Midazolam, Rosuvastatin, and Simvastatin and the Effect of Itraconazole on the Pharmacokinetics of GDC-0853|Completed||Phase 1|63|Actual|Genentech, Inc.||4|||f||||f|t|f||||||||2017-10-10 21:00:48.843912|2017-10-10 21:00:48.843912
NCT03174028|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-10|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|January 1, 2020|Anticipated|2020-01-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Laparoscopically Assisted Anorectal Pull-through Versus Posterior Sagittal Anorectoplasty|Laparoscopically Assisted Anorectal Pull-through Versus Posterior Sagittal Anorectoplasty for High and Intermediate Anorectal Malformations : A Comparative Study|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f|||||f|f||||||No||2017-10-10 21:00:48.933061|2017-10-10 21:00:48.933061
NCT03174015|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SanDem||Sanitation Demand Creation in Peri-Urban Slums of Lusaka, Zambia|Sanitation Demand Creation in Peri-Urban Slums of Lusaka, Zambia|Not yet recruiting||N/A|1072|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t|f|f||||||Yes|De-identified individual participant data (IPD) will be available with consent from the principal investigators. The study will collect only basic demographic information on individuals along with knowledge/attitudes/preferences data, so there will be little to identify individuals from the shared IPD and little that is very sensitive.|2017-10-10 21:00:48.991071|2017-10-10 21:00:48.991071
NCT03174002|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-10-04|||June 19, 2017|Actual|2017-06-19|October 2017|2017-10-01|June 15, 2020|Anticipated|2020-06-15|September 15, 2019|Anticipated|2019-09-15||Interventional|HOT-ICU||Handling Oxygenation Targets in the Intensive Care Unit|Handling Oxygenation Targets in Adults With Acute Hypoxaemic Respiratory Failure in the Intensive Care Unit: A Randomised Clinical Trial of a Lower Versus a Higher Oxygenation Target|Recruiting||Phase 4|2928|Anticipated|Aalborg Universitetshospital||2|||f||||t|f|f|||f|||||2017-10-10 21:00:49.197507|2017-10-10 21:00:49.197507
NCT03173989|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-31|||August 2, 2014|Actual|2014-08-02|May 2017|2017-05-01|November 5, 2016|Actual|2016-11-05|August 5, 2016|Actual|2016-08-05||Interventional|||Strategies for Patients With Osteoarthritis, by Using Assistive Technology and Exercises.|Comparison Between Care Strategies for Patients With Osteoarthritis of the Hands Based on the Use of Joint Protection, Assistive Technology and Exercises.|Completed||N/A|200|Actual|University of Sao Paulo||2|||f||||f|f|f||||||Undecided||2017-10-10 21:00:49.523885|2017-10-10 21:00:49.523885
NCT03173976|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-18|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2022|Anticipated|2022-07-01||Interventional|||Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial|Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial|Recruiting||Phase 1|15|Anticipated|University of Iowa||1|||f||||t|t|f||||||||2017-10-10 21:00:49.614246|2017-10-10 21:00:49.614246
NCT03173950|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-07-15|||July 13, 2017|Actual|2017-07-13|June 28, 2017|2017-06-28|December 1, 2021|Anticipated|2021-12-01|December 1, 2021|Anticipated|2021-12-01||Interventional|||Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers|Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients With Select Rare CNS Cancers|Recruiting||Phase 2|180|Anticipated|National Institutes of Health Clinical Center (CC)||4|||t|||||t|f||||||||2017-10-10 21:00:49.819606|2017-10-10 21:00:49.819606
NCT03173937|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-04|||June 13, 2017|Actual|2017-06-13|July 31, 2017|2017-07-31|April 30, 2021|Anticipated|2021-04-30|April 29, 2021|Anticipated|2021-04-29||Interventional|||Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome|Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome|Recruiting||Phase 1/Phase 2|62|Anticipated|National Institutes of Health Clinical Center (CC)||1|||t|||||t|f||||||||2017-10-10 21:00:49.93309|2017-10-10 21:00:49.93309
NCT03173924|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-31|2017-08-29|||June 6, 2017|Actual|2017-06-06|August 23, 2017|2017-08-23|January 30, 2025|Anticipated|2025-01-30|January 30, 2020|Anticipated|2020-01-30||Interventional|||18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer|Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer|Recruiting||Phase 2|90|Anticipated|National Institutes of Health Clinical Center (CC)||2|||t|||||t|f||||||||2017-10-10 21:00:50.070227|2017-10-10 21:00:50.070227
NCT03173911|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-31|||May 1, 2016|Actual|2016-05-01|May 2017|2017-05-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Effects of the Elastic Bandage on the Postural Balance of Young Women|Effects of the Elastic Bandage on the Postural Balance of Young Women|Completed||N/A|48|Actual|Universidade Norte do Paraná||4|||f||||f|f|t|f|f|t|||No||2017-10-10 21:00:50.173336|2017-10-10 21:00:50.173336
NCT03173898|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-01|||July 6, 2015|Actual|2015-07-06|May 2017|2017-05-01|January 31, 2016|Actual|2016-01-31|January 31, 2016|Actual|2016-01-31||Interventional|PDL||PDL Anesthesia Versus Local Infiltration|Periodontal Ligament Injection Versus Routine Local Infiltration, for the Non-surgical Single Posterior Maxillary Permanent Tooth Extraction: Comparative Double Blinded Randomized Clinical Study|Completed||N/A|55|Actual|University of Jordan||2|||f||||t|f|f||||||Undecided||2017-10-10 21:00:50.263199|2017-10-10 21:00:50.263199
NCT03173885|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-31|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|January 30, 2022|Anticipated|2022-01-30|May 17, 2019|Anticipated|2019-05-17||Interventional|BIOPS||Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening|An RCT Evaluating the Implantation Potential of Vitrified Embryos Screened by Next Generation Sequencing Following Trophectoderm Biopsy, Versus Vitrified Unscreened Embryos in Good Prognosis Patients Undergoing IVF|Recruiting||N/A|276|Anticipated|University Hospital, Ghent||2|||f|||||f|f||||||||2017-10-10 21:00:50.340479|2017-10-10 21:00:50.340479
NCT03173872|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-09|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||The Acceptance of Reiki Therapy as a Complementary and Alternative Option for the Management of Chronic Pain|The Acceptance of Reiki Therapy as a Complementary and Alternative Option for the Management of Chronic Pain|Completed||N/A|30|Actual|Landstuhl Regional Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:00:50.437292|2017-10-10 21:00:50.437292
NCT03173859|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-31|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 1, 2021|Anticipated|2021-12-01|July 1, 2021|Anticipated|2021-07-01||Interventional|AERA||Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients|A Randomized Phase II Study to Investigate the Efficacy of Rotations Between Abiraterone Acetate and Apalutamide Versus Sequential Administration in Chemo-naïve Metastatic Castration Resistant Prostate Cancer Patients|Not yet recruiting||Phase 2|100|Anticipated|University of Athens||2|||f|||||f|f|||f|||No||2017-10-10 21:00:50.554696|2017-10-10 21:00:50.554696
NCT03173846|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-01|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|NPAD||Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (NPAD)|Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease|Recruiting||N/A|100|Anticipated|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation|||1||f||||f|f|f||||||No||2017-10-10 21:00:50.657672|2017-10-10 21:00:50.657672
NCT03173833|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-31|||August 1, 2017|Anticipated|2017-08-01|April 2017|2017-04-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Fulfilling Care Needs of Adolescents With Cancer|Fulfilling Care Needs of Adolescents With Cancer|Not yet recruiting||N/A|720|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:00:50.741821|2017-10-10 21:00:50.741821
NCT03173820|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-01|||April 30, 2015|Actual|2015-04-30|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients|Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients|Recruiting||N/A|120|Anticipated|Khon Kaen University||2|||f||||f|t|f|||t|||No||2017-10-10 21:00:50.846949|2017-10-10 21:00:50.846949
NCT03173807|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-04|||August 31, 2017|Anticipated|2017-08-31|October 2017|2017-10-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|ProNEST||Prostate Nutrition and Exercise STudy (ProNEST)|Prostate Nutrition and Exercise STudy (ProNEST)|Withdrawn||N/A|0|Actual|University of Pittsburgh||2||Unable to find adequate funding|f||||t|f|f||||||||2017-10-10 21:00:50.939112|2017-10-10 21:00:50.939112
NCT03173794|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||April 2018|Anticipated|2018-04-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||CommunityRx for Hunger: A Hospital-Based Intervention|CommunityRx for Hunger: A Children's Hospital-Based Intervention to Support Caregivers in an African American Community|Not yet recruiting||N/A|840|Anticipated|University of Chicago||2|||f|||||f|f||||||||2017-10-10 21:00:51.014888|2017-10-10 21:00:51.014888
NCT03173781|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-05-30|||April 2016||2016-04-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|droxidopa||Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease|Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease|Recruiting||N/A|30|Anticipated|Colorado Springs Neurological Associates||2|||f||||t||||||||Yes|movement disorder meeting/poster/paper|2017-10-10 21:00:51.108108|2017-10-10 21:00:51.108108
NCT03173768|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-06-01|||November 1, 2015|Actual|2015-11-01|June 2017|2017-06-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Appropriateness of Intravenous Antibiotics Prescriptions at Hospital Discharge|Quasi-experimental Study Comparing Intravenous Antibiotics Prescriptions at Hospital Discharge With and Without ID Consultation|Completed||N/A|173|Actual|Chiang Mai University||2|||f||||f|f|f||||||No||2017-10-10 21:00:51.24237|2017-10-10 21:00:51.24237
NCT03173755|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-27|||August 29, 2017|Actual|2017-08-29|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Pain Discomfort Enjoyment Levels During Moderate Exercise|Relationships of Pain, Discomfort and Enjoyment During Exercise to Weight Status and Diet Quality.|Recruiting||N/A|144|Anticipated|Texas Tech University|||2||f|||||f|f||||||||2017-10-10 21:00:51.363537|2017-10-10 21:00:51.363537
NCT03173742|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-30|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)|Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA, Abbott Laboratórios do Brasil Ltda, Brazil)|Completed||Phase 1|54|Actual|Chemo||6|||f||||f|f|f||||||Undecided||2017-10-10 21:00:51.480969|2017-10-10 21:00:51.480969
NCT03173729|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-30|||February 11, 2017|Actual|2017-02-11|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||Point of Care Test to Diagnosed Colorectal Cancer and Polyps in Low Middle Income Countries|Point of Care, Real-time Urine Metabolomics Test to Diagnose Colorectal Cancers and Polyps in Low and Middle Income Countries|Recruiting||N/A|1170|Anticipated|Obafemi Awolowo University Teaching Hospital|||7||f||||f|f|f||||Samples Without DNA|"     A urine sample is collected with 3 weeks of their surgery or colonoscopy.   "|Yes|Will follow the NIH/NCI approved guidelines|2017-10-10 21:00:51.616435|2017-10-10 21:00:51.616435
NCT03173703|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-08-22|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair|Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair|Recruiting||N/A|144|Anticipated|LeMaitre Vascular||2|||f||||t|f|t|f|f|t|||||2017-10-10 21:00:51.800673|2017-10-10 21:00:51.800673
NCT03173690|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-07|||February 6, 2017|Actual|2017-02-06|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|July 6, 2017|Actual|2017-07-06||Interventional|||Medicines Reconciliation at an Intensive Care Unit|Medicines Reconciliation at an Intensive Care Unit|Recruiting||N/A|50|Anticipated|University Hospital, Akershus||2|||f||||f|f|f||||||||2017-10-10 21:00:51.881786|2017-10-10 21:00:51.881786
NCT03173677|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-31|||February 2, 2016|Actual|2016-02-02|May 2017|2017-05-01|April 29, 2016|Actual|2016-04-29|April 24, 2016|Actual|2016-04-24||Interventional|||Macrophage Polarization in Response to Macronutrient Intake in Healthy Humans: A Randomized Clinical Study|Monocyte Differentiation and Macrophage Polarization in Circulation in Response to Macronutrient Intake in Healthy Humans: A Randomized Clinical Study|Completed||N/A|36|Actual|King Saud Bin Abdulaziz University for Health Sciences||3|||f||||f|f|f||||||No||2017-10-10 21:00:51.985064|2017-10-10 21:00:51.985064
NCT03173664|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-30|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01||Observational|||Post-Approval Study With the KAMRA Inlay|Post-Approval Study of Clinical Outcomes and Visual Symptoms With the KAMRA Inlay|Not yet recruiting||N/A|529|Anticipated|AcuFocus, Inc.|||1||f||||f|f|t|f|f|t|||No||2017-10-10 21:00:52.108763|2017-10-10 21:00:52.108763
NCT03173651|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-05-31|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||The Efficiency of Different Oropharyngeal Airways as a Conduit for Fiberoptic Intubation. Comparative Study|The Efficiency of Different Oropharyngeal Airways as a Conduit for Fiberoptic Intubation. Comparative Study|Completed||N/A|60|Actual|Kasr El Aini Hospital||3|||f||||t|f|f||||||Undecided||2017-10-10 21:00:52.189385|2017-10-10 21:00:52.189385
NCT03173638|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|||Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy|Phase II Safety Assessment of Intravitreal Injection of Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy (NAION)|Not yet recruiting||Phase 2|5|Anticipated|Instituto Universitario de Oftalmobiología Aplicada||1|||f||||t|f|f||||||||2017-10-10 21:00:52.313522|2017-10-10 21:00:52.313522
NCT03173625|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-25|||November 29, 2016|Actual|2016-11-29|July 2017|2017-07-01|April 15, 2017|Actual|2017-04-15|April 15, 2017|Actual|2017-04-15||Interventional|||A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body|Single-center, Double-blind, Placebo-controlled, Randomized, Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of AC-076 in Healthy Male Subjects|Completed||Phase 1|72|Actual|Actelion||2|||f||||||||||||||2017-10-10 21:00:52.394276|2017-10-10 21:00:52.394276
NCT03173612|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-31|||August 2016||2016-08-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia|The Efficiency of CAMS-2016 Trial for the Newly Diagnosed Pediatric Acute Myeloid Leukemia: A Prospective Single Centre Trial From China|Recruiting||N/A|132|Anticipated|Institute of Hematology & Blood Diseases Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:00:52.473781|2017-10-10 21:00:52.473781
NCT03173599|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-31|||December 2010|Actual|2010-12-01|May 2017|2017-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers|A Safety and Tolerability Evaluation of Ascending Single Oral Doses of Metacavir Enteric-coated Capsules Using a Randomized，Double-blind, Placebo-controlled Design Conducted in Chinese Healthy Adult Volunteers|Completed||Phase 1|48|Actual|Guangzhou Yipinhong Pharmaceutical CO.,LTD||7|||f||||f|f|f|||f|||No||2017-10-10 21:00:52.571492|2017-10-10 21:00:52.571492
NCT03173586|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||September 16, 1999|Actual|1999-09-16|May 2017|2017-05-01|March 31, 2009|Actual|2009-03-31|March 31, 2009|Actual|2009-03-31||Observational|||Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women|Association Between Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women|Completed||N/A|33000|Actual|Harvard School of Public Health|||1||f||||f|f|f||||Samples Without DNA|"     The major goal of the project was to analyze blood samples collected from 33,000 women     participating in the Nurses' Health Study. The aim of the original grant was to asses plasma     sex hormone levels in relation to risk of breast cancer; plasma beta-carotene, Vitamin E and     omega-3 fatty acids and risk of breast and colon cancer; specific lipoprotein fractions,     apoproteins and fatty acids and risk of CVD.   "|No|Data are de-identified|2017-10-10 21:00:52.676868|2017-10-10 21:00:52.676868
NCT03173573|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-17|||June 27, 2017|Actual|2017-06-27|May 2017|2017-05-01|March 5, 2018|Anticipated|2018-03-05|March 5, 2018|Anticipated|2018-03-05||Interventional|||A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants|A Five Part Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetic (PK) Profile of Single and Repeat Oral Doses of FDL176 in Healthy and Cystic Fibrosis (CF) Participants|Recruiting||Phase 1|112|Anticipated|Flatley Discovery Lab LLC||9|||f||||t|f|f||||||||2017-10-10 21:00:52.775488|2017-10-10 21:00:52.775488
NCT03173560|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-09-21|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 15, 2021|Anticipated|2021-06-15|January 15, 2021|Anticipated|2021-01-15||Interventional|||Trial to Assess Safety and Efficacy of Lenvatinib in Combination With Everolimus in Participants With Renal Cell Carcinoma|A Randomized, Double-blind, Phase 2 Trial to Assess Safety and Efficacy of Lenvatinib at Two Different Starting Doses (18 mg vs. 14 mg QD) in Combination With Everolimus (5 mg QD) in Renal Cell Carcinoma Following One Prior VEGF-Targeted Treatment|Recruiting||Phase 2|306|Anticipated|Eisai Inc.||2|||f||||t|t|f||||||||2017-10-10 21:00:52.863917|2017-10-10 21:00:52.863917
NCT03173547|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-17|||April 25, 2017|Actual|2017-04-25|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris|A Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of 146-9251 Cream Applied Twice-daily for Six Weeks in Subjects With Ichthyosis Vulgaris|Recruiting||Phase 2|80|Anticipated|Crown Laboratories, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:00:54.464359|2017-10-10 21:00:54.464359
NCT03173534|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-09|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|August 2020|Anticipated|2020-08-01||Interventional|||WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement|WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement|Not yet recruiting||N/A|400|Anticipated|The Cleveland Clinic||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:00:54.604414|2017-10-10 21:00:54.604414
NCT03173521|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-10-03|||July 17, 2017|Actual|2017-07-17|October 2017|2017-10-01|June 1, 2022|Anticipated|2022-06-01|April 30, 2020|Anticipated|2020-04-30||Interventional|||Gene Therapy in Patients With Mucopolysaccharidosis Disease|A Phase I/II Open Label, Dose Escalation, Safety Study in Subjects With Mucopolysaccharidosis Type VI (MPS VI) Using Adeno-Associated Viral Vector 8 to Deliver the Human ARSB Gene to Liver|Recruiting||Phase 1/Phase 2|10|Anticipated|Fondazione Telethon||1|||f|||||f|f||||||||2017-10-10 21:00:54.694851|2017-10-10 21:00:54.694851
NCT03173508|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Acetazolamide on Right Ventricular Function at Rest in Patients With Respiratory Disease at Altitude|Effect of Acetazolamide on Right Ventricular Function at Rest in Patients With Chronic Obstructive Pulmonary Disease at Altitude. A Randomized, Placebo-controlled, Double-blind Parallel Trial|Recruiting||Phase 4|100|Anticipated|University of Zurich||2|||f||||f|f|f||||||Undecided||2017-10-10 21:00:54.797459|2017-10-10 21:00:54.797459
NCT03173495|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-31|||January 10, 2016|Actual|2016-01-10|May 2017|2017-05-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||Effects of Exercise on Fructose-induced Postprandial Lipemia|Effects of Exercise on Fructose-induced Postprandial Lipemia|Completed||N/A|12|Actual|Federal University of Rio Grande do Sul||3|||f||||f|f|f|||f|||No||2017-10-10 21:00:54.903601|2017-10-10 21:00:54.903601
NCT03173482|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-13|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Observational|||Prevalence of Cesarean Section on Demand in Assiut University Hospital & Abnob Central Hospital|Prevalence of Cesarean Section on Demand in Assiut University Hospital & Abnob Central Hospital|Recruiting||N/A|144|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 21:00:54.985341|2017-10-10 21:00:54.985341
NCT03173469|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|August 15, 2018|Anticipated|2018-08-15|June 15, 2018|Anticipated|2018-06-15||Observational|||Preoperative Breast Magnetic Resonance Imaging for Patients Undergoing Mammoplasty|The Role of Preoperative Breast Magnetic Resonance Imaging for Surgical Decision in Patients Undergoing Therapeutic Mammoplasty|Recruiting||N/A|40|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:00:55.051653|2017-10-10 21:00:55.051653
NCT03173456|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-12|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Comparing Five Oral Analgesics for Treatment of Acute Pain in the ED|Comparing the Efficacy of Five Oral Analgesics for Treatment of Acute Musculoskeletal Extremity Pain in the ED|Not yet recruiting||Phase 2|550|Anticipated|Albert Einstein College of Medicine, Inc.||5|||f||||t|t|f||||||||2017-10-10 21:00:55.121036|2017-10-10 21:00:55.121036
NCT03173443|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-31|||May 31, 2017|Actual|2017-05-31|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Insertion Time Over Fiberoptic Bronchoscope of Double Lumen Tube and Single Lumen Tube|Comparison of Insertion Time Over Fiberoptic Bronchoscope Between Double Lumen Tube and Single Lumen Tube|Recruiting||N/A|80|Anticipated|Ajou University School of Medicine||2|||f||||f|f|f||||||No||2017-10-10 21:00:55.212759|2017-10-10 21:00:55.212759
NCT03173430|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||May 27, 2017|Actual|2017-05-27|May 2017|2017-05-01|November 27, 2019|Anticipated|2019-11-27|November 27, 2018|Anticipated|2018-11-27||Interventional|||Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma|Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma|Recruiting||Early Phase 1|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t|t|f||||||||2017-10-10 21:00:55.287281|2017-10-10 21:00:55.287281
NCT03173417|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|December 1, 2020|Anticipated|2020-12-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)|Safety and Efficacy Evaluation of IM19 CAR-T Cells On CD19+ Refractory or Relapsed B-ALL Patients|Recruiting||Phase 1/Phase 2|300|Anticipated|Beijing Immunochina Medical Science & Technology Co., Ltd.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:00:55.436063|2017-10-10 21:00:55.436063
NCT03173404|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||July 1, 2014|Actual|2014-07-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Benefits of Hysteroscopy Prior to Performing a Cycle of in Vitro Fertilization/Intracytoplasmic Sperm Injection|Benefits of Hysteroscopy Prior to Performing a Cycle of in Vitro Fertilization/Intracytoplasmic Sperm Injection|Completed||N/A|75|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||f|f|f||||||No||2017-10-10 21:00:55.529312|2017-10-10 21:00:55.529312
NCT03173391|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-11|||July 18, 2017|Actual|2017-07-18|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Long-term Efficacy and Safety of HMS5552 in T2DM|A 24-week Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of HMS5552 With Additional 28-week Open-label Treatment in T2DM|Recruiting||Phase 3|450|Anticipated|Hua Medicine Limited||2|||f||||f|f|f||||||||2017-10-10 21:00:55.60797|2017-10-10 21:00:55.60797
NCT03173378|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|NARCOWORK||Evaluation of Academic and Professional Trajectories of Narcoleptic Patients|Evaluation of Academic and Professional Trajectories of Narcoleptic Patients|Not yet recruiting||N/A|300|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 21:00:55.731845|2017-10-10 21:00:55.731845
NCT03173365|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-21|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|BRIMOCAN||The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients|Half‐Side Controlled Analysis of the Effect of Topical Brimonidine Tartrate on the Frequency and Severity of Hand‐Foot Syndrome (HFS) in Cancer Patients Receiving Antineoplastic Agents (BRIMOCAN)|Recruiting||Phase 2|24|Anticipated|Heinrich-Heine University, Duesseldorf||1|||f||||f|f|f||||||||2017-10-10 21:00:55.826912|2017-10-10 21:00:55.826912
NCT03173352|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-01|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|IH||A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China|A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China|Recruiting||N/A|10000|Anticipated|Zhujiang Hospital|||1||f|||||f|f||||||||2017-10-10 21:00:55.931776|2017-10-10 21:00:55.931776
NCT03173339|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-23|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|August 24, 2017|Actual|2017-08-24|August 24, 2017|Actual|2017-08-24||Interventional|||Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia|Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia|Completed||N/A|92|Actual|Keimyung University Dongsan Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:00:56.02572|2017-10-10 21:00:56.02572
NCT03173326|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-21|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Patient Satisfaction and Postoperative Analgesia Between Subarachnoid Block With 2-chloroprocaine Versus General Anesthesia for Knee Arthroscopy|Randomized Controlled Trial Evaluating Patient Satisfaction and Postoperative Analgesia Between Subarachnoid Block With 2-chloroprocaine Versus General Anesthesia for Knee Arthroscopy|Recruiting||N/A|70|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:00:56.157849|2017-10-10 21:00:56.157849
NCT03173313|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-01|||April 14, 2017|Actual|2017-04-14|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||COOL-AMI EU Pivotal Trial|COOL-AMI EU Pivotal Trial: A Multicenter, Prospective, Randomized-Controlled Trial to Assess the Safety and Effectiveness of Cooling As an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction|Enrolling by invitation||N/A|468|Anticipated|ZOLL Circulation, Inc., USA||2|||f||||t|f|f||||||No||2017-10-10 21:00:56.280775|2017-10-10 21:00:56.280775
NCT03173300|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Observational|||Natural History Study Protocol in PMM2-CDG (CDG-Ia)|Clinical and Basic Investigations Into Phosphomannomutase Deficiency (PMM2-CDG)|Not yet recruiting||N/A|48|Anticipated|Glycomine, Inc.|||1||f||||f|f|f||||||||2017-10-10 21:00:56.39248|2017-10-10 21:00:56.39248
NCT03173287|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-31|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|March 1, 2017|Actual|2017-03-01||Interventional|IVIM-MRI||Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI|Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI.|Recruiting||N/A|63|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 21:00:56.5139|2017-10-10 21:00:56.5139
NCT03173274|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-07|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|ProjectMIST||Incentives to Promote Smoking Cessation in Low SES Women|Incentives to Promote Smoking Cessation in Low SES Women|Recruiting||N/A|20|Anticipated|Brown University||2|||f|||||f|f||||||No||2017-10-10 21:00:56.593348|2017-10-10 21:00:56.593348
NCT03173261|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-31|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Role of Genexpert in Extra Pulmonary Tuberculosis|Role of Genexpert in Extra Pulmonary Tuberculosis|Not yet recruiting||N/A|2|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 21:00:56.669875|2017-10-10 21:00:56.669875
NCT03173248|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-10-05|||June 20, 2017|Actual|2017-06-20|October 2017|2017-10-01|June 2022|Anticipated|2022-06-01|April 2022|Anticipated|2022-04-01||Interventional|AGILE||Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Patients With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation|A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination With Azacitidine in Subjects ≥ 18 Years of Age With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation|Recruiting||Phase 3|392|Anticipated|Agios Pharmaceuticals, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:00:56.746009|2017-10-10 21:00:56.746009
NCT03171441|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-25|||January 2013|Actual|2013-01-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Observational|MicroChild||Microvascular Reactivity in Prepubertal Children|Microcirculation, Adiposity, and Traditional and Emerging Cardiovascular Risk Factors in Prepubertal Children|Completed||N/A|98|Actual|Rio de Janeiro State University|||3||f||||f|f|f||||||No||2017-10-10 21:01:11.190115|2017-10-10 21:01:11.190115
NCT03173235|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-11|||August 1, 2015|Actual|2015-08-01|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Plasma Concentrations of Calcium, Phosphate, FGF23, Klotho, 25 (OH) D3 and 1,25 (OH) 2D3 From Patients Who Wants to Have Children|Plasma Concentrations of Calcium, Phosphate, FGF23, Klotho, 25 (OH) D3 and 1,25 (OH) 2D3 From Patients Who Wants to Have Children|Recruiting||N/A|80|Anticipated|University Women's Hospital Tübingen|||2||f|||||f|f||||Samples With DNA|"     Blood plasma   "|||2017-10-10 21:00:56.838344|2017-10-10 21:00:56.838344
NCT03173222|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-26|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|February 29, 2020|Anticipated|2020-02-29|February 28, 2019|Anticipated|2019-02-28||Interventional|||Electroacupuncture for Acute Pancreatitis|A Clinical Study of Electroacupuncture for Abdominal Pain Relief in Patients With Acute Pancreatitis|Not yet recruiting||N/A|99|Anticipated|DongGuk University||3|||f||||f|f|f||||||||2017-10-10 21:00:56.910767|2017-10-10 21:00:56.910767
NCT03173209|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||January 17, 2015|Actual|2015-01-17|May 2017|2017-05-01|October 13, 2016|Actual|2016-10-13|October 13, 2016|Actual|2016-10-13||Interventional|CMC||Evaluating the Effectiveness of the Calm Moments Cards Program Implemented by School Personnel|Evaluating the Effectiveness of the Calm Moments Cards Program Implemented by School Personnel|Completed||N/A|93|Actual|Cleveland State University||1|||f||||f|f|f||||||No||2017-10-10 21:00:56.972966|2017-10-10 21:00:56.972966
NCT03173196|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-10|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|July 10, 2017|Actual|2017-07-10||Observational|SAEACG||Prospective Analysis of Septic Associated Encephalopathy Using the Non-invasive Acoustocerebrography-ACG|Prospective Analysis of the Occurrence and Severity of Septic Encephalopathy in Patients With Severe Sepsis or Septic Shock, Including Non-invasive Multispectral Sonography|Completed||N/A|20|Actual|University of Rostock|||2||f||||f|f|f|||f|||||2017-10-10 21:00:57.041374|2017-10-10 21:00:57.041374
NCT03173183|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis|Clinical Research on Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis: a Randomized Double-blind Placebo Controlled Trial|Not yet recruiting||N/A|90|Anticipated|China Academy of Chinese Medical Sciences||3|||f||||t|f|f||||||No||2017-10-10 21:00:57.115248|2017-10-10 21:00:57.115248
NCT03173170|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-20|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|July 24, 2017|Anticipated|2017-07-24|July 24, 2017|Anticipated|2017-07-24||Interventional|||A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult Participants|A Single-Sequence, Open-Label, 2-Period Crossover Trial to Evaluate the Effect of the Potent Cytochrome P-450 3A4 Inhibitor Itraconazole on the Pharmacokinetics of TAK-954 in Healthy Adult Subjects|Active, not recruiting||Phase 1|10|Anticipated|Takeda||1|||f||||f|t|f||||||||2017-10-10 21:00:57.296699|2017-10-10 21:00:57.296699
NCT03173157|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-31|||February 27, 2017|Actual|2017-02-27|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|November 1, 2017|Anticipated|2017-11-01||Interventional|||Effect of Targeted Interventions to Improve Value Based Health Care for Inpatient Cardiology Patients|Effect of Targeted Interventions to Improve Value Based Health Care for Inpatient Cardiology Patients: A Choosing Wisely Initiative|Recruiting||N/A|850|Anticipated|Vanderbilt University Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:00:57.386745|2017-10-10 21:00:57.386745
NCT03173144|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-30|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2019|Anticipated|2019-03-31|16 Weeks|Observational [Patient Registry]|BELIEVE||Chronic Inflammatory Disease, Lifestyle and Treatment Response|Impact of Red and Processed Meat and Fibre Intake on Treatment Outcome Among Patients With Chronic Inflammatory Diseases: Protocol for a Prospective Cohort Study on Prognostic Factors and Personalised Medicine|Not yet recruiting||N/A|320|Anticipated|University of Southern Denmark|||1||f||||f|f|f||||Samples With DNA|"     blood, urine, feces, intestinal biopsies   "|Yes|"Pseudoanonymised data on Health, lifestyle, treatment response and biological analyses will be shared with the Horizon 2020-project A Systems medicine approach to chronic inflammatory disease (SYSCID) partners."|2017-10-10 21:00:57.495017|2017-10-10 21:00:57.495017
NCT03173131|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-30|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Opioid Consumption After Orthopaedic Surgery|Opioid Consumption After Orthopaedic Surgery: Prospective Randomized Trial on the Effects of Pre-Operative Counseling|Enrolling by invitation||N/A|280|Anticipated|Thomas Jefferson University||2|||f|||||f|f||||||No||2017-10-10 21:00:57.651798|2017-10-10 21:00:57.651798
NCT03173118|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-14|||November 29, 2016|Actual|2016-11-29|August 2017|2017-08-01|April 14, 2018|Anticipated|2018-04-14|November 27, 2017|Anticipated|2017-11-27||Interventional|||Elastography in the Diagnosis of Chronic Pancreatitis|Elastography in the Diagnosis of Chronic Pancreatitis|Recruiting||N/A|104|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 21:00:57.724825|2017-10-10 21:00:57.724825
NCT03173092|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-08|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|August 31, 2023|Anticipated|2023-08-31|August 31, 2023|Anticipated|2023-08-31||Interventional|||An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen (TOURMALINE MM-6)|An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) in Patients With Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen (TOURMALINE US MM-6)|Not yet recruiting||Phase 4|160|Anticipated|Takeda||1|||f|||||f|f||||||||2017-10-10 21:00:57.980882|2017-10-10 21:00:57.980882
NCT03173079|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-31|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|September 15, 2018|Anticipated|2018-09-15|March 15, 2018|Anticipated|2018-03-15||Observational|||Geriatric Assessment and Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement|Geriatric Assessment and Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement|Recruiting||N/A|150|Anticipated|Campus Bad Neustadt|||1||f||||f|f|f||||||Undecided||2017-10-10 21:00:58.074331|2017-10-10 21:00:58.074331
NCT03173066|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-11|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography|Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Brigham and Women's Hospital||1|||f||||t|t|f|||f|||||2017-10-10 21:00:58.188739|2017-10-10 21:00:58.188739
NCT03173053|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-28|||January 1, 2018|Anticipated|2018-01-01|May 2017|2017-05-01|August 1, 2021|Anticipated|2021-08-01|January 1, 2021|Anticipated|2021-01-01||Interventional|CARRIER||S. Aureus Decolonization in HPN Patients.|Long-term StaphyloCoccus Aureus decolonizAtion in Patients on Home parenteRal nutRition: a randomIzed multicEnter tRial.|Recruiting||N/A|138|Anticipated|Radboud University||2|||f||||f|f|f||||||||2017-10-10 21:00:58.276608|2017-10-10 21:00:58.276608
NCT03173040|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-24|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis|The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis: a Study Protocol for a Multicenter, Randomized, Controlled Clinical Trial|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t|f|f||||||Undecided||2017-10-10 21:00:58.451381|2017-10-10 21:00:58.451381
NCT03173027|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-02|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||The Efficacy of the Traditional Chinese Medicine Fangji Huangqi Pill Combined With Mobic on Active Knee Osteoarthritis|The Efficacy of the Traditional Chinese Medicine Fangji Huangqi Pill Combined With Mobic on Active Knee Osteoarthritis: a Study Protocol for a Randomized, Controlled Clinical Trial|Not yet recruiting||Phase 2/Phase 3|200|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t|f|f|||f|||||2017-10-10 21:00:58.577477|2017-10-10 21:00:58.577477
NCT03173014|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-07-18|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|June 5, 2018|Anticipated|2018-06-05|May 30, 2018|Anticipated|2018-05-30||Observational|||EEG Monitoring in Children With Moyamoya Disease|EEG Finding in Moyamoya Disease in Children|Recruiting||N/A|10|Anticipated|Seoul National University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:00:58.700698|2017-10-10 21:00:58.700698
NCT03173001|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-31|||January 1, 2015|Actual|2015-01-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|6 Months|Observational [Patient Registry]|||Possible Association of Intestinal Helminths and Protozoa With Colorectal Cancer Pathogenesis|Intestinal Helminths and Protozoan Infections in Patients With Colorectal Cancer: Prevalence and Possible Association With Cancer Pathogenesis|Active, not recruiting||N/A|500|Anticipated|Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan|||8||f||||t|f|f||||||||2017-10-10 21:00:58.783042|2017-10-10 21:00:58.783042
NCT03172988|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-03|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery|Impact of Perioperative Dexamethasone and Flurbiprofen Axetil on Long-term Survival After Surgery for Non-small Cell Lung Cancer: A 2x2 Factorial Randomized Controlled Trial|Recruiting||Phase 4|844|Anticipated|Peking University First Hospital||4|||f||||t|f|f|||f|||||2017-10-10 21:00:58.869665|2017-10-10 21:00:58.869665
NCT03172975|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-31|||July 15, 2017|Anticipated|2017-07-15|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|December 15, 2018|Anticipated|2018-12-15||Interventional|||Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection|Phase 2 Study to Assess the Safety, Efficacy and Immunogenicity of Na-GST-1/Alhydrogel Co-administered With Different Toll-Like Receptor Agonists in Hookworm- Naïve Adults|Not yet recruiting||Phase 2|48|Anticipated|Baylor College of Medicine||4|||f||||f|t|f||||||Undecided||2017-10-10 21:00:59.021733|2017-10-10 21:00:59.021733
NCT03172962|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-21|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|IRMA20||Effect of Strength Training for Chronic Low Back Pain Patients (IRMA20)|Effect of Strength Training for Chronic Low Back Pain Patients: Randomized Clinical Trial|Active, not recruiting||N/A|50|Anticipated|National Research Centre for the Working Environment, Denmark||2|||f||||f|f|f||||||||2017-10-10 21:00:59.13559|2017-10-10 21:00:59.13559
NCT03172949|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-05-30|||May 15, 2017||2017-05-15||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:00:59.233114|2017-10-10 21:00:59.233114
NCT03172936|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-12|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|February 16, 2020|Anticipated|2020-02-16|January 9, 2020|Anticipated|2020-01-09||Interventional|||Study of the Safety and Efficacy of MIW815 With PDR001 to Patients With Advanced/Metastatic Solid Tumors or Lymphomas|A Phase I, Open Label, Multicenter Study of the Safety and Efficacy of MIW815 (ADU-S100) Administered by Intratumoral Injection to Patients With Advanced/Metastatic Solid Tumors or Lymphomas|Recruiting||Phase 1|175|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:00:59.287282|2017-10-10 21:00:59.287282
NCT03172923|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-18|||October 8, 2010|Actual|2010-10-08|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|September 1, 2016|Actual|2016-09-01||Interventional|||Nail Versus Sliding Hip Screw for Trochanteric Hip Fractures|Randomised Trial of Trochanteric Hip Fractures Treated With Either a Sliding Hip Screw on an Intramedullary Nail|Completed||N/A|400|Actual|Peterborough and Stamford Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 21:00:59.449849|2017-10-10 21:00:59.449849
NCT03172910|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-30|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Ciraparantag Administered to Volunteers Anticoagulated With Rivaroxaban, Measure Clotting Times Using WBCT|Phase 2 Placebo-Controlled, Single-Site, Single-Blind Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT|Recruiting||Phase 2|48|Anticipated|Perosphere, Inc.||6|||f|||||t|f||||||Undecided||2017-10-10 21:00:59.543519|2017-10-10 21:00:59.543519
NCT03172897|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-31|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|October 31, 2018|Anticipated|2018-10-31|October 1, 2018|Anticipated|2018-10-01||Interventional|||Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients|Low-dose Dexmedetomidine for Delirium Prevention in Mechanically Ventilated Patients in Intensive Care Unit: a Multicenter, Randomised, Double-blinded, Placebo-controlled Trial|Recruiting||Phase 4|260|Anticipated|Peking University First Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:00:59.692398|2017-10-10 21:00:59.692398
NCT03172884|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-25|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|November 20, 2018|Anticipated|2018-11-20|August 28, 2018|Anticipated|2018-08-28||Interventional|||Study of Copanlisib in Hepatic or Renal Impairment|An Open-label Non-randomized, Phase 1 Single Dose Study to Evaluate the Pharmacokinetics and Safety of Copanlisib in Subjects With Impaired Hepatic or Renal Function in Comparison to Healthy Subjects|Recruiting||Phase 1|32|Anticipated|Bayer||3|||f||||f|f|f||||||||2017-10-10 21:00:59.848983|2017-10-10 21:00:59.848983
NCT03172871|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-30|||May 31, 2017|Anticipated|2017-05-31|May 2017|2017-05-01|January 30, 2020|Anticipated|2020-01-30|July 28, 2019|Anticipated|2019-07-28||Interventional|||Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia|A Multicenter, Randomized, Double-blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Aripiprazole Intramuscular Depot in the Acute Treatment of Adults With Schizophrenia|Not yet recruiting||Phase 3|430|Anticipated|Otsuka Beijing Research Institute||2|||f||||f|f|f||||||No||2017-10-10 21:00:59.930848|2017-10-10 21:00:59.930848
NCT03172858|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-12|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Randomized Control Trial of Intracervical Balloon Placement vs Oxytocin in Women With Term PROM and Unripe Cervices|A Randomized Trial of Intracervical Balloon Placement Versus Intravenous Oxytocin in Women With Premature Rupture of Membranes and Unripe Cervices|Not yet recruiting||N/A|200|Anticipated|Northwestern University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:00.010051|2017-10-10 21:01:00.010051
NCT03172845|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-12|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|May 30, 2019|Anticipated|2019-05-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Optical Coherence Tomography (OCT) Findings and Coronary Bifurcation Lesions|Clinical Significance of Vulnerable Plaque in Bifurcation Lesions Detected by Optical Coherence Tomography|Recruiting||N/A|300|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t|f|f|||t|||||2017-10-10 21:01:00.235606|2017-10-10 21:01:00.235606
NCT03172832|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-08-31|||August 20, 2017|Actual|2017-08-20|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|February 2020|Anticipated|2020-02-01||Interventional|INTERCPT||A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors|A Multicenter Randomized Trial of Percutaneous Transhepatic Biliary Drainage vs. Endoscopic Retrograde Cholangiography for Decompression of Suspected Malignant Biliary Hilar Obstruction - the INTERCPT Trial|Recruiting||N/A|184|Anticipated|Medical University of South Carolina||2|||f||||t|f|f||||||||2017-10-10 21:01:00.362056|2017-10-10 21:01:00.362056
NCT03172819|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-06-22|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|July 2020|Anticipated|2020-07-01||Interventional|||Special Combination of OBP-301 and Pembrolizumab|An Open Label Phase I Study to Evaluate the Safety and Efficacy of OBP-301 With Pembrolizumab in Patients With Advanced Solid Tumors|Not yet recruiting||Phase 1|28|Anticipated|National Cancer Center Hospital East||1|||f||||f|f|f|||t|||No||2017-10-10 21:01:00.576376|2017-10-10 21:01:00.576376
NCT03172806|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-31|||August 1, 2016|Actual|2016-08-01|May 2017|2017-05-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31|1 Month|Observational [Patient Registry]|||Comparison of the New Algorithm of STOP-Bang in the Detection of Severe OSA Patients|Comparison of the New Algorithm of STOP-Bang in the Detection of Severe OSA Patients|Recruiting||N/A|250|Anticipated|Astes|||1||f||||f|f|f||||||No||2017-10-10 21:01:00.688107|2017-10-10 21:01:00.688107
NCT03172793|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-08|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Telavancin Pharmacokinetics in Cystic Fibrosis Patients|Pharmacokinetics and Tolerability of Telavancin at Differing Dosing Regimens in Cystic Fibrosis Adults Admitted With Acute Pulmonary Exacerbations|Recruiting||Phase 4|18|Anticipated|Hartford Hospital||3|||f||||f|t|f|||f|||||2017-10-10 21:01:00.79538|2017-10-10 21:01:00.79538
NCT03172780|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-09-21|||May 24, 2017|Actual|2017-05-24|September 2017|2017-09-01|December 16, 2017|Anticipated|2017-12-16|December 16, 2017|Anticipated|2017-12-16||Interventional|||"A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"|A Randomized, Double Blind, Three-arm, Parallel, Placebocontrolled, Clinical Study to Evaluate the Bioequivalence Using Clinical Endpoint of Diclofenac Sodium Gel, 1% (Mylan Inc.) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc.) in Patients With Osteoarthritis (OA) of the Knee|Recruiting||Phase 3|1212|Anticipated|Mylan Inc.||3|||f||||f|t|f|||t|||||2017-10-10 21:01:00.969868|2017-10-10 21:01:00.969868
NCT03172767|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-30|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|September 20, 2017|Anticipated|2017-09-20|September 20, 2017|Anticipated|2017-09-20|1 Day|Observational [Patient Registry]|Preterm||The Relationship Between School Readiness and Sensory Processing Disorder in Preterm Preschooler|The Relationship Between School Readiness and Sensory Processing Disorder in Preterm Preschooler|Recruiting||N/A|60|Anticipated|Gazi University|||2||f|||||f|f||||||||2017-10-10 21:01:01.239551|2017-10-10 21:01:01.239551
NCT03172754|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-06-12|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma|Phase I/II Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma|Recruiting||Phase 1/Phase 2|98|Anticipated|Fox Chase Cancer Center||3|||f||||t|t|f||||||||2017-10-10 21:01:01.324169|2017-10-10 21:01:01.324169
NCT03172741|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-30|||January 1, 2018|Anticipated|2018-01-01|May 2017|2017-05-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis|The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Colorado State University||4|||f||||f|f|f|||f|||No||2017-10-10 21:01:01.423516|2017-10-10 21:01:01.423516
NCT03172728|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-29|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Psycho-education Intervention for Postpartum OCD and it's Influence on Symptom Severity and Treatment Self Referral Rates|Psycho-education Intervention for Postpartum Obsessive Compulsive Disorder (OCD) and it's Influence on Symptom Severity and Treatment Self Referral Rates: A Prospective Randomized Double Blinded Control Trial|Not yet recruiting||N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:01:01.538402|2017-10-10 21:01:01.538402
NCT03171428|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-31|||January 1, 2007|Actual|2007-01-01|May 2017|2017-05-01|April 1, 2015|Actual|2015-04-01|December 31, 2013|Actual|2013-12-31||Observational|||Hepatectomy With or Without the Thoraco-abdominal Approach|Hepatectomy With or Without the Thoraco-abdominal Approach: Impact on Perioperative Outcome|Completed||N/A|744|Actual|University of Milan|||2||f||||f|f|f||||||No||2017-10-10 21:01:11.254775|2017-10-10 21:01:11.254775
NCT03172702|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-10-04|||September 4, 2017|Actual|2017-09-04|October 2017|2017-10-01|September 10, 2019|Anticipated|2019-09-10|September 10, 2019|Anticipated|2019-09-10||Interventional|||Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia|A Phase 3 Multicenter Open-label Maintenance Study to Investigate the Long-term Safety of ZS (Sodium Zirconium Cyclosilicate) in Japanese Subjects With Hyperkalemia|Recruiting||Phase 3|150|Anticipated|AstraZeneca||1|||f|||||f|f||||||||2017-10-10 21:01:01.863551|2017-10-10 21:01:01.863551
NCT03172689|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-28|||August 29, 2017|Actual|2017-08-29|January 2017|2017-01-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|CQPiCCO||Validation of CardioQ Versus PiCCO in Children|Validation of an Ultrasound Oesophageal Doppler Cardiac Output Monitor (ODM+, CardioQ) Versus a Transpulmonary Thermodilution Cardiac Output Monitor (TPTD, PiCCO)|Recruiting||N/A|17|Anticipated|Radboud University||1|||f||||f|f|f|||f|||||2017-10-10 21:01:02.015526|2017-10-10 21:01:02.015526
NCT03172676|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-08-03|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura|Effects of Helicobacter Pylori Eradication Therapy in Children With Chronic Immune Thrombocytopenic Purpura|Not yet recruiting||Phase 4|75|Anticipated|Assiut University||3|||f|||||f|f||||||||2017-10-10 21:01:02.115921|2017-10-10 21:01:02.115921
NCT03172663|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-04|||May 1, 2018|Anticipated|2018-05-01|May 2017|2017-05-01|November 1, 2019|Anticipated|2019-11-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Body Mass Index and Audiology Function|Effect of Increased Body Mass Index on Auditory Function|Not yet recruiting||N/A|50|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:01:02.235545|2017-10-10 21:01:02.235545
NCT03172650|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-13|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|||Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions|Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions: Observational Case Control Study in Upper Egypt|Recruiting||N/A|120|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 21:01:02.321084|2017-10-10 21:01:02.321084
NCT03172637|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Female Sexual Dysfunction in Renal Failure|Female Sexual Dysfunctions in Patients With Chronic Renal Failure|Not yet recruiting||N/A|100|Anticipated|Assiut University|||2||f|||||f|f||||||||2017-10-10 21:01:02.418208|2017-10-10 21:01:02.418208
NCT03172624|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-08-23|||May 26, 2017|Actual|2017-05-26|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer|A Phase II Study of Nivolumab Plus Ipilimumab in Patients With Recurrent/Metastatic Salivary Cancers|Recruiting||Phase 2|64|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f|||f|||||2017-10-10 21:01:02.49022|2017-10-10 21:01:02.49022
NCT03172611|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-29|||January 3, 2017|Actual|2017-01-03|May 2017|2017-05-01|March 15, 2017|Actual|2017-03-15|March 8, 2017|Actual|2017-03-08||Interventional|||A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles|A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles|Completed||N/A|33|Actual|Texas Woman's University||1|||f||||f|f|f||||||No||2017-10-10 21:01:02.670131|2017-10-10 21:01:02.670131
NCT03172598|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-07-26|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy|A Phase IIa, Multi-Centre, Randomised, Double-Blind, Cross-Over, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy Incorporating an Open Label Pilot Arm|Recruiting||Phase 2|58|Anticipated|Mitsubishi Tanabe Pharma Corporation||5|||f|||||f|f||||||||2017-10-10 21:01:02.817972|2017-10-10 21:01:02.817972
NCT03172585|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Transthoracic Sonography Versus High Resolution Computed Tomography in Alveolar Intersitial Syndrome|Can High Frequency Transthoracic Sonography Play a Competition Role With High Resolution Computed Tomography in Assessment of Alveolar Intersitial Syndrome|Not yet recruiting||N/A|1|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 21:01:02.963381|2017-10-10 21:01:02.963381
NCT03172572|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|MI-PD||A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers|Outcomes After Minimally Invasive or Open Pancreatoduodenectomy in High-volume Centers; a Pan-European Retrospective Propensity-score Matched Cohort Study|Enrolling by invitation||N/A|4000|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f|f|f||||||No||2017-10-10 21:01:03.071023|2017-10-10 21:01:03.071023
NCT03172559|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-29|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2028|Anticipated|2028-09-01|September 2025|Anticipated|2025-09-01||Interventional|RADBRI||Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)|"A Multi-Center Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy as a Bridge Prior to Liver Transplant for Hepatocellular Carcinoma Versus no Intervention in Patients Not Eligible to Transarterial Chemoembolization or Ablation"|Not yet recruiting||N/A|332|Anticipated|University Health Network, Toronto||2|||f||||t|f|f||||||No||2017-10-10 21:01:03.183593|2017-10-10 21:01:03.183593
NCT03172546|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-07-21|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|ANTIGOAG||Determinants of Oral Anticoagulants' Activity|Clinical, Biological and Genetic Determinants of Oral Anticoagulants' Activity|Recruiting||N/A|550|Anticipated|University Hospital, Lille|||2||f||||f|f|f||||||||2017-10-10 21:01:03.265466|2017-10-10 21:01:03.265466
NCT03172533|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-01|||March 15, 2016|Actual|2016-03-15|June 2017|2017-06-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|HOSAN||Estrogen Replacement in Anorexia Nervosa|Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial on the Effects of an Estrogen-progestin Combination as add-on to Inpatient Psychotherapy in Adult Female Patients Suffering From Anorexia Nervosa|Recruiting||Phase 2|30|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f|||||f|f||||||||2017-10-10 21:01:03.35504|2017-10-10 21:01:03.35504
NCT03172520|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-30|2017-05-30|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Automatic Periodic Stimulation and Continuous Electromyography (EMG) for Facial Nerve Monitoring During Parotidectomy|Use of Automatic Periodic Stimulation and Continuous EMG for Facial Nerve Monitoring During Parotidectomy|Not yet recruiting||N/A|50|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:01:03.469027|2017-10-10 21:01:03.469027
NCT03172507|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-10-02|||September 20, 2017|Actual|2017-09-20|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01|4 Weeks|Observational [Patient Registry]|ATHEROSTEM||The Role of Stem Cells on Immune Cells in the Development of Cardiovascular Diseases|"Phenotypic and Epigenetic Trained Immunity Characteristics of Hematopoietic Stem and Progenitor Cells in Patients With Established Atherosclerosis"|Recruiting||N/A|30|Anticipated|Radboud University|||2||f||||t|f|f|||f|Samples With DNA|"     whole blood, serum, plasma and bone marrow   "|||2017-10-10 21:01:03.550389|2017-10-10 21:01:03.550389
NCT03172494|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-02|||May 25, 2017|Actual|2017-05-25|October 2017|2017-10-01|December 30, 2018|Anticipated|2018-12-30|December 10, 2018|Anticipated|2018-12-10||Interventional|DUAL™ I China||A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)|A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)|Recruiting||Phase 3|720|Anticipated|Novo Nordisk A/S||3|||f||||f|t|f|||t|||||2017-10-10 21:01:03.655216|2017-10-10 21:01:03.655216
NCT03172481|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-19|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|August 19, 2017|Actual|2017-08-19||Interventional|||PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Laboratory Classroom Study to Evaluate the Safety and Efficacy of PRC-063 Compared to Placebo in Children (6-12 Years of Age) With ADHD|Active, not recruiting||Phase 3|145|Anticipated|Purdue Pharma, Canada||2|||f||||f|t|f||||||||2017-10-10 21:01:03.929659|2017-10-10 21:01:03.929659
NCT03172468|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-07|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Observational|HETOCA||Definition of Hemodynamic Thresholds in Out-of-Hospital Cardiac Arrest|Definition of Hemodynamic Thresholds in Out-of-Hospital Cardiac Arrest: Advancing Advanced Life Support Towards Goal Directed Resuscitation|Recruiting||N/A|22|Anticipated|Medical University of Graz|||2||f||||f|f|f||||||||2017-10-10 21:01:04.046486|2017-10-10 21:01:04.046486
NCT03172455|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-29||||||May 2017|2017-05-01||||||||Expanded Access|||Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)|Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)|Available||N/A|||Impatients N.V. trading as myTomorrows|||||f||||||||||||||2017-10-10 21:01:04.152349|2017-10-10 21:01:04.152349
NCT03172442|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-25|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|September 15, 2018|Anticipated|2018-09-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Treatment of Skeletal Class III Malocclusion Using Orthodontic Removable Traction Appliance|Dentoskeletal Effects of The Orthodontic Removable Traction Appliance in The Treatment of Skeletal Class III Malocclusion: A Randomized Controlled Trial|Recruiting||N/A|22|Anticipated|Damascus University||2|||f||||t|f|f||||||Yes|Individual participant data will be available to the researchers in the department of Orthodontics, Damascus University|2017-10-10 21:01:04.227597|2017-10-10 21:01:04.227597
NCT03172429|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|||Cerebral Tissue Oxygenation in Highlanders/Lowlanders|Cerebral Tissue Oxygenation in Highlanders With Pulmonary Hypertension Compared to Highlanders Without Pulmonary Hypertension and Lowlanders|Recruiting||N/A|120|Anticipated|University of Zurich|||3||f||||f|f|f||||||Undecided||2017-10-10 21:01:04.326253|2017-10-10 21:01:04.326253
NCT03172416|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-05-29|||April 12, 2017|Actual|2017-04-12|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|PIPAC||Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal Carcinomatosis|Phase 1 Study of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal Carcinomatosis|Recruiting||Phase 1|21|Anticipated|National University Hospital, Singapore||1|||f||||t|f|f|||f|||No||2017-10-10 21:01:04.403796|2017-10-10 21:01:04.403796
NCT03172403|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-13|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|April 30, 2020|Anticipated|2020-04-30|September 30, 2019|Anticipated|2019-09-30||Interventional|MYOCAC||Skeletal Muscle Expression of Myostatin and Colon Cancer Associated Cachexia|Skeletal Muscle Expression of Myostatin and Colon Cancer Associated Cachexia(MYOCAC Study)|Not yet recruiting||N/A|45|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 21:01:04.496723|2017-10-10 21:01:04.496723
NCT03172390|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-29|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance|In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||No||2017-10-10 21:01:04.597658|2017-10-10 21:01:04.597658
NCT03172377|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-23|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|LADI||Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients|Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients|Recruiting||Phase 4|174|Anticipated|Radboud University||2|||f||||t|f|f|||f|||||2017-10-10 21:01:04.681769|2017-10-10 21:01:04.681769
NCT03172364|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-02|||June 12, 2017|Actual|2017-06-12|August 2017|2017-08-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Interventional|||To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin|A Clinical Study to Assess the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleansers in Healthy Females With Sensitive Skin Under Normal Conditions of Use|Completed||N/A|190|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 21:01:04.824597|2017-10-10 21:01:04.824597
NCT03172351|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-29|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||EDoF IOLs vs Monofocal IOL|Prospective Randomized Clinical Trial Comparing Extended Depth of Focus Intraocular Lenses With a Monofocal Intraocular Lens|Recruiting||Phase 4|216|Anticipated|Carl Zeiss Meditec AG||3|||f|||||f|f||||||||2017-10-10 21:01:04.895293|2017-10-10 21:01:04.895293
NCT03172338|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-29|||June 2, 2015|Actual|2015-06-02|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28|3 Months|Observational [Patient Registry]|||SMART - Systems Medicine of Heart Failure|Smart - Systems Medicine of Heart Failure|Recruiting||N/A|60|Anticipated|German Heart Institute|||1||f|||||f|f||||||||2017-10-10 21:01:04.97098|2017-10-10 21:01:04.97098
NCT03172325|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-29|||November 18, 2015|Actual|2015-11-18|May 2017|2017-05-01|January 4, 2017|Actual|2017-01-04|August 17, 2016|Actual|2016-08-17||Interventional|||Study to Demonstrate Non-Inferiority Efficacy and Safety of CinnoRA® Produced by CinnaGen Company Versus Humira® for Treatment of Active Rheumatoid Arthritis|A Phase III, Randomized, Two-armed, Double-blind (Patient and Assessor Blinded), Parallel Active Controlled Non-Inferiority Clinical Trial to Determine the Non-inferior Therapeutic Efficacy and Safety of Two Disease-modifying Anti Rheumatic Drugs CinnoRA® (Produced by CinnaGen Company) Versus Humira® for Treatment of Active Rheumatoid Arthritis|Completed||Phase 3|136|Actual|Cinnagen||2|||f||||f|f|f|||f|||No||2017-10-10 21:01:05.082171|2017-10-10 21:01:05.082171
NCT03172312|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-31|||January 1, 2014|Actual|2014-01-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|6 Months|Observational [Patient Registry]|IPSS||Clinical Utility of Intraoperative Parathyroid Scores System in Thyroidectomy|Clinical Utility of Intraoperative Parathyroid Scores System in Thyroidectomy|Completed||N/A|500|Actual|Fujian Medical University|||2||f||||f|f|f||||||No||2017-10-10 21:01:05.173872|2017-10-10 21:01:05.173872
NCT03172299|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-06|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2024|Anticipated|2024-12-01|June 2024|Anticipated|2024-06-01||Interventional|PROTECT||Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma|Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-Vascular Endothelial Growth Factor in Patients Treated With Proton Therapy for a Large Choroidal Melanoma|Not yet recruiting||Phase 3|56|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||t|f|f||||||||2017-10-10 21:01:05.262843|2017-10-10 21:01:05.262843
NCT03172286|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-29|||April 10, 2017|Actual|2017-04-10|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|April 1, 2018|Anticipated|2018-04-01||Interventional|||Radiofrequency Technic's Impact on Perineal Postpartum Pain|Radiofrequency Technic's Impact on Perineal Postpartum Pain|Recruiting||N/A|62|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f|f|f||||||No||2017-10-10 21:01:05.367976|2017-10-10 21:01:05.367976
NCT03172273|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-07-29|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|September 18, 2019|Anticipated|2019-09-18|September 18, 2019|Anticipated|2019-09-18||Interventional|||Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites|Early Use of Transjugular Intrahepatic Portosystemic Shunt（TIPS）With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites|Recruiting||N/A|180|Anticipated|Fourth Military Medical University||2|||f||||f|f|f||||||||2017-10-10 21:01:05.490404|2017-10-10 21:01:05.490404
NCT03172247|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-07|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|March 15, 2017|Actual|2017-03-15||Observational|||How Diabetic Patient Are Taken Care in Cardiology Service Actually?|How Diabetic Patient Are Taken Care in Cardiology Service Actually?|Active, not recruiting||N/A|32|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||||2017-10-10 21:01:05.679678|2017-10-10 21:01:05.679678
NCT03172234|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-07-04|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|November 15, 2017|Anticipated|2017-11-15|October 15, 2017|Anticipated|2017-10-15||Interventional|15/5/2017||Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation|Oral Amantadine Versus Gabapentin to Attenuate the Hemodynamic Response to Laryngoscopy and Tracheal Intubation and Their Effect on β-endorphin|Recruiting||Phase 2/Phase 3|60|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 21:01:05.736453|2017-10-10 21:01:05.736453
NCT03172221|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-16|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|December 24, 2017|Anticipated|2017-12-24||Observational|HSRDT MiP||Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women|Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women|Recruiting||N/A|1710|Anticipated|Foundation for Innovative New Diagnostics, Switzerland|||1||f||||f|f|f||||||||2017-10-10 21:01:05.843267|2017-10-10 21:01:05.843267
NCT03172208|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-19|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.|A Phase I Single Center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Caplacizumab in Japanese and White Healthy Volunteers.|Active, not recruiting||Phase 1|60|Actual|Ablynx||12|||f||||f|t|f||||||||2017-10-10 21:01:05.930846|2017-10-10 21:01:05.930846
NCT03172195|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-21|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up|Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up|Enrolling by invitation||N/A|100|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 21:01:06.023399|2017-10-10 21:01:06.023399
NCT03172182|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-09-22|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Perioperative Effects of Operating Room Virtual Tour|The Effects of Operating Room Virtual Tour on Preoperative Anxiety, Emergence Delirium and Postoperative Behavioral Changes of Pediatric Patients: Prospective, Randomized, and Controlled Trial|Recruiting||N/A|86|Anticipated|Seoul National University Bundang Hospital||2|||f||||f|f|f||||||||2017-10-10 21:01:06.094686|2017-10-10 21:01:06.094686
NCT03172169|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-04|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01|3 Months|Observational [Patient Registry]|||Specific Small RNA in Plasma for Predicting Diaphragm Dysfunction in Mechanically Ventilated Patients|Observational Study of Specific Small RNA in Plasma Muscle Tissue for Predicting Diaphragm Dysfunction in Mechanically Ventilated Patients|Not yet recruiting||N/A|140|Anticipated|Southeast University, China|||3||f||||t|f|f||||||Undecided||2017-10-10 21:01:06.177736|2017-10-10 21:01:06.177736
NCT03172143|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-14|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease|Mesenteric Sparing Versus High Ligation Ileocolic Resection for the Prevention of Recurrent Crohn's Disease|Not yet recruiting||N/A|214|Anticipated|Mayo Clinic||2|||f||||t|f|f||||||||2017-10-10 21:01:06.319216|2017-10-10 21:01:06.319216
NCT03172130|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-05-27|||October 13, 2014|Actual|2014-10-13|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Sham CPAP vs. Straight CPAP for Chronic Cough|Prospective Study of Efficacy of Sham CPAP vs. Straight CPAP on Cough Intensity in Patients With Chronic Cough|Recruiting||N/A|58|Anticipated|University of Utah||2|||f||||f|f|t|f|f||||No||2017-10-10 21:01:06.391021|2017-10-10 21:01:06.391021
NCT03172117|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-29|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.|Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.|Recruiting||Phase 1/Phase 2|45|Anticipated|Medipost Co Ltd.||3|||f||||t|f|f||||||||2017-10-10 21:01:06.466907|2017-10-10 21:01:06.466907
NCT03172104|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-29|||January 1, 2011|Actual|2011-01-01|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Observational|VIBeS-2||Neurobehavioural Development of Infants Born <30 Weeks Gestational Age Between Birth and Five Years of Age|Neurobehavioural Development of Infants Born <30 Weeks Gestational Age and Their Parents Psychological Wellbeing Between Birth and Five Years of Age|Recruiting||N/A|300|Anticipated|Murdoch Childrens Research Institute|||2||f||||f|f|f||||||No||2017-10-10 21:01:06.547645|2017-10-10 21:01:06.547645
NCT03172091|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-08|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|VOC-TP||Volatile Organic Compounds as Markers of Acute Rejection in Lung Transplant|Analysis of Volatile Organic Compounds in the Exhaled Air Breath of in Bilateral Lung Transplant Recipients Bi-pulmonary Transplant Patients: Search for Acute Rejection Markers|Recruiting||N/A|120|Anticipated|Hopital Foch||2|||f||||f|f|f||||||||2017-10-10 21:01:06.613941|2017-10-10 21:01:06.613941
NCT03172078|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-26|||September 30, 2017|Anticipated|2017-09-30|March 2017|2017-03-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|||Sedation of Advanced Endoscopic Procedure|Sedation of Advanced Endoscopic Procedure: Comparison Between Manually Controlled Infusion With Target-controlled Infusion|Not yet recruiting||N/A|400|Anticipated|National Taiwan University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:01:06.696687|2017-10-10 21:01:06.696687
NCT03172065|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-28|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Dexmedetomidine and Laparoscopic Surgery|Intrathecal Dexmedetomidine Versus I.V Ketorolac in Prevention of Shoulder Tip Pain in Gynecological Laparoscopic Surgery|Recruiting||N/A|60|Anticipated|Assiut University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:06.78015|2017-10-10 21:01:06.78015
NCT03172052|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-03|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 30, 2020|Anticipated|2020-06-30|June 1, 2019|Anticipated|2019-06-01||Interventional|||Evaluating Different Modalities for Pleural Adhesiolysis at Assuit University Hospital|Evaluating Different Modalities for Pleural Adhesiolysis at Assuit University Hospital|Not yet recruiting||Phase 4|100|Anticipated|Assiut University||4|||f|||||t|t|f||f|||||2017-10-10 21:01:06.858722|2017-10-10 21:01:06.858722
NCT03172039|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-06-01|||May 12, 2017|Actual|2017-05-12|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Antimicrobial Use and Stewardship in an Outpatient Hemodialysis Unit|Antimicrobial Use and Stewardship in an Outpatient Hemodialysis Unit|Active, not recruiting||N/A|70|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||No||2017-10-10 21:01:06.931529|2017-10-10 21:01:06.931529
NCT03172026|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-27|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|MAROS||Maraviroc to Augment Rehabilitation Outcomes After Stroke|Maraviroc to Augment Rehabilitation Outcomes After Stroke|Not yet recruiting||Phase 2/Phase 3|60|Anticipated|University of California, Los Angeles||2|||f||||t|t|f|||f|||||2017-10-10 21:01:07.000298|2017-10-10 21:01:07.000298
NCT03172013|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-05-30|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients|Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients|Recruiting||N/A|100|Anticipated|Tanta University|||3||f||||t|f|f||||||Undecided||2017-10-10 21:01:07.08152|2017-10-10 21:01:07.08152
NCT03172000|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-05-30|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Detection of Helicobacter Pylori in Ulcerative Colitis Patients|Detection of Helicobacter Pylori in Colonic Tissue in Newly Diagnosed Ulcerative Colitis Patients|Recruiting||N/A|60|Anticipated|Tanta University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:01:07.154358|2017-10-10 21:01:07.154358
NCT03171987|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-08|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||The Safety and Efficacy of 5% Lidocaine Patch and Flurbiprofen Patch for Relieving Acute Low Back Pain|The Safety and Efficacy of 5% Lidocaine Patch and Flurbiprofen Patch for Relieving Acute Low Back Pain|Recruiting||Phase 4|120|Anticipated|Taipei Medical University Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:01:07.239901|2017-10-10 21:01:07.239901
NCT03171974|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-30|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Ultrasound Guided Treatment of Steroids for Capsular Contracture in Patients With Reconstructed/Augmented Breast|Ultrasound Guided Treatment of Steroids for Capsular Contracture in Patients With Reconstructed/Augmented Breast|Not yet recruiting||N/A|30|Anticipated|Rabin Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:01:07.341219|2017-10-10 21:01:07.341219
NCT03171961|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-09-12|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Online Visit Compared With In-person Clinic Visit on Weight Loss|Effectiveness of Online Visit Compared With In-person Clinic Visit on Weight Loss in Overweight and Obese Women, a Randomized Clinical Trial|Enrolling by invitation||N/A|120|Anticipated|Novindiet Clinic||3|||f||||f|f|f||||||||2017-10-10 21:01:07.417504|2017-10-10 21:01:07.417504
NCT03171948|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-09-12|||June 10, 2017|Actual|2017-06-10|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of a Limited Almond Consumption After a Weight Loss Plan on Weight Maintenance|Effects of a Limited Almond Consumption After a Successful Weight Loss by a Comprehensive Weight Loss Plan on Weight Maintenance in Healthy Obese Female Adults: a Randomised Clinical Trial|Enrolling by invitation||N/A|120|Anticipated|Novindiet Clinic||2|||f||||f|f|f||||||||2017-10-10 21:01:07.501937|2017-10-10 21:01:07.501937
NCT03171935|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-08-04|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Wean Early With HFNCO vs NPPV in Patients With AHRF|Wean Early With High-Flow Nasal Cannula Oxygenation Versus Noninvasive Positive Pressure Ventilation in Patients With Acute Hypoxemic Respiratory Failure: a Multicenter, Randomized, Controlled Trial (the WHEN Study)|Recruiting||N/A|270|Anticipated|Beijing Chao Yang Hospital||3|||f||||t|f|f||||||||2017-10-10 21:01:07.589249|2017-10-10 21:01:07.589249
NCT03171922|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-09-12|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of Internet-based Diet Plus Online Dietary Coach Compared With in Person Clinic Visit Approach on Weight Loss|Effects of Internet-based Diet Plus Online Dietary Coach Compared With in Person Clinic Visit Approach on Weight Loss in Healthy Obese Women in a Weight-loss Program: a Randomized Clinical Trial|Enrolling by invitation||N/A|120|Anticipated|Novindiet Clinic||2|||f||||f|f|f||||||||2017-10-10 21:01:07.738558|2017-10-10 21:01:07.738558
NCT03171909|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-28|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01|8 Years|Observational [Patient Registry]|MonoReg||Austrian Registry on the Outcome of Monochorionic Pregnancies|Austrian Registry on the Outcome of Monochorionic Multiple Pregnancies: A Multicenter Registry Study|Recruiting||N/A|1000|Anticipated|Medical University of Graz|||1||f||||f|f|f||||||No||2017-10-10 21:01:07.878663|2017-10-10 21:01:07.878663
NCT03171896|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-28|||November 1, 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|LaborClown||Effect of the Involvement of a Medical Clown on the Labor Experience|Effect of the Involvement of a Medical Clown on the Labor Experience|Not yet recruiting||N/A|40|Anticipated|The Baruch Padeh Medical Center, Poriya||2|||f||||f|f|f||||||Yes|With the medical and general public|2017-10-10 21:01:08.066257|2017-10-10 21:01:08.066257
NCT03171883|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-30|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Ultrasound of Supraspinatus Muscle Tears|The Value of Ultrasound in the Diagnosis of Supraspinatus Muscle Tears|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 21:01:08.147872|2017-10-10 21:01:08.147872
NCT03171870|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis|Clinical, Radiological Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis Patients|Not yet recruiting||N/A|1|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 21:01:08.214701|2017-10-10 21:01:08.214701
NCT03171857|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-30|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Doppler Ultrasound in Characterization of Superficial Soft Tissue Masses|Role of Doppler Ultrasound in Evaluation of Superficial Soft Tissue Masses|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 21:01:08.292812|2017-10-10 21:01:08.292812
NCT03171844|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-29|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|PA2PRéaNice||Early Skin to Skin in Neonatal Reanimation|Early Skin to Skin in Neonatal reanimation_Risk Assessment in the Newborn With an Umbilical Venous Catheter|Not yet recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f|f|f||||||||2017-10-10 21:01:08.36082|2017-10-10 21:01:08.36082
NCT03171831|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-27|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|April 1, 2022|Anticipated|2022-04-01|December 31, 2021|Anticipated|2021-12-31||Interventional|||Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major|Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major|Recruiting||Phase 4|30|Anticipated|First Affiliated Hospital of Guangxi Medical University||1|||f||||t|f|f|||f|||||2017-10-10 21:01:08.439066|2017-10-10 21:01:08.439066
NCT03171818|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-30|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|April 1, 2021|Anticipated|2021-04-01|October 1, 2019|Anticipated|2019-10-01||Interventional|DINOSAUR||Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration|Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration|Recruiting||Phase 2|80|Anticipated|UMC Utrecht||2|||f||||t|t|f|||t|||||2017-10-10 21:01:08.559247|2017-10-10 21:01:08.559247
NCT03171805|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 30, 2020|Anticipated|2020-12-30|May 15, 2018|Anticipated|2018-05-15||Interventional|||The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices|Post-balloon Occluded Retrograde Transvenous Obliteration Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices|Recruiting||N/A|74|Anticipated|West China Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:08.668489|2017-10-10 21:01:08.668489
NCT03171792|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||June 10, 2017|Anticipated|2017-06-10|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Observational|DMS-AJA||Experience of Chronic (Non-malignant) Musculoskeletal Pain of French Adolescent and Young Adult: a Qualitative Research With Their Physicians and Non-medical Practitioners|Experience of Chronic (Non-malignant) Musculoskeletal Pain of French Adolescent and Young Adult: a Qualitative Research With Their Physicians and Non-medical Practitioners|Not yet recruiting||N/A|25|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||No||2017-10-10 21:01:08.761557|2017-10-10 21:01:08.761557
NCT03171779|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-05-29|||June 17, 2015|Actual|2015-06-17|May 2017|2017-05-01|September 4, 2017|Anticipated|2017-09-04|September 4, 2017|Anticipated|2017-09-04||Observational|SCOP3 quali||Impact of Interprofessional Training and Co-ordination on Early Identification and Proactive Approach to End-of-life Situations in the Context of Primary Care|Impact of Interprofessional Training and Co-ordination on Early Identification and Proactive Approach to End-of-life Situations in the Context of Primary Care|Recruiting||N/A|1175|Anticipated|Centre Hospitalier Universitaire, Amiens|||3||f|||||f|f||||||||2017-10-10 21:01:08.849738|2017-10-10 21:01:08.849738
NCT03171766|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-22|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|October 15, 2017|Anticipated|2017-10-15||Observational|||Pre-operative Neurocognitive Disorder and Low Near-infrared Spectrometry is Associated With Postoperative Delirium|Pre-operative Neurocognitive Disorder and Low Near-infrared Spectrometry is Associated With Postoperative Delirium in Neurosurgical Patients|Recruiting||N/A|100|Anticipated|Centro Hospitalar do Porto|||1||f||||f|f|f||||||No||2017-10-10 21:01:08.939564|2017-10-10 21:01:08.939564
NCT03171753|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-15|||February 15, 2016|Actual|2016-02-15|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Preoperative Anxiety and Music Therapy|Anxiety, Preoperative Stress and Music Therapy|Completed||N/A|60|Actual|University of Foggia||2|||f||||f||||||||||2017-10-10 21:01:09.030635|2017-10-10 21:01:09.030635
NCT03171740|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-09-12|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|January 15, 2018|Anticipated|2018-01-15|December 1, 2017|Anticipated|2017-12-01||Interventional|||Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children|Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children: Superiority Randomized Clinical Trial|Recruiting||Phase 3|42|Anticipated|Brasilia University Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:01:09.124109|2017-10-10 21:01:09.124109
NCT03171727|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 30, 2019|Anticipated|2019-12-30|May 15, 2019|Anticipated|2019-05-15||Interventional|||Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction|Post-TIPS Short-term Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction|Recruiting||N/A|117|Anticipated|West China Hospital||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:01:09.230642|2017-10-10 21:01:09.230642
NCT03171714|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-06|||March 27, 2017|Actual|2017-03-27|June 2017|2017-06-01|December 15, 2017|Anticipated|2017-12-15|November 30, 2017|Anticipated|2017-11-30||Interventional|||Derma-Stent Novel Abscess Packing Device|Derma-Stent Novel Abscess Packing Device (Pilot Study)|Recruiting||Phase 1/Phase 2|60|Anticipated|Wayne State University||2|||f||||f|f|f||||||No||2017-10-10 21:01:09.313356|2017-10-10 21:01:09.313356
NCT03171701|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-29|2017-06-07|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|October 1, 2018|Anticipated|2018-10-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Color Doppler Ultrasonography in Prediction of Arteriovenous Fistula Maturation in Hemodialysis Patients|Role of Color Doppler Ultrasonography in Prediction of Arteriovenous Fistula Maturation and Its Complications in Hemodialysis Patients|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:01:09.409105|2017-10-10 21:01:09.409105
NCT03171688|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-09-12|||May 1, 2016|Actual|2016-05-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Risk Factors for Nausea and Vomiting After Cesarean|Risk Factors for Nausea and Vomiting After Cesarean: Observational Prospective Study|Recruiting||N/A|230|Anticipated|Brasilia University Hospital|||2||f||||f|f|f||||||||2017-10-10 21:01:09.469741|2017-10-10 21:01:09.469741
NCT03171675|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-07-20|||December 25, 2014|Actual|2014-12-25|July 2017|2017-07-01|June 16, 2015|Actual|2015-06-16|March 2, 2015|Actual|2015-03-02||Observational|||Gingival Crevicular Fluid and Placental Tissue Levels of Interleukin-17 as a Possible Marker for Preterm Labor in Patients With Chronic Periodontitis|Gingival Crevicular Fluid and Placental Tissue Levels of Interleukin-17 as a Possible Marker for Preterm Labor in Patients With Chronic Periodontitis|Completed||N/A|40|Actual|Ain Shams University|||4||f|||||f|f||||Samples With DNA|"     Gingival crevicular fluid and placental tissue samples   "|||2017-10-10 21:01:09.557766|2017-10-10 21:01:09.557766
NCT03171662|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-06-05|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 1, 2019|Anticipated|2019-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Imaging and Histopathological Examination for Evaluation of Pediatric Appendicitis Score|Imaging and Histopathological Examination for Evaluation of Pediatric Appendicitis Score ( PAS ) as a Diagnostic Tool for Acute Appendicitis in Children|Not yet recruiting||N/A|75|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 21:01:09.633344|2017-10-10 21:01:09.633344
NCT03171649|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-28|||November 10, 2016|Actual|2016-11-10|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|RETRAINER-S1||Reaching Training Based on Robotic Hybrid Assistance for Stroke Patients|Reaching Training Based on Robotic Hybrid Assistance for Stroke Patients|Recruiting||N/A|68|Anticipated|Villa Beretta Rehabilitation Center||2|||f||||f|f|f||||||No||2017-10-10 21:01:09.69502|2017-10-10 21:01:09.69502
NCT03171636|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients at Erasto Gaertner Hospital|Analysis of the Types and Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients at Erasto Gaertner Hospital, Curitiba, Brazil.|Recruiting||N/A|130|Anticipated|Hospital Erasto Gaertner|||1||f|||||f|f||||||||2017-10-10 21:01:09.804151|2017-10-10 21:01:09.804151
NCT03171623|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-26|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Assessment of Single-Dose Safety,Tolerability, Phamacokinetics and Phamacodynamic of Globalagliatin Hydrochloride|A Randomised,Double-blind,Placebo-controlled Study to Assessment of Single-Dose Safety,Tolerability, Phamacokinetics and Phamacodynamic of Globalagliatin Hydrochloride (SY-004) in Chinese Healthy Subjects|Recruiting||Phase 1|44|Anticipated|Yabao Pharmaceutical Group||5|||f||||f|f|f||||||No||2017-10-10 21:01:09.868596|2017-10-10 21:01:09.868596
NCT03171610|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-30|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Study on Efficacy of iv PCA With Fentanyl or Sufentanil in Patients Undergoing Laparoscopic Nephrectomy|Randomized Double-blind Study on Efficacy of iv PCA With Fentanyl or Sufentanil in Patients Undergoing Laparoscopic Nephrectomy|Not yet recruiting||N/A|86|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:01:09.960668|2017-10-10 21:01:09.960668
NCT03171597|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-28|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.|Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.|Not yet recruiting||Phase 4|240|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||4|||f||||t|f|f||||||Undecided||2017-10-10 21:01:10.069565|2017-10-10 21:01:10.069565
NCT03171584|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-28|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|November 1, 2019|Anticipated|2019-11-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Antifungal Drugs in Treatment of Onychomycosis|Comparative Study of Systemic Antifungal Drugs Used in Treatment of Onychomycosis|Not yet recruiting||Phase 3|60|Anticipated|Assiut University||3|||f||||f|f|f||||||No||2017-10-10 21:01:10.167201|2017-10-10 21:01:10.167201
NCT03171571|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-26|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|C2H||Personal Lifestyle Assistant for Better Health Through Nutrition|Personal Lifestyle Assistant for Better Health Through Nutrition : Cook to Health Study|Active, not recruiting||N/A|20|Actual|University Hospital, Grenoble||1|||f||||t||||||||No||2017-10-10 21:01:10.241933|2017-10-10 21:01:10.241933
NCT03171558|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-30|||March 16, 2017|Actual|2017-03-16|May 2017|2017-05-01|March 2023|Anticipated|2023-03-01|March 2022|Anticipated|2022-03-01||Interventional|GPU vs ALT||Gastric Pull up Versus Free Flap Reconstruction for Laryngo-pharyngeal Defects|Gastric Pull up Versus Free Flaps Reconstruction (Anterolateral Thigh and Radial Forearm Free Flap) for Laryngo-pharyngeal Defects: A Prospective Randomized Trial|Recruiting||N/A|20|Anticipated|University of British Columbia||2|||f||||f|f|f||||||No|Individual participant data will not be shared with other researchers.|2017-10-10 21:01:10.310719|2017-10-10 21:01:10.310719
NCT03171545|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||February 1, 2018|Anticipated|2018-02-01|May 2017|2017-05-01|October 15, 2021|Anticipated|2021-10-15|October 15, 2021|Anticipated|2021-10-15||Interventional|Dialysafe||Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)|Enhancing the Cardiovascular Safety of Hemodialysis Care: A Cluster-Randomized, Comparative Effectiveness Trial of Multimodal Provider Education and Patient Activation Interventions (Dialysafe)|Not yet recruiting||N/A|1400|Anticipated|University of Michigan||4|||f||||f|f|f||||||No||2017-10-10 21:01:10.437755|2017-10-10 21:01:10.437755
NCT03171532|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-28|||December 1, 2015|Actual|2015-12-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 1, 2018|Anticipated|2018-12-01||Interventional|||Clinical and Functional Outcomes at 2 Years of 4-strand Versus 5-strand Hamstring Autograft in Anterior Cruciate Ligament Reconstruction|Comparison of Clinical and Functional Outcomes at 2 Years of 4-strand Versus 5-strand Hamstring Autograft in Anterior Cruciate Ligament (ACL) Reconstruction: A Prospective Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|National University Hospital, Singapore||2|||f||||t|f|f||||||No||2017-10-10 21:01:10.605839|2017-10-10 21:01:10.605839
NCT03171506|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-08-08|||November 9, 2015|Actual|2015-11-09|August 2017|2017-08-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification|Targeted Disruption to Cancer Metabolism Through Dietary Macronutrient Modification|Completed||N/A|57|Actual|University of Alabama at Birmingham||2|||f||||f|f|f||||||||2017-10-10 21:01:10.773377|2017-10-10 21:01:10.773377
NCT03171493|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-25|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy|Neoadjuvant Intravesical NIS Measles Virus (MV-NIS) in Patients Undergoing Cystectomy for Urothelial Carcinoma But Ineligible for Neoadjuvant Cisplatin-based Chemotherapy|Not yet recruiting||Phase 1|16|Anticipated|Vyriad, Inc.||1|||f||||t|t|f||||||Yes||2017-10-10 21:01:10.856943|2017-10-10 21:01:10.856943
NCT03171480|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|NOPE||Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia|Randomized Controlled Trial of Nitric-oxide Donor (NOD) Isosorbide Mononitrate (IMN) Versus Placebo for Induction of Labor in Pregnancies Complicated by Preeclampsia|Not yet recruiting||N/A|400|Anticipated|Ohio State University||2|||f||||t|f|f|||f|||||2017-10-10 21:01:10.921387|2017-10-10 21:01:10.921387
NCT03171467|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-28|||August 1, 2016|Actual|2016-08-01|May 2017|2017-05-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|SaLCHE||Salpingectomy at the Time of Elective Laparoscopic Cholecystectomy (SaLCHE)|Salpingectomy in Women Undergoing Elective Laparoscopic Cholecystectomy (SaLCHE): A Feasibility Study|Recruiting||N/A|100|Anticipated|Medical University of Graz||1|||f||||f|f|f||||||No||2017-10-10 21:01:10.998397|2017-10-10 21:01:10.998397
NCT03171454|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-06|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Immediate and Delayed Intrauterine Balloon in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis|Randomized, Controlled Trial Comparing Immediate and Delayed Intrauterine Balloon Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis|Recruiting||N/A|180|Anticipated|Fu Xing Hospital, Capital Medical University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:11.097685|2017-10-10 21:01:11.097685
NCT03171415|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-07-25|||July 25, 2017|Actual|2017-07-25|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers|A Double Blind, Randomized, Placebo Controlled, Dose Escalation Phase 2a Clinical Trial for the Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers|Recruiting||Phase 2|32|Anticipated|Raziel Therapeutics Ltd.||2|||f||||f|t|f||||||||2017-10-10 21:01:13.00636|2017-10-10 21:01:13.00636
NCT03171402|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Astringency and Bitterness Perception|Astringency and Bitterness Perception Among High and Low Fruit and Vegetable Consumers|Recruiting||N/A|480|Anticipated|Purdue University|||2||f||||f|f|f||||Samples Without DNA|"     Saliva   "|No||2017-10-10 21:01:13.099333|2017-10-10 21:01:13.099333
NCT03171389|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-26|||March 22, 2017|Actual|2017-03-22|May 2017|2017-05-01|September 22, 2020|Anticipated|2020-09-22|September 22, 2018|Anticipated|2018-09-22||Interventional|POETIG||POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST|Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) Following Failure or Intolerance of Prior Therapy With Imatinib|Recruiting||Phase 2|81|Anticipated|Universität Duisburg-Essen||3|||f||||f|t|f|||t|||Undecided||2017-10-10 21:01:13.176781|2017-10-10 21:01:13.176781
NCT03171376|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-12|||October 14, 2016|Actual|2016-10-14|September 2017|2017-09-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|||Effect of Coronal Extent of Obturation on Endo-perio Lesions|Effect of Coronal Extent of Obturation in Relation to Marginal Bone on Endodontic - Periodontal Lesions Without Communication: A Randomized Controlled Trial|Active, not recruiting||N/A|60|Actual|Postgraduate Institute of Dental Sciences Rohtak||3|||f||||t||||||||||2017-10-10 21:01:13.280096|2017-10-10 21:01:13.280096
NCT03171363|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-30|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Gaze Contingent Feedback for Anxiety Disorders in Children|Gaze-Contingent Music Reward Treatment for Anxiety Disorders in Children: A Case Series|Recruiting||N/A|12|Anticipated|Tel Aviv University||1|||f||||f|f|f||||||No||2017-10-10 21:01:13.343987|2017-10-10 21:01:13.343987
NCT03171350|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-05-28|||May 24, 2017|Actual|2017-05-24|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis.|A Prospective Multi-Centre Study of the Performance of the Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis|Recruiting||N/A|400|Anticipated|Ellume Pty Ltd||1|||f||||f|f|f|||f|||No||2017-10-10 21:01:13.420465|2017-10-10 21:01:13.420465
NCT03171337|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-02|||June 10, 2017|Anticipated|2017-06-10|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||The Efficacy of Acupuncture and Fu's Subcutaneous Needling (FSN ) in Treating Chronic Tension-type Headache by fMRI|To Explore the Cerebral Function Efficacy of Acupuncture and Fu's Subcutaneous Needling (FSN) in the Treatment of Chronic Tension-type Headache by Means of fMRI: a Single-blinded, Randomized Controlled Trials.|Not yet recruiting||N/A|45|Anticipated|South China Normal University||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:01:13.506344|2017-10-10 21:01:13.506344
NCT03171324|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-05-31|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Infants|a Randomized Control Trial to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Small for Gestational Age and Appropriate for Gestational Age Infants at 1 Year|Recruiting||Phase 4|300|Anticipated|Postgraduate Institute of Medical Education and Research||4|||f|||||f|f|||f|||No|Not to be shared|2017-10-10 21:01:13.583726|2017-10-10 21:01:13.583726
NCT03171311|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-28|2017-08-30|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|May 2029|Anticipated|2029-05-01|May 2020|Anticipated|2020-05-01||Interventional|OCTOBER||The OCTOBER Trial - Nordic-Baltic-British Study on Optical Coherence Tomography Optimized Bifurcation Event Reduction|Nordic-Baltic-British Study on Optical Coherence Tomography Optimized Bifurcation Event Reduction - the OCTOBER Trial|Recruiting||N/A|1200|Anticipated|Aarhus University Hospital Skejby||2|||f||||t|f|f||||||||2017-10-10 21:01:13.685564|2017-10-10 21:01:13.685564
NCT03171298|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-28|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision|Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision|Not yet recruiting||N/A|100|Anticipated|Assiut University||1|||f|||||f|f||||||No||2017-10-10 21:01:14.086276|2017-10-10 21:01:14.086276
NCT03171285|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-05-31|||May 2, 2009|Actual|2009-05-02|May 2017|2017-05-01|December 12, 2009|Actual|2009-12-12|December 12, 2009|Actual|2009-12-12||Observational|||Cardiovascular Disease in Soccer Referees|Risk of Cardiovascular Disease in Soccer Referees: a Cross Sectional Study|Completed||N/A|50|Actual|University of Sao Paulo|||2||f||||f|f|f||||||Undecided||2017-10-10 21:01:14.199675|2017-10-10 21:01:14.199675
NCT03171272|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-14|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Inspiratory Muscle Training on the Functional Gait Performance of Individuals After Stroke|Effects of Inspiratory Muscle Training on the Functional Gait Performance of Individuals After Stroke|Recruiting||N/A|50|Anticipated|Sarah Network of Rehabilitation Hospitals||2|||f||||t|f|f||||||||2017-10-10 21:01:14.292425|2017-10-10 21:01:14.292425
NCT03171259|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-26|||November 15, 2017|Anticipated|2017-11-15|May 2017|2017-05-01|February 18, 2020|Anticipated|2020-02-18|December 31, 2019|Anticipated|2019-12-31||Observational|PORTRAIT-CLI||PORTRAIT-Critical Limb Ischemia|Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories in Critical Limb Ischemia|Not yet recruiting||N/A|80|Anticipated|Saint Luke's Health System|||1||f||||f|f|f||||||Undecided||2017-10-10 21:01:14.393796|2017-10-10 21:01:14.393796
NCT03171246|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-16|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||CD-TREAT Diet: a Novel Therapy for Active Luminal Crohn's Disease|An Open Label Pilot Study of the CD-TREAT Diet as a Novel Therapy for Active Luminal Crohn's Disease|Not yet recruiting||N/A|20|Anticipated|NHS Greater Glasgow and Clyde||1|||f||||f|f|f||||||||2017-10-10 21:01:14.485897|2017-10-10 21:01:14.485897
NCT03171233|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-05-27|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|June 30, 2017|Anticipated|2017-06-30||Interventional|||Immediate Effects of Two Ankle Mobilization Techniques in the Amplitude of Dorsiflexion and Dynamic Valgus Knee|Immediate Effects of Two Ankle Mobilization Techniques in the Amplitude of Dorsiflexion and Dynamic Valgus Knee: a Random Clinical Test|Recruiting||N/A|102|Anticipated|Universidade Federal do Ceara||2|||f||||f|f|f||||||No||2017-10-10 21:01:14.577012|2017-10-10 21:01:14.577012
NCT03171220|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-06-02|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|NRT-01||Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors|Single Center Single Arm Clinical Prospective Study of Neoantigen Reactive T Cells (NRTs) Combined With Programmed Cell Death-1（PD-1） Inhibitor in the Treatment of Chinese Patients With Advanced Refractory Solid Tumors|Recruiting||Phase 1/Phase 2|40|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||f|f|f||||||Undecided||2017-10-10 21:01:14.680571|2017-10-10 21:01:14.680571
NCT03171207|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-30|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of a Novel Gait Training Device to Support Body Weight|Evaluation of a Novel Gait Training Device Using a Pressurized Lower Body Suit to Support Body Weight|Not yet recruiting||N/A|10|Anticipated|Lite Run Inc.||2|||f||||f|f|t|f||f|||No||2017-10-10 21:01:14.784208|2017-10-10 21:01:14.784208
NCT03171194|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-26|||April 27, 2017|Actual|2017-04-27|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Phase I Mesenchymal Stem Cells for Systemic Lupus Erythematosus|A Phase I Safety Trial of Allogeneic Mesenchymal Stem Cells for Systemic Lupus Erythematosus|Recruiting||Phase 1|6|Anticipated|Medical University of South Carolina||1|||f||||t|t|f||||||No||2017-10-10 21:01:14.881503|2017-10-10 21:01:14.881503
NCT03171181|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-23|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 2015|Actual|2015-03-01||Interventional|||Unilateral Peripheral Vestibular Dysfunction: Reeducation and Spatial Orientation.|Unilateral Peripheral Vestibular Dysfunction: Reeducation and Spatial Orientation.|Active, not recruiting||N/A|90|Anticipated|Universidad de Zaragoza||3|||f||||t|f|f||||||||2017-10-10 21:01:14.978774|2017-10-10 21:01:14.978774
NCT03171168|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-26|||November 30, 2016|Actual|2016-11-30|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|November 30, 2017|Anticipated|2017-11-30||Interventional|AposKnee||The Effect of AposTherapy on Knee Pain|The Effect of AposTherapy on Pain and Function in Knee Osteoarthritis Population: A Randomized Controlled Trial|Recruiting||N/A|147|Anticipated|Montefiore Medical Center||2|||f||||f|f|t|f||f|||No||2017-10-10 21:01:15.185509|2017-10-10 21:01:15.185509
NCT03171155|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-26|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Clinical Study of the Medeon Biodesign XPro™|Prospective, Multi-Center, Single Arm Study of the Medeon Biodesign XPro™ Suture-Mediated Vascular Closure Device System|Not yet recruiting||N/A|60|Anticipated|Medeon Biodesign, Inc.||1|||f||||f|f|f||||||No||2017-10-10 21:01:15.31425|2017-10-10 21:01:15.31425
NCT03171142|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-26|||May 1, 2015|Actual|2015-05-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|August 1, 2016|Actual|2016-08-01||Interventional|||Effect of Heliox on RSV Bronchiolitis|Effect of Heliox on Infants With Respiratory Syncytial Virus Acute Bronchiolitis-A Revisit Study|Completed||Phase 3|104|Actual|Mansoura University Children Hospital||2|||f||||t|f|f||||||||2017-10-10 21:01:15.38931|2017-10-10 21:01:15.38931
NCT03171129|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-08-22|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||ADINA vs. High Flow Nasal Cannula Comparison Study|Adaptive Dynamic Inspiratory Nasal Apparatus (ADINA): Comparison to High Flow Nasal Cannula (HFNC)|Not yet recruiting||N/A|40|Anticipated|Loma Linda University||2|||f||||f|f|t|f|f|t|||||2017-10-10 21:01:15.448674|2017-10-10 21:01:15.448674
NCT03171116|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-28|||January 1, 2013|Actual|2013-01-01|May 2017|2017-05-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Observational|||Ghrelin and Obestatin in CKD Children|Unacylated Ghrelin and Obestatin as Promising Biomarkers of Protein Energy Wasting in Children With Chronic Kidney Disease: a Cross-sectional Case-control Study|Completed||N/A|154|Actual|Azienda Ospedaliero Universitaria Maggiore della Carita|||4||f|||||f|f||||||No||2017-10-10 21:01:15.528736|2017-10-10 21:01:15.528736
NCT03171103|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-27|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01|3 Years|Observational [Patient Registry]|||Systemic Lupus and Adverse Pregnancy Outcome|Systemic Lupus and Pregnancy Outcome in Benisuef Localities|Enrolling by invitation||N/A|100|Anticipated|Beni-Suef University|||1||f||||t|f|f||||||Undecided||2017-10-10 21:01:15.684277|2017-10-10 21:01:15.684277
NCT03171090|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-10|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|September 15, 2017|Anticipated|2017-09-15||Interventional|||Efficacy of Bilateral Ultrasonic Guided Sphenopalatine Ganglion Block in Maxilofacial Cancer Surgeries|Efficacy of Bilaterally Ultrasonic Guided Sphenopalatine Ganglion Block for Perioperative Pain Management in Maxilofacial Cancer Surgeries|Recruiting||N/A|60|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:01:15.758701|2017-10-10 21:01:15.758701
NCT03171077|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-27|2017-09-10|||June 10, 2017|Actual|2017-06-10|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Virtual Rehabilitation and PNF in the Recovery of the Motor Function Post Stroke|Effectiveness of Virtual Rehabilitation and Proprioceptive Neuromuscular Facilitation in the Recovery of the Motor Function Post Stroke: A Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|Federal University of Bahia||3|||f||||t|f|f|||f|||||2017-10-10 21:01:15.851332|2017-10-10 21:01:15.851332
NCT03171064|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||June 5, 2017|Anticipated|2017-06-05|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|November 30, 2018|Anticipated|2018-11-30||Interventional|Sportivumab||Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment|Sportivumab - Feasibility of Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment|Not yet recruiting||Phase 2|40|Anticipated|University Hospital Heidelberg||2|||f||||t|f|f||||||Undecided|Maybe pooling data with a comparable project in the united states|2017-10-10 21:01:15.95582|2017-10-10 21:01:15.95582
NCT03170349|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-07|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|July 2018|Anticipated|2018-07-01||Interventional|CLASP||The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study|The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study|Recruiting||N/A|130|Anticipated|Edwards Lifesciences||1|||f||||t|f|f|||t|||||2017-10-10 21:01:21.813112|2017-10-10 21:01:21.813112
NCT03171051|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-13|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|June 9, 2017|Actual|2017-06-09|June 9, 2017|Actual|2017-06-09||Interventional|||LED Device for Non-Invasive Lipolysis|Feasibility Study of a 950 nm Wavelength LED Device for Non-Invasive Lipolysis of the Flanks|Completed||N/A|10|Actual|Venus Concept||2|||f||||f|f|t|f|||||Undecided|This is a feasibility study. Sharing of IPD may occur if the study supports further development of the device.|2017-10-10 21:01:16.03166|2017-10-10 21:01:16.03166
NCT03171038|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-31|||April 1, 2008|Actual|2008-04-01|May 2017|2017-05-01|August 1, 2015|Actual|2015-08-01|August 1, 2015|Actual|2015-08-01||Interventional|TEMA-HFLT||The TElemonitoring in the Management of Heart Failure (TEMA-HF) 1 Long-term Follow-up Study|Long-term Impact of a 6-months Telemedical Care Program on Mortality, Readmissions and Healthcare Costs in Patients With Chronic Heart Failure The TElemonitoring in the Management of Heart Failure (TEMA-HF) 1 Long-term Follow-up Study|Completed||N/A|160|Actual|Hasselt University||2|||f||||f|f|f||||||No||2017-10-10 21:01:16.104129|2017-10-10 21:01:16.104129
NCT03171025|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-26|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Interventional|NEXT||Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer|A Phase II Open Label Single Arm Study of Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer (NEXT)|Recruiting||Phase 2|28|Anticipated|University of Utah||1|||f||||t|t|f||||||||2017-10-10 21:01:16.17824|2017-10-10 21:01:16.17824
NCT03171012|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Addition of Proprioceptive Neuromuscular Facilitation to Cardio Respiratory Training Post Stroke|Proprioceptive Neuromuscular Facilitation Repercussions Associated With Cardiorespiratory Training in Postal Individuals Stroke to the Functions Motor, Respiratory and Quality of Life: Randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|Universidade Federal do Rio Grande do Norte||4|||f||||t|f|f||||||Undecided||2017-10-10 21:01:16.27517|2017-10-10 21:01:16.27517
NCT03170999|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-26|||January 31, 2018|Anticipated|2018-01-31|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Observational|||Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)|Generation and Cognitive Testing of Informative and Suitable Items for a COPD Exacerbation Recognition Tool (CERT) for Detection of Exacerbations of COPD in Chinese Patients|Not yet recruiting||N/A|210|Anticipated|GlaxoSmithKline|||3||f||||f|f|f||||||||2017-10-10 21:01:16.381339|2017-10-10 21:01:16.381339
NCT03170986|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-25|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Multi-Sectoral Agricultural Intervention to Improve Nutrition, Health, and Developmental Outcomes of HIV-infected and Affected Children in Western Kenya|Multi-Sectoral Agricultural Intervention to Improve Nutrition, Health, and Developmental Outcomes of HIV-infected and Affected Children in Western Kenya|Recruiting||N/A|704|Anticipated|University of Connecticut||2|||f||||t|f|f||||||No|Following publication of the main paper(s) for this study, we will make survey data publicly available in the form of an electronic database for researchers who successfully complete a registration process. Survey data will be de-identified and will not contain any direct identifiers or indirect identifiers that could identify participants by inference. Users must submit brief proposals regarding intended use of the data; the study team will determine the scientific soundness of the proposal as part of the decision for the researcher to be able to access the public use dataset.|2017-10-10 21:01:16.461798|2017-10-10 21:01:16.461798
NCT03170973|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-30|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Influence of Exercise on Trans Fatty Acids|Influences of Physical Activity in the Profile of Trans Fatty Acids in the Serum of Individuals With Body Weight Changes|Recruiting||N/A|66|Anticipated|Faculdade Adventista da Bahia||2|||f||||t|f|f||||||No|The data will not be available in an individual way, only with general data about the population without any form of identification of the subjects|2017-10-10 21:01:16.63878|2017-10-10 21:01:16.63878
NCT03170960|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-26|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|August 2019|Anticipated|2019-08-01||Interventional|||Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors|A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|156|Anticipated|Exelixis||5|||f||||t|t|f||||||||2017-10-10 21:01:16.737426|2017-10-10 21:01:16.737426
NCT03170947|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of Insoles in Patients With Rheumatoid Arthritis: Randomized Controlled Trial.|Effects of Insoles in Patients With Rheumatoid Arthritis Through Measurement of Quality of Life and Physical Activity: Randomized Controlled Trial.|Not yet recruiting||N/A|96|Anticipated|University of Malaga||2|||f||||t|f|f||||||No||2017-10-10 21:01:16.857266|2017-10-10 21:01:16.857266
NCT03170934|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-08|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||The Effectiveness of Psychotherapy Classes in Reducing Suicidal Ideation|The Effectiveness of Psychotherapy Classes in Reducing Suicidal Ideation|Recruiting||N/A|250|Anticipated|University of Manitoba|||1||f||||f|f|f||||||||2017-10-10 21:01:16.937464|2017-10-10 21:01:16.937464
NCT03170921|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-26|||January 25, 2016|Actual|2016-01-25|May 2017|2017-05-01|February 28, 2016|Actual|2016-02-28|January 30, 2016|Actual|2016-01-30||Interventional|||Psychophysiological Characterization of Different Capoeira Performances in Experienced Individuals|Psychophysiological Characterization of Different Capoeira Performances in Experienced Individuals|Completed||N/A|11|Actual|Universidade Federal do vale do São Francisco||3|||f||||t|f|f||||||No|No.|2017-10-10 21:01:17.012802|2017-10-10 21:01:17.012802
NCT03170908|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||Effective Implementation of Interpersonal Psychotherapy|Pragmatic Strategies for Assessing and Enhancing High Fidelity Delivery of Interpersonal Psychotherapy (IPT) in Community Practice|Not yet recruiting||N/A|425|Anticipated|University of Iowa|||2||f||||f|f|f||||||No|we do not plan to share IPD|2017-10-10 21:01:17.080353|2017-10-10 21:01:17.080353
NCT03169842|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||May 25, 2017|Actual|2017-05-25|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts|Accuracy of Cyst Fluid Glucose for the On-site Diagnosis of Mucinous Pancreatic Cysts|Recruiting||N/A|400|Anticipated|Ochsner Health System||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:01:25.944825|2017-10-10 21:01:25.944825
NCT03170895|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-14|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|October 1, 2021|Anticipated|2021-10-01|November 1, 2020|Anticipated|2020-11-01||Interventional|||Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD|A Phase II Single-arm Open-labeled Study Evaluating Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD|Recruiting||Phase 2|40|Anticipated|The University of Hong Kong||1|||f||||t|f|f||||||||2017-10-10 21:01:17.149811|2017-10-10 21:01:17.149811
NCT03170869|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|April 1, 2019|Anticipated|2019-04-01|June 1, 2018|Anticipated|2018-06-01||Interventional|SPEED||Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE|SPEED 1 Trial: Bridge to Orthotopic Liver Transplantation (OLT) - (Surefire Precision vs Endhole Embolization With DEBTACE)|Recruiting||N/A|50|Anticipated|University of Colorado, Denver||1|||f||||t|f|t|f|f|f|||No||2017-10-10 21:01:17.494554|2017-10-10 21:01:17.494554
NCT03170856|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-10-03|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effects of a Sub-maximal Exercise Program on Adolescents Who Sustained a Concussion|The Effects of a Sub-maximal Exercise Program on Adolescents Who Sustained a Concussion|Not yet recruiting||N/A|25|Anticipated|Boston Children’s Hospital||1|||f||||t|f|f||||||||2017-10-10 21:01:17.574189|2017-10-10 21:01:17.574189
NCT03170843|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-07-16|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|March 31, 2018|Anticipated|2018-03-31||Interventional|||RCT to Test the Plastic Wound Retractor in the Effect of Reducing SSI|Randomized Controlled Trial to Evaluate the Effectiveness and Efficacy of a Sterile Circular Polyethylene Drape Compared to Conventional Surgical Dressing in Prevention of Surgical Site Infection|Recruiting||N/A|458|Anticipated|Saint Vincent's Hospital, Korea||2|||f||||t|f|f|||f|||||2017-10-10 21:01:17.630852|2017-10-10 21:01:17.630852
NCT03170830|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-26|||August 1, 2015|Actual|2015-08-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Diagnostic Value of CircRNA-Uck2 for Acute Myocardial Infarction|Study on CircRNA-Uck2 as a New Diagnostic Marker of Acute Myocardial Infarction|Recruiting||N/A|178|Anticipated|Beijing Haidian Hospital||3|||f||||f|f|f||||||||2017-10-10 21:01:17.79874|2017-10-10 21:01:17.79874
NCT03170817|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT|Quantitative Rest/Stress Cardiac Perfusion Digital PET/CT: Comparison Between Noninvasive Imaging and Invasive Coronary Angiography.|Recruiting||N/A|30|Anticipated|Stanford University||1|||f||||t|f|t|f|f||||No|GE Healthcare is the monitoring entity because GE Healthcare is the Study Sponsor. The monitoring visits will be conducted by a GE Clinical Research Associate (CRA).|2017-10-10 21:01:17.905289|2017-10-10 21:01:17.905289
NCT03170804|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2018|Anticipated|2018-01-01|30 Days|Observational [Patient Registry]|||Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer|Registry for Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer|Recruiting||N/A|200|Anticipated|Aventura Hospital and Medical Center|||1||f||||f|f|f||||||No||2017-10-10 21:01:18.023692|2017-10-10 21:01:18.023692
NCT03170791|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-01|||October 23, 2015|Actual|2015-10-23|June 2017|2017-06-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Noninvasive Vagal Nerve Stimulation for Arm Recovery After Stroke|Feasibility and Acceptability of Transcutaneous Vagal Nerve Stimulation in Recovery of Upper Limb Function Post Stroke|Recruiting||N/A|20|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t|f|f||||||No|no individual participant data will be shared|2017-10-10 21:01:18.106548|2017-10-10 21:01:18.106548
NCT03170778|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-26|||February 13, 2016|Actual|2016-02-13|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||Ocular and Vision Problems in Patients After Fontan Operation|Ocular and Vision Problems in Patients After Fontan Operation|Recruiting||N/A|75|Anticipated|Stanford University|||1||f||||t|f|f||||||No||2017-10-10 21:01:18.189657|2017-10-10 21:01:18.189657
NCT03170765|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||March 14, 2017|Actual|2017-03-14|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Randomized Controlled Trial of Measles Vaccination Schedule|Comparison of Three Different Schedules of Measles Vaccination in Infants: a Pilot Randomized Controlled Trial|Enrolling by invitation||N/A|120|Anticipated|Postgraduate Institute of Medical Education and Research||3|||f||||t|f|f||||||No|Individual participant data will be shared with institutional ethics committee on request.|2017-10-10 21:01:18.269281|2017-10-10 21:01:18.269281
NCT03170752|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-28|||September 6, 2017|Anticipated|2017-09-06|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CASP||Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)|Implementing and Testing a Cardiovascular Assessment Screening Program to Promote Healthy Aging (CASP)|Not yet recruiting||N/A|70|Anticipated|Memorial University of Newfoundland||2|||f||||f|f|f||||||||2017-10-10 21:01:18.372178|2017-10-10 21:01:18.372178
NCT03170739|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-04|||June 6, 2017|Anticipated|2017-06-06|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of Dexmedetomidine and Dopamine on Renal Function After Major Surgery|Effects of Dexmedetomidine and Dopamine on Renal Function After Selective Major Surgery in Adult Patients|Not yet recruiting||Phase 4|180|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||4|||f|||||f|f||||||||2017-10-10 21:01:18.459982|2017-10-10 21:01:18.459982
NCT03170726|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-26|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|November 15, 2017|Anticipated|2017-11-15|October 30, 2017|Anticipated|2017-10-30||Interventional|||Impact of Preemptive Intravenous Ibuprofen on Intraoperative Analgesia in Third Molar Teeth|Impact of Preemptive Intravenous Ibuprofen on Intraoperative Analgesia in Third Molar Teeth|Active, not recruiting||N/A|60|Anticipated|Erzincan University||3|||f||||f|f|f|||f|||No||2017-10-10 21:01:18.558701|2017-10-10 21:01:18.558701
NCT03170713|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-26|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|November 15, 2017|Anticipated|2017-11-15|October 30, 2017|Anticipated|2017-10-30||Interventional|||Impact of Preemptive Intravenous Ibuprofen on Postoperative Edema and Trismus in the Third Molar Teeth|Impact of Preemptive Intravenous Ibuprofen on Postoperative Edema and Trismus in the Third Molar Teeth|Active, not recruiting||N/A|60|Anticipated|Erzincan University||3|||f||||f|f|f||||||No||2017-10-10 21:01:18.670892|2017-10-10 21:01:18.670892
NCT03170700|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-26|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Online Videos and New Feeding Content to Enhance a Current EFNEP Program|Use of Engaging Online Videos in Conjunction With New Feeding Content to Enhance a Current EFNEP Program in the Prevention of Child Obesity|Recruiting||N/A|350|Anticipated|Baylor College of Medicine||3|||f||||f|f|f||||||||2017-10-10 21:01:18.796253|2017-10-10 21:01:18.796253
NCT03170687|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||January 24, 2017|Actual|2017-01-24|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Comparative Outcomes Between Foot Cast and Short Leg Cast in the Patients With Acute Closed Fracture of Proximal Fifth Metatarsal (Zone II)|Comparative Outcomes Between Foot Cast and Short Leg Cast in the Patients With Acute Closed Fracture of Proximal Fifth Metatarsal (Zone II)|Recruiting||N/A|100|Anticipated|Ramathibodi Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:01:18.93381|2017-10-10 21:01:18.93381
NCT03170674|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-07|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Interventional|||CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette|CSD170501: A Randomized, Controlled Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette|Completed||N/A|114|Actual|RAI Services Company||4|||f||||f|f|f||||||||2017-10-10 21:01:19.075146|2017-10-10 21:01:19.075146
NCT03170661|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-26|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|BLISS 4||Effect of Deep Versus Moderate Neuromuscular Block During Sevoflurane Anesthesia on Intraoperative Surgical Conditions.|Effect of Deep Versus Moderate Neuromuscular Block During Sevoflurane Anesthesia on Intraoperative Surgical Conditions, Hemodynamics and Postoperative Pain in Patients Undergoing Laparoscopic Retroperitoneal Surgery for Prostatectomy or Nephrectomy|Not yet recruiting||Phase 4|60|Anticipated|Leiden University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:01:19.176165|2017-10-10 21:01:19.176165
NCT03170648|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-14|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|May 31, 2023|Anticipated|2023-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study|Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study|Not yet recruiting||N/A|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|f|t|f|f||||No||2017-10-10 21:01:19.263259|2017-10-10 21:01:19.263259
NCT03170635|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-26|||March 1, 2013|Actual|2013-03-01|May 2017|2017-05-01|March 1, 2014|Actual|2014-03-01|March 1, 2014|Actual|2014-03-01||Interventional|(EMCRR)||Refreshing Recess: Staff and Student Feedback Outcome Study (EMCRR)|The Refreshing Recess Program for Promoting Student Participation and Enjoyment: An Outcome Study|Completed||N/A|485|Actual|Cleveland State University||1|||f||||f|f|f||||||No||2017-10-10 21:01:19.387785|2017-10-10 21:01:19.387785
NCT03170622|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-30|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|August 2018|Anticipated|2018-08-01||Observational|VOX||Evaluation of Faecal Volatile Organic Compounds in the Diagnosis of Paediatric Inflammatory Bowel Disease|Evaluation of Faecal Volatile Organic Compounds in the Diagnosis of Paediatric Inflammatory Bowel Disease|Not yet recruiting||N/A|286|Anticipated|Alder Hey Children's NHS Foundation Trust|||1||f||||f|f|f||||||No||2017-10-10 21:01:19.469739|2017-10-10 21:01:19.469739
NCT03170596|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-19|||June 2, 2017|Actual|2017-06-02|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Comparison Between Microneedling Daycare Procedure and Tazarotene 0.1% Gel Local Application in Acne Scarring|Microneedling Versus Topical Tazarotene 0.1% Gel for the Treatment of Atrophic Post Acne Scarring - a Randomized Controlled Study|Recruiting||N/A|36|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f|f|f|||f|||||2017-10-10 21:01:19.686093|2017-10-10 21:01:19.686093
NCT03170583|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-29|||June 8, 2017|Actual|2017-06-08|September 2017|2017-09-01|September 1, 2025|Anticipated|2025-09-01|August 1, 2025|Anticipated|2025-08-01||Observational|Brady MRI PAS||SJM Brady MRI Post Approval Study|SJM Brady MRI Post Approval Study|Recruiting||N/A|1756|Anticipated|St. Jude Medical|||1||f||||f|f|t|t|f|f|||||2017-10-10 21:01:19.80798|2017-10-10 21:01:19.80798
NCT03170570|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||December 1, 2016|Actual|2016-12-01|April 2017|2017-04-01|January 31, 2020|Anticipated|2020-01-31|April 30, 2019|Anticipated|2019-04-30||Interventional|||the Re-irradiation of Recurrent Cervical Cancer by IMRT|A Prospective Study on the Efficacy and Safety of the Re-irradiation of Recurrent Cervical Cancer Within the Irradiated Field by Intensity Modulated Radiotherapy|Recruiting||N/A|108|Anticipated|Sun Yat-sen University||1|||f||||t|f|f||||||No||2017-10-10 21:01:19.96341|2017-10-10 21:01:19.96341
NCT03170557|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-27|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Randomized Comparative Trial for Persistent Pain in Spinal Cord Injury: Acupuncture vs Aspecific Needle Skin Stimulation|A Randomized, Double Blind, Comparative Trial to Assess the Efficacy of Traditional Acupuncture vs Aspecific Needle Skin Stimulation for Persistent Pain in Subjects With Spinal Cord Injury|Recruiting||N/A|114|Anticipated|Montecatone Rehabilitation Institute S.p.A.||2|||f||||f|f|f||||||||2017-10-10 21:01:20.08291|2017-10-10 21:01:20.08291
NCT03170531|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||A Custom-Designed MR Coil for Spine Radiotherapy Treatment Planning|A Custom-Designed MR Coil for Spine Radiotherapy Treatment Planning|Recruiting||N/A|15|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f|||||f|f||||||Undecided||2017-10-10 21:01:20.333199|2017-10-10 21:01:20.333199
NCT03170518|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-22|||July 21, 2017|Actual|2017-07-21|September 2017|2017-09-01|June 28, 2021|Anticipated|2021-06-28|June 28, 2021|Anticipated|2021-06-28||Interventional|||A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus|A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (≥10 to <18 Years) With Type 2 Diabetes Mellitus|Recruiting||Phase 3|172|Anticipated|Janssen Research & Development, LLC||2|||f||||t|t|f||||||||2017-10-10 21:01:20.429719|2017-10-10 21:01:20.429719
NCT03170505|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||May 27, 2015|Actual|2015-05-27|May 2017|2017-05-01|May 27, 2017|Actual|2017-05-27|May 27, 2017|Actual|2017-05-27||Observational|||Using of Acellular Dermal Matrix in Cleft Palatal Fistula and Compare With Use of Conchal Cartolage|Using of Acellular Dermal Matrix in Cleft Palatal Fistula and Compare With Use of Conchal Cartolage|Completed||N/A|60|Actual|Isfahan University of Medical Sciences|||2||f|||||f|f||||||||2017-10-10 21:01:20.645878|2017-10-10 21:01:20.645878
NCT03170492|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-25|||January 30, 2017|Actual|2017-01-30|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|CCT||Does Computerized Cognitive Training Improve Executive Functioning in the Older Adult?|Does Computerized Cognitive Training Improve Executive Functioning in the Older Adult?|Recruiting||N/A|34|Anticipated|University of the Sciences in Philadelphia||2|||f||||t|f|f||||||No||2017-10-10 21:01:20.703889|2017-10-10 21:01:20.703889
NCT03170479|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2017-05-25|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|November 2016|Actual|2016-11-01||Interventional|||Developmental Screening and Nutritional Intervention of Severe Acute Malnourished Children in Southern Punjab, Pakistan|Developmental Screening and Nutritional Intervention of Severe Acute Malnourished Children in Southern Punjab, Pakistan|Completed||Phase 2|185|Actual|University of the Punjab||2|||f||||t||||||||Yes||2017-10-10 21:01:20.78279|2017-10-10 21:01:20.78279
NCT03170466|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-25|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Primary Palliative Care in Heart Failure: A Pilot Trial|Primary Palliative Care in Heart Failure: A Pilot Trial|Not yet recruiting||N/A|30|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||No||2017-10-10 21:01:20.860634|2017-10-10 21:01:20.860634
NCT03170453|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-30|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|PerspectivesII||Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder|Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder|Recruiting||N/A|100|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||Yes|Data will be shared through the National Database for Autism Research|2017-10-10 21:01:21.018278|2017-10-10 21:01:21.018278
NCT03170440|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-21|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|December 15, 2020|Anticipated|2020-12-15|August 15, 2020|Anticipated|2020-08-15||Interventional|||Non-invasive Vagal Nerve Stimulation and Sleep|Non-invasive Vagal Nerve Stimulation and Sleep|Not yet recruiting||N/A|200|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 21:01:21.137697|2017-10-10 21:01:21.137697
NCT03170427|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-25|||January 1, 2013|Actual|2013-01-01|May 2017|2017-05-01|May 31, 2014|Actual|2014-05-31|January 1, 2014|Actual|2014-01-01||Interventional|||Impedance Cardiography as Tool for Continuous Hemodynamic Monitoring During Cesarean Section|Impedance Cardiography as Tool for Continuous Hemodynamic Monitoring During Cesarean Section: Randomized, Prospective Double Blind Study|Completed||N/A|62|Actual|University of Foggia||2|||f|||||f|f||||||||2017-10-10 21:01:21.245905|2017-10-10 21:01:21.245905
NCT03170414|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-14|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|||Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients|A Prospective Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients|Recruiting||N/A|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t|f|f||||||||2017-10-10 21:01:21.324116|2017-10-10 21:01:21.324116
NCT03170401|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-25|||November 2016||2016-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Supplemental Enteral Protein in Critical Illness|Supplemental Enteral Protein in Critical Illness|Recruiting||N/A|100|Anticipated|University of Washington||2|||f||||t||||||||Undecided||2017-10-10 21:01:21.40785|2017-10-10 21:01:21.40785
NCT03170388|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-12|||August 30, 2017|Anticipated|2017-08-30|June 2017|2017-06-01|August 18, 2018|Anticipated|2018-08-18|June 18, 2018|Anticipated|2018-06-18||Interventional|||A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris|A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris|Not yet recruiting||Phase 2|750|Anticipated|Valeant Pharmaceuticals International, Inc.||5|||||||t|t|f|||f|||Yes||2017-10-10 21:01:21.492984|2017-10-10 21:01:21.492984
NCT03170375|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Dietary Prevention of Heart Failure in Hypertensive Metabolic Syndrome|Dietary Prevention of Heart Failure in Hypertensive Metabolic Syndrome|Not yet recruiting||N/A|130|Anticipated|VA Office of Research and Development||4|||f||||t|f|f|||f|||No||2017-10-10 21:01:21.580136|2017-10-10 21:01:21.580136
NCT03170362|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-08-22|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|March 31, 2022|Anticipated|2022-03-31|September 30, 2020|Anticipated|2020-09-30||Interventional|PRIME Care||PRIME Care (PRecision Medicine In MEntal Health Care)|PRIME Care (PRecision Medicine In MEntal Health Care)|Enrolling by invitation||N/A|2000|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:01:21.694547|2017-10-10 21:01:21.694547
NCT03170336|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-02|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|ANTI-UPRO||A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein|The Effect and Safety of Amiloride in Decreasing Proteinuria for Patients With Chronic Kidney Disease in a Prospective , Crossover, Open-label Study.|Recruiting||Phase 4|54|Anticipated|Guangdong General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:01:21.904333|2017-10-10 21:01:21.904333
NCT03170323|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-06-02|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|MMF-STOP-IMN||Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy|A Prospective Randomized, Controlled Trial of Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy|Recruiting||Phase 4|128|Anticipated|Guangdong General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:01:22.010212|2017-10-10 21:01:22.010212
NCT03170310|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||February 21, 2017|Actual|2017-02-21|May 2017|2017-05-01|September 21, 2019|Anticipated|2019-09-21|February 21, 2019|Anticipated|2019-02-21||Interventional|||Apatinib Treatment for Advanced Esophagus Cancer|Apatinib Treatment for Advanced Esophagus Cancer ,One-armed，Exploratory，Openting , Clinical Trail.|Recruiting||Phase 2|60|Anticipated|Henan Cancer Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:01:22.11617|2017-10-10 21:01:22.11617
NCT03170297|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-30|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|VIPER||SC2i VIPER: EnVenomation Investigation Pilot to Evaluate Recovery|SC2i VIPER: EnVenomation Investigation Pilot to Evaluate Recovery|Recruiting||N/A|15|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine|||1||f||||f|f|f||||Samples With DNA|"     Blood samples collected will be used for quantification of over one hundred micro RNA (levels     will be assessed) as well as multiple markers of inflammation such as Interleukins 1-36 and     their receptors, interferons and their receptors, tumor necrosis factors and their receptors,     CCL and CXCL family chemokines and their receptors, macrophage and granulocyte colony     stimulating factors and their receptors, and lymphocyte secreted products related to the     action of these proteins will be evaluated. No genetic testing will be performed.   "|No|The PI will ensure that there is no unauthorized use of the data or samples. As this study is unblinded and nonrandomized it is felt that a formal Data Safety Monitoring Board is not necessary to insure the prompt implementation of patient safeguards. Data for this sub-study will be entered in a separate REDCap database, with data specific to this sub-study (i.e., PSFS, hospital re-admissions from phone follow-ups). This database will only be available to appropriately delegated key personnel. Any data shared outside of Duke key personnel will be de-identified,|2017-10-10 21:01:22.194424|2017-10-10 21:01:22.194424
NCT03170284|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||June 17, 2008|Actual|2008-06-17|May 2017|2017-05-01|August 1, 2012|Actual|2012-08-01|August 1, 2012|Actual|2012-08-01||Observational|AVALANCHE||Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer|A Multi-Center Observational Survey of the Efficacy and Safety of Avastin in Addition to Platimun-Based Chemotherapy for First-Line Treatment of Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology|Completed||N/A|150|Actual|Hoffmann-La Roche|||1||f||||f|t|f||||||||2017-10-10 21:01:22.283343|2017-10-10 21:01:22.283343
NCT03170271|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-22|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|May 10, 2019|Anticipated|2019-05-10|May 10, 2019|Anticipated|2019-05-10||Interventional|ANDHI||A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.|A Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients With Severe Asthma Uncontrolled on Standard of Care Treatment|Recruiting||Phase 3|800|Anticipated|AstraZeneca||2|||f||||f|t|f|||f|||||2017-10-10 21:01:22.4203|2017-10-10 21:01:22.4203
NCT03170258|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-08-31|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Self-activation of the Midbrain in Individuals With Nicotine Dependence|Self-activation of Ventral Tegmental Area (VTA) Using Real-time fMRI in Individuals With Nicotine Dependence|Not yet recruiting||N/A|70|Anticipated|Duke University||2|||f||||t|f|t|f|||||||2017-10-10 21:01:22.616097|2017-10-10 21:01:22.616097
NCT03170245|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-28|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|November 1, 2019|Anticipated|2019-11-01||Observational|||Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia Patients|Adiponectin, Interleukin-6 (IL-6) and High Sensitive C-reactive Protein (hsC-RP) in Relation to Carotid Intima-media Thickness in B-thalassemia Patients|Not yet recruiting||N/A|80|Anticipated|Assiut University|||2||f||||f|f|f||||Samples Without DNA|"     Whole blood and serum to be used   "|||2017-10-10 21:01:22.726141|2017-10-10 21:01:22.726141
NCT03170232|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-28|||October 10, 2017|Anticipated|2017-10-10|September 2017|2017-09-01|March 6, 2019|Anticipated|2019-03-06|March 6, 2019|Anticipated|2019-03-06||Interventional|||A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Sponsor Open, Placebo-controlled, 52 Week Study Evaluating the Effect of Danirixin (GSK1325756) on Lung Function and Health Related Quality of Life in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)|Not yet recruiting||Phase 2|100|Anticipated|GlaxoSmithKline||2|||f||||f|t|t|f|f||||||2017-10-10 21:01:22.830278|2017-10-10 21:01:22.830278
NCT03170219|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|SUBQ-HF||Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study|Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study|Not yet recruiting||Phase 2|300|Anticipated|Duke University||2|||f||||t|t|t|f|||||||2017-10-10 21:01:22.92749|2017-10-10 21:01:22.92749
NCT03170206|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-26|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|March 31, 2024|Anticipated|2024-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer|Phase I/II Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|72|Anticipated|Dana-Farber Cancer Institute||4|||f||||t|t|f||||||||2017-10-10 21:01:23.07613|2017-10-10 21:01:23.07613
NCT03170193|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-28|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|November 6, 2017|Anticipated|2017-11-06|November 6, 2017|Anticipated|2017-11-06||Interventional|||AMG 529 20160338 First in Human Study|A Phase 1, Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 529 in Healthy Subjects|Active, not recruiting||Phase 1|50|Actual|Amgen||2|||f||||f|t|f||||||||2017-10-10 21:01:23.213157|2017-10-10 21:01:23.213157
NCT03170180|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer|Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer|Recruiting||Phase 2|21|Anticipated|Samsung Medical Center||3|||f||||t|f|f||||||Undecided||2017-10-10 21:01:23.313492|2017-10-10 21:01:23.313492
NCT03170167|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-05-25|||October 2016||2016-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Communitas: A Program for Teens Living With Chronic Illness and Their Families|Effectiveness of a Mind-Body and Peer Support Program for Teens Living With Chronic Illness and Their Parents: A Pilot Study|Recruiting||N/A|100|Anticipated|University of California, San Francisco|||2||f||||f||||||||Undecided||2017-10-10 21:01:23.415271|2017-10-10 21:01:23.415271
NCT03170154|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-09-26|||July 25, 2017||2017-07-25||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:01:23.534946|2017-10-10 21:01:23.534946
NCT03170141|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-07|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|January 2019|Anticipated|2019-01-01||Interventional|||4SCAR-IgT Against Glioblastoma Multiform|4SCAR-IgT Cells Expressing PD-L1 and PD1 Antibodies Against Glioblastoma Multiform|Enrolling by invitation||Phase 1/Phase 2|20|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||f|f|f||||||No||2017-10-10 21:01:23.582713|2017-10-10 21:01:23.582713
NCT03170128|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-08-14|||August 3, 2014|Actual|2014-08-03|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||Functional Outcomes After Radial Head Fractures Treated Non-operatively|Functional Outcomes After Radial Head Fractures Treated Non-operatively|Completed||N/A|51|Actual|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:01:23.667472|2017-10-10 21:01:23.667472
NCT03170115|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|ICAR||Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer|Phase II Randomized Study of Induction Chemotherapy Followed by Chemoradiotherapy With or Without Aspirin in High Risk Locally Advanced Rectal Cancer|Not yet recruiting||Phase 2|80|Anticipated|Instituto Nacional de Cancer, Brazil||2|||f||||f|f|f|||t|||||2017-10-10 21:01:23.755582|2017-10-10 21:01:23.755582
NCT03170102|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-26|||May 1, 2016|Actual|2016-05-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|January 15, 2017|Actual|2017-01-15||Interventional|OTFW||Building Capacity of OT Students to Address Children's Mental Health During Fieldwork (OTFW)|Building Capacity of OT Students to Address Children's Mental Health During Fieldwork|Completed||N/A|18|Actual|Cleveland State University||1|||f||||f|f|f||||||No||2017-10-10 21:01:23.841416|2017-10-10 21:01:23.841416
NCT03170089|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-26|||June 30, 2017|Anticipated|2017-06-30|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Oral Health Awareness and Oral Hygiene in Insulin Dependent Diabetes Mellitus|Effect of Oral Health Educational Program on Awareness and Oral Health Status of Children With Insulin Dependent Diabetes Mellitus: A Randomized Clinical Trial|Not yet recruiting||N/A|44|Anticipated|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 21:01:23.898778|2017-10-10 21:01:23.898778
NCT03170076|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-26|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs|Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs: Prospective Controlled Clinical Trial|Not yet recruiting||N/A|1|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:01:23.962224|2017-10-10 21:01:23.962224
NCT03170063|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-26|2017-05-26|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|SAVE001||FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)|FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort) (SAVE001)|Not yet recruiting||N/A|50|Anticipated|Michael J. Fox Foundation for Parkinson's Research|||2||f||||f||||||Samples With DNA|"     Cerebrospinal Fluid, whole blood, serum, and plasma   "|No||2017-10-10 21:01:24.016118|2017-10-10 21:01:24.016118
NCT03170050|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-25|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds|A Multicenter, Active-controlled, Randomized, Evaluator and Subject Blinded, Split-face, Comparative, Non-inferiority and Confirmatory Clinical Study of the Efficacy and Safety Between YYD701-2 and Restylane Perlane Lidocaine for Temporary Correction of Moderate to Severe Nasolabial Folds|Recruiting||Phase 3|107|Anticipated|Yooyoung Pharmaceutical Co.,Ltd.||2|||f|||||f|f||||||||2017-10-10 21:01:24.117805|2017-10-10 21:01:24.117805
NCT03170037|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-12|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|May 11, 2017|Actual|2017-05-11|May 11, 2017|Actual|2017-05-11||Interventional|||Comparison of Two-hand Mask Ventilation Technique: Standard V-E Versus Reversal V-E Technique|Comparison of Two-hand Mask Ventilation Technique: Standard V-E Versus Reversal V-E Technique|Completed||N/A|92|Actual|Vanderbilt University Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 21:01:24.190913|2017-10-10 21:01:24.190913
NCT03170024|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-25|||October 31, 2015|Actual|2015-10-31|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|||Health Literacy in Adults|Assessment of Health Literacy in Adults With Congenital Heart Disease|Recruiting||N/A|150|Anticipated|Stanford University|||1||f||||t|f|f||||||No||2017-10-10 21:01:24.253105|2017-10-10 21:01:24.253105
NCT03170011|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-26|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Interventional|||Biodex Sit2Stand for Individuals With Cardiac Disease|The Effects of the Biodex Sit2Stand Trainer on Function for Individuals With Cardiac Disease|Not yet recruiting||N/A|20|Anticipated|St. Ambrose University||1|||f||||f|f|f||||||No||2017-10-10 21:01:24.310356|2017-10-10 21:01:24.310356
NCT03169998|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Effect of Goal-directed Fluid Therapy on Postoperative Complications|The Effect of Goal-directed Fluid Therapy on Postoperative Complications in Patients Undergoing Laparoscopic Hepatobiliary or Pancreatic Surgery|Recruiting||N/A|324|Anticipated|Seoul National University Bundang Hospital|||2||f||||t|f|f||||||||2017-10-10 21:01:24.376752|2017-10-10 21:01:24.376752
NCT03169972|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-08-25|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||ADYNOVATE Drug Use-Results Survey|ADYNOVATE Drug Use-Results Survey|Recruiting||N/A|130|Anticipated|Baxalta US Inc.|||2||f||||f||f||||||||2017-10-10 21:01:24.668596|2017-10-10 21:01:24.668596
NCT03169959|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-11|||May 29, 2017|Actual|2017-05-29|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|August 3, 2017|Actual|2017-08-03||Interventional|||A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.|A Randomised, 3-Period, 3-Treatment, Single-dose, Open-label, Single-center, Crossover Study to Assess the Fed-state Bioequivalence of a Triple Fixed-Combination Drug Product of 2.5 mg Saxagliptin / 5 mg Dapagliflozin / 1000 mg Metformin XR and 5 mg Saxagliptin / 10 mg Dapagliflozin / 1000 mg Metformin XR Relative to Individual Components (Onglyza® and XIGDUO® XR) Co-administered to Healthy Subjects|Completed||Phase 1|85|Actual|AstraZeneca||12|||f||||f|t|f||||||||2017-10-10 21:01:24.790648|2017-10-10 21:01:24.790648
NCT03169946|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||October 14, 2016|Actual|2016-10-14|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Chlorhexidine-Metronidazole Combination as an Intracanal Medicament on Periodontal Healing|Effects of Chlorhexidine-Metronidazole Combination as an Intracanal Medicament on Periodontal Healing in Concurrent Endodontic Periodontal Lesions With Communication: A Randomized Controlled Clinical Study|Active, not recruiting||N/A|36|Anticipated|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||Yes||2017-10-10 21:01:24.942781|2017-10-10 21:01:24.942781
NCT03169933|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-27|||January 2, 2004|Actual|2004-01-02|June 2017|2017-06-01|January 2, 2017|Actual|2017-01-02|January 10, 2009|Actual|2009-01-10||Interventional|||Combined, Intensified and Modulated Adjuvant Therapy in Prostate Carcinoma|Combined, Intensified and Modulated Adjuvant Therapy in Prostate Carcinoma: a Phase II Trial|Completed||N/A|123|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||t||||||||No||2017-10-10 21:01:25.090956|2017-10-10 21:01:25.090956
NCT03169920|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-26|||November 30, 2016|Actual|2016-11-30|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy of PRF With M-MIST in the Treatment of Intrabony Defects|Evaluation of the Efficacy of Autologous Platelet Rich Fibrin With Modified Minimally Invasive Surgical Technique (M-MIST) in the Treatment of Intrabony Defects: A Randomized Clinical Trial|Recruiting||N/A|36|Anticipated|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||Yes||2017-10-10 21:01:25.196218|2017-10-10 21:01:25.196218
NCT03169907|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-25|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Cardiac Functions as a New Method for Evaluation of Fetal Anemia Pre and Post Intrauterine Fetal Blood Transfusion|Cardiac Functions as a New Method for Evaluation of Fetal Anemia Pre and Post Intrauterine Fetal Blood Transfusion|Recruiting||N/A|150|Anticipated|National Research Center, Egypt||1|||f||||f|f|f||||||Undecided||2017-10-10 21:01:25.300521|2017-10-10 21:01:25.300521
NCT03169894|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-25|||July 14, 2017|Actual|2017-07-14|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease|Phase Ib Open-Label, Signal-Finding Study to Evaluate the Safety, Tolerability, and Short-Term Efficacy of the Anti-Light Monoclonal Antibody MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease Who Previously Failed Treatment With an Anti-TNFα Agent|Recruiting||Phase 1|8|Anticipated|Aevi Genomic Medicine||1|||f||||t|t|f||||||||2017-10-10 21:01:25.421665|2017-10-10 21:01:25.421665
NCT03169881|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2023|Anticipated|2023-09-01|September 2022|Anticipated|2022-09-01||Interventional|Darbe||Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants|Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants|Not yet recruiting||Phase 3|650|Anticipated|NICHD Neonatal Research Network||2|||f||||t|t|f||||||Yes|NIH has had a long-standing policy to share and make available to the public the results and accomplishments of the activities that it funds. The NRN plans to share de-identified data after final publication in an NIH supported data repository such as the NICHD Data and Specimen Hub (https://dash.nichd.nih.gov) or NHLBI BIOLINCC (https://biolincc.nhlbi.nih.gov/home/).|2017-10-10 21:01:25.528892|2017-10-10 21:01:25.528892
NCT03169868|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Enhanced Medication Reconciliation For Serious Mental Illness|A Pilot Prospective, Randomized Controlled Trial Assessing Enhanced Medication Reconciliation With a Clinical Decision Support Tool in Patients With Serious Mental Illness.|Not yet recruiting||N/A|150|Anticipated|Sano Informed Prescribing||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:25.739043|2017-10-10 21:01:25.739043
NCT03169855|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-12|||May 2, 2017|Actual|2017-05-02|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|ContrastVal||Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability|Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability (ContrastVal) - Influence of Dynamic Glare on (Aged) Motorist (With/Without Media Opacities)|Recruiting||N/A|40|Anticipated|Aalen University|||2||f||||t|f|f||||||||2017-10-10 21:01:25.831001|2017-10-10 21:01:25.831001
NCT03169816|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||May 25, 2017|Actual|2017-05-25|May 2017|2017-05-01|December 30, 2018|Anticipated|2018-12-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder|Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder|Recruiting||Phase 2/Phase 3|60|Anticipated|New York State Psychiatric Institute||2|||f||||t|t|f||||||No||2017-10-10 21:01:26.132934|2017-10-10 21:01:26.132934
NCT03169803|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|June 19, 2018|Anticipated|2018-06-19|May 19, 2018|Anticipated|2018-05-19||Interventional|||Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF)|Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF) - System Design Study|Recruiting||N/A|40|Anticipated|NeuroTronik Inc.||1|||f||||t|f|f||||||Undecided||2017-10-10 21:01:26.230945|2017-10-10 21:01:26.230945
NCT03169790|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-19|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL|NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL|Not yet recruiting||Phase 1/Phase 2|67|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||No||2017-10-10 21:01:26.339341|2017-10-10 21:01:26.339341
NCT03169777|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-19|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC|NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC|Not yet recruiting||Phase 1/Phase 2|79|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||No||2017-10-10 21:01:26.458288|2017-10-10 21:01:26.458288
NCT03169764|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-19|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy|NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and Anti-programmed Cell Death Protein 1 (PD-1)/Programmed Death-ligand 1 (PD-L1) Therapy|Not yet recruiting||Phase 1/Phase 2|113|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||No||2017-10-10 21:01:26.602892|2017-10-10 21:01:26.602892
NCT03169738|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-19|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors|NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With Programmed Cell Death Protein 1 (PD-1)/Programmed Death-ligand 1 (PD-L1) Inhibitors|Not yet recruiting||Phase 1/Phase 2|85|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||No||2017-10-10 21:01:26.800767|2017-10-10 21:01:26.800767
NCT03169725|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-11|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|May 31, 2019|Anticipated|2019-05-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants|A Prospective, Multi-national, Multi-center, Double-blind, Randomized, Active Controlled, Parallel-group, Seamless Phase II/III Clinical Study to Evaluate the Safety and Immunogenicity of 'LBVC (Sabin Poliomyelitis Vaccine (Inactivated))' Compared With 'Imovax® Polio (Poliomyelitis Vaccine (Inactivated))' in Healthy Infants|Recruiting||Phase 2/Phase 3|1329|Anticipated|LG Chem||4|||f||||t|f|f||||||||2017-10-10 21:01:26.914721|2017-10-10 21:01:26.914721
NCT03169712|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-25|||December 20, 2012|Actual|2012-12-20|May 2017|2017-05-01|August 1, 2016|Actual|2016-08-01|May 1, 2016|Actual|2016-05-01||Interventional|||IRT and CBT in Sexual Assault Victims With PTSD|Efficacy of Sequential Imagery Rehearsal Therapy and Cognitive-Behavioural Therapy in Sexual Assault Victims With Posttraumatic Stress Disorder: a Randomized Control Trial|Completed||N/A|42|Actual|Laval University||2|||f||||f|f|f||||||No||2017-10-10 21:01:26.989105|2017-10-10 21:01:26.989105
NCT03169699|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-30|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data|Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data|Recruiting||N/A|600|Anticipated|KK Women's and Children's Hospital|||2||f||||f|f|f||||||Undecided||2017-10-10 21:01:27.062111|2017-10-10 21:01:27.062111
NCT03169686|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||'WeChat WeQuit' Smoking Cessation Program|The Efficacy of WeChat Based and Interprofessional Team Support Interventions ('WeChat WeQuit' Program) for Smoking Cessation in China: a Randomized Trial|Not yet recruiting||N/A|2000|Anticipated|Central South University||2|||f||||t|f|f||||||Yes||2017-10-10 21:01:27.132117|2017-10-10 21:01:27.132117
NCT03169673|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||September 21, 2007|Actual|2007-09-21|May 2017|2017-05-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Observational|||Healthy Lung Study- Development of 3 Tesla MRI Hardware and Software for Helium-3 Gas Imaging of the Lung: Healthy Volunteer Development Study|Healthy Lung Study- Development of 3 Tesla MRI Hardware and Software for Helium-3 Gas Imaging of the Lung: Healthy Volunteer Development Study|Recruiting||N/A|100|Anticipated|Western University, Canada|||1||f||||f|||||t|||No||2017-10-10 21:01:27.184526|2017-10-10 21:01:27.184526
NCT03169660|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-05-25|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intravitreal Vascular Endothelial Growth Factor Trap-eye for Submacular Hemorrhage|Efficacy of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Submacular Hemorrhage Secondary to Exudative Age-Related Macular Degeneration|Recruiting||Phase 4|30|Anticipated|Kim's Eye Hospital||1|||f||||f||||||||||2017-10-10 21:01:27.261297|2017-10-10 21:01:27.261297
NCT03169647|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-16|||August 17, 2017|Anticipated|2017-08-17|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Evaluating the Effectiveness of Treatment for Metacognition in Moderate and Severe Traumatic Brain Injury|Evaluating the Effectiveness of Treatment for Metacognition in Moderate and Severe Traumatic Brain Injury|Recruiting||N/A|40|Anticipated|Kessler Foundation||2|||f||||f|f|f||||||||2017-10-10 21:01:27.342285|2017-10-10 21:01:27.342285
NCT03169634|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-04|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||A Study Using Metaphyseal Cones Versus a Cemented Stem Construct in Revision TKR|A Prospective, Randomised Internal Pilot Study Investigating the Use of Metaphyseal Cones Versus a Cemented Stem Construct in Revision Total Knee Replacement in Patients With Anderson Orthopaedic Research Institute Grade 2 Defects- a Comparison of Clinical, Functional and Radiological Outcome|Recruiting||N/A|51|Anticipated|Royal Devon and Exeter NHS Foundation Trust||3|||f||||t|f|f||||||||2017-10-10 21:01:27.413098|2017-10-10 21:01:27.413098
NCT03169621|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-16|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|ChEndometritis||Diagnosis of Chronic Endometritis in Endometrial Fluid Using Molecular Techniques to Improve the Outcomes of Assisted Reproductive Treatments|Diagnosis of Chronic Endometritis in Endometrial Fluid Using Molecular Techniques to Improve the Outcomes of Assisted Reproductive Treatments|Recruiting||N/A|39|Anticipated|Igenomix|||1||f||||f|f|f||||Samples With DNA|"     DNA will be analyzed in the endometrial fluid. These samples will be completely exhausted     during the analysis.   "|No||2017-10-10 21:01:27.54839|2017-10-10 21:01:27.54839
NCT03169608|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-26|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|July 14, 2019|Anticipated|2019-07-14|July 14, 2019|Anticipated|2019-07-14||Observational|||Autonomic State, Cardiovascular Control and Outcomes in Coronary Surgery|Predicting Post-surgery Complications in Patients Undergoing Coronary Artery Bypass Graft Through the Assessment of Perioperative Cardiovascular Control Indices|Recruiting||N/A|200|Anticipated|IRCCS Policlinico S. Donato|||1||f||||f|f|f||||||No||2017-10-10 21:01:27.632684|2017-10-10 21:01:27.632684
NCT03169595|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-26|||October 7, 2015|Actual|2015-10-07|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Observational|EE-META||Epithelioid Hemangioma of Bone And Soft Tissue|Epithelioid Hemangioma of Bone And Soft Tissue: a Benign Tumor With Metastatic Potential|Completed||N/A|70|Actual|Istituto Ortopedico Rizzoli|||1||f|||||f|f||||||Yes|publish a manuscript in international journal|2017-10-10 21:01:27.723942|2017-10-10 21:01:27.723942
NCT03169582|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-26|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction|Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction: Non- Inferiority, Randomized, Crossover, Open Clinical Trial|Recruiting||Phase 4|78|Anticipated|Hospital Nacional de Parapléjicos de Toledo||2|||f||||f|f|f|||f|||No||2017-10-10 21:01:27.790506|2017-10-10 21:01:27.790506
NCT03169569|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-25|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Hemostatic Powder in Preventing Bleeding After Gastric Endoscopic Submucosal Dissection in High-risk Patients: A Prospective Randomized Control Study|Efficacy of Hemostatic Powder in Preventing Bleeding After Gastric Endoscopic Submucosal Dissection in High-risk Patients: A Prospective Randomized Control Study|Not yet recruiting||N/A|138|Anticipated|Yonsei University||2|||f||||t|f|f||||||Yes||2017-10-10 21:01:27.873766|2017-10-10 21:01:27.873766
NCT03169556|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-25|||December 19, 2016|Actual|2016-12-19|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|July 31, 2017|Anticipated|2017-07-31||Interventional|||Comparison of Conventional Lightwand Intubation Versus Video-laryngoscope Guided Lightwand Intubation in Simulated Cervical Spine-immobilized Patients|Comparison of Conventional Lightwand Intubation Versus Video-laryngoscope Guided Lightwand Intubation in Simulated Cervical Spine-immobilized Patients|Recruiting||N/A|318|Anticipated|Yonsei University||2|||f||||t|f|f||||||No||2017-10-10 21:01:27.952582|2017-10-10 21:01:27.952582
NCT03169543|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-30|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|January 31, 2020|Anticipated|2020-01-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation|Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation|Recruiting||N/A|60|Anticipated|University of Pennsylvania||1|||f||||f|f|f||||||No||2017-10-10 21:01:28.051917|2017-10-10 21:01:28.051917
NCT03169530|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-15|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|July 31, 2026|Anticipated|2026-07-31|February 28, 2026|Anticipated|2026-02-28||Interventional|MACH15||Moderate Alcohol and Cardiovascular Health Trial|Moderate Alcohol and Cardiovascular Health Trial|Not yet recruiting||N/A|7800|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:01:28.120883|2017-10-10 21:01:28.120883
NCT03169517|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-04|||May 27, 2017|Actual|2017-05-27|September 2017|2017-09-01|September 4, 2017|Actual|2017-09-04|September 4, 2017|Actual|2017-09-04||Observational|||Blood Flow Index as an Indicator of Successful Peripheral Nerve Block|Blood Flow Index as an Indicator of Successful Peripheral Nerve Block : A Prospective Observational Study Using Laser Speckle Contrast Imaging.|Completed||N/A|110|Actual|Huazhong University of Science and Technology|||1||f||||f|f|f||||||||2017-10-10 21:01:28.201108|2017-10-10 21:01:28.201108
NCT03169504|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-25|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease|Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease: a Multi-center, Randomized, Controlled Trial|Not yet recruiting||Phase 3|150|Anticipated|Henan University of Traditional Chinese Medicine||3|||f||||t|f|f||||||||2017-10-10 21:01:29.972667|2017-10-10 21:01:29.972667
NCT03169491|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||July 4, 2016|Actual|2016-07-04|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|June 30, 2018|Anticipated|2018-06-30||Interventional|||Effect of CPAP and Adenotonsillectomy in Upper Airway Volume of Children With OSAS|Caliber of Upper Airway Measured by Acoustic Pharyngometry in Children With Obstructive Sleep Apnea Before and After the Use of Presurgical CPAP and After Adentonsillectomy, and Their Relation With Surgical Complications and Residual Apneas|Recruiting||N/A|100|Anticipated|Instituto Nacional de Enfermedades Respiratorias||3|||f||||f|f|t|f|f|t|||No|Data from the study could be provided if solicited at the main author's e-mail adress.|2017-10-10 21:01:30.090109|2017-10-10 21:01:30.090109
NCT03169478|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-06|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|May 30, 2019|Anticipated|2019-05-30||Interventional|||Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Formation After Hysteroscopic Myomectomy|The Efficacy of Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Formation After Hysteroscopicremovalof Multiple Fibroids|Recruiting||N/A|112|Anticipated|Fu Xing Hospital, Capital Medical University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:30.198545|2017-10-10 21:01:30.198545
NCT03169465|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-29|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Open Versus Endoscopic Surgical Management Of Posterior Calcaneal Deformity.|Open Versus Endoscopic Surgical Management Of Posterior Calcaneal (HAGLUND) Deformity. A Pilot Non Randomized Trial|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:01:30.304114|2017-10-10 21:01:30.304114
NCT03169452|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-08|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||Clinical Application and Outcome of Non-invasive Ventilation in Different Chest Diseases|Clinical Application and Outcome of Non-invasive Ventilation in Different Chest Diseases|Recruiting||N/A|150|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 21:01:30.365774|2017-10-10 21:01:30.365774
NCT03169439|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|August 1, 2019|Anticipated|2019-08-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Irreversible Electroporation for Treatment of Solid Abdominal Tumors|Irreversible Electroporation for Treatment of Solid Abdominal Tumors|Not yet recruiting||N/A|25|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 21:01:30.435708|2017-10-10 21:01:30.435708
NCT03169426|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-26|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|May 17, 2018|Anticipated|2018-05-17|March 17, 2018|Anticipated|2018-03-17||Interventional|||Effect of Beta-blocker on Cardioprotective Effect of Remote Ischemic Conditioning|Effect of Beta-blocker on Cardioprotective Effect of Remote Ischemic Conditioning|Recruiting||Phase 4|11|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:01:30.49927|2017-10-10 21:01:30.49927
NCT03169413|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-28|||January 2018|Anticipated|2018-01-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|January 2020|Anticipated|2020-01-01||Observational|||Gene Study for Infantile Onset Diabetes|Human Leucocytic Antigen Typing and Mutation of Adenosine Triphosphate Sensitive Potassium Channel Gene in Diabetic Patients Diagnosed Under the Age of One Year.|Not yet recruiting||N/A|100|Anticipated|Assiut University|||3||f||||f|f|f||||||No||2017-10-10 21:01:30.575822|2017-10-10 21:01:30.575822
NCT03169400|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31|6 Months|Observational [Patient Registry]|||Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)|Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification|Not yet recruiting||N/A|20|Anticipated|University of Milan|||2||f|||||f|t|f|f|f|||No||2017-10-10 21:01:30.663827|2017-10-10 21:01:30.663827
NCT03169387|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-29|||June 30, 2017|Anticipated|2017-06-30|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Body Composition of Individuals With Cardiovascular Diseases|Body Composition of Individuals With Cardiovascular Diseases Submitted to Conventional Cardiac or Virtual Reality Rehabilitation: A Randomized Clinical Trial|Not yet recruiting||N/A|24|Anticipated|Universidade do Oeste Paulista||2|||f||||t|f|f||||||No|No plans for sharing data with other reserarchers|2017-10-10 21:01:30.762405|2017-10-10 21:01:30.762405
NCT03169374|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Virtual Reality for Anxiety Management in Mechanically Vented Patients|Virtual Reality for Anxiety Management in Mechanically Vented Patients|Not yet recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f|f|f||||||||2017-10-10 21:01:30.926211|2017-10-10 21:01:30.926211
NCT03169361|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||May 24, 2017|Actual|2017-05-24|May 2017|2017-05-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Observational|||"NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) Relapsed/Refractory Multiple Myeloma"|"NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) Relapsed/Refractory Multiple Myeloma"|Recruiting||N/A|480|Anticipated|Takeda|||1||f||||f|f|f||||||No||2017-10-10 21:01:31.014311|2017-10-10 21:01:31.014311
NCT03169348|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-07-11|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia|The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia|Not yet recruiting||N/A|50|Anticipated|Assiut University||1|||f||||f|f|f||||||||2017-10-10 21:01:31.104669|2017-10-10 21:01:31.104669
NCT03169335|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-22|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 10, 2018|Anticipated|2018-12-10|June 12, 2018|Anticipated|2018-06-12||Interventional|||Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer|A Multi-center, Randomized, Double-blind, Parallel, Two-group Phase III Clinical Study of the Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer|Recruiting||Phase 3|512|Anticipated|Qilu Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:31.196148|2017-10-10 21:01:31.196148
NCT03169322|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||October 14, 2016|Actual|2016-10-14|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Influence of Mouth Breathing on Periodontal Healing|Influence of Mouth Breathing on Outcome of Scaling and Root Planing in Chronic Periodontitis|Recruiting||N/A|60|Anticipated|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||Yes||2017-10-10 21:01:31.32377|2017-10-10 21:01:31.32377
NCT03169309|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-09|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|BEST||The BEST Study: The Efficacy of Brain Entrainment Sleep Technology in Military Healthcare Beneficiaries|The BEST Study: The Efficacy of Brain Entrainment Sleep Technology in Military Healthcare Beneficiaries|Active, not recruiting||N/A|162|Anticipated|Landstuhl Regional Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:01:31.41652|2017-10-10 21:01:31.41652
NCT03169296|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30|5 Years|Observational [Patient Registry]|||Clinical and Genomic Registry of MDS in Asia|Clinical and Genomic Registry of Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukaemia (AML) in Asia|Recruiting||N/A|2600|Anticipated|The University of Hong Kong|||1||f||||t|f|f||||||No||2017-10-10 21:01:31.524165|2017-10-10 21:01:31.524165
NCT03169283|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-05-25|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Investigation of How Morning Nutrition Influences Cognitive Performance|Investigation of How Morning Nutrition Influences Cognitive Performance|Completed||N/A|24|Actual|PepsiCo Global R&D||2|||f||||f||||||||||2017-10-10 21:01:31.614291|2017-10-10 21:01:31.614291
NCT03169270|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-25|||November 2005|Actual|2005-11-01|May 2017|2017-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Muscular Training-induced Changes in COPD|Muscular Adaptations After Endurance Exercise Training in Patients With COPD|Completed||N/A|26|Actual|Hospital Clinic of Barcelona||2|||f||||f|f|f||||||No||2017-10-10 21:01:31.704385|2017-10-10 21:01:31.704385
NCT03169257|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-26|||January 15, 2015|Actual|2015-01-15|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|February 8, 2017|Actual|2017-02-08||Interventional|||Paediatric Obesity and Cardiovascular Dysfunction|Paediatric Obesity and Cardiovascular Dysfunction: Searching for Early Markers of Damage|Active, not recruiting||N/A|100|Actual|Azienda Ospedaliero Universitaria Maggiore della Carita||2|||f|||||f|f||||||Undecided||2017-10-10 21:01:31.790834|2017-10-10 21:01:31.790834
NCT03169244|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-13|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Buproprion for Binge Drinking|Efficacy and Safety of the Melanocortin Activator Bupropion in Treating Binge Drinking|Recruiting||Phase 2|60|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|t|f|||f|||||2017-10-10 21:01:31.901176|2017-10-10 21:01:31.901176
NCT03169231|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-14|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|September 28, 2019|Anticipated|2019-09-28|June 2, 2019|Anticipated|2019-06-02||Interventional|||Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty|A Phase 2b, Randomized, Blinded and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Longeveron Allogenic Human Mesenchymal Stem Cells Infusion in Patients With Aging Frailty|Recruiting||Phase 2|120|Anticipated|Longeveron LLC||4|||f||||t|t|f||||||||2017-10-10 21:01:32.000344|2017-10-10 21:01:32.000344
NCT03169218|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-26|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|MTSTC||Effects of Mirror Therapy on Pain and Function on Bilateral Carpal Tunnel Syndrom|Effects of Mirror Therapy on Pain and Function on Bilateral Carpal Tunnel Syndrom (MTSTC)|Completed||N/A|18|Actual|Hospital de Manises||2|||f||||f|f|f||||||No||2017-10-10 21:01:32.09723|2017-10-10 21:01:32.09723
NCT03169205|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01|2 Years|Observational [Patient Registry]|||Diabetes Mellitus With Pregnancy in Benisuef Localities|Diabetes Mellitus With Pregnancy in Benisuef Localities|Enrolling by invitation||N/A|200|Anticipated|Beni-Suef University|||3||f||||t|f|f|||f|||||2017-10-10 21:01:32.181462|2017-10-10 21:01:32.181462
NCT03169192|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Diagnosis of Osteogenesis Imperfecta in Children|Molecular Genetic Study of Suspected Cases of Osteogenesis Imperfecta Attending Assiut University Children Hospital|Not yet recruiting||N/A|40|Anticipated|Assiut University|||1||f||||f|f|f||||Samples With DNA|"     we collect blood samples of patients to detect COLLAGEN I AI gene and COLLAGEN 1 A2 gene   "|No||2017-10-10 21:01:32.249325|2017-10-10 21:01:32.249325
NCT03169179|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-08-08|||April 19, 2017|Actual|2017-04-19|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Physical Activity Wearables in the Police Force: The PAW-Force Trial|Physical Activity Wearables in the Police Force: The PAW-Force Trial|Active, not recruiting||N/A|182|Actual|University of Exeter||1|||f||||f|f|f||||||||2017-10-10 21:01:32.322402|2017-10-10 21:01:32.322402
NCT03169166|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|October 1, 2019|Anticipated|2019-10-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies|The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies: A Prospective Randomized Controlled Trial|Recruiting||Phase 4|282|Anticipated|American University of Beirut Medical Center||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:01:32.409837|2017-10-10 21:01:32.409837
NCT03169153|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-27|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|March 19, 2018|Anticipated|2018-03-19|March 19, 2018|Anticipated|2018-03-19||Interventional|||Clinical Comparison of Silicone Hydrogel Monthly Lenses|One-month Clinical Comparison of Silicone Hydrogel Monthly Lenses in High Lipid Depositors|Recruiting||N/A|140|Anticipated|Alcon Research||2|||f|||||f|f|||f|||||2017-10-10 21:01:32.555896|2017-10-10 21:01:32.555896
NCT03169140|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-25|||February 14, 2017|Actual|2017-02-14|May 2017|2017-05-01|February 14, 2018|Anticipated|2018-02-14|February 14, 2018|Anticipated|2018-02-14||Interventional|||Effect of at Home Pain Management Products on Acute Low Back Pain, Disability, and Range of Motion|Effect of Biofreeze®, TheraBand® Kinesiology Tape, or the Combination of Products on Acute Low Back Pain, Disability, and Range of Motion|Recruiting||N/A|120|Anticipated|Sport and Spine Rehab Clinical Research Foundation||4|||f||||f|f|t|f|f||||No||2017-10-10 21:01:32.645931|2017-10-10 21:01:32.645931
NCT03169127|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-07-03|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|April 1, 2019|Anticipated|2019-04-01|December 30, 2017|Anticipated|2017-12-30||Interventional|||Clinical Pharmacogenetic of Ibuprofen After Lower Third Molar Surgeries|Clinical Pharmacogenetic of Ibuprofen Enantiomers After Lower Third Molar Surgeries|Recruiting||Phase 4|200|Anticipated|University of Sao Paulo||1|||f||||t|f|f|||f|||||2017-10-10 21:01:32.787389|2017-10-10 21:01:32.787389
NCT03169114|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-25|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|RIPASA-TWO||Raja Isteri Pengiran Anak Saleha Appendicitis Treatment Without Operation|Raja Isteri Pengiran Anak Saleha Appendicitis Treatment Without Operation - Antibiotic Non-operative Management Strategy Versus Surgery Management Strategy, a Non-Inferiority Randomised Controlled Trial.|Not yet recruiting||N/A|228|Anticipated|Raja Isteri Pengiran Anak Saleha Hospital||2|||f||||t|f|f||||||Undecided|Written request to Ministry of Health, Brunei Darussalam via Principal Investigator for approval to share IPD.|2017-10-10 21:01:33.031586|2017-10-10 21:01:33.031586
NCT03169101|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-24|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|HCS||Cognition and Smoking Relapse (HCS)|Understanding the Role of Cognitive Dysfunction in the Treatment of Nicotine Dependence Among HIV-infected Smokers|Recruiting||N/A|300|Anticipated|University of Pennsylvania|||2||f||||f|t|f|||f|Samples With DNA|"     Two samples (one 10 mL and one 8 mL) of blood will be drawn at the Intake visit to evaluate     the nicotine metabolite ratio and neuroinflammatory markers. All specimens are to be     collected solely for research purposes.   "|No||2017-10-10 21:01:33.186726|2017-10-10 21:01:33.186726
NCT03169088|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-24|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|C2H2||"Cook to Health Study 2"|"Cook to Health 2 : Monitoring Wellbeing and Health in the Community"|Recruiting||N/A|100|Anticipated|University Hospital, Grenoble||1|||f||||f|f|f||||||No||2017-10-10 21:01:33.316722|2017-10-10 21:01:33.316722
NCT03169075|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-29|||June 19, 2017|Anticipated|2017-06-19|May 2017|2017-05-01|February 15, 2027|Anticipated|2027-02-15|March 15, 2026|Anticipated|2026-03-15||Interventional|QUALIOR||QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program|Study Evaluating the Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program, for Metastatic Cancer Patients Receiving Oral Targeted Therapy: The UNICANCER SdS 01 QUALIOR Study|Not yet recruiting||N/A|312|Anticipated|UNICANCER||2|||f||||f|f|f||||||No||2017-10-10 21:01:33.455405|2017-10-10 21:01:33.455405
NCT03169062|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-13|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of Coronary Artery Calcification Using Gated Stationary Chest Tomosynthesis|Evaluation of Coronary Artery Calcification Using Gated Stationary Chest Tomosynthesis|Recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:01:33.653668|2017-10-10 21:01:33.653668
NCT03169049|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Nerve Conduction Block Using Transcutaneous Electrical Currents|Peripheral Nerve Conduction Block Using a High Frequency Alternating Stimulation: A Pilot Study|Not yet recruiting||N/A|10|Anticipated|University of Castilla-La Mancha||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:33.7714|2017-10-10 21:01:33.7714
NCT03169036|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||July 31, 2015|Actual|2015-07-31|July 2015|2015-07-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01|10 Years|Observational [Patient Registry]|MelEx||Melanomas Excised in Primary Care vs Secondary Care Excision|Melanomas Excised in Primary Care vs Secondary Care Excision|Completed||N/A|9367|Actual|University of Aberdeen|||1||f||||f||||||||||2017-10-10 21:01:33.855866|2017-10-10 21:01:33.855866
NCT03169023|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||February 21, 2017|Actual|2017-02-21|May 2017|2017-05-01|February 21, 2018|Anticipated|2018-02-21|February 21, 2018|Anticipated|2018-02-21||Interventional|||Scale Down for Endometrial Cancer|Scale Down: A Randomized, Controlled Weight Management Intervention for Women With Endometrial Cancer|Recruiting||N/A|120|Anticipated|Washington University School of Medicine||2|||f||||f|f|f||||||No||2017-10-10 21:01:33.9208|2017-10-10 21:01:33.9208
NCT03169010|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-07|||May 6, 2017|Actual|2017-05-06|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31|5 Years|Observational [Patient Registry]|||Registration Study for Rare Type of Pulmonary Hypertension|Registration Study for Rare Type of Pulmonary Hypertension|Recruiting||N/A|2000|Anticipated|China National Center for Cardiovascular Diseases|||7||f||||t|f|f||||Samples With DNA|"     All subjects will have a sample of blood taken for Sanger or whole genome sequencing.   "|||2017-10-10 21:01:34.045599|2017-10-10 21:01:34.045599
NCT03168997|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-25|||July 15, 2017|Anticipated|2017-07-15|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Memantine Treatment in Alzheimer's Disease Patients|Memantine Treatment in Alzheimer's Disease Patients Stratified With Behavioral and Psychological Symptoms of Dementia (BPSD) Symptoms and Cognitive Severity: A Multi-center, Open-label, Parallel-group and Prospective Clinical Study|Not yet recruiting||Phase 4|222|Anticipated|Xuanwu Hospital, Beijing||3|||f|||||f|f|||f|||Undecided||2017-10-10 21:01:34.217546|2017-10-10 21:01:34.217546
NCT03168984|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-17|||May 5, 2017|Actual|2017-05-05|August 2017|2017-08-01|August 14, 2017|Actual|2017-08-14|August 14, 2017|Actual|2017-08-14||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects|A Single-Centre, Investigator/Subject Blind, Placebo-Controlled, Single and Multiple Oral Dose Investigation of Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|48|Actual|UCB Pharma||2|||f||||f|f|f||||||||2017-10-10 21:01:34.331079|2017-10-10 21:01:34.331079
NCT03168971|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-25|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their Caregivers|Managing Anxiety From Cancer (MAC): A Pilot Randomized Controlled Trial of a Psychological Intervention for Anxiety in Older Adults With Cancer and Their Caregivers|Recruiting||N/A|80|Anticipated|Weill Medical College of Cornell University||2|||f||||f|f|f||||||No||2017-10-10 21:01:34.447991|2017-10-10 21:01:34.447991
NCT03168958|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-26|||May 25, 2017|Actual|2017-05-25|May 2017|2017-05-01|July 25, 2019|Anticipated|2019-07-25|May 25, 2019|Anticipated|2019-05-25||Interventional|||Methadone and Quality of Postoperative Recovery|Methadone and Quality of Postoperative Recovery|Recruiting||Phase 4|130|Anticipated|NorthShore University HealthSystem Research Institute||2|||f||||f|t|f|||f|||No|This data will not be shared with other researchers until publication|2017-10-10 21:01:34.572725|2017-10-10 21:01:34.572725
NCT03168945|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-05-24|||November 2016||2016-11-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|XACT-2||Xpert Active Case-finding Trial 2: Community-based Active Case-finding for Tuberculosis in South Africa|Quantifying Infectiousness of Undiagnosed Tuberculosis Cases and the Impact of Enhanced Community-based Active Case Finding Strategy Using Novel Diagnostic Tools: A Randomized Controlled Trial|Recruiting||N/A|600|Anticipated|University of Cape Town||2|||f||||f||||||||No||2017-10-10 21:01:34.6896|2017-10-10 21:01:34.6896
NCT03168932|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-06-05|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01|2 Years|Observational [Patient Registry]|||Quantification of Fetal Brains' Sulci Along Gestation|Detecting and Quantifying Sulci and White Matter in Fetus' Brain Along the Third Stage of Gestation|Active, not recruiting||N/A|150|Anticipated|Rambam Health Care Campus|||1||f||||t|f|f||||||Undecided||2017-10-10 21:01:34.824775|2017-10-10 21:01:34.824775
NCT03168919|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-25|||May 4, 2016|Actual|2016-05-04|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma|Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma|Recruiting||N/A|20|Anticipated|University of Alabama at Birmingham||1|||f|||||f|t|f|f||||No||2017-10-10 21:01:34.927947|2017-10-10 21:01:34.927947
NCT03168906|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-14|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|RAIN||Renal AL Amyloid Involvement and NEOD001|The RAIN Study, a Multicenter Randomized Double-blind Phase 2b Study of NEOD001 in Previously Treated Subjects With Systemic Light-chain (AL) Amyloidosis and Persistent Renal Involvement|Recruiting||Phase 2|100|Anticipated|Tufts Medical Center||2|||f||||t|t|f||||||||2017-10-10 21:01:35.169753|2017-10-10 21:01:35.169753
NCT03168893|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|May 17, 2020|Anticipated|2020-05-17|December 17, 2017|Anticipated|2017-12-17||Interventional|||Deep Brain Stimulation for Patients With Chronic, Severe and Resistant Anorexia Nervosa|Deep Brain Stimulation on the Subgenual Cingulate and Accumbens Nucleus for Patients With Chronic, Severe and Resistant Anorexia Nervosa|Recruiting||N/A|8|Anticipated|Parc de Salut Mar||2|||f||||t|f|f||||||No||2017-10-10 21:01:35.309755|2017-10-10 21:01:35.309755
NCT03168880|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-25|||April 2010||2010-04-01|May 2017|2017-05-01|November 30, 2024|Anticipated|2024-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|TNBC||A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer|A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer|Recruiting||Phase 3|720|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:01:35.848413|2017-10-10 21:01:35.848413
NCT03168867|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-27|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|August 2021|Anticipated|2021-08-01||Interventional|3Ms||Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)|Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)|Recruiting||N/A|212|Anticipated|Wayne State University||2|||f||||t|f|f||||||||2017-10-10 21:01:35.94695|2017-10-10 21:01:35.94695
NCT03168854|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-03|||July 26, 2017|Actual|2017-07-26|July 19, 2017|2017-07-19|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites|A Phase 1, Two Arm, Open Label Trial to Evaluate the Safety, Immunogenicity and Preliminary Efficacy of Genetically-attenuated p52-/p36/sap1- Plasmodium Falciparum Parasites (GAP3KO) Administered Via the Bite of Infected Anopheles Stephensi Mosquitoes to Malaria-Naïve Adults Living in the United States|Recruiting||Phase 1|28|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f|||||t|f|||f|||||2017-10-10 21:01:36.05942|2017-10-10 21:01:36.05942
NCT03168841|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-24|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|November 13, 2018|Anticipated|2018-11-13|November 13, 2018|Anticipated|2018-11-13||Interventional|||Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients|Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients|Recruiting||Phase 3|48|Anticipated|Western University of Health Sciences||1|||f||||f|t|f|||t|||No||2017-10-10 21:01:36.148367|2017-10-10 21:01:36.148367
NCT03168828|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-20|||April 24, 2017|Actual|2017-04-24|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury|A Prospective, Multi-center, Open-label Study of Trospium Delivered Intravesically by TAR-302-5018 to Spinal Cord Injury Subjects With Neurogenic Detrusor Overactivity (NDO)|Recruiting||Phase 1|6|Anticipated|Taris Biomedical LLC||1|||f|||||t|f||||||||2017-10-10 21:01:36.232472|2017-10-10 21:01:36.232472
NCT03168815|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy|Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy: A Randomized Controlled Trial|Not yet recruiting||N/A|98|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f|f|f||||||No||2017-10-10 21:01:36.344861|2017-10-10 21:01:36.344861
NCT03168802|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-08|||April 21, 2017|Actual|2017-04-21|August 2017|2017-08-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||MRgFUS and RFA for Treatment of Facet-joint Osteoarthritis Low Back Pain|Comparative Study of Magnetic Resonance-guided Focused Ultrasound and Radiofrequency Ablation for Treatment of Facet-joint Osteoarthritis Low Back Pain|Active, not recruiting||N/A|100|Anticipated|Taipei Medical University Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:01:36.460553|2017-10-10 21:01:36.460553
NCT03168789|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-05-25|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Tension Tamer Randomized Control Trial|Smartphone Delivered Meditation for BP Control Among Prehypertensives|Enrolling by invitation||N/A|180|Anticipated|Medical University of South Carolina||2|||f||||f|f|f||||||No||2017-10-10 21:01:36.67176|2017-10-10 21:01:36.67176
NCT03168763|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-25|2017-09-25|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Effect of Physician Attire on Patients' Preference of Physician|Advanced Cancer Patients' Perception of Physician Compassion and Professionalism - A Randomized, Double Blind, Cross Over Trial|Recruiting||N/A|108|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|f|f||||||||2017-10-10 21:01:36.886742|2017-10-10 21:01:36.886742
NCT03168750|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-27|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 1, 2028|Anticipated|2028-12-01|August 1, 2028|Anticipated|2028-08-01||Interventional|||Analysis of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component|Prospective, Multicenter Study to Assess Performance of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component in Total Hip Arthroplasty|Not yet recruiting||N/A|300|Anticipated|Medacta USA||1|||f|||||f|f|||f|||||2017-10-10 21:01:37.035585|2017-10-10 21:01:37.035585
NCT03168737|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-26|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Test-Retest of (18)F-Fluoroazomycin Arabinoside ([18F]FAZA) PET-CT of Solid Tumors|Test-Retest of (18)F-Fluoroazomycin Arabinoside ([18F]FAZA) PET-CT of Solid Tumors|Recruiting||Early Phase 1|15|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:01:37.165474|2017-10-10 21:01:37.165474
NCT03168724|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-13|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Goal Management Training, Executive Functions and HIV|Efficacy Potential of Goal Management Training to Improve Cognitive Function in Older People Living With HIV|Enrolling by invitation||N/A|60|Anticipated|McGill University||2|||f||||f|f|f||||||||2017-10-10 21:01:37.29|2017-10-10 21:01:37.29
NCT03168711|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|SURE-ALS2||Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)|Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)|Not yet recruiting||Phase 2|30|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||||2017-10-10 21:01:37.392575|2017-10-10 21:01:37.392575
NCT03168698|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-12|||May 25, 2017|Actual|2017-05-25|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Carbetocin vs. Oxytocin at Elective Cesarean Section|Carbetocin vs. Oxytocin at Elective Cesarean Section: a Double-blind, Randomized Controlled Non-inferiority Trial of High and Low Dose Regimens|Recruiting||N/A|250|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||4|||f||||f|f|f||||||||2017-10-10 21:01:37.497984|2017-10-10 21:01:37.497984
NCT03168685|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-23|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|May 11, 2018|Anticipated|2018-05-11|May 11, 2018|Anticipated|2018-05-11||Interventional|||Hemophilia Mobile App Usability Pilot|Bayer/HITLAB - Hemophilia Mobile App Usability Pilot|Active, not recruiting||N/A|20|Anticipated|Healthcare Innovation Technology Lab||1|||f||||f|f|t|f|||||No||2017-10-10 21:01:37.627341|2017-10-10 21:01:37.627341
NCT03168672|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-18|||September 18, 2017|Anticipated|2017-09-18|August 2017|2017-08-01|September 18, 2029|Anticipated|2029-09-18|September 18, 2021|Anticipated|2021-09-18||Interventional|Global ICON||GLOBAL ICON Stemless Shoulder System Post Market Clinical Follow Up Study|GLOBAL ICON Stemless Shoulder System Post Market Clinical Follow Up Study|Not yet recruiting||N/A|157|Anticipated|DePuy Orthopaedics||1|||f||||f|f|f||||||||2017-10-10 21:01:37.71459|2017-10-10 21:01:37.71459
NCT03168659|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|April 2020|Anticipated|2020-04-01||Interventional|||CardioFocus HeartLight Post-Approval Study|Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation|Not yet recruiting||Phase 4|250|Anticipated|CardioFocus||1|||f||||f|f|t|f||f|||No||2017-10-10 21:01:37.794688|2017-10-10 21:01:37.794688
NCT03168646|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-26|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Arthroscopic Wafer and Ulnar Shortening in Ulnar Abutment|Comparative Study Between Arthroscopic Wafer and Ulnar Shortening Osteotomy in Ulnar Abutment Syndrome|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f|||||f|f||||||No||2017-10-10 21:01:37.894278|2017-10-10 21:01:37.894278
NCT03168633|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-05-24|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||Lifestyle Advises Sent Via Email in Attempt of Improving A1C in DM2 Patients|Effects of Reading Information Sent Via Email and Glycemic Control and Compliance to Recommendations Among Patients With Type 2 Diabetes Mellitus -Prospective Research|Completed||N/A|50|Actual|Rambam Health Care Campus||1|||f||||f|f|f||||||Undecided||2017-10-10 21:01:37.979972|2017-10-10 21:01:37.979972
NCT03168620|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-25|||May 20, 2015|Actual|2015-05-20|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Effect of Glass Ionomer Cement as an Interim Restoration in Diagnosis of Pulpal Status|Evaluation of the Effect of Glass Ionomer Cement as an Interim Restoration in Diagnosis of Pulpal Status in Permanent Teeth: A Prospective Randomized Clinical Trial|Completed||N/A|146|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t|f|f||||||Yes||2017-10-10 21:01:38.052797|2017-10-10 21:01:38.052797
NCT03168607|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-30|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|May 2, 2020|Anticipated|2020-05-02|May 2, 2019|Anticipated|2019-05-02||Interventional|||Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma|Phase II Study of FOLFIRI as the Seconde Line Chemotherapy in Advanced or Metastatic Neuroendocrine Carcinoma|Recruiting||Phase 2|45|Anticipated|Peking University||1|||f||||t|f|f||||||No||2017-10-10 21:01:38.146208|2017-10-10 21:01:38.146208
NCT03168594|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-30|||April 29, 2017|Actual|2017-04-29|May 2017|2017-05-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma|A Randomized, Controlled Phase II Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma|Recruiting||Phase 2|144|Anticipated|Peking University||2|||f||||t|f|f||||||No||2017-10-10 21:01:38.247635|2017-10-10 21:01:38.247635
NCT03168581|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-02|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|March 1, 2019|Anticipated|2019-03-01|November 1, 2018|Anticipated|2018-11-01||Interventional|CATCH||A Proof of Concept Study to Evaluate CN-105 in ICH Patients|A Proof of Concept Study to Evaluate Administration of CN-105 in Patients With Acute Supratentorial Intracerebral Hemorrhage|Enrolling by invitation||Phase 2|60|Anticipated|AegisCN LLC||1|||f||||t|t|f||||||||2017-10-10 21:01:38.350169|2017-10-10 21:01:38.350169
NCT03168386|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-25|||November 1, 2016|Actual|2016-11-01|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Effect of Intensive Motor Rehabilitation in Subacute Stroke Patient|Effect of Intensive Motor Rehabilitation in Subacute Stroke Patient|Recruiting||N/A|196|Anticipated|Samsung Medical Center||1|||f|||||f|f||||||No||2017-10-10 21:01:39.647908|2017-10-10 21:01:39.647908
NCT03168568|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|December 24, 2018|Anticipated|2018-12-24|October 1, 2018|Anticipated|2018-10-01||Interventional|VASCEND||Differential Vascular and Endocrine Effects of Valsartan/Sacubitril in Heart Failure With Reduced Ejection Fraction|Differential Vascular and Endocrine Effects of Valsartan/Sacubitril in Heart Failure With Reduced Ejection Fraction: A Double-blind Randomized Controlled Phase IV Trial (VASCEND)|Recruiting||Phase 4|80|Anticipated|University of Zurich||2|||f|||||f|f||||||||2017-10-10 21:01:38.441173|2017-10-10 21:01:38.441173
NCT03168555|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-28|||June 22, 2017|Actual|2017-06-22|May 2017|2017-05-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|BACH||Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy|Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy|Enrolling by invitation||Phase 4|20|Anticipated|Zealand University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:01:38.534078|2017-10-10 21:01:38.534078
NCT03168542|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-14|||May 1, 2017||2017-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:01:38.613657|2017-10-10 21:01:38.613657
NCT03168529|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|OBSERVE-IVA||Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit|A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Ivabradine Initiated at the Time of Discharge From the Observation Unit|Not yet recruiting||Phase 4|132|Anticipated|Wayne State University||2|||f||||t|t|f|||f|||No||2017-10-10 21:01:38.655697|2017-10-10 21:01:38.655697
NCT03168516|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-23|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|October 2022|Anticipated|2022-10-01||Interventional|FiO2-C||Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants|Effects of Closed-loop Automatic Control of the Inspiratory Fraction of Oxygen (FiO2-C) on Outcome of Extremely Preterm Infants - a Randomized Controlled Parallel Group Multicenter Trial for Safety and Efficacy|Not yet recruiting||N/A|2340|Anticipated|University Hospital Tuebingen||2|||f||||t|f|f||||||Undecided||2017-10-10 21:01:38.757132|2017-10-10 21:01:38.757132
NCT03168503|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-23|||December 2013|Actual|2013-12-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|SAIMES||Synbiotic Approach to Immunity and Metabolism in the Elderly Study|Randomised, Double-blind, Placebo Controlled Cross-over Study to Determine the Beneficial Effects of Synbiotics and PromitorTM (Soluble Corn Flour)on Metabolism and Immunity in Healthy 60-80 Years Old Individuals|Completed||N/A|40|Actual|University of Roehampton||4|||f||||f|f|f|||f|||No||2017-10-10 21:01:38.843429|2017-10-10 21:01:38.843429
NCT03168490|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-26|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|April 1, 2018|Anticipated|2018-04-01|January 20, 2018|Anticipated|2018-01-20||Interventional|||In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease|"In Vivo Human Intervention Approach to Test the Effects of Gluten Friendly Bread in Coeliac Disease Patients: GLUTEN FRIENDLY STUDY"|Recruiting||N/A|60|Anticipated|University of Roehampton||5|||f||||t|f|f||||||No||2017-10-10 21:01:38.923504|2017-10-10 21:01:38.923504
NCT03168477|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-04|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Dry Needling and Manipulation vs. Manual Therapy, Exercise and Electrothermal Modalities for Shoulder Impingement|Electric Dry Needling and Spinal Manipulation vs. Impairment-based Manual Therapy, Exercise and Electro-thermal Modalities for Patients With Shoulder Impingement: a Multi-center Randomized Control Trial|Recruiting||N/A|110|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||f|f|f||||||||2017-10-10 21:01:39.009186|2017-10-10 21:01:39.009186
NCT03168464|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-08-18|||September 9, 2017|Anticipated|2017-09-09|August 2017|2017-08-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2021|Anticipated|2021-12-30||Interventional|||Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)|Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)|Recruiting||Phase 1/Phase 2|45|Anticipated|Weill Medical College of Cornell University||1|||f||||t|t|f|||f|||||2017-10-10 21:01:39.104746|2017-10-10 21:01:39.104746
NCT03168451|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-24|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|AI STOMP||American Indians STOp Smoking by Mobile Phone||Recruiting||N/A|500|Anticipated|Washington State University||2|||f||||f|f|f||||||No||2017-10-10 21:01:39.20079|2017-10-10 21:01:39.20079
NCT03168438|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-09|||May 24, 2017|Actual|2017-05-24|August 2017|2017-08-01|September 20, 2024|Anticipated|2024-09-20|April 9, 2021|Anticipated|2021-04-09||Interventional|||NY-ESO-1ᶜ²⁵⁹T Alone and in Combination With Pembrolizumab for Multiple Myeloma|Open-Label Randomized Pilot Study to Assess the Safety, Tolerability and Antitumor Activity of Genetically Engineered NY-ESO-1 Specific (c259) T Cells Alone or in Combination With Pembrolizumab in HLA-A2+ Subjects With NY-ESO-1 and/or LAGE 1A Positive Relapsed and Refractory Multiple Myeloma (rrMM) (ADP-0011-008) (KEYNOTE-487)|Recruiting||Early Phase 1|20|Anticipated|Adaptimmune||2|||f||||f|t|f||||||||2017-10-10 21:01:39.291356|2017-10-10 21:01:39.291356
NCT03168412|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-08-17|||May 25, 2017|Actual|2017-05-25|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)|A Study on Immunogenicity of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® Using Accelerated Vaccination Schedule in Adults (Aged Over 18 Years)|Active, not recruiting||Phase 4|126|Anticipated|Xiamen Innovax Biotech Co., Ltd||2|||f||||f|f|f||||||||2017-10-10 21:01:39.466059|2017-10-10 21:01:39.466059
NCT03168399|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-09|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PKU Explore||Evaluation of PKU Explore|A Study to Evaluate the Acceptability of PKU Explore, a Renovated Phenylalanine Free Second Stage Protein Substitute for Use in the Dietary Management of Phenylketonuria in Infants From 6 Months to 5 Years of Age With Regard to Product Tolerance and Adherence.|Recruiting||N/A|15|Anticipated|Vitaflo International, Ltd||1|||f||||f|f|f||||||||2017-10-10 21:01:39.548988|2017-10-10 21:01:39.548988
NCT03168373|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-25|||November 1, 2016|Actual|2016-11-01|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Effect of Intensive Language Therapy in Subacute Stroke Patients|Effect of Intensive Language Therapy in Subacute Stroke Patients|Recruiting||N/A|150|Anticipated|Samsung Medical Center||2|||f|||||f|f||||||No||2017-10-10 21:01:39.735835|2017-10-10 21:01:39.735835
NCT03168360|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-26|||November 1, 2016|Actual|2016-11-01|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Effect of Intensive Cognitive Rehabilitation in Subacute Stroke Patient|Effect of Intensive Cognitive Rehabilitation in Subacute Stroke Patient|Recruiting||N/A|150|Anticipated|Samsung Medical Center||2|||f|||||f|f||||||No||2017-10-10 21:01:39.804221|2017-10-10 21:01:39.804221
NCT03168347|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-06-06|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|February 1, 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Assessing Patient Confidence in Biologic Medications|Assessing Patient Confidence in Biologic Medications|Recruiting||N/A|300|Anticipated|Wake Forest University Health Sciences||4|||f||||f|f|f||||||No||2017-10-10 21:01:39.879416|2017-10-10 21:01:39.879416
NCT03168334|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-15|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Multi-center, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study in the Treatment of Acne Vulgaris|A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-123 Lotion and IDP-123 Vehicle Lotion in the Treatment of Acne Vulgaris|Recruiting||Phase 3|800|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||||||t|t|f||||||||2017-10-10 21:01:39.962978|2017-10-10 21:01:39.962978
NCT03168321|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-11|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study in the Treatment of Acne Vulgaris|A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-123 Lotion and IDP-123 Vehicle Lotion in the Treatment of Acne Vulgaris|Recruiting||Phase 3|800|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||||||t|t|f||||||||2017-10-10 21:01:40.087921|2017-10-10 21:01:40.087921
NCT03168308|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-25|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients|Sugammadex Versus Neostigmine for Reversal of Rocuronium-induced Neuromuscular Blockade: A Study of Thoracic Surgical Patients|Not yet recruiting||Phase 4|100|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t|t|f|||t|||No||2017-10-10 21:01:40.157795|2017-10-10 21:01:40.157795
NCT03168295|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria|SGLT2 INHIBITION AND STIMULATIION OF ENDOGENOUS GLUCOSE PRODUCTION Significance - PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria|Recruiting||Phase 4|40|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t|t|f|||f|||No||2017-10-10 21:01:40.395479|2017-10-10 21:01:40.395479
NCT03168282|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-12|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|CNSARI||Evaluation of Culture Negative Severe Acute Respiratory Infection in Mexico|Evaluation of Culture Negative Severe Acute Respiratory Infection in Mexico|Recruiting||N/A|100|Anticipated|Mexican Emerging Infectious Diseases Clinical Research Network|||1||f||||f|f|f||||Samples Without DNA|"     Nasopharyngeal swab; Broncho-alveolar Lavage   "|||2017-10-10 21:01:40.505408|2017-10-10 21:01:40.505408
NCT03168269|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-25|||January 27, 2016|Actual|2016-01-27|May 2017|2017-05-01|February 25, 2016|Actual|2016-02-25|February 25, 2016|Actual|2016-02-25||Observational|||Can CCTA Technicians Provide Accurate Interpretation of Findings in Patients Presenting to the ED in After Hours?|Can CCTA Technicians Provide Accurate Interpretation of Findings in Chest Pain Patients Presenting to the Emergency Department in After Hours?|Completed||N/A|100|Actual|Jordan Collaborating Cardiology Group|||1||f||||f|f|f||||||Undecided||2017-10-10 21:01:40.596816|2017-10-10 21:01:40.596816
NCT03168256|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||February 2018|Anticipated|2018-02-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|||CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis|A Phase 3 Randomized, Double-Blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Daily CF101 Administered Orally in Patients With Moderate-to-Severe Plaque Psoriasis|Not yet recruiting||Phase 3|407|Anticipated|Can-Fite BioPharma||4|||f||||f|f|f||||||||2017-10-10 21:01:40.660667|2017-10-10 21:01:40.660667
NCT03168243|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-19|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||High Energy High Protein Tube Feed Study|Evaluating the Tolerance, Compliance and Acceptability of a Nutritionally Complete, High Energy, High Protein, Enteral Feed in Adults - a Pilot Study|Recruiting||N/A|50|Anticipated|Nutricia UK Ltd||1|||f||||f|f|f||||||No||2017-10-10 21:01:40.773817|2017-10-10 21:01:40.773817
NCT03168230|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||February 27, 2004|Actual|2004-02-27|May 2017|2017-05-01|May 21, 2016|Actual|2016-05-21|May 21, 2016|Actual|2016-05-21||Observational|||Impact of PVE on Patient's Long-term Survival, Complications and Cancer Recurrence.|Impact of Portal Vein Embolization on Patient's Long-term Survival, Complications and Cancer Recurrence.|Completed||N/A|128|Actual|Université de Sherbrooke|||2||f||||f|f|f||||||No||2017-10-10 21:01:40.872021|2017-10-10 21:01:40.872021
NCT03168217|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-25|||January 2003||2003-01-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|January 2010|Actual|2010-01-01||Observational|||Classification of Periodontitis Revisited: A Cluster Analysis|Classification of Periodontitis Revisited: A Cluster Analysis|Active, not recruiting||N/A|235|Actual|University Paris 7 - Denis Diderot|||1||f||||f||||||||Yes|IPD Will be shared on request|2017-10-10 21:01:40.962472|2017-10-10 21:01:40.962472
NCT03168204|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-23|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|D-SCOPE||Evaluating the Efficacy of a Detection and Prevention Program for Frail Community-dwelling Older Adults|Study Protocol of the D-SCOPE Project With a Randomized Controlled Trial, Evaluating the Efficacy of a Detection and Prevention Program for Frail Community-dwelling Older Adults|Not yet recruiting||N/A|900|Anticipated|Vrije Universiteit Brussel||4|||f|||||f|f||||||||2017-10-10 21:01:41.05179|2017-10-10 21:01:41.05179
NCT03168178|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-24|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Intrapartum Fever: Antibiotics Versus no Treatment|A Randomized Trial in Intrapartum Fever Of No Antibiotics for Low-risk Women (RATIONAL)|Not yet recruiting||Phase 4|175|Anticipated|University of Utah||2|||f||||t|t|f|||f|||No||2017-10-10 21:01:41.279747|2017-10-10 21:01:41.279747
NCT03168152|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-03|||May 11, 2017|Actual|2017-05-11|July 2017|2017-07-01|April 1, 2022|Anticipated|2022-04-01|April 1, 2022|Anticipated|2022-04-01||Interventional|||Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma|A Phase II Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|University of Michigan Cancer Center||2|||f||||t|f|f||||||||2017-10-10 21:01:41.655262|2017-10-10 21:01:41.655262
NCT03168139|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-31|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|Keynote-559||Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer|A Two-part, Open-label Phase 1/2 Study to Evaluate Pharmacodynamic Effects and Safety of Olaptesed Pegol Monotherapy and Safety and Efficacy of Olaptesed Pegol / Pembrolizumab Combination Therapy in Metastatic Colorectal and Pancreatic Cancer|Recruiting||Phase 1/Phase 2|20|Anticipated|NOXXON Pharma AG||1|||f|||||f|f||||||||2017-10-10 21:01:41.746942|2017-10-10 21:01:41.746942
NCT03168126|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||January 2014||2014-01-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|AHM||Advanced Hemodynamic Monitoring in Free Flap Surgery|Advanced Hemodynamic Monitoring in Free Flap Surgery|Completed||N/A|31|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||No||2017-10-10 21:01:41.834948|2017-10-10 21:01:41.834948
NCT03168113|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-14|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|||Atopic Dermatitis (AD) and Food Allergy|Skin Barrier in Childhood Atopic Dermatitis With and Without Food Allergy (ADRN-10)|Recruiting||N/A|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||f|f|f||||Samples With DNA|"     Serum, Plasma, DNA, Skin tape strip samples and any derivatives, Skin swabs and any     derivatives, Stool samples and any derivatives   "|Yes|The plan is to share data in ImmPort [https://immport.niaid.nih.gov/ ], a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts, upon completion of the study.|2017-10-10 21:01:41.900609|2017-10-10 21:01:41.900609
NCT03168100|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-04|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|July 2028|Anticipated|2028-07-01|June 2020|Anticipated|2020-06-01||Interventional|||2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma|University of Arkansas (UARK# 2017-03): A Single-Arm, Open-label Study of Anti-SLAMF7 mAb Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma (Total Therapy 8)|Recruiting||Phase 2|115|Anticipated|University of Arkansas||1|||f||||f|t|f|||f|||||2017-10-10 21:01:41.983958|2017-10-10 21:01:41.983958
NCT03168087|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-15|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Plasmalyte-148 Solution and Blood Coagulation|The Effect of a Plasmalyte-148 Solution on Blood Coagulation: In Vitro, Volunteer Study Using Rotational Thromboelastometry|Recruiting||N/A|12|Anticipated|Seoul National University Hospital|||4||f||||f|f|f||||||||2017-10-10 21:01:42.100064|2017-10-10 21:01:42.100064
NCT03168074|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-06-14|||March 28, 2017|Actual|2017-03-28|February 2017|2017-02-01|March 28, 2021|Anticipated|2021-03-28|March 28, 2021|Anticipated|2021-03-28||Interventional|||Phase II Study of Single Agent Lenvatinib|A Phase II Window-of-opportunity Study of Single Agent Lenvatinib in Estrogen Receptor Positive Early Stage Breast Cancer|Recruiting||Phase 2|30|Anticipated|National University Hospital, Singapore||1|||f||||f|f|f||||||No||2017-10-10 21:01:42.198595|2017-10-10 21:01:42.198595
NCT03168048|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|OPTIMISE-1||Oncologic Therapy Support Via Means of a Dedicated Mobile App|Oncologic Therapy Support Via Means of a Dedicated Mobile App - a Prospective Feasibility Evaluation|Not yet recruiting||N/A|50|Anticipated|Heidelberg University||1|||f||||f|f|f||||||No||2017-10-10 21:01:42.412752|2017-10-10 21:01:42.412752
NCT03168035|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-24|||November 2013|Actual|2013-11-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma|A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma|Active, not recruiting||Phase 1|40|Actual|NanoCarrier Co., Ltd.||1|||f||||f|t|f||||||||2017-10-10 21:01:42.494884|2017-10-10 21:01:42.494884
NCT03168022|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-26|||December 16, 2015|Actual|2015-12-16|May 2017|2017-05-01|January 26, 2016|Actual|2016-01-26|January 26, 2016|Actual|2016-01-26||Interventional|||Bioequivalence Study of TNX-102 SL 2.8 mg Sublingual Tablets From Two Manufacturers.|A SINGLE-DOSE, RANDOMIZED, OPEN-LABEL, TWO-WAY CROSSOVER BIOEQUIVALENCE STUDY OF TNX-102 SL (CYCLOBENZAPRINE HCL SUBLINGUAL TABLETS) 2.8 mg FROM TWO MANUFACTURERS IN HEALTHY SUBJECTS UNDER FASTING CONDITIONS|Completed||Phase 1|42|Actual|Tonix Pharmaceuticals, Inc.||2|||f||||f|t|||||||Undecided||2017-10-10 21:01:42.586013|2017-10-10 21:01:42.586013
NCT03168009|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||May 24, 2017|Actual|2017-05-24|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Brown Fat Activity and Bariatric Surgery|The Role of Alternatively Activated Brown Fat in Bariatric Surgery-mediated Metabolic Improvements|Recruiting||N/A|46|Anticipated|Medical University of Vienna||1|||f|||||f|f||||||||2017-10-10 21:01:42.671756|2017-10-10 21:01:42.671756
NCT03167996|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-24|||June 23, 2016|Actual|2016-06-23|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|HealthPals||Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology|Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology|Recruiting||N/A|100|Anticipated|Stanford University||2|||f|||||f|t|t|f|t|||No||2017-10-10 21:01:42.75347|2017-10-10 21:01:42.75347
NCT03167983|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-14|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|||Microbiome and Dementia|The Gut-Brain Axis in Dementia: Biomarker and Novel Intervention Strategies|Recruiting||N/A|40|Anticipated|Medical University of Graz|||2||f||||f||||||Samples Without DNA|"     Stool, serum, plasma   "|||2017-10-10 21:01:42.857936|2017-10-10 21:01:42.857936
NCT03167970|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-14|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|March 14, 2018|Anticipated|2018-03-14|September 14, 2017|Anticipated|2017-09-14||Observational|||Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy|Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy for Screening of Barrett's Esophagus: A Prospective Tandem Study|Recruiting||N/A|20|Anticipated|Midwest Biomedical Research Foundation|||1||f||||f|f|t|f|f|t|||No|This is a funded study. A copy of de-identified data set will be provided to the sponsor in the form of case report forms (CRF) at the end of the study.|2017-10-10 21:01:42.940562|2017-10-10 21:01:42.940562
NCT03167957|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis|A Single-Center, Open-Label, Pilot Study to Evaluate the Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis|Not yet recruiting||Phase 2|16|Anticipated|Matinas BioPharma Nanotechnologies, Inc.||2|||f||||f|t|f||||||No||2017-10-10 21:01:43.027439|2017-10-10 21:01:43.027439
NCT03167944|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|October 30, 2018|Anticipated|2018-10-30|March 25, 2018|Anticipated|2018-03-25||Interventional|||Traditional Electrosurgery System Versus Low Thermal Tissue Dissection System for Total Mastectomy|"Comparison of Traditional Electrosurgery System Versus Low Thermal Tissue Dissection System for Total Mastectomy: A Prospective Randomized Controlled Trial"|Recruiting||N/A|60|Anticipated|Mahidol University||2|||f|||||f|t|f|f|t|||||2017-10-10 21:01:43.12645|2017-10-10 21:01:43.12645
NCT03167931|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-31|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|NEUROMOD||Neuromodulation by Non-invasive Brain Stimulation|Neuromodulation by Non-invasive Brain Stimulation (NEUROMOD)|Not yet recruiting||N/A|120|Anticipated|University Hospital, Grenoble||2|||f||||f|f|f||||||||2017-10-10 21:01:43.209918|2017-10-10 21:01:43.209918
NCT03167918|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-24|||July 21, 2014|Actual|2014-07-21|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|April 1, 2017|Actual|2017-04-01||Interventional|||Lung Function in Patients With Early Type 2 Diabetes Mellitus|Liaoning University of Traditional Chinese Medicine|Completed||Phase 2/Phase 3|200|Actual|Liaoning University of Traditional Chinese Medicine||3|||f||||t|f|f||||||No||2017-10-10 21:01:43.291131|2017-10-10 21:01:43.291131
NCT03167905|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-18|||June 15, 2017|Actual|2017-06-15|April 2017|2017-04-01|March 16, 2020|Anticipated|2020-03-16|January 16, 2020|Anticipated|2020-01-16||Interventional|CODEPAD||CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)|Comparison of the Role of Epidural Analgesia Versus Non-epidural Analgesia in Postnatal Depression and Persistent Pain Development: a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|1326|Anticipated|KK Women's and Children's Hospital||2|||f||||f|f|f||||||||2017-10-10 21:01:43.384186|2017-10-10 21:01:43.384186
NCT03167892|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-30|||September 15, 2017|Anticipated|2017-09-15|May 2017|2017-05-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Oral Screens in Post Stroke Training|Oral Screens in Post Stroke Training|Recruiting||N/A|70|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||No||2017-10-10 21:01:43.502492|2017-10-10 21:01:43.502492
NCT03167879|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-27|||June 15, 2017|Actual|2017-06-15|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Integrating Safer Conception Counseling to Transform HIV Family Planning Services|Integrating Counseling to Transform HIV Family Planning Services|Recruiting||Phase 2/Phase 3|360|Anticipated|RAND||3|||f||||f|f|f||||||||2017-10-10 21:01:43.587847|2017-10-10 21:01:43.587847
NCT03167866|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-24|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Effect of Motivation Text Messages on Diabetes Patients|The Influence of Motivational Text Messages on Glycemic Control and Healthy Lifestyle Choices in Patients With Diabetes|Not yet recruiting||N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||f|f|f||||||No||2017-10-10 21:01:43.673033|2017-10-10 21:01:43.673033
NCT03167853|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-30|||April 6, 2017|Actual|2017-04-06|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of JS001 in Patients With Advanced Neuroendocrine Tumors|Phase Ib Study of Safety and Efficacy of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Patients With Advanced Neuroendocrine Tumors Following Failure of First-Line|Recruiting||Phase 1|40|Anticipated|Peking University||1|||f||||t|f|f||||||No||2017-10-10 21:01:43.762726|2017-10-10 21:01:43.762726
NCT03167840|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-08-13|||August 6, 2017|Actual|2017-08-06|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|FallsPACT||Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment|Falls Prevention Through Physical And Cognitive Training (Falls PACT) in Older Adults With Mild Cognitive Impairment: A Randomised Controlled Trial|Recruiting||N/A|120|Anticipated|The Hong Kong Polytechnic University||4|||f||||f|f|f||||||||2017-10-10 21:01:43.848302|2017-10-10 21:01:43.848302
NCT03167827|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-25|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Effects of Physical Training and Isoflavone Supplementation On Pelvic Floor in Women in the Postmenopausal Period|Effects of Physical Training and Isoflavone Supplementation On Pelvic Floor Musculature in Women in the Postmenopausal Period: Controlled Randomized Clinical Trial|Completed||Phase 4|22|Actual|Federal University of Uberlandia||2|||f||||t|f|f||||||No||2017-10-10 21:01:43.942008|2017-10-10 21:01:43.942008
NCT03167814|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-24|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2025|Anticipated|2025-12-31||Interventional|||Prevention of Chyle-leak After Major Pancreatic Surgery|Prevention of Chyle-leak After Major Pancreatic Surgery|Recruiting||N/A|96|Anticipated|Helsinki University Central Hospital||2|||f||||f|f|f||||||||2017-10-10 21:01:44.021327|2017-10-10 21:01:44.021327
NCT03167801|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-09|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|MELATETRA||Melatonin Secretion and Sleep Quality in Spinal Cord Injury Patients|Melatonin Secretion and Sleep Quality in Spinal Cord Injury Patients|Not yet recruiting||N/A|40|Anticipated|Centre d'Investigation Clinique et Technologique 805|||2||f||||f|f|f||||Samples Without DNA|"     urinary samples   "|No||2017-10-10 21:01:44.096898|2017-10-10 21:01:44.096898
NCT03167788|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-06|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery|A RANDOMISED CONTROLLED TRIAL OF RED CELL REJUVENATION FOR THE ATTENUATION OF TRANSFUSION ASSOCIATED ORGAN INJURY IN CARDIAC SURGERY: The REDJUVENATE Trial|Not yet recruiting||Phase 2|132|Anticipated|University of Leicester||2|||f||||t|f|f||||||||2017-10-10 21:01:44.180899|2017-10-10 21:01:44.180899
NCT03167775|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-24|||November 28, 2016|Actual|2016-11-28|May 2017|2017-05-01|November 27, 2019|Anticipated|2019-11-27|May 27, 2019|Anticipated|2019-05-27||Interventional|||Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer|Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer|Recruiting||N/A|30|Anticipated|BeiJing Yijiayi Medicine Techonoloy Co., Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:01:44.292893|2017-10-10 21:01:44.292893
NCT03167762|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Photographing the Skin During Photodynamic Therapy|Fluorescence and Thermal Imaging of the Skin Before and During Photodynamic Therapy|Enrolling by invitation||N/A|20|Anticipated|University of Dundee||1|||f||||f|f|f||||||No||2017-10-10 21:01:44.368532|2017-10-10 21:01:44.368532
NCT03167749|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||January 2018|Anticipated|2018-01-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Observational|||Effect of Liver Cirrhosis on Semen Parameters and Reproductive Hormones|Effect of Type and Severity of Liver Cirrhosis on Semen Parameters and Reproductive Hormones|Not yet recruiting||N/A|90|Anticipated|Assiut University|||2||f||||f|f|f||||||No||2017-10-10 21:01:44.439412|2017-10-10 21:01:44.439412
NCT03167736|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Dry Needling and Spinal Manipulation vs. Conventional PT for Lumbar Spinal Stenosis|The Addition of Electric Dry Needling and Spinal Manipulation to Impairment-based Manual Therapy, Stretching, Strengthening and Electrothermal Modalities for Patients With Lumbar Spinal Stenosis: a Multi-randomized Clinical Trial|Recruiting||N/A|110|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:44.607935|2017-10-10 21:01:44.607935
NCT03167723|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|August 31, 2019|Anticipated|2019-08-31|May 30, 2019|Anticipated|2019-05-30||Interventional|||Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions|Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions|Recruiting||N/A|200|Anticipated|Carolinas Healthcare System||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:01:44.76738|2017-10-10 21:01:44.76738
NCT03167710|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Dry Needling, Manipulation and Stretching vs. Manual Therapy, Exercise and Ultrasound for Lateral Epicondylalgia|Electric Dry Needling, Thrust Manipulation and Stretching Versus Impairment-based Manual Therapy, Exercise and Ultrasound for Patients With Lateral Epicondylitis: A Multi-center Randomized Control Trial|Recruiting||N/A|110|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:44.886077|2017-10-10 21:01:44.886077
NCT03167697|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-24|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia|Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia|Enrolling by invitation||N/A|50|Anticipated|Nutricia UK Ltd||2|||f||||f|f|f||||||No|No IPD will be shared with other researchers.|2017-10-10 21:01:44.99366|2017-10-10 21:01:44.99366
NCT03167684|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-09-10|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Effect of Oral Appliance Therapy on Glucose Levels in Patients With T2DM and OSA: A Pilot Trial|The Effect of Oral Appliance Therapy on Cardiometabolic Outcomes in Patients With Type 2 Diabetes and Obstructive Sleep Apnea: A Pilot RCT|Recruiting||N/A|50|Anticipated|McGill University Health Center||2|||f||||f|f|f|||f|||||2017-10-10 21:01:45.127489|2017-10-10 21:01:45.127489
NCT03167671|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-24|||June 25, 2017|Anticipated|2017-06-25|May 2017|2017-05-01|July 24, 2018|Anticipated|2018-07-24|June 24, 2018|Anticipated|2018-06-24||Interventional|AposBack||The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain|The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain Population. A Randomized Controlled Trial|Not yet recruiting||N/A|147|Anticipated|Montefiore Medical Center||2|||f||||f|f|f|||f|||No||2017-10-10 21:01:45.239478|2017-10-10 21:01:45.239478
NCT03167658|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Impact of Employee Wellness Programs|The Impact of Employee Wellness Programs|Active, not recruiting||N/A|16000|Anticipated|Harvard School of Public Health||3|||f||||f|f|f||||||No||2017-10-10 21:01:45.348433|2017-10-10 21:01:45.348433
NCT03167645|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-07-05|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|SUPERADD||SUbstition of PERioperative Albumin Deficiency Disorders|Does Perioperative Substitution of Albumin Deficiency Reduce Postoperative Complications?|Recruiting||Phase 4|400|Anticipated|Technische Universität München||2|||f||||t|f|f||||||||2017-10-10 21:01:45.469145|2017-10-10 21:01:45.469145
NCT03167632|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||August 10, 2015|Actual|2015-08-10|May 2017|2017-05-01|October 25, 2015|Actual|2015-10-25|October 25, 2015|Actual|2015-10-25||Observational|||Oral Ulcer Prevalence: Hospital-based Cross-sectional Study|Oral Ulcer Prevalence of and Quality of Life: a Hospital-based Cross-sectional Study|Completed||N/A|605|Actual|Cairo University|||1||f||||t|f|f||||||Yes|Whenever asked for meta-analysis, the IPD will be available in the form of an excel sheet having no identifiers, where each patient is given an ID number of the study.|2017-10-10 21:01:45.604941|2017-10-10 21:01:45.604941
NCT03167619|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|DORA||Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)|Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer|Not yet recruiting||Phase 2|60|Anticipated|Duke University||2|||f|||||t|f||||||No||2017-10-10 21:01:45.671398|2017-10-10 21:01:45.671398
NCT03167606|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-24|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM|A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM|Recruiting||N/A|700|Anticipated|Columbia University||2|||f||||f|f|f||||||No||2017-10-10 21:01:45.768595|2017-10-10 21:01:45.768595
NCT03167593|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||October 1, 2015||2015-10-01|May 2017|2017-05-01|April 30, 2016|Actual|2016-04-30|January 7, 2016|Actual|2016-01-07||Interventional|||Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.|Evaluation of the Effects of Consumption of the Probiotic Strain Lactobacillus Coryniformis CECT5711 on the Immune Response to Influenza Vaccine in Adults Over 65 Years of Age.|Completed||Phase 2|98|Actual|Biosearch S.A.||2|||f||||||||||||No||2017-10-10 21:01:45.903142|2017-10-10 21:01:45.903142
NCT03167580|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|March 1, 2020|Anticipated|2020-03-01|December 31, 2019|Anticipated|2019-12-31||Interventional|RELAx||REstricted Versus Liberal Positive End-Expiratory Pressure in Patients Without ARDS|REstricted Versus Liberal Positive End-Expiratory Pressure in Patients Without Acute Respiratory Distress Syndrome|Not yet recruiting||N/A|980|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t|f|f||||||Undecided||2017-10-10 21:01:45.984958|2017-10-10 21:01:45.984958
NCT03167567|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|MedClown||The Effect of Medical Clowning During Labor|The Effect of Medical Clowning on Primipara Women During Labor|Not yet recruiting||N/A|50|Anticipated|The Baruch Padeh Medical Center, Poriya||2|||f||||t|f|f||||||No||2017-10-10 21:01:46.088676|2017-10-10 21:01:46.088676
NCT03167554|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||May 2016|Actual|2016-05-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultrasound Guided Therapeutic Percutaneous Electrolysis in Achilles Tendinopathy.|Effectiveness of Therapeutic Percutaneous (EPTE®) Guided by Ultrasound as a Treatment of Achilles Tendinopathy. A Randomized Controlled Clinical Trial.|Recruiting||N/A|96|Anticipated|Hospital Universitario Infanta Leonor||3|||f||||f|f|f||||||Undecided||2017-10-10 21:01:46.15754|2017-10-10 21:01:46.15754
NCT03167528|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|TOOLBOX||Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients|Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients|Recruiting||N/A|80|Anticipated|Hopital Foch||1|||f||||f|f|f||||||No||2017-10-10 21:01:46.387364|2017-10-10 21:01:46.387364
NCT03167515|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis|A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis|Recruiting||N/A|85|Anticipated|Ferndale Laboratories, Inc.||1|||f||||f|f|t|t|f|f|||Undecided||2017-10-10 21:01:46.512118|2017-10-10 21:01:46.512118
NCT03167502|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|EX-ART||Performance in Walking in Osteoarthritis Patients|Performance in Walking in Osteoarthritis Patients: the Role of Fatigue and the Effect of an Eccentric Muscle Building Program|Not yet recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:46.625407|2017-10-10 21:01:46.625407
NCT03167489|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-07-20|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|||Lifestyle Intervention Plus Emotion Regulation Group Intervention Impact on Women's Cardiovascular Risk Reduction|Impact of Lifestyle Intervention Plus Emotion Regulation Group Intervention on Cardiovascular Risk Reduction in Female Hospital Employees: A Pilot Study|Enrolling by invitation||N/A|14|Actual|Hadassah Medical Organization||1|||f||||f|f|f||||||||2017-10-10 21:01:46.715141|2017-10-10 21:01:46.715141
NCT03167476|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||August 1, 2016|Actual|2016-08-01|August 2016|2016-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma|Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma|Recruiting||N/A|200|Anticipated|University of Electronic Science and Technology of China|||2||f|||||f|f||||||||2017-10-10 21:01:46.806423|2017-10-10 21:01:46.806423
NCT03167463|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-24|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Stentless Endoscopic Transnasal Transseptal Choanoplasty|Stentless Endoscopic Transnasal Transseptal Choanoplasty|Recruiting||N/A|20|Anticipated|Assiut University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:01:46.88922|2017-10-10 21:01:46.88922
NCT03167424|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-09|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|RIBS VII||Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis|Observational Study of Treatment of Bioresorbable Vascular Scaffolds Restenosis|Recruiting||N/A|100|Anticipated|Spanish Society of Cardiology|||1||f||||t|f|f||||||||2017-10-10 21:01:47.159997|2017-10-10 21:01:47.159997
NCT03167411|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-21|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection|A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effect of Exenatide on the Pharmacokinetics and Pharmacodynamics of Bexagliflozin in Healthy Subjects|Completed||Phase 1|20|Actual|Theracos||2|||f||||t|t|f||||||||2017-10-10 21:01:47.282101|2017-10-10 21:01:47.282101
NCT03167398|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-09-27|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Fecal Microbiota Transplantation for Eradication of CRE|Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization|Not yet recruiting||N/A|60|Anticipated|Rambam Health Care Campus||1|||f|||||f|f||||||||2017-10-10 21:01:47.35966|2017-10-10 21:01:47.35966
NCT03167385|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||March 22, 2017|Actual|2017-03-22|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma|The Effectiveness and Safety of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma: a Phase 2 Trial.|Recruiting||Phase 2|20|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f|||||f|f|||f|||Undecided|Undecided|2017-10-10 21:01:47.420769|2017-10-10 21:01:47.420769
NCT03167372|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-02|||September 6, 2017|Actual|2017-09-06|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Pilot N-of-1 Light Therapy Study|Comparison of N-of-1 Trials of Light Therapy for Depressive Symptoms in Cancer Survivors|Recruiting||N/A|30|Anticipated|Columbia University||2|||f||||f|f|f||||||||2017-10-10 21:01:47.493485|2017-10-10 21:01:47.493485
NCT03167359|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||December 2010||2010-12-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Hypofractionated Radiotherapy in Breast Cancer|A Pilot Study of Hypofractionated Simultaneous Integrated Boost Radiotherapy in Stage 0, I and III Breast Cancer Patients|Recruiting||N/A|86|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 21:01:47.622974|2017-10-10 21:01:47.622974
NCT03167346|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|May 31, 2017|Anticipated|2017-05-31||Observational|IPACSS||The Investigation of Public Awareness of Core Stroke Symptoms|The Investigation of Public Awareness of Core Stroke Symptoms|Recruiting||N/A|200000|Anticipated|Peking Union Medical College Hospital|||1||f|||||f|f||||||||2017-10-10 21:01:47.716536|2017-10-10 21:01:47.716536
NCT03167333|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-24|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 18, 2019|Anticipated|2019-07-18|July 18, 2018|Anticipated|2018-07-18||Interventional|||The Role of Synovitis in Osteoarthritis|Does Synovitis Affect Treatment Efficacy in Intra-articular Injection Therapy to Osteoarthritis|Recruiting||N/A|100|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f|||||f|f||||||Undecided||2017-10-10 21:01:47.786652|2017-10-10 21:01:47.786652
NCT03167320|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-05-23|||October 2014||2014-10-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|LOVIC||Low Von Willebrand in Ireland Cohort Study|Low Von Willebrand in Ireland Cohort Study|Recruiting||N/A|200|Anticipated|St. James's Hospital, Ireland|||1||f||||f||||||Samples With DNA|"     Peripheral venous blood samples will be taken at study enrolment and stored for further     analysis, including samples for DNA analysis.   "|Undecided||2017-10-10 21:01:47.876493|2017-10-10 21:01:47.876493
NCT03167307|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-05-24|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|Omega-3-pMDD||The Omega-3 Fatty Acid Paediatric Depression Trial|OMEGA-3 FATTY ACIDS AS FIRST-LINE TREATMENT IN PAEDIATRIC DEPRESSION. A Phase III, 36-week, Multi-centre, Double-blind, Placebo-controlled Randomized Superiority Study|Recruiting||Phase 3|220|Anticipated|Psychiatric University Hospital, Zurich||2|||f||||t|f|f||||||Yes|A BioBank will be established. Access to the Biobank can be requested upon completion of the trial contacting the sponsor-investigator Dr. Gregor Berger|2017-10-10 21:01:47.949471|2017-10-10 21:01:47.949471
NCT03167294|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-05-24|||December 14, 2014|Actual|2014-12-14|May 2017|2017-05-01|April 27, 2017|Actual|2017-04-27|June 30, 2016|Actual|2016-06-30||Interventional|ABS||AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia|PROCEPT AQUABEAM Study for the Treatment of Benign Prostatic Hyperplasia (ABS)|Completed||N/A|48|Actual|PROCEPT BioRobotics||1|||f||||t||||||||||2017-10-10 21:01:48.059337|2017-10-10 21:01:48.059337
NCT03167281|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||February 17, 2017|Actual|2017-02-17|May 2017|2017-05-01|February 16, 2018|Anticipated|2018-02-16|February 16, 2018|Anticipated|2018-02-16||Interventional|ELEVATE||Early Intrapleural TPA Instillation Versus Late|Early Intrapleural TPA Instillation Versus Late|Recruiting||Phase 4|60|Anticipated|Palmetto Health||2|||f||||f|t|f|||t|||No||2017-10-10 21:01:48.131683|2017-10-10 21:01:48.131683
NCT03167268|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-24|||August 3, 2016|Actual|2016-08-03|May 2017|2017-05-01|November 30, 2019|Anticipated|2019-11-30|May 31, 2019|Anticipated|2019-05-31||Interventional|PaSTo||Panitumumab Skin Toxicity Prevention Trial|Double-blind, Phase II Study to Assess the Effectiveness of Lycopene vs Placebo to Reduce Skin Toxicity in Patients With Colorectal Carcinoma Treated With Panitumumab|Recruiting||Phase 2|100|Anticipated|Ospedale San Carlo Borromeo||2|||f||||f|f|f||||||||2017-10-10 21:01:48.207259|2017-10-10 21:01:48.207259
NCT03167255|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-09-06|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)|A Phase II, Open-Label, Extension Study to Assess the Safety and Efficacy of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)|Enrolling by invitation||Phase 2|16|Anticipated|NS Pharma, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:01:48.305516|2017-10-10 21:01:48.305516
NCT03167242|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-20|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|October 11, 2019|Anticipated|2019-10-11|September 26, 2019|Anticipated|2019-09-26||Interventional|||Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria|A Phase 2 Interventional, Multicenter, Randomized Open Label Study to Determine the Effective and Tolerable Dose of KAF156 and Lumefantrine Solid Dispersion Formulation in Combination, Given Once Daily for 1, 2 and 3-days to Adults and Children With Uncomplicated Plasmodium Falciparum Malaria|Recruiting||Phase 2|512|Anticipated|Novartis||8|||f||||t|f|f||||||||2017-10-10 21:01:50.005771|2017-10-10 21:01:50.005771
NCT03167229|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|TDF||TDF Medicine to Prevent Mother to Child Transmission of Hepatitis B|Prevention of Mother-to-child Transmission of Hepatitis B Virus (PMTCT-HBV): a One Arm, Open Label Intervention Study to Estimate the Optimal Timing of Tenofovir (TDF) in Pregnancy|Not yet recruiting||Phase 4|170|Anticipated|University of Oxford||1|||f||||f|f|f|||f|||Yes||2017-10-10 21:01:50.112867|2017-10-10 21:01:50.112867
NCT03167216|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-29|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction|Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction|Recruiting||Early Phase 1|20|Anticipated|Northwestern University||1|||f||||f|t|f|||t|||||2017-10-10 21:01:50.185518|2017-10-10 21:01:50.185518
NCT03167190|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||May 25, 2017|Anticipated|2017-05-25|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Ultrasound-Assisted Lumbar Puncture|Ultrasound-localized Landmark Identification in Hospitalized Patients Requiring Lumbar Puncture: Implications for Safety, Quality, and Procedural Success|Not yet recruiting||N/A|102|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 21:01:50.342387|2017-10-10 21:01:50.342387
NCT03167177|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-27|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy|NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed on or After Chemotherapy and Anti-programmed Cell Death Protein 1 (PD-1)/Programmed Death Ligand 1 (PD-L1) Therapy|Not yet recruiting||Phase 1/Phase 2|67|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||No||2017-10-10 21:01:50.432748|2017-10-10 21:01:50.432748
NCT03167164|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-27|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy|NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After Anti-programmed Death-ligand 1 (PD-L1) Therapy|Not yet recruiting||Phase 1/Phase 2|67|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||No||2017-10-10 21:01:50.5327|2017-10-10 21:01:50.5327
NCT03167151|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-14|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|November 2019|Anticipated|2019-11-01||Interventional|PemBla||Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)|A Parallel Group Phase I/II Marker Lesion Study to Assess the Safety, Tolerability and Efficacy of Intravenous or Intravesical Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer|Recruiting||Phase 1/Phase 2|36|Anticipated|University of Oxford||2|||f||||f|f|f||||||||2017-10-10 21:01:50.634301|2017-10-10 21:01:50.634301
NCT03167138|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-16|||July 14, 2017|Actual|2017-07-14|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Micro-Fragmented Adipose Tissue (Lipogems®) Injection for Chronic Shoulder Pain in Persons With Spinal Cord Injury|Treatment of Chronic Shoulder Pain in Persons With Spinal Cord Injury Using Injection With Autologous Micro-Fragmented Adipose Tissue Under Ultrasound Guidance|Recruiting||Early Phase 1|6|Anticipated|Kessler Foundation||1|||f||||f|f|t|f||t|||||2017-10-10 21:01:50.836175|2017-10-10 21:01:50.836175
NCT03167125|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-03|||September 5, 2017|Actual|2017-09-05|October 2017|2017-10-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|PROMPT||Participatory Research to Advance Colon Cancer Prevention|Participatory Research to Advance Colon Cancer Prevention|Recruiting||N/A|15000|Anticipated|Kaiser Permanente||3|||f||||t|f|f||||||||2017-10-10 21:01:50.955598|2017-10-10 21:01:50.955598
NCT03167112|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-08-28|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|Folfirinox||A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer|A Study of Preoperative FOLFIRINOX For Potentially Curable Pancreatic Cancer|Recruiting||Phase 2|20|Anticipated|McGill University Health Center||1|||f|||||f|f|||f|||||2017-10-10 21:01:51.068106|2017-10-10 21:01:51.068106
NCT03167099|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-05-30|||March 2015||2015-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|WtBrFemFx||Immediate Weight Bearing Versus Protected Weight Bearing in Supracondylar Distal Femur Fractures|Immediate Weight Bearing as Tolerated Versus Protected Weight Bearing in Supracondylar Distal Femur Fractures; a Prospective, Randomized Study|Enrolling by invitation||N/A|150|Anticipated|West Virginia University||2|||f||||f||||||||No|No individual participant data will be shared with other researchers. Shared group data will be presented at Orthopaedic conferences and through manuscript submission.|2017-10-10 21:01:51.204984|2017-10-10 21:01:51.204984
NCT03167086|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-08-01|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Single Session Pain Catastrophizing Treatment: Comparative Efficacy & Mechanisms|Single Session Pain Catastrophizing Treatment: Comparative Efficacy & Mechanisms|Recruiting||N/A|231|Anticipated|Stanford University||3|||f||||t|f|f||||||||2017-10-10 21:01:51.318792|2017-10-10 21:01:51.318792
NCT03167073|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-05|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Impact of a Smartphone Application on Postpartum Weight Loss and Breastfeeding Rates Among Low-income, Urban Women|Impact of a Novel Smartphone Application on Postpartum Weight Loss and Breastfeeding Rates Among Low-income, Urban Women|Recruiting||N/A|170|Anticipated|Washington University School of Medicine||2|||f||||t|f|f||||||||2017-10-10 21:01:51.422349|2017-10-10 21:01:51.422349
NCT03167060|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-05|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|November 30, 2018|Anticipated|2018-11-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||BrainCool-Migraine Intranasal Cooling Trial|"Nasal Cavity Cooling for the Symptomatic Relief of Migraine Headache - A Randomized, Double Blind, Placebo Controlled Study , the BrainCool-Migraine Study"|Recruiting||N/A|90|Anticipated|Cumbria Partnership NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 21:01:51.537361|2017-10-10 21:01:51.537361
NCT03167047|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-23|||November 1, 2016|Actual|2016-11-01|May 2017|2017-05-01|August 30, 2017|Anticipated|2017-08-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Post-operative Pain Relief for Paediatric Inguinal-Scrotal Surgery|Post-operative Pain Relief for Paediatric Inguinal-Scrotal Surgery|Recruiting||N/A|50|Anticipated|Medway NHS Foundation Trust||2|||f||||t|f|f||||||Undecided||2017-10-10 21:01:51.657905|2017-10-10 21:01:51.657905
NCT03167034|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Acetazolamide on Right Ventricular Function During Exercise in Patients With Respiratory Disease at Altitude|Effect of Acetazolamide on Right Ventricular Function During Exercise in Patients With Chronic Obstructive Pulmonary Disease at Altitude. A Randomized, Placebo-controlled, Double-blind Parallel Trial.|Recruiting||Phase 4|100|Anticipated|University of Zurich||2|||f||||f|f|f||||||Undecided||2017-10-10 21:01:51.759141|2017-10-10 21:01:51.759141
NCT03167021|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-05|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Observational|CANNACY||Survey on the Place of Community Pharmacists in the Detection of Cannabis Use: a Student's Point of View|Survey on the Place of Community Pharmacists in the Detection of Cannabis Use: a Student's Point of View|Completed||N/A|150|Actual|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 21:01:51.853309|2017-10-10 21:01:51.853309
NCT03167008|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Vitamin D Level vs Semen Parameters|Correlation Between the Level of Vitamin D and Semen Parameters|Not yet recruiting||N/A|60|Anticipated|Assiut University|||2||f|||||f|f||||||||2017-10-10 21:01:51.932316|2017-10-10 21:01:51.932316
NCT03166995|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Postural Exercises in Women With Fibromyalgia|Study of the Effect of a Postural Exercise Program in Women With Fibromyalgia: a Randomized Clinical Trial|Recruiting||N/A|54|Anticipated|University of Valencia||3|||f||||f|f|f||||||No||2017-10-10 21:01:52.007993|2017-10-10 21:01:52.007993
NCT03166982|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-05-23|||October 26, 2016|Actual|2016-10-26|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DTOA||Drainage of Tubo - Ovarian Abscess: DTOA|Comparative Effectiveness Clinical Early of Transvaginal and Laparoscopic Approaches for Drainage of Tubo -Ovarian Abscess. Randomized Noninferiority|Recruiting||N/A|80|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:01:52.095071|2017-10-10 21:01:52.095071
NCT03166969|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-23|||February 2007||2007-02-01|May 2017|2017-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|HOLTER-21J||Predictors of Occult Atrial Fibrillation in 171 Patients With Cryptogenic TIA and Minor Stroke||Completed||N/A|171|Actual|Versailles Hospital||1|||f||||f||||||||No||2017-10-10 21:01:52.201839|2017-10-10 21:01:52.201839
NCT03166956|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-25|||June 1, 2012|Actual|2012-06-01|May 2017|2017-05-01|December 31, 2014|Actual|2014-12-31|August 31, 2014|Actual|2014-08-31||Interventional|||Effect of Glutamine and Vitamin C on Interleukin-6 and Clinical Outcomes in Surgical Intensive Care Unit Patients|The Effect of Enteral Glutamine and Vitamin C Supplementation on Interleukin-6 and Clinical Outcomes in Surgical Intensive Care Unit Patients: A Prospective, Double-Blind, Randomized Controlled Trial|Completed||N/A|41|Actual|Chung Shan Medical University||2|||f||||f|f|f||||||No||2017-10-10 21:01:52.266458|2017-10-10 21:01:52.266458
NCT03166943|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-23|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|||the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Function|An Investigative Study on the Possible Effect of the Antiviral Inhibitors (Sofosbuvir and Daclatasvir) for Treatment of Hepatitis C Virus Infection in Cardiac Function|Recruiting||N/A|130|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:01:52.345736|2017-10-10 21:01:52.345736
NCT03166930|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-25|||October 2, 2017|Anticipated|2017-10-02|May 2017|2017-05-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|STC||Evaluation of a Spasticity Management Program for People With Multiple Sclerosis|Evaluation of a Spasticity Management Program for People With Multiple Sclerosis|Not yet recruiting||N/A|220|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:01:52.423657|2017-10-10 21:01:52.423657
NCT03166917|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|August 1, 2021|Anticipated|2021-08-01||Interventional|||Clinical Application of Personal Designed 3D Printing Implants in Bone Defect Restoration|Shenzhen Hospital of Southern Medical University|Recruiting||N/A|300|Anticipated|Shenzhen Hospital of Southern Medical University||2|||f||||t|f|f||||||Yes||2017-10-10 21:01:52.517191|2017-10-10 21:01:52.517191
NCT03166904|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-26|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RICTOR_SC||Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy|AZD2014 in RICTOR Amplified Solid Cancer|Not yet recruiting||Phase 2|27|Anticipated|Samsung Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:01:52.692294|2017-10-10 21:01:52.692294
NCT03166891|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-18|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase Ib Study of Chiauranib in Patients With Ovarian Cancer|Efficacy and Safety of Chiauranib in Relapsed/Refractory Ovarian Cancer: a Single-arm, Open-label, Multi-site, Exploratory Study|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Chipscreen Biosciences, Ltd.||1|||f||||f|f|f||||||||2017-10-10 21:01:52.779478|2017-10-10 21:01:52.779478
NCT03166878|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-22|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma|Phase I/II Study to Determine the Safety, Tolerability, Biological Activity and Efficacy of Universal CRISPR-Cas9 Gene-Editing CAR-T Cells Targeting CD19(UCART019) in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma|Recruiting||Phase 1/Phase 2|80|Anticipated|Chinese PLA General Hospital||1|||f||||f|f|f|||f|||||2017-10-10 21:01:52.879254|2017-10-10 21:01:52.879254
NCT03166865|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|October 1, 2019|Anticipated|2019-10-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis|Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis|Recruiting||Phase 1/Phase 2|60|Anticipated|Liaocheng People's Hospital||2|||f|||||f|f||||||||2017-10-10 21:01:52.971189|2017-10-10 21:01:52.971189
NCT03166852|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||April 27, 2016|Actual|2016-04-27|May 2017|2017-05-01|November 27, 2016|Actual|2016-11-27|November 27, 2016|Actual|2016-11-27||Interventional|||Compliance to HIT-program at Home With the Use of Technology|Compliance to HIT-program at Home With the Use of Technology|Completed||N/A|21|Actual|University College of Northern Denmark||1|||f||||f|f|f||||||No||2017-10-10 21:01:53.069126|2017-10-10 21:01:53.069126
NCT03166839|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-25|||March 2009|Actual|2009-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|June 2016|Actual|2016-06-01||Observational|||Management of Postpartum Haemorrhage and Effect of Geographic Region|Management of Postpartum Haemorrhage and Effect of Geographic Region: A Secondary Analysis of the World Maternal Antifibrinolytic (WOMAN) Trial|Completed||N/A|20060|Actual|London School of Hygiene and Tropical Medicine|||3||f||||f|f|f||||||No||2017-10-10 21:01:53.150026|2017-10-10 21:01:53.150026
NCT03166826|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-05-24|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Development of Modified Combined Apgar Scoring System for Evaluation of Infants in the Delivery Room|Development of Modified Combined Apgar Scoring System for Evaluation of Infants in the Delivery Room|Recruiting||N/A|800|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:01:53.228386|2017-10-10 21:01:53.228386
NCT03166813|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-24|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|June 30, 2020|Anticipated|2020-06-30||Interventional|||Remote Ischaemic Preconditioning in Childhood Cancer|Remote Ischaemic Preconditioning in Paediatric Cancer Patients Receiving Anthracycline Therapy|Not yet recruiting||N/A|68|Anticipated|The University of Hong Kong||2|||f||||f|f|f||||||No||2017-10-10 21:01:53.295253|2017-10-10 21:01:53.295253
NCT03166800|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-25|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|MS||MitoQ for Fatigue in Multiple Sclerosis|MitoQ for Fatigue in Multiple Sclerosis: a Placebo Controlled Trial|Recruiting||Phase 1/Phase 2|60|Anticipated|Oregon Health and Science University||3|||f||||t|t|f||||||Undecided||2017-10-10 21:01:53.426814|2017-10-10 21:01:53.426814
NCT03166774|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-19|||July 7, 2016|Actual|2016-07-07|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 1, 2017|Actual|2017-07-01||Interventional|||Support of the Sexual Health in Oncology|Support of the Sexual Health in Oncology|Recruiting||N/A|400|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||f|f|f||||||||2017-10-10 21:01:53.617036|2017-10-10 21:01:53.617036
NCT03166761|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-14|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection|Randomized Prospective Study of Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Steroid Injection|Enrolling by invitation||Phase 4|102|Anticipated|Vanderbilt University Medical Center||2|||f|||||t|f||||||||2017-10-10 21:01:53.691903|2017-10-10 21:01:53.691903
NCT03166748|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-23|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical and Radiographic Assessments of Potassium Nitrate in Polycarboxylate Versus Mineral Trioxide Aggregate as Pulpotomy Biomaterials in Immature Mandibular First Permanent Molars|Compare the Clinical/Radiographic Outcomes of Potassium Nitrate in Polycarboxylate Cement and MTA as Pulpotomy Biomaterials Used for Asymptomatic Vital Immature Permanent Lower First Molars|Not yet recruiting||N/A|50|Anticipated|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 21:01:53.784187|2017-10-10 21:01:53.784187
NCT03166735|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-10-02|||June 6, 2017|Actual|2017-06-06|October 2017|2017-10-01|July 9, 2018|Anticipated|2018-07-09|June 11, 2018|Anticipated|2018-06-11||Interventional|||Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH|A Multi-centre, Double-blind, Parallel-group, Randomised, Placebo Controlled Phase II a Study to Investigate Pharmacodynamics, Safety and Pharmacokinetics of Different Doses of Orally Administered BI 1467335 During a 12-week Treatment Period Compared to Placebo in Patients With Clinical Evidence of NASH.|Recruiting||Phase 2|150|Anticipated|Boehringer Ingelheim||5|||f||||f|t|f||||||||2017-10-10 21:01:53.893533|2017-10-10 21:01:53.893533
NCT03143517|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-15|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|CALFE||Fecal Calprotectin Collection Protocol|CALFE Stool Sample Collection Protocol|Recruiting||N/A|175|Anticipated|DiaSorin Inc.|||3||f|||||f|||||Samples Without DNA|"     Human Stool   "|||2017-10-10 21:05:45.145068|2017-10-10 21:05:45.145068
NCT03166722|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-26|||September 20, 2017|Actual|2017-09-20|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2019|Anticipated|2019-08-31||Interventional|COSGOD||Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition|Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition After Birth: An Investigator-initiated Randomised Multi-centre Multinational Clinical Trial|Recruiting||N/A|726|Anticipated|Medical University of Graz||2|||f||||t|f|f||||||||2017-10-10 21:01:54.028039|2017-10-10 21:01:54.028039
NCT03166709|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-30|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|PARS||Preventing Addiction Related Suicide (PARS)|Preventing Addiction Related Suicide (PARS) - Controlled Trial of Secondary Suicide Prevention|Recruiting||N/A|900|Anticipated|University of Washington||2|||f||||t|f|f||||||No||2017-10-10 21:01:54.116355|2017-10-10 21:01:54.116355
NCT03166696|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-24|||January 3, 2000|Actual|2000-01-03|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01|10 Years|Observational [Patient Registry]|AMIAC||Acute Myocardial Infarction and Acute Cerebral Infarction (AMIAC) Registry and Follow-up|The Registry and Follow-up of Patients With Acute Myocardial Infarction or Acute Cerebral Infarction|Active, not recruiting||N/A|30000|Anticipated|Guangdong General Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:01:54.239153|2017-10-10 21:01:54.239153
NCT03166683|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-17|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|April 2020|Anticipated|2020-04-01||Interventional|IBERLIVER||Standard of Care Versus Hemopatch® During Liver Resection|Standard of Care Versus a New Collagen and Polyethylene Glycol Haemostatic/Sealant Patch (Hemopatch) During Liver Resection. A Multicentre, Non-inferiority Prospective Randomized Study (IBERLIVER-study)|Not yet recruiting||N/A|284|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f|f|f||||||||2017-10-10 21:01:54.314815|2017-10-10 21:01:54.314815
NCT03166670|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-01|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|October 30, 2018|Anticipated|2018-10-30|July 1, 2018|Anticipated|2018-07-01||Observational|||Parasitic Causes of Secretory Diarrhea in Children and Chronically Ill Adult.|Parasitic Causes of Secretory Diarrhea in Children and Chronically Ill Adult.|Not yet recruiting||N/A|100|Anticipated|Assiut University|||2||f||||f|f|f||||||||2017-10-10 21:01:54.402202|2017-10-10 21:01:54.402202
NCT03166657|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-05-24|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Office Hysteroscopy in Secondary Infertility After Cesarean Section|Role of Office Hysteroscopy in Cases of Secondary Infertility After Cesarean Section|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:01:54.464994|2017-10-10 21:01:54.464994
NCT03166644|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-25|||July 4, 2017|Actual|2017-07-04|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|PHOENIX||Individualized Goal-directed Sufentanil Administration Versus Standard Therapy in Patients Undergoing Major Abdominal Surgery|Individualized Goal-directed Sufentanil Administration Versus Standard Therapy in Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Feasibility Trial.|Recruiting||N/A|120|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:01:54.528181|2017-10-10 21:01:54.528181
NCT03166631|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-10-02|||September 18, 2017|Actual|2017-09-18|October 2017|2017-10-01|July 2, 2021|Anticipated|2021-07-02|January 15, 2020|Anticipated|2020-01-15||Interventional|||A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread|An Open-label Phase I Dose Finding Trial With BI 891065 Alone and in Combination With BI 754091 to Characterise Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy in Patients With Advanced and/or Metastatic Malignancies|Recruiting||Phase 1|93|Anticipated|Boehringer Ingelheim||3|||f||||t|t|f||||||||2017-10-10 21:01:54.655047|2017-10-10 21:01:54.655047
NCT03166618|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-16|||April 24, 2017|Actual|2017-04-24|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing|A Multicenter, Single-Blind, Randomized, Parallel-Group, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing|Terminated||N/A|189|Anticipated|Allergan||2||Business decision to stop the program.|f||||f|f|t|f|f||||||2017-10-10 21:01:54.739171|2017-10-10 21:01:54.739171
NCT03166605|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Ingestion of Simethicone After Capsule Ingestion and Its Impact on Quality of Video Capsule Endoscopy- a Pilot Study|Ingestion of Simethicone After Capsule Ingestion and Its Impact on Quality of Video Capsule Endoscopy- a Pilot Study|Recruiting||N/A|36|Anticipated|Albany Medical College||3|||f||||f|f|f|||f|||No||2017-10-10 21:01:54.811396|2017-10-10 21:01:54.811396
NCT03166592|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-24|2017-08-13|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Observational|||Evaluation of Intra Axial Brain Masses Based on Magnetic Resonance in Adults|Impact of Advanced Neuroimaging Techniques in Evaluation of Intra Axial Brain Masses Based on Magnetic Resonance Diagnostic Strategy in Adults|Recruiting||N/A|150|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 21:01:54.888054|2017-10-10 21:01:54.888054
NCT03166579|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||July 2010|Actual|2010-07-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Effectiveness Evaluation of 'The Endeavour Programme'|Evaluating the Effectiveness of 'The Endeavour Programme': DBT for Irish Adults With Borderline Personality Disorder|Completed||N/A|71|Actual|Health Service Executive, Ireland||1|||f||||f|f|f||||||No||2017-10-10 21:01:54.954578|2017-10-10 21:01:54.954578
NCT03166566|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||March 1, 2011|Actual|2011-03-01|May 2017|2017-05-01|September 2, 2016|Actual|2016-09-02|December 2, 2015|Actual|2015-12-02||Interventional|||Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.|Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.|Completed||N/A|15|Actual|Federal University of Minas Gerais||1|||f||||f|f|f||||||Undecided||2017-10-10 21:01:55.10103|2017-10-10 21:01:55.10103
NCT03166553|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||November 28, 2016|Actual|2016-11-28|May 2017|2017-05-01|November 27, 2019|Anticipated|2019-11-27|May 28, 2019|Anticipated|2019-05-28||Interventional|||Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer|Clinical Trial of Elemene Injection/Elemene Oral Emulsion in Combination With Systematic Chemotherapy Including Oxaliplatin in the First -Line Treatment of Advanced Primary Liver Cancer|Recruiting||N/A|150|Anticipated|BeiJing Yijiayi Medicine Techonoloy Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:01:55.197929|2017-10-10 21:01:55.197929
NCT03166540|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-07-18|||May 10, 2017|Actual|2017-05-10|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|P4L||Bioavailability and Beneficial Properties of Coffee and Cocoa Bioactive Compounds|Bioavailability and Beneficial Properties of Espresso Coffee and Confectionery Derived Coffee Bioactive Compounds|Active, not recruiting||N/A|21|Actual|University of Parma||3|||f|||||f|f||||||||2017-10-10 21:01:55.328773|2017-10-10 21:01:55.328773
NCT03166527|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2018|Anticipated|2018-12-15||Interventional|Panzyga-CIDP||Panzyga in CIDP Administered at Different Infusion Rates|Prospective, Open-Label, Phase IIIb Study Evaluating the Safety, Tolerability and Efficacy of Panzyga® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Administered at Standard and High Infusion Rates|Not yet recruiting||Phase 3|30|Anticipated|University Health Network, Toronto||1|||f||||f|f|f|||f|||No||2017-10-10 21:01:55.433225|2017-10-10 21:01:55.433225
NCT03166514|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-23|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|NB16||Glycemic Response of a Commercial Food Bar|Pharmacokinetic and Glycemic Response of a Commercially Available Food Bar|Completed||N/A|20|Actual|Texas A&M University||2|||f||||t|f|f||||||No||2017-10-10 21:01:55.532814|2017-10-10 21:01:55.532814
NCT03166501|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|June 1, 2019|Anticipated|2019-06-01||Interventional|||NMDA Receptor Modulation for Hyperarousal in PTSD|NMDA Receptor Modulation for Hyperarousal in PTSD|Not yet recruiting||Phase 1|24|Anticipated|Baylor College of Medicine||2|||f||||t|t|f||||||No||2017-10-10 21:01:55.646185|2017-10-10 21:01:55.646185
NCT03166488|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-23|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||MRE Evaluation of Liver Stiffness After Tricuspid Valvular Repair|Evaluation of Liver Stiffness After Tricuspid Valvular Repair Using Magnetic Resonance Elastography|Not yet recruiting||N/A|30|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|f||||Undecided||2017-10-10 21:01:55.748572|2017-10-10 21:01:55.748572
NCT03166475|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||September 30, 2016|Actual|2016-09-30|May 2017|2017-05-01|March 30, 2017|Actual|2017-03-30|January 10, 2017|Actual|2017-01-10||Interventional|||Ridge Preservation With Provisional Ovoid Pontic|Ridge Preservation With Provisional Ovoid Pontic: a Randomized and Controlled Clinical-tomographic Trial|Completed||N/A|30|Actual|Federal University of Juiz de Fora||3|||f||||t|f|f||||||No|IPD will not be shared with other researchers, the data will be used for the same researcher on other research later.|2017-10-10 21:01:55.82704|2017-10-10 21:01:55.82704
NCT03166462|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Obstructive Sleep Apnea in Elective Orthopaedic Surgery|Effects of Obstructive Sleep Apnea in Elective Orthopaedic Surgery|Not yet recruiting||N/A|100|Anticipated|University of Miami||2|||f||||t|f|f||||||Undecided||2017-10-10 21:01:55.920007|2017-10-10 21:01:55.920007
NCT03166449|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-24|||July 1, 2014|Actual|2014-07-01|May 2017|2017-05-01|July 31, 2015|Actual|2015-07-31|July 31, 2015|Actual|2015-07-31||Interventional|||Effects of Immunonutrition on Biomarkers in Traumatic Brain Injury|Effects of Immunonutrition on Biomarkers in Traumatic Brain Injury Patients in Malaysia: a Prospective Randomized Controlled Trial.|Completed||N/A|36|Actual|University of Malaya||2|||f||||t|f|f||||||No||2017-10-10 21:01:55.992581|2017-10-10 21:01:55.992581
NCT03166436|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-25|||June 8, 2017|Anticipated|2017-06-08|May 2017|2017-05-01|May 8, 2020|Anticipated|2020-05-08|May 8, 2019|Anticipated|2019-05-08||Interventional|||RFA for Malignant Biliary Obstruction|Radiofrequency Ablation Plus Stenting Versus Stenting Alone for Treatment of Malignant Biliary Obstruction|Recruiting||N/A|140|Anticipated|Institute for Clinical and Experimental Medicine||2|||f||||f|f|f||||||No||2017-10-10 21:01:56.094475|2017-10-10 21:01:56.094475
NCT03166423|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-24|||November 12, 2015|Actual|2015-11-12|May 2017|2017-05-01|July 1, 2017|Anticipated|2017-07-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers|Clinical Trial Phase I-II of Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers|Active, not recruiting||Phase 1/Phase 2|90|Anticipated|University of Chile||2|||f||||f|f|f||||||No||2017-10-10 21:01:56.191732|2017-10-10 21:01:56.191732
NCT03166410|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints|Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints|Recruiting||N/A|500|Anticipated|Texas Plastic Surgery||1|||f||||||||||||||2017-10-10 21:01:56.283747|2017-10-10 21:01:56.283747
NCT03166397|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients|A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients|Recruiting||Phase 2|30|Anticipated|Sheba Medical Center||1|||f||||t|f|f||||||Undecided|To be considered|2017-10-10 21:01:56.354391|2017-10-10 21:01:56.354391
NCT03166384|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-23|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2021|Anticipated|2021-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|ELBCE||ELectrosurgical Bipolar Devices VS Convention Electronicautery|A Prospective Randomized Study Comparing Surgery Using Electrosurgical Bipolar Sealing Devices and Surgery Using Conventional Electro-cautery|Recruiting||N/A|82|Anticipated|Severance Hospital||2|||f||||t|f|t|f|f|t|||No||2017-10-10 21:01:56.451843|2017-10-10 21:01:56.451843
NCT03166371|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-10-02|||October 30, 2017|Anticipated|2017-10-30|October 2017|2017-10-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Glutathione (GSH) Supplementation After Hospitalization|Bioavailable Glutathione Supplementation: During Hospitalization and Beyond|Not yet recruiting||N/A|50|Anticipated|Emory University||2|||f||||f|f|f||||||||2017-10-10 21:01:56.553848|2017-10-10 21:01:56.553848
NCT03166358|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||September 1, 2015|Actual|2015-09-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Yoga for Pediatric Tension-Type Headache|Yoga for Pediatric Tension-Type Headache|Recruiting||N/A|40|Anticipated|Meharry Medical College||2|||f||||f|f|f||||||No|Individual participant data will not be made available to other researchers.|2017-10-10 21:01:56.657355|2017-10-10 21:01:56.657355
NCT03166345|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-15|||August 15, 2017|Anticipated|2017-08-15|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|December 30, 2017|Anticipated|2017-12-30||Interventional|PRPITM||Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium|Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium For IVF Women|Recruiting||N/A|30|Anticipated|Ibn Sina Hospital||3|||f||||t|f|f||||||||2017-10-10 21:01:56.762505|2017-10-10 21:01:56.762505
NCT03166332|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-27|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|February 1, 2021|Anticipated|2021-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|IMPACTBCN||Improving Mothers for a Better PrenAtal Care Trial Barcelona|Improving Mothers for a Better PrenAtal Care Trial Barcelona|Recruiting||N/A|1218|Anticipated|Hospital Clinic of Barcelona||3|||f||||t|f|f||||||No|Participants will be recruited in our unit and data will be available only for researchers involved in the study.|2017-10-10 21:01:56.843793|2017-10-10 21:01:56.843793
NCT03166319|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-29|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) Vasculitis|The Utility of Intracranial Vessel Wall Imaging for Suspected CNS Vasculitis Diagnosis and Assessment of Disease Activity.|Recruiting||N/A|15|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|f||||||2017-10-10 21:01:56.934651|2017-10-10 21:01:56.934651
NCT03166306|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-11|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|May 31, 2019|Anticipated|2019-05-31||Interventional|AIPAH||Angiogenic Imaging in Pulmonary Arterial Hypertension|Angiogenic Imaging in Pulmonary Arterial Hypertension|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Brigham and Women's Hospital||3|||f||||f|t|f||||||||2017-10-10 21:01:57.036385|2017-10-10 21:01:57.036385
NCT03166293|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-01|||June 1, 2017|Actual|2017-06-01|April 2017|2017-04-01|May 31, 2022|Anticipated|2022-05-31|May 31, 2022|Anticipated|2022-05-31||Interventional|||Early Intensive Exercise to Improve Walking in Children With Spastic Diplegia|Early Intensive Exercise to Improve Walking in Children With Spastic Diplegia From Encephalopathy of Prematurity|Recruiting||N/A|80|Anticipated|University of Alberta||4|||f||||t|f|f||||||No||2017-10-10 21:01:57.150386|2017-10-10 21:01:57.150386
NCT03166280|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-23|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Observational|hepatitisc||Hepatitis c and Vitamin D and Iron Status|Evaluation of Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients Before and After Treatment|Not yet recruiting||N/A|87|Anticipated|Assiut University|||2||f||||t|t|f|||f|Samples Without DNA|"     serum   "|Undecided||2017-10-10 21:01:57.277553|2017-10-10 21:01:57.277553
NCT03166267|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|||Real Life Weight Bearing After Tibial Fractures|A Prospective Case Series Study to Monitor Healing Progression and Real Life Weight Bearing After Tibial Fracture Using Smart Biofeedback Systems|Not yet recruiting||N/A|10|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f|f|f||||||No||2017-10-10 21:01:57.387282|2017-10-10 21:01:57.387282
NCT03166254|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-07|||November 30, 2017|Anticipated|2017-11-30|September 2017|2017-09-01|January 31, 2027|Anticipated|2027-01-31|March 31, 2022|Anticipated|2022-03-31||Interventional|||Combination of a Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab in Non-Small Cell Lung Cancer|Pilot Feasibility Study of the Combination of a Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab in Non-Small Cell Lung Cancer|Not yet recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:01:57.46484|2017-10-10 21:01:57.46484
NCT03166241|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.|Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction and Correlation With Disease Severity.|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:01:57.598723|2017-10-10 21:01:57.598723
NCT03166228|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-23|||July 5, 2017|Anticipated|2017-07-05|May 2017|2017-05-01|September 17, 2018|Anticipated|2018-09-17|September 17, 2018|Anticipated|2018-09-17||Interventional|||Hemodynamic Changes During Operative Hysteroscopy|Hematological, Biochemical and Hemodynamic Changes During Operative Hysteroscopy Using Consecutive Distension Media|Not yet recruiting||Phase 2|60|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:01:57.684038|2017-10-10 21:01:57.684038
NCT03166215|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-08|||June 13, 2017|Actual|2017-06-13|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation Study With an Open-Label Phase to Examine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-935 as an Adjunctive Therapy in Subjects With Developmental and/or Epileptic Encephalopathies|Recruiting||Phase 2|20|Anticipated|Takeda||3|||f||||f|t|f||||||||2017-10-10 21:01:57.765411|2017-10-10 21:01:57.765411
NCT03166202|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||September 5, 2017|Anticipated|2017-09-05|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Age-Related Macular Degeneration, Scotopic Dysfunction, and Driving Performance in a Simulator|Age-Related Macular Degeneration, Scotopic Dysfunction, and Driving Performance in a Simulator|Not yet recruiting||N/A|40|Anticipated|University of Alabama at Birmingham|||1||f||||f|f|f||||||Undecided|Once study is completed and published in the peer review literature, we will arrange for a data sharing process with other researchers|2017-10-10 21:01:57.875672|2017-10-10 21:01:57.875672
NCT03166189|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-27|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures|Open Randomized Trial of Clinical Efficiency and Safety of Cell Product of Autologous Bone Marrow-derived Mesenchymal Stem Cells for Reparative Treatment of Destructively Changed Endometrium in Patients With Repeated IVF Failures|Recruiting||Phase 2|60|Anticipated|D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology||2|||f|||||f|f||||||||2017-10-10 21:01:57.94436|2017-10-10 21:01:57.94436
NCT03166176|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|TSC1/2_SC||Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy|SAMSUNG MEDICAL CENTER|Not yet recruiting||Phase 2|27|Anticipated|Samsung Medical Center||1|||f|||||f|f||||||||2017-10-10 21:01:58.045729|2017-10-10 21:01:58.045729
NCT03166163|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||May 20, 2017|Actual|2017-05-20|May 2017|2017-05-01|June 11, 2017|Anticipated|2017-06-11|June 11, 2017|Anticipated|2017-06-11||Interventional|mouthwash||Evaluation of Bleeding on Brushing Using Neem Extract Mouthwash Versus Chlorhexidine Mouthwash|Evaluation of Bleeding on Brushing Among a Group of Egyptian Children After Using Azadirachta Indica (Neem Extract)Mouthwash Versus Chlorhexidine Mouthwash: A Randomized Controlled Trial|Enrolling by invitation||N/A|86|Anticipated|Cairo University||2|||f||||t|f|f||||||No|it will be available when it is finished|2017-10-10 21:01:58.11158|2017-10-10 21:01:58.11158
NCT03166150|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-24|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|M-FALS||Muscle and Functional Assessment in Leakage Study|Muscle and Functional Assessment in Leakage Study|Not yet recruiting||N/A|200|Anticipated|Baltimore VA Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:01:58.205555|2017-10-10 21:01:58.205555
NCT03166137|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Carbon Dioxide Laser and Cryotherapy in Treatment of Warts|Comparative Evaluation of Carbon Dioxide Laser and Cryotherapy by Dermoscopy in Treatment of Viral Wart|Not yet recruiting||N/A|60|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:01:58.311088|2017-10-10 21:01:58.311088
NCT03166124|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-10-02|||May 24, 2017|Actual|2017-05-24|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus|Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro Following Single Dose Administration in Elderly and Younger Adults With Type 1 Diabetes Mellitus|Recruiting||Phase 1|84|Anticipated|Eli Lilly and Company||4|||f||||f|t|f|||t|||||2017-10-10 21:01:58.42104|2017-10-10 21:01:58.42104
NCT03166111|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-11|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery|Effect of Self-administered Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery: A Randomized Controlled Study|Not yet recruiting||Phase 3|120|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 21:01:58.56921|2017-10-10 21:01:58.56921
NCT03166098|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-31|||July 5, 2016|Actual|2016-07-05|May 2017|2017-05-01|July 5, 2020|Anticipated|2020-07-05|July 5, 2020|Anticipated|2020-07-05||Observational|||The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders|The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders|Recruiting||N/A|210|Anticipated|New York University School of Medicine|||5||f||||f|f|f||||||||2017-10-10 21:01:58.659605|2017-10-10 21:01:58.659605
NCT03166085|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-16|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer|A Phase 1b Study of PU-H71 With Nab-paclitaxel (Abraxane) in Patients With HER2-Negative Metastatic Breast Cancer|Recruiting||Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||Undecided||2017-10-10 21:01:58.86955|2017-10-10 21:01:58.86955
NCT03166072|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-22|||September 1, 2018|Anticipated|2018-09-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Low-vision Rehabilitation Program for Low-vision Patients and Care Givers|Low-vision Rehabilitation Program for Low-vision Patients and Care Givers: A Single Blind Longitudinal Randomized Controlled Trial|Not yet recruiting||N/A|150|Anticipated|Lawson Health Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:01:59.008188|2017-10-10 21:01:59.008188
NCT03166059|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||CaveoVasc Thrombolysis Protection System, Access Protection Study|Prospective, Single Arm, Study to Assess the Safety and Performance of the CaveoVasc® Thrombolysis Protection System, for Femoral Artery Access and Protection in Patients Treated With Thrombolysis for Limb Ischemia|Not yet recruiting||N/A|20|Anticipated|CaveoMed GmbH||1|||f||||f|f|f||||||No||2017-10-10 21:01:59.102989|2017-10-10 21:01:59.102989
NCT03166046|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|November 21, 2017|Anticipated|2017-11-21||Interventional|PSWT||Migraine Prevention Using ActiPatch|Migraine Prevention Using Pulsed Shortwave Therapy|Recruiting||Phase 1|80|Anticipated|BioElectronics Corporation||2|||f||||f|f|t|f||f|||No||2017-10-10 21:01:59.188823|2017-10-10 21:01:59.188823
NCT03166033|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||January 1, 2013|Actual|2013-01-01|May 2017|2017-05-01|April 1, 2015|Actual|2015-04-01|December 31, 2014|Actual|2014-12-31||Observational|||Case-control Study on Individual Risk Factors of CTS|Case-control Study on Individual Risk Factors of Carpal Tunnel Syndrome|Completed||N/A|6048|Actual|Fudan University|||2||f||||f|f|f||||||No||2017-10-10 21:01:59.289455|2017-10-10 21:01:59.289455
NCT03166020|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|ERGOTACT||Evaluation of a Video-ludic Re-education of the Paretic Upper Limb in Chronic Hemipartic Patients Post Cerebral Vascular Accident|Evaluation of a Video-ludic Re-education of the Paretic Upper Limb in Chronic Hemipartic Patients Post Cerebral Vascular Accident|Not yet recruiting||N/A|28|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||f|f|f||||||No||2017-10-10 21:01:59.360799|2017-10-10 21:01:59.360799
NCT03166007|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-05-22|||June 2014||2014-06-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|AMBER||Abdominal Massage for Bowel Dysfunction|Abdominal Massage for Neurogenic Bowel Dysfunction in People With Multiple Sclerosis (AMBER Abdominal Massage for Bowel Dysfunction Effectiveness Research).|Completed||N/A|191|Actual|Glasgow Caledonian University||2|||f||||t||||||||Yes|Results will be published, lay summaries produced and massage training guidelines (+DVD) will be made available.|2017-10-10 21:01:59.442913|2017-10-10 21:01:59.442913
NCT03165994|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-28|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers|A Pilot Study of APX005M in Combination With Concurrent Chemoradiation as Neoadjuvant Therapy for Resectable Esophageal and Gastroesophageal Junction Cancers|Not yet recruiting||Phase 2|16|Anticipated|University of California, San Francisco||1|||f||||t|t|f||||||||2017-10-10 21:01:59.558681|2017-10-10 21:01:59.558681
NCT03165981|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-09-25|||August 25, 2017|Actual|2017-08-25|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Fever After Simultaneous Versus Sequential Vaccination in Young Children|A Prospective, Randomized, Open-label Clinical Trial to Assess Fever Following Simultaneous Versus Sequential Administration of PCV13, DTaP Vaccine and IIV in Young Children|Recruiting||Phase 4|280|Anticipated|Duke University||2|||f||||f|t|f||||||||2017-10-10 21:01:59.715968|2017-10-10 21:01:59.715968
NCT03165968|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-22|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Observational|NINADiPAS||Test and Evaluation of Non-Invasive Neuro-Assessment Devices (NINAD): NeuroKinetics, Inc, iPAS|Test and Evaluation of Non-Invasive Neuro-Assessment Devices (NINAD): NeuroKinetics, Inc, iPAS|Not yet recruiting||N/A|150|Anticipated|Uniformed Services University of the Health Sciences|||1||f||||f||||||||Yes|Upload to FITBIR Database NIH|2017-10-10 21:01:59.900701|2017-10-10 21:01:59.900701
NCT03165955|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-22|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients|A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients|Recruiting||Phase 1|24|Anticipated|Kinex Pharmaceuticals Inc||1|||f||||f|t|f|||t|||Undecided||2017-10-10 21:01:59.986679|2017-10-10 21:01:59.986679
NCT03165942|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-12|||September 8, 2016|Actual|2016-09-08|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Neuroendocrine Response to Oral Alcohol Administration|Neuroendocrine Response to Oral Alcohol Administration|Recruiting||Phase 1|85|Anticipated|Yale University||2|||f||||t|t|f|||t|||||2017-10-10 21:02:00.154345|2017-10-10 21:02:00.154345
NCT03165929|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-23|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Oral Flurbiprofen Spray for Mucosal Graft Harvesting at the Palatal Area|Oral Flurbiprofen Spray for Mucosal Graft Harvesting at the Palatal Area: A Randomized Placebo-controlled Study|Completed||Early Phase 1|48|Actual|Gazi University||4|||f||||f|f|f||||||No||2017-10-10 21:02:00.258467|2017-10-10 21:02:00.258467
NCT03165916|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-22|||September 15, 2014|Actual|2014-09-15|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Study to Compare the Incidence of Biliary Complications After Liver Transplantation|A Randomized Controlled Prospective Study to Compare the Incidence of Biliary Complications After Liver Transplantation|Enrolling by invitation||N/A|120|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|t|f|f||||No||2017-10-10 21:02:00.353366|2017-10-10 21:02:00.353366
NCT03165903|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-29|||February 2013|Actual|2013-02-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Habitual and Neurocognitive Processes in Adolescent Obesity Prevention|Habitual and Neurocognitive Processes in Adolescent Obesity Prevention|Completed||N/A|187|Actual|Claremont Graduate University||2|||f||||t|f|f||||||Yes|The adolescent baseline and follow-up and parent's baseline and follow up data will be available. The baseline/follow up surveys and data dictionaries will be available. The data are currently available from the Principal Investigator, and the study team is working toward placement of the materials with a national data sharing center.|2017-10-10 21:02:00.444046|2017-10-10 21:02:00.444046
NCT03165890|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Acetazolamide on Cognition in Patients With Respiratory Disease at Altitude|Effect of Acetazolamide on Visuomotor Learning Performance in Patients With Chronic Obstructive Pulmonary Disease at Altitude|Recruiting||Phase 4|70|Anticipated|University of Zurich||2|||f||||f|f|f||||||Undecided||2017-10-10 21:02:00.539038|2017-10-10 21:02:00.539038
NCT03165877|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-22|||May 31, 2016|Actual|2016-05-31|May 2017|2017-05-01|October 13, 2016|Actual|2016-10-13|October 13, 2016|Actual|2016-10-13||Interventional|LGIM||Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy|Effect of Low-glycemic Index Lunches and Dinners Intake on Indicators of Satiety, Metabolic Parameters and Liver Steatosis Degree on Women With Type 2 Diabetes Under Metformin Therapy: Controlled Clinical Trial|Completed||N/A|13|Actual|Universidad de Valparaiso||2|||f||||t||||||||No||2017-10-10 21:02:00.665088|2017-10-10 21:02:00.665088
NCT03165864|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-22|||June 6, 2017|Anticipated|2017-06-06|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered Subcutaneously to Healthy Volunteers|A Double-Blind, Placebo-Controlled, Dose-Escalation, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 702843 Administered Subcutaneously to Healthy Volunteers|Recruiting||Phase 1|44|Anticipated|Ionis Pharmaceuticals, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:02:00.761484|2017-10-10 21:02:00.761484
NCT03165851|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-24|||April 10, 2005|Actual|2005-04-10|May 2017|2017-05-01|December 31, 2015|Actual|2015-12-31|December 31, 2012|Actual|2012-12-31||Observational|||Efficacy Analysis of Comparison of CAMS（Chinese Academy of Medical Sciences）-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia|Efficacy Analysis of Comparison of CAMS-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia|Completed||N/A|320|Actual|Institute of Hematology & Blood Diseases Hospital|||2||f||||f|f|f||||||Undecided|The outcomes of CAMS（Chinese Academy of Medical Sciences）-2009 trial are retrospectively analyzed, and compared to the CAMS-2005 trial.|2017-10-10 21:02:00.845888|2017-10-10 21:02:00.845888
NCT03165838|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-08-14|||November 18, 2013|Actual|2013-11-18|August 2017|2017-08-01|June 20, 2017|Actual|2017-06-20|March 3, 2016|Actual|2016-03-03||Interventional|||Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance|Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance|Completed||N/A|364|Actual|Virginia Commonwealth University||2|||f||||f|f|f||||||||2017-10-10 21:02:00.927905|2017-10-10 21:02:00.927905
NCT03165825|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-14|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||Cervical Interlaminar Versus Transforaminal Epidural Steroid Injection|Pragmatic Randomized Prospective Study of Cervical Interlaminar Epidural Injection of Particulate Steroid and Cervical Transforaminal Epidural Injection of Non-particulate Steroid in Patients With Cervical Radicular Pain|Not yet recruiting||Phase 4|102|Anticipated|Vanderbilt University Medical Center||2|||f|||||t|f|||f|||||2017-10-10 21:02:01.016651|2017-10-10 21:02:01.016651
NCT03165812|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-09-05|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|DIMS||A Diabetes Improvement in Medical Therapy Versus SADJB Study|Single Anastomosis Duodeno Jejunal Bypass With Sleeve Gastrectomy (SADJB-SG) Versus Intensive Medical Therapy (IMT) in the Treatment of Type 2 Diabetes Mellitus Among Asian Patients With BMI 23.5 - 30 kg/m2: A Clinical Trial|Recruiting||N/A|84|Anticipated|Universiti Putra Malaysia||2|||f||||t|f|f||||||||2017-10-10 21:02:01.104855|2017-10-10 21:02:01.104855
NCT03165799|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-23|||January 31, 2017|Actual|2017-01-31|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|March 15, 2017|Actual|2017-03-15||Interventional|MHC||Mindfulness to the Clinical Setting: The Mind Hand Connection Study|Mindfulness to the Clinical Setting: The Mind Hand Connection Study|Completed||N/A|32|Actual|University of Michigan||2|||f||||f|f|f||||||No||2017-10-10 21:02:01.254818|2017-10-10 21:02:01.254818
NCT03165786|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||May 6, 2016|Actual|2016-05-06|May 2017|2017-05-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|FREE||A Cognitive Behavioral Intervention to Reduce Fear of Hypoglycemia in Young Adults With Type 1 Diabetes|A Cognitive Behavioral Intervention to Reduce Fear of Hypoglycemia in Young Adults With Type 1 Diabetes|Recruiting||N/A|10|Anticipated|University of Illinois at Chicago||2|||f||||t|f|f||||||Undecided|undecided|2017-10-10 21:02:01.338029|2017-10-10 21:02:01.338029
NCT03165773|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-23|||August 24, 2015|Actual|2015-08-24|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Four-hour Glycemic Kinetic Response Following 13C-enriched Oatmeal Breakfast Compared to Hot Corn Grits|Four-hour Glycemic Kinetic Response Following 13C-enriched Oatmeal Breakfast Compared to Hot Corn Grits|Completed||N/A|15|Actual|PepsiCo Global R&D||2|||f||||f|f|f||||||No||2017-10-10 21:02:01.461559|2017-10-10 21:02:01.461559
NCT03165760|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-23|||July 1, 2015|Actual|2015-07-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Protective Mechanical Ventilation and Risk of Postoperative Complications in Abdominal Surgery|Protective Mechanical Ventilation and Risk of Postoperative Complications in Abdominal Surgery|Completed||N/A|80|Actual|Mongi Slim Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:02:01.557364|2017-10-10 21:02:01.557364
NCT03165721|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-18|||August 16, 2017|Actual|2017-08-16|August 14, 2017|2017-08-14|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer|A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), In Children And Adults With Wild Type GIST, Pheochromocytoma And Paraganglioma Associated With Succinate Dehydrogenase Deficiency And HLRCC-Associated Kidney Cancer|Recruiting||Phase 2|70|Anticipated|National Institutes of Health Clinical Center (CC)||3|||t|||||t|f||||||||2017-10-10 21:02:01.91918|2017-10-10 21:02:01.91918
NCT03165708|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||January 2, 2017|Actual|2017-01-02|May 2017|2017-05-01|May 20, 2017|Actual|2017-05-20|May 16, 2017|Actual|2017-05-16||Observational|||Epidural Computer Controlled System for the Epidural Space Verification|Identification of the Epidural Space: a Double Blind Comparison Between th CompuFlo® Epidural Computer Controlled System and the Standard LOR to Saline Technique in Obstetrics|Completed||N/A|30|Actual|Città di Roma Hospital|||1||f|||||f|f||||||No||2017-10-10 21:02:02.042294|2017-10-10 21:02:02.042294
NCT03165695|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults|Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults|Not yet recruiting||Phase 4|50|Anticipated|Brigham and Women's Hospital||2|||f||||f|t|f|||f|||No||2017-10-10 21:02:02.133012|2017-10-10 21:02:02.133012
NCT03165682|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-23|||March 1, 2018|Anticipated|2018-03-01|May 2017|2017-05-01|November 30, 2018|Anticipated|2018-11-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Fatigue, Depression, and Cortical Excitability in Systemic Lupus|Fatigue, Depression, and Cortical Excitability Changes in Systemic Lupus Erythematosus|Not yet recruiting||N/A|75|Anticipated|Assiut University|||3||f|||||f|f||||||||2017-10-10 21:02:02.224324|2017-10-10 21:02:02.224324
NCT03165669|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-25|||May 25, 2017|Actual|2017-05-25|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Evaluation of the Efficacy of Cervical Pillows in Subjects With Non-specific Chronic Neck Pain|Randomized, Controlled Clinical Trial With Cross-over on the Efficacy of Cervical Pillows and an Educational Intervention in Patients With Chronic Non-specific Neck Pain|Recruiting||N/A|70|Anticipated|University of Bologna||2|||f||||f|f|f||||||No||2017-10-10 21:02:02.296156|2017-10-10 21:02:02.296156
NCT03165656|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|3 Days|Observational [Patient Registry]|||Right Ventricular Function at Rest in Highlanders/Lowlanders|Right Ventricular Function at Rest in Highlanders With Pulmonary Hypertension Compared to Highlanders Without Pulmonary Hypertension and Lowlanders|Recruiting||N/A|120|Anticipated|University of Zurich|||3||f||||f|f|f||||||Undecided||2017-10-10 21:02:02.407556|2017-10-10 21:02:02.407556
NCT03165643|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-23|||March 6, 2014|Actual|2014-03-06|May 2017|2017-05-01|October 18, 2014|Actual|2014-10-18|October 18, 2014|Actual|2014-10-18||Observational|||The DNA Methylation of ARHGEF11 in Macrosomia|Epigenetic Alteration of Rho Guanine Nucleotide Exchange Factor 11 (ARHGEF11) in Cord Blood Samples in Macrosomia Exposed to Intrauterine Hyperglycaemia|Completed||N/A|239|Actual|Peking University First Hospital|||4||f|||||f|f||||||||2017-10-10 21:02:02.47852|2017-10-10 21:02:02.47852
NCT03165630|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-08|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|SPORT||Stroke Patients' Outpatient Rehabilitation Therapy (SPORT)|A Randomized Controlled Trial to Improve the Uptake of and Adherence to Outpatient Rehabilitation Services Among Stroke Patients|Recruiting||N/A|300|Anticipated|National University, Singapore||3|||f||||f|f|f||||||Undecided||2017-10-10 21:02:02.539001|2017-10-10 21:02:02.539001
NCT03165617|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-10-03|||May 24, 2017|Actual|2017-05-24|October 2017|2017-10-01|March 17, 2019|Anticipated|2019-03-17|March 17, 2019|Anticipated|2019-03-17||Interventional|||Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to ≤18 Years of Age|A Phase III/IV, Stratified, Randomized, Observer Blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of a Cell-Based Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Influenza Comparator Vaccine in Subjects ≥2 to <18 Years of Age|Recruiting||Phase 4|6368|Anticipated|Seqirus||2|||f||||t|t|f||||||||2017-10-10 21:02:02.620193|2017-10-10 21:02:02.620193
NCT03165604|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||The Effect of Information on Physical Fitness Measures and Training in Overweight Children|The Effect of Information on Physical Fitness Measures and Training in Overweight Children|Not yet recruiting||N/A|60|Anticipated|Meir Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:02:02.73652|2017-10-10 21:02:02.73652
NCT03165591|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-23|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|February 28, 2020|Anticipated|2020-02-28||Interventional|V3-P||Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer|Open Label Phase II Immunotherapy Trial of Inoperable Pancreatic Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|Immunitor LLC||1|||f||||f|f|f||||||Undecided|The data will be shared with other researchers upon request on study conclusion|2017-10-10 21:02:02.816914|2017-10-10 21:02:02.816914
NCT03165578|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-22|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Neural Correlates of Neurofeedback Training|Neural Correlates of Neurofeedback Training|Recruiting||N/A|210|Anticipated|Psychiatric University Hospital, Zurich||2|||f||||f|f|f||||||No||2017-10-10 21:02:02.89406|2017-10-10 21:02:02.89406
NCT03165565|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Facilitating Treatment Entry and Family Planning in Substance-using NICU Mothers|Facilitating Treatment Entry and Family Planning in Substance-using NICU Mothers|Recruiting||N/A|64|Anticipated|The University of Texas Health Science Center, Houston||2|||f|||||f|f||||||||2017-10-10 21:02:02.972132|2017-10-10 21:02:02.972132
NCT03165552|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-10-02|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|ED-AKI-P||An Educational Intervention to Prevent Acute Kidney Injury in Primary Care. The ED-AKI-P Implementation Study|An Educational Intervention to Prevent Acute Kidney Injury in Primary Care. The ED-AKI-P Implementation Study|Active, not recruiting||N/A|50|Anticipated|University of Leicester||1|||f||||f||||||||||2017-10-10 21:02:03.050835|2017-10-10 21:02:03.050835
NCT03165539|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||September 2015||2015-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients|The Effect of Intraoperative Cerebral Oxygen Desaturation on Post-Operative Delirium in Thoracic Surgical Patients: A Pilot Study|Recruiting||N/A|200|Anticipated|University of Manitoba|||1||f||||f||||||||No||2017-10-10 21:02:03.112431|2017-10-10 21:02:03.112431
NCT03165526|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-10-04|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Observational|PIVSD PAS||The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study|The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study|Not yet recruiting||N/A|30|Anticipated|St. Jude Medical|||2||f||||f|f|t|f|f|t|||||2017-10-10 21:02:03.331609|2017-10-10 21:02:03.331609
NCT03165513|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||July 1, 2014|Actual|2014-07-01|May 2017|2017-05-01|March 20, 2015|Actual|2015-03-20|March 20, 2015|Actual|2015-03-20||Interventional|Dialogue||Dialogue to Empower Traditional and Faith Healers to Deliver mhGAP-IG Adapted Psychosocial Interventions in Kenya|Dialogue to Empower, Supervise, Support and Include the Traditional and Faith Healers to Deliver Evidence-based mhGAP-IG Adapted Psychosocial Interventions to Reduce Treatment Gap in Kenya|Completed||N/A|4081|Actual|Africa Mental Health Foundation||1|||f||||f|f|f||||||Yes|Deidentified data will be made available to the researchers on request through the principal investigator. A data request form available at AMHF will be used to make the request|2017-10-10 21:02:03.478158|2017-10-10 21:02:03.478158
NCT03165500|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-22|||December 23, 2015|Actual|2015-12-23|May 2017|2017-05-01|May 4, 2017|Actual|2017-05-04|December 20, 2016|Actual|2016-12-20||Interventional|||Comparative Evaluation of Three Anxiety Control Protocols in Third Molar Extraction|Comparative Evaluation of Three Anxiety Control Protocols in Third Molar Extraction With Midazolam, Diazepam and Nitrous Oxide - Randomized Clinical Trial.|Completed||Early Phase 1|3|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||t|f|f||||||No||2017-10-10 21:02:03.57438|2017-10-10 21:02:03.57438
NCT03165487|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|||Comparison of the Breast Tumor Microenvironment|Differential Comparison of the Breast Tumor Microenvironment Between Luminal A and Triple Negative Breast Cancer With and Without Radiation Treatment|Recruiting||N/A|30|Anticipated|Columbia University|||2||f||||t|f|f||||Samples With DNA|"     Two specimens will be collected. A shaved margin of the area surrounding the tumor,     considered as normal tissue, will be collected at two time points. The tissue will be     collected prior to intraoperative radiation therapy, and immediately after. Blood will also     be collected.   "|No||2017-10-10 21:02:03.693296|2017-10-10 21:02:03.693296
NCT03165474|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-22|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Intervention INC: Interactive Nutrition Comics for Urban Minority Youth|Intervention INC: Interactive Nutrition Comics for Urban Minority Youth|Not yet recruiting||N/A|164|Anticipated|Hunter College of City University of New York||2|||f||||f|f|f||||||No||2017-10-10 21:02:03.812549|2017-10-10 21:02:03.812549
NCT03165461|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-04|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Observational|IKING||Evaluation of the Use of Tracheal Intubation Through a Laryngeal Tube to Intubate Anesthetized Patients|Evaluation of the Use of Tracheal Intubation Through a Laryngeal Tube to Intubate Anesthetized Patients|Recruiting||N/A|34|Anticipated|Formacion Internacional para la Docencia e Investigación de la Vía Aérea|||1||f||||t||||||||No||2017-10-10 21:02:03.904435|2017-10-10 21:02:03.904435
NCT03165448|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-22|||May 1, 2016|Actual|2016-05-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|December 1, 2016|Actual|2016-12-01||Observational|||Validation of Universal Scale in Oral Surgery (USOS) for Patient's Psycho-emotional Status Rating|Validation of Universal Scale in Oral Surgery (USOS) for Patient's Psycho-emotional Status Rating|Completed||N/A|90|Actual|Lithuanian University of Health Sciences|||1||f||||f|f|f||||||No|Individual participants data is not important or study outcomes and will not be shared in any circumstances.|2017-10-10 21:02:03.996302|2017-10-10 21:02:03.996302
NCT03165435|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-20|||June 23, 2017|Anticipated|2017-06-23|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|October 1, 2018|Anticipated|2018-10-01||Interventional|||A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis|A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy of Subcutaneous Injections of the Active Targeted Immunotherapy CV-MG01 in Patients With Moderate to Severe Myasthenia Gravis.|Recruiting||Phase 2/Phase 3|66|Anticipated|CuraVac||2|||f||||t|f|f||||||No||2017-10-10 21:02:04.11733|2017-10-10 21:02:04.11733
NCT03165422|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-10-05|||March 1, 2017|Actual|2017-03-01|October 2017|2017-10-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Observational|||A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan|A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan|Recruiting||N/A|80|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:02:04.235137|2017-10-10 21:02:04.235137
NCT03165409|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-10-04|||February 27, 2017|Actual|2017-02-27|October 2017|2017-10-01|September 30, 2017|Actual|2017-09-30|September 30, 2017|Actual|2017-09-30||Observational|||Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread|Economic Burden of Adverse Events Associated With Follow-Up Frequency Among Patients With Metastatic Melanoma|Completed||N/A|1828|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:02:04.348307|2017-10-10 21:02:04.348307
NCT03165396|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-05|||November 10, 2016|Actual|2016-11-10|May 2017|2017-05-01|September 1, 2018|Anticipated|2018-09-01|October 1, 2017|Anticipated|2017-10-01||Interventional|MCI||Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI|The Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With Mild Cognitive Impairment|Recruiting||N/A|100|Anticipated|The Third Central Clinical College of Tianjin Medical University||4|||f||||t|f|f||||||||2017-10-10 21:02:04.4334|2017-10-10 21:02:04.4334
NCT03165383|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-23|||February 11, 2013|Actual|2013-02-11|May 2017|2017-05-01|August 20, 2014|Actual|2014-08-20|July 10, 2014|Actual|2014-07-10||Interventional|TAP||The Analgesic Efficacy of Ultrasound Guided Transversus Abdominal Plane Block After Abdominal Cancer Surgeries|The Analgesic Efficacy of Ultrasound Guided Transversus Abdominis Plane (TAP) Block in Lower Abdominal OncoSurgeries|Completed||N/A|60|Actual|Rajiv Gandhi Cancer Institute & Research Center, India||2|||f||||t|f|f||||||No||2017-10-10 21:02:04.527771|2017-10-10 21:02:04.527771
NCT03165370|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-23|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|May 4, 2018|Anticipated|2018-05-04|May 4, 2018|Anticipated|2018-05-04||Observational|||The Study of the Relationship of Insomnia in the Traditional Chinese Medicine and Western Medicine at Local Clinic|The Study of the Relationship of Insomnia in the Traditional Chinese Medicine and Western Medicine at Local Clinic|Recruiting||N/A|200|Anticipated|China Medical University Hospital|||1||f|||||f|f||||||No||2017-10-10 21:02:04.605136|2017-10-10 21:02:04.605136
NCT03165357|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||October 10, 2015|Actual|2015-10-10|May 2017|2017-05-01|April 5, 2016|Actual|2016-04-05|March 10, 2016|Actual|2016-03-10||Interventional|||Sodium Bicarbonate Supplementation in Athletes|The Effect of Sodium Bicarbonate Supplementation on Physical Capacity and Body Composition in Trained Athletes|Completed||Phase 3|26|Actual|Poznan University of Life Sciences||2|||f||||f||||||||Undecided|Shared data will be exclusively related to the level recorded indicators (body composition, aerobic and anaerobic capacity indicators, levels of biochemical markers), without personal data. The data obtained will be attached to scientific publications, depending on the requirements of the journal|2017-10-10 21:02:04.682481|2017-10-10 21:02:04.682481
NCT03165344|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-21|||February 10, 2017|Actual|2017-02-10|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma|Effectiveness Evaluation of Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Early Esophageal Cancer Invading More Than 2/3 Esophageal Perimeter|Enrolling by invitation||N/A|76|Anticipated|Peking University Third Hospital||2|||f||||t|f|f||||||||2017-10-10 21:02:04.772922|2017-10-10 21:02:04.772922
NCT03165331|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|UNGFaceIT||Online Psychosocial Support for Young People With a Visible Difference: A Randomised Control Study|Online Psychosocial Support for Young People Distressed by Appearance-altering Conditions: A Randomised Control Trial (RCT)|Recruiting||N/A|150|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||Undecided|Norwegian data may be shared anonymously with the collaborating Centre for Appearance Research, Bristol, UK.|2017-10-10 21:02:04.882503|2017-10-10 21:02:04.882503
NCT03165318|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||March 7, 2017|Actual|2017-03-07|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pulsed Electromagnetic Field (PEMF) Systems to Promote the Maintenance of Bone and Muscle|A Randomized, Sham-Controlled Pilot Study of Pulsed Electromagnetic Field Therapy in Promoting the Maintenance of Muscle Following Anterior Cruciate Ligament (ACL) Reconstruction|Enrolling by invitation||N/A|22|Anticipated|National University Hospital, Singapore||2|||f||||f|f|f||||||No||2017-10-10 21:02:04.974339|2017-10-10 21:02:04.974339
NCT03165305|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants|The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants|Recruiting||N/A|200|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:02:05.091673|2017-10-10 21:02:05.091673
NCT03165292|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-06|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2025|Anticipated|2025-06-01|June 2023|Anticipated|2023-06-01||Interventional|VERITAS||Trial Evaluating and Comparing Two Intensification Treatment Strategies for Metastatic Neuroblastoma Patients With a Poor Response to Induction Chemotherapy|An International Multicenter Phase II Randomised Trial Evaluating and Comparing Two Intensification Treatment Strategies for Metastatic Neuroblastoma Patients With a Poor Response to Induction Chemotherapy|Not yet recruiting||Phase 2|150|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t|f|f||||||||2017-10-10 21:02:05.173802|2017-10-10 21:02:05.173802
NCT03165279|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-22|||December 7, 2016|Actual|2016-12-07|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01|2 Years|Observational [Patient Registry]|ZEPHYR||ZEnith AlPHa for AneurYsm Repair|ZEnith AlPHa for AneurYsm Repair (ZEPHYR)|Recruiting||N/A|450|Anticipated|Catharina Ziekenhuis Eindhoven|||1||f||||t|f|f||||||No||2017-10-10 21:02:05.270476|2017-10-10 21:02:05.270476
NCT03165266|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|January 1, 2018|Anticipated|2018-01-01||Observational|||Right Ventricular Involvement in Inferior Myocardial Infarction Patients Using 2 Dimensional Speckle Tracking Echocardiography|Incremental Role of 2 Dimensional Speckle Tracking Echocardiography in Diagnosis of Right Ventricular Involvement in Patients With Inferior Wall Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 21:02:05.432964|2017-10-10 21:02:05.432964
NCT03165253|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||June 2011|Actual|2011-06-01|May 2017|2017-05-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children|"The Effects of the Synbiotic Bifidobacterium Lactis B94 Plus Inulin Addition on Standard Triple Therapy of Helicobacter Pylori Eradication in Children"|Completed||N/A|69|Actual|Bulent Ecevit University||2|||f||||t|f|f||||||No||2017-10-10 21:02:05.491667|2017-10-10 21:02:05.491667
NCT03165240|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-10-04|||October 5, 2017|Anticipated|2017-10-05|October 2017|2017-10-01|September 24, 2018|Anticipated|2018-09-24|July 11, 2018|Anticipated|2018-07-11||Interventional|||This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 5 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated|Randomised, Double-blind, Placebo-controlled (Within Dose Groups) and Active Controlled (Eplerenone Group) Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 5 Oral Doses of BI 690517 Over 28 Days in Female and Male Patients With Diabetic Nephropathy|Not yet recruiting||Phase 1|126|Anticipated|Boehringer Ingelheim||7|||f||||f|f|f||||||||2017-10-10 21:02:05.575279|2017-10-10 21:02:05.575279
NCT03165227|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-10-02|||October 17, 2017|Anticipated|2017-10-17|October 2017|2017-10-01|August 13, 2018|Anticipated|2018-08-13|August 13, 2018|Anticipated|2018-08-13||Interventional|||This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)|Randomised, Double-blind, Placebo-controlled Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 4 Multiple Rising Oral Doses of BI 685509 Over 28 Days in Male and Female Patients With Diabetic Nephropathy|Not yet recruiting||Phase 1|100|Anticipated|Boehringer Ingelheim||5|||f||||f|t|f||||||||2017-10-10 21:02:05.649786|2017-10-10 21:02:05.649786
NCT03165214|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-08-13|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Embolization of Pelvic Veins in Treatment of Pelvic Congestion Syndrome|Effectiveness of Embolization of Pelvic Veins in Treatment of Pelvic Congestion Syndrome|Recruiting||N/A|52|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 21:02:05.71683|2017-10-10 21:02:05.71683
NCT03165201|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-18|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|July 1, 2019|Anticipated|2019-07-01||Observational|RADIcAL2||Non-Invasive Rapid Assessment of Patients With Liver Transplants Using Magnetic Resonance Imaging With LiverMultiScan|Non-invasive Rapid Assessment of Patients With Liver Transplants Using Magnetic Resonance Imaging With LiverMultiScan.|Recruiting||N/A|200|Anticipated|Perspectum Diagnostics Ltd|||1||f||||f|f|f||||Samples With DNA|"     Optional serum biobanking   "|||2017-10-10 21:02:05.796849|2017-10-10 21:02:05.796849
NCT03165188|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|June 2031|Anticipated|2031-06-01|June 2031|Anticipated|2031-06-01||Observational|||Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy|Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy|Not yet recruiting||N/A|500|Anticipated|NewLink Genetics Corporation|||1||f||||f|f|f||||||Undecided||2017-10-10 21:02:05.884436|2017-10-10 21:02:05.884436
NCT03165175|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-07|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|December 15, 2017|Anticipated|2017-12-15|October 15, 2017|Anticipated|2017-10-15||Interventional|MAPDE||Mobile Application for Prescription Drug-Abuse Education (MAPDE)|Mobile Application for Prescription Drug-Abuse Education (MAPDE)|Recruiting||N/A|60|Anticipated|Naval Health Research Center||2|||f||||f|f|f||||||No||2017-10-10 21:02:05.942486|2017-10-10 21:02:05.942486
NCT03165162|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-28|||May 22, 2017|Actual|2017-05-22|July 2017|2017-07-01|July 28, 2019|Anticipated|2019-07-28|July 28, 2019|Anticipated|2019-07-28||Interventional|NTR||Assessing Consumer's Characterization of the Term Natural in a Food Context|Assessing Consumer's Characterization of the Term Natural in a Food Context|Active, not recruiting||N/A|100|Anticipated|Institute for Food Safety and Health, United States||1|||f||||f|f|f||||||||2017-10-10 21:02:06.04247|2017-10-10 21:02:06.04247
NCT03165149|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-06-27|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of a Topical Ketamine on Acute and Chronic Pain, Dose Finding|Effect of a Topical Ketamine on Acute and Chronic Post-mastectomy Pain, Dose Finding - Clinical Study|Recruiting||Phase 2/Phase 3|90|Anticipated|Assiut University||3|||f||||t|t|f|||t|||Undecided||2017-10-10 21:02:06.11382|2017-10-10 21:02:06.11382
NCT03165136|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-22|||November 1, 2017|Anticipated|2017-11-01|May 2017|2017-05-01|February 1, 2023|Anticipated|2023-02-01|November 1, 2022|Anticipated|2022-11-01||Interventional|BBQ||Hydroxychloroquine for Prevention of Recurrent Miscarriage.|Prévention Des Fausses Couches Spontanées Répétées Par Hydroxychloroquine. Essai thérapeutique Multicentrique, randomisé, en Double Insu, Contre Placebo|Not yet recruiting||Phase 3|300|Anticipated|University Hospital, Brest||2|||f||||t|f|f||||||No||2017-10-10 21:02:06.224242|2017-10-10 21:02:06.224242
NCT03165123|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-24|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 1, 2020|Anticipated|2020-12-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Effect of Using Erythromycin A Versus Placebo With Dexamethasone in Prevention of Post-spinal Nausea and Vomiting.|Effect of Adding Erythromycin A to Dexamethasone in Preventing Post-operative Nausea and Vomiting in Caesarean Section Under Spinal Anesthesia With Spinal Opiate.|Not yet recruiting||Phase 4|160|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:02:06.30553|2017-10-10 21:02:06.30553
NCT03165110|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-22|||March 17, 2017|Actual|2017-03-17|May 2017|2017-05-01|May 12, 2017|Actual|2017-05-12|May 12, 2017|Actual|2017-05-12||Interventional|||Evaluation of an Ascensia Diabetes Care Blood Glucose Meter and App System|US ONYX 2.0 Study: A Clinical Study of the Onyx 2.0 System for Blood Glucose Monitoring in Patients With Diabetes|Completed||N/A|47|Actual|Ascensia Diabetes Care||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:02:06.387357|2017-10-10 21:02:06.387357
NCT03165097|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-26|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|November 28, 2017|Anticipated|2017-11-28|November 28, 2017|Anticipated|2017-11-28||Interventional|||Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy Subjects|A Single-center, Double-blind, Parallel-group, Randomized, Placebo-controlled, Multiple-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-709478 in Healthy Subjects|Recruiting||Phase 1|40|Anticipated|Actelion||2|||f||||f|f|f||||||||2017-10-10 21:02:06.472839|2017-10-10 21:02:06.472839
NCT03165084|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-22|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Person-centred Interactive Self-management Support in Primary Healthcare for People With Type 2 Diabetes|iSMS: Person-centred Interactive Self-management Support in Primary Healthcare for People With Type 2 Diabetes - A Randomized Controlled Trial|Recruiting||N/A|140|Anticipated|Umeå University||3|||f||||f|f|f||||||No||2017-10-10 21:02:06.59211|2017-10-10 21:02:06.59211
NCT03165071|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-07-26|||June 3, 2017|Actual|2017-06-03|July 2017|2017-07-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Interventional|||A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease|A Single-center, Open Label, Single-dose Study to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics of ACT-132577|Recruiting||Phase 1|16|Anticipated|Actelion||1|||f|||||f|f||||||||2017-10-10 21:02:06.730195|2017-10-10 21:02:06.730195
NCT03165058|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Assessment of Colonic Epithelial Integrity With Mucosal Impedance|Assessment of Colonic Epithelial Integrity With Mucosal Impedance|Enrolling by invitation||N/A|60|Anticipated|Vanderbilt University Medical Center|||2||f||||f|f|f||||||No||2017-10-10 21:02:06.819795|2017-10-10 21:02:06.819795
NCT03165045|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-21|||May 26, 2017|Actual|2017-05-26|September 2017|2017-09-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Observational|||Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)|AERIAL®: Changes in Health and Functional Status in Patients With COPD During Therapy With Spiolto® Respimat®|Recruiting||N/A|1300|Anticipated|Boehringer Ingelheim|||1||f|||||t|f||||||||2017-10-10 21:02:06.927998|2017-10-10 21:02:06.927998
NCT03165032|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|3 Days|Observational [Patient Registry]|||Right Ventricular Function During Exercise in Highlanders/Lowlanders|Right Ventricular Function During Exercise in Highlanders With Pulmonary Hypertension Compared to Highlanders Without Pulmonary Hypertension and Lowlanders|Recruiting||N/A|120|Anticipated|University of Zurich|||3||f||||f|f|f||||||Undecided||2017-10-10 21:02:09.289079|2017-10-10 21:02:09.289079
NCT03165019|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|||Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.|Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.|Recruiting||N/A|120|Anticipated|University of Zurich|||3||f||||f|f|f||||||Undecided||2017-10-10 21:02:09.380029|2017-10-10 21:02:09.380029
NCT03165006|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-22|||January 1, 2013|Actual|2013-01-01|May 2017|2017-05-01|December 31, 2015|Actual|2015-12-31|June 30, 2014|Actual|2014-06-30||Observational|||Effect of Interval Cancer and Screening Process on Survival and Disease-free Period in Breast Cancer|CAMISS Retrospective Cohort - Effect of Interval Cancer and Screening Process on Survival and Disease-free Period in Breast Cancer|Completed||N/A|1086|Actual|Parc de Salut Mar|||1||f||||f|f|f||||||No||2017-10-10 21:02:09.465707|2017-10-10 21:02:09.465707
NCT03164993|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-06|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|March 1, 2024|Anticipated|2024-03-01|November 1, 2020|Anticipated|2020-11-01||Interventional|ALICE||Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer|ALICE: A Randomized Placebo-controlled Phase II Study Evaluating Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer|Recruiting||Phase 2|75|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:02:09.547599|2017-10-10 21:02:09.547599
NCT03164980|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-23|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Observational|COMPASS||Comparison of QoL Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer|Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer|Not yet recruiting||N/A|206|Anticipated|North Eastern Germany Society of Gynaecologic Oncology|||2||f||||||||||||||2017-10-10 21:02:09.676332|2017-10-10 21:02:09.676332
NCT03164967|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-23|||December 29, 2016|Actual|2016-12-29|March 2017|2017-03-01|June 30, 2021|Anticipated|2021-06-30|March 31, 2021|Anticipated|2021-03-31||Interventional|||Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16|A Phase IV, Multicenter, Open-label Study to Evaluate the Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Disorders in Subjects Aged 2 to 16|Recruiting||Phase 4|18|Anticipated|Biotest Pharmaceuticals Corporation||1|||f||||t|t|f||||||Undecided|Not yet determined|2017-10-10 21:02:09.782066|2017-10-10 21:02:09.782066
NCT03164603|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-05|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||NLG802 Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors|A Phase 1 Study of NLG802 for Adult Patients With Recurrent Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|NewLink Genetics Corporation||1|||||||f|t|f||||||||2017-10-10 21:02:12.975599|2017-10-10 21:02:12.975599
NCT03164954|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-01|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|ALDO||"Observational Study of an Automatic Detection of Patients at Risk of Chronic Postoperative Pain (Alerte Douleur)"|Étude Observationnelle Prospective d'Une Alerte Douleur informatisée Automatique Par Les Applications Informatiques hospitalières Des HUG Pour prédire l'Apparition de Douleurs Chroniques Post opératoires|Recruiting||N/A|450|Anticipated|University Hospital, Geneva|||1||f||||f|f|f||||||||2017-10-10 21:02:09.901327|2017-10-10 21:02:09.901327
NCT03164941|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Observational|SLOS||Effect of SLT Location on Treatment Outcomes|Effect of 180 Degree Selective Laser Trabeculoplasty Location on Treatment Outcomes|Recruiting||N/A|84|Anticipated|St. Joseph's Healthcare Hamilton|||2||f|||||f|f||||||||2017-10-10 21:02:10.11206|2017-10-10 21:02:10.11206
NCT03164915|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||September 27, 2016|Actual|2016-09-27|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 10, 2017|Anticipated|2017-09-10||Interventional|||A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)|A Multicenter, Open-Label, Phase III Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)|Recruiting||Phase 3|39|Anticipated|SK Plasma Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 21:02:10.367259|2017-10-10 21:02:10.367259
NCT03164902|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-28|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|DASH||Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence|Evaluation of Wirelessly Observed Therapy to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence to Treatment|Recruiting||N/A|253|Anticipated|Proteus Digital Health, Inc.||1|||f||||t|f|t|f|f|f|||||2017-10-10 21:02:10.474479|2017-10-10 21:02:10.474479
NCT03164889|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-05-23|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients|Clinical and Basic Research of Relationship Between Hepatitis B Virus Quasi-Species Evolution and Function of Natural Killer Cells With Antiviral Therapy Response in Chronic Hepatitis B Patients|Recruiting||N/A|220|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:02:10.608486|2017-10-10 21:02:10.608486
NCT03164876|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-23|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|April 20, 2018|Anticipated|2018-04-20|April 20, 2018|Anticipated|2018-04-20||Interventional|||Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.|A Randomised, Double-blind, Placebo-controlled Study of the Safety, Pharmacokinetics and Exploratory Pharmacodynamics of AUT00206 for 28 Days as Adjunctive Therapy in Patients With Recently Diagnosed Schizophrenia|Recruiting||Phase 1|24|Anticipated|Autifony Therapeutics Limited||2|||f||||f|f|f||||||Yes|Data will be made publicly available on completion of the trial|2017-10-10 21:02:10.72372|2017-10-10 21:02:10.72372
NCT03164863|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||March 6, 2017|Actual|2017-03-06|May 2017|2017-05-01|March 6, 2018|Anticipated|2018-03-06|March 6, 2018|Anticipated|2018-03-06||Observational|||Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients|Feasibility Study of Motility Contrast Tomography for Predicting Therapeutic Response|Recruiting||N/A|150|Anticipated|Animated Dynamics, Inc.|||1||f||||f|f|f||||||No||2017-10-10 21:02:10.823508|2017-10-10 21:02:10.823508
NCT03164850|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-22|||December 9, 2016|Actual|2016-12-09|May 2017|2017-05-01|April 28, 2017|Actual|2017-04-28|April 5, 2017|Actual|2017-04-05||Observational|LTI||Laparoscopic Tactile Imaging in Urogynecologic Surgery|Laparoscopic Tactile Imaging in Urogynecologic Surgery|Completed||N/A|5|Actual|Advanced Tactile Imaging, Inc.|||1||f||||f|f|t|t||f|||Yes|Scientific Publications of the study results|2017-10-10 21:02:10.913602|2017-10-10 21:02:10.913602
NCT03164837|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-23|2017-05-23|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients|Safety and Diagnostic Performance of 68Gallium-labeled NOTA-RM26 PET/CT in Prostate Cancer Patients|Recruiting||Phase 1|30|Anticipated|Peking Union Medical College Hospital||1|||f|||||f|f||||||||2017-10-10 21:02:11.004503|2017-10-10 21:02:11.004503
NCT03164824|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-05-22|||April 2009||2009-04-01|May 2017|2017-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Thai Version of Functional Rating Index|Thai Version of the Functional Rating Index for Patients With Back and Neck Pain: Cross-cultural Adaptation and Psychometric Properties Testing|Completed||N/A|247|Actual|Mahidol University|||1||f||||t||||||||No||2017-10-10 21:02:11.100363|2017-10-10 21:02:11.100363
NCT03164811|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-22|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|April 1, 2018|Anticipated|2018-04-01|December 30, 2017|Anticipated|2017-12-30||Interventional|||GDFT Based on PPV Compared With Standard Fluid Therapy in Patients Undergoing Complex Spine Surgery: RCT|Goal Directed Fluid Therapy Based on Pulse Pressure Variation Compared With Standard Fluid Therapy in Patients Undergoing Complex Spine Surgery: a Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Mahidol University||2|||f||||t|f|f||||||No||2017-10-10 21:02:11.172165|2017-10-10 21:02:11.172165
NCT03164798|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-26|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|December 31, 2018|Anticipated|2018-12-31||Observational|BDNF||Serum BDNF Role as a Biomarker for Stroke Rehabilitation|Serum BDNF Role as a Biomarker for Stroke Rehabilitation|Recruiting||N/A|150|Anticipated|Samsung Medical Center|||1||f|||||f|f||||Samples With DNA|"     BDNF Val66Met polymorphism   "|No|There is no plan to make IPD available to other researchers.|2017-10-10 21:02:11.248065|2017-10-10 21:02:11.248065
NCT03164772|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2024|Anticipated|2024-07-01|October 2020|Anticipated|2020-10-01||Interventional|||Phase 1/2 Study of Combination Immunotherapy and mRNA Vaccine in Subjects With NSCLC|A Phase 1/2 Study of Combination Immunotherapy and mRNA Vaccine in Subjects With Non-small Cell Lung Cancer (NSCLC)|Not yet recruiting||Phase 1/Phase 2|56|Anticipated|Ludwig Institute for Cancer Research||2|||f||||f|t|f||||||No||2017-10-10 21:02:11.426964|2017-10-10 21:02:11.426964
NCT03164759|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Correlation Between Radiographic Bone Density in CBCT and Implant Stability Quotient Value: Clinical Observational Study|Correlation Between Radiographic Bone Density in CBCT and Implant Stability Quotient Value: Clinical Observational Study|Not yet recruiting||N/A|35|Anticipated|Cairo University|||1||f|||||f|f||||||||2017-10-10 21:02:11.547372|2017-10-10 21:02:11.547372
NCT03164746|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||December 2007||2007-12-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PACKING||Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism With Severe Injurious Behavior.|Demonstration of the Effectiveness of Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism Spectrum Disorder With Severe Injurious Behavior.|Completed||N/A|48|Actual|University Hospital, Lille||2|||f||||t|f|f||||||Undecided||2017-10-10 21:02:11.609358|2017-10-10 21:02:11.609358
NCT03164733|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||Age Dependency of Biological Reaction on Wear Particles|Age Dependency of Biological Reaction on Wear Particles|Not yet recruiting||N/A|80|Anticipated|University of Jena|||4||f||||f|f|f||||Samples With DNA|"     Blood samples of patients that have received a total hip arthroplasty   "|No||2017-10-10 21:02:11.717652|2017-10-10 21:02:11.717652
NCT03164720|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis|Serum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis|Not yet recruiting||N/A|60|Anticipated|Assiut University|||1||f||||t|f|f||||||Undecided|use Serum/Urinary monocyte chemoattractant protein-1 level as a marker for lupus nephritis|2017-10-10 21:02:11.78402|2017-10-10 21:02:11.78402
NCT03164707|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Predictive Value Of Admission Blood Glucose Level In Patients With Acute Myocardial Infarction|Predictive ValueOf Admission Blood Glucose Level In Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Angioplasty|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 21:02:11.832608|2017-10-10 21:02:11.832608
NCT03164694|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||May 20, 2017|Actual|2017-05-20|May 2017|2017-05-01|May 20, 2020|Anticipated|2020-05-20|May 20, 2019|Anticipated|2019-05-20||Interventional|APPEAL||APatinib Plus Chemotherapy vErsus Chemotherapy As First-line Treatment for Advanced NSCLC|A Multicenter Phase II Trial of Pemetrexed Plus Carboplatin With or Without Apatinib in Patients With Advanced Non-small Cell Lung Cancer Without EGFR Mutation, ALK Gene Rearrangement, and ROS1 Gene Rearrangement|Recruiting||Phase 2|128|Anticipated|Sun Yat-sen University||2|||f||||f|f|f||||||||2017-10-10 21:02:12.011041|2017-10-10 21:02:12.011041
NCT03164681|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 30, 2018|Anticipated|2018-12-30|November 30, 2018|Anticipated|2018-11-30||Observational|||Red Blood Cell Distribution Width as a Marker of Contrast Induced Nephropathy in Patients With Coronary Intervention|Red Blood Cell Distribution Width as a Predictor Marker of Contrast Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention|Not yet recruiting||N/A|126|Anticipated|Assiut University|||1||f||||f|f|f||||Samples Without DNA|"     whole blood ,serum,   "|No||2017-10-10 21:02:12.111215|2017-10-10 21:02:12.111215
NCT03164668|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes|Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes|Recruiting||N/A|40|Anticipated|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f|f|f||||||||2017-10-10 21:02:12.1835|2017-10-10 21:02:12.1835
NCT03164655|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|November 2021|Anticipated|2021-11-01|June 2021|Anticipated|2021-06-01||Interventional|SULTAN||SULTAN (Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network)|A Randomized Phase II Study Comparing Treatment Intensification With Hepatic Arterial Infusion Chemotherapy Plus Systemic Chemotherapy to Systemic Chemotherapy Alone in Patients With Liver-only Colorectal Metastases Considered Still Non Resectable After at Least Two Months of Systemic Induction Chemotherapy: SULTAN (Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network)|Not yet recruiting||Phase 2|140|Anticipated|UNICANCER||2|||f|||||f|f||||||||2017-10-10 21:02:12.284318|2017-10-10 21:02:12.284318
NCT03164642|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-09-13|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Using the LENA System in Early Intervention|Enhancing Communication Between Children in EI and Their Depressed Mothers|Not yet recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 21:02:12.364387|2017-10-10 21:02:12.364387
NCT03164629|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||April 17, 2017|Actual|2017-04-17|May 2017|2017-05-01|October 18, 2018|Anticipated|2018-10-18|June 18, 2018|Anticipated|2018-06-18||Interventional|||3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization|3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization|Recruiting||N/A|50|Anticipated|University of Miami||2|||f||||f|f|t|t|f|f|||No||2017-10-10 21:02:12.473575|2017-10-10 21:02:12.473575
NCT03164616|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-09-15|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|July 12, 2021|Anticipated|2021-07-12|July 31, 2019|Anticipated|2019-07-31||Interventional|POSEIDON||Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).|A Phase III, Randomized, Multi-Center, Open-Label, Comparative Global Study to Determine the Efficacy of Durvalumab or Durvalumab and Tremelimumab in Combination With Platinum-Based Chemotherapy for First-Line Treatment in Patients With Metastatic Non Small-Cell Lung Cancer (NSCLC) (POSEIDON)|Recruiting||Phase 3|801|Anticipated|AstraZeneca||3|||f||||t|t|f||||||||2017-10-10 21:02:12.580158|2017-10-10 21:02:12.580158
NCT03164590|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-16|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines|Effects of Local Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Inflammatory Cytokines Response After Total Abdominal Hysterectomy|Recruiting||Phase 4|90|Anticipated|Assiut University||3|||f||||t|t|f|||t|||||2017-10-10 21:02:13.058479|2017-10-10 21:02:13.058479
NCT03164577|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-22|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Utilizing Traditional Practices|Utilizing Traditional Practices to Decrease Substance Use Among Native Americans|Not yet recruiting||N/A|60|Anticipated|University of California, Los Angeles||2|||f||||t|f|f||||||No||2017-10-10 21:02:13.148711|2017-10-10 21:02:13.148711
NCT03164564|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women|A Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women|Not yet recruiting||Phase 3|3200|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 21:02:13.218509|2017-10-10 21:02:13.218509
NCT03164551|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-09-21|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|April 28, 2019|Anticipated|2019-04-28|April 28, 2019|Anticipated|2019-04-28||Interventional|TICON||TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment|A Phase IV, Single-blinded, Prospective, Randomized, Controlled, Multi-center Study to Compare the Clinical Outcomes of Genea Embryo Review Instrument Plus (GERI+) Time Lapse System With a Conventional Embryo Culture and Assessment System|Not yet recruiting||Phase 4|1386|Anticipated|Merck KGaA||2|||f||||f|f|f||||||||2017-10-10 21:02:13.329336|2017-10-10 21:02:13.329336
NCT03164538|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-08-28|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|(BEHOLD-16)||A Psychological-behavioral Intervention to Increase Activity in Type 2 Diabetes|A Psychological-behavioral Intervention to Increase Activity in Type 2 Diabetes: a 16-week Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||||2017-10-10 21:02:13.438022|2017-10-10 21:02:13.438022
NCT03164525|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||October 1, 2015|Actual|2015-10-01|May 2017|2017-05-01|September 15, 2016|Actual|2016-09-15|July 15, 2016|Actual|2016-07-15||Observational|||Validation of the Thai Version CPOT and BPS in Postoperative ICU Patients|Validation of the Thai Version Critical Care Pain Observation Tool and Behavioral Pain Scale in Postoperative Mechanically Ventilated ICU Patients|Completed||N/A|27|Actual|Mahidol University|||1||f||||f|f|f||||||No||2017-10-10 21:02:13.554875|2017-10-10 21:02:13.554875
NCT03164512|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-28|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol|The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol|Not yet recruiting||Phase 1|24|Anticipated|Johns Hopkins University||4|||f||||f|t|f||||||||2017-10-10 21:02:13.634106|2017-10-10 21:02:13.634106
NCT03164499|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Intensive Intervention to Improve Lifestyles in Subjects With Intermediate Cardiovascular Risk.|Effectiveness of an Intensive Intervention to Improve Lifestyles in Subjects With Intermediate Cardiovascular Risk: a Randomized Controlled Trial.|Not yet recruiting||N/A|200|Anticipated|Fundacion para la Investigacion y Formacion en Ciencias de la Salud||2|||f||||f|f|f||||||||2017-10-10 21:02:13.715114|2017-10-10 21:02:13.715114
NCT03164486|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||November 2016||2016-11-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide|First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide|Recruiting||Early Phase 1|27|Anticipated|University of California, Davis||1|||f||||t|t|f||||||||2017-10-10 21:02:13.841052|2017-10-10 21:02:13.841052
NCT03164473|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|January 2022|Anticipated|2022-01-01||Interventional|MAINRITSEG||Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.|MAINtenance of Remission With RITuximab Versus Azathioprine for Patients With Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis. A Prospective, Randomized, Controlled, Double-blind Study: the MAINRITSEG Trial|Not yet recruiting||Phase 4|98|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||No||2017-10-10 21:02:13.946836|2017-10-10 21:02:13.946836
NCT03164460|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Reirradiation for Small Inoperable Head and Neck Tumors|Phase II Randomized Trial of Stereotactic Onco-Ablative Reirradiation Versus Conventionally Fractionated Conformal Radiotherapy for Patients With Small Inoperable Head and Neck Tumors (SOAR-HN)|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|f|t|f|||||||2017-10-10 21:02:14.102134|2017-10-10 21:02:14.102134
NCT03164447|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-21|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|||UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients|A Multicenter, Randomized, Parallel-Arm, 24-Week Study of UB-421 in Combination With Optimized Background Therapy (OBT) Regimen in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection|Not yet recruiting||Phase 2/Phase 3|30|Anticipated|United BioPharma||2|||f|||||t|f||||||||2017-10-10 21:02:14.299118|2017-10-10 21:02:14.299118
NCT03164434|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-21|||September 2014||2014-09-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Influence of Drainage on EVD ICP-signal|Influence of Drainage of Cerebrospinal Fluid on ICP Signals Obtained Through an External Ventricular Drain.|Completed||N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 21:02:14.477425|2017-10-10 21:02:14.477425
NCT03164421|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-23|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||N-Acetylcysteine and L-carnitine in Pcos|N-Acetylcysteine Versus L-carnitine in Clomiphene Citrate Resistant Pcos Women. a Randomized Controlled Trial|Recruiting||Phase 2|100|Anticipated|Zagazig University||2|||f||||t|f|f|||f|||Yes|the collected data willbe available within 6 months|2017-10-10 21:02:14.573511|2017-10-10 21:02:14.573511
NCT03164408|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-21|||January 1, 2014|Actual|2014-01-01|May 2017|2017-05-01|April 5, 2017|Actual|2017-04-05|December 31, 2015|Actual|2015-12-31||Observational|||Orthopaedic Implant Removal|High Early Post-operative Complication Rate After Elective Aseptic Orthopedic Implant Removal of Upper and Lower Limb|Completed||N/A|1545|Actual|Universitätsmedizin Mannheim|||1||f||||t|f|f||||||No||2017-10-10 21:02:14.71796|2017-10-10 21:02:14.71796
NCT03164395|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-08-07|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation|The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation|Recruiting||N/A|30|Anticipated|University of Kentucky||2|||f||||f|f|f||||||||2017-10-10 21:02:14.825711|2017-10-10 21:02:14.825711
NCT03164382|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-25|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma|A Phase III Randomized Trial of Comparison of Survival Benefit of Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin With Sorafenib for Patients With Barcelona-Clinic Liver Cancer (BCLC)-C Stage Hepatocellular Carcinoma|Recruiting||Phase 3|130|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||No||2017-10-10 21:02:14.956419|2017-10-10 21:02:14.956419
NCT03164369|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-23|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Observational|Accuro||Real Time 3D Navigation and Traditional US to Identify Epidural Space Depth in Pregnancy|Accuracy of Real Time 3D Navigation Device to Identify Lumbar Epidural Spacy in Pregnant Patients. A Comparison With Standard Ultrasound.|Completed||N/A|90|Actual|Città di Roma Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:02:15.065729|2017-10-10 21:02:15.065729
NCT03164356|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-05-19|||November 9, 2016|Actual|2016-11-09|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees|Portable Bioimpedance Monitoring: Testing a New Diagnostic Interface|Recruiting||N/A|118|Anticipated|University of Washington||3|||f|||||f|f||||||||2017-10-10 21:02:15.151746|2017-10-10 21:02:15.151746
NCT03164343|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|September 22, 2018|Anticipated|2018-09-22|May 22, 2018|Anticipated|2018-05-22||Interventional|||Pain Neuroscience Education in Healthy Children|Pain Neuroscience Education in Healthy Children: A Pilot Study|Not yet recruiting||N/A|30|Anticipated|Vrije Universiteit Brussel||1|||f||||f|f|f||||||No|IPD will not be shared with other researchers|2017-10-10 21:02:15.381666|2017-10-10 21:02:15.381666
NCT03164330|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-22|||July 11, 2016|Actual|2016-07-11|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Illinois Workplace Wellness Study|Illinois Workplace Wellness Study|Active, not recruiting||N/A|4834|Actual|National Bureau of Economic Research, Inc.||7|||f||||f|f|f||||||Yes|Our study will collect detailed data on human subjects and perform several analyses using these data. These data will include self-reported survey data, biometric data, employer administrative data, and health care insurance claims data. Because our data are confidential and include protected health information, we can only share a de-identified version of the data. A statement is included on the study's informed consent form to secure participant's consent to make the de-identified data available to outside researchers. We will also provide replication code that will allow individuals to replicate all of our results. The public use version of our data and replication code for our analyses will be posted publicly on our study's website, which will be hosted at www.nber.org, as well as on the PI's websites.|2017-10-10 21:02:15.568795|2017-10-10 21:02:15.568795
NCT03164317|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-23|||April 6, 2017|Actual|2017-04-06|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|July 15, 2017|Anticipated|2017-07-15||Interventional|||To Test the Effectiveness of a Trained Nurse Led, M-health Enabled Intervention to Control Blood Pressure in India|A Cluster Randomised Controlled Trial of M-health Enabled, Nurse Care Coordinator Led Intervention to Improve Management of Hypertension in India: m-Power Heart Project|Enrolling by invitation||N/A|1872|Anticipated|Centre for Chronic Disease Control, India||2|||f||||f|f|f||||||No||2017-10-10 21:02:15.772013|2017-10-10 21:02:15.772013
NCT03164304|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-22|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|July 14, 2018|Anticipated|2018-07-14|May 30, 2018|Anticipated|2018-05-30||Interventional|||Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia|Efficacy and Safety of One Gram Versus Two Grams Intravenous Maintenance Dose of Magnesium Sulfate in Women With Severe Pre-eclampsia: a Randomized Clinical Trial.|Recruiting||Phase 4|222|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 21:02:15.917634|2017-10-10 21:02:15.917634
NCT03164291|ClinicalTrials.gov processed this data on October 10, 2017|2008-01-14|2017-05-19|||June 1984||1984-06-01|May 2017|2017-05-01|May 18, 2017|Actual|2017-05-18|September 2006|Actual|2006-09-01||Interventional|||Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex|Clinical Efficacy of Rifabutin in the Treatment of Serious and Life Threatening Infections Due to Mycobacterium Avium Complex, or Drug Resistant Mycobacterium Tuberculosis, or Other Drug Resistant Mycobacterium|Completed||Phase 3|170|Actual|The University of Texas Health Science Center at Tyler||1|||f||||f||||||||No||2017-10-10 21:02:16.059755|2017-10-10 21:02:16.059755
NCT03164278|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-08|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|SERT||Effectiveness of Web-Based Training (SERT)|Studying the Effectiveness of Remote Training|Not yet recruiting||N/A|200|Anticipated|University of Pittsburgh||3|||f||||f|f|f||||||||2017-10-10 21:02:16.175931|2017-10-10 21:02:16.175931
NCT03164252|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-05|||February 23, 2016|Actual|2016-02-23|September 2017|2017-09-01|December 6, 2016|Actual|2016-12-06|June 7, 2016|Actual|2016-06-07||Interventional|||Evaluation of Two Low-power Laser Protocols in the Post Operative Period of Patients With Lower Third Molar Surgery.|Evaluation of Two Protocols for the Application of Low-power Laser in Tissue Repair and in the Postoperative Period of Patients Submitted to Lower Third Molar Surgery Included - Double-blind Randomized Clinical Trial.|Completed||N/A|7|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||t|f|f||||||||2017-10-10 21:02:16.384403|2017-10-10 21:02:16.384403
NCT03164239|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-23|||April 1, 2011|Actual|2011-04-01|May 2017|2017-05-01|February 1, 2012|Actual|2012-02-01|October 1, 2011|Actual|2011-10-01||Interventional|AiS||Aktiv i Sør: a Randomized Controlled Trial|The Effect of a Tailored Telephone and Email Based Physical Activity Intervention on Physical Fitness and Body Composition: a Randomized Controlled Trial|Completed||N/A|111|Actual|University of Agder||2|||f||||t|f|f||||||No|The IPD of the present study will be shared through publications (articles).|2017-10-10 21:02:16.501345|2017-10-10 21:02:16.501345
NCT03164226|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-22|||May 15, 2015|Actual|2015-05-15|May 2017|2017-05-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||The Evaluation of Endothelial Function in the Diagnosis of Acute Coronary Syndrome (ACS)|The Evaluation of Endothelial Function in the Diagnosis of Acute Coronary Syndrome (ACS)|Recruiting||N/A|500|Anticipated|University of Monastir||1|||f||||t|f|f||||||Undecided||2017-10-10 21:02:16.604765|2017-10-10 21:02:16.604765
NCT03164213|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-02|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|April 30, 2020|Anticipated|2020-04-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Facilitation of Brain Plasticity for Language Recovery in Patients With Aphasia Due to Stroke|Facilitation of Brain Plasticity for Language Recovery in Patients With Aphasia Due to Stroke|Not yet recruiting||N/A|30|Anticipated|Loewenstein Hospital||2|||f|||||f|f||||||||2017-10-10 21:02:16.726423|2017-10-10 21:02:16.726423
NCT03164200|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-22|||December 14, 2011|Actual|2011-12-14|May 2017|2017-05-01|October 30, 2013|Actual|2013-10-30|October 30, 2013|Actual|2013-10-30||Interventional|||An Egg Based Breakfast Maintains Flexibility in Older Adults|An Egg Based Breakfast Maintains Flexibility in Older Adults|Completed||N/A|33|Actual|University of Alabama at Birmingham||2|||f||||f|f|f||||||No||2017-10-10 21:02:16.860551|2017-10-10 21:02:16.860551
NCT03164187|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-19|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|June 10, 2017|Actual|2017-06-10|May 15, 2017|Actual|2017-05-15||Observational|||Evaluation of Type 2 Diabetes Treatment|Evaluation of Type 2 Diabetes Treatment in AZERbaijan|Completed||N/A|150|Anticipated|Servier|||1||f|||||f|f||||||||2017-10-10 21:02:16.962521|2017-10-10 21:02:16.962521
NCT03164174|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-27|||May 17, 2017|Actual|2017-05-17|September 2017|2017-09-01|June 30, 2024|Anticipated|2024-06-30|May 13, 2024|Anticipated|2024-05-13||Observational|APRICOTS||Atherosclerosis-Progression in Coronary Arteries Compared to Periphery Vessels|Atherosclerosis-Progression in Coronary Arteries Compared to Periphery Vessels|Recruiting||N/A|55|Anticipated|Medical University Innsbruck|||1||f||||||||||||||2017-10-10 21:02:17.064462|2017-10-10 21:02:17.064462
NCT03164161|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-05-22|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Relationship Between Saliva β-endorphins Levels, Cold Pressor Test and Perception of Pain in Oral Surgery Procedures|The Relationship Between Saliva β-endorphins Levels, Sensitivity and Tolerance to Cold Pain and Perception of Pain in Oral Surgery Procedures in Adult Patients|Not yet recruiting||N/A|100|Anticipated|Lithuanian University of Health Sciences||4|||f||||f|f|f||||||No|No individual data will be available for sharing.|2017-10-10 21:02:17.160805|2017-10-10 21:02:17.160805
NCT03164148|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|May 16, 2018|Anticipated|2018-05-16|October 16, 2017|Anticipated|2017-10-16||Interventional|||Heart Rate Variability (HRV) in Pituitary Adenoma|A Study to Observe the Change of the Biological Signal (Heart Rate) During the Combined Pituitary Stimulation Test|Recruiting||N/A|50|Anticipated|Seoul St. Mary's Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:02:17.301445|2017-10-10 21:02:17.301445
NCT03164135|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-22|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|May 20, 2021|Anticipated|2021-05-20|May 20, 2019|Anticipated|2019-05-20||Interventional|||Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances|Safety and Feasibility Study of Allotransplantation of CRISPR/Cas9 CCR5 Gene Modified CD34+ Hematopoietic Stem/Progenitor Cells in HIV-infected Subjects With Hematological Malignances|Recruiting||N/A|5|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f|||||f|f||||||No||2017-10-10 21:02:17.413015|2017-10-10 21:02:17.413015
NCT03164122|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-19|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|AMIPREP||EVALUATION OF AN INNOVATIVE TREATMENT FOR RADIOCARPAL OSTEOARTHRITIS USING INTRA-ARTICULAR INJECTION OF A MIXTURE OF AUTOLOGOUS MICROFAT AND AUTOLOGOUS PLATELET-RICH PLASMA|EVALUATION OF AN INNOVATIVE TREATMENT FOR RADIOCARPAL OSTEOARTHRITIS USING INTRA-ARTICULAR INJECTION OF A MIXTURE OF AUTOLOGOUS MICROFAT AND AUTOLOGOUS PLATELET-RICH PLASMA|Recruiting||Phase 1/Phase 2|12|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||t|f|f||||||||2017-10-10 21:02:17.541483|2017-10-10 21:02:17.541483
NCT03164109|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-22|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase 1, Randomized, Placebo-and Positive-Controlled Crossover Study to Determine the Effect of Single-Dose GC4419 on QTc Interval in Healthy Volunteers|A Phase 1, Randomized, Placebo-and Positive-Controlled Crossover Study to Determine the Effect of Single-Dose GC4419 on QTc Interval in Healthy Volunteers|Not yet recruiting||Phase 1|28|Anticipated|Galera Therapeutics, Inc.||3|||f||||f|t|f||||||No||2017-10-10 21:02:17.648286|2017-10-10 21:02:17.648286
NCT03164096|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-09-26|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||The Effect of Some Parturients' Characteristics on Sensory Block Level After Spinal Anesthesia|The Effect of Body Mass Index, Intra-abdominal Pressure, Abdominal Girth and Waist Circumference on Sensory Block Level After Single-shot Spinal Anesthesia for Cesarean Section|Recruiting||Phase 4|100|Anticipated|Assiut University||1|||f||||t|f|f|||f|||||2017-10-10 21:02:17.7945|2017-10-10 21:02:17.7945
NCT03164083|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-10-03|||December 10, 2017|Anticipated|2017-12-10|May 2017|2017-05-01|July 5, 2018|Anticipated|2018-07-05|May 21, 2018|Anticipated|2018-05-21||Interventional|||The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis|Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells and Stromal Vascular Fraction Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial|Not yet recruiting||Phase 2|40|Anticipated|SCARM Institute, Tabriz, Iran||2|||f||||t|f|f||||||||2017-10-10 21:02:17.904482|2017-10-10 21:02:17.904482
NCT03163901|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-17|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury|The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury|Recruiting||N/A|180|Anticipated|Michigan State University||4|||f|||||f|f||||||||2017-10-10 21:02:20.149713|2017-10-10 21:02:20.149713
NCT03164070|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Study of the Laboratory-based Evaluation of the Degrees of Activity of Osteoarthritis|Study of the Laboratory-based Evaluation of the Degrees of Activity of Medium and Large Joint Osteoarthritis|Enrolling by invitation||N/A|70|Anticipated|The Republican Research and Practical Center for Epidemiology and Microbiology|||1||f||||f|f|f||||Samples Without DNA|"     Synovial fluid samples stored in the tube with sodium heparin. Venous blood samples drained     into tube with sodium heparin.   "|No||2017-10-10 21:02:18.039632|2017-10-10 21:02:18.039632
NCT03164057|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-29|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|June 30, 2027|Anticipated|2027-06-30|June 30, 2025|Anticipated|2025-06-30||Interventional|||A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase II Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia|Recruiting||Phase 2|200|Anticipated|St. Jude Children's Research Hospital||24|||f||||f|t|f||||||||2017-10-10 21:02:18.139694|2017-10-10 21:02:18.139694
NCT03164044|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||January 3, 2017|Actual|2017-01-03|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Observational|||Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy|Improved Basophil Activation Test (BAT) in the Diagnostics of IgE-mediated Drug Allergy|Enrolling by invitation||N/A|100|Anticipated|The Republican Research and Practical Center for Epidemiology and Microbiology|||1||f||||f|f|f||||Samples Without DNA|"     Whole blood drained into tubes with sodium heparin   "|No||2017-10-10 21:02:18.518296|2017-10-10 21:02:18.518296
NCT03164031|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-07-21|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Feasibility and Acceptability of Orthotic Shorts for People With Multiple Sclerosis|A Clinical Trial Evaluating the Feasibility and Acceptability of Orthotic Shorts for Walking Function in People With Multiple Sclerosis.|Not yet recruiting||N/A|16|Anticipated|Sheffield Hallam University||2|||f||||f|f|f||||||||2017-10-10 21:02:18.774108|2017-10-10 21:02:18.774108
NCT03164018|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-22|||March 7, 2017|Actual|2017-03-07|March 2017|2017-03-01|March 7, 2018|Anticipated|2018-03-07|March 7, 2018|Anticipated|2018-03-07||Observational|FAMILY||Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis|Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis|Recruiting||N/A|130|Anticipated|Genesis Pharma CNS & Specialty|||1||f|||||f|f||||||Undecided||2017-10-10 21:02:18.931069|2017-10-10 21:02:18.931069
NCT03164005|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-21|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|September 1, 2017|Anticipated|2017-09-01||Observational|Obesity||The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease|The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease|Recruiting||N/A|120|Anticipated|Wuhan Union Hospital, China|||4||f||||f|f|f||||Samples With DNA|"     Plasma，Peripheral blood mononuclear cells   "|No||2017-10-10 21:02:19.098419|2017-10-10 21:02:19.098419
NCT03163992|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-21|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib|Pembrolizumab in HCC|Not yet recruiting||Phase 2|60|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||t|||||2017-10-10 21:02:19.223998|2017-10-10 21:02:19.223998
NCT03163979|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-21|||July 1, 2015|Actual|2015-07-01|May 2017|2017-05-01|July 31, 2019|Anticipated|2019-07-31|April 30, 2019|Anticipated|2019-04-30||Interventional|PROGRAMMA||Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer|Individualized Precise Radiotherapy With the Guidance of Radiosensitivity: A Study on the Clinical Management Model of Locally Advanced Cervical Cancer|Recruiting||Phase 2/Phase 3|300|Anticipated|Nanjing Medical University||4|||f||||f|f|f||||||No||2017-10-10 21:02:19.393456|2017-10-10 21:02:19.393456
NCT03163966|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-19|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis|A Randomized, Double Blind, Placebo-controlled, Dose Response, Phase II, Multicentre Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of Oral CR6086 Administered at the Doses of 30, 90 or 180 mg Bid for 12 Weeks in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis|Not yet recruiting||Phase 2|240|Anticipated|Rottapharm Biotech||4|||f|||||f|f||||||||2017-10-10 21:02:19.533225|2017-10-10 21:02:19.533225
NCT03163953|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-01|||June 5, 2017|Anticipated|2017-06-05|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|November 30, 2017|Anticipated|2017-11-30||Interventional|||Promoting Physical Activity and Break in Office Workers|Survey and Promoting Physical Activity in Employees and Entrepreneurial Projects of Software Park Thailand Under the Office of Science and Technology (NSTDA.)|Recruiting||N/A|120|Anticipated|Mahidol University||3|||f||||f|f|f||||||Yes|All data will be made available for other researchers after the end of the study.|2017-10-10 21:02:19.638167|2017-10-10 21:02:19.638167
NCT03163940|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-21|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Laughter Yoga Intervention for People With Major Depressive Disorder|Laughter Yoga for Improving Depression, Anxiety and Stress in People Diagnosed With Major Depressive Disorder: A Feasibility Study|Not yet recruiting||N/A|72|Anticipated|The Hong Kong Polytechnic University||2|||f||||f|f|f||||||No||2017-10-10 21:02:19.777137|2017-10-10 21:02:19.777137
NCT03163927|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-19|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Simulation-Based Training on Performance and Stress in the Clinical Setting|The Effect of Simulation-Based Training on Performance and Stress in the Clinical Setting|Enrolling by invitation||N/A|40|Anticipated|Rigshospitalet, Denmark||2|||f||||f|f|f||||||No||2017-10-10 21:02:19.889645|2017-10-10 21:02:19.889645
NCT03163914|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-19|||July 19, 2017|Anticipated|2017-07-19|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Effect of Vasopressors on Spinal Anaesthesia Induced Hypotension|Comparison of the Effect of Epinephrine, Norepinephrine and Phenylephrine on Spinal Anesthesia Induced Hypotension|Recruiting||Phase 4|96|Anticipated|Cukurova University||3|||f||||f|f|f||||||||2017-10-10 21:02:20.008229|2017-10-10 21:02:20.008229
NCT03163706|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-22|||September 21, 2016|Actual|2016-09-21|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Interventional|STROOP||Evaluation of Stroop Effect in Patients With Schizophrenia|Evaluation of Stroop Effect in Patients With Schizophrenia|Recruiting||N/A|80|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:02:21.438438|2017-10-10 21:02:21.438438
NCT03163888|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-21|||January 1, 2000|Actual|2000-01-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Observational|||Effects of Navigation Versus Conventional Total Knee Arthroplasty on the Levels of Inflammation Markers|Effects of Computer Navigation Versus Conventional Total Knee Arthroplasty on the Levels of Inflammation Markers: A Prospective Comparative Study|Completed||N/A|200|Actual|Chang Gung Memorial Hospital|||2||f||||f|f|f||||Samples With DNA|"     Blood sampling and collection of hemovac drainage after TKR surgeries.   "|No||2017-10-10 21:02:20.24789|2017-10-10 21:02:20.24789
NCT03163875|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-25|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|June 10, 2018|Anticipated|2018-06-10||Observational|||Quality of Life in Patients With Chronic Urticaria|Quality of Life,Anxity,Depression and Quality of Sleep in Patients With Chronic Urticaria|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:02:20.311452|2017-10-10 21:02:20.311452
NCT03163862|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-16|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score|Granulocyte Stimulating Factor (G-CSF) to Increase the Rate of Implantation Success in IVF Patients in Preferable Preceptive Endometrium Scroe|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Istishari Arab Hospital||3|||f||||f|f|f|||f|||Undecided||2017-10-10 21:02:20.366197|2017-10-10 21:02:20.366197
NCT03163849|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-22|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|December 1, 2018|Anticipated|2018-12-01||Interventional|||Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients|Assessment of Haematological and Immunological Effect After New Direct Acting Antiviral Drugs in Chronic Hepatitis c Virus Egyptian Patients in Assiut Province|Not yet recruiting||Phase 3|50|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:02:20.447933|2017-10-10 21:02:20.447933
NCT03163836|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-24|||April 1, 2006|Actual|2006-04-01|May 2017|2017-05-01|March 10, 2023|Anticipated|2023-03-10|March 10, 2023|Anticipated|2023-03-10||Observational|||Concomitant Surgical Atrial Fibrillation Ablation in Double Valve Replacement|Impact of Concomitant Surgical Atrial Fibrillation Ablation in Patients Undergoing Double Valve Replacement|Recruiting||N/A|500|Anticipated|Guangzhou General Hospital of Guangzhou Military Command|||2||f|||||f|f||||||Undecided||2017-10-10 21:02:20.52419|2017-10-10 21:02:20.52419
NCT03163823|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-11|||February 23, 2017|Actual|2017-02-23|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|iPad||CTSI-iPad for Vented Patient Communication|A Randomized Controlled Trial of an iPad for Patient Communication During Mechanical Ventilation|Recruiting||N/A|75|Anticipated|Medical College of Wisconsin||2|||f||||f|f|f||||||||2017-10-10 21:02:20.618316|2017-10-10 21:02:20.618316
NCT03163810|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-05-21|||February 6, 2017|Actual|2017-02-06|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)|A Pilot Evaluation of the Effect of the Erchonia Verjú™ and EVRL Lasers on Reducing Aminoalanine Transaminase (ALT) in Individuals With Nonalcoholic Steatohepatitis (NASH)|Recruiting||N/A|30|Anticipated|Erchonia Corporation||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:02:20.706132|2017-10-10 21:02:20.706132
NCT03163797|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-29|||August 1, 2015|Actual|2015-08-01|April 2017|2017-04-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|PETMROPSCC||PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation|Usefulness of Integrated PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation|Recruiting||N/A|160|Anticipated|Chang Gung Memorial Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:02:20.790327|2017-10-10 21:02:20.790327
NCT03163784|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|SHIFT||SHIFT: Studying HIV Immunology After Fecal Transplant|SHIFT: Studying HIV Immunology After Fecal Transplant|Not yet recruiting||Phase 1/Phase 2|55|Anticipated|Massachusetts General Hospital||3|||f||||f|t|f||||||Undecided||2017-10-10 21:02:20.900522|2017-10-10 21:02:20.900522
NCT03163771|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-05-22|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Observational|PEROXY4G||Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases|Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases|Not yet recruiting||N/A|60|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||Samples With DNA|"     blood   "|No||2017-10-10 21:02:21.010079|2017-10-10 21:02:21.010079
NCT03163758|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-05-20|||January 2013||2013-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cerebral Reorganization of Stroke Patients After Repetitive Transcranial Magnetic Stimulation by Neuroimaging Analysis|Study of Cerebral Structural and Functional Reorganization of Stroke Patients After Repetitive Transcranial Magnetic Stimulation (rTMS) Using the Method of Neuroimaging Brain Network Analysis|Recruiting||N/A|50|Anticipated|Peking Union Medical College Hospital||2|||f|||||f|f||||||||2017-10-10 21:02:21.082316|2017-10-10 21:02:21.082316
NCT03163745|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-21|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|September 14, 2019|Anticipated|2019-09-14|June 14, 2019|Anticipated|2019-06-14||Observational|||Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis|Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis in Upper Egypt : A Prospective Hospital Based Study|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f|||||f|f||||||Undecided||2017-10-10 21:02:21.165084|2017-10-10 21:02:21.165084
NCT03163732|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-29|||June 29, 2017|Actual|2017-06-29|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|PROFILER 02||Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors.|A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (315 Cancer-related Gene Panel FoundationOne) Versus a Limited Molecular Profiling Panel (74 Cancer-related Gene Panel CONTROL) in Advanced Solid Tumors.|Recruiting||N/A|250|Anticipated|Centre Leon Berard||2|||f||||f|f|f||||||No||2017-10-10 21:02:21.243979|2017-10-10 21:02:21.243979
NCT03163719|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-22|||November 28, 2016|Actual|2016-11-28|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Impact of Early Lactate Dosage Compared to CK for Diagnosis of a Suspected Seizure|Impact of Early Lactate Dosage Compared to CK for Diagnosis of a Suspected Seizure, on Patient Admitted to an Emergency Unit|Recruiting||N/A|100|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 21:02:21.355082|2017-10-10 21:02:21.355082
NCT03163693|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-20|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG|The Effects of Dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in Patients Undergoing Off-pump Coronary Artery Bypass Grafting|Active, not recruiting||N/A|40|Actual|General Hospital of Ningxia Medical University||2|||f||||t||||||||No|safety|2017-10-10 21:02:21.51667|2017-10-10 21:02:21.51667
NCT03163680|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-03|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers|Efficacy of Low Dose of Proton Pumb Inhabitor in Treatment Upper Gastrointestinal Bleeding|Active, not recruiting||N/A|200|Anticipated|Damascus Hospital|||1||f||||t|f|f||||||||2017-10-10 21:02:21.59408|2017-10-10 21:02:21.59408
NCT03163667|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-06-02|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 1, 2021|Anticipated|2021-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|||CB-839 With Everolimus vs. Placebo With Everolimus in Patients With RCC|A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing CB-839 in Combination With Everolimus (CBE) vs. Placebo With Everolimus (PboE) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)|Not yet recruiting||Phase 2|252|Anticipated|Calithera Biosciences, Inc||2|||f||||t|t|f||||||No||2017-10-10 21:02:21.663546|2017-10-10 21:02:21.663546
NCT03163654|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-25|||December 2014||2014-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|NPDMMAGR||Novel Porcine Dermal Matrix in the Treatment of Multiple Adjacent Gingival Recessions|Novel Porcine Dermal Matrix Vs. Connective Tissue Graft in the Treatment of Multiple Adjacent Gingival Recessions of Miller Class I and II: a 12-month Randomized Controlled Clinical Trial|Completed||N/A|16|Actual|Botiss Medical AG||2|||f||||t|f|f||||||Undecided||2017-10-10 21:02:21.753843|2017-10-10 21:02:21.753843
NCT03163641|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-25|||November 5, 2017|Anticipated|2017-11-05|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Safety and Effectiveness of the EyeGate Ocular Bandage Gel Versus a Bandage Contact Lens for Acceleration of Re-epithelialization of Large Corneal Epithelial Defects in Patients Having Undergone PRK.|A Randomized, Masked (Reading Center), Prospective Pilot Study of the Safety and Effectiveness of the EyeGate Ocular Bandage Gel, a 0.75% Crosslinked Hyaluronic Acid Applied Topically, Versus a Bandage Contact Lens for Acceleration of Re-epithelialization of Large Corneal Epithelial Defects in Patients Having Undergone Photorefractive Keratectomy (PRK).|Not yet recruiting||Phase 1/Phase 2|45|Anticipated|Eyegate Pharmaceuticals, Inc.||3|||||||f|f|t|t|||||||2017-10-10 21:02:21.874438|2017-10-10 21:02:21.874438
NCT03163628|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-22|2017-07-12|||June 6, 2017|Actual|2017-06-06|July 2017|2017-07-01|June 13, 2019|Anticipated|2019-06-13|June 13, 2019|Anticipated|2019-06-13||Interventional|ANTOINE||biomArkers to differeNtiate bacTerial From vIral iNfEctions|Performance Assessment of 7 Biomarkers for the Diagnosis of Severe Bacterial Infections in Children Aged From 7 Days to 36 Months.|Recruiting||N/A|800|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:02:21.969272|2017-10-10 21:02:21.969272
NCT03163615|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-25|||June 17, 2017|Actual|2017-06-17|July 2017|2017-07-01|May 30, 2018|Anticipated|2018-05-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Effect of Tibet Rhodiola Capsule on Hypoxia and Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea|A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Effect of Tibet Rhodiola Capsule on Hypoxia and Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea: A Pilot Trial|Recruiting||N/A|80|Anticipated|Beijing Anzhen Hospital||2|||f|||||f|f||||||||2017-10-10 21:02:22.114434|2017-10-10 21:02:22.114434
NCT03163602|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-20|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|STP||Surgical Treatment of Peri-implantitis|Surgical Treatment of Peri-implantitis. A Randomised Controlled Trial.|Recruiting||N/A|40|Anticipated|The University of Western Australia||2|||f||||f|f|f|||f|||No||2017-10-10 21:02:22.245359|2017-10-10 21:02:22.245359
NCT03163589|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-29|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy|Effect of Erythropoietin and Hypothermia on Management of Neonatal Hypoxic Ischemic Encephalopathy|Not yet recruiting||Phase 3|40|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:02:22.349812|2017-10-10 21:02:22.349812
NCT03163576|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-21|2017-05-22|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis|The Efficacy and Safety of Niacin on Hyperphosphatemia in End Stage Renal Disease Patients Undergoing Haemodialysis|Not yet recruiting||Phase 4|150|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:02:22.431294|2017-10-10 21:02:22.431294
NCT03163563|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-05-21|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Perioperative Hypothermia Hypothermia in Ambulatory Surgery|Perioperative Hypothermia Hypothermia in Ambulatory Surgery by Self-warming or Forced-air Warming Blanket, a Randomised Controlled Trial|Completed||N/A|112|Actual|Aleris Helse|||2||f||||f|f|f||||||No||2017-10-10 21:02:22.503434|2017-10-10 21:02:22.503434
NCT03163550|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-20|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|September 10, 2017|Anticipated|2017-09-10|September 10, 2017|Anticipated|2017-09-10||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789|A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and the Drug-Drug Interaction Potential of Oral ACHN-383 and ACHN-789 in Healthy Subjects and to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ACHN-383 and ACHN-789 in Otherwise Healthy Subjects With Renal Impairment|Recruiting||Phase 1|44|Anticipated|Achaogen, Inc.||6|||f|||||f|f||||||||2017-10-10 21:02:22.574843|2017-10-10 21:02:22.574843
NCT03163537|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-29|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|May 13, 2017|Actual|2017-05-13|May 12, 2017|Actual|2017-05-12||Observational|||Disturbing Factors in the Operating Room|Disturbing Factors and Stress Levels in Vascular Surgeons During Kidney Transplantations|Completed||N/A|45|Actual|Radboud University|||3||f|||||f|t|f|f||||||2017-10-10 21:02:22.70274|2017-10-10 21:02:22.70274
NCT03163524|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-06-09|||March 2016||2016-03-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Behavioural Insights to Improve Take up of SRH Services (Uganda)|Applying Behavioural Insights to Improve Take up of Sexual and Reproductive Health Services|Recruiting||N/A|2000|Anticipated|Marie Stopes International||2|||f||||f||||||||||2017-10-10 21:02:22.761195|2017-10-10 21:02:22.761195
NCT03163511|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-07|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness|An Open-Label, First-In-Human Study Evaluating the Safety, Tolerability, and Efficacy of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness|Recruiting||Phase 1/Phase 2|55|Anticipated|ViaCyte||2|||f|||||t|f||||||||2017-10-10 21:02:22.839596|2017-10-10 21:02:22.839596
NCT03163498|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-09-26|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01|1 Month|Observational [Patient Registry]|||Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients|Sleep, Mood and Physical Activity Level in Patients With Hypertension|Recruiting||N/A|60|Anticipated|Universidade Federal de Goias|||2||f||||t|f|f||||||||2017-10-10 21:02:22.924817|2017-10-10 21:02:22.924817
NCT03163485|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-20|||July 25, 2017|Anticipated|2017-07-25|May 2017|2017-05-01|October 25, 2018|Anticipated|2018-10-25|September 25, 2018|Anticipated|2018-09-25||Interventional|||Hybrid Device DIALYTRODE for Multimodal Neuro-monitoring of Patients With Brain Injury and Status Epilepticus|Prospective, Open Label, Multi-centre, Controlled Phase 2a Clinical Trial to Investigate the Safety and Diagnostic Performance of the Multifunctional Hybrid Device Combining a Micro-dialysis Probe With an Intra-cortical Depth Electrode (DIALYTRODE) for Short Time Continuous Multimodal Neuro-monitoring of NICU Patients With Severe Brain Injury and Suspected Status Epilepticus in Surface EEG|Not yet recruiting||N/A|17|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f|f|f||||||Undecided||2017-10-10 21:02:23.141728|2017-10-10 21:02:23.141728
NCT03163472|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-23|||November 14, 2012|Actual|2012-11-14|May 2017|2017-05-01|August 7, 2013|Actual|2013-08-07|August 7, 2013|Actual|2013-08-07||Interventional|||Effect of Local Anaesthetic Volume on Axillary Brachial Plexus Block Duration|A Comparison of the Effects of Two Volumes (10 vs 30 mL) of Lidocaine 2% With Epinephrine 1:200 000 on the Duration of Ultrasound Guided Axillary Brachial Plexus Block.|Completed||N/A|30|Actual|Cork University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:02:23.269686|2017-10-10 21:02:23.269686
NCT03163459|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|September 16, 2018|Anticipated|2018-09-16|May 31, 2018|Anticipated|2018-05-31||Interventional|||Short-duration Selective Brain Cooling for Patients Undergoing Mechanical Thrombectomy|Short-duration Selective Brain Cooling for Ischemic Stroke Patients Undergoing Mechanical Thrombectomy: a Randomized Controlled Trial|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|Capital Medical University||2|||f||||t|f|f|||f|||No||2017-10-10 21:02:23.374915|2017-10-10 21:02:23.374915
NCT03163433|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-22|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|June 2019|Anticipated|2019-06-01||Interventional|||Feedback in the Consultation - a Dialogue-based Tool in Personalised Care Planning Using Systematic Patient Involvement|Feedback in the Consultation - a Dialogue-based Tool in Personalised Care Planning Using Systematic Patient Involvement|Not yet recruiting||N/A|282|Anticipated|University of Aarhus||2|||f||||f|f|f||||||No||2017-10-10 21:02:23.606705|2017-10-10 21:02:23.606705
NCT03163420|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-20|||July 2016||2016-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis|Effect of Pre-operative Diclofenac Potassium on the Anesthetic Efficacy of Inferior Alveolar Nerve Block in Cases With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial|Active, not recruiting||Phase 2/Phase 3|68|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:02:23.689115|2017-10-10 21:02:23.689115
NCT03163407|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|January 31, 2017|Actual|2017-01-31|December 31, 2016|Actual|2016-12-31||Interventional|||Norepinephrine Versus Ephedrine in Treatment of Hypotension During Spinal Anesthesia for Caesarean Section|Norepinephrine Versus Ephedrine for Treatment of Hypotension During Spinal Anesthesia for Caesarean Section|Completed||N/A|110|Actual|Mongi Slim Hospital||2|||f||||||||||||No||2017-10-10 21:02:23.805231|2017-10-10 21:02:23.805231
NCT03163394|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||April 23, 2017|Actual|2017-04-23|May 2017|2017-05-01|December 22, 2017|Anticipated|2017-12-22|December 22, 2017|Anticipated|2017-12-22||Observational|||HD5 Levels in Catheter Versus Bag Urine Specimens in Young Children for the Diagnosis of UTI|HD5 Levels in Catheter Versus Bag Urine Specimens in Young Children for the Diagnosis of UTI|Recruiting||N/A|450|Anticipated|Le Bonheur Children's Hospital|||1||f|||||f|f||||||||2017-10-10 21:02:23.898242|2017-10-10 21:02:23.898242
NCT03163381|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-22|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|April 11, 2019|Anticipated|2019-04-11|October 11, 2017|Anticipated|2017-10-11||Interventional|||Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.|Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.|Recruiting||Phase 2|40|Anticipated|Henan Cancer Hospital||1|||f||||f|f|f||||||Undecided|Temporarily not sure whether to be Shared the data.|2017-10-10 21:02:24.000238|2017-10-10 21:02:24.000238
NCT03163368|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-22|||May 9, 2017|Actual|2017-05-09|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors|A Phase 1 Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors|Recruiting||N/A|25|Anticipated|Cedars-Sinai Medical Center||1|||f||||t|f|t|f|||||No||2017-10-10 21:02:24.107668|2017-10-10 21:02:24.107668
NCT03163355|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-23|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 21, 2019|Anticipated|2019-05-21|May 21, 2019|Anticipated|2019-05-21||Interventional|||Comparison of Pureed Rice Using a Gelling Agent and Standard Pureed Rice|Comparison of Pureed Rice Using a Gelling Agent and Standard Pureed Rice in Swallowing in Elderly Patients With Dysphagia|Recruiting||N/A|100|Anticipated|Showa Inan General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:02:24.225361|2017-10-10 21:02:24.225361
NCT03163342|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-30|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Immune Response Following Seasonal Influenza Vaccination|Extent and Durability of Immune Response Following Seasonal Influenza Vaccination in Healthy Volunteers|Active, not recruiting||Phase 4|20|Anticipated|Altimmune, Inc.||1|||f||||f|t|f|||t|||No||2017-10-10 21:02:24.33346|2017-10-10 21:02:24.33346
NCT03163329|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-05-22|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|July 31, 2024|Anticipated|2024-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis|A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients Who Have Severe, Calcific, Bicuspid, Aortic Stenosis Requiring Aortic Valve Replacement|Not yet recruiting||Phase 2|300|Anticipated|China National Center for Cardiovascular Diseases||2|||f|||||f|f||||||||2017-10-10 21:02:24.447112|2017-10-10 21:02:24.447112
NCT03163316|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-20|2017-07-28|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|May 31, 2018|Anticipated|2018-05-31||Observational|||The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients.|The Role of Unenhanced Magnetic Resonance Imaging in Quantitative Assessment of Metastatic Involvement of Axillary Lymph Nodes in Patients With Breast Cancer: Observational Descriptive Study.|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 21:02:24.544386|2017-10-10 21:02:24.544386
NCT03163303|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-14|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|STAND||Smoking Tobacco and Drinking Study|Using Facebook to Address Smoking and Heavy Drinking in Young Adults|Not yet recruiting||Phase 4|160|Anticipated|University of California, San Francisco||2|||f||||f|t|f||||||||2017-10-10 21:02:24.640331|2017-10-10 21:02:24.640331
NCT03163290|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-23|||May 12, 2017|Actual|2017-05-12|May 2017|2017-05-01|March 12, 2018|Anticipated|2018-03-12|November 12, 2017|Anticipated|2017-11-12||Interventional|||Effect of Two Strengthening Protocols for Lower Limbs in Patients With Patellofemoral Pain|Effect of Two Strengthening Protocols for Lower Limbs in Patients With Patellofemoral Pain: Randomized Clinical Trial|Recruiting||N/A|52|Anticipated|Universidade Federal do Ceara||2|||f||||t|f|f||||||No|IPD will not be shared.|2017-10-10 21:02:24.776598|2017-10-10 21:02:24.776598
NCT03163277|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-22|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|March 30, 2019|Anticipated|2019-03-30|November 30, 2018|Anticipated|2018-11-30||Interventional|(MARAND-X)||Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)|MARaviroc-based Treatment Switch in HIV-positive Patients With HAND: Consequences of Reducing Antiretroviral-associated Neurotoxicity|Recruiting||Phase 4|76|Anticipated|University of Turin, Italy||2|||f||||f|f|f||||||No||2017-10-10 21:02:24.871668|2017-10-10 21:02:24.871668
NCT03163264|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|March 31, 2020|Anticipated|2020-03-31||Interventional|MTG||The Move Toward Your Goals Intervention|Testing the Efficacy of a Technology-assisted Intervention to Improve Weight Management of Obese Patients Within Patient Aligned Care Teams at the VA|Not yet recruiting||N/A|520|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:02:25.013928|2017-10-10 21:02:25.013928
NCT03163251|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 13, 2017|Anticipated|2017-06-13||Interventional|READ-SG||The READ-SG Study: Effect of Peer-Facilitated Small Group Discussions|The Reflect, Empathize, Analyze, and Discuss in Small Groups Study: The Effect of Peer-facilitated Small Group Discussions on Burnout and Professional Development Among Physician Trainees|Recruiting||N/A|250|Anticipated|Columbia University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:02:25.17076|2017-10-10 21:02:25.17076
NCT03163238|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-23|||May 30, 2017|Actual|2017-05-30|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Dexmedetomidine and the Inflammatory Response in Pediatric Cardiac Surgery|The Effect of Dexmedetomidine on the Inflammatory Response in Children Under Congenital Heart Disease Repair With Cardiopulmonary Bypass: A Randomized Controlled Clinical Trial|Recruiting||Phase 2|60|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 21:02:25.295591|2017-10-10 21:02:25.295591
NCT03163225|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-19|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Opportunities in Outpatient Care|Characterizing and Quantifying Challenges and Opportunities in Outpatient Care|Not yet recruiting||N/A|1000|Anticipated|Intermountain Health Care, Inc.|||1||f||||f|f|f||||||No||2017-10-10 21:02:25.405591|2017-10-10 21:02:25.405591
NCT03163212|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants|Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants|Not yet recruiting||Early Phase 1|20|Anticipated|University of Virginia||3|||f||||f|f|f||||||Undecided|Specimens which have been unidentified may be shared with outside labs for analysis|2017-10-10 21:02:25.532141|2017-10-10 21:02:25.532141
NCT03163199|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-19|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|TRIAGE||TRanslesIonal Assessment of Gradients During Endovascular Therapy|TRanslesIonal Assessment of Gradients During Endovascular Therapy|Recruiting||N/A|30|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:02:25.608476|2017-10-10 21:02:25.608476
NCT03163186|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||December 1, 2015|Actual|2015-12-01|May 2017|2017-05-01|August 18, 2016|Actual|2016-08-18|April 20, 2016|Actual|2016-04-20||Observational|ACCESS||Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).|Transradial Versus Transfemoral Arterial Access for Transarterial Embolization Therapy of Hepatic Carcinoma: A Patient Outcomes, Satisfaction, and Cost Analysis|Completed||N/A|55|Actual|Medical University of South Carolina|||1||f||||t|f|f||||||||2017-10-10 21:02:25.669469|2017-10-10 21:02:25.669469
NCT03163173|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-19|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subjects|A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subjects|Not yet recruiting||Phase 1|6|Anticipated|Galera Therapeutics, Inc.||1|||f||||f|t|f||||||No||2017-10-10 21:02:25.738047|2017-10-10 21:02:25.738047
NCT03163160|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-18|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|June 20, 2019|Anticipated|2019-06-20|June 20, 2018|Anticipated|2018-06-20||Interventional|||Electrolysis Technique vs Manual Therapy in Pelvic Pain|Intratissue Percutaneous Electrolysis Technique vs. Manual Therapy in Women With Dyspareunia and Pelvic Pain|Recruiting||N/A|58|Anticipated|Quirón Madrid University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:02:25.837144|2017-10-10 21:02:25.837144
NCT03163147|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-19|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||The Effect and Frequency of Helicobacter Pylori Infection in Primary Immune Thrombocytopenic Patients|The Effect and Frequency of Helicobacter Pylori Infection in Primary Immune Thrombocytopenic Patients Not Respond on Steroid Therapy.|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||No||2017-10-10 21:02:25.939511|2017-10-10 21:02:25.939511
NCT03163134|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-17|2017-05-26||February 3, 2011|Actual|2011-02-03|May 2017|2017-05-01|April 27, 2015|Actual|2015-04-27|April 27, 2015|Actual|2015-04-27||Interventional|||Lumbar Drain After Endoscopic Surgery of the Skull Base|Lumbar Drain After Endoscopic Surgery of the Skull Base|Terminated||N/A|170|Actual|University of Pittsburgh||2||Due to the fact data results were statistically significant among the two groups|f||||t|f|t|f|f|t|||||2017-10-10 21:02:25.999364|2017-10-10 21:02:25.999364
NCT03163121|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-08-25|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers|Safety and Protective Efficacy of Genetically Attenuated Pf∆b9∆Slarp (PfSPZ-GA1) Malaria Parasites in Healthy Dutch Volunteers|Recruiting||Phase 1|67|Anticipated|Sanaria Inc.||7|||f||||t|t|f||||||||2017-10-10 21:02:26.274903|2017-10-10 21:02:26.274903
NCT03163108|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-23|||March 15, 2017|Actual|2017-03-15|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|CLAC-4||Closed-loop Automatic Oxygen Control (CLAC-4) in Preterm Infants|Closed-loop Automatic Oxygen Control (CLAC-4) in Preterm Infants: a Randomized Controlled Trial of a Revised Algorithm|Recruiting||N/A|18|Anticipated|University Hospital Tuebingen||3|||f||||f|f|f||||||No|Sharing individual participant data is not intended|2017-10-10 21:02:26.393066|2017-10-10 21:02:26.393066
NCT03163095|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|July 2022|Anticipated|2022-07-01||Interventional|||Closed or Open Abdomen for the Management of Abdominal Sepsis|Closed Versus Open Abdomen in the Surgical Treatment of Severe Secondary Peritonitis: a Randomized Controlled Clinical Trial|Not yet recruiting||N/A|300|Anticipated|University of Calgary||2|||f||||f|f|f||||||No|Not shared.|2017-10-10 21:02:26.543803|2017-10-10 21:02:26.543803
NCT03163082|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-26|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Couple Interaction and Health Behaviors|Targeting Couple Coercion to Impact Health Behaviors and Regimen Adherence|Recruiting||N/A|200|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:02:26.634866|2017-10-10 21:02:26.634866
NCT03163056|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-19|||January 26, 2015|Actual|2015-01-26|May 2017|2017-05-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Smoking Cessation Treatment for Depressed Smokers|Behavioral Activation and Voucher-based Contingency Management for Smokers With Depression|Recruiting||N/A|150|Anticipated|University of Oviedo||3|||f||||f|f|f||||||No||2017-10-10 21:02:26.790905|2017-10-10 21:02:26.790905
NCT03163043|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||October 22, 2016|Actual|2016-10-22|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|July 31, 2017|Anticipated|2017-07-31||Interventional|IAAO-C||Protein Requirements for Active Children|Evaluation of Protein Requirements in Active Children|Recruiting||N/A|8|Anticipated|University of Toronto||1|||f||||f|f|f|||f|||No||2017-10-10 21:02:26.890797|2017-10-10 21:02:26.890797
NCT03163030|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||August 2014||2014-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Autonomic Regulation Therapy in Heart Failure With Preserved Ejection Fraction|Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure With Preserved Ejection Fraction (ANTHEM-HFpEF) Study|Recruiting||N/A|50|Anticipated|Cyberonics, Inc.||1|||f||||t|f|f||||||No||2017-10-10 21:02:26.957423|2017-10-10 21:02:26.957423
NCT03163017|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Assessment of Ability of 3D Fluorscopy in Aiding Accurate Syndesmotic Reduction Following Traumatic Ankle Injury|Does Intraoperative 3D Fluoroscopy Accurately Assess Syndesmotic Reduction Following Traumatic Ankle Injury?|Recruiting||N/A|30|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:02:27.045956|2017-10-10 21:02:27.045956
NCT03163004|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-19|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Implementation of Standing Desks at School|Implementing Standing Desks in Primary and Secondary Schools to Reduce Sedentary Time: Effect and Process Evaluation.|Active, not recruiting||N/A|343|Actual|University Ghent||2|||f|||||f|f||||||||2017-10-10 21:02:27.126057|2017-10-10 21:02:27.126057
NCT03162991|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-18|||October 26, 2017|Anticipated|2017-10-26|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|The A-TEAM||Aerobic Treadmill Exercise And Metabolism|The Effect of a 12-Week Aerobic Treadmill Exercise on Markers of Glucose Metabolism|Not yet recruiting||N/A|20|Anticipated|University of South Carolina||2|||f||||f|f|f|||f|||||2017-10-10 21:02:27.187193|2017-10-10 21:02:27.187193
NCT03162978|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Sprint to Fitness: Effect of Outcome Expectations on Responses to Interval Exercise Training|Effect of Outcome Expectations on Psychological and Physiological Responses to Interval Exercise Training|Recruiting||N/A|60|Anticipated|USDA Grand Forks Human Nutrition Research Center||2|||f||||f|f|f||||||||2017-10-10 21:02:28.894399|2017-10-10 21:02:28.894399
NCT03162965|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-07|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|March 1, 2019|Anticipated|2019-03-01|May 1, 2018|Anticipated|2018-05-01||Interventional|TI||Innovations in HIV Testing|Innovations in HIV Testing to Enhance Care for Young Women and Their Peers and Partners|Recruiting||N/A|3600|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|t|f||t|||No||2017-10-10 21:02:28.981129|2017-10-10 21:02:28.981129
NCT03162952|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-26|||September 30, 2011|Actual|2011-09-30|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|June 30, 2018|Anticipated|2018-06-30||Observational|CERC||RAND Center of Excellence for the Study of Appropriateness of Care in CAM|RAND Center of Excellence for the Study of Appropriateness of Care in CAM|Recruiting||N/A|2025|Anticipated|RAND|||1||f||||t|f|f||||||||2017-10-10 21:02:29.076126|2017-10-10 21:02:29.076126
NCT03162926|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-07|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Safety and Tolerability Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus|An Open-Label Study Evaluating the Safety and Tolerability of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus|Recruiting||Phase 1|15|Anticipated|ViaCyte||1|||f|||||t|f||||||||2017-10-10 21:02:29.151204|2017-10-10 21:02:29.151204
NCT03162913|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-24|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults|The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults|Not yet recruiting||N/A|49|Anticipated|USDA Human Nutrition Research Center on Aging||2|||f||||f|f|f||||||No||2017-10-10 21:02:29.225023|2017-10-10 21:02:29.225023
NCT03162900|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-29|||June 9, 2017|Actual|2017-06-09|September 2017|2017-09-01|October 16, 2017|Anticipated|2017-10-16|September 23, 2017|Actual|2017-09-23||Interventional|B1371023||A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects|A Phase 1, Single Center, Randomized, 4-way Crossover, Double Blinded, Placebo And Moxifloxacin Controlled Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects|Recruiting||Phase 1|36|Anticipated|Pfizer||2|||f||||f|f|f||||||||2017-10-10 21:02:29.338699|2017-10-10 21:02:29.338699
NCT03162887|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||February 6, 2014|Actual|2014-02-06|May 2017|2017-05-01|August 11, 2016|Actual|2016-08-11|July 12, 2014|Actual|2014-07-12||Interventional|||Educational Module and Decision Counseling Program in Increasing Mammography Screening Rates in Formerly Homeless Women With Serious Mental Illness|Mammogram Decision Support for Formerly Homeless Women With Serious Mental Illness|Completed||N/A|23|Actual|Thomas Jefferson University||1|||f||||f|f|f||||||||2017-10-10 21:02:29.442346|2017-10-10 21:02:29.442346
NCT03162874|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-12|||July 4, 2017|Actual|2017-07-04|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 15, 2018|Anticipated|2018-12-15||Interventional|AMBLED||Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients|A Multi-centre, Double-blind, Randomised, Placebo-controlled, Parallel-arm Phase IIa Trial to Evaluate the Efficacy, Safety and Tolerability of 28-Day Oral Treatment With PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Subjects With Parkinson's Disease Experiencing End-of-dose Wearing Off and Levodopa-Induced Dyskinesia (AMBLED)|Recruiting||Phase 2|165|Anticipated|Prexton Therapeutics||3|||f||||f|f|f||||||||2017-10-10 21:02:29.5419|2017-10-10 21:02:29.5419
NCT03162861|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-18|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Lumbar Plexus-sciatic Nerve Block With Sevoflurane on Cognitive Function in Elderly Patients After Hip Arthroplasty|Effects of Lumbar Plexus-sciatic Nerve Block Combined With Sevoflurane on Cognitive Function in Elderly Patients After Hip Arthroplasty: Study Protocol for a Prospective, Single-center, Open-label, Randomized, Controlled, Clinical Trial|Active, not recruiting||N/A|70|Anticipated|Qinghai University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:02:29.825253|2017-10-10 21:02:29.825253
NCT03162848|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-19|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ECHO||SystemCHANGE™ Intervention on Medication Adherence in Older Adults With Heart Failure|Impact of SystemCHANGE™ Intervention on Medication Adherence in Older Adults With Heart Failure: A Pilot RCT|Not yet recruiting||N/A|16|Anticipated|University of Missouri, Kansas City||2|||f||||f|f|f||||||No||2017-10-10 21:02:29.917065|2017-10-10 21:02:29.917065
NCT03162835|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-01|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|September 22, 2018|Anticipated|2018-09-22|May 22, 2018|Anticipated|2018-05-22||Observational|||Development and Clinimetric Properties of the Dutch Pediatric Neurophysiology of Pain Questionnaire in Healthy Children|Development and Clinimetric Properties of the Dutch Pediatric Neurophysiology of Pain Questionnaire in Healthy Children|Not yet recruiting||N/A|60|Anticipated|Vrije Universiteit Brussel|||2||f||||f|f|f||||||No|IPD will not be shared with other researchers.|2017-10-10 21:02:29.991881|2017-10-10 21:02:29.991881
NCT03162822|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-25|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Caregiver-Child Interaction and Health Behaviors|Targeting Parent-Child Coercion to Impact Health Behaviors and Regimen Adherence|Recruiting||N/A|200|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:02:30.109981|2017-10-10 21:02:30.109981
NCT03162809|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-25|||May 9, 2017|Actual|2017-05-09|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Observational|||Venopuncture-Free IVF for Monitoring IVF Patient Cycles|Venopuncture-Free IVF: Are More Frequent Sequential Salivary Hormone Measurements More Informative Than Daily Serum Monitoring of IVF Patients?|Recruiting||N/A|300|Anticipated|Boston IVF|||1||f||||f|f|f||||||No||2017-10-10 21:02:30.214038|2017-10-10 21:02:30.214038
NCT03162796|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-10-03|||August 24, 2017|Actual|2017-08-24|October 2017|2017-10-01|July 20, 2020|Anticipated|2020-07-20|October 11, 2019|Anticipated|2019-10-11||Interventional|Discover-1||A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNF Alpha Agents|Recruiting||Phase 3|360|Anticipated|Janssen Research & Development, LLC||3|||f||||t|t|f||||||||2017-10-10 21:02:30.325746|2017-10-10 21:02:30.325746
NCT03162783|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-31|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome|A Single-Center, Phase 2a, Randomized, Double Masked, Clinical Study to Assess the Safety, Tolerability, and Pharmacodynamic Activity of ADX-102 Ophthalmic Solution in Subjects With Dry Eye Syndrome|Recruiting||Phase 2|45|Anticipated|Aldeyra Therapeutics, Inc.||3|||f||||f|t|f||||||No||2017-10-10 21:02:30.652801|2017-10-10 21:02:30.652801
NCT03162770|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-19|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|June 30, 2018|Anticipated|2018-06-30|March 1, 2018|Anticipated|2018-03-01||Interventional|||Mindfulness Meditation Practice During Hemodialysis|Physiological and Psychological Impact of Mindfulness Meditation Practice on Chronic Hemodialysis Patients|Enrolling by invitation||N/A|50|Actual|Hospital Israelita Albert Einstein||2|||f||||t|f|f||||||Yes|Regular notification when treatment is discontinued, e.g., transplant treatment, death or transfer of dialysis unit|2017-10-10 21:02:30.727481|2017-10-10 21:02:30.727481
NCT03162757|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-19|||January 26, 2017|Actual|2017-01-26|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|JI vs SC||Comparison of Ultrasound-guided Central Venous Catherterization Via the Lower Internal Jugular Vein or the Subclavian Vein|Comparison of Ultrasound-guided Central Venous Catherterization Via the Lower Internal Jugular Vein or the Subclavian Vein|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f|f|f||||||No||2017-10-10 21:02:30.808329|2017-10-10 21:02:30.808329
NCT03162744|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-22|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Observational|ProFAES||Protective Factors Against Elderly Suicide|Methodical Search of Protective Factors During Interview of Suicidal Elderly Patients: Effect on the Proposed Care|Not yet recruiting||N/A|82|Anticipated|Groupe Hospitalier de la Rochelle Ré Aunis|||1||f||||f|f|f||||||Undecided||2017-10-10 21:02:30.912061|2017-10-10 21:02:30.912061
NCT03162731|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-24|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|November 2021|Anticipated|2021-11-01||Interventional|||Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage IVA-B Head and Neck Cancer|A Pilot Trial of Nivolumab and Ipilimumab in Combination With Radiotherapy in Patients With Locally Advanced Head and Neck Cancer; CA209-931|Recruiting||Early Phase 1|24|Anticipated|Thomas Jefferson University||1|||||||t|t|f||||||||2017-10-10 21:02:31.001123|2017-10-10 21:02:31.001123
NCT03162718|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-15|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer Surgery|A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer Surgery|Recruiting||N/A|30|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:02:31.107564|2017-10-10 21:02:31.107564
NCT03162705|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-19|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Observational|MPSCLC||Molecular Profiling in Small Cell Lung Cancer|Prospective Molecular Profiling in Small Cell Lung Cancer|Recruiting||N/A|120|Anticipated|Zhujiang Hospital|||1||f||||t|f|f||||||Undecided||2017-10-10 21:02:31.290779|2017-10-10 21:02:31.290779
NCT03162692|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Observational|||Preoperative Anxiety's Incidence and Related Factors in Surgical Patients|Preoperative Anxiety's Incidence and Related Factors in Surgical Patients|Recruiting||N/A|2000|Anticipated|Xuzhou Medical University|||1||f||||f|f|f||||||No||2017-10-10 21:02:31.388928|2017-10-10 21:02:31.388928
NCT03162679|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-23|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Culture-sensitive Emotion Regulation Group Therapy for Traumatized Refugees|Culture-sensitive Emotion Regulation Group Therapy for Traumatized Refugees: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Ludwig-Maximilians - University of Munich||2|||f|||||f|f||||||||2017-10-10 21:02:31.504342|2017-10-10 21:02:31.504342
NCT03162666|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-19|||May 25, 2017|Anticipated|2017-05-25|May 2017|2017-05-01|February 28, 2020|Anticipated|2020-02-28|December 31, 2019|Anticipated|2019-12-31||Observational|||Patient Outcomes Using an Expandable Spacer|Post-market Surveillance Study of Altera™ Minimally Invasive Articulating Expandable Spacer in a TLIF Interbody Fusion Device|Not yet recruiting||N/A|30|Anticipated|Globus Medical Inc|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:02:31.610475|2017-10-10 21:02:31.610475
NCT03162653|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|ALBINO||Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome|Effect of ALlopurinol in Addition to Hypothermia for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a Blinded Randomized Placebo-controlled Parallel Group Multicenter Trial for Superiority (Phase III)|Not yet recruiting||Phase 3|846|Anticipated|University Hospital Tuebingen||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:02:31.685442|2017-10-10 21:02:31.685442
NCT03162640|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-09|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Observational|||Impulsivity and Time Perception|Link Between Impulsivity and Time Anticipation|Not yet recruiting||N/A|120|Anticipated|University Hospital, Strasbourg, France|||2||f||||f|f|f||||||No||2017-10-10 21:02:31.854299|2017-10-10 21:02:31.854299
NCT03162627|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-17|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|August 2026|Anticipated|2026-08-01|August 2026|Anticipated|2026-08-01||Interventional|||Selumetinib and Olaparib in Solid Tumors|Evaluation of the Combination of Selumetinib and Olaparib in Endometrial, Ovarian and Other Solid Tumors With Ras Pathway Alterations, and Ovarian Tumors With PARP Resistance|Recruiting||Phase 1|90|Anticipated|M.D. Anderson Cancer Center||5|||f||||f|t|f||||||||2017-10-10 21:02:31.95298|2017-10-10 21:02:31.95298
NCT03162614|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-13|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|September 3, 2018|Anticipated|2018-09-03|July 6, 2018|Anticipated|2018-07-06||Interventional|||Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults|Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Various Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults|Recruiting||Phase 2|150|Anticipated|GlaxoSmithKline||6|||f|||||t|f||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 21:02:32.101472|2017-10-10 21:02:32.101472
NCT03162601|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-19|||April 4, 2017|Actual|2017-04-04|May 2017|2017-05-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Observational|||C-arm Computed Tomography Scan Image Quality in Patients With Neurovascular Diseases|C-arm Computed Tomography Scan Image Quality in Patients With Neurovascular Diseases: Observational Study|Recruiting||N/A|50|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||No||2017-10-10 21:02:32.254988|2017-10-10 21:02:32.254988
NCT03162588|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-19|||May 1, 2010|Actual|2010-05-01|June 2017|2017-06-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya|Feasibility Study of Multiple Burrhole Therapy Combined With Intravenous Erythropoietin Pretreatment for Unstable Moyamoya|Completed||Phase 1/Phase 2|37|Actual|Ajou University School of Medicine||1|||f|||||f|f||||||||2017-10-10 21:02:32.363783|2017-10-10 21:02:32.363783
NCT03162575|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-19|||January 18, 2017|Actual|2017-01-18|May 2017|2017-05-01|February 28, 2019|Anticipated|2019-02-28|June 30, 2018|Anticipated|2018-06-30||Interventional|||Mindfulness-Based Cognitive Therapy (MBCT) in Fatigued Patients With Inflammatory Bowel Disease (IBD)|The Possible Beneficial Effects of Mindfulness-Based Cognitive Therapy (MBCT) in Fatigued Adult Patients With Inflammatory Bowel Disease (IBD)|Recruiting||N/A|128|Anticipated|University Medical Center Groningen||2|||f||||f|f|f||||||No||2017-10-10 21:02:32.479664|2017-10-10 21:02:32.479664
NCT03162562|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-07-26|||May 30, 2017|Actual|2017-05-30|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|August 2018|Anticipated|2018-08-01||Interventional|||The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer|Prospective Phase Ib Clinical Trial to Evaluate the Safety and Efficacy of Oregovomab and Hiltonol® as a Combinatorial Immunotherapy Strategy in Patients With Recurrent Advanced Epithelial Cancer of Ovarian, Tubal, or Peritoneal Origin|Recruiting||Phase 1|10|Anticipated|OncoQuest Inc.||1|||f||||t|t|f||||||||2017-10-10 21:02:32.623814|2017-10-10 21:02:32.623814
NCT03162549|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-18|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|December 2100|Anticipated|2100-12-01|December 2100|Anticipated|2100-12-01|15 Years|Observational [Patient Registry]|||Corrona Inflammatory Bowel Disease (IBD) Registry|Corrona Inflammatory Bowel Disease (IBD) Registry|Enrolling by invitation||N/A|1000|Anticipated|Corrona, LLC.|||1||f||||f|f|f||||||No||2017-10-10 21:02:32.76331|2017-10-10 21:02:32.76331
NCT03162523|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-23|||January 2004|Actual|2004-01-01|May 2017|2017-05-01|October 15, 2016|Actual|2016-10-15|October 15, 2016|Actual|2016-10-15|10 Years|Observational [Patient Registry]|||Experiences With HDR-brachytherapy in Norway|Norwegian Experiences With Interstitial Radiation Treatment (Brachytherapy) for Men With High-risk Localised Prostate Cancer|Completed||N/A|325|Actual|Oslo University Hospital|||2||f||||f||||||||No||2017-10-10 21:02:32.999048|2017-10-10 21:02:32.999048
NCT03162510|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-05-19|||July 2017|Anticipated|2017-07-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|SOLAR||Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers|An Phase I Dose-Escalation Study of Biweekly Abraxane in Combination With Oxaliplatin and Oral S-1/LV (SOLAR Regimen) as First-line Chemotherapy in Patients With Advanced Gastric, Pancreatic and Biliary Cancers|Not yet recruiting||Phase 1|18|Anticipated|National Health Research Institutes, Taiwan||1|||f||||t|f|f||||||No||2017-10-10 21:02:33.080809|2017-10-10 21:02:33.080809
NCT03162497|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-06-22|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction|Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction - Comparison to Oral Treatment With Doxycycline|Not yet recruiting||Phase 4|40|Anticipated|Medical University of Vienna||2|||f||||f|f|f||||||Undecided||2017-10-10 21:02:33.186383|2017-10-10 21:02:33.186383
NCT03162484|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-05-19|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|PASBI||Physical Activity and Chronic Acquired Brain Injury|Effect of a Physical Activity Group Programme on the Health of People With Chronic Acquired Brain Injury|Completed||N/A|60|Actual|Universidad Politecnica de Madrid||2|||f||||f||||||||Undecided||2017-10-10 21:02:33.284069|2017-10-10 21:02:33.284069
NCT03162471|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-19|||May 1, 2005|Actual|2005-05-01|May 2017|2017-05-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Observational|||How Astigmatism Influences Corneal Biomechanics and Intraocular Pressure|Impact of Preoperative Astigmatism on Corneal Biomechanics and Accurate Intraocular Pressure Measurement After Micro-incision Phacoemulsification|Completed||N/A|39|Actual|Medical Universtity of Lodz|||1||f||||f|f|f||||||No||2017-10-10 21:02:33.387222|2017-10-10 21:02:33.387222
NCT03162445|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-19|||January 11, 2010|Actual|2010-01-11|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Bone Mass Accrual in Children With Autism Spectrum Disorder|Bone Mass Accrual in Children With Autism Spectrum Disorder|Completed||N/A|49|Actual|Massachusetts General Hospital|||2||f||||f||||||||No||2017-10-10 21:02:33.553748|2017-10-10 21:02:33.553748
NCT03162432|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade|High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade|Not yet recruiting||Phase 3|50|Anticipated|Boston Children’s Hospital||1|||f||||f|t|f||||||||2017-10-10 21:02:33.643164|2017-10-10 21:02:33.643164
NCT03162419|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-19|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|April 25, 2019|Anticipated|2019-04-25|April 25, 2019|Anticipated|2019-04-25||Interventional|||To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF).|To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF)-A Randomized Controlled Trial.|Recruiting||N/A|188|Anticipated|Institute of Liver and Biliary Sciences, India||3|||f||||f|f|f||||||No||2017-10-10 21:02:33.748474|2017-10-10 21:02:33.748474
NCT03162406|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-22|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|Protocol01||Effects of Vitamin D Supplementation During a Non-surgical Treatment of Generalized Chronic Periodontitis|Effects of Vitamin D Supplementation During a Non-surgical Treatment of Generalized Chronic Periodontitis: A Randomized Double-blinded Placebo Controlled Clinical Trial|Recruiting||N/A|30|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f|f|f||||||Undecided|It will be decided at the end of the study|2017-10-10 21:02:33.892098|2017-10-10 21:02:33.892098
NCT03162393|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||The Surgical Treatment of Total Brachial Plexus Avulsion Injury-A Retrospective Study of 73 Patients|The Optimal Surgical Strategy for the Treatment of Total Brachial Plexus Avulsion Injury Patients|Completed||N/A|73|Actual|Huashan Hospital|||6||f|||||f|f||||||||2017-10-10 21:02:34.047564|2017-10-10 21:02:34.047564
NCT03162380|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||May 22, 2017|Anticipated|2017-05-22|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Observational|||Occupational Stress and Bipolar Disorder|Assessment of Occupational Stress and Well-being in French Patients Suffering From Bipolar Disorder|Recruiting||N/A|200|Anticipated|University Hospital, Montpellier|||1||f||||f|f|f||||||Undecided|NC|2017-10-10 21:02:34.275723|2017-10-10 21:02:34.275723
NCT03162367|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||November 10, 2017|Anticipated|2017-11-10|May 2017|2017-05-01|May 27, 2018|Anticipated|2018-05-27|March 15, 2018|Anticipated|2018-03-15||Interventional|||Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn|Comparison Study OF Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Second Degree Burn|Not yet recruiting||Phase 2|20|Anticipated|SCARM Institute, Tabriz, Iran||2|||f||||t|f|f||||||No||2017-10-10 21:02:34.379421|2017-10-10 21:02:34.379421
NCT03162354|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||The CDR Implementation Trial|Implementation Trial of a Validated Clinical Decision Rule for Pediatric Abusive Head Trauma (NIH Grant Number P50HD089922)|Enrolling by invitation||N/A|400|Anticipated|Milton S. Hershey Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:02:34.498098|2017-10-10 21:02:34.498098
NCT03162341|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-22|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|GOUT-DECTUS||Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit|Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit in Urate Lowering Therapy Initiators|Recruiting||N/A|80|Anticipated|Lille Catholic University||1|||f||||f|f|f||||||||2017-10-10 21:02:34.653105|2017-10-10 21:02:34.653105
NCT03162328|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-19|||April 25, 2017||2017-04-25||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:02:35.292936|2017-10-10 21:02:35.292936
NCT03162315|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-05-19|||March 2016||2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||The Value of Progesterone for the Timing of the Embryo Transfer in IVF/ICSI: a Prospective Randomised Trial|The Value of Progesterone for the Timing of the Embryo Transfer in IVF/ICSI: a Prospective Randomised Trial|Recruiting||N/A|164|Anticipated|University Hospital, Ghent||2|||f||||||||||||No||2017-10-10 21:02:35.348312|2017-10-10 21:02:35.348312
NCT03162302|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-05|||May 24, 2017|Actual|2017-05-24|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Observational|||Liver Fat and Iron Quantification MRI|Free-Breathing Liver Fat and Iron Quantification Using 3D Stack-of-Radial MRI|Recruiting||N/A|42|Anticipated|University of California, Los Angeles|||2||f||||f|f|f||||||||2017-10-10 21:02:35.454336|2017-10-10 21:02:35.454336
NCT03162289|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-24|||May 10, 2017|Actual|2017-05-10|July 2017|2017-07-01|May 10, 2022|Anticipated|2022-05-10|May 10, 2021|Anticipated|2021-05-10||Interventional|FIT2||Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers|Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers - a Randomized, Controlled, Two-armed Intervention Study With Additional Observational Control Group|Recruiting||N/A|150|Anticipated|Charite University, Berlin, Germany||3|||f|||||f|f||||||||2017-10-10 21:02:36.509827|2017-10-10 21:02:36.509827
NCT03162276|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-07-04|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|October 1, 2020|Anticipated|2020-10-01||Interventional|||Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers|Evaluating the Effectiveness of Inquiry Based Stress Reduction (IBSR) Intervention Versus Regular Care of no Treatment on Well-being, Optimism and Health Behavior of BRCA1/2 Carriers: A Randomized Controlled Trial, RCT.|Recruiting||Phase 3|118|Anticipated|Sheba Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:02:37.235264|2017-10-10 21:02:37.235264
NCT03162263|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-08-17|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|May 25, 2017|Actual|2017-05-25||Interventional|||Improving Functional Outcomes and Neuroplasticity by Using Ekso|Does Ekso Improve Motor Function and Neuroplasticity in Pazients Affected by Chronic Stroke? A Rondomized Pilot Study|Completed||N/A|20|Actual|"IRCCS Centro Neurolesi Bonino-Pulejo"||2|||f||||t|f|f|||f|||||2017-10-10 21:02:37.39599|2017-10-10 21:02:37.39599
NCT03162250|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-25|||July 13, 2017|Actual|2017-07-13|September 2017|2017-09-01|September 7, 2018|Anticipated|2018-09-07|September 7, 2018|Anticipated|2018-09-07||Interventional|||Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics|A Phase IB, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care Antibiotics|Recruiting||Phase 1|24|Anticipated|Genentech, Inc.||4|||f||||f|t|f||||||||2017-10-10 21:02:37.483384|2017-10-10 21:02:37.483384
NCT03162237|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-05-19|||July 2013||2013-07-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy Study of Islets Xenotransplantation|Investigation of Safety and Efficacy Study of Islets Xenotransplantation for Patients With Type 1 Diabetes|Enrolling by invitation||N/A|20|Anticipated|Central South University||2|||f||||t||||||||No||2017-10-10 21:02:37.640097|2017-10-10 21:02:37.640097
NCT03162211|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-23|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|PCMBC||Feedback to Improve Depression Outcomes|Improving Outcomes of Depression Through Person-centered Measurement-based Care and Individualized Feedback|Not yet recruiting||N/A|304|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||No||2017-10-10 21:02:37.890697|2017-10-10 21:02:37.890697
NCT03162198|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-19|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|April 25, 2019|Anticipated|2019-04-25|April 25, 2019|Anticipated|2019-04-25||Observational|||Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)|Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)|Recruiting||N/A|50|Anticipated|Institute of Liver and Biliary Sciences, India|||2||f||||f|f|f||||||No||2017-10-10 21:02:37.961458|2017-10-10 21:02:37.961458
NCT03162185|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Serotonin and Motor Plasticity|The Effects of Serotonergic Challenge on Motor Learning and Neuroplasticity|Recruiting||Phase 4|60|Anticipated|Max Planck Institute for Human Cognitive and Brain Sciences||2|||f||||t|f|f|||f|||No||2017-10-10 21:02:38.048166|2017-10-10 21:02:38.048166
NCT03162172|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-19|||September 15, 2015|Actual|2015-09-15|May 2017|2017-05-01|March 15, 2016|Actual|2016-03-15|March 15, 2016|Actual|2016-03-15||Observational|OPALE GH||Growth Hormone (GH) in Congenital Adrenal Hyperplasia|Evaluation of the Adult Height Gain With Growth Hormone Treatment in Children With Congenital Adrenal Hyperplasia (CDAH), Using the OPALE Prediction Model|Completed||N/A|25|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 21:02:38.143784|2017-10-10 21:02:38.143784
NCT03162159|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-19|||September 2010|Actual|2010-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2014|Actual|2014-12-01||Observational|OPALE Model||Adult Height Prediction in Congenital Adrenal Hyperplasia|An Adult Height Prediction Model for Congenital Adrenal Hyperplasia From a National Cohort (OPALE Model Study)|Recruiting||N/A|600|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||||No||2017-10-10 21:02:38.218829|2017-10-10 21:02:38.218829
NCT03162146|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-19|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|TEAMIC||Team Elements Associated With Mortality in Intensive Care|Influence of Medical and Nursing Teams Composition on Patient Mortality in Intensive Care|Not yet recruiting||N/A|43378|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 21:02:38.328224|2017-10-10 21:02:38.328224
NCT03162133|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-19|||November 10, 2016|Actual|2016-11-10|May 2017|2017-05-01|August 4, 2017|Anticipated|2017-08-04|June 4, 2017|Anticipated|2017-06-04||Interventional|||Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy|A Randomized Controlled Trial Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy|Recruiting||N/A|86|Anticipated|Guangdong General Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:02:38.417411|2017-10-10 21:02:38.417411
NCT03162120|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-21|||October 20, 2017|Anticipated|2017-10-20|August 2017|2017-08-01|September 20, 2019|Anticipated|2019-09-20|September 20, 2019|Anticipated|2019-09-20||Interventional|PRESERVE-SR||Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation|A Single Site, Interventional, Comparative Study to Evaluate the Safety and Efficacy of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Elpen Pharmaceutical Co. Inc.||2|||f||||f|f|f||||||||2017-10-10 21:02:38.52102|2017-10-10 21:02:38.52102
NCT03162107|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-19|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Observational|PRAXIS||Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa|Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa PRAXIS Study (PRospective Study of Adherence in M/XDR-TB Implementation Science)|Recruiting||N/A|200|Anticipated|Centre for the AIDS Programme of Research in South Africa|||1||f||||f|f|f||||Samples With DNA|"     Hair samples PBMCs TB Isolates   "|No||2017-10-10 21:02:38.634797|2017-10-10 21:02:38.634797
NCT03162094|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-24|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|AVX012CT001||Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome|A Phase I/II, Double-blind, Placebo-controlled Study Assessing the Safety and Efficacy of AVX-012 Ophthalmic Solution in Subjects With Mild-to-moderate Dry Eye Syndrome|Recruiting||Phase 1/Phase 2|172|Anticipated|Avizorex Pharma, S.L.||3|||f||||t|f|f||||||No||2017-10-10 21:02:38.723256|2017-10-10 21:02:38.723256
NCT03162081|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-22|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01|2 Weeks|Observational [Patient Registry]|||Medication Misuse and Dependence Among Elderly|Medication Misuse and Dependence in Elderly Patients|Recruiting||N/A|500|Anticipated|University Hospital, Akershus|||3||f||||f|f|f||||||No||2017-10-10 21:02:38.863241|2017-10-10 21:02:38.863241
NCT03162068|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-19|||April 4, 2017|Actual|2017-04-04|May 2017|2017-05-01|May 2024|Anticipated|2024-05-01|May 2019|Anticipated|2019-05-01||Observational|SOCS||Cushing's Osteoporosis Specificities|Specificities of Cushing's Osteoporosis Compare to Postmenopausal Osteoporosis : pQCT Analysis in Comparison With a Group of Controls.|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||3||f|||||f|f||||||||2017-10-10 21:02:38.994873|2017-10-10 21:02:38.994873
NCT03162055|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-10-03|||May 25, 2017|Actual|2017-05-25|October 2017|2017-10-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|AERISTO||Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease|A Randomised, Double-Blind, Double-Dummy, Multicentre, Parallel Group Study to Assess the Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (AERISTO)|Recruiting||Phase 3|1000|Anticipated|AstraZeneca||2|||f||||f|t|f||||||||2017-10-10 21:02:39.121817|2017-10-10 21:02:39.121817
NCT03162042|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-19|||November 2, 2015|Actual|2015-11-02|May 2017|2017-05-01|May 2017|Actual|2017-05-01|February 2016|Actual|2016-02-01||Observational|MYOCACH||Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers|Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers|Completed||N/A|60|Actual|University Hospital, Clermont-Ferrand|||2||f|||||f|f||||||||2017-10-10 21:02:39.652581|2017-10-10 21:02:39.652581
NCT03162029|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-18|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Assessment of Mandibular Osseous Changes in Patients With End Stage Renal Failure|Assessment of Mandibular Osseous Changes Using Radiomorphometric Indices By Cone Beam Computed Tomography in Patients With End Stage Renal Failure Versus Normal Population|Not yet recruiting||N/A|26|Anticipated|Cairo University|||2||f|||||f|f||||||||2017-10-10 21:02:39.78805|2017-10-10 21:02:39.78805
NCT03162016|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-22|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|November 18, 2019|Anticipated|2019-11-18|May 18, 2018|Anticipated|2018-05-18||Interventional|MUCODERM||Treatment Off Gingival Recession Defects Using a Xenogenic Acellular Dermal Matrix Compared to Connective Tissue Graft.|Treatment of Multiple Gingival Recession Defects Using a Xenogenic Acellular Dermal Matrix Compared to Connective Tissue Graft: a Randomized Controlled Clinical Study|Active, not recruiting||N/A|12|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||No||2017-10-10 21:02:39.90409|2017-10-10 21:02:39.90409
NCT03162003|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|February 2025|Anticipated|2025-02-01|February 2024|Anticipated|2024-02-01||Observational|iPROSPECT||Irish Programme for Stratified Prostate Cancer Therapy|Irish Programme for Stratified Prostate Cancer Therapy|Active, not recruiting||N/A|55|Actual|Cancer Trials Ireland|||2||f||||f|f|f||||Samples With DNA|"     Whole blood processed to Plasma, serum and filtered for Circulating Tumour Cells.   "|No||2017-10-10 21:02:40.022152|2017-10-10 21:02:40.022152
NCT03161990|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-19|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Observational|||DAIR for Infected Total Hip Arthroplasty - Does the Operative Approach Influence the Functional Result?|Debridement, Antibiotics and Implant Retention (DAIR) for Infected Total Hip Arthroplasty- Does the Operative Approach Influence the Functional Result?|Not yet recruiting||N/A|300|Anticipated|University Hospital, Akershus|||2||f||||f|f|f||||||No||2017-10-10 21:02:40.155367|2017-10-10 21:02:40.155367
NCT03161977|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-27|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|||The Effect of Mannitol on the Serum Potassium During Craniotomy|The Effect of Mannitol on Intraoperative Serum Potassium in Patients Undergoing Craniotomy：an Observational Study|Completed||N/A|30|Actual|The Affiliated Hospital of Xuzhou Medical University|||1||f||||t|f|f||||||||2017-10-10 21:02:40.294179|2017-10-10 21:02:40.294179
NCT03161964|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-14|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Propranolol in Treating Hypoglycemia Unawareness|Propranolol as a Treatment for Impaired Awareness of Hypoglycemia in Type 1 Diabetes|Not yet recruiting||Phase 2|10|Anticipated|University of Utah||2|||f||||f|t|f|||f|||||2017-10-10 21:02:40.424219|2017-10-10 21:02:40.424219
NCT03161951|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||January 3, 2017|Actual|2017-01-03|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Differential Diagnostics of Etiology of Acute Infections|Differential Diagnostics of Etiology of Acute Infections Based on the Analysis of Expression of Activation Markers on the Surface of Peripheral Blood Monocytes and Neutrophils.|Enrolling by invitation||N/A|100|Anticipated|The Republican Research and Practical Center for Epidemiology and Microbiology|||2||f||||f|f|f||||Samples Without DNA|"     Whole blood   "|No||2017-10-10 21:02:40.608599|2017-10-10 21:02:40.608599
NCT03161938|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-19|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|DEX-GANZ||High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase|High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Periacetabular (GANZ) Osteotomy|Recruiting||Phase 4|64|Anticipated|Rigshospitalet, Denmark||2|||f||||t|f|f|||f|||No||2017-10-10 21:02:40.732097|2017-10-10 21:02:40.732097
NCT03161925|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||November 28, 2016|Actual|2016-11-28|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|CLCS||Chinese Liver Cancer Clinical Survey|Chinese Liver Cancer Clinical Survey|Active, not recruiting||N/A|5000|Actual|Beijing Insight Science & Technology Co. Ltd.|||1||f||||f|f|f||||||No||2017-10-10 21:02:40.894772|2017-10-10 21:02:40.894772
NCT03161912|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-09-27|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|June 30, 2020|Anticipated|2020-06-30||Observational|AURIGA||A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease|An Observational Study Program to Investigate the Effectiveness of Intravitreal Aflibercept in Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion in a Real World Setting|Not yet recruiting||N/A|2050|Anticipated|Bayer|||4||f||||f|t|f|||t|||||2017-10-10 21:02:40.987871|2017-10-10 21:02:40.987871
NCT03161899|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-07-17|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|May 31, 2018|Anticipated|2018-05-31||Observational|||Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital|Evaluation of Nutritional Status in Patients With Thalassemia Major in Assiut University Children Hospital|Not yet recruiting||N/A|246|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 21:02:41.147582|2017-10-10 21:02:41.147582
NCT03161886|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-19|2017-05-19|||December 1, 2014|Actual|2014-12-01|May 2017|2017-05-01|January 10, 2016|Actual|2016-01-10|December 1, 2015|Actual|2015-12-01||Observational|CCE||24-Week Mucosal Healing and Deep Remission Assessment of Pediatric Crohn's Disease by Colon Capsule Endoscopy|A Prospective 24-Week Mucosal Healing and Deep Remission Assessment of Small Bowel and Colonic Crohn's Disease as Detected by Colon Capsule Endoscopy|Completed||N/A|48|Actual|Azienda Policlinico Umberto I|||1||f||||f|f|f||||||No||2017-10-10 21:02:41.279233|2017-10-10 21:02:41.279233
NCT03161873|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-22|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|SUSAVA||Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)|Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)|Recruiting||N/A|430|Anticipated|University of Zurich|||3||f||||f|f|t|f|f|f|||No||2017-10-10 21:02:41.40449|2017-10-10 21:02:41.40449
NCT03161860|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|APIC||Effect of Personalised Citizen Assistance for Social Participation(APIC) on Older Adults Health and Social Participation|Effect of Personalised Citizen Assistance for Social Participation (APIC) on Older Adults' Health and Social Participation: a Pragmatic Multicentre Randomised Controlled Trial (RCT)|Not yet recruiting||N/A|376|Anticipated|Université de Sherbrooke||2|||f||||t|f|f||||||Undecided||2017-10-10 21:02:41.536351|2017-10-10 21:02:41.536351
NCT03161847|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Observational|NH-OPMD||Natural History Study of Oculopharyngeal Muscular Dystrophy|Natural History Study of Oculopharyngeal Muscular Dystrophy|Not yet recruiting||N/A|60|Anticipated|University of New Mexico|||1||f||||t|f|f||||||No||2017-10-10 21:02:41.647828|2017-10-10 21:02:41.647828
NCT03161834|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-18|||January 13, 2017|Actual|2017-01-13|May 2017|2017-05-01|January 13, 2022|Anticipated|2022-01-13|January 13, 2019|Anticipated|2019-01-13||Observational|||Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer|LCCC 1642: Plasma Circulating Tumor DNA (ctDNA) Analyses in ER+ Metastatic Breast Cancer|Recruiting||N/A|110|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||f|f|f||||Samples With DNA|"     10 mL blood samples   "|No||2017-10-10 21:02:41.767284|2017-10-10 21:02:41.767284
NCT03161821|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-18|||December 9, 2011|Actual|2011-12-09|May 2017|2017-05-01|December 1, 2022|Anticipated|2022-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Circulating Tumor Cells in Solid Tumors|Quantification and Characterization of Circulating Tumor Cells in Solid Tumors|Recruiting||N/A|250|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||f|f|f||||||No||2017-10-10 21:02:41.895141|2017-10-10 21:02:41.895141
NCT03161808|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Observational|RARE||Rare CFTR Mutation Cell Collection Protocol (RARE)|Rare CFTR Mutation Cell Collection Protocol (RARE)|Not yet recruiting||N/A|500|Anticipated|University of Alabama at Birmingham|||1||f||||f|f|f||||Samples With DNA|"     Nasal epithelial cells and blood (to confirm CFTR genotype and to derive iPSCs) will be     collected from all subjects; consent for whole genome sequencing analysis and rectal biopsy     samples will be optional.   "|||2017-10-10 21:02:42.019179|2017-10-10 21:02:42.019179
NCT03161795|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01|6 Months|Observational [Patient Registry]|||Addressing the Risks of Long-Term Opioid Therapy in Korean Chronic Non-Cancer Pain Patients|Addressing the Risks of Long-Term Opioid Therapy in Korean Chronic Non-Cancer Pain Patients|Recruiting||N/A|300|Anticipated|Seoul National University|||1||f||||t|f|f||||||No||2017-10-10 21:02:42.138207|2017-10-10 21:02:42.138207
NCT03161782|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-25|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|July 25, 2017|Actual|2017-07-25|May 15, 2017|Actual|2017-05-15||Interventional|||The Efficacy of Different Types of Stretching on Range of Motion, Pain and Function in Elbow Limitation|The Efficacy of Proprioceptive Neuromuscular Facilitation Stretching and Static Stretching on Range of Motion, Pain and Function in Elbow Limitation|Completed||N/A|40|Actual|Istanbul University||2|||f||||f|f|f||||||||2017-10-10 21:02:42.270973|2017-10-10 21:02:42.270973
NCT03161769|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||April 21, 2017|Actual|2017-04-21|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01|30 Months|Observational [Patient Registry]|MAX-PIPE||MAXimizing Flow Diversion Effect On the Treatment of Large Intracranial Aneurysms With Embolization Devices|"MAX-PIPE Registry - Maximizing Flow Diversion Effect On The Treatment of Large Intracranial Aneurysms With PIPEline Flex Embolization Devices Using Optical Flow Imaging Software AneurysmFlow"|Recruiting||N/A|30|Anticipated|University Health Network, Toronto|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:02:42.402904|2017-10-10 21:02:42.402904
NCT03161756|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-18|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|CHARLI||Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma|A Phase Ib/II Trial of Ipilimumab-Nivolumab-Denosumab and Nivolumab-Denosumab in Patients With Unresectable Stage III and IV Melanoma|Not yet recruiting||Phase 1/Phase 2|72|Anticipated|Australia and New Zealand Melanoma Trials Group||2|||f||||t|t|f|||t|||Undecided||2017-10-10 21:02:42.515588|2017-10-10 21:02:42.515588
NCT03161743|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-08|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|||Calculation of Platelet-rich Plasma Preparation Yield|Calculation of Platelet-rich Plasma Preparation Yield From Baseline CBC Platelet Count|Enrolling by invitation||N/A|40|Anticipated|Harrison, Theodore, M.D.|||1||f||||f|f|f||||||||2017-10-10 21:02:42.652325|2017-10-10 21:02:42.652325
NCT03161730|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Comparison of McGrath Videolaryngoscope, Pentax Airway Scope and Macintosh Laryngoscope in Manikin by Novice|Comparison of McGrath Videolaryngoscope, Pentax Airway Scope and Macintosh Laryngoscope in a Normal and Cervical Immobilized Manikin by Novice|Not yet recruiting||N/A|35|Anticipated|Ajou University School of Medicine||3|||f||||t|f|f||||||||2017-10-10 21:02:42.725689|2017-10-10 21:02:42.725689
NCT03161717|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||March 11, 2015|Actual|2015-03-11|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Efficacy and Safety of Electrical Stimulation-guided Epidural Analgesia for Vaginal Delivery|A Comparative Study of Success Rate, Efficacy, Safety Between Electrical Stimulation-guided Epidural Catheter Placement and the Loss of Resistance Conventional Method for Vaginal Delivery|Recruiting||N/A|40|Anticipated|Korea University Guro Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:02:42.81691|2017-10-10 21:02:42.81691
NCT03161704|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-07-14|||July 8, 2016||2016-07-08|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01|3 Months|Observational [Patient Registry]|||Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol|Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol|Recruiting||N/A|500|Anticipated|Yale University|||1||f||||t|f|f||||Samples With DNA|"     Collection of endometrial biopsy tissue, serum, plasma, whole blood for DNA extraction and     urine   "|||2017-10-10 21:02:42.965706|2017-10-10 21:02:42.965706
NCT03161691|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Observational|||Perfusion and Collaterals Imaging With C-arm CT|Perfusion and Collateral Imaging Using C-arm Computed Tomography in the Neuro-Angiography Suite|Recruiting||N/A|30|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||No||2017-10-10 21:02:43.088633|2017-10-10 21:02:43.088633
NCT03161678|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||CES1 Crossover Trial of Clopidogrel and Ticagrelor|Impact of Genetic Variation in CES1 on Antiplatelet Therapy|Not yet recruiting||Phase 4|90|Anticipated|University of Maryland||3|||f||||f|t|f|||f|||Yes|It is possible that deidentified data will be deposited into large public databases as per NIH data sharing policies (e.g. dbGAP, PharmGKB). Data to be shared would include, but not limited to, anthropometric data, study outcome data, and relevant covariate data used in statistical models of association. It is anticipated that data would be available after the completion of the trial. The data will be obtained from the participants and the study-related research procedures.|2017-10-10 21:02:43.194074|2017-10-10 21:02:43.194074
NCT03161665|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||January 14, 2016|Actual|2016-01-14|May 2017|2017-05-01|January 14, 2018|Anticipated|2018-01-14|November 14, 2017|Anticipated|2017-11-14||Interventional|||"Patient and Caregiver Participation Through an Educational Health Information Technology System (BMT Roadmap) in the Context of Hematopoietic Cell Transplantation"|"A Pilot Study of Patient and Caregiver Participation Through an Educational Health Information Technology System (BMT Roadmap) in the Context of Hematopoietic Cell Transplantation (Adult Protocol)"|Recruiting||N/A|40|Anticipated|University of Michigan Cancer Center||1|||f||||t|f|f||||||||2017-10-10 21:02:43.277556|2017-10-10 21:02:43.277556
NCT03161652|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-10-03|||May 2016||2016-05-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|||Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema|Clinical Trial to Evaluate the Safety and Efficacy of Levosulpiride to Improve Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.|Recruiting||Phase 2|120|Anticipated|Universidad Nacional Autonoma de Mexico||8|||f||||f|f|f|||f|||||2017-10-10 21:02:43.388202|2017-10-10 21:02:43.388202
NCT03161639|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||September 2, 2016|Actual|2016-09-02|May 2017|2017-05-01|September 2, 2020|Anticipated|2020-09-02|September 2, 2017|Anticipated|2017-09-02||Interventional|||Influence of Working Length Methods in the Performance of Pulpectomies in Primary Teeth|Influence of Working Length Methods in the Performance of Pulpectomies in Primary Teeth - Randomized Clinical Trial|Recruiting||N/A|64|Anticipated|Universidade Federal de Santa Catarina||3|||f||||t|f|f||||||Undecided||2017-10-10 21:02:43.572417|2017-10-10 21:02:43.572417
NCT03161626|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-11|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery|A Multicenter, Post-Marketing Registry Study of COAGADEX® in the Peri-operative Management of Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery|Not yet recruiting||N/A|3|Anticipated|Bio Products Laboratory|||1||f||||f|t|f||||||||2017-10-10 21:02:43.693816|2017-10-10 21:02:43.693816
NCT03161613|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-26|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Observational|||Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico.|Postmarketing Study to Assess the Safety of Nivolumab as a First- and Second-line Treatment in Patients With Metastatic Melanoma or as a Second-line Treatment for Metastatic Lung Cancer (Squamous and Nonsquamous), Metastatic Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adult Patients in Mexico|Recruiting||N/A|60|Anticipated|Bristol-Myers Squibb|||1||f||||||||||||||2017-10-10 21:02:43.788987|2017-10-10 21:02:43.788987
NCT03161600|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning|Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning|Recruiting||N/A|25|Anticipated|Carevive Systems, Inc.||1|||f||||f|f|f||||||No||2017-10-10 21:02:43.939298|2017-10-10 21:02:43.939298
NCT03161587|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-27|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Observational|||Patient Characteristics and Treatment Modalities in COPD Patients in China|Patient Characteristics and Treatment Modalities in COPD Patients Assessed by GOLD2016 : a Cross-Sectional Study in China|Recruiting||N/A|1000|Anticipated|GlaxoSmithKline|||1||f||||f|f|f||||||||2017-10-10 21:02:44.020601|2017-10-10 21:02:44.020601
NCT03161574|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-17|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer|FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for MRI-defined Circumferential Radial Margin (CRM) Positive Rectal Cancer|Enrolling by invitation||Phase 2|32|Anticipated|Guangxi Medical University||1|||f||||t|f|f||||||||2017-10-10 21:02:44.10883|2017-10-10 21:02:44.10883
NCT03161561|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-18|||November 16, 2011|Actual|2011-11-16|May 2017|2017-05-01|June 1, 2017|Anticipated|2017-06-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||Mechanisms and Impact of Bacterial Colonisation in COPD|Mechanisms, Impact and Therapeutic Targeting of Bacterial Colonisation in COPD|Active, not recruiting||N/A|37|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f|f|f||||||No||2017-10-10 21:02:44.204333|2017-10-10 21:02:44.204333
NCT03161548|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-24|||July 18, 2011|Actual|2011-07-18|May 2017|2017-05-01|January 4, 2017|Actual|2017-01-04|January 27, 2016|Actual|2016-01-27||Interventional|||A Study of Tongue Conservation Surgery for Oral Tongue Cancer|A Phase II Study of Tongue Conservation Surgery for Advanced Oral Tongue Cancer: Induction Chemotherapy, Followed by Tongue Conservation Surgery and Postoperative Chemoradoitherapy|Terminated||Phase 2|23|Actual|Taipei Veterans General Hospital, Taiwan||1||Diffiult patient recruitment|f||||f|f||||f|||No||2017-10-10 21:02:44.456325|2017-10-10 21:02:44.456325
NCT03161535|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2023|Anticipated|2023-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Effectiveness of a Rehabilitation Program in Improving Quality of Life in Patients With Esophageal Cancer|Effectiveness of a Rehabilitation Program in Improving Sleep Quality, Emotional Distress, Circadian Rhythms, and Quality of Life in Patients With Esophageal Cancer|Not yet recruiting||N/A|175|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f|||||f|f||||||||2017-10-10 21:02:44.639813|2017-10-10 21:02:44.639813
NCT03161522|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-09|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Interventional|||Chemoradiation +/- Surgery Versus Systemic Therapy for Esophageal or Gastric Cancer With Oligometastases|A Randomized Trial Comparing Early Local Chemoradiation Therapy +/- Surgery Versus Systemic Therapy for Patients With Esophageal or Gastric Cancer With Oligometastases|Not yet recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f|||f|||||2017-10-10 21:02:44.806168|2017-10-10 21:02:44.806168
NCT03161509|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-28|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pharmacokinetics of Paracetamol and Antiepileptic Drugs After Sleeve Gastrectomy|Effect of Sleeve Gastroctomy on Pharmacokinetics of Paracetamol and Antiepileptic Drugs|Not yet recruiting||Phase 4|50|Anticipated|Rambam Health Care Campus||2|||f||||f|f|f||||||Undecided|IPD will be shared upon request|2017-10-10 21:02:44.939371|2017-10-10 21:02:44.939371
NCT03161496|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-07|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||A Research in Pharmacogenomics and Accurate Medication of Novel Oral Anticoagulants|A Research in Pharmacogenomics and Accurate Medication of Novel Oral Anticoagulants|Recruiting||N/A|1200|Anticipated|Peking University First Hospital|||2||f|||||f|f||||||||2017-10-10 21:02:45.061694|2017-10-10 21:02:45.061694
NCT03161483|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-28|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|February 11, 2020|Anticipated|2020-02-11|December 20, 2019|Anticipated|2019-12-20||Interventional|||A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus|A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-220 IN SUBJECTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS|Recruiting||Phase 2|280|Anticipated|Celgene||4|||f||||t|t|f||||||||2017-10-10 21:02:45.190189|2017-10-10 21:02:45.190189
NCT03161470|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-09|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|June 8, 2018|Anticipated|2018-06-08|June 8, 2018|Anticipated|2018-06-08||Interventional|||Efficacy of a Mechanical Chair for Treatment of Benign Paroxysmal Positional Vertigo (BPPV)|Efficacy of a Mechanical Chair for Treatment of Benign Paroxysmal Positional Vertigo (BPPV)|Enrolling by invitation||N/A|300|Anticipated|Vanderbilt University Medical Center||3|||f||||f|f|f||||||No||2017-10-10 21:02:45.589694|2017-10-10 21:02:45.589694
NCT03161457|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-18|||February 27, 2017|Actual|2017-02-27|May 2017|2017-05-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis|A Randomised, Double-blind, Parallel Group, Multicentre Study to Compare the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety, and Efficacy of JHL1101 Versus EU-sourced MabThera® in Anti TNF Inadequate Responder Patients With Moderate to Severe Rheumatoid Arthritis (RA) on Background Methotrexate (MTX) Therapy|Recruiting||Phase 1|150|Anticipated|JHL Biotech, Inc.||2|||f|||||f|f||||||||2017-10-10 21:02:45.688673|2017-10-10 21:02:45.688673
NCT03161444|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|January 21, 2018|Anticipated|2018-01-21|November 21, 2017|Anticipated|2017-11-21||Interventional|ZIKAVIH||Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.|Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.|Recruiting||N/A|362|Anticipated|University Hospital Center of Martinique||1|||f||||f|f|f||||||No||2017-10-10 21:02:45.926992|2017-10-10 21:02:45.926992
NCT03161431|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab|A Phase 1, Open-Label, Dose-Escalation With Expansion Study of SX-682 in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab|Not yet recruiting||Phase 1|77|Anticipated|Syntrix Biosystems, Inc.||2|||f||||f|t|f||||||No||2017-10-10 21:02:46.051301|2017-10-10 21:02:46.051301
NCT03161418|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-27|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Study of the Safety of KSP Heptapeptide (KSP-910638G)|Study of the Safety of KSP Heptapeptide (KSP-910638G) in Humans for the Early Detection of GI Malignancies|Recruiting||Phase 1|25|Anticipated|University of Michigan||2|||f||||t|t|f||||||||2017-10-10 21:02:46.158912|2017-10-10 21:02:46.158912
NCT03161405|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-13|||May 26, 2017|Actual|2017-05-26|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|||A Study to Evaluate the Effect of the Potent CYP3A4 Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-906 in Healthy Participants|A Single-Sequence, Open-Label, 2-Period, Crossover Trial to Evaluate the Effect of the Potent CYP3A4 Inhibitor Itraconazole on the Single-Dose Pharmacokinetics of Oral TAK-906 in Healthy Adult Subjects|Completed||Phase 1|12|Actual|Takeda||1|||f||||f|t|f||||||||2017-10-10 21:02:46.242338|2017-10-10 21:02:46.242338
NCT03161392|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||March 16, 2016|Actual|2016-03-16|May 2017|2017-05-01|March 13, 2019|Anticipated|2019-03-13|March 13, 2017|Actual|2017-03-13||Observational|||Correlation of Solitary Dilated Duct at Mammography With Ultrasonography and Anatomopathological Findings|Evaluation of Solitary Dilated Duct Visualized by Mammography in Correlation With Ultrasonography and Anatomopathological Findings.|Active, not recruiting||N/A|135|Actual|Faculdade de Medicina do ABC|||2||f||||f|f|f||||||No||2017-10-10 21:02:46.3344|2017-10-10 21:02:46.3344
NCT03161379|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Phase 2 GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer|A Phase II Clinical Trial of GVAX Pancreas Vaccine (With Cyclophosphamide) in Combination With Nivolumab and Stereotactic Body Radiation Therapy (SBRT) Followed by Definitive Resection for Patients With Borderline Resectable Pancreatic Adenocarcinoma|Not yet recruiting||Phase 2|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:02:46.417976|2017-10-10 21:02:46.417976
NCT03161366|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-25|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|December 1, 2017|Anticipated|2017-12-01||Interventional|||Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine|An Open-label, Single Arm Study to Provide Additional Information on Safety and Effectiveness of rVSVΔG-ZEBOV-GP|Suspended||Phase 3|500|Anticipated|Epicentre||1||As there are no new cases of Ebola disease, the study is put on hold|f||||t|f|f||||||||2017-10-10 21:02:46.501851|2017-10-10 21:02:46.501851
NCT03161353|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-18|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|PHERGain||Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.|Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive (Human Epidermal Receptor) Breast Cancer: FDG-PET Response-adapted Strategy. The PHERGain Study|Recruiting||Phase 2|400|Anticipated|MedSIR||3|||f||||t|f|f|||f|||||2017-10-10 21:02:46.59491|2017-10-10 21:02:46.59491
NCT03161327|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-18|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|October 15, 2017|Anticipated|2017-10-15||Interventional|||Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease|Sensitivity and Specificity of Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease: A Single Center, Prospective Clinical Trial|Recruiting||N/A|400|Anticipated|St. Louis University||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:02:47.0547|2017-10-10 21:02:47.0547
NCT03161314|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-17|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Observational|Subproject1||Plantar Heel Pain: Multisegment Foot Motion and Muscle Function, FFI Translation, and Evaluation of Treatments|Plantar Heel Pain: Multisegment Foot Motion and Muscle Function, FFI Translation, and Evaluation of Treatments-Subproject1 Investigation of Multisegmental Foot Motion and Muscle Activity in Patients With PHP Compared to the Normal Healthy|Recruiting||N/A|96|Anticipated|Mahidol University|||2||f||||f|f|f||||||No||2017-10-10 21:02:47.142769|2017-10-10 21:02:47.142769
NCT03161301|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||May 7, 2015|Actual|2015-05-07|May 2017|2017-05-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01||Observational|ITS||Role of IL-37 Genetic Variants in Modulating Innate Immune Response to Periodontal Pathogens|Role of IL-37 Genetic Variants in Modulating Innate Immune Response to Periodontal Pathogens|Recruiting||N/A|93|Anticipated|University of North Carolina, Chapel Hill|||3||f||||f|f|f||||Samples With DNA|"     Saliva, subgingival dental plaque, gingival cervicular fluid and interdental gingival biopsy     tissue.   "|No||2017-10-10 21:02:47.235718|2017-10-10 21:02:47.235718
NCT03161288|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-01|||May 29, 2017|Actual|2017-05-29|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of KY1005 in Healthy Volunteers and Volunteers With Psoriasis|A Single and Multiple Ascending Dose, Placebo-Controlled, Double-Blind, Phase 1 Study of KY1005 in Healthy Volunteers and Volunteers With Psoriasis|Recruiting||Phase 1|88|Anticipated|Kymab Limited||3|||f||||f|f|f|||f|||||2017-10-10 21:02:47.358247|2017-10-10 21:02:47.358247
NCT03161275|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-05-17|||July 2012||2012-07-01|May 2017|2017-05-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01|2 Years|Observational [Patient Registry]|||Measurement of the Cerebral Saturation for Assessment of Safety of Epidural Anaesthesia During Abdominal Surgery|Measurement of the Cerebral Saturation for Assessment of Safety of Epidural Anaesthesia During Abdominal Surgery|Completed||N/A|101|Actual|Jagiellonian University|||2||f||||f||||||||No|"The day before the surgery will be performed basic blood tests (morphology, gas analysis) and test Short Scale Mental State Examination.
During the operation, in addition to standard monitoring the electrical activity of the heart, blood pressure and peripheral oxygen saturation levels, will be assessed non-invasively cerebral oximetry.
When during general anesthesia bradycardia occurs, then half of the patients in this group will be set up into the esophagus electrode, which will provide the ability to route atrial pacing hemodynamically optimal heart rate (80 / min). However, in the second half of the patients at the time of the occurrence of bradycardia is given intravenously at a dose of atropine 0.5 mg.
In about two hours after the surgery will be taken blood tests (morphology + gas analysis) to determine the potential impact of intraoperative bleeding changes oximetry.
On postoperative day 5 will be repeated test Short Scale Mental State Examination"|2017-10-10 21:02:47.51827|2017-10-10 21:02:47.51827
NCT03161262|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-10|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||SMS-Based Follow-Ups to Improve Post-Discharge Surgical Outcomes|SMS-Based Follow-Ups to Improve Post-Discharge Surgical Outcomes|Recruiting||N/A|200|Anticipated|Emory University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:02:47.630584|2017-10-10 21:02:47.630584
NCT03161249|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-22|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Psychoeducative Treatment of FEP With Mobile Training|Psychoeducative Treatment of First Episode Psychosis With Mobile Training:Study Protocol for a Randomised Controlled Trial|Not yet recruiting||N/A|50|Anticipated|International University of La Rioja||2|||f||||f|f|f||||||No||2017-10-10 21:02:47.76874|2017-10-10 21:02:47.76874
NCT03161236|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-18|||October 31, 2016|Actual|2016-10-31|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Assessing Balance Changes Following an Exercise Program Among Middle-Aged Adults|Assessing Balance Changes Following an Exercise Program Among Middle-Aged Adults|Recruiting||N/A|70|Anticipated|Loma Linda University||2|||f||||f|f|f||||||No||2017-10-10 21:02:47.900395|2017-10-10 21:02:47.900395
NCT03161223|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-25|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma|Phase 1/2a Study of the Anti-PD-L1 Monoclonal Antibody Durvalumab in Combination With Pralatrexate and Romidepsin, Oral 5-Azacitidine and Romidepsin, Romidepsin Alone, or Oral 5-Azacitidine Alone for the Treatment of Patients With Relapsed and Refractory Peripheral T-Cell Lymphoma|Not yet recruiting||Phase 1/Phase 2|148|Anticipated|Columbia University||4|||f||||t|t|f|||f|||||2017-10-10 21:02:48.022923|2017-10-10 21:02:48.022923
NCT03161210|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-19|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Pain Regression in Patients With Myofascial Facial Pain Using Dextrose, Local Anaesthesia and Saline.|Evaluation of Pain Regression in Patients With Myofascial Facial Pain Treated by Dextrose Prolotherapy Versus Local Anesthetic Injections: A Prospective Double-blind Randomized Placebo-controlled Clinical Trial.|Not yet recruiting||N/A|80|Anticipated|Cairo University||3|||f||||f|f|f||||||Undecided||2017-10-10 21:02:48.175941|2017-10-10 21:02:48.175941
NCT03161197|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-18|||April 24, 2015|Actual|2015-04-24|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|PRIMER||Pain Relief Intervention of Meditation in Renal Disease (PRIMER)|Pain Relief Intervention of Meditation in Renal Disease|Active, not recruiting||N/A|60|Anticipated|Weill Medical College of Cornell University||1|||f||||f|f|f||||||Undecided|Undecided|2017-10-10 21:02:49.960867|2017-10-10 21:02:49.960867
NCT03161184|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-18|||July 23, 2013|Actual|2013-07-23|May 2017|2017-05-01|June 25, 2014|Actual|2014-06-25|June 25, 2014|Actual|2014-06-25||Interventional|SUSTAIN1||Impact of a Smartphone Intervention on Tanzanian Women's Childbirth Location|Evaluation of an mHealth Intervention to Improve Women's Access to Maternal Health Services in Rural Tanzania|Completed||N/A|572|Actual|University of Toronto||2|||f||||f|f|f||||||No|Sharing raw data is inconsistent with what was stated in the ethics application form and participant informed consent materials.|2017-10-10 21:02:50.071209|2017-10-10 21:02:50.071209
NCT03161171|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-18|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III|Behavioral Challenges in Children With Mucopolysaccharidosis Type I-III and Parental Coping Strategies|Not yet recruiting||N/A|30|Anticipated|University Hospital Heidelberg|||1||f||||f|f|f||||||No||2017-10-10 21:02:50.195195|2017-10-10 21:02:50.195195
NCT03161158|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-30|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure|PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure|Not yet recruiting||N/A|864|Anticipated|Fresenius Medical Care Deutschland GmbH||2|||f||||t|f|f||||||||2017-10-10 21:02:50.285956|2017-10-10 21:02:50.285956
NCT03161145|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-10-02|||December 9, 2016|Actual|2016-12-09|October 2017|2017-10-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Observational|||A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread|Treatment Patterns and Outcomes in Unresectable or Metastatic Renal Cell Carcinoma (mRCC) Patients in Japan|Completed||N/A|297|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:02:50.430359|2017-10-10 21:02:50.430359
NCT03161132|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|December 2017|Anticipated|2017-12-01||Interventional|ROLANDO||Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin|Multicentric Single Arm Phase II Clinical Trial, to Evaluate Safety and Efficacy of the Combination of Olaparib and PLD for Platinum Resistant Ovarian Primary Peritoneal Carcinoma, and Fallopian Tube Cancer Patients.|Not yet recruiting||Phase 2|32|Anticipated|Grupo Español de Investigación en Cáncer de Ovario||2|||f||||t|f|f||||||No||2017-10-10 21:02:50.502977|2017-10-10 21:02:50.502977
NCT03161119|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-17|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Comparing Two Different Embryo Transfer Catheters|Prospective Randomized Controlled Trial Comparing Two Different Embryo Transfer (ET) Catheters|Not yet recruiting||N/A|352|Anticipated|Istituto Clinico Humanitas||2|||f||||t|f|f||||||No||2017-10-10 21:02:50.596531|2017-10-10 21:02:50.596531
NCT03161106|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-03|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.|To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis- A Randomised Controlled Trial|Recruiting||N/A|150|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f|f|f||||||||2017-10-10 21:02:50.683071|2017-10-10 21:02:50.683071
NCT03161093|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-25|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|March 2019|Anticipated|2019-03-01||Interventional|FACT OA1||A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip|A Phase 3 Randomized, Double-blind, Multi-dose, Placebo and Naproxen-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip|Recruiting||Phase 3|3640|Anticipated|Regeneron Pharmaceuticals||5|||f|||||t|f|||t|||||2017-10-10 21:02:50.778417|2017-10-10 21:02:50.778417
NCT03161080|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-18|||February 9, 2017|Actual|2017-02-09|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome|Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome|Recruiting||N/A|60|Anticipated|Medical University of Vienna||3|||f|||||f|f||||||||2017-10-10 21:02:51.004556|2017-10-10 21:02:51.004556
NCT03161067|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-08-14|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 15, 2018|Anticipated|2018-12-15|September 2018|Anticipated|2018-09-01||Interventional|BiCNS||Investigation on the Bidirectional Cortical Neuroprosthetic System|Investigation on the Bidirectional Cortical Neuroprosthetic System|Recruiting||N/A|5|Anticipated|Johns Hopkins University||1|||f||||t|f|t|t|f||||||2017-10-10 21:02:51.155262|2017-10-10 21:02:51.155262
NCT03161054|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|||Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas|A Phase II Study of Metronomic Chemotherapy in Elderly Non-fit Patients (>65 Years) With Aggressive B-Cell Lymphomas|Not yet recruiting||Phase 2|60|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f|f|f||||||No||2017-10-10 21:02:51.282192|2017-10-10 21:02:51.282192
NCT03161041|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|April 2021|Anticipated|2021-04-01||Interventional|Bev-IP||Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis|Perioperative Chemotherapy With Bevacizumab in Patients Undergoing Cytoreduction and Intraperitoneal Chemoperfusion for Colorectal Carcinomatosis|Not yet recruiting||Phase 2|70|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||No||2017-10-10 21:02:51.630089|2017-10-10 21:02:51.630089
NCT03161028|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-05|||November 1, 2017|Anticipated|2017-11-01|June 2017|2017-06-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2021|Anticipated|2021-04-01||Interventional|||Lipoic Acid for Progressive Multiple Sclerosis (MS)|Lipoic Acid for the Treatment of Progressive Multiple Sclerosis|Not yet recruiting||Phase 2|100|Anticipated|VA Office of Research and Development||2|||f||||f|t|f||||||No||2017-10-10 21:02:51.750066|2017-10-10 21:02:51.750066
NCT03161015|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-17|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Single-Dose PK Study of GBT440 in Subjects With Renal Impairment|A Non-Randomized, Open-Label, Parallel Group, Single-Dose Study to Compare the Pharmacokinetics of GBT440 in Subjects With Renal Impaired Function to Healthy Subjects|Recruiting||Phase 1|40|Anticipated|Global Blood Therapeutics||4|||f||||f|t|f||||||Undecided||2017-10-10 21:02:51.906602|2017-10-10 21:02:51.906602
NCT03161002|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-06|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||A Research in Pharmacogenomics and Accurate Medication of New Antiplatelet Drug Ticagrelor|A Research in Pharmacogenomics and Accurate Medication of New Antiplatelet Drug Ticagrelor|Recruiting||N/A|400|Anticipated|Peking University First Hospital|||2||f|||||f|f||||||||2017-10-10 21:02:52.03654|2017-10-10 21:02:52.03654
NCT03160989|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-19|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Acute and Chronic Responses to Blood Pressure After Exercise|Acute and Chronic Responses to Blood Pressure After Exercise|Completed||N/A|14|Actual|Federal University of Uberlandia||1|||f||||t|f|f||||||No||2017-10-10 21:02:52.145121|2017-10-10 21:02:52.145121
NCT03160976|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-22|||May 25, 2017|Anticipated|2017-05-25|May 2017|2017-05-01|October 25, 2017|Anticipated|2017-10-25|August 25, 2017|Anticipated|2017-08-25||Interventional|||Cryolipolysis on Localized Adiposity|Effects of Cryolipolysis on Localized Adiposity: Randomized Clinical Trial|Not yet recruiting||N/A|28|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t|f|f||||||No||2017-10-10 21:02:52.256731|2017-10-10 21:02:52.256731
NCT03160963|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-31|||January 25, 2017|Actual|2017-01-25|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|January 30, 2018|Anticipated|2018-01-30||Observational|||Clinical Power Testing Across Human Lifetime|Optimal Manner of Measuring Power Across the Lifespan|Recruiting||N/A|100|Anticipated|University of Miami|||7||f||||f|f|f||||||||2017-10-10 21:02:52.36848|2017-10-10 21:02:52.36848
NCT03160950|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-17|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Efficacy of Crowns Fabricated Using LuxaCrown|Evaluating the Longevity and Safety of Full-coverage Crowns Fabricated With LuxaCrown Over a Period of 5 Years in 25-60 Year Old Indian Population: An Uncontrolled Trial|Not yet recruiting||N/A|50|Anticipated|DMG Dental Material Gesellschaft mbH||1|||f|||||f|f||||||Undecided||2017-10-10 21:02:52.486725|2017-10-10 21:02:52.486725
NCT03160937|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-17|||January 10, 2017|Actual|2017-01-10|May 2017|2017-05-01|April 10, 2017|Actual|2017-04-10|March 10, 2017|Actual|2017-03-10||Interventional|||Neurodynamic Mobilization and Foam Rolling|Neurodynamic Mobilization and Foam Rolling in Delayed-onset Muscle Soreness in a Healthy Adult Population: a Randomized Controlled Clinical Trial|Completed||N/A|32|Actual|Centro Universitario La Salle||2|||f||||t|f|f||||||No||2017-10-10 21:02:52.58966|2017-10-10 21:02:52.58966
NCT03160924|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-17|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy|The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy: A Randomized Controlled Trial|Recruiting||Phase 3|50|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||No|The data of the patients will only be available to researches participating in this study.|2017-10-10 21:02:52.674501|2017-10-10 21:02:52.674501
NCT03160911|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-07-25|||July 26, 2017|Anticipated|2017-07-26|July 2017|2017-07-01|December 1, 2019|Anticipated|2019-12-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||The Use of Over-the-scope-clip for Prevention of Rebleeding in High Risk Peptic Ulcers|The Use of Over-the-scope-clip (OTSC) Versus Standard Therapy for the Prevention of Rebleeding in High Risk Peptic Ulcers: a Randomised Controlled Trial.|Not yet recruiting||N/A|152|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|t|t||t|||||2017-10-10 21:02:52.792897|2017-10-10 21:02:52.792897
NCT03160898|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-29|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Phase 2, Multi-Center, Double-Blind, Randomized, Dose-Ranging, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)|Recruiting||Phase 2|445|Anticipated|Cytokinetics||4|||||||t|t|f||||||||2017-10-10 21:02:52.907687|2017-10-10 21:02:52.907687
NCT03160885|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-04|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|November 6, 2019|Anticipated|2019-11-06|November 6, 2019|Anticipated|2019-11-06||Interventional|ECZTRA 2||Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)|A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Tralokinumab Monotherapy in Subjects With Moderate to Severe Atopic Dermatitis Who Are Candidates for Systemic Therapy|Recruiting||Phase 3|780|Anticipated|LEO Pharma||6|||f||||t|t|f||||||||2017-10-10 21:02:53.163642|2017-10-10 21:02:53.163642
NCT03160872|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-18|||January 1, 2013|Actual|2013-01-01|May 2017|2017-05-01|December 15, 2016|Actual|2016-12-15|June 30, 2016|Actual|2016-06-30||Observational|||Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women|Ovarian Reserve Does Not Predict Pregnancy in Non-Infertile Women: An Assessment Using the Donor Sperm Insemination Model|Completed||N/A|143|Actual|Institut Universitari Dexeus|||1||f||||f|f|f||||||No||2017-10-10 21:02:53.641828|2017-10-10 21:02:53.641828
NCT03160859|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-28|||January 8, 2018|Anticipated|2018-01-08|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|January 31, 2020|Anticipated|2020-01-31||Interventional|||Prospective RCT Of Water Exchange (WE) vs. WE Plus Cap-Assisted Colonoscopy|Prospective RCT of Water Exchange (WE) vs. WE Plus Cap-Assisted Colonoscopy|Not yet recruiting||N/A|256|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:02:53.73041|2017-10-10 21:02:53.73041
NCT03160846|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||August 25, 2014|Actual|2014-08-25|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01|1 Year|Observational [Patient Registry]|INTERPRET||The Inotrope Evaluation and Research Patient Registry|Inotrope, Evaluation and Research (INTERPRET) Patient Registry Program|Recruiting||N/A|120|Anticipated|Coram Clinical Trials|||1||f|||||f|f||||||||2017-10-10 21:02:53.845739|2017-10-10 21:02:53.845739
NCT03160833|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-22|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study of HMPL-453 in Patients With Advanced Solid Malignancies|A Phase I/II, Open-label, Multi-center, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of HMPL-453 in Patients With Advanced Solid Malignancies|Recruiting||Phase 1/Phase 2|96|Anticipated|Hutchison Medipharma Limited||1|||f||||f|f|f||||||Undecided||2017-10-10 21:02:53.970379|2017-10-10 21:02:53.970379
NCT03160820|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-17|||March 2016||2016-03-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine|Comparison of Immunization Schedules of Beijing Tiantan Biological's MMR Vaccine in 18-72 Month-Old Children|Completed||Phase 4|873|Actual|Centers for Disease Control and Prevention, China||4|||f||||t||||||||No||2017-10-10 21:02:54.075874|2017-10-10 21:02:54.075874
NCT03160807|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-05-18|||April 15, 2017|Actual|2017-04-15|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|Levolet-KZ16||Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections|An Open Label Non Placebo Study to Evaluate Efficacy and Safety of Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections|Recruiting||Phase 4|214|Anticipated|Dr. Reddy's Laboratories Limited||2|||f||||f|f|f||||||Yes||2017-10-10 21:02:54.172732|2017-10-10 21:02:54.172732
NCT03160794|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-30|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy|Phase II Study: [18F]DCFPyL PET/MRI for Personalizing Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy (MRgRT)|Recruiting||Phase 2|75|Anticipated|University Health Network, Toronto||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:02:54.281207|2017-10-10 21:02:54.281207
NCT03160781|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||January 28, 2014|Actual|2014-01-28|May 2017|2017-05-01|January 10, 2015|Actual|2015-01-10|January 10, 2015|Actual|2015-01-10||Interventional|||Intraosseous PRP for Knee Osteoarthritis: Pilot Study|Pilot Study to Evaluate Combination of Intraosseous With Intra-articular Infiltrations of Plasma Rich in Growth Factors (PRGF®-Endoret®) in the Treatment of Knee Osteoarthritis.|Completed||Phase 2|19|Actual|Unidad de Cirugía Artroscópica||1|||f||||f|f|f|||f|||No||2017-10-10 21:02:54.379|2017-10-10 21:02:54.379
NCT03160768|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-07-07|||May 25, 2017|Actual|2017-05-25|July 2017|2017-07-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Observational|||Feasibility of Isolating P16 Expression|Feasibility of Isolating P16 Expression|Recruiting||N/A|60|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     Blood specimen.   "|||2017-10-10 21:02:54.459913|2017-10-10 21:02:54.459913
NCT03160755|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-07|||April 18, 2017|Actual|2017-04-18|June 2017|2017-06-01|October 8, 2017|Anticipated|2017-10-08|October 8, 2017|Anticipated|2017-10-08||Observational|MAPP-I||Motivation-Audit-Positive Psychology Intervention Study|Developing a Group-based Positive Psychology and Physical Activity Intervention in Patients With Metabolic Syndrome: Qualitative Research Phase|Recruiting||N/A|20|Anticipated|Massachusetts General Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:02:54.542877|2017-10-10 21:02:54.542877
NCT03160742|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-06-07|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Pilot Study of a Non-Invasive Central Venous Pressure Monitoring System in Children|Pilot Study of a Non-Invasive Central Venous Pressure Monitoring System in Children|Not yet recruiting||N/A|30|Anticipated|Boston Children’s Hospital|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:02:54.630677|2017-10-10 21:02:54.630677
NCT03160729|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|DEX-NEF||High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Nephrectomy|High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Nephrectomy (DEX-NEF)|Recruiting||Phase 4|88|Anticipated|Rigshospitalet, Denmark||2|||f||||t|f|f||||||No||2017-10-10 21:02:54.707363|2017-10-10 21:02:54.707363
NCT03160716|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-07-06|||May 16, 2017|Actual|2017-05-16|July 2017|2017-07-01|November 1, 2017|Anticipated|2017-11-01|October 15, 2017|Anticipated|2017-10-15||Interventional|||Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation|A Multicenter, Open-Label, Prospective Study of Cannula Injection of Restylane Lyft With Lidocaine for Cheek Augmentation and the Correction of Age Related Midface Contour Deficiencies|Active, not recruiting||N/A|60|Actual|Q-Med AB||1|||f||||f|f|t|f|f||||||2017-10-10 21:02:54.801262|2017-10-10 21:02:54.801262
NCT03160703|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-09-15|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|August 26, 2017|Actual|2017-08-26|August 26, 2017|Actual|2017-08-26||Interventional|||Study to Investigate the Stain Control of Two Stannous Fluoride Dentifrices|A Proof of Principal Study to Investigate the Stain Control of Two Stannous Fluoride Dentifrices|Completed||Phase 4|220|Actual|GlaxoSmithKline||4|||f||||f|f|f||||||||2017-10-10 21:02:54.876049|2017-10-10 21:02:54.876049
NCT03160690|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||June 17, 2017|Anticipated|2017-06-17|May 2017|2017-05-01|May 17, 2018|Anticipated|2018-05-17|November 17, 2017|Anticipated|2017-11-17||Observational|||Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy|Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy|Not yet recruiting||N/A|20|Anticipated|Germans Trias i Pujol Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:02:54.961128|2017-10-10 21:02:54.961128
NCT03160677|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-08-29|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|BP-TARGET||Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy|Comparison of Two Strategies for Blood Pressure Control in the Setting of Acute Ischemic Stroke to Reduce Cerebral Hemorrhage After Thrombectomy: Systolic Blood Pressure Target of Less Than 130 mmHg vs Less Than 185 mmHg, for 24 Hours Following Reperfusion, in Patients With Cerebral Infarction Due to Occlusion of the Anterior Circulation|Recruiting||N/A|320|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||t|f|f||||||||2017-10-10 21:02:55.048762|2017-10-10 21:02:55.048762
NCT03160664|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-17|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|March 31, 2020|Anticipated|2020-03-31||Interventional|||Magnetic Seizure Therapy for Bipolar Mania|Research on Optimization Program of Magnetic Seizure Therapy for Bipolar Mania Patients|Not yet recruiting||N/A|60|Anticipated|Shanghai Mental Health Center||2|||f||||t|f|f||||||No||2017-10-10 21:02:55.150794|2017-10-10 21:02:55.150794
NCT03160651|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-23|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|June 2020|Anticipated|2020-06-01||Interventional|||Corticosteroids in Alcoholic Hepatitis|Corticosteroids in Severe Alcoholic Hepatitis Patients With Early Spontaneous Improvement|Not yet recruiting||N/A|140|Anticipated|Erasme University Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:02:55.240581|2017-10-10 21:02:55.240581
NCT03160638|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-06|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|April 30, 2019|Anticipated|2019-04-30|December 1, 2018|Anticipated|2018-12-01||Interventional|||Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis|A Prospective, Randomized Pilot Study of the Immunomodulatory Effects of Azithromycin in Adults With Pulmonary Tuberculosis|Not yet recruiting||Phase 2|24|Anticipated|University Medical Center Groningen||2|||f||||f|f|f|||f|||No||2017-10-10 21:02:55.319962|2017-10-10 21:02:55.319962
NCT03160625|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|RESPOND HF||Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF|Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF|Recruiting||N/A|100|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f|f|f||||||||2017-10-10 21:02:55.401522|2017-10-10 21:02:55.401522
NCT03160612|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2016|Actual|2016-08-01||Interventional|||Independent Transfer Training|Investigation of the Effects of Independent Transfer Training|Active, not recruiting||N/A|94|Actual|University of Pittsburgh||2|||f||||f|f|f||||||No|There is no plan to make individual participant data available to other researchers.|2017-10-10 21:02:55.642077|2017-10-10 21:02:55.642077
NCT03160599|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-17|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Restricted Calorie Ketogenic Diet as a Treatment in Glioblastoma Multiforme|Restricted Calorie Ketogenic Diet as a Treatment in Glioblastoma Multiforme: a Clinical Study|Recruiting||N/A|50|Anticipated|Second Affiliated Hospital of Guangzhou Medical University||1|||f|||||f|f||||||||2017-10-10 21:02:55.775372|2017-10-10 21:02:55.775372
NCT03160586|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Stuttering and Anxiety|Stuttering Severity and Anxiety in Egyptian School-age Children|Recruiting||N/A|100|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:02:55.876148|2017-10-10 21:02:55.876148
NCT03160573|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-17|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Controlling Oral Malodor by ClōSYS Oral Rinse|Efficacy of ClōSYS Oral Rinse Products in Human Subjects in Controlling Oral Malodor|Completed||N/A|100|Actual|Rowpar Pharmaceuticals, Inc.||3|||f||||t||||||||Undecided||2017-10-10 21:02:55.984575|2017-10-10 21:02:55.984575
NCT03160560|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-18|||August 2016||2016-08-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Controlling Oral Malodor by ClōSYS® Oral Rinse|Efficacy of ClōSYS® Oral Rinse Products in Human Subjects in Controlling Oral Malodor|Completed||N/A|100|Actual|Rowpar Pharmaceuticals, Inc.||3|||f||||t||||||||Undecided||2017-10-10 21:02:56.092009|2017-10-10 21:02:56.092009
NCT03160534|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-26|||July 1, 2016|Actual|2016-07-01|February 2017|2017-02-01|November 1, 2017|Anticipated|2017-11-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Effect of Preoperative Exercise in Patients Undergoing Total Knee Arthroplasty|Effect of Preoperative Exercise in Patients Undergoing Total Knee Arthroplasty: A Randomized Controlled Pilot Trial|Recruiting||N/A|20|Anticipated|Balgrist University Hospital||2|||f||||f|f|f||||||No|no there is not|2017-10-10 21:02:56.246448|2017-10-10 21:02:56.246448
NCT03160521|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-17|||May 9, 2017|Actual|2017-05-09|February 2017|2017-02-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|PRISMA-3||Study to Evaluate the Efficacy and Safety of Risperidone In Situ Microparticles® (ISM®) in Patients With Acute Schizophrenia|Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia|Recruiting||Phase 3|393|Anticipated|Rovi Pharmaceuticals Laboratories||3|||f||||t|t|f||||||No||2017-10-10 21:02:56.338128|2017-10-10 21:02:56.338128
NCT03160508|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-18|2017-05-22|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|||TFNA Weight Bearing|A Prospective Study to Investigate Postoperative Real Life Weight Bearing Measured in Patients Treated With a Trochanter Fixation Nail Advanced (TFNA)|Not yet recruiting||N/A|30|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f|f|f||||||No||2017-10-10 21:02:56.445565|2017-10-10 21:02:56.445565
NCT03160326|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-05-18|||September 2016||2016-09-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Observational|||The QUALITY Vets Project: Muscle Quality and Kidney Disease|The Quantitative Ultrasound Assessment of Lean and Intramuscular Adipose Tissue in Veterans With Chronic Kidney Disease|Recruiting||N/A|75|Anticipated|Washington D.C. Veterans Affairs Medical Center|||1||f||||f||||||||Yes|Data will be shared between the two study sites: the Washington DC and San Francisco VA Medical Centers|2017-10-10 21:02:58.010224|2017-10-10 21:02:58.010224
NCT03160495|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-23|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|December 30, 2018|Anticipated|2018-12-30|September 30, 2018|Anticipated|2018-09-30|1 Day|Observational [Patient Registry]|FIGHHT||Functional ImaGing of Heterogeneity in Head and Neck Tumors - Validation From Surgical Specimens|Functional ImaGing of Heterogeneity in Head and Neck Tumors - Validation From Surgical Specimens|Recruiting||N/A|40|Anticipated|Rigshospitalet, Denmark|||1||f||||f|f|f||||Samples With DNA|"     The gross specimen will be examined, sectioned and placed in tissue cassettes as done in     routine. Six tissue blocks will be picked for microscopic evaluation and IHC staining. The     specific selection of cancer related IHC biomarkers is based on their relationship with tumor     cell metabolism, radiotherapy resistance (proliferation and hypoxia), association with FDG     accumulation and institutional experience from a previous study   "|No||2017-10-10 21:02:56.514266|2017-10-10 21:02:56.514266
NCT03160482|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|October 15, 2017|Anticipated|2017-10-15|July 15, 2017|Anticipated|2017-07-15||Observational|||Expression of Protein Convertases in Thyroid Nodules|The Expression of Protein Convertases Amongst Well Differentiated Thyroid Cancers|Enrolling by invitation||N/A|30|Anticipated|Université de Sherbrooke|||6||f||||f|f|f||||Samples Without DNA|"     Formalin-fixed, paraffin-embedded thyroid tissue, kept at the CIUSSS de l'Estrie - CHUS     Pathology archives   "|No||2017-10-10 21:02:56.6177|2017-10-10 21:02:56.6177
NCT03160469|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|January 31, 2017|Actual|2017-01-31||Interventional|||Prospective Study Of The Procedure-less Intra-gastric Elipse Balloon: Is It Effective & Safe?|Prospective Study Of The Procedure-less Intra-gastric Elipse Balloon: Is It Effective & Safe?|Completed||N/A|50|Actual|Amiri Hospital||1|||f||||t|f|f||||||Yes|This is a study for publication in International surgical journal to be shared by all clinicians using this device|2017-10-10 21:02:56.746939|2017-10-10 21:02:56.746939
NCT03160456|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-08-17|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TESLA-home||Domiciliary Transcutaneous Electrical Stimulation in Obstructive Sleep Apnoea|Randomised Controlled Trial of Domiciliary Transcutaneous Electrical Stimulation in Obstructive Sleep Apnoea|Not yet recruiting||N/A|68|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t|f|f||||||||2017-10-10 21:02:56.866949|2017-10-10 21:02:56.866949
NCT03160443|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-22|||May 3, 2017|Actual|2017-05-03|March 2017|2017-03-01|May 2, 2021|Anticipated|2021-05-02|November 2, 2019|Anticipated|2019-11-02||Interventional|NEUROPSY_TCA||Impact of Neuropsychological Alteration of Decision-making Abilities on the Functioning of Patients With Eating Disorders|Impact of Neuropsychological Alteration of Decision-making Abilities on the Functioning of Patients With Eating Disorders|Recruiting||N/A|340|Anticipated|University Hospital, Montpellier||1|||f||||f|f|f||||||No||2017-10-10 21:02:57.006145|2017-10-10 21:02:57.006145
NCT03160430|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-26|||December 15, 2017|Anticipated|2017-12-15|September 2017|2017-09-01|July 15, 2018|Anticipated|2018-07-15|July 15, 2018|Anticipated|2018-07-15||Interventional|||A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis|A Two-Part Phase 2a Study in Patients With End-Stage Renal Disease Treated With Hemodialysis; Part A is an Open-Label Study Arm to Evaluate the Effect of Hemodialysis on the Pharmacokinetics of 100 mg RVX000222; and Part B is a Double-Blind, Randomized, Placebo-Controlled, Sequential Cross-Over Study Arm to Evaluate the Efficacy, Safety, and Pharmacokinetics of RVX000222|Not yet recruiting||Phase 1/Phase 2|44|Anticipated|Resverlogix Corp||3|||f||||f|t|f||||||||2017-10-10 21:02:57.125093|2017-10-10 21:02:57.125093
NCT03160417|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-19|||April 26, 2016|Actual|2016-04-26|May 2017|2017-05-01|July 31, 2017|Anticipated|2017-07-31|July 30, 2017|Anticipated|2017-07-30||Observational|DTCHT||Doppler Ultrasound in Rewarming After Targeted Control Management in Cardiac Arrest||Recruiting||N/A|40|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 21:02:57.244336|2017-10-10 21:02:57.244336
NCT03160404|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-18|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Zolpidem, Exercise and Insomnia|The Effects of Zolpidem and Exercise on Chronic Insomnia|Not yet recruiting||Early Phase 1|45|Anticipated|Universidade Federal de Goias||3|||f||||t|f|f||||||Undecided||2017-10-10 21:02:57.315536|2017-10-10 21:02:57.315536
NCT03160391|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-05-17|||January 1, 2012|Actual|2012-01-01|May 2017|2017-05-01|November 30, 2013|Actual|2013-11-30|November 30, 2013|Actual|2013-11-30||Interventional|||Cognitive Effects of Music and Dance Training in Children|Cognitive Effects of Music and Dance Training in Children: A Randomized Controlled Trial|Completed||N/A|75|Actual|York University||3|||f|||||f|f||||||Undecided||2017-10-10 21:02:57.446455|2017-10-10 21:02:57.446455
NCT03160378|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||May 22, 2017|Anticipated|2017-05-22|May 2017|2017-05-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|OST||Organizational Skills Training for Children With ADHD|Organizational Skills Training for Children With ADHD|Not yet recruiting||N/A|98|Anticipated|Region Syddanmark||2|||f||||t|f|f||||||Undecided|After the competition of the study, data will be stored in Danish National Archives, where data can be accessed after previous approval.|2017-10-10 21:02:57.536016|2017-10-10 21:02:57.536016
NCT03160365|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-13|||November 6, 2017|Anticipated|2017-11-06|September 2017|2017-09-01|January 6, 2020|Anticipated|2020-01-06|January 6, 2020|Anticipated|2020-01-06||Interventional|FOCUS||Innovative Planning and Guidance System for Prostate Focal Brachytherapy|Innovative Planning and Guidance System for Prostate Focal Brachytherapy|Not yet recruiting||N/A|25|Anticipated|University Hospital, Brest||1|||f||||t|f|f||||||||2017-10-10 21:02:57.669319|2017-10-10 21:02:57.669319
NCT03160352|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-12|||May 12, 2017|Actual|2017-05-12|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|June 25, 2017|Actual|2017-06-25||Interventional|||Effects of Exergames on Vestibular Function in Healthy Community Dwellers.|Effects of a Virtual Reality-based Dual-task Exercise on Vestibular Function in Healthy Community Dwellers. A Pilot Study|Completed||N/A|11|Actual|University of Zurich||1|||f||||f|f|f||||||||2017-10-10 21:02:57.751609|2017-10-10 21:02:57.751609
NCT03160339|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-23|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047|A Phase 1 Two-Arm, Randomized, Double-blind, Active-controlled Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047 (Adenovirus Type 4 and Type 7 Vaccine [A549 Cells], Live, Oral)|Recruiting||Phase 1|25|Anticipated|PaxVax, Inc.||2|||f||||f|t|f||||||Undecided||2017-10-10 21:02:57.845126|2017-10-10 21:02:57.845126
NCT03160313|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-17|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|InFuSe||Effects of an Interdisciplinary Fitness and Social Engagement Intervention|Effects of an Interdisciplinary Fitness and Social Engagement Intervention on Physical Activity, Sleep Quality and Community Integration|Recruiting||N/A|24|Anticipated|Washington D.C. Veterans Affairs Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:02:58.141283|2017-10-10 21:02:58.141283
NCT03160300|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effect of Binaural Beats on Pain Perception and Analgesic Medication Use in Patients Suffering From Chronic Pain|Placebo-Controlled, Randomized, Double-Blind Trial on the Effect of Binaural Beats on Pain Perception and Analgesic Medication Use in Patients Suffering From Chronic Pain|Recruiting||N/A|20|Anticipated|Aristotle University Of Thessaloniki||2|||f|||||f|f||||||Undecided||2017-10-10 21:02:58.262373|2017-10-10 21:02:58.262373
NCT03160287|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-17|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|MobMPATI||Mobile Motivational Physical Activity Targeted Intervention|Mobile Motivational Physical Activity Targeted Intervention (MobMPATI) to Improve Sleep in Older Adults With Osteoarthritis|Not yet recruiting||N/A|40|Anticipated|University of Washington||1|||f|||||f|f||||||||2017-10-10 21:02:58.379091|2017-10-10 21:02:58.379091
NCT03160274|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-17|||October 19, 2005|Actual|2005-10-19|May 2017|2017-05-01|December 31, 2030|Anticipated|2030-12-31|December 31, 2030|Anticipated|2030-12-31|30 Years|Observational [Patient Registry]|||Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions|Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions|Recruiting||N/A|2000|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||t|f|f||||Samples With DNA|"     Samples from affected individuals will be obtained as:        -  DNA from peripheral blood lymphocytes,        -  DNA from tumor tissue, or        -  Frozen peripheral blood lymphocytes for nucleic acid purification        -  Frozen tumor tissue for nucleic acid purification        -  Lymphoblastoid cell lines, if available        -  Buccal cells obtained by cheek swab or saliva      Samples from unaffected relatives will be obtained as:        -  DNA from peripheral blood lymphocytes, or        -  Frozen peripheral blood lymphocytes for nucleic acid purification   "|No|Aggregate data will be available in the form of publications and pertinent data will be deposited in public depositories|2017-10-10 21:02:58.476153|2017-10-10 21:02:58.476153
NCT03160261|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-06|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Effect of Exenatide on Cortisol Secretion|Effect of Exenatide on Cortisol Secretion|Enrolling by invitation||Phase 4|10|Anticipated|University of Tartu||1|||f||||f|f|f|||f|||||2017-10-10 21:02:58.582965|2017-10-10 21:02:58.582965
NCT03160248|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-16|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|APREMINUM||An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema|An Investigator-initiated, Randomized, Double-blind, Placebo Controlled Study of Apremilast to Demonstrate Efficacy in Subjects With Nummular Eczema|Recruiting||Phase 2|40|Anticipated|Technische Universität München||2|||f||||t|f|f|||f|||||2017-10-10 21:02:58.683777|2017-10-10 21:02:58.683777
NCT03160235|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-17|||February 1, 2013|Actual|2013-02-01|May 2017|2017-05-01|January 31, 2018|Anticipated|2018-01-31|January 1, 2018|Anticipated|2018-01-01||Interventional|MAP-PV||Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Voluntary Patients|Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Voluntary Patients|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||3|||f||||t|f|f||||||No||2017-10-10 21:02:58.792973|2017-10-10 21:02:58.792973
NCT03160222|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-05-17|||January 2017||2017-01-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|USVALID||Validation of Bedside Ultrasound to Predict Body Composition in Non- and Critically Ill Patients|Validation of Bedside Ultrasound to Predict Body Composition in Non- and Critically Ill Patients: The USVALID Prospective Study|Recruiting||N/A|250|Anticipated|Medical University of Vienna||1|||f||||f||||||||No||2017-10-10 21:02:58.912808|2017-10-10 21:02:58.912808
NCT03160209|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-27|||July 26, 2017|Actual|2017-07-26|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|July 2019|Anticipated|2019-07-01||Observational|||HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi|LCCC 1608 - HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi|Recruiting||N/A|600|Anticipated|UNC Lineberger Comprehensive Cancer Center|||2||f||||f|f|f||||||||2017-10-10 21:02:59.032822|2017-10-10 21:02:59.032822
NCT03160196|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||January 2018|Anticipated|2018-01-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|OSI-DM||Efficacy of an Electronic System to Support Clinical Decisions in Adults With Type 2 Diabetes Mellitus.|Efficacy of an Electronic System to Support Clinical Decisions Based on an Evidence-based Clinical Practice Guide for Metabolic Control of Adults With Type 2 Diabetes Mellitus: Clinical and Cluster-randomized Controlled Trial.|Not yet recruiting||N/A|1768|Anticipated|Sanitas University||2|||f||||f|f|f||||||No||2017-10-10 21:02:59.163708|2017-10-10 21:02:59.163708
NCT03160183|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-17|||September 2016||2016-09-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|September 2020|Anticipated|2020-09-01||Observational|||Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi|Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi|Recruiting||N/A|200|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||f||||||||Undecided||2017-10-10 21:02:59.256739|2017-10-10 21:02:59.256739
NCT03160170|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-19|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Efficacy of Suction Enabled Retraction Device|Intraoperative Efficacy of Suction Enabled Retraction Device in Lumbar Spine Surgery|Recruiting||N/A|40|Anticipated|University of Miami||2|||f||||f|f|t|f||f|||No|There is no plan to share individual participant data (IPD)|2017-10-10 21:02:59.47476|2017-10-10 21:02:59.47476
NCT03160157|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||December 2016||2016-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|RCT||Comparing the Outcomes of Laparoscopic Cholecystectomy vs. Robotic Cholecystectomy|Prospective Randomized Controlled Trial Comparing the Outcomes of Laparoscopic Cholecystectomy vs. Robotic Cholecystectomy|Recruiting||N/A|200|Anticipated|University of Illinois at Chicago|||2||f||||f||||||||No|Data will be coded and will be analyzed by the research staff only. No IPD will be shared with other researchers.|2017-10-10 21:02:59.577478|2017-10-10 21:02:59.577478
NCT03160144|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-17|||January 12, 2017|Actual|2017-01-12|May 2017|2017-05-01|January 31, 2019|Anticipated|2019-01-31|December 31, 2018|Anticipated|2018-12-31||Interventional|PROVOLON||The PROtective Ventilation Using Open Lung Approach Or Not Trial|Effects of Open Lung Approach on Intraoperative Respiratory Function and Postoperative Recovery of Patients With Laparoscopic Colorectal Resection|Recruiting||N/A|280|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 21:02:59.671337|2017-10-10 21:02:59.671337
NCT03160131|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-17|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|IBOS-NVT||Rehabilitation of Visual Function After Brain Injury|Rehabilitation of Visual Function After Brain Injury - Effect of Neuro Vision Technology (NVT)|Not yet recruiting||N/A|25|Anticipated|University Hospital, Gentofte, Copenhagen||1|||f||||f|f|f||||||No||2017-10-10 21:02:59.854568|2017-10-10 21:02:59.854568
NCT03160118|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-17|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|May 15, 2017|Actual|2017-05-15||Interventional|||Study of Biomarkers of Immune Activation Associated With Symptoms and Immune Responses After Influenza Vaccination in Adults|A Clinical Study of Biomarkers of Innate and Adaptive Immune Activation Associated With Symptoms and Immune Responses After Administration of a Single Dose of a Quadrivalent Inactivated Split Virus Influenza Vaccine to Healthy Young Adults.|Active, not recruiting||Phase 4|20|Anticipated|University Hospital, Ghent||1|||f||||f|f|f||||||No||2017-10-10 21:02:59.974135|2017-10-10 21:02:59.974135
NCT03160105|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|May 2020|Anticipated|2020-05-01||Interventional|Simpl'HIV||Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)|Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection: a Non-inferiority, Randomized, Controlled, Open-label Clinical Trial|Recruiting||Phase 4|184|Anticipated|University Hospital, Geneva||4|||f||||t|f|f|||f|||No||2017-10-10 21:03:00.090878|2017-10-10 21:03:00.090878
NCT03160092|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-17|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|September 1, 2018|Anticipated|2018-09-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||The Feasibility of a Novel Intervention for At Risk Mental State|Assessing the Feasibility of a Novel Intervention for Young People With At Risk Mental State and Attenuated Positive Psychotic Symptoms: The Viability of Its Use in the NHS and of a Future Trial|Recruiting||N/A|12|Anticipated|University of East Anglia||1|||f||||f|f|f||||||No||2017-10-10 21:03:00.226663|2017-10-10 21:03:00.226663
NCT03160079|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-08|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow Lymphoblasts|A Phase I/II Study of Blinatumomab in Combination With Pembrolizumab (MK-3475) for Adults With Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia With High Bone Marrow Lymphoblast Percentage|Recruiting||Phase 1/Phase 2|24|Anticipated|University of California, San Diego||1|||f||||t|t|f||||||||2017-10-10 21:03:00.315198|2017-10-10 21:03:00.315198
NCT03160066|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-05-24|||July 2015||2015-07-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Effects of Lactobacillus Rhamnosus (JB-1) on Stress and Cognition|The Effects of Lactobacillus Rhamnosus (JB-1) on Stress and Cognition in Healthy Volunteers|Completed||N/A|29|Actual|University College Cork||2|||f||||f|f|f||||||No||2017-10-10 21:03:00.424639|2017-10-10 21:03:00.424639
NCT03160053|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-17|||June 23, 2015|Actual|2015-06-23|May 2017|2017-05-01|November 20, 2019|Anticipated|2019-11-20|November 20, 2015|Actual|2015-11-20||Interventional|||Improving Keloids Using Targeted Ultraviolet-B Irradiation|Improving Keloids Using Targeted Ultraviolet-B Irradiation|Suspended||N/A|50|Anticipated|Johns Hopkins University||2||PI wants to halt recruitment while reviewing preliminary data.|f||||f|f|f||||||||2017-10-10 21:03:00.515343|2017-10-10 21:03:00.515343
NCT03160040|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 17, 2017|Anticipated|2017-11-17|November 17, 2017|Anticipated|2017-11-17||Observational|||A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting|Retrospective, Observational Evaluation of the Utilization, Outcomes, and Adverse Events Associated With Minocin IV for the Treatment of Infections Presumed or Confirmed to be Caused by Gram-negative Bacteria in a Real World Setting|Recruiting||N/A|100|Anticipated|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)|||1||f||||f|t|f||||||||2017-10-10 21:03:00.581701|2017-10-10 21:03:00.581701
NCT03160027|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|March 31, 2018|Anticipated|2018-03-31||Interventional|PBM Dementia||Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia)|Examining the Impact of Photobiomodulation (PBM) on Brain Function in Dementia|Recruiting||Phase 2/Phase 3|10|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||Undecided||2017-10-10 21:03:00.684494|2017-10-10 21:03:00.684494
NCT03160014|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||June 2015||2015-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment|Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment (Single-Center, Open-label, Parallel-Group, Single-Dose Study)|Recruiting||Phase 1|32|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||4|||f||||||||||||||2017-10-10 21:03:00.778976|2017-10-10 21:03:00.778976
NCT03160001|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-08|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Niclosamide With Etanercept in Rheumatoid Arthritis|Adjuvant Use of Niclosamide With Etanercept in Rheumatoid Arthritis: Experimental and Clinical Study|Recruiting||Phase 1/Phase 2|110|Anticipated|University of Baghdad||2|||f||||t|t|f|||t|||No||2017-10-10 21:03:00.860091|2017-10-10 21:03:00.860091
NCT03159988|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-05-17|||April 2016||2016-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients|Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients|Recruiting||Phase 2|16|Anticipated|University of Arizona||1|||f||||t||||||||Undecided||2017-10-10 21:03:00.96784|2017-10-10 21:03:00.96784
NCT03159065|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Postprandial Efficacy of Probiotic Fruit Beverages on Glucose Tolerance and Insulin Resistance|Early Postprandial Efficacy of Probiotic Fruit Beverages on Glucose Tolerance and Insulin Resistance in Healthy Adults|Completed||N/A|12|Actual|Lund University||6|||f||||f|f|f||||||No||2017-10-10 21:03:11.041785|2017-10-10 21:03:11.041785
NCT03159975|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-18|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|August 20, 2018|Anticipated|2018-08-20|March 5, 2018|Anticipated|2018-03-05||Interventional|||Safety and Immunogenicity Study of GX-70 in TB Patient|A Open-label, Dose Escalation, Phase 1 Clinical Trial to Evaluate the Tolerability, Safety and Immunogenicity of GX-70, a DNA-based Therapeutic Vaccine, Administered Intramuscularly by Electroporation (EP) in Patients With Pulmonary Tuberculosis Who Have High Risk Factors for Relapse or Treatment Failure|Not yet recruiting||Phase 1|18|Anticipated|Yonsei University||3|||f||||f|f|f||||||No||2017-10-10 21:03:01.055973|2017-10-10 21:03:01.055973
NCT03159962|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-18|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01||Interventional|||Mandibular Response After Maxillary Orthopedic Expansion in Class II Growing Subjects|Mandibular Response After Rapid Maxillary Expansion in Class II Growing Patients: a Pilot Randomized Controlled Trial|Completed||N/A|30|Actual|University of Rome Tor Vergata||3|||f||||t|f|f||||||No|no individual participant data are to be shared|2017-10-10 21:03:01.162344|2017-10-10 21:03:01.162344
NCT03159936|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-18|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)|Open Label Phase 2 Pilot Trial of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)|Recruiting||Early Phase 1|12|Anticipated|Tufts Medical Center||1|||f||||f|t|f|||t|||No||2017-10-10 21:03:01.378138|2017-10-10 21:03:01.378138
NCT03159923|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-23|||January 19, 2017|Actual|2017-01-19|May 2017|2017-05-01|January 19, 2021|Anticipated|2021-01-19|January 19, 2021|Anticipated|2021-01-19||Observational|TRAP||Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation|Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation|Recruiting||N/A|200|Anticipated|Rennes University Hospital|||1||f|||||f|f||||||||2017-10-10 21:03:01.507694|2017-10-10 21:03:01.507694
NCT03159910|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-23|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Reducing Shoulder Complaints in Employees With High Mechanical Shoulder Exposures|Reducing Shoulder Complaints in Employees With High Mechanical Shoulder Exposures - a Cluster-randomised Trial|Enrolling by invitation||N/A|250|Anticipated|Central Jutland Regional Hospital||2|||f||||f|f|f||||||||2017-10-10 21:03:01.667486|2017-10-10 21:03:01.667486
NCT03159884|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-07-16|||October 2015||2015-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|STAR||The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)|The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)|Recruiting||Phase 4|300|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.||2|||f||||||||||||||2017-10-10 21:03:02.179853|2017-10-10 21:03:02.179853
NCT03159871|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-18|||June 29, 2016|Actual|2016-06-29|May 2017|2017-05-01|March 20, 2018|Anticipated|2018-03-20|March 20, 2018|Anticipated|2018-03-20||Interventional|||Closing Uterine Incision During C-section Using Barbed Suture (Stratafix) or Vicryl Suture.|Closing Uterine Incision During C-section Using Barbed Suture (Stratafix) or Vicryl Suture: a Randomized Control Study|Recruiting||N/A|200|Anticipated|Barzilai Medical Center||2|||f|||||f|f||||||||2017-10-10 21:03:02.374497|2017-10-10 21:03:02.374497
NCT03159858|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17||||||May 2017|2017-05-01||||||||Expanded Access|||Compassionate Use Treatment for a Single Patient With a Custom Made Branched/Fenestrated Endovascular Device for the Treatment of Complex Abdominal Aortic Aneurysm|Compassionate Use Treatment for a Single Patient With a Custom Made Branched/Fenestrated Endovascular Device for the Treatment of Complex Abdominal Aortic Aneurysm|No longer available||N/A|||New York University School of Medicine||||||t|||||||||||||2017-10-10 21:03:02.466903|2017-10-10 21:03:02.466903
NCT03159845|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-09|||January 1, 2014|Actual|2014-01-01|June 2017|2017-06-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|ZENITH||Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies|A Mono-centric, No-profit, Case-control Study With Daily Oral Supplementation of Zinc Sulphate After Autologous Stem Cell Transplantation in Patients Affected by Multiple Myeloma|Recruiting||Phase 2|50|Anticipated|Azienda Ospedaliero, Universitaria Pisana||2|||f||||t|f|f|||f|||No||2017-10-10 21:03:02.52566|2017-10-10 21:03:02.52566
NCT03159832|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||June 2015||2015-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient|Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient (Open-label, Parallel-Group, Single-Dose Study)|Recruiting||Phase 1|24|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-10 21:03:02.616562|2017-10-10 21:03:02.616562
NCT03159819|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-23|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma|Clinical Study of Redirected Autologous T Cells With a Claudin18.2-targeted Chimeric Antigen Receptor in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma|Not yet recruiting||N/A|24|Anticipated|Changhai Hospital||1|||f||||t|f|f||||||||2017-10-10 21:03:02.69766|2017-10-10 21:03:02.69766
NCT03159806|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Detecting Markers of Kidney Function With Intravenous Microdialysis|Optimising the Recovery of Kidney Function Markers Using a CE-marked Intravenous Microdialysis Probe|Not yet recruiting||N/A|20|Anticipated|Accunea Ltd.|||1||f||||f|f|t|f|f|f|Samples Without DNA|"     Blood samples retained as per hospital lab protocol, microdialysis samples retained until     analysis then discarded   "|No||2017-10-10 21:03:02.800177|2017-10-10 21:03:02.800177
NCT03159793|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of Different Modelling Techniques on Child Anxiety (RCT)|Evaluation of Live Modelling and Filmed Modelling Techniques Versus no Modelling on Child Anxiety During Dental Treatment: A Randomized Clinical Trial|Not yet recruiting||N/A|51|Anticipated|Cairo University||3|||f||||t|f|f||||||Undecided||2017-10-10 21:03:02.89081|2017-10-10 21:03:02.89081
NCT03159780|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-24|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Prevalence of Corneal Astigmatism Before Glaucoma Surgery in Chinese Patients With Primary Angle-closure Glaucoma|Prevalence of Corneal Astigmatism Before Glaucoma Surgery in Chinese Patients With Primary Angle-closure Glaucoma|Recruiting||N/A|1200|Anticipated|Zhongshan Ophthalmic Center, Sun Yet-sen University|||1||f||||f|f|f||||||||2017-10-10 21:03:02.958825|2017-10-10 21:03:02.958825
NCT03159767|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis|Validation of a New Method of Measuring Spinal Flexibility in Axial Spondyloarthritis Using Inertial Motion (IMU) Sensors|Recruiting||N/A|40|Anticipated|Western Health and Social Care Trust||2|||f||||f|f|f||||||No||2017-10-10 21:03:03.037648|2017-10-10 21:03:03.037648
NCT03159754|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-01|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Interventional|||Optimal Care of Complicated Appendicitis|Optimal Care of Complicated Appendicitis|Recruiting||N/A|40|Anticipated|University of Michigan||3|||f|||||f|f||||||||2017-10-10 21:03:03.135806|2017-10-10 21:03:03.135806
NCT03159741|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-29|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigation of GLP-2 Mechanism of Action|Investigation of GLP-2 Mechanism of Action|Recruiting||N/A|8|Anticipated|University of Copenhagen||4|||f|||||f|f||||||||2017-10-10 21:03:03.349472|2017-10-10 21:03:03.349472
NCT03159728|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-10|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Effectiveness Program Caregivers Care|Efect of Program Caregivers of With Chronic Diseases|Recruiting||N/A|100|Anticipated|Universidad de Santander||2|||f||||t|f|f||||||||2017-10-10 21:03:03.562638|2017-10-10 21:03:03.562638
NCT03159715|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Internet-based Depression Treatment: Differential Efficacy of Different Therapeutic Components|Internet-based Depression Treatment. Differential Efficacy of Different Specific Therapeutic Components: Behavioral Activation and Positive Psychology.|Recruiting||N/A|102|Anticipated|Universitat Jaume I||3|||f||||t|f|f||||||No||2017-10-10 21:03:03.661052|2017-10-10 21:03:03.661052
NCT03159702|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-24|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 1, 2023|Anticipated|2023-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation|Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation|Not yet recruiting||Phase 2|43|Anticipated|Medical College of Wisconsin||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:03:03.790167|2017-10-10 21:03:03.790167
NCT03159689|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||January 1, 2018|Anticipated|2018-01-01|May 2017|2017-05-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||The Effect of a Healthy Snack on Body Weight and Composition|Mixed Nuts as Healthy Snack: Effect on Body Weight and Composition|Not yet recruiting||N/A|154|Anticipated|University of California, Los Angeles||2|||f||||f|f|f||||||No|There is no plan to share IPD|2017-10-10 21:03:03.932827|2017-10-10 21:03:03.932827
NCT03159676|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-08-18|||May 12, 2017|Actual|2017-05-12|August 2017|2017-08-01|June 2029|Anticipated|2029-06-01|June 2019|Anticipated|2019-06-01||Observational|||Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer|Proton-Based Stereotactic Ablative Body Radiotherapy (SABR) for Select Patients With Clinically Localized Prostate Cancer.|Recruiting||N/A|150|Anticipated|Mayo Clinic|||1||f|||||f|f||||||||2017-10-10 21:03:04.044541|2017-10-10 21:03:04.044541
NCT03159663|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-21|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2017|Anticipated|2017-06-01||Observational|||Assessment of Quality of Life in Hemophiliac Patients|Assessment of Quality of Life in Hemophiliac Patients|Enrolling by invitation||N/A|100|Actual|Assiut University|||1||f||||||||||||Undecided||2017-10-10 21:03:04.15604|2017-10-10 21:03:04.15604
NCT03159650|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 1, 2019|Anticipated|2019-10-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Comparative Study Between Intravascular Ultrasonography Guided and Angiography-guided Recanalization of Coronary Chronic Total Occlusions|Randomized Comparative Study Between Intravascular Ultrasonography Guided and Angiography-guided Recanalization of Coronary Chronic Total Occlusions|Not yet recruiting||N/A|80|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:03:04.230532|2017-10-10 21:03:04.230532
NCT03159637|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-06|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Observational|||Pneumoperitoneum and Gynecological Laparoscopic Surgery: An Observational Clinical Study|Impact Of Posture and Prolonged Pneumoperitoneum on Intra-Operative and Postoperative Outcomes During Gynecological Laparoscopic Surgery: An Observational Clinical Study|Recruiting||N/A|60|Anticipated|Assiut University|||1||f||||t|f|f||||||Undecided||2017-10-10 21:03:04.320876|2017-10-10 21:03:04.320876
NCT03159624|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||November 13, 2014|Actual|2014-11-13|May 2017|2017-05-01|March 21, 2016|Actual|2016-03-21|March 21, 2016|Actual|2016-03-21||Interventional|||Nasal Septal Flap for Donor Site Reconstruction|Use of Porcine Small Intestinal Submucosa (SIS) Graft to Aid in Nasal Septal Remucosalization and Tissue Healing in Patients Following Use of Nasoseptal Flap Elevation for Skull Base Surgery|Completed||N/A|46|Actual|University of Alabama at Birmingham||2|||f|||||f|f||||||No||2017-10-10 21:03:04.442378|2017-10-10 21:03:04.442378
NCT03159611|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-10-04|||February 19, 2016|Actual|2016-02-19|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Trial of Efficacy and Safety of Tenoten for Children Liquid Dosage Form in the Treatment of Sequelae of Perinatal Injury to Central Nervous System in Children|Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children® Liquid Dosage Form in the Treatment of Sequelae of Perinatal Injury to Central Nervous System in Children|Recruiting||Phase 3|184|Anticipated|Materia Medica Holding||2|||f|||||f|f||||||||2017-10-10 21:03:04.589221|2017-10-10 21:03:04.589221
NCT03159598|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-07-17|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Drain-Less Abdominally Based Breast Reconstruction Using Lysine-Derived Urethane Adhesive|Drain-Less Abdominally Based Breast Reconstruction Using a Novel Lysine-Derived Urethane Adhesive (TissueGlu, Cohera Medical)|Not yet recruiting||N/A|198|Anticipated|Case Comprehensive Cancer Center||3|||f||||t|f|t|f|f|f|||||2017-10-10 21:03:04.811689|2017-10-10 21:03:04.811689
NCT03159585|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-02|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor (TCR) Affinity Enhancing Specific T Cell in Solid Tumors|Application of NY-ESO-1-specific TCR Affinity Enhancing Specific T Cell Therapy (TAEST16001) in Solid Tumors Including Bone and Soft Tissue Sarcoma, Melanoma, Liver Cancer, Esophageal Cancer, Breast Cancer, Thyroid Cancer and Ovarian Cancer|Recruiting||Phase 1|20|Anticipated|Zhujiang Hospital||1|||f|||||f|f||||||||2017-10-10 21:03:04.94199|2017-10-10 21:03:04.94199
NCT03159572|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||March 28, 2017|Actual|2017-03-28|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|June 2018|Anticipated|2018-06-01||Observational|HITOMI||Homologous Recombination Inquiry Through Ovarian Malignancy Investigations|Homologous Recombination Inquiry Through Ovarian Malignancy Investigations|Recruiting||N/A|700|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||t|f|f||||Samples With DNA|"     tumor tissue   "|Undecided||2017-10-10 21:03:05.075155|2017-10-10 21:03:05.075155
NCT03159559|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||January 2017||2017-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes|A Randomized, Open-label Single-center Trial of Lipo-prostaglandin E1 Improves Coronary Microcirculation Dysfunction in Patients With Ischemic Heart Disease Combine With Diabetes Mellitus|Active, not recruiting||Phase 4|60|Anticipated|Tongji Hospital||2|||f||||||||||||||2017-10-10 21:03:05.170077|2017-10-10 21:03:05.170077
NCT03159546|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-01|||May 13, 2017|Actual|2017-05-13|September 2017|2017-09-01|August 24, 2017|Actual|2017-08-24|July 18, 2017|Actual|2017-07-18||Observational|||FreeStyle Libre Flash Glucose Monitoring System Accuracy|FreeStyle Libre Flash Glucose Monitoring System Accuracy Study|Completed||N/A|50|Actual|Abbott Diabetes Care|||1||f||||f|f|t|t|f||||||2017-10-10 21:03:05.252764|2017-10-10 21:03:05.252764
NCT03159533|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-17|||March 9, 2017|Actual|2017-03-09|May 2017|2017-05-01|March 9, 2018|Anticipated|2018-03-09|March 9, 2018|Anticipated|2018-03-09||Interventional|IMPACT||Project IMPACT: CHW Intervention|Project IMPACT: Community Health Care Worker (CHW) Intervention|Recruiting||N/A|730|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:03:05.336878|2017-10-10 21:03:05.336878
NCT03159520|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-17|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|COPPAS||Control of Pain From Braces With Patient Advice Sheets|A Randomised Clinical Trial of Advice Regarding Acupressure or NSAIDs for the Control of Orthodontic Pain|Not yet recruiting||N/A|36|Anticipated|University of Dundee||2|||f||||f|f|f||||||No||2017-10-10 21:03:05.446521|2017-10-10 21:03:05.446521
NCT03159507|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-10-03|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Omega-3 Index on Cellular Metabolism and Quality of Life|Effect of Omega-3 Index on Cellular Metabolism and Quality of Life Following the Administration of a Customized Dose of Omega-3 Oil|Recruiting||Phase 4|16|Anticipated|SCF Pharma||1|||f||||f|f|f||||||||2017-10-10 21:03:05.521776|2017-10-10 21:03:05.521776
NCT03159494|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-17|||February 14, 2014|Actual|2014-02-14|May 2017|2017-05-01|November 13, 2015|Actual|2015-11-13|November 13, 2015|Actual|2015-11-13||Interventional|||High-intensity Training, Self-monitoring and Diabetes 2|A Self-monitoring Approach in Evaluating the Effect of 3 Weeks of High-Intense Interval Training in Type 2 Diabetics|Completed||N/A|10|Actual|University College of Northern Denmark||1|||f||||f|f|f||||||No||2017-10-10 21:03:05.613027|2017-10-10 21:03:05.613027
NCT03159481|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-10-04|||November 27, 2017|Anticipated|2017-11-27|October 2017|2017-10-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|GOAL||Glaucoma Management Optimism for African Americans Living With Glaucoma|Enhancing Glaucoma Medication Adherence Among African Americans|Not yet recruiting||N/A|240|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f|||t|||||2017-10-10 21:03:05.688099|2017-10-10 21:03:05.688099
NCT03159468|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-17|||December 31, 2016|Actual|2016-12-31|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Emotion Regulation Interventions for Alcohol-Related Sexual Aggression|Alcohol-Related Sexual Aggression: An Emotion Regulation Intervention|Recruiting||N/A|210|Anticipated|University of Washington||3|||f||||f|f|f||||||No||2017-10-10 21:03:05.766933|2017-10-10 21:03:05.766933
NCT03159455|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-10-02|||June 7, 2017|Actual|2017-06-07|October 2017|2017-10-01|December 17, 2017|Anticipated|2017-12-17|December 3, 2017|Anticipated|2017-12-03||Interventional|||This Study Tests BI 1467335 in Healthy Japanese and Caucasian Men. The Study Tests How Different Doses of BI 1467335 Are Taken up in the Body and How Well They Are Tolerated|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1467335 in Healthy Japanese Male Volunteers With Multiple Oral Doses at the Highest Dose in Caucasian for Comparison (Randomised, Double-blind, Placebo-controlled Trial)|Recruiting||Phase 1|48|Anticipated|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 21:03:05.837531|2017-10-10 21:03:05.837531
NCT03159442|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-22|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|October 4, 2017|Anticipated|2017-10-04|October 4, 2017|Anticipated|2017-10-04||Interventional|||Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects|A Phase I, Single Centre, Randomised, Single Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Inhaled AZD8871 in Healthy Male Japanese Subjects.|Active, not recruiting||Phase 1|25|Actual|AstraZeneca||3|||f||||f|f|f||||||||2017-10-10 21:03:05.932323|2017-10-10 21:03:05.932323
NCT03159429|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-06|||June 30, 2017|Anticipated|2017-06-30|June 2017|2017-06-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|RehabSHV||Nasal Ventilation Versus Voluntary Hypoventilation in the Rehabilitation of Hyperventilation Syndrome|Nasal Ventilation Versus Voluntary Hypoventilation in the Rehabilitation of Hyperventilation Syndrome: a Randomized, Controlled Trial|Not yet recruiting||N/A|50|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f||||||||2017-10-10 21:03:06.045065|2017-10-10 21:03:06.045065
NCT03159403|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting|Retrospective, Observational Evaluation of the Utilization, Outcomes, and Adverse Events Associated With Orbactiv® for the Treatment of Infections Presumed or Confirmed to be Caused by Gram Positive Bacteria in a Real World Setting|Active, not recruiting||N/A|300|Anticipated|The Medicines Company|||1||f||||f|t|f||||||No||2017-10-10 21:03:06.238021|2017-10-10 21:03:06.238021
NCT03159390|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-19|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2015|Actual|2015-04-01||Interventional|OCERA OP||Metabolism of Ornithine Phenylacetate|Human Metabolism of Ornithine Phenylacetate: A Study in Healthy Volunteers|Active, not recruiting||N/A|20|Actual|Texas A&M University||1|||f||||f|f|f||||||No||2017-10-10 21:03:06.368295|2017-10-10 21:03:06.368295
NCT03159377|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Ultra-Low Dose CT Denoising for Lung Nodule Detection|Ultra-Low Dose CT Denoising for Lung Nodule Detection|Not yet recruiting||N/A|200|Anticipated|Sheba Medical Center|||1||f||||t|f|t|t||f|||Undecided|The only specific data of this study is low dose CT images while everything else is patient's usual care and not part of the study. Have not decided who may or may not use our low dose images.|2017-10-10 21:03:06.449151|2017-10-10 21:03:06.449151
NCT03159364|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-08-28|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Virus Specific Immune Lymphocytes (Virus-CTL) in the Treatment of Opportunistic Viral Diseases Post Transplantation|Phase I/II and Multicenter Trial of Virus Specific Immune Lymphocytes (Virus-CTL) in the Treatment of Opportunistic Viral Diseases Post Transplantation|Recruiting||Phase 1/Phase 2|100|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||f|f|f||||||||2017-10-10 21:03:06.511948|2017-10-10 21:03:06.511948
NCT03159351|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-16|||June 1, 2017|Anticipated|2017-06-01|January 2017|2017-01-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||The Antidepressant Effects of rTMS After Ischemic Stroke|Repetitive Transcranial Magnetic Stimulation for Depression After Basal Ganglia Ischemic Stroke: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial|Not yet recruiting||N/A|66|Anticipated|Zhujiang Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:03:06.597509|2017-10-10 21:03:06.597509
NCT03159338|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-18|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Platelet-rich Fibrin on Nerve Regeneration After Bilateral Sagittal Split Osteotomy|The Effect of Platelet-rich Fibrin on Nerve Regeneration After Bilateral Sagittal Split Osteotomy of the Mandible|Not yet recruiting||N/A|25|Anticipated|Shiraz University of Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 21:03:06.675108|2017-10-10 21:03:06.675108
NCT03159325|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-10-03|||August 20, 2017|Actual|2017-08-20|October 2017|2017-10-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Interventional|||The Healing Circles Project|Delivery of Self-management Through a Peer-support Telehealth Intervention in Patients With Cardiovascular Disease: The Healing Circles Project|Recruiting||N/A|250|Anticipated|Simon Fraser University||2|||f|||||f|f||||||||2017-10-10 21:03:06.766067|2017-10-10 21:03:06.766067
NCT03159312|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-17|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|March 13, 2018|Anticipated|2018-03-13|January 15, 2018|Anticipated|2018-01-15||Interventional|||Influence of a Moderate Physical Exercise Program in Health of Patients Underwent Bariatric Surgery in Talca City, Chile|Influence of a Moderate Physical Exercise Program in Health of Patients Underwent Bariatric Surgery in Talca City, Chile|Active, not recruiting||N/A|40|Actual|Universidad de Granada||2|||f||||t|f|f||||||||2017-10-10 21:03:06.872171|2017-10-10 21:03:06.872171
NCT03159299|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-16|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City|Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City|Recruiting||N/A|135|Anticipated|Yale University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:03:06.947665|2017-10-10 21:03:06.947665
NCT03159286|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||March 22, 2017|Actual|2017-03-22|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Network||Experimental Test of Facebook Social Drinking Norms on Adolescent Alcohol Use|Experimental Test of Facebook Social Drinking Norms on Adolescent Alcohol Use|Recruiting||N/A|300|Anticipated|University of Washington||3|||f||||f|f|f||||||No|A select number of researchers will have access to unidentified participant data at the close of the study.|2017-10-10 21:03:07.058645|2017-10-10 21:03:07.058645
NCT03159273|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-05-16|||January 2014||2014-01-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Nitrate Supplementation During Final Examination Stress|Dietary Supplementation of Nitrate by Beetroot Juice to Boost Immunity, Mood, Cardiovascular Function During Academic Stress|Active, not recruiting||N/A|100|Anticipated|Southern Methodist University||2|||f||||f||||||||||2017-10-10 21:03:07.136363|2017-10-10 21:03:07.136363
NCT03159260|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||November 1, 2016|Actual|2016-11-01|May 2017|2017-05-01|June 10, 2017|Anticipated|2017-06-10|May 30, 2017|Anticipated|2017-05-30||Interventional|||Effect of Theraworx/[pH]Uel on Night-time Leg Cramps and Spasm Symptoms|The Effect of Theraworx/[pH]Uel on Night-time Leg Cramps and Spasm Symptoms Including Quality of Life, Depression and Sleep Quality|Recruiting||N/A|50|Anticipated|Sport and Spine Rehab Clinical Research Foundation||2|||f||||f|f|t|f|f||||No||2017-10-10 21:03:09.076773|2017-10-10 21:03:09.076773
NCT03159247|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-16|||January 12, 2017|Actual|2017-01-12|May 2017|2017-05-01|October 12, 2019|Anticipated|2019-10-12|October 12, 2019|Anticipated|2019-10-12||Interventional|eyeGuide||The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program|The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program|Recruiting||N/A|57|Anticipated|University of Michigan||1|||f||||f|f|f||||||No||2017-10-10 21:03:09.16743|2017-10-10 21:03:09.16743
NCT03159234|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Prediction of Fetal Lung Maturity|Evaluation of New Methods for Prediction of Fetal Lung Maturity in Diabetic Mothers|Completed||N/A|54|Actual|Assiut University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:03:09.273516|2017-10-10 21:03:09.273516
NCT03159221|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-05-17|||April 2011||2011-04-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|ADAPT||Behavioral Family Systems Therapy (BFST) for Teens With Type 2 Diabetes|Behavioral Family Systems Therapy for Teens With Type 2 Diabetes: A Pilot|Completed||N/A|24|Actual|Nemours Children's Clinic||2|||f||||t||||||||No||2017-10-10 21:03:09.347932|2017-10-10 21:03:09.347932
NCT03159208|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||April 17, 2017|Actual|2017-04-17|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|June 2022|Anticipated|2022-06-01||Observational|||Prediction of Functional Outcomes From Chronic Critical Illness|Prediction of Functional Outcomes From Chronic Critical Illness|Recruiting||N/A|800|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f|f|f||||Samples With DNA|"     Whole Blood, Serum, Urine   "|Yes|A deidentified dataset will be available to investigators one year following primary publication of the study. Data can be obtained upon application to primary investigators.|2017-10-10 21:03:09.435228|2017-10-10 21:03:09.435228
NCT03159195|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-28|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|IRIS||Ibrance Real World Insights [IRIS]|Treatment Patterns And Clinical Outcomes Among Patients Receiving Palbociclib Combinations For Hr+/her2- Advanced/Metastatic Breast Cancer In Real World Settings|Recruiting||N/A|1|Anticipated|Pfizer|||1||f||||f||f||||||||2017-10-10 21:03:09.549735|2017-10-10 21:03:09.549735
NCT03159182|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||September 2018|Anticipated|2018-09-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Study of Silicone Material Inserts To Treat Burn Scars|Effectiveness of Silicone Material Inserts Within Pressure Garments in the Treatment of Hypertrophic Burn Scars|Withdrawn||N/A|0|Actual|University of Manitoba||2||First required to complete a proof of principle study for a new outcome measure.|f||||f|f|f||||||No||2017-10-10 21:03:09.62694|2017-10-10 21:03:09.62694
NCT03159169|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-16|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|NU-BURST||Treatment of Neck and Upper Limb Pain Using BurstDR (De Ridder) Stimulation|Treatment of Neck and Upper (NU) Limb Pain Using BurstDR Stimulation|Not yet recruiting||N/A|50|Anticipated|St. Jude Medical||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:03:09.711683|2017-10-10 21:03:09.711683
NCT03159156|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-17|||September 15, 2015|Actual|2015-09-15|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation|Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation|Recruiting||N/A|408|Anticipated|McGill University||4|||f||||f|f|f||||||Undecided||2017-10-10 21:03:09.815413|2017-10-10 21:03:09.815413
NCT03159143|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-08-10|2017-07-12||December 17, 2004|Actual|2004-12-17|August 2017|2017-08-01|December 2, 2009|Actual|2009-12-02|June 2, 2009|Actual|2009-06-02||Interventional|||Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract|A Phase II, Single-arm Study of Docetaxel and Oxaliplatin in Metastatic Cisplatin-resistant Transitional Cell Carcinoma of the Urinary Bladder|Completed||Phase 2|22|Actual|University of Pittsburgh||1|||f||||t|t|f|||f|||||2017-10-10 21:03:10.028052|2017-10-10 21:03:10.028052
NCT03159130|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-16|||June 2012|Anticipated|2012-06-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||OnQ Pain Pump Effectiveness in Post Operative Pain Control in Bariatric Patients|OnQ Pain Pump Effectiveness in Post Operative Pain Control in Bariatric Patients|Withdrawn||N/A|0|Actual|William Beaumont Army Medical Center|||2|PI dropped the study|f||||f||||||||No||2017-10-10 21:03:10.413732|2017-10-10 21:03:10.413732
NCT03159117|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma|A Phase I Open-Label Dose Escalation and Expansion Study of GD3 ADC (Pfizer PF-06688992) in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma (B802WI209568)|Recruiting||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||Undecided||2017-10-10 21:03:10.506548|2017-10-10 21:03:10.506548
NCT03159104|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-10-04|||August 25, 2015|Actual|2015-08-25|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children|Multicenter Double-blind Placebo-Controlled Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children|Recruiting||Phase 3|264|Anticipated|Materia Medica Holding||2|||f|||||f|f||||||||2017-10-10 21:03:10.613386|2017-10-10 21:03:10.613386
NCT03159091|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-09-28|||June 16, 2017|Actual|2017-06-16|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease|Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||Phase 4|238|Anticipated|Materia Medica Holding||2|||f|||||f|f||||||||2017-10-10 21:03:10.749431|2017-10-10 21:03:10.749431
NCT03159078|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-06-19|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|MUSEUM||Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens|Polymyxin B Monotherapy Versus Polymyxin B-Carbapenem Combination Therapy in Critically Ill Patients With Multi-drug Resistant Gram-negative Infection: A Prospective, Parallel-Group, Double-Blind, Randomized Controlled Study|Recruiting||Phase 3|40|Anticipated|University of Puerto Rico||2|||f||||f|t|f|||t|||No||2017-10-10 21:03:10.900248|2017-10-10 21:03:10.900248
NCT03159052|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Clinical Trial to Evaluate the Efficacy and Safety of SHR3824 as Monotherapy in in Chinese Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise|Not yet recruiting||Phase 3|450|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f|||||f|f||||||||2017-10-10 21:03:11.121562|2017-10-10 21:03:11.121562
NCT03159039|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-17|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|preterm||Repercussions of Respiratory Physiotherapy in Preterm Infants Under Mechanical Ventilation|Study of Clinical Repercussions of Conventional Respiratory Physiotherapy Versus Prolonged Slow Expiration in Preterms Under Mechanical Ventilation|Active, not recruiting||N/A|43|Actual|Universidade Cidade de Sao Paulo||2|||f|||||f|f||||||No||2017-10-10 21:03:11.261077|2017-10-10 21:03:11.261077
NCT03159026|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-17|||April 6, 2017|Actual|2017-04-06|May 2017|2017-05-01|April 15, 2022|Anticipated|2022-04-15|April 15, 2022|Anticipated|2022-04-15||Observational|||Review of Charts From Amish/Mennonite Variant PA Patients|Chart Review of Patients Who Have the Amish/Mennonite Variant of Propionic Acidemia|Recruiting||N/A|150|Anticipated|University of Pittsburgh|||1||f||||f|f|f||||||No||2017-10-10 21:03:11.345953|2017-10-10 21:03:11.345953
NCT03159013|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-17|||September 22, 2016|Actual|2016-09-22|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|November 19, 2016|Actual|2016-11-19||Interventional|||Toxicokinetic Study of Lambda-cyhalothrin Biomarkers of Exposure|La Lambda-cyhalothrine Comme Insecticide privilégié en Milieu Agricole: étude de la toxicocinétique de Biomarqueurs Pour le Suivi de l'Exposition Des Travailleurs|Completed||N/A|7|Actual|Université de Montréal||2|||f||||f|f|f||||||No||2017-10-10 21:03:11.416088|2017-10-10 21:03:11.416088
NCT03159000|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-16|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks|Double-Blind, Placebo Controlled Trial of Greater Occipital Nerve Block for the Treatment of Migraine Attacks|Recruiting||Phase 4|50|Anticipated|Thomas Jefferson University||2|||f||||f|t|f|||f|||No||2017-10-10 21:03:11.498868|2017-10-10 21:03:11.498868
NCT03158987|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-06-08|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|August 31, 2017|Anticipated|2017-08-31||Observational|HIVRegional||Regional Differences in Human Immunodeficiency Virus (HIV) Testing|Regional Differences in Human Immunodeficiency Virus (HIV) Testing Procedures in Eastern German Federal States|Recruiting||N/A|300|Anticipated|Jena University Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:03:11.592455|2017-10-10 21:03:11.592455
NCT03158974|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||A Trial of a New Botanical Drug For the Treatment of External Condylomata Acuminata in Adult Subjects|A Phase 2, Open-label, Safety, Tolerability, and Efficacy Trial of a Botanical Drug At One Dose Level for the Treatment of External Condylomata Acuminata (Genital Warts) in Adult Immunocompetent Subjects|Not yet recruiting||Phase 2|30|Anticipated|ViroXis Corporation||1|||f||||f|t|f||||||No||2017-10-10 21:03:11.673015|2017-10-10 21:03:11.673015
NCT03158961|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-12|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||The Feasibility and Safety of the TOETVA for Benign Thyroid Nodules|A Prospective Evaluation of the Feasibility and Safety of the Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) as a Treatment for Benign Thyroid Nodules|Recruiting||N/A|10|Anticipated|The University of Hong Kong||1|||f||||t|f|f||||||||2017-10-10 21:03:11.834916|2017-10-10 21:03:11.834916
NCT03158948|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-07-04|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM in Patients With Septic Shock|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM in Patients With Septic Shock. A Randomised, Double-blind, Two-Stage, Placebo Controlled Study|Recruiting||Phase 2|48|Anticipated|Inotrem||4|||f||||t|f|f||||||||2017-10-10 21:03:11.969559|2017-10-10 21:03:11.969559
NCT03158935|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-22|||July 7, 2017|Actual|2017-07-07|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ACTIVATE||The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial|Phase Ib Trial of Pembrolizumab Administered in Combination With or Following Adoptive Cell Therapy- A Multiple Cohort Study; The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial|Recruiting||Phase 1|24|Anticipated|University Health Network, Toronto||2|||f||||t|t|f|||t|||||2017-10-10 21:03:12.082538|2017-10-10 21:03:12.082538
NCT03158922|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-18|||April 29, 2016|Actual|2016-04-29|May 2017|2017-05-01|April 29, 2021|Anticipated|2021-04-29|December 31, 2018|Anticipated|2018-12-31||Observational|BARCODE1Pilot||The BARCODE 1 Study|The BARCODE 1 Pilot Study: The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening|Recruiting||N/A|300|Anticipated|Institute of Cancer Research, United Kingdom|||2||f||||t|f|f||||Samples With DNA|"     Saliva, blood, urine   "|Yes|Anonymised data can be applied for via the Data Access Committee.|2017-10-10 21:03:12.227298|2017-10-10 21:03:12.227298
NCT03158909|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-17|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of a Non-pharmacological Intervention to Prevent Delirium Among Elderly In-patients|Randomized Clinical Trial to Evaluate the Effect of a Non-pharmacological Intervention to Prevent Delirium Among Elderly In-patients|Not yet recruiting||N/A|284|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||Undecided||2017-10-10 21:03:12.33529|2017-10-10 21:03:12.33529
NCT03158896|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease|A Phase I Study To Evaluate the Safety of Umbilical Cord - Derived, Ex-Vivo Cultured and Expanded Wharton's Jelly Mesenchymal Stem Cells for the Treatment of De Novo High Risk Acute or Steroid Refractory Acute Graft Versus Host Disease|Not yet recruiting||Phase 1|10|Anticipated|University of Kansas Medical Center||1|||f||||t|t|f||||||No||2017-10-10 21:03:12.456889|2017-10-10 21:03:12.456889
NCT03155490|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||April 2016||2016-04-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Team Leadership Training Effect on Patient Care|Translating Simulation-based Team Leadership Training Into Patient-level Outcomes|Recruiting||N/A|70|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 21:03:47.47698|2017-10-10 21:03:47.47698
NCT03158883|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-28|||May 17, 2017|Actual|2017-05-17|September 2017|2017-09-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients|A Pilot Study of Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients Previously Treated With a PD-1 Inhibitor|Recruiting||Early Phase 1|26|Anticipated|University of California, Davis||2|||f||||t|t|f||||||||2017-10-10 21:03:12.562729|2017-10-10 21:03:12.562729
NCT03158870|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-17|2017-05-17|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CCAP||Surgeon-Anesthesiologist Collaboration|Influence of Surgeon-anesthesiologist Collaboration on Patient Outcomes After Pheochromocytoma Surgery|Not yet recruiting||N/A|1122|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 21:03:12.692432|2017-10-10 21:03:12.692432
NCT03158857|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-08-30|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Hepatitis C Treatment Study in Myanmar|A Clinical and Pharmacokinetic Study of the Effectiveness of Hepatitis C Treatment (Sofosbuvir+Daclatasvir) in HIV Co-infected and Non HIV Co-infected Patients at the Level of Non-hospital Based Management in Myanmar|Not yet recruiting||N/A|200|Anticipated|Myanmar Oxford Clinical Research Unit|||2||f||||f|f|f||||Samples With DNA|"     Dried blood spots for assessment of Hepatitis C genotype   "|||2017-10-10 21:03:12.777072|2017-10-10 21:03:12.777072
NCT03158844|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-30|||May 16, 2017|Actual|2017-05-16|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|COLAH||HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia|HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia|Recruiting||N/A|315|Anticipated|University of Alabama at Birmingham|||2||f||||f|f|f||||None Retained|"     Blood will be drawn via phlebotomy for patients for whom CD4 and HIV viral load results are     not available at baseline. For participants that have initiated ART treatment, we will     collect a dried blood spot card using 5 drops of blood from finger prick to measure viral     load 90 days after discharge.   "|||2017-10-10 21:03:12.889222|2017-10-10 21:03:12.889222
NCT03158831|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-16|||January 13, 2016|Actual|2016-01-13|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Drug Challenges Without Prior Skin Testing|Drug Challenges Without Prior Skin Testing|Recruiting||N/A|200|Anticipated|Montefiore Medical Center||1|||f||||t|f|f|||t|||No|We do not plan to make IPD available to other researchers.|2017-10-10 21:03:13.003491|2017-10-10 21:03:13.003491
NCT03158818|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-16|||August 23, 2016|Actual|2016-08-23|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|HUTCH||Chronic Hepatitis B Virus Infection in Zambia|Chronic Hepatitis B Virus Infection in Zambia: a Prospective Clinical Cohort Study|Recruiting||N/A|500|Anticipated|University of Alabama at Birmingham|||1||f||||f|f|f||||Samples Without DNA|"     Blood collected (up to 15 mL) from a vein in the arm for various tests related to HBV and     general health at each visit   "|Undecided||2017-10-10 21:03:13.116359|2017-10-10 21:03:13.116359
NCT03158805|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)|A Randomized, Placebo-Controlled Study of Liraglutide 3mg Daily (Saxenda®) in Obese or Overweight Patients With Stable Bipolar Disorder|Recruiting||Phase 2|60|Anticipated|Lindner Center of HOPE||2|||f||||f|t|f|||f|||No||2017-10-10 21:03:13.225526|2017-10-10 21:03:13.225526
NCT03158792|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-09-08|||October 24, 2015|Actual|2015-10-24|September 2017|2017-09-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Interventional|||Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function|Evaluation of Non-Surgical Venous Thromboembolism Prophylaxis Dosing Strategies: Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function|Completed||Phase 4|32|Actual|Lebanese American University||2|||f||||f|f|f||||||||2017-10-10 21:03:13.342507|2017-10-10 21:03:13.342507
NCT03158779|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-16|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|March 28, 2021|Anticipated|2021-03-28|March 28, 2019|Anticipated|2019-03-28||Interventional|||Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer|Phase II Trial Evaluating Stereotactic Body Radiation Therapy (SBRT) After Induction Chemotherapy for Patients With Locally Advanced Unresectable Pancreatic Cancer|Recruiting||Phase 2|45|Anticipated|Istituto Clinico Humanitas||1|||f||||t|f|f||||||No||2017-10-10 21:03:13.458472|2017-10-10 21:03:13.458472
NCT03158766|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||May 22, 2017|Anticipated|2017-05-22|May 2017|2017-05-01|May 22, 2019|Anticipated|2019-05-22|June 22, 2018|Anticipated|2018-06-22||Observational|SPInE-ID||Subclinical Propionibacterium Acnes Infection Estimation in the Intervertebral Disc (SPInE-ID)|Subclinical Propionibacterium Acnes Infection Estimation in the Intervertebral Disc (SPInE-ID): a Prospective Cohort|Not yet recruiting||N/A|95|Anticipated|Hospital Israelita Albert Einstein|||1||f||||t|f|f||||Samples Without DNA|"     Lumbar Intervertebral Disc, Flavum ligament, Multifidus muscle   "|Yes||2017-10-10 21:03:13.575816|2017-10-10 21:03:13.575816
NCT03158753|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-17|||February 2, 2017|Actual|2017-02-02|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|PIPA||Perfusion Index and Pain in Ankle Surgery|Perfusion Index and Pain in Ankle Surgery - an Exploratory Study|Recruiting||N/A|20|Anticipated|Herlev Hospital|||1||f|||||f|f||||||||2017-10-10 21:03:13.737215|2017-10-10 21:03:13.737215
NCT03158740|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-07-18|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|September 14, 2017|Anticipated|2017-09-14|September 7, 2017|Anticipated|2017-09-07||Interventional|IMAGINE||Watermelon Focused Dietary Inflammatory Index Intervention|A Watermelon Focused Dietary Inflammatory Index Counseling System to Reduce Systemic Inflammation|Recruiting||N/A|30|Anticipated|Connecting Health Innovation||2|||f||||f|f|f||||||||2017-10-10 21:03:13.833679|2017-10-10 21:03:13.833679
NCT03158727|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-16|||January 30, 2017|Actual|2017-01-30|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|March 2019|Anticipated|2019-03-01||Interventional|SEPCELL||Cx611-0204 SEPCELL Study|A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit|Recruiting||Phase 1/Phase 2|180|Anticipated|Cellerix||2|||f||||t|f|f||||||Undecided||2017-10-10 21:03:13.954687|2017-10-10 21:03:13.954687
NCT03158714|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-16|||August 11, 2016|Actual|2016-08-11|May 2017|2017-05-01|September 29, 2020|Anticipated|2020-09-29|September 29, 2020|Anticipated|2020-09-29||Interventional|AHMREI||Alabama Community Healthy Marriage Initiative Evaluation Project for Couples|The Alabama Healthy Marriage and Relationship Education Initiative|Enrolling by invitation||N/A|1500|Anticipated|Auburn University||3|||f||||f|f|f||||||No||2017-10-10 21:03:14.175703|2017-10-10 21:03:14.175703
NCT03158701|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-17|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Prevelance of Fragmented QRS Complex and Prolonged QT Interval in Cirrhotic Patients|Prevelance of Fragmented QRS Complex and Prolonged QT Interval in Cirrhotic Patients and Its Correlation With the Severity of the Disease|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||No||2017-10-10 21:03:14.277575|2017-10-10 21:03:14.277575
NCT03158675|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-16|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo|Fractional Carbon Dioxide Laser Combined With Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo.|Not yet recruiting||N/A|25|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 21:03:14.492997|2017-10-10 21:03:14.492997
NCT03158662|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-08-23|||April 2, 2017|Actual|2017-04-02|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa|Survey to Identify Burdens and Unmet Needs of EB Patients in the US|Completed||N/A|150|Actual|Amicus Therapeutics|||1||f|||||f|f||||||||2017-10-10 21:03:14.687066|2017-10-10 21:03:14.687066
NCT03158649|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-05-18|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Novel Web-based Positive Psychology Intervention Addressed to Pregnant Women|A Novel Web-based Positive Psychology Intervention Addressed to Pregnant Women|Not yet recruiting||N/A|164|Anticipated|University of Valencia||2|||f||||f|f|f||||||||2017-10-10 21:03:14.76646|2017-10-10 21:03:14.76646
NCT03158636|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-17|||September 2016||2016-09-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01|3 Years|Observational [Patient Registry]|PROSPER||Profiling of Oncology Patients as Part of Clinical Care and Research|Profiling of Oncology Patients as Part of Clinical Care and Research|Recruiting||N/A|120|Anticipated|University of Auckland, New Zealand|||1||f||||t|f|f||||Samples With DNA|"     Retrospective tissue collection. Circulating tumour DNA. Prospective tumour biopsies (where     feasible).   "|Yes|Deidentified patient data will be available for other research through applications to the governance committee of PROSPER. Applications will require ethics approval.|2017-10-10 21:03:14.912532|2017-10-10 21:03:14.912532
NCT03158623|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-17|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|December 20, 2016|Actual|2016-12-20|December 6, 2016|Actual|2016-12-06||Interventional|||Wound Additives in Primary Total Joint Athroplasty|The Effects of Platelet-Rich Plasma and Activated Collagen on Wound Healing in Primary Total Joint Arthroplasty|Completed||Phase 3|90|Actual|Salt Lake Orthopedic Clinic||2|||f||||t|f|f||||||No|no plan on sharing data|2017-10-10 21:03:15.012765|2017-10-10 21:03:15.012765
NCT03158610|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-28|||October 17, 2017|Anticipated|2017-10-17|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer|Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer|Recruiting||Phase 2/Phase 3|250|Anticipated|Ruijin Hospital||2|||f||||t|f|f||||||||2017-10-10 21:03:15.120371|2017-10-10 21:03:15.120371
NCT03158597|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-12|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Transcriptome Study of Acute Myocardial Infarction|Screening Pathogenic Genes Associated With Acute Myocardial Infarction and Studying Its Relevant Molecular Mechanism|Recruiting||N/A|20|Anticipated|Beijing Institute of Heart, Lung and Blood Vessel Diseases|||2||f|||||f|f||||||||2017-10-10 21:03:15.224123|2017-10-10 21:03:15.224123
NCT03158584|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-21|||January 1, 2017|Actual|2017-01-01|July 2016|2016-07-01|July 1, 2017|Anticipated|2017-07-01|March 1, 2017|Actual|2017-03-01||Interventional|||Effect of Intrathecal Morphine in Children Undergoing Major Abdominal Surgeries,|Safety and Efficacy of Intrathecal Morphine in Children Undergoing Major Abdominal Surgeries, Dose-finding Clinical Study|Active, not recruiting||N/A|45|Anticipated|Assiut University||3|||f||||t|f|f|||f|||Undecided|undecided|2017-10-10 21:03:15.304121|2017-10-10 21:03:15.304121
NCT03158571|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31|5 Years|Observational [Patient Registry]|FORCE-1||Chilean Gastric Cancer Task Force (FORCE 1)|Chilean Gastric Cancer Task Force (FORCE 1): A Study Protocol to Obtain a Clinical and Molecular Classification of a Cohort of Gastric Cancer Patients.|Recruiting||N/A|200|Anticipated|Pontificia Universidad Catolica de Chile|||1||f||||f|f|f||||Samples With DNA|"     RNA and DNA   "|Yes|Public information of the data base|2017-10-10 21:03:15.44184|2017-10-10 21:03:15.44184
NCT03158558|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-17|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD|Multi-Couple Group Intervention for PTSD|Recruiting||N/A|48|Anticipated|Penn State University||1|||f||||t|f|f||||||No||2017-10-10 21:03:15.567964|2017-10-10 21:03:15.567964
NCT03158545|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-11|||October 10, 2016|Actual|2016-10-10|September 2017|2017-09-01|September 4, 2017|Actual|2017-09-04|September 4, 2017|Actual|2017-09-04||Interventional|||26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults|Efficacy Evaluation of 26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults|Completed||N/A|78|Actual|Northumbria University||3|||f||||f|f|f||||||||2017-10-10 21:03:15.685576|2017-10-10 21:03:15.685576
NCT03158532|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-07-06|||July 6, 2017|Actual|2017-07-06|May 2017|2017-05-01|November 30, 2019|Anticipated|2019-11-30|October 31, 2019|Anticipated|2019-10-31||Interventional|Patens||Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin|Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin|Recruiting||Phase 3|2128|Anticipated|Instituto de Cardiologia de Santa Catarina||4|||f||||f|f|f|||f|||||2017-10-10 21:03:15.786762|2017-10-10 21:03:15.786762
NCT03158519|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-01|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||iMETX (Individualized Metabolic RX): a Pilot Study|iMETX (Individualized Metabolic RX): a Pilot Study of an Environmental Intervention to Increase Energy Expenditure Among Breast Cancer Survivors|Recruiting||N/A|60|Anticipated|Indiana University||1|||f||||t|f|f||||||No||2017-10-10 21:03:15.94936|2017-10-10 21:03:15.94936
NCT03158506|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-16|||March 29, 2017|Actual|2017-03-29|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|April 26, 2017|Actual|2017-04-26||Interventional|||Human Mass Balance Study of HMS5552 in Healthy Subjects|An Open-Label, Single Center Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of 50 mg (90 uCi) [14C]-HMS5552 in Healthy Adult Male Subjects|Active, not recruiting||Phase 1|6|Actual|Hua Medicine Limited||1|||f|||||f|f||||||No||2017-10-10 21:03:16.07873|2017-10-10 21:03:16.07873
NCT03158493|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-22|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01|4 Weeks|Observational [Patient Registry]|||Assessment of qSOFA in the Latin America Sepsis Institute Database|Assessment of qSOFA in the Latin America Sepsis Institute Database|Completed||N/A|8435|Actual|Federal University of São Paulo|||1||f||||f|f|f||||||Undecided|undecided|2017-10-10 21:03:16.189804|2017-10-10 21:03:16.189804
NCT03158480|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-28|||June 25, 2017|Actual|2017-06-25|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Safety and Efficacy of Immune Therapy for Condyloma|Safety and Efficacy of Immune Therapy for Condyloma|Recruiting||N/A|80|Anticipated|Shenzhen Second People's Hospital||2|||f|||||f|f||||||Undecided||2017-10-10 21:03:16.313131|2017-10-10 21:03:16.313131
NCT03158467|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|November 15, 2019|Anticipated|2019-11-15|May 15, 2019|Anticipated|2019-05-15||Observational|||RCT of ACP for Transplant|A Pilot Randomized Control Trial of Advance Care Planning and Triggered Palliative Care for Cancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)|Recruiting||N/A|100|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t|f|f||||||||2017-10-10 21:03:16.42526|2017-10-10 21:03:16.42526
NCT03158454|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-01|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Capsula Closure vs. Non-Capsula Closure: Hip Arthroscopy in Danish Patients With Femoroacetabular Impingement (FAI)|Capsula Closure Versus Non-Capsula Closure During Hip Arthroscopy in Danish Patients With Femoroacetabular Impingement (FAI)|Recruiting||N/A|200|Anticipated|Aarhus University Hospital||2|||f|||||f|f||||||||2017-10-10 21:03:16.524002|2017-10-10 21:03:16.524002
NCT03158441|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||DTi Diffusion Findings in Breast MRI Screening and Diagnostic|DTi Diffusion Findings in Breast MRI Screening and Diagnostic|Not yet recruiting||N/A|200|Anticipated|Rabin Medical Center|||2||f|||||f|f||||||Undecided||2017-10-10 21:03:16.618908|2017-10-10 21:03:16.618908
NCT03158428|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-07|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|July 25, 2017|Actual|2017-07-25|July 25, 2017|Actual|2017-07-25||Interventional|||CSD170202: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products|CSD170202: A Crossover Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products|Completed||N/A|55|Actual|RAI Services Company||2|||f||||f|f|f||||||||2017-10-10 21:03:16.694841|2017-10-10 21:03:16.694841
NCT03158415|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-07-25|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||Parents of Young Adults With Type 1 Diabetes: An Exploratory Study|Parents of Young Adults With Type 1 Diabetes: An Exploratory Study|Completed||N/A|30|Actual|University of Florida||1|||f||||f|f|f||||||||2017-10-10 21:03:16.781455|2017-10-10 21:03:16.781455
NCT03158402|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|EMI HiPo||Preoperative Inspiratory Muscle Training Effects on the Perioperative Inflammatory Reaction in Cardiac Surgery.|High Intensity Preoperative Inspiratory Muscle Training (IMTHi) Effects on the Perioperative Inflammatory Reaction in Cardiac Surgery With an Associated Biocollection.|Not yet recruiting||N/A|30|Anticipated|University Hospital, Angers||2|||f|||||f|f||||||||2017-10-10 21:03:16.85796|2017-10-10 21:03:16.85796
NCT03158389|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2023|Anticipated|2023-09-30||Interventional|N²M²||NCT Neuro Master Match - N²M² (NOA-20)|Umbrella Protocol for Phase I/IIa Trials of Molecularly Matched Targeted Therapies Plus Radiotherapy in Patients With Newly Diagnosed Glioblastoma Without MGMT Promoter Methylation: NCT Neuro Master Match - N²M² (NOA-18)|Not yet recruiting||Phase 1/Phase 2|350|Anticipated|University Hospital Heidelberg||7|||f||||t|f|f||||||No||2017-10-10 21:03:16.940694|2017-10-10 21:03:16.940694
NCT03158376|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-24|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|GABATHOMIE||Preoperative Gabapentin for Chronic Pain After Thoracotomy (GABATHOMIE).|Perioperative Gabapentin for Chronic Post-thoracotomy Pain: a Randomized, Double Blind, Placebo-controlled Study.|Recruiting||Phase 3|200|Anticipated|University Hospital, Lille||2|||f||||t||f||||||No||2017-10-10 21:03:17.134433|2017-10-10 21:03:17.134433
NCT03158350|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||August 3, 2015|Actual|2015-08-03|May 2017|2017-05-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Toothbrush Wear and Its Effect on Subgingival Inflammation Using Two Different Brushing Techniques|A Tooth Brushing Technique That Reduces Gingival Inflammation and Toothbrush Deformation|Completed||N/A|48|Actual|Tufts University School of Dental Medicine||2|||f||||f|f|f||||||No||2017-10-10 21:03:17.349007|2017-10-10 21:03:17.349007
NCT03158337|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||May 1, 2010|Actual|2010-05-01|May 2017|2017-05-01|May 2026|Anticipated|2026-05-01|May 5, 2016|Actual|2016-05-05||Interventional|BIM||Effects of Regular Exercise on Cerebrovascular Reserve in Older Adults|Effects of Regular Exercise on Cerebrovascular Reserve in Older Adults: Role in the Prevention of Age-Related Cognitive Decline|Active, not recruiting||N/A|286|Actual|University of Calgary||1|||f|||||f|f||||||||2017-10-10 21:03:17.429138|2017-10-10 21:03:17.429138
NCT03158324|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-14|||May 22, 2017|Actual|2017-05-22|April 2017|2017-04-01|November 30, 2020|Anticipated|2020-11-30|May 22, 2020|Anticipated|2020-05-22||Interventional|||Phase IIa Dose-Expansion and Biomarker Study of OPB-111077|Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 in An Enriched Population of Treatment-Refractory Advanced Solid Tumors|Recruiting||Phase 2|52|Anticipated|National University Hospital, Singapore||1|||f||||f|f|f||||||No||2017-10-10 21:03:17.509917|2017-10-10 21:03:17.509917
NCT03158311|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-07-13|||October 16, 2017|Anticipated|2017-10-16|July 2017|2017-07-01|April 17, 2019|Anticipated|2019-04-17|March 29, 2019|Anticipated|2019-03-29||Interventional|ARGON||Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium|A Multicenter, Partially-blinded, Randomized, 24-week, Parallel-group, Non-inferiority, Open-label Active Controlled Study to Compare the Efficacy and Safety of QVM149 With a Free Triple Combination of Salmeterol/Fluticasone + Tiotropium in Patients With Uncontrolled Asthma|Not yet recruiting||Phase 3|1500|Anticipated|Novartis||3|||f||||f|f|f||||||||2017-10-10 21:03:17.594689|2017-10-10 21:03:17.594689
NCT03158298|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-08|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|May 31, 2018|Anticipated|2018-05-31||Observational|Bilharzia||Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas|Association of Schistosomiasis Seropositivity With Adverse Birth Events in Migrants From Bilharzia-endemic Areas|Recruiting||N/A|200|Anticipated|Jena University Hospital|||1||f||||f|f|f||||Samples Without DNA|"     Serum Placenta (optional)   "|No||2017-10-10 21:03:17.670838|2017-10-10 21:03:17.670838
NCT03158285|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-10-03|||July 12, 2017|Actual|2017-07-12|October 2017|2017-10-01|October 20, 2021|Anticipated|2021-10-20|February 11, 2020|Anticipated|2020-02-11||Interventional|||A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Subjects With Active Psoriatic Arthritis|Recruiting||Phase 3|684|Anticipated|Janssen Research & Development, LLC||3|||f||||t|t|f||||||||2017-10-10 21:03:17.772439|2017-10-10 21:03:17.772439
NCT03158272|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-10-05|||May 25, 2017|Actual|2017-05-25|October 2017|2017-10-01|November 30, 2020|Anticipated|2020-11-30|November 29, 2020|Anticipated|2020-11-29||Interventional|||A Study to of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread|A Phase 1 Study of Cabiralizumab (BMS-986227, FPA008) Administered Alone or in Combination With Nivolumab (BMS-936558) in Advanced Malignancies|Recruiting||Phase 1|36|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f|||t|||||2017-10-10 21:03:18.427446|2017-10-10 21:03:18.427446
NCT03158259|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|May 15, 2021|Anticipated|2021-05-15|May 15, 2020|Anticipated|2020-05-15||Interventional|Treat-NASPP||Prehospital Advanced Diagnostics and Treatment of Acute Stroke|Advanced Diagnostics of Acute Stroke (Biomarkers, Blood Analysis, Stroke Scales and Cerebral CT Examinations) and Initiation of rtPa Treatment in an Air Ambulance Model|Recruiting||N/A|400|Anticipated|Norwegian Air Ambulance Foundation||2|||f||||t|f|f||||||No||2017-10-10 21:03:18.553282|2017-10-10 21:03:18.553282
NCT03158246|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-21|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 2, 2020|Anticipated|2020-03-02|December 31, 2019|Anticipated|2019-12-31||Interventional|||Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women|Generic Zoledronic Acid Versus Original Zoledronic Acid: A Multicenter, Randomized, Open, Paralled-controlled Clinical Postmenopausal Osteoporotic Women Efficacy and Safety Research.|Not yet recruiting||Phase 4|466|Anticipated|Cttq||2|||f||||t|f|f||||||Undecided||2017-10-10 21:03:18.663992|2017-10-10 21:03:18.663992
NCT03158233|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-10-04|||April 29, 2017|Actual|2017-04-29|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Zika Case Definition and Surveillance Study|Prospective Surveillance and Case Definition Study of Zika Virus Disease and Infection in Adolescents and Adults in Latin America in Preparation for an Efficacy Trial of a Zika Virus Whole Virion, Purified Inactivated Vaccine|Recruiting||N/A|2400|Anticipated|Sanofi|||1||f||||f|f|f||||Samples Without DNA|"     Blood samples and urine samples   "|||2017-10-10 21:03:18.764221|2017-10-10 21:03:18.764221
NCT03158207|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||September 15, 2015|Actual|2015-09-15|May 2017|2017-05-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||Safety and Efficacy of a Novel Facemask for Positive Pressure Ventilation|Safety and Efficacy of a Novel Facemask for Positive Pressure Ventilation|Completed||N/A|152|Actual|Medical University of South Carolina||2|||f||||t|f|f||||||Undecided||2017-10-10 21:03:19.050937|2017-10-10 21:03:19.050937
NCT03158194|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-08-16|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|April 28, 2018|Anticipated|2018-04-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Cognitive Behavior Therapy for Anxiety-related Asthma in Adults.|Cognitive Behavior Therapy for Anxiety-related Asthma in Adults.|Recruiting||N/A|10|Anticipated|Karolinska Institutet||1|||f||||f|f|f||||||||2017-10-10 21:03:19.136644|2017-10-10 21:03:19.136644
NCT03158181|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-19|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|ARIBO 2||Improvement of Intraoperative Behavior of Staff to Prevent Postoperative Complications|Improvement of Intraoperative Behavior of Staff to Prevent Postoperative Complications|Not yet recruiting||N/A|17760|Anticipated|Nantes University Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:03:19.247744|2017-10-10 21:03:19.247744
NCT02826174|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-04|||December 2015||2015-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP||Recruiting||N/A|60|Anticipated|Wenzhou Medical University||4|||f||||||||||||||2017-10-10 22:01:00.769156|2017-10-10 22:01:00.769156
NCT03158168|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts|Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts, A Randomized Clinical Trial|Not yet recruiting||Phase 3|70|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:03:19.432316|2017-10-10 21:03:19.432316
NCT03158155|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-05|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|July 18, 2018|Anticipated|2018-07-18|July 15, 2018|Anticipated|2018-07-15|1 Day|Observational [Patient Registry]|||Prevalence of Early Childhood Caries in Egyptian Children With Serum Vitamin D Deficiency.|Prevalence of Early Childhood Caries in Egyptian Children With Serum Vitamin D Deficiency.|Not yet recruiting||N/A|288|Anticipated|Cairo University|||1||f||||t|f|f||||Samples Without DNA|"     Blood samples will be obtained from children recruited in the study at the day of diagnosis,     seven mm of blood will collect approximately, using radioimmunoassay technique for measuring     vitamin D serum level All serum analysis will be done in Radioisotope Department, Nuclear     Research Center, and Atomic Energy Authority.   "|Undecided||2017-10-10 21:03:19.519203|2017-10-10 21:03:19.519203
NCT03158142|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-17|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|October 15, 2017|Anticipated|2017-10-15||Interventional|||The Influence of Atropine on Choroidal Thickness|The Influence of Atropine on Choroidal Thickness|Recruiting||Phase 4|20|Anticipated|State University of New York College of Optometry||1|||f|||||t|f|||f|||No|All IPD collected from the study will be made available to other the investigators that have been listed on this study. IPD will be de-identified before making it available to the other investigators. IPD will become available after the end of study data collection. Deidentified IPD will be obtained by other investigator in excel files sent by the primary investigator|2017-10-10 21:03:19.603772|2017-10-10 21:03:19.603772
NCT03158129|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-11|||June 9, 2017|Actual|2017-06-09|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Study Of Induction Checkpoint Blockade For Untreated Stage I-IIIA Non-Small Cell Lung Cancers Amenable For Surgical Resection|Phase II Study Of Induction Checkpoint Blockade For Untreated Stage I-IIIA Non-Small Cell Lung Cancers Amenable For Surgical Resection, NEOSTAR/INDUCTION - Strategic Alliance: BMS|Recruiting||Phase 2|66|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:03:19.69428|2017-10-10 21:03:19.69428
NCT03158116|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-01|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|A-PACT||The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas|A-PACT: The Use of Inhaled Aztreonam to Eliminate or Decrease the Bacterial Burden of Pseudomonas Aeruginosa in Children With a Tracheostomy Tube.|Recruiting||Phase 4|15|Anticipated|Children's Hospital & Research Center Oakland||1|||f||||f|t|f|||t|||||2017-10-10 21:03:19.810169|2017-10-10 21:03:19.810169
NCT03158103|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-06-30|||April 15, 2017|Actual|2017-04-15|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)|A Phase I Study of Binimetinib in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)|Recruiting||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:03:19.914641|2017-10-10 21:03:19.914641
NCT03158090|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-05-22|||August 30, 2017|Anticipated|2017-08-30|May 2017|2017-05-01|January 30, 2051|Anticipated|2051-01-30|December 30, 2050|Anticipated|2050-12-30||Observational|||The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research|The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research|Not yet recruiting||N/A|1965|Anticipated|Ginkgo Leaf Center for Rare Disorders|||3||f||||f|f|f||||||Undecided||2017-10-10 21:03:20.070335|2017-10-10 21:03:20.070335
NCT03158077|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-16|||November 15, 2016|Actual|2016-11-15|May 2017|2017-05-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Observational|KIRAL||Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection|Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection: Observational Retrospective Study at 48 Weeks - KIRAL Study|Completed||N/A|467|Actual|Fundacion SEIMC-GESIDA|||1||f||||f|f|f||||||No||2017-10-10 21:03:20.157401|2017-10-10 21:03:20.157401
NCT03158064|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-22|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors|A Single-arm, Phase II Study of Durvalumab (MEDI4736) and Tremelimumab for Relapsed/Refractory Germ Cell Tumors|Recruiting||Phase 2|29|Anticipated|Memorial Sloan Kettering Cancer Center||1||||||||t|f||||||||2017-10-10 21:03:20.28888|2017-10-10 21:03:20.28888
NCT03158051|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|April 30, 2022|Anticipated|2022-04-30|December 31, 2021|Anticipated|2021-12-31||Interventional|MyHEART||Young Adult Hypertension Self-Management Clinical Trial|The MyHEART Study: A Young Adult Hypertension Self-Management Randomized Controlled Trial|Not yet recruiting||N/A|310|Anticipated|University of Wisconsin, Madison||2|||f||||t|f|f||||||No||2017-10-10 21:03:20.412512|2017-10-10 21:03:20.412512
NCT03158038|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-20|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|December 21, 2017|Anticipated|2017-12-21|December 21, 2017|Anticipated|2017-12-21||Interventional|FluMist||Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season|A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults|Active, not recruiting||Phase 4|300|Actual|MedImmune LLC||2|||f||||f|t|f||||||||2017-10-10 21:03:20.574474|2017-10-10 21:03:20.574474
NCT03158025|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-18|||April 19, 2017|Actual|2017-04-19|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users|A Randomized, Double-Blind, 6-Way Crossover Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users|Recruiting||Phase 1|48|Anticipated|Eisai Inc.||6|||f||||f|t|f||||||||2017-10-10 21:03:20.680678|2017-10-10 21:03:20.680678
NCT03155126|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-13|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Different Crystalloids on AKI in Shock|The Effect of Different Crystalloids on the Incidence of Acute Kidney Injury in Shock Patients|Enrolling by invitation||N/A|600|Anticipated|Southeast University, China|||2||f||||f|f|f||||||Undecided||2017-10-10 21:03:51.229683|2017-10-10 21:03:51.229683
NCT03158012|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-16|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients|Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients|Recruiting||Phase 1|27|Anticipated|University of California, San Diego||2|||f||||t|t|f||||||Undecided||2017-10-10 21:03:20.877657|2017-10-10 21:03:20.877657
NCT03157999|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-27|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|December 13, 2019|Anticipated|2019-12-13|December 4, 2019|Anticipated|2019-12-04||Interventional|CAST||Community Assets Supporting Transitions (CAST)|A Pragmatic Effectiveness-implementation Trial to Evaluate a Hospital-to-home Transitional Care Intervention Compared to Usual Care for Older Adults With Multiple Chronic Conditions and Depression|Recruiting||N/A|216|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 21:03:20.980235|2017-10-10 21:03:20.980235
NCT03157986|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Effects of Whole-Body Vibration Training Versus Balance Training in Patients With Severe Chronic Obstructive Pulmonary Disease|Effects of a Three Week Whole Body Vibration Training Versus Conventional Balance Training in Patients With Severe Chronic Obstructive Pulmonary Disease|Recruiting||N/A|48|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f|||||f|f||||||Yes||2017-10-10 21:03:21.113207|2017-10-10 21:03:21.113207
NCT03157973|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Modern Technology For Learning and Psychosocial Support In Patients With Abdominal Aortic Aneurysm|Modern Technology For Learning and Psychosocial Support In Patients With Abdominal Aortic Aneurysm|Recruiting||N/A|115|Anticipated|Karolinska University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:03:21.213128|2017-10-10 21:03:21.213128
NCT03157960|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||February 1, 2012|Actual|2012-02-01|May 2017|2017-05-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Effect of Acute Fructose Load in Human|The Effect of Acute Fructose Load in Patients With Chronic Kidney Disease and Patients With Type 2 Diabetes Compared to Healthy Subjects|Recruiting||N/A|120|Anticipated|Karolinska University Hospital||6|||f||||f|f|f||||||No||2017-10-10 21:03:21.302034|2017-10-10 21:03:21.302034
NCT03157947|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-08-23|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer|Development and Testing of a Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer|Recruiting||N/A|100|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|f|f||||||||2017-10-10 21:03:21.427841|2017-10-10 21:03:21.427841
NCT03157934|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01|3 Months|Observational [Patient Registry]|FAST||Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)|Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)|Not yet recruiting||N/A|12000|Anticipated|University Hospital Heidelberg|||3||f||||f|f|f||||||Undecided|Subject to approval by ethics committee|2017-10-10 21:03:21.521214|2017-10-10 21:03:21.521214
NCT03157921|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Observational|||Prevalence of Pregnancy in Polycystic Ovary Syndrome|Prevalence of Spontaneous Ovulation and Pregnancy in Patients With Polycystic Ovary Syndrome|Completed||N/A|70|Actual|Assiut University|||1||f||||f|f|f||||||Undecided||2017-10-10 21:03:21.607397|2017-10-10 21:03:21.607397
NCT03157908|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-01|||July 12, 2017|Actual|2017-07-12|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||CareConekta: A Pilot Study of a Smartphone App in South Africa|A Pilot Study to Assess the Acceptability and Feasibility of a Smartphone App to Improve Retention in Postpartum HIV Care in South Africa|Recruiting||N/A|30|Anticipated|Vanderbilt University Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:03:21.672089|2017-10-10 21:03:21.672089
NCT03157895|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-16|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||A Trial of Connecting to Promote Foster Teen Well-Being|A Trial of Connecting to Prevent Drug Abuse and Risky Behavior in Foster Teens|Recruiting||N/A|240|Anticipated|University of Washington||2|||f||||f|f|f||||||Undecided||2017-10-10 21:03:21.758962|2017-10-10 21:03:21.758962
NCT03157882|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-16|||October 2016||2016-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Pediatric Pain Assessment in the Emergency Department|Pediatric Pain Assessment in the Emergency Department|Recruiting||N/A|270|Anticipated|Carolinas Healthcare System|||1||f||||f||||||||No||2017-10-10 21:03:21.852762|2017-10-10 21:03:21.852762
NCT03157869|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-16|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|November 2017|Anticipated|2017-11-01||Interventional|||Influence of Transcranial Direct Stimulation Current on Motor Learning of Young Adults|Influence of Transcranial Direct Stimulation Current on Motor Learning of Young Adults|Recruiting||N/A|36|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:03:21.925723|2017-10-10 21:03:21.925723
NCT03157856|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-08|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|Bio-Prost||Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection|Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection|Recruiting||N/A|12|Anticipated|University Hospital, Grenoble|||1||f||||f|f|f||||||No||2017-10-10 21:03:22.12549|2017-10-10 21:03:22.12549
NCT03157843|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2017-05-16|||February 2015||2015-02-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|AURELIO||Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards|Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards|Recruiting||N/A|1000|Anticipated|University of Roma La Sapienza|||2||f||||t||||||||No||2017-10-10 21:03:22.264976|2017-10-10 21:03:22.264976
NCT03157830|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-13|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2021|Anticipated|2021-06-01||Observational|||Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab.|Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab.|Recruiting||N/A|75|Anticipated|Providence Health & Services|||1||f||||t|f|f|||t|||No||2017-10-10 21:03:22.354574|2017-10-10 21:03:22.354574
NCT03157817|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-31|||October 18, 2016|Actual|2016-10-18|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15|1 Week|Observational [Patient Registry]|SPAaRC||Sedentary Behaviour, Physical Activity and Cardiometabolic Risk in Chronic Obstructive Pulmonary Disease|Sedentary Behaviour, Physical Activity and Cardiometabolic Risk in Chronic Obstructive Pulmonary Disease|Completed||N/A|90|Actual|Loughborough University|||2||f||||f|f|f||||||||2017-10-10 21:03:22.465445|2017-10-10 21:03:22.465445
NCT03157804|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-16|||January 2016||2016-01-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|FANCOLEN-1||Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A|Clinical Trial Phase I / II to Evaluate the Safety and Efficacy of the Infusion of Autologous CD34 + Cells Transduced With a Lentiviral Vector Carrying the Gene FANCA in Patients With FA Subtype A (FANCOLEN-1)|Recruiting||Phase 1/Phase 2|5|Anticipated|Hospital Infantil Universitario Niño Jesús, Madrid, Spain||1|||f||||||||||||||2017-10-10 21:03:22.536374|2017-10-10 21:03:22.536374
NCT03157791|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-18|||May 22, 2017|Anticipated|2017-05-22|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Simethicone and Bowel Preparation in Colonoscopy|Addition of Oral Simethicone to Bowel Preparation in Colonoscopy|Not yet recruiting||Phase 4|400|Anticipated|University of Manitoba||2|||f||||t|t|f|||f|||No||2017-10-10 21:03:22.638563|2017-10-10 21:03:22.638563
NCT03157778|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-23|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CannaPREG||Relation Between Pregnenolone Endocannabinoids in Normal-weight and Obese Men|Relation Between Pregnenolone Endocannabinoids in Normal-weight and Obese Men|Not yet recruiting||N/A|24|Anticipated|University Hospital, Bordeaux||2|||f||||f|f|f||||||No||2017-10-10 21:03:22.732126|2017-10-10 21:03:22.732126
NCT03157765|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Trial of Endometrial Scratch Prior to Frozen Embryo Transfer in Patients With Recurrent Implantation Failure|A Randomized Study on the Value of an Endometrial Scratch Prior to a Frozen Embryo Transfer Cycle in the Treatment of Recurrent Implantation Failure|Not yet recruiting||N/A|250|Anticipated|Brown Fertility||2|||f|||||f|f||||||||2017-10-10 21:03:22.848138|2017-10-10 21:03:22.848138
NCT03157752|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||May 31, 2017|Anticipated|2017-05-31|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Anticipated|2017-06-30||Observational|ESCAL||Evaluation of the Satisfaction of Patients With Conization Under Local Anesthesia|Evaluation of the Satisfaction of Patients With Conization Under Local Anesthesia, Prospective Study|Not yet recruiting||N/A|80|Anticipated|University Hospital, Montpellier|||1||f||||f|f|f||||||Undecided|NC|2017-10-10 21:03:22.936117|2017-10-10 21:03:22.936117
NCT03157739|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine|MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine|Not yet recruiting||N/A|30|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f|f|f||||||||2017-10-10 21:03:23.005255|2017-10-10 21:03:23.005255
NCT03157726|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-18|||June 25, 2017|Anticipated|2017-06-25|April 2017|2017-04-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|ERP||Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate|Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate: A Multi-center Randomized Control Trial|Recruiting||N/A|294|Anticipated|Zhujiang Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:03:23.099019|2017-10-10 21:03:23.099019
NCT03157713|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-15|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|FIReWoRk||Financial Incentives for Weight Reduction Study|Financial Incentive Strategies for Weight Loss in Obese Patients Living in Socioeconomically Disadvantaged Neighborhoods|Not yet recruiting||N/A|795|Anticipated|University of California, Los Angeles||3|||f||||t|f|f||||||No||2017-10-10 21:03:23.250231|2017-10-10 21:03:23.250231
NCT03157700|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-15|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Interactive Technology for Media Literacy Drug Prevention in Community Groups|Interactive Technology for Media Literacy Drug Prevention in Community Groups|Not yet recruiting||N/A|1200|Anticipated|Real Prevention, LLC||2|||f||||t|f|f||||||Undecided||2017-10-10 21:03:23.405338|2017-10-10 21:03:23.405338
NCT03157687|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Detection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic Inflammation|Detection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic Inflammation Under Mixed Diet|Recruiting||N/A|75|Anticipated|University of Erlangen-Nürnberg Medical School|||3||f||||f|f|f||||||No||2017-10-10 21:03:23.492502|2017-10-10 21:03:23.492502
NCT03157661|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-29|||October 24, 2016|Actual|2016-10-24|May 2017|2017-05-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|HASS||Prevalence of Hypertensive Disease in Patients Presenting for Elective Surgery in the Western Cape, South Africa|A Multicentre Cross-sectional Study of the Prevalence of Hypertensive Disease in Patients Presenting for Elective Surgery in the Western Cape|Completed||N/A|382|Actual|University of Cape Town|||1||f||||f|f|f||||||Yes|Individual anonymous participant data will be collected and stored on REDCap which is a mature, secure web application for building and managing online surveys and databases. Access to individual patient information will be possible by contacting Dr MB Nejthardt at mb.nejthardt@uct.ac.za. A review of the enquiry will be undertaken by the HASS research team and the requesting person notified my email.|2017-10-10 21:03:23.670006|2017-10-10 21:03:23.670006
NCT03157648|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-16|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Relationship Between Core-peripheral Temperature Difference and Shivering Symptom in Patients in PACU|Relationship Between Core-peripheral Temperature Difference and Shivering Symptom in Patients in PACU|Recruiting||N/A|200|Anticipated|Mahidol University|||1||f||||t|f|f||||||No|When the other researcher required data, please direct contact to principle investigator.|2017-10-10 21:03:23.762177|2017-10-10 21:03:23.762177
NCT03157635|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-25|||November 14, 2016|Actual|2016-11-14|September 2017|2017-09-01|February 22, 2020|Anticipated|2020-02-22|February 17, 2018|Anticipated|2018-02-17||Interventional|||Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria|An Adaptive Phase I/II Study to Assess Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of RO7112689 in Healthy Volunteers and Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)|Recruiting||Phase 1/Phase 2|39|Anticipated|Hoffmann-La Roche||4|||f|||||f|f||||||||2017-10-10 21:03:23.858999|2017-10-10 21:03:23.858999
NCT03157622|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-07-03|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Single-Case Study on Therapeutic Change in Chronic Low Back Pain|Comparing Therapeutic Change During Exposure and Cognitive-Behavioral Therapy in the Context Chronic Low Back Pain|Completed||N/A|12|Actual|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-10-10 21:03:24.023002|2017-10-10 21:03:24.023002
NCT03157596|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-16|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|January 17, 2017|Actual|2017-01-17|December 30, 2016|Actual|2016-12-30||Interventional|||Oral Health Education for Caregivers of Children With Disabilities|Effectiveness of an Oral Health Education Program for Caregivers of Children With Developmental Disabilities: A Cluster Randomized Trial|Completed||N/A|61|Actual|ElTyeb, Sara Amir Hassan, M.D.||2|||f||||t||||||||Undecided||2017-10-10 21:03:24.21154|2017-10-10 21:03:24.21154
NCT03157583|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-07-17|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|||A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations|Determination of the Sun Protection Factor (SPF) and in Vitro UVA Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations|Completed||N/A|9|Actual|GlaxoSmithKline||8|||f||||f|f|f||||||||2017-10-10 21:03:24.29055|2017-10-10 21:03:24.29055
NCT03157570|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-31|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Effects of Home Exercise Intervention on Bone Density, Muscle Functions, QoL, and Curve Progression in Girls With AIS|Effects of Home Exercise Intervention on Bone Density, Muscle Functions, Quality of Life, and Curve Progression in Girls With Adolescent Idiopathic Scoliosis|Recruiting||N/A|40|Anticipated|Chinese University of Hong Kong||2|||f|||||f|f||||||||2017-10-10 21:03:24.389287|2017-10-10 21:03:24.389287
NCT03157557|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-19|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Multidisciplinary Lifestyle-enhancing Treatment for People With Severe Mental Illness in Sheltered Housing Facilities|Multidisciplinary Lifestyle-enhancing Treatment for Long-term Severe Mentally Ill Inpatients: Sheltered Housing|Recruiting||N/A|168|Anticipated|GGZ Centraal||2|||f|||||f|f||||||||2017-10-10 21:03:24.481561|2017-10-10 21:03:24.481561
NCT03157544|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-16|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Complementary Management of Chronic Neck and/or Low Back Pain With a Pain Relief Kit|Complementary Management of Chronic Neck and/or Low Back Pain With a Multimodal Non-pharmacological Pain Relief Kit|Recruiting||N/A|30|Anticipated|Sport and Spine Rehab Clinical Research Foundation||1|||f||||f|f|f||||||No||2017-10-10 21:03:24.58106|2017-10-10 21:03:24.58106
NCT03157531|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-10-02|||September 6, 2017||2017-09-06||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:03:24.668212|2017-10-10 21:03:24.668212
NCT03157518|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-10-04|||July 1, 2017|Actual|2017-07-01|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects|Oral Probiotic Administration to Modulate the Airway Microbiome in Obese Asthmatic Subjects|Recruiting||N/A|5|Anticipated|University of Alabama at Birmingham||1|||f||||f|f|f||||||||2017-10-10 21:03:24.709877|2017-10-10 21:03:24.709877
NCT03157505|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||January 5, 2014|Actual|2014-01-05|May 2017|2017-05-01|March 2, 2017|Actual|2017-03-02|December 30, 2016|Actual|2016-12-30||Interventional|LARbirch||Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis|Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis|Completed||Phase 3|78|Actual|Medical University of Silesia||2|||f||||t|f|f||||||Undecided||2017-10-10 21:03:24.797475|2017-10-10 21:03:24.797475
NCT03157492|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-10|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|September 30, 2019|Anticipated|2019-09-30|September 2019|Anticipated|2019-09-01||Interventional|||Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology|Enhanced Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology|Recruiting||N/A|24|Anticipated|Gallaudet University||2|||f||||f|f|f||||||||2017-10-10 21:03:24.89455|2017-10-10 21:03:24.89455
NCT03157479|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-14|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|Inprove4large||Intraoperative Protective Ventilation for Obese Patients Undergoing Gynaecological Laparoscopic Surgery|Intraoperative Protective Ventilation for Obese Patients Undergoing Gynaecological Laparoscopic Surgery. A Single-centre Randomized, Controlled Trial|Recruiting||N/A|60|Anticipated|Catholic University of the Sacred Heart||2|||f||||f|f|f||||||Undecided||2017-10-10 21:03:25.008462|2017-10-10 21:03:25.008462
NCT03157466|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 3, 2018|Anticipated|2018-01-03|December 31, 2017|Anticipated|2017-12-31||Observational|||Respiratory Muscle Function After Thyroid Hormone Replacement Therapy in Nonthyroidal Illness Syndrome|Diaphragmatic Efficiency After Thyroid Hormone Replacement Therapy in Ventilated Patients With the Nonthyroidal Illness Syndrome: a Physiological Study|Not yet recruiting||N/A|15|Anticipated|Policlinico Universitario Agostino Gemelli|||1||f|||||f|f||||||||2017-10-10 21:03:25.136607|2017-10-10 21:03:25.136607
NCT03142360|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|April 4, 2019|Anticipated|2019-04-04|April 4, 2019|Anticipated|2019-04-04||Interventional|||Effect of Beraprost Sodium (Berasil) on Hemodialysis|Effect of Beraprost Sodium (Berasil) on Hemodialysis|Recruiting||N/A|60|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:05:50.491863|2017-10-10 21:05:50.491863
NCT03157440|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Novel Device for Screening Patients With Symptoms of OSA|Validation of a Novel Device for Screening Patients With Symptoms of OSA|Recruiting||N/A|97|Anticipated|Chinese University of Hong Kong|||1||f|||||f|f||||||||2017-10-10 21:03:25.345257|2017-10-10 21:03:25.345257
NCT03157427|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-11|||June 21, 2017|Actual|2017-06-21|September 2017|2017-09-01|September 12, 2017|Actual|2017-09-12|September 12, 2017|Actual|2017-09-12||Interventional|CBT||Clinical Evaluation of the Performance of a Difluoroethane-based Cyto-selective Cryotherapy to Treat Dark Spots on the Hand in 30 Volunteers.|Clinical Evaluation of the Performance of a Difluoroethane-based Cyto-selective Cryotherapy to Treat Dark Spots on the Hand in 30 Volunteers.|Completed||N/A|30|Actual|Cryobeauty||2|||f||||f|f|f||||||||2017-10-10 21:03:25.42754|2017-10-10 21:03:25.42754
NCT03157414|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-15|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EMPA-RenalTx||Empagliflozin in Renal Transplant Recipients|Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Post-transplantation Diabetes Mellitus|Recruiting||Phase 4|50|Anticipated|Oslo University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:03:25.525011|2017-10-10 21:03:25.525011
NCT03157401|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Observational|||Two Different Administration Methods of Tranexamic Acid on Perioperative Blood Loss During Total Hip Arthroplasty|Effects of Two Different Administration Methods of Tranexamic Acid on Perioperative Blood Loss During Total Hip Arthroplasty: a Prospective, Open-label, Randomized, Controlled Clinical Trial|Active, not recruiting||N/A|90|Anticipated|Tengzhou Central People's Hospital|||3||f||||t|f|f||||||Undecided||2017-10-10 21:03:25.64522|2017-10-10 21:03:25.64522
NCT03157388|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-26|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis.|The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis.|Recruiting||N/A|15|Anticipated|University of Aarhus||1|||f||||f|f|f||||||||2017-10-10 21:03:25.717419|2017-10-10 21:03:25.717419
NCT03157375|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-15|||October 6, 2014||2014-10-06|May 2017|2017-05-01|October 2, 2015|Actual|2015-10-02|October 2, 2015|Actual|2015-10-02||Interventional|Rot P261||Rotation of an Intraocular Lens - HOYA Vivinex iSert P261|Rotation of an Intraocular Lens - HOYA Vivinex iSert P261|Completed||N/A|66|Actual|Medical University of Vienna||4|||f||||||||||||||2017-10-10 21:03:25.808096|2017-10-10 21:03:25.808096
NCT03157362|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-19|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|SPP||Effects of Social Presence and Perception in Virtual Reality on Pain|Effects of Social Presence and Perception in Virtual Reality on Pain|Not yet recruiting||N/A|75|Anticipated|Cornell University||4|||f||||t|f|f||||||||2017-10-10 21:03:25.879812|2017-10-10 21:03:25.879812
NCT03157349|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-16|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Effect of Biofreeze® Versus Placebo on Acute Neck Pain, Disability, and Range of Motion|Immediate and Short-term Effect of Biofreeze® Versus Placebo on Acute Neck Pain, Disability, and Range of Motion|Recruiting||N/A|60|Anticipated|Sport and Spine Rehab Clinical Research Foundation||2|||f||||f|f|f||||||No||2017-10-10 21:03:25.976814|2017-10-10 21:03:25.976814
NCT03157336|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-08-29|||July 30, 2017|Actual|2017-07-30|August 2017|2017-08-01|August 31, 2021|Anticipated|2021-08-31|June 30, 2021|Anticipated|2021-06-30||Interventional|||Cassava Intervention Project|Toxicodietary and Genetic Determinants of Susceptibility to Neurodegeneration|Recruiting||N/A|1200|Anticipated|Ministry of Public Health, Democratic Republic of the Congo||2|||f||||f|f|f||||||||2017-10-10 21:03:26.069344|2017-10-10 21:03:26.069344
NCT03157323|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-22|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Low GI Diet in Children and Adolescents With ALL|Implementing a Low Glycemic Diet in Children and Adolescents Undergoing Treatment for Acute Lymphoblastic Leukemia|Recruiting||N/A|50|Anticipated|Columbia University||1|||f||||f|f|f||||||||2017-10-10 21:03:27.861865|2017-10-10 21:03:27.861865
NCT03157310|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||May 1, 2009|Actual|2009-05-01|May 2017|2017-05-01|July 12, 2015|Actual|2015-07-12|May 1, 2013|Actual|2013-05-01||Interventional|||Bone Metastasis on the Survival of Gefitinib Effective Patients|Bone Metastasis on the Survival of Gefitinib Effective Patients With Non-small Cell Lung Cancer|Completed||N/A|265|Actual|Qilu Hospital of Shandong University||1|||f||||f|f|f||||||No|The patients' data were not allowed to been using outside this research.|2017-10-10 21:03:27.975|2017-10-10 21:03:27.975
NCT03157297|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-03|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MARVEL||Micra Atrial Tracking Using a Ventricular Accelerometer Study|Micra Atrial Tracking Using a Ventricular Accelerometer Study|Recruiting||Phase 1|75|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f|f|f||||||||2017-10-10 21:03:28.073388|2017-10-10 21:03:28.073388
NCT03157284|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-16|||January 23, 2017|Actual|2017-01-23|May 2017|2017-05-01|March 30, 2018|Anticipated|2018-03-30|July 1, 2017|Anticipated|2017-07-01||Interventional|||Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis|Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis : Randomized, Double-Blind, Placebo-Controlled Trial|Active, not recruiting||N/A|56|Anticipated|Heinz Italia SpA||2|||f||||f|f|f||||||No||2017-10-10 21:03:28.183313|2017-10-10 21:03:28.183313
NCT03157271|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Addition of Dry Needling in the Treatment of Patients With Patellofemoral Pain Syndrome|The Addition of Dry Needling in the Treatment of Patients With Patellofemoral Pain Syndrome|Not yet recruiting||N/A|111|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 21:03:28.291218|2017-10-10 21:03:28.291218
NCT03142581|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-03|||November 29, 2016||2016-11-29||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:05:54.825934|2017-10-10 21:05:54.825934
NCT03157258|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-08|||June 8, 2017|Actual|2017-06-08|May 2017|2017-05-01|May 31, 2022|Anticipated|2022-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||Social Network Intervention to Engage Community PLH to Engage in HIV Medical Care|Social Network Intervention to Engage Community PLH to Engage in HIV Medical Care|Enrolling by invitation||N/A|320|Anticipated|Medical College of Wisconsin||2|||f||||f|f|f||||||No||2017-10-10 21:03:28.363003|2017-10-10 21:03:28.363003
NCT03157245|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-07|||June 2, 2017|Actual|2017-06-02|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|THROMBOCAT||Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery|Interest of Doppler Ultrasound for the Assessment of Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery|Recruiting||N/A|60|Anticipated|Central Hospital, Nancy, France|||1||f||||f|f|f||||||No||2017-10-10 21:03:28.439379|2017-10-10 21:03:28.439379
NCT03157232|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-19||June 19, 2009|Actual|2009-06-19|June 2017|2017-06-01|June 29, 2009|Actual|2009-06-29|June 29, 2009|Actual|2009-06-29||Interventional|||Rainbow DCI vs. R1-25 Sensor SpHb Sub-Range Performance Equivalence||Completed||N/A|18|Actual|Masimo Corporation||1|||f|||||f|t|f||f|||||2017-10-10 21:03:28.535472|2017-10-10 21:03:28.535472
NCT03157219|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-18|||September 10, 2015|Actual|2015-09-10|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|September 9, 2018|Anticipated|2018-09-09|3 Years|Observational [Patient Registry]|MHFR||Manipal Heart Failure Registry (MHFR)|Manipal Heart Failure Registry (MHFR): A Long Term, Prospective and Descriptive Study of Heart Failure in a Tertiary Care Hospital in South India|Recruiting||N/A|500|Anticipated|Manipal University|||1||f||||t|f|f||||||No||2017-10-10 21:03:28.703711|2017-10-10 21:03:28.703711
NCT03157206|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-07|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|September 18, 2020|Anticipated|2020-09-18|July 18, 2019|Anticipated|2019-07-18||Observational|REGARD1||Diabetic Retinopathy Assessed by Ultra-wide|Peripheral Ischemia Evolution Assessed by Ultra-wide Field Angiography in Patients With Diabetic Macular Edema|Recruiting||N/A|49|Anticipated|Association Pour La Recherche En Vision Du Service D'Ophtalmologie De L'Hôpital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:03:28.809178|2017-10-10 21:03:28.809178
NCT03157193|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Hyaluronic Acid on Perimplantitis|Effect of Hyaluronic Acid on Peri-implant Pathology: A Double-blind, Randomized, Controlled Clinical Trial.|Completed||Phase 4|61|Actual|Universidad de Granada||3|||f||||f|f|f||||||No||2017-10-10 21:03:28.984934|2017-10-10 21:03:28.984934
NCT03157180|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01|6 Weeks|Observational [Patient Registry]|||The Clinical Study on Pseudo-allergic Reaction to Anesthetic Drugs During General Anesthesia|The Clinical Study on Pseudo-allergic Reaction to Anesthetic Drugs During General Anesthesia|Recruiting||N/A|200|Anticipated|Central South University|||2||f||||||||||Samples With DNA|"     Blood specimen   "|Undecided||2017-10-10 21:03:29.10266|2017-10-10 21:03:29.10266
NCT03157167|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-07-10|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) Injection in Kaposi Sarcoma (KS)|An Evaluation of the Safety of Escalating Doses of Tc 99m Tilmanocept by Intravenous (IV) Injection in Human Immunodeficiency Virus (HIV) Subjects Diagnosed With Kaposi Sarcoma (KS)|Not yet recruiting||Early Phase 1|24|Anticipated|Navidea Biopharmaceuticals||6|||f||||f|t|f||||||||2017-10-10 21:03:29.213309|2017-10-10 21:03:29.213309
NCT03157154|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-08-09|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|ERHEA||Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies|Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies|Recruiting||N/A|140|Anticipated|Nantes University Hospital|||2||f||||f|f|f||||||||2017-10-10 21:03:29.336488|2017-10-10 21:03:29.336488
NCT03157141|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-16|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Observational|AO-IFAB||Ankle Osteoarthritis|Ankle Osteoarthritis and Its Treatments : Impact on Foot & Ankle Biomechanics|Recruiting||N/A|120|Anticipated|Hospices Civils de Lyon|||3||f||||f|f|f||||||||2017-10-10 21:03:29.460532|2017-10-10 21:03:29.460532
NCT03157115|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Validation of Kinocardiography, New Technology for Cardiac Linear and Torsional Contractility Measurement, to Assess Heart Failure Patient With Low Ejection Fraction|Validation of Kinocardiography, New Technology for Cardiac Linear and Torsional Contractility Measurement, to Assess Heart Failure Patient With Low Ejection Fraction|Not yet recruiting||N/A|50|Anticipated|Brugmann University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:03:29.747865|2017-10-10 21:03:29.747865
NCT03157102|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-16|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|CANULASTHM||High Flow Nasal Cannula in Children With Status Asthmaticus|High Flow Nasal Cannula Versus Standard Oxygen Therapy in Children With Status Asthmaticus: a Randomized Controlled Trial|Not yet recruiting||N/A|268|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||No||2017-10-10 21:03:29.859524|2017-10-10 21:03:29.859524
NCT03157089|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-10-03|||October 16, 2017|Anticipated|2017-10-16|October 2017|2017-10-01|February 19, 2021|Anticipated|2021-02-19|June 28, 2019|Anticipated|2019-06-28||Interventional|LUX-Lung IO||Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung|LUX-Lung IO: A Phase II, Open Label, Non-randomised Study of Afatinib in Combination With Pembrolizumab in Patients With Locally Advanced or Metastatic Squamous Cell Carcinoma of the Lung|Not yet recruiting||Phase 2|60|Anticipated|Boehringer Ingelheim||1|||f||||f|t|f||||||||2017-10-10 21:03:29.951793|2017-10-10 21:03:29.951793
NCT03157076|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|BIO CREATE||Pilot Study to Investigate the Creation of Physiological Rhythm by Closed Loop Stimulation in hEart Failure pAtients With chronoTropic incompEtence|"BIO|CREATE Pilot Study"|Recruiting||N/A|100|Anticipated|Biotronik SE & Co. KG||2|||f||||f|f|f||||||No||2017-10-10 21:03:30.044157|2017-10-10 21:03:30.044157
NCT03157063|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-09-25|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2018|Anticipated|2018-05-15||Observational|AAAA||Pilot Data Collection for Activity, Adiposity, and Appetite in Adolescents|Pilot Data Collection for Activity, Adiposity, and Appetite in Adolescents|Recruiting||N/A|60|Anticipated|Children's Mercy Hospital Kansas City|||4||f||||f|f|f||||Samples Without DNA|"     hormones related to satiety and hunger (insulin, leptin, ghrelin, peptide YY, glucagon-like     peptide-1) obtained during blood samples (BLOOD) from an indwelling catheter.   "|||2017-10-10 21:03:30.134337|2017-10-10 21:03:30.134337
NCT03157050|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||January 14, 2016|Actual|2016-01-14|May 2017|2017-05-01|May 16, 2017|Actual|2017-05-16|May 15, 2017|Actual|2017-05-15||Observational|||Intravenous Iron May Increase Depression Among Hemodialysis Patients|Intravenous Iron May Increase Depression Among Hemodialysis Patients|Completed||N/A|112|Actual|Benha University|||1||f||||t|f|f||||||No||2017-10-10 21:03:30.220869|2017-10-10 21:03:30.220869
NCT03157037|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|GOOD-IDES||An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES)|An Open-Label Phase II Study in Anti-GBM Disease (Goodpasture's Disease) With Adverse Renal Prognosis to Evaluate the Efficacy and Safety of IdeS --GOOD-IDES|Recruiting||Phase 2|15|Anticipated|Linkoeping University||1|||f||||t|f|f||||||No||2017-10-10 21:03:30.279349|2017-10-10 21:03:30.279349
NCT03157024|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||April 4, 2016|Actual|2016-04-04|May 2017|2017-05-01|June 2, 2016|Actual|2016-06-02|June 2, 2016|Actual|2016-06-02||Interventional|||Validation of a Newly Developed Sham Press Needle|Validation of a Newly Developed Sham Press Needle|Completed||N/A|84|Actual|Kyunghee University||3|||f||||f|f|f||||||No||2017-10-10 21:03:30.368875|2017-10-10 21:03:30.368875
NCT03157011|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-23|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|GASTRO-SGS||Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome|Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome|Recruiting||N/A|151|Anticipated|University Hospital, Limoges||1|||f||||f|f|f||||||||2017-10-10 21:03:30.4718|2017-10-10 21:03:30.4718
NCT03156985|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-09-18|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|DONATE||Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China|Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China|Recruiting||N/A|3000|Anticipated|AstraZeneca|||1||f||||f|f|f||||||||2017-10-10 21:03:30.671664|2017-10-10 21:03:30.671664
NCT03156972|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Speckle Tracking for Timing of Surgical Operation in Severe Mitral Regurge|Assessment of Rheumatic Heart Disease Patients With Chronic Severe Mitral Regurge by Speckle Tracking Echocardiography for Proper Timing of Surgical Operation.|Recruiting||N/A|30|Anticipated|Assiut University||2|||f||||t|f|f||||||No||2017-10-10 21:03:30.851349|2017-10-10 21:03:30.851349
NCT03156959|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-22|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|December 31, 2022|Anticipated|2022-12-31|May 31, 2022|Anticipated|2022-05-31||Interventional|TREAT-EMDR||CBT-Eb Plus EMDR Versus CBT-Eb in Patients With Eating Disorders|Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Plus Broad Form of Enhanced Cognitive Behavioural Therapy (CBT-Eb) in Patients With Eating Disorders. A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Universita di Verona||2|||f||||f|f|f||||||No||2017-10-10 21:03:30.963561|2017-10-10 21:03:30.963561
NCT03156946|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-20|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|ALAIS||Evaluation of a Peer Counseling Breastfeeding Support Program for Mother-preterm Infant Dyads|Supporting Breastfeeding for Preterm Infants by Peer Counselors: a Cluster Randomized Controlled Trial|Not yet recruiting||N/A|2400|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||No||2017-10-10 21:03:31.17697|2017-10-10 21:03:31.17697
NCT03156933|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-16|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Observational|ASLIC||Alternative Splicing and Leukemia Initiating Cells|Alternative Splicing and Leukemia Initiating Cells|Recruiting||N/A|500|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||Samples Without DNA|"     RNA   "|||2017-10-10 21:03:31.319719|2017-10-10 21:03:31.319719
NCT03156920|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-08-03|||May 23, 2017|Actual|2017-05-23|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers|Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers. Development of a Pragmatic Migraine Model|Active, not recruiting||N/A|30|Anticipated|Danish Headache Center||2|||f||||f|f|f||||||||2017-10-10 21:03:31.41372|2017-10-10 21:03:31.41372
NCT03156907|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-16|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|SEVROP||High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid|High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid After Failure of an Opioid Tapering-off Strategy.|Not yet recruiting||Phase 2|60|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 21:03:31.504784|2017-10-10 21:03:31.504784
NCT03156894|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-06-07|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg Experience|Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg Experience|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 21:03:31.598447|2017-10-10 21:03:31.598447
NCT03156881|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Global Osteopathic Treatment for Patients With NAFLD|Global Osteopathic Treatment for Patients With Non-Alcoholic Fatty Liver Disease|Not yet recruiting||N/A|48|Anticipated|Canadian College of Osteopathy||2|||f||||f|f|f||||||Undecided|Data sets that will be shared is anonymous blood work comparisons before and after osteopathic treatments to compare differences in a persons physiology. Also the results of the questionnaires given. Data will be only obtained if given permission from Dr.Kevork Peltekian and Jenna Wilcox.|2017-10-10 21:03:31.673896|2017-10-10 21:03:31.673896
NCT03156868|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||August 3, 2016|Actual|2016-08-03|May 2017|2017-05-01|August 3, 2019|Anticipated|2019-08-03|August 3, 2018|Anticipated|2018-08-03||Observational|||Analysis of Soluble Mediators, Cytokines, and Circulating Angiogenic Factors (FACs) as Potential Predictors / Prognostic Factors in Advanced Non-squamous Lung Carcinoma|Analysis of Soluble Mediators, Cytokines, and Circulating Angiogenic Factors (FACs) as Potential Predictors / Prognostic Factors in Antiangiogenic Therapy Following Failure of First-line Chemotherapy in Advanced Non-squamous Lung Carcinoma|Recruiting||N/A|200|Anticipated|Spanish Lung Cancer Group|||1||f||||f|f|f||||Samples Without DNA|"     Soluble mediators analyzed (cytokines, FACs)   "|Undecided||2017-10-10 21:03:31.760193|2017-10-10 21:03:31.760193
NCT03156855|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-05-16|||September 2015||2015-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication|Comparison of the Efficacy of Sequential Therapy and Bismuth Quadruple Therapy in the First Line and Second Line Therapy for Helicobacter Pylori Infection- A Multi-center Randomized Trial|Recruiting||Phase 4|620|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 21:03:31.870426|2017-10-10 21:03:31.870426
NCT03156842|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-08-09|||May 29, 2017|Actual|2017-05-29|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|August 31, 2018|Anticipated|2018-08-31||Interventional|FIRST||Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia|A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia Who Fail to Respond Adequately to Fimasartan Monotherapy|Recruiting||Phase 3|135|Anticipated|Boryung Pharmaceutical Co., Ltd||3|||f||||f|f|f||||||||2017-10-10 21:03:32.00215|2017-10-10 21:03:32.00215
NCT03156829|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-15|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Effectiveness of Cortisone Injection and Splinting for Trigger Finger|Effectiveness of Cortisone Injection and Splinting for Trigger Finger: A Prospective Randomized Controlled Trial|Not yet recruiting||Phase 4|120|Anticipated|Lawson Health Research Institute||3|||f||||f|f|f|||f|||No||2017-10-10 21:03:32.096703|2017-10-10 21:03:32.096703
NCT03156816|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-16|2017-05-16|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|COVERT-MI||COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction|COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction, a Phase II, Multicenter, Randomized, Double Blinded, Placebo Controlled Clinical Trial|Not yet recruiting||Phase 2|194|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:03:32.245598|2017-10-10 21:03:32.245598
NCT03156803|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-05-15|||October 2015||2015-10-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Enhancing Knowledge Translation in Nutrition Through a Healthy Eating Blog|Enhancing Knowledge Translation in Nutrition Through a Healthy Eating Blog: a Randomized Controlled Trial|Recruiting||N/A|144|Anticipated|Laval University||2|||f||||f||||||||No||2017-10-10 21:03:32.350543|2017-10-10 21:03:32.350543
NCT03156790|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||December 15, 2017|Anticipated|2017-12-15|May 2017|2017-05-01|July 31, 2021|Anticipated|2021-07-31|March 30, 2021|Anticipated|2021-03-30||Interventional|||PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia|A Clinical Phase II Trial to Describe Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of Spectrila® With the Pharmaceutical Active Ingredient Recombinant L Asparaginase in Adult Subjects With Newly Diagnosed Acute B-Cell Lymphoblastic Leukaemia|Not yet recruiting||Phase 2|40|Anticipated|medac GmbH||1|||f||||f|f|f||||||No||2017-10-10 21:03:32.433144|2017-10-10 21:03:32.433144
NCT03156777|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-15|||January 2016||2016-01-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|||Application Value of CTCs Detection for Advanced Gastric Cancer Patients|A Single Center Observational Study to Evaluate the Application Value of Circulating Tumor Cell Detection for Advanced Gastric Cancer Patients in Prediction of the Prognosis and Evaluation of the Outcome of Adjuvant Chemotherapy|Recruiting||N/A|200|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||||Undecided||2017-10-10 21:03:32.541918|2017-10-10 21:03:32.541918
NCT03156764|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-16|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|December 31, 2017|Anticipated|2017-12-31||Observational|||Qp/Qs Ratio by Noninvasive Methods in Children With Shunt Dependent Pulmonary Circulation|The Accuracy of Qp/Qs Calculated by Noninvasive Methods in Children With Shunt Dependent Pulmonary Circulation|Recruiting||N/A|70|Anticipated|Seoul National University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:03:32.619227|2017-10-10 21:03:32.619227
NCT03156751|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||May 1, 2013|Actual|2013-05-01|May 2017|2017-05-01|September 30, 2013|Actual|2013-09-30|September 30, 2013|Actual|2013-09-30||Observational|||Feasibility of Introducing an Onsite Test for Syphilis in the Package of Antenatal Care in Burkina Faso|Feasibility of Introducing an Onsite Test for Syphilis in the Package of Antenatal Care at the Rural Primary Health Care Level in Burkina Faso|Completed||N/A|1205|Actual|Institut de Recherche en Sciences de la Sante, Burkina Faso|||1||f||||f|f|f||||||No|The individual participant data could be obtained if requested by other researchers to the principal investigator.|2017-10-10 21:03:32.706974|2017-10-10 21:03:32.706974
NCT03156738|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-18|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers|A Randomised, Double-blind, Placebo-controlled, Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of MT-2990 in Healthy Male Subjects|Recruiting||Phase 1|48|Anticipated|Mitsubishi Tanabe Pharma Corporation||6|||f||||f|f|f||||||||2017-10-10 21:03:32.771384|2017-10-10 21:03:32.771384
NCT03156725|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||May 19, 2014|Actual|2014-05-19|May 2017|2017-05-01|June 4, 2016|Actual|2016-06-04|September 14, 2014|Actual|2014-09-14||Interventional|||Assessment of Iron Absorption From Aspergillus Oryzae|Iron Absorption From Iron-enriched Aspergillus Oryzae is Similar to Ferrous Sulfate|Completed||N/A|16|Actual|Iowa State University||2|||f||||f|f|f||||||No|Publication in a journal|2017-10-10 21:03:32.864255|2017-10-10 21:03:32.864255
NCT03156712|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||May 29, 2013|Actual|2013-05-29|May 2017|2017-05-01|February 13, 2014|Actual|2014-02-13|November 20, 2013|Actual|2013-11-20||Interventional|BIEFS||Iron Absorption From Iron-enriched Aspergillus Oryzae|Serum Iron Increase With From Iron-enriched Aspergillus Compared to Ferrous Sulfate in Healthy Female Subjects|Completed||N/A|17|Actual|Iowa State University||3|||f||||f|f|f||||||No|Publish a paper|2017-10-10 21:03:32.935684|2017-10-10 21:03:32.935684
NCT03156699|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-18|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|||The Incidence, Effect and Persistence of Fragmented-QRS, in Patients Presenting With ST-Elevation Myocardial Infarction|The Incidence, Effect and Persistence of Fragmented-QRS, in Patients Presenting With ST-Elevation Myocardial Infarction|Not yet recruiting||N/A|100|Anticipated|The Royal Wolverhampton Hospitals NHS Trust|||1||f||||f|f|f||||||||2017-10-10 21:03:33.017367|2017-10-10 21:03:33.017367
NCT03156686|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-10|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|SAFE HOME AHF||SAFEty and Efficacy of HOME-based Hospitalization Versus Inpatient Care for Patients With Acute Heart Failure in Chronic Heart Failure.|SAFEty and Efficacy of HOME-based Hospitalization Versus Inpatient Care for Patients With Acute Heart Failure in Chronic Heart Failure.|Recruiting||N/A|64|Anticipated|French Cardiology Society||2|||f||||t|f|f||||||||2017-10-10 21:03:33.083957|2017-10-10 21:03:33.083957
NCT03156673|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-16|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|June 30, 2022|Anticipated|2022-06-30|December 31, 2021|Anticipated|2021-12-31||Interventional|||Treatment of COPD by Autologous Transplantation of Bronchial Basal Cells|Primary Research on Treatment of Chronic Obstructive Pulmonary Disease (COPD) by Transplantation of Autologous Bronchial Basal Cells|Recruiting||Early Phase 1|20|Anticipated|First Affiliated Hospital of Shantou University Medical College||1|||f|||||f|f||||||No||2017-10-10 21:03:33.16988|2017-10-10 21:03:33.16988
NCT03156660|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Efficacy of Two Novel Behavioral Post-cessation Weight Gain Interventions|Efficacy of Two Novel Behavioral Post-cessation Weight Gain Interventions|Not yet recruiting||N/A|400|Anticipated|University of Tennessee||3|||f||||t|f|f||||||Yes|It is anticipated that a cleaned data set of study-specific data will be provided within two years following the termination of the study for the data archive and this data set would be made public. Confidentiality of individual participants would be maintained with all releases of data. The final study analytical database would be processed according to HIPAA definitions for public data sharing. Documentation would be provided along with the data sharing file that includes but is not limited to: data dictionary, data code book, valid variable ranges (where provided), the protocol, procedure and operational manuals, intervention manual or programs and any electronic versions of any paper forms that were used in data collection.|2017-10-10 21:03:33.258601|2017-10-10 21:03:33.258601
NCT03156647|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|PARKSYN||Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome|Alpha-synuclein Level in the Saliva as a Potential Diagnostic Aid to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f|f|f||||Samples With DNA|"     Saliva   "|No||2017-10-10 21:03:33.336742|2017-10-10 21:03:33.336742
NCT03156634|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-15|||April 15, 2017|Actual|2017-04-15|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Pilot Study of the Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making|The Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making About Antihypertensive Medication: A Pilot Study|Recruiting||N/A|120|Anticipated|Weill Medical College of Cornell University||2|||f||||f|f|f||||||No||2017-10-10 21:03:33.547497|2017-10-10 21:03:33.547497
NCT03156621|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Study in Participants ≥12 Years of Age With Homozygous Familial Hypercholesterolemia (hoFH)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Alirocumab in Patients With Homozygous Familial Hypercholesterolemia|Not yet recruiting||Phase 3|54|Anticipated|Regeneron Pharmaceuticals||2|||f||||f|t|f|||t|||||2017-10-10 21:03:33.660847|2017-10-10 21:03:33.660847
NCT03156608|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-15|||March 6, 2017|Actual|2017-03-06|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|Novii||Novii External Fetal Monitoring Device|Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison|Recruiting||N/A|200|Anticipated|Intermountain Health Care, Inc.||2|||f||||t|f|t|t|f|f|||||2017-10-10 21:03:33.774777|2017-10-10 21:03:33.774777
NCT03156595|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-15|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|NHYP||Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies|Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies|Not yet recruiting||N/A|108|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||No||2017-10-10 21:03:33.998842|2017-10-10 21:03:33.998842
NCT03154593|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-27|||August 2016||2016-08-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Prevalence of Chronic Oedema in Obese Patients|Prevalence and Impact of Chronic Oedema in a Population of Patients Prior to and Following Bariatric Surgery|Recruiting||N/A|60|Anticipated|University of Nottingham|||2||f||||f||||||||||2017-10-10 21:03:55.064296|2017-10-10 21:03:55.064296
NCT03156582|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-15|||April 1, 2016|Actual|2016-04-01|February 2017|2017-02-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|Impact AFP||Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)|Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)|Recruiting||N/A|562|Anticipated|University Hospital, Grenoble|||1||f||||f|f|f||||||No||2017-10-10 21:03:34.11379|2017-10-10 21:03:34.11379
NCT03156569|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-15|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|May 2017|Actual|2017-05-01|4 Months|Observational [Patient Registry]|||Salivary Markers in Patients With Xerostomia|Oral Health and Salivary Markers in Patients With Xerostomia|Recruiting||N/A|30|Anticipated|Universidad de Murcia|||1||f||||f|f|f||||||No||2017-10-10 21:03:34.213125|2017-10-10 21:03:34.213125
NCT03156556|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|October 15, 2017|Anticipated|2017-10-15||Interventional|||Improving Access to the Treatment of Anxiety and Depression Among Youth Linguistic Minorities|Improving Access to the Treatment of Anxiety and Depression Among Linguistic Minorities: A Feasibility Open Trial of Internet-Delivered Transdiagnostic Cognitive Behaviour Therapy Amongst French Canadians Young Adults|Not yet recruiting||N/A|20|Anticipated|Universite de Moncton||1|||f||||f|f|f||||||No||2017-10-10 21:03:34.312905|2017-10-10 21:03:34.312905
NCT03156543|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-15|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Microcurrent Dressing to Treat Infections, Before, During and After Surgery|Evaluation of a Microcurrent Dressing for Prophylaxis Against Perioperative Prosthetic Joint Infection|Recruiting||N/A|20|Anticipated|University of Michigan||2|||f||||t|f|t|f|f|t|||No||2017-10-10 21:03:34.430885|2017-10-10 21:03:34.430885
NCT03156530|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-15|||March 1, 2015|Actual|2015-03-01|March 2016|2016-03-01|November 1, 2016|Actual|2016-11-01|March 1, 2016|Actual|2016-03-01||Interventional|||Effect of the Auricular Acupunture of the Lower Limbs on the Equilibrium Response Evaluated by Static Stabilometry|Auricular Acupuncture Versus Control Group in the Treatment of Balance: a Randomized Controlled Trial|Completed||N/A|40|Actual|University of Sao Paulo||2|||f||||f|f|f|||f|||No||2017-10-10 21:03:34.53473|2017-10-10 21:03:34.53473
NCT03156517|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-29|||April 20, 2014|Actual|2014-04-20|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|Tremorstim||A Controlled Comparison of Two DBS Targets for Upper Extremity Action Tremor|Deep Brain Stimulation in Disabling Action Tremor: A Randomized, Double-blind Study Comparing the Ventral Intermediate Nucleus (VIM) of the Thalamus and the Posterior Subthalamic Area (PSA) / Zona Incerta (The TREMORSTIM Study)|Enrolling by invitation||N/A|44|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:03:34.617833|2017-10-10 21:03:34.617833
NCT03156504|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-18|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|Bio-K||The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.|The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.|Enrolling by invitation||Phase 1|100|Anticipated|Mayo Clinic||1|||f||||f|t|f|||f|||||2017-10-10 21:03:34.723806|2017-10-10 21:03:34.723806
NCT03156491|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-01|2017-05-15|||June 2010||2010-06-01|May 2017|2017-05-01|July 2012|Actual|2012-07-01|July 2011|Actual|2011-07-01||Observational|MEER||Maternal Embryo Interaction in Recurrent Miscarriages|The Maternal-embryo Interaction and Its Role in the Etiology of Recurrent Miscarriages|Completed||N/A|58|Actual|UMC Utrecht|||2||f||||f||||||Samples With DNA|"     endometrial biopsies and peripheral blood samples   "|Undecided||2017-10-10 21:03:34.808816|2017-10-10 21:03:34.808816
NCT03156478|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-15|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|December 2037|Anticipated|2037-12-01|December 2018|Anticipated|2018-12-01||Interventional|StopDia||STOP DIABETES - Knowledge-based Solutions|STOP DIABETES - Knowledge-based Solutions|Recruiting||N/A|10000|Anticipated|University of Eastern Finland||3|||f||||t|f|f||||||No||2017-10-10 21:03:34.884226|2017-10-10 21:03:34.884226
NCT03156465|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-15|||September 15, 2011|Actual|2011-09-15|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants|Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants|Recruiting||N/A|15|Anticipated|University of Iowa||1|||f||||f|f|t|t|f||||No||2017-10-10 21:03:35.072676|2017-10-10 21:03:35.072676
NCT03156452|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-16|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|FLIGHT||Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate|A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate|Not yet recruiting||Phase 3|120|Anticipated|University Hospitals Bristol NHS Foundation Trust||2|||f||||t|f|f|||f|||No||2017-10-10 21:03:35.196699|2017-10-10 21:03:35.196699
NCT03156439|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||May 22, 2017|Anticipated|2017-05-22|May 2017|2017-05-01|August 18, 2017|Anticipated|2017-08-18|August 11, 2017|Anticipated|2017-08-11||Interventional|||Bioavailability, Safety, and Tolerability of BIS-001 ER|Evaluation of the Bioavailability, Safety, and Tolerability of BIS-001 ER Following Multiple Dose Administration in Healthy Subjects|Recruiting||Phase 1|8|Anticipated|Biscayne Neurotherapeutics, Inc.||1|||f|||||f|f||||||||2017-10-10 21:03:35.294672|2017-10-10 21:03:35.294672
NCT03156426|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-17|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|||Prognostic Biomarkers For Acute Kidney Injury In Liver Cirrhosis|Prognostic Biomarkers For Acute Kidney Injury In Liver Cirrhosis|Not yet recruiting||N/A|70|Anticipated|University of Edinburgh|||1||f||||f|f|f||||Samples Without DNA|"     Blood:      Haematology: FBC, INR Biochemistry: U&E, LFT Plasma - biomarkers: KIM-1 Urine - proteinuria,     fractional excretion of sodium Urinary biomarkers - KIM-1, L-FABP   "|No|No individual patient data will be available to other researchers|2017-10-10 21:03:35.40082|2017-10-10 21:03:35.40082
NCT03156413|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-24|||May 29, 2017|Actual|2017-05-29|July 2017|2017-07-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Interventional|||The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea|The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea|Completed||N/A|12|Actual|Fisher and Paykel Healthcare||1|||f||||t|f|f||||||||2017-10-10 21:03:35.499259|2017-10-10 21:03:35.499259
NCT03156400|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-21|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|January 30, 2018|Anticipated|2018-01-30||Interventional|||Parkinson's Autonomic Responses to Treadmill Walking|Assessment of Autonomic Function and Cardiovascular Response to Exercise Testing in Parkinson's Disease Patients|Recruiting||N/A|30|Anticipated|University of Miami||2|||f|||||f|f||||||||2017-10-10 21:03:35.575593|2017-10-10 21:03:35.575593
NCT03156387|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||February 1, 2015|Actual|2015-02-01|May 2017|2017-05-01|May 10, 2017|Actual|2017-05-10|June 30, 2015|Actual|2015-06-30||Interventional|||Clinical Efficacy of Frenectomies Using Diode Laser Versus Conventional Techniques|Patient Perceptions and Clinical Efficacy of Frenectomies Using Diode Laser Versus Conventional Techniques|Completed||N/A|28|Actual|T.C. Dumlupınar Üniversitesi||2|||f||||f|f|f||||||No|The patients will be instructed to record the postoperative degrees of pain, redness, swelling, and functional complications, including chewing and speech, on a 10 cm horizontal visual analog scale (VAS), by placing a vertical mark between the two endpoints, from the first through seventh days.|2017-10-10 21:03:35.661853|2017-10-10 21:03:35.661853
NCT03156374|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-15|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 28, 2017|Anticipated|2017-12-28||Interventional|||Timing Frozen Embryo Transfer by Following Two Different Methods|Proof of Concept Study To Assess Women's Likability and Stress in Timing Frozen Embryo Transfer by Following Two Different Methods|Enrolling by invitation||N/A|40|Anticipated|SPD Development Company Limited||1|||f||||f|f|f||||||No||2017-10-10 21:03:35.739682|2017-10-10 21:03:35.739682
NCT03156361|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-18|||May 18, 2017|Actual|2017-05-18|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus|A Randomized Controlled Trial Comparing 21 Days of Continuous Subcutaneous Insulin Infusion (CSII) Using Hepatic Directed Vesicle (HDV) Insulin to Standard CSII in Type 1 Diabetes Mellitus|Recruiting||Phase 2|24|Anticipated|Diasome Pharmaceuticals||2|||f||||f|t|f||||||No||2017-10-10 21:03:35.834064|2017-10-10 21:03:35.834064
NCT03156348|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-15|||May 2, 2015|Actual|2015-05-02|May 2017|2017-05-01|December 22, 2017|Anticipated|2017-12-22|September 22, 2017|Anticipated|2017-09-22||Interventional|||Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults|Impact of Clinical Pharmacist on Post-discharge Prevention of Adverse Drug Events in Older Adults: Randomized Clinical Trial.|Recruiting||N/A|611|Anticipated|University of Chile||2|||f||||t|f|f||||||No||2017-10-10 21:03:35.96908|2017-10-10 21:03:35.96908
NCT03156335|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)|Phase I Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)|Recruiting||N/A|6|Anticipated|Sunnybrook Health Sciences Centre||1|||f|||||f|f||||||||2017-10-10 21:03:36.517829|2017-10-10 21:03:36.517829
NCT03156322|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-16|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|January 1, 2017|Actual|2017-01-01|December 1, 2016|Actual|2016-12-01||Interventional|||Different Epidural Initiation Volumes|Effects of Different Epidural Initiation Volumes on Postoperative Analgesia in Cesarean Delivery|Completed||N/A|81|Actual|Inonu University||3|||f||||f|f|f||||||No||2017-10-10 21:03:36.605338|2017-10-10 21:03:36.605338
NCT03156296|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-10|||June 10, 2017|Actual|2017-06-10|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Transversus Abdominis Plane Block Using Dexmedetomidine and Bupivacaine|Ultrasound Guided Transversus Abdominis Plane Block Using Dexmedetomidine and Bupivacaine in Children Undergoing Laparoscopic Orcheopexy: Randomized Controlled Trial|Recruiting||Phase 2|80|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:03:36.728448|2017-10-10 21:03:36.728448
NCT03156283|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-26|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||SleepWell24: An Innovative Smartphone Application to Improve PAP Adherence|SleepWell24: An Innovative Smartphone Application to Improve PAP Adherence|Not yet recruiting||N/A|110|Anticipated|Arizona State University||2|||f||||t|f|f||||||No||2017-10-10 21:03:36.819184|2017-10-10 21:03:36.819184
NCT03156270|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-19|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction|A Prospective, Non-Randomized Study to Evaluate Treatment Outcome of Nasal Airway Obstruction Using the Aerin Medical Vivaer™ Stylus|Recruiting||N/A|15|Anticipated|Aerin Medical||1|||f||||f|f|t|f||f|||||2017-10-10 21:03:36.919059|2017-10-10 21:03:36.919059
NCT03156257|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-13|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Observational|OR-DRPD-SRI||The Role of the Space Environment on Vascular Endothelial and Smooth Muscle Cell Processes|OR-DRPD-SRI/CASIS2016: The Role of the Space Environment on Vascular Endothelial and Smooth Muscle Cell Processes|Recruiting||N/A|20|Anticipated|University of Florida|||1||f||||f|f|f||||Samples With DNA|"     Blood   "|Undecided||2017-10-10 21:03:37.017775|2017-10-10 21:03:37.017775
NCT03156244|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-20|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients|LCCC 1636: Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients|Recruiting||N/A|80|Anticipated|UNC Lineberger Comprehensive Cancer Center|||2||f||||t|f|f||||||||2017-10-10 21:03:37.094701|2017-10-10 21:03:37.094701
NCT03156231|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory Disease|Acetazolamide for Prevention of Altitude Related Illness in Patients With Chronic Obstructive Pulmonary Disease (COPD). Randomized, Placebo-Controlled, Double-Blind Trial.|Recruiting||Phase 4|180|Anticipated|University of Zurich||2|||f||||f|f|f||||||Undecided||2017-10-10 21:03:37.175787|2017-10-10 21:03:37.175787
NCT03156218|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||The Effect of FiO2 on PaO2/FiO2 Ratio|The Effect of Inspiratory Oxygen Fraction on the Ratio of Partial Arterial Oxygen Pressure and Inspiratory Oxygen Fraction (PaO2/FiO2 Ratio) in Mechanically Ventilated Patients With and Without Mild to Moderate ARDS|Not yet recruiting||N/A|20|Anticipated|VU University Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:03:37.275801|2017-10-10 21:03:37.275801
NCT03156205|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of Patient-Directed Interactive Music Therapy on Sleep, Delirium and Melatonin Levels is Critically Ill Elderly Patients|Effects of Patient-Directed Interactive Music Therapy on Sleep, Delirium and Melatonin Levels is Critically Ill Elderly Patients|Recruiting||N/A|150|Anticipated|Yonsei University||3|||f||||f|f|f||||||No||2017-10-10 21:03:37.345568|2017-10-10 21:03:37.345568
NCT03156192|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||January 2, 2017|Actual|2017-01-02|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Music Use and Perceived Psycho-social Benefits of Music of Caregivers of Patients in an Intensive Care Unit|Music Use and Perceived Psycho-social Benefits of Music of Caregivers of Patients in an Intensive Care Unit|Recruiting||N/A|200|Anticipated|Yonsei University||1|||f||||f|f|f||||||No||2017-10-10 21:03:37.460288|2017-10-10 21:03:37.460288
NCT03156179|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||September 1, 2015|Actual|2015-09-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Study of Calcium Metabolism in Teenage Girls With Type 1 Diabetes|Assessment of Calcium Metabolism in Adolescent Girls With Type 1 Diabetes|Completed||N/A|22|Actual|University of Rochester|||1||f||||f|f|f||||||No||2017-10-10 21:03:37.540769|2017-10-10 21:03:37.540769
NCT03156166|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-15|||June 12, 2017|Actual|2017-06-12|April 2017|2017-04-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Distance From the Glottis to the Grille in Children|Distance From the Glottis to the Grille in Children: Ambu AuraGainTM , I-gel, LMA Supreme and LMA Classic as Intubation Conduits|Recruiting||N/A|88|Anticipated|Seoul National University Hospital||4|||f||||t|f|f||||||Undecided||2017-10-10 21:03:37.630668|2017-10-10 21:03:37.630668
NCT03156153|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of Bumetanide for the Treatment of Autism Spectrum Disorders|A Study of Bumetanide for the Treatment of Children With Autism Spectrum Disorder：a Randomized Double-blind Placebo-controlled Trial|Not yet recruiting||Phase 2|120|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f|||||f|f||||||Undecided||2017-10-10 21:03:37.727653|2017-10-10 21:03:37.727653
NCT03156140|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|Motion||Pulse Oximeter Motion Study|Four Types of Pulse Oximeters Accurately Detect Hypoxia During Low Perfusion and Motion|Completed||N/A|10|Actual|University of California, San Francisco||1|||f||||f|f|f|||f|||No||2017-10-10 21:03:37.92346|2017-10-10 21:03:37.92346
NCT03156127|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-09|||May 19, 2017|Actual|2017-05-19|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet|A Randomized, Open-label, Single Dose, Two-way Crossover Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet in Healthy Female Volunteers|Withdrawn||Phase 1|0|Actual|Boryung Pharmaceutical Co., Ltd||2||Problem of Investigational Products|f||||f|f|f||||||||2017-10-10 21:03:38.006246|2017-10-10 21:03:38.006246
NCT03156114|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-10-02|||June 13, 2017|Actual|2017-06-13|October 2017|2017-10-01|November 15, 2019|Anticipated|2019-11-15|November 15, 2019|Anticipated|2019-11-15||Interventional|||This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.|An Open Label, Phase I Dose-finding Study of BI 754111 in Combination With BI 754091 in Patients With Advanced Solid Cancers and of BI 754111 Monotherapy With Subsequent Combination With BI 754091 in Patients With Follicular Lymphoma, Followed by an Expansion Cohort at the RPIID of the Combination in Patients With Non-small Cell Lung Cancer|Recruiting||Phase 1|120|Anticipated|Boehringer Ingelheim||2|||f||||f|t|f||||||||2017-10-10 21:03:38.119157|2017-10-10 21:03:38.119157
NCT03156101|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|December 30, 2020|Anticipated|2020-12-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects|A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Relapse or Refractory Acute Lymphoblastic Leukemia and Lymphoma Subjects|Recruiting||Phase 1/Phase 2|24|Anticipated|Shenzhen BinDeBio Ltd.||1|||f||||t|f|f||||||No||2017-10-10 21:03:38.276807|2017-10-10 21:03:38.276807
NCT03156088|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-15|||January 1, 2012|Actual|2012-01-01|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|June 1, 2017|Anticipated|2017-06-01|12 Months|Observational [Patient Registry]|||Clinical and Urodynamic Predictors for Sacral Neuromodulation Outcomes in Overactive Bladder|Clinical and Urodynamic Predictors for Sacral Neuromodulation Outcomes in Patients With Overactive Bladder: A Cohort Study|Active, not recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t||||||||Undecided||2017-10-10 21:03:38.380117|2017-10-10 21:03:38.380117
NCT03156075|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-17|||July 2014|Actual|2014-07-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Postoperative Intervention Program Effectiveness in Hip Fracture Patients: A Randomized Clinical Trial|Sponsor Investigator, Assistant Professor at Public Health and Community Medicine Department, Faculty of Medicine, Assiut University|Completed||N/A|124|Actual|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:03:38.492548|2017-10-10 21:03:38.492548
NCT03156062|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-15|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis|Climatotherapy at Red Sea - Hurghada Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:03:38.56416|2017-10-10 21:03:38.56416
NCT03156049|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-15|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|PDPH||Sphenopalatine Ganglion Block Versus Occiptal Nerve Block in Treatment of Post Dural Puncture Headache|Sphenopalatine Ganglion Block Versus Occiptal Nerve Block in Treatment of Postduarl Puncture Headache|Recruiting||N/A|90|Anticipated|Assiut University||2|||f||||t|f|f|||f|||No||2017-10-10 21:03:38.65139|2017-10-10 21:03:38.65139
NCT03153670|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-24|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||MRI in Patients With Deep Brain Stimulation (DBS)|MRI in Patients With Deep Brain Stimulation (DBS)|Recruiting||Early Phase 1|30|Anticipated|University Health Network, Toronto||1|||f||||f|f|f|||f|||No||2017-10-10 21:04:03.521687|2017-10-10 21:04:03.521687
NCT03156036|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-15|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Phase II Study of Preoperative Chemoradiotherapy With Capecitabine With or Without Temozolomide in Patients With Locally Advanced Rectal Cancer|Preoperative Chemoradiotherapy With Capecitabine With or Without Temozolomide in Patients With Locally Advanced Rectal Cancer; A Prospective Randomised Phase 2 Study Stratified by MGMT (O6-methylguanine DNA Methyltransferase) Status|Not yet recruiting||Phase 2|246|Anticipated|Asan Medical Center||4|||f||||f|f|f||||||No||2017-10-10 21:03:38.767551|2017-10-10 21:03:38.767551
NCT03156023|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-06|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|October 20, 2018|Anticipated|2018-10-20|October 20, 2018|Anticipated|2018-10-20||Interventional|||Multiple Ascending Doses of AMG 570 in Subjects With Rheumatoid Arthritis|A Randomized, Double Blind Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of AMG 570 in Subjects With Rheumatoid Arthritis|Recruiting||Phase 1|24|Anticipated|Amgen||2|||f|||||t|f||||||||2017-10-10 21:03:38.882281|2017-10-10 21:03:38.882281
NCT03156010|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-20|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Oculomotor Assessment of Traumatic Brain Injury (TBI)|Oculomotor Assessment of Traumatic Brain Injury (TBI)|Recruiting||N/A|240|Anticipated|Walter Reed National Military Medical Center||2|||f||||f|f|t|t||t|||||2017-10-10 21:03:38.986043|2017-10-10 21:03:38.986043
NCT03155997|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-10-03|||July 12, 2017|Actual|2017-07-12|October 2017|2017-10-01|June 28, 2027|Anticipated|2027-06-28|June 28, 2022|Anticipated|2022-06-28||Interventional|monarchE||A Study to Compare Treatment After Surgery of Abemaciclib (LY2835219) Combined With Standard Endocrine Therapy Versus Endocrine Therapy Alone in Participants With Breast Cancer|A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer|Recruiting||Phase 3|3580|Anticipated|Eli Lilly and Company||2|||t||||t|t|f||||||||2017-10-10 21:03:39.210593|2017-10-10 21:03:39.210593
NCT03155984|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-19|||July 1, 2015|Actual|2015-07-01|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Optimizing HBV Management During Anti-CD20 Antibodies|Establishing Monitoring Strategies in Individuals With Prior Hepatitis B Virus Exposure Undergoing Anti-CD20 Antibody Containing Chemotherapy: A Prospective Observational Study|Recruiting||N/A|100|Anticipated|The University of Hong Kong|||1||f||||f|t|f|||f|||No|No such plan|2017-10-10 21:03:41.323444|2017-10-10 21:03:41.323444
NCT03155971|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|February 1, 2019|Anticipated|2019-02-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)|Efficacy and Safety of Paclitaxel-Coated Balloon Catheter in Patients With Long De Novo Lesions of Main Coronary Arteries|Not yet recruiting||N/A|60|Anticipated|The People's Hospital of Liaoning Province||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:03:41.420563|2017-10-10 21:03:41.420563
NCT03155958|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|July 1, 2019|Anticipated|2019-07-01||Observational|||Ocular Finding in Alopecia Areata|Ocular Comorbidities of Alopecia Areata|Not yet recruiting||N/A|1|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:03:41.508745|2017-10-10 21:03:41.508745
NCT03155945|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-23|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects With Crohn's Disease Experiencing Abdominal Pain|A Randomized, Open-label, Parallel, Phase 2a Study to Determine the Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects With Crohn's Disease Experiencing Abdominal Pain|Recruiting||Phase 2|20|Anticipated|Arena Pharmaceuticals||2||||||||t|f||||||||2017-10-10 21:03:41.580638|2017-10-10 21:03:41.580638
NCT03155932|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis|An Open-label, Pilot, Proof of Concept Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Etrasimod (APD334) in Patients With Primary Biliary Cholangitis|Not yet recruiting||Phase 2|20|Anticipated|Arena Pharmaceuticals||1|||f|||||t|f|||t|||||2017-10-10 21:03:41.662384|2017-10-10 21:03:41.662384
NCT03155919|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||February 2014|Actual|2014-02-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Taurine Supplementation and Triathletes|Effects of Taurine and Chocolate Milk Supplementation in Body Composition, Athletic Performance and Oxidative Stress in Triathletes.|Completed||N/A|15|Actual|University of Sao Paulo||2|||f||||t|f|f||||||No|IPD won´t be available|2017-10-10 21:03:41.742107|2017-10-10 21:03:41.742107
NCT03155906|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-22|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|August 8, 2022|Anticipated|2022-08-08|May 8, 2020|Anticipated|2020-05-08||Interventional|INTRO-HCV||Integrated Treatment of Hepatitis C Virus Infection|Integrated Treatment of Hepatitis C Virus Infection Among Patients With Injecting Drug Abuse:a Randomised Controlled Trial (INTRO-HCV)|Recruiting||N/A|200|Anticipated|Haukeland University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:03:41.82009|2017-10-10 21:03:41.82009
NCT03155880|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-16|||January 2011|Actual|2011-01-01|May 2017|2017-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Obesity Heterogeneity Study|National Health and Nutrition Examination Survey (NHANES), Obesity Heterogeneity Study|Completed||N/A|1685|Actual|St. Michael's Hospital, Toronto|||1||f||||f|f|f||||||No||2017-10-10 21:03:42.091775|2017-10-10 21:03:42.091775
NCT03155867|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-29|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|May 18, 2017|Actual|2017-05-18|May 18, 2017|Actual|2017-05-18||Interventional|||Glycemic Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus|Plasma Glucose and Insulin Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus|Completed||N/A|13|Actual|Nestlé||6|||f|||||f|f||||||||2017-10-10 21:03:42.14112|2017-10-10 21:03:42.14112
NCT03155854|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-15|||September 2016||2016-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring|The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring for Dupuytren's Contracture Patients With Pretendinous Cord - Prospective Randomized Clinical Study (Pilot)|Recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||Undecided||2017-10-10 21:03:42.298016|2017-10-10 21:03:42.298016
NCT03155841|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-06-19|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Reducing HIV Vulnerability Through A Multilevel Life Skills Intervention For Adolescent Men|Reducing HIV Vulnerability Through A Multilevel Life Skills Intervention For Adolescent Men|Not yet recruiting||N/A|600|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||No||2017-10-10 21:03:42.380294|2017-10-10 21:03:42.380294
NCT03155828|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||July 2016||2016-07-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea|A Novel Method of Restoring Menstrual Cyclicity or Ovulatory Function in PCOS Patients: The Use of CPAP to Improve More Than Sleep Quality|Enrolling by invitation||N/A|5|Anticipated|University of Louisville|||1||f||||f||||||||No||2017-10-10 21:03:42.476027|2017-10-10 21:03:42.476027
NCT03155815|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||September 2000|Actual|2000-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|March 2014|Actual|2014-03-01||Observational|DemPoRT||Assessing Dementia Risk in the Community: The Dementia Population Risk Tool|Dementia Population Risk Tool (DemPoRT): A Predictive Algorithm for Assessing Dementia Risk in the Community Setting|Active, not recruiting||N/A|35000|Anticipated|Ottawa Hospital Research Institute|||2||f|||||f|f||||||No||2017-10-10 21:03:42.541761|2017-10-10 21:03:42.541761
NCT03155802|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-15|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines|Use of Novel Biomarkers and Echocardiography to Assess Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines|Recruiting||N/A|35|Anticipated|Stony Brook University|||1||f||||f|f|f||||Samples Without DNA|"     Serum will be kept in -70 oC for future research   "|No||2017-10-10 21:03:42.608448|2017-10-10 21:03:42.608448
NCT03155789|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||July 2010|Actual|2010-07-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Clinical Outcome After Lumbar Fusion|Clinical Outcome After Lumbar Fusion for the Treatment of Chronic Low Back Pain|Completed||N/A|90|Actual|Louisiana State University Health Sciences Center in New Orleans|||3||f||||f|f|f||||||No||2017-10-10 21:03:42.684864|2017-10-10 21:03:42.684864
NCT03155776|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-08|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Observational|GUS||Estimation of Preoperative Gastric Volume Using Ultrasound|Ultrasound Assessment of Gastric Volume in Infants Undergoing General Anesthesia: Validation Study|Recruiting||N/A|50|Anticipated|Seoul National University Hospital|||1||f|||||f|f||||||||2017-10-10 21:03:42.775226|2017-10-10 21:03:42.775226
NCT03155763|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-16|||April 1, 2005|Actual|2005-04-01|May 2017|2017-05-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|KALIMBO||Histology of Implantation Biopsies and Kidney Allograft Outcomes|Impact of Acute and Chronic Individual Histological Lesions and Composite Scores in Implantation Biopsies on Short-term and Long-term Kidney Allograft Outcomes|Completed||N/A|130|Actual|State Institution, Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine|||1||f||||f|f|f||||Samples Without DNA|"     Formalin-fixed paraplast-embedded kidney biopsies were retained in a biorepository.   "|Yes|We are going to share raw data on kidney baseline histology, graft function and survival up to 5 years after the publication of all results obtained. IPD will be available through an open access repository of data (ClinicalTrials.gov)|2017-10-10 21:03:42.852919|2017-10-10 21:03:42.852919
NCT03155750|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-08-04|||June 5, 2017|Actual|2017-06-05|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia|Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia: A Pilot Randomized Controlled Trial|Recruiting||N/A|32|Anticipated|The Hong Kong Polytechnic University||2|||f||||f|f|f||||||||2017-10-10 21:03:42.937491|2017-10-10 21:03:42.937491
NCT03155737|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-08-04|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Self-administered Acupressure for Knee Osteoarthritis: A Pilot Randomized Controlled Trial|Self-administered Acupressure for Knee Osteoarthritis in Middle- and Older Adults: A Pilot Randomized Controlled Trial|Recruiting||N/A|36|Anticipated|The Hong Kong Polytechnic University||2|||f||||f|f|f||||||||2017-10-10 21:03:43.02986|2017-10-10 21:03:43.02986
NCT03155724|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-27|||May 19, 2017|Actual|2017-05-19|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||QP ExCELs: MultiPole Pacing (MPP) Sub-Study|QP ExCELs: MultiPole Pacing (MPP) Sub-Study|Recruiting||N/A|100|Anticipated|Biotronik, Inc.||1|||f||||t|f|t|f||f|||||2017-10-10 21:03:43.137542|2017-10-10 21:03:43.137542
NCT03155711|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-07|||May 5, 2017|Actual|2017-05-05|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||HFNC for Induction During Bariatric Surgery Patients.|Study Protocol for the Use of High Flow Nasal Oxygen During the Anesthesia Induction and Weaning in Patients Scheduled for Bariatric Surgery. A Randomized Pilot Study|Recruiting||N/A|32|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f|f|f||||||No||2017-10-10 21:03:43.366227|2017-10-10 21:03:43.366227
NCT03155698|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||July 2, 2017|Anticipated|2017-07-02|May 2017|2017-05-01|October 1, 2019|Anticipated|2019-10-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma|Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma|Not yet recruiting||N/A|50|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 21:03:43.469047|2017-10-10 21:03:43.469047
NCT03155685|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-15|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|NEUROPAL||Use of Antipsychotics in Palliative Care (NEUROPAL)|Of the Use of Antipsychotics in Palliative Care : Prospective, Multicenter, Observational Study.|Not yet recruiting||N/A|100|Anticipated|University Hospital, Caen|||1||f||||f|f|f||||||No||2017-10-10 21:03:43.565293|2017-10-10 21:03:43.565293
NCT03155672|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-28|||May 15, 2017|Actual|2017-05-15|July 2017|2017-07-01|December 15, 2018|Anticipated|2018-12-15|May 15, 2018|Anticipated|2018-05-15||Observational|||A PHASE I, SINGLE-CENTER, MIXED METHODS STUDY ON THE HEALTH OUTCOMES OF VISUAL SELF EXPRESSION|A PHASE I, SINGLE-CENTER, MIXED METHODS STUDY ON THE HEALTH OUTCOMES OF VISUAL SELF EXPRESSION|Recruiting||N/A|80|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t|f|f||||||||2017-10-10 21:03:43.648243|2017-10-10 21:03:43.648243
NCT03155659|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-15|||January 1989|Actual|1989-01-01|May 2017|2017-05-01|July 2012|Actual|2012-07-01|December 2011|Actual|2011-12-01||Observational|||Fish, Polyunsaturated Fatty Acids Intake and Mortality|Fish, Polyunsaturated Fatty Acids Intake and Mortality: Analysis of CHNS and NHANES|Completed||N/A|50145|Actual|Zhejiang University|||2||f|||||f|f||||||||2017-10-10 21:03:43.728935|2017-10-10 21:03:43.728935
NCT03155646|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-10|||June 10, 2017|Actual|2017-06-10|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Dexmedetomidine Versus Clonidine in TAP Block|Dexmedetomidine Versus Clonidine Adjuvants to Levobupivacaine for Transversus Abdominis Plane Block in Pediatric Laparoscopic Orcheopexy: Randomized Double-blind Study|Recruiting||Phase 2/Phase 3|80|Anticipated|Assiut University||2|||f|||||f|f|||f|||No||2017-10-10 21:03:43.795741|2017-10-10 21:03:43.795741
NCT03155633|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-15|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|October 20, 2016|Actual|2016-10-20||Interventional|CRS||"Run, Recovery, Repeat, Always Healthy (Corre, Recupera, Repite, Siempre Saludable)"|"Corre, Recupera, Repite, Siempre Saludable."|Completed||N/A|98|Actual|Universitat Jaume I||3|||f||||t|f|f||||||Yes|The data are administered by the Investigator Principal, other researchers must request the data they need by written request|2017-10-10 21:03:45.808155|2017-10-10 21:03:45.808155
NCT03155607|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Novel Virtual Reality for Burn Wound Care Pain in Adolescents|Novel Virtual Reality for Burn Wound Care Pain in Adolescents|Not yet recruiting||N/A|72|Anticipated|University of Arkansas||2|||f||||f|f|f||||||||2017-10-10 21:03:46.295634|2017-10-10 21:03:46.295634
NCT03155594|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-15|||May 9, 2017|Actual|2017-05-09|May 2017|2017-05-01|August 1, 2017|Anticipated|2017-08-01|July 15, 2017|Anticipated|2017-07-15||Interventional|||CGM to Aid Transition From Inpatient to Outpatient|Continuous Glucose Monitoring in the Hospital to Aid in Care and Improve Transition of Care to Outpatient|Active, not recruiting||N/A|15|Anticipated|Methodist Medical Center of Illinois||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:03:46.375187|2017-10-10 21:03:46.375187
NCT03155581|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-18|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Increasing Attendance to Cervical Cancer-screening Among Immigrants|A Community-based Health Intervention Trial to Increase Attendance to Cervical Cancer-screening Program Among Immigrants in Norway.|Active, not recruiting||N/A|750|Anticipated|University of Bergen||2|||f||||f|f|f||||||No|No plan|2017-10-10 21:03:46.470346|2017-10-10 21:03:46.470346
NCT03155568|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-06-13|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Safety and Efficacy of Three Local Block Techniques for Diabetic Foot Surgery|Safety and Efficacy of Single Ankle, Single Popliteal or Combined Ankle and Popliteal Block for Diabetic Foot Surgery: A Comparative Study|Not yet recruiting||N/A|90|Anticipated|Assiut University||3|||f||||t|f|f|||t|||Undecided||2017-10-10 21:03:46.556857|2017-10-10 21:03:46.556857
NCT03155555|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-15|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Comparison of Carotid Peak Systolic Velocity Variation With Aortic Peak Systolic Velocity Variation in Pediatric Non-Cardiac Surgery|Comparison of Carotid Peak Systolic Velocity Variation With Aortic Peak Systolic Velocity Variation in Pediatric Non-Cardiac Surgery|Recruiting||N/A|50|Anticipated|Postgraduate Institute of Medical Education and Research|||1||f||||f|f|f||||||No||2017-10-10 21:03:46.658775|2017-10-10 21:03:46.658775
NCT03155542|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-21|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|March 29, 2017|Actual|2017-03-29|March 22, 2017|Actual|2017-03-22||Observational|||Alcohol Intake, Alcohol Metabolizing Enzymes Gene Polymorphisms and the Risk of Colorectal Cancer|Alcohol Intake, Alcohol Metabolizing Enzymes Gene Polymorphisms and the Risk of Colorectal Cancer|Completed||N/A|140|Actual|National Taiwan University Hospital|||2||f||||f|f|f||||Samples With DNA|"     5-10 ml venous blood sample   "|No||2017-10-10 21:03:46.773292|2017-10-10 21:03:46.773292
NCT03155529|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-15|||September 2016||2016-09-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01|4 Years|Observational [Patient Registry]|||Three-dimensional Study on the Structural Destruction of Pelvic Anatomy in Cervical Cancer|Three-dimensional Study on the Structural Destruction of Pelvic Organs and Pelvic Floor After Radical Hysterectomy in Cervical Cancer|Recruiting||N/A|80|Anticipated|Nanfang Hospital of Southern Medical University|||1||f||||t||||||||No||2017-10-10 21:03:46.978076|2017-10-10 21:03:46.978076
NCT03155516|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-15|||August 30, 2016|Actual|2016-08-30|May 2017|2017-05-01|August 29, 2019|Anticipated|2019-08-29|August 29, 2019|Anticipated|2019-08-29||Interventional|GPM||Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients|Evaluation of the Effect of Good Pain Management (GPM) Ward Program on Pattern of Care and Patient-Reported Outcomes of Moderate to Severe Cancer Pain Patients|Recruiting||N/A|150|Anticipated|Taiwan Mundipharma Pharmaceuticals Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:03:47.159508|2017-10-10 21:03:47.159508
NCT03155503|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-02|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|SUVN-911||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects|A Single-center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SUVN-911 After Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects|Recruiting||Phase 1|64|Anticipated|Suven Life Sciences Limited||2|||f||||t|t|f||||||No||2017-10-10 21:03:47.334365|2017-10-10 21:03:47.334365
NCT03155477|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-15|||June 10, 2016|Actual|2016-06-10|May 2017|2017-05-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|||Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D|Effect Of Curcuma Xanthorrhiza Supplementation In Systemic Lupus Erythematosus Patients (SLE) With Hypovitamin D Which Were Given Vitamin D3 Towards Disease Activity (SLEDAI), Interleukin-6 (IL-6) And Tumor Growth Factor-β1 (TGF-β1) Serum|Completed||N/A|39|Actual|Saiful Anwar Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:03:47.603712|2017-10-10 21:03:47.603712
NCT03155464|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-15|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Intraoperative ICG for Systemic Sclerosis|A Prospective Study of the Utility of Intraoperative, Quantitative Indocyanine Green Angiography in Microvascular Surgery for Systemic Scerlosis|Not yet recruiting||Phase 4|40|Anticipated|Duke University||2|||f||||f|t|f|||t|||No||2017-10-10 21:03:47.725976|2017-10-10 21:03:47.725976
NCT03155451|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-08-16|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|December 31, 2019|Anticipated|2019-12-31||Observational|ctDNA_EOC||Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.|Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.|Recruiting||N/A|50|Anticipated|RenJi Hospital|||1||f||||t|f|f||||Samples With DNA|"     blood samples   "|||2017-10-10 21:03:47.8614|2017-10-10 21:03:47.8614
NCT03155438|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|March 30, 2018|Anticipated|2018-03-30||Observational|||Oxidative Stress-related Gene Expression in Cumulus Cells Among Low Responders|Oxidative Stress-related Gene Expression in Cumulus Cells Among Low Responders to Controlled Ovarian Hyperstimulation During in Vitro Fertilization|Not yet recruiting||N/A|56|Anticipated|Chulalongkorn University|||2||f||||f|f|f||||Samples With DNA|"     Cumulus cell , Follicular fluid , Blood from IVF patients.   "|No||2017-10-10 21:03:47.992691|2017-10-10 21:03:47.992691
NCT03155425|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||An Phase 2 Study of PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma|An Open-Label, Single Arm, Multi-Center, Phase 2 Study of PD-1 Antibody SHR-1210 in Subjects With Relapsed or Refractory Classic Hodgkin's Lymphoma|Not yet recruiting||Phase 2|60|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f|||||f|f||||||No||2017-10-10 21:03:48.156869|2017-10-10 21:03:48.156869
NCT03155412|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-31|||January 2016||2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|LIMEX||Adipose Tissue Expandability and Type 2 Diabetes|Limited Adipose Tissue Expandability as a Risk Factor for Development of Type 2 Diabetes: the Role of Preadipocytes|Recruiting||N/A|50|Anticipated|Charles University, Czech Republic|||2||f||||f||||||Samples With DNA|"     adipose tissue plasma / serum preadipocytes (cells)   "|No||2017-10-10 21:03:48.245513|2017-10-10 21:03:48.245513
NCT03155399|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||July 2013|Actual|2013-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|BAT||Proprioceptive Stimulation With Manual Bilateral Rhythmic Exercise in Post-stroke Patients|Proprioceptive Stimulation With Manual Bilateral Rhythmic Exercise in Post-stroke Patients (Stimolazione Propriocettiva Manuale Con Esercizio Ritmico Bilaterale in Pazienti Post Ictus - BAT)|Recruiting||N/A|54|Anticipated|IRCCS San Camillo, Venezia, Italy||2|||f||||t|f|f||||||No||2017-10-10 21:03:48.375408|2017-10-10 21:03:48.375408
NCT03155386|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-07-06|||May 18, 2017|Actual|2017-05-18|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|OPTIAM||Optimized Angiomammography and Comparison With Standard Angiomammography|Evaluation of the Clinical Performance of Optimized Angiomammography and Comparison With Standard Angiomammography|Recruiting||N/A|100|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||2||f||||f|f|f||||||||2017-10-10 21:03:48.560602|2017-10-10 21:03:48.560602
NCT03155373|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||February 9, 2017|Actual|2017-02-09|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|October 1, 2018|Anticipated|2018-10-01||Observational|RIPCOM 1||The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease Study|The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease|Recruiting||N/A|50|Anticipated|Imperial College London|||3||f||||f|f|f||||Samples Without DNA|"     Left and right ventricular biopsies taken at time of clinically indicated surgery   "|No||2017-10-10 21:03:48.673336|2017-10-10 21:03:48.673336
NCT03155360|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-08|||May 18, 2017|Actual|2017-05-18|August 2017|2017-08-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Observational|COLIGRAINE||Infants Colics : Towards a Migrainous Origin ?|Association Between Infant Colics and Parental Migraine ? Non Interventional Study in the Pediatric Emergency Unit of Nancy (France) University Hospital|Recruiting||N/A|300|Anticipated|Central Hospital, Nancy, France|||2||f||||f|f|f||||||||2017-10-10 21:03:48.818453|2017-10-10 21:03:48.818453
NCT03155347|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-21|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|March 20, 2020|Anticipated|2020-03-20|January 10, 2019|Anticipated|2019-01-10||Interventional|||An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy|A Randomized, Multi-Center, Double Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Subcutaneous (SC) Tocilizumab (TCZ) in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Patients With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current DMARD Therapy|Recruiting||Phase 3|425|Anticipated|Hoffmann-La Roche||3|||f||||f|f|f|||t|||||2017-10-10 21:03:48.926371|2017-10-10 21:03:48.926371
NCT03155334|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-15|||January 31, 2017|Actual|2017-01-31|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Understanding Evaluation of Patient Information Sheets by User Testing Method|Understanding Evaluation of Patient Information Sheets of Two Multiple Sclerosis Studies Through User Testing Method in a Randomized, Open Label, Crossover Design|Recruiting||N/A|100|Anticipated|Fondazione Italiana Sclerosi Multipla||2|||f||||t|f|f||||||Yes||2017-10-10 21:03:49.121983|2017-10-10 21:03:49.121983
NCT03155321|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-13|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||SAGES Safe Cholecystectomy Program in Polish Reality - Awareness, Implementation and Opinion on Usefulness|The Assessment of Awareness and Implementation of the SAGES Safe Cholecystectomy Program Among Polish Surgeons, as Well as Their Opinion on the Usefulness of the SAGES Safe Cholecystectomy Rules: Increasing the Safety of Cholecystectomy by Popularising the SAGES Safe Cholecystectomy Program|Recruiting||N/A|500|Anticipated|Jagiellonian University|||1||f||||f|f|f||||||No||2017-10-10 21:03:49.245407|2017-10-10 21:03:49.245407
NCT03155308|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-14|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|August 1, 2017|Anticipated|2017-08-01|July 1, 2017|Anticipated|2017-07-01||Observational|||Validation of the NICE Classification Using Pentax Chromoendoscopy|Validation of the NICE Classification Using Pentax Chromoendoscopy (I-scan and Optical Enhancement System|Recruiting||N/A|60|Anticipated|Instituto Ecuatoriano de Enfermedades Digestivas|||1||f||||t|f|f||||Samples Without DNA|"     colorectal polyps will be resected y biopsed   "|No||2017-10-10 21:03:49.455314|2017-10-10 21:03:49.455314
NCT03155295|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-15|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|May 31, 2018|Anticipated|2018-05-31||Observational|||Simulated Surgery Rehearsal|Patient-specific Simulated Procedure Rehearsal for Minimally Invasive Surgery|Not yet recruiting||N/A|110|Anticipated|University of Rochester|||2||f||||f|f|f||||||||2017-10-10 21:03:49.630942|2017-10-10 21:03:49.630942
NCT03155282|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-07-18|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|August 29, 2017|Anticipated|2017-08-29|August 27, 2017|Anticipated|2017-08-27||Observational|||Utility of EUS-elastography to Predict Portal Hypertension|Diagnostic Accuracy of Spleen and Liver Stiffness Measurement by EUS-elastography, to Predict Portal Hypertension in Patients With Cirrhosis.|Recruiting||N/A|60|Anticipated|Instituto Ecuatoriano de Enfermedades Digestivas|||2||f||||t|f|f||||||||2017-10-10 21:03:49.724462|2017-10-10 21:03:49.724462
NCT03155269|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-08-03|||May 25, 2017|Actual|2017-05-25|August 2017|2017-08-01|January 17, 2018|Anticipated|2018-01-17|January 17, 2018|Anticipated|2018-01-17||Interventional|||To Investigate the Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25- 45 Years) After 6 Months of Intervention|Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25-45 Yrs; Inclusive) After 6 Months of Intervention: a Randomised Double Blind Controlled Trial|Recruiting||N/A|120|Anticipated|GlaxoSmithKline||2|||f|||||f|f||||||||2017-10-10 21:03:49.873324|2017-10-10 21:03:49.873324
NCT03155256|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Treatment of Gastric Varices Using EUS Guided Techniques|Comparative EUS Guided Techniques in Treatment of Gastric Varice: a Prospective, Ranzomized Study|Recruiting||N/A|50|Anticipated|Instituto Ecuatoriano de Enfermedades Digestivas||2|||f||||t||||||||||2017-10-10 21:03:50.007914|2017-10-10 21:03:50.007914
NCT03155243|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-09-14|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|June 20, 2019|Anticipated|2019-06-20|June 20, 2019|Anticipated|2019-06-20||Observational|HOPE||Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice|Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice -HOPE|Recruiting||N/A|150|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:03:50.170262|2017-10-10 21:03:50.170262
NCT03155230|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-06-05|||September 1, 2015|Actual|2015-09-01|June 2017|2017-06-01|July 31, 2017|Anticipated|2017-07-31|July 1, 2017|Anticipated|2017-07-01||Observational|||Nationwide Results on Chronic Pain After Bilateral Transabdominal Pre-peritoneal Inguinal Hernia Repair (TAPP)|Nationwide Results on Chronic Pain After Bilateral Transabdominal Pre-peritoneal Inguinal Hernia Repair (TAPP)|Active, not recruiting||N/A|209|Actual|Hvidovre University Hospital|||1||f|||||f|f||||||||2017-10-10 21:03:50.332477|2017-10-10 21:03:50.332477
NCT03155217|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-15|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|November 30, 2018|Anticipated|2018-11-30||Observational|TOLBRIPA||Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old|Safety of Targeted Therapies in Elderly Patients (Over 5 and 75 Year-old) With Metastatic Melanoma|Recruiting||N/A|358|Anticipated|University Hospital, Montpellier|||3||f||||f|f|f||||||Undecided||2017-10-10 21:03:50.422072|2017-10-10 21:03:50.422072
NCT03155204|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-06-12|||April 25, 2017|Actual|2017-04-25|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With A Reference Product|Phase I Randomised, Five-period Cross-over Study in Healthy Male and Female Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Four Test pMDI Products With Spiriva Respimat|Recruiting||Early Phase 1|50|Anticipated|3M||5|||f||||f|f|f||||||No|publication|2017-10-10 21:03:50.521325|2017-10-10 21:03:50.521325
NCT03155191|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-26|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|TBI-1501||Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia|A Multicenter Phase I/II Study for Relapsed or Refractory CD19+ B-acute Lymphoblastic Leukemia|Recruiting||Phase 1/Phase 2|21|Anticipated|Takara Bio Inc.||1|||f||||t|f|f||||||No||2017-10-10 21:03:50.659312|2017-10-10 21:03:50.659312
NCT03155178|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-09||2017-08-09|December 5, 2016|Actual|2016-12-05|August 2017|2017-08-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|||In Vivo Preoperative Skin Preparation Persistence|Evaluation of Antimicrobial Persistence of 3M CHG/IPA Preoperative Skin Preparation Against Resident Human Skin Flora on the Abdominal and Inguinal Regions|Completed||Phase 2|59|Actual|3M||2|||f|||||t|f|||t|||||2017-10-10 21:03:50.789151|2017-10-10 21:03:50.789151
NCT03155165|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-05-13|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Observational|||Retroview™ Colonoscope and Lesion Detection Rate|Retroview™ vs. Conventional Colonoscopy: it is Time to Change?|Recruiting||N/A|100|Anticipated|Instituto Ecuatoriano de Enfermedades Digestivas|||2||f||||t||||||Samples Without DNA|"     Histology sample of polypectomies   "|Undecided||2017-10-10 21:03:50.887171|2017-10-10 21:03:50.887171
NCT03155152|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-01|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Decremental Exercise: a New Training Approach?|Decremental Exercise Protocol as a Training Stimulus: More or Less Efficient Than Traditional High-intensity Interval Training?|Recruiting||N/A|60|Anticipated|Swiss Federal Institute of Technology||2|||f||||f|f|f||||||No||2017-10-10 21:03:51.022628|2017-10-10 21:03:51.022628
NCT03155139|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-07-18|||June 3, 2017|Actual|2017-06-03|July 2017|2017-07-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|PA-China||Primary Aldosteronism In Hypertensive Patients in China|Primary Aldosteronism In Hypertensive Patients in China|Recruiting||N/A|4000|Anticipated|Chongqing Medical University|||2||f||||t|f|f||||Samples With DNA|"     Some subtye of PA such as glucocorticoid remediable aldosteronism(GRA) should be diagnosed by     DNA   "|||2017-10-10 21:03:51.11345|2017-10-10 21:03:51.11345
NCT03155113|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-13|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy|Role of the Host Immunity in the Non-response to DAA Therapy|Not yet recruiting||N/A|75|Anticipated|Azienda Ospedaliero-Universitaria di Parma||1|||f||||f|f|f||||||No||2017-10-10 21:03:51.307325|2017-10-10 21:03:51.307325
NCT03155100|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-08-06|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|June 30, 2023|Anticipated|2023-06-30|June 21, 2020|Anticipated|2020-06-21||Interventional|KEd||Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines|Phase 2 Study of Carfilzomib + Elotuzumab + Dexamethasone for Relapsed or Progressed Multiple Myeloma After 1-3 Prior Treatment Lines|Recruiting||Phase 2|40|Anticipated|Helsinki University Central Hospital||1|||f||||t|f|f||||||||2017-10-10 21:03:51.402383|2017-10-10 21:03:51.402383
NCT03155087|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||June 2013|Actual|2013-06-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|||PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy|The Influence of AMPK Subunit Alpha (PRKAA2) Genetic Polymorphisms With Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy|Completed||N/A|750|Actual|People's Hospital of Zhengzhou University|||2||f|||||t|f|||f|||No||2017-10-10 21:03:51.517319|2017-10-10 21:03:51.517319
NCT03155074|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-25|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2019|Anticipated|2019-06-01||Interventional|HILT||High-Intensity Training Following Lung Transplantation|High-Intensity Training Following Lung Transplantation: a Randomized Controlled Trial|Recruiting||N/A|64|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:03:51.577563|2017-10-10 21:03:51.577563
NCT03155061|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-15|||April 10, 2017|Actual|2017-04-10|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors|Phase 1 Dose Escalation Study of ONO-4578 Given as Monotherapy and Combinations of ONO-4578 and ONO-4538 in Subjects Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|54|Anticipated|Ono Pharmaceutical Co. Ltd||2|||f||||t|f|f||||||||2017-10-10 21:03:51.652175|2017-10-10 21:03:51.652175
NCT03155048|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-16|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Observational|||The Effects of Estrogen on Artificial Endometrium|The Effects of Transdermal Estradiol and Oral Estradiol Valerate on Clinical Outcomes of Frozen-thawed Embryo Transfer Cycles: A Randomized Clinical Trial|Not yet recruiting||N/A|60|Anticipated|Memorial Sisli Hospital, Istanbul|||1||f||||t|f|f||||||No||2017-10-10 21:03:51.724891|2017-10-10 21:03:51.724891
NCT03155035|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-07-11|||March 7, 2017|Actual|2017-03-07|July 2017|2017-07-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Interventional|||Effect of Routine Deworming on Weight of Children|Effect of Routine Deworming on Weight of Children 5-16 Years Old in an Urban Slum of Karachi: a Randomized Controlled Trial|Completed||N/A|300|Actual|Dow University of Health Sciences||2|||f||||f|f|f||||||||2017-10-10 21:03:51.783402|2017-10-10 21:03:51.783402
NCT03155022|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|CARIOCA||Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction|Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction: A Multicenter, Randomized, Controlled Clinical Trial (CARIOCA Study)|Not yet recruiting||N/A|710|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:03:51.861489|2017-10-10 21:03:51.861489
NCT03155009|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-25|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|May 28, 2020|Anticipated|2020-05-28|July 19, 2019|Anticipated|2019-07-19||Interventional|ATALK||A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer|An Open-Label, Multicenter, Single-Arm, Phase II Study to Assess the Efficacy and Safety of Alectinib in Patients With ALK-Rearranged Non−Small Cell Lung Cancer After Disease Progression on Prior ALK Inhibitor Therapy|Recruiting||Phase 2|73|Anticipated|Hoffmann-La Roche||1|||f||||t|f|f||||||||2017-10-10 21:03:51.94441|2017-10-10 21:03:51.94441
NCT03154996|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-18|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Chronic Convection Enhanced Delivery of Topotecan|Chronic Convection Enhanced Delivery of Topotecan for Recurrent High Grade Gliomas|Not yet recruiting||Phase 1|20|Anticipated|Columbia University||2|||f||||t|t|f||||||Undecided||2017-10-10 21:03:52.062066|2017-10-10 21:03:52.062066
NCT03154983|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-18|||May 20, 2017|Anticipated|2017-05-20|May 2017|2017-05-01|November 20, 2019|Anticipated|2019-11-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer|The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer|Not yet recruiting||Phase 2|48|Anticipated|Zhongnan Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:03:52.262246|2017-10-10 21:03:52.262246
NCT03154970|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-12|||May 22, 2017|Anticipated|2017-05-22|May 2017|2017-05-01|August 30, 2017|Anticipated|2017-08-30|July 30, 2017|Anticipated|2017-07-30||Interventional|||Cervical Stabilization in Individuals With Obstructive Sleep Apnea|Cervical Stabilization in Individuals With Obstructive Sleep Apnea: a Randomized Clinical Trial|Recruiting||N/A|22|Anticipated|Universidade Federal de Santa Maria||2|||f||||f|f|f||||||||2017-10-10 21:03:52.379837|2017-10-10 21:03:52.379837
NCT03154957|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-14|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Management of Acute Dislocation of Emergency in the University Hospital of Strasbourg Shoulder: Retrospective Evaluation of Practices and Proposal of a Clinical Path|Management of Acute Dislocation of Emergency in the University Hospital of Strasbourg Shoulder: Retrospective Evaluation of Practices and Proposal of a Clinical Path|Not yet recruiting||N/A|50|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 21:03:52.482111|2017-10-10 21:03:52.482111
NCT03154944|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-15|2017-05-22|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|August 15, 2017|Anticipated|2017-08-15|August 1, 2017|Anticipated|2017-08-01||Interventional|||A Clinical Investigation Evaluating Three New 1-piece Ostomy Products|A Clinical Investigation Evaluating Three New 1-piece Ostomy Products|Recruiting||N/A|45|Anticipated|Coloplast A/S||3|||f||||f|f|f||||||No||2017-10-10 21:03:52.544581|2017-10-10 21:03:52.544581
NCT03154931|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-05-14|||October 2015||2015-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|GCFT-PTSD||Efficacy of Compassion Focused Therapy in Group for Posttraumatic Stress Disorder|Group Compassion Focused Therapy for Posttraumatic Stress Disorder|Enrolling by invitation||N/A|80|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:03:52.63946|2017-10-10 21:03:52.63946
NCT03154918|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-14|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma|A Study of Gemcitabine, L- Asparaginase, Ifosfamide, Dexamethasone and Etoposide Chemotherapy Followed by ASCT for Newly Diagnosed Stage IV, Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type|Recruiting||Phase 2|60|Anticipated|Sichuan University||1|||f||||f|f|f||||||Yes|on-line shared files|2017-10-10 21:03:52.73448|2017-10-10 21:03:52.73448
NCT03154905|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-05-14|||February 2012||2012-02-01|May 2017|2017-05-01|January 9, 2016|Actual|2016-01-09|December 2014|Actual|2014-12-01||Observational|||The Role of Peripheral and Tissue Chitinase 3-like 1 Protein Levels as a Bio-marker in IBD|The Role of Peripheral and Tissue Chitinase 3-like 1 Protein (YKL 40) Levels as a Bio-marker for Gastrointestinal and Liver Disease|Completed||N/A|60|Actual|Shaare Zedek Medical Center|||2||f||||||||||Samples With DNA|"     The study allows the measurements of chitinase 3 like 1 proteins in blood and tissues. Upon     consenting to participation in the study, each volunteer may consent to specimens' storage     and additional testing. Even though the samples contain DNA, and participation may include     analysis in the RNA level, direct DNA sequencing will not be performed and is not included in     the additional testing permitted by the subject.   "|No||2017-10-10 21:03:52.825129|2017-10-10 21:03:52.825129
NCT03154892|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-14|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma|The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma|Recruiting||N/A|30|Anticipated|Second Affiliated Hospital of Xi'an Jiaotong University||2|||f||||f|f|f|||f|||No|No plan to share IPD|2017-10-10 21:03:52.904062|2017-10-10 21:03:52.904062
NCT03154879|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-14|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Observational|FRONTEER||Frontal Amplitude-integrated Electroencephalogram in Early Prognostication After Cardiac Arrest|Prospective Multi-center Study to Verify Neurological Prognostic Value of Amplitude-integrated Electroencephalogram in Cardiac Arrest Patients Treated With Therapeutic Hypothermia|Recruiting||N/A|500|Anticipated|Seoul St. Mary's Hospital|||1||f||||t|f|t|f||t|||Yes|Web based Case Report Form|2017-10-10 21:03:53.004865|2017-10-10 21:03:53.004865
NCT03154866|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-16|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Lactobacillus Kefiri LKF01 (DSM32079) in Newborns Born by Caesarian Section|Ability of Lactobacillus Kefiri LKF01 (DSM32079) to Colonize the Intestinal Environment and Modify the Gut Microbiota Composition of Newborns Born by Caesarian Section|Not yet recruiting||Phase 4|60|Anticipated|Policlinico Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:03:53.11785|2017-10-10 21:03:53.11785
NCT03154853|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-21|||November 4, 2016|Actual|2016-11-04|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Neuromuscular Study to Assess Foot Intrinsic Muscles|Neuromuscular Assessments of Foot Intrinsic Muscles: (1) Between Individuals With and Without Functional Flatfoot and (2) Before and After a 3-week Short Foot Exercise Training in Individuals With Functional Flatfoot|Recruiting||N/A|45|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:03:53.196296|2017-10-10 21:03:53.196296
NCT03154840|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-18|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|July 10, 2017|Actual|2017-07-10||Interventional|||Relative Bioavailability Among Different Eutropin Formulations|A Randomized, Open Label, Single Subcutaneous Dose 6x3 Crossover Study to Investigate the Relative Bioavailability Among Different Eutropin Formulations in Healthy Male Volunteers|Active, not recruiting||Phase 1|24|Actual|LG Chem||3|||f|||||f|f|||f|||||2017-10-10 21:03:53.287227|2017-10-10 21:03:53.287227
NCT03154827|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-14|||September 17, 2017|Anticipated|2017-09-17|May 2017|2017-05-01|March 17, 2022|Anticipated|2022-03-17|March 17, 2021|Anticipated|2021-03-17||Interventional|||A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study|A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|BioLineRx, Ltd.||1|||f||||t|t|f||||||No||2017-10-10 21:03:53.382742|2017-10-10 21:03:53.382742
NCT03154814|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-14|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|April 1, 2017|Actual|2017-04-01||Interventional|||Ulinastatin Improves Postoperative Oxygenation After Cardiopulmonary Bypass|High-dose Ulinastatin Improves Postoperative Oxygenation in Patients Undergoing Aortic Valve Surgery With Cardiopulmonary Bypass|Completed||Phase 4|80|Actual|Konkuk University Medical Center||2|||f||||t|f|f||||||Yes||2017-10-10 21:03:53.458201|2017-10-10 21:03:53.458201
NCT03154801|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-11|||July 26, 2017|Actual|2017-07-26|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|January 26, 2020|Anticipated|2020-01-26||Interventional|NEUROSEX||Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors (NEUROSEX)|Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors|Recruiting||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||||2017-10-10 21:03:53.54677|2017-10-10 21:03:53.54677
NCT03154788|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-21|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Falls Risk Awareness Video Study|Developing and Evaluating a Series of Falls Risk Awareness Corporate Videos Which Target Community-dwelling Older People: a Sequential Mixed-method Study.|Enrolling by invitation||N/A|150|Anticipated|Curtin University|||1||f||||f|f|f||||||Undecided||2017-10-10 21:03:53.633861|2017-10-10 21:03:53.633861
NCT03154775|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-13|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Study of Safety and Efficacy of C-CAR011 in B-NHL Patients|Study of Safety and Efficacy of Anti-CD19 Chimeric Antigen Receptor T Cell(C-CAR011) Treatment in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma|Recruiting||Phase 1|15|Anticipated|Cellular Biomedicine Group Ltd.||1|||f||||t|f|f||||||Undecided||2017-10-10 21:03:53.696352|2017-10-10 21:03:53.696352
NCT03154762|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||Anti-inflammatory Effect of Nocturnal NIPPV on Acute Asthma|National Institute of Respiratory Diseases Mexico|Not yet recruiting||N/A|20|Anticipated|National Institute of Respiratory Diseases, Mexico||2|||f||||f|f|t|f|f|t|||Yes|Through this organization and will be provided at the individual request of each interested researcher.|2017-10-10 21:03:53.793454|2017-10-10 21:03:53.793454
NCT03154749|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||TC (Docetaxel/Carboplatin) Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer|A Phase II Prospective Randomized Trial of Docetaxel in Combination With Carboplatin(TC) Versus EC Followed by Docetaxel as Neoadjuvant Chemotherapy for Triple-Negative, Early-Stage Breast Cancer|Recruiting||Phase 2|74|Anticipated|Guangdong General Hospital||2|||f|||||f|f||||||||2017-10-10 21:03:53.884011|2017-10-10 21:03:53.884011
NCT03154736|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|SPICES PHASE 1||Scaling-up Packages of Interventions for Cardiovascular Disease Prevention in Selected Sites in Europe and Sub-Saharan Africa: An Implementation Research|Scaling-up Packages of Interventions for Cardiovascular Disease Prevention in Selected Sites in Europe and Sub-Saharan Africa: An Implementation Research|Not yet recruiting||N/A|44|Anticipated|University Hospital, Brest||1|||f||||f|f|f||||||||2017-10-10 21:03:53.969728|2017-10-10 21:03:53.969728
NCT03154723|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-18|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|November 30, 2018|Anticipated|2018-11-30||Interventional|||Effects of Early Vitamin A Supplementation on the Risk for Retinopathy of Prematurity in Extremely Preterm Infants||Recruiting||N/A|52|Anticipated|Zhengzhou Children's Hospital, China||1|||f||||t|f|f||||||||2017-10-10 21:03:54.049981|2017-10-10 21:03:54.049981
NCT03154710|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-19|||July 12, 2017|Actual|2017-07-12|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response|Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response (SENTINEL Lymphome)|Recruiting||N/A|80|Anticipated|Weprom||2|||f||||f|f|f||||||||2017-10-10 21:03:54.146768|2017-10-10 21:03:54.146768
NCT03154697|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-05-12|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Observational|||Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances|Development of Clinical Database of Individuals With Smith-Magenis Syndrome|Recruiting||N/A|1000|Anticipated|Vanda Pharmaceuticals|||1||f||||f|f|f||||||||2017-10-10 21:03:54.269924|2017-10-10 21:03:54.269924
NCT03154684|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-12|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|STARK||Spitex-SpiTal-Autonomie-Reha-Kraft|Efficacy of the STARK Comprehensive Autonomy Health Care Package in Functional Recovery After a Hip Fracture: A Randomized Controlled Trial|Not yet recruiting||N/A|20|Anticipated|University of Zurich||2|||f||||f|f|f||||||No||2017-10-10 21:03:54.346097|2017-10-10 21:03:54.346097
NCT03154671|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-21|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 31, 2021|Anticipated|2021-03-31|June 1, 2019|Anticipated|2019-06-01||Interventional|||Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer|Clinical and Cost-effectiveness of a Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer: the 5C Study|Not yet recruiting||N/A|350|Anticipated|University of Toronto||2|||f||||t|f|f||||||||2017-10-10 21:03:54.463192|2017-10-10 21:03:54.463192
NCT03154658|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-12|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Serratus Anterior Plane Block in Patients Undergoing Mastectomy|Serratus Anterior Plane Block: Sub-Serratus vs Supra-Serratus Plane Block for Pain Control in Patients Undergoing Mastectomy|Enrolling by invitation||Phase 4|66|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|t|f|||f|||No||2017-10-10 21:03:54.548326|2017-10-10 21:03:54.548326
NCT03154645|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-13|||August 12, 2017|Actual|2017-08-12|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|ASPIRATE||Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy|Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy|Recruiting||Phase 1|100|Anticipated|Stanford University||2|||f||||t|t|f|||f|||||2017-10-10 21:03:54.634278|2017-10-10 21:03:54.634278
NCT03154632|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-12|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effectiveness of Digital Capacitive Diathermy Versus Ultrasound on Myofascial Trigger Points|Effectiveness of Digital Capacitive Diathermy Versus Ultrasound on Myofascial Trigger Points|Not yet recruiting||N/A|19|Anticipated|Universidad San Jorge||2|||f||||f|f|f||||||Yes||2017-10-10 21:03:54.724244|2017-10-10 21:03:54.724244
NCT03154619|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-12|||November 2016||2016-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers|Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers: a Two-arm, Double-blind, Placebo-controlled, Randomized Controlled Trial.|Recruiting||Phase 2|80|Anticipated|SerenaGroup, Inc.||2|||f||||f||||||||No||2017-10-10 21:03:54.80991|2017-10-10 21:03:54.80991
NCT03154606|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-12|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake|The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake|Recruiting||N/A|32|Anticipated|Purdue University||2|||f|||||f|f||||||||2017-10-10 21:03:54.917954|2017-10-10 21:03:54.917954
NCT03154580|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-12|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|MCN||Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users|Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users: A Pilot Test of Glutamatergic Modulation|Recruiting||Phase 1|45|Anticipated|Wayne State University||4|||f||||t|t|f|||f|||No||2017-10-10 21:03:55.153383|2017-10-10 21:03:55.153383
NCT03154567|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-12|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects of Stress and Drug-cue Exposure (SCM)|Effects of Stress and Drug-cue Exposure on Craving and Marijuana Seeking Behavior in Regular Cannabis Smokers|Not yet recruiting||Phase 1|20|Anticipated|Wayne State University||6|||f||||t|t|f|||f|||No||2017-10-10 21:03:55.247638|2017-10-10 21:03:55.247638
NCT03154554|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-12|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||Epidemiology of Patients Consulting for Original LBP Spinal Adult Emergency|Epidemiology of Patients Consulting for Original LBP Spinal Adult Emergency Hautepierre and 3 Months Course of Care|Not yet recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 21:03:55.344107|2017-10-10 21:03:55.344107
NCT03154541|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-12|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||SynRinse Irrigation Pilot (SIP) Trial|SynRinse Irrigation Pilot (SIP) Trial|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|University of Washington||2|||f||||f|f|f|||f|||No||2017-10-10 21:03:55.40924|2017-10-10 21:03:55.40924
NCT03154528|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-13|2017-05-13|||November 30, 2017|Anticipated|2017-11-30|May 2017|2017-05-01|December 12, 2018|Anticipated|2018-12-12|August 21, 2018|Anticipated|2018-08-21||Observational|||Role of Vitamin D in Androgenetic Alopecia|Role of Vitamin D in Androgenetic Alopecia|Not yet recruiting||N/A|90|Anticipated|Assiut University|||2||f||||f|f|f||||Samples With DNA|"     blood sample   "|No||2017-10-10 21:03:55.482251|2017-10-10 21:03:55.482251
NCT03154515|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-12|||January 2010|Actual|2010-01-01|May 2017|2017-05-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults|Randomised Double Blind Placebo Controlled Multicenter Study for Evaluation of Clinical Efficacy and Safety of Ingavirin 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults.|Completed||Phase 4|445|Actual|Valenta Pharm JSC||2|||f||||f|f|f||||||No||2017-10-10 21:03:55.567726|2017-10-10 21:03:55.567726
NCT03154502|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-12|||March 1, 2015|Actual|2015-03-01|May 2017|2017-05-01|October 30, 2016|Actual|2016-10-30|October 30, 2016|Actual|2016-10-30||Observational|||Sodium Intake in Ecuadorian Population|Sodium Urinary Excretion Measurement in Ecuadorian Population|Completed||N/A|130|Actual|Universidad San Francisco de Quito|||1||f||||f|f|f||||Samples Without DNA|"     Urine   "|No||2017-10-10 21:03:55.789505|2017-10-10 21:03:55.789505
NCT03154489|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-28|||May 22, 2017|Actual|2017-05-22|April 2017|2017-04-01|September 22, 2018|Anticipated|2018-09-22|May 22, 2018|Anticipated|2018-05-22||Interventional|||Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care|Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care|Recruiting||N/A|204|Anticipated|Universidad San Jorge||2|||f||||f|f|f||||||||2017-10-10 21:03:55.883633|2017-10-10 21:03:55.883633
NCT03154476|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-06|||July 5, 2017|Actual|2017-07-05|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|SiFALD||Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study|Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study|Recruiting||Early Phase 1|40|Anticipated|Mayo Clinic||2|||f||||t|t|f|||f|||||2017-10-10 21:03:56.001817|2017-10-10 21:03:56.001817
NCT03154463|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-04|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|August 31, 2017|Actual|2017-08-31||Interventional|||Analgesic Effect of Three-point Transversus Abdominis Plane Block Compared With Continuous Epidural Infusion for Post-laparoscopic Nephrectomy|Analgesic Effect of Three-point Transversus Abdominis Plane Block Compared With Continuous Epidural Infusion for Post-laparoscopic Nephrectomy|Recruiting||N/A|50|Anticipated|Indonesia University||2|||f|||||f|f||||||||2017-10-10 21:03:56.153243|2017-10-10 21:03:56.153243
NCT03154450|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-12|||January 21, 2016|Actual|2016-01-21|May 2017|2017-05-01|November 11, 2017|Anticipated|2017-11-11|November 11, 2017|Anticipated|2017-11-11||Interventional|||EncoreAnywhere Use in Motor Neurone Disease|Monitoring and Promoting Effectiveness and Adherence to Non-invasive Ventilation in Motor Neurone Disease Using EncoreAnywhere Telemonitoring.|Recruiting||N/A|40|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t|f|f||||||No|no plan to share IPD|2017-10-10 21:03:56.255414|2017-10-10 21:03:56.255414
NCT03154424|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-12|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Dynamic External Fixation in Treatment Distal Radius Fractures - Elderly Patients|Bridging Versus Non-bridging Dynamic External Fixation in Early Total Care Treatment Unstable Distal Radius Fractures in Elderly Polytrauma Patients: A Randomized Controlled Study|Completed||N/A|150|Actual|Faculdade de Medicina do ABC||2|||f||||f|f|f|||f|||No||2017-10-10 21:03:56.445932|2017-10-10 21:03:56.445932
NCT03154411|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-07-31|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 1, 2018|Anticipated|2018-12-01||Interventional|||A Microdose Evaluation Study of ABY-029 in Primary Sarcoma|A Phase 0 Open Label, Single-center Clinical Trial of ABY-029, an Anti-EGFR Fluorescence Imaging Agent Via Single Intravenous Injection to Subjects With Primary Sarcoma.|Not yet recruiting||Early Phase 1|18|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:03:56.520645|2017-10-10 21:03:56.520645
NCT03154398|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-14|2017-05-16|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|AssuitU||Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.|Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.|Enrolling by invitation||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||No|evaluate thyroid dysfunction in patients with diabetes in diabetic nephropathy|2017-10-10 21:03:56.603703|2017-10-10 21:03:56.603703
NCT03154385|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-14|||March 13, 2017|Actual|2017-03-13|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RITUX PLUS||Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia|RITUX-PLUS. A Prospective Open Trial to Assess the Efficacy and Safety of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia.|Recruiting||N/A|15|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t|f|f||||||||2017-10-10 21:03:56.67154|2017-10-10 21:03:56.67154
NCT03154372|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||September 20, 2016|Actual|2016-09-20|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Deliberate Practice With Validated Metrics Improves Skills Acquisition|Deliberate Practice With Validated Metrics Improves Skill Acquisition in Performance of Ultrasound Guided Peripheral Nerve Block in a Simulated Setting|Active, not recruiting||N/A|18|Actual|University College Cork||2|||f||||||||||||||2017-10-10 21:03:56.758177|2017-10-10 21:03:56.758177
NCT03154359|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-12|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Observational|||Atomoxetine PBPK-PD Clinical Study|An Open-Label, Single- and Multi-Dose Study to Evaluate the Relationship Between the Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes of Atomoxetine in CYP2D6 Extensive, Intermediate, and Poor Metabolizers in Children With Attention Deficit/Hyperactivity Disorder|Not yet recruiting||N/A|120|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f|t|f|||f|||Undecided||2017-10-10 21:03:56.823522|2017-10-10 21:03:56.823522
NCT03154346|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-27|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01|4 Years|Observational [Patient Registry]|||The Baseline Study|The Baseline Study|Recruiting||N/A|10000|Anticipated|Baseline Study LLC|||1||f||||t|f|f||||||||2017-10-10 21:03:56.89664|2017-10-10 21:03:56.89664
NCT03154333|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-28|||May 31, 2017|Actual|2017-05-31|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety and Efficacy of Diacerein 1% Ointment Topical Formulation Compared to Placebo for Subjects With Epidermolysis Bullosa Simplex (EBS)|An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex (EBS)|Recruiting||Phase 2|80|Anticipated|Castle Creek Pharmaceuticals, LLC||2|||f||||t|t|f||||||||2017-10-10 21:03:57.024061|2017-10-10 21:03:57.024061
NCT03154320|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-12|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Interventional|||A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV|A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV|Not yet recruiting||N/A|600|Anticipated|Brigham and Women's Hospital||2|||f||||t|f|f||||||Yes|When the study has been completed, anonymized data will be made publicly available, which will permit replication of reported outcomes.|2017-10-10 21:03:58.002267|2017-10-10 21:03:58.002267
NCT03154307|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-12|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Repeated TMS at Low Frequencies to Reduce Seizure Occurrence|Repeated TMS at Low Frequencies to Reduce Seizure Occurrence|Recruiting||N/A|100|Anticipated|Baptist Health South Florida||3|||f||||f|f|t|f|f||||||2017-10-10 21:03:58.112595|2017-10-10 21:03:58.112595
NCT03154294|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-12|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors|A Phase 1 Evaluation of the Safety and Tolerability of TAK-228 in Combination With TAK-117 and Paclitaxel in Advanced Solid Tumors|Not yet recruiting||Phase 1|30|Anticipated|Avera McKennan Hospital & University Health Center||5|||f||||f|t|f||||||No||2017-10-10 21:03:58.230045|2017-10-10 21:03:58.230045
NCT03154281|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-15|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Ovarian and Breast|A Phase 1 Evaluation of the Safety and Tolerability of Niraparib in Combination With Everolimus in Advanced Ovarian and Breast Cancer|Not yet recruiting||Phase 1|24|Anticipated|Avera McKennan Hospital & University Health Center||4|||f||||f|t|f||||||No||2017-10-10 21:03:58.361226|2017-10-10 21:03:58.361226
NCT03154268|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-11|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|GWGCPW||Retrospective Longitudinal Study of Gestational Weight Gain Among Chinese Pregnant Women|Retrospective Longitudinal Study of Gestational Weight Gain Among Chinese Pregnant Women|Completed||N/A|10422|Actual|West China Hospital|||1||f||||t|f|f||||||Undecided||2017-10-10 21:03:58.469135|2017-10-10 21:03:58.469135
NCT03154255|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-23|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|GOOD-DAY||GOOD-DAY Trial in Paediatric Obesity|GOOD-DAY: Efficacy of Gamification of an educatiOnal Training tO meDiterranean Diet on Weight and Metabolic Control in pAediatric obesitY: a Pilot Open-label Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita||2|||f||||t|f|f||||||No||2017-10-10 21:03:58.568721|2017-10-10 21:03:58.568721
NCT03154242|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-13|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Effect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung Cancer|Effect of Genetic Polymorphisms on Clinical Outcome of Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients|Recruiting||N/A|60|Anticipated|Ain Shams University|||1||f||||||f|||f|||||2017-10-10 21:03:58.680975|2017-10-10 21:03:58.680975
NCT03154216|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-12|||May 20, 2017|Actual|2017-05-20|June 2017|2017-06-01|January 1, 2019|Anticipated|2019-01-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Milk as a Recovery Beverage After Exercise for Improving Metabolic Health|The Effect of Milk as a Recovery Beverage After Exercise on Next-day Postprandial Triglycerides|Recruiting||N/A|20|Anticipated|University of Saskatchewan||4|||f||||f|f|f||||||No||2017-10-10 21:03:58.856266|2017-10-10 21:03:58.856266
NCT03154203|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-08-16|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|SAFAR-China||Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Chinese Population|The Study of Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Population Of Chinese Patient (SAFAR-China)|Recruiting||N/A|3000|Anticipated|Shanghai 10th People's Hospital|||1||f|||||f|f||||||||2017-10-10 21:03:58.963666|2017-10-10 21:03:58.963666
NCT03154190|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-05-12|||December 15, 2016|Actual|2016-12-15|May 2017|2017-05-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer|St. Judes-Stanford Comprehensive Support Initiative|Recruiting||N/A|200|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 21:03:59.061328|2017-10-10 21:03:59.061328
NCT03154177|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-12|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|May 24, 2019|Anticipated|2019-05-24|March 24, 2019|Anticipated|2019-03-24||Interventional|PTBi Rwanda||Group Antenatal/Postnatal Care in Rwanda|Group Antenatal/Postnatal Care in Rwanda: a Cluster Randomized Control Trial (RCT) to Measure Its Effectiveness on Increasing Gestational Age, Mortality Among Preterm and Low Birth Weight Infants|Enrolling by invitation||N/A|11000|Anticipated|University of California, San Francisco||4|||f||||f|f|f||||||Undecided|Data from the study will be shared, but the extent to which individual participant data can be shared is yet to be determined. This will be done to the extent possible, conforming to any partner requirements or Rwanda IRB requirements.|2017-10-10 21:03:59.205196|2017-10-10 21:03:59.205196
NCT03154164|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-12|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|LEFFE||Study on the Learning Curve for Fundus First With Ultrasonic Tissue Coagulation in Elective Cholecystectomy|Study on the Learning Curve for Fundus First With Ultrasonic Tissue Coagulation in Elective Cholecystectomy|Recruiting||N/A|225|Anticipated|Karolinska Institutet|||1||f||||f|f|f||||||No|All data will be saved and analysed after anonymising the participant.|2017-10-10 21:03:59.340839|2017-10-10 21:03:59.340839
NCT03154151|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-08-23|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Online Therapy for Posttraumatic Stress Symptoms in WTC Responders|Internet-based Psychotherapies for PTSD Symptoms in World Trade Center (WTC) Responders|Recruiting||N/A|112|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|f|f||||||||2017-10-10 21:03:59.417206|2017-10-10 21:03:59.417206
NCT03154138|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-30|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|August 2019|Anticipated|2019-08-01||Interventional|PEQUIE||Prismatic Adaptation for Rehabilitation of Postural Imbalance After Stroke|Assessment of the Rehabilitation of Postural Imbalance After Chronic Right Supratensorial Stroke by Prismatic Adaptation: Multicentric Randomised Sham-controlled Trial|Not yet recruiting||N/A|28|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:03:59.519435|2017-10-10 21:03:59.519435
NCT03154125|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-28|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2019|Anticipated|2019-07-30||Interventional|||Sayana® Press Extension Study|A Study to Evaluate the Effectiveness, Pharmacokinetics, Safety, and Acceptability of Sayana® Press When Injected Every Four Months|Recruiting||Phase 3|750|Anticipated|FHI 360||3|||f||||t|f|f||||||||2017-10-10 21:03:59.623054|2017-10-10 21:03:59.623054
NCT03154112|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-07-18|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|||Validation of a Novel Oxygen Consumption Measurement Technique in Neonates|Validation of a Novel Oxygen Consumption Measurement Technique in Neonates|Recruiting||N/A|50|Anticipated|Boston Children’s Hospital|||1||f||||t|f|f||||||||2017-10-10 21:03:59.722742|2017-10-10 21:03:59.722742
NCT03154099|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-16|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Critical Illness Related Corticosteroids Insufficiency|Critical Illness Related Corticosteroid Insufficiency|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f||||t|f|f||||||Undecided|Prevalence of CIRCI . most common presentations of CIRCI . the best method of replacment|2017-10-10 21:03:59.798348|2017-10-10 21:03:59.798348
NCT03154086|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-22|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers|A Phase I, First Time in Human, Two Part, Randomized, Placebo-Controlled, Double-Blind (Sponsor Unblind), Single and Repeat Dose Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers|Recruiting||Phase 1|64|Anticipated|GlaxoSmithKline||4|||f||||f|f|f||||||No||2017-10-10 21:03:59.871901|2017-10-10 21:03:59.871901
NCT03154073|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|GLYDE||Effects of Progressive Intensity Exercise Training on Glycemic Control in Older Adults|Effects of Progressive Intensity Exercise Training on Glycemic Control in Older Adults Who Are at Risk for Diabetes|Not yet recruiting||N/A|24|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 21:03:59.96643|2017-10-10 21:03:59.96643
NCT03154060|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-08-04|||May 19, 2017|Actual|2017-05-19|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|OUT OF SIGHT||Evaluation of the Accuracy and Precision of Flash Glucose Monitoring Sensors in Different Sites|Evaluation of the Accuracy and Precision of Flash Glucose Monitoring Sensors in Different Sites: the Abdomen and Upper Thigh Compared to the Upper Arm|Completed||N/A|23|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f|||f|||||2017-10-10 21:04:00.052534|2017-10-10 21:04:00.052534
NCT03154047|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-10-05|||June 14, 2017|Actual|2017-06-14|October 2017|2017-10-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Study in Subjects With Light Chain (AL) Amyloidosis|A Phase 2b Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of NEOD001 in Subjects With Light Chain (AL) Amyloidosis Who Were Previously Enrolled in Study NEOD001-201 (PRONTO)|Recruiting||Phase 2|100|Anticipated|Prothena Therapeutics Ltd.||1|||f||||f|t|f||||||||2017-10-10 21:04:00.136121|2017-10-10 21:04:00.136121
NCT03154034|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-12|||August 13, 2014|Actual|2014-08-13|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31|2 Years|Observational [Patient Registry]|||Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation|Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation - a Single Center, Observational Echocardiographic Study|Active, not recruiting||N/A|40|Anticipated|University Hospital Regensburg|||1||f||||f|f|f||||Samples With DNA|"     blood (serum and plasma samples)   "|No||2017-10-10 21:04:00.349793|2017-10-10 21:04:00.349793
NCT03154021|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-14|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Next Science Antimicrobial Mouth Rinse Study|Clinical Effectiveness of Next Science Oral Rinse in Controlling Plaques and Gingival Inflammation|Recruiting||Phase 1|150|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 21:04:00.451839|2017-10-10 21:04:00.451839
NCT03154008|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-14|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|PORT||Predictors of Response to Treatment for Depression|Neural Predictors of Response to Cognitive Behavioral Therapy for Adolescent Depression|Recruiting||N/A|80|Anticipated|Milton S. Hershey Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 21:04:00.571587|2017-10-10 21:04:00.571587
NCT03153995|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-12|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Alveolar Ridge Augmentation Following Two Different Approaches of Self-Inflating Soft Tissue Expanders|Alveolar Ridge Augmentation Following Two Different Approaches of Self-Inflating Soft Tissue Expanders: A Randomized Clinical and Histological Study|Not yet recruiting||N/A|16|Anticipated|Ain Shams University||2|||f||||f|f|f||||||No||2017-10-10 21:04:00.650989|2017-10-10 21:04:00.650989
NCT03153969|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-03|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|||Clinical Evaluation of a New Giomer Restorative System in Class V Restorations|A Clinical Trial to Evaluate a New Giomer Restorative System in Class V Restorations|Not yet recruiting||N/A|50|Anticipated|Tufts University School of Dental Medicine||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:04:00.934402|2017-10-10 21:04:00.934402
NCT03153956|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-12|||April 16, 2015|Actual|2015-04-16|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy of AposTherapy® in Knee OA|A Prospective, Randomized Double-Armed Efficacy Evaluation of AposTherapy® for the Treatment of Knee Osteoarthritis|Recruiting||N/A|120|Anticipated|New York University School of Medicine||2|||f||||f|f|t|f|f||||||2017-10-10 21:04:01.110459|2017-10-10 21:04:01.110459
NCT03153943|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-08-11|||March 29, 2017|Actual|2017-03-29|August 2017|2017-08-01|March 29, 2020|Anticipated|2020-03-29|March 29, 2019|Anticipated|2019-03-29||Interventional|||HIP Mobile: A Community-based Monitoring, Rehabilitation and Learning e-System for Patients Following a Hip Fracture|HIP Mobile: A Community-based Monitoring, Rehabilitation and Learning e-System for Patients Following a Hip Fracture|Recruiting||N/A|188|Anticipated|McGill University Health Center||2|||f||||f|f|f||||||||2017-10-10 21:04:01.274733|2017-10-10 21:04:01.274733
NCT03153930|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-12|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|June 1, 2019|Anticipated|2019-06-01||Interventional|SBHO||Sedentary Behavior and Health Outcomes Study|Metabolic Effects of Interrupting Sedentary Time in Youth In-lab and in Free-living Settings|Not yet recruiting||N/A|65|Anticipated|University of Southern California||2|||f||||f|f|f||||||No|We do not intend to share IPD with other researchers outside of our study.|2017-10-10 21:04:01.434572|2017-10-10 21:04:01.434572
NCT03153917|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-20|||June 2, 2017|Actual|2017-06-02|April 2017|2017-04-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|MELACTI-12||Biological Rhythms Impact of 12 Hours Shift Work|Wake-sleep Cycle and Melatonin Secretion Dynamics Associated With 12 Hours Shift Work in French Nurses|Recruiting||N/A|14|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:04:01.5577|2017-10-10 21:04:01.5577
NCT03153904|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-12|||October 2013||2013-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Connecticut Child STEPs|Child STEPs for Youth Mental Health in Connecticut|Active, not recruiting||N/A|210|Actual|Harvard University||2|||f||||t||||||||||2017-10-10 21:04:01.722251|2017-10-10 21:04:01.722251
NCT03153891|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-19|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Nature as a Buffer Among People With Chronic Pain|Virtual Nature: Benefits for Older Adults Who Experience Chronic Pain?|Active, not recruiting||N/A|50|Anticipated|Cornell University||3|||f||||t|f|f||||||||2017-10-10 21:04:01.843732|2017-10-10 21:04:01.843732
NCT03153878|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31|1 Year|Observational [Patient Registry]|||The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease|The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease|Not yet recruiting||N/A|1800|Anticipated|West China Hospital|||1||f||||t|f|f||||Samples With DNA|"     whole blood   "|No|share the original data 5 years after the study completion|2017-10-10 21:04:01.962365|2017-10-10 21:04:01.962365
NCT03153865|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-12|||June 2, 2017|Anticipated|2017-06-02|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|NATIONAL-1||New Therapeutic System of Unruptured Intracranial Aneurysms Based on Big Data From Chinese Population|New Therapeutic System of Unruptured Intracranial Aneurysms Based on Big Data From Chinese Population|Recruiting||N/A|2000|Anticipated|Changhai Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:04:02.077026|2017-10-10 21:04:02.077026
NCT03151759|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-10|||November 6, 2002|Actual|2002-11-06|May 2017|2017-05-01|March 16, 2007|Actual|2007-03-16|March 16, 2007|Actual|2007-03-16||Observational|MMP-7||MMP-7 Modulation by Short and Long Term Radiotherapy in Rectal Cancer Patients|Effect of Long and Short Radiotherapy on MMP-7 Levels in Rectal Cancer Treatment|Completed||N/A|77|Actual|Region Skane|||3||f||||f|f|f||||||No||2017-10-10 21:04:24.30234|2017-10-10 21:04:24.30234
NCT03153852|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-15|||November 15, 2017|Anticipated|2017-11-15|August 2017|2017-08-01|December 15, 2020|Anticipated|2020-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|||Modified Jessner's Solution With Trichloroacetic Acid Versus Glycolic Acid With Trichloroacetic Acid|The Efficacy of Combined Peels in Treatment of Melasma Using Modified Jessner's Solution With 20%Trichloroacetic Acid Versus 70%Glycolic Acid With 20% Trichloroacetic Acid : A Split-face Study|Not yet recruiting||Phase 4|30|Anticipated|Assiut University||1|||f|||||f|f||||||||2017-10-10 21:04:02.159439|2017-10-10 21:04:02.159439
NCT03153839|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-12|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Influence of the Aquatic Physical Activity for the Neurologic Development of the Babies|Influence of the Aquatic Physical Activity for the Neurologic Development of the Babies|Recruiting||N/A|145|Anticipated|Universidad de Granada||2|||f||||t||||||||||2017-10-10 21:04:02.268889|2017-10-10 21:04:02.268889
NCT03153826|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-12|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|August 15, 2019|Anticipated|2019-08-15|March 15, 2019|Anticipated|2019-03-15||Interventional|AMI-EX-BPCO||Determinants of Lower Limb Muscle Atrophy Induced During an Hospitalization for Exacerbation of COPD|Determinants of Lower Limb Muscle Atrophy Induced During an Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|120|Anticipated|University Hospital, Montpellier||1|||f||||f|f|f||||||No||2017-10-10 21:04:02.370784|2017-10-10 21:04:02.370784
NCT03153813|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-05-12|||July 2015||2015-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CHILI-OB||Capsaicin Patches In Knee Osteoarthritis In Obese Patients|Efficacy And Safety Of High Concentration Capsaicin Patches In Knee Osteoarthritis In Obese Patients: A Randomized Prospective Double Blind Placebo Controlled Study|Recruiting||Phase 3|22|Anticipated|Hospital Ambroise Paré Paris||2|||f||||f||||||||||2017-10-10 21:04:02.479822|2017-10-10 21:04:02.479822
NCT03153800|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-12|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|October 4, 2019|Anticipated|2019-10-04|April 4, 2019|Anticipated|2019-04-04||Interventional|||Autologous Bronchial Basal Cells Transplantation for Treatment of CRD Including COPD, BE and PF|Autologous Bronchial Basal Cells Transplantation for Treatment of Chronic Respiratory Disease (CRD) Including Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis (BE) and Pulmonary Fibrosis (PF)|Recruiting||Early Phase 1|30|Anticipated|Regend Therapeutics||1|||f|||||f|f||||||No||2017-10-10 21:04:02.581202|2017-10-10 21:04:02.581202
NCT03153787|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-05|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|RIFMicrobiome||Vaginal Microbiome Influence on the Results of Assisted Reproduction Techniques|Influence of Vaginal and Endometrial Microbiome on the Results of Assisted Reproduction Techniques and Probiotic Administration Effect: Controlled Before-and-after Study|Recruiting||N/A|30|Anticipated|Instituto Bernabeu||1|||f||||f|f|f||||||||2017-10-10 21:04:02.696452|2017-10-10 21:04:02.696452
NCT03153774|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-12|||November 3, 2014|Actual|2014-11-03|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|PRESAR-HF||Assessments of Sarcopenia Prevalence in Chronic Heart Failure Patients and in Subjects Before TAVI|Assessments of Sarcopenia Prevalence in Chronic Heart Failure Patients and in Subjects Before Transcatheter Aortic Valve Implantation|Recruiting||N/A|300|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:04:02.797899|2017-10-10 21:04:02.797899
NCT03153761|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-07|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|September 21, 2017|Anticipated|2017-09-21|September 21, 2017|Anticipated|2017-09-21||Interventional|||CSD170201: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products|CSD170201: A Crossover Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products|Recruiting||N/A|64|Anticipated|RAI Services Company||2|||f||||f|f|f||||||||2017-10-10 21:04:02.917533|2017-10-10 21:04:02.917533
NCT03153748|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-12|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|1 Year|Observational [Patient Registry]|NATIONAL-2||New Therapeutic System of Ruptured Intracranial Aneurysms Based on Big Data From Chinese Population|New Therapeutic System of Ruptured Intracranial Aneurysms Based on Big Data From Chinese Population|Recruiting||N/A|10000|Anticipated|Changhai Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:04:03.012052|2017-10-10 21:04:03.012052
NCT03153735|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-12|||December 2, 2016|Actual|2016-12-02|April 2017|2017-04-01|February 9, 2018|Anticipated|2018-02-09|November 9, 2017|Anticipated|2017-11-09||Interventional|||Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement|A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement|Recruiting||N/A|68|Anticipated|CHA MEDITECH Co., Ltd.||2|||f|||||f|f||||||Undecided||2017-10-10 21:04:03.094697|2017-10-10 21:04:03.094697
NCT03153722|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-16|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Pediatric Ward Discharge Quality Improvement|Pediatric Ward Discharge Quality Improvement|Enrolling by invitation||N/A|4000|Anticipated|University of California, Davis||1|||f||||f|f|f||||||No||2017-10-10 21:04:03.19454|2017-10-10 21:04:03.19454
NCT03153709|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-13|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2021|Anticipated|2021-06-01||Observational|FP-ART||Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPA|A Prospective Cohort Evaluating the Pregnancy Rates and Pharmacokinetic Interactions Among HIV-infected Malawian Women on Efavirenz Initiating the Levonorgestrel Implant or the Depot Medroxyprogesterone Acetate Injectable|Recruiting||N/A|1420|Anticipated|University of North Carolina, Chapel Hill|||1||f||||t|f|f||||||||2017-10-10 21:04:03.281824|2017-10-10 21:04:03.281824
NCT03153696|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-04|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Initial Evaluation of the Cellie Coping Kit for Children With Injury|Application of Theory and Evidence to Promote Full Recovery From Pediatric Injury|Recruiting||N/A|80|Anticipated|University of Kentucky||2|||f||||f|f|f||||||||2017-10-10 21:04:03.356802|2017-10-10 21:04:03.356802
NCT03153683|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-11|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01||Observational|BACTRAC||Blood And Clot Thrombectomy Registry And Collaboration|Blood And Clot Thrombectomy Registry And Collaboration (BACTRAC)|Recruiting||N/A|250|Anticipated|University of Kentucky|||1||f||||f|f|f||||Samples With DNA|"     1 cc of arterial distal blood, thrombus, and 5 cc of peripheral arterial blood   "|Undecided|To be announced.|2017-10-10 21:04:03.447336|2017-10-10 21:04:03.447336
NCT03153657|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-11|||December 13, 2016|Actual|2016-12-13|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching|Preemptive Use of Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching: Randomized, Triple-blind, Controlled Clinical Trial|Active, not recruiting||Phase 3|50|Anticipated|Universidade Federal de Sergipe||2|||f||||f|f|f|||f|||No||2017-10-10 21:04:03.59536|2017-10-10 21:04:03.59536
NCT03153644|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-15|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 30, 2018|Anticipated|2018-06-30||Observational|||Improving Contraceptive Care for Women With Medical Conditions|Improving Contraceptive Care for Women With Chronic Conditions: A Novel, Web-Based Decision Aid in Primary Care|Recruiting||N/A|90|Anticipated|University of Michigan|||3||f||||f|f|f||||||||2017-10-10 21:04:03.688207|2017-10-10 21:04:03.688207
NCT03153631|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-13|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Female Sexual Dysfunction in Breast Cancer Patients|Evaluating Female Sexual Dysfunction in Breast Cancer Patients After Mastectomy|Not yet recruiting||N/A|75|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:04:03.785215|2017-10-10 21:04:03.785215
NCT03153618|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-12|||September 1, 2017|Anticipated|2017-09-01|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|VALIDATE||VALIDATE: Virtual Agent Linked Intelligent Disease Assessment Tool Engine|VALIDATE: Virtual Agent Linked Intelligent Disease Assessment Tool Engine|Withdrawn||N/A|0|Actual|Stanford University||2||Funding and proposal withdrawn|f||||f|f|f||||||||2017-10-10 21:04:03.843522|2017-10-10 21:04:03.843522
NCT03153605|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-27|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|December 9, 2017|Anticipated|2017-12-09|October 9, 2017|Anticipated|2017-10-09||Interventional|||The Correlation and Relationship Between Chromaticity Parameters and Treatment Satisfaction Before and After Tooth Bleaching|The Correlation and Relationship Between Chromaticity Parameters and Treatment Satisfaction Before and After Tooth Bleaching|Enrolling by invitation||N/A|1|Actual|Fujian Medical University||1|||f||||t|f|f||||||||2017-10-10 21:04:03.909308|2017-10-10 21:04:03.909308
NCT03153592|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-14|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|July 30, 2018|Anticipated|2018-07-30||Interventional|Vetrapo||Effects of Mechanical Ventilation Guided by Transpulmonary Pressure on Gas Exchange During Robotic Surgery|Effects of Mechanical Ventilation Guided by Transpulmonary Pressure on Gas Exchange During Robotic Surgery|Recruiting||N/A|26|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita||2|||f||||f|f|f||||||||2017-10-10 21:04:03.965362|2017-10-10 21:04:03.965362
NCT03153579|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-04|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|May 1, 2021|Anticipated|2021-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|LSD-assist||LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders|LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study|Recruiting||Phase 2|40|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f||||||Undecided||2017-10-10 21:04:04.066152|2017-10-10 21:04:04.066152
NCT03153566|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-15|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients|Comparison Between Tuberculin Vaccine and Cryotherapy in the Treatment of Genital Wart Patients|Not yet recruiting||Phase 3|45|Anticipated|Assiut University||3|||f||||f|f|f||||||No||2017-10-10 21:04:04.196284|2017-10-10 21:04:04.196284
NCT03153553|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-10-05|||April 5, 2017|Actual|2017-04-05|October 2017|2017-10-01|August 17, 2018|Anticipated|2018-08-17|August 17, 2018|Anticipated|2018-08-17||Interventional|||Ischemic Preconditioning, Exercise Tolerance and Multiple Sclerosis|Ischemic Preconditioning, Exercise Tolerance and Multiple Sclerosis|Recruiting||N/A|40|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t|f|f||||||||2017-10-10 21:04:04.277404|2017-10-10 21:04:04.277404
NCT03153540|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-12|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|November 14, 2017|Anticipated|2017-11-14||Interventional|||Transcranial Magnetic Stimulation in Nonfluent/Agrammatic Variant Primary Progressive Aphasia|A Randomized, Double-blinded, Sham-controlled Cross-over Study of Theta-burst Transcranial Magnetic Stimulation in Nonfluent/Agrammatic Variant Primary Progressive Aphasia|Not yet recruiting||N/A|6|Anticipated|University of British Columbia||2|||f||||f|f|f|||f|||No||2017-10-10 21:04:04.354814|2017-10-10 21:04:04.354814
NCT03153527|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-06-04|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TOASST||Taper Or Abrupt Steroid Stop: TOASSTtrial|Glucocorticoid Withdrawal and Glucocorticoid-induced Adrenal Insufficiency: a Randomized Controlled Multicenter Trial|Recruiting||Phase 4|573|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f|||f|||No|No sharing planned|2017-10-10 21:04:04.442926|2017-10-10 21:04:04.442926
NCT03153514|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-07-28|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter`s Transformation Requiring Allogeneic Stem Cell Transplantation|Obinutuzumab Containing Conditioning Regimen for CLL Patients and Patients With Richter`s Transformation Requiring an Allogeneic Stem Cell Transplantation|Recruiting||Phase 2|40|Anticipated|German CLL Study Group||1|||f||||t|f|f||||||||2017-10-10 21:04:04.564899|2017-10-10 21:04:04.564899
NCT03153501|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-12|||February 8, 2011|Actual|2011-02-08|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|February 1, 2017|Actual|2017-02-01||Interventional|||Efficiency and Safety of Pleural Biopsy Methods in the Diagnosis of Pleural Diseases|How Should be Invasive Diagnostic Algorithm in Pleural Diseases|Completed||N/A|164|Actual|Eskisehir Osmangazi University||1|||f||||f|f|f||||||No||2017-10-10 21:04:04.670815|2017-10-10 21:04:04.670815
NCT03153488|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-28|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response|Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response|Not yet recruiting||Phase 4|60|Anticipated|Massachusetts General Hospital||2|||f||||f|t|f|||t|||||2017-10-10 21:04:04.749326|2017-10-10 21:04:04.749326
NCT03141840|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-16|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial of Topical ABL01 Treatment of Onychomycosis|Clinical Trial of Safety and Efficacy of Topical ABL01 Treatment of Onychomycosis|Recruiting||N/A|70|Anticipated|Abbell AB||2|||f||||f|f|f|||f|||||2017-10-10 21:06:01.415444|2017-10-10 21:06:01.415444
NCT03153475|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-08-14|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|February 24, 2025|Anticipated|2025-02-24|February 24, 2025|Anticipated|2025-02-24||Interventional|||ATTUNE Revision System in the Revision Total Knee Arthroplasty Population|Multi-Center Clinical Evaluation of the ATTUNE® Revision System in Revision Total Knee Arthroplasty|Recruiting||N/A|400|Anticipated|DePuy Orthopaedics||1|||f||||f|f|t|f|f|t|||||2017-10-10 21:04:04.838213|2017-10-10 21:04:04.838213
NCT03153462|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-21||||||August 2017|2017-08-01||||||||Expanded Access|ZUMA-9||Axicabtagene Ciloleucel Expanded Access Study|Multicenter, Open-label, Expanded Access Study of Axicabtagene Ciloleucel for the Treatment of Relapsed/Refractory Transplant-Ineligible Aggressive Non-Hodgkin Lymphoma (NHL)|Available||N/A|||Kite Pharma, Inc.||||||||t|||||||||||2017-10-10 21:04:06.847858|2017-10-10 21:04:06.847858
NCT03153436|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-13|||August 28, 2016|Actual|2016-08-28|May 2017|2017-05-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|||The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation|The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation|Completed||Phase 1/Phase 2|41|Actual|Sohag University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:04:07.037915|2017-10-10 21:04:07.037915
NCT03153423|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-01|||August 5, 2017|Actual|2017-08-05|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Basic Intermittent Exotropia and Risk Factors for Postoperative Overcorrection and Under Correction|Basic Intermittent Exotropia; is the Axial Length of the Globe One of the Prognostic Factors for Overcorrection and Undercorrection After Binocular Surgery|Recruiting||N/A|60|Anticipated|Minia University||1|||f|||||f|f||||||||2017-10-10 21:04:07.116856|2017-10-10 21:04:07.116856
NCT03153410|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas|A Pilot Study of a GVAX Pancreas Vaccine (With Cyclophosphamide) in Combination With a PD-1 Blockade Antibody (Pembrolizumab) and a Macrophage Targeting Agent (CSF1R Inhibitor) for the Treatment of Patients With Borderline Resectable Adenocarcinoma of the Pancreas|Not yet recruiting||Early Phase 1|12|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||Undecided||2017-10-10 21:04:07.226237|2017-10-10 21:04:07.226237
NCT03153397|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-18|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)|Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)|Not yet recruiting||N/A|22|Anticipated|Duke University||2|||f||||f|f|f|||f|||||2017-10-10 21:04:07.341183|2017-10-10 21:04:07.341183
NCT03153384|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-08-08|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|September 2020|Anticipated|2020-09-01|6 Weeks|Observational [Patient Registry]|UniEndo||Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis|Impact of the Blood Culture Technique on the Diagnosis of Infectious Diseases: Case of Infective Endocarditis.|Not yet recruiting||N/A|500|Anticipated|Central Hospital, Nancy, France|||1||f||||t|f|f||||||||2017-10-10 21:04:07.437768|2017-10-10 21:04:07.437768
NCT03153371|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-11|||April 4, 2016|Actual|2016-04-04|May 2017|2017-05-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2021|Anticipated|2021-03-31||Observational|EOAD-Subtype||Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks|Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks|Recruiting||N/A|180|Anticipated|University of California, Los Angeles|||3||f|||||f|f||||||No||2017-10-10 21:04:07.568311|2017-10-10 21:04:07.568311
NCT03153358|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-13|||June 2, 2017|Anticipated|2017-06-02|May 2017|2017-05-01|May 2, 2019|Anticipated|2019-05-02|November 2, 2017|Anticipated|2017-11-02||Interventional|||Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation|Icotinib Combined With Stereotactic Body Radiation Therapy (SBRT) for Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Sensitive Mutation|Not yet recruiting||Phase 2|60|Anticipated|Sichuan Cancer Hospital and Research Institute||1|||f|||||f|f||||||No||2017-10-10 21:04:07.679393|2017-10-10 21:04:07.679393
NCT03153345|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-12|||March 1, 2015|Actual|2015-03-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|October 31, 2016|Actual|2016-10-31||Interventional|||The Efficacy of Bedside Respiratory Muscle Training in Stroke Patients|The Efficacy of Bedside Respiratory Muscle Training in Stroke Patients: A Randomized Controlled Trial|Completed||N/A|40|Actual|Korea University Anam Hospital||2|||f|||||f|t|f|f|t|||||2017-10-10 21:04:07.863779|2017-10-10 21:04:07.863779
NCT03153319|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-11|||June 5, 2017|Actual|2017-06-05|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I and II|Phase 1/2 Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I and II|Recruiting||Phase 1/Phase 2|14|Anticipated|Los Angeles Biomedical Research Institute||3|||f|||||t|f||||||||2017-10-10 21:04:08.072826|2017-10-10 21:04:08.072826
NCT03153306|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-12|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient||Recruiting||Phase 4|60|Anticipated|Hainan People's Hospital||2|||f||||t||||||||Yes||2017-10-10 21:04:08.210351|2017-10-10 21:04:08.210351
NCT03150641|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-25|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Delayed Cord Clamping at Term Cesarean|Maternal Blood Loss With Delayed Cord Clamping During Cesarean Delivery at Term|Recruiting||N/A|110|Anticipated|Columbia University||2|||f||||f|f|f||||||||2017-10-10 21:04:37.797935|2017-10-10 21:04:37.797935
NCT03153293|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-02|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy|Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy|Recruiting||Phase 2/Phase 3|48|Anticipated|Huazhong University of Science and Technology||2|||f||||t|f|f||||||||2017-10-10 21:04:08.316714|2017-10-10 21:04:08.316714
NCT03153280|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-12|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|August 2019|Anticipated|2019-08-01||Interventional|Lithium||Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer|A Phase Ib, Dose Escalation Study of Lithium When Added to Standard Chemotherapy of Oxaliplatin and Capecitabine in Patients With Advanced Oesophago-Gastric or Colorectal Cancer|Not yet recruiting||Phase 1|24|Anticipated|Cancer Trials Ireland||1|||f||||t|f|f||||||No||2017-10-10 21:04:08.440987|2017-10-10 21:04:08.440987
NCT03153267|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-05-12|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Duration of Doxycycline Treatment in EM Patients|Duration of Doxycycline Treatment in Patients With Erythema Migrans (EM). A Randomized Clinical Trial.|Not yet recruiting||N/A|300|Anticipated|University Medical Centre Ljubljana||3|||f||||f|f|f|||f|||Undecided||2017-10-10 21:04:08.590246|2017-10-10 21:04:08.590246
NCT03153254|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-12|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|March 31, 2018|Anticipated|2018-03-31||Interventional|ARTHE||Active Smart Wearable Orthosis for Enhanched Rehabilitation THErapy|Usability Study of an Active Smart Wearable Orthosis for Enhanched Rehabilitation Therapy in Stroke Patients|Not yet recruiting||N/A|20|Anticipated|Thomas More Kempen||2|||f||||f|f|f||||||No||2017-10-10 21:04:08.715402|2017-10-10 21:04:08.715402
NCT03153241|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-12|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|December 1, 2017|Anticipated|2017-12-01|1 Month|Observational [Patient Registry]|||Subglottic Secretion Culture in Predicting Tracheal Microbial Flora|Value of Subglottic Secretion Culture in Predicting Microbial Flora of Tracheal Secretions in Intubated Patients. A Prospective Observational Study|Not yet recruiting||N/A|200|Anticipated|Policlinico Universitario Agostino Gemelli|||1||f||||f|f|f||||Samples Without DNA|"     subglottic secretions and tracheal aspirates   "|Undecided||2017-10-10 21:04:08.835307|2017-10-10 21:04:08.835307
NCT03153228|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-12|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Observational|||Acute Response to Cigarette and E-cigarette Smoking Assesed in Exhaled Breath Condensate in Healthy Smokers of Traditional and E-cigarettes|The Comparison of Biomarkers of Acute Response to Cigarette Smoking and E-cigarettes Smoking Assesed in Exhaled Breath Condensate in Healthy Smokers of Traditional and Electronical Cigarettes.|Enrolling by invitation||N/A|87|Anticipated|Medical University of Warsaw|||3||f||||f|f|f|||f|Samples With DNA|"     exhaled breath condensate   "|||2017-10-10 21:04:08.934464|2017-10-10 21:04:08.934464
NCT03153215|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-12|||May 6, 2017|Actual|2017-05-06|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|IUGR||Sildenafil in Sever Intrauterine Growth Retardation|Evaluation of Addition of Sildenafil Citrate for Treatment of Severe Intrauterine Growth Restriction|Recruiting||N/A|46|Anticipated|Beni-Suef University||2|||f||||t|f|f||||||No||2017-10-10 21:04:09.02096|2017-10-10 21:04:09.02096
NCT03153202|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-19|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|May 2022|Anticipated|2022-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)|Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)|Recruiting||Phase 1/Phase 2|40|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|t|f||||||||2017-10-10 21:04:09.135096|2017-10-10 21:04:09.135096
NCT03153189|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-06-01|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|PA||Correlates of Physical Activity With Quality of Life in College Women of Manipal University|Correlates of Physical Activity With Anthropometric Traits, Mental Health and Quality of Life in College Women of Manipal University|Completed||N/A|61|Actual|Manipal University|||1||f||||t|f|f||||||No||2017-10-10 21:04:09.250188|2017-10-10 21:04:09.250188
NCT03153176|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-06-04|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|October 25, 2019|Anticipated|2019-10-25|October 24, 2017|Anticipated|2017-10-24||Interventional|EA||"Escola em Ação (School in Action)"|"Escola em Ação: School Based Interventions of Incentive to the Practice Physical and Life Habits of Healthy Promotion"|Recruiting||N/A|320|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||t|f|f||||||No|This sharing is available for principal researchers and collaborators and may be obtained by individual report after data analysis|2017-10-10 21:04:09.330708|2017-10-10 21:04:09.330708
NCT03153163|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-27|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|September 10, 2019|Anticipated|2019-09-10|November 20, 2018|Anticipated|2018-11-20||Interventional|||Study of the Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Participants With Locally Advanced Inoperable or Metastatic HER2+ Breast Cancer|A Phase I Study of Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Patients With Logically Advanced Inoperable or Metastatic HER2-Positive Breast Cancer Who Have Received Prior Trastuzumab Based Therapy|Recruiting||Phase 1|8|Anticipated|Hoffmann-La Roche||1|||f||||f|t|f|||t|||||2017-10-10 21:04:09.446553|2017-10-10 21:04:09.446553
NCT03153150|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-12|||July 3, 2017|Anticipated|2017-07-03|May 2017|2017-05-01|July 1, 2023|Anticipated|2023-07-01|July 2, 2022|Anticipated|2022-07-02||Interventional|SoSTART||Start or STop Anticoagulants Randomised Trial (SoSTART)|Start or STop Anticoagulants Randomised Trial (SoSTART) After Spontaneous Intracranial Haemorrhage|Not yet recruiting||Phase 3|800|Anticipated|University of Edinburgh||2|||f||||t|f|f||||||Yes|The Chief Investigator (Prof. Rustam Al-Shahi Salman) has established the Collaboration Of Controlled Randomised trials of Oral Antithrombotic drugs after intraCranial Haemorrhage (COCROACH) working towards a pre-planned individual patient data meta-analysis|2017-10-10 21:04:09.551742|2017-10-10 21:04:09.551742
NCT03152981|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-05-18|||July 1, 2016|Actual|2016-07-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Analysis of Change of Optic Nerve Sheath Diameter in Robot Assisted Laparoscopic Radical Prostatectomy|Analysis of Change of Optic Nerve Sheath Diameter Using Ultrasonography in Robot Assisted Laparoscopic Radical Prostatectomy|Recruiting||N/A|60|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 21:04:11.723083|2017-10-10 21:04:11.723083
NCT03153137|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-09-29|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|March 9, 2020|Anticipated|2020-03-09|June 9, 2019|Anticipated|2019-06-09||Interventional|RUBATO||Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects|Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Adult and Adolescent Subjects.|Recruiting||Phase 3|134|Anticipated|Actelion||2|||f||||t|t|f||||||||2017-10-10 21:04:09.802738|2017-10-10 21:04:09.802738
NCT03153124|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-12|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|December 30, 2018|Anticipated|2018-12-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||EFFECTS OF RESPIRATORY MUSCLE TRAINING IN MUSCLE FORCE, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN HEMODIALYSIS PATIENTS|EFFECTS OF RESPIRATORY MUSCLE TRAINING IN MUSCLE FORCE, FUNCTIONAL CAPACITY AND QUALITY OF LIFE IN HEMODIALYSIS PATIENTS|Recruiting||N/A|46|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f|||||f|f||||||||2017-10-10 21:04:10.033169|2017-10-10 21:04:10.033169
NCT03153098|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-12|||January 7, 2016|Actual|2016-01-07|April 2017|2017-04-01|January 7, 2019|Anticipated|2019-01-07|January 7, 2019|Anticipated|2019-01-07||Observational|||An Evaluation of the Active Herts Physical Activity Programme|Physical Activity Promotion in Areas of Deprivation for Inactive Adults With Cardiovascular Disease (CVD) Risk: An Evaluation of Active Herts|Recruiting||N/A|739|Anticipated|University of East Anglia|||2||f||||f|f|f||||||||2017-10-10 21:04:10.576044|2017-10-10 21:04:10.576044
NCT03153085|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-28|||May 25, 2017|Actual|2017-05-25|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Study of Combination With TBI-1401(HF10) and Ipilimumab in Japanese Patients With Unresectable or Metastatic Melanoma|A Phase II Study of Combination Treatment With TBI-1401(HF10), a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab in Japanese Patients With Stage IIIB, IIIC, or IV Unresectable or Metastatic Malignant Melanoma|Recruiting||Phase 2|25|Anticipated|Takara Bio Inc.||1|||f||||t|f|f|||f|||||2017-10-10 21:04:10.708079|2017-10-10 21:04:10.708079
NCT03153072|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-12|||September 6, 2016|Actual|2016-09-06|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|Enteramio||Evaluation of the Pharmacokinetic Profile, Pharmacodynamic Effects, Acceptability and Tolerability of an Oral Amiodarone Solution of 15 mg / mL in Children With Supra Ventricular Tachycardia|Evaluation of the Pharmacokinetic Profile, Pharmacodynamic Effects, Acceptability and Tolerability of an Oral Amiodarone Solution of 15 mg / mL in Children With Supra Ventricular Tachycardia|Withdrawn||Phase 2|0|Actual|Centre Hospitalier Universitaire, Amiens||1||decision of the investigator|f|||||f|f||||||||2017-10-10 21:04:10.891515|2017-10-10 21:04:10.891515
NCT03153059|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||May 11, 2017|Anticipated|2017-05-11|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Gut Microbiota and Stool Frequency|The Association Between Gut Microbiota and Stool Frequency|Recruiting||N/A|60|Anticipated|Kosin University Gospel Hospital|||3||f||||f|f|f||||Samples With DNA|"     We will collect the stool from participants, and extract DNA from stool sample. We plan to     acquire the Human Derivative Research Description.   "|No|We have no plan to share IPD to other researchers.|2017-10-10 21:04:10.98981|2017-10-10 21:04:10.98981
NCT03153046|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-12|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|Prepsy||The Effects of Prebiotics on Cognitive Functioning and Weight Gain in Psychosis|Effects of Modulating the Immune System With Prebiotics on Cognition and Weight in Patients With Psychosis|Recruiting||N/A|40|Anticipated|University of Oxford||2|||f||||f|f|f||||||Undecided||2017-10-10 21:04:11.085932|2017-10-10 21:04:11.085932
NCT03153033|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-15|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Fatigue Induced by Overground Wheelchair Propulsion in Persons With a Spinal Cord Injury: Upper Limb Saving or Straining?|The Effect of a Wheelchair Propulsion-induced Fatigue Protocol on Biomechanical and Neuromuscular Risk Factors of Shoulder Pain in Persons With a Spinal Cord Injury Living in Switzerland: a Cross-sectional Study With a Repeated Measures Within Subject Design|Recruiting||N/A|50|Anticipated|Swiss Paraplegic Research|||1||f||||t|f|f||||||Undecided||2017-10-10 21:04:11.213377|2017-10-10 21:04:11.213377
NCT03153020|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|December 2017|Anticipated|2017-12-01||Observational|OBSTACLE||Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône|Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône|Not yet recruiting||N/A|750|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 21:04:11.385563|2017-10-10 21:04:11.385563
NCT03153007|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-03|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Study of Subjects With Diabetic Foot Ulcer (DFU)|Qualitative Research in Patients With Diabetic Foot Ulcer|Not yet recruiting||N/A|1|Anticipated|GlaxoSmithKline|||1||f||||f|f|f||||||||2017-10-10 21:04:11.50957|2017-10-10 21:04:11.50957
NCT03152994|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-11|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|May 1, 2020|Anticipated|2020-05-01|April 1, 2020|Anticipated|2020-04-01|3 Years|Observational [Patient Registry]|||The Early Predictors for Developing Type 2 Diabetes Mellitus in Patients With Chronic Obstructive Pulmonary Disease|The Early Predictors,Neutrophil-lymphocyte Ratio (NLR), Platelet-lymphocyte Ratio (PLR) and Lymphocyte-monocyte Ratio (LMR) for Developing Type 2 Diabetes Mellitus in Stable Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|500|Anticipated|Zhujiang Hospital|||2||f||||t|f|f||||||Undecided||2017-10-10 21:04:11.589246|2017-10-10 21:04:11.589246
NCT03152604|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-11|||June 28, 2017|Anticipated|2017-06-28|May 2017|2017-05-01|August 8, 2018|Anticipated|2018-08-08|August 8, 2018|Anticipated|2018-08-08||Observational|||Effectiveness of a Pain Management Programme|The Effectiveness of a Pain Management Programme for Patients With Persistent Pain|Recruiting||N/A|30|Anticipated|Teesside University|||1||f|||||f|f||||||||2017-10-10 21:04:14.971096|2017-10-10 21:04:14.971096
NCT03152968|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-01|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31|1 Month|Observational [Patient Registry]|FMS||To Observe Ability of Fundamental Movement Skills in School Children of Age 5 to 10-year-old in Udupi District|Proficiency of Fundamental Movement Skills in 5 -10 Years Old School Children in Udupi District|Completed||N/A|461|Actual|Manipal University|||1||f||||t|f|f||||||No||2017-10-10 21:04:11.838116|2017-10-10 21:04:11.838116
NCT03152955|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-12|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Postoperative Analgesia in Patients With Microvascular Decompression|Efficacy and Safety of Multimodal Analgesia Used in Patients With Microvascular Decompression|Not yet recruiting||Phase 4|90|Anticipated|Xiangya Hospital of Central South University||3|||f|||||f|f||||||Undecided||2017-10-10 21:04:11.91439|2017-10-10 21:04:11.91439
NCT03152942|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-05-11|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|PROGRAM||Progesterone and Aminophylline for the Prevention of Preterm Labour|A Randomised Controlled Feasibility Study of the Tolerability of the Combination of Progesterone and Aminophylline for the Prevention of Preterm Labour|Not yet recruiting||Phase 1|70|Anticipated|St Stephens Aids Trust||2|||f||||f|f|f|||f|||No||2017-10-10 21:04:12.032376|2017-10-10 21:04:12.032376
NCT03152929|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-11|||December 20, 2016|Actual|2016-12-20|May 2017|2017-05-01|February 1, 2023|Anticipated|2023-02-01|February 1, 2022|Anticipated|2022-02-01||Interventional|||Paravertebral Block Versus Pectoral Nerve Block|Paravertebral Block Versus Pectoral Nerve Block for Analgesia Following Mastectomy|Recruiting||Phase 3|128|Anticipated|Spectrum Health Hospitals||2|||f||||f|t|f||||||No||2017-10-10 21:04:12.123588|2017-10-10 21:04:12.123588
NCT03152916|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-12|||January 1, 2014|Actual|2014-01-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Application of 3D Printing Technology in Subtalar Arthrodesis|Application of 3D Printing Technology in Subtalar Arthrodesis|Recruiting||N/A|20|Anticipated|Southwest Hospital, China||1|||f|||||f|f||||||No||2017-10-10 21:04:12.27043|2017-10-10 21:04:12.27043
NCT03152903|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-12|||July 15, 2017|Anticipated|2017-07-15|May 2017|2017-05-01|November 20, 2019|Anticipated|2019-11-20|August 20, 2019|Anticipated|2019-08-20||Interventional|||Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence in India|A Multicenter Phase II/III Double-Blind, Randomized, Placebo Controlled Study To Evaluate The Efficacy And Safety Of VPM1002 In The Prevention Of Tuberculosis (TB) Recurrence In Pulmonary TB Patients After Successful TB Treatment In India|Not yet recruiting||Phase 2/Phase 3|2000|Anticipated|Serum Institute of India Pvt. Ltd.||2|||f||||t|f|f||||||No||2017-10-10 21:04:12.364544|2017-10-10 21:04:12.364544
NCT03152890|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-15|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|May 15, 2018|Anticipated|2018-05-15|April 15, 2018|Anticipated|2018-04-15||Interventional|INS_LTPL||Insulin Therapy for Postreperfusion Hyperglycemia|Insulin Therapy for Postreperfusion Hyperglycemia in Liver Transplantation|Recruiting||Phase 4|20|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:04:12.447066|2017-10-10 21:04:12.447066
NCT03152877|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy of Extended-Release Liposomal Bupivacaine for Post-Partum Pain Management Following Obstetrical Laceration|Efficacy of Extended-Release Liposomal Bupivacaine for Post-Partum Pain Management Following Obstetrical Laceration: A Prospective, Randomized, Single-Blinded Trial|Not yet recruiting||N/A|96|Anticipated|Walter Reed National Military Medical Center||2|||f||||f|f|f|||f|||No||2017-10-10 21:04:12.567328|2017-10-10 21:04:12.567328
NCT03152864|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-24|||March 1, 2018|Anticipated|2018-03-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|SRMH||Stabilizing Behavioral Rhythms to Improve Mental Health|Stabilizing Behavioral Rhythms to Improve Mental Health|Not yet recruiting||N/A|128|Anticipated|HealthRhythms, Inc.||2|||f||||t|f|f||||||||2017-10-10 21:04:12.691384|2017-10-10 21:04:12.691384
NCT03152851|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-13|||November 2016||2016-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Effect of Sonographic Bladder Compressive Technique for Bag Urine Collection in Pediatrics|The Effect of Sonographic Bladder Compressive Stimulation Technique for Bag Urine Collection in Pediatrics: Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Seoul National University Bundang Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:04:12.772772|2017-10-10 21:04:12.772772
NCT03152838|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-12|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|September 1, 2018|Anticipated|2018-09-01||Observational|||The Role of Epigenetic Modifications in Autism Spectrum Disorder|The Role of Epigenetic Modifications in Autism Spectrum Disorder Through DNA Methylation|Not yet recruiting||N/A|40|Anticipated|Assiut University|||2||f||||f|f|f||||||No||2017-10-10 21:04:12.998242|2017-10-10 21:04:12.998242
NCT03152825|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-09-12|||May 10, 2017|Actual|2017-05-10|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01|12 Months|Observational [Patient Registry]|CARISMA_CTO||Stress CMR in Patients With Coronary Chronic Total Occlusions|Stress Perfusion Cardiac Magnetic Resonance for Ischaemia and Viability Detection in Patients With Coronary Chronic Total Occlusions|Recruiting||N/A|400|Anticipated|Ospedale San Donato|||4||f|||||f|f||||||||2017-10-10 21:04:13.12681|2017-10-10 21:04:13.12681
NCT03152812|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-05-20|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01|2 Years|Observational [Patient Registry]|||Functional Outcome of Free Muscle Flaps Versus Free Skin Flaps for Post-traumatic Foot Plantar Surface Reconstruction|Functional Outcome of Free Muscle Flaps Versus Free Skin Flaps for Post-traumatic Foot Plantar Surface Reconstruction|Enrolling by invitation||N/A|40|Anticipated|Assiut University|||2||f||||f|f|f||||||No||2017-10-10 21:04:13.265322|2017-10-10 21:04:13.265322
NCT03152799|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-11|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|August 1, 2019|Anticipated|2019-08-01||Interventional|RICE PAC||Remote Ischaemic Conditioning in Endovascular Recanalization for Proximal Anterior Circulation Occlusion Study|Remote Ischaemic Conditioning in Endovascular Recanalization for Proximal Anterior Circulation Occlusion (RICE PAC) Study|Not yet recruiting||Phase 1|60|Anticipated|University College, London||2|||f||||t|f|f||||||No||2017-10-10 21:04:13.371885|2017-10-10 21:04:13.371885
NCT03152136|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-08-29|||July 26, 2017||2017-07-26||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:04:19.738417|2017-10-10 21:04:19.738417
NCT03152786|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery|Evaluating the Effect of ADRB2 Blockers on PKA/BAD/CREB Signaling in Patients Undergoing Prostatectomy|Not yet recruiting||Phase 2|50|Anticipated|Wake Forest University Health Sciences||2|||f||||t|t|f||||||||2017-10-10 21:04:13.521385|2017-10-10 21:04:13.521385
NCT03152773|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-12|2017-08-09|||August 2, 2017|Actual|2017-08-02|June 30, 2017|2017-06-30|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Right Heart Catheterization Using Magnetic Resonance Imaging Fluoroscopy and Passive Guidewires|Right Heart Catheterization Using MRI Fluoroscopy and Passive Guidewires|Recruiting||Phase 1/Phase 2|12|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f|||||t|t|f|||||||2017-10-10 21:04:13.64402|2017-10-10 21:04:13.64402
NCT03152747|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-11|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|May 2018|Anticipated|2018-05-01||Observational|MYOPRED||Influence of Posterior Vitreous Detachment on Retinal Detachment After Lens Surgery in Myopic Eyes|Influence of Posterior Vitreous Detachment on Retinal Detachment After Lens Surgery in Myopic Eyes|Recruiting||N/A|618|Anticipated|Vienna Institute for Research in Ocular Surgery|||2||f|||||f|f||||||||2017-10-10 21:04:13.862537|2017-10-10 21:04:13.862537
NCT03152734|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|March 31, 2018|Anticipated|2018-03-31||Observational|POSE||Periinterventional Outcome Study in the Elderly|Periinterventional Outcome Study in the Elderly (POSE): European, Multi-centre, Prospective Observational Cohort Study|Not yet recruiting||N/A|7500|Anticipated|RWTH Aachen University|||1||f||||f|f|f||||||No||2017-10-10 21:04:13.971713|2017-10-10 21:04:13.971713
NCT03152721|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-12|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|May 30, 2018|Anticipated|2018-05-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease|Interventional Study of the Effect of Parkinson Kinetigraph Recordings on the Clinical Management and Outcome in Parkinson's Disease|Enrolling by invitation||N/A|120|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:04:14.112588|2017-10-10 21:04:14.112588
NCT03152708|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-20|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 1, 2017|Anticipated|2017-12-01||Observational|||CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma|The Exploratory Study on CAN008 Biomarker CD95 Ligand and Its Promoter (CpG2) Methylation in Chinese Patients With Glioblastoma|Not yet recruiting||N/A|62|Anticipated|CANbridge Life Sciences Ltd.|||1||f||||f|f|f||||||||2017-10-10 21:04:14.269193|2017-10-10 21:04:14.269193
NCT03152695|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-27|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|HIFU||High-intensity Focused Ultrasound (HIFU) for the Symptom Relief of Inoperable Abdominal Tumors|To Evaluate the Safety and Efficacy of High-intensity Focused Ultrasound (HIFU) for the Symptom Relief of Inoperable Abdominal Tumors|Recruiting||N/A|30|Anticipated|National Taiwan University Hospital||1|||f|||||f|f||||||||2017-10-10 21:04:14.33457|2017-10-10 21:04:14.33457
NCT03152682|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-26|||April 22, 2017|Actual|2017-04-22|July 2017|2017-07-01|August 29, 2017|Anticipated|2017-08-29|August 8, 2017|Anticipated|2017-08-08||Interventional|||A Study Evaluating Good Idea on Glucose Homeostasis in a Healthy Population|A Multi-centre Randomized, Double-blind, Placebo-controlled, Crossover, Proof-of-concept Study to Evaluate the Efficacy and Safety of Good IdeaTM on Glucose Homeostasis in a Healthy Population|Recruiting||Phase 1|60|Anticipated|DoubleGood AB||2|||f||||f|f|f||||||||2017-10-10 21:04:14.42072|2017-10-10 21:04:14.42072
NCT03152669|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-28|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|April 30, 2028|Anticipated|2028-04-30|April 30, 2028|Anticipated|2028-04-30||Observational|||"The Extended Salford Lung Study (Ex-SLS) Data Access Project"|"The Extended Salford Lung Study (Ex-SLS) Data Access Project"|Not yet recruiting||N/A|3500|Anticipated|GlaxoSmithKline|||2||f||||f|f|f||||||||2017-10-10 21:04:14.534861|2017-10-10 21:04:14.534861
NCT03152656|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||July 2015|Actual|2015-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|1 Year|Observational [Patient Registry]|||A Registration Study for Familial Hypercholesterolemia in Taiwan|A Registration Study for Familial Hypercholesterolemia in Taiwan|Recruiting||N/A|1000|Anticipated|National Taiwan University Hospital|||1||f||||t|f|f||||||Yes||2017-10-10 21:04:14.601295|2017-10-10 21:04:14.601295
NCT03152643|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|CLBR-CBSET||Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer|Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer:A Multicenter, Prospective, Randomized, Blinded Controlled Trial|Not yet recruiting||N/A|1200|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f|||||f|f||||||No||2017-10-10 21:04:14.688581|2017-10-10 21:04:14.688581
NCT03152630|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||March 30, 2016|Actual|2016-03-30|May 2017|2017-05-01|January 2036|Anticipated|2036-01-01|January 2036|Anticipated|2036-01-01||Observational|||Research on the Early and Prognosis Diagnosis of Vascular Dementia|Research on the Early and Prognosis Diagnosis of Vascular Dementia|Recruiting||N/A|600|Anticipated|National Taiwan University Hospital|||1||f||||t|f|f||||||Yes||2017-10-10 21:04:14.768552|2017-10-10 21:04:14.768552
NCT03152617|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-05-29|||April 2015||2015-04-01|May 2017|2017-05-01|December 2027|Anticipated|2027-12-01|April 2027|Anticipated|2027-04-01|10 Years|Observational [Patient Registry]|BASUN||BASUN - Risks for Malnutrition, Metabolic Bone Disease and Impaired Oral Health After Obesity Treatment|BASUN - Risks for Malnutrition, Metabolic Bone Disease and Impaired Oral Health After Obesity Treatment - Interaction With Gastrointestinal Microbiota, Psychiatric Morbidity and Socioeconomics|Recruiting||N/A|1400|Anticipated|Göteborg University|||1||f||||f||||||Samples With DNA|"     Blood   "|No||2017-10-10 21:04:14.857576|2017-10-10 21:04:14.857576
NCT03152591|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-12|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|PCOS||Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome|A Randomized, Subject- and Investigator-blinded, Placebo-controlled Pharmacodynamic Study of Oral LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome|Recruiting||Phase 2|24|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:04:15.080637|2017-10-10 21:04:15.080637
NCT03152578|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee|Randomized, Double Blind, Placebo Controlled Crossover Trial With Open Label Extension Of Topical 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin In The Treatment Of Pain Caused By Osteoarthritis Of The Knee|Not yet recruiting||Phase 2|56|Anticipated|Panag Pharma Inc.||3|||f|||||f|f||||||||2017-10-10 21:04:15.18835|2017-10-10 21:04:15.18835
NCT03152565|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-15|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|AVEVAC||Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients.|A Single Arm Phase I-II Multicenter Trial With Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Mismatch Repair-proficient (MSS) Metastatic Colorectal Cancer Patients.|Not yet recruiting||Phase 1/Phase 2|33|Anticipated|Grupo Espanol Multidisciplinario del Cancer Digestivo||1|||f||||t|f|f||||||No||2017-10-10 21:04:15.302872|2017-10-10 21:04:15.302872
NCT03152552|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-08-09|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|November 5, 2018|Anticipated|2018-11-05|November 5, 2018|Anticipated|2018-11-05||Interventional|||A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure|A Multi-center, Randomized, Double-blind, Parallel-group Dose-finding Study to Assess the Effect of 3 Doses of LIK066 Compared to Placebo or Empagliflozin in Type 2 Diabetes Mellitus Patients With Heart Failure|Recruiting||Phase 2|496|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 21:04:15.381777|2017-10-10 21:04:15.381777
NCT03152539|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-11|||June 7, 2012|Actual|2012-06-07|May 2017|2017-05-01|June 7, 2017|Anticipated|2017-06-07|June 6, 2017|Anticipated|2017-06-06||Interventional|MAP-VS||Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Healthy Volunteers|Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Healthy Volunteers|Recruiting||N/A|800|Anticipated|University Hospital, Grenoble||3|||f||||t|f|f||||||No||2017-10-10 21:04:15.50439|2017-10-10 21:04:15.50439
NCT03152526|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-21|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2021|Anticipated|2021-06-01||Interventional|||CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR|A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for Adults With Acute Myelogenous Leukemia Who Have Failed 1 or 2 Induction Attempts|Not yet recruiting||Phase 2|41|Anticipated|Miltenyi Biotec GmbH||1|||f||||t|f|t|t|f||||||2017-10-10 21:04:15.600409|2017-10-10 21:04:15.600409
NCT03152513|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-11|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|1 Day|Observational [Patient Registry]|||"A Review of Anesthesia Stat! in the Pediatric Operating Room"|"A Combined Retrospective and Prospective Review of Anesthesia Stat! Events in the Pediatric Operating Room"|Recruiting||N/A|260|Anticipated|Wake Forest University Health Sciences|||1||f||||f|f|f||||||No||2017-10-10 21:04:15.676192|2017-10-10 21:04:15.676192
NCT03152500|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-12|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|October 30, 2017|Anticipated|2017-10-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Evaluation of Stability After Implantation of Two Different Lens Models: FEMTIS-study|A Randomised, Subject-masked Evaluation of Stability After Implantation of Two Different Lens Models: FEMTIS-study|Recruiting||N/A|40|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||No|No IPD will be shared|2017-10-10 21:04:15.757045|2017-10-10 21:04:15.757045
NCT03152487|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-17|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Trial Comparing EUS-guided Celiac Ganglion Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis|Randomized Trial Comparing Endoscopic Ultrasound-guided Celiac Ganglion Radiofrequency Ablation vs.Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Alleviation of Abdominal Pain in Patients With Pancreatic Cancer|Recruiting||N/A|30|Anticipated|Florida Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:04:15.853446|2017-10-10 21:04:15.853446
NCT03152474|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-15|||February 1993||1993-02-01|April 2017|2017-04-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Adrenal Cortical Function and Vitamin A Deficiency in Sepsis|Adrenal Cortical Function and Vitamin A Deficiency in Sepsis, Severe Sepsis and Septic Shock: Prospective Randomized, Double Blind Placebo Controlled Clinical Trials|Completed||Phase 4|300|Actual|Los Angeles Biomedical Research Institute||3|||f||||f|f|f||||||Yes|Only the de-identified study data will be shared with the other researchers.|2017-10-10 21:04:15.952775|2017-10-10 21:04:15.952775
NCT03152461|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-30|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Observational|||Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge|Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge in Adult Patients Undergoing Major Surgical Procedures|Enrolling by invitation||N/A|278|Anticipated|HemoSonics LLC|||1||f||||f|f|t|t|f|f|||No||2017-10-10 21:04:16.054719|2017-10-10 21:04:16.054719
NCT03152448|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-05-10|||September 1, 2015|Actual|2015-09-01|May 2017|2017-05-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01|5 Years|Observational [Patient Registry]|P-PROVE||Prospective Prolaris Value and Efficacy|Two-Part Prospective Study to Measure Impact of Prolaris® Testing Added to Treatment Decision Following Biopsy in Newly Diagnosed Prostate Cancer Patients to Measure Prediction of Progression/Recurrence in Men Treated at VAMC|Recruiting||N/A|1500|Anticipated|Myriad Genetic Laboratories, Inc.|||1||f||||f|f|f||||Samples With DNA|"     Formalin-fixed paraffin-embedded (FFPE) tissue from blocks or slides of prostatic     adenocarcinoma biopsies   "|Yes|Results of Prolaris testing to be shared with provider and patient per commercial process; study results to be presented in a pier reviewed publication in aggregate form only (no individual participant data to be shared through publications or abstracts)|2017-10-10 21:04:16.143936|2017-10-10 21:04:16.143936
NCT03152435|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-08-13|||June 15, 2017|Actual|2017-06-15|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||EGFR CART Cells for Patients With Metastatic Colorectal Cancer|Phase I/II Study of EGFR CART Cells for Patients With Metastatic Colorectal Cancer.|Recruiting||Phase 1/Phase 2|20|Anticipated|Shenzhen Second People's Hospital||1|||f||||f|f|f||||||||2017-10-10 21:04:16.295961|2017-10-10 21:04:16.295961
NCT03152422|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-11|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|May 8, 2017|Actual|2017-05-08||Observational|uPROPHET||Urinary Proteomics in Predicting Heart Transplantation Outcomes|Urinary Proteomics in Predicting Heart Transplantation Outcomes|Active, not recruiting||N/A|352|Actual|Katholieke Universiteit Leuven|||1||f||||f|f|f||||||No||2017-10-10 21:04:16.48191|2017-10-10 21:04:16.48191
NCT03152409|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-13|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Interventional|SAD||Salicylic Augmentation in Depression|Salicylic Augmentation in Depression|Not yet recruiting||Phase 2|74|Anticipated|Brigham and Women's Hospital||2|||f||||f|t|f|||t|||||2017-10-10 21:04:16.558251|2017-10-10 21:04:16.558251
NCT03152396|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-25|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|RxIALTA||Pharmacist CVD Intervention for Patients With Inflammatory Arthritis|RxIALTA: Pharmacist CVD Intervention for Patients With Inflammatory Arthritis|Recruiting||N/A|100|Anticipated|Epidemiology Coordinating and Research Centre, Canada||1|||f||||f|f|f||||||||2017-10-10 21:04:16.693824|2017-10-10 21:04:16.693824
NCT03152383|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||June 22, 2012|Actual|2012-06-22|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Examination of Differential Valuation of Leisure Items and Attention as Reinforcers in Children With Autism|Examination of Differential Valuation of Leisure Items and Attention as Reinforcers in Children With Autism|Recruiting||N/A|100|Anticipated|Emory University||3|||f||||f|f|f||||||Undecided||2017-10-10 21:04:16.841165|2017-10-10 21:04:16.841165
NCT03152370|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-09-21|||May 17, 2017|Actual|2017-05-17|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|PRAER 1||Preoperative Radiotherapy and E7046 in Rectum Cancer|An Open-Label Multicenter Phase 1b Study of E7046 in Combination With Radiotherapy/Chemoradiotherapy (RT/CRT) in Preoperative Treatment of Subjects With Rectum Cancer|Recruiting||Phase 1|68|Anticipated|Eisai Inc.||2|||f||||t|t|f||||||||2017-10-10 21:04:16.966919|2017-10-10 21:04:16.966919
NCT03152357|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||A Retrospective Study to Evaluate the ConforMIS iUni, iDuo & iTotal® KRS|A Retrospective Study to Evaluate the ConforMIS iUni, iDuo & iTotal® CR (Cruciate Retaining) Knee Replacement Systems|Recruiting||N/A|1000|Anticipated|ConforMIS, Inc.|||1||f||||f|f|t|f|f|t|||No||2017-10-10 21:04:17.104445|2017-10-10 21:04:17.104445
NCT03152344|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||January 2, 2017|Actual|2017-01-02|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Observational|Equil-BPCO||Evaluation of a Simple Clinical Test to Detect the Risk of Falling in Patients With BPCO and Research for Predictive Factors of Fall Risk.|Evaluation of a Simple Clinical Test to Detect the Risk of Falling in Patients With Chronic Obstructive Pulmonary Disease and Research for Predictive Factors of Fall Risk.|Recruiting||N/A|80|Anticipated|University Hospital, Clermont-Ferrand|||2||f|||||f|f||||||||2017-10-10 21:04:17.208109|2017-10-10 21:04:17.208109
NCT03152331|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-28|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|April 19, 2018|Anticipated|2018-04-19|April 19, 2018|Anticipated|2018-04-19||Interventional|||Nurse and Physician Stress Reduction: Learning Receptive Awareness Via EEG Feedback|Nurse and Physician Stress Reduction: Learning Receptive Awareness Via EEG Feedback|Recruiting||N/A|50|Anticipated|Mercy Health, Ohio||1|||f||||f|f|f||||||||2017-10-10 21:04:17.314122|2017-10-10 21:04:17.314122
NCT03152318|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-18|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|August 1, 2023|Anticipated|2023-08-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2|A Phase I Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2, a Genetically Engineered HSV-1 Virus, and Immunomodulation With Cyclophosphamide|Recruiting||Phase 1|108|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 21:04:17.438591|2017-10-10 21:04:17.438591
NCT03152305|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||July 21, 2014|Actual|2014-07-21|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|May 2017|Anticipated|2017-05-01||Observational|MigICP||Intracranial Pressure During Migraine|Measure of Intracranial Pressure Variations During Migraine Attacks|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||2||f|||||f|f||||||||2017-10-10 21:04:17.56293|2017-10-10 21:04:17.56293
NCT03152292|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-06-12|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study|Management of Parkinson's Disease Psychosis in Actual Practice (The INSYTE Study)|Recruiting||N/A|750|Anticipated|ACADIA Pharmaceuticals Inc.|||3||f||||f|f|f||||||No||2017-10-10 21:04:17.670902|2017-10-10 21:04:17.670902
NCT03152279|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-12|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance|Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance|Enrolling by invitation||N/A|50|Anticipated|Vanderbilt University Medical Center|||2||f||||f|f|f||||||No||2017-10-10 21:04:17.775832|2017-10-10 21:04:17.775832
NCT03152266|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-23|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Observational|||Function Outcome of Impaction Injuries in Acetabular Fractures|Short-Term Outcome of Surgical Treatment of Osteochondral Impaction in Acetabular Fractures|Recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 21:04:17.866133|2017-10-10 21:04:17.866133
NCT03152253|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Individually Tailored and Integrated Social Support Network for Tobacco Cessation|Live Inspired: Individually Tailored and Integrated Social Support Network for Tobacco Cessation|Recruiting||N/A|280|Anticipated|The Miriam Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:04:17.971671|2017-10-10 21:04:17.971671
NCT03141255|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|CHILL-SHOCK||Cardiogenic Shock Intravascular Cooling Trial|Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK)|Recruiting||N/A|20|Anticipated|University of Chicago||2|||f||||t|f|t|f|||||||2017-10-10 21:06:07.989356|2017-10-10 21:06:07.989356
NCT03152240|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-07-17|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01|1 Year|Observational [Patient Registry]|TAPAC||Coronary Anatomy Study and Times Since the Onset of Acute Myocardial Infarction Symptoms in Women Until the Opening of the Artery (TAPAC Study)|Coronary Anatomy Study and Times Since the Onset of Acute MyocardiaI Infarction Symptoms in Women Until the Opening of the Artery (TAPAC Study)|Not yet recruiting||N/A|400|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||2||f||||f|f|f||||||||2017-10-10 21:04:18.08084|2017-10-10 21:04:18.08084
NCT03152227|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-05-11|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|ATONU||Nutrition-sensitive Agricultural Interventions for Ethiopia|Evaluation of Integrated Agriculture and Nutrition Sensitive Interventions for the African Chicken Genetic Gains (ACGG) Program in Ethiopia|Recruiting||N/A|2100|Anticipated|Harvard School of Public Health||3|||f||||f||||||||Yes|data sharing agreement in progress|2017-10-10 21:04:18.185653|2017-10-10 21:04:18.185653
NCT03152214|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-25|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PACE||Physical Activity and Community Engagement (PACE) Among Returning Veterans|Physical Activity and Community Engagement (PACE) Among Returning Veterans|Recruiting||N/A|75|Anticipated|University of Texas at Austin||3|||f||||f|f|f||||||||2017-10-10 21:04:18.30448|2017-10-10 21:04:18.30448
NCT03152201|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-11|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Observational|||New Findings About Somatosensory Evoked Potentials (SEP) During Surgery for Cerebral Aneurysms|I Potenziali Somato-sensoriali Nella Chirurgia Degli Aneurismi Cerebrali|Recruiting||N/A|30|Anticipated|Ente Ospedaliero Cantonale, Bellinzona|||1||f||||f|f|f||||||No||2017-10-10 21:04:18.405891|2017-10-10 21:04:18.405891
NCT03152175|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-11|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Posttraumatic Stress Disorders in Police and 911 Operators|Posttraumatic Stress Disorders in Police and 911 Operators: A Cost-effectiveness and Efficacy Comparison of Treatment as Usual and a Novel Intervention|Recruiting||Phase 2|64|Anticipated|Douglas Mental Health University Institute||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:04:18.592809|2017-10-10 21:04:18.592809
NCT03152162|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-18|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 2028|Anticipated|2028-05-01|May 2019|Anticipated|2019-05-01||Observational|||A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System|A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System|Recruiting||N/A|100|Anticipated|ConforMIS, Inc.|||1||f||||f|f|t|f|f|t|||||2017-10-10 21:04:18.715369|2017-10-10 21:04:18.715369
NCT03151044|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL|A Prospective, Open, Randomized Controlled, Multi-center Phase III Clinical Trial Comparing High-dose Epirubicin and Standard-dose Epirubicin in R±CEOP in Newly Diagnosed Young Patients With Medium/High-risk Diffuse Large B-cell Lymphoma|Recruiting||Phase 3|408|Anticipated|Jiangsu Cancer Institute & Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:04:18.997169|2017-10-10 21:04:18.997169
NCT03151031|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-09-11|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|September 11, 2017|Actual|2017-09-11|September 11, 2017|Actual|2017-09-11||Interventional|||Effect on Dynamic Postural Stability After Application of Cryotherapy to the Knee Joint|Effect on Dynamic Postural Stability After Application of Cryotherapy to the Knee Joint: A Pilot Randomized Controlled Trial|Completed||N/A|24|Actual|Maharishi Markendeswar University||2|||f||||t|f|f||||||||2017-10-10 21:04:19.172753|2017-10-10 21:04:19.172753
NCT03151018|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-05-10|||May 2015||2015-05-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01|3 Years|Observational [Patient Registry]|HOST-ONYX||Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis|Harmonizing Optimal Strategy for Treatment of Coronary Atherosclerotic Lesions - Registry-based Study on the Effect and Safety of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerotic Lesions: HOST-Onyx Registry|Recruiting||N/A|4000|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-10 21:04:19.255534|2017-10-10 21:04:19.255534
NCT03151005|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-09|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|October 1, 2017|Anticipated|2017-10-01||Interventional|||The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS|Randomized Clinical Trial to Evaluate The Effect of Metformin-GLP-1 Receptor Agonist Versus Oral Contraceptive (OC) Therapy on Reproductive Disorders and Cardiovascular Risks in Overweight Polycystic Ovarian Syndrome (PCOS) Patients|Recruiting||Phase 4|30|Anticipated|Xinqiao Hospital of Chongqing||2|||f|||||t|f|||t|||Yes||2017-10-10 21:04:19.443201|2017-10-10 21:04:19.443201
NCT03150992|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-27|||July 19, 2017|Actual|2017-07-19|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|EDMONd||EDMONd - Elemental Diet in Bowel Obstruction|A Feasibility Study of Elemental Diet as an Alternative to Parenteral Nutrition for Patients With Inoperable Malignant Bowel Obstruction|Recruiting||N/A|34|Anticipated|Royal Surrey County Hospital NHS Foundation Trust||1|||f||||f|f|f||||||||2017-10-10 21:04:19.547891|2017-10-10 21:04:19.547891
NCT03150979|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effects of a Provision of a Cane After Stroke|Effects of a Provision of a Cane on Locomotion and Social Participation of Individuals With Stroke: a Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Federal University of Minas Gerais||2|||f||||f|f|f||||||No||2017-10-10 21:04:19.649584|2017-10-10 21:04:19.649584
NCT03152123|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|July 31, 2017|Anticipated|2017-07-31|July 1, 2017|Anticipated|2017-07-01||Interventional|||Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users|A Randomized, Double-Blind, Active- and Placebo-Controlled, Single-Dummy, 4-Way Crossover Study to Determine the Abuse Potential of Pitolisant Compared to Phentermine and Placebo, in Healthy, Non-Dependent Recreational Stimulant Users|Recruiting||Phase 1|44|Anticipated|Bioprojet||4|||f||||f|f|f||||||No||2017-10-10 21:04:19.777597|2017-10-10 21:04:19.777597
NCT03152110|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|HIIT-SCI||HIIT in Spinal Cord Injury|Feasibility and Acceptability of Six-weeks of High Intensity Interval Training in Wheelchair Users With SCI|Not yet recruiting||N/A|10|Anticipated|University of Pittsburgh||1|||f||||t|f|f||||||||2017-10-10 21:04:19.877259|2017-10-10 21:04:19.877259
NCT03152097|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-22|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|TMAO||Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study|Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study|Not yet recruiting||N/A|12|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 21:04:19.958962|2017-10-10 21:04:19.958962
NCT03152084|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-28|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|DAPASALT||The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.|DAPASALT: An Open Label, Phase IV, Mechanistic, Three-Arm Study to Evaluate the Natriuretic Effect of 2-Week Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Either Preserved or Impaired Renal Function and Non-Diabetics With Impaired Renal Function|Recruiting||Phase 4|51|Anticipated|AstraZeneca||3|||f||||f|f|f||||||||2017-10-10 21:04:20.047343|2017-10-10 21:04:20.047343
NCT03152058|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-17|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy|Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)|Recruiting||Phase 2|50|Anticipated|University of Utah||1|||f||||t|t|f||||||No||2017-10-10 21:04:20.270832|2017-10-10 21:04:20.270832
NCT03152032|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||August 1, 2014|Actual|2014-08-01|May 2017|2017-05-01|July 31, 2016|Actual|2016-07-31|July 31, 2016|Actual|2016-07-31||Interventional|||Employment Outcomes After Vocational Training|Employment Outcomes After In-House Vocational Training Programs for Individuals With Chronic Psychiatric Disorders|Completed||N/A|323|Actual|TsaoTun Psychiatric Center, Department of Health, Taiwan||1|||f||||t|f|f||||||No|No IPD sharing plan.|2017-10-10 21:04:20.478911|2017-10-10 21:04:20.478911
NCT03152019|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-21|||May 22, 2017|Actual|2017-05-22|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|TACRO||Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)|Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT) - A Double Blind, Randomized, Placebo-controlled, Multicenter Trial|Recruiting||Phase 2|48|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 21:04:20.672397|2017-10-10 21:04:20.672397
NCT03152006|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-12|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 30, 2021|Anticipated|2021-06-30|May 30, 2020|Anticipated|2020-05-30||Interventional|ACT||Adolescent Coordinated Transition Nigerian HIV+ Youth|Adolescent Coordinated Transition (ACT) to Improve Health Outcomes Among Nigerian HIV+ Youth|Not yet recruiting||N/A|216|Anticipated|University of Nevada, Las Vegas||2|||f||||t|f|f||||||No||2017-10-10 21:04:20.871103|2017-10-10 21:04:20.871103
NCT03151993|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||July 15, 2016|Actual|2016-07-15|May 2017|2017-05-01|December 27, 2018|Anticipated|2018-12-27|December 27, 2018|Anticipated|2018-12-27||Interventional|||Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS|Multicenter Open Lable Randomized Comparative Study of Efficacy and Safety of Single Bolus Injection of Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase (Actillyse) in Patients With Ischemic Stroke|Recruiting||Phase 3|336|Anticipated|Supergene, LLC||2|||f||||f||||||||No||2017-10-10 21:04:21.105521|2017-10-10 21:04:21.105521
NCT03151980|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-08|||May 12, 2017|Actual|2017-05-12|August 2017|2017-08-01|May 14, 2017|Actual|2017-05-14|May 14, 2017|Actual|2017-05-14||Interventional|||The Use of Sun Protection After Hamam (Turkish Bath)|The Use of Sun Protection After Hamam (Turkish Bath): a Randomized, Controlled, Blinded Trial|Completed||N/A|12|Actual|Herlev and Gentofte Hospital||2|||f||||f|f|f||||||||2017-10-10 21:04:21.352473|2017-10-10 21:04:21.352473
NCT03151967|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-05-10|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Lactobacillus Probiotic for Prevention of UTI|Lactobacillus Probiotic for Prevention of UTI|Active, not recruiting||Phase 2/Phase 3|27|Actual|University of Washington||2|||f||||t||||||||Undecided||2017-10-10 21:04:21.505528|2017-10-10 21:04:21.505528
NCT03151954|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-15|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||The Activation of Hippo Pathway in Nasal Polyps|Yap, the Nuclear Target of Hippo Signaling, Regulates Nasal Epithelium Stem Cells Aberrant Proliferation and Differentiation in Nasal Polyps|Recruiting||N/A|100|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:04:21.656585|2017-10-10 21:04:21.656585
NCT03151928|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-08-04|||July 6, 2017|Actual|2017-07-06|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|DAP||Diagnostic Accuracy By Providers Study|Diagnostic Accuracy By Providers Study|Recruiting||N/A|200|Anticipated|University of Pittsburgh|||1||f||||f|f|f||||||||2017-10-10 21:04:21.925935|2017-10-10 21:04:21.925935
NCT03151915|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-12|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|March 1, 2017|Actual|2017-03-01||Observational|||Neonatal Outcome for Laser Coagulation in Twin-to-twin-transfusion Syndrome|Neonatales Outcome Nach Intrauteriner Laserablation Mit 1.0mm-Optik Bei Fetofetalem Transfusionssyndrom|Recruiting||N/A|100|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||1||f||||f|f|f||||||Undecided||2017-10-10 21:04:22.085167|2017-10-10 21:04:22.085167
NCT03151902|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-08|||July 2, 2017|Actual|2017-07-02|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Detection of Viral Particels in Urticaria Patients|Detection of Viral Particels in Urticaria Patients|Recruiting||N/A|50|Anticipated|HaEmek Medical Center, Israel|||1||f||||f|f|f||||||||2017-10-10 21:04:22.228602|2017-10-10 21:04:22.228602
NCT03151889|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-21|||August 30, 2017|Anticipated|2017-08-30|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Interventional|TENS_HIR||Eletric Stimulation for Hipossalivation Induced by Radiotherapy|Transcutaneous Electric Nerve Stimulation (TENS) Treatment for Hipossalivation Induced by Radiotherapy|Not yet recruiting||N/A|80|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||f|f|f|||f|||||2017-10-10 21:04:22.348046|2017-10-10 21:04:22.348046
NCT03151876|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-06-12|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma|Chidamide Combined With Cladribine/Gemcitabine/Busulfan (ChiCGB) With Autologous Stem-Cell Transplantation in Relapsed and Refractory Diffuse Large B Cell Lymphoma|Recruiting||Phase 2|93|Anticipated|Sichuan University||1|||f||||f|f|f||||||Yes|electronic case report form (eCRF)|2017-10-10 21:04:22.444479|2017-10-10 21:04:22.444479
NCT03151863|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-14|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|INDEX||Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care|Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care Setting: a Cross Over, Superiority, Double-blind, Controlled and Randomized Clinical Trial|Not yet recruiting||Phase 3|66|Anticipated|University Hospital, Geneva||2|||f||||f|f|f||||||Undecided|In case of request for a systematic review/meta-analysis, IPD can be shared after publication.|2017-10-10 21:04:22.638689|2017-10-10 21:04:22.638689
NCT03151850|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-05-10|||July 2016||2016-07-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis|The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Ulcerative Colitis Associated Different Clinical Classification|Recruiting||N/A|50|Anticipated|Shandong University|||2||f||||f||||||||No||2017-10-10 21:04:23.226766|2017-10-10 21:04:23.226766
NCT03151837|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-14|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|December 16, 2017|Anticipated|2017-12-16|December 16, 2017|Anticipated|2017-12-16||Interventional|||Hypoglycemic Efficacy of Greenyn Momordica Charantia Extracts in Diabetic Subjects|A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Hypoglycemic Efficacy of Greenyn Momordica Charantia Extracts in Diabetic Subjects|Recruiting||N/A|40|Anticipated|Chung Shan Medical University||2|||f||||f|f|f||||||No||2017-10-10 21:04:23.357085|2017-10-10 21:04:23.357085
NCT03151824|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||October 25, 2013|Actual|2013-10-25|May 2017|2017-05-01|October 24, 2014|Actual|2014-10-24|October 24, 2014|Actual|2014-10-24||Observational|||Gender-specific Associations Between Quality of Life and Leukocyte Telomere Length|Gender-specific Associations Between Quality of Life and Leukocyte Telomere Length: A Cross-sectional Study|Completed||N/A|164|Actual|Chung-Ang University Hosptial, Chung-Ang University College of Medicine|||1||f|||||f|f||||||||2017-10-10 21:04:23.502429|2017-10-10 21:04:23.502429
NCT03151798|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-30|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|May 31, 2029|Anticipated|2029-05-31|May 31, 2022|Anticipated|2022-05-31||Interventional|||The Liver Health Study for Patients With NAFLD|Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction|Recruiting||N/A|90|Anticipated|University of Missouri-Columbia||3|||f||||t|f|f||||||No||2017-10-10 21:04:23.956564|2017-10-10 21:04:23.956564
NCT03151785|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-11|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||The School Lifesavers Study|The School Lifesavers Study: A Randomised Controlled Trial Comparing the Impact of Lifesaver Programme Only, Lifesaver With Face-to-face Training and Face-to-face Training Only on CPR Knowledge, Skills and Attitudes in School Children|Completed||N/A|90|Actual|University of Birmingham||3|||f||||||||||||||2017-10-10 21:04:24.121066|2017-10-10 21:04:24.121066
NCT03151772|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-10-03|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|INSIDE||Bioavailability of Disulfiram and Metformin in Glioblastomas|Drug Level and Investigation of Novel Substances Indicated Downstream Effect in Glioblastoma|Not yet recruiting||Early Phase 1|40|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f|f|f|||f|||||2017-10-10 21:04:24.210311|2017-10-10 21:04:24.210311
NCT02818439|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-27|||October 2013||2013-10-01|June 2016|2016-06-01||||October 2015|Actual|2015-10-01||Interventional|ARPEGE||Anticipating and Tracking: Pack of Gerontological Assessment Embedded|Anticipating and Tracking: Pack of Gerontological Assessment Embedded|Completed||N/A|216|Actual|CHU de Reims||1|||f||||||||||||||2017-10-10 22:02:16.65804|2017-10-10 22:02:16.65804
NCT03151746|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-12|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion|Effect of Preoperative Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion: a Double Blind, Randomized, Placebo Controlled Trial|Not yet recruiting||Phase 4|70|Anticipated|Northwestern University||2|||f||||t|t|f|||f|||||2017-10-10 21:04:24.370234|2017-10-10 21:04:24.370234
NCT03151733|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-06|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|August 2024|Anticipated|2024-08-01|August 2019|Anticipated|2019-08-01||Interventional|SILCS||Single Incision Laparoscopic Colorectal Surgery|Single Incision Laparoscopic Surgery (SILS) for Colorectal Disease|Recruiting||N/A|200|Anticipated|Ruijin Hospital||2|||f||||t|f|f||||||||2017-10-10 21:04:24.504473|2017-10-10 21:04:24.504473
NCT03151720|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-30|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|July 8, 2017|Actual|2017-07-08|July 8, 2017|Actual|2017-07-08||Interventional|||A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets|A Single-Dose, Randomized, Open-Label, Two-Treatment, Four-Period, Crossover Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Subjects Compared to Clarityne Tablets|Completed||Phase 1|28|Actual|Xian-Janssen Pharmaceutical Ltd.||4|||f||||f|f|f||||||||2017-10-10 21:04:24.623876|2017-10-10 21:04:24.623876
NCT03151707|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Effects of Nicotinamide Riboside Supplementation on NAD+/NADH Ratio and Bioenergetics|The Effects of Nicotinamide Riboside Supplementation on Nicotinamide Adenine Dinucleotide (NAD+/NADH) Ratio and Bioenergetics|Not yet recruiting||Phase 4|60|Anticipated|Mclean Hospital||1|||f|||||t|f|||t|||||2017-10-10 21:04:24.733452|2017-10-10 21:04:24.733452
NCT03151694|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-11|||February 1, 2011|Actual|2011-02-01|April 2017|2017-04-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Observational|||Brain-to-Society Diagnostic for Prevention of Childhood Obesity and Chronic Disease|Foundational Work for a Brain-to-Society Diagnostic for Prevention of Childhood Obesity and Its Chronic Diseases Consequences|Active, not recruiting||N/A|1224|Actual|McGill University|||1||f||||f|f|f||||Samples With DNA|"     DNA saliva samples were collected for healthy participants between the ages of 6 and 12 years     old before proceeding with genotyping of the 7-repeat risk allele on dopamine-4 receptor     (DRD4) gene.   "|No||2017-10-10 21:04:24.851456|2017-10-10 21:04:24.851456
NCT03151681|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-11|||November 1, 2015|Actual|2015-11-01|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol|Treating Adjustment Disorders Stemming From Romantic Betrayals: An Open-label Trial of Impairing Memory Reconsolidation Using Propranolol|Recruiting||Phase 2/Phase 3|40|Anticipated|Douglas Mental Health University Institute||1|||f||||t|f|f||||||Undecided||2017-10-10 21:04:24.950795|2017-10-10 21:04:24.950795
NCT03151668|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-14|||January 4, 2017|Actual|2017-01-04|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Dexmedetomidine on Perfusion Index and Microcirculation in Severe Sepsis and Septic Shock Patients|The Effect of Dexmedetomidine on Perfusion Index and Microcirculation in Patients With Severe Sepsis and Septic Shock: Randomized Controlled Study|Recruiting||Phase 3|40|Anticipated|Cairo University||2|||f||||||||||||||2017-10-10 21:04:25.146468|2017-10-10 21:04:25.146468
NCT03151655|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-05-11|||January 2018|Anticipated|2018-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Changing Opioid Users' Negative Attitudes Toward Medication Assisted Treatment|Changing Opioid Users' Negative Attitudes Toward Medication Assisted Treatment|Not yet recruiting||N/A|60|Anticipated|Butler Hospital||2|||f|||||f|f||||||||2017-10-10 21:04:25.260169|2017-10-10 21:04:25.260169
NCT03151642|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-31|||April 5, 2017|Actual|2017-04-05|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Observational|||A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION|A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION|Recruiting||N/A|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t|f|f||||||||2017-10-10 21:04:25.342731|2017-10-10 21:04:25.342731
NCT03151629|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-13|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2022|Anticipated|2022-06-01|5 Years|Observational [Patient Registry]|IRONMAN||Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN)|Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN)|Recruiting||N/A|5000|Anticipated|Prostate Cancer Clinical Trials Consortium|||2||f||||f|f|f||||||||2017-10-10 21:04:25.432795|2017-10-10 21:04:25.432795
NCT03151616|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||April 1, 2003|Actual|2003-04-01|May 2017|2017-05-01|March 31, 2014|Actual|2014-03-31|March 31, 2014|Actual|2014-03-31||Observational|||Anticholinergic Risk Scale and Resource Use After Elective Noncardiac Surgery|Association of Anticholinergic Risk Scale and Healthcare Resource Use After Elective Noncardiac Surgery: a Population-based Cohort Study|Completed||N/A|245000|Actual|Ottawa Hospital Research Institute|||3||f||||f|f|f||||||||2017-10-10 21:04:25.524408|2017-10-10 21:04:25.524408
NCT03151603|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-06-02|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|May 2019|Anticipated|2019-05-01||Interventional|REGATTA||Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial|Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial|Recruiting||Phase 4|430|Anticipated|University Medical Center Goettingen||2|||f|||||f|f||||||||2017-10-10 21:04:25.62086|2017-10-10 21:04:25.62086
NCT03151590|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||January 9, 2017|Actual|2017-01-09|May 2017|2017-05-01||||December 31, 2019|Anticipated|2019-12-31||Interventional|NRE2||Non-Response to Exercise|Non-Response to Exercise - Identification of Factors Contributing to Exercise Non-response.|Recruiting||N/A|||University Hospital Tuebingen|||||f||||f|f|f||||||No||2017-10-10 21:04:27.577322|2017-10-10 21:04:27.577322
NCT03151577|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-11|||January 1, 2015|Actual|2015-01-01|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|January 31, 2017|Actual|2017-01-31||Interventional|||Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent|Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent|Active, not recruiting||N/A|150|Actual|Swiss Vision Network||1|||f||||f|f|f|||t|||No||2017-10-10 21:04:27.654745|2017-10-10 21:04:27.654745
NCT03151564|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||May 9, 2017|Actual|2017-05-09|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques|Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques|Recruiting||N/A|104|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 21:04:27.726382|2017-10-10 21:04:27.726382
NCT03151551|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-10-02|||August 24, 2017|Actual|2017-08-24|October 2017|2017-10-01|June 21, 2019|Anticipated|2019-06-21|September 17, 2018|Anticipated|2018-09-17||Interventional|SPIRIT-H2H||A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis|A 52-Week Multicenter, Randomized, Open-Label, Parallel- Group Study Evaluating the Efficacy and Safety of Ixekizumab Versus Adalimumab in Patients With Psoriatic Arthritis Who Are Biologic Disease-Modifying Anti-Rheumatic Drug Naive|Recruiting||Phase 4|550|Anticipated|Eli Lilly and Company||2|||f||||f|t|f||||||||2017-10-10 21:04:27.853194|2017-10-10 21:04:27.853194
NCT03151538|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-15|||April 19, 2017|Actual|2017-04-19|August 2017|2017-08-01|June 14, 2017|Actual|2017-06-14|June 7, 2017|Actual|2017-06-07||Interventional|||Effects on Pes Planus Exercise Training Mixed With Play on Pre-school Children|Assessment Effects on Pes Planus and Femoral Anteversion Angle of Exercise Training Mixed With Play on Pre-school Children|Completed||N/A|90|Actual|Inonu University||2|||f||||f|f|f||||||||2017-10-10 21:04:28.655791|2017-10-10 21:04:28.655791
NCT03151525|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|April 3, 2020|Anticipated|2020-04-03|October 3, 2019|Anticipated|2019-10-03||Interventional|SCILLA||Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis|Comparison Between Two Therapeutic Strategies for the Maintenance of Clinical and Endoscopic Remission in Patients With Ulcerative Colitis Treated by Infliximab|Recruiting||Phase 4|100|Anticipated|Istituto Clinico Humanitas||2|||f||||f|f|f|||f|||No||2017-10-10 21:04:28.787883|2017-10-10 21:04:28.787883
NCT03151512|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-11|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Observational|UNDISTORT||UNDISTORT Correction of Distortions in Diffusion MRI V1.0|Correction of Distortions in Diffusion MRI|Recruiting||N/A|155|Anticipated|University College, London|||1||f||||f|f|f||||||No|The funder would like to see the best use made of data. As yet we are undecided on the scope or mechanism for this, but data would only be shared anonymously and under a material transfer agreement. Participants agree at the time of consent to their data being used in further research and teaching.|2017-10-10 21:04:28.893268|2017-10-10 21:04:28.893268
NCT03151499|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-07-20|||May 30, 2017|Actual|2017-05-30|July 2017|2017-07-01|July 11, 2017|Actual|2017-07-11|July 11, 2017|Actual|2017-07-11||Interventional|||Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers|Effect of Rifampicin on the Pharmacokinetics of BI 409306 Following Oral Administration in Healthy Male Subjects (an Open-label, Two-period, Fixed Sequence Trial)|Completed||Phase 1|15|Actual|Boehringer Ingelheim||1|||f||||f|f|f||||||||2017-10-10 21:04:28.975059|2017-10-10 21:04:28.975059
NCT03151486|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-25|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|February 5, 2018|Anticipated|2018-02-05|February 5, 2018|Anticipated|2018-02-05||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female Participants|A Double-Blind, Placebo-Controlled, Randomized Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female Subjects|Recruiting||Phase 1|83|Anticipated|Janssen-Cilag International NV||10|||f||||f|f|f||||||||2017-10-10 21:04:29.050935|2017-10-10 21:04:29.050935
NCT03151473|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-11|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|September 30, 2027|Anticipated|2027-09-30|May 31, 2027|Anticipated|2027-05-31||Observational|||Longitudinal Observational Study Of Chinese With NAFLD/NASH|Prospective Cohort Assessing The Prevalence And Progress Of Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic Steatohepatitis (NASH) In Chinese Subjects|Recruiting||N/A|20000|Anticipated|Humanity and Health Research Centre|||1||f||||t|f|f||||Samples Without DNA|"     Serum/Plasma/Liver biopsy   "|No||2017-10-10 21:04:29.181794|2017-10-10 21:04:29.181794
NCT03151460|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dopaminergic Modulation of Declarative Memory|Dopaminergic Modulation of Declarative Memory|Completed||Phase 4|40|Actual|I.R.C.C.S. Fondazione Santa Lucia||2|||f|||||f|f||||||No||2017-10-10 21:04:29.266167|2017-10-10 21:04:29.266167
NCT03151447|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-11|||March 6, 2017|Actual|2017-03-06|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer|A Phase I Trial of Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Metastatic Triple Negative Breast Cancer|Recruiting||Phase 1|18|Anticipated|Fudan University||1|||f||||t|f|f||||||No||2017-10-10 21:04:29.361085|2017-10-10 21:04:29.361085
NCT03151434|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-21|||February 7, 2017|Actual|2017-02-07|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|March 28, 2018|Anticipated|2018-03-28||Interventional|VATS||Comparison of Three Different Pain Blocks for Subjects Undergoing VATS (Video Assisted Thoracoscopic Surgery) Procedure.|Randomized Prospective Study Comparing Paravertebral Catheters, Single Shot Paravertebral Block, Thoracic Epidural, for Postoperative Analgesia Following Video-assisted Thoracoscopic Surgery|Recruiting||N/A|120|Anticipated|Indiana University||3|||f||||t|f|f||||||||2017-10-10 21:04:29.486951|2017-10-10 21:04:29.486951
NCT03151421|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-10|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|October 30, 2019|Anticipated|2019-10-30|September 1, 2018|Anticipated|2018-09-01||Interventional|TackSHSWP4||Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home|Measuring for Change: Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home|Active, not recruiting||N/A|200|Anticipated|Institut Català d'Oncologia||1|||f||||t|f|f||||||No||2017-10-10 21:04:29.661473|2017-10-10 21:04:29.661473
NCT03151408|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-14|||June 23, 2017|Actual|2017-06-23|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia|A Phase III, Double-Blind, Placebo-Controlled, Multicenter, Randomized Study Of Pracinostat In Combination With Azacitidine In Patients ≥18 Years With Newly Diagnosed Acute Myeloid Leukemia Unfit For Standard Induction Chemotherapy|Recruiting||Phase 3|500|Anticipated|Helsinn Healthcare SA||2|||f|||||t|f||||||||2017-10-10 21:04:29.897275|2017-10-10 21:04:29.897275
NCT03151382|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||May 20, 2017|Anticipated|2017-05-20|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease|A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease|Not yet recruiting||Phase 4|30|Anticipated|Zhejiang Provincial People’s Hospital||2|||f|||||f|f||||||||2017-10-10 21:04:30.328852|2017-10-10 21:04:30.328852
NCT03151369|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-07-07|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|August 20, 2017|Anticipated|2017-08-20|August 20, 2017|Anticipated|2017-08-20||Interventional|||Visual Pain Score and Perfusion Index in Postoperative Patients|The Relationship Between Visual Pain Score and Perfusion Index in Postoperative Patients|Recruiting||N/A|80|Anticipated|Tokat Gaziosmanpasa University||1|||f|||||f|f||||||||2017-10-10 21:04:30.435814|2017-10-10 21:04:30.435814
NCT03151356|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|PHI-1||Prostate Health Index for Prostate Cancer Diagnosis|Value of Prostate Health Index for Prostate Cancer Diagnosis|Not yet recruiting||N/A|400|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 21:04:30.541901|2017-10-10 21:04:30.541901
NCT03151343|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-05-10|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|SIMPLE||SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk|Effects of SGLT-2 Inhibitor on Myocardial Perfusion, Function and Metabolism in Type 2 DM Patients at High Cardiovascular Risk: The SIMPle Randomized Clinical Trial|Recruiting||Phase 3|92|Anticipated|Herlev and Gentofte Hospital||2|||f||||f|f|f|||f|||No|Any sharing of data must be approved by the regional ethics committee, and at the time of protocol writing there was no justification for data sharing outside of the current project|2017-10-10 21:04:30.649682|2017-10-10 21:04:30.649682
NCT03151330|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-09-11|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Serum Assessment of Preterm Birth: Outcomes Compared to Historical Controls|Serum Assessment of Preterm Birth: Outcomes Compared to Historical Controls|Not yet recruiting||N/A|2110|Anticipated|Christiana Care Health Services||1|||f||||f|f|f||||||||2017-10-10 21:04:30.840436|2017-10-10 21:04:30.840436
NCT03151317|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-08-18|||May 12, 2017|Actual|2017-05-12|May 2017|2017-05-01|July 30, 2017|Actual|2017-07-30|July 30, 2017|Actual|2017-07-30||Observational|APARDetp||Effects of a Therapeutic Education Program on Treatment Adherence Among Patients Prescribed At-home CPAP or At-home NIV|Effects of a Therapeutic Education Program on Treatment Adherence Among Patients Prescribed At-home Continuous Positive Airway Pressure or At-home Non-invasive Ventilation|Completed||N/A|1200|Anticipated|University Hospital, Montpellier|||2||f||||f|f|f||||||||2017-10-10 21:04:30.988142|2017-10-10 21:04:30.988142
NCT03151291|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|March 31, 2019|Anticipated|2019-03-31||Interventional|||Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients|Effects of Physical Exercise in the Form of Whole-body Electromyostimulation (WB-EMS) Combined With Individualized Nutritional Therapy Using Specific Dietary Supplements on Cancer Patients Undergoing Curative or Palliative Anti-cancer Treatment|Recruiting||N/A|200|Anticipated|University of Erlangen-Nürnberg Medical School||8|||f||||f|f|f||||||No||2017-10-10 21:04:31.27944|2017-10-10 21:04:31.27944
NCT03151278|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||January 2011||2011-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ZFA-RAA||Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias|Multi-center, Randomized, Controlled Trial to Compare Feasibility, Safety and Efficacy of Zero-Fluoroscopic Navigation With Conventional Fluoroscopic Navigation for the Ablation of Right Atrial Arrhythmias|Recruiting||N/A|450|Anticipated|Tongji Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:04:31.42617|2017-10-10 21:04:31.42617
NCT03151265|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-05|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||A Prospective Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain|A Prospective Open Label Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain in Two Different Populations|Recruiting||N/A|40|Anticipated|dorsaVi Ltd||2|||f||||f|f|t|f|f|t|||||2017-10-10 21:04:31.601264|2017-10-10 21:04:31.601264
NCT03151252|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-13|||October 2014|Actual|2014-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Improvement of Foodallergy Diagnostic in Gastrointestinal Tract|Improvement of Foodallergy Diagnostic in Gastrointestinal Tract With a New Kind of Sampling|Recruiting||N/A|60|Anticipated|University of Erlangen-Nürnberg Medical School||3|||f|||||f|f||||||||2017-10-10 21:04:31.767241|2017-10-10 21:04:31.767241
NCT03151239|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-08-02|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|NMN||"Effect of Nicotinamide Mononucleotide (NMN) on Cardiometabolic Function"|Effect of NMN (Nicotinomide Mononucleotide) Supplementation on Cardiometabolic Function|Recruiting||N/A|50|Anticipated|Washington University School of Medicine||2|||f||||t|f|f||||||||2017-10-10 21:04:31.896289|2017-10-10 21:04:31.896289
NCT03134365|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||August 4, 2016|Actual|2016-08-04|April 2017|2017-04-01|December 2, 2016|Actual|2016-12-02|November 23, 2016|Actual|2016-11-23||Interventional|||Palatability and Postprandial Sensations|Factors to Determine the Responses to Meal Ingestion: Palatability|Completed||N/A|22|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f|||||f|f||||||||2017-10-10 21:07:10.879018|2017-10-10 21:07:10.879018
NCT03151226|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-05-11|||August 2015||2015-08-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||OSA Screen Negative With Spinal Duramorph|A Prospective, Observational, Double-blind (Black-Box) Study Evaluating Incidence, Severity and Predictive Factors of Respiratory Depression and Sleep Disorder Pattern During Postoperative Neuraxial Opioid Analgesia in OSA Screened Negative With BMI>=35 Kg/m2 Obstetric Patients After Cesarean Delivery Using Current Standard Intermittent Postoperative Monitoring Compared to Continuous Pulse Oximetry/Capnography|Terminated||N/A|3|Actual|Wake Forest University Health Sciences||1||Technical difficulty and feasibility issues|f||||t||||||||||2017-10-10 21:04:32.017337|2017-10-10 21:04:32.017337
NCT03151213|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|pregabalin||Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver|Effect of Preoperative Administration of Oral Pregabalin on the Postoperative Analgesia in Patients Scheduled for Radiofrequency Ablationof Focal Lesions in the Liver|Recruiting||Phase 4|100|Anticipated|Tanta University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:04:32.12343|2017-10-10 21:04:32.12343
NCT03151200|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-05-11|||January 2014||2014-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Visual Functional Connectivity and Visual Improvement After TMS/Binocular Treatment|Visual Functional Connectivity and Visual Function in Amblyopia Before and After TMS and/or Binocular Treatment|Enrolling by invitation||N/A|20|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-10 21:04:32.258405|2017-10-10 21:04:32.258405
NCT03151187|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Evaluation of a Teaching Curriculum on Disruptive Behaviour Disorders|Assessment of the Impact of a Teaching Curriculum on Disruptive Behavior Disorders in Children and Youth: A Pilot Study|Recruiting||N/A|278|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||f|f|f||||||||2017-10-10 21:04:32.369538|2017-10-10 21:04:32.369538
NCT03151174|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-24|||April 29, 2017|Actual|2017-04-29|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Vitamin D Supplementation on Strength, Bone Density, and Injury Risk in Collegiate Athletes|Vitamin D, Strength, and Bone Density in Collegiate Athletes|Recruiting||Early Phase 1|60|Anticipated|Virginia Polytechnic Institute and State University||3|||f||||f|t|f||||||No||2017-10-10 21:04:32.488453|2017-10-10 21:04:32.488453
NCT03151161|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-11|2017-05-11|||December 2015||2015-12-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|June 2017|Anticipated|2017-06-01||Interventional|||Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation|A Prospective,Multi-center, Open-labeled Phase 2 Randomized and Comparative Clinical Study of First Line Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in ⅢB/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation|Recruiting||Phase 2|118|Anticipated|Sun Yat-sen University||2|||f||||f||||||||Undecided||2017-10-10 21:04:32.633844|2017-10-10 21:04:32.633844
NCT03151148|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-10-02|||September 28, 2017|Actual|2017-09-28|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Targeted Microbiome Transplant in Atopic Dermatitis|A First in Man Evaluation of the Safety and Efficacy of an Allogeneic Targeted Microbiome Transplant in Adults With Moderate-to-Severe Atopic Dermatitis (ADRN-08)|Recruiting||Phase 1/Phase 2|54|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 21:04:32.748534|2017-10-10 21:04:32.748534
NCT03151135|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-11|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|December 31, 2017|Anticipated|2017-12-31||Observational|||Energy Turnover in Patients With Anorexia Nervosa|Does Energy Turnover After Short-term Nutritional Recovery Predict Subsequent Weight Course in Patients With Anorexia Nervosa?|Recruiting||N/A|10|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||Undecided||2017-10-10 21:04:32.919826|2017-10-10 21:04:32.919826
NCT03151122|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-12|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of a Nurse-led Continuous Support Program on Neurodevelopment of Preterm Infants|The Effect of Nurse-led Continuous Support Program on Neurodevelopment of Preterm Infants and Psychological Well-being of the Parents: A Randomized Controlled Trial|Not yet recruiting||N/A|140|Anticipated|Wuhan University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:04:33.139359|2017-10-10 21:04:33.139359
NCT03151109|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-10|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Observational|EPBG||Glenoid Bone Grafting for RTSA: Clinical & Radiographic Outcomes|Glenoid Bone Grafting for Reverse Shoulder Arthroplasty: Clinical and Radiographic Outcomes|Enrolling by invitation||N/A|85|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 21:04:33.2508|2017-10-10 21:04:33.2508
NCT03151096|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|RiboBP||Pilot Evaluation of the Effect of Riboflavin Supplementation on Blood Pressure and Possible Effect Modification by the MTHFR C677T Genotype|Pilot Evaluation of the Effect of Riboflavin Supplementation on Blood Pressure and Possible Effect Modification by the MTHFR C677T Genotype|Not yet recruiting||N/A|204|Anticipated|Medical Research Council Unit, The Gambia||2|||f||||f|f|f||||||||2017-10-10 21:04:33.384536|2017-10-10 21:04:33.384536
NCT03151083|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-08-18|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|June 1, 2022|Anticipated|2022-06-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Implementing and Evaluating Computer-Based Interventions for Mental Health: Testing an Implementation Strategy for VA Outpatient Care|Implementing and Evaluating Computer-Based Interventions for Mental Health (CDA 14-420)|Recruiting||N/A|116|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 21:04:33.517952|2017-10-10 21:04:33.517952
NCT03151070|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||December 15, 2013|Actual|2013-12-15|May 2017|2017-05-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Observational|QVLM||Scaling Up an Integrated Approach to Improve Delivery Care in North Guatemala With Stepped Wedge Design|Scaling Up an Integrated Approach to Improve Delivery Care and Reduce Maternal and Perinatal Mortality in North Guatemala With Stepped Wedge Design|Completed||N/A|32000|Actual|Hospital San Juan de Dios Guatemala|||6||f||||f|f|f||||||No||2017-10-10 21:04:33.683443|2017-10-10 21:04:33.683443
NCT03151057|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-10-05|||April 20, 2017|Actual|2017-04-20|October 2017|2017-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Idelalisib Post Allogeneic BMT in B Cell Derived Malignancies: A Phase 1 Toxicity Trial|Idelalisib Post Allogeneic BMT in B Cell Derived Malignancies: A Phase 1 Toxicity Trial|Active, not recruiting||Phase 1|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:04:33.80194|2017-10-10 21:04:33.80194
NCT03150953|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-25|||May 26, 2016|Actual|2016-05-26|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Evaluation of a Novel Patient Warming System During MRI|Evaluation of a Novel Patient Warming System During MRI|Recruiting||N/A|60|Anticipated|Children's Research Institute||3|||f||||f|f|f||||||No||2017-10-10 21:04:34.034662|2017-10-10 21:04:34.034662
NCT03150940|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-11|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Observational|||Changing the Pulse of Athletics: Applying a Standardized Cardiac Athletic Screening for NCAA Athletes|Changing the Pulse of Athletics: Applying a Standardized Cardiac Athletic Screening for NCAA Athletes|Recruiting||N/A|50|Anticipated|Duke University|||1||f||||t|f|f||||||No||2017-10-10 21:04:34.152371|2017-10-10 21:04:34.152371
NCT03150927|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-10|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Study of Novel Probiotic Microbial Composite™ to Treat Undernourished Young Children|A Clinical Study to Determine the Effects of a Novel Probiotic Microbial Composite™ on Improving Digestive Health and Key Growth Parameters in Undernourished Young Children|Not yet recruiting||N/A|250|Anticipated|Biowish Technologies, Inc.||2|||f||||t|f|f||||||Undecided||2017-10-10 21:04:34.257438|2017-10-10 21:04:34.257438
NCT03150914|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-10|||June 6, 2017|Anticipated|2017-06-06|May 2017|2017-05-01|June 6, 2021|Anticipated|2021-06-06|June 6, 2020|Anticipated|2020-06-06||Interventional|MILED||Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial|Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial|Not yet recruiting||Phase 3|60|Anticipated|University of Cincinnati||2|||f||||t|t|f||||||Yes|Data will be publicly available once the study in published|2017-10-10 21:04:34.390629|2017-10-10 21:04:34.390629
NCT03150901|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||February 20, 2015|Actual|2015-02-20|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|February 1, 2016|Actual|2016-02-01||Observational|||Role of Adiponectine in Pathophysiology Ogf Diabetic Foot|Role of Adiponectine in Pathophysiology Ogf Diabetic Foot|Completed||N/A|70|Actual|Wolfson Medical Center|||1||f||||f|f|f||||||Undecided||2017-10-10 21:04:34.536023|2017-10-10 21:04:34.536023
NCT03150888|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-10|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Multi-provincial Cohort for Hypertension (MUCH)|Multi-provincial Cohort for Hypertension in China|Not yet recruiting||N/A|30000|Anticipated|Beijing Institute of Heart, Lung and Blood Vessel Diseases|||2||f||||f|f|f||||Samples With DNA|"     Serum, plasma, blood cell, urine and DNA   "|||2017-10-10 21:04:34.602121|2017-10-10 21:04:34.602121
NCT03150875|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-10|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC|Efficacy and Safety Evaluation of IBI308 Versus Docetaxel in Patients With Advanced or Metastatic Non-squamous Cell Lung Cancer After Failure of First-line Platinum-based Therapy- a Randomized, Open-label, Multicenter, Parallel, Phase 3 Study (ORIENT-3)|Not yet recruiting||Phase 3|266|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:04:34.69266|2017-10-10 21:04:34.69266
NCT03150862|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-29|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|October 31, 2021|Anticipated|2021-10-31|June 30, 2021|Anticipated|2021-06-30||Interventional|||A Study Assessing BGB-290 With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma|A Phase 1b/2 Study to Assess the Safety, Tolerability and Efficacy of BGB-290 in Combination With Radiation Therapy (RT) and/or Temozolomide (TMZ) in Subjects With First-line or Recurrent/Refractory Glioblastoma|Recruiting||Phase 1/Phase 2|300|Anticipated|BeiGene||6|||f||||f|t|f|||t|||||2017-10-10 21:04:34.789097|2017-10-10 21:04:34.789097
NCT03150849|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-11|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Observational|||C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia|C-X-C Chemokine Receptor 4 as Prognostic Marker in Chronic Lymphocytic Leukemia|Not yet recruiting||N/A|50|Anticipated|Assiut University|||2||f||||f|f|f||||||No||2017-10-10 21:04:34.976685|2017-10-10 21:04:34.976685
NCT03150836|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-31|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|September 1, 2024|Anticipated|2024-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|||Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer|Multi-Institutional Phase II Study of Radiation Therapy and Anti-PD-L1 Checkpoint Inhibition (Durvalumab) With or Without Anti-CTLA-4 Inhibition (Tremelimumab) in Patients With Unresectable, Muscle-Invasive or Metastatic Urothelial Bladder Cancer That Are Ineligible or Refusing Chemotherapy|Not yet recruiting||Phase 2|74|Anticipated|University of California, San Francisco||6|||f||||t|t|f||||||||2017-10-10 21:04:35.07868|2017-10-10 21:04:35.07868
NCT03150823|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-20|||November 2, 2017|Anticipated|2017-11-02|May 2017|2017-05-01|May 2, 2018|Anticipated|2018-05-02|December 1, 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of the Upstream and Downstream Direct Current on the Handgrip Strength|Effectiveness of the Upstream and Downstream Direct Current on the Handgrip Strength: Assessment Through Dynamometry and Miofeedback|Not yet recruiting||N/A|200|Anticipated|Quiropraxia y Equilibrio||3|||f||||t|f|f||||||||2017-10-10 21:04:35.240784|2017-10-10 21:04:35.240784
NCT03150654|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||October 1, 2015|Actual|2015-10-01|May 2017|2017-05-01|July 12, 2016|Actual|2016-07-12|June 8, 2016|Actual|2016-06-08||Interventional|||The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes|The Effect of Laser Pan-retinal Photocoagulation on Macular Pigment Optical Density in Cases With Diabetic Retinopathy|Completed||N/A|36|Actual|Afyon Kocatepe University Hospital||1|||f||||t|f|t|f||f|||Undecided||2017-10-10 21:04:37.667011|2017-10-10 21:04:37.667011
NCT03150810|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-10-03|||July 12, 2017|Actual|2017-07-12|October 2017|2017-10-01|August 1, 2020|Anticipated|2020-08-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors|A Phase 1b Study to Assess the Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|150|Anticipated|BeiGene||3|||f||||f|t|f|||t|||||2017-10-10 21:04:35.367831|2017-10-10 21:04:35.367831
NCT03150797|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-10|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|MAP||Melatonin for Adolescent Migraine Prevention Study|Melatonin for Adolescent Migraine Prevention Study (The MAP Study).|Not yet recruiting||Phase 2|210|Anticipated|University of California, San Francisco||3|||f||||t|t|f||||||No||2017-10-10 21:04:35.535072|2017-10-10 21:04:35.535072
NCT03150784|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-11|||October 2016||2016-10-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Rhythmic Motor Learning in Children With Developmental Coordination Disorders|Brain Plasticity and Motor Skill Competence Development in Young People With Development Coordination Disorder|Recruiting||N/A|60|Anticipated|Oxford Brookes University||2|||f||||t||||||||No|As per ethical outline, data will not be stored in a shared repository. All data will be stored in an anonymised format on site. Data access requests should be made to the principle investigator in writing which will be discussed in the data monitoring committee meetings.|2017-10-10 21:04:35.672855|2017-10-10 21:04:35.672855
NCT03150771|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-13|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia|A Phase 1, Open-label, Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Aripiprazole 2 Month Intramuscular Depot Administered Gluteally in Adult Subjects With Schizophrenia|Recruiting||Phase 1|36|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f|||||t|f||||||||2017-10-10 21:04:35.78|2017-10-10 21:04:35.78
NCT03150758|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-08-09|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intra-operative Assessment of Cavernosal Nerve Stimulus Threshold|Intra-operative Assessment of Cavernosal Nerve Stimulus Threshold|Recruiting||N/A|7|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f|f|||||2017-10-10 21:04:35.884024|2017-10-10 21:04:35.884024
NCT03150745|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-13|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Diagnosis of Cervical Lesions in Women With Unhealthy Looking Cervix|Office Hysteroscopy Versus Stationary Coloposcopy for Diagnosis of Cervical Lesions in Women With Unhealthy Looking Cervix|Recruiting||N/A|112|Anticipated|Assiut University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:04:35.970711|2017-10-10 21:04:35.970711
NCT03150732|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||July 12, 2017|Anticipated|2017-07-12|May 2017|2017-05-01|July 11, 2018|Anticipated|2018-07-11|May 10, 2018|Anticipated|2018-05-10||Interventional|||Systemic Nalbuphine Versus Intravenous Regional Anesthesia|Comparison of Systemic Nalbuphine Versus Intravenous Regional Anesthesia|Not yet recruiting||N/A|106|Anticipated|Assiut University||2|||f|||||f|f|||f|||||2017-10-10 21:04:36.04033|2017-10-10 21:04:36.04033
NCT03150719|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-11|||April 13, 2017|Actual|2017-04-13|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF)|Phase 3b, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor (TEZ/IVA) in an Orkambi-experienced Population Who Are Homozygous for the F508del CFTR Mutation|Recruiting||Phase 3|90|Anticipated|Vertex Pharmaceuticals Incorporated||2|||t||||t|t|f||||||||2017-10-10 21:04:36.111056|2017-10-10 21:04:36.111056
NCT03150706|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer|A Phase II Study of Avelumab in Patients With Mismatch Repair Deficient or POLE Mutated Metastatic Colorectal Cancer|Not yet recruiting||Phase 2|33|Anticipated|Asan Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:04:36.266337|2017-10-10 21:04:36.266337
NCT03150693|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-29|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|August 2024|Anticipated|2024-08-01|March 2023|Anticipated|2023-03-01||Interventional|||Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia|A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL|Recruiting||Phase 3|310|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t|t|f||||||||2017-10-10 21:04:36.383669|2017-10-10 21:04:36.383669
NCT03150680|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-06|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|February 2020|Anticipated|2020-02-01|12 Months|Observational [Patient Registry]|GESS||Development of a Risk Prediction Algorithm Through the Investigation of Genetic Risk Factors and the Complexity of Coronary Artery Disease to Estimate Future Risk of Cardiovascular Events: Angiographic (SYNTAX Score), Clinical and Pharmacogenetic Analysis.|Development of a Risk Prediction Algorithm Through the Investigation of Genetic Risk Factors and the Complexity of Coronary Artery Disease to Estimate Future Risk of Cardiovascular Events: Angiographic (SYNTAX Score), Clinical and Pharmacogenetic Analysis.|Recruiting||N/A|1080|Anticipated|AHEPA University Hospital|||3||f||||f|f|f||||Samples With DNA|"     DNA will be extracted from obtained subject blood samples at the AHEPA University General     Hospital of Thessaloniki. DNAs will be labeled by anonymized subject ID # (de-identified),     and shipped to LABNET IAE - Private Reference Diagnostic Laboratory for genotyping and     genetic analysis.   "|||2017-10-10 21:04:37.25724|2017-10-10 21:04:37.25724
NCT03150667|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-10|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|CPRS-CKD||Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD|Pragmatic Randomized Controlled Trial Comparing Treatment Effectiveness of Guideline Indicated Anti-platelet Therapy for Acute Coronary Syndrome in Patients With Chronic Kidney Disease|Recruiting||Phase 4|220|Anticipated|North Texas Veterans Healthcare System||2|||f||||t|t|f||||||No||2017-10-10 21:04:37.52766|2017-10-10 21:04:37.52766
NCT03150628|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-09|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2025|Anticipated|2025-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|CISCA||Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study|Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study|Not yet recruiting||Phase 2|20|Anticipated|UMC Utrecht||1|||f||||t|f|f|||f|||No||2017-10-10 21:04:37.928171|2017-10-10 21:04:37.928171
NCT03150615|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-07-29|||September 2016||2016-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Enteral Nutrition After Pancreaticoduodenectomy|Effect of Enteral Nutrition on Delayed Gastric Emptying After Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Nanjing Medical University||3|||f||||f||||||||||2017-10-10 21:04:38.066258|2017-10-10 21:04:38.066258
NCT03150602|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-10|||August 30, 2016|Actual|2016-08-30|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy|A Multi-Center, Open-Labelled, Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy|Recruiting||Phase 4|22|Anticipated|Taiwan Mundipharma Pharmaceuticals Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:04:38.193735|2017-10-10 21:04:38.193735
NCT03150576|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-05-10|||May 2016||2016-05-01|May 2017|2017-05-01|January 2032|Anticipated|2032-01-01|January 2022|Anticipated|2022-01-01||Interventional|PARTNER||Platinum and Polyadenosine 5'Diphosphoribose Polymerisation (PARP) Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer (TNBC) and/or Germline BRCA (gBRCA) Positive Breast Cancer|Randomised, Phase II/III, 3 Stage Trial to Evaluate the Safety and Efficacy of the Addition of Olaparib to Platinum-based Neoadjuvant Chemotherapy in Breast Cancer Patients With TNBC and/or gBRCA.|Recruiting||Phase 2/Phase 3|527|Anticipated|Cambridge University Hospitals NHS Foundation Trust||3|||f||||t||||||||Undecided||2017-10-10 21:04:38.450586|2017-10-10 21:04:38.450586
NCT03150563|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-05-09|||May 9, 2017|Actual|2017-05-09|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Differents Intensities of Passive Stretching on ROM, Neuromuscular and Performance in Soccer Players: A Blinded RCT|Effects of Different Intensities of Passive Static Stretching on Flexibility, Neuromuscular and Functional Performance in Soccer Athletes: A Blinded, Randomized Controlled Trial.|Recruiting||N/A|40|Anticipated|Universidade Federal do Rio Grande do Norte||4|||f||||t|f|f||||||No||2017-10-10 21:04:38.628135|2017-10-10 21:04:38.628135
NCT03150550|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-10|||January 21, 2017|Actual|2017-01-21|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|Mindfulness||Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention|Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention|Recruiting||N/A|200|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:04:38.776138|2017-10-10 21:04:38.776138
NCT03150537|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-23|||May 12, 2017|Actual|2017-05-12|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|Med-Jet™||Comparison of Routine IM Influenza Immunization and Administration by Jet-injector in Healthy Young Adults|Comparison of Routine IM Influenza Immunization and Administration by Jet-injector in Healthy Young Adults|Active, not recruiting||Phase 4|80|Actual|McGill University Health Center||3|||f||||f|f|f||||||No||2017-10-10 21:04:38.946578|2017-10-10 21:04:38.946578
NCT03150524|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-08-21|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||RCVS: The Rational Approach to Diagnosis and Treatment|RCVS: The Rational Approach to Diagnosis and Treatment|Recruiting||Phase 4|40|Anticipated|Johns Hopkins University||2|||f||||t|t|f|||f|||||2017-10-10 21:04:39.094844|2017-10-10 21:04:39.094844
NCT03150511|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-09|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury|Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy, and Improve Functional Outcomes Following Peripheral Nerve Injury|Not yet recruiting||Phase 2|36|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||No||2017-10-10 21:04:39.232628|2017-10-10 21:04:39.232628
NCT03150498|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-17|||May 3, 2017|Actual|2017-05-03|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001|A Phase 1 Cross-over Study to Determine Food Effects on the Pharmacokinetics of Oral BTD-001 and Metabolites in Healthy Volunteers, Followed by an Optional Multiple Dose Study to Assess Pharmacokinetics of Oral BTD-001|Active, not recruiting||Phase 1|12|Anticipated|Balance Therapeutics||2|||f||||f|t|f||||||||2017-10-10 21:04:39.320767|2017-10-10 21:04:39.320767
NCT03150485|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-09|||March 27, 2017||2017-03-27||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:04:39.400897|2017-10-10 21:04:39.400897
NCT03150472|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-09|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|IvoryGraft||Safety and Efficacy Evaluation of the Ivory Dentin Graft Device|Safety and Efficacy Evaluation of the Ivory Dentin Graft Device|Not yet recruiting||N/A|20|Anticipated|Ivory Graft Ltd.||2|||f||||f|f|f||||||No|IPD is not intended to be shared as this will be a single site study. The study will be public at ClinicalTrial.gov|2017-10-10 21:04:39.444076|2017-10-10 21:04:39.444076
NCT03150459|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-29|||July 26, 2017|Actual|2017-07-26|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LIVERHOPE||Simvastatin Plus Rifaximin in Decompensated Cirrhosis|Safety and Tolerability of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis: a Multicenter, Double-blind, Placebo Controlled Randomized Clinical Trial.|Recruiting||Phase 2|45|Anticipated|Institut d'Investigacions Biomèdiques August Pi i Sunyer||3|||f||||t|f|f||||||||2017-10-10 21:04:39.549868|2017-10-10 21:04:39.549868
NCT03150446|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-10|||April 1, 2009|Actual|2009-04-01|May 2017|2017-05-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Interventional|FC-DM||The Usefulness of Flexible Cystoscopy for Preventing Double-J Stent Malposition After Laparoscopic Ureterolithotomy|The Usefulness of Flexible Cystoscopy for Preventing Double-J Stent Malposition After Laparoscopic Ureterolithotomy|Completed||N/A|50|Actual|Korea University Anam Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:04:39.705209|2017-10-10 21:04:39.705209
NCT03150433|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-02|||September 5, 2017|Anticipated|2017-09-05|August 2017|2017-08-01|May 30, 2021|Anticipated|2021-05-30|July 31, 2020|Anticipated|2020-07-31||Interventional|||Sleep and Pain in Sickle Cell Disease|Sleep and Pain in Sickle Cell Disease|Not yet recruiting||N/A|120|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-10 21:04:39.786731|2017-10-10 21:04:39.786731
NCT03150420|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-23|||May 24, 2017|Actual|2017-05-24|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|CALISTA||A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients|A Phase 3, Intravenous Sodium Thiosulfate for Acute Calciphylaxis Treatment: A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial|Recruiting||Phase 3|111|Anticipated|Hope Pharmaceuticals||2|||||||t|t|f||||||||2017-10-10 21:04:39.862528|2017-10-10 21:04:39.862528
NCT03150407|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||May 1, 2017||2017-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:04:39.954317|2017-10-10 21:04:39.954317
NCT03150394|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-08-24|||April 4, 2017|Actual|2017-04-04|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice.|A Randomized, Double-blind, Placebo-controlled Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice|Recruiting||Phase 4|80|Anticipated|Hospital Clínico Universitario de Valladolid||2|||f||||f|f|f||||||||2017-10-10 21:04:40.003403|2017-10-10 21:04:40.003403
NCT03150381|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||May 1, 2012|Actual|2012-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|DSNCARES||Promoting Weight-Loss in African American Cancer Survivors in the Deep South||Active, not recruiting||N/A|369|Actual|University of Alabama at Birmingham||3|||f||||t|f|f||||||No||2017-10-10 21:04:40.100393|2017-10-10 21:04:40.100393
NCT03150368|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-12|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Extended Use of ModraDoc006/r|Safety of Extended Use of ModraDoc006/r in Patients With Advanced Solid Tumours|Recruiting||Phase 1|22|Anticipated|Modra Pharmaceuticals||1|||f||||f|f|f||||||No||2017-10-10 21:04:40.187589|2017-10-10 21:04:40.187589
NCT03150355|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Outcomes of Geriatric Hip Fractures in Assiut University Hospital|Outcomes of Geriatric Hip Fractures in Assiut University Hospital|Completed||N/A|301|Actual|Assiut University|||3||f||||t|f|f||||||No||2017-10-10 21:04:40.269003|2017-10-10 21:04:40.269003
NCT03150342|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-15|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|August 31, 2017|Anticipated|2017-08-31||Observational|||Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging|Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging|Recruiting||N/A|100|Anticipated|Far Eastern Memorial Hospital|||1||f|||||f|f||||||||2017-10-10 21:04:40.338846|2017-10-10 21:04:40.338846
NCT03150329|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-15|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pembrolizumab and Vorinostat in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, or Hodgkin Lymphoma|A Phase 1 Study of Pembrolizumab Plus Vorinostat for Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Hodgkin Lymphoma|Recruiting||Phase 1|60|Anticipated|City of Hope Medical Center||1|||||||t|t|f||||||||2017-10-10 21:04:40.436961|2017-10-10 21:04:40.436961
NCT03150316|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-06-08|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|November 19, 2019|Anticipated|2019-11-19|June 29, 2018|Anticipated|2018-06-29||Interventional|||CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma|A Phase I, Open-Label, Multi-Center Study of CKD-581 in Combination With Lenalidomide and Dexamethasone in Patients With Previously Treated Multiple Myeloma|Recruiting||Phase 1|18|Anticipated|Chong Kun Dang Pharmaceutical||1|||f||||f|f|f||||||Undecided||2017-10-10 21:04:40.551796|2017-10-10 21:04:40.551796
NCT03150303|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|May 2019|Anticipated|2019-05-01||Observational|PRADICO||Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology|Survey About Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology|Not yet recruiting||N/A|2000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f|f|f||||||No||2017-10-10 21:04:40.644328|2017-10-10 21:04:40.644328
NCT03150290|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|BATALS||Brown Adipose Tissue in ALS|Energy Expenditure and Brown Adipose Tissue in Amyotrophic Lateral Sclerosis|Not yet recruiting||N/A|10|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f|f|f||||||No||2017-10-10 21:04:40.733169|2017-10-10 21:04:40.733169
NCT03150277|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-19|||May 13, 2017|Actual|2017-05-13|June 2017|2017-06-01|June 7, 2017|Actual|2017-06-07|June 7, 2017|Actual|2017-06-07||Interventional|||Post - Activation Potentiation After Plyometric and Heavy Resistance Exercise in Soccer Players|Post - Activation Potentiation Following Acute Bouts of Plyometric Versus Heavy Resistance Exercise in Collegiate Soccer Players|Completed||N/A|14|Actual|Jamia Millia Islamia||2|||f||||f|f|f||||||No|Data will be kept secure with principal investigator (Md. Shahid Raza) and sub-investigator (Sourabh Kumar Sharma) due to confidentiality issues|2017-10-10 21:04:40.812353|2017-10-10 21:04:40.812353
NCT03150264|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-15|||January 16, 2017|Actual|2017-01-16|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Prospective Clinical Study of PCV and PCV-VG in Patients Undergoing Bariatric Surgery|The Comparison of Pressure-controlled Ventilation and Pressure-controlled Ventilation Volume-guaranteed on Respiratory Dynamics and Clinical Outcome in Patients Undergoing Bariatric Surgery: Prospective Clinical Study|Recruiting||N/A|140|Anticipated|Huashan Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:04:40.887596|2017-10-10 21:04:40.887596
NCT03150251|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||November 28, 2016|Actual|2016-11-28|May 2017|2017-05-01|April 15, 2017|Actual|2017-04-15|March 31, 2017|Actual|2017-03-31||Interventional|||Glycemic and Insulinemic Response to Oats Soaked Overnight in Milk Compared to Cream of Rice in Healthy Subjects|Glycemic and Insulinemic Response to Oats Soaked Overnight in Milk Compared to Cream of Rice in Healthy Subjects|Completed||N/A|40|Actual|PepsiCo Global R&D||3|||f||||f|f|f||||||No||2017-10-10 21:04:40.974273|2017-10-10 21:04:40.974273
NCT03150238|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-11|||April 13, 2017|Actual|2017-04-13|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|January 31, 2019|Anticipated|2019-01-31||Observational|POCD2017||Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building|A Multicenter Prospective Cohort Study of Surgically Resected Crohn's Disease Patients Aiming to Identify Prognostic Factors for Re-operation: a New Score|Recruiting||N/A|220|Anticipated|Istituto Clinico Humanitas|||1||f||||f|f|f||||||Undecided|TO BE DETERMINED|2017-10-10 21:04:41.052476|2017-10-10 21:04:41.052476
NCT03150225|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-08-14|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|February 26, 2018|Anticipated|2018-02-26||Interventional|DAEM||Physical Exercise for Men With Andropause|The Impact of Physical Exercise on Androgen Deficiency of Male Aging in Physical, Psychological, Hormonal and Sexual Aspects: a Randomized Clinical Trial|Not yet recruiting||N/A|58|Anticipated|Laboratório de Pesquisa em Lazer e Atividade Física||2|||f||||t|f|f||||||||2017-10-10 21:04:41.134273|2017-10-10 21:04:41.134273
NCT03150212|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-07-12|||March 20, 2017|Actual|2017-03-20|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|IBS-GO||Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype|Randomized Double Blind Placebo-controlled Clinical Study : Effect of IBSIUM on the Improvement of Gastro-intestinal Disorders Associated to the Irritable Bowel Syndrome (IBS) With C Phenotype (Predominant-constipation)|Recruiting||N/A|456|Anticipated|Lesaffre International||2|||f|||||f|f||||||||2017-10-10 21:04:41.208908|2017-10-10 21:04:41.208908
NCT03150199|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-08-28|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|BEHOLD-8||A Psychological-behavioral Intervention for Physical Activity in Type 2 Diabetes|A Psychological-behavioral Intervention for Physical Activity in Type 2 Diabetes|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||||2017-10-10 21:04:41.308308|2017-10-10 21:04:41.308308
NCT03150186|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-10|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|October 31, 2019|Anticipated|2019-10-31|March 1, 2018|Anticipated|2018-03-01||Observational|||Environmental Assessment of Secondhand Smoke Exposure in Private Settings and Outdoor Settings in Europe|Environmental Assessment of Secondhand Smoke Exposure in Private Settings and Outdoor Settings in Europe|Active, not recruiting||N/A|1080|Anticipated|Institut Català d'Oncologia|||3||f||||t|f|f||||||No||2017-10-10 21:04:41.404182|2017-10-10 21:04:41.404182
NCT03150173|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|O-BMT||Onsite Buprenorphine Treatment|Buprenorphine Treatment at Syringe Exchanges to Reduce Opioid Misuse and HIV Risk|Not yet recruiting||N/A|250|Anticipated|Montefiore Medical Center||2|||f||||t|f|f|||f|||No||2017-10-10 21:04:41.481744|2017-10-10 21:04:41.481744
NCT03150160|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-27|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|June 4, 2019|Anticipated|2019-06-04|June 4, 2019|Anticipated|2019-06-04||Interventional|||Additive Effect of Twice-daily Brinzolamide 1% / Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma|A 6-week, Double Masked, Placebo-controlled Study to Evaluate the Efficacy and Safety of Twice-daily Brinzolamide 1% / Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to Travoprost 0.004% in Reducing Intraocular Pressure in Patients With Normal Tension Glaucoma.|Recruiting||Phase 4|200|Anticipated|Novartis||2|||f||||f|f|f||||||||2017-10-10 21:04:41.55292|2017-10-10 21:04:41.55292
NCT03150147|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-10|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|NIHP||A Randomized Controlled Trial Comparing Non-ischemic to Ischemic Preservation in Adult Cardiac Transplantation|A Randomized Controlled Trial Comparing Non-ischemic Hypothermic Cardioplegic Perfusion to Ischemic Cold Static Preservation of Donor Hearts in Adult Cardiac Transplantation|Recruiting||N/A|34|Anticipated|Region Skane||2|||f||||t|f|f||||||||2017-10-10 21:04:41.738182|2017-10-10 21:04:41.738182
NCT03150134|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-09|||January 1, 2010|Actual|2010-01-01|May 2017|2017-05-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients|Early Tapering of Immunosuppressive Agents After Allogeneic Hematopoietic Stem Cell Transplantation Can Improve the Survival of Patients With Advanced Acute Myeloid Leukemia.|Recruiting||Phase 4|100|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t|f|f|||f|||Yes||2017-10-10 21:04:41.933277|2017-10-10 21:04:41.933277
NCT03150121|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-09|||June 29, 2014|Actual|2014-06-29|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|BEDOCA||Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage|Identification of Novel Biomarkers for Early Detection of Ovarian Cancer in High-risk and Normal-risk Populations Using Uterine Lavage|Recruiting||N/A|500|Anticipated|Sheba Medical Center||3|||f||||f|f|f||||||No||2017-10-10 21:04:42.091804|2017-10-10 21:04:42.091804
NCT03150108|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-09|||May 16, 2017|Actual|2017-05-16|August 2017|2017-08-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects|A Phase 1, Open-label, Randomized, Cross-over Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of rhPTH(1-84) Administered Subcutaneously in Japanese Healthy Subjects Compared With Matched Non-Hispanic, Caucasian Healthy Adult Subjects and to Assess Dose Proportionality of 3 Doses of rhPTH(1-84) in the Japanese Subjects|Completed||Phase 1|24|Actual|Shire||2|||f|||||t|f||||||||2017-10-10 21:04:42.228599|2017-10-10 21:04:42.228599
NCT03150095|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-10|||July 2018|Anticipated|2018-07-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Health Coaching to Improve Self-Management in Thoracic Transplant Candidates|Health Coaching to Improve Self-Management in Thoracic Transplant Candidates|Not yet recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||t|f|f||||||No||2017-10-10 21:04:42.348356|2017-10-10 21:04:42.348356
NCT03150082|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-09-14|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 28, 2017|Actual|2017-08-28|August 28, 2017|Actual|2017-08-28||Interventional|||Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects|An Open-label, Randomised, Single-dose, Two-period Cross-over Study to Evaluate Bioequivalence of GR37547 Ciprofloxacin 500 mg Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Participants Under Fasting Conditions|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 21:04:42.440592|2017-10-10 21:04:42.440592
NCT03150069|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-10|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|May 10, 2019|Anticipated|2019-05-10|May 10, 2018|Anticipated|2018-05-10||Observational|MorqPreg||Pregnancy With Morquio Syndrome - What Are Patients' Perspectives and Has ERT Changed Them?|Pregnancy With Morquio Syndrome - What Are Patients' Perspectives and Has ERT Changed Them?|Recruiting||N/A|12|Anticipated|Emory University|||4||f||||t|f|f||||||No|IPD will not be shared with other researchers|2017-10-10 21:04:42.550808|2017-10-10 21:04:42.550808
NCT03150056|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-07|||May 31, 2017|Actual|2017-05-31|August 2017|2017-08-01|July 29, 2019|Anticipated|2019-07-29|September 28, 2018|Anticipated|2018-09-28||Interventional|||Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer|A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)|Recruiting||Phase 1|130|Anticipated|GlaxoSmithKline||2|||f||||f|t|f||||||||2017-10-10 21:04:42.647743|2017-10-10 21:04:42.647743
NCT03150043|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||May 10, 2017|Anticipated|2017-05-10|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Continuous Non-Invasive Measurement of Hemoglobin During Parturition|Continuous Non-Invasive Measurement of Hemoglobin During Parturition|Not yet recruiting||N/A|100|Anticipated|The University of Texas Medical Branch, Galveston||1|||f||||t|f|t|f|f|t|||Undecided||2017-10-10 21:04:42.782847|2017-10-10 21:04:42.782847
NCT03150030|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-11|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|HYPO-HEART||Hypoglycaemia and Cardiac Arrhythmias in Type 2 Diabetes|Hypoglycaemia and Cardiac Arrhythmias in Type 2 Diabetes|Enrolling by invitation||N/A|42|Anticipated|University Hospital, Gentofte, Copenhagen|||2||f||||t|f|f||||||||2017-10-10 21:04:42.869182|2017-10-10 21:04:42.869182
NCT03150017|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-10|||March 8, 2017|Actual|2017-03-08|May 2017|2017-05-01|August 23, 2017|Anticipated|2017-08-23|August 23, 2017|Anticipated|2017-08-23||Interventional|||An Internet-Delivered Pain Management Programme for Spinal Cord Injury Pain|The Impact of an Internet-Delivered Cognitive Behavioural Therapy Pain Management Programme (PMP) on People With Spinal Cord Injuries: A Pilot Study|Active, not recruiting||N/A|70|Anticipated|University College Dublin||2|||f||||f|f|f||||||No||2017-10-10 21:04:42.971055|2017-10-10 21:04:42.971055
NCT03150004|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-03|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia|Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia|Recruiting||Phase 2|90|Anticipated|Medical College of Wisconsin||1|||f||||t|t|f|||f|||||2017-10-10 21:04:43.095194|2017-10-10 21:04:43.095194
NCT03149991|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)|A Double-Blind, Placebo-Controlled Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)|Recruiting||Phase 4|50|Anticipated|Massachusetts General Hospital||2|||f||||f|t|f||||||||2017-10-10 21:04:43.252168|2017-10-10 21:04:43.252168
NCT03149978|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||July 1, 2014||2014-07-01|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis|Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis|Recruiting||N/A|500|Anticipated|Fudan University|||1||f||||t||||||Samples With DNA|"     blood, plasma，serum and urine   "|||2017-10-10 21:04:43.458166|2017-10-10 21:04:43.458166
NCT03149965|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-14|||October 2, 2014|Actual|2014-10-02|May 2017|2017-05-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Interventional|AVD||Maternal Body Mass Index and Anovaginal Distance|Maternal Body Mass Index and Anovaginal Distance in Active Phase of Labor at Term Pregnancy|Completed||N/A|207|Actual|Linkoeping University||2|||f||||f|f|f||||||No||2017-10-10 21:04:43.575184|2017-10-10 21:04:43.575184
NCT03149952|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-09|||September 20, 2017|Anticipated|2017-09-20|May 2017|2017-05-01|March 20, 2019|Anticipated|2019-03-20|March 20, 2019|Anticipated|2019-03-20||Interventional|CABALLO||A Pilot Study of the Feasibility of Setting up a Logbook for Allogeneic Haematopoietic Stem Cell Patients at the University Hospital of Amiens|A Pilot Study of the Feasibility of Setting up a Logbook for Allogeneic Haematopoietic Stem Cell Patients at the University Hospital of Amiens|Not yet recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:04:43.683587|2017-10-10 21:04:43.683587
NCT03149939|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-10|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|April 1, 2017|Actual|2017-04-01||Interventional|||Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients|Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients|Completed||N/A|19|Actual|Benha University||1|||f||||t|f|f||||||No||2017-10-10 21:04:43.795131|2017-10-10 21:04:43.795131
NCT03149926|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-11|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Emotional Reaction and Self Injury in Patients With Borderline Personality Disorder and Healthy Controls|Emotional Reaction of Patients With Borderline Personality Disorder (BPD)on Stimuli Connected to Self-injury - A Comparison Between Patients With BPD and a Healthy Control Group.|Not yet recruiting||N/A|60|Anticipated|University of Oldenburg|||2||f||||f|f|f||||||Undecided||2017-10-10 21:04:43.894339|2017-10-10 21:04:43.894339
NCT03149913|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-10|||December 15, 2016|Actual|2016-12-15|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|December 30, 2018|Anticipated|2018-12-30||Interventional|SAMBA||Local Paclitaxel or Balloon Angioplasty Below the Knee|Does Local Paclitaxel Improve the Efficacy of Balloon Angioplasty Without Stent Implantation for Treatment of Below the Knee Artery Lesions?|Recruiting||N/A|120|Anticipated|Klinikum Rosenheim||2|||f|||||f|f||||||||2017-10-10 21:04:44.040995|2017-10-10 21:04:44.040995
NCT03149900|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-11|||October 2016||2016-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|BIOMARKER||Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients|Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients|Recruiting||N/A|40|Anticipated|University of Luebeck|||1||f||||f||||||Samples With DNA|"     Blood samples   "|No||2017-10-10 21:04:44.245971|2017-10-10 21:04:44.245971
NCT03149887|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|December 30, 2017|Anticipated|2017-12-30||Interventional|||Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair|Use of Liposomal Bupivacaine for Postoperative Pain Management After Arthroscopic Rotator Cuff Repair|Recruiting||Phase 4|50|Anticipated|University of Pittsburgh||2|||f||||t|t|f||||||||2017-10-10 21:04:44.382947|2017-10-10 21:04:44.382947
NCT03149874|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||December 1, 2014|Actual|2014-12-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|April 30, 2017|Actual|2017-04-30||Interventional|||Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients|Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients, Does it Works?|Completed||N/A|114|Actual|Benha University||2|||f||||t|f|f||||||No||2017-10-10 21:04:44.472063|2017-10-10 21:04:44.472063
NCT03149861|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-28|||June 8, 2017|Actual|2017-06-08|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|PSMA-DOCS||Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR|Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR|Recruiting||N/A|57|Anticipated|University Health Network, Toronto||2|||f||||f|f|f||||||||2017-10-10 21:04:44.545551|2017-10-10 21:04:44.545551
NCT03149848|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-05|||June 6, 2017|Actual|2017-06-06|September 2017|2017-09-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Interventional|||Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects|Phase I, Single-center, Open Label, Fixed-sequence Cross-over Study to Evaluate the Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects|Recruiting||Phase 1|15|Anticipated|ViiV Healthcare||2|||f||||f|f|f||||||||2017-10-10 21:04:44.63544|2017-10-10 21:04:44.63544
NCT03149835|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-09|||May 1, 2007|Actual|2007-05-01|April 2007|2007-04-01|May 31, 2011|Actual|2011-05-31|May 1, 2011|Actual|2011-05-01||Interventional|||NIV Reduces CBF in COPD Patients Without Cognitive Function|Acute Non-invasive Ventilation Reduces Cerebral Blood Flow in COPD Patients and Healthy Controls Without Effects on Cognitive Function|Completed||N/A|21|Actual|Universidade Federal do Ceara||2|||f||||t|f|f||||||No||2017-10-10 21:04:44.733773|2017-10-10 21:04:44.733773
NCT03149822|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma|Phase I/II Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma|Not yet recruiting||Phase 1/Phase 2|55|Anticipated|University of Colorado, Denver||3|||f||||t|t|f|||f|||||2017-10-10 21:04:44.796063|2017-10-10 21:04:44.796063
NCT03149809|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-22|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|BOSS PD||Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease|Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease|Not yet recruiting||Phase 3|90|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||Yes|Final data sets underlying publications resulting from the proposed research will be shared outside VA through a de-identified, anonymized Dataset under a written agreement that adheres to any applicable Informed Consent provisions and prohibits the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset.|2017-10-10 21:04:44.896969|2017-10-10 21:04:44.896969
NCT03149796|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-10|2017-05-14|||March 23, 2011|Actual|2011-03-23|May 2017|2017-05-01|May 1, 2013|Actual|2013-05-01|May 1, 2013|Actual|2013-05-01||Observational|||Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients|The Effect of Tocilizumab (Anti-interleukin-6) Treatment on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients|Completed||N/A|80|Actual|Carmel Medical Center|||2||f||||||||||Samples Without DNA|"     periferal blood and serum   "|Yes||2017-10-10 21:04:45.013361|2017-10-10 21:04:45.013361
NCT03149783|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-06-28|||September 13, 2017|Anticipated|2017-09-13|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|TAP RCT||Study to Determine if Pre- and Post- Operative TAP Catheters With Ropivacaine Versus Placebo Affects Anesthetic, Narcotic Dosing, and Pain Scores|A Randomized Controlled Trial to Determine if Pre- and Post- Operative Regional Pain Control (Transversus Abdominis Plane Block) With Ropivacaine Versus Placebo Leads to Lower Anesthetic and Narcotic Dosing, and Alters Pain Scores|Recruiting||Phase 2|80|Anticipated|University of Colorado, Denver||2|||f||||t|t|f|||f|||No|No sharing|2017-10-10 21:04:45.18437|2017-10-10 21:04:45.18437
NCT03149770|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-10-04|||September 18, 2017|Actual|2017-09-18|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Naloxone, Hypoglycemia and Exercise|Hypoglycemia After Exercise in Type 1 Diabetes: Intranasal Naloxone as a Novel Therapy to Preserve Hypoglycemia Counterregulation|Recruiting||Phase 2|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|t|f|||f|||||2017-10-10 21:04:45.279167|2017-10-10 21:04:45.279167
NCT03149757|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-16|||May 16, 2017|Actual|2017-05-16|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial|Connecting Youth and Young Adults to Optimize ART Adherence: Testing the Efficacy of the Youth Thrive Intervention|Recruiting||N/A|408|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||Yes|The investigators will assure the timely release and sharing of data two years after the publication of the main trial findings from the final dataset. Study variables will be available; however, the investigators will protect the rights and privacy of human subjects by redacting all identifiers from the data set. The de-identified data from this project will be available through individual requests directed to the Principal Investigator.|2017-10-10 21:04:45.366115|2017-10-10 21:04:45.366115
NCT03149224|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-05-09|||June 1, 2017|Anticipated|2017-06-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Observational|DERPSP||Detection of Error Related Potentials in Stroke Patients|Detection of Error Related Potentials in Stroke Patients|Not yet recruiting||N/A|20|Anticipated|Bnai Zion Medical Center|||1||f||||||||||||||2017-10-10 21:04:51.461681|2017-10-10 21:04:51.461681
NCT03149744|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||February 28, 2017|Actual|2017-02-28|May 2017|2017-05-01|June 9, 2017|Anticipated|2017-06-09|May 31, 2017|Anticipated|2017-05-31||Observational|||Mixed Methods Evaluation of a Novel Apnoea Event Detection Monitor|A Mixed-methods Evaluation of a Novel Apnoea Event Detection Monitor in Comparison to Standard of Care Limited Overnight Polysomnography|Recruiting||N/A|127|Anticipated|PMD Solutions|||1||f||||f|f|f||||||No||2017-10-10 21:04:45.519347|2017-10-10 21:04:45.519347
NCT03149731|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|November 1, 2017|Anticipated|2017-11-01||Observational|||Monitoring of Cerebral and Abdominal Tissue Oxygen Saturation in Neonates|Monitoring of Cerebral and Abdominal Tissue Oxygen Saturation in Neonates|Recruiting||N/A|120|Anticipated|Xijing Hospital|||1||f||||t|f|t|f|f||||||2017-10-10 21:04:45.585576|2017-10-10 21:04:45.585576
NCT03149705|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||October 13, 2016|Actual|2016-10-13|May 2017|2017-05-01|October 2026|Anticipated|2026-10-01|May 4, 2017|Actual|2017-05-04||Observational|HIBISCUSSTROKE||Cohort of Ischemic STROKE Patients|CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke.|Recruiting||N/A|300|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     In usual care of patients admitted for ischemic STROKE at Pierre Wertheimer Hospital, blood     samples were taken on admission in the neurovascular unit (H0), 6h, 24h and 48h after     reperfusion , and during the 3 month clinical visit.      For the constitution of the serum bank of Hibiscus-STROKE cohort, extra tubes are collected     at the same time as the blood tests done routinely.      These additional samples will be centrifuged and treated to form a collection of biological     samples of total serum and plasma and blood stored at the Biological Resource Center of HCL     Neurobiotec at -80 ° C (DC- 2008-72, AC-2013-1867 certified NFS96900 FR13-018140).   "|Undecided||2017-10-10 21:04:45.737151|2017-10-10 21:04:45.737151
NCT03149692|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||December 11, 2014|Actual|2014-12-11|May 2017|2017-05-01|December 11, 2021|Anticipated|2021-12-11|December 11, 2020|Anticipated|2020-12-11||Interventional|||Penile Transplant Study|Penile Allograft Transplantation for Men With Penile Loss After Ritual Circumcision|Recruiting||N/A|3|Anticipated|University of Stellenbosch||1|||f||||f|f|f||||||Yes|Via publication or request. Low subject numbers expected|2017-10-10 21:04:45.805346|2017-10-10 21:04:45.805346
NCT03149679|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-09|||May 9, 2017|Actual|2017-05-09|July 2017|2017-07-01|June 2025|Anticipated|2025-06-01|June 2020|Anticipated|2020-06-01||Interventional|||The p53 Colorectal Cancer Trial|Treatment of Patients With Metastatic Colorectal Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Colorectal Cancer Trial|Recruiting||Phase 2|50|Anticipated|Haukeland University Hospital||1|||f||||t|f|f|||f|||||2017-10-10 21:04:45.900967|2017-10-10 21:04:45.900967
NCT03149666|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-09|||February 1, 2015|Actual|2015-02-01|May 2017|2017-05-01|July 1, 2016|Actual|2016-07-01|January 31, 2016|Actual|2016-01-31||Observational|||Quantitative Evaluation of Bitter Taste in Obesity|Anthropometric Variables and Perception of Bitter Taste in Obese Adults or Not|Completed||N/A|262|Actual|University of Sao Paulo|||1||f||||t|f|f||||||No||2017-10-10 21:04:45.990582|2017-10-10 21:04:45.990582
NCT03149653|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-09|||January 15, 2012|Actual|2012-01-15|May 2017|2017-05-01|June 30, 2016|Actual|2016-06-30|January 7, 2016|Actual|2016-01-07||Interventional|||Crossover Study on the Effect of Omegaven in Combination With Different Lipid Emulsions in Home Parenteral Nutrition|A Prospective, Randomized, Controlled, Double-blind, Crossover-Design, Mono-center, Phase IV Study Comparing the Effect of Omegaven in Combination With Clinoleic or Lipoplus or SMOFlipid in Home Parenteral Nutrition Patients|Completed||Phase 4|24|Actual|General University Hospital, Prague||3|||f||||f|f|f|||f|||No||2017-10-10 21:04:47.831385|2017-10-10 21:04:47.831385
NCT03149640|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-09|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|AMIKINHAL||Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia|Double-blinded Multicenter Randomized Controlled Trial Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia|Not yet recruiting||Phase 3|850|Anticipated|University Hospital, Tours||2|||f||||t|f|f||||||No||2017-10-10 21:04:47.978655|2017-10-10 21:04:47.978655
NCT03149627|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-30|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Observational|HEP-ZED||Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults|Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults|Recruiting||N/A|6000|Anticipated|University of Alabama at Birmingham|||1||f||||f|f|f||||Samples Without DNA|"     Part 1: The Investigators will test for active HBV infection using a rapid point-of-care     HBsAg test. In addition, as a service to clients who have not had an HIV test in the past     year (as recommended by Ministry of Health), for 20% of participants (selected randomly at     household level), the Investigators will also collect a dried blood spot using finger prick     method to perform HBcAb test, an epidemiologic test for lifetime exposure to HBV.      Part 2: Participants will have physical examination, a liver ultrasound, transient     elastography (TE), and blood will be collected for HBV viral load and other markers.   "|||2017-10-10 21:04:48.183122|2017-10-10 21:04:48.183122
NCT03149614|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||MANUAL MOBILIZATION IN CERVICAL DISORDES|SPINAL MOBILIZATION VERSUS RESONANT OSCILLATION MOBILIZATION (POLD) IN NECK PAIN. A RANDOMIZED CLINICAL TRIAL|Recruiting||N/A|50|Anticipated|Universidad Rey Juan Carlos||2|||f||||t|f|f||||||No||2017-10-10 21:04:48.290313|2017-10-10 21:04:48.290313
NCT03149601|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||March 7, 2017|Actual|2017-03-07|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Composition and Collection Feasibility of Gut Microbiota in Children With and Without Obesity|Composition and Collection Feasibility of Gut Microbiota in Children With and Without Obesity|Recruiting||N/A|150|Anticipated|University of Illinois College of Medicine at Peoria|||2||f|||||f|f||||Samples With DNA|"     Stool samples will be processed and retained for DNA and RNA genomic analysis of microbiome   "|||2017-10-10 21:04:48.379282|2017-10-10 21:04:48.379282
NCT02777762|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-06-30|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Strategies to Promote Physical Activity|Strategies to Promote Physical Activity|Not yet recruiting||N/A|50|Anticipated|Stanford University||2|||f|||||f|f||||||||2017-10-10 22:11:18.444894|2017-10-10 22:11:18.444894
NCT03149588|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-10|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Propofol and Sevoflurane as Maintaining Anesthetics During General Anesthesia of Cesarean Section|Comparison of Effects of Propofol and Sevoflurane as Maintaining Anesthetics During General Anesthesia on Maternal and Fetal Outcomes After Cesarean Section|Recruiting||Phase 4|60|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f|||||f|f||||||||2017-10-10 21:04:48.449588|2017-10-10 21:04:48.449588
NCT03149575|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-11|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|STAR-3||VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM|A Pivotal Randomized, Controlled Trial of VAL-083 in Patients With Recurrent Glioblastoma Who Have Failed Standard Temozolomide/Radiation Therapy and Bevacizumab (STAR-3)|Recruiting||Phase 3|180|Anticipated|DelMar Pharmaceuticals, Inc.||2|||t||||t|t|f||||||||2017-10-10 21:04:48.531638|2017-10-10 21:04:48.531638
NCT03149562|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-09|||January 1, 2011|Actual|2011-01-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|PT||Association of Plasma Transfusions and Invasive Fungal Infection|Association of Plasma Transfusions and Invasive Fungal Infection|Recruiting||N/A|500|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University|||2||f||||t|f|f||||||||2017-10-10 21:04:48.750199|2017-10-10 21:04:48.750199
NCT03149549|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-10-05|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors|A Phase 1-2, Open-Label, Dose-Finding, Proof of Concept, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CX-2009 in Adults With Metastatic or Locally Advanced Unresectable Solid Tumors (PROCLAIM-CX-2009)|Recruiting||Phase 1/Phase 2|150|Anticipated|CytomX Therapeutics||2|||f||||t|t|f||||||||2017-10-10 21:04:48.856432|2017-10-10 21:04:48.856432
NCT03149536|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-10|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|November 30, 2020|Anticipated|2020-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Pharmacogenetic Algorithm for Individualized Controlled Ovarian Stimulation|Pharmacogenetic Algorithm for Individualized Controlled Ovarian Stimulation (iCOS) in Assisted Reproductive Technology Cycles|Not yet recruiting||N/A|1350|Anticipated|Clínica Origen||6|||f||||f|f|f||||||Undecided||2017-10-10 21:04:48.982488|2017-10-10 21:04:48.982488
NCT03149523|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-16|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|ExhauCRF||Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors|Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors to Define Potential Targets of Targeted and/or Immunomodulatory Therapies|Not yet recruiting||N/A|150|Anticipated|European Georges Pompidou Hospital|||3||f||||t|f|f||||Samples With DNA|"     blood samples, urine collection, tumor sample and tumor microenvironment sample   "|No|The IPD (individual participant data) will not be shared. To protect confidentiality and integrity of patient information, only investigators of the study will have a regulated access to data with authorizations.|2017-10-10 21:04:49.106512|2017-10-10 21:04:49.106512
NCT03149510|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-09|||March 6, 2017|Actual|2017-03-06|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||The Effects of Self-monitoring With a Mobile Application in Heart Failure|A Patient-centered Mobile Intervention to Promote Self-management and Improve Patient Outcomes in Chronic Heart Failure|Recruiting||N/A|80|Anticipated|University of Michigan||2|||f||||f|f|f||||||No||2017-10-10 21:04:49.231594|2017-10-10 21:04:49.231594
NCT03149497|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Anterior Only Surgery for Management of Traumatic Subaxial Cervical Spine Instability|Anterior Only Surgery for Management of Traumatic Subaxial Cervical Spine Instability|Active, not recruiting||N/A|30|Actual|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:04:49.327071|2017-10-10 21:04:49.327071
NCT03149484|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-09|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Use of RM Technology in Pediatric BAI Recipients|Remote Microphone Technology in Pediatric Bone Anchored Implant Recipients|Enrolling by invitation||N/A|30|Anticipated|University of Miami|||2||f|||||f|t|f|f||||||2017-10-10 21:04:49.398417|2017-10-10 21:04:49.398417
NCT03149471|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-09|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Observational|||The Role of Endothelial Function Test in Risk Stratification for Early and Late Complications After Pulmonary Embolism|The Role of Endothelial Function Test in Risk Stratification for Early and Late Complications After Pulmonary Embolism|Not yet recruiting||N/A|200|Anticipated|Sheba Medical Center|||2||f||||f|f|f||||||No|No IPD plan|2017-10-10 21:04:49.485964|2017-10-10 21:04:49.485964
NCT03149458|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-09|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|DanceStudio||Dance Workshop on Balance of Hemiparetic Patients|Effects of a Dance Workshop on the Balance Abilities of Hemiparetic Patients|Recruiting||N/A|40|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||f|f|f||||||No||2017-10-10 21:04:49.575506|2017-10-10 21:04:49.575506
NCT03149445|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-10|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|TM002||Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)|A Double-blind, Randomized, Placebo-controlled, Multiple-dose, Multi-centre Safety and Efficacy Study of Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)|Recruiting||Phase 2|15|Anticipated|Saniona||2|||f||||t|f|f||||||No||2017-10-10 21:04:49.691706|2017-10-10 21:04:49.691706
NCT03149432|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-05-10|||February 22, 2017|Actual|2017-02-22|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|MIR-PHAN||Effectiveness of Mirror Therapy in Patients With Amputations of Lower Limbs of Vascular Origin|Effectiveness of Mirror Therapy in Patients With Amputations of Lower Limbs of Vascular Origin|Recruiting||N/A|40|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||t|f|f||||||Undecided||2017-10-10 21:04:49.791082|2017-10-10 21:04:49.791082
NCT03149419|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-09|||March 1, 2016|Actual|2016-03-01|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Hot Flash as a Marker of Cardiovascular Risk in Recent Postmenopause: Effects of Non-hormonal Treatments|Endothelial, Autonomic and Pressure Effects of Paroxetine in Recent Postmenopause Women With Hot Flashes: a Randomized Placebo Controlled Clinical Trial|Recruiting||Phase 4|140|Anticipated|Rio de Janeiro State University||2|||f|||||f|f|||f|||No||2017-10-10 21:04:49.906938|2017-10-10 21:04:49.906938
NCT03149406|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-11|||December 26, 2012|Actual|2012-12-26|May 2017|2017-05-01|December 26, 2020|Anticipated|2020-12-26|December 26, 2020|Anticipated|2020-12-26||Observational|||Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest|Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest|Recruiting||N/A|245|Anticipated|Centre Hospitalier Universitaire, Amiens|||2||f|||||f|f||||||||2017-10-10 21:04:50.003115|2017-10-10 21:04:50.003115
NCT03149393|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-05-10|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Clinical Study on Post Evaluation After Listing of Qizhi Weitong Granules|Clinical Study on Post Evaluation After Listing of Qizhi Weitong Granules|Not yet recruiting||Phase 1/Phase 2|384|Anticipated|Xiyuan Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||No||2017-10-10 21:04:50.082486|2017-10-10 21:04:50.082486
NCT03149380|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-08-28|||January 2017||2017-01-01|August 2017|2017-08-01|October 2024|Anticipated|2024-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of Alzheimer's Universe (Www.Alzu.Org) on Knowledge and Behavior|Evaluating the Effectiveness of Web-based Education Via Alzheimer's Universe (Www.Alzu.Org) on Knowledge and Behavior: A Randomized Trial|Recruiting||N/A|10000|Anticipated|Weill Medical College of Cornell University||1|||f||||f|f|f||||||||2017-10-10 21:04:50.156914|2017-10-10 21:04:50.156914
NCT03149367|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Surgical Management of Blepharoptosis|Fixed Versus Adjustable Sutures in Management of Blepheroptosis|Active, not recruiting||N/A|40|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:04:50.223319|2017-10-10 21:04:50.223319
NCT03149354|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-09|||December 19, 2012|Actual|2012-12-19|May 2017|2017-05-01|December 19, 2022|Anticipated|2022-12-19|December 19, 2022|Anticipated|2022-12-19||Interventional|PrévalenceTHYV||Prevalence of Thyroid Function Abnormalities in HIV-infected Patients: State of Play in 2012|Prevalence of Thyroid Function Abnormalities in HIV-infected Patients: State of Play in 2012|Recruiting||N/A|104|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:04:50.307644|2017-10-10 21:04:50.307644
NCT03149341|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-05-11|||February 2008||2008-02-01|May 2017|2017-05-01|February 2025|Anticipated|2025-02-01|January 2025|Anticipated|2025-01-01||Observational|||MRI and Computational Simulation Cardiology Study|MR Imaging and Computational Simulation of Cardiovascular Physiology Including Velocity, Pressure, and Wall Shear Stress|Recruiting||N/A|75|Anticipated|Stanford University|||2||f||||t||||||||Yes|Publication|2017-10-10 21:04:50.379729|2017-10-10 21:04:50.379729
NCT03149328|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-25|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney)|Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney)|Not yet recruiting||N/A|459|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 21:04:50.454635|2017-10-10 21:04:50.454635
NCT03149315|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-09|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Inhibition of Anaphylaxis by Ibrutinib|Inhibition of Anaphylaxis by Ibrutinib|Recruiting||Phase 2|6|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f|t|f||||||No||2017-10-10 21:04:50.666998|2017-10-10 21:04:50.666998
NCT03149302|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-09|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effects of Local Treatment With and Without Sensorimotor and Balance Exercises in Neck Pain|Effects of Local Neck Treatment With and Without Tailored Sensorimotor Control and Balance Exercises for Individuals With Chronic Neck Pain: Protocol for a Randomized Controlled Trial|Not yet recruiting||N/A|120|Anticipated|Chiang Mai University||4|||f||||f|f|f||||||No||2017-10-10 21:04:50.792981|2017-10-10 21:04:50.792981
NCT03149289|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-09|||March 1, 2015||2015-03-01|January 2017|2017-01-01|February 1, 2017|Actual|2017-02-01|March 1, 2016|Actual|2016-03-01||Observational|||Hepatitis C Virus Infection in Patients With Hemoglobinopathies|Treatment of Hepatitis C Virus Infection With Direct-acting Antiviral Drugs in Patients With Hemoglobinopathies|Completed||N/A|168|Actual|Società Italiana Talassemie ed Emoglobinopatie|||1||f|||||t|f||||||No||2017-10-10 21:04:50.945412|2017-10-10 21:04:50.945412
NCT03149276|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-11|||January 6, 2015|Actual|2015-01-06|May 2017|2017-05-01|April 15, 2015|Actual|2015-04-15|April 15, 2015|Actual|2015-04-15||Observational|||Limited English Proficiency Occupational Therapy Patients Receiving Interpreter Services Perception of Quality of Care|Limited English Proficiency Occupational Therapy Patients Receiving Interpreter Services Perception of Quality of Care|Completed||N/A|8|Actual|Rush University Medical Center|||2||f||||f|f|f||||||Undecided||2017-10-10 21:04:51.044672|2017-10-10 21:04:51.044672
NCT03149263|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-05-10|||November 10, 2015|Actual|2015-11-10|May 2017|2017-05-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Observational|CLOWN-TOX||Evaluation of the Effect of the Presence Of Clowns on Pain and Anxiety Seen During Injections Botulinum Toxin in Child|Evaluation of the Effect of the Presence Of Clowns on Pain and Anxiety Seen During Injections Botulinum Toxin in Child|Completed||N/A|80|Actual|University Hospital, Brest|||2||f||||f||||||||No||2017-10-10 21:04:51.159082|2017-10-10 21:04:51.159082
NCT03149250|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 1, 2018|Anticipated|2018-02-01|December 31, 2017|Anticipated|2017-12-31||Observational|||Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia|Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia - a Cross-sectional Study|Not yet recruiting||N/A|60|Anticipated|Goethe University|||3||f||||f|f|f||||||||2017-10-10 21:04:51.280026|2017-10-10 21:04:51.280026
NCT03149237|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-01|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Partners-based HIV Treatment for Couples Attending Antenatal Care|Partners-based HIV Treatment for Sero-concordant Couples Attending Antenatal Care|Not yet recruiting||N/A|3240|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:04:51.373596|2017-10-10 21:04:51.373596
NCT03149211|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-09|||January 2018|Anticipated|2018-01-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults|A Phase III, Randomized, Open-label, Controlled Trial to Investigate the Efficacy and Safety of UB-421 Monotherapy as Substitution for Stable Antiretroviral Therapy in HIV-1 Infected Adults|Not yet recruiting||Phase 3|375|Anticipated|United BioPharma||2|||f||||t|f|f||||||||2017-10-10 21:04:51.528861|2017-10-10 21:04:51.528861
NCT03149198|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-05|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|December 7, 2017|Anticipated|2017-12-07||Interventional|||Mat Pilates Method in the Treatment of Women With Fibromyalgia|Assessment of the Effectiveness of the Mat Pilates Method in the Treatment of Women With Fibromyalgia in the Santa Cruz City, Rio Grande do Norte, Brazil: A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Universidade Federal do Rio Grande do Norte||2|||f||||t|f|f||||||||2017-10-10 21:04:51.617655|2017-10-10 21:04:51.617655
NCT03149185|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-09|||May 25, 2012|Actual|2012-05-25|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PC-CHIP||Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate Cancer|Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate Cancer|Active, not recruiting||N/A|230|Anticipated|Northwestern University||2|||f||||t|f|f||||||No||2017-10-10 21:04:51.706702|2017-10-10 21:04:51.706702
NCT03149172|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||October 20, 2014|Actual|2014-10-20|May 2017|2017-05-01|December 7, 2016|Actual|2016-12-07|June 7, 2016|Actual|2016-06-07||Interventional|||Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials|Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials|Completed||N/A|25|Actual|Tufts University School of Dental Medicine||3|||f||||f|f|t|f|f||||No||2017-10-10 21:04:51.799396|2017-10-10 21:04:51.799396
NCT03149159|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-09|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|December 1, 2020|Anticipated|2020-12-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab|An Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab|Not yet recruiting||Phase 2|36|Anticipated|Medical University of South Carolina||1|||f||||t|t|f||||||No||2017-10-10 21:04:51.892126|2017-10-10 21:04:51.892126
NCT03149146|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-09|||March 13, 2017|Actual|2017-03-13|May 2017|2017-05-01|December 7, 2017|Anticipated|2017-12-07|July 31, 2017|Anticipated|2017-07-31||Interventional|||Improving Clinical Decision Making Skills for Myanmar Physical Therapists by Series of Workshop|Improving Clinical Decision Making Skills of Physical Therapists in Myanmar By Series of Educational Workshop|Recruiting||N/A|68|Anticipated|Mahidol University||2|||f||||t|f|f||||||Yes||2017-10-10 21:04:51.995474|2017-10-10 21:04:51.995474
NCT03149133|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-08-16|||April 5, 2017|Actual|2017-04-05|August 2017|2017-08-01|August 16, 2017|Actual|2017-08-16|August 15, 2017|Actual|2017-08-15||Interventional|||Comparison of Occlusive and Classical Hypertrophy Training in Terms of Thickness and Stiffness of The Muscle|Comparison of Occlusive and Classical Hypertrophy Training in Terms of Thickness and Stiffness of The Muscle, An Ultrasound-Based Study|Completed||N/A|25|Actual|Istanbul University||2|||f||||f|f|f||||||||2017-10-10 21:04:52.091609|2017-10-10 21:04:52.091609
NCT03149120|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-17|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|August 17, 2017|Actual|2017-08-17||Interventional|||Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas|Phase II Randomized Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas After One Prior Line of Systemic Therapy or Ineligible to Receive an Anthracycline-based Treatment|Withdrawn||Phase 2|0|Actual|New York University School of Medicine||2||No patient enrolled as new similar study will be in system within 3 months|f||||t|t|f|||f|||||2017-10-10 21:04:52.187775|2017-10-10 21:04:52.187775
NCT03149107|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||September 2016||2016-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ESPRIT-B1||"Multimodal Prevention of Psychosis - a Randomized Trial Investigating the Efficacy of N-Acetylcysteine (NAC) and Integrated Preventive Psychological Intervention (IPPI) in Subjects Clinically at High Risk for Psychosis"||Not yet recruiting||Phase 3|200|Anticipated|University Hospital, Bonn||2|||f||||t||||||||Undecided||2017-10-10 21:04:52.284057|2017-10-10 21:04:52.284057
NCT03149094|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-09|||April 27, 2017|Actual|2017-04-27|April 2017|2017-04-01|April 27, 2018|Anticipated|2018-04-27|April 27, 2018|Anticipated|2018-04-27||Interventional|||CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue|Feasibility and Acceptability of an mHealth Cognitive Behavioral Stress Management Intervention to Ameliorate HIV-related Fatigue|Recruiting||N/A|20|Anticipated|Medical University of South Carolina||1|||f||||t|f|f||||||No||2017-10-10 21:04:52.385537|2017-10-10 21:04:52.385537
NCT03149081|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-14|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|August 30, 2018|Anticipated|2018-08-30||Interventional|||"A Window Trial on Boswellia for Breast Cancer and Colon Cancer Primary Tumors"|"A Window Trial on Boswellia, an Extract From Frankincense, for Breast and Colon Cancer Primary Tumors"|Recruiting||Phase 1|60|Anticipated|Medical University of South Carolina||1|||f||||t|t|f||||||||2017-10-10 21:04:52.512402|2017-10-10 21:04:52.512402
NCT03149068|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-13|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01|12 Months|Observational [Patient Registry]|||Studying the Relationship Between Mean Platelet Volume and Neutrophil/ Lymphocyte Ratio With Inflammation and Proteinuria in Chronic Kidney Disease|Studying the Relationship Between Mean Platelet Volume and Neutrophil/ Lymphocyte Ratio With Inflammation and Proteinuria in Chronic Kidney Disease|Not yet recruiting||N/A|100|Anticipated|Assiut University|||2||f||||t|f|f||||||Undecided||2017-10-10 21:04:52.585378|2017-10-10 21:04:52.585378
NCT03149055|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-09|||May 4, 2017|Actual|2017-05-04|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)|A Single Center, Open-label Trial of Isavuconazole Prophylaxis Against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)|Recruiting||Phase 2|92|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:04:52.644521|2017-10-10 21:04:52.644521
NCT03149042|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||May 28, 2016|Actual|2016-05-28|May 2017|2017-05-01|May 28, 2018|Anticipated|2018-05-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Validation of a Computed Tomography (CT) Based Fractional Flow Reserve (FFR) Software Using the 320 Detector Aquilion ONE CT Scanner.|Validation of a Computed Tomography (CT) Based Fractional Flow Reserve (FFR) Software Using the 320 Detector Aquilion ONE CT Scanner.|Recruiting||N/A|50|Anticipated|State University of New York at Buffalo||1|||f||||f|f|t|f|f||||No||2017-10-10 21:04:52.722727|2017-10-10 21:04:52.722727
NCT03149029|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-25|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma|A Phase II Trial of Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Patients With Unresectable or Metastatic Melanoma|Not yet recruiting||Phase 2|50|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||||2017-10-10 21:04:52.803408|2017-10-10 21:04:52.803408
NCT03149016|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-31|||August 20, 2016|Actual|2016-08-20|August 2017|2017-08-01|November 15, 2017|Anticipated|2017-11-15|August 20, 2017|Actual|2017-08-20||Interventional|||The Use of Corticotomy for Upper Incisors Retraction|Evaluation of Treatment Outcomes of Corticotomy-accelerated Upper Incisors' Retraction: A Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|Damascus University||2|||f||||t|f|f||||||||2017-10-10 21:04:52.918328|2017-10-10 21:04:52.918328
NCT03149003|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-03|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|WIZARD201G||A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy|A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab Versus Bevacizumab Alone in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy|Recruiting||Phase 2|200|Anticipated|Boston Biomedical, Inc||2|||f|||||t|f||||||||2017-10-10 21:04:53.015186|2017-10-10 21:04:53.015186
NCT03148990|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||January 8, 2018|Anticipated|2018-01-08|April 2017|2017-04-01|November 30, 2018|Anticipated|2018-11-30|May 7, 2018|Anticipated|2018-05-07||Interventional|BIOMR||Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella|A Phase II / III, Clinical Trial to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella, Produced by Bio-Manguinhos / Fiocruz in 11-month-old Infants.|Not yet recruiting||Phase 2/Phase 3|432|Anticipated|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||2|||f||||t|f|f||||||No||2017-10-10 21:04:53.110458|2017-10-10 21:04:53.110458
NCT03148977|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-06-09|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|April 1, 2020|Anticipated|2020-04-01|April 30, 2019|Anticipated|2019-04-30||Observational|||Evaluating MMPs in Burns|Evaluating a Point-of-Care, Quantitative Matrix Metalloproteinase Assay as a Predictor of Successful Graft Take in Patients Undergoing Cutaneous Auto Grafting for Acute Burn Injury- A Pilot Study|Recruiting||N/A|60|Anticipated|University of Florida|||1||f||||f|f|f||||Samples With DNA|"     Acute burn wound exudate Acute burn wound tissue   "|No||2017-10-10 21:04:53.198966|2017-10-10 21:04:53.198966
NCT03148964|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-10|||October 1996|Actual|1996-10-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|PRIMO||Primary Infection Cohort|Multicentric Cohort of HIV-1 (Human Immunodeficiency Virus 1) Primary Infection Cohort ANRS CO6 PRIMO|Recruiting||N/A|2550|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f|f|f||||Samples With DNA|"     plasma, full blood, serum, lymphocytes and cells samples   "|No||2017-10-10 21:04:53.297527|2017-10-10 21:04:53.297527
NCT03148951|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-10|||May 10, 2017|Anticipated|2017-05-10|May 2017|2017-05-01|July 10, 2019|Anticipated|2019-07-10|May 10, 2019|Anticipated|2019-05-10|1 Day|Observational [Patient Registry]|||The Relation of MPV and NLR With Postoperative Pain in Patients Undergoing Total Knee Arthroplasty|The Relation of MPV and NLR With Postoperative Pain in Patients Undergoing Total Knee Arthroplasty|Not yet recruiting||N/A|300|Anticipated|Akdeniz University|||4||f||||f|f|f||||||No||2017-10-10 21:04:53.541905|2017-10-10 21:04:53.541905
NCT03148938|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-10-02|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MSCopilot||Digitalization of Neurofunctional Tests Via a Mobile Application DAMS for Multiple Sclerosis Patients|" Digitalization of Neurofunctional Tests Via a Mobile Application, Digital Assessment Multiple Sclerosis (DAMS), for Multiple Sclerosis Patients"|Recruiting||N/A|222|Anticipated|Ad scientiam||2|||f|||||f|f||||||||2017-10-10 21:04:53.632189|2017-10-10 21:04:53.632189
NCT03148925|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-10-03|||May 11, 2017|Actual|2017-05-11|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers|A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Pharmacodynamics of Increasing Subcutaneous Doses of SELA-070 in Healthy Adult Smokers|Recruiting||Phase 1|48|Anticipated|Selecta Biosciences, Inc.||2|||f|||||t|f|||t|||||2017-10-10 21:04:53.789502|2017-10-10 21:04:53.789502
NCT03148912|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-08|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|HIT||Optimizing the Diagnosis of Heparin Induced Thrombocytopenia|Optimizing the Diagnosis of Heparin Induced Thrombocytopenia Using Quantified Anti-Platelet Factor 4 Immunological Testing: A Pilot Multicentre Cohort Study|Not yet recruiting||N/A|180|Anticipated|Ottawa Hospital Research Institute||1|||f||||t|f|f||||||No||2017-10-10 21:04:53.903147|2017-10-10 21:04:53.903147
NCT03148899|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-11|||July 27, 2016|Actual|2016-07-27|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep|Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep|Recruiting||Phase 2|10|Anticipated|George Washington University||2|||f||||f|t|f||||||||2017-10-10 21:04:54.007136|2017-10-10 21:04:54.007136
NCT03148886|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-09|||October 2016||2016-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ABLE||Advanced Breast Cancer and Lifestyle Exercise Study|Advanced Breast Cancer and Lifestyle Exercise Study|Recruiting||N/A|60|Anticipated|Centre Leon Berard||1|||f||||f|f|f||||||No||2017-10-10 21:04:54.130271|2017-10-10 21:04:54.130271
NCT03148873|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|||RespiraSense Versus Capnography & Manual Counting|Evaluation of a Continuous Monitoring Device in Capturing Respiratory Rate Compared to Industry Standard & Gold Standard|Recruiting||N/A|21|Anticipated|PMD Solutions|||1||f||||f|f|f||||||No||2017-10-10 21:04:54.253216|2017-10-10 21:04:54.253216
NCT03148860|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-23|||December 15, 2016|Actual|2016-12-15|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|MUST||Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA|Impact of Concomitant Methotrexate on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active Psoriasis Arthritis|Recruiting||Phase 3|198|Anticipated|Fraunhofer Institute for Molecular Biology and Applied Ecology||4|||f||||t|f|f||||||No||2017-10-10 21:04:54.341957|2017-10-10 21:04:54.341957
NCT03148847|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-09|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|RENAU-OAP||Management of Cardiogenic Pulmonary Edema (RENAU-OAP)|Evaluation of Professional Practices on the Management of Cardiogenic Pulmonary Edema (RENAU-OAP)|Recruiting||N/A|2000|Anticipated|Centre Hospitalier de la Région d'Annecy|||2||f|||||f|f||||||No||2017-10-10 21:04:54.551556|2017-10-10 21:04:54.551556
NCT03148834|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-09|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|DUPAP||Dextran Use for Primary Angioplasty Protection in Acute Myocardial Infarction|A Randomized Study to Evaluate Controlled Reperfusion With Venous Blood and Dextran for Myocardial Protection Compared With Standard Angioplasty During Primary Angioplasty in Patients With Acute Myocardial Infarction and TIMI 0/1 Flow.|Not yet recruiting||N/A|100|Anticipated|Centro Cardiovascular Salta||2|||f||||t|f|f||||||No||2017-10-10 21:04:54.677714|2017-10-10 21:04:54.677714
NCT03148821|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-07-11|||July 1, 2017|Actual|2017-07-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Pressure Area Distribution on a Variety of Clinical Surfaces|Pressure Area Distribution on a Variety of Clinical Surfaces in a Group of 51 Volunteers|Recruiting||N/A|51|Anticipated|Brighton and Sussex University Hospitals NHS Trust|||1||f||||f|f|f||||||||2017-10-10 21:04:54.773919|2017-10-10 21:04:54.773919
NCT03148808|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-26|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|June 3, 2019|Anticipated|2019-06-03|June 3, 2019|Anticipated|2019-06-03||Interventional|||Natural Vascular Scaffold (NVS) Therapy|Natural Vascular Scaffold (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)|Recruiting||Phase 1|15|Anticipated|Alucent Medical, Inc.||1|||f||||t|t|t|t|||||No||2017-10-10 21:04:54.876426|2017-10-10 21:04:54.876426
NCT03148795|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-28|||July 4, 2017|Actual|2017-07-04|September 2017|2017-09-01|March 3, 2022|Anticipated|2022-03-03|August 2, 2019|Anticipated|2019-08-02||Interventional|||A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer|A Phase 2, Open-label, 2-arm, Response Rate Study Of Talazoparib In Men With Dna Repair Defects And Metastatic Castration-resistant Prostate Cancer Who Previously Received Taxane-based Chemotherapy And Progressed On At Least 1 Novel Hormonal Agent (Enzalutamide And/or Abiraterone Acetate/Prednisone)|Recruiting||Phase 2|150|Anticipated|Pfizer||1|||f|||||t|f||||||||2017-10-10 21:04:55.018901|2017-10-10 21:04:55.018901
NCT03148782|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-09-08|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Brain Plasticity Underlying Acquisition of New Organizational Skills in Children|Brain Plasticity Underlying Acquisition of New Organizational Skills in Children|Recruiting||N/A|50|Anticipated|New York University School of Medicine||1|||f||||f|f|f||||||||2017-10-10 21:04:55.203573|2017-10-10 21:04:55.203573
NCT03148769|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-08|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|PRO-BAC||Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors|Spanish Cohort of Bacteriemias 2016: Epidemiology, Clinical Management and Prognostic Factors at Diagnosis.|Recruiting||N/A|5000|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla|||1||f||||t|f|f||||Samples With DNA|"     Microbial strains   "|Yes||2017-10-10 21:04:55.300939|2017-10-10 21:04:55.300939
NCT03148756|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||May 11, 2017|Anticipated|2017-05-11|May 2017|2017-05-01|November 21, 2018|Anticipated|2018-11-21|November 21, 2018|Anticipated|2018-11-21||Interventional|||Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis|Phase 2, Open-Label, Randomized, Multicenter Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Documented Infective Endocarditis|Not yet recruiting||Phase 2|150|Anticipated|Allergan||2|||f|||||t|f||||||||2017-10-10 21:04:55.566117|2017-10-10 21:04:55.566117
NCT03148743|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-30|||May 20, 2017|Actual|2017-05-20|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|||Fecal Microbiota Transplantation in Gut aGVHD Treated|Department of Hematology of First Affiliated Hospital of Soochow University|Recruiting||N/A|20|Anticipated|The First Affiliated Hospital of Soochow University|||1||f||||t|f|f||||||||2017-10-10 21:04:55.694851|2017-10-10 21:04:55.694851
NCT03148730|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-29|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|December 30, 2017|Anticipated|2017-12-30||Interventional|||Manual vs Automated Anesthesia : Impact On The Incidence Of POCD|Manual vs Automated Optimization of Anesthesia, Analgesia, Fluid Management and Ventilation Using Closed-loop Systems: Impact On The Incidence Of POCD In Elderly Patients Undergoing Moderate to High Risk Surgery|Recruiting||N/A|84|Anticipated|Erasme University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:04:55.762487|2017-10-10 21:04:55.762487
NCT03148717|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-10|||May 10, 2017|Anticipated|2017-05-10|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preoperative vs. Postoperative Rectal Misoprostol in Cesarean Section|Preoperative vs. Postoperative Rectal Misoprostol in Cesarean Section: A Randomized, Double Blind Clinical Trial|Recruiting||Phase 2/Phase 3|300|Anticipated|Ain Shams University||2|||f|||||f|f||||||||2017-10-10 21:04:55.861806|2017-10-10 21:04:55.861806
NCT03148704|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-08|||March 8, 2017|Actual|2017-03-08|May 2017|2017-05-01|June 8, 2018|Anticipated|2018-06-08|March 8, 2018|Anticipated|2018-03-08||Observational|||Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules (Ruo Shan®)|Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules|Recruiting||N/A|3000|Anticipated|Cttq|||1||f|||||f|f|||f|||No||2017-10-10 21:04:55.942748|2017-10-10 21:04:55.942748
NCT03148496|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-08-25|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Tissue Reinforcement of Incisional Closure Among High Risk Patients|Tissue Reinforcement of Incisional Closure Among High Risk Patients|Recruiting||N/A|192|Anticipated|The University of Texas Health Science Center, Houston||4|||f||||t|f|t|f|f||||||2017-10-10 21:04:57.662763|2017-10-10 21:04:57.662763
NCT03148691|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-07-19|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis|A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of A-101(Hydrogen Peroxide) Topical Solution in Subjects With Seborrheic Keratosis Lesions on the Trunk, Extremities, and Face|Recruiting||Phase 2|250|Anticipated|Aclaris Therapeutics, Inc.||3|||f||||f|t|f||||||||2017-10-10 21:04:56.040765|2017-10-10 21:04:56.040765
NCT03148678|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-13|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Scrutinizing and Promoting Mindfulness Via New Technologies|Scrutinizing and Promoting Mindfulness Via New Technologies: Smartphone-based Assessment and Micro-intervention and Functional Magnetic Resonance Imaging (fMRI) (-Neurofeedback)|Recruiting||N/A|60|Anticipated|University Hospital, Basel, Switzerland||4|||f||||f|f|f||||||||2017-10-10 21:04:56.142371|2017-10-10 21:04:56.142371
NCT03148665|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-16|||April 14, 2017|Actual|2017-04-14|May 2017|2017-05-01|May 30, 2020|Anticipated|2020-05-30|May 30, 2019|Anticipated|2019-05-30||Interventional|Detect 44||Saliva-based Detection of CD44|A Prospective, Multi-site Trial of a Point of Care Saliva Based Detection Test Based on Soluble CD44 (OncAlert) for Presence of Disease in Previously Untreated Oral Cavity and Oropharynx Squamous Cell Carcinoma|Recruiting||N/A|300|Anticipated|University of California, San Diego||2|||f||||t|f|t|t|||||No||2017-10-10 21:04:56.253731|2017-10-10 21:04:56.253731
NCT03148652|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-09|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Cognitive and Emotional Skills to Aid Smoking Cessation|Cognitive and Emotional Skills to Aid Smoking Cessation|Not yet recruiting||N/A|74|Anticipated|Boston University Charles River Campus||2|||f||||f|f|f||||||No||2017-10-10 21:04:56.382275|2017-10-10 21:04:56.382275
NCT03148639|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-20|||September 1, 2015|Actual|2015-09-01|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|March 31, 2017|Actual|2017-03-31||Interventional|||Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia|Emotion Regulation Using Virtual Reality in Schizophrenia: a Clinical and Mechanistic Trial of Avatar Therapy for Refractory Auditory Hallucinations|Active, not recruiting||N/A|19|Actual|Ciusss de L'Est de l'Île de Montréal||2|||f||||f|f|f||||||||2017-10-10 21:04:56.46783|2017-10-10 21:04:56.46783
NCT03148626|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-20|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Does a Mindfulness Curriculum Prevent Physician Burnout During Pediatric Internship?|Can a Mindfulness Curriculum Prevent Burnout During Pediatric Internship? A Multi-center Cluster Randomized Controlled Trial.|Recruiting||N/A|300|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:04:56.560283|2017-10-10 21:04:56.560283
NCT03148613|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-08|||February 2, 2017||2017-02-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:04:56.659196|2017-10-10 21:04:56.659196
NCT03148600|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-08|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|RAP||Rehabilitation After Ileo-anal Pouch Surgery|Behavioural Treatment Following Ileo-Anal Pouch Formation:|Recruiting||N/A|60|Anticipated|St Vincent's Hospital Melbourne||2|||f||||t|f|f||||||No||2017-10-10 21:04:56.700038|2017-10-10 21:04:56.700038
NCT03148587|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-08|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|MASC||Medical Abortion Self-Confirmation (MASC)|Medication Abortion Self-Confirmation (MASC): Comparison of Two Home Pregnancy Tests as an Alternative to Office Follow-up|Enrolling by invitation||N/A|100|Anticipated|Stanford University||2|||f||||t|f|f||||||||2017-10-10 21:04:56.912429|2017-10-10 21:04:56.912429
NCT03148574|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery|Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery to Reduce Intraoperative and Postoperative Blood Loss: A Randomized Clinical Trial.|Not yet recruiting||Phase 3|240|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:04:57.040567|2017-10-10 21:04:57.040567
NCT03148561|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Management of Women With an Incomplete Evacuation|Medical Versus Expectant Management in Women With an Incomplete Evacuation of the Uterus After Misoprostol Treatment for First Trimester Miscarriage|Recruiting||N/A|60|Anticipated|Assiut University||2|||f||||f|f|f||||||Yes||2017-10-10 21:04:57.133516|2017-10-10 21:04:57.133516
NCT03148548|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-05-08|||November 2016||2016-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01|3 Days|Observational [Patient Registry]|||Substudy - Evaluation of Patients With Iliac Vein Thrombosis|Iliofemoral Thrombosis and Postthrombotic Syndrome: Registration and Analysis Within the Frankfurt Thrombophilia Registry|Recruiting||N/A|160|Anticipated|Cardioangiologisches Centrum Bethanien|||2||f||||f||||||Samples With DNA|"     whole blodd, serum   "|No||2017-10-10 21:04:57.25313|2017-10-10 21:04:57.25313
NCT03148535|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Guidance Model of Standardized Treatment of Antidepressants in Bipolar Disorder|Clinical Psychopharmacology Division Institute of Mental Health, Peking University|Recruiting||Phase 4|100|Anticipated|Peking University||2|||f||||f|f|f||||||No||2017-10-10 21:04:57.378189|2017-10-10 21:04:57.378189
NCT03148522|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 30, 2021|Anticipated|2021-12-30|December 30, 2021|Anticipated|2021-12-30||Interventional|||A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward System|Clinical Psychopharmacology Division,Institute of Mental Health,Peking University|Not yet recruiting||Phase 4|120|Anticipated|Peking University||3|||f||||f|f|f||||||No||2017-10-10 21:04:57.488956|2017-10-10 21:04:57.488956
NCT03148509|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward Pathway|Clinical Psychopharmacology Division Institute of Mental Health, Peking University|Not yet recruiting||Phase 4|300|Anticipated|Peking University||3|||f||||f|f|f|||f|||No||2017-10-10 21:04:57.577323|2017-10-10 21:04:57.577323
NCT03148483|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-12|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|January 1, 2019|Anticipated|2019-01-01||Interventional|IMPROVE||Calcium-vitamin D & Periodontal Therapy for Improving Metabolic and Inflammatory Profile Among Pregnant Women|Calcium and Vitamin D Supplementation and Periodontal Therapy for Improving Metabolic and Inflammatory Profile Among Pregnant Women: a Feasibility Trial (THE IMPROVE TRIAL)|Recruiting||N/A|120|Anticipated|University of Westminster||4|||f||||f|f|f||||||Undecided|External users will be bound by a data sharing agreement (in Portuguese and English) which will be available as part of the application to share data on the University website|2017-10-10 21:04:57.794963|2017-10-10 21:04:57.794963
NCT03148470|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-08|||September 2016||2016-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Impact of rTMS Over the Left DLPFC on Language Switching|Impact of Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex on Language Switching and Cognitive Flexibility|Recruiting||N/A|40|Anticipated|University of Fribourg||2|||f||||f||||||||No||2017-10-10 21:04:57.932965|2017-10-10 21:04:57.932965
NCT03148444|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-10|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome|Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome|Not yet recruiting||Phase 4|400|Anticipated|Kaplan Medical Center||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:04:58.224422|2017-10-10 21:04:58.224422
NCT03148431|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-10-02|||May 24, 2017|Actual|2017-05-24|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of LY3002815 in Healthy Participants|A Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3002815 in Healthy Subjects|Active, not recruiting||Phase 1|45|Actual|Eli Lilly and Company||2|||f||||f|t|f|||t|||||2017-10-10 21:04:58.334755|2017-10-10 21:04:58.334755
NCT03148418|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-08-24|||September 16, 2017|Anticipated|2017-09-16|August 2017|2017-08-01|August 5, 2027|Anticipated|2027-08-05|August 5, 2027|Anticipated|2027-08-05||Interventional|||A Study in Participants Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)|An Open-Label, Multicenter Extension Study in Patients Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study|Not yet recruiting||Phase 3|215|Anticipated|Hoffmann-La Roche||1|||f|||||t|f||||||||2017-10-10 21:04:58.454145|2017-10-10 21:04:58.454145
NCT03148392|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-08|||May 22, 2017|Anticipated|2017-05-22|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|May 1, 2019|Anticipated|2019-05-01||Observational|||Assess Differences in Pain Following Cryo and Radiofrequency Atrial Fibrillation Ablation|A Prospective Comparison of Quality of Life Following Atrial Fibrillation Ablation Using the Arctic Front Advance Cryo Balloon Compared to Contact Force Sensing Radiofrequency Catheter Ablation|Not yet recruiting||N/A|100|Anticipated|Langhorne Cardiology Consultants, Inc.|||2||f||||f|||||f|||No||2017-10-10 21:04:58.68416|2017-10-10 21:04:58.68416
NCT03148379|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-27|||October 15, 2017|Anticipated|2017-10-15|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|||Single-use Efficiency Instruments With Patient Specific Technique (MyKnee®) Versus Traditional Metal Instruments With Conventional Surgical Technique|A Multi-center, Prospective, Randomized Study Comparing Surgical and Economic Parameters of Total Knee Replacement Performed With Single-use Efficiency Instruments With Patient Specific Technique (MyKnee®) Versus Traditional Metal Instruments With Conventional Surgical Technique.|Not yet recruiting||N/A|300|Anticipated|Medacta USA||2|||f||||f|f|f||||||||2017-10-10 21:04:58.80357|2017-10-10 21:04:58.80357
NCT03148366|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-05-08|||February 2015||2015-02-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of the Levofloxacin Sequential Therapy and Quadruple Therapy in Second Line Treatment for HP|Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Bismuth Quadruple Therapy in the Second Line and Third Line Therapy for Helicobacter Pylori Infection- A Multi-center Randomized Trial|Recruiting||Phase 3|560|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||No|The investigators will not share the data.|2017-10-10 21:04:58.949553|2017-10-10 21:04:58.949553
NCT03148353|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-19|||May 30, 2017|Actual|2017-05-30|May 2017|2017-05-01|April 26, 2018|Anticipated|2018-04-26|April 26, 2018|Anticipated|2018-04-26||Interventional|SMCSINJ||Standardized and Modified Corticosteroid Subacromial Injection for Shoulder Impingement Syndrome|Comparative Effectiveness of the Standardized and Modified Ultrasound Guided Corticosteroid Subacromial Injection for Participants With Shoulder Impingement Syndrome|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:04:59.110899|2017-10-10 21:04:59.110899
NCT03148340|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-20|||April 14, 2017|Actual|2017-04-14|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|VITAL||Volumetric Integral Phase-shift Spectroscopy for Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Acute Brain Pathology|VITAL: Volumetric Integral Phase-shift Spectroscopy (VIPS) for the Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Acute Brain Pathology|Active, not recruiting||N/A|316|Anticipated|Cerebrotech Medical Systems, Inc.|||1||f||||t|f|f||||||||2017-10-10 21:04:59.234083|2017-10-10 21:04:59.234083
NCT03148327|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-24|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy|Randomized Phase I/II Study of Ablative Radiotherapy +/- MEDI 4736 (Durvalumab) for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer|Not yet recruiting||Phase 1/Phase 2|105|Anticipated|Jonsson Comprehensive Cancer Center||3|||f||||t|t|f|||t|||||2017-10-10 21:04:59.351193|2017-10-10 21:04:59.351193
NCT03148314|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Vaginal Misoprostol In Management Of First Trimester Missed Abortion.|Home-Based Extended Low Dose Buccal Misoprostol Versus Hospital-Based Standard Vaginal Dose In Management Of First Trimester Missed Abortion.|Not yet recruiting||Phase 2|100|Anticipated|Assiut University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:04:59.458519|2017-10-10 21:04:59.458519
NCT03148301|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Spina Bifida in Daily Life: an Exploratory Study|Spina Bifida in Daily Life: an Exploratory Study|Not yet recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f|f|f||||||No||2017-10-10 21:04:59.550412|2017-10-10 21:04:59.550412
NCT03148288|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-09|2017-05-09|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Vitamin D Supplementation in IBS|Vitamin D Supplementation in IBS|Not yet recruiting||N/A|90|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:04:59.640654|2017-10-10 21:04:59.640654
NCT03148275|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-09-28|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Interventional|||Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery|A Non-randomized, Open-Label, Phase 2 Study of Trametinib in Patients With Unresectable or Metastatic Epithelioid Hemangioendothelioma|Recruiting||Phase 2|27|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:04:59.732019|2017-10-10 21:04:59.732019
NCT03148262|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||May 10, 2017|Actual|2017-05-10|January 2017|2017-01-01|June 1, 2018|Anticipated|2018-06-01|April 12, 2018|Anticipated|2018-04-12||Interventional|||High-Flow Nasal Cannula and Desaturation Episodes in the Morbidly Obese Patients|Use of High-Flow Nasal Cannula to Prevent Desaturation Episodes in the Morbidly Obese Patients Undergoing Colonoscopy:A Prospective Randomized Clinical Trial|Recruiting||N/A|118|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|f|t|f||t|||Yes||2017-10-10 21:04:59.969408|2017-10-10 21:04:59.969408
NCT03148249|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-26|||October 10, 2014|Actual|2014-10-10|June 2017|2017-06-01|February 1, 2017|Actual|2017-02-01|February 17, 2016|Actual|2016-02-17||Interventional|CBS||A Trial of Patients With a Charles Bonnet Syndrome|A Randomized Control Trial of Patients With a Charles Bonnet Syndrome|Completed||N/A|34|Actual|Vienna Institute for Research in Ocular Surgery||2|||f||||f|f|f||||||No||2017-10-10 21:05:00.083201|2017-10-10 21:05:00.083201
NCT03148236|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-09-27|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|VitC-AF||Vitamin C in Atrial Fibrillation Ablation|Pilot Study of the Safety and Efficacy of Intravenous Vitamin C in Patients Undergoing Atrial Fibrillation Ablation|Recruiting||Phase 2|20|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f||||||||2017-10-10 21:05:00.149947|2017-10-10 21:05:00.149947
NCT03148223|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-11|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|March 20, 2018|Anticipated|2018-03-20|November 30, 2017|Anticipated|2017-11-30||Interventional|||Auriculotherapy in the Treatment of Dysmenorrhea|Effect of Auriculotherapy in the Treatment of Dysmenorrhea: Protocol of a Randomized Controlled Clinical Trial|Not yet recruiting||N/A|72|Anticipated|University of Sorocaba||2|||f||||t|f|f||||||Yes|We intend to share the data six months after the conclusion of the study|2017-10-10 21:05:00.255562|2017-10-10 21:05:00.255562
NCT03148210|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-09-14|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|April 30, 2023|Anticipated|2023-04-30|April 30, 2022|Anticipated|2022-04-30||Interventional|||Undiagnosed COPD and Asthma Population Study (UCAP)|A Randomized, Controlled, Clinical Trial to Address the Burden of Undiagnosed Airflow Obstruction in Canadian Adults|Enrolling by invitation||Phase 4|550|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:05:00.359877|2017-10-10 21:05:00.359877
NCT03148197|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-17|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|COLLECT||Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT)|Changes Over Time in the Gut Microbiota of High-risk Hematological Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT)|Recruiting||N/A|120|Anticipated|University of Cologne|||2||f||||t|f|f||||None Retained|"     PBMCs, plasma, urine and stool samples, retention until analysis   "|||2017-10-10 21:05:00.452949|2017-10-10 21:05:00.452949
NCT03148184|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-08|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Observational|||Reverse Shoulder Replacement: Age 60 or Younger Outcomes|Reverse Shoulder Arthroplasty in Patients 60 Years Old and Younger: Short-term Clinical and Radiographic Results|Enrolling by invitation||N/A|150|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 21:05:00.539378|2017-10-10 21:05:00.539378
NCT03148171|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-10|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|PrEP-R||Project PrEP-R: Network Support to Engage and Retain Younger Black MSM in PrEP Care|Project PrEP-R: Network Support to Engage and Retain Younger Black MSM in PrEP Care|Not yet recruiting||N/A|240|Anticipated|University of Chicago||2|||f||||t|f|f|||t|||No||2017-10-10 21:05:00.599203|2017-10-10 21:05:00.599203
NCT03148158|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-16|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|June 15, 2019|Anticipated|2019-06-15|June 15, 2018|Anticipated|2018-06-15||Observational|||Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident|Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident|Not yet recruiting||N/A|300|Anticipated|Mansoura University|||1||f||||t|f|f||||Samples With DNA|"     Bladder biopsy and urine cytology   "|Yes|meta-analyses by contact the Prof. Hassan Abol-Enein, MD, Phd (Study Chair)|2017-10-10 21:05:00.661343|2017-10-10 21:05:00.661343
NCT03148145|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||CalFitness Smartphone-Delivered Physical Activity Intervention With Messaging|Mobile Phone-Based Physical Activity Intervention on University Staff|Recruiting||N/A|80|Anticipated|University of California, Berkeley||4|||f|||||f|f||||||||2017-10-10 21:05:00.730224|2017-10-10 21:05:00.730224
NCT03147729|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-08|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|May 3, 2017|Actual|2017-05-03||Interventional|||Radiofrequency in Anal Incontinence: Randomized Clinical Trials|Radiofrequency in Anal Incontinence: Randomized Clinical Trials|Enrolling by invitation||N/A|100|Actual|Escola Bahiana de Medicina e Saude Publica||1|||f||||t|f|f|||f|||Yes|Publication in scientific articles.|2017-10-10 21:05:05.447914|2017-10-10 21:05:05.447914
NCT03148132|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-08-28|||May 23, 2017|Actual|2017-05-23|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP|Comparison of the Vascular Endothelial Growth Factor Serum Concentrations After Intravitreal Use of Bevacizumab or Ranibizumab as a Treatment for Type 1 Retinopathy of Prematurity|Recruiting||Phase 4|20|Anticipated|Universidad Autonoma de San Luis Potosí||2|||f|||||f|f||||||||2017-10-10 21:05:00.801702|2017-10-10 21:05:00.801702
NCT03148119|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-08|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of QRH-882260 Heptapeptide Application in the Colon|Phase IB Study of QRH-882260 Heptapeptide Application in the Colon|Recruiting||Phase 1|120|Anticipated|University of Michigan||1|||f||||t|t|t|f|||||No||2017-10-10 21:05:00.891137|2017-10-10 21:05:00.891137
NCT03148106|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-08|||April 4, 2017|Actual|2017-04-04|May 2017|2017-05-01|November 1, 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|DOSES||Hand Rehabilitation Study for Stroke Patients|Optimizing Peripheral Stimulation Parameters to Modulate the Sensorimotor Cortex for Post-stroke Motor Recovery.|Recruiting||N/A|25|Anticipated|University of California, San Francisco||1|||f|||||f|f||||||||2017-10-10 21:05:00.959528|2017-10-10 21:05:00.959528
NCT03148093|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-15|||May 31, 2017|Actual|2017-05-31|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01|15 Months|Observational [Patient Registry]|||The CHOICE Registry|The CHOICE Registry: A Research Initiative Examining Clinical, Economic, and Humanistic Outcomes in the Management of Metastatic Colorectal Cancer|Recruiting||N/A|1000|Anticipated|Taiho Oncology, Inc.|||1||f||||f|f|f||||||||2017-10-10 21:05:01.0335|2017-10-10 21:05:01.0335
NCT03148080|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-27|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Observational|WAYS||Work Ability in Young Adult Survivors|Work Ability in Young Adult Survivors (WAYS)|Not yet recruiting||N/A|200|Anticipated|Wake Forest University Health Sciences|||4||f||||t|f|f||||||||2017-10-10 21:05:01.113801|2017-10-10 21:05:01.113801
NCT03148067|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-09|||September 15, 2015|Actual|2015-09-15|May 2017|2017-05-01|April 3, 2017|Actual|2017-04-03|April 3, 2017|Actual|2017-04-03||Observational|||Incidence and Risk Factors for Surgical Site Infection After Intramedullary Nailing of Femoral and Tibial Fractures|Prospective Study on the Incidence and Risk Factors for the Occurrence of Surgical Site Infection After Intramedullary Nailing of Diaphyseal Femoral and Tibial Fractures|Completed||N/A|225|Actual|University of Sao Paulo|||1||f||||f|f|f||||||No||2017-10-10 21:05:01.194457|2017-10-10 21:05:01.194457
NCT03148054|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-05-08|||February 17, 2017|Actual|2017-02-17|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Computed Tomography vs. Endoscopy Study|Computed Tomography With Rectal Contrast and Early Endoscopy for the Detection of Anastomotic Leaks After Left Sided Colorectal Resection. A Single Center, Prospective Trial.|Recruiting||N/A|350|Anticipated|Spital Limmattal Schlieren|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:05:01.285176|2017-10-10 21:05:01.285176
NCT03148041|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-13|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|March 2, 2018|Anticipated|2018-03-02|December 30, 2017|Anticipated|2017-12-30||Interventional|||The Effect of Health Education Program on Level of Awareness for Stroke Among Population|The Effectiveness of Health Education Program on Level of Awareness of Stroke Among Population at Risk Attending Primary Health Care Center, Jeddah, Saudi Arabia, a Randomized Control Field Trial|Not yet recruiting||N/A|90|Anticipated|Taibah University||2|||f|||||f|f||||||Undecided||2017-10-10 21:05:01.557657|2017-10-10 21:05:01.557657
NCT03148028|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-08|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|June 1, 2020|Anticipated|2020-06-01||Observational|||Immunological Characteristics of Patients With PID and IBD|Immunological Characteristics of Patients With Primary Immunodeficiencies and Inflammatory Bowel Diseases|Recruiting||N/A|45|Anticipated|Sheba Medical Center|||1||f||||f|f|f||||Samples Without DNA|"     PBMCs Serum Stool   "|No||2017-10-10 21:05:01.658192|2017-10-10 21:05:01.658192
NCT03148015|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-08|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)|Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)|Recruiting||N/A|30|Anticipated|Sentara Norfolk General Hospital|||3||f||||f|f|f||||Samples With DNA|"     Biopsy or surgical tissue specimen slides.   "|No||2017-10-10 21:05:01.810806|2017-10-10 21:05:01.810806
NCT03148002|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-18|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation|An Evaluation of the Efficacy and Safety of a Polyethylene Glycol (PEG) Based Bowel Protocol for the Management of Constipation in Peritoneal Dialysis Patients: A Pilot Study|Recruiting||Phase 4|30|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f|||f|||||2017-10-10 21:05:01.915732|2017-10-10 21:05:01.915732
NCT03147989|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-11|||May 18, 2017|Actual|2017-05-18|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients|A Parallel-Group Comparison of Two Doses Of Multihance (0.10 mmol/Kg and 0.05 mmol/Kg) When Used For Magnetic Resonance Imaging (MRI) of The Central Nervous System (CNS)|Recruiting||N/A|320|Anticipated|Bracco Diagnostics, Inc|||2||f||||f||||||||||2017-10-10 21:05:02.081866|2017-10-10 21:05:02.081866
NCT03147976|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-23|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors|A Phase 2 Study of AMG 337 in Subjects With Advanced or Metastatic Solid Tumors That Overexpress Mesenchymal Epithelial Transition (MET) Factor|Not yet recruiting||Phase 2|89|Anticipated|NantPharma, LLC||1|||||||f|t|f||||||No||2017-10-10 21:05:02.21459|2017-10-10 21:05:02.21459
NCT03147963|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-07|||December 20, 2015|Actual|2015-12-20|May 2017|2017-05-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer|A Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety of a Single Agent Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer to a 3-weeks Regimen|Recruiting||Phase 2|90|Anticipated|Zhejiang Cancer Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:05:02.313156|2017-10-10 21:05:02.313156
NCT03147950|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-05|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Prone Versus Prone-Flexed Position For Percutaneous Nephrolithotomy (PCNL)|Prone Versus Prone-Flexed Position For Percutaneous Nephrolithotomy (PCNL) Comparing Efficacy and Complication According to Clavien-Dindo Classification Score Randomised Controlled Study|Not yet recruiting||N/A|100|Anticipated|Mansoura University||2|||f||||t|f|f||||||Yes|meta-analyses by contact the Prof. Ahmed Shoma, MD, Phd (Study Chair)|2017-10-10 21:05:02.439827|2017-10-10 21:05:02.439827
NCT03147937|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-09|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|||Cognitive Changes After Major Joint Replacement - Full Trial (Cognigram 2)|Assessing Postoperative Cognitive Changes After Major Joint Arthroplasty: A Prospective Cohort Study|Recruiting||N/A|505|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f|f|f||||||Undecided||2017-10-10 21:05:02.562154|2017-10-10 21:05:02.562154
NCT03147924|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-08|||March 6, 2017|Actual|2017-03-06|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Examining the Effects of an Improvisation Group|Examining the Effects of an Improvisation Group on Social Anxiety Among Help-seeking Youth|Recruiting||N/A|15|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f|f|f||||||No||2017-10-10 21:05:02.701444|2017-10-10 21:05:02.701444
NCT03147911|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-09-02|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|||Predictors Associated With Stroke or Systemic Embolism in Atrial Fibrillation Patients With a CHA2DS2-VA Score of 0 or 1|Clinical and Genetic Predictors Associated With the Stroke or Systemic Embolism in Atrial Fibrillation Patients Defined as a Low Risk Group Based on a CHA2DS2-VASc Score|Recruiting||N/A|1000|Anticipated|Korea University Guro Hospital|||2||f||||f|f|f||||Samples With DNA|"     Genomic DNA extractions from the blood samples.   "|||2017-10-10 21:05:02.833875|2017-10-10 21:05:02.833875
NCT03147898|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-10-04|||April 12, 2017|Actual|2017-04-12|June 2017|2017-06-01|December 13, 2017|Anticipated|2017-12-13|December 13, 2017|Anticipated|2017-12-13||Observational|||Observational Study Describing the Immune Profile Induced By Pertussis Vaccines|Characterization of Humoral and Cell-Mediated Immune Responses Following a Booster Dose of Pertussis Vaccine|Active, not recruiting||N/A|120|Anticipated|Sanofi|||4||f||||f|f|f||||Samples Without DNA|"     blood draw   "|||2017-10-10 21:05:02.98722|2017-10-10 21:05:02.98722
NCT03147885|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-12|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 28, 2018|Anticipated|2018-12-28|June 29, 2018|Anticipated|2018-06-29||Interventional|||Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma|A Phase 1b/2 Investigator Initiated Study of RCHOP in Combination With Selinexor (KPT-330) in B Cell Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|44|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 21:05:03.081383|2017-10-10 21:05:03.081383
NCT03147872|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-19|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Evaluation of the Impact of Reduced Oxygen Concentration on Live Birth Rate|Lo2 Phase II: A Comparison of Live Birth Rates Between Embryos Cultured in 2% vs. 5% After Day 3 of Embryo Culture|Recruiting||N/A|500|Anticipated|Reproductive Medicine Associates of New Jersey||2|||f||||f|f|f||||||No||2017-10-10 21:05:03.191712|2017-10-10 21:05:03.191712
NCT03147859|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-11|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 21, 2018|Anticipated|2018-12-21|December 21, 2018|Anticipated|2018-12-21||Interventional|HAVARTI||Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection|Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection|Not yet recruiting||Phase 2|12|Anticipated|Ottawa Hospital Research Institute||1|||f||||t|f|f||||||Yes|Study dataset, after study closure and publication, by request.|2017-10-10 21:05:03.306903|2017-10-10 21:05:03.306903
NCT03147846|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-07|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||The Hematologic Impact of Umbilical Cord Milking Versus Deferred Cord Clamping in Premature Neonates.|The Hematologic Impact of Umbilical Cord Milking Versus Deferred Cord Clamping in Premature Neonates. A Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Zagazig University||2|||f||||t|f|f||||||No||2017-10-10 21:05:03.403841|2017-10-10 21:05:03.403841
NCT03147833|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Protein Before Night Sleep to Improve Recovery and Performance in Runners|Ingestion of Protein Before Each Night Sleep to Improve Recovery and Performance in Runners|Not yet recruiting||N/A|32|Anticipated|University of Aarhus||2|||f||||t|f|f||||||Undecided||2017-10-10 21:05:03.497282|2017-10-10 21:05:03.497282
NCT03147040|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|July 1, 2029|Anticipated|2029-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|GELATO||AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer|AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer: GELATO-trial|Not yet recruiting||Phase 2|40|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 21:05:03.571701|2017-10-10 21:05:03.571701
NCT03147027|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-23|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Observational|nsVT||Catheter Ablation for Nonsustained Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy|Catheter Ablation for Nonsustained Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy|Recruiting||N/A|72|Anticipated|Heinrich-Heine University, Duesseldorf|||2||f||||f|f|f||||||||2017-10-10 21:05:03.702715|2017-10-10 21:05:03.702715
NCT03147014|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-06|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease|Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease|Enrolling by invitation||N/A|600|Anticipated|Beijing Anzhen Hospital||1|||f|||||f|f||||||||2017-10-10 21:05:03.794945|2017-10-10 21:05:03.794945
NCT03147001|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||April 30, 2016|Actual|2016-04-30|May 2017|2017-05-01|January 10, 2017|Actual|2017-01-10|January 10, 2017|Actual|2017-01-10||Interventional|||Protein Ingestion Before Training Low|Nutritional Strategies for Optimizing Adaptations and Recovery Following Training 'Low'.|Completed||N/A|9|Actual|University of Aarhus||2|||f||||t|f|f||||||No||2017-10-10 21:05:03.871127|2017-10-10 21:05:03.871127
NCT03146988|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-11|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta|Randomised, Double-Blind, Single, 6 mg Fixed Dose, Two Treatment, Two-Period, Two-Sequence, Two-Way Crossover Comparative Pharmacokinetic and Pharmacodynamic (Phase I) Study of RGB-02 Compared to Neulasta® in Healthy Adult Subjects|Active, not recruiting||Phase 1|150|Anticipated|Gedeon Richter Plc.||2|||f|||||f|f||||||||2017-10-10 21:05:03.933819|2017-10-10 21:05:03.933819
NCT03146975|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-28|||March 2, 2014|Actual|2014-03-02|June 2017|2017-06-01|June 28, 2017|Actual|2017-06-28|June 20, 2017|Actual|2017-06-20||Interventional|PETREBED||Effects of Gum Disease Treatment on Host Defense Factors|Effects of Non-surgical Periodontal Treatment on Gingival Beta Defensins in Different Clinical Conditions : a Short-term Clinica Trial|Completed||N/A|120|Actual|Federal University of Minas Gerais||6|||f||||t|f|f||||||No|Individual participant data will not be shared. Only data without identification will be submitted to statistical analysis.|2017-10-10 21:05:04.006302|2017-10-10 21:05:04.006302
NCT03146962|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-14|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies|A Phase II Study of High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies|Recruiting||Phase 2|50|Anticipated|Weill Medical College of Cornell University||1|||f||||t|t|f||||||||2017-10-10 21:05:04.092134|2017-10-10 21:05:04.092134
NCT03146949|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-05|||January 5, 2017|Actual|2017-01-05|April 2017|2017-04-01|July 31, 2017|Anticipated|2017-07-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Blood Isoflurane Concentration and the Oxygenator|Does the Type of Oxygenator Influence Arterial Blood Concentration of Isoflurane During Cardiopulmonary Bypass?|Recruiting||N/A|50|Anticipated|University of Edinburgh||2|||f||||f|f|f|||f|||No||2017-10-10 21:05:04.208079|2017-10-10 21:05:04.208079
NCT03146936|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-16|||February 28, 2017|Actual|2017-02-28|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31|5 Years|Observational [Patient Registry]|||Swiss Primary Sclerosing Cholangitis Cohort Study|Swiss Primary Sclerosing Cholangitis Cohort Study|Recruiting||N/A|120|Anticipated|Fondazione Epatocentro Ticino|||1||f|||||f|f||||||||2017-10-10 21:05:04.285499|2017-10-10 21:05:04.285499
NCT03146923|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-05|||March 6, 2017|Actual|2017-03-06|May 2017|2017-05-01|June 16, 2017|Anticipated|2017-06-16|May 16, 2017|Anticipated|2017-05-16||Interventional|DIP HD||Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices|Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices|Recruiting||N/A|200|Anticipated|University College Cork||2|||f||||f|f|f||||||No||2017-10-10 21:05:04.381536|2017-10-10 21:05:04.381536
NCT03146910|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||February 15, 2017|Actual|2017-02-15|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31|5 Years|Observational [Patient Registry]|||Swiss Primary Biliary Cholangitis Cohort Study|Swiss Primary Biliary Cholangitis Cohort Study|Recruiting||N/A|500|Anticipated|Fondazione Epatocentro Ticino|||1||f|||||f|f||||||||2017-10-10 21:05:04.564263|2017-10-10 21:05:04.564263
NCT03146897|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-12|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition|Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition (MAM) in Children: Sierra Leone Cost-Effectiveness Study|Recruiting||N/A|6000|Anticipated|Tufts University||4|||f||||f|f|f||||||No||2017-10-10 21:05:04.667781|2017-10-10 21:05:04.667781
NCT03147820|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-09|||February 2010||2010-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:05:04.793186|2017-10-10 21:05:04.793186
NCT03147807|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-09|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|April 1, 2019|Anticipated|2019-04-01||Interventional|BLUE-CarbA||BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU|BetaLACTA® Test-guided Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections Diagnosed in Intensive Care Unit - BLUE¬-CarbA Study|Not yet recruiting||N/A|646|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:04.835966|2017-10-10 21:05:04.835966
NCT03147794|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-08|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Functional Electrical Stimulation for Children With Upper Limb Weakness Post Stroke|Functional Electrical Stimulation Therapy for Children With Upper Limb Weakness Post Stroke: Evaluation of the Mynd Move Technology|Not yet recruiting||N/A|3|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||1|||f||||f|f|f||||||No|The researchers will not make individual patient data available to other researchers.|2017-10-10 21:05:04.93944|2017-10-10 21:05:04.93944
NCT03147781|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-08|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Auricular Therapy for Postpartum Lactation|The Effect of Auricular Therapy on Lactation: A Pilot Study|Recruiting||N/A|90|Anticipated|The Hong Kong Polytechnic University||3|||f||||f|f|f||||||No||2017-10-10 21:05:05.011739|2017-10-10 21:05:05.011739
NCT03147768|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-09|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|LTW||Laser Tissue Welding - Distal Pancreatectomy Sealing Study|Phase I Feasibility Trial To Study The Safety Of Sealing Resected Pancreatic Surfaces After Partial Distal Pancreatectomy Using Laser Tissue Welding|Recruiting||Phase 1|10|Anticipated|Laser Tissue Welding, Inc.||1|||f||||t|f|t|t|||||No||2017-10-10 21:05:05.169918|2017-10-10 21:05:05.169918
NCT03147755|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-08|||May 2010|Actual|2010-05-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|Marato-11||PREVALENCE, RISK FACTORS AND COMPLICATIONS OF OROPHARYNGEAL DYSPHAGIA IN STROKE PATIENTS|PREVALENCE, RISK FACTORS AND COMPLICATIONS OF OROPHARYNGEAL DYSPHAGIA IN STROKE PATIENTS|Completed||N/A|395|Actual|Hospital de Mataró|||2||f||||f|f|f||||||No||2017-10-10 21:05:05.314311|2017-10-10 21:05:05.314311
NCT03147742|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-03||||||July 2017|2017-07-01||||||||Expanded Access|||An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant|An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant|Available||N/A|||Incyte Corporation|||||||t||||||||||||2017-10-10 21:05:05.391751|2017-10-10 21:05:05.391751
NCT03147716|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-08|||October 2013|Actual|2013-10-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|April 2017|Actual|2017-04-01||Interventional|||Parent Engagement Package: Comparing Strategies for Engaging Parents Into Parenting Programs|Effectiveness Trial of Methods for Engaging Parents Into Parenting Interventions|Active, not recruiting||N/A|950|Anticipated|Arizona State University||5|||f||||f|f|f||||||No||2017-10-10 21:05:07.362389|2017-10-10 21:05:07.362389
NCT03147703|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-11|||June 1, 2015|Actual|2015-06-01|April 2017|2017-04-01|July 31, 2015|Actual|2015-07-31|July 1, 2015|Actual|2015-07-01||Interventional|OMTIME-MIC||Timing of Food Intake Impacts Daily Rhythms of Human Saliva Microbiota|Timing of Food Intake Impacts Daily Rhythms of Human Saliva Microbiota in a Mediterranean Population|Completed||N/A|10|Actual|Universidad de Murcia||2|||f||||t|f|f||||||No|Spain: Ministry of Health and consumption|2017-10-10 21:05:07.467496|2017-10-10 21:05:07.467496
NCT03147690|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-05|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children|A Multicenter Trial of Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Solid Organ Injuries in Pediatric Trauma|Not yet recruiting||Phase 1/Phase 2|146|Anticipated|Boston Children’s Hospital||1|||f||||t|t|f|||f|||||2017-10-10 21:05:07.554246|2017-10-10 21:05:07.554246
NCT03147677|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-07|||July 2016||2016-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan|A Prospective, Multi-center, Randomized, Open-label, Parallel-arm Controlled Study of Treating Type 2 Diabetic Nephropathy (Stage II-IV) With Alfacalcidol and Irbesartan|Recruiting||Phase 4|216|Anticipated|The Third Xiangya Hospital of Central South University||3|||f||||f||||||||No||2017-10-10 21:05:07.65985|2017-10-10 21:05:07.65985
NCT03147664|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-14|||January 1, 2014|Actual|2014-01-01|May 2017|2017-05-01|March 30, 2017|Actual|2017-03-30|April 30, 2014|Actual|2014-04-30||Observational|||Cardiopulmonary Exercise Test to Quantify Enzyme Replacement Response in Pediatric Pompe Disease|Cardiopulmonary Exercise Test to Quantify Enzyme Replacement Response in Pediatric Pompe Disease|Completed||N/A|5|Actual|Rambam Health Care Campus|||1||f||||f|f|f||||||No||2017-10-10 21:05:07.778443|2017-10-10 21:05:07.778443
NCT03147651|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-07|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Exercise Capacity in Patients With Cystic Fibrosis vs. Non-cystic Fibrosis Bronchiectasis|Exercise Capacity in Patients With Cystic Fibrosis vs. Non-cystic Fibrosis Bronchiectasis|Recruiting||N/A|119|Anticipated|Rambam Health Care Campus|||2||f||||f|f|f||||||No||2017-10-10 21:05:07.84309|2017-10-10 21:05:07.84309
NCT03147638|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-09|||January 11, 2017|Actual|2017-01-11|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|January 11, 2019|Anticipated|2019-01-11||Interventional|HIT||Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)|Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)|Recruiting||Phase 3|70|Anticipated|Marshall University||2|||f||||t|t|f|||t|||No||2017-10-10 21:05:07.921833|2017-10-10 21:05:07.921833
NCT03147625|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|SHAPE||Salutogenic Healthy Aging Program Embracement (SHAPE) for Elderly-only Households|Salutogenic Healthy Aging Program Embracement (SHAPE) for Elderly-only Households|Not yet recruiting||N/A|154|Anticipated|National University, Singapore||2|||f||||t|f|f||||||No||2017-10-10 21:05:08.018686|2017-10-10 21:05:08.018686
NCT03147612|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-07|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Study of the Combination of Low-Intensity Chemotherapy and Ponatinib in Patients With Philadelphia Chromosome (Ph)-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)|Phase II Study of the Combination of Low-Intensity Chemotherapy and Ponatinib in Patients With Philadelphia Chromosome (Ph)-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)|Not yet recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f|||f|||||2017-10-10 21:05:08.136306|2017-10-10 21:05:08.136306
NCT03147599|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-16|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Mebeverine For Daytime And Nocturnal Incontinence and After Orthotopic W-Ileal Neobladders|Mebeverine For Daytime And Nocturnal Incontinence and After Orthotopic W-Ileal Neobladders - Assessment Of Efficacy And Quality Of Life Effect Within 1 Year Post-Surgery: A Randomized Cross-over Controlled Study|Recruiting||Phase 4|120|Anticipated|Mansoura University||2|||f||||t|f|f|||f|||Yes|meta-analyses by contact the Prof. Hassan Abol-Enein, MD, Phd (Study Chair)|2017-10-10 21:05:08.290502|2017-10-10 21:05:08.290502
NCT03147586|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-05-09|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy|Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy and Bladder Substitutions: A Randomized Controlled Trial|Active, not recruiting||Phase 4|100|Anticipated|Mansoura University||2|||f||||f|f|f|||f|||Yes|meta-analyses by contact the Prof. Atallah Ahmed Shaaban MD (Study Chair)|2017-10-10 21:05:08.546807|2017-10-10 21:05:08.546807
NCT03147573|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-18|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Validity of 1BPM for Diagnosis of Hypertension|Validity of 1-hour Blood Pressure Monitoring Against the Usual Methods for Diagnosis of Hypertension|Recruiting||N/A|214|Anticipated|Consorci d'Atenció Primària de Salut de l'Eixample||1|||f||||f|f|f||||||||2017-10-10 21:05:08.686429|2017-10-10 21:05:08.686429
NCT03147560|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-09|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants|Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants|Recruiting||Phase 4|450|Anticipated|Zhejiang Provincial Center for Disease Control and Prevention||3|||f||||f|f|f|||f|||No||2017-10-10 21:05:08.839683|2017-10-10 21:05:08.839683
NCT03147547|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-08|||January 2009|Actual|2009-01-01|May 2017|2017-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Parent Engagement Package: Initial Testing of Strategies to Increase Participation in Parenting Interventions|Participation in Preventive Parenting Interventions|Completed||N/A|122|Actual|Arizona State University||2|||f||||f|f|f||||||No||2017-10-10 21:05:08.944894|2017-10-10 21:05:08.944894
NCT03147534|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-08|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Interventional|CIT-CRCP||Comparison of Thermometry in Canada for Pediatrics|Comparison of the InstaTemp MD® Infrared Thermometer With Standard Thermometry in Canadian Routine Clinical Practice|Recruiting||N/A|261|Anticipated|ARC Devices||3|||f||||f|f|t|f|f|t|||No||2017-10-10 21:05:09.038403|2017-10-10 21:05:09.038403
NCT03147521|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-08|||April 28, 2015|Actual|2015-04-28|May 2017|2017-05-01|January 31, 2017|Actual|2017-01-31|December 28, 2016|Actual|2016-12-28||Interventional|||Accidental Falls Care Bundle|Stepped Wedge Cluster Randomized Controlled Trial for the Evaluation of Effectiveness of a Accidental Falls Care Bundle Implementation in Elderly Hospital Patients.|Completed||N/A|10000|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||f|f|f||||||No||2017-10-10 21:05:09.137259|2017-10-10 21:05:09.137259
NCT03147508|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-05-05|||September 2016||2016-09-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01|1 Week|Observational [Patient Registry]|||Investigating Clinical Indicators of Spine Related Dysfunction Patterns. A Clinical Study on Neck Pain Patients.||Enrolling by invitation||N/A|1000|Anticipated|University Ghent|||1||f||||||||||||No||2017-10-10 21:05:09.204693|2017-10-10 21:05:09.204693
NCT03147495|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-07-05|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Observational|||The Inclination of the Proximal Tibiofibular Joint Surface and Medial Compartment Knee Osteoarthritis|Research on the Association Between the Inclination of the Proximal Tibiofibular Joint Surface and Medial Compartment Knee Osteoarthritis|Recruiting||N/A|80|Anticipated|113th Hospital of Chinese People's Liberation Army|||2||f||||f|f|f||||||||2017-10-10 21:05:09.288851|2017-10-10 21:05:09.288851
NCT03147482|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||March 20, 2017||2017-03-20||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:05:09.36383|2017-10-10 21:05:09.36383
NCT03147469|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-16|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||The Influence of Head and Neck Position on Performance of Ambu AuraGain™|The Influence of Head and Neck Position on Performance of Ambu AuraGain™|Recruiting||N/A|40|Anticipated|Seoul National University Hospital||4|||f||||t|f|f||||||Undecided||2017-10-10 21:05:09.405069|2017-10-10 21:05:09.405069
NCT03147456|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-09|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Protein Supplementation Impact On Body Muscle Mass And Fat Mass In Qataris Post Bariatric Surgery, Randomized Controlled Trials (Rct)|Protein Supplementation Impact On Body Muscle Mass And Fat Mass In Qataris Post Bariatric Surgery, Randomized Controlled Trials (Rcts)|Recruiting||N/A|80|Anticipated|Hamad Medical Corporation||2|||f||||t|f|f||||||No||2017-10-10 21:05:09.499769|2017-10-10 21:05:09.499769
NCT03147443|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-06|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|November 1, 2018|Anticipated|2018-11-01||Interventional|||Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials|"The Study on the Effects of Traditional Chinese Medicine Through a Series of N-of-1 Trials Based on the Mathematical Model of Carryover Effect"|Recruiting||Phase 4|36|Anticipated|Shanghai University of Traditional Chinese Medicine||3|||f||||f|f|f||||||No||2017-10-10 21:05:09.586709|2017-10-10 21:05:09.586709
NCT03147430|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-10-03|||May 8, 2017|Actual|2017-05-08|October 2017|2017-10-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Observational|||Early Detection of Breast Cancer in Women With Suspicious Mammograms|Early Detection of Breast Cancer in Women With Suspicious Mammograms|Recruiting||N/A|150|Anticipated|Sentara Norfolk General Hospital|||2||f||||f|f|f||||Samples With DNA|"     Surgical tissue specimen slides, blood and saliva.   "|||2017-10-10 21:05:09.681156|2017-10-10 21:05:09.681156
NCT03147417|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||March 20, 2017||2017-03-20||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:05:09.7595|2017-10-10 21:05:09.7595
NCT03147404|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|June 2019|Anticipated|2019-06-01||Interventional|MS100070-0177||Phase II Study of Avelumab in Metastatic Gastronetro-pancreatic （GEP） Neuroendocrine Carcinoma （NEC, WHO Grade 3） as Second-line Treatment After Failing to Etoposide+Cisplatin: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes|SAMSUND MEDICAL CENTER|Not yet recruiting||Phase 2|30|Anticipated|Samsung Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:05:09.801897|2017-10-10 21:05:09.801897
NCT03147391|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-05-06|||April 14, 2014|Actual|2014-04-14|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|November 30, 2016|Actual|2016-11-30||Observational|||Left Atrial Appendage Closure With the LAmbre|Percutaneous Left Atrial Appendage Closure Using the LAmbre Device in Patients With Atrial Fibrillation: a Single-center, Retrospective, Long-term Real-world Study|Completed||N/A|66|Actual|Shanghai 10th People's Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:05:09.877477|2017-10-10 21:05:09.877477
NCT03147378|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-12|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|February 1, 2019|Anticipated|2019-02-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Food Effect Study of ModraDoc006 in Combination With Ritonavir|Food-effect Study of Weekly Administration of (bi-)Daily Oral Docetaxel (ModraDoc006) in Combination With Ritonavir|Recruiting||Phase 1|16|Anticipated|Modra Pharmaceuticals||2|||f||||t|f|f||||||No||2017-10-10 21:05:09.949473|2017-10-10 21:05:09.949473
NCT03147365|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-05-10|||March 5, 2017|Actual|2017-03-05|May 2017|2017-05-01|August 5, 2018|Anticipated|2018-08-05|March 5, 2018|Anticipated|2018-03-05||Interventional|||Effect of Different Exercises on Quality of Life of Leukemia Patients.|Aerobic Training Versus Strength Exercises on Quality of Life and Functional Capacity on Children With Leukemia.|Recruiting||N/A|75|Anticipated|Children's Cancer Hospital Egypt 57357||3|||f||||t|f|f||||||No||2017-10-10 21:05:10.044701|2017-10-10 21:05:10.044701
NCT03147352|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-06|||February 2013|Actual|2013-02-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|6 Months|Observational [Patient Registry]|ProTreat||Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study|ProTreat - Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study|Recruiting||N/A|310|Anticipated|Rigshospitalet, Denmark|||2||f||||t|f|f||||Samples With DNA|"     Whole blood and plasma/serum   "|No||2017-10-10 21:05:10.143002|2017-10-10 21:05:10.143002
NCT03147339|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-09-18|||January 10, 2017|Actual|2017-01-10|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Interventional|AGEs||The Effects of Restricted Dietary of AGEs on the Glycemic Control, Oxidative Stress and Inflammation|The Effects of Restricted Dietary of Advanced Glycation End Products(AGEs) on the Glycemic Control, Oxidative Stress and Systemic-inflammation in Patients With Metabolic.|Completed||N/A|40|Actual|National Nutrition and Food Technology Institute||2|||f||||t|f|f||||||||2017-10-10 21:05:10.394419|2017-10-10 21:05:10.394419
NCT03147326|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-08|||October 2012|Actual|2012-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|September 2015|Actual|2015-09-01||Interventional|RAMP||Diagnostic Imaging of Myeloma Bone Lesions|The Diagnostic Value of FDG-PET-CT, NaF-PET-CT and Whole-body MRI Compared to Whole-body Xray in the Detection of Bone Lesions in Multiple Myeloma Patients|Completed||N/A|14|Actual|Herlev Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:05:10.507373|2017-10-10 21:05:10.507373
NCT03147313|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-09|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|April 2020|Anticipated|2020-04-01||Interventional|||Extracorporal Shock Wave Treatment to Improve Nerve Regeneration|Extracorporal Shock Wave Treatment After Microsurgical Coaptation to Improve Nerve Regeneration|Recruiting||N/A|60|Anticipated|Ludwig Boltzmann Gesellschaft||3|||f||||f|f|f||||||No||2017-10-10 21:05:10.616022|2017-10-10 21:05:10.616022
NCT03147300|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-30|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|BetterBack||Implementation of a Best Practice Primary Health Care Model for Low Back Pain|Implementation of a Best Practice Primary Health Care Model for Low Back Pain in Sweden (BetterBack): A Cluster Randomised Trial|Recruiting||N/A|600|Anticipated|Linkoeping University||2|||f||||f|f|f||||||||2017-10-10 21:05:10.764477|2017-10-10 21:05:10.764477
NCT03147287|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-08-13|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Palbociclib After CDK and Endocrine Therapy (PACE)|Palbociclib After CDK and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic Breast Cancer|Recruiting||Phase 2|220|Anticipated|Dana-Farber Cancer Institute||3|||f||||t|t|f||||||||2017-10-10 21:05:10.881639|2017-10-10 21:05:10.881639
NCT03147274|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-20|||May 3, 2017|Actual|2017-05-03|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SMART T1D||Group Education Curriculum for Older Teens With Type 1 Diabetes|Evaluation of a Group Curriculum to Improve Self-Management Adherence and Transition Readiness in Older Teens With Type 1 Diabetes|Recruiting||N/A|70|Anticipated|Boston Children’s Hospital||2|||f||||t|f|f||||||||2017-10-10 21:05:10.998673|2017-10-10 21:05:10.998673
NCT03147261|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||December 2015||2015-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Interventional|IGENOI||Impact of Comprehensive Intervention on the Cardiometabolic Risk in Children With Central Obesity (IGENOI)Obesity|Impacto de Una intervención Integral Sobre el Riesgo cardiometabólico en niños Con Obesidad Central: Estudio de Marcadores genéticos y epigenéticos|Recruiting||N/A|120|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||f||||||||Undecided||2017-10-10 21:05:11.126829|2017-10-10 21:05:11.126829
NCT03147248|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-11|||September 12, 2016|Actual|2016-09-12|May 2017|2017-05-01|July 19, 2019|Anticipated|2019-07-19|December 7, 2018|Anticipated|2018-12-07||Interventional|||A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA|A Randomized, Parallel-Group, Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safety Between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients With Active RA|Active, not recruiting||Phase 3|312|Anticipated|Celltrion||2|||f||||t||||||||No||2017-10-10 21:05:11.269707|2017-10-10 21:05:11.269707
NCT03147235|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-14|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|August 18, 2017|Anticipated|2017-08-18|August 18, 2017|Anticipated|2017-08-18||Interventional|||The Effects of a Music Therapist Designed Listening Program on Intraoperative Vitrectomy|The Effects of a Music Therapist Designed Listening Program on Intraoperative Vitrectomy|Recruiting||N/A|60|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:05:11.390834|2017-10-10 21:05:11.390834
NCT03147222|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-07-05|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Function Focused Care: Hip Care at Home|Hip Fracture Caregiver Intervention - Function Focused Care: Hip Care at Home|Not yet recruiting||N/A|45|Anticipated|University of Maryland||1|||f||||t|f|f||||||||2017-10-10 21:05:11.491577|2017-10-10 21:05:11.491577
NCT03147209|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-15|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|PIE WHEEL||Pilot Intervention-Exercise for the Weight, Healthy Eating, and Exercise for the Long-Haul|Pilot Intervention-Exercise for the Weight, Healthy Eating, and Exercise for the Long-Haul|Recruiting||N/A|30|Anticipated|University of Utah||1|||f||||f|f|f||||||No||2017-10-10 21:05:11.603641|2017-10-10 21:05:11.603641
NCT03147196|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-27|||June 27, 2017|Actual|2017-06-27|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery|Neoadjuvant Treatment of Prostate Cancer With Bicalutamide and Raloxifene Prior to Radical Prostatectomy|Recruiting||Phase 2|27|Anticipated|Mayo Clinic||4|||f||||t|t|f||||||||2017-10-10 21:05:11.683499|2017-10-10 21:05:11.683499
NCT03147183|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Kinetic Study of CD8+ CMV-specific Cellular Immunity in Renal Transplant Patients After Receiving Thymoglobulin|Kinetic Study of CD8+ CMV-specific Cellular Immunity in Renal Transplant Patients After Receiving Thymoglobulin|Active, not recruiting||N/A|150|Anticipated|Maimónides Biomedical Research Institute of Córdoba|||1||f||||f|t|f|||f|||No||2017-10-10 21:05:11.817938|2017-10-10 21:05:11.817938
NCT03147170|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-25|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|||A Biomarker to Detect Salt Sensitivity|Use of NT-proBNP as a Biomarker to Treat Salt Sensitive in Hypertensive Individuals|Recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||||Undecided||2017-10-10 21:05:11.898153|2017-10-10 21:05:11.898153
NCT03146442|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-08-18|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Increased Protein at Breakfast for Weight Management in Overweight Adolescents|Increased Protein at Breakfast for Weight Management in Overweight Adolescents|Not yet recruiting||N/A|150|Anticipated|Purdue University||3|||f||||f|f|f|||f|||||2017-10-10 21:05:16.440524|2017-10-10 21:05:16.440524
NCT03147157|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-11|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|April 2025|Anticipated|2025-04-01|April 2021|Anticipated|2021-04-01||Interventional|||The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation|The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen|Not yet recruiting||N/A|120|Anticipated|First Hospital of Jilin University||6|||f|||||f|f||||||||2017-10-10 21:05:11.984269|2017-10-10 21:05:11.984269
NCT03147144|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Ultrasonographic Measurements of Uterine Junctional Zone and Association With In Vitro Fertilization Treatment Outcome|Ultrasonographic Measurements of Uterine Junctional Zone and Association With In Vitro Fertilization Treatment Outcome|Not yet recruiting||N/A|80|Anticipated|Hillel Yaffe Medical Center|||1||f||||t|f|f||||||No||2017-10-10 21:05:12.066289|2017-10-10 21:05:12.066289
NCT03147131|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-05-14|||August 1, 2010|Actual|2010-08-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|February 2012|Actual|2012-02-01||Interventional|||Periprosthetic Bone Mineral Density Changes After Implantation Of A Short Hip Stem Compared To A Straight Stem|Periprosthetic Bone Mineral Density Changes After Implantation Of A Short Hip Stem Compared To A Straight Stem: Five-Year Results Of A Prospective, Randomized DEXA-Analysis|Active, not recruiting||N/A|126|Anticipated|University Hospital Ulm||2|||f||||f||||||||No|Individual participant data will not be shared.|2017-10-10 21:05:12.138649|2017-10-10 21:05:12.138649
NCT03147118|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-09|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Observational|||Evaluating Palpation Guided Injections in Trapeziometacarpal Arthritis|Evaluating Palpation Guided Injections in Trapeziometacarpal Arthritis|Enrolling by invitation||N/A|50|Anticipated|Greenville Health System|||1||f||||f|f|f||||||No||2017-10-10 21:05:12.220655|2017-10-10 21:05:12.220655
NCT03147105|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-24|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Interventional|AMBOS||Armergometry to Improve Mobility in MS|Armergometry to Improve Mobility in Chronic Progressive Multiple Sclerosis|Recruiting||N/A|50|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f|f|f||||||Yes|Enclose access to publication|2017-10-10 21:05:12.300106|2017-10-10 21:05:12.300106
NCT03147092|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-09|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|MatCH||Matão Controlling Hypertension (MatCH Study): Rationale and Design|Matão Controlling Hypertension (MatCH Study): Rationale and Design. Project to Reduce Incidence of Arterial Hypertension in City of Matão, Brazil.|Not yet recruiting||Early Phase 1|15000|Anticipated|Centro Neurológico de Pesquisa e Reabiitação, Brazil||1|||f||||t|f|f||||||Yes||2017-10-10 21:05:12.416703|2017-10-10 21:05:12.416703
NCT03147079|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-04|||January 1, 2011|Actual|2011-01-01|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 31, 2013|Actual|2013-12-31||Interventional|Mighty Mums||Study of Antenatal Care Intervention Directed to Pregnant Women With Obesity|Mighty Mums - a Lifestyle Intervention at Primary Care Level for Pregnant Women With Obesity|Active, not recruiting||N/A|1354|Actual|Göteborg University||3|||f||||f|f|f||||||||2017-10-10 21:05:12.524139|2017-10-10 21:05:12.524139
NCT03147066|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-10|||September 1, 2017|Actual|2017-09-01|August 2017|2017-08-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Dezocine for Prevention of Catheter-related Bladder Discomfort|Efficacy of Dezocine for the Prevention of Catheter-related Bladder Discomfort|Recruiting||Phase 4|96|Anticipated|Zhongda Hospital||2|||f||||t|f|f||||||||2017-10-10 21:05:12.604533|2017-10-10 21:05:12.604533
NCT03147053|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-09|||April 27, 2017|Actual|2017-04-27|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Jiedu Tongluo Granules for Post-stroke Depression|The Efficacy and Safety of Jiedu Tongluo Granules on Patients With Post-stroke Depression: a Double-blind, Randomized and Placebo-controlled Trial|Recruiting||Early Phase 1|80|Anticipated|Xiyuan Hospital of China Academy of Chinese Medical Sciences||2|||f|||||f|f||||||Undecided||2017-10-10 21:05:12.691499|2017-10-10 21:05:12.691499
NCT03146884|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||February 16, 2017|Actual|2017-02-16|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31|5 Years|Observational [Patient Registry]|||Swiss Autoimmune Hepatitis Cohort Study|Swiss Autoimmune Hepatitis Cohort Study|Recruiting||N/A|500|Anticipated|Fondazione Epatocentro Ticino|||1||f|||||f|f||||Samples With DNA|"     1. Serum (BD Vacutainer® SST II Advance)        2. RNA (PAXgene™ Blood RNA tube- 762165)   "|||2017-10-10 21:05:12.77763|2017-10-10 21:05:12.77763
NCT03146871|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-18|||April 20, 2017|Actual|2017-04-20|August 2017|2017-08-01|April 20, 2021|Anticipated|2021-04-20|April 20, 2020|Anticipated|2020-04-20||Interventional|||Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent|A Pilot/Safety Study of sEphB4-HSA in Combination With a Hypomethylating Agent (HMA) for Patients With Relapsed or Refractory Myelodysplastic Syndrome (MDS) and AML Previously Treated With a Hypomethylating Agent|Recruiting||Phase 2|12|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 21:05:12.884871|2017-10-10 21:05:12.884871
NCT03146858|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-10-05|||August 25, 2017|Actual|2017-08-25|October 2017|2017-10-01|March 30, 2018|Anticipated|2018-03-30|December 30, 2017|Anticipated|2017-12-30||Interventional|PENNY PCI||Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study|Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study|Recruiting||Phase 4|20|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t|f|f||||||||2017-10-10 21:05:12.99287|2017-10-10 21:05:12.99287
NCT03146845|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-05|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|April 30, 2018|Anticipated|2018-04-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Evaluation Of An Advanced Borderless Dressing|A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing|Recruiting||Phase 4|40|Anticipated|Smith & Nephew, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:05:13.078121|2017-10-10 21:05:13.078121
NCT03146832|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-07-03|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Therapeutic Strategies During Exposure to Pain in an Experimental Design|Exposure Works, But How? Testing Different Therapeutic Strategies During Exposure to Pain in an Experimental Design|Completed||N/A|139|Actual|Philipps University Marburg Medical Center||3|||f||||f|f|f||||||||2017-10-10 21:05:13.26928|2017-10-10 21:05:13.26928
NCT03146819|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-07-13|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Observational|||A Single Time-Point Study to Evaluate the ConforMIS iTotal (PS) Knee Replacement System Versus Off-the-Shelf|A Single Time-Point Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System Versus Off-the-Shelf Knee Replacement Systems|Enrolling by invitation||N/A|100|Anticipated|ConforMIS, Inc.|||2||f||||f|f|t|f|f|t|||||2017-10-10 21:05:13.38153|2017-10-10 21:05:13.38153
NCT03146806|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-07-31|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Intranasal (NAS) Ketamine for Cancer Pain|Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer Related Pain|Recruiting||Phase 1/Phase 2|15|Anticipated|Emory University||1|||f||||t|t|f||||||||2017-10-10 21:05:13.512263|2017-10-10 21:05:13.512263
NCT03146793|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-08|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Observational|||The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort|National Follow-up of Dialysis Patients With Sodium Thiosufate-treated Calciphylaxis Under Temporary Use Authorization|Recruiting||N/A|600|Anticipated|Centre Hospitalier St Esprit|||1||f||||t|f|f||||||No||2017-10-10 21:05:13.630356|2017-10-10 21:05:13.630356
NCT03146780|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-08|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Digital vs Conventional Impressions Study|Clinical Evaluation of Digital Versus Conventional Impressions Part I: Marginal and Internal Fit|Not yet recruiting||N/A|20|Anticipated|University of Rochester||4|||f||||f|f|f||||||No||2017-10-10 21:05:13.747149|2017-10-10 21:05:13.747149
NCT03146767|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-05|||February 2013|Actual|2013-02-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Staircase Phenomenon Implications on Neuromuscular Block Monitoring|The Staircase Phenomenon and His Implications on Neuromuscular Block Monitoring During General Anesthesia|Completed||N/A|50|Actual|Hospital Universitario La Fe||2|||f|||||f|||||||||2017-10-10 21:05:13.843964|2017-10-10 21:05:13.843964
NCT03146754|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-06-26|||May 4, 2017|Actual|2017-05-04|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|LUPE||A Study to Evaluate Lung Ultrasound as a Method to Measure Changes in Extravascular Lung Water Induced by Positional Changes (LUPE)|A Study to Evaluate Lung Ultrasound as a Method to Measure Changes in Extravascular Lung Water Induced by Positional Changes or Exercise in Patients Stabilized Following Hospitalization for Acute Decompensated Heart Failure|Recruiting||N/A|15|Anticipated|University of Pennsylvania||1|||f||||f|f|f||||||Yes|De identified IPD will be shared with collaborators|2017-10-10 21:05:13.943379|2017-10-10 21:05:13.943379
NCT03146741|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-17|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|USHER||Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)|Open-Labeled Trial Of Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Pennsylvania||1|||f||||t|t|f|||t|||Undecided||2017-10-10 21:05:14.046803|2017-10-10 21:05:14.046803
NCT03146728|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-05-08|||November 2011||2011-11-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Observational|||Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia|Finding the Optimal Voluntary Exercise Parameters for Generating a Health Benefit in Those Living With Quadriplegia|Completed||N/A|46|Actual|University of Manitoba|||2||f||||f||||||||||2017-10-10 21:05:14.179419|2017-10-10 21:05:14.179419
NCT03146715|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-05|||April 1, 2015|Actual|2015-04-01|May 2017|2017-05-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Interventional|||The Effect of a Nutrient Dense Food on the Skin CarotenoidLevels of School Age Children|The Effect of a Nutrient Dense Food on the Skin Carotenoid Levels of School Age Children|Completed||N/A|48|Actual|Utah State University||2|||f||||f|f|f||||||No||2017-10-10 21:05:14.272762|2017-10-10 21:05:14.272762
NCT03146702|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-08|2017-05-09|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01|1 Week|Observational [Patient Registry]|||Turkish Translation of The Emphasis-10 Questionnaire|Evaluation of the Validity and Reliability of the Turkish Translation of The Emphasis-10 Questionnaire in Patients With Pulmonary Hypertension|Recruiting||N/A|100|Anticipated|Istanbul University|||1||f||||f|f|f||||||No||2017-10-10 21:05:14.34939|2017-10-10 21:05:14.34939
NCT03146689|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Ibuprofen Gel or Capsaicin Cream for my Painful Knee Osteoarthritis?|Identifying Treatment Responders to a Topical Non-steroidal Anti-inflammatory Drug (NSAID) or Topical Capsaicin in Painful Knee Osteoarthritis: A Pilot Series of N-of-1 Trials|Not yet recruiting||N/A|22|Anticipated|University of Nottingham||1|||f||||f|f|f||||||Undecided|Requests for the IPD can be made to the authors.|2017-10-10 21:05:14.425147|2017-10-10 21:05:14.425147
NCT03146676|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-31|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2018|Anticipated|2018-01-01||Observational|||The Ohio State University Dermatology Biorepository, Molecular Biology and Genetics of Hidradenitis Suppurativa|The Ohio State University Dermatology Biorepository, SPARC|Recruiting||N/A|175|Anticipated|Ohio State University|||1||f|||||f|f||||Samples With DNA|"     Skin Tissue, Peripheral blood mononuclear cells, skin swabs, and saliva.   "|||2017-10-10 21:05:14.534386|2017-10-10 21:05:14.534386
NCT03146663|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-13|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|September 2018|Anticipated|2018-09-01||Interventional|||NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer|A Phase II Open-Label Study of NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer|Recruiting||Phase 2|64|Anticipated|NuCana BioMed Ltd.||2|||f||||t|t|f||||||||2017-10-10 21:05:14.636681|2017-10-10 21:05:14.636681
NCT03146650|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-25|||May 19, 2017|Actual|2017-05-19|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|July 2021|Anticipated|2021-07-01||Interventional|||Nivolumab and Ipilimumab in Treating Patients With Metastatic Recurrent Major or Minor Salivary Gland Cancer|Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma and Non-adenoid Cystic Carcinoma Malignant Tumors of the Salivary Gland|Recruiting||Phase 2|63|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 21:05:14.787281|2017-10-10 21:05:14.787281
NCT03146637|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-10|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 27, 2019|Anticipated|2019-12-27|May 31, 2018|Anticipated|2018-05-31||Interventional|||Study of PD-1 Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer|Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Liver Cancer|Recruiting||Phase 2|60|Anticipated|Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.||2|||f||||t|f|f||||||Undecided||2017-10-10 21:05:14.934645|2017-10-10 21:05:14.934645
NCT03146624|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-09|||December 1, 2015|Actual|2015-12-01|May 2017|2017-05-01|March 28, 2017|Actual|2017-03-28|February 21, 2017|Actual|2017-02-21||Interventional|||Evaluation of Patients Satisfaction of Attachment Retained Versus Clasp Retained Obturators in Unilateral Total Maxillectomy|Evaluation of Patients Satisfaction of Attachment Retained Versus Clasp Retained Obturators in Unilateral Total Maxillectomy|Completed||N/A|14|Actual|Cairo University||2|||f|||||f|f||||||||2017-10-10 21:05:15.196097|2017-10-10 21:05:15.196097
NCT03146611|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-05-09|||March 11, 2016|Actual|2016-03-11|May 2017|2017-05-01|April 20, 2017|Actual|2017-04-20|March 1, 2017|Actual|2017-03-01||Observational|||nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD|Neutrophil CD64 Versus Neutrophil/Lymphocyte Ratio (NLR) as Markers Predicting In-hospital Outcome in Acute Exacerbation of COPD|Completed||N/A|75|Actual|Assiut University|||2||f|||||f|f||||||No||2017-10-10 21:05:15.279271|2017-10-10 21:05:15.279271
NCT03146598|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-05|||January 1, 2012|Actual|2012-01-01|May 2017|2017-05-01|January 1, 2012|Actual|2012-01-01|January 1, 2012|Actual|2012-01-01||Observational|SPS-AFO||Side Pole Static Ankle Foot Orthosis in Children With Neurological Disorders|Use and Tolerability of a Side Pole Static Ankle Foot Orthosis in Children With Neurological Disorders|Completed||N/A|100|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 21:05:15.359301|2017-10-10 21:05:15.359301
NCT03146585|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-07-10|||November 1, 2015|Actual|2015-11-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|||Glycocalyx Damage in Critically Ill Patients|Alterations of Glycocalyx in Critical Illness and During Major Surgery and Approaches for Glycocalyx Protection|Recruiting||N/A|75|Anticipated|University Hospital Hradec Kralove|||3||f||||f|f|f||||||||2017-10-10 21:05:15.432425|2017-10-10 21:05:15.432425
NCT03146572|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-07|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|April 3, 2019|Anticipated|2019-04-03|April 3, 2018|Anticipated|2018-04-03||Interventional|||Primary Care and Parenting|Utilizing the Primary Care Setting to Deliver a Brief Program to Enhance Parenting Behaviors|Recruiting||Early Phase 1|60|Anticipated|University of Illinois at Chicago||2|||f|||||f|f||||||||2017-10-10 21:05:15.521465|2017-10-10 21:05:15.521465
NCT03146559|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-08-24|||May 25, 2017|Actual|2017-05-25|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Using EMG of the Healthy Hand to Control TENS of the Affected Hand in Hemiparetic Patients|Using EMG of the Healthy Hand to Control TENS of the Affected Hand in Hemiparetic Patients|Recruiting||N/A|14|Anticipated|Loewenstein Hospital||2|||f|||||f|f||||||||2017-10-10 21:05:15.631999|2017-10-10 21:05:15.631999
NCT03146546|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-09-13|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Resistin in Septic Shock and Acute Kidney Injury|Effect of Resistin on Neutrophil Function in Patients With Septic Shock and Acute Kidney Injury|Recruiting||N/A|40|Anticipated|Milton S. Hershey Medical Center|||2||f||||f|f|f||||Samples With DNA|"     Blood and urine   "|||2017-10-10 21:05:15.728986|2017-10-10 21:05:15.728986
NCT03146533|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-16|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||CD19 CART Cells for Patients With Relapse and Refractory CD19+ B-cell Lymphoma.|Phase I/II Study of CD19 CART Cells for Patients With Relapse and Refractory CD19+ B-cell Lymphoma.|Recruiting||Phase 1/Phase 2|20|Anticipated|Shenzhen Second People's Hospital||1|||f||||f|f|f||||||||2017-10-10 21:05:15.821781|2017-10-10 21:05:15.821781
NCT03146520|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-09|||December 13, 2016|Actual|2016-12-13|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Observational|||Clinical Validation of Stool DNA-based SDC2 Methylation Test for Colorectal Cancer Detection|Clinical Study for the Validation of Real Time qPCR for SDC2 Methylation in Stool DNA for Early Detection of Colorectal Cancer|Enrolling by invitation||N/A|626|Anticipated|Genomictree, Inc.|||4||f||||f|f|f||||||No||2017-10-10 21:05:15.925256|2017-10-10 21:05:15.925256
NCT03146507|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-08-18|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2018|Anticipated|2018-03-01||Observational|||Assessment of Cardiac Sparing in Fetal Hypoxia|Doppler Echocardiography Assessment of Cardiac Sparing Effect in Fetal Hypoxia|Recruiting||N/A|50|Anticipated|Assiut University|||1||f|||||f|f||||||||2017-10-10 21:05:16.010278|2017-10-10 21:05:16.010278
NCT03146494|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-07|||May 1, 2015|Actual|2015-05-01|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01|2 Years|Observational [Patient Registry]|||The Role of Thyroid Function in the Development and Prognosis of Stanford Type A Aortic Dissection.|The Role of Thyroid Function in the Development and Prognosis of Stanford Type A Aortic Dissection.|Recruiting||N/A|300|Anticipated|Beijing Anzhen Hospital|||2||f|||||f|f||||||||2017-10-10 21:05:16.078408|2017-10-10 21:05:16.078408
NCT03146481|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-09|||July 2016||2016-07-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis|Effect of Pre-operative Aceclofenac on the Anesthetic Efficacy of Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial|Active, not recruiting||Phase 2/Phase 3|70|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:05:16.144578|2017-10-10 21:05:16.144578
NCT03146468|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-07|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|NIVALLO||Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation|Pilot Study of the Tolerability of Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Haematopoietic Stem Cell Transplantation|Recruiting||Phase 2|14|Anticipated|Melbourne Health||1|||f||||t|t|f|||t|||No|IPD will not be shared by researchers outside of this clinical trial|2017-10-10 21:05:16.24432|2017-10-10 21:05:16.24432
NCT03146455|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-06-07|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Thromboelastography Normal Reference Values in China Hunan Province|Establishment for Thromboelastography Normal Reference Values of Healthy Adults in China Hunan Province: A Multicenter Observational Study|Recruiting||N/A|1500|Anticipated|The Third Xiangya Hospital of Central South University|||1||f||||t|f|f||||||No||2017-10-10 21:05:16.342112|2017-10-10 21:05:16.342112
NCT03146416|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-07|2017-05-07|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Evinacumab in Healthy Japanese and Caucasian Subjects|Recruiting||Phase 1|72|Anticipated|Regeneron Pharmaceuticals||3|||f||||t|t|f|||t|||||2017-10-10 21:05:16.589551|2017-10-10 21:05:16.589551
NCT03146403|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-21|||May 24, 2017|Actual|2017-05-24|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection|A Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of a Maintenance Dose of GEN-003 in Subjects With Genital Herpes Infection|Active, not recruiting||Phase 2|33|Actual|Genocea Biosciences, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:05:16.667664|2017-10-10 21:05:16.667664
NCT03146390|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-08|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Essential Oils With and Without Alcohol: Substantivity and Antiplaque Effect|Essential Oils With and Without Alcohol: in Vivo Antibacterial Effect|Recruiting||Phase 4|20|Anticipated|University of Santiago de Compostela||3|||f||||f|f|f||||||Undecided||2017-10-10 21:05:16.767932|2017-10-10 21:05:16.767932
NCT03146377|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-06|||April 2014||2014-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal Cancer|An Open-label, Single-centre, Single-arm Phase II Study of Triplet Combination of Capecitabine, Oxaliplatin and Irinotecan (Xeloxiri) as Salvage Therapy in Patients With Refractory Metastatic Colorectal Cancer|Completed||Phase 2|32|Actual|The University of Hong Kong||1|||f||||f||||||||||2017-10-10 21:05:16.86164|2017-10-10 21:05:16.86164
NCT03146364|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-05-06|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Executive Function With Virtual Reality Among People With Schizophrenia|Evaluation of Executive Function With Static and Dynamic Shopping Assignment in Virtual Reality Among People With Schizophrenia|Not yet recruiting||N/A|40|Anticipated|HaEmek Medical Center, Israel||2|||f||||f|f|f|||f|||No||2017-10-10 21:05:16.938281|2017-10-10 21:05:16.938281
NCT03146351|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-08|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||The Effects of Family Centered Intervention Program on Preterm Infants|The Effects of Family Centered Physiotherapy Program on Preterm Infants|Completed||N/A|52|Actual|Gazi University||2|||f||||f|f|f||||||Undecided|We have no decided yet|2017-10-10 21:05:17.01232|2017-10-10 21:05:17.01232
NCT03146338|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-19|||July 4, 2017|Actual|2017-07-04|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|November 2019|Anticipated|2019-11-01||Interventional|OPTIMAG||Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)|Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR Monoclonal Antibody|Recruiting||N/A|166|Anticipated|Weprom||2|||f||||f|f|f||||||||2017-10-10 21:05:17.188824|2017-10-10 21:05:17.188824
NCT03146325|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||November 2012||2012-11-01|May 2017|2017-05-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|HEISA||Helicobacter Pylori and Body Iron in Adults|Helicobacter Pylori and Body Iron in Adults|Withdrawn||Phase 4|0|Actual|The University of Texas Health Science Center, Houston||2||Study was not funded and PI has left the institution|f||||t||||||||||2017-10-10 21:05:17.356984|2017-10-10 21:05:17.356984
NCT03146312|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-10|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|July 30, 2017|Anticipated|2017-07-30|June 9, 2017|Anticipated|2017-06-09||Interventional|||Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Indices of Human Health|Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Gene Expression, Epigenetics and Nutritional Status in Healthy Adults|Recruiting||N/A|30|Anticipated|USANA Health Sciences||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:17.454675|2017-10-10 21:05:17.454675
NCT03146299|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-05-08|||April 1, 2014|Actual|2014-04-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparison of TLH and LAVH With Over Than 500g|Comparison of Total Laparoscopic Hysterectomy and Laparoscopic Assisted Vaginal Hysterectomy With Over Giant Uterus of Than 500g: A Randomized Controlled Trial|Completed||N/A|34|Actual|Hanyang University Seoul Hospital||2|||f|||||f|f||||||||2017-10-10 21:05:17.558655|2017-10-10 21:05:17.558655
NCT03146286|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||August 1, 2015|Actual|2015-08-01|May 2017|2017-05-01|December 3, 2015|Actual|2015-12-03|December 3, 2015|Actual|2015-12-03||Interventional|||Skeletal Muscle Protein Metabolism and Insulin Sensitivity in Overweight Individuals: Effects of Meals With Various Fatty Acid Compositions|Skeletal Muscle Protein Metabolism and Insulin Sensitivity in Overweight Individuals: Effects of Meals With Various Fatty Acid Compositions|Completed||N/A|8|Actual|University of Nottingham||2|||f||||f|f|f||||||No||2017-10-10 21:05:17.638492|2017-10-10 21:05:17.638492
NCT03146273|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-05-06|||May 9, 2017|Anticipated|2017-05-09|May 2017|2017-05-01|July 1, 2017|Anticipated|2017-07-01|June 10, 2017|Anticipated|2017-06-10||Interventional|||Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)|A Pharmacokinetic Crossover Comparison Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)|Not yet recruiting||N/A|20|Anticipated|Galilee CBR||2|||f||||f|f|f||||||No|The study results will be published.|2017-10-10 21:05:17.722358|2017-10-10 21:05:17.722358
NCT03146260|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-09-27|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||TESE and Non Obstructive Azoospermia|Predictors for Successful Sperm Reterival by Testicular Sperm Extraxtion(TESE) in Patients With Non Obstructive Azospermia|Not yet recruiting||N/A|148|Anticipated|Assiut University||2|||f||||t|f|f||||||||2017-10-10 21:05:17.790961|2017-10-10 21:05:17.790961
NCT03146247|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-28|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|February 28, 2019|Anticipated|2019-02-28|December 31, 2018|Anticipated|2018-12-31||Interventional|Itch||Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients|Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients|Recruiting||Phase 4|40|Anticipated|University of Luebeck||1|||f||||f|f|f||||||||2017-10-10 21:05:17.883465|2017-10-10 21:05:17.883465
NCT03120767|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-07|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|May 30, 2021|Anticipated|2021-05-30|May 30, 2021|Anticipated|2021-05-30||Interventional|WIN||Wellness Initiative at New York University|Wellness Initiative at New York University|Not yet recruiting||N/A|200|Anticipated|New York University School of Medicine||3|||f||||t|f|f||||||||2017-10-10 21:09:20.398727|2017-10-10 21:09:20.398727
NCT03146234|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-05|||March 17, 2017|Actual|2017-03-17|May 2017|2017-05-01|June 15, 2020|Anticipated|2020-06-15|December 16, 2019|Anticipated|2019-12-16||Interventional|||CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma|Clinical Study of Redirected Autologous T Cells With a GPC3-targeted Chimeric Antigen Receptor in Patients With Refractory Hepatocellular Carcinoma|Recruiting||N/A|20|Anticipated|RenJi Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:05:17.969158|2017-10-10 21:05:17.969158
NCT03146221|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-19|||June 20, 2017|Anticipated|2017-06-20|July 2017|2017-07-01|June 20, 2020|Anticipated|2020-06-20|June 20, 2020|Anticipated|2020-06-20||Interventional|FEMIA||Search for Restenosis Markers in Lower Limb Arteritis|Search for Restenosis Markers in Lower Limb Arteritis|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire, Amiens||1||investigator wish|f|||||f|f||||||||2017-10-10 21:05:18.070241|2017-10-10 21:05:18.070241
NCT03146208|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-06|2017-05-08|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 20, 2019|Anticipated|2019-01-20|October 15, 2018|Anticipated|2018-10-15|11 Months|Observational [Patient Registry]|||Role of Endothelial Biomarkers in Patients With Coronary Artery Disease|Biomarkers of Coronary Artery Diseases|Not yet recruiting||N/A|54|Anticipated|Assiut University|||3||f||||t|f|f||||Samples With DNA|"     Quantitative Analysis of telomere length & GDF-15 by Real-time PCR in plasma, HUVCES, and     Cell line.   "|Yes||2017-10-10 21:05:18.146588|2017-10-10 21:05:18.146588
NCT03146195|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-05|||September 2016||2016-09-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Observational|||The 3D Reconstruction Research of Pelvic Organ Prolapse Disease|The 3D Reconstruction Research of Pelvic Organ Prolapse Disease and the Establishment of Assessment for Space Coordinates|Recruiting||N/A|80|Anticipated|Nanfang Hospital of Southern Medical University|||2||f||||t||||||||No||2017-10-10 21:05:18.225688|2017-10-10 21:05:18.225688
NCT03146182|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-09|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|BIO-CAP||Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia|Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia|Recruiting||N/A|300|Anticipated|Nordsjaellands Hospital||3|||f||||t|f|f||||||Undecided||2017-10-10 21:05:18.325291|2017-10-10 21:05:18.325291
NCT03146169|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||September 1, 2015|Actual|2015-09-01|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Training Program for Community Health Campaign: Fitter Families Project|Training Program for Community Health Campaign: Fitter Families Project|Recruiting||N/A|50|Anticipated|The University of Hong Kong||1|||f||||t|f|f||||||Yes|"The minimal anonymized dataset will be available upon request to interested researchers. For interested researchers, please contact, Ms Grace Lau (email gclau@hku.hk), (School of Public Health, The University of Hong Kong) for further information."|2017-10-10 21:05:18.431509|2017-10-10 21:05:18.431509
NCT03146156|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-05|||January 3, 2017|Actual|2017-01-03|May 2017|2017-05-01|December 1, 2021|Anticipated|2021-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||Lifestyle Intervention in Preparation for Pregnancy (LIPP)|Lifestyle Intervention in Preparation for Pregnancy (LIPP)|Recruiting||N/A|200|Anticipated|MetroHealth Medical Center||2|||f||||t|f|f||||||Yes|The results of the study will be available in a de-identified manner by contacting the Principal Investigator, after the results have been published.|2017-10-10 21:05:18.539337|2017-10-10 21:05:18.539337
NCT03146143|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-08-21|||May 15, 2017|Actual|2017-05-15|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Ultrafiltration Effect on Extravascular Lung Water in Pediatric Cardiac Surgery|Effect of Ultra Filtration on Extravascular Lung Water Assessed by Lung Ultrasound in Pediatric Cardiac Surgery|Active, not recruiting||N/A|70|Anticipated|Kasr El Aini Hospital||2|||f||||f|f|f||||||||2017-10-10 21:05:18.739199|2017-10-10 21:05:18.739199
NCT03146130|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-04|||September 20, 2017|Anticipated|2017-09-20|May 2017|2017-05-01|December 20, 2019|Anticipated|2019-12-20|December 20, 2019|Anticipated|2019-12-20||Interventional|NoISE-PD||Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders (TCI) Induced by Dopaminergic Treatments in Parkinson's Disease|Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders (TCI) Induced by Dopaminergic Treatments in Parkinson's Disease|Not yet recruiting||Phase 3|70|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:05:18.832122|2017-10-10 21:05:18.832122
NCT03146117|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-09|||April 1, 2017|Actual|2017-04-01|March 2017|2017-03-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|||PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer|Application of Integrated PET and Dual Energy CT Imaging for Staging and Imaged Based Radiotherapy Treatment Planning in Lung Cancer|Recruiting||N/A|50|Anticipated|Medical University of South Carolina|||1||f||||t|f|f||||||No||2017-10-10 21:05:18.910832|2017-10-10 21:05:18.910832
NCT03146104|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-19|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Comparison of Total Intravenous Anesthesia vs. Inhalational Anesthesia in Acute Subdural Hematoma Patients|Comparison of Total Intravenous Anesthesia vs. Inhalational Anesthesia on Brain Relaxation, Subdural Pressure and Hemodynamics in Patients With Acute Subdural Hematoma Undergoing Emergency Craniotomy- A Randomized Control Trial|Recruiting||Phase 4|90|Anticipated|Jawaharlal Institute of Postgraduate Medical Education & Research||2|||f|||||f|f|||f|||||2017-10-10 21:05:18.977978|2017-10-10 21:05:18.977978
NCT03146091|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-15|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Interventional|MUD||Outpatient Treatment of Uncomplicated Diverticulitis With Either Antibiotic or Nonantibiotic Treatment|Study on Outpatient Treatment of Uncomplicated Diverticulitis With Either Antibiotic or Nonantibiotic Treatment: a Randomized Pilot Trial|Not yet recruiting||N/A|40|Anticipated|Jewish General Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:05:19.078317|2017-10-10 21:05:19.078317
NCT03146078|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-13|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|RUSH2A||Rate of Progression in USH2A Related Retinal Degeneration|Rate of Progression in USH2A Related Retinal Degeneration|Recruiting||N/A|120|Anticipated|Jaeb Center for Health Research|||2||f||||t|f|f||||Samples With DNA|"     Saliva samples   "|Yes|A de-identified database is placed in the public domain on the FFB/Jaeb public website after the completion of each protocol and publication of the primary manuscript.|2017-10-10 21:05:19.206763|2017-10-10 21:05:19.206763
NCT03146065|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-10-03|||May 10, 2017|Actual|2017-05-10|October 2017|2017-10-01|May 2, 2018|Anticipated|2018-05-02|May 2, 2018|Anticipated|2018-05-02||Interventional|||Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512|A Phase 1, Randomized, Double Blind, Sponsor-open, Placebo-controlled, First-in-human Trial To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Pf-06730512 After Single And Multiple Ascending Intravenous Infusion Or Subcutaneous Administration To Healthy Adult Subjects And An Open-label Evaluation In Healthy Japanese Subjects|Recruiting||Phase 1|78|Anticipated|Pfizer||2|||f||||f|t|f||||||||2017-10-10 21:05:19.407667|2017-10-10 21:05:19.407667
NCT03146052|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||Comparison Between Asymmetric And Standard Split-Dose Regimen For Bowel Preparation|Comparison Between Asymmetric (Low Dose In The Morning) And Standard Split-Dose Regimen Of Polyethylene Glycol Plus Bisacodyl For Bowel Preparation For Screening And Surveillance Colonoscopy: A Randomized Non-Inferiority Clinical Trial.|Completed||N/A|81|Actual|ASST Rhodense||2|||f||||f|f|f|||f|||No||2017-10-10 21:05:19.508099|2017-10-10 21:05:19.508099
NCT03146039|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-16|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|NICER||Non-Invasive Cervical Cancer Radiotherapy for Stage IB-IVB|Non-Invasive Cervical Cancer Radiotherapy: Phase II Clinical Trial of Stereotactic Body Radiotherapy Boost for Stage IB-IVB Cervical Cancer|Not yet recruiting||Phase 2|35|Anticipated|University of California, San Diego||1|||f||||t|f|t|f|f|f|||||2017-10-10 21:05:19.589938|2017-10-10 21:05:19.589938
NCT03146026|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-18|||February 8, 2016|Actual|2016-02-08|July 2017|2017-07-01|May 6, 2016|Actual|2016-05-06|May 2, 2016|Actual|2016-05-02||Interventional|||The Effects of a Combined Exercise Training Program on Vascular Health and Metabolic Profile in Obese Adolescent Girls.|The Effects of a 12- Week Combined Exercise Training Program on Arterial Stiffness, Endothelial Function, Inflammatory Markers and Metabolic Profile in Obese Adolescent Girls: A Pilot Study.|Completed||N/A|30|Actual|Pusan National University||2|||f|||||f|f||||||||2017-10-10 21:05:19.675964|2017-10-10 21:05:19.675964
NCT03146013|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-06-09|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|||Dual Algorithm Post Market Clinical Study|Evaluation of the MP Diagnostics HTLV Blot 2.4|Completed||N/A|100|Actual|MP Biomedicals, LLC|||1||f||||f|t|t|f|f||||Yes|Individual patient data (IPD) was deidentified prior to sharing.|2017-10-10 21:05:19.755325|2017-10-10 21:05:19.755325
NCT03146000|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Lidocaine-prilocaine Cream Versus Rectal Meloxicam on Relief of Post-episiotomy Pain|Effect of Topical Lidocaine-prilocaine Cream Versus Rectal Meloxicam Suppository on Relief of Post-episiotomy Pain: A Randomized Clinical Trial|Recruiting||Phase 3|190|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:05:19.862983|2017-10-10 21:05:19.862983
NCT03145987|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-26|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|April 2017|Actual|2017-04-01||Interventional|||Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults.|A Randomized, Double-blinded, Clinical Trial on Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Healthy Older Adults.|Active, not recruiting||N/A|111|Actual|"Azienda Ospedaliera Universitaria Policlinico G. Martino"||2|||f||||t|f|f||||||||2017-10-10 21:05:19.959929|2017-10-10 21:05:19.959929
NCT03145974|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-12|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|PANDORA||Prevalence and Outcome of Acute Hypoxemic Respiratory Failure|Prevalence and Outcome of Acute Hypoxemic Respiratory Failure (PANDORA Study)|Recruiting||N/A|1000|Anticipated|Dr. Negrin University Hospital|||1||f||||f|f|f||||||No|Patients' data will be anonymized and recorded in a case report form (CRF) specifically designed for this study. Data will be presented globally at the end of the study|2017-10-10 21:05:20.099026|2017-10-10 21:05:20.099026
NCT03145961|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-05|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 1, 2021|Anticipated|2021-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|c-TRAK-TN||A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients|c-TRAK TN: A Randomised Trial Utilising ctDNA Mutation Tracking to Detect Minimal Residual Disease and Trigger Intervention in Patients With Moderate and High Risk Early Stage Triple Negative Breast Cancer|Not yet recruiting||Phase 2|200|Anticipated|Institute of Cancer Research, United Kingdom||2|||f||||t|f|f|||f|||Undecided|Formal requests for data sharing will be considered in line with ICR-CTSU procedure with due regard given to funder and sponsor guidelines. Requests are via a standard pro forma describing the nature of the proposed research and extent of data requirements. Data recipients are required to sign a data release form which describes the conditions for release and requirements for data transfer, storage, archiving, publication and Intellectual Property.|2017-10-10 21:05:20.361448|2017-10-10 21:05:20.361448
NCT03145948|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-08-28|||May 9, 2017|Actual|2017-05-09|August 2017|2017-08-01|August 16, 2017|Actual|2017-08-16|August 16, 2017|Actual|2017-08-16||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis|Withdrawn||Phase 1|0|Actual|AbbVie||6||Safety reason|f||||f|t|f||||||||2017-10-10 21:05:20.53267|2017-10-10 21:05:20.53267
NCT03145935|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-08-20|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Diagnosis Accuracy of Abdominal Compression and Hemoconcentration to Detect Diuretic Induced Fluid Removal Intolerance.|Diagnosis Accuracy of Abdominal Compression and Hemoconcentration to Detect Diuretic Induced Fluid Removal Intolerance.|Recruiting||N/A|40|Anticipated|Hopital Louis Pradel|||1||f||||f|f|f||||||||2017-10-10 21:05:20.683306|2017-10-10 21:05:20.683306
NCT03145922|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||January 2016||2016-01-01|May 2017|2017-05-01|January 2026|Anticipated|2026-01-01|January 2021|Anticipated|2021-01-01||Observational|||Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis|Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis|Recruiting||N/A|45|Anticipated|University of California, San Francisco|||2||f||||||||||||||2017-10-10 21:05:20.784699|2017-10-10 21:05:20.784699
NCT03145909|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-29|||July 11, 2017|Actual|2017-07-11|September 2017|2017-09-01|September 3, 2019|Anticipated|2019-09-03|June 25, 2019|Anticipated|2019-06-25||Interventional|||A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)|A Phase 1 Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)|Recruiting||Phase 1|100|Anticipated|AbbVie||2|||f||||f|t|f||||||||2017-10-10 21:05:20.867004|2017-10-10 21:05:20.867004
NCT03145896|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-08|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 1, 2018|Anticipated|2018-09-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients|The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients|Not yet recruiting||N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f|f|f|||f|||No||2017-10-10 21:05:20.960122|2017-10-10 21:05:20.960122
NCT03145870|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||September 20, 2017|Anticipated|2017-09-20|May 2017|2017-05-01|September 20, 2019|Anticipated|2019-09-20|September 20, 2019|Anticipated|2019-09-20||Interventional|||Prevalence of Asymptomatic Thrombosis in Multiple Myeloma|Prevalence of Asymptomatic Thrombosis in Multiple Myeloma|Not yet recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:05:21.14797|2017-10-10 21:05:21.14797
NCT03145857|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use|A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive Tumours|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|University of Alberta||1|||f||||f|f|f||||||No||2017-10-10 21:05:21.223312|2017-10-10 21:05:21.223312
NCT03145844|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-08|||April 9, 2017|Actual|2017-04-09|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|December 31, 2017|Anticipated|2017-12-31||Observational|HEPCTURKEY||Direct Acting Agents in Hepatitis C Patients|Evaluation of Efficacy and Safety of Direct Acting Agents in Hepatitis C Patients|Recruiting||N/A|1000|Anticipated|Viral Hepatitis Society|||1||f||||f|f|f|||f|||Undecided||2017-10-10 21:05:21.326545|2017-10-10 21:05:21.326545
NCT03145831|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-08|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|January 31, 2020|Anticipated|2020-01-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency|An Open-Label, Long-Term Safety Study of Long-acting Human Growth Hormone Somavaratan (VRS-317) in Japanese Children With Growth Hormone Deficiency|Recruiting||Phase 3|75|Anticipated|Versartis Inc.||1|||f||||t|f|f|||f|||No||2017-10-10 21:05:21.427689|2017-10-10 21:05:21.427689
NCT03145818|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-04|||May 8, 2017|Anticipated|2017-05-08|May 2017|2017-05-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|VD-HCBS Eval||Evaluation of Veteran-Directed Home and Community Based Services|Evaluation of Veteran Directed Home and Community Based Services|Not yet recruiting||N/A|1500|Anticipated|VA Office of Research and Development|||4||f||||f|f|f|||f|||No||2017-10-10 21:05:22.102796|2017-10-10 21:05:22.102796
NCT03145805|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-18|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|December 31, 2017|Anticipated|2017-12-31||Observational|||Bupivacaine Levels in Liver Resection Patients|Blood Levels of Bupivacaine in Liver Resection Patients Sited With an Epidural Catheter for Postoperative Pain Control|Recruiting||N/A|20|Anticipated|Queen's University|||1||f||||f|f|f|||f|Samples Without DNA|"     Diagnostic 4 ml blood samples will be drawn from 20 liver resection patients sited with an     epidural catheter for 3-5 days of bupivacaine infusion to manage their postoperative pain.     Blood will be drawn by phlebotomy with standard of care blood blood-work at 4 time points:     preoperatively, upon entry to the post-anesthesia care unit, 2 days postoperatively and then     immediately before discontinuation bupivacaine infusion. Blood will be immediately     centrifuged by the hospital laboratory and plasma divided into 2 aliquots to be stored at -70     until all samples are collected- at which point they will be shipped to collaborators for     analysis of AGP as well as bound and unbound bupivacaine.   "|||2017-10-10 21:05:22.256797|2017-10-10 21:05:22.256797
NCT03145792|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-04|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Online Coping Skills Counseling for Problem Gambling and Trauma|Online Coping Skills Counseling for Problem Gambling and Trauma|Recruiting||N/A|84|Anticipated|University of Windsor||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:22.375295|2017-10-10 21:05:22.375295
NCT03145779|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-04|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2028|Anticipated|2028-07-01|July 2027|Anticipated|2027-07-01||Observational|||Evaluation of Phenotypic Variability in Fabry Disease|Evaluation of Phenotypic Variability in Fabry Disease|Not yet recruiting||N/A|25|Anticipated|Boston Children’s Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:05:22.479735|2017-10-10 21:05:22.479735
NCT03145766|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-06-28|||April 18, 2017|Actual|2017-04-18|June 2017|2017-06-01|January 17, 2018|Anticipated|2018-01-17|January 17, 2018|Anticipated|2018-01-17||Interventional|||Immunogenicity and Safety of a Purified Vero Rabies Vaccine|Immunogenicity and Safety of a Purified Vero Rabies Vaccine Serum Free When Administered According to a Simulated Rabies Post Exposure Regimen in Healthy Adults|Recruiting||Phase 2|320|Anticipated|Sanofi||5|||f||||f|t|f||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available at Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:05:22.56988|2017-10-10 21:05:22.56988
NCT03145753|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-10|||November 18, 2016|Actual|2016-11-18|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|DRIVE||Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03)|"Impact on New HIV/HCV Infection Diagnoses and Costs of Two HIV/HCV Testing Programs Education and Support Only Versus Education and Support Plus a Resourced External Program (DRIVE 03)"|Recruiting||N/A|8000|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||t|f|f||||||No||2017-10-10 21:05:22.698681|2017-10-10 21:05:22.698681
NCT03145740|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-05|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Intensive Faciltiation of Swallowing in Patients With Severe Dysphagia After Acquired Brain Injury|The Effect of Intensive Facial Oral Tract Therapy (F.O.T.T.®) on Swallowing Function in Patients After Acquired Brain Injury (ABI)|Completed||N/A|10|Actual|Rigshospitalet, Denmark||2|||f||||t|f|f||||||No||2017-10-10 21:05:22.845735|2017-10-10 21:05:22.845735
NCT03145727|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-08-21|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|October 30, 2018|Anticipated|2018-10-30|December 30, 2017|Anticipated|2017-12-30||Interventional|TENS-NV||Electric Stimulation on Nausea and Vomit Chemotherapy Induced|Transcutaneous Electric Nerve Stimulation Effects on Nausea and Vomit Chemotherapy-induced|Recruiting||N/A|84|Anticipated|Federal University of Health Science of Porto Alegre||3|||f|||||f|f|||f|||||2017-10-10 21:05:22.96927|2017-10-10 21:05:22.96927
NCT03145714|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-28|||April 2016||2016-04-01|May 2017|2017-05-01|August 28, 2017|Actual|2017-08-28|August 10, 2017|Actual|2017-08-10||Interventional|POCD||To Study the Effect of Sevoflurane and Propofol V Sevoflurane and Dexmedetomidine on Postoperative Cognitive Dysfunction|To Study the Effect of Sevoflurane and Propofol Versus Sevoflurane and Dexmedetomidine on Postoperative Cognitive Dysfunction|Completed||N/A|60|Actual|Rajiv Gandhi Cancer Institute & Research Center, India||2|||f||||f|f|f|||f|||||2017-10-10 21:05:23.128232|2017-10-10 21:05:23.128232
NCT03145701|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-07-27|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Doppler Flow Wires in Cerebral Angiography|Predicting Cerebral Aneurysm Recurrence Using Doppler Guidewire Measurements|Recruiting||N/A|90|Anticipated|University of Washington|||1||f||||f|f|f||||||||2017-10-10 21:05:23.246898|2017-10-10 21:05:23.246898
NCT03145688|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-05-04|||November 2016||2016-11-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Family Habit Physical Activity Study|Promoting Habit Formation in Family Physical Activity|Recruiting||N/A|300|Anticipated|University of Victoria||3|||f||||f||||||||||2017-10-10 21:05:23.36075|2017-10-10 21:05:23.36075
NCT03145675|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-08-07|||May 12, 2017|Actual|2017-05-12|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|OPTIENOX-PCI||Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)|Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention|Recruiting||Phase 4|120|Anticipated|Peking Union Medical College Hospital||4|||f||||f|f|f||||||||2017-10-10 21:05:23.491646|2017-10-10 21:05:23.491646
NCT03145662|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-04|||March 23, 2017|Actual|2017-03-23|April 2017|2017-04-01|March 23, 2019|Anticipated|2019-03-23|March 23, 2019|Anticipated|2019-03-23||Interventional|||High Pressure Balloon vs Cutting Balloon|Cutting Balloon vs. High Pressure Balloon for the Treatment of AV Graft Stenosis|Recruiting||N/A|128|Anticipated|University of Toledo Health Science Campus||2|||f||||f|f|t|f|f||||No||2017-10-10 21:05:23.662974|2017-10-10 21:05:23.662974
NCT03145649|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||January 12, 2010|Actual|2010-01-12|May 2017|2017-05-01|July 16, 2011|Actual|2011-07-16|October 21, 2010|Actual|2010-10-21||Observational|||Breast Milk Hormones and Early Infant Growth of Women With Gestational Diabetes Mellitus|Breast Milk Hormones and Early Infant Growth of Women With Gestational Diabetes Mellitus|Completed||N/A|96|Actual|Peking Union Medical College Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Breast milk specimens were collected from women during lactation period.   "|No||2017-10-10 21:05:23.755234|2017-10-10 21:05:23.755234
NCT03145636|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|ReNEW||The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol|The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol|Recruiting||N/A|200|Anticipated|EnteroMedics||1|||f||||t|f|t|f|f|f|||||2017-10-10 21:05:23.874677|2017-10-10 21:05:23.874677
NCT03145623|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-04|||June 2, 2017|Anticipated|2017-06-02|May 2017|2017-05-01|July 1, 2018|Anticipated|2018-07-01|June 2, 2018|Anticipated|2018-06-02||Observational|||Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney Disease|Retrospective Efficacy and Safety Study With Elbasvir 50 mg/Grazoprevir 100 mg in HCV-infected Patients With Chronic Kidney Disease Stage 4-5 During the French Temporary Authorization for Use (ATU) Program: Data From Real-life|Not yet recruiting||N/A|100|Anticipated|University Hospital, Toulouse|||1||f||||f|f|f||||||No||2017-10-10 21:05:23.984055|2017-10-10 21:05:23.984055
NCT03145610|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-08|||June 1, 2013|Actual|2013-06-01|May 2017|2017-05-01|January 14, 2015|Actual|2015-01-14|May 30, 2014|Actual|2014-05-30||Interventional|||Impact of a Triclosan-containing Toothpaste During the Progression of Experimental Peri-implant Mucositis|Impact of a Triclosan-containing Toothpaste During the Progression of Experimental Peri-implant Mucositis: Clinical Parameters and Local Pattern of Osteo-immunoinflammatory Mediators in Peri-implant Fluid|Completed||N/A|22|Actual|Paulista University||2|||f||||t|f|f||||||No||2017-10-10 21:05:24.068144|2017-10-10 21:05:24.068144
NCT03145597|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-05-04|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|facings||Survival Rate of Adhesively Luted Veneers|Survival Rate of Adhesively Luted Veneers, an In-vivo Study|Not yet recruiting||N/A|70|Anticipated|University Medical Center Groningen||2|||f||||t|f|f||||||No||2017-10-10 21:05:24.14235|2017-10-10 21:05:24.14235
NCT03145584|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-05-08|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|December 31, 2015|Actual|2015-12-31|December 20, 2015|Actual|2015-12-20||Interventional|||Continuous Versus Single-Shot Adductor Canal Block in Total Knee Arthroplasty|A Comparison of the Effects of Continuous and Single-Shot Adductor Canal Blocks on Analgesia and Knee Flexion Following Total Knee Arthroplasty|Completed||N/A|40|Actual|University College Cork||2|||f||||f|f|f||||||No||2017-10-10 21:05:24.296552|2017-10-10 21:05:24.296552
NCT03145571|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-05|||January 1, 2011|Actual|2011-01-01|May 2017|2017-05-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Validation of a Midwifery Model in Palestine 1|Validation of a Midwifery Model in Palestine - Usage and Quality|Completed||N/A|5760|Actual|Oslo University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:05:24.437542|2017-10-10 21:05:24.437542
NCT03145558|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-09|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|TATE||TATE Versus TACE in Intermediate Stage HCC|TATE Versus TACE, an Open-label Randomized Study Comparing TransArterial Tirapazamine Embolization Versus TransArterial ChemoEmbolization in Intermediate Stage Hepatocellular Carcinoma|Not yet recruiting||Phase 2|114|Anticipated|Teclison Ltd.||2|||f||||t|t|f||||||No||2017-10-10 21:05:24.545983|2017-10-10 21:05:24.545983
NCT03145532|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Transcranial Direct-Current Stimulation (tCDS) and Robotics for Children With Hemiplegia|Transcranial Direct-Current Stimulation (tCDS) and Robotics for Children With Hemiplegia|Recruiting||N/A|40|Anticipated|Blythedale Children's Hospital||2|||f||||f|f|f||||||Yes|The investigators plan to share deidentified data in the NIH DASH (Data and Specimen Hub) database, sponsored by the National Institute of Child Health and Development (NICHD). Data will be archived to DASH upon study completion.|2017-10-10 21:05:24.71455|2017-10-10 21:05:24.71455
NCT03145519|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-05-08|||February 15, 2017|Actual|2017-02-15|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|May 30, 2017|Anticipated|2017-05-30||Interventional|||A Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population|A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population|Recruiting||N/A|188|Anticipated|Optomeditech Oy||2|||f||||f|f|f||||||No||2017-10-10 21:05:24.805754|2017-10-10 21:05:24.805754
NCT03145506|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-15|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|December 2016|Actual|2016-12-01||Observational|||Spectrally Guided Mohs Surgery|Spectrally Guided Mohs Surgery|Active, not recruiting||N/A|40|Anticipated|Seton Healthcare Family|||1||f||||f|f|f||||||||2017-10-10 21:05:24.895834|2017-10-10 21:05:24.895834
NCT03145493|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-18|||October 3, 2014|Actual|2014-10-03|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Suction Drains in Total Knee Arthroplasty With Tranexamic Acid|(L'Effet Des Drains Aspiratifs en Arthroplastie du Genou Avec l'Utilisation de l'Acide Tranexamique)|Recruiting||N/A|140|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t|f|f||||||||2017-10-10 21:05:24.965156|2017-10-10 21:05:24.965156
NCT03145480|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-28|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients|Two-arm Phase II Trial Exploring the Use of the Targeted Agents Ibrutinib and Obinutuzumab for the Treatment of Patients With a Diagnosis of Richter's Transformation (RT) or Richter's Syndrome (RS)|Recruiting||Phase 2|43|Anticipated|Northwell Health||2|||f||||t|t|f|||t|||||2017-10-10 21:05:25.082886|2017-10-10 21:05:25.082886
NCT03145467|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-08|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency Department|Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine Headache in Emergency Department: Randomize Controlled Trial|Completed||Phase 4|200|Actual|Pamukkale University||2|||f||||t||f|||f|||No||2017-10-10 21:05:25.185415|2017-10-10 21:05:25.185415
NCT03145454|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|March 3, 2019|Anticipated|2019-03-03|March 3, 2019|Anticipated|2019-03-03||Interventional|TAMALOU||Objective Markers of Pain Perception in Pediatric Emergency|Objective Markers of Pain Perception in Pediatric Emergency|Recruiting||N/A|64|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||No||2017-10-10 21:05:25.281599|2017-10-10 21:05:25.281599
NCT03145441|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-10-05|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation|The Impact of Pre-emptive Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation|Not yet recruiting||N/A|60|Anticipated|Semmelweis University||2|||f|||||f|t|f||t|||||2017-10-10 21:05:25.400379|2017-10-10 21:05:25.400379
NCT03145428|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-07-26|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Observational|MDW||Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis|Evaluation of Monocyte Volume Width Distribution (MDW) for Early Detection of Sepsis or Developing Sepsis on the UniCell DxH800 Hematology Analyzer|Recruiting||N/A|5000|Anticipated|Beckman Coulter, Inc.|||1||f||||f||||||||||2017-10-10 21:05:25.506717|2017-10-10 21:05:25.506717
NCT03145415|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-08|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Comparison of Pudendal Nerve Block and Caudal Block for Hypospadias in Young Children|Comparison of Pudendal Nerve Block vs Caudal Block for Hypospadias Repair in Young Children: A Blinded Randomized Trial|Not yet recruiting||N/A|60|Anticipated|Nemours Children's Clinic||2|||f||||f|f|f||||||No||2017-10-10 21:05:25.621697|2017-10-10 21:05:25.621697
NCT03145402|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-02|||October 20, 2017|Anticipated|2017-10-20|September 2017|2017-09-01|December 2, 2018|Anticipated|2018-12-02|September 28, 2018|Anticipated|2018-09-28||Interventional|ICMNC-HF||ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients|The Effect of Intracoronary Autologous Bone Marrow Derived Mononuclear Stem Cell Transplantation in Heart Failure (HF) Patients|Not yet recruiting||Phase 1/Phase 2|5|Anticipated|SCARM Institute, Tabriz, Iran||2|||f||||t|f|f||||||||2017-10-10 21:05:25.730099|2017-10-10 21:05:25.730099
NCT03145389|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-05|||March 20, 2016|Actual|2016-03-20|May 2017|2017-05-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Observational|||Effect of Continuous Thoracic Epidural Analgesia on Gut Motility Following Emergency Laparotomy|Effect of Continuous Thoracic Epidural Analgesia on Gut Motility Following Emergency Laparotomy for Intestinal Perforation Under General Anesthesia|Completed||N/A|60|Actual|Banaras Hindu University|||2||f||||t|f|f||||||Undecided||2017-10-10 21:05:25.873378|2017-10-10 21:05:25.873378
NCT03145376|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-04|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 30, 2020|Anticipated|2020-10-30|May 30, 2020|Anticipated|2020-05-30||Observational|||Clinical and Geriatric Assessment in Elderly Patients Before and After TAVI or MitraClip Positioning|Clinical Evaluation and Geriatric Assessment in Elderly Patients Before and After Percutaneous Aortic Valve Implantation (TAVI) or MitraClip Positioning|Not yet recruiting||N/A|100|Anticipated|University of Roma La Sapienza|||1||f||||f|f|f||||||No||2017-10-10 21:05:25.980671|2017-10-10 21:05:25.980671
NCT03145363|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-17|||June 29, 2016|Actual|2016-06-29|July 2017|2017-07-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||Mobile Phone Intervention to Reduce Youth Suicide in Rural Communities|Mobile Phone Intervention to Reduce Youth Suicide in Rural Communities|Completed||N/A|222|Actual|University of Rochester||2|||f||||f|f|f||||||||2017-10-10 21:05:26.094729|2017-10-10 21:05:26.094729
NCT03145350|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-05-04|||December 2016||2016-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of a High-fat vs. High-sugar Diet on Liver Fat Accumulation and Metabolism|The Effect of a High Fat Compared to a High Sugar Diet on Liver Fat Accumulation and Metabolism|Recruiting||N/A|16|Anticipated|University of Oxford||2|||f||||f||||||||Yes|Following completion of the study, all individual data obtained from participants may potentially be shared with other researchers, both here in the United Kingdom and abroad, in appropriate circumstances. If data is to be shared with other researchers, it will be done so under fully anonymised conditions.|2017-10-10 21:05:28.551391|2017-10-10 21:05:28.551391
NCT03145337|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-17|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Reconstruction Outcomes in Immediate Post-mastectomy Breast Reconstruction With ADM|A Prospective, Randomized, Multi-Center Clinical Study Comparing Outcomes in Patients Undergoing Prosthetic, Acellular Dermal Matrix (ADM) Assisted, Immediate Post-Mastectomy Breast Reconstruction|Enrolling by invitation||N/A|224|Anticipated|Musculoskeletal Transplant Foundation||2|||f||||f|f|f||||||||2017-10-10 21:05:28.686045|2017-10-10 21:05:28.686045
NCT03145324|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-05-04|||October 2013||2013-10-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2014|Actual|2014-10-01||Observational|||Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations|Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations|Completed||N/A|166|Actual|University of Oxford|||1||f||||f||||||||||2017-10-10 21:05:28.821772|2017-10-10 21:05:28.821772
NCT03145311|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-05|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||First rTMS for Treatment of Drug Induced Tardive Syndromes. Double Randomized Clinical Trial|First Repetitive Transcranial Magnetic Stimulation for Treatment of Drug Induced Tardive Syndromes. Double Randomized Clinical Trial|Active, not recruiting||N/A|20|Anticipated|Assiut University||2|||f||||f|f|f||||||No||2017-10-10 21:05:28.925911|2017-10-10 21:05:28.925911
NCT03145298|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-15|||August 30, 2017|Anticipated|2017-08-30|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|January 1, 2020|Anticipated|2020-01-01||Interventional|ALPHA||ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy|A Phase I Study of the Safety and Feasibility of Central Intravenous Delivery of Allogeneic Human Cardiosphere-Derived Stem Cells in Patients With Pulmonary Arterial Hypertension ALPHA Trial|Recruiting||Phase 1|26|Anticipated|Cedars-Sinai Medical Center||2|||f||||t|t|f||||||||2017-10-10 21:05:29.013904|2017-10-10 21:05:29.013904
NCT03145285|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-09|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|April 18, 2021|Anticipated|2021-04-18|April 18, 2020|Anticipated|2020-04-18||Interventional|ABACUS||Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma|Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma|Active, not recruiting||Phase 2|10|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||t|f|f|||f|||No||2017-10-10 21:05:29.118163|2017-10-10 21:05:29.118163
NCT03145272|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-31|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 1, 2019|Anticipated|2019-11-01|October 1, 2018|Anticipated|2018-10-01||Interventional|PedPK||Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients|Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients : a Pilot Study|Not yet recruiting||Phase 4|20|Anticipated|Mahidol University||1|||f||||t|f|f|||f|||||2017-10-10 21:05:29.227528|2017-10-10 21:05:29.227528
NCT03145259|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-29|||April 19, 2017|Actual|2017-04-19|August 2017|2017-08-01|April 19, 2018|Anticipated|2018-04-19|January 19, 2018|Anticipated|2018-01-19||Interventional|||Evaluation of Bioavailability of Diclofenac Dermal Products|Evaluation of Bioavailability of Diclofenac Dermal Products|Recruiting||Early Phase 1|12|Anticipated|University of Maryland||3|||f||||f|t|f|||f|||||2017-10-10 21:05:29.300653|2017-10-10 21:05:29.300653
NCT03145246|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-05-05|||January 2015||2015-01-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Long-Term Outcome Following Regenerative Periodontal Treatment of Intrabony Defects|Long-Term Outcome Following Regenerative Periodontal Treatment of Intrabony Defects: A Retrospective Study at Mahidol University|Completed||N/A|89|Actual|Mahidol University|||3||f||||f||||||||No||2017-10-10 21:05:29.387668|2017-10-10 21:05:29.387668
NCT03145233|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-02|||August 1, 2017|Actual|2017-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Isometric Versus Isotonic Exercise for Greater Trochanteric Pain Syndrome|Isometric Versus Isotonic Exercise for Greater Trochanteric Pain Syndrome - a Randomised Controlled Trial Comparing Two Rehabilitation Programmes|Recruiting||N/A|30|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f|f|f||||||||2017-10-10 21:05:29.459216|2017-10-10 21:05:29.459216
NCT03145220|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-05-04|||June 2016||2016-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|EASI||Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)|Randomized Double Blind Placebo-controlled Phase II Study on the Effects of EA-230 on the Systemic Inflammatory Response Following On-pump Cardiac Surgery|Enrolling by invitation||Phase 2|180|Anticipated|Radboud University||2|||f||||t||||||||Undecided||2017-10-10 21:05:29.640451|2017-10-10 21:05:29.640451
NCT03145207|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-08|||December 14, 2016|Actual|2016-12-14|May 2017|2017-05-01|July 17, 2018|Anticipated|2018-07-17|February 17, 2018|Anticipated|2018-02-17||Interventional|||PK and DPK of Lidocaine Dermal Products|Evaluation of Bioavailability of Lidocaine Dermal Products|Recruiting||Early Phase 1|12|Anticipated|University of Maryland||7|||f||||f|t|f|||f|||Undecided||2017-10-10 21:05:29.784954|2017-10-10 21:05:29.784954
NCT03145194|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-25|||January 30, 2017|Actual|2017-01-30|May 2017|2017-05-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI|A Randomised Mechanistic Study Comparing the Effects of Different Anti-platelet Combinations (Ticagrelor vs. Placebo/ Clopidogrel) With Aspirin in Patients Presenting With Anterior STEMI Treated With Primary PCI|Recruiting||Phase 2|140|Anticipated|Papworth Hospital NHS Foundation Trust||2|||f||||t|f|f|||f|||No||2017-10-10 21:05:29.954434|2017-10-10 21:05:29.954434
NCT03144804|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-24|||August 31, 2017|Anticipated|2017-08-31|May 2017|2017-05-01|November 30, 2024|Anticipated|2024-11-30|November 30, 2020|Anticipated|2020-11-30||Interventional|||A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer|A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer|Not yet recruiting||Phase 2|32|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f|||t|||||2017-10-10 21:05:33.633512|2017-10-10 21:05:33.633512
NCT03145181|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-14|||May 16, 2017|Actual|2017-05-16|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Dose Escalation Study of JNJ-64007957, a Humanized BCMA CD3 DuoBody® Antibody, in Participants With Relapsed or Refractory Multiple Myeloma|A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-64007957, a Humanized BCMA x CD3 DuoBody® Antibody in Subjects With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1|60|Anticipated|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 21:05:30.220663|2017-10-10 21:05:30.220663
NCT03145168|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-22|||May 25, 2017|Actual|2017-05-25|April 2017|2017-04-01|July 25, 2019|Anticipated|2019-07-25|July 25, 2019|Anticipated|2019-07-25||Interventional|||High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics|High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics -A Randomized Controlled Trial|Active, not recruiting||N/A|2|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f|f|f||||||||2017-10-10 21:05:30.378963|2017-10-10 21:05:30.378963
NCT03145129|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-25|||March 24, 2017|Actual|2017-03-24|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|December 30, 2017|Anticipated|2017-12-30||Observational|PAIR2||PAIR Study-PAP And IOP Relationship: Study 2|Positive Airway Pressure and Intraocular Relationship: Study 2- The Impact of CPAP on Nocturnal IOP.|Recruiting||N/A|30|Anticipated|Papworth Hospital NHS Foundation Trust|||2||f||||f|f|f||||||No||2017-10-10 21:05:30.767738|2017-10-10 21:05:30.767738
NCT03145116|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|UVEA509||Clincial Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses|Clincial Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses - Retro Prospective Study|Not yet recruiting||Phase 4|282|Anticipated|Carl Zeiss Meditec AG||1|||f||||f|f|f||||||No||2017-10-10 21:05:30.927672|2017-10-10 21:05:30.927672
NCT03145103|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|UVEA409||Clinical Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses|Clinical Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses - Retro Prospective Study|Not yet recruiting||Phase 4|282|Anticipated|Carl Zeiss Meditec AG||1|||f||||f|f|f||||||No||2017-10-10 21:05:31.017496|2017-10-10 21:05:31.017496
NCT03145090|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||September 11, 2017|Anticipated|2017-09-11|April 2017|2017-04-01|October 11, 2019|Anticipated|2019-10-11|October 11, 2018|Anticipated|2018-10-11||Observational|PUC-INTEVO||Bone Scintigraphy and Unicompartimental Knee Arthroplasty|Interest of Bone Scintigraphy in Pre-operative Assessment of Knee Osteoarthritis in Patients Undergoing Unicompartmental Knee Arthroplasty|Not yet recruiting||N/A|100|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 21:05:31.099869|2017-10-10 21:05:31.099869
NCT03145077|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-04|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Using Magnetic Resonance Imaging (MRI) to Assess Normal Tissue and Tumor Response to Radiation Therapy|Using Magnetic Resonance Imaging (MRI) to Assess Normal Tissue and Tumor Response to Radiation Therapy|Recruiting||N/A|1400|Anticipated|M.D. Anderson Cancer Center||5|||f||||f|f|f||||||||2017-10-10 21:05:31.173017|2017-10-10 21:05:31.173017
NCT03145064|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-28|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|October 15, 2018|Anticipated|2018-10-15||Interventional|||Study of BTK Inhibitor BGB-3111 in Subjects With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma|A Phase 2, Single Arm, Multicenter, Open-label Study of Bruton's Tyrosine Kinase (BTK) Inhibitor BGB-3111 in Subjects With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma|Recruiting||Phase 2|100|Anticipated|BeiGene||1|||||||t|t|f||||||||2017-10-10 21:05:31.284598|2017-10-10 21:05:31.284598
NCT03145051|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-31|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|Respire||Efficacy of Nasal Irrigation With Respimer® Netiflow® vs Saline Among Patients With Cystic Fibrosis and Chronic Rhinosinusitis|Prospective, Randomized, Cross-over, Multicenter, Trial Comparing the Efficacy and Tolerability of Nasal Irrigation With Respimer® Netiflow® Mineral Salts Solution Versus Saline Among Patients With Cystic Fibrosis and Suffering From Chronic Rhinosinusitis|Active, not recruiting||N/A|50|Actual|Laboratoire de la Mer||2|||f||||f||||||||||2017-10-10 21:05:31.390495|2017-10-10 21:05:31.390495
NCT03145038|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-13|||May 16, 2017|Actual|2017-05-16|September 2017|2017-09-01|October 16, 2017|Anticipated|2017-10-16|August 29, 2017|Actual|2017-08-29||Interventional|||Relative Bioavailability and Food Effect Study With Vericiguat to Characterize the Pediatric Formulation in Adult Healthy Subjects|Relative Bioavailability and Food Effect Study With Vericiguat to Characterize the Pediatric Formulation in Adult Healthy Subjects|Active, not recruiting||Phase 1|30|Actual|Bayer||6|||f||||f|f|f||||||||2017-10-10 21:05:31.4792|2017-10-10 21:05:31.4792
NCT03145025|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-04|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|July 2020|Anticipated|2020-07-01||Observational|||Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant|An Observational Change-From-Baseline Evaluation of Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant|Not yet recruiting||N/A|80|Anticipated|Bausch & Lomb Incorporated|||1||f||||t|t|t|f|f||||Yes||2017-10-10 21:05:31.57351|2017-10-10 21:05:31.57351
NCT03145012|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-04|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|October 31, 2018|Anticipated|2018-10-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity|Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity|Not yet recruiting||Phase 4|30|Anticipated|Nova Scotia Health Authority||1|||f||||t|f|f|||f|||No|There is no plan to share the IPD with other researchers.|2017-10-10 21:05:31.637312|2017-10-10 21:05:31.637312
NCT03144999|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-16|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59|A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal Injection of AAVCAGsCD59 in Patients With Advanced Non-Exudative (Dry) Age-Related Macular Degeneration With Geographic Atrophy|Recruiting||Phase 1|25|Anticipated|Hemera Biosciences||3|||f||||f|t|f||||||No||2017-10-10 21:05:31.738016|2017-10-10 21:05:31.738016
NCT03144986|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-28|||September 2012|Actual|2012-09-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa|A Pilot Study to Determine the Safety and Efficacy of H-Coil Deep Transmagnetic Stimulation in Treatment Resistant Anorexia Nervosa|Completed||N/A|9|Actual|Centre for Addiction and Mental Health||1|||f||||f|f|f|||f|||||2017-10-10 21:05:31.961583|2017-10-10 21:05:31.961583
NCT03144973|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-04|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2025|Anticipated|2025-12-31||Interventional|||Periodontitis and Upper gi Post-operative Complications|Meaning of Periodontitis in Post-operative Complications After Upper Gastrointestinal Tract Surgery|Recruiting||N/A|200|Anticipated|Helsinki University Central Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:05:32.085062|2017-10-10 21:05:32.085062
NCT03144960|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-04|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Mechanical Thrombectomy Of Acute Occlusion In Ischemic Stroke|Mechanical Thrombectomy Of Acute Occlusion In Ischemic Stroke|Not yet recruiting||N/A|20|Anticipated|Assiut University||1|||f||||t|f|f||||||Undecided||2017-10-10 21:05:32.177823|2017-10-10 21:05:32.177823
NCT03144947|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-04|||November 29, 2016|Actual|2016-11-29|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|IMMUN-HER||Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in Patients With HER2-positive Breast Cancer|Phase II, Open Label, Randomized, Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Subcutaneous (SC) Trastuzumab in Patients With Operable or Locally Advanced/Inflammatory HER2-positive Breast Cancer (ImmunHER)|Recruiting||Phase 2|60|Anticipated|Gruppo Oncologico Italiano di Ricerca Clinica||2|||f||||t|f|f|||f|||||2017-10-10 21:05:32.275949|2017-10-10 21:05:32.275949
NCT03144934|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-04|||February 10, 2017|Actual|2017-02-10|April 2017|2017-04-01|March 30, 2018|Anticipated|2018-03-30|December 15, 2017|Anticipated|2017-12-15||Interventional|||Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers|A Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers|Recruiting||Phase 1|32|Anticipated|Genexine, Inc.||5|||f||||t|f|f||||||Undecided||2017-10-10 21:05:32.547281|2017-10-10 21:05:32.547281
NCT03144921|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-28|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||EPIC: An Intervention for Early-stage AD Dyads|EPIC: A Group-based Intervention for Early-stage AD Dyads in Diverse Communities|Not yet recruiting||N/A|320|Anticipated|Arizona State University||2|||f||||f|f|f||||||No||2017-10-10 21:05:32.686349|2017-10-10 21:05:32.686349
NCT03144908|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|May 1, 2020|Anticipated|2020-05-01||Observational|||Healthcare Decisions on Dietary and Environmental Allergen Exposure|Medical Provider Experience and Assessment on Healthcare Decisions Regarding Dietary and Environmental Allergen Exposure|Active, not recruiting||N/A|200|Actual|Data Collection Analysis Business Management|||1||f||||t|f|f||||||||2017-10-10 21:05:32.815912|2017-10-10 21:05:32.815912
NCT03144895|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|March 28, 2020|Anticipated|2020-03-28|March 28, 2020|Anticipated|2020-03-28||Interventional|ACTIVE||Arterial Catheterization by Ultrasound: Impact on Success Rates and Complications in Patients Hospitalized in Resuscitation|Arterial Catheterization by Ultrasound: Impact on Success Rates and Complications in Patients Hospitalized in Resuscitation|Recruiting||N/A|380|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:05:32.917314|2017-10-10 21:05:32.917314
NCT03144882|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||February 2, 2015|Actual|2015-02-02|May 2017|2017-05-01|February 2, 2017|Actual|2017-02-02|February 2, 2016|Actual|2016-02-02||Interventional|||Evaluation of Curcumin's Effect on Inflammation in Hemodialysis Patients|Evaluation of Curcumin's Effect on Inflammation in Hemodialysis Patients|Completed||N/A|71|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t|f|f||||||No||2017-10-10 21:05:33.006855|2017-10-10 21:05:33.006855
NCT03144869|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-09|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Physical Activity Monitoring Paediatric Type 1 Diabetes|Feasibility and Acceptability of Physical Activity Monitoring as an Educational Tool in the Management of Paediatric Type 1 Diabetes|Not yet recruiting||N/A|12|Anticipated|Sheffield Hallam University||2|||f||||f|f|f||||||No||2017-10-10 21:05:33.082254|2017-10-10 21:05:33.082254
NCT03144856|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||February 22, 2017|Actual|2017-02-22|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers|Phase II Study of Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancer|Recruiting||Phase 2|39|Anticipated|Sun Yat-sen University||1|||f||||f|f|f||||||No||2017-10-10 21:05:33.18463|2017-10-10 21:05:33.18463
NCT03144843|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||January 13, 2017|Actual|2017-01-13|May 2017|2017-05-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.|A Phase II Multicenter, Randomized, Double-blind Study of Apatinib Combined With Paclitaxol Versus Placebo With Paclitaxol as Second Line Therapy for Advanced Gastric / Esophagogastric Junction Adenocarcinoma With Peritoneal Metastasis.|Recruiting||Phase 2|110|Anticipated|Sun Yat-sen University||2|||f||||f|f|f||||||No||2017-10-10 21:05:33.288023|2017-10-10 21:05:33.288023
NCT03144830|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-05-04|||June 2016||2016-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Exoskeleton Use in Acute Rehab Post Spinal Cord Injury; a Safety and Feasibility Study|Exoskeleton Use in Acute Rehab Post Spinal Cord Injury; a Safety and Feasibility Study|Recruiting||N/A|10|Anticipated|University of Calgary||1|||f||||f||||||||No||2017-10-10 21:05:33.404566|2017-10-10 21:05:33.404566
NCT03144791|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|LiHR||Lighting and Human Response in Motor Time, Autonomic Nervous System, and Emotion|Lnfluence of Light Conditions on Brain Activity, Response Time, Autonomic Nervous Response, and Emotion in the Elderly and Young Adults|Not yet recruiting||N/A|40|Anticipated|Mahidol University|||1||f|||||f|f|||t|||No||2017-10-10 21:05:33.754004|2017-10-10 21:05:33.754004
NCT03144778|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-12|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Checkpoint Inhibitors Assessment in Oropharynx Carcinoma (CIAO)|Checkpoint Inhibitors Assessment in Oropharynx Carcinoma (CIAO)|Recruiting||Early Phase 1|28|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:05:33.833164|2017-10-10 21:05:33.833164
NCT03144765|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-08|||April 21, 2017|Actual|2017-04-21|May 2017|2017-05-01|June 1, 2022|Anticipated|2022-06-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Multicenter Phase II Study of Transanal TME (taTME)|Multicenter Phase II Study of Transanal Total Mesorectal Excision (taTME) With Laparoscopic Assistance for Rectal Cancer|Recruiting||N/A|100|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|f|f||||||No||2017-10-10 21:05:33.974747|2017-10-10 21:05:33.974747
NCT03144752|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||April 14, 2017|Actual|2017-04-14|May 2017|2017-05-01|February 8, 2019|Anticipated|2019-02-08|December 23, 2018|Anticipated|2018-12-23||Observational|||Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression|Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression|Recruiting||N/A|300|Anticipated|Janssen Research & Development, LLC|||2||f||||f|f|f||||||||2017-10-10 21:05:34.113011|2017-10-10 21:05:34.113011
NCT03144739|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Collaborative Care for Children's Mental Health Problems|Collaborative Child Mental Healthcare in Low-Resource Settings|Not yet recruiting||N/A|1440|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||Yes|Will be provided as part of the National Database for Clinical Trials Related to Mental Illness (NDCT)|2017-10-10 21:05:34.20253|2017-10-10 21:05:34.20253
NCT03144726|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||RCT on NPWT for Incisions Following Major Lower-limb Amputation to Reduce Surgical Site Infection|Single Center Prospective Randomized Control Trial on Negative Pressure Wound Therapy for Incisions Following Major Lower-limb Amputation to Reduce Surgical Site Infection|Not yet recruiting||N/A|290|Anticipated|London Health Sciences Centre||2|||f||||f|f|f||||||Yes||2017-10-10 21:05:34.306991|2017-10-10 21:05:34.306991
NCT03144713|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-07-01|||June 28, 2017|Actual|2017-06-28|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis|Randomized Trial Comparing the Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis|Recruiting||N/A|100|Anticipated|Institute of Liver and Biliary Sciences, India||3|||f||||f|f|f||||||||2017-10-10 21:05:34.380527|2017-10-10 21:05:34.380527
NCT03144700|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||January 1, 2010|Actual|2010-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||The Natural History and Prognostic Factors of Compensated Cirrhosis.|The Natural History and Prognostic Factors of Compensated Cirrhosis: An Ambi Prospective Cohort Study|Recruiting||N/A|166|Anticipated|Institute of Liver and Biliary Sciences, India|||1||f||||f|f|f||||||No||2017-10-10 21:05:34.480473|2017-10-10 21:05:34.480473
NCT03144687|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-09-13|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis|An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis|Recruiting||Phase 2|42|Anticipated|Incyte Corporation||2|||t||||f|t|f||||||||2017-10-10 21:05:34.568602|2017-10-10 21:05:34.568602
NCT03144674|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-08-18|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)|A Phase 2, Open-Label, 2-Cohort Study of INCB050465, a PI3Kδ Inhibitor, in Subjects With Relapsed or Refractory Marginal Zone Lymphoma With or Without Prior Exposure to a BTK Inhibitor (CITADEL-204)|Recruiting||Phase 2|120|Anticipated|Incyte Corporation||2|||f||||t|t|f||||||||2017-10-10 21:05:34.688752|2017-10-10 21:05:34.688752
NCT03144661|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-06-14|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|February 2021|Anticipated|2021-02-01||Interventional|||An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies|A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies|Recruiting||Phase 1|100|Anticipated|Incyte Corporation||4|||f||||f|t|f||||||Undecided||2017-10-10 21:05:34.831826|2017-10-10 21:05:34.831826
NCT03144648|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-05|2017-05-05|||October 12, 2012|Actual|2012-10-12|May 2017|2017-05-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Observational|PRECAMA||PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women|Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women (PRECAMA): a Multicenter Population-based Case-control Study|Recruiting||N/A|3000|Anticipated|International Agency for Research on Cancer|||2||f|||||f|f||||Samples With DNA|"     serum, plasma, red blood cells, buffy coats, urine, and for cases, DNA from tumor tissues   "|||2017-10-10 21:05:35.29926|2017-10-10 21:05:35.29926
NCT03144635|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-04|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir|A Prospective Multicenter Observational Study for Characterization of Renal Function G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir|Recruiting||Phase 4|80|Anticipated|Kyushu University||1|||f||||t|f|f||||||No||2017-10-10 21:05:35.488715|2017-10-10 21:05:35.488715
NCT02731014|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-01|||June 2016||2016-06-01|September 2017|2017-09-01||||March 2019|Anticipated|2019-03-01||Interventional|||Dry Needling for Patients With Neck Pain|Dry Needling for Patients With Neck Pain: A Randomized Clinical Trial|Recruiting||N/A|76|Anticipated|Franklin Pierce University||2|||f||||||||||||||2017-10-10 22:19:45.300003|2017-10-10 22:19:45.300003
NCT03144622|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-04|||September 6, 2016|Actual|2016-09-06|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||18F-FSPG PET/CT Imaging in Patients With Cancers|(4S)-4-(3-[18F]Fluoropropyl)-L-glutamate Radiotracer (FSPG) PET/CT for Imaging xC- Transporter Activity in Cancers|Recruiting||N/A|120|Anticipated|National Taiwan University Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:05:35.651373|2017-10-10 21:05:35.651373
NCT03144609|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-08|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|April 2017|Actual|2017-04-01||Interventional|||Mechanical Ventilation of Obese Patients During Oral Surgical Procedures|Impact of Protective Mechanical Ventilation of Obese Patients on the Postoperative Respiratory Function During Oral Surgical Procedures|Active, not recruiting||N/A|75|Anticipated|Klarić, Vlasta, M.D.||3|||f||||f||||||||No||2017-10-10 21:05:35.744094|2017-10-10 21:05:35.744094
NCT03144596|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||October 29, 2015|Actual|2015-10-29|May 2017|2017-05-01|November 19, 2016|Actual|2016-11-19|February 3, 2016|Actual|2016-02-03||Interventional|||The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil|The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia|Completed||Phase 4|63|Actual|Kocatepe University||2|||f||||t|t|f|||t|||Undecided||2017-10-10 21:05:35.847068|2017-10-10 21:05:35.847068
NCT03144583|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-18|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|CART19-BE-01||Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy|Pilot Study on the Infusion of Differentiated Autologous T-cells From Peripheral Blood, Expanded and Transduced With a Lentivirus to Express a Chimeric Antigen Receptor With Anti-CD19 Specificity Conjugated With the Co-stimulatory Regions 4-1BB and CD3z in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy|Recruiting||Phase 1|10|Anticipated|Institut d'Investigacions Biomèdiques August Pi i Sunyer||1|||f||||t|f|f||||||||2017-10-10 21:05:35.969223|2017-10-10 21:05:35.969223
NCT03144570|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-10|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01|3 Months|Observational [Patient Registry]|EURECA||EURopean Study on Encephalitis in Intensive CAre|EURopean Study on Encephalitis in Intensive CAre|Recruiting||N/A|1000|Anticipated|ICUREsearch|||1||f||||f|f|f||||||||2017-10-10 21:05:36.090849|2017-10-10 21:05:36.090849
NCT03144557|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||January 2, 2017|Actual|2017-01-02|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Efficacy of an Education Protocol in the Correction of Inhalation Techniques in COPD|Efficacy of an Education Protocol in the Correction of Inhalation Techniques in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|61|Actual|Hospital Italiano de Buenos Aires||1|||f||||t|f|f||||||Undecided||2017-10-10 21:05:36.271279|2017-10-10 21:05:36.271279
NCT03144544|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-08|||May 2, 2016|Actual|2016-05-02|May 2017|2017-05-01|June 15, 2017|Anticipated|2017-06-15|October 27, 2016|Actual|2016-10-27||Observational|||Physiological Complexity of Pediatric Surgery Between Types of Hospitals|Incidences of Non-physiologically Complex Surgical Procedures Performed in Children and Their Similarity of Distribution Between Pediatric Specialist Hospitals and Other Hospitals Performing Pediatric Surgery|Active, not recruiting||N/A|830830|Actual|The Hospital for Sick Children|||2||f||||f|f|f||||||No|All relevant data are within the paper.|2017-10-10 21:05:36.427078|2017-10-10 21:05:36.427078
NCT03144531|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-05|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SKIP||Sleep Intervention for Kids and Parents: A Self-Management Pilot Study|Sleep Intervention for Kids and Parents (SKIP): A Self-Management Pilot Study|Recruiting||N/A|60|Anticipated|University of Washington||1|||f||||t|f|f||||||Undecided||2017-10-10 21:05:36.536266|2017-10-10 21:05:36.536266
NCT03144518|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-31|||September 1, 2017|Actual|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Mood and Influenza Vaccine Response: A Feasibility Trial|A Feasibility Trial of a Brief Positive Affect Intervention to Improve the Effectiveness of Influenza Vaccine Response in Older Adults.|Recruiting||N/A|110|Anticipated|University of Nottingham||2|||f||||f|f|f||||||||2017-10-10 21:05:36.641927|2017-10-10 21:05:36.641927
NCT03144505|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-05|||February 2014||2014-02-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|D2FIT||Comparing Moderate and High-intensity Interval Training Protocols on Biomarkers in Type 2 Diabetes Patients|A 12-Month Randomized Control Trial in Patients With Type 2 Diabetes: Comparing Moderate and High-intensity Interval Training Protocols on Biomarkers and Quality of Life|Completed||N/A|96|Actual|University of Lisbon||3|||f||||f||||||||||2017-10-10 21:05:36.766236|2017-10-10 21:05:36.766236
NCT03144492|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-30|||May 26, 2017|Actual|2017-05-26|May 2017|2017-05-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2019|Anticipated|2019-05-15||Observational|||Microgravity Effects on Co-cultured Vascular Cells Types|Microgravity Effects on Co-cultured Vascular Cells Types|Recruiting||N/A|10|Anticipated|University of Florida|||1||f||||f|f|f||||Samples With DNA|"     stem cell acquisition and differentiation   "|No||2017-10-10 21:05:37.641853|2017-10-10 21:05:37.641853
NCT03144479|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-05|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||New Technique to Assess Correct Positioning of the Right-sided Double Lumen Tube|A New Technique to Assess the Correct Positioning of a Right-sided Double-lumen Tube Without Fiberoptic Bronchoscopy|Recruiting||N/A|10|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f|f|f||||||No||2017-10-10 21:05:37.744464|2017-10-10 21:05:37.744464
NCT03144466|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-05|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|PAPAYA||A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer|Phase I Study of the Anti-PD1 Immune Checkpoint Inhibitor Pembrolizumab And Platinum in Combination With Radical radiotherApY in Cervix cAncer.|Not yet recruiting||Phase 1|26|Anticipated|Royal Marsden NHS Foundation Trust||3|||f|||||t|f|||t|||No||2017-10-10 21:05:37.84749|2017-10-10 21:05:37.84749
NCT03144453|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Recovery From Anesthesia After Robotic Assisted Radical Cystectomy|Recovery From Anesthesia After Robotic Assisted Radical Cystectomy. Two Different Reversal of Neuromuscular Blockade|Recruiting||Phase 4|50|Anticipated|Regina Elena Cancer Institute||2|||f|||||t|f|||t|||||2017-10-10 21:05:37.964408|2017-10-10 21:05:37.964408
NCT03144440|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-05|||December 13, 2016|Actual|2016-12-13|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel|Real World Experience of Chronic Hepatitis C Treatment in Israeli Patients With Advanced Liver Fibrosis With Fixed Dose Combination (FDC) Grazoprevir (100 mg)/Elbasvir (50mg) (Zepatier) ± Ribavirin: A Retrospective Multicenter Cohort Study|Active, not recruiting||N/A|100|Anticipated|Carmel Medical Center|||1||f|||||f|f||||||Yes||2017-10-10 21:05:38.069912|2017-10-10 21:05:38.069912
NCT03144427|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-05|||February 24, 2017|Actual|2017-02-24|May 2017|2017-05-01|August 30, 2020|Anticipated|2020-08-30|August 2020|Anticipated|2020-08-01||Observational|ABRUPT||The Acute Burn Resuscitation Multicenter Prospective Observational Trial|The Acute Burn Resuscitation Multicenter Prospective Observational Trial|Recruiting||N/A|400|Anticipated|American Burn Association|||1||f||||f|f|f||||||No||2017-10-10 21:05:38.153499|2017-10-10 21:05:38.153499
NCT03144414|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-05|||May 20, 2017|Anticipated|2017-05-20|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Laparoscopic Assisted Doderlin Vaginal Hysterectomy|Laparoscopic Assisted Doderlin Vaginal Hysterectomy vs. Laparoscopic Assisted Vaginal Hysterectomy: A Randomized Clinical Trial.|Recruiting||N/A|60|Anticipated|Ain Shams University||2|||f|||||f|f||||||||2017-10-10 21:05:38.321911|2017-10-10 21:05:38.321911
NCT03144401|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-05|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Preoperative vs. Postoperative Misoprostol in Elective Cesarean Section|Preoperative vs. Postoperative Misoprostol in Elective Cesarean Section: A Double-blind Randomized Clinical Trial|Recruiting||Phase 2/Phase 3|240|Anticipated|Ain Shams University||2|||f|||||f|f|||f|||||2017-10-10 21:05:38.41065|2017-10-10 21:05:38.41065
NCT03144388|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Task-specificity for Locomotor Recovery Following SCI|Task-specificity for Locomotor Recovery Following SCI|Not yet recruiting||N/A|20|Anticipated|Indiana University||2|||f||||f|f|f||||||No|Data available as requested|2017-10-10 21:05:38.508758|2017-10-10 21:05:38.508758
NCT03144375|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-04|||December 2015||2015-12-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||QOL Outcomes in CRS With Polyps|Comparison of Outcomes After Peri-operative Optimization and Standard Surgical Treatment or Standard of Care Surgical Treatment in Patients Who Have Chronic Rhinosinusitis With Polyposis.|Terminated||N/A|28|Actual|University of Miami||2||"inability to promptly see local allergists as part of medical maximization which lead to delays   in care for these patients"|f||||f||||||||||2017-10-10 21:05:38.605185|2017-10-10 21:05:38.605185
NCT03144362|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Neurodynamic Study|Unilateral and Bilateral Neurodynamic Sliding Techniques as a Means of Treating Non-compressive Sciatic Leg Pain: A Pilot Study for a Randomised Controlled Trial|Recruiting||N/A|33|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||3|||f||||f||||||||Undecided||2017-10-10 21:05:38.706401|2017-10-10 21:05:38.706401
NCT03144349|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-08-20|||December 2016||2016-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|||Diagnosis Accuracy of Hemoconcentration to Detect Hypovolemia During CRRT|Is Variation of Plasmatic Protein Concentration During Continuous Renal Replacement Therapy Predictive of Hypovolemia in Intensive Care Unit?|Recruiting||N/A|52|Anticipated|Hopital Louis Pradel|||1||f||||f||||||Samples Without DNA|"     Ionogram Protidemia Hemogram   "|||2017-10-10 21:05:38.791513|2017-10-10 21:05:38.791513
NCT03144336|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-31|||May 24, 2017|Actual|2017-05-24|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|MOTIVES||Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention|Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention (MOTIVES)|Recruiting||N/A|200|Anticipated|RAND||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:38.903762|2017-10-10 21:05:38.903762
NCT03144323|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-01|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||The Effectiveness of Electronic Reminders in Improving Elastic Compliance in Orthodontic Patients|The Effectiveness of Electronic Reminders in Improving Intra-oral Elastic Compliance in Orthodontic Patients: A Randomised Clinical Trial|Recruiting||N/A|128|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f|f|f||||||||2017-10-10 21:05:38.989691|2017-10-10 21:05:38.989691
NCT03144310|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-11|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01|1 Day|Observational [Patient Registry]|||Role of Lung Ultrasonography for Detection of Atlelectasis in Robot Assisted Laproscopic Pelvic Sugeries|ROLE OF LUNG ULTRASONOGRAPHY FOR DETECTION OF ATELECTASIS IN ADULTS UNDERGOING ROBOT ASSISTED LAPAROSCOPIC PELVIC SURGERIES|Not yet recruiting||N/A|30|Anticipated|Postgraduate Institute of Medical Education and Research|||1||f||||t|f|f||||||No||2017-10-10 21:05:39.09295|2017-10-10 21:05:39.09295
NCT03144297|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||March 2015||2015-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Intracranial Pressure vs Percentage Body Fat|Correlation Between Intracranial Pressure as Measured by Lumbar Puncture Manometry and Percentage Body Fat as Measured by Air-displacement Plethysmography|Recruiting||N/A|100|Anticipated|Gloucestershire Hospitals NHS Foundation Trust|||1||f||||f|f|f||||||No||2017-10-10 21:05:39.163369|2017-10-10 21:05:39.163369
NCT03144284|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-05|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|||Assessment of Knowledge, Attitude, and Practice of Minimal Intervention Dentistry in a Group of Dental Interns|Assessment of Knowledge, Attitude, and Practice of Minimal Intervention Dentistry in a Group of Dental Interns in Egypt: A Cross-sectional Study|Not yet recruiting||N/A|200|Anticipated|Cairo University|||1||f|||||f|f||||||No|IPD are not going to be shared. The names of dental interns are going to be replaced by codes during data collection.|2017-10-10 21:05:39.233399|2017-10-10 21:05:39.233399
NCT03144102|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-10|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|August 8, 2018|Anticipated|2018-08-08|May 8, 2018|Anticipated|2018-05-08||Interventional|||Combining tDCS With VR-based Motor Training in Stroke|The Effects of Combining Transcranial Direct Current Stimulation (tDCS) With VR-based Motor Training in Hemiparetic Stroke Patients|Not yet recruiting||N/A|36|Anticipated|Universitat Pompeu Fabra||4|||f|||||f|f|||f|||||2017-10-10 21:05:40.682173|2017-10-10 21:05:40.682173
NCT03144271|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||June 11, 2007|Actual|2007-06-11|May 2017|2017-05-01|October 8, 2007|Actual|2007-10-08|October 8, 2007|Actual|2007-10-08||Interventional|||Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects|A Randomised, Double-blind, Placebo-controlled, Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects|Completed||Phase 1|58|Actual|Novo Nordisk A/S||2|||f||||f|f|f||||||Yes|According to the Novo Nordisk disclosure commitment on novonordisk-trials.com|2017-10-10 21:05:39.313018|2017-10-10 21:05:39.313018
NCT03144258|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||January 2, 2018|Anticipated|2018-01-02|May 2017|2017-05-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Observational|||Evaluation of the Microcirculation During the Corrective Surgery of Congenital Heart Defects in Children|Evaluation of the Systemic Microcirculation in the Course of Cardiopulmonary Bypass Used in the Surgery for Repair of Congenital Heart Defects in Infants and Children|Not yet recruiting||N/A|100|Anticipated|National Institute of Cardiology, Laranjeiras, Brazil|||1||f||||f|f|f||||||No||2017-10-10 21:05:39.397451|2017-10-10 21:05:39.397451
NCT03144245|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-23|||March 20, 2017|Actual|2017-03-20|June 2017|2017-06-01|February 20, 2020|Anticipated|2020-02-20|February 20, 2020|Anticipated|2020-02-20||Interventional|||Study of AMV564 in Patients With AML|A Phase 1, First in Human, Open Label, Dose Escalation Study of AMV564, a CD33 x CD3 Tandem Diabody in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Recruiting||Phase 1|50|Anticipated|Amphivena Therapeutics, Inc.||1|||f||||f|t|f||||||Undecided||2017-10-10 21:05:39.465845|2017-10-10 21:05:39.465845
NCT03144232|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2021|Anticipated|2021-04-01||Interventional|||A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder|A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder|Not yet recruiting||N/A|72|Anticipated|Medical University of South Carolina||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:05:39.552692|2017-10-10 21:05:39.552692
NCT03144219|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|May 30, 2018|Anticipated|2018-05-30||Observational|||Transcranial Doppler Pulsatility Index as a Marker of Impaired Cerebral Compliance|Transcranial Doppler Pulsatility Index Accuracy on the Indication of Impaired Cerebral Compliance|Recruiting||N/A|40|Anticipated|University of Sao Paulo|||1||f||||f|f|f||||||No||2017-10-10 21:05:39.635623|2017-10-10 21:05:39.635623
NCT03144206|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-07-27|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Evaluation of Hyperbaric Oxygen Therapy on Wound Healing Following Management of Soft Tissue Sarcoma With Neo-Adjuvant Radiation and Surgical Resection|Prospective, Randomized Evaluation of Hyperbaric Oxygen Therapy on Wound Healing Following Management of Soft Tissue Sarcoma With Neo-Adjuvant Radiation and Surgical Resection|Not yet recruiting||Phase 4|180|Anticipated|Duke University||2|||f|||||t|f|||f|||||2017-10-10 21:05:39.719802|2017-10-10 21:05:39.719802
NCT03144193|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-08|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|December 1, 2017|Anticipated|2017-12-01||Interventional|||Efficacy in Daily Use of a Novel Skin Care Product for the Treatment of Photoaged Skin|Assessment of Efficacy in Daily Use of a Novel Skin Care Product (CG Skin Ltd.) for the Treatment of Photoaged Skin|Not yet recruiting||N/A|60|Anticipated|University of Manchester||2|||f||||f|f|f||||||Undecided|Source data will be shared with the study funder (CG Skin Ltd) on completion of the study and will collaborators at the University's Biostatistics Collaboration Unit.|2017-10-10 21:05:39.929648|2017-10-10 21:05:39.929648
NCT03144180|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|qcup||Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques|Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques: A Feasibility Study|Not yet recruiting||N/A|30|Anticipated|Texas Tech University Health Sciences Center, El Paso||2|||f||||f|f|f||||||No||2017-10-10 21:05:40.056831|2017-10-10 21:05:40.056831
NCT03144167|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-19|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|January 20, 2021|Anticipated|2021-01-20|January 20, 2021|Anticipated|2021-01-20||Interventional|SPECTROBEVA||Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy|Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy|Not yet recruiting||N/A|170|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:05:40.148251|2017-10-10 21:05:40.148251
NCT03144154|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-03|||February 13, 2017|Actual|2017-02-13|May 2017|2017-05-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Impact of an Intervention Combining Self-care and Hypnosis on the Well-being of Cancer Patients and Their Partners|Impact of an Intervention Combining Self-care and Hypnosis on the Well-being of Cancer Patients and Their Partners|Recruiting||N/A|116|Anticipated|University Hospital of Liege||2|||f||||f|f|f|||f|||No||2017-10-10 21:05:40.237653|2017-10-10 21:05:40.237653
NCT03144141|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||February 24, 2017|Actual|2017-02-24|May 2017|2017-05-01|March 24, 2019|Anticipated|2019-03-24|March 24, 2019|Anticipated|2019-03-24||Interventional|RACE||Association Between Holter Electro Hysterogram (EHG) and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery|Association Between Holter Electro Hysterogram (EHG) and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:05:40.340759|2017-10-10 21:05:40.340759
NCT03144128|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-29|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Vitamin D for Muscle Metabolic Function in Cancer Cachexia|The Contribution of Vitamin D to Muscle Metabolic Function in Cancer Cachexia|Not yet recruiting||N/A|56|Anticipated|University of Kentucky||2|||f||||t|f|f||||||||2017-10-10 21:05:40.435035|2017-10-10 21:05:40.435035
NCT03144115|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Does Oxytocin Modulate Rewarding Effects in Women and Fluctuating Across the Menstrual Cycle|Does Oxytocin Modulate Rewarding Effect of Metaphorical Compliments Fluctuating With Women's Fertility and Luteal Phase in a Romantic Context|Recruiting||Early Phase 1|80|Anticipated|University of Electronic Science and Technology of China||4|||f|||||f|f||||||||2017-10-10 21:05:40.544721|2017-10-10 21:05:40.544721
NCT03144089|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-27|||July 11, 2017|Actual|2017-07-11|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Articulated Oral Airway as an Aid to Mask Ventilation|The Articulated Oral Airway as an Aid to Mask Ventilation, a Prospective Interventional, Non-Inferiority Study|Recruiting||N/A|58|Anticipated|University of Iowa||2|||f||||t|f|f|||f|||||2017-10-10 21:05:40.805172|2017-10-10 21:05:40.805172
NCT03144076|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-24|||September 2013||2013-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Value of Health Insurance: A Field Experiment in India|The Value of Health Insurance: A Field Experiment in India|Active, not recruiting||N/A|11000|Anticipated|University of Chicago||4|||f||||f||||||||No||2017-10-10 21:05:40.917019|2017-10-10 21:05:40.917019
NCT03144063|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-17|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|||Improving the Assessment of SLE Disease Activity|Improving the Assessment of Systemic Lupus Erythematosus Disease Activity|Enrolling by invitation||N/A|100|Anticipated|University Health Network, Toronto|||3||f||||f|f|f|||f|||||2017-10-10 21:05:41.011748|2017-10-10 21:05:41.011748
NCT03144050|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||April 14, 2017|Actual|2017-04-14|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Optical Imaging For Assessment of Foot Perfusion|Optical Imaging For Assessment of Foot Perfusion|Recruiting||N/A|400|Anticipated|Modulated Imaging Inc.|||6||f||||f|f|f||||||Undecided||2017-10-10 21:05:41.096345|2017-10-10 21:05:41.096345
NCT03144037|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-01|||April 26, 2017|Actual|2017-04-26|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|October 26, 2017|Anticipated|2017-10-26||Observational|ALPA||Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors|Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors - (AIs)|Recruiting||N/A|100|Anticipated|Texas Tech University Health Sciences Center, El Paso|||1||f||||t|f|f||||||||2017-10-10 21:05:41.191951|2017-10-10 21:05:41.191951
NCT03144024|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||September 14, 2016|Actual|2016-09-14|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|BvsRR||Comparison of Rigid Annuloplasty Ring With a Band in the Correction of Secondary Tricuspid Insufficiency|Comparison of Rigid Annuloplasty Ring With a Band in the Correction of Secondary Tricuspid Insufficiency|Recruiting||N/A|314|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t|f|f||||||||2017-10-10 21:05:41.270141|2017-10-10 21:05:41.270141
NCT03144011|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||February 8, 2017|Actual|2017-02-08|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Acute Kidney Injury in Children After Cardiopulmonary Bypass|Early Diagnosis of Acute Kidney Injury in Children With Congenital Heart Disease After Cardiopulmonary Bypass|Recruiting||N/A|150|Anticipated|Meshalkin Research Institute of Pathology of Circulation|||1||f||||f|f|f||||||||2017-10-10 21:05:41.377592|2017-10-10 21:05:41.377592
NCT03143998|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-28|||February 12, 2018|Anticipated|2018-02-12|September 2017|2017-09-01|January 12, 2019|Anticipated|2019-01-12|January 12, 2019|Anticipated|2019-01-12||Interventional|||Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)|A Multi-Site, Open-Label, Trial of the Efficacy and Safety of Fixed-dose Elbasvir/Grazoprevir (EBR/GZR) in Brazilian Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)|Not yet recruiting||Phase 4|120|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||f|t|f||||||||2017-10-10 21:05:41.448465|2017-10-10 21:05:41.448465
NCT03143985|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-23|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||TEW-7197 in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma|A Phase I Trial of TEW-7197 in Combination With Pomalidomide (POM) in Relapsed or Relapsed and Refractory Multiple Myeloma|Recruiting||Phase 1|18|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:05:41.528496|2017-10-10 21:05:41.528496
NCT03143972|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-18|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PIRAD||Pharmacodynamic Interaction of REMI and DMED|Pharmacodynamic Interactions Between Remifentanil and Dexmedetomidine (PIRAD)|Recruiting||Phase 4|30|Anticipated|University Medical Center Groningen||3|||f||||f|f|f|||f|||||2017-10-10 21:05:41.646602|2017-10-10 21:05:41.646602
NCT03143959|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-07|||September 1, 2014|Actual|2014-09-01|May 2017|2017-05-01|September 30, 2016|Actual|2016-09-30|March 31, 2016|Actual|2016-03-31||Observational|||Functional Improvement With Abdominoplasty|A Prospective Study of the Impact of Abdominoplasty on the Symptoms of Back Pain and Urinary Incontinence in the Post Partum Population.|Completed||N/A|214|Actual|The Caps Clinic|||1||f||||f|f|f||||||No||2017-10-10 21:05:41.751812|2017-10-10 21:05:41.751812
NCT03143946|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-08|||December 2016||2016-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor|Towards Optimal Personalized Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor|Recruiting||N/A|53|Anticipated|University Medical Center Groningen||1|||f||||f||||||||No||2017-10-10 21:05:41.818764|2017-10-10 21:05:41.818764
NCT03143933|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-05-04|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison Between IV Propofol and Propofol/ Fentanyl Anesthesia on Patients Stress Response|Comparison Between IV Propofol and Propofol/ Fentanyl Anesthesia on Patients Surgical Stress Response Using BIS|Recruiting||Phase 2/Phase 3|40|Anticipated|Cairo University||2|||f||||||||||||||2017-10-10 21:05:41.907995|2017-10-10 21:05:41.907995
NCT03143920|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-03|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|October 30, 2020|Anticipated|2020-10-30|June 1, 2020|Anticipated|2020-06-01||Interventional|HBOTCICrUTI||Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder|Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder: A Feasibility Trial|Not yet recruiting||Early Phase 1|40|Anticipated|University of California, San Diego||1|||f||||f|t|t|f|f||||No|Individual patient data will not be shared. Summarized/group data will be shared between sponsor-investigator and Co-PI's at conclusion of patient enrollment. Data will be obtained by prospective collection and analysis.|2017-10-10 21:05:41.994157|2017-10-10 21:05:41.994157
NCT03143907|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-07-19|||September 2017|Anticipated|2017-09-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Mindfulness Group-based Intervention for Early Psychosis|Mindfulness Group-based Intervention for Early Psychosis: A Multi-Site Randomized Control Trial|Not yet recruiting||N/A|120|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:05:42.08391|2017-10-10 21:05:42.08391
NCT03143894|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||April 21, 2017|Actual|2017-04-21|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation|Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation|Recruiting||N/A|45|Anticipated|Johns Hopkins University||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:05:42.189386|2017-10-10 21:05:42.189386
NCT03143881|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|January 1, 2017|Actual|2017-01-01|March 31, 2016|Actual|2016-03-31||Interventional|||Assessment Of Educational Strategies In Heart Failure Patients Presenting To The Emergency Department For Care|Assessment Of Patient Knowledge And Effects Of Educational Strategies In Un- And Under-Insured Heart Failure Patients Presenting To The Emergency Department For Care|Completed||N/A|94|Actual|Baylor College of Medicine||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:42.31137|2017-10-10 21:05:42.31137
NCT03143868|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Role of Acute Exercise Modality on Appetite Regulation and Energy Intake|Role of Acute Exercise Modality on Appetite Regulation and Energy Intake|Recruiting||N/A|16|Anticipated|University of Colorado, Denver||3|||f||||f|f|f||||||||2017-10-10 21:05:42.387735|2017-10-10 21:05:42.387735
NCT03143855|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-05|||January 30, 2017|Actual|2017-01-30|May 2017|2017-05-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder|Phase I Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder|Recruiting||Phase 1|18|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f|||t|||No||2017-10-10 21:05:42.475208|2017-10-10 21:05:42.475208
NCT03143842|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-14|||April 27, 2017|Actual|2017-04-27|September 2017|2017-09-01|January 31, 2020|Anticipated|2020-01-31|April 27, 2018|Anticipated|2018-04-27||Interventional|||Investigating Accelerated Learning in Tinnitus Participants Implanted With Vagus Nerve Stimulation|Can we Accelerate Learning in Tinnitus Participants Enrolled in the Vagus Nerve Stimulation (VNS) Study NCT01962558 /13-79?|Active, not recruiting||N/A|6|Anticipated|The University of Texas at Dallas||1||||||||f|t|f|||||||2017-10-10 21:05:42.571769|2017-10-10 21:05:42.571769
NCT03143829|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-03|||August 11, 2016|Actual|2016-08-11|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Promoting Cancer Symptom Management in Older Adults|Promoting Cancer Symptom Management in Older Adults|Recruiting||N/A|66|Anticipated|University of Central Florida||2|||f||||t|f|f||||||No||2017-10-10 21:05:42.645708|2017-10-10 21:05:42.645708
NCT03143816|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-11|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Interventional|STAT||Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study|Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study|Recruiting||Phase 4|60|Anticipated|University of Colorado Denver School of Medicine Barbara Davis Center||2|||f||||t|t|f|||t|||||2017-10-10 21:05:42.736084|2017-10-10 21:05:42.736084
NCT03143803|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-01|||May 5, 2017|Actual|2017-05-05|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 14, 2017|Actual|2017-08-14||Interventional|||Control of Blood Glucose Fluctuation With Usage of Polyherbal|Control of Glycemic Variability Using a Polyherbal: A Randomized Placebo Controlled Study of Whole Herb Formulations|Completed||N/A|50|Actual|Organic India||2|||f||||t|f|f||||||||2017-10-10 21:05:42.832561|2017-10-10 21:05:42.832561
NCT03143790|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-05-04|||August 2014||2014-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|ESWT||Ekstracorporal Shock Wave Therapy as a Treatment for Erectile Dysfunction in Men After Prostatectomy|Ekstracorporal Shock Wave Therapy as a Treatment for Erectile Dysfunction in Men After Prostatectomy|Suspended||N/A|18|Anticipated|Odense University Hospital||2||Capacity problems|f||||f|f|f|||f|||No|All results will be published|2017-10-10 21:05:42.907354|2017-10-10 21:05:42.907354
NCT03143777|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-05-03|||April 2014||2014-04-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Does the Sara Combilizer®, an Early Mobilization Aid, Reduce the Time Taken to First Mobilise Ventilated Patients in Intensive Care?|Does the Sara Combilizer®, an Early Mobilization Aid, Reduce the Time Taken to First Mobilise Ventilated Patients in Intensive Care?|Completed||Phase 1|80|Actual|University Hospital Birmingham NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 21:05:42.985586|2017-10-10 21:05:42.985586
NCT03143764|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-03|||September 1, 2014|Actual|2014-09-01|May 2017|2017-05-01|December 1, 2016|Actual|2016-12-01|June 15, 2015|Actual|2015-06-15||Interventional|||Cardiorespiratory Fitness Using Electrically Assisted Bicycles|Bicycle Usage and Cardiorespiratory Fitness Among Inactive Adults Provided With Electrically Assisted Bicycles|Completed||N/A|25|Actual|University of Bergen||1|||f||||f|f|f||||||No||2017-10-10 21:05:43.055086|2017-10-10 21:05:43.055086
NCT03143751|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-04|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|COBI||Continuous Hyperosomolar Therapy for Traumatic Brain-injured Patients|Continuous Hyperosomolar Therapy for Traumatic Brain-injured Patients Study Protocol for a Multicenter Randomized Open-label Trial With Blinded Adjudication of Primary Outcome|Not yet recruiting||Phase 3|370|Anticipated|Nantes University Hospital||2|||f||||t|f|f||||||||2017-10-10 21:05:43.135277|2017-10-10 21:05:43.135277
NCT03143738|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Regional Anesthesia Techniques After Total Knee Arthroplasty|Continuous Adductor Canal Block in Comparison to Continuous Femoral Nerve Block in Patients After Total Knee Arthroplasty: Randomized Control Trail|Recruiting||N/A|120|Anticipated|Medical University of Lublin||2|||f||||f|f|f|||f|||No||2017-10-10 21:05:43.225384|2017-10-10 21:05:43.225384
NCT03143725|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-19|||April 14, 2017|Actual|2017-04-14|June 2017|2017-06-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Interventional|||Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution|Open-label Study to Compare the Bioavailability of an Oral Wet Granulation Tablet of GLPG1972 Relative to an Oral Solution and to an Oral Direct Compression Tablet After Single-dose Intake in Healthy Subjects, and to Evaluate the Effect of Food on the Bioavailability of an Oral Wet Granulation Tablet.|Completed||Phase 1|12|Actual|Galapagos NV||4|||f||||f|f|f||||||Undecided||2017-10-10 21:05:43.32611|2017-10-10 21:05:43.32611
NCT03143712|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-19|||April 18, 2017|Actual|2017-04-18|June 2017|2017-06-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|||Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet|An Open Label Study to Compare the Oral Bioavailability of a Tablet of GLPG1690 Relative to a Capsule After Single-dose Intake in Healthy Subjects and to Evaluate the Effect of Food on the Tablet|Completed||Phase 1|12|Actual|Galapagos NV||3|||f||||f|f|f||||||Undecided||2017-10-10 21:05:43.400306|2017-10-10 21:05:43.400306
NCT03143699|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-01|||March 28, 2017|Actual|2017-03-28|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|November 6, 2017|Anticipated|2017-11-06||Interventional|||The Effect of Immediate Feedback on Long-term Blood Pressure Measurement Skills: a Randomized Controlled Trial|The Effect of Immediate Feedback on Long-term Blood Pressure Measurement Skills: a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Federal University of Juiz de Fora||2|||f||||f|f|f||||||||2017-10-10 21:05:43.485875|2017-10-10 21:05:43.485875
NCT03143686|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-05-03|||November 2011||2011-11-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|December 2012|Actual|2012-12-01||Observational|||ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)||Completed||N/A|250|Actual|Symetis SA|||1||f||||f||||||||||2017-10-10 21:05:43.569432|2017-10-10 21:05:43.569432
NCT03143673|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-07-31|||January 2011||2011-01-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2011|Actual|2011-07-01||Interventional|TA-PILOT||ACURATE™ Transapical Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2010-01)|ACURATE™ Transapical Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis|Completed||N/A|50|Actual|Symetis SA||1|||f||||t||||||||||2017-10-10 21:05:43.678439|2017-10-10 21:05:43.678439
NCT03143660|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-05-03|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||FITLINE: Pediatric Practice-based Obesity Intervention to Support Families|Pediatric Practice-based Obesity Intervention to Support Families:FITLINE|Not yet recruiting||N/A|512|Anticipated|University of Massachusetts, Worcester||2|||f||||t|f|f||||||No||2017-10-10 21:05:43.764074|2017-10-10 21:05:43.764074
NCT03143647|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-24|||May 24, 2017|Anticipated|2017-05-24|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|1 Day|Observational [Patient Registry]|MgCedVD||Magnesium and Platelet Function Testing|Influence of Therapeutic Magnesium on Platelet Function Testing|Not yet recruiting||N/A|20|Anticipated|Ziekenhuis Oost-Limburg|||2||f||||f|f|f||||||No||2017-10-10 21:05:43.848566|2017-10-10 21:05:43.848566
NCT03143634|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-09|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|MPMH||The Modular Protocol for Mental Health (MPMH)|The Modular Protocol for Mental Health (MPMH): A Pilot Randomised Clinical Trial of a Transdiagnostic Psychological Treatment for Mood and Anxiety Disorders in Adults|Enrolling by invitation||Phase 1/Phase 2|50|Anticipated|Medical Research Council Cognition and Brain Sciences Unit||2|||f||||f|f|f||||||||2017-10-10 21:05:43.92292|2017-10-10 21:05:43.92292
NCT03143621|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-30|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||The Effect of Coffee After Resection of Small Bowel|The Effect of Coffee Consumption on Return to Bowel Function After Small Bowel Resection|Not yet recruiting||N/A|120|Anticipated|Mount Carmel Health System||2|||f||||f|f|f||||||||2017-10-10 21:05:44.18179|2017-10-10 21:05:44.18179
NCT03143608|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-05|||May 1, 2014|Actual|2014-05-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|1 Year|Observational [Patient Registry]|GERD||GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery|Laparoscopic Hiatal Hernia Repair Followed Immediately By Transoral Incisionless Fundoplication Using the Esophyx Device: Efficacy And Safety In 99 Patients In A Community Setting|Completed||N/A|99|Actual|Mavrelis, Peter G., M.D.|||2||f||||f|f|t|f|f|t|||Yes|presentation at national meeting|2017-10-10 21:05:44.267409|2017-10-10 21:05:44.267409
NCT03143595|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-03|||July 2016|Actual|2016-07-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Observational|||Clinical Outcomes in Elderly Patients With Preoperative Cognitive Dysfunction|Cognitive Trajectories and Clinical Outcomes in Elderly Patients With Preoperative Cognitive Dysfunction|Recruiting||N/A|500|Anticipated|Zhongda Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:05:44.383137|2017-10-10 21:05:44.383137
NCT03143582|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-03|||January 31, 2017|Actual|2017-01-31|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Examining the Effects of a Team-based Running Program|Examining the Effects of a Team-based Running Program on the Mental Health and Cognition of Emerging Adults: A Pilot Study|Recruiting||N/A|30|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f|f|f||||||No||2017-10-10 21:05:44.481364|2017-10-10 21:05:44.481364
NCT03143569|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-07|||May 20, 2017|Actual|2017-05-20|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|VAD-ANTIX||Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial|Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial|Recruiting||N/A|20|Anticipated|Washington University School of Medicine||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:05:44.618719|2017-10-10 21:05:44.618719
NCT03143543|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-28|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder|Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder|Recruiting||Phase 1|60|Anticipated|Virginia Commonwealth University||4|||f|||||t|f|||f|||||2017-10-10 21:05:44.861742|2017-10-10 21:05:44.861742
NCT03143530|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-03|||May 7, 2017|Anticipated|2017-05-07|May 2017|2017-05-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Effect of Pectoralis Block on Analgesia After Simple Mastectomy|The Effect of Pectoralis Block on Analgesia After Simple Mastectomy|Not yet recruiting||Phase 4|60|Anticipated|Vanderbilt University Medical Center||2|||f||||f|t|f|||f|||No||2017-10-10 21:05:44.993849|2017-10-10 21:05:44.993849
NCT03143504|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-08|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|August 5, 2019|Anticipated|2019-08-05|August 5, 2019|Anticipated|2019-08-05||Interventional|STAR||A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study|A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study|Recruiting||N/A|150|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f|f|f||||||No||2017-10-10 21:05:45.275355|2017-10-10 21:05:45.275355
NCT03143491|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)|Phase 2a Dose-Rising, Safety, Tolerability, and Efficacy Study of Topical SOR007 for Cervical Intraepithelial Neoplasia (CIN)|Not yet recruiting||Phase 2|21|Anticipated|DFB Soria, LLC||3|||f||||f|t|f||||||No||2017-10-10 21:05:45.381041|2017-10-10 21:05:45.381041
NCT03143478|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-03|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Mechanical Muscle Activity With Real-time Kinematics (M-MARK): A Novel Combination of Existing Technologies to Improve Arm Recovery Following Stroke|Mechanical Muscle Activity With Real-time Kinematics (M-MARK): A Novel Combination of Existing Technologies to Improve Arm Recovery Following Stroke|Not yet recruiting||N/A|10|Anticipated|University of Southampton||1|||f||||f|f|f||||||No||2017-10-10 21:05:45.488059|2017-10-10 21:05:45.488059
NCT03143465|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pharmacologically Triggered Migraine Without Aura and Neuroimaging||Recruiting||N/A|36|Anticipated|Danish Headache Center||3|||f||||||||||||||2017-10-10 21:05:45.583836|2017-10-10 21:05:45.583836
NCT03143452|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison Between 2% Lidocaine Gel and 5% Tetracaine Eye Drop as Topical Anesthesia in Phacoemulsification|Comparison Between 2% Lidocaine Gel and 5% Tetracaine Eye Drop as Topical Anesthesia in Phacoemulsification|Recruiting||N/A|72|Anticipated|Indonesia University||2|||f|||||f|f||||||Undecided||2017-10-10 21:05:45.68736|2017-10-10 21:05:45.68736
NCT03143439|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-03|||July 2016||2016-07-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 30, 2019|Anticipated|2019-09-30||Observational|||Evaluation of the Fathers Advancing Communities Together (FACT) Program|Evaluation of the Fathers Advancing Communities Together (FACT) Program|Recruiting||N/A|520|Anticipated|Urban Institute|||2||f|||||f|f||||||||2017-10-10 21:05:45.790231|2017-10-10 21:05:45.790231
NCT03143426|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-22|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Does 3D Visualisation Improve Performance of Laparoscopic Cholecystectomy by Junior Surgeons?|Does 3D Visualisation Improve Performance of Laparoscopic Cholecystectomy by Junior Surgeons? A Randomised Controlled Trial|Recruiting||N/A|100|Anticipated|Clinical Research Centre, Malaysia||2|||f||||f|f|f||||||No||2017-10-10 21:05:45.893859|2017-10-10 21:05:45.893859
NCT03143413|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||March 24, 2017|Actual|2017-03-24|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Observational|||Echo Systemic Sclerosis|Ultrasonography Features of the Salivary Glands in Patient With Systemic Sclerosis: Comparison With Gougerot-Sjogren Syndrome and Sicca Asthenia Polyalgia Syndrome|Recruiting||N/A|100|Anticipated|University Hospital, Clermont-Ferrand|||3||f|||||f|f||||||||2017-10-10 21:05:46.003306|2017-10-10 21:05:46.003306
NCT03143400|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||April 6, 2017|Actual|2017-04-06|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PROBIOSIN||Behavior of Various Galenic Forms of a Probiotic in the Digestive Tract.|Behavior of Various Galenic Forms of a Probiotic in the Digestive Tract|Recruiting||N/A|18|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:05:46.108795|2017-10-10 21:05:46.108795
NCT03143387|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-10-04|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|October 30, 2017|Anticipated|2017-10-30|October 15, 2017|Anticipated|2017-10-15||Interventional|||Discomfort Evaluation During Atraumatic Restorative Treatment in Children|Discomfort Evaluation During Atraumatic Restorative Treatment in Children- Clinical Trial|Recruiting||N/A|40|Anticipated|Faculty Sao Leopoldo Mandic Campinas||2|||f|||||f|f||||||||2017-10-10 21:05:46.226899|2017-10-10 21:05:46.226899
NCT03143374|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-03|||September 2016||2016-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|September 2017|Anticipated|2017-09-01||Observational|PET Tau||Positron Emission Tomography (PET) Imaging of Tau Pathology in Neurodegenerative Disease|Positron Emission Tomography (PET) Imaging of Tau Pathology in Neurodegenerative Disease|Recruiting||N/A|120|Anticipated|University of Pennsylvania|||1||f||||f||||||||No||2017-10-10 21:05:46.34518|2017-10-10 21:05:46.34518
NCT03143361|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-09-24|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2029|Anticipated|2029-10-01|November 2019|Anticipated|2019-11-01||Observational|E-AVR||Prospective European Multicenter Study on Aortic Valve Replacement: (E-AVR Registry)|Outcome Comparison of Different Surgical Strategies for the Management of Severe Aortic Valve Stenosis: Study Protocol of a Prospective Multicentre European Registry (E-AVR Registry)|Not yet recruiting||N/A|8000|Anticipated|University of Parma|||1||f||||t|f|f||||||||2017-10-10 21:05:46.450928|2017-10-10 21:05:46.450928
NCT03143348|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-07-05|||June 4, 2017|Actual|2017-06-04|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|ProCard||Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass|Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass (ProCard): an Observational Pilot Study|Recruiting||N/A|60|Anticipated|University of Oklahoma|||3||f||||f|f|f||||||||2017-10-10 21:05:46.60304|2017-10-10 21:05:46.60304
NCT03143335|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-03|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2020|Anticipated|2020-05-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Direct to Implant Breast Reconstruction Based Pre- or Retropectoral|Direct to Implant Extracellular Matrix Hammock Based pre-or Retropectoral Breast Reconstruction|Recruiting||N/A|70|Anticipated|Odense University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:05:46.730233|2017-10-10 21:05:46.730233
NCT03143140|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-09|||May 22, 2014|Actual|2014-05-22|May 2017|2017-05-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular Carcinoma|The Clinical Value of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular Carcinoma|Recruiting||N/A|120|Anticipated|Beijing Cancer Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:05:50.381877|2017-10-10 21:05:50.381877
NCT03143322|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-25|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 1, 2022|Anticipated|2022-07-01|December 1, 2020|Anticipated|2020-12-01||Interventional|STEREO-OS||Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 3 Bone-only Metastases|Extracranial Stereotactic Body Radiation Therapy (SBRT) Added to Standard Treatment Versus Standard Treatment Alone in Solid Tumors Patients With Between 1 and 3 Bone-only Metastases|Not yet recruiting||N/A|196|Anticipated|UNICANCER||2|||f||||t|f|f||||||||2017-10-10 21:05:46.848517|2017-10-10 21:05:46.848517
NCT03143309|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-07|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|July 15, 2017|Anticipated|2017-07-15|July 15, 2017|Anticipated|2017-07-15||Interventional|||Physical Activity Intervention to Promote Walking Among Female University Students|WhatsApp Physical Activity Intervention to Promote Walking Among Female University Students in Al-Qassim, Saudi Arabia: A Randomized Controlled Trial.|Recruiting||N/A|200|Anticipated|Qassim University||2|||f||||f|f|f||||||No||2017-10-10 21:05:46.93339|2017-10-10 21:05:46.93339
NCT03143296|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-23|||February 7, 2018|Anticipated|2018-02-07|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Observational|||Reverberation Effects on MED-EL Recipients|The Effects of Reverberation on Speech Understanding in MED-EL Cochlear Implant Recipients|Enrolling by invitation||N/A|50|Anticipated|University of Miami|||1||f||||f|f|f||||||||2017-10-10 21:05:47.02476|2017-10-10 21:05:47.02476
NCT03143283|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||An ED-based RCT of Lethal Means Counseling for Parents of At-Risk Youth|An ED-based Randomized Clinical Trial of Lethal Means Counseling for Parents of Youth at Risk for Suicide|Not yet recruiting||N/A|1500|Anticipated|Northeastern University||2|||f||||t|f|f||||||No||2017-10-10 21:05:47.108367|2017-10-10 21:05:47.108367
NCT03143270|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-09-13|||April 28, 2017|Actual|2017-04-28|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer|A Multicenter Pilot Study of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Advanced Hepatocellular Carcinoma|Recruiting||Early Phase 1|14|Anticipated|Memorial Sloan Kettering Cancer Center||3||||||||t|f||||||||2017-10-10 21:05:47.185586|2017-10-10 21:05:47.185586
NCT03143257|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-14|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|ACES||Ambispective Clinical Evaluation of Sophono™|Ambispective Clinical Evaluation of Sophono™|Enrolling by invitation||N/A|100|Anticipated|Medtronic Surgical Technologies|||1||f||||f|f|t|f|f|t|||||2017-10-10 21:05:47.283441|2017-10-10 21:05:47.283441
NCT03143244|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-05-03|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 29, 2016|Actual|2016-11-29||Interventional|||Dexmedetomidine vs. Ketorolac/ Midazolam for Retinal Surgery|Dexmedetomidine Versus Ketorolac/ Midazolam on Perioperative Outcome During Retinal Surgery.|Completed||Phase 4|60|Actual|Mansoura University||3|||f||||t|f|f||||||Undecided||2017-10-10 21:05:47.363418|2017-10-10 21:05:47.363418
NCT03143231|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-06-09|||March 1, 2016|Actual|2016-03-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 30, 2017|Actual|2017-05-30||Interventional|||Normal Saline vs Hypertonic Saline in the Treatment of Bronchiolitis|Normal Saline Versus Hypertonic Saline in the Treatment of Bronchiolitis|Completed||N/A|128|Actual|Makassed General Hospital||2|||f|||||f|f||||||No||2017-10-10 21:05:47.436968|2017-10-10 21:05:47.436968
NCT03143218|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-04|||April 17, 2017|Actual|2017-04-17|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|January 15, 2020|Anticipated|2020-01-15||Interventional|RTSS-SMC||Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)|A Phase IIIB Comparative Trial of Seasonal Vaccination With the Malaria Vaccine RTS,S/AS01, Seasonal Malaria Chemoprevention and of the Two Interventions Combined|Recruiting||Phase 3|6000|Anticipated|London School of Hygiene and Tropical Medicine||3|||f||||t|f|f||||||Yes|Data will be made available through the LSHTM Data Compass system|2017-10-10 21:05:47.553045|2017-10-10 21:05:47.553045
NCT03143205|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-12|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men|Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men|Recruiting||N/A|40|Anticipated|University of California, San Francisco||2|||f|||||f|f||||||||2017-10-10 21:05:47.678273|2017-10-10 21:05:47.678273
NCT03143192|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-05|||March 8, 2017|Actual|2017-03-08|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|DAM||Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser|Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser|Recruiting||Phase 2/Phase 3|30|Anticipated|Toronto Retina Institute||2|||f||||f|f|f|||f|||No|The results of this study will be analyzed statistically which will be shared with other members of the scientific community but the individual participant data along with their identifiers will not be available to other researchers.|2017-10-10 21:05:47.753521|2017-10-10 21:05:47.753521
NCT03143179|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-05|||October 1, 2018|Anticipated|2018-10-01|May 2017|2017-05-01|September 30, 2021|Anticipated|2021-09-30|October 1, 2020|Anticipated|2020-10-01||Observational|||Acute Cardiac Responses to Spinal Cord Injury|Acute Hemodynamic and Cardiac Responses to Spinal Cord Injury: A Feasibility Study|Not yet recruiting||N/A|10|Anticipated|University of British Columbia|||1||f||||t|f|f||||||No||2017-10-10 21:05:47.844817|2017-10-10 21:05:47.844817
NCT03143166|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-16|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|August 2, 2017|Actual|2017-08-02|July 27, 2017|Actual|2017-07-27||Interventional|||Pradaxa Tablet Proton Pump Inhibitor [PPI] Bioavailability [BA] Study in Japan|Relative Bioavailability of Tablet Formulation of Dabigatran Etexilate With and Without Co-administration of Rabeprazole in Healthy Male Subjects (an Open-label, Single-dose, Two-period, Single-arm Study)|Completed||Phase 1|36|Actual|Boehringer Ingelheim||1|||f||||f|f|f||||||||2017-10-10 21:05:47.897671|2017-10-10 21:05:47.897671
NCT03143153|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-10-05|||June 19, 2017|Actual|2017-06-19|October 2017|2017-10-01|December 30, 2021|Anticipated|2021-12-30|May 25, 2020|Anticipated|2020-05-25||Interventional|CheckMate 648||A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin|A Randomized Phase 3 Study of Nivolumab Plus Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin in Subjects With Unresectable Advanced, Recurrent or Metastatic Previously Untreated Esophageal Squamous Cell Carcinoma|Recruiting||Phase 3|939|Anticipated|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 21:05:47.998536|2017-10-10 21:05:47.998536
NCT03142347|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Remote Endarterectomy vs Remote Endarterectomy + Drug Coated Balloon (DCB) Angioplasty in Patients With the Femoral Artery Occlusive Disease|Remote Endarterectomy vs Remote Endarterectomy Supplement DCB Balloon Angioplasty in Patients With the Femoral Artery Occlusive Disease (TASCII D)|Recruiting||N/A|50|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:50.606433|2017-10-10 21:05:50.606433
NCT03143127|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-08-28|||May 9, 2017||2017-05-09||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:05:50.723601|2017-10-10 21:05:50.723601
NCT03143114|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-06-03|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Effect of Myomectomy for Intramural Myoma on Fertility Outcomes in Infertile Women|Effect of Myomectomy for Intramural Myoma on Fertility Outcomes in Infertile Women: a Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|Mansoura University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:50.776268|2017-10-10 21:05:50.776268
NCT03143101|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-09-20|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|October 2, 2017|Anticipated|2017-10-02|October 2, 2017|Anticipated|2017-10-02||Interventional|FluMist||Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age|A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age|Active, not recruiting||Phase 4|200|Actual|MedImmune LLC||3|||f||||f|t|f||||||||2017-10-10 21:05:50.862591|2017-10-10 21:05:50.862591
NCT03143088|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-04|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||The Effect of Medical Clowns on Blood Pressure Measurement in Children Presenting to the Emergency Department|The Effect of Medical Clowns on Blood Pressure Measurement in Children Presenting to the Emergency Department|Not yet recruiting||N/A|200|Anticipated|Meir Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:05:50.977206|2017-10-10 21:05:50.977206
NCT03143075|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-18|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?|Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?|Recruiting||N/A|90|Anticipated|Region Skane||2|||f||||t|f|f||||||||2017-10-10 21:05:51.060028|2017-10-10 21:05:51.060028
NCT03143062|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-03|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||The National Early Warning Score: Preceding Dynamics in the Score for Those Who Suffer an In-hospital Cardiac Arrest|The National Early Warning Score: Preceding Dynamics in the Score for Those Who Suffer an In-hospital Cardiac Arrest|Not yet recruiting||N/A|450|Anticipated|Region Skane|||2||f||||f|f|f||||||No||2017-10-10 21:05:51.201308|2017-10-10 21:05:51.201308
NCT03143049|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-03|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma|Randomized Phase 3 Study of Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma. An AMN Study|Not yet recruiting||Phase 3|120|Anticipated|National University Hospital, Singapore||2|||f|||||f|f|||f|||||2017-10-10 21:05:51.285677|2017-10-10 21:05:51.285677
NCT03143036|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-03|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma|Phase 2 Study of Daratumumab in Combination With Thalidomide and Dexamethasone in Relapse and / or Refractory Myeloma|Not yet recruiting||Phase 2|100|Anticipated|National University Hospital, Singapore||1|||f|||||f|f||||||||2017-10-10 21:05:51.401007|2017-10-10 21:05:51.401007
NCT03143023|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-06|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Dentifrices Containing Arginine Versus Fluoride on Microbial Acid|Efficacy of Dentifrices Containing Arginine Versus Fluoride on Microbial Acid Using Chair Side(Potential of Hydrogen) pH Meter Assessment Method in Adult Population: Randomized Clinical Trial|Not yet recruiting||N/A|28|Anticipated|Cairo University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:05:51.516141|2017-10-10 21:05:51.516141
NCT03143010|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-07|||May 7, 2017|Actual|2017-05-07|May 2017|2017-05-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Interventional|||Comparison of Different Doses of Dexmedetomidine Effect in the Duration of Spinal Anesthesia|Comparison of Different Doses of Dexmedetomidine Effect in the Duration of Spinal Anesthesia|Recruiting||N/A|200|Anticipated|Cairo University||4|||f||||f|f|f||||||Undecided||2017-10-10 21:05:51.585821|2017-10-10 21:05:51.585821
NCT03142997|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-04|2017-05-07|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Observational|||Spontaneous Ventilation Versus Controlled Ventilation on Lung Atelectasis in Children.|Effect of Spontaneous Ventilation Versus Controlled Ventilation on Lung Atelectasis Assessed by Lung Ultrasound in Children.|Recruiting||N/A|40|Anticipated|Cairo University|||2||f||||f|f|f||||||No||2017-10-10 21:05:51.68267|2017-10-10 21:05:51.68267
NCT03142984|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-14|||July 4, 2017|Actual|2017-07-04|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|BOND||UK Baby Study Using a Baby Wash and Lotion Regimen|A Randomized Controlled Trial of Gentle Touch/Early Massage With a New Wash and Lotion Regimen for Improved Skin Barrier Strength, Parental Bonding, and Physical Development in Newborn Babies: The Barrier Optimizing Skincare for Newborn Development (BOND) Trial|Recruiting||N/A|150|Anticipated|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f|f|f||||||||2017-10-10 21:05:51.772209|2017-10-10 21:05:51.772209
NCT03142971|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-09|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|May 4, 2016|Actual|2016-05-04|May 4, 2016|Actual|2016-05-04||Interventional|||Shock Wave Therapy for Lateral Hip Pain, Caused by Tendon Pathology|Focused Extracorporeal Shock Wave Therapy for Greater Trochanteric Pain Syndrome With Gluteal Tendinopathy: a Randomized Controlled Trial|Completed||N/A|50|Actual|Foundation IRCCS San Matteo Hospital||2|||f||||||||||||||2017-10-10 21:05:51.972554|2017-10-10 21:05:51.972554
NCT03142958|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-25|||May 2, 2017|Actual|2017-05-02|August 2017|2017-08-01|May 2028|Anticipated|2028-05-01|May 2020|Anticipated|2020-05-01||Interventional|Cadence||Clinical Evaluation of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement (CADENCE)|A Post-Market, Prospective, Non-Randomized, Multi-Center, Open-Label, Clinical Evaluation of the Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement|Recruiting||N/A|131|Anticipated|Integra LifeSciences Corporation||1|||f||||f|f|t|f|f||||||2017-10-10 21:05:52.059435|2017-10-10 21:05:52.059435
NCT03142945|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-28|||May 15, 2017|Actual|2017-05-15|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Mechanical Diagnosis and Therapy vs Traditional Physical Therapy in the Treatment of Mechanical Headaches|Mechanical Diagnosis and Therapy vs Traditional Physical Therapy in the Treatment of Mechanical Headaches|Recruiting||N/A|34|Anticipated|Grand Valley State University||2|||f||||f|f|f||||||||2017-10-10 21:05:52.171209|2017-10-10 21:05:52.171209
NCT03142932|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-03|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|C2Q||COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation|COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation|Not yet recruiting||N/A|150|Anticipated|Johns Hopkins University||2|||f|||||f|t|f|||||||2017-10-10 21:05:52.270882|2017-10-10 21:05:52.270882
NCT03142919|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-03|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Lipopolysaccharide (LPS) Challenge in Depression|Lipopolysaccharide (LPS) Challenge in Depression|Recruiting||Phase 1|22|Anticipated|Laureate Institute for Brain Research, Inc.||4|||f||||t|t|f||||||Undecided||2017-10-10 21:05:52.389885|2017-10-10 21:05:52.389885
NCT03142906|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-03|||April 4, 2017|Actual|2017-04-04|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|April 14, 2018|Anticipated|2018-04-14||Interventional|POCUS-RCT||Perioperative Point-of-Care Ultrasound|Perioperative Point-of-Care Ultrasound: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||No||2017-10-10 21:05:52.503818|2017-10-10 21:05:52.503818
NCT03142893|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-12|||May 8, 2017|Actual|2017-05-08|April 2017|2017-04-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Hormonal Mechanisms of Sleep Restriction - Axis Study|Hormonal Mechanisms of Sleep Restriction - Axis Study|Recruiting||Phase 1|80|Anticipated|Los Angeles Biomedical Research Institute||4|||f||||t|t|f||||||No||2017-10-10 21:05:52.637283|2017-10-10 21:05:52.637283
NCT03142880|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Spinal Marginally Hyperbaric Ropivacaine for Cesarean Delivery|Spinal Ropivacaine for Cesarean Delivery: A Comparison of Commonly Hyperbaric and Marginally Hyperbaric Solutions|Not yet recruiting||N/A|120|Anticipated|Qilu Hospital of Shandong University (Qingdao)||2|||f||||f|f|f||||||No||2017-10-10 21:05:52.779079|2017-10-10 21:05:52.779079
NCT03142867|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-10|||August 25, 2015|Actual|2015-08-25|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Observational|PREV||The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults|The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults|Recruiting||N/A|950|Anticipated|The Geneva Foundation|||3||f||||f|f|f||||Samples Without DNA|"     An additional 5 ml of whole blood and 5 ml of serum will be collected and stored by a     research coordinator, nurse, research assistant, or investigator for analysis of specific     biomarkers to include Hyaluronic acid, CK-18 (M30), FGF-21, Mac-2BP, FAS, AFP, YKL-40,     Alpha-2-macroglobulin and a panel of 46 fatty acids during the liver biopsy appointment.   "|No||2017-10-10 21:05:52.856699|2017-10-10 21:05:52.856699
NCT03142854|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-07|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|July 30, 2017|Actual|2017-07-30||Interventional|||Efficacy of Tailored Bowel Preparation Strategy Guided by a Predictive Model|Efficacy of Tailored Bowel Preparation Strategy Guided by a Predictive Model: a Randomized Controlled Study|Completed||N/A|429|Actual|Shandong University||2|||f||||t|f|f||||||||2017-10-10 21:05:52.947238|2017-10-10 21:05:52.947238
NCT03142828|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-04|||April 15, 2017|Actual|2017-04-15|May 2017|2017-05-01|May 30, 2018|Anticipated|2018-05-30|June 1, 2017|Anticipated|2017-06-01||Interventional|CHX-HA||Implant Healing Abutment and Chlorhexidine|Effect of the Application of Chlorhexidine in the Pillars of Implant Healing to Prevent Plate Accumulation. Controlled Random Blind Clinical Study.|Recruiting||Phase 4|100|Anticipated|Universidad de Murcia||2|||f||||t|f|f|||f|||Yes|Non-personal data|2017-10-10 21:05:53.119161|2017-10-10 21:05:53.119161
NCT03142802|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-04|||September 16, 2005|Actual|2005-09-16|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 14, 2011|Actual|2011-10-14||Interventional|||Low-Dose CT - Stage I Testicular Cancer|Phase II Study of Effectiveness of Using Low-dose CT in Patient Undergoing Surveillance for Clinical Stage I Testicular Cancer|Active, not recruiting||Phase 2|256|Actual|University Health Network, Toronto||1|||f||||f|f|f||||||Undecided||2017-10-10 21:05:53.277877|2017-10-10 21:05:53.277877
NCT03142789|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-07|||May 9, 2017|Anticipated|2017-05-09|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Adductor Canal Block After Total Knee Replacement - a Suture-method Catheter vs a Standard Catheter vs a Single Bolus|Comparison of the Analgesic Effect of an ACB (Adductor Canal Block) Using a New Suture-method Catheter vs a Standard Perineural Catheter vs a Single Bolus: A Randomized, Blinded, Controlled Study|Recruiting||Phase 4|153|Anticipated|University Hospital, Gentofte, Copenhagen||3|||f||||t|f|f|||f|||Undecided|We have not yet decided whether IPD will be made available to other researchers|2017-10-10 21:05:53.347727|2017-10-10 21:05:53.347727
NCT03142776|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||March 2014||2014-03-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Nonsurgical Periodontal Treatment Associated or Not With Systemic Antibiotics and Photodynamic Therapy|Evaluation of the Local Effect of Nonsurgical Periodontal Treatment of Generalized Aggressive Periodontitis Associated or Not With Systemic Antibiotics and Photodynamic Therapy.: a Randomized Clinical Trial|Completed||N/A|60|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||4|||f||||f|f|f|||f|||Undecided||2017-10-10 21:05:53.456414|2017-10-10 21:05:53.456414
NCT03142763|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-04|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2017|Actual|2017-04-01||Interventional|||Assessment of TMAO Formation With Egg Intake Versus Choline Supplement in a Healthy Population|Assessment of TMAO Formation With Egg Intake Versus Choline Supplement in a Healthy Population|Active, not recruiting||N/A|30|Actual|University of Connecticut||2|||f||||t|f|f||||||No||2017-10-10 21:05:53.535591|2017-10-10 21:05:53.535591
NCT03142750|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-06-28|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Design of a Dressing for Gastrostomy Buttons in Pediatric Population|Design of a Dressing for Gastrostomy Buttons in Pediatric Population|Not yet recruiting||N/A|40|Anticipated|University of Colorado, Denver||1|||f||||f|f|f||||||No||2017-10-10 21:05:53.599564|2017-10-10 21:05:53.599564
NCT03142737|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-22|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||"Are the Ounce-equivalents in the Protein Foods Groups Really Equivalent?"|"Are the Ounce-equivalents in the Protein Foods Groups Really Equivalent?"|Recruiting||N/A|50|Anticipated|University of Arkansas||5|||f||||f|f|f||||||||2017-10-10 21:05:53.656779|2017-10-10 21:05:53.656779
NCT03142711|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-26|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|VALUE||Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus|Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus|Recruiting||N/A|80|Anticipated|Lupus Research Alliance|||1||f||||f|f|f||||Samples With DNA|"     Blood and Urine samples   "|||2017-10-10 21:05:53.824438|2017-10-10 21:05:53.824438
NCT03142698|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-04|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|STEA-MRI||Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis|Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 21:05:53.917606|2017-10-10 21:05:53.917606
NCT03142685|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-04|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Utility of Bowel Ultrasound in Diagnosing Necrotizing Eneterocolitis in Congenital Heart Disease|Pilot Randomized Control Trial of Necrotizing Enterocolitis Screening Using Abdominal Radiograph Versus Bowel Ultrasound Plus Abdominal Radiograph in Congenital Heart Disease Patients|Recruiting||N/A|20|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||t|f|t|f|f||||No||2017-10-10 21:05:53.999566|2017-10-10 21:05:53.999566
NCT03142672|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-04|||January 28, 2016|Actual|2016-01-28|May 2017|2017-05-01|May 30, 2016|Actual|2016-05-30|April 27, 2016|Actual|2016-04-27||Interventional|||Postoperative Pain and Recovery Time After Pulpotomy|Immediate Postoperative Pain and Recovery Time After Pulpotomy Performed Under General Anaesthesia in Young Children|Completed||N/A|90|Actual|Adnan Menderes University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:54.221669|2017-10-10 21:05:54.221669
NCT03142659|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-04|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 30, 2021|Anticipated|2021-07-30|July 30, 2020|Anticipated|2020-07-30|10 Years|Observational [Patient Registry]|||Evaluation and Management of Heart Failure Patients|Evaluation and Management of Heart Failure Patients|Not yet recruiting||N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f|||||f|f||||||||2017-10-10 21:05:54.309748|2017-10-10 21:05:54.309748
NCT03142646|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-05-04|||August 30, 2016|Actual|2016-08-30|April 2017|2017-04-01|October 1, 2018|Anticipated|2018-10-01|June 1, 2018|Anticipated|2018-06-01||Interventional|IM19CAR-T||Safety and Efficacy Evaluation of IM19 CAR-T Cells|Safety and Efficacy Evaluation of IM19 CAR-T Cells on Refractory or Relapsed B-ALL Patients|Recruiting||Phase 1|20|Anticipated|Beijing Immunochina Medical Science & Technology Co., Ltd.||1|||f||||||||||||No||2017-10-10 21:05:54.380527|2017-10-10 21:05:54.380527
NCT03142633|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-04|||September 9, 2016|Actual|2016-09-09|March 2017|2017-03-01|June 1, 2017|Anticipated|2017-06-01|June 1, 2017|Anticipated|2017-06-01||Observational|||MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome|MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome|Recruiting||N/A|60|Anticipated|Holbaek Sygehus|||1||f||||t|f|f||||Samples With DNA|"     Serum Buffy Coat   "|Undecided||2017-10-10 21:05:54.472748|2017-10-10 21:05:54.472748
NCT03142620|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-05-04|||March 2015||2015-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|vDHp||Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study|Delineation of Therapeutic Potential and the Causal Relationship Between Vitamin D and Helicobacter Pylori (HP) Infection and Gastritis|Recruiting||Phase 3|96|Anticipated|Chinese University of Hong Kong||3|||f||||t||||||||No||2017-10-10 21:05:54.559888|2017-10-10 21:05:54.559888
NCT03142607|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-04|||February 3, 2017|Actual|2017-02-03|May 2017|2017-05-01|February 2, 2018|Anticipated|2018-02-02|January 2, 2018|Anticipated|2018-01-02||Interventional|||Comparative Evaluation of Chlorhexidine, Metronidazole and Combination Gels on Gingivitis|Comparative Evaluation of Chlorhexidine, Metronidazole and Combination Gels on Gingivitis: A Randomized Clinical Trial|Recruiting||Phase 3|90|Anticipated|Aga Khan University||3|||f||||t|f|f||||||No||2017-10-10 21:05:54.684851|2017-10-10 21:05:54.684851
NCT03142594|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-03|||December 1, 2016||2016-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:05:54.786897|2017-10-10 21:05:54.786897
NCT03142568|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-06|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|SIL02||Safety of Sildenafil in Premature Infants|Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia|Not yet recruiting||Phase 2|120|Anticipated|University of North Carolina, Chapel Hill||6|||f||||t|t|f||||||||2017-10-10 21:05:54.867709|2017-10-10 21:05:54.867709
NCT03142555|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-03|||May 11, 2017|Anticipated|2017-05-11|May 2017|2017-05-01|October 11, 2019|Anticipated|2019-10-11|July 11, 2019|Anticipated|2019-07-11||Interventional|||Smoking Cessation Programme in Workplaces in Hong Kong (Phase III)|Assessing the Corporate Environment in Promoting Tobacco Control and Evaluation of a Smoking Cessation Programme in Workplaces in Hong Kong|Not yet recruiting||N/A|700|Anticipated|The University of Hong Kong||2|||f||||t|f|f||||||Undecided||2017-10-10 21:05:54.99714|2017-10-10 21:05:54.99714
NCT03142542|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-04|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|DA8159_EDP_IIT||The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy|A Randomized, Double-blind, Placebo-controlled, Investigator Initiated Clinical Trial to Evaluate the Efficacy and Safety of Udenafil Dosed Once a Day in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy|Not yet recruiting||Phase 4|99|Anticipated|Samsung Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:05:55.106812|2017-10-10 21:05:55.106812
NCT03142529|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-08-01|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|February 15, 2018|Anticipated|2018-02-15|November 15, 2017|Anticipated|2017-11-15||Interventional|||Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease|Clinical Observation of Therapeutic Effects on Traditional Chinese Medicine Colon Dialysis Treating Non-dialysis End-Stage Kidney Disease|Recruiting||Phase 1/Phase 2|20|Anticipated|Jinan University Guangzhou||2|||f||||t|f|f|||f|||||2017-10-10 21:05:55.193735|2017-10-10 21:05:55.193735
NCT03142516|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-24|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2021|Anticipated|2021-02-28||Interventional|OPALO||FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status|A Phase II Trial to Evaluate the Efficacy and Safety of FOLFIRI + Panitumumab as First-line Treatment in Elderly Patients With RAS/BRAF Wild-type Unresectable Metastatic Colorectal Cancer and Good Performance Status|Not yet recruiting||Phase 2|80|Anticipated|Grupo Espanol Multidisciplinario del Cancer Digestivo||1|||f||||f|f|f|||f|||No||2017-10-10 21:05:55.31064|2017-10-10 21:05:55.31064
NCT03142503|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-04|||January 21, 2013|Actual|2013-01-21|May 2017|2017-05-01|June 22, 2015|Actual|2015-06-22|March 16, 2015|Actual|2015-03-16||Interventional|DIET||The DIET Trial - Dietetic Intervention in Psoriatic Arthritis|Effectiveness of a Dietary Intervention Program on Disease Activity, Metabolism and Oxidative Stress in Patients With Psoriatic Arthritis and Psoriasis Activity: A Clinical, Randomized, Placebo-controlled Trial|Completed||N/A|194|Actual|Federal University of São Paulo||3|||f||||||||||||||2017-10-10 21:05:55.490676|2017-10-10 21:05:55.490676
NCT03142490|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-03|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Acupuncture as a Complementary Therapy for in Vitro Fertilization Patients: a Randomized Controlled Trial|Acupuncture as a Complementary Therapy for Infertile Patients on Treatment With in Vitro Fertilization: a Randomized Controlled Clinical Trial|Recruiting||N/A|100|Anticipated|Federal University of Minas Gerais||2|||f||||t|f|f||||||No||2017-10-10 21:05:55.57688|2017-10-10 21:05:55.57688
NCT03142477|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||August 1, 2016|Actual|2016-08-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Effects of Therapeutic Touch in Patients With Female Genital Neoplasia: a Randomized Controlled Clinical Trial|Effects of Therapeutic Touch in Patients With Female Genital Neoplasia: a Randomized Controlled Clinical Trial|Recruiting||N/A|90|Anticipated|Federal University of Minas Gerais||3|||f||||t|f|f||||||No||2017-10-10 21:05:55.675423|2017-10-10 21:05:55.675423
NCT03142464|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-05-05|||July 1, 2015|Actual|2015-07-01|May 2017|2017-05-01|July 30, 2016|Actual|2016-07-30|July 30, 2016|Actual|2016-07-30||Interventional|||Intravenous Fluids After Laparoscopic Cholecystectomy|Intravenous Fluids After Laparoscopic Cholecystectomy: Necessary or Dispensable. A Randomized Clinical Trial|Completed||N/A|100|Actual|Federal University of Minas Gerais||2|||f||||f|f|f||||||No||2017-10-10 21:05:55.775603|2017-10-10 21:05:55.775603
NCT03142451|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-09-04|||June 9, 2017|Actual|2017-06-09|April 2017|2017-04-01|October 22, 2018|Anticipated|2018-10-22|September 13, 2018|Anticipated|2018-09-13||Interventional|||A Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea|A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular Rosacea (FX2016-11 and 12)|Recruiting||Phase 3|1500|Anticipated|Foamix Ltd.||2|||f||||f|t|f|||t|||||2017-10-10 21:05:55.857426|2017-10-10 21:05:55.857426
NCT03142438|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-07-19|||May 30, 2017|Actual|2017-05-30|July 2017|2017-07-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Interventional|||The Evaluation of a Full Face and Nasal Mask for the Treatment of Obstructive Sleep Apnea|The Evaluation of a Full Face and Nasal Mask for the Treatment of Obstructive Sleep Apnea|Completed||N/A|61|Actual|Fisher and Paykel Healthcare||1|||f||||t|f|t|f|f|f|||||2017-10-10 21:05:56.093262|2017-10-10 21:05:56.093262
NCT03142425|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-23|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy|Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy|Recruiting||N/A|150|Anticipated|DxTerity Diagnostics|||1||f||||f|f|f||||||||2017-10-10 21:05:56.173865|2017-10-10 21:05:56.173865
NCT03142412|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-03|||April 17, 2017|Actual|2017-04-17|May 2017|2017-05-01|October 17, 2021|Anticipated|2021-10-17|October 17, 2021|Anticipated|2021-10-17||Observational|LIFT||Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization|Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization|Recruiting||N/A|2500|Anticipated|DxTerity Diagnostics|||1||f||||f|f|f||||||No||2017-10-10 21:05:56.245456|2017-10-10 21:05:56.245456
NCT03141853|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-05|||May 20, 2017|Actual|2017-05-20|July 2017|2017-07-01|April 3, 2018|Anticipated|2018-04-03|November 30, 2017|Anticipated|2017-11-30||Interventional|HEAT||Horses and Education as Arthritis Therapy|Equine-assisted Therapy for Adults and Older Adults With Arthritis: A Randomized Controlled Trial|Recruiting||N/A|22|Anticipated|University of Missouri, Kansas City||2|||f||||f|f|f||||||||2017-10-10 21:06:01.223256|2017-10-10 21:06:01.223256
NCT03142399|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Effect of Whey Protein' Supplementation and Exercise in Patients With Heart Failure|Effect of Supplementation With Whey Protein in Preservation of Muscle Mass and Strength, Quality of Life of Patients With Heart Failure in Cardiac Rehabilitation|Recruiting||N/A|4|Anticipated|National Institute of Cardiology, Laranjeiras, Brazil||2|||f||||f|f|f||||||No|All volunteer information obtained during the collection, intervention and data analysis will not be available other researchers.|2017-10-10 21:05:56.310332|2017-10-10 21:05:56.310332
NCT03142386|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-03|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Osteopathic Manipulative Treatment in Oncology Patients' Management|Pain and Quality of Life Management in Oncology Geriatric Patients With Osteopathic Manipulative Treatment: a Pilot Study|Completed||N/A|23|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f|f|f||||||Undecided||2017-10-10 21:05:56.395396|2017-10-10 21:05:56.395396
NCT03142373|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-03|||June 2010|Actual|2010-06-01|May 2017|2017-05-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Interventional|||Effect of CV4 and Rib Raising Techniques on Autonomic Balance|Variations of Heart Rate Variability and Skin Conductance Reveal the Influence of CV4 and Rib Raising Osteopathic Techniques on the Autonomic Nervous System: a Randomized Controlled Trial|Completed||N/A|48|Actual|Fondazione Don Carlo Gnocchi Onlus||3|||f||||t|f|f||||||Undecided||2017-10-10 21:05:56.476903|2017-10-10 21:05:56.476903
NCT03142321|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Defining Predictors of RT Response to Vedolizumab in IBD|Defining Predictors of Radiological Transmural Response to Vedolizumab in Small Bowel Crohn's Disease Through Serum Proteomic Biomarkers|Not yet recruiting||Phase 4|80|Anticipated|Washington University School of Medicine||1|||f|||||t|f||||||Undecided||2017-10-10 21:05:57.133709|2017-10-10 21:05:57.133709
NCT03142308|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-02|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Observational|multi-center||Surgeons' Satisfaction With the Surgical Training Program in Egypt|Young Surgeons' Satisfaction With the Surgical Training Program in Egyptian University Hospitals: A Multi-center Cross-sectional Study|Recruiting||N/A|500|Anticipated|Zagazig University|||1||f||||f|f|f||||||No||2017-10-10 21:05:57.229926|2017-10-10 21:05:57.229926
NCT03142295|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-06-23|||June 24, 2017|Anticipated|2017-06-24|June 2017|2017-06-01|February 1, 2018|Anticipated|2018-02-01|January 1, 2018|Anticipated|2018-01-01||Interventional|SHUTUP||Controlled Human Urine Transfusion for UTI|Safety and Tolerability of Controlled Human Urine Transfusion for Urinary Tract Infection Prevention (SHUTUP): a Pilot Study|Recruiting||N/A|6|Anticipated|Leiden University Medical Center||1|||f||||t|f|f||||||No||2017-10-10 21:05:57.310376|2017-10-10 21:05:57.310376
NCT03142282|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 31, 2024|Anticipated|2024-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|MCRC-LC1||Maintenance Chemotherapy Versus Consolidative Radiotherapy Plus Maintenance Chemotherapy for Unresectable Metastatic Colorectal Cancer: A Randomized Phase II Trial|Maintenance Chemotherapy Versus Consolidative Radiotherapy Plus Maintenance Chemotherapy for Unresectable Metastatic Colorectal Cancer: A Randomized Phase II Trial|Not yet recruiting||Phase 2|200|Anticipated|Wuhan Union Hospital, China||2|||f||||t|f|f||||||Yes||2017-10-10 21:05:57.413255|2017-10-10 21:05:57.413255
NCT03142269|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-05-02|||January 1, 2015|Actual|2015-01-01|May 2017|2017-05-01|July 31, 2016|Actual|2016-07-31|July 1, 2015|Actual|2015-07-01||Interventional|||The Influences Of Anterior Capsule Polishing On Anterior Capsular Changes and Intraocular Lenses Stability of Super High Myopic Eyes|The Influences of 360° Anterior Capsule Polishing on Refraction, Anterior Capsular Opening Size and IOL Stability Among Super High Myopia Patients|Completed||N/A|20|Actual|Wenzhou Medical University||2|||f|||||f|f||||||||2017-10-10 21:05:57.510851|2017-10-10 21:05:57.510851
NCT03142256|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-03|||March 24, 2017|Actual|2017-03-24|May 2017|2017-05-01|April 6, 2018|Anticipated|2018-04-06|April 6, 2018|Anticipated|2018-04-06||Interventional|3P||3Ps for Prevention Study (Perception, Partners, Pills)|A Pilot Prospective Cohort Evaluation of Uptake and Adherence to PrEP in Young South African Women|Recruiting||Phase 4|200|Anticipated|Desmond Tutu HIV Centre||2|||f||||t|t|f|||t|||No||2017-10-10 21:05:57.588207|2017-10-10 21:05:57.588207
NCT03142243|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-17|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|AsymFemaleTP||Morphological Asymmetry in Elite Female Tennis Players|Morphological Asymmetry in Elite Female Tennis Players Competing in an International Tournament in Belgium: an Observational Study|Not yet recruiting||N/A|30|Anticipated|Vrije Universiteit Brussel|||1||f||||f|f|f||||||No|Individual Participant Data (IPD) will not be shared or will not be available to other researchers|2017-10-10 21:05:57.701652|2017-10-10 21:05:57.701652
NCT03142230|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-05|||October 14, 2016|Actual|2016-10-14|May 2017|2017-05-01|October 14, 2018|Anticipated|2018-10-14|October 14, 2017|Anticipated|2017-10-14||Interventional|DOLATSONG||Prevention of Pain Caused by the Oro-gastric Tube Laying in Neonatology|Prevention of Pain Caused by the Oro-gastric Tube Laying in Neonatology|Recruiting||N/A|96|Anticipated|Centre Hospitalier Sud Francilien||2|||f|||||f|f||||||||2017-10-10 21:05:57.776505|2017-10-10 21:05:57.776505
NCT03142217|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||March 26, 2015|Actual|2015-03-26|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|Huntington||Characterization of the Profile of Dysarthria in Huntington's Disease, Using the Clinical Evaluation Battery of Dysarthria|Characterization of the Profile of Dysarthria in Huntington's Disease, Using the Clinical Evaluation Battery of Dysarthria|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire, Amiens||1||decision of investigator|f|||||f|f||||||||2017-10-10 21:05:57.86178|2017-10-10 21:05:57.86178
NCT02707341|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-06-22|||April 2015||2015-04-01|April 2017|2017-04-01|December 2100|Anticipated|2100-12-01|December 2100|Anticipated|2100-12-01|8 Years|Observational [Patient Registry]|||The Corrona Psoriasis (PSO) Registry|Corrona Psoriasis (PSO) Registry|Enrolling by invitation||N/A|10000|Anticipated|Corrona, LLC.|||1||f||||f||||||||||2017-10-10 22:24:00.646609|2017-10-10 22:24:00.646609
NCT03142204|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-18|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||[18F]FAraG (VisAcT) PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy|Study of the Kinetics, Dosimetry and Safety of [18F]F-AraG (VisAcT), a Positron Emission Tomography Tracer for Imaging the Activation of the Immune System in Cancer Patients Expected to Undergo Immunotherapy|Recruiting||Phase 1|30|Anticipated|CellSight Technologies, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:05:57.926301|2017-10-10 21:05:57.926301
NCT03142178|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-04|||April 30, 2017|Actual|2017-04-30|April 2017|2017-04-01|March 30, 2018|Anticipated|2018-03-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||3VM for Treatment of Post Herpetic Neuralgia|A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Tolerability of 3VM1001 Cream for the Treatment of Pain Associated With Post-Herpetic Neuralgia: A Proof of Concept Study|Recruiting||Phase 1/Phase 2|30|Anticipated|CDA Research Group, Inc.||2|||f||||f|t|f||||||No||2017-10-10 21:05:58.252804|2017-10-10 21:05:58.252804
NCT03142165|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-26|||May 11, 2017|Actual|2017-05-11|September 2017|2017-09-01|November 10, 2017|Anticipated|2017-11-10|November 9, 2017|Anticipated|2017-11-09||Interventional|||A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants|A Randomized, Placebo-Controlled, Double-Blind, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants|Recruiting||Phase 1|33|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 21:05:58.392538|2017-10-10 21:05:58.392538
NCT03142152|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-24|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 1, 2025|Anticipated|2025-10-01|October 1, 2021|Anticipated|2021-10-01||Interventional|||The CARILLON Trial - Transcatheter Treatment of Functional Mitral Regurgitation|Assessment of the Carillon® Mitral Contour System® in Treating Functional Mitral Regurgitation Associated With Heart Failure|Not yet recruiting||N/A|400|Anticipated|Cardiac Dimensions Pty Ltd||2|||f||||t|f|t|t|||||||2017-10-10 21:05:58.531633|2017-10-10 21:05:58.531633
NCT03142139|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-08|||January 1, 1997|Actual|1997-01-01|May 2017|2017-05-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Observational|||Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age?|Timing of Vaccination With the Non-live DTaP-IPV-Hib Vaccine and Development of Atopic Dermatitis Before 1 Year of Age - a Danish Register Based Cohort Study|Completed||N/A|1027559|Actual|Bandim Health Project|||1||f||||f|f|f||||||No||2017-10-10 21:05:58.694501|2017-10-10 21:05:58.694501
NCT03142126|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||August 6, 2014|Actual|2014-08-06|May 2017|2017-05-01|September 5, 2015|Actual|2015-09-05|August 5, 2015|Actual|2015-08-05||Interventional|||Accelerated Ambulation After Vascular Access Closure Device|Angioseal Groin Management After Left Heart Catheterization|Completed||N/A|28|Actual|Ascension St John Providence||1|||f||||f|f|f|||f|||No||2017-10-10 21:05:58.776985|2017-10-10 21:05:58.776985
NCT03142113|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-05-02|||November 2016||2016-11-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|December 2016|Actual|2016-12-01||Observational|CEDAR UC||Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis|A Retrospective Multicentric Belgian Observational Trial to Evaluate the Successfulness of Adalimumab Dose Escalation and De-escalation in Patients With Moderate-to-severe Ulcerative Colitis Treated With Adalimumab|Recruiting||N/A|250|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||Undecided||2017-10-10 21:05:58.851007|2017-10-10 21:05:58.851007
NCT03142100|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-05-04|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|June 15, 2019|Anticipated|2019-06-15|April 1, 2019|Anticipated|2019-04-01||Observational|||Combined Acoustic and Electric Hearing (CI/HA) in Adult Bimodal Users Using a HA With a Bimodal Fitting Formula|Assessment of the Contribution of Combined Acoustic Hearing Via a Hearing Aid and Electric Hearing Via a Cochlear Implant in Adult Bimodal Users Following Using a HA With a Dedicated Bimodal Fitting Formula|Not yet recruiting||N/A|40|Anticipated|Bnai Zion Medical Center|||2||f|||||f|t|f|f|f|||Undecided||2017-10-10 21:05:58.956811|2017-10-10 21:05:58.956811
NCT03142087|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-12|||March 21, 2017|Actual|2017-03-21|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Virtual Reality Exercises on Balance in Children With Brain Tumors|The Effect of Virtual Reality Exercises on Balance in Children With Brain Tumors|Active, not recruiting||N/A|30|Anticipated|Bezmialem Vakif University||2|||f||||t|f|f||||||||2017-10-10 21:05:59.027599|2017-10-10 21:05:59.027599
NCT03142074|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-05-02|||January 2017|Actual|2017-01-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01|1 Day|Observational [Patient Registry]|||Biomechanical and Microstructural Properties of Ascending Aortic Aneurysms|BIOMECHANICAL AND MICROSTRUCTURAL PROPERTIES OF THE AORTIC WALL: A Pilot Study in Patients Undergoing Surgery for Ascending Aortic Aneurysms|Recruiting||N/A|180|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f|f|f||||Samples Without DNA|"     Aneurismatic tissue   "|Undecided||2017-10-10 21:05:59.112527|2017-10-10 21:05:59.112527
NCT03142061|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-07-11|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|June 1, 2019|Anticipated|2019-06-01||Interventional|||Electrochemotherapy for the Inoperable Vulva Carcinoma|Prospective Evaluation of Clinical Efficacy and Symptom Control Using Electrochemotherapy for the Inoperable Advanced Vulva Carcinoma|Recruiting||N/A|50|Anticipated|University Women's Hospital Tübingen||1|||f||||f|f|f||||||||2017-10-10 21:05:59.207609|2017-10-10 21:05:59.207609
NCT03142048|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-03|||December 10, 2014|Actual|2014-12-10|April 2017|2017-04-01|December 10, 2016|Actual|2016-12-10|September 10, 2015|Actual|2015-09-10||Interventional|||Community Intervention to Reduce Social Isolation in Elderly People: a Mixed Methods Multi-approach Evaluation|Community Intervention to Reduce Social Isolation in Elderly People in Disadvantaged Urban Areas: Study Protocol for a Mixed Methods Multi-approach Evaluation|Completed||N/A|135|Actual|Agència de Salut Pública de Barcelona||2|||f||||f|f|f||||||No||2017-10-10 21:05:59.286001|2017-10-10 21:05:59.286001
NCT03142035|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-03|||June 22, 2017|Anticipated|2017-06-22|May 2017|2017-05-01|February 22, 2020|Anticipated|2020-02-22|February 22, 2020|Anticipated|2020-02-22||Interventional|||Dienogest Versus GnRH-a Pre-treatment in Women With Endometriosis Undergoing IVF|Dienogest Versus Gonadotropin Releasing Hormone Agonist Pre-treatment in Women With Endometriosis Undergoing in Vitro Fertilization|Not yet recruiting||N/A|189|Anticipated|American University of Beirut Medical Center||3|||f||||f|f|f||||||No||2017-10-10 21:05:59.372588|2017-10-10 21:05:59.372588
NCT03142022|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-02|||November 2014||2014-11-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Sleep-disordered Breathing After Solid Organ Transplantation||Recruiting||N/A|300|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||No||2017-10-10 21:05:59.470814|2017-10-10 21:05:59.470814
NCT03142009|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-04|||April 1, 2014|Actual|2014-04-01|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|April 2018|Anticipated|2018-04-01||Interventional|||Family Listening Program: Multi-Tribal Implementation and Evaluation|Family Listening Program: Multi-Tribal Implementation and Evaluation|Recruiting||N/A|576|Anticipated|University of New Mexico||2|||f||||t|f|f||||||No||2017-10-10 21:05:59.562422|2017-10-10 21:05:59.562422
NCT03141996|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|NEGLECT||Use of Vibration to Improve Visual/Spatial Neglect in Patients Affected by Stroke|Use of Vibration to Improve Visual/Spatial Neglect in Patients Affected by Stroke|Not yet recruiting||N/A|30|Anticipated|Intermountain Health Care, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:05:59.700634|2017-10-10 21:05:59.700634
NCT03141983|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-07-06|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|April 2020|Anticipated|2020-04-01||Interventional|ACTION||Anti-Cytokine Therapy for Hemodialysis InflammatION|Anti-Cytokine Therapy for Hemodialysis InflammatION (ACTION): A Phase II Multi-center Study to Evaluate the Safety and Tolerability of Anakinra, an IL-1 Receptor Antagonist, for Patients Treated With Maintenance Hemodialysis|Not yet recruiting||Phase 2|80|Anticipated|University of Pennsylvania||2|||f||||t|t|f|||f|||||2017-10-10 21:05:59.802003|2017-10-10 21:05:59.802003
NCT03141970|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-03|||July 1, 2015|Actual|2015-07-01|May 2017|2017-05-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Prednisolone Trial in Children Younger Than 4 Years|Randomized, Multicentric, Open Label, Parallel Group Trial to Compare the Efficacy of 6-months Versus 3-months Therapy With Prednisolone for the First Episode of Idiopathic Nephrotic Syndrome in Children Younger Than 4 Years|Recruiting||Phase 3|156|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t|t|f||||||Yes|Following anonymisation to protect patient identity, data from patients in USA will be pooled and analyzed with that from Indian patients. Data will be available once all subjects have completed the study and data has been analyzed. No interim data analysis will be conducted|2017-10-10 21:05:59.943072|2017-10-10 21:05:59.943072
NCT03141957|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-04|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|HELP||Hypermetabolism in the Elderly Lung Cancer Patient|Hypermetabolism in the Elderly Lung Cancer Patient|Completed||N/A|27|Actual|University of Paris 5 - Rene Descartes|||2||f||||f|f|f||||||No||2017-10-10 21:06:00.085088|2017-10-10 21:06:00.085088
NCT03141944|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-02|||February 23, 2017|Actual|2017-02-23|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Observational|IMPACT||Evolution of Hypodopaminergic Syndrome in Early Parkinson's Disease|Improvement of Hypodopaminergic Syndrome With Dopaminergic Treatment in Early Parkinson's Disease|Recruiting||N/A|90|Anticipated|University Hospital, Grenoble|||2||f||||t|f|f||||||No||2017-10-10 21:06:00.156313|2017-10-10 21:06:00.156313
NCT03141931|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-03|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effects of Dietary Supplementation With a Combination of Flaxseed Oil, Borage Oil and Fish Oil Omega-3 Fatty Acids on Ocular Comfort Including Symptoms of Dry Eye|The Effects of Dietary Supplementation With a Combination of Flaxseed Oil, Borage Oil and Fish Oil Omega-3 Fatty Acids on Ocular Comfort Including Symptoms of Dry Eye|Recruiting||N/A|138|Anticipated|The University of New South Wales||2|||f||||f|f|f||||||||2017-10-10 21:06:00.356117|2017-10-10 21:06:00.356117
NCT03141918|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-05-04|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 10, 2017|Anticipated|2017-12-10|June 12, 2017|Anticipated|2017-06-12||Interventional|||Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS|Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS|Not yet recruiting||N/A|20|Anticipated|Universidade Federal do Rio Grande do Norte||4|||f||||t|f|f|||t|||No||2017-10-10 21:06:00.523256|2017-10-10 21:06:00.523256
NCT03141905|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease|Can a Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease?|Not yet recruiting||N/A|800|Anticipated|University of Maryland||2|||f||||t|f|f||||||||2017-10-10 21:06:00.699526|2017-10-10 21:06:00.699526
NCT03141892|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-06|||April 13, 2017|Actual|2017-04-13|July 2017|2017-07-01|May 30, 2017|Actual|2017-05-30|May 23, 2017|Actual|2017-05-23||Observational|||FreeStyle Libre Flash Glucose Monitoring System Accuracy Study|FreeStyle Libre Flash Glucose Monitoring System Accuracy Study|Completed||N/A|50|Actual|Abbott Diabetes Care|||1||f||||f|f|t|t|f|f|||||2017-10-10 21:06:00.812581|2017-10-10 21:06:00.812581
NCT03141879|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-02|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|KARE||Keeping Active in Residential Elderly|"Assessing the Feasibility and Impact of Physical Activity in Healthy Ageing, With a Specialised Chair-based Resistance Training Intervention, in Residential Care Populations With Pre-existing Frailty and Limited Independence."|Not yet recruiting||N/A|48|Anticipated|University of Birmingham||2|||f||||f|f|f||||||Yes||2017-10-10 21:06:00.915795|2017-10-10 21:06:00.915795
NCT03141866|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SPAA||Seated Physical Activity in Ageing|"Determining the Feasibility of Chair-based Physical Activity Interventions, Aimed at Improving Various Aspects of Health and Wellbeing in Geriatric Populations With Pre-existing Frailty, Within a Hospital Ward Setting"|Not yet recruiting||N/A|60|Anticipated|University of Birmingham||2|||f||||f|f|f||||||Yes||2017-10-10 21:06:01.044563|2017-10-10 21:06:01.044563
NCT03141827|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-04|||April 14, 2016|Actual|2016-04-14|May 2017|2017-05-01|April 26, 2017|Actual|2017-04-26|February 15, 2017|Actual|2017-02-15||Interventional|LPNI||The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production|The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production|Completed||Phase 2/Phase 3|9|Actual|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 21:06:01.5125|2017-10-10 21:06:01.5125
NCT03141814|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-07-12|||October 2015||2015-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|ARMS||Asthma Origins and Remission Study|A Better Understanding of Molecular Mechanisms Leading to Asthma and Its Remission|Recruiting||N/A|80|Anticipated|University Medical Center Groningen|||4||f||||f||||||Samples With DNA|"     blood sputum bronchial biopsies bronchial brushes nasal brushes particles in exhaled air   "|||2017-10-10 21:06:01.635022|2017-10-10 21:06:01.635022
NCT03141801|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-02|||August 1, 2016|Actual|2016-08-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Blood Flow Restriction to Improve Muscle Strength After ACL Injury|Blood Flow Restriction Training to Improve Muscle Strength and Function Following Anterior Cruciate Ligament Injury|Recruiting||N/A|60|Anticipated|University of Michigan||4|||f||||f|f|f||||||No||2017-10-10 21:06:01.759214|2017-10-10 21:06:01.759214
NCT03141788|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-03|||January 30, 2017|Actual|2017-01-30|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Evaluation of Clear Aligner Trays to Straighten Teeth|Evaluation of 3M Clear Aligner for Correction of Class I, II and III Malocclusion Study|Recruiting||N/A|180|Anticipated|3M||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:06:01.930063|2017-10-10 21:06:01.930063
NCT03141775|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|IBIS||Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)|Incidence and Economic Burden of Community and Hospital- Acquired Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)|Not yet recruiting||N/A|541|Anticipated|University of Cologne|||1||f||||t|f|f|||f|||No||2017-10-10 21:06:02.15445|2017-10-10 21:06:02.15445
NCT03141762|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-02|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01|12 Months|Observational [Patient Registry]|||Understanding the Impact of Critical Illness on Falls Risk - a 12 Month Observational Study|Understanding the Impact of Critical Illness on Falls Risk - a 12 Month Observational Study|Recruiting||N/A|200|Anticipated|University of Melbourne|||1||f||||t|f|f||||||Undecided|Currently undecided if plan to make IPD available will update the Clinical Trials Registry.|2017-10-10 21:06:02.247423|2017-10-10 21:06:02.247423
NCT03141749|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||January 2000|Actual|2000-01-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|November 2014|Actual|2014-11-01||Observational|DM1-VTE||Venous Thromboembolism in DM1|Incidence and Predictors of Venous Thromboembolism in Myotonic Dystrophy|Completed||N/A|2810|Actual|Institut de Myologie, France|||1||f||||t|f|f||||||Undecided||2017-10-10 21:06:02.37904|2017-10-10 21:06:02.37904
NCT03141736|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-16|||May 19, 2019|Anticipated|2019-05-19|August 2017|2017-08-01|August 12, 2019|Anticipated|2019-08-12|August 12, 2019|Anticipated|2019-08-12||Interventional|||Kangaroo Mother Care With Plastic Bag (Trials 1A & 1B)|Randomized Trials of Kangaroo Mother Care With Plastic Bag to Prevent Neonatal Hypothermia in Preterm Infants (Trial 1A and 1B)|Not yet recruiting||N/A|420|Anticipated|University of Alabama at Birmingham||4|||f||||t|f|f||||||||2017-10-10 21:06:02.460278|2017-10-10 21:06:02.460278
NCT03141723|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-16|||May 19, 2017|Actual|2017-05-19|August 2017|2017-08-01|August 12, 2017|Actual|2017-08-12|August 12, 2017|Actual|2017-08-12||Interventional|||Kangaroo Mother Care With Plastic Bag (Trials 2A & 2B)|Randomized Trials of Kangaroo Mother Care With Plastic Bag to Prevent Neonatal Hypothermia in Preterm Infants (Trial 2A and 2B)|Completed||N/A|420|Anticipated|University of Alabama at Birmingham||4|||f||||t|f|f||||||||2017-10-10 21:06:02.574472|2017-10-10 21:06:02.574472
NCT03141710|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-22|||May 10, 2017|Actual|2017-05-10|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|June 30, 2017|Anticipated|2017-06-30||Interventional|||Commercial Prebiotic Supplement Study|Effect of Prebiotic in Type 2 Diabetes (Diabetes and Health Study)|Recruiting||N/A|12|Anticipated|University of Aberdeen||1|||f||||f|f|f||||||No||2017-10-10 21:06:02.68486|2017-10-10 21:06:02.68486
NCT03141697|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-04|||April 1, 2012|Actual|2012-04-01|May 2017|2017-05-01|August 31, 2014|Actual|2014-08-31|August 31, 2014|Actual|2014-08-31||Interventional|||The Use of CO2 in Routine-Colonoscopy|Is CO2 Insufflation an Amelioration of Routine Colonoscopy?|Completed||N/A|150|Actual|University of Leipzig||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:06:02.783125|2017-10-10 21:06:02.783125
NCT03141684|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-27|||March 3, 2017|Actual|2017-03-03|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery|A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma|Recruiting||Phase 2|26|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:06:02.878298|2017-10-10 21:06:02.878298
NCT03141671|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-06-01|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)|Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone Acetate and Apalutamide (ARN-509) for Rising PSA After Radical Prostatectomy With Adverse Features.(FORMULA-509 Trial)|Not yet recruiting||Phase 2|190|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||No||2017-10-10 21:06:03.092966|2017-10-10 21:06:03.092966
NCT03141645|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-14|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of IV Fluid Loading and Ondansetron in Reduction of PONV After LC|Comparison of Preoperative Intravenous Fluid Loading and Ondansetron in Reduction of Incidence Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Study|Recruiting||N/A|153|Anticipated|Siriraj Hospital||3|||f||||t|f|f|||f|||||2017-10-10 21:06:03.288826|2017-10-10 21:06:03.288826
NCT03141632|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-22|||October 17, 2016|Actual|2016-10-17|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|June 2017|Actual|2017-06-01||Interventional|GATE||Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake|"Effects of GLP-1 Analogues on Fluid Intake in Healthy Volunteers - The GATE-Study"|Active, not recruiting||Phase 2|17|Actual|University Hospital, Basel, Switzerland||2|||f||||f|f|f|||f|||No||2017-10-10 21:06:03.410354|2017-10-10 21:06:03.410354
NCT03141619|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-02|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Observational|CONFOCAL-2||Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2|Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2|Not yet recruiting||N/A|200|Anticipated|Queen's University|||1||f||||t|f|f|||f|Samples Without DNA|"     Samples will be collected for proteomic assessments.   "|Undecided||2017-10-10 21:06:03.506192|2017-10-10 21:06:03.506192
NCT03141606|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|24 Months|Observational [Patient Registry]|iLAV||Left Atrial Volume as Predictor for Arrhythmic Events and CRT Response|Left Atrial Volume as Predictor for Arrhythmic Events and CRT Response|Recruiting||N/A|230|Anticipated|Ospedale Borgo Trento - Verona|||1||f|||||f|f||||||||2017-10-10 21:06:03.589846|2017-10-10 21:06:03.589846
NCT03141593|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-01|||September 21, 2017|Anticipated|2017-09-21|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||Oral Vitamin D Substitution Weekly or Monthly and Adherence|Oral Vitamin D Substitution Weekly or Monthly - Which Procedure Leads to Highest Adherence? A Prospective Intervention Study in Outpatient Care|Not yet recruiting||Phase 4|120|Anticipated|University Hospital, Basel, Switzerland||4|||f||||f|f|f||||||||2017-10-10 21:06:03.661948|2017-10-10 21:06:03.661948
NCT03141580|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-02|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Long-term Follow-up NIRS-IVUS Imaging of Pre-existing Carotid Stents|Long-term Follow-up Near-infrared Spectroscopy and Intravascular Ultrasound Imaging of Internal Carotid Artery Stenosis Treated With Stenting|Not yet recruiting||N/A|50|Anticipated|University Hospital, Motol||1|||f||||f|f|f||||||No||2017-10-10 21:06:03.744646|2017-10-10 21:06:03.744646
NCT03141567|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-10-04|||May 18, 2017|Actual|2017-05-18|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|LYFT-HF||LYmphangiogenesis FacTors in Heart Failure States|LYmphangiogenesis FacTors in Heart Failure States (LYFT-HF Study)|Recruiting||N/A|100|Anticipated|Medical University of South Carolina|||2||f||||f|f|f||||Samples With DNA|"     plasma or serum   "|||2017-10-10 21:06:03.840006|2017-10-10 21:06:03.840006
NCT03141554|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-05|||May 5, 2017|Actual|2017-05-05|June 2017|2017-06-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||The Effect of Oral Antiseptic Gargles on the Oral Cavity Microbiome|The Effect of Oral Antiseptic Gargles on the Oral Cavity Microbiome|Completed||Phase 4|12|Actual|Mundipharma Manufacturing Pte Ltd.||3|||f||||f|f|f||||||No||2017-10-10 21:06:03.916815|2017-10-10 21:06:03.916815
NCT03141541|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-15|||April 1, 2017|Actual|2017-04-01|March 2017|2017-03-01|September 1, 2019|Anticipated|2019-09-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Pain Management for Patients With Low Back Pain and Psychosocial Risk Factors in a Hospital Setting.|Does a Patient Education Focused on Pain Management Improve Disability, Pain Coping and Quality of Life in Patients With Low Back Pain and Psychosocial Risk Factors?|Recruiting||N/A|130|Anticipated|Central Jutland Regional Hospital||2|||f||||f|f|f||||||||2017-10-10 21:06:03.999884|2017-10-10 21:06:03.999884
NCT03141528|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-02|||February 9, 2017|Actual|2017-02-09|May 2017|2017-05-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Self-learning vs Instructor-led Learning in BLS|Self-learning Versus Instructor-led Learning in Basic Life Support Training - A Randomized Controlled Trial|Recruiting||N/A|230|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f||||||No||2017-10-10 21:06:04.087791|2017-10-10 21:06:04.087791
NCT03141515|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-15|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Sonographic Assessment of Postural Lung Recruitment in Pediatric Patients Under General Anesthesia|Sonographic Assessment of Postural Lung Recruitment in Pediatric Patients Under General Anesthesia|Not yet recruiting||N/A|40|Anticipated|Hospital Privado de Comunidad de Mar del Plata||2|||f||||t|f|f|||f|||No||2017-10-10 21:06:05.849758|2017-10-10 21:06:05.849758
NCT03141502|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-04|||May 11, 2017|Anticipated|2017-05-11|April 2017|2017-04-01|October 31, 2018|Anticipated|2018-10-31|August 31, 2018|Anticipated|2018-08-31||Interventional|SSDRCT||The New Skin Stretching Device for Treatment of Limb Tension Wounds|The New Skin Stretching Device for Treatment of Limb Tension Wounds: A Multicenter Randomized Controlled Clinical Study|Not yet recruiting||Phase 4|100|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||f|f|f||||||No||2017-10-10 21:06:05.953226|2017-10-10 21:06:05.953226
NCT03141489|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-03|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RFS||Refeeding Syndrome Among Older Adults|Safe Refeeding of Severely Malnourished Patients 65 Years or Older|Recruiting||N/A|126|Anticipated|Diakonhjemmet Hospital||2|||f||||t|f|f||||||||2017-10-10 21:06:06.060824|2017-10-10 21:06:06.060824
NCT03141476|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-11|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Adequacy of Perioperative Cefuroxime Dosage According to the BMI|Perioperative Cefuroxime in Obese Patients: Dosage According to the BMI|Recruiting||Phase 4|60|Anticipated|Universitätsklinikum Hamburg-Eppendorf||3|||f||||f|f|f|||f|||No||2017-10-10 21:06:06.158404|2017-10-10 21:06:06.158404
NCT03141463|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-05-02|||January 13, 2017|Actual|2017-01-13|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions|Immune Modulating Effects and Safety of Vvax001, a Therapeutic Semliki Forest Virus Based Cancer Vaccine, in Patients With a History of (Pre) Malignant Cervical Lesions.|Recruiting||Phase 1|12|Anticipated|University Medical Center Groningen||1|||f|||||f|f||||||||2017-10-10 21:06:06.259349|2017-10-10 21:06:06.259349
NCT03141450|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Plasma Concentrations of Prophylactic Cefazolin in Pediatric Patients Undergoing Cardiac Surgery With CPB|Plasma Concentrations of Prophylactic Cefazolin in Pediatric Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Recruiting||N/A|18|Anticipated|Mahidol University|||1||f|||||f|f||||||||2017-10-10 21:06:06.361445|2017-10-10 21:06:06.361445
NCT03141437|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-14|||April 23, 2017|Actual|2017-04-23|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Patient-Centered Decision Counseling for Women at Risk of Cancer-Related Infertility|Patient-Centered Decision Counseling for Women at Risk of Cancer-Related Infertility: Efficacy Study and Comparative-Effectiveness Randomized Trial|Recruiting||N/A|160|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|f|f||||||||2017-10-10 21:06:06.43115|2017-10-10 21:06:06.43115
NCT03141424|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-05|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma|Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma|Not yet recruiting||N/A|110|Anticipated|Hvidovre University Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 21:06:06.550968|2017-10-10 21:06:06.550968
NCT03141411|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-25|||May 10, 2017|Actual|2017-05-10|April 2017|2017-04-01|August 24, 2017|Actual|2017-08-24|August 24, 2017|Actual|2017-08-24||Observational|||Assisted Fluid Management vs Manual GDFT|Assisted Versus Manual Goal Directed Fluid Therapy in Major Abdominal Surgery|Completed||N/A|46|Actual|Erasme University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:06:06.627508|2017-10-10 21:06:06.627508
NCT03141398|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-07-24|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|CGMs||Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group|Continuous Glucose Monitoring (CGM) Versus Oral Glucose Tolerance Test (OGTT) Versus T2* MRI Of The Pancreas In High-Risk Group (Hemoglobinopathies, Lymphoma & Acute Lymphoblastic Leukemia): A Comparative Study|Withdrawn||N/A|0|Actual|Hamad Medical Corporation|||1|Due to issues with study design|f||||t|f|f|||t|||||2017-10-10 21:06:06.695825|2017-10-10 21:06:06.695825
NCT03141385|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||April 7, 2017|Actual|2017-04-07|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|April 1, 2018|Anticipated|2018-04-01||Interventional|RenRIPC-TAR||Renal Effects of RIPC in Patients After Total Arch Replacement|Renal Effects of Remote Ischemic Preconditioning in Patients After Total Arch Replacement|Recruiting||N/A|130|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:06:06.911945|2017-10-10 21:06:06.911945
NCT03141372|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-06-01|||May 16, 2017|Actual|2017-05-16|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Urinary Retention Rates After Immediate Removal of Foley Catheter Versus Backfill Void Trial Following Total Laparoscopic Hysterectomy|Urinary Retention Rates After Immediate Removal of Foley Catheter Versus Backfill Void Trial Following Total Laparoscopic Hysterectomy: A Randomized Controlled Trial|Recruiting||N/A|210|Anticipated|The Cleveland Clinic||2|||f||||f|f|t|f|f||||No||2017-10-10 21:06:07.038986|2017-10-10 21:06:07.038986
NCT03141359|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-10-03|||May 15, 2017|Actual|2017-05-15|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC|LCI-LUN-NSC-SBRT-001: Phase II Prospective Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer|Recruiting||Phase 2|56|Anticipated|Carolinas Healthcare System||1|||f||||t|f|t|f|f||||||2017-10-10 21:06:07.166086|2017-10-10 21:06:07.166086
NCT03141346|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-04|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|MAMITA||Improving the Eating Habits of Mother and Her Infant Via Sugar Reduction|Home Intervention for Reducing Sugary Drinks and Obesity in Hispanic Women-infants|Not yet recruiting||N/A|240|Anticipated|University of Southern California||3|||f||||t|f|f||||||||2017-10-10 21:06:07.288253|2017-10-10 21:06:07.288253
NCT03141333|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-04|||February 6, 2017|Actual|2017-02-06|January 2017|2017-01-01|June 30, 2017|Anticipated|2017-06-30|May 12, 2017|Anticipated|2017-05-12||Interventional|DCD||A Teleintervention in Developmental Coordination Disorder|A Randomized Feasibility Trial Evaluating a Teleintervention for Families of Children With Developmental Coordination Disorder (DCD)|Active, not recruiting||N/A|31|Anticipated|Université de Sherbrooke||2|||f|||||f|f||||||No||2017-10-10 21:06:07.378688|2017-10-10 21:06:07.378688
NCT03141320|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-02|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Confident Birthing: What Influences Women's Confidence for Birth?|Confident Birthing: A Qualitative Study Exploring the Influences on Women's Confidence for Birth During Pregnancy and Labour|Active, not recruiting||N/A|24|Actual|University of Southampton|||1||f|||||f|f||||||No||2017-10-10 21:06:07.46599|2017-10-10 21:06:07.46599
NCT03141307|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||February 2018|Anticipated|2018-02-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|October 2018|Anticipated|2018-10-01||Interventional|EICI||The Effect of Electronic Informed Consent Information (EICI) on Residual Newborn Specimen Research|The Effect of Electronic Informed Consent Information (EICI) on Residual Newborn Specimen Research|Not yet recruiting||N/A|650|Anticipated|University of Utah||2|||f||||f|f|f||||||No|Individual data regarding knowledge about retention of newborn screening dried bloodspots is not useful data|2017-10-10 21:06:07.540529|2017-10-10 21:06:07.540529
NCT03141294|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-04|||July 1, 2012|Actual|2012-07-01|May 2017|2017-05-01|February 15, 2017|Actual|2017-02-15|December 30, 2016|Actual|2016-12-30||Interventional|||Reformative Versus Single Step Dilation Percutaneous Dilatational Tracheostomy|Reformative Versus Single Step Dilation Percutaneous Dilatational Tracheostomy: a Randomized Trial|Completed||N/A|46|Actual|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t|f|f||||||Yes||2017-10-10 21:06:07.672888|2017-10-10 21:06:07.672888
NCT03141281|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-03|||July 26, 2017|Anticipated|2017-07-26|July 2017|2017-07-01|April 1, 2020|Anticipated|2020-04-01|December 15, 2019|Anticipated|2019-12-15||Interventional|ICE-ACT||Intervention Comparative Effectiveness for Adult Cognitive Training|Intervention Comparative Effectiveness for Adult Cognitive Training|Recruiting||N/A|200|Anticipated|Florida State University||4|||f||||t|f|f||||||||2017-10-10 21:06:07.769123|2017-10-10 21:06:07.769123
NCT03141268|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-02|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Observational|RapidoIBS||Rapid Orocecal Transit Time and Fermentation in IBS.|Orocecal Transit Time and Fermentation in IBS|Recruiting||N/A|1000|Anticipated|Uppsala University|||3||f||||f|f|f||||||Yes|Data are freely available to anyone. Data coded.|2017-10-10 21:06:07.899712|2017-10-10 21:06:07.899712
NCT03141242|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-24|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|ENACT||ENgaging in Advance Care Planning Talks Group Visit Intervention|Refining an Advance Care Planning Group Visit Intervention - A Novel Intervention to Engage Older Adults in Advance Care Planning.|Recruiting||N/A|120|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 21:06:08.09596|2017-10-10 21:06:08.09596
NCT03141229|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-24|||December 2016||2016-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|GIK||Health, Integration, Concentration: Mindfulness in Schools|Gesundheit, Integration, Konzentration: Achtsamkeitsbasierte Stabilisierung Von LehrerInnen Und SchülerInnen|Recruiting||N/A|100|Anticipated|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-10 21:06:08.194523|2017-10-10 21:06:08.194523
NCT03141216|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-02|||March 9, 2017|Actual|2017-03-09|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Mechanical Ventilation on Pulmonary Electrical Impedance, Diaphragmatic Mobility and Patient-ventilator Synchrony|Effects of Mechanical Ventilation on Controlled Volume, Controlled Pressure and Pressure Support in the Immediate Postoperative Period of Cardiac Surgery on Pulmonary Electrical Impedance, Diaphragmatic Mobility and Synchrony at Weaning: a Parallel Clinical Trial|Recruiting||N/A|50|Anticipated|Universidade Federal de Pernambuco||2|||f||||t|f|f||||||Yes|to be shared are: data provided by electrical impedance tomograph, by ultrasound and general clinical one (such as blood pressure, oxygen supplementary concentration, heart rate, respiratory rate, mechanical ventilation duration, surgery duration). These data will be available for sharing after the end of the study and it will be obtained by a copy in a USB flash drive.|2017-10-10 21:06:08.292069|2017-10-10 21:06:08.292069
NCT03141203|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-02|||July 13, 2015|Actual|2015-07-13|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|RomiCar||Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients|Phase I/II Study to Determine the Maximum Tolerated Dose and Activity of the Combination of Romidepsin and Carfilzomib in Relapsed or Refractory Peripheral T-cell Lymphoma|Recruiting||Phase 1/Phase 2|58|Anticipated|University of Birmingham||6|||f||||t|t|f|||t|||No||2017-10-10 21:06:08.384638|2017-10-10 21:06:08.384638
NCT03141190|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-02|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Mindful Mental Training for Surgeons to Enhance Resilience and Performance Under Stress|Mindfulness Training to Improve Mental Health, Stress and Performance In Physicians|Enrolling by invitation||N/A|80|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||No||2017-10-10 21:06:08.519756|2017-10-10 21:06:08.519756
NCT03141177|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-08-01|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|August 3, 2022|Anticipated|2022-08-03|February 15, 2021|Anticipated|2021-02-15||Interventional|CheckMate 9ER||A Study of Nivolumab Combined With Cabozantinib or Nivolumab and Ipilimumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma|A Phase 3, Randomized, Open-Label Study of Nivolumab Combined With Cabozantinib or Nivolumab and Ipilimumab Combined With Cabozantinib Versus Sunitinib in Participants With Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma|Recruiting||Phase 3|1014|Anticipated|Bristol-Myers Squibb||3|||f||||t|t|f||||||||2017-10-10 21:06:08.615669|2017-10-10 21:06:08.615669
NCT03141164|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-15|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|May 30, 2020|Anticipated|2020-05-30|May 30, 2019|Anticipated|2019-05-30||Interventional|PVTS||Peripheral Vision Training Study|Peripheral Vision Training Study|Recruiting||N/A|30|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f||||||No||2017-10-10 21:06:09.116071|2017-10-10 21:06:09.116071
NCT03141151|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-25|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|COACH||Competency-based Approaches to Community Health|Competency-based Approaches to Community Health|Recruiting||N/A|240|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:06:09.201068|2017-10-10 21:06:09.201068
NCT03141125|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-27|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy|The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard Therapy to Reduce Skin Fibrosis Based on Modified Rodnan Skin Score, Reduce Inflammation, Immunological Response and Fibrosis|Completed||N/A|62|Actual|Indonesia University||2|||f||||f||||||||||2017-10-10 21:06:09.39536|2017-10-10 21:06:09.39536
NCT03141112|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-03|||August 2016||2016-08-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis|The Benefits of Early Initiation of Continuous Renal Replacement Therapy (CRRT) in Patients With Severe Sepsis|Enrolling by invitation||N/A|200|Anticipated|University Hospital Olomouc|||2||f||||f||||||||Undecided||2017-10-10 21:06:09.494947|2017-10-10 21:06:09.494947
NCT03141099|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-09-26|||March 10, 2017|Actual|2017-03-10|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|BOX||Blood Pressure and OXygenation Targets After OHCA|Blood Pressure and Oxygenation Targets in Post-resuscitation Care, a Randomized Clinical Trial|Recruiting||N/A|800|Anticipated|Rigshospitalet, Denmark||4|||f||||t|f|f||||||||2017-10-10 21:06:09.571157|2017-10-10 21:06:09.571157
NCT03140956|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-25|||April 19, 2017|Actual|2017-04-19|September 2017|2017-09-01|August 3, 2017|Actual|2017-08-03|July 3, 2017|Actual|2017-07-03||Interventional|||Pharmacokinetic of Levodopa Study in Healthy Males|Pharmacokinetics of Levodopa After Repeated Doses of Different Pellet Formulations; An Open, Randomized Study With Crossover Design in Healthy Male Subjects|Completed||Phase 1|20|Actual|Orion Corporation, Orion Pharma||8|||f||||f|f|f||||||||2017-10-10 21:06:10.739653|2017-10-10 21:06:10.739653
NCT03141086|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-10-02|||July 26, 2017|Actual|2017-07-26|October 2017|2017-10-01|May 12, 2018|Anticipated|2018-05-12|May 11, 2018|Anticipated|2018-05-11||Interventional|||A Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and Pharmacokinetics (PK) of LML134 in Shift Work Disorder|A Randomized, Subject and Investigator-blinded, Placebo Controlled, Cross-over, Multi-center Proof of Concept (PoC) Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and PK of LML134 in Shift Work Disorder (SWD) Patients|Recruiting||Phase 2|46|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:06:09.698142|2017-10-10 21:06:09.698142
NCT03141073|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Long-term Efficacy and Safety of HMS5552 as add-on to Metformin in T2DM|A 24-week Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of HMS5552 as add-on to Metformin With Additional 28-week Open-label Treatment in T2DM|Not yet recruiting||Phase 3|750|Anticipated|Hua Medicine Limited||2|||f||||f|f|f||||||No||2017-10-10 21:06:09.803969|2017-10-10 21:06:09.803969
NCT03141060|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 2020|Anticipated|2020-11-01|July 2019|Anticipated|2019-07-01||Interventional|||Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB|A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB|Not yet recruiting||Phase 1/Phase 2|48|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t|t|f|||f|||||2017-10-10 21:06:09.897296|2017-10-10 21:06:09.897296
NCT03141047|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-05-05|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Lifespan Integration After Sexual Trauma|Lifespan Integration After Sexual Trauma, a Randomized Treatment Study|Recruiting||N/A|100|Anticipated|Insamlingsstiftelsen Wonsa, World of No Sexual Abuse||2|||f||||t||||||||||2017-10-10 21:06:09.994467|2017-10-10 21:06:09.994467
NCT03141021|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-03|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|April 28, 2027|Anticipated|2027-04-28|April 28, 2027|Anticipated|2027-04-28|10 Years|Observational [Patient Registry]|||Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors|Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors|Recruiting||N/A|1000|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||Samples With DNA|"     Biospecimens collected under associated banks (frozen or paraffin-embedded, germline (or     normal tissue DNA) samples, and any previously somatic whole-exome or whole-genome sequencing     data for aggregate analyses) and prospectively collect MPNST samples for analysis.   "|No||2017-10-10 21:06:10.244196|2017-10-10 21:06:10.244196
NCT03141008|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-15|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|December 31, 2018|Anticipated|2018-12-31||Observational|||Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet|Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet|Recruiting||N/A|100|Anticipated|Virginia Commonwealth University|||2||f||||t|f|f||||Samples Without DNA|"     routine care labs will be done on patients including Comprehensive metabolic panel, A1c,     lipids and insulin levels. Additional specimens will be taken for serum, urine, stool and     saliva. These will be collected at time points 0, (additional timepoint of 1 month for     saliva, stool and urine), 3 months, 6 months and 12 months.   "|||2017-10-10 21:06:10.359593|2017-10-10 21:06:10.359593
NCT03140995|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-03|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sleep and Exercise in Rheumatoid Arthritis|Does Exercise Have an Effect on Sleep and Mood in People Who Have Rheumatoid Arthritis: a Pilot Randomised Controlled Trial|Not yet recruiting||N/A|40|Anticipated|University Hospital of Limerick||2|||f||||f|f|f||||||Yes|The investigating team only will have access to the patient's names and/or identifying factors for participants at the site and University of Limerick (UL) researchers will have access to the full data set from the single site. Participants will be allocated a study code. Thereafter It is anticipated that the results will be used in presentations to conferences such as European League against Rheumatism (EULAR) and American College of Rheumatology (ACR). Additionally papers will be prepared for submission to peer reviewed journals, through Arthritis Ireland and the UL Research office. Results will also be made available at aggregate level to Consultant Rheumatologists Dr. Alexander Fraser and Dr. Joe Devlin, Department of Rheumatology, University Hospitals Limerick. Results will be shared via supplementary material thereafter.|2017-10-10 21:06:10.448904|2017-10-10 21:06:10.448904
NCT03140982|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-26|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|Top&Bottom||Is Anesthetic Loss of Consciousness a Top Down or Bottom up Phenomenon. What Does the Neurologic Examination Say?.|Is Anesthetic Loss of Consciousness a Cortical or Brainstem Phenomenon? What Does the Neurological Examination Say?|Completed||N/A|16|Actual|Universidad del Desarrollo||2|||f||||f|f|f||||||No||2017-10-10 21:06:10.533083|2017-10-10 21:06:10.533083
NCT03140969|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Evaluate QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene|An Open-label, Single Arm, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene|Recruiting||Phase 1/Phase 2|12|Anticipated|ProQR Therapeutics||1|||f||||t|t|f||||||||2017-10-10 21:06:10.636491|2017-10-10 21:06:10.636491
NCT03113864|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-10|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Effects of Lutein on Visual Function|Beneficial Effects of Lutein on Visual Function in Healthy Subjects|Not yet recruiting||N/A|96|Anticipated|Kemin Foods LC||2|||f||||f|f|f||||||No||2017-10-10 21:10:26.214679|2017-10-10 21:10:26.214679
NCT03140943|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-03|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma|Single Arm, Multicentre Study of Carfilzomib in Combination With Thalidomide and Dexamethasone (CaTD) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)|Not yet recruiting||Phase 2|100|Anticipated|National University Hospital, Singapore||1|||f|||||f|f||||||||2017-10-10 21:06:10.827089|2017-10-10 21:06:10.827089
NCT03140930|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-28|||May 12, 2017|Actual|2017-05-12|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effect of Duodenal, Ileal or Combined Infusion of Tastants on Food Intake|The Effect of Duodenal, Ileal or Combined Infusion of Tastants on Food Intake|Recruiting||N/A|15|Anticipated|Maastricht University Medical Center||4|||f||||t|f|f||||||||2017-10-10 21:06:10.914431|2017-10-10 21:06:10.914431
NCT03140917|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-04|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Multimodal Assessment of Liver Volume and Function|Multimodal Assessment of Liver Volume and Function in Patients With Colorectal Liver Metastases|Recruiting||N/A|20|Anticipated|Karolinska University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:06:11.009715|2017-10-10 21:06:11.009715
NCT03140904|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-01|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Reducing the Frequency of Follow up and Task Sharing in the Treatment of Uncomplicated Severe Acute Malnutrition|Reducing the Frequency of Follow up and Task Sharing in the Treatment of Uncomplicated Severe Acute Malnutrition: an Evaluation of Monthly Visits and Home-based Surveillance for Access-limited and High-burden Settings|Not yet recruiting||N/A|3500|Anticipated|Epicentre||2|||f||||t|f|f||||||||2017-10-10 21:06:11.188058|2017-10-10 21:06:11.188058
NCT03140891|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-03|||April 15, 2017|Actual|2017-04-15|April 2017|2017-04-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15||Interventional|HFO||Nasal HFO(High Frequency Oscillation) for Respiratory Distress Syndrome|Nasal HFO(High Frequency Oscillation) for Respiratory Distress Syndrome in Preterm Infants: A Randomized Controlled Trial|Recruiting||N/A|250|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t|f|f||||||Yes||2017-10-10 21:06:11.305374|2017-10-10 21:06:11.305374
NCT03140878|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-03|||April 16, 2017|Actual|2017-04-16|May 2017|2017-05-01|June 11, 2017|Anticipated|2017-06-11|June 11, 2017|Anticipated|2017-06-11||Interventional|||Defining the Normal Human Response to Probiotics|Defining the Normal Human Response to Probiotics and Developing an in Vitro System to Identify New Microbes With Probiotic Functions|Recruiting||N/A|24|Anticipated|Chr Hansen||2|||f||||f|f|f||||||No||2017-10-10 21:06:11.404235|2017-10-10 21:06:11.404235
NCT03140865|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-05-03|||January 2014||2014-01-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|January 2021|Anticipated|2021-01-01|5 Years|Observational [Patient Registry]|ADCC||Wake Forest Alzheimer's Disease Clinical Core|Wake Forest Alzheimer's Disease Clinical Core|Recruiting||N/A|500|Anticipated|Wake Forest University Health Sciences|||5||f||||f|f|f||||Samples With DNA|"     Blood collection for routine laboratory tests (hemoglobin A1c, CBC, BMP 8, lipid panel, TSH,     Vitamin B12, insulin, and coagulation). Blood will also be drawn for genotyping and     determining ApoE status as well as stored for future assays.      CSF will be collected on a subset of participants and used to analyze amyloid beta, t-tau,     p-tau, and stored for future assays.   "|Yes|The ADCC is an observational study that will collect and store data at study entry and longitudinally for use in future studies. As part of the ADCC, the investigator will ask permission to store biological samples (blood, cerebrospinal fluid), as well as cognitive and medical data (neuroimaging, cognitive status, metabolic function markers, and family history information) indefinitely for future analyses. The Wake ADCC is part of a National collection of ADCCs funded by the NIA and as such, all centers contribute data to a central repository (National Alzheimer's Coordinating Center (NACC) at University of Washington). Participants will consent to have their de-identified data sent to the NACC.|2017-10-10 21:06:11.495306|2017-10-10 21:06:11.495306
NCT03140852|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-02|||April 25, 2017|Actual|2017-04-25|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SHAIP||Community-Based Continence Promotion: Sustaining Healthy Aging in Place (SHAIP) Through Mind Over Matter (MOM)|Community-Based Continence Promotion: Sustaining Healthy Aging in Place (SHAIP) Through Mind Over Matter (MOM)|Recruiting||N/A|150|Anticipated|University of Wisconsin, Madison||2|||f||||f|f|f||||||No||2017-10-10 21:06:11.58131|2017-10-10 21:06:11.58131
NCT03140839|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-10|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Treating Negative Mental Images and Memories in Social Anxiety|Understanding the Psychological Effects and Mechanisms of Imagery Rescripting for Social Anxiety Disorder: A Controlled Experimental Study|Recruiting||N/A|120|Anticipated|University of Waterloo||3|||f||||f|f|f||||||||2017-10-10 21:06:11.659239|2017-10-10 21:06:11.659239
NCT03140826|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|ASARI II||Amplification and Selection of Antimicrobial Resistance in the Intestine II|Amplification and Selection of Antimicrobial Resistance in the Intestine II|Not yet recruiting||N/A|100|Anticipated|University Hospital Tuebingen|||2||f||||f|t|f|||f|Samples With DNA|"     Stool Samples   "|No||2017-10-10 21:06:11.765979|2017-10-10 21:06:11.765979
NCT03140813|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-18|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||An Initial Study of AZD7325 in Adults With Fragile X Syndrome|An Initial Double-Blind, Placebo-Controlled Two-Dose Crossover Study of AZD7325 in Adults With Fragile X Syndrome|Not yet recruiting||Phase 1|15|Anticipated|Children's Hospital Medical Center, Cincinnati||6|||f|||||t|f||||||||2017-10-10 21:06:11.868456|2017-10-10 21:06:11.868456
NCT03140800|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Observational|||Use Sonography in Patients With Intrauterine Device Presenting With Bleeding|Intrauterine Contraceptive Device:Clinical and Sonographic Correlation in Patients Presenting With Bleeding|Not yet recruiting||N/A|60|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:06:11.968012|2017-10-10 21:06:11.968012
NCT03140787|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-26|||May 15, 2016|Actual|2016-05-15|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|May 15, 2017|Actual|2017-05-15||Interventional|||Efficacy and Safety of Primary Teeth Anesthesia Using Nasal Spray in Children|Assessment of Efficacy and Safety of Primary Maxillary Second Molars Anesthesia Using Nasal Spray in Children|Completed||N/A|68|Actual|Damascus University||2|||f||||t|f|f||||||||2017-10-10 21:06:12.024012|2017-10-10 21:06:12.024012
NCT03140774|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-17|||May 17, 2017|Actual|2017-05-17|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|PRISM||Persistence of the Immune Response After Ebola Vaccine Immunisation|Evaluating the Long Term Immunogenicity of Ebola Virus Vaccines Ad26-ZEBOV and MVA-BN-Filo|Active, not recruiting||N/A|56|Anticipated|University of Oxford|||1||f||||f|f|f||||Samples With DNA|"     We will seek consent for storage of excess blood samples in the Biobank. Participants will be     separately consented for this.   "|||2017-10-10 21:06:12.12636|2017-10-10 21:06:12.12636
NCT03140761|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-18|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Month|Observational [Patient Registry]|||The Occurence of Secondary Adrenal Insufficiency in Hospitalised Patients With Exacerbation of COPD in Glucocorticoid Treatment Related to Differenct Gene Polymorphisms of the Glucocorticoid Receptor Gene|The Occurence of Secondary Adrenal Insufficiency in Hospitalised Patients With Exacerbation of COPD in Glucocorticoid Treatment Related to Differenct Gene Polymorphisms of the Glucocorticoid Receptor Gene|Not yet recruiting||N/A|77|Anticipated|Chronic Obstructive Pulmonary Disease Trial Network, Denmark|||1||f|||||f|f||||Samples With DNA|"     Blood samples and DNA from gene analyses   "|||2017-10-10 21:06:12.206495|2017-10-10 21:06:12.206495
NCT03140748|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-02|||March 6, 2017|Actual|2017-03-06|May 2017|2017-05-01|April 6, 2019|Anticipated|2019-04-06|April 6, 2019|Anticipated|2019-04-06||Interventional|PERIGLUC1||Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation|Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:06:12.281233|2017-10-10 21:06:12.281233
NCT03140735|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-19|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|June 20, 2027|Anticipated|2027-06-20|June 20, 2027|Anticipated|2027-06-20||Interventional|VOPRABIO||Interest of Pulse Wave Velocity Measurement as a Predictor of Severity of Aortic Stenosis|Interest of Pulse Wave Velocity Measurement as a Predictor of Severity of Aortic Stenosis|Recruiting||N/A|900|Anticipated|Centre Hospitalier Universitaire, Amiens||4|||f|||||f|f||||||||2017-10-10 21:06:12.370879|2017-10-10 21:06:12.370879
NCT03140722|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-09-14|||May 23, 2017|Actual|2017-05-23|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents|Phase 2, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents (FO2RWARD)|Recruiting||Phase 2|50|Anticipated|Akebia Therapeutics||2|||f|||||t|f||||||||2017-10-10 21:06:12.461129|2017-10-10 21:06:12.461129
NCT03140709|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-05-02|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids|Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids|Completed||N/A|28|Actual|Stanford University|||2||f||||f||||||Samples With DNA|"     Saliva and blood samples will be obtained from study participants to monitor oxytocin levels.     Observational study. Standard of care management. Oxytocin assays during normal clinical     care.   "|No||2017-10-10 21:06:12.592017|2017-10-10 21:06:12.592017
NCT03140696|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-02|||March 10, 2017|Actual|2017-03-10|May 2017|2017-05-01|October 24, 2017|Anticipated|2017-10-24|October 24, 2017|Anticipated|2017-10-24||Interventional|||Formative Research Study to Address Protein Intake in Children and Analysis of Breast Milk Nutrient Content in Mothers|Formative Research on the Use of Egg as a Nutritional Supplement for Young Bangladeshi Children and Breast Milk Nutrient Content of Bangladeshi Women|Recruiting||N/A|30|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||f|f|f||||||No|The data will be entirely a property of organization and will be under lock and key under Principal Investigator. No participant data will make available to public without participants concents|2017-10-10 21:06:12.689208|2017-10-10 21:06:12.689208
NCT03140683|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-06-29|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|||Predictors of Scar Dehiscence in Patients With Previous Caesarean Section|Predictors of Scar Dehiscence in Patients With Previous Caesarean Section; a Study of Different Variables Tenderness Versus Non-stress Test|Recruiting||N/A|180|Anticipated|Assiut University|||1||f||||f|f|f||||||No||2017-10-10 21:06:12.774898|2017-10-10 21:06:12.774898
NCT03140670|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-03|2017-05-03|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2022|Anticipated|2022-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|||Rucaparib in BRCA1/2 or PALB2 Mutated Pancreatic Cancer|A Phase 2, Open Label Study of Rucaparib in Patients With Advanced Pancreatic Cancer and a Known Deleterious Germline or Somatic BRCA or PALB2 Mutation|Recruiting||Phase 2|42|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t|t|f|||f|||||2017-10-10 21:06:12.840225|2017-10-10 21:06:12.840225
NCT03140644|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-25|||May 16, 2017|Actual|2017-05-16|August 2017|2017-08-01|November 16, 2019|Anticipated|2019-11-16|May 16, 2019|Anticipated|2019-05-16||Interventional|SARCOLOWDOSE||SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis|SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis|Recruiting||N/A|50|Anticipated|Rennes University Hospital||1|||f||||f|f|f||||||||2017-10-10 21:06:13.03067|2017-10-10 21:06:13.03067
NCT03140631|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-03|||March 23, 2017|Actual|2017-03-23|May 2017|2017-05-01|March 23, 2018|Anticipated|2018-03-23|March 23, 2018|Anticipated|2018-03-23||Interventional|||Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation|Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation: A Randomized Trial|Recruiting||Phase 4|150|Anticipated|University of Michigan||2|||f||||f|t|f|||f|||No||2017-10-10 21:06:13.134266|2017-10-10 21:06:13.134266
NCT03140618|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-02|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|LEPPIC||The Light- and Environment Project in Psychiatric Inpatient Care|The Light- and Environment Project in Psychiatric Inpatient Care|Not yet recruiting||N/A|1|Anticipated|Umeå University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:06:13.232937|2017-10-10 21:06:13.232937
NCT03140605|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-15|||January 10, 2017|Actual|2017-01-10|May 2017|2017-05-01|January 10, 2019|Anticipated|2019-01-10|January 10, 2019|Anticipated|2019-01-10|1 Month|Observational [Patient Registry]|GRegistry-FH||Greek Registry - Familial Hypercholesterolaemia|Hellenic Registry for Familial Hypercholesterolemia|Recruiting||N/A|1000|Anticipated|Hellenic College of Treatment of Atherosclerosis|||1||f||||f|f|f||||||Undecided||2017-10-10 21:06:13.30778|2017-10-10 21:06:13.30778
NCT03140592|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-03|||January 14, 2015|Actual|2015-01-14|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue|EUS-guided Biopsy of Pancreatic Mass Lesions for Developing Patient -Derived Cancer Models|Recruiting||N/A|100|Anticipated|Stony Brook University|||1||f||||t|f|f||||Samples With DNA|"     biopsies of your pancreatic mass   "|No||2017-10-10 21:06:13.378412|2017-10-10 21:06:13.378412
NCT03140579|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-31|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|APRV||Effect of PEEP on Lung Recruitment and Homogeneity Over Time in Moderate to Severe ARDS|Estimation of Long Term PEEP Effect on Lung Homogeneity and Recruitment Using APRV Ventilation:Measurement of End Expiratory Lung Volume With Nitrogen Wash-out/wash-in Technique and End Expiratory Lung Impedance With EIT at Different Times.|Not yet recruiting||N/A|15|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f|f|f|||f|||||2017-10-10 21:06:13.452286|2017-10-10 21:06:13.452286
NCT03140566|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-05|||June 3, 2017|Actual|2017-06-03|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|CAVA-ADHF||Ultrasound Evaluation of the IVC in Addition to Clinical Assessment to Guide Decongestion in ADHF|Ultrasound Evaluation of the Inferior Vena Cava in Addition to Clinical Assessment to Guide Decongestion in Acute Decompensated Heart Failure: a Pilot Study|Recruiting||N/A|388|Anticipated|University of Luebeck||2|||f||||t|f|f||||||||2017-10-10 21:06:13.550419|2017-10-10 21:06:13.550419
NCT03140553|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-03|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||TCH (Docetaxel/Carboplatin/Trastuzumab) Versus EC -TH(Epirubicin/Cyclophosphamide Followed by Docetaxe/Trastuzumab) as Neoadjuvant Treatment for HER2-Positive Breast Cancer|TCH (Docetaxel/Carboplatin/Trastuzumab) Versus EC -TH(Epirubicin/Cyclophosphamide Followed by Docetaxe/Trastuzumab) as Neoadjuvant Treatment for HER2-Positive Breast Cancer|Recruiting||Phase 2|70|Anticipated|Guangdong General Hospital||2|||f|||||f|f||||||||2017-10-10 21:06:13.654055|2017-10-10 21:06:13.654055
NCT03140540|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-05-05|||April 2016||2016-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||TEE as a Guide for Fluid Optimization in Major Abdominal Oncosurgery|Transesophageal Echocardiography as a Guide for Fluid Optimization in Major Abdominal Oncosurgery|Recruiting||N/A|60|Anticipated|Rajiv Gandhi Cancer Institute & Research Center, India||2|||f||||t||||||||No||2017-10-10 21:06:13.736032|2017-10-10 21:06:13.736032
NCT03140527|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-04|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis|A Multi-Center, Randomized, Placebo-Controlled, Phase 1, Two-Part Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis|Recruiting||Phase 1|120|Anticipated|Proteostasis Therapeutics, Inc.||9|||f||||t|t|f||||||||2017-10-10 21:06:13.826516|2017-10-10 21:06:13.826516
NCT03140514|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-28|||September 28, 2017|Actual|2017-09-28|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Urine CXCL10 Chemokine Monitoring Post-renal Transplant|Urine CXCL10 Chemokine Monitoring Post-renal Transplant|Recruiting||N/A|178|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f||||||||2017-10-10 21:06:13.985585|2017-10-10 21:06:13.985585
NCT03140501|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MobileApp||Improving Self-Management Skills Among People With Spinal Cord Injury|Improving Self-Management Skills Among People With Spinal Cord Injury|Not yet recruiting||N/A|110|Anticipated|University of British Columbia||2|||f||||f|f|f||||||No||2017-10-10 21:06:14.074306|2017-10-10 21:06:14.074306
NCT03140488|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-13|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|OPS||The Obese Pitocin Study|High Dose vs. Low Dose Oxytocin for Labor Induction in Obese Women: a Randomized Controlled Trial - the OPS (Obese Pitocin Study) Trial|Recruiting||Phase 4|140|Anticipated|University of Arizona||4|||f||||f|t|f|||t|||No||2017-10-10 21:06:14.149689|2017-10-10 21:06:14.149689
NCT03140475|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-29|||May 29, 2017|Actual|2017-05-29|May 2017|2017-05-01|April 19, 2019|Anticipated|2019-04-19|April 19, 2019|Anticipated|2019-04-19||Observational|METASENS||Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition|Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition|Recruiting||N/A|100|Anticipated|Versailles Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:06:14.233483|2017-10-10 21:06:14.233483
NCT03140462|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-03|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Influence of Genetic Polymorphism of Donor on Tacrolimus Concentration in Liver Transplant|The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism of Donor on Tacrolimus Blood Concentration in Liver Transplant Patients|Not yet recruiting||N/A|400|Anticipated|National Taiwan University Hospital|||1||f||||f|f|f|||f|Samples With DNA|"     whole blood , paraffin-embedded liver biopsy, or saliva   "|No||2017-10-10 21:06:14.443709|2017-10-10 21:06:14.443709
NCT03140449|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||September 5, 2013|Actual|2013-09-05|September 2013|2013-09-01|April 25, 2017|Actual|2017-04-25|November 7, 2016|Actual|2016-11-07||Interventional|||Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis|Study of Combination Therapy With Topical Rapamycin and Calcitriol for Cutaneous Lesions of Tuberous Sclerosis: A Double-blind Randomized Controlled Trial|Completed||Phase 3|52|Actual|National Taiwan University Hospital||3|||f||||||||||||Undecided||2017-10-10 21:06:14.526709|2017-10-10 21:06:14.526709
NCT03140436|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Clinical Comparison of the Stain Removal Efficacy of Two Air Polishing Powders|Clinical Comparison of the Stain Removal Efficacy of Two Air Polishing Powders|Completed||N/A|35|Actual|Mahidol University||2|||f|||||f|f||||||No||2017-10-10 21:06:14.619665|2017-10-10 21:06:14.619665
NCT03140423|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-02|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Mupirocin-Iodophor ICU Decolonization Swap Out Trial|Cluster-randomized Non-inferiority Trial Comparing Mupirocin vs Iodophor for Nasal Decolonization of ICU Patients to Assess Impact on S. Aureus Clinical Cultures and All-cause Bloodstream Infection During Routine Chlorhexidine Bathing|Recruiting||Phase 4|137|Anticipated|Harvard Pilgrim Health Care||2|||f||||f|t|f|||f|||No||2017-10-10 21:06:14.727749|2017-10-10 21:06:14.727749
NCT03140410|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-09-10|||April 28, 2017|Actual|2017-04-28|September 2017|2017-09-01|January 2, 2018|Anticipated|2018-01-02|October 20, 2017|Anticipated|2017-10-20||Observational|ELiCSIR||Linezolid-resistant Staphylococcus Epidermidis in ICU and Risk Factors Analysis|Evaluation of the Emergence of the Resistance to Linezolid in Staphylococcus Epidermidis and Risk Factors Analysis : a Mono-centric Case-control Study|Active, not recruiting||N/A|103|Anticipated|Centre Hospitalier Universitaire de Besancon|||2||f||||f|f|f||||Samples With DNA|"     Stapylococcus epidermidis meticillin-resistant strains, isolated from blood cultures   "|||2017-10-10 21:06:15.088164|2017-10-10 21:06:15.088164
NCT03140397|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||January 2016||2016-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||Oral Bioavailability and Bioactivity of Prenylflavonoids From Hops|Examination of the Bioavailability and Bioactivity of the Two Natural Food Ingredients 6-Prenylnaringenin and 8-Prenylnaringenin.|Active, not recruiting||Early Phase 1|16|Actual|University of Hohenheim||3|||f||||f|f|f||||||No||2017-10-10 21:06:15.173399|2017-10-10 21:06:15.173399
NCT03140384|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-19|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|July 20, 2019|Anticipated|2019-07-20|July 20, 2019|Anticipated|2019-07-20||Interventional|Misoprostol||Compare the Different Routes of Administration of Misoprostol During Medicinal Abortion Between 7 and 9 Weeks of Amenorrhoea (SA)|Compare the Different Routes of Administration of Misoprostol During Medicinal Abortion Between 7 and 9 Weeks of Amenorrhoea (SA)|Not yet recruiting||Phase 3|444|Anticipated|Centre Hospitalier Universitaire, Amiens||3|||f|||||f|f||||||||2017-10-10 21:06:15.30394|2017-10-10 21:06:15.30394
NCT03140371|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-18|||July 14, 2017|Actual|2017-07-14|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||High Energy High Protein Peptide Feed Study|An Evaluation of the Tolerance, Compliance and Acceptability of a Ready to Use, Liquid, High Energy, High Protein, Peptide-based Feed for Adults in Need of Nutrition Support - a Pilot Study|Recruiting||N/A|60|Anticipated|Nutricia UK Ltd||1|||f||||f|f|f||||||||2017-10-10 21:06:15.387185|2017-10-10 21:06:15.387185
NCT03140358|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-05|||July 2, 2017|Anticipated|2017-07-02|June 2017|2017-06-01|May 2, 2023|Anticipated|2023-05-02|May 2, 2021|Anticipated|2021-05-02||Interventional|||The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)|The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)|Recruiting||Phase 3|570|Anticipated|Singapore National Eye Centre||4|||f||||t|f|f||||||No||2017-10-10 21:06:15.519374|2017-10-10 21:06:15.519374
NCT03140345|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-06-29|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|November 30, 2019|Anticipated|2019-11-30|October 1, 2019|Anticipated|2019-10-01||Observational|||Integrative HD Vascular Access Assessment|Integrative Nursing Assessment on Hemodialysis Vascular Access|Recruiting||N/A|200|Anticipated|National Taiwan University of Nursing and Health Sciences|||1||f||||f|f|f||||||||2017-10-10 21:06:15.608726|2017-10-10 21:06:15.608726
NCT03140332|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-02|||October 21, 2016|Actual|2016-10-21|May 2017|2017-05-01|October 21, 2019|Anticipated|2019-10-21|October 21, 2019|Anticipated|2019-10-21||Interventional|HCC-CTPerf||Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.|Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.|Recruiting||N/A|75|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:06:15.695193|2017-10-10 21:06:15.695193
NCT03140319|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-13|||December 10, 2017|Anticipated|2017-12-10|May 2017|2017-05-01|February 26, 2018|Anticipated|2018-02-26|January 15, 2018|Anticipated|2018-01-15||Interventional|||Transplantation of Fibroblast for Correction of Nasolabial Folds|Autologous Transplantation of Cultured Fibroblast for Correction of Nasolabial Folds|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|SCARM Institute, Tabriz, Iran||2|||f||||t|f|f||||||||2017-10-10 21:06:15.777222|2017-10-10 21:06:15.777222
NCT03140306|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-12|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||CT Using MBIR in Crohn's Disease: Prospective Clinical Evaluation of Diagnostic Efficacy, Safety and Patient Outcome.|Use of Low Dose CT Scanning of the Abdomen and Pelvis Using Model Based Iterative Reconstruction (MBIR) in Patients With Inflammatory Bowel Disease: Prospective Clinical Evaluation of Diagnostic Efficacy, Safety and Patient Outcome.|Not yet recruiting||N/A|35|Anticipated|University College Cork||1|||f||||f|f|f|||f|||No||2017-10-10 21:06:15.883899|2017-10-10 21:06:15.883899
NCT03140293|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-02|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Pain Perception During Chorionic Villus Sampling|A Randomized Trial to Determine if Local Anesthesia Decreases Pain Perception in Women Undergoing Chorionic Villus Sampling|Recruiting||Early Phase 1|120|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|t|f||||||No||2017-10-10 21:06:15.954207|2017-10-10 21:06:15.954207
NCT03140280|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-14|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome|A Pilot Study to Investigate the Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome|Recruiting||Phase 2|21|Anticipated|Medical College of Wisconsin||1|||||||t|t|f||||||Undecided||2017-10-10 21:06:16.057547|2017-10-10 21:06:16.057547
NCT03140267|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-05|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|May 15, 2019|Anticipated|2019-05-15|April 15, 2019|Anticipated|2019-04-15||Interventional|EFES||Assessment of Inspiratory Muscles Strength and Endurance Evolution on Difficult to Wean Patients in Intensive Care Unit|Assessment of the Evolution of Force and Endurance of Inspiratory Muscles in Intubated and Mechanically-ventilated ICU Patients With Difficult Weaning|Not yet recruiting||N/A|80|Anticipated|University Hospital, Bordeaux||1|||f||||f|f|f||||||No||2017-10-10 21:06:16.161089|2017-10-10 21:06:16.161089
NCT03140254|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-30||2017-05-16|September 2016|Actual|2016-09-01|May 2017|2017-05-01|March 17, 2017|Actual|2017-03-17|March 17, 2017|Actual|2017-03-17||Interventional|||Evaluating Safety and Effectiveness of N,N'-(1,10-decanediyldi-1(4H)-Pyridinyl-4-ylidene)-Bis-(1-octanamine) Dihydrochloride||Completed||Phase 2|56|Actual|CareFusion||3|||f||||f||||||||No||2017-10-10 21:06:16.259785|2017-10-10 21:06:16.259785
NCT03140241|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-26|||April 20, 2017|Actual|2017-04-20|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|June 29, 2017|Actual|2017-06-29||Interventional|||Pain Assessment by Pupil Dilation Reflex (PDR) and Pupillary Pain Index (PPI) in Response to Noxious Stimulation in Anesthetized Adults|Pain Assessment by Pupil Dilation Reflex (PDR) and Pupillary Pain Index (PPI) in Response to Noxious Stimulation in Anesthetized Adults|Completed||N/A|34|Actual|University Hospital, Antwerp||1|||f||||f|f|f||||||||2017-10-10 21:06:16.3384|2017-10-10 21:06:16.3384
NCT03140228|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-02|||February 16, 2017|Actual|2017-02-16|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|August 15, 2017|Anticipated|2017-08-15||Interventional|||Postoperative Sore Throat in Children: Comparison Between Two Supraglottic Devices, Ambu® AuraOnce™ Laryngeal Mask Airway (LMA) and I-Gel®.|Postoperative Sore Throat in Children: Comparison Between Two Supraglottic Devices, Ambu® AuraOnce™ Laryngeal Mask Airway (LMA) and I-Gel® in Children Undergoing Elective Lower Abdominal or Orthopedic Surgery.|Recruiting||N/A|70|Anticipated|Aga Khan University||2|||f||||t|f|f|||f|||||2017-10-10 21:06:16.41436|2017-10-10 21:06:16.41436
NCT03140202|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-18|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|October 1, 2017|Anticipated|2017-10-01|September 15, 2017|Anticipated|2017-09-15||Interventional|CILICA-QS||Compression Is Life In Cardiac Arrest - Quality Study (CILICA-QS)|Impact of a Feedback Device, CPRmeter®, on Chest Compression Quality Preservation During Cardio-pulmonary Resuscitation: A Manikin Study|Recruiting||N/A|65|Anticipated|University Hospital, Caen||2|||f||||f|f|f||||||||2017-10-10 21:06:16.589442|2017-10-10 21:06:16.589442
NCT03140189|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-06|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 1, 2023|Anticipated|2023-07-01|July 1, 2018|Anticipated|2018-07-01|5 Years|Observational [Patient Registry]|RAILE||Robot-assisted IVOR-LEWIS Esophagectomy|Robot- Assisted Ivor-Lewis Esophagectomy for Esophageal Cancer: Short- Term and Long Term Outcomes of a Single-Arm Phase II Trial|Recruiting||N/A|51|Anticipated|Ruijin Hospital|||1||f|||||f|f||||||||2017-10-10 21:06:16.685667|2017-10-10 21:06:16.685667
NCT03140163|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-05-02|||October 2016||2016-10-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|October 2017|Anticipated|2017-10-01||Interventional|ULTRACHEST||Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR]|Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT and Conventional Chest Radiography|Recruiting||N/A|200|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||No||2017-10-10 21:06:16.832934|2017-10-10 21:06:16.832934
NCT03140150|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-03|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|SAFECARE||Safety Acceptability and Benefits of Tracking Cardiac Pacemakers by Carelink Express|Safety Acceptability and Benefits of Tracking Cardiac Pacemakers by Carelink Express|Not yet recruiting||N/A|147|Anticipated|University Hospital, Brest||2|||f||||t|f|f||||||||2017-10-10 21:06:16.920201|2017-10-10 21:06:16.920201
NCT03140137|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-10-03|||January 23, 2017|Actual|2017-01-23|September 2017|2017-09-01|January 23, 2018|Anticipated|2018-01-23|January 23, 2018|Anticipated|2018-01-23||Observational|||Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases|Retrospective Observational Study on the Safety of Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma and Lung Cancers in Patients With Pre-Existing Autoimmune Diseases|Recruiting||N/A|50|Anticipated|University Hospital, Brest|||1||f|||||f|f||||||||2017-10-10 21:06:17.013364|2017-10-10 21:06:17.013364
NCT03140124|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-02|||November 3, 2015|Actual|2015-11-03|May 2017|2017-05-01|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|||Enhancing Therapy Process With Movement Strategies|Enhancing Therapy Process With Movement Strategies|Terminated||N/A|1|Actual|Boston University Charles River Campus||2||Feasibility - unable to recruit therapists to enter the study|f||||f||||||||No||2017-10-10 21:06:17.099043|2017-10-10 21:06:17.099043
NCT03140111|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-08|||October 16, 2017|Anticipated|2017-10-16|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients|Post-approval Study to Assess the Effectiveness of LAMELLEYE vs Comparator for the Treatment of Dry Eye Symptoms in Patients With Primary Sjögren's Syndrome|Not yet recruiting||N/A|12|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f|f|f||||||||2017-10-10 21:06:17.186184|2017-10-10 21:06:17.186184
NCT03140098|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-15|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|June 1, 2018|Anticipated|2018-06-01||Observational|||Evaluation of COVA™+ CARD in Adult Cardiac Surgery|Evaluation of the Tolerance and Efficacy of COVA™+ CARD in Adult Cardiac Surgery. A Prospective, Observational and Single Center Study.|Not yet recruiting||N/A|10|Anticipated|Biom'Up SA|||1||f||||f|f|f||||||No||2017-10-10 21:06:17.27195|2017-10-10 21:06:17.27195
NCT03140085|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-04|||November 1, 2015|Actual|2015-11-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate|Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate: A Randomized, Placebo-controlled, Double-blind Clinical Trial|Recruiting||Phase 2/Phase 3|81|Anticipated|Balgrist University Hospital||3|||f|||||f|f||||||||2017-10-10 21:06:17.328845|2017-10-10 21:06:17.328845
NCT03139578|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-27|||April 28, 2017|Actual|2017-04-28|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Short-Term Clinical Comparison of Two Silicone Hydrogel Daily Disposable Contact Lenses|Short-Term Clinical Comparison of Two Silicone Hydrogel Daily Disposable Contact Lenses|Recruiting||N/A|60|Anticipated|Johnson & Johnson Vision Care, Inc.||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:06:23.089379|2017-10-10 21:06:23.089379
NCT03140059|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-02|||June 2016|Actual|2016-06-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison Between Surgical Access and Repeated Applications of APDT|Comparison Between Surgical Access and Repeated Applications of APDT to Residual Pockets Treatment in Generalized Aggressive Periodontitis: Randomized Clinical Trial|Active, not recruiting||N/A|44|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f|f|f||||||Undecided||2017-10-10 21:06:17.501997|2017-10-10 21:06:17.501997
NCT03140046|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-03|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Visual Outcomes of Topography Guided Photorefractive Keratectomy (PRK) for Treatment of Patients With Irregular Cornea|Visual Outcomes of Topography Guided Photorefractive Keratectomy (PRK) for Treatment of Patients With Irregular Cornea|Recruiting||N/A|10|Anticipated|Assiut University||1|||f||||f|f|f||||||No||2017-10-10 21:06:17.564195|2017-10-10 21:06:17.564195
NCT03140033|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-02|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery|Sublingual Misoprostol Versus Placebo to Reduce Blood Loss During Elective Cesarean Delivery : A Randomized Controlled Study|Recruiting||Phase 2|158|Anticipated|Ain Shams Maternity Hospital||2|||f||||t|f|f|||f|||Yes||2017-10-10 21:06:17.626645|2017-10-10 21:06:17.626645
NCT03140020|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-04|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|July 2019|Anticipated|2019-07-01||Observational|||Cognition and Functional Connectivity After Elective Treatment of Brain Aneurysms|Cognition and Functional Connectivity After Elective Treatment of Brain Aneurysms|Not yet recruiting||N/A|57|Anticipated|Medical University of Vienna|||3||f||||f|f|f||||||No||2017-10-10 21:06:17.7161|2017-10-10 21:06:17.7161
NCT03140007|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-04|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|June 15, 2018|Anticipated|2018-06-15|February 15, 2018|Anticipated|2018-02-15||Interventional|Cholangioscopy||Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .|Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic - a Randomized Controlled Study|Not yet recruiting||N/A|60|Anticipated|Asian Institute of Gastroenterology, India||2|||f||||f|f|f||||||No||2017-10-10 21:06:17.947493|2017-10-10 21:06:17.947493
NCT03139994|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-05-01|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Observational|MAPA||Altered MAstication Contribute to TMJ PAin|One Habitual Chewing Side May Contribute to Chronic Temporomandibular Joint Disorder Pain|Recruiting||N/A|30|Anticipated|University of Santiago de Compostela|||1||f||||f||||||||Yes|Data will be shared in a on-line appendix linked from the article in a JCR Journal.|2017-10-10 21:06:18.042978|2017-10-10 21:06:18.042978
NCT03139981|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-03|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 5, 2017|Anticipated|2017-12-05||Interventional|||A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis|A Randomized, Double -Blind, Placebo-Controlled, Sequential, Multiple-Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002 In Subjects With Moderate-To-Severe Atopic Dermatitis|Recruiting||Phase 1|48|Anticipated|Asana BioSciences||4|||f||||f|t|f||||||||2017-10-10 21:06:18.15613|2017-10-10 21:06:18.15613
NCT03139968|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-27|||January 16, 2017|Actual|2017-01-16|June 2017|2017-06-01|August 1, 2017|Anticipated|2017-08-01|June 1, 2017|Actual|2017-06-01||Interventional|RECAP||Reduction of Catheterization Radiation Exposure Pad|Reduction of the Operator's Radiation Exposure During CAG and PCI With RADPAD, a Randomized Controlled Double-blinded Trial|Active, not recruiting||Phase 3|766|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||f|f|f||||||Undecided||2017-10-10 21:06:18.30275|2017-10-10 21:06:18.30275
NCT03139955|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-15|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|3 Days|Observational [Patient Registry]|||Bodytrak® Feasibility Study|Feasibility Study of Using Bodytrak® in a Medical Setting|Not yet recruiting||N/A|24|Anticipated|Inova Design Solutions Ltd|||1||f||||t|f|f||||||||2017-10-10 21:06:18.38297|2017-10-10 21:06:18.38297
NCT03139942|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-02|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|OPTIC||Optical Polyp Testing for In Vivo Classification|Optical Polyp Testing for In Vivo Classification|Recruiting||N/A|20|Anticipated|Imperial College London||1|||f||||f|f|f||||||Undecided|Only anonymised data will be shared. The research team may share findings from the study with non-Imperial College academic collaborators, who will further develop aspects of its imaging capabilities.|2017-10-10 21:06:18.495549|2017-10-10 21:06:18.495549
NCT03139929|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-06-28|||May 9, 2017|Actual|2017-05-09|June 2017|2017-06-01|February 1, 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Measurement of MSFP and Stressed Volume With CardioQ+®|Measurement of Mean Systemic Filling Pressure & Stressed Volume With CardioQ+® Oesophageal Doppler Measurement|Recruiting||N/A|42|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f|f|f|||||"     Blood samples   "|No||2017-10-10 21:06:18.608163|2017-10-10 21:06:18.608163
NCT03139916|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-06-16|||July 30, 2017|Anticipated|2017-07-30|June 2017|2017-06-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma|Phase II Clinical Trial of Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 2|36|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||No||2017-10-10 21:06:18.726351|2017-10-10 21:06:18.726351
NCT03139565|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-20|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Interventional|||High Dose vs. Standard Influenza Vaccine in Adult SOT|A Randomized Controlled Trial Comparing High-dose vs. Standard Influenza Vaccine in Adult Solid Organ Transplant Recipients|Active, not recruiting||Phase 3|173|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 21:06:23.172671|2017-10-10 21:06:23.172671
NCT03139903|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-02|||July 28, 2010|Actual|2010-07-28|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 16, 2013|Actual|2013-07-16||Observational|NANPIM||The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type II|The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type II (MOPDII).|Completed||N/A|30|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 21:06:18.848473|2017-10-10 21:06:18.848473
NCT03139890|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-23|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Macronutrients and Postprandial Vascular Function|The Effects of Macronutrients on Postprandial Vascular Function in Overweight and Slightly Obese Men|Not yet recruiting||N/A|20|Anticipated|Maastricht University Medical Center||3|||f||||f|f|f||||||||2017-10-10 21:06:18.9359|2017-10-10 21:06:18.9359
NCT03139877|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-02|||September 13, 2016|Actual|2016-09-13|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Pediatric Obesity Observational Prospective Trial|Pediatric Obesity Observational Prospective Trial: Microbiome and Metabolism During Obesity Target Therapeutics|Recruiting||N/A|350|Anticipated|Duke University|||3||f||||f|f|f||||Samples With DNA|"     Fecal samples: Samples will be kept at 4ºC for < 18 hours prior to moving to the lab -80ºC     freezer.      Using the Human Microbiome Roadmap (REFS), Ribosomal DNA will be amplified using multiplexing     primers per Caparoso et al method. Pooled amplicons will be sequenced. Sequences will be     stored on the Center for Genomes in Microbial Systems (GeMS) without PHI.      A 20 mL(milliliter) blood sample will be collected for isolation of mononuclear cells and     plasma for genetic and metabolomics studies.      Sampling will not exceed 2 ml/kg or 90 ml over the course of the study. Mononuclear cell DNA     will be isolated from peripheral samples and applied to a focused polymorphism analysis for     29 obesity risk alleles using Sequenom technology at the David H. Murdock Research Institute.   "|No||2017-10-10 21:06:19.062958|2017-10-10 21:06:19.062958
NCT03139864|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-04|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|DIABSPORT||Comparison of the Use of Energy Substrates and Hormonal Regulation of Blood Sugar During Exercise of Increasing Intensity Between Children With Type 1 Diabetes and Non-diabetic Control Children.|Comparison of the Use of Energy Substrates and Hormonal Regulation of Blood Sugar During Exercise of Increasing Intensity Between Children With Type 1 Diabetes and Non-diabetic Control Children.|Not yet recruiting||N/A|48|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:06:19.15912|2017-10-10 21:06:19.15912
NCT03139851|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-27|||June 27, 2017|Anticipated|2017-06-27|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|CHEMOIMMUNE||Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide|CHEMOIMMUNE - A Phase II Study Evaluating an Anti-PD1 Monoclonal Antibody (Pembrolizumab) in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide|Recruiting||Phase 2|36|Anticipated|Centre Leon Berard||1|||f||||t|f|f||||||No||2017-10-10 21:06:19.263445|2017-10-10 21:06:19.263445
NCT03139838|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|PONDER-ICU||Prognosticating Outcomes and Nudging Decisions With Electronic Records in the ICU Trial|Behavioral Economic Approaches to Improve Palliative Care for Critically Ill Patients|Not yet recruiting||N/A|4750|Anticipated|University of Pennsylvania||4|||f||||t|f|f||||||||2017-10-10 21:06:19.385754|2017-10-10 21:06:19.385754
NCT03139825|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||February 22, 2017|Actual|2017-02-22|May 2017|2017-05-01|February 22, 2018|Anticipated|2018-02-22|February 22, 2018|Anticipated|2018-02-22||Interventional|EEG-NIRS||Connectivity and Social Cognition in Adolescent Girls With Borderline Personality Disorder, a Pilot Study|Connectivity and Social Cognition in Adolescent Girls With Borderline Personality Disorder, a Pilot Study|Recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:06:19.524782|2017-10-10 21:06:19.524782
NCT03139812|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-01|||January 15, 2012|Actual|2012-01-15|May 2017|2017-05-01|October 15, 2012|Actual|2012-10-15|October 15, 2012|Actual|2012-10-15||Interventional|EW23||Daily Irrigation With Silicone Hydrogel Contact Lens Continuous Wear|Effects of Daily Irrigation on Corneal Epithelial Permeability and Adverse Events With Silicone Hydrogel Contact Lens Continuous Wear|Completed||Phase 4|161|Actual|University of California, Berkeley||2|||f||||f|f|f||||||||2017-10-10 21:06:19.608686|2017-10-10 21:06:19.608686
NCT03139799|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-21|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Long-term Tablet-computer Based Casual Puzzle Video Game Intervention in Healthy Older and Cognitively Impaired Persons|Long-term Tablet-computer Based Casual Puzzle Video Game Intervention in Healthy Older and Cognitively Impaired Persons|Not yet recruiting||N/A|80|Anticipated|University of Bern||2|||f||||t|f|f||||||||2017-10-10 21:06:19.701076|2017-10-10 21:06:19.701076
NCT03139786|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-02|||October 14, 2011|Actual|2011-10-14|May 2017|2017-05-01|October 14, 2021|Anticipated|2021-10-14|October 14, 2021|Anticipated|2021-10-14||Observational|||Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia|Prospective Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia: Multicentre Study|Recruiting||N/A|232|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:06:19.819587|2017-10-10 21:06:19.819587
NCT03139773|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-03|||May 15, 2016|Actual|2016-05-15|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Nutrition Intervention to Measure Metabolic Response in Children|Nutrition Intervention to Improve Energy Metabolism, Energy Intake, and Metabolic Response in Overweight and Obese School-aged Children|Completed||N/A|27|Actual|University of Arkansas, Fayetteville||2|||f||||f|f|f||||||No||2017-10-10 21:06:19.896821|2017-10-10 21:06:19.896821
NCT03139760|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-09-12|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|POWERSforID||POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability|POWERSforID: Personalized Online Weight and Exercise Response System for Adults With Intellectual Disability|Recruiting||N/A|100|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f||||||||2017-10-10 21:06:19.985546|2017-10-10 21:06:19.985546
NCT03139747|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-02|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|April 3, 2020|Anticipated|2020-04-03|April 3, 2019|Anticipated|2019-04-03||Interventional|||UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone|UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone|Recruiting||Phase 2|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t|t|f|||f|||||2017-10-10 21:06:20.083369|2017-10-10 21:06:20.083369
NCT03139734|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-01|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Sacral Neuromodulation for Pelvic Pain Associated With Endometriosis|Sacral Neuromodulation for Pelvic Pain Associated With Endometriosis|Not yet recruiting||N/A|50|Anticipated|Seinajoki Central Hospital||1|||f||||f|f|f|||f|||No||2017-10-10 21:06:20.158302|2017-10-10 21:06:20.158302
NCT03139721|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-28|||June 19, 2017|Actual|2017-06-19|May 2017|2017-05-01|August 31, 2021|Anticipated|2021-08-31|June 30, 2019|Anticipated|2019-06-30||Observational|||Medtronic HAMMOCK Post Approval Study|Medtronic Hancock II® and Mosaic Mitral and Aortic Valves: A Study to Observe the Effects of the Stent Material Change to PEEK Post Approval Study (HAMMOCK PAS)|Recruiting||N/A|100|Anticipated|Medtronic Cardiovascular|||1||f||||f|f|t|f|f|t|||||2017-10-10 21:06:20.235804|2017-10-10 21:06:20.235804
NCT03139708|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-08-18|||September 2016||2016-09-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients|The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients, Pressure Control and Pupil Effects|Recruiting||Phase 1|20|Anticipated|Wake Forest University Health Sciences||3|||f||||f||||||||||2017-10-10 21:06:20.310247|2017-10-10 21:06:20.310247
NCT03139695|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-01|||November 2012||2012-11-01|May 2017|2017-05-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Observational|||Using Ultrasound to Study Respiratory Muscle Function in Critically Ill Patients|High Resolution Ultrasound of Intercostal Muscle and Diaphragm as a Biomarker of Respiratory Muscle Function in Patients on Mechanical Ventilation|Completed||N/A|75|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||No||2017-10-10 21:06:20.404145|2017-10-10 21:06:20.404145
NCT03139682|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-03|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|August 3, 2020|Anticipated|2020-08-03|August 3, 2018|Anticipated|2018-08-03||Observational|||Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury|Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Traumatic Brain Injury|Recruiting||N/A|120|Anticipated|Nova Scotia Health Authority|||1||f|||||f|f||||Samples Without DNA|"     Serum tau protein (sTau), von Willebrand factor (vWF), brain derived neurotrophic factor     (BDNF), glial fibrillary acidic protein (GFAP),S100β, and serum neurofilament light (sNFL).   "|||2017-10-10 21:06:20.487041|2017-10-10 21:06:20.487041
NCT03139669|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-05-01|||June 2016||2016-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|HPV home test||Cultural Acceptability and Feasibility of HPV Cervical Self Collection Aided by Lay Navigators|Cultural Acceptability and Feasibility of HPV Cervical Self Collection Aided by Lay Navigators|Completed||N/A|100|Actual|University of Virginia||1|||f||||f||||||||No||2017-10-10 21:06:20.555683|2017-10-10 21:06:20.555683
NCT03139656|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-01|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ABC3||Assessment of the Predictors and Moderators of Health Behavior Change|Assessment of the Predictors and Moderators of Health Behavior Change|Recruiting||N/A|191|Anticipated|Boston University Charles River Campus||3|||f||||f|f|f||||||No||2017-10-10 21:06:20.628959|2017-10-10 21:06:20.628959
NCT03139643|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-05-03|||June 2014|Actual|2014-06-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|ABC||Assessment of the Predictors and Moderators of Behavior Change|Assessment of the Predictors and Moderators of Behavior Change|Active, not recruiting||N/A|243|Anticipated|Boston University Charles River Campus||3|||f||||f||||||||No||2017-10-10 21:06:20.721188|2017-10-10 21:06:20.721188
NCT03139630|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-04-29|||March 2016||2016-03-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|COPANA||COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV—Infected Patients|COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV—Infected Patients|Completed||N/A|193|Actual|Saint Antoine University Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma samples taken from the Biobank stored at Tenon Hospital, Paris (Biochemistry     department).      ELISA Cyclex.      Plasma PCSK9 concentrations assayed in triplicates using a quantitative sandwich ELISA assay     and following the manufacturer instructions (Circulex CY-8079, CycLex Co, Nagano, Japan).      The ELISA kit relies on a quantitative sandwich enzyme immunoassay technique with inter- and     intraplate CVs of 2.9-7.3% and 1.5-2.6%, respectively.   "|No|no plan to share IPD|2017-10-10 21:06:20.823902|2017-10-10 21:06:20.823902
NCT03139617|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-05-03|||June 2015||2015-06-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|IKH||Comparison Between Ultrasound Guided Femoral 3 in 1 Block Versus Blind Fascia Iliaca Block Before Spinal Anaesthesia|Comparison the Efficacy as Analgesia Between Ultrasound Guided Femoral 3 in 1 Block Versus Blind Fascia Iliaca Block for Positioning Prior Spinal Anaesthesia in Femur Fracture Surgery|Completed||N/A|60|Actual|University of Science Malaysia||2|||f||||f||||||||No||2017-10-10 21:06:20.903482|2017-10-10 21:06:20.903482
NCT03139604|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-10-02|||June 8, 2017|Actual|2017-06-08|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|April 2019|Anticipated|2019-04-01||Interventional|||GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease|GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease|Recruiting||Phase 3|436|Anticipated|Incyte Corporation||2|||f||||t|t|f||||||||2017-10-10 21:06:21.008396|2017-10-10 21:06:21.008396
NCT03139591|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-08-15|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|May 31, 2017|Actual|2017-05-31|January 31, 2017|Actual|2017-01-31||Interventional|||Comparison Between Lidocaine Inhalation and Intravenous Dexamethasone in Reducing Pain After Laryngeal Mask Insertion|Comparison Between Lidocaine Inhalation and Intravenous Dexamethasone to Reduce Pain After Laryngeal Mask Insertion|Completed||N/A|196|Actual|Indonesia University||2|||f|||||f|f||||||||2017-10-10 21:06:23.013057|2017-10-10 21:06:23.013057
NCT03139539|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-03|||March 2016||2016-03-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|ICON||Intraoperative Microbial Contamination|Intraoperative Microbial Contamination, Its Prevention and Its Consequences for Outcomes Following Joint Replacement Surgery|Recruiting||N/A|1200|Anticipated|University of Copenhagen||2|||f||||t||||||||Yes|We are making a database and keeping the records for ten years. Fellow researchers will have acces to the database.|2017-10-10 21:06:23.349121|2017-10-10 21:06:23.349121
NCT03139526|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-03|||January 1, 2014|Actual|2014-01-01|May 2017|2017-05-01|July 1, 2014|Actual|2014-07-01|July 1, 2014|Actual|2014-07-01||Observational|CRANIO||Social Participation After Childhood Craniopharyngioma|Social Participation After Childhood Craniopharyngioma|Completed||N/A|20|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 21:06:23.463474|2017-10-10 21:06:23.463474
NCT03139513|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-07-31|||October 27, 2016|Actual|2016-10-27|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|MELANIS||A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])|Survival in Adult Patients With BRAF V600 Mutation-Positive Advanced Melanoma: A Non-Interventional Ambispective Study of a Cohort of Patients Treated With Cobimetinib During the French Early Access Program (TAU)|Active, not recruiting||N/A|200|Anticipated|Hoffmann-La Roche|||1||f|||||t|f||||||||2017-10-10 21:06:23.535297|2017-10-10 21:06:23.535297
NCT03139500|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-09-05|||May 17, 2017|Actual|2017-05-17|September 2017|2017-09-01|June 20, 2018|Anticipated|2018-06-20|December 7, 2017|Anticipated|2017-12-07||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and to Evaluate the Effect of JNJ-61803534 on the Pharmacokinetics of Midazolam in Healthy Participants|A Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and an Open-Label Study to Evaluate the Effect of JNJ-61803534 on the Pharmacokinetics of Midazolam in Healthy Participants|Recruiting||Phase 1|108|Anticipated|Janssen Research & Development, LLC||3|||f||||f|f|f||||||||2017-10-10 21:06:23.800848|2017-10-10 21:06:23.800848
NCT03139487|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-02|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|November 2017|Anticipated|2017-11-01||Interventional|PRIORITY||A Randomized Phase II Study to Compare the Safety and Efficacy of Dalteparin vs. Rivaroxaban for Cancer-associated Venous Thromboembolism|A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Oral Rivaroxaban for Cancer-associated Venous Thromboembolism in Patients With Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer (PRIORITY)|Recruiting||Phase 2|176|Anticipated|Asan Medical Center||2|||f||||t|t|f|||t|||Yes||2017-10-10 21:06:23.899139|2017-10-10 21:06:23.899139
NCT03139474|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-02|2017-05-02|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality|Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality in Intracytoplasmic Sperm Injection Cycles.|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|Assiut University||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:06:24.030305|2017-10-10 21:06:24.030305
NCT03139461|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-03|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|April 2018|Anticipated|2018-04-01||Interventional|PT-REFER||Physical Therapists - Recommending EnhanceFitness to Expand Reach|Promoting Healthy Aging by Scaling Up What Works|Active, not recruiting||N/A|20|Actual|University of Washington||2|||f||||t|f|f||||||No||2017-10-10 21:06:24.123184|2017-10-10 21:06:24.123184
NCT03139448|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-06-21|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy|Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy: a Prospective Randomized Trial|Recruiting||N/A|160|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:06:24.225897|2017-10-10 21:06:24.225897
NCT03139435|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-15|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 11, 2018|Anticipated|2018-05-11||Interventional|||Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer|A Pilot Study Using Ultrasound for the Detection of Taxane-Induced Peripheral Neuropathy|Recruiting||N/A|20|Anticipated|Wake Forest University Health Sciences||1|||f||||t|f|f||||||||2017-10-10 21:06:24.356347|2017-10-10 21:06:24.356347
NCT03139422|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-08-13|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss|Tranexamic Acid Versus Calcium Dobesilate for the Treatment of Copper Intra Uterine Contraceptive Device Associated Heavy Menstrual Blood Loss : A Randomized , Open-labelled , Clinical Trial.|Recruiting||Phase 3|140|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 21:06:24.488361|2017-10-10 21:06:24.488361
NCT03139409|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-07-18|||July 20, 2017|Anticipated|2017-07-20|July 2017|2017-07-01|July 27, 2018|Anticipated|2018-07-27|July 20, 2018|Anticipated|2018-07-20||Interventional|||Digital Radiography in Detection of Recurrent Caries Underneath Chlorhexidine Containing Adhesive Versus Conventional Adhesive After One Year Follow up: Randomized Clinical Trial|Digital Radiography in Detection of Recurrent Caries Underneath Chlorhexidine Containing Adhesive Versus Conventional Adhesive After One Year Follow up.|Recruiting||N/A|37|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 21:06:24.575954|2017-10-10 21:06:24.575954
NCT03139396|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-03|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|||Assessment Of Inlay Retained Bridge Designs In Missing Posterior Teeth Cases. (Randomized Clinical Trial)|Clinical Assessment Of Inlay Retained Bridge Designs (Tub Shaped And Inlay Shaped) In Missing Posterior Teeth Cases. (Randomized Clinical Trial)|Not yet recruiting||N/A|12|Anticipated|Cairo University||2|||f||||t|f|f||||||No||2017-10-10 21:06:24.668795|2017-10-10 21:06:24.668795
NCT03139383|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-03|||September 30, 2014|Actual|2014-09-30|May 2017|2017-05-01|October 31, 2015|Actual|2015-10-31|September 28, 2015|Actual|2015-09-28||Interventional|||Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery|Intraoperative Intravenous Dextrose Administration and the Incidence of Nausea and Vomiting After the Gynecologic Laparoscopic Surgery A Randomized Double-Blinded Controlled Study|Completed||N/A|100|Actual|Chiang Mai University||2|||f||||t|f|f||||||No||2017-10-10 21:06:24.743762|2017-10-10 21:06:24.743762
NCT03139370|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-31|||May 8, 2017|Actual|2017-05-08|August 2017|2017-08-01|February 2024|Anticipated|2024-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study Evaluating the Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Subjects With Advanced Cancers|A Phase 1 Study Evaluating the Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Subjects With Advanced Cancers|Recruiting||Phase 1|50|Anticipated|Kite Pharma, Inc.||1|||f|||||t|t|t|f||||||2017-10-10 21:06:24.843289|2017-10-10 21:06:24.843289
NCT03139357|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-05-02|||December 22, 2016|Actual|2016-12-22|May 2017|2017-05-01|December 22, 2019|Anticipated|2019-12-22|December 22, 2019|Anticipated|2019-12-22||Observational|||Behavioral Monitoring in Primary Care|Behavioral Monitoring in Primary Care|Recruiting||N/A|800|Anticipated|University of Pittsburgh|||1||f||||f|f|f||||||Undecided||2017-10-10 21:06:24.929885|2017-10-10 21:06:24.929885
NCT03139344|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||August 1, 2015|Actual|2015-08-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Long Duration Activity and Metabolic Control After Spinal Cord Injury|Long Duration Activity and Metabolic Control After Spinal Cord Injury|Recruiting||N/A|96|Anticipated|University of Iowa||2|||f||||f|f|f||||||No||2017-10-10 21:06:25.022085|2017-10-10 21:06:25.022085
NCT03139331|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-29|||April 25, 2017|Actual|2017-04-25|August 2017|2017-08-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma|Phase 1 Study of Pazopanib in Combination With Irinotecan and Temozolomide (PAZIT) for Children and Young Adults With Relapsed or Refractory Sarcoma|Recruiting||Phase 1|18|Anticipated|University of California, San Francisco||1|||f||||t|t|f||||||||2017-10-10 21:06:25.128104|2017-10-10 21:06:25.128104
NCT03139318|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-05|||July 25, 2017|Actual|2017-07-25|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity|Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity|Recruiting||N/A|12|Anticipated|University of Arkansas||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:06:25.240248|2017-10-10 21:06:25.240248
NCT03139305|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|GIO B||Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects|Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects|Not yet recruiting||Phase 1|30|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida||3|||f|||||t|f||||||||2017-10-10 21:06:25.336655|2017-10-10 21:06:25.336655
NCT03139292|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-02|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway|Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway in Spontaneously Breathing Patients Undergoing Elective Surgery Under General Anaesthesia|Recruiting||N/A|160|Anticipated|Tata Main Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:06:25.445102|2017-10-10 21:06:25.445102
NCT03139279|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-04|||May 5, 2017|Anticipated|2017-05-05|May 2017|2017-05-01|May 5, 2018|Anticipated|2018-05-05|May 5, 2018|Anticipated|2018-05-05||Interventional|||Propofol and Dexmedetomidine Versus a Propofol Only Regimen for Sedation During Colonoscopy|Comparing Time to Readiness for Discharge After Colonoscopy: Propofol and Dexmedetomidine vs Propofol Only Sedation|Not yet recruiting||Phase 4|100|Anticipated|State University of New York - Downstate Medical Center||2|||f||||t|t|f|||f|||No||2017-10-10 21:06:25.667944|2017-10-10 21:06:25.667944
NCT03139266|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-02|||April 7, 2015|Actual|2015-04-07|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Project UPLIFT to Reduce Anxiety and Depression in CF Patients|Project UPLIFT to Reduce Anxiety and Depression in CF Patients|Recruiting||N/A|70|Anticipated|Virginia Commonwealth University||2|||f||||t|f|f||||||No||2017-10-10 21:06:25.820748|2017-10-10 21:06:25.820748
NCT03139253|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-05-02|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment|Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment|Not yet recruiting||Phase 4|120|Anticipated|Shandong University||5|||f||||t|f|f||||||No||2017-10-10 21:06:25.943365|2017-10-10 21:06:25.943365
NCT03139240|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-22|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Opioid Analgesia for MAB|Opioid Analgesia for MAB: A Randomized Controlled Trial|Recruiting||Phase 4|152|Anticipated|Oregon Health and Science University||2|||f||||f|t|f|||f|||||2017-10-10 21:06:26.061052|2017-10-10 21:06:26.061052
NCT03139227|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-23|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Apigenin in Increasing Health Benefits in High Risk Breast Clinic Patients|Celery-Based Dietary Intervention: A Feasibility Study|Recruiting||N/A|12|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-10 21:06:26.164855|2017-10-10 21:06:26.164855
NCT03139214|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||August 27, 2001|Actual|2001-08-27|May 2017|2017-05-01|December 30, 2015|Actual|2015-12-30|December 30, 2015|Actual|2015-12-30||Interventional|||Parenting Intervention and Metabolic Syndrome|Parenting Intervention and Metabolic Syndrome|Completed||N/A|391|Actual|Northwestern University||2|||f||||f|f|f||||||No||2017-10-10 21:06:26.263178|2017-10-10 21:06:26.263178
NCT03139201|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-02|||September 21, 2016|Actual|2016-09-21|April 2017|2017-04-01|December 8, 2016|Actual|2016-12-08|December 8, 2016|Actual|2016-12-08||Interventional|||Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens|A Prospective Randomized Controlled Study to Evaluate the Clinical Performance of OxyAqua Silicone Hydrogel Soft Contact Lens|Completed||N/A|36|Actual|Visco Vision Inc.||2|||f||||f|f|f|||f|||No||2017-10-10 21:06:26.347036|2017-10-10 21:06:26.347036
NCT03139188|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-22|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Palliative Care Unit Transfert Announcements|Palliative Care Transfer Announcements: Qualitative Analysis of the Perspective of Physicians and Their Patients With Cancer|Recruiting||N/A|10|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 21:06:26.426924|2017-10-10 21:06:26.426924
NCT03139175|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-02|||May 6, 2016|Actual|2016-05-06|May 2017|2017-05-01|December 25, 2017|Anticipated|2017-12-25|December 20, 2017|Anticipated|2017-12-20||Interventional|||Association Between TMD and LBP Back Pain|Association Between Temporomadibular Disorder and Low Back Pain|Recruiting||N/A|60|Anticipated|Tri-Service General Hospital||3|||f||||t|f|f||||||No|I can share the conclusions of my research.|2017-10-10 21:06:26.510482|2017-10-10 21:06:26.510482
NCT03139162|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-02|||January 1, 2015|Actual|2015-01-01|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2015|Actual|2015-12-31||Observational|IndiRAI||Development of Clinical Indicators From the Swiss RAI-HC|Development of Frailty and Complexity Indices From Data Collected With Resident Assessment Instrument - Home Care Adapted for Switzerland|Active, not recruiting||N/A|10000|Actual|School of Health Sciences Geneva|||1||f||||f|f|f||||||No|The coded datasets supporting the findings of this study are not publicly available for they belong to imad and are not the property of the authors of the study. The data analyzed for the study could be made available from the authors upon reasonable request and with prior agreement by imad.|2017-10-10 21:06:26.600535|2017-10-10 21:06:26.600535
NCT03139149|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-10-05|||October 11, 2017|Anticipated|2017-10-11|October 2017|2017-10-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|COTACSO||Comparison of Early Operative Treatment and 48 h Conservative Treatment in Small Bowel Obstruction|Comparison of Early Operative Treatment (12 h) and 48 h Conservative Treatment in Acute Small Bowel Obstruction|Not yet recruiting||N/A|200|Anticipated|Pirogov Russian National Research Medical University||2|||f||||f|f|f||||||||2017-10-10 21:06:26.679767|2017-10-10 21:06:26.679767
NCT03139136|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-29|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis|A 12-Week, Double-Blind, Placebo-Controlled, Phase 2a Study to Investigate the Safety, Tolerability and Efficacy of MBS2320 in Patients With Active Rheumatoid Arthritis Receiving Methotrexate|Recruiting||Phase 2|108|Anticipated|Modern Biosciences plc||2|||f||||t|f|f||||||||2017-10-10 21:06:26.770589|2017-10-10 21:06:26.770589
NCT03139123|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-02|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Observational|PRELOAD-CRRT||Prevalence of Hypotension Associated With Preload Dependence During Continuous Renal Replacement Therapy|Prevalence of Hypotension Associated With Preload Dependence During Continuous Renal Replacement Therapy|Not yet recruiting||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 21:06:26.869981|2017-10-10 21:06:26.869981
NCT03139110|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|February 2019|Anticipated|2019-02-01||Observational|MEDIA||Impact of a Mediator for Patient Intake in Emergency Departments|Welcoming Patients in Emergency Departments: Impact of the Mediator|Not yet recruiting||N/A|31300|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 21:06:26.959522|2017-10-10 21:06:26.959522
NCT03139097|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-09|||January 16, 2017|Actual|2017-01-16|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge|Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge|Recruiting||N/A|140|Anticipated|HemoSonics LLC|||1||f||||f|f|t|t|f|f|||No||2017-10-10 21:06:27.044746|2017-10-10 21:06:27.044746
NCT03139084|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-21|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Observational|BOTA-PAH||Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension|An Observational, Non-interventional, Multicenter Study to Evaluate the Efficacy and Safety of Upfront Combination of Bosentan and Tadalafil in Pulmonary Arterial Hypertension in Greek Patients|Not yet recruiting||N/A|20|Anticipated|Elpen Pharmaceutical Co. Inc.|||1||f||||f|f|f||||||||2017-10-10 21:06:27.146375|2017-10-10 21:06:27.146375
NCT03139071|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-01|||August 2008|Actual|2008-08-01|May 2017|2017-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Coffee Consumption and Coronary Artery Calcium Score|Coffee Consumption and Coronary Artery Calcium Score: Results From the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)|Completed||N/A|4426|Actual|University of Sao Paulo|||1||f||||||||||||No||2017-10-10 21:06:27.230509|2017-10-10 21:06:27.230509
NCT03139058|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-19|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|June 20, 2019|Anticipated|2019-06-20|June 20, 2019|Anticipated|2019-06-20||Interventional|fibr'HOM||Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck|Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck|Not yet recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:06:27.297216|2017-10-10 21:06:27.297216
NCT03139045|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-19|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|January 20, 2018|Anticipated|2018-01-20|January 20, 2018|Anticipated|2018-01-20||Interventional|VeinGER||Impact of VeinViewer® Vision to Guide Peripheral Venipuncture in Geriatrics|Impact of VeinViewer® Vision to Guide Peripheral Venipuncture in Geriatrics|Not yet recruiting||Phase 3|200|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:06:27.380735|2017-10-10 21:06:27.380735
NCT03139032|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-18|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations|A Phase 2a, Proof of Concept, Open-label Study Evaluating the Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations|Recruiting||Phase 2|20|Anticipated|Arena Pharmaceuticals||1|||f||||f|t|f|||t|||||2017-10-10 21:06:27.467727|2017-10-10 21:06:27.467727
NCT03139019|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-05-01|||June 2014|Actual|2014-06-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|MIPCD||Medicaid Incentives for the Prevention of Chronic Diseases: Diabetes Prevention|Medicaid Incentives for the Prevention of Chronic Diseases: Diabetes Prevention|Completed||N/A|596|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-10 21:06:27.592173|2017-10-10 21:06:27.592173
NCT03139006|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-02|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01|1 Day|Observational [Patient Registry]|CLARITY||Application of speCtraL Computed tomogrAphy to impRove specIficity of Cardiac compuTed tomographY|Diagnostic Accuracy of Spectral Computed Tomography for Detection of Flow Limiting Coronary Stenosis Using Fractional Flow Reserve as the Standard of Reference|Recruiting||N/A|75|Anticipated|UMC Utrecht|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:06:27.707739|2017-10-10 21:06:27.707739
NCT03138993|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-01|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|January 31, 2018|Anticipated|2018-01-31||Interventional|eDecide2Rest||Improving Older Adults' Decision Making for OSAT|Improving Older Adults' Decision Making for Obstructive Sleep Apnea Treatment (Phase 3)|Enrolling by invitation||N/A|36|Anticipated|University of California, Los Angeles||2|||f||||f|f|f||||||No||2017-10-10 21:06:27.780329|2017-10-10 21:06:27.780329
NCT03138980|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-26|||January 30, 2016|Actual|2016-01-30|June 2017|2017-06-01|September 22, 2016|Actual|2016-09-22|September 22, 2016|Actual|2016-09-22||Interventional|||Mobile Self-Management of Irritable Bowel Syndrome for Adolescents|Mobile Self-Management of Irritable Bowel Syndrome for Adolescents: Pilot Study|Completed||N/A|26|Actual|University of California, Los Angeles||1|||f|||||f|f||||||||2017-10-10 21:06:27.853356|2017-10-10 21:06:27.853356
NCT03138967|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-09-19|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Investigation of Sugammadex in Outpatient Urological Procedures|A Phase IV Investigation of Sugammadex in Outpatient Urological Procedures|Recruiting||Phase 4|50|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f|||f|||||2017-10-10 21:06:27.920448|2017-10-10 21:06:27.920448
NCT03138954|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-29|||May 21, 2015|Actual|2015-05-21|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Endoscopic Rectal UltraSound With Elastosonography and Contrast in Deep Pelvic Endometriosis With Bowel Involvement|Place of Endoscopic Rectal Ultrasound With Elastosonography and Contrast in Diagnosis and Supported of Deep Pelvic Endometriosis With Bowel Involvement|Recruiting||N/A|50|Anticipated|Société Française d'Endoscopie Digestive|||1||f|||||f|f||||||No||2017-10-10 21:06:28.017054|2017-10-10 21:06:28.017054
NCT03138941|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-08|||September 1, 2013|Actual|2013-09-01|May 2017|2017-05-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2025|Anticipated|2025-12-31|10 Years|Observational [Patient Registry]|APLCLLDAS||Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region|Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region|Recruiting||N/A|2000|Anticipated|Monash University|||1||f||||t|f|f||||||No|Patient data collected and collated by the Asia Pacific Lupus Collaboration (APLC) is guided by strict protocols and procedures to ensure that privacy and other ethical principles are maintained at all times. Data sharing will strictly follows the APLC Data Access Policy. Under no circumstances will individual subject data be made available to any third parties.|2017-10-10 21:06:28.096755|2017-10-10 21:06:28.096755
NCT03138928|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-03|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Observational|||An Innovation in Glaucoma Surgery: XEN45 Gel Stent Implantation|XEN45 Gel Stent Implantation in Glaucoma Surgery|Completed||N/A|15|Actual|Trakya University|||1||f||||t|f|f|||f|||Yes|This clinical trial is under review for publishing. If it is accepted for publishing,our results will be shared.|2017-10-10 21:06:28.398226|2017-10-10 21:06:28.398226
NCT03138915|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-10-03|||May 18, 2017|Actual|2017-05-18|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|rHVPG||Radiomics-based Hepatic Venous Pressure Gradient (rHVPG) (CHESS1701)|Radiomics-based Hepatic Venous Pressure Gradient (rHVPG) for Clinically Significant Portal Hypertension in Cirrhosis|Recruiting||N/A|350|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t|f|f||||||||2017-10-10 21:06:28.496231|2017-10-10 21:06:28.496231
NCT03138902|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-02|||June 1, 2013|Actual|2013-06-01|April 2017|2017-04-01|December 31, 2013|Actual|2013-12-31|December 31, 2013|Actual|2013-12-31||Interventional|Curves1||Carbohydrate Intolerance Questionnaire Study|Validation of Carbohydrate Intolerance Questionnaire|Completed||N/A|108|Actual|Texas A&M University||1|||f||||t|f|f||||||No||2017-10-10 21:06:28.636906|2017-10-10 21:06:28.636906
NCT03138889|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-15|||June 9, 2017|Actual|2017-06-09|August 2017|2017-08-01|May 30, 2020|Anticipated|2020-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|PROPEL||A Study of a CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-L1 (Atezolizumab) in Patients With Metastatic Urothelial Bladder Cancer or Metastatic Non-Small Cell Lung Cancer|A Phase 1b, Open-label, Multicenter Study to Investigate the Safety and Preliminary Efficacy of NKTR 214 and Anti-PD-L1 (Atezolizumab) in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer or Metastatic Non-Small Cell Lung Cancer|Recruiting||Phase 1|36|Anticipated|Nektar Therapeutics||1|||f||||f|t|f||||||||2017-10-10 21:06:28.705646|2017-10-10 21:06:28.705646
NCT03138876|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-01|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|February 27, 2018|Anticipated|2018-02-27|February 27, 2018|Anticipated|2018-02-27||Interventional|||EEG Cap for Identification of Non-Convulsive Status Epilepticus|EEG Cap Placement for Expedited Identification of Non-Convulsive Status Epilepticus|Not yet recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:06:28.822687|2017-10-10 21:06:28.822687
NCT03138863|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-08|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Pilot Trial FETO for CDH|Pilot Trial of Fetal Endoscopic Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH) at Mayo Clinic|Recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||t|f|t|t|f||||No||2017-10-10 21:06:28.928688|2017-10-10 21:06:28.928688
NCT03138850|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-07-06|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||Improve Oxygenation and Capnographic Detection During Sedative EGD|Comparison of Techniques to Improve Oxygenation and Capnographic Detection During Sedative Gastrointestinal Endoscopy|Completed||N/A|170|Actual|Taipei Veterans General Hospital, Taiwan||3|||f||||t|f|f||||||||2017-10-10 21:06:29.031471|2017-10-10 21:06:29.031471
NCT03138837|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-16|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Observational|||Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage|Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage. Potential Role of the Apparent Diffusion Coefficient (ADC) Value|Recruiting||N/A|385|Anticipated|Mansoura University|||1||f||||t|f|f||||Samples With DNA|"     Bladder Biopsy   "|Yes|meta-analyses by contact the Prof. Hassan Abol-Enein, MD, Phd (Study Chair)|2017-10-10 21:06:29.140297|2017-10-10 21:06:29.140297
NCT03138824|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-19|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC|Storz Professional Image Enhancement System (SPIES) Versus Conventional White Light Imaging (WLI) Assisted Transurethral Resection of Bladder Tumour (TURBT) for Treatment of Non-muscle Invasive Bladder Cancer (NMIBC)|Active, not recruiting||N/A|100|Anticipated|Mansoura University||2|||f||||t|f|f||||||Yes|meta-analyses by contact the Prof. Ahmed Elshal, MD|2017-10-10 21:06:29.233593|2017-10-10 21:06:29.233593
NCT03138811|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-09|||September 29, 2017|Anticipated|2017-09-29|August 2017|2017-08-01|July 15, 2019|Anticipated|2019-07-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma|A Randomized, Subject- and Investigator-blinded, Placebo-controlled, Paralleldesign, Bronchoprovocation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of Inhaled CSJ117 in Adult Subjects With Mild Atopic Asthma|Not yet recruiting||Phase 1|55|Anticipated|Novartis||2|||f||||f|f|f||||||||2017-10-10 21:06:29.326167|2017-10-10 21:06:29.326167
NCT03138798|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-29|||January 6, 2017|Actual|2017-01-06|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dental Support Device in the Second Stage of Labor|Dental Support Device in the Second Stage of Labor at a Major Tertiary Care Center; A Randomized Controlled Trial|Recruiting||N/A|348|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|t|f|f||||No||2017-10-10 21:06:29.434808|2017-10-10 21:06:29.434808
NCT03138785|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-29|||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|July 1, 2017|Anticipated|2017-07-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||UVX as an Adjuvant in the Treatment of Fungal Keratitis|UVX as an Adjuvant in the Treatment of Fungal Keratitis|Active, not recruiting||N/A|20|Actual|Farabi Eye Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:06:29.535407|2017-10-10 21:06:29.535407
NCT03138772|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-10-03|||October 5, 2017|Anticipated|2017-10-05|October 2017|2017-10-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Observational|LCITRACK||Tracking CF Lung Disease Through the Early Years: Utility of the LCI|Tracking CF Lung Disease Through the Early Years: Utility of the LCI|Recruiting||N/A|180|Anticipated|The Hospital for Sick Children|||2||f||||f|f|f||||||||2017-10-10 21:06:29.616634|2017-10-10 21:06:29.616634
NCT03138759|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-01|||February 27, 2017|Actual|2017-02-27|May 2017|2017-05-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|||Effect of Probenecid on Pexidartinib Pharmacokinetics|An Open-label, Randomized, 2-treatment, 2-period, Crossover Study to Evaluate the Effect of Probenecid on the Pharmacokinetics of Pexidartinib in Healthy Subjects|Completed||Phase 1|16|Actual|Daiichi Sankyo, Inc.||2|||f|||||t|f||||||||2017-10-10 21:06:29.7213|2017-10-10 21:06:29.7213
NCT03138746|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-01|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|HOTAIR4||Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric Air|Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric Air|Not yet recruiting||N/A|40|Anticipated|University of Adelaide|||2||f||||f|f|f||||Samples Without DNA|"     Serum   "|No||2017-10-10 21:06:29.83991|2017-10-10 21:06:29.83991
NCT03138733|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-29|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia|A Randomized, Double-blind, Multi-center Study to Establish the Efficacy and Safety of Ceftobiprole Medocaril Compared to Daptomycin in the Treatment of Staphylococcus Aureus Bacteremia, Including Infective Endocarditis|Not yet recruiting||Phase 3|390|Anticipated|Basilea Pharmaceutica||2|||f||||t|t|f||||||No||2017-10-10 21:06:29.94867|2017-10-10 21:06:29.94867
NCT03138720|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-26|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|May 15, 2018|Anticipated|2018-05-15||Interventional|||Pre-operative Treatment for Patients With Untreated Pancreatic Cancer|A Phase II Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Paricalcitol as Pre-operative Treatment in Patients With Untreated Resectable, Borderline Resectable and Locally Advanced Adenocarcinoma of the Pancreas|Recruiting||Phase 2|24|Anticipated|HonorHealth Research Institute||1|||f||||f|t|f|||f|||No|IPD will not be shared with outside researchers.|2017-10-10 21:06:30.039123|2017-10-10 21:06:30.039123
NCT03138707|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-05-02|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Patients Who Die Within Emergency Department|Demographic Characteristics of Patients Who Die Within Emergency Department|Completed||N/A|355|Actual|Adiyaman University Research Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:06:30.140376|2017-10-10 21:06:30.140376
NCT03138694|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-02|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies|Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies|Not yet recruiting||N/A|500|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||t|f|f||||||No||2017-10-10 21:06:30.215564|2017-10-10 21:06:30.215564
NCT03138681|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-03|||May 3, 2017|Actual|2017-05-03|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Rapid Antidepressant Effects of ATP and Phosphocreatine|A Preliminary Clinical Study on the Rapid Antidepressant Effects of Adenosine Triphosphate (ATP) and Phosphocreatine Combinated With Fluoxetine|Recruiting||Phase 2|42|Anticipated|Zhujiang Hospital||3|||f||||t|f|f||||||No||2017-10-10 21:06:30.296188|2017-10-10 21:06:30.296188
NCT03138668|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-06-13|||May 19, 2017|Actual|2017-05-19|March 2017|2017-03-01|June 9, 2017|Actual|2017-06-09|June 9, 2017|Actual|2017-06-09||Interventional|||Cutaneous Anesthesia of the Lateral Femoral Cutaneous Nerve|The Influence of Different Doses of Local Anesthetic on the Distribution of Anesthesia of the Lateral Femoral Cutaneous Nerve - a Randomized, Blinded, Paired Study of Healthy Individuals|Completed||Phase 2|20|Actual|Zealand University Hospital||2|||f||||f|f|f|||f|||Yes|If data is requested by an editor, it will be allowed.|2017-10-10 21:06:30.384071|2017-10-10 21:06:30.384071
NCT03138655|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-15|||June 28, 2017|Actual|2017-06-28|September 2017|2017-09-01|November 4, 2020|Anticipated|2020-11-04|December 2, 2019|Anticipated|2019-12-02||Interventional|||Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease|A Phase 2, Randomized, Double-Blind, Dose-Ranging Study to Determine the Pharmacokinetics, Safety and Tolerability of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease|Recruiting||Phase 2|80|Anticipated|Takeda||2|||f|||||t|f||||||||2017-10-10 21:06:30.526574|2017-10-10 21:06:30.526574
NCT03138642|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-09|||April 18, 2011|Actual|2011-04-18|July 2017|2017-07-01|May 30, 2020|Anticipated|2020-05-30|May 30, 2017|Actual|2017-05-30||Observational|||Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era|A Prospective Multi-center Observational Study in Patients With Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era|Recruiting||N/A|50|Anticipated|Sun Yat-sen University|||1||f||||t|f|f||||||||2017-10-10 21:06:30.772886|2017-10-10 21:06:30.772886
NCT03138629|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-01||||||May 2017|2017-05-01||||||||Expanded Access|||Expanded Access to VAL-083|Expanded Access to VAL-083|Available||N/A|||DelMar Pharmaceuticals, Inc.||||||t|t||||||||||||2017-10-10 21:06:30.872072|2017-10-10 21:06:30.872072
NCT03138616|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-05|||November 1, 2016|Actual|2016-11-01|May 2017|2017-05-01|January 31, 2019|Anticipated|2019-01-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||The Impact of Vitamin D Supplementation on Glucose Metabolism in Chinese Women With Former Gestational Diabetes Mellitus|The Impacts of Vitamin D Supplementation on Glucose Metabolism in Chinese Women With Vitamin D Deficiency and Former Gestational Diabetes Mellitus:A Randomised Control Trial|Enrolling by invitation||Phase 4|180|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||4|||f||||t|f|f||||||No||2017-10-10 21:06:30.925322|2017-10-10 21:06:30.925322
NCT03138603|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-12|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|ORION||Metoprolol to Reduce Perioperative Myocardial Injury|Metoprolol to Reduce Perioperative Myocardial Injury|Recruiting||Phase 3|600|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 21:06:31.016897|2017-10-10 21:06:31.016897
NCT03138590|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-11|||April 4, 2017|Actual|2017-04-04|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Investigating Accelerated Learning in Healthy Subjects: Trigeminal Nerve Stimulation|Investigating Accelerated Learning in Healthy Subjects|Active, not recruiting||N/A|20|Anticipated|The University of Texas at Dallas||2|||f||||f|f|t|f|||||Undecided||2017-10-10 21:06:31.114871|2017-10-10 21:06:31.114871
NCT03138577|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-18|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular BPB|Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Brachial Plexus Blockade|Not yet recruiting||N/A|30|Anticipated|Weill Medical College of Cornell University||1|||f||||f|f|f||||||No||2017-10-10 21:06:31.189164|2017-10-10 21:06:31.189164
NCT03138564|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-06|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|||An Effectiveness-Implementation Trial of SPIRIT in ESRD|An Effectiveness-Implementation Trial of SPIRIT in ESRD|Not yet recruiting||N/A|800|Anticipated|Emory University||2|||f||||t|f|f||||||||2017-10-10 21:06:31.268441|2017-10-10 21:06:31.268441
NCT03138551|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||October 11, 2015|Actual|2015-10-11|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Examining Relationships Between Family Mealtime and Feeding Outcomes in Young Children With Sensory Food Aversions|Examining Relationships Between Family Mealtime Routines and Feeding Outcomes in Young Children With Sensory Food Aversions|Recruiting||N/A|20|Anticipated|University of Pittsburgh||1|||f||||t||||||||No|There is currently no plan to make individual participant data available to other researchers.|2017-10-10 21:06:31.433874|2017-10-10 21:06:31.433874
NCT03138538|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-19|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|January 18, 2019|Anticipated|2019-01-18|January 18, 2019|Anticipated|2019-01-18||Interventional|M8891||M8891 First in Human in Solid Tumors|An Open-label, Phase I Dose Escalation Trial of Methionine Aminopeptidase 2 Inhibitor M8891 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|42|Anticipated|EMD Serono||1|||f||||f|t|f||||||||2017-10-10 21:06:31.52374|2017-10-10 21:06:31.52374
NCT03138525|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-07-12|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis|Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis|Recruiting||N/A|130|Anticipated|Brigham and Women's Hospital|||2||f||||f|f|f|||f|Samples With DNA|"     Serum, plasma, and peripheral blood mononuclear cells.   "|||2017-10-10 21:06:31.742587|2017-10-10 21:06:31.742587
NCT03138512|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-10-05|||July 5, 2017|Actual|2017-07-05|October 2017|2017-10-01|July 7, 2023|Anticipated|2023-07-07|September 5, 2022|Anticipated|2022-09-05||Interventional|CheckMate 914||A Study Comparing the Combination of Nivolumab and Ipilimumab Versus Placebo in Participants With Localized Renal Cell Carcinoma|A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination vs Placebo in Participants With Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse|Recruiting||Phase 3|800|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 21:06:31.874673|2017-10-10 21:06:31.874673
NCT03138499|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-10-03|||May 16, 2017|Actual|2017-05-16|October 2017|2017-10-01|July 27, 2023|Anticipated|2023-07-27|November 29, 2020|Anticipated|2020-11-29||Interventional|CheckMate 812||A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,|Randomized, Open-label, Phase 3 Trial of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Participants With Relapsed Refractory or Ineligible for Autologous Stem Cell Transplant (ASCT) Advanced Stage Classical Hodgkin Lymphoma (CheckMate 812: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 812)|Recruiting||Phase 3|340|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 21:06:32.442837|2017-10-10 21:06:32.442837
NCT03138473|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-03|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of ACS Patients With Multi-Vessel Disease|Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of Acute Coronary Syndrome Patients With Multi-Vessel Disease|Not yet recruiting||N/A|108|Anticipated|Assiut University|||1||f||||f|f|f||||||No|IPD will not be shared with other researchers.|2017-10-10 21:06:32.705292|2017-10-10 21:06:32.705292
NCT03138460|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-02|||January 1, 2015|Actual|2015-01-01|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Analysis of Orthopedic Patients Response to New Pain Modulating Substances and Drugs|Effect of New Pain Modulating Substances in Orthopedics|Recruiting||N/A|100|Anticipated|Rabin Medical Center|||1||f||||f|f|f||||||No||2017-10-10 21:06:32.823338|2017-10-10 21:06:32.823338
NCT03138447|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-01|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|DHIT||A Digital Health Tool for Insulin Titration (DHIT) Individuals With Type 2 Diabetes: A Prospective Outcomes Study With a Retrospective Control Group|A Digital Health Tool for Insulin Titration (DHIT) for Individuals With Type 2 Diabetes: A Prospective Outcomes Study With a Retrospective Control Group.|Recruiting||N/A|30|Anticipated|Amalgam Rx, Inc.||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:06:32.917343|2017-10-10 21:06:32.917343
NCT03138434|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-05-05|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Advanced MRI in AAA|Advanced MRI in AAA|Recruiting||N/A|25|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f|f|f|||f|||Undecided||2017-10-10 21:06:33.014536|2017-10-10 21:06:33.014536
NCT03138421|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-08-03|||August 1, 2017|Actual|2017-08-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Central Pain Study for ABX-1431|A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of ABX-1431 in Patients With Central Pain|Recruiting||Phase 1|32|Anticipated|Abide Therapeutics||2|||f||||f|f|f||||||||2017-10-10 21:06:33.119556|2017-10-10 21:06:33.119556
NCT03138408|ClinicalTrials.gov processed this data on October 10, 2017|2017-05-01|2017-09-29|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|June 15, 2021|Anticipated|2021-06-15|August 31, 2020|Anticipated|2020-08-31||Interventional|||A Study of SC‑004 in Subjects With Advanced Solid Tumors|An Open Label, Phase 1 Study of SC‑004 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|108|Anticipated|AbbVie||1|||f||||f|t|f||||||||2017-10-10 21:06:33.224674|2017-10-10 21:06:33.224674
NCT03138395|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-29|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|August 15, 2019|Anticipated|2019-08-15|February 15, 2018|Anticipated|2018-02-15||Observational|iCare3||iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML|Predicting Disease Relapse by Monitoring Circulating Cancer DNA After Chemotherapy in Patients With MDS and AML|Withdrawn||N/A|0|Actual|University of Florida|||1|"Study design modified to collect specimens from a bank requiring a separate IRB-approved   protocol."|f||||t|f|f||||Samples With DNA|"     -  venipuncture peripheral blood        -  bone marrow        -  finger stick peripheral blood        -  saliva   "|||2017-10-10 21:06:33.317332|2017-10-10 21:06:33.317332
NCT03138382|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-19|||August 25, 2017|Actual|2017-08-25|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VeSTIM||Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry|Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry|Recruiting||N/A|10|Anticipated|University of California, San Diego||2|||f||||f|f|f||||||||2017-10-10 21:06:33.403524|2017-10-10 21:06:33.403524
NCT03138369|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-19|||October 16, 2017|Anticipated|2017-10-16|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|VeSTAL||Vestibular Stimulation to Trigger Adipose Loss Clinical Trial|A Randomized, Double Blind Controlled Trial to Evaluate Efficacy of Vestibular Nerve Stimulation, Combined With a Lifestyle Modification Program, Compared to a Sham Control and Lifestyle Program, as a Means of Reducing Excess Body Fat|Recruiting||N/A|40|Anticipated|University of California, San Diego||2|||f||||f|f|f|||f|||||2017-10-10 21:06:33.50696|2017-10-10 21:06:33.50696
NCT03138356|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-09-21|||May 25, 2017|Actual|2017-05-25|September 2017|2017-09-01|November 28, 2017|Anticipated|2017-11-28|November 28, 2017|Anticipated|2017-11-28||Interventional|||Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects|A Randomized, Single-dose, Open-label, Single-center, Crossover Study to Assess the Fed- and Fasted State Bioequivalence of Fixed-Dose Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects|Recruiting||Phase 1|126|Anticipated|AstraZeneca||9|||f||||f|f|f||||||||2017-10-10 21:06:33.643909|2017-10-10 21:06:33.643909
NCT03138343|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-01|||April 28, 2017||2017-04-28||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:06:33.76328|2017-10-10 21:06:33.76328
NCT03138330|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-01|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|November 2016|Actual|2016-11-01||Observational|||Validation of a Food Frequency Questionnaire|Validation of Dietary Patterns and Inflammatory Salivary Biomarkers Among Healthy Toddlers of 15-36 Months Old in Singapore|Completed||N/A|95|Actual|Danone Asia Pacific Holdings Pte, Ltd.|||1||f||||t|f|f||||Samples Without DNA|"     saliva   "|Undecided|the whole data set (without traceability to the participant) may be available for other researchers for secondary analyses|2017-10-10 21:06:33.801183|2017-10-10 21:06:33.801183
NCT03138317|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-05-10|||January 2, 2017|Actual|2017-01-02|April 2017|2017-04-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Evaluation of Platelet Rich Plasma (PRP) for Knee Osteoarthritis|Evaluation of Platelet Rich Plasma (PRP) for Knee Osteoarthritis|Recruiting||Phase 2|60|Anticipated|University of Sao Paulo||3|||f|||||f|f||||||||2017-10-10 21:06:33.859395|2017-10-10 21:06:33.859395
NCT03138304|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-08-22|||May 2, 2017|Actual|2017-05-02|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Trial of a Video Game Intervention to Recalibrate Physician Heuristics: A Followup Study|Trial of a Video Game Intervention to Recalibrate Physician Heuristics: A Followup Study|Completed||N/A|142|Actual|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 21:06:33.939115|2017-10-10 21:06:33.939115
NCT03138291|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-04-30|||June 2016||2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|OSApod||Efficacy of Oral Appliances on Obstructive Sleep Apnea During Pregnancy|Efficacy of Oral Appliances on Obstructive Sleep Apnea During Pregnancy|Recruiting||N/A|25|Anticipated|Université de Montréal||1|||f||||f||||||||Yes||2017-10-10 21:06:34.016287|2017-10-10 21:06:34.016287
NCT03138278|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|VIP2||Impact on Family or Care-givers of Very Old ICU-survivors, Trajectories and 6 Months' Outcome in the Very Old.|Impact on Family or Care-givers of Very Old ICU-survivors, Trajectories and 6 Months' Outcome in the Very Old.|Not yet recruiting||N/A|1000|Anticipated|University of Bergen||2|||f||||f|f|f||||||No||2017-10-10 21:06:34.089438|2017-10-10 21:06:34.089438
NCT03138265|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-05-05|||September 2015||2015-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|eHIT||HIT Training in the Frail Elderly.|Improvements in Aerobic Performance Following a Four-week Period of High Intensity Interval Training in the Elderly.|Recruiting||N/A|34|Anticipated|University of Nottingham||1|||f||||||||||||||2017-10-10 21:06:34.161198|2017-10-10 21:06:34.161198
NCT03138252|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2017-08-30|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin|Randomized Controlled Trial: Cervical Ripening Balloon With and Without Oxytocin for Cervical Ripening in Multiparas|Completed||Phase 3|180|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 21:06:34.248319|2017-10-10 21:06:34.248319
NCT03138239|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-02|||July 2, 2017|Anticipated|2017-07-02|February 2017|2017-02-01|July 2, 2019|Anticipated|2019-07-02|July 2, 2018|Anticipated|2018-07-02||Interventional|||The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG|The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG|Not yet recruiting||N/A|16|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:06:34.316503|2017-10-10 21:06:34.316503
NCT03138226|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-02|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2020|Anticipated|2020-12-31|10 Years|Observational [Patient Registry]|UTx-twin||Living Donor Uterus Transplantation Between Identical Twins|Living Donor Uterus Transplantation Between Identical Twins|Recruiting||N/A|6|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||f|f|f||||Samples Without DNA|"     Cervical biopsies   "|No|Published in articles|2017-10-10 21:06:34.379608|2017-10-10 21:06:34.379608
NCT03138213|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-28|||March 1, 2018|Anticipated|2018-03-01|April 2017|2017-04-01|September 1, 2020|Anticipated|2020-09-01|March 1, 2020|Anticipated|2020-03-01||Interventional|||Comparing Three Dimension Laparoscopic Versus Open Pancreaticoduodenectomy|Randomized Clinical Trial Comparing Three Dimension Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy|Not yet recruiting||N/A|150|Anticipated|Tongji Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:06:34.445265|2017-10-10 21:06:34.445265
NCT03138200|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-28|||March 8, 2017|Actual|2017-03-08|April 2017|2017-04-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||The Role of Central Venous Oxygen Saturation (ScvO2) as an Indicator of Blood Transfusion in the Critically Ill|The Role of Central Venous Oxygen Saturation (ScvO2) as an Indicator of Blood Transfusion in the Critically Ill|Recruiting||N/A|160|Anticipated|Szeged University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:06:34.512526|2017-10-10 21:06:34.512526
NCT03138187|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-06-19|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Physical Exercise and Energy Balance|Effect of Physical Exercise Intensity on Spontaneous Physical Activity Energy Expenditure and Energy Intake in Overweight Adults: a Study Protocol for a Randomized Controlled Trial.|Recruiting||N/A|81|Anticipated|Rio de Janeiro State University||3|||f||||f|f|f||||||No||2017-10-10 21:06:34.600418|2017-10-10 21:06:34.600418
NCT03138174|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-27|||March 23, 2017|Actual|2017-03-23|June 2017|2017-06-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Observational|OTVFSA||OneTouch Verio Flex System Accuracy Evaluation|OneTouch Verio Flex System Accuracy Evaluation|Completed||N/A|100|Actual|LifeScan|||1||f||||f|f|t|f|f|f|None Retained|"     Capillary blood samples   "|No|De identified data may be shared by way of study reports and publications|2017-10-10 21:06:34.69359|2017-10-10 21:06:34.69359
NCT03138161|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-26|||April 13, 2017|Actual|2017-04-13|May 2017|2017-05-01|August 31, 2020|Anticipated|2020-08-31|June 30, 2020|Anticipated|2020-06-30||Interventional|||Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue Sarcoma|Phase 1/2 Study of Safety/Efficacy Using TRABECTEDIN, IPILIMUMAB and NIVOLUMAB Triple Therapy as First Line Treatment of Advanced Soft Tissue Sarcoma|Recruiting||Phase 1/Phase 2|45|Anticipated|Sarcoma Oncology Research Center, LLC||1|||f||||t|t|f|||f|||No||2017-10-10 21:06:34.769528|2017-10-10 21:06:34.769528
NCT03138148|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-02|||May 26, 2010|Actual|2010-05-26|May 2017|2017-05-01|January 6, 2017|Actual|2017-01-06|October 17, 2012|Actual|2012-10-17||Observational|Asynchrony||Evaluation of the Patient-ventilator Asynchrony During Mechanical Ventilation for Pediatric Acute Respiratory Failure|Evaluation of the Patient-ventilator Asynchrony During Mechanical Ventilation for Pediatric Acute Respiratory Failure|Completed||N/A|60|Actual|St. Justine's Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:06:34.874676|2017-10-10 21:06:34.874676
NCT03138135|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-01|||January 9, 2017|Actual|2017-01-09|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||HOME Study: Evaluation of a Combination Support Package to Increase Uptake of Pre-Exposure Prophylaxis and HIV/STI Testing Among Young Black and Latino MSM in the San Francisco Bay Area.|HOME Study: Evaluation of a Combination Support Package to Increase Uptake of Pre-exposure Prophylaxis and HIV/STI Testing Among Young Black and Latino MSM in the San Francisco Bay Area.|Recruiting||N/A|200|Anticipated|Public Health Foundation Enterprises, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:06:34.939685|2017-10-10 21:06:34.939685
NCT03138122|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||February 9, 1993|Actual|1993-02-09|April 2017|2017-04-01|December 31, 2043|Anticipated|2043-12-31|December 31, 2043|Anticipated|2043-12-31||Observational|||The Study of Men Born in 1943|The Study of Men Born in 1943 - A Longitudinal Cohort Study From Middle-Age and Onward|Active, not recruiting||N/A|798|Actual|Sahlgrenska University Hospital, Sweden|||1||f||||f|f|f||||||No||2017-10-10 21:06:35.049709|2017-10-10 21:06:35.049709
NCT03138109|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-05-02|||August 31, 2015|Actual|2015-08-31|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||Analysis of Incidence and Risk Factors of Severe Cardiovascular Events in Patients With Diastolic Dysfunction|Analysis of Incidence and Risk Factors of Severe Cardiovascular Events in Patients With Diastolic Dysfunction|Completed||N/A|4347|Actual|Peking University First Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:06:35.116002|2017-10-10 21:06:35.116002
NCT03138096|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-28|||May 29, 2017|Actual|2017-05-29|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|PbVac||Safety and Protective Efficacy of Pb(PfCS@UIS4)|Safety and Protective Efficacy of Genetically Modified Plasmodium Berghei (Pb(PfCS@UIS4)) Malaria Parasites in Healthy Volunteers|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Radboud University||5|||f||||t|f|f||||||||2017-10-10 21:06:35.184845|2017-10-10 21:06:35.184845
NCT03138070|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-26|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719|A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719|Not yet recruiting||N/A|30|Anticipated|Lawson Health Research Institute||1|||f|||||f|f||||||||2017-10-10 21:06:35.439065|2017-10-10 21:06:35.439065
NCT03138057|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-21|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|June 12, 2017|Actual|2017-06-12||Observational|||BM Characterization Pilot|Comparison of Fecal Digestive Enzymes in Infant Aged Between 0-1 Years Old|Active, not recruiting||N/A|25|Actual|Kimberly-Clark Corporation|||1||f||||f|f|f||||||No||2017-10-10 21:06:35.549437|2017-10-10 21:06:35.549437
NCT03138044|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-09-24|||May 20, 2017|Actual|2017-05-20|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular Carcinoma|Long Term Outcome of Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment (CILDAT) of the Large Hepatocellular Carcinoma (HCC)|Recruiting||N/A|12|Anticipated|The National Ribat University||1|||f||||f|f|f||||||||2017-10-10 21:06:35.619297|2017-10-10 21:06:35.619297
NCT03138031|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-09-24|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|May 1, 2018|Anticipated|2018-05-01||Interventional|||Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular Carcinoma|Outcome of Percutaneous Ethanol Alcohol Injection (PEI) for the Large and Unresectable Hepatocellular Carcinoma.|Recruiting||N/A|15|Anticipated|The National Ribat University||1|||f||||f|f|f||||||||2017-10-10 21:06:35.729227|2017-10-10 21:06:35.729227
NCT03138018|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-04|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 1, 2022|Anticipated|2022-07-01|July 1, 2022|Anticipated|2022-07-01||Interventional|AGING||Aging Stereotypes and Prodromal Alzheimer's Disease|The Potential Impact of Aging Stereotypes in the Assessment of Memory Deficits and Screening for Prodromal State of Alzheimer's Disease|Not yet recruiting||N/A|260|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f|f|f||||||No||2017-10-10 21:06:35.822898|2017-10-10 21:06:35.822898
NCT03138005|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|EXACT||Reduction of Oxygen After Cardiac Arrest|Reduction of Oxygen After Cardiac Arrest (EXACT): The EXACT Study|Not yet recruiting||N/A|1416|Anticipated|Monash University||2|||f||||t|f|f|||f|||||2017-10-10 21:06:35.932221|2017-10-10 21:06:35.932221
NCT03137992|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-04-30|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|December 29, 2017|Anticipated|2017-12-29|December 15, 2017|Anticipated|2017-12-15||Interventional|||Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness|A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Crossover, Multicenter Clinical Study to Assess the Efficacy and Safety of Once Daily Administration of Lupin Tiotropium Bromide Inhalation Powder Compared to SPIRIVA® HANDIHALER® and Placebo in Patients With COPD Including a 12-Week Open Label Extension to Assess Inhaler Robustness|Recruiting||Phase 3|240|Anticipated|Lupin Ltd.||3|||f||||f|t|f|||f|||||2017-10-10 21:06:36.173396|2017-10-10 21:06:36.173396
NCT03137979|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-28|||January 2017||2017-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Gingiva Mesenchymal Stem Cells Treatment of Chronic Periodontitis|The Safety and Efficacy Evaluation of Gingiva Mesenchymal Stem Cells Transplantation in Chronic Periodontitis Patients|Recruiting||Phase 1/Phase 2|30|Anticipated|Hebei Medical University||3|||f||||t|f|f||||||No||2017-10-10 21:06:36.373446|2017-10-10 21:06:36.373446
NCT03137966|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-30|2017-08-18|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|DEFEHU||Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers|Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers|Not yet recruiting||Phase 2|174|Anticipated|Karolinska University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:06:36.498058|2017-10-10 21:06:36.498058
NCT03137953|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-08|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Role of Imaging to Predict the Deep Surgical Margin in Gingivobuccal Complex Tumors|Role of Imaging to Predict the Deep Surgical Margin in Gingivobuccal Complex Tumors|Recruiting||N/A|30|Anticipated|HealthCare Global Enterprise Ltd.||1|||f||||f||||||||No||2017-10-10 21:06:36.602313|2017-10-10 21:06:36.602313
NCT03137940|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-30|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|March 30, 2018|Anticipated|2018-03-30|March 20, 2018|Anticipated|2018-03-20||Interventional|||A Study on Safety of tDCS One-shot in UCP|"A Study on Safety and Feasibility of a Session of Transcranial Electrical Stimulation (tDCS One-shot) in Children and Young Adults With Unilateral Cerebral Palsy (UCP)"|Recruiting||N/A|12|Anticipated|IRCCS Fondazione Stella Maris||2|||f||||t|f|f||||||No||2017-10-10 21:06:36.714559|2017-10-10 21:06:36.714559
NCT03137927|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-14|||June 13, 2017|Actual|2017-06-13|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine|A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine; A Randomized Placebo-controlled Dose-escalating Study of Single-use GamLPV Safety and Tolerability in Healthy Human Volunteers|Recruiting||Phase 1|36|Anticipated|Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation||6|||f||||t|f|f||||||Undecided||2017-10-10 21:06:36.815901|2017-10-10 21:06:36.815901
NCT03137914|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-28|||May 8, 2015|Actual|2015-05-08|April 2017|2017-04-01|January 2, 2020|Anticipated|2020-01-02|January 2, 2019|Anticipated|2019-01-02||Interventional|||Nasal Septum Autologous Chondrocytes Transplantation for Condylar Resorption After Orthognathic Surgery|Clinical Study for the Evaluation of the Safety and Effectiveness of Autologous Chondrocytes Transplantation for the Treatment of Condylar Resorption Associated With Dentofacial Deformities|Recruiting||Phase 1|10|Anticipated|Faculdade de Medicina de Petrópolis Faculdade Arthur Sá Earp Neto||1|||f||||t|f|f||||||Undecided||2017-10-10 21:06:36.930318|2017-10-10 21:06:36.930318
NCT03137901|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-29|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|Capstesia||Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring|Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring.|Completed||N/A|40|Actual|Erasme University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:06:37.055328|2017-10-10 21:06:37.055328
NCT03137888|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-10-04|||September 20, 2017|Actual|2017-09-20|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma|Pilot Study of Spectroscopic MRI-Guided, Dose-Escalated Radiation Therapy for Newly-Diagnosed Glioblastoma|Recruiting||Phase 2|36|Anticipated|Emory University||1|||f||||t|t|f||||||||2017-10-10 21:06:37.124808|2017-10-10 21:06:37.124808
NCT03137875|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-22|2017-04-28|||March 2011||2011-03-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis|Evaluation of the PCR Using DNA Extracts From Stained Slides and Sputum Collected on Filter Paper for Identification and Detection of Tuberculosis and Multidrug Resistant (MDR) Tuberculosis|Completed||N/A|122|Actual|Epicentre|||3||f||||t||||||||No||2017-10-10 21:06:37.261279|2017-10-10 21:06:37.261279
NCT03137862|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-08|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|December 13, 2017|Anticipated|2017-12-13|April 2, 2017|Actual|2017-04-02||Interventional|GLUFR||"Gluten Friendly Treatment in Celiac Disease"|"A Prospective, Double Blind, Placebo-controlled Trial to Evaluate Efficacy and Safety of a Gluten Friendly Bread in Population With Celiac Disease"|Enrolling by invitation||N/A|45|Actual|Casa Sollievo della Sofferenza IRCCS||3|||f||||f|f|f||||||No||2017-10-10 21:06:37.358734|2017-10-10 21:06:37.358734
NCT03137849|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-18|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|December 20, 2018|Anticipated|2018-12-20|June 30, 2018|Anticipated|2018-06-30||Interventional|YOGINI||Yoga Poses and Breath Control Cardiovascular Changes in Hypertensive Post-Menopause Women|Autonomic and Cardiovascular Changes of Yoga Poses, Breath Control and Stretching Exercises in Hypertensive Post-Menopause Women: Randomized Controlled Trial|Enrolling by invitation||N/A|100|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||4|||f||||t|f|f||||||||2017-10-10 21:06:37.444297|2017-10-10 21:06:37.444297
NCT03137836|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-04-28|||January 4, 2016|Actual|2016-01-04|April 2017|2017-04-01|June 17, 2016|Actual|2016-06-17|June 9, 2016|Actual|2016-06-09||Interventional|||Classroom Standing Desks for Reducing Sitting Time in Children|Effects of Sit-to-stand Desks on Behavior and Cognitive Function in Children|Completed||N/A|49|Actual|University of Lisbon||2|||f||||f|f|f||||||No||2017-10-10 21:06:38.135329|2017-10-10 21:06:38.135329
NCT03137823|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Diagnosis of GABHS Tonsillitis - Comparison Between Culture From Tonsills and Culture From the Bucal Surface|Diagnosis of GABHS Tonsillitis - Comparison Between Culture From Tonsills and Culture From the Bucal Surface|Not yet recruiting||N/A|100|Anticipated|Bait Balev Hospital||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:06:38.225714|2017-10-10 21:06:38.225714
NCT03137810|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-13|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|November 1, 2017|Anticipated|2017-11-01||Interventional|PLCD||Placental Cord Drainage Versus no Placental Drainage in the Management of Third Stage of Labour|Placental Cord Drainage Versus no Placental Drainage in the Management of Third Stage of Labour: Randomized Controlled Trial|Recruiting||N/A|180|Anticipated|Ain Shams University||2|||f||||t|f|f||||||||2017-10-10 21:06:38.293646|2017-10-10 21:06:38.293646
NCT03137797|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-04-28|||February 2004||2004-02-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|COPANA||Cohort of Patients Naive of Antiretroviral Treatment at Enrollment|Cohort of Patients Naive of Antiretroviral Treatment at Enrollment|Completed||N/A|800|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f||||||||No||2017-10-10 21:06:38.388114|2017-10-10 21:06:38.388114
NCT03137784|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-28|||May 17, 2017|Anticipated|2017-05-17|April 2017|2017-04-01|April 16, 2018|Anticipated|2018-04-16|April 16, 2018|Anticipated|2018-04-16||Interventional|||Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma|A Multicenter, Randomized, Double-blind, Placebo-controlled 3-period Complete Cross-over Study to Assess the Bronchodilator Effects and Safety of Glycopyrronium Bromide (NVA237) (25 ug and 50 ug o.d.) in Asthma Patients.|Not yet recruiting||Phase 2/Phase 3|144|Anticipated|Novartis||6|||f||||f|t|f||||||Undecided||2017-10-10 21:06:38.478767|2017-10-10 21:06:38.478767
NCT03137771|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-29|||April 7, 2017|Actual|2017-04-07|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|September 2020|Anticipated|2020-09-01||Interventional|||Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer|Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial|Recruiting||Phase 2|300|Anticipated|NRG Oncology||2|||f||||t|t|f||||||||2017-10-10 21:06:38.608508|2017-10-10 21:06:38.608508
NCT03137758|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-18|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer|A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 1|48|Anticipated|Pellficure Pharmaceuticals, Inc||6|||f||||t|t|f||||||||2017-10-10 21:06:39.016717|2017-10-10 21:06:39.016717
NCT03137745|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||March 2015||2015-03-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Coagulation Profile of Patients Undergoing CRS(Cytoreductive Surgery) and Hyperthermic Intraperitoneal Chemotherapy|To Study the Changes in Coagulation Profile in Patients Undergoing CRS(CYTOREDUCTIVE SURGERY) and HIPEC(HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY)|Completed||N/A|60|Actual|Rajiv Gandhi Cancer Institute & Research Center, India|||1||f||||t||||||||||2017-10-10 21:06:39.12526|2017-10-10 21:06:39.12526
NCT03137732|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|SPARC||Surgical Versus Anaesthetic Placement of Rectus Sheath Catheters|Surgical Placement Versus Anaesthetic Placement of Rectus Sheath Catheter for Pain Relief Following Major Abdominal Surgery (SPARC). A Single Centre Randomised Controlled Trial|Not yet recruiting||N/A|50|Anticipated|Countess of Chester NHS Foundation Trust||2|||f||||t|f|f||||||Undecided||2017-10-10 21:06:39.191459|2017-10-10 21:06:39.191459
NCT03137719|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-28|||January 1, 2011|Actual|2011-01-01|April 2017|2017-04-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Observational|||Infections in Hospitalized Cirrhotic Patients|Infections and Other Complications of Cirrhosis: A Prospective Multi-Center Study|Active, not recruiting||N/A|385|Actual|Baylor Research Institute|||1||f|||||f|f||||||||2017-10-10 21:06:39.269281|2017-10-10 21:06:39.269281
NCT03137706|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-29|2017-04-29|||November 14, 2016|Actual|2016-11-14|April 2017|2017-04-01|February 14, 2019|Anticipated|2019-02-14|February 14, 2018|Anticipated|2018-02-14||Observational|||Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer|Characterization of Mechanical Tissue Properties in Pancreas, Liver and Colon|Recruiting||N/A|40|Anticipated|University of Southern California|||1||f||||t|f|f||||Samples With DNA|"     Tissue   "|Undecided||2017-10-10 21:06:39.34541|2017-10-10 21:06:39.34541
NCT03137693|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-10-04|||April 28, 2017|Actual|2017-04-28|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer|A Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy|Recruiting||N/A|40|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|f|f||||||||2017-10-10 21:06:39.456585|2017-10-10 21:06:39.456585
NCT03137680|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-04-28|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|March 20, 2019|Anticipated|2019-03-20|December 15, 2018|Anticipated|2018-12-15||Interventional|||Pre-Operative Forearm Exercise On Arteriovenous Fistula Mauration|Effect Of Pre-Operative Forearm Exercise On Arteriovenous Fistula Mauration and Blood Flow|Not yet recruiting||N/A|40|Anticipated|Changi General Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:06:39.551763|2017-10-10 21:06:39.551763
NCT03137667|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||November 30, 2015|Actual|2015-11-30|May 2017|2017-05-01|July 31, 2016|Actual|2016-07-31|January 15, 2016|Actual|2016-01-15||Interventional|SKIPP RCT2||School-located Influenza Vaccination Clinics for Adolescents|Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York|Completed||N/A|17650|Actual|University of California, Los Angeles||2|||f||||f||f||||||Undecided||2017-10-10 21:06:39.651487|2017-10-10 21:06:39.651487
NCT03137654|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-16|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Sex Differences, Cognitive Training & Emotion Processing|Sex Differences, Cognitive Training & Emotion Processing|Recruiting||N/A|100|Anticipated|University of Florida||3|||f||||f|f|f||||||||2017-10-10 21:06:39.722709|2017-10-10 21:06:39.722709
NCT03137641|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||June 15, 2017|Anticipated|2017-06-15|April 2017|2017-04-01|June 15, 2018|Anticipated|2018-06-15|June 15, 2018|Anticipated|2018-06-15||Observational|CACIES||Nurses Internal Contamination by Antineoplastic Drugs.|Assessment of Nurses Internal Contamination by Antineoplastic Drugs in Hospital Centers.|Not yet recruiting||N/A|225|Anticipated|University Hospital, Bordeaux|||1||f||||f|f|f||||Samples Without DNA|"     Urine samples   "|No||2017-10-10 21:06:39.828177|2017-10-10 21:06:39.828177
NCT03137615|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-04-28|||November 2014||2014-11-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||The Cardiovascular Changes Associated With Septal Local Anaesthesia|An Observational Study of the Cardiovascular Response to Infiltration of Local Anaesthetic Into the Nasal Septum in Patients Undergoing Trans-sphenoidal Resection of a Pituitary Lesion|Completed||N/A|15|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 21:06:41.826916|2017-10-10 21:06:41.826916
NCT03137602|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-04-28|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||ATOMIC (Active Teens With MultIple sClerosis) Teens: A Feasibility Study|ATOMIC (Active Teens With MultIple sClerosis) Teens: A Feasibility Study|Not yet recruiting||N/A|15|Anticipated|The Hospital for Sick Children||1|||f||||f|f|f||||||No||2017-10-10 21:06:41.9112|2017-10-10 21:06:41.9112
NCT03137589|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-22|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|October 31, 2021|Anticipated|2021-10-31|October 31, 2021|Anticipated|2021-10-31||Observational|TELnet@NRW||Telemedical, Intersectoral Network as New Digital Health Structure to Measurably Improve the Local Health Care|Telemedical, Intersectoral Network as New Digital Health Structure to Measurably Improve the Local Health Care|Recruiting||N/A|40000|Anticipated|RWTH Aachen University|||2||f||||t|f|f||||||No||2017-10-10 21:06:41.996947|2017-10-10 21:06:41.996947
NCT03137576|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-05|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|April 14, 2018|Anticipated|2018-04-14|April 14, 2018|Anticipated|2018-04-14||Observational|||Non-intubated Thoracoscopic Lung Resections|Non-intubated Thoracoscopic Lung Resections: Serratus Plane Block as an Alternative to Thoracic Epidural Anesthesia|Not yet recruiting||N/A|90|Anticipated|Sacro Cuore Don Calabria General Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:06:42.085489|2017-10-10 21:06:42.085489
NCT03137563|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-04|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|August 30, 2017|Anticipated|2017-08-30||Observational|||Acceptability of HPV-self Sampling|Evaluation of the Acceptability of HPV Self-sampling Among French Women Eligible for Cervical Cancer Screening|Not yet recruiting||N/A|230|Anticipated|University Hospital, Montpellier|||1||f||||f|f|f||||||Undecided|NC|2017-10-10 21:06:42.167395|2017-10-10 21:06:42.167395
NCT03137550|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-04-28|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|COMBAT-CAD||Combined Use of Multiple Biomarkers With Stress Testing to Detect Coronary Artery Disease|Combined Use of Multiple Biomarkers With Stress Testing to Detect Coronary Artery Disease|Recruiting||N/A|3000|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f|f|f||||||No||2017-10-10 21:06:42.2536|2017-10-10 21:06:42.2536
NCT03136874|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-26|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|DonDon||Motivations and Psychological Aspects of the Gametes' Donation|Motivations and Psychological Aspects of the Gametes' Donation|Recruiting||N/A|800|Anticipated|University Hospital, Toulouse|||2||f||||f|f|f||||||No||2017-10-10 21:06:48.286547|2017-10-10 21:06:48.286547
NCT03137537|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-28|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|April 30, 2023|Anticipated|2023-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.|Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.|Not yet recruiting||Phase 2|60|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f|||t|||No||2017-10-10 21:06:42.331083|2017-10-10 21:06:42.331083
NCT03137524|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-03|||May 24, 2017|Actual|2017-05-24|August 2017|2017-08-01|July 26, 2017|Actual|2017-07-26|July 26, 2017|Actual|2017-07-26||Interventional|||Fan Therapy in COPD Patients|A Pilot Study of Hand-held Fan Therapy in Breathless Chronic Obstructive Pulmonary Disease (COPD) Patients|Completed||N/A|14|Actual|City, University of London||2|||f||||f|f|f||||||||2017-10-10 21:06:42.433268|2017-10-10 21:06:42.433268
NCT03137511|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-07|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|May 23, 2018|Anticipated|2018-05-23|May 23, 2018|Anticipated|2018-05-23||Interventional|OASE Melanome||Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist|Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist|Recruiting||N/A|532|Anticipated|Nantes University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:06:42.508567|2017-10-10 21:06:42.508567
NCT03137498|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-28|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|March 6, 2019|Anticipated|2019-03-06|March 6, 2019|Anticipated|2019-03-06||Interventional|||Lidocaine vs Ketorolac for Renal Colic|Lidocaine Versus Ketorolac for the Management of Renal Colic|Recruiting||Phase 4|60|Anticipated|The Brooklyn Hospital Center||2|||f||||t|t|f|||f|||No||2017-10-10 21:06:42.615541|2017-10-10 21:06:42.615541
NCT03137485|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-28|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison Between Conventional vs. Endoscopic Lumbar Discectomy|Management of Lumbar Postero-lateral Single Level Disc Herniation: Comparative Study Between Conventional and Endoscopic Lumbar Discectomy|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f|||||f|f||||||Yes||2017-10-10 21:06:42.863836|2017-10-10 21:06:42.863836
NCT03137472|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-08-22|||April 24, 2017|Actual|2017-04-24|August 2017|2017-08-01|June 29, 2018|Anticipated|2018-06-29|June 29, 2018|Anticipated|2018-06-29||Interventional|||TMS for Complex Regional Pain Syndrome|Transcranial Magnetic Stimulation (TMS) for Complex Regional Pain Syndrome (CRPS)|Recruiting||N/A|40|Anticipated|Stanford University||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:06:42.970137|2017-10-10 21:06:42.970137
NCT03137459|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-27|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 31, 2020|Anticipated|2020-07-31|January 31, 2020|Anticipated|2020-01-31||Interventional|STAMP||STAMP: Sharing and Talking About My Preferences|STAMP: Sharing and Talking About My Preferences|Not yet recruiting||N/A|1000|Anticipated|Yale University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:06:43.063467|2017-10-10 21:06:43.063467
NCT03137446|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-27|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|RIFTS||Restrictive Intravenous Fluids Trial in Sepsis|Assessing Targeted Fluid Resuscitation Strategies Among Patients With Severe Sepsis and Septic Shock|Recruiting||N/A|150|Anticipated|Rhode Island Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:06:43.154844|2017-10-10 21:06:43.154844
NCT03137433|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-01|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|April 1, 2022|Anticipated|2022-04-01|March 31, 2022|Anticipated|2022-03-31||Interventional|||Weight Loss With Meal-Replacement Therapy in Teens|Enhancing Weight Loss With Meal-Replacement Therapy in Teens With Severe Obesity|Not yet recruiting||N/A|142|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||||2017-10-10 21:06:43.289851|2017-10-10 21:06:43.289851
NCT03137420|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-01|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Observational|||Psychological Distress in Relatives of Severely Injured Patients|Psychological Distress in Relatives of Severely Injured Patients|Recruiting||N/A|100|Anticipated|University of Zurich|||2||f||||f|f|f||||||No||2017-10-10 21:06:43.381607|2017-10-10 21:06:43.381607
NCT03137407|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-11|||June 12, 2017|Actual|2017-06-12|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis|A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis|Recruiting||Phase 2|60|Anticipated|Revance Therapeutics, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:06:43.48887|2017-10-10 21:06:43.48887
NCT03137394|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-01|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|September 30, 2020|Anticipated|2020-09-30|October 31, 2019|Anticipated|2019-10-31||Observational|||Development of a Model of Shoulder Pain Following Spinal Cord Injury|Development of a Biopsychosocial Prospective Surveillance Model of Shoulder Pain in Individuals With Spinal Cord Injury|Not yet recruiting||N/A|68|Anticipated|Drexel University|||2||f||||f|f|f||||||Yes|Results will be presented at annual meetings, as described below as well as anticipated numerous manuscripts, regardless of the results. The outcomes will be of interest to the public, researchers, policy makes, and funding sources. Final Research Data (de-identified and unidentifiable) defined as recorded factual material commonly accepted in the scientific community as necessary to document and support research findings will be available upon request of such agencies as the DOD, the Food and Drug Administration (FDA), Medicare/Medicaid, or others who hold interest or cause to review the raw data. No protected health information (PHI) will be collected for this study.|2017-10-10 21:06:43.617299|2017-10-10 21:06:43.617299
NCT03137381|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-15|||August 9, 2017|Actual|2017-08-09|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata|Recruiting||Phase 2|90|Anticipated|Concert Pharmaceuticals||3|||f||||t|t|f||||||||2017-10-10 21:06:43.727092|2017-10-10 21:06:43.727092
NCT03136354|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2017-04-27|||May 2009||2009-05-01|April 2017|2017-04-01||||July 2017|Anticipated|2017-07-01||Interventional|LGE||Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection Against Laparoscopic Assisted Gastrectomy for Treatment of Early Gastric Cancer||Recruiting||N/A|86|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-10 21:06:52.737411|2017-10-10 21:06:52.737411
NCT03137368|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-19|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 30, 2023|Anticipated|2023-06-30|June 30, 2023|Anticipated|2023-06-30||Interventional|STEP||A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）|A Randomized Controlled Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）|Recruiting||Phase 4|300|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||t|t|f|||t|||No||2017-10-10 21:06:43.846251|2017-10-10 21:06:43.846251
NCT03137355|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-04-28|||June 17, 2015|Actual|2015-06-17|April 2017|2017-04-01|June 17, 2025|Anticipated|2025-06-17|June 17, 2025|Anticipated|2025-06-17|10 Years|Observational [Patient Registry]|||The Leigh Syndrome Registry|The International Database for Leigh Syndrome|Recruiting||N/A|200|Anticipated|The University of Texas Health Science Center, Houston|||1||f|||||f|f||||||||2017-10-10 21:06:43.961954|2017-10-10 21:06:43.961954
NCT03137342|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-01|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Pepped on Pre-exposure Prophylaxis (PrEP): A Counseling and Problem-Solving PrEP Adherence Intervention for Stimulant Using Men Who Have Sex With Men (MSM).|Pepped on Pre-exposure Prophylaxis (PrEP): Pilot-randomized Controlled Trial (RCT) to Assess the Feasibility/Acceptability of the Pepped-for-PrEP Package (Counseling and Problem-solving PrEP Adherence Intervention With Behavioral Activation (BA) Approach) Among Stimulant Abusing MSM.|Recruiting||N/A|30|Anticipated|Brown University||2|||f||||t|f|f||||||Yes||2017-10-10 21:06:44.049201|2017-10-10 21:06:44.049201
NCT03137329|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-08|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Surgical vs. Lifestyle in Obese Older Adults|Comparison of Surgical vs. Lifestyle Weight Treatment in Obese Older Adults|Recruiting||N/A|20|Anticipated|Beth Israel Deaconess Medical Center||2|||f|||||f|f||||||No||2017-10-10 21:06:44.151734|2017-10-10 21:06:44.151734
NCT03137316|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-01|||January 1, 2014|Actual|2014-01-01|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|February 28, 2017|Actual|2017-02-28||Observational|||Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy|Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy|Completed||N/A|437|Actual|Benha University|||1||f||||f|f|f||||||No||2017-10-10 21:06:44.284099|2017-10-10 21:06:44.284099
NCT03137303|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-27|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 30, 2019|Anticipated|2019-11-30|November 1, 2019|Anticipated|2019-11-01||Interventional|REDEFINE||Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)|Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)|Not yet recruiting||Phase 3|460|Anticipated|University of Illinois at Chicago||2|||f||||f|f|f||||||Yes||2017-10-10 21:06:44.358035|2017-10-10 21:06:44.358035
NCT03137290|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-05-01|||December 1, 2014|Actual|2014-12-01|May 2017|2017-05-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|JS||Comparing Reversal With Neostigmine and Sugammadex in Paediatric|Comparison Between the Efficacy of Neostigmine Versus Sugammadex Reversal of Rocuronium Induced Neuromuscular Blockade In Paediatric Patients.|Completed||N/A|80|Actual|University of Science Malaysia||2|||f||||t|f|f||||||No||2017-10-10 21:06:44.48248|2017-10-10 21:06:44.48248
NCT03137277|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-04|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|September 2016|Actual|2016-09-01||Observational|||A Study Between Two Instrument Generations to Improve Adenoma Detection in Screening Colonoscopy|A Randomized Comparative Study Between Two Instrument Generations to Improve Adenoma Detection in Screening Colonoscopy|Completed||N/A|1221|Actual|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f|f|f||||Samples Without DNA|"     Colon Polyps and Adenoma   "|||2017-10-10 21:06:44.593502|2017-10-10 21:06:44.593502
NCT03137264|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-29|||October 9, 2017|Anticipated|2017-10-09|September 2017|2017-09-01|September 28, 2020|Anticipated|2020-09-28|September 28, 2020|Anticipated|2020-09-28||Observational|RADIANCE||Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients|An Open-Label, Non-randomized, Prospective Biomarker Study to Assess Analytic Concordance Between Non-invasive Testing and Tissue Testing for EGFR T790M Mutation Detection in Patients With Non-small Cell Lung Cancer|Not yet recruiting||N/A|470|Anticipated|AstraZeneca|||2||f||||f|t|f|||f|Samples With DNA|"     Whole blood, urine, and tissue   "|||2017-10-10 21:06:44.84849|2017-10-10 21:06:44.84849
NCT03137251|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-09-30|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 2, 2018|Anticipated|2018-05-02|November 1, 2017|Anticipated|2017-11-01||Interventional|||Evaluation of the Effectiveness of Transcutaneous Electrical Nerve Stimulation During Labor.|Evaluation of the Effectiveness of Transcutaneous Electrical Nerve Stimulation During Labor. A Triple Blind Randomized Clinical Trial|Recruiting||N/A|63|Anticipated|University of Las Palmas de Gran Canaria||3|||f||||f|f|f||||||||2017-10-10 21:06:45.010575|2017-10-10 21:06:45.010575
NCT03137238|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-01|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|January 1, 2018|Anticipated|2018-01-01||Observational|SMP_PD||Self-motion Perception in Parkinson's Disease|Optic Flow and Vestibular Sensory Integration in Self-motion Perception in Parkinson's Disease|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center|||4||f||||f|f|f||||||No|There is currently no plan for sharing IPD|2017-10-10 21:06:45.153199|2017-10-10 21:06:45.153199
NCT03137225|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-26|||April 15, 2017|Actual|2017-04-15|April 2017|2017-04-01|October 30, 2019|Anticipated|2019-10-30|April 15, 2019|Anticipated|2019-04-15||Interventional|||Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants|Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants|Recruiting||N/A|15|Anticipated|Virginia Commonwealth University||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:06:45.262489|2017-10-10 21:06:45.262489
NCT03137212|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-30|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|SEPCIT||Safety and Efficacy of Percutaneous Coronary Intervention Combined With Thrombolysis at Different Time|Study of Safety and Efficacy of Percutaneous Coronary Intervention Combined With Thrombolysis by Recombinant Human Prourokinase at Different Time|Recruiting||N/A|120|Anticipated|Second Hospital of Jilin University||2|||f||||t|f|f|||f|||Yes|when the investigators complete the study and publish our data|2017-10-10 21:06:45.367674|2017-10-10 21:06:45.367674
NCT03136159|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-24|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications|The Role of Adherent Occlusive Antimicrobial Absorbent Foam Dressing in Prevention of Cesarean Section Wound Complications|Recruiting||N/A|185|Anticipated|Loyola University||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:06:54.073047|2017-10-10 21:06:54.073047
NCT03137199|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-12|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ASTEC||Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma|A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Mild Asthma|Recruiting||Phase 1|6|Anticipated|University of Miami||2|||f||||t|t|f||||||||2017-10-10 21:06:45.478582|2017-10-10 21:06:45.478582
NCT03137186|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-04-29|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|Mansmed||Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer|Mansmed Trial : Repurposing Metformin as Anticancer Drug, RCT in Advanced Prostate Cancer|Recruiting||Phase 2|120|Anticipated|Mansoura University||2|||f||||t|t|f|||t|||No||2017-10-10 21:06:45.674562|2017-10-10 21:06:45.674562
NCT03137173|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-29|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections|A Randomized, Double-blind, Multicenter Study to Establish the Safety and Efficacy of Ceftobiprole Medocaril Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections|Not yet recruiting||Phase 3|674|Anticipated|Basilea Pharmaceutica||2|||f||||f|t|f||||||No||2017-10-10 21:06:45.781941|2017-10-10 21:06:45.781941
NCT03137160|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-10-02|||May 4, 2017|Actual|2017-05-04|October 2017|2017-10-01|May 31, 2018|Anticipated|2018-05-31|March 1, 2018|Anticipated|2018-03-01||Interventional|||An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum|An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum|Recruiting||Phase 2|5|Anticipated|Ohio State University||1|||f||||t|t|f|||f|||||2017-10-10 21:06:45.870547|2017-10-10 21:06:45.870547
NCT03137147|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-10-03|||February 2, 2016|Actual|2016-02-02|October 2017|2017-10-01|October 2, 2018|Anticipated|2018-10-02|June 2, 2018|Anticipated|2018-06-02||Interventional|I-SPY||Intervention for Sleep and Pain in Youth|Intervention for Sleep and Pain in Youth: A Feasibility Study of Cognitive-Behavioral Intervention|Recruiting||N/A|25|Anticipated|Seattle Children's Hospital||1|||f||||f|f|f||||||||2017-10-10 21:06:45.96273|2017-10-10 21:06:45.96273
NCT03137134|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-08|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|October 11, 2017|Anticipated|2017-10-11|September 17, 2017|Anticipated|2017-09-17||Interventional|||A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.|A Phase 1, Open-label, Single Dose Study To Evaluate The Effects Of Food And The Proton Pump Inhibitor, Esomeprazole, On The Pharmacokinetics Of Crizotinib In A Coated Microsphere Formulation In Adult Healthy Volunteers|Active, not recruiting||Phase 1|18|Actual|Pfizer||5|||f||||f|t|f|||f|||||2017-10-10 21:06:46.070395|2017-10-10 21:06:46.070395
NCT03137121|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-19|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients|Olanzapine for the Treatment of Chronic Nausea and/or Vomiting, Unrelated to Chemotherapy or Radiation, in Advanced Cancer Patient - A Pilot, Dose-Finding Trial|Recruiting||Phase 2/Phase 3|30|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f||||||No||2017-10-10 21:06:46.179931|2017-10-10 21:06:46.179931
NCT03137108|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-26|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects of Transcutaneous Spinal Cord Stimulation on Residual Voluntary Motor Control in Individuals With Incomplete Spinal Cord Injury|Effects of Transcutaneous Spinal Cord Stimulation on Residual Voluntary Motor Control, Standing, and Overground Walking in Individuals With Incomplete Spinal Cord Injury Single Centre Pilot Study Investigating Immediate Effects of Transcutaneous Electrical Spinal Cord Stimulation on Voluntary Ankle and Knee Control, Standing and Overground Walking in Incomplete Spinal Cord Injury|Not yet recruiting||N/A|15|Anticipated|University of Zurich||1|||f|||||f|f||||||||2017-10-10 21:06:46.278429|2017-10-10 21:06:46.278429
NCT03137095|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-31|||February 20, 2017|Actual|2017-02-20|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients and Non-Cancer Control Participants|Longitudinal Pilot Mechanistic Study of the Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients and Non-Cancer Control Participants|Recruiting||N/A|150|Anticipated|University of Rochester|||2||f||||t|f|f||||Samples With DNA|"     whole blood, serum, plasma   "|||2017-10-10 21:06:46.345725|2017-10-10 21:06:46.345725
NCT03137082|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-27|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)|Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)|Recruiting||Phase 1/Phase 2|60|Anticipated|Stony Brook University||2|||f||||t|t|f|||f|||No||2017-10-10 21:06:46.443364|2017-10-10 21:06:46.443364
NCT03137069|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-09-28|||May 26, 2017|Actual|2017-05-26|September 2017|2017-09-01|April 10, 2018|Anticipated|2018-04-10|April 10, 2018|Anticipated|2018-04-10||Interventional|||Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)|A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study of GDC-0853 in Patients With Refractory Chronic Spontaneous Urticaria (CSU)|Recruiting||Phase 2|45|Anticipated|Hoffmann-La Roche||2|||f||||f|f|f||||||||2017-10-10 21:06:46.548045|2017-10-10 21:06:46.548045
NCT03137056|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-27|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|DIALOMIC||Characterization of Removal Capacities of the Theranova Membrane by Proteomic Investigations|Characterization of Proteins and Forms of Albumin Removal Capacities of the Theranova Membrane by Innovating Proteomic Investigations|Not yet recruiting||N/A|20|Anticipated|Hospices Civils de Lyon||3|||f||||f|f|f||||||||2017-10-10 21:06:46.635981|2017-10-10 21:06:46.635981
NCT03137043|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-09-18|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 28, 2018|Anticipated|2018-12-28|December 28, 2018|Anticipated|2018-12-28||Observational|||Prevalence of Severe Asthma in Spanish Hospitals|Observational Study to Describe the Prevalence of Severe Asthma in Spanish Hospitals|Not yet recruiting||N/A|1600|Anticipated|GlaxoSmithKline|||2||f||||f|f|f||||||||2017-10-10 21:06:46.724507|2017-10-10 21:06:46.724507
NCT03135808|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-24|||May 18, 2017|Actual|2017-05-18|April 2017|2017-04-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|WISE||Surgical Anatomy and 'Waisting' of the sIgmoid SpEcimen|Surgical Anatomy and 'Waisting' of the sIgmoid SpEcimen|Recruiting||N/A|20|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||t|f|f||||||No||2017-10-10 21:06:57.279162|2017-10-10 21:06:57.279162
NCT03137030|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-19|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults|A Relative Bioavailability Trial to Investigate the Pharmacokinetics of Different Amounts of Tablets of Two Immediate Release Fixed Dose Combinations of Hydrocodone Bitartrate 5 mg/Acetaminophen 325 mg (a New Abuse Deterrent Tablet and a Marketed Tablet) Under Fasted Conditions in Healthy Male and Female Adult Subjects|Withdrawn||Phase 1|0|Actual|Grünenthal GmbH||6||program discontinued|f||||f|t|f||||||||2017-10-10 21:06:46.809589|2017-10-10 21:06:46.809589
NCT03137017|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-19|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults|A Relative Bioavailability Trial to Investigate the Pharmacokinetics of Two Immediate Release Fixed Dose Combinations of Hydrocodone Bitartrate and Acetaminophen (a New Abuse Deterrent Tablet and a Marketed Tablet) Administered Under Fasted and Fed Conditions in Healthy Male and Female Adult Subjects|Withdrawn||Phase 1|0|Actual|Grünenthal GmbH||4||program discontinued|f||||f|t|f||||||||2017-10-10 21:06:46.907553|2017-10-10 21:06:46.907553
NCT03137004|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-05|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 10, 2018|Anticipated|2018-10-10|April 10, 2018|Anticipated|2018-04-10||Interventional|||Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer|A Single-arm Phase II Trial of Biweekly Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer|Not yet recruiting||Phase 2|47|Anticipated|Fujian Cancer Hospital||1|||f||||f|f|f|||f|||No||2017-10-10 21:06:46.998175|2017-10-10 21:06:46.998175
NCT03136991|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-09-27|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|November 17, 2017|Anticipated|2017-11-17|November 17, 2017|Anticipated|2017-11-17||Interventional|||A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease|A Phase I, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4831 After Multiple Ascending Dose Administration to Healthy Male Subjects|Recruiting||Phase 1|60|Anticipated|AstraZeneca||4|||f||||t|t|f||||||||2017-10-10 21:06:47.094543|2017-10-10 21:06:47.094543
NCT03136978|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-01|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|November 15, 2018|Anticipated|2018-11-15|May 15, 2018|Anticipated|2018-05-15||Observational|||Evaluation of M1 and M2 Macrophages in Endometriotic Tissue of Women Affected by Endometriosis at Different Stages.|Evaluation of Evaluate M1 and M2 Macrophages in Endometriotic Tissue of Women Affected by Endometriosis at Different Stages.|Recruiting||N/A|80|Anticipated|University of Messina|||2||f||||f|f|f||||Samples Without DNA|"     -  Endometriotic tissue (histologically confirmed) from patients affected by endometriosis          at different stages (cases).        -  Tissue samples from ovarian functional cysts (controls).   "|Yes||2017-10-10 21:06:47.21726|2017-10-10 21:06:47.21726
NCT03136965|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-26|||August 18, 2016|Actual|2016-08-18|April 2017|2017-04-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|PRP||Platelet-Rich Plasma Therapy for Patellar Tendinopathy|Platelet-Rich Plasma (PRP) Therapy for Patellar Tendinopathy: A Randomized Controlled Trial Correlating Clinical, Biomechanical and Novel Imaging Biomarkers|Recruiting||Phase 2|66|Anticipated|University of Wisconsin, Madison||3|||f||||f|t|f|||f|||No||2017-10-10 21:06:47.324689|2017-10-10 21:06:47.324689
NCT03136952|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-11|||April 28, 2017|Actual|2017-04-28|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|February 28, 2018|Anticipated|2018-02-28||Observational|||Cerebral Oxygenation, Different Measurement Points and Their Correlation in Pediatric Population|How Cerebral Oxygenation Correlates, Measured at Various Cranial Points, Frontally and Occipital in Children Under 1 Years Old, During General Anesthesia and Surgery|Recruiting||N/A|25|Anticipated|Göteborg University|||1||f||||f|f|f||||||No||2017-10-10 21:06:47.51612|2017-10-10 21:06:47.51612
NCT03136939|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-06-28|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|May 31, 2017|Actual|2017-05-31|May 30, 2017|Actual|2017-05-30||Observational|||Study of IGRP-specific T Cell in Peripheral Blood of Type 1 Diabetes Mellitus|Study of IGRP-specific T Cell in Peripheral Blood of Type 1 Diabetes Mellitus|Completed||N/A|30|Actual|First Affiliated Hospital of Zhejiang University|||3||f||||f|f|f||||||No|IPD be shared while request by email|2017-10-10 21:06:47.60463|2017-10-10 21:06:47.60463
NCT03136926|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-26|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|SAFE-ICU||Screening Anti-Fungal Exposure in Intensive Care Units|An International, Multi-centre Prospective Pharmacokinetic Evaluation of Antifungal Drug Exposure in Intensive Care Unit Patients Receiving Conventional Dosing Regimens|Recruiting||N/A|150|Anticipated|The University of Queensland|||1||f||||f|f|f||||||No||2017-10-10 21:06:47.696436|2017-10-10 21:06:47.696436
NCT03136913|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-03|||February 17, 2015|Actual|2015-02-17|May 2017|2017-05-01|October 11, 2016|Actual|2016-10-11|April 1, 2016|Actual|2016-04-01||Interventional|||A Comparison Between Primary and Secondary Flap Coverage in Extraction Sites: A Pilot Study|A Comparison Between Primary and Secondary Flap Coverage in Extraction Sites: A Pilot Study|Completed||N/A|13|Actual|Tufts University School of Dental Medicine||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:06:47.951688|2017-10-10 21:06:47.951688
NCT03136900|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-01|||April 27, 2017|Actual|2017-04-27|April 2017|2017-04-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|DIETCHIRCARD||Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of With Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation,After Surgery for Congenital Heart Disease, in Infants.|Controlled, Randomized, Double-blind, Monocentric Clinical Study Evaluating the Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation, After Surgery for Congenital Heart Disease, in Children Aged Zero to Two Years Old|Recruiting||N/A|150|Anticipated|Queen Fabiola Children's University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:06:48.047937|2017-10-10 21:06:48.047937
NCT03136887|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-06|||July 28, 2017|Actual|2017-07-28|September 2017|2017-09-01|April 2029|Anticipated|2029-04-01|April 2029|Anticipated|2029-04-01||Interventional|||JOURNEY II XR Safety and Effectiveness PMCF|A Prospective, Multicenter, Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the JOURNEY™ II XR Total Knee System|Recruiting||N/A|174|Anticipated|Smith & Nephew, Inc.||1|||f||||f|f|t|f|||||||2017-10-10 21:06:48.145845|2017-10-10 21:06:48.145845
NCT03136861|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-07-25|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|February 22, 2019|Anticipated|2019-02-22|November 2, 2018|Anticipated|2018-11-02||Interventional|SKIPPAIN||SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis|A 24-week, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Secukinumab in Controlling Spinal Pain in Patients With Axial Spondyloarthritis|Recruiting||Phase 3|352|Anticipated|Novartis||2|||f||||f|f|f||||||||2017-10-10 21:06:48.507194|2017-10-10 21:06:48.507194
NCT03136848|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-26|||December 19, 2016|Actual|2016-12-19|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|NEVKP||The Feasibility and Safety of Normothermic ex Vivo Kidney Perfusion|A Single Centre Study of the Feasibility and Safety of Using Normothermic ex Vivo Machine Perfusion to Store Human Kidneys for Transplantation.|Recruiting||N/A|25|Anticipated|University Health Network, Toronto||1|||f||||f||||||||No||2017-10-10 21:06:48.62246|2017-10-10 21:06:48.62246
NCT03136835|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-10-05|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|MATCH||Maternal Hyperoxygenation in Congenital Heart Disease|Maternal Hyperoxygenation in Congenital Heart Disease|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|The Hospital for Sick Children||1|||f||||f|f|f||||||||2017-10-10 21:06:48.746472|2017-10-10 21:06:48.746472
NCT03136822|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-04-28|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|December 26, 2017|Anticipated|2017-12-26|December 26, 2017|Anticipated|2017-12-26||Interventional|DERMAN||DERMALIX Efficacy on Diabetic Foot Ulcers|Clinical Evaluation of the Wound Dressing Impregnated With Microparticules (DERMALIX) on Diabetic Foot Ulcers|Recruiting||N/A|48|Anticipated|Dermis Pharma||2|||f||||f|f|f||||||No||2017-10-10 21:06:48.825198|2017-10-10 21:06:48.825198
NCT03136809|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-07-18|||May 8, 2017|Actual|2017-05-08|July 2017|2017-07-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||ALS Treatment Extension Study|A Treatment Continuation Study for Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease Who Have Successfully Completed Study CMD-2016-001|Recruiting||Phase 1/Phase 2|50|Anticipated|Collaborative Medicinal Development Pty Limited||1|||f||||t|t|f|||t|||||2017-10-10 21:06:48.941218|2017-10-10 21:06:48.941218
NCT03136796|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-05-07|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|May 2, 2018|Anticipated|2018-05-02|December 31, 2017|Anticipated|2017-12-31||Observational|||Glycocalyx Damage and Beta-lactam Antibiotics in Surgical Critically Ill|Alterations of Glycocalyx in Critical Illness and During Major Surgery and Approaches for Glycocalyx Protection|Enrolling by invitation||N/A|20|Anticipated|University Hospital Hradec Kralove|||1||f||||f|t|f||||||No||2017-10-10 21:06:49.041032|2017-10-10 21:06:49.041032
NCT03136783|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-04-28|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|September 22, 2019|Anticipated|2019-09-22|September 22, 2019|Anticipated|2019-09-22||Interventional|SkinTher||New Tumor Models in Three Dimensions and in a Human Skin Environment for Personalized Melanoma Therapy|New Tumor Models in Three Dimensions and in a Human Skin Environment for Personalized Melanoma Therapy|Recruiting||N/A|8|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:06:49.116228|2017-10-10 21:06:49.116228
NCT03136770|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-04-27|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|April 10, 2017|Actual|2017-04-10|April 10, 2017|Actual|2017-04-10||Interventional|||A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K)|A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K) and Red Ginseng Extracts 2.94 g After a Single Oral Dose in Healthy Male Volunteers|Completed||N/A|25|Actual|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 21:06:49.200253|2017-10-10 21:06:49.200253
NCT03136757|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-07-19|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Observational|||Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells|Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:06:49.281308|2017-10-10 21:06:49.281308
NCT03136744|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Reducing Sedentary Behaviour: A Novel Opportunity for Managing Comorbidity in MS?|Reducing Sedentary Behaviour: A Novel Opportunity for Managing Comorbidity in MS?|Not yet recruiting||N/A|40|Anticipated|University of Alberta||1|||f||||f|f|f||||||Yes|Participants de-identified data may be shared with our co-PI, Dr. Motl, with University of Alabama at Birmingham|2017-10-10 21:06:49.348216|2017-10-10 21:06:49.348216
NCT03136731|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-26|||May 8, 2017|Anticipated|2017-05-08|April 2017|2017-04-01|December 31, 2032|Anticipated|2032-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|||Evidence-based Screening Strategies for Celiac Disease|Improving Case-finding Strategies for Celiac Disease in Family Members: a Follow-up Study|Not yet recruiting||N/A|3517|Anticipated|Tampere University Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:06:49.446265|2017-10-10 21:06:49.446265
NCT03136718|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-27|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|September 30, 2018|Anticipated|2018-09-30|July 31, 2018|Anticipated|2018-07-31||Observational|m2Hear||mHealth Technologies for Hearing Aid Users|The Feasibility of mHealth Technologies to Improve Hearing Aid Use and Benefit in First-time Hearing Aid Users|Recruiting||N/A|77|Anticipated|Nottingham University Hospitals NHS Trust|||1||f||||f|f|f||||||No||2017-10-10 21:06:49.522006|2017-10-10 21:06:49.522006
NCT03136705|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-27|||February 3, 2016|Actual|2016-02-03|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Healthy Combine Study|Short-Term Effects of Nicotinamide and Lanthanum Carbonate on Phosphorus Homeostasis in Healthy Volunteers|Recruiting||Phase 1|80|Anticipated|Northwestern University||4|||f||||t|t|f|||f|||No||2017-10-10 21:06:49.64244|2017-10-10 21:06:49.64244
NCT03136692|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-11|||May 1, 2016|Actual|2016-05-01|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Analysis of De-identified Data From Commercially-available App Lose It!|Analysis of De-identified Data From Commercially-available App Lose It!|Active, not recruiting||N/A|7007|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||f|f|f||||||No||2017-10-10 21:06:49.759321|2017-10-10 21:06:49.759321
NCT03135600|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-25|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|May 21, 2017|Actual|2017-05-21|May 17, 2017|Actual|2017-05-17||Interventional|||The Influence of Running to ACL Deficiency|The Influence of Running to Kinematic Parameters of Patients With ACL Deficiency|Completed||N/A|60|Actual|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f|f|f||||||No||2017-10-10 21:07:00.649082|2017-10-10 21:07:00.649082
NCT03136679|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-05-02|||March 22, 2017|Actual|2017-03-22|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|April 30, 2019|Anticipated|2019-04-30||Observational|BVB||Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease|Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease|Recruiting||N/A|220|Anticipated|Baylor Research Institute|||3||f||||f|f|f||||Samples With DNA|"     All samples will be analyzed using a targeted metabolomic platform by liquid chromatography     mass spectrometry (LC-MS). Further analysis will include determining 28 metabolite ratios     from this data that will indicate activity of specific pathways. In addition, the     investigators will analyze plasma samples for levels of vitamin B9 (folate), vitamin B12,     vitamin B6, and several other metabolites related to methylation (8 metabolites).      DNA will be extracted from whole blood for genotyping of the following mutations using     Taqman® SNP genotyping assays from Life Technologies. This analysis will include genotyping     of ApoE4 and SNP's related to folate metabolism.   "|No||2017-10-10 21:06:49.823512|2017-10-10 21:06:49.823512
NCT03136666|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-28|2017-04-28|||April 19, 2010|Actual|2010-04-19|April 2017|2017-04-01|June 7, 2010|Actual|2010-06-07|June 7, 2010|Actual|2010-06-07||Interventional|||Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.|Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.|Completed||Phase 1|12|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 21:06:49.903918|2017-10-10 21:06:49.903918
NCT03136653|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-07-03|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma|A Phase 2 Open-label, Single-arm, Multicenter Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Refractory and Relapsed Multiple Myeloma|Recruiting||Phase 1/Phase 2|40|Anticipated|Molecular Partners AG||1|||f||||t|f|f||||||||2017-10-10 21:06:49.998704|2017-10-10 21:06:49.998704
NCT03136640|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-12|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer|Multicenter Safety, Feasibility and Pharmacokinetic Phase II Trial of ModraDoc006/r in Patients With Metastatic Castration-resistant Prostate Cancer|Recruiting||Phase 2|20|Anticipated|Modra Pharmaceuticals||1|||f||||t|f|f||||||No||2017-10-10 21:06:50.106527|2017-10-10 21:06:50.106527
NCT03136627|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-28|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC|A Phase 1b/2, Open-Label, Multi-Center Study of Tivozanib in Combination With Nivolumab in Subjects With Metastatic Renal Cell Carcinoma|Recruiting||Phase 1/Phase 2|32|Anticipated|AVEO Pharmaceuticals, Inc.||1|||f||||f|f|f||||||No||2017-10-10 21:06:50.192786|2017-10-10 21:06:50.192786
NCT03136614|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-29|||June 2016||2016-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prognostic Value of the Arteriograph in the Surgical Theatre and at the Intensive Care Unit|Prognostic Value of the Arteriograph in the Surgical Theatre and at the Intensive Care Unit|Recruiting||N/A|30|Anticipated|Szeged University||3|||f||||f||||||||||2017-10-10 21:06:50.287391|2017-10-10 21:06:50.287391
NCT03136601|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-27|||October 1, 2016||2016-10-01|April 2017|2017-04-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested Need|Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested Need|Recruiting||N/A|70|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:06:50.35226|2017-10-10 21:06:50.35226
NCT03136588|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-11|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Information and Communication Technology (ICT) Based Centralized Clinical Trial Monitoring System for Drug Adherence|The Efficacy and Stability of Information and Communication Technology Based Centralized Clinical Trial Monitoring System of Adherence to Immunosuppressive Medication in Kidney Transplant Recipients|Recruiting||N/A|100|Anticipated|Kyungpook National University||2|||f||||t|f|f||||||No||2017-10-10 21:06:50.421736|2017-10-10 21:06:50.421736
NCT03136575|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-01|||March 28, 2016|Actual|2016-03-28|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Impact of Qigong on Quality of Life and Sleep Disturbance in Head and Neck Patients Undergoing Radiotherapy|The Impact of the Digital Traditional Qigong Regimen Exercises on Quality of Life and Sleep Disturbance in Head and Neck Patients Undergoing Radiotherapy|Recruiting||N/A|60|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:06:50.506681|2017-10-10 21:06:50.506681
NCT03136562|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-02|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|February 1, 2019|Anticipated|2019-02-01||Observational|||Prevalence of Adrenal Insufficiency in Kidney Transplanted Patients in Glucocorticoid Treatment|Prevalence of Adrenal Insufficiency in Kidney Transplanted Patients (NTx) in Glucocorticoid Treatment|Recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark|||2||f||||t|f|f||||Samples With DNA|"     Whole blood and saliva.   "|Undecided||2017-10-10 21:06:50.585325|2017-10-10 21:06:50.585325
NCT03136549|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-05|||June 10, 2017|Anticipated|2017-06-10|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Cuff Inflation-supplemented Videoscope-guided Nasal Intubation|Cuff Inflation-supplemented Videoscope-guided Nasal Intubation: The Effect of Tube Thermo-softening on the Nasotracheal Navigability|Not yet recruiting||N/A|100|Anticipated|Hallym University Kangnam Sacred Heart Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:06:50.780992|2017-10-10 21:06:50.780992
NCT03136536|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-10-02|||May 3, 2017|Actual|2017-05-03|April 2017|2017-04-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Observational|ODEA||Organ Failure After Advanced Endovascular Thoracoabdominal Aortic Surgery|Kärlkirurgi Vid Komplicerade kroppspulsåderbråck - Utfall, Riskfaktorer Och sökande Efter biomarkörer för Organskada|Recruiting||N/A|60|Anticipated|Region Örebro County|||1||f||||f|f|f||||Samples Without DNA|"     Plasma, urine, cerebrospinal fluid, intraperitoneal microdialysate   "|||2017-10-10 21:06:50.86336|2017-10-10 21:06:50.86336
NCT03136523|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-09-06|||March 2016||2016-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|LUNGTMA||Tissue Microarrays (TMAs) Construction in Lung Cancer Samples|Evaluation of the Prognostic and Predictive Significance of EGFR, Kirsten Rat Sarcoma (KRAS), Anaplastic Lymphoma Kinase , Programmed Death-Ligand 1 (PD-L1) Protein and Microsatellite Instability (MSI) in Lung Cancer|Recruiting||N/A|500|Anticipated|Oncology Center of Biochemical Education And Research|||1||f||||f||||||Samples With DNA|"     Tissue samples from small biopsies ( core needle biopsy, FNB, excisional biopsy, incisional     biopsy) or surgical resection   "|||2017-10-10 21:06:50.947151|2017-10-10 21:06:50.947151
NCT03136510|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-02|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|ECAN||Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban|Prospective Study With Biological Assessment: Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban|Recruiting||N/A|60|Anticipated|Hopital Lariboisière||2|||f||||t|f|f||||||No||2017-10-10 21:06:51.044152|2017-10-10 21:06:51.044152
NCT03136497|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-05|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|May 30, 2020|Anticipated|2020-05-30|May 30, 2020|Anticipated|2020-05-30||Interventional|||A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma|Phase Ib Dose Finding Study of ABT-199 (A-1195425.0) Plus Ibrutinib (PCI-32765) and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell NHL (DLBCL)|Recruiting||Phase 1|30|Anticipated|Hackensack University Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:06:51.155562|2017-10-10 21:06:51.155562
NCT03136484|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-28|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|November 21, 2018|Anticipated|2018-11-21|October 11, 2018|Anticipated|2018-10-11||Interventional|SUSTAIN 8||Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes|Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes|Recruiting||Phase 3|784|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 21:06:51.329445|2017-10-10 21:06:51.329445
NCT03136471|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-27|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Impact of CMS Reimbursement Policy Supporting Care Coordination in Louisiana|Natural Experiments of the Impact of Population-Targeted Health Policies to Prevent Diabetes and Its Complications|Recruiting||N/A|12000|Anticipated|Tulane University|||6||f||||f|f|f||||||Undecided||2017-10-10 21:06:51.741296|2017-10-10 21:06:51.741296
NCT03136458|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-22|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|PAIR||Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR)|Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR Trial)|Suspended||N/A|144|Anticipated|Fundacion Clinica Valle del Lili||2||No resources|f||||t|f|f||||||||2017-10-10 21:06:51.832416|2017-10-10 21:06:51.832416
NCT03136445|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-26|||June 2015||2015-06-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Interventional|TREATT||TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia|A Double-blind, Randomised Controlled Trial Evaluating the Safety and Efficacy of Antifibrinolytics (Tranexamic Acid) in Patients With Haematological Malignancies With Severe Thrombocytopenia|Recruiting||Phase 3|616|Anticipated|NHS Blood and Transplant||2|||f||||t||||||||||2017-10-10 21:06:51.92641|2017-10-10 21:06:51.92641
NCT03136432|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-28|||December 14, 2016|Actual|2016-12-14|June 2017|2017-06-01|September 15, 2017|Anticipated|2017-09-15|August 15, 2017|Anticipated|2017-08-15|1 Day|Observational [Patient Registry]|||Clinical Determinants of the 6 Minute Walk Test in Cerebral Palsy|Clinical Determinants of the 6 Minute Walk Test in Children With Cerebral Palsy|Recruiting||N/A|25|Anticipated|Gazi University|||1||f||||t|f|f||||||||2017-10-10 21:06:52.080448|2017-10-10 21:06:52.080448
NCT03136419|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-27|||October 31, 2016|Actual|2016-10-31|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|October 31, 2018|Anticipated|2018-10-31||Interventional|MEP1||Microbiota and Immune microEnvironment in Pouchitis|Microbiota and Immune microEnvironment in Pouchitis: Randomized Controlled Trial Oral Administration of Lactobacillus Casei DG After Ileostomy Closure in Ileal Pouch Mucosa|Recruiting||N/A|32|Anticipated|University of Padova||2|||f||||f|f|f||||||No||2017-10-10 21:06:52.177354|2017-10-10 21:06:52.177354
NCT03136406|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-08-23|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy|NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy|Recruiting||Phase 1/Phase 2|80|Anticipated|NantCell, Inc.||1|||||||f|t|f||||||||2017-10-10 21:06:52.296861|2017-10-10 21:06:52.296861
NCT03136393|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-04-27|||November 1, 2015|Actual|2015-11-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|April 12, 2017|Actual|2017-04-12||Interventional|||Effect of Dietary Counseling During Pregnancy on Infant Birthweight in Mangochi , Malawi|A Protocol for a Cluster Randomized Controlled Trial Measuring the Effect of Dietary Counseling During Pregnancy on Infant Birthweight in Nankumba, Mangochi District, Malawi|Active, not recruiting||N/A|300|Actual|University of Oslo||2|||f||||f||||||||Undecided||2017-10-10 21:06:52.399851|2017-10-10 21:06:52.399851
NCT03136380|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-14|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Study of Danirixin in Japanese Healthy Elderly Male Subjects|A Single Centre, Double Blind (Sponsor Open), Placebo Controlled, 3-Period Crossover, Ascending Dose Study in Japanese Healthy Elderly Male Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of Danirixin in the Fed State (Part1) and an Open Label, 2-way Crossover to Evaluate Food Effect on the Pharmacokinetics of Danirixin (Part2)|Completed||Phase 1|34|Actual|GlaxoSmithKline||5|||f||||f|f|f||||||||2017-10-10 21:06:52.483067|2017-10-10 21:06:52.483067
NCT03136367|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-27|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|October 31, 2019|Anticipated|2019-10-31|March 1, 2019|Anticipated|2019-03-01||Interventional|||What Matters Most: Choosing the Right Breast Cancer Surgery for You|Comparative Effectiveness of Encounter Decision Aids for Early-Stage Breast Cancer Across Socioeconomic Strata|Not yet recruiting||N/A|1100|Anticipated|Dartmouth-Hitchcock Medical Center||3|||f||||t|f|f||||||No||2017-10-10 21:06:52.594212|2017-10-10 21:06:52.594212
NCT03136341|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-18|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor|A Placebo-controlled, Double-blind, Randomized, Cross Over Pilot Study of the Efficacy and Tolerability of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor|Not yet recruiting||Phase 4|25|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|t|f|||f|||||2017-10-10 21:06:52.826561|2017-10-10 21:06:52.826561
NCT03136328|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-26|||May 16, 2016|Actual|2016-05-16|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|15-06-274||Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET-CT Scan|Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET-CT Scan|Completed||Phase 3|11|Actual|Montefiore Medical Center||1|||||||t|t|f||||||No||2017-10-10 21:06:52.93778|2017-10-10 21:06:52.93778
NCT03136315|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-09-11|||September 7, 2017|Actual|2017-09-07|April 2017|2017-04-01|September 10, 2017|Actual|2017-09-10|September 10, 2017|Actual|2017-09-10||Interventional|INFERNAL||Evaluation of the Renal Function in an Ultra-endurance Race.|Renal Function Evaluation in an Ultra Endurance Race: On the Interest of Monitoring Specific Biomarkers to Asses Renal Risk.|Completed||N/A|54|Actual|Central Hospital, Nancy, France||1|||f||||t|f|f||||||||2017-10-10 21:06:53.003387|2017-10-10 21:06:53.003387
NCT03136302|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-27|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Observational|||Correlation of Tractography and Motor Evoked Potentials in Deep Brain Stimulation|Correlation of Tractography and Motor Evoked Potentials in Deep Brain Stimulation|Not yet recruiting||N/A|60|Anticipated|Nova Scotia Health Authority|||3||f||||f|f|f||||||Undecided||2017-10-10 21:06:53.077294|2017-10-10 21:06:53.077294
NCT03136289|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-27|||December 2013|Actual|2013-12-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|||Family Consumer Behaviors, Adolescent Prediabetes and Diabetes|Family Consumer Behaviors, Adolescent Prediabetes and Diabetes in the National Health and Nutrition Examination Survey (2007-2010)|Completed||N/A|2520|Actual|Rutgers University|||1||f||||f|f|f||||||No|Secondary de-identified CDC NHANES data, no IPD|2017-10-10 21:06:53.15467|2017-10-10 21:06:53.15467
NCT03136276|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-27|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||One Year Clinical Evaluation of IPS Empress CAD Versus Polished Celtra Duo Ceramic Laminate Veneers|One Year Clinical Evaluation of IPS Empress CAD Versus Polished Celtra Duo Ceramic Laminate Veneers|Not yet recruiting||N/A|36|Anticipated|Cairo University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:06:53.216379|2017-10-10 21:06:53.216379
NCT03136263|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Oxytocin and Cognitive Control in Adult ADHD|Effects of Oxytocin on Cognitive Control in Adults With Attention Deficit/Hyperactivity Disorder|Not yet recruiting||Early Phase 1|24|Anticipated|Massachusetts General Hospital||2|||f||||f|t|f||||||||2017-10-10 21:06:53.294358|2017-10-10 21:06:53.294358
NCT03136250|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-10|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Interventional|||Effects of Autogenic and Reciprocal Inhibition, Muscle Energy Techniques in the Management of Mechanical Neck Pain|Effects of Autogenic and Reciprocal Inhibition, Muscle Energy Techniques in the Management of Mechanical Neck Pain|Completed||N/A|78|Actual|Foundation University Islamabad||3|||f||||t|f|f||||||||2017-10-10 21:06:53.388956|2017-10-10 21:06:53.388956
NCT03136237|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-01|||February 17, 2017|Actual|2017-02-17|April 2017|2017-04-01|August 15, 2017|Anticipated|2017-08-15|May 15, 2017|Anticipated|2017-05-15||Interventional|||A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions|A Phase 1 Study to Evaluate the Effect of BCX7353 on the Single Dose Pharmacokinetics of the P-gp Substrate Digoxin and the BCRP Substrate Rosuvastatin and the Effect of the P-gp Inhibitor Cyclosporine on the Single Dose Pharmacokinetics of BCX7353|Active, not recruiting||Phase 1|54|Actual|BioCryst Pharmaceuticals||3|||f||||f|f|f||||||||2017-10-10 21:06:53.473246|2017-10-10 21:06:53.473246
NCT03136224|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-26|||May 1, 2014|Actual|2014-05-01|April 2017|2017-04-01|May 1, 2015|Actual|2015-05-01|May 1, 2014|Actual|2014-05-01||Interventional|||Examination of Short and Long Term Complications of Thermocautery, Plastic Clamping and Surgical Circumcision Techniques|Comparison of Short and Long Term Complications According to the Circumcision Technique Applied During the Childhood|Completed||N/A|2062|Actual|Kocatepe University||3|||f||||f|f|f||||||Yes||2017-10-10 21:06:53.568595|2017-10-10 21:06:53.568595
NCT03136211|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-02|||February 15, 2017|Actual|2017-02-15|May 2017|2017-05-01|November 30, 2018|Anticipated|2018-11-30|September 30, 2018|Anticipated|2018-09-30||Interventional|EIRA||Complex Multiple Risk Behavior Intervention in People Between 45 to 75 Years (EIRA Study)|A Hybrid Effectiveness-Implementation Trial of a Complex Multiple Risk Intervention to Promote Healthy Behaviors in People Between 45 to 75 Years Attended in Primary Health Care|Recruiting||N/A|3640|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f|f|f||||||No||2017-10-10 21:06:53.654606|2017-10-10 21:06:53.654606
NCT03136198|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-08-19|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2019|Anticipated|2019-06-30||Interventional|BLUSHED-AHF||B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial|B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial|Recruiting||Phase 2|130|Anticipated|Indiana University||2|||f||||t|t|t|f|f|f|||||2017-10-10 21:06:53.78297|2017-10-10 21:06:53.78297
NCT03136185|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-21|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||IMG-7289 in Patients With Myelofibrosis|A Multi-Center, Open Label Study to Assess the Safety, Steady-State Pharmacokinetics and Pharmacodynamics of IMG-7289 in Patients With Myelofibrosis|Recruiting||Phase 1|15|Anticipated|Imago BioSciences,Inc.||1|||f||||t|f|f||||||||2017-10-10 21:06:53.908023|2017-10-10 21:06:53.908023
NCT03136172|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-15|||May 8, 2017|Actual|2017-05-08|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Monitoring of Systemic or Organ Perfusion for Preterm Infants|Observational Study on Monitoring of Systemic or Organ Blood Circulation and Perfusion for Preterm Infants|Recruiting||N/A|70|Anticipated|Inha University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:06:53.987912|2017-10-10 21:06:53.987912
NCT03133949|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-25|||July 8, 2010|Actual|2010-07-08|April 2017|2017-04-01|July 8, 2020|Anticipated|2020-07-08|July 8, 2020|Anticipated|2020-07-08||Observational|||Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria|Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria|Recruiting||N/A|206|Anticipated|Centre Hospitalier Universitaire, Amiens|||2||f|||||f|f||||||||2017-10-10 21:07:14.215255|2017-10-10 21:07:14.215255
NCT03136146|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-10|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|August 2025|Anticipated|2025-08-01|August 2025|Anticipated|2025-08-01||Interventional|||Study of Clofarabine, Etoposide, Cyclophosphamide [CEC], Liposomal Vincristine (VCR), Dexamethasone and Bortezomib in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)|Lead-in and Phase II Study of Clofarabine, Etoposide, Cyclophosphamide [CEC], Liposomal Vincristine (VCR), Dexamethasone and Bortezomib in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)|Recruiting||Phase 2|42|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f|||f|||||2017-10-10 21:06:54.165887|2017-10-10 21:06:54.165887
NCT03136133|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-09-14|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Protein Supplements to Cyclists|Effekt of Marine Peptide Supplementation on Recovery Following Endurance Cycling|Recruiting||N/A|16|Anticipated|Haukeland University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:06:54.401963|2017-10-10 21:06:54.401963
NCT03136120|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-09-08|||October 3, 2017|Anticipated|2017-10-03|September 2017|2017-09-01|October 12, 2018|Anticipated|2018-10-12|October 12, 2018|Anticipated|2018-10-12||Observational|||Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease|Study to Assess Inhaled Drug Distribution in the Distal Lung and Interstitium Using Cryobiopsy Samples From Subjects With Suspected Interstitial Lung Disease Undergoing Cryobiopsy for Clinical Reasons|Not yet recruiting||N/A|20|Anticipated|GlaxoSmithKline|||1||f||||f|f|f||||Samples With DNA|"     Lung biopsy samples collected from fibrotic regions of the lung using transbrochial     cryobiopsy technique will be collected for this study. Endobronchial biopsy samples will also     be taken. The samples will be embedded to a suitable polymer and frozen at -80 degree Celsius     ready for analysis.   "|||2017-10-10 21:06:54.518482|2017-10-10 21:06:54.518482
NCT03136107|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-17|||May 30, 2017|Actual|2017-05-30|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Determination of the Sun Protection Factor (SPF) of a Cosmetic Daily De-fence Skin Cream|Determination of the Sun Protection Factor of a Cosmetic Daily Defence Skin Cream|Completed||N/A|30|Actual|GlaxoSmithKline||3|||f||||f|f|f||||||||2017-10-10 21:06:54.614371|2017-10-10 21:06:54.614371
NCT03136094|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-08|||January 30, 2018|Anticipated|2018-01-30|June 2017|2017-06-01|March 31, 2022|Anticipated|2022-03-31|July 30, 2021|Anticipated|2021-07-30||Interventional|SPUNKY||Suicide Prevention for Urban Native Kids and Youth|Collaborative Hub to Reduce the Burden of Suicide Among Urban American Indian and Alaska Native Youth|Not yet recruiting||N/A|2400|Anticipated|University of Colorado, Denver||3|||f||||f|f|f||||||No||2017-10-10 21:06:54.704665|2017-10-10 21:06:54.704665
NCT03136081|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-27|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|IMMUNOCANDIDA||Candida Host Defense Response After Septic Shock in the Critically Ill|IMMUNOCANDIDA Candida Host Defense Response After Septic Shock in the Critically Ill|Completed||N/A|50|Actual|University Hospital, Montpellier|||1||f||||f|f|f||||Samples Without DNA|"     It will be simply about additional tubes taken during the taking of the day blood, usually     realized on the catheter thus without pain nor risk of bruise. We also préleverons one sample     of urine every 2 days for analysis of laboratory.   "|No||2017-10-10 21:06:54.826885|2017-10-10 21:06:54.826885
NCT03136068|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-04-26|||February 23, 2017|Actual|2017-02-23|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation|Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation: a Placebo-controlled, Double-blinded Randomized Controlled Trial|Recruiting||Phase 4|180|Anticipated|University of California, San Francisco||2|||||||t|t|f||||||||2017-10-10 21:06:54.912878|2017-10-10 21:06:54.912878
NCT03136055|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-25|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|June 19, 2020|Anticipated|2020-06-19|June 19, 2019|Anticipated|2019-06-19||Interventional|||Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas|A Pilot Study of Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas|Recruiting||Phase 2|42|Anticipated|University of California, San Francisco||1|||f||||t|t|f|||t|||||2017-10-10 21:06:55.039397|2017-10-10 21:06:55.039397
NCT03136042|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-31|||January 15, 2016|Actual|2016-01-15|August 2017|2017-08-01|July 5, 2018|Anticipated|2018-07-05|August 31, 2017|Actual|2017-08-31||Interventional|||Sputum Induction by Physiotherapy and Hypertonic Saline Techniques in Asthmatic Children|A Randomized Crossover Study of Sputum Induction by Physiotherapy and Hypertonic Saline Techniques in Asthmatic Children.|Recruiting||N/A|30|Anticipated|University of Sao Paulo||3|||f|||||f|f||||||||2017-10-10 21:06:55.163168|2017-10-10 21:06:55.163168
NCT03136016|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-27|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Nudging, Healthy Diet and Physical Activity|Design of a School Randomized Trial for Nudging Students Towards Healthy Diet and Physical Activity|Not yet recruiting||N/A|1300|Anticipated|Rio de Janeiro State University||4|||f||||f|f|f||||||No||2017-10-10 21:06:55.402508|2017-10-10 21:06:55.402508
NCT03136003|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-10|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||DDAVP vs. Exercise|DDAVP vs Exercise in Patients With Mild Hemophilia A - Which is Better and do They Work Synergistically in Improving Hemostasis?|Recruiting||Phase 4|30|Anticipated|The Hospital for Sick Children||4|||f||||t|f|f||||||||2017-10-10 21:06:55.508546|2017-10-10 21:06:55.508546
NCT03135990|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-06-02|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Using Virtual Reality in Exposure-Based Treatment for Social Anxiety in Youth|Using Virtual Reality in Exposure-Based Treatment for Social Anxiety in Youth|Not yet recruiting||N/A|24|Anticipated|Weill Medical College of Cornell University||1|||f||||f|f|f||||||No||2017-10-10 21:06:55.64092|2017-10-10 21:06:55.64092
NCT03135587|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-17|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 13, 2017|Actual|2017-05-13||Interventional|||The Relationship Between Increasing Loading and Kinematic Parameters|Are There Correlations Between Increasing Loading and Kinematic Parameters of Normal People?|Completed||N/A|20|Actual|Guangzhou General Hospital of Guangzhou Military Command||6|||f||||f|f|f||||||No||2017-10-10 21:07:00.833225|2017-10-10 21:07:00.833225
NCT03135977|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-05-09|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy|A Clincal Trial of Apatinib Mesylate and Etoposide(VP-16) as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy|Recruiting||Phase 2|36|Anticipated|Sichuan Cancer Hospital and Research Institute||1|||f||||f|f|f||||||Undecided||2017-10-10 21:06:55.747256|2017-10-10 21:06:55.747256
NCT03135964|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-04-26|||February 2011||2011-02-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|January 2015|Actual|2015-01-01||Interventional|NPWT||The Study of Wound Dressings for Portable NPWT|The Study of Wound Dressings for Portable Negative Pressure Wound Therapy|Completed||N/A|57|Actual|Tainan Municipal Hospital||2|||f||||f||||||||||2017-10-10 21:06:55.86539|2017-10-10 21:06:55.86539
NCT03135951|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-12|||May 11, 2017|Actual|2017-05-11|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics of SPI-2012 (Eflapegrastim) in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) Chemotherapy|Pharmacokinetics of SPI-2012 (Eflapegrastim) in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) Chemotherapy|Recruiting||Phase 1|25|Anticipated|Spectrum Pharmaceuticals, Inc||1|||f||||f|t|f||||||||2017-10-10 21:06:55.965226|2017-10-10 21:06:55.965226
NCT03135938|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-26|||August 1, 2017|Anticipated|2017-08-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|Grading vs||Grading Versus Classic Inferior Oblique Anterior Transposition in Patient With Asymmetric Dissociated Vertical Deviation|Grading Versus Classic Inferior Oblique Anterior Transposition in Patient With Asymmetric Dissociated Vertical Deviation|Recruiting||Phase 1/Phase 2|38|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||f|f|f||||||||2017-10-10 21:06:56.07185|2017-10-10 21:06:56.07185
NCT03135925|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-05|||September 2016||2016-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PREeMPT||Feasibility of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation|Is it Feasible to Conduct a Randomised Controlled Trial of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation?|Recruiting||N/A|24|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||Undecided||2017-10-10 21:06:56.157467|2017-10-10 21:06:56.157467
NCT03135912|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-10-05|||January 3, 2017|Actual|2017-01-03|October 2017|2017-10-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Interventional|||Three-Arm Trial of Novel Treatment for Tinea Pedis|Three-Arm Trial of Novel Treatment for Tinea Pedis|Completed||Phase 2|90|Actual|South End Skin Care||3|||f||||f||||||||||2017-10-10 21:06:56.258142|2017-10-10 21:06:56.258142
NCT03135899|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-10-02|||May 18, 2017|Actual|2017-05-18|October 2017|2017-10-01|January 17, 2018|Anticipated|2018-01-17|October 24, 2017|Anticipated|2017-10-24||Interventional|||BI 443651 Methacholine Challenge|A Two Part Phase I, Multiple-dose, Single- and Double-blind, Randomised, Double-dummy, Placebo-controlled, Four-way Crossover Study to Assess Safety and Tolerability of BI 443651 Via Respimat® Versus Placebo Via Respimat® in Subjects With Mild Asthma Following Methacholine Challenge.|Recruiting||Phase 1|36|Anticipated|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 21:06:56.368347|2017-10-10 21:06:56.368347
NCT03135886|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-06-09|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Project I Test: Implementing HIV Testing in Opioid Treatment Programs|A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs|Recruiting||N/A|51|Anticipated|Columbia University||3|||f||||t|f|f||||||Yes|The data and associated documentation may become available to other researchers under a data-sharing agreement. All interested researchers must contact the PI and provide a proposal explaining the analysis that will be conducted and specify which IPD is needed to accomplish this.|2017-10-10 21:06:56.46948|2017-10-10 21:06:56.46948
NCT03135873|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-26|||March 8, 2017|Actual|2017-03-08|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|MAST4HEALTH||Mastiha Treatment for Obese With NAFLD Diagnosis|Mastiha Treatment for Obese With NAFLD Diagnosis|Recruiting||Early Phase 1|52|Anticipated|Harokopio University||2|||f|||||f|f||||||Undecided||2017-10-10 21:06:56.595686|2017-10-10 21:06:56.595686
NCT03135860|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-14|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|August 21, 2017|Actual|2017-08-21|August 21, 2017|Actual|2017-08-21||Interventional|||Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen|Exploratory Study to Assess the Effect of Pulsed Inhaled Nitric Oxide on Functional Respiratory Imaging Parameters in Subjects With WHO Group 3 Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (COPD) on Long Term Oxygen Therapy (LTOT).|Terminated||Early Phase 1|7|Actual|Bellerophon||1||This was an exploratory open-label study and has met its initial objectives|f||||t|||||t|||||2017-10-10 21:06:56.692922|2017-10-10 21:06:56.692922
NCT03135847|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-28|||June 1, 2016|Actual|2016-06-01|April 2017|2017-04-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Prosthetic Limb Movement Feedback for Upper and Lower Extremity Amputees|Physiologically Relevant Prosthetic Limb Movement Feedback for Upper and Lower Extremity Amputees|Enrolling by invitation||N/A|180|Anticipated|The Cleveland Clinic||1|||f|||||f|f||||||Yes|Videos, photographic data and experimental data may be shared across institutions. Data sharing and transfer will be done through a Cleveland Clinic issued, firewall protected FTP network server.|2017-10-10 21:06:56.77786|2017-10-10 21:06:56.77786
NCT03135821|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-04-26|||March 2015||2015-03-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Traditional Chinese Medicine for Treatment of Irritable Bowel Syndrome|Randomized Placebo Controlled Trial of Traditional Chinese Medicine for Treatment of Irritable Bowel Syndrome|Recruiting||Phase 2/Phase 3|104|Anticipated|Singapore General Hospital||2|||f||||t||||||||No||2017-10-10 21:06:57.153294|2017-10-10 21:06:57.153294
NCT03135795|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-26|||February 6, 2017|Actual|2017-02-06|April 2017|2017-04-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||The Epigenetic Modification in OPRM1 on Postoperative Analgesia and Side Effect Induced by Sufentanil|The Influence of Epigenetic Modification in OPRM1 on Postoperative Analgesia and Side Effect Induced by μ-opioid Receptor Agonists|Recruiting||Phase 4|100|Anticipated|Huazhong University of Science and Technology||1|||f||||t|f|f|||f|||No||2017-10-10 21:06:57.362839|2017-10-10 21:06:57.362839
NCT03135769|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-22|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|February 2023|Anticipated|2023-02-01|May 2019|Anticipated|2019-05-01||Interventional|TROPHIMMUN||Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias|A Phase II Trial of Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias (GTN)|Recruiting||Phase 2|29|Anticipated|Hospices Civils de Lyon||1|||f||||t|f|f||||||||2017-10-10 21:06:57.57137|2017-10-10 21:06:57.57137
NCT03135756|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-26|||March 19, 2015|Actual|2015-03-19|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Mechanisms of Anxiety and Depression Study|Transdiagnostic Endophenotypes of Anxiety and Depression|Recruiting||N/A|50|Anticipated|Palo Alto University|||2||f|||||f|f||||||Undecided||2017-10-10 21:06:57.690957|2017-10-10 21:06:57.690957
NCT03135743|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-07-19|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|June 20, 2019|Anticipated|2019-06-20|June 20, 2019|Anticipated|2019-06-20||Observational|LYMPHOSYNCHRO||Retrospective Analysis of Lymphomas and Cancers Synchronous Occurrence in Picardy From 2007 to 2012|Retrospective Analysis of Lymphomas and Cancers Synchronous Occurrence in Picardy From 2007 to 2012|Not yet recruiting||N/A|750|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:06:57.761648|2017-10-10 21:06:57.761648
NCT03135730|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-28|||June 1, 2013|Actual|2013-06-01|April 2017|2017-04-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31|10 Years|Observational [Patient Registry]|||International Rapid-onset Obesity With Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation (ROHHAD) Registry|International Rapid-onset Obesity With Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) REDCap Registry|Recruiting||N/A|200|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f|f|f||||||||2017-10-10 21:06:57.823657|2017-10-10 21:06:57.823657
NCT03135717|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||December 2011|Actual|2011-12-01|April 2017|2017-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|PEW||Wasting in Chronic Kidney Disease|Wasting in Chronic Kidney Disease: Refeeding Techniques and Artificial Nutrition Practices|Completed||N/A|48|Actual|Hospices Civils de Lyon|||1||f|||||f|f||||||||2017-10-10 21:06:57.897828|2017-10-10 21:06:57.897828
NCT03135704|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-03|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||"Comparison of Two Treatments for Low Back Pain: Re Spine vs. Physiotherapy"|"Comparison of Two Treatments for Low Back Pain: Re Spine vs. Physiotherapy"|Not yet recruiting||N/A|60|Anticipated|Hillel Yaffe Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:06:57.952138|2017-10-10 21:06:57.952138
NCT03135691|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-12|||March 18, 2017|Actual|2017-03-18|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Intraop Ventilation Management and Postop Pulmonary Complications in High Risk Patients for OSA|Intraoperative Ventilation Management and Postoperative Pulmonary Complications in Patients at High Risk for Obstructive Sleep Apnea|Recruiting||N/A|2636|Anticipated|Ohio State University|||1||f||||f|f|f||||||No||2017-10-10 21:06:59.883172|2017-10-10 21:06:59.883172
NCT03135678|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-05-29|||May 12, 2017|Actual|2017-05-12|May 2017|2017-05-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23|1 Week|Observational [Patient Registry]|||Study to Verify the Feasibility of Collecting a Broad Variety of Individual Health Data|Observe Pilot, a Prospective Study to Verify the Feasibility of Collecting a Broad Variety of Individual Health Data|Completed||N/A|12|Actual|Hilbert Paradox NV|||1||f||||f|f|f||||||No||2017-10-10 21:06:59.968927|2017-10-10 21:06:59.968927
NCT03135665|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-01|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Using Radiation-free Ultrasound for Screening Scoliosis Among School Children in Hong Kong to Reduce Unnecessary X-ray Exposure|Using Radiation-free Ultrasound for Screening Scoliosis Among School Children in Hong Kong to Reduce Unnecessary X-ray Exposure|Not yet recruiting||N/A|442|Anticipated|Chinese University of Hong Kong||1|||f||||t|f|f||||||No||2017-10-10 21:07:00.044884|2017-10-10 21:07:00.044884
NCT03135652|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-06-21|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation|Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation|Not yet recruiting||Phase 2|120|Anticipated|Wuhan Union Hospital, China||2|||f|||||f|f||||||||2017-10-10 21:07:00.13576|2017-10-10 21:07:00.13576
NCT03135639|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-28|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|PACS||Effects of Alpha tACS|Evaluating Transcranial Alternating Current Stimulation (tACS) for Enhancing Creativity|Completed||N/A|35|Actual|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||Undecided|No plan.|2017-10-10 21:07:00.234256|2017-10-10 21:07:00.234256
NCT03135626|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||March 15, 2013|Actual|2013-03-15|April 2017|2017-04-01|February 15, 2016|Actual|2016-02-15|January 15, 2014|Actual|2014-01-15||Interventional|||Comparison of The Success Rates of Four Different Pulpotomy Techniques|Comparison of The Success Rates of Four Different Pulpotomy Techniques|Completed||Phase 3|38|Actual|Istanbul University||4|||f||||f|f|f||||||Undecided||2017-10-10 21:07:00.330103|2017-10-10 21:07:00.330103
NCT03135613|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|May 25, 2017|Anticipated|2017-05-25|May 20, 2017|Anticipated|2017-05-20||Interventional|||Kinematics of Knees of Patients With Tumor Around Knee After Microwave Ablation With Plate Internal Fixation|Kinematics of the Healthy Knee and the Surgery Knee in Patients With Tumor Around Knee After Microwave Ablation With Plate Internal Fixation.|Recruiting||N/A|60|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f|f|f|||f|||No||2017-10-10 21:07:00.468476|2017-10-10 21:07:00.468476
NCT03135574|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-26|||April 9, 2017|Actual|2017-04-09|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|HYPER-III||Prevalence of a High-intensity Signal of the Oculomotor Nerve on T2 MRI Sequence in Patients With Ophthalmoplegia|Prevalence of a High-intensity Signal of the Oculomotor Nerve on T2 MRI Sequence in Patients With Ophthalmoplegia|Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 21:07:01.073665|2017-10-10 21:07:01.073665
NCT03135561|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-26|||November 12, 2015|Actual|2015-11-12|April 2017|2017-04-01|December 9, 2016|Actual|2016-12-09|September 29, 2016|Actual|2016-09-29||Interventional|||A Pedometer-based Intervention With and Without Email Counselling in General Practice|A Pedometer-based Walking Intervention With and Without Email Counselling in General Practice: a Pilot Randomised Controlled Trial|Completed||N/A|37|Actual|Charles University, Czech Republic||2|||f||||f|f|f||||||No||2017-10-10 21:07:01.158483|2017-10-10 21:07:01.158483
NCT03135548|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-10-02|||May 30, 2017|Actual|2017-05-30|October 2017|2017-10-01|June 29, 2018|Anticipated|2018-06-29|March 9, 2018|Anticipated|2018-03-09||Interventional|||Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients|Multi-center, Double-blind, Randomised, Placebo-controlled, Phase IIa Study to Investigate Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacogenomics of Multiple Intravenous Doses of BI 655130 in Patients With Palmoplantar Pustulosis (PPP)|Recruiting||Phase 2|60|Anticipated|Boehringer Ingelheim||3|||f||||t|f|f||||||||2017-10-10 21:07:01.241696|2017-10-10 21:07:01.241696
NCT03135535|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-11|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Micro-mobile Foot Compression and Diabetic Foot|Micro-mobile Foot Compression Device to Improve Motor-function in People With Diabetes and Loss of Protective Sensation|Recruiting||Phase 2|30|Anticipated|Baylor College of Medicine||1|||f||||f|f|t|f|f||||||2017-10-10 21:07:01.38787|2017-10-10 21:07:01.38787
NCT03135522|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-12|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|March 31, 2019|Anticipated|2019-03-31||Interventional|ZICO||Pilot of Zinc Acetate to Improve Chronic Cough|Pilot of Zinc Acetate to Improve Chronic Cough|Not yet recruiting||Phase 2|36|Anticipated|Johns Hopkins University||2|||f||||t|t|f|||f|||||2017-10-10 21:07:01.487409|2017-10-10 21:07:01.487409
NCT03135509|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-30|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|June 28, 2017|Actual|2017-06-28|June 28, 2017|Actual|2017-06-28||Interventional|||A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects|A Phase 1, Open-label, Single-center Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects|Completed||Phase 1|16|Actual|Celgene||2|||f||||f|t|f||||||||2017-10-10 21:07:01.596901|2017-10-10 21:07:01.596901
NCT03135496|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-09-07|||December 14, 2016|Actual|2016-12-14|September 2017|2017-09-01|August 20, 2017|Actual|2017-08-20|December 21, 2016|Actual|2016-12-21||Observational|DYVA2||Evaluation of Endothelial Dysfunction During Aortic Valvular Replacement by Bioprosthesis With and Without Extracorporeal Circulation|Evaluation of Endothelial Dysfunction During Aortic Valvular Replacement by Bioprosthesis With and Without Extracorporeal Circulation|Completed||N/A|60|Actual|Centre Hospitalier Universitaire, Amiens|||2||f|||||f|f||||||||2017-10-10 21:07:01.686462|2017-10-10 21:07:01.686462
NCT03135483|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-26|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01|12 Months|Observational [Patient Registry]|clinical audit||Assessment of Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery in Critical Patients|Assessment of Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery in Critical Patients|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||t|f|f||||||Undecided|adult above 18years admitted to assiut university hospital intensive care units after non cardiac surgery|2017-10-10 21:07:01.758381|2017-10-10 21:07:01.758381
NCT03135470|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-26|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Pain Medication After Ambulatory Surgery|Adequacy and Adverse Effects of Pain Medication After Ambulatory Surgery, Observational Study|Recruiting||N/A|1200|Anticipated|Helsinki University Central Hospital|||3||f|||||f|f||||||Undecided||2017-10-10 21:07:01.815389|2017-10-10 21:07:01.815389
NCT03135457|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-04|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||TACO Crossover TRIAL|A Cross-over Randomized Controlled Trial; Pulmonary Edema Detection After Fluid Loading With Blood Versus Saline in Patients After CABG|Recruiting||N/A|16|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f|f|f||||||||2017-10-10 21:07:01.901761|2017-10-10 21:07:01.901761
NCT03135444|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-25|||May 2, 2017|Actual|2017-05-02|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||PSA TOOL for Prostate Cancer Screening Discussions|Testing of a Brief Tool (PSA TOOL) for Prostate Cancer Screening Discussions in Primary Care Settings|Recruiting||N/A|165|Anticipated|Case Comprehensive Cancer Center||2|||f||||f|f|f||||||||2017-10-10 21:07:02.028438|2017-10-10 21:07:02.028438
NCT03135431|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-11|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|October 30, 2019|Anticipated|2019-10-30|May 30, 2019|Anticipated|2019-05-30||Interventional|||Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery|Opportunistic Salpingectomy at the Time of Cesarean Delivery: A Randomized Controlled Trial of the Safety of Salpingectomy vs Tubal Ligation|Enrolling by invitation||N/A|120|Anticipated|Mayo Clinic||2|||f||||t|f|f||||||No||2017-10-10 21:07:02.14586|2017-10-10 21:07:02.14586
NCT03135405|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-28|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Controlling Hypertension in Native American and Other Populations|Controlling Hypertension in Native American and Other Populations|Recruiting||N/A|512|Anticipated|Kaiser Permanente||2|||f||||f|f|f||||||No||2017-10-10 21:07:02.321805|2017-10-10 21:07:02.321805
NCT03135392|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-27|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer|Return of Breast Sensation Following Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer: An Evaluation of Clinical, Sensory, and Quality of Life Outcomes|Not yet recruiting||N/A|200|Anticipated|Case Comprehensive Cancer Center||3|||f||||t|f|f||||||||2017-10-10 21:07:02.420895|2017-10-10 21:07:02.420895
NCT03135366|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-24|||January 4, 2016|Actual|2016-01-04|August 2017|2017-08-01|April 14, 2017|Actual|2017-04-14|December 31, 2016|Actual|2016-12-31||Interventional|||Self-verification and Support Via Mobile Phones Drastically Improves Tuberculosis Treatment Success in LMIC Settings|Delivering Community-based Interventions and Disease Management Tools Across a Digital Platform in Order to Increase TB Treatment Adherence in LMICs|Completed||N/A|1190|Actual|Harvard University||2|||f||||f|f|f||||||||2017-10-10 21:07:02.59098|2017-10-10 21:07:02.59098
NCT03135353|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-09|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|November 25, 2017|Anticipated|2017-11-25||Interventional|||Saline Sonohystrography and Office Hysteroscopy in Evaluation of Cases of Abnormal Uterine Bleeding|Comparison Between 3D Saline Infusion Sonohystrography and Office Hysteroscopy in the Evaluation of Patients With Irregular Uterine Bleeding|Recruiting||N/A|250|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||f|f|f|||f|||No||2017-10-10 21:07:02.777908|2017-10-10 21:07:02.777908
NCT03135340|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-07-12|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|November 2033|Anticipated|2033-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Wide-Awake Local Anesthesia vs. Regional/General Anesthesia for Flexor Tendon Repair|Comparison of Wide-Awake Local Anesthesia vs. Regional/General Anesthesia for Hand Flexor Tendon Repair in Zones I and II: a Prospective Randomized Controlled Trial|Not yet recruiting||N/A|88|Anticipated|Western University, Canada||2|||f||||f|f|f||||||||2017-10-10 21:07:02.880595|2017-10-10 21:07:02.880595
NCT03135327|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-28|||January 1, 2007|Actual|2007-01-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Clinical Applications of Advanced Ophthalmic Imaging|Clinical Applications of Advanced Ophthalmic Imaging|Recruiting||N/A|5000|Anticipated|University of Miami|||1||f||||f|f|f||||||No||2017-10-10 21:07:02.988384|2017-10-10 21:07:02.988384
NCT03135314|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-19|||May 2, 2016|Actual|2016-05-02|May 2017|2017-05-01|July 30, 2016|Actual|2016-07-30|July 30, 2016|Actual|2016-07-30||Interventional|||Cocoa Flavanol Intake and Exercise in Hypoxia|The Effect of Cocoa Flavanol Intake on Cerebral and Muscle Perfusion and Oxygenation in Hypoxia - Implications for Cognitive and Exercise Performance|Completed||N/A|15|Actual|Vrije Universiteit Brussel||4|||f|||||f|f||||||||2017-10-10 21:07:03.075325|2017-10-10 21:07:03.075325
NCT03135301|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-06-29|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome|Efficacy of Combined Letrozole-metformin in Comparison With Letrozole Only in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome|Recruiting||Phase 3|80|Anticipated|Assiut University||2|||f||||f|f|f|||f|||Yes||2017-10-10 21:07:03.163467|2017-10-10 21:07:03.163467
NCT03135288|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-08-13|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|||Cell-phone Assisted Postpartum Counseling on the Use of Long-acting Reversible Contraceptives|Effect of Cell-phone Assisted Postpartum Counseling on the Use of Long-acting Reversible Contraceptives: a Randomized Controlled Trial|Recruiting||N/A|864|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 21:07:03.263153|2017-10-10 21:07:03.263153
NCT03135275|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-25|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|MULTISTARS AMI||MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial|MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction - The MULTISTARS AMI Trial|Recruiting||N/A|1200|Anticipated|University of Zurich||2|||f||||t|f|f|||f|||No||2017-10-10 21:07:03.34316|2017-10-10 21:07:03.34316
NCT03135249|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-25|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|SUPPRESS||Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis|Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis (SUPPRESS)|Not yet recruiting||Phase 4|40|Anticipated|University of Texas Southwestern Medical Center||1|||f|||||t|f|||t|||Undecided||2017-10-10 21:07:03.659068|2017-10-10 21:07:03.659068
NCT03135236|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-27|2017-04-27|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|September 30, 2017|Anticipated|2017-09-30||Interventional|||Parents as the Primary Sexuality Educators for Their Young Adults With Down Syndrome|Parents as the Primary Sexuality Educators for Their Young Adults With Down Syndrome: The Effectiveness of a Family-based Training|Recruiting||N/A|30|Anticipated|Advocate Health Care||1|||f||||f|f|f||||||No|IPD will not be shared with other researchers.|2017-10-10 21:07:03.76081|2017-10-10 21:07:03.76081
NCT02679599|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-09-01|||March 2016||2016-03-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Increasing Exercise and Decreasing Sedentary Behavior Among Patients in a Cardiac Rehabilitation Clinic||Completed||N/A|23|Actual|The Miriam Hospital||2|||f||||||||||||||2017-10-10 22:28:48.989463|2017-10-10 22:28:48.989463
NCT03135223|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-25|||September 1, 2014|Actual|2014-09-01|April 2017|2017-04-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Interventional|||Participatory Research to Promote Physical Activity|Development of Intervention Strategies to Increase Physical Activity and Reduce Sedentary Behaviour in Secondary Schoolgirls by Means of Participatory Health Research|Completed||N/A|196|Actual|University Ghent||2|||f|||||f|f||||||||2017-10-10 21:07:03.862729|2017-10-10 21:07:03.862729
NCT03135197|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-12|||June 8, 2017|Actual|2017-06-08|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Observational|||German Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.|German Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.|Enrolling by invitation||N/A|60|Anticipated|University Hospital Muenster|||1||f||||f|f|f||||||No||2017-10-10 21:07:04.02999|2017-10-10 21:07:04.02999
NCT03135184|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-10-02|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia|HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia|Recruiting||N/A|20|Anticipated|HDL Therapeutics||1|||f||||t|f|t|t|f||||||2017-10-10 21:07:04.115528|2017-10-10 21:07:04.115528
NCT03135171|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-30|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab|A Phase 1 Multi-Center Trial of Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab|Recruiting||Phase 1|20|Anticipated|University of Michigan Cancer Center||1|||||||t|t|f|||f|||||2017-10-10 21:07:04.202808|2017-10-10 21:07:04.202808
NCT03135158|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-26|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Observational|||The Association Between Shock Index and Severity of Postpartum Blood Loss|The Association Between Shock Index and Severity of Postpartum Blood Loss: An Observational Study|Recruiting||N/A|1000|Anticipated|Gynuity Health Projects|||1||f||||t|f|f||||||||2017-10-10 21:07:04.291152|2017-10-10 21:07:04.291152
NCT03135145|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-26|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|June 30, 2017|Anticipated|2017-06-30|June 15, 2017|Anticipated|2017-06-15||Interventional|||Post-operative Lite Run Study|Post-operative Use of Lite Run in a Pediatric Population With Cerebral Palsy|Not yet recruiting||N/A|20|Anticipated|Gillette Children's Specialty Healthcare||2|||f||||t|f|t|t|f|f|||No||2017-10-10 21:07:04.383984|2017-10-10 21:07:04.383984
NCT03135132|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-26|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of Mild Weight Loss on Circulating Metabolite Profiles|Metabolomics Identifies Increases in Acylcarnitine Profiles in Plasma of Overweight Subjects in Response to Mild Weight Loss|Completed||N/A|100|Actual|Yonsei University||2|||f|||||f|f||||||No||2017-10-10 21:07:04.51499|2017-10-10 21:07:04.51499
NCT03135119|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-08-28|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|TF-CBT+AAT||Integrating Animal-Assisted Therapy Into Trauma-Focused Cognitive-Behavioral Therapy for Maltreated Youth|Integrating Animal-Assisted Therapy Into Trauma-Focused Cognitive-Behavioral Therapy for Maltreated Youth: A Randomized Feasibility Trial|Not yet recruiting||N/A|60|Anticipated|Milton S. Hershey Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:07:04.597504|2017-10-10 21:07:04.597504
NCT03135106|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-09-20|||April 14, 2017|Actual|2017-04-14|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|September 1, 2017|Actual|2017-09-01||Interventional|||A Study to Evaluate the Effect of Fluconazole and Itraconazole on Erdafitinib Pharmacokinetics in Healthy Adult Participants|A Randomized, Open-Label, Parallel Group, Drug-drug Interaction Study to Evaluate the Effect of Fluconazole and Itraconazole on the Pharmacokinetics of Erdafitinib in Healthy Adult Subjects|Completed||Phase 1|54|Actual|Janssen Research & Development, LLC||3|||f||||f|f|f||||||||2017-10-10 21:07:04.668873|2017-10-10 21:07:04.668873
NCT03135093|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Upper Limb Function and Visuospatial Exploration After Stroke|Assessing Pathological Synergies of Upper Limb Function and the Relationship to Visuospatial Exploration After Stroke|Recruiting||N/A|35|Anticipated|University of Zurich|||2||f||||f|f|f||||||Yes|The anonymized project data will be shared within the partners of the European Horizon2020 - SoftPro (No.688857) project.|2017-10-10 21:07:04.749566|2017-10-10 21:07:04.749566
NCT03135080|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-06-22|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Long-Term HEAD START Training on Surgical Skill Levels|The Effect of Long-Term HEAD START Training on Surgical Skill Levels|Active, not recruiting||N/A|30|Actual|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||No||2017-10-10 21:07:04.849243|2017-10-10 21:07:04.849243
NCT03135067|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-06|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk|Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk|Recruiting||N/A|2010|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|f|||f|||No||2017-10-10 21:07:04.931402|2017-10-10 21:07:04.931402
NCT03135054|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-15|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD|A Phase II Single-arm Open-labeled Study Evaluating Combination of Quizartinib and Omacetaxine Mepesuccinate (QUIZOM) in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD|Not yet recruiting||Phase 2|40|Anticipated|The University of Hong Kong||1|||f||||t|f|f||||||||2017-10-10 21:07:05.057761|2017-10-10 21:07:05.057761
NCT03135028|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-10-05|||May 18, 2017|Actual|2017-05-18|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|Japanese AML||Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults|A Phase 1b Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Entospletinib (ENTO) as Monotherapy in Japanese Subjects With Relapsed or Refractory Hematologic Malignancies and in Combination With Chemotherapy in Japanese Subjects With Previously Untreated Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|12|Anticipated|Gilead Sciences||2|||f||||f|t|f|||t|||||2017-10-10 21:07:05.240183|2017-10-10 21:07:05.240183
NCT03135015|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-07-15|||April 26, 2017|Actual|2017-04-26|July 2017|2017-07-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|||Acute Effect of Axulin on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans|Acute Effect of Axulin on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans|Completed||Phase 1|22|Actual|Glycemic Index Laboratories, Inc||2|||f||||f|f|f||||||||2017-10-10 21:07:05.479852|2017-10-10 21:07:05.479852
NCT03135002|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-10-02|||January 10, 2017|Actual|2017-01-10|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|December 1, 2017|Anticipated|2017-12-01||Observational|LCC-CKD||The Leicester City and County Chronic Kidney Disease Cohort|The Leicester City and County Chronic Kidney Disease Study: An Observational Chronic Kidney Disease Cohort to Study Cardiovascular and Renal Outcomes in Multi-ethnicity Primary Care|Recruiting||N/A|25000|Anticipated|University of Leicester|||1||f|||||f|f||||||||2017-10-10 21:07:05.590515|2017-10-10 21:07:05.590515
NCT03133897|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-25|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|||Dexamethasone Versus Prednisone for Asthma Treatment in the Pediatric Inpatient Population; a Feasibility Study|Dexamethasone Versus Prednisone for Asthma Treatment in the Pediatric Inpatient Population; a Feasibility Study|Not yet recruiting||Phase 3|51|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||f|f|f||||||No||2017-10-10 21:07:05.668122|2017-10-10 21:07:05.668122
NCT03133884|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-25|||June 2016||2016-06-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Acupuncture for Patients With Chronic Tension-type Headache|Acupuncture for Patients With Chronic Tension-type Headache : a Randomized Controlled Trial|Recruiting||N/A|218|Anticipated|Chengdu University of Traditional Chinese Medicine||2|||f||||t|f|f||||||No||2017-10-10 21:07:05.755936|2017-10-10 21:07:05.755936
NCT03133871|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-25|||April 28, 2017|Anticipated|2017-04-28|April 2017|2017-04-01|April 20, 2020|Anticipated|2020-04-20|April 20, 2020|Anticipated|2020-04-20||Observational|||Evaluation of Scanoskin for the Assessment of Vitiligo|Comparison of Scanoskin With Planimetry as an Objective Measure of Vitiligo.|Recruiting||N/A|15|Anticipated|Chelsea and Westminster NHS Foundation Trust|||1||f||||f|f|f||||||Yes||2017-10-10 21:07:05.868727|2017-10-10 21:07:05.868727
NCT03133858|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-01|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 31, 2021|Anticipated|2021-05-31|December 30, 2020|Anticipated|2020-12-30||Observational|||Longitudinal Cohort Study - for the Treatment of Acute Postoperative Pain and Postoperative Delirium, Postoperative Cognitive Dysfunctions, and Chronic Pain.|Longitudinal Cohort Study - for the Treatment of Acute Postoperative Pain and Postoperative Delirium, Postoperative Cognitive Dysfunctions, and Chronic Pain.|Recruiting||N/A|500|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||||2017-10-10 21:07:05.962708|2017-10-10 21:07:05.962708
NCT03133845|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-04-25|||October 2015||2015-10-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|SHARP||Shaping Anesthetic Techniques to Reduce Post-operative Delirium|Shaping Anesthetic Techniques to Reduce Post-Operative Delirium|Recruiting||N/A|190|Anticipated|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 21:07:06.066177|2017-10-10 21:07:06.066177
NCT03134989|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-26|||August 2017||2017-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:07:06.221703|2017-10-10 21:07:06.221703
NCT03134976|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-15|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Wound Complications in Head and Neck Surgery|Wound Complications in Head and Neck Surgery|Active, not recruiting||N/A|144|Anticipated|University of Michigan|||2||f||||f|t|f|||f|||No||2017-10-10 21:07:06.267706|2017-10-10 21:07:06.267706
NCT03134963|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-16|||May 5, 2017|Actual|2017-05-05|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study|Cerebral Haemodynamic Changes During Cognitive Testing: a Functional Transcranial Doppler (fTCD) Study|Recruiting||N/A|44|Anticipated|University of Leicester|||4||f||||f|f|f||||||No||2017-10-10 21:07:06.358189|2017-10-10 21:07:06.358189
NCT03134950|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-28|||July 20, 2015|Actual|2015-07-20|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Improving Care for Youth With FAP: A Stepped Care CBT Delivery Approach|Improving Care for Youth With Functional Abdominal Pain: A Stepped Care CBT Delivery Approach|Recruiting||N/A|160|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f|f|f||||||||2017-10-10 21:07:06.486269|2017-10-10 21:07:06.486269
NCT03134937|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-28|||August 25, 2017|Actual|2017-08-25|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|HFNOGastricUS||High-Flow Heated and Humidified Oxygen Therapy and Gastric Distension|Prospective Study on the Possible Effects of High-Flow Heated and Humidified Nasal Oxygen Therapy (HFNO) on Gastric Distension|Recruiting||N/A|60|Anticipated|University Health Network, Toronto||1|||f||||f|f|f||||||||2017-10-10 21:07:06.591627|2017-10-10 21:07:06.591627
NCT03134924|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-28|||May 3, 2013|Actual|2013-05-03|April 2017|2017-04-01|February 5, 2014|Actual|2014-02-05|February 5, 2014|Actual|2014-02-05||Interventional|||"Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention WASH-2"|"Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention WASH-2"|Completed||N/A|128|Actual|University of Miami||2|||f||||t|f|f||||||Yes|Available from the PI upon request.|2017-10-10 21:07:06.681121|2017-10-10 21:07:06.681121
NCT03134911|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-10-03|||April 24, 2017|Actual|2017-04-24|October 2017|2017-10-01|October 27, 2017|Anticipated|2017-10-27|October 27, 2017|Anticipated|2017-10-27||Observational|RE-QoL||Health-related Quality of Life in Patients on Anticoagulants|Non-Interventional, Cross-sectional Study to Describe Health-related Quality of Life Among Controlled and Uncontrolled Patients With Nonvalvular Atrial Fibrillation on Anticoagulants. RE-QUOL Study.|Recruiting||N/A|500|Anticipated|Boehringer Ingelheim|||2||f||||f|t|f||||||||2017-10-10 21:07:06.765434|2017-10-10 21:07:06.765434
NCT03134898|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-26|||November 24, 2013|Actual|2013-11-24|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension|Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension|Recruiting||N/A|1025|Anticipated|Delos Clinical|||1||f||||f|f|f||||||No||2017-10-10 21:07:06.849799|2017-10-10 21:07:06.849799
NCT03134885|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-25|||September 2016||2016-09-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|VIGILANS||Evaluation of a Regional Post-discharge Monitoring System for Suicide Attempters|Evaluation of a Regional Post-discharge Monitoring System for Suicide Attempters in the North-Pas de Calais Region of France|Recruiting||N/A|16000|Anticipated|University Hospital, Lille|||1||f||||f||||||||No||2017-10-10 21:07:07.074231|2017-10-10 21:07:07.074231
NCT03134872|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-25|||May 25, 2017|Actual|2017-05-25|April 2017|2017-04-01|June 30, 2021|Anticipated|2021-06-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC|A Phase III, Randomized, Open-Label, Multi-center Study of SHR-1210(Anti-PD-1 Antibody) in Combination With Pemetrexed and Carboplatin as First Line Therapy in Subjects With Advanced/Metastatic Non-squamous Non-small Cell Lung Cancer|Recruiting||Phase 3|412|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:07:07.295379|2017-10-10 21:07:07.295379
NCT03134859|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-02|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|May 2020|Anticipated|2020-05-01||Interventional|Tummytime||Determining Optimal Dosage of Prone Positioning in Early Infancy|Determining Optimal Dosage of Prone Positioning to Facilitate Motor Development and Body Composition in Early Infancy|Not yet recruiting||N/A|35|Anticipated|State University of New York - Upstate Medical University||3|||f||||f|f|f||||||No||2017-10-10 21:07:07.396197|2017-10-10 21:07:07.396197
NCT03134846|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-25|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|ICON||Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate|Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate|Not yet recruiting||Phase 1/Phase 2|79|Anticipated|University Medical Center Groningen||4|||f|||||f|f||||||||2017-10-10 21:07:07.468869|2017-10-10 21:07:07.468869
NCT03134833|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-06|||May 6, 2017|Actual|2017-05-06|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Engaging Seronegative Youth to Optimize HIV Prevention Continuum|Engaging Seronegative Youth to Optimize HIV Prevention Continuum|Recruiting||Phase 3|1500|Anticipated|University of California, Los Angeles||4|||f||||t|f|f||||||No||2017-10-10 21:07:07.55622|2017-10-10 21:07:07.55622
NCT03134820|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-26|||December 15, 2015|Actual|2015-12-15|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|December 31, 2016|Actual|2016-12-31||Observational|||Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease|Time of Treatment With Low Molecular Weight Heparins in Cancer Patients With Thromboembolic Disease. Procoagulant Role of Phospholipid-dependent Microparticles.|Completed||N/A|352|Actual|Delos Clinical|||1||f||||f|f|f||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 21:07:07.678453|2017-10-10 21:07:07.678453
NCT03134807|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||November 1, 2016|Actual|2016-11-01|April 2017|2017-04-01|October 31, 2017|Anticipated|2017-10-31|May 31, 2017|Anticipated|2017-05-31||Observational|VIP1||The Very Old Intensive Care Patient: A Multinational Prospective Observation Study|The Very Old Intensive Care Patient: A Multinational Prospective Observation Study|Recruiting||N/A|2000|Anticipated|University of Bergen|||1||f||||t|f|f||||||No||2017-10-10 21:07:07.749365|2017-10-10 21:07:07.749365
NCT03134794|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-05-04|||March 22, 2017|Actual|2017-03-22|May 2017|2017-05-01|September 22, 2018|Anticipated|2018-09-22|July 22, 2018|Anticipated|2018-07-22||Interventional|EDUCAR MS||Medical Education for Better Multiple Sclerosis Outcomes|Decision Making Under Uncertainty in MS Care: an Innovative Educational Intervention Applying Concepts From Neuroeconomics|Recruiting||N/A|160|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||No||2017-10-10 21:07:07.830265|2017-10-10 21:07:07.830265
NCT03134781|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-02|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|July 2016|Actual|2016-07-01||Interventional|FFIT||The Fun & Functional Interval Training and Obesity|The Effects of a Novel Hybrid Exercise Training Program on Body Composition, Body Weight and Energy Balance in Sedentary Overweight/Obese Women|Completed||N/A|49|Actual|University of Thessaly||3|||f||||f|f|f||||||||2017-10-10 21:07:07.920652|2017-10-10 21:07:07.920652
NCT03134768|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-01|||May 2, 2016|Actual|2016-05-02|May 2017|2017-05-01|December 20, 2017|Anticipated|2017-12-20|November 16, 2016|Actual|2016-11-16||Observational|||Effect of Birth on Immunological Parameters in Cord Blood|To Investigate the Immediate Effect of Birth on Immunological Parameters in Cord Blood, and Compare With Data of CS Born Infants Collected in the JULIUS SN Study|Active, not recruiting||N/A|50|Actual|Danone Asia Pacific Holdings Pte, Ltd.|||1||f||||t|f|f||||Samples Without DNA|"     cord blood   "|No||2017-10-10 21:07:08.006515|2017-10-10 21:07:08.006515
NCT03134755|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-10|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|October 30, 2020|Anticipated|2020-10-30||Observational|STAR||Stress and Treatment Response in Puerto Rican Children With Asthma|Stress and Treatment Response in Puerto Rican Children With Asthma|Not yet recruiting||N/A|300|Anticipated|University of Pittsburgh|||1||f||||f|f|f||||Samples With DNA|"     Nasal epithelial samples for DNA and RNA extraction   "|||2017-10-10 21:07:08.065516|2017-10-10 21:07:08.065516
NCT03134742|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||March 13, 2017|Actual|2017-03-13|April 2017|2017-04-01|April 13, 2019|Anticipated|2019-04-13|April 13, 2019|Anticipated|2019-04-13||Observational|||Abscopal Radiation Effects on Bone|Prospective Evaluation of Abscopal Radiation Effects on Regional and Distant Bone|Enrolling by invitation||N/A|50|Anticipated|State University of New York - Upstate Medical University|||4||f||||f|f|f||||||No||2017-10-10 21:07:08.146925|2017-10-10 21:07:08.146925
NCT03134729|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-05-04|||May 4, 2017|Actual|2017-05-04|April 2017|2017-04-01|March 31, 2020|Anticipated|2020-03-31|April 30, 2018|Anticipated|2018-04-30||Interventional|PATHOS||PATHOS Study Pain Assessment in Thoracic Oncologic Surgery|PATHOS Study Pain Assessment in Thoracic Oncologic Surgery: a Prospective Randomized Trial on Pain Management After Video Assisted Major Lung Resections.|Recruiting||N/A|150|Anticipated|Sacro Cuore Don Calabria General Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:07:08.226892|2017-10-10 21:07:08.226892
NCT03134716|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-04-25|||April 2016||2016-04-01|April 2017|2017-04-01|April 2023|Anticipated|2023-04-01|April 2022|Anticipated|2022-04-01||Observational|PROMS||Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis|Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis|Recruiting||N/A|50|Anticipated|Turku University Hospital|||2||f||||f||||||Samples With DNA|"     Correlation of blood biomarkers and MS progression   "|Undecided|Multi-center collaboration under discussion|2017-10-10 21:07:08.314027|2017-10-10 21:07:08.314027
NCT03134703|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-26|||February 27, 2017|Actual|2017-02-27|April 2017|2017-04-01|February 27, 2019|Anticipated|2019-02-27|February 27, 2018|Anticipated|2018-02-27||Interventional|||Methadone Demonstration Project|Methadone Demonstration Project|Recruiting||Phase 2|100|Anticipated|Johns Hopkins All Children's Hospital||2|||f||||t|t|f|||f|||No||2017-10-10 21:07:08.387517|2017-10-10 21:07:08.387517
NCT03134690|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-26|||January 2016||2016-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response|"Evaluation of a Novel  Delayed Start Protocol With Gonadotropin-releasing Hormone Antagonist in Poor Responders: A Randomized Clinical Trial Phase 3"|Recruiting||N/A|60|Anticipated|Royan Institute||2|||f||||t|f|f||||||No||2017-10-10 21:07:08.473872|2017-10-10 21:07:08.473872
NCT03134677|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-04|||July 23, 2014|Actual|2014-07-23|May 2017|2017-05-01|August 23, 2016|Actual|2016-08-23|July 23, 2016|Actual|2016-07-23||Interventional|||The Effects of Different Anesthetic Techniques on QT, Corrected QT (QTc), and P Wave Dispersions in Cesarean Section|The Effects of Different Anesthetic Techniques on QT, Corrected QT (QTc), and P Wave Dispersions in Cesarean Section|Completed||Phase 4|90|Actual|Trakya University||2|||f||||f|||||f|||Undecided||2017-10-10 21:07:08.649389|2017-10-10 21:07:08.649389
NCT03134664|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-26|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Supercapsular Percutaneously Assisted Total Hip Approach for the Elderly With Femoral Neck Fractures|Supercapsular Percutaneously Assisted Total Hip Approach for the Elderly With Femoral Neck Fractures: a Prospective, Open-label, Randomized, Controlled Clinical Trial|Active, not recruiting||N/A|40|Anticipated|Shanghai Pudong Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:08.763575|2017-10-10 21:07:08.763575
NCT03134651|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-25|||July 24, 2014|Actual|2014-07-24|April 2017|2017-04-01|September 24, 2016|Actual|2016-09-24|July 24, 2016|Actual|2016-07-24||Interventional|||Preoperative Anxiety at Oocyte Retrieval|The Effect of Preoperative Anxiety With Depth of Anesthesia During Oocyte Retrieval on IVF Success|Completed||N/A|131|Actual|Trakya University||2|||f|||||f|f|||f|||No||2017-10-10 21:07:08.875838|2017-10-10 21:07:08.875838
NCT03134638|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-10-04|||May 12, 2017|Actual|2017-05-12|May 2017|2017-05-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||A Phase 1 Study of SY-1365 in Adult Patients With Advanced Solid Tumors|A Phase 1 Study of SY-1365, a Selective CDK7 Inhibitor, in Adult Patients With Advanced Solid Tumors|Recruiting||Phase 1|70|Anticipated|Syros Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 21:07:08.975428|2017-10-10 21:07:08.975428
NCT03134625|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-12|||June 28, 2016|Actual|2016-06-28|March 2017|2017-03-01|July 31, 2019|Anticipated|2019-07-31|July 30, 2018|Anticipated|2018-07-30||Observational|||Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation|Identification of Metabolite Biomarkers Related to Acute Rejection of Patients With Kidney Transplantation|Recruiting||N/A|200|Anticipated|Seoul National University Hospital|||1||f||||||||||Samples Without DNA|"     urine   "|||2017-10-10 21:07:09.075853|2017-10-10 21:07:09.075853
NCT03134612|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection|Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection|Completed||Phase 2|104|Actual|Indonesia University||2|||f||||||||||||Undecided||2017-10-10 21:07:09.15886|2017-10-10 21:07:09.15886
NCT03134599|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-31|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|August 30, 2017|Anticipated|2017-08-30|July 31, 2017|Anticipated|2017-07-31||Interventional|||Comparison of Clinical Performance and Subjective Preference Out of Three Cosmetic Contact Lenses (Limbal Ring-enhancing Lenses, LRE Lenses)|Comparison of Clinical Performance and Subjective Preference Out of Three Cosmetic Contact Lenses (Limbal Ring-enhancing Lenses, LRE Lenses)|Recruiting||N/A|60|Anticipated|Coopervision, Inc.||3|||f||||f|f|f|||f|||No||2017-10-10 21:07:09.269971|2017-10-10 21:07:09.269971
NCT03134586|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-04-25|||June 2016||2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ANDI||Advanced Non-Invasive Diagnostics in Inflammatory Bowel Disease|A Comparative Study of the Diagnostic Validity of Ultrasound, Magnetic Resonance Imaging and Capsule Endoscopy of Both the Small and Large Intestine in Suspected Crohn's Disease|Recruiting||N/A|150|Anticipated|Sydvestjysk Hospital||1|||f||||f||||||||No||2017-10-10 21:07:09.361736|2017-10-10 21:07:09.361736
NCT03134560|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||April 2016||2016-04-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Intravenous Cannulation Using Vein Display Instrument and Without Using Vein Display Instrument in Pediatric Patients|Comparison Between Using Vein Display Instrument and Without Using Vein Display Instrument for Successful Intravenous Cannulation in Pediatric Patients|Completed||N/A|88|Actual|Indonesia University||2|||f||||||||||||Undecided||2017-10-10 21:07:09.559287|2017-10-10 21:07:09.559287
NCT03134547|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-28|||June 1, 2016|Actual|2016-06-01|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|December 31, 2016|Actual|2016-12-31||Interventional|||A Comparison of Emergence Agitation by Sevoflurane for Intraoperative Sedation Associated With Caudal Block|A Comparison of Postoperative Emergence Agitation by Sevoflurane for Intraoperative Sedation Associated With Caudal Block in Children: Randomised Comparison of Two Dose|Completed||N/A|40|Actual|Yeungnam University College of Medicine||2|||f||||t|f|f||||||Yes||2017-10-10 21:07:09.654627|2017-10-10 21:07:09.654627
NCT03134534|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-09-06|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Robot-assisted vs VATS Lobectomy for NSCLC|The Study of Robot-assisted Thoracoscopic Surgery Versus Video-assisted Thoracoscopic Surgery Lobectomy for Non-small Cell Lung Cancer on Short-term and Long-term Outcomes|Recruiting||N/A|300|Anticipated|Ruijin Hospital||2|||f||||f|f|f||||||||2017-10-10 21:07:09.738253|2017-10-10 21:07:09.738253
NCT03134521|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-10|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Population Pharmacokinetic Analysis of Daptomycin in Patients With Osteoarticular Infections|Population Pharmacokinetic Analysis of Daptomycin in Patients With Osteoarticular Infections|Active, not recruiting||N/A|189|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 21:07:09.857729|2017-10-10 21:07:09.857729
NCT03134508|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|March 2016|Actual|2016-03-01||Observational|EVASION||Population Based Evaluation of the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases|Evaluation of Adherence to Guidelines, and of the Risk to Benefit Ratio, in the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases. Study on the French National PMSI Database|Completed||N/A|8726|Actual|Centre Hospitalier Universitaire Dijon|||2||f|||||f|f||||||||2017-10-10 21:07:09.925601|2017-10-10 21:07:09.925601
NCT03134495|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|March 2015|Actual|2015-03-01||Observational|UTOPIE||the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections.|A Cohort Study to Assess the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections|Completed||N/A|290286|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||f|f|f||||||||2017-10-10 21:07:09.997705|2017-10-10 21:07:09.997705
NCT03134482|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-01|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|September 23, 2019|Anticipated|2019-09-23|September 23, 2018|Anticipated|2018-09-23||Interventional|||Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS|Comparison of Clinical Outcomes Between in Vitro Maturation and Minimal Stimulation in Vitro Fertilization in Patients With Polycystic Ovarian Syndrome; Prospective, Randomized Controlled, Parallel, Open-label, Clinical Trial|Recruiting||N/A|240|Anticipated|CHA University||2|||f|||||f|f||||||Undecided||2017-10-10 21:07:10.090441|2017-10-10 21:07:10.090441
NCT03134469|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-26|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy of Probiotics on Excessive Gas Accumulation|Efficacy of Probiotics on Excessive Gas Accumulation|Recruiting||N/A|64|Anticipated|Probi AB||2|||f||||f|f|f||||||No||2017-10-10 21:07:10.186544|2017-10-10 21:07:10.186544
NCT03134456|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 29, 2020|Anticipated|2020-02-29|October 30, 2019|Anticipated|2019-10-30||Interventional|||Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX|Pembrolizumab for Metastatic Non-small Cell Lung Cancer (NSCLC) Patients Expressing PD-L1 Who Have Their Own Patient-derived Xenograft (PDX): Comparative Study of Clinical Response and In-vivo Antitumor Response Using Their Humanized CD34 PDX (Hu-CD34 PDX)|Not yet recruiting||Phase 4|50|Anticipated|Samsung Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:07:10.276513|2017-10-10 21:07:10.276513
NCT03134443|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-27|||December 1, 2016|Actual|2016-12-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis|Combined With Andrographolide Sulfonate on the Basis of Conventional Therapy in the Treatment of Acute Tonsillitis: a Randomized, Single Blind, Placebo-controlled, Multicenter Study|Recruiting||Phase 4|144|Anticipated|Jiangxi Qingfeng Pharmaceutical Co. Ltd.||2|||f||||||||||||Undecided||2017-10-10 21:07:10.349169|2017-10-10 21:07:10.349169
NCT03134430|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-06|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|May 1, 2023|Anticipated|2023-05-01|May 1, 2022|Anticipated|2022-05-01||Interventional|||Effects of Regional Nerve Block on Cancer Recurrence|Effects of Regional Nerve Block on Cancer Recurrence|Recruiting||N/A|400|Anticipated|The First Affiliated Hospital of Nanchang University||2|||f|||||f|f||||||||2017-10-10 21:07:10.446119|2017-10-10 21:07:10.446119
NCT03134417|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-27|||February 1, 2016|Actual|2016-02-01|April 2017|2017-04-01|June 1, 2020|Anticipated|2020-06-01|December 31, 2019|Anticipated|2019-12-31||Interventional|||Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes|Parathyroid Hormone and Cardiometabolic Outcomes in Obesity: Role of Magnesium and Vitamin D Supplementation|Recruiting||N/A|123|Anticipated|Drexel University||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:07:10.532353|2017-10-10 21:07:10.532353
NCT03134404|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-09-20|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|RAMP||Project to Assess Feasibility of a Rapid Access Metastatic Bone Disease Program|A Pilot Project to Assess the Feasibility of Integrating a Multidisciplinary Rapid Access Metastatic Bone Disease Program (RAMP) at The Ottawa Hospital|Not yet recruiting||N/A|130|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-10 21:07:10.624731|2017-10-10 21:07:10.624731
NCT03134391|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-15|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|May 31, 2017|Actual|2017-05-31|October 30, 2016|Actual|2016-10-30||Interventional|||Comparison Between Vapocoolant Spray and Eutectic Mixture of Local Anesthetics in Reducing Pain From Spinal Injection|Comparison Between Vapocoolant Spray and Eutectic Mixture of Local Anesthetics in Reducing Pain From Spinal Injection|Completed||N/A|97|Actual|Indonesia University||2|||f||||f|f|f||||||||2017-10-10 21:07:10.697413|2017-10-10 21:07:10.697413
NCT03134378|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-27|||October 3, 2016|Actual|2016-10-03|April 2017|2017-04-01|May 12, 2017|Anticipated|2017-05-12|May 5, 2017|Anticipated|2017-05-05||Interventional|||10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication|Comparison of Triple Therapy Regimens Effectiveness Over 10 Days and 14 Days in Eradication of Helicobacter Pylori Infection: Double Blind Randomized Clinical Trial|Recruiting||Phase 4|73|Anticipated|Indonesia University||2|||f||||t|f|f||||||No||2017-10-10 21:07:10.779929|2017-10-10 21:07:10.779929
NCT03134352|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-18|||April 26, 2017|Actual|2017-04-26|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema|A Multi-center, Randomized, Double-blind, Parallel, Placebo Controlled Phase II Study to Evaluate the Efficacy and Safety of Fugan Ointment (ZL-3101) in Subjects With Subacute Eczema|Recruiting||Phase 2|310|Anticipated|Zai Lab Pty. Ltd.||3|||f|||||f|f||||||No||2017-10-10 21:07:10.954132|2017-10-10 21:07:10.954132
NCT03134339|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-04-27|||January 5, 2017|Actual|2017-01-05|April 2017|2017-04-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||The Effect of Nicotine Delivery Rate on Reinforcement|The Effect of Nicotine Delivery Rate on Reinforcement|Recruiting||Early Phase 1|18|Anticipated|Yale University||4|||f||||t|t|f||||||No||2017-10-10 21:07:11.059084|2017-10-10 21:07:11.059084
NCT03134326|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-19||June 18, 2009|Actual|2009-06-18|June 2017|2017-06-01|July 2, 2009|Actual|2009-07-02|July 2, 2009|Actual|2009-07-02||Interventional|||Rainbow R2-25 vs. R1-25 SpHb Sub-Range Performance Equivalence||Completed||N/A|21|Actual|Masimo Corporation||1|||f|||||f|t|f|||||||2017-10-10 21:07:11.164379|2017-10-10 21:07:11.164379
NCT03134313|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||December 12, 2008|Actual|2008-12-12|June 2017|2017-06-01|June 19, 2009|Actual|2009-06-19|June 19, 2009|Actual|2009-06-19||Interventional|||Accuracy of Noninvasive Rainbow Adhesive R1 Pulse Oximeter Sensor||Completed||N/A|25|Actual|Masimo Corporation||1|||f|||||f|t|f|||||||2017-10-10 21:07:11.311166|2017-10-10 21:07:11.311166
NCT03134300|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-27|||May 18, 2017|Anticipated|2017-05-18|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population|Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population|Not yet recruiting||N/A|30|Anticipated|Baylor College of Medicine||2|||f||||f|f|f||||||No||2017-10-10 21:07:11.453428|2017-10-10 21:07:11.453428
NCT03134287|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-15|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|May 31, 2017|Actual|2017-05-31|May 1, 2017|Actual|2017-05-01||Interventional|||Nasogastric Tube Placement on Intubated Patient: Two-Finger Method vs Reverse Sellick's Maneuver|Feasibility of Nasogastric Tube Placement on Intubated Patient: Comparison Between Two-Finger Method and Reverse Sellick's Maneuver|Completed||N/A|210|Actual|Indonesia University||2|||f|||||f|f||||||||2017-10-10 21:07:11.514267|2017-10-10 21:07:11.514267
NCT03134274|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-17|||May 7, 2017|Actual|2017-05-07|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study Assessing the Usability and Patient Satisfaction With Digital Urinalysis in the Context of Routine Pre-natal Care.|Healthy.io Urine Dipstick Home Testing: a Pilot Study Among Pregnant Women|Recruiting||N/A|300|Anticipated|Healthy.io Ltd.||1|||f||||f|f|t|t|||||||2017-10-10 21:07:11.592297|2017-10-10 21:07:11.592297
NCT03134261|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-02|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|DIMAB||Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients|A Prospective Study Comparing the Diagnostic Accuracy of Bone SPECT-CT, Choline-PET-CT, PSMA-PET-CT, NaF-PET-CT and WB-MRI in the Detection of Prostate Cancer Bone Metastases|Recruiting||N/A|300|Anticipated|Herlev Hospital||3|||f||||f|f|f||||||No||2017-10-10 21:07:11.682468|2017-10-10 21:07:11.682468
NCT03134248|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-06-13|||October 19, 2016|Actual|2016-10-19|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|April 12, 2017|Actual|2017-04-12||Interventional|||Bilateral Dispensing Study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric Lenses|Bilateral Dispensing Study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric Lenses|Recruiting||N/A|52|Anticipated|Coopervision, Inc.||3|||f||||f|f|f||||||No||2017-10-10 21:07:11.768519|2017-10-10 21:07:11.768519
NCT03134222|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-10-04|||May 24, 2017|Actual|2017-05-24|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety and Efficacy of Filgotinib and GS-9876 in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib and GS-9876 in Female Subjects With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)|Recruiting||Phase 2|50|Anticipated|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 21:07:11.940523|2017-10-10 21:07:11.940523
NCT03134209|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-27|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study Investigating the Efficacy of Various Wound Closure Devices in Reducing Postoperative Wound Complications|A Single-center, Phase IV, Randomized, Prospective Study Investigating the Efficacy of Various Wound Closure Devices in Reducing Postoperative Wound Complications|Recruiting||N/A|200|Anticipated|New York University School of Medicine||3|||f||||f|f|t|f|f|f|||||2017-10-10 21:07:12.053782|2017-10-10 21:07:12.053782
NCT03134196|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-10-04|||August 23, 2017|Actual|2017-08-23|October 2017|2017-10-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|ZEDS||Zoster Eye Disease Study|Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus|Recruiting||Phase 4|1050|Anticipated|New York University School of Medicine||2|||f||||t|t|f||||||||2017-10-10 21:07:12.136897|2017-10-10 21:07:12.136897
NCT03134183|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-06|||November 19, 2016|Actual|2016-11-19|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E|A Randomized Double-blinded Comparison of 24-hour Interval-Mifepristone and Buccal Misoprostol Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation in Second-Trimester Surgical Abortion|Completed||Phase 4|72|Actual|Virginia Commonwealth University||2|||f|||||t|f|||f|||||2017-10-10 21:07:12.276353|2017-10-10 21:07:12.276353
NCT03134170|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-27|||August 1, 2015|Actual|2015-08-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effect of Pharmacists Treating Diabetes in a FQHC|Impact of Adding a Pharmacist to the Health Care Team in a Federally Qualified Health Center|Recruiting||N/A|220|Anticipated|Rutgers, The State University of New Jersey||2|||f||||t|f|f||||||Yes|In addition, the pharacists at the clinic who are treating the have access to the patient data|2017-10-10 21:07:12.351856|2017-10-10 21:07:12.351856
NCT03134157|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-26|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women|Evaluation the Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Patients|Recruiting||Phase 3|60|Anticipated|Royan Institute||3|||f||||t|f|f||||||No||2017-10-10 21:07:12.424799|2017-10-10 21:07:12.424799
NCT03134144|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Chairless Chair Exoskeleton. Work-physiological-biomechanical Analysis of the Lower Extremities|Chairless Chair Exoskeleton. Work-physiological-biomechanical Analysis of the Lower Extremities|Recruiting||Phase 1|30|Anticipated|University Hospital Tuebingen||1|||f|||||f|f||||||||2017-10-10 21:07:12.5131|2017-10-10 21:07:12.5131
NCT03134131|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-14||||||July 2017|2017-07-01||||||||Expanded Access|||Expanded Access Program for ONC201 to Treat Recurrent Histone H3 Mutant Glioma||Available||N/A|||Oncoceutics, Inc.||||||t|||||||||||||2017-10-10 21:07:12.696211|2017-10-10 21:07:12.696211
NCT03134118|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-28|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|NIVOTHYM||Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)|Single-arm, Multicentre, Phase II Study of Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy|Not yet recruiting||Phase 2|55|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||t|f|f||||||||2017-10-10 21:07:12.789955|2017-10-10 21:07:12.789955
NCT03134105|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-08-16|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|AWARE||A Wearable EducAtional Intervention to REduce Angina|A Wearable EducAtional Intervention to REduce Angina|Withdrawn||N/A|0|Actual|Duke University||2||Sponsor/funding source decided to not move forward.|f||||f|f|f||||||||2017-10-10 21:07:12.923153|2017-10-10 21:07:12.923153
NCT03134092|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-30|||June 28, 2017|Actual|2017-06-28|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 1, 2018|Anticipated|2018-09-01||Interventional|||The Life STORRIED Study|Life Stories for Opioid Risk Reduction in the ED|Recruiting||N/A|1100|Anticipated|University of Pennsylvania||3|||f||||t|f|f||||||||2017-10-10 21:07:13.006668|2017-10-10 21:07:13.006668
NCT03134066|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-27|||September 2016||2016-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Neurocognitive Features of Patients With Treatment-Resistant Depression||Enrolling by invitation||N/A|30|Anticipated|Massachusetts General Hospital|||1||f||||||||||||||2017-10-10 21:07:13.241143|2017-10-10 21:07:13.241143
NCT03134053|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Effect of Extracorporeal Shock Waves on Hypertrophy Scar|Assessment of the Effect of Extracorporeal Shock Waves on Hypertrophy Scar|Not yet recruiting||N/A|22|Anticipated|Mackay Memorial Hospital||2|||f|||||f|t|f|f|t|||||2017-10-10 21:07:13.310694|2017-10-10 21:07:13.310694
NCT03134040|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-06-01|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Small Monetary Incentives to Promote Exercise (Exercise4Good; EX4G)|Using Behavioral Economics to Promote Exercise Among Overweight Inactive Adults|Active, not recruiting||N/A|82|Actual|Brown University||3|||f||||f|f|f||||||Yes|De-identified data will be shared with interested parties after all of the initial study analyses and outcomes have been published.|2017-10-10 21:07:13.428871|2017-10-10 21:07:13.428871
NCT03134027|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-01|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|Immune PDX||Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers|Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers|Recruiting||N/A|5|Anticipated|Duke University|||1||f||||f|f|f||||||||2017-10-10 21:07:13.526491|2017-10-10 21:07:13.526491
NCT03134014|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-27|||December 12, 2016|Actual|2016-12-12|April 2017|2017-04-01|December 12, 2017|Anticipated|2017-12-12|December 12, 2017|Anticipated|2017-12-12||Interventional|||High Protein Breakfast on Weight Management and Glycemic Control in 'Breakfast-skipping' Teens|Long-term Effects of Consuming a High Protein, Beef Breakfast on Weight Management and Glycemic Control in Overweight 'Breakfast-skipping' Young People|Recruiting||N/A|88|Anticipated|Purdue University||3|||f|||||f|f||||||No||2017-10-10 21:07:13.640079|2017-10-10 21:07:13.640079
NCT03134001|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-03|||June 1, 2015|Actual|2015-06-01|April 2017|2017-04-01|November 30, 2015|Actual|2015-11-30|November 30, 2015|Actual|2015-11-30||Interventional|||Evaluation of Oral PCA Device - PCoA™ Acute|Evaluation of Oral Patient-Controlled Analgesia (PCA) Device - PCoA™ Acute , for Hospitalized Patients With Post-operative Pain|Completed||N/A|70|Actual|Dosentrx Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:07:13.795095|2017-10-10 21:07:13.795095
NCT03133988|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-22||||||June 2017|2017-06-01||||||||Expanded Access|||Margetuximab Expanded Access Program|An Expanded Access (Compassionate Use) Program Providing Margetuximab in the Treatment of HER2+ Metastatic Breast Cancer and Other HER2+ Carcinomas in Single, Individually-approved Patients|Available||N/A|||MacroGenics||||||t|||||||||||||2017-10-10 21:07:13.908167|2017-10-10 21:07:13.908167
NCT03133975|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-27|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|July 1, 2018|Anticipated|2018-07-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Vitamin D Supplementation for Treatment of Dyslipidemia|Vitamin D Supplementation for Reduction of Dyslipidemia in Premenopausal Women|Recruiting||Phase 3|30|Anticipated|Mansoura University||2|||f||||f|f|f||||||No||2017-10-10 21:07:13.990446|2017-10-10 21:07:13.990446
NCT03133962|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-11|||November 3, 2014|Actual|2014-11-03|May 2017|2017-05-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|EchoPAC||Evaluation of the Contribution of the Ultrasound Tracking and the Positioning of the Distal End During the Implantation of Implantable Chamber or Long-lasting Venous Catheter|Evaluation of the Contribution of the Ultrasound Tracking and the Positioning of the Distal End During the Implantation of Implantable Chamber or Long-lasting Venous Catheter|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire, Amiens||1||Decision of the investigator|f|||||f|f||||||||2017-10-10 21:07:14.129042|2017-10-10 21:07:14.129042
NCT03133936|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-15|||December 2016||2016-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of the Effects of Age, Prior Exposure, and Previous Vaccination on Response to the Flu Vaccine|Evaluation of the Effects of Age, Prior Exposure, and Previous Vaccination on the B Cell Response to Inactivated Influenza Vaccine in Healthy Adults and Children|Active, not recruiting||N/A|8|Anticipated|University of Rochester||1|||f||||f||||||||||2017-10-10 21:07:14.302131|2017-10-10 21:07:14.302131
NCT03133923|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-02|||May 20, 2017|Actual|2017-05-20|April 2017|2017-04-01|July 1, 2018|Anticipated|2018-07-01|November 30, 2017|Anticipated|2017-11-30||Interventional|||Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants|Safety and Efficacy of Attenuated Mumps Vaccine (Human Diploid Cell)|Active, not recruiting||Phase 2|1080|Anticipated|Chinese Academy of Medical Sciences||3|||f||||t|f|f||||||||2017-10-10 21:07:14.39594|2017-10-10 21:07:14.39594
NCT03133910|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-25|||March 9, 2017|Actual|2017-03-09|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Pharmacokinetics and Pharmacodynamics of Ceftazidime in Pediatric ICU Patients|Pharmacokinetics and Pharmacodynamics of Ceftazidime in Pediatric ICU Patients|Enrolling by invitation||N/A|20|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||||No||2017-10-10 21:07:14.509153|2017-10-10 21:07:14.509153
NCT03133832|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-25|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|July 10, 2017|Anticipated|2017-07-10|June 30, 2017|Anticipated|2017-06-30||Interventional|||The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium|Efficacy of Chinese-made Versus WHO-PQ Praziquantel for Treatment of Schistosoma Haematobium in Zanzibar: a Randomized Controlled Trial|Recruiting||Phase 3|120|Anticipated|Jiangsu Institute of Parasitic Diseases||3|||f||||t|f|f||||||No||2017-10-10 21:07:14.598633|2017-10-10 21:07:14.598633
NCT03133819|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-04|||November 2016||2016-11-01|May 2016|2016-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||The Early Intervention and Prevention of Diabetes Foot|The Early Intervention and Prevention of Diabetes Foot|Enrolling by invitation||N/A|400|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||No||2017-10-10 21:07:14.700774|2017-10-10 21:07:14.700774
NCT03133806|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-25|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|August 15, 2018|Anticipated|2018-08-15|August 2018|Anticipated|2018-08-01||Interventional|CLASS||Canadian Left Atrial Appendage Closure Study|CLASS Canadian Left Atrial Appendage Closure Study|Recruiting||N/A|30|Anticipated|Cardia Inc.||1|||f|||||f|f||||||No||2017-10-10 21:07:14.782316|2017-10-10 21:07:14.782316
NCT03133793|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||November 2017|Anticipated|2017-11-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||CoQ10 and D-ribose in Patients With Diastolic Heart Failure|Reducing Symptom Burden in Patients With Heart Failure With Preserved Ejection Fraction Using Ubiquinol and/or D-ribose|Not yet recruiting||Phase 2|250|Anticipated|University of Kansas Medical Center||4|||f||||t|t|f||||||||2017-10-10 21:07:14.92779|2017-10-10 21:07:14.92779
NCT03133780|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-06-23|||August 25, 2017|Anticipated|2017-08-25|June 2017|2017-06-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Sedation During Spinal Anesthesia|A Comparison of the Sedative Effect of Dexamedetomidine and Midazolam During Spinal Anaesthesia for Elective Unilateral Inguinal Hernia Repair: A Randomized Comparative Trial|Not yet recruiting||Phase 2|100|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:07:15.0865|2017-10-10 21:07:15.0865
NCT03133767|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-15|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation|Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation|Recruiting||Phase 4|156|Anticipated|University of Iowa||2|||f||||f|t|f|||t|||No||2017-10-10 21:07:15.199839|2017-10-10 21:07:15.199839
NCT03133754|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-06-07|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||OLA to Lowest DP in Cardiac Surgery|Open-lung Ventilatory Approach With Positive End-expiratory Pressure Titrated to Lowest Driving Pressure in Cardiac Surgery Patients|Not yet recruiting||N/A|60|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f|f|f||||||Yes||2017-10-10 21:07:15.313526|2017-10-10 21:07:15.313526
NCT03133741|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2017|Anticipated|2017-07-01||Interventional|GA-3||Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist|Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist (GA-3)|Recruiting||N/A|18|Anticipated|University Hospital, Gentofte, Copenhagen||4|||f||||t|f|f||||||No||2017-10-10 21:07:15.404476|2017-10-10 21:07:15.404476
NCT03133728|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-15|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|September 29, 2019|Anticipated|2019-09-29|December 1, 2018|Anticipated|2018-12-01||Observational|CDC Detect||Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants|To Improve Rates of Antiretroviral Therapy Initiation for HIV-1 Infected Infants Through Point-of-Care Diagnosis|Not yet recruiting||N/A|7540|Anticipated|University of Alabama at Birmingham|||2||f||||f|f|f||||||||2017-10-10 21:07:15.500861|2017-10-10 21:07:15.500861
NCT03133715|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-18|||May 1, 2018|Anticipated|2018-05-01|September 2017|2017-09-01|June 2023|Anticipated|2023-06-01|December 2022|Anticipated|2022-12-01||Interventional|||Laparoscopic Versus Robot-assisted Ventral Hernia Repair: a Single Institution Randomized Controlled Trial|Laparoscopic Versus Robot-assisted Ventral Hernia Repair: The Immediate, Intermediate, and Long Term Outcome Differences. A Single Institution Randomized Controlled Trial|Suspended||N/A|1000|Anticipated|University of Florida||2||Study not IRB approved.|f||||f|f|f||||||||2017-10-10 21:07:15.580561|2017-10-10 21:07:15.580561
NCT03133702|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-27|||January 1, 2014|Actual|2014-01-01|April 2017|2017-04-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Observational|||Traumatic Characteristics of the Forensic Cases Admitted to Emergency Department and Errors in the Forensic Reports|Characteristics of the Traumatic Forensic Cases Admitted to Emergency Department and Errors in the Forensic Reports|Completed||N/A|4300|Actual|Adiyaman University Research Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:07:15.651847|2017-10-10 21:07:15.651847
NCT03133533|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-18|||May 2018|Anticipated|2018-05-01|September 2017|2017-09-01|June 2023|Anticipated|2023-06-01|December 2022|Anticipated|2022-12-01||Interventional|||Laparoscopic Versus Robot-assisted Inguinal Hernia Repair: A Single Institution Randomized Controlled Trial|Laparoscopic Versus Robot-assisted Inguinal Hernia Repair: The Immediate, Intermediate, and Long Term Outcome Differences. A Single Institution Randomized Controlled Trial|Suspended||N/A|1000|Anticipated|University of Florida||2||Not approved by the IRB.|f||||f|f|f||||||||2017-10-10 21:07:18.912052|2017-10-10 21:07:18.912052
NCT03133689|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-04-27|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|June 30, 2017|Anticipated|2017-06-30||Observational|||Alcohol Consumption and Coronary Heart Disease Onset|Alcohol Consumption and Time-to-onset for Coronary Heart Disease: An Individual Participant Data Meta-analysis|Active, not recruiting||N/A|64926|Anticipated|University College, London|||6||f||||t|f|f||||||Yes|Researchers can request access to anonymised data. The data are already available to bona fide researchers via application: European Prospective Investigation of Cancer-Norfolk (EPIC-Norfolk; http://www.srl.cam.ac.uk/epic/contact/), Gaz et Electricité (GAZEL; http://www.gazel.inserm.fr/en/projects/submitting-a-project.html), Medical Research Council National Survey of Health and Development 1946 (NSHD; http://www.nshd.mrc.ac.uk/data/), West of Scotland Twenty-07 Study (T-07-1930s and T-07-1950s; http://2007study.sphsu.mrc.ac.uk/Information-on-data-sharing.html), and Whitehall II (WII; http://www.ucl.ac.uk/whitehallII/data-sharing).|2017-10-10 21:07:15.753725|2017-10-10 21:07:15.753725
NCT03133676|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-08-18|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 Administered Via Intra-Articular Injection in Subjects With Osteoarthritis of the Knee|Not yet recruiting||Phase 1|60|Anticipated|California Institute for Biomedical Research||2|||f||||f|t|f||||||||2017-10-10 21:07:15.855038|2017-10-10 21:07:15.855038
NCT03133663|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-07-01|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|HEART||Heart Rate Evaluation and Resuscitation Trial in Preterm Neonates|Heart Rate Evaluation and Resuscitation Trial in Preterm Neonates|Recruiting||N/A|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:07:15.934903|2017-10-10 21:07:15.934903
NCT03133650|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-09-27|||April 26, 2017|Actual|2017-04-26|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing|A Phase I Trial of Vascular-Targeted Photodynamic Therapy in Esophagogastric Cancer Patients With Moderate to Severe Dysphagia|Recruiting||Phase 1|36|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:07:16.024932|2017-10-10 21:07:16.024932
NCT03133637|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-25|||March 2016||2016-03-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|CEFT||Ceftriaxone and Jaundice in Neonates|Effect of Ceftriaxone on Neonatal Jaundice|Recruiting||Phase 2|40|Anticipated|University of Rochester||1|||f||||f||||||||Undecided||2017-10-10 21:07:16.103358|2017-10-10 21:07:16.103358
NCT03133624|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-06-10|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31|1 Year|Observational [Patient Registry]|CIAP-2||A Study on a Multidimensional Prediction Model for Rupture Risk of Unruptured Intracranial Aneurysms|This is a Registry Study on a Multidimensional Prediction Model for Rupture Risk of Unruptured Intracranial Aneurysms in China|Recruiting||N/A|5000|Anticipated|Beijing Neurosurgical Institute|||1||f||||t|f|f||||Samples With DNA|"     whole blood   "|Yes|we can share the original data 5 years after the study.|2017-10-10 21:07:16.18976|2017-10-10 21:07:16.18976
NCT03133611|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-26|2017-05-01|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Detecting Parkinson's Disease Through Speech Analysis|Automatic Acoustic Speech Analysis and REM Sleep Behaviour Disorder for Detecting Subjects at High Risk for Parkinson's Disease and Other Alpha-synucleinopathies|Recruiting||N/A|350|Anticipated|Czech Technical University in Prague||3|||f||||f|f|f||||||Yes|De-identified clinical data (speech recordings and associated clinical scales) may be shared with the Michael J. Fox Foundation (the study funder). This data may be kept for storage at a central repository either hosted by the Michael J. Fox Foundation, its collaborators, or consultants.|2017-10-10 21:07:16.364589|2017-10-10 21:07:16.364589
NCT03133598|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-27|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 30, 2021|Anticipated|2021-12-30|December 30, 2020|Anticipated|2020-12-30||Observational|||Study of Treatment of Unruptured Intracranial Aneurysms in China|Prospective Cohort Study of Interventional Therapy and Craniotomy for Unruptured Aneurysms|Not yet recruiting||N/A|1500|Anticipated|Zhujiang Hospital|||1||f||||t||||||||Yes|invertigators can share the original data 5 years after the study|2017-10-10 21:07:16.489517|2017-10-10 21:07:16.489517
NCT03133585|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-25|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|KISSS||Study on the Stoma Appliance Flexima®/Softima® 3S|Non-Interventional, International, Post-Marketing Clinical Follow-up Study on the Stoma Appliance Flexima®/Softima® 3S|Not yet recruiting||N/A|1500|Anticipated|BBraun Medical SAS|||1||f||||f|f|f||||||No||2017-10-10 21:07:16.591468|2017-10-10 21:07:16.591468
NCT03133559|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-04-25|||April 19, 2017|Actual|2017-04-19|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Observational|||Mapping the Human HIV Chronobiome|Mapping the Human HIV Chronobiome|Recruiting||N/A|6|Anticipated|University of Pennsylvania|||3||f||||f||||||||Yes|To be determined|2017-10-10 21:07:16.747278|2017-10-10 21:07:16.747278
NCT03133546|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-28|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|BOOSTER||Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M (BOOSTER)|A Randomised Phase II Trial of Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M|Recruiting||Phase 2|154|Anticipated|European Thoracic Oncology Platform||2|||f||||t|f|f||||||||2017-10-10 21:07:16.831781|2017-10-10 21:07:16.831781
NCT03133156|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-08-01|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2018|Anticipated|2018-12-15||Interventional|||Exercise Regulation of Human Adipose Tissue|Exercise Regulation of Human Adipose Tissue|Recruiting||N/A|40|Anticipated|Joslin Diabetes Center||4|||f||||f|f|f||||||||2017-10-10 21:07:21.729871|2017-10-10 21:07:21.729871
NCT03133520|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-08|||November 1, 2016|Actual|2016-11-01|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|December 1, 2017|Anticipated|2017-12-01||Interventional|HFOT||Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure|Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure|Recruiting||N/A|50|Anticipated|TC Erciyes University||2|||f||||f|f|f||||||No||2017-10-10 21:07:19.003883|2017-10-10 21:07:19.003883
NCT03133507|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-25|||November 14, 2012|Actual|2012-11-14|April 2017|2017-04-01|September 26, 2013|Actual|2013-09-26|September 26, 2013|Actual|2013-09-26||Interventional|||Emotion Regulation and Pain in Children With Cancer|Effects of Reappraisal, Reassurance, and Distraction on Pain and Distress in Children Undergoing Treatment for Cancer|Completed||N/A|73|Actual|University of California, Irvine||3|||f||||f|f|f||||||No||2017-10-10 21:07:19.093655|2017-10-10 21:07:19.093655
NCT03133494|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-05-15|||April 1, 2015|Actual|2015-04-01|May 2017|2017-05-01|April 1, 2016|Actual|2016-04-01|April 1, 2016|Actual|2016-04-01||Interventional|ABG||Arterial Blood Gas Analysis in Laparoscopic Cholecystectomy|Comparing Arterial Blood Gas(ABG) in Laparoscopic Cholecystectomy Between Smokers and Non Smokers: A Randomized Double Blind Case Control Study|Completed||N/A|60|Actual|Banaras Hindu University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:19.171888|2017-10-10 21:07:19.171888
NCT03133481|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-25|||October 22, 2014|Actual|2014-10-22|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty|Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty|Active, not recruiting||Phase 3|100|Actual|University of Alabama at Birmingham||2|||f||||t|t|||||||Undecided||2017-10-10 21:07:19.242788|2017-10-10 21:07:19.242788
NCT03133468|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-23|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Interventional|||Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State|A First-in-Human, Randomised, Double Blind, Placebo Controlled, Single and Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State|Recruiting||Phase 1|184|Anticipated|Eisai Inc.||6|||f||||f|f|f||||||||2017-10-10 21:07:19.333092|2017-10-10 21:07:19.333092
NCT03133455|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-27|||September 16, 2015|Actual|2015-09-16|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|PRFM-1||Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia|Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:07:19.433949|2017-10-10 21:07:19.433949
NCT03133442|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-27|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Effect of Vestibular Stimulation on Sleep in Elderly|Effect of Vestibular Stimulation on Sleep in Elderly|Recruiting||N/A|32|Anticipated|Swiss Federal Institute of Technology||2|||f||||t|f|f||||||No||2017-10-10 21:07:19.533928|2017-10-10 21:07:19.533928
NCT03133429|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||October 2016||2016-10-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|MER||Clinical Study to Evaluate the Safety and Effectiveness of MER® Stents in Carotid Revascularisation.|Badanie Kliniczne oceniające bezpieczeństwo i skuteczność Stosowania stentów Szyjnych MER® w Rewaskularyzacji tętnic Szyjnych.|Recruiting||N/A|100|Anticipated|Balton Sp.zo.o.||1|||f||||t|f|f||||||No||2017-10-10 21:07:19.60812|2017-10-10 21:07:19.60812
NCT03133416|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-25|||August 1, 2016|Actual|2016-08-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Platelet-rich Plasma Injections and Physiotherapy in the Treatment of Chronic Rotator Cuff Tendinopathy|Platelet-rich Plasma Injections and Physiotherapy in the Treatment of Chronic Rotator Cuff Tendinopathy|Recruiting||N/A|165|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital||3|||f||||t|f|f||||||Undecided||2017-10-10 21:07:19.713249|2017-10-10 21:07:19.713249
NCT03133403|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-27|||November 2013||2013-11-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|MIST||Hematopoietic Stem Cell Therapy for Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy|Hematopoietic Stem Cell Therapy for Patients With Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized Study|Recruiting||Phase 2/Phase 3|5|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||No|no individual data will be shared|2017-10-10 21:07:19.940701|2017-10-10 21:07:19.940701
NCT03133377|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|May 2022|Anticipated|2022-05-01||Interventional|TEAM(III)||Treatment of Invasively Ventilated Adults With Early Activity and Mobilisation|A Prospective Multicentre Phase III Randomised Controlled Trial of Early Activity and Mobilisation Compared With Standard Care in Invasively Ventilated Patients in Intensive Care|Not yet recruiting||Phase 3|750|Anticipated|Australian and New Zealand Intensive Care Research Centre||2|||f||||t|f|f||||||||2017-10-10 21:07:20.151819|2017-10-10 21:07:20.151819
NCT03133364|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-21|||May 17, 2017|Actual|2017-05-17|September 2017|2017-09-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Interventional|||Developing and Testing Delicious and Nutritious for the Old People|Developing and Testing Delicious and Nutritious for the Old People|Completed||N/A|52|Actual|University of Copenhagen||2|||f||||f|f|f||||||||2017-10-10 21:07:20.270007|2017-10-10 21:07:20.270007
NCT03133351|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-25|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy Volunteers|Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy Volunteers|Recruiting||N/A|240|Anticipated|Entegrion, Inc.|||1||f||||f|f|t|t||f|||||2017-10-10 21:07:20.353386|2017-10-10 21:07:20.353386
NCT03133338|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-28|||August 1, 2013|Actual|2013-08-01|April 2017|2017-04-01|July 31, 2014|Actual|2014-07-31|July 31, 2014|Actual|2014-07-31|3 Months|Observational [Patient Registry]|||Effect of Early Pelvic Binder Use in Emergency Management of Suspected Pelvic Trauma: a Retrospective Cohort Study|Division of Traumatic and General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center|Completed||N/A|204|Actual|Tri-Service General Hospital|||1||f|||||f|f||||||||2017-10-10 21:07:20.423318|2017-10-10 21:07:20.423318
NCT03133325|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-23|||April 19, 2017|Actual|2017-04-19|August 2017|2017-08-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Interventional|||A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine|A Randomized, Split Arm Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine|Completed||N/A|12|Actual|Q-Med AB||1|||f|||||f|f|||f|||||2017-10-10 21:07:20.485327|2017-10-10 21:07:20.485327
NCT03133312|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-29|||May 2, 2017|Actual|2017-05-02|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery|A Single Site Prospective Randomized Controlled Trial Comparing Chlorhexidine Gluconate and Povidone-Iodine as Vaginal Preparation Antiseptics for Cesarean Section to Determine Effect on Bacterial Load|Recruiting||Phase 4|100|Anticipated|Metro Health, Michigan||2|||f||||f|t|f|||f|||||2017-10-10 21:07:20.554308|2017-10-10 21:07:20.554308
NCT03133299|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-27|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma|A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma|Not yet recruiting||Phase 2/Phase 3|30|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:20.656271|2017-10-10 21:07:20.656271
NCT03133286|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-02|||April 6, 2017|Actual|2017-04-06|May 2017|2017-05-01|September 6, 2018|Anticipated|2018-09-06|September 6, 2018|Anticipated|2018-09-06||Observational|RADIANT||Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)|Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)|Recruiting||N/A|500|Anticipated|DxTerity Diagnostics|||1||f||||f|f|f||||||No||2017-10-10 21:07:20.750802|2017-10-10 21:07:20.750802
NCT03133273|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-25|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|ONCOGRAM||Study of the Therapeutic Response and Survival of Patients With Metastatic Colorectal Cancer (Stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme® (ONCOGRAM)|Study of the Therapeutic Response and Survival of Patients With Metastatic Colorectal Cancer (Stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme®|Not yet recruiting||N/A|230|Anticipated|University Hospital, Limoges||2|||f||||f|f|f||||||No||2017-10-10 21:07:20.838949|2017-10-10 21:07:20.838949
NCT03133260|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-22|||May 2, 2017|Actual|2017-05-02|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|April 30, 2019|Anticipated|2019-04-30||Observational|||A Project to Improve the Diagnosis and Prognosis of Myocardial Injury Associated to Non Cardiac Surgery|A Project to Improve the Diagnosis and Prognosis of Myocardial Injury Associated to Non Cardiac Surgery|Recruiting||N/A|1000|Anticipated|Parc de Salut Mar|||1||f||||f|f|f||||||||2017-10-10 21:07:20.942295|2017-10-10 21:07:20.942295
NCT03133247|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-06-27|||June 26, 2017|Actual|2017-06-26|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients|A Phase 1, Open-Label, Multicenter, Non-Randomized, Dose Escalation Study to Evaluate the Safety and Tolerability of SHR-1316 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|30|Anticipated|Atridia Pty Ltd.||1|||f||||t|t|f||||||No||2017-10-10 21:07:21.023653|2017-10-10 21:07:21.023653
NCT03133221|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Interventional|||1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation|1630GCC: A Pilot Study of Zydelig in Patients With B-cell Malignancies as Post-Autologous Transplant Remission Maintenance|Not yet recruiting||Phase 2|34|Anticipated|University of Maryland||1|||f||||t|t|f||||||||2017-10-10 21:07:21.183254|2017-10-10 21:07:21.183254
NCT03133208|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-10|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Sepsis Associated Encephalopathy (SAE) Biomarkers|Serum Biomarkers in Sepsis Associated Encephalopathy (SAE)|Recruiting||N/A|110|Anticipated|University of Florida|||3||f||||f|f|f||||Samples With DNA|"     blood samples (serum).   "|||2017-10-10 21:07:21.282917|2017-10-10 21:07:21.282917
NCT03133195|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-27|||May 17, 2017|Anticipated|2017-05-17|April 2017|2017-04-01|March 1, 2019|Anticipated|2019-03-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA|A Phase III, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With Proximal Femoral Nail Antirotation (PFNA)|Not yet recruiting||Phase 3|60|Anticipated|King Chulalongkorn Memorial Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:07:21.381433|2017-10-10 21:07:21.381433
NCT03133182|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-25|||April 2002|Actual|2002-04-01|April 2017|2017-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Polypharmacy and Outcomes After Elective Noncardiac Surgery|Association of Polypharmacy With Outcomes After Elective Noncardiac Surgery: a Population-based Cohort Study|Completed||N/A|200000|Actual|Ottawa Hospital Research Institute|||2||f||||f|f|f||||||No||2017-10-10 21:07:21.492701|2017-10-10 21:07:21.492701
NCT03133169|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-04-25|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Erythrocyte Glutamine/Glutamate Ratio Relation to Pulmonary Hypertension Risk in Thalassemic Children|Erythrocyte Glutamine/Glutamate Ratio Relation to Pulmonary Hypertension Risk in Thalassemic Children in Assiut University Children Hospital|Not yet recruiting||N/A|30|Anticipated|Assiut University|||1||f|||||f|f||||||Undecided||2017-10-10 21:07:21.62761|2017-10-10 21:07:21.62761
NCT03133143|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-25|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|GAME-S||Video Games Among People With Schizophrenia|The Impact of Video Gaming on Cognitive Functioning of People With Schizophrenia|Not yet recruiting||N/A|144|Anticipated|The Hong Kong Polytechnic University||3|||f||||f|f|f||||||No||2017-10-10 21:07:21.832943|2017-10-10 21:07:21.832943
NCT03133130|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-27|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Study to Investigate the Pharmacokinetics, Safety, and Tolerability of BMT101 in Healthy Male Volunteers|A Randomized, Single Blind, Single Dose, Placebo-controlled, Dose-escalation Phase I Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Intradermal Dosage Form of BMT101 in Healthy Male Volunteers|Not yet recruiting||Phase 1|32|Anticipated|Hugel||2|||f||||f|f|f||||||No||2017-10-10 21:07:21.943663|2017-10-10 21:07:21.943663
NCT03133117|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-27|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|VISIOPERICENT||Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma)|Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma)|Recruiting||N/A|60|Anticipated|University Hospital, Grenoble||1|||f||||f|f|f||||||||2017-10-10 21:07:22.026976|2017-10-10 21:07:22.026976
NCT03133104|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-10|||January 2017||2017-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Repeat Antenatal Corticosteroids|Retrospective Review of Repeat Antenatal Corticosteroids in Preterm Premature Rupture of Membranes|Enrolling by invitation||N/A|200|Anticipated|St. Louis University|||2||f||||f||||||||||2017-10-10 21:07:22.118336|2017-10-10 21:07:22.118336
NCT03133091|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-04-27|||September 2015||2015-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PIEBvsPCEA||Epidural Analgesia During Labour|Epidural Analgesia During Labour Randomized Clinical Trial Comparing Patient Controlled Epidural Analgesia Versus Patient Intermittent Epidural Boluses With Levobupivacaine|Recruiting||Phase 3|114|Anticipated|Hospital del Río Hortega||2|||f||||f||||||||Undecided||2017-10-10 21:07:22.19579|2017-10-10 21:07:22.19579
NCT03133078|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-05-03|||November 2016||2016-11-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Impact of Fatigue on Jumping Performance|Impact of Fatigue on Jumping Performance|Completed||N/A|20|Actual|Creighton University||2|||f||||f||||||||No||2017-10-10 21:07:22.310316|2017-10-10 21:07:22.310316
NCT03133065|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-25|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs|Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs|Completed||Phase 4|89|Actual|Ain Shams University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:22.391944|2017-10-10 21:07:22.391944
NCT03133052|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-25|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|November 2019|Anticipated|2019-11-01||Interventional|CTA-MCI||CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI)|The CTA-MCI Study: a Randomized Controlled Clinical Trial to Evaluate the Effect of Cognitive Control Training on Episodic Memory Function in Patients With Amnestic Mild Cognitive Impairment|Active, not recruiting||N/A|70|Anticipated|First Affiliated Hospital of Zhejiang University||2|||f|||||f|f||||||No||2017-10-10 21:07:22.462273|2017-10-10 21:07:22.462273
NCT03133039|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-27|||October 1, 2015|Actual|2015-10-01|April 2017|2017-04-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||A New Type of Bioabsorbable Screw in the Hallux Valgus Surgery|Comparative Experimental and Clinical Study: a New Type of Bioabsorbable Screw and the Titanium Screw in the Hallux Valgus Surgery|Recruiting||N/A|2|Anticipated|Tampere University Hospital||2|||f|||||f|f||||||||2017-10-10 21:07:22.564044|2017-10-10 21:07:22.564044
NCT03133026|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||June 2016||2016-06-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation|The Role of Cholangioscopy and Biliary Radio Frequency Ablation in the Management of Occluded Biliary Self-expanding Metal Stent.|Recruiting||N/A|4|Anticipated|Asian Institute of Gastroenterology, India||2|||f||||f||||||||No||2017-10-10 21:07:22.645333|2017-10-10 21:07:22.645333
NCT03133013|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-15|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Objective Evaluation of Depression Using Sleep EEG|A Study on Realization of Objective Evaluation Method of Depression Using Sleep EEG|Not yet recruiting||N/A|64|Anticipated|Stanford University||2|||f||||f|f|f||||||No||2017-10-10 21:07:22.741253|2017-10-10 21:07:22.741253
NCT03133000|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-25|||January 1, 2010|Actual|2010-01-01|April 2017|2017-04-01|September 30, 2016|Actual|2016-09-30|September 30, 2015|Actual|2015-09-30|1 Year|Observational [Patient Registry]|||Mini- or Less-Open Sublay Operation (MILOS) of Incisional Hernias|Mini- or Less-Open Sublay Operation (MILOS) - a New Minimally Invasive Technique for the Extraperitoneal Repair of Incisional Hernias|Completed||N/A|615|Actual|Gross Sand Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:07:22.823584|2017-10-10 21:07:22.823584
NCT03132987|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-15|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Characterizing Clinical and Biomechanical Contributions to Function Following ACL Reconstruction|Characterizing Clinical and Biomechanical Contributions to Function Following ACL Reconstruction|Completed||N/A|39|Actual|Creighton University||1|||f||||f||||||||||2017-10-10 21:07:22.891355|2017-10-10 21:07:22.891355
NCT03132974|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-31|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Evaluation of Efficacy and Safety of Herbal Medicine With Manipulation Therapy on Chronic Low Back Pain|Evaluation of Efficacy and Safety of Herbal Medicine With Manipulation Therapy on Chronic Low Back Pain -Multi-center, Randomized, Double Blinded, Parallel Group, Placebo -Controlled Pilot Study-|Not yet recruiting||Phase 2/Phase 3|150|Anticipated|Gachon University Gil Oriental Medical Hospital||3|||f||||t|f|f||||||||2017-10-10 21:07:22.980098|2017-10-10 21:07:22.980098
NCT02679404|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-04-10|||May 2015||2015-05-01|April 2017|2017-04-01|May 2029|Anticipated|2029-05-01|May 2024|Anticipated|2024-05-01||Observational|SURE-AVR||Sorin Universal REgistry on Aortic Valve Replacement|Sorin Universal REgistry on Aortic Valve Replacement|Recruiting||N/A|5000|Anticipated|LivaNova|||1||f||||f||||||||No||2017-10-10 22:28:50.735042|2017-10-10 22:28:50.735042
NCT03132961|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-10-04|||April 2018|Anticipated|2018-04-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops|Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops|Not yet recruiting||N/A|28|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||6||f||||f|f|f||||||||2017-10-10 21:07:23.066586|2017-10-10 21:07:23.066586
NCT03132948|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-04-25|||October 2010||2010-10-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy|Physical Activity and Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy|Recruiting||N/A|25|Anticipated|Connecticut Children's Medical Center||1|||f||||f|f|f||||||Undecided||2017-10-10 21:07:23.180277|2017-10-10 21:07:23.180277
NCT03132935|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-24|||January 1, 2014|Actual|2014-01-01|April 2017|2017-04-01|July 31, 2015|Actual|2015-07-31|July 31, 2015|Actual|2015-07-31||Observational|||Telemedical vs. Conventional Prehospital Care in Acute Coronary Syndromes|Quality Outcomes in Acute Coronary Syndromes Between Telemedically Supported Paramedics and Conventional On-scene Physician Care|Completed||N/A|221|Actual|RWTH Aachen University|||2||f||||f|f|f||||||No||2017-10-10 21:07:23.274898|2017-10-10 21:07:23.274898
NCT03132922|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-26|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||MAGE-A4ᶜ¹º³²T for Multi-Tumor|Phase 1 Dose Escalation, Multi-tumor Study to Assess the Safety, Tolerability and Antitumor Activity of Genetically Engineered MAGE-A4ᶜ¹º³²T in HLA-A2+ Subjects With MAGE-A4 Positive Tumors|Recruiting||Phase 1|32|Anticipated|Adaptimmune||1|||f||||f|t|f||||||||2017-10-10 21:07:23.35926|2017-10-10 21:07:23.35926
NCT03132909|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-19|||March 16, 2017|Actual|2017-03-16|July 2017|2017-07-01|January 16, 2018|Anticipated|2018-01-16|January 16, 2018|Anticipated|2018-01-16||Observational|ATTRESMED||Attitudes and Feelings of Doctors Caring for Their Colleagues: a Qualitative Study in Picardy|Attitudes and Feelings of Doctors Caring for Their Colleagues: a Qualitative Study in Picardy|Recruiting||N/A|1000|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:07:23.465997|2017-10-10 21:07:23.465997
NCT03132896|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-25|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|ROSETTA||Re-Evaluation of Systemic Early Neuromuscular Blockade and Transthoracic Ultrasound Assessment of the Diaphragm|Re-Evaluation of Systemic Early Neuromuscular Blockade and Transthoracic Ultrasound Assessment of the Diaphragm|Not yet recruiting||N/A|180|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||Yes||2017-10-10 21:07:23.53032|2017-10-10 21:07:23.53032
NCT03132883|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-25|||October 17, 2017|Anticipated|2017-10-17|April 2017|2017-04-01|October 17, 2018|Anticipated|2018-10-17|October 17, 2018|Anticipated|2018-10-17||Observational|EBUS-Picardie||Evolution of Indications for Transbronchial Ganglionic Ultrasound in the Picardie Region Over the Period 2008 - 2013|Evolution of Indications for Transbronchial Ganglionic Ultrasound in the Picardie Region Over the Period 2008 - 2013|Not yet recruiting||N/A|1000|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:07:23.628201|2017-10-10 21:07:23.628201
NCT03132870|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-25|||June 20, 2017|Anticipated|2017-06-20|April 2017|2017-04-01|September 20, 2020|Anticipated|2020-09-20|September 20, 2020|Anticipated|2020-09-20||Observational|EBUS-R-PTB||Predictive Diagnostic Criteria for Diagnosis of Transbronchial Biopsies, Echo-guided by Mini-probe in Peripheral Lung Lesions|Predictive Diagnostic Criteria for Diagnosis of Transbronchial Biopsies, Echo-guided by Mini-probe in Peripheral Lung Lesions|Not yet recruiting||N/A|67|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:07:23.687233|2017-10-10 21:07:23.687233
NCT03132857|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-25|||June 20, 2017|Anticipated|2017-06-20|April 2017|2017-04-01|April 20, 2018|Anticipated|2018-04-20|April 20, 2018|Anticipated|2018-04-20||Observational|Epic-SaPE||The State of Play in Picardy of the Knowledge of the Elderly at Risk of Falling at Home in Terms of Prevention and Evaluation.|The State of Play in Picardy of the Knowledge of the Elderly at Risk of Falling at Home in Terms of Prevention and Evaluation.|Not yet recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:07:23.753887|2017-10-10 21:07:23.753887
NCT03132844|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-25|||March 16, 2017|Actual|2017-03-16|April 2017|2017-04-01|September 16, 2017|Anticipated|2017-09-16|September 16, 2017|Anticipated|2017-09-16||Observational|PICARVAC||Epidemiological Study on the Vaccination Coverage of the Population Aged 75 Years and Over in Picardy. According to the Study of 200 Patients Followed by General Practitioners of the Somme in 2016.|Epidemiological Study on the Vaccination Coverage of the Population Aged 75 Years and Over in Picardy. According to the Study of 200 Patients Followed by General Practitioners of the Somme in 2016.|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:07:23.818236|2017-10-10 21:07:23.818236
NCT03132831|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-25|||June 20, 2017|Anticipated|2017-06-20|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|JourOpDMS||Influence of the Operative Day on the Average Duration of Stay in Primary Hip and Knee Replacements|Influence of the Operative Day on the Average Duration of Stay in Primary Hip and Knee Replacements|Not yet recruiting||N/A|800|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:07:23.889063|2017-10-10 21:07:23.889063
NCT03132818|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-19|||August 20, 2017|Anticipated|2017-08-20|July 2017|2017-07-01|September 20, 2018|Anticipated|2018-09-20|September 20, 2018|Anticipated|2018-09-20||Observational|SEXODON||Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple|Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple|Not yet recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire, Amiens|||3||f|||||f|f||||||||2017-10-10 21:07:23.95828|2017-10-10 21:07:23.95828
NCT03132805|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-25|||June 1, 2016|Actual|2016-06-01|April 2017|2017-04-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2021|Anticipated|2021-04-30||Interventional|P2P+IY||An Evaluation of an Integrated Approach to Prevention and Early Intervention in the Elementary School Years|An Evaluation of an Integrated Approach to Prevention and Early Intervention in the Elementary School Years|Recruiting||N/A|5760|Anticipated|Johns Hopkins Bloomberg School of Public Health||3|||f||||t|f|f||||||No||2017-10-10 21:07:24.035607|2017-10-10 21:07:24.035607
NCT03076788|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-17|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|June 1, 2019|Anticipated|2019-06-01|December 31, 2018|Anticipated|2018-12-31||Observational|INFINITE||Intracardiac Flow Remodeling in Athletes|Intracardiac Flow Remodeling in Athletes|Recruiting||N/A|100|Anticipated|University Hospital, Caen|||2||f||||f||||||||No||2017-10-10 21:16:33.96669|2017-10-10 21:16:33.96669
NCT03132792|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-04|||May 8, 2017|Actual|2017-05-08|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||AFPᶜ³³²T in Advanced HCC|A Phase I Open Label Clinical Trial Evaluating the Safety and Anti-Tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha Fetoprotein (AFPᶜ³³²T) in HLA-A2 Positive Subjects With Advanced Hepatocellular Carcinoma (HCC)|Recruiting||Phase 1|30|Anticipated|Adaptimmune||1|||f|||||t|f||||||||2017-10-10 21:07:24.232517|2017-10-10 21:07:24.232517
NCT03132779|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-25|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|February 20, 2018|Anticipated|2018-02-20|January 20, 2018|Anticipated|2018-01-20||Interventional|||Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion|Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortions|Not yet recruiting||Phase 1|34|Anticipated|Ain Shams Maternity Hospital||1|||f||||f|f|f|||f|||Undecided||2017-10-10 21:07:24.40581|2017-10-10 21:07:24.40581
NCT03132766|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-25|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Brief Interventions for the Prevention of Suicide and the Promotion of Resilience|New Hope and the Elders' Resilience Interventions for the Prevention of Suicide and Promotion of Resilience in Suicidal American Indian Youth|Not yet recruiting||N/A|280|Anticipated|Johns Hopkins Bloomberg School of Public Health||4|||f||||t|f|f||||||Undecided|Data may be shared at the discretion of the Tribe(s).|2017-10-10 21:07:24.501915|2017-10-10 21:07:24.501915
NCT03132753|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-17|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 30, 2020|Anticipated|2020-07-30|January 30, 2020|Anticipated|2020-01-30||Interventional|SUPPORT||Developing SUPPORT, a Community-Driven, Recovery-Oriented System of Care|Developing SUPPORT, a Community-Driven, Recovery-Oriented System of Care|Not yet recruiting||N/A|80|Anticipated|Indiana University||2|||f||||f|f|f||||||||2017-10-10 21:07:24.607444|2017-10-10 21:07:24.607444
NCT03132740|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-06|||June 15, 2017|Anticipated|2017-06-15|March 2017|2017-03-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma|Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma|Recruiting||N/A|2000|Anticipated|Zhujiang Hospital|||1||f|||||f|f||||Samples Without DNA|"     The biospecimen will be comformed by histopathological examination   "|||2017-10-10 21:07:24.704197|2017-10-10 21:07:24.704197
NCT03132727|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-11|||March 23, 2017|Actual|2017-03-23|March 2017|2017-03-01|May 23, 2019|Anticipated|2019-05-23|April 23, 2019|Anticipated|2019-04-23||Observational|Larynx MRI||Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer|Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 21:07:24.801902|2017-10-10 21:07:24.801902
NCT03132714|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-26|||March 2015||2015-03-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis|Local Effect of Periodontal Debridement Associated With Different Systemic Antibiotic Protocols and Single or Repeated Application of Photodynamic Therapy to Treat Generalized Aggressive Periodontitis: Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|46|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||6|||f||||t|f|f|||f|||Undecided||2017-10-10 21:07:24.899381|2017-10-10 21:07:24.899381
NCT03132701|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-07-18|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||The Effect of Magnesium Supplementation During General Anesthesia on the Quality of Postoperative Recovery in Children|The Effect of Magnesium Supplementation During General Anesthesia on the Quality of Postoperative Recovery in Children|Recruiting||N/A|66|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||||2017-10-10 21:07:25.055807|2017-10-10 21:07:25.055807
NCT03132688|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-26|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|April 22, 2017|Actual|2017-04-22|April 22, 2017|Actual|2017-04-22||Observational|||A Study on Safety and Efficacy of Propofol in Small Children Under 2 Years of Age|A Retrospective Study on Safety and Efficacy of Propofol in Small Children|Completed||N/A|100|Actual|Seoul National University Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:07:25.164186|2017-10-10 21:07:25.164186
NCT03132675|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-10-01|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|December 1, 2020|Anticipated|2020-12-01|October 1, 2020|Anticipated|2020-10-01||Interventional|PISCES||pIL-12 and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment|A Multicenter Phase 2, Open-Label Trial of Intratumoral pIL-12 Plus Electroporation in Combination With Intravenous Pembrolizumab in Patients With Stage III/IV Melanoma Who Are Progressing on Either Pembrolizumab or Nivolumab Treatment|Recruiting||Phase 2|48|Anticipated|OncoSec Medical Incorporated||1|||f||||t|t|t|t|f||||||2017-10-10 21:07:25.249136|2017-10-10 21:07:25.249136
NCT03132662|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-26|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Omega-3 vs Very Low Calorie Diet for Liver Size Reduction|Comparative Trial of Omega-3 Polyunsaturated Fatty Acids vs a Very Low Calorie Liquid Diet for Liver Volume Reduction Prior to Bariatric Surgery|Not yet recruiting||N/A|60|Anticipated|McMaster University||3|||f||||f|f|f|||f|||No||2017-10-10 21:07:25.363636|2017-10-10 21:07:25.363636
NCT03132649|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-06-06|||June 15, 2017|Anticipated|2017-06-15|February 2017|2017-02-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma|Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma|Not yet recruiting||N/A|300|Anticipated|Zhujiang Hospital|||1||f||||f|f|f||||Samples Without DNA|"     The biospecimen will be comformed by histopathological examination   "|No||2017-10-10 21:07:25.473896|2017-10-10 21:07:25.473896
NCT03132636|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-01|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01||Interventional|||PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy|A Phase 2 Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy|Recruiting||Phase 2|137|Anticipated|Regeneron Pharmaceuticals||2|||f||||t|t|f||||||||2017-10-10 21:07:25.564078|2017-10-10 21:07:25.564078
NCT03132623|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-27|||December 1, 2016|Actual|2016-12-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|December 30, 2017|Anticipated|2017-12-30||Interventional|||Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis|The Efficacy and Safety of Andrographolide Sulfonate in the Treatment of Acute Bronchitis: a Randomized,Double-blind,Placebo Parallel Controlled,Multicenter Study|Recruiting||Phase 4|144|Anticipated|Jiangxi Qingfeng Pharmaceutical Co. Ltd.||2|||f|||||f|f||||||Undecided||2017-10-10 21:07:25.662673|2017-10-10 21:07:25.662673
NCT03132610|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-26|||December 1, 2016|Actual|2016-12-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis|Efficacy and Safety of Combined With Andrographolide Sulfonate on the Basis of Conventional Therapy in Patients With Acute Exacerbation of Chronic Bronchitis: a Randomized, Single Blind, Placebo-controlled, Multicenter Study|Recruiting||Phase 4|240|Anticipated|Jiangxi Qingfeng Pharmaceutical Co. Ltd.||2|||f||||||||||||Undecided||2017-10-10 21:07:25.769182|2017-10-10 21:07:25.769182
NCT03132597|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-31|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|August 31, 2024|Anticipated|2024-08-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||"Impact of Teaching Meditation Techniques on the Mental Health and Quality of Life of Medical Students"|"Impact of Teaching Meditation Techniques on the Mental Health and Quality of Life of Medical Students"|Recruiting||N/A|360|Anticipated|Federal University of Juiz de Fora||3|||f||||f|f|f||||||||2017-10-10 21:07:25.873101|2017-10-10 21:07:25.873101
NCT03132584|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-15|||July 30, 2017|Actual|2017-07-30|September 2017|2017-09-01|May 1, 2023|Anticipated|2023-05-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Cyclophosphamide and Alemtuzumab In Lymphoma|A Phase 1 Study of Cyclophosphamide and Alemtuzumab in CD52 Positive Relapsed/Refractory Double-Hit Lymphoma, Diffuse Large B-cell Lymphoma or High Grade B-cell Lymphoma, NOS With MYC and BCL-2 Over-expression, MYC-Positive Transformed Follicular Lymphoma, and CD52 Positive Mature T-cell Lymphoproliferative Disorder|Recruiting||Phase 1|43|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:07:26.016183|2017-10-10 21:07:26.016183
NCT03132571|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-26|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|NBC||Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia and Diabetes|A Pilot Trial of Naltrexone-Bupropion Combination Versus Placebo Combined With Bupropion for Weight Loss in Comorbid Schizophrenia and Diabetes|Recruiting||Phase 4|40|Anticipated|Yale University||3|||f||||f|t|f|||f|||Yes|All de-identified data resulting from this award involving human subjects will be submitted to the NIMH Data Archive (NDA) - National Database for Clinical Trials Related to Mental Illness (NDCT) The Principal Investigator will work with NDA support staff to plan an appropriate data submission schedule and provide information on the steps for submission and sharing of data. Communication of this data sharing plan to appropriate research staff to ensure the timely submission of data. All human subject data provided will include an NDA Global Unique Identifier (GUID) and will not include personally identifiable information (PII). Analyzed data will be submitted no later than the time of publication. Even if a publication focuses on only part of an analyzed dataset, the entire analyzed dataset will be submitted when the first paper is published. All data made available for public use via NDA will be de-identified data.|2017-10-10 21:07:26.142557|2017-10-10 21:07:26.142557
NCT03132558|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||September 2016||2016-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Contrast Induced Acute Kidney in Patients With Acute Stroke||Recruiting||N/A|200|Anticipated|Nanjing Medical University|||2||f||||f||||||||No||2017-10-10 21:07:26.283939|2017-10-10 21:07:26.283939
NCT03132545|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-24|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Resting Metabolic Rate, Fat Distribution, Endocrine and Metabolic Features in Polycystic Ovary Syndrome|Resting Metabolic Rate, Fat Distribution, Endocrine and Metabolic Features in Polycystic Ovary Syndrome|Completed||N/A|160|Actual|Policlinico Universitario Agostino Gemelli|||2||f|||||f|f||||||||2017-10-10 21:07:26.373499|2017-10-10 21:07:26.373499
NCT03132532|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-07-31|||July 31, 2017|Actual|2017-07-31|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Phase II Trial of Standard Chemotherapy (Carboplatin & Paclitaxel) +Various Proton Beam Therapy (PBT) Doses|MC1623:Phase II Trial of Standard Chemotherapy (Carboplatin & Paclitaxel) +Various Proton Beam Therapy (PBT) Doses in Order to Determine the Optimal Dose of PBT for Unresectable Stage 2/3 Non-Small Cell Lung Cancer|Recruiting||Phase 2|120|Anticipated|Mayo Clinic||3|||f||||f|t|t|f|f|t|||||2017-10-10 21:07:26.444418|2017-10-10 21:07:26.444418
NCT03132519|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-04-28|||October 2013||2013-10-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|REX||Optimal Remifentanil Ce for Preventing Severe Cough and Hyperdynamic Response During Tracheal Extubation|Optimal Remifentanil Site-effect Concentration for Preventing Severe Cough and Hyperdynamic Response During Tracheal Extubation After Sevoflurane vs. Desflurane. A Randomized Clinical Trial|Completed||Phase 4|364|Actual|Fundacion Clinica Valle del Lili||6|||f||||t||||||||Yes|Data available for future validations at institutional database system from Clinical Research Center, Fundación Valle del Lili of|2017-10-10 21:07:26.588008|2017-10-10 21:07:26.588008
NCT03132506|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-11|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|December 31, 2017|Anticipated|2017-12-31||Observational|||E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research|E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research Focused on Capture of Patient Reported Outcomes With Within PRAEGNANT Study Network|Recruiting||N/A|300|Anticipated|University Women's Hospital Tübingen|||2||f||||f|f|f||||||||2017-10-10 21:07:26.702445|2017-10-10 21:07:26.702445
NCT03132493|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-10-04|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|NIVEX||Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient|A Retrospective, Multicenter and Observational Study of Nivolumab Monotherapy Treatment in Subjects With Advanced or Metastatic Squamous (Sq) or Non-Squamous (Non-Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimens for the Treatment of Stage IIIb/IV NSCLC Within the Expanded Access Program (EAP) in SPAIN|Recruiting||N/A|1000|Anticipated|Spanish Lung Cancer Group|||1||f||||f|t|f|||f|||||2017-10-10 21:07:26.816101|2017-10-10 21:07:26.816101
NCT03132480|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-22|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|April 30, 2018|Anticipated|2018-04-30||Interventional|forehead||Fluid Responsiveness Using Forehead Sensor in Children|Study on TFA-1 Adhesive Forehead Sensors to Predict Fluid Responsiveness in Pediatric Patients Undergoing General Anesthesia|Recruiting||N/A|30|Anticipated|Seoul National University Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:07:26.929055|2017-10-10 21:07:26.929055
NCT03132467|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-10-05|||June 13, 2017|Actual|2017-06-13|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluating Anti-PD-L1 Antibody (Durvalumab) Plus Anti-CTLA-4 Antibody (Tremelimumab) in HR+/HER2- Breast Cancer|A Pilot Pre-Surgical Study Evaluating Anti-PD-L1 Antibody (Durvalumab [MEDI4736]) Plus Anti-CTLA-4 Antibody (Tremelimumab) in Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer|Recruiting||Early Phase 1|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:07:26.999081|2017-10-10 21:07:26.999081
NCT03132454|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-08-23|||July 25, 2017|Actual|2017-07-25|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Study of Palbociclib Alone and in Combination in Patients With Relapsed and Refractory (R/R) Leukemias|Phase I Study of Palbociclib Alone and in Combination in Patients With Relapsed and Refractory (R/R) Leukemias|Recruiting||Phase 1|54|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:07:27.107047|2017-10-10 21:07:27.107047
NCT03132441|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-05-10|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Cardiac Rehab for Advanced Heart Failure-LVAD Candidates|A Prospective Trial to Evaluate the Utility of Focused Frailty Interventions on Patients Undergoing Evaluation for Left Ventricular Assist Device (LVAD) Placement|Recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||No||2017-10-10 21:07:27.21434|2017-10-10 21:07:27.21434
NCT03132428|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-09-17|||July 27, 2017|Actual|2017-07-27|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Observational|PaTTerN||Registry Evaluating Premature and Term-Near-Term Neonates With Pulmonary Hypertension Receiving Inhaled Nitric Oxide|Multicenter, Prospectively Defined Observational Registry With Retrospective Data Collection, Evaluating Premature and Term-Near-Term Neonates With Pulmonary Hypertension Receiving Inhaled Nitric Oxide Via Invasive or Noninvasive Ventilation|Recruiting||N/A|168|Anticipated|Mallinckrodt|||2||f||||f|t|||||||||2017-10-10 21:07:27.298664|2017-10-10 21:07:27.298664
NCT03132415|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|April 2020|Anticipated|2020-04-01||Interventional|||Get Connected Efficacy Trial|Get Connected: Linking YMSM to Adequate Care Through a Multilevel, Tailored WebApp Intervention|Not yet recruiting||N/A|480|Anticipated|University of Pennsylvania||2|||f||||t|f|f||||||||2017-10-10 21:07:27.386293|2017-10-10 21:07:27.386293
NCT03132402|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-24|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Observational|ELISA||ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. Falciparum|ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. Falciparum Using Field Samples From Prevalence Surveys.|Not yet recruiting||N/A|2000|Anticipated|University of Oxford|||1||f||||f|f|f||||Samples With DNA|"     Stored blood samples from participants who participated in TMT protocol with sufficient     volume   "|Yes||2017-10-10 21:07:27.494581|2017-10-10 21:07:27.494581
NCT03132389|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-15|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Prevalence of Sexually Transmitted Infections Among People Attending the Sexual Assault Centre in Oslo, Norway.|Prevalence of Sexually Transmitted Infections Among People Attending the Sexual Assault Centre in Oslo, Norway: a Cohort Study at the Sexual Assault Centre in Oslo, Norway.|Recruiting||N/A|600|Anticipated|University of Oslo|||1||f||||f|f|f||||||No||2017-10-10 21:07:27.548053|2017-10-10 21:07:27.548053
NCT03132376|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-17|||June 2016||2016-06-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Effects of Consuming Protein Shakes, Varying in Protein Source, on Appetite, Satiety and Energy Intake|Effects of Consuming Protein Shakes, Varying in Protein Source, on Appetite, Satiety and Energy Intake|Completed||N/A|12|Actual|Purdue University||1|||f||||f|f|f||||||No||2017-10-10 21:07:27.626591|2017-10-10 21:07:27.626591
NCT03132363|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-26|||May 7, 2008||2008-05-07||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:07:27.695235|2017-10-10 21:07:27.695235
NCT03132350|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-26|||December 19, 2007||2007-12-19||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:07:27.731567|2017-10-10 21:07:27.731567
NCT03132337|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|SOSBiomarker||Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study|Biomarkers of Endothelial Dysfunction in Pediatric Patients Receiving High Intensity Chemotherapy/Irradiation|Recruiting||N/A|80|Anticipated|Indiana University|||1||f||||f|f|f||||Samples With DNA|"     Blood   "|No||2017-10-10 21:07:27.767898|2017-10-10 21:07:27.767898
NCT03132324|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-05|||April 27, 2017|Actual|2017-04-27|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease|A Phase 1 Open-Label, Dose-Escalation Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease|Recruiting||Phase 1|30|Anticipated|Incyte Corporation||2|||||||f|t|f||||||No||2017-10-10 21:07:27.988704|2017-10-10 21:07:27.988704
NCT03132311|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-06|||May 29, 2017|Actual|2017-05-29|July 2017|2017-07-01|December 2028|Anticipated|2028-12-01|December 2018|Anticipated|2018-12-01||Interventional|YF-HIV||Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals|Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals|Recruiting||Phase 4|400|Anticipated|Oswaldo Cruz Foundation||2|||f||||f|f|f|||f|||||2017-10-10 21:07:28.092115|2017-10-10 21:07:28.092115
NCT03132116|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-08-21|||May 31, 2017|Actual|2017-05-31|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|September 2020|Anticipated|2020-09-01||Interventional|BIGG||Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis|Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis: A Randomized Controlled Study|Recruiting||Phase 3|100|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||||2017-10-10 21:07:29.787086|2017-10-10 21:07:29.787086
NCT03132298|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||August 17, 2015|Actual|2015-08-17|April 2017|2017-04-01|October 30, 2016|Actual|2016-10-30|October 30, 2016|Actual|2016-10-30||Interventional|||Effects of a Single-session Implicit Theories of Personality Intervention on Early Adolescent Psychopathology|Effects of a Single-session Implicit Theories of Personality Intervention on Recovery From Social Stress and Long-term Psychological Functioning in Early Adolescents|Completed||N/A|96|Actual|Harvard University||2|||f|||||f|f||||||Yes|IPD sharing plan is consistent with NIH guidelines for sharing participant-level data at the conclusion of the fellowship period.|2017-10-10 21:07:28.237798|2017-10-10 21:07:28.237798
NCT03132285|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-06|||March 11, 2017|Actual|2017-03-11|September 2017|2017-09-01|June 17, 2017|Actual|2017-06-17|April 22, 2017|Actual|2017-04-22||Interventional|||Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device|Safety and Acceptability Study of Non-Surgical Male Circumcision Device for Adult Male Population When Removing the Foreskin Shortly After Placement of Device Performed at Lusaka and Livingstone, Zambia|Completed||N/A|500|Actual|Ministry of Health, Zambia||1|||f||||t|f|f||||||||2017-10-10 21:07:28.373345|2017-10-10 21:07:28.373345
NCT03132272|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-04-26|||June 2016||2016-06-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|IMAD||Immunoadsorption for Treatment of Alzheimer's Disease|Efficacy of Immunoadsorption for Treatment of Persons With Alzheimer Dementia and Agonistic Autoantibodies Against alpha1A-adrenoceptor (IMAD)|Recruiting||N/A|15|Anticipated|University Medicine Greifswald||1|||f||||f||||||||No||2017-10-10 21:07:28.463456|2017-10-10 21:07:28.463456
NCT03132259|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-05-25|||May 2016||2016-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach|Comparative Low and High Dose of Dexmedethomidine Can Stabilize Hemodynamics and Blood Loss in Pituitary Tumor Removal by Transphenoid Approach|Recruiting||Phase 4|124|Anticipated|Mahidol University||2|||f||||f||||||||Undecided||2017-10-10 21:07:28.589439|2017-10-10 21:07:28.589439
NCT03132246|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-30|||April 2014||2014-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MICRO||MICRO Study: Detecting Bacterial Infections Related to Orthopaedic Surgical Implants|Early Determination of Biofilm Formation on Orthopaedic Devices|Recruiting||N/A|500|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-10 21:07:28.693917|2017-10-10 21:07:28.693917
NCT03132233|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-28|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|MigraKet||Energy for the Brain|Safety, Tolerability and Efficacy of Exogenous Ketone Bodies for Preventive Treatment of Migraine: A Randomised, Placebo-controlled, Double-blind Study|Recruiting||N/A|45|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f||||||||2017-10-10 21:07:28.793873|2017-10-10 21:07:28.793873
NCT03132220|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-26|||September 15, 2016|Actual|2016-09-15|April 2017|2017-04-01|September 15, 2019|Anticipated|2019-09-15|July 15, 2018|Anticipated|2018-07-15||Interventional|||A Mindfulness Based Cognitive Therapy (MBCT) Resiliency Program for Critical Care Nurses|A Mindfulness Based Cognitive Therapy (MBCT) Resiliency Program for Critical Care Nurses|Recruiting||N/A|120|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||No|The plan to share IPD is through a limited summary of the data. The information will be de-identified.|2017-10-10 21:07:28.919255|2017-10-10 21:07:28.919255
NCT03132207|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-09|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Observational|C4M||The 4th Month Oral Consultation at Pregnant Women|The 4th Month Oral Consultation at Pregnant Women : Investigation Carried in Pregnant Women and Health Care Professionals of Nantes and Brest|Recruiting||N/A|650|Anticipated|Nantes University Hospital|||2||f||||f|f|f||||||||2017-10-10 21:07:29.029982|2017-10-10 21:07:29.029982
NCT03132194|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-05-03|||August 8, 2016|Actual|2016-08-08|May 2017|2017-05-01|January 30, 2017|Actual|2017-01-30|January 16, 2017|Actual|2017-01-16||Interventional|||Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris|A Single-center, Double-blind, Randomized, Parallel-group Study, Comparing DPSG to a Placebo Control in the Treatment of Acne Vulgaris|Completed||Phase 1|1125|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||No||2017-10-10 21:07:29.132815|2017-10-10 21:07:29.132815
NCT03132181|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-27|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|EMPA||Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes|Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes|Recruiting||Phase 2|40|Anticipated|RWTH Aachen University||2|||f||||f|f|f||||||No||2017-10-10 21:07:29.228264|2017-10-10 21:07:29.228264
NCT03132168|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-26|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Postoperative Delirium in Patients Undergoing Radical Cystectomy|Postoperative Delirium in Patients Undergoing Radical Cystectomy|Recruiting||N/A|50|Anticipated|Ohio State University||1|||f||||f|f|f||||||No||2017-10-10 21:07:29.370828|2017-10-10 21:07:29.370828
NCT03132155|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-23|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma|A Phase 2 Study of AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma That Contains the Ewing Sarcoma Breakpoint Region 1-activating Transcription Factor-1 (EWSR1-ATF1) Gene Fusion|Not yet recruiting||Phase 2|10|Anticipated|NantPharma, LLC||1|||||||f|t|f||||||No||2017-10-10 21:07:29.481922|2017-10-10 21:07:29.481922
NCT03132142|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol|Temporal Profile of the Nociceptive Desensitization Induced by 8% Topical Capsaicin and the Functional Independence of Transient Receptor Potential Ankyrin 1 (TPRA1)- and Vanilloid 1 (TRPV1)-Expressing Nociceptive Afferents|Recruiting||N/A|22|Anticipated|Aalborg University||4|||f||||f|f|f||||||No||2017-10-10 21:07:29.576208|2017-10-10 21:07:29.576208
NCT03132129|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-24|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Observational|PREDICT||Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus|Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus|Not yet recruiting||N/A|200|Anticipated|University of Leicester|||2||f||||t|f|f||||Samples With DNA|"     Quantitative buffy coat and plasma samples will be stored for future potential biomarker and     genotyping studies.   "|No||2017-10-10 21:07:29.690228|2017-10-10 21:07:29.690228
NCT03132103|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-24|||January 6, 2016|Actual|2016-01-06|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|April 28, 2017|Anticipated|2017-04-28||Interventional|||Vitamin D Supplementation and Immunity/Physical Performance|The Effect of Vitamin D Supplementation on Vitamin D Status, Immunity and Physical Performance|Recruiting||N/A|260|Anticipated|Bangor University||4|||f||||t|f|f||||||No||2017-10-10 21:07:29.95426|2017-10-10 21:07:29.95426
NCT03132090|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-24|||September 29, 2014|Actual|2014-09-29|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI|Early Response Monitoring of Systemic Therapies in Patients With Advanced Melanoma by Simultaneous Positron-emission-tomography (PET)/Magnetic Resonance Imaging (MRI)|Recruiting||N/A|106|Anticipated|University Hospital Tuebingen||1|||f||||t|f|f||||||No||2017-10-10 21:07:30.056665|2017-10-10 21:07:30.056665
NCT03132077|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-26|||October 1, 2017|Anticipated|2017-10-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|January 30, 2018|Anticipated|2018-01-30||Observational|||Analysis of Patient Outcome Questionnaire Following Primary Knee Replacement|Retrospective Analysis of Patient Outcome Questionnaire Following Primary Knee Replacement|Not yet recruiting||N/A|400|Anticipated|University of Salford|||1||f||||t|f|f||||||No||2017-10-10 21:07:30.132509|2017-10-10 21:07:30.132509
NCT03132064|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-07-04|||September 15, 2017|Anticipated|2017-09-15|July 2017|2017-07-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2018|Anticipated|2018-02-01||Observational|||The Association Between Pre-operative Pain Psychology and Hypersensitivity With Poor Functional Outcome After Knee Replacement.|The Association Between Pre-operative Pain Psychology and Hypersensitivity With Poor Functional Outcome After Knee Replacement|Not yet recruiting||N/A|50|Anticipated|University of Salford|||1||f||||t|f|f||||||||2017-10-10 21:07:30.226255|2017-10-10 21:07:30.226255
NCT03132051|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-24|||April 2013|Actual|2013-04-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Sonographic Evaluation of Patients With Carpal Tunnel Syndrome Following Steroid Injection|Sonographic Evaluation of Patients With Carpal Tunnel Syndrome Following Steroid Injection|Recruiting||N/A|54|Anticipated|Taipei Veterans General Hospital, Taiwan||1|||f|||||f|f|||f|||||2017-10-10 21:07:30.334189|2017-10-10 21:07:30.334189
NCT03132038|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-24|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|March 2024|Anticipated|2024-03-01|September 2019|Anticipated|2019-09-01||Interventional|NISCAHN||Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck|A Phase II, Multicenter, Non Randomized, Open Label Study of Nivolumab In Recurrent and/or Metastatic Salivary Gland Carcinoma of the Head and Neck|Recruiting||Phase 2|92|Anticipated|UNICANCER||1|||f||||t|f|f||||||No|no individual participant data is shared|2017-10-10 21:07:30.448948|2017-10-10 21:07:30.448948
NCT03132025|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-26|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer|Phase 1 Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer|Not yet recruiting||Phase 2|40|Anticipated|Harbin Medical University||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:07:30.612809|2017-10-10 21:07:30.612809
NCT03132012|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-14|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection|Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection|Active, not recruiting||N/A|80|Actual|Yale University||2|||f||||f|f|f||||||||2017-10-10 21:07:30.697685|2017-10-10 21:07:30.697685
NCT03131999|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-27|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Interventional|LAMP-1||LAM Pilot Study With Imatinib Mesylate|LAM Pilot Study With Imatinib Mesylate|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Medical University of South Carolina||2|||f||||t|t|f|||t|||No||2017-10-10 21:07:30.777157|2017-10-10 21:07:30.777157
NCT03131986|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-27|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|March 30, 2019|Anticipated|2019-03-30|March 30, 2019|Anticipated|2019-03-30||Observational|||Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia|Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia Who Achieve Stable Deep Molecular Response|Recruiting||N/A|30|Anticipated|The University of Hong Kong|||1||f||||f|f|f||||Samples With DNA|"     For analysis by cytogenetic/ molecular methods for better understanding of the disease     biology   "|Undecided||2017-10-10 21:07:30.877183|2017-10-10 21:07:30.877183
NCT03131973|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-25|2017-04-25|||May 13, 2017|Anticipated|2017-05-13|April 2017|2017-04-01|June 21, 2017|Anticipated|2017-06-21|June 21, 2017|Anticipated|2017-06-21||Interventional|||Effects of Concomitant Administration of BMS-986195 on Methotrexate|Effects of Concomitant Administration of BMS-986195 on the Single-dose Pharmacokinetics of Methotrexate in Healthy Participants|Not yet recruiting||Phase 1|12|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 21:07:30.958514|2017-10-10 21:07:30.958514
NCT03131960|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-19|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|VNS-REHAB||Pivotal Study of VNS During Rehab After Stroke (VNS-REHAB)|A Pivotal Randomized Study Assessing Vagus Nerve Stimulation (VNS) During Rehabilitation for Improved Upper Limb Motor Function After Stroke (VNS-REHAB)|Recruiting||N/A|120|Anticipated|MicroTransponder Inc.||2|||f||||t|f|t|t|f||||||2017-10-10 21:07:31.057872|2017-10-10 21:07:31.057872
NCT03131947|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-24|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|HOST||HIV in Orthopaedic Skeletal Trauma Study|HOST Study - HIV in Orthopaedic Skeletal Trauma Study; Fracture Healing in HIV-positive Patients|Not yet recruiting||N/A|420|Anticipated|Wellcome Trust Liverpool Glasgow Centre for Global Health Research|||2||f||||t|f|f||||||No||2017-10-10 21:07:31.19335|2017-10-10 21:07:31.19335
NCT03131934|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-10|||September 15, 2017|Anticipated|2017-09-15|May 2017|2017-05-01|September 15, 2024|Anticipated|2024-09-15|October 31, 2019|Anticipated|2019-10-31||Interventional|ITREC||Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant|Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant|Not yet recruiting||Early Phase 1|18|Anticipated|University College, London||1|||f||||t|f|f||||||Undecided||2017-10-10 21:07:31.279607|2017-10-10 21:07:31.279607
NCT03129802|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-05-10|||July 2016|Actual|2016-07-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Incidence and Risk Factors of Extubation Failure in Pediatric Resuscitation||Recruiting||N/A|60|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:07:53.372215|2017-10-10 21:07:53.372215
NCT03131921|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-01|||April 5, 2016|Actual|2016-04-05|April 2017|2017-04-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|RECODE||Determining Energy Needs in Colorectal Cancer|Resting Energy Expenditure in Cancer - Associations With Body Composition, Dietary Intake, and Exercise Habits|Recruiting||N/A|81|Anticipated|University of Alberta|||1||f||||f|f|f|||f|||Undecided||2017-10-10 21:07:31.367705|2017-10-10 21:07:31.367705
NCT03131908|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-21|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss|Phase I/II Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss|Recruiting||Phase 1/Phase 2|41|Anticipated|M.D. Anderson Cancer Center||1|||||||f|t|f||||||||2017-10-10 21:07:31.487498|2017-10-10 21:07:31.487498
NCT03131895|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-07-28|||April 25, 2017|Actual|2017-04-25|July 2017|2017-07-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Interventional|||Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants|A Phase 1, Randomized, Open-Label, Single-Center, Single-Dose, Two-Period Two-Part Crossover Study in Healthy Subjects to Compare the Bioavailability of Dexlansoprazole From Dexlansoprazole Delayed-Release Capsules 30 mg and 60 mg Manufactured by Takeda GmbH Plant Oranienburg Relative to Dexlansoprazole Delayed-Release Capsules 30 mg and 60 mg Manufactured by Takeda Pharmaceutical Company Limited Osaka Plant|Completed||Phase 1|116|Actual|Takeda||4|||f||||f|t|f||||||||2017-10-10 21:07:31.59935|2017-10-10 21:07:31.59935
NCT03131882|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-01|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Efficacy of Ultrasound Guided Hyaluronic Injection in Treatment of Trigger Finger|Comparing the Efficacy of Ultrasound Guided Hyaluronic Injection With Ultrasound Guided Corticosteroid Injection in Treatment of Trigger Finger|Recruiting||Phase 2/Phase 3|120|Anticipated|Mahidol University||2|||f||||f|t|f|||t|||No||2017-10-10 21:07:31.733572|2017-10-10 21:07:31.733572
NCT03131869|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||February 22, 2017|Actual|2017-02-22|April 2017|2017-04-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Development of Novel, Biophysically Designed Fluids for Swallowing Disorders|Development of Novel, Biophysically Designed Fluids for Swallowing Disorders|Recruiting||N/A|200|Anticipated|Swallow Solutions|||1||f||||f|f|f||||||No||2017-10-10 21:07:31.86849|2017-10-10 21:07:31.86849
NCT03131856|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-24|||October 15, 2012|Actual|2012-10-15|April 2017|2017-04-01|December 31, 2015|Actual|2015-12-31|August 17, 2015|Actual|2015-08-17||Interventional|||Nutritional Intervention in Geriatric Patients|A Multidisciplinary Nutritional Intervention Programme Across Sectors to Improve the Nutritional Status of Geriatric Patients at Nutritional Risk - A Randomized Controlled Trial.|Completed||N/A|150|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||f|f|f||||||No||2017-10-10 21:07:31.970908|2017-10-10 21:07:31.970908
NCT03131843|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-01|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination|A Pilot Randomized Controlled Trial Assessing the Effectiveness of Alcohol Swabs in Preventing Infections in Pediatric Patients Receiving Vaccinations|Recruiting||Phase 3|170|Anticipated|University of Toronto||2|||f||||t|f|f||||||No|There is no plan to make IPD available to other researchers.|2017-10-10 21:07:32.054418|2017-10-10 21:07:32.054418
NCT03131830|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-27|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|November 1, 2017|Anticipated|2017-11-01||Observational|||Individual Choice of Delivery Mode|Individual Choice of Delivery Mode - A Prospective Study Using Online Surveys|Enrolling by invitation||N/A|1600|Anticipated|University Women's Hospital Tübingen|||4||f||||f|f|f||||||No||2017-10-10 21:07:32.143266|2017-10-10 21:07:32.143266
NCT03131817|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-04-24|||December 16, 2016|Actual|2016-12-16|April 2017|2017-04-01|December 16, 2021|Anticipated|2021-12-16|December 16, 2020|Anticipated|2020-12-16||Interventional|PC+S_PFC||Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients|Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's|Enrolling by invitation||N/A|10|Anticipated|University of California, San Francisco||1|||f||||f||||||||No||2017-10-10 21:07:32.221398|2017-10-10 21:07:32.221398
NCT03131804|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-14|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|April 1, 2018|Anticipated|2018-04-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Effect of Intradialytic Exercise In The United Arab Emirates|Effect of Intradialytic Exercise Among Hemodialysis Patients in the United Arab Emirates on Cardio-Metabolic Markers, Dialysis Adequacy, Quality of Life and Cost Effectiveness|Recruiting||N/A|45|Anticipated|Zayed University||1|||f|||||f|f||||||No||2017-10-10 21:07:32.298102|2017-10-10 21:07:32.298102
NCT03131791|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-09-06|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|July 1, 2017|Actual|2017-07-01||Interventional|||Comparing the Radial Extracorporeal Shock Waves and Botulinum Toxin Injection for Spasticity|Radial Extracorporeal Shock Wave Versus Botulinum Toxin A in the Treatment of Post-Stroke Upper Limb Spasticity: A Randomized Non-Inferiority Trial|Recruiting||N/A|41|Anticipated|Mackay Memorial Hospital||2|||f|||||f|f|||f|||||2017-10-10 21:07:32.401656|2017-10-10 21:07:32.401656
NCT03131778|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-27|||April 1, 2010|Actual|2010-04-01|April 2017|2017-04-01|June 30, 2011|Actual|2011-06-30|June 30, 2011|Actual|2011-06-30||Interventional|||The Inflammatory Response to Stress and Angiogenesis in Liver Resection|The Inflammatory Response to Stress and Angiogenesis in Open Versus Laparoscopic Liver Resection for Colorectal Liver Metastases|Completed||N/A|40|Actual|University Hospital, Ghent||2|||f||||t|f|f||||||No||2017-10-10 21:07:32.487357|2017-10-10 21:07:32.487357
NCT03131765|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-24|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors|Phase 1, Open Label, Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|41|Anticipated|Yisheng Biopharma (Singapore) Pte. Ltd.||1|||f||||t|f|f||||||No||2017-10-10 21:07:32.681158|2017-10-10 21:07:32.681158
NCT03131752|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-24|||June 7, 2017|Anticipated|2017-06-07|April 2017|2017-04-01|March 7, 2019|Anticipated|2019-03-07|August 7, 2017|Anticipated|2017-08-07||Interventional|||Early Pulmonary Rehabilitation in Exacerbated COPD Patients|Early Pulmonary Rehabilitation With Elastic Resistance in Exacerbated COPD Patients|Recruiting||N/A|38|Anticipated|Universidade Federal de Sao Carlos||2|||f||||f|f|f||||||No||2017-10-10 21:07:32.800355|2017-10-10 21:07:32.800355
NCT03131739|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-24|||December 2018|Anticipated|2018-12-01|April 2017|2017-04-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Observational|ANCHRR||Alaska Native Collaborative Hub for Resilience Research|Alaska Native Resilience Research Study|Not yet recruiting||N/A|585|Anticipated|University of Alaska Fairbanks|||2||f||||t|f|f||||||Yes|The Tribal Health Organizations and the research team jointly own all data, consistent with the principles of community-based participatory research (CBPR). De-identified data and results will be shared at every meeting of the AN External Advisory Council, Collaborative Hub and Research Steering Committee. Datasets are shared by request and approval by the Tribal Health Organizations and Project PIs as they become available. The research team propose to development Tribal Data Sharing and Ownership Agreements (DSOA) with the three participating Tribal Health Organizations in Year 1 of the ANCHRR project.|2017-10-10 21:07:32.992592|2017-10-10 21:07:32.992592
NCT03131726|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-29|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 30, 2019|Anticipated|2019-12-30|October 1, 2019|Anticipated|2019-10-01||Interventional|||Treatment of Graves´Ophthalmopathy With Diclofenac or Simvastatin (GO-DS)|Treatment of Graves´Ophthalmopathy With Diclofenac or Simvastatin (GO-DS)|Not yet recruiting||Phase 3|115|Anticipated|Lund University||3|||f|||||f|f|||f|||||2017-10-10 21:07:33.095006|2017-10-10 21:07:33.095006
NCT03131713|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-20|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Preoperative Acetaminophen and Carbohydrate Loading|Impact of Preoperative Acetaminophen and Carbohydrate Loading to on Pain and Functional Status in Patients Undergoing Mohs Micrographic Surgery for Non-melanoma Skin Cancers|Active, not recruiting||Phase 3|100|Anticipated|Tufts Medical Center||2|||f||||f|t|f||||||||2017-10-10 21:07:33.207948|2017-10-10 21:07:33.207948
NCT03131700|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-12|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator|Phase I, Double Blind, Randomized, Parallel-Arm, Single-Dose, Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator (Avastin®, Roche) in Healthy Male Volunteers|Not yet recruiting||Phase 1|60|Anticipated|TRPHARM||2|||f||||t|f|f||||||||2017-10-10 21:07:33.323923|2017-10-10 21:07:33.323923
NCT03131687|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-28|||May 24, 2017|Actual|2017-05-24|September 2017|2017-09-01|May 29, 2018|Anticipated|2018-05-29|May 29, 2018|Anticipated|2018-05-29||Interventional|||A Study of LY3298176 in Participants With Type 2 Diabetes Mellitus|A Phase 2 Study of Once-Weekly LY3298176 Compared With Placebo and Dulaglutide in Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 2|300|Anticipated|Eli Lilly and Company||6|||f||||t|t|f||||||||2017-10-10 21:07:33.455604|2017-10-10 21:07:33.455604
NCT03131674|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-24|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|October 1, 2020|Anticipated|2020-10-01|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Effect of Cervical Physical Therapy Treatment in Patients With Somatic Tinnitus|The Effect of Cervical Physical Therapy Treatment in Patients With Somatic Tinnitus|Recruiting||N/A|100|Anticipated|Universiteit Antwerpen||2|||f|||||f|f||||||||2017-10-10 21:07:33.828135|2017-10-10 21:07:33.828135
NCT03131661|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-10-03|||June 9, 2017|Actual|2017-06-09|October 2017|2017-10-01|June 29, 2020|Anticipated|2020-06-29|March 31, 2020|Anticipated|2020-03-31||Observational|SIRENA||A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs|A Prospective, Observational Study, in Patients With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) According to ASAS Criteria, naïve to Conventional (cDMARDs), Targeted (tsDMARDs) and Biological DMARDs (bDMARDs) - SIRENA Study (Spondyloarthritis Italian Registry: Evidence From a National Pathway)|Recruiting||N/A|500|Anticipated|Janssen-Cilag S.p.A.|||1||f||||f||f||||||||2017-10-10 21:07:33.92667|2017-10-10 21:07:33.92667
NCT03131648|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-04|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|June 8, 2020|Anticipated|2020-06-08|February 24, 2020|Anticipated|2020-02-24||Interventional|ECZTRA 1||Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)|A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Tralokinumab Monotherapy in Subjects With Moderate to Severe Atopic Dermatitis Who Are Candidates for Systemic Therapy|Recruiting||Phase 3|780|Anticipated|LEO Pharma||6|||f||||t|t|f||||||||2017-10-10 21:07:34.120731|2017-10-10 21:07:34.120731
NCT03131635|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-30|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|DRTP||Effectiveness of a Developmental Reciprocity Treatment Program in Autism|Effectiveness of a Developmental Reciprocity Treatment Program in Autism|Recruiting||N/A|52|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 21:07:35.119679|2017-10-10 21:07:35.119679
NCT03131622|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-04-24|||December 2016||2016-12-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Impact of Ibis on Patients With Advanced COPD|Impact of Ibis, a Digital Health Solution for Patient Activation and Early Intervention, on Acute Care Utilization by Patients With Advanced COPD|Enrolling by invitation||N/A|240|Anticipated|Senscio Systems||2|||f||||f||||||||Undecided||2017-10-10 21:07:35.220484|2017-10-10 21:07:35.220484
NCT03131609|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-24|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Patients in the Emergency Department|Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Patients in the Emergency Department|Completed||N/A|1471|Actual|Stanford University|||4||f||||f||||||||No||2017-10-10 21:07:35.289458|2017-10-10 21:07:35.289458
NCT03131596|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-05-02|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Intrauterine Balloon Therapy to Prevent the Recurrence of Intrauterine Adhesions|The Efficacy of Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Reformation Following Hysteroscopic Adhesiolysis|Recruiting||N/A|200|Anticipated|Fu Xing Hospital, Capital Medical University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:07:35.38293|2017-10-10 21:07:35.38293
NCT03131583|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-03|||February 17, 2017|Actual|2017-02-17|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout|A Phase I, Single-Center, Open-Label, Single-Group Study to Evaluate Potential Pharmacodynamics of Drug-Drug Interaction Between SHR4640 and Febuxostat and Between SHR4640 and Colchicine in Patients With Gout|Recruiting||Phase 1|15|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:07:35.476661|2017-10-10 21:07:35.476661
NCT03131570|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-05-22|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Safety and Efficacy of Secukinumab in Mild Psoriasis|Safety and Efficacy of Secukinumab in Adults With Chronic Plaque Type Psoriasis With a PASI Score of 6 to 12|Recruiting||Phase 2|40|Anticipated|Rockefeller University||2|||f||||f|t|f||||||Undecided||2017-10-10 21:07:35.57744|2017-10-10 21:07:35.57744
NCT03131557|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-14|||June 12, 2017|Actual|2017-06-12|August 2017|2017-08-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||Quality Control of CE-Certified Phonak Hearing Aids - 2017_13|Quality Control of CE-Certified Phonak Hearing Aids - 2017_13|Completed||N/A|20|Actual|Sonova AG||2|||f|||||f|f||||||||2017-10-10 21:07:35.705658|2017-10-10 21:07:35.705658
NCT03131544|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-24|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Observational|||MRI Guided Transrectal Prostate Laser Ablation for Benign Prosatic Hypertrophy (BPH)|MRI Guided Transrectal Prostate Laser Ablation for Benign Prosatic Hypertrophy (BPH)|Recruiting||N/A|10|Anticipated|Prostate Laser Center, PLLC|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:07:35.800353|2017-10-10 21:07:35.800353
NCT03131531|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-24|||March 23, 2017|Actual|2017-03-23|April 2017|2017-04-01|March 23, 2037|Anticipated|2037-03-23|March 23, 2027|Anticipated|2027-03-23|20 Years|Observational [Patient Registry]|||Bergamo Lymphoid Cancer Registry|Bergamo Lymphoid Cancer Registry|Recruiting||N/A|6000|Anticipated|A.O. Ospedale Papa Giovanni XXIII|||3||f||||f|f|f||||Samples With DNA|"     Biological specimens include peripheral blood, serum, plasma, bone marrow, lymph node, normal     or disease-infiltrated tissues   "|No||2017-10-10 21:07:35.887657|2017-10-10 21:07:35.887657
NCT03131518|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-19|||June 2, 2017|Actual|2017-06-02|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||From Cars to Bikes - the Feasibility and Effect of Bicycling for Transportation Among Parents of Toddlers|From Cars to Bikes - the Feasibility and Effect of Using E-bikes, Traditional Bikes and Longtail Bikes for Transportation Among Parents of Children Attending Kindergarten: a Randomized Cross-over Trial|Active, not recruiting||N/A|36|Actual|University of Agder||3|||f||||f|f|f||||||||2017-10-10 21:07:35.97923|2017-10-10 21:07:35.97923
NCT03131505|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-26|||February 22, 2017|Actual|2017-02-22|April 2017|2017-04-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Observational|INCLUDE||INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1|Perspectives on the INternational CLassification of Diseases (11th Revision); Using Lived Experience to Improve Mental Health Diagnosis in NHS England: INCLUDE Study|Recruiting||N/A|105|Anticipated|Norfolk and Suffolk NHS Foundation Trust|||1||f||||f|f|f||||||No||2017-10-10 21:07:36.08459|2017-10-10 21:07:36.08459
NCT03131492|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-24|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|July 31, 2018|Anticipated|2018-07-31|May 31, 2018|Anticipated|2018-05-31|30 Days|Observational [Patient Registry]|EDMOCS||Early Dehiscence Markers in Ovarian Cancer Surgery|Procalcitonin and C-Reactive Protein as Early Anastomotic Dehiscence Markers in Ovarian Cancer Surgery|Recruiting||N/A|70|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||1||f||||f|f|f||||||No||2017-10-10 21:07:36.167115|2017-10-10 21:07:36.167115
NCT03131479|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-13|||April 28, 2017|Actual|2017-04-28|June 2017|2017-06-01|February 14, 2018|Anticipated|2018-02-14|February 14, 2018|Anticipated|2018-02-14||Interventional|||Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.|An Open-label, Parallel-group Study to Assess the Effect of LIK066 on Urinary Glucose Excretion, Pharmacokinetics, Safety and Tolerability Following Multiple Dose Administration in Patients With Decreased Renal Function Compared to Subjects With Normal Renal Function|Recruiting||Phase 2|50|Anticipated|Novartis||5|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:07:36.266706|2017-10-10 21:07:36.266706
NCT03131466|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-06-12|||April 28, 2017|Actual|2017-04-28|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||High-voltage Pulsed Radiofrequency on Gasserian Ganglion to Treat Patients With Primary Trigeminal Neuralgia|Effectiveness and Safety of High-voltage Pulsed Radiofrequency on Gasserian Ganglion to Treat Patients With Primary Trigeminal Neuralgia|Recruiting||N/A|134|Anticipated|Beijing Tiantan Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:07:36.375133|2017-10-10 21:07:36.375133
NCT03131453|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-10-05|||August 3, 2017|Actual|2017-08-03|October 2017|2017-10-01|July 30, 2024|Anticipated|2024-07-30|July 30, 2024|Anticipated|2024-07-30||Interventional|Generation S2||A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CNP520 in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (AD).|Recruiting||Phase 2/Phase 3|2000|Anticipated|Novartis||3|||f||||t|t|f||||||||2017-10-10 21:07:36.492411|2017-10-10 21:07:36.492411
NCT03131440|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-17|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer Survivors|Designing With Dissemination in Mind: Optimization of a mHealth Physical Activity Intervention for Breast Cancer Survivors|Recruiting||N/A|256|Anticipated|Northwestern University||32|||f||||f|f|f||||||Yes|Data collected in this study will be made available to other researchers in compliance with the NIH Data Sharing Policy.|2017-10-10 21:07:36.642554|2017-10-10 21:07:36.642554
NCT03131427|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-24|||June 13, 2015|Actual|2015-06-13|April 2017|2017-04-01|April 28, 2027|Anticipated|2027-04-28|April 28, 2022|Anticipated|2022-04-28|10 Years|Observational [Patient Registry]|||China Registry for Genetic / Metabolic Liver Diseases|A Nation-wide Hospital-based Registry:China Registry for Genetic / Metabolic Liver Diseases|Recruiting||N/A|20000|Anticipated|Beijing Friendship Hospital|||5||f||||f|f|f||||Samples With DNA|"     whole blood, serum   "|No||2017-10-10 21:07:36.862899|2017-10-10 21:07:36.862899
NCT03131414|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-24|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 1, 2023|Anticipated|2023-06-01|June 1, 2022|Anticipated|2022-06-01|5 Years|Observational [Patient Registry]|IMAGINE||The IMAGINE-SPOR CIHR Chronic Disease Network|Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE-CIHR SPOR Chronic Disease Network|Not yet recruiting||N/A|8000|Anticipated|Hamilton Health Sciences Corporation|||4||f||||t|f|f||||Samples With DNA|"     Whole blood, serum, urine and stool   "|Undecided||2017-10-10 21:07:39.123868|2017-10-10 21:07:39.123868
NCT03131401|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-09-12|||January 1, 2018|Anticipated|2018-01-01|April 2017|2017-04-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Observational|||Prevalence of LF Infection in Districts Not Included in LF Control Activities|Determination of the Prevalence of LF Infection in Districts Not Included in LF Control Activities and of the Basis for Integrated Implementation of LF - Onchocerciasis Elimination Strategies in Potentially Co-endemic Areas|Not yet recruiting||N/A|4500|Anticipated|Noguchi Memorial Institute for Medical Research|||1||f||||f|f|f|||t|Samples With DNA|"     Only parasite positive blood specimen and DNA will be retained.   "|||2017-10-10 21:07:39.25692|2017-10-10 21:07:39.25692
NCT03131388|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-24|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||Clinical Performance Evaluation of AMH Assay|Clinical Performance Evaluation of AMH Assay|Recruiting||N/A|400|Anticipated|Beckman Coulter, Inc.|||1||f||||f|||||t|||No||2017-10-10 21:07:39.343157|2017-10-10 21:07:39.343157
NCT03131375|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-10|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Dexmedetomidine Reduces Emergence Delirium in Children Undergoing Tonsillectomy With Propofol Anesthesia|Dexmedetomidine Reduces Emergence Delirium in Children Undergoing Tonsillectomy With Propofol Anesthesia: a Prospective, Randomized, Double-blind, Single-center Study.|Recruiting||Phase 2/Phase 3|60|Anticipated|"Athens General Children's Hospital Pan. & Aglaia Kyriakou"||2|||f|||||f|f|||f|||||2017-10-10 21:07:39.459797|2017-10-10 21:07:39.459797
NCT03131362|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-26|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|July 30, 2019|Anticipated|2019-07-30|July 30, 2019|Anticipated|2019-07-30||Observational|REAL||Realize the Current Situation of COPD Patients in China|REALizing and Improving Management of Stable COPD in China--A Multi-centre, Prospective, Observational Study to Realize the Current Situation of COPD Patients in China.|Recruiting||N/A|5000|Anticipated|AstraZeneca|||1||f||||f|f|f||||||||2017-10-10 21:07:39.605877|2017-10-10 21:07:39.605877
NCT03131349|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-24|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01|6 Months|Observational [Patient Registry]|zincandiron||Zinc and Iron in Children With Short Stature|Zinc and Iron in Children With Short Stature|Not yet recruiting||N/A|50|Anticipated|Assiut University|||2||f||||t|f|f||||||Undecided|patients aging 2-18years old will be dbtained at the start of the study|2017-10-10 21:07:39.721344|2017-10-10 21:07:39.721344
NCT03131336|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-18|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery|A Controlled, Randomized, Multi-centre, Double Blind, Phase II Study to Evaluate Efficacy and Safety of Topical PeproStat in Intraoperative Surgical Haemostasis|Recruiting||Phase 2|240|Anticipated|Haemostatix Ltd||2|||f||||f|f|f||||||No||2017-10-10 21:07:39.834241|2017-10-10 21:07:39.834241
NCT03131323|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-26|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01|12 Months|Observational [Patient Registry]|nasalfinding||Nasal Findings in Reactive Airway Diseases|Nasal Findings in Reactive Airway Diseases|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||t|f|f||||||Undecided|children with age group 2years to 18 years will be obtained at the start of the study attenindin to emergency unit|2017-10-10 21:07:40.099937|2017-10-10 21:07:40.099937
NCT03131310|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-08-23|||May 1, 2018|Anticipated|2018-05-01|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01|1 Year|Observational [Patient Registry]|clinicalaudit||Managment of Cardiorespiratory Arrest|Managment of Cardiorespiratory Arrest|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t|f|f||||||||2017-10-10 21:07:40.192521|2017-10-10 21:07:40.192521
NCT03131297|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-24|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|RADIOFIST||Multicenter Prospective Evaluation of Radiofrequency for Anal Fistulas|Multicenter Prospective Evaluation of Radiofrequency for Anal Fistulas|Recruiting||N/A|50|Anticipated|F Care Systems NV||1|||f||||t|f|f||||||No||2017-10-10 21:07:40.261666|2017-10-10 21:07:40.261666
NCT03131284|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-08-02|||July 1, 2014|Actual|2014-07-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Prevention of Obesity in Toddlers (PROBIT) Trial.|Prevention of Obesity in Toddlers (PROBIT): a Randomized Clinical Trial of Primary Pediatric Care From Birth Onwards.|Active, not recruiting||N/A|569|Actual|Azienda Ospedaliera Universitaria Integrata Verona||2|||f|||||f|f||||||||2017-10-10 21:07:40.390152|2017-10-10 21:07:40.390152
NCT03131271|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-27|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention|Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention|Completed||N/A|104|Actual|TC Erciyes University||2|||f||||f|f|f||||||No||2017-10-10 21:07:40.503114|2017-10-10 21:07:40.503114
NCT03131258|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-24|||June 2014||2014-06-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Interventional|||The Effects of Pre-operative Anxiety on Anesthetic Recovery and Post-operative Pain in Donor Nephrectomy|The Effects of Pre-operative Anxiety on Anesthetic Recovery and Post-operative Pain in Donor Nephrectomy|Completed||N/A|48|Actual|Ege University||1|||f||||f||||||||Yes||2017-10-10 21:07:40.574538|2017-10-10 21:07:40.574538
NCT03131245|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-22|||April 23, 2017|Actual|2017-04-23|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 17, 2019|Anticipated|2019-12-17||Observational|ONSD||Optic Nerve Sheath Diameter in Craniosynostosis|Changes of Optic Nerve Sheath Diameter in Modified Prone Position in Craniosynostosis Children|Recruiting||N/A|30|Anticipated|Seoul National University Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:07:40.640463|2017-10-10 21:07:40.640463
NCT03131232|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-24|||December 10, 2015|Actual|2015-12-10|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|August 1, 2017|Anticipated|2017-08-01|6 Months|Observational [Patient Registry]|Empa||The Effect of Empagliflozin on Glucose Metabolism, Weight, Blood Pressure and Cardiac Function (NT-proBNP) Should be Investigated|The Aim of This Study is to Investigate the Protective Effect of Empagliflozin on the Cardiovascular System in Diabetes Mellitus Patients|Active, not recruiting||N/A|46|Actual|RWTH Aachen University|||1||f||||f|f|f||||||No||2017-10-10 21:07:40.714759|2017-10-10 21:07:40.714759
NCT03073330|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-03-02|||June 2016||2016-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|OTSAS||One Step Versus Two Step Approach for Gestational Diabetes Mellitus Screening|One vs Two Step Approach for GDM Screening|Recruiting||N/A|284|Anticipated|Thomas Jefferson University||2|||f||||f||||||||No||2017-10-10 21:17:08.277132|2017-10-10 21:17:08.277132
NCT03131206|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-25|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer|A Phase 1/2 Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer|Recruiting||Phase 1/Phase 2|78|Anticipated|Dana-Farber Cancer Institute||4|||f||||t|t|f||||||||2017-10-10 21:07:40.865339|2017-10-10 21:07:40.865339
NCT03131193|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-24|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|June 30, 2020|Anticipated|2020-06-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Primary Care Provider Supply and Patient Outcomes|Estimating the Returns to Provider Human Capital|Recruiting||N/A|21600|Anticipated|RAND||6|||f||||f|f|f||||||Undecided||2017-10-10 21:07:40.987484|2017-10-10 21:07:40.987484
NCT03131180|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-24|||July 1, 2016|Actual|2016-07-01|April 2017|2017-04-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|RLHS||Rapid Learning Healthcare System in Pediatric Surgery|Randomized Controlled Trial: Rapid Learning Healthcare System in Pediatric Surgery|Recruiting||N/A|126|Anticipated|Nationwide Children's Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:07:41.082882|2017-10-10 21:07:41.082882
NCT03131167|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-06|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|April 27, 2018|Anticipated|2018-04-27|April 27, 2018|Anticipated|2018-04-27||Interventional|||Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma|A Randomized, Double-masked, Placebo-controlled Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Daily and Multiple Daily Ascending Doses of SHP639 Topical Ophthalmic Solution in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma (POAG)|Recruiting||Phase 1|120|Anticipated|Shire||2|||f||||f|t|f||||||No||2017-10-10 21:07:41.166594|2017-10-10 21:07:41.166594
NCT03131154|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-06|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase 3 Study to Evaluate ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.|A Phase 3, Randomized, Double-masked, Vehicle-controlled Trial to Evaluate the Safety and Efficacy of ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.|Recruiting||Phase 3|100|Anticipated|Aldeyra Therapeutics, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:07:41.250501|2017-10-10 21:07:41.250501
NCT03131141|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-24|||January 8, 2017|Actual|2017-01-08|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781|An Open Label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of 14C-BC-3781 Administered Via the Intravenous or Oral Routes to Healthy Male Subjects|Active, not recruiting||Phase 1|10|Anticipated|Nabriva Therapeutics AG||2|||f||||f|t|f||||||No||2017-10-10 21:07:41.391058|2017-10-10 21:07:41.391058
NCT03131128|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-27|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|February 28, 2019|Anticipated|2019-02-28|December 1, 2017|Anticipated|2017-12-01||Interventional|||The Effectiveness of Mindfulness-based Intervention as a Workplace Health Promotion Program on Weight Loss|A Pilot Study of the Effectiveness of Mindfulness-based Intervention as a Workplace Health Promotion Program on Weight Loss|Not yet recruiting||N/A|200|Anticipated|Chung Shan Medical University||2|||f||||f|f|f||||||No||2017-10-10 21:07:41.481854|2017-10-10 21:07:41.481854
NCT03131115|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||November 2016||2016-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Lateral Crural Strut Graft vs Bone-Anchored Suspension for Treatment of Lateral Nasal Wall Insufficiency|Lateral Crural Strut Graft vs Bone-Anchored Suspension for Treatment of Lateral Nasal Wall Insufficiency: A Randomized Clinical Trial.|Recruiting||N/A|34|Anticipated|Stanford University||2|||f||||t||||||||No|no plan to share IPD|2017-10-10 21:07:41.567492|2017-10-10 21:07:41.567492
NCT03131102|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-22|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|PERISCOPE||Perioperative Early Tiredness (Acute Fatigue) in Patients With Epithelial Ovarian Cancer|Association of Perioperative Early Tiredness (Acute Fatigue) With Hemodynamic, Immunologic, Endothelial, Metabolic, Gastrointestinal Measures and Complications in Patients With Epithelial Ovarian Cancer|Not yet recruiting||N/A|60|Anticipated|Charite University, Berlin, Germany|||3||f||||f|f|f||||Samples With DNA|"     Muscle biopsies   "|||2017-10-10 21:07:41.70299|2017-10-10 21:07:41.70299
NCT03131089|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-26|||April 11, 2013|Actual|2013-04-11|April 2017|2017-04-01|April 10, 2023|Anticipated|2023-04-10|February 17, 2018|Anticipated|2018-02-17||Observational|YBC||Young Breast Cancer Cohort Study|Prospective Cohort Study for Development of Personalized Treatment Strategy Based on Biologic Tumor Behavior and Clinical Characteristics in Young Breast Cancer (YBC) Patients|Recruiting||N/A|2000|Anticipated|Samsung Medical Center|||1||f||||t|f|f||||Samples With DNA|"     DNA from breast cancer tissue   "|No||2017-10-10 21:07:41.973479|2017-10-10 21:07:41.973479
NCT03131076|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-26|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2018|Anticipated|2018-08-31|3 Months|Observational [Patient Registry]|||Quality of Life Assessment in Patients Who Are Under Surveillance for IPMN|Intraduktaalisen Papillaarisen Musinoosisen Neoplasian Vuoksi Seurannassa Olevien Potilaiden elämänlaatu|Not yet recruiting||N/A|300|Anticipated|Helsinki University Central Hospital|||1||f|||||f|f||||||No|Data will not be shared.|2017-10-10 21:07:42.050994|2017-10-10 21:07:42.050994
NCT03131063|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-26|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|April 2015|Actual|2015-04-01||Observational|PHARMECMO||Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation (PHARMECMO)|A Pilot Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation in Intensive Care Unit|Completed||N/A|45|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||f||||||||No||2017-10-10 21:07:42.129226|2017-10-10 21:07:42.129226
NCT03127410|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-20|||March 30, 2017|Actual|2017-03-30|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Traction for Low Back Pain|Predictive Validity of Lumbopelvic Stress Tests to Determine Those Who Benefit From Lumbar Traction: A Pilot Study|Recruiting||N/A|40|Anticipated|Texas Woman's University||1|||f||||f|f|f||||||No||2017-10-10 21:08:17.808668|2017-10-10 21:08:17.808668
NCT03131050|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-03|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|March 15, 2018|Anticipated|2018-03-15||Interventional|SCE||Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD|A Double-blind, Controlled, Randomized Study Comparing Escitalopram Combined With Scopolamine or Escitalopram in Patients With Major Depressive Disorder|Recruiting||Phase 4|66|Anticipated|Capital Medical University||3|||f||||t|f|f|||f|||||2017-10-10 21:07:42.210206|2017-10-10 21:07:42.210206
NCT03131037|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-27|||May 4, 2017|Actual|2017-05-04|June 2017|2017-06-01|May 2022|Anticipated|2022-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer|Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer|Recruiting||Phase 1|12|Anticipated|Advantagene, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:07:42.344385|2017-10-10 21:07:42.344385
NCT03131024|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-25|||July 15, 2017|Anticipated|2017-07-15|April 2017|2017-04-01|June 14, 2020|Anticipated|2020-06-14|February 1, 2020|Anticipated|2020-02-01||Interventional|CREATE||Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects|The Effects of Short-term Exercise or Caloric Restriction on Anthracycline Chemotherapy-related Treatment Toxicity|Not yet recruiting||N/A|56|Anticipated|University of Alberta||3|||f||||f|f|f||||||No||2017-10-10 21:07:42.437756|2017-10-10 21:07:42.437756
NCT03131011|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-24|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SPOT||Body-image Satisfaction Following Permanent Black or Invisible UV Ink Tattoos|Body-image Satisfaction Following Permanent Black or Invisible UV Ink Tattoos for Localization of Adjuvant Radiotherapy Fields in Breast Cancer Patients|Not yet recruiting||N/A|60|Anticipated|CancerCare Manitoba||2|||f||||f|f|f||||||No||2017-10-10 21:07:42.551118|2017-10-10 21:07:42.551118
NCT03130998|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-24|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Cluster Randomized Trial of Knowledge Brokering to Integrate Mood and Smoking Cessation in Ontario Primary Care|A Cluster Randomized Trial of Tailored vs Generic Knowledge Brokering to Integrate Mood Management Into Smoking Cessation Interventions in Primary Care Settings in Ontario, Canada|Not yet recruiting||N/A|15000|Anticipated|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||No||2017-10-10 21:07:42.629981|2017-10-10 21:07:42.629981
NCT03130985|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-05-02|||May 12, 2015|Actual|2015-05-12|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31|2 Years|Observational [Patient Registry]|PREDICT-AF||Tissue, Blood and Biomarkers to Predict Future Atrial Fibrillation|Tissue, Blood and Biomarkers to Predict Future Atrial Fibrillation|Recruiting||N/A|150|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     Left atrial appendages will be deep frozen and fixed Plasma samples and whole blood will be     collected   "|||2017-10-10 21:07:42.739788|2017-10-10 21:07:42.739788
NCT03130972|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-04-24|||January 2009||2009-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|MDD||Etiology of Motor Developmental Delay in Children|Etiology of Motor Developmental Delay in Children|Completed||N/A|1355|Actual|Bundang CHA Hospital|||1||f||||f||||||||No||2017-10-10 21:07:42.842217|2017-10-10 21:07:42.842217
NCT03130959|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-27|||June 6, 2017|Actual|2017-06-06|September 2017|2017-09-01|June 15, 2021|Anticipated|2021-06-15|June 14, 2021|Anticipated|2021-06-14||Interventional|CheckMate 908||An Investigational Immuno-therapy Study of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Patients With High Grade Primary CNS Malignancies|Phase Ib /II Clinical Trial of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Subjects With High Grade Primary CNS Malignancies|Recruiting||Phase 2|170|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 21:07:42.930536|2017-10-10 21:07:42.930536
NCT03130946|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-25|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes|Comparison of the Accuracy and Safety of Biopsy in Suspicious Axillary Lymph Nodes With a Crypo-assisted Stick Freeze Biopsy Device or Fine Needle Aspiration|Not yet recruiting||N/A|135|Anticipated|Peking University People's Hospital||2|||f||||f|f|t|f|f|t|||Undecided||2017-10-10 21:07:43.248871|2017-10-10 21:07:43.248871
NCT03130933|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-14|||April 2010|Actual|2010-04-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Complications After Lower Third Molar Surgery|Does a Single Dose of Systemic Antibiotics Prevent Postoperative Inflammatory Complications After Lower Third Molar Surgery? A Randomized Controlled Trial|Completed||Phase 1/Phase 2|400|Actual|University of Zagreb||4|||f||||t|f|f||||||Undecided||2017-10-10 21:07:43.399209|2017-10-10 21:07:43.399209
NCT03130920|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-07-04|||April 20, 2017|Actual|2017-04-20|July 2017|2017-07-01|April 20, 2018|Anticipated|2018-04-20|July 4, 2017|Actual|2017-07-04||Interventional|||Hepatoprotective Effect of Remote vs Local Preconditioning of Liver|Comparison of Hepatoprotective Effect From Ischemia-reperfusion Injury of Remote Ischemic Preconditioning of the Liver vs. Local Ischemic Preconditioning of the Liver During Human Liver Resections|Active, not recruiting||N/A|60|Actual|University Hospital Dubrava||3|||f||||f|f|f||||||||2017-10-10 21:07:43.557346|2017-10-10 21:07:43.557346
NCT03130907|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-26|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Role of Ureteral Stenting Following Uncomplicated Ureteroscopy for Ureteral and Renal Stones: A Randomized, Controlled Trial|The Role of Ureteral Stenting Following Uncomplicated Ureteroscopy for Ureteral and Renal Stones: A Randomized, Controlled Trial|Not yet recruiting||N/A|214|Anticipated|San Antonio Uniformed Services Health Education Consortium||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:43.652105|2017-10-10 21:07:43.652105
NCT03130894|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-25|||January 1, 2012|Actual|2012-01-01|April 2017|2017-04-01|June 30, 2016|Actual|2016-06-30|December 30, 2014|Actual|2014-12-30||Observational|||Association Between TMAO and Diabetes|Association Between Microbiota-dependent Metabolite Trimethylamine-N-oxide and Type 2 Diabetes|Completed||N/A|2694|Actual|Huazhong University of Science and Technology|||2||f|||||f|f||||||||2017-10-10 21:07:43.75425|2017-10-10 21:07:43.75425
NCT03130881|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-23|||November 8, 2016|Actual|2016-11-08|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC.|A Phase I Open-label, Multicenter Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of PLB1003 in Patients With ALK-positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|60|Anticipated|Beijing Pearl Biotechnology Limited Liability Company||1|||f||||f|f|f||||||Undecided||2017-10-10 21:07:43.833053|2017-10-10 21:07:43.833053
NCT03130868|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-20|||May 15, 2017|Actual|2017-05-15|April 2017|2017-04-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2018|Anticipated|2018-05-15||Observational|Microbiome||Microbiome Changes in Severe Burns|Microbiome Changes in Severe Burns|Recruiting||N/A|2|Anticipated|HealthPartners Institute|||1||f||||f|f|f||||Samples With DNA|"     fecal samples from patients will be non-invasively collected   "|No||2017-10-10 21:07:43.948437|2017-10-10 21:07:43.948437
NCT03130855|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-05-08|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|August 1, 2017|Anticipated|2017-08-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||Comparison Between Efficiency of Inferior Alveolar Nerve Block and Buccal Infiltration Techniques Using Articaine 4% 1:100000|Buccal Infiltration Technique Compared to Inferior Alveolar Nerve Block Technique for Alleviation of Intraoperative Pain During Pulpal Treatment of Mandibular Primary Molars: A Randomized Controlled Clinical Trial.|Not yet recruiting||N/A|48|Anticipated|Cairo University||2|||f||||t|f|f||||||No||2017-10-10 21:07:44.056827|2017-10-10 21:07:44.056827
NCT03130842|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-23|||September 17, 2016|Actual|2016-09-17|April 2017|2017-04-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy|Comparing Efficacy of Oral Midazolam and Sublingual Alprazolam in Reducing Anxiety and Pain/Discomfort Related to Diagnostic Upper Gastrointestinal Endoscopy in Adults|Completed||Phase 2/Phase 3|136|Actual|Isfahan University of Medical Sciences||2|||f||||f|f|f||||||Undecided|Data may be available based on the IUMS policy|2017-10-10 21:07:44.164576|2017-10-10 21:07:44.164576
NCT03130829|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-26|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|April 30, 2020|Anticipated|2020-04-30|February 28, 2020|Anticipated|2020-02-28||Interventional|||To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC|A Randomized, Double-blind, Placebo-controlled, Parallel, Pilot Study to Evaluate the Quality of Life Improvement of Oral Oligo Fucoidan as an Adjuvant in Subjects Receiving Platinum-based Chemotherapy With NSCLC|Not yet recruiting||N/A|100|Anticipated|Hi-Q Marine Biotech International, Ltd.||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:44.27503|2017-10-10 21:07:44.27503
NCT03130816|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-23|||July 29, 2015|Actual|2015-07-29|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Mechanism of Allogeneic UCB Therapy in Cerebral Palsy|Mechanism of Allogeneic Umbilical Cord Blood Therapy in Cerebral Palsy|Recruiting||Phase 1/Phase 2|90|Anticipated|Bundang CHA Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:07:44.423118|2017-10-10 21:07:44.423118
NCT03130803|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-27|||October 2016||2016-10-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Biomarkers of Insufficient Sleep and Sleepiness|Biomarkers of Insufficient Sleep and Sleepiness|Recruiting||N/A|12|Anticipated|University of Colorado, Boulder||2|||f||||t||||||||Yes|Any data generated from the proposed work that is presented in a peer reviewed journal will be uploaded, de-identified, into the Metabolomics Data Repository and Coordinating Center (DRCC) (U01) through UCSD; http://www.metabolomicsworkbench.org/nihmetabolomics/datasharing.html. In addition, .raw data that is presented in a peer reviewed journal will be archived indefinitely and made available upon request.|2017-10-10 21:07:44.526876|2017-10-10 21:07:44.526876
NCT03130790|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-06-04|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|December 2018|Anticipated|2018-12-01||Interventional|||Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)|A Two-Part Phase 2/ 3 Multicentre, Double-Blind, Randomized, Placebo Controlled Study of Varlitinib Plus mFOLFOX6 Verses Placebo Plus mFOLFOX6 In Subjects With HER1/ HER2 Co Expressing Advanced or Metastatic Gastric Cancer Without Prior Exposure to Systemic Therapy|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Aslan Pharmaceuticals||2|||f||||f|f|f||||||No||2017-10-10 21:07:44.634874|2017-10-10 21:07:44.634874
NCT03130777|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-09-11|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALTERRA||Multicenter Trial of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 THV With the Alterra Adaptive Prestent|Multicenter Early Feasibility Study of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 Transcather Heart Valve With the Alterra Adaptive Prestent|Recruiting||N/A|15|Anticipated|Edwards Lifesciences||1|||f||||t|f|t|t|f||||||2017-10-10 21:07:44.885851|2017-10-10 21:07:44.885851
NCT03130764|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-01|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC|Identification of Tumor Neoantigens During Immune Checkpoint Blockade in Resectable Non-Small Cell Lung Cancer (NSCLC)|Not yet recruiting||Phase 2|30|Anticipated|Columbia University||1|||f||||t|t|f||||||Undecided||2017-10-10 21:07:45.007985|2017-10-10 21:07:45.007985
NCT03130738|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-06-22|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis|Dose-Ranging Study of the Efficacy and Safety of Miconazole Oil Used for 7 or 14 Days Compared With Vehicle in the Treatment of Otomycosis|Recruiting||Phase 2|36|Anticipated|Hill Dermaceuticals, Inc.||3|||f|||||t|f||||||No||2017-10-10 21:07:45.245764|2017-10-10 21:07:45.245764
NCT03130725|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-04-25|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|September 1, 2017|Anticipated|2017-09-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Retention of Bonded Amalgam Sealants Versus Resin-based Sealants|Comparison of Six Months Retention of Bonded Amalgam Sealants Versus Resin-based Sealants: A Randomized Controlled Trial|Recruiting||N/A|246|Anticipated|Aga Khan University||2|||f||||t|f|f||||||No||2017-10-10 21:07:45.35925|2017-10-10 21:07:45.35925
NCT03130712|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-04-22|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)|￼An Open-label, Uncontrolled, Single-arm Pilot Study to Evaluate Intratumor Injection Mediated GPC3-targeted Chimeric Antigen Receptor T Cells in Advanced Hepatocellular Carcinoma|Recruiting||Phase 1/Phase 2|10|Anticipated|Shanghai GeneChem Co., Ltd.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:07:45.45971|2017-10-10 21:07:45.45971
NCT03130699|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-10-03|||June 22, 2017|Actual|2017-06-22|October 2017|2017-10-01|August 2021|Anticipated|2021-08-01|February 2021|Anticipated|2021-02-01||Interventional|DD-Me||Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes|Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes|Recruiting||N/A|414|Anticipated|Scripps Whittier Diabetes Institute||3|||f||||t|f|f||||||||2017-10-10 21:07:45.549099|2017-10-10 21:07:45.549099
NCT03130686|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-24|||December 21, 2015|Actual|2015-12-21|April 2017|2017-04-01|March 31, 2016|Actual|2016-03-31|February 18, 2016|Actual|2016-02-18||Observational|||A Clinical Evaluation of Omron Digital Blood Pressure Monitor|A Clinical Evaluation of OMRON Digital Blood Pressure Monitor, HEM-9210T, Blood Pressure Measurement Accuracy Based on Auscultation|Completed||N/A|92|Actual|Omron Healthcare Co., Ltd.|||1||f||||f|f|t|t|f|t|||No|No plan to share the data.|2017-10-10 21:07:45.670894|2017-10-10 21:07:45.670894
NCT03130673|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-04-25|||September 1, 2014|Actual|2014-09-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Observational|||Challenges of Hip Fracture Care in Developing Countries. Experience at a Level 3 Center in Panama|Hip Fracture Epidemiology at Hospital Regional Rafael Hernandez. September 2014 to March 2015.|Active, not recruiting||N/A|104|Anticipated|"Hospital del Niño Dr. José Renán Esquivel"|||1||f||||f||||||||No||2017-10-10 21:07:45.74925|2017-10-10 21:07:45.74925
NCT03130660|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-04-25|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|April 19, 2018|Anticipated|2018-04-19|April 19, 2018|Anticipated|2018-04-19||Interventional|||Short Versus Long Axis Ultrasound Guided Approach for Internal Jugular Vein Cannulations|Short Versus Long Axis Ultrasound Guided Approach for Internal Jugular Vein Cannulations: A Prospective Randomised Controlled Trial.|Recruiting||N/A|100|Anticipated|Institute of Medical Sciences and SUM Hospital||2|||f||||t|f|f||||||Undecided|We havent decided yet|2017-10-10 21:07:45.875178|2017-10-10 21:07:45.875178
NCT03130647|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-08|||May 15, 2017|Anticipated|2017-05-15|September 2017|2017-09-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||The Effects of Transcranial Focused Ultrasound on Human Motor Learning|The Effects of Transcranial Focused Ultrasound on Human Motor Learning|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||1||PI Left university|f||||f|f|t|f|f|f|||||2017-10-10 21:07:46.000349|2017-10-10 21:07:46.000349
NCT03130634|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-09-19|||April 2016||2016-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment||Recruiting||Phase 4|50|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t|f|f||||||||2017-10-10 21:07:46.08235|2017-10-10 21:07:46.08235
NCT03130621|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-04-22|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Screening of Hereditary Upper Gastrointestinal Cancer in China|Screening of Hereditary Upper Gastrointestinal Cancer in China|Recruiting||N/A|200|Anticipated|Peking University|||2||f|||||f|f|||f|||No||2017-10-10 21:07:46.184782|2017-10-10 21:07:46.184782
NCT03130608|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-08|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Inspiratory Muscle Training Post-Liver Transplant|Comparison of Inspiratory Muscle Training and Usual Care in Individuals Post-Liver Transplant|Enrolling by invitation||N/A|50|Anticipated|University of Miami||2|||f||||f|f|f||||||||2017-10-10 21:07:46.269979|2017-10-10 21:07:46.269979
NCT03130595|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-05-10|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|December 2030|Anticipated|2030-12-01|April 30, 2018|Anticipated|2018-04-30|15 Years|Observational [Patient Registry]|WestPORTS||West Sweden Parkinson Objective Measurement Registry Study|West Sweden Parkinson Objective Measurement Registry Study - an Observational Cohort Study of the Prevalence and Development of Motor Symptoms Assessed With Automated Accelerometry in People With Parkinson's Disease in West Sweden|Enrolling by invitation||N/A|600|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||f|f|f|||f|||Yes|Clinical registry data will be immediately available as part of the national Parkinson Registry. Study specific data from objective measurements will be made available within the registry one year after final subject has been recruited. Access to data requires ethical permission and permission from the registry scientific committee SWEPAR.|2017-10-10 21:07:46.376417|2017-10-10 21:07:46.376417
NCT03130582|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-04-26|||November 2005|Actual|2005-11-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01|10 Years|Observational [Patient Registry]|||High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT|2008 WHO Myeloid and Lymphocytic Tumor Diagnostic Criteria|Completed||N/A|88|Actual|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|||2||f|||||t|f||||||||2017-10-10 21:07:46.463142|2017-10-10 21:07:46.463142
NCT03130569|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-10-05|||August 26, 2015|Actual|2015-08-26|October 2017|2017-10-01|August 31, 2017|Actual|2017-08-31|August 18, 2017|Actual|2017-08-18||Interventional|SOMBRA||Skin Health Online for Melanoma: Better Risk Assessment|Personalized Genomic Testing for Skin Cancer - Maximizing Utility and Reach|Completed||N/A|628|Actual|University of New Mexico||2|||f||||t|f|f||||||||2017-10-10 21:07:46.536134|2017-10-10 21:07:46.536134
NCT03130556|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-07-28|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|July 21, 2017|Actual|2017-07-21|July 6, 2017|Actual|2017-07-06||Interventional|B1371026||A Study Of Glasdegib In Healthy Volunteers To Establish The Bioequivalence Of The Phase 2 Formulation To The ICH Formulation|A Phase 1, Randomized, Open-label Study Of Glasdegib (Pf-04449913) In Healthy Volunteers To Establish The Bioequivalence Of The Phase 2 Formulation To The Glasdegib Ich Formulation And To Estimate The Potential Effect Of Food And A Proton Pump Inhibitor On Glasdegib Plasma Pharmacokinetics|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f|t|f||||||||2017-10-10 21:07:46.632523|2017-10-10 21:07:46.632523
NCT03130543|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-24|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|March 6, 2022|Anticipated|2022-03-06|March 6, 2022|Anticipated|2022-03-06||Interventional|||A Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted After Choking Spell|A Randomized Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted to Boston Children's Hospital After Brief Resolved Unexplained Event|Recruiting||N/A|120|Anticipated|Boston Children’s Hospital||3|||f||||f|f|f||||||No||2017-10-10 21:07:46.716648|2017-10-10 21:07:46.716648
NCT03130530|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||June 1, 2015|Actual|2015-06-01|April 2017|2017-04-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Observational|||Retrospective Study on Colorectal Robotic Surgery Results Obtained Using a New Robotic Platform|Retrospective Study on Colorectal Robotic Surgery Results Obtained Using a New Robotic Platform|Completed||N/A|45|Actual|Istituto Clinico Humanitas|||1||f||||f|f|f||||||No||2017-10-10 21:07:46.823708|2017-10-10 21:07:46.823708
NCT03130517|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-26|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|IVIG||Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease|Efficacy of Intravenous Immunoglobulin in Management of RH and ABO Incompatibility Disease of Newborn and Its Effect in Decrease Duration of Hospital Stay and Need for Exchange Transfusion|Not yet recruiting||Early Phase 1|30|Anticipated|Assiut University||2|||f||||t|f|f|||f|||Undecided|patients with Rh and ABO incompatibility disease will recieve intravenous immunoglobulin|2017-10-10 21:07:46.894685|2017-10-10 21:07:46.894685
NCT03130504|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-09-24|||April 1, 2016|Actual|2016-04-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Intramuscular Hydroxyprogesterone Caproate and Placenta Previa|The Use Of Intramuscular Hydroxyprogesterone Caproate For Management Of Placenta Previa Before 34 Weeks Of Gestation|Completed||Phase 2|240|Actual|Assiut University||2|||f||||f|f|f||||||||2017-10-10 21:07:46.977664|2017-10-10 21:07:46.977664
NCT03130491|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-25|||March 8, 2017|Actual|2017-03-08|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|September 8, 2017|Anticipated|2017-09-08||Interventional|||European Study Evaluating the EMBLOK Embolic Protection System During TAVR|European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)|Recruiting||N/A|30|Anticipated|Innovative Cardiovascular Solutions||1|||f||||t|f|f||||||No||2017-10-10 21:07:47.052306|2017-10-10 21:07:47.052306
NCT03130452|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-21|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Helicobacter Pylori Eradication Study|Helicobacter Pylori Eradication Rates of Concomitant Therapy and Tailored Therapy Based on 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance: A Multicenter Prospective Randomized Study|Active, not recruiting||Phase 4|280|Anticipated|Inje University||3|||f||||t|f|f|||f|||No|There is no plan to make individual patient data available to other researchers.|2017-10-10 21:07:47.449387|2017-10-10 21:07:47.449387
NCT03130439|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-06-08|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|November 30, 2024|Anticipated|2024-11-30|November 30, 2020|Anticipated|2020-11-30||Interventional|||Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer|A Phase 2 Study of Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer|Recruiting||Phase 2|37|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 21:07:47.543075|2017-10-10 21:07:47.543075
NCT03130426|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-09-18|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|November 2018|Anticipated|2018-11-01||Interventional|REMIT-iGL||Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi|Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi|Recruiting||Phase 3|160|Anticipated|Population Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:07:47.627174|2017-10-10 21:07:47.627174
NCT03130413|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-25|||November 2016||2016-11-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|Nira||Comparing Between Air-Q Intubating Laryngeal Airway and Ambu® AuraGain™|Comparing the Effectiveness Between Air-Q Intubating Laryngeal Airway and Ambu® AuraGain™ Laryngeal Mask for Controlled Ventilation in Paediatric Patients: A Randomized Controlled Trial.|Recruiting||N/A|64|Anticipated|University of Science Malaysia||2|||f||||t||||||||No||2017-10-10 21:07:47.7468|2017-10-10 21:07:47.7468
NCT03130400|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-05-17|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 14, 2017|Actual|2017-05-14||Observational|||Kinematic Parameters to Predict Knee Diseases.|Can Gait Parameters Predict Knee Injuries/Arthritis?|Completed||N/A|1914|Actual|Guangzhou General Hospital of Guangzhou Military Command|||5||f||||f|f|f||||||No||2017-10-10 21:07:47.85179|2017-10-10 21:07:47.85179
NCT03130387|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-22|2017-04-25|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|Niche||Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding|Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding|Completed||N/A|95|Actual|Ain Shams University||1|||f||||t|f|f||||||Undecided||2017-10-10 21:07:48.097519|2017-10-10 21:07:48.097519
NCT03130374|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-22|||January 3, 2017|Actual|2017-01-03|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells|Treatment of Laryngotracheal Stenosis Using Autologous Olfactory-mucosa-derived Mesenchymal Stem Cells|Enrolling by invitation||Phase 1/Phase 2|12|Anticipated|The Republican Research and Practical Center for Epidemiology and Microbiology||2|||f||||f|f|f||||||No||2017-10-10 21:07:48.189454|2017-10-10 21:07:48.189454
NCT03130361|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-04-21|||January 2017||2017-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Wearable Noninvasive Positive Pressure Ventilation Device in COPD|Evaluation of the Impact of a Wearable Noninvasive Positive Pressure Ventilation Device on Physical Activity and Quality of Life in Patients With COPD|Recruiting||N/A|40|Anticipated|Icadom||1|||f||||t||||||||Undecided||2017-10-10 21:07:48.2925|2017-10-10 21:07:48.2925
NCT03130348|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-28|||October 15, 2017|Anticipated|2017-10-15|April 2017|2017-04-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis|Phase II Study of Ibrutinib With or Without Bortezomib and Dexamethasone for the Treatment of Patients With Relapsed/Refractory Immunoglobulin Light Chain Amyloidosis|Not yet recruiting||Phase 2|40|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:07:48.409951|2017-10-10 21:07:48.409951
NCT03130335|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-17|||April 28, 2017|Actual|2017-04-28|July 2017|2017-07-01|January 1, 2019|Anticipated|2019-01-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Intra-articular Autologous Bone Marrow Aspirate Injection for Knee Osteoarthritis|Intra-articular Autologous Bone Marrow Aspirate Injection for the Treatment of Knee Osteoarthritis: a Pilot Study With Radiological Follow-up|Recruiting||N/A|20|Anticipated|Hospital for Special Surgery, New York||1|||f||||f|f|f||||||||2017-10-10 21:07:48.584039|2017-10-10 21:07:48.584039
NCT03130322|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-19|||December 9, 2015|Actual|2015-12-09|September 2017|2017-09-01|December 9, 2017|Anticipated|2017-12-09|November 9, 2017|Anticipated|2017-11-09||Interventional|||SLeep and IMagery Correlates (SOMMEIL-IMAGERIE)|Neurophysiological Correlates of Sleep Motor Consolidation Following Motor Imagery Practice|Recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||4|||f|||||f|f||||||||2017-10-10 21:07:48.672285|2017-10-10 21:07:48.672285
NCT03130309|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-02|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Results of a Mobile Unicompartimental Knee Prosthesis|Survival Rates of Atients Wearing a Mobile Unicompartimental Knee Prosthesis for the Past 10 Years|Recruiting||N/A|70|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 21:07:48.786869|2017-10-10 21:07:48.786869
NCT03130296|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-11|||February 16, 2017|Actual|2017-02-16|April 2017|2017-04-01|February 16, 2020|Anticipated|2020-02-16|February 16, 2020|Anticipated|2020-02-16||Observational|||"Genotyping FcɣRs Genes of HIV-1 Patients Progressor: Correlation With the Changing Profile of the Infection"|"Genotyping FcɣRs Genes of HIV-1 Patients Progressor: Correlation With the Changing Profile of the Infection"|Recruiting||N/A|230|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 21:07:48.884757|2017-10-10 21:07:48.884757
NCT03130283|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-09|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|May 30, 2018|Anticipated|2018-05-30||Interventional|||Study Design of the Empirical Evaluation of the AISBE Program in Catalonia|Study Design of the Empirical Evaluation of the AISBE Program in Catalonia|Not yet recruiting||N/A|400|Anticipated|Hospital Clinic of Barcelona||2|||f||||t|f|f||||||||2017-10-10 21:07:48.982167|2017-10-10 21:07:48.982167
NCT03130270|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-21|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma|Phase II Trial of Maintenance Apatinib After Second-Line Treatment for Locally Recurrent or Metastatic Nasopharyngeal Carcinoma|Recruiting||Phase 2|25|Anticipated|Guilin Medical University, China||1|||f|||||f|f||||||No||2017-10-10 21:07:49.093794|2017-10-10 21:07:49.093794
NCT03130244|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-07-28|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Endoscopic Procedure for Jejunal to Ileal Diversion to Treat Type 2 Diabetes|A Trial for an Endoscopic Procedure for Jejunal to Ileal Diversion to Treat Type 2 Diabetes|Recruiting||N/A|25|Anticipated|GI Windows, Inc.||2|||f||||t|f|f||||||||2017-10-10 21:07:49.304554|2017-10-10 21:07:49.304554
NCT03130231|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-04-25|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Observational|||Predictive Value of β2-microspheres for Postoperative Delirium|The Predictive Value of β2-microspheres for Postoperative Delirium in the Elderly After Orthopedic Surgery|Recruiting||N/A|160|Anticipated|Zhongda Hospital|||2||f||||t|f|f||||Samples With DNA|"     plasma and cerebrospinal fluid   "|No||2017-10-10 21:07:49.393526|2017-10-10 21:07:49.393526
NCT03130218|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-10-03|||June 8, 2017|Actual|2017-06-08|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients|Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients|Recruiting||N/A|72|Anticipated|Lancaster General Hospital||2|||f||||f|f|f||||||||2017-10-10 21:07:49.477756|2017-10-10 21:07:49.477756
NCT03130205|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-24|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2021|Anticipated|2021-01-01||Observational|PROGRESS||Biomarker Study in Pancreatic Neuroendocrine Tumours|Prospective Longitudinal Biomarker Study in Pancreatic Neuroendocrine Tumours|Recruiting||N/A|30|Anticipated|Uppsala University|||1||f||||f|f|f||||Samples With DNA|"     Core needle Biopsy Phlebotomy   "|||2017-10-10 21:07:49.587934|2017-10-10 21:07:49.587934
NCT03130192|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-04-25|||December 22, 2016|Actual|2016-12-22|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||A Study of the Correlation Between Cancer-related Fatigue, Survival and Physiological Factors in Non-Small Cell Lung Cancer (NSCLC) Patients Under Chemotherapy|An Observational Study of the Correlation Between Cancer-related Fatigue, Survival and Physiological Factors in Non-Small Cell Lung Cancer (NSCLC) Patients Under Chemotherapy|Recruiting||N/A|60|Anticipated|Chung Shan Medical University|||1||f||||f|f|f||||||No||2017-10-10 21:07:49.715293|2017-10-10 21:07:49.715293
NCT03130179|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-15|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.|A Single-dose, Two-period, Crossover, Randomized, Fasting, Open-label, Bioequivalence Study Between Nicorette Strongmint Lozenge 4 mg and Niquitin Minimint Lozenge 4 mg in Adult Healthy Smokers Motivated to Quit.|Completed||Phase 1|244|Anticipated|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f|f|f||||||||2017-10-10 21:07:49.785913|2017-10-10 21:07:49.785913
NCT03126617|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-31||||||May 2017|2017-05-01||||||||Expanded Access|||Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma|Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma|Available||N/A|||Bristol-Myers Squibb|||||f|t|||||||||||||2017-10-10 21:08:24.079839|2017-10-10 21:08:24.079839
NCT03130166|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-25|||November 2017|Anticipated|2017-11-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|May 2019|Anticipated|2019-05-01||Interventional|||Intracorporeal Versus Extracorporeal Anastomosis in Robotic Right Colectomy|Intracorporeal Versus Extracorporeal Anastomosis in Robotic Right Colectomy - a Double-blinded Randomized Controlled Trial|Not yet recruiting||N/A|100|Anticipated|Herlev and Gentofte Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:49.89237|2017-10-10 21:07:49.89237
NCT03130153|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-06-29|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|July 31, 2017|Anticipated|2017-07-31|July 15, 2017|Anticipated|2017-07-15||Interventional|||Topical Analgesic Versus Saline Mouth Rinses in Post Extraction Healing|Comparison of Topical Analgesic With Saline Rinses in Post Extraction Healing Among Hypertensive and Non-Hypertensive Patients|Enrolling by invitation||Early Phase 1|60|Actual|Aga Khan University||3|||f||||t|f|f|||f|||No||2017-10-10 21:07:49.982478|2017-10-10 21:07:49.982478
NCT03130140|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-25|||February 26, 2016|Actual|2016-02-26|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||MOSE to Improve the Diagnostic Accuracy During EUS-guided FNA Using a 19-gauge Needle for Solid Lesions|Macroscopic On-site Quality Evaluation of Biopsy Specimens to Improve the Diagnostic Accuracy During EUS-guided FNA Using a 19-gauge Needle for Solid Lesions: a Multicenter Prospective Randomized Controlled Study|Recruiting||N/A|244|Anticipated|Chinese University of Hong Kong||2|||f||||||||||||Undecided||2017-10-10 21:07:50.204702|2017-10-10 21:07:50.204702
NCT03130127|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-25|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis|Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis: A Prospective Non-randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|General Hospital of Shenyang Military Region||2|||f||||f|f|f||||||No||2017-10-10 21:07:50.29601|2017-10-10 21:07:50.29601
NCT03130114|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-05-15|||May 13, 2017|Actual|2017-05-13|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|ABCD||Antibiotics for Children With Severe Diarrhoea|Antibiotics for Children With Severe Diarrhoea|Recruiting||Phase 3|11500|Anticipated|World Health Organization||2|||f||||t|f|f|||f|||Undecided|The Principal investigators are currently discussing this between themselves and their research organizations. The plan is to make the data available as soon as possible.|2017-10-10 21:07:50.418922|2017-10-10 21:07:50.418922
NCT03130101|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-21|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Insulin Management for Exercise in Patients With Type 1 Diabetes|OmniPod®-Type 1 Diabetes Insulin Management for Exercise Study|Recruiting||N/A|16|Anticipated|York University||3|||f||||f|f|f||||||No||2017-10-10 21:07:50.601741|2017-10-10 21:07:50.601741
NCT03130088|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-21|||October 1, 2017|Anticipated|2017-10-01|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|December 31, 2017|Anticipated|2017-12-31|30 Days|Observational [Patient Registry]|EuReCa TWO||European Registry of Cardiac Arrest Study Two|European Registry of Cardiac Arrest - Study Two (EuReCa TWO) An International, Prospective, Multi-centre, Three-month Survey of Epidemiology, Treatment and Outcome of Patients Suffering an Out-of-hospital Cardiac Arrest in Europe|Not yet recruiting||N/A|30000|Anticipated|German Resuscitation Registry|||1||f||||f|f|f||||||No||2017-10-10 21:07:50.766479|2017-10-10 21:07:50.766479
NCT03130075|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-26|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|August 25, 2017|Anticipated|2017-08-25|July 25, 2017|Anticipated|2017-07-25||Observational|VERSION||Reliability and Validity of the Turkish Version of Caregiver Functional Use Survey (CFUS)|Reliability and Validity of the Turkish Version of Caregiver Functional Use Survey (CFUS)|Active, not recruiting||N/A|50|Anticipated|Gazi University|||1||f||||f|f|f||||||No||2017-10-10 21:07:50.892114|2017-10-10 21:07:50.892114
NCT03130062|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-25|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Resistance Exercise in Woman With Primary Sjörgen Syndrome.|Effectiveness of Resistance Exercise in Daily Motor Activity Index and Functional Fitness in Women With Primary Sjögren Syndrome: a Randomized Clinical Trial|Completed||N/A|51|Actual|Federal University of São Paulo||2|||f||||t|f|f||||||Yes|The questionaries SF-36 and ESSDAI used in the present study were shared with other researches.|2017-10-10 21:07:50.992427|2017-10-10 21:07:50.992427
NCT03130049|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-27|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|February 1, 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Popliteal Plexus Block for Postoperative Pain After ACL Reconstruction|The Effect of the Popliteal Plexus Block on Postoperative Pain After Reconstruction of the Anterior Cruciate Ligament|Not yet recruiting||N/A|100|Anticipated|University of Aarhus||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:51.094448|2017-10-10 21:07:51.094448
NCT03130036|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-21|||June 9, 2015|Actual|2015-06-09|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose Using Positron Emission Tomography (PET) Scanning|Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Varying Risk Factors for Alzheimer's Disease and Subjects on a Ketogenic Diet|Enrolling by invitation||N/A|30|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||No||2017-10-10 21:07:51.249637|2017-10-10 21:07:51.249637
NCT03130023|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-23|||May 30, 2017|Anticipated|2017-05-30|April 2017|2017-04-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||The Relationship Between Oxygen Reserve Index and PaO2|The Relationship Between Oxygen Reserve Index and PaO2 in Children|Not yet recruiting||N/A|500|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:07:51.355112|2017-10-10 21:07:51.355112
NCT03130010|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-05-12|||August 31, 2016|Actual|2016-08-31|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effect of Nefopam on Catheter-related Bladder Discomfort|The Effect of Nefopam on Catheter-related Bladder Discomfort: A Double-blind, Randomized, Controlled, Parallel Design Study|Recruiting||N/A|110|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 21:07:51.447219|2017-10-10 21:07:51.447219
NCT03129997|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-25|||March 3, 2016|Actual|2016-03-03|April 2017|2017-04-01|March 3, 2017|Actual|2017-03-03|December 2, 2016|Actual|2016-12-02||Interventional|||Effect of Gluten-free Diets on Anthropometric and Dietary Data of Healthy Eutrophic Women|Effect of Gluten-free Diets on Anthropometric and Dietary Data of Healthy Eutrophic Women|Completed||N/A|30|Actual|Federal University of Minas Gerais||2|||f||||t|f|f||||||No||2017-10-10 21:07:51.563514|2017-10-10 21:07:51.563514
NCT03129984|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-02|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|dépist-By||Mandibular Movement Test as a Screening Tool for Polysomnography Candidates|A Mandibular Movement Test as a Screening Tool for Polysomnography Candidates Among Patients With Sleep Apnea: a Retrospective Feasibility Study|Completed||N/A|4231|Actual|University Hospital, Montpellier|||1||f||||f|f|f||||||||2017-10-10 21:07:51.667173|2017-10-10 21:07:51.667173
NCT03129971|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-25|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Platelet-rich Plasma Combined With Conventional Surgery in the Treatment of Atrophic Nonunion of Femoral Shaft Fractures|Platelet-rich Plasma Combined With Conventional Surgery in the Treatment of Atrophic Nonunion of Femoral Shaft Fractures: a Prospective, Randomized, Controlled Clinical Trial|Active, not recruiting||N/A|92|Actual|Qinghai University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:51.787898|2017-10-10 21:07:51.787898
NCT03129958|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-28|||June 1, 2016||2016-06-01|April 2017|2017-04-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Observational|||Correlation Between Neck Pain and Postural Abnormalities Among Female Office Workers at University of Dammam|Correlation Between Neck Pain and Postural Abnormalities Among Female Office Workers at University of Dammam|Completed||N/A|140|Actual|Imam Abdulrahman Bin Faisal University|||1||f||||f|f|f||||||No||2017-10-10 21:07:51.884332|2017-10-10 21:07:51.884332
NCT03129945|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-08-08|||November 2014||2014-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor|Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor|Active, not recruiting||N/A|38|Actual|University of California, Irvine||2|||f||||f||||||||||2017-10-10 21:07:51.968142|2017-10-10 21:07:51.968142
NCT03129932|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-25|||January 10, 2015|Actual|2015-01-10|April 2017|2017-04-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Effects Gluten Intake on Body Composition, Energy Expenditure and Adipokine Profile in Non-celiac Women With Obesity|Effects Gluten on Body Composition, Energy Expenditure and Adipokine Profile in Non-celiac Women With Obesity|Active, not recruiting||N/A|40|Anticipated|Federal University of Minas Gerais||2|||f||||f|f|f||||||No||2017-10-10 21:07:52.09149|2017-10-10 21:07:52.09149
NCT03129919|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-25|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Arch Dimension and Inclination of the Upper and Lower Incisors Changes|Arch Dimension and Inclination of the Upper and Lower Incisors Changes in Patients Treated With Interactive and Passive Self-ligation Brackets|Not yet recruiting||N/A|60|Anticipated|Fundación Universitaria CIEO||2|||f||||f|f|f|||f|||No||2017-10-10 21:07:52.221553|2017-10-10 21:07:52.221553
NCT03129906|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||September 25, 2015||2015-09-25|April 2017|2017-04-01|October 4, 2016|Actual|2016-10-04|October 4, 2016|Actual|2016-10-04||Interventional|||Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients|Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients|Completed||N/A|26|Actual|Federal University of Minas Gerais||2|||f||||t|f|f||||||No||2017-10-10 21:07:52.31596|2017-10-10 21:07:52.31596
NCT03129893|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-21|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|PICU-BG-TT||Cuffed Versus Uncuffed Tracheal Tubes in PICU (PICU-BG-TT Study)|Ventilator Associated Complications in Neonate and Small Infant Undergoing Cardiac Surgery Using Cuffed and Uncuffed Tracheal Tubes. The PICU-BG-TT Study|Recruiting||N/A|242|Anticipated|Fondazione per la Ricerca Ospedale Maggiore|||2||f||||f|f|t|f|f|t|||No||2017-10-10 21:07:52.426205|2017-10-10 21:07:52.426205
NCT03129880|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-10|||March 13, 2016|Actual|2016-03-13|August 2017|2017-08-01|March 12, 2021|Anticipated|2021-03-12|March 12, 2021|Anticipated|2021-03-12||Interventional|||Intensive Versus Traditional Voice Therapy|Voice-related Outcomes in Response to Intensive Versus Traditional Therapy Programs|Recruiting||N/A|73|Anticipated|University of Wisconsin, Madison||2|||f||||f|f|f||||||||2017-10-10 21:07:52.517687|2017-10-10 21:07:52.517687
NCT03129867|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-21|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|AD-HOC||ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome|Incidence and Models of Ticagrelor Discontinuation in Patients With Acute Coronary Syndrome|Not yet recruiting||N/A|480|Anticipated|Fondazione per la Ricerca Ospedale Maggiore|||1||f||||f|t|f|||f|||No||2017-10-10 21:07:52.630175|2017-10-10 21:07:52.630175
NCT03129854|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-25|||March 29, 2017|Actual|2017-03-29|April 2017|2017-04-01|June 30, 2025|Anticipated|2025-06-30|January 1, 2025|Anticipated|2025-01-01||Interventional|||Androgen Deprivation Therapy (ADT) Versus ADT Plus Prostate Cryotherapy for Metastatic Prostate Cancer (mPCa)|A Randomized Study of Androgen Deprivation Therapy Versus Androgen Deprivation Therapy Plus Prostate Cryotherapy in the Treatment of Patients With Primary Diagnosed Metastatic Prostate Cancer|Recruiting||N/A|250|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||No||2017-10-10 21:07:52.720065|2017-10-10 21:07:52.720065
NCT03129841|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-09-12|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Late Dinner Against Early Dinner on Weight Loss Healthy Obese Women|Effects of Late Dinner Against Early Dinner on Weight Loss Healthy Obese Women in a Weight-loss Program: a Randomized Clinical Trial|Active, not recruiting||N/A|70|Actual|Novindiet Clinic||2|||f||||f|f|f||||||||2017-10-10 21:07:52.828239|2017-10-10 21:07:52.828239
NCT03129828|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-24|||March 17, 2017|Actual|2017-03-17|April 2017|2017-04-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|ImbruVeRCHOP||Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2|Ibrutinib (Imbruvica®), Bortezomib (Velcade®) s.c., Rituximab, CHOP for the Treatment of Elderly Patients (Age 61-80 Years) With CD20+ Diffuse Large B-cell Lymphoma, IPI ≥ 2|Recruiting||Phase 1/Phase 2|60|Anticipated|Charite University, Berlin, Germany||1|||f|||||f|f|||f|||No||2017-10-10 21:07:53.076749|2017-10-10 21:07:53.076749
NCT03129815|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-05-10|||July 2016|Actual|2016-07-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Effectiveness of the Routine Use of Extubation Protocol on the Incidence of Occurrence of Failures Number of Extubation in Pediatric Resuscitation||Recruiting||N/A|70|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:07:53.249326|2017-10-10 21:07:53.249326
NCT03072186|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-30|||September 2017||2017-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:17:20.844682|2017-10-10 21:17:20.844682
NCT03129789|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-22|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Volumetric Bladder Ultrasound Training for Pediatric Residents|Volumetric Bladder Ultrasound Training for Pediatric Residents: Curriculum Implementation and Learning Trajectory|Recruiting||N/A|30|Anticipated|Northwell Health||1|||f||||f|f|f||||||No||2017-10-10 21:07:53.474602|2017-10-10 21:07:53.474602
NCT03129776|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer (LACC) Cervical Cancer|Hyperpolarized 13C MR Imaging of Lactate in Patients With Locally Advanced Cervical Cancer for Treatment With Definitive Chemoradiation Therapy|Not yet recruiting||Phase 1|10|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|t|f|||t|||||2017-10-10 21:07:53.568062|2017-10-10 21:07:53.568062
NCT03129763|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-29|||January 7, 2017|Actual|2017-01-07|May 2017|2017-05-01|May 25, 2017|Actual|2017-05-25|May 5, 2017|Actual|2017-05-05||Interventional|||Perfusion Assessment With Indocyanine Green-SPY Angiography After Tissue Expander Filling|Perfusion Assessment With Indocyanine Green-SPY Angiography After Tissue Expander Filling for Optimization of Expansion Capsule Pressure|Completed||N/A|30|Actual|Shanghai Jiao Tong University School of Medicine||5|||f||||f|f|f||||||||2017-10-10 21:07:53.675|2017-10-10 21:07:53.675
NCT03129750|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-06-07|||August 2016||2016-08-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Observational|||Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions|Safety and Efficacy of the Drug Coated Balloon (DCB) for the Treatment of the Superficial Femoral Artery (SFA) Ischemic Vascular Disease in Symptomatic Patients Presenting With TASC C and D Lesions: a Pilot Study|Recruiting||N/A|150|Anticipated|Ettore Sansavini Health Science Foundation|||1||f||||t||||||||No||2017-10-10 21:07:53.798847|2017-10-10 21:07:53.798847
NCT03129737|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-27|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|February 2020|Anticipated|2020-02-01||Interventional|PROCIDA||PROphylactic triCuspID Annuloplasty in Patients With Dilated Tricuspid Annulus|Multi-centre Randomised Trial Investigating the Effect of PROphylactic triCuspID Annuloplasty in Patients With Dilated Tricuspid Annulus on Tricuspid Regurgitation Progression, Right Ventricular Remodeling and Functional Outcomes|Recruiting||N/A|200|Anticipated|Ettore Sansavini Health Science Foundation||2|||f||||t|f|f||||||No||2017-10-10 21:07:53.946149|2017-10-10 21:07:53.946149
NCT03129724|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-04-21|||September 2016||2016-09-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib||Not yet recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:07:54.085673|2017-10-10 21:07:54.085673
NCT03129711|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-24|2017-04-29|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Patient Satisfaction of Glazed IPS Empress CAD Versus Glazed Celtra Duo Ceramic Laminate Veneers|Patient Satisfaction and One Year Clinical Evaluation of Glazed IPS Empress CAD Versus Glazed Celtra Duo Ceramic Laminate Veneers|Not yet recruiting||N/A|36|Anticipated|Cairo University||2|||f|||||f|f||||||Undecided||2017-10-10 21:07:54.157085|2017-10-10 21:07:54.157085
NCT03129698|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-04-27|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer|Phase II Study of Apatinib in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer|Recruiting||Phase 2|52|Anticipated|Peking Union Medical College||1|||f|||||f|f||||||||2017-10-10 21:07:54.244933|2017-10-10 21:07:54.244933
NCT03129685|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-09-24|||May 20, 2017|Actual|2017-05-20|April 2017|2017-04-01|July 30, 2018|Anticipated|2018-07-30|May 19, 2018|Anticipated|2018-05-19||Interventional|NRU||Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma|Short-term Outcome of Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma|Recruiting||N/A|12|Anticipated|The National Ribat University||1|||f||||f|f|f||||||||2017-10-10 21:07:54.339337|2017-10-10 21:07:54.339337
NCT03129672|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-04-25|||May 20, 2017|Anticipated|2017-05-20|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the Ankle|Distal Tibia Sarcoma Treatment Using Allograft Arthrodesis of the Ankle|Recruiting||N/A|20|Anticipated|"Hospital del Niño Dr. José Renán Esquivel"|||1||f||||f||||||||Undecided||2017-10-10 21:07:54.434454|2017-10-10 21:07:54.434454
NCT03129659|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-06-17|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|COURSE||Coronary CT Angiography for Improved Assessment of Suspected Acute Coronary Syndrome|Coronary CT Angiography for Improved Assessment of Suspected Acute Coronary Syndrome With Inconclusive Diagnostic Work-up|Not yet recruiting||N/A|230|Anticipated|Erasmus Medical Center||1|||f|||||f|f||||||||2017-10-10 21:07:54.546115|2017-10-10 21:07:54.546115
NCT03129646|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-02|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa|An Open Label, Phase III, Randomized Controlled, Multicentre Non-Inferiority Trial to Compare Efficacy and Safety of Miltefosine and Paromomycin With SSG and PM Combination for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa|Not yet recruiting||Phase 3|576|Anticipated|Drugs for Neglected Diseases||3|||f||||f|f|f|||f|||Undecided||2017-10-10 21:07:54.639504|2017-10-10 21:07:54.639504
NCT03129633|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-21|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|September 29, 2018|Anticipated|2018-09-29|September 29, 2018|Anticipated|2018-09-29||Interventional|||Raices: A Promotores Network to Improve Latino Immigrant Health|Raices: A Promotores Network to Improve the Health Behaviors and Health Outcomes of Latino Immigrants Living in an Emerging Latino Community|Recruiting||N/A|400|Anticipated|University of Pittsburgh||2|||f|||||f|f||||||||2017-10-10 21:07:54.780108|2017-10-10 21:07:54.780108
NCT03129620|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2017-04-21|||March 2013||2013-03-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Observational|||Pharmacokinetics of Ampicillin in Neonates With Moderate to Severe Hypoxic-Ischemic Encephalopathy|Pharmacokinetics of Ampicillin in Neonates With Moderate to Severe Hypoxic-Ischemic Encephalopathy Undergoing Controlled Hypothermia|Completed||N/A|14|Actual|Drexel University|||1||f||||f||||||||No||2017-10-10 21:07:54.870765|2017-10-10 21:07:54.870765
NCT03129594|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-10-03|||February 2013|Actual|2013-02-01|October 2017|2017-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction|Prognostic Value of Plasma Glucagon-like Peptide-1 Levels in Acute Myocardial Infarction|Completed||N/A|709|Actual|Chinese PLA General Hospital|||1||f|||||f|f||||||||2017-10-10 21:07:55.02948|2017-10-10 21:07:55.02948
NCT03129568|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-23|||April 14, 2017|Actual|2017-04-14|April 2017|2017-04-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|TICAP-DCM||Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy|A Randomized Phase 1 Trial of Cardiac Progenitor Cell Therapy in Children With Dilated Cardiomyopathy|Recruiting||Phase 1|31|Anticipated|Okayama University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:07:55.197887|2017-10-10 21:07:55.197887
NCT03129555|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-30|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|DANNOAC-VTE||The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)|The Danish Non-vitamin K Antagonist Oral Anticoagulation Study. A Cluster Randomized Study Comparing Safety and Efficacy of Edoxaban, Apixaban, Rivaroxaban and Dabigatran for Oral Anticoagulation in Patients With Venous Thromboembolism.|Recruiting||Phase 4|5000|Anticipated|Danish Heart Foundation||4|||f||||t|f|f|||f|||Undecided||2017-10-10 21:07:55.301291|2017-10-10 21:07:55.301291
NCT03129542|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-26|||August 28, 2017|Anticipated|2017-08-28|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Midodrine Hydrochloride in Early Sepsis|Oral Midodrine Hydrochloride in Early Sepsis: Randomized, Double Blind and Placebo-Controlled Feasibility Study|Not yet recruiting||Phase 1|36|Anticipated|Mayo Clinic||2|||f||||f|t|f||||||||2017-10-10 21:07:55.461575|2017-10-10 21:07:55.461575
NCT03129529|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-25|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|January 1, 2017|Actual|2017-01-01|March 1, 2016|Actual|2016-03-01||Interventional|||Comparing the Effect of Focused and Radial Extracorporeal Shock Waves on Post-stroke Hypertonia|Comparing the Effect of Focused and Radial Extracorporeal Shock Waves on Post-stroke Hypertonia|Completed||N/A|32|Actual|Mackay Memorial Hospital||2|||f|||||f|||||||||2017-10-10 21:07:55.54977|2017-10-10 21:07:55.54977
NCT03129516|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-22|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Observational|||Turkish Version of the Movement Imagery Questionnaire-3|Reliability and Validity of the Turkish Version of the Movement Imagery Questionnaire-3|Completed||N/A|185|Actual|Hacettepe University|||1||f|||||f|f||||||||2017-10-10 21:07:55.62058|2017-10-10 21:07:55.62058
NCT03129503|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-06-24|||April 28, 2017|Actual|2017-04-28|June 2017|2017-06-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31|5 Years|Observational [Patient Registry]|OPTICO-ACS||Optical Coherence Tomography in Acute Coronary Syndrome|Optical Coherence Tomography in Acute Coronary Syndrome|Recruiting||N/A|414|Anticipated|Charite University, Berlin, Germany|||1||f||||t|f|f||||Samples With DNA|"     Blood and coronary thrombus   "|No||2017-10-10 21:07:55.680603|2017-10-10 21:07:55.680603
NCT03129490|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-30|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|DANNOAC-AF||The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation|The Danish Non-vitamin K Antagonist Oral Anticoagulation Study. A Cluster Randomized Study Comparing Safety and Efficacy of Edoxaban, Apixaban, Rivaroxaban and Dabigatran for Oral Anticoagulation in Atrial Fibrillation (DANNOAC-AF).|Recruiting||Phase 4|11000|Anticipated|Danish Heart Foundation||4|||f||||t|f|f|||f|||Undecided||2017-10-10 21:07:55.777197|2017-10-10 21:07:55.777197
NCT03129477|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-04-25|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|TELECOPD||TELE-monitoring in Chronic Obstructive Pulmonary Disease|TELE-monitoring in Chronic Obstructive Pulmonary Disease|Not yet recruiting||N/A|50|Anticipated|Conde, Bebiana, M.D.||2|||f||||f|f|f||||||Yes|Clinical data of the patients are required to adjust the ventilation parameters.|2017-10-10 21:07:55.951249|2017-10-10 21:07:55.951249
NCT03129464|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-03|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Cold Therapy Implementation on Multi-modal Postoperative Pain Management|Effect of Cold Therapy Implementation on Multi-modal Postoperative Pain Management in Women Undergoing Laparoscopic Hysterectomy|Recruiting||N/A|56|Anticipated|The Cleveland Clinic||2|||f||||t|f|t|f||f|||||2017-10-10 21:07:56.045974|2017-10-10 21:07:56.045974
NCT03129451|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Observational|||The Microbiome in Parkinson's Disease|The Microbiome in Parkinson's Disease|Recruiting||N/A|210|Anticipated|Spectrum Health Hospitals|||7||f||||f|f|f||||||No||2017-10-10 21:07:56.151746|2017-10-10 21:07:56.151746
NCT03129438|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-28|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|CERTA||Continuous EEG Randomized Trial in Adults|Impact on Clinical Outcome of Continuous Video-electroencephalography (cEEG) Monitoring in Patients With Disorders of Consciousness: A Randomized Controlled Trial|Recruiting||N/A|350|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f|f|f|||f|||||2017-10-10 21:07:56.290751|2017-10-10 21:07:56.290751
NCT03129256|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-21|||December 1, 2016|Actual|2016-12-01|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|EASE||An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer|An Exploratory Study of Low-dose Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer|Recruiting||Phase 2|52|Anticipated|Changzhou Cancer Hospital of Soochow University||1|||f||||f|f|f||||||No||2017-10-10 21:07:59.578504|2017-10-10 21:07:59.578504
NCT03129425|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-21|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ReNACE-PD01||Quasi-experimental Study With a Control Group to Evaluate a Psychoeducational Intervention in Parkinson's Disease Patients and Carers|Quasi-experimental Study With a Control Group to Evaluate a Multidisciplinary Psychoeducational Intervention on Coping Skills, Psychosocial Adaptation and Quality of Life in Parkinson's Disease Patients and Cares|Recruiting||N/A|200|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||f|f|f||||||No|Participant data from scales will not be shared with other researchers.|2017-10-10 21:07:56.42556|2017-10-10 21:07:56.42556
NCT03129412|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-25|||April 14, 2017|Actual|2017-04-14|April 2017|2017-04-01|April 23, 2023|Anticipated|2023-04-23|April 23, 2023|Anticipated|2023-04-23||Interventional|||Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions|The Clinical Curative Efficacy and Side Effect of Oligo-metastases Nasopharyngeal Carcinoma Patients Received Radical Radiation for Primary Tumors and Treatments for Metastatic Lesions|Recruiting||Phase 2|64|Anticipated|Zhejiang Cancer Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:07:56.548411|2017-10-10 21:07:56.548411
NCT03129399|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-20|||May 20, 2017|Actual|2017-05-20|May 2017|2017-05-01|June 20, 2018|Anticipated|2018-06-20|May 20, 2018|Anticipated|2018-05-20||Interventional|||Comparison of King Vision Video Laryngoscope to McGrath MAC Video Laryngoscope for Nasal Intubation|Nasal Intubation Using the King Vision Video Laryngoscope:a Randomized,Controlled Comparison With McGrath MAC Video Laryngoscope|Recruiting||N/A|80|Anticipated|Shanghai 9th People's Hospital||2|||f||||f|f|t|f|f|t|||||2017-10-10 21:07:56.645418|2017-10-10 21:07:56.645418
NCT03129386|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-21|||June 8, 2016|Actual|2016-06-08|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|SNIFF II||Defining the Normal Range for Maximal Sniff Diaphragm Thickening Fraction|Defining the Normal Range for Maximal Sniff Diaphragm Thickening Fraction|Recruiting||N/A|60|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||No|Currently, there is no plan to make data IPD available to others.|2017-10-10 21:07:56.738727|2017-10-10 21:07:56.738727
NCT03129373|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-18|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Clinical Study : Efficacy and Safety of Three Cryotherapy Devices for Wart Treatment|Clinical Trial to Demonstrate the Comparative Efficacy of a Cryogenic Treatment (Medical Device) In Common and Plantar Warts Management|Completed||N/A|138|Actual|Oystershell NV||3|||f||||f|f|f||||||||2017-10-10 21:07:56.815449|2017-10-10 21:07:56.815449
NCT03129360|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-20|||August 1, 2016|Actual|2016-08-01|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|April 1, 2017|Actual|2017-04-01||Interventional|||Levetiracetam in Early Psychosis|A Randomized, Double-blind, Placebo-controlled Trial Investigating the Effects of Levetiracetam in Early Psychosis|Withdrawn||Phase 2|0|Actual|New York University School of Medicine||3||"While 33 people signed consent, no one was enrolled in the study, because none of these   patients developed pain in the recovery room."|f|||||t|f|||t|||||2017-10-10 21:07:56.884038|2017-10-10 21:07:56.884038
NCT03129347|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-10|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|June 9, 2017|Actual|2017-06-09||Interventional|||Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers|Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers|Completed||Phase 1|14|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||f|t|f||||||||2017-10-10 21:07:56.962595|2017-10-10 21:07:56.962595
NCT03129334|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-21|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MSPDA||Preventing Prescription Drug Abuse in Middle School Students|Preventing Prescription Drug Abuse in Middle School Students|Active, not recruiting||N/A|4500|Anticipated|National Health Promotion Associates, Inc.||2|||f||||t|f|f||||||No||2017-10-10 21:07:57.054887|2017-10-10 21:07:57.054887
NCT03129321|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-08-03||2017-08-03|March 15, 2016|Actual|2016-03-15|August 2017|2017-08-01|November 17, 2016|Actual|2016-11-17|November 17, 2016|Actual|2016-11-17||Interventional|||Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis|Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Econazole Nitrate Cream, 1% (Renaissance Pharma, Inc.) to Econazole Nitrate Cream, 1% (Perrigo New York Inc.) in Tinea Pedis|Completed||Phase 3|876|Actual|Mylan Inc.||3|||f|||||t|f|||t|||||2017-10-10 21:07:57.117489|2017-10-10 21:07:57.117489
NCT03129308|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-21|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01|1 Year|Observational [Patient Registry]|||Prevalence of Cutaneous Autoimmune Phenomena in HIV Infected Patients|A Controlled Cross Sectional Study: Prevalence of Cutaneous Autoimmune Phenomena in HIV Infected Patients|Recruiting||N/A|900|Anticipated|Medical University of Vienna|||2||f||||f|f|f||||Samples Without DNA|"     4.5ml of blood will be collected per patient and serum will be stored until final processing.   "|No||2017-10-10 21:07:59.020983|2017-10-10 21:07:59.020983
NCT03129295|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase II Proof of Concept Study in Uncomplicated UTI|A Randomized, Double-Blind, Placebo-Controlled, MultiCenter Study of the Efficacy and Safety of MPC-SHRC for the Relief of Symptoms Associated With Uncomplicated Urinary Tract Infections|Not yet recruiting||Phase 2|200|Anticipated|Mission Pharmacal||2|||f||||f|t|f||||||No||2017-10-10 21:07:59.151931|2017-10-10 21:07:59.151931
NCT03129282|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-21|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Pathway Study WS3 - Home Based Metacognitive Therapy for Cardiac Rehabilitation Patients|A Feasibility Study on Integrating Home-based Metacognitive Therapy for Anxiety and Depression in the Cardiac Rehabilitation Pathway (PATHWAY STUDY WS3)|Recruiting||N/A|108|Anticipated|University of Manchester||2|||f|||||f|f||||||||2017-10-10 21:07:59.245562|2017-10-10 21:07:59.245562
NCT03129269|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-04-21|||January 2, 2017|Actual|2017-01-02|April 2017|2017-04-01|December 31, 2021|Anticipated|2021-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|COGFRAIL||Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults|Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults|Recruiting||N/A|345|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||Undecided||2017-10-10 21:07:59.404978|2017-10-10 21:07:59.404978
NCT03129243|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-23|2017-08-13|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Observational|||Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome|Relation of Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome in Couples With Male Infertility|Recruiting||N/A|80|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 21:07:59.691571|2017-10-10 21:07:59.691571
NCT03129230|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-22|||August 1, 2012|Actual|2012-08-01|April 2017|2017-04-01|March 1, 2017|Actual|2017-03-01|September 1, 2016|Actual|2016-09-01||Interventional|||Free Nonvascularized Fibula Autograft for Tumor-like Lesions in Femoral Neck Using in Pediatric Patients|Yulin Orthopedics Hospital of Chinese and Western Medicine|Completed||N/A|16|Actual|Yulin Orthopedics Hospital of Chinese and Western Medicine||1|||f||||t|f|f||||||No||2017-10-10 21:07:59.792708|2017-10-10 21:07:59.792708
NCT03129217|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-21|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Observational|SNIFF III||The Validity of Maximal Diaphragm Thickening Fraction to Measure Diaphragm Function in Mechanically Ventilated Patients|The Validity of Maximal Diaphragm Thickening Fraction to Measure Diaphragm Function in Mechanically Ventilated Patients|Recruiting||N/A|30|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||No|Currently, there is no plan to make data available to other researchers.|2017-10-10 21:07:59.864968|2017-10-10 21:07:59.864968
NCT03129204|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-29|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|July 1, 2017|Anticipated|2017-07-01||Interventional|SAF-T||Sensation Awareness Focused Training for Spouses|Prevention of Post Intensive Care Syndrome in Family With SAF-T Intervention: Feasibility Study|Recruiting||N/A|10|Anticipated|University of South Florida||2|||f||||f|f|f||||||Undecided||2017-10-10 21:07:59.944803|2017-10-10 21:07:59.944803
NCT03129191|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-14|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Audiological Benefit With Non-implantable Bone Conduction Hearing Systems|Audiological Benefit With Non-implantable Bone Conduction Hearing Systems|Recruiting||N/A|15|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f|||f|||||2017-10-10 21:08:00.083063|2017-10-10 21:08:00.083063
NCT03129178|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-06-25|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 1, 2019|Anticipated|2019-03-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon|Beet the Cold: The Effect of Inorganic Nitrate Supplementation on Peripheral Blood Flow and Pain in Individuals With Raynaud's Phenomenon. A Pilot, Double-blind, Placebo Controlled, Randomised Crossover Trial|Recruiting||N/A|30|Anticipated|University of Portsmouth||2|||f||||t|f|f||||||No|There is no plan to release IPD, until all avenues of further funding have been exhausted.|2017-10-10 21:08:00.281292|2017-10-10 21:08:00.281292
NCT03129165|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-21|||May 11, 2015|Actual|2015-05-11|April 2017|2017-04-01|May 11, 2018|Anticipated|2018-05-11|May 11, 2018|Anticipated|2018-05-11||Interventional|ProSALUTE||ProSALUTE: Community Program for Cardiovascular Health|ProSALUTE: a New Community Program for Cardiovascular Health|Enrolling by invitation||N/A|600|Anticipated|Centro Cardiologico Monzino||1|||f||||f|f|f||||||Undecided||2017-10-10 21:08:00.400455|2017-10-10 21:08:00.400455
NCT03127891|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-04-24|||November 2016||2016-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|yoga||Effect of Yoga on Anesthesia Management|Effect of Short Term Pranayama on Anaesthesia Management in Patients Undergoing Cardiac Surgery|Recruiting||N/A|60|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||No||2017-10-10 21:08:00.525531|2017-10-10 21:08:00.525531
NCT03127878|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-27|||January 12, 2017|Actual|2017-01-12|April 2017|2017-04-01|January 12, 2020|Anticipated|2020-01-12|January 12, 2020|Anticipated|2020-01-12||Interventional|||Effects of Upper-limb Training Addition to a Conventional ET Program on PA Level and ADL Performance.|Effects of Upper-limb Endurance Exercise Training Addition to a Conventional High-intensity Exercise Training Program on Physical Activity Level and Activities of Daily Living Performance in Patients With COPD|Recruiting||N/A|64|Anticipated|Universidade Estadual de Londrina||2|||f||||f|f|f||||||No||2017-10-10 21:08:00.663473|2017-10-10 21:08:00.663473
NCT03127865|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-08-17|||April 18, 2017|Actual|2017-04-18|August 2017|2017-08-01|August 16, 2017|Actual|2017-08-16|August 14, 2017|Actual|2017-08-14||Observational|||Evaluation of Electrical Velocimetry for Assessment of Extra-vascular Lung Water in Pre-eclamptic Patients|Evaluation of Electrical Velocimetry for Assessment of Extra-vascular Lung Water in Pre-eclamptic Patients|Completed||N/A|60|Actual|Cairo University|||1||f||||f|f|f||||||||2017-10-10 21:08:00.81242|2017-10-10 21:08:00.81242
NCT03129152|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-25|||September 13, 2013||2013-09-13||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:00.902401|2017-10-10 21:08:00.902401
NCT03129139|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-10|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™Capsules in Patients With Advanced Solid Tumors|A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™Capsules Given Daily for 21 Days Followed by 7 Days Off Schedule in Patients With Advanced Solid Tumors|Not yet recruiting||Phase 1|54|Anticipated|Minneamrita Therapeutics LLC||2|||f||||f|t|f||||||||2017-10-10 21:08:00.966193|2017-10-10 21:08:00.966193
NCT03129126|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-21|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||The Safety, Tolerability and Efficacy of LP-10 With Placebo in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis|A Multicenter, Double-blind, Randomized, Dose-Ranging, Placebo Controlled Trial Comparing the Safety, Tolerability and Efficacy of LP-10 With Placebo in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis|Not yet recruiting||Phase 2|18|Anticipated|Lipella Pharmaceuticals, Inc.||4|||||||t|t|f||||||Undecided||2017-10-10 21:08:01.069287|2017-10-10 21:08:01.069287
NCT03129113|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-06-03|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|MAVMET||A Randomised Controlled Trial of Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV|A Multicentre, 48 Week Randomised Controlled Factorial Trial of Adding Maraviroc and/or Metformin for Hepatic Steatosis in HIV-1-infected Adults on Combination Antiretroviral Therapy.|Not yet recruiting||Phase 2/Phase 3|88|Anticipated|Medical Research Council||4|||f||||t|f|f||||||No||2017-10-10 21:08:01.172687|2017-10-10 21:08:01.172687
NCT03129100|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-10-02|||April 19, 2017|Actual|2017-04-19|October 2017|2017-10-01|March 1, 2021|Anticipated|2021-03-01|January 23, 2020|Anticipated|2020-01-23||Interventional|||A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis|A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis|Recruiting||Phase 3|750|Anticipated|Eli Lilly and Company||3|||f||||f|t|f||||||||2017-10-10 21:08:01.314674|2017-10-10 21:08:01.314674
NCT03129087|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-08-22|||May 23, 2017|Actual|2017-05-23|April 2017|2017-04-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia|The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia|Enrolling by invitation||N/A|20|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:08:02.229057|2017-10-10 21:08:02.229057
NCT03129074|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-25|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|||Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer|A Phase 2, Single Arm Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as First-line Systemic Therapy|Not yet recruiting||Phase 2|40|Anticipated|Aslan Pharmaceuticals||1|||f||||f|f|f||||||No||2017-10-10 21:08:02.31037|2017-10-10 21:08:02.31037
NCT03129061|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-08|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)|A Pilot Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 1|24|Anticipated|CellSight Technologies, Inc.||2|||f||||f|t|f||||||No||2017-10-10 21:08:02.408479|2017-10-10 21:08:02.408479
NCT03129048|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-24|||September 1, 2016||2016-09-01|April 2017|2017-04-01|March 1, 2021|Anticipated|2021-03-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults|Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults|Recruiting||N/A|180|Anticipated|University of Illinois at Chicago||3|||f||||t|f|f||||||Undecided||2017-10-10 21:08:02.499536|2017-10-10 21:08:02.499536
NCT03129035|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-25|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Bilateral Internal Iliac Artery Ligation Before Cesarean Hysterectomy|Bilateral Internal Iliac Artery Ligation Before Cesarean Hysterectomy : A Randomized Controlled Trial|Not yet recruiting||N/A|100|Anticipated|Cairo University||2|||f||||t|f|f||||||Yes||2017-10-10 21:08:02.598515|2017-10-10 21:08:02.598515
NCT03129022|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-31|||April 30, 2017|Actual|2017-04-30|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Failed Epidural Anesthesia During Labor: Evaluation of Risk Factors and Outcome|Failed Epidural Anesthesia During Labor: Evaluation of Risk Factors and Impact on Labor ,Maternal and Fetal Outcomes|Recruiting||N/A|500|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 21:08:02.686947|2017-10-10 21:08:02.686947
NCT03129009|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-20|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Hemodynamics and Vital Organ Function in Intracerebral Hemorrhage|Changes of Hemodynamics and Vital Organ Function in Intracerebral Hemorrhage During Different General Anesthesia|Recruiting||N/A|90|Anticipated|Xuzhou Medical University||2|||f||||t|f|f||||||No|IPD will be available when this trial is finished and the article have been published|2017-10-10 21:08:02.809676|2017-10-10 21:08:02.809676
NCT03128996|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-01|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|April 2024|Anticipated|2024-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders|A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders|Recruiting||Phase 1/Phase 2|29|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||No||2017-10-10 21:08:02.99601|2017-10-10 21:08:02.99601
NCT03128983|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-21|||February 1, 2015|Actual|2015-02-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|PDMC||Physiological Data in the Menstrual Cycle|Variations of Physiological Data Throughout the Menstrual Cycle|Completed||N/A|39|Actual|Ava AG|||1||f||||f|f|f||||||No||2017-10-10 21:08:03.105464|2017-10-10 21:08:03.105464
NCT03128970|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-04-21|||April 21, 2017|Actual|2017-04-21|April 2017|2017-04-01|May 10, 2018|Anticipated|2018-05-10|January 15, 2018|Anticipated|2018-01-15||Interventional|||Synchronizing Blastocyst in Frozen Embryo Transfer|Synchronizing Blastocyst at Hatching or Hatched Stage in Frozen Embryo Transfer Cycles|Recruiting||N/A|742|Anticipated|Al-Yasmeen Fertility and Gynecology Center||2|||f||||t|f|f||||||Yes||2017-10-10 21:08:03.161457|2017-10-10 21:08:03.161457
NCT03128957|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-06|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|May 21, 2019|Anticipated|2019-05-21|May 21, 2019|Anticipated|2019-05-21||Interventional|||Correlating Brain Tissue Oxygen and Regional Cerebral Oximetry|Correlating Brain Tissue Oxygen Tension (PbrO2) and Regional Cerebral Oximetry (rSO2) in Normal Human Brain Under the Conditions of Changing Ventilation Strategy|Recruiting||N/A|15|Anticipated|University of Michigan||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:08:03.230913|2017-10-10 21:08:03.230913
NCT03128931|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|||December 23, 2016||2016-12-23||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:03.360287|2017-10-10 21:08:03.360287
NCT03128918|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-04-21|||July 2015||2015-07-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients|Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients: a Prospective, Longitudinal Study Employing Serum Cytokeratin 18 and Transient Elastography (Fibroscan)|Recruiting||N/A|40|Anticipated|McGill University Health Center|||1||f||||f||||||||||2017-10-10 21:08:03.400745|2017-10-10 21:08:03.400745
NCT03128879|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-24|||June 16, 2017|Actual|2017-06-16|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Study of Venetoclax (ABT-199) Added to Ibrutinib in Patients With High-Risk Chronic Lymphocytic Leukemia (CLL)|A Phase II Study of Venetoclax (ABT-199) Added to Ibrutinib in Patients With High-Risk Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 2|2|Actual|M.D. Anderson Cancer Center||1|||||||f|t|f||||||||2017-10-10 21:08:03.659733|2017-10-10 21:08:03.659733
NCT03128866|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-05-19|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Reducing Blood Loss in Hemipelvectomy Surgery With the Use Tranexamic Acid (TXA)|Reducing Blood Loss in Hemipelvectomy Surgery With the Use Tranexamic Acid (TXA)|Recruiting||Early Phase 1|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:08:03.866607|2017-10-10 21:08:03.866607
NCT03128853|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-09|||October 31, 2016||2016-10-31||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:03.980058|2017-10-10 21:08:03.980058
NCT03128840|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-09|||October 2011||2011-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:04.036137|2017-10-10 21:08:04.036137
NCT03127852|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-04-20|||August 23, 2016|Actual|2016-08-23|August 2016|2016-08-01|August 23, 2017|Anticipated|2017-08-23|August 23, 2017|Anticipated|2017-08-23||Interventional|||Effects of Remote Patient Monitoring on Chronic Disease Management|Randomized Controlled Trial of a Mobile Phone-based Telemonitoring Application for Self-management and Clinical Decision Support for Patients With Complex Chronic Conditions|Recruiting||N/A|146|Anticipated|University Health Network, Toronto||2|||f||||||||||||No||2017-10-10 21:08:04.093418|2017-10-10 21:08:04.093418
NCT03127839|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-20|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|December 30, 2019|Anticipated|2019-12-30|April 1, 2019|Anticipated|2019-04-01||Interventional|SAPS||Type of Exercise and Education in Patients With SubAcromial Pain Syndrome|The Effectiveness of Exercise and Education Type in Patients With SubAcromial Pain Syndrome (SAPS): A Randomized Controlled Trial|Recruiting||N/A|240|Anticipated|Brooke Army Medical Center||4|||f||||f|f|f||||||Yes|Requests for data must go through a Data Sharing Agreement Application submitted and approved through the Defense Health Agency|2017-10-10 21:08:04.207657|2017-10-10 21:08:04.207657
NCT03127826|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Validation of the STarT Back Screening Tool in the Military|Validation of the STarT Back Screening Tool in the Primary Care Management of Low Back Pain in the Military Health System: A Randomized Trial of Risk-stratified vs. Usual Care|Recruiting||N/A|290|Anticipated|Brooke Army Medical Center||2|||f||||f|f|f||||||Yes|Data sharing must go through a Data Sharing Agreement via the Defense Health Agency|2017-10-10 21:08:04.31503|2017-10-10 21:08:04.31503
NCT03127813|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-20|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|PAIR||PAIR Study-PAP And IOP Relationship: Study 1|The PAIR Study. Positive Airway Pressure and Intraocular Relationship: IOP Response to a Short-term Application of CPAP|Recruiting||N/A|90|Anticipated|Papworth Hospital NHS Foundation Trust||3|||f||||f|f|f||||||No||2017-10-10 21:08:04.433068|2017-10-10 21:08:04.433068
NCT03127800|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-20|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|MIMOSA||Morphine in Moderate Obstructive Sleep Apnoea|The Effect of Acute Intravenous Morphine Administration on Sleep Disordered Breathing (SDB) in Patients With Moderate Obstructive Sleep Apnoea (OSA): A Paired Design Trial|Recruiting||Phase 3|26|Anticipated|Papworth Hospital NHS Foundation Trust||1|||f||||t||||||||No|There is no plan to make individual participant data available|2017-10-10 21:08:04.56385|2017-10-10 21:08:04.56385
NCT03127787|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-20|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||Clinical Performance Evaluation of DxN CMV Assay|Clinical Performance Evaluation of DxN CMV Assay|Recruiting||N/A|50|Anticipated|Beckman Coulter, Inc.|||1||f||||f|||||t|||No||2017-10-10 21:08:04.689594|2017-10-10 21:08:04.689594
NCT03127774|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-08-10|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|May 2023|Anticipated|2023-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma|Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma|Recruiting||Phase 2|30|Anticipated|Columbia University||1|||f||||t|t|f|||f|||||2017-10-10 21:08:04.796876|2017-10-10 21:08:04.796876
NCT03127761|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-11|||July 25, 2017|Actual|2017-07-25|September 2017|2017-09-01|April 2028|Anticipated|2028-04-01|May 2027|Anticipated|2027-05-01||Observational|||Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma|Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma: A Study to Develop Evidence of Effectiveness for the Centers for Medicare and Medicaid Services (CMS)|Recruiting||N/A|544|Anticipated|Center for International Blood and Marrow Transplant Research|||2||f||||f|f|f||||||||2017-10-10 21:08:04.928723|2017-10-10 21:08:04.928723
NCT03127748|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2017-04-20|||July 1, 2015|Actual|2015-07-01|April 2017|2017-04-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Cardiac Function After Transcatheter VSD Closure|Changes in Ventricular Remodeling and Exercise Cardiopulmonary Function After Transcatheter Closure of Ventricular Septal Defect|Recruiting||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 21:08:05.049074|2017-10-10 21:08:05.049074
NCT03128827|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-09|||August 4, 2011||2011-08-04||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:05.157885|2017-10-10 21:08:05.157885
NCT03128814|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-20|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|January 31, 2022|Anticipated|2022-01-31|December 15, 2020|Anticipated|2020-12-15||Observational|AsymTen||The Degree, Development and Interrelationship of Structural and Functional Asymmetry in (Pre)Adolescent Elite Tennis Players|The Degree, Development and Interrelationship of Structural and Functional Asymmetry in (Pre)Adolescent Elite Tennis Players: A Prospective Cohort Study With a Link to Growth and Maturation, Technical Skill Performance and Whole Body Injury|Not yet recruiting||N/A|240|Anticipated|Vrije Universiteit Brussel|||2||f||||f|f|f||||||No|Individual Participant Data (IPD) will not be shared or will not be available to other researchers|2017-10-10 21:08:05.197705|2017-10-10 21:08:05.197705
NCT03128801|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-24|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Self-Stretching Posture and Segmental Stabilization in Patients With Chronic Low Back Pain|Effects of Self-Stretching Posture and Segmental Stabilization on Pain and Disability in Patients With Chronic Low Back Pain: Randomized Controlled Trial and Blinded|Recruiting||N/A|86|Anticipated|University of Sao Paulo||2|||f||||t||||||||Yes|The results will be available in manuscripts published in peer reviewed journals.|2017-10-10 21:08:05.285036|2017-10-10 21:08:05.285036
NCT03128788|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-24|||March 2, 2017|Actual|2017-03-02|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparison of Thoracic Epidural Pressure in the Prone and Lateral Decubitus Position|Comparison of Extent of Epidurography and Thoracic Epidural Pressure in the Prone and Lateral Decubitus Position|Recruiting||N/A|30|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:08:05.385139|2017-10-10 21:08:05.385139
NCT03128775|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-06-20|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|PAAPASNudge||Nudging Students Towards Healthy Diet and Physical Activity to Prevent Obesity|School Randomized Factorial Trial for Nudging Students Towards Healthy Diet and Physical Activity to Prevent Obesity: a Study Protocol|Not yet recruiting||N/A|1300|Anticipated|Rio de Janeiro State University||4|||f|||||f|f||||||No||2017-10-10 21:08:05.471205|2017-10-10 21:08:05.471205
NCT03128762|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-27|||June 25, 2014|Actual|2014-06-25|April 2017|2017-04-01|June 23, 2015|Actual|2015-06-23|April 14, 2015|Actual|2015-04-14||Observational|ILC2-Asthma||Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study|Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study|Completed||N/A|36|Actual|University Hospital, Montpellier|||2||f||||f|f|f||||||||2017-10-10 21:08:05.564458|2017-10-10 21:08:05.564458
NCT03128749|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-24|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Mindfulness-Based Cognitive Therapy: Efficacy and fMRI-based Response Predictors in a Group of OCD Patients|Mindfulness-Based Cognitive Therapy: Efficacy and fMRI-based Response Predictors in a Group of OCD Patients Non-responders to CBT|Not yet recruiting||N/A|60|Anticipated|Corporacion Parc Tauli||2|||f||||t|f|f||||||No||2017-10-10 21:08:05.65409|2017-10-10 21:08:05.65409
NCT03128736|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||April 1, 2014|Actual|2014-04-01|April 2017|2017-04-01|March 30, 2016|Actual|2016-03-30|February 28, 2016|Actual|2016-02-28||Interventional|||Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B|A Pilot Study Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole 60 mg and Esomeprazole 40 mg for Gastroesophageal Reflux Disease Grade A and B|Completed||Phase 4|175|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f|||||f|f||||||No||2017-10-10 21:08:05.795603|2017-10-10 21:08:05.795603
NCT03128723|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-17|||April 30, 2017|Actual|2017-04-30|July 2017|2017-07-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|||A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris|A Single Center Clinical Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris|Completed||N/A|45|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:08:05.886732|2017-10-10 21:08:05.886732
NCT03128710|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Prostate Cancer Survey|Identifying Patient-relevant Adverse Events Following Prostate Radiotherapy|Recruiting||N/A|375|Anticipated|University of Maryland|||2||f||||t|f|f||||||No||2017-10-10 21:08:05.979263|2017-10-10 21:08:05.979263
NCT03128697|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-25|||October 1, 2004|Actual|2004-10-01|April 2017|2017-04-01|September 30, 2008|Actual|2008-09-30|September 30, 2008|Actual|2008-09-30||Interventional|||Impact of a Satiating Diet in Obese Men With a Low Satiety Phenotype|Clinical Evaluation to Improve Obesity Intervention Prescription: Functional Foods as a Potential Solution for Individuals With a Low Satiety Quotient Phenotype?|Completed||N/A|70|Actual|Laval University||4|||f||||f|f|f||||||No||2017-10-10 21:08:06.064737|2017-10-10 21:08:06.064737
NCT03128684|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||The Effects of Lentil-containing Food Products on Satiety and Food Intake|The Effects of Lentil-containing Food Products on Satiety and Food Intake in Healthy Adults|Not yet recruiting||N/A|24|Anticipated|University of Guelph||9|||f||||f|f|f||||||No||2017-10-10 21:08:06.196983|2017-10-10 21:08:06.196983
NCT03128671|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-30|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|FAVoR||Family Automated Voice Reorientation Study|Reorientation Intervention for Delirium in ICU|Recruiting||N/A|178|Anticipated|University of South Florida||2|||f||||t|f|f||||||Undecided||2017-10-10 21:08:06.300436|2017-10-10 21:08:06.300436
NCT03128658|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-06-07|||February 27, 2017|Actual|2017-02-27|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|TrICI||Trauma Induced Coagulopathy and Inflammation|Trauma Induced Coagulopathy and Inflammation|Recruiting||N/A|300|Anticipated|University of Pennsylvania|||1||f||||f|f|f||||Samples With DNA|"     During the initial trauma evaluation, 15 ml of blood will be collected for research purposes     during the routine blood trauma blood draw. Additional 15 ml samples will be collected at 3     hours, 6 hours, 12 hours, 24 hours, 48 hours and 5 days post admission.      Blood samples will be analyzed for coagulation parameters using thromboelastography.   "|No||2017-10-10 21:08:06.391049|2017-10-10 21:08:06.391049
NCT03128645|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-28|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|September 15, 2017|Anticipated|2017-09-15|September 1, 2017|Anticipated|2017-09-01||Observational|||The Effect of the Abdominal Corset on Colonoscopy|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital|Recruiting||N/A|80|Anticipated|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital|||2||f|||||f|f||||||||2017-10-10 21:08:06.479947|2017-10-10 21:08:06.479947
NCT03128632|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||November 2007||2007-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:06.549314|2017-10-10 21:08:06.549314
NCT03072173|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-06|||March 1, 2017|Actual|2017-03-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Role of the Nose in Snoring and Sleep Apnea|The Role of the Nose in Snoring and Sleep Apnea|Recruiting||N/A|30|Anticipated|Lovisenberg Diakonale Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:17:20.887311|2017-10-10 21:17:20.887311
NCT03128619|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-17|||August 2, 2017|Actual|2017-08-02|April 2017|2017-04-01|August 2, 2021|Anticipated|2021-08-02|August 2, 2020|Anticipated|2020-08-02||Interventional|||Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer|A Phase Ib Trial Evaluating the Safety of Copanlisib, Letrozole, and Palbociclib in Metastatic Breast Cancer and Phase II Trial Comparing the Molecular Effects of Neoadjuvant Copanlisib in Combination With Palbociclib and Letrozole, vs. Copanlisib With Letrozole, vs. Palbociclib With Letrozole for Patients With Hormone Receptor Positive, HER2 Normal Breast Cancer|Recruiting||Phase 1/Phase 2|102|Anticipated|Jonsson Comprehensive Cancer Center||4|||f||||t|t|f||||||||2017-10-10 21:08:06.590567|2017-10-10 21:08:06.590567
NCT03128606|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-08-22|||March 28, 2017|Actual|2017-03-28|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects|Assessment of Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of GLPG3067 and the Combination of GLPG3067 and GLPG2222 in Healthy Female Subjects, Including a Relative Bioavailability and Food Effect Part for Single Dose of GLPG3067|Recruiting||Phase 1|81|Anticipated|Galapagos NV||9|||f||||f|f|f|||f|||||2017-10-10 21:08:06.725596|2017-10-10 21:08:06.725596
NCT03128580|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-15|||April 21, 2017|Actual|2017-04-21|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Observational|AMOS||Embryo Aneuploidies and Morphokinetics in Ovarian Stimulated and Non Stimulated IVF Cycles|Embryo Aneuploidies and Morphokinetics in Ovarian Stimulated and Non Stimulated Cycles. An Intrapatient Comparison Using Next Generation Sequencing in Biopsy of Blastocysts and Time Lapse Evaluation.|Recruiting||N/A|80|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA|||2||f||||f|f|f||||||No||2017-10-10 21:08:07.027589|2017-10-10 21:08:07.027589
NCT03128567|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-01|||June 2017|Anticipated|2017-06-01|November 2016|2016-11-01|March 2021|Anticipated|2021-03-01|January 2020|Anticipated|2020-01-01|12 Months|Observational [Patient Registry]|STTARTLATE||Deep Brain Stimulation for Patients With Parkinson's Disease.|Effets de la Stimulation cérébrale Profonde Chez Les Patients âgés Avec Maladie de Parkinson : Essai contrôlé randomisé Multicentrique|Not yet recruiting||N/A|50|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||||No||2017-10-10 21:08:07.117362|2017-10-10 21:08:07.117362
NCT03128554|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Interventional|||Smoking Reduction: Testing a Novel Approach to Cessation in Primary Care Practice Settings|Smoking Reduction: Testing a Novel Approach to Cessation in Primary Care Practice Settings: A Pilot Study|Not yet recruiting||N/A|50|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f|f|f||||||||2017-10-10 21:08:07.186649|2017-10-10 21:08:07.186649
NCT03128541|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-31|||April 14, 2017|Actual|2017-04-14|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|||Influence of Body Positioning on the Identification of Tuffier's Line Using the Palpation Method: An Ultrasound Study|Influence of Body Positioning on the Identification of Tuffier's Line Using the Traditional Palpation Method: An Ultrasound Study.|Recruiting||N/A|80|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||2||f||||f|f|f|||f|||||2017-10-10 21:08:07.279245|2017-10-10 21:08:07.279245
NCT03128515|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-06|||July 26, 2017|Actual|2017-07-26|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|July 2019|Anticipated|2019-07-01||Interventional|NOHARM-MTD||Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas|Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study|Recruiting||Phase 3|180|Anticipated|Indiana University||2|||f||||t|f|f||||||||2017-10-10 21:08:07.477399|2017-10-10 21:08:07.477399
NCT03128502|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-21|2017-06-14|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Observational|||Estimation of Pentrexin-3 Levels in GCF and Saliva of Patients With Periodontal Disease|Assessment of Pentraxin-3 Levels in Gingival Crevicular Fluid and Saliva in Periodontal Health and Disease|Completed||N/A|40|Actual|Cairo University|||4||f||||f|f|f||||Samples Without DNA|"     salivary and GCF samples   "|No||2017-10-10 21:08:07.617084|2017-10-10 21:08:07.617084
NCT03128489|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-26|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants|Immunogenicity and Safety of GSK Biologicals' DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) (SB213503) in Healthy Indian Infants|Not yet recruiting||Phase 3|112|Anticipated|GlaxoSmithKline||1|||f|||||f|f||||||||2017-10-10 21:08:07.695914|2017-10-10 21:08:07.695914
NCT03128476|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-20|||March 3, 2016|Actual|2016-03-03|February 2017|2017-02-01|January 30, 2017|Actual|2017-01-30|November 7, 2016|Actual|2016-11-07||Interventional|||Effects of Essence of Chicken on Physical Fatigue, Working Memory and Attention|Effects of the Supplementation of Essence of Chicken on Physical Fatigue and Brain Functions Such as Working Memory and Attention Among Healthy Adults|Completed||N/A|364|Actual|Sprim Advanced Life Sciences||3|||f||||t|f|f||||||||2017-10-10 21:08:07.807139|2017-10-10 21:08:07.807139
NCT03128463|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-20|||February 28, 2017|Actual|2017-02-28|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases|Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases|Recruiting||N/A|5000|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|||4||f||||t|f|f||||||No||2017-10-10 21:08:07.896803|2017-10-10 21:08:07.896803
NCT03128450|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-13|||April 15, 2017|Actual|2017-04-15|May 2017|2017-05-01|November 1, 2018|Anticipated|2018-11-01|June 1, 2018|Anticipated|2018-06-01||Interventional|hNSCPD||A Study To Evaluate the Safety and Efficacy of Human Neural Stem Cells for Parkinson's Disease Patient|A Single Arm, Open-Label，Pilot Study to Evaluate the Safety and Efficacy of Human Neural Stem Cells Injection (ANGE-S003) Through Nasal Way Delivery to Patients With Parkinson's Disease|Enrolling by invitation||Phase 2/Phase 3|12|Anticipated|Second Affiliated Hospital of Soochow University||1|||f||||t|f|f||||||||2017-10-10 21:08:08.018768|2017-10-10 21:08:08.018768
NCT03128437|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-22|||May 9, 2017|Actual|2017-05-09|May 2017|2017-05-01|August 10, 2018|Anticipated|2018-08-10|April 10, 2018|Anticipated|2018-04-10||Interventional|||Anxiety, Mood, and Health Behaviors in Young Adults|The Relationship Between Anxiety, Mood, and Health Behaviors in Young Adults|Recruiting||N/A|60|Anticipated|Virginia Commonwealth University||2|||f||||f|f|f||||||No||2017-10-10 21:08:08.119914|2017-10-10 21:08:08.119914
NCT03128424|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-29|||March 2016||2016-03-01|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Long Segment Lesion Peripheral Artery Revascularization Feasibility Study|Long Segment Lesion Peripheral Artery Revascularization Feasibility Study|Recruiting||N/A|65|Anticipated|PQ Bypass, Inc.||1|||f||||t|f|t|t|f|t|||||2017-10-10 21:08:08.228728|2017-10-10 21:08:08.228728
NCT03128411|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-28|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|November 30, 2020|Anticipated|2020-11-30|May 31, 2019|Anticipated|2019-05-31||Interventional|||Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia|A Phase 2, Open-label, Single-arm Study To Evaluate Efficacy And Safety Of Bosutinib Monotherapy In Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia|Recruiting||Phase 2|60|Anticipated|Pfizer||1|||f||||f|f|f||||||||2017-10-10 21:08:08.317705|2017-10-10 21:08:08.317705
NCT03128398|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-20|||October 2014||2014-10-01|April 2017|2017-04-01|December 2034|Anticipated|2034-12-01|December 2034|Anticipated|2034-12-01||Expanded Access|Domperidone||Use of Domperidone for Treatment of Upper Gastrointestinal Disorders|Use of Domperidone for Treatment of Upper Gastrointestinal Disorders|Temporarily not available||N/A|||Palo Alto Medical Foundation|||||||t||||||||||||2017-10-10 21:08:08.462491|2017-10-10 21:08:08.462491
NCT03128385|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-20|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evidence-Based Neurorehabilitation in Children With CP|Comparative Efficacy Research of Intensive and Distributed Constraint-Induced Therapy: Evidence-Based Neurorehabilitation in Children With CP|Not yet recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:08:08.524644|2017-10-10 21:08:08.524644
NCT03128372|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-20|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||Validation of Next Generation INVOS NIRS Cerebral and Tissue Oximeter|Validation of Next Generation INVOS NIRS Cerebral and Tissue Oximeter to Measure Cerebral and Somatic Tissue Oxygen Saturation in Healthy Volunteers|Completed||N/A|32|Actual|Medtronic - MITG||1|||f||||f|f|t|t|f|f|||||2017-10-10 21:08:08.630859|2017-10-10 21:08:08.630859
NCT03128359|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-14|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant|A Pilot Study of Post-transplant High Dose Cyclophosphamide (PTCY) as Part of Graft-Versus-Host Disease (GVHD) Prophylaxis in T-Cell Replete HLA-Mismatched Unrelated Donor (MMUD) Ablative and Reduced Intensity Hematopoietic Cell Transplantation (HCT) for Hematological Malignancies|Recruiting||Phase 2|38|Anticipated|City of Hope Medical Center||3|||f||||t|t|f||||||||2017-10-10 21:08:08.722907|2017-10-10 21:08:08.722907
NCT03128346|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-09-01|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Analgesic Effects of Transversus Thoracic Plane (TTP) Block in Cardiac Surgery|Analgesic Effects of Transversus Thoracic Plane (TTP) Block in Cardiac Surgery - Pilot Study|Not yet recruiting||N/A|100|Anticipated|Western University, Canada||2|||f||||f|f|f||||||||2017-10-10 21:08:08.977166|2017-10-10 21:08:08.977166
NCT03128333|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||April 21, 2017|Actual|2017-04-21|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||The SMART-COACH Trial|Effectiveness of Self-monitoring Physical Activity With a Smartphone Application and Physiotherapy Coaching in Cancer Patients: a Randomized Controlled Trial (SMART-COACH Trial)|Recruiting||N/A|62|Anticipated|University Medical Center Groningen||2|||f||||f|f|f||||||No||2017-10-10 21:08:09.093258|2017-10-10 21:08:09.093258
NCT03128294|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Long Term Survivors in Ovarian Cancer|Long Term Survivors in Ovarian Cancer|Recruiting||N/A|80|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 21:08:09.353675|2017-10-10 21:08:09.353675
NCT03128281|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-08-10|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Pneumoperitoneum Management With Low vs. Higher Pressure|A Single Center, Prospective, Randomized, Controlled Study to Evaluate Shoulder Pain, Cardiovascular Changes, Pulmonary Pressures and Perioperative Outcomes Related to the Use of the AirSeal® Insufflation System (AIS) at Low and Higher Pressure Pneumoperitoneum vs. Conventional Insufflation|Not yet recruiting||Phase 2|240|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|f|t|f||f|||||2017-10-10 21:08:09.441768|2017-10-10 21:08:09.441768
NCT03128268|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works|THE EFFECTIVENESS OF 4D IMAGE ACQUISITION AND POST-PROCESSING WITH VIOS WORKS: A Phase Design Prospective Clinical Trial to Assess 4D Software Produced by GE and Arterys for Evaluating Cardiac Disease.|Not yet recruiting||N/A|150|Anticipated|Northwell Health||1|||f||||f|f|t|t||f|||||2017-10-10 21:08:09.553182|2017-10-10 21:08:09.553182
NCT03128255|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-03|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Observational|FUSION iENA||Fusion UltraSound Imaging Of the Thyroid GlaNd With I-124 PET. Evaluation of Nodule Allocation.|I-124 PET/US for Benign Thyroid Diseases - Blinded, Multicentric Assessment of Augmented Thyroid Work-up Versus Regular Thyroid Diagnostics|Recruiting||N/A|70|Anticipated|Jena University Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:08:09.645223|2017-10-10 21:08:09.645223
NCT03128242|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-20|||November 25, 2016|Actual|2016-11-25|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Oxytocin's Effect on Attention Training|An Eye-tracking Study to Investigate Oxytocin's Effect on Attentional Bias Training|Recruiting||N/A|60|Anticipated|University of Electronic Science and Technology of China||2|||f|||||f|f||||||||2017-10-10 21:08:09.73409|2017-10-10 21:08:09.73409
NCT03128229|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-20|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|DKA||Diabetic Kidney Alarm (DKA) Study|Diabetic Kidney Alarm (DKA) Study - Tubulopathy in New Onset Diabetic Ketoacidosis|Not yet recruiting||N/A|40|Anticipated|University of Colorado Denver School of Medicine Barbara Davis Center|||1||f||||t|f|f||||Samples Without DNA|"     Serum and urine collection at 0-8h and 12-24h after starting IV insulin, and at 3 month     follow-up.   "|No||2017-10-10 21:08:09.823767|2017-10-10 21:08:09.823767
NCT03128216|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-24|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Local Anesthetic Infiltration VS Trasversalis Fascia Block VS Spinal Anesthesia|Comparison of Local Anesthetic Infiltration, Trasversalis Fascia Block or Spinal Anesthesia for Inguinal Hernia Repair|Not yet recruiting||N/A|48|Anticipated|Istituti Ospitalieri di Cremona||3|||f||||f|f|f||||||No||2017-10-10 21:08:09.905158|2017-10-10 21:08:09.905158
NCT03128203|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Effects of Intranasal Oxytocin on Striatal Functional Connectivity|Effects of Intranasal Oxytocin on Striatal Functional Connectivity in Healthy Males|Completed||N/A|135|Actual|University of Electronic Science and Technology of China||2|||f||||||||||||||2017-10-10 21:08:09.989877|2017-10-10 21:08:09.989877
NCT03128190|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-20|||June 1, 2007|Actual|2007-06-01|April 2017|2017-04-01|June 30, 2010|Actual|2010-06-30|June 1, 2010|Actual|2010-06-01||Interventional|GDTPPV||Multi-center Trial of Goal-directed Fluid Management Based on Pulse Pressure Variation Monitoring|A Pragmatic Multi-center Trial of Goal-directed Fluid Management Based on Pulse Pressure Variation Monitoring During High-risk Surgery|Completed||N/A|256|Actual|Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo||2|||f||||t|f|f||||||Undecided||2017-10-10 21:08:10.071274|2017-10-10 21:08:10.071274
NCT03128177|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-25|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Nocturnal Hypertension and Non-Dipping Blood Pressure|Mechanisms of Nocturnal Hypertension and Non-Dipping Blood Pressure Patterns|Enrolling by invitation||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||No||2017-10-10 21:08:10.155915|2017-10-10 21:08:10.155915
NCT03128164|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-24|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||A Study of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or no Standard of Care Existed|A Phase 1 Open-Label Study to Assess the Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or No Standard of Care Existed|Not yet recruiting||Phase 1|83|Anticipated|Hutchison Medipharma Limited||1|||f||||f|f|f||||||||2017-10-10 21:08:10.21877|2017-10-10 21:08:10.21877
NCT03128151|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-25|||June 20, 2017|Anticipated|2017-06-20|April 2017|2017-04-01|June 20, 2018|Anticipated|2018-06-20|June 20, 2017|Anticipated|2017-06-20||Observational|PORCzero||Reducing the Incidence of PostOperative Residual Curarization|PORCzero: PostOperative Residual Curarization|Not yet recruiting||N/A|3000|Anticipated|Hospital Universitario La Fe|||2||f||||f|f|f||||||Undecided||2017-10-10 21:08:10.294965|2017-10-10 21:08:10.294965
NCT03128138|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-07-16|||December 2016||2016-12-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Describe Pharmacokinetics/Pharmacodynamics, and the Safety and of SPH3127 Tablet in Chinese Healthy Volunteers|Recruiting||Phase 1|48|Anticipated|Shanghai Pharmaceuticals Holding Co., Ltd||6|||f||||f|f|f||||||||2017-10-10 21:08:10.363092|2017-10-10 21:08:10.363092
NCT03128125|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-03|||April 6, 2017|Actual|2017-04-06|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|MOHPI||Study of Gesture and Executive Functions in Children With High Intellectual Potential|Study of Gesture and Executive Functions in Children With High Intellectual Potential|Recruiting||N/A|60|Anticipated|University Hospital, Brest||2|||f|||||f|f||||||||2017-10-10 21:08:10.561337|2017-10-10 21:08:10.561337
NCT03128112|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-14|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Healthy Weight Poster, Multi-site Study|Using a Poster Depicting Healthy Weight to Improve Perception of Weight, a Multi-site Study|Recruiting||N/A|1000|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-10 21:08:10.715078|2017-10-10 21:08:10.715078
NCT03128099|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-20|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|VR-SS||Virtual Reality Training for Social Skills in Schizophrenia|Physiology-based Virtual Reality Training for Social Skills in Schizophrenia|Recruiting||N/A|40|Anticipated|Vanderbilt University||2|||f||||t|f|f||||||No||2017-10-10 21:08:10.852456|2017-10-10 21:08:10.852456
NCT03128086|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-19|||September 2016||2016-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Weaning From Mechanical Ventilation in Neurological Patients|Protocol-directed Weaning From Mechanical Ventilation in Neurological Patients: a Controlled Trial|Recruiting||N/A|218|Anticipated|Hospital General Universitario de Castellón||2|||f||||f||||||||No||2017-10-10 21:08:10.956908|2017-10-10 21:08:10.956908
NCT03128073|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-27|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to the Intraperitoneal Fluid in the Device, in Order to Maintain a Stable Intraperitoneal Osmolarity and Thereby Enhance Ultrafiltration.|A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to the Intraperitoneal Fluid in the Device, in Order to Maintain a Stable Intraperitoneal Osmolarity and Thereby Enhance Ultrafiltration.|Recruiting||N/A|4|Anticipated|Triomed AB||1|||f||||f|f|f||||||No||2017-10-10 21:08:11.045893|2017-10-10 21:08:11.045893
NCT03128060|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-20|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Expanding Access to Home-Based Palliative Care|Expanding Access to Home-Based Palliative Care Through Primary Care Medical Groups|Not yet recruiting||N/A|1185|Anticipated|University of Southern California||2|||f||||t|f|f||||||No||2017-10-10 21:08:11.151176|2017-10-10 21:08:11.151176
NCT03128047|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-04-20|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||HUMC 1612: Optune NovoTTF-200A System|HUMC 1612: A Phase I Trial of the Optune NovoTTF-200A System With and Without Concomitant Temozolomide and Bevacizumab in Pediatric Patients With High-grade Glioma|Recruiting||Phase 1|12|Anticipated|Hackensack University Medical Center||2|||f||||t|f|t|f||f|||No||2017-10-10 21:08:11.258487|2017-10-10 21:08:11.258487
NCT03128034|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 19, 2026|Anticipated|2026-04-19|July 19, 2021|Anticipated|2021-07-19||Interventional|||211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome|A Study Evaluating Escalating Doses of 211^At-labeled Anti-CD45 MAb BC8-B10 (211^At-BC8-B10) Followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), or Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1/Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f|t|f||||||||2017-10-10 21:08:11.39533|2017-10-10 21:08:11.39533
NCT03128021|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-23|||May 24, 2017|Actual|2017-05-24|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|April 2022|Anticipated|2022-04-01||Interventional|NEMO||Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)|Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)|Recruiting||Phase 4|140|Anticipated|University of Pittsburgh||3|||f||||t|t|f|||f|||||2017-10-10 21:08:11.593274|2017-10-10 21:08:11.593274
NCT03127995|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-04-26|||September 2016||2016-09-01|April 2017|2017-04-01|September 2029|Anticipated|2029-09-01|September 2021|Anticipated|2021-09-01||Interventional|HYPOG-01||Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence|Multicenter Randomized Phase III Trial Comparing Hypofractionated Versus Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation in Terms of Lymphedema Occurrence|Recruiting||N/A|1012|Anticipated|UNICANCER||2|||f||||t|f|f||||||Undecided||2017-10-10 21:08:11.884937|2017-10-10 21:08:11.884937
NCT03127982|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-24|||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|September 1, 2017|Anticipated|2017-09-01||Interventional|||Unified Protocol for Emotional Problems in Victims of the Armed Conflict in Colombia|Effects of the Adaptation of the Unified Protocol for Emotional Problems in Victims of the Armed Conflict in Colombia: A Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|University of Los Andes, Columbia||2|||f||||t|f|f||||||No||2017-10-10 21:08:12.167242|2017-10-10 21:08:12.167242
NCT03127969|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-20|||February 16, 2012|Actual|2012-02-16|April 2017|2017-04-01|June 18, 2013|Actual|2013-06-18|June 18, 2013|Actual|2013-06-18||Interventional|||Is Fluidotherapy Effective in Rheumatoid Hand?|Is Fluidotherapy Effective in Rheumatoid Hand? A Randomized Controlled Trial|Completed||N/A|93|Actual|Dokuz Eylul University||2|||f||||f||f||||||No||2017-10-10 21:08:12.279993|2017-10-10 21:08:12.279993
NCT03127943|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-13|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Buffered 1% vs. Non-Buffered 1% Lidocaine Used in Mandibular Nerve Block|Pilot Study: Comparison of Buffered 1% vs. Non-Buffered 1% Lidocaine Used in Dental and Oral Surgical Procedures: Clinical Outcomes Mandible|Active, not recruiting||Phase 4|24|Actual|University of North Carolina, Chapel Hill||2|||f||||f|t|f|||f|||||2017-10-10 21:08:12.69256|2017-10-10 21:08:12.69256
NCT03127930|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-01|||June 1, 2010|Actual|2010-06-01|May 2017|2017-05-01|July 30, 2013|Actual|2013-07-30|July 30, 2013|Actual|2013-07-30||Interventional|||Improving Caregiver Mediated Medication Management- The 3M Study|Improving Caregiver Mediated Medication Management|Completed||N/A|183|Actual|University of Pittsburgh||2|||f||||t|f|f||||||No||2017-10-10 21:08:12.788594|2017-10-10 21:08:12.788594
NCT03127917|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-24|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of L-Citrulline on Vascular Function|Impact of Reduced Arterial Stiffness on Peripheral Vascular Function and Mobility|Active, not recruiting||N/A|25|Actual|Texas Tech University||2|||f||||f|f|f||||||Yes|"Raw data for outcome variables will be made available on the online general repository figshare within 12 months of funding end date."|2017-10-10 21:08:12.869586|2017-10-10 21:08:12.869586
NCT03127904|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-25|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|September 30, 2019|Anticipated|2019-09-30|March 31, 2019|Anticipated|2019-03-31||Interventional|||Vein Fitness System vs Compressive Therapy for Venous Ulcers: a Bayesian Adaptive Trial|Pragmatic, Bayesian Adaptive Trial Comparing the Venfit System Against Standard Compressive Therapy in the Treatment of Venous Ulcers|Not yet recruiting||N/A|120|Anticipated|Pró Circulação®||2|||f||||f|f|f||||||No||2017-10-10 21:08:12.950178|2017-10-10 21:08:12.950178
NCT03127722|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-09-29|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|May 29, 2023|Anticipated|2023-05-29|May 29, 2023|Anticipated|2023-05-29||Interventional|||Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization|An Open-label, Non-randomized, Prospective Observational Cohort Study to Assess Post Procedural Outcomes in Two Cohorts of Women Who Chose to Undergo Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization|Recruiting||N/A|2800|Anticipated|Bayer||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:08:13.161642|2017-10-10 21:08:13.161642
NCT03127709|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-07-25|||April 7, 2017|Actual|2017-04-07|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis|A Clinical, Structural, and Functional Neuroimaging Study of Cognition in Adults With Erdheim-Chester Disease, Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Other Histiocytoses|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f|||||f|t|f|f||||||2017-10-10 21:08:13.289497|2017-10-10 21:08:13.289497
NCT03127696|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-27|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|September 30, 2018|Anticipated|2018-09-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM|A Randomised Placebo-controlled Study of Fecal Microbiota Transplant (FMT) to Impact Body Weight and Glycemic Control in Obese Subjects With Type 2 Diabetes Mellitus|Recruiting||N/A|60|Anticipated|Chinese University of Hong Kong||3|||f|||||f|f||||||No||2017-10-10 21:08:13.419119|2017-10-10 21:08:13.419119
NCT03127683|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-24|||May 31, 2017|Anticipated|2017-05-31|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||The Influence of Head and Neck Position on Performance of Ambu AuraGainTM in Children|The Influence of Head and Neck Position on Performance of Ambu AuraGainTM in Children|Not yet recruiting||N/A|40|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:08:13.575575|2017-10-10 21:08:13.575575
NCT03127670|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-20|||November 14, 2016|Actual|2016-11-14|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion|Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion|Recruiting||Phase 2|25|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||1|||f||||f|f|f||||||No||2017-10-10 21:08:13.662384|2017-10-10 21:08:13.662384
NCT03127657|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-20|||November 17, 2016|Actual|2016-11-17|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Effect of Cock's Comb Extract in the Treatment of Arsenical Skin Lesion|Effect of Cock's Comb Extract in the Treatment of Arsenical Skin Lesion|Recruiting||Phase 2|25|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||1|||f||||f|f|f||||||No||2017-10-10 21:08:13.745898|2017-10-10 21:08:13.745898
NCT03127644|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-22|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|February 14, 2018|Anticipated|2018-02-14|February 14, 2018|Anticipated|2018-02-14||Interventional|||ZS Ph2/3 Dose-response Study in Japan|A Phase 2/3 Multicenter, Dose-response Study to Assess Efficacy and Safety of ZS (Sodium Zirconium Cyclosilicate), in Japanese Patients With Hyperkalemia|Recruiting||Phase 2/Phase 3|102|Anticipated|AstraZeneca||3|||f||||f|f|f||||||||2017-10-10 21:08:13.831991|2017-10-10 21:08:13.831991
NCT03127631|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-04-20|||October 2015||2015-10-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|RADICALPC||A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients|The Role of Androgen Deprivation Therapy In Cardiovascular Disease - A Longitudinal Prostate Cancer Study (RADICAL PC1) & A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2)|Recruiting||N/A|6000|Anticipated|McMaster University||2|||f||||t||||||||No||2017-10-10 21:08:13.967955|2017-10-10 21:08:13.967955
NCT03127618|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-15||||||July 2017|2017-07-01||||||||Expanded Access|||Lorlatinib - PF-06463922||Available||N/A|||Pfizer|||||f|t|||||||||||||2017-10-10 21:08:14.117441|2017-10-10 21:08:14.117441
NCT03127605|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-24||||||April 2017|2017-04-01||||||||Expanded Access|||Inotuzumab Ozogamicin - PF-05208773||Available||N/A|||Pfizer|||||f|t|||||||||||||2017-10-10 21:08:14.167635|2017-10-10 21:08:14.167635
NCT03127592|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-11|||December 1, 2017|Anticipated|2017-12-01|April 2017|2017-04-01|December 18, 2018|Anticipated|2018-12-18|August 30, 2018|Anticipated|2018-08-30||Interventional|FDCETCB-III||Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction|Phase III Randomized, Unicentric, Double-masked, Parallel Trial for the Efficacy and Tolerability of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus the Isolated Active Substances (Flancox® 400 mg And Miosan® 10 mg) in Postoperative Pain Control After Impacted Third Molar Extraction|Not yet recruiting||Phase 3|465|Anticipated|Apsen Farmaceutica S.A.||3|||f||||t|f|f||||||No||2017-10-10 21:08:16.000902|2017-10-10 21:08:16.000902
NCT03127579|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-20|||November 2016||2016-11-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Family Meal Duration and Children's Eating Behavior||Recruiting||N/A|40|Anticipated|Max Planck Institute for Human Development||2|||f||||f||||||||||2017-10-10 21:08:16.077307|2017-10-10 21:08:16.077307
NCT03127566|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||August 28, 2015||2015-08-28||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:16.149327|2017-10-10 21:08:16.149327
NCT03127553|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-20|||December 2014|Actual|2014-12-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||ProAliFun_6.7_Health Effects of a Low-Salt Bread on Hypertensive Subjects (ProAliFun67)|Technological and Clinical Innovative Protocols for the Production of Functional Foods - 6.7 (ProAliFun67)|Completed||N/A|57|Actual|Azienda Ospedaliero-Universitaria Consorziale||3|||f||||t||||||||No||2017-10-10 21:08:16.187971|2017-10-10 21:08:16.187971
NCT03126734|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-25|||March 3, 2017|Actual|2017-03-03|April 2017|2017-04-01|April 20, 2017|Actual|2017-04-20|March 15, 2017|Actual|2017-03-15||Interventional|||Effects of Infant Massage on Acceptance, Commitment and Conscience of Influence of Parents With Down Syndrome Babies|Effects on Acceptance, Commitment and Awareness of Influence of Parents of Babies With Down Syndrome, After Participation in a Course of Infant Massage. Study on the Spanish Population.|Completed||N/A|32|Actual|University of Seville||2|||f||||f|f|f||||||No||2017-10-10 21:08:16.554975|2017-10-10 21:08:16.554975
NCT03126721|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-24|||April 18, 2017|Actual|2017-04-18|July 2017|2017-07-01|July 11, 2017|Actual|2017-07-11|July 11, 2017|Actual|2017-07-11||Interventional|||The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults|A Phase 1, Open-label, Fixed-sequence Design Study To Assess The Effect Of Multiple Dose Administration Of Pf-06751979 On The Single Dose Pharmacokinetics Of Oral Midazolam In Healthy Adult Subjects|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f|t|f|||t|||||2017-10-10 21:08:16.631883|2017-10-10 21:08:16.631883
NCT03126708|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-19|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Recurrent and/or Metastatic Esophageal Squamous Cell Carcinoma|A Phase II, Multicenter, Open-Label, Randomized, Controlled Study to Assess Efficacy and Safety of Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Chinese Subjects With Recurrent and/or Metastatic Esophageal Squamous Cell Carcinoma.|Recruiting||Phase 2|150|Anticipated|Peking University||2|||f|||||f|f|||f|||||2017-10-10 21:08:16.80167|2017-10-10 21:08:16.80167
NCT03126695|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-08-01|||May 12, 2017|Actual|2017-05-12|July 2017|2017-07-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|||A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered|An Open-label, Randomized, 4-period, 4-treatment, Cross-over, Single-center, Single-dose Study to Assess the Relative Bioavailability of Ticagrelor in Different Formulations in Healthy Adult Subjects|Completed||Phase 1|44|Actual|AstraZeneca||4|||f||||f|f|f||||||||2017-10-10 21:08:16.907952|2017-10-10 21:08:16.907952
NCT03126682|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-08-28|||August 25, 2017|Actual|2017-08-25|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Effect of Bupropion on Seizure Threshold in Depressed Patients|Effect of Bupropion on Seizure Threshold in Depressed Patients|Recruiting||Phase 4|10|Anticipated|Duke University||2|||f||||t|t|f|||t|||||2017-10-10 21:08:17.036957|2017-10-10 21:08:17.036957
NCT03126669|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||November 1, 2014|Actual|2014-11-01|April 2017|2017-04-01|March 25, 2017|Actual|2017-03-25|November 30, 2016|Actual|2016-11-30||Interventional|||Oxygen as a Limiting Factor for Performing Multitasking|Oxygen as a Limiting Factor for Performing Multitasking: Functional Evaluation Under Normobaric and Hyperbaric Oxygenation of Healthy Participants|Completed||N/A|24|Actual|Assaf-Harofeh Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:08:17.145951|2017-10-10 21:08:17.145951
NCT03127501|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||December 30, 2011||2011-12-30||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:17.229669|2017-10-10 21:08:17.229669
NCT03127488|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-24|||November 6, 2007||2007-11-06||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:17.272234|2017-10-10 21:08:17.272234
NCT03127475|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-20|||August 1, 2016|Actual|2016-08-01|April 2017|2017-04-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Neurophysiological Dissection and Intervention of Freezing of Gait in Parkinson's Disease|Neurophysiological Dissection and Intervention of Freezing of Gait in Parkinson's Disease|Recruiting||N/A|20|Anticipated|China Medical University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:08:17.316805|2017-10-10 21:08:17.316805
NCT03127462|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-20|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||A Nurse-led Individualized Educational Intervention|Efficiency of a Nurse-led Individualized Educational Intervention in Newly Referred Patients With Psoriasis. A Pragmatic Controlled Study.|Not yet recruiting||N/A|60|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||t|f|f||||||No||2017-10-10 21:08:17.417104|2017-10-10 21:08:17.417104
NCT03127449|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-24|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations|Multiple-Centered Study of AST2818 in Patients With Advanced Non-small Cell Lung Cancer With EGFR Mutations|Not yet recruiting||N/A|81|Anticipated|Allist Pharmaceuticals, Inc.||1|||f|||||f|f||||||||2017-10-10 21:08:17.514049|2017-10-10 21:08:17.514049
NCT03127436|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-08|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30|6 Months|Observational [Patient Registry]|||Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe|A Prospective, Open, Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe in Patients With HDM-induced Rhinoconjunctivitis With or Without Allergic Asthma|Recruiting||N/A|100|Anticipated|University Hospital of Cologne|||1||f||||f||||||||No||2017-10-10 21:08:17.612755|2017-10-10 21:08:17.612755
NCT03127423|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-06-23|||December 2016||2016-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison Between One-stop Hybrid Ablation and Thoracoscopic Surgical Ablation for Refactory Atrial Fibrillation|Comparison Between One-stop Hybrid Ablation and Thoracoscopic Surgical Ablation for Refactory Atrial Fibrillation|Recruiting||N/A|90|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||||||||||Undecided||2017-10-10 21:08:17.716294|2017-10-10 21:08:17.716294
NCT03127397|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-24|||April 24, 2017|Anticipated|2017-04-24|April 2017|2017-04-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||"Contribution of Praise Messages to HIV Treatment Retention and Adherence Among Female Sex Workers in Ethiopia"|"Contribution of Praise Messages to HIV Treatment Retention and Adherence Among Female Sex Workers in Ethiopia"|Not yet recruiting||N/A|810|Anticipated|Reed College||2|||f||||f|f|f||||||No||2017-10-10 21:08:17.885774|2017-10-10 21:08:17.885774
NCT03127384|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-07|||April 20, 2017|Actual|2017-04-20|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars|A Randomised, Evaluator-blind Comparative Study to Evaluate Performance and Safety of Restylane Lidocaine and No-treatment Control for Treatment of Depressed Facial Acne Scars|Recruiting||Phase 4|60|Anticipated|Q-Med AB||2|||f||||f|f|f||||||||2017-10-10 21:08:17.952745|2017-10-10 21:08:17.952745
NCT03127371|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-20|||September 2016||2016-09-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Adjunctive Nitrous Oxide During ED Incision and Drainage of Abscess|Adjunctive Nitrous Oxide to Lidocaine Anesthesia During ED Incision and Drainage of Abscess in Adults: A Randomized Controlled Trial|Recruiting||N/A|140|Anticipated|Albert Einstein Healthcare Network||2|||f||||t||||||||No||2017-10-10 21:08:18.046097|2017-10-10 21:08:18.046097
NCT03127358|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-20|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|March 1, 2019|Anticipated|2019-03-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs|Smartphone Based Automated-Directly Observed Treatment Improves Adherence and SVR to Fixed-Dose Elbasvir and Grazoprevir in PWIDs: A Randomized Control Trial|Not yet recruiting||N/A|75|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f|f|f||||||Yes|De-identified specimens and information will be kept for up to 50 years for future studies.|2017-10-10 21:08:18.156939|2017-10-10 21:08:18.156939
NCT03127345|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-20|||March 2018|Anticipated|2018-03-01|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|March 2021|Anticipated|2021-03-01||Interventional|||Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health|Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health|Not yet recruiting||Phase 2|30|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f||||||Undecided||2017-10-10 21:08:18.25079|2017-10-10 21:08:18.25079
NCT03127332|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-22|||December 15, 2017|Anticipated|2017-12-15|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Metastatic Breast Cancer Treatment Planning|Impact of Electronic Treatment Plans on Shared Decision Making for Metastatic Breast Cancer: An Educational/Research Initiative|Not yet recruiting||N/A|100|Anticipated|Carevive Systems, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:08:18.337277|2017-10-10 21:08:18.337277
NCT03127319|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-05-04|||May 2017|Anticipated|2017-05-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study of Apatinib Plus Docetaxel for Treatment of Advanced EGFR Wild Type Non-squamous Non-small Cell Lung Cancer With Bone Metastases|A Study of Apatinib Plus Docetaxel for Treatment of Advanced EGFR Wild Type Non-squamous Non-small Cell Lung Cancer With Bone Metastases|Not yet recruiting||Phase 2|40|Anticipated|Affiliated Hospital of Hebei University||2|||f|||||f|f||||||||2017-10-10 21:08:18.413454|2017-10-10 21:08:18.413454
NCT03127306|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-18|||June 12, 2017|Actual|2017-06-12|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Observational|POL-BPS||Validation of the Polish Version of BPS (POL-BPS).|Validation of the Polish Version of the Behavioral Pain Scale in a Postoperative Cardiac Surgery Unit.|Completed||N/A|59|Actual|Pomeranian Medical University Szczecin|||2||f||||f|f|f||||||||2017-10-10 21:08:18.480585|2017-10-10 21:08:18.480585
NCT03127293|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-04-24|||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|December 15, 2015|Actual|2015-12-15|December 15, 2015|Actual|2015-12-15||Observational|||Hyperemesis Gravidarum and Osteoporosis|Is Hyperemesis Gravidarum a Risk Factor for Osteoporosis ?|Completed||N/A|79|Actual|Adana Numune Training and Research Hospital|||2||f||||t|f|f|||f|Samples Without DNA|"     Serum and plasma of samples were than seperated and stored at -80 ºC until the assay. Serum     phosphorus (P) and calcium (Ca) were measured by Ion selective electrode (ISE) and alkaline     phosphatase (ALP) activity was measured by kinetic enzymatic method, with reagents of Beckman     Coulter, on an auto-analyser (Olympus AU5400, Beckman Coulter, Inc., U.S.A.). Serum intact     parathormone (iPTH) was analyzed by two-site immunoenzymatic method and 25-hidroxy D levels     were analyzed by competetive immunoenzymatic method on UniCel DxI 800 Immunoassay System     (Beckman Coulter, Inc., U.S.A.).   "|Yes|if needed.|2017-10-10 21:08:18.714292|2017-10-10 21:08:18.714292
NCT03127280|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-20|||November 4, 2014|Actual|2014-11-04|April 2017|2017-04-01|February 1, 2018|Anticipated|2018-02-01|January 1, 2018|Anticipated|2018-01-01||Interventional|CAUTI||Can Investigators Reduce Urinary Catheter Use and Lower Urinary Tract Infection Among Women Undergoing Benign Gynecologic Surgery?|Can Investigators Reduce Urinary Catheter Use and Lower Urinary Tract Infection Among Women Undergoing Benign Gynecologic Surgery?|Recruiting||N/A|200|Anticipated|The Christ Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:08:18.813459|2017-10-10 21:08:18.813459
NCT03127267|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-20|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Phase 3 Study to Compare the Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients|A Prospective, Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel Groups, Phase 3 Study to Compare the Efficacy and Safety of Masitinib in Combination With Riluzole Versus Placebo in Combination With Riluzole in the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)|Not yet recruiting||Phase 3|406|Anticipated|AB Science||2|||f||||t|t|f||||||Undecided||2017-10-10 21:08:18.928529|2017-10-10 21:08:18.928529
NCT03127254|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-18|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Can Making Video Narratives Benefit Adolescents With Cancer|Can Making Video Narratives Benefit Adolescents With Cancer|Not yet recruiting||N/A|100|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|f|f||||||||2017-10-10 21:08:19.009194|2017-10-10 21:08:19.009194
NCT03127241|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-19|||June 16, 2017|Actual|2017-06-16|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|USEFUL||User-centred Assistive System for Arm Functions in Neuromuscular Subjects|USEFUL: User-centred Assistive SystEm for Arm Functions in neUromuscuLar Subjects|Recruiting||N/A|38|Anticipated|Politecnico di Milano||2|||f|||||f|f||||||||2017-10-10 21:08:19.126232|2017-10-10 21:08:19.126232
NCT03127228|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-27|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis|Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis: A Randomized Controlled Clinical Trial|Recruiting||N/A|24|Anticipated|University of Michigan||2|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:08:19.258999|2017-10-10 21:08:19.258999
NCT03127215|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|NCT-PMO-1603||Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors|A Randomized Phase-2 Study of Trabectedin/Olaparib Compared to Physician's Choice in Subjects With Previously Treated Advanced or Recurrent Solid Tumors Harboring DNA Repair Deficiencies|Not yet recruiting||Phase 2|90|Anticipated|National Center for Tumor Diseases, Heidelberg||2|||f||||t|f|f||||||||2017-10-10 21:08:19.395887|2017-10-10 21:08:19.395887
NCT03127202|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-04-24|||November 2012||2012-11-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ORPHEE||Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulation|Evaluation of Left Ventricular Pacing Vectors Use in Phrenic Nerve Stimulation Management and Left Ventricular Parameters Adjustment|Completed||N/A|90|Actual|LivaNova||1|||f||||f||||||||Undecided||2017-10-10 21:08:19.498607|2017-10-10 21:08:19.498607
NCT03127176|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-08|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|MOB||Dysbiosis in Bipolar Disorder|Dysbiosis in Bipolar Disorder: MicrObiota Bipolar Study|Not yet recruiting||N/A|150|Anticipated|Hospital Clinic of Barcelona|||3||f||||||||||Samples With DNA|"     Stool sample   "|||2017-10-10 21:08:19.747011|2017-10-10 21:08:19.747011
NCT03127163|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-23|||January 10, 2015|Actual|2015-01-10|April 2017|2017-04-01|January 10, 2017|Actual|2017-01-10|January 10, 2016|Actual|2016-01-10||Interventional|||Intraestromal Corneal Ring in Mild Keratoconus|Intrastromal Corneal Ring Was Effective for the Treatment of Mild Keratoconus|Completed||N/A|65|Actual|University of Sao Paulo||1|||f||||f|f|f|||f|||No||2017-10-10 21:08:19.844506|2017-10-10 21:08:19.844506
NCT03127137|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-11|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 15, 2022|Anticipated|2022-01-15|December 31, 2021|Anticipated|2021-12-31||Interventional|||Epidural Steroid Injections With Low-dose Lidocaine Cause Transient Objective Upper Extremity Weakness|Do Cervical Interlaminar Epidural Steroid Injections With Low-dose Lidocaine Cause Transient Objective Upper Extremity Weakness? A Prospective Randomized Controlled Trial|Not yet recruiting||Phase 4|145|Anticipated|Northwestern University||3|||f||||t|t|f|||f|||No||2017-10-10 21:08:20.016171|2017-10-10 21:08:20.016171
NCT03127124|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-05-23|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||QUILT-2.022: NANT-008 in Combination With 5-fluorouracil, Bevacizumab, Leucovorin, and Oxaliplatin in Subjects With Pancreatic Cancer|An Open-label, Multicenter, Single-arm, Phase 1b/2 Study of NANT-008 in Combination With 5-fluorouracil, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Adenocarcinoma.|Not yet recruiting||Phase 1/Phase 2|64|Anticipated|NantPharma, LLC||1|||||||f|t|f||||||No||2017-10-10 21:08:20.130279|2017-10-10 21:08:20.130279
NCT03127111|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-05-30|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2022|Anticipated|2022-09-01||Observational|||Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer|The Identification, Validation and Implementation of Molecular Markers to Predict Response to Fluorouracil-based Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients - Prospective Clinical Observational Study|Not yet recruiting||N/A|300|Anticipated|Renmin Hospital of Wuhan University|||1||f||||f|f|f||||Samples With DNA|"     Blood, serum, tumor tissue, normal colorectal tissue   "|No||2017-10-10 21:08:20.218172|2017-10-10 21:08:20.218172
NCT03127098|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-10-04|||June 26, 2017|Actual|2017-06-26|October 2017|2017-10-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer|Phase 1b/2 Study of ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer|Active, not recruiting||Phase 1/Phase 2|3|Actual|NantCell, Inc.||1|||||||f|t|f||||||||2017-10-10 21:08:20.316866|2017-10-10 21:08:20.316866
NCT03127085|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-23|||April 21, 2017|Actual|2017-04-21|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|||A.Fib Emergency Department Study Atrial Fibrillation|Patient Specific Reasons for Attending the Emergency Department in the Setting of a Background History of Atrial Fibrillation|Recruiting||N/A|778|Anticipated|Queen's University|||1||f||||f|f|f||||||No||2017-10-10 21:08:20.407691|2017-10-10 21:08:20.407691
NCT03127072|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-23|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM|A Prospective, Randomized, One-center Study Assessing Overall Survival Using RFA Plus Chemotherapy ± Target Therapy and Chemotherapy ± Target Therapy Alone in Patients With Unresectable Unresectable Colorectal Cancer Liver Metastases|Recruiting||Phase 4|200|Anticipated|Fudan University||2|||f||||t|f|f||||||||2017-10-10 21:08:20.473742|2017-10-10 21:08:20.473742
NCT03127059|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-06-28|||April 27, 2017|Actual|2017-04-27|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|BEAT_DB||Breathing Exercises in Asthma Targeting Dysfunctional Breathing|BEAT DB-study; Breathing Exercises in Asthma Targeting Dysfunctional Breathing—a Randomised Controlled Trial|Recruiting||N/A|220|Anticipated|Naestved Hospital||2|||f|||||f|f||||||Undecided||2017-10-10 21:08:20.550947|2017-10-10 21:08:20.550947
NCT03127046|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-23|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|April 23, 2017|Anticipated|2017-04-23|April 16, 2017|Actual|2017-04-16||Interventional|DW6008||Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, 3-way Crossover Study to Evaluate the Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers|Enrolling by invitation||Phase 1|30|Actual|Dong Wha Pharmaceutical Co. Ltd.||6|||f||||f|t|f|||t|||No||2017-10-10 21:08:20.669447|2017-10-10 21:08:20.669447
NCT03127033|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-23|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 1, 2017|Anticipated|2017-11-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Comparison Between Acrylic and Soft Liner Telescopic Overdentures Regarding Patient Satisfaction|Patient Satisfaction of Soft Liner Versus Acrylic Resin Telescopes in Complete Overdenture Patients With Ectodermal Dysplasia: Non-Randomized Clinical Trial|Not yet recruiting||N/A|6|Anticipated|Cairo University||1|||f||||t|f|f||||||No||2017-10-10 21:08:20.781047|2017-10-10 21:08:20.781047
NCT03127020|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-04-19|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients|Open-Label, Non-Randomized Phase 2 Study With Safety Run-in Evaluating Efficacy and Safety of PQR309 in Patients With Relapsed or Refractory Lymphoma|Recruiting||Phase 2|72|Anticipated|PIQUR Therapeutics AG||1|||f||||f|f|f|||f|||Undecided||2017-10-10 21:08:20.841558|2017-10-10 21:08:20.841558
NCT03127007|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-22|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|R-IMMUNE||Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer|A Phase Ib/II Study to Evaluate Safety and Efficacy of Atezolizumab Combined With Radio-chemotherapy in a Preoperative Setting for Patients With Localized Rectal Cancer|Not yet recruiting||Phase 1/Phase 2|54|Anticipated|Grand Hôpital de Charleroi||2|||f||||f|f|f|||f|||No||2017-10-10 21:08:20.949332|2017-10-10 21:08:20.949332
NCT03126994|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-14|||April 11, 2017||2017-04-11||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:21.036687|2017-10-10 21:08:21.036687
NCT03126981|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-08-11|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Effects of Almonds on Insulin Sensitivity in Prediabetes|A Randomized, Crossover Trial to Assess the Effects of Replacing Refined Carbohydrates With Almonds on Insulin Sensitivity in Men and Women With Prediabetes.|Recruiting||N/A|42|Anticipated|Midwest Center for Metabolic and Cardiovascular Research||2|||f|||||f|f||||||||2017-10-10 21:08:21.072607|2017-10-10 21:08:21.072607
NCT03126968|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-25|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|PROPHET||Prophylactic Topical Epinephrine to Reduce Bleeding in Transbronchial Lung Biopsies|Prophylactic Topical Epinephrine to Reduce Transbronchial Lung Biopsy-related Hemorrhage in Lung Transplant Recipients: a Prospective Double-blind Placebo-controlled Trial (PROPHylactic Epinephrine in Transbronchial Biopsy [PROPHET] Trial)|Recruiting||Phase 2/Phase 3|100|Anticipated|University of Maryland||2|||f||||t|t|f|||t|||||2017-10-10 21:08:21.317737|2017-10-10 21:08:21.317737
NCT03126955|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-21|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|October 30, 2018|Anticipated|2018-10-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Diagnostic Test of Choice for HELPS Syndrome|Microvascular Decompression for HELPS Syndrome: What is the Best Diagnostic Test?|Not yet recruiting||N/A|6|Anticipated|University of British Columbia|||1||f||||f|f|f||||||No||2017-10-10 21:08:21.501601|2017-10-10 21:08:21.501601
NCT03126942|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-29|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 20, 2020|Anticipated|2020-12-20|March 30, 2020|Anticipated|2020-03-30||Interventional|||Single-implant Overdentures Retained by the Novaloc Attachment System|Single-implant Overdentures Retained by the Novaloc Attachment System: Study Protocol for a Mixed Methods Randomized Cross-over Trial|Not yet recruiting||N/A|26|Anticipated|McGill University||2|||f||||f|f|f|||f|||||2017-10-10 21:08:21.593786|2017-10-10 21:08:21.593786
NCT03126929|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-21|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Further Psychometric Data for the Reliability and the Diagnostic Validity of CRS-R|Further Psychometric Data for the Reliability and the Diagnostic Validity of the Coma Recovery Scale-Revised|Completed||N/A|169|Actual|Hangzhou Normal University|||3||f||||t|f|f||||||Yes||2017-10-10 21:08:21.707385|2017-10-10 21:08:21.707385
NCT03126916|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-08|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma|A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Standard Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)|Not yet recruiting||Phase 3|774|Anticipated|Children's Oncology Group||5|||f||||f|t|f||||||||2017-10-10 21:08:21.793399|2017-10-10 21:08:21.793399
NCT03126903|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-16|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||A Clinical Study to Evaluate the KeraKlear Keratoprosthesis in Patients With Corneal Opacity|A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Probable Benefit of the KeraKlear Non-Penetrating Keratoprosthesis in Subjects With Corneal Opacity With Poor Prognosis for Corneal Transplant|Recruiting||N/A|35|Anticipated|KeraMed, Inc.||1|||f||||f|f|t|t|f||||||2017-10-10 21:08:22.19486|2017-10-10 21:08:22.19486
NCT03126890|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-04-26|||December 2016||2016-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response and Adverse Reactions|Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response and Adverse Reactions|Recruiting||N/A|1000|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples Without DNA|"     Blood for drug concentration monitoring   "|||2017-10-10 21:08:22.307685|2017-10-10 21:08:22.307685
NCT03126877|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-07-11|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopic Patients With Treatments to Optimize the Ocular Surface Before Implantation|A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopic Patients With Treatments to Optimize the Ocular Surface Before Implantation|Recruiting||Phase 4|40|Anticipated|Whitten Laser Eye||2|||f||||f|t|t|f|f|t|||||2017-10-10 21:08:22.406988|2017-10-10 21:08:22.406988
NCT03126864|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-25|||August 4, 2017|Actual|2017-08-04|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia|A Phase 1 Safety Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia|Recruiting||Phase 1|39|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:08:22.508889|2017-10-10 21:08:22.508889
NCT03126851|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-10|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Promoting Safe Use of Children's Cough/Cold Medicines|"Identifying Best Practices for the Safe Use of Pediatric Cough and Cold Medications"|Recruiting||N/A|820|Anticipated|New York University School of Medicine||4|||f||||f|f|f|||f|||Undecided||2017-10-10 21:08:22.660316|2017-10-10 21:08:22.660316
NCT03126838|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-04-21|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||Diaphragmatic Dysfunction and Cardiac Surgery; Perioperative Assessment and Effect on Outcome|Diaphragmatic Dysfunction and Cardiac Surgery; Perioperative Assessment and Effect on Outcome; Prospective Observational Study|Recruiting||N/A|100|Anticipated|National Heart Institute, Egypt|||2||f||||f|f|f||||||No||2017-10-10 21:08:22.774027|2017-10-10 21:08:22.774027
NCT03126825|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-28|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|September 1, 2017|Anticipated|2017-09-01|August 13, 2017|Anticipated|2017-08-13||Interventional|||CLEAR Clinical Study|Clinical Evaluation of the SpatialNR Noise Reduction Algorithm|Not yet recruiting||N/A|48|Anticipated|Cochlear||2|||f||||f|f|f|||f|||No|Currently no plan to make IPD available to other researchers.|2017-10-10 21:08:22.8752|2017-10-10 21:08:22.8752
NCT03126812|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-13|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|June 2025|Anticipated|2025-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer|Feasibility Study of Neo-adjuvant Treatment With Carboplatin, Paclitaxel and Pembrolizumab in Primary Stage IV Serous Ovarian Cancer|Not yet recruiting||Phase 1/Phase 2|15|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 21:08:22.98251|2017-10-10 21:08:22.98251
NCT03126799|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-19|||November 1, 2016|Actual|2016-11-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|AvaTa||A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)|A Randomized Phase II Study of Erlotinib Alone Versus Erlotinib Plus Bevacizumab for Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating Mutations|Recruiting||Phase 2|128|Anticipated|National Cancer Center, Korea||2|||f||||f|f|f||||||No||2017-10-10 21:08:23.082954|2017-10-10 21:08:23.082954
NCT03126760|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-22|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|OPTIONS||Pilot Study to Assess the Efficacy & Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis|A Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group, Pilot Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis|Recruiting||Phase 4|66|Anticipated|Mallinckrodt||2|||f|||||t|f|||f|||||2017-10-10 21:08:23.506721|2017-10-10 21:08:23.506721
NCT03126656|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-04|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Effects of Testosterone on Myocardial Repolarization|Effects of Testosterone on Myocardial Repolarization in Patients With Hypogonadism With/Without Chronic Heat Failure (NYHA Class I-II)|Completed||Phase 4|123|Actual|University of Roma La Sapienza||3|||f||||||||||||||2017-10-10 21:08:23.77093|2017-10-10 21:08:23.77093
NCT03126643|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-19||||||April 2017|2017-04-01||||||||Expanded Access|||Expanded Access for Nivolumab (Opdivo)|Expanded Access for Nivolumab (Opdivo)|Available||N/A|||Bristol-Myers Squibb|||||f|t|||||||||||||2017-10-10 21:08:23.861085|2017-10-10 21:08:23.861085
NCT03126630|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-28|||February 9, 2018|Anticipated|2018-02-09|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|||Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma|Phase 1 Safety Run-in and Phase 2 Randomized Clinical Trial of Anetumab Ravtansine and Pembrolizumab Compared to Pembrolizumab for Mesothelin-Positive Malignant Pleural Mesothelioma|Not yet recruiting||Phase 1/Phase 2|134|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 21:08:23.942396|2017-10-10 21:08:23.942396
NCT03126604|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Pelvic Floor Function After Vaginal and Cesarean Delivery Among Egyptian Women|Evaluation of Pelvic Floor Function After Vaginal and Cesarean Delivery Among Egyptian Women|Not yet recruiting||N/A|5000|Anticipated|Cairo University|||2||f||||t|f|f||||||Yes||2017-10-10 21:08:24.149693|2017-10-10 21:08:24.149693
NCT03126591|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-28|||July 3, 2017|Actual|2017-07-03|September 2017|2017-09-01|February 13, 2020|Anticipated|2020-02-13|March 19, 2019|Anticipated|2019-03-19||Interventional|||A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma|An Open-Label, Multicenter, Phase 1a/1b Study of Olaratumab (LY3012207) Plus Pembrolizumab (MK3475) in Patients With Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma (STS) Who Have Failed Standard Treatments|Recruiting||Phase 1|37|Anticipated|Eli Lilly and Company||3|||f||||f|t|f||||||||2017-10-10 21:08:24.25507|2017-10-10 21:08:24.25507
NCT03126578|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-08-09|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam|Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam|Recruiting||Phase 1|70|Anticipated|LEO Pharma||1|||f|||||f|f|||f|||||2017-10-10 21:08:24.409406|2017-10-10 21:08:24.409406
NCT03126565|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of the Philips Lifeline CareSage Risk Assessment System|Evaluating the Impact of an Integrated Risk Assessment System (Philips Lifeline Personal Emergency Response Service) on Healthcare Utilization|Not yet recruiting||N/A|370|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||||2017-10-10 21:08:24.538554|2017-10-10 21:08:24.538554
NCT03126552|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-15|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|August 15, 2017|Actual|2017-08-15||Interventional|CHHIL||Establishing a Controlled Human Hookworm Infection Model at Leiden University Medical Center|Establishing a Controlled Human Hookworm Infection Model at Leiden University Medical Center|Active, not recruiting||N/A|4|Actual|Leiden University Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:08:24.658922|2017-10-10 21:08:24.658922
NCT03126539|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-20|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure|Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure|Not yet recruiting||Phase 2|50|Anticipated|Johns Hopkins University||2|||f||||f|t|f||||||||2017-10-10 21:08:24.757026|2017-10-10 21:08:24.757026
NCT03126526|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-19|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||A Multimodal Outcome Study of Eating Disorders|Targeting Top-down and Bottom-up Processing in Eating Disorders Using Computerized Training Approaches: A Multimodal Outcome Study|Not yet recruiting||N/A|120|Anticipated|King's College London||3|||f||||t|f|f||||||No||2017-10-10 21:08:24.906852|2017-10-10 21:08:24.906852
NCT03126513|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-20|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|October 1, 2018|Anticipated|2018-10-01|May 1, 2018|Anticipated|2018-05-01||Interventional|G-POEM||Gastric Per Oral Endoscopic Myotomy (G-POEM) in Refractory Gastroparesis|Safety and Efficacy of Gastric Per Oral Endoscopic Myotomy (G-POEM) in Patients With Refractory Gastroparesis|Recruiting||N/A|50|Anticipated|Coordinación de Investigación en Salud, Mexico||1|||f||||t|f|f||||||No||2017-10-10 21:08:25.126447|2017-10-10 21:08:25.126447
NCT03126500|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-08|||May 31, 2017|Anticipated|2017-05-31|May 2017|2017-05-01|August 30, 2017|Anticipated|2017-08-30|July 30, 2017|Anticipated|2017-07-30||Observational|||Post - Hospital Syndrome: Profile of Functional Status by Malnutrition|Post-Hospital Syndrome: Evaluation of Functional Status in Malnourished, Geriatric Patients at Hospital Discharge|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||1||f||||f|f|f||||||No||2017-10-10 21:08:25.239482|2017-10-10 21:08:25.239482
NCT03126487|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-02|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|June 25, 2019|Anticipated|2019-06-25|April 25, 2019|Anticipated|2019-04-25||Interventional|MRHEATBREAST||High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast Cancer|High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast Cancer. Phase II Pilot Study : Effectiveness and Procedures Standardization|Recruiting||N/A|35|Anticipated|Centre Antoine Lacassagne||1|||f||||t|f|f||||||Undecided||2017-10-10 21:08:25.358219|2017-10-10 21:08:25.358219
NCT03126474|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-19|||February 17, 2017|Actual|2017-02-17|April 2017|2017-04-01|June 28, 2017|Anticipated|2017-06-28|May 28, 2017|Anticipated|2017-05-28||Observational|||Defining Displacement Thresholds for Surgical Intervention for Distal Radius Fractures - a Delphi Study|Defining Displacement Thresholds for Surgical Intervention for Distal Radius Fractures - a Delphi Study|Recruiting||N/A|40|Anticipated|University of Leicester|||1||f||||f|f|f||||||No||2017-10-10 21:08:25.465689|2017-10-10 21:08:25.465689
NCT03126461|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-07-28|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients|Phase 2 Trial of SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients|Not yet recruiting||Phase 2|24|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t|t|f|||f|||||2017-10-10 21:08:25.553909|2017-10-10 21:08:25.553909
NCT03126448|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-10-03|||December 21, 2015|Actual|2015-12-21|October 2017|2017-10-01||||July 31, 2018|Anticipated|2018-07-31||Interventional|||BBOT: Bacterial Burden in Ortho Trauma Procedures|Prospective Evaluation of Bacterial Burden in Orthopaedic Trauma Procedures Using Highly Sensitive Assays|Recruiting||N/A|124|Anticipated|University of Maryland||3|||f||||t||||||||||2017-10-10 21:08:25.649894|2017-10-10 21:08:25.649894
NCT03126435|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||EndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment|A Randomized Controlled, Open Label, Adaptive Phase-3 Trial to Evaluate Safety and Efficacy of EndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment|Not yet recruiting||Phase 3|214|Anticipated|SynCore Biotechnology Co., Ltd.||2||||||||t|f||||||||2017-10-10 21:08:25.771893|2017-10-10 21:08:25.771893
NCT03126422|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-02|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Effects of Different Doses of Dexmedetomidine on Fentanyl-induced Cough|Effects of Different Doses of Dexmedetomidine on Fentanyl-induced Cough|Recruiting||Phase 1|240|Anticipated|Yangzhou University||4|||f|||||f|f|||f|||||2017-10-10 21:08:25.880426|2017-10-10 21:08:25.880426
NCT03126409|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-24|||May 14, 2017|Actual|2017-05-14|April 2017|2017-04-01|October 14, 2019|Anticipated|2019-10-14|May 14, 2019|Anticipated|2019-05-14||Interventional|||No-Touch Versus Conventional Saphenous Vein Harvesting Technique|No-Touch Versus Conventional Saphenous Vein Harvesting Technique: A Multi-Center Prospective Randomized Controled Clinical Trial|Recruiting||N/A|1500|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t|f|f||||||No||2017-10-10 21:08:25.969818|2017-10-10 21:08:25.969818
NCT03126396|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-21|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|CASSIOPEE||Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers|Assessment of Efficacy, Tolerance and Acceptability of Urgo 310 3166 Dressing in the Treatment of Local Venous or Mixed Leg Ulcers|Not yet recruiting||N/A|40|Anticipated|Laboratoires URGO||1|||f||||f|f|f||||||No||2017-10-10 21:08:26.095022|2017-10-10 21:08:26.095022
NCT03126383|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||May 10, 2017|Anticipated|2017-05-10|April 2017|2017-04-01|April 10, 2018|Anticipated|2018-04-10|April 10, 2018|Anticipated|2018-04-10||Observational|AMISS||Inflammatory Myopathies in Primary Sjögren's Syndrome|Characterization of Inflammatory Muscle Involvement in Patients With Primary Sjögren's Syndrome|Not yet recruiting||N/A|30|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 21:08:26.18318|2017-10-10 21:08:26.18318
NCT03126370|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)|Effects of Ledipasvir/Sofosbuvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) in Patients With HIV.|Not yet recruiting||Phase 4|15|Anticipated|University of Colorado, Denver||1|||f||||f|t|f|||f|||||2017-10-10 21:08:26.26593|2017-10-10 21:08:26.26593
NCT03126357|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-23|||April 17, 2017|Actual|2017-04-17|June 2017|2017-06-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||CSD170401: Study to Assess Elements of Abuse Liability for Three Electronic Tobacco Vapor Products During an 11-Day In-Clinic Confinement|CSD170401: A Single-Center, Randomized, Open-Label, Crossover Study to Assess Elements of Abuse Liability for Three Electronic Tobacco Vapor Products During an 11-Day In-Clinic Confinement|Completed||N/A|40|Actual|RAI Services Company||10|||f||||f|f|f||||||No||2017-10-10 21:08:26.39649|2017-10-10 21:08:26.39649
NCT03126344|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-20|||May 20, 2017|Actual|2017-05-20|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|May 20, 2018|Anticipated|2018-05-20||Interventional|||Nasal Intubation Using King Vision Video Laryngoscopy|Comparison King Vision Video Laryngoscopy 、McGrath MAC Video Laryngoscopy With Macintosh Laryngoscopy for Nasal Intubation|Recruiting||N/A|90|Anticipated|Shanghai 9th People's Hospital||3|||f||||f|f|t|f|f|t|||||2017-10-10 21:08:26.535395|2017-10-10 21:08:26.535395
NCT03126331|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-08-07|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|||Intermittent Nivolumab in Metastatic Renal Cell Carcinoma Patients|A Single-arm Phase II Trial of Intermittent Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy|Recruiting||Phase 2|40|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:08:26.640803|2017-10-10 21:08:26.640803
NCT03126318|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-21|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|September 1, 2018|Anticipated|2018-09-01|March 31, 2018|Anticipated|2018-03-31||Interventional|COR-001-SC1||A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001|A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Cohort Dose-Escalation Study in Patients With Chronic Kidney Disease to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of COR-001 (COR-001-SC1)|Recruiting||Phase 1|16|Anticipated|University of Colorado, Denver||2|||f||||t|t|f||||||No||2017-10-10 21:08:26.733526|2017-10-10 21:08:26.733526
NCT03126305|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|March 1, 2018|Anticipated|2018-03-01||Observational|OC-GoPhaseI||Initial Development and Dissemination of OC-Go|Facilitating Fidelity and Dissemination of Evidence Based Treatment for Childhood OCD Via an Interactive Crowd-sourced Patient-provider Tool|Enrolling by invitation||N/A|15|Anticipated|University of California, Los Angeles|||1||f||||f|f|f||||||No||2017-10-10 21:08:26.83618|2017-10-10 21:08:26.83618
NCT03126292|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-21|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Child Development and Primary Care|Promoting Early Child Development in Primary Care for Low-Income Families|Not yet recruiting||N/A|60|Anticipated|University of Illinois at Chicago||2|||f||||f|f|f||||||No||2017-10-10 21:08:26.92414|2017-10-10 21:08:26.92414
NCT03126279|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-21|||August 2015||2015-08-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|||fMRI and Central Sensitization in Chronic Knee Osteoarthritis. A Pre and Post TKR Study|Predicting Chronic Post TKR Pain by Assessing Central Sensitisation Using Functional Brain MRI|Recruiting||N/A|50|Anticipated|University of Nottingham|||2||f||||f|f|f||||||No||2017-10-10 21:08:27.011826|2017-10-10 21:08:27.011826
NCT03126266|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Re-Irradiation of Progressive or Recurrent DIPG|ReRAD: A Phase II Canadian Pediatric Brain Tumour Consortium Study of Re-Irradiation as Treatment of Progressive or Recurrent Diffuse Intrinsic Pontine Glioma|Not yet recruiting||N/A|25|Anticipated|University of Calgary||1|||f||||t|f|f||||||No||2017-10-10 21:08:27.121572|2017-10-10 21:08:27.121572
NCT03126253|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||May 11, 2011|Actual|2011-05-11|April 2017|2017-04-01|January 18, 2012|Actual|2012-01-18|July 8, 2011|Actual|2011-07-08||Observational|||The Burden of Childhood Anemia in Bangladesh: Does Socioeconomic Status Matter?|The Burden of Childhood Anemia in Bangladesh:|Completed||N/A|2320|Actual|Shahjalal University of Science and Technology|||1||f||||t|f|f||||||No||2017-10-10 21:08:27.19917|2017-10-10 21:08:27.19917
NCT03126240|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-21|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 1, 2019|Anticipated|2019-06-01|May 1, 2019|Anticipated|2019-05-01||Observational|||The Role of Sleeve Gastrectomy in Dyslpidemia|The Role of Sleeve Gastrectomy in Dyslpidemia|Not yet recruiting||N/A|20|Anticipated|Assiut University|||1||f||||t|f|f||||||Undecided||2017-10-10 21:08:27.27735|2017-10-10 21:08:27.27735
NCT03126214|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-19|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|September 1, 2019|Anticipated|2019-09-01|May 1, 2019|Anticipated|2019-05-01||Interventional|PIAAF Rx||Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing|Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing: Program for the Identification of 'Actionable' AF (PIAAF) Rx Study|Recruiting||Phase 4|370|Anticipated|University of Alberta||2|||f||||t|f|f||||||No||2017-10-10 21:08:27.523825|2017-10-10 21:08:27.523825
NCT03126201|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-09-23|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Actual|2017-09-01||Observational|||Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis|Predictors of Disease Progression in Patients With Primary Focal Segmental Glomerulosclerosis|Active, not recruiting||N/A|100|Anticipated|Istanbul University|||1||f||||f|f|f||||||||2017-10-10 21:08:27.606733|2017-10-10 21:08:27.606733
NCT03126188|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression|Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression|Recruiting||Phase 4|100|Anticipated|All India Institute of Medical Sciences, Bhubaneswar||3|||f||||f|f|f|||f|||Undecided||2017-10-10 21:08:27.673989|2017-10-10 21:08:27.673989
NCT03126175|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-28|||October 15, 2017|Anticipated|2017-10-15|June 2017|2017-06-01|December 15, 2018|Anticipated|2018-12-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Above Versus Below-elbow Casting for Conservative Treatment of Distal Radius Fractures|Above Versus Below-elbow Casting for Conservative Treatment of Distal Radius Fractures: a Randomized Controlled Trial|Not yet recruiting||N/A|106|Anticipated|Hospital Dr. Fernando Mauro Pires da Rocha||2|||f||||t|f|f||||||||2017-10-10 21:08:27.77514|2017-10-10 21:08:27.77514
NCT03126162|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-08|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|May 30, 2018|Anticipated|2018-05-30|May 1, 2018|Anticipated|2018-05-01||Interventional|||Postoperative Bladder Testing After Total Laparoscopic Hysterectomy|A Randomized, Controlled Trial Evaluating 2 Techniques of Postoperative Bladder Testing for Patients Undergoing Same-day Total Laparoscopic Hysterectomy|Recruiting||N/A|250|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||Undecided|Authorized representatives of Magee-Womens Hospital of UPMC may have access to research data/documents for the purpose of research. These 'external persons' may include other investigators from both inside and outside Magee-Womens Hospital of UPMC who are conducting similar research after IRB approval. The data that would be shared would be de-identified research data/materials. The investigators currently do not have a data sharing plan with individuals other than the current investigators/research staff involved with this research project. Should the investigators decide to share data in the future, the investigators will contact the Office of Research before sharing de-identified research data/materials to determine whether an agreement needs to be executed.|2017-10-10 21:08:27.852172|2017-10-10 21:08:27.852172
NCT03126149|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-10-01|||May 11, 2017|Actual|2017-05-11|October 2017|2017-10-01|September 5, 2017|Actual|2017-09-05|September 5, 2017|Actual|2017-09-05||Interventional|||First in Human Study for PF-06667272|A Phase 1, Randomized, Double-blind (Sponsor-open), Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Single Escalating Oral Doses Of Pf-06667272 Under Fed And Fasted Conditions, In Healthy Adult Subjects|Completed||Phase 1|16|Actual|Pfizer||16|||f||||f|t|f|||t|||||2017-10-10 21:08:27.947117|2017-10-10 21:08:27.947117
NCT03126123|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||March 7, 2017|Actual|2017-03-07|April 2017|2017-04-01|July 7, 2018|Anticipated|2018-07-07|July 7, 2018|Anticipated|2018-07-07||Interventional|||Assessment of the Predictive Value of the Acetic Acid Test in Surgery Condition for the Detection of Dysplastic Lesions in Patients With Anal Condylomatosis|Assessment of the Predictive Value of the Acetic Acid Test in Surgery Condition for the Detection of Dysplastic Lesions in Patients With Anal Condylomatosis|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon||1|||f|||||f|f||||||||2017-10-10 21:08:28.154434|2017-10-10 21:08:28.154434
NCT03126110|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-08-02|||April 13, 2017|Actual|2017-04-13|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies|A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies|Recruiting||Phase 1/Phase 2|450|Anticipated|Incyte Corporation||3|||||||f|t|f||||||||2017-10-10 21:08:28.24147|2017-10-10 21:08:28.24147
NCT03126097|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-31|||April 13, 2017|Actual|2017-04-13|August 2017|2017-08-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females|A Phase 1, Open-label Study in Healthy Female Subjects to Investigate the Drug-drug Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone|Terminated||Phase 1|18|Actual|Janssen Research & Development, LLC||1||Study stopping rules were met.|f||||f|t|f||||||||2017-10-10 21:08:28.376785|2017-10-10 21:08:28.376785
NCT03126084|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-08-15|||May 2, 2017|Actual|2017-05-02|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 25, 2017|Anticipated|2017-08-25||Interventional|||Postoperative Effects of TAP Block Versus QLB Type 2 Block|Comparison of Postoperative Analgesic Effects of Transversus Abdominis Plane Block and Quadratus Lumborum Block Type 2|Recruiting||Phase 4|90|Anticipated|Bozyaka Training and Research Hospital||3|||f||||f|f|f||||||||2017-10-10 21:08:28.492068|2017-10-10 21:08:28.492068
NCT03125356|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Low-calorie Sweeteners and Adipose Signaling|Low-calorie Sweeteners Induce Metabolic Dysregulation Via Alterations in Adipose Signaling|Recruiting||N/A|30|Anticipated|George Washington University||1|||f||||f|f|f||||||No||2017-10-10 21:08:36.616601|2017-10-10 21:08:36.616601
NCT03126071|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|February 15, 2020|Anticipated|2020-02-15|August 15, 2018|Anticipated|2018-08-15||Interventional|||Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer|A Phase II Study of Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer|Recruiting||Phase 2|100|Anticipated|Jiangsu Cancer Institute & Hospital||2|||f|||||f|f|||f|||||2017-10-10 21:08:28.610725|2017-10-10 21:08:28.610725
NCT03126058|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-07-03|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|January 2018|Anticipated|2018-01-01||Interventional|ERASC1||Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study (ERASC1)|Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study|Recruiting||N/A|1000|Anticipated|Jinling Hospital, China||1|||f||||t|f|f||||||||2017-10-10 21:08:28.719417|2017-10-10 21:08:28.719417
NCT03126045|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-11|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|SPPLAASH||A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology|SPPLAASH Study : a Randomized Study Aiming at Evaluating the Incidence of Post Lumbar Puncture Headache (PLPH) With the Use of Atraumatic Needles in Hematology|Recruiting||N/A|68|Anticipated|Institut de Cancérologie de la Loire||2|||f||||f|f|f||||||||2017-10-10 21:08:29.126956|2017-10-10 21:08:29.126956
NCT03126032|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-24|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|EDGE||Early Detection of Glycocalyx Damage in Emergency Room Patients|Early Detection of Glycocalyx Damage in Emergency Room Patients|Recruiting||N/A|360|Anticipated|University Hospital Muenster|||3||f||||f|f|f||||||No||2017-10-10 21:08:29.258695|2017-10-10 21:08:29.258695
NCT03126019|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-09-29|||June 29, 2017|Actual|2017-06-29|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Open-Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)|A Phase 2, Multicenter, Open-Label, Randomized Study Comparing INCB050465, a PI3Kδ Inhibitor, to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)|Recruiting||Phase 2|180|Anticipated|Incyte Corporation||3|||f||||t|t|f||||||||2017-10-10 21:08:29.373432|2017-10-10 21:08:29.373432
NCT03126006|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||February 1, 2015|Actual|2015-02-01|April 2017|2017-04-01|September 1, 2017|Anticipated|2017-09-01|August 1, 2017|Anticipated|2017-08-01||Interventional|NSPT||The Effect of Non-surgical Periodontal Therapy on Adverse Birth Outcomes Randomized Controlled Trial|The Effect of Non-surgical Periodontal Therapy on Adverse Birth Outcomes: A Randomized Controlled Trial|Recruiting||N/A|118|Anticipated|Aga Khan University||2|||f||||f|f|f||||||No||2017-10-10 21:08:29.567059|2017-10-10 21:08:29.567059
NCT03125993|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-21|||April 25, 2017|Anticipated|2017-04-25|April 2017|2017-04-01|August 30, 2017|Anticipated|2017-08-30|August 25, 2017|Anticipated|2017-08-25||Interventional|||Effects of Brisk Walking on Overweight/Obesity Population|Effects of Brisk Walking on Overweight/Obesity Population|Not yet recruiting||N/A|150|Anticipated|Guangdong Center for Disease Prevention and Control||1|||f||||f|f|f||||||No|individual participant data will not be shared with other researchers, for data safety.|2017-10-10 21:08:29.683662|2017-10-10 21:08:29.683662
NCT03125980|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-19|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2027|Anticipated|2027-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer|Perioperative CapeOX Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Resectable Colon Cancer: An Open Label Randomized Controlled Phase III Trial|Recruiting||Phase 3|1370|Anticipated|Fudan University||2|||f|||||f|f||||||||2017-10-10 21:08:29.79901|2017-10-10 21:08:29.79901
NCT03125967|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-28|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Daily Light Exposure for Sleep Disturbance, Fatigue, and Functional Outcomes in Acute Brain Injury|Effects of Colored Light Exposure on Sleep Disturbance, Fatigue, and Functional Outcomes Following Acute Brain Injury|Recruiting||N/A|52|Anticipated|St. Luke's Rehabilitation Institute||2|||f||||f|f|f||||||Undecided||2017-10-10 21:08:29.904081|2017-10-10 21:08:29.904081
NCT03125954|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-08|||May 8, 2017|Actual|2017-05-08|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Changes in Physical Inactivity in Patients With Knee Osteoarthritis|Changes in Physical Inactivity Secondary to Exercise Therapy in Patients With Knee Osteoarthritis: A Prospective Cohort Study|Recruiting||N/A|50|Anticipated|Frederiksberg University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:08:30.032653|2017-10-10 21:08:30.032653
NCT03125941|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-19|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|DEX-MAS||High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy|Effect of High vs Low Dose Intravenous Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy- a Randomized, Dobble-blind, Controlled Trial|Recruiting||Phase 4|130|Anticipated|Rigshospitalet, Denmark||2|||f||||t|f|f||||||No|Not planned to share IPD|2017-10-10 21:08:30.122543|2017-10-10 21:08:30.122543
NCT03125928|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-06-07|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer|Single Arm, Phase IIA Clinical Trial Assessing The Safety And Efficacy of Atezolizumab in Combination With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer|Recruiting||Phase 2|50|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:08:30.269904|2017-10-10 21:08:30.269904
NCT03125915|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-20|2017-04-20|||April 1, 2014|Actual|2014-04-01|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Addressing Substance Use Through CVCT|Addressing Substance Use Through Couples Voluntary Counseling and Testing (CVCT)|Recruiting||N/A|160|Anticipated|Hunter College of City University of New York||4|||f||||t|f|f||||||Undecided||2017-10-10 21:08:30.393348|2017-10-10 21:08:30.393348
NCT03125733|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-06-28|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|May 14, 2019|Anticipated|2019-05-14|June 14, 2018|Anticipated|2018-06-14||Interventional|STESD||A New Treatment for Zenker's Diverticulum-submucosal Tunneling Endoscopic Septum Division|A Prospective International Multicenter Study on the Efficacy and Safety of Submucosal Tunneling Endoscopic Septum Division (STESD) for the Treatment of Zenker's Diverticulum|Recruiting||N/A|20|Anticipated|Shanghai Zhongshan Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:08:31.948679|2017-10-10 21:08:31.948679
NCT03125889|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-19|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|November 22, 2017|Anticipated|2017-11-22|April 24, 2017|Anticipated|2017-04-24||Interventional|AHA II||Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II|Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II|Active, not recruiting||N/A|11|Actual|PROCEPT BioRobotics||1|||f||||f|f|f|||t|||Undecided||2017-10-10 21:08:30.968781|2017-10-10 21:08:30.968781
NCT03125876|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-04-19|||April 25, 2017|Anticipated|2017-04-25|April 2017|2017-04-01|April 10, 2019|Anticipated|2019-04-10|January 10, 2019|Anticipated|2019-01-10||Interventional|||A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)|A Phase Ib, Multi-center, Open, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Ningetinib (CT053PTSA) in Relapsed / Refractory Acute Myeloid Leukemia (AML)|Not yet recruiting||Phase 1|34|Anticipated|Sunshine Lake Pharma Co., Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:08:31.045574|2017-10-10 21:08:31.045574
NCT03125863|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-04-19|||August 26, 2016|Actual|2016-08-26|April 2017|2017-04-01|May 31, 2017|Anticipated|2017-05-31|September 9, 2016|Actual|2016-09-09||Interventional|AHA||Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia|Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia|Active, not recruiting||N/A|21|Actual|PROCEPT BioRobotics||1|||f||||f|f|f||||||Undecided||2017-10-10 21:08:31.138508|2017-10-10 21:08:31.138508
NCT03125850|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-19|||April 27, 2017|Anticipated|2017-04-27|April 2017|2017-04-01|July 31, 2017|Anticipated|2017-07-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Study of Hospitalization of Patients in Day and Inpatient Glaucoma Wards in Zhongshan Ophthalmic Center|Study of Hospitalization of Patients in Day and Inpatient Glaucoma Wards in Zhongshan Ophthalmic Center|Not yet recruiting||N/A|300|Anticipated|Zhongshan Ophthalmic Center, Sun Yet-sen University||2|||f||||t|f|f||||||No|No.|2017-10-10 21:08:31.248315|2017-10-10 21:08:31.248315
NCT03125837|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-19|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Observational|||Establishment of Airway Database for Surgical Patients|Study on the Method of Difficult Airway Prediction Based on Artificial Intelligence|Not yet recruiting||N/A|50000|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University|||1||f||||t|f|f||||Samples Without DNA|"     Digital photographs of the face and neck   "|No||2017-10-10 21:08:31.313427|2017-10-10 21:08:31.313427
NCT03125811|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-09|||July 17, 2017|Actual|2017-07-17|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|VOMIITED||Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)|Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)|Recruiting||Early Phase 1|300|Anticipated|Texas Tech University Health Sciences Center, El Paso||2|||f||||f|t|f||||||||2017-10-10 21:08:31.434141|2017-10-10 21:08:31.434141
NCT03125798|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-09-22|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Comparison of LigaSure to Conventional Electrocoagulation in Video-assisted Thoracoscopic Surgery Lobectomy|Comparison of LigaSure Technology to the Conventional Electrocoagulation in Video-assisted Thoracoscopic Surgery (VATS) Lobectomy Followed by Systemic Lymphadenectomy: A Prospective Randomized Controlled Study|Not yet recruiting||N/A|200|Anticipated|Wielkopolskie Centrum Pulmonologii i Torakochirurgii||2|||f||||f|f|t|f|f|t|||||2017-10-10 21:08:31.536039|2017-10-10 21:08:31.536039
NCT03125785|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-23|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01|4 Weeks|Observational [Patient Registry]|||The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo|The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo|Not yet recruiting||N/A|80|Anticipated|St. Erik Eye Hospital|||2||f||||||||||||No||2017-10-10 21:08:31.61086|2017-10-10 21:08:31.61086
NCT03125772|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-04-21|||June 2011||2011-06-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|Tuxedo||Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics|A Prospective, Single Blind, Multi-center, Randomized Trial to Compare the TAXUS Element™ Coronary Stent System Against the XIENCE Prime™ Coronary Stent System in the Treatment of a Diabetic Patient PopulatiOn in India|Completed||N/A|1830|Actual|Fortis Escorts Heart Institute||2|||f||||t||||||||||2017-10-10 21:08:31.6789|2017-10-10 21:08:31.6789
NCT03125759|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-21|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2025|Anticipated|2025-12-31||Observational|||The Association of Omentin and Ischemic Stroke|The Association of Omentin and Ischemic Stroke|Recruiting||N/A|2000|Anticipated|Xi'an No.3 Hospital|||2||f||||||||||Samples With DNA|"     Whole Blood   "|Yes||2017-10-10 21:08:31.798693|2017-10-10 21:08:31.798693
NCT03125746|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-08-08|||June 12, 2017|Actual|2017-06-12|August 2017|2017-08-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|||A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors|A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profiles and the Antitumor Activity of LXI-15029 Alone or in Combination With Exemestane at Single Ascending Dose and Multiple Ascending Doses in Chinese Patients With Advanced Malignant Solid Tumors|Recruiting||Phase 1|72|Anticipated|Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.||2|||f|||||f|f||||||||2017-10-10 21:08:31.871058|2017-10-10 21:08:31.871058
NCT03125720|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-21|||April 14, 2017|Actual|2017-04-14|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|GUIDE-CRT||Image Fusion of SPECT MPI and Fluoroscopy Venography to Guide LV Lead Placement for Improved CRT Response (GUIDE-CRT II)|Image Fusion of SPECT MPI and Fluoroscopy Venography to Guide LV Lead Placement for Improved CRT Response (GUIDE-CRT II)|Recruiting||N/A|300|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:08:32.072856|2017-10-10 21:08:32.072856
NCT03125707|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-04-25|||May 2013||2013-05-01|April 2017|2017-04-01|January 2038|Anticipated|2038-01-01|January 2037|Anticipated|2037-01-01|20 Years|Observational [Patient Registry]|||German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)|German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)|Recruiting||N/A|2000|Anticipated|University of Ulm|||1||f||||f|f|f||||||No||2017-10-10 21:08:32.222852|2017-10-10 21:08:32.222852
NCT03125694|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-19|||February 1, 2015|Actual|2015-02-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea|Efficacy, Durability, Safety, and Tolerability of Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea: a 52-week, Randomized, Open-label, Parallel-group, Phase 3 Clinical Trial|Completed||Phase 3|250|Actual|Tehran University of Medical Sciences||2|||f|||||f|f||||||||2017-10-10 21:08:32.391835|2017-10-10 21:08:32.391835
NCT03125681|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-12|||May 11, 2017|Actual|2017-05-11|June 2017|2017-06-01|May 30, 2019|Anticipated|2019-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Remote Ischemic Conditioning and Platelet Dysfunction|Effect of Remote Ischemic Conditioning on Platelet Dysfunction Following Off-pump Coronary Artery Bypass Surgery|Recruiting||N/A|78|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:08:32.462316|2017-10-10 21:08:32.462316
NCT03125668|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-21|||October 1, 2015|Actual|2015-10-01|April 2017|2017-04-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin|Impact of Telephone Follow-up in Patient's Health-related Quality of Life During the First Six Months of Warfarin Use: Randomized Clinical Trial|Recruiting||N/A|46|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 21:08:34.229262|2017-10-10 21:08:34.229262
NCT03125655|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-26|||April 22, 2014|Actual|2014-04-22|June 2017|2017-06-01|April 28, 2019|Anticipated|2019-04-28|April 10, 2018|Anticipated|2018-04-10||Observational|||Regulation of Inflammatory Genes in Psoriasis|Regulation of Inflammatory Genes in Psoriasis|Recruiting||N/A|13|Anticipated|University of Alabama at Birmingham|||1||f||||f|f|f||||||No||2017-10-10 21:08:34.322952|2017-10-10 21:08:34.322952
NCT03125642|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-10-04|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|April 30, 2026|Anticipated|2026-04-30|April 30, 2023|Anticipated|2023-04-30||Interventional|||Auto Stem Cell Transplant for Lymphoma Patients|Autologous Stem Cell Transplant In Patients With Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphomas (NHL)|Recruiting||Phase 2|150|Anticipated|Masonic Cancer Center, University of Minnesota||3|||f||||t|t|f|||f|||||2017-10-10 21:08:34.392085|2017-10-10 21:08:34.392085
NCT03125629|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-10|||May 2014||2014-05-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of PET/CT vs. PET/MRI|Comparison of PET/CT vs. PET/MRI|Suspended||N/A|200|Anticipated|Stanford University||1||Business decision|f||||t|f|f||||||||2017-10-10 21:08:34.512155|2017-10-10 21:08:34.512155
NCT03125616|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-08|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|August 2, 2019|Anticipated|2019-08-02|January 2, 2019|Anticipated|2019-01-02||Interventional|BEAR Men B||Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B|Babies Born Early Antibody Response to Men B Vaccination: A Phase IV Multicentre Randomised Study to Evaluate the Primary and Booster Immune Responses in UK Preterm Infants Receiving Routine Immunisations and Incorporating a Three Dose Versus a Two Dose Schedule of 4CMenB (Bexsero®) for Primary Immunisation.|Active, not recruiting||Phase 4|132|Anticipated|St George's, University of London||2|||f||||f|f|f|||f|||||2017-10-10 21:08:34.592251|2017-10-10 21:08:34.592251
NCT03125603|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-19|||April 13, 2017|Actual|2017-04-13|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31|20 Months|Observational [Patient Registry]|||Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer|Census and Follow-up of the Side Effects in the New Immunotherapeutic Treatments Anti-PD-(L)-1 and Anti-CTLA-4 of the Non Small Cells Lung Cancer|Recruiting||N/A|140|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||No||2017-10-10 21:08:34.694514|2017-10-10 21:08:34.694514
NCT03125590|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-28|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|August 11, 2017|Actual|2017-08-11|July 9, 2017|Actual|2017-07-09||Observational|||Validation, Reliability and Pilot Test of the Personalized Exercise Questionnaire (PEQ)|Reliability and Validity Study of the Facilitators and Barriers Exercise Questionnaire|Completed||N/A|114|Actual|McMaster University|||1||f||||t|f|f||||||||2017-10-10 21:08:34.787408|2017-10-10 21:08:34.787408
NCT03125577|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-29|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Combination CAR-T Cell Therapy Targeting Hematological Malignancies|Combination CAR-T Therapy of 4SCAR19 Plus 4SCAR20, 22, 38, and 123 Targeting Hematological Malignancies|Recruiting||Phase 1/Phase 2|100|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||f|f|f||||||No||2017-10-10 21:08:34.853536|2017-10-10 21:08:34.853536
NCT03125564|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-19|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|July 31, 2019|Anticipated|2019-07-31|January 2, 2019|Anticipated|2019-01-02||Interventional|||FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment|A Randomised, Placebo-controlled Study on Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome With Fecal and Mucosal Microbiota Assessment|Recruiting||N/A|90|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||No||2017-10-10 21:08:34.939444|2017-10-10 21:08:34.939444
NCT03125551|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-19|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||ROTEM and Dietary Supplements|Viscoelastic Point-of-Care Coagulation Monitoring and Dietary Supplements: A Randomized, Double-blind, Placebo-controlled Trial|Not yet recruiting||N/A|50|Anticipated|University of Pretoria||5|||f||||t|f|f||||||No||2017-10-10 21:08:35.133944|2017-10-10 21:08:35.133944
NCT03124966|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||December 9, 2009|Actual|2009-12-09|June 2017|2017-06-01|December 31, 2009|Actual|2009-12-31|December 31, 2009|Actual|2009-12-31||Interventional|||Accuracy of Hemoglobin Measurement for Various Rainbow Pulse Oximeter Sensors||Completed||N/A|118|Actual|Masimo Corporation||1|||f|||||f|t|f|||||||2017-10-10 21:08:41.005569|2017-10-10 21:08:41.005569
NCT03125538|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-27|||February 25, 2017|Actual|2017-02-25|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|MIPA||Motor Imagery Practice on Amputees (MIPA)|Therapeutic Effects of Motor Imagery Practice Following Lower-limb Amputation|Recruiting||N/A|40|Anticipated|Laboratoire Interuniversitaire de Biologie de la Motricité||2|||f||||f|f|f||||||No||2017-10-10 21:08:35.23774|2017-10-10 21:08:35.23774
NCT03125525|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-21|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|||Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Refractory Migraine|Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Patients With Refractory Migraine or With Migraine and Intolerance to Topiramate: a Prospective Exploratory Clinical Study|Completed||N/A|37|Actual|Corfu Headache Clinic|||1||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:08:35.346033|2017-10-10 21:08:35.346033
NCT03125512|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-04-24|||February 27, 2017|Actual|2017-02-27|April 2017|2017-04-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|||Positional Therapy Versus CPAP for Positional OSA|Comparing a Convenient Positional Therapy Device to CPAP for Treatment of Positional Obstructive Sleep Apnea, A Crossover Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Changi General Hospital||2|||f||||t|f|t|f|f|t|||Undecided||2017-10-10 21:08:35.427975|2017-10-10 21:08:35.427975
NCT03125499|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-18|||July 27, 2017|Actual|2017-07-27|September 2017|2017-09-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Observational|||A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees|A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees|Enrolling by invitation||N/A|75|Anticipated|OrthoTrophix, Inc|||1||f||||f|f|f||||||||2017-10-10 21:08:35.529157|2017-10-10 21:08:35.529157
NCT03125486|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-07-31||||||July 2017|2017-07-01||||||||Expanded Access|||Compassionate Use for Subcutaneous (SC) Belimumab|Compassionate Use for Subcutaneous (SC) Belimumab|Available||N/A|||GlaxoSmithKline||||||t|||||||||||||2017-10-10 21:08:35.599324|2017-10-10 21:08:35.599324
NCT03125473|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-21|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|August 30, 2018|Anticipated|2018-08-30|May 7, 2018|Anticipated|2018-05-07||Interventional|||Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers|A Phase 1b, Open-Label, Dose-Optimization Trial of an Adenoviral-vector Based Norovirus Vaccine (VXA-G1.1-NN) Expressing GI.1 VP1 and dsRNA Adjuvant Administered Orally to Healthy Volunteers|Recruiting||Phase 1|60|Anticipated|Vaxart||4|||f||||t|t|f||||||Undecided||2017-10-10 21:08:35.678855|2017-10-10 21:08:35.678855
NCT03125460|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-19|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer|Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer|Recruiting||N/A|530|Anticipated|Cepheid|||2||f|||||f|||||||No||2017-10-10 21:08:35.786736|2017-10-10 21:08:35.786736
NCT03125447|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-06|||May 29, 2017|Actual|2017-05-29|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|PAM||Mobility and Attention Capacity in Former Premature Children|Posture and Mobility Influence on Attention Capacity in Former Premature Children at 6 Years of Age.|Recruiting||N/A|48|Anticipated|Central Hospital, Nancy, France||2|||f||||f|f|f||||||||2017-10-10 21:08:35.950405|2017-10-10 21:08:35.950405
NCT03125434|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-28|||April 27, 2017|Actual|2017-04-27|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|NDMS||Normative Dynamic & Magnetic Spine|Normative Dynamic & Magnetic Spine. Musculoskeletal Characteristics Static and Dynamic of Spine in Healthy Subject|Recruiting||N/A|48|Anticipated|Centre d'Investigation Clinique et Technologique 805||1|||f||||f|f|f||||||No||2017-10-10 21:08:36.050197|2017-10-10 21:08:36.050197
NCT03125421|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|PSA||Prevention of Pressure Sores in the Prone Position in ARDS Patients|A Nursing Strategy to Prevent Pressure Sores in the Prone Position in ARDS Patients. A Multicenter Controlled Prospective Stepped Wedge Trial|Not yet recruiting||N/A|180|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:08:36.129029|2017-10-10 21:08:36.129029
NCT03125408|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-19|||May 2, 2012||2012-05-02|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Observational|||Clinical Performance Evaluation of DxN HCV Assay|Clinical Utility of the DxN HCV Assay as an Aid in the Management of HCV-Infected Individuals Undergoing Antiviral Therapy|Active, not recruiting||N/A|350|Anticipated|Beckman Coulter, Inc.|||1||f||||f|||||t|Samples Without DNA|"     Frozen plasma samples are retained for this study and possible future studies.   "|No||2017-10-10 21:08:36.20772|2017-10-10 21:08:36.20772
NCT03125395|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-30|||May 12, 2017|Actual|2017-05-12|October 2016|2016-10-01|July 26, 2019|Anticipated|2019-07-26|July 26, 2019|Anticipated|2019-07-26||Interventional|||A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|A Phase 3, Rollover Study to Evaluate the Safety of Long-term Treatment With Lumacaftor/Ivacaftor Combination Therapy in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|Enrolling by invitation||Phase 3|56|Anticipated|Vertex Pharmaceuticals Incorporated||2|||f||||t|t|f||||||||2017-10-10 21:08:36.278856|2017-10-10 21:08:36.278856
NCT03125382|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-04-18|||April 2012|Actual|2012-04-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|PORTLink||PORTuguese Research on Telemonitoring With CareLink® (PORTLink)|PORTuguese Research on Telemonitoring With CareLink® (PORTLink)|Completed||N/A|141|Actual|Medtronic Bakken Research Center||4|||f||||t|f|f||||||Undecided||2017-10-10 21:08:36.400513|2017-10-10 21:08:36.400513
NCT03125369|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-04-19|||August 2015||2015-08-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Single Loop DJB Sleeve Gastrectomy for Poorly Controlled T2DM|Prospective Randomized Trial Comparing Single Loop Duodenojejunal Bypass With Sleeve Gastrectomy Versus Standard Roux-en-Y Gastric Bypass in Patients With Poorly Controlled Type 2 Diabetes Mellitus: From Clinical Outcomes to Hormonal Mechanism|Recruiting||N/A|80|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||Undecided||2017-10-10 21:08:36.504118|2017-10-10 21:08:36.504118
NCT03124953|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||March 2009||2009-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:41.167931|2017-10-10 21:08:41.167931
NCT03125343|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-21|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|April 2024|Anticipated|2024-04-01|April 2021|Anticipated|2021-04-01||Interventional|WoW||Watch and Wait as Treatment for Patients With Rectal Cancer|A Multicenter Prospective National Cohort Study for Patients With Advanced Rectal Cancer - is it Possible to Induce Remission and Avoid Surgery - Watch and Wait?|Active, not recruiting||N/A|200|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f|f|f||||||Undecided||2017-10-10 21:08:36.697471|2017-10-10 21:08:36.697471
NCT03125330|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-21|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|||The Impact of Professional Coaching on Early Career Academic Emergency Physicians|The Impact of Professional Coaching on Early Career Academic Emergency Physician Well-Being, Burnout, Leadership Strengths, and Goal Attainment: A Pilot Randomized, Controlled Trial|Recruiting||N/A|90|Anticipated|Mayo Clinic||3|||f||||f|f|f||||||||2017-10-10 21:08:36.895466|2017-10-10 21:08:36.895466
NCT03125317|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-17|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|July 9, 2017|Actual|2017-07-09|June 30, 2017|Actual|2017-06-30||Observational|||Evaluating the Efficacy of Valsalva's Maneuver and Music Therapy on Peripheral Venous Cannulation|Evaluating the Efficacy of Valsalva's Maneuver and Music Therapy on Peripheral Venous Cannulation Pain and Anxiety|Completed||N/A|150|Actual|Tokat Gaziosmanpasa University|||3||f||||f|f|f||||||||2017-10-10 21:08:37.029021|2017-10-10 21:08:37.029021
NCT03125304|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-20|||May 21, 2017|Actual|2017-05-21|July 2017|2017-07-01|May 30, 2020|Anticipated|2020-05-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Acupuncture for Pain of Endometriosis|Acupuncture for Pain of Endometriosis: A Multicenter, Randomized, and Controlled Trial|Recruiting||N/A|106|Anticipated|State Administration of Traditional Chinese Medicine of the People's Republic of China||2|||f|||||f|f||||||||2017-10-10 21:08:37.110008|2017-10-10 21:08:37.110008
NCT03125291|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-21|||July 28, 2015|Actual|2015-07-28|April 2017|2017-04-01|September 1, 2019|Anticipated|2019-09-01|April 15, 2019|Anticipated|2019-04-15||Interventional|Bridges||Optimizing a Drug Abuse Prevention Program for Dissemination|Optimizing a Drug Abuse Prevention Program for Dissemination|Recruiting||N/A|600|Anticipated|Arizona State University||2|||f||||t|f|f||||||No||2017-10-10 21:08:37.21268|2017-10-10 21:08:37.21268
NCT03125278|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-19|||April 11, 2017|Actual|2017-04-11|March 2017|2017-03-01|May 1, 2018|Anticipated|2018-05-01|October 1, 2017|Anticipated|2017-10-01||Observational|||Patient Knowledge of Medication Indication|Patient Knowledge of Medication Indication|Recruiting||N/A|40|Anticipated|HealthPartners Institute|||2||f||||f|f|f||||||No||2017-10-10 21:08:37.298285|2017-10-10 21:08:37.298285
NCT03125265|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-20|||January 5, 2014|Actual|2014-01-05|April 2017|2017-04-01|January 31, 2016|Actual|2016-01-31|January 31, 2016|Actual|2016-01-31||Observational|||DIETary Intake, Death and Hospitalization in Adult With End-stage Kidney Disease Treated With HemoDialysis (DIET-HD) Study|DIETary Intake, Death and Hospitalization in Adult With End-stage Kidney Disease Treated With HemoDialysis (DIET-HD) Study|Completed||N/A|9757|Actual|University of Bari|||1||f|||||f|f||||||||2017-10-10 21:08:37.384867|2017-10-10 21:08:37.384867
NCT03125252|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-04-21|||October 27, 2016|Actual|2016-10-27|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|DELIREA||Impact of Non-pharmacological Prevention Measures on the Incidence of Delirium in Adult Intensive Care Units|Impact of Non-pharmacological Prevention Measures on the Incidence of Delirium in Adult Intensive Care Units|Recruiting||N/A|952|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-10 21:08:37.458486|2017-10-10 21:08:37.458486
NCT03125239|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-10|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 1 Study of Merestinib in Combination With LY2874455 in Relapsed or Refractory Acute Myeloid Leukemia|Recruiting||Phase 1|31|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:08:37.643277|2017-10-10 21:08:37.643277
NCT03125226|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-15|||September 14, 2017|Anticipated|2017-09-14|August 2017|2017-08-01|May 16, 2019|Anticipated|2019-05-16|May 16, 2018|Anticipated|2018-05-16||Interventional|||TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer|TraceIT TM Hydrogel Tissue Marker for Patients Receiving Definitive Chemoradiation for Bladder Cancer|Recruiting||N/A|12|Anticipated|University of Washington||1|||f||||t|f|t|f|||||||2017-10-10 21:08:37.746115|2017-10-10 21:08:37.746115
NCT03125200|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-29|||May 12, 2017|Actual|2017-05-12|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Study of ADCT-502 in Patients With Advanced Solid Tumors With HER2 Expression|A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-502 in Patients With Advanced Solid Tumors With HER2 Expression|Recruiting||Phase 1|278|Anticipated|ADC Therapeutics SARL||1|||f||||f|t|f||||||||2017-10-10 21:08:37.951846|2017-10-10 21:08:37.951846
NCT03125187|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-18|||December 12, 2017|Anticipated|2017-12-12|March 2017|2017-03-01|May 30, 2018|Anticipated|2018-05-30|March 12, 2018|Anticipated|2018-03-12||Interventional|||Study With Heparin Sodium in Intravenous Administration|Phase I Study With Pharmacodynamic Determination of Unfractionated Heparin of Porcine Origin of the Company União Química of Intravenous Use in Healthy Participants|Not yet recruiting||Phase 1|24|Anticipated|União Química Farmacêutica Nacional S/A||2|||f||||t|t|f|||t|||No||2017-10-10 21:08:38.052997|2017-10-10 21:08:38.052997
NCT03125174|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-20|||March 10, 2017|Actual|2017-03-10|July 2017|2017-07-01|June 27, 2017|Actual|2017-06-27|June 27, 2017|Actual|2017-06-27||Observational|||Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls|Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls|Completed||N/A|30|Actual|University of North Carolina, Chapel Hill|||2||f||||f|f|f||||Samples Without DNA|"     sputum   "|||2017-10-10 21:08:38.170741|2017-10-10 21:08:38.170741
NCT03124940|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||January 6, 2010||2010-01-06||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:41.208761|2017-10-10 21:08:41.208761
NCT03125161|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-21|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM|A Prospective, Randomized, One-center Study Comparing Hepatic Arterial Infusion Plus Chemotherapy ± Target Therapy and Chemotherapy ± Target Therapy Alone in Patients With Unresectable Colorectal Cancer Liver Metastases|Recruiting||Phase 3|150|Anticipated|Fudan University||2|||f|||||f|f||||||||2017-10-10 21:08:38.255132|2017-10-10 21:08:38.255132
NCT03125148|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-03|||May 27, 2017|Actual|2017-05-27|April 2017|2017-04-01|March 19, 2018|Anticipated|2018-03-19|March 19, 2018|Anticipated|2018-03-19||Interventional|||Comparison of Duodenal Stenting vs Transpyloric and Duodenal Stenting for Malignant Obstruction|Comparison of Duodenal Stenting vs Transpyloric and Duodenal Stenting for Malignant Obstruction|Recruiting||N/A|40|Anticipated|Medical College of Wisconsin||2|||f||||f|f|t|f|||||No||2017-10-10 21:08:38.37468|2017-10-10 21:08:38.37468
NCT03125135|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||November 12, 2014||2014-11-12||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:38.49039|2017-10-10 21:08:38.49039
NCT03125122|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||September 30, 2014||2014-09-30||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:39.209564|2017-10-10 21:08:39.209564
NCT03125109|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||March 2, 2015||2015-03-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:39.249274|2017-10-10 21:08:39.249274
NCT03125096|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||August 28, 2015||2015-08-28||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:39.286047|2017-10-10 21:08:39.286047
NCT03125083|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-25|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|RIP-LC||Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus|Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus|Recruiting||N/A|40|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 21:08:39.324741|2017-10-10 21:08:39.324741
NCT03125070|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||January 16, 2018|Anticipated|2018-01-16|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant|INSPIRE: A Multicenter Randomized Controlled Trial Integrating Health Informatics in a Scalable Stepped Care Self-management Program for Survivors After Hematopoietic Cell Transplantation|Not yet recruiting||N/A|2650|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t|f|f||||||||2017-10-10 21:08:39.418217|2017-10-10 21:08:39.418217
NCT03125057|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-12|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain|A Pilot Study of Hemoporfin Photodynamic Therapy in Children (7-14 Years Old) With Port-wine Stain|Recruiting||Phase 4|40|Anticipated|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:08:39.578117|2017-10-10 21:08:39.578117
NCT03125044|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||May 2, 2014||2014-05-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:39.672951|2017-10-10 21:08:39.672951
NCT03125031|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||July 10, 2014|Actual|2014-07-10|June 2017|2017-06-01|July 25, 2014|Actual|2014-07-25|July 25, 2014|Actual|2014-07-25||Interventional|||Comparison of Noninvasive Hemoglobin Disposable Sensors||Completed||N/A|44|Actual|Masimo Corporation||2|||f|||||f|t|f|f|f|||||2017-10-10 21:08:39.715646|2017-10-10 21:08:39.715646
NCT03125018|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||September 30, 2014|Actual|2014-09-30|June 2017|2017-06-01|October 9, 2014|Actual|2014-10-09|October 9, 2014|Actual|2014-10-09||Interventional|||Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)||Completed||N/A|13|Actual|Masimo Corporation||1|||f|||||f|t|f|f|f|||||2017-10-10 21:08:39.8802|2017-10-10 21:08:39.8802
NCT03125005|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||April 12, 2012|Actual|2012-04-12|June 2017|2017-06-01|June 21, 2012|Actual|2012-06-21|June 21, 2012|Actual|2012-06-21||Interventional|||Accuracy of Methemoglobin Measurement for Rainbow Universal Pulse Oximeter Sensor||Completed||N/A|51|Actual|Masimo Corporation||1|||f|||||f|t|f|||||||2017-10-10 21:08:40.036853|2017-10-10 21:08:40.036853
NCT03124524|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-24|||January 15, 2015|Actual|2015-01-15|April 2017|2017-04-01|October 10, 2016|Actual|2016-10-10|September 20, 2016|Actual|2016-09-20||Interventional|||Treatment Choice in Primary Dysmenorrhea|Which do You Think is the Best Treatment Choice in Primary Dysmenorrhea?|Completed||Phase 4|99|Actual|Adana Numune Training and Research Hospital||3|||f||||t|f|f||||||Yes|if needed|2017-10-10 21:08:40.404392|2017-10-10 21:08:40.404392
NCT03124511|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-10-05|||August 15, 2017|Actual|2017-08-15|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Neuropathic Pain After Breast Surgery|DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Breast Surgery|Recruiting||N/A|275|Anticipated|Danish Pain Research Center|||1||f||||t|f|f||||Samples With DNA|"     Blood   "|||2017-10-10 21:08:40.533833|2017-10-10 21:08:40.533833
NCT03124498|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||November 2017|Anticipated|2017-11-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA|A Phase I/II, Open Label Study to Evaluate the Safety and Efficacy of Autologous Cytokine-Induced Killer (CIK) Cell for Patients With Hepatocellular Carcinoma (HCC) After Transarterial Chemoembolization (TACE), Percutaneous Ethanol Injection Therapy (PEIT) or RadioFrequency Ablation (RFA) Therapy|Not yet recruiting||Phase 1/Phase 2|55|Anticipated|Chuan An Biotechnology Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 21:08:40.684145|2017-10-10 21:08:40.684145
NCT03124992|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||January 18, 2012||2012-01-18||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:40.776093|2017-10-10 21:08:40.776093
NCT03124979|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||January 18, 2012|Actual|2012-01-18|June 2017|2017-06-01|April 10, 2012|Actual|2012-04-10|April 10, 2012|Actual|2012-04-10||Interventional|||Accuracy of Noninvasive Pulse Oximeter Sensor (LNCS DBI)||Completed||N/A|13|Actual|Masimo Corporation||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:08:40.831243|2017-10-10 21:08:40.831243
NCT03124914|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-04-25|||April 2017|Anticipated|2017-04-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|ACT PHY HIV||Relationship Between Neuromuscular Fatigue, Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV|Relationship Between Neuromuscular Fatigue, Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV|Not yet recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||No||2017-10-10 21:08:41.421742|2017-10-10 21:08:41.421742
NCT03124901|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-08|2017-05-08||September 30, 2008|Actual|2008-09-30|May 2017|2017-05-01|October 27, 2008|Actual|2008-10-27|October 27, 2008|Actual|2008-10-27||Interventional|||Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor||Completed||N/A|147|Actual|Masimo Corporation||1|||f|||||f|t|f|f|f|||||2017-10-10 21:08:41.506748|2017-10-10 21:08:41.506748
NCT03124888|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||December 10, 2008||2008-12-10||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:41.698776|2017-10-10 21:08:41.698776
NCT03124875|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-12|||June 8, 2017|Actual|2017-06-08|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System|Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System for Creating an AV Fistula for the Treatment of Critical Limb Ischemia|Recruiting||N/A|10|Anticipated|LimFlow, Inc.||1|||||||t|f|t|t|||||||2017-10-10 21:08:41.743498|2017-10-10 21:08:41.743498
NCT03124862|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||March 17, 2009||2009-03-17||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:41.835569|2017-10-10 21:08:41.835569
NCT03124849|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||December 10, 2008||2008-12-10||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:41.876105|2017-10-10 21:08:41.876105
NCT03124836|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||November 18, 2009|Actual|2009-11-18|June 2017|2017-06-01|December 17, 2009|Actual|2009-12-17|December 17, 2009|Actual|2009-12-17||Interventional|||Accuracy of Methemoglobin Measurement of Various Rainbow Pulse Oximeter Sensors||Completed||N/A|28|Actual|Masimo Corporation||1|||f|||||f|t|f|||||||2017-10-10 21:08:41.919673|2017-10-10 21:08:41.919673
NCT03124823|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|2017-05-08||August 28, 2015|Actual|2015-08-28|June 2017|2017-06-01|September 8, 2015|Actual|2015-09-08|September 8, 2015|Actual|2015-09-08||Interventional|||Accuracy of Noninvasive Pulse Oximeter Sensor (Rainbow DCI)||Completed||N/A|11|Actual|Masimo Corporation||1|||f|||||f|t|f|f|f|||||2017-10-10 21:08:42.06742|2017-10-10 21:08:42.06742
NCT03124485|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|August 2020|Anticipated|2020-08-01||Interventional|||Endoscopic Sleeve Gastroplasty for Morbid Obesity|Prospective Randomized Trial Comparing Endoscopic Sleeve Gastroplasty Versus Conventional Laparoscopic Sleeve Gastrectomy in Patients With Morbid Obesity: From Physical and Functional Outcomes to Changes in Hormonal Profiles|Not yet recruiting||N/A|37|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||Undecided||2017-10-10 21:08:42.200472|2017-10-10 21:08:42.200472
NCT03124472|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa|Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa|Not yet recruiting||N/A|200|Anticipated|Cairo University||2|||f||||t|f|f||||||Yes||2017-10-10 21:08:42.292922|2017-10-10 21:08:42.292922
NCT03124446|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|MB-College||Mindfulness-Based College: Pilot RCT|Mindfulness-Based College: Pilot Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Brown University||2|||f||||f|f|f||||||Yes|Personally de-identified data will be made available to researchers with IRB approval.|2017-10-10 21:08:42.517127|2017-10-10 21:08:42.517127
NCT03124433|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-08-11|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|June 1, 2018|Anticipated|2018-06-01||Interventional|||Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer|Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in the Treatment of Intermediate to High Risk Prostate Cancer|Recruiting||Phase 2|30|Anticipated|Singapore General Hospital||1|||f||||f|f|f|||f|||||2017-10-10 21:08:42.620007|2017-10-10 21:08:42.620007
NCT03124420|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||April 14, 2017|Actual|2017-04-14|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Intraluminal Therapy for Helicobacter Pylori Infection|Intraluminal Therapy for Helicobacter Pylori Infection|Recruiting||Phase 4|100|Anticipated|Mackay Memorial Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 21:08:42.710474|2017-10-10 21:08:42.710474
NCT03124407|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Randomized, Multi-Dose, Placebo-Controlled OA Knee Pain Relief Study of 0.25% 920-CGS-200|A Randomized, Multi-Dose, Placebo-Controlled Pain Relief Study of 0.25% 920-CGS-200 in Subjects With Preexisting Knee Pain (for at Least 6 Months) Caused by Osteoarthritis (OA)|Completed||Phase 4|120|Actual|Vizuri Health Sciences LLC||4|||f||||f|f|f|||f|||No||2017-10-10 21:08:42.818402|2017-10-10 21:08:42.818402
NCT03124394|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-20|||June 1, 2015|Actual|2015-06-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31|5 Years|Observational [Patient Registry]|||Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study|Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study|Recruiting||N/A|100|Anticipated|Kantonsspital Winterthur KSW|||1||f||||f|f|f||||||Undecided||2017-10-10 21:08:42.900973|2017-10-10 21:08:42.900973
NCT03124810|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||March 2, 2016||2016-03-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:42.973265|2017-10-10 21:08:42.973265
NCT03124680|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-15|||April 20, 2017|Actual|2017-04-20|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|||Opioid Free Anesthesia and Continuous Post-operative Pulse Oximetry Monitoring in the Obese Patient|Opioid Free Anesthesia and Continuous Post-operative Pulse Oximetry Monitoring in the Obese Patient: How About Another Approach?|Completed||N/A|30|Actual|Université Libre de Bruxelles||2|||f||||t|f|f||||||||2017-10-10 21:08:43.917131|2017-10-10 21:08:43.917131
NCT03124667|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-18|||September 2016||2016-09-01|April 2017|2017-04-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|CORTEX-II||Cognitive Regulation Training and Exercise Trial|Cognitive Regulation Training and Exercise (CORTEX)-II With Middle-Aged Adults|Recruiting||N/A|250|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f|f|f||||||Yes|Upon study completion and after publication of the primary aims and hypotheses, the investigators will provide de-identified data to any interested parties with the provision that they consult with the investigators about the study design, analytical procedures, and to avoid redundancy in future planned analyses or manuscripts. The PI will be given priority and will work closely with other investigators in maximizing ways to leverage the data to address other research questions. Data generated from this project will be made available in multiple formats with codebooks via NCBI's BioProject within 12 months of completing aforementioned priorities. These include demographic information (e.g., age, gender, and education), group assignment codes, and outcome measures. No personally identifying information will be included. Users must also agree to the conditions of use governing access to the public release data.|2017-10-10 21:08:44.011889|2017-10-10 21:08:44.011889
NCT03124654|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-02|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|July 30, 2017|Actual|2017-07-30||Observational|||Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)|Development and Validation of a Novel Educational Program for Patients Prescribed Non-vitamin K Anticoagulants (NOAC)|Completed||N/A|60|Actual|University Hospital, Basel, Switzerland|||1||f|||||f|f||||||||2017-10-10 21:08:44.138079|2017-10-10 21:08:44.138079
NCT03124628|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-29|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|CP-Flywheel||Effects of Flywheel Exercise on Muscle and Walking Function in Teenagers and Young Adults With Cerebral Palsy|Effects of Flywheel Resistance Exercise Training on Muscle and Walking Function in Teenagers and Young Adults With Cerebral Palsy|Recruiting||N/A|40|Anticipated|Karolinska Institutet||2|||f||||t|f|f||||||No||2017-10-10 21:08:44.369176|2017-10-10 21:08:44.369176
NCT03124615|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-20|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|EFFECT||Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer|Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer|Recruiting||Phase 2|47|Anticipated|Macquarie University, Australia||1|||f||||f|f|f|||f|||No||2017-10-10 21:08:44.476905|2017-10-10 21:08:44.476905
NCT03124602|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-08|||March 7, 2017||2017-03-07||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:44.57311|2017-10-10 21:08:44.57311
NCT03124589|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-29|||April 21, 2017|Actual|2017-04-21|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparing the Efficacy of an Online Gambling Intervention to a no Intervention Control Condition|Comparing the Efficacy of an Online Gambling Intervention to a no Intervention Control Condition: Randomized Controlled Trial|Active, not recruiting||N/A|321|Actual|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||No||2017-10-10 21:08:44.616312|2017-10-10 21:08:44.616312
NCT03124576|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-04-18|||November 2016||2016-11-01|April 2017|2017-04-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|RACE V- WP 5||Reappraisal of Atrial Fibrillation: RACE V - Work Package 5|Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of AF- Closing the Translational Gap|Recruiting||N/A|380|Anticipated|Academisch Ziekenhuis Maastricht|||4||f||||t||||||Samples With DNA|"     atrial tissue samples, whole blood   "|Undecided||2017-10-10 21:08:44.695734|2017-10-10 21:08:44.695734
NCT03124550|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-11|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Development of An Exergame for Caregivers of Family Members With Alzheimer's Disease|Development of An Exergame for Caregivers of Family Members With Alzheimer's Disease|Recruiting||N/A|20|Anticipated|Brandeis University||1|||f||||f|f|f||||||No||2017-10-10 21:08:44.894665|2017-10-10 21:08:44.894665
NCT03124537|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-12|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Increasing Physical Activity Among Sedentary Older Adults:What, Where, When, and With Whom|Increasing Physical Activity Among Sedentary Older Adults:What, Where, When, and With Whom|Not yet recruiting||N/A|30|Anticipated|Brandeis University||3|||f||||f|f|f||||||||2017-10-10 21:08:44.986914|2017-10-10 21:08:44.986914
NCT03047720|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-02-06|||November 2016||2016-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Scheduled Awakenings for the Treatment of Nocturnal Enuresis|Scheduled Awakenings for the Treatment of Nocturnal Enuresis|Recruiting||N/A|40|Anticipated|Indiana University||2|||f||||f||||||||Undecided||2017-10-10 21:21:25.458412|2017-10-10 21:21:25.458412
NCT03124368|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-10-03|||August 9, 2017|Actual|2017-08-09|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN|A Phase 2a Proof-of-Mechanism, Open-Label Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With Low C3 Levels Due to Either C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)|Recruiting||Phase 2|10|Anticipated|Achillion Pharmaceuticals||2|||f|||||t|f|||t|||||2017-10-10 21:08:45.12051|2017-10-10 21:08:45.12051
NCT03124342|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-12|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|VIP||Vanderbilt ICU Recovery Program Pilot Trial|Vanderbilt ICU Recovery Program Pilot Trial|Recruiting||N/A|550|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 21:08:45.342378|2017-10-10 21:08:45.342378
NCT03124329|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-09|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Efficacy of Methods to Treat Multiple Gingival Recession Defects|An Open Prospective Randomized Controlled Clinical Trial to Examine the Efficacy of Methods to Treat Multiple Gingival Recession Defects|Recruiting||N/A|100|Anticipated|University of Southern California||4|||f||||f|f|t|f|f|f|||Yes|The intra-oral clinical photography, CBCT scans, study models and clinical data will be shared with other investigators for data analysis.|2017-10-10 21:08:45.458134|2017-10-10 21:08:45.458134
NCT03124316|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-19|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|September 30, 2017|Anticipated|2017-09-30||Interventional|||Testing a Behavioural Approach to Improving Cancer Screening Rates|Testing a Behavioural Approach to Improving Cancer Screening Rates Through Increased Use of Primary Care Feedback Reports|Active, not recruiting||N/A|5710|Anticipated|Women's College Hospital||8|||f||||f|f|f||||||No||2017-10-10 21:08:45.567943|2017-10-10 21:08:45.567943
NCT03124303|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-18|||February 13, 2017|Actual|2017-02-13|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|IPOD-B3||Interventions for Postoperative Delirium: Biomarker-3|Interventions for Postoperative Delirium: Biomarker-3|Recruiting||N/A|155|Anticipated|University of Wisconsin, Madison|||1||f||||f|f|f|||f|Samples Without DNA|"     Participant blood will be collected and stored for future analysis.   "|No||2017-10-10 21:08:45.669188|2017-10-10 21:08:45.669188
NCT03124290|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-20|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|May 20, 2017|Actual|2017-05-20|May 14, 2017|Actual|2017-05-14||Interventional|||The Effect of Attention Distractor on the Quality of Chest Compression|The Effect of Attention Distractor During Cardiopulmonary Resuscitation on the Quality of Chest Compression: Randomized Crossover Trial With Simulated Situation|Completed||N/A|44|Actual|Inje University||2|||f|||||f|f||||||||2017-10-10 21:08:45.763339|2017-10-10 21:08:45.763339
NCT03124277|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-09-15|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nutritional Support for Rehabilitation In Parkinsonism|A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Patients With Parkinsonism Undergoing Rehabilitation Treatment: a Randomized Trial|Recruiting||N/A|140|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||f|f|f||||||||2017-10-10 21:08:45.839738|2017-10-10 21:08:45.839738
NCT03124264|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||October 4, 2011||2011-10-04||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:45.937418|2017-10-10 21:08:45.937418
NCT03124251|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||January 2010||2010-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:45.978813|2017-10-10 21:08:45.978813
NCT03124238|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-21|||May 1, 2016|Actual|2016-05-01|April 2017|2017-04-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional|||Effect of Massage Therapy on Muscle Fatigue|Effect of Massage Therapy on Muscle Fatigue in Individuals With Low Back Pain: Physiological or Clinical Changes|Completed||N/A|36|Actual|Université du Québec à Trois-Rivières||2|||f||||f|f|f||||||No|No data sharing will be done|2017-10-10 21:08:46.019831|2017-10-10 21:08:46.019831
NCT03124225|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||June 2011||2011-06-01|September 2016|2016-09-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Observational|||Ultrasound Utility in Routine Clinical Practise|The Impact of Rheumatologist-performed Ultrasound on Diagnosis and Management of Inflammatory Arthritis in Routine Clinical Practice|Completed||N/A|258|Actual|Barts & The London NHS Trust|||2||f||||f||||||||||2017-10-10 21:08:46.085041|2017-10-10 21:08:46.085041
NCT03124212|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-18|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|September 30, 2022|Anticipated|2022-09-30|March 31, 2018|Anticipated|2018-03-31||Observational|CASCADE||Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland|Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland|Recruiting||N/A|700|Anticipated|University of Basel|||1||f||||t|f|f||||||Yes|Upon request, including purpose and expected timeline, anonymized patient data will be shared|2017-10-10 21:08:46.153949|2017-10-10 21:08:46.153949
NCT03124186|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-03|||April 1, 2008|Actual|2008-04-01|May 2017|2017-05-01|June 30, 2013|Actual|2013-06-30|June 30, 2013|Actual|2013-06-30||Interventional|||Sensory-driven Motor Recovery in Poorly Recovered Subacute Stroke Patients|Sensory-driven Motor Recovery in Poorly Recovered Subacute Stroke Patients|Completed||N/A|73|Actual|University of Kentucky||2|||f||||f|f|f||||||No||2017-10-10 21:08:46.370256|2017-10-10 21:08:46.370256
NCT03124160|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-07|||May 26, 2017|Actual|2017-05-26|September 2017|2017-09-01|November 1, 2021|Anticipated|2021-11-01|May 1, 2021|Anticipated|2021-05-01||Interventional|||Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard|A Multi-center, Single-blind, Randomized Clinical Trial to Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard|Recruiting||Phase 3|1000|Anticipated|Health Decisions||2|||f||||t|t|f||||||||2017-10-10 21:08:46.537346|2017-10-10 21:08:46.537346
NCT03124147|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-21|||August 2011|Actual|2011-08-01|April 2017|2017-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Hemiparesis|Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Severe Post-stroke Hemiparesis|Completed||N/A|38|Actual|University of Kentucky||4|||f||||f|f|f||||||No||2017-10-10 21:08:46.732414|2017-10-10 21:08:46.732414
NCT03124134|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|GLIDE||Gelesis Glycemic Index Study|A Randomized, Open-label, Crossover Study Assessing the Effects of Gelesis200 on Glucose and Insulin Following a Single Administration of Gelesis200 in Healthy Subjects|Active, not recruiting||N/A|20|Actual|Gelesis, Inc.||6|||f||||f|f|f|||f|||No|The individual data will not be available to other researchers.|2017-10-10 21:08:46.828243|2017-10-10 21:08:46.828243
NCT03124121|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-03|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|GO-LEVEL||Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels|Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels|Not yet recruiting||Phase 4|84|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f|t|f|||f|||No||2017-10-10 21:08:46.924326|2017-10-10 21:08:46.924326
NCT03124108|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-10-03|||April 5, 2017|Actual|2017-04-05|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Elafibranor at Doses of 80 mg and 120mg After 12 Weeks of Treatment in Patients With Primary Biliary Cholangitis and Inadequate Response to Ursodeoxycholic Acid|Recruiting||Phase 2|45|Anticipated|Genfit||3|||f||||f|t|f||||||||2017-10-10 21:08:47.006514|2017-10-10 21:08:47.006514
NCT03124095|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-20|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|+Vida||Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer|Effects of Combined Training on Quality of Life, Neuromuscular and Cardiorespiratory Parameters in Patients Who Have Completed the Primary Treatment for Breast Cancer: a Randomized Clinical Trial|Recruiting||N/A|42|Anticipated|Federal University of Pelotas||2|||f||||t||||||||||2017-10-10 21:08:47.182832|2017-10-10 21:08:47.182832
NCT03124082|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-04-18|||January 4, 2017|Actual|2017-01-04|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|OFA||OFA - Opioid Free Anesthesia|"Study Protocol OFA: Opioid-Free Anesthesia."|Recruiting||Phase 4|64|Anticipated|University of Parma||2|||f||||t|f|f||||||No||2017-10-10 21:08:47.285767|2017-10-10 21:08:47.285767
NCT03124069|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-06|||April 24, 2017||2017-04-24||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:47.377006|2017-10-10 21:08:47.377006
NCT03124056|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-18|||January 10, 2013|Actual|2013-01-10|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28|1 Year|Observational [Patient Registry]|BIOECP_GVHD||Clinical and Biomarker Study of the Efficacy of Extracorporeal Photopheresis in Graft-versus-host Disease|Clinical and Biological Study of the Efficacy of the Use of Closed Extracorporeal Photopheresis in Acute or Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Transplantation|Completed||N/A|62|Actual|Fundación para la Investigación del Hospital Clínico de Valencia|||1||f||||t|f|t|f|f|f|||Undecided||2017-10-10 21:08:47.419148|2017-10-10 21:08:47.419148
NCT03124043|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-07|||April 2015||2015-04-01|July 2017|2017-07-01|May 1, 2017|Actual|2017-05-01|September 2016|Actual|2016-09-01||Interventional|GIT-2||Get In Touch Phase 2|Get In Touch Phase 2 - Evaluating a Diabetes Care Support Program Facilitated by Cellular-enabled Glucose Meters, a Randomized Crossover Trial|Completed||N/A|120|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-10 21:08:47.501574|2017-10-10 21:08:47.501574
NCT03124030|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-20|||August 2, 2016|Actual|2016-08-02|April 2017|2017-04-01|November 15, 2018|Anticipated|2018-11-15|November 15, 2017|Anticipated|2017-11-15||Observational|NOADB||Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy|Evaluation of the Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy Patients: a Longitudinal Observational Cohort Study|Recruiting||N/A|128|Anticipated|University of Trieste|||2||f||||f|f|f||||||No||2017-10-10 21:08:47.587263|2017-10-10 21:08:47.587263
NCT03124017|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients|Electronic Alert System Combined With a Risk Score Calculation Tool for Improving Appropriate Thromboprophylaxis in Hospitalized Medical Patients: a Randomized Controlled Trial|Completed||N/A|1756|Actual|University Hospital Inselspital, Berne||2|||f||||||||||||||2017-10-10 21:08:47.717895|2017-10-10 21:08:47.717895
NCT03124004|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-18|||August 15, 2016|Actual|2016-08-15|April 2017|2017-04-01|November 15, 2018|Anticipated|2018-11-15|November 15, 2017|Anticipated|2017-11-15||Observational|NOADB_db||Evaluation of the Intra- and Post- Operative Bleeding After Periodontal Debridement in Direct Anticoagulant Patients|Evaluation of the Intra- and Post- Operative Bleeding After After Periodontal Debridement in Direct Oral Anticoagulation Patients: a Longitudinal Observational Cohort Study|Recruiting||N/A|128|Anticipated|University of Trieste|||2||f||||f|f|f||||||No||2017-10-10 21:08:47.79385|2017-10-10 21:08:47.79385
NCT03123991|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-18|||October 10, 2016|Actual|2016-10-10|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Applying the Spanish Version of the UP-A as a Universal School-based Anxiety and Depression Prevention Program|Applying the Spanish Version of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Adolescents as a Universal School-based Anxiety and Depression Prevention Program: a Cluster Randomized Controlled-trial|Active, not recruiting||N/A|157|Actual|Universidad Nacional de Educación a Distancia||2|||f|||||f|f||||||Undecided||2017-10-10 21:08:47.907983|2017-10-10 21:08:47.907983
NCT03123978|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-22|||January 9, 2017|Actual|2017-01-09|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|July 2020|Anticipated|2020-07-01||Interventional|||Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer|A Safety Trial of Enzalutamide in Combination With PDMX1001/Niclosamide in Castration-Resistant Prostate Cancer (CRPC)|Recruiting||Phase 1|12|Anticipated|University of California, Davis||1|||f||||t|t|f||||||||2017-10-10 21:08:48.158682|2017-10-10 21:08:48.158682
NCT03123328|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-19|||June 30, 2016|Actual|2016-06-30|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|March 24, 2017|Actual|2017-03-24||Interventional|||Evaluation of Non-Invasive Hemoglobin in Trauma Patients|Evaluation of Non-Invasive Hemoglobin in Trauma Patients Using FDA-Cleared Masimo Pulse CO-Oximeter|Active, not recruiting||N/A|380|Actual|Masimo Corporation||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:08:48.302048|2017-10-10 21:08:48.302048
NCT03123315|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Optimization of Ureterolysis During Hysterectomy|Optimization of Parameters for Ureterolysis During Minimally Invasive Hysterectomy; Determining Variation in Ureter Position and Degree of Thermal Spread|Not yet recruiting||N/A|24|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|f|t|f|f||||||2017-10-10 21:08:48.384987|2017-10-10 21:08:48.384987
NCT03123302|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-02|||May 10, 2017|Anticipated|2017-05-10|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|February 1, 2018|Anticipated|2018-02-01||Observational|||Our Anesthesia Experience During MRI Scan|Our Anesthesia Experience During MRI Scan|Not yet recruiting||N/A|1000|Anticipated|Akdeniz University|||4||f||||f|f|f||||||||2017-10-10 21:08:48.495811|2017-10-10 21:08:48.495811
NCT03123289|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-19|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Novel Gallium 68 Citrate in Orthopedic Infections|Novel Gallium 68 Citrate in Orthopedic Infections|Recruiting||Phase 2|17|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|t|f||||||||2017-10-10 21:08:48.592417|2017-10-10 21:08:48.592417
NCT03123276|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-18|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|GEMMK||Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma|A Phase I Study to Assess the Safety and Tolerability of Pembrolizumab in Combination With Fixed Rate Gemcitabine Chemotherapy in Patients With Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t|f|f||||||No||2017-10-10 21:08:48.717589|2017-10-10 21:08:48.717589
NCT03123263|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-20|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|||Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer|Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer|Active, not recruiting||N/A|500|Anticipated|Texas Tech University Health Sciences Center, El Paso|||1||f||||f|f|f||||||No||2017-10-10 21:08:48.827203|2017-10-10 21:08:48.827203
NCT03123250|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-30|||September 6, 2017|Anticipated|2017-09-06|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|November 2019|Anticipated|2019-11-01||Interventional|WATERII||Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II|Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II|Recruiting||N/A|100|Anticipated|PROCEPT BioRobotics||1|||f||||t|f|t|t|f||||||2017-10-10 21:08:48.906344|2017-10-10 21:08:48.906344
NCT03123237|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-04-20|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Quantitative Renal Uptake Using TC99m DMSA in Hypertensive &/or Diabetic Patients.|Quantitative Renal Uptake Using TC99m DMSA in Hypertensive &/or Diabetic Patients.|Recruiting||Phase 4|45|Anticipated|Assiut University||4|||f|||||f|f|||f|||||2017-10-10 21:08:49.10732|2017-10-10 21:08:49.10732
NCT03123224|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-20|||August 2015||2015-08-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|COACH||The COACH Project: Combined Online Assistance for Caregiver Health|Combined Online Assistance for Caregiver Health (COACH): The Efficacy of a Combined Physical Activity and Coping Skills Training Intervention for Caregivers|Recruiting||N/A|200|Anticipated|Palo Alto Veterans Institute for Research||2|||f||||f||||||||No||2017-10-10 21:08:49.198473|2017-10-10 21:08:49.198473
NCT03123211|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18||||||April 2017|2017-04-01||||||||Expanded Access|||Expanded Access to Veliparib|Expanded Access to Veliparib|Available||N/A|||AbbVie||||||t|t||||||||||||2017-10-10 21:08:49.299276|2017-10-10 21:08:49.299276
NCT03123198|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-20|||March 2010|Actual|2010-03-01|April 2017|2017-04-01|December 2025|Anticipated|2025-12-01|March 2025|Anticipated|2025-03-01||Interventional|DBT-RU||Dialectical Behavior Therapy Rutgers University Research Program|Dialectical Behavior Therapy Rutgers University Research Program|Recruiting||N/A|100|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f|f|f||||||No||2017-10-10 21:08:49.371915|2017-10-10 21:08:49.371915
NCT03123185|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-10-04|||April 27, 2017|Actual|2017-04-27|October 2017|2017-10-01|December 18, 2017|Anticipated|2017-12-18|December 18, 2017|Anticipated|2017-12-18||Interventional|||Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 705564 (Single-blind, Partially Randomised, Placebo-controlled Parallel Group Design) and Food Effect on a Tablet Formulation of BI 705564 (Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Design) in Healthy Male Subjects|Recruiting||Phase 1|88|Anticipated|Boehringer Ingelheim||2|||f|||||f|f||||||||2017-10-10 21:08:49.467684|2017-10-10 21:08:49.467684
NCT03123172|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-08-21|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|July 15, 2017|Actual|2017-07-15|July 15, 2017|Actual|2017-07-15||Interventional|||The Validity of Central Venous to Arterial Co2 Difference During Living Donor Liver Transplantation|The Validity of Central Venous to Arterial Carbon Dioxide Difference to Predict Adequate Fluid Resuscitation During Living Donor Liver Transplantation|Completed||N/A|20|Actual|Kasr El Aini Hospital||1|||f||||f|f|f||||||||2017-10-10 21:08:49.566184|2017-10-10 21:08:49.566184
NCT03123159|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-19|||May 27, 2014|Actual|2014-05-27|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|||Clinical Performance Evaluation of DxN HBV Assay|Clinical Utility of the DxN HBV Assay as an Aid in the Management of HBV-Infected Individuals Undergoing Antiviral Therapy|Recruiting||N/A|260|Anticipated|Beckman Coulter, Inc.|||1||f||||f|||||t|Samples Without DNA|"     Frozen plasma samples are retained for this study and possible future studies.   "|No||2017-10-10 21:08:49.651855|2017-10-10 21:08:49.651855
NCT03123146|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-19|||June 1, 2010|Actual|2010-06-01|April 2017|2017-04-01|February 1, 2014|Actual|2014-02-01|February 1, 2014|Actual|2014-02-01||Interventional|||Cognitive Behavioural Therapy for Children With Autism Spectrum Disorder and Obsessive Compulsive Behaviour|Functional Behavior-based Cognitive-Behavioral Therapy for Obsessive Compulsive Behavior in Children With Autism Spectrum Disorder: A Randomized Controlled Trial|Completed||N/A|37|Actual|Brock University||2|||f|||||f|f||||||||2017-10-10 21:08:49.765067|2017-10-10 21:08:49.765067
NCT03123965|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18||||||April 2017|2017-04-01||||||||Expanded Access|||Expanded Access to Glecaprevir/ Pibrentasvir|Expanded Access to Glecaprevir/ Pibrentasvir|Available||N/A|||AbbVie||||||t|||||||||||||2017-10-10 21:08:49.864099|2017-10-10 21:08:49.864099
NCT03123952|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18||||||April 2017|2017-04-01||||||||Expanded Access|||Expanded Access to ABT-414|Expanded Access to ABT-414|Available||N/A|||AbbVie||||||t|t||||||||||||2017-10-10 21:08:49.940323|2017-10-10 21:08:49.940323
NCT03123939|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-02||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Treatment Protocol in Acute Lymphoblastic Leukemia|Expanded Treatment Protocol for Relapsed/Refractory Pediatric/Young Adult Acute Lymphoblastic Leukemia Patients to be Treated With CTL019|Available||N/A|||Novartis|||||f||||||||||||||2017-10-10 21:08:50.006402|2017-10-10 21:08:50.006402
NCT03123926|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-18|||November 2016||2016-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Spontaneous Preterm Birth Marker Test|Spontaneous Preterm Birth Marker Test (SPBMT): Preterm Prediction Prospective Study|Recruiting||N/A|600|Anticipated|Sprim Advanced Life Sciences|||1||f|||||f|f||||Samples Without DNA|"     Saliva, cervicovaginal fluid, serum and dried blood spot   "|||2017-10-10 21:08:50.101517|2017-10-10 21:08:50.101517
NCT03123913|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|STARFISH||Study of Testosterone and rHGH in FSHD|Study of Testosterone and rHGH in FSHD (STARFISH): A Proof-of-Concept Study|Recruiting||Phase 1|20|Anticipated|University of Rochester||1|||f|||||t|f|||f|||||2017-10-10 21:08:50.177243|2017-10-10 21:08:50.177243
NCT03123900|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-17|||November 26, 2015|Actual|2015-11-26|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of Physical and Cognitive Training in Neuroplasticity, Health and Cognition. Movement Project|Neuroplasticity in Adulthood: Physical Exercise and Cognitive Training; Integrative Omics Study on the Neurobiological Effects of Physical Activity and Cognitive Stimulation|Recruiting||N/A|140|Anticipated|University of Barcelona||4|||f||||f|f|f||||||Undecided||2017-10-10 21:08:50.284872|2017-10-10 21:08:50.284872
NCT03123887|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-17|||July 10, 2015|Actual|2015-07-10|April 2017|2017-04-01|October 10, 2016|Actual|2016-10-10|June 3, 2016|Actual|2016-06-03||Observational|BLING||Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL|A Retrospective Study to Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia(ALL)|Completed||N/A|632|Actual|Harbin Hematology and Oncology Institute|||1||f|||||t|t|f|f|f|||No|To protect the privacy of individual who participate in this trial we would not share the individual data with other researchers|2017-10-10 21:08:50.411292|2017-10-10 21:08:50.411292
NCT03123874|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-29|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|April 15, 2018|Anticipated|2018-04-15|October 2, 2017|Anticipated|2017-10-02||Interventional|MiLC||"Milk in Life Conditions (MiLC): Bacterial Composition of Human Milk Pumped and Stored in Real-Life Conditions"|"Milk in Life Conditions (MiLC): Characterizing the Bacterial Composition of Human Milk Pumped and Stored in Real-life Conditions"|Active, not recruiting||N/A|52|Actual|Cornell University||2|||f||||f|f|t|f|f||||||2017-10-10 21:08:50.512857|2017-10-10 21:08:50.512857
NCT03123861|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-06-26|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Gabapentin for Postop Pain After SSLF|RCT of Gabapentin Versus Placebo for Postoperative Pain After Sacrospinous Ligament Fixation for Pelvic Organ Prolapse|Recruiting||Phase 4|75|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|t|f|||f|||No||2017-10-10 21:08:50.589397|2017-10-10 21:08:50.589397
NCT03123848|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-06-16|||April 14, 2017|Actual|2017-04-14|June 2017|2017-06-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants|An Open-label Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single-oral Administration of Darunavir/Cobicistat Fixed-Dose Combination Tablet in Healthy Japanese Adult Subjects|Completed||Phase 4|8|Actual|Janssen Pharmaceutical K.K.||1|||f||||f|t|f|||t|||||2017-10-10 21:08:50.68166|2017-10-10 21:08:50.68166
NCT03123835|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-04-17|||March 2016||2016-03-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Outcome Analysis of POEM and Endoluminal Therapies|Outcome Analysis of Endoluminal Therapies for Gastrointestinal Conditions Compared to Current Treatment Paradigms|Enrolling by invitation||N/A|500|Anticipated|University of California, Davis||1|||f||||f||||||||Undecided|de-identified data will be maintained until study closure. Statistical summary of data will be published with any journal articles submitted for review/approval.|2017-10-10 21:08:50.758927|2017-10-10 21:08:50.758927
NCT03123822|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|SLICK||To Compare the Effectiveness of 3 Different Types of Lens and Lens Coating in Eliminating Symptoms for Children With Prolonged Visual Symptoms Due to a Concussion.|Spectacles Lens in Concussed Kids|Recruiting||N/A|90|Anticipated|University of Alabama at Birmingham||3|||f||||f|f|t|f||t|||||2017-10-10 21:08:50.836136|2017-10-10 21:08:50.836136
NCT03123809|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-20|||January 10, 2017|Actual|2017-01-10|April 2017|2017-04-01|December 15, 2020|Anticipated|2020-12-15|May 15, 2020|Anticipated|2020-05-15||Interventional|GES+PP||Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis|Combined Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis: Can Pyloroplasty be Effective Without GES?|Recruiting||N/A|50|Anticipated|Texas Tech University Health Sciences Center, El Paso||2|||f||||f||||||||No||2017-10-10 21:08:50.919928|2017-10-10 21:08:50.919928
NCT03123796|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-09-23|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Actual|2017-09-01||Observational|||Effects of Proton Pump Inhibitors on Kidney Transplant Recipients|Effects of Proton Pump Inhibitors on Kidney Transplant Recipients|Active, not recruiting||N/A|300|Anticipated|Istanbul University|||4||f||||f|f|f||||||||2017-10-10 21:08:51.004137|2017-10-10 21:08:51.004137
NCT03123783|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-29|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|||CD40 Agonistic Antibody APX005M in Combination With Nivolumab|A Study to Evaluate the Safety and Efficacy of the CD40 Agonistic Antibody APX005M Administered in Combination With Nivolumab in Subjects With Non-small Cell Lung Cancer and Subjects With Metastatic Melanoma|Recruiting||Phase 1/Phase 2|99|Anticipated|Apexigen, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:08:51.071242|2017-10-10 21:08:51.071242
NCT03123770|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-18|||December 2016||2016-12-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|ESNDBCP||Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients|The Efficacy and Safety of Neoadjuvant Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel in Breast Cancer Patients: A Multicentric, Open-label, Non-randomized Concurrent Control, Non-inferiority Trial|Recruiting||Phase 4|384|Anticipated|Zhejiang University||2|||f||||t||||||||Undecided||2017-10-10 21:08:51.223477|2017-10-10 21:08:51.223477
NCT03123757|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-17|||April 1, 2015|Actual|2015-04-01|April 2017|2017-04-01|August 31, 2015|Actual|2015-08-31|August 31, 2015|Actual|2015-08-31||Interventional|||Assessing the Determinants of 6-minute Walk Test and Its Correlation With Quality of Life|Assessing the Determinants of 6-minute Walk Test and Its Correlation With Quality of Life: A Survey of Older Adults|Completed||N/A|207|Actual|Precision Health Economics||1|||f||||f|f|f||||||Undecided||2017-10-10 21:08:51.336681|2017-10-10 21:08:51.336681
NCT03123744|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-20|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|April 1, 2024|Anticipated|2024-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Histology-Independent Study of Palbociclib in Patients With Advanced Cancer|A Histology-Independent Study of the Cyclin Inhibitor Palbociclib in Patients With Advanced Cancer Harboring Aberrations in the Cyclin Pathway|Not yet recruiting||Phase 2|200|Anticipated|University of California, San Diego||1|||f||||t|t|f|||f|||No||2017-10-10 21:08:51.409323|2017-10-10 21:08:51.409323
NCT03123731|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-18|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIV|iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIV|Not yet recruiting||N/A|150|Anticipated|University of California, San Diego||3|||f||||f|f|f||||||No||2017-10-10 21:08:51.506631|2017-10-10 21:08:51.506631
NCT03123718|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-21|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL|Prospective, Multicenter, Randomized ,Open-labeled, Phase III Study Comparing High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for the Prophylaxis of Central Nervous System Relapse in Diffuse Large B Cell Lymphoma|Not yet recruiting||Phase 3|205|Anticipated|Chonnam National University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:08:51.599953|2017-10-10 21:08:51.599953
NCT03123705|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-21|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|August 31, 2019|Anticipated|2019-08-31|April 15, 2019|Anticipated|2019-04-15||Observational|EPB||El Paso Public Health Biorepository|TTUHSC El Paso Public Health Biorepository (Research Core Laboratories Dental Biorepository)|Recruiting||N/A|450|Anticipated|Texas Tech University Health Sciences Center, El Paso|||1||f||||f|f|f||||Samples With DNA|"     Saliva and blood samples potentially with DNA will be stored   "|No||2017-10-10 21:08:51.673548|2017-10-10 21:08:51.673548
NCT03123692|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-20|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|Emera003COPD||NBMI - Clinical Study on COPD|A Randomised, Placebo-controlled, Blinded, Cross-over, Pilot Study to Explore Safety and Efficacy of NBMI Treatment of Patients With Mild, Moderate and Severe Chronic Obstructive Pulmonary Disease (COPD)|Not yet recruiting||Phase 2|12|Anticipated|EmeraMed||2|||f|||||f|f||||||||2017-10-10 21:08:51.743239|2017-10-10 21:08:51.743239
NCT03123679|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-30|||May 10, 2017|Anticipated|2017-05-10|April 2017|2017-04-01|April 2, 2020|Anticipated|2020-04-02|April 2, 2019|Anticipated|2019-04-02||Interventional|||The Added Value of Quantification of Lung Function in Patients Undergoing Radiotherapy, Using Tc-99m-MAA SPECT-CT|The Added Value of Quantification of Lung Function in Patients Undergoing Radiotherapy, Using Tc-99m-MAA SPECT-CT|Not yet recruiting||N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f|f|f||||||Undecided||2017-10-10 21:08:51.808855|2017-10-10 21:08:51.808855
NCT03123666|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-04-19|||April 19, 2017|Actual|2017-04-19|April 2017|2017-04-01|April 19, 2018|Anticipated|2018-04-19|April 19, 2018|Anticipated|2018-04-19||Interventional|||Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis|Randomized Controlled Trial of Recombinant Human Granulocye Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis|Recruiting||N/A|208|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f|f|f||||||No||2017-10-10 21:08:51.857002|2017-10-10 21:08:51.857002
NCT03123653|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-07-01|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|April 25, 2019|Anticipated|2019-04-25|April 25, 2019|Anticipated|2019-04-25||Interventional|||To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.|To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy|Recruiting||N/A|120|Anticipated|Institute of Liver and Biliary Sciences, India||1|||f||||f|f|f||||||||2017-10-10 21:08:51.929799|2017-10-10 21:08:51.929799
NCT03123640|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-08-01|||April 24, 2017|Actual|2017-04-24|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EPIMERR||Drug Safety in Emergency Patients -RTC on the Effect of Medication Reconciliation and Review on Readmission Rate|Drug Safety in Emergency Patients -a Randomized Controlled Trial Investigating the Effect of Medication Reconciliation and Review on Readmission Rate|Recruiting||N/A|800|Anticipated|Diakonhjemmet Hospital||2|||f||||f|f|f||||||||2017-10-10 21:08:53.846105|2017-10-10 21:08:53.846105
NCT03123627|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-19|2017-05-05|||August 23, 2016|Actual|2016-08-23|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|July 2018|Anticipated|2018-07-01||Interventional|||RANDOMIZED CLINICAL TRIAL, OPEN, MULTICENTER PARALLEL, NO SUSPENSION Inferiority Prophylactic Treatment With Valganciclovir IN KIDNEY TRANSPLANT CMV-seropositive CELLULAR IMMUNITY TO DEVELOP CD8 + CMV-SPECIFIC TREATMENT AFTER INDUCTION Thymoglobulin.||Recruiting||Phase 3|80|Anticipated|Maimónides Biomedical Research Institute of Córdoba||2|||f||||||||||||||2017-10-10 21:08:53.992196|2017-10-10 21:08:53.992196
NCT03123614|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-17|||September 19, 2014|Actual|2014-09-19|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Lotoprednol vs. Prednisolone and Fluorometholone|Efficacy and Safety of Loteprednol 0.5% Gel for Routine Prophylaxis After Photorefractive Keratectomy Compared to Prednisolone Acetate 1% Suspension and Fluorometholone 0.1% Suspension|Active, not recruiting||Phase 4|214|Actual|University of Utah||2|||f|||||t|f|||t|||||2017-10-10 21:08:54.086164|2017-10-10 21:08:54.086164
NCT03123601|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-18|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|May 30, 2017|Anticipated|2017-05-30|April 30, 2017|Anticipated|2017-04-30||Interventional|||Feasibility of Risk Sign Displays to Prevent Falls, Dehydration and Pulmonary Aspiration in Nursing Homes|Feasibility of Risk Sign Displays to Prevent Falls, Dehydration and Pulmonary Aspiration in Nursing Homes: a Clinical Study Protocol|Recruiting||N/A|20|Anticipated|Campus Neurológico Sénior||1|||f||||f|f|f||||||No||2017-10-10 21:08:54.184708|2017-10-10 21:08:54.184708
NCT03123588|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-11|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)|A Double-Blind, Double-Dummy Phase 2 Randomized Study to Evaluate the Efficacy and Safety of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)|Recruiting||Phase 2|120|Anticipated|Incyte Corporation||2|||t||||t|t|f||||||||2017-10-10 21:08:54.283234|2017-10-10 21:08:54.283234
NCT03123575|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-08|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|PODIUM||Polypharmacy and Clinically Significant Drug Interactions Among HIV-Infected Patients Receiving Antiretroviral Therapy|Polypharmacy and Clinically Significant Drug Interactions Among HIV-Infected Patients Receiving Antiretroviral Therapy in The Region Of Madrid: A Population-Based, Cross-Sectional Study|Not yet recruiting||N/A|1000|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||f|f|f||||||No||2017-10-10 21:08:54.463007|2017-10-10 21:08:54.463007
NCT03123562|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-17|||April 1, 2014|Actual|2014-04-01|April 2017|2017-04-01|October 31, 2016|Actual|2016-10-31|September 30, 2016|Actual|2016-09-30||Interventional|||Outcomes of Stem Cells for Cerebral Palsy Related to Neonatal Jaundice|Outcomes of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy Related to Neonatal Jaundice: An Open-label Uncontrolled Clinical Trial|Completed||Phase 2|40|Actual|Vinmec Research Institute of Stem Cell and Gene Technology||1|||f||||t|f|f||||||No||2017-10-10 21:08:54.528384|2017-10-10 21:08:54.528384
NCT03123549|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-10-03|||April 1, 2017|Actual|2017-04-01|October 2017|2017-10-01|January 2023|Anticipated|2023-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Investigation of the Two Level Simplify® Cervical Artificial Disc|Clinical Study Protocol for the Investigation Of The Two Level Simplify® Cervical Artificial Disc|Recruiting||N/A|200|Anticipated|Simplify Medical Inc.||2|||f||||f|f|t|t|f||||||2017-10-10 21:08:54.634357|2017-10-10 21:08:54.634357
NCT03123536|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-20|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|||Use of Point-of-care Ultrasound in High Risk Surgical Patients|Effects of Perioperative Point-of-care Ultrasound Assessment on Postoperative Outcomes in High Risk Surgical Patients|Recruiting||N/A|200|Anticipated|Zhongda Hospital|||2||f||||t|f|f||||||No||2017-10-10 21:08:54.733483|2017-10-10 21:08:54.733483
NCT03123523|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-18|||October 18, 2016|Actual|2016-10-18|April 2017|2017-04-01|April 18, 2020|Anticipated|2020-04-18|April 18, 2020|Anticipated|2020-04-18||Observational|FABRY-Image||Study of the Relation Between Lipid Myocardial Overload Evaluated by Cardiac Magnetic Resonance Imaging (MRI), Alteration of Longitudinal Myocardial Deformations by Echocardiography, and Clinical Achievements (Functional, Biological and Electrical) in Fabry Disease, and Its Outcomes.||Recruiting||N/A|55|Anticipated|University Hospital, Bordeaux|||2||f||||f|f|f||||||No||2017-10-10 21:08:54.980381|2017-10-10 21:08:54.980381
NCT03123510|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-18|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|November 1, 2017|Anticipated|2017-11-01|July 31, 2017|Anticipated|2017-07-31||Interventional|||Effect of a Synbiotic Supplement on a High-protein Diet|Role of Synbiotics on a Weight Loss Intervention Program: Effect on Microbiome|Recruiting||N/A|40|Anticipated|South Dakota State University||2|||f||||f|f|f||||||Yes|Result of the study will be made available to the scientific community trough manuscript publication. Each participant will be assigned a code to maintain patient confidentiality.|2017-10-10 21:08:55.145473|2017-10-10 21:08:55.145473
NCT03123497|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-18|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|2 Months|Observational [Patient Registry]|KIT||Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)|Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura|Recruiting||N/A|183|Anticipated|University Hospital, Angers|||1||f||||f|f|f||||||No||2017-10-10 21:08:55.271518|2017-10-10 21:08:55.271518
NCT03123484|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-18|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC|β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer|Not yet recruiting||Phase 2|80|Anticipated|China Medical University, China||2|||f||||t|f|f||||||Undecided||2017-10-10 21:08:55.398181|2017-10-10 21:08:55.398181
NCT03123471|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-28|||May 16, 2017|Actual|2017-05-16|September 2017|2017-09-01|March 19, 2019|Anticipated|2019-03-19|October 18, 2018|Anticipated|2018-10-18||Interventional|STYLE||A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp|A Phase 3, Multi-Center, Randomized, Place-Controlled, Double-Blind, Study of the Efficacy and Safety of Apremilast (CC-10004 in Subjects With Moderate to Sever Plaque Psoriasis of the Scalp)|Recruiting||Phase 3|300|Anticipated|Celgene||2|||f||||f|t|f||||||||2017-10-10 21:08:55.533925|2017-10-10 21:08:55.533925
NCT03123458|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-14|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders|Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders|Enrolling by invitation||Phase 1|100|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f|||||f|f||||||||2017-10-10 21:08:55.787944|2017-10-10 21:08:55.787944
NCT03123445|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-18|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|||Endostar First-line Treatment of Advanced NSCLC|The Efficacy and Safety of Continuous Administration of Endostar Combined With Chemotherapy for Patients With Advanced no Small Cell Lung Cancer: An Open-label, no Randomized Controlled Multicenter Phase II Study|Not yet recruiting||Phase 2|150|Anticipated|China Medical University, China||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:08:55.886353|2017-10-10 21:08:55.886353
NCT03123432|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-20|||June 1, 2011|Actual|2011-06-01|April 2017|2017-04-01|September 1, 2016|Actual|2016-09-01|June 1, 2016|Actual|2016-06-01||Interventional|||Immunomodulating Nutrients in Perioperative Patients With Gastric Cancer|Combination of Arginine, Glutamine, and Omega-3 Fatty Acid Supplements for Perioperative Enteral Nutrition in Surgical Patients With Gastric Adenocarcinoma or Gastrointestinal Stromal Tumor (GIST)|Completed||N/A|34|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f|||||f|f|||f|||No||2017-10-10 21:08:55.994851|2017-10-10 21:08:55.994851
NCT03123406|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-13|||April 25, 2017|Actual|2017-04-25|September 2017|2017-09-01|September 27, 2019|Anticipated|2019-09-27|April 21, 2019|Anticipated|2019-04-21||Interventional|ACTIVE||Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT|A Multi-center Study Evaluating Efficacy and Safety of Cinacalcet Hydrochloride(HCL) in Calcium, Phosphorus and Intact Parathyroid Hormone(iPTH) Serum Levels in Chinese Chronic Kidney Disease(CKD) Hemodialysis(HD) Patients With Mild, Moderate and Severe Secondary Hyperparathyroidism(SHPT)|Recruiting||Phase 4|750|Anticipated|Kyowa Hakko Kirin China Pharmaceutical Co.,LTD.||3|||f||||f|f|f||||||||2017-10-10 21:08:56.170543|2017-10-10 21:08:56.170543
NCT03123393|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-06|||June 26, 2017|Anticipated|2017-06-26|June 2017|2017-06-01|June 8, 2019|Anticipated|2019-06-08|June 8, 2019|Anticipated|2019-06-08||Interventional|||TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Phase 2 Study of TAK-659 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After at Least 2 Prior Lines of Chemotherapy|Not yet recruiting||Phase 2|82|Anticipated|Takeda||1|||f||||f|t|f||||||No||2017-10-10 21:08:56.370017|2017-10-10 21:08:56.370017
NCT03123380|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-19|||December 20, 2012||2012-12-20||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:56.453407|2017-10-10 21:08:56.453407
NCT03123367|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-07-18|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Actual|2017-06-30||Interventional|VIOLET||Evaluation of the NelLa Women's Care Line|An Evaluation of the Safety and TechnIcal Feasibility Of the NelLa Women's Care Line for Female Gynecological ExaminaTions and Procedures|Recruiting||N/A|140|Anticipated|Ceek Enterprises||4|||f||||f|f|t|t|f|f|||||2017-10-10 21:08:56.496719|2017-10-10 21:08:56.496719
NCT03123354|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-19|||May 1, 2015|Actual|2015-05-01|June 2017|2017-06-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|||Calibration and Validation of Masimo's O3 Regional Oximetry Device in Neonates, Infants and Children|Calibration and Validation of Masimo's O3 Regional Oximetry Device in Neonates, Infants and Children Undergoing Cardiac Catherization|Completed||N/A|44|Actual|Masimo Corporation||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:08:56.590323|2017-10-10 21:08:56.590323
NCT03123341|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-19|||March 1, 2011||2011-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:08:56.659684|2017-10-10 21:08:56.659684
NCT03123133|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-29|||April 6, 2017|Actual|2017-04-06|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Observational|||Gene Expression That Predicts Radiation Exposure in Humans|Gene Expression That Predicts Radiation Exposure in Humans|Recruiting||N/A|200|Anticipated|DxTerity Diagnostics|||1||f||||f|f|f||||Samples With DNA|"     Whole blood for genomic analysis   "|||2017-10-10 21:08:56.804319|2017-10-10 21:08:56.804319
NCT03123120|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-10-02|||June 7, 2017|Actual|2017-06-07|October 2017|2017-10-01|July 20, 2018|Anticipated|2018-07-20|February 5, 2018|Anticipated|2018-02-05||Interventional|||A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy|Proof-of-concept Study of BI 655130 add-on Treatment in Patients With Mild-to-moderately Active Ulcerative Colitis During TNF Inhibitor Therapy|Recruiting||Phase 2|30|Anticipated|Boehringer Ingelheim||2|||f||||t|f|f||||||||2017-10-10 21:08:56.91241|2017-10-10 21:08:56.91241
NCT03123107|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-07-31|||July 6, 2017|Actual|2017-07-06|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vitamin C in Cardiac Surgery Patients|Advancing the Cardiovascular Science of Vitamin C in Cardiac Surgery Patients|Recruiting||Phase 1|8|Anticipated|Geisinger Clinic||1|||f||||t|t|f|||f|||||2017-10-10 21:08:57.090842|2017-10-10 21:08:57.090842
NCT03123094|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-22|||May 16, 2017|Actual|2017-05-16|August 2017|2017-08-01|December 16, 2017|Anticipated|2017-12-16|December 16, 2017|Anticipated|2017-12-16||Interventional|||Single Rising Dose Trial of BI 655130 for Healthy Japanese Male Subjects|Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Dose and Single Subcutaneous Dose of BI 655130 in Healthy Japanese Male Volunteers (Double-blind, Randomised, Placebo-controlled Design).|Active, not recruiting||Phase 1|32|Anticipated|Boehringer Ingelheim||6|||f|||||f|f||||||||2017-10-10 21:08:57.77049|2017-10-10 21:08:57.77049
NCT03123081|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-07-10|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|||Role of Umbilical Cord Milking in the Management of Hypoxic-ischemic Encephalopathy in Neonates|Role of Umbilical Cord Milking in the Management of Hypoxic-ischemic Encephalopathy in Neonates: a Randomized Controlled Trial|Not yet recruiting||N/A|400|Anticipated|Jubilee Mission Medical College and Research Institute||2|||f||||t|f|f|||f|||||2017-10-10 21:08:57.866348|2017-10-10 21:08:57.866348
NCT03123068|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-25|||April 17, 2017|Actual|2017-04-17|August 2017|2017-08-01|March 25, 2019|Anticipated|2019-03-25|September 25, 2018|Anticipated|2018-09-25||Interventional|||Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery|Cocoa Flavanols for Modulating the Surgical Immune Response and Accelerating Clinical Recovery|Recruiting||Phase 1/Phase 2|36|Anticipated|Stanford University||2|||f||||f|f|f|||t|||||2017-10-10 21:08:57.983761|2017-10-10 21:08:57.983761
NCT03123055|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-13|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|December 30, 2018|Anticipated|2018-12-30||Interventional|FIERCE 22||A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma|A Multi-Center, Single-Arm, Open-Label Phase 1b Study of a Novel FGFR3 Inhibitor (B-701) Combined With Pembrolizumab in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma Who Have Progressed Following Platinum-based Chemotherapy|Recruiting||Phase 1|48|Anticipated|BioClin Therapeutics, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:08:58.084146|2017-10-10 21:08:58.084146
NCT03123042|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-04|||March 20, 2017|Actual|2017-03-20|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|SENORITA2||Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection|Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Patients After Non-curative Endoscopic Resection|Recruiting||N/A|247|Anticipated|National Cancer Center, Korea||1|||f||||t|f|f||||||||2017-10-10 21:08:58.242677|2017-10-10 21:08:58.242677
NCT03123029|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18||||||April 2017|2017-04-01||||||||Expanded Access|||Expanded Access to Venetoclax|Expanded Access to Venetoclax|Available||N/A|||AbbVie||||||t|||||||||||||2017-10-10 21:08:58.417917|2017-10-10 21:08:58.417917
NCT03123016|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-06-08|||April 14, 2017|Actual|2017-04-14|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|||Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo|A Split Body Study of the Effects of Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo|Recruiting||Phase 2|20|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|t|f||||||No||2017-10-10 21:08:58.4873|2017-10-10 21:08:58.4873
NCT03123003|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-18|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|August 1, 2018|Anticipated|2018-08-01|March 31, 2018|Anticipated|2018-03-31||Interventional|||Bone Age Assessment in Children Using Ultrasound Compared to Wrist X-ray|Bone Age Assessment in Children Using Ultrasound Compared to Wrist X-ray|Not yet recruiting||N/A|300|Anticipated|Meir Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:08:58.584534|2017-10-10 21:08:58.584534
NCT03122990|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-18|||June 1, 2016|Actual|2016-06-01|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|PERIO-HYPERTEN||Acute-phase Response & Periodontal Treatment in Patients With Hypertension|Acute-phase Response & Periodontal Treatment in Patients With High Blood Pressure|Recruiting||N/A|38|Anticipated|University of Pisa||2|||f|||||f|f||||||||2017-10-10 21:08:58.665481|2017-10-10 21:08:58.665481
NCT03122977|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-18|||June 1, 2016|Actual|2016-06-01|April 2017|2017-04-01|January 1, 2020|Anticipated|2020-01-01|June 1, 2019|Anticipated|2019-06-01||Interventional|PERIO-OBESE||Acute-phase Response & Periodontal Treatment in Obese Patients|Acute-phase Response Following Full-mouth Versus Quadrant Non-surgical Periodontal Treatment in Obese Subjects: A Randomized Clinical Trial|Recruiting||N/A|38|Anticipated|University of Pisa||2|||f|||||f|f||||||||2017-10-10 21:08:58.771784|2017-10-10 21:08:58.771784
NCT03122964|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-20|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|April 30, 2018|Anticipated|2018-04-30||Observational|||Multi Institutional Study in Patient Presenting With Hematuria|Multi Institutional Study To Evaluate Dna Methlyation Markers For Detection Of Primary Bladder Cancer In Urine Samples From A Cohort Of Patients With Hematuria|Recruiting||N/A|700|Anticipated|MDx Health|||1||f||||f|f|f||||||No||2017-10-10 21:08:58.869593|2017-10-10 21:08:58.869593
NCT03122951|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-22|||April 21, 2017|Actual|2017-04-21|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Clearblue® Advanced Ovulation Test User Study|Clearblue® Advanced Ovulation Test User Study|Recruiting||N/A|450|Anticipated|SPD Development Company Limited||1|||f||||f|f|f||||||No||2017-10-10 21:08:58.950811|2017-10-10 21:08:58.950811
NCT03122938|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2017-04-20|||April 2016||2016-04-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Lactoferrin Supplementation and Iron Metabolism in Healthy Pregnant Women|Effect of Daily Bovine Lactoferrin Supplementation on Fetal Development and Iron Metabolism in Healthy Pregnant Women: A Randomized Double-blind Controlled Trial|Enrolling by invitation||N/A|120|Anticipated|Beingmate Baby & Child Food Co Ltd .||2|||f||||f||||||||No|Available when oversight authorities require.|2017-10-10 21:08:59.044236|2017-10-10 21:08:59.044236
NCT03122925|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-24|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||TCA Cycle in the Dentate in Friedreich's Ataxia|Measurement of the TCA Cycle Rate in the Dentate Nucleus in Friedreich's Ataxia|Enrolling by invitation||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f|f|t|f|f|f|Samples Without DNA|"     Blood   "|||2017-10-10 21:08:59.129903|2017-10-10 21:08:59.129903
NCT03122912|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-24|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 1, 2021|Anticipated|2021-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Explore Effects of Dietary Fish Oil in Human Skin|Explore Effects of Dietary Fish Oil in Human Skin|Not yet recruiting||Phase 1|46|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 21:08:59.199245|2017-10-10 21:08:59.199245
NCT03122899|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-10-03|||October 3, 2017|Actual|2017-10-03|October 2017|2017-10-01|January 2024|Anticipated|2024-01-01|October 2019|Anticipated|2019-10-01||Interventional|SALLY||Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants|Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants|Recruiting||N/A|50|Anticipated|SI-BONE, Inc.||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:08:59.277943|2017-10-10 21:08:59.277943
NCT03122886|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-07-17|||July 14, 2017|Actual|2017-07-14|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin|Double-Blinded, Placebo-Controlled Pilot Trial to Explore Whether Lipids Prevent Carboplatin and Oxaliplatin Hypersensitivity Reactions|Recruiting||N/A|40|Anticipated|Mayo Clinic||2|||f||||t|f|f||||||||2017-10-10 21:08:59.397816|2017-10-10 21:08:59.397816
NCT03122873|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-29|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis|Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis|Completed||N/A|125|Actual|Mayo Clinic|||3||f||||f||f||||||||2017-10-10 21:08:59.483259|2017-10-10 21:08:59.483259
NCT03122860|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-19|||April 24, 2017|Actual|2017-04-24|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis|A Phase 2, 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis|Recruiting||Phase 2|630|Anticipated|Samumed LLC||6|||f||||f|t|f||||||||2017-10-10 21:08:59.559908|2017-10-10 21:08:59.559908
NCT03122847|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-07|||June 7, 2017|Anticipated|2017-06-07|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Observational|||Glucocorticoids and Bone in Graves' Ophthalmopathy|The Effect of 4.5 Gram Methylprednisolone Administered Once Weekly for 12 Weeks on Bone Metabolism in Graves´ Ophthalmopathy|Recruiting||N/A|30|Anticipated|Aarhus University Hospital|||1||f||||f|t|f|||f|Samples Without DNA|"     Blood samples stored at -80C for batch analysis at study completion   "|Undecided||2017-10-10 21:08:59.923095|2017-10-10 21:08:59.923095
NCT03122834|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-24|||April 15, 2017|Actual|2017-04-15|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Observational|SNPs||Effect of Genetic Polymorphism on the Clinical Outcome of Patients With Heart Failure|Effect of Genetic Polymorphism on the Clinical Outcome, Echocardiographic Parameters and Cardiac Biomarkers of Patients With Heart Failure|Recruiting||N/A|200|Anticipated|Ain Shams University|||2||f|||||f|f|||f|Samples With DNA|"     Peripheral blood samples will be collected and stored in - 20°C environment for DNA     extraction by DNA extraction kit according to manufacturer recommendation.   "|||2017-10-10 21:09:00.047262|2017-10-10 21:09:00.047262
NCT03122821|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-21|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|September 20, 2017|Anticipated|2017-09-20|June 15, 2017|Anticipated|2017-06-15||Interventional|||Trans Cranial Brain Stimulation for Stroke Rehabilitation|Effect of Transcranial Stimulation Augmented With Mental Imagery in Upper Limb Stroke Rehabilitation: A Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|Majmaah University||4|||f||||t|f|f||||||No||2017-10-10 21:09:00.147455|2017-10-10 21:09:00.147455
NCT03122808|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-21|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||Uterine Activity in Moderate-Severe Neonatal Encephalopathy: A Case Control Study|Intrapartum Uterine Activity Monitoring and Partogram Characteristics: Can They Help Predict Foetuses With Poor Tolerance of Labour?|Recruiting||N/A|300|Anticipated|The Rotunda Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:09:00.323213|2017-10-10 21:09:00.323213
NCT03122795|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-12|||May 15, 2017|Actual|2017-05-15|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|August 30, 2018|Anticipated|2018-08-30||Interventional|||Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)|Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)|Recruiting||N/A|30|Anticipated|Region Skane||1|||f||||f|f|f||||||No|Data will be presented at group level for personal integrity reasons.|2017-10-10 21:09:00.449661|2017-10-10 21:09:00.449661
NCT03122782|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-27|||August 1, 2017|Anticipated|2017-08-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy|Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy|Not yet recruiting||Phase 3|80|Anticipated|Ain Shams University||2|||f|||||f|f|||f|||||2017-10-10 21:09:00.562555|2017-10-10 21:09:00.562555
NCT03122769|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18|||April 20, 2017|Anticipated|2017-04-20|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Cardiac Uptake of Metformin, Visualized by Positron Emission Tomography|Cardiac Uptake of Metformin and Expression of Metformin Membrane Transporter Proteins in the Human Failing Myocardium|Recruiting||Phase 1|8|Anticipated|Aarhus University Hospital||1|||f|||||f|f|||f|||||2017-10-10 21:09:00.655775|2017-10-10 21:09:00.655775
NCT03122756|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-10|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Intravenous Dexamethasone Before Spinal Anesthesia on Post-cesarean Section Pain|Effect of Intravenous Dexamethasone Before Spinal Anesthesia on Post-cesarean Section Pain: Randomized Controlled Trial|Recruiting||Early Phase 1|100|Anticipated|Ain Shams Maternity Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:09:00.750285|2017-10-10 21:09:00.750285
NCT03122743|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-25|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer|Correlation of Serum Catecholamine With Emotional Stress in Men With Prostate Cancer: A Pilot Study|Recruiting||N/A|60|Anticipated|Wake Forest University Health Sciences|||1||f|||||f|f||||||||2017-10-10 21:09:00.859783|2017-10-10 21:09:00.859783
NCT03122730|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-24|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB|A Two-Part Pharmacodynamic Study to Compare VentaProst (Epoprostenol Solution for Inhalation Via Custom Drug Delivery System) Dosing to Conventionally Administered Aerosolized Epoprostenol Dosing in Cardiac Surgery Patients|Recruiting||Phase 2|20|Anticipated|Aerogen Pharma Limited||1|||f||||f|t|f||||||||2017-10-10 21:09:00.961276|2017-10-10 21:09:00.961276
NCT03122717|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-10|||May 9, 2017|Actual|2017-05-09|August 2017|2017-08-01|April 2023|Anticipated|2023-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer|A Phase 1 Study of Osimertinib in Combination or Alternating With Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer|Recruiting||Phase 1|64|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f|||f|||||2017-10-10 21:09:01.050771|2017-10-10 21:09:01.050771
NCT03122704|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-04-17|||October 2015||2015-10-01|April 2017|2017-04-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF|Prevalence of Group B Streptococcus Infection in Pregnant Women Conceived Through IVF Diagnosed With Preterm Labor.|Withdrawn||N/A|0|Actual|Vietnam National University||1|||f||||f||||||||||2017-10-10 21:09:01.208079|2017-10-10 21:09:01.208079
NCT03122691|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-28|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Differences in Cannabis Impairment and Its Measurement Due to Route of Administration|Differences in Cannabis Impairment and Its Measurement Due to Route of Administration|Not yet recruiting||Phase 1|30|Anticipated|Johns Hopkins University||6|||f||||f|t|f||||||||2017-10-10 21:09:01.31863|2017-10-10 21:09:01.31863
NCT03122678|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-18|||November 5, 2016|Actual|2016-11-05|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Thiamine Supplementation in Patients With Septic Shock|Thiamine Supplementation in Patients With Septic Shock: A Randomized, Double Blind, Placebo Controlled Trial|Recruiting||Phase 1|100|Anticipated|The Cleveland Clinic||2|||f||||t|t|f|||f|||No||2017-10-10 21:09:01.444969|2017-10-10 21:09:01.444969
NCT03122652|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-03|||July 6, 2017|Anticipated|2017-07-06|May 2017|2017-05-01|July 6, 2021|Anticipated|2021-07-06|July 6, 2019|Anticipated|2019-07-06||Interventional|TERIS||Multi-center, Interventional, Phase 3, Randomized, Double-blinded Study of Treatment:Teriflunomide®, in Radiologically Isolated Syndrome|Multi-center, Randomized, Double-blinded Study of Teriflunomide® in Radiologically Isolated Syndrome (RIS) The TERIS Study|Not yet recruiting||Phase 3|200|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||No||2017-10-10 21:09:01.727936|2017-10-10 21:09:01.727936
NCT03122639|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-17|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|August 30, 2021|Anticipated|2021-08-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Endothelial Function in Obstructive Sleep Apnea|Vascular Endothelial Activation in Obstructive Sleep Apnea|Not yet recruiting||Early Phase 1|245|Anticipated|Columbia University||2|||f||||t|t|f|||f|||No||2017-10-10 21:09:01.929251|2017-10-10 21:09:01.929251
NCT03122626|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-20|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|November 30, 2018|Anticipated|2018-11-30|August 31, 2018|Anticipated|2018-08-31||Interventional|||Does Participation in a Group, Task-oriented Community-based Exercise Program Improve the Ability to do Everyday Activities Among People With Stroke?|Increasing Access to Community-based Task-oriented Exercise Programs Through Healthcare-recreation Partnerships to Improve Function Post-stroke: Feasibility of a 2-group Randomized Controlled Trial Protocol|Recruiting||N/A|60|Anticipated|University of Toronto||2|||f||||f|f|f||||||No||2017-10-10 21:09:02.056832|2017-10-10 21:09:02.056832
NCT03122613|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-28|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis|A Double-blind, Randomized, Placebo-Controlled Trial of Curcumin Versus Placebo for Prevention of Relapse in Patients With Ulcerative Colitis|Recruiting||N/A|172|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 21:09:02.225175|2017-10-10 21:09:02.225175
NCT03122600|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-20|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Ankle Brachial Index Versus Conventional Cardiac Risk Indices|Ankle Brachial Index (ABI) Versus Conventional Cardiac Risk Indices To Predict Cardiac Affection In High Risk Patients Under General Anesthesia|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t||||||||Undecided||2017-10-10 21:09:02.351479|2017-10-10 21:09:02.351479
NCT03122587|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-23|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Non-Invasive Brain Stimulation and Substance Use|Non-Invasive Brain Stimulation and Substance Use|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill||3|||f||||t|f|t|f|||||No||2017-10-10 21:09:02.412081|2017-10-10 21:09:02.412081
NCT03122574|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-17|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Effects of Aromatherapy on the Incidence and Severity of Acute Pain|A Feasibility Study of the Effects of Aromatherapy on the Incidence and Severity of Acute Pain in Pediatric Patients|Completed||N/A|21|Actual|Children's Research Institute||3|||f||||f|f|f||||||No||2017-10-10 21:09:02.52988|2017-10-10 21:09:02.52988
NCT03122561|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-20|||December 3, 2016|Actual|2016-12-03|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Estimation of Paracetamol in Urine to Assess the Diurnal Variation|Estimation of Paracetamol in Urine to Assess the Diurnal Variation|Recruiting||N/A|41|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||3|||f||||f|f|f||||||No||2017-10-10 21:09:02.620282|2017-10-10 21:09:02.620282
NCT03122535|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-04-17|||September 2014||2014-09-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||70 vs 110 Degree Side-cut Angles in Femtosecond LASIK|70 Versus 110 Degrees Side-cut Angles in Femtosecond Laser-assisted in Situ Keratomileusis|Recruiting||N/A|200|Anticipated|University of Utah||2|||f||||f||||||||No||2017-10-10 21:09:02.847573|2017-10-10 21:09:02.847573
NCT03122522|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-08-14|||April 17, 2017|Actual|2017-04-17|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy|A Phase II Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy|Recruiting||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f|||t|||||2017-10-10 21:09:02.932693|2017-10-10 21:09:02.932693
NCT03122509|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-05-01|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer|Phase II Study to Assess the Efficacy of Durvalumab (MEDI4736) and Tremelimumab Plus Radiotherapy or Ablation in Patients With Metastatic Colorectal Cancer|Recruiting||Phase 2|33|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f||||||Undecided||2017-10-10 21:09:03.047025|2017-10-10 21:09:03.047025
NCT03122496|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-10-03|||April 25, 2017|Actual|2017-04-25|October 2017|2017-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer|A Pilot Study of Durvalumab (MEDI4736) With Tremelimumab in Combination With Image Guided Stereotactic Body Radiotherapy (SBRT) in the Treatment of Metastatic Anaplastic Thyroid Cancer|Recruiting||Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:09:03.156499|2017-10-10 21:09:03.156499
NCT03122483|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-16|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Observational|||Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)|Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)|Completed||N/A|250|Actual|Beckman Coulter, Inc.|||2||f||||f|f|t|t|f|t|Samples Without DNA|"     Whole blood and serum   "|||2017-10-10 21:09:03.41456|2017-10-10 21:09:03.41456
NCT03122470|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-17|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer|Assessment of Advanced Imaging Techniques in the Evaluation and Management of Prostate Cancer|Not yet recruiting||N/A|162|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:09:03.513048|2017-10-10 21:09:03.513048
NCT03122457|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-17|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide|Improvement of Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide 1.2%/3.75% Combination Gel|Recruiting||Phase 2|40|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|t|f||||||No||2017-10-10 21:09:03.617397|2017-10-10 21:09:03.617397
NCT03122431|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-17|||June 5, 2017|Anticipated|2017-06-05|March 2017|2017-03-01|June 5, 2022|Anticipated|2022-06-05|June 1, 2020|Anticipated|2020-06-01||Interventional|||Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases|Relevance of Monitoring Blood Levels Compared to Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases: Adherence and Understanding the Possible Underlying Mechanisms Involved in Effectiveness and in Adverse Effects|Not yet recruiting||Phase 4|296|Anticipated|University of Sao Paulo General Hospital||5|||f||||f|f|f||||||No||2017-10-10 21:09:03.797997|2017-10-10 21:09:03.797997
NCT03122418|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-19|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Use of Personal Fitness Device in Adult (> 21 Years Old) Patients With Cystic Fibrosis|Use of Personal Fitness Device in Adult (> 21 Years Old) Patients With Cystic Fibrosis|Recruiting||N/A|25|Anticipated|University of Oklahoma||1|||f||||t|f|f||||||Undecided|Data will be de-identified prior to sharing if this is done. Data will be available after the study is complete and would be obtained through written request to the PI|2017-10-10 21:09:03.930738|2017-10-10 21:09:03.930738
NCT03122405|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-05|||December 2, 2014||2014-12-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:09:04.021114|2017-10-10 21:09:04.021114
NCT03122392|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-17|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|AUS||Pressure-Volume Measurements on the AMS 800TM Cuff|Pressure-Volume Measurements on the AMS 800TM Cuff|Not yet recruiting||Early Phase 1|6|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:09:04.0712|2017-10-10 21:09:04.0712
NCT03122379|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-19|||August 2, 2011||2011-08-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:09:04.16145|2017-10-10 21:09:04.16145
NCT03122366|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-19|||February 2, 2009|Actual|2009-02-02|April 2017|2017-04-01|September 27, 2017|Anticipated|2017-09-27|September 27, 2011|Actual|2011-09-27||Observational|||TLR4 Polymorphisms and Risk of Skin Cancer|TLR4 Polymorphisms and Predisposition for Skin Cancer Development|Active, not recruiting||N/A|392|Actual|University of Alabama at Birmingham|||1||f||||f|f|f||||||No||2017-10-10 21:09:04.203936|2017-10-10 21:09:04.203936
NCT03122353|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-25|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis|A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis|Recruiting||Phase 1|700|Anticipated|Tolmar Inc.||3|||f||||f|t|f||||||No||2017-10-10 21:09:04.287645|2017-10-10 21:09:04.287645
NCT03122340|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-19|||November 1, 2015|Actual|2015-11-01|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|POLYNCOR||Polyprenols (Ropren) in Acute Coronary Syndrome|Single-center Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Polyprenols (ROPREN) in Subjects With Acute Coronary Syndrome|Enrolling by invitation||Phase 3|70|Anticipated|Tomsk National Research Medical Center of the Russian Academy of Sciences||2|||f||||f|f|f||||||Undecided||2017-10-10 21:09:04.53599|2017-10-10 21:09:04.53599
NCT03122327|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-23|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2022|Anticipated|2022-05-01|May 1, 2020|Anticipated|2020-05-01||Observational|||cGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.|Comprehensive Geriatric Assessment (cGA) in Newly-diagnosed Elderly Multiple Myeloma (MM) Patients: a Multi-center, Prospective, Non-interventional Study.|Not yet recruiting||N/A|200|Anticipated|Peking Union Medical College Hospital|||1||f||||f|f|f||||||No|There is no plan to make IPD available to other researchers.|2017-10-10 21:09:04.649834|2017-10-10 21:09:04.649834
NCT03122314|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-20|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Nontraumatic Musculoskeletal Pain|Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Nontraumatic Musculoskeletal Pain in the Emergency Department: A Double-Blinded, Randomized, Controlled Trial|Completed||Phase 4|200|Actual|Pamukkale University||2|||f||||t||||||||No||2017-10-10 21:09:04.723376|2017-10-10 21:09:04.723376
NCT03121937|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-17|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Feasibility of a Technology-Based Treatment Support System|Feasibility of a Technology-Based Treatment Support System|Not yet recruiting||N/A|30|Anticipated|Northwestern University||2|||f||||t|f|f||||||No||2017-10-10 21:09:08.005117|2017-10-10 21:09:08.005117
NCT03122301|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-06-07|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer|Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer: A Pilot Randomized Sham-Controlled Trial|Recruiting||Phase 2|20|Anticipated|Northwestern University||2|||f||||f|f|f|||f|||||2017-10-10 21:09:04.83864|2017-10-10 21:09:04.83864
NCT03122288|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-09|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|TOPS||Individualized Cognitive Training in HIV|Individualized-Targeted Cognitive Training in Older Adults With HAND|Recruiting||N/A|146|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 21:09:04.966881|2017-10-10 21:09:04.966881
NCT03122275|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-27|||April 27, 2017|Actual|2017-04-27|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|SCAN-CC||Stepwise Strategy to Improve CANcer Screening Adherence: Cervical Cancer|Stepwise Strategy to Improve Cervical Cancer Screening Adherence (SCAN-CC): Automatic Text Messages, Phone Calls and Face-to-face Interviews|Recruiting||N/A|1136|Anticipated|Universidade do Porto||2|||f||||f|f|f||||||No||2017-10-10 21:09:05.107967|2017-10-10 21:09:05.107967
NCT03122262|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-04-16|||January 2017||2017-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADVANCE||ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy|A 96-week Randomised, Phase 3 Non-inferiority Study of DTG + TAF + FTC Compared With DTG + TDF + FTC and EFV + TDF+FTC in Patients Infected With HIV-1 Starting First-line Antiretroviral Therapy|Recruiting||Phase 3|1110|Anticipated|University of Witwatersrand, South Africa||3|||f||||t||||||||Undecided||2017-10-10 21:09:05.240708|2017-10-10 21:09:05.240708
NCT03122249|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-04-17|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|OASIS||Oncology Associated Symptoms & Individualized Strategies|Use of Telehealth Technologies for Symptom Management Support for People With Advanced Cancer Living in Rural Communities|Recruiting||N/A|40|Anticipated|University of Iowa||1|||f||||t|f|f||||||Undecided||2017-10-10 21:09:05.389172|2017-10-10 21:09:05.389172
NCT03122236|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-06-16|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||Combining tDCS and Neurorehabilitation to Treat Age-related Deficits of Mobility and Cognition: UPfront Walking Study|Combining tDCS and Neurorehabilitation to Treat Age-related Deficits of Mobility and Cognition: UPfront Walking Study|Recruiting||N/A|35|Anticipated|University of Florida||3|||f||||t|f|f||||||Undecided||2017-10-10 21:09:05.497006|2017-10-10 21:09:05.497006
NCT03122223|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-04-17|||June 5, 2017|Anticipated|2017-06-05|April 2017|2017-04-01|December 5, 2018|Anticipated|2018-12-05|December 5, 2018|Anticipated|2018-12-05||Interventional|HVTN120||Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®-or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants|A Phase 1/2a Clinical Trial to Evaluate the Safety and Immunogenicity of ALVAC-HIV (vCP2438) and of MF59®-or AS01B-adjuvanted Clade C Env Protein, in Healthy, HIV-uninfected Adult Participants|Not yet recruiting||Phase 1/Phase 2|320|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t|t|f|||t|||No||2017-10-10 21:09:05.613106|2017-10-10 21:09:05.613106
NCT03122210|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18|||January 5, 2010|Actual|2010-01-05|April 2017|2017-04-01|April 13, 2017|Actual|2017-04-13|August 8, 2013|Actual|2013-08-08||Interventional|FreeO2 SCA||Comparaison of 2 SpO2 Level Measured by Pulse Oxymetry in Complications of Acute Coronary Syndrome.|Comparaison of 2 SpO2 Level Measured by Pulse Oxymetry in Complications of Acute Coronary Syndrome.|Completed||N/A|60|Actual|Laval University||3|||f||||f|f|f||||||||2017-10-10 21:09:05.772711|2017-10-10 21:09:05.772711
NCT03122197|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-20|||May 16, 2017|Actual|2017-05-16|July 2017|2017-07-01|April 14, 2019|Anticipated|2019-04-14|April 14, 2018|Anticipated|2018-04-14||Interventional|||Study of Letrozole in Recurrent Gliomas|A Phase 0/1 Exploratory Pharmacokinetic and Pharmacodynamics Study of Letrozole in Recurrent Gliomas|Recruiting||Early Phase 1|12|Anticipated|University of Cincinnati||1|||f||||t|t|f|||f|||||2017-10-10 21:09:05.853091|2017-10-10 21:09:05.853091
NCT03122184|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-28|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|PEACE-IV||Positive Psychology for Acute Coronary Syndrome Patients|Positive Psychology for Acute Coronary Syndrome Patients: a Randomized, Controlled Pilot Trial|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||||2017-10-10 21:09:05.936441|2017-10-10 21:09:05.936441
NCT03122171|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-17|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Use of Low Cost Prostheses to Improve Upper Extremity Function in Children With Cerebral Palsy|Use of Low Cost Prostheses to Improve Upper Extremity Function in Children With Cerebral Palsy|Enrolling by invitation||N/A|12|Anticipated|New York University School of Medicine||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:09:06.051695|2017-10-10 21:09:06.051695
NCT03122158|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-19|||April 8, 2017|Actual|2017-04-08|April 2017|2017-04-01|December 15, 2018|Anticipated|2018-12-15|September 15, 2018|Anticipated|2018-09-15||Interventional|||Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders|The Effect and Reliability of Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders|Active, not recruiting||Phase 4|60|Anticipated|Erzurum Regional Training & Research Hospital||2|||f||||f|f|f|||f|||Yes|clinical severity of the participants measured by psychiatric tools and mean drug dose will be shared during the course of the study|2017-10-10 21:09:06.129855|2017-10-10 21:09:06.129855
NCT03122145|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-06-16|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|March 15, 2019|Anticipated|2019-03-15||Interventional|||Normal Breathing and Swallowing in Healthy Volunteers|Establishing Normal Swallowing and Breathing Profiles in Healthy Adults Across the Age Span|Recruiting||Phase 1/Phase 2|120|Anticipated|University of Florida||1|||f||||t|t|f||||||No|The study team will not be sharing individual IDP information with other researchers.|2017-10-10 21:09:06.22434|2017-10-10 21:09:06.22434
NCT03122132|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-19|||February 20, 2017|Actual|2017-02-20|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|August 1, 2017|Anticipated|2017-08-01||Observational|3D8||Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks|Efficacy and Safety in Clinical Practice of Ombitasvir/Paritaprevir/ Ritonavir and Dasabuvir Administered for 8 Weeks (3D8) in Treatment-naïve Genotype 1b Hepatitis C Virus Infected Patients: Analysis of Data From Hepa-C Registry.|Recruiting||N/A|50|Anticipated|Hepa C|||1||f|||||t|f||||||||2017-10-10 21:09:06.318984|2017-10-10 21:09:06.318984
NCT03122119|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-19|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Effectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac Joint|Effectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac Joint to Relieve Low Back Pain|Recruiting||Phase 4|100|Anticipated|Star Spine and Sport||3|||f||||t|t|f|||f|||No||2017-10-10 21:09:06.408774|2017-10-10 21:09:06.408774
NCT03122080|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-19|||September 30, 2016|Actual|2016-09-30|April 2017|2017-04-01|September 30, 2019|Anticipated|2019-09-30|January 1, 2019|Anticipated|2019-01-01||Interventional|||Efficacy of EA on Depression Related Insomnia: Study Protocol for a Multicenter RCT|Efficacy and Safety of Electroacupuncture on Treating Depression Related Insomnia: Study Protocol for a Multicenter Randomized Controlled Trial|Recruiting||N/A|270|Anticipated|Shanghai Municipal Hospital of Traditional Chinese Medicine||3|||f||||t|f|f||||||Undecided||2017-10-10 21:09:06.753881|2017-10-10 21:09:06.753881
NCT03122067|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-17|||January 10, 2017|Actual|2017-01-10|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Oxytocin's Effect on Social Pain Empathy|Oxytocinergic Modulation of Perceived Social Exclusion|Recruiting||N/A|60|Anticipated|University of Electronic Science and Technology of China||2|||f|||||f|f||||||||2017-10-10 21:09:06.860908|2017-10-10 21:09:06.860908
NCT03122054|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-23|||November 1, 2015|Actual|2015-11-01|April 2017|2017-04-01|February 15, 2017|Actual|2017-02-15|November 1, 2016|Actual|2016-11-01||Interventional|||Early Versus Delayed Cholecystectomy|Should Surgical Experience Change Our Treatment Strategy on Acute Cholecystitis? Early Versus Delayed Cholecystectomy|Completed||N/A|176|Actual|Sisli Etfal Training & Research Hospital||2|||f||||t|f|f||||||No|I can share study data only without sharing patient names and protocol numbers.|2017-10-10 21:09:06.944406|2017-10-10 21:09:06.944406
NCT03122041|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-19|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome|Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance IGT and Type 2 Diabetes T2D in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome PCOS|Completed||Phase 4|30|Actual|University Medical Centre Ljubljana||2|||f||||f|f|f||||||No||2017-10-10 21:09:07.023732|2017-10-10 21:09:07.023732
NCT03122028|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-19|||November 5, 2013|Actual|2013-11-05|April 2017|2017-04-01|November 9, 2016|Actual|2016-11-09|March 9, 2016|Actual|2016-03-09||Interventional|||Clinical Investigation of the LAmbre Left Atrial Appendage Closure System|A Prospective, Non-Randomized, Multi-Center, Open-Label, Non-Comparative, Interventional Clinical Investigation of the LAmbre Left Atrial Appendage Closure System|Completed||N/A|61|Actual|Lifetech Scientific (Shenzhen) Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 21:09:07.097354|2017-10-10 21:09:07.097354
NCT03122015|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-17|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||The Use of Therapeutic Clown in Painful Procedures in Children|The Use of Therapeutic Clown in Painful Procedures in Children: A Pilot Study|Not yet recruiting||N/A|24|Anticipated|St. Justine's Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:09:07.174748|2017-10-10 21:09:07.174748
NCT03122002|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-16|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Observational|||Predictors and Prognostic Factors on the Acute Ischemic Stroke|A Prospective Cohort Study of Predictors and Prognostic Factors on the Acute Ischemic Stroke|Not yet recruiting||N/A|5000|Anticipated|Tongji Hospital|||2||f|||||f|f||||Samples With DNA|"     blood sample   "|No||2017-10-10 21:09:07.242184|2017-10-10 21:09:07.242184
NCT03121989|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-07|||October 21, 2017|Anticipated|2017-10-21|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 28, 2018|Anticipated|2018-10-28||Interventional|LABC||Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy|Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy|Not yet recruiting||Phase 1|13|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|t|f|||t|||||2017-10-10 21:09:07.356165|2017-10-10 21:09:07.356165
NCT03121976|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-26|||January 2, 2012|Actual|2012-01-02|April 2017|2017-04-01|March 31, 2013|Actual|2013-03-31|December 31, 2012|Actual|2012-12-31||Interventional|||A Comparison of US and Evoked Motor Response-guided Placement of Continuous Femoral Nerve Block Following TKA|Comparison of Continuous Femoral Nerve Block Using Ultrasound Versus Ultrasound and Nerve Stimulation Using Stimulating Catheter in Patients Undergoing Total Knee Arthroplasty: A Prospective Randomized Controlled Trial|Completed||N/A|82|Actual|Sunnybrook Health Sciences Centre||2|||f||||f|f|f||||||No||2017-10-10 21:09:07.45449|2017-10-10 21:09:07.45449
NCT03121963|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pain Management in Head and Neck Surgery Patients|Pain Management in Head and Neck Surgery Patients|Recruiting||Phase 4|60|Anticipated|University of Alabama at Birmingham||2|||f||||f|t|f|||f|||||2017-10-10 21:09:07.704906|2017-10-10 21:09:07.704906
NCT03121950|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-19|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Movement and Music Intervention for Individuals With Dementia|Movement and Music Intervention for Individuals With Dementia|Recruiting||N/A|30|Anticipated|Ohio State University||2|||f||||f|f|f||||||No||2017-10-10 21:09:07.83703|2017-10-10 21:09:07.83703
NCT03121924|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-04-17|||September 2015||2015-09-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Timing of Oocyte Denudation Before ICSI in an Oocyte Donation Model|Effect of Timing of Oocyte Denudation Before ICSI and Its Results in an Oocyte Donation Model: a Cluster Randomized Controlled Clinical Trial|Recruiting||N/A|180|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||No||2017-10-10 21:09:08.103072|2017-10-10 21:09:08.103072
NCT03121911|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-07|||December 4, 2017|Anticipated|2017-12-04|August 2017|2017-08-01|October 31, 2019|Anticipated|2019-10-31|February 28, 2019|Anticipated|2019-02-28||Interventional|||Effects of Interval Physical Training on Expiratory Flow Limitation in Recent Myocardial Infarction|Effects of Interval Physical Training on Inflammatory Markers, Cardiac Autonomic Modulation at Rest, Expiratory Flow Limitation and Respiratory Efficiency in Recent Myocardial Infarction|Not yet recruiting||N/A|54|Anticipated|Federal University of Uberlandia||3|||f||||t|f|f||||||||2017-10-10 21:09:08.23902|2017-10-10 21:09:08.23902
NCT03121898|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-22|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Observational|PLATFORM||PLATelet Function Operating Room Monitoring|PLATelet Function Operating Room Monitoring|Recruiting||N/A|800|Anticipated|IRCCS Policlinico S. Donato|||1||f||||f|f|f||||||||2017-10-10 21:09:08.402852|2017-10-10 21:09:08.402852
NCT03121885|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-20|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|July 20, 2017|Actual|2017-07-20||Interventional|||Human Metabolic Dynamics at Rest and During Aerobic Exercise Under Normobaric Normoxic and Moderate Hypoxic Conditions|MetaboDyn- Liquid-liquid Extraction of Single Drops of Whole Capillary Blood as a Reliable Method of Measuring Metabolic Effects of Exercise: A Pilot Study.|Active, not recruiting||N/A|25|Anticipated|Charite University, Berlin, Germany||1|||f||||f|f|f||||||||2017-10-10 21:09:08.508513|2017-10-10 21:09:08.508513
NCT03121872|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-21|||May 21, 2014|Actual|2014-05-21|April 2017|2017-04-01|August 5, 2016|Actual|2016-08-05|May 20, 2016|Actual|2016-05-20||Interventional|||Titanium Prepared Platelet Rich Fibrin for Multiple Gingival Recessions|Effectiveness and Predictability of Titanium-Prepared Platelet-Rich Fibrin for the Management of Multiple Gingival Recessions|Completed||N/A|34|Actual|Karadeniz Technical University||2|||f||||f|f|f||||||No||2017-10-10 21:09:08.583204|2017-10-10 21:09:08.583204
NCT03121859|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-19|||October 1, 2015|Actual|2015-10-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Analgesic Current Therapies for Chronic Neck Pain|Does The Use Of Analgesic Current Therapies Increase The Effectiveness Of Neck Stabilization Exercises For Improving Pain, Disability, Mood, And Quality Of Life In Chronic Neck Pain? A Randomized, Controlled, Single-Blind Study|Completed||N/A|81|Actual|Ege University||3|||f||||f|f|f||||||No||2017-10-10 21:09:08.680258|2017-10-10 21:09:08.680258
NCT03121846|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-19|||May 1, 2017|Actual|2017-05-01|March 2017|2017-03-01|May 1, 2019|Anticipated|2019-05-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy|Mesylate Apatinib for Stage Ⅳ Soft Tissue Sarcoma Patients After Failure of Traditional Chemotherapy: Prospective, Open-label, Single-Arm, Multi-center Phase II Clinical Trial|Recruiting||Phase 2|80|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:09:08.786144|2017-10-10 21:09:08.786144
NCT03121833|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-15|||May 1, 2017|Actual|2017-05-01|March 2017|2017-03-01|May 1, 2019|Anticipated|2019-05-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma|Randomized, Double-blind, Placebo-controlled (2: 1), Multicenter Clinical Study (IIB) for the Treatment of Stage Ⅳ Soft Tissue Sarcoma With Recombinant Human Endostatin(Endostar) Combined With Chemotherapy|Recruiting||Phase 2|150|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:09:08.890633|2017-10-10 21:09:08.890633
NCT03121807|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-04-17|||September 1, 2014|Actual|2014-09-01|April 2017|2017-04-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric Cancer|A Pilot Study of Home Parenteral Nutrition for Malnourished Patients With Unresectable Stage IV Gastric Receiving Salvage Chemotherapy|Recruiting||N/A|20|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:09:09.123059|2017-10-10 21:09:09.123059
NCT03121794|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-23|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Ultrasonographic Identification of the Proximal Humerus Landmarks for Intra-Osseous Vascular Access Across Different Body Habitus|Ultrasonographic Identification of the Proximal Humerus Landmarks for Intra-Osseous Vascular Access Across Different Body Habitus|Recruiting||N/A|30|Anticipated|The Cleveland Clinic|||3||f||||f|f|f|||f|||||2017-10-10 21:09:09.289404|2017-10-10 21:09:09.289404
NCT03121781|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-19|||November 1, 2016|Actual|2016-11-01|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Diaphragm Electrical Activity of Preterm Infants on nCPAP With Binasal Prongs Versus RAM Cannula|Effect of Nasal Continuous Positive Airway Pressure (nCPAP) With RAM Cannula Versus Standard Binasal Prongs on Diaphragm Electrical Activity in Very Low Birth Weight (VLBW) Preterm Infants|Recruiting||N/A|20|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|f|f||||||No||2017-10-10 21:09:09.387306|2017-10-10 21:09:09.387306
NCT03121768|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-14|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|April 1, 2022|Anticipated|2022-04-01|December 1, 2019|Anticipated|2019-12-01||Observational|||A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)|A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer Using Clinical Histopathological and Biological Markers|Recruiting||N/A|761|Anticipated|Mansoura University|||1||f||||t|f|f||||Samples With DNA|"     bladder biopsy of TURBT   "|Yes|meta-analyses by contact the Prof. Ahmed Mosbah MD (Study Chair)|2017-10-10 21:09:09.49732|2017-10-10 21:09:09.49732
NCT03121742|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-09|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of a Smartphone-based Intervention for Suicidal Inpatients|A Pilot Study of a Smartphone-based Intervention for Suicidal Inpatients|Not yet recruiting||N/A|20|Anticipated|Harvard University||2|||f||||f|f|f||||||||2017-10-10 21:09:09.662166|2017-10-10 21:09:09.662166
NCT03121729|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-03|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|ERASG1||Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study|Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study|Recruiting||N/A|1000|Anticipated|Jinling Hospital, China||1|||f||||t|f|f||||||||2017-10-10 21:09:09.754517|2017-10-10 21:09:09.754517
NCT03121716|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-13|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Using the Combination Treatment of SHR-1210, Gemcitabine and Cis-platinum by Recurrent and Metastatic NPC Subjects|An Open-Label, Single Center, Nonrandomized, Phase 1 Study to Evaluate Safety and Efficacy of Using the Combination Treatment of SHR-1210, Gemcitabine and Cis-platinum by Recurrent and Metastatic NPC|Recruiting||Phase 1|20|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t|f|f||||||Undecided||2017-10-10 21:09:10.006115|2017-10-10 21:09:10.006115
NCT03121703|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-17|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|June 30, 2017|Anticipated|2017-06-30|May 30, 2017|Anticipated|2017-05-30||Interventional|||The Effects of Lumbar Stabilization Exercise on Transversus Abdominis Muscle Activation Capacity and Function in Chronic Low Back Pain Patients|Main Researcher for Effects of Lumbar Stabilization Exercise on Transversus Abdominis Muscle Activation Capacity and Function in Chronic Low Back Pain Patients|Not yet recruiting||N/A|30|Anticipated|Inje University||2|||f|||||f|f||||||||2017-10-10 21:09:10.092923|2017-10-10 21:09:10.092923
NCT03121690|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-04|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||The Applicability of Different Scoring Systems and Use of Steroids in the Treatment of Hospital Acquired Pneumonia|The Applicability of Different Scoring Systems and Use of Steroids in the Treatment of Hospital Acquired Pneumonia|Not yet recruiting||Phase 4|500|Anticipated|Assiut University||2|||f|||||t|f|||t|||||2017-10-10 21:09:10.154637|2017-10-10 21:09:10.154637
NCT03121677|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-08|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 31, 2027|Anticipated|2027-01-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Personalized Synthetic Long Peptide Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma|Pilot Study of a Personalized Synthetic Long Peptide Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma|Not yet recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:09:10.231215|2017-10-10 21:09:10.231215
NCT03121664|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-10-02|||April 7, 2017|Actual|2017-04-07|October 2017|2017-10-01|September 14, 2017|Actual|2017-09-14|September 14, 2017|Actual|2017-09-14||Interventional|||A Study To Estimate The Effects Of Itraconazole On Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects|A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Steady-state Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects|Completed||Phase 1|11|Actual|Pfizer||1|||f||||f|t|f|||t|||||2017-10-10 21:09:10.341531|2017-10-10 21:09:10.341531
NCT03121651|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-19|||November 11, 2016|Actual|2016-11-11|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|M-MIND||Medication Management Among Individuals With Neurodevelopmental Disabilities|Medication Management Among Individuals With Neurodevelopmental Disabilities|Recruiting||N/A|12|Anticipated|University of Michigan||1|||f||||f|f|f||||||No|No plan to share IPD|2017-10-10 21:09:10.419306|2017-10-10 21:09:10.419306
NCT03121638|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-19|||November 2012|Actual|2012-11-01|April 2017|2017-04-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Safety Study of NBP608 in Healthy Adult Volunteers|An Open Label, Active Controlled, Parallel Group Phase I Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of NBP608 in Healthy Adult Volunteers|Completed||Phase 1|150|Actual|SK Chemicals Co.,Ltd.||5|||f||||t|f|f||||||No||2017-10-10 21:09:10.49904|2017-10-10 21:09:10.49904
NCT03121625|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-04-23|||December 26, 2016|Actual|2016-12-26|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies|CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies|Recruiting||Phase 1|30|Anticipated|Hebei Senlang Biotechnology Inc., Ltd.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:09:10.581021|2017-10-10 21:09:10.581021
NCT03121612|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-09-25|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of CPAP Machines With Reusable vs Disposable Circuits|Randomised Trial Comparing CPAP Machines With Reusable vs Disposable Circuits|Recruiting||N/A|80|Anticipated|Medical Technology Transfer and Services Hong Kong Ltd||2|||f||||t|f|f||||||||2017-10-10 21:09:10.670927|2017-10-10 21:09:10.670927
NCT03121599|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-24|||June 11, 2017|Actual|2017-06-11|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms|A Study of 18F-FLT Positron Emission Tomography (PET)/Computed Tomography Imaging in Pediatrics With Myeloproliferative Neoplasms|Recruiting||N/A|20|Anticipated|Hamad Medical Corporation||1|||f||||t|f|t|f|f|t|||||2017-10-10 21:09:10.827323|2017-10-10 21:09:10.827323
NCT03121586|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-17|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|May 2021|Anticipated|2021-05-01|August 2020|Anticipated|2020-08-01||Interventional|||Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia|A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia|Recruiting||Phase 3|500|Anticipated|ACADIA Pharmaceuticals Inc.||1|||f||||t|t|f||||||No||2017-10-10 21:09:10.939735|2017-10-10 21:09:10.939735
NCT03121573|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-18|||December 15, 2014|Actual|2014-12-15|April 2017|2017-04-01|January 17, 2017|Actual|2017-01-17|September 26, 2016|Actual|2016-09-26||Interventional|||Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial|Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial|Completed||N/A|30|Actual|Taichung Veterans General Hospital||1|||f||||f|f|f||||||No|no plan|2017-10-10 21:09:11.035187|2017-10-10 21:09:11.035187
NCT03121560|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-19|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation|Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation|Not yet recruiting||N/A|96|Anticipated|Brugmann University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:09:11.103877|2017-10-10 21:09:11.103877
NCT03121547|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-19|||May 19, 2015|Actual|2015-05-19|April 2017|2017-04-01|January 29, 2016|Actual|2016-01-29|January 29, 2016|Actual|2016-01-29||Interventional|||Opioid Induced Gait Variability|Opioid Induced Gait Variability|Completed||Phase 1/Phase 2|24|Actual|Frederiksberg University Hospital||3|||f||||f|f|f|||f|||Undecided||2017-10-10 21:09:11.197891|2017-10-10 21:09:11.197891
NCT03121534|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-10-05|||June 22, 2017|Actual|2017-06-22|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of Blinatumomab in Richter Transformation|A Phase II Study of Blinatumomab in Richter Transformation|Recruiting||Phase 2|21|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:09:11.277377|2017-10-10 21:09:11.277377
NCT03121521|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-19|||September 1, 2012|Actual|2012-09-01|April 2017|2017-04-01|December 15, 2016|Actual|2016-12-15|September 30, 2016|Actual|2016-09-30||Interventional|||The Effects of Melatonin on Elevated Liver Enzymes During Statins Treatment|The Effects of Melatonin on Elevated Liver Enzymes During Statins Treatment|Completed||Phase 4|60|Actual|Medical Universtity of Lodz||2|||f|||||f|f||||||||2017-10-10 21:09:11.39573|2017-10-10 21:09:11.39573
NCT03121508|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-05|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|June 24, 2018|Anticipated|2018-06-24|April 24, 2018|Anticipated|2018-04-24||Interventional|TODAY||Taking on Diabetes to Advance You (TODAY)|Taking on Diabetes to Advance You|Recruiting||N/A|8|Anticipated|Colorado State University||1|||f||||f|f|f||||||||2017-10-10 21:09:11.500093|2017-10-10 21:09:11.500093
NCT03121495|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-20|||November 16, 2016|Actual|2016-11-16|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study on Second Forward View Examination in the Right Colon|Comparison of Second Forward View Examination and Conventional Withdrawal Examination in the Right Colon on Polyp Detection in Screening and Surveillance Colonoscopies: A Randomized Controlled Study (SFVRC Study)|Recruiting||N/A|1004|Anticipated|Chinese University of Hong Kong||2|||f||||t|f|f||||||Undecided||2017-10-10 21:09:11.587026|2017-10-10 21:09:11.587026
NCT03121482|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-09|||April 19, 2017|Actual|2017-04-19|June 2017|2017-06-01|April 6, 2020|Anticipated|2020-04-06|April 6, 2020|Anticipated|2020-04-06||Interventional|HIGH-WEAN||High-flow Nasal Cannula Oxygen Therapy With or Without NIV During the Weaning Period|High-flow Nasal Cannula Oxygen Therapy With or Without Non-invasive Ventilation (NIV) During the Weaning Period: a Multicenter Randomized Controlled Trial|Recruiting||N/A|590|Anticipated|Poitiers University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:09:11.659321|2017-10-10 21:09:11.659321
NCT03121469|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-22|||November 30, 2017|Anticipated|2017-11-30|April 2017|2017-04-01|November 30, 2020|Anticipated|2020-11-30|November 30, 2020|Anticipated|2020-11-30||Interventional|RPO-S+||Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer|Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer|Not yet recruiting||N/A|47|Anticipated|Centre Antoine Lacassagne||1|||f||||t|f|f||||||||2017-10-10 21:09:13.847371|2017-10-10 21:09:13.847371
NCT03121456|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-05|||April 30, 2017|Actual|2017-04-30|April 2017|2017-04-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2021|Anticipated|2021-04-30||Interventional|LYMPHODTECT||18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma|18F-FDG PET Scan and MRI Diffusion : Correlation Study of the Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma|Recruiting||N/A|74|Anticipated|Centre Antoine Lacassagne||1|||f||||t|f|f||||||||2017-10-10 21:09:13.918555|2017-10-10 21:09:13.918555
NCT03121443|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-07-07|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|July 5, 2017|Actual|2017-07-05|July 2, 2017|Actual|2017-07-02||Observational|||Patient Positions and Perfusion Index|The Association Between Surgical Patient Positions and Perfusion Index|Completed||N/A|61|Actual|Tokat Gaziosmanpasa University|||1||f||||t|f|f||||||||2017-10-10 21:09:14.030288|2017-10-10 21:09:14.030288
NCT03121430|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-04-20|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|July 2020|Anticipated|2020-07-01||Interventional|||Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion|The Safety and Efficacy of Drug Eluting Peripheral Vascular Stent System for the Treatment of Superficial Femoral Artery Stenosis and /or Occlusion: a Multi-center Stratified Randomized Single- Blind Controlled Trial|Not yet recruiting||N/A|138|Anticipated|Zhejiang Zylox Medical Device Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:09:14.118277|2017-10-10 21:09:14.118277
NCT03121417|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-08-11|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer|Biomarker-Driven Phase 2 Study of Nivolumab in Advanced Metastatic NSCLC|Recruiting||Phase 2|35|Anticipated|Emory University||1|||f||||t|t|f||||||||2017-10-10 21:09:14.228411|2017-10-10 21:09:14.228411
NCT03121404|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-03|||November 14, 2008|Actual|2008-11-14|July 2017|2017-07-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2025|Anticipated|2025-12-31||Observational|||Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting|Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting|Recruiting||N/A|40|Anticipated|The Cleveland Clinic|||2||f||||t|f|f||||||||2017-10-10 21:09:14.315165|2017-10-10 21:09:14.315165
NCT03121391|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-05|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||An Algorithmic Approach to Ventilator Withdrawal at the End of Life|An Algorithmic Approach to Ventilator Withdrawal at the End of Life|Enrolling by invitation||N/A|265|Anticipated|Wayne State University||2|||f||||t|f|f||||||||2017-10-10 21:09:14.397475|2017-10-10 21:09:14.397475
NCT03121378|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-14|||April 12, 2017|Actual|2017-04-12|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|APJAB||Multiple Electrode Aggregometry to Assess Platelet Function in Patients Undergoing Hip Joint Alloplasty With and Without Bone Cement|Multiple Electrode Aggregometry to Assess Platelet Function in Patients Undergoing Hip Joint Alloplasty With and Without Bone Cement|Recruiting||N/A|44|Anticipated|Medical University of Warsaw|||2||f||||f|f|f||||Samples With DNA|"     3ml Blood samples.   "|||2017-10-10 21:09:14.475847|2017-10-10 21:09:14.475847
NCT03121352|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-06-07|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer|Pilot Study of Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer|Recruiting||Phase 2|30|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:09:14.717784|2017-10-10 21:09:14.717784
NCT03121339|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-08|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults|A Phase 1, Open-Label, Randomized, 2×2 Crossover Study of Pharmacodynamics Comparing the Impact of Tablet Size and Fasting Status With an Oral Human Influenza A/California/04/2009 (H1N1) HA Adenoviral-Vector Based Vaccine and dsRNA Adjuvant|Active, not recruiting||Phase 1|8|Actual|Vaxart||2|||f||||f|t|f||||||No||2017-10-10 21:09:14.832323|2017-10-10 21:09:14.832323
NCT03121326|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-17|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|March 15, 2017|Actual|2017-03-15||Observational|||The Study of Sarcopenia and Aging Biomarkers by the Metabolomics|The Study of Sarcopenia and Aging Biomarkers by the Metabolomics|Recruiting||N/A|650|Anticipated|Chang Gung Memorial Hospital|||1||f||||t|f|f||||Samples Without DNA|"     blood and urine   "|Undecided||2017-10-10 21:09:14.914848|2017-10-10 21:09:14.914848
NCT03121313|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-05-11|||February 26, 2015|Actual|2015-02-26|April 2017|2017-04-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+|A Phase II Study of Maintenance Tegafur-uracil in Patients With Squamous Cell Carcinoma of Oral Cavity With Extracapsular Spreading of Lymph Nodes|Recruiting||Phase 2|68|Anticipated|Chang Gung Memorial Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:09:14.993223|2017-10-10 21:09:14.993223
NCT03121300|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-19|||February 6, 2017|Actual|2017-02-06|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Functional Imaging in Lung SBRT|Functional Outcomes for Stereotactic Body Radiotherapy of Lung Lesions in High Risk Patients|Recruiting||N/A|20|Anticipated|University of Michigan Cancer Center||1|||f||||t|f|f||||||No||2017-10-10 21:09:15.133743|2017-10-10 21:09:15.133743
NCT03121287|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-08-02|||September 23, 2015|Actual|2015-09-23|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Early Imaging Biomarkers in NSCLC|Early Imaging Biomarkers to Predict Radiation-Induced Cardiopulmonary Toxicity in Patients With Thoracic Malignancies|Recruiting||N/A|20|Anticipated|University of Michigan Cancer Center||1|||f||||t|f|f||||||||2017-10-10 21:09:15.230792|2017-10-10 21:09:15.230792
NCT03121274|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-07-31|||May 30, 2017|Actual|2017-05-30|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Versus Delayed Pushing in the Second Stage of Labor|Early Versus Delayed Pushing in the Second Stage of Labor|Recruiting||N/A|300|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 21:09:15.31661|2017-10-10 21:09:15.31661
NCT03121261|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-19|||October 2015||2015-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Local Anesthetic and Clonidine on the Cutaneous Silent Period During Spinal Anesthesia|The Effect of Local Anesthetic and Clonidine on the Cutaneous Silent Period During and After Spinal Anesthesia|Active, not recruiting||Phase 4|60|Anticipated|University Hospital Dubrava||2|||f||||f||||||||||2017-10-10 21:09:15.396215|2017-10-10 21:09:15.396215
NCT03121248|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-14|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|January 31, 2027|Anticipated|2027-01-31|January 31, 2022|Anticipated|2022-01-31||Interventional|HAI-5-III||Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years|A Partially Randomized Patient Preference Trial, Comparing Adjuvant Hypofractionated Radiotherapy in 15 Versus 5 Fractions After Breast Conserving Surgery or Mastectomy for Early or Locally Advanced Breast Cancer in Women Above 65 Years|Recruiting||N/A|798|Anticipated|University Hospital, Ghent||10|||f||||f|f|f||||||No||2017-10-10 21:09:15.482912|2017-10-10 21:09:15.482912
NCT03121235|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|October 15, 2019|Anticipated|2019-10-15|October 15, 2019|Anticipated|2019-10-15||Observational|AzorMan||PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.|PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. A Prospective Multicenter Observational Study.|Recruiting||N/A|280|Anticipated|Erasmus Medical Center|||1||f|||||f|f|||f|Samples With DNA|"     Broncho-alveolar lavage specimens   "|Undecided||2017-10-10 21:09:15.623385|2017-10-10 21:09:15.623385
NCT03121222|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-20|||November 1, 2015|Actual|2015-11-01|April 2017|2017-04-01|September 12, 2016|Actual|2016-09-12|February 15, 2016|Actual|2016-02-15||Interventional|||The Effects of N-acetylcysteine on Performance and Redox Homeostasis|N-acetylcysteine Supplementation in Individuals With Low Glutathione Levels: the Effects on Physical Performance and Redox Homeostasis|Completed||Phase 2|36|Actual|Aristotle University Of Thessaloniki||2|||f||||f|f|f||||||No||2017-10-10 21:09:15.736664|2017-10-10 21:09:15.736664
NCT03121209|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-08-15|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|CREST-H||Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)|Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics|Not yet recruiting||N/A|500|Anticipated|Columbia University|||1||f||||t||||||||||2017-10-10 21:09:15.818232|2017-10-10 21:09:15.818232
NCT03121196|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-14|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Social Deprivation and Pregnancy|Social Deprivation and Pregnancy|Not yet recruiting||N/A|615|Anticipated|University Hospital, Clermont-Ferrand|||2||f|||||f|f||||||||2017-10-10 21:09:15.906804|2017-10-10 21:09:15.906804
NCT03121183|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-07-31|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|GAINE LASER||Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers|Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers: a Retrospective Observational Study|Active, not recruiting||N/A|45|Actual|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 21:09:16.010796|2017-10-10 21:09:16.010796
NCT03120780|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-26|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Epidural Fentanyl for 2nd Stage Labor Analgesia|High Dose Epidural Fentanyl for Second Stage Labor Analgesia|Recruiting||Phase 4|150|Anticipated|Ohio State University||2|||f||||f|t|f|||f|||No|No plan to share IPD.|2017-10-10 21:09:20.300178|2017-10-10 21:09:20.300178
NCT03121170|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-04-20|||February 4, 2017|Actual|2017-02-04|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Extracorporeal Shock Wave Therapy in the Treatment of Primary Dysmenorrhea|Extracorporeal Shock Wave Therapy in the Treatment of Primary Dysmenorrhea:a Randomized Controlled-placebo Trial|Active, not recruiting||N/A|48|Anticipated|Xuhui Central Hospital, Shanghai||3|||f||||f|f|f||||||No||2017-10-10 21:09:16.102536|2017-10-10 21:09:16.102536
NCT03121157|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-13|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|DYAAP||Detroit Young Adult Asthma Project|Multi-component Technology Intervention for African American Emerging Adults With Asthma|Recruiting||N/A|192|Anticipated|Wayne State University||2|||f||||t|f|f||||||No||2017-10-10 21:09:16.195346|2017-10-10 21:09:16.195346
NCT03121144|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-14|||March 1, 2017||2017-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:09:16.279113|2017-10-10 21:09:16.279113
NCT03121131|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-08-25|||May 5, 2017|Actual|2017-05-05|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||CT and Radiologist RCT|How Important is a Clinical Data for a Radiologist? A Double-Blinded Randomized Controlled Trial of Radiologic Interpretation of Ventral Hernias Following Selectively-Provided Clinical Information|Active, not recruiting||N/A|7|Actual|The University of Texas Health Science Center, Houston||3|||f||||f|f|f||||||||2017-10-10 21:09:16.318074|2017-10-10 21:09:16.318074
NCT03121118|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-14|||September 17, 2014|Actual|2014-09-17|April 2017|2017-04-01|September 30, 2019|Anticipated|2019-09-30|December 31, 2018|Anticipated|2018-12-31||Observational|||Return of Amyloid Imaging Results (Result Study)|Return of Amyloid Imaging Results|Enrolling by invitation||N/A|80|Anticipated|University of Pittsburgh|||2||f||||t||||||||No||2017-10-10 21:09:16.500166|2017-10-10 21:09:16.500166
NCT03121105|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-14|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|July 31, 2017|Anticipated|2017-07-31|May 31, 2017|Anticipated|2017-05-31||Observational|IIDD||Pathologic-MRI Findings in Atypical IIDD|A Pathologic-MRI Reappraisal of Patients With Atypical Idiopathic Inflammatory Demyelinating Disorders|Active, not recruiting||N/A|25|Anticipated|University Hospital, Montpellier|||1||f||||t|f|f||||||Undecided|NC|2017-10-10 21:09:16.581729|2017-10-10 21:09:16.581729
NCT03121092|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-14|||May 16, 2012|Actual|2012-05-16|April 2017|2017-04-01|March 7, 2017|Actual|2017-03-07|March 7, 2017|Actual|2017-03-07||Interventional|ACE/ARB||ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients|Should Ambulatory Surgery and Day of Surgery Admission Patients Discontinue Angiotensin Converting Enzyme Inhibitors (ACEI's) and Angiotension Receptor Blockers (ARB's) Preoperatively?|Terminated||N/A|188|Actual|State University of New York - Downstate Medical Center||2||"Due to difficulty with recruiting patients meeting the inclusion criteria the PI decided to   retire this project."|f||||f||||||||||2017-10-10 21:09:16.653887|2017-10-10 21:09:16.653887
NCT03121079|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-18|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation|Interferon-α Prevents Leukemia Relapse of AML Patients Undergoing HLA-identical Allogeneic Hematopoietic Stem Cell Transplantation With Pretransplant MRD|Recruiting||N/A|29|Anticipated|Peking University People's Hospital||1|||f||||t|f|f|||f|||No||2017-10-10 21:09:16.744985|2017-10-10 21:09:16.744985
NCT03121066|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-19|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|October 2018|Anticipated|2018-10-01||Interventional|TMSAD||Transcranial Magnetic Stimulation for Alzheimer's Disease Treatment|Intervention Based on Transcranial Magnetic Stimulation for Alzheimer's Disease Patients: Randomized Clinical Trial|Not yet recruiting||N/A|45|Anticipated|Universitat Oberta de Catalunya||3|||f|||||f|f|||f|||No||2017-10-10 21:09:16.854818|2017-10-10 21:09:16.854818
NCT03121053|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-18|||October 2016||2016-10-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|PANTER||Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement|Preventing Contrast Induced Nephropathy After Transcatheter Aortic Valve Replacement|Recruiting||Phase 4|200|Anticipated|St. Antonius Hospital||2|||f||||t||||||||||2017-10-10 21:09:16.93836|2017-10-10 21:09:16.93836
NCT03121040|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-18|||May 2, 2009|Actual|2009-05-02|April 2017|2017-04-01|July 22, 2009|Actual|2009-07-22|July 16, 2009|Actual|2009-07-16||Interventional|||Clinical Trial for Vespa Amino Acid Mixture (VAAM®)|Improved ATP Generation Efficiency for Younger Athletes by Ingestion of a Vespa Amino Acid Mixture|Completed||N/A|10|Actual|Shanghai Meiji Health Science and Technology Co., Ltd.||3|||f||||f|f|f|||f|||No||2017-10-10 21:09:17.041532|2017-10-10 21:09:17.041532
NCT03121027|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-14|||May 11, 2011|Actual|2011-05-11|April 2017|2017-04-01|January 18, 2012|Actual|2012-01-18|July 8, 2011|Actual|2011-07-08||Observational|||Burden of Anemia Among Ever-married Women in Bangladesh: Does Household Economic Inequality Matter?|Burden of Anemia Among Ever-married Women in Bangladesh|Completed||N/A|5920|Actual|Shahjalal University of Science and Technology|||1||f||||t|f|f||||||No||2017-10-10 21:09:17.122241|2017-10-10 21:09:17.122241
NCT03121014|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-17|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|April 24, 2024|Anticipated|2024-04-24|April 24, 2023|Anticipated|2023-04-24||Interventional|||Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes|A Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes|Recruiting||Phase 2|38|Anticipated|University of Illinois at Chicago||1|||f||||t|t|f|||f|||||2017-10-10 21:09:17.189527|2017-10-10 21:09:17.189527
NCT03121001|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-05-17|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|October 28, 2026|Anticipated|2026-10-28|October 28, 2026|Anticipated|2026-10-28||Interventional|||Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease|A Phase II Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease|Recruiting||Phase 2|50|Anticipated|University of Illinois at Chicago||1|||f||||t|t|f|||f|||||2017-10-10 21:09:17.298033|2017-10-10 21:09:17.298033
NCT03120988|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-14|||July 2016||2016-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|PPP||Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage|Assessing Catabolic Marker Levels in the Knee Synovial Fluid Microenvironment After Lavage With Platelet Poor Plasma (PPP)|Active, not recruiting||Phase 1|10|Anticipated|Regenerative Sciences, LLC||1|||f||||f||||||||No||2017-10-10 21:09:17.398052|2017-10-10 21:09:17.398052
NCT03120975|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-20|||April 1, 2018|Anticipated|2018-04-01|April 2017|2017-04-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|COMPASS||Computerized Antibiotic Stewardship Study|Improvement of Antibiotic Use in Hospitals Through Pragmatic, Multifaceted, Computerized Interventions: a Multicentre, Cluster-randomized Trial - COMPASS Study (COMPuterized Antibiotic Stewardship Study)|Not yet recruiting||N/A|5000|Anticipated|University Hospital, Geneva||2|||f||||f|f|f||||||No||2017-10-10 21:09:17.502747|2017-10-10 21:09:17.502747
NCT03120962|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-16|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01||Interventional|||Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia|Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia|Not yet recruiting||N/A|140|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||t|f|f|||f|||No||2017-10-10 21:09:17.655975|2017-10-10 21:09:17.655975
NCT03120949|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-08-17|||July 4, 2017|Actual|2017-07-04|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|July 2021|Anticipated|2021-07-01||Interventional|CREDO 4||Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regimens of Olokizumab (OKZ), in Subjects With Rheumatoid Arthritis (RA) Who Previously Completed 24 Weeks of Blinded Treatment in One of the Core Studies - CREDO 1, 2 or 3.|A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis|Recruiting||Phase 3|1880|Anticipated|R-Pharm||2|||f||||t|t|f||||||||2017-10-10 21:09:17.825375|2017-10-10 21:09:17.825375
NCT03120936|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-19|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community|The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community|Recruiting||Phase 4|188|Anticipated|Public Health Foundation Enterprises, Inc.||1|||f||||f|t|f|||f|||||2017-10-10 21:09:19.232428|2017-10-10 21:09:19.232428
NCT03120923|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-16|||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||Combined Corticosteroid With Low Volume Compared to High Volume in Impingement Syndrome|A Short Term Outcomes of Subacromial Injection of Combined Corticosteroid With Low Volume Compared to High Volume of Local Anesthetic for Rotator Cuff Impingement Syndrome: A Randomized Controlled Trials|Completed||Phase 4|52|Actual|Ramathibodi Hospital||2|||f||||t|t|f||||||Undecided||2017-10-10 21:09:19.404191|2017-10-10 21:09:19.404191
NCT03120910|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-14|||December 15, 2016||2016-12-15||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:09:19.506381|2017-10-10 21:09:19.506381
NCT03120897|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-28|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:09:19.55477|2017-10-10 21:09:19.55477
NCT03120884|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-16|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Intracytoplasmic Sperm Injection in Non-male Factor Infertility in Advanced Maternal Age|Intracytoplasmic Sperm Injection in Non-male Factor Infertility in Advanced Maternal Age|Not yet recruiting||N/A|1422|Anticipated|International Peace Maternity and Child Health Hospital||2|||f||||t|f|f||||||Undecided|undecided|2017-10-10 21:09:19.599067|2017-10-10 21:09:19.599067
NCT03120871|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-26|||May 12, 2017|Actual|2017-05-12|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|MISS||Microbiome Insulin Sensitivity Study|Sex Differences in Youth-Onset Type 2 Diabetes: Exploring Mechanisms|Recruiting||N/A|75|Anticipated|University of Colorado, Denver|||1||f||||f|f|f||||Samples Without DNA|"     Stool, urine, and serum and plasma will be collected and banked for future research.   "|No||2017-10-10 21:09:19.709692|2017-10-10 21:09:19.709692
NCT03120858|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-08-10|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Observational|||Turkish Version of the Kinesthetic and Visual Imagery Questionnaire|Reliability and Validity of the Turkish Version of the Kinesthetic and Visual Imagery Questionnaire|Completed||N/A|185|Actual|Hacettepe University|||1||f|||||f|f||||||||2017-10-10 21:09:19.825192|2017-10-10 21:09:19.825192
NCT03120845|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-18|||February 2, 2015||2015-02-02|April 2017|2017-04-01|February 26, 2017|Actual|2017-02-26|February 2, 2017|Actual|2017-02-02||Interventional|||Incidence of Post-operative Pain After Single-visit Versus Two-visit Treatment|Incidence of Post-operative Pain After Single-visit Versus Two-visit Root Canal Treatment of Teeth With Necrotic Pulp and Apical Periodontitis|Completed||N/A|110|Actual|Universidad Autonoma de Baja California||2|||f||||t|f|f||||||Yes|Each participant will be evaluated a week after the treatment.|2017-10-10 21:09:19.897205|2017-10-10 21:09:19.897205
NCT03120832|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-18|||December 2016||2016-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1 Trial of PAN-301-1 in Cancer Patients|Phase 1, Open Label Trial to Evaluate the Safety and Immunogenicity of PAN-301-1 in Cancer Patients|Recruiting||Phase 1|18|Anticipated|Panacea Pharmaceuticals, Inc.||1|||||||t|t|f||||||||2017-10-10 21:09:19.967956|2017-10-10 21:09:19.967956
NCT03120819|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-14|||August 1, 2010|Actual|2010-08-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|July 31, 2011|Actual|2011-07-31||Interventional|||Exercise Information for Women With Cancer|A Randomized Controlled Trial to Determine the Effect of Supplementing an Oncologist's Recommendation to Exercise With Multimedia on Fatigue Levels in Breast Cancer Patients|Completed||N/A|95|Actual|Oregon Health and Science University||2|||f||||f|f|f||||||No||2017-10-10 21:09:20.059801|2017-10-10 21:09:20.059801
NCT03120806|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-16|2017-04-16|||April 16, 2017|Actual|2017-04-16|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparative Study Between Interrupted and Continuous Subcuticular Skin Suturing in Women Undergoing Elective Cesarean Section.|Comparative Study Between Interrupted and Continuous Subcuticular Skin Suturing in Women Undergoing Elective Cesarean Section. A Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Cairo University||2|||f||||t|f|f||||||Yes||2017-10-10 21:09:20.139046|2017-10-10 21:09:20.139046
NCT03120793|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-24|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|September 20, 2017|Anticipated|2017-09-20|September 20, 2017|Anticipated|2017-09-20||Observational|||ARDS Esophageal Balloon Pressure Changes With Positioning Study|Assessing Pleural Pressure Changes Between Supine, Upright and Prone Mechanical Ventilation|Recruiting||N/A|10|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f|f|t|f|||||No||2017-10-10 21:09:20.216589|2017-10-10 21:09:20.216589
NCT03120754|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-15|||March 24, 2017|Actual|2017-03-24|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|July 30, 2018|Anticipated|2018-07-30||Interventional|||Study of Abdominal Drainage in LCBDE+PC|Clinical Study of Abdominal Drainage in Laparoscopic Common Bile Duct Exploration With Primary Closure|Recruiting||N/A|80|Anticipated|Zhongshan Hospital Xiamen University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:09:20.496851|2017-10-10 21:09:20.496851
NCT03120741|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-04-14|||May 2017|Anticipated|2017-05-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Dementia Patient's Behavior Evaluation Using Noninvasive Ambient Sensor|Dementia Patient's Behavior Evaluation Using Noninvasive Ambient Sensor|Not yet recruiting||N/A|35|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 21:09:20.573031|2017-10-10 21:09:20.573031
NCT03120728|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-13|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|June 30, 2018|Anticipated|2018-06-30||Interventional|AFTER||Application for the Etonogestrel/Ethinyl Estradiol Ring|AFTER: Application for the Etonogestrel/Ethinyl Estradiol Ring--potential for Emergency Contraception|Recruiting||Phase 4|36|Anticipated|University of Southern California||3|||f|||||t|f|||t|||||2017-10-10 21:09:20.652829|2017-10-10 21:09:20.652829
NCT03120715|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-14|||July 1, 2016|Actual|2016-07-01|April 2017|2017-04-01|September 5, 2017|Anticipated|2017-09-05|June 30, 2017|Anticipated|2017-06-30||Interventional|||Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo Transfer|Comparison of Clinical Pregnancy Rates Between Two Protocols, With or Without Low Molecular Weight Heparin Administration Before Frozen Embryo Transfer in Hormonal Replacement Cycles: a Prospective Randomized Controlled Trial|Recruiting||Phase 4|342|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:09:20.759575|2017-10-10 21:09:20.759575
NCT03120702|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-18|||July 23, 2013||2013-07-23||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:09:21.001162|2017-10-10 21:09:21.001162
NCT03120689|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-04-16|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|VITOM||VITOM Study: A Randomized, Controlled Trial.|Learner Satisfaction and Experience With Use of a Vaginal Field Telescopic, High-definition Telescopic Camera System During Vaginal Reconstructive Procedures: A Randomized, Controlled Trial.|Recruiting||N/A|150|Anticipated|University of Louisville||4|||f||||f||||||||No||2017-10-10 21:09:21.06856|2017-10-10 21:09:21.06856
NCT03120676|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-17|2017-09-27|||April 14, 2017|Actual|2017-04-14|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma|A Phase II Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma|Recruiting||Phase 2|57|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f|||f|||||2017-10-10 21:09:21.22713|2017-10-10 21:09:21.22713
NCT03120663|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-19|||November 30, 2016|Actual|2016-11-30|April 2017|2017-04-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|TAPAS||Target Attainment and Pharmacokinetics of Antimicrobials in Non-critically Ill Surgery Patients (TAPAS)|Target Attainment and Pharmacokinetics of Antimicrobials in Non-critically Ill Surgery Patients|Recruiting||N/A|120|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f|f|f|||f|Samples Without DNA|"     Per patient, blood samples during 1 antimicrobial dosing interval and the measured creatinine     clearance based on an 8-hour urinary collection (CrCl8h) will be collected.   "|No||2017-10-10 21:09:21.361476|2017-10-10 21:09:21.361476
NCT03120650|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-23|||January 20, 2017|Actual|2017-01-20|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|April 20, 2019|Anticipated|2019-04-20||Interventional|LUSA||Scalp Acupuncture for Dyskinesia After Ischemic Stroke|Scalp Acupuncture for Dyskinesia After Ischemic Stroke|Recruiting||N/A|116|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t|f|f||||||No||2017-10-10 21:09:21.461556|2017-10-10 21:09:21.461556
NCT03120637|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-18|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|CRuMBS||Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue|Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue in Sepsis: A Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f|f|f||||||No||2017-10-10 21:09:21.577312|2017-10-10 21:09:21.577312
NCT03120624|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-09-18|||September 15, 2017|Actual|2017-09-15|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer|Phase I Trial of Intravenous Administration of Vesicular Stomatitis Virus Genetically Engineered to Express Thyroidal Sodium Iodide Symporter (NIS) and Human Interferon Beta (hIFNb) in Patients With Metastatic or Recurrent Endometrial Cancer|Recruiting||Phase 1|33|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:09:21.687456|2017-10-10 21:09:21.687456
NCT03120611|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-22|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Virtual Reality Versus Conventional Exercise Intradialysis|Comparison of Two Exercise Programs Intradialysis: Virtual Reality Exercise Versus Conventional Exercise|Completed||N/A|18|Actual|Cardenal Herrera University||2|||f||||f|f|f||||||No||2017-10-10 21:09:21.823695|2017-10-10 21:09:21.823695
NCT03120598|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-04-18|||January 5, 2015|Actual|2015-01-05|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment|Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment|Enrolling by invitation||N/A|195|Anticipated|RTI International||2|||f||||f|f|f||||||Undecided||2017-10-10 21:09:21.921957|2017-10-10 21:09:21.921957
NCT03120585|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-04-15|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Fluid Restriction in Respiratory Distress of the Newborn|Multicenter Randomized Controlled Trial Of Restrictive Fluid Management For Respiratory Distress in the Newborn Period|Recruiting||N/A|400|Anticipated|University of Oklahoma||2|||f||||t|f|f||||||Undecided||2017-10-10 21:09:22.092536|2017-10-10 21:09:22.092536
NCT03120208|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-24|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|PSYCHE||Prevalence of Psychological Disorders After Immediate Postpartum Hemorrhage|Prevalence of Psychological Disorders After Immediate Postpartum Hemorrhage|Recruiting||N/A|1542|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:09:26.211385|2017-10-10 21:09:26.211385
NCT03120572|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-18|||August 2013||2013-08-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01|2 Months|Observational [Patient Registry]|||Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer|Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer|Completed||N/A|45|Actual|Mackay Memorial Hospital|||1||f||||||||||||||2017-10-10 21:09:22.185381|2017-10-10 21:09:22.185381
NCT03120559|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-15|||June 1, 2015|Actual|2015-06-01|April 2017|2017-04-01|March 30, 2016|Actual|2016-03-30|March 30, 2016|Actual|2016-03-30||Interventional|||Improving Dental Floss Adherence and Gingival Health With SMS and an Innovative Floss Holder|Can we Still Save Dental Floss? Improving Dental Floss Adherence and Gingival Health With SMS and an Innovative Floss Holder in a Randomized Controlled Trial|Completed||N/A|144|Actual|University of Lisbon||3|||f||||f|f|f||||||No||2017-10-10 21:09:22.267661|2017-10-10 21:09:22.267661
NCT03120546|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-18|||May 30, 2017|Anticipated|2017-05-30|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Cervical Spine Motion During Tracheal Intubation: Video Laryngoscope vs Rigid Video Stylet|A Randomized Comparison of Cervical Spine Motion During Tracheal Intubation Using Video Laryngoscope or Rigid Video Stylet in Patients With Simulated Cervical Immobilization|Not yet recruiting||N/A|22|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:09:22.351747|2017-10-10 21:09:22.351747
NCT03120533|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-13|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|TISSUE-PoC||Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study|Therapeutic Iontophoresis of Treprostinil in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|University Hospital, Grenoble||2|||f||||t|f|f||||||No||2017-10-10 21:09:22.443704|2017-10-10 21:09:22.443704
NCT03120520|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-18|2017-09-06|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation|A Randomized, Double-blind, Placebo-controlled, 3 Dose Level, Parallel Group Study of the Efficacy and Safety of Plecanatide in Adolescents 12 to < 18 Years of Age With Chronic Idiopathic Constipation (CIC)|Recruiting||Phase 2|120|Anticipated|Synergy Pharmaceuticals Inc.||4|||f||||f|t|f||||||||2017-10-10 21:09:22.570351|2017-10-10 21:09:22.570351
NCT03120507|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-18|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Observational|ROUTiNE||Resuscitation Outcomes in the Netherlands|Resuscitation Outcomes in the Netherlands Study|Recruiting||N/A|600|Anticipated|Erasmus Medical Center|||1||f||||t|f|f||||||No||2017-10-10 21:09:23.603659|2017-10-10 21:09:23.603659
NCT03120494|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-18|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part B|Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part B|Enrolling by invitation||Phase 4|75|Actual|Puerto Rico Community Network for Clinical Research on AIDS||1|||f||||f|f|f|||f|||No||2017-10-10 21:09:23.787854|2017-10-10 21:09:23.787854
NCT03120481|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-14|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|February 28, 2037|Anticipated|2037-02-28|February 28, 2037|Anticipated|2037-02-28|20 Years|Observational [Patient Registry]|||Controls for Respiratory Diseases|The Registry of Controls for Respiratory Diseases|Recruiting||N/A|1572|Anticipated|Seoul National University Hospital|||1||f||||f|f|f||||Samples With DNA|"     DNA Plasma Serum   "|No||2017-10-10 21:09:23.895262|2017-10-10 21:09:23.895262
NCT03120468|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-15|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder|Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder|Recruiting||Early Phase 1|16|Anticipated|University of Virginia||2|||||||f|t|f||||||No||2017-10-10 21:09:23.996906|2017-10-10 21:09:23.996906
NCT03120455|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-09-12|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of Almond Versus Pistachio on Weight Loss|Effects of Almond Versus Pistachio on Weight Loss of Obese and Overweight Female Adults During Hypoenergetic Diet - a Randomized, 12 Week Clinical Trial|Enrolling by invitation||N/A|120|Anticipated|Novindiet Clinic||3|||f||||f|f|f||||||||2017-10-10 21:09:24.126692|2017-10-10 21:09:24.126692
NCT03120442|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-06-14|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|August 2021|Anticipated|2021-08-01|May 2021|Anticipated|2021-05-01||Interventional|||Postoperative Delirium After Total Knee Arthroplasty Under Regional Anesthesia|Postoperative Delirium After Total Knee Arthroplasty Under Regional Anesthesia: a Comparison Between Intraoperative Sedation With Fentanyl, Fentanyl-dexmedetomidine and Fentanyl-propofol|Enrolling by invitation||N/A|600|Anticipated|Mahidol University||3|||f||||f|f|f||||||Undecided||2017-10-10 21:09:24.233762|2017-10-10 21:09:24.233762
NCT03120429|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-09-12|||June 25, 2017|Actual|2017-06-25|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of Moderate Consumption of Lean Fish on Weight Loss|Effects of Moderate Consumption Lean Fish on Weight Loss of Overweight and Obese Women During a Weight Loss Program, a 24 Week Randomized Controlled Trial|Enrolling by invitation||N/A|120|Anticipated|Novindiet Clinic||2|||f||||f|f|f||||||||2017-10-10 21:09:24.388213|2017-10-10 21:09:24.388213
NCT03120416|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-14|||January 25, 2017|Actual|2017-01-25|April 2017|2017-04-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Resistance Exercise Training in Chronic Kidney Disease|Effect of Resistance Exercise Training on Endothelial Function and Cardiovascular Risk Factors in Patients With Chronic Kidney Disease|Recruiting||N/A|32|Anticipated|University of Illinois at Chicago||2|||f||||t|f|f||||||No||2017-10-10 21:09:24.494544|2017-10-10 21:09:24.494544
NCT03120403|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-18|||July 1, 2016|Actual|2016-07-01|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|||Safety and Efficacy of Intrathecal Morphine in Children|Safety and Efficacy of Intrathecal Morphine in Children Undergoing Major Abdominal Surgeries, Dose-finding Clinical Study|Completed||Phase 2|45|Actual|Assiut University||3|||f|||||||||t|||Undecided||2017-10-10 21:09:24.590454|2017-10-10 21:09:24.590454
NCT03120390|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-12|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|November 20, 2022|Anticipated|2022-11-20|November 20, 2021|Anticipated|2021-11-20||Interventional|||Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors|Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity: The ROSA Trial (Phase II, Randomized Controlled Trial for Early Stage Breast Cancer Survivors)|Not yet recruiting||N/A|240|Anticipated|University of Southern California||3|||f||||t|f|t|f|||||||2017-10-10 21:09:24.663898|2017-10-10 21:09:24.663898
NCT03120377|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-14|||March 2, 2017|Actual|2017-03-02|April 2017|2017-04-01|December 15, 2017|Anticipated|2017-12-15|October 23, 2017|Anticipated|2017-10-23||Interventional|||Efficiency of a Whole Body Vibration Training Program in Adult Renal Transplanted Patients|Respiratory and Musculoskeletal Effects After a Whole Body Vibration Training Program in Adult Renal Transplant Recipients: A Randomized Controlled Trial|Recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco||2|||f||||t|f|f||||||Undecided||2017-10-10 21:09:24.790079|2017-10-10 21:09:24.790079
NCT03120364|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-17|||September 9, 2015|Actual|2015-09-09|April 2017|2017-04-01|April 28, 2016|Actual|2016-04-28|December 16, 2015|Actual|2015-12-16||Interventional|||Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over|A Randomized, Double Blinded, Multi-center Phase III Confirmatory Study to Assess the Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over|Completed||Phase 3|824|Actual|SK Chemicals Co.,Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:09:24.909047|2017-10-10 21:09:24.909047
NCT03120338|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-01|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|eCAP:DAWBA||DAWBA as a Rapid Online Assessment Tool|eHealth Services for Child and Adolescent Psychiatry (eCAP): A Multi-site Trial of the DAWBA as a Rapid Online Assessment Tool|Recruiting||N/A|226|Anticipated|University of Aberdeen||2|||f||||t|f|f||||||Yes||2017-10-10 21:09:25.278341|2017-10-10 21:09:25.278341
NCT03120325|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-19|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|July 1, 2018|Anticipated|2018-07-01|March 1, 2018|Anticipated|2018-03-01||Interventional|VNS||Vagal Nerve Stimulation for Gastroparesis|Therapeutic Potential and Neuroimmune Mechanisms of Vagal Nerve Stimulation on Gastrointestinal Motility and Inflammation|Recruiting||N/A|45|Anticipated|Stanford University||1|||f||||f|f|t|t|f|f|||Undecided||2017-10-10 21:09:25.381825|2017-10-10 21:09:25.381825
NCT03120312|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-04-15|||May 30, 2017|Anticipated|2017-05-30|April 2017|2017-04-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|THR||Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement|Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacements During Past 5 Years :A Retrospective Analysis|Not yet recruiting||N/A|1500|Anticipated|Second Hospital of Shanxi Medical University|||1||f||||||||||||||2017-10-10 21:09:25.476303|2017-10-10 21:09:25.476303
NCT03120299|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-04-27|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)|The Effect of Omega-3 Fatty Acids on Hypertriglyceridemia in Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 4|350|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f|||||f|f||||||||2017-10-10 21:09:25.557845|2017-10-10 21:09:25.557845
NCT03120286|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-05-10|||December 2014||2014-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||OVERWEIGHT AND OBESITY ADVERSELY AFFECT IVF OUTCOMES IN WOMEN WITH PCOS|OVERWEIGHT AND OBESITY ADVERSELY AFFECT IN VITRO FERTILIZATION (IVF) OUTCOMES IN WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS)|Completed||N/A|146|Actual|Assiut University|||2||f||||t||||||||No||2017-10-10 21:09:25.680413|2017-10-10 21:09:25.680413
NCT03120273|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-14|||May 5, 2017|Anticipated|2017-05-05|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）|A Phase 1 Clinical Trial to Evaluate Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety in Healthy Chinese Adults After Multiple Intravenous Administration of Dexlansoprazole|Recruiting||Phase 1|70|Anticipated|First Affiliated Hospital of Zhejiang University||2|||f|||||f|f||||||||2017-10-10 21:09:25.745048|2017-10-10 21:09:25.745048
NCT03120260|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-15|2017-09-12|||June 15, 2017|Actual|2017-06-15|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Comparing Effect of Short Sleep Duration on Weight Loss of Overweight and Obese Women Attending a Weight Loss Program|Comparing the Effect of Short Sleep Duration on Weight Loss of Overweight and Obese Women Attending a Weight Loss Program: A 12 Week Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Novindiet Clinic||2|||f||||t|f|f||||||||2017-10-10 21:09:25.855473|2017-10-10 21:09:25.855473
NCT03120247|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-15|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|OTM/DEX/PK||Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Dexmedetomidine.|Pharmacokinetics and Pharmacodynamics of Three Doses of Oral Trans-mucosal Dexmedetomidine for Premedication in Patients Undergoing Modified Radical Mastectomy|Recruiting||Phase 2/Phase 3|24|Anticipated|Assiut University||3|||f||||t|t|f|||t|||No||2017-10-10 21:09:25.937885|2017-10-10 21:09:25.937885
NCT03120234|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-04-17|||January 2017||2017-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of Opioid Based and Opioid Free Anaesthesia in Transsphenoidal Surgery|Comparison of Opioid Based and Opioid Free Anaesthesia in Transsphenoidal Surgery for Haemodynamic Stability and Recovery Characteristics|Recruiting||N/A|60|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||Undecided||2017-10-10 21:09:26.024202|2017-10-10 21:09:26.024202
NCT03120221|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-07-04|||July 4, 2017|Anticipated|2017-07-04|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Iodine Status in Pregnant Women in Israel|Iodine Status in Pregnant Women in Israel|Recruiting||N/A|160|Anticipated|Clalit Health Services|||1||f||||f|f|f||||||||2017-10-10 21:09:26.113608|2017-10-10 21:09:26.113608
NCT03120195|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-20|||January 27, 2017|Actual|2017-01-27|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study|EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study|Recruiting||N/A|30|Anticipated|Foundation for Liver Research||1|||f||||t|f|f||||||No||2017-10-10 21:09:26.310304|2017-10-10 21:09:26.310304
NCT03120182|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-14|||January 1, 2018|Anticipated|2018-01-01|April 2017|2017-04-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|SECA||Chronic Subdural Hematoma and Aspirin|Impact of Perioperative Maintenance or Interruption of Low-dose Aspirin on Recurrence Rate and Thrombotic Events After Burr-hole Drainage of Chronic Subdural Hematoma: a Randomized, Placebo Controlled, Double Blinded Study|Not yet recruiting||N/A|142|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f|||f|||No||2017-10-10 21:09:26.407443|2017-10-10 21:09:26.407443
NCT03120169|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-18|||March 30, 2017|Actual|2017-03-30|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Treadmill Versus Cycling Endurance Training in Patients With COPD|Effects of a Three Week Treadmill Versus Cycling Endurance Training on Balance, Gait Performance and Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease - a Pilot Study|Recruiting||N/A|30|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f|||||f|f||||||||2017-10-10 21:09:26.52972|2017-10-10 21:09:26.52972
NCT03120156|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-30|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Effects of Sensomotoric Insoles on Postural Control in Elderly People|Effects of Sensomotoric Insoles on Postural Control in Elderly People - a Prospective Randomized Controlled Trial|Not yet recruiting||N/A|50|Anticipated|Ludwig-Maximilians - University of Munich||3|||f||||f|f|f||||||No||2017-10-10 21:09:26.631677|2017-10-10 21:09:26.631677
NCT03120143|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-18|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Small-sided Ball Game Training and Protein Intake in Older Adults|Effect of Small-sided Team Sport Training and Protein Intake on Muscle Mass, Physical Function and Markers of Health in Older Untrained Adults|Completed||N/A|70|Actual|University of Copenhagen||3|||f|||||f|f||||||||2017-10-10 21:09:26.725041|2017-10-10 21:09:26.725041
NCT03120130|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-06-19|||November 30, 2017|Anticipated|2017-11-30|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|January 30, 2018|Anticipated|2018-01-30||Interventional|Amblyomin-X||Study of Amblyomin-X in Advanced Solid Tumor|Phase I Study (First in Humans) of the Amblyomin-X in the Treatment of Patients With Advanced Solid Tumors Refractory or Without Indication / Access to Standard Treatment|Suspended||Phase 1|24|Anticipated|União Química Farmacêutica Nacional S/A||6||Delay in the R & D stage|f||||t|f|f||||||No||2017-10-10 21:09:26.804714|2017-10-10 21:09:26.804714
NCT03120117|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-18|||August 2013|Actual|2013-08-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|DISST||Importance of Patient Positioning at Cough Test When Considering Success Following Sling Procedures|Importance of Patient Positioning at Cough Test When Considering Success Following Sling Procedures|Active, not recruiting||N/A|87|Actual|Michigan Institution of Women's Health PC||1|||f||||f|f|f|||f|||No||2017-10-10 21:09:26.89402|2017-10-10 21:09:26.89402
NCT03120104|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-18|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Physical Exercise for Colorectal Cancer Patients After Transanal Total Mesorectal Excision|Physical Exercise for Colorectal Cancer Patients After Transanal Total Mesorectal Excision|Recruiting||N/A|20|Anticipated|Taipei Medical University WanFang Hospital||2|||f|||||f|f||||||||2017-10-10 21:09:26.986954|2017-10-10 21:09:26.986954
NCT03120091|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-18|||July 1, 2014|Actual|2014-07-01|April 2017|2017-04-01|January 31, 2015|Actual|2015-01-31|January 31, 2015|Actual|2015-01-31||Observational|||Assessment of the Accuracy,Feasibility,Safety of Continuous Glucose Monitoring System|The Accuracy, Feasibility, Safety and Confounding Factors of Real-time Continuous Glucose Monitoring System|Completed||N/A|22|Actual|West China Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:09:27.106723|2017-10-10 21:09:27.106723
NCT03120078|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-27|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|||A Prospective Study of Diagnostic Accuracy of Ultrasound|Diagnostic Accuracy of Ultrasound for Adenomyosis, Development of Scoring System and Correlation With Various Pelvic Pathologies: a Prospective Study.|Recruiting||N/A|50|Anticipated|Texas Tech University Health Sciences Center, El Paso|||1||f||||f|f|f||||||||2017-10-10 21:09:27.202897|2017-10-10 21:09:27.202897
NCT03120052|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-19|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Observational|||Physical Therapy Components for Maximum TKR Outcome|Defining Components of Physical Therapy Achieving Maximum Function After Total Knee Replacement|Not yet recruiting||N/A|360|Anticipated|University of Massachusetts, Worcester|||1||f||||f|f|f||||||No||2017-10-10 21:09:27.402114|2017-10-10 21:09:27.402114
NCT03120039|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-13|||May 1, 2015|Actual|2015-05-01|April 2017|2017-04-01|May 1, 2016|Actual|2016-05-01|May 1, 2016|Actual|2016-05-01||Observational|||Measuring Upper Extremity Functional Movement With Accelerometry: FitBit® vs Actigraph®|Measuring Upper Extremity Functional Movement With Accelerometry: FitBit vs Actigraph|Completed||N/A|71|Actual|Rowe, Veronica, M.D.|||1||f||||f|f|f||||||No||2017-10-10 21:09:27.481548|2017-10-10 21:09:27.481548
NCT03120026|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-06-06|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|IRIS||Improving Rehabilitation In Sarcopenia (IRIS)|A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Sarcopenia in Older Adults Undergoing Physical Rehabilitation the IRIS (Improving Rehabilitation In Sarcopenia) Study: a Randomized, Double-blind, Placebo-controlled Trial.|Recruiting||N/A|140|Anticipated|Azienda di Servizi alla Persona di Pavia||2|||f||||f|f|f||||||Undecided||2017-10-10 21:09:27.561816|2017-10-10 21:09:27.561816
NCT03044210|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-10-03|||April 4, 2017|Actual|2017-04-04|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|METABO-CS||Metabolic Study of Cockayne Syndrome|Metabolic Study of Cockayne Syndrome|Recruiting||N/A|45|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||||2017-10-10 21:23:40.911195|2017-10-10 21:23:40.911195
NCT03120013|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-09-05|||February 6, 2017|Actual|2017-02-06|September 2017|2017-09-01|December 23, 2018|Anticipated|2018-12-23|December 1, 2018|Anticipated|2018-12-01||Interventional|CStDCSAtaxia||Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia|Rehabilitative Trial With Cerebello-Spinal tDCS for the Treatment of Neurodegenerative Ataxia|Active, not recruiting||N/A|21|Actual|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||t|f|f|||f|||||2017-10-10 21:09:27.720539|2017-10-10 21:09:27.720539
NCT03120000|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-22|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma|Open-label, Non-randomized, Phase 2 Study Evaluating Efficacy and Safety of PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma|Not yet recruiting||Phase 2|21|Anticipated|PIQUR Therapeutics AG||1|||f||||f|f|f||||||Undecided||2017-10-10 21:09:27.876191|2017-10-10 21:09:27.876191
NCT03119987|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-04-18|||January 1, 2011|Actual|2011-01-01|April 2017|2017-04-01|December 30, 2014|Actual|2014-12-30|December 30, 2012|Actual|2012-12-30||Observational|||Predictive Role of Red Cell Distribution Width in Upper GI Bleeding Patients|Efficacy of Red Cell Distribution Width as a Predictor of High Risk and Early Mortality in Upper Gastro-intestinal Bleeding|Completed||N/A|400|Actual|Konkuk University Medical Center|||1||f||||t|f|f||||||No||2017-10-10 21:09:28.027286|2017-10-10 21:09:28.027286
NCT03119974|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-05-22|||April 18, 2017|Actual|2017-04-18|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|STOP-AGO||Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP|Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in Immune Thrombocytopenia: a Prospective Multicenter Open Study|Recruiting||Phase 4|48|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||||2017-10-10 21:09:28.116807|2017-10-10 21:09:28.116807
NCT03119961|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-02|||June 26, 2017|Actual|2017-06-26|May 2017|2017-05-01|July 1, 2019|Anticipated|2019-07-01|April 1, 2019|Anticipated|2019-04-01||Interventional|BOREAL1||Blood Brain Barrier Opening in Alzheimer' Disease|Phase 1/2 Open Single-arm Monocentric Study Evaluating the Tolerance and Interest of Transient Opening of the Blood-Brain Barrier by Low Intensity Pulsed Ultrasound With the SONOCLOUD® Implantable Medical Device in Mild Alzheimer's Disease Patients (MMSE 20-26)|Recruiting||Phase 1/Phase 2|10|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t|f|f||||||||2017-10-10 21:09:28.211105|2017-10-10 21:09:28.211105
NCT03119948|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-04-13|||December 2014||2014-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|GENUFLEX||Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis|Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A to Improve Gait in Hemiparesis. A Randomized Multicenter Placebo-controlled Trial|Recruiting||Phase 2|66|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-10-10 21:09:28.336837|2017-10-10 21:09:28.336837
NCT03119935|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-14|2017-08-17|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|September 1, 2017|Anticipated|2017-09-01|June 1, 2017|Actual|2017-06-01||Interventional|||Amflow-device Can Help Proper Ambu-bag Ventilation|Evaluation of an Amflow-device Assist Ambu-bagging to Improve Accuracy of Tidal Volumes Delivered.|Recruiting||N/A|80|Anticipated|Konkuk University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:09:28.440826|2017-10-10 21:09:28.440826
NCT03119922|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-04-13|||March 2014||2014-03-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|EVADREP||Quality of Care of Children With Sickle Cell Disease (SCD) Screened at Birth in France|National Project for Healthcare Assessment of SCD Children Diagnosed by Newborn Screening in France|Completed||N/A|1750|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 21:09:28.525227|2017-10-10 21:09:28.525227
NCT03119909|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-13|||September 24, 2015|Actual|2015-09-24|March 2017|2017-03-01|September 24, 2018|Anticipated|2018-09-24|August 24, 2018|Anticipated|2018-08-24||Interventional|ADAPCO||Cognitive Adaptation|Cognitive Adaptation and Frontal Cortex|Recruiting||N/A|90|Anticipated|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 21:09:28.594825|2017-10-10 21:09:28.594825
NCT03119896|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-19|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Supporting Self-management of Chronic Pain|Supporting Self-management in Chronic Pain: a Collaborative Approach Providing Relevant Tools to Healthcare Professionals and People With Pain.|Recruiting||N/A|48|Anticipated|Pain Concern||2|||f|||||f|f||||||||2017-10-10 21:09:28.679158|2017-10-10 21:09:28.679158
NCT03119883|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-14|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Assessing Glutamine Metabolism in MGUS and Myeloma|Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma|Not yet recruiting||N/A|80|Anticipated|Mayo Clinic||2|||f||||t|f|f||||||No||2017-10-10 21:09:28.805217|2017-10-10 21:09:28.805217
NCT03119870|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-07-06|||January 9, 2013|Actual|2013-01-09|July 2017|2017-07-01|July 4, 2017|Actual|2017-07-04|September 6, 2013|Actual|2013-09-06||Interventional|EEG-Feedback||Organization of the Cingulate Cortex|Structure-function Relationships Within the Cingulate Cortex|Completed||N/A|31|Actual|Hospices Civils de Lyon||1|||f|||||f|f||||||||2017-10-10 21:09:28.881183|2017-10-10 21:09:28.881183
NCT03119857|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2017-04-13|||February 2009||2009-02-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14|A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation +/- Taxotere (Docetaxel) for Non-metastatic Prostate Cancer Patients With a Rising PSA|Recruiting||Phase 3|430|Anticipated|Göteborg University||2|||f||||t||||||||||2017-10-10 21:09:28.950508|2017-10-10 21:09:28.950508
NCT03119844|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-08|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Interventional|||Effects of Phototherapy Associated to Exercise-based Rehabilitation Program in Heart Failure|Effects of Phototherapy Associated to Exercise-based Cardiac Rehabilitation Program in Chronic Heart Failure: Clinical Trial|Completed||N/A|40|Actual|Federal University of São Paulo||2|||f||||t|f|f||||||||2017-10-10 21:09:29.056817|2017-10-10 21:09:29.056817
NCT03119831|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-07-23|2017-04-22||November 2015|Actual|2015-11-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effectiveness of Three Different Mouthrinses in Dental Plaque Control and Early Wound Healing|A Randomized Controlled Clinical Trial on the Effectiveness of Three Different Mouthrinses, Adjunct to Periodontal Surgery, in Dental Plaque Control and Early Wound Healing|Completed||N/A|42|Actual|National and Kapodistrian University of Athens||3|||f|||||f|f||||||||2017-10-10 21:09:29.274573|2017-10-10 21:09:29.274573
NCT03119818|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-08|||June 14, 2017|Actual|2017-06-14|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|CIPHEMO||Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy|Intracellular Phosphate and Adenosine Triphosphate (ATP) Concentration Evolution by Magnetic Resonance (MR) Spectroscopy in Patients During Hemodialysis|Recruiting||N/A|15|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:09:29.972166|2017-10-10 21:09:29.972166
NCT03119805|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-04-14|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|6 Months|Observational [Patient Registry]|ReFlaP||Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.|Defining Cut-off Values for Widely-used Composite Scores and Patient-reported Outcome Measures in Psoriatic Arthritis Corresponding to Remission and Flare Assessed by the Physician and the Patient|Not yet recruiting||N/A|450|Anticipated|Groupe Hospitalier Pitie-Salpetriere|||1||f||||f|f|f||||||No||2017-10-10 21:09:30.100861|2017-10-10 21:09:30.100861
NCT03119792|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-18|||November 2016||2016-11-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Salud Integral Colombia|Salud Integral Colombia (SI! Colombia II).|Recruiting||N/A|1200|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|f||||||No||2017-10-10 21:09:30.181198|2017-10-10 21:09:30.181198
NCT03119779|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-07-21|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Effect of Pulpotomy Using TheraCal Versus MTA on Survival Rate of Cariously-Exposed Vital Permanent Molars|The Effect of Pulpotomy (Partial or Complete) Using Resin-Modified Calcium Silicate Versus MTA-Anglus on Survival Rate of Cariously-Exposed Vital Young Permanent Molars:A Randomized Clinical Trial|Completed||N/A|22|Actual|Cairo University||2|||f||||t|f|f|||t|||||2017-10-10 21:09:30.296442|2017-10-10 21:09:30.296442
NCT03119766|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-10-04|||June 28, 2017|Actual|2017-06-28|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients|Multicenter Double-blind Placebo-controlled Randomized Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients|Recruiting||Phase 4|370|Anticipated|Materia Medica Holding||2|||f|||||f|f||||||||2017-10-10 21:09:30.403751|2017-10-10 21:09:30.403751
NCT03119753|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-14|||June 10, 2017|Anticipated|2017-06-10|April 2017|2017-04-01|September 10, 2017|Anticipated|2017-09-10|July 10, 2017|Anticipated|2017-07-10||Interventional|||Dimensional Accuracy of Complete Denture With Rapid Prototyping and Conventional Method|Dimensional Accuracy of Maxillary Complete Denture Base Fabricated by Rapid Prototyping Method Compared With the Conventional Method: A Randomized Controlled Trial|Not yet recruiting||N/A|14|Anticipated|Cairo University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:09:30.627155|2017-10-10 21:09:30.627155
NCT03119740|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-13|||August 1, 2016|Actual|2016-08-01|April 2017|2017-04-01|November 30, 2016|Actual|2016-11-30|October 30, 2016|Actual|2016-10-30||Observational|||Postoperative Complications After Appendectomy|Clinical Value of Postoperative C-reactive Protein in the Detection of Complications After Open and Laparoscopic Appendectomy|Completed||N/A|744|Actual|Ludwig Boltzmann Institute for Operative Laparoscopy|||2||f||||f|f|f||||||Undecided||2017-10-10 21:09:30.702596|2017-10-10 21:09:30.702596
NCT03119727|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-13|||January 30, 2017|Actual|2017-01-30|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|FreeO24G||Clinical Evaluation of FreeO2 (Version 4) in All Patients Receiving Oxygen|Clinical Evaluation of the Automatic Oxygen Adjustment by FreeO2 in a Medical Population in Hospital|Recruiting||N/A|50|Anticipated|Laval University||1|||f||||f|f|f||||||||2017-10-10 21:09:30.780205|2017-10-10 21:09:30.780205
NCT03119714|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-04-13|||November 2016||2016-11-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|PEMAG||Pemirolast in Allergen Challenge (PEMAG)|A Placebo-controlled, Cross-over, Study to Assess the Efficacy of the Oral Mast Cell Inhibitor Pemirolast in Allergen-induced Airway Obstruction and Inflammation in Subjects With Allergic Asthma|Recruiting||Phase 2|12|Anticipated|Karolinska University Hospital||2|||f||||t||||||||No|Not planing to share data|2017-10-10 21:09:30.87131|2017-10-10 21:09:30.87131
NCT03119701|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-13|||January 31, 2017|Actual|2017-01-31|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|INFORAAA||Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of MOF on Patients After Open Surgery for a RAAA|A Randomised, Parallel Group 2:1 Comparison of the Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) and Placebo in the Prevention of Multi-Organ Failure on Patients Surviving Open Surgery for a Ruptured Abdominal Aortic Aneurysm|Recruiting||Phase 2|152|Anticipated|Faron Pharmaceuticals Ltd||2|||f||||t|f|f||||||No||2017-10-10 21:09:31.001922|2017-10-10 21:09:31.001922
NCT03119688|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-08|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT)|A Clinical Study to Assess the Mildness of a Cosmetic Cleanser in Healthy Subjects Using the Forearm-Controlled Application Technique (FCAT)|Completed||N/A|50|Actual|GlaxoSmithKline||3|||f||||f|f|f||||||||2017-10-10 21:09:31.147574|2017-10-10 21:09:31.147574
NCT03119675|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-25|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Evaluation of a Smartphone Application, GoCheckKids™ as a Photo Screening Tool in a Pediatric Population|Prospective Evaluation of a Smartphone Application, GoCheckKids™ as a Photo Screening Tool in a Pediatric Population|Completed||N/A|352|Actual|Gobiquity Mobile Health||1|||f|||||f|f||||||||2017-10-10 21:09:31.233939|2017-10-10 21:09:31.233939
NCT03119662|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease|Parallel-Group, Placebo-Controlled Randomized Study Investigating the Effect of Intravenous Iso-osmolar Iodinated Contrast Material Iodixanol (Visipaque™ Injection 320 mgI/mL) on Renal Function in Adults With Chronic Kidney Disease (CKD) Stage III or Stage IV Who Have Undergone Endovascular Aneurysm Repair (EVAR)|Not yet recruiting||Phase 4|1164|Anticipated|GE Healthcare||2|||f||||t|t|f||||||||2017-10-10 21:09:31.315792|2017-10-10 21:09:31.315792
NCT03119467|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-24|||May 11, 2017|Actual|2017-05-11|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma|A Phase I/Ib, Study to Evaluate Safety and Efficacy of RP4010, in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma|Recruiting||Phase 1|60|Anticipated|Rhizen Pharmaceuticals SA||1|||f|||||t|f||||||||2017-10-10 21:09:32.706825|2017-10-10 21:09:32.706825
NCT03119649|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-12|||March 18, 2017|Actual|2017-03-18|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis|A Phase IIa, Randomized, Double-blind, Placebo-controlled Study to Evaluate Multiple Doses of GLPG2222 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation|Active, not recruiting||Phase 2|50|Anticipated|Galapagos NV||6|||f||||t|t|f||||||||2017-10-10 21:09:31.398978|2017-10-10 21:09:31.398978
NCT03119636|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-13|||May 2017|Anticipated|2017-05-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease|A Phase I/II, Open-Label Study to Assess the Safety and Efficacy of Striatum Transplantation of Human Embryonic Stem Cells-derived Neural Precursor Cells in Patients With Parkinson's Disease|Recruiting||Phase 1/Phase 2|50|Anticipated|Chinese Academy of Sciences||3|||f||||t|f|f||||||Undecided||2017-10-10 21:09:31.528134|2017-10-10 21:09:31.528134
NCT03119623|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-02|||June 1, 2017|Anticipated|2017-06-01|June 2017|2017-06-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|PARADOR||Comparing ARNI With ACE Inhibitor on Endothelial Function|Prospective Comparison of an ARNI With an ACE Inhibitor on enDOthelial Function by Brachial Artery Reactivity (PARADOR)|Not yet recruiting||Phase 4|204|Anticipated|University of Wisconsin, Madison||2|||f||||t|t|f|||t|||No||2017-10-10 21:09:31.618778|2017-10-10 21:09:31.618778
NCT03119610|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-10-02|||September 22, 2017|Actual|2017-09-22|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|INOSO||The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity|The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity|Recruiting||Phase 1/Phase 2|36|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f|t|f||||||||2017-10-10 21:09:31.715833|2017-10-10 21:09:31.715833
NCT03119597|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-24|||January 12, 2017|Actual|2017-01-12|May 2017|2017-05-01|December 22, 2017|Anticipated|2017-12-22|November 27, 2017|Anticipated|2017-11-27||Interventional|||An Investigation Into the Effects of Blueberry Anthocyanin on Cognitive Functioning and Mood in Adolescents.|A Randomized, Double-blind, Placebo-controlled Study Investigating the Effects of Blueberry Anthocyanin on Cognitive Functioning and Mood in Adolescents.|Recruiting||N/A|120|Anticipated|University of Reading||2|||f||||t|f|f||||||Yes||2017-10-10 21:09:31.823391|2017-10-10 21:09:31.823391
NCT03119584|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-03|||September 1, 2015|Actual|2015-09-01|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation|Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial|Active, not recruiting||Phase 4|23|Actual|Texas Tech University Health Sciences Center, El Paso||2|||f||||f|t|f|||f|||No||2017-10-10 21:09:31.917786|2017-10-10 21:09:31.917786
NCT03119571|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-20|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|June 2020|Anticipated|2020-06-01||Interventional|||ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest|ACCESS to the Cardiac Catheterization Laboratory in Patients Without ST-segment Elevation Myocardial Infarction Resuscitated From Out-of-hospital Ventricular Fibrillation Cardiac Arrest|Not yet recruiting||N/A|864|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||||2017-10-10 21:09:32.008638|2017-10-10 21:09:32.008638
NCT03119545|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-12|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Family-Centered Intervention When a Parent is Cared for in Specialized Homecare|A Family-Centered Intervention When a Parent is Cared for in Specialized Homecare|Recruiting||N/A|30|Anticipated|Ersta Sköndal University College||2|||f|||||f|f||||||No||2017-10-10 21:09:32.23716|2017-10-10 21:09:32.23716
NCT03119532|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-04-17|||July 2015||2015-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Investigating Trends in Compliance With Quality Assurance Metrics|Investigating Trends in Compliance With Quality Assurance Metrics|Completed||N/A|672|Actual|University of Michigan||2|||f||||f||||||||No||2017-10-10 21:09:32.337925|2017-10-10 21:09:32.337925
NCT03119519|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-13|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Local Definitive Radiotherapy in Synchronous Oligometastatic Non-small-cell Lung Cancer|A Randomized Phase III Trial of First-line Chemotherapy or Targeted Therapy Plus Local Definitive Radiotherapy or Not for Patients With Synchronous Oligometastatic Non-small-cell Lung Cancer|Not yet recruiting||Phase 3|590|Anticipated|Southern Medical University, China||2|||f|||||f|f||||||||2017-10-10 21:09:32.41895|2017-10-10 21:09:32.41895
NCT03119506|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-13|||March 16, 2016|Actual|2016-03-16|April 2017|2017-04-01|February 27, 2020|Anticipated|2020-02-27|November 30, 2016|Actual|2016-11-30||Observational|||Effects of Recess Timing and Activity on Children's Eating Behaviors|Effects of Recess Timing and Activity on Children's Eating Behaviors|Active, not recruiting||N/A|151|Actual|University of Illinois at Urbana-Champaign|||4||f|||||f|f||||||||2017-10-10 21:09:32.500322|2017-10-10 21:09:32.500322
NCT03119493|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-13|||June 1, 2015|Actual|2015-06-01|April 2017|2017-04-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Periodized Aerobic Interval Training in Metabolic Syndrome|Effects of Periodized Aerobic Interval Training on Autonomic Modulation and Cardiovascular and Anthropometric Variables in Individuals With Metabolic Syndrome|Completed||N/A|52|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||t||||||||No|I don't have plans|2017-10-10 21:09:32.562092|2017-10-10 21:09:32.562092
NCT03119480|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-13|||April 20, 2017|Anticipated|2017-04-20|April 2017|2017-04-01|August 11, 2018|Anticipated|2018-08-11|April 11, 2018|Anticipated|2018-04-11||Observational|||Electronic Warning Systems in Diagnosis and Treatment of AKI|The Effect of Electronic Warning Systems in the Process of Diagnosis and Treatment of Patients With Acute Kidney Injury|Not yet recruiting||N/A|600|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University|||1||f||||t|f|f||||||||2017-10-10 21:09:32.637071|2017-10-10 21:09:32.637071
NCT03119454|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-04-13|||October 2016||2016-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01|2 Months|Observational [Patient Registry]|||"Corticoid-16 in Long Term When Administered Systemically in Patients in Routine Medical Practice"|"Evaluation of Pharmacokinetic Parameters of Diprospan"|Completed||N/A|40|Actual|Federal State Budgetary Scientific Institution, Scientific Research Institute of Rheumatology|||2||f||||t||||||Samples Without DNA|"     Urine   "|||2017-10-10 21:09:32.796313|2017-10-10 21:09:32.796313
NCT03119441|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-29|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Dental Waterjet on Oral Hygiene for Patients With Braces|The Efficacy of Dental Water Jet in Plaque Removal During Orthodontic Treatment With Fixed Appliances: A Randomized Controlled Trial|Not yet recruiting||N/A|30|Anticipated|Riyadh Colleges of Dentistry and Pharmacy||2|||f||||f|f|f|||f|||||2017-10-10 21:09:32.869825|2017-10-10 21:09:32.869825
NCT03119428|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-25|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors|A Phase 1a Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of OMP-313M32 Administered as a Single Agent to Subjects With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|30|Anticipated|OncoMed Pharmaceuticals, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:09:32.954382|2017-10-10 21:09:32.954382
NCT03119415|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-17|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|Prosocial||Enlisting Peer Cooperation and Prosociality in the Service of Substance Use Prevention in Middle School|Enlisting Peer Cooperation and Prosociality in the Service of Substance Use Prevention in Middle School|Recruiting||N/A|1500|Anticipated|Oregon Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:09:34.936144|2017-10-10 21:09:34.936144
NCT03119402|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-06-20|||April 18, 2017|Actual|2017-04-18|June 2017|2017-06-01|September 4, 2017|Anticipated|2017-09-04|September 4, 2017|Anticipated|2017-09-04||Interventional|||Effects of the Combination of RRT With tDCS on Dyslexic Adults|Combining A Rhythmic Intervention With tDCS to Improve Reading Skills in Dyslexic Adults|Recruiting||N/A|20|Anticipated|Catholic University of the Sacred Heart||2|||f|||||f|f|||f|||Undecided||2017-10-10 21:09:35.041146|2017-10-10 21:09:35.041146
NCT03119389|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-13|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Direct Gloving Strategy: A Cluster-randomized Trial|Efficacy of a Direct Gloving Strategy to Improve Compliance With Infection Prevention Practices: A Cluster-randomized Trial|Enrolling by invitation||N/A|14|Anticipated|University of Maryland||2|||f||||f||||||||No||2017-10-10 21:09:35.151554|2017-10-10 21:09:35.151554
NCT03119376|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-13|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Web-based Tool to Improve the Assessment of Reporting (COBPeer)|Evaluation of an Online Tool (COBPeer) Dedicated to Junior Peer Reviewers for Assessing the Reporting of Randomized Controlled Trial Reports|Enrolling by invitation||N/A|120|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f|f|f||||||No||2017-10-10 21:09:35.231958|2017-10-10 21:09:35.231958
NCT03119363|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-11|||September 1, 2015|Actual|2015-09-01|July 2017|2017-07-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Treating Cancer-Related Fatigue Through Systematic Light Exposure (Light for Fatigue Study)|Treating Cancer-Related Fatigue Through Systematic Light Exposure|Recruiting||N/A|200|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|f||||||||2017-10-10 21:09:35.308411|2017-10-10 21:09:35.308411
NCT03119350|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-18|||April 1, 2016|Actual|2016-04-01|April 2017|2017-04-01|September 15, 2016|Actual|2016-09-15|July 1, 2016|Actual|2016-07-01||Interventional|||Mitochondrial Energy Metabolism in Obese Women|Mitochondrial Energy Metabolism in Obese Women Undergoing Concurrent Physical Training|Completed||N/A|14|Actual|University of Sao Paulo||1|||f||||t|f|f||||||No||2017-10-10 21:09:35.39992|2017-10-10 21:09:35.39992
NCT03119337|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-11|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|2WT||Text-based Follow-up in Zimbabwe's Voluntary Medical Male Circumcision Program|Reducing Provider Workload While Preserving Patient Safety: A 2-Way Texting Intervention in Zimbabwe's Voluntary Medical Male Circumcision Program|Not yet recruiting||N/A|780|Anticipated|University of Washington||2|||f||||t|f|f||||||||2017-10-10 21:09:35.495243|2017-10-10 21:09:35.495243
NCT03119324|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-13|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|June 2016|Actual|2016-06-01||Interventional|||Low Level Laser Therapy in the Treatment of Temporomandibular Joint Disorders (TMJDs) Related Pain|Evaluation of the Efficacy of a New Low Level Laser Therapy (LLLT) Home Protocol in the Treatment of the Temporomandibular Joint Disorders Related Pain. A Randomized, Double Blind Placebo Controlled Clinical Trial|Completed||N/A|90|Actual|University of Roma La Sapienza||3|||f||||t|f|f||||||No||2017-10-10 21:09:35.59185|2017-10-10 21:09:35.59185
NCT03119311|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-18|||April 25, 2017|Actual|2017-04-25|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|June 30, 2017|Actual|2017-06-30||Interventional|||A Novel Diagnostic Method for Exotropia Using Video-oculography|A Novel Diagnostic Method for Exotropia Using Video-oculography|Completed||N/A|34|Actual|Inje University||2|||f||||f|f|f||||||||2017-10-10 21:09:35.676458|2017-10-10 21:09:35.676458
NCT03119298|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-12|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Measuring Fear of Physical Activity in Patients With Heart Failure|Measuring Fear of Physical Activity in Patients With Heart Failure Using Questionnaires and Physiological Parameters|Recruiting||N/A|60|Anticipated|University of Trier|||3||f||||t|f|f||||||No||2017-10-10 21:09:35.85527|2017-10-10 21:09:35.85527
NCT03119285|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-04-13|||April 2013||2013-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Genes Contributing to Hereditary Ovarian Cancer in African American Women and BRCA1/2 Wildtype Families|Genes Contributing to Hereditary Ovarian Cancer in African American Women and BRCA1/2 Wildtype Families|Recruiting||N/A|150|Anticipated|University of Washington|||1||f||||f||||||Samples With DNA|"     Blood will be obtained and constitutional DNA extracted. The investigators will obtain     paraffin embedded tumor blocks from enrolled participants.   "|No||2017-10-10 21:09:35.943043|2017-10-10 21:09:35.943043
NCT03119168|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-13|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Effect of Simethicone on Screening Colonoscopy|Effect of Simethicone on Bowel Preparation for Screening Colonoscopy.|Recruiting||N/A|300|Anticipated|Texas Tech University Health Sciences Center, El Paso||2|||f||||f|f|f|||f|||No||2017-10-10 21:09:37.428586|2017-10-10 21:09:37.428586
NCT03119272|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-04-13|||April 2016||2016-04-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|Microbiome||Microbiome-mediated Weight, Anxiety, and Stress Dysregulation in Anorexia Nervosa|Microbiome-mediated Weight, Anxiety, and Stress Dysregulation in Anorexia Nervosa|Recruiting||N/A|200|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"     Stool samples.   "|||2017-10-10 21:09:36.024847|2017-10-10 21:09:36.024847
NCT03119259|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-08-14|||July 2018|Anticipated|2018-07-01|August 2017|2017-08-01|July 1, 2023|Anticipated|2023-07-01|January 1, 2023|Anticipated|2023-01-01||Interventional|iCare-AD||iCare-AD: A Mobile Health Application for Caregivers of Patients With Dementia.|iCare-AD: A Randomized Controlled Trial to Test the Efficacy of a Mobile Health Technology Application in Reducing the Behavioral and Psychological Symptoms of Patients With Alzheimer's Dementia and the Distress of Their Informal Caregivers|Not yet recruiting||N/A|448|Anticipated|Indiana University||2|||f||||t|f|f||||||||2017-10-10 21:09:36.120272|2017-10-10 21:09:36.120272
NCT03119246|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-04-13|||June 2016||2016-06-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CAPIT-HD Beta||Beta Testing of a New Assessment in Huntington's Disease (HD)|Beta Testing of a New Assessment Protocol for Assessment of Complex Therapies in Huntington's Disease (HD)|Recruiting||N/A|40|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 21:09:36.23228|2017-10-10 21:09:36.23228
NCT03119233|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-29|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Detour II Study|PQ Bypass System for Femoropopliteal Bypass II|Not yet recruiting||N/A|165|Anticipated|PQ Bypass, Inc.||1|||f|||||f|t|t|f||||||2017-10-10 21:09:36.326827|2017-10-10 21:09:36.326827
NCT03119220|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-18|||May 8, 2015|Actual|2015-05-08|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Applying a Stress Framework to Health Behavior Change: A Fitbit Study|Applying a Stress Framework to Health Behavior Change: A Fitbit Study|Completed||N/A|104|Actual|Brandeis University||2|||f||||f|f|f||||||Yes||2017-10-10 21:09:36.417206|2017-10-10 21:09:36.417206
NCT03119207|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-17|||November 4, 2012|Actual|2012-11-04|April 2017|2017-04-01|June 22, 2014|Actual|2014-06-22|June 22, 2014|Actual|2014-06-22||Interventional|||Creating Naptime: An Overnight, Non-Pharmacologic Intensive Care Unit Sleep Promotion Protocol|Creating Naptime: An Overnight, Non-Pharmacologic Intensive Care Unit Sleep Promotion Protocol|Completed||N/A|85|Actual|Yale University||3|||f||||f|f|f||||||No||2017-10-10 21:09:36.497599|2017-10-10 21:09:36.497599
NCT03119194|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-23|||January 27, 2017|Actual|2017-01-27|August 2017|2017-08-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|||Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067|An Open-Label, Single-Dose, Single-Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067 in Healthy Male Subjects|Completed||Phase 1|7|Actual|Bial - Portela C S.A.||1|||f||||f|f|f||||||||2017-10-10 21:09:36.584034|2017-10-10 21:09:36.584034
NCT03118089|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-12|||September 1, 2014|Actual|2014-09-01|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Efficacy of a Nutrition Biscuit in Malnutrition Management||Enrolling by invitation||N/A|80|Anticipated|University of Ulster||2|||f||||f|f|f||||||No||2017-10-10 21:09:36.66645|2017-10-10 21:09:36.66645
NCT03118076|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-14|||April 20, 2017|Anticipated|2017-04-20|April 2017|2017-04-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||The Effect of Dexmedetomidine as an Adjuvant for Lower Limb Nerve Blocks|The Effect of Dexmedetomidine as an Adjuvant for Lower Limb Nerve Blocks Following Oromaxillofacial Reconstruction|Not yet recruiting||Phase 4|40|Anticipated|China Medical University, China||2|||f||||f|f|f||||||No||2017-10-10 21:09:36.745027|2017-10-10 21:09:36.745027
NCT03118063|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-17|||February 10, 2017|Actual|2017-02-10|April 2017|2017-04-01|December 10, 2018|Anticipated|2018-12-10|December 10, 2017|Anticipated|2017-12-10||Interventional|||Comparison of the Strength of Maximum Glute and Medium Glutenum Muscles Of Latin and Active Lombar Guidelines|Comparison of the Strength of Maximum Glute and Medium Glutenum Muscles Of Latin and Active Lombar Guidelines: A Clinical Test|Recruiting||N/A|600|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||3|||f|||||f|f||||||||2017-10-10 21:09:36.823511|2017-10-10 21:09:36.823511
NCT03118050|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-05-31|||May 28, 2017|Actual|2017-05-28|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Identifying Therapeutic Targets of Accelerated Sarcopenia|Identifying Therapeutic Targets of Accelerated Sarcopenia|Recruiting||N/A|102|Anticipated|The University of Texas Medical Branch, Galveston||7|||f||||f|f|f||||||No|Small physiological study. Few subjects. Risk of loss of confidentiality|2017-10-10 21:09:36.908167|2017-10-10 21:09:36.908167
NCT03118037|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-14|||June 14, 2017|Actual|2017-06-14|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|July 2023|Anticipated|2023-07-01|5 Years|Observational [Patient Registry]|SAGE||Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry|Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE)|Recruiting||N/A|100|Anticipated|Gynesonics|||1||f||||f|f|t|t|f|t|||No||2017-10-10 21:09:37.011426|2017-10-10 21:09:37.011426
NCT03118024|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-04-12|||March 13, 2017|Actual|2017-03-13|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Perioperative Management of DIEP Flaps|Perioperative Management of Deep Inferior Epgastric Perforator (DIEP) Flap for Breast Reconstruction|Recruiting||N/A|100|Anticipated|University of Regensburg||2|||f||||t|f|f||||||No||2017-10-10 21:09:37.104844|2017-10-10 21:09:37.104844
NCT03118011|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-12|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Substance Use Disorders and Tobacco Habits|Tobacco Habits and the Ability to Quit Smoking Among Patients With Substance Use Disorders|Recruiting||N/A|200|Anticipated|Uppsala University||2|||f||||f|f|f||||||No||2017-10-10 21:09:37.195646|2017-10-10 21:09:37.195646
NCT03117998|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-25|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|July 31, 2018|Anticipated|2018-07-31||Interventional|||Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus|A Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of Multiple Doses of REMD-477 in Subjects With Type 1 Diabetes Mellitus|Recruiting||Phase 2|75|Anticipated|REMD Biotherapeutics, Inc.||3|||f|||||t|f||||||||2017-10-10 21:09:37.289914|2017-10-10 21:09:37.289914
NCT03119181|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-09|||April 27, 2017||2017-04-27||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:09:37.383289|2017-10-10 21:09:37.383289
NCT03119155|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-18|||January 1, 2018|Anticipated|2018-01-01|April 2017|2017-04-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31|2 Years|Observational [Patient Registry]|||Improvement on Diagnosis of Fetal Congenital Heart Disease Based on Multi-center Collaboration in China|Improvement on Diagnosis of Fetal Congenital Heart Disease Based on Multi-center Collaboration in China|Not yet recruiting||N/A|5000|Anticipated|Beijing Anzhen Hospital|||1||f||||t|f|f||||||Undecided||2017-10-10 21:09:37.625219|2017-10-10 21:09:37.625219
NCT03119142|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-31|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|July 2, 2019|Anticipated|2019-07-02|November 2, 2018|Anticipated|2018-11-02|6 Months|Observational [Patient Registry]|CASSIOPEA||Economic Crisis and Adherence to the Mediterranean Diet (CASSIOPEA)|Economic Crisis and Adherence to the Mediterranean Diet: Possible Impact on Biomarkers of Inflammation and Metabolic Phenotypes in the Cohort of the MOLI-SANI Study|Recruiting||N/A|7000|Anticipated|Neuromed IRCCS|||1||f|||||f|f||||Samples With DNA|"     Blood samples will be obtained from participants who had fasted overnight and had refrained     from smoking for at least 6 h and stored in liquid nitrogen in the Biological bank of the     Moli-sani study.   "|Undecided||2017-10-10 21:09:37.725442|2017-10-10 21:09:37.725442
NCT03119129|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-13|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15||Interventional|||The Development and Evaluation of the Ho'Ouna Pono Drug Prevention Curriculum|The Development and Evaluation of the Ho'Ouna Pono Drug Prevention|Active, not recruiting||N/A|486|Actual|Hawaii Pacific University||4|||f||||f|f|f||||||No||2017-10-10 21:09:37.816326|2017-10-10 21:09:37.816326
NCT03119116|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-22|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Use of Direct Oral Anticoagulants in UK|Pattern of Use of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients in UK General Practices|Active, not recruiting||N/A|3000|Anticipated|Bayer|||3||f||||f|f|f||||||||2017-10-10 21:09:37.905158|2017-10-10 21:09:37.905158
NCT03119103|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-13|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|September 30, 2018|Anticipated|2018-09-30|August 15, 2017|Anticipated|2017-08-15||Interventional|||Functional Bed Sheet Capturing Pressure Variation and Respiratory Effort Over Time|Functional Bed Sheet Capturing Respiratory Effort|Not yet recruiting||N/A|20|Anticipated|Studio 1 Labs||1|||f|||||f|f||||||Undecided||2017-10-10 21:09:38.004735|2017-10-10 21:09:38.004735
NCT03119090|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-13|||September 2015||2015-09-01|April 2017|2017-04-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Observational|FIB||Fontan Imaging Biomarkers (FIB) Study|Cross-sectional Analysis of Non-invasive Measures of Ventricular Systolic and Diastolic Function and Biomarkers in the Fontan Circulation|Recruiting||N/A|200|Anticipated|Boston Children’s Hospital|||1||f||||f|f|f||||Samples Without DNA|"     Blood and urine samples are biobanked for current and future study.   "|No||2017-10-10 21:09:38.097535|2017-10-10 21:09:38.097535
NCT03119077|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-22|||April 27, 2017|Actual|2017-04-27|August 2017|2017-08-01|November 29, 2017|Anticipated|2017-11-29|October 26, 2017|Anticipated|2017-10-26||Interventional|||Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116|Randomized, Double-blind, Placebo-controlled, Escalating Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered BAY1161116 in Healthy Postmenopausal Women Including Food-effect and Drug-drug-interaction With Itraconazole|Active, not recruiting||Phase 1|48|Anticipated|Bayer||2|||f||||f|f|f||||||||2017-10-10 21:09:38.185064|2017-10-10 21:09:38.185064
NCT03119064|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-13|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|329||BrUOG 329 GBM Onyvide With TMZ|BrUOG 329: Onivyde (Nanoliposomal Irinotecan) and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: A Phase IB/IIA Brown University Oncology Research Group Study|Not yet recruiting||Phase 1/Phase 2|25|Anticipated|Brown University||3|||f||||t|t|f|||f|||No||2017-10-10 21:09:38.296427|2017-10-10 21:09:38.296427
NCT03119051|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-22|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01||Interventional|SIMPLE||Shanghai Cognitive Intervention of Mild Cognitive Impairment for Delaying Progress With Longitudinal Evaluation|Shanghai Cognitive Intervention of Mild Cognitive Impairment for Delaying Progress With Longitudinal Evaluation|Recruiting||N/A|250|Anticipated|Ruijin Hospital||2|||f|||||f|f||||||No||2017-10-10 21:09:38.412133|2017-10-10 21:09:38.412133
NCT03119038|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-13|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Replacement|Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Arthroplasty: A Prospective, Blinded, Randomized Controlled Study|Recruiting||Phase 4|200|Anticipated|Rush University Medical Center||2|||f||||f||||||||No||2017-10-10 21:09:38.520315|2017-10-10 21:09:38.520315
NCT03119025|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-13|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection|Safety/Efficacy of Vaccination With Autologous Dendritic Cells Pulsed With Recombinant HCV-Antigens (Core and NS3) for Treatment of Patients With Chronic HCV-Infection|Recruiting||Phase 1/Phase 2|30|Anticipated|Russian Academy of Medical Sciences||1|||f|||||f|f||||||Undecided||2017-10-10 21:09:38.627134|2017-10-10 21:09:38.627134
NCT03118999|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-13|||February 28, 2017|Actual|2017-02-28|March 2017|2017-03-01|August 31, 2017|Anticipated|2017-08-31|April 30, 2017|Anticipated|2017-04-30||Interventional|||Plasma Level of Various Omega-3 Lipids|Plasma Level of Various Omega-3 Lipids|Recruiting||N/A|24|Anticipated|Nestlé||3|||f||||f|f|f||||||No||2017-10-10 21:09:38.862738|2017-10-10 21:09:38.862738
NCT03117985|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-12|||February 13, 2017|Actual|2017-02-13|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|TESOVIR||Tracking and Exploring the Source of Viral REbound|Tracking and Exploring the Source of Viral REbound|Recruiting||N/A|10|Anticipated|Centre Hospitalier Régional d'Orléans||1|||f||||f|f|f||||||No||2017-10-10 21:09:47.524578|2017-10-10 21:09:47.524578
NCT03118986|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-28|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|June 2021|Anticipated|2021-06-01||Interventional|||RCT of Olanzapine for Control of CIV in Children Receiving HSCT Conditioning|Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant|Recruiting||Phase 2|200|Anticipated|The Hospital for Sick Children||2|||f||||t|t|f|||t|||||2017-10-10 21:09:38.977856|2017-10-10 21:09:38.977856
NCT03118973|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-13|||September 27, 2016|Actual|2016-09-27|April 2017|2017-04-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Evaluation of Efficacy and Safety of Goff Transpancreatic Septotomy vs. Double Wire Technique for Achieving Biliary Access in Technically Challenging ERCPs|Evaluation of Efficacy and Safety of Goff Transpancreatic Septotomy vs. Double Wire Technique for Achieving Biliary Access in Technically Challenging ERCPs|Recruiting||N/A|500|Anticipated|Stanford University||2|||f||||t|f|f||||||No||2017-10-10 21:09:39.599843|2017-10-10 21:09:39.599843
NCT03118960|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-13|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Effectiveness of the Freedom Bed as Compared to Alternating Pressure Mattress in Treatment of Pressure Injuries in Persons With Limited Mobility Due to Traumatic Brain Injury and /or Spinal Cord Injury|Effectiveness of the Freedom Bed and Alternating Pressure Mattress in Treatment of Pressure Injuries in Persons With Limited Mobility Due to Traumatic Brain Injury and /or Spinal Cord Injury|Active, not recruiting||N/A|9|Anticipated|Northeast Center for Rehabilitation and Brain Injury||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:09:39.717449|2017-10-10 21:09:39.717449
NCT03118947|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-26|||February 23, 2017|Actual|2017-02-23|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease|A 52-Week Open-Label Extension Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease|Recruiting||Phase 2|432|Anticipated|ACADIA Pharmaceuticals Inc.||1|||f||||f|t|f||||||||2017-10-10 21:09:39.841351|2017-10-10 21:09:39.841351
NCT03118934|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-02|||May 17, 2017|Actual|2017-05-17|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 7, 2017|Actual|2017-07-07||Interventional|||Assessing Fitting Guides in Alcon Multifocal Contact Lenses|Assessing Fitting Guides in Alcon Multifocal Contact Lenses|Completed||N/A|188|Actual|Alcon Research||3|||f|||||f|t|f|f|t|||||2017-10-10 21:09:40.038142|2017-10-10 21:09:40.038142
NCT03118921|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-10|||April 20, 2017|Actual|2017-04-20|July 2017|2017-07-01|May 3, 2018|Anticipated|2018-05-03|April 20, 2018|Anticipated|2018-04-20||Interventional|REVAM||Body Image Disorder in Anorexia Nervosa and Virtual Reality|Body Image Disorder in Anorexia Nervosa and Virtual Reality|Recruiting||N/A|20|Anticipated|University Hospital, Brest||1|||f||||f|f|f||||||||2017-10-10 21:09:40.193237|2017-10-10 21:09:40.193237
NCT03118908|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-03|||April 24, 2017|Actual|2017-04-24|July 2017|2017-07-01|October 10, 2017|Anticipated|2017-10-10|October 10, 2017|Anticipated|2017-10-10||Interventional|||Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome|Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen and Smart B by Women With Climacteric Syndrome|Active, not recruiting||N/A|107|Actual|I.M. Sechenov First Moscow State Medical University||2|||f||||f|f|f||||||||2017-10-10 21:09:40.292968|2017-10-10 21:09:40.292968
NCT03118895|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-09-25|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|December 30, 2020|Anticipated|2020-12-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Leaders Free III: BioFreedom™ Clinical Trial|A Study Evaluating the Safety and Efficacy of the BioFreedom™ Biolimus A9™ Coated Cobalt Chromium Coronary Stent System in Patients at High Risk of Bleeding|Not yet recruiting||N/A|370|Anticipated|Biosensors Europe SA||1|||f||||t|f|f||||||||2017-10-10 21:09:40.414607|2017-10-10 21:09:40.414607
NCT03118882|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-18|||May 2010||2010-05-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|STIVI||STI.VI. Study: How to Improve Lifestyles in Screening Contexts|Pilot RCT on Lifestyles Impact on Health Outcomes in the General Population Invited to Mammography and Colorectal Cancer Screening Programmes. (STI.li di VI.ta - Lifestyles) STI.VI.|Completed||N/A|1270|Actual|Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte||4|||f||||f||||||||No||2017-10-10 21:09:40.550212|2017-10-10 21:09:40.550212
NCT03118869|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-25|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|October 30, 2017|Anticipated|2017-10-30|October 1, 2017|Anticipated|2017-10-01||Observational|polymorphism||B2 Adrenergic Receptor Gene Polymorphism in Bronchial Asthma|B2adrenergic Receptor Gene Polymorphism in Bronchial Asthma: Relation to Disease Severity and Control|Active, not recruiting||N/A|75|Anticipated|Assiut University|||1||f||||f|f|f||||||||2017-10-10 21:09:40.663966|2017-10-10 21:09:40.663966
NCT03118856|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-13|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Electronic Chromoendoscopy for Polyp Characterization|Real-time Assessment of the Histology of Colorectal Polyps Using Electronic Chromoendoscopy|Recruiting||N/A|200|Anticipated|University of Erlangen-Nürnberg Medical School|||2||f|||||f|f||||||||2017-10-10 21:09:40.743409|2017-10-10 21:09:40.743409
NCT03118830|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-31|||April 21, 2017|Actual|2017-04-21|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI|Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI|Recruiting||Phase 4|100|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 21:09:41.183552|2017-10-10 21:09:41.183552
NCT03117972|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-10-05|||August 4, 2017|Actual|2017-08-04|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|April 2021|Anticipated|2021-04-01||Interventional|CLavSyn||Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels|Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan-1 Levels|Recruiting||Phase 2|177|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f|||||f|f||||||||2017-10-10 21:09:47.616148|2017-10-10 21:09:47.616148
NCT03118817|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-28|||May 19, 2017|Actual|2017-05-19|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers|A Single-arm, Open-label, Multi-center, Phase I Expansion Study Evaluating the Efficacy and Safety of HM95573 Monotherapy in Patients With BRAF, KRAS or NRAS Mutation-positive Solid Cancers|Recruiting||Phase 1|100|Anticipated|Hanmi Pharmaceutical Company Limited||1|||f|||||f|f||||||||2017-10-10 21:09:41.300004|2017-10-10 21:09:41.300004
NCT03118804|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-07-30|||October 18, 2016|Actual|2016-10-18|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Weaning From Mechanical Ventilation Guide by Assessment of Lung Tidal Distribution With EIT|Weaning From Mechanical Ventilation Guide by Assessment of Lung Tidal Distribution With EIT|Recruiting||N/A|53|Anticipated|Southeast University, China|||1||f|||||f|f||||||||2017-10-10 21:09:41.427565|2017-10-10 21:09:41.427565
NCT03118791|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-08|||April 7, 2017|Actual|2017-04-07|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|August 8, 2017|Actual|2017-08-08||Interventional|||Dose-Dependent Effects of Anthocyanins on Endothelial Function in Healthy Men|Investigation on Acute Dose-Dependent Effects of Anthocyanins on Endothelial Function|Active, not recruiting||N/A|10|Actual|Heinrich-Heine University, Duesseldorf||6|||f||||f|f|f||||||||2017-10-10 21:09:41.512156|2017-10-10 21:09:41.512156
NCT03118778|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-24|||May 9, 2017|Actual|2017-05-09|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Observational|ECHO||Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population|Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population: A Descriptive Retrospective Observational Study Using Database|Completed||N/A|90895|Actual|AstraZeneca|||1||f||||f|f|f||||||||2017-10-10 21:09:41.596584|2017-10-10 21:09:41.596584
NCT03118765|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-18|||March 24, 2017|Actual|2017-03-24|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Dose Ranging, Parallel Group, Active (Spiriva® Respimat®) And Placebo Controlled Study To Assess Relative Bioavailability, Pharmacodynamics And Safety Of Three Doses Of Tiotropium Bromide Inhalation Solution In Subjects With Mild To Moderate Chronic Obstructive Pulmonary Disease|Completed||Phase 2|156|Actual|Glenmark Specialty S.A.||5|||f||||f|t|f||||||||2017-10-10 21:09:41.677991|2017-10-10 21:09:41.677991
NCT03118739|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-18|||May 18, 2017|Actual|2017-05-18|September 2017|2017-09-01|June 28, 2018|Anticipated|2018-06-28|March 22, 2018|Anticipated|2018-03-22||Interventional|||Intensive Uric Acid Lowering With RDEA3170 and Febuxostat in Patients With Albuminuria|Effects of Intensive Uric Acid Lowering Therapy With RDEA3170 (Verinurad) and Febuxostat in Patients With Albuminuria|Recruiting||Phase 2|60|Anticipated|AstraZeneca||2|||f||||f|t|f||||||||2017-10-10 21:09:41.949827|2017-10-10 21:09:41.949827
NCT03118726|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-17|||April 13, 2017|Actual|2017-04-13|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Evaluation of Immediate Postpartum LARC Implementation Programs|Evaluation of Immediate Postpartum LARC Implementation Programs|Enrolling by invitation||N/A|30|Anticipated|University of New Mexico|||1||f||||f|f|f|||f|||No||2017-10-10 21:09:42.082217|2017-10-10 21:09:42.082217
NCT03118713|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-17|||March 23, 2017|Actual|2017-03-23|May 2017|2017-05-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria|A Phase 4, Randomized, Open-label, Active-controlled, Multicenter Study to Evaluate the Renal Protective Effect (UACR), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria|Recruiting||Phase 4|174|Anticipated|Astellas Pharma Inc||2|||f||||f|f|f||||||Undecided||2017-10-10 21:09:42.159208|2017-10-10 21:09:42.159208
NCT03118700|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-12|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CHeER||Central Hemodynamic Exercise Responses Study|Postexercise Central Blood Pressure and Hemodynamic Response After Continuous and Aerobic Interval Exercise|Terminated||N/A|5|Actual|Arizona State University||3||Researcher left|f|||||f|f||||||||2017-10-10 21:09:42.28378|2017-10-10 21:09:42.28378
NCT03118687|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-03|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|April 30, 2028|Anticipated|2028-04-30|February 28, 2028|Anticipated|2028-02-28||Observational|HIP||Human Immunome Program|Human Immunome Program|Not yet recruiting||N/A|7|Anticipated|Vanderbilt University Medical Center|||1||f||||f|f|f||||Samples With DNA|"     -  Peripheral blood mononuclear cell (PBMCs)        -  Microbiome (stool, tongue, skin swabs)(optional)   "|Yes||2017-10-10 21:09:42.380652|2017-10-10 21:09:42.380652
NCT03118674|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-11|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|August 30, 2022|Anticipated|2022-08-30|August 30, 2022|Anticipated|2022-08-30||Interventional|||Harvoni Treatment Porphyria Cutanea Tarda|Newer Direct-Acting Anti-Viral Agents as Sole Therapy of Porphyria Cutanea Tarda in Subjects With Chronic Hepatitis C|Recruiting||Phase 2|49|Anticipated|Wake Forest University Health Sciences||1|||f||||t|t|f|||t|||||2017-10-10 21:09:42.457726|2017-10-10 21:09:42.457726
NCT03118661|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 30, 2025|Anticipated|2025-09-30|September 30, 2025|Anticipated|2025-09-30||Interventional|||Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant|Effect of CCR5 Inhibition by Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant for Any Indication and Its Observed Effect on Graft Versus Host Disease and HIV-1 Persistence|Not yet recruiting||Phase 1|5|Anticipated|Washington University School of Medicine||1|||f||||t|f|f||||||||2017-10-10 21:09:42.604894|2017-10-10 21:09:42.604894
NCT03118479|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-14|2017-04-17|||May 2010|Actual|2010-05-01|April 2017|2017-04-01|September 1, 2010|Actual|2010-09-01|September 1, 2010|Actual|2010-09-01||Interventional|||Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)|Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism|Terminated||Phase 1|7|Actual|Massachusetts General Hospital||2||Because the PI left the institution.|f||||t||||||||||2017-10-10 21:09:44.230188|2017-10-10 21:09:44.230188
NCT03118648|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-21|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Observational|Post AVC-AVQ||Recovery of Upper Limb Paresis at Discharge After Stroke and Its Level of Use in Activities of Daily Living 3 to 6 Months Later (Post AVC-AVQ)|Relations Between the Level Upper Limb Paresis Recovery in Output of the Hospital Unit Continued Care and Rehabilitation and Its Level of Use in Lifestyle at Three and Six Months|Not yet recruiting||N/A|192|Anticipated|University Hospital, Bordeaux|||1||f||||f|f|f||||||No||2017-10-10 21:09:42.72509|2017-10-10 21:09:42.72509
NCT03118635|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-13|||June 15, 2016|Actual|2016-06-15|March 2017|2017-03-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2016|Actual|2016-09-01||Interventional|PHAST||Effect of the Enhanced Summer Food Service Program on Schoolchildren|Assessing the Effect of the Enhanced Summer Food Service Program on the Health of Schoolchildren|Active, not recruiting||N/A|85|Actual|The Miriam Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:09:42.835105|2017-10-10 21:09:42.835105
NCT03118622|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-05-30|||May 31, 2017|Actual|2017-05-31|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|Pentax||Pentax Videolaryngoscopy in Children|A Comparison of Pentax AWS Videolaryngoscopy and Macintosh Laryngoscopy for Orotracheal Intubation in Children: a Randomized Controlled Trial|Recruiting||N/A|136|Anticipated|Ajou University School of Medicine|||2||f||||f|f|f||||||No||2017-10-10 21:09:42.931049|2017-10-10 21:09:42.931049
NCT03118609|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-08-09|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|January 30, 2018|Anticipated|2018-01-30|January 1, 2018|Anticipated|2018-01-01||Interventional|||Understanding Needs|Understanding the Needs of Informal Caregivers|Recruiting||N/A|150|Anticipated|Colorado State University||1|||f||||f|f|f||||||||2017-10-10 21:09:43.037259|2017-10-10 21:09:43.037259
NCT03118596|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-30|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Fibre-optic Guided Tracheal Intubation Through SADs|Fibre-optic Guided Tracheal Intubation Through Supraglottic Airway Devices - a Randomised Comparison Between I-gel and the LMA ProtectorTM|Recruiting||N/A|180|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust||2|||f|||||f|f||||||||2017-10-10 21:09:43.131837|2017-10-10 21:09:43.131837
NCT03118583|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-08-11|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers|An Open-label, Pilot Trial to Assess the Effects of a Dietary Supplement on Fasting Lipoprotein Lipids and a Marker of Inflammation in Men and Women With Above-desirable Levels of Low-density Lipoprotein Cholesterol|Recruiting||N/A|12|Anticipated|Midwest Center for Metabolic and Cardiovascular Research||1|||f|||||f|f||||||||2017-10-10 21:09:43.235046|2017-10-10 21:09:43.235046
NCT03118557|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-08-22|||March 15, 2017|Actual|2017-03-15|August 2017|2017-08-01|August 21, 2017|Actual|2017-08-21|August 21, 2017|Actual|2017-08-21||Interventional|||Pilates Pelvic Floor Strengthening Program to Improve Urinary Incontinence|HLP-16-003H: Does a Twice Weekly, 12-week Pilates Pelvic Floor Strengthening Program Improve Short- and Long-term Measures of Stress Urinary Incontinence Symptoms in Women Ages 45-70 Years of Age.|Completed||N/A|27|Actual|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 21:09:43.588902|2017-10-10 21:09:43.588902
NCT03118544|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-26|||March 26, 2017|Actual|2017-03-26|June 2017|2017-06-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01|1 Day|Observational [Patient Registry]|REDUCe||REduction of Contrast Via DyeVert Used in CTO Procedures|REduction of Contrast Via DyeVert Used in CTO Procedures (REDUCe)|Recruiting||N/A|100|Anticipated|Minneapolis Heart Institute Foundation|||1||f||||f|f|t|f|||||No||2017-10-10 21:09:43.678258|2017-10-10 21:09:43.678258
NCT03118531|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-02|||April 17, 2017|Actual|2017-04-17|August 2017|2017-08-01|December 30, 2023|Anticipated|2023-12-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||China Resolute Integrity 34/38 mm Study|Evaluation of the Clinical Safety and Efficacy of the 34/38 mm Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Subjects According to the Indication for Use|Active, not recruiting||N/A|40|Actual|Medtronic Vascular||1|||f|||||f|f||||||||2017-10-10 21:09:43.776412|2017-10-10 21:09:43.776412
NCT03118518|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-31|||June 16, 2017|Actual|2017-06-16|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|STOP AF First||STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation|STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation|Recruiting||N/A|210|Anticipated|Medtronic Atrial Fibrillation Solutions||2|||f||||f|f|t|f|f||||||2017-10-10 21:09:43.867277|2017-10-10 21:09:43.867277
NCT03118505|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-29|||June 29, 2017|Actual|2017-06-29|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|June 2020|Anticipated|2020-06-01||Interventional|||A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions|A Prospective, Randomized, Multi-Center, Open-Label Pilot Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions|Recruiting||N/A|125|Anticipated|Medtronic Spinal and Biologics||4|||f||||t|f|t|f|||||||2017-10-10 21:09:43.952068|2017-10-10 21:09:43.952068
NCT03118492|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-13|||June 21, 2017|Actual|2017-06-21|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis|A Pilot Study of Reduced Intensity HLA-Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide in Patients With Advanced Myelofibrosis|Recruiting||Phase 1|12|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:09:44.072419|2017-10-10 21:09:44.072419
NCT03118102|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-04-14|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|August 15, 2017|Anticipated|2017-08-15|July 10, 2017|Anticipated|2017-07-10||Observational|||Audiological Evaluation of Anesthetists|the Effects of Noise in Operating Rooms on Anesthetists Hearing|Recruiting||N/A|50|Anticipated|Assiut University|||2||f|||||f|f||||||||2017-10-10 21:09:47.44528|2017-10-10 21:09:47.44528
NCT03118466|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-21|||August 31, 2017|Anticipated|2017-08-31|July 2017|2017-07-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia|Phase 2 Study of Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia|Not yet recruiting||Phase 2|40|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 21:09:44.333344|2017-10-10 21:09:44.333344
NCT03118453|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-13|||November 2016||2016-11-01|April 2017|2017-04-01|April 2022|Anticipated|2022-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Implementation of a Behavioural Medicine Approach in Physical Therapy for Treatment of Chronic Pain|A Behavioural Medicine Approach in Physical Therapy for Treatment of Chronic Pain - Evaluation of the Implementation Process and Outcome|Recruiting||N/A|230|Anticipated|Mälardalen University||2|||f||||f|f|f||||||No|No plan to share IPD because the participants have been assured of confidentiality and that only the researchers in the Project will have access to IPD|2017-10-10 21:09:44.588221|2017-10-10 21:09:44.588221
NCT03118440|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-13|||January 2013||2013-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|ZF-PMSC||Zero-fluoroscopic Navigation Versus Conventional Fluoroscopic Navigation for Single-chamber Pacemaker Implantation|Multi-center, Randomized, Controlled Trial to Compare Feasibility, Safety and Efficacy of Zero-Fluoroscopic Navigation With Conventional Fluoroscopic Navigation for Single-chamber Pacemaker Implantation|Recruiting||N/A|100|Anticipated|Tongji Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:09:44.739443|2017-10-10 21:09:44.739443
NCT03118427|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-13|||January 2013||2013-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|ZF-PMDC||Zero-fluoroscopic Navigation Versus Conventional Fluoroscopic Navigation for Double-chamber Pacemaker Implantation|Multi-center, Randomized, Controlled Trial to Compare Feasibility, Safety and Efficacy of Zero-Fluoroscopic Navigation With Conventional Fluoroscopic Navigation for Double-chamber Pacemaker Implantation|Recruiting||N/A|100|Anticipated|Tongji Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:09:44.889837|2017-10-10 21:09:44.889837
NCT03118414|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-17|||February 10, 2016|Actual|2016-02-10|April 2017|2017-04-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|||Effects of Physical Exercise, Virtual Reality and Brain Exercise on Balance of the Elderly|Effects of Physical Exercise, Virtual Reality and Brain Exercise on Balance of the Elderly|Completed||N/A|84|Actual|Mahidol University||4|||f||||f|f|f||||||No||2017-10-10 21:09:45.039243|2017-10-10 21:09:45.039243
NCT03118401|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-07-17|||July 4, 2017|Actual|2017-07-04|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|RITUELIM||Stool Ritual: Impact on the Number of Nights Without Stools Among Dependent Residents in Institutions for Dependent Elderly People|Stool Ritual: Impact on the Number of Nights Without Stools Among Dependent Residents in Institutions for Dependent Elderly People|Recruiting||N/A|50|Anticipated|University Hospital, Limoges||2|||f||||f|f|f||||||||2017-10-10 21:09:45.137968|2017-10-10 21:09:45.137968
NCT03118388|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-13|||September 18, 2009|Actual|2009-09-18|April 2017|2017-04-01|August 31, 2011|Actual|2011-08-31|August 31, 2011|Actual|2011-08-31||Interventional|SEI||Engaging Homeless Youth in Vocational Training to Meet Their Mental Health Needs|Engaging Homeless Youth in Vocational Training to Meet Their Mental Health Needs|Completed||Phase 2|72|Actual|Arizona State University||2|||f||||t|f|f||||||No||2017-10-10 21:09:45.239274|2017-10-10 21:09:45.239274
NCT03118375|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-20|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||Super Power in BAI|Hearing Outcomes Using Super-power Processors in Bone Anchored Implant Recipients|Enrolling by invitation||N/A|50|Anticipated|University of Miami|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:09:45.326442|2017-10-10 21:09:45.326442
NCT03118362|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-09-26|||August 9, 2017|Actual|2017-08-09|September 2017|2017-09-01|October 9, 2018|Anticipated|2018-10-09|September 9, 2018|Anticipated|2018-09-09||Interventional|CARE||Fluid Resuscitation in Burn Patients|Clearance of Acetate During Fluid Resuscitation of Critically Ill Burn Patients: The CARE Trial.|Recruiting||Phase 3|28|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:09:45.415827|2017-10-10 21:09:45.415827
NCT03118349|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-13|||June 1, 2017|Actual|2017-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy|Phase I, Open-Label, Multi-Center, Dose Escalation With Expansion Trial of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy in Relapse/Refractory Subjects With Pancreatic Cancer or Other CA19-9 Positive Malignancies|Recruiting||Phase 1|22|Anticipated|MabVax Therapeutics, Inc.||2|||f||||f|t|f||||||No||2017-10-10 21:09:45.524076|2017-10-10 21:09:45.524076
NCT03118336|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-06-19|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|May 2019|Anticipated|2019-05-01||Interventional|EMPACEF||Impact of Empaglifozine on Cardiac Ectopic Fat|Impact of Empaglifozine on Cardiac Ectopic Fat|Recruiting||Phase 3|56|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f|f|f||||||Undecided||2017-10-10 21:09:45.650115|2017-10-10 21:09:45.650115
NCT03118323|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-08|||July 8, 2017|Actual|2017-07-08|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Patients' Willingness-to-pay of Endodontic Treatment|Patients' Willingness-to-pay of Endodontic Treatment|Enrolling by invitation||N/A|200|Anticipated|University of Göttingen|||1||f||||f|f|f||||||||2017-10-10 21:09:45.740091|2017-10-10 21:09:45.740091
NCT03118310|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-17|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|TREND||Treatment of NAFLD With Two Different Diets|Treatment of NAFLD With Two Different Diets|Recruiting||Phase 2|60|Anticipated|Karolinska University Hospital||3|||f||||f|f|f||||||No||2017-10-10 21:09:45.819894|2017-10-10 21:09:45.819894
NCT03118297|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-27|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|INTERRUPT||Intervention to End Recurrent Unscheduled Bleeding Trial|Intervention to End Recurrent Unscheduled Bleeding Trial: A Randomized-controlled Trial of Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users|Recruiting||Phase 3|104|Anticipated|Washington University School of Medicine||2|||||||t|t|f|||t|||||2017-10-10 21:09:45.918957|2017-10-10 21:09:45.918957
NCT03118284|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-12|||October 31, 2016|Actual|2016-10-31|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Observational|FCRBD||Foley Catheter Related Bladder Discomfort (FCRBD): Role of Neutrophil Cells|Foley Catheter Related Bladder Discomfort (FCRBD): Role of Neutrophil Cells|Recruiting||N/A|120|Anticipated|Washington University School of Medicine|||2||f||||f|f|f||||Samples With DNA|"     mtDNA samples isolated from blood and supernatants from urine will be retained and frozen for     future research   "|No||2017-10-10 21:09:46.029226|2017-10-10 21:09:46.029226
NCT03118271|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-18|||January 2017||2017-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparison of the Effect of Lumbar Traction, Spinal Manipulation, and Surgery in the Treatment of Lumbar Disc Herniation|Comparison of the Effect of Lumbar Traction, Spinal Manipulation, and Surgery in the Treatment of Lumbar Disc Herniation|Recruiting||N/A|60|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:09:46.128722|2017-10-10 21:09:46.128722
NCT03118258|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-14|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|August 31, 2018|Anticipated|2018-08-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Improve Access to Cervical Cancer Screening|Improve Access to Cervical Cancer Screening for Deprived and Eligible Women Met in Doctors of the World's Programs|Recruiting||N/A|1258|Anticipated|Médecins du Monde||2|||f||||t|f|f||||||No||2017-10-10 21:09:46.232003|2017-10-10 21:09:46.232003
NCT03118245|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-06-15|||June 12, 2017|Actual|2017-06-12|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Ambu AuraGain Laryngeal Mask Airway and I-gel in Children|A Randomized Comparison of Ambu AuraGain (Original Name of Product) Laryngeal Mask Airway and I-gel in Children|Recruiting||N/A|88|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:09:46.319136|2017-10-10 21:09:46.319136
NCT03118232|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-06-08|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|June 2022|Anticipated|2022-06-01||Interventional|PROTECT||Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization|Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization|Recruiting||Phase 4|28|Anticipated|University of California, Irvine||2|||f||||f|t|f||||||No|The resource sharing plan involves sharing 1) sharing of trial materials and tools, and 2) making bacterial isolates available.|2017-10-10 21:09:46.415662|2017-10-10 21:09:46.415662
NCT03118219|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-21|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|PACI||Positive Adjustment Coping Intervention|Positive Adjustment in Case of Involuntary Childlessness - a Smartphone-supported Intervention Study as RCT|Recruiting||N/A|240|Anticipated|University Hospital Heidelberg||2|||f||||f|f|f||||||||2017-10-10 21:09:46.60599|2017-10-10 21:09:46.60599
NCT03118206|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-18|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparison of the Effect of Lumbar Spinal Manipulation, Physical Therapy and Surgical Management in the Treatment of Lumbar Spinal Stenosis|Comparison of the Effect of Lumbar Spinal Manipulation, Physical Therapy and Surgical Management in the Treatment of Lumbar Spinal Stenosis|Recruiting||N/A|60|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:09:46.707076|2017-10-10 21:09:46.707076
NCT03118193|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-19|||June 16, 2017|Actual|2017-06-16|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|BIORESA||Biomarkers of Antidepressant Resistance|Biomarkers of Antidepressant Resistance - BIORESA|Recruiting||N/A|50|Anticipated|University Hospital, Tours||1|||f||||f|f|f||||||No||2017-10-10 21:09:46.804376|2017-10-10 21:09:46.804376
NCT03118180|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-14|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma|The Safety and Efficacy Evaluation of CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma|Recruiting||Phase 1/Phase 2|50|Anticipated|Zhejiang University||1|||f||||t|f|f||||||Undecided||2017-10-10 21:09:46.907261|2017-10-10 21:09:46.907261
NCT03118167|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-05-16|||May 2014||2014-05-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Intervention Effect of TP and AOB-w on Acrylamide Exposure in Chinese Adolescents|Intervention Effect of Tea Polyphenols (TP) and Water-Soluble Antioxidant Of Bamboo Leaves (AOB-w) on Short- and Long-term Internal Exposure of Acrylamide in Chinese Adolescents|Completed||N/A|110|Actual|Zhejiang University||3|||f||||f||||||||No||2017-10-10 21:09:47.001146|2017-10-10 21:09:47.001146
NCT03118154|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-22|||March 31, 2017|Actual|2017-03-31|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|October 1, 2017|Anticipated|2017-10-01||Observational|Endo2017||Efficacy of Manual Therapy to Improve Quality of Life and Decrease Pain in Subjects With Endometriosis|Efficacy of Manual Therapy to Improve Quality of Life and Decrease Pain in Subjects With Endometriosis|Terminated||N/A|8|Actual|Clear Passage Therapies, Inc|||2|Recruitment|f||||f|f|f||||||||2017-10-10 21:09:47.091523|2017-10-10 21:09:47.091523
NCT03118141|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-12|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|CESE-PGS||Cumulative Live Birth Rate With eSET After Preimplantation Genetic Screening Versus Conventional In-vitro Fertilization|Cumulative Live Birth Rate With eSET After In-vitro Fertilization With Preim-plantation Genetic Screening by Next Generation Sequencing Versus Conventional In-vitro Fertilization: A Pragmatic Randomized Controlled Clinical Trial|Not yet recruiting||N/A|1208|Anticipated|Shandong University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:09:47.190587|2017-10-10 21:09:47.190587
NCT03118128|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-07-04|||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|April 30, 2017|Actual|2017-04-30|December 1, 2016|Actual|2016-12-01||Interventional|||Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia|Effect of the Addition of Metformin Hydrochloride on the Prognosis of Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia With High Expression of ABCB1 Gene|Completed||N/A|102|Actual|Hospital General de Mexico||2|||f||||f||||||||||2017-10-10 21:09:47.300231|2017-10-10 21:09:47.300231
NCT03118115|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-12|||March 21, 2017|Actual|2017-03-21|April 2017|2017-04-01|December 22, 2017|Anticipated|2017-12-22|December 22, 2017|Anticipated|2017-12-22||Interventional|MONITRANS||Bioimpedance Variation of Free Flap for After Clamping|Bioimpedance Variation of Free Flap for After Clamping - MONITRANS|Recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f|f|f||||||No||2017-10-10 21:09:47.369028|2017-10-10 21:09:47.369028
NCT03117959|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-04-12|||February 2014||2014-02-01|April 2017|2017-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||TKA Using Patient-Specific Instrumentation|A Randomized Control Trial Comparing an Anatomical Axis Aligned and Conventional Mechanical Axis Total Knee Arthroplasty Using Patient-Specific Instrumentation|Withdrawn||Phase 4|0|Actual|Queen's University||2||no longer RCT - same surgical technique and implant used|f||||f||||||||No||2017-10-10 21:09:47.747319|2017-10-10 21:09:47.747319
NCT03117946|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-10-05|||May 29, 2017|Actual|2017-05-29|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|i-RTCT||Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy|Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy|Recruiting||N/A|70|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f|f|f||||||||2017-10-10 21:09:47.820007|2017-10-10 21:09:47.820007
NCT03117933|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-29|||March 9, 2017|Actual|2017-03-09|September 2017|2017-09-01|November 30, 2021|Anticipated|2021-11-30|March 30, 2021|Anticipated|2021-03-30||Interventional|OCTOVA||Olaparib +/- Cediranib or Chemotherapy in Patients With BRCA Mutated Platinum-resistant Ovarian Cancer|Randomised Phase II Trial of Olaparib, Chemotherapy or Olaparib and Cediranib in Patients With BRCA Mutated Platinum-resistant Ovarian Cancer|Recruiting||Phase 2|132|Anticipated|University of Oxford||3|||f||||f|f|f||||||||2017-10-10 21:09:47.910534|2017-10-10 21:09:47.910534
NCT03117920|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-13|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|February 15, 2019|Anticipated|2019-02-15|May 15, 2018|Anticipated|2018-05-15||Interventional|MinPAC||A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer|MinPAC: A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer.|Recruiting||Phase 2|35|Anticipated|Queen Mary University of London||1|||f||||t|t|f||||||||2017-10-10 21:09:48.046316|2017-10-10 21:09:48.046316
NCT03117907|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-13|||March 24, 2016|Actual|2016-03-24|April 2016|2016-04-01|March 24, 2018|Anticipated|2018-03-24|March 24, 2018|Anticipated|2018-03-24||Observational|||Comparison of Peripheral Perfusion Level Between Two Groups of Newborns According to Their Infectious Status Defined by the Criteria of the Center for Disease Control and Prevention (CDC)|Comparison of Peripheral Perfusion Level Between Two Groups of Newborns According to Their Infectious Status Defined by the Criteria of the Center for Disease Control and Prevention (CDC)|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire, Amiens|||2||f||||f||||||||||2017-10-10 21:09:48.166988|2017-10-10 21:09:48.166988
NCT03117894|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-29|||May 23, 2017|Actual|2017-05-23|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PECS-2 for Breast Surgery|Regional Anesthesia for Breast Cancer Surgery, Effects on Postoperative Wellbeing and Disease Recurrence.|Recruiting||N/A|200|Anticipated|Umeå University||2|||f||||f|f|f||||||No||2017-10-10 21:09:48.229331|2017-10-10 21:09:48.229331
NCT03117881|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-12|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|TEAMS||Tele-Exercise and Multiple Sclerosis|Comparative Effectiveness Trial Between a Clinic- and Home-Based Complementary and Alternative Medicine Telerehabilitation Intervention for Adults With Multiple Sclerosis (MS)|Not yet recruiting||N/A|820|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||No||2017-10-10 21:09:48.357946|2017-10-10 21:09:48.357946
NCT03117868|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-13|2017-04-25|||May 25, 2016|Actual|2016-05-25|April 2017|2017-04-01|November 24, 2017|Anticipated|2017-11-24|November 24, 2017|Anticipated|2017-11-24||Observational|FESF-Amiens||Mortality of Patients Undergoing Fracture of the Upper Extremity u Femur at the University Hospital of Amiens|Mortality of Patients Undergoing Fracture of the Upper Extremity u Femur at the University Hospital of Amiens|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:09:48.828583|2017-10-10 21:09:48.828583
NCT03117855|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-04-12|||December 2016||2016-12-01|April 2017|2017-04-01||||June 2019|Anticipated|2019-06-01||Interventional|||Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery|A Phase I Clinical Trial of Capecitabine and SIR-Spheres® Y-90-Radioembolization in Patients With Advanced Intrahepatic Cholangiocarcinoma|Withdrawn||Phase 1|0|Actual|City of Hope Medical Center||1||Company no longer interested in supporting this trial|f||||t||||||||||2017-10-10 21:09:48.955771|2017-10-10 21:09:48.955771
NCT03117842|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-18|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|April 1, 2019|Anticipated|2019-04-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Using a Theory-based SMS/VM Intervention to Improve Sexual and Reproductive Health of Female Entertainment Workers in Cambodia|Using a Theory-based SMS/VM Intervention to Improve Sexual and Reproductive Health of Female Entertainment Workers in Cambodia: Study Protocol of a Randomized Controlled Trial|Not yet recruiting||N/A|600|Anticipated|Touro University, California||2|||f||||f|f|f||||||No||2017-10-10 21:09:49.073758|2017-10-10 21:09:49.073758
NCT03117829|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-17|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|BFIT||Study: Diet and Exercise Study to Improve Brain Blood Flow: Blood Flow Improvement Trial|Diet and Exercise Trial to Improve Insulin Resistance, Increase Cerebral Blood Flow, Alter Metabolomic Biomarkers, and Decrease Alzheimer's Disease Risk|Recruiting||N/A|40|Anticipated|University of Wisconsin, Madison||1|||f||||f|f|f||||||No||2017-10-10 21:09:49.232366|2017-10-10 21:09:49.232366
NCT03117816|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-21|||May 4, 2017|Actual|2017-05-04|April 2017|2017-04-01|December 2024|Anticipated|2024-12-01|September 2021|Anticipated|2021-09-01||Interventional|ENDURE-CML-IX||ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission|Efficacy and Safety of Pegylated Proline Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients With Chronic Myeloid Leukemia (CML) Who Discontinue ABL-Kinase Inhibitor Therapy - a Randomized Phase II, Multicenter Trial With Post-study Follow-up|Recruiting||Phase 2|214|Anticipated|Philipps University Marburg Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:09:49.349495|2017-10-10 21:09:49.349495
NCT03117803|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-02|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|December 30, 2021|Anticipated|2021-12-30|December 30, 2020|Anticipated|2020-12-30|1 Year|Observational [Patient Registry]|||The Natural Course of Unruptured Intracranial Aneurysms in a Chinese Cohort|The Natural Course of Unruptured Intracranial Aneurysms in a Chinese Cohort|Recruiting||N/A|5000|Anticipated|Tang-Du Hospital|||1||f||||t|f|f||||Samples With DNA|"     whole blood   "|||2017-10-10 21:09:49.645993|2017-10-10 21:09:49.645993
NCT03117790|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-21|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Impact of Dexmedetomidine on Sleep Quality|Impact of Dexmedetomidine Supplemented Analgesia on Sleep Quality in Elderly Patients After Major Surgery: A Randomized, Double-blind, and Placebo-controlled Pilot Study|Recruiting||Phase 4|76|Anticipated|Peking University First Hospital||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:09:49.749116|2017-10-10 21:09:49.749116
NCT03117777|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-12|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Group Cognitive Behavioral Therapy for Insomnia in Older Adults|Group Cognitive Behavioral Therapy for Insomnia (CBT-I) in OIder Adults: the Clinical Outcomes of a Pilot Project|Not yet recruiting||N/A|60|Anticipated|Nova Scotia Health Authority|||1||f||||f|f|f||||||No||2017-10-10 21:09:49.912101|2017-10-10 21:09:49.912101
NCT03117764|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluation of the Impact of Intravenous Antibiotics on Muscular Strength in Patients With Cystic Fibrosis.|Evaluation of the Impact of Intravenous Antibiotics on Muscular Strength in Patients With Cystic Fibrosis.|Not yet recruiting||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f|f|f||||||||2017-10-10 21:09:50.027467|2017-10-10 21:09:50.027467
NCT03117751|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-10-04|||March 29, 2017|Actual|2017-03-29|October 2017|2017-10-01|March 31, 2028|Anticipated|2028-03-31|September 30, 2026|Anticipated|2026-09-30||Interventional|||Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma|Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma|Recruiting||Phase 2/Phase 3|1000|Anticipated|St. Jude Children's Research Hospital||8|||||||t|t|f||||||||2017-10-10 21:09:50.173219|2017-10-10 21:09:50.173219
NCT03117738|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-19|||April 3, 2017|Actual|2017-04-03|July 2017|2017-07-01|November 30, 2018|Anticipated|2018-11-30|October 26, 2018|Anticipated|2018-10-26||Interventional|||A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease|A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AstroStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Patients With Alzheimer's Disease|Recruiting||Phase 1/Phase 2|60|Anticipated|Nature Cell Co. Ltd.||2|||f||||f|t|f||||||||2017-10-10 21:09:50.54249|2017-10-10 21:09:50.54249
NCT03117725|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-12|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|December 30, 2017|Anticipated|2017-12-30||Interventional|||Melatonin Study Between Diminished and Normal Responder in IVF|Comparison of IVF Outcome and Endometrium Effect in Infertility Patients Between Diminished and Normal Ovarian Reserve After Melatonin Administration.|Not yet recruiting||N/A|100|Anticipated|Bundang CHA Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:09:50.667118|2017-10-10 21:09:50.667118
NCT03117712|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-26|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Cerebral Blood Supply During Cardiopulmonary Bypass|Influence of Cerebral Blood Supply During Cardiopulmonary Bypass on the Incidence of Postoperative Delirium in Open-heart Surgery|Not yet recruiting||N/A|40|Anticipated|Medical University of Vienna|||2||f||||f|f|f||||||No||2017-10-10 21:09:50.762958|2017-10-10 21:09:50.762958
NCT03117699|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-12|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|November 10, 2017|Anticipated|2017-11-10|October 10, 2017|Anticipated|2017-10-10||Interventional|PADH2||Seated - Standing Passage of the Hemiplegic|Continuation of the Exploration of the Standing Seated Passage of the Hemiplegic for the Realization of a New Transport Device|Recruiting||N/A|45|Anticipated|University Hospital, Brest||2|||f||||f|f|f||||||No||2017-10-10 21:09:50.860835|2017-10-10 21:09:50.860835
NCT03117686|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-25|||June 10, 2017|Anticipated|2017-06-10|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|June 22, 2017|Anticipated|2017-06-22||Observational|||Lung Ultrasound in High Altitude Lung Edema|Estimation of Pulmonary Arterial Pressure With Transesophageal Echocardiography: A Pilot Study|Not yet recruiting||N/A|20|Anticipated|Medical University of Vienna|||2||f||||f|f|f||||||No||2017-10-10 21:09:50.971348|2017-10-10 21:09:50.971348
NCT03117673|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-25|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Estimation of Pulmonary Arterial Pressure With Transesophageal Echocardiography: a Pilot Study|Estimation of Pulmonary Arterial Pressure With Transesophageal Echocardiography: a Pilot Study|Not yet recruiting||N/A|39|Anticipated|Medical University of Vienna|||3||f||||f|f|f||||||No||2017-10-10 21:09:51.061244|2017-10-10 21:09:51.061244
NCT03117660|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-12|||April 24, 2017|Anticipated|2017-04-24|April 2017|2017-04-01|April 24, 2027|Anticipated|2027-04-24|April 24, 2027|Anticipated|2027-04-24||Interventional|||Effects of Retinoids on CYP2D6 Activity During Pregnancy|Effects of Retinoids on CYP2D6 Activity and Variability in Special Populations|Recruiting||Phase 1|100|Anticipated|University of Washington||2|||f||||f|t|f|||f|||Yes|The investigators will adhere to the NIH Grant Policy on Sharing Research Data. That is, after final data collection and analysis and after full peer review is performed on the data, the de-identified data generated by this project will be made available when requested by the academic community and researchers-at-large contingent upon Material Transfer Agreements with the University of Washington.|2017-10-10 21:09:51.143261|2017-10-10 21:09:51.143261
NCT03117647|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-19|||May 1, 2013|Actual|2013-05-01|April 2017|2017-04-01|December 7, 2016|Actual|2016-12-07|December 7, 2016|Actual|2016-12-07||Observational|||Mansoura-VV Uterine Compression Suture for Primary Atonic Postpartum Hemorrhage|Is Early Intervention Using Mansoura-VV Uterine Compression Sutures an Effective Procedure in the Management of Primary Atonic Postpartum Hemorrhage? : A Prospective Study|Completed||N/A|108|Actual|Mansoura University|||1||f|||||f|f||||||||2017-10-10 21:09:51.225425|2017-10-10 21:09:51.225425
NCT03117634|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-10-03|||October 1, 2017|Actual|2017-10-01|April 2017|2017-04-01|July 1, 2019|Anticipated|2019-07-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy Using a Modified Intensive Treat and Extend Regime to a Fixed Dosing Regimen|An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy Using a Modified Intensive Treat and Extend Regime to a Fixed Dosing Regimen|Recruiting||Phase 4|52|Anticipated|Singapore National Eye Centre||2|||f||||t|f|f|||f|||||2017-10-10 21:09:51.284354|2017-10-10 21:09:51.284354
NCT03116945|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-19|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Novel Gallium Imaging in Hepatocellular Carcinoma|68Gallium Citrate Imaging in Newly Diagnosed Hepatocellular Carcinoma|Recruiting||Phase 2|18|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 21:09:58.706168|2017-10-10 21:09:58.706168
NCT03117621|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-09|||March 22, 2017|Actual|2017-03-22|June 2017|2017-06-01|February 22, 2022|Anticipated|2022-02-22|February 22, 2022|Anticipated|2022-02-22||Observational|||Observational Study of Blinatumomab|An Observational Study of Blinatumomab Safety and Effectiveness, Utilization, and Treatment Practices|Recruiting||N/A|350|Anticipated|Amgen|||1||f||||f||f||||||Yes|Protocol, study status, and report(s) to be included in regulatory communications in line with the risk management plan, PSURs, and other regulatory requirements. Interim reports provided as part of PSURs, will include descriptive analyses and results for the primary and secondary objectives. Safety concerns identified during interim analyses will be immediately communicated to regulatory authorities in accordance with GVP. Final study report will be completed within a year of the end of data collection, and will be prepared whether the study is completed or prematurely terminated. Final study report will be submitted to the EMA and to the respective Competent Authorities as applicable. The summary of the final results will be provided to all participating HCPs. Any manuscript and/or abstract for scientific presentation(s) will be developed and submitted in accordance in with the 2012 Guideline on Good Pharmacovigilance Practice (GVP): Module VIII - Post-Authorisation Safety Studies|2017-10-10 21:09:51.374597|2017-10-10 21:09:51.374597
NCT03117608|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-28|||February 24, 2017|Actual|2017-02-24|August 2017|2017-08-01|February 24, 2024|Anticipated|2024-02-24|August 24, 2022|Anticipated|2022-08-24||Interventional|LIPOJOINT||A Single Intra-articular Injection of aMAT vs PRP in Patients With OA of the Knee|A SINGLE-BLIND, RANDOMIZED, CONTROLLED STUDY OF A SINGLE, INTRA-ARTICULAR INJECTION OF AUTOLOGOUS MICRO-FRAGMENTED ADIPOSE TISSUE (aMAT) VERSUS (VS) PRP IN PATIENTS WITH OSTEOARTHRITIS (OA) OF THE KNEE|Recruiting||Phase 4|118|Anticipated|Lipogems International spa||2|||f||||t|f|f||||||||2017-10-10 21:09:51.464148|2017-10-10 21:09:51.464148
NCT03117595|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-08-31|||September 18, 2017|Anticipated|2017-09-18|August 2017|2017-08-01|February 25, 2018|Anticipated|2018-02-25|December 18, 2017|Anticipated|2017-12-18||Interventional|SSS||CSE for Labour Analgesia: A Comparison of Two Intrathecal Regimens|Combined Spinal Epidural Analgesia in Labour: A Comparison of Two Intrathecal Regimens of Single Shot Spinal|Not yet recruiting||Phase 4|94|Anticipated|Lagos State Health Service Commission||2|||f||||t|f|f|||f|||||2017-10-10 21:09:51.553589|2017-10-10 21:09:51.553589
NCT03117582|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-04-17|||December 9, 2016|Actual|2016-12-09|March 2017|2017-03-01|December 9, 2026|Anticipated|2026-12-09|December 9, 2026|Anticipated|2026-12-09|1 Year|Observational [Patient Registry]|FMT||Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics|Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics|Enrolling by invitation||N/A|75|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f|f|f||||Samples With DNA|"     donor stool (25mL aliquot) stool specimen (4 samples, each ~3mL)   "|||2017-10-10 21:09:51.641374|2017-10-10 21:09:51.641374
NCT03117569|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-29|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|SMART-C||Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients|A Phase IIIb, Open-label, Multicentre, International Randomised Controlled Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir (300mg)/Pibrentasvir (120mg) in Chronic HCV Treatment naïve Patients Without Cirrhosis|Recruiting||Phase 3|375|Anticipated|Kirby Institute||2|||f||||t|f|f||||||||2017-10-10 21:09:51.728363|2017-10-10 21:09:51.728363
NCT03117556|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-08|||August 31, 2017|Actual|2017-08-31|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer|Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer|Recruiting||N/A|40|Anticipated|University of Louisville||2|||f||||f|f|f||||||||2017-10-10 21:09:51.903791|2017-10-10 21:09:51.903791
NCT03117543|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-04-12|||March 2016||2016-03-01|March 2016|2016-03-01||||September 2017|Anticipated|2017-09-01||Observational|||Diagnostic Approaches in Gestational Diabetes and Impact of Ethnicity|Screening and Diagnostic Approaches in Gestational Diabetes (GDM) and the Impact of Ethnicity on Markers of Glycaemia in Pregnancy|Recruiting||N/A|102|Anticipated|King's College Hospital NHS Trust|||1||f||||f||||||Samples Without DNA|"     Serum samples, fasting and at 60 min and 120 min post 75g oral glucose.   "|No||2017-10-10 21:09:52.00191|2017-10-10 21:09:52.00191
NCT03117530|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-04-17|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Measuring Brain Inflammation in Autism|Targeting Microglial Activation for Treatment of Autism Spectrum Disorder (ASD): A Proof-of-Concept, Target-Engagement Study|Recruiting||Phase 1|30|Anticipated|University of California, Los Angeles||1|||f||||t|t|f|||t|||No|IPD will not be shared|2017-10-10 21:09:52.084564|2017-10-10 21:09:52.084564
NCT03117517|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-10-05|||March 20, 2017|Actual|2017-03-20|October 2017|2017-10-01|December 25, 2017|Anticipated|2017-12-25|November 25, 2017|Anticipated|2017-11-25||Interventional|||Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome|Effects of Metformin and Combination of Metformin and Pioglitazone on Plasma Interleukin-6 and Interleukin-8 Levels in Polycystic Ovarian Syndrome|Recruiting||Early Phase 1|102|Anticipated|Khyber Medical University Peshawar||2|||f||||t|f|f|||f|||||2017-10-10 21:09:52.170199|2017-10-10 21:09:52.170199
NCT03117504|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-17|||January 5, 2016|Actual|2016-01-05|April 2017|2017-04-01|July 20, 2017|Anticipated|2017-07-20|May 20, 2017|Anticipated|2017-05-20||Observational|||Assessment of Prevalence of Stress Urinary Incontinence During Pregnancy|Assessment of Prevalence of Stress Urinary Incontinence During Pregnancy|Suspended||N/A|500|Actual|Ain Shams Maternity Hospital|||2|lack of funding|f||||f|f|f||||||No||2017-10-10 21:09:52.273638|2017-10-10 21:09:52.273638
NCT03117491|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-04|||December 1, 2015|Actual|2015-12-01|April 2017|2017-04-01|December 1, 2016|Actual|2016-12-01|November 1, 2016|Actual|2016-11-01||Interventional|||Effect of Inferior Alveolar and Gow-Gates Nerve Block Techniques for Symptomatic Mandibular Molars|Effect of Inferior Alveolar and Gow-Gates Nerve Block Techniques for Symptomatic Mandibular Molars|Completed||Phase 3|150|Actual|Isfahan University of Medical Sciences||3|||f||||f||||||||No||2017-10-10 21:09:52.353593|2017-10-10 21:09:52.353593
NCT03117478|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-05|||March 19, 2016|Actual|2016-03-19|February 2017|2017-02-01|March 19, 2021|Anticipated|2021-03-19|February 19, 2021|Anticipated|2021-02-19||Interventional|MEDITATION||Brain and Mindfulness|The Impact of Meditation Practice on Attention and Emotion Regulation :Studies on Neural Correlation in Brain Imagery and Biomarkers of Stress and Inflammation|Recruiting||N/A|285|Anticipated|Hospices Civils de Lyon||4|||f||||f|f|f||||||||2017-10-10 21:09:52.459161|2017-10-10 21:09:52.459161
NCT03117465|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-12|||July 2015||2015-07-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Scalp Acupuncture Combined rTMS on Brain White Matter Microstructure of Hemiplegic Patients With Stroke|Based on the Method of Tract-based Spatial Statistics Investigated Scalp Acupuncture Combined Low-frequency Repetitive Transcranial Magnetic Stimulation on Brain White Matter Microstructure of Hemiplegic Patients With Stroke|Active, not recruiting||N/A|28|Anticipated|Shenzhen Sixth People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:09:52.569679|2017-10-10 21:09:52.569679
NCT03117452|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-17|||February 23, 2017|Actual|2017-02-23|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Evaluation of a Visual Remediation Intervention for Schizophrenia|Evaluation of a Visual Remediation Intervention for Schizophrenia|Recruiting||N/A|40|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||No||2017-10-10 21:09:54.242318|2017-10-10 21:09:54.242318
NCT03117439|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-20|||July 2016||2016-07-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Beta-Glucan Driven vs. Empirical Antifungal Therapy in Critically Ill Patients|(1-3)-Beta-D-Glucan Driven vs. Empirical Antifungal Therapy in High Risk Critically Ill Patients A Randomized Study|Recruiting||N/A|96|Anticipated|Policlinico Universitario Agostino Gemelli||2|||f||||f||||||||No||2017-10-10 21:09:54.420443|2017-10-10 21:09:54.420443
NCT03117426|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-20|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||A Randomised Evaluation of Visual Function After Bilateral Implantation of Two Types of Presbyopia-correcting IOLs|A Randomised, Subject-masked Evaluation of Visual Function After Bilateral Implantation of Two Types of Presbyopia-correcting IOLs: the Symfony-study|Recruiting||N/A|30|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||No|No IPD will be shared|2017-10-10 21:09:54.494019|2017-10-10 21:09:54.494019
NCT03117413|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-11|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|UniTEP||Positron Emission Tomography Imaging of Brain Reorganisation of the Central Auditory Cortex in Asymetrical Profound Deaf Patient With a Cochlear Implantation.|Positron Emission Tomography Imaging of Brain Reorganisation of the Central Auditory Cortex in Asymetrical Profound Deaf Patient With a Cochlear Implantation|Not yet recruiting||N/A|20|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-10 21:09:54.588551|2017-10-10 21:09:54.588551
NCT03117400|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-19|||May 2, 2013|Actual|2013-05-02|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|November 2016|Actual|2016-11-01||Observational|||Systematic Description of the Post EMR Defect|Visible Vessels do Not Predict Clinically Significant Bleeding After EMR - a Systematic Description of the Post EMR Defect|Completed||N/A|482|Actual|Western Sydney Local Health District|||2||f||||t|f|f||||||No||2017-10-10 21:09:54.681545|2017-10-10 21:09:54.681545
NCT03117387|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-12|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of the TOF CUFF for Perioperative Neuromuscular Transmission|Evaluation of the TOF CUFF for Perioperative Neuromuscular Transmission Monitoring During Recovery of Moderate and Deep Neuromuscular Block Compared to Acceleromyography and Electromyography|Not yet recruiting||N/A|200|Anticipated|Leiden University Medical Center|||4||f|||||f|f||||||||2017-10-10 21:09:54.741433|2017-10-10 21:09:54.741433
NCT03117374|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-12|||September 9, 2011|Actual|2011-09-09|April 2017|2017-04-01|August 30, 2013|Actual|2013-08-30|June 23, 2013|Actual|2013-06-23||Interventional|||Impact of Web-based School Nutrition Intervention to Increase Fruits, Vegetables and Dairy|The Impact of an Innovative Web-based School Nutrition Intervention to Increase Fruits and Vegetables and Dairy Products in Adolescents|Completed||N/A|282|Actual|Laval University||2|||f|||||f|f||||||No||2017-10-10 21:09:54.813497|2017-10-10 21:09:54.813497
NCT03117361|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-06-09|||November 15, 2016|Actual|2016-11-15|April 2017|2017-04-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2019|Anticipated|2019-05-15||Interventional|||Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide|Phase II Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide|Recruiting||Phase 2|64|Anticipated|PharmaMar||1|||f||||f||f||||||||2017-10-10 21:09:54.872321|2017-10-10 21:09:54.872321
NCT03117348|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-15|||April 15, 2017|Actual|2017-04-15|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|June 30, 2018|Anticipated|2018-06-30||Interventional|GIGENAS||Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients|Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients: A Clinical Randomized Controlled Trial|Recruiting||N/A|196|Anticipated|Jinling Hospital, China||2|||f||||t|f|f|||f|||No||2017-10-10 21:09:55.002444|2017-10-10 21:09:55.002444
NCT03117335|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-12|||November 10, 2011|Actual|2011-11-10|April 2017|2017-04-01|January 17, 2017|Actual|2017-01-17|November 14, 2016|Actual|2016-11-14||Interventional|||Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer|Recombinant Endostatin With Vinorelbine and Cisplatin (NP) Plus Maintenance Therapy With Recombinant Endostatin for Advanced Non-small Cell Lung Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study|Completed||Phase 3|560|Actual|Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.||2|||f||||f|f|f|||f|||No||2017-10-10 21:09:55.133218|2017-10-10 21:09:55.133218
NCT03117322|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-26|||June 5, 2017|Actual|2017-06-05|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Synbiotic, Prebiotics and Probiotics in Children With Cerebral Palsy and Constipation|Efficacy of the Supplementation With a Symbiotic, a Prebiotic and a Probiotic to Produce a Beneficial Effect on the Intestinal Microbiota and on the Characteristics of Feces in Children With Cerebral Palsy (CP) and Chronic Constipation|Recruiting||Phase 4|40|Anticipated|Hospital Civil Juan I. Menchaca||4|||f||||f|f|f|||f|||||2017-10-10 21:09:55.414152|2017-10-10 21:09:55.414152
NCT03117309|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-08|||April 24, 2017|Actual|2017-04-24|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma|Phase II Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma. HCRN: GU16-260|Recruiting||Phase 2|120|Anticipated|Hoosier Cancer Research Network||2|||f||||t|t|f|||t|||||2017-10-10 21:09:55.550478|2017-10-10 21:09:55.550478
NCT03117296|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-14|||December 3, 2014|Actual|2014-12-03|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|July 31, 2015|Actual|2015-07-31|30 Days|Observational [Patient Registry]|PTOTtAVR||Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement|Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement|Enrolling by invitation||N/A|400|Anticipated|Henry Ford Health System|||2||f||||f|f|f||||||Yes|Shared internally on a secure intranet via REDcap or Excel database with identifying information removed.|2017-10-10 21:09:55.675313|2017-10-10 21:09:55.675313
NCT03117283|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-12|||March 28, 2017|Actual|2017-03-28|April 2017|2017-04-01|April 1, 2022|Anticipated|2022-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Laparoscopic Total Gastrectomy With Versus Without Bursectomy|Laparoscopic Total Gastrectomy With Bursectomy in a Left Outside Bursa Omentalis Approach Versus Laparoscopic Total Gastrectomy Without Bursectomy for Advanced Posterior Gastric Wall Cancer: a Randomized Controlled Study|Recruiting||Phase 2|56|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||t|f|f||||||No|The data has not been published.|2017-10-10 21:09:55.768499|2017-10-10 21:09:55.768499
NCT03117270|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-10-03|||March 7, 2017|Actual|2017-03-07|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|TORTUGA||A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis|A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Study to Assess the Efficacy and Safety of Filgotinib Administered for 12 Weeks to Subjects With Active Ankylosing Spondylitis|Recruiting||Phase 2|100|Anticipated|Galapagos NV||2|||f||||t|f|f||||||||2017-10-10 21:09:55.880231|2017-10-10 21:09:55.880231
NCT03117257|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-14|||August 19, 2016|Actual|2016-08-19|April 2017|2017-04-01|August 20, 2021|Anticipated|2021-08-20|August 19, 2019|Anticipated|2019-08-19||Interventional|||Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN|A Prospective Phase II Randomized Clinical Trial: Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Lobaplatin Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 2|144|Anticipated|Guiyang Medical University||2|||f||||t|f|f||||||No||2017-10-10 21:09:56.009189|2017-10-10 21:09:56.009189
NCT03117244|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-14|||December 12, 2016|Actual|2016-12-12|April 2016|2016-04-01|December 10, 2019|Anticipated|2019-12-10|December 10, 2017|Anticipated|2017-12-10||Interventional|||The Effectiveness of a Protocol for Muscular Foot Strengthening On a Capacity to Control the Deformation of the DOT Plantar Medial|A Protocol for Muscular Foot Strengthening On a Capacity to Control the Deformation of the DOT Plantar Medial|Recruiting||N/A|60|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||3|||f|||||f|f||||||||2017-10-10 21:09:56.099418|2017-10-10 21:09:56.099418
NCT03117218|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-16|||July 1, 2014|Actual|2014-07-01|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Correlation Between Quantitative Analysis of Coronary MRA and FFR|Quantitative Analysis of 3T Whole Heart Coronary Magnetic Resonance Angiogram Improves Detection of Functionally Significant Coronary Artery Disease|Recruiting||N/A|89|Anticipated|Seoul National University Bundang Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:09:56.271446|2017-10-10 21:09:56.271446
NCT03117205|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-14|||December 10, 2014|Actual|2014-12-10|September 2014|2014-09-01|January 23, 2017|Actual|2017-01-23|December 10, 2016|Actual|2016-12-10||Interventional|||The Effect of Kinesio Taping® on Motor Control in Patients With Patellofemoral Pain Syndrome|The Effect of Kinesio Taping® on Motor Control in Patients With Patellofemoral Pain Syndrome|Completed||N/A|40|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f|||||f|f||||||||2017-10-10 21:09:56.343275|2017-10-10 21:09:56.343275
NCT03117192|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-12|||September 1, 2013|Actual|2013-09-01|April 2017|2017-04-01|February 1, 2014|Actual|2014-02-01|February 1, 2014|Actual|2014-02-01||Interventional|||Zinc Supplementation on Cellular Immunity in Thalassemia Major|Zinc Supplementation on Cellular Immunity in Thalassemia Major|Completed||Phase 4|58|Actual|Fakultas Kedokteran Universitas Indonesia||2|||f||||f|f|f||||||No||2017-10-10 21:09:56.407016|2017-10-10 21:09:56.407016
NCT03117179|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-11|||November 26, 2013|Actual|2013-11-26|May 2017|2017-05-01|May 25, 2018|Anticipated|2018-05-25|May 25, 2018|Anticipated|2018-05-25||Interventional|||Patient Follow-up After Consultation in Emergency Department|Patient Follow-up After Consultation in Emergency Department|Recruiting||N/A|389|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:09:56.480219|2017-10-10 21:09:56.480219
NCT03117166|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-05-08|||January 2010|Actual|2010-01-01|May 2017|2017-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing|Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing|Terminated||Phase 1/Phase 2|19|Actual|Drexel University||2||multidisciplinary participation could not be overcome.|f||||t|t|f|||t|||No||2017-10-10 21:09:56.552198|2017-10-10 21:09:56.552198
NCT03117153|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-12|||August 4, 2014|Actual|2014-08-04|April 2017|2017-04-01|February 11, 2015|Actual|2015-02-11|September 15, 2014|Actual|2014-09-15||Interventional|||Effect of a Liquid Toothpaste on Periodontal Disease|Effect of a Liquid Toothpaste on Periodontal Disease : a Randomized, Double-blind, Placebo-controlled Study|Completed||N/A|98|Actual|Dong-A Pharmaceutical||2|||f|||||f|f||||||No||2017-10-10 21:09:56.629397|2017-10-10 21:09:56.629397
NCT03117140|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-07-03|||December 2013||2013-12-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block|A Prospective Triple-masked Randomized Controlled Trial Measuring Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block|Completed||Phase 4|160|Actual|University of Iowa||4|||f||||t||||||||||2017-10-10 21:09:56.706267|2017-10-10 21:09:56.706267
NCT03117127|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-14|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Muscle Protein Synthesis After Whole Egg vs. Egg White Consumption|The Consumption of Whole Eggs Versus Egg Whites to Stimulate Postprandial Muscle Protein Synthesis|Active, not recruiting||N/A|10|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||t|f|f||||||No||2017-10-10 21:09:56.82943|2017-10-10 21:09:56.82943
NCT03117114|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-13|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|EVASTA||Endocuff Vision Assisted vs. Standard Polyp Resection in the Colorectum|Endocuff Vision Assisted vs. Standard Polyp Resection in the Colorectum|Not yet recruiting||N/A|250|Anticipated|Technische Universität München||2|||f||||f|f|f||||||No||2017-10-10 21:09:57.029462|2017-10-10 21:09:57.029462
NCT03117101|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-04-14|||March 2014||2014-03-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study of the AL3810 in the Treatment of Advanced Solid Tumor|An Open-label, Dose-finding Phase I Study to Determine the Maximum Tolerated Dose, Recommended Dose, Pharmacokinetics, Pharmacodynamics of the Dual -VEGFR-FGFR Tyrosine Kinase Inhibitor, AL3810, Givenorally as Single Agent to Patients With Advanced Solid Tumours|Completed||Phase 1|17|Actual|ShangHai HaiHe Pharmaceutical||1|||f||||t||||||||Undecided||2017-10-10 21:09:57.147479|2017-10-10 21:09:57.147479
NCT03117088|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-05|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|Safe-SCOPE||Safe-SCOPE Pilot Study|Safe-SCOPE Pilot Study: Standardized Checklist Of Patient Information Exchange|Recruiting||N/A|7|Anticipated|RWTH Aachen University||2|||f||||f|f|f||||||||2017-10-10 21:09:57.248973|2017-10-10 21:09:57.248973
NCT03117075|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-04-12|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|April 14, 2018|Anticipated|2018-04-14|November 14, 2017|Anticipated|2017-11-14||Interventional|pain||The Efficacy of Pain Management With Self-reporting Pain Monitoring System in Cancer Patient|The Efficacy of Pain Management With Self-reporting Pain Monitoring|Not yet recruiting||N/A|68|Anticipated|The Catholic University of Korea||1|||f||||f|f|f||||||No||2017-10-10 21:09:57.388115|2017-10-10 21:09:57.388115
NCT03117062|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-12|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Occlusal Reduction and Postoperative Pain|Evaluation of Postoperative Pain Intensity Following Occlusal Reduction in Teeth Associated With Symptomatic Irreversible Pulpitis and Symptomatic Apical Periodontitis: A Randomized Clinical Study|Completed||N/A|44|Actual|Cairo University||2|||f|||||f|f||||||No|IPD data are confidential and secured. Only accessed by principal investigator and supervisors|2017-10-10 21:09:57.473837|2017-10-10 21:09:57.473837
NCT03117049|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-05|||June 13, 2017|Actual|2017-06-13|April 2017|2017-04-01|July 2022|Anticipated|2022-07-01|April 2020|Anticipated|2020-04-01||Interventional|||Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer|A Multicenter, Randomized, Double-Blind Trial in Subjects With Non-Squamous Non-Small Cell Lung Cancer|Recruiting||Phase 3|530|Anticipated|Ono Pharmaceutical Co. Ltd||2|||f||||t|f|f||||||||2017-10-10 21:09:57.567115|2017-10-10 21:09:57.567115
NCT03117036|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-18|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|February 28, 2022|Anticipated|2022-02-28|February 28, 2022|Anticipated|2022-02-28|3 Years|Observational [Patient Registry]|||Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III|A Prospective Study for Patients With Lymphoid Malignancy at the Samsung Medical Center|Recruiting||N/A|600|Anticipated|Samsung Medical Center|||1||f||||f|f|f||||Samples With DNA|"     serum and cell-free DNA from patients' peripheral blood   "|Undecided||2017-10-10 21:09:57.764089|2017-10-10 21:09:57.764089
NCT03117023|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-14|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|June 1, 2017|Anticipated|2017-06-01|May 15, 2017|Anticipated|2017-05-15||Interventional|||The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer|The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer: A Prospective Randomized Clinical Trial|Not yet recruiting||Phase 3|50|Anticipated|Nanjing PLA General Hospital||2|||f||||f|f|f||||||||2017-10-10 21:09:57.865654|2017-10-10 21:09:57.865654
NCT03117010|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-12|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2020|Anticipated|2020-12-31|3 Years|Observational [Patient Registry]|||Prospective Cohort for Adult Hemophagocytosis|A Prospective Cohort for Subjects With Adult Hemophagocytic Lymphohistiocytosis Like Syndrome|Recruiting||N/A|81|Anticipated|Samsung Medical Center|||1||f||||f|f|f||||Samples With DNA|"     1. Serum sample collection will be done as follows: Baseline, 4 weeks after treatment,          Relapse or progression        2. Germline DNA collection from peripheral blood will be done at the enrollment   "|Undecided||2017-10-10 21:09:57.938261|2017-10-10 21:09:57.938261
NCT03116997|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-27|||April 7, 2017|Actual|2017-04-07|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant|Randomized Controlled Assessor Blinded Clinical Trial of Sugammadex Versus Neostigmine /Glycopyrrolate for Reversal of Rocuronium Induced Neuromuscular Blockade: Time to Discharge From Post Anesthesia Care Unit and Patient Satisfaction With Recovery|Recruiting||Phase 3|202|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f|||t|||||2017-10-10 21:09:58.036002|2017-10-10 21:09:58.036002
NCT03116984|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-11|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|May 28, 2019|Anticipated|2019-05-28||Interventional|TACE-EBRT||A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC|A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for HCC Which is Unresectable But Confined to the Liver|Recruiting||Phase 3|300|Anticipated|Shanghai Zhongshan Hospital||2|||f|||||f|f||||||No||2017-10-10 21:09:58.133365|2017-10-10 21:09:58.133365
NCT03116971|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-28|||May 25, 2017|Actual|2017-05-25|September 2017|2017-09-01|January 31, 2021|Anticipated|2021-01-31|November 20, 2019|Anticipated|2019-11-20||Interventional|||Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)|A Multicenter Study With an Open Label Phase Ib Part Followed by a Randomized, Placebo-controlled, Double-blind, Phase II Part to Evaluate Efficacy, Safety, Tolerability, and PK of M3814 in Combination With Etoposide and Cisplatin in Subjects With Treatment-naïve Small Cell Lung Cancer (SCLC) Extensive Disease (ED)|Recruiting||Phase 1/Phase 2|183|Anticipated|EMD Serono||3|||f||||t|t|f||||||||2017-10-10 21:09:58.289843|2017-10-10 21:09:58.289843
NCT03116958|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-11|||November 2016||2016-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|MyOSA||MyOSA : Management and Treatment of Patients With Obstructive Sleep Apnea Syndrome(OSAS) Through a Telemedicine System|MyOSA : Management and Treatment of Patients With Obstructive Sleep Apnea Syndrome(OSAS) Through a Telemedicine System|Recruiting||N/A|60|Anticipated|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||f||||||||No||2017-10-10 21:09:58.61089|2017-10-10 21:09:58.61089
NCT03116932|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-11|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|||Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part A|Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part A|Enrolling by invitation||N/A|225|Actual|Puerto Rico Community Network for Clinical Research on AIDS|||1||f||||f|f|f|||t|None Retained|"     Dried Blood Spots are obtained at 2 time points for participants in part B in order to assess     adequate drug levels are retained for bulk shipping for processing at collaborating lab.   "|Undecided||2017-10-10 21:09:58.797099|2017-10-10 21:09:58.797099
NCT03116919|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-14|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|January 2021|Anticipated|2021-01-01|July 2020|Anticipated|2020-07-01||Interventional|PHRIES||Potatoes, Hypertension RIsk and Endothelial Function Study|Potatoes, Hypertension RIsk and Endothelial Function Study|Not yet recruiting||N/A|90|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:09:58.862375|2017-10-10 21:09:58.862375
NCT03116906|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-10-02|||April 24, 2017|Actual|2017-04-24|October 2017|2017-10-01|November 7, 2017|Anticipated|2017-11-07|November 7, 2017|Anticipated|2017-11-07||Interventional|||Safety and Tolerability of BI 685509 in Healthy Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 685509 in Healthy Male Subjects|Recruiting||Phase 1|36|Anticipated|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 21:09:58.925558|2017-10-10 21:09:58.925558
NCT03116893|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-06-06|||April 19, 2017|Actual|2017-04-19|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect|Effect of P-gp Inhibition, OATP-inhibition and Food on the Kinetics of a Single Oral Dose BI 685509 in Healthy Male Subjects|Completed||Phase 1|15|Actual|Boehringer Ingelheim||4|||f||||f|f|f||||||No||2017-10-10 21:09:59.001195|2017-10-10 21:09:59.001195
NCT03116880|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-09|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||In Vivo Evaluation of Image Registration Techniques During Endovascular Repair|In Vivo Evaluation of Image Registration Techniques During Endovascular Repair|Recruiting||N/A|10|Anticipated|Norwegian University of Science and Technology|||1||f||||f|f|f||||||Undecided||2017-10-10 21:09:59.076322|2017-10-10 21:09:59.076322
NCT03116867|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-12|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Sonosalpingography After Hysteroscopic Tubal Occlusion|Sonosalpingography in Assessment of Efficacy of Hysteroscopic Tubal Occlusion by Roller Ball Electrode|Recruiting||N/A|56|Anticipated|Ain Shams University|||1||f||||f|f|f||||||No||2017-10-10 21:09:59.252817|2017-10-10 21:09:59.252817
NCT03116854|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-12|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Observational|UPB-ACS||Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China|Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China：a Prospective, Multicenter, Observational Research|Recruiting||N/A|3000|Anticipated|Henan Institute of Cardiovascular Epidemiology|||1||f||||t|f|f||||||||2017-10-10 21:09:59.336658|2017-10-10 21:09:59.336658
NCT03116841|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-08-28|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|VISTAEXE||Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation|Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation (VISTAEXE)|Recruiting||Phase 4|25|Anticipated|Takeda||1|||f||||f|f|f||||||||2017-10-10 21:09:59.423758|2017-10-10 21:09:59.423758
NCT03116828|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-25|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|February 11, 2019|Anticipated|2019-02-11|February 11, 2019|Anticipated|2019-02-11||Interventional|||A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures|Efficacy and Safety of Eslicarbazepine Acetate as First Add-on to Levetiracetam or Lamotrigine Monotherapy or as Later Adjunctive Treatment for Subjects With Uncontrolled Partial-onset Seizures: A Multicenter, Open-label, Non-randomized Trial|Recruiting||Phase 4|190|Anticipated|Sunovion||2|||f||||f|t|f||||||||2017-10-10 21:09:59.537117|2017-10-10 21:09:59.537117
NCT03116815|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-24|||May 16, 2017|Actual|2017-05-16|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|May 16, 2018|Anticipated|2018-05-16||Interventional|||The Feasibility of a Web-based Application to Monitor Home Blood Pressure|The Feasibility of a Web-based Application to Monitor Home Blood Pressure|Active, not recruiting||N/A|20|Actual|Loyola University||1|||f||||f|f|f||||||||2017-10-10 21:09:59.680067|2017-10-10 21:09:59.680067
NCT03116802|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-11|||March 8, 2017|Actual|2017-03-08|April 2017|2017-04-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Yellow Fever Vaccine on Statin/ Non Statin Subjects|Using Systems Vaccinology to Elucidate the Effects of Anti-inflammatory Therapy on Immune Response After Vaccination With a Live Attenuated Vaccine|Recruiting||Phase 2|70|Anticipated|Singapore General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:09:59.768452|2017-10-10 21:09:59.768452
NCT03116789|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-10-02|||April 11, 2017|Actual|2017-04-11|October 2017|2017-10-01|April 10, 2019|Anticipated|2019-04-10|January 10, 2019|Anticipated|2019-01-10||Interventional|||Analysis of Ameliorative Effects of Oral Probiotics on Bacterial Vaginosis|Analysis of Ameliorative Effects of Oral Probiotics on Bacterial Vaginosis|Recruiting||N/A|80|Anticipated|GenMont Biotech Incorporation||2|||f||||f|f|f||||||||2017-10-10 21:09:59.877379|2017-10-10 21:09:59.877379
NCT03116776|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-08-13|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|November 6, 2017|Anticipated|2017-11-06||Interventional|||Walnut Shell Glasses Moxibustion for Dry Eye Syndrome|Walnut Shell Glasses Moxibustion for Dry Eye Syndrome: a Randomized Controlled Trial|Recruiting||N/A|128|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 21:09:59.980364|2017-10-10 21:09:59.980364
NCT03116763|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-11|||March 28, 2017|Actual|2017-03-28|April 2017|2017-04-01|September 30, 2019|Anticipated|2019-09-30|May 31, 2019|Anticipated|2019-05-31||Interventional|iPeer2Peer||The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis|The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis: A Randomized Controlled Trial|Recruiting||N/A|262|Anticipated|The Hospital for Sick Children||2|||f||||f|f|f||||||||2017-10-10 21:10:00.102862|2017-10-10 21:10:00.102862
NCT03116750|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-11|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|April 30, 2021|Anticipated|2021-04-30|October 30, 2018|Anticipated|2018-10-30||Observational|P-MAX||Post-Market Clinical Follow-up Study With ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT|Post-Market Clinical Follow-up Study With the ASPIREX®S Endovascular System to Assess the Safety and Effectiveness in the Treatment of DVT Patients and Special Patient Groups|Recruiting||N/A|80|Anticipated|Straub Medical AG|||1||f||||f|f|f||||||No||2017-10-10 21:10:00.227498|2017-10-10 21:10:00.227498
NCT03116724|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-22|||October 27, 2016|Actual|2016-10-27|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Direct Measurement of Ideal Depth of Central Line|Direct Measurement of Ideal Depth of Central Line for Right Internal Jugular Venous Catheterization in Adults|Completed||N/A|89|Actual|Keimyung University Dongsan Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:10:00.420568|2017-10-10 21:10:00.420568
NCT03116711|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-11|||November 1, 2013|Actual|2013-11-01|March 2017|2017-03-01|July 1, 2015|Actual|2015-07-01|July 1, 2015|Actual|2015-07-01||Interventional|Curves3||Effects of Diet Selection Based on Genetic Screening on Success to a Weight Loss Program|Effects of Diet Type Selection Based on Response to a Carbohydrate Intolerance Questionnaire and Genetic Screening on Success to a Weight Loss and Exercise Program|Completed||N/A|51|Actual|Texas A&M University||4|||f||||t|f|f||||||No||2017-10-10 21:10:00.500966|2017-10-10 21:10:00.500966
NCT03116698|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-05-26|||February 14, 2017|Actual|2017-02-14|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Evaluate the Dose-Response Relationship of the Efficacy and Safety of Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period|Recruiting||Phase 2/Phase 3|240|Anticipated|Dr. Reddy's Laboratories Limited||4|||f||||f|t|f||||||No||2017-10-10 21:10:00.604266|2017-10-10 21:10:00.604266
NCT03116685|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-14|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria|A Phase III Double-blind, Randomised Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria|Not yet recruiting||Phase 3|18|Anticipated|OxThera||2|||f|||||t|f||||||||2017-10-10 21:10:00.767066|2017-10-10 21:10:00.767066
NCT03116672|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-14|||February 2, 2016|Actual|2016-02-02|April 2017|2017-04-01|February 10, 2017|Actual|2017-02-10|February 6, 2017|Actual|2017-02-06||Interventional|PreOp||The Outcome of Preoperative Administration of Single-dose Ketorolac, Non-steroidal Anti-inflammatory Drug and Placebo|The Outcome of Preoperative Administration of Single-dose Ketorolac, Non-steroidal Anti-inflammatory Drug and Placebo on Postoperative Pain in Teeth With Irreversible Pulpitis and Apical Periodontitis|Completed||N/A|3|Actual|Universidad Autonoma de Baja California||3|||f||||t|f|f||||||Yes|Invitation to participate. Offer to the public All the clinical procedure and risks were explained to each participant.|2017-10-10 21:10:00.838019|2017-10-10 21:10:00.838019
NCT03116659|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-29|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|June 30, 2018|Anticipated|2018-06-30||Interventional|||CTCL Directed Therapy|CTCL Directed Therapy|Recruiting||Early Phase 1|8|Anticipated|James J. Peters Veterans Affairs Medical Center||1|||f|||||t|f|||t|||||2017-10-10 21:10:00.936142|2017-10-10 21:10:00.936142
NCT03116646|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-08|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|September 1, 2017|Actual|2017-09-01||Interventional|||The Reliability and Validity of Family Report Chewing Evaluation|The Reliability and Validity of Family Report Chewing Evaluation|Completed||N/A|50|Actual|Hacettepe University||1|||f||||t|f|f||||||||2017-10-10 21:10:01.029936|2017-10-10 21:10:01.029936
NCT03116633|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-08-15|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy|An Observational Multicenter Study to Evaluate the Performance and Utility of Inivata Liquid Biopsy Analysis Compared With Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Lung Cancer|Recruiting||N/A|260|Anticipated|Inivata|||3||f||||f|f|f||||||||2017-10-10 21:10:01.109034|2017-10-10 21:10:01.109034
NCT03116620|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-15|||April 15, 2017|Actual|2017-04-15|August 2017|2017-08-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||Chewing Function in Pediatric Neuromuscular Disorders|Chewing Function in Pediatric Neuromuscular Disorders|Completed||N/A|68|Actual|Hacettepe University||1|||f||||t|f|f||||||||2017-10-10 21:10:01.227958|2017-10-10 21:10:01.227958
NCT03116607|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-18|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmaceutical Intervention Program at Readmission and User Satisfaction in a Emergency Department|Impact of a Pharmaceutical Intervention Program at Readmission and User Satisfaction in a Emergency Department, Randomized Clinical Study|Completed||N/A|1001|Actual|University of Chile||2|||f||||t|f|f||||||No||2017-10-10 21:10:01.308914|2017-10-10 21:10:01.308914
NCT03116594|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-12|||January 3, 2014|Actual|2014-01-03|April 2017|2017-04-01|March 7, 2015|Actual|2015-03-07|April 8, 2014|Actual|2014-04-08||Interventional|||Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over|A Multi-center, Randomized, Double Blinded, Parallel-group Study to Assess the Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over|Completed||Phase 2/Phase 3|675|Actual|SK Chemicals Co.,Ltd.||3|||f||||f|f|f||||||No||2017-10-10 21:10:01.388753|2017-10-10 21:10:01.388753
NCT03116581|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-11|||February 3, 2014|Actual|2014-02-03|March 2017|2017-03-01|July 22, 2016|Actual|2016-07-22|July 22, 2016|Actual|2016-07-22||Interventional|||Altruistic Decisions|Study on the Parameters That Influence Perceptual Decisions|Terminated||N/A|159|Actual|Hospices Civils de Lyon||2||Insufficient on-site staff to manage study|f|||||f|f||||||||2017-10-10 21:10:01.490173|2017-10-10 21:10:01.490173
NCT03116568|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-28|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|September 27, 2027|Anticipated|2027-09-27|April 14, 2022|Anticipated|2022-04-14||Observational|||Bacterial Transmission In Utero and IBD Risk|A Prospective Study of Pregnant Women With and Without IBD in Order to Better Understand the Patterns of Bacterial Transmission From the Mother to the Baby (Bacterial Transmission In Utero and IBD Risk)|Recruiting||N/A|180|Anticipated|Chinese University of Hong Kong|||2||f|||||f|f||||Samples With DNA|"     Stool, meconium, placenta, saliva and cord blood.   "|||2017-10-10 21:10:01.589531|2017-10-10 21:10:01.589531
NCT03116555|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-16|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|March 2019|Anticipated|2019-03-01||Interventional|||Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA|A Prospective, Multicenter Clinical Study of Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in Locally Advanced or Metastatic Gastric or Gastroesophageal Junctional Adenocarcinoma|Recruiting||Phase 2|66|Anticipated|China Medical University, China||2|||f||||t|f|f||||||||2017-10-10 21:10:01.684941|2017-10-10 21:10:01.684941
NCT03116542|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-24|||May 7, 2017|Actual|2017-05-07|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|PMF/ET-FLT||18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia|A Study of 18F-FLT Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Cases of Prefibrotic/Early Primary Myelofibrosis (PMF) and Essential Thrombocythemia (ET)|Recruiting||N/A|21|Anticipated|Hamad Medical Corporation||1|||f||||t|f|t|f|f|t|||||2017-10-10 21:10:01.869886|2017-10-10 21:10:01.869886
NCT03116529|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-06-21|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|NEXIS||Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma|Neoadjuvant Anti-PD-L1 (Durvalumab/MEDI4736) Plus Anti-CTLA-4 (Tremelimumab) and Radiation for High Risk Soft-Tissue Sarcoma|Recruiting||Phase 1/Phase 2|35|Anticipated|University of Maryland||1|||f||||t|t|f||||||Undecided||2017-10-10 21:10:02.037384|2017-10-10 21:10:02.037384
NCT03116516|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-12|||April 21, 2017|Actual|2017-04-21|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin|A Randomized, Open-label, Single Dose, Crossover Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin in Healthy Volunteers|Recruiting||Phase 1|180|Anticipated|Yuhan Corporation||2|||f||||f|f|f||||||||2017-10-10 21:10:02.218996|2017-10-10 21:10:02.218996
NCT03116503|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-11|||June 2016||2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Bipolarity - Depression in Children and Adolescent Suicide Attempters: Better Diagnosis to Prevent Recurrence|Bipolarity - Depression in Children and Adolescent Suicide Attempters: Better Diagnosis to Prevent Recurrence|Recruiting||N/A|100|Anticipated|Fondation Lenval||1|||f||||f||||||||No||2017-10-10 21:10:02.354963|2017-10-10 21:10:02.354963
NCT03116490|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-04-14|||January 16, 2017|Actual|2017-01-16|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||The Effects of Anesthesia Type on the Prognosis of Hip Fracture Surgery on Elderly Patients|The Comparative Effects of Regional or General Anesthesia on the Prognosis of Hip Fracture Surgery on Elderly Patients|Recruiting||N/A|600|Anticipated|Wenzhou Medical University|||2||f||||t||||||||||2017-10-10 21:10:02.48643|2017-10-10 21:10:02.48643
NCT03116464|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-22|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|April 15, 2019|Anticipated|2019-04-15|April 16, 2018|Anticipated|2018-04-16||Interventional|||Family Telemental Health Intervention for Veterans With Dementia|Family Telemental Health Intervention for Veterans With Dementia|Recruiting||N/A|20|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 21:10:02.617231|2017-10-10 21:10:02.617231
NCT03116451|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-11|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|May 1, 2017|Anticipated|2017-05-01||Interventional|||Nurses' Foot Health and Work Well-being|Nurses' Foot Health and Work Well-being - Development and Testing of an Electronic Foot Health Program|Recruiting||N/A|260|Anticipated|University of Turku||2|||f||||f|f|f||||||No||2017-10-10 21:10:02.6926|2017-10-10 21:10:02.6926
NCT03116438|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-14|||June 16, 2017|Anticipated|2017-06-16|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|SOLDIER||CADence Performance as a Rule-Out Modality in Long Beach Veterans Administration Heart Catheterization Lab Patients|CADence Performance as a Rule-Out Modality in Long Beach Veterans Administration Heart Catheterization Lab Patients|Not yet recruiting||N/A|100|Anticipated|VA Long Beach Healthcare System||1|||f|||||f|f||||||||2017-10-10 21:10:02.927721|2017-10-10 21:10:02.927721
NCT03116425|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-11|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|December 30, 2020|Anticipated|2020-12-30|October 30, 2020|Anticipated|2020-10-30||Interventional|RETONIC||Personalized Non-invasive Neuromodulation by rTMS for Chronic and Treatment Resistant Catatonia|Personalized Non-invasive Neuromodulation by rTMS for Chronic and Treatment Resistant Catatonia - A Proof of Concept Study|Recruiting||N/A|24|Anticipated|University Hospital, Strasbourg, France||3|||f||||f|f|f||||||No||2017-10-10 21:10:03.057525|2017-10-10 21:10:03.057525
NCT03116412|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-11|||April 20, 2017|Anticipated|2017-04-20|April 2017|2017-04-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2024|Anticipated|2024-12-31||Interventional|TRIM||A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma|A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma|Not yet recruiting||N/A|1300|Anticipated|Uppsala University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:03.216297|2017-10-10 21:10:03.216297
NCT03116399|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-21|||April 20, 2017|Actual|2017-04-20|August 2017|2017-08-01|October 31, 2019|Anticipated|2019-10-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||PRISM 2.0: Field Trial|PRISM 2.0: Field Trial|Recruiting||N/A|258|Anticipated|University of Miami||2|||f||||t|f|f||||||||2017-10-10 21:10:03.35211|2017-10-10 21:10:03.35211
NCT03116386|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-14|||January 20, 2017|Actual|2017-01-20|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|NoDelayFall||Time Spent on Floor After Falls of Frailty People Overnight|Reduced Time on Floor After Falls at Night of People Living in Long Term Care Facilities - NoDelayFall Study|Active, not recruiting||N/A|120|Anticipated|Centre Hospitalier de la Région d'Annecy||3|||f|||||f|f||||||No||2017-10-10 21:10:03.459364|2017-10-10 21:10:03.459364
NCT03116373|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-06-12|||May 29, 2017|Actual|2017-05-29|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|Fix-IOT||Impact of Tracheal Tube Fixing Site on Its Mobility During Head Mobilization|Impact of Tracheal Tube Fixing Site on Its Mobility During Head Mobilization|Recruiting||N/A|36|Anticipated|University Hospital, Brest||2|||f||||f|f|f||||||No||2017-10-10 21:10:03.562878|2017-10-10 21:10:03.562878
NCT03116360|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-11|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of Ultrasound and X-ray as Screening Tests for Diagnosis of Lower Extremity Stress Fracture.|Comparison of Ultrasound and X-ray as Screening Tests for Diagnosis of Lower Extremity Stress Fracture|Not yet recruiting||N/A|200|Anticipated|University of Virginia||1|||f||||f|f|f||||||No||2017-10-10 21:10:03.661874|2017-10-10 21:10:03.661874
NCT03116334|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-14|||September 2009|Actual|2009-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Genetic Influences Between Cognitive Function and BMI|Shared Genetic Influences Between Cognitive Function and Body Mass Index (BMI) in the Texas Twin Project|Completed||N/A|869|Actual|Baylor College of Medicine|||1||f||||f|f|f||||||No|This protocol involves secondary data analysis of existing studies. Data will not be shared with other investigators since they should obtain data from the primary sources.|2017-10-10 21:10:03.887087|2017-10-10 21:10:03.887087
NCT03116321|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-12|||December 3, 2016|Actual|2016-12-03|April 2017|2017-04-01|January 5, 2017|Actual|2017-01-05|January 5, 2017|Actual|2017-01-05||Interventional|||Bioequivalence of Two Different Sources of Eslicarbazepine Acetate|A Single Center, Single Dose, Open Label, Laboratory Blind, Randomized, Three Period, Six Sequence, Crossover Study to Determine the Bioequivalence of Two Different Sources of Eslicarbazepine Acetate (800 mg) and to Assess the Dose Equivalence of Two Different Dose Strengths of Eslicarbazepine Acetate (200 and 800 mg) in Healthy Subjects|Completed||Phase 1|24|Actual|Bial - Portela C S.A.||3|||f||||f|f|f||||||Undecided||2017-10-10 21:10:03.962858|2017-10-10 21:10:03.962858
NCT03116308|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-12|||November 21, 2014|Actual|2014-11-21|April 2017|2017-04-01|January 28, 2015|Actual|2015-01-28|January 28, 2015|Actual|2015-01-28||Interventional|||Effect of Food on Opicapone|Effect of Food on Opicapone Bioavailability and Pharmacodynamics in Healthy Subjects|Completed||Phase 1|28|Actual|Bial - Portela C S.A.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:10:04.057121|2017-10-10 21:10:04.057121
NCT03116295|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-07-24|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|July 21, 2017|Actual|2017-07-21||Interventional|||Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone|A Comparative, Randomized, Open-label, Fasted, Single-dose, 2-way Crossover Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone in Healthy Subjects|Active, not recruiting||Phase 1|56|Actual|Bial - Portela C S.A.||2|||f||||f|f|f||||||||2017-10-10 21:10:04.149514|2017-10-10 21:10:04.149514
NCT03116282|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-11|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|April 15, 2019|Anticipated|2019-04-15|April 15, 2019|Anticipated|2019-04-15||Interventional|||E-alcohol Therapy - an Evaluation of Alcohol Therapy Delivered Via Video Conference|E-alcohol Therapy - an Evaluation of Alcohol Therapy Delivered Via Video Conference|Not yet recruiting||N/A|375|Anticipated|University of Southern Denmark||2|||f||||t|f|f||||||No||2017-10-10 21:10:04.2445|2017-10-10 21:10:04.2445
NCT03116269|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-12|||March 1, 2012|Actual|2012-03-01|April 2017|2017-04-01|October 31, 2014|Actual|2014-10-31|October 31, 2014|Actual|2014-10-31||Interventional|PASS||The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients|The Effect of Cilostazol Compared to Aspirin on Endothelial Function Measured by Flow Mediated Dilatation in Acute Cerebral Ischemia Patients|Completed||Phase 4|80|Actual|Ajou University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:10:04.351942|2017-10-10 21:10:04.351942
NCT03116256|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-05|||January 9, 2017|Actual|2017-01-09|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|May 31, 2019|Anticipated|2019-05-31||Interventional|VLCDex||The Effect of Very Low Calorie Diet With and Without Exercise on Muscle Synthesis in Middle-aged Overweight Male.|The Effect of Very Low Calorie Diet (VLCD) With and Without Concomitant Resistance Exercise Training (RET) or High Intensity Interval Training (HIIT) on Muscle Protein Synthesis (MPS) in Middle-aged Overweight Male.|Recruiting||N/A|36|Anticipated|University of Nottingham||3|||f||||f|f|f||||||Undecided|No specific plan yet for data sharing.|2017-10-10 21:10:04.432521|2017-10-10 21:10:04.432521
NCT03116243|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-14|||March 4, 2017|Actual|2017-03-04|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|MSHS||Migrant and Seasonal Head Start Study|Migrant and Seasonal Head Start (MSHS) Study|Recruiting||N/A|3140|Anticipated|Abt Associates|||1||f|||||f|f||||||Yes|The MSHS Study team will prepare restricted use datasets and documentation, to be archived with a data storage site such as the Inter-university Consortium for Political and Social Research (ICPSR) at the University of Michigan, so that future researchers may use the MSHS Study data to replicate findings and explore new areas of inquiry.|2017-10-10 21:10:04.541105|2017-10-10 21:10:04.541105
NCT03116230|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Gait Modification Treatments for Knee Pathology|Analysis of Pain, Function, and Joint Mechanics in Response to Two Treatments for Knee Pathology|Not yet recruiting||N/A|40|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 21:10:04.621936|2017-10-10 21:10:04.621936
NCT03116217|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-28|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2022|Anticipated|2022-08-31||Interventional|Antenatal||Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves|Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves|Not yet recruiting||N/A|400|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||No||2017-10-10 21:10:04.714156|2017-10-10 21:10:04.714156
NCT02661191|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-01-18|||October 2012||2012-10-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|AVD||Vitamin D Deficiency and Asthma Exacerbation|Effect of Vitamin D Repletion on Asthma Exacerbation|Completed||N/A|119|Actual|University of Turin, Italy||1|||f||||f||||||||Undecided||2017-10-10 22:32:06.763496|2017-10-10 22:32:06.763496
NCT03116204|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-11|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Observational|SAS||Validation of a SOFMER Activity Scale|Validation of a Score Assessing Physical and Cognitive Activities of Patients in Follow-up Care and Rehabilitation Departments: the SOFMER Activity Score|Not yet recruiting||N/A|450|Anticipated|Hospices Civils de Lyon|||1||f||||f|f|f||||||No||2017-10-10 21:10:04.976239|2017-10-10 21:10:04.976239
NCT03116191|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-11|||February 23, 2017|Actual|2017-02-23|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects|Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects|Recruiting||Phase 2|120|Anticipated|Sanwa Kagaku Kenkyusho Co., Ltd.||4|||f|||||f|f||||||||2017-10-10 21:10:05.073092|2017-10-10 21:10:05.073092
NCT03116178|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-04-13|||March 2016||2016-03-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||PVI Based Intraoperative Fluid Management in Head and Neck Free Flap Reconstructive Surgeries|Pleth Variability Index Based Intraoperative Fluid Management in Head and Neck Free Flap Reconstructive Surgeries|Completed||N/A|80|Actual|Rajiv Gandhi Cancer Institute & Research Center, India||2|||f||||t||||||||No||2017-10-10 21:10:05.151766|2017-10-10 21:10:05.151766
NCT03116165|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-17|||April 18, 2017|Actual|2017-04-18|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Cognitive-Behavioural Therapy as a Preventive Treatment for Post Traumatic Stress Disorder|Cognitive-Behavioural Therapy as a Preventive Treatment for Post Traumatic Stress Disorder: An Randomized Controlled Trial in the Acute Trauma Care|Recruiting||N/A|352|Anticipated|Karolinska Institutet||2|||f||||t|f|f||||||||2017-10-10 21:10:05.228667|2017-10-10 21:10:05.228667
NCT03116152|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-13|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluate Efficacy and Safety of IBI308 and Paclitaxel/Irinotecan in Patients With Advanced/Metastatic Esophageal Squamous Cell Carcinoma|Efficacy and Safety Evaluation of IBI308 Versus Paclitaxel/Irinotecan in Patients With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment: a Randomized, Open-label, Multicenter, Phase 2 Study|Not yet recruiting||Phase 2|180|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||2|||f||||f|f|f||||||||2017-10-10 21:10:05.329761|2017-10-10 21:10:05.329761
NCT03116139|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-07|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|VQ/CT||Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT|1 R01 HL132358: The Contribution of Contrast Media Exposure to Acute Kidney Injury in Patients Evaluated for Pulmonary Embolism in the Emergency Care Setting: a Prospective, Randomized Trial|Recruiting||N/A|700|Anticipated|Indiana University||3|||f||||f|f|f||||||||2017-10-10 21:10:05.413193|2017-10-10 21:10:05.413193
NCT03116126|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-15|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|NorAD||Noradrenergic Add-on Therapy With Guanfacine|Randomised Clinical Trial of Noradrenergic Add-on Therapy With Extended-Release Guanfacine in Alzheimer's Disease|Not yet recruiting||Phase 3|160|Anticipated|Imperial College London||2|||f||||t|f|f|||f|||||2017-10-10 21:10:05.511133|2017-10-10 21:10:05.511133
NCT03116113|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-13|||March 16, 2017|Actual|2017-03-16|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|XIRIUS||A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa|A Dose Escalation, Phase 1/2 Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using an Adeno-Associated Viral Vector (AAV) Encoding Retinitis Pigmentosa GTPase Regulator (RPGR)|Recruiting||Phase 1/Phase 2|24|Anticipated|NightstaRx Limited||3|||f||||t|f|f||||||No||2017-10-10 21:10:05.616356|2017-10-10 21:10:05.616356
NCT03116100|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-25|||June 15, 2017|Anticipated|2017-06-15|April 2017|2017-04-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Observational|NEUGERPRAT||Clinical Situations Leading to the Prescription of Neuroleptics by General Practitioner in the Elderly. Practice Survey|Clinical Situations Leading to the Prescription of Neuroleptics by General Practitioner in the Elderly. Practice Survey|Not yet recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:10:05.698003|2017-10-10 21:10:05.698003
NCT03116087|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2017-04-13|||March 1, 2007|Actual|2007-03-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Testosterone Replacement in Postmenopausal Women With Stress Urinary Incontinence|Testosterone Replacement in Postmenopausal Women With Stress Urinary Incontinence|Active, not recruiting||N/A|60|Anticipated|Charles Drew University of Medicine and Science||2|||f||||t||||||||Yes|Plan to share IPD: Presentation (grand rounds, scientific meetings) and peer-reviewed publications.|2017-10-10 21:10:05.766659|2017-10-10 21:10:05.766659
NCT03116074|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-13|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|PDTK||Interactive Patient-Centered Discharge Toolkit|Interactive Patient-Centered Discharge Toolkit to Promote Self-Management During Transitions|Recruiting||N/A|500|Anticipated|Brigham and Women's Hospital||3|||f||||f|f|f||||||No||2017-10-10 21:10:05.856379|2017-10-10 21:10:05.856379
NCT03116061|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-14|||July 2014|Actual|2014-07-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01||Observational|||The Reported Frequency of FP Visits and Family Difficulties Should Alert FPs and Help Them to Prevent Severe Outcomes in Multimorbid Outpatients|The Frequency of Family Physician Visits and the Extent of Family Difficulties Reported by Family Physicians Appear to be Decompensation Risk Factors for Multimorbid Outpatients in a Primary Care Feasibility Study|Completed||N/A|96|Actual|University Hospital, Brest|||1||f||||f|f|f||||||No||2017-10-10 21:10:05.947871|2017-10-10 21:10:05.947871
NCT03116048|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-22|||May 2, 2017|Actual|2017-05-02|September 2017|2017-09-01|September 24, 2017|Anticipated|2017-09-24|June 12, 2017|Actual|2017-06-12||Interventional|||Evaluation of Persistent Postsurgical Pain After Breast Surgery With a Pectoral Nerves Block (Pecs) Type II|Evaluation of Persistent Postsurgical Pain After Breast Surgery With a Pectoral Nerves Block (Pecs) Type II: a Prospective Follow-up After a Prospective Double Blind Placebo-controlled Randomized Controlled Trail|Active, not recruiting||N/A|121|Actual|GZA Ziekenhuizen Campus Sint-Augustinus||2|||f||||f|f|f||||||||2017-10-10 21:10:06.011848|2017-10-10 21:10:06.011848
NCT03115684|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-13|||March 1, 2016|Actual|2016-03-01|April 2017|2017-04-01|May 30, 2016|Actual|2016-05-30|May 30, 2016|Actual|2016-05-30||Observational|||Pain Relief in the Emergency Department Waiting Room: a Prevalence Study|Antalgie à l'Accueil Des Urgences- étude de prévalence|Completed||N/A|2371|Actual|University Hospital, Geneva|||1||f||||f|f|f||||||||2017-10-10 21:10:09.43284|2017-10-10 21:10:09.43284
NCT03116035|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-12|||April 24, 2014|Actual|2014-04-24|April 2017|2017-04-01|May 1, 2017|Anticipated|2017-05-01|June 28, 2016|Actual|2016-06-28||Interventional|||Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-Making|A Randomized Controlled Trial Evaluating the Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-Making|Enrolling by invitation||N/A|244|Actual|University of Wisconsin, Madison||2|||f||||f|f|f||||||No||2017-10-10 21:10:06.084207|2017-10-10 21:10:06.084207
NCT03116022|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-12|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|January 31, 2019|Anticipated|2019-01-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women|Use of Estriol at Distal Third of the Vaginal Wall Relieving Coital Pain in Women After Menopause: a Randomized, Blinded and Controlled Trial|Not yet recruiting||Phase 1|132|Anticipated|University of Sao Paulo||3|||f||||t|t|f|||f|||Undecided||2017-10-10 21:10:06.14188|2017-10-10 21:10:06.14188
NCT03116009|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-12|||March 19, 2017|Actual|2017-03-19|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|REDSOAP||Randomization of Early Diabetes Screening Among Obese Pregnant Women.|Randomization of Early Versus Standard Diabetes Screening Among Obese Pregnant Women|Recruiting||N/A|600|Anticipated|University of Illinois at Chicago||2|||f||||f|f|f||||||No||2017-10-10 21:10:06.234727|2017-10-10 21:10:06.234727
NCT03115996|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-12|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN3918 in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose and Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously and Subcutaneously Administered Human Monoclonal Antibody REGN3918 in Healthy Volunteers.|Recruiting||Phase 1|56|Anticipated|Regeneron Pharmaceuticals||4|||f||||f|f|f||||||||2017-10-10 21:10:06.324082|2017-10-10 21:10:06.324082
NCT03115983|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-25|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2020|Anticipated|2020-12-01||Interventional|||LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis|A Concurrently Controlled Study of the LimiFlex™ Paraspinous Tension Band in the Treatment of Lumbar Degenerative Spondylolisthesis With Spinal Stenosis|Recruiting||N/A|291|Anticipated|Empirical Spine, Inc.||2|||f||||t|f|t|t|f||||||2017-10-10 21:10:06.43931|2017-10-10 21:10:06.43931
NCT03115970|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-04-12|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|July 31, 2017|Anticipated|2017-07-31|1 Day|Observational [Patient Registry]|||Feasibility of Lactate Level Evaluation in Prehospital Care in Trauma|Feasibility of Lactate Level Evaluation in Prehospital Care in Trauma|Not yet recruiting||N/A|30|Anticipated|Masaryk Hospital Usti nad Labem|||1||f||||f|f|f||||||Undecided||2017-10-10 21:10:06.551669|2017-10-10 21:10:06.551669
NCT03115957|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-13|||April 14, 2017|Actual|2017-04-14|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|June 30, 2018|Anticipated|2018-06-30||Interventional|PNASIT||Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients|Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients With Nutritional Risk and Initial Enteral Nutrition Intolerance: A Clinical Randomized Trial|Recruiting||N/A|540|Anticipated|Jinling Hospital, China||2|||f||||t|f|f|||f|||No||2017-10-10 21:10:06.624753|2017-10-10 21:10:06.624753
NCT03115944|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-04-11|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pro00019086 - Ultra Circumference Reduction|A Multi-Center Pilot Study to Assess the Safety and Efficacy of the vShape Ultra UltraSpeed Handpiece for Abdomen Circumference Reduction|Recruiting||N/A|21|Anticipated|Alma Lasers Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:10:06.763569|2017-10-10 21:10:06.763569
NCT03115931|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-13|||April 14, 2017|Actual|2017-04-14|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Observational|PNAS||The Effect of Preoperative Nutritional Assessment and Nutritional Support on Clinical Outcomes|The Effect of Preoperative Nutritional Assessment and Nutritional Support on Clinical Outcomes in Elective Abdominal Surgery Patients: A Prospective Observational Study|Recruiting||N/A|2600|Anticipated|Jinling Hospital, China|||1||f||||t|f|f||||Samples Without DNA|"     The serum were collected to assess the nutrition risk.   "|No||2017-10-10 21:10:06.843471|2017-10-10 21:10:06.843471
NCT03115918|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-11|||August 2016||2016-08-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Pancreatic Duct Stent for Acute Necrotizing Pancreatitis|Randomized Trial Examining the Impact of Pancreatic Duct Stent Placement in Patients With Acute Necrotizing Pancreatitis in the Prevention of Walled-off Necrosis|Recruiting||N/A|28|Anticipated|Florida Hospital||2|||f||||t||||||||No|No plan to share individual participant data.|2017-10-10 21:10:07.133732|2017-10-10 21:10:07.133732
NCT03115905|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-10|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 30, 2021|Anticipated|2021-12-30|December 30, 2020|Anticipated|2020-12-30|1 Year|Observational [Patient Registry]|CIAP-5||A Registry Study for Emergency Medical Service of Aneurysmal Subarachnoid Hemorrhage in China|A Registry Study for Emergency Medical Service of Aneurysmal Subarachnoid Hemorrhage With Different Economic Development Levels Areas in China|Not yet recruiting||N/A|15000|Anticipated|Xuanwu Hospital, Beijing|||1||f||||t|f|f||||||Yes|we can share the original data 5 years after the study.|2017-10-10 21:10:07.307512|2017-10-10 21:10:07.307512
NCT03115892|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-26|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|RCT||Green Tea With Aloe Vera Mouthwash and Chlorohexidine Mouthwash|The Effect of Mouthwash Containing Green Tea With Aloe Vera and Chlorhexidine Mouthwash on Oral Malodour Among a Group of Egyptian Children: Randomized Clinical Trial|Enrolling by invitation||Phase 1/Phase 2|27|Anticipated|Cairo University||2|||f||||f|f|f|||f|||No|it will be available after finished|2017-10-10 21:10:07.421715|2017-10-10 21:10:07.421715
NCT03115879|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-11|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|||The Effect High Velocity Low Amplitude Hip Mobilization on Strength in Subjects With Lower Extremity Pathology|The Effect of High Velocity Low Amplitude Hip Mobilization on Strength in Subjects With Lower Extremity Pathology|Completed||N/A|40|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f|||||f|f||||||||2017-10-10 21:10:07.526671|2017-10-10 21:10:07.526671
NCT02659319|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-14|||May 2005||2005-05-01|January 2016|2016-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|FiSH||Families and Schools for Health|Intervening in Family and Peer Contexts to Decrease Child Overweight|Completed||N/A|541|Actual|Oklahoma State University||5|||f||||f||||||||No||2017-10-10 22:32:26.127849|2017-10-10 22:32:26.127849
NCT03115866|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||January 15, 2015|Actual|2015-01-15|April 2017|2017-04-01|January 15, 2019|Anticipated|2019-01-15|December 15, 2016|Actual|2016-12-15||Interventional|FRUVEDomics||FRUVEDomics: Behavioral Intervention in Young Adults to Identify Metabolomics and Microbiome Risk|FRUVEDomics Study: Use of a Behavioral Nutrition Intervention in Young Adults to Identify Modifiable Metabolomics and Microbiome Risk|Active, not recruiting||N/A|53|Actual|West Virginia University||3|||f||||f|f|f||||||No|There is no plan to share IPD at this time.|2017-10-10 21:10:07.61138|2017-10-10 21:10:07.61138
NCT03115853|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-07-25|2017-07-25||June 2009||2009-06-01|July 2017|2017-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function|The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function|Completed||Phase 4|31|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 21:10:07.759981|2017-10-10 21:10:07.759981
NCT03115840|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-21|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Observational|MOSAIC||Measuring Outcomes of Activity in Intensive Care|Long-term Outcomes of Physical Activity in Older Adults With Critical Illness|Recruiting||N/A|312|Anticipated|Vanderbilt University Medical Center|||1||f||||f|f|f|||f|Samples With DNA|"     Blood   "|No||2017-10-10 21:10:08.107184|2017-10-10 21:10:08.107184
NCT03115827|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-19|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|April 17, 2018|Anticipated|2018-04-17|April 17, 2018|Anticipated|2018-04-17||Interventional|||Norepinephrine-targeted Therapy for Action Control in Parkinson Disease|Norepinephrine-targeted Therapy for Action Control in Parkinson Disease|Recruiting||Phase 4|15|Anticipated|Vanderbilt University Medical Center||1|||f||||t|t|f|||f|||No||2017-10-10 21:10:08.273889|2017-10-10 21:10:08.273889
NCT03115814|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-06-28|||April 17, 2017|Actual|2017-04-17|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Observational|||Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease|Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease: Study Protocol of a Prospective, Self-control Phase I Trial|Recruiting||N/A|6|Anticipated|Chinese PLA General Hospital|||1||f||||t|f|f||||||Undecided||2017-10-10 21:10:08.435725|2017-10-10 21:10:08.435725
NCT03115801|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-08-08|||November 2016||2016-11-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers|A Phase II Randomized Controlled Trial of Programmed Death -1/Programmed Death Ligand-1(PD-1/PDL-1) Axis Blockade Versus PD-1/PDL-1 Axis Blockade Plus Radiotherapy in Metastatic Genitourinary (Renal/Urothelial) Malignancies|Recruiting||Phase 2|112|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-10 21:10:08.519441|2017-10-10 21:10:08.519441
NCT03115788|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-04-13|||May 15, 2016|Actual|2016-05-15|January 2017|2017-01-01|June 1, 2018|Anticipated|2018-06-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Pain Effect on Attention Using an Ipad Game App|The Effect of Pain on Short Term Cognitive Performance Using a Computer Assisted/Ipad Game Interface|Recruiting||N/A|60|Anticipated|Wake Forest University Health Sciences||2|||f||||t|f|f||||||No||2017-10-10 21:10:08.638394|2017-10-10 21:10:08.638394
NCT03115775|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-05|||May 12, 2017|Actual|2017-05-12|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|TM||CLA and Vitamin D on Protein Turnover|Randomized Controlled Trial to Evaluate the Independent and Combined Effects of Conjugated Linoleic Acids and Vitamin D on Muscle Protein Turnover in Older Adults|Recruiting||N/A|40|Anticipated|Washington University School of Medicine||4|||f||||t|f|f||||||||2017-10-10 21:10:08.742044|2017-10-10 21:10:08.742044
NCT03115762|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-13|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pharmacokinetics and Safety Study of ASKB1202 in Chinese Healthy Subjects|Pharmacokinetics,Safety and Immunogenicity of ASKB1202 in Chinese Healthy Subjects: a Randomized, Double-blinded, Single-dose, Parallel-arm, Active-comparator Clinical Phase I Study|Not yet recruiting||Phase 1|126|Anticipated|Jiangsu Aosaikang Pharmaceutical Co., Ltd.||3|||f|||||f|f||||||Undecided||2017-10-10 21:10:08.84304|2017-10-10 21:10:08.84304
NCT03115749|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|COSMIC||Intestinal Mesenchymal Stem Stells and Inflammatory Bowel Diseases|Characterization of Mesenchymal Stem Cells From the Colon and Small Intestine of Patients With Inflammatory Bowel Disease - The COSMIC Study|Not yet recruiting||N/A|60|Anticipated|University Hospital, Montpellier||3|||f||||f|f|f||||||No||2017-10-10 21:10:08.941208|2017-10-10 21:10:08.941208
NCT03115736|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-10|||May 23, 2017|Actual|2017-05-23|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|||TAF for HIV-HBV With Renal Dysfunction|Prospective Cohort Study to Assess the Safety and Efficacy of Replacing Tenofovir Disoproxil Fumarate by Tenofovir Alafenamide in HIV/HBV-coinfected Patients With Mild or Moderate Renal Dysfunction|Recruiting||Phase 2|50|Anticipated|University Hospital Inselspital, Berne||1|||f||||f|t|f|||t|||||2017-10-10 21:10:09.052212|2017-10-10 21:10:09.052212
NCT03115723|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||January 2012|Actual|2012-01-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|1 Year|Observational [Patient Registry]|ACIRA-REHOSP||Analysis of Hospitalizations One Year After Acts of CAG and PCI in the Aquitaine région - ACIRA Register Data Analysis|Frequency and Characteristics of Rehospitalizations During One Year After Percutaneous Coronary Intervention and Coronary Angiography - Results of the ACIRA Registry, Aquitaine Region|Completed||N/A|25000|Actual|University Hospital, Bordeaux|||2||f||||f|f|f||||||No||2017-10-10 21:10:09.156408|2017-10-10 21:10:09.156408
NCT03115710|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||December 28, 2015|Actual|2015-12-28|April 2017|2017-04-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Observational|||The K-Map Study, Global Prevalence of KC|The K-Map Study, Global Prevalence of KC|Recruiting||N/A|700|Anticipated|University Hospital, Geneva|||1||f|||||f|f||||||||2017-10-10 21:10:09.271572|2017-10-10 21:10:09.271572
NCT03115697|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-06-07|||May 25, 2017|Actual|2017-05-25|April 2017|2017-04-01|April 15, 2019|Anticipated|2019-04-15|April 15, 2019|Anticipated|2019-04-15||Interventional|||High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.|High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit-A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:09.35309|2017-10-10 21:10:09.35309
NCT03115671|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-04-17|||November 30, 2016|Actual|2016-11-30|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)|An Open-label Pilot Study on the Efficacy of Phosphatidylserine-Omega 3 (Vayarin) in Pediatric Patients Diagnosed With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)|Recruiting||N/A|50|Anticipated|Institute of Mental Health, Singapore||2|||f||||f|f|f||||||No||2017-10-10 21:10:09.512955|2017-10-10 21:10:09.512955
NCT03115658|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-11|||September 8, 2009|Actual|2009-09-08|April 2017|2017-04-01|January 28, 2011|Actual|2011-01-28|August 31, 2010|Actual|2010-08-31||Interventional|||Physical Activity and First Degree Female Relatives of Breast Cancer Patients|Physical Activity and First Degree Female Relatives of Breast Cancer Patients|Completed||N/A|27|Actual|University of California, San Diego||1|||f||||f|f|f||||||No||2017-10-10 21:10:09.615668|2017-10-10 21:10:09.615668
NCT03115645|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-10|||January 23, 2017|Actual|2017-01-23|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Evaluation of the Dynamic Work Intervention for Office Workers to Reduce Sedentary Behaviour|Evaluation of the Dynamic Work Intervention for Office Workers to Reduce Sedentary Behaviour|Enrolling by invitation||N/A|250|Anticipated|VU University Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:09.680444|2017-10-10 21:10:09.680444
NCT03115632|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-10-02|||October 31, 2017|Anticipated|2017-10-31|June 2017|2017-06-01|October 31, 2022|Anticipated|2022-10-31|October 31, 2021|Anticipated|2021-10-31||Observational|||Contributing Factors in the Pathobiology of Airway Remodeling in Obesity|Contributing Factors in the Pathobiology of Airway Remodeling in Obesity|Not yet recruiting||N/A|125|Anticipated|Duke University|||4||f||||t|f|f||||Samples With DNA|"     blood plasma, bronchoscopy with endobronchial biopsy and bronchoalveolar, RNA   "|||2017-10-10 21:10:09.773096|2017-10-10 21:10:09.773096
NCT03115619|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-10-02|||April 18, 2017|Actual|2017-04-18|October 2017|2017-10-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|PNEUMON||Quality of Life Study in Participants With IPF Under Pirfenidone Treatment|A Multicenter, Post-Marketing, Non-Interventional, Observational Study to Evaluate Quality of Life in Patients in Greece With Idiopathic Pulmonary Fibrosis Under Treatment With Pirfenidone - The Pneumon Study|Recruiting||N/A|100|Anticipated|Hoffmann-La Roche|||1||f||||f|t|f|||f|||||2017-10-10 21:10:09.860399|2017-10-10 21:10:09.860399
NCT03115606|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-04-14|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of C-Mac D Blade and Fastrach Laryngeal Mask Airway Intubation Conditions in Cervical Discectomy|Comparison of C-Mac D Blade and Fastrach Laryngeal Mask Airway Intubation Conditions in Cervical Discectomy|Recruiting||N/A|30|Anticipated|Diskapi Teaching and Research Hospital||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:10:09.965165|2017-10-10 21:10:09.965165
NCT03115593|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-11|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer|Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer|Not yet recruiting||N/A|360|Anticipated|Brugmann University Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:10:10.05355|2017-10-10 21:10:10.05355
NCT03115580|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-12|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|ORBID-FFR||Side Branch FFR After Provisional Stenting|Optical Coherence Tomography Predictors of Functionally Significant Side Branch Compromise After Provisional Main Vessel Stenting In Calcific Coronary Artery Disease Assessed by Fractional Flow Reserve|Recruiting||N/A|150|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|t|f|||||No||2017-10-10 21:10:10.149849|2017-10-10 21:10:10.149849
NCT03115567|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-04-11|||February 16, 2017|Actual|2017-02-16|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption|A Randomized Phase II Study of Topical Steroids as Preemptive Therapy for Epidermal Growth Factor Receptor Inhibitor-Induced Papulopustular Eruption|Recruiting||Phase 2|84|Anticipated|Northwestern University||2|||f||||t|t|f||||||No||2017-10-10 21:10:10.246863|2017-10-10 21:10:10.246863
NCT03115554|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-13|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Comparison of PVI Plus Catheter Ablation or PVI Alone for the Treatment of AFib for Patients With Paroxysmal Atrial Fibrillation|Comparison of Pulmonary Vein Isolation Plus Additional Catheter Ablation or Pulmonary Vein Isolation Alone for the Treatment of Atrial Fibrillation for Patients With Paroxysmal Atrial Fibrillation: A Prospective, Randomized Study|Recruiting||N/A|284|Anticipated|Aurora Health Care||2|||f|||||f|f||||||||2017-10-10 21:10:10.344671|2017-10-10 21:10:10.344671
NCT03115541|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-13|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Observational|||Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection|The Contemporary Significance of Deep Venous Thrombosis and Pulmonary Embolus in Patients Undergoing Esophagectomy: A Pilot Study to Evaluate the Incidence of DVT and PE After Major Esophageal Resections|Recruiting||N/A|150|Anticipated|McMaster University|||1||f||||t|f|f||||||||2017-10-10 21:10:10.482398|2017-10-10 21:10:10.482398
NCT03115515|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-11|||August 2011||2011-08-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy|Randomized, Prospective Trial Comparing the Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy|Recruiting||N/A|60|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-10 21:10:10.686286|2017-10-10 21:10:10.686286
NCT02630511|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-05|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Asthma Exacerbations and Vascular Function|Asthma Exacerbations and Vascular Function|Recruiting||N/A|60|Anticipated|University of Alberta||5|||f||||||||||||||2017-10-10 22:39:35.009691|2017-10-10 22:39:35.009691
NCT03115502|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-11|||August 2013||2013-08-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||Hemodynamic Changes and Vascular Tone Control After Bariatric Surgery|Hemodynamic Changes and Vascular Tone Control After Bariatric Surgery. Prognostic Value Regarding Hypertension and Target Organ Damage|Recruiting||N/A|50|Anticipated|Parc de Salut Mar|||1||f||||f||||||||No||2017-10-10 21:10:10.777238|2017-10-10 21:10:10.777238
NCT03115489|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-22|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|May 2019|Anticipated|2019-05-01||Interventional|||Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus|Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus- a Pilot Study|Recruiting||Phase 2/Phase 3|32|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||t|||No||2017-10-10 21:10:10.853831|2017-10-10 21:10:10.853831
NCT03115476|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-20|||June 16, 2017|Actual|2017-06-16|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp|Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle|Enrolling by invitation||Phase 3|1080|Anticipated|LEO Pharma||3|||f||||f|t|f||||||||2017-10-10 21:10:10.96824|2017-10-10 21:10:10.96824
NCT03115463|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-26|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|STARTPreterm||Saturation Targets and Resuscitation in Preterm Trial|Saturation Targets and Resuscitation in Preterm Infants the Delivery Room: A Randomized Controlled Trial|Not yet recruiting||N/A|75|Anticipated|University of Texas Southwestern Medical Center||3|||f||||t|f|f||||||||2017-10-10 21:10:13.056385|2017-10-10 21:10:13.056385
NCT03115450|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-26|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2019|Anticipated|2019-05-15||Observational|CUSPICP||Comparison of Pupilometer and Ultrasound of Optic Nerve Sheath Diameter in Estimating Intracranial Pressure (ICP)|Comparative Analysis of Pupilometer and Ultrasound Assessment of Optic Nerve Sheath Diameter in Estimating Intracranial Pressure (ICP)|Recruiting||N/A|50|Anticipated|Loma Linda University|||1||f||||t|f|t|f|f|t|||||2017-10-10 21:10:13.15556|2017-10-10 21:10:13.15556
NCT03115437|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-11|||September 13, 2017|Anticipated|2017-09-13|April 2017|2017-04-01|July 31, 2018|Anticipated|2018-07-31|January 31, 2018|Anticipated|2018-01-31||Interventional|RRI_Interv4||Effects of Shoe Cushioning and Body Mass on Injury Risk in Running|Role of Shoe Cushioning, Body Mass and Running Biomechanics on Injury Risk: a Randomized Controlled Trial|Not yet recruiting||N/A|800|Anticipated|Luxembourg Institute of Health||2|||f||||f|f|f||||||No|The IPD will not be shared.|2017-10-10 21:10:13.249181|2017-10-10 21:10:13.249181
NCT03115424|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-07-16|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|May 2020|Anticipated|2020-05-01||Interventional|||Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy|Effect of GLP-1 Receptor Agonism on Weight and Caloric Intake in Subjects After Sleeve Gastrectomy|Recruiting||Phase 3|75|Anticipated|Mayo Clinic||3|||f||||t|t|f|||f|||||2017-10-10 21:10:13.35176|2017-10-10 21:10:13.35176
NCT03115411|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-13|||September 6, 2011|Actual|2011-09-06|April 2017|2017-04-01|April 10, 2018|Anticipated|2018-04-10|April 10, 2018|Anticipated|2018-04-10||Interventional|||Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction|Prospective Evaluation of Wing Biliary Stent Patency in Patients With Benign Biliary Obstruction|Recruiting||N/A|50|Anticipated|Stanford University||1|||f||||f|f|f||||||No||2017-10-10 21:10:13.443934|2017-10-10 21:10:13.443934
NCT03115398|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-11|||February 16, 2017|Actual|2017-02-16|April 2017|2017-04-01|February 16, 2023|Anticipated|2023-02-16|February 16, 2021|Anticipated|2021-02-16||Interventional|||A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery|A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery: A Randomized Trial|Recruiting||N/A|166|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t|f|f||||||No||2017-10-10 21:10:13.527007|2017-10-10 21:10:13.527007
NCT03115385|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-10|||May 30, 2015|Actual|2015-05-30|April 2017|2017-04-01|April 11, 2016|Actual|2016-04-11|April 11, 2016|Actual|2016-04-11||Interventional|||Probiotics and the Gut Microbiome in Obese Hispanic Youth|Probiotics and the Gut Microbiome in Obese Hispanic Youth|Terminated||N/A|22|Actual|University of Southern California||2||Funds ended.|f||||f||||||||No||2017-10-10 21:10:13.620526|2017-10-10 21:10:13.620526
NCT03115372|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-05|||February 2012|Actual|2012-02-01|May 2017|2017-05-01|September 1, 2015|Actual|2015-09-01|July 1, 2015|Actual|2015-07-01||Interventional|||Lay Health Worker Outreach in Increasing Colorectal Cancer Screening in Asian Americans|AANCART: The National Center for Reducing Asian American Cancer Health Disparities Research Project on Lay Health Workers and Asian Americans|Completed||N/A|982|Actual|University of California, San Francisco||2|||f||||t|f|f||||||Undecided||2017-10-10 21:10:13.697662|2017-10-10 21:10:13.697662
NCT03115359|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-31|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|July 15, 2021|Anticipated|2021-07-15|June 30, 2021|Anticipated|2021-06-30||Interventional|STAMP||Strategies to Assist With Management of Pain|A Comparative Effectiveness Randomized Controlled Trial of Mindfulness Meditation Versus Cognitive Behavioral Therapy for Opioid-Treated Chronic Low Back Pain|Recruiting||N/A|766|Anticipated|University of Wisconsin, Madison||2|||f||||t|f|f||||||||2017-10-10 21:10:13.893039|2017-10-10 21:10:13.893039
NCT03115346|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-14|||April 15, 2017|Actual|2017-04-15|September 2017|2017-09-01|April 15, 2021|Anticipated|2021-04-15|October 31, 2018|Anticipated|2018-10-31||Interventional|PROVEE-AAA||Preferences for Open Vs. Endovascular Repair for Aortic Abdominal Aneurysm|Alignment of Treatment Preferences and Repair Type for Veterans With AAA|Recruiting||N/A|240|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 21:10:14.032283|2017-10-10 21:10:14.032283
NCT03115333|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-19|||April 14, 2017|Actual|2017-04-14|April 2017|2017-04-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma|Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma|Recruiting||N/A|165|Anticipated|Eastern Cooperative Oncology Group||1|||f||||f|f|f||||||No||2017-10-10 21:10:14.118474|2017-10-10 21:10:14.118474
NCT03113682|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-12|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|CBT-RD||A Study of Cognitive-Behavioral Therapy for Rumination Disorder|A Pilot Study of Cognitive-Behavioral Therapy for Rumination Disorder|Recruiting||N/A|10|Anticipated|Drexel University||1|||f|||||f|f||||||||2017-10-10 21:10:27.564956|2017-10-10 21:10:27.564956
NCT03115320|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-10|||January 2017|Actual|2017-01-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Frozen-thawed Embryo Transfer in a Naturally Stimulated Cycle: Does hCG Triggering Bring Any Advantage in Comparison to Testing LH Surge With Home Tests?|A Protocol for a Randomized, Two-Parallel-group Study to Compare the Efficacy of Testing LH Surge at Home Versus Medically Triggered Ovulation With hCG (Pregnyl®) in the Naturally Stimulated Cycle in the Frozen-thawed Embryo Transfer|Recruiting||Phase 4|330|Anticipated|Tampere University Hospital||2|||f||||t|f|f||||||||2017-10-10 21:10:14.217308|2017-10-10 21:10:14.217308
NCT03115307|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-10|||January 2017|Actual|2017-01-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Luteal Phase Support in Insemination Cycles|A Protocol for a Randomized, Controlled Study to Compare the Use of Gonodotropin-releasing Hormone Agonist Triptoreline (Gonapeptyl®) for Luteal Phase Support Versus Natural Luteal Phase in the Insemination Cycles|Recruiting||Phase 4|242|Anticipated|Tampere University Hospital||2|||f||||t|f|f||||||||2017-10-10 21:10:14.303986|2017-10-10 21:10:14.303986
NCT03115294|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-10|||May 16, 2016|Actual|2016-05-16|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|CardiomeDIC||Digital Image Correlation in Right Ventricular Evaluation|Digital Image Correlation in Right Ventricular Evaluation in Cardiac Surgery|Recruiting||N/A|30|Anticipated|Tampere University Hospital||1|||f||||f|f|f||||||Undecided|non-identifiable data to Tampere University of Technology research group|2017-10-10 21:10:14.40383|2017-10-10 21:10:14.40383
NCT03115281|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-03|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Observational|WIN||Registry to Assess the STENTYS Xposition S for Revascularization of Coronary Arteries In Routine cliNical Practice|World-wide Registry to Assess the STENTYS Xposition S for Revascularization of Coronary Arteries In Routine cliNical Practice|Recruiting||N/A|750|Anticipated|Stentys|||1||f|||||f|f||||||||2017-10-10 21:10:14.494292|2017-10-10 21:10:14.494292
NCT03115268|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-31|||May 16, 2017|Actual|2017-05-16|March 2017|2017-03-01|February 25, 2019|Anticipated|2019-02-25|February 15, 2019|Anticipated|2019-02-15||Interventional|||Delivering Group Support for People With Aphasia Through Eva Park|Delivering Group Support for People With Aphasia Through Eva Park|Recruiting||N/A|32|Anticipated|City, University of London||2|||f||||f|f|f||||||||2017-10-10 21:10:14.576992|2017-10-10 21:10:14.576992
NCT03115255|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-10|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab|Serum Concentrations of Vascular Endothelial Growth Factor in Infants Treated With Ranibizumab for Retinopathy of Prematurity|Not yet recruiting||N/A|30|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f|||||f|f||||||No||2017-10-10 21:10:14.676652|2017-10-10 21:10:14.676652
NCT03115242|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-04-10|||August 2015||2015-08-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CUSCAS||Contrast Enhanced Ultrasound of Carotid Plaque in Acute Ischemic Stroke|Contrast Enhanced Ultrasound of Carotid Plaque in Acute Ischemic Stroke|Recruiting||N/A|60|Anticipated|Versailles Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:10:14.766939|2017-10-10 21:10:14.766939
NCT03115229|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-17|||June 10, 2015|Actual|2015-06-10|March 2017|2017-03-01|May 27, 2016|Actual|2016-05-27|March 7, 2016|Actual|2016-03-07||Interventional|||Obesity Intervention Program for University Students|The Effects of Protectıve Nursing Interventions on Reduction of Obesity Risk In University Students: Randomise Controlled Study|Completed||N/A|70|Actual|Selcuk University||2|||f||||f|f|f||||||No||2017-10-10 21:10:14.854196|2017-10-10 21:10:14.854196
NCT03115216|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-04-17|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FLIRT||The Femtosecond Laser in Residency Training (FLIRT) Pilot Study|The Femtosecond Laser in Residency Training (FLIRT) Pilot Study: Femtosecond Laser-Assisted Versus Manual Cataract Extraction and Intraocular Lens Implantation|Not yet recruiting||N/A|180|Anticipated|University of Southern California||2|||f||||f|f|f||||||||2017-10-10 21:10:14.930207|2017-10-10 21:10:14.930207
NCT03115203|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-13|||August 8, 2016|Actual|2016-08-08|April 2017|2017-04-01|August 8, 2021|Anticipated|2021-08-08|August 8, 2021|Anticipated|2021-08-08||Interventional|SIMOVI IRM 2||Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.|Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:10:15.0279|2017-10-10 21:10:15.0279
NCT03115190|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-14|||April 18, 2017|Anticipated|2017-04-18|April 2017|2017-04-01|April 18, 2019|Anticipated|2019-04-18|April 18, 2018|Anticipated|2018-04-18||Interventional|Urgent||Improving the Referral of Patients With Chest Pain|A Prospective Cohort Study to Improve the Accuracy of Referrals of Patients With Chest Pain to the Emergency Department: to Decrease the Delay in Acute Coronary Syndrome Patients and Rule Out Non-cardiac Chest Pain Patients (URGENT)|Not yet recruiting||N/A|350|Anticipated|VieCuri Medical Centre||3|||f||||t|f|f||||||No|IPD will not be made available to other researchers to secure privacy in study patients.|2017-10-10 21:10:15.146772|2017-10-10 21:10:15.146772
NCT03115177|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-04-10|||November 2015||2015-11-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Can Addition of Doxycycline Perioperatively Reduce Propionibacterium Acnes in Shoulder Arthroplasty?|Can Addition of Doxycycline Perioperatively Reduce Propionibacterium Acnes in Shoulder Arthroplasty?|Completed||N/A|56|Actual|Rush University Medical Center||2|||f||||t||||||||No||2017-10-10 21:10:15.227602|2017-10-10 21:10:15.227602
NCT03115164|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||August 18, 2016|Actual|2016-08-18|April 2017|2017-04-01|August 18, 2017|Anticipated|2017-08-18|August 18, 2017|Anticipated|2017-08-18||Observational|DIA/DIG||Astrocytoma / Desmoplastic Gamliogliomes (DIA / DIG) - Study of the French Cohort of the Last 20 Years : Clinical, Anatomopathological, Molecular and Radiological Charactersics|Astrocytoma / Desmoplastic Gamliogliomes (DIA / DIG) - Study of the French Cohort of the Last 20 Years : Clinical, Anatomopathological, Molecular and Radiological Charactersics|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:10:15.297366|2017-10-10 21:10:15.297366
NCT03115151|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-06-01|||May 8, 2017|Actual|2017-05-08|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery|A Comparison of Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery: A Prospective Randomized Study|Recruiting||Phase 4|58|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|t|f||||||No||2017-10-10 21:10:15.373477|2017-10-10 21:10:15.373477
NCT03115138|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||March 9, 2016|Actual|2016-03-09|April 2017|2017-04-01|March 8, 2020|Anticipated|2020-03-08|March 8, 2020|Anticipated|2020-03-08||Interventional|Bi-GLAM||Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.|Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:10:15.460907|2017-10-10 21:10:15.460907
NCT03115125|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||April 20, 2016|Actual|2016-04-20|April 2017|2017-04-01|May 19, 2017|Anticipated|2017-05-19|May 19, 2017|Anticipated|2017-05-19||Interventional|DELyBREG||Descriptive Study of the Evolution in Proportion of Regulatory B Lymphocytes in Patients Hospitalized in Intensive Care for Severe Sepsis|Descriptive Study of the Evolution in Proportion of Regulatory B Lymphocytes in Patients Hospitalized in Intensive Care for Severe Sepsis|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:10:15.536251|2017-10-10 21:10:15.536251
NCT03115112|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-05|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects|A Phase 3, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Effects of Bexagliflozin Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin|Not yet recruiting||Phase 3|374|Anticipated|Theracos||2|||f||||t|t|f||||||||2017-10-10 21:10:15.611336|2017-10-10 21:10:15.611336
NCT03115099|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-10-02|||May 31, 2017|Actual|2017-05-31|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes|A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3325656 After Single Dose in Healthy Subjects and Patients With Type 2 Diabetes|Recruiting||Phase 1|80|Anticipated|Eli Lilly and Company||6|||f||||f|t|f|||t|||||2017-10-10 21:10:15.789807|2017-10-10 21:10:15.789807
NCT03115086|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-08-14|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|August 2030|Anticipated|2030-08-01|July 2030|Anticipated|2030-07-01|10 Years|Observational [Patient Registry]|||The REPLACE Registry|A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam®/Kolbam® (Cholic Acid)|Recruiting||N/A|110|Anticipated|Retrophin, Inc.|||1||f||||f||||||||||2017-10-10 21:10:15.904942|2017-10-10 21:10:15.904942
NCT03115073|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-09-21|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||ProF-001_Phase IIa|A Phase IIa Randomized, Active-controlled, Double-blind, Dose-escalation Study in Patients With Vulvovaginal Candidiasis to Evaluate Dose Response Relationship of Clinical Efficacy, Safety and Tolerability of Topically Administered ProF-001|Recruiting||Phase 2/Phase 3|84|Anticipated|ProFem GmbH||4|||f||||t|f|f||||||||2017-10-10 21:10:16.022752|2017-10-10 21:10:16.022752
NCT03115060|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-12|||April 1, 2015|Actual|2015-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparison of Plasmalyte A, Normal Saline and Ringer Lactate as Intraoperative Fluid During Renal Transplantation|Comparison of Plasmalyte A, Normal Saline and Ringer Lactate as Intraoperative Fluids in Patients Undergoing Renal Transplantation.|Recruiting||Phase 4|105|Anticipated|Postgraduate Institute of Medical Education and Research||3|||f||||t|f|f||||||No||2017-10-10 21:10:16.161879|2017-10-10 21:10:16.161879
NCT03115047|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-07-21|||May 7, 2017|Actual|2017-05-07|April 2017|2017-04-01|April 24, 2018|Anticipated|2018-04-24|April 24, 2018|Anticipated|2018-04-24||Interventional|||Shivering Treatment After Cesarean Delivery: Meperidine vs. Dexmedetomidine|Traitement Des Frissons Lors de la césarienne Sous anesthésie péridurale Durant le Travail - un Essai Clinique randomisé Comparant la dexmédétomidine et la mépéridine|Recruiting||Phase 3|80|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f|f|f|||f|||||2017-10-10 21:10:16.248877|2017-10-10 21:10:16.248877
NCT03115034|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-10|||June 1, 2016|Actual|2016-06-01|March 2017|2017-03-01|June 1, 2017|Anticipated|2017-06-01|May 1, 2017|Anticipated|2017-05-01||Interventional|||Melatonin in Patients Under Carotid Endarterectomy|The Protective Effect of Melatonin in Patients Under Carotid Endarterectomy|Recruiting||Phase 4|90|Anticipated|Peking Union Medical College Hospital||3|||f||||t|t|f||||||Undecided||2017-10-10 21:10:16.354258|2017-10-10 21:10:16.354258
NCT03115021|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-11|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Neurophysiological Effects of tPCS and tDCS on Patients With Disorders of Consciousness|Neurophysiological Effects of tPCS and tDCS on Patients With Disorders of Consciousness|Not yet recruiting||N/A|20|Anticipated|Spaulding Rehabilitation Hospital||3|||f||||f|f|f||||||||2017-10-10 21:10:16.479356|2017-10-10 21:10:16.479356
NCT03115008|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-10-03|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|January 2018|Anticipated|2018-01-01||Interventional|COMPLETE||Improving Competency and Metrics for PoLypectomy Skills Using Evaluation Tools and VidEo Feedback (COMPLETE)|Training for COMPLETE Polyp Resection During Colonoscopy -Improving Competency and Metrics for PoLypectomy Skills Using Evaluation Tools and VidEo Feedback|Enrolling by invitation||N/A|22|Anticipated|San Francisco Veterans Affairs Medical Center||2|||f|||||f|f||||||||2017-10-10 21:10:16.570369|2017-10-10 21:10:16.570369
NCT03114995|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-13|||February 1, 2012|Actual|2012-02-01|April 2017|2017-04-01|October 1, 2015|Actual|2015-10-01|October 1, 2015|Actual|2015-10-01||Interventional|||Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients|Effect of Tailored Use of Tirofiban in Patients With Non-ST-elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention|Completed||Phase 4|140|Actual|Seoul National University Bundang Hospital||3|||f||||f|t|f|||f|||No|not planned|2017-10-10 21:10:16.641695|2017-10-10 21:10:16.641695
NCT03114982|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-11|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|||The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age|Randomized, Double-blinded, Parallel-group, Exploratory Study to Assess The Immunogenicity and Safety of NBP608 and Varivax in Healthy Children|Completed||Phase 2|152|Actual|SK Chemicals Co.,Ltd.||4|||f||||t|f|f||||||No||2017-10-10 21:10:16.736201|2017-10-10 21:10:16.736201
NCT03114813|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-24|||January 2017||2017-01-01|April 2017|2017-04-01|January 2024|Anticipated|2024-01-01|January 2019|Anticipated|2019-01-01||Observational|B-SMaRT||Can MRI Evaluate Beta-blocker Response in Portal Hypertension?|Beta-blocker Stratification Using Quantitative MRI Techniques to Assess Portal Pressure and Response to Treatment in Patients With Portal Hypertension|Recruiting||N/A|68|Anticipated|University of Nottingham|||1||f||||f||||||||No||2017-10-10 21:10:18.035845|2017-10-10 21:10:18.035845
NCT03114956|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-18|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Surface Decontamination in Treatment of Peri-Implantitis|Effects of Implant Surface Decontamination on Control of Peri-Implant Inflammation|Not yet recruiting||N/A|68|Anticipated|University of Southern California||4|||f||||f|f|f||||||Yes|At the end of the study, the clinical data and radiographs will be shared with other investigators included in this study for analysis.|2017-10-10 21:10:17.02086|2017-10-10 21:10:17.02086
NCT03114943|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-11|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|February 2017|Actual|2017-02-01||Interventional|||Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age|A Multi-national, Multi-center, Randomized, Double Blinded, Parallel-group Study to Assess the Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age|Active, not recruiting||Phase 3|516|Actual|SK Chemicals Co.,Ltd.||2|||f||||t|f|f||||||No||2017-10-10 21:10:17.11194|2017-10-10 21:10:17.11194
NCT03114930|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||March 30, 2016|Actual|2016-03-30|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|COMPLISTAN||Study of the Prevalence of Complications Occurring in the Mother-newborn Couple During the First Month After Returning Home, Since the Introduction of Standard Outpatients (According to HAS 2014 Recommendations) at the Amiens-Picardie University Hospital|Study of the Prevalence of Complications Occurring in the Mother-newborn Couple During the First Month After Returning Home, Since the Introduction of Standard Outpatients (According to HAS 2014 Recommendations) at the Amiens-Picardie University Hospital|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:10:17.193019|2017-10-10 21:10:17.193019
NCT03114917|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-01|||May 12, 2017|Actual|2017-05-12|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|CARMS||Cognitive AppRoaches to coMbatting Suicidality|A Psychological Intervention for Suicide Applied to Patents With Psychosis: the CARMS Trial (Cognitive Approaches to Combatting Suicidality)|Recruiting||N/A|280|Anticipated|University of Manchester||2|||f||||t|f|f||||||||2017-10-10 21:10:17.274045|2017-10-10 21:10:17.274045
NCT03114904|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-11|||February 27, 2016|Actual|2016-02-27|May 2017|2017-05-01|May 16, 2018|Anticipated|2018-05-16|May 16, 2018|Anticipated|2018-05-16||Interventional|NEUROSEV||Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebroses|Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebroses: Randomized Controlled Trial.|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:10:17.431377|2017-10-10 21:10:17.431377
NCT03114891|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-26|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Accelerated TMS to a Novel Brain Target in MDD and PTSD|Accelerated TMS to a Novel Brain Target in MDD and PTSD|Recruiting||N/A|40|Anticipated|University of Pennsylvania||2|||f||||t|f|f||||||No||2017-10-10 21:10:17.514579|2017-10-10 21:10:17.514579
NCT03114878|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-04-10|||October 2016||2016-10-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||The Value of EMDR in the Treatment of Tinnitus|The Value of Eye Movement Desensitization Reprocessing in the Treatment of Tinnitus|Recruiting||N/A|166|Anticipated|University Hospital, Antwerp||2|||f||||||||||||||2017-10-10 21:10:17.617402|2017-10-10 21:10:17.617402
NCT03114865|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-15|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance|A Pilot Study of Blinatumomab in Patients With Pre B-cell Acute Lymphoblastic Leukemia (ALL) and B-cell Non-Hodgkin Lymphoma (NHL) as Post-allogeneic Stem Cell Transplant (Allo-HSCT) Remission Maintenance|Not yet recruiting||Early Phase 1|12|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:10:17.709517|2017-10-10 21:10:17.709517
NCT03114852|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-10|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|March 20, 2019|Anticipated|2019-03-20|March 20, 2018|Anticipated|2018-03-20||Observational|REGENT||Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro|The REGENT Study: Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro|Recruiting||N/A|1800|Anticipated|Universidade Federal Fluminense|||2||f|||||f|f||||Samples With DNA|"     A blood collection of patients with familial history of renal disease will be done to extract     DNA and to perform analysis of mutations and sequencing. After that, the samples will not be     retained.   "|Undecided||2017-10-10 21:10:17.799801|2017-10-10 21:10:17.799801
NCT03114839|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-26|||September 4, 2017|Anticipated|2017-09-04|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|October 31, 2017|Anticipated|2017-10-31||Interventional|ROBIN||Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN)|The Effect of Daily Consumption of a Probiotic Drink Containing Lactobacillus Casei Strain Shirota on the Small Intestinal Microbiota in Healthy Male Subjects as Measured by the IntelliCap Sampling Capsule System.|Recruiting||N/A|6|Anticipated|Yakult Honsha European Research Center, ESV||1|||f||||f|f|f||||||No||2017-10-10 21:10:17.878674|2017-10-10 21:10:17.878674
NCT03114826|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||October 6, 2016|Actual|2016-10-06|April 2017|2017-04-01|October 5, 2019|Anticipated|2019-10-05|October 5, 2019|Anticipated|2019-10-05||Observational|VE-CART||Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients|Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients|Recruiting||N/A|272|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:10:17.969303|2017-10-10 21:10:17.969303
NCT03114787|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-11|||August 30, 2016|Actual|2016-08-30|May 2017|2017-05-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|KISEVEN||Does Respiratory Physiotherapy Allow for Earlier Withdrawal of Mechanical Ventilation in Respiratory Resuscitation Service?|Does Respiratory Physiotherapy Allow for Earlier Withdrawal of Mechanical Ventilation in Respiratory Resuscitation Service? Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:10:18.184689|2017-10-10 21:10:18.184689
NCT03114774|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-10|||April 15, 2017|Anticipated|2017-04-15|March 2017|2017-03-01|June 1, 2017|Anticipated|2017-06-01|May 1, 2017|Anticipated|2017-05-01||Observational|||Effectivity of Bispectral Index Monitoring in Cases of Endoscopic Retrograde Cholangiopancreatography|Evaluation of Effectivity of Bispectral Index Monitoring in Cases of Endoscopic Retrograde Cholangiopancreatography Received Sedoanalgesia|Not yet recruiting||N/A|60|Anticipated|Istanbul Medeniyet University|||2||f|||||f|f||||||||2017-10-10 21:10:18.254988|2017-10-10 21:10:18.254988
NCT03114761|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-11|||September 5, 2016|Actual|2016-09-05|April 2017|2017-04-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Interventional|CTA-IH||CTA for Internal Herniation After RYGB Surgery|Abdominal CT Angiography of Mesenteric Vessels for Diagnosing Internal Herniation After Roux-en-Y Gastric Bypass Surgery|Recruiting||N/A|12|Anticipated|Rijnstate Hospital||1|||f|||||f|f||||||||2017-10-10 21:10:18.358404|2017-10-10 21:10:18.358404
NCT03114748|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-10|||May 2012||2012-05-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|March 2016|Actual|2016-03-01||Interventional|EEG-DBS||Electroencephalographic Monitoring in Patients Treated by Deep Brain Stimulation|Monitoring électroencéphalographique Chez Les Patients traités Par Stimulation cérébrale Profonde|Active, not recruiting||N/A|60|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||No||2017-10-10 21:10:18.517708|2017-10-10 21:10:18.517708
NCT03114735|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-04-10|||April 15, 2017|Anticipated|2017-04-15|March 2017|2017-03-01|June 1, 2017|Anticipated|2017-06-01|May 1, 2017|Anticipated|2017-05-01||Observational|||Effects of Preoperative Anxiety and Pain Sensitivity in Cases of Endoscopic Ultrasonography Received Sedoanalgesia|The Effects of Preoperative Anxiety and Pain Sensitivity on the Intraoperative Hemodynamics, Consumption of Propofol and Postoperative Recovery in Cases of Endoscopic Ultrasonography (EUS) Received Sedoanalgesia|Not yet recruiting||N/A|80|Anticipated|Istanbul Medeniyet University|||1||f||||||||||||||2017-10-10 21:10:18.615554|2017-10-10 21:10:18.615554
NCT03114722|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-06-14|||July 31, 2017|Anticipated|2017-07-31|March 2017|2017-03-01|December 30, 2018|Anticipated|2018-12-30|July 31, 2018|Anticipated|2018-07-31||Interventional|||Citrate 4% Versus Heparinised Saline in Preventing Peripherally Inserted Central Catheter (PICC) Occlusions|Citrate 4% Versus Heparinised Saline in Preventing Peripherally Inserted Central Catheter (PICC) Occlusions|Not yet recruiting||Phase 2|130|Anticipated|National University Hospital, Singapore||2|||f||||f|f|f||||||No||2017-10-10 21:10:18.678092|2017-10-10 21:10:18.678092
NCT03114709|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-10|||November 1, 2017|Anticipated|2017-11-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Mindful Movement for Physical Activity and Wellbeing in Older Adults|Mindful Movement for Physical Activity and Wellbeing in Older Adults: A Community Based Randomized Hybrid Effectiveness-Implementation Study|Not yet recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||No|Data will be provided in aggregate.|2017-10-10 21:10:18.789697|2017-10-10 21:10:18.789697
NCT03114696|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-05|||April 25, 2017|Actual|2017-04-25|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Benefit of IQP-AO-101 for Sleep|Double-blind, Placebo-controlled, Randomised Pilot Clinical Trial to Explore Benefit and Tolerability of IQP-AO-101 in Healthy Subjects With Sleep Complaints|Recruiting||N/A|50|Anticipated|InQpharm Group||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:18.901529|2017-10-10 21:10:18.901529
NCT03114683|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|December 30, 2018|Anticipated|2018-12-30||Interventional|ORIENT-1||Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma: a Multicenter, Single Arm, Phase II Study|Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma: a Multicenter, Single Arm, Phase II Study|Not yet recruiting||Phase 2|90|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||1|||f||||f|f|f||||||||2017-10-10 21:10:18.988817|2017-10-10 21:10:18.988817
NCT03114670|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-06-13|||March 25, 2017|Actual|2017-03-25|June 2017|2017-06-01|March 18, 2021|Anticipated|2021-03-18|March 18, 2019|Anticipated|2019-03-18||Interventional|||Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT|Donor-derived Anti-CD123 Chimeric Antigen Receptors Modified T Cells for Recurred Acute Myeloid Leukaemia After Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 1|20|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:10:19.058004|2017-10-10 21:10:19.058004
NCT03114657|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-25|||March 29, 2017|Actual|2017-03-29|September 2017|2017-09-01|October 28, 2022|Anticipated|2022-10-28|October 28, 2021|Anticipated|2021-10-28||Interventional|CREAD 2||A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Crenezumab in Patients With Prodromal to Mild Alzheimer's Disease|Recruiting||Phase 3|750|Anticipated|Hoffmann-La Roche||2|||f||||t|t|f||||||||2017-10-10 21:10:19.2084|2017-10-10 21:10:19.2084
NCT03114644|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||January 21, 2016|Actual|2016-01-21|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|SynchroPrema||Reading Stories to Premature Babies Reinforces Mother-baby Synchronies?|Reading Stories to Premature Babies Reinforces Mother-baby Synchronies?|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:10:19.838541|2017-10-10 21:10:19.838541
NCT03114631|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-13|||January 9, 2017|Actual|2017-01-09|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer|Single-center Trial Evaluating the Safety and Efficacy of MUC-1/WT-1 Peptide or Tumor Lysate-pulsed Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer|Enrolling by invitation||Phase 1/Phase 2|30|Anticipated|The Republican Research and Practical Center for Epidemiology and Microbiology||3|||f||||t|f|f||||||Undecided||2017-10-10 21:10:19.912147|2017-10-10 21:10:19.912147
NCT03114618|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-10|||March 2013||2013-03-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|ONCOTHROMB||A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient|Genomic Predictors Indicating the Risk of Venous Thromboembolic Disease in Cancer Patients Treated in Outpatient Clinics|Completed||N/A|406|Actual|Hospital General Universitario Gregorio Marañon|||1||f||||t||||||Samples With DNA|"     EDTA Blood sample   "|Undecided||2017-10-10 21:10:20.001308|2017-10-10 21:10:20.001308
NCT03114605|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-10|||October 10, 2016|Actual|2016-10-10|March 2017|2017-03-01|January 10, 2018|Anticipated|2018-01-10|January 10, 2018|Anticipated|2018-01-10||Interventional|||Mindfulness-based Intervention in Police Officers - the POLICE Study|imPact Of a mindfuLness-based Intervention on Quality of Life and reduCtion of Burnout Symptoms in policE Officers - the POLICE Study|Enrolling by invitation||N/A|160|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:20.102631|2017-10-10 21:10:20.102631
NCT03114592|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-06-27|||June 16, 2017|Actual|2017-06-16|April 2017|2017-04-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|Change AKI||Understanding the Role of Patient Behavior Change in Improving AKI Outcomes|Understanding the Role of Patient Behavior Change in Improving AKI Outcomes (Change AKI Study)|Recruiting||N/A|50|Anticipated|Duke University||2|||f||||f|f|f||||||No|We are not sharing IPD|2017-10-10 21:10:20.196981|2017-10-10 21:10:20.196981
NCT03114579|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-13|||February 11, 2015|Actual|2015-02-11|April 2017|2017-04-01|February 11, 2017|Actual|2017-02-11|February 11, 2017|Actual|2017-02-11||Interventional|NEXFIN||Evaluation of the Measurement of Cardiac Output by the NEXFIN HD Monitor in Peroperative|Evaluation of the Measurement of Cardiac Output by the NEXFIN HD Monitor in Peroperative|Completed||N/A|42|Actual|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:10:20.295812|2017-10-10 21:10:20.295812
NCT03114566|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-18|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors|Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors|Recruiting||N/A|80|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f|||||f|f||||||Undecided||2017-10-10 21:10:20.373022|2017-10-10 21:10:20.373022
NCT03114553|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-11|||July 23, 2017|Actual|2017-07-23|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Family History in a Singaporean Healthy Population|Integration of Family Health History Data Into a Singaporean Healthy Population Cohort Database to Understand the Associations Between Family Health History and Genomics|Recruiting||N/A|1000|Anticipated|Duke University|||1||f||||f|f|f||||None Retained|"     blood   "|||2017-10-10 21:10:20.451278|2017-10-10 21:10:20.451278
NCT03114540|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-31|||March 17, 2017|Actual|2017-03-17|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment|A Phase 1, Open-Label Study to Characterize the Pharmacokinetics and Safety of a Single Oral Dose of GBT440 in Subjects With Hepatic Impairment|Recruiting||Phase 1|28|Anticipated|Global Blood Therapeutics||4|||f||||f|t|f||||||Undecided||2017-10-10 21:10:20.532259|2017-10-10 21:10:20.532259
NCT03114514|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-13|||June 17, 2016|Actual|2016-06-17|May 2017|2017-05-01|May 10, 2017|Actual|2017-05-10|April 20, 2017|Actual|2017-04-20||Interventional|||Efficacy of Platelet-rich Plasma (PRP) in the Treatment of Dark Circles Under the Eyes|Efficacy of Platelet-Rich Plasma (PRP) in the Treatment of Periorbital Hyperpigmentation|Completed||N/A|40|Actual|Damascus University||1|||f||||t|f|f||||||No||2017-10-10 21:10:20.733844|2017-10-10 21:10:20.733844
NCT03114501|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-07-17|||April 11, 2017|Actual|2017-04-11|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers|Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers|Recruiting||N/A|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 21:10:20.809539|2017-10-10 21:10:20.809539
NCT03114488|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-13|||December 2017||2017-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:10:20.89393|2017-10-10 21:10:20.89393
NCT03114475|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-31|||June 15, 2016|Actual|2016-06-15|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|April 20, 2017|Actual|2017-04-20||Interventional|||Effect of CO2 Laser on Enamel White Spot Lesion Formation Around Orthodontic Brackets|Evaluation of Enamel Resistance to White Spot Lesion Formation Around Orthodontic Brackets After CO2 Laser Irradiation: A Randomized Controlled Clinical Trial|Active, not recruiting||N/A|25|Anticipated|Damascus University||2|||f||||t|f|f||||||||2017-10-10 21:10:20.928374|2017-10-10 21:10:20.928374
NCT03114462|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-08-10|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|August 2027|Anticipated|2027-08-01|August 2027|Anticipated|2027-08-01||Interventional|||Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer|A Phase I Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer|Recruiting||Phase 1|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|f|f||||||||2017-10-10 21:10:21.107569|2017-10-10 21:10:21.107569
NCT03114449|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-10|||October 2012|Actual|2012-10-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|AA_K-TEP||Auricular Acupuncture vs. Sham Procedure for Pain Control After Knee Arthroplasty|Auricular Acupuncture (AA) vs. Sham AA Procedure for Pain Control After Elective Knee Arthroplasty - a Randomized Controlled Trial|Completed||N/A|150|Actual|University Medicine Greifswald||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:21.220824|2017-10-10 21:10:21.220824
NCT03114436|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-11|||August 31, 2016|Actual|2016-08-31|April 2017|2017-04-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|CanadaDONATE||National Observational Study of Clinical Practices in Deceased Organ Donation|Canada-DONATE: National Observational Study of Clinical Practices in Deceased Organ Donation|Recruiting||N/A|450|Anticipated|McMaster University|||1||f||||f|f|f||||||Undecided||2017-10-10 21:10:21.302253|2017-10-10 21:10:21.302253
NCT03114423|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-05-02|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|||Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment of Substance Use Disorders|The Efficiency of Eye Movement Desensitization and Reprocessing (EMDR) for the Treatment of Substance Use Disorders: A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Center of Integrative Addiction Research, Austria||2|||f||||f|f|f||||||No||2017-10-10 21:10:21.467103|2017-10-10 21:10:21.467103
NCT03114410|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-10|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||An Evaluation of Re:MIX: a Teen Pregnancy Prevention Program With Young Parents as Peer Educators, EngenderHealth||Recruiting||N/A|||Child Trends|||||f||||f|f|f||||||No||2017-10-10 21:10:21.590237|2017-10-10 21:10:21.590237
NCT03114397|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Long-term Effect of tDCS in Patients With Disorders of Consciousness|Long-term Effect of 20 Sessions of Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness: a Double Blind Sham Controlled Clinical Trial.|Not yet recruiting||N/A|124|Anticipated|University Hospital of Liege||2|||f|||||f|f||||||||2017-10-10 21:10:21.682017|2017-10-10 21:10:21.682017
NCT03114384|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-11|||April 14, 2017|Anticipated|2017-04-14|April 2017|2017-04-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Interventional|ADULT||Patient-ventilator Asynchrony During Noninvasive Ventilation Assessed Using Diaphragm Ultrasonography|Patient-ventilator Asynchrony During Noninvasive Ventilation Assessed Using Diaphragm Ultrasonography|Recruiting||N/A|15|Anticipated|Centre Hospitalier Saint Joseph Saint Luc de Lyon||1|||f||||f|f|f||||||No||2017-10-10 21:10:21.780318|2017-10-10 21:10:21.780318
NCT03114371|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-05-02|||November 28, 2016|Actual|2016-11-28|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|Oxyjeune||Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years|Effects of Intranasal Administrations of Oxytocin on Behavioural Troubles, Hyperphagia and Social Skills in Children With Prader-Willi Syndrome Aged From 3 to 12 Years.|Recruiting||N/A|40|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-10 21:10:21.866463|2017-10-10 21:10:21.866463
NCT03114358|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-17|||June 1, 2016|Actual|2016-06-01|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Carbapenems De-escalation as Antimicrobial Stewardship|A Cluster Randomized Controlled Trial Comparing Early and Late Carbapenems De-escalation in the Medicine Units, Maharaj Nakorn Chiang Mai Hospital|Completed||N/A|104|Actual|Chiang Mai University||2|||f||||f|f|f||||||No||2017-10-10 21:10:22.002113|2017-10-10 21:10:22.002113
NCT03114345|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-13|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|VASCIP||Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient|Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient|Not yet recruiting||N/A|50|Anticipated|University Hospital, Montpellier||1|||f||||f|f|f||||||No||2017-10-10 21:10:22.089227|2017-10-10 21:10:22.089227
NCT03114332|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||December 2015||2015-12-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Subcutaneous Drains And Cesarean Section|Subcutaneous Drains In Lean Women Undergoing Cesarean Section, A Randomized Controlled Trial|Completed||N/A|150|Actual|Menoufia University||2|||f|||||f|f||||||Undecided||2017-10-10 21:10:22.193943|2017-10-10 21:10:22.193943
NCT03114319|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-29|||May 26, 2017|Actual|2017-05-26|September 2017|2017-09-01|March 18, 2020|Anticipated|2020-03-18|March 18, 2020|Anticipated|2020-03-18||Interventional|||Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors|An Open-label, Multi-center, Phase I, Dose Finding Study of Oral TNO155 in Adult Patients With Advanced Solid Tumors|Recruiting||Phase 1|105|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:10:22.29187|2017-10-10 21:10:22.29187
NCT03114306|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-09-01|||April 5, 2017|Actual|2017-04-05|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Interventional|KneeOptOut||Evaluation of a Fast-track Knee Arthroplasty Concept|Implementation of a Fast-track Knee Arthroplasty Concept: a Randomized, Controlled, Open Clinical Trial|Completed||N/A|40|Actual|Charite University, Berlin, Germany||2|||f||||t|f|f||||||||2017-10-10 21:10:22.421518|2017-10-10 21:10:22.421518
NCT03114293|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-02|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|May 30, 2017|Anticipated|2017-05-30|May 30, 2017|Anticipated|2017-05-30||Interventional|PIA||Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS|Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS|Active, not recruiting||N/A|40|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:22.543765|2017-10-10 21:10:22.543765
NCT03114280|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-10-02|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|PICH||Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)|Induction Therapy With Docetaxel, Cisplatin, 5-Fluoro Uracil and Pembrolizumab in Untreated Locally-advanced Unresectable Squamous Cell Head and Neck Carcinoma (Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma. PICH Study)|Not yet recruiting||Phase 2|55|Anticipated|Centre Antoine Lacassagne||1|||f||||t|f|f||||||||2017-10-10 21:10:22.65928|2017-10-10 21:10:22.65928
NCT03114267|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-11|||January 6, 2012|Actual|2012-01-06|April 2017|2017-04-01|January 6, 2015|Actual|2015-01-06|January 6, 2015|Actual|2015-01-06||Observational|Etude thyrovir||Involvement of Viral Infections in the Pathogenesis of Chronic Lymphocytic Thyroiditis|Involvement of Viral Infections in the Pathogenesis of Chronic Lymphocytic Thyroiditis|Completed||N/A|64|Actual|Centre Hospitalier Universitaire, Amiens|||2||f|||||f|f||||||||2017-10-10 21:10:22.756014|2017-10-10 21:10:22.756014
NCT03114254|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-04-10|||December 5, 2014|Actual|2014-12-05|April 2017|2017-04-01|November 16, 2016|Actual|2016-11-16|November 16, 2016|Actual|2016-11-16||Interventional|JAVA-P||A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis|A Phase II Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis|Completed||Phase 2|17|Actual|University Hospitals Bristol NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 21:10:22.826153|2017-10-10 21:10:22.826153
NCT03113877|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-04-10|||August 2016||2016-08-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Evaluation of Autonomic Function in Individuals With Cornelia de Lange Syndrome (CdLS)|Evaluation of Autonomic Function in Individuals With Cornelia de Lange Syndrome (CdLS), a Pilot Study.|Recruiting||N/A|10|Anticipated|Mayo Clinic|||1||f||||f||||||||No||2017-10-10 21:10:26.117264|2017-10-10 21:10:26.117264
NCT03114241|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-06-06|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Long-term Effects of a 3-month Pedometer-based Program to Enhance Physical Activity in Patients With Severe COPD|Long-term Effects of a 3-month Pedometer-based Program to Enhance Physical Activity in Patients With Severe COPD|Recruiting||N/A|74|Anticipated|University of Zurich||2|||f||||f|f|f||||||No||2017-10-10 21:10:22.930311|2017-10-10 21:10:22.930311
NCT03114228|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-04-28||||||April 2017|2017-04-01||||||||Expanded Access|||An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)|An Open-labeled, Multi-Center, Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy|Available||N/A|||Novartis||||||||t|||||||||||2017-10-10 21:10:23.025974|2017-10-10 21:10:23.025974
NCT03114215|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-01|||June 29, 2016|Actual|2016-06-29|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 12, 2017|Actual|2017-06-12||Interventional|MD1003-ALS||Effect of MD1003 in Amyotrophic Lateral Sclerosis|Effect of MD1003 in Amyotrophic Lateral Sclerosis: a Randomized Double Blind Placebo Controlled Pilot Study|Active, not recruiting||Phase 2|30|Actual|MedDay Pharmaceuticals SA||2|||f||||t|f|f||||||||2017-10-10 21:10:23.095035|2017-10-10 21:10:23.095035
NCT03114202|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-07-14|||April 18, 2017|Actual|2017-04-18|March 2017|2017-03-01|October 1, 2018|Anticipated|2018-10-01|August 6, 2018|Anticipated|2018-08-06||Interventional|||Effects of Nutritional Counseling on Nutritional Status and Quality of Life of Head and Neck Cancer Patients|Effects of Intensive Nutritional Counseling on Nutritional Status and Quality of Life of Patients With Head and Neck Cancer Undergoing Radiation Therapy|Recruiting||N/A|90|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 21:10:23.1895|2017-10-10 21:10:23.1895
NCT03114189|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-04-10|||November 2016||2016-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|KWAI||Kneipp Water Applications for Insomnia|Effects of Ascending Warm Footbaths on Sleep Disturbances in Women Before Climacteric|Recruiting||N/A|52|Anticipated|Universität Duisburg-Essen||2|||f||||||||||||||2017-10-10 21:10:23.291781|2017-10-10 21:10:23.291781
NCT03114176|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||May 25, 2016|Actual|2016-05-25|April 2017|2017-04-01|July 10, 2016|Actual|2016-07-10|July 10, 2016|Actual|2016-07-10||Interventional|||Effects of Ketogenic Diet in Divers Breathing Enriched Air Nitrox|Effects of Exercise and Dietary Inatke on Muscle Metabolism and Inflammatory Status Modulated by Oxygen Free Radicals and Cytokines in Humans|Completed||N/A|6|Actual|University of Padova||1|||f|||||f|f|||f|||No||2017-10-10 21:10:23.37167|2017-10-10 21:10:23.37167
NCT03114163|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-10-03|||May 4, 2017|Actual|2017-05-04|October 2017|2017-10-01|July 1, 2024|Anticipated|2024-07-01|July 1, 2024|Anticipated|2024-07-01||Observational|||Observational Study of Nivolumab in Patients in Germany With Squamous Cell Carcinoma of the Head and Neck Progressing on or After Platinum-Based Therapy|A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (BMS-936558) in Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy|Recruiting||N/A|385|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:10:23.443529|2017-10-10 21:10:23.443529
NCT03114150|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-11|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Exercise Effects on Brain Health and Learning From Minutes to Months|Exercise to Improve Hippocampal Connectivity and Learning in Older Adults|Not yet recruiting||N/A|120|Anticipated|University of Iowa||2|||f||||t|f|f||||||||2017-10-10 21:10:23.568006|2017-10-10 21:10:23.568006
NCT03114137|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-10|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|CADRE||Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose|Heart, Arteries and Sikle Cell Disease, a Multicentric Cohort of Cardiovascular Complications in Subsaharan Africa|Recruiting||N/A|4500|Anticipated|Cardiologie et Développement|||2||f||||f|f|f||||Samples With DNA|"     whole blood plasma saliva urines   "|No||2017-10-10 21:10:23.687244|2017-10-10 21:10:23.687244
NCT03114124|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-23|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|May 30, 2019|Anticipated|2019-05-30|April 1, 2019|Anticipated|2019-04-01||Interventional|||Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation|Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success|Recruiting||N/A|30|Anticipated|University of Florida||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:10:23.859979|2017-10-10 21:10:23.859979
NCT03114111|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-24|||January 2017||2017-01-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis||Recruiting||N/A|12|Anticipated|University of California, Davis||2|||f||||||||||||||2017-10-10 21:10:23.947588|2017-10-10 21:10:23.947588
NCT03114098|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-13|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|November 30, 2018|Anticipated|2018-11-30|May 30, 2018|Anticipated|2018-05-30||Interventional|M4P||Pharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic Drugs|Personalized Medicine: Pharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic Drugs|Recruiting||N/A|22|Anticipated|Fondation Lenval||1|||f||||f|f|f||||||No||2017-10-10 21:10:24.028764|2017-10-10 21:10:24.028764
NCT03114085|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-12|||May 20, 2017|Anticipated|2017-05-20|May 2017|2017-05-01|May 20, 2019|Anticipated|2019-05-20|March 20, 2019|Anticipated|2019-03-20||Interventional|||Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma|Apatinib Combined With Capecitabine Compared With Apatinib in the Treatment of Advanced Non-resectable Hepatocellular Carcinoma|Not yet recruiting||Phase 2|170|Anticipated|First Affiliated Hospital of Guangxi Medical University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:10:24.123289|2017-10-10 21:10:24.123289
NCT03114072|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-15|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|March 2019|Anticipated|2019-03-01||Interventional|||Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep|Nightly Light Exposure in Pregnancy: Blue-blocking Glasses as an Intervention to Ease Sleep Disturbances and to Improve Mood|Not yet recruiting||N/A|60|Anticipated|University of Bergen||2|||f||||f|f|f||||||No||2017-10-10 21:10:24.200838|2017-10-10 21:10:24.200838
NCT03114059|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Observational|||5 Years Long Term Results After Standalone CyPass-Implantation|Retro- and Prospective Monocentric Study to Evaluate the Safety and Effectiveness of the CyPass Stent 5 Years After Implantation|Enrolling by invitation||N/A|130|Anticipated|Dietrich-Bonhoeffer-Klinikum|||1||f||||f|f|f||||||Yes|results will be published in ophthalmological journals|2017-10-10 21:10:24.302103|2017-10-10 21:10:24.302103
NCT03114046|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-08|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Constraint-induced Movement Therapy to Improve Gait and Mobility of People With Chronic Stroke|Constraint-induced Movement Therapy to Improve Gait and Mobility of People With Chronic Stroke|Recruiting||N/A|8|Anticipated|University of Alabama at Birmingham||1|||f||||f|f|f||||||No||2017-10-10 21:10:24.384331|2017-10-10 21:10:24.384331
NCT03114033|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-19|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|TAME||Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest|TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial|Not yet recruiting||N/A|1700|Anticipated|Australian and New Zealand Intensive Care Research Centre||2|||f||||f|f|f||||||||2017-10-10 21:10:24.470004|2017-10-10 21:10:24.470004
NCT03114020|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-07|||March 22, 2017|Actual|2017-03-22|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency|Phase 2 Randomized Parallel-Group Double-Blind Placebo-Controlled Multiple-Dose Proof-of-Concept Study to Evaluate the Efficacy/Safety of Hyaluronic Acid Inhalation Solution for Treatment of Emphysema|Recruiting||Phase 2|40|Anticipated|Turino, Gerard, M.D.||2|||f||||f|t|f||||||No||2017-10-10 21:10:24.556048|2017-10-10 21:10:24.556048
NCT03114007|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-10|||April 24, 2017|Anticipated|2017-04-24|April 2017|2017-04-01|December 14, 2021|Anticipated|2021-12-14|September 14, 2021|Anticipated|2021-09-14||Interventional|||Integrated Prevention and Collaborative Care for Youth Mental Health|Inter-Venture: A Cluster Randomized Controlled Trial Investigating the Effect of School-based Personality-targeted Interventions and Collaborative Youth Mental Health Care|Recruiting||N/A|4000|Anticipated|St. Justine's Hospital||3|||f||||t|f|f||||||||2017-10-10 21:10:24.836103|2017-10-10 21:10:24.836103
NCT03113994|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-06-07|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|RoBaCO||Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk|The Efficacy and Safety of Rosuvastatin for Modifying Bone Mass and Cardiometabolic Disease Outcomes|Not yet recruiting||Phase 2|54|Anticipated|Toronto Rehabilitation Institute||2|||f||||t|t|f|||f|||No||2017-10-10 21:10:24.98706|2017-10-10 21:10:24.98706
NCT03113981|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2034|Anticipated|2034-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®|Randomized Controlled Non-inferiority Trial Assessing the Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)|Not yet recruiting||N/A|380|Anticipated|Laboratoire Ceraver-Osteal||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:10:25.141442|2017-10-10 21:10:25.141442
NCT03113968|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-20|||April 7, 2017|Actual|2017-04-07|July 2017|2017-07-01|April 1, 2022|Anticipated|2022-04-01|March 1, 2021|Anticipated|2021-03-01||Interventional|ELEKT-D||ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)|ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)|Recruiting||Phase 2/Phase 3|400|Anticipated|The Cleveland Clinic||2|||f||||t|t|f|||f|||||2017-10-10 21:10:25.258096|2017-10-10 21:10:25.258096
NCT03113955|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-13|||August 31, 2017|Anticipated|2017-08-31|March 2017|2017-03-01|May 31, 2019|Anticipated|2019-05-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma|A Single-arm Trial of Transcatheter Arterial Chemoembolization With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma|Not yet recruiting||N/A|109|Anticipated|Boston Scientific Corporation||1|||f||||f|f|f||||||No||2017-10-10 21:10:25.408297|2017-10-10 21:10:25.408297
NCT03113942|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-22|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|SPACE||Study of Pomalidomide in Anal Cancer Precursors|Study of Pomalidomide in Anal Cancer Precursors (SPACE): a Phase 2 Study of Immunomodulation in People With Persistent HPV-associated High Grade Squamous Intraepithelial Lesions|Recruiting||Phase 2|26|Anticipated|Kirby Institute||1|||f||||f|f|f||||||||2017-10-10 21:10:25.506355|2017-10-10 21:10:25.506355
NCT03113929|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-07-06|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)|Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)|Recruiting||N/A|20|Anticipated|The Cleveland Clinic|||1||f||||||||||||||2017-10-10 21:10:25.642808|2017-10-10 21:10:25.642808
NCT03113916|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||June 23, 2014|Actual|2014-06-23|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||De Por Vida: A Diabetes Risk Reduction Intervention for Hispanic Women|Culturally Competent Behavioral Intervention for Diabetes Risk Reduction|Active, not recruiting||N/A|200|Actual|Kaiser Permanente||2|||f||||t|f|f||||||No||2017-10-10 21:10:25.752781|2017-10-10 21:10:25.752781
NCT03113903|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-10|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PSQ-F||Validation of the French Version of the Pain Sensitivity Questionnaire|Validation of the French Version of the Pain Sensitivity Questionnaire|Not yet recruiting||N/A|235|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:10:25.864899|2017-10-10 21:10:25.864899
NCT03113890|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-09-25|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|GPS||McLean and Genomind Prospective Study|McLean and Genomind Prospective Study of Pharmacogenetic Testing|Recruiting||N/A|200|Anticipated|Mclean Hospital||2|||f||||f|f|f||||||||2017-10-10 21:10:25.986452|2017-10-10 21:10:25.986452
NCT02628847|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-01-03|||March 2012||2012-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Sildenafil and Stroke Recovery|Sildenafil and Stroke Recovery|Terminated||Phase 1|11|Actual|University of Utah||2||Recruitment was problematic|f||||f||||||||Undecided||2017-10-10 22:39:57.373556|2017-10-10 22:39:57.373556
NCT03113851|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-06|||July 30, 2017|Anticipated|2017-07-30|April 2017|2017-04-01|October 14, 2018|Anticipated|2018-10-14|August 14, 2018|Anticipated|2018-08-14||Interventional|||Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer|Observation of Abscopal Effect of Radiation in Combination With rhGM-CSF for Patients With Metastatic Non-small Cell Lung Cancer|Recruiting||Phase 2|40|Anticipated|Beijing Cancer Hospital||1|||f||||f|f|f||||||||2017-10-10 21:10:26.312242|2017-10-10 21:10:26.312242
NCT03113838|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-10|||April 17, 2017|Anticipated|2017-04-17|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|8 Weeks|Observational [Patient Registry]|||Surveillance for Early Liver Injuries Caused by Yangxue Shengfa Capsule.|A Registry Study to Surveil Early Liver Injuries Caused by Yangxue Shengfa Capsule (YXSF Capsule).|Not yet recruiting||N/A|1000|Anticipated|Beijing 302 Hospital|||1||f|||||f|f||||Samples With DNA|"     serum, plasma, histology and urine   "|Undecided||2017-10-10 21:10:26.417376|2017-10-10 21:10:26.417376
NCT03113825|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-25|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery|An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery|Recruiting||Phase 2|110|Anticipated|Avelas Biosciences, Inc.||1|||f||||t|t|t|t|f||||||2017-10-10 21:10:26.520021|2017-10-10 21:10:26.520021
NCT03113812|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||January 1, 2014|Actual|2014-01-01|April 2017|2017-04-01|July 30, 2015|Actual|2015-07-30|July 30, 2015|Actual|2015-07-30||Interventional|||Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients|A Randomized, Placebo-controlled, Parallel Group, Double-blinded, Single-center Phase-I, Pilot Study to Assess Tolerability and Safety of Repeated Subcutaneous Administration of ABvac40 in Patients With Mild to Moderate Alzheimer's Disease.|Completed||Phase 1|24|Actual|Araclon Biotech S.L.||2|||f||||t|f|f||||||No||2017-10-10 21:10:26.678148|2017-10-10 21:10:26.678148
NCT03113799|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-10|||April 12, 2017|Anticipated|2017-04-12|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|SED||A Study Evaluate Aqueduct's Smart External Drain|A Study to Evaluate the Performance and Safety of Aqueduct's Smart External Device (SED) Compared to Standard EVD Drains|Recruiting||N/A|75|Anticipated|Aqueduct Critical Care||1|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:10:26.762769|2017-10-10 21:10:26.762769
NCT03113786|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-10|||November 2, 2011|Actual|2011-11-02|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|December 2017|Anticipated|2017-12-01||Interventional|||CLARIX™ 100 & CLARIX CORD 1K for Discectomy Patients|Efficacy of Amniotic Tissue (CLARIX 100 & CLARIX CORD 1K) in Pain Reduction and Improvement of Function in Low Back & Leg Pain in Discectomy Patients|Recruiting||Phase 4|120|Anticipated|Amniox Medical, Inc.||3|||f||||f|f|f||||||No||2017-10-10 21:10:26.852409|2017-10-10 21:10:26.852409
NCT03113773|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-25|||June 7, 2017|Actual|2017-06-07|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|LILACS||Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes|Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes|Recruiting||Phase 1/Phase 2|57|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t|f|f||||||||2017-10-10 21:10:26.933361|2017-10-10 21:10:26.933361
NCT03113760|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-15|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency|Multicenter, Randomized, Double-blind, Placebo-controlled Trial With Tadekinig Alfa (r-hIL-18BP) in Patients With IL-18 Driven Monogenic Auto Inflammatory Conditions: NLRC4 Mutation and XIAP Deficiency|Recruiting||Phase 3|10|Anticipated|AB2 Bio Ltd.||2|||||||t|t|f||||||Yes|This information will be provided soon|2017-10-10 21:10:27.028752|2017-10-10 21:10:27.028752
NCT03113747|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-25|||March 25, 2015|Actual|2015-03-25|April 2017|2017-04-01|December 26, 2018|Anticipated|2018-12-26|December 26, 2018|Anticipated|2018-12-26||Interventional|ADSCs-BWs||Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)|Safety and Efficacy Evaluation of Tissue Engineered Construct Based on Allogeneic Adipose-derived Multipotent Mesenchymal Stromal Cells and Platelet-poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds|Recruiting||Phase 1/Phase 2|20|Anticipated|A.A. Partners, LLC||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:10:27.146088|2017-10-10 21:10:27.146088
NCT03113734|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-06-19|||April 29, 2017|Actual|2017-04-29|June 2017|2017-06-01|May 29, 2019|Anticipated|2019-05-29|May 29, 2019|Anticipated|2019-05-29||Observational|ACL-TS||Clinical Screening of Acute Ruptures of the Anterior Cruciate Ligament of the Knee|Construction and Validation of a Functional Score for the Detection of Ruptures of the Anterior Cruciate Ligament in the Immediate Post-traumatic Period|Recruiting||N/A|380|Anticipated|French Arthroscopic Society|||1||f||||f|f|f||||||No|In this study, the individual participant data (IPD) is not available to other researchers|2017-10-10 21:10:27.244557|2017-10-10 21:10:27.244557
NCT03113721|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-17|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Observational|||Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis|Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the HBP Assay to Predict Development of Severe Sepsis in Patients With Suspected Infection Following ED Admission|Recruiting||N/A|300|Anticipated|Axis Shield Diagnostics Ltd|||1||f||||f|f|f||||Samples Without DNA|"     Human plasma   "|No||2017-10-10 21:10:27.326287|2017-10-10 21:10:27.326287
NCT03113708|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-04-13|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|June 20, 2017|Anticipated|2017-06-20|May 20, 2017|Anticipated|2017-05-20||Interventional|LBWH||The Effect of Heparinization Due to LBW|The Effect of Heparinization Due to LBW in Cardiac Surgery|Not yet recruiting||Phase 4|50|Anticipated|Adiyaman University Research Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:10:27.398537|2017-10-10 21:10:27.398537
NCT03113695|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-12|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome|Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome|Not yet recruiting||Phase 1|10|Anticipated|University of California, San Diego||1|||f||||t|t|f|||t|||No||2017-10-10 21:10:27.481538|2017-10-10 21:10:27.481538
NCT03113669|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||October 6, 2016|Actual|2016-10-06|April 2017|2017-04-01|October 5, 2017|Anticipated|2017-10-05|October 5, 2017|Anticipated|2017-10-05||Interventional|||Project BITE: Binge Intervention Target Effectiveness|An Investigation of Appetitive Cognitive Control: Impact on Treat Outcomes for Binge Eating|Recruiting||N/A|20|Anticipated|Drexel University||1|||f|||||f|f||||||No||2017-10-10 21:10:27.642525|2017-10-10 21:10:27.642525
NCT03113656|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-14|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Weighted Blankets With Infants With NAS|The Use of Weighted Blankets in the Care of Infants With Neonatal Abstinence Syndrome (NAS)|Recruiting||N/A|30|Anticipated|TriHealth Inc.||2|||f|||||f|f||||||||2017-10-10 21:10:27.783157|2017-10-10 21:10:27.783157
NCT03113643|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-25|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|May 31, 2023|Anticipated|2023-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||SL-401 in Combination With Azacitidine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)|Phase 1 Study of SL-401 in Combination With Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia (AML) or in Treatment-Naive AML Not Eligible for Standard Therapy or in Subjects With High-Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1|36|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:10:27.916724|2017-10-10 21:10:27.916724
NCT03113630|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-08|||February 2, 2016|Actual|2016-02-02|April 2017|2017-04-01|October 4, 2016|Actual|2016-10-04|August 3, 2016|Actual|2016-08-03||Interventional|||Virtual Task in Amyotrophic Lateral Sclerosis|Efficacy of Different Interaction Devices Using Virtual Task in Amyotrophic Lateral Sclerosis|Completed||N/A|60|Actual|University of Sao Paulo||6|||f||||f|f|f||||||Undecided||2017-10-10 21:10:28.043309|2017-10-10 21:10:28.043309
NCT03113617|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-15|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|April 10, 2021|Anticipated|2021-04-10|April 10, 2020|Anticipated|2020-04-10||Interventional|||68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer|68Ga-RM2 PET/CT for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer|Recruiting||Phase 2|90|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 21:10:28.162448|2017-10-10 21:10:28.162448
NCT03113604|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||November 20, 2015|Actual|2015-11-20|April 2017|2017-04-01|November 20, 2016|Actual|2016-11-20|November 20, 2016|Actual|2016-11-20||Observational|SLAMF3||Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients|Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire, Amiens|||3|The study has been stopped because no one is|f|||||f|f||||||||2017-10-10 21:10:28.30087|2017-10-10 21:10:28.30087
NCT03113591|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-08|||August 29, 2016|Actual|2016-08-29|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluate the Effect of Osteo Introducer System in Total Hip Arthroplasty|Evaluate the Effect of Osteo Introducer System in Total Hip Arthroplasty: A Prospective, Multicenter, Randomized Controlled Study|Recruiting||N/A|60|Anticipated|Suzhou MicroPort OrthoRecon Co. LTD||2|||f||||f|f|f||||||No||2017-10-10 21:10:28.409448|2017-10-10 21:10:28.409448
NCT03113578|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-08|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|July 15, 2017|Anticipated|2017-07-15|June 15, 2017|Anticipated|2017-06-15||Observational|||Evaluation of the DiLumen Device During Colonoscopy|First-in-Human, Single Center, Evaluation of the DiLumen Device in Routine Colonoscopy|Not yet recruiting||N/A|30|Anticipated|Lumendi, LLC|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:10:28.514386|2017-10-10 21:10:28.514386
NCT03113565|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-23|||August 9, 2017|Actual|2017-08-09|March 2017|2017-03-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15|12 Months|Observational [Patient Registry]|BECSuP||Connected Electronic Wrist Strap for Patient Follow-up After Cardiac Surgery|Connected Electronic Wrist Strap for Patient Follow-up After Cardiac Surgery|Recruiting||N/A|100|Anticipated|CMC Ambroise Paré|||1||f||||f|f|f||||||||2017-10-10 21:10:28.618233|2017-10-10 21:10:28.618233
NCT03113552|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||February 4, 2013|Actual|2013-02-04|April 2017|2017-04-01|February 4, 2018|Anticipated|2018-02-04|February 4, 2018|Anticipated|2018-02-04||Observational|IPPVM||Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty|Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty|Recruiting||N/A|348|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:10:28.711832|2017-10-10 21:10:28.711832
NCT03113539|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-05-06|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Low-dose Gated CT Validity for the Evaluation of Ascendant Aortic Aneurysm.|Low-dose, EKG-gated CT Validity for the Evaluation of Ascendant Aortic Aneurysm.|Recruiting||N/A|99|Anticipated|Université de Sherbrooke||1|||f||||t|f|f||||||No||2017-10-10 21:10:28.782921|2017-10-10 21:10:28.782921
NCT03113526|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||December 1, 2015|Actual|2015-12-01|April 2017|2017-04-01|January 1, 2019|Anticipated|2019-01-01|December 1, 2018|Anticipated|2018-12-01||Interventional|SLNDs||Neck Drains for SLNDs|A Randomized Clinical Trial Comparing Output Volume Thresholds For Drain Removal After Selective Lateral Neck Dissections|Recruiting||N/A|100|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||No||2017-10-10 21:10:28.890944|2017-10-10 21:10:28.890944
NCT03113513|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||May 1, 2016|Actual|2016-05-01|April 2017|2017-04-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|SLF vs McCall||Randomized Trial of Sacrospinous Ligament Fixation Versus McCall Culdoplasty in Women Undergoing Vaginal Hysterectomy and Repairs for Prolapse|Randomized Trial of Sacrospinous Ligament Fixation Versus McCall Culdoplasty in Women Undergoing Vaginal Hysterectomy and Repairs for Prolapse|Recruiting||N/A|312|Anticipated|Medical University of Graz||2|||f||||f|f|f||||||No|The sponsor has access to all study relevant data. In the specific centers only authorized study personnel has access to the data.|2017-10-10 21:10:31.094185|2017-10-10 21:10:31.094185
NCT03113500|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-15|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma|A Phase 2 Study of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed by BV Consolidation in Patients With CD30-Positive Peripheral T-Cell Lymphomas|Recruiting||Phase 2|44|Anticipated|City of Hope Medical Center||1|||f||||t|t|f|||f|||||2017-10-10 21:10:31.190414|2017-10-10 21:10:31.190414
NCT03113487|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-02|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Phase II Study of a P53MVA Vaccine in Combination With Pembrolizumab in Platinum Resistant Ovarian Cancer|Not yet recruiting||Phase 2|28|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:10:31.35391|2017-10-10 21:10:31.35391
NCT03113474|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-05-22|||September 15, 2015|Actual|2015-09-15|May 2017|2017-05-01|October 8, 2015|Actual|2015-10-08|October 8, 2015|Actual|2015-10-08||Interventional|Lekkere trek||Profiling the Endocannabinoid Response to Hedonic Eating|Profiling the Endocannabinoid Response to Hedonic Eating|Completed||N/A|25|Actual|Wageningen University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:31.454174|2017-10-10 21:10:31.454174
NCT03113448|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-04-12|||January 19, 2017|Actual|2017-01-19|April 2017|2017-04-01|June 15, 2017|Anticipated|2017-06-15|April 21, 2017|Anticipated|2017-04-21||Interventional|||0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy|0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy: A Randomized, Double- Blind, Crossover, Placebo-Controlled Trial|Recruiting||Phase 3|42|Anticipated|Thammasat University||2|||f||||t|t|f|||f|||No||2017-10-10 21:10:31.628356|2017-10-10 21:10:31.628356
NCT03113435|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-28|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|August 1, 2019|Anticipated|2019-08-01|July 1, 2019|Anticipated|2019-07-01||Interventional|HEART-CORE||Patient Management During Major Abdominal Surgery: an Oxygen Consumption Protocol Compared to Standard Approach|Patient Management During Major Abdominal Surgery: the Impact of a Hemodynamic Approach Oriented to Oxygen Consumption Optimization Compared to Standard Approach Targeting Preload-dependency and a Clinically-guided Strategy|Not yet recruiting||N/A|76|Anticipated|Policlinico Universitario Agostino Gemelli||3|||f||||t|f|f||||||Undecided||2017-10-10 21:10:31.724501|2017-10-10 21:10:31.724501
NCT03113422|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-12|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|November 2021|Anticipated|2021-11-01||Interventional|PrE0403||Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy|Phase II Study of Venetoclax (ABT-199/GDC-0199) in Combination With Obinutuzumab and Bendamustine in Patients With High Tumor Burden Follicular Lymphoma as Front Line Therapy|Not yet recruiting||Phase 2|56|Anticipated|PrECOG, LLC.||2|||f||||t|t|f||||||No|Data is proprietary.|2017-10-10 21:10:31.813284|2017-10-10 21:10:31.813284
NCT03113409|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-13|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|December 30, 2018|Anticipated|2018-12-30||Interventional|||Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol|Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol|Recruiting||Phase 2/Phase 3|30|Anticipated|New York State Psychiatric Institute||3|||f||||t|t|f||||||||2017-10-10 21:10:31.923409|2017-10-10 21:10:31.923409
NCT03113396|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-08|||February 1, 2012|Actual|2012-02-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Baclofen for Rumination|A Double-blind, Placebo-controlled, Cross-over Study Using Baclofen in the Treatment of Rumination Syndrome|Completed||Phase 4|20|Actual|Universitaire Ziekenhuizen Leuven||2|||f|||||t|f|||f|||Undecided||2017-10-10 21:10:32.144246|2017-10-10 21:10:32.144246
NCT03113383|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-06|||August 18, 2017|Actual|2017-08-18|September 2017|2017-09-01|January 2026|Anticipated|2026-01-01|January 2024|Anticipated|2024-01-01||Interventional|||Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms|Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms|Enrolling by invitation||N/A|15|Anticipated|Vanderbilt University Medical Center||1|||f||||t|f|t|t|f||||||2017-10-10 21:10:32.239377|2017-10-10 21:10:32.239377
NCT03113370|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-01|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|September 1, 2019|Anticipated|2019-09-01|December 1, 2018|Anticipated|2018-12-01||Interventional|PRO-3||Preventing Tobacco Relapse With Omega-3s Trial|Preventing Tobacco Relapse With Omega-3s (PRO-3) Trial|Not yet recruiting||N/A|90|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:10:32.36404|2017-10-10 21:10:32.36404
NCT03113357|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|RCT||The Effect of Myofascial Release in Patients With Cervicogenic Headache|The Effect of Myofascial Release Technique on Headache Intensity,Duration,Frequency and Pressure Pain Threshold in Patients With Cervicogenic Headache|Completed||N/A|34|Actual|University of Social Welfare and Rehabilitation Science||2|||f||||t|f|f||||||||2017-10-10 21:10:32.456539|2017-10-10 21:10:32.456539
NCT03113344|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2025|Anticipated|2025-12-31|October 1, 2025|Anticipated|2025-10-01|28 Days|Observational [Patient Registry]|||Population Pharmacokinetics of Antibiotics in Chinese Neonates With Infectious Diseases|Population Pharmacokinetics of Antibiotics in Chinese Neonates With Infectious Diseases|Not yet recruiting||N/A|800|Anticipated|Beijing Children's Hospital|||1||f|||||f|f||||Samples With DNA|"     whole blood and plasma   "|||2017-10-10 21:10:32.569703|2017-10-10 21:10:32.569703
NCT03113331|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-18|||May 25, 2010|Actual|2010-05-25|April 2017|2017-04-01|March 2028|Anticipated|2028-03-01|February 2015|Actual|2015-02-01||Observational|3D||The 3D Cohort Study (Design, Develop, Discover)|3D Cohort Study: The Integrated Research Network in Perinatology of Quebec and Eastern Ontario|Active, not recruiting||N/A|2366|Actual|Université de Sherbrooke|||1||f||||f|f|f||||Samples With DNA|"     Maternal: blood, urine, vaginal secretions, nails, cord blood, placenta, hair, saliva Infant:     hair, meconium, blood, urine, saliva Father: Blood, urine, saliva   "|Undecided||2017-10-10 21:10:32.705786|2017-10-10 21:10:32.705786
NCT03113318|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||October 2015||2015-10-01|April 2017|2017-04-01|October 2022|Anticipated|2022-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal Cancer|Total Mediastinal Lymph Node Dissection in Pulmonary Metastasectomy From Colorectal Cancer - a Randomized, Controlled Trial|Recruiting||N/A|200|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 21:10:32.801596|2017-10-10 21:10:32.801596
NCT03113305|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-12|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Observational|||Changes in Ingestive Behaviour Following Gastric Bypass|Changes in Ingestive Behaviour Following Gastric Bypass|Recruiting||N/A|48|Anticipated|University of Ulster|||3||f||||f|f|f||||Samples Without DNA|"     DNA, Plasma and serum samples   "|Yes||2017-10-10 21:10:32.938256|2017-10-10 21:10:32.938256
NCT03113292|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-08-16|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|RCTPilates||Effects of the Pilates Method Versus Home Exercise in Individuals With Chronic Non-specific Back Pain|Cost-effectiveness of the Pilates Method Compared to Home Therapeutic Exercises in Individuals With Non-specific Chronic Low Back Pain: A Randomized Controlled Trial|Enrolling by invitation||N/A|80|Anticipated|University of Brasilia||2|||f||||f|f|f||||||||2017-10-10 21:10:33.066206|2017-10-10 21:10:33.066206
NCT03113279|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-12|||August 1, 2014|Actual|2014-08-01|April 2017|2017-04-01|August 1, 2016|Actual|2016-08-01|March 1, 2016|Actual|2016-03-01||Observational|||Mechanisms of Age-Related Muscle Loss|Influence of Increasing Physical Activity on Body Composition, Metabolic Health and Muscle Anabolism in Old Obese Adults|Completed||N/A|38|Actual|University of Birmingham|||3||f||||f|f|f||||||No||2017-10-10 21:10:33.172164|2017-10-10 21:10:33.172164
NCT03113266|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-09|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|February 2022|Anticipated|2022-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Safety and Efficacy of JS001 for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma|A Phase II, Open, Multi-center and Single Arm Study Investigating Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Injection in Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma|Recruiting||Phase 2|370|Anticipated|Shanghai Junshi Bioscience Co.,Ltd.||1|||f||||t|f|f||||||Yes||2017-10-10 21:10:33.263666|2017-10-10 21:10:33.263666
NCT03113253|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||September 22, 2016|Actual|2016-09-22|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|TRANBURN||TRANexamic Acid to Reduce Bleeding in BURN Surgery|The Effect of Tranexamic Acid (TXA) on Blood Loss in Burn Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial|Recruiting||Phase 4|102|Anticipated|Centre Hospitalier Saint Joseph Saint Luc de Lyon||2|||f||||f||||||||No||2017-10-10 21:10:33.37953|2017-10-10 21:10:33.37953
NCT03113240|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-10-04|||April 1, 2017|Actual|2017-04-01|October 2017|2017-10-01|October 1, 2017|Actual|2017-10-01|October 1, 2017|Actual|2017-10-01||Interventional|||Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients|Effects of Enteral Glutamine on Intestinal Permeability in Hospitalized Patients With Enteral Feeding in Intensive Care Unit|Completed||Phase 3|60|Actual|Shahid Beheshti University||2|||f||||t|f|f|||f|||||2017-10-10 21:10:33.522002|2017-10-10 21:10:33.522002
NCT03113227|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-07-13|||April 15, 2017|Actual|2017-04-15|July 2017|2017-07-01|July 9, 2017|Actual|2017-07-09|July 9, 2017|Actual|2017-07-09||Interventional|||Value of Measuring Cervical Angle and Length by Ultrasound in Prediction of Successful Induction of Delivery|Diagnostic Accuracy of Posterior Cervical Angle and Cervical Length in Prediction of Successful Induction of Labor|Completed||N/A|70|Actual|Cairo University||2|||f||||f|f|f||||||||2017-10-10 21:10:33.614379|2017-10-10 21:10:33.614379
NCT03113214|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-19|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|February 2, 2019|Anticipated|2019-02-02|February 2, 2018|Anticipated|2018-02-02||Interventional|||PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer|Phase I Study of PET/CT-directed Hyperfractionated Radiation Dose Escalation With Concurrent Weekly Carboplatin and Paclitaxel in Esophageal Cancer|Recruiting||N/A|18|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||6|||f|||||f|f||||||No||2017-10-10 21:10:33.703311|2017-10-10 21:10:33.703311
NCT03113201|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|Collabri Flex||Collabri Flex - Effect of Collaborative Care for People With Depression in General Practice|Projekt Collabri Flex - The Effect of a Danish Model for Collaborative Care for People With Depression in General Practice|Not yet recruiting||N/A|240|Anticipated|Mental Health Centre Copenhagen||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:33.814213|2017-10-10 21:10:33.814213
NCT03113188|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-09|2017-09-07|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors|Phase 1b Clinical Study of CBP501, Cisplatin and Nivolumab Administered Every 3 Weeks in Patients With Advanced Refractory Tumors|Recruiting||Phase 1|42|Anticipated|CanBas Co. Ltd.||1|||f||||t|t|f||||||||2017-10-10 21:10:33.907807|2017-10-10 21:10:33.907807
NCT03113175|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Collabri Flex - Effect of Collaborative Care for People With Anxiety in General Practice|Project Collabri Flex - The Effect of a Danish Model for Collaborative Care for People With Anxiety and Depression in General Practice|Not yet recruiting||N/A|284|Anticipated|Mental Health Centre Copenhagen||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:34.002408|2017-10-10 21:10:34.002408
NCT03113162|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-03|||May 29, 2015|Actual|2015-05-29|May 2017|2017-05-01|May 29, 2022|Anticipated|2022-05-29|May 29, 2020|Anticipated|2020-05-29||Interventional|||Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis|Evaluation of the Safety and Efficacy of Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Multiple Sclerosis|Recruiting||Phase 1|15|Anticipated|Makati Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:10:34.100334|2017-10-10 21:10:34.100334
NCT03113149|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-21|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Strongest Predictors of a Positive Outcome After Physiotherapy for Knee Osteoarthritis|Which Factors Are the Strongest Predictors of a Positive Outcome After Physiotherapy for Patients With Knee Osteoarthritis?|Terminated||N/A|3|Actual|Norwegian University of Science and Technology|||1|Recruitment too slow, probably due to the procedure considered too complicated.|f||||f|f|f||||||||2017-10-10 21:10:34.325285|2017-10-10 21:10:34.325285
NCT03113136|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-25|||June 29, 2017|Actual|2017-06-29|September 2017|2017-09-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Examination of Low Wattage and High Wattage E-Cigarettes|Examination of Low Wattage and High Wattage E-Cigarettes|Recruiting||N/A|453|Anticipated|University of Oklahoma||3|||f||||f|f|f||||||||2017-10-10 21:10:34.41413|2017-10-10 21:10:34.41413
NCT03113123|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-12|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|ANRS-PREVENIR||"Prevention of HIV in Île-de-France"|"Prevention of HIV in Île-de-France"|Recruiting||N/A|3000|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t|f|f||||||No||2017-10-10 21:10:34.520218|2017-10-10 21:10:34.520218
NCT03113110|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-08|||January 15, 2017|Actual|2017-01-15|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|EMPTRA-DM||Empagliflozin in Post-Transplantation Diabetes Mellitus|Empagliflozin in Post-Transplantation Diabetes Mellitus|Recruiting||Phase 2|16|Anticipated|Medical University of Vienna||1|||f||||f|f|f||||||No||2017-10-10 21:10:34.761833|2017-10-10 21:10:34.761833
NCT03113097|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-10|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?|Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?|Completed||N/A|627|Actual|Ain Shams University||2|||f|||||f|f||||||||2017-10-10 21:10:34.85886|2017-10-10 21:10:34.85886
NCT03113084|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-07|||November 30, 2017|Anticipated|2017-11-30|February 2017|2017-02-01|April 30, 2018|Anticipated|2018-04-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Study With Heparin Sodium in Subcutaneous Administration|Phase I Study With Pharmacodynamic Determination of Unfractionated Heparin of Porcine Origin of the Company União Química of Subcutaneous Use in Healthy Participants|Not yet recruiting||Phase 1|38|Anticipated|União Química Farmacêutica Nacional S/A||2|||f||||t|t|f|||t|||No||2017-10-10 21:10:34.941322|2017-10-10 21:10:34.941322
NCT03113071|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-25|||June 2, 2017|Actual|2017-06-02|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|December 2020|Anticipated|2020-12-01||Interventional|||Safety and Activity of Digoxin With Decitabine in Adult AML and MDS|A Phase Ib/II Study of the Safety and Activity of Digoxin With Decitabine in Adult AML and MDS|Recruiting||Phase 1/Phase 2|97|Anticipated|Fox Chase Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:10:35.059306|2017-10-10 21:10:35.059306
NCT03113058|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-19|||May 2, 2017|Anticipated|2017-05-02|April 2017|2017-04-01|November 1, 2018|Anticipated|2018-11-01|October 5, 2018|Anticipated|2018-10-05||Interventional|||"Treatment of Active HBV With γδT Cells Clinical Trial Protocol"|"Treatment of HBeAg-positive Chronic Hepatitis B With γδT Cells Clinical Trial Protocol"|Not yet recruiting||Early Phase 1|60|Anticipated|Jinan University Guangzhou||1|||f||||f|f|f||||||Undecided||2017-10-10 21:10:35.165332|2017-10-10 21:10:35.165332
NCT03113045|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-04-09|||January 31, 2017|Actual|2017-01-31|April 2017|2017-04-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Seated Time for 90% Incidence of Hypotension|Seated Time for Hypotension in Cesarean Delivery: A Biased Coin Design Trial for 90% Efficacy|Recruiting||N/A|60|Anticipated|Royal Victoria Hospital, Canada||1|||f||||f|f|f||||||No||2017-10-10 21:10:35.263297|2017-10-10 21:10:35.263297
NCT03113032|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-04|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|P-SEC||Novel Pre-Surgery Exercise-Conditioning in Patients Waiting for Total Knee Arthroplasty (TKA)|Novel Pre-Surgery Exercise-Conditioning in Patients Waiting for Total Knee Arthroplasty (TKA)|Recruiting||N/A|60|Anticipated|Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust||3|||f||||t|f|f||||||Undecided||2017-10-10 21:10:35.356394|2017-10-10 21:10:35.356394
NCT03113019|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-09|||February 11, 2014|Actual|2014-02-11|March 2017|2017-03-01|September 11, 2017|Anticipated|2017-09-11|February 11, 2017|Actual|2017-02-11||Interventional|BC-LDC||Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer|Investigation of the Clinical and Laboratory Efficacy of Autogemotherapy Based on Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer|Active, not recruiting||Early Phase 1|26|Actual|Research Institute of Fundamental and Clinical Immunology||1|||f||||f|f|f|||f|||No||2017-10-10 21:10:35.473045|2017-10-10 21:10:35.473045
NCT03113006|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-26|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|April 30, 2020|Anticipated|2020-04-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)|The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study: IMPETUS 2018 - TREAT|Recruiting||N/A|58|Anticipated|Odense University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:10:35.574117|2017-10-10 21:10:35.574117
NCT03112993|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-31|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery|A Prospective, Randomized, Double-Blind Clinical Trial Evaluating the Speed of Recovery and Safety of Reversal of Neuromuscular Blockade With Sugammadex (Bridion™) Versus Neostigmine in Geriatric Patients Undergoing Spine Surgery|Recruiting||Phase 4|45|Anticipated|University of Missouri-Columbia||2|||f||||f|t|f|||f|||No||2017-10-10 21:10:35.697646|2017-10-10 21:10:35.697646
NCT03112980|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-24|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|DEDICATE||Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Intermediate Risk of Mortality|Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE|Recruiting||N/A|1600|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t|f|f||||||No||2017-10-10 21:10:35.800437|2017-10-10 21:10:35.800437
NCT03112967|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-13|||April 20, 2017|Actual|2017-04-20|August 2017|2017-08-01|August 13, 2017|Actual|2017-08-13|August 13, 2017|Actual|2017-08-13||Interventional|||Safety and Efficacy of Low-volume Preparation in the Elderly: Oral Sulfate Solution|Safety and Efficacy of Low-volume Preparation in the Elderly: Oral Sulfate Solution vs 4L PEG Dolution|Completed||N/A|193|Actual|Kyung Hee University Hospital at Gangdong||2|||f||||f|f|f||||||||2017-10-10 21:10:35.936305|2017-10-10 21:10:35.936305
NCT03112954|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-07|||May 29, 2014|Actual|2014-05-29|April 2017|2017-04-01|June 20, 2014|Actual|2014-06-20|June 11, 2014|Actual|2014-06-11||Interventional|||Floral Remedies for Sleep-bruxism Patients|Floral Remedies for Sleep Bruxism Patients: A Randomized Trial for Attenuating Temporal Cephalic Pain|Completed||N/A|74|Actual|Universidade Federal Fluminense||2|||f||||f|f|f||||||No||2017-10-10 21:10:36.029056|2017-10-10 21:10:36.029056
NCT03112941|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-08|||January 2012|Actual|2012-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Hyperbaric Oxygen and Orthopedic Comprehensive Treatment for Traumatic Incomplete Spinal Cord Injury in the Plateau|Hyperbaric Oxygen and Orthopedic Comprehensive Treatment for Traumatic Incomplete Spinal Cord Injury in the Plateau: an Open-label Randomized Controlled Clinical Trial|Active, not recruiting||N/A|164|Anticipated|Qinghai University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:10:36.113805|2017-10-10 21:10:36.113805
NCT03112928|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-11|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Phantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLP|Phantom Motor Execution Via Myoelectric Pattern Recognition, Virtual and Augmented Reality, and Serious Gaming as a Treatment of Phantom Limb Pain|Recruiting||N/A|66|Anticipated|Integrum||2|||f||||f|f|f||||||No||2017-10-10 21:10:36.195825|2017-10-10 21:10:36.195825
NCT03112915|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-09-24|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|September 12, 2018|Anticipated|2018-09-12|August 1, 2018|Anticipated|2018-08-01||Interventional|||Comparison of the Quadratus Lumborum Block With the Transversus Abdominis Plan Block|Comparison of Quadratus Lumborum Block and Transversus Abdominis Plane Block for Postoperative Pain Control After Laparoscopic Cholecystectomy|Recruiting||N/A|60|Anticipated|Kecioren Education and Training Hospital||2|||f||||f|f|f||||||||2017-10-10 21:10:36.315446|2017-10-10 21:10:36.315446
NCT03112902|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance|Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance|Recruiting||N/A|145|Anticipated|University of Colorado, Denver||12|||f|||||f|t|f|f|f|||||2017-10-10 21:10:36.411075|2017-10-10 21:10:36.411075
NCT03112889|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-05-11|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|April 5, 2017|Actual|2017-04-05||Interventional|||Sodium Valproate for GSDV|A Phase II Pilot Study to Explore Treatment With Sodium Valproate in Adults With McArdle Disease (Glycogen Storage Disorder Type V, GSDV)|Active, not recruiting||Phase 2|8|Anticipated|University College, London||1|||f||||t||||||||||2017-10-10 21:10:36.511188|2017-10-10 21:10:36.511188
NCT03112876|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-04-07|||June 27, 2014|Actual|2014-06-27|April 2017|2017-04-01|February 26, 2016|Actual|2016-02-26|February 26, 2016|Actual|2016-02-26||Observational|Sebum||Sebum Collection and Skin Barrier Function Analysis|Sebum Collection for Analysis and Correlation to Sebum Production, Barrier Function, and With Cutaneous and Internal Inflammatory Disease|Completed||N/A|41|Actual|University of California, Davis|||5||f||||f||||||||||2017-10-10 21:10:36.592703|2017-10-10 21:10:36.592703
NCT03112863|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-07|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of the Cosmetic Effects of Bakuchiol and Retinol|Comparison of the Cosmetic Effects of Bakuchiol and Retinol|Recruiting||Phase 1/Phase 2|40|Anticipated|University of California, Davis||2|||f|||||f|f||||||||2017-10-10 21:10:36.681142|2017-10-10 21:10:36.681142
NCT03112850|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-13|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Cognition Effects of Hearing Aids and Auditory Training in Older Age|Investigating the Impact of Hearing Aid Use and Auditory Training on Cognition, Mood and Social Interaction in Older Adults With Hearing Loss|Recruiting||N/A|40|Anticipated|Swinburne University of Technology||2|||f||||f|f|f||||||Undecided|There is no plan|2017-10-10 21:10:36.757638|2017-10-10 21:10:36.757638
NCT03112837|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-18|||March 10, 2017|Actual|2017-03-10|May 2017|2017-05-01|December 20, 2017|Anticipated|2017-12-20|December 5, 2017|Anticipated|2017-12-05||Interventional|||Effect of Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules on Oral Mucositis in Nasopharyngeal Carcinoma Patients Receiving Radiotherapy.|Effect of Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules on Oral Mucositis in Nasopharyngeal Carcinoma Patients Receiving Radiotherapy.|Recruiting||N/A|40|Anticipated|Jiangxi Provincial Cancer Hospital||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:10:36.864702|2017-10-10 21:10:36.864702
NCT03112824|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-10-04|||October 5, 2017|Actual|2017-10-05|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Functional Assessment of Ashwagandaha Root Extract During Weight Loss|Functional Assessment of Ashwagandaha Root Extract During Weight Loss|Recruiting||Phase 3|50|Anticipated|Loma Linda University||2|||f||||t|t|f||||||||2017-10-10 21:10:36.938875|2017-10-10 21:10:36.938875
NCT03112811|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-07|||April 3, 2007|Actual|2007-04-03|April 2017|2017-04-01|January 1, 2021|Anticipated|2021-01-01|December 31, 2020|Anticipated|2020-12-31||Interventional|||Influence of Techniques of Chest Physiotherapy in the Pediatric Intensive Care|Influence of Techniques of Chest Physiotherapy on the Respiratory Status and the Hemodynamic Impact in the Pediatric Intensive Care|Recruiting||N/A|80|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f|||||f|f||||||No||2017-10-10 21:10:37.108902|2017-10-10 21:10:37.108902
NCT03112798|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-08|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01|4 Months|Observational [Patient Registry]|||Miller vs Macintosh Size 0 Blades for Tracheal Intubation of Infants|Miller vs Macintosh Size 0 Blades for Tracheal Intubation of Infants Under 1 Month: a Randomized Comparative Study|Not yet recruiting||N/A|25|Anticipated|Istanbul Science University|||2||f||||f|f|f|||f|||Undecided||2017-10-10 21:10:37.201313|2017-10-10 21:10:37.201313
NCT03112785|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-07|||March 17, 2011|Actual|2011-03-17|April 2017|2017-04-01|June 2026|Anticipated|2026-06-01|June 2026|Anticipated|2026-06-01||Interventional|||Fitmore Versus CLS Stem in Total Hip Arthroplasty. Bilateral One-stage Operations|Randomized Comparison Between the Fitmore and the CLS Stem in Patients Operated in One-stage Due to Bilateral Symptomatous Hip Disease|Active, not recruiting||N/A|44|Actual|Sahlgrenska University Hospital, Sweden||1|||f||||t|f|f||||||No||2017-10-10 21:10:37.276329|2017-10-10 21:10:37.276329
NCT03112772|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-15|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|November 20, 2017|Anticipated|2017-11-20|July 20, 2017|Anticipated|2017-07-20||Interventional|||Socket Preservation for Dental Implant Site Development.|Socket Preservation for Dental Implant Site Development.|Active, not recruiting||N/A|100|Anticipated|Imam Abdulrahman Al Faisal Hospital||3|||f|||||f|f|||f|||Yes|Data will be available after statistical analysis|2017-10-10 21:10:37.351207|2017-10-10 21:10:37.351207
NCT03112759|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-08|||September 9, 2017|Actual|2017-09-09|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Assessing the Utility of Cognitive Behavioral Therapy for Pain Control in Patients With Chronic Pancreatitis|Assessing the Utility of Cognitive Behavioral Therapy for Pain Control in Patients With Chronic Pancreatitis|Recruiting||N/A|88|Anticipated|University of Louisville||2|||f||||f|f|f||||||||2017-10-10 21:10:37.434791|2017-10-10 21:10:37.434791
NCT03112746|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-12|||March 26, 2009|Actual|2009-03-26|April 2017|2017-04-01|March 26, 2010|Actual|2010-03-26|February 10, 2010|Actual|2010-02-10||Interventional|||Efficacy of the CO-OP Approach With Brazilian Children With Developmental Coordination Disorder|Efficacy of the Cognitive Orientation to Daily Occupational Performance (CO-OP) Approach With Brazilian Children With Developmental Coordination Disorder|Completed||N/A|8|Actual|Federal University of Minas Gerais||1|||f||||f|f|f||||||No||2017-10-10 21:10:37.541267|2017-10-10 21:10:37.541267
NCT03112733|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-07|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01|12 Months|Observational [Patient Registry]|||Serum Biomarkers in Diagnosis and Predicting Prognosis of Endometrial and Ovarian Cancers|Value of TFF3, SFRP4, Romo1 and NFKB as Serum Biomarkers in Diagnosis and Predicting Prognosis of Endometrial and Ovarian Cancers|Recruiting||N/A|180|Anticipated|Istanbul University|||3||f||||t|f|f||||||Yes|All data may be shared with researchers planning to perform a metaanalysis.|2017-10-10 21:10:37.626889|2017-10-10 21:10:37.626889
NCT03112720|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-04-07|||September 2016||2016-09-01|April 2017|2017-04-01|July 2025|Anticipated|2025-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache|A Comparison of the Efficacy of Sphenopalatine Ganglion (SPG) Block With 5% Lidocaine Versus Epidural Blood Patch (EBP) for the Treatment of Post-Dural Puncture Headache (PDPH)|Recruiting||N/A|500|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||No||2017-10-10 21:10:37.723631|2017-10-10 21:10:37.723631
NCT03112707|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-08-17|||April 14, 2017|Actual|2017-04-14|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|POEM||Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT|Performance of Bioresorbable Polymer-Coated Everolimus-Eluting Synergy® Stent in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Revascularization Followed by 1-Month Dual Antiplatelet Therapy|Recruiting||Phase 4|1023|Anticipated|Humanitas Hospital, Italy||1|||f||||t|f|f||||||||2017-10-10 21:10:37.816071|2017-10-10 21:10:37.816071
NCT03112694|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-28|||April 4, 2017|Actual|2017-04-04|August 2017|2017-08-01|December 14, 2017|Anticipated|2017-12-14|December 14, 2017|Anticipated|2017-12-14||Observational|||Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors|A Multicenter, Retrospective, Medical Record Review Of The Effectiveness Of Lanreotide Following Treatment With Octreotide In Patients With Neuroendocrine Tumors|Recruiting||N/A|100|Anticipated|Ipsen|||1||f||||f||f|||f|||||2017-10-10 21:10:37.904594|2017-10-10 21:10:37.904594
NCT03112681|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-06-27|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|EPICS||A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)|A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS )|Not yet recruiting||Phase 2|36|Anticipated|Zydus Discovery DMCC||3|||f||||t|t|f||||||||2017-10-10 21:10:37.991065|2017-10-10 21:10:37.991065
NCT03112668|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-21|||April 17, 2017|Actual|2017-04-17|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners|Couple-Focused ACT Intervention for Couples Coping With Cancer: A Pilot Study|Recruiting||N/A|30|Anticipated|Rutgers, The State University of New Jersey||1|||f||||t|f|f||||||||2017-10-10 21:10:38.136992|2017-10-10 21:10:38.136992
NCT03112655|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-07|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|DiTECT-WP4||Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure|Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP4 Early Test-of-cure|Recruiting||N/A|250|Anticipated|Institut de Recherche pour le Developpement||1|||f||||f|f|f||||||No||2017-10-10 21:10:38.256462|2017-10-10 21:10:38.256462
NCT03112642|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-04-07|||November 2013||2013-11-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery|Does the Use of a Nerve Stimulator Improve the Outcome of Ultrasound-Guided Supraclavicular Block (Anesthesia) for Upper Extremity Surgery?|Recruiting||N/A|100|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 21:10:38.352341|2017-10-10 21:10:38.352341
NCT03112629|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-06-13|||March 23, 2017|Actual|2017-03-23|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|March 31, 2019|Anticipated|2019-03-31|12 Months|Observational [Patient Registry]|||Study to Improve Outcomes in Aortic Stenosis|IMPULSE Enhanced - Study to Improve Outcomes in Aortic Stenosis - International, Multi-centre, Prospective, Observational Cohort Study|Recruiting||N/A|800|Anticipated|Institut für Pharmakologie und Präventive Medizin|||2||f||||f|f|f||||||No|no sharing of individual patient data is planned|2017-10-10 21:10:38.445374|2017-10-10 21:10:38.445374
NCT03112616|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-05-05|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|VIBR-HEMI||The Long-lasting Effects of Repetitive Neck Muscle Vibrations on Postural Disturbances in Standing Position in Chronic Stroke Patients|The Long-lasting Effects of Repetitive Neck Muscle Vibrations on Postural Disturbances in Standing Position and on Spatial Frame Reference in Chronic Stroke Patients|Recruiting||N/A|40|Anticipated|Rennes University Hospital|||2||f||||f||||||||No||2017-10-10 21:10:38.533916|2017-10-10 21:10:38.533916
NCT03112603|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-28|||June 23, 2017|Actual|2017-06-23|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|July 2019|Anticipated|2019-07-01||Interventional|||A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)|A Phase III Randomized Open-label Multi-center Study of Ruxolitinib vs. Best Available Therapy in Patients With Corticosteroid-refractory Chronic Graft vs Host Disease After Allogenic Stem Cell Transplantation (REACH3)|Recruiting||Phase 3|324|Anticipated|Incyte Corporation||2|||t||||f|t|f||||||||2017-10-10 21:10:38.650836|2017-10-10 21:10:38.650836
NCT03112590|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-05-12|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer|A Phase I-II Study of Interferon-gamma Plus Weekly Paclitaxel, Trastuzumab and Pertuzumab in Patients With HER-2 Positive Breast Cancer|Recruiting||Phase 1/Phase 2|43|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 21:10:40.796292|2017-10-10 21:10:40.796292
NCT03112577|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-07|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of REGN3500 and Dupilumab in Patients With Asthma|A Randomized, Placebo-controlled, Parallel Panel Study to Assess the Effects of REGN3500, Dupilumab, and Combination of REGN3500 Plus Dupilumab on Markers of Inflammation After Bronchial Allergen Challenge in Patients With Allergic Asthma|Not yet recruiting||Phase 1|38|Anticipated|Regeneron Pharmaceuticals||5|||f||||t|f|f||||||||2017-10-10 21:10:40.920478|2017-10-10 21:10:40.920478
NCT03112564|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-07|||March 1, 2013|Actual|2013-03-01|April 2017|2017-04-01|December 15, 2014|Actual|2014-12-15|November 30, 2014|Actual|2014-11-30||Interventional|||Endotracheal Intubation Without Muscle Relaxants|Evaluation of the Effectiveness and Safety of Endotracheal Intubation for Inhalational Anesthesia Without the Use of Muscle Relaxants or Analgesics|Completed||N/A|91|Actual|Puerta de Hierro University Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:10:41.009991|2017-10-10 21:10:41.009991
NCT03112551|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-07-29|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Safety and Efficacy of Twelve Hours Duration of MgSO4 in the Treatment of Eclampsia in Low Resource Setting in Sudan|Safety and Efficacy of Twelve Hours Duration of Magnesium Sulphate in the Treatment of Eclampsia in Low Resource Setting in Sudan|Enrolling by invitation||N/A|100|Anticipated|Gadarif University||2|||f||||t|f|f|||f|||||2017-10-10 21:10:41.109297|2017-10-10 21:10:41.109297
NCT03112538|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-04-09|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy|Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy|Recruiting||Phase 4|118|Anticipated|Clinical Research Centre, Malaysia||2|||f||||f||||||||No||2017-10-10 21:10:41.184455|2017-10-10 21:10:41.184455
NCT03112525|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-07-27|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|DAPHNE||DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic|DAPHNE Study: Real-Life Observational Study to Evaluate the Impact of the CYP3A4/5/7 and P-gp Pharmacogenetics and Phenotypic Activity on the Pharmacokinetic Profile of the Direct Oral Anticoagulants Rivaroxaban and Apixaban in Hospitalised Patients|Recruiting||N/A|350|Anticipated|University Hospital, Geneva|||2||f||||f|f|f||||Samples With DNA|"     whole blood   "|||2017-10-10 21:10:41.303565|2017-10-10 21:10:41.303565
NCT03112512|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-08|||April 18, 2017|Anticipated|2017-04-18|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||A Comparison of Optimal PEEP Determination Guided by EIT and Protective Ventilation Tool by G5(MV) in Moderate and Severe ARDS Patients|A Comparison of Optimal Positive End-expiratory Pressure Determination Guided by Electrical Impedance Tomography and Protective Ventilation Tool by G5(MV) in Moderate and Severe Acute Respiratory Distress Syndrome Patients|Recruiting||N/A|32|Anticipated|Far Eastern Memorial Hospital||2|||f||||f|f|f||||||No|no sharing plan, including what IPD are to be shared with other researchers|2017-10-10 21:10:41.408794|2017-10-10 21:10:41.408794
NCT03112499|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-15|||May 5, 2017|Actual|2017-05-05|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Three Endourological Procedures for the Management of Renal Calculi Regarding Acute Kidney Injury|The Effect of Three Endourological Procedures for the Management of Renal Calculi Regarding Acute Kidney Injury: a Prospective Randomized 3-arm Study.|Recruiting||N/A|75|Anticipated|Institute for the Study of Urological Diseases, Greece||3|||f||||f|f|f||||||||2017-10-10 21:10:41.504863|2017-10-10 21:10:41.504863
NCT03112486|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-22|||May 26, 2017|Actual|2017-05-26|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Out-of-hospital Cardiac Arrest (OHCA) Biomarkers|Predicting Neurological Outcome Following Out of Hospital Cardiac Arrest (OHCA) by Quantitative Measurement of Serial Serum Biomarkers of Brain Injury.|Recruiting||N/A|130|Anticipated|University of Florida|||2||f||||f|f|f||||Samples With DNA|"     blood biomarkers   "|||2017-10-10 21:10:41.609729|2017-10-10 21:10:41.609729
NCT03112473|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-04-12|||November 24, 2016|Actual|2016-11-24|April 2017|2017-04-01|April 24, 2019|Anticipated|2019-04-24|November 24, 2018|Anticipated|2018-11-24||Interventional|||Effect of Bilateral TENS With TOT on Upper Limb Function in Patients With Chronic Stroke|A Randomized, Controlled Clinical Trial of Upper Limb Training With Bilateral Cutaneous Electrical Stimulation to Improve Upper Limb Functions in Patients With Chronic Stroke|Recruiting||N/A|120|Anticipated|The Hong Kong Polytechnic University||4|||f||||f|f|f||||||No||2017-10-10 21:10:41.831289|2017-10-10 21:10:41.831289
NCT03112460|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-07|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|July 31, 2017|Anticipated|2017-07-31|1 Month|Observational [Patient Registry]|||Cardiopulmonary Resuscitation Training Program Based on Quality Control|Cardiopulmonary Resuscitation Training Program Based on Quality Control in Gottsegen György Hungarian Institute of Cardiology|Not yet recruiting||N/A|20|Anticipated|Hungarian Institute of Cardiology|||1||f||||f|f|t|f|f|t|||No||2017-10-10 21:10:41.948955|2017-10-10 21:10:41.948955
NCT03112447|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-12|||August 1, 2007|Actual|2007-08-01|April 2017|2017-04-01|August 1, 2012|Actual|2012-08-01|August 1, 2012|Actual|2012-08-01||Interventional|||Treatment of Medial Humeral Epicondyle Fractures in Children With Absorbable Cartilage Nails|Treatment of Medial Humeral Epicondyle Fractures in Children With Absorbable Cartilage Nails|Completed||N/A|32|Actual|Children's Hospital of Chongqing Medical University||2|||f||||t|f|f||||||No||2017-10-10 21:10:42.037827|2017-10-10 21:10:42.037827
NCT03112434|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-11|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Muscle Elastography in Spastic Cerebral Palsy|Use of Elastography to Quantify Change in Upper Extremity Muscle Spasticity Following Botox Injection in Children With Spastic Cerebral Palsy|Enrolling by invitation||N/A|20|Actual|Hospital for Special Surgery, New York|||1||f|||||t|f|||f|||||2017-10-10 21:10:42.122118|2017-10-10 21:10:42.122118
NCT03112421|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-07|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|April 14, 2017|Actual|2017-04-14|April 14, 2017|Actual|2017-04-14||Observational|||Method and Sample Comparison Study Minicare BNP - COMP-BNP-CE03-AN2016|Method and Sample Comparison Study of Minicare BNP at a Central Laboratory|Completed||N/A|296|Actual|Philips Handheld Diagnostics|||1||f|||||f|f||||||||2017-10-10 21:10:42.195848|2017-10-10 21:10:42.195848
NCT03112408|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Eye Movements and Visuo-spatial Perception|Coupling Between Adaptation of Saccadic Eye Movements and Visuo-spatial Perception and Attention Processes: a Behavioural Study in Humans.|Not yet recruiting||N/A|75|Anticipated|Hospices Civils de Lyon||5|||f||||f|f|f||||||||2017-10-10 21:10:42.267695|2017-10-10 21:10:42.267695
NCT03112395|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-06-16|||April 25, 2017|Actual|2017-04-25|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Local Application of Combined Optical and Magnetic Stimulation (COMS) for Treatment of Chronic Wounds: Safety Evaluation|Local Application of Combined Optical and Magnetic Stimulation (COMS) in a Population of 24 Patients Suffering From Chronic Wounds at Lower Extremities: Safety Evaluation|Recruiting||N/A|24|Anticipated|Piomic Medical AG||1|||f||||t|f|f|||f|||||2017-10-10 21:10:42.385205|2017-10-10 21:10:42.385205
NCT03112382|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-06|||November 2015||2015-11-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|SLC30A8||Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus||Completed||Phase 4|80|Anticipated|Cairo University||3|||f||||||||||||||2017-10-10 21:10:42.471277|2017-10-10 21:10:42.471277
NCT03112369|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-15|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|January 30, 2021|Anticipated|2021-01-30||Interventional|||Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use|Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use|Recruiting||N/A|200|Anticipated|University of Washington||2|||f||||t|f|f||||||||2017-10-10 21:10:42.555357|2017-10-10 21:10:42.555357
NCT03112356|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-19|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|October 14, 2018|Anticipated|2018-10-14|October 14, 2018|Anticipated|2018-10-14||Interventional|PLEIM||The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials|The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials|Recruiting||Phase 4|30|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||No||2017-10-10 21:10:42.649319|2017-10-10 21:10:42.649319
NCT03112343|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-20|||September 25, 2017|Anticipated|2017-09-25|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|September 30, 2018|Anticipated|2018-09-30||Interventional|ICT||Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment|An Information and Communication Technology-based Centralized Clinical Trial to Determine the Efficacy and Safety of Insulin Dose Adjustment Education Based on a Smartphone Personal Health Record Application|Not yet recruiting||N/A|96|Anticipated|Samsung Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:10:42.760703|2017-10-10 21:10:42.760703
NCT03112317|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-07-29|||April 30, 2017|Actual|2017-04-30|July 2017|2017-07-01|July 15, 2017|Actual|2017-07-15|July 15, 2017|Actual|2017-07-15||Observational|||Mild Hypothermia Influence on Patient Outcome in Major Abdominal Surgery|Does Mild Hypothermia Increase Intra-Operative Blood Loss and Surgical Site Infections in Major Abdominal Surgery?|Completed||N/A|1650|Actual|Haukeland University Hospital|||2||f||||f|f|f||||||||2017-10-10 21:10:43.001937|2017-10-10 21:10:43.001937
NCT03112304|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-07|||September 2011||2011-09-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|July 2014|Actual|2014-07-01||Interventional|||Child STEPS for Youth Mental Health in Maine Sustainability|Child STEPS for Youth Mental Health in Maine: Sustainability of MATCH in the Public Sector|Completed||N/A|153|Actual|Harvard University||2|||f||||t||||||||||2017-10-10 21:10:43.103866|2017-10-10 21:10:43.103866
NCT03112291|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-09|||November 25, 2011|Actual|2011-11-25|April 2017|2017-04-01|October 8, 2016|Actual|2016-10-08|June 10, 2015|Actual|2015-06-10||Interventional|||Antimicrobial Pastes and Clinical Cases of Apexogenesis|Clinical and Microbiological Evaluation of a Series of Clinical Cases of Permanent Teeth With Incomplete Apexogenesis and Traumatic Necrosis, Treated With Double Antimicrobial Paste, Revascularization Procedures, and MTA|Completed||N/A|14|Actual|Universidade Federal do Ceara||1|||f||||t|f|f|||f|||No||2017-10-10 21:10:43.208741|2017-10-10 21:10:43.208741
NCT03112278|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-09|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|April 2, 2021|Anticipated|2021-04-02|April 14, 2017|Anticipated|2017-04-14||Interventional|UOVTDE||Clinical Evaluation of Ultrathin Occlusal Veneers for the Treatment of Severe Dental Erosion|Clinical Evaluation of Ultrathin Occlusal Veneers for the Treatment of Severe Dental Erosion|Active, not recruiting||N/A|10|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t|f|f||||||No||2017-10-10 21:10:43.314519|2017-10-10 21:10:43.314519
NCT03112265|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-07|||January 2015||2015-01-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Using Neuroimaging to Understand Children's Mental Health and Treatment Outcomes|Using Neuroimaging to Understand Children's Mental Health and Treatment Outcomes|Recruiting||N/A|84|Anticipated|Harvard University||2|||f||||t||||||||||2017-10-10 21:10:43.408543|2017-10-10 21:10:43.408543
NCT03112252|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-19|||April 19, 2017|Actual|2017-04-19|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|July 1, 2017|Anticipated|2017-07-01||Observational|||App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season|App-basierte Patientenbefragung Von Allergiepatienten Unter Medikation in Der Pollenflug-Saison Zur Bestimmung Der Auswirkung Einer Allergischen Rhinitis Auf Die Lebensqualität|Recruiting||N/A|350|Anticipated|University Hospital of Cologne|||1||f||||f|f|f||||||No||2017-10-10 21:10:43.546328|2017-10-10 21:10:43.546328
NCT03112239|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-04-09|||March 2014|Actual|2014-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|January 2015|Actual|2015-01-01||Interventional|||Chronic Effects Using Light-Emitting Diode Therapy (LEDT) During a Resistance Exercise Protocol for Asthmatic Patients|Chronic Effects Using Light-Emitting Diode Therapy (LEDT) During a Resistance Exercise Protocol for Moderate to Severe Asthmatic Patients: a Randomized Controlled Clinical Trial.|Completed||N/A|30|Actual|University of Nove de Julho||2|||f||||t||||||||No|IPD will not be shared with other researchers since there is no third party interest in the data collected.|2017-10-10 21:10:43.622857|2017-10-10 21:10:43.622857
NCT03112226|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function|Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function|Not yet recruiting||N/A|30|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 21:10:43.720439|2017-10-10 21:10:43.720439
NCT03112213|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-27|||January 12, 2017|Actual|2017-01-12|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|CONIFER||Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment|CONIFER (Characterization of NSAID Intake for Established Rheumatoid Arthritis)|Recruiting||N/A|135|Anticipated|Hoffmann-La Roche|||1||f|||||t|f||||||||2017-10-10 21:10:43.816644|2017-10-10 21:10:43.816644
NCT03112200|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-31|||March 29, 2017|Actual|2017-03-29|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Subchondroplasty® Knee RCT|A Randomized Controlled Trial of the Subchondroplasty® Procedure With Arthroscopy Versus Arthroscopy Alone for Treatment of Bone Marrow Lesions in the Knee|Recruiting||N/A|201|Anticipated|Zimmer Biomet||2|||f||||f|f|f|||t|||||2017-10-10 21:10:43.984238|2017-10-10 21:10:43.984238
NCT03112187|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-07|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|October 30, 2017|Anticipated|2017-10-30||Interventional|FLIPS||FLIPS: Ferfer Liposomal Iron Performance Study|FLIPS: Ferfer Liposomal Iron Performance Study|Not yet recruiting||Phase 4|400|Anticipated|PharmEvo Pvt Ltd||1|||f||||f|t|f|||f|||No||2017-10-10 21:10:44.123695|2017-10-10 21:10:44.123695
NCT03112174|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-29|||May 12, 2017|Actual|2017-05-12|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|March 2022|Anticipated|2022-03-01||Interventional|||Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)|Phase 3 Study of Ibrutinib in Combination With Venetoclax in Subjects With Mantle Cell Lymphoma|Recruiting||Phase 3|287|Anticipated|Pharmacyclics LLC.||3|||f||||t|t|f||||||||2017-10-10 21:10:44.21109|2017-10-10 21:10:44.21109
NCT03112161|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-07|||June 14, 2005|Actual|2005-06-14|April 2017|2017-04-01|October 1, 2015|Actual|2015-10-01|October 1, 2015|Actual|2015-10-01||Interventional|||The Effects of Energy Imbalance on Food Intake Behaviors|The Effects of Energy Imbalance on Food Intake Behaviors|Completed||N/A|76|Actual|University of Colorado, Denver||3|||f||||f|f|f||||||No||2017-10-10 21:10:44.323003|2017-10-10 21:10:44.323003
NCT03112148|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-10-01|||September 11, 2017|Actual|2017-09-11|October 2017|2017-10-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|||PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations|A Phase 1, Randomized, Open Label, Partial Crossover Study To Evaluate The Pharmacokinetics And Safety Of Three Age-appropriate Modified Release Formulations And The Immediate Release Solution Of Tofacitinib In Healthy Adult Volunteers|Recruiting||Phase 1|24|Anticipated|Pfizer||6|||f||||t|t|f||||||||2017-10-10 21:10:44.422178|2017-10-10 21:10:44.422178
NCT03112135|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-12|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Topical and Systemic Tranexemic Acid on Bleeding During Ear Exploration Surgery|Effect of Topical and Systemic Tranexemic Acid on Bleeding and Quality of Surgical Field During Ear Exploration Surgery. A Double Blind Randomized Clinical Trial|Recruiting||Phase 2|90|Anticipated|Assiut University||3|||f||||f|f|f||||||No||2017-10-10 21:10:44.518438|2017-10-10 21:10:44.518438
NCT03112122|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-12|||March 11, 2016|Actual|2016-03-11|April 2017|2017-04-01|March 11, 2024|Anticipated|2024-03-11|March 11, 2024|Anticipated|2024-03-11||Interventional|BME-TARGET||Study for the Treatment of the Bone Marrow Edema:Core Decompression VS Bone Marrow Concentrate (BMC) VS Bone Substitute|Randomized, Double-blind Study for the Treatment of the Bone Marrow Edema:Core Decompression Versus (VS) Subchondral Injections of Autologous BMC VS Subchondral Injections of Bone Substitute|Recruiting||Phase 4|120|Anticipated|Istituto Ortopedico Rizzoli||3|||f||||f|f|f||||||No||2017-10-10 21:10:44.615138|2017-10-10 21:10:44.615138
NCT03112109|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-08|||March 1, 2014|Actual|2014-03-01|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Anticipated|2017-09-01||Observational|SmartCare||SMARTCARE Project: Deploying Integrated Health & Social Services for Independent Living by Older People|SmartCare Project: Joining up ICT and Service Processes for Quality Integrated Care in Europe|Active, not recruiting||N/A|2111|Anticipated|Him SA|||2||f||||t|f|f||||||||2017-10-10 21:10:44.703889|2017-10-10 21:10:44.703889
NCT03112096|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-05-17|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease|A Phase I [18F]THK-5351 Positron Emission Computed Tomography Study of Biodistribution, Pharmacokinetics and Safety in Cognitively Healthy Subjects and Patients With Alzheimer's Disease|Recruiting||Phase 1|20|Anticipated|Asan Foundation||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:44.783027|2017-10-10 21:10:44.783027
NCT03112083|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-07|||October 6, 2015|Actual|2015-10-06|April 2017|2017-04-01|June 17, 2016|Actual|2016-06-17|June 17, 2016|Actual|2016-06-17||Interventional|||Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood Pressure|Prospective, Randomized, Single-center, Double-blinded, Placebo-controlled Study on Safety and Tolerability of the Krill Powder Product in Slightly Obese Study Subjects With Moderately Elevated Blood Pressure|Completed||N/A|35|Actual|Olympic Seafood AS||2|||f||||f|f|f||||||No||2017-10-10 21:10:44.882654|2017-10-10 21:10:44.882654
NCT03112070|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-20|||April 4, 2016|Actual|2016-04-04|July 2017|2017-07-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Post-Exercise Hypotension After Water Exercise|Post-Exercise Hypotension After Water Exercise in Older Women With Hypertension: A Randomized Crossover Clinical Trial|Completed||N/A|24|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f|||||f|f||||||||2017-10-10 21:10:44.980395|2017-10-10 21:10:44.980395
NCT03112044|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-20|||September 19, 2017|Actual|2017-09-19|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|April 3, 2018|Anticipated|2018-04-03||Interventional|||Lung Transplant HCV, Pilot Study|Lung Transplantation Using Hepatitis C Positive Donors to Hepatitis C Negative Recipients: A Pilot Study|Recruiting||Early Phase 1|20|Anticipated|University Health Network, Toronto||1|||f||||f|f|f||||||||2017-10-10 21:10:45.128585|2017-10-10 21:10:45.128585
NCT03112031|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Treatment With Tamoxifen in Cryptococcal Meningitis|A Randomized Trial of Tamoxifen Combined With Amphotericin B and Fluconazole for Cryptococcal Meningitis|Not yet recruiting||Phase 2|50|Anticipated|Oxford University Clinical Research Unit, Vietnam||2|||f||||t|f|f||||||||2017-10-10 21:10:45.219838|2017-10-10 21:10:45.219838
NCT03112018|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-11|||July 2016||2016-07-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|PTBi-KE-UG||Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda|Strengthening Intrapartum and Immediate Newborn Care to Reduce Morbidity and Mortality of Preterm Infants in Health Facilities in Migori County, Kenya and Busoga Region, Uganda: an Implementation Science RCT|Recruiting||N/A|123000|Anticipated|University of California, San Francisco||2|||f||||f||||||||Undecided||2017-10-10 21:10:45.387269|2017-10-10 21:10:45.387269
NCT03112005|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-12|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool|Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool|Enrolling by invitation||N/A|595|Anticipated|Eyenuk, Inc.|||1||f||||f|f|t|t||t|||Undecided||2017-10-10 21:10:45.504741|2017-10-10 21:10:45.504741
NCT03111992|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-08|||August 14, 2017|Anticipated|2017-08-14|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma|Phase I/Ib, Multi-center, Open-label, Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1|70|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 21:10:45.569181|2017-10-10 21:10:45.569181
NCT03111979|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-12|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in the Over 60s|The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in the Over 60s|Suspended||Phase 4|24|Anticipated|Nottingham Trent University||2||Time restrictions on leading investigator|f||||f|f|f||||||No||2017-10-10 21:10:45.818206|2017-10-10 21:10:45.818206
NCT03111966|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-11|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|April 30, 2017|Anticipated|2017-04-30|8 Months|Observational [Patient Registry]|||Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort|Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort|Recruiting||N/A|130|Anticipated|Hepa C|||1||f|||||t|f||||||||2017-10-10 21:10:45.978416|2017-10-10 21:10:45.978416
NCT03111953|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-07|||January 9, 2014|Actual|2014-01-09|April 2017|2017-04-01|June 28, 2016|Actual|2016-06-28|June 28, 2016|Actual|2016-06-28||Interventional|BPD-Mingrone||Effect of Biliopancreatic Diversion on Glucose Homeostasis|Effect of Biliopancreatic Diversion on Glucose Homeostasis|Completed||N/A|24|Actual|Washington University School of Medicine||2|||f||||f|f|f||||||No||2017-10-10 21:10:46.097562|2017-10-10 21:10:46.097562
NCT03111940|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-04-12|||August 2016||2016-08-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|OXOPT-PCI||The Oxford Optimisation of PCI Study (OXOPT-PCI Study)|The Oxford Optimisation of PCI Study (OXOPT-PCI Study)|Recruiting||N/A|100|Anticipated|Oxford University Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 21:10:46.198514|2017-10-10 21:10:46.198514
NCT03111927|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-12|||March 13, 2017|Actual|2017-03-13|June 2017|2017-06-01|July 30, 2021|Anticipated|2021-07-30|March 30, 2021|Anticipated|2021-03-30||Interventional|||Infant Nutrition and Brain Development|The Effect of Myelin-Relevant Nutrients in Infant Formula on Brain Myelination and Cognitive Development|Recruiting||N/A|410|Anticipated|Nestlé||3|||f||||t|f|f||||||No|MRI scans will be shared between sites. No Personal Identifiable Information will be shared.|2017-10-10 21:10:46.294899|2017-10-10 21:10:46.294899
NCT03111914|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-25|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer|Applications of Dual Energy CT for Improving Staging and Monitoring of Therapy Response in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer|Recruiting||N/A|100|Anticipated|Duke University||1|||f|||||f|t|f|f|f|||||2017-10-10 21:10:46.417266|2017-10-10 21:10:46.417266
NCT03111888|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-18|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant|Small Feasibility Study for Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant|Not yet recruiting||N/A|5|Anticipated|The Cleveland Clinic||1|||f||||t|f|t|f|||||||2017-10-10 21:10:46.658378|2017-10-10 21:10:46.658378
NCT03111875|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-07|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Perioperative Hypothermia and Myocardial Injury After Non-cardiac Surgery|Perioperative Hypothermia and Myocardial Injury After Non-cardiac Surgery|Recruiting||N/A|5100|Anticipated|The Cleveland Clinic||2|||f||||t|f|f|||f|||Yes|Investigators are welcome to propose collaborative analyses.|2017-10-10 21:10:46.773985|2017-10-10 21:10:46.773985
NCT03042403|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-01|||October 2012||2012-10-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Observational|||Effects of the Breath Stacking Technic in Healthy Individuals|Effects of the Breath Stacking Technic in Healthy Individuals|Completed||N/A|52|Actual|Federal University of Uberlandia|||1||f||||t|f|f||||||No||2017-10-10 21:23:59.318017|2017-10-10 21:23:59.318017
NCT03111862|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-01|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|July 1, 2018|Anticipated|2018-07-01|3 Months|Observational [Patient Registry]|||Safety of Accelerated Rule-out Protocols in Patients Admitted With Chest Pain to a Crowded Chest Pain Unit (CPU)|Observational Study on the Safety of Accelerated Rule-out Protocols in Patients Admitted With Chest Pain to a Crowded CPU|Not yet recruiting||N/A|500|Anticipated|University Hospital Heidelberg|||1||f||||f|f|f||||Samples Without DNA|"     Clinical Chemistry, in particular High-sensitivity troponin T   "|No||2017-10-10 21:10:46.881746|2017-10-10 21:10:46.881746
NCT03111849|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-07|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|SARCOBS||Sarcopenia in COPD Patients: a French Study|Prevalence of Sarcopenia in Chronic Obstructive Patients Hospitalized in Pneumology at the CHU of Clermont-Ferrand|Recruiting||N/A|50|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 21:10:46.975104|2017-10-10 21:10:46.975104
NCT03111836|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-07|||June 1, 2012|Actual|2012-06-01|April 2017|2017-04-01|June 1, 2015|Actual|2015-06-01|July 1, 2014|Actual|2014-07-01||Interventional|||Effectiveness of User and Expert Driven Internet-based Lifestyle Interventions on Hypertension Control|Effectiveness of User and Expert Driven Internet-based Lifestyle Interventions on Hypertension Control|Completed||N/A|129|Actual|University of Toronto||3|||f||||f|f|f||||||No||2017-10-10 21:10:47.095777|2017-10-10 21:10:47.095777
NCT03111823|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-10|||July 7, 2016|Actual|2016-07-07|July 2017|2017-07-01|July 7, 2019|Anticipated|2019-07-07|July 7, 2018|Anticipated|2018-07-07||Interventional|||Exercise Program During Chemotherapy in Metastatic Colorectal Cancer|Feasibility of a 6-Week Aerobic Exercise Program During Chemotherapy for Metastatic Colorectal Cancer|Recruiting||N/A|40|Anticipated|University of Southern California||1|||f||||t|f|f||||||||2017-10-10 21:10:47.201649|2017-10-10 21:10:47.201649
NCT03111810|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-10-05|||May 25, 2017|Actual|2017-05-25|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|TICSI||Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition|Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition (TICSI)|Recruiting||Phase 2|32|Anticipated|University of Oxford||2|||f||||t|f|f|||f|||||2017-10-10 21:10:47.347431|2017-10-10 21:10:47.347431
NCT03111797|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-13|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|April 30, 2017|Anticipated|2017-04-30|April 30, 2017|Anticipated|2017-04-30||Observational|||Robot-assisted Lobectomy Versus Video-assisted Lobectomy|Robot-assisted Lobectomy Versus Video-assisted Lobectomy : a Prospective Observational Study|Recruiting||N/A|230|Anticipated|Hospital Nord|||2||f||||f|f|f||||||No||2017-10-10 21:10:47.488705|2017-10-10 21:10:47.488705
NCT03111784|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-12|||December 1, 2015|Actual|2015-12-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|July 30, 2016|Actual|2016-07-30||Interventional|||Effect of Fish Consumption on Cardiovascular Risk Factors||Completed||N/A|100|Actual|Eastern University, Sri Lanka||1|||f||||f|f|f||||||No||2017-10-10 21:10:47.596902|2017-10-10 21:10:47.596902
NCT03111771|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-07|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|MYOMEC||Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract|Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||3||f|||||f|f||||||||2017-10-10 21:10:47.709036|2017-10-10 21:10:47.709036
NCT03111758|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-12|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Flow Augmentation Study in Postthrombotic Patients|Flow Augmentation With Geko Device in Patients With Postthrombotic Syndrome a Prospective Randomised Cross-Over Trial|Recruiting||N/A|20|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f|||f|||||2017-10-10 21:10:47.870061|2017-10-10 21:10:47.870061
NCT03111732|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-12|2017-09-12|||June 14, 2017|Actual|2017-06-14|August 29, 2017|2017-08-29|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)|A Phase 2 Study of Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in Subjects With Advanced Biliary Tract Carcinoma (BTC)|Recruiting||Phase 2|19|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f|||||t|f||||||||2017-10-10 21:10:48.046343|2017-10-10 21:10:48.046343
NCT03111719|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-07|||January 4, 2010|Actual|2010-01-04|March 2017|2017-03-01|October 10, 2018|Anticipated|2018-10-10|October 10, 2018|Anticipated|2018-10-10||Observational|||Human Brown Adipose Tissue and Mitochondrial Respiration|Human Brown Adipose Tissue Histological and Mitochondrial Respiratory Analysis|Recruiting||N/A|180|Anticipated|Maastricht University Medical Center|||1||f||||||||||||||2017-10-10 21:10:48.165671|2017-10-10 21:10:48.165671
NCT03111706|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-08|2017-04-13|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|||2D and 3D Ultrasound Assessment of Cesarean Section Scars|2D and 3D Ultrasound Assessment of Cesarean Section Scars and Its Correlation to Intraoperative Findings|Not yet recruiting||N/A|300|Anticipated|Cairo University|||2||f||||t|f|f||||||Undecided||2017-10-10 21:10:48.242377|2017-10-10 21:10:48.242377
NCT03111693|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-07|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|RisqOScan||CT Evaluation of Cardiovascular Risk Markers in Obese Patients|CT Evaluation of Cardiovascular Risk Markers in Obese Patients|Recruiting||N/A|123|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 21:10:48.335095|2017-10-10 21:10:48.335095
NCT03111680|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-12|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01||Interventional|||Healthy Families to Change Obesity in Public Housing Residents|Healthy Families: a Cluster Randomized Study to Change Obesity in Public Housing|Completed||N/A|211|Actual|University of Washington||2|||f||||f|f|f||||||No||2017-10-10 21:10:48.425382|2017-10-10 21:10:48.425382
NCT03111667|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-07|||May 15, 2016|Actual|2016-05-15|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|June 2019|Anticipated|2019-06-01||Interventional|TMCU5||A Hybrid Effectiveness-Implementation Trial of a School-Based Teen Marijuana Checkup|A Hybrid Effectiveness-Implementation Trial of a School-Based Teen Marijuana Checkup|Recruiting||N/A|327|Anticipated|University of Washington||6|||f||||t|f|f||||||No||2017-10-10 21:10:48.512772|2017-10-10 21:10:48.512772
NCT03111654|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-12|||July 14, 2016|Actual|2016-07-14|April 2017|2017-04-01|January 13, 2018|Anticipated|2018-01-13|January 13, 2018|Anticipated|2018-01-13||Interventional|RIVAFAG||A Pilot Study on the Prevention of the Vascular RISK Related to Atrial Fibrillation After Intracranial Hemorrhage by Closing the Left Auricle|A Pilot Study on the Prevention of the Vascular RISK Related to Atrial Fibrillation After Intracranial Hemorrhage by Closing the Left Auricle|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:10:48.626487|2017-10-10 21:10:48.626487
NCT03111641|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-09-28|||June 18, 2017|Actual|2017-06-18|September 2017|2017-09-01|September 28, 2017|Actual|2017-09-28|August 1, 2017|Actual|2017-08-01||Interventional|||The Role of Lung Ultrasound During Perioperative Evaluation|Comparison of Lung Ultrasound Assessment and Chest Radiography During Perioperative Evaluation: a Prospective Study|Completed||N/A|90|Actual|University of Pisa||1|||f|||||f|f||||||||2017-10-10 21:10:48.732177|2017-10-10 21:10:48.732177
NCT03111615|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-04-21|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|HOTBreast||HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer|Hormone Therapy Initiation Immediately After Histological Diagnosis of Breast Cancer, Can it Make Any Difference?|Not yet recruiting||Phase 4|90|Anticipated|Centro Hospitalar Lisboa Ocidental||3|||f||||t|f|f||||||No||2017-10-10 21:10:48.89117|2017-10-10 21:10:48.89117
NCT03111602|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-07|||May 2011|Actual|2011-05-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|June 2015|Actual|2015-06-01||Interventional|||Increase of Prostaglandin E2 in Reversal of Ductal Constriction After Dietary Restriction of Polyphenols|Increase of Prostaglandin E2 in Reversal of Ductal Constriction After Dietary Restriction of Polyphenols|Completed||N/A|75|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||f|f|f||||||No||2017-10-10 21:10:49.002266|2017-10-10 21:10:49.002266
NCT03111589|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-07|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.|Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization|Recruiting||N/A|120|Anticipated|Brugmann University Hospital||4|||f||||f|f|f||||||No||2017-10-10 21:10:49.078542|2017-10-10 21:10:49.078542
NCT03111576|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-07-19|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PE||Vascular Changes in Pre-Eclamptic Patients and Its Impact on Pregnancy Outcome.|Assessment ofMaternal and FetalVascular Changes inNormotensive andPre-Eclamptic Patients and Its Impact on Pregnancy Outcome.|Recruiting||N/A|100|Anticipated|Beni-Suef University|||2||f||||t|f|f||||||||2017-10-10 21:10:49.221172|2017-10-10 21:10:49.221172
NCT03111563|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-07|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness of Warm Saline Distension Media on Relieving Pain in Office Hysteroscopy|Effectiveness of Warm Saline Distension Media on Relieving Pain in Office Hysteroscopy|Active, not recruiting||N/A|82|Anticipated|Ain Shams University||2|||f||||t|f|f||||||No||2017-10-10 21:10:49.34565|2017-10-10 21:10:49.34565
NCT03111550|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-18|||May 10, 2017||2017-05-10||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:10:49.409443|2017-10-10 21:10:49.409443
NCT03111537|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-04-06|||May 2015||2015-05-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|COMET||Methods Project 4: Clinical Trial - Amended|Project 4: Clinical Trial Method for Assessing a Tobacco Product Part of Models for Tobacco Product Evaluation:|Recruiting||Phase 3|550|Anticipated|University of Minnesota - Clinical and Translational Science Institute||6|||f||||f||||||||||2017-10-10 21:10:49.461939|2017-10-10 21:10:49.461939
NCT03111524|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-06|||October 15, 2016|Actual|2016-10-15|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|CCR||The Classroom Communication Resource (CCR) Intervention to Change Grade 7 Peer's Attitudes Towards Children Who Stutter (CWS)|The Classroom Communication Resource (CCR) Intervention to Change Grade 7 Peer's Attitudes Towards Children Who Stutter (CWS) in the Western Cape: A Protocol for a Cluster-Randomised Controlled Trial|Active, not recruiting||N/A|453|Actual|University of Cape Town||10|||f||||t|f|f||||||No|The individual participant data willl be shared amongst the primary researcher, research assistants, contributing authors and the statistician. Once the data is analysed, the findings will be reported in an article. The study looks at clusters and thus it is not necessary to share IPD. If any researchers are wanting access to statistical data, this can be requested|2017-10-10 21:10:49.578005|2017-10-10 21:10:49.578005
NCT03111511|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-01|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|August 23, 2017|Actual|2017-08-23|August 23, 2017|Actual|2017-08-23||Interventional|||A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)|A Phase 1, Open-label Study in Healthy Female Subjects to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)|Completed||Phase 1|18|Actual|Janssen Sciences Ireland UC||1|||f||||f|f|f||||||||2017-10-10 21:10:49.672446|2017-10-10 21:10:49.672446
NCT03111498|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-07|||March 9, 2017|Actual|2017-03-09|April 2017|2017-04-01|March 13, 2018|Anticipated|2018-03-13|March 13, 2018|Anticipated|2018-03-13||Interventional|||Technical Skills Training Programme for Conducting Vacuum Assisted Deliveries|Technical Skills Training Programme for Conducting Vacuum Assisted Deliveries - a Randomized Controlled Trial|Recruiting||N/A|20|Anticipated|Medical University of Vienna||2|||f||||f|f|f||||||Undecided||2017-10-10 21:10:49.75573|2017-10-10 21:10:49.75573
NCT03111485|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-07|||December 2016||2016-12-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease|Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease|Recruiting||Phase 4|42|Anticipated|McGill University Health Center||2|||f||||f||||||||Undecided||2017-10-10 21:10:49.841361|2017-10-10 21:10:49.841361
NCT03111472|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-11|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Development and Evaluation of a Guide to Help People With Parkinson's and Their Caregivers to Self-manage Falling|Development and Evaluation of a Self-management Guide for Community-dwelling People With Parkinson's Disease Who Fall and Their Informal Caregivers|Not yet recruiting||N/A|40|Anticipated|University of Southampton||1|||f||||f|f|f||||||No||2017-10-10 21:10:49.934968|2017-10-10 21:10:49.934968
NCT03111459|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-15|||August 1, 2017|Actual|2017-08-01|April 2017|2017-04-01|May 2024|Anticipated|2024-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Repair of Thoracoabdominal Aortic Aneurysms|Endograft Repair of Thoracoabdominal Aortic Aneurysms (TAAA)|Recruiting||N/A|15|Anticipated|The Christ Hospital||2|||f||||t|f|t|t|||||||2017-10-10 21:10:50.013629|2017-10-10 21:10:50.013629
NCT03111446|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-07|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||General Anesthesia Versus Spinal Anesthesia in Patients of HELLP Syndrome|General Anesthesia Versus Spinal Anesthesia in Patients of HELLP Syndrome|Not yet recruiting||N/A|60|Anticipated|Assiut University||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:10:50.105041|2017-10-10 21:10:50.105041
NCT03111433|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-06|||March 19, 2017|Actual|2017-03-19|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus|Effect of Coenzyme Q10 on Markers of Endothelial Dysfunction in Pediatric Patients With Type 1 Diabetes Mellitus|Active, not recruiting||Phase 2|49|Actual|Ain Shams University||2|||f|||||f|f|||f|||||2017-10-10 21:10:52.077719|2017-10-10 21:10:52.077719
NCT03111420|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-06-28|||January 9, 2017|Actual|2017-01-09|June 2017|2017-06-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Study of AggreGuide A-100 (ADP) Assay|Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Detection of Platelet Dysfunction Due to P2Y12 Antiplatelet Drugs|Enrolling by invitation||N/A|300|Anticipated|Aggredyne, Inc.||3|||f||||t|f|t|t|f|t|||No||2017-10-10 21:10:52.210041|2017-10-10 21:10:52.210041
NCT03111407|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||April 2014|Actual|2014-04-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||iAssist vs. Conventional Instrumentation in Total Knee Arthroplasty|Evaluation of Zimmer® iASSIST™ vs. Conventional Instrumentation in Total Knee Arthroplasty: Radiographic, Clinical and Economic Outcomes|Recruiting||N/A|100|Anticipated|Zimmer Biomet||2|||f||||f|f|f||||||No||2017-10-10 21:10:52.287918|2017-10-10 21:10:52.287918
NCT03111394|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-18|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||Study of myMS in Participants With a Diagnosis of Multiple Sclerosis|A Pilot Study Evaluating the Feasibility of A Mobile Application to Collect Clinical, Magnetic Resonance Imaging Information and Genetic Data in Participants With Multiple Sclerosis|Recruiting||N/A|200|Anticipated|University of Southern California|||1||f||||f||||||Samples With DNA|"     Saliva samples are collected for DNA analysis   "|Undecided|Participants will have the option to opt in or out for researchers to be able to share individual participant data (IPD) with researchers outside of USC.|2017-10-10 21:10:52.375991|2017-10-10 21:10:52.375991
NCT03111381|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-12|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|TRUST||Toradol to Reduce Ureteroscopic Symptoms Trial|Toradol to Reduce Ureteroscopic Symptoms Trial|Recruiting||Phase 2|126|Anticipated|Yale University||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:10:52.450379|2017-10-10 21:10:52.450379
NCT03111368|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-04-11|||April 27, 2015|Actual|2015-04-27|June 2016|2016-06-01|June 23, 2016|Actual|2016-06-23|June 23, 2016|Actual|2016-06-23||Interventional|EUS-FNA||EUS-FNA of Solid Pancreatic Mass: Comparison Between Negative Pressure and Slow-pull Technique|Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) of Solid Pancreatic Mass: Comparison Between Negative Pressure and Slow-pull Technique|Completed||N/A|1|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 21:10:52.539924|2017-10-10 21:10:52.539924
NCT03111355|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-06|||March 1, 2013|Actual|2013-03-01|April 2017|2017-04-01|April 19, 2016|Actual|2016-04-19|August 15, 2014|Actual|2014-08-15||Interventional|SUBRANUT||Effects of Genetic Variations in the Response to Brazil Nut Supplementation|Genetic Variants in Selenoprotein Genes and Gender Influence Biomarkers of Se Status in Response to Brazil Nut Supplementation in Healthy Brazilians|Completed||N/A|129|Actual|University of Sao Paulo||1|||f||||f|f|f||||||No||2017-10-10 21:10:52.611798|2017-10-10 21:10:52.611798
NCT03111342|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-21|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intracervical Anesthesia and Pain Associated With Intrauterine Contraceptive Insertion|Effect of Intracervical Anesthesia on Pain Associated With the Insertion of Levonorgestrel-releasing Intrauterine System in Nulligravida Women: a Randomized Controlled Trial|Recruiting||Phase 4|300|Anticipated|University of Sao Paulo||3|||f||||f|f|f|||f|||||2017-10-10 21:10:52.689545|2017-10-10 21:10:52.689545
NCT03111316|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-06-02|||April 9, 2017|Actual|2017-04-09|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening|Combined Use of the Controlled Release Dinoprostone Insert and Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening and Labor Induction in Term Women: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|University of Oklahoma||2|||f||||f|f|t|t|f|f|||No||2017-10-10 21:10:52.932048|2017-10-10 21:10:52.932048
NCT03111303|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-11|||January 1, 2011|Actual|2011-01-01|April 2017|2017-04-01|April 6, 2017|Actual|2017-04-06|December 31, 2016|Actual|2016-12-31||Observational|||Mechanical Ventilation Parameters in HAP Patients|Nosocomial Pneumonia as a Factor Influencing Parameters of Mechanical Ventilation: Results of a Retrospective, Observational Study|Completed||N/A|2654|Actual|University Hospital Olomouc|||2||f||||f|f|f||||||No||2017-10-10 21:10:53.142753|2017-10-10 21:10:53.142753
NCT03111290|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-06|||January 2014||2014-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Modulating Oscillations and Working Memory in Patients With Subdural Electrodes|Modulating Oscillations and Working Memory in Patients With Subdural Electrodes|Enrolling by invitation||N/A|20|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||Yes|De-identified electrophysiology data and task information (e.g. timing of each trial, timing of responses) will be shared at the end of the study in a central repository (e.g. zenodo)|2017-10-10 21:10:53.235421|2017-10-10 21:10:53.235421
NCT03111277|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-09-14|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||MR Guided Focused Ultrasound for Treatment of Neuropathic Pain|Phase 1 Clinical Trial for MR Guided Focused Ultrasound (FUS) Thalamotomy of Central Lateral Thalamic Nucleus for the Treatment of Neuropathic Pain|Recruiting||N/A|5|Anticipated|University of Maryland||1|||||||t|f|t|f|f||||||2017-10-10 21:10:53.343955|2017-10-10 21:10:53.343955
NCT03111264|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-09-27|||June 17, 2016|Actual|2016-06-17|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|October 2018|Anticipated|2018-10-01||Interventional|||Building Blocks for Healthy Preschoolers|Building Blocks for Healthy Preschoolers: Child Care and Family Models|Enrolling by invitation||N/A|2610|Anticipated|University of Maryland||3|||f||||t|f|f||||||||2017-10-10 21:10:53.476638|2017-10-10 21:10:53.476638
NCT03111251|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-13|||March 2015||2015-03-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics|Multi-component Interventions for Patients and Providers to Increase HPV Vaccination in a Network of Pediatric Clinics in Houston, TX|Recruiting||N/A|1000|Anticipated|The University of Texas Health Science Center, Houston||2|||f|||||f|f||||||||2017-10-10 21:10:53.603308|2017-10-10 21:10:53.603308
NCT03111238|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-31|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||The Efficacy and Safety of Rexmyelocel-T to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM|The Efficacy and Safety of Intra-arterial Administration of Rexmyelocel-T to Treat Ischemic Rest Pain in Subjects With Critical Limb Ischemia (CLI) Rutherford Category 4 and Diabetes Mellitus (DM): a Pivotal, Placebo-controlled, Double-blind, Parallel-group, Adaptive Trial|Recruiting||Phase 3|60|Anticipated|Rexgenero Limited||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:10:53.723051|2017-10-10 21:10:53.723051
NCT03111225|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-19|||June 6, 2016|Actual|2016-06-06|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Thoracic Paraspinal Soft Tissue Mobilizations in Treatment of Patients With Upper Limb Complex Regional Pain Syndrome|Thoracic Paraspinal Soft Tissue Mobilizations in Treatment of Patients With Upper Limb Complex Regional Pain Syndrome|Recruiting||N/A|56|Anticipated|Reuth Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:10:53.828681|2017-10-10 21:10:53.828681
NCT03111212|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-25|||June 2018|Anticipated|2018-06-01|April 2017|2017-04-01|January 2021|Anticipated|2021-01-01|October 2020|Anticipated|2020-10-01||Interventional|ThIlo||Iloprost in Acute Respiratory Distress Syndrome|Therapeutic Iloprost for the Treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial)|Not yet recruiting||Phase 3|900|Anticipated|University Hospital Tuebingen||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:10:53.939452|2017-10-10 21:10:53.939452
NCT03111199|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-06|||April 17, 2017|Anticipated|2017-04-17|April 2017|2017-04-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Influence of Cryotherapy Combined to TENS Burst in Patients With Non-specific Chronic Lombar Pain|Influence of Cryotherapy Combined to TENS Burst in Pain, Functional Capacity and Quality of Life Patients With Non-specific Chronic Lombar Pain: A Blind Controlled Randomized Clinical Trial|Not yet recruiting||N/A|48|Anticipated|Universidade Federal do Rio Grande do Norte||4|||f||||t|f|f||||||||2017-10-10 21:10:54.041847|2017-10-10 21:10:54.041847
NCT03111186|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-09|||June 5, 2017|Anticipated|2017-06-05|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery|A Randomized Trial Comparing Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Outpatient Soft Tissue Hand Surgery|Not yet recruiting||Phase 2|168|Anticipated|University of Southern California||2|||f||||f|t|f|||t|||Yes|Data will be shared as required with the USC Health Sciences Institutional Review Board. Participant data will be coded with coding identifiers kept separately by research personnel only and destroyed upon completion of the study.|2017-10-10 21:10:54.152135|2017-10-10 21:10:54.152135
NCT03111173|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-23|||June 5, 2017|Anticipated|2017-06-05|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Can Conventional ECG Technology Capture Fetal Cardiac Activity?|Can Conventional ECG Technology Capture Fetal Cardiac Activity?|Recruiting||Early Phase 1|50|Anticipated|University of Washington||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:10:54.276289|2017-10-10 21:10:54.276289
NCT03111160|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-04-05|||November 16, 2016|Actual|2016-11-16|April 2017|2017-04-01|January 15, 2017|Actual|2017-01-15|January 15, 2017|Actual|2017-01-15||Interventional|||Lower Femtosecond Laser Energy Levels Lead to Better Visual Recovery After Small-incision Lenticule Extraction for Myopia|Lower Femtosecond Laser Energy Levels Lead to Better Visual Recovery After Small-incision Lenticule Extraction for Myopia|Completed||N/A|150|Actual|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:10:54.357848|2017-10-10 21:10:54.357848
NCT03103893|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-05-23|||July 12, 2017|Anticipated|2017-07-12|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Novel Compositions for Treating or Preventing Dermal Disorders|Novel Compositions for Treating or Preventing Dermal Disorders|Not yet recruiting||Phase 1/Phase 2|120|Anticipated|Drexel University||1|||f||||f|t|f|||f|||No||2017-10-10 21:12:03.358665|2017-10-10 21:12:03.358665
NCT03111147|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-01|||April 12, 2017|Actual|2017-04-12|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|March 2020|Anticipated|2020-03-01||Interventional|||Impact of Humeral Component Version on Outcomes Following RTSA|The Impact of Humeral Component Version on Outcomes Following Reverse Total Shoulder Arthroplasty: A Prospective Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|William Beaumont Hospitals||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:10:54.436266|2017-10-10 21:10:54.436266
NCT03111134|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-07|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||A New Abdomen Closure Technology Based on Component Separation: a Prospective Randomized Controlled Trial|A New Abdomen Closure Technology Based on Component Separation: a Prospective Randomized Controlled Trial|Not yet recruiting||N/A|220|Anticipated|Xijing Hospital of Digestive Diseases||2|||f|||||f|f||||||||2017-10-10 21:10:54.508318|2017-10-10 21:10:54.508318
NCT03111121|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-09|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|April 15, 2018|Anticipated|2018-04-15||Interventional|||Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy|Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy|Recruiting||Phase 4|84|Anticipated|West Virginia University||2|||f||||t|t|f||||||No|no plan to share IPD|2017-10-10 21:10:54.58288|2017-10-10 21:10:54.58288
NCT03111108|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-27|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|October 6, 2018|Anticipated|2018-10-06|October 6, 2018|Anticipated|2018-10-06||Interventional|||Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection|A Multi-Site, Open-Label, Partially-Randomized Trial of the Efficacy and Safety of Fixed Dose Elbasvir/Grazoprevir (EBR/GZR) Based Regimens in French Subjects With Chronic Hepatitis C Virus (HCV) Genotype 4 Infection|Recruiting||Phase 4|120|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f|f|f||||||||2017-10-10 21:10:54.66809|2017-10-10 21:10:54.66809
NCT03111095|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-12|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Postpartum Hypertension: Remote Patient Monitoring|Remote Patient Monitoring- Telehealth for Management of Women With Postpartum Hypertension|Recruiting||N/A|440|Anticipated|University of Wisconsin, Madison||2|||f||||f|f|f||||||||2017-10-10 21:10:54.777974|2017-10-10 21:10:54.777974
NCT03111082|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-11|||April 17, 2017|Anticipated|2017-04-17|April 2017|2017-04-01|April 16, 2018|Anticipated|2018-04-16|April 16, 2018|Anticipated|2018-04-16||Observational|||Incidence of Postoperative Neuromuscular Blockade in Post-Anesthesia Care Unit at Parkland Hospital: Does Size Matter?|Incidence of Postoperative Neuromuscular Blockade in the Post-Anesthesia Care Unit at Parkland Hospital: Does Size Matter?|Not yet recruiting||N/A|100|Anticipated|University of Texas Southwestern Medical Center|||3||f||||f|f|f||||||No||2017-10-10 21:10:54.854353|2017-10-10 21:10:54.854353
NCT03111069|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-09|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children|A Phase I Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children|Not yet recruiting||Phase 1|28|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:10:54.912778|2017-10-10 21:10:54.912778
NCT03111056|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-11|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Web-Based Treatment of Heavy Drinking Among Women With a History of Sexual Trauma|Web-Based Treatment of Heavy Drinking Among Women With a History of Sexual Trauma|Recruiting||N/A|200|Anticipated|University of Washington||2|||f||||f|f|f||||||No||2017-10-10 21:10:55.114662|2017-10-10 21:10:55.114662
NCT03111043|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-15|||December 1, 2015|Actual|2015-12-01|May 2017|2017-05-01||||December 1, 2017|Anticipated|2017-12-01||Interventional|||Head-to-pelvis Computed Tomography Evaluation of Sudden Death Survivors|Head-to-pelvis Computed Tomography Evaluation of Sudden Death Survivors|Recruiting||N/A|100|Anticipated|University of Washington||1|||f||||t|f|f||||||Undecided|Unclear plan for sharing data.|2017-10-10 21:10:55.219718|2017-10-10 21:10:55.219718
NCT03111030|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-10-03|||April 28, 2017|Actual|2017-04-28|October 2017|2017-10-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||ProACTIVE SCI Intervention|ProACTIVE SCI Physical Activity Coaching Intervention|Active, not recruiting||N/A|30|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 21:10:55.321312|2017-10-10 21:10:55.321312
NCT03111017|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-04-05|||April 17, 2017|Anticipated|2017-04-17|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Mechanisms and Management of Exercise Intolerance in Older Heart Failure Patients|Mechanisms and Management of Exercise Intolerance in Older Heart Failure Patients With Preserved Ejection Fraction|Recruiting||N/A|48|Anticipated|The University of Texas at Arlington||2|||f||||f|f|f||||||No||2017-10-10 21:10:55.43609|2017-10-10 21:10:55.43609
NCT03111004|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-08-08|||September 1, 2014|Actual|2014-09-01|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|June 30, 2016|Actual|2016-06-30||Observational|BeyondSilos||BeyondSilos - More Personalised and Coordinated Care and Improved Outcomes for Elderly Patients|BeyondSilos - Integrated Care Leading to a More Personalised and Coordinated Care, Improving Outcomes for Elderly Patients, Delivering More Effective Care and Support, and Provide More Cost Efficient Health and Social Services|Active, not recruiting||N/A|1840|Anticipated|Him SA|||2||f||||t|f|f||||||||2017-10-10 21:10:55.556435|2017-10-10 21:10:55.556435
NCT03110991|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-05|||October 1, 2017|Anticipated|2017-10-01|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|App Depression||Cognitive-behavioral Intervention Via a Smartphone App for Depressive Symptoms in Caregivers|A Randomized Controlled Trial on the Efficacy of a Cognitive-behavioral Intervention Via a Smartphone App for Caregivers With Depressive Symptoms|Not yet recruiting||N/A|174|Anticipated|University of Santiago de Compostela||3|||f||||f|f|f||||||No||2017-10-10 21:10:55.658667|2017-10-10 21:10:55.658667
NCT03110796|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-11|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|DISCOVERY||Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers|Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers: a Prospective, Randomized, Controlled, Double-blind, European Multicentre Clinical Trial|Not yet recruiting||N/A|||Laboratoires URGO||3|||f||||f|f|f||||||No||2017-10-10 21:10:57.064656|2017-10-10 21:10:57.064656
NCT03110978|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-14|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I, Selected Stage IIa or Isolated Lung Parenchymal Recurrent Non-Small Cell Lung Cancer: I-SABR|Phase II Randomized Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I, Selected Stage IIa or Isolated Lung Parenchymal Recurrent Non-Small Cell Lung Cancer: I-SABR|Recruiting||Phase 2|140|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:10:55.765699|2017-10-10 21:10:55.765699
NCT03110965|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-11|||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|January 1, 2019|Anticipated|2019-01-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Yoga in the Treatment of Adolescent Idiopathic and Degenerative Scoliosis|Yoga in the Treatment of Adolescent Idiopathic and Degenerative Scoliosis|Recruiting||N/A|100|Anticipated|Manhattan Physical Medicine and Rehabilitation, LLP||1|||f||||f|f|f||||||No||2017-10-10 21:10:55.881485|2017-10-10 21:10:55.881485
NCT03110952|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-04-05|||January 2016||2016-01-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant|A Phase 1, Randomized, Placebo-Controlled, Observer-Blind, Single-Center, Study of TDENV-PIV and TDENV-F17 Dengue Vaccine Platforms in a Heterologous Prime Boost Strategy in Healthy Adults in a Non-Endemic Region|Withdrawn||Phase 1|0|Actual|U.S. Army Medical Research and Materiel Command||4||lack of materials, not moving forward|f||||f||||||||||2017-10-10 21:10:55.967004|2017-10-10 21:10:55.967004
NCT03110939|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-17|||March 21, 2017|Actual|2017-03-21|April 2017|2017-04-01|April 5, 2021|Anticipated|2021-04-05|April 5, 2019|Anticipated|2019-04-05||Interventional|||Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal Cancer|A Phase III, Single Center Randomized Controlled Trial of Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal Cancer|Recruiting||N/A|440|Anticipated|Henan Cancer Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:10:56.066783|2017-10-10 21:10:56.066783
NCT03110926|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-21|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Induction Chemotherapy for Locally Advanced Esophageal Cancer|Induction Chemotherapy for Locally Advanced Esophageal Cancer: A Phase II Study|Recruiting||Phase 2|40|Anticipated|University of Rochester||1|||||||t|t|f||||||||2017-10-10 21:10:56.148573|2017-10-10 21:10:56.148573
NCT03110913|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-11|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Metabolic Availability of Metionine From Lentils in Adult Men|Study Title: Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Methionine From Canadian Lentils, in Healthy Young Adult Men|Recruiting||N/A|6|Anticipated|The Hospital for Sick Children||1|||f||||f|f|f||||||No||2017-10-10 21:10:56.255967|2017-10-10 21:10:56.255967
NCT03110900|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-23|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|August 14, 2019|Anticipated|2019-08-14|August 14, 2019|Anticipated|2019-08-14||Interventional|loxapine||Inhaled Loxapine vs IM Haloperidol + Lorazepam for Agitation|A Randomized Double-blind Multicenter Double-dummy Non-inferiority Trial of Inhaled Loxapine and Intramuscular Haloperidol + Lorazepam for the Reduction of Agitation|Not yet recruiting||Phase 4|140|Anticipated|University of Arkansas||2|||f||||t|t|f|||t|||||2017-10-10 21:10:56.338513|2017-10-10 21:10:56.338513
NCT03110887|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-11|||November 20, 2015|Actual|2015-11-20|August 2017|2017-08-01|November 9, 2016|Actual|2016-11-09|October 21, 2016|Actual|2016-10-21||Observational|MONET||Monitoring Outcome in Neonatal Thrombocytopenia|Monitoring Outcome in Neonatal Thrombocytopenia|Completed||N/A|700|Actual|Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research|||1||f||||f|f|f||||||||2017-10-10 21:10:56.441798|2017-10-10 21:10:56.441798
NCT03110874|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-06|||October 8, 2015|Actual|2015-10-08|April 2017|2017-04-01|July 31, 2017|Anticipated|2017-07-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control|A Multi-center, Randomized, Interventional, Open, Phase Ⅳ Clinical Trial on Education Method of Fluterol® Inhalation Capsule 250/50 μg Inhaler for Asthma Control in Patients With Partly Controlled Asthma|Active, not recruiting||Phase 4|192|Anticipated|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||Undecided||2017-10-10 21:10:56.524511|2017-10-10 21:10:56.524511
NCT03110861|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-07|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PULSTA® Transcatheter Pulmonary Valve Korean Multicenter Study|A Prospective, Multicenter, Single Arm Study to Evaluate the Safety and Effectiveness of Implantation of 'Transcatheter Pulmonary Valve (TPV)' for the Treatment of Congenital Heart Disease With Pulmonary Valve Disease|Recruiting||N/A|15|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:10:56.625631|2017-10-10 21:10:56.625631
NCT03110848|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-05|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|STAGO||Effects of Statins in Graves' Orbitopathy (GO) in Hypercholesterolemic Patients|Evaluation of the Effects of Statins on Graves' Orbitopathy (GO) in Hypercholesterolemic Patients With Moderate-to-severe and Active GO Submitted to Intravenous Glucocorticoid Therapy: The STAGO Study.|Not yet recruiting||Phase 4|88|Anticipated|University of Pisa||2|||f||||f|f|f||||||No||2017-10-10 21:10:56.734117|2017-10-10 21:10:56.734117
NCT03110835|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-05|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Observational|LORIGRAVES||Low-dose Radioiodine Ablation in Graves' Disease|Use of Low-dose Radioiodine for Ablation of Thyroid Remnants in Patients With Graves' Disease Following Thyroidectomy|Completed||N/A|12|Actual|University of Pisa|||2||f||||f|f|f||||||No||2017-10-10 21:10:56.827183|2017-10-10 21:10:56.827183
NCT03110822|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-06|||February 6, 2017|Actual|2017-02-06|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|February 2020|Anticipated|2020-02-01||Interventional|||A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients|A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients|Recruiting||Phase 1|28|Anticipated|Oncotherapeutics||1|||f||||t|t|f||||||No||2017-10-10 21:10:56.890812|2017-10-10 21:10:56.890812
NCT03110809|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-06|||April 17, 2017|Anticipated|2017-04-17|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|August 20, 2019|Anticipated|2019-08-20||Interventional|BAT CAP||The Effects of Capsinoids on Brown Adipose Tissue Activation in Obesity|The Effects of Capsinoids on Brown Adipose Tissue Recruitment and Activation in Obesity|Not yet recruiting||N/A|42|Anticipated|Northwestern University||4|||f||||f|f|f||||||No||2017-10-10 21:10:56.994689|2017-10-10 21:10:56.994689
NCT03110783|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-26|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|November 1, 2018|Anticipated|2018-11-01||Interventional|||Bioseal Dural Sealing Study|A Prospective, Randomized, Controlled, Single Blinded, Study to Evaluate the Safety and Effectiveness of Bioseal as an Adjunct to Sutured Dural Repair|Not yet recruiting||Phase 3|200|Anticipated|Guangzhou Bioseal Biotechnology Co., Ltd.||2|||f|||||f|f|||f|||||2017-10-10 21:10:57.130354|2017-10-10 21:10:57.130354
NCT03110770|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-18|||March 29, 2017|Actual|2017-03-29|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|DNA||VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents|VRC 705: A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a Zika Virus DNA Vaccine in Healthy Adults and Adolescents|Recruiting||Phase 2|2500|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t|t|f||||||||2017-10-10 21:10:57.237526|2017-10-10 21:10:57.237526
NCT03110757|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-10-05|||October 26, 2017|Anticipated|2017-10-26|June 21, 2017|2017-06-21|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults|A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults|Not yet recruiting||Phase 1|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||9|||f|||||t|f|||f|||||2017-10-10 21:10:57.393176|2017-10-10 21:10:57.393176
NCT03110744|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-11|||August 1, 2017|Anticipated|2017-08-01|April 2017|2017-04-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|NCT-PMO-1601||CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma|CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)|Not yet recruiting||Phase 2|43|Anticipated|National Center for Tumor Diseases, Heidelberg||1|||f||||t|f|f|||f|||No||2017-10-10 21:10:57.5059|2017-10-10 21:10:57.5059
NCT03110731|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-11|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|December 29, 2016|Actual|2016-12-29|December 24, 2016|Actual|2016-12-24||Interventional|||Effect of Strength Training on the Quality and Duration of Sleep and Daytime Sleepiness of Institutionalized Adolescents|Effect of Strength Training on the Quality and Duration of Sleep and Daytime Sleepiness of Institutionalized Adolescents: A Randomized Study|Completed||N/A|20|Actual|University of Pernambuco||2|||f||||f|f|f||||||No||2017-10-10 21:10:57.576657|2017-10-10 21:10:57.576657
NCT03110718|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-06|||January 2, 2015|Actual|2015-01-02|April 2017|2017-04-01|October 1, 2015|Actual|2015-10-01|June 2, 2015|Actual|2015-06-02||Interventional|||Role of Armeo-Power and Muscle Vibration in Upper Limb Rehabilitation|Can Upper Limb Robotic Rehabilitation Plus Muscle Vibration Improve Motor Function? A Pilot Study|Completed||N/A|20|Actual|"IRCCS Centro Neurolesi Bonino-Pulejo"||2|||f|||||f|t|f|f|f|||||2017-10-10 21:10:57.73074|2017-10-10 21:10:57.73074
NCT03110705|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-04-11|||March 12, 2015|Actual|2015-03-12|March 2017|2017-03-01|November 17, 2016|Actual|2016-11-17|September 30, 2015|Actual|2015-09-30||Observational|DIVSTRESS||Recreational Diving Practice for Stress Management|Recreational Diving Practice for Stress Management: an Exploratory Controlled Trial|Completed||N/A|67|Actual|Institut de Recherche Biomedicale des Armees|||2||f||||f||||||||No||2017-10-10 21:10:57.813951|2017-10-10 21:10:57.813951
NCT03110692|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-10|||February 10, 2017|Actual|2017-02-10|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Default Options to Reduce Unnecessary Daily Imaging During Palliative Radiation|Health System Initiative to Reduce Unnecessary Daily X-Ray Image Guidance During Palliative Radiation Treatment|Active, not recruiting||N/A|800|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 21:10:57.90117|2017-10-10 21:10:57.90117
NCT03110679|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-06|||February 18, 2016|Actual|2016-02-18|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|August 2019|Anticipated|2019-08-01||Interventional|OA-bi-Blind||Randomized Double-blind Study on the Treatment of Osteoarthritis of the Bilateral Knee: Autologous Bone Marrow Concentrate vs. Hyaluronic Acid|Randomized Double-blind Study on the Treatment of Osteoarthritis of the Bilateral Knee: Autologous Bone Marrow Concentrate vs. Hyaluronic Acid|Recruiting||Phase 4|60|Anticipated|Istituto Ortopedico Rizzoli||2|||f|||||f|f||||||No||2017-10-10 21:10:58.00169|2017-10-10 21:10:58.00169
NCT03110666|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-06|||July 25, 2016|Actual|2016-07-25|April 2017|2017-04-01|July 25, 2021|Anticipated|2021-07-25|July 25, 2018|Anticipated|2018-07-25||Interventional|IOC-target||Treatment for Knee Osteoarthritis With Injections of BMC at the Bone-cartilage Interface. Pilot Study|Treatment for Knee Osteoarthritis With Injections of Autologous Concentrated Bone Marrow Aspirate at the Bone-cartilage Interface Via Percutaneous. Pilot Study|Recruiting||Phase 4|30|Anticipated|Istituto Ortopedico Rizzoli||1|||f||||f|f|f||||||No||2017-10-10 21:10:58.092376|2017-10-10 21:10:58.092376
NCT03110653|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-15|||April 15, 2017|Actual|2017-04-15|July 2017|2017-07-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation|Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation|Recruiting||N/A|26|Anticipated|Université Libre de Bruxelles||2|||f||||t|f|f||||||||2017-10-10 21:10:58.199319|2017-10-10 21:10:58.199319
NCT03110640|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-11|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma|A Phase I Study of Administrating CD19 Chimeric Antigen Receptor Expressing T Cells Followed by Allogeneic Stem Cell Transplantation in Patients With Refractory CD19+ B-linage Leukemia/Lymphoma|Not yet recruiting||Phase 1|20|Anticipated|First Affiliated Hospital of Wenzhou Medical Univeristy||1|||f||||t|f|f||||||Undecided||2017-10-10 21:10:58.300486|2017-10-10 21:10:58.300486
NCT03110627|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-06-08|||March 31, 2017|Actual|2017-03-31|June 2017|2017-06-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|Dx-AF||Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead|Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead: The Dx-AF Study|Recruiting||N/A|378|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t|f|f||||||No||2017-10-10 21:10:58.404505|2017-10-10 21:10:58.404505
NCT03110081|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-04|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|QL Analgesia||Comparing the Efficacy of Epidural and Quadratus Lumborum Analgesia After Open Nephrectomy Surgery|Comparing the Efficacy of Epidural and Quadratus Lumborum Analgesia After Open Nephrectomy Surgery|Recruiting||N/A|100|Anticipated|The Cleveland Clinic||2|||f||||t|f|f|||f|||||2017-10-10 21:11:03.190958|2017-10-10 21:11:03.190958
NCT03110614|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-06|||November 25, 2013|Actual|2013-11-25|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|||Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD|Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Recruiting||N/A|188|Anticipated|University of Alabama at Birmingham|||1||f||||t|f|f||||Samples Without DNA|"     Blood and Exhaled breath condensate for inflammatory markers.   "|No||2017-10-10 21:10:58.549907|2017-10-10 21:10:58.549907
NCT03110601|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-05-16|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of PM Modulation Therapy in Trial Phase|Trialing of PM Modulation Therapy in Patients With Chronic Intractable Low Back Pain With or Without Leg Pain|Recruiting||N/A|25|Anticipated|Stimgenics LLC||1|||f|||||f|t|t|||||||2017-10-10 21:10:58.643594|2017-10-10 21:10:58.643594
NCT03110588|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-15|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 1, 2022|Anticipated|2022-11-01|November 1, 2020|Anticipated|2020-11-01||Interventional|||Phase I Trial of PACE for Metastatic Prostate Cancer|Phase I Trial of Prednisone, Abiraterone, Cabazitaxel and Enzalutamide (PACE) for Metastatic Castration-resistant Prostate Cancer (mCRPC)|Not yet recruiting||Phase 1|12|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||f|||||2017-10-10 21:10:58.720566|2017-10-10 21:10:58.720566
NCT03110575|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-06|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients|A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD|Not yet recruiting||Phase 3|420|Anticipated|Tonix Pharmaceuticals, Inc.||1|||f||||t|t|f||||||Undecided||2017-10-10 21:10:58.836857|2017-10-10 21:10:58.836857
NCT03110562|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-06-08|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|BOSTON||Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma|A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)|Recruiting||Phase 3|364|Anticipated|Karyopharm Therapeutics Inc||2|||||||t|t|f||||||No||2017-10-10 21:10:59.003663|2017-10-10 21:10:59.003663
NCT03110549|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-11|||November 21, 2016|Actual|2016-11-21|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers|A Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Sequential Single Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Subcutaneously and Intramuscularly Administered TMB-607 in HIV-Negative Volunteers|Recruiting||Phase 1|35|Anticipated|Temple University||7|||f||||t|t|f|||f|||||2017-10-10 21:10:59.161942|2017-10-10 21:10:59.161942
NCT03110536|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-08-15|||April 15, 2017|Actual|2017-04-15|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|June 15, 2017|Actual|2017-06-15||Observational|BurN_ED||The Burnout Syndrome in Emergency Department Triage Nurses|Sindromul de Burnout la asistenții Medicali de Triaj Din unitățile de Primire urgențe|Active, not recruiting||N/A|56|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy|||3||f||||f|f|f||||||||2017-10-10 21:10:59.268629|2017-10-10 21:10:59.268629
NCT03110510|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-11|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study|SAMSUNG MEDICAL CENTER|Not yet recruiting||Phase 2|38|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||f|||||2017-10-10 21:10:59.440407|2017-10-10 21:10:59.440407
NCT03110497|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-11|||April 17, 2017|Anticipated|2017-04-17|April 2017|2017-04-01|April 17, 2019|Anticipated|2019-04-17|April 17, 2018|Anticipated|2018-04-17||Interventional|||Single Application Brachytherapy in Cervical Cancer|A Feasibility and Safety Study of Single Application Multi-fractionated High Dose Rate (HDR) Brachytherapy in Locally Advanced Cervical Cancer|Not yet recruiting||N/A|40|Anticipated|Tata Memorial Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:10:59.532979|2017-10-10 21:10:59.532979
NCT03110484|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-04-07|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study|SAMSUNG MEDICAL CENTER|Not yet recruiting||Phase 2|38|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||t|||||2017-10-10 21:10:59.625869|2017-10-10 21:10:59.625869
NCT03110471|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-12|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|September 2017|Anticipated|2017-09-01||Observational|||Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation|Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation of the Impact and Sustainability of the West Wales Adverse Drug Reaction (WWADR) Profile and Pharmacist Involvement|Recruiting||N/A|30|Anticipated|Swansea University|||10||f||||t|f|f||||||No|Individual participant data, will not be shared & participants not identified. The investigators aim to publish the outcomes in 2018. Swansea university website.|2017-10-10 21:10:59.714343|2017-10-10 21:10:59.714343
NCT03110458|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-29|||April 12, 2017|Actual|2017-04-12|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SENS 111-201||Efficacy of SENS-111 in Patients Suffering From Acute Unilateral Vestibulopathy|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 2 Dose Regimens of Orally Administered SENS-111 (100 mg and 200 mg) Given During 4 Days in Patients Suffering From Acute Unilateral Vestibulopathy|Recruiting||Phase 2/Phase 3|207|Anticipated|Sensorion||3|||f||||f|t|f||||||||2017-10-10 21:10:59.869108|2017-10-10 21:10:59.869108
NCT02613130|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-09-29|||November 2015||2015-11-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Evaluate Oral Malodor and Other Outcomes Following The Use of Two-Step Toothpaste Oral Hygiene||Completed||N/A|60|Actual|Procter and Gamble||2|||f|||||f|f||||||||2017-10-10 22:43:02.539754|2017-10-10 22:43:02.539754
NCT03110445|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-10-05|||February 2018|Anticipated|2018-02-01|October 2017|2017-10-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|rVV-740CTA||Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus|Monocentric Open Label Phase I Immunotherapy Trial of Breast Cancer Patients With a Non-replicating Recombinant Vaccinia Virus Expressing Cancer/Testis Antigens and Cluster of Differentiation Antigen 80 (CD80)-CD40L Costimulatory Molecules.|Not yet recruiting||Phase 1|15|Anticipated|University Hospital, Basel, Switzerland||1|||f||||f|f|f||||||||2017-10-10 21:10:59.954849|2017-10-10 21:10:59.954849
NCT03110432|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-08-02|||May 18, 2017|Actual|2017-05-18|July 2017|2017-07-01|February 16, 2021|Anticipated|2021-02-16|December 30, 2020|Anticipated|2020-12-30||Observational|PERI-DYS||Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry|Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry|Recruiting||N/A|2000|Anticipated|GWT-TUD GmbH|||2||f||||f|f|f||||||||2017-10-10 21:11:00.035446|2017-10-10 21:11:00.035446
NCT03110419|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-04-05|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of a Multicomponent Training in Pre-frail Elderly|Effects of a Multicomponent Training on Postural Control and Cardiovascular and Musculoskeletal Systems in Pre-frail Elderly|Not yet recruiting||N/A|36|Anticipated|Universidade Federal de Sao Carlos||2|||f||||f||||||||No||2017-10-10 21:11:00.129764|2017-10-10 21:11:00.129764
NCT03110406|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-11|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|March 10, 2018|Anticipated|2018-03-10|September 30, 2017|Anticipated|2017-09-30||Interventional|||Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation|Effects of Whole-body Vibration Training on the Heart Rate Variability Cardiac in Kidney Transplantation: a Randomized Controlled Trial|Recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco||2|||f|||||f|f||||||No||2017-10-10 21:11:00.223984|2017-10-10 21:11:00.223984
NCT03110393|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-08|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|September 6, 2017|Actual|2017-09-06|September 6, 2017|Actual|2017-09-06||Interventional|||Ambu®AuraGain™ Versus I-gel® in Obese Patients|Prospective Randomized Comparison Between a Fiber Optic Intubation Via the Ambu® AuraGain ™ or the i-Gel® Laryngeal Mask Until a Complete Airway Protection in Obese Patients|Completed||N/A|44|Actual|Schulthess Klinik||2|||f||||f|f|f||||||||2017-10-10 21:11:00.313482|2017-10-10 21:11:00.313482
NCT03110367|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-06-29|||August 15, 2017|Anticipated|2017-08-15|June 2017|2017-06-01|August 15, 2018|Anticipated|2018-08-15|August 15, 2018|Anticipated|2018-08-15||Interventional|||Reframe the Pain: A Parent-Led Intervention to Alter Children's Memories for Pain|Reframe the Pain: A Parent-Led Intervention to Alter Children's Memories for Pain|Not yet recruiting||N/A|90|Anticipated|University of Calgary||3|||f||||f|f|f||||||||2017-10-10 21:11:00.699082|2017-10-10 21:11:00.699082
NCT03110354|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-09-28|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|March 27, 2019|Anticipated|2019-03-27|March 27, 2019|Anticipated|2019-03-27||Interventional|||DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)|A Phase 1 Study of DS-3201b in Subjects With Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)|Recruiting||Phase 1|60|Anticipated|Daiichi Sankyo, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:11:00.932212|2017-10-10 21:11:00.932212
NCT03110341|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-28|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome|Effect of Early Application of Recombinant Human Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome|Recruiting||Phase 3|400|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||t|f|f|||f|||||2017-10-10 21:11:01.033546|2017-10-10 21:11:01.033546
NCT03110328|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-11|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes|Phase II Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes|Not yet recruiting||Phase 2|33|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||f|||||2017-10-10 21:11:01.193571|2017-10-10 21:11:01.193571
NCT03110315|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-06|||March 28, 2017|Actual|2017-03-28|April 2017|2017-04-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|DREAM||A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia|A Double-blind, Crossover, Placebo-controlled Study to Compare the Effects of Nighttime Administration of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia|Recruiting||Phase 4|30|Anticipated|EvergreenHealth||2|||f||||f|t|f|||t|||No|There is no plan to share individual participant data.|2017-10-10 21:11:01.281847|2017-10-10 21:11:01.281847
NCT03110302|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-06|||October 2012|Actual|2012-10-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||In-Home Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD)|In-Home Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD)|Recruiting||N/A|175|Anticipated|Veterans Medical Research Foundation||3|||f||||t|f|f||||||No||2017-10-10 21:11:01.396438|2017-10-10 21:11:01.396438
NCT03110289|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-14|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|RESTORE-UC||Restoration of the Microbiome Through Superdonor Selection|Fecal Microbiota Transplantation in Patients With Active Ulcerative Colitis: Restoration of the Microbiome Through Superdonor Selection|Not yet recruiting||N/A|108|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t|f|f||||||No||2017-10-10 21:11:01.497918|2017-10-10 21:11:01.497918
NCT03110276|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-11|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Study Evaluating Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Escalating Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of EYP001a in Healthy Male Subjects|Completed||Phase 1|80|Actual|Enyo Pharma||2|||f||||f|f|f||||||No||2017-10-10 21:11:01.584729|2017-10-10 21:11:01.584729
NCT03110263|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-25|||June 10, 2016|Actual|2016-06-10|September 2017|2017-09-01|November 1, 2017|Anticipated|2017-11-01|July 1, 2017|Actual|2017-07-01||Interventional|i-Sleep||i-Sleep: Internet-based Treatment for Insomnia|i-Sleep: Internet-based Treatment for Insomnia. A Randomized Controlled Trial|Active, not recruiting||N/A|225|Anticipated|University of Bern||3|||f||||t|f|f||||||||2017-10-10 21:11:01.671451|2017-10-10 21:11:01.671451
NCT03110250|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-06|||February 26, 2017|Actual|2017-02-26|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|A-HIT2||Familial Hypercholesterolemia in Turkey (A-HIT2)|A Nation-wide Registry of Familial Hypercholesterolemia : Clinical Status in Turkey (A-HIT2)|Recruiting||N/A|1000|Anticipated|Ege University|||1||f||||t|f|f||||||No||2017-10-10 21:11:01.768444|2017-10-10 21:11:01.768444
NCT03110237|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-11|||April 10, 2017|Anticipated|2017-04-10|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||A Multidimensional Inpatient Balance Training Class to Improve Functional Outcomes in Rehabilitation Inpatients With ABI|A Multidimensional Inpatient Balance Training Class to Improve Functional Outcomes in Rehabilitation Inpatients With ABI|Not yet recruiting||N/A|20|Anticipated|University of British Columbia||2|||f|||||f|f||||||No||2017-10-10 21:11:01.850922|2017-10-10 21:11:01.850922
NCT03110224|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-31|||September 18, 2012|Actual|2012-09-18|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31|5 Years|Observational [Patient Registry]|||SCP® Observational Study of the Knee|Zimmer Knee Creations SCP® Observational Cohort Follow-Up Study|Recruiting||N/A|1000|Anticipated|Zimmer Biomet|||1||f||||f|f|f||||||||2017-10-10 21:11:01.969551|2017-10-10 21:11:01.969551
NCT03110211|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-08-23|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|April 28, 2018|Anticipated|2018-04-28|April 28, 2018|Anticipated|2018-04-28||Interventional|IMPAC||Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home|Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home|Recruiting||N/A|250|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 21:11:02.131434|2017-10-10 21:11:02.131434
NCT03110198|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-04-06|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis|A Randomized, Double-blind Study Investigating the Efficacy and Safety of Mesalazine With Hydrocortisone Sodium Succinate (100mg QD) Enema for 4-Week Treatment in Patients With Ulcerative Colitis (UC)|Recruiting||Phase 4|528|Anticipated|Xijing Hospital of Digestive Diseases||3|||f||||f|f|f||||||||2017-10-10 21:11:02.244659|2017-10-10 21:11:02.244659
NCT03110185|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-09-14|||January 2016||2016-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Postoperative Delirium: Brain Vulnerability and Recovery|Postoperative Delirium: Brain Vulnerability and Recovery|Recruiting||N/A|55|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 21:11:02.35225|2017-10-10 21:11:02.35225
NCT03110172|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-12|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Short-term Efficacy of Antidepressant in Patients Underwent TKA||Active, not recruiting||Phase 1/Phase 2|32|Anticipated|Dalian Municipal Central Hospital||4|||f||||||||||||Yes||2017-10-10 21:11:02.44859|2017-10-10 21:11:02.44859
NCT03110159|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-13|||October 20, 2017|Anticipated|2017-10-20|April 2017|2017-04-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients|Cyclic PDT for the Prevention of Actinic Keratosis and Non Melanoma Skin Cancer in Solid Organ Transplant Recipients|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|University of Arizona||1|||f||||t|t|f|||f|||Undecided||2017-10-10 21:11:02.536128|2017-10-10 21:11:02.536128
NCT03110146|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-04-06|||January 4, 2017|Actual|2017-01-04|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31|1 Day|Observational [Patient Registry]|||EnSite Precision 2.1 Feasibility Study|EnSite Precision 2.1 Feasibility Study|Enrolling by invitation||N/A|80|Actual|St. Jude Medical|||1||f||||f|f|f||||||Undecided||2017-10-10 21:11:02.635824|2017-10-10 21:11:02.635824
NCT03110133|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-24|||May 8, 2017|Actual|2017-05-08|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff|A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrence of Clostridium Difficile Infection|Recruiting||Phase 2|240|Anticipated|Crestovo LLC||3|||f|||||t|f||||||||2017-10-10 21:11:02.701668|2017-10-10 21:11:02.701668
NCT03110107|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-07|2017-09-15|||April 28, 2017|Actual|2017-04-28|September 2017|2017-09-01|March 20, 2021|Anticipated|2021-03-20|April 6, 2020|Anticipated|2020-04-06||Interventional|||First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Patients With Advanced Solid Tumors|Phase 1/2a First-In-Human Study of BMS-986218 Monoclonal Antibody Alone and in Combination With Nivolumab in Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|452|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 21:11:02.970479|2017-10-10 21:11:02.970479
NCT03110094|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-21|||March 13, 2017|Actual|2017-03-13|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|PROMETHEE||Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis|Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis, With Analysis of CD4 + Follicular Helper T Subpopulations|Recruiting||N/A|40|Anticipated|Rennes University Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:11:03.096792|2017-10-10 21:11:03.096792
NCT03110068|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-06|||April 10, 2017|Anticipated|2017-04-10|April 2017|2017-04-01|April 15, 2019|Anticipated|2019-04-15|April 10, 2019|Anticipated|2019-04-10||Observational|||Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma|Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma|Not yet recruiting||N/A|370|Anticipated|Sun Yat-sen University|||1||f||||f|f|f|||f|||No||2017-10-10 21:11:03.270255|2017-10-10 21:11:03.270255
NCT03110055|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-11|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|ZEPATIER||the Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC.|Pilot Study to Assess the Effect of Grazoprevir/Elbasvir (ZEPATIER™) and Transarterial Chemoembolization (TACE) vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated Hepatocellular Carcinoma|Not yet recruiting||N/A|20|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:11:03.346844|2017-10-10 21:11:03.346844
NCT03110042|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-05|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01|1 Year|Observational [Patient Registry]|||HILO-HF Registry: High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure|High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure|Recruiting||N/A|200|Anticipated|University of Alberta|||1||f|||||f|f||||||||2017-10-10 21:11:03.422765|2017-10-10 21:11:03.422765
NCT03110029|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-04-05|||September 2015||2015-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish|Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish|Active, not recruiting||Phase 4|20|Anticipated|University of Alabama at Birmingham||2|||f||||f|t|f||||||No||2017-10-10 21:11:03.502768|2017-10-10 21:11:03.502768
NCT03110016|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-26|||May 16, 2017|Actual|2017-05-16|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Smartphone Intervention for Subthreshold Depression|Feasibility, Usability, User Satisfaction, and Preliminary Efficacy of a Smartphone Intervention for Subthreshold Depression|Completed||N/A|22|Actual|Kibi International University||1|||f|||||f|f||||||||2017-10-10 21:11:03.586927|2017-10-10 21:11:03.586927
NCT03110003|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-05|||June 27, 2016|Actual|2016-06-27|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparing Low-dose Bupivacaine With Epidural Volume Extension to Standard Bupivacaine Dosing for Short Obstetric Procedures|Comparing Low-dose Bupivacaine With Epidural Volume Extension to Standard Bupivacaine Dosing for Short Obstetric Procedures: A Prospective, Randomized Study|Recruiting||Phase 3|50|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||t|||No||2017-10-10 21:11:03.668582|2017-10-10 21:11:03.668582
NCT03109990|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-05-07|||April 2, 2017|Actual|2017-04-02|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Impact of Dexmedetomidine on Breast Cancer Recurrence After Surgery|Impact of Dexmedetomidine on Postoperative Tumor Recurrence in Patients With Primary Breast Cancer|Recruiting||N/A|460|Anticipated|RenJi Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:11:03.771311|2017-10-10 21:11:03.771311
NCT03109977|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-21|||March 31, 2017|Actual|2017-03-31|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Imaging With a New Agent That Finds a Cancer Protein Called HER2|First-in-human Imaging With 89Zr-DFO-pertuzumab in Patients With HER2 Positive Malignancies|Active, not recruiting||Phase 1|6|Actual|Memorial Sloan Kettering Cancer Center||1||||||||t|f||||||||2017-10-10 21:11:03.86375|2017-10-10 21:11:03.86375
NCT03109951|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-19|||March 25, 2017|Actual|2017-03-25|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|December 31, 2018|Anticipated|2018-12-31|1 Month|Observational [Patient Registry]|||Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation|Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation|Recruiting||N/A|2000|Anticipated|Catholic Kwandong University|||1||f||||t|t|f|||f|||No||2017-10-10 21:11:04.022754|2017-10-10 21:11:04.022754
NCT03109938|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-23|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Observational|||Comparison of Diagnostic Accuracies of Various Endoscopic Examination Techniques|Comparison of Diagnostic Accuracies of Various Endoscopic Examination Techniques for Evaluating the Invasion Depth of Lateral Spreading Tumours (LST).|Recruiting||N/A|340|Anticipated|Nanfang Hospital of Southern Medical University|||1||f||||f|f|f||||||No||2017-10-10 21:11:04.107596|2017-10-10 21:11:04.107596
NCT03109925|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-06|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement|Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement|Not yet recruiting||Phase 2|22|Anticipated|University Hospital Southampton NHS Foundation Trust||1|||f||||t|f|t|f||f|||Undecided|Currently there is no plan to make individual participant data available to other researchers.|2017-10-10 21:11:04.167228|2017-10-10 21:11:04.167228
NCT03109912|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-06|||June 17, 2015|Actual|2015-06-17|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Do More, B'More, Live Fit|Do More, B'More, Live Fit: An Outpatient Fitness-training Pilot Program Designed to Optimize the Habit of Exercise in Adolescents and Young Adults With Cystic Fibrosis|Completed||N/A|45|Actual|Johns Hopkins University||2|||f|||||f|f||||||||2017-10-10 21:11:04.237798|2017-10-10 21:11:04.237798
NCT03109899|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-25|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PHASTT||Personalized HIV and STI Testing Tool|Randomized, Controlled Trial of the Sex Pro Mobile App for Young Black MSM in San Francisco and Oakland, CA|Not yet recruiting||N/A|80|Anticipated|Public Health Foundation Enterprises, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:11:04.308849|2017-10-10 21:11:04.308849
NCT03109873|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-22|||March 27, 2017|Actual|2017-03-27|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer|Pilot Study of Metformin in Head and Neck Cancer and Its Effect on Proinflammatory Cytokines and Exosomes Implicated in Acute and Chronic Toxicity|Recruiting||Early Phase 1|50|Anticipated|Thomas Jefferson University||2|||f||||t|t|f|||t|||||2017-10-10 21:11:04.542311|2017-10-10 21:11:04.542311
NCT03109860|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-11|||April 17, 2015|Actual|2015-04-17|April 2017|2017-04-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Observational|||Can the Perception of a Treatment Influence Pain Processing - an Examination of Psychological and Neurobiological Mechanisms|Can the Perception of a Treatment Influence Pain Processing - an Examination of Psychological and Neurobiological Mechanisms|Completed||N/A|19|Actual|University of Aarhus|||1||f||||f|f|f||||||No||2017-10-10 21:11:04.639218|2017-10-10 21:11:04.639218
NCT03109847|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-25|||January 5, 2017|Actual|2017-01-05|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Metformin Hydrochloride in Mitigating Side Effects of Radioactive Iodine Treatment in Patients With Differentiated Thyroid Cancer|Pilot Study of Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Well-Differentiated Thyroid Cancers|Recruiting||Phase 2|60|Anticipated|Thomas Jefferson University||2|||f||||t|t|f|||t|||||2017-10-10 21:11:04.691511|2017-10-10 21:11:04.691511
NCT03109834|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-06|||March 25, 2004|Actual|2004-03-25|April 2017|2017-04-01|March 28, 2007|Actual|2007-03-28|March 28, 2007|Actual|2007-03-28||Interventional|FM-01||Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women|Choice of Foods, Weight Loss and Metabolic Changes in Overweight Women Willing to Lose Weight With Dietary/Nutritional Therapy Intervention|Completed||Phase 3|105|Actual|Bonn Education Association for Dietetics r.A., Cologne, Germany||4|||f||||f|f|f||||||No||2017-10-10 21:11:04.928503|2017-10-10 21:11:04.928503
NCT03109821|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-28|||April 21, 2017|Actual|2017-04-21|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|PHETHAS-1||Home-based Rehabilitation Following a Total Hip Replacement|Home-based Rehabilitation Following a Total Hip Replacement - do Patients Follow the Exercise Prescription and How Does it Relate to Postoperative Recovery? The Pragmatic Home-Based Exercise After Total Hip Arthroplasty Silkeborg 1 (PHETHAS-1) Trial|Recruiting||N/A|88|Anticipated|Central Jutland Regional Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:11:05.075885|2017-10-10 21:11:05.075885
NCT03109808|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-11|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|October 15, 2018|Anticipated|2018-10-15|February 15, 2018|Anticipated|2018-02-15||Interventional|GOPERIO||Impact of a Personalized Video in Oral Hygiene Motivation|Impact of a Personalized Video in Oral Hygiene Motivation|Recruiting||N/A|86|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||No||2017-10-10 21:11:05.267965|2017-10-10 21:11:05.267965
NCT03109795|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-27|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|ATLAS||Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System|Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System|Recruiting||Phase 4|72|Anticipated|University of Iowa||2|||f||||f|t|f|||t|||No||2017-10-10 21:11:05.434039|2017-10-10 21:11:05.434039
NCT03109782|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-13|||December 2012|Actual|2012-12-01|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01|3 Years|Observational [Patient Registry]|ASCIS||The Austrian Spinal Cord Injury Study|The Austrian Spinal Cord Injury Study (ASCIS)|Recruiting||N/A|1000|Anticipated|Paracelsus Medical University|||1||f|||||f|f||||||||2017-10-10 21:11:05.672965|2017-10-10 21:11:05.672965
NCT03109756|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-14|||April 3, 2017|Actual|2017-04-03|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Single Dose Pharmacokinetic (PK) Study|A Phase 1 Single Dose PK Study in Adolescent Subjects With Fragile X Syndrome or Angelman Syndrome|Active, not recruiting||Phase 1|12|Actual|Ovid Therapeutics Inc.||1|||f||||f|t|f||||||||2017-10-10 21:11:06.051853|2017-10-10 21:11:06.051853
NCT03109743|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-07-18|||May 26, 2017|Actual|2017-05-26|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Group Clinical Visit Adherence Intervention for HIV+ Women of Color|Development and Testing of a Group Clinical Visit Adherence Intervention for HIV+ Women of Color|Active, not recruiting||N/A|60|Anticipated|Montefiore Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:11:06.187887|2017-10-10 21:11:06.187887
NCT03109717|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-10|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|MAOI||Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression|Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression|Recruiting||N/A|24|Anticipated|The Cleveland Clinic|||2||f||||f|t|f||||||No||2017-10-10 21:11:06.543419|2017-10-10 21:11:06.543419
NCT03109522|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-06-01|||November 2016||2016-11-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|ARM||Axillary Reverse Mapping (ARM) Technique|A Pilot Randomized Controlled Trial Comparing the Axillary Reverse Mapping (ARM) Technique to Standard Axillary Surgery in Breast Cancer Patients.|Recruiting||N/A|130|Anticipated|McMaster University||2|||f||||t||||||||No||2017-10-10 21:11:08.049335|2017-10-10 21:11:08.049335
NCT03109704|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-13|||February 1, 2016|Actual|2016-02-01|April 2017|2017-04-01|October 26, 2016|Actual|2016-10-26|October 24, 2016|Actual|2016-10-24||Interventional|||Thoracic Spine Thrust Manipulation Compared to Sham Manipulation in Individuals With Subacromial Pain Syndrome|The Immediate Effects of a Seated Versus Supine Upper Thoracic Spine Thrust Manipulation Compared to Sham Manipulation in Individuals With Subacromial Pain Syndrome: A Randomized Controlled Trial|Completed||N/A|60|Actual|Sacred Heart University||3|||f||||f|f|f||||||Undecided|data regarding scapular kinematics during upper extremity elevation, pectoralis minor muscle length in standing, and force production in MMT positions for middle trapezius, lower trapezius, and serratus anterior; request for data should be made by email to: grimesj@sacredheart.edu|2017-10-10 21:11:06.6422|2017-10-10 21:11:06.6422
NCT03109691|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Ultrasound Guided Bilateral Superficial Cervical Block for Postoperative Pain Therapy in Thyroid Surgery|Ultrasound Guided Bilateral Superficial Cervical Block for Postoperative Pain Therapy in Thyroid Surgery|Not yet recruiting||N/A|60|Anticipated|Assiut University||3|||f|||||f|f||||||||2017-10-10 21:11:06.756936|2017-10-10 21:11:06.756936
NCT03109678|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-11|||July 12, 2011|Actual|2011-07-12|April 2017|2017-04-01|March 7, 2012|Actual|2012-03-07|March 7, 2012|Actual|2012-03-07||Interventional|||A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™|A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™|Completed||N/A|80|Actual|Asklepios Kliniken Hamburg GmbH||4|||f||||f|f|f||||||No||2017-10-10 21:11:06.852891|2017-10-10 21:11:06.852891
NCT03109665|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-05|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|GwNICOLA||Glaucoma Within Northern Ireland Cohort for the Longitudinal Study of Ageing|Glaucoma Within Northern Ireland Cohort for the Longitudinal Study of Ageing|Enrolling by invitation||N/A|200|Anticipated|Queen's University, Belfast|||1||f||||f|f|f|||f|||No||2017-10-10 21:11:06.936722|2017-10-10 21:11:06.936722
NCT03109652|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-10|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Serial Use of Intravenous and Oral Tranexamic Acid in Primary Total Knee Arthroplasty Patients|Serial Use of Intravenous and Oral Tranexamic Acid in Primary Total Knee Arthroplasty Patients: A Randomized Controlled Study|Recruiting||Phase 4|144|Anticipated|Seoul National University Hospital||3|||f||||f|f|f|||f|||||2017-10-10 21:11:07.020017|2017-10-10 21:11:07.020017
NCT03109639|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-09-07|||April 13, 2017|Actual|2017-04-13|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||A Randomized Prospective Comparison of the New EUS Guided Acquire TM Needle Biopsy vs EUS Guided Fine Needle Aspiration for Suspected Solid Gastrointestinal Lesions|A Randomized Prospective Comparison of the New EUS Guided Acquire TM Needle Biopsy vs EUS Guided Fine Needle Aspiration for Suspected Solid Gastrointestinal Lesions|Recruiting||N/A|36|Anticipated|Singapore General Hospital||2|||f||||t|f|t|f||t|||||2017-10-10 21:11:07.149219|2017-10-10 21:11:07.149219
NCT03109626|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-19|||June 17, 2015|Actual|2015-06-17|May 2017|2017-05-01|August 30, 2018|Anticipated|2018-08-30|September 17, 2015|Actual|2015-09-17||Interventional|SCA38DHA||Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38|Translating Molecular Pathology Into a Therapeutic Strategy in SCA38, a Newly Identified Form of Spinocerebellar Ataxia|Active, not recruiting||N/A|10|Actual|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||t|f|f||||||Yes|to share data after study publication|2017-10-10 21:11:07.249354|2017-10-10 21:11:07.249354
NCT03109613|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-11|||April 11, 2016|Actual|2016-04-11|April 2017|2017-04-01|June 6, 2018|Anticipated|2018-06-06|April 6, 2018|Anticipated|2018-04-06||Interventional|||PEEP and V/Q Mismatch in Premature Infants|Selecting PEEP in Ventilated Premature Infants by Reducing Ventilation/Perfusion Mismatch: a Pilot Feasibility Study|Recruiting||Phase 1/Phase 2|12|Anticipated|University of Pennsylvania||1|||f||||f|f|f||||||No||2017-10-10 21:11:07.354642|2017-10-10 21:11:07.354642
NCT03109600|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-12|||April 18, 2017|Actual|2017-04-18|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)|A Randomized, Observer Blinded, Comparative, Phase I Safety Study in Two Age De-escalating Cohorts to Assess the Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)|Recruiting||Phase 1|100|Anticipated|PT Bio Farma||4|||f||||f|f|f||||||||2017-10-10 21:11:07.452201|2017-10-10 21:11:07.452201
NCT03109587|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-03|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|ProDP||Pilot Study of a Synbiotic in Pre-diabetic Adolescents|Pilot Study of a Synbiotic in Pre-diabetic Adolescents|Not yet recruiting||N/A|16|Anticipated|Seattle Children's Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:11:07.57112|2017-10-10 21:11:07.57112
NCT03109574|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-06|||August 29, 2016|Actual|2016-08-29|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ADOPT||Access in Dialysis for Better Outcomes in Patient Therapy|A Pragmatic Multicenter Pilot Trial Evaluating the Cost-Effectiveness of BioFlo DuraMax Hemodialysis Catheter vs Standard of Care Catheter|Enrolling by invitation||N/A|128|Anticipated|Angiodynamics, Inc.||2|||f||||f|f|t|f|f|t|||||2017-10-10 21:11:07.668965|2017-10-10 21:11:07.668965
NCT03109561|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-11|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Observational|||Apolipoprotein E (ApoE) and Metabolism|APOE, Metabolism and Cognitive Function: An Assessment Via Indirect Calorimetry|Not yet recruiting||N/A|75|Anticipated|University of Kentucky|||1||f||||f|f|f||||Samples With DNA|"     2 tablespoons of blood for DNA Testing   "|||2017-10-10 21:11:07.776883|2017-10-10 21:11:07.776883
NCT03109548|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-27|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Observational|||Pre-treatment Factors for the Development of Chronic Pain in Low Back Pain Patients|Pre-treatment Factors for the Development of Chronic Pain in Low Back Pain Patients|Recruiting||N/A|80|Anticipated|Aalborg University|||1||f||||t|f|f||||||No||2017-10-10 21:11:07.88898|2017-10-10 21:11:07.88898
NCT03109535|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-26|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|December 15, 2016|Actual|2016-12-15||Interventional|||MapTrek for Sedentary Workers|MapTrek for Sedentary Workers|Completed||N/A|146|Actual|University of Iowa||2|||f||||f|f|f||||||No||2017-10-10 21:11:07.984993|2017-10-10 21:11:07.984993
NCT03109509|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-26|||July 20, 2016|Actual|2016-07-20|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|October 30, 2016|Actual|2016-10-30||Interventional|||Testing the Efficacy of Pokemon Go for Increasing Physical Activity|Pokémon Go Modestly Increases Time Spent Active Among Healthy Adults|Completed||N/A|100|Actual|University of Iowa||2|||f||||f|f|f||||||No|No plan to share individual data with other researchers.|2017-10-10 21:11:08.172878|2017-10-10 21:11:08.172878
NCT03109496|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||April 20, 2017|Anticipated|2017-04-20|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||The URT and Middle Ear Microbiota in Health and During Chronic OME|Study of the Upper Respiratory Tract Microbiota and the Potential of Probiotics for the Treatment of Chronic Otitis Media With Effusion.|Not yet recruiting||N/A|200|Anticipated|University Hospital, Antwerp|||2||f||||f|f|f||||||No||2017-10-10 21:11:08.248934|2017-10-10 21:11:08.248934
NCT03109483|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-11|||March 17, 2017|Actual|2017-03-17|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 2018|Anticipated|2018-04-01||Interventional|||Effectiveness of the Geriatric Activation Program Pellenberg (GAPP) on the Geriatric Rehabilitation Ward|Effectiveness of the Geriatric Activation Program Pellenberg (GAPP) on the Geriatric Rehabilitation Ward|Recruiting||N/A|100|Anticipated|Katholieke Universiteit Leuven||1|||f||||f|f|f||||||Undecided||2017-10-10 21:11:08.350525|2017-10-10 21:11:08.350525
NCT03109470|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-04-12|||November 2012|Actual|2012-11-01|November 2013|2013-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience|The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience|Withdrawn||N/A|0|Actual|Pope Research Corporation|||1|Insufficient enrollment potential|f||||f||||||||||2017-10-10 21:11:08.491989|2017-10-10 21:11:08.491989
NCT03109457|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-11|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Observational|||Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma|Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma. (Retrospective-cohort Study)|Not yet recruiting||N/A|40|Anticipated|Cairo University|||2||f|||||f|f||||||||2017-10-10 21:11:08.569448|2017-10-10 21:11:08.569448
NCT03109444|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Observational|||Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound|Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound|Not yet recruiting||N/A|75|Anticipated|University of California, San Francisco|||1||f||||f|f|f||||||No||2017-10-10 21:11:08.652081|2017-10-10 21:11:08.652081
NCT03109431|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-06-06|||May 6, 2017|Actual|2017-05-06|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Stepped Care for Youth Living With HIV|Optimizing the HIV Treatment Continuum With a Stepped Care Model for Youth Living With HIV|Recruiting||N/A|220|Anticipated|University of California, Los Angeles||2|||f||||t|f|f||||||No||2017-10-10 21:11:08.734477|2017-10-10 21:11:08.734477
NCT03109418|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||June 2, 2016|Actual|2016-06-02|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea|Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea: A Prospective, Randomized, Controlled, Double-Blind Study|Recruiting||Phase 2/Phase 3|150|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||t|||No||2017-10-10 21:11:08.885313|2017-10-10 21:11:08.885313
NCT03109405|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-05|||June 2015||2015-06-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Assess Veinplicity Venous Access Device Safety and Effectiveness|A Prospective, Single Center, Randomized, Cross-over Clinical Trial to Assess the Safety and Effectiveness of the Veinplicity Venous Access Device|Completed||N/A|200|Actual|Physeon GmbH||2|||f||||f||||||||No||2017-10-10 21:11:09.004287|2017-10-10 21:11:09.004287
NCT03109392|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-13|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||A Randomized Trial of 4% Nebulized Lignocaine vs. 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy|A Randomized-controlled Trial to Compare the Effectiveness of 4% Nebulized Lignocaine Versus 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy|Not yet recruiting||Phase 2/Phase 3|750|Anticipated|Postgraduate Institute of Medical Education and Research||3|||f||||t|f|f||||||No||2017-10-10 21:11:09.07235|2017-10-10 21:11:09.07235
NCT03109379|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-20|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder|A Prospective, Multi-center, Open-label Study of Trospium Delivered Intravesically by TAR-302-5018 to Subjects With Idiopathic Overactive Bladder (iOAB) and Urinary Incontinence|Recruiting||Phase 1|10|Anticipated|Taris Biomedical LLC||1|||f|||||t|f||||||||2017-10-10 21:11:09.149537|2017-10-10 21:11:09.149537
NCT03109366|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2017-04-05|||May 2011||2011-05-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Electronic Tool for Interaction Between Patients and Health Professionals|Flexible Collaborative Networks and Patient-provider Partnerships in Health Care: Critical Factors|Completed||N/A|20|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-10 21:11:09.231457|2017-10-10 21:11:09.231457
NCT03109353|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-25|||September 20, 2017|Actual|2017-09-20|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease|Modification of Extracorporeal Photopheresis Technology With 5-aminolevulinic Acid in Patients With Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease - A Proof-of-concept Study|Recruiting||Phase 1/Phase 2|20|Anticipated|St. Olavs Hospital||1|||f||||t|f|f||||||||2017-10-10 21:11:10.983117|2017-10-10 21:11:10.983117
NCT03109340|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-05|||May 1, 2013|Actual|2013-05-01|April 2017|2017-04-01|May 1, 2014|Actual|2014-05-01|November 1, 2013|Actual|2013-11-01||Interventional|||Efficacy of ECE PEDO (Equipment for Clever Exercise) on Abdominal Obesity|Efficacy of Moderate Intensity Walking Provided Feedback by ECE PEDO on Abdominal Fat in Women With Overweight and Obesity|Completed||N/A|65|Actual|Pamukkale University||2|||f||||t|f|f||||||Undecided|Plan not defined as work is completed|2017-10-10 21:11:11.0809|2017-10-10 21:11:11.0809
NCT03106454|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-07|||August 2014||2014-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Ovulation Incidence in Oral Contraceptive Users||Active, not recruiting||Phase 3|58|Anticipated|University of Southern California||2|||f||||f||||||||No||2017-10-10 21:11:38.350237|2017-10-10 21:11:38.350237
NCT03109327|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-05|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|OMS002_UK||Investigating the Clinical Utility of the MDS|Investigating the Clinical Utility of the MDS Test for the Oncogenic Activity in Nevi Suspected of Being Melanoma|Not yet recruiting||N/A|400|Anticipated|Orlucent, Inc|||2||f||||t|f|f||||||Undecided||2017-10-10 21:11:11.159712|2017-10-10 21:11:11.159712
NCT03109314|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-12|||May 1, 2012|Actual|2012-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human The Effect of Donepezil on Perceptual Learning in Adult Amblyopia|The Effect of Donepezil on Perceptual Learning in Adult Amblyopia|Recruiting||Phase 4|20|Anticipated|National Eye Institute (NEI)||2|||f||||f|t|f|||t|||||2017-10-10 21:11:11.227607|2017-10-10 21:11:11.227607
NCT03109288|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-11|2017-09-13|||August 11, 2017|Actual|2017-08-11|September 12, 2017|2017-09-12|June 1, 2029|Anticipated|2029-06-01|June 1, 2029|Anticipated|2029-06-01||Interventional|||Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)|Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)|Recruiting||Phase 1/Phase 2|250|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f|||||t|f||||||||2017-10-10 21:11:11.411968|2017-10-10 21:11:11.411968
NCT03109275|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-05|||January 22, 2016|Actual|2016-01-22|February 2017|2017-02-01|June 25, 2016|Actual|2016-06-25|June 25, 2016|Actual|2016-06-25||Interventional|AGE-CONNECT||Connectome Characterization With Aging|Connectome Characterization With Aging Using Functional and Structural MRI|Completed||N/A|10|Actual|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 21:11:11.500484|2017-10-10 21:11:11.500484
NCT03109262|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|February 15, 2020|Anticipated|2020-02-15|February 15, 2020|Anticipated|2020-02-15||Interventional|||Yttrium Y 90 Glass Microspheres PET/CT in Imaging Patients With Liver Tumors|High Quality Imaging and Dosimetry of Yttrium-90 (90Y) SIRT Using a Digital PET/CT|Recruiting||N/A|75|Anticipated|Stanford University||1|||f||||t|f|f||||||||2017-10-10 21:11:11.566734|2017-10-10 21:11:11.566734
NCT03109249|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-24|||July 15, 2017|Anticipated|2017-07-15|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer|Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer|Not yet recruiting||Phase 1|99|Anticipated|Sun Pharma Advanced Research Company Limited||2|||f||||f|t|f||||||No||2017-10-10 21:11:11.666989|2017-10-10 21:11:11.666989
NCT03109236|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-05|||April 15, 2017|Anticipated|2017-04-15|February 2017|2017-02-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis|Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis|Recruiting||Phase 3|66|Anticipated|National University Hospital, Singapore||2|||f||||t|f|f||||||||2017-10-10 21:11:12.039671|2017-10-10 21:11:12.039671
NCT03109223|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|2-FL||Addition to Infant Formula of 2-fucosyllactose (2-FL)|Effects of Addition to Infant Formula of 2-fucosyllactose (2-FL) on Growth, Fecal Bacterial Populations and Safety|Not yet recruiting||N/A|200|Anticipated|PBM Nutritionals||3|||f||||f|f|f||||||Undecided||2017-10-10 21:11:12.147643|2017-10-10 21:11:12.147643
NCT03109210|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-08|||April 15, 2017|Actual|2017-04-15|June 2017|2017-06-01|April 14, 2023|Anticipated|2023-04-14|April 14, 2021|Anticipated|2021-04-14||Interventional|||Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea|Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea|Recruiting||N/A|384|Anticipated|National Jewish Health||2|||f||||t|f|f||||||No||2017-10-10 21:11:12.222708|2017-10-10 21:11:12.222708
NCT03109197|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||October 1, 2014|Actual|2014-10-01|April 2017|2017-04-01|September 1, 2021|Anticipated|2021-09-01|September 1, 2019|Anticipated|2019-09-01|5 Years|Observational [Patient Registry]|SUDC||Sudden Unexplained Death in Childhood (SUDC) Registry|The SUDC Registry and Research Collaborative|Recruiting||N/A|1300|Anticipated|New York University School of Medicine|||2||f||||t|f|f||||Samples With DNA|"     For retrospective SUDC cases: Mucosal swab or blood samples for DNA analysis, pathology     slides, tissue blocks, tissue samples or organs retained at autopsy.      For prospective SUDC cases: Mucosal swab or blood samples for DNA analysis, pathology slides,     tissue blocks, tissue samples except heart and brain tissue that will undergo full cardiac     pathology consultation or neuropathology consultation will be transferred to pathologists at     NYU or Mayo (based on pathologist availability).   "|||2017-10-10 21:11:12.346493|2017-10-10 21:11:12.346493
NCT03109184|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Violence Prevention for Middle School Boys|Partner Violence Prevention for Middle School Boys: A Dyadic Web-Based Intervention|Recruiting||N/A|120|Anticipated|Northeastern University||2|||f||||f|f|f||||||No||2017-10-10 21:11:12.436404|2017-10-10 21:11:12.436404
NCT03109171|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||May 17, 2017|Anticipated|2017-05-17|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea|Accuracy of the Sensory Test Performed Using the Laryngopharyngeal Endoscopic Esthesiometer and Rangefinder in Patients With Suspected Obstructive Sleep Apnoea Hypopnea (OSA): a Prospective Double-blinded, Randomised, Pilot Study|Not yet recruiting||N/A|117|Anticipated|Fundación Neumologica Colombiana||2|||f||||f|f|f||||||No||2017-10-10 21:11:12.531274|2017-10-10 21:11:12.531274
NCT03103880|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-31|||March 28, 2017|Actual|2017-03-28|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Assessing the Use of Mobile Technology in Adult Asthma Patients|Assessing the Use of Mobile Technology in Adult Asthma Patients: A Remote Observational Study|Recruiting||N/A|100|Anticipated|CoheroHealth||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:12:03.480818|2017-10-10 21:12:03.480818
NCT03109158|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-05|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Phase I/II Clinical Trial of NC-6004 in Combination With 5-FU and Cetuximab as First-line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1/Phase 2|80|Anticipated|NanoCarrier Co., Ltd.||1|||f||||f|t|f||||||||2017-10-10 21:11:12.682181|2017-10-10 21:11:12.682181
NCT03109145|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-04-05|||October 2014||2014-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|MEANS||MyHealtheVet to Enable Shared Decision Making Regarding Menopausal in Postmenopausal Women Veterans (MEANS)|MyHealtheVet to Enable Shared Decision Making Regarding Menopausal and Associated Symptoms in Postmenopausal Women Veterans|Recruiting||N/A|400|Anticipated|Miami VA Healthcare System||2|||f||||f|f|f||||||No||2017-10-10 21:11:12.771239|2017-10-10 21:11:12.771239
NCT03109132|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-06-22|||April 23, 2017|Actual|2017-04-23|June 2017|2017-06-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Comfort Check of CO2 Monitoring Cannulas With Oxygen Delivery|Comfort Check of CO2 Monitoring Cannulas With Oxygen Delivery|Recruiting||N/A|60|Anticipated|Medtronic - MITG||6|||f||||f|f|f|||f|||No||2017-10-10 21:11:12.858882|2017-10-10 21:11:12.858882
NCT03109119|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-05|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Does Sevoflurane Cause Genomic Damage|Does Sevoflurane Induce Genomic Instability in Patients Undergoing General Anaesthesia?|Recruiting||Phase 4|60|Anticipated|Jubilee Mission Medical College and Research Institute||2|||f||||f|t|f|||f|||No||2017-10-10 21:11:12.95057|2017-10-10 21:11:12.95057
NCT03109106|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-26|||April 15, 2017|Actual|2017-04-15|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Procalcitonin for Stewardship in Respiratory Infections A Stewardship Project|Proposed Procalcitonin Re-Implementation Protocol for Johns Hopkins Bayview Medical Center (JHBMC): A Stewardship Project|Recruiting||N/A|400|Anticipated|Johns Hopkins University||2|||f||||t|f|f|||f|||No||2017-10-10 21:11:13.045979|2017-10-10 21:11:13.045979
NCT03109093|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-06-27|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia|A Multicenter, Single-arm Study to Assess the Efficacy, Safety, and Tolerability of the BiTE® Antibody Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (Blast Successor Trial)|Recruiting||Phase 2|30|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||f|f|f|||f|||Undecided||2017-10-10 21:11:13.143844|2017-10-10 21:11:13.143844
NCT03109067|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-05|||September 21, 2011|Actual|2011-09-21|January 2017|2017-01-01|November 21, 2015|Actual|2015-11-21|November 21, 2015|Actual|2015-11-21||Interventional|HDL-PP||Genetic and Metabolism of Post-prandial HDL Particles|Influence of TaqIB (rs708272) Polymorphism in Cholesteryl Ester Transfer Protein (CETP) Gene on Functionality of HDL Particles, in the Pathway of Reverse Transport of Fasting and Post-prandial Cholesterol.|Completed||N/A|100|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f|f|f||||||No||2017-10-10 21:11:13.431971|2017-10-10 21:11:13.431971
NCT03109054|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-05|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|June 15, 2017|Anticipated|2017-06-15|May 15, 2017|Anticipated|2017-05-15||Observational|||Endogenous Melatonin Level and Pre- Postoperative Anxiety in Bariatric Surgery Patients.|Role of Endogenous Melatonin Level in Preoperative and Postoperative Anxiety in Bariatric Surgery Patients|Enrolling by invitation||N/A|50|Anticipated|Inonu University|||2||f||||f|f|f||||||No|no a plan|2017-10-10 21:11:13.525228|2017-10-10 21:11:13.525228
NCT03109041|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-18|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|July 1, 2019|Anticipated|2019-07-01||Interventional|||Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source|Initial Feasibility Study to Treat Resectable Pancreatic Cancer With the Permanently Implantable LDR CivaSheet®|Recruiting||Phase 1|12|Anticipated|CivaTech Oncology||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:11:13.749512|2017-10-10 21:11:13.749512
NCT03109028|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-10|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|MEHIRA||Mental Health in Refugees and Asylum Seekers|Stepped Care Model Supporting Mental Health in Refugees and Asylum Seekers|Not yet recruiting||N/A|952|Anticipated|Charite University, Berlin, Germany||2|||f|||||f|f||||||||2017-10-10 21:11:13.898833|2017-10-10 21:11:13.898833
NCT03109015|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-28|||September 27, 2017|Actual|2017-09-27|July 2017|2017-07-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|ASSET||Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing|Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing|Recruiting||Phase 2|30|Anticipated|Duke University||2|||f||||f|t|f|||f|||||2017-10-10 21:11:14.036358|2017-10-10 21:11:14.036358
NCT03109002|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-06-07|||January 15, 2017|Actual|2017-01-15|May 2017|2017-05-01|May 18, 2017|Actual|2017-05-18|May 18, 2017|Actual|2017-05-18||Observational|||An Epidemiology Study of Treatment Resistant Depression in the United States (US)|Epidemiology of Treatment Resistant Depression in the US: Analysis of Health Services Databases|Completed||N/A|200000|Actual|Janssen Research & Development, LLC|||1||f||||f|f|f||||||No|The data for this study came from health services databases to which access is available under contracts that limit further distribution.|2017-10-10 21:11:14.168315|2017-10-10 21:11:14.168315
NCT03108989|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||February 8, 2017|Actual|2017-02-08|April 2017|2017-04-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Comparison the Postoperative Quality of Recovery Between Neostigmine and Sugammadex in Elderly Patients Undergoing Trans Pars Plana Vitrectomy With General Anesthesia -Randomized Controlled Trial-||Recruiting||N/A|90|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:11:14.235322|2017-10-10 21:11:14.235322
NCT03108976|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-05|||April 10, 2015|Actual|2015-04-10|March 2017|2017-03-01|April 10, 2019|Anticipated|2019-04-10|March 10, 2019|Anticipated|2019-03-10||Interventional|ASD-BARN||Build-up of Action Representation in Autism Spectrum Disorders|Build-up of Action Representation During Neurodevelopment: Dysfunctions in Autism Spectrum Disorders?|Recruiting||N/A|150|Anticipated|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 21:11:14.318683|2017-10-10 21:11:14.318683
NCT03108963|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-21|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||L-carnitine and Metformin in Obese PCOS Women.|L-carnitine Plus Metformin in Clomiphene-resistant Obese PCOS Women, Reproductive and Metabolic Effects: a Randomized Clinical Trial|Recruiting||Phase 2|100|Anticipated|Zagazig University||2|||f||||t|f|f|||f|||No||2017-10-10 21:11:14.433271|2017-10-10 21:11:14.433271
NCT03108950|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TExT-ME||From Clinic to Community: An Information and Communication Technology (ICT) Home-Based Exercise Training System for Translating Clinical Findings|Dose-Response Effects of Transformative Exercise in Improving Health and Function in Adults With Spinal Cord Injury and Multiple Sclerosis|Enrolling by invitation||N/A|60|Anticipated|University of Alabama at Birmingham||1|||f||||f|f|f||||||Undecided||2017-10-10 21:11:14.527901|2017-10-10 21:11:14.527901
NCT03108924|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-09-19|||April 14, 2017|Actual|2017-04-14|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|September 3, 2017|Actual|2017-09-03||Interventional|||The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)|An Open-Label, Single-Dose Study to Investigate the Influence of Renal Insufficiency on the Pharmacokinetics of MK-7264|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||4|||f||||f|t|f||||||||2017-10-10 21:11:14.721337|2017-10-10 21:11:14.721337
NCT03108911|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-07-28|||July 27, 2017|Actual|2017-07-27|July 2017|2017-07-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|||Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy|Gluten Free Diet for AML Patients Undergoing Induction Chemotherapy|Recruiting||Phase 2|120|Anticipated|Rutgers, The State University of New Jersey||2|||f|||||f|f||||||||2017-10-10 21:11:14.819236|2017-10-10 21:11:14.819236
NCT03108898|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-08-28|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Progenitor Cells in Human Esophagus|Progenitor Cells in Human Esophagus|Active, not recruiting||N/A|10|Actual|Mayo Clinic|||1||f||||f|f|f||||Samples With DNA|"     Esophageal tissue will be collected at the time of the patient's surgery in excess of     clinical diagnosis (i.e. tissue that would otherwise be discarded). The researchers will     analyze sections of adult esophagus tissue for the presence of CD34+ sox2+ progenitor cells     to determine the number of progenitors present at a particular age of patient. The     researchers will also examine sections of different portions of the esophagus, to determine     whether certain sections contain more progenitors, and thus perhaps a greater ability to     regenerate, than others.   "|||2017-10-10 21:11:14.921432|2017-10-10 21:11:14.921432
NCT03108872|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-05-23|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|October 30, 2017|Anticipated|2017-10-30|September 30, 2017|Anticipated|2017-09-30|4 Years|Observational [Patient Registry]|||Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation|Long Term Clinical Outcomes of Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation; From Korean Multicenter Registry|Recruiting||N/A|300|Anticipated|Sejong General Hospital|||2||f|||||f|t|f|||||||2017-10-10 21:11:15.103826|2017-10-10 21:11:15.103826
NCT03108859|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-13|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|August 2019|Anticipated|2019-08-01||Observational|||Pre-and In-hospital First Aid Programs and Specifications for Spine and Spinal Cord Injury in Beijing of China|Pre-and In-hospital First Aid Programs and Specifications for Spine and Spinal Cord Injury in Beijing of China: a Prospective, Multicenter, Case Series Trial|Not yet recruiting||N/A|200|Anticipated|Peking University People's Hospital|||1||f||||t|f|f||||||Undecided||2017-10-10 21:11:15.218891|2017-10-10 21:11:15.218891
NCT03108846|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|S-CitAD||Escitalopram for Agitation in Alzheimer's Disease|Escitalopram for Agitation in Alzheimer's Disease|Not yet recruiting||Phase 3|392|Anticipated|JHSPH Center for Clinical Trials||2|||f||||t|t|f|||t|||No||2017-10-10 21:11:15.322155|2017-10-10 21:11:15.322155
NCT03108833|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-15|||May 9, 2017|Actual|2017-05-09|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Interventional|ERUPTE||A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism|A Phase IIa Trial to Assess the Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Pulmonary Embolism|Recruiting||Phase 2|108|Anticipated|Tasly Pharmaceuticals, Inc.||3|||f||||f|f|f|||f|||||2017-10-10 21:11:15.434898|2017-10-10 21:11:15.434898
NCT03108820|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-10-04|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|December 21, 2025|Anticipated|2025-12-21|December 31, 2022|Anticipated|2022-12-31||Interventional|||Trauma Medical Home for Older Injured Patients|Collaborative Care for the Older Injured Patient: A Trauma Medical Home|Recruiting||N/A|430|Anticipated|Indiana University||2|||f||||t|f|f||||||||2017-10-10 21:11:15.578281|2017-10-10 21:11:15.578281
NCT03108807|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-11|||April 24, 2017|Actual|2017-04-24|September 2017|2017-09-01|August 19, 2017|Actual|2017-08-19|August 19, 2017|Actual|2017-08-19||Observational|||National Early Warning Score and D-dimer to Identify Medical Patients at Low Risk of 30-day Mortality|Combined Use of the National Early Warning Score and D-dimer to Identify Medical Patients at Low Risk of 30-day Mortality in a Danish Emergency Department|Completed||N/A|1700|Actual|Hospital of South West Jutland|||1||f||||t|f|f||||||||2017-10-10 21:11:15.68582|2017-10-10 21:11:15.68582
NCT03108794|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-04-06|||June 30, 2012|Actual|2012-06-30|June 2012|2012-06-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2022|Anticipated|2022-12-31|10 Years|Observational [Patient Registry]|||A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B|A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B|Recruiting||N/A|200000|Anticipated|Beijing Friendship Hospital|||7||f||||f|f|f||||||No||2017-10-10 21:11:15.782806|2017-10-10 21:11:15.782806
NCT03108781|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-04-05|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|||The Role of Aromatherapy With Lavender Oil in the Long-term Care on a Patients Behavioral Problems Associated With Dementia|The Role of Aromatherapy With Lavender Oil in the Long-term Care on a Patients Behavioral Problems Associated With Dementia|Not yet recruiting||N/A|60|Anticipated|Soroka University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:11:16.086898|2017-10-10 21:11:16.086898
NCT03108768|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-15|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|||Quality Control of CE-Certified Phonak Hearing Aids - 2016_37|Quality Control of CE-Certified Phonak Hearing Aids - 2016_37|Completed||N/A|20|Actual|Sonova AG||2|||f||||f|f|f||||||No||2017-10-10 21:11:16.153462|2017-10-10 21:11:16.153462
NCT03108755|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-06|2017-07-27|||May 23, 2017|Actual|2017-05-23|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects|A Phase 1 Combined Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects|Recruiting||Phase 1|148|Anticipated|Astellas Pharma Inc||6|||f||||f|f|f||||||||2017-10-10 21:11:16.229283|2017-10-10 21:11:16.229283
NCT03108742|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-18|||October 1, 2016|Actual|2016-10-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Randomized Control Study of Dermal Staples vs Subcuticular Sutures on Postoperative Scar After Thyroidectomy|Randomized Control Study of Dermal Staples vs Subcuticular Sutures on Postoperative Scar After Thyroidectomy|Recruiting||N/A|40|Anticipated|Inje University||2|||f||||f|f|f||||||||2017-10-10 21:11:16.4837|2017-10-10 21:11:16.4837
NCT03108729|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-09-21|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|August 31, 2021|Anticipated|2021-08-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug|An Open-label Eslicarbazepine Acetate Long-term Safety and Tolerability Study in Children and Adolescents (4 - 17 Years)|Active, not recruiting||Phase 3|1|Actual|Sunovion||1|||f||||t|t|f||||||||2017-10-10 21:11:16.5892|2017-10-10 21:11:16.5892
NCT03108716|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-05|||January 2011|Actual|2011-01-01|April 2017|2017-04-01|June 2013|Actual|2013-06-01|January 2012|Actual|2012-01-01||Interventional|||Hamate Hook Removal, Microscrew Internal Fixation and Plaster Fixation for the Treatment of Hamate Hook Fractures|Hamate Hook Removal, Microscrew Internal Fixation and Plaster Fixation for the Treatment of Hamate Hook Fractures: a Case Series|Completed||N/A|28|Actual|Siping Central People's Hospital||3|||f||||t|f|f||||||Undecided||2017-10-10 21:11:16.738772|2017-10-10 21:11:16.738772
NCT03108703|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-04-05|||June 2015||2015-06-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|January 2019|Anticipated|2019-01-01||Interventional|AQuOS-RCC||Assessment of QoL and Outcomes With SBRT for RCC|Assessment of Quality of Life and Outcomes in Patients Treated With Stereotactic Body Radiation Therapy (SBRT) for Primary Renal Cell Carcinoma (RCC) - AQuOS-RCC|Recruiting||N/A|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||No||2017-10-10 21:11:16.824292|2017-10-10 21:11:16.824292
NCT03108690|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia|Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia|Not yet recruiting||Phase 4|124|Anticipated|Hvidovre University Hospital||2|||f|||||t|f|||f|||||2017-10-10 21:11:16.93387|2017-10-10 21:11:16.93387
NCT03108677|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-28|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01|3 Years|Observational [Patient Registry]|||Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma|A Pilot Study of Circulating Exosome RNA as Diagnostic and Prognostic Markers in Lung Metastases of Primary High-Grade Osteosarcoma|Recruiting||N/A|40|Anticipated|Ruijin Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Samples with purified exosome RNA   "|No||2017-10-10 21:11:17.035496|2017-10-10 21:11:17.035496
NCT03108664|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-12|||May 18, 2017|Actual|2017-05-18|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)|HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye|Recruiting||Phase 3|300|Anticipated|Sylentis, S.A.||2|||f|||||f|f||||||||2017-10-10 21:11:17.167136|2017-10-10 21:11:17.167136
NCT03108651|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-08-02|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Mobile Motivational Messages for Change (3M4Chan) Intervention in TMU|Mobile Motivational Messages for Change (3M4Chan) Intervention in TMU|Not yet recruiting||N/A|100|Anticipated|Taipei Medical University||2|||f||||f|f|f||||||||2017-10-10 21:11:17.34464|2017-10-10 21:11:17.34464
NCT03108638|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-04-05|||October 2015||2015-10-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|R3||Supporting Sustainable Positive Interactions in the Child Welfare System: The R3 Supervisor Strategy|Supporting Sustainable Positive Interactions in the Child Welfare System: The R3 Supervisor Strategy|Enrolling by invitation||N/A|355|Anticipated|Oregon Social Learning Center|||4||f||||f||||||||No||2017-10-10 21:11:17.429211|2017-10-10 21:11:17.429211
NCT03108612|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-08-30|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|April 30, 2018|Anticipated|2018-04-30||Interventional|ACT-ACHS||Diagnostic Value of Workload Analysis Instrument to Detect Occupational Risks of Upper Limb Musculoskeletal Conditions|Exactitud diagnóstica Del Instrumento Análisis de Carga de Trabajo Para Identificar Riesgos Laborales en Trabajadores Con Trastornos músculo esqueléticos de Extremidades Superiores Que se evalúan en la Asociación Chilena de Seguridad.|Recruiting||N/A|900|Anticipated|Medwave Estudios Limitada||1|||f||||f|f|f||||||||2017-10-10 21:11:17.646868|2017-10-10 21:11:17.646868
NCT03108599|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-05|||April 17, 2017|Anticipated|2017-04-17|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|Tech4Rest||Tech4Rest Trial With Team Truck Drivers|Engineering and Behavioral Controls for Truck Drivers' Sleep, Safety, and Health|Not yet recruiting||N/A|80|Anticipated|Oregon Health and Science University||2|||f||||f|f|f||||||No|Only de-identified data will be shared with researchers outside of the primary research team. De-identified data will be shared only after receiving IRB approval.|2017-10-10 21:11:17.743351|2017-10-10 21:11:17.743351
NCT03108586|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-05|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|CaCIA||Caries Cognition and Identification in Adults|Caries Associated With Restorations or Sialants Cognition and Identification in Adults|Recruiting||N/A|152|Anticipated|Federal University of Pelotas||2|||f||||f|f|f||||||No||2017-10-10 21:11:17.8529|2017-10-10 21:11:17.8529
NCT03108573|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-05|||December 12, 2012|Actual|2012-12-12|March 2017|2017-03-01|July 31, 2013|Actual|2013-07-31|July 31, 2013|Actual|2013-07-31||Observational|FLAIR-SEP||Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters|Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters|Completed||N/A|27|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f|||||f|f||||||||2017-10-10 21:11:17.945649|2017-10-10 21:11:17.945649
NCT03108560|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-17|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Interventional|||Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer|A Multi-center, Randomized-controlled, Open-label Clinical Trial: Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer|Recruiting||N/A|600|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f|f|f||||||Yes|The data of all case report forms are to be collected and shared with other researchers at the end of followup.|2017-10-10 21:11:18.003303|2017-10-10 21:11:18.003303
NCT03108547|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-05|||June 13, 2014|Actual|2014-06-13|April 2017|2017-04-01|January 5, 2015|Actual|2015-01-05|January 5, 2015|Actual|2015-01-05||Observational|||Hair Cortisol and Testosterone Levels in Patients With Sarcoidosis|Hair Cortisol and Testosterone Levels in Patients With Sarcoidosis Associated Fatigue|Completed||N/A|32|Actual|Erasmus Medical Center|||3||f||||f||||||Samples Without DNA|"     Scalp hair string   "|No||2017-10-10 21:11:18.10354|2017-10-10 21:11:18.10354
NCT03108534|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-11|||February 28, 2017|Actual|2017-02-28|April 2017|2017-04-01|September 22, 2017|Anticipated|2017-09-22|September 22, 2017|Anticipated|2017-09-22||Interventional|||A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients.|A Single Dose, Randomised, Double Blind, Double Dummy, Placebo Controlled, 3-way Crossover Clinical Study, Comparing the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 100/6 µg NEXThaler® Versus CHF1535 100/6 µg pMDI in Asthmatic Patients.|Recruiting||Phase 2|60|Anticipated|Chiesi Farmaceutici S.p.A.||3|||f||||f|f|f||||||No||2017-10-10 21:11:18.221676|2017-10-10 21:11:18.221676
NCT03108521|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-04-10|||April 2016||2016-04-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|glape||Genomic Study of Dipeptidyl Peptidase-4 (DPP-4) and Glucagon-Like Peptide 1 Receptor (GLP1R) in Chinese and it's Apply in Antidiabetes|Sichuan Provincial People's Hospital|Recruiting||Phase 4|150|Anticipated|Sichuan Provincial People's Hospital||2|||f||||t||||||||No||2017-10-10 21:11:18.33966|2017-10-10 21:11:18.33966
NCT03108508|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-05|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|BIOSILICI||Non-inferiority Bioavailabilty Study of 3 Silicon-rich Supplements|Randomized, Crossover, Double Blinded, Non-inferiority Study of Three Products Rich in Organic Silicon, in Postprandrial Situation|Recruiting||N/A|5|Anticipated|Technological Centre of Nutrition and Health, Spain||3|||f||||f|f|f||||||Undecided||2017-10-10 21:11:18.465731|2017-10-10 21:11:18.465731
NCT03108495|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-13|||June 22, 2017|Actual|2017-06-22|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma|A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety Using Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients With Recurrent, Metastatic or Persistent Cervical Carcinoma|Recruiting||Phase 2|47|Anticipated|Iovance Biotherapeutics, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:11:18.575713|2017-10-10 21:11:18.575713
NCT03108482|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-05|||February 13, 2017|Actual|2017-02-13|April 2017|2017-04-01|September 20, 2017|Anticipated|2017-09-20|September 13, 2017|Anticipated|2017-09-13||Interventional|||Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.|A Randomized, Double-blind, Active- (Tramadol and Celecoxib) and Placebo-controlled, Parallel Groups, Phase 3 Clinical Trial to Establish the Efficacy of Co-crystal E-58425 for the Management of Moderate to Severe Post-surgical Pain After Bunionectomy.|Recruiting||Phase 3|630|Anticipated|Laboratorios del Dr. Esteve, S.A.||4|||f||||f|t|f||||||No||2017-10-10 21:11:18.687196|2017-10-10 21:11:18.687196
NCT03108469|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-10-03|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ISIS 546254 for Preventive Treatment of Chronic Migraine|Recruiting||Phase 2|30|Anticipated|Smith, Timothy R., M.D.||2|||||||f|t|f||||||||2017-10-10 21:11:18.826541|2017-10-10 21:11:18.826541
NCT03108443|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Observational|||Novel Markers for Detecting Early Progression of Glaucoma|Novel Markers for Detecting Early Progression of Glaucoma|Not yet recruiting||N/A|250|Anticipated|Nova Scotia Health Authority|||2||f||||f|f|f||||||No||2017-10-10 21:11:19.157515|2017-10-10 21:11:19.157515
NCT03108430|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-05|||August 22, 2016|Actual|2016-08-22|April 2017|2017-04-01|August 21, 2017|Anticipated|2017-08-21|August 21, 2017|Anticipated|2017-08-21||Observational|PrevAsPI-Obs||Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation|Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens|||3||f|||||f|f||||||||2017-10-10 21:11:19.249496|2017-10-10 21:11:19.249496
NCT03108417|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-09-18|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Home Study of Subjects Who Have Completed a Previous Continuous Negative External Pressure (cNEP) Clinical Trial|"Home Study of Subjects With Obstructive Sleep Apnea Who Have Previously Completed an In-Lab Continuous Negative External Pressure (cNEP) Titration and Were Considered to be Responders"|Not yet recruiting||N/A|13|Anticipated|Sommetrics, Inc.||1|||f||||f|f|t|t|f||||||2017-10-10 21:11:19.348087|2017-10-10 21:11:19.348087
NCT03108404|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-11|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|January 6, 2020|Anticipated|2020-01-06|January 6, 2020|Anticipated|2020-01-06||Observational|PPROM||Predictive Score for Neonatal Mortality for Women With Premature Rupture of Membranes Between 22 and 28 Weeks of Gestation|Predictive Score for Neonatal Mortality for Women With Premature Rupture of Membranes Between 22 and 28 Weeks of Gestation|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:11:19.465981|2017-10-10 21:11:19.465981
NCT03108391|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-11|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients|A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients|Recruiting||N/A|100|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:11:19.553108|2017-10-10 21:11:19.553108
NCT03108378|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-05|||October 2014||2014-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With Control|A Prospective Multicenter Cohort Study Evaluating the Long Term Retention of Gadolinium in Human Bone and Skin After the Retrospective Administration of MultiHance or ProHance in Comparison With a Control Group Receiving No Exposure to Gadolinium|Recruiting||N/A|36|Anticipated|Bracco Diagnostics, Inc|||5||f||||f||||||Samples Without DNA|"     Bone & Skin Tissue   "|No||2017-10-10 21:11:19.646507|2017-10-10 21:11:19.646507
NCT03108365|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-10|||December 19, 2014|Actual|2014-12-19|April 2017|2017-04-01|March 24, 2016|Actual|2016-03-24|March 24, 2016|Actual|2016-03-24||Interventional|||Evaluating the Effectiveness of Axiostat Hemostatic Dressing Material Versus Conventional Method of Hemostasis and Healing of Extraction Wounds in Patients on Oral Anti-Platelet Drugs - A Comparative Study|Evaluating the Effectiveness of Axiostat Hemostatic Dressing Material Versus Conventional Method of Hemostasis and Healing of Extraction Wounds in Patients on Oral Anti-Platelet Drugs - A Comparative Study|Completed||N/A|40|Actual|Axio Biosolutions Pvt. Ltd.||2|||f|||||f|f|||f|||||2017-10-10 21:11:19.728746|2017-10-10 21:11:19.728746
NCT03108352|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-05|||May 2016||2016-05-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion|Multi-center, Randomized, Double-masked, Placebo-controlled Phase III Clinical Study of Conbercept Ophthalmic Injection for Patients With BRVO.|Recruiting||Phase 3|252|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.||2|||f||||f||||||||||2017-10-10 21:11:19.801318|2017-10-10 21:11:19.801318
NCT03108339|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-04-24|||August 15, 2017|Anticipated|2017-08-15|April 2017|2017-04-01|August 15, 2019|Anticipated|2019-08-15|August 15, 2018|Anticipated|2018-08-15||Observational|MOS||Markers of Outcome - a Cohort Study of LBP in Primary Health Care|Markers of Outcome - a Cohort Study of LBP in Primary Health Care|Not yet recruiting||N/A|600|Anticipated|Karolinska Institutet|||1||f||||f||||||||Undecided||2017-10-10 21:11:20.082137|2017-10-10 21:11:20.082137
NCT03108326|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-05|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|May 30, 2022|Anticipated|2022-05-30|March 31, 2022|Anticipated|2022-03-31|3 Years|Observational [Patient Registry]|RUN-CD||Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease|Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease in Conjunction With Long-term Outcome|Not yet recruiting||N/A|600|Anticipated|Ced Service GmbH|||4||f||||t|t|||||||Undecided||2017-10-10 21:11:20.170378|2017-10-10 21:11:20.170378
NCT03108313|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-27|||March 3, 2017|Actual|2017-03-03|July 2017|2017-07-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Role of Aloe Vera Versus Fluoride Toothpaste in Changing High to Low Salivary Bacterial Count|Role of Aloe Vera Versus Fluoride Toothpaste in Changing High to Low Salivary Bacterial Count :Randomized Controlled Trial|Recruiting||Phase 2|58|Anticipated|Cairo University||2|||f||||t|t|f|||t|||||2017-10-10 21:11:20.262577|2017-10-10 21:11:20.262577
NCT03108300|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-05|||August 30, 2017|Anticipated|2017-08-30|April 2017|2017-04-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Use of Propranolol Hydrochloride in the Treatment of Metastatic STS|The Use of Propranolol Hydrochloride Combined With Anthracyclin Based Chemotherapy in the Treatment of Metastatic Soft Tissue Sarcoma|Not yet recruiting||Phase 2|50|Anticipated|Ain Shams University||1|||f||||f|f|f||||||No||2017-10-10 21:11:20.359446|2017-10-10 21:11:20.359446
NCT03108287|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-20|||April 1, 2013|Actual|2013-04-01|March 2017|2017-03-01|February 28, 2015|Actual|2015-02-28|January 31, 2015|Actual|2015-01-31||Interventional|||Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori|Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori|Completed||Phase 4|162|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 21:11:20.450698|2017-10-10 21:11:20.450698
NCT03108274|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-15|||April 18, 2017|Actual|2017-04-18|June 2017|2017-06-01|June 16, 2017|Actual|2017-06-16|June 2, 2017|Actual|2017-06-02||Interventional|||A Phase I DDI Study Between ACH-0144471 and Midazolam, Fexofenadine and Mycophenolate Mofetil|A Three-Part Phase I Study to Determine the Potential Drug Interaction Between ACH-0144471 and Midazolam, Fexofenadine and Mycophenolate Mofetil in Healthy Subjects|Completed||Phase 1|35|Actual|Achillion Pharmaceuticals||6|||f||||f|t|f|||t|||No||2017-10-10 21:11:20.533265|2017-10-10 21:11:20.533265
NCT03108248|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||January 1, 2011|Actual|2011-01-01|April 2017|2017-04-01|March 25, 2017|Actual|2017-03-25|December 12, 2016|Actual|2016-12-12||Observational|||ISP-TACE Versus TACE for HCC With PVTT|Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: Survival Benefit of Transarterial Chemoembolization in Combination With Irradiation Stent Placement|Completed||N/A|126|Actual|Zhongda Hospital|||2||f|||||f|f||||||||2017-10-10 21:11:20.667584|2017-10-10 21:11:20.667584
NCT03108235|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-05|||January 1, 2018|Anticipated|2018-01-01|April 2017|2017-04-01|December 30, 2019|Anticipated|2019-12-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||HOMe-based HEart Failure Self-Management Programme Study (The HOM-HEMP Study)|HOMe-based HEart Failure Self-Management Programme Study (The HOM-HEMP Study): A Randomized Controlled Trial|Not yet recruiting||N/A|213|Anticipated|National University, Singapore||3|||f||||t|f|f||||||No||2017-10-10 21:11:20.757029|2017-10-10 21:11:20.757029
NCT03108222|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease|Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease|Recruiting||N/A|20|Anticipated|Purdue University|||2||f||||t|f|f||||||No||2017-10-10 21:11:20.860161|2017-10-10 21:11:20.860161
NCT03108209|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-05|||July 2016||2016-07-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Prevention of Phototoxicities in Patients Undergoing Vemurafenib Treatment|Evaluation of the Interest and Tolerance of a Photoprotection Strategy in Prevention of Phototoxicities in Patients Undergoing Vemurafenib Treatment Associated or Not With Cobimetinib|Recruiting||N/A|222|Anticipated|NAOS||1|||f||||f|f|f||||||No||2017-10-10 21:11:20.965567|2017-10-10 21:11:20.965567
NCT03108196|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-15|||May 1, 2017|Actual|2017-05-01|November 2016|2016-11-01|September 30, 2021|Anticipated|2021-09-30|July 1, 2020|Anticipated|2020-07-01||Interventional|||Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder|A Multicenter Randomized Controlled Study to Compare the Safety and Efficacy of Detaenial Sigmoid Neobladder and Hautmann Ileal Neobladder in Patients With Bladder Cancer|Enrolling by invitation||N/A|96|Anticipated|Zhujiang Hospital||2|||f||||f|f|f||||||Yes|All released data will be available for other researchers.|2017-10-10 21:11:21.070402|2017-10-10 21:11:21.070402
NCT03108183|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-05|||March 2, 2017|Actual|2017-03-02|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Apicoectomy Longterm Results|A Prospective Study to Evaluate the Longterm Treatment Results After Micro-surgical Root Resection of Teeth With Post and Core and Crown|Recruiting||N/A|73|Anticipated|Medical University of Graz|||1||f||||f|f|f||||||No||2017-10-10 21:11:21.189784|2017-10-10 21:11:21.189784
NCT03108170|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-07-24|||April 12, 2017|Actual|2017-04-12|July 2017|2017-07-01|October 25, 2017|Anticipated|2017-10-25|October 20, 2017|Anticipated|2017-10-20||Interventional|||Digital Perineal Massage and Pelvic Floor Muscle Exercise During Pregnancy for Prevention of Perineal Laceration|Digital Perineal Massage and Pelvic Floor Muscle Exercise as an Antenatal Program for Prevention of Perineal Trauma in Elderly Women, a Randomized Controlled Trial|Recruiting||N/A|90|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 21:11:21.293217|2017-10-10 21:11:21.293217
NCT03108157|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||January 30, 2017|Actual|2017-01-30|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF|Endometrial Scratch Effect on Pregnancy Rates When Performed During the Previous Cycle of Embryo Transfer in Patients Undergoing Egg-donation IVF|Recruiting||N/A|332|Anticipated|Procreatec||2|||f||||f|f|f||||||No||2017-10-10 21:11:21.398992|2017-10-10 21:11:21.398992
NCT03108144|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-11|||April 11, 2016|Actual|2016-04-11|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|COMBAT||Personalized Alerts and Care Pathways to Prompt Prevention Interventions for Alcohol and Tobacco Users in Primary Care|Personalized Patient Alerts and Care Pathways to Prompt Prevention Interventions for Combined Alcohol and Tobacco Users in Primary Care|Recruiting||N/A|15000|Anticipated|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||No||2017-10-10 21:11:21.515261|2017-10-10 21:11:21.515261
NCT03108131|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-08-10|||April 7, 2017|Actual|2017-04-07|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Cobimetinib and Atezolizumab in Advanced Rare Tumors|A Phase II, Open-label, Single-arm, Multi-cohort, Proof-of-principle Study to Investigate the Efficacy of Cobimetinib and Atezolizumab in Advanced Rare Tumors|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f|||f|||||2017-10-10 21:11:21.625081|2017-10-10 21:11:21.625081
NCT03108118|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||June 25, 2013|Actual|2013-06-25|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|MYOTRAUMA||Diaphragm Injury and Dysfunction During Mechanical Ventilation|Diaphragm Injury and Dysfunction During Mechanical Ventilation|Recruiting||N/A|60|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||No||2017-10-10 21:11:21.727774|2017-10-10 21:11:21.727774
NCT03108105|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-08-23|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Multicenter Study to Describe the Performance of the AOS-C2001-B Device in Patients With Colostomy|Multicenter Pilot Study to Describe the Performance of the AOS-C2001-B Device in Patients With Colostomy|Recruiting||N/A|30|Anticipated|BBraun Medical SAS||1|||f||||f|f|f||||||||2017-10-10 21:11:21.810259|2017-10-10 21:11:21.810259
NCT03108092|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Health Economic Evaluation Alongside the OPERAM Trial|Health Economic Evaluation Alongside the OPERAM Trial (OPtimising thERapy to Prevent Avoidable Hospital Admissions in the Multimorbid Older People: a Cluster Randomised Controlled Trial).|Recruiting||N/A|2000|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f||||||Undecided||2017-10-10 21:11:21.880926|2017-10-10 21:11:21.880926
NCT03108079|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-10|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Bladder Morphology Using 2 Different Catheter Designs|Bladder Morphology Using 2 Different Catheter Designs Foley Catheter vs. Cystosure Urinary Access System|Recruiting||N/A|3|Anticipated|The Pelvic Floor Institute||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:11:22.018588|2017-10-10 21:11:22.018588
NCT03108066|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-23|||May 10, 2017|Actual|2017-05-10|April 2017|2017-04-01|September 2022|Anticipated|2022-09-01|April 2022|Anticipated|2022-04-01||Interventional|||PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma|An Open Label Phase 2 Study to Evaluate PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma|Active, not recruiting||Phase 2|4|Actual|Peloton Therapeutics, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:11:22.134109|2017-10-10 21:11:22.134109
NCT03108053|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-10|||June 1, 2014|Actual|2014-06-01|March 2017|2017-03-01|January 1, 2019|Anticipated|2019-01-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Results of Safety Guidewire Use in Ureteroscopic Stone Surgery|Results of a Prospective Randomized Trial of Safety Guidewire Use in Ureteroscopic Stone Surgery: to Use or Not to Use|Recruiting||N/A|250|Anticipated|Marmara University||2|||f||||f|f|f||||||No||2017-10-10 21:11:22.223973|2017-10-10 21:11:22.223973
NCT03108040|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-11|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|July 10, 2018|Anticipated|2018-07-10|May 10, 2018|Anticipated|2018-05-10||Observational|||Evaluation of Fetal Cardiac Function and Vascular Hemodynamics in Intrauterine Growth Restriction|Evaluation of Non Invasive Fetal Cardiac Functions and Fetal Arterial&Venous Doppler Study in Intrauterine Growth Restriction as Predictive Parameters of Perinatal Outcome|Recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t||||||||Undecided||2017-10-10 21:11:22.311084|2017-10-10 21:11:22.311084
NCT03108027|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-07-11|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|April 19, 2018|Anticipated|2018-04-19|April 19, 2018|Anticipated|2018-04-19||Interventional|QVM149||Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma|A Randomized, Double-blind, Repeat Dose Cross-over Study to Assess the Bronchodilator Effects of Once Daily QVM149 Following Morning or Evening Dosing for 14 Days Compared to Placebo in Patients With Asthma|Recruiting||Phase 2|36|Anticipated|Novartis||6|||f||||f|f|f||||||||2017-10-10 21:11:22.384372|2017-10-10 21:11:22.384372
NCT03108014|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-28|||September 17, 2017|Anticipated|2017-09-17|June 2017|2017-06-01|December 1, 2026|Anticipated|2026-12-01|September 1, 2025|Anticipated|2025-09-01||Observational|||Beginnings Study Follow up|Beginnings Study Follow up|Not yet recruiting||N/A|1173|Anticipated|Arkansas Children's Hospital Research Institute|||3||f||||f|f|f||||||No||2017-10-10 21:11:22.481578|2017-10-10 21:11:22.481578
NCT03108001|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-05|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|March 1, 2031|Anticipated|2031-03-01|March 1, 2031|Anticipated|2031-03-01||Observational|||Glowing and Expecting Follow Up|Glowing and Expecting Follow Up|Recruiting||N/A|514|Anticipated|Arkansas Children's Hospital Research Institute|||5||f||||t|f|f||||Samples With DNA|"     Blood samples will be collected.   "|No||2017-10-10 21:11:22.551923|2017-10-10 21:11:22.551923
NCT03107988|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|May 2020|Anticipated|2020-05-01||Interventional|||Study of Lorlatinib (PF-06463922)|Phase 1 Study of Lorlatinib (PF-06463922), an Oral Small Molecule Inhibitor of ALK/ROS1, for Patients With ALK-Driven Relapsed or Refractory Neuroblastoma|Recruiting||Phase 1|40|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||4|||f||||t|t|f||||||||2017-10-10 21:11:22.632422|2017-10-10 21:11:22.632422
NCT03107975|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-24|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy|Effect of Intrathecal Transplant of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy|Enrolling by invitation||Phase 1|10|Anticipated|The Second Affiliated Hospital of Fujian Medical University||1|||f||||t|f|f||||||Undecided||2017-10-10 21:11:22.797416|2017-10-10 21:11:22.797416
NCT03107962|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-04|||February 19, 2017|Actual|2017-02-19|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma|PD-1 Blockade With Pembrolizumab in Relapsed or Refractory Natural Killer/T Cell Lymphoma|Recruiting||Phase 2|20|Anticipated|Zhengzhou University||1|||f|||||t|f|||t|||No||2017-10-10 21:11:22.879396|2017-10-10 21:11:22.879396
NCT03107949|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-20|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|January 30, 2018|Anticipated|2018-01-30|December 30, 2017|Anticipated|2017-12-30||Interventional|RESCUE1||Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1)|Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing|Recruiting||N/A|15|Anticipated|Lungpacer Medical Inc.||1|||f||||t|f|t|t|f||||||2017-10-10 21:11:22.971527|2017-10-10 21:11:22.971527
NCT03107936|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-13|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|smokeSCREEN||Development of a Videogame Prototype Targeting Cigarette and Marijuana Smoking, and Tobacco Product Prevention Among Young Adolescents||Recruiting||N/A|150|Anticipated|Yale University||5|||f||||f||||||||No||2017-10-10 21:11:23.070456|2017-10-10 21:11:23.070456
NCT03107923|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||April 26, 2017|Anticipated|2017-04-26|April 2017|2017-04-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01|1 Year|Observational [Patient Registry]|||Better Patient Selection to Transcatheter Aortic Valve Implantation|Better Patient Selection to Transcatheter Aortic Valve Implantation|Not yet recruiting||N/A|150|Anticipated|Oslo University Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:11:23.161372|2017-10-10 21:11:23.161372
NCT03107910|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|May 2021|Anticipated|2021-05-01|December 2019|Anticipated|2019-12-01||Interventional|||Stigma and Online Counseling to Increase HIV/STI Testing|Novel Stigma/Structural Interventions for HIV/STI Testing|Recruiting||N/A|500|Anticipated|University of Connecticut||2|||f||||t|f|f||||||No|Individual participant data will not be shared with other researchers.|2017-10-10 21:11:23.240511|2017-10-10 21:11:23.240511
NCT03107897|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-06|||August 17, 2016|Actual|2016-08-17|June 2017|2017-06-01|December 30, 2017|Anticipated|2017-12-30|August 30, 2017|Anticipated|2017-08-30||Interventional|TAVR-Prehab||Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement|Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement|Recruiting||N/A|70|Anticipated|WellSpan Health||2|||f||||t|f|f||||||Undecided||2017-10-10 21:11:23.309898|2017-10-10 21:11:23.309898
NCT03107884|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-10|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Role of Metformin on Muscle Health of Older Adults|Metformin to Prevent Inactivity-induced Loss of Muscle Health During Aging|Not yet recruiting||Early Phase 1|30|Anticipated|University of Utah||2|||f||||t|t|f|||f|||No||2017-10-10 21:11:23.383736|2017-10-10 21:11:23.383736
NCT03107871|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-09-26|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|ValEAR||Randomized Controlled Trial of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants|Randomized Controlled Trial of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants: ValEAR Trial|Not yet recruiting||Phase 3|108|Anticipated|University of Utah||2|||f||||t|t|f||||||||2017-10-10 21:11:23.469956|2017-10-10 21:11:23.469956
NCT03107858|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-10|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 1, 2019|Anticipated|2019-11-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft Function|The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft Function|Not yet recruiting||Phase 2/Phase 3|44|Anticipated|Assiut University||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:11:23.648647|2017-10-10 21:11:23.648647
NCT03107845|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-06-30|||April 15, 2017|Actual|2017-04-15|June 2017|2017-06-01|October 1, 2019|Anticipated|2019-10-01|September 15, 2019|Anticipated|2019-09-15||Interventional|||Randomized Controlled Trial to Evaluate Personalized Prediction and Adaptation Tools in Psychotherapy|Randomized Controlled Trial to Evaluate the Effects of Psychometric Feedback on Treatment Outcome and Its Mediators and Moderators in Outpatient Psychotherapy|Recruiting||N/A|423|Anticipated|University of Trier||3|||f||||f|f|f||||||||2017-10-10 21:11:23.714929|2017-10-10 21:11:23.714929
NCT03107832|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-11|||December 30, 2012|Actual|2012-12-30|April 2017|2017-04-01|December 29, 2013|Actual|2013-12-29|August 25, 2013|Actual|2013-08-25||Interventional|EVGAC||Thoracic Epidural Versus General Anaesthesia in Cholecystectomy|Comparison of Bi-spectral Index-Controlled Sedation During a Thoracic Epidural Anesthesia With General Anesthesia in Laparoscopic Cholecystectomy|Completed||N/A|40|Actual|Abant Izzet Baysal University||2|||f||||f|f|f|||f|||No||2017-10-10 21:11:23.799516|2017-10-10 21:11:23.799516
NCT03107819|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-04|||March 29, 2017|Actual|2017-03-29|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Metabolomics for Biomarker Discovery in Children With EoE|Plasma and Urine Metabolomics for Biomarker Discovery in Children With Eosinophilic Esophagitis|Recruiting||N/A|8|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||t|f|f||||Samples With DNA|"     Peripheral venous blood, urine, esophageal mucosa biopsies   "|No||2017-10-10 21:11:24.005599|2017-10-10 21:11:24.005599
NCT03107806|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-04-04|||April 2013|Actual|2013-04-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|COMGAMI||Monitoring Glucose Levels in Patients With Myocardial Infarction|COMGAMI Continuous Monitoring of Glucose in Acute Myocardial Infarction|Terminated||N/A|14|Actual|Karolinska Institutet||2||Blood withdrawal problems despite use of different catheters.|f||||f||||||||||2017-10-10 21:11:24.154542|2017-10-10 21:11:24.154542
NCT03107780|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-10|2017-09-04|||October 27, 2017|Anticipated|2017-10-27|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||MDM2 Inhibitor AMG-232 in Treating Patients With Recurrent or Newly Diagnosed Glioblastoma|Phase 0/I Study of AMG 232 Concentrations in Brain Tissue in Patients With Recurrent Glioblastoma and of AMG 232 in Combination With Radiation in Patients With Newly Diagnosed Glioblastoma and Unmethylated MGMT Promoters|Not yet recruiting||Phase 1|92|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:11:24.575931|2017-10-10 21:11:24.575931
NCT03107767|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-05|||June 1, 2016|Actual|2016-06-01|April 2017|2017-04-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|PRO-Malleol||Study of Re-operation Rate After Introduction of Evidence Based Algorithm for the Treatment of Ankle Fractures|The PRO-malleol Study|Recruiting||N/A|200|Anticipated|Hvidovre University Hospital||2|||f||||f|f|f||||||Yes|Data will be anonymized and openly shared with any who requests it, after study publication.|2017-10-10 21:11:24.71449|2017-10-10 21:11:24.71449
NCT03107754|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Buffered Lidocaine in Paracervical Blocks|Buffered Lidocaine for Paracervical Block to Decrease Injection Pain During First Trimester Uterine Aspirations|Not yet recruiting||N/A|98|Anticipated|University of Hawaii||2|||f||||f|f|f||||||No||2017-10-10 21:11:24.82857|2017-10-10 21:11:24.82857
NCT03107741|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-05|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Tai Chi Training on Metabolic Syndrome|Effectiveness of Tai Chi Training to Alleviate Metabolic Syndrome in Abdominal Obese Older Adults: A Randomized Controlled Trial|Recruiting||N/A|390|Anticipated|The Hong Kong Polytechnic University||3|||f||||||||||||||2017-10-10 21:11:24.925529|2017-10-10 21:11:24.925529
NCT03107728|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-03|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|||The IM ABLE Study: A Study of Warriors & Veterans Following Neuromusculoskeletal Injury of the Lower Limb|The IM ABLE Study: A Cross-Sector, Multisite Initiative to Advance Care for Warriors and Veterans Following Neuromusculoskeletal Injury of the Lower Limb|Not yet recruiting||N/A|120|Anticipated|University of South Florida||2|||f|||||f|f||||||||2017-10-10 21:11:25.055723|2017-10-10 21:11:25.055723
NCT03107715|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-07|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|July 2017|Anticipated|2017-07-01||Interventional|||Prenatal Interventions to Promote Exclusive Breastfeeding|Assessing the Feasibility of a Breastfeeding Champion Intervention and a Positive Messaging Module During the Prenatal Period - a Pilot|Recruiting||N/A|250|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:11:25.14105|2017-10-10 21:11:25.14105
NCT03107702|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-04|||March 29, 2017|Actual|2017-03-29|April 2017|2017-04-01|July 30, 2017|Anticipated|2017-07-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Melatonin Level and Postoperative Analgesia Consumption in Bariatric Surgery Patients.|Relationship Between Melatonin Level and Postoperative Analgesia Consumption in Bariatric Surgery Patients.|Enrolling by invitation||N/A|35|Anticipated|Inonu University|||1||f||||f|f|f|||f|||No||2017-10-10 21:11:25.246965|2017-10-10 21:11:25.246965
NCT03107689|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-04-10|||May 2012||2012-05-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients|Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients|Recruiting||N/A|100|Anticipated|University of Southern California|||1||f||||f||||||||No||2017-10-10 21:11:25.334076|2017-10-10 21:11:25.334076
NCT03107676|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-09-14|||February 20, 2017|Actual|2017-02-20|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|November 20, 2017|Anticipated|2017-11-20||Interventional|||Trunk Extension Endurance Among Physical Therapy Students|Trunk Extension Endurance Using Four Arms Positions Among Physical Therapy Collegiate Students|Enrolling by invitation||N/A|50|Anticipated|General Committee of Teaching Hospitals and Institutes, Egypt||4|||f||||t|f|f||||||||2017-10-10 21:11:25.42636|2017-10-10 21:11:25.42636
NCT03107663|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-08-02|||June 19, 2017|Actual|2017-06-19|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||89Zr-Df-IAB22M2C PET/CT in Patients With Selected, Metastatic Solid Malignancies or Hodgkin's Lymphoma|A Phase I Study of Positron Emission Tomography With 89Zr-Df-IAB22M2C in Patients With Selected, Metastatic Solid Malignancies (Non Small Cell Lung Cancer, Small Cell Lung Cancer, Squamous Cell Carcinoma Head and Neck, Melanoma, Merkel Cell Tumor, Renal, Bladder, Hepatocellular, Triple Negative Breast, or Gastroesophageal Cancer) or Hodgkin's Lymphoma|Recruiting||Phase 1|24|Anticipated|ImaginAb, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:11:25.514426|2017-10-10 21:11:25.514426
NCT03107650|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|February 2023|Anticipated|2023-02-01|January 2021|Anticipated|2021-01-01||Observational|PREMARE||Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer|Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer|Not yet recruiting||N/A|60|Anticipated|Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta|||2||f||||t|f|f||||||No||2017-10-10 21:11:25.602822|2017-10-10 21:11:25.602822
NCT03107637|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-05|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Observational|ETO||Transesophageal Echocardiography in Embolic Stroke of Undetermined Source|Therapeutic Implications of Early Transesophageal Echocardiography in Embolic Stroke of Undetermined Source (ESUS)|Recruiting||N/A|150|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:11:25.668848|2017-10-10 21:11:25.668848
NCT03107611|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-08-03||2017-08-03|February 29, 2016|Actual|2016-02-29|August 2017|2017-08-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis|A Randomized, Prospective, Multicenter, Double Blind, Parallel Assignment, Placebo Controlled Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® (Pimecrolimus) Cream, 1% in Patients With Mild to Moderate Atopic Dermatitis|Completed||Phase 3|654|Actual|Mylan Inc.||3|||f||||f|t|f|||t|||||2017-10-10 21:11:25.821314|2017-10-10 21:11:25.821314
NCT03107598|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-04-04|||March 2016||2016-03-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|CPvsCC||Colloid Preload Versus Crystalloid Co-load in Cesarean Section Under Spinal Anesthesia|Colloid Preload Versus Crystalloid Co-load in Cesarean Section Under Spinal Anesthesia Randomized Controlled Trial|Terminated||N/A|127|Actual|University Hospital, Mahdia||2|||f||||f||||||||No||2017-10-10 21:11:25.963241|2017-10-10 21:11:25.963241
NCT03107585|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-04|||January 2015||2015-01-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|ICPBUS||Intermediate Cervical Block Under Ultrasound for Thyroid Surgery: Impact on Per and Postoperative Opioid Consumption|Bilateral Intermediate Cervical Plexus Block Under Ultrasound for Thyroid Surgery: Impact on Perioperative Opioid Consumption|Completed||N/A|70|Actual|University Hospital, Mahdia||2|||f||||f||||||||No||2017-10-10 21:11:26.033977|2017-10-10 21:11:26.033977
NCT03107572|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-04|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Predictive and Prognostic Value of Cellular Dysoxia Markers After Cardiac Surgery With Extracorporeal Circulation|Comparison of the Predictive and Prognostic Value of Cellular Dysoxia Markers in the Postoperative Period of Cardiac Surgery With Extracorporeal Circulation|Recruiting||N/A|340|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||Samples Without DNA|"     Blood samples in All patients, Microcirculation reactivity using thenar StO2 and vascular     occlusion test, VCO2 and VO2 measurement using indirect calorimetry (at the discretion of     attending physician)   "|No||2017-10-10 21:11:26.102457|2017-10-10 21:11:26.102457
NCT03107559|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-20|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|August 1, 2017|Anticipated|2017-08-01|July 15, 2017|Anticipated|2017-07-15||Observational|||Perfusion Index and Labor Analgesia|Can the Perfusion Index be Used as an Objective Instrument for the Assessment of Pain in the Labor Analgesia?|Recruiting||N/A|30|Anticipated|Erzincan University|||1||f||||f|f|f||||||No||2017-10-10 21:11:26.173639|2017-10-10 21:11:26.173639
NCT03107546|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-08-04|||May 11, 2017|Actual|2017-05-11|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Comparison of Scar Formation in Syndactyly Release Surgery With Full Thickness Skin Graft Versus Skin Graft Substitute|Comparison of Scar Formation in Syndactyly Release Surgery With Full Thickness Skin Graft Versus Skin Graft Substitute|Recruiting||N/A|40|Anticipated|Gillette Children's Specialty Healthcare||2|||f|||||f|t|f|f||||||2017-10-10 21:11:26.243723|2017-10-10 21:11:26.243723
NCT03107533|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-05|||March 30, 2017|Actual|2017-03-30|April 2017|2017-04-01|March 30, 2020|Anticipated|2020-03-30|March 30, 2020|Anticipated|2020-03-30||Observational|||Scoliosis Shared Decision Making|Scoliosis Shared Decision Making|Recruiting||N/A|25|Anticipated|Mayo Clinic|||1||f||||f|f|f||||||No||2017-10-10 21:11:26.360394|2017-10-10 21:11:26.360394
NCT03107520|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-30|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow After Surgical Hip Reduction for DDH|Use of Intraoperative Contrast-Enhanced Ultrasound to Evaluate Femoral Head Perfusion in Infants With Developmental Hip Dysplasia After Surgical Reduction|Active, not recruiting||Early Phase 1|35|Anticipated|Children's Hospital of Philadelphia||1|||f||||f|t|f|||t|||||2017-10-10 21:11:26.434357|2017-10-10 21:11:26.434357
NCT03107507|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-05|||March 25, 2017|Actual|2017-03-25|March 2017|2017-03-01|December 30, 2017|Anticipated|2017-12-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG|Efficacy of Levetiracetam in Control of Neonatal Seizures|Recruiting||Phase 4|40|Anticipated|Cairo University||2|||f|||||t|f|||f|||||2017-10-10 21:11:26.51255|2017-10-10 21:11:26.51255
NCT03107481|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-06-04|||June 4, 2017|Actual|2017-06-04|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acetaminophen IV vs Hydromorphone IV in the ED|Acetaminophen 1g IV vs Hydromorphone 1mg IV for the Treatment of Acute Pain in the Emergency Department|Recruiting||Phase 4|220|Anticipated|Montefiore Medical Center||2|||f||||t|t|f|||t|||No||2017-10-10 21:11:26.698543|2017-10-10 21:11:26.698543
NCT03107468|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-11|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Korean Medicine for Symptomatic Lumbar Spinal Spondylolisthesis|The Effectiveness and Safety of Traditional Korean Medicine for Symptomatic Lumbar Spinal Spondylolisthesis: a Randomized Controlled International Collaborative Multi-center Trial|Not yet recruiting||N/A|122|Anticipated|Mokhuri Oriental Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:11:26.80477|2017-10-10 21:11:26.80477
NCT03107455|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||MitraClip in Acute Mitral Regurgitation|European Registry of MitraClip in Acute Myocardial Infarction|Enrolling by invitation||N/A|50|Anticipated|Fundación Investigación Sanitaria en León|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:11:26.922833|2017-10-10 21:11:26.922833
NCT03107442|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-04|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|EJERCITALES||Exercise and Arterial Stiffness in Systemic Lupus Erythematosus|Effects of an Aerobic Exercise Intervention Program on Arterial Stiffness and Inflammation in Women With Systemic Lupus Erythematosus|Completed||N/A|58|Actual|Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental||2|||f||||f|f|f||||||||2017-10-10 21:11:26.982854|2017-10-10 21:11:26.982854
NCT03107429|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-04|||March 1, 2015|Actual|2015-03-01|April 2017|2017-04-01|October 1, 2015|Actual|2015-10-01|October 1, 2015|Actual|2015-10-01||Interventional|TaPPs||Effect of Acetazolamide on Intraocular Pressure After Being in the Trendelenburg Position.|A Pilot Crossover Study in Healthy Volunteers to Assess the Effect of Acetazolamide on Intraocular Pressure After Being in the Trendelenburg Position.|Completed||N/A|9|Actual|University of Nottingham||2|||f||||f|f|f||||||No||2017-10-10 21:11:27.071702|2017-10-10 21:11:27.071702
NCT03107416|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-10-04|||April 5, 2017|Actual|2017-04-05|October 2017|2017-10-01|April 5, 2019|Anticipated|2019-04-05|April 5, 2019|Anticipated|2019-04-05||Interventional|||Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells|Phase I/II Study of Transarterial Hepatic Embolization With Bumetanide in Unresectable Hepatocellular Carcinoma|Recruiting||Phase 1/Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:11:27.150301|2017-10-10 21:11:27.150301
NCT03107403|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|DreamDeath||Dreams and Bereavement|Investigation of the Links Between Waking-life and Dream Content in the Case of the Death of a Close Relative|Not yet recruiting||N/A|50|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:11:27.233633|2017-10-10 21:11:27.233633
NCT03107390|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||October 28, 2013|Actual|2013-10-28|April 2017|2017-04-01|June 30, 2029|Anticipated|2029-06-30|June 30, 2029|Anticipated|2029-06-30||Interventional|NT-pro-MICI||Evaluation of NT-proBNP in Chronic Inflammatory Bowel Disease|Evaluation of NT-proBNP in Chronic Inflammatory Bowel Disease|Recruiting||N/A|400|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:11:27.311435|2017-10-10 21:11:27.311435
NCT03107377|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-06-30|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Phase 2B Double-blinded Placebo-controlled|Phase 2B Double-blinded Placebo-controlled Efficacy Trial of Amphora® Gel for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection|Not yet recruiting||Phase 2|634|Anticipated|Evofem Inc.||2|||f||||f|t|f||||||||2017-10-10 21:11:27.375716|2017-10-10 21:11:27.375716
NCT03107364|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-05|||March 21, 2017|Actual|2017-03-21|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|ELIPSE||Trend in Hospital Lengths of Stay and Readmissions|Association Between Trend in Length of Stay and Risk of Readmission at Hospital After Surgery|Recruiting||N/A|100000|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 21:11:27.442597|2017-10-10 21:11:27.442597
NCT03107351|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-04|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|MultiKinVal||Cardiac Linear and Torsional Contractility Measurements With a New Technology: Multi Dimensional Kineticardiography|Validation Study of Cardiac Linear and Torsional Contractility Measurements With a New Technology: Multi Dimensional Kineticardiography (MKCG)|Recruiting||N/A|32|Anticipated|Erasme University Hospital||2|||f|||||f|f||||||||2017-10-10 21:11:27.509868|2017-10-10 21:11:27.509868
NCT03107338|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-11|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|November 7, 2015|Actual|2015-11-07|October 30, 2015|Actual|2015-10-30||Interventional|UMU||Preventive Treatment of Pain After Dental Implant Surgery|Effects of the Preoperative Administration of Dexketoprofen Trometamol on Pain and Swelling After Implant Surgery: a Randomized, Double-blind Controlled Trial.|Completed||Phase 4|100|Actual|Universidad de Murcia||2|||f||||f|t|f|||f|||Yes|All data there will be share by personal e-mail|2017-10-10 21:11:27.574459|2017-10-10 21:11:27.574459
NCT03107325|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-27|||April 1, 2018|Anticipated|2018-04-01|September 2017|2017-09-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging|Biokinetics Study for F-18 FDG for Dose Reduction in Pediatric Molecular Imaging|Not yet recruiting||Phase 4|25|Anticipated|Boston Children’s Hospital||1|||f||||f|t|f|||t|||||2017-10-10 21:11:29.564719|2017-10-10 21:11:29.564719
NCT03107312|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-05-11|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|StikoSero||Bioarray for the Serological Assessment of Immunity Against Vaccine-preventable Infections|Bioarray Compilation for the Serological Assessment of Immunity Against Vaccine-preventable Infections of Available Prophylaxis in Refugees and Immigrants|Recruiting||N/A|900|Anticipated|Jena University Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Serum   "|No||2017-10-10 21:11:29.657104|2017-10-10 21:11:29.657104
NCT03107299|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-10|||July 1, 2016|Actual|2016-07-01|April 2017|2017-04-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Interventional|METHO-PR||Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis|Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire, Amiens||3|||f|||||f|f||||||||2017-10-10 21:11:29.744247|2017-10-10 21:11:29.744247
NCT03107286|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-27|||April 1, 2018|Anticipated|2018-04-01|September 2017|2017-09-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Biokinetics Study for Tc-99m MAG3 in Pediatric Molecular Imaging|Biokinetics Study for Tc-99m MAG3 Dose Reduction in Pediatric Molecular Imaging|Not yet recruiting||Phase 4|25|Anticipated|Boston Children’s Hospital||1|||f||||f|t|f|||t|||||2017-10-10 21:11:29.817649|2017-10-10 21:11:29.817649
NCT03107273|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-05|||June 16, 2016|Actual|2016-06-16|April 2017|2017-04-01|June 15, 2018|Anticipated|2018-06-15|June 15, 2018|Anticipated|2018-06-15||Observational|HEMASTEM||Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes.|Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes.|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire, Amiens|||2||f|||||f|f||||||||2017-10-10 21:11:29.893238|2017-10-10 21:11:29.893238
NCT03107260|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-05|||January 15, 2016|Actual|2016-01-15|April 2017|2017-04-01|July 13, 2018|Anticipated|2018-07-13|July 13, 2018|Anticipated|2018-07-13||Interventional|NIRS-1||The Association Between Variation in Oxygen Saturation (ScO2) and Incidence of Postoperative Cognitive Dysfunction (POCD) in a Population of Elderly Patients Admitted for Emergency Surgery.|The Association Between Variation in Oxygen Saturation (ScO2) and Incidence of Postoperative Cognitive Dysfunction (POCD) in a Population of Elderly Patients Admitted for Emergency Surgery.|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:11:29.966378|2017-10-10 21:11:29.966378
NCT03107247|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-27|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Biokinetics Study for Tc-99m MDP in Pediatric Molecular Imaging|Biokinetics Study for Tc-99m MDP for Dose Reduction in Pediatric Molecular Imaging|Not yet recruiting||Phase 4|25|Anticipated|Boston Children’s Hospital||1|||f||||f|t|f|||t|||||2017-10-10 21:11:30.055023|2017-10-10 21:11:30.055023
NCT03107234|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-05|2017-04-10|||July 20, 2015|Actual|2015-07-20|April 2017|2017-04-01|July 17, 2018|Anticipated|2018-07-17|July 17, 2018|Anticipated|2018-07-17||Observational|CarcIno||Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast Cancers|Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast Cancers|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:11:30.140746|2017-10-10 21:11:30.140746
NCT03107221|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-04-04|||August 2016||2016-08-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Eating Disorders: Online Self-help & Usual Treatment (TAU) vs TAU Only|"The Effectiveness and Acceptability of the Internet-based Smart Eating Self-help Programme Alongside Treatment as Usual for the Management of Eating Disorders: A Pilot Study"|Recruiting||N/A|42|Anticipated|University of Edinburgh||2|||f||||t||||||||Yes|A summary of study findings for participants are available on request|2017-10-10 21:11:30.210279|2017-10-10 21:11:30.210279
NCT03107208|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-06-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes|Management of Diabetic Ketoacidosis in Children: Does Early Glargine Prevent Rebound Hyperglycemia?|Not yet recruiting||Phase 4|100|Anticipated|University of Colorado, Denver||2|||f||||f|f|f|||f|||No||2017-10-10 21:11:30.300269|2017-10-10 21:11:30.300269
NCT03107195|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-27|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Biokinetics Study of Tc-99m DMSA in Pediatric Molecular Imaging|Biokinetics Study of Tc-99m DMSA for Dose Reduction in Pediatric Molecular Imaging|Not yet recruiting||Phase 4|25|Anticipated|Boston Children’s Hospital||1|||f||||f|t|f|||t|||||2017-10-10 21:11:30.484199|2017-10-10 21:11:30.484199
NCT03107182|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-05|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|OPTIMA II||Oropharyngeal Tumor Induction Chemotherapy and Response-stratified Locoregional Therapy Trial in Order to Minimize Long-term Adverse Events|A Phase II Trial of Nivolumab/Nab-paclitaxel/Carboplatin Induction Chemotherapy Followed by Response-stratified Locoregional Therapy for Patients With Locoregionally Advanced HPV-related Oropharyngeal Cancer- the OPTIMA II Trial|Recruiting||Phase 2|56|Anticipated|University of Chicago||4|||f||||t|t|f||||||||2017-10-10 21:11:30.60024|2017-10-10 21:11:30.60024
NCT03107169|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-15|||February 1, 2015|Actual|2015-02-01|April 2017|2017-04-01|September 30, 2015|Actual|2015-09-30|September 30, 2015|Actual|2015-09-30||Interventional|||Treatment of Initial Clostridium Difficile Infection|Fecal Microbiota Transplant Versus Vancomycin for Treatment of Initial Clostridium Difficile Infection|Completed||N/A|10|Actual|Universidad Autonoma de Nuevo Leon||2|||f||||t|f|f||||||No||2017-10-10 21:11:30.761975|2017-10-10 21:11:30.761975
NCT03107156|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-22|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Understanding Evidence-Based Practice Patterns in Advanced NSCLC|Understanding Evidence-Based Practice Patterns in Advanced NSCLC: An Educational/Research Initiative in Mid-Atlantic States|Not yet recruiting||N/A|375|Anticipated|Carevive Systems, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:11:30.84092|2017-10-10 21:11:30.84092
NCT03107143|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||June 15, 2016|Actual|2016-06-15|April 2017|2017-04-01|May 1, 2017|Anticipated|2017-05-01|October 31, 2016|Actual|2016-10-31||Interventional|||Study of TurnCare's Q-2 System on the Sacral Pressure Ulcer Prevention in High Risk Patients|A Randomized, Non-blind Study of TurnCare's Q-2 System on the Sacral Pressure Ulcer Prevention in High Risk Patients at St. Vincent's Medical Center|Active, not recruiting||N/A|431|Actual|TurnCare Inc.||2|||f||||t|f|t|t|||||No||2017-10-10 21:11:30.914468|2017-10-10 21:11:30.914468
NCT03107130|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-10-02|||February 28, 2017|Actual|2017-02-28|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Urodynamic Studies Prior to Surgery for Stress Urinary Incontinence|Complex Urodynamic Testing: Who Requires it? A Retrospective Review|Active, not recruiting||N/A|25|Anticipated|TriHealth Inc.|||1||f||||f|f|f||||||||2017-10-10 21:11:30.992354|2017-10-10 21:11:30.992354
NCT03107117|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|April 30, 2020|Anticipated|2020-04-30|January 30, 2020|Anticipated|2020-01-30||Interventional|JJMISCOPE||Computer-Assisted Brief Intervention|Computer-Assisted Brief Intervention Protocol for Marijuana Using Juvenile Offenders|Not yet recruiting||N/A|90|Anticipated|Brown University||2|||f||||t|f|f||||||||2017-10-10 21:11:31.075446|2017-10-10 21:11:31.075446
NCT03107104|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-03|||March 30, 2017|Actual|2017-03-30|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Triton Fundus Autofluorescence and Fluorescein Angiography|Topcon DRI OCT Triton (Plus) Fundus Autofluorescence and Fluorescein Angiography Image Quality Evaluation Study|Active, not recruiting||N/A|100|Anticipated|Topcon Medical Systems, Inc.||1|||f||||f|f|t|t|f|f|||||2017-10-10 21:11:31.157002|2017-10-10 21:11:31.157002
NCT03107091|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-07-11|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites|Safety and Efficacy of Low-dose Terlipressin Delivered by Continuous Intravenous Infusion in Patients With Cirrhosis and Ascites Refractory to, or Intolerant of, Diuretic Therapy, Requiring Large Volume Paracentesis|Recruiting||Phase 2|6|Anticipated|BioVie Inc.||1|||f||||t|t|f||||||||2017-10-10 21:11:31.233979|2017-10-10 21:11:31.233979
NCT03107078|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-16|||October 1, 2016|Actual|2016-10-01|April 2017|2017-04-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial|Using A Novel Classification System in Intravenous Glucocorticoids Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial|Recruiting||Phase 4|200|Anticipated|The Third Affiliated Hospital of Southern Medical University||4|||f||||t|f|f|||f|||No||2017-10-10 21:11:31.354454|2017-10-10 21:11:31.354454
NCT03107065|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-08-02|||December 8, 2016|Actual|2016-12-08|December 2016|2016-12-01|October 31, 2017|Anticipated|2017-10-31|July 2017|Actual|2017-07-01||Interventional|||Single-Treatment, Study of Percutaneous-Temperature Controlled-RF Electrocoagulation on Axilla Tissue|A Pilot, Open-Label, Single-Center, Single-Treatment, Safety And Effectiveness Evaluation Of Percutaneous-Temperature Controlled-Radiofrequency Electrocoagulation Used To Contract Tissue Associated With Axillary Sweat Glands|Active, not recruiting||N/A|20|Actual|ThermiGen, LLC||1|||f||||f||||||||||2017-10-10 21:11:31.467055|2017-10-10 21:11:31.467055
NCT03107039|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-11|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Exploring the Effects of Strength Training on Depressive Symptoms and Cardiovascular Risk in Black Men|Exploring the Effects of Strength Training on Depressive Symptoms and Cardiovascular Risk in Black Men|Active, not recruiting||N/A|50|Anticipated|Teachers College, Columbia University||2|||f||||f|f|f||||||No||2017-10-10 21:11:31.78702|2017-10-10 21:11:31.78702
NCT03107013|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-19|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|HV103||A Study to Investigate the Mass Balance of BTD-001|An Open Label, Single-Dose, Single-Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BTD-001 in Healthy Male Subjects|Active, not recruiting||Phase 1|6|Actual|Balance Therapeutics||1|||f||||f|t|f||||||Undecided||2017-10-10 21:11:32.352184|2017-10-10 21:11:32.352184
NCT03107000|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-24|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy|Corneal Endothelial Cell Loss After Trabeculectomy Versus Combined Trabeculectomy Phakoemulsification and IOL Implantation|Not yet recruiting||N/A|30|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|f|f||||||||2017-10-10 21:11:32.456741|2017-10-10 21:11:32.456741
NCT03106987|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-28|||June 8, 2017|Actual|2017-06-08|September 2017|2017-09-01|May 7, 2021|Anticipated|2021-05-07|November 8, 2020|Anticipated|2020-11-08||Interventional|OReO||A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.|A Phase IIIb, Randomised, Double-blind, Placebo-controlled, Multicentre Study of Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer Previously Treated With a PARPi and Responding to Repeat Platinum Chemotherapy.|Recruiting||Phase 3|416|Anticipated|AstraZeneca||2|||f||||t|f|f|||f|||||2017-10-10 21:11:32.610932|2017-10-10 21:11:32.610932
NCT03106974|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-04-13|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|Ovesion||A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Obese Patients|A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope|Recruiting||N/A|1440|Anticipated|AnestesiaR||2|||f||||t|f|t|f|f|f|||Undecided||2017-10-10 21:11:32.99172|2017-10-10 21:11:32.99172
NCT03106961|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-04-04|||March 30, 2017|Actual|2017-03-30|October 2016|2016-10-01|June 30, 2018|Anticipated|2018-06-30|March 22, 2018|Anticipated|2018-03-22||Observational|||OCT and Scaffold Embedding After NC Balloon|An Optical Coherence Tomography Evaluation of the Effects of High-Pressure, Non-compliant Ballooning on Scaffold Embedding|Recruiting||N/A|50|Anticipated|St. Francis Hospital, New York|||1||f||||f||||||||Undecided||2017-10-10 21:11:33.137124|2017-10-10 21:11:33.137124
NCT03106948|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-06|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 31, 2018|Anticipated|2018-01-31||Interventional|||Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis|Balloon Angioplasty of Dialysis AV Fistulae: Effect of Local Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis|Recruiting||Phase 2|30|Anticipated|Southeast Renal Research Institute||3|||f||||t|t|f|||f|||||2017-10-10 21:11:33.300366|2017-10-10 21:11:33.300366
NCT03106935|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-10|||July 2015||2015-07-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Recurrent Pregnancy Loss and Thyroid Disease|Effect of Levothyroxine Treatment on Pregnancy Outcome in RPL Women With Subclinical Hypothyroidism|Enrolling by invitation||Early Phase 1|300|Anticipated|Second Affiliated Hospital of Soochow University||2|||f||||t|t|||||||Undecided||2017-10-10 21:11:33.459601|2017-10-10 21:11:33.459601
NCT03106922|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-04|||April 2016||2016-04-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children|A Randomised, Single-blind, Active Controlled, Multi-centre Trial to Evaluate the Efficacy, Safety, Tolerability, Acceptability and Palatability of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children Aged From 2 to Less Than 6, From 6 to Less Than 12, and Adolescents From 12 to Less Than 18 Years of Age Requiring a Diagnostic Procedure Concerning the Colon|Recruiting||Phase 3|430|Anticipated|Alfa Wassermann S.p.A.||2|||f||||f||||||||No||2017-10-10 21:11:33.58918|2017-10-10 21:11:33.58918
NCT03106909|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-07-17|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Pulmonary CT in Pneumonia Complicating Stroke|Feasibility and Reliability of Pulmonary Computed Tomography as a Radiological Reference Standard for Evaluating Chest X-ray and Candidate Biomarkers in Suspected Pneumonia Complicating Stroke|Recruiting||N/A|60|Anticipated|Salford Royal NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 21:11:33.799215|2017-10-10 21:11:33.799215
NCT03106896|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-04-04|||April 2017|Anticipated|2017-04-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Involvement of Reorganization of Cerebral Functional Connectivity in the Process of Transition to Postherpetic Neuralgia|Involvement of Reorganization of Cerebral Functional Connectivity in the Process of Transition to Postherpetic Neuralgia|Not yet recruiting||N/A|75|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University|||3||f||||||||||||No||2017-10-10 21:11:33.924121|2017-10-10 21:11:33.924121
NCT03106883|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-04-04|||January 30, 2017|Actual|2017-01-30|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Affective Attentional Bias Training In Depression|Affective Attentional Bias Training In Depression: An Eye-Tracking Study|Recruiting||N/A|30|Anticipated|Queen's University||2|||f||||f|f|f||||||No||2017-10-10 21:11:34.004664|2017-10-10 21:11:34.004664
NCT03106870|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-19|2017-04-14||June 2016|Actual|2016-06-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus|Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus and Improving Neonatal Outcome Regarding Birth Weight|Completed||N/A|62|Actual|Ain Shams University||2|||f||||t||||||||No||2017-10-10 21:11:34.129181|2017-10-10 21:11:34.129181
NCT03106857|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-10|||December 2015||2015-12-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|constipation||Effect of Weight Reduction on Constipation|A Proposed Physical Activity and Diet Control to Manage Constipation in Middle Age Obese Women|Completed||N/A|125|Actual|Ahlia University||2|||f||||t|||||f|||Yes|publication|2017-10-10 21:11:34.506903|2017-10-10 21:11:34.506903
NCT03106844|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-27|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||The ICON Study: Outcomes After FMT for Patients With IBD and CDI|The ICON Study: Inflammatory Bowel Disease and Recurrent Clostridium Difficile Infection: Outcomes After Fecal Microbiota Transplantation|Recruiting||Phase 1/Phase 2|50|Anticipated|Brigham and Women's Hospital||1|||f||||f|t|f||||||||2017-10-10 21:11:34.594289|2017-10-10 21:11:34.594289
NCT03106818|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-23|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Postoperative Pain Alleviation in Open Heart Surgery|Postoperative Pain Alleviation in Patients Undergoing Cardiac Surgery; Presternal Local Anesthetic Infiltration Versus Conventional Intravenous Analgesia|Completed||N/A|90|Actual|Assiut University||3|||f||||f|f|f||||||||2017-10-10 21:11:34.802787|2017-10-10 21:11:34.802787
NCT03106805|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-13|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|||Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion|Early (4th Week) Versus Late (6thweek) Interval Postpartum Copper Intrauterine Device Insertion: a Randomized Controlled Trial|Recruiting||N/A|486|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 21:11:34.920228|2017-10-10 21:11:34.920228
NCT03106792|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-11|||July 24, 2017|Anticipated|2017-07-24|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Trial to Evaluate the Effectiveness of Hairfinity on Improving Hair Health and Rate of Growth|A Randomized, Double-blind, Placebo-controlled, 4-arm Parallel Study to Evaluate the Effectiveness of Hairfinity on Improving Hair Health and Rate of Growth|Recruiting||Phase 2|152|Anticipated|Brock Beauty Inc.||4|||f||||f|f|f||||||||2017-10-10 21:11:35.148541|2017-10-10 21:11:35.148541
NCT03106779|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-31|||September 6, 2017|Anticipated|2017-09-06|August 2017|2017-08-01|March 22, 2024|Anticipated|2024-03-22|March 22, 2024|Anticipated|2024-03-22||Interventional|||Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs|A Phase 3, Multi-center, Open-label, Randomized Study of Oral ABL001 Versus Bosutinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated With 2 or More Tyrosine Kinase Inhibitors|Recruiting||Phase 3|222|Anticipated|Novartis||2|||f||||t|t|f||||||||2017-10-10 21:11:35.30991|2017-10-10 21:11:35.30991
NCT03106766|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-28|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|August 14, 2017|Actual|2017-08-14|August 14, 2017|Actual|2017-08-14||Interventional|||Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.|A Single-center, Double-blind, Controlled Study to Evaluate the Effect of Next Science™ Acne Cream on Mild to Moderate Facial Acne in Adult Females Over 6 Months.|Terminated||Early Phase 1|2|Actual|Next Science TM||2||Decision from the Sponsor|f||||f|t|f|||f|||||2017-10-10 21:11:35.443434|2017-10-10 21:11:35.443434
NCT03106753|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-01|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Success of External Cephalic Version Study|Success of External Cephalic Version With Immediate Spinal Anesthesia Versus Spinal Anesthesia When Attempt Without Anesthesia Has Failed: A Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|t|f||||||No||2017-10-10 21:11:35.549145|2017-10-10 21:11:35.549145
NCT03106740|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-11|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|IGNITE||Evaluating the Role of Neuroinflammation in Low Back Pain|Imaging Glia-mediated NeuroInflammation and Treatment Efficacy (the IGNITE Study)|Recruiting||Phase 2|145|Anticipated|Massachusetts General Hospital||3|||||||f|t|f|||f|||||2017-10-10 21:11:35.692326|2017-10-10 21:11:35.692326
NCT03106727|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-03|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|July 31, 2019|Anticipated|2019-07-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Evaluating the Impact of a Community Health Worker Program in Neno, Malawi|Evaluating the Impact of a Community Health Worker Program in Neno, Malawi: A Stepped-Wedge Cluster Randomized Controlled Trial|Recruiting||N/A|122395|Anticipated|Partners in Health||6|||f||||f|f|f||||||No||2017-10-10 21:11:35.826443|2017-10-10 21:11:35.826443
NCT03106714|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-18|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Observational|ZikaBra||Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil|Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil|Recruiting||N/A|1300|Anticipated|Oswaldo Cruz Foundation|||1||f|||||f|f||||Samples With DNA|"     Samples with DNA: whole blood and PBMC Also collected and stored: serum, semen, saliva,     crevicular fluid, urine, vaginal secretions, menstrual blood, rectal swab, tears, sweat and     breast milk   "|||2017-10-10 21:11:35.974876|2017-10-10 21:11:35.974876
NCT03106701|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-10-02|||March 14, 2017|Actual|2017-03-14|October 2017|2017-10-01|November 14, 2017|Anticipated|2017-11-14|October 30, 2017|Anticipated|2017-10-30||Interventional|||Epicardial Ablation in Brugada Syndrome. An Extension Study of 200 BrS.Patients|Epicardial Ablation in 200 Consecutive Brugada Syndrome Patients|Recruiting||N/A|200|Anticipated|IRCCS Policlinico S. Donato||1|||f||||t|f|f||||||||2017-10-10 21:11:36.086823|2017-10-10 21:11:36.086823
NCT03106688|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-04-27|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|December 1, 2022|Anticipated|2022-12-01|December 1, 2022|Anticipated|2022-12-01||Interventional|||Neuromolecular Risk Factors for Obesity (PROSPECT)|Detecting Neuromolecular Risk Factors for Obesity|Recruiting||N/A|60|Anticipated|Turku University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:11:36.201041|2017-10-10 21:11:36.201041
NCT03106675|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-21|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|March 30, 2022|Anticipated|2022-03-30|January 30, 2022|Anticipated|2022-01-30||Interventional|||MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases|MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases|Not yet recruiting||N/A|30|Anticipated|Turku University Hospital||2|||f||||f|f|f||||||Yes|Possible collaboration in the future with Karolinska Institute, Stockholm, during later stages of the study when performing randomized experiments. Data to be shared would be MRI- and CT-data, laboratory results and health-questionnaire results.|2017-10-10 21:11:36.362009|2017-10-10 21:11:36.362009
NCT03106662|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-04-08|||October 2014||2014-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies|Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies|Recruiting||Phase 3|40|Anticipated|Ankara University||1|||f||||t||||||||||2017-10-10 21:11:36.506773|2017-10-10 21:11:36.506773
NCT03106649|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-04|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Echocardiography Based Algorithm for Spinal Anaesthesia|Echocardiography Based Algorithm for Prevention and Treatment of Spinal Hypotension- A Prospective Randomised Controlled Study|Recruiting||N/A|60|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f|f|f||||||No||2017-10-10 21:11:36.637903|2017-10-10 21:11:36.637903
NCT03106441|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-23|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|June 21, 2018|Anticipated|2018-06-21|June 21, 2018|Anticipated|2018-06-21||Interventional|PREOPTI-POOP||Preoxygenation Optimisation in Obese Patients|"PREOPTI-POOP: Preoxygenation Optimisation in Obese Patients: High-flow Nasal Cannula Oxygen Versus Non-invasive Ventilation : A Single-centre Randomized Controlled Study. "|Recruiting||N/A|100|Anticipated|Nantes University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:11:38.43847|2017-10-10 21:11:38.43847
NCT03106636|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-04-14|||February 2014||2014-02-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|KEEP-P||Trial of KEEP-P, a Preventive Intervention for Foster Preschoolers (KEEP-P)|Randomized Trial of KEEP-P, a Preventive Intervention for Foster Preschoolers|Recruiting||N/A|240|Anticipated|University of Oregon||2|||f||||f|f|f||||||Undecided|De-identified IPD data will be shared with other researchers upon completion of the data set as well as completion of a data sharing agreement.|2017-10-10 21:11:36.763647|2017-10-10 21:11:36.763647
NCT03106623|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-25|||April 7, 2017|Actual|2017-04-07|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|August 29, 2017|Actual|2017-08-29||Interventional|||Study of ONO-8577 in Patients With Overactive Bladder|Phase 2a Exploratory, Randomized, Double-blind, Parallel-group Study of ONO-8577 Compared to Combination of Solifenacin Succinate/ Mirabegron for Overactive Bladder|Recruiting||Phase 2|200|Anticipated|Ono Pharmaceutical Co. Ltd||3|||f||||f|f|f||||||||2017-10-10 21:11:37.002969|2017-10-10 21:11:37.002969
NCT03106610|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-07|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy|A Pilot Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy|Recruiting||Phase 1|10|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:11:37.158412|2017-10-10 21:11:37.158412
NCT03106597|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-04|||August 20, 2015|Actual|2015-08-20|April 2017|2017-04-01|December 10, 2018|Anticipated|2018-12-10|December 10, 2018|Anticipated|2018-12-10||Interventional|||Manidipine Versus Amlodipine in Patients With Hypertension|Manidipine Versus Amlodipine in Patients With Hypertension: Effects on Peripheral Edema Evaluated by Bioimpedance Analysis|Recruiting||Phase 4|100|Anticipated|Korea University Guro Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 21:11:37.265816|2017-10-10 21:11:37.265816
NCT03106584|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-04|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|October 1, 2017|Anticipated|2017-10-01|August 31, 2017|Anticipated|2017-08-31||Interventional|MOANi||The Marigot Osteoarthritis Nutritional Intervention (MOANi) Trial|Investigating the Potential for Marigot's Nutrition Supplement to Improve Symptoms and Physical Function in Those With Mild to Moderate Knee Osteoarthritis (KOA) Versus the Current Market Leader (Glucosamine Sulphate)|Not yet recruiting||N/A|30|Anticipated|University College Dublin||2|||f||||t|f|f||||||No||2017-10-10 21:11:37.401234|2017-10-10 21:11:37.401234
NCT03106571|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-09|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|POMA-MA-Ph1||Study of Pomaglumetad and Methamphetamine|Phase 1 Safety-interaction Study of Pomaglumetad Methionil for Methamphetamine Use Disorder|Not yet recruiting||Phase 1|24|Anticipated|University of California, Los Angeles||4|||f||||t|t|f||||||No||2017-10-10 21:11:37.540745|2017-10-10 21:11:37.540745
NCT03106558|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-04|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Post-Market Study of Robotic-Arm Assisted Total Knee Arthroplasty|Post-Market Study of Robotic-Arm Assisted Total Knee Arthroplasty|Enrolling by invitation||N/A|400|Anticipated|Rothman Institute Orthopaedics||2|||f|||||f|t|f|f||||||2017-10-10 21:11:37.651488|2017-10-10 21:11:37.651488
NCT03106545|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-26|||January 2, 2017|Actual|2017-01-02|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|June 26, 2017|Actual|2017-06-26||Interventional|||Liposome Bupivacaine for ANKLE Blocks|Ultrasound-guided Specific Blocks of the Distal Tibial and Deep Peroneal Nerves at the Level of the Ankle With a Mixture of Bupivacaine + Liposome Bupivacaine v Bupivacaine Alone v General Anesthesia|Recruiting||Phase 2|45|Anticipated|New York School of Regional Anesthesia||3|||f||||t|t|f||||||||2017-10-10 21:11:37.744683|2017-10-10 21:11:37.744683
NCT03106532|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-07|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma|A Multicenter, Randomized, Placebo-controlled, Double-blind, Dose-finding Phase 2 Clinical Trial to Evaluate the Efficacy in Reduction of Intraocular Pressure and Safety of PHP-201 in Patients With Normal Tension Glaucoma|Recruiting||Phase 2|138|Anticipated|pH Pharma||3|||f|||||f|f||||||Undecided||2017-10-10 21:11:37.835092|2017-10-10 21:11:37.835092
NCT03106519|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-26|||January 2, 2017||2017-01-02|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|June 28, 2017|Actual|2017-06-28||Interventional|||Liposome Bupivacaine for WRIST Blocks|Distal Extremity (Wrist) Nerve Blocks With a Mixture of Liposome Bupivacaine + Bupivacaine Versus Bupivacaine Alone for Patients Having Dupuytren's Contracture Release: a Blinded Randomized Controlled Trial|Recruiting||Phase 2|34|Anticipated|New York School of Regional Anesthesia||2|||f|||||t|f||||||||2017-10-10 21:11:37.92533|2017-10-10 21:11:37.92533
NCT03106506|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-21|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|July 2016|Actual|2016-07-01||Interventional|||Influence of Connective Tissue Graft Around Implants|Influence of Connective Tissue Graft Placement on the Volume of Soft Tissue Around Implants Placed in Aesthetic Areas. Randomized Controlled Clinical Trial.|Completed||N/A|40|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f|f|f||||||No||2017-10-10 21:11:38.021322|2017-10-10 21:11:38.021322
NCT03106493|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-25|||July 1, 2008|Actual|2008-07-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|Upstate KIDS||Upstate New York Infant Development Screening Program|Upstate New York Infant Development Screening Program|Active, not recruiting||N/A|6171|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||3||f||||f|f|f||||Samples With DNA|"     Plasma, urine, saliva (in subgroup under ongoing future work)   "|Yes|Data will be made available for public use by NIH data sharing system.|2017-10-10 21:11:38.097963|2017-10-10 21:11:38.097963
NCT03106480|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-04-03|||October 6, 2016|Actual|2016-10-06|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|October 2019|Anticipated|2019-10-01||Observational|CICADA||Diabetes Mellitus and HIV Study in Mwanza|Diabetes and Associated Complications in HIV Patients|Recruiting||N/A|1900|Anticipated|National Institute for Medical Research, Tanzania|||1||f||||f|f|f||||Samples Without DNA|"     serum samples   "|No||2017-10-10 21:11:38.178232|2017-10-10 21:11:38.178232
NCT03106467|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-07|||November 11, 2014|Actual|2014-11-11|March 2017|2017-03-01|August 31, 2016|Actual|2016-08-31|June 30, 2016|Actual|2016-06-30||Interventional|PASTA||Practical Advantages of Single-port Over Three-port Laparoscopic Appendectomy in Children|Practical Advantages of Single-port Over Conventional Three-port Laparoscopic Appendectomy in Children: A Randomized Controlled Trial of 400 Cases|Completed||N/A|400|Actual|Hallym University Medical Center||2|||f||||t|f|f||||||Yes||2017-10-10 21:11:38.270699|2017-10-10 21:11:38.270699
NCT03106428|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-18|||March 29, 2017|Actual|2017-03-29|September 2017|2017-09-01|July 7, 2020|Anticipated|2020-07-07|July 7, 2020|Anticipated|2020-07-07||Interventional|||A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies|A Phase 1 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Antitumor Activity of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies|Recruiting||Phase 1|228|Anticipated|MedImmune LLC||3|||f||||t|t|f||||||||2017-10-10 21:11:38.660449|2017-10-10 21:11:38.660449
NCT03106415|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-27|||September 26, 2017|Actual|2017-09-26|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer|Phase I/II Trial of Pembrolizumab in Combination With Binimetinib in Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer|Recruiting||Phase 1/Phase 2|38|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:11:38.793184|2017-10-10 21:11:38.793184
NCT03106402|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-03|||October 1, 2013|Actual|2013-10-01|April 2017|2017-04-01|July 30, 2015|Actual|2015-07-30|June 30, 2015|Actual|2015-06-30||Observational|||Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification|Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification|Completed||N/A|316|Actual|Kyungpook National University|||2||f||||f|f|f||||||Undecided||2017-10-10 21:11:38.902584|2017-10-10 21:11:38.902584
NCT03106389|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-07|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|July 31, 2017|Anticipated|2017-07-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy|Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy: A Randomized Controlled Trial|Recruiting||Phase 4|108|Anticipated|Ain Shams Maternity Hospital||2|||f||||t|f|f|||f|||Yes|Data will be available after publication of the study upon formal request by researchers and research centers that collaborate with Ain Shams Maternity Hospital. Data could be obtained through contacting PI by email.|2017-10-10 21:11:38.978556|2017-10-10 21:11:38.978556
NCT03106376|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Magnetic Resonance Spectroscopy Studies of Acute Hypoxic and Hyperoxic Breathing in Healthy Volunteers|Magnetic Resonance Spectroscopy Studies of Acute Hypoxic and Hyperoxic Breathing in Healthy Volunteers|Not yet recruiting||N/A|12|Anticipated|Mclean Hospital||1|||f||||f|f|f||||||||2017-10-10 21:11:39.093505|2017-10-10 21:11:39.093505
NCT03106363|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-18|||July 4, 2017|Actual|2017-07-04|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||Combined Alcohol and Cannabis Effects on Skills of Young Drivers|Effects of Combined Alcohol and Cannabis on Young Drivers' Simulated Driving|Recruiting||Early Phase 1|70|Anticipated|Centre for Addiction and Mental Health||4|||f||||f|f|f|||f|||||2017-10-10 21:11:39.175009|2017-10-10 21:11:39.175009
NCT03106350|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-07|||March 1, 2015|Actual|2015-03-01|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28|1 Year|Observational [Patient Registry]|||Symptoms Experienced and Quality of Life in Breast Cancer Receiving Radiotherapy|Symptoms Experienced and Quality of Life in Patients With Breast Cancer Receiving Radiotherapy Across One Year|Completed||N/A|103|Actual|Chulabhorn Cancer Center|||1||f||||t|f|f||||||Yes||2017-10-10 21:11:39.314959|2017-10-10 21:11:39.314959
NCT03106337|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-04-13|2017-04-13||January 2010|Actual|2010-01-01|April 2017|2017-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||All enrolled participants.|Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid|A Multivariate Analysis of Factors Predictive of Carcinoma in Follicular Neoplasms of the Thyroid Gland|Completed||N/A|35|Actual|Massachusetts General Hospital||1|||f||||t|f|t|f|f||||No||2017-10-10 21:11:39.404988|2017-10-10 21:11:39.404988
NCT03106324|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-17|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|March 31, 2025|Anticipated|2025-03-31|March 31, 2025|Anticipated|2025-03-31|8 Years|Observational [Patient Registry]|||A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant|"A Prospective Non-interventional Post-authorization Safety Study (PASS) of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant (Transplant Noneligible [TNE])"|Recruiting||N/A|888|Anticipated|Celgene|||2||f||||f|f|f||||||||2017-10-10 21:11:39.602457|2017-10-10 21:11:39.602457
NCT03106311|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-07|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|July 7, 2017|Actual|2017-07-07|June 29, 2017|Actual|2017-06-29||Interventional|||The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes|Use of Beta Subunit of Human Chorionic Gonadotropin Assay as a Diagnostic Tool for Premature Rupture of Membranes|Completed||N/A|100|Actual|Cairo University||2|||f||||f|f|f||||||||2017-10-10 21:11:39.805869|2017-10-10 21:11:39.805869
NCT03106298|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-04|||December 18, 2015|Actual|2015-12-18|April 2017|2017-04-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|INDIGO||Iron Deficiency and FGF23 Regulation in CKD and HF|Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure|Recruiting||N/A|60|Anticipated|Northwestern University|||1||f||||f|t|f|||f|Samples Without DNA|"     Serum and plasma samples will be processed and stored in the study freezers with a     de-identified study number and collection date.   "|No|Individual participant data will not be shared with other researchers|2017-10-10 21:11:39.895702|2017-10-10 21:11:39.895702
NCT03106285|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-10|||April 14, 2017|Anticipated|2017-04-14|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Effectiveness of Probiotic Supplementation on Crying Time in Infantile Colic|Effectiveness of Lactobacillus Reuteri DSM17938 Supplementation on Crying Time in Infantile Colic|Not yet recruiting||N/A|60|Anticipated|BioGaia AB||2|||f||||f|f|f||||||No||2017-10-10 21:11:40.01474|2017-10-10 21:11:40.01474
NCT03106272|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-17|||April 13, 2017|Actual|2017-04-13|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|||Evaluating the AMH Levels During Natural Cycle|Anti-Mullerian Hormone Dynamics During Natural Cycle Using Automated Assay|Recruiting||N/A|30|Anticipated|IVI Middle East Fertility Clinic|||1||f||||f|f|f||||Samples With DNA|"     Anonymized samples will be obtained, nurses are those charged with patient blood extraction     by venipuncture from a vein in the arm.   "|||2017-10-10 21:11:40.10674|2017-10-10 21:11:40.10674
NCT03106259|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-31|||June 29, 2016|Actual|2016-06-29|August 2017|2017-08-01|March 21, 2021|Anticipated|2021-03-21|January 24, 2017|Actual|2017-01-24||Observational|||Assess the Safety of FURESTEM-RA Lnj. In Patients With Moderate to Severe Rheumatoid Arthritis|Observational Study to Evaluate the Safety of FURESTEM-RA Lnj. in Moderate to Severe Rheumatoid Arthritis Patients Who Participated in Phase 1 Clinical Trial of FURESTEM-RA Lnj|Active, not recruiting||N/A|9|Actual|Kang Stem Biotech Co., Ltd.|||1||f||||t|f|f||||||||2017-10-10 21:11:40.206819|2017-10-10 21:11:40.206819
NCT03106246|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-04|||December 2016||2016-12-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||Circulating Extracellular Vesicles Released by Human Islets of Langerhans|Immune Response to Extracellular Vesicles Released by Human Islets of Langerhans|Recruiting||N/A|100|Anticipated|McGill University Health Center|||5||f||||f||||||Samples With DNA|"     Peripheral blood samples. Cellular component will be retained for studies using subject     specific peripheral blood mononuclear cells. EV will be purified from plasma and also     retained separately.   "|No||2017-10-10 21:11:40.303697|2017-10-10 21:11:40.303697
NCT03106233|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-04-03|||September 2012|Actual|2012-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction|The Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction: A Prospective Analysis of 138 Flaps|Completed||N/A|86|Actual|Maastricht University Medical Center|||1||f||||f|f|f||||||Undecided||2017-10-10 21:11:41.057414|2017-10-10 21:11:41.057414
NCT03106220|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Exercise Intervention - and Impact on Hospitalization|Exercise Intervention and Its Impact on Hospitalization - a Mulitcentered Study|Recruiting||N/A|32|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||No||2017-10-10 21:11:41.145156|2017-10-10 21:11:41.145156
NCT03106207|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-04-04|||October 1, 2013|Actual|2013-10-01|April 2017|2017-04-01|December 5, 2016|Actual|2016-12-05|October 1, 2015|Actual|2015-10-01||Interventional|||Preoperative and Postoperative Endoscopic Alterations in Patients Submitted to Gastric Bypass Without a Ring|Prospective Single-center Study to Evaluate Preoperative and Postoperative Endoscopic Alterations in Patients Submitted to Gastric Bypass Without a Ring.|Completed||N/A|30|Actual|Kaiser Clinic and Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:11:41.248052|2017-10-10 21:11:41.248052
NCT03106194|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-12|||July 2016||2016-07-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CM-HCV||Case Management in HCV Infected PWID|Case Management in Hepatitis C Virus Infected People Who Inject Drugs in Belgium|Recruiting||N/A|300|Anticipated|Hasselt University||1|||f||||f||||||||Undecided||2017-10-10 21:11:41.333365|2017-10-10 21:11:41.333365
NCT03106181|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-07|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 1, 2019|Anticipated|2019-12-01|May 31, 2019|Anticipated|2019-05-31||Interventional|||A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent|A Randomised Controlled Trial of Cataract Surgery Versus Combined Cataract Surgery With Insertion of iStent Inject®|Not yet recruiting||N/A|100|Anticipated|Center for Eye Research Australia||2|||f||||f|f|f||||||No||2017-10-10 21:11:41.433999|2017-10-10 21:11:41.433999
NCT03106168|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-11|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Evaluation of Anesthetic Efficacy in Extraction on Mandibular Molars|Evaluation of Anesthetic Efficacy in Extraction on Mandibular Molars With Periapical Granuloma|Recruiting||N/A|80|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||||2017-10-10 21:11:41.515551|2017-10-10 21:11:41.515551
NCT03106155|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-27|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|[SUKSES-D]||Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification|Phase II, Single-arm Study of Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification(SUKSE-D)|Recruiting||Phase 2|28|Anticipated|Samsung Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:11:41.613113|2017-10-10 21:11:41.613113
NCT03106142|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-05-02|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|November 2014|Actual|2014-11-01||Interventional|||Knee Osteoarthritis Care: A Quality Improvement Intervention in General Practice|Improving Current General Practitioners Care: Feasibility and Effectiveness of a Simple Educational Intervention. Knee Osteoarthritis Care: a Quality Improvement in General Practice|Completed||N/A|177|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 21:11:41.694384|2017-10-10 21:11:41.694384
NCT03106129|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||February 9, 2017|Actual|2017-02-09|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|February 28, 2019|Anticipated|2019-02-28||Observational|||Opioid Requirements Post Discharge of Patients Having Total Knee Arthroplasty (TKA)|Opioid Requirements Post Discharge of Patients Having Total Knee Arthroplasty (TKA)|Recruiting||N/A|200|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f|f|f||||||No||2017-10-10 21:11:41.777702|2017-10-10 21:11:41.777702
NCT03106116|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|EECPVF||Efficacy of Enhanced External Counterpulsation on Ventricular Function|A Prospective, Randomized Study of Enhanced External Counterpulsation Therapy on Ventricular Function in Patients With Coronary Heart Disease|Recruiting||N/A|150|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||No||2017-10-10 21:11:41.868007|2017-10-10 21:11:41.868007
NCT03106103|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-04-04|||February 2009||2009-02-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01|1 Year|Observational [Patient Registry]|||Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women|Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study With or Without Antibiotic Prophylaxis in Women With Urinary Incontinence|Completed||N/A|217|Actual|Federal University of São Paulo|||1||f||||t||||||||||2017-10-10 21:11:41.962272|2017-10-10 21:11:41.962272
NCT03106090|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-17|||April 19, 2017|Actual|2017-04-19|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Studying Survivorship Care Plans in Head and Neck Cancer|Comparison of Enhanced Survivorship Care Plans in a Head and Neck Cancer Clinic to Standard of Care|Recruiting||N/A|90|Anticipated|Duke University||3|||f||||f|f|f||||||No||2017-10-10 21:11:42.025916|2017-10-10 21:11:42.025916
NCT03102801|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-03-30|||December 2016||2016-12-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes|A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes|Recruiting||N/A|50|Anticipated|University of Hull||2|||f||||||||||||||2017-10-10 21:12:14.028532|2017-10-10 21:12:14.028532
NCT03106077|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-25|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Mirvetuximab Soravtansine in Localized Triple-Negative Breast Cancer (TNBC)|Women's Triple-Negative First-Line Study: A Phase II Trial of Mirvetuximab Soravtansine in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy (NACT), Including a Lead-in Cohort to Establish Activity in Patients With Metastatic TNBC|Recruiting||Phase 2|57|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:11:42.1208|2017-10-10 21:11:42.1208
NCT03106064|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-12|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Independence in Self Care - A Program Focused on Nursing Care|Independence in Self Care - A Program Focused on Nursing Care|Recruiting||N/A|158|Anticipated|Centro Hospitalar do Porto||2|||f|||||f|f||||||||2017-10-10 21:11:42.213375|2017-10-10 21:11:42.213375
NCT03106051|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-04|||February 18, 2016|Actual|2016-02-18|March 2017|2017-03-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|LAPIS-PsA||Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions|Long-term Documentation on the Use of Apremilast in Patients With Psoriatic Arthritis in Practice Conditions|Recruiting||N/A|500|Anticipated|Celgene|||1||f||||f||f||||||No||2017-10-10 21:11:42.299554|2017-10-10 21:11:42.299554
NCT03106038|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-16|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Dose-escalation Study of a Contrast Agent for Delineation of Urological Anatomy in Minimally Invasive Surgery|A Phase I/IIa Dose-escalation Study to Evaluate the Use of an Investigational Imaging Agent for the Detection of Urologic Anatomy Via Near Infrared Fluorescence Imaging in the Setting of Minimally Invasive Surgery|Recruiting||Phase 1/Phase 2|32|Anticipated|Li-Cor, Inc.||1|||f||||t|t|f||||||Undecided||2017-10-10 21:11:42.388747|2017-10-10 21:11:42.388747
NCT03106025|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-22|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|RDOcularUS||Use of Ocular Point of Care Ultrasound in Diagnosing Retinal Detachment in the Emergency Department|Use of Ocular Point of Care Ultrasound in Diagnosing Retinal Detachment in the Emergency Department: A Prospective Study.|Not yet recruiting||N/A|100|Anticipated|Loma Linda University||1|||f||||t|f|t|f|f|t|||||2017-10-10 21:11:42.456587|2017-10-10 21:11:42.456587
NCT03106012|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-04-04|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Role of Hysterolaparoscopy in Infertile Patients With Normal Hysterosalpingography|The Value of Diagnostic Hysterolaparoscopy in Infertile Patients With Normal Hysterosalpingography|Recruiting||N/A|80|Anticipated|Cairo University||1|||f||||t|f|f||||||No||2017-10-10 21:11:42.540227|2017-10-10 21:11:42.540227
NCT03105999|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-03|||February 1, 2016|Actual|2016-02-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|STORICO||Observational Study On The Characterization Of 24-Hour Symptoms In Patients With COPD|Observational Study On The Characterization Of 24-Hour Symptoms In Patients With COPD|Recruiting||N/A|600|Anticipated|Laboratori Guidotti S.p.A.|||1||f|||||f|f||||||||2017-10-10 21:11:42.615719|2017-10-10 21:11:42.615719
NCT03105986|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-08-14|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Interventional|||A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adults|A Phase 1, Randomized, Open-label, Crossover Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adult Subjects|Completed||Phase 1|18|Actual|Janssen-Cilag International NV||2|||f||||f|f|f||||||||2017-10-10 21:11:42.740993|2017-10-10 21:11:42.740993
NCT03105973|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Technology Enabled Mental Health Intervention for Individuals in the Criminal Justice System|Technology Enabled Mental Health Intervention for Individuals in the Criminal Justice System|Not yet recruiting||N/A|65|Anticipated|Jail Education Solutions, Inc.||1|||f||||t|f|f||||||No||2017-10-10 21:11:42.808551|2017-10-10 21:11:42.808551
NCT03105960|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-04|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|June 1, 2017|Anticipated|2017-06-01|June 1, 2017|Anticipated|2017-06-01||Interventional|mouthwash||Garlic With Lime Juice and Chlorhexidine Mouthwash|Evaluation of Garlic With Lime Juice and Chlorhexidine Mouthwash on Gingival Bleeding in Group of Egyptian Children: A Randomized Clinical Trial|Enrolling by invitation||N/A|36|Anticipated|Cairo University||2|||f||||f|f|f|||f|||No|it will be available when it finish|2017-10-10 21:11:42.868966|2017-10-10 21:11:42.868966
NCT03105947|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-07|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|COB||Trial of Different Dietary Fats on Blood Lipids and Metabolic Measures in Healthy Participants|Randomized Trial of Coconut Oil, Butter or Olive Oil on Blood Lipids and Metabolic Measures in Healthy Participants|Not yet recruiting||N/A|90|Anticipated|University of Cambridge||3|||f||||f|f|f||||||Yes|Anonymised IPD data from the trial will be available at the end of the study with publication of the results, through contact with the principal investigator|2017-10-10 21:11:43.067385|2017-10-10 21:11:43.067385
NCT03105934|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension|Repeatability of Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IV-US) in Pulmonary Arterial Hypertension|Recruiting||N/A|15|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||f|f|f||||||||2017-10-10 21:11:43.19902|2017-10-10 21:11:43.19902
NCT03105921|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-10|||October 24, 2014|Actual|2014-10-24|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma|Intérêt de l'électroporation irréversible Dans le Traitement de l'adénocarcinome du pancréas|Recruiting||N/A|20|Anticipated|Poitiers University Hospital||1|||f|||||f|f||||||||2017-10-10 21:11:43.305536|2017-10-10 21:11:43.305536
NCT03105908|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-15|||March 16, 2017|Actual|2017-03-16|August 2017|2017-08-01|October 10, 2018|Anticipated|2018-10-10|October 10, 2018|Anticipated|2018-10-10||Interventional|iACT||Internet-delivered ACT for Chronic Pain|Internet-delivered ACT Treatment for Patients With Chronic Pain: A Randomized Controlled Trial|Active, not recruiting||N/A|113|Actual|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 21:11:43.454249|2017-10-10 21:11:43.454249
NCT03105895|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-08|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01|24 Months|Observational [Patient Registry]|VISIBLE||Prevention of Incisional Hernia With an Onlay Mesh Visible on MRI|Multicenter Study on Prevention of Incisional Hernia After Laparotomy With an Onlay Mesh Visible on MRI|Enrolling by invitation||N/A|200|Anticipated|Henares University Hospital|||1||f||||f|f|f||||||Yes|This is study to watch the behavior of an onlay mesh for incisional hernia prevention after laparotomy|2017-10-10 21:11:43.566748|2017-10-10 21:11:43.566748
NCT03105882|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-24|||March 30, 2017|Actual|2017-03-30|August 2017|2017-08-01|April 2027|Anticipated|2027-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pilot Study of the Neuro-Spinal Scaffold for the Treatment of AIS A Cervical Acute SCI|Pilot Study of Clinical Safety and Feasibility of the Neuro-Spinal Scaffold for the Treatment of Complete (AIS A) Traumatic Acute Spinal Cord Injury at the C5 - T1 Neurological Levels|Active, not recruiting||N/A|10|Anticipated|InVivo Therapeutics||1|||f||||t|f|t|t|f||||||2017-10-10 21:11:43.706726|2017-10-10 21:11:43.706726
NCT03105869|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-06-23|||December 16, 2014|Actual|2014-12-16|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium|Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium|Completed||N/A|20|Actual|Poitiers University Hospital||1|||f||||f|f|f|||f|||No||2017-10-10 21:11:43.816733|2017-10-10 21:11:43.816733
NCT03105856|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-04-03|||January 3, 2017|Actual|2017-01-03|April 2017|2017-04-01|February 28, 2019|Anticipated|2019-02-28|September 1, 2017|Anticipated|2017-09-01||Interventional|FASTER||FASTER-Tlalpan Study|HPV Vaccination Impact on Cervical Cancer Screening Program: FASTER-Tlalpan Study in Mexico|Active, not recruiting||Phase 4|18000|Anticipated|Instituto Nacional de Salud Publica, Mexico||3|||f||||f||||||||||2017-10-10 21:11:43.90096|2017-10-10 21:11:43.90096
NCT03105843|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-09|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|August 31, 2018|Anticipated|2018-08-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Hypertonic Saline|Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Hypertonic Saline in Individuals With Cough Variant Asthma and Chronic Cough|Not yet recruiting||Phase 4|30|Anticipated|Queen's University||3|||f||||f|t|f|||f|||No||2017-10-10 21:11:44.035809|2017-10-10 21:11:44.035809
NCT03105830|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-04-07|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 20, 2018|Anticipated|2018-04-20||Interventional|||Pain Management at Latent Period of Labour|Pain Management Efficiency at Latent Period of Labour|Not yet recruiting||N/A|150|Anticipated|Western Galilee Hospital-Nahariya||1|||f||||t|f|f||||||Undecided||2017-10-10 21:11:44.175648|2017-10-10 21:11:44.175648
NCT03105804|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-07-19|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes|CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes|Active, not recruiting||N/A|140|Anticipated|RAI Services Company||4|||f||||f|f|f||||||||2017-10-10 21:11:44.383776|2017-10-10 21:11:44.383776
NCT03105791|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Effect of Patient Education on Opioid Consumption||Completed||N/A|140|Actual|Rothman Institute Orthopaedics||2|||f|||||f|f||||||||2017-10-10 21:11:44.494401|2017-10-10 21:11:44.494401
NCT03105778|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Point of Care Precision and Sample Comparison Study of Minicare BNP at Innsbruck Hospital - MI-BNP-CE04-AN2016|Point of Care Precision and Sample Comparison Study of Minicare BNP at Innsbruck Hospital - MI-BNP-CE04-AN2016|Recruiting||N/A|100|Anticipated|Philips Handheld Diagnostics|||1||f|||||f|f||||Samples Without DNA|"     plasma samples will be retained for future research purposes   "|Undecided|Data outcome of study may be included in publication|2017-10-10 21:11:44.592774|2017-10-10 21:11:44.592774
NCT03105765|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-04-03|||January 2011||2011-01-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2014|Actual|2014-08-01||Interventional|||Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.|Effects of Prophylactic Administration of Ketamine on Acute and Chronic Pain After Thoracotomy for Lung Cancer, a Double Blind Randomised Trial.|Completed||N/A|200|Actual|Dr. Horst Schmidt Klinik GmbH||2|||f||||f||||||||||2017-10-10 21:11:44.739259|2017-10-10 21:11:44.739259
NCT03105752|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of Readability of Consent Forms on the Understanding of the Information Received by Volunteers|Evaluation of the Readability of Information and Consent Forms on the Understanding of the Information Received by Participants in Biomedical Research|Completed||N/A|240|Actual|Groupe Hospitalier Pitie-Salpetriere||1|||f||||f|f|||||||No||2017-10-10 21:11:44.843561|2017-10-10 21:11:44.843561
NCT03105739|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-03|||October 5, 2016||2016-10-05|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|March 29, 2017|Actual|2017-03-29||Interventional|||Timing of Withdrawal of the Laryngeal Mask Airway (LMA) in Children|Timing of Withdrawal of the Laryngeal Mask Airway (LMA) in Children: Early or Late Removal?|Completed||N/A|148|Actual|Hôpital d'enfants Béchir-Hamza||2|||f||||f|f|f||||||No||2017-10-10 21:11:44.929272|2017-10-10 21:11:44.929272
NCT03105726|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-25|||November 2010|Actual|2010-11-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Observational|MEVADE||Medical Care Versus Ventricular Assist Device for the Management of End-stage Heart Failure (MEVADE)|Medical Care Versus Ventricular Assist Device in Patients With NYHA Class IV Congestive Heart Failure: a Non Randomized Comparison of Clinical and Economic Outcomes|Completed||N/A|224|Actual|Groupe Hospitalier Pitie-Salpetriere|||2||f||||f|f|f||||||No||2017-10-10 21:11:45.028016|2017-10-10 21:11:45.028016
NCT03026647|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-21|||January 31, 2017|Actual|2017-01-31|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Observational|||Suture Material for Closure of Hysterotomy|Evaluation of Suture Material for Closure of Hysterotomy|Withdrawn||N/A|0|Actual|St. Louis University|||1|Not moving forward staff shortage|f||||f|f|f||||||||2017-10-10 21:26:31.701109|2017-10-10 21:26:31.701109
NCT03105713|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-29|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|September 2019|Anticipated|2019-09-01||Interventional|PASC||Development and Implementation of Patient Safety Checklists Before, During and After In-hospital Surgery|Development and Implementation of Surgical Safety Checklists for Patients to Use Before Admission, Before Discharge and After Discharge (PASC) - a Stepped Wedge Cluster Randomized Controlled Trial|Active, not recruiting||N/A|4400|Anticipated|Haukeland University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:11:45.127599|2017-10-10 21:11:45.127599
NCT03105700|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-03|||November 2015||2015-11-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|LFTMS TLE||Low Frequency TMS for Depression in Epilepsy|Safety and Feasibility of Accelerated Low-Frequency Transcranial Magnetic Stimulation for Medication-Resistant Depression in Patients With Temporal Lobe Epilepsy|Recruiting||N/A|20|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||No|Individual participant data will be de-identified and then available upon request from PI.|2017-10-10 21:11:45.228096|2017-10-10 21:11:45.228096
NCT03105687|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-07-18|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|SPPA||Effectiveness of SMS Reminders of Blood Pressure-lowering Drugs Intake|A Multicenter, Assessor-blinded, Controlled, Randomised, Parallel Group, Superiority, Pragmatic Trial Assessing the Effectiveness of Daily SMS-reminders in Pharmaceutical Care of Older Adults With Hypertension on Improving Patients' Adherence to Blood Pressure-lowering Medication|Recruiting||N/A|300|Anticipated|Comenius University||2|||f||||f|f|f||||||||2017-10-10 21:11:45.351037|2017-10-10 21:11:45.351037
NCT03105674|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-07-21|||May 1, 2017|Anticipated|2017-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Multi-Drug Analgesia vs. Standard Solution for Anal Surgery|Multi-drug Analgesia Versus Standard Solution for Perianal Block - A Prospective Study to Determine the Efficacy, Cost and Narcotic Consumption in the Post-operative Period|Withdrawn||Phase 4|0|Actual|Columbia University||2||Not yet IRB approved and PI will be leaving institution in September.|f||||f|t|f||||||||2017-10-10 21:11:45.532234|2017-10-10 21:11:45.532234
NCT03105661|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-12|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|March 4, 2019|Anticipated|2019-03-04|March 4, 2018|Anticipated|2018-03-04||Interventional|||Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients|Use of Impedance Cardiography to Decrease the Risk of Preeclampsia in Obese Patients|Recruiting||Early Phase 1|400|Anticipated|University of Tennessee Graduate School of Medicine||2|||f||||t|t|f|||t|||Yes|Present at national medical conference and publish in medical journal|2017-10-10 21:11:45.621877|2017-10-10 21:11:45.621877
NCT03105648|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||July 1, 2016|Actual|2016-07-01|April 2017|2017-04-01|April 20, 2026|Anticipated|2026-04-20|April 20, 2026|Anticipated|2026-04-20||Observational|||Diagnostic and Prognostic Significance of Computerized Cytologic Morphometry of the Thyroid Neoplasm|Diagnostic and Prognostic Significance of Computerized Cytologic Morphometry of the Thyroid Neoplasm|Recruiting||N/A|1000|Anticipated|National Taiwan University Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:11:45.734551|2017-10-10 21:11:45.734551
NCT03105635|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-20|||May 18, 2017|Actual|2017-05-18|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||ARC -Access to Resources in the Community|ARC - Access to Resources in the Community/Accès Aux Ressources Communautaires|Active, not recruiting||N/A|468|Anticipated|Ottawa Hospital Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:11:45.833392|2017-10-10 21:11:45.833392
NCT03105622|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-07-18|||April 15, 2017|Actual|2017-04-15|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Exercising With a Screen or Music and Post-exercise Energy Compensation in Adolescents|Does Exercising With a Screen or Music Lead to Post-exercise Energy Compensation in Adolescents?|Recruiting||N/A|25|Anticipated|Children's Hospital of Eastern Ontario||3|||f||||f|f|f||||||||2017-10-10 21:11:45.918573|2017-10-10 21:11:45.918573
NCT03105609|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-07-30|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging|Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging|Recruiting||N/A|100|Anticipated|Center for Eye Research Australia|||1||f||||f|f|f||||||||2017-10-10 21:11:46.027637|2017-10-10 21:11:46.027637
NCT03105596|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-09|||April 11, 2017|Anticipated|2017-04-11|April 2017|2017-04-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)|Study of Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)|Not yet recruiting||Phase 2|46|Anticipated|Peking University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:11:46.132313|2017-10-10 21:11:46.132313
NCT03105583|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-08-18|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|April 2017|Actual|2017-04-01||Observational|PREVIM||A Cross-sectional Study Evaluating Pregnancy Related Use of Vitamins and Medication|A Cross-sectional Study Evaluating Pregnancy Related Use of Vitamins and Medication|Enrolling by invitation||N/A|381|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-10 21:11:46.209052|2017-10-10 21:11:46.209052
NCT03105570|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-09|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2024|Anticipated|2024-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|||The Oncological Safety and Cosmetic Outcome of Areola Sparing Mastectomy : a Single Arm, Prospective, Cohort Study|The Oncological Safety and Cosmetic Outcome of Areola Sparing Mastectomy : a Single Arm, Prospective, Cohort Study|Not yet recruiting||N/A|145|Anticipated|Peking University People's Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:11:46.277476|2017-10-10 21:11:46.277476
NCT03105557|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-11|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Rickets Device - Feasibility Study|Rachitis Device Study|Not yet recruiting||N/A|10|Anticipated|Capturin Distribution B.V.|||1||f||||t||||||||||2017-10-10 21:11:46.38735|2017-10-10 21:11:46.38735
NCT03105544|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-04-03|||July 2016||2016-07-01|April 2017|2017-04-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Improving Detection of Fetuses at Risk - Who Needs Systematic Training?|Improving Detection of Fetuses at Risk - Who Needs Systematic Training?|Recruiting||N/A|70|Anticipated|Copenhagen Academy for Medical Education and Simulation||2|||f||||f|f|f||||||Undecided||2017-10-10 21:11:46.47291|2017-10-10 21:11:46.47291
NCT03105531|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-19|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|April 2022|Anticipated|2022-04-01|April 2020|Anticipated|2020-04-01||Observational|PRIMAL||Screening for Primary Aldosteronism in a Population of Patients With Hypertension|Screening for Primary Aldosteronism in a Population of Patients With Hypertension|Recruiting||N/A|1200|Anticipated|Uppsala University|||1||f||||f|f|f||||Samples With DNA|"     Blood samples from patients with documented primary aldosteronism are going to be (with the     patients informed conscent) obtained to be stored in Uppsala Biobank for future scientific     purposes.   "|Undecided||2017-10-10 21:11:46.614566|2017-10-10 21:11:46.614566
NCT03105505|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-19|||April 28, 2017|Anticipated|2017-04-28|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Efficacy of Permethrin 5% Treatment for Demodex - Blepharitis in Comparison to Fucithalmic (Fusidic Acid 1%) and Synthomycine 5%|The Efficacy Of Lyclear (Permethrin 5%) Vs Fusidic Acid1% and Synthomycine 5% for Demodex -Blepharitis Treatment, Prospective-Randomized Trial.|Enrolling by invitation||Phase 4|75|Anticipated|Barzilai Medical Center||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:11:46.821254|2017-10-10 21:11:46.821254
NCT03105479|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-08-16|||April 14, 2017|Actual|2017-04-14|August 2017|2017-08-01|March 22, 2021|Anticipated|2021-03-22|March 2, 2021|Anticipated|2021-03-02||Interventional|||Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)|A Prospective, Multicenter Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Cadazolid Versus Vancomycin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea|Recruiting||Phase 2/Phase 3|200|Anticipated|Actelion||7|||f||||t|t|f||||||||2017-10-10 21:11:46.979713|2017-10-10 21:11:46.979713
NCT03105466|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-04-07|||February 2016||2016-02-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea|Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea|Recruiting||N/A|50|Anticipated|Zhongshan Ophthalmic Center, Sun Yet-sen University||1|||f||||||||||||||2017-10-10 21:11:47.126828|2017-10-10 21:11:47.126828
NCT03105453|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-03|||September 2016||2016-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)|The Microbiome in Subfertility and Assisted Reproductive Technologies|Recruiting||N/A|300|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||f||||||Samples Without DNA|"     Microbiome analysis using 16S ribosomal RNA sequencing   "|Undecided||2017-10-10 21:11:47.210137|2017-10-10 21:11:47.210137
NCT03105440|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-04-17|||January 2013||2013-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|April 2017|Actual|2017-04-01||Interventional|||Innovation Oncological Rehabilitation: Applicability of the Different Techniques Physiotherapeutic Post Breast Cancer|Innovation Oncological Rehabilitation: Applicability of the Different Techniques Physiotherapeutic Post Breast Cancer|Recruiting||N/A|6|Anticipated|Universidade do Vale do Paraíba||6|||f||||f||||||||No||2017-10-10 21:11:47.29828|2017-10-10 21:11:47.29828
NCT03105427|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-04|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Observational|LeukoCAPE-2||Leukocytes and Cardiovascular Perioperative Events-2|Assoziationen Von Leukozyten-Sub-Populationen im Blut kardiovaskulärer Risikopatienten Mit Der Inzidenz Perioperativer kardiovaskulärer Ereignisse|Recruiting||N/A|233|Anticipated|University Hospital Heidelberg|||1||f||||f||||||Samples Without DNA|"     Plasma   "|No||2017-10-10 21:11:49.598706|2017-10-10 21:11:49.598706
NCT03105414|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-05-08|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2018|Anticipated|2018-05-15||Observational|INCIPAVE||INCIPAVE Study: Incidence of Ventilator Acquired Pneumonia in Children|Etude INCIPAVE: INCidence Des Pneumopathies Acquises Sous Ventilation Chez l'Enfant|Recruiting||N/A|2100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||Undecided||2017-10-10 21:11:49.684255|2017-10-10 21:11:49.684255
NCT03105401|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-04-04|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|HALLUPARK||Phenomenological and Psychopathological Factors Associated to Hallucinations in Parkinson's Disease|Phenomenological and Psychopathological Factors Associated to Hallucinations in Parkinson's Disease|Not yet recruiting||N/A|80|Anticipated|Hospices Civils de Lyon|||1||f|||||f|f||||||||2017-10-10 21:11:49.757311|2017-10-10 21:11:49.757311
NCT03105388|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-02|||March 1, 2015|Actual|2015-03-01|March 2017|2017-03-01|October 1, 2016|Actual|2016-10-01|February 29, 2016|Actual|2016-02-29||Observational|||STOP-BANG and Cephalometry in Prediction of Difficult Airway in Patients at Risk of OSA|STOP-BANG Score and Cephalometry in Prediction of Difficult Airway in Patients at Risk of Obstructive Sleep Apnoea|Completed||N/A|41|Actual|University of Science Malaysia|||1||f||||f|f|f||||||No||2017-10-10 21:11:49.833787|2017-10-10 21:11:49.833787
NCT03105375|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-07|||February 21, 2017|Actual|2017-02-21|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Healthy Subjects|Recruiting||Early Phase 1|36|Anticipated|Cinclus Pharma AG||3|||f||||t|f|f||||||No||2017-10-10 21:11:49.940291|2017-10-10 21:11:49.940291
NCT03105362|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-08-15|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome|Tolerability of an Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome|Recruiting||N/A|5|Anticipated|Boston Children’s Hospital||1|||f||||f|f|f||||||||2017-10-10 21:11:50.118544|2017-10-10 21:11:50.118544
NCT03105349|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-07-31|||July 1, 2017|Anticipated|2017-07-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|C-RESCUE||A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A|A Phase III, Open Label, Multicentric Clinical Trial of a Single Arm of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotype 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A|Withdrawn||Phase 4|0|Actual|Fundacion SEIMC-GESIDA||1||No availability of investigational medication.|f||||f|f|f||||||||2017-10-10 21:11:50.224125|2017-10-10 21:11:50.224125
NCT03105323|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-06|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome|Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome|Not yet recruiting||N/A|40|Anticipated|Ain Shams Maternity Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:11:50.545235|2017-10-10 21:11:50.545235
NCT03105310|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-04-03|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D|Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D|Active, not recruiting||Phase 2|20|Anticipated|Aga Khan University||2|||f||||t|t|f|||f|||No||2017-10-10 21:11:50.629423|2017-10-10 21:11:50.629423
NCT03105284|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-07|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction|Adipose-tissue Derived Stem Cells: Characterization of Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction|Enrolling by invitation||N/A|20|Anticipated|University of Aarhus||2|||f|||||f|f||||||||2017-10-10 21:11:50.829498|2017-10-10 21:11:50.829498
NCT03105271|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-06|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Acute Kidney Injury in Patients With Sickle Cell Disease|Acute Kidney Injury in Patients With Sickle Cell Disease|Recruiting||N/A|60|Anticipated|University of Alabama at Birmingham|||1||f||||f|f|f||||Samples Without DNA|"     Urine and blood will be stored in biorepository.   "|No||2017-10-10 21:11:50.914026|2017-10-10 21:11:50.914026
NCT03105245|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-02|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|March 30, 2019|Anticipated|2019-03-30|March 30, 2019|Anticipated|2019-03-30||Interventional|||Understanding How Anaesthesia Affects ECT Outcomes|Understanding How Anaesthesia Affects ECT Outcomes|Recruiting||Phase 3|72|Anticipated|The University of New South Wales||4|||f||||f|f|f|||f|||No||2017-10-10 21:11:51.022544|2017-10-10 21:11:51.022544
NCT03105232|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-07|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Observational|ORS||Opioid-Redox Study|Opioid-Redox Study|Recruiting||N/A|300|Anticipated|Pavol Jozef Safarik University|||4||f||||f|f|f|||f|||No||2017-10-10 21:11:51.122852|2017-10-10 21:11:51.122852
NCT03105219|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|May 30, 2021|Anticipated|2021-05-30|May 30, 2021|Anticipated|2021-05-30||Interventional|BENCH||IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease|IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease|Not yet recruiting||Phase 3|770|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t|t|f|||t|||||2017-10-10 21:11:51.209652|2017-10-10 21:11:51.209652
NCT03105206|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-05-20|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||A Multicenter Prospective Research on the Treatment of Low Pole Renal Calculus by Flexible Ureteroscope|A Multicenter Prospective Research on the Treatment of Low Pole Renal Calculus by Flexible Ureteroscope|Not yet recruiting||N/A|1100|Anticipated|Changhai Hospital|||1||f||||||||||||||2017-10-10 21:11:51.304832|2017-10-10 21:11:51.304832
NCT03105193|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-06|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|October 30, 2018|Anticipated|2018-10-30|August 1, 2018|Anticipated|2018-08-01||Interventional|||Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections|Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections|Not yet recruiting||Phase 4|60|Anticipated|University of Auckland, New Zealand||2|||f||||t|t|f|||f|||No||2017-10-10 21:11:51.421072|2017-10-10 21:11:51.421072
NCT03105180|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-03|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29||Observational|||Irrigating Fluid and Blood Coagulation|The Effect of a Mixture of 2.7% Sorbitol-0.54% Mannitol Solution on Blood Coagulation: In-vitro, Observational Healthy-volunteer Study Using Rotational Thromboelastometry (ROTEM®)|Completed||N/A|12|Actual|Seoul National University Bundang Hospital|||4||f||||f|f|f||||||No||2017-10-10 21:11:51.523028|2017-10-10 21:11:51.523028
NCT03105167|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-06|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|December 13, 2021|Anticipated|2021-12-13|December 13, 2020|Anticipated|2020-12-13||Interventional|||Cortical Bone Trajectory Screws vs. Traditional Pedicle Screws Fixation|Transforaminal Lumbar Interbody Fusion With Cortical Bone Trajectory Screws vs. Traditional Pedicle Screws Fixation: a Multicentre Randomised Controlled Trial|Not yet recruiting||N/A|108|Anticipated|Second Affiliated Hospital of Wenzhou Medical University||2|||f|||||f|f||||||||2017-10-10 21:11:51.596146|2017-10-10 21:11:51.596146
NCT03105154|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-06|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|PREVENA||Groin Wound Infection Rate Using Prevena Compared to Standard Dressing in Vascular Surgery Patients With High Risk|Experience With the Negative Pressure Incision Management System (Prevena) in Vascular Surgery Patients With High Risk for Groin Wound Infection|Recruiting||N/A|26|Anticipated|The Cleveland Clinic||2|||f||||f|f|f||||||Undecided||2017-10-10 21:11:51.679048|2017-10-10 21:11:51.679048
NCT03105141|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-08|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|April 2019|Anticipated|2019-04-01||Interventional|||Optimized Remote Ischemic Conditioning (RIC) Treatment for Patients With Chronic Cerebal Ischemia|The Impact of Repeated Bilateral Limb Remote Ischemic Conditioning on Patients With Chronic Cerebral Ischemia: Establishment of Optimized Algorithm on the Basis of Feasibility, Safety and Efficacy|Not yet recruiting||Phase 2/Phase 3|600|Anticipated|Capital Medical University||4|||f||||t|f|f||||||Undecided||2017-10-10 21:11:51.773323|2017-10-10 21:11:51.773323
NCT03105128|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-22|||December 29, 2017|Anticipated|2017-12-29|September 2017|2017-09-01|February 14, 2020|Anticipated|2020-02-14|October 22, 2019|Anticipated|2019-10-22||Interventional|||A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease|A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease|Not yet recruiting||Phase 3|940|Anticipated|AbbVie||6|||f||||t|t|f||||||||2017-10-10 21:11:51.885352|2017-10-10 21:11:51.885352
NCT03105115|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-10|||May 25, 2017|Actual|2017-05-25|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Effect of Intrathecal Fentanyl on Spinal Anesthesia During Dexmedetomidine Infusion|Effect of Intrathecal Fentanyl on Spinal Anesthesia During Dexmedetomidine|Recruiting||N/A|56|Anticipated|Seoul National University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:11:51.981674|2017-10-10 21:11:51.981674
NCT03105102|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-22|||March 29, 2018|Anticipated|2018-03-29|September 2017|2017-09-01|February 7, 2023|Anticipated|2023-02-07|April 15, 2020|Anticipated|2020-04-15||Interventional|||A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991|A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991|Not yet recruiting||Phase 3|912|Anticipated|AbbVie||6|||f||||t|t|f||||||||2017-10-10 21:11:52.079061|2017-10-10 21:11:52.079061
NCT03105089|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-07-29|||March 2016||2016-03-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|||Effect of Cardiac Preconditioning Upon the Inotrope Score|Impact of Variable Types of Preconditioning Upon the Inotrope Score in Adult Patients, Undergoing Cardiac Surgery|Completed||N/A|60|Actual|Assiut University||2|||f||||t|f|f||||||||2017-10-10 21:11:52.190862|2017-10-10 21:11:52.190862
NCT03105076|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-06|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|March 31, 2019|Anticipated|2019-03-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Impact of Decision Aids on Breast Cancer Surgery Choice: A Randomized Controlled Trial|Impact of Decision Aids on Breast Cancer Surgery Choice: A Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Taipei Medical University Shuang Ho Hospital||2|||f|||||f|f||||||No||2017-10-10 21:11:52.278404|2017-10-10 21:11:52.278404
NCT03105063|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-03|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|AIISUS||Evaluation of the AIIS Using Hip Ultrasound(AIISUS)|Evaluation of the AIIS Using Hip Ultrasound(AIISUS)|Not yet recruiting||N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t|f|f||||||No||2017-10-10 21:11:52.477515|2017-10-10 21:11:52.477515
NCT03105050|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-10|||April 9, 2017|Actual|2017-04-09|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Observational|||Access to Bariatric Surgery In Europe|Access to Bariatric Surgery In Europe|Enrolling by invitation||N/A|51|Actual|Rijnstate Hospital|||1||f||||f|f|f||||||Yes|Data will become available for other researchers in the form of articles, presentations and if requested|2017-10-10 21:11:52.56106|2017-10-10 21:11:52.56106
NCT03105037|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-04-03|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|May 1, 2017|Anticipated|2017-05-01|April 30, 2017|Anticipated|2017-04-30||Observational|||Do SGAs Improve Identification of the CTM|Does the Insertion of a Supraglottic Airway Device Improve a Clinicans Ability to Correctly Identify the Cricothyroid Membrane?|Recruiting||N/A|72|Anticipated|The Rotunda Hospital|||2||f||||f|f|f||||||Undecided||2017-10-10 21:11:52.671305|2017-10-10 21:11:52.671305
NCT03105024|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-07|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Self-efficacy Enhancement and Exposure Therapy|Enhancing Exposure: the Impact of Self-efficacy Enhancement on Treatment Outcome|Recruiting||N/A|66|Anticipated|Ruhr University of Bochum||3|||f||||f|f|f||||||No||2017-10-10 21:11:52.767989|2017-10-10 21:11:52.767989
NCT03105011|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-06-14|||March 13, 2017|Actual|2017-03-13|June 2017|2017-06-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Utilizing Off-the-shelf Technology to Improve Diabetes Management in a Rural Population|Utilizing Off-the-shelf Technology to Improve Diabetes Management in a Rural Population|Recruiting||N/A|50|Anticipated|University of Missouri-Columbia||1|||f||||f|f|f||||||No||2017-10-10 21:11:52.903194|2017-10-10 21:11:52.903194
NCT03104998|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-03|||April 10, 2017|Anticipated|2017-04-10|March 2017|2017-03-01|May 30, 2018|Anticipated|2018-05-30|March 31, 2018|Anticipated|2018-03-31||Interventional|Neotility||Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility|Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility|Not yet recruiting||Phase 4|200|Anticipated|PharmEvo Pvt Ltd||2|||f||||f|t|f|||f|||No||2017-10-10 21:11:52.994248|2017-10-10 21:11:52.994248
NCT03104972|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-09|||October 1, 2017|Anticipated|2017-10-01|April 2017|2017-04-01|January 1, 2019|Anticipated|2019-01-01|September 30, 2018|Anticipated|2018-09-30||Interventional|||Non-invasive Brain Stimulation for Pediatric ADHD|Non-invasive Brain Stimulation for Pediatric ADHD|Not yet recruiting||N/A|100|Anticipated|Hadassah Medical Organization||3|||f||||f|f|f||||||No||2017-10-10 21:11:53.170638|2017-10-10 21:11:53.170638
NCT03104959|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-04-24|||January 2016||2016-01-01|April 2017|2017-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol|Use of N-acetyl Cysteine (NAC) in Alleviation or Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol|Recruiting||N/A|200|Anticipated|St. Luke's Hospital and Health Network, Pennsylvania||2|||f||||f||||||||||2017-10-10 21:11:53.277738|2017-10-10 21:11:53.277738
NCT03104946|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-02|||September 1, 2013|Actual|2013-09-01|March 2017|2017-03-01|November 30, 2016|Actual|2016-11-30|November 30, 2015|Actual|2015-11-30||Observational|||To Research the Relation Between Neonatal Morbidities and Poor Outcome in Preterm Infants|Clinical Research on the Predictive Effect of Neonatal Morbidities on the Poor Outcomes to Very Low Birth-weight and Extremely Low Birth-weight Infants|Completed||N/A|834|Actual|Guangdong Women and Children Hospital|||8||f|||||f|f||||||||2017-10-10 21:11:53.369508|2017-10-10 21:11:53.369508
NCT03104933|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-03|||July 2016||2016-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|proADM||Proadrenomedullin and Copeptin in Patients With Septic Shock|Proadrenomedullin and Copeptin as Predictors of Vasopressor Requirements and Volume Resuscitation in Patients With Septic Shock|Recruiting||N/A|100|Anticipated|Spanish Network for Research in Infectious Diseases|||1||f||||f||||||Samples Without DNA|"     Blood Samples   "|No||2017-10-10 21:11:53.457493|2017-10-10 21:11:53.457493
NCT03104920|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-01|||March 27, 2017|Actual|2017-03-27|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy|ERAS (Early Recovery After Surgery) Program Improve the Recovery of the Patient Undergoing Curative Hepatectomy: a Prospective Multicenter Cohort Trial|Recruiting||N/A|392|Anticipated|Southwest Hospital, China||2|||f||||t|f|f||||||No||2017-10-10 21:11:53.539749|2017-10-10 21:11:53.539749
NCT03104907|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-01|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Prostatic Artery Embolization for Obstructive Uropathy Due to Locally Advanced Prostate Cancer|Prostatic Artery Embolization for Obstructive Uropathy Due to Locally Advanced Prostate Cancer|Recruiting||N/A|30|Anticipated|Rigshospitalet, Denmark||1|||f||||t|f|f||||||No||2017-10-10 21:11:53.647743|2017-10-10 21:11:53.647743
NCT03104894|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-19|||August 2015||2015-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Meibomian Glands Massage on Signs and Symptoms of Dry Eye|The Effect of Meibomian Glands Massage on Signs and Symptoms of Dry Eye|Enrolling by invitation||N/A|50|Anticipated|Barzilai Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:11:53.742007|2017-10-10 21:11:53.742007
NCT03104881|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-04-10|||April 2015||2015-04-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Comparisons of Two Types of Rehabilitation Robot for Upper Extremities|Comparisons of Two Types of Rehabilitation Robot for Upper Extremities: 3 Dimension Exoskeleton Type Upper Extremity Robot vs. 2 Dimension End-effector Type Robot): Randomized Controlled Trial|Completed||N/A|40|Actual|National Rehabilitation Center, Seoul, Korea||2|||f||||f||||||||||2017-10-10 21:11:53.8192|2017-10-10 21:11:53.8192
NCT03104868|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-01|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|April 2022|Anticipated|2022-04-01|January 2022|Anticipated|2022-01-01||Interventional|||Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial|Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial|Not yet recruiting||N/A|700|Anticipated|Northwestern University||2|||f||||t|f|f||||||No||2017-10-10 21:11:53.919584|2017-10-10 21:11:53.919584
NCT03104855|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-05-17|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|CF||Clearance of 25-hydroxyvitamin D in Cystic Fibrosis|Clearance of 25-hydroxyvitamin D in Cystic Fibrosis|Recruiting||Phase 1|20|Anticipated|University of Washington||1|||f||||f|t|f||||||Yes||2017-10-10 21:11:53.990435|2017-10-10 21:11:53.990435
NCT03104842|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-03|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|July 2024|Anticipated|2024-07-01|July 2023|Anticipated|2023-07-01||Interventional|||Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone|Clinical Phase II, Multicenter, Open-label Study Evaluating iNduction, Consolidation and Maintenance With Isatuximab (SAR650984), Carfilzomib, LEnalidomide and Dexamethasone (I-KRd) in Primary Diagnosed High-risk Multiple Myeloma paTients|Not yet recruiting||Phase 2|153|Anticipated|University Hospital Tuebingen||2|||f||||t|f|f||||||No||2017-10-10 21:11:54.09184|2017-10-10 21:11:54.09184
NCT03104829|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-04-01|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||DSME or DSME + MI in T1DM on Glycemic Control|A Randomized Control Trial Compare Between Diabetic Knowledge and Self-care Behaviors (DSME) With and Without Motivational Interviewing, on Glycemic Control Among Children and Adolescents With Diabetes Mellitus Type 1|Recruiting||N/A|60|Anticipated|Mahidol University||2|||f||||t||||||||Yes||2017-10-10 21:11:54.223141|2017-10-10 21:11:54.223141
NCT03104816|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-03|||October 2016||2016-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion|The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion: a Prospective, Randomized Controlled Trial|Recruiting||Phase 4|128|Anticipated|University of Southern California||3|||f||||t|t|f|||f|||No|The data will kept for a minimum of 3 years after the study is completed. All documents containing identifiers will be shredded. Electronic documents will be deleted.|2017-10-10 21:11:54.325167|2017-10-10 21:11:54.325167
NCT03104803|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-08-08|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|June 4, 2018|Anticipated|2018-06-04|April 4, 2018|Anticipated|2018-04-04||Interventional|||Long-term Paired Associative Stimulation as a Treatment for Incomplete Spinal Cord Injury of Non-traumatic Origin|Long-term Paired Associative Stimulation as a Treatment for Incomplete Spinal Cord Injury of Non-traumatic Origin|Enrolling by invitation||N/A|5|Anticipated|Helsinki University Central Hospital||2|||f|||||f|f|||f|||||2017-10-10 21:11:54.429797|2017-10-10 21:11:54.429797
NCT03104621|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-01|||March 2013|Actual|2013-03-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients|Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients|Completed||Phase 4|20|Actual|Gangnam Severance Hospital||2|||f||||t|f|f||||||||2017-10-10 21:11:55.986084|2017-10-10 21:11:55.986084
NCT03104790|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-30|||September 30, 2017|Anticipated|2017-09-30|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|August 30, 2018|Anticipated|2018-08-30||Interventional|Flushed||Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls|Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls|Not yet recruiting||Phase 4|400|Anticipated|Public Health England||2|||f||||f|f|f||||||No|not appllicable|2017-10-10 21:11:54.512689|2017-10-10 21:11:54.512689
NCT03104777|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-08-22|||November 9, 2016|Actual|2016-11-09|January 2017|2017-01-01|October 30, 2017|Anticipated|2017-10-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||A Trial to Improve the Healthiness of Packed Lunches in Primary School Aged Children|A Cluster Randomised Controlled Trial Using Behavioural Insights to Improve the Healthiness of Packed Lunches in Primary Schools in Derby|Enrolling by invitation||N/A|17|Actual|Public Health England||2|||f||||f|f|f||||||||2017-10-10 21:11:54.601673|2017-10-10 21:11:54.601673
NCT03104764|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-07|||August 1, 2014|Actual|2014-08-01|September 2014|2014-09-01|January 25, 2016|Actual|2016-01-25|November 4, 2015|Actual|2015-11-04||Interventional|||Labial Frenulum Surgery - a Comparative Study of Conventional Scalpel and Er-Yag Laser Technique|Evaluation of Wound Healing and Patients´Experiences of Labial Frenulum Surgery - a Randomized, Controlled Comparative Study of Conventional Scalpel Technique and Er-Yag Laser Technique|Completed||N/A|40|Actual|Public Dental Health in Uppsala Region||2|||f||||f|f|f||||||No|Individual participant data are not planned to be shared|2017-10-10 21:11:54.683724|2017-10-10 21:11:54.683724
NCT03104751|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-03|||June 30, 2016|Actual|2016-06-30|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Neurodevelopment in Infants With Complex Congenital Heart Defects|Neurodevelopment in Infants With Complex Congenital Heart Defects|Recruiting||N/A|45|Anticipated|Ohio State University|||2||f||||f|f|f||||||||2017-10-10 21:11:54.75153|2017-10-10 21:11:54.75153
NCT03104725|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-29|||September 25, 2017|Actual|2017-09-25|August 8, 2017|2017-08-08|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?|Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?|Recruiting||N/A|35|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f|||||f|f||||||||2017-10-10 21:11:54.914123|2017-10-10 21:11:54.914123
NCT03104712|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-18|||April 27, 2017|Actual|2017-04-27|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|November 1, 2017|Anticipated|2017-11-01||Interventional|||A Trial on the GI of Spaghetti Versus Rice as Mixed Meals|The Importance of Glycemic Index on Postprandial Glycemia and Insulinemia in the Context of the Addition of Fat to Carbohydrate Foods: A Randomized Controlled Trial on Spaghetti Versus Rice as Mixed Meals|Recruiting||N/A|13|Anticipated|University of Parma||9|||f||||f|f|f||||||||2017-10-10 21:11:55.014054|2017-10-10 21:11:55.014054
NCT03104699|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-23|||April 11, 2017|Actual|2017-04-11|June 2017|2017-06-01|September 30, 2019|Anticipated|2019-09-30|March 1, 2019|Anticipated|2019-03-01||Interventional|||Phase 1 / 2 Study of AGEN2034 in Advanced Tumors and Cervical Cancer|Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second-Line Cervical Cancer|Recruiting||Phase 1/Phase 2|75|Anticipated|Agenus Inc.||1|||f||||f|t|f||||||No||2017-10-10 21:11:55.304183|2017-10-10 21:11:55.304183
NCT03104686|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-03|||April 10, 2017|Anticipated|2017-04-10|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Pasta and Bread Prepared With Durum Wheat Semolina: Effect on Post-prandial Glucose and Insulin Metabolism|Pasta and Bread Prepared With Durum Wheat Semolina: Effect on Post-prandial Glucose and Insulin Metabolism|Not yet recruiting||N/A|30|Anticipated|University of Parma||4|||f||||f|f|f||||||No||2017-10-10 21:11:55.451726|2017-10-10 21:11:55.451726
NCT03104673|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-08|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|MSP_Ext||Molecular Signature Children|Molecular Signature of Karen and Burmese Children Until Two Years of Age on the Thailand--Myanmar Border: a Study Extension of TMEC 15-062|Recruiting||N/A|400|Anticipated|University of Oxford|||1||f||||f|f|f||||Samples With DNA|"     Early childhood Transcriptome from capillary blood (Risk-minimum) This point will enable us     to understand whether preterm infants have different gene expression than their term     counterparts and if so, how it evolves in the early period of life. Moreover, specific     signals for children at risk for or suffering from malnutrition or stunting resulting from     gastrointestinal inflammation or barrier disruption could be picked up. Total blood 0.85 mL     in 2 years   "|Yes||2017-10-10 21:11:55.58268|2017-10-10 21:11:55.58268
NCT03104660|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-06|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|March 2037|Anticipated|2037-03-01|March 2027|Anticipated|2027-03-01||Interventional|||Coronary and Structural Interventions Ulm - Transcatheter Mitral Valve Repair (CSI-Ulm-TMVR)|Coronary and Structural Interventions Ulm - Transcatheter Mitral Valve Repair (CSI-Ulm-TMVR)|Recruiting||N/A|1000|Anticipated|University of Ulm||1|||f||||f|f|f||||||No||2017-10-10 21:11:55.69024|2017-10-10 21:11:55.69024
NCT03104634|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-27|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|July 1, 2019|Anticipated|2019-07-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in Smokers|The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in Smokers: a Randomized, Double-blind, Placebo-controlled, Cross-over Trial|Recruiting||Phase 3|40|Anticipated|McGill University Health Center||2|||f||||f|f|f|||f|||||2017-10-10 21:11:55.887237|2017-10-10 21:11:55.887237
NCT03104608|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-22|||June 1, 2018|Anticipated|2018-06-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD)|Automatic Self Transcending Meditation (ASTM) Plus Treatment As Usual (TAU) Versus TAU Alone in Patients With Severe Age Related Macular Degeneration (AMD), a Single Blind Randomized Controlled Longitudinal Study|Not yet recruiting||N/A|140|Anticipated|Lawson Health Research Institute||2|||f|||||f|f||||||||2017-10-10 21:11:56.077479|2017-10-10 21:11:56.077479
NCT03104595|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-08|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer|EC-18 for Management of Chemotherapy-Induced Neutropenia in Patients With Advanced BC Receiving Low Febrile Neutropenia Risk Chemotherapy: Dose-Escalation, Open-label, Trial to Assess Safety and Tolerability of EC-18|Not yet recruiting||Phase 2|12|Anticipated|Enzychem Lifesciences Corporation||4|||f||||t|t|f||||||||2017-10-10 21:11:56.190325|2017-10-10 21:11:56.190325
NCT03104582|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-07-14|||November 1, 2011|Actual|2011-11-01|July 2017|2017-07-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Interventional|||Best Biliary Drainage Option in Advanced Klatskin Tumor|Best Biliary Drainage Option in Type II、III、IV Klatskin Tumor：ERCP or PTBD|Completed||N/A|180|Actual|Hepatopancreatobiliary Surgery Institute of Gansu Province||2|||f||||t|f|f||||||||2017-10-10 21:11:56.312572|2017-10-10 21:11:56.312572
NCT03104569|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-07-14|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma|Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma: A Prospective Double-blind Multicenter Randomized Controlled Study|Recruiting||N/A|100|Anticipated|Hepatopancreatobiliary Surgery Institute of Gansu Province||2|||f||||t|f|f||||||||2017-10-10 21:11:56.434145|2017-10-10 21:11:56.434145
NCT03104556|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-01|||April 14, 2017|Anticipated|2017-04-14|April 2017|2017-04-01||||December 31, 2019|Anticipated|2019-12-31||Observational|STRONG||Silent sTROke duriNG MitraClip Implantation|Silent sTROke duriNG MitraClip Implantation - STRONG-MitraClip|Not yet recruiting||N/A|70|Anticipated|Charite University, Berlin, Germany|||1||f||||t|f|f||||||No||2017-10-10 21:11:56.57531|2017-10-10 21:11:56.57531
NCT03104543|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-15|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|March 1, 2022|Anticipated|2022-03-01|March 1, 2022|Anticipated|2022-03-01||Interventional|CHIIP||Communicating Health Information and Improving Coordination With Primary Care|Communicating Health Information and Improving Coordination With Primary Care - an Ancillary Study of the Childhood Cancer Survivor Study|Enrolling by invitation||N/A|650|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t|f|f||||||Yes|After study completion and analysis is completed, study data will join other CCSS data as a NCI-supported shared resource, available to approved external investigators.|2017-10-10 21:11:56.650538|2017-10-10 21:11:56.650538
NCT03104530|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-09-14|||May 24, 2017|Actual|2017-05-24|March 2017|2017-03-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Observational|||Crabmeat and Health Study|Crabmeat and Health Study: Do Brown Crabmeat Consumers Have a Higher Body Burden of Cadmium Compared to Non-crabmeat Consumers?|Completed||N/A|41|Actual|University of Aberdeen|||2||f||||f|f|f||||||||2017-10-10 21:11:56.766133|2017-10-10 21:11:56.766133
NCT03104517|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-03|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|CELLEBRATE||Two Treatments of Autologous Muscle Derived Cells for Female Urinary Sphincter Repair|Cellebrate: A Double-Blind, Stratified, Randomized, Controlled Trial Comparing the Safety and Efficacy of Two Treatments of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence|Not yet recruiting||Phase 3|156|Anticipated|Cook MyoSite||2|||f||||t|t|f||||||No||2017-10-10 21:11:56.864874|2017-10-10 21:11:56.864874
NCT03104504|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-03|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|October 31, 2022|Anticipated|2022-10-31|October 31, 2022|Anticipated|2022-10-31||Interventional|SOS||A System of Safety (SOS)|A System of Safety: Preventing Suicided Through Healthcare System Transformation|Enrolling by invitation||N/A|310000|Anticipated|University of Massachusetts, Worcester||2|||f||||t|f|f||||||||2017-10-10 21:11:56.964778|2017-10-10 21:11:56.964778
NCT03104491|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-28|||March 21, 2017|Actual|2017-03-21|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia|Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia|Recruiting||Phase 1/Phase 2|44|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:11:57.074737|2017-10-10 21:11:57.074737
NCT03104478|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-07-11|||May 9, 2017|Actual|2017-05-09|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|February 2019|Anticipated|2019-02-01||Observational|RT3||Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)|Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)|Recruiting||N/A|194|Anticipated|The Lymphoma Academic Research Organisation|||1||f||||f|f|f||||Samples With DNA|"     Blood samples are collected at time of enrollment in the trial.   "|||2017-10-10 21:11:57.216591|2017-10-10 21:11:57.216591
NCT03104465|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-15|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Adaptation of Mindfulness Training to Treat Chronic Pain in the Military|Adaptation of Mindfulness Training to Treat Chronic Pain in the Military|Recruiting||N/A|40|Anticipated|RTI International||1|||f||||t|f|f||||||No||2017-10-10 21:11:57.383447|2017-10-10 21:11:57.383447
NCT03104452|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-08|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|||Helping Moms Who Smoke|Enhancing the Delivery of Tobacco Treatment During Pregnancy and Postpartum Though Systems-Change|Not yet recruiting||N/A|60|Anticipated|University of Kansas Medical Center|||1||f||||f|f|f||||||No||2017-10-10 21:11:57.521398|2017-10-10 21:11:57.521398
NCT03104439|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-05-29|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|October 31, 2024|Anticipated|2024-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer|Nivolumab and Ipilimumab and Radiation Therapy in Microsatellite Stable (MSS) and Microsatellite Instability (MSI) High Colorectal and Pancreatic Cancer|Recruiting||Phase 2|80|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||No||2017-10-10 21:11:57.597051|2017-10-10 21:11:57.597051
NCT03104426|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|EPO-4-Rhesus||EPO-4-Rhesus: Role of Darbepoetin Alfa in Reducing Late Anaemia in Neonates With Red Blood Cell Alloimmunization After Intrauterine Transfusions|Randomized Controlled Trial on the Use of EPO to Reduce Top-up Transfusions in Neonates With Red Blood Cell Alloimmunization Treated With Intrauterine Transfusions|Not yet recruiting||Phase 2/Phase 3|42|Anticipated|Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research||2|||f||||t|t|f|||f|||||2017-10-10 21:11:57.727633|2017-10-10 21:11:57.727633
NCT03104413|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-22|||December 29, 2017|Anticipated|2017-12-29|September 2017|2017-09-01|June 17, 2019|Anticipated|2019-06-17|March 24, 2019|Anticipated|2019-03-24||Interventional|||A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment|Not yet recruiting||Phase 3|579|Anticipated|AbbVie||6|||f||||t|t|f||||||||2017-10-10 21:11:57.816526|2017-10-10 21:11:57.816526
NCT03104400|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-29|||July 27, 2017|Actual|2017-07-27|September 2017|2017-09-01|November 8, 2022|Anticipated|2022-11-08|October 23, 2019|Anticipated|2019-10-23||Interventional|SELECT - PsA 1||A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug|A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) - SELECT - PsA 1|Recruiting||Phase 3|1640|Anticipated|AbbVie||5|||f||||t|t|f||||||||2017-10-10 21:11:57.972586|2017-10-10 21:11:57.972586
NCT03104387|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-20|||May 16, 2017|Actual|2017-05-16|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|BioTrack||Health Effects of Occupational Exposure to Combustion Particles - a Study on Volunteers Performing as Train Conductors|Effects of Diesel Combustion Generated Air Pollution on Cardiovascular Function and Oxidatively Damaged DNA in Healthy Volunteers|Recruiting||N/A|35|Anticipated|University of Copenhagen||2|||f||||f|f|f||||||No||2017-10-10 21:11:58.40624|2017-10-10 21:11:58.40624
NCT03104374|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-04|2017-09-29|||April 17, 2017|Actual|2017-04-17|September 2017|2017-09-01|May 27, 2022|Anticipated|2022-05-27|August 21, 2019|Anticipated|2019-08-21||Interventional|SELECT - PsA 2||A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug|A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo in Subjects With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (bDMARD)|Recruiting||Phase 3|630|Anticipated|AbbVie||4|||f||||t|t|f||||||||2017-10-10 21:11:58.548302|2017-10-10 21:11:58.548302
NCT03104361|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-03|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis|Intravesical Injections of Platelet-Rich Plasma (PRP) in Treatment of Interstitial Cystitis Refractory to Conventional Treatment - A Prospective, Clinical Trial|Not yet recruiting||Phase 1|30|Anticipated|Buddhist Tzu Chi General Hospital||1|||f||||t|f|f||||||No|No plan to share data with other researchers|2017-10-10 21:11:59.048121|2017-10-10 21:11:59.048121
NCT03104348|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-08-31|||April 7, 2017|Actual|2017-04-07|August 2017|2017-08-01|December 7, 2018|Anticipated|2018-12-07|October 7, 2018|Anticipated|2018-10-07||Interventional|UNANIME||Screening for COPD in Primary Care: a Synergistic Approach - Dentists - Pharmacists -Physiotherapists - Nurses - Physicians|Screening for COPD in Primary Care: a Synergistic Approach - Dentists - Pharmacists -Physiotherapists - Nurses - Physicians|Recruiting||N/A|480|Anticipated|University Hospital, Brest||1|||f||||t|f|f||||||||2017-10-10 21:11:59.167882|2017-10-10 21:11:59.167882
NCT03104335|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-04-09|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|November 30, 2019|Anticipated|2019-11-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial|Apatinib for Advanced Soft Tissue Sarcoma Patients After Failure of Traditional Therapy: an One-armed, Phase 2, Open-label, Multicenter Prospective Trial|Recruiting||Phase 2|37|Anticipated|Peking University People's Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:11:59.284017|2017-10-10 21:11:59.284017
NCT03104322|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-15|||June 15, 2017|Actual|2017-06-15|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis|A Randomised, Crossover Study of Self-monitoring of Symptoms and Spirometry Via the patientMpower Platform in Patients With Idiopathic Pulmonary Fibrosis|Recruiting||N/A|8|Anticipated|patientMpower Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:11:59.443073|2017-10-10 21:11:59.443073
NCT03104309|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-13|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Levonorgestrel Intrauterine System and Adenomyosis|Can the Effect of Levonorgestrel Intrauterine System for Treatment of Adenomyosis be Predicted at Baseline Visit?|Completed||N/A|100|Actual|Assiut University||1|||f||||f|f|f||||||Yes||2017-10-10 21:11:59.567801|2017-10-10 21:11:59.567801
NCT03104296|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-03|||November 1, 2013|Actual|2013-11-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Correlation Between Cerebral Oxygenation and Neurodevelopment in VLBW Preterm Infants.|Correlation Between Neonatal Cerebral Oxygenation and Later Psychomotor Outcome in Very-low-birth-weight Preterm Infants.|Completed||N/A|63|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||f|f|f||||||No||2017-10-10 21:11:59.644273|2017-10-10 21:11:59.644273
NCT03104283|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-08-22|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Apatinib for the Elderly Advanced Gastric Cancer|A Multicenter, Single-arm, Phase Ⅱ Clinical Trial of Apatinib Monotherapy in Elderly Patients With Advanced Gastric Cancer(GC)|Recruiting||Phase 2|60|Anticipated|Affiliated Hospital of Qinghai University||1|||f|||||f|f||||||||2017-10-10 21:11:59.729019|2017-10-10 21:11:59.729019
NCT03104075|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-25|||April 17, 2017|Actual|2017-04-17|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines|Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines|Recruiting||N/A|40|Anticipated|The Jackson Laboratory||2|||f||||f|f|f|||f|||||2017-10-10 21:12:01.532249|2017-10-10 21:12:01.532249
NCT03104270|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-06|||March 13, 2017|Actual|2017-03-13|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|February 2020|Anticipated|2020-02-01||Interventional|||Combination Study for High Risk Multiple Myeloma Patients|A Phase 2 Trial of the Efficacy and Safety of Elotuzumab in Combination With Pomalidomide, Carfilzomib and Dexamethasone Among High Risk Relapsed/ Refractory Multiple Myeloma Patients|Recruiting||Phase 2|40|Anticipated|Oncotherapeutics||1|||f||||t|t|f||||||No||2017-10-10 21:11:59.844332|2017-10-10 21:11:59.844332
NCT03104257|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-07-21|||December 2016||2016-12-01|December 2016|2016-12-01|July 2021|Anticipated|2021-07-01|January 2021|Anticipated|2021-01-01||Observational|||The Neural Correlates of Cannabis Use|The Neural Correlates of Cannabis Use|Recruiting||N/A|37|Anticipated|Yale University|||2||f||||t||||||Samples With DNA|"     When specimens and information are stored, researchers are careful to try to protect your     identity from discovery by others. Samples and information will receive a unique code. Other     researchers will only receive coded samples and information, and will not be able to link the     code to subjects. Strict security safeguards are in place to reduce the chance of misuse or     unplanned release of information.   "|||2017-10-10 21:11:59.972419|2017-10-10 21:11:59.972419
NCT03104244|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-06-09|||July 2016||2016-07-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Longitudinal Brain Health in Youth Tackle Football Players|Longitudinal Brain Health in Youth Tackle Football Players|Recruiting||N/A|280|Anticipated|More Foundation|||2||f||||t||||||||No||2017-10-10 21:12:00.096842|2017-10-10 21:12:00.096842
NCT03104231|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-07|||April 1, 2016|Actual|2016-04-01|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|April 30, 2017|Actual|2017-04-30||Interventional|||VR-3D Movie-based Education|OCULUS: a 3-D Movie to Improve Patient Compliance|Completed||N/A|100|Actual|Medical University of Warsaw||1|||f||||f|f|f||||||Yes|We will be able to share all of the data. They will be available on april 2017th.|2017-10-10 21:12:00.220505|2017-10-10 21:12:00.220505
NCT03104218|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-14|||January 11, 2016|Actual|2016-01-11|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Transcranial Direct Current Stimulation to Enhance Rehabilitation in Individuals With Rotator Cuff Tendinopathy|Transcranial Direct Current Stimulation to Enhance Rehabilitation in Individuals With Rotator Cuff Tendinopathy: a Triple-blind Randomized Control Trial|Completed||N/A|40|Actual|Laval University||2|||f||||t|f|f||||||||2017-10-10 21:12:00.307631|2017-10-10 21:12:00.307631
NCT03104205|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-06-26|||September 2018|Anticipated|2018-09-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|April 2020|Anticipated|2020-04-01||Interventional|||MOWI Home-Based Pilot|Mobile Health Obesity Wellness Intervention in Rural Older Adults (MOWI): Home-Based Pilot|Not yet recruiting||N/A|40|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t|f|f||||||No||2017-10-10 21:12:00.411861|2017-10-10 21:12:00.411861
NCT03104192|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-06-26|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||MOWI Research Pilot|Mobile Health Obesity Wellness Intervention in Rural Older Adults (MOWI): Research Pilot|Recruiting||N/A|24|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:12:00.536249|2017-10-10 21:12:00.536249
NCT03104179|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-03-31|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|REMOTE||Removal of Cytokines in Patients Undergoing Cardiac Surgery With CPB|Removal of Cytokines in Patients Undergoing Cardiac Surgery With CPB (The REMOTE Study)|Not yet recruiting||N/A|80|Anticipated|Klinikum Nürnberg||2|||f||||t|f|f||||||No||2017-10-10 21:12:00.652147|2017-10-10 21:12:00.652147
NCT03104166|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-04-07|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|ModuVas||Modulation of Vascular Calcification in Chronic Dialysis Patients|Modulation of Vascular Calcification in Chronic Dialysis Patients|Not yet recruiting||N/A|50|Anticipated|Charite University, Berlin, Germany||2|||f||||f|f|f||||||No||2017-10-10 21:12:00.782016|2017-10-10 21:12:00.782016
NCT03104153|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-31|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|June 30, 2016|Actual|2016-06-30|April 30, 2016|Actual|2016-04-30||Interventional|||Effect of Early Removal of Wound Drains After Mastectomy or Lymph Node Dissection|Effect of Early Removal of Wound Drains After Mastectomy or Lymph Node Dissection on Clinical Outcome and Quality of Life in Breast Cancer Patients|Completed||N/A|106|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f|f|f||||||No||2017-10-10 21:12:00.87061|2017-10-10 21:12:00.87061
NCT03104140|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-25|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|October 15, 2017|Anticipated|2017-10-15|October 1, 2017|Anticipated|2017-10-01||Interventional|||Ketamine Versus Low Dose Thiopental for Induction of Anesthesia in Septic Shock|Ketamine Versus Low Dose Thiopental for Rapid-sequence Induction of Anesthesia in Patients With Septic Shock|Recruiting||Phase 3|22|Anticipated|Cairo University||2|||f|||||f|f|||f|||||2017-10-10 21:12:00.955817|2017-10-10 21:12:00.955817
NCT03104127|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-04-07|||April 24, 2017|Anticipated|2017-04-24|March 2017|2017-03-01|December 1, 2019|Anticipated|2019-12-01|April 25, 2018|Anticipated|2018-04-25||Interventional|||Effect of Using a Lower Limb Robotic Device for Patients With Chronic Stroke|Effect of a Community-based, Bionic Leg Rehabilitation Program on Biomechanical, Cardiovascular and Performance Outcomes in Patients With Chronic Stroke|Not yet recruiting||N/A|45|Anticipated|University of Winchester||3|||f||||t|f|t|f|f|t|||No||2017-10-10 21:12:01.071669|2017-10-10 21:12:01.071669
NCT03104114|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-02|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|May 2, 2018|Anticipated|2018-05-02||Interventional|BSPAP||Pharmacist-led Intervention on Adherence in Patients Undergoing Treatment With an Oral Oncology Medication|Evaluating Adherence and Persistence in Patients Receiving Oral Oncolytic Therapy in a Safety Net Hospital's Pharmacist-driven Medication Management Program|Recruiting||N/A|72|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:12:01.191381|2017-10-10 21:12:01.191381
NCT03104101|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-03|||November 1, 2014|Actual|2014-11-01|March 2017|2017-03-01|March 5, 2016|Actual|2016-03-05|November 30, 2015|Actual|2015-11-30||Interventional|||Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in Females|Evaluation of Transcutaneous Posterior Tibial Nerve Electro Stimulation With or Without Low Dose Trospium Chloride in the Management of Overactive Bladder in Females|Completed||N/A|30|Actual|Alexandria University||2|||f|||||f|f|||f|||Yes||2017-10-10 21:12:01.283782|2017-10-10 21:12:01.283782
NCT03104088|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-10|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Studying Cognition in SPG4|Studying Cognition in SPG4 Compared to Healthy Controls|Recruiting||N/A|50|Anticipated|University Hospital Tuebingen|||2||f||||f|f|f||||||No||2017-10-10 21:12:01.396301|2017-10-10 21:12:01.396301
NCT03104062|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-09|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial Infarction|Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial Infarction|Recruiting||N/A|48|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 21:12:01.658449|2017-10-10 21:12:01.658449
NCT03104049|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-31|||November 20, 2015|Actual|2015-11-20|March 2017|2017-03-01|January 8, 2017|Actual|2017-01-08|December 18, 2016|Actual|2016-12-18||Interventional|NMTPD||Pilot Study on the Effects of Neuromuscular Taping in Parkinson's Disease Patients|Pilot Study on the Effects of Neuromuscular Taping in Parkinson's Disease Patients|Completed||N/A|46|Actual|IRCCS San Raffaele||2|||f||||t|f|t||f|f|||Undecided||2017-10-10 21:12:01.761014|2017-10-10 21:12:01.761014
NCT03104036|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-31|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|FACTU||Faecal Bacteriotherapy for Ulcerative Colitis|Faecal Bacteriotherapy for Ulcerative Colitis|Recruiting||Phase 2|60|Anticipated|Institute for Clinical and Experimental Medicine||2|||f||||f|f|f||||||No||2017-10-10 21:12:01.861921|2017-10-10 21:12:01.861921
NCT03104023|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-25|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Staple Line Inversion vs Buttressing on Postoperative Vomits After LSG|Influence of Staple Line Inversion vs Buttressing on Postoperative Nausea or Vomits After Laparoscopic Sleeve Gastrectomy (LSG)|Recruiting||Phase 3|100|Anticipated|Hospital General Universitario Elche||2|||f||||t|f|f||||||No||2017-10-10 21:12:02.039977|2017-10-10 21:12:02.039977
NCT03104010|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-31|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|September 2022|Anticipated|2022-09-01|February 2022|Anticipated|2022-02-01||Interventional|||A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD|A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of Adult Growth Hormone Deficiency (AGHD)|Recruiting||Phase 2|180|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||2|||f|||||f|f||||||||2017-10-10 21:12:02.141887|2017-10-10 21:12:02.141887
NCT03103997|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-31|||January 6, 2017|Actual|2017-01-06|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 1, 2018|Anticipated|2018-06-01||Interventional|||Wet Heparin for Obtaining Liver Tissue for EUS Guided Liver Biopsy|Wet Heparinized Suction: A Novel Technique to Enhance Tissue Acquisition for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB): A Prospective Trial|Recruiting||N/A|40|Anticipated|Geisinger Clinic||3|||f||||t|f|f||||||||2017-10-10 21:12:02.301543|2017-10-10 21:12:02.301543
NCT03103984|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-06|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Immunosuppression and Diet: the Role of Inflammation in the Adipose Tissue Remodeling|Immunosuppression and Diet: the Role of Inflammation in the Adipose Tissue Remodeling After Liver Transplantation|Active, not recruiting||N/A|40|Actual|Federal University of Minas Gerais||2|||f||||t|f|f||||||||2017-10-10 21:12:02.443168|2017-10-10 21:12:02.443168
NCT03103971|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-09-07|||September 28, 2017|Anticipated|2017-09-28|September 2017|2017-09-01|July 17, 2033|Anticipated|2033-07-17|July 17, 2019|Anticipated|2019-07-17||Interventional|||huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia|A Two-Stage Phase 1 Open-Label Study of huJCAR014, CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells Bearing a Human Binding Domain, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Acute Lymphocytic Leukemia|Recruiting||Phase 1|66|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f||||||||2017-10-10 21:12:02.549293|2017-10-10 21:12:02.549293
NCT03103958|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-31|||June 28, 2016|Actual|2016-06-28|March 2017|2017-03-01|September 6, 2016|Actual|2016-09-06|August 9, 2016|Actual|2016-08-09||Interventional|||Effects of Probiotic on Modulation of the Intestinal Microbiota in Constipated Patients|Phase IV, Double Blind, Randomized, Study Between Probiatop and Placebo for the Assessment of Improving the Gastrointestinal Function and Intestinal Bacterial Flora in Constipated Patients|Completed||N/A|120|Actual|Farmoquimica S.A.||2|||f||||t|f|f||||||No||2017-10-10 21:12:02.675538|2017-10-10 21:12:02.675538
NCT03103945|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-07-25|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|STAR||Prospective Physician-Initiated Observational Study of The Contact Detection System (CDS) in Patients Undergoing Radiofrequency Ablation Using the Niobe™ Remote Magnetic Navigation System|Prospective Physician-Initiated Observational Study of The Contact Detection System (CDS) in Patients Undergoing Radiofrequency Ablation Using the Niobe™ Remote Magnetic Navigation System (STAR)|Recruiting||N/A|30|Anticipated|Erasmus Medical Center|||1||f|||||f|f||||||||2017-10-10 21:12:02.755646|2017-10-10 21:12:02.755646
NCT03103932|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-26|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|RADAR||Biomarker Guided Discharge of Heart Failure Patients|BiomarkeR cAndidates to Guide Discharge of Patients Admitted to Hospital With heARt Failure|Not yet recruiting||N/A|750|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t|f|f||||||No|IPD will not be available to other researchers. Only results will be shared.|2017-10-10 21:12:02.848325|2017-10-10 21:12:02.848325
NCT03103919|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-27|||March 16, 2017|Actual|2017-03-16|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management|A Multicenter, Open-Label, Two-Arm Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management|Recruiting||Phase 4|40|Anticipated|UCB Pharma||2|||f||||f|t|t|f|f|f|||||2017-10-10 21:12:02.945149|2017-10-10 21:12:02.945149
NCT03103906|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-26|||May 10, 2017|Actual|2017-05-10|July 2017|2017-07-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|||Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure|A Randomized, Evaluator-blind, Single-center and Two Arm Clinical Study Designed to Evaluate the Local Tolerance and Cosmetic Efficacy of a Topical Skin Care Formulation in Healthy Female Subjects With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a 70% Glycolic Acid Facial Peel Procedure|Completed||N/A|115|Actual|GlaxoSmithKline||2|||f|||||f|f||||||||2017-10-10 21:12:03.063792|2017-10-10 21:12:03.063792
NCT03103867|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-31|||February 23, 2017|Actual|2017-02-23|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|QUEST||QUality of Control and slEep in Children With diabeteS, Using New Technology|Evaluation of Two Different Glucose Monitoring Treatments and Their Impact on Time in Target, Sleep and Quality of Life in Children With Type 1 Diabetes and Primary Caregivers.|Recruiting||N/A|36|Anticipated|Centre Hospitalier du Luxembourg||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:12:03.615605|2017-10-10 21:12:03.615605
NCT03103854|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-31|||January 1, 2014|Actual|2014-01-01|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|BURST||Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease|The Impact of Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease|Recruiting||N/A|500|Anticipated|Cambridge Cardiac Care Centre||4|||f||||f|f|f||||||No||2017-10-10 21:12:03.740278|2017-10-10 21:12:03.740278
NCT03103841|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-03-31|||March 6, 2017|Actual|2017-03-06|December 2016|2016-12-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Observational|||Investigation of Sleep Quality and Prevalence of Sleep-disordered Breathing in Children and Young People With Epilepsy|Investigation of Sleep Quality and Prevalence of Sleep-disordered Breathing in Children and Young People With Epilepsy|Recruiting||N/A|83|Anticipated|NHS Lothian|||2||f||||f||||||||No||2017-10-10 21:12:03.921574|2017-10-10 21:12:03.921574
NCT03103828|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|STAMPVA||Sharing and Talking About my Preferences|Promoting Healthcare Planning as a Healthy Behavior (STAMP VA)|Not yet recruiting||N/A|484|Anticipated|VA Connecticut Healthcare System||4|||f|||||f|f||||||Undecided||2017-10-10 21:12:04.091374|2017-10-10 21:12:04.091374
NCT03103815|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-24|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|October 20, 2018|Anticipated|2018-10-20|October 20, 2018|Anticipated|2018-10-20||Interventional|||Trial of Amivita in Amyotrophic Lateral Sclerosis|Trial of Amivita in Amyotrophic Lateral Sclerosis: a Single-center, Single-blind, Self-controlled Clinical Trial|Recruiting||N/A|30|Anticipated|Wujin People's Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:12:04.208633|2017-10-10 21:12:04.208633
NCT03103802|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-09|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|February 27, 2018|Anticipated|2018-02-27|October 30, 2017|Anticipated|2017-10-30||Interventional|||Evaluation of the Accuracy of Digital Models Obtained Using Intraoral and Extraoral Scanners|Evaluation of the Accuracy of Digital Models Obtained Using Intraoral and Extraoral Scanners Versus Gold Standard Plaster Model (Diagnostic Accuracy Study)|Recruiting||N/A|24|Anticipated|Cairo University||5|||f||||t|f|f||||||Yes||2017-10-10 21:12:04.337689|2017-10-10 21:12:04.337689
NCT03103789|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||April 29, 2014|Actual|2014-04-29|March 2017|2017-03-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device|Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device|Enrolling by invitation||N/A|75|Anticipated|Vanderbilt University Medical Center|||2||f||||t|f|f||||||No||2017-10-10 21:12:04.456825|2017-10-10 21:12:04.456825
NCT03103776|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-05|||March 22, 2016|Actual|2016-03-22|March 2017|2017-03-01|October 8, 2017|Anticipated|2017-10-08|October 8, 2017|Anticipated|2017-10-08||Interventional|IPoTAIG||Involvement of Polyomaviruses in the Pathogenesis of Autoimmune Thyroiditis and Goitrigenesis.|Involvement of Polyomaviruses in the Pathogenesis of Autoimmune Thyroiditis and Goitrigenesis.|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:12:04.56636|2017-10-10 21:12:04.56636
NCT03103763|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-06|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|ATIVO||Anticoagulation Therapy in the Very Old|ATIVO Study - Anticoagulation Therapy in the Very Old|Recruiting||N/A|240|Anticipated|Penobscot Bay Medical Center|||3||f||||f|f|f||||||No|date will not be shared|2017-10-10 21:12:04.662578|2017-10-10 21:12:04.662578
NCT03103750|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-06-27|||August 15, 2017|Anticipated|2017-08-15|June 2017|2017-06-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD|Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Study of Stimulant-induced Dopamine Release Using [11C]-Raclopride PET in Healthy Humans|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Yale University||2|||f||||f|t|f|||t|||No||2017-10-10 21:12:04.808554|2017-10-10 21:12:04.808554
NCT03103737|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-31|||January 2012|Actual|2012-01-01|March 2017|2017-03-01|August 31, 2013|Actual|2013-08-31|August 31, 2013|Actual|2013-08-31||Interventional|||Promotion of Emotional Well-being in Hospitalized Cancer Patients by Information and Communication Technologies (ICTs)|Evaluation of a Brief Psychological Intervention That Uses ICTs to Improve Well-being in Hospitalized Cancer Patients|Completed||N/A|36|Actual|University of Valencia||2|||f|||||f|f||||||||2017-10-10 21:12:04.948401|2017-10-10 21:12:04.948401
NCT03103724|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-21|||March 16, 2017|Actual|2017-03-16|April 2017|2017-04-01|March 16, 2019|Anticipated|2019-03-16|March 16, 2019|Anticipated|2019-03-16||Interventional|EXCALIBUR||A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.|A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.|Recruiting||Phase 2|68|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f|f|f||||||No||2017-10-10 21:12:05.05663|2017-10-10 21:12:05.05663
NCT03103711|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-31|||July 2010|Actual|2010-07-01|March 2017|2017-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Promotion of Emotional Well-being in Hospitalized Cancer Patients by Virtual Reality|A Brief Psychological Intervention Using Virtual Reality for the Promotion of Emotional Well-being in Hospitalized Cancer Patients|Completed||N/A|76|Actual|University of Valencia||2|||f|||||f|f||||||||2017-10-10 21:12:05.180046|2017-10-10 21:12:05.180046
NCT03103698|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-10|||October 17, 2016|Actual|2016-10-17|April 2017|2017-04-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Interventional|ANI||The Interest of the ANI in the Monitoring of Peroperative Analgesia in Bariatric Surgery|The Interest of the ANI in the Monitoring of Peroperative Analgesia in Bariatric Surgery: a Randomized Single Blind Study.|Recruiting||N/A|90|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:12:05.279902|2017-10-10 21:12:05.279902
NCT03103685|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.|Effect of Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving Dual-antiplatelet Therapy Undergoing Dental Procedure.|Not yet recruiting||Phase 4|428|Anticipated|Chiang Mai University||2|||f||||f|t|f|||t|||No||2017-10-10 21:12:05.377663|2017-10-10 21:12:05.377663
NCT03103672|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-05|||January 2, 2017|Actual|2017-01-02|March 2017|2017-03-01|July 3, 2017|Anticipated|2017-07-03|June 1, 2017|Anticipated|2017-06-01||Observational|||Total Intravenous Anesthesia in Percutaneous Transhepatic Cholangiography|Comparison of Inhalation Anesthesia and Total Intravenous Anesthesia in Percutaneous Transhepatic Cholangiography|Active, not recruiting||N/A|60|Anticipated|Inonu University|||2||f|||||f|f||||||No||2017-10-10 21:12:05.494839|2017-10-10 21:12:05.494839
NCT03103659|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-05|||April 27, 2017|Anticipated|2017-04-27|March 2017|2017-03-01|April 27, 2019|Anticipated|2019-04-27|April 27, 2018|Anticipated|2018-04-27||Interventional|ONCO-EHPAD||Optimization and Improvement of Care Course for 75 Years and Over Patient With Cancer and Living in Nursing Home on the Marseille Agglomeration|Optimization and Improvement of Care Course for 75 Years and Over Patient With Cancer and Living in Nursing Home on the Marseille Agglomeration|Not yet recruiting||N/A|50|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f|f|f||||||No||2017-10-10 21:12:05.604801|2017-10-10 21:12:05.604801
NCT03103646|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-23|||March 28, 2017|Actual|2017-03-28|May 2017|2017-05-01|November 10, 2017|Anticipated|2017-11-10|November 10, 2017|Anticipated|2017-11-10||Interventional|||Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women|Interventional, Open-label, One-sequence Crossover Study Evaluating the Effect of Multiple Doses of Itraconazole (Inhibitor of CYP3A4/5) on the Pharmacokinetics, Safety and Tolerability of Lu AF35700 in Healthy Young Men and Women|Recruiting||Phase 1|28|Anticipated|H. Lundbeck A/S||2|||f||||f|f|f||||||||2017-10-10 21:12:05.699487|2017-10-10 21:12:05.699487
NCT03103633|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-05|||March 5, 2017|Actual|2017-03-05|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||The Effects of Individualized Oxygen Dynamic on Prognosis of Patients With High-risk Cardiac Surgery|The Effects of Regulation in Individualized Oxygen Dynamics on the Prognosis of Patients With High-risk Cardiac Surgery:A Single Center, Prospective,Randomzied,Controlled,Double Blinded Study.|Recruiting||N/A|240|Anticipated|The First Affiliated Hospital of Anhui Medical University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:05.820558|2017-10-10 21:12:05.820558
NCT03103620|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-06|||September 10, 2015|Actual|2015-09-10|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|eCOBRA||Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry|Safety And Effectiveness Evaluation Of COBRA PzF™ Coronary Stent System: A French Observational Postmarketing Registry|Active, not recruiting||N/A|1027|Actual|CeloNova BioSciences, Inc.|||1||f||||f|f|f||||||No||2017-10-10 21:12:05.94234|2017-10-10 21:12:05.94234
NCT03103607|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-31|||January 1, 2010|Actual|2010-01-01|March 2017|2017-03-01|February 28, 2016|Actual|2016-02-28|December 31, 2014|Actual|2014-12-31||Observational|DISGO||Disappearance of Graves' Orbitopathy|Evaluation of the Disappearance of Graves' Orbitopathy in the Long Term|Completed||N/A|99|Actual|University of Pisa|||1||f||||f|f|f||||||No||2017-10-10 21:12:06.052143|2017-10-10 21:12:06.052143
NCT03103594|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-08|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A|Comparison of the Treatment of Refractory Bladder Pain Syndrome With Dimethyl Sulfoxide (DMSO) Alone and DMSO as a Carrier Molecule for Botulinum Toxin A Instillation.|Completed||Early Phase 1|2|Actual|University of Pennsylvania||2|||f||||t|t|f|||t|||No|No plan to share individual participant data.|2017-10-10 21:12:06.126963|2017-10-10 21:12:06.126963
NCT03103581|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects|A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects|Recruiting||Phase 2|60|Anticipated|Braintree Laboratories||1|||f||||f|t|f||||||No||2017-10-10 21:12:06.204231|2017-10-10 21:12:06.204231
NCT03103568|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-09|||March 28, 2017|Actual|2017-03-28|August 2017|2017-08-01|July 24, 2017|Actual|2017-07-24|June 10, 2017|Actual|2017-06-10||Interventional|||A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy Volunteers|An Open-label, Non-randomized, 2-arm, 2-period Fixed Sequence Phase 1 Study to Evaluate the Potential Inhibition of Nitisinone on Cytochrome P450 2C9, 2D6, and 2E1 and the Organic Anion Transporters OAT1 and OAT3 in Healthy Volunteers|Completed||Phase 1|36|Actual|Swedish Orphan Biovitrum||2|||f||||f|f|f|||f|||||2017-10-10 21:12:06.29021|2017-10-10 21:12:06.29021
NCT03103555|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-01|||February 27, 2017|Actual|2017-02-27|April 2017|2017-04-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Treatment of Adult-Onset Immunodeficiency With Bortezomib|Treatment of Anti-Interferon-Gamma Autoantibody Associated Acquired Immunodeficiency Syndrome With Bortezomib: Pilot Study|Recruiting||Phase 2|5|Anticipated|Mahidol University||1|||f||||f|f|f|||f|||No||2017-10-10 21:12:06.396259|2017-10-10 21:12:06.396259
NCT03103542|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-10-05|||August 29, 2017|Actual|2017-08-29|October 2017|2017-10-01|April 1, 2020|Anticipated|2020-04-01|February 1, 2019|Anticipated|2019-02-01||Interventional|ReITIrate||Study of rFVIIIFc for ITI in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies|A Non-Controlled, Open-Label, Multicenter, Study of Immune Tolerance Induction Performed With rFVIIIFc Within a Timeframe of 60 Weeks in Severe Haemophilia A Patients With Inhibitors Who Have Failed Previous Immune Tolerance Induction Therapies|Recruiting||Phase 4|20|Anticipated|Swedish Orphan Biovitrum||1|||f||||f|t|f|||t|||||2017-10-10 21:12:06.488022|2017-10-10 21:12:06.488022
NCT03103529|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-05-01|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|January 2017|Actual|2017-01-01||Interventional|||Safety and Feasibility of Early Active Rehabilitation in Children After Concussion|Safety and Feasibility of Early Active Rehabilitation in Children After Concussion|Active, not recruiting||N/A|20|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 21:12:06.580128|2017-10-10 21:12:06.580128
NCT03103516|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-01|2017-04-13|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Epidural Decompression Surgery Within 24 Hours After Acute Spinal Cord Injury Improves Spinal Nerve Function|Epidural Decompression Surgery Within 24 Hours After Acute Spinal Cord Injury Improves Spinal Nerve Function: a Prospective, Multicenter, Non-randomized, Controlled Trial|Not yet recruiting||N/A|200|Anticipated|Peking University People's Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:06.64751|2017-10-10 21:12:06.64751
NCT03103490|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-08-31|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||PET/MRI Imaging of Cardiac Sarcoidosis|18F-FSPG PET/MRI Imaging of Cardiac Sarcoidosis or Inflammation|Recruiting||Phase 2|20|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 21:12:06.915942|2017-10-10 21:12:06.915942
NCT03103477|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-04-18|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|December 30, 2018|Anticipated|2018-12-30|June 1, 2018|Anticipated|2018-06-01||Observational|||Platelet Activating Factor Stability in Urine|Platelet Activating Factor Stability in Urine|Enrolling by invitation||N/A|30|Anticipated|St. Louis University|||2||f||||f|f|f||||Samples Without DNA|"     This study is proposing to assess PAF and PAF-AH activity in urine after using various     handling methods of the urine specimen. Better understanding of PAF stability will allow for     better design of future experiments involving PAF in interstitial cystitis patients.   "|No||2017-10-10 21:12:06.992304|2017-10-10 21:12:06.992304
NCT03103464|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-19|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Sit-to-Stand Progression Using Movi Chair vs Traditional Practices|Sit-to-Stand Progression Using Movi Chair vs Traditional Practices|Not yet recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f|||f|||No||2017-10-10 21:12:07.063849|2017-10-10 21:12:07.063849
NCT03103451|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-14|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-121 in Healthy Subjects|A Comparative Randomized Single-Blind Placebo-controlled Study of the Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Single Escalating Subcutaneous Doses of BCD 121 in Healthy Volunteers|Completed||Phase 1|28|Actual|Biocad||7|||f|||||f|f||||||||2017-10-10 21:12:07.148971|2017-10-10 21:12:07.148971
NCT03103438|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-14|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||First-in-human Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-089 in Healthy Subjects|An Open-Label, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Dose of BCD-089 in Healthy Volunteers|Completed||Phase 1|19|Actual|Biocad||7|||f|||||f|f||||||||2017-10-10 21:12:07.232301|2017-10-10 21:12:07.232301
NCT03103425|ClinicalTrials.gov processed this data on October 10, 2017|2009-06-26|2017-03-31|||June 2009||2009-06-01|March 2017|2017-03-01|June 1, 2014|Actual|2014-06-01|June 1, 2014|Actual|2014-06-01||Observational|||Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings|Evaluation of StatNet Device for EEG Recordings|Completed||N/A|40|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-10 21:12:07.30909|2017-10-10 21:12:07.30909
NCT03103412|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-19|||May 4, 2017|Actual|2017-05-04|July 2017|2017-07-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)|Study 0146: A Phase 1a, Double-Blinded, Randomized, Placebo Controlled, Single Ascending Dose (SAD) Study to Evaluate the Safety, Tolerability, and Systemic Exposure of TD−3504 in Healthy Subjects and Subjects With Ulcerative Colitis (UC)|Recruiting||Phase 1|32|Anticipated|Theravance Biopharma R & D, Inc.||4|||f||||f|t|f||||||||2017-10-10 21:12:07.363045|2017-10-10 21:12:07.363045
NCT03103399|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-31|||September 26, 2006|Actual|2006-09-26|March 2017|2017-03-01|September 21, 2007|Actual|2007-09-21|September 21, 2007|Actual|2007-09-21||Interventional|||"Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With Wearingoff Phenomenon"|"A Multicentre, Double-blind, Randomised, Active- and Placebo-controlled Trial to Investigate the Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With Wearingoff Phenomenon Treated With Levodopa/Carbidopa or Levodopa/Benserazide"|Completed||Phase 2|254|Actual|Bial - Portela C S.A.||5|||f||||f|f|f||||||Undecided||2017-10-10 21:12:09.449761|2017-10-10 21:12:09.449761
NCT03103386|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-03-31|||April 2015||2015-04-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|September 2015|Actual|2015-09-01||Interventional|RyeClaim||Effects of Fermented Rye Bran Products on Helicobacter Pylori (HP) Infection and Metabolic Risk Factors|Effects of Fermented Rye Bran Products on HP Infection and Metabolic Risk Factors|Active, not recruiting||N/A|181|Actual|Fudan University||2|||f||||f||||||||No||2017-10-10 21:12:09.561246|2017-10-10 21:12:09.561246
NCT03103373|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-31|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Assessment of Plasma Lactate in Non-cardiac Surgery Monitoring by Transthoracic Echocardiography|Assessment of Plasma Lactate in Patients Underwent Non-cardiac Surgery Monitoring by Transthoracic Echocardiography|Recruiting||N/A|60|Anticipated|Federal University of Juiz de Fora||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:12:09.683711|2017-10-10 21:12:09.683711
NCT03103360|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|||Pupillary Pain Index and Reaction to Skin Incision|Relationship Between the Pupillary Pain Index Measured One Minute Before Incision and the Motor, Hemodynamic and Electroencephalographic Reaction to Skin Incision in Patients Under General Anesthesia|Completed||N/A|19|Actual|Hôpital Armand Trousseau|||1||f||||t||||||||No||2017-10-10 21:12:09.778002|2017-10-10 21:12:09.778002
NCT03103347|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-06|||March 17, 2014|Actual|2014-03-17|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Observational|PD-EEG||Quantification of Beta Activity in Routine EEG Recordings in Parkinson's Disease Patients|Quantification of Beta Activity in Routine EEG Recordings in Parkinson's|Completed||N/A|27|Actual|Duke University|||1||f||||f|f|f||||||No||2017-10-10 21:12:09.837975|2017-10-10 21:12:09.837975
NCT03103334|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||June 2014||2014-06-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||A Bioavailability Study of Methotrexate 25 mg Administered by Needle Injection and a Pre Filled Needle-free Device in Healthy Volunteers.|A Single Center Single Dose Open-label Randomized Two Period Crossover Study to Determine the Bioavailability of Two Formulations of Methotrexate 25 mg Administered by Needle Injection and a Pre-filled Needle-free Device in at Least 48 Healthy Volunteers.|Completed||Phase 1|58|Actual|Crossject||4|||f||||f||||||||No||2017-10-10 21:12:09.897824|2017-10-10 21:12:09.897824
NCT03103321|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-07-18|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer|Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men|Recruiting||Phase 3|172|Anticipated|Alliance for Clinical Trials in Oncology||4|||f||||t|f|f||||||||2017-10-10 21:12:09.974292|2017-10-10 21:12:09.974292
NCT03103308|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-31|||May 16, 2017|Actual|2017-05-16|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|HSCT||Hematopoetic Stem Cell Transplant and Physical Function|Effects of a Multidirectional Walking Program on Physical Function and Quality of Life in Hematopoetic Stem Cell Transplant Patients|Recruiting||N/A|40|Anticipated|University of Miami||2|||f|||||f|f||||||||2017-10-10 21:12:10.094964|2017-10-10 21:12:10.094964
NCT03103295|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-05-10|||November 20, 2015|Actual|2015-11-20|May 2017|2017-05-01|December 20, 2018|Anticipated|2018-12-20|December 20, 2018|Anticipated|2018-12-20||Interventional|3-D-TEBE||3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects|Safety and Efficacy Study of Traumatic Bone Defects Treatment With Use of 3D Tissue Engineered Equivalent.|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|A.A. Partners, LLC||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:12:10.168668|2017-10-10 21:12:10.168668
NCT03103282|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Post-market Clinical Study to Confirm Safety and Performance of PuraStat® Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery.|A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat® Absorbable Haemostatic Material for the Management of Bleeding In Vascular Surgery.|Not yet recruiting||N/A|65|Anticipated|3-D Matrix Europe SAS|||1||f||||||||||||||2017-10-10 21:12:10.243309|2017-10-10 21:12:10.243309
NCT03103269|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-02|2017-03-31|||September 2009||2009-09-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Challenge||Challenge! Adolescent Obesity Prevention|Challenge! in Baltimore City Middle Schools|Completed||N/A|789|Actual|University of Maryland||4|||f||||t||||||||||2017-10-10 21:12:10.296773|2017-10-10 21:12:10.296773
NCT03103256|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-07|||May 17, 2017|Actual|2017-05-17|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of YHP1701|A Multi-center, Randomized, Double-blind, Parallel-group Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP1701 Fixed Dose Combination in Patients With Dyslipidemia and Hypertension|Recruiting||Phase 3|114|Anticipated|Yuhan Corporation||3|||f||||f|f|f||||||||2017-10-10 21:12:10.480106|2017-10-10 21:12:10.480106
NCT03103243|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-30|||April 27, 2017|Actual|2017-04-27|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|LUPP||Pilot Study to Investigate Contemplative Intervention in Lupus Patients|A Pilot Study to Investigate a Contemplation-Based Intervention and Health Outcomes in Systemic Lupus Erythematosus Patients|Recruiting||N/A|44|Anticipated|University of Virginia||1|||f||||f|f|f||||||||2017-10-10 21:12:10.595414|2017-10-10 21:12:10.595414
NCT03103230|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-03-31|||April 2014|Actual|2014-04-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|APHA-TMS||Electro-physiological Signs to Prognostic Aphasia Recovery After a Stroke|Recherche de Marqueurs Pronostiques électro-physiologiques précoces Chez l'Aphasique après un Accident Vasculaire cérébral.APHA-TMS|Completed||N/A|130|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 21:12:10.711538|2017-10-10 21:12:10.711538
NCT03103217|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-03-31|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|January 2017|Actual|2017-01-01||Interventional|||Exploring the Effectiveness of a Brief CBT Intervention for Anxious Pregnant Women|Exploring the Effectiveness of a Brief CBT Intervention for Anxious Pregnant Women|Active, not recruiting||N/A|29|Actual|University of Edinburgh||1|||f||||f||||||||No||2017-10-10 21:12:10.796905|2017-10-10 21:12:10.796905
NCT03103204|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-11|||January 21, 2017|Actual|2017-01-21|April 2017|2017-04-01|December 28, 2017|Anticipated|2017-12-28|July 28, 2017|Anticipated|2017-07-28||Interventional|CLIMBEO||Treatment of Periodontitis in Obese Individuals|Clinical, Microbial and Biochemistry Evaluation of Obese Individuals Submitted to One-stage Full-mouth Disinfection. A Clinical Control Parallel Study|Recruiting||Phase 4|96|Anticipated|University of Taubate||5|||f||||t|f|f||||||No|IPD will not be shared|2017-10-10 21:12:10.896516|2017-10-10 21:12:10.896516
NCT03103191|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-31|||June 2016||2016-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|||Diagnostic Value of KL-6 in ILD|Diagnostic Value of KL-6 in Interstitial Lung Diseases|Recruiting||N/A|250|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||t|f|f||||||||2017-10-10 21:12:11.0043|2017-10-10 21:12:11.0043
NCT03103178|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-31|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01|6 Months|Observational [Patient Registry]|||Spanish Version of the KBILD Questionnaire|Translation Into Spanish of an Interstitial Lung Disease Quality of Life Questionnaire (KBILD)|Recruiting||N/A|100|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||t|f|f||||||||2017-10-10 21:12:11.086838|2017-10-10 21:12:11.086838
NCT03103165|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||October 2012||2012-10-01|March 2017|2017-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||SimCoach Evaluation: : A Virtual Human Intervention to Encourage Servicemember Help-seeking for PTSD and Depression|SimCoach Evaluation: A Virtual Human Intervention to Encourage Servicemember Help-seeking for PTSD and Depression|Completed||N/A|333|Actual|University of Southern California||3|||f||||t||||||||||2017-10-10 21:12:11.155872|2017-10-10 21:12:11.155872
NCT03102229|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-03-30|||July 2016||2016-07-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|RAMPART||Real-time Activity Monitoring to Prevent Admissions During RadioTherapy|Real-time Activity Monitoring to Prevent Admissions During RadioTherapy|Recruiting||N/A|40|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t|f|f||||||No||2017-10-10 21:12:19.223603|2017-10-10 21:12:19.223603
NCT03103152|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-04-05|||December 2016||2016-12-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|PROVENT||A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression|PROVENT: A Randomised, Double Blind, Placebo Controlled Feasibility Study to Examine the Clinical Effectiveness of Aspirin and/or Vitamin D3 to Prevent Disease Progression in Men on Active Surveillance for Prostate Cancer|Recruiting||Phase 2/Phase 3|102|Anticipated|Queen Mary University of London||6|||f||||t||||||||No||2017-10-10 21:12:11.233083|2017-10-10 21:12:11.233083
NCT03103139|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-03-30|||November 2016||2016-11-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Randomized Controlled Trial Of Endoscopic Stenting Across the Papilla Versus the Leak Site to Treat Bile Leak|Randomized Controlled Trial Of Endoscopic Stenting Across the Papilla Versus the Leak Site to Treat Bile Leak|Enrolling by invitation||N/A|92|Anticipated|University of Southern California||2|||f||||t||||||||No||2017-10-10 21:12:11.378503|2017-10-10 21:12:11.378503
NCT03103126|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-30|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|HOtBED||HOme-Based Exercise for Patients With Type 2 Diabetes|The Effects of HOme-Based Combined Exercise on Glycaemic Control and Anthropometric Measurements in Patients With Type 2 Diabetes|Not yet recruiting||N/A|18|Anticipated|University of Portsmouth||2|||f||||f|f|f||||||No|The data will be stored in link-anonymised form and will not be made available outside of the research team.|2017-10-10 21:12:11.469322|2017-10-10 21:12:11.469322
NCT03103113|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||April 30, 2012|Actual|2012-04-30|March 2017|2017-03-01|December 31, 2012|Actual|2012-12-31|December 31, 2012|Actual|2012-12-31||Observational|||The Evolution of Relationship Between Results of Peripheral Blood Test and Outcomes of in Vitro Fertilization|Division of Infertility, Lee Women's Hospital, Taichung, Taiwan|Completed||N/A|500|Actual|Chung Shan Medical University|||1||f||||||||||||Yes|IPD can be shared after manuscription publication|2017-10-10 21:12:11.546597|2017-10-10 21:12:11.546597
NCT03103100|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||October 8, 2015|Actual|2015-10-08|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation|Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation: A Prospective, Randomized, Double-Blind Study|Recruiting||Phase 3|45|Anticipated|University of Alabama at Birmingham||3|||f||||t|t|f|||t|||No||2017-10-10 21:12:11.607592|2017-10-10 21:12:11.607592
NCT03103087|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-07|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids|LIBERTY 2: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy & Safety Study of Relugolix Co-Administered With/Without Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids|Recruiting||Phase 3|390|Anticipated|Myovant Sciences GmbH||3|||f||||t|t|f||||||||2017-10-10 21:12:11.714838|2017-10-10 21:12:11.714838
NCT03103074|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-05|||May 24, 2017|Anticipated|2017-05-24|March 2017|2017-03-01|June 23, 2018|Anticipated|2018-06-23|November 23, 2017|Anticipated|2017-11-23||Interventional|||Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa|Randomized Double Blind Placebo Controlled Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa|Recruiting||N/A|20|Anticipated|University Hospital of North Norway||2|||f||||f|f|f||||||No||2017-10-10 21:12:11.79722|2017-10-10 21:12:11.79722
NCT03103061|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-05|||February 9, 2016|Actual|2016-02-09|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System|Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System|Recruiting||Phase 2|30|Anticipated|Medical University of South Carolina||1|||||||||||||||No||2017-10-10 21:12:11.888946|2017-10-10 21:12:11.888946
NCT03103048|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-18|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Application of Different Techniques of Elastic Bandage|Application of Different Techniques of Elastic Bandage: Quantification Electromyographic at the Isometric Effort of Flexor Muscle of Fist|Not yet recruiting||N/A|40|Anticipated|University of Mogi das Cruzes||4|||f||||t|f|f||||||Undecided||2017-10-10 21:12:11.970014|2017-10-10 21:12:11.970014
NCT03103035|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-04-05|||April 2014||2014-04-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Enhancing Knowledge Translation in Nutrition Through a Healthy Eating Blog|Enhancing Knowledge Translation in Nutrition Through a Healthy Eating Blog: A Mixed Methods Feasibility Study|Completed||N/A|80|Actual|Laval University||2|||f||||f||||||||No||2017-10-10 21:12:12.045558|2017-10-10 21:12:12.045558
NCT03103022|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-13|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|March 1, 2019|Anticipated|2019-03-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus|Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus in Premature Infants: A Pilot Study|Recruiting||Phase 1|20|Anticipated|University of Florida||1|||f||||t|t|f||||||No||2017-10-10 21:12:12.107276|2017-10-10 21:12:12.107276
NCT03103009|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-07|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|March 22, 2019|Anticipated|2019-03-22|March 22, 2019|Anticipated|2019-03-22||Interventional|||Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia|Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia|Recruiting||Phase 1|1|Anticipated|University of Colorado, Denver||1|||f||||f|t|f||||||Yes|Data will be shared with Novartis.|2017-10-10 21:12:12.334992|2017-10-10 21:12:12.334992
NCT03102996|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-08-09|||June 12, 2017|Actual|2017-06-12|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|April 2021|Anticipated|2021-04-01||Interventional|||Preserve-Transplant Study|Preservation of Kidney Function in Kidney Transplant Recipients by Alkali Therapy (Preserve-Transplant Study): a Multi-center Randomized Single-blind Placebo- Controlled Trial|Recruiting||Phase 4|300|Anticipated|University of Zurich||2|||f|||||f|f||||||||2017-10-10 21:12:12.428679|2017-10-10 21:12:12.428679
NCT03102983|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-05|||October 6, 2016|Actual|2016-10-06|March 2017|2017-03-01|May 6, 2018|Anticipated|2018-05-06|April 6, 2018|Anticipated|2018-04-06||Interventional|NEUROPHONE||Sensory-motor Interactions in the Perception of Vowels: a Study in Repetition - Suppression|Sensory-motor Interactions in the Perception of Vowels: a Study in Repetition - Suppression|Recruiting||N/A|25|Anticipated|University Hospital, Grenoble||1|||f||||f|f|f||||||No||2017-10-10 21:12:12.532541|2017-10-10 21:12:12.532541
NCT03102970|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-09-22|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MorphoCOPD1b||Pain Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.|Morpho-COPD1b : Pain Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.|Recruiting||N/A|50|Anticipated|University Hospital, Grenoble|||1||f||||f|f|f||||||||2017-10-10 21:12:12.63885|2017-10-10 21:12:12.63885
NCT03102957|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-05|||June 17, 2009|Actual|2009-06-17|March 2017|2017-03-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|||Cartography of Functional and Epileptic Cerebral Areas by Functional MRI and Electroencephalography in Epileptic Patients Before and After Surgery|Cartography of Functional and Epileptic Cerebral Areas by Functional MRI and Electroencephalography in Epileptic Patients Before and After Surgery|Completed||N/A|80|Actual|University Hospital, Grenoble||2|||f||||f|f|f||||||No||2017-10-10 21:12:12.725285|2017-10-10 21:12:12.725285
NCT03102944|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-07|||March 21, 2017|Actual|2017-03-21|March 2017|2017-03-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Observational|||Determining Normal Values of BNP Levels for the Minicare BNP IVD Assay.|Minicare BNP Normal Value Study - MI-BNP-CE02-NV2016|Completed||N/A|160|Actual|Philips Handheld Diagnostics|||1||f|||||f|f||||Samples Without DNA|"     Leftover plasma samples (without cells/ RNA/DNA) will be aliquoted and stored at Sponsor for     potential future analysis/ projects.   "|No||2017-10-10 21:12:12.797477|2017-10-10 21:12:12.797477
NCT03102931|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-06-23|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Switching to Low Oxidant Content Cigarettes in Adult Smokers|Switching to Low Oxidant Content Cigarettes in Adult Smokers|Not yet recruiting||N/A|30|Anticipated|Milton S. Hershey Medical Center||1|||f|||||f|f|||t|||Undecided|At this time we have no plan for sharing, however if need should arise, then sharing may be a possibility.|2017-10-10 21:12:12.862279|2017-10-10 21:12:12.862279
NCT03102918|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-26|||February 20, 2016|Actual|2016-02-20|April 2017|2017-04-01|January 20, 2018|Anticipated|2018-01-20|January 20, 2018|Anticipated|2018-01-20||Interventional|CBD||Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder|Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder|Recruiting||Phase 1|60|Anticipated|Mclean Hospital||2|||f||||f|t|f||||||No||2017-10-10 21:12:12.953913|2017-10-10 21:12:12.953913
NCT03102905|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||December 13, 2016|Actual|2016-12-13|March 2017|2017-03-01|June 13, 2017|Anticipated|2017-06-13|June 13, 2017|Anticipated|2017-06-13||Observational|REPLIPO||Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema?|Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema?|Recruiting||N/A|45|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:12:13.074682|2017-10-10 21:12:13.074682
NCT03102892|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-03-30|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|December 10, 2018|Anticipated|2018-12-10|October 10, 2018|Anticipated|2018-10-10||Interventional|||Antimicrobial Photodynamic Therapy on Periodontal Treatment and Salivary Status of Type 1 Diabetes Mellitus Patients|Adjuvant Effect of Antimicrobial Photodynamic Therapy on Periodontal Treatment and Salivary Status of Type 1 Diabetes Mellitus Patients|Recruiting||N/A|60|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||No||2017-10-10 21:12:13.161597|2017-10-10 21:12:13.161597
NCT03102879|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-05|||September 23, 2016|Actual|2016-09-23|April 2017|2017-04-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|RanoKure||Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.|Encapsulated Mesenchymal Stem Cells for Endodontic Treatment of Permanent Teeth With Apical Lesion: a Controlled Clinical Trial.|Recruiting||Phase 1/Phase 2|40|Anticipated|Universidad Los Andes, Chile||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:13.266106|2017-10-10 21:12:13.266106
NCT03102866|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-10-05|||August 30, 2017|Actual|2017-08-30|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer|Can Aerobic and Strength Training Exercise Initiated During and Continued After Radiation Therapy for Breast Cancer Improve Fitness and Arm Health 1 Year Later?|Recruiting||N/A|44|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t|f|f||||||||2017-10-10 21:12:13.387441|2017-10-10 21:12:13.387441
NCT03102853|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-31|||August 15, 2016|Actual|2016-08-15|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Healthy Nordic Foods to Prevent Cardiometabolic Risk in Obese Subjects|Effects of a Healthy Nordic Diet on Abdominal Obesity, Body Weight Maintenance and Cardiometabolic Risk: a 2-year Randomised Controlled Study|Recruiting||N/A|80|Anticipated|Lund University||2|||f|||||f|f||||||||2017-10-10 21:12:13.527844|2017-10-10 21:12:13.527844
NCT03102840|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-13|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|May 17, 2018|Anticipated|2018-05-17||Observational|||Understanding Pneumococcal Carriage and Disease 2017/2018|Cross-sectional Study to Establish the Point Prevalence of Serotype 19A Pneumococcal Nasopharyngeal Carriage of Fully Vaccinated Children Aged 13-48 Months 7 Years Following Introduction of PCV-13|Recruiting||N/A|1600|Anticipated|University of Oxford|||2||f||||t|f|f||||Samples Without DNA|"     Bacteria grown from nasopharyngeal swabs Serum to measure serotype specific antibodies levels   "|||2017-10-10 21:12:13.640351|2017-10-10 21:12:13.640351
NCT03102827|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-11|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|FLOAT-CS||High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure|High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure|Recruiting||Phase 3|20|Anticipated|Heart and Diabetes Center North-Rhine Westfalia||2|||f||||f|f|f||||||No||2017-10-10 21:12:13.752239|2017-10-10 21:12:13.752239
NCT03102814|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-09-12|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|BRIDGE||The BRIDGE Rehabilitation Trial|The BRIDGE Trial: A Multicenter RCT to Improve Continuity and Quality in Rehabilitation of People With Rheumatic and Musculoskeletal Diseases|Recruiting||N/A|500|Anticipated|National Resource Center for Rehabilitation in Rheumatology||2|||f||||f|f|f||||||||2017-10-10 21:12:13.878166|2017-10-10 21:12:13.878166
NCT03102788|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-08-04|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|December 31, 2021|Anticipated|2021-12-31|December 15, 2018|Anticipated|2018-12-15||Interventional|||Task Shifting in the Care for Patients With Hand Osteoarthritis|Task Shifting in the Care for Patients With Hand Osteoarthritis: May the First Consultation in Specialist Health Care be Performed by an Occupational Therapy Specialist?|Not yet recruiting||N/A|400|Anticipated|National Resource Center for Rehabilitation in Rheumatology||2|||f||||f|f|f||||||||2017-10-10 21:12:14.131144|2017-10-10 21:12:14.131144
NCT03102775|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-05|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|December 30, 2021|Anticipated|2021-12-30|May 30, 2019|Anticipated|2019-05-30||Interventional|CRCT-HOLF||Comprehensive Follow-up of Low Income Families. A Cluster-randomized Study|A Cluster-randomised Study Evaluating the Effectiveness of a Skill-training Programme for Social Work Professionals for Improving the Follow-up of Low Income Families Within Norwegian Welfare Services|Recruiting||N/A|650|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f|f|f||||||No|After embargo + 5 years after finishing study (2026)|2017-10-10 21:12:14.280906|2017-10-10 21:12:14.280906
NCT03102762|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-05|||January 3, 2017|Actual|2017-01-03|April 2017|2017-04-01|March 3, 2018|Anticipated|2018-03-03|January 3, 2018|Anticipated|2018-01-03||Interventional|||Botulinum Toxin for Erectile Dysfunction|Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Erectile Dysfunction (Phase 2 Study)|Recruiting||Phase 2/Phase 3|160|Anticipated|Cairo University||2|||f||||t|t|f|||t|||Undecided||2017-10-10 21:12:14.464918|2017-10-10 21:12:14.464918
NCT03102749|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-03-30|||June 2012||2012-06-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|March 2013|Actual|2013-03-01||Observational|SCANN'AIR||Mechanism and Dynamics of Bronchial Hyper-reactivity to Methacholine in Distal Airway on Obese Patients With Asthma|Mechanism and Dynamics of Bronchial Hyper-reactivity to Methacholine in Distal Airway on Obese Patients With Asthma|Completed||N/A|35|Actual|University Hospital, Montpellier|||3||f||||f||||||||||2017-10-10 21:12:14.587019|2017-10-10 21:12:14.587019
NCT03102736|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-04-13|||February 14, 2017|Actual|2017-02-14|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Ketamine and Nitroprusside for Depression|Pharmacologic Attenuation of Ketamine Using Nitroprusside|Recruiting||Phase 2|100|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:14.681732|2017-10-10 21:12:14.681732
NCT03102723|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-03-30|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|February 2020|Anticipated|2020-02-01||Interventional|PITRI||Platelet Inhibition to Target Reperfusion Injury|Platelet Inhibition to Target Reperfusion Injury|Not yet recruiting||Phase 2|210|Anticipated|National Heart Centre Singapore||2|||f||||t|t|f|||t|||No||2017-10-10 21:12:14.79557|2017-10-10 21:12:14.79557
NCT03102710|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-04-05|||May 2016||2016-05-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Neuromodulation of Lidocaine and Capsaicin Cream Effects on Pain Experience|Neuromodulation of Placebo and Nocebo Effects|Recruiting||N/A|78|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||No||2017-10-10 21:12:14.923334|2017-10-10 21:12:14.923334
NCT03102697|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-30|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|October 1, 2017|Anticipated|2017-10-01||Observational|||Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons in the Treatment of Obesity|Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons (Heliosphere Bag®) in the Treatment of Obesity: A Prospective Clinical Study|Recruiting||N/A|30|Anticipated|Kaiser Clinic and Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:12:15.023821|2017-10-10 21:12:15.023821
NCT03102684|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-10|||September 2016||2016-09-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|December 2017|Anticipated|2017-12-01||Interventional|TackSHSWP6||Impact of Secondhand Exposure to E-cigarettes Aerosols on the Respiratory System|Clinical Impact of Secondhand Exposure to Aerosols Produced by E-cigarettes on the Respiratory System (TackSHS Project)|Active, not recruiting||N/A|40|Anticipated|Institut Català d'Oncologia||3|||f||||t|f|f||||||No||2017-10-10 21:12:15.128653|2017-10-10 21:12:15.128653
NCT03102671|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-30|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Effectiveness of the HeartHab Application on Exercise Capacity in Patients With Coronary Artery Disease|HeartHab: a Prospective Cross-over Trial Investigating the Effectiveness of an App Based Telerehabilitation Program on Exercise Capacity, Lifestyle and Risk Factors in Patients With Coronary Artery Disease|Recruiting||N/A|30|Anticipated|Hasselt University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:12:15.364635|2017-10-10 21:12:15.364635
NCT03102658|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-26|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|MICADO||Micafungin Pharmacokinetics in Obese Patients|Micafungin (Mycamine®) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (MICADO).|Completed||Phase 4|24|Actual|Radboud University||3|||f||||f||||||||||2017-10-10 21:12:15.577331|2017-10-10 21:12:15.577331
NCT03102645|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-26|||May 16, 2017|Actual|2017-05-16|September 2017|2017-09-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|||Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter?|Effect of Single Dose Imipramine on the Urethral and Anal Sphincter in Healthy Women Measured With Urethral Pressure Reflectometry (UPR) and Anal Acoustic Reflectometry (AAR)|Completed||Phase 1|16|Actual|Bispebjerg Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:12:15.693356|2017-10-10 21:12:15.693356
NCT03102632|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-12|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease|A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease|Recruiting||N/A|32|Anticipated|The Rogosin Institute||2|||f||||f|f|f||||||Undecided||2017-10-10 21:12:15.789558|2017-10-10 21:12:15.789558
NCT03102619|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-30|||March 23, 2017|Actual|2017-03-23|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|WARD||Wireless Assessment of Respiratory and Circulatory Distress; A Pilot Study|Wireless Assessment of Respiratory and Circulatory Distress; A Pilot Study|Recruiting||N/A|50|Anticipated|Bispebjerg Hospital|||1||f|||||f|f||||||||2017-10-10 21:12:15.90584|2017-10-10 21:12:15.90584
NCT03102242|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-14|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Atezolizumab Immunotherapy in Patients With Advanced NSCLC|Phase II Trial of Induction Immunotherapy With Atezolizumab for Patients With Unresectable Stage IIIA and IIIB NSCLC Eligible for Chemoradiotherapy With Curative Intent.|Not yet recruiting||Phase 2|63|Anticipated|Alliance Foundation Trials, LLC.||1|||f||||t|t|f|||f|||||2017-10-10 21:12:19.136831|2017-10-10 21:12:19.136831
NCT03102606|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-30|||March 13, 2017|Actual|2017-03-13|November 2016|2016-11-01|June 15, 2018|Anticipated|2018-06-15|March 15, 2018|Anticipated|2018-03-15||Interventional|Protective-1||Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy|A Phase 2/3, Multicenter, Randomized, Double Blind, Study to Evaluate Duration of Severe Neutropenia With Plinabulin Versus Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy (Protective 1)|Recruiting||Phase 2/Phase 3|170|Anticipated|BeyondSpring Pharmaceuticals Inc.||4|||f||||t|t|f||||||No||2017-10-10 21:12:15.989081|2017-10-10 21:12:15.989081
NCT03102593|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-04|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP|A Randomized, Double-blind, Placebo-controlled, Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Primary Immune Thrombocytopenia|Recruiting||Phase 2|36|Anticipated|arGEN-X BVBA||3|||f||||t|f|f||||||||2017-10-10 21:12:16.115302|2017-10-10 21:12:16.115302
NCT03102580|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-03-30|||September 1, 2017|Anticipated|2017-09-01|March 2017|2017-03-01|October 17, 2021|Anticipated|2021-10-17|April 16, 2021|Anticipated|2021-04-16||Interventional|||Development of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions|Patient Osteoarthritis Care Plan To Inform Optimal Treatment|Not yet recruiting||N/A|8000|Anticipated|University of Massachusetts, Worcester||2|||f||||f|f|f||||||No|There is no plan to make individual participant data available to other researchers|2017-10-10 21:12:16.253765|2017-10-10 21:12:16.253765
NCT03102567|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-30|||October 18, 2016|Actual|2016-10-18|March 2017|2017-03-01|February 13, 2017|Actual|2017-02-13|February 13, 2017|Actual|2017-02-13||Interventional|||This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects|Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect of Aging of Multiple Oral Doses of GLPG1205 in Healthy Male Subjects|Completed||Phase 1|32|Actual|Galapagos NV||3|||f|||||f|f||||||||2017-10-10 21:12:16.353223|2017-10-10 21:12:16.353223
NCT03102554|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-30|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Genetics of Disorders of Sex Development and Hypospadias|Utilizing Whole Exome Sequencing and Genomics to Improve Our Understanding of Disorders of Sex Development (DSD) and Hypospadias|Not yet recruiting||N/A|300|Anticipated|Boston Children’s Hospital||1|||f||||f|f|f||||||||2017-10-10 21:12:16.465792|2017-10-10 21:12:16.465792
NCT03102541|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||November 1, 2014|Actual|2014-11-01|April 2017|2017-04-01|June 1, 2016|Actual|2016-06-01|October 31, 2015|Actual|2015-10-31||Observational|||Effects of Oral Protein Load on Kidney Function in Patients Undergoing Cardiac Surgery|Effects of Oral Protein Load on Kidney Function in Patients Undergoing Cardiac Surgery - A Matched Case-control Study|Completed||N/A|214|Actual|University of Giessen|||1||f||||f|f|f||||||No||2017-10-10 21:12:16.568905|2017-10-10 21:12:16.568905
NCT03102528|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||November 1, 2014|Actual|2014-11-01|March 2017|2017-03-01|June 20, 2016|Actual|2016-06-20|October 31, 2015|Actual|2015-10-31||Observational|||Acute Kidney Injury and Renal Recovery After Cardiac Surgery|Acute Kidney Injury and Renal Recovery After Cardiac Surgery - A Retrospective Single-center Study|Completed||N/A|546|Actual|University of Giessen|||1||f||||f|f|f||||||No||2017-10-10 21:12:16.643795|2017-10-10 21:12:16.643795
NCT03102515|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||May 29, 2016|Actual|2016-05-29|March 2017|2017-03-01|October 26, 2016|Actual|2016-10-26|October 26, 2016|Actual|2016-10-26||Interventional|TAP-CAT||Transversus Abdominis Plane Block vs Continuous Infiltration Wound Catheter for Analgesia After Caesarean Section|Transversus Abdominis Plane Block vs Continuous Infiltration Wound Catheter for Analgesia After Caesarean Section: a Randomized Trial. (TAP-CAT Study)|Completed||Phase 4|109|Actual|University Hospital, Caen||2|||f||||||||||||||2017-10-10 21:12:16.7245|2017-10-10 21:12:16.7245
NCT03102502|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|January 10, 2018|Anticipated|2018-01-10|October 10, 2017|Anticipated|2017-10-10||Interventional|EECPVHS||Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status|Study of the Effects of Enhanced External Counterpulsation on Vascular Hemodynamics and Status|Recruiting||N/A|110|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||No||2017-10-10 21:12:16.811753|2017-10-10 21:12:16.811753
NCT03102489|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-15|||February 22, 2017|Actual|2017-02-22|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|June 21, 2017|Actual|2017-06-21||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers|Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP101 After Multiple Doses Administration in Healthy Volunteers|Active, not recruiting||Phase 1|18|Actual|Ivix LLX||2|||f||||f|f|f||||||||2017-10-10 21:12:16.917095|2017-10-10 21:12:16.917095
NCT03102476|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-07-22|||June 2016||2016-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Environmental Effects Type 1 Diabetes Mellitus|A Study to Assess Environmental Effects of Temperature and Humidity on Pharmacokinetics and Pharmacodynamics of Prandial Insulin in Subjects With Type 1 Diabetes|Recruiting||N/A|10|Anticipated|University of Hull||1|||f||||||||||||||2017-10-10 21:12:17.015304|2017-10-10 21:12:17.015304
NCT03102463|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-10|||October 2015||2015-10-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||The Role of Milk Derived Peptides on Glycaemic Control|The Role of Milk Derived Peptides on Glycaemic Control|Completed||N/A|6|Actual|University College Dublin||3|||f||||t||||||||||2017-10-10 21:12:17.109242|2017-10-10 21:12:17.109242
NCT03102450|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-30|||May 31, 2017|Anticipated|2017-05-31|March 2017|2017-03-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|BZK40+||Contraceptive Efficacy, Tolerance and Acceptability of a Benzalkonium Chloride Spermicide Cream In Women Aged Over 40 Years of Age|Contraceptive Efficacy, Tolerance and Acceptability of a Benzalkonium Chloride Spermicide Cream In Women Aged Over 40 Years of Age|Not yet recruiting||Phase 4|150|Anticipated|Laboratoire Innotech International||1|||f||||f|f|f||||||No||2017-10-10 21:12:17.206969|2017-10-10 21:12:17.206969
NCT03102437|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-19|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15||Interventional|FIX-HF-5CA||Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System|FIX-HF-5CA: Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%|Recruiting||N/A|250|Anticipated|Impulse Dynamics||1|||f||||f|f|t|f|||||||2017-10-10 21:12:17.302938|2017-10-10 21:12:17.302938
NCT03102424|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-07-06|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus|A Prospective, Double Blind, Randomized, Placebo- Controlled Trial of Transcutaneous Electrical Nerve Stimulator (DW1330) to Improve Blood Glucose Control in Patients With Type 2 Diabetes|Recruiting||N/A|160|Anticipated|Taiwan Resonant Waves Research Corporation||2|||f||||f|f|f||||||||2017-10-10 21:12:17.426117|2017-10-10 21:12:17.426117
NCT03102411|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-10|||March 9, 2017|Actual|2017-03-09|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Impact of Diet on Functional Gastrointestinal Symptoms|Impact of Diet on Functional Gastrointestinal Symptoms; a National Population Based Survey|Active, not recruiting||N/A|1718|Actual|TriHealth Inc.|||1||f||||f|f|f||||||No||2017-10-10 21:12:17.541188|2017-10-10 21:12:17.541188
NCT03102398|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-06-28|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||A Study in Healthy Volunteers and Erectile Dysfunction Patients With Erectile Dysfunction|An Open-Label Phase I/IIa Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients|Recruiting||Phase 1/Phase 2|26|Anticipated|Tritech Biopharmaceuticals Co., Ltd.||1|||f||||f|f|f|||f|||No||2017-10-10 21:12:17.614965|2017-10-10 21:12:17.614965
NCT03102385|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-04|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|April 3, 2019|Anticipated|2019-04-03|April 3, 2019|Anticipated|2019-04-03||Interventional|||A Survey of Attitudes of Experienced Blood Donors|A Survey of Attitudes of Experienced Blood Donors|Enrolling by invitation||N/A|1000|Anticipated|Ohio University||2|||f||||f|f|f||||||Yes|De-identified participant data may be obtained after data collection is completed. Individual participant data requests should be directed to the Principal Investigator.|2017-10-10 21:12:17.701315|2017-10-10 21:12:17.701315
NCT03102372|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-05|||January 8, 2016|Actual|2016-01-08|February 2017|2017-02-01|May 2, 2016|Actual|2016-05-02|April 4, 2016|Actual|2016-04-04||Interventional|||Preservation of Fat Free Mass During Weight Loss|Preservation of Fat Free Mass During Weight Loss|Completed||N/A|29|Actual|University of Aarhus||2|||f||||t|f|f|||f|||No||2017-10-10 21:12:17.789383|2017-10-10 21:12:17.789383
NCT03102359|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-05|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Brain Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation|Cerebral Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation|Recruiting||Phase 2|100|Anticipated|Huazhong University of Science and Technology||4|||f||||f|f|f||||||No||2017-10-10 21:12:17.884579|2017-10-10 21:12:17.884579
NCT03102346|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-04-09|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|ASSIST||efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs|A Perspective Randomized Controlled Clinical Trial to Investigate the Effect of Home-based Cardiac Rehabilitation Monitored by Mobile Phone Interaction on Exercise Capacity and One-year Clinical Outcome in Chinese Revascularized Patients|Not yet recruiting||N/A|2000|Anticipated|Chinese PLA General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:12:17.968249|2017-10-10 21:12:17.968249
NCT03102333|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-30|||January 2017||2017-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparison: Constant-rate Infusion Plus Demanding Dosing VS Variable-rate Feedback Infusion Plus Demanding Dosing|Comparison: Constant-rate Infusion Plus Demanding Dosing VS Variable-rate|Recruiting||N/A|78|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:12:18.062245|2017-10-10 21:12:18.062245
NCT03102307|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-30|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|October 1, 2019|Anticipated|2019-10-01|February 28, 2019|Anticipated|2019-02-28||Observational|||Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)|A Prospective, Multicenter, Registry Trial to Evaluate Utilization Frequency and Feasibility of Targeted Axillary Dissection (TAD) After Needle Biopsy and Clip Placement in Early Breast Cancer With Clinically Affected Lymph Nodes|Recruiting||N/A|300|Anticipated|Kliniken Essen-Mitte|||3||f||||t|f|f||||||No||2017-10-10 21:12:18.443496|2017-10-10 21:12:18.443496
NCT03102294|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-03|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Inspiratory Muscle Training in Chronic Thromboembolic Pulmonary Hypertension|Inspiratory Muscle Training in Patients With Chronic Thromboembolic Pulmonary Hypertension: a Randomized Controlled Trial|Not yet recruiting||N/A|32|Anticipated|Federal University of São Paulo||2|||f||||f|f|f||||||||2017-10-10 21:12:18.745525|2017-10-10 21:12:18.745525
NCT03102281|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-30|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Observational|||Microbiomes in Patients of Recurrent Common Bile Duct Stones|Gastrointestinal Microbiomes in Patients of Recurrent Common Bile Duct Stones After Endoscopic Sphincterotomy（EST）|Recruiting||N/A|100|Anticipated|The Second Hospital of Nanjing Medical University|||2||f||||t|f|f||||||No||2017-10-10 21:12:18.866412|2017-10-10 21:12:18.866412
NCT03102268|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-30|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31|3 Years|Observational [Patient Registry]|||ncRNAs in Exosomes of Cholangiocarcinoma|Exosomes-derived ncRNAs As Biomarkers In Cholangiocarcinoma Patients|Recruiting||N/A|80|Anticipated|The Second Hospital of Nanjing Medical University|||2||f||||t|f|f||||||No||2017-10-10 21:12:18.956509|2017-10-10 21:12:18.956509
NCT03102216|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-08|||February 13, 2017|Actual|2017-02-13|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|EPOC-BEX-ED||Early Point-Of-Care Blood Tests, ECG & X-rays in the Emergency Department|An Assessment of the Impact of Enhanced Workflow Patterns Associated With Upfront, Early Point-of-care Testing on Costs, Waiting and Disposition Times in an Emergency Department|Completed||N/A|1134|Actual|Helen Joseph Hospital||12|||f||||f|f|f||||||||2017-10-10 21:12:19.346225|2017-10-10 21:12:19.346225
NCT03102203|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-30|||June 8, 2016|Actual|2016-06-08|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|||Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging|Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Prospective Multicenter Clinical Trial With Multimodality MR Imaging|Recruiting||N/A|350|Anticipated|Nanjing Jinling Hospital|||1||f|||||f|f||||||||2017-10-10 21:12:19.493973|2017-10-10 21:12:19.493973
NCT03102190|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-06-07|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|||Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps|Phase Ib/II Clinical Trial of Topical Verapamil Hydrochloride for Chronic Rhinosinusitis With Nasal Polyps|Recruiting||Phase 1/Phase 2|40|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||t|t|f||||||No||2017-10-10 21:12:19.575413|2017-10-10 21:12:19.575413
NCT03102177|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-04|||May 31, 2011|Actual|2011-05-31|March 2017|2017-03-01|July 26, 2016|Actual|2016-07-26|November 30, 2013|Actual|2013-11-30||Interventional|||Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics|Hypothyroidism Treatment in Aging and Thyroid Cancer|Completed||Early Phase 1|41|Actual|Georgetown University||1|||f||||f|t|f|||f|||No||2017-10-10 21:12:19.707235|2017-10-10 21:12:19.707235
NCT03102164|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-29|||April 21, 2016|Actual|2016-04-21|March 2017|2017-03-01|July 7, 2018|Anticipated|2018-07-07|December 21, 2017|Anticipated|2017-12-21||Observational|||Skeletal Muscles in Acute Heart Failure|Evaluation of Skeletal Muscles During Acute Heart Failure|Recruiting||N/A|30|Anticipated|University School of Physical Education in Wroclaw|||2||f||||f|f|f||||Samples Without DNA|"     Collection of blood samples for centrifugation, pipetting, frozing and the anaysis of     ferritin, iron, albumin + protein + bilirubin, GGT, AST + ALT, hsCRP, NTproBNP, creatinine,     complete blood count with smear creatine kinase + enzymes, CK-mass, venous blood gasometry   "|No||2017-10-10 21:12:19.802512|2017-10-10 21:12:19.802512
NCT03102151|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-03-29|||May 2014||2014-05-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|ReduceDUP||Reducing the Duration of Untreated Psychosis|Reducing the Duration of Untreated Psychosis Through Community Education|Recruiting||N/A|145|Anticipated|University of Southern California|||1||f||||t||||||||No||2017-10-10 21:12:19.933228|2017-10-10 21:12:19.933228
NCT03102138|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-09-13|||September 21, 2016|Actual|2016-09-21|September 2017|2017-09-01|October 4, 2020|Anticipated|2020-10-04|October 4, 2020|Anticipated|2020-10-04||Observational|||Retinal Pigment Epithelium Safety Study For Patients In B4711001|Long Term, Open-label, Safety Follow Up Study Following Transplantation Of Pf-05206388 (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (Rpe)) In Subjects With Acute Wet Age Related Macular Degeneration And Recent Rapid Vision Decline|Recruiting||N/A|10|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 21:12:20.04156|2017-10-10 21:12:20.04156
NCT03102125|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-03-29|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Stress Cardiac MRI in Heart Transplant|Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction|Not yet recruiting||Phase 4|36|Anticipated|University of California, San Diego||2|||||||f|t|f||||||No||2017-10-10 21:12:20.125576|2017-10-10 21:12:20.125576
NCT03102112|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-03-30|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|March 3, 2018|Anticipated|2018-03-03|April 10, 2017|Anticipated|2017-04-10||Observational|NPGSOG||Noninvasively Predicting Gene Status of Glioma|Noninvasively Predicting Isocitrate Dehydrogenase Gene Status in Glioma by Amide Proton Transfer Imaging|Enrolling by invitation||N/A|50|Anticipated|Tang-Du Hospital|||1||f||||t|f|f||||||Undecided||2017-10-10 21:12:20.254744|2017-10-10 21:12:20.254744
NCT03102099|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-29|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Contrast-enhanced Ultrasound-guided Fine-needle Aspiration Biopsy in the Evaluation of Thyroid Nodules|Application Value of Contrast-enhanced Ultrasound-guided Fine-needle Aspiration Biopsy in the Evaluation of Thyroid Nodules|Active, not recruiting||N/A|400|Anticipated|Peking University Third Hospital|||2||f||||t|f|f||||||Undecided||2017-10-10 21:12:20.359713|2017-10-10 21:12:20.359713
NCT03102086|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Observational|||The Association Between Nephrolithiasis and Periodontal Status|The Association Between Nephrolithiasis and Periodontal Status|Not yet recruiting||N/A|20|Anticipated|Rambam Health Care Campus|||1||f||||f|f|f||||Samples Without DNA|"     kidney stones and dental calculus   "|No||2017-10-10 21:12:20.45455|2017-10-10 21:12:20.45455
NCT03102073|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-29|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|March 30, 2017|Actual|2017-03-30|February 27, 2017|Actual|2017-02-27||Observational|||Validation of Romanian Version of Radner Reading Charts|Validation of Romanian Version of Radner Reading Charts|Completed||N/A|70|Actual|Opera Contract Research Organization SRL|||1||f||||f|f|f||||||No||2017-10-10 21:12:20.535793|2017-10-10 21:12:20.535793
NCT03102060|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-21|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|||Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant|Gluten Free Diet for GVHD Prophylaxis|Recruiting||N/A|70|Anticipated|Rutgers, The State University of New Jersey||1|||f|||||f|f||||||||2017-10-10 21:12:20.621194|2017-10-10 21:12:20.621194
NCT03102047|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-07|||October 2017|Anticipated|2017-10-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer|A Phase II Study to Assess the Activity of PD-L1 Inhibition With Durvalumab (MEDI4736) After Chemo-Radiotherapy in Patients With Stage II-IV Microsatellite Stable (MSS) Rectal Cancer|Not yet recruiting||Phase 2|47|Anticipated|NSABP Foundation Inc||1|||f||||f|t|f||||||||2017-10-10 21:12:20.750735|2017-10-10 21:12:20.750735
NCT03101696|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-05|||February 5, 2017|Actual|2017-02-05|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Determination of Coronarphysiological Parameters With the Method of Thermodillution|Determination of Coronarphysiological Parameters With the Method of Thermodillution|Recruiting||N/A|50|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f|f|f||||||Yes||2017-10-10 21:12:23.777191|2017-10-10 21:12:23.777191
NCT03102034|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-18|||March 30, 2017|Actual|2017-03-30|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age|Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, D46/NS2/N/ΔM2-2-HindIII, Lot RSV#011B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age|Recruiting||Phase 1|33|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 21:12:20.855819|2017-10-10 21:12:20.855819
NCT03102021|ClinicalTrials.gov processed this data on October 10, 2017|2007-12-26|2017-03-30|||March 2006||2006-03-01|March 2017|2017-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Human Recombinant Erythropoietin in Acute Renal Failure|The Effect of High Dose Erythropoietin in Acute Renal Failure|Completed||Phase 2|25|Actual|North Texas Veterans Healthcare System||2|||f||||t|t|f||||||No||2017-10-10 21:12:21.008778|2017-10-10 21:12:21.008778
NCT03102008|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-29|||January 12, 2017|Actual|2017-01-12|March 2017|2017-03-01|July 15, 2018|Anticipated|2018-07-15|January 11, 2018|Anticipated|2018-01-11||Interventional|||Unified Protocol for Adolescents (UP-A) Change Processes|An Analysis of Change Processes in the Transdiagnostic Treatment of Emotional Disorders in Adolescents|Recruiting||N/A|12|Anticipated|University of Miami||4|||f||||f|f|f||||||No||2017-10-10 21:12:21.117141|2017-10-10 21:12:21.117141
NCT03101995|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-05-11|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 1, 2019|Anticipated|2019-07-01|January 31, 2018|Anticipated|2018-01-31||Interventional|||Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease|A Phase II Clinical Trial to Evaluate the Potential of Concomitant Chemoradiotherapy With Gemcitabine in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease|Not yet recruiting||Phase 2|18|Anticipated|National Institute of Cancerología||1|||f||||t|f|f|||f|||No||2017-10-10 21:12:21.295028|2017-10-10 21:12:21.295028
NCT03101982|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-31|||March 2018|Anticipated|2018-03-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Hyperbaric Oxygenation (HBO) in Traumatic Spinal Cord Injury. (EOS) - Pilot Study|Hyperbaric Oxygenation (HBO) in Traumatic Spinal Cord Injury. (EOS) - Pilot Study|Not yet recruiting||Phase 2|100|Anticipated|Medical University of Graz||2|||f||||t|f|f||||||||2017-10-10 21:12:21.402411|2017-10-10 21:12:21.402411
NCT03101969|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-03-29|||August 2014||2014-08-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Human Outreach to Improve Adherence With Scheduled Pain Clinic Appointments|Targeted Intervention (a Telephone Call in the Dominant Language) to Increase Attendance at Scheduled Appointment in an Inner City Academic Pain Clinic|Completed||N/A|1022|Actual|Montefiore Medical Center|||1||f||||f||||||||Yes||2017-10-10 21:12:21.461877|2017-10-10 21:12:21.461877
NCT03101956|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-03|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Lumbar Manipulation for Hip and Muscle Stregth|Spinal Manipulation for Improving Hip and Knee Muscle Strength in Patients With Patellofemoral Pain Syndrome - A Randomized, Placebo-Controlled, Clinical Trial|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:12:21.536081|2017-10-10 21:12:21.536081
NCT03101943|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-18|||March 29, 2017|Actual|2017-03-29|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|May 1, 2019|Anticipated|2019-05-01||Interventional|||Preventing Early Childhood Obesity, Part 1: Family Spirit Nurture, 3-9 Months|Preventing Early Childhood Obesity, Part 1: Family Spirit Nurture, 3-9 Months|Recruiting||N/A|136|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f|f|f||||||||2017-10-10 21:12:21.622183|2017-10-10 21:12:21.622183
NCT03101930|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-08|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|September 1, 2021|Anticipated|2021-09-01|March 1, 2021|Anticipated|2021-03-01||Interventional|||Cardiovascular Effects of GLP-1 Receptor Activation|Cardiovascular Effects of GLP-1 Receptor Activation|Recruiting||Phase 4|160|Anticipated|Vanderbilt University Medical Center||3|||f||||t|t|f|||t|||Undecided||2017-10-10 21:12:21.729045|2017-10-10 21:12:21.729045
NCT03101917|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-30|||October 2018|Anticipated|2018-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)|Microtable® Microstereotactic Frame and Drill Press and Associated Method for Cochlear Implantation|Enrolling by invitation||N/A|12|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|t|t|f||||||2017-10-10 21:12:21.839129|2017-10-10 21:12:21.839129
NCT03101891|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-30|||March 18, 2017|Actual|2017-03-18|March 2017|2017-03-01|March 18, 2026|Anticipated|2026-03-18|March 18, 2020|Anticipated|2020-03-18||Interventional|RAFT||Renal Agenesis Fetal Therapy|Renal Agenesis Fetal Therapy (RAFT) Trial|Recruiting||N/A|15|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||No||2017-10-10 21:12:21.995315|2017-10-10 21:12:21.995315
NCT03101878|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-24|||April 5, 2017|Actual|2017-04-05|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ionis AGT-LRx in Healthy Volunteers and Hypertensive Patients With Blood Pressure Controlled on ACE Inhibitors or ARBs|A Blinded, Placebo-Controlled, Dose-Escalation, Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 757456 Administered Subcutaneously to Healthy Volunteers and Hypertensive Patients With Blood Pressure Controlled on ACE Inhibitors or ARBs|Recruiting||Phase 1/Phase 2|82|Anticipated|Ionis Pharmaceuticals, Inc.||2|||f||||t|f|f||||||||2017-10-10 21:12:22.097329|2017-10-10 21:12:22.097329
NCT03101865|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-10|||August 8, 2017|Actual|2017-08-08|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||The Artificial Pancreas in Very Young Children With T1D - Pilot (KidsAP01)|An Open-label, Multi-centre, Randomised, 2-period Cross-over Study to Assess the Efficacy and Safety of Closed Loop Insulin Delivery Using Diluted Insulin in Comparison With Closed Loop With Non-diluted Insulin Over 21 Days in Children With Type 1 Diabetes Aged 1 to 7 Years in the Home Setting|Recruiting||N/A|30|Anticipated|University of Cambridge||2|||f||||t|f|f||||||||2017-10-10 21:12:22.178994|2017-10-10 21:12:22.178994
NCT03101852|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-29|||April 2015|Actual|2015-04-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|March 2017|Actual|2017-03-01||Interventional|SNAC'S||Nutritional Rehabilitation in Senegalese HIV-infected Children and Adolescents|Effectiveness and Acceptability of Nutritional Rehabilitation Based on Ready-to-use Food in HIV-infected Children and Adolescents in Senegal: The Multicentre SNAC'S Study|Active, not recruiting||N/A|185|Actual|Institut de Recherche pour le Developpement||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:22.31259|2017-10-10 21:12:22.31259
NCT03101826|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory|Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory|Recruiting||N/A|25|Anticipated|Indiana University||1|||f||||f|f|f||||||||2017-10-10 21:12:22.46653|2017-10-10 21:12:22.46653
NCT03101813|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-30|||June 2012|Actual|2012-06-01|March 2017|2017-03-01|June 2047|Anticipated|2047-06-01|June 2037|Anticipated|2037-06-01||Observational|||International Diffuse Intrinsic Pontine Glioma (DIPG) Registry and Repository|International Diffuse Intrinsic Pontine Glioma (DIPG) Registry and Repository|Recruiting||N/A|1500|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f|f|f||||Samples With DNA|"     Sources of tumor tissue may be from diagnostic biopsy, surgery or autopsy samples. Fresh     tumor tissue may be utilized immediately for biological studies.   "|Yes|"Clinical, radiographic, pathologic data and biological specimens may be released to qualified investigators after a subset of the study committee for this protocol has judged their proposals for scientific merit, clinical priority, and feasibility.
Patient-identifying data/specimens will never be released to investigators. If the use of the samples and/or data released from the repository constitutes human subjects research per 45 CFR 46 or genetic research, IRB approval will be required to be submitted with the investigator's application."|2017-10-10 21:12:22.576131|2017-10-10 21:12:22.576131
NCT03101800|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-08-08|||December 14, 2016|Actual|2016-12-14|August 2017|2017-08-01|December 14, 2018|Anticipated|2018-12-14|December 14, 2018|Anticipated|2018-12-14||Interventional|||Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis|Low-dose Azathioprine and Allopurinol- Versus Azathioprine Monotherapy in Patients With Ulcerative Colitis: An Investigator-initiated, Open, Multicentre, Parallel-arm, Randomised Controlled Trial|Recruiting||Phase 3|84|Anticipated|Hvidovre University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:12:22.650566|2017-10-10 21:12:22.650566
NCT03101787|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-05-10|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|INCEPTION||Early Initiation of Extracorporeal Life Support in Refractory OHCA|Early Initiation of Extracorporeal Life Support in Refractory OHCA (INCEPTION)|Recruiting||N/A|110|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:12:22.746384|2017-10-10 21:12:22.746384
NCT03101774|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-29|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|March 1, 2016|Actual|2016-03-01|February 1, 2016|Actual|2016-02-01||Interventional|||Inspiratory Muscle Training on Respiratory Muscle Function，Quality of Life and Exercise Capacity in Stable COPD|Effects of Respiratory Physiology-oriented Inspiratory Muscle Training on Respiratory Muscle Function，Quality of Life and Exercise Capacity in Stable COPD With Inspiratory Muscle Weakness: a Randomised Controlled Trial|Completed||N/A|60|Actual|Guangzhou Institute of Respiratory Disease||3|||f||||f|f|f||||||Yes||2017-10-10 21:12:22.967989|2017-10-10 21:12:22.967989
NCT03101761|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-29|||February 1, 2016|Actual|2016-02-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|March 31, 2016|Actual|2016-03-31||Observational|||Characteristics and the Future of the City Chilblains|Characteristics and the Future of the City Chilblains|Completed||N/A|50|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||No||2017-10-10 21:12:23.102524|2017-10-10 21:12:23.102524
NCT03101748|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-25|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||3HT With Taxol for Metastatic Breast Cancer|A Phase 1b Study of Neratinib, Pertuzumab and Trastuzumab With Taxol (3HT) in Primary Metastatic and Locally Advanced Breast Cancer, and Phase II Study of 3HT Followed by AC in HER2 + Primary IBC, and Neratinib With Taxol (NT) Followed by AC in HR+ /HER2- Primary IBC|Not yet recruiting||Phase 1/Phase 2|99|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:12:23.188754|2017-10-10 21:12:23.188754
NCT03101735|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-29|||September 23, 2016|Actual|2016-09-23|March 2017|2017-03-01|September 23, 2018|Anticipated|2018-09-23|September 23, 2018|Anticipated|2018-09-23||Observational|FIDELITY||Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece|A Real Life, Non-interventional, Multicentre Study to Assess Resource Utilization and Quality of Life of Patients With Relapsing Forms of Multiple Sclerosis Treated With Dimethyl Fumarate in Greece - the FIDELITY Study|Recruiting||N/A|400|Anticipated|Genesis Pharma CNS & Specialty|||1||f|||||f|f||||||Undecided||2017-10-10 21:12:23.397984|2017-10-10 21:12:23.397984
NCT03101722|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-07-30|||May 15, 2017|Actual|2017-05-15|July 2017|2017-07-01|December 1, 2021|Anticipated|2021-12-01|May 15, 2021|Anticipated|2021-05-15||Interventional|||Effects of Hearing Rehabilitative Interventions and Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD)|Combination of Hearing Rehabilitative Interventions and Huperzine A for Presbycusis Related Tinnitus Suppression, Hearing and Cognitive Function Protection in Presbycusis|Recruiting||N/A|550|Anticipated|Fudan University||4|||f|||||f|f||||||||2017-10-10 21:12:23.49034|2017-10-10 21:12:23.49034
NCT03101709|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma|The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma|Recruiting||Phase 1|30|Anticipated|Henan Cancer Hospital||1|||f||||f|f|f||||||||2017-10-10 21:12:23.648601|2017-10-10 21:12:23.648601
NCT03101683|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-01|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Radiotherapy After Mastectomy for Breast Cancer Patients at Increased Risk of Local Recurrence|Partial Chest Wall Radiation Therapy After Total/Skin Sparing Mastectomy and Immediate Implant-based Reconstruction for Breast Cancer Patients at Increased Risk of Local Recurrence|Not yet recruiting||N/A|28|Anticipated|Fondazione del Piemonte per l'Oncologia||1|||f||||f|f|f||||||||2017-10-10 21:12:23.912149|2017-10-10 21:12:23.912149
NCT03101670|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-10-03|||March 9, 2017|Actual|2017-03-09|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|EQUATOR||A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis|A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Study to Assess the Efficacy and Safety of Filgotinib Administered for 16 Weeks to Subjects With Moderately to Severely Active Psoriatic Arthritis|Recruiting||Phase 2|124|Anticipated|Galapagos NV||2|||f||||t|f|f||||||||2017-10-10 21:12:24.089012|2017-10-10 21:12:24.089012
NCT03101657|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-03-30|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|||Evaluation of Total Disability (I.T.T.) in Victims of Psychotraumatism.|Evaluation of the Total Incapacity of Work (I.T.T.) in the Victims of Psychotraumatism Taken Care of in the Medico-judicial Unit of the CHU of Montpellier by Forensic Doctors and Psychologists|Completed||N/A|250|Actual|University Hospital, Montpellier|||1||f||||t|f|f||||||Undecided|NC|2017-10-10 21:12:24.294851|2017-10-10 21:12:24.294851
NCT03101644|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-24|||March 23, 2017|Actual|2017-03-23|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Optimization of Darunavir Therapy and Dosage Recommendations|Optimization of Darunavir Therapy Through Population Pharmacokinetic Modeling, Simulations and Dosage Guidelines|Recruiting||Phase 4|150|Anticipated|Université Catholique de Louvain||1|||f||||f|t|f|||t|||No||2017-10-10 21:12:24.368806|2017-10-10 21:12:24.368806
NCT03101631|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-26|||January 2, 2014|Actual|2014-01-02|May 2017|2017-05-01|January 30, 2015|Actual|2015-01-30|July 30, 2014|Actual|2014-07-30||Interventional|ELDERLY||Frailty Evaluation in Elderly Population With Cancer|Exploratory Study of Frailty Evaluation in Elderly Population With Cancer|Completed||N/A|62|Actual|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||t|f|f||||||No||2017-10-10 21:12:24.534293|2017-10-10 21:12:24.534293
NCT03101618|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-03-30|||August 24, 2016|Actual|2016-08-24|March 2017|2017-03-01|November 27, 2016|Actual|2016-11-27|November 27, 2016|Actual|2016-11-27||Observational|||Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers|The Prevalence of Animal Allergy and Sensitization to Animal Allergen Among Participants in International Symposium of Korean Association for Laboratory Science and Companion Animal Exhibition|Completed||N/A|643|Actual|Gachon University Gil Medical Center|||6||f||||t|f|f||||||No||2017-10-10 21:12:24.680341|2017-10-10 21:12:24.680341
NCT03101605|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-08-01|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||E-learning on the Trainees' Ability to Diagnose and Treat Acute Otitis Media Among Children|Impact of E-learning on the Trainees' Ability to Diagnose and Treat Acute Otitis Media Among Children; A Randomized Educational Trial|Recruiting||N/A|80|Anticipated|St. Justine's Hospital||2|||f||||f|f|f||||||||2017-10-10 21:12:24.85297|2017-10-10 21:12:24.85297
NCT03101592|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-06-02|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|May 22, 2020|Anticipated|2020-05-22|May 22, 2018|Anticipated|2018-05-22||Interventional|INTERVAL||INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV|INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV|Recruiting||N/A|8200|Anticipated|University of California, Los Angeles||3|||f||||f|f|f||||||No||2017-10-10 21:12:24.94888|2017-10-10 21:12:24.94888
NCT03101566|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-14|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|November 1, 2020|Anticipated|2020-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer|A Multi-Center Randomized Phase II Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer [CA209-9FC]|Recruiting||Phase 2|64|Anticipated|University of Michigan Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:12:25.176479|2017-10-10 21:12:25.176479
NCT03101553|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-18|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Computerized Treatment for Social Anxiety|Computerized Treatment for Social Anxiety|Active, not recruiting||N/A|67|Actual|Florida State University||2|||f||||f|f|f||||||||2017-10-10 21:12:25.289578|2017-10-10 21:12:25.289578
NCT03101540|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-26|||August 2011|Actual|2011-08-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD|Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD|Terminated||Early Phase 1|27|Actual|University of Iowa||1||Insufficient recruitment|f||||f|t|f||||||No|The Investigator will not be sharing IPD|2017-10-10 21:12:25.374632|2017-10-10 21:12:25.374632
NCT03101527|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-26|||May 2011|Actual|2011-05-01|April 2017|2017-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During Pregnancy|Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During Pregnancy|Terminated||Early Phase 1|3|Actual|University of Iowa||1||Insufficient recruitment|f||||f|t|f||||||No|The Investigator does not intend to share IPD|2017-10-10 21:12:25.454275|2017-10-10 21:12:25.454275
NCT03101514|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-25|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study|First Affiliated Hospital of Harbin Medical University|Recruiting||Phase 2|49|Anticipated|First Affiliated Hospital of Harbin Medical University||1|||f||||f|f|f||||||No|The investigators have no other clinical trial about cancer of head and neck|2017-10-10 21:12:25.530588|2017-10-10 21:12:25.530588
NCT03101501|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-19|||February 14, 2017|Actual|2017-02-14|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.|A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.|Recruiting||Phase 4|60|Anticipated|Key-Whitman Eye Center||1|||f||||f|t|t|f|f|f|||||2017-10-10 21:12:25.645119|2017-10-10 21:12:25.645119
NCT03101488|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-30|||March 21, 2017|Actual|2017-03-21|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of KN035 in Subjects With Advanced Solid Tumors|A Phase I, Single Arm, Multiple Dose, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KN035 Administered in Subcutaneous Injection as a Single Agent to Subjects With Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|3D Medicines (Sichuan) Co., Ltd.||1|||f||||t|f|f|||f|||No||2017-10-10 21:12:25.733989|2017-10-10 21:12:25.733989
NCT03101475|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-04|||October 1, 2017|Anticipated|2017-10-01|March 2017|2017-03-01|September 1, 2022|Anticipated|2022-09-01|December 1, 2020|Anticipated|2020-12-01||Interventional|ILOC||Synergism of Immunomodulation and Tumor Ablation|Phase II of Immunotherapy Plus Local Tumor Ablation (RFA or Stereotactic Radiotherapy) in Patients With Colorectal Cancer Liver Metastases|Not yet recruiting||Phase 2|70|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||t|f|f||||||||2017-10-10 21:12:25.821725|2017-10-10 21:12:25.821725
NCT03101449|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-03-30|||March 2016||2016-03-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Analysis of the Effects of Vocal Conditioning Through Semi-occluded Vocal Tract Exercises in Choir Singers|Analysis of the Effects of Vocal Conditioning Through Semi-occluded Vocal Tract Exercises in Choir Singers|Active, not recruiting||N/A|30|Actual|Federal University of Health Science of Porto Alegre||3|||f||||t||||||||No||2017-10-10 21:12:25.987036|2017-10-10 21:12:25.987036
NCT03101436|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-04|||February 2, 2015|Actual|2015-02-02|March 2017|2017-03-01|May 6, 2015|Actual|2015-05-06|May 6, 2015|Actual|2015-05-06||Interventional|OLIWINE||Extra Virgin Olive Oil, Red Wine Polyphenols and Fecal Microbiota|Extra Virgin Olive Oil and Red Wine Polyphenols in the Modulation of Fecal Microbiota: an Interventional Study|Completed||N/A|20|Actual|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||2|||f||||f|f|f||||||No||2017-10-10 21:12:26.063209|2017-10-10 21:12:26.063209
NCT03101423|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-05-08|||August 1, 2016|Actual|2016-08-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism|Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism|Recruiting||N/A|10|Anticipated|First Affiliated Hospital of Guangxi Medical University||2|||f|||||f|f||||||||2017-10-10 21:12:26.123584|2017-10-10 21:12:26.123584
NCT03101410|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-30|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|GLUTHEALTH||Gluten Sensibility in Elite Athletes|Gluten Sensibility in Elite Athletes|Enrolling by invitation||N/A|60|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:12:26.207855|2017-10-10 21:12:26.207855
NCT03101397|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-11|||February 2013|Actual|2013-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2016|Actual|2016-10-01||Observational|||The Clinical Value of Serum KL-6 Changes on Evaluating Disease Development in Different Diffuse Parenchymal Lung Disease|The Clinical Value of Serum KL-6 Changes on Evaluating Disease Development in Different Diffuse Parenchymal Lung Disease|Active, not recruiting||N/A|180|Actual|The First Affiliated Hospital of Guangzhou Medical University|||3||f||||f|f|f||||Samples Without DNA|"     blood biomakers   "|No||2017-10-10 21:12:26.319891|2017-10-10 21:12:26.319891
NCT03101384|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-06-01|||April 11, 2017|Actual|2017-04-11|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|IDEA-PE||Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism|Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism|Recruiting||N/A|302|Anticipated|European Georges Pompidou Hospital|||2||f|||||f|f||||||Undecided||2017-10-10 21:12:26.382671|2017-10-10 21:12:26.382671
NCT03101371|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-08-21|||October 10, 2017|Anticipated|2017-10-10|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|April 10, 2018|Anticipated|2018-04-10||Interventional|||Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion|Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion|Not yet recruiting||Phase 2|250|Anticipated|University of Colorado, Denver||2|||f||||t|t|f|||f|||||2017-10-10 21:12:26.475169|2017-10-10 21:12:26.475169
NCT03101358|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-11|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Topical SOR007 Ointment for Cutaneous Metastases|Phase 2 Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases|Not yet recruiting||Phase 2|24|Anticipated|NanOlogy, LLC||3|||f||||t|t|f||||||||2017-10-10 21:12:26.57215|2017-10-10 21:12:26.57215
NCT03101345|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-10-04|||April 3, 2017|Actual|2017-04-03|October 2017|2017-10-01|July 21, 2017|Actual|2017-07-21|July 7, 2017|Actual|2017-07-07||Interventional|||High Energy Phosphate Metabolites in Brain|Assessment of Nutrition on Brain Energy Metabolism: Measurement of High Energy Phosphate Metabolites by 31-phosphorous Magnetic Resonance Spectroscopy.|Completed||N/A|25|Actual|Nestlé||1|||f||||f|f|f||||||||2017-10-10 21:12:26.646953|2017-10-10 21:12:26.646953
NCT03101332|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-04-20|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Virtual Reality for Panic Disorder With Agoraphobia|Virtual Reality for Panic Disorder With Agoraphobia: a Clinical Trial|Not yet recruiting||N/A|25|Anticipated|Karolinska Institutet||1|||f||||f|f|f||||||No||2017-10-10 21:12:26.707047|2017-10-10 21:12:26.707047
NCT03101319|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-30|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Role of Vitamin D Supplementation in Schizophrenia|Role of Vitamin D Supplementation in First Episode Schizophrenia: A Double Blind Placebo Controlled Study|Not yet recruiting||N/A|56|Anticipated|Central Institute of Psychiatry, Ranchi, India||2|||f||||t|f|f||||||||2017-10-10 21:12:26.784967|2017-10-10 21:12:26.784967
NCT03101306|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-29|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|MR Cervix||A Pilot Study Using Magnetic Resonance (MR) to Assess Cervix Motion During Radiotherapy Treatment.|A Pilot Study Using Magnetic Resonance (MR) to Assess Cervix Motion During Radiotherapy Treatment.|Not yet recruiting||N/A|20|Anticipated|The Christie NHS Foundation Trust||1|||f||||f|f|f||||||No||2017-10-10 21:12:26.867439|2017-10-10 21:12:26.867439
NCT03101293|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-06|||March 29, 2017|Actual|2017-03-29|June 2017|2017-06-01|May 24, 2017|Actual|2017-05-24|May 19, 2017|Actual|2017-05-19||Interventional|||A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation|A Randomized, Open-Label, Single-Dose, 2-Period, Crossover Design, Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 T2 Tablet Formulation in Healthy Subjects|Completed||Phase 1|15|Actual|Takeda||2|||f||||f|t|f||||||||2017-10-10 21:12:26.933735|2017-10-10 21:12:26.933735
NCT03101280|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-03|2017-08-01|||May 4, 2017|Actual|2017-05-04|August 2017|2017-08-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|||A Combination Study of Rucaparib and Atezolizumab in Participants With Solid Tumors and Advanced Gynecologic Cancers, With a Focus on Ovarian Cancer|A Phase IB Combination Study of Rucaparib (CO-338) and Atezolizumab (MPDL3280A) in Participants With Solid Tumors and Advanced Gynecologic Cancers, With a Focus on Ovarian Cancer|Recruiting||Phase 1|48|Anticipated|Hoffmann-La Roche||2|||f|||||f|f||||||||2017-10-10 21:12:27.011944|2017-10-10 21:12:27.011944
NCT03101267|ClinicalTrials.gov processed this data on October 10, 2017|2017-04-02|2017-08-02|||April 13, 2017|Actual|2017-04-13|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|||A Dose-finding Study of ASP4070|Phase II Dose-finding Study of ASP4070 -A Randomized, Double-blind, Placebo-controlled, Dose-finding Study in Environmental Exposure Chamber in Patients With Cedar Pollinosis-|Active, not recruiting||Phase 2|150|Actual|Astellas Pharma Inc||3|||f||||f|f|f||||||||2017-10-10 21:12:29.18449|2017-10-10 21:12:29.18449
NCT03101254|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-07-13|||June 6, 2017|Actual|2017-06-06|April 2017|2017-04-01|October 30, 2023|Anticipated|2023-10-30|October 30, 2020|Anticipated|2020-10-30||Interventional|||LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma|A Phase I/II Study of LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma|Recruiting||Phase 1/Phase 2|43|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:12:29.295014|2017-10-10 21:12:29.295014
NCT03101228|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-05-16|||April 25, 2017|Actual|2017-04-25|May 2017|2017-05-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Medical and Physiological Benefits of Reduced Sitting|Medical and Physiological Benefits and Mechanisms of Reduced Sitting Without Meeting the Current Physical Activity Recommendations|Recruiting||N/A|64|Anticipated|Turku University Hospital||2|||f||||f|f|f||||||Undecided|IPD of the main outcome measures will be opened if possible.|2017-10-10 21:12:29.513125|2017-10-10 21:12:29.513125
NCT03101215|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-04|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|March 24, 2018|Anticipated|2018-03-24|March 24, 2018|Anticipated|2018-03-24||Interventional|||Workload of Water Polo Players Following a Phosphorus Manipulated High Carbohydrate Meal|Workload of Water Polo Players Following a Phosphorus Manipulated High Carbohydrate Meal|Recruiting||N/A|17|Anticipated|American University of Beirut Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:12:29.620329|2017-10-10 21:12:29.620329
NCT03101202|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-29|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||To Compare Endotracheal Tube (ET) With Subglottic Suction Drainage and Standard ET in the Incidence of VAP|Comparison of Endotracheal Tube With Subglottic Suction Drainage With Standard Endotracheal Tube in the Incidence of Airway Colonization and Ventilator Associated Pneumonia|Recruiting||N/A|100|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f|||||f|t|f|f|f|||No||2017-10-10 21:12:29.722008|2017-10-10 21:12:29.722008
NCT03101189|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-26|||March 15, 2017|Actual|2017-03-15|July 2017|2017-07-01|April 26, 2017|Actual|2017-04-26|April 24, 2017|Actual|2017-04-24||Interventional|||A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects|A Single-center, Double-blind, Placebo-controlled, Randomized Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-dose ACT-541468 in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|40|Actual|Actelion||3|||f||||f|f|f||||||||2017-10-10 21:12:29.816767|2017-10-10 21:12:29.816767
NCT03101176|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-18|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2022|Anticipated|2022-09-01||Interventional|||Multiparametric Ultrasound Imaging in Prostate Cancer|Multiparametric Ultrasound (mpUS) as Imaging Modality for the Detection and Localization of Prostate Cancer|Recruiting||N/A|200|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f|f|f||||||||2017-10-10 21:12:29.918472|2017-10-10 21:12:29.918472
NCT03101163|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-03|||December 2015|Actual|2015-12-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee|Multicenter, Randomized, Open-Label, Standard Treatment-Controlled Parallel Group Phase 2 Study to Evaluate Efficacy and Safety of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells and Hyaluronic Acid Adjuvant Therapy Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee With an Optional Open-Label Extension for the Standard Treatment-Controlled Group|Recruiting||Phase 2|120|Anticipated|KLSMC Stem Cells, Inc.||2|||f||||t|t|f||||||Undecided||2017-10-10 21:12:30.025798|2017-10-10 21:12:30.025798
NCT03101137|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-08-15|||February 2016||2016-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects Of Adjuvants to Caudal Anesthesia on Hemodynamics Measured By Electrical Cardiometry In Children|Effects Of Adjuvants (Dexamethasone and Dexmedetomidine) to Caudal Anesthesia on Cardiac Output and Hemodynamics Measured By Electrical Cardiometry In Children: A Randomized Double Blind Study|Enrolling by invitation||Phase 4|48|Actual|Kasr El Aini Hospital||3|||f||||t||||||||||2017-10-10 21:12:30.391531|2017-10-10 21:12:30.391531
NCT03101124|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-13|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery|Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery|Recruiting||Phase 2|36|Anticipated|St. Olavs Hospital||3|||f||||t|f|f||||||||2017-10-10 21:12:30.524501|2017-10-10 21:12:30.524501
NCT03101111|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-17|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|March 28, 2019|Anticipated|2019-03-28|March 28, 2019|Anticipated|2019-03-28||Interventional|||Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area|Phase 2 Study of a Live Attenuated Measles Virus-Vectored Chikungunya Vaccine in a Previously Epidemic Area|Recruiting||Phase 2|100|Anticipated|Themis Bioscience GmbH||2|||f||||f|t|f||||||||2017-10-10 21:12:30.666927|2017-10-10 21:12:30.666927
NCT03101098|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-03|||April 10, 2017|Anticipated|2017-04-10|March 2017|2017-03-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|||Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus|Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus: A Randomized Controlled Trial|Not yet recruiting||N/A|54|Anticipated|Kangbuk Samsung Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:12:30.773719|2017-10-10 21:12:30.773719
NCT03101085|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-06-05|||May 5, 2017|Actual|2017-05-05|June 2017|2017-06-01|October 30, 2019|Anticipated|2019-10-30|September 30, 2019|Anticipated|2019-09-30||Interventional|SEAD2||S-Equol in Alzheimer's Disease 2 Trial|S-Equol in Alzheimer's Disease 2 (SEAD2) Trial|Recruiting||Phase 1/Phase 2|40|Anticipated|University of Kansas Medical Center||2|||f||||f|t|f|||f|||No||2017-10-10 21:12:30.865778|2017-10-10 21:12:30.865778
NCT03101072|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-26|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|PIRATE||Antibiotic Durations for Gram-negative Bacteremia|The PIRATE PROJECT: a Point-of-care, Informatics-based Randomized Controlled Trial for Decreasing Over-utilization of Antibiotic ThErapy in Gram-negative Bacteremia|Recruiting||N/A|500|Anticipated|University of Geneva, Switzerland||3|||f||||t|f|f|||f|||No|(There is no plan to share IPD.)|2017-10-10 21:12:30.971592|2017-10-10 21:12:30.971592
NCT03101059|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-03|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|||Airway Collapse in Patients With Mounier-Kuhn Syndrome: Titration With Positive Pressure to Reduce Collapse|Evaluation of the Presence of Airway Collapse in Patients With Mounier-Kuhn Syndrome and Titration With Continuous Positive Pressure Through Non-invasive Mechanical Ventilation to Reduce Collapse|Not yet recruiting||N/A|15|Anticipated|University of Sao Paulo General Hospital||1|||f|||||f|f||||||No||2017-10-10 21:12:31.09872|2017-10-10 21:12:31.09872
NCT03101046|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-03|||October 1, 2017|Anticipated|2017-10-01|March 2017|2017-03-01|April 1, 2023|Anticipated|2023-04-01|April 1, 2021|Anticipated|2021-04-01||Interventional|TACTIK||Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic|Personalized Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic During Chemotherapy: A GETUG-AFU 28 Study|Not yet recruiting||Phase 2|792|Anticipated|UNICANCER||3|||f||||t|t|f|||f|||Undecided||2017-10-10 21:12:31.181551|2017-10-10 21:12:31.181551
NCT03101020|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-08|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 31, 2017|Anticipated|2017-07-31|July 6, 2017|Anticipated|2017-07-06||Interventional|||Visceral Manipulation in Patients With Chronic Low Back Pain|Visceral Manipulation in Patients With Chronic Low Back Pain: Randomized Controlled Trial|Not yet recruiting||N/A|20|Anticipated|University of Sorocaba||2|||f||||t|f|f||||||No||2017-10-10 21:12:31.361293|2017-10-10 21:12:31.361293
NCT03101007|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-26|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|ALKNEE||RSA RCT: Attune RP TKA Versus LCS RP TKA|A CLINICAL RANDOMIZED CONTROLLED RSA TRIAL COMPARING THE CEMENTLESS ATTUNE ROTATING PLATFORM KNEE SYSTEM TO THE CEMENTLESS LCS ROTATING PLATFORM KNEE SYSTEM|Not yet recruiting||N/A|60|Anticipated|Spaarne Gasthuis||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:12:31.473396|2017-10-10 21:12:31.473396
NCT03100994|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-29|||March 28, 2017|Actual|2017-03-28|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Post-operative Analgesia Efficacy Using Ultrasound-guided Transmuscular Quadratus Lumborum Block Versus Ultrasound-guided Quadratus Lumborum Type II Block.|Post-operative Analgesia Efficacy Using Ultrasound-guided Transmuscular Quadratus Lumborum Block Versus Ultrasound-guided Quadratus Lumborum Type II Block.|Recruiting||Phase 4|180|Anticipated|Tri-Service General Hospital||3|||f||||t|t|t|f|f|t|||No||2017-10-10 21:12:31.588259|2017-10-10 21:12:31.588259
NCT03100981|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-29|||February 24, 2016|Actual|2016-02-24|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate Cancer|Internet-delivered Mindfulness-Based Cognitive Therapy for Symptoms of Depression, Anxiety, and Stress Among Women Treated for Breast Cancer and Men Treated for Prostate Cancer - Effects and Mechanisms|Recruiting||N/A|155|Anticipated|University of Aarhus||2|||f||||t|f|f||||||No||2017-10-10 21:12:31.690733|2017-10-10 21:12:31.690733
NCT03100968|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-03-29|||June 22, 2015|Actual|2015-06-22|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Utility of Ultrasound in Identification of Midline and Placement of Epidural in Severely Obese Parturients|Utility of Ultrasound in Identification of Midline and Placement of Epidural in Severely Obese Parturients: A Randomized, Prospective Study|Recruiting||N/A|150|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|t|f|f||||No||2017-10-10 21:12:31.814695|2017-10-10 21:12:31.814695
NCT03100955|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-29|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|August 1, 2019|Anticipated|2019-08-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer|A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer|Recruiting||Phase 3|120|Anticipated|Qingdao University||2|||f||||t|f|f||||||No||2017-10-10 21:12:31.911125|2017-10-10 21:12:31.911125
NCT03100942|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-10-04|||May 1, 2017|Actual|2017-05-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome|A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome|Recruiting||Phase 2|140|Anticipated|Gilead Sciences||4|||f||||f|t|f||||||||2017-10-10 21:12:32.012682|2017-10-10 21:12:32.012682
NCT03100929|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-21|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|April 1, 2019|Anticipated|2019-04-01|October 30, 2018|Anticipated|2018-10-30||Interventional|||Nuchal Cord Detection in Sonographic Evaluation by a First Year Resident.|The Efficiency in Nuchal Cord Detection in Sonographic Evaluation as Performed by an Unexperienced First Year Resident With Minimal Training.|Recruiting||N/A|200|Anticipated|Rambam Health Care Campus||1|||f||||f|f|f||||||||2017-10-10 21:12:32.322476|2017-10-10 21:12:32.322476
NCT03100916|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-10-02|||May 5, 2017|Actual|2017-05-05|October 2017|2017-10-01|November 24, 2017|Anticipated|2017-11-24|November 24, 2017|Anticipated|2017-11-24||Interventional|||This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 690517 in Healthy Male Subjects (Single-blind, Partially Randomised, Placebo-controlled Within Dose Groups) and Effect of Food on the Bioavailability of BI 690517 (Openlabel, Randomised, Two-way Cross-over)|Recruiting||Phase 1|72|Anticipated|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 21:12:32.422232|2017-10-10 21:12:32.422232
NCT03100903|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-09-25|||April 24, 2017|Actual|2017-04-24|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy Subjects|Safety, Tolerability, and Pharmacokinetics of Two Dose Strengths of a Single Subcutaneous Dose of BI 655130 and One Single Intravenous Dose of BI 655130 in Healthy Male and Female Subjects (Open-label, Parallel Group Design)|Active, not recruiting||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||f|f|f||||||||2017-10-10 21:12:32.53371|2017-10-10 21:12:32.53371
NCT03100890|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-25|||March 16, 2017|Actual|2017-03-16|May 2017|2017-05-01|March 2, 2018|Anticipated|2018-03-02|March 1, 2018|Anticipated|2018-03-01||Interventional|home_ATR||In-home Versus Hospital Preoperative Training for Patients Undergoing Total Knee Replacement|In-home Versus Hospital Preoperative Training for Patients Undergoing Total Knee Replacement|Recruiting||N/A|63|Anticipated|University of Valencia||3|||f||||f|f|f||||||Undecided||2017-10-10 21:12:32.627153|2017-10-10 21:12:32.627153
NCT03100877|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-08|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|May 24, 2020|Anticipated|2020-05-24|May 24, 2020|Anticipated|2020-05-24||Interventional|||Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma|Phase I-II Single Cycle Melphalan/Total Marrow Irradiation (TMI) and Autologous Stem Cell Transplantation (ASCT) Followed by Maintenance in Patients With High-Risk Myeloma and/or Poor Response to Induction Therapy Within 12 Months of Diagnosis|Recruiting||Phase 1/Phase 2|63|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:12:32.72769|2017-10-10 21:12:32.72769
NCT03100864|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-10-02|||May 22, 2017|Actual|2017-05-22|October 2017|2017-10-01|June 26, 2018|Anticipated|2018-06-26|January 24, 2018|Anticipated|2018-01-24||Interventional|||This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients|Exploratory Trial to Assess Mechanism of Action, Clinical Effect, Safety and Tolerability of 12 Weeks of Treatment With BI 655130 in Patients With Active Ulcerative Colitis (UC)|Recruiting||Phase 2|10|Anticipated|Boehringer Ingelheim||1|||f||||t|f|f||||||||2017-10-10 21:12:32.912872|2017-10-10 21:12:32.912872
NCT03100851|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-06-28|||August 2, 2015|Actual|2015-08-02|June 2017|2017-06-01|March 17, 2017|Actual|2017-03-17|September 26, 2016|Actual|2016-09-26||Interventional|||Effect of Probiotic on Constipation|Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota on Chinese People With Constipation|Completed||Phase 3|62|Actual|China Agricultural University||1|||f||||||||||||||2017-10-10 21:12:33.013908|2017-10-10 21:12:33.013908
NCT03100838|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-10-04|||March 20, 2017|Actual|2017-03-20|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets|A Single-Dose, Open-label, Randomized, Crossover, Drug-Drug Interaction Study of Nifedipine Extended-release Tablets With or Without Multiple-dose Administration of Proton-Pump Inhibitor Omeprazole/Sodium Bicarbonate in Healthy Volunteers|Active, not recruiting||Phase 1|64|Anticipated|Food and Drug Administration (FDA)||4|||f||||f|t|f|||f|||||2017-10-10 21:12:33.105446|2017-10-10 21:12:33.105446
NCT03100825|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-16|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|May 27, 2019|Anticipated|2019-05-27|November 6, 2018|Anticipated|2018-11-06||Interventional|||A Long-term Safety Study of QVM149 in Japanese Patients With Asthma|A Multicenter, Open-label, Single Arm, 52-week Treatment Study to Assess the Safety of QVM149 in Japanese Patients With Asthma|Recruiting||Phase 3|100|Anticipated|Novartis||1|||f||||f|f|f||||||No||2017-10-10 21:12:33.232598|2017-10-10 21:12:33.232598
NCT03100812|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-03-29|||September 23, 2010|Actual|2010-09-23|March 2017|2017-03-01|May 3, 2016|Actual|2016-05-03|May 3, 2016|Actual|2016-05-03||Interventional|AsPIRE||Asian American Partnerships in Research and Empowerment (AsPIRE)|Asian American Partnerships in Research and Empowerment (AsPIRE)|Completed||N/A|1000|Actual|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:12:33.382954|2017-10-10 21:12:33.382954
NCT03100799|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-07-29|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|||An Exploratory Clinical Study to Investigate Biomarkers of Senescence in Patients With Osteoarthritis of the Knee|An Exploratory Clinical Study to Investigate Biomarkers of Senescence in Patients With Mild, Moderate and Severe Osteoarthritis of the Knee|Completed||N/A|30|Actual|Unity Biotechnology, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:12:33.483546|2017-10-10 21:12:33.483546
NCT03100786|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 1, 2022|Anticipated|2022-06-01|August 1, 2021|Anticipated|2021-08-01||Interventional|||Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis|A Randomized Double Blind Placebo Controlled Non-inferiority Trial of Adjunctive Dexamethasone for the Treatment of HIV-uninfected Adults With Tuberculous Meningitis Stratified by Leukotriene A4 Hydrolase Genotype|Not yet recruiting||Phase 3|640|Anticipated|Oxford University Clinical Research Unit, Vietnam||2|||f||||t|f|f||||||||2017-10-10 21:12:33.609908|2017-10-10 21:12:33.609908
NCT03100773|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-03-28|||January 2015||2015-01-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Impact of Atraumatic Restorative Treatment and Oral Health Promotion on Psychological and Salivary Aspects of Children|Impact of Atraumatic Restorative Treatment Associated With Oral Health Educational Strategy on Dental Anxiety, Oral Health-related Quality of Life and Salivary Biochemical and Microbiological Characteristics of Brazilian Schoolchildren|Completed||N/A|78|Actual|University of Campinas, Brazil||3|||f||||t||||||||Undecided||2017-10-10 21:12:33.7778|2017-10-10 21:12:33.7778
NCT03099668|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-28|||November 17, 2016|Actual|2016-11-17|March 2017|2017-03-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Multidisciplinary Team Care in Rheumatoid Arthritis|The Multidisciplinary Team: Truly Beneficial or Just the Flavour of the Day?A Randomized Controlled Study to Study Outcomes From MDT Care in Rheumatoid Arthritis|Recruiting||N/A|140|Anticipated|National University Hospital, Singapore||2|||f||||f|f|f||||||No||2017-10-10 21:12:33.883865|2017-10-10 21:12:33.883865
NCT03099655|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-27|||July 7, 2017|Actual|2017-07-07|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||Attain Stability™ Quad Clinical Study|Attain Stability™ Quad Clinical Study|Enrolling by invitation||N/A|471|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f|f|t|t|f||||||2017-10-10 21:12:34.009235|2017-10-10 21:12:34.009235
NCT03099642|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-11|||June 10, 2017|Actual|2017-06-10|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ultrasound-Assisted Lumbar Puncture in Children|Emergency Physician Performed Ultrasound-Assisted Lumbar Puncture in a Pediatric Population: A Randomized Controlled Trial|Recruiting||N/A|162|Anticipated|St. Justine's Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:12:34.732181|2017-10-10 21:12:34.732181
NCT03099629|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-31|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy of Inspiratory Muscle Training on Respiratory Performance in Patients With Esophageal Cancer Receiving Combined Modality Therapy|Efficacy of Inspiratory Muscle Training on Respiratory Performance in Patients With Esophageal Cancer Receiving Combined Modality Therapy|Completed||N/A|6|Actual|Mackay Memorial Hospital||1|||f||||||||||||||2017-10-10 21:12:34.831099|2017-10-10 21:12:34.831099
NCT03099616|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-10-03|||April 4, 2017|Actual|2017-04-04|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Automated Closed Loop Propofol Anaesthesia Versus Desflurane Inhalation Anaesthesia In Bariatric Surgery|Automated Closed Loop Propofol Anaesthesia Versus Desflurane Inhalation Anaesthesia In Obese Patients Undergoing Bariatric Surgery: A Comparative Randomized Analysis of Recovery Profile|Recruiting||Phase 4|40|Anticipated|Sir Ganga Ram Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:12:34.913804|2017-10-10 21:12:34.913804
NCT03099603|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-31|||March 24, 2017|Actual|2017-03-24|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||A Study of HTD1801 in Healthy Subjects|A First in Human, Randomized, Double-Blind Study to Assess Safety, Tolerability, and Pharmacokinetics of Single, Ascending Doses of HTD1801 in Healthy Subjects|Recruiting||Phase 1|32|Anticipated|HighTide Biopharma Pty Ltd||4|||f||||t|f|f||||||No|Not provided|2017-10-10 21:12:35.045139|2017-10-10 21:12:35.045139
NCT03099590|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-07-31|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|Alkontrol||Alkontrol-herbal Effects on Alcohol Drinking|Alkontrol-herbal (Isoflavone) Effects on Alcohol Drinking in an Outpatient Setting|Not yet recruiting||Phase 2|40|Anticipated|Mclean Hospital||2|||f||||t|f|f||||||||2017-10-10 21:12:35.166198|2017-10-10 21:12:35.166198
NCT03099577|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-05|||January 2, 2017|Actual|2017-01-02|April 2017|2017-04-01|January 4, 2019|Anticipated|2019-01-04|January 4, 2018|Anticipated|2018-01-04||Interventional|||PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer|Phase I Study of PET/CT-directed Hyperfractionated Radiation Dose Escalation With Concurrent Weekly Carboplatin and Paclitaxel in Stage III Non-small Cell Lung Cancer|Recruiting||N/A|21|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||7|||f|||||f|f||||||No||2017-10-10 21:12:35.259504|2017-10-10 21:12:35.259504
NCT03099564|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-13|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Pembrolizumab Plus Y90 Radioembolization in HCC Subjects|A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma With Preserved Liver Function. HCRN: GI15-225|Recruiting||Early Phase 1|30|Anticipated|Hoosier Cancer Research Network||1|||f||||f|t|t|f|f|f|||||2017-10-10 21:12:35.517206|2017-10-10 21:12:35.517206
NCT03099551|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-31|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|March 2017|Actual|2017-03-01||Interventional|||Randomized Trial to Evaluate the Efficacy of Two Different Toothbrushes on Plaque Control|Randomized Trial to Evaluate the Efficacy of Two Different Toothbrushes on Plaque Control|Active, not recruiting||Phase 4|56|Actual|Faculty Sao Leopoldo Mandic Campinas||2|||f||||t|f|f||||||No||2017-10-10 21:12:35.665011|2017-10-10 21:12:35.665011
NCT03100760|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-28|||April 2017||2017-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:12:35.794461|2017-10-10 21:12:35.794461
NCT03099681|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-22|||August 22, 2017|Actual|2017-08-22|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|May 1, 2020|Anticipated|2020-05-01||Observational|EPISObs||An Observational Study on Epithelioid Sarcoma|Epithelioid Sarcoma. An Observational Study|Active, not recruiting||N/A|100|Anticipated|Italian Sarcoma Group|||1||f||||f|f|f||||Samples With DNA|"     Tumor sample materiale   "|||2017-10-10 21:12:46.623872|2017-10-10 21:12:46.623872
NCT03100721|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-11|||November 2017|Anticipated|2017-11-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Pain Neuroscience Education in Chronic Musculoskeletal Pain|Effects of Pain Neuroscience Education as Complement to Physiotherapy in Chronic Musculoskeletal Pain: A Randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|University of Malaga||2|||f||||t|f|f||||||||2017-10-10 21:12:36.119649|2017-10-10 21:12:36.119649
NCT03100708|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-03-28|||April 2016||2016-04-01|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|PIPAC_01||Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy)|Evaluation of Molecular and Pathophysiological Mechanisms of Peritoneal Carcinomatosis and Monitoring of the Efficiency of PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy) as a Local Chemotherapeutical Treatment.|Recruiting||N/A|500|Anticipated|University of Leipzig|||1||f||||f||||||||No||2017-10-10 21:12:36.217582|2017-10-10 21:12:36.217582
NCT03100695|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-28|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|T-PAC||Tibial Fracture - Platelet-rich Plasma and Bone Marrow Concentrate|A Prospective, Randomised, Single-centre Feasibility Study of Combined Autologous Platelet-rich Plasma and Concentrated Autologous Bone Marrow in Adult Patients With a Fresh Unilateral Tibial Diaphyseal Fracture Treated With Either Fine Wire Ring Fixator Device (Ilizarov) or Reamed Intramedullary Nailing|Not yet recruiting||N/A|45|Anticipated|University of Leeds||2|||f||||f|f|f||||||No||2017-10-10 21:12:36.878142|2017-10-10 21:12:36.878142
NCT03100682|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-02|||March 18, 2017|Actual|2017-03-18|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|March 2022|Anticipated|2022-03-01||Observational|||Prevention of Human Papillomavirus (HPV) Infection in Paediatric Kidney and Liver Transplant Recipients and in Paediatric Patients With Advanced Chronic Kidney Disease|Prevention of Human Papillomavirus (HPV) Infection in Paediatric Kidney and Liver Transplant Recipients and in Paediatric Patients With Advanced Chronic Kidney Disease: a Prospective, Observational Multi-centre Vaccine Surveillance Study (HPVaxResponse Study)|Recruiting||N/A|140|Anticipated|University Hospital Heidelberg|||1||f||||f|f|f||||Samples Without DNA|"     Serum rest material   "|Undecided||2017-10-10 21:12:36.982217|2017-10-10 21:12:36.982217
NCT03100669|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-04|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|February 20, 2018|Anticipated|2018-02-20|September 30, 2017|Anticipated|2017-09-30|10 Weeks|Observational [Patient Registry]|||Implementing a Postoperative MIRP (Minimally Invasive Repair of Pectus) Program Via Tele-monitoring|Implementing a Postoperative MIRP (Minimally Invasive Repair of Pectus) Program: Short and Long-term Evaluation of Pain, Nausea, Sleep, and Rehabilitation Via Tele-monitoring|Recruiting||N/A|15|Anticipated|University Hospital, Antwerp|||1||f||||f|f|f||||||No||2017-10-10 21:12:37.064201|2017-10-10 21:12:37.064201
NCT03100656|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-08|||November 10, 2016|Actual|2016-11-10|April 2017|2017-04-01|March 31, 2021|Anticipated|2021-03-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Study of Food Aversion in Patients With Anorexia Nervosa|Solving EPHX2 and Polyunsaturated Fatty Acid Interactions in Anorexia Nervosa|Recruiting||N/A|300|Anticipated|University of California, San Diego||1|||f||||f|f|f||||||No||2017-10-10 21:12:37.186254|2017-10-10 21:12:37.186254
NCT03100643|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-28|||August 1, 2015|Actual|2015-08-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|N'Gage||Development of a Couple-Based Mobile Health Intervention for Enhancing HIV Care Engagement Outcomes (N'Gage)|Development of a Couple-Based Mobile Health Intervention for Enhancing HIV Care Engagement Outcomes (N'Gage)|Recruiting||N/A|85|Anticipated|University of California, San Francisco|||1||f|||||f|f||||||||2017-10-10 21:12:37.333807|2017-10-10 21:12:37.333807
NCT03100630|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-05|||May 9, 2017|Actual|2017-05-09|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Compare Bioavailability of BMS-986089 After Subcutaneous Injection|An Open-label, Randomized, Parallel-group, Single Dose Study to Compare the Bioavailability of Subcutaneous Injections in the Arm, Thigh, and Abdomen and to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BMS-986089 in Healthy Participants|Recruiting||Phase 1|75|Anticipated|Hoffmann-La Roche||3|||f||||f|t|f||||||||2017-10-10 21:12:37.429322|2017-10-10 21:12:37.429322
NCT03100617|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-22|||August 26, 2017|Actual|2017-08-26|September 2017|2017-09-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Alzheimer's Family Caregiver Intervention in Vietnam|Single Arm Study of Modified REACH-VA Alzheimer's Caregiver Intervention in Vietnam|Recruiting||N/A|8|Anticipated|University of California, Davis||1|||f||||t|f|f||||||||2017-10-10 21:12:37.548929|2017-10-10 21:12:37.548929
NCT03100591|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-26|||March 28, 2017|Actual|2017-03-28|July 2017|2017-07-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|||A Study to Evaluate ACT-132577 in Healthy Male Subjects|Single-center, Open-label Study With 14C-radiolabeled ACT-132577 to Investigate the Mass Balance, Pharmacokinetics, and Metabolism Following Single Oral Administration to Healthy Male Subjects|Completed||Phase 1|6|Actual|Actelion||1|||f|||||f|f||||||||2017-10-10 21:12:37.743097|2017-10-10 21:12:37.743097
NCT03100578|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-03-29|||April 18, 2017|Anticipated|2017-04-18|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|PROMETHEUS||RANDOMIZED MULTICENTER STUDY COMPARING PLASTIC STENTS AND SELF-EXPANDING METALLIC STENTS IN THE EUS-GUIDED TRANSMURAL DRAINAGE OF WALLED-OFF PANCREATIC NECROSIS|RANDOMIZED MULTICENTER STUDY COMPARING PLASTIC STENTS AND SELF-EXPANDING METALLIC STENTS USED IN THE EUS-GUIDED TRANSMURAL DRAINAGE OF WALLED-OFF PANCREATIC NECROSIS|Not yet recruiting||N/A|114|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t|f|t|f|f|f|||Undecided||2017-10-10 21:12:37.840196|2017-10-10 21:12:37.840196
NCT03100565|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-06-27|||September 2016||2016-09-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Lidocaine Spray vs Coughing for Pain Relief During Colposcopy|Comparison of Lidocaine Spray With Forced Coughing in Pain Relief During Colposcopy Guided Cervical Biopsy Procedure: A Randomized Controlled Trial|Recruiting||N/A|35|Anticipated|Yuzuncu Yıl University||2|||f||||t|f|f||||||No||2017-10-10 21:12:37.93097|2017-10-10 21:12:37.93097
NCT03100552|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-28|||August 1, 2013|Actual|2013-08-01|March 2017|2017-03-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Observational|SERRESH||Prediction of Dysplasia Within Sessile Serrated Polyps Using Endoscopic Imaging; a Prospective Observational Study|Prediction of Dysplasia Within Sessile Serrated Polyps Using Endoscopic Imaging; a Prospective Observational Study|Completed||N/A|86|Actual|Western Sydney Local Health District|||1||f||||f|f|f||||||No||2017-10-10 21:12:38.029078|2017-10-10 21:12:38.029078
NCT03100539|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-05|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|March 30, 2021|Anticipated|2021-03-30|October 30, 2020|Anticipated|2020-10-30||Interventional|TOMCATT||Trial Outcomes for Massage: Caregiver-Assisted vs. Therapist-Treated|Trial Outcomes for Massage: Caregiver-Assisted vs. Therapist-Treated (TOMCATT)|Recruiting||N/A|468|Anticipated|VA Office of Research and Development||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:12:38.129053|2017-10-10 21:12:38.129053
NCT03100526|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-28|||November 2013|Actual|2013-11-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Patient Aligned Care Team (PACT) Intensive Management (PIM) Project|Patient Aligned Care Team (PACT) Intensive Management (PIM) Project|Enrolling by invitation||N/A|2210|Actual|Veteran Affairs Office of Patient Care Services||2|||f||||f|f|f||||||No||2017-10-10 21:12:38.249824|2017-10-10 21:12:38.249824
NCT03100513|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-25|||March 11, 2017|Actual|2017-03-11|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy|Randomized Trial Comparing The Efficacy of PEG (Polyethylene Glycol) Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy|Recruiting||Phase 4|100|Anticipated|Tanta University||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:12:38.329128|2017-10-10 21:12:38.329128
NCT03100500|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-16|||April 25, 2017|Actual|2017-04-25|May 2017|2017-05-01|February 8, 2019|Anticipated|2019-02-08|July 23, 2018|Anticipated|2018-07-23||Interventional|||A Long-term Safety Study of QMF149 in Japanese Patients With Asthma|A Multicenter, Open-label, Single Arm, 52-week Treatment Study to Assess the Safety of QMF149 in Japanese Patients With Asthma|Recruiting||Phase 3|66|Anticipated|Novartis||1|||f||||f|f|f||||||No||2017-10-10 21:12:38.420469|2017-10-10 21:12:38.420469
NCT03100487|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-03-29|||August 2016||2016-08-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy of Audio Recorded Guided Imagery vs Deep Breathing Exercises on Functional Gastrointestinal Pain Disorders|Efficacy of Remote Audio Recorded Guided Imagery vs Deep Breathing Exercises on Primary Pediatric Care Patients With Functional Gastrointestinal Pain Disorders (TCH Pediatric Pilot Award)|Recruiting||N/A|58|Anticipated|Baylor College of Medicine||2|||f||||f||||||||No||2017-10-10 21:12:38.513301|2017-10-10 21:12:38.513301
NCT03100474|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-03|||December 2016||2016-12-01|March 2017|2017-03-01|January 2024|Anticipated|2024-01-01|January 2020|Anticipated|2020-01-01|5 Years|Observational [Patient Registry]|||Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:|Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound (TcMRgFUS) of Neurological Disorders:|Recruiting||N/A|500|Anticipated|InSightec|||1||f||||f|f|f||||||Undecided|Data will be shared via request from the publication committee. Active site participants will have access; however, it has not been decided when or if data will be shared with researchers not participating on this registry.|2017-10-10 21:12:38.594423|2017-10-10 21:12:38.594423
NCT03100461|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-03-29|||October 1, 2017|Anticipated|2017-10-01|March 2017|2017-03-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|AIMSS||Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations|Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations|Not yet recruiting||N/A|550|Anticipated|University of Kansas Medical Center||4|||f||||f|f|f||||||||2017-10-10 21:12:38.68659|2017-10-10 21:12:38.68659
NCT03100448|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-29|||February 24, 2017|Actual|2017-02-24|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|T-190||A 1-year Clinical Investigation on the On1 Concept|An Open, Prospective, Multi-center Study Evaluating the On1 Concept on NobelActive Implants|Recruiting||N/A|68|Anticipated|Nobel Biocare||1|||f||||t|f|t|f|f|f|||No||2017-10-10 21:12:38.789282|2017-10-10 21:12:38.789282
NCT03100435|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-12|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Er:YAG Laser in Decontamination of Dental Implants: An In-Vitro Study|Efficacy of Er:YAG Laser in Decontamination of Dental Implants: An In-Vitro Study|Recruiting||N/A|8|Anticipated|Tufts University School of Dental Medicine||4|||f||||f|f|t|f|f|t|||No||2017-10-10 21:12:38.88722|2017-10-10 21:12:38.88722
NCT03100422|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-28|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2018|Anticipated|2018-10-30||Interventional|MultiVIT-ARMin||Strategies of Therapy With the Exoskeleton Robot ARMin|Strategies of Therapy With the Exoskeleton Robot ARMinMulti VIT-ARMin|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Swiss Federal Institute of Technology||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:38.967371|2017-10-10 21:12:38.967371
NCT03100409|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-03|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of a Low Residue Diet in Comparison to the Dietetic Recommendations From the INCan in Cervical Cancer Patients|Effect of a Low Residue Diet in Comparison to the Dietary Recommendations From the INCan: A Randomized Clinical Trial to Assess Malnutrition, Gastrointestinal Toxicity and Quality of Life of Advanced Cervical Cancer Patients (IB2-IVA)|Recruiting||N/A|320|Anticipated|National Institute of Cancerología||2|||f||||f|f|f||||||No||2017-10-10 21:12:39.047502|2017-10-10 21:12:39.047502
NCT03100396|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-12|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|May 22, 2019|Anticipated|2019-05-22|May 22, 2018|Anticipated|2018-05-22||Observational|DREAMY||Direct REporting of Awareness in MaternitY Patients|Direct Reporting of Awareness in Maternity Patients: a Prospective Evaluation of Accidental Awareness Under General Anaesthesia in Obstetric Surgery Patients|Recruiting||N/A|2000|Anticipated|St George's, University of London|||1||f||||t|f|f||||||No||2017-10-10 21:12:39.165747|2017-10-10 21:12:39.165747
NCT03100383|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-03-29|||November 1, 2013|Actual|2013-11-01|March 2017|2017-03-01|November 30, 2014|Actual|2014-11-30|June 1, 2014|Actual|2014-06-01|9 Months|Observational [Patient Registry]|||Influence of Medical Nutrition Therapy and Eating Behavior on Gestational Weight Gain|Influence of Medical Nutrition Therapy and Eating Behavior on Gestational Weight Gain in Women With Diabetes|Completed||N/A|57|Actual|Materno-Perinatal Hospital of the State of Mexico|||1||f||||f|f|f||||||No||2017-10-10 21:12:39.246238|2017-10-10 21:12:39.246238
NCT03100370|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-04-20|||May 2016||2016-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Combined Spinal Direct Current Stimulation on Upper Limb Recovery in Acquired Brain Injury|Effects of Combined Spinal Direct Current Stimulation on Upper Limb Recovery in Acquired Brain Injury (ABI)|Recruiting||N/A|10|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||f||||||||Yes||2017-10-10 21:12:39.301827|2017-10-10 21:12:39.301827
NCT03100357|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-28|||October 31, 2014|Actual|2014-10-31|March 2017|2017-03-01|September 30, 2018|Anticipated|2018-09-30|March 2, 2017|Actual|2017-03-02||Observational|||Changes in Esophageal Motility and Swallowing Symptoms After Thyroid Surgery|Changes in Esophageal Motility and Swallowing Symptoms After Thyroid Surgery - a Prospective Cohort Study|Active, not recruiting||N/A|39|Actual|University of Southern Denmark|||1||f||||f|f|f||||||No||2017-10-10 21:12:39.402423|2017-10-10 21:12:39.402423
NCT03100344|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-28|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Dose-ranging Study of Nemolizumab in Atopic Dermatitis|A Randomized, Double-blind, Multi-center, Parallel-group, Placebo-controlled Dose-ranging Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Moderate-to-severe Atopic Dermatitis Subjects With Severe Pruritus Receiving Topical Corticosteroids|Recruiting||Phase 2|250|Anticipated|Galderma R&D||4|||||||t|t|f||||||||2017-10-10 21:12:39.465904|2017-10-10 21:12:39.465904
NCT03100331|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-28|||January 13, 2017|Actual|2017-01-13|March 2017|2017-03-01|January 13, 2020|Anticipated|2020-01-13|January 13, 2020|Anticipated|2020-01-13||Interventional|||Neuropsychological Outcomes of Internationally-Adopted Children Who Are Perinatally-Infected With Human Immunodeficiency Virus|Neuropsychological Outcomes of Internationally-Adopted Children Who Are Perinatally-Infected With Human Immunodeficiency Virus|Enrolling by invitation||N/A|20|Anticipated|Spectrum Health Hospitals||1|||f||||f|f|f||||||Yes|We may share the data with future co-investigators at the NIH Peds HIV observational cohort study|2017-10-10 21:12:39.991557|2017-10-10 21:12:39.991557
NCT03100318|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-07|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Interventional|||Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout|Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 for Hyperuricemia With or Without Gout to Evaluate the Safety and Noninferiority of FYU-981 (Phase III Study)|Active, not recruiting||Phase 3|200|Anticipated|Fuji Yakuhin Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 21:12:40.088947|2017-10-10 21:12:40.088947
NCT03100305|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-28|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Amino Acids Profiles in Premature Infants Receiving Nutritional Support|A Prospective Study of Amino Acids Profiles in Premature Infants Receiving Nutritional Support|Recruiting||N/A|150|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 21:12:40.178887|2017-10-10 21:12:40.178887
NCT03100292|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-04-03|||September 2016||2016-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|KOBESS||Korean OBEsity Surgical Treatment Study|Efficacy and Safety of Bariatric Surgery for Korean Morbidly Obese Patients : Prospective Multicenter Cohort Study|Recruiting||N/A|100|Anticipated|Seoul National University Bundang Hospital||1|||f||||f||||||||No||2017-10-10 21:12:40.26472|2017-10-10 21:12:40.26472
NCT03100279|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-28|||July 1, 2005|Actual|2005-07-01|March 2017|2017-03-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2022|Anticipated|2022-08-31||Interventional|||Process and Outcomes in CBT for Anxious and Depressed Youth|Psychotherapy Process and Outcomes in Cognitive-Behavioral Treatment for Anxious and Depressed Youth|Recruiting||N/A|400|Anticipated|Rutgers University||1|||f||||f|f|f||||||No|There is no intention to share IPD.|2017-10-10 21:12:40.374744|2017-10-10 21:12:40.374744
NCT03100266|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-03|||January 2016||2016-01-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Probiotics for Modic Changes in Low Back Pain Patients|Probiotics for Modic Changes: a Randomised Controlled Study to Elucidate the Effect of Probiotics on Vertebral Inflammatory End-plate Changes, So-called Type 1 Modic Changes|Recruiting||N/A|94|Anticipated|Regionshospitalet Silkeborg||2|||f||||f||||||||Undecided||2017-10-10 21:12:40.55687|2017-10-10 21:12:40.55687
NCT03100253|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-10-03|||November 1, 2017|Anticipated|2017-11-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|RAFTING||Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation|Open-label, Randomized Controlled Trial Comparing Tocilizumab to Anti-TNF Treatment and Discovery of Biomarkers for Treatment Selection in Rheumatoid Arthritis Patients With Inadequate Response to a First Anti-TNF|Not yet recruiting||Phase 4|400|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||t|f|f||||||||2017-10-10 21:12:41.318864|2017-10-10 21:12:41.318864
NCT03100227|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-07-06|||September 15, 2014|Actual|2014-09-15|July 2017|2017-07-01|July 6, 2017|Actual|2017-07-06|September 16, 2015|Actual|2015-09-16||Interventional|BDD-FDG||(18)F-FDG PET Database of Adult Healthy Individuals|(18)F-FDG PET Database of Adult Healthy Individuals for Clinical Studies in Epileptic Patients|Completed||N/A|41|Actual|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 21:12:41.632306|2017-10-10 21:12:41.632306
NCT03100214|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-29|||August 2016||2016-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of an Early Rehabilitation Program During Hospitalization in Patients With Cystic Fibrosis|Effects of an Early Rehabilitation Program During Hospitalization in Adolescents and Adults Patients With Cystic Fibrosis: Randomized Clinical Trial|Recruiting||N/A|68|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:12:41.729835|2017-10-10 21:12:41.729835
NCT03100201|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-28|||February 2, 2016|Actual|2016-02-02|March 2017|2017-03-01|February 28, 2019|Anticipated|2019-02-28|September 30, 2018|Anticipated|2018-09-30||Interventional|RASTA||Robotic-assisted Training After Upper Arm Fracture|Robotic-assisted Training After Upper Arm Fracture - a Multicentre, Controlled and Randomized Intervention Study|Recruiting||N/A|60|Anticipated|Robert Bosch Gesellschaft für Medizinische Forschung mbH||2|||f||||f|f|f||||||No||2017-10-10 21:12:41.834527|2017-10-10 21:12:41.834527
NCT03100188|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-29|||July 1, 2015|Actual|2015-07-01|March 2017|2017-03-01|December 15, 2016|Actual|2016-12-15|September 30, 2016|Actual|2016-09-30||Interventional|||Designer Dialysis Peritoneal Dialysis|Designer Dialysis: Designing a Peritoneal Dialysis Prescription That Fits a Patient's Lifestyle|Completed||N/A|7|Actual|Louisiana State University Health Sciences Center in New Orleans||1|||f||||f|f|f||||||No||2017-10-10 21:12:41.942264|2017-10-10 21:12:41.942264
NCT03100175|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-28|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Strength and Aerobic Training in Elderly Lymphoma Patients During Chemotherapy and Its Impact on Treatment Outcomes, Patients Functioning and Biological Markers of Aging|Strength and Aerobic Training in Elderly Lymphoma Patients During Chemotherapy and Its Impact on Treatment Outcomes, Patients Functioning and Biological Markers of Ageing|Not yet recruiting||N/A|100|Anticipated|Rabin Medical Center||2|||f||||f|f|f||||||No|no paln to share data, study will be done in our center only|2017-10-10 21:12:42.039208|2017-10-10 21:12:42.039208
NCT03100162|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-28|||February 27, 2016|Actual|2016-02-27|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Oral Supplementation With Probiotics|Effect of Oral Supplementation With Probiotics on Cardiometabolic Risk Factors, Microflora and Intestinal Epithelial Permeability, Mineral Content and Lifestyle in Obese Women With Postmenopausal Metabolic Syndrome: Double-blind, Randomized Clinical Trial.|Recruiting||N/A|90|Anticipated|Poznan University of Medical Sciences||3|||f||||f|f|f||||||Undecided||2017-10-10 21:12:42.121363|2017-10-10 21:12:42.121363
NCT03100149|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-25|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|June 29, 2021|Anticipated|2021-06-29|March 31, 2020|Anticipated|2020-03-31||Interventional|PASADENA||A Study to Evaluate the Efficacy of RO7046015 in Participants With Early Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, 52-Week Phase II Study to Evaluate the Efficacy of Intravenous RO7046015 (PRX002) in Participants With Early Parkinson's Disease With a 52-Week Blinded Extension|Recruiting||Phase 2|300|Anticipated|Hoffmann-La Roche||5|||f|||||t|f||||||||2017-10-10 21:12:42.243872|2017-10-10 21:12:42.243872
NCT03100136|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-28|||November 16, 2016||2016-11-16|March 2017|2017-03-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Interventional|||Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer|A Non-randomized, Open-label, Exploratory Study With A Non-pharmacologically Active Dose To Evaluate The Binding Kinetics Of A Novel Monoacylglicerol Lipase Positron Emission Tomography Radiotracer [11C]PF-06809247 In Healthy Male Subjects|Completed||Phase 1|7|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 21:12:42.445718|2017-10-10 21:12:42.445718
NCT03100123|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-28|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|APPLE||AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study|A Pilot Study Assessing the Feasibility of a Randomized Controlled Trial Evaluating Aspirin Versus Low-molecular-weight Heparin (LMWH) and Aspirin in Women With Antiphospholipid Syndrome and Pregnancy Loss|Not yet recruiting||Early Phase 1|24|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:42.546197|2017-10-10 21:12:42.546197
NCT03100110|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-28|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|February 2019|Anticipated|2019-02-01||Interventional|NCC-1701||NeuroCognitive Communicator: Safety Study|NeuroCognitive Communicator Exploratory Safety Study of an Assistive Neuroprosthetic Device for Patients With Severe Upper Motor Disability.|Not yet recruiting||N/A|2|Anticipated|Ottawa Hospital Research Institute||1|||f||||f|f|f||||||No||2017-10-10 21:12:42.659559|2017-10-10 21:12:42.659559
NCT03100097|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-05-01|||December 16, 2013|Actual|2013-12-16|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|ARREST||A Prospective, Multicenter, Randomized Control Study To Determine Clinical Effectiveness, Patient Wellness and Cost of Pain Related Care of In-Elastic Lumbar Sacral Orthoses Versus Standard Medical Treatment in Patients Presenting With Acute Low Back Pain In Primary Care Centers (The ARREST Study)|A Prospective, Multicenter, Randomized Control Study To Determine Clinical Effectiveness, Patient Wellness and Cost of Pain Related Care of In-Elastic Lumbar Sacral Orthoses Versus Standard Medical Treatment in Patients Presenting With Acute Low Back Pain In Primary Care Centers|Terminated||N/A|62|Actual|Aspen Medical Products||2||Difficulties recruiting patients|f||||f||||||||||2017-10-10 21:12:42.736576|2017-10-10 21:12:42.736576
NCT03100084|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-28|||September 15, 2016|Actual|2016-09-15|March 2017|2017-03-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2022|Anticipated|2022-09-01||Observational|PREPPeD||PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome|"The PREPPeD Study: PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome"|Recruiting||N/A|1000|Anticipated|Oslo University Hospital|||7||f||||t|f|f||||Samples With DNA|"     Maternal plasma, serum and DNA   "|Undecided|Depending on when the permission for the dataset usage for the project's outcome measures ends (OUH personal data officer/Regional Ethical Comittee) AND Norwegian legislation regarding personal data protection. It is unlikely that a major part of the data set will be shared openly due to these restrictions on sensitive personal data matters.|2017-10-10 21:12:42.823723|2017-10-10 21:12:42.823723
NCT03100071|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-22|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Observational|||Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients|A Pilot Study in Cancer Patients With Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in the Upper Extremity Treated With Low Molecular Weight Heparin (LMWH) and Apixaban (Catheter 3)|Recruiting||N/A|70|Anticipated|Lawson Health Research Institute|||1||f||||f|t|f|||f|||||2017-10-10 21:12:42.954743|2017-10-10 21:12:42.954743
NCT03100058|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-29|||January 1, 2000|Actual|2000-01-01|September 2017|2017-09-01|August 27, 2018|Anticipated|2018-08-27|February 6, 2018|Anticipated|2018-02-06||Interventional|||A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults|A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo|Recruiting||Phase 2|432|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:12:43.070134|2017-10-10 21:12:43.070134
NCT03100045|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-20|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|ART-AIN||Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)|A Phase I Study of Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)|Recruiting||Phase 1|18|Anticipated|Johns Hopkins University||6|||f||||t|t|f||||||No||2017-10-10 21:12:43.404006|2017-10-10 21:12:43.404006
NCT03100032|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-05|||January 2017||2017-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|Spine1||Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis|A Prospective Multi-centre, Randomised, Controlled Study to Evaluate the Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis by Interbody Fusion (L1 - S1)|Recruiting||Phase 1/Phase 2|36|Anticipated|Novadip Biosciences||2|||f||||f||||||||||2017-10-10 21:12:43.538395|2017-10-10 21:12:43.538395
NCT03100019|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-28|||May 13, 2014|Actual|2014-05-13|March 2017|2017-03-01|April 30, 2015|Actual|2015-04-30|April 30, 2015|Actual|2015-04-30||Interventional|||Supplementation of 500mg Trans-resveratrol Within Hypoxic and Normoxic Conditions, in Healthy Humans.|The Effects of Acute Trans-resveratrol Supplementation on Aspects of Cognitive Function and Cerebral Blood Flow, During Hypoxia and Normoxia, in Healthy, Young Humans.|Completed||N/A|24|Actual|Northumbria University||4|||f|||||f|f||||||No||2017-10-10 21:12:43.642629|2017-10-10 21:12:43.642629
NCT03100006|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-28|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2019|Anticipated|2019-08-31||Interventional|ORION-01||Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin|A Phase Ib/IIa Clinical Trial to Evaluate the Safety and Activity of Oregovomab and Nivolumab as a Combinatorial Immunotherapy Strategy in Patients With Recurrent Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin|Recruiting||Phase 1/Phase 2|32|Anticipated|National Cancer Centre, Singapore||1|||f||||f|f|f||||||Undecided||2017-10-10 21:12:43.708904|2017-10-10 21:12:43.708904
NCT03099993|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-28|||April 15, 2017|Anticipated|2017-04-15|March 2017|2017-03-01|June 1, 2017|Anticipated|2017-06-01|June 1, 2017|Anticipated|2017-06-01||Interventional|MouvsupTCIHemi||Sensitivity of an Upper Limb Motion Analysis Protocol to Changes in Kinematics and Muscle Activity After Constraint Induced Therapy in Children With Hemiplegia|Quantified Analysis of the Movements of the Upper Limb of Children With Hemiparesis Participating in the Stress Induced Therapy Program|Not yet recruiting||N/A|34|Anticipated|Nantes University Hospital||3|||f||||f|f|f||||||||2017-10-10 21:12:43.79129|2017-10-10 21:12:43.79129
NCT03099980|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-04-04|||July 11, 2016|Actual|2016-07-11|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa|Open-label, Investigator-Initiated, Single Site Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa|Recruiting||Early Phase 1|21|Anticipated|Tufts Medical Center||1|||f||||f|t|f|||f|||No||2017-10-10 21:12:43.86945|2017-10-10 21:12:43.86945
NCT03099967|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-03-29|||January 1, 2005||2005-01-01|March 2017|2017-03-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Observational|||Cardiac Troponin T After Transcatheter Closure of the Interatrial Septum|Cardiac Troponin T After Transcatheter Closure of the Interatrial Septum|Completed||N/A|51|Actual|Skane University Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:12:43.946311|2017-10-10 21:12:43.946311
NCT03099954|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-08-24|||January 19, 2017|Actual|2017-01-19|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|August 1, 2017|Actual|2017-08-01||Observational|||Withings Pulse Wave Velocity and Blood Pressure Study|Withings Pulse Wave Velocity and Blood Pressure Study|Active, not recruiting||N/A|300|Actual|Scripps Translational Science Institute|||1||f||||f|f|f||||||||2017-10-10 21:12:44.003888|2017-10-10 21:12:44.003888
NCT03099941|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-04|||May 11, 2015|Actual|2015-05-11|April 2017|2017-04-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||The Effectiveness of Two Different Feedbacks in Core Stabilization Education for Chronic Nonspecific Low Back Pain|The Comparison of the Effects of Two Different Feedback in the Core Stabilization Training for Patients With Chronic Nonspecific Low Back Pain (CNLBP): Randomized Parallel Group Trial|Completed||N/A|38|Actual|Istanbul University||2|||f||||f|f|f||||||No||2017-10-10 21:12:44.217914|2017-10-10 21:12:44.217914
NCT03099928|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-05-15|||March 1, 2015|Actual|2015-03-01|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Observational|||Developing a Positive Psychology Intervention to Improve Health Behaviors in Type 2 Diabetes: Qualitative Research|Developing a Positive Psychology Intervention to Improve Health Behaviors in Type 2 Diabetes: Qualitative Research|Completed||N/A|31|Actual|Massachusetts General Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:12:44.343628|2017-10-10 21:12:44.343628
NCT03099915|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-28|||March 17, 2017|Actual|2017-03-17|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|October 17, 2017|Anticipated|2017-10-17||Observational|AERO||Asthma Attack in the Emergency Department : Reasons Of This Attendance|Asthma Attack in the Emergency Department : Reasons Of This Attendance|Recruiting||N/A|150|Anticipated|University Paris 7 - Denis Diderot|||1||f||||f|f|f||||||No||2017-10-10 21:12:44.439507|2017-10-10 21:12:44.439507
NCT03099902|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-10|||November 1, 2010|Actual|2010-11-01|April 2017|2017-04-01|September 1, 2015|Actual|2015-09-01|September 1, 2015|Actual|2015-09-01||Observational|||Secondhand Smoking in Asthmatic Children|Association Between Maternal Smoking and GSTP1 and TNFa Polymorphism in Children With Asthma/Wheezing|Completed||N/A|90|Actual|AHEPA University Hospital|||2||f||||f|f|f||||Samples With DNA|"     Whole blood   "|No||2017-10-10 21:12:44.566773|2017-10-10 21:12:44.566773
NCT03099889|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-28|||April 15, 2015|Actual|2015-04-15|March 2017|2017-03-01|July 1, 2021|Anticipated|2021-07-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||WHISH-2-Prevent Heart Failure|Women's Health Initiative Strong and Healthy Exercise Trial-2-Prevent Heart Failure|Active, not recruiting||N/A|49936|Actual|Memorial Hospital of Rhode Island||2|||f||||t|f|f||||||Yes|Within two years of completion of study, de-identified data will be made available via WHI website after approval by the Publications and Presentation committee and data use agreement signed|2017-10-10 21:12:44.68259|2017-10-10 21:12:44.68259
NCT03099694|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-07-13|||April 27, 2017|Actual|2017-04-27|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)|Noninvasive Ventilation for Preterm Neonates With Respiratory Distress Syndrome: a Multi-center Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|Jiulongpo No.1 People's Hospital||2|||f||||t|f|f||||||||2017-10-10 21:12:46.49886|2017-10-10 21:12:46.49886
NCT03099876|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-06|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01|7 Weeks|Observational [Patient Registry]|||A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients|A Study on Eradication Rate of Triple Therapy Including Low Dose-PPI, Clarithromycin, Amoxicillin According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients|Recruiting||N/A|320|Anticipated|Il-Yang Pharm. Co., Ltd.|||2||f|||||f|f||||Samples With DNA|"     Blood to anlysis of CYP polymorphism   "|||2017-10-10 21:12:44.823214|2017-10-10 21:12:44.823214
NCT03099863|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-03|||April 2016||2016-04-01|March 2017|2017-03-01||||June 2017|Anticipated|2017-06-01||Interventional|||Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection|Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Infection: A Randomized Controlled Study|Recruiting||Phase 4|242|Anticipated|MetroHealth Medical Center||2|||f||||t||||||||||2017-10-10 21:12:44.975894|2017-10-10 21:12:44.975894
NCT03099850|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-19|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies|Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies - PROCEED Study|Recruiting||N/A|999|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||||||2017-10-10 21:12:45.139857|2017-10-10 21:12:45.139857
NCT03099837|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-28|||January 10, 2013|Actual|2013-01-10|March 2017|2017-03-01|January 10, 2023|Anticipated|2023-01-10|January 10, 2023|Anticipated|2023-01-10||Observational|TMCHC||Tongji Maternal and Child Health Cohort|Maternal and Infant Health Survey|Active, not recruiting||N/A|8000|Actual|Huazhong University of Science and Technology|||3||f||||f|f|f||||||No||2017-10-10 21:12:45.261646|2017-10-10 21:12:45.261646
NCT03099824|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-06-21|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of the Safety, Tolerability and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study Designed to Compare the Safety and Pharmacokinetics of Orally Administered Superoxide Dismutase Mimetic GC4711 With Intravenously Administered Superoxide Dismutase Mimetic GC4419 (Part 1), With Assessment of Food Effect (Part 2), in Healthy Volunteers|Not yet recruiting||Phase 1|58|Anticipated|Galera Therapeutics, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:12:45.344084|2017-10-10 21:12:45.344084
NCT03099811|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-17|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|October 1, 2018|Anticipated|2018-10-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Financial Incentives to Reduce Pediatric Tobacco Smoke Exposures|Contingency Management for Controlling Secondhand Smoke Exposures Among Asthmatic Children|Recruiting||N/A|150|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-10 21:12:45.484926|2017-10-10 21:12:45.484926
NCT03099798|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-28|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|SPLENIQ||Traumatic Splenic Injury and Management (SPLENIQ Study)|Traumatic Splenic Injury and Management (SPLENIQ Study) Quality of Life and Clinical Outcomes of Treatment for Splenic Injury After Trauma|Recruiting||N/A|100|Anticipated|Elisabeth-TweeSteden Ziekenhuis|||3||f||||f|f|f||||||No||2017-10-10 21:12:45.586262|2017-10-10 21:12:45.586262
NCT03099785|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-28|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D|A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)|Not yet recruiting||Phase 2|342|Anticipated|Cosmo Technologies Ltd||3|||f||||f|t|f|||f|||No|None. IPD not to be shared.|2017-10-10 21:12:45.72888|2017-10-10 21:12:45.72888
NCT03099772|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-28|||April 2007|Actual|2007-04-01|March 2017|2017-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||CBT for GAD: Impact of Cognitive Processing on Treatment Outcome|Cognitive-Behavioural Treatment for Generalized Anxiety Disorder: Impact of Cognitive Processing on Short- and Long-Term Outcomes|Completed||N/A|80|Actual|Concordia University||1|||f||||f|f|f||||||No||2017-10-10 21:12:45.854489|2017-10-10 21:12:45.854489
NCT03099759|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-20|||June 27, 2016|Actual|2016-06-27|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|VitD||Vitamin D Raising and Maintaining Blood Serum 25(OH)D3 Levels|Effectiveness of Various Vitamin D Protocols on Raising and Maintaining Blood Serum 25(OH)D3 Levels Over a Three Month Period|Completed||N/A|49|Actual|The Cleveland Clinic||3|||f||||f|f|f||||||No||2017-10-10 21:12:45.943632|2017-10-10 21:12:45.943632
NCT03099746|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-28|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|INVOLVE||Decision Support Among Surrogate Decision Makers of the Chronically Critically Ill (INVOLVE)|A Clinical Trial of Decision Support for End of Life Care Among Surrogate Decision Makers of the Chronically Critically Ill|Recruiting||N/A|270|Anticipated|Case Western Reserve University||3|||f||||t|f|f||||||Undecided||2017-10-10 21:12:46.0427|2017-10-10 21:12:46.0427
NCT03099733|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-05-22|||February 6, 2017|Actual|2017-02-06|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|texting||Concussion Texting Study|Development and Implementation of a Real-Time Assessment and Intervention for mTBI Patients Post-Discharge From the Emergency Department|Recruiting||N/A|40|Anticipated|Carolinas Healthcare System||1|||f||||f|f|f||||||No||2017-10-10 21:12:46.173557|2017-10-10 21:12:46.173557
NCT03099720|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-04|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|July 25, 2017|Anticipated|2017-07-25|July 25, 2017|Anticipated|2017-07-25||Interventional|||Local Analgesia to Prevent Pain in Patient Undergoing Removal of the Uterus Through Vaginal Route|Role of Ropivacaine Postincisional Infiltration With Intraperitoneal Instillation Analgesia in Postoperative Pain Relief in Patients Undergoing Non Descent Vaginal Hysterectomy: Randomized Controlled Trial|Recruiting||Phase 4|48|Anticipated|Cairo University||2|||f|||||f|f||||||Undecided||2017-10-10 21:12:46.261762|2017-10-10 21:12:46.261762
NCT03099707|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-12|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Treatment Ambassador Program: A Pilot Intervention to Increase Treatment Initiation|The Treatment Ambassador Program: Pilot Testing a Peer-driven Intervention to Increase Treatment Initiation Among HIV-positive South Africans|Recruiting||N/A|90|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:12:46.38202|2017-10-10 21:12:46.38202
NCT03099525|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-03-28|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01|5 Years|Observational [Patient Registry]|||Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD)|Treatment Outcome and Prognostic Factors for RA Patients With Interstitial Lung Disease|Recruiting||N/A|600|Anticipated|Hanyang University|||2||f||||f|f|f||||||No||2017-10-10 21:12:46.857965|2017-10-10 21:12:46.857965
NCT03099512|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-28|||March 30, 2017|Anticipated|2017-03-30|March 2017|2017-03-01|August 30, 2017|Anticipated|2017-08-30|August 15, 2017|Anticipated|2017-08-15||Interventional|||The Foot Exercises in Patellofemoral Pain|The Effects of Foot Exercises on Pain, Biomechanical Characteristics and Functionality of Lower Extremity in Patients With Patellofemoral Pain|Not yet recruiting||N/A|30|Anticipated|Hacettepe University||2|||f|||||f|f||||||||2017-10-10 21:12:46.948492|2017-10-10 21:12:46.948492
NCT03099499|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-07-12|||June 8, 2017|Actual|2017-06-08|July 2017|2017-07-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer|A Phase 2 Study of Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer|Recruiting||Phase 2|36|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:12:47.026164|2017-10-10 21:12:47.026164
NCT03099486|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-07-28|||October 30, 2017|Anticipated|2017-10-30|July 2017|2017-07-01|October 22, 2020|Anticipated|2020-10-22|October 22, 2019|Anticipated|2019-10-22||Interventional|||Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC|A Pilot Phase II, Single Arm, Open Label, Investigator-initiated Clinical Trial of Regorafenib Plus 5-Fluorouracil/Leucovorin (5FU/LV) Beyond Progression on Regorafenib Monotherapy in Metastatic Colorectal Cancer (mCRC)|Not yet recruiting||Phase 2|15|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:12:47.10591|2017-10-10 21:12:47.10591
NCT03099473|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-28|||April 6, 2017|Anticipated|2017-04-06|March 2017|2017-03-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Effects of Ocular Electroacupuncture on Trochlear Nerve Palsy|A Randomized Trial of Ocular Electroacupuncture for Trochlear Nerve Palsy|Recruiting||N/A|144|Anticipated|First Affiliated Hospital of Harbin Medical University||3|||f||||t|f|f||||||No||2017-10-10 21:12:47.17377|2017-10-10 21:12:47.17377
NCT03099460|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-28|||April 6, 2017|Anticipated|2017-04-06|March 2017|2017-03-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Effects of Ocular Electroacupuncture on Abducens Nerve Palsy|A Randomized Trial of Ocular Electroacupuncture for Abducens Nerve Palsy|Recruiting||N/A|150|Anticipated|First Affiliated Hospital of Harbin Medical University||3|||f||||t|f|f||||||No||2017-10-10 21:12:47.253249|2017-10-10 21:12:47.253249
NCT03099447|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-28|||April 6, 2017|Anticipated|2017-04-06|March 2017|2017-03-01|July 25, 2019|Anticipated|2019-07-25|March 25, 2019|Anticipated|2019-03-25||Interventional|||Effects of Ocular Electroacupuncture on Oculomotor Nerve Palsy|A Randomized Trial of Ocular Electroacupuncture for Oculomotor Nerve Palsy|Recruiting||N/A|177|Anticipated|First Affiliated Hospital of Harbin Medical University||3|||f||||t|f|f||||||No||2017-10-10 21:12:47.346432|2017-10-10 21:12:47.346432
NCT03099434|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-28|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|ENGAGE||Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media|Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media|Not yet recruiting||N/A|1350|Anticipated|Johns Hopkins University||3|||f||||t|f|f||||||No||2017-10-10 21:12:47.499427|2017-10-10 21:12:47.499427
NCT03099421|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-01|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Prostatic Artery Embolization for Benign Prostatic Obstruction|Prostatic Artery Embolization for Benign Prostatic Obstruction|Recruiting||N/A|30|Anticipated|Rigshospitalet, Denmark||1|||f||||t|f|f||||||No||2017-10-10 21:12:47.571282|2017-10-10 21:12:47.571282
NCT03099408|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-07-13|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis|A Pilot Study of Efficacy and Safety of Oral Metronidazole Versus Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent the Recurrence of Bacterial Vaginosis|Recruiting||Phase 4|66|Anticipated|Peking University Shenzhen Hospital||2|||f||||f|f|f||||||||2017-10-10 21:12:47.653855|2017-10-10 21:12:47.653855
NCT03099395|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-03|||June 1, 2015|Actual|2015-06-01|April 2017|2017-04-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01|8 Years|Observational [Patient Registry]|PRECLUDE-MI||Pattern of Repeat Cardiovascular Events During Follow-up After First Diagnosed Event-MI|Pattern of Repeat Cardiovascular Events During Follow-up After First Diagnosed Event-MI - PRECLUDE-MI - A Retrospective Cohort Study|Active, not recruiting||N/A|100000|Actual|Uppsala University|||1||f||||f|f|f||||||No||2017-10-10 21:12:47.732151|2017-10-10 21:12:47.732151
NCT03099382|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-25|||May 10, 2017|Actual|2017-05-10|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of SHR-1210 Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal Cancer|A Phase III Randomized Open-Label Study of Single Agent SHR-1210 vs Investigator's Choice Standard Therapy in Subjects With Advanced/Metastatic Esophageal Cancer|Recruiting||Phase 3|438|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:12:47.784546|2017-10-10 21:12:47.784546
NCT03099369|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-17|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|EASY FIT||Daily Step-based Exercise Using Fitness Monitors for Peripheral Artery Disease|The Effectiveness of Daily Step-based Exercise Therapy Using Fitness Monitors for Peripheral Artery Disease: The EASY FIT Trial|Recruiting||N/A|40|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|f||||||||2017-10-10 21:12:47.860456|2017-10-10 21:12:47.860456
NCT03099356|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-23|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|May 12, 2023|Anticipated|2023-05-12|May 12, 2022|Anticipated|2022-05-12||Interventional|||Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer|An Open Label Phase II Trial Evaluating the Efficacy of Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer|Recruiting||Phase 2|19|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:12:47.946967|2017-10-10 21:12:47.946967
NCT03099343|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-21|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Tailored Messaging to Reduce Sodium Intake|Location-based Tailored Messaging to Reduce Sodium Intake in Hypertensive Patients|Recruiting||N/A|50|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 21:12:48.025719|2017-10-10 21:12:48.025719
NCT03099330|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-15|||July 19, 2017|Actual|2017-07-19|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics|Phase I Study of Tolerance and Pharmacokinetics of TQ-B3139 in Patients With Advanced Cancer|Recruiting||Phase 1|20|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f|f|f|||f|||||2017-10-10 21:12:48.10148|2017-10-10 21:12:48.10148
NCT03099317|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-07-03|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|April 30, 2018|Anticipated|2018-04-30||Interventional|||Sinew Acupuncture for Knee Osteoarthritis|Sinew Acupuncture for Knee Osteoarthritis (KOA): A Randomized, Sham Controlled, Patient and Assessor Blinded, Pilot Trial|Recruiting||N/A|86|Anticipated|The University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 21:12:48.181583|2017-10-10 21:12:48.181583
NCT03099304|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-09-29|||April 19, 2017|Actual|2017-04-19|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo|A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo|Recruiting||Phase 2|150|Anticipated|Incyte Corporation||5|||||||f|t|f||||||||2017-10-10 21:12:50.052236|2017-10-10 21:12:50.052236
NCT03099291|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-23|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants and Children 6 to 24 Months of Age|Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, D46/NS2/N/ΔM2-2-HindIII, Lot RSV#011B, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age|Recruiting||Phase 1|33|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 21:12:50.201915|2017-10-10 21:12:50.201915
NCT03099278|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-28|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Ezetimibe for Patients With Chronic Hepatitis D|Ezetimibe for Patients With Chronic Hepatitis D|Recruiting||Phase 2|20|Anticipated|Ziauddin Hospital||1|||f||||f|t|f|||f|||No||2017-10-10 21:12:50.296946|2017-10-10 21:12:50.296946
NCT03099265|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-01|||June 26, 2017|Actual|2017-06-26|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma|Phase II Study to Evaluate Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma|Recruiting||Phase 2|28|Anticipated|Yale University||1|||f||||t|t|f|||t|||||2017-10-10 21:12:50.370715|2017-10-10 21:12:50.370715
NCT03099252|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-08-04|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|ONesiE||Caring for Babies: A Study of Ontario Maternal-Newborn Hospitals on the Effectiveness of Parent-targeted Education|Caring for Babies: A Study of Ontario Maternal-Newborn Hospitals on the Effectiveness of Parent-targeted Education (ONesiE)|Not yet recruiting||N/A|20|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||f|f|f||||||||2017-10-10 21:12:50.456761|2017-10-10 21:12:50.456761
NCT03099239|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-27|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|January 3, 2019|Anticipated|2019-01-03|January 3, 2019|Anticipated|2019-01-03||Interventional|hCT-MSCs||hCT-MSCs for Children With Autism Spectrum Disorder (ASD)|A Phase I Study of hCT-MSC, An Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder|Enrolling by invitation||Phase 1|12|Anticipated|Duke University||3|||f||||t|t|f||||||No||2017-10-10 21:12:50.542121|2017-10-10 21:12:50.542121
NCT03099226|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-31|||July 15, 2008|Actual|2008-07-15|March 2017|2017-03-01|April 3, 2009|Actual|2009-04-03|April 3, 2009|Actual|2009-04-03||Interventional|||Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Dose Regimens of BIA 5-453|A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Dose Regimens of Etamicastat (BIA 5-453) in Hypertensive Subjects|Completed||Phase 1|23|Actual|Bial - Portela C S.A.||3|||f||||f|f|f||||||Undecided||2017-10-10 21:12:50.637555|2017-10-10 21:12:50.637555
NCT03099213|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||November 1, 2008||2008-11-01|March 2017|2017-03-01|April 23, 2010|Actual|2010-04-23|April 23, 2010|Actual|2010-04-23||Interventional|HOPETips||An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event|A Study of Patients Treated With Ramipril for Cardiovascular Risk Reduction The HOPE Tips: The HOPE Study Translated Into PracticeS|Completed||Phase 4|179|Actual|Sanofi||1|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:12:50.740386|2017-10-10 21:12:50.740386
NCT03099200|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-03-31|||December 12, 2016|Actual|2016-12-12|March 2017|2017-03-01|March 17, 2017|Actual|2017-03-17|March 17, 2017|Actual|2017-03-17||Observational|||An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer|UK HER2 Positive Breast Cancer Productivity & Utility Non-Interventional Study (PURPOSE)|Completed||N/A|300|Actual|Hoffmann-La Roche|||3||f||||f||||||||||2017-10-10 21:12:50.928355|2017-10-10 21:12:50.928355
NCT03099187|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-10-02|||May 14, 2017|Actual|2017-05-14|October 2017|2017-10-01|January 17, 2020|Anticipated|2020-01-17|January 17, 2020|Anticipated|2020-01-17||Interventional|||A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease|Multicenter, International, Double-blind, Two-Arm, Randomized, Placebo-controlled Phase II Trial of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing ILD|Recruiting||Phase 2|250|Anticipated|Hoffmann-La Roche||2|||f||||t|t|f|||t|||||2017-10-10 21:12:51.092054|2017-10-10 21:12:51.092054
NCT03099005|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-01|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|September 30, 2020|Anticipated|2020-09-30||Interventional|||Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain|Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain Primary Study - Phase 2|Not yet recruiting||Phase 2|120|Anticipated|University of California, San Diego||3|||f||||t|t|f||||||Yes|The principal investigator, Brook Henry PhD (blhenry@ucsd.edu), will supply individual participant data to other researchers after the project is completed.|2017-10-10 21:12:53.071022|2017-10-10 21:12:53.071022
NCT03099174|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-31|2017-10-03|||May 4, 2017|Actual|2017-05-04|October 2017|2017-10-01|July 10, 2020|Anticipated|2020-07-10|December 6, 2018|Anticipated|2018-12-06||Interventional|||This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.|An Open Label, Phase Ib Dose-escalation Study Evaluating the Safety and Tolerability of BI 836845 and Abemaciclib in Patients With Locally Advanced or Metastatic Solid Tumors and in Combination With Endocrine Therapy in Patients With Locally Advanced or Metastatic Hormone Receptor-positive Breast Cancer, Followed by Expansion Cohorts|Recruiting||Phase 1|90|Anticipated|Boehringer Ingelheim||6|||f||||f|t|f||||||||2017-10-10 21:12:51.417453|2017-10-10 21:12:51.417453
NCT03099161|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-22|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|July 8, 2019|Anticipated|2019-07-08|July 8, 2019|Anticipated|2019-07-08||Interventional|||Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)|A Phase Ib/II Study to Evaluate the Safety and Tolerability of Preladenant as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Malignancies|Recruiting||Phase 1|120|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f|t|f||||||||2017-10-10 21:12:51.586522|2017-10-10 21:12:51.586522
NCT03099148|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-10-02|||April 4, 2017|Actual|2017-04-04|October 2017|2017-10-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||A Study of LY3337641 in Healthy Participants|Relative Bioavailability and the Effect of Food on the Bioavailability of LY3337641 in Healthy Subjects|Completed||Phase 1|32|Actual|Eli Lilly and Company||4|||f||||f|t|f||||||||2017-10-10 21:12:51.731173|2017-10-10 21:12:51.731173
NCT03099135|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-30|2017-09-11|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|January 7, 2022|Anticipated|2022-01-07|December 6, 2021|Anticipated|2021-12-06||Interventional|||A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection|A Prospective 3-Year Follow-up Study in Subjects Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection|Recruiting||Phase 3|250|Anticipated|Janssen Research & Development, LLC||1|||f||||f|t|f||||||||2017-10-10 21:12:51.816834|2017-10-10 21:12:51.816834
NCT03099122|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-09-12|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|START-DCD||A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant|A Prospective, Multi-center, Single-arm, Interventional Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant in China|Recruiting||Phase 4|200|Anticipated|Sanofi||1|||f||||f|f|f|||f|||||2017-10-10 21:12:51.99969|2017-10-10 21:12:51.99969
NCT03099109|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-10-04|||April 12, 2017|Actual|2017-04-12|October 2017|2017-10-01|June 14, 2020|Anticipated|2020-06-14|June 14, 2020|Anticipated|2020-06-14||Interventional|||A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors|A Phase 1a/1b Study of LY3321367, an Anti-TIM-3 Antibody, Administered Alone or in Combination With LY3300054, an Anti-PD-L1 Antibody, in Advanced Relapsed/Refractory Solid Tumors|Recruiting||Phase 1|172|Anticipated|Eli Lilly and Company||4|||f||||f|t|f||||||||2017-10-10 21:12:52.109486|2017-10-10 21:12:52.109486
NCT03099083|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-07-05|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Observational|RAPSODI||Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab|Real-World Outcome of Psoriasis Patients in Korea on Adalimumab|Recruiting||N/A|100|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:12:52.498597|2017-10-10 21:12:52.498597
NCT03099070|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-28|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||Acute Stress Response in Migraine Sufferers|Acute Stress Response in Migraine Sufferers|Recruiting||N/A|212|Anticipated|Massachusetts General Hospital||4|||f||||f|f|f||||||No||2017-10-10 21:12:52.619518|2017-10-10 21:12:52.619518
NCT03099057|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-07-10|||March 7, 2017|Actual|2017-03-07|July 2017|2017-07-01|March 7, 2027|Anticipated|2027-03-07|March 7, 2027|Anticipated|2027-03-07||Observational|PRINT||Study of Prognostic Factors in Interventional Rhythmology|Study of Prognostic Factors in Interventional Rhythmology|Recruiting||N/A|5000|Anticipated|University Hospital, Brest|||1||f||||f|f|f||||||||2017-10-10 21:12:52.730337|2017-10-10 21:12:52.730337
NCT03099044|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-28|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|April 27, 2017|Anticipated|2017-04-27|March 10, 2017|Actual|2017-03-10||Interventional|DAD||"Fermented Dairy Beverage on Inflammation/Immune Function in Stressful Exercise"|"Effects of Two Doses of Fermented Dairy Beverage on Inflammation/Immune Function in Healthy Adults Undergoing Stressful Exercise; Compared to a Placebo Beverage"|Active, not recruiting||N/A|45|Actual|Dairy A Day, Inc.||3|||f||||f|f|f||||||No|There is no such plan.|2017-10-10 21:12:52.816983|2017-10-10 21:12:52.816983
NCT03099031|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-28|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|PREDICARE||Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)|Prediction of Thromboembolic Recurrences in Cancer Patients With Venous Thromboembolic Disease (TED)|Active, not recruiting||N/A|420|Actual|LEO Pharma|||1||f||||f|f|f||||||No||2017-10-10 21:12:52.90416|2017-10-10 21:12:52.90416
NCT03099018|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-13|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Comparison of Two Rapid Antigen Detection Tests for the Detection of Group-A Streptococcal Pharyngitis in Children|Comparison of Two Rapid Antigen Detection Tests for the Detection of Group-A Streptococcal Pharyngitis in Children|Completed||N/A|1000|Actual|University Hospital, Geneva|||1||f||||f|f|f|||f|||No||2017-10-10 21:12:52.999709|2017-10-10 21:12:52.999709
NCT02587039|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-08-10|||June 2014||2014-06-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||An Intervention to Reduce Delirium After Cardiac Surgery|An Intervention to Reduce Delirium After Cardiac Surgery|Completed||N/A|53|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 22:48:13.520643|2017-10-10 22:48:13.520643
NCT03098992|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-28|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Efficacy and Safety of Fotona Smooth® Device for the Treatment of Stress Urinary Incontinence|Post-market, Prospective, Randomised, Sham-controlled Clinical Trial Designed to Confirm the Efficacy and Safety of the Fotona Smooth® Device to Treat Female Stress Urinary Incontinence|Recruiting||N/A|120|Anticipated|Cork University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:12:53.187399|2017-10-10 21:12:53.187399
NCT03098953|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-16|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|May 12, 2017|Actual|2017-05-12|May 12, 2017|Actual|2017-05-12||Interventional|||Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Installations|Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of LE Ophthalmic Gel|Completed||Phase 1|15|Actual|Bausch & Lomb Incorporated||1|||f||||t|t|f||||||Yes||2017-10-10 21:12:53.729668|2017-10-10 21:12:53.729668
NCT03098940|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-28|||January 2018|Anticipated|2018-01-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||A Bioavailability Study on Dronabinol|A Two Part, Open Label, Randomized, Four Period Cross-over Study to Compare the Bioavailability of Two Different Dronabinol Formulations in Healthy Male and Female Volunteers|Not yet recruiting||Phase 1|50|Anticipated|Axim Biotechnologies||2|||f||||f|t|f|||f|||No||2017-10-10 21:12:53.806855|2017-10-10 21:12:53.806855
NCT03098927|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-28|||September 1, 2014|Actual|2014-09-01|March 2017|2017-03-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|BCI||Mirror Neuron Network Based Motor Imagery Training to Improve Brain Computer Interface Performance in Spinal Cord Injury Patients|Mirror Neuron Network Based Motor Imagery Training Paradigms to Improve Brain Computer Interface (BCI) Performance in Spinal Cord Injury Patients|Recruiting||N/A|8|Anticipated|The Cleveland Clinic||2|||f||||f|f|f||||||No||2017-10-10 21:12:53.862703|2017-10-10 21:12:53.862703
NCT03098914|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-03|||April 11, 2017|Anticipated|2017-04-11|April 2017|2017-04-01|May 1, 2019|Anticipated|2019-05-01|April 1, 2019|Anticipated|2019-04-01||Observational|||Clinical Characteristics and Microbiology of Community-Acquired Pneumonia|Clinical Characteristics and Microbiology of Community-Acquired Pneumonia: A Prospective Study|Recruiting||N/A|2000|Anticipated|Beijing Haidian Hospital|||3||f|||||f|f||||||||2017-10-10 21:12:53.956434|2017-10-10 21:12:53.956434
NCT03098901|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-03|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15||Interventional|||Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease|Tc99m-PYP Scintigraphy in Order to Establish Incidence of Cardiac Transthyretin Amyloidosis Among Patients With Otherwise Unexplained Cardiomyopathies|Not yet recruiting||N/A|100|Anticipated|Kaplan Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:12:54.051951|2017-10-10 21:12:54.051951
NCT03098888|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-28|||March 23, 2017|Actual|2017-03-23|March 2017|2017-03-01|March 23, 2019|Anticipated|2019-03-23|March 23, 2019|Anticipated|2019-03-23||Observational|REA-LBA||Bronchoalveolar Lavages for Cytologic Assessment in Intensive Care Unit Patients|Bronchoalveolar Lavages in the Intensive Care Unit : Indications, Adverse Respiratory Effects, Contribution to Diagnosis and Therapy. A Multicenter, Prospective, Observational Study|Recruiting||N/A|300|Anticipated|Centre Hospitalier Régional d'Orléans|||1||f||||f|f|f||||||No||2017-10-10 21:12:54.136918|2017-10-10 21:12:54.136918
NCT03098875|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-03-28|||January 2009||2009-01-01|March 2017|2017-03-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Interventional|||Heart Rate Variability Under Propofol and Sevoflurane|Spectral Analysis of Heart Rate Variability at BIS 25 and BIS 55 Under Propofol or Sevoflurane|Completed||N/A|40|Actual|Hôpital Armand Trousseau||2|||f||||f||||||||No||2017-10-10 21:12:54.234237|2017-10-10 21:12:54.234237
NCT03098849|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-31|||January 25, 2017|Actual|2017-01-25|January 2017|2017-01-01|November 30, 2017|Anticipated|2017-11-30|November 15, 2017|Anticipated|2017-11-15||Interventional|||Effectiveness of a Buteyko-based Breathing Technique for Asthma Patients|Effectiveness of a Buteyko-based Breathing Technique on Psycho-physiological Parameters of Adults With Asthma - a Randomized, Controlled Study|Recruiting||N/A|64|Anticipated|ARCIM Institute Academic Research in Complementary and Integrative Medicine||2|||f||||f|f|f||||||||2017-10-10 21:12:54.520481|2017-10-10 21:12:54.520481
NCT03098836|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-07-18|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2021|Anticipated|2021-06-01||Interventional|PANTHER||Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer|Prospective Study of Apalutamide and Abiraterone Acetate iN ChemoTHerapy-Naïve mEn With mCRPC Stratified by Race|Recruiting||Phase 2|100|Anticipated|Duke University||2|||f||||t|t|f||||||||2017-10-10 21:12:54.658777|2017-10-10 21:12:54.658777
NCT03098823|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-26|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|RIFLE||A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE|A Randomized, Double-Blind, Active Comparator-Controlled, Crossover Study to Assess the Capacity of RAYOS® Compared to Immediate-Release Prednisone to Improve Fatigue and Control Morning Symptoms in Subjects With Systemic Lupus Erythematosus|Recruiting||Phase 4|62|Anticipated|Ampel BioSolutions, LLC||2|||f||||f|t|f||||||||2017-10-10 21:12:54.781142|2017-10-10 21:12:54.781142
NCT03098810|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-31|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Effect of Zinc Supplementation on Appetite and Growth in Primary Malnourished Children|Effect of Zinc Supplementation on Appetite and Growth of Primary Malnourished Children|Not yet recruiting||Phase 4|50|Anticipated|Ain Shams University||2|||f||||t|t|f|||f|||No||2017-10-10 21:12:54.944455|2017-10-10 21:12:54.944455
NCT03098797|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-08|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|TAZPOWER||A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Barth Syndrome|Recruiting||Phase 2/Phase 3|12|Anticipated|Stealth BioTherapeutics Inc.||2|||f||||t|t|f||||||Undecided||2017-10-10 21:12:55.019838|2017-10-10 21:12:55.019838
NCT03098784|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-03-31|||November 2011||2011-11-01|March 2017|2017-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|NPAF||Nanoparticles Emitted by Aircraft Engines, Impact on Respiratory Function|Nanoparticles Emitted by Aircraft Engines, Impact on Respiratory Function|Completed||N/A|472|Actual|University Hospital, Montpellier|||2||f||||t||||||||Yes|NC|2017-10-10 21:12:55.128832|2017-10-10 21:12:55.128832
NCT03098771|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-27|||January 2018|Anticipated|2018-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Peripheral Blood Autologous CD34+ Cell Transplantation Promotes Angiogenesis With Atherosclerotic Ischemia for Elderly|Peripheral Blood Autologous CD34+ Cell Transplantation Promotes Angiogenesis in Elderly Patients With Atherosclerotic Ischemia: Study Protocol for a Prospective, Single-center, Open-label, Randomized, Controlled, Clinical Trial|Not yet recruiting||N/A|20|Anticipated|Qingdao University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:55.232436|2017-10-10 21:12:55.232436
NCT03098758|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-04-03|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric Cancer|Pilot Study of Comparative Molecular Analysis CK20, CEA and BER-EP4 in Peritoneal Washing Citology for Locally Advanced Gastric Cancer and Their Ability to Predict Peritoneal Dissemination|Not yet recruiting||N/A|20|Anticipated|Corporacion Parc Tauli|||1||f|||||f|f||||Samples With DNA|"     gastric cancer cells in peritoneal washing   "|||2017-10-10 21:12:55.330048|2017-10-10 21:12:55.330048
NCT03098745|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-05-17|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|April 11, 2017|Actual|2017-04-11|March 1, 2017|Actual|2017-03-01||Interventional|||Fitting Evaluation of Hydrogel and Silicone Hydrogel Sphere Design Contact Lenses|Fitting Evaluation of Hydrogel and Silicone Hydrogel Sphere Design Contact Lenses.|Completed||N/A|40|Actual|Coopervision, Inc.||3|||f||||f|f|f|||f|||No||2017-10-10 21:12:55.401048|2017-10-10 21:12:55.401048
NCT03098732|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-27|||March 22, 2017|Actual|2017-03-22|March 2017|2017-03-01|October 31, 2018|Anticipated|2018-10-31|July 31, 2018|Anticipated|2018-07-31||Interventional|MEDIS||Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial|A Prospective International Multicentre Randomised Controlled Single Blind Clinical Investigation of Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS)|Recruiting||N/A|120|Anticipated|Pulse Therapeutics||2|||f||||t|f|t|t||t|||No||2017-10-10 21:12:55.488281|2017-10-10 21:12:55.488281
NCT03098719|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-27|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|GISMO||GISMO - Geographical Information Support for Healthy Mobility|GISMO - Geographical Information Support for Healthy Mobility|Recruiting||N/A|70|Anticipated|Paracelsus Medical University||2|||f||||f|f|f||||||No||2017-10-10 21:12:55.630919|2017-10-10 21:12:55.630919
NCT03098706|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-04-06|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 1, 2021|Anticipated|2021-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|HYPOREME||"Therapeutic Hypothermia in Expanded Criteria Brain-dead Donors and Kidney-graft Function"|"Impact of Therapeutic Hypothermia in Expanded Criteria Brain-dead Donors on Kidney-graft Function in the Kidney-transplant Recipients: Multicenter Randomized Controlled Trial HYPOREME"|Not yet recruiting||N/A|516|Anticipated|Nantes University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:12:55.756342|2017-10-10 21:12:55.756342
NCT03098693|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-27|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Observational|DDCP||Dyadic-Based Diagnosis, Care and Prevention for HIV Discordant Couples in Tanzania|Dyadic-Based Diagnosis, Care and Prevention for HIV Discordant Couples in Tanzania|Not yet recruiting||N/A|120|Anticipated|Medical University of South Carolina|||1||f||||f||f||||||||2017-10-10 21:12:55.881363|2017-10-10 21:12:55.881363
NCT03098680|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-02|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|February 29, 2020|Anticipated|2020-02-29|February 29, 2020|Anticipated|2020-02-29||Interventional|PRIME||A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems|A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems|Recruiting||Phase 1|32|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 21:12:55.969249|2017-10-10 21:12:55.969249
NCT03098667|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-28|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|December 20, 2017|Anticipated|2017-12-20|October 1, 2017|Anticipated|2017-10-01||Interventional|||Laryngeal Mask Airway (LMA) Protector for Minimally Invasive Thyroidectomy|Study of the Laryngopharyngeal Symptoms After Minimally Invasive Thyroidectomy: Comparison Between the Protector Laryngeal Mask Airway and the Endotracheal Tube.|Recruiting||N/A|80|Anticipated|424 General Military Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:12:56.095287|2017-10-10 21:12:56.095287
NCT03098472|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-09|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|CADUCeuS||Cholinesterase Activity and DeliriUm During Critical Illness Study|Cholinesterase Activity and Delirium During Critical Illness Study|Recruiting||N/A|240|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||||No||2017-10-10 21:12:58.07879|2017-10-10 21:12:58.07879
NCT03098654|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-10-03|||January 15, 2018|Anticipated|2018-01-15|October 2017|2017-10-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care In Kisarawe, Tanzania|Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care: An RCT In Kisarawe, Tanzania|Not yet recruiting||N/A|178|Anticipated|Medical University of South Carolina||2|||f||||f|f|f||||||||2017-10-10 21:12:56.218898|2017-10-10 21:12:56.218898
NCT03098641|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-16|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|Restorelle||Smartmesh Technology in Pelvic Floor Repair Procedures|Etude rétrospective Chez Des Patientes opérées d'un Prolapsus génital Avec l'Implant de Renfort Restorelle Direct Fix : à Propos Des premières Poses en France Entre Janvier 2013 et décembre 2016 (Restorelle).|Recruiting||N/A|100|Anticipated|Groupe Hospitalier de la Rochelle Ré Aunis|||1||f||||f|f|f||||||Undecided||2017-10-10 21:12:56.327095|2017-10-10 21:12:56.327095
NCT03098628|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-27|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|March 30, 2021|Anticipated|2021-03-30|August 30, 2020|Anticipated|2020-08-30||Interventional|VPTII||Trial of Simplified Pneumococcal Vaccination in Vietnam II|Trial of Simplified Pneumococcal Vaccination in Vietnam II: The Herd Immunity Approach|Recruiting||Phase 2/Phase 3|2500|Anticipated|Murdoch Childrens Research Institute||5|||f||||t|f|f|||f|||No||2017-10-10 21:12:56.491676|2017-10-10 21:12:56.491676
NCT03098615|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-27|||September 2015||2015-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study Evaluating the Effect of Jublia on Dermatophytomas|An Investigator Initiated Pilot Study Evaluating the Efficacy of Efinaconazole 10% Solution (Jublia) for the Treatment of Onychomycosis With Dermatophytomas|Active, not recruiting||Phase 4|5|Anticipated|University of Alabama at Birmingham||1|||f||||f|t|f||||||No||2017-10-10 21:12:56.607569|2017-10-10 21:12:56.607569
NCT03098602|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-04-26|||February 28, 2017||2017-02-28||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:12:56.704185|2017-10-10 21:12:56.704185
NCT03098589|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-06-07|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|October 2, 2021|Anticipated|2021-10-02|October 2, 2021|Anticipated|2021-10-02||Observational|||Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)|Revlimid® Capsules Drug Use-results Surveillance Relapsed or Refractory Adult T-cell Leukemia Lymphoma|Recruiting||N/A|80|Anticipated|Celgene|||1||f||||f|f|f||||||||2017-10-10 21:12:56.7444|2017-10-10 21:12:56.7444
NCT03098576|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-03-28|||March 28, 2017|Actual|2017-03-28|March 2017|2017-03-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2020|Anticipated|2020-04-01||Observational|||Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute|Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute|Recruiting||N/A|301|Anticipated|Cedars-Sinai Medical Center|||2||f||||f|f|f||||Samples With DNA|"     Fresh or archived tissue Blood   "|No||2017-10-10 21:12:56.830949|2017-10-10 21:12:56.830949
NCT03098563|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-27|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|September 1, 2020|Anticipated|2020-09-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis|Maximizing Analgesia to Reduce Pain Sensitivity in Chronic Knee Osteoarthritis Pain Patients|Not yet recruiting||Phase 2|80|Anticipated|Johns Hopkins University||4|||f||||f|t|f|||f|||No||2017-10-10 21:12:56.918129|2017-10-10 21:12:56.918129
NCT03098550|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-28|2017-10-03|||June 7, 2017|Actual|2017-06-07|October 2017|2017-10-01|October 23, 2020|Anticipated|2020-10-23|June 16, 2019|Anticipated|2019-06-16||Interventional|||A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread|Phase 1/2 Study to Evaluate the Safety and Preliminary Efficacy of Nivolumab Combined With Daratumumab in Participants With Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|120|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 21:12:57.011744|2017-10-10 21:12:57.011744
NCT03098537|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-27|||August 1, 2016|Actual|2016-08-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Effects of Enteral Nutrition on Stress Ulcer Hemorrage. Multicenter Randomized Controlled Trial|Effects of Enteral Nutrition on Stress Ulcer Hemorrage. Multicenter Randomized Controlled|Recruiting||N/A|500|Anticipated|TC Erciyes University||2|||f||||f|f|f||||||No||2017-10-10 21:12:57.191016|2017-10-10 21:12:57.191016
NCT03098524|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-03|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|April 15, 2020|Anticipated|2020-04-15|April 15, 2020|Anticipated|2020-04-15||Interventional|MECANO||Low Tidal MEChanical Ventilation Against NO Ventilation During Cardiopulmonary Bypass Heart Surgery|Low Tidal MEChanical Ventilation Against NO Ventilation During Cardiopulmonary Bypass Heart Surgery : a Randomized Controlled Trial|Recruiting||N/A|1500|Anticipated|CMC Ambroise Paré||2|||f||||f|f|f||||||||2017-10-10 21:12:57.305941|2017-10-10 21:12:57.305941
NCT03098511|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-08|||April 25, 2017|Actual|2017-04-25|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|INDex-CTP||CT-Perfusion for Neurological Diagnostic Evaluation|CT-Perfusion for Neurological Diagnostic Evaluation: a Prospective Canadian Multicenter Diagnostic Test Study|Recruiting||N/A|300|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t|f|f||||||No||2017-10-10 21:12:57.652037|2017-10-10 21:12:57.652037
NCT03098498|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-30|||June 1, 2016|Actual|2016-06-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|ATTGAIN16||Impact of Debridement Invasiveness on Attachment Gain After Antiinfective Periodontal Therapy|Impact of Debridement Invasiveness on Attachment Gain After Antiinfective Periodontal Therapy|Recruiting||N/A|44|Anticipated|Wuerzburg University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:12:57.863558|2017-10-10 21:12:57.863558
NCT03098485|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-04-03|||January 2017||2017-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 2017|Anticipated|2017-12-01||Interventional|||Healthy Patients & Effect of Antibiotics|Prospective Study Characterizing Fecal Microbiome Disruptions During and After Receipt of Antimicrobials|Active, not recruiting||N/A|20|Actual|Washington University School of Medicine||4|||f||||f||||||||No|Summarized metagenomics sequence data will be made available through public repositories at the time of manuscript publication.|2017-10-10 21:12:57.976988|2017-10-10 21:12:57.976988
NCT02585661|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-01-11|||October 2015||2015-10-01|October 2015|2015-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Iron Bioavailability From Dairy Product|Iron Bioavailability From Fortified Dairy Product in Healthy Women|Completed||N/A|20|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 22:48:31.521518|2017-10-10 22:48:31.521518
NCT03098459|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|INSIGHT-ICU||Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU Study|Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU Study|Not yet recruiting||N/A|900|Anticipated|Vanderbilt University Medical Center|||1||f||||t|f|f||||Samples With DNA|"     Blood   "|||2017-10-10 21:12:58.155348|2017-10-10 21:12:58.155348
NCT03098446|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-23|||April 8, 2017|Actual|2017-04-08|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal|The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal|Recruiting||N/A|10|Anticipated|University of Texas at Austin||2|||f||||f|f|f||||||No||2017-10-10 21:12:58.243154|2017-10-10 21:12:58.243154
NCT03098433|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-05-09|||February 1, 2018|Anticipated|2018-02-01|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Acute Effects of Liothyronine in Single Administration|Effects of Liothyronine on Energy Expenditure and Cardiovascular Function|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Virginia Commonwealth University||3|||f|||||t|f||||||No||2017-10-10 21:12:58.32991|2017-10-10 21:12:58.32991
NCT03098420|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-09-04|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section|Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section: A Prospective Randomized Double-Blinded Clinical Study|Recruiting||Phase 2/Phase 3|60|Anticipated|University of Alabama at Birmingham||3|||f||||t|t|f|||f|||||2017-10-10 21:12:58.408271|2017-10-10 21:12:58.408271
NCT03098407|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-07|||April 20, 2017|Actual|2017-04-20|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Opioid Dependence Treatment Therapies in Pregnancy|A Pilot Randomized Comparative Effectiveness Clinical Trial of Buprenorphine vs. Methadone for the Treatment of Opioid Dependence in Pregnancy.|Recruiting||N/A|50|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||No||2017-10-10 21:12:58.55172|2017-10-10 21:12:58.55172
NCT03098394|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-09-26|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Use of a Rapid Turnaround Test for NG/CT to Improve Treatment of Women Presenting With Possible STIs|Use of a Rapid Turnaround Test for Gonorrhea & Chlamydia to Improve Treatment of Women Presenting With Possible Sexually Transmitted Infections|Not yet recruiting||N/A|100|Anticipated|University of Maryland||2|||f||||f|f|t|f|f|t|||||2017-10-10 21:12:58.687649|2017-10-10 21:12:58.687649
NCT03098381|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-27|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|September 2016|Actual|2016-09-01||Observational|||Alteration in Body Composition and Metabolic Profile During Ramadan Fasting in Healthy Men|Alteration in Body Composition and Metabolic Profile Without Changes on Serum Leptin and Adiponectin Levels During Ramadan Fasting in Healthy Men|Completed||N/A|27|Actual|Chulalongkorn University|||1||f||||t|f|f||||||No||2017-10-10 21:12:58.783509|2017-10-10 21:12:58.783509
NCT03098368|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-27|||September 2016||2016-09-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors||Active, not recruiting||Phase 4|40|Anticipated|Chulalongkorn University||2|||f||||||||||||||2017-10-10 21:12:58.850433|2017-10-10 21:12:58.850433
NCT03098355|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-06-13|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|July 15, 2019|Anticipated|2019-07-15||Interventional|||Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies|Anti-CD19/CD22 4th Generation CAR-T Cells (4SCAR19/22) Followed by Interleukin-2 Treating Pediatric Relapsed and Refractory B Cell Malignancies|Recruiting||Phase 1/Phase 2|30|Anticipated|Zhujiang Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:12:58.930734|2017-10-10 21:12:58.930734
NCT03098342|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-27|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|January 31, 2019|Anticipated|2019-01-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment|Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment in Asians|Not yet recruiting||N/A|42|Anticipated|Chulalongkorn University||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:12:59.029855|2017-10-10 21:12:59.029855
NCT03098329|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-03|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|April 1, 2022|Anticipated|2022-04-01||Interventional|||Check it: A New Approach to Controlling Chlamydia Transmission in Young People|A New Approach to Controlling Chlamydia Transmission in Young People|Recruiting||N/A|4854|Anticipated|Tulane University||1|||f||||f|f|f|||t|||||2017-10-10 21:12:59.133579|2017-10-10 21:12:59.133579
NCT03098316|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-31|||January 31, 2017|Actual|2017-01-31|March 2017|2017-03-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|MISO||Metabolomics in Surgical Ophthalmological Patients|Metabolomics in Surgical Ophthalmological Patients|Recruiting||N/A|90|Anticipated|Universitaire Ziekenhuizen Leuven|||3||f||||t|f|f||||Samples Without DNA|"     Blood plasma, urine, aqueous humor   "|Undecided||2017-10-10 21:12:59.217596|2017-10-10 21:12:59.217596
NCT03098303|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-27|||December 23, 2014|Actual|2014-12-23|March 2017|2017-03-01|December 13, 2016|Actual|2016-12-13|December 13, 2016|Actual|2016-12-13||Observational|PROTOACCEPT||Criteria Associated With Patient Willingness to Participate in Biomedical Research|Criteria Associated With Patient Willingness to Participate in Biomedical Research: a Prospective, Observational Study|Completed||N/A|1000|Actual|University Hospital, Montpellier|||1||f||||f|f|f||||||||2017-10-10 21:12:59.32116|2017-10-10 21:12:59.32116
NCT03098290|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-06-11|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01|12 Months|Observational [Patient Registry]|IDOMENEO||IDOMENEO - Is Treatment Reality in Vascular Medicine Evidence-based and Follows Guideline Recommendations? A Project for Quality Development Exemplified by Peripheral Arterial Disease (PAD)|IDOMENEO: Multimethodical and Multistage Registry-based Longitudinal Study Project to Collect Primary Registry Data and Health Insurance Claims Data of Patients Invasively Treated for Peripheral Artery Disease (PAD) in Germany|Not yet recruiting||N/A|10000|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||2||f||||t||||||||||2017-10-10 21:12:59.391129|2017-10-10 21:12:59.391129
NCT03098277|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-03-25|||May 6, 2016|Actual|2016-05-06|March 2017|2017-03-01|December 6, 2018|Anticipated|2018-12-06|June 6, 2018|Anticipated|2018-06-06||Interventional|||Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy|Accelerometry to Optimize and Monitor Human Performance in Cancer Chemotherapy Outpatients|Recruiting||N/A|60|Anticipated|University of Southern California||1|||f||||t|f|f||||||||2017-10-10 21:12:59.48273|2017-10-10 21:12:59.48273
NCT03098264|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-11|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||Safety and Efficacy of Simultaneous or Staged Surgery on Complicated Hepatolithiasis|A Cohort Study on Safety and Efficacy of Simultaneous or Staged Surgery in Complicated Hepatolithiasis|Recruiting||N/A|92|Anticipated|Southwest Hospital, China||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:59.585699|2017-10-10 21:12:59.585699
NCT03098251|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-11|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||Effect of 3D Typing on Surgical Treatment of Hepatolithiasis|Efficacy of 3D Typing and Routine Typing on Surgical Treatment of Hepatolithiasis|Recruiting||N/A|400|Anticipated|Southwest Hospital, China||2|||f||||t|f|f||||||Undecided||2017-10-10 21:12:59.670463|2017-10-10 21:12:59.670463
NCT03098238|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-30|||April 10, 2017|Anticipated|2017-04-10|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|July 30, 2019|Anticipated|2019-07-30||Interventional|MICROMARK RJ||Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation|Endothelial Microparticules as Biomarker of Antibody-mediated Rejection in Kidney Transplantation|Not yet recruiting||N/A|250|Anticipated|University Hospital, Montpellier||3|||f||||t|f|f||||||Undecided|NC|2017-10-10 21:12:59.750653|2017-10-10 21:12:59.750653
NCT03098225|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-31|||January 1, 2018|Anticipated|2018-01-01|March 2017|2017-03-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|ORGO||A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy|A Phase IV, Randomized, Multi-center Clinical Trial to Compare the Efficacy of Orbital Radiotherapy in Association With Intravenous Glucocorticoids vs Intravenous Glucocorticoids Alone for Moderately Severe and Active Graves' Orbitopathy|Not yet recruiting||Phase 4|120|Anticipated|University of Pisa||2|||f||||f|f|f|||f|||No||2017-10-10 21:12:59.831687|2017-10-10 21:12:59.831687
NCT03098212|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-27|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Aromatherapy for Reducing Labor Pain|Efficacy of Aromatherapy for Reducing Pain During Labor|Completed||N/A|94|Actual|ChaingMai University||2|||f||||f|f|f||||||No||2017-10-10 21:12:59.916883|2017-10-10 21:12:59.916883
NCT03098199|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-27|||October 22, 2015|Actual|2015-10-22|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||AMH and Dosing Regimens for Initial IVF Stimulation Protocols|AMH and Dosing Regimens for Initial IVF Stimulation Protocols|Enrolling by invitation||N/A|170|Anticipated|Reproductive Specialists of New York||4|||f||||f|f|f||||||Undecided||2017-10-10 21:12:59.982532|2017-10-10 21:12:59.982532
NCT03098186|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-30|||April 18, 2017|Anticipated|2017-04-18|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|March 2018|Anticipated|2018-03-01||Interventional|||TXT2HEART COLOMBIA: Evaluation of the Efficacy and Safety of Text Messages to Improve Adherence to Cardiovascular Medications in Secondary Prevention|TXT2HEART COLOMBIA: Evaluation of the Efficacy and Safety of Text Messages to Improve Adherence to Cardiovascular Medications in Secondary Prevention|Recruiting||N/A|1600|Anticipated|Fundación Cardiovascular de Colombia||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:00.107079|2017-10-10 21:13:00.107079
NCT03098173|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-06-05|||January 29, 2016|Actual|2016-01-29|June 2017|2017-06-01|May 4, 2019|Anticipated|2019-05-04|March 31, 2019|Anticipated|2019-03-31||Interventional|||Comparing Early Versus Elective Colonoscopy|A Multi-center, Randomized Controlled Trial Comparing Early Versus Elective Colonoscopy in Outpatients With Acute Lower Gastrointestinal Bleeding|Recruiting||N/A|162|Anticipated|Tokyo University||2|||f||||t|f|f||||||No||2017-10-10 21:13:00.234481|2017-10-10 21:13:00.234481
NCT03098160|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-06-12|||May 10, 2017|Actual|2017-05-10|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Immunotherapy Study of Evofosfamide in Combination With Ipilimumab|A Phase 1 Immunotherapy Study of Evofosfamide in Combination With Ipilimumab in Patients With Advanced Solid Malignancies|Recruiting||Phase 1|69|Anticipated|Threshold Pharmaceuticals||1|||||||t|t|f|||f|||Undecided|Safety and efficacy data may be shared in the form of a paper or trials in progress poster at a conference. Additionally, data may be shared via the clinical study report.|2017-10-10 21:13:00.445285|2017-10-10 21:13:00.445285
NCT03098147|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-30|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01|1 Year|Observational [Patient Registry]|||The Influence of Benign Prostatic Hyperplasia on Bladder Function|The Influence of Benign Prostatic Hyperplasia on Bladder Function: A Multi-centre, Prospective and Case-control Study|Recruiting||N/A|500|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||1||f|||||f|f||||||No||2017-10-10 21:13:00.540228|2017-10-10 21:13:00.540228
NCT03098134|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-27|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|May 1, 2018|Anticipated|2018-05-01|December 31, 2017|Anticipated|2017-12-31||Interventional|VR-DENT||The Efficacy of a VR Enhanced Video Exposure Therapy for Dental Phobia|The Efficacy of a VR Enhanced Video Exposure Therapy for Dental Phobia - a Randomized Controlled Trial|Not yet recruiting||Phase 2|100|Anticipated|Ruhr University of Bochum||2|||f||||f|f|f||||||No||2017-10-10 21:13:00.606806|2017-10-10 21:13:00.606806
NCT03098121|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-30|||June 20, 2017|Anticipated|2017-06-20|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Efficacy and Tolerability of Grazoprevir and Elbasvir in Peginterferon Alfa Plus Ribavirin Experienced Patients With Chronic Genotype 1 HCV and HIV Co-infection: a Non-randomised, Open-label Clinical Trial|Efficacy and Tolerability of Grazoprevir and Elbasvir in Peginterferon Alfa Plus Ribavirin Experienced Patients With Chronic Genotype 1 HCV and HIV Co-infection: a Non-randomised, Open-label Clinical Trial|Not yet recruiting||Phase 4|40|Anticipated|Taoyuan General Hospital||1|||f||||f|t|f|||t|||Yes|The study will be conducted at 3 different hospitals, and we will share the data with other researchers every 3 months|2017-10-10 21:13:00.67811|2017-10-10 21:13:00.67811
NCT03097926|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-03-30|||May 2013||2013-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Long_limb_DS||Duodenal Switch With a Standard Versus Long Alimentary Limb|Prospective Randomized Trial of Duodenal Switch With a Standard Versus Long Alimentary Limb.|Active, not recruiting||N/A|20|Actual|Laval University||2|||f||||f||||||||Undecided|Publication in peer-reviewed journal|2017-10-10 21:13:02.556483|2017-10-10 21:13:02.556483
NCT03098108|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-27|||February 9, 2017|Actual|2017-02-09|March 2017|2017-03-01|October 31, 2021|Anticipated|2021-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|RECCPT||Concurrent Chemo-proton Radiotherapy With or Without Resection and Spacer Insertion for Loco-regional Recurrence of Previous Irradiated Rectal Cancer|Concurrent Chemo-proton Radiotherapy With or Without Resection and Spacer Insertion for Loco-regional Recurrence of Previous Irradiated Rectal Cancer: Prospective Phase II Trial|Recruiting||N/A|24|Anticipated|Samsung Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:13:00.753139|2017-10-10 21:13:00.753139
NCT03098095|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-10-03|||April 26, 2017|Actual|2017-04-26|October 2017|2017-10-01|September 18, 2018|Anticipated|2018-09-18|September 18, 2017|Actual|2017-09-18||Interventional|||A Smartphone Application to Support Physical Activity in HIV Infected People|The Use of a Mobile Application to Support Physical Activity and Lifestyle Changes in Persons Living With HIV: the SMARTAPP Study.|Recruiting||N/A|60|Anticipated|Scientific Institute San Raffaele||2|||f||||t|f|f||||||||2017-10-10 21:13:00.850837|2017-10-10 21:13:00.850837
NCT03098082|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-10|||July 6, 2017|Actual|2017-07-06|March 2017|2017-03-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis|Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis|Recruiting||N/A|1825|Anticipated|Indiana University||1|||f||||f|f|t|t|f|f|||||2017-10-10 21:13:00.940318|2017-10-10 21:13:00.940318
NCT03098069|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-31|||August 2016||2016-08-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|KMC-Scaleup||Implementation Research on Scaling up Kangaroo Mother Care (KMC)|Kangaroo Mother Care Implementation Research for Accelerating Scale-up|Active, not recruiting||N/A|300|Anticipated|Society for Applied Studies|||1||f||||f|f|f||||||Yes||2017-10-10 21:13:01.033819|2017-10-10 21:13:01.033819
NCT03098056|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-30|||August 1, 2016|Actual|2016-08-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|November 18, 2016|Actual|2016-11-18||Interventional|||Safety and Tolerance of a Nutritional Intervention Program- In.Form 1.2|Safety Evaluation of a Lifestyle Modification Program for Healthy Weight and Cardiometabolic Function - Second Phase|Completed||N/A|50|Actual|Nature's Sunshine Products, Inc.||1|||f||||t|f|f||||||No||2017-10-10 21:13:01.104339|2017-10-10 21:13:01.104339
NCT03098043|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-26|||April 3, 2017|Anticipated|2017-04-03|March 2017|2017-03-01|April 3, 2020|Anticipated|2020-04-03|April 3, 2020|Anticipated|2020-04-03||Observational|||Post-Static Cold Storage Hypothermic Oxygenated Perfusion in Bergamo Liver Transplant Program|Post-Static Cold Storage Hypothermic Oxygenated Perfusion in Bergamo Liver Transplant Program: a Prospective Observational Study|Not yet recruiting||N/A|20|Anticipated|Papa Giovanni XXIII Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:13:01.175152|2017-10-10 21:13:01.175152
NCT03098030|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-10-03|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer|A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer|Recruiting||Phase 2/Phase 3|470|Anticipated|United Therapeutics||4|||f||||t|t|f||||||||2017-10-10 21:13:01.249639|2017-10-10 21:13:01.249639
NCT03098017|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-27|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Pasta and Couscous Prepared With Durum Wheat Semolina: Effect on Post-prandial Glucose and Insulin Metabolism|Pasta and Couscous Prepared With Durum Wheat Semolina: Effect on Post-prandial Glucose and Insulin Metabolism|Not yet recruiting||N/A|30|Anticipated|University of Parma||4|||f||||f|f|f||||||No||2017-10-10 21:13:01.750865|2017-10-10 21:13:01.750865
NCT03098004|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-18|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|January 1, 2018|Anticipated|2018-01-01|August 31, 2017|Anticipated|2017-08-31||Interventional|||Effects of e-Cigarettes on Nicotine Withdrawal|Effects of Electronic Cigarettes on Nicotine Withdrawal Among Smokers|Recruiting||N/A|40|Anticipated|University of Southern California||2|||f||||f|f|f||||||No||2017-10-10 21:13:01.883366|2017-10-10 21:13:01.883366
NCT03097991|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-03-27|||August 2015||2015-08-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01||Interventional|CoparentRCT||Randomized Controlled Trial of Prenatal Coparenting Intervention (CoparentRCT)|Randomized Controlled Trial of Prenatal Coparenting Intervention for African American Fragile Families|Recruiting||N/A|300|Anticipated|University of South Florida||2|||f||||t||||||||Yes|Once all data collection for this project has been completed and study results published, study data stripped of all subject identifiers will be available upon request, provided through electronic means in the original data management files, to qualified researchers. Any request for study data which meets reasonable standards of scientific integrity will be considered by the study investigators, with the expectation that any costs incurred in providing such data accrued from this project will be covered by the requesting investigator|2017-10-10 21:13:01.979856|2017-10-10 21:13:01.979856
NCT03097978|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-27|||June 2013|Actual|2013-06-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Pattern Recognition Control and Direct Control in TMR|Clinical Trials of Pattern Recognition, Electrode Grid, RIC Arm in TMR Subjects|Recruiting||N/A|15|Anticipated|Shirley Ryan AbilityLab||4|||f||||f||||||||No||2017-10-10 21:13:02.116654|2017-10-10 21:13:02.116654
NCT03097965|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-25|||August 1, 2015|Actual|2015-08-01|March 2017|2017-03-01|December 31, 2015|Actual|2015-12-31|November 20, 2015|Actual|2015-11-20||Interventional|||Safety Evaluation of a Lifestyle Modification Program In.Form 1.1|Safety Evaluation of a Lifestyle Modification Program for Healthy Weight and Cardiometabolic Function|Completed||N/A|44|Actual|Nature's Sunshine Products, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:13:02.225683|2017-10-10 21:13:02.225683
NCT03097952|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-26|||January 2008||2008-01-01|March 2017|2017-03-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Observational|||"Real-life Cohort Study on Patients With Chronic HBV Infection in Jiangsu"|"Real-life Cohort Study on Patients With Chronic Hepatitis B Virus Infection in Jiangsu"|Recruiting||N/A|20000|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|||1||f||||||||||Samples With DNA|"     Liver biopsy tissue, blood (serum, plasma, and DNA)   "|||2017-10-10 21:13:02.335104|2017-10-10 21:13:02.335104
NCT03097939|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-03|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma|A Phase II Trial Of Ipilimumab In Combination With Nivolumab In Patients With Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 2|35|Anticipated|National Cancer Centre, Singapore||1|||f||||f|f|f||||||No||2017-10-10 21:13:02.438724|2017-10-10 21:13:02.438724
NCT03097913|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-09|||April 5, 2017|Actual|2017-04-05|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|August 8, 2019|Anticipated|2019-08-08||Observational|video-stylet||Technique Using Trachway to Safely Navigate Endotracheal Tube Through Nasal Cavity|Kaohsiung Medical University Chung-Ho Memorial Hospital|Enrolling by invitation||N/A|100|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:13:02.646009|2017-10-10 21:13:02.646009
NCT03097900|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Does Caffeine Enhance Bowel Recovery After Colorectal Surgery?|Does Caffeine Enhance Bowel Recovery After Colorectal Surgery?|Not yet recruiting||Phase 2|50|Anticipated|Hadassah Medical Organization||2|||f|||||f|f|||f|||||2017-10-10 21:13:02.737187|2017-10-10 21:13:02.737187
NCT03097887|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-25|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Omega Loop Gastric Bypass With And Without Anti-Reflux Sutures|Prospective, Randomized, Controlled Trial of Omega Loop Gastric Bypass With and Without Anti-reflux Sutures - a Pilot Study|Not yet recruiting||N/A|100|Anticipated|Medical University of Vienna||2|||f||||f|f|f||||||No|Analysis will be performed on anonymized data only. A list cross-linking the patient number to the name will be kept secure and is only available to the principal researcher. Written informed consent will be kept for 15 years.|2017-10-10 21:13:02.875754|2017-10-10 21:13:02.875754
NCT03097874|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-10-03|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|April 1, 2022|Anticipated|2022-04-01|February 1, 2022|Anticipated|2022-02-01||Interventional|||Adaptive Treatment for Adolescent Anorexia Nervosa|Confirming the Efficacy/Mechanism of an Adaptive Treatment for Adolescent Anorexia|Recruiting||N/A|150|Anticipated|Stanford University||2|||f||||t|f|f||||||||2017-10-10 21:13:02.989777|2017-10-10 21:13:02.989777
NCT03097861|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-22|||February 13, 2017|Actual|2017-02-13|August 2017|2017-08-01|June 27, 2017|Actual|2017-06-27|June 11, 2017|Actual|2017-06-11||Interventional|||Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo|A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo, in Adult Subjects With Chronic Idiopathic Constipation|Completed||Phase 3|552|Actual|Sucampo Pharma Americas, LLC||3|||f||||f|t|f||||||||2017-10-10 21:13:03.133638|2017-10-10 21:13:03.133638
NCT03097848|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-04|||May 4, 2017|Actual|2017-05-04|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 30, 2018|Anticipated|2018-12-30||Interventional|ESCALATOR||Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma|Efficacy and Safety of Combination of Sorafenib as Preoperative Adjuvant and Latter Radiofrequency Ablation in the Treatment Of Recurrent Hepatocellular Carcinoma: A Prospective Multicenter Cohort Study|Recruiting||N/A|450|Anticipated|Southwest Hospital, China||2|||f||||t|f|f||||||Undecided||2017-10-10 21:13:03.355237|2017-10-10 21:13:03.355237
NCT03097835|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-25|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Skin Quality Improvement|Evaluation of Skin Quality Improvement When Hyper-Diluted OnabotulinumtoxinA (Botox®, Botox® Cosmetic /BTXa/) is Injected Into The Superficial Dermis of the Mid-Face|Recruiting||Phase 2|15|Anticipated|Steve Yoelin M.D. Medical Associates, Inc.||2|||f||||f|t|f||||||Yes|IPD will be shared through the form of either a published paper or poster presentation.|2017-10-10 21:13:03.459032|2017-10-10 21:13:03.459032
NCT03097822|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-27|||January 2017||2017-01-01|March 2017|2017-03-01||||December 2018|Anticipated|2018-12-01||Observational|||Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging|Response Prediction After Gamma Knife Surgery (GKS) in Patients With Vestibular Schwannoma Using Dynamic Contrast-Enhanced (DCE) MR Imaging|Not yet recruiting||N/A|90|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-10 21:13:03.55304|2017-10-10 21:13:03.55304
NCT03097809|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-27|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||SEEG Investigation of Mood Dysregulation in Epilepsy|SEEG Investigation of Mood Dysregulation in People With Epilepsy|Enrolling by invitation||N/A|20|Anticipated|The Cleveland Clinic|||1||f||||f|f|f||||||No||2017-10-10 21:13:03.631253|2017-10-10 21:13:03.631253
NCT03097796|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients|An Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of PUL-042 Inhalation Solution in Subjects With Hematologic Malignancies and Recipients of Stem Cell Transplantation|Not yet recruiting||Phase 1|18|Anticipated|Pulmotect, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:13:03.70263|2017-10-10 21:13:03.70263
NCT03097783|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-02|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency|A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Efficacy and Safety of Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency|Recruiting||N/A|168|Anticipated|Q-Med AB||2|||f||||f|f|f||||||No||2017-10-10 21:13:03.800277|2017-10-10 21:13:03.800277
NCT03097770|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-26|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20|Clinical Study of CD19/CD20 tanCAR T Cells in Relapsed and/or Chemotherapy Refractory B-cell Leukemias and Lymphomas|Recruiting||N/A|20|Anticipated|Chinese PLA General Hospital||1|||f||||t|f|f||||||||2017-10-10 21:13:03.895788|2017-10-10 21:13:03.895788
NCT03097757|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-03-30|||January 24, 2017|Actual|2017-01-24|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of Ultrasound Guidance for Reduction of Pediatric Forearm Fractures|Randomized Controlled Trial of Ultrasound Guidance for Reduction of Pediatric Forearm Fractures|Recruiting||N/A|112|Anticipated|Montefiore Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:13:04.002844|2017-10-10 21:13:04.002844
NCT03097744|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-07-18|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|STITCHRetro||Predictors of Early Success From Circumferential Compression STITCH Meniscal Repairs|Predictors of Early Success From Circumferential Compression STITCH Meniscal Repairs|Enrolling by invitation||N/A|60|Anticipated|Ceterix Orthopaedics, Inc.|||1||f||||f|f|t|f|f|f|||||2017-10-10 21:13:04.111176|2017-10-10 21:13:04.111176
NCT03097731|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-06-23|||October 20, 2017|Anticipated|2017-10-20|June 2017|2017-06-01|December 1, 2018|Anticipated|2018-12-01|May 30, 2018|Anticipated|2018-05-30|3 Years|Observational [Patient Registry]|||Epidemiological Screening of IL10RA Mutation Rate in China|Epidemiological Screening of p.R101W and p.T179T IL10RA Mutation Rates in Henan Province, China|Not yet recruiting||N/A|10000|Anticipated|Children's Hospital of Fudan University|||1||f||||t|f|f||||Samples With DNA|"     Samples will be stored in 4 degrees refrigerator for the future research   "|Undecided||2017-10-10 21:13:04.182938|2017-10-10 21:13:04.182938
NCT03097718|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-03-27|||January 2016||2016-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Central Proprioceptive Processing and Postural Control in LBP|Central Proprioceptive Processing and Postural Control in Individuals With and Without Recurrent Non-specific Low Back Pain|Recruiting||N/A|40|Anticipated|Katholieke Universiteit Leuven|||2||f||||t|f|f||||||No||2017-10-10 21:13:04.294535|2017-10-10 21:13:04.294535
NCT03097705|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-26|||April 20, 2017|Anticipated|2017-04-20|March 2017|2017-03-01|March 12, 2018|Anticipated|2018-03-12|September 12, 2017|Anticipated|2017-09-12||Interventional|||Effect of Steep Trendelenburg in Laparoscopic Surgery on IOP & RNFL Thickness|The Effect of Steep Trendelenburg Position Used During Laparoscopic Surgery on Intraocular Pressure During Surgery and on the Retinal Nerve Fiber Thickness After Surgery|Not yet recruiting||N/A|50|Anticipated|Carmel Medical Center||1|||f||||t|f|f||||||No||2017-10-10 21:13:04.41097|2017-10-10 21:13:04.41097
NCT03097692|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-31|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Does Ischemic Preconditioning Affects Neutrophil-Lymphocyte Ratio in Patients Undergoing Open Heart Surgery ?|Does Ischemic Preconditioning Affects Neutrophil-Lymphocyte Ratio in Patients Undergoing Open Heart Surgery ? a Randomized Double Blind Clinical Trial|Recruiting||N/A|30|Anticipated|Assiut University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:13:04.478|2017-10-10 21:13:04.478
NCT03097679|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-28|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|BIOFLEX-COF||Self-expanding Nitinol Stents of High vs. Low Chronic Outward Force in De-novo Femoropopliteal Occlusive Arterial Lesions|Self-expanding Nitinol Stents of High vs. Low Chronic Outward Force in De-novo Femoropopliteal Occlusive Arterial Lesions|Recruiting||N/A|80|Anticipated|Medical University of Vienna||2|||f||||f|f|f|||f|||||2017-10-10 21:13:04.57588|2017-10-10 21:13:04.57588
NCT03097666|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-30|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Evaluation of Safety and Dose Response Using C2 CryoBalloon™ Swipe Ablation System for Barrett's Esophagus|Clinical Trial to Evaluate Safety and Dose Response Using the C2 CryoBalloon™ Swipe Ablation System for the Treatment of Barrett's Esophagus|Recruiting||N/A|30|Anticipated|C2 Therapeutics, Inc.||1|||f||||t|f|t|t|f|t|||No|Data will not be shared.|2017-10-10 21:13:04.701863|2017-10-10 21:13:04.701863
NCT03097653|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-10-03|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Decision-aid on Breast Cancer Screening|New Invited Women to Breast Cancer Screening: a Multi-centre, Longitudinal, Controlled, Randomised Study on a Decision-aid to Support Informed Choice|Recruiting||N/A|816|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||f|f|f||||||||2017-10-10 21:13:04.842227|2017-10-10 21:13:04.842227
NCT03097640|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-05|||November 2016||2016-11-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|CHAMP||Understanding Perspectives of Frequently-Admitted Hospital Patients|Understanding Perspectives of Frequently-Admitted Hospital Patients|Recruiting||N/A|200|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 21:13:04.966517|2017-10-10 21:13:04.966517
NCT03097627|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-03|||February 1, 2016|Actual|2016-02-01|April 2017|2017-04-01|February 1, 2027|Anticipated|2027-02-01|February 1, 2021|Anticipated|2021-02-01||Interventional|||Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions|Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions|Recruiting||Phase 1/Phase 2|100|Anticipated|Brigham and Women's Hospital||1|||f||||t|t|f|||t|||No|There is no plan at this time to share any individual participant data with other researchers.|2017-10-10 21:13:05.082498|2017-10-10 21:13:05.082498
NCT03097614|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-09-13|||March 31, 2017||2017-03-31||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:13:05.168239|2017-10-10 21:13:05.168239
NCT03097601|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-02|||June 2, 2016|Actual|2016-06-02|March 2017|2017-03-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2018|Anticipated|2018-12-30||Observational|SUNITRES||ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib|ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib and New Relevant Therapeutic Targets in Refractory Patients|Active, not recruiting||N/A|60|Actual|Centre Antoine Lacassagne|||1||f||||f|f|f||||Samples With DNA|"     Experiment on cell lines, on human samples and animal models. CXCL cytokines as predictive     markers of sunitinib efficacy in order to demonstrate the mechanisms linked to the production     of CXCL cytokines by mRCC or in response to treatments   "|No||2017-10-10 21:13:05.213794|2017-10-10 21:13:05.213794
NCT03097588|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-15|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|||Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant|A Phase II Clinical Trial of NEPA (Netupitant/Palonosetron) for Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patient Receiving the BEAM Conditioning Regimen Prior to Hematopoietic Cell Transplantation (HSCT)|Recruiting||Phase 2|43|Anticipated|OHSU Knight Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:13:07.017158|2017-10-10 21:13:07.017158
NCT03097575|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-09-25|||January 6, 2015|Actual|2015-01-06|September 2017|2017-09-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Bronchial NIR Image-guided Resection|Bronchial NIR Image-guided Resection, Mapping And Targeted Lymphadenectomy for Lung Lesions|Recruiting||Phase 1/Phase 2|100|Anticipated|Brigham and Women's Hospital||1|||f||||t|t|f|||t|||||2017-10-10 21:13:07.124769|2017-10-10 21:13:07.124769
NCT03097029|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-08-14|||March 24, 2017|Actual|2017-03-24|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SBS||Use of Pancreatic Enzymes in Short Bowel Syndrome|Use of Pancreatic Enzymes in Short Bowel Syndrome|Recruiting||Phase 2|26|Anticipated|Children's Hospital of Philadelphia||1|||f||||f|t|f||||||||2017-10-10 21:13:12.142175|2017-10-10 21:13:12.142175
NCT03097562|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-31|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CATALYS||Wound Architecture and Functional Outcome After Cataract Surgery With Manual vs.Femtosecond Laser Assisted Procedures|Wound Architecture and Functional Outcome After Cataract Surgery With Manual vs. Femtosecond Laser Assisted Procedures|Recruiting||N/A|253|Anticipated|Maisonneuve-Rosemont Hospital||3|||f||||t|f|f||||||||2017-10-10 21:13:07.219882|2017-10-10 21:13:07.219882
NCT03097549|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-03|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Mobile App-treatment of Mixed and Urgency Urinary Incontinence in Women|Mobile App-treatment of Mixed and Urgency Urinary Incontinence in Women - a Randomized Controlled Study|Recruiting||N/A|120|Anticipated|Umeå University||2|||f||||t|f|f||||||No||2017-10-10 21:13:07.323019|2017-10-10 21:13:07.323019
NCT03097536|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-04-04|||March 2016||2016-03-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Migraine and Homeostasis:What Can we Learn From Glucose|Migraine and Homeostasis:What Can we Learn From Glucose|Recruiting||N/A|30|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:07.450887|2017-10-10 21:13:07.450887
NCT03097523|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-14|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|NSBRI||Mitigating Cephalad Fluid Shifts: A NSBRI Study|Validation of a Cephalad Fluid Shift Countermeasure: Selection of Optimal Thigh Cuff Design Followed by Intracranial Pressure (ICP) Measurements During Extended Thigh Cuff Application|Completed||N/A|3|Actual|John Wayne Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 21:13:07.543801|2017-10-10 21:13:07.543801
NCT03097510|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-30|||October 2009|Actual|2009-10-01|March 2017|2017-03-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||Meditation and Emotional Intelligence|Meditation and Emotional Intelligence: A Randomized Controlled Trial|Completed||N/A|96|Actual|Maharishi University of Management||2|||f||||f|f|f||||||Undecided|data may be available upon request from other researchers but at the discretion of the principal investigator|2017-10-10 21:13:07.627141|2017-10-10 21:13:07.627141
NCT03097497|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-24|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|May 30, 2017|Anticipated|2017-05-30|April 30, 2017|Anticipated|2017-04-30||Interventional|||Physiotherapy Re-education of Pre-activation of the Transverse Abdominis in Patients With Chronic Low Back Pain|The Effectiveness of a Physiotherapeutic Re-education Based on the Pre-activation of the Transverse Abdominis in Patients With Non-specific Chronic Low Back Pain in Primary Care.|Active, not recruiting||N/A|108|Anticipated|Universitat de Lleida||2|||f||||t|f|f||||||||2017-10-10 21:13:07.711074|2017-10-10 21:13:07.711074
NCT03097484|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-30|||July 25, 2015|Actual|2015-07-25|March 2017|2017-03-01|July 25, 2017|Anticipated|2017-07-25|July 25, 2017|Anticipated|2017-07-25||Interventional|||The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels|The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels|Enrolling by invitation||Phase 3|80|Anticipated|University of Kentucky||2|||f||||f|t|f||||||No||2017-10-10 21:13:07.812207|2017-10-10 21:13:07.812207
NCT03097471|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-27|||May 2011||2011-05-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Observational|||BPK-S Integration (Ceramic) Post Market Clinical Follow-Up|Prospektive, Klinische Studie Zur Marktbeobachtung (Post Market Follow-Up Study) Der Knieendoprothese BPK-S Integration Aus Keramikwerkstoff BIOLOX (R) Delta (Prospective Clinical Post Market Follow-up Study of the Total Knee Endoprosthesis BPK-S (Brehm Precision Knee System)Made of Ceramic Material BIOLOX (R) Delta|Active, not recruiting||N/A|40|Actual|Klinikum Wels-Grieskirchen|||1||f||||f|f|f||||||No||2017-10-10 21:13:07.918636|2017-10-10 21:13:07.918636
NCT03097458|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-24|||February 4, 2017|Actual|2017-02-04|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Enhancing Adjustment to Parental Cancer: Short-term Counselling for Families|Enhancing Adjustment to Parental Cancer: Short-term Counselling for Families. A Randomized, Wait-list Controlled Intervention Study|Recruiting||N/A|55|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:08.098135|2017-10-10 21:13:08.098135
NCT03097445|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-06-15|||June 4, 2017|Actual|2017-06-04|June 2017|2017-06-01|October 31, 2019|Anticipated|2019-10-31|September 15, 2019|Anticipated|2019-09-15||Interventional|||Long-term Effectiveness of Mailed Nicotine Replacement Therapy: A 5-year Follow-up|Long-term Effectiveness of Mailed Nicotine Replacement Therapy: A 5-year Follow-up|Enrolling by invitation||N/A|1000|Actual|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||No||2017-10-10 21:13:08.222918|2017-10-10 21:13:08.222918
NCT03097432|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-30|||October 20, 2016|Actual|2016-10-20|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment|A Prospective, Open, Multi-centre, Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment|Recruiting||N/A|250|Anticipated|University Hospital of Cologne|||1||f||||f||||||||No||2017-10-10 21:13:08.31947|2017-10-10 21:13:08.31947
NCT03097419|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-03-27|||November 28, 2012|Actual|2012-11-28|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|EDICT||Ischemic Conditioning in STEMI Patients|The Effect of Remote Ischemic Conditioning on the Metabolomic Profile of NSTEMI Patients|Active, not recruiting||N/A|300|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t|f|f||||||Undecided|We may make the de-identified data available.|2017-10-10 21:13:08.447531|2017-10-10 21:13:08.447531
NCT03097406|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-27|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2021|Anticipated|2021-01-01||Observational|||Functional Outcome and Complications After Global Unite ® Prostheses|Functional Outcome and Complications After Global Unite ® Prostheses in Osteoarthritis and Displaced Fractures of the Proximal Humerus.|Recruiting||N/A|88|Anticipated|Herlev and Gentofte Hospital|||4||f||||f|f|f||||||No||2017-10-10 21:13:08.548041|2017-10-10 21:13:08.548041
NCT03097393|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-03-25|||January 1, 2014|Actual|2014-01-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|February 28, 2017|Actual|2017-02-28||Observational|||Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis|Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis|Completed||N/A|67|Actual|Benha University|||2||f||||t|f|f||||||No||2017-10-10 21:13:08.710486|2017-10-10 21:13:08.710486
NCT03097367|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-31|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Predictor of Early Recovery on Urinary Continence After Laparoscopic Radical Prostatectomy|Predictor of Early Recovery on Urinary Continence After Laparoscopic Radical Prostatectomy: Bladder Neck Level and the Association With Urodynamic Parameters|Completed||N/A|48|Actual|Buddhist Tzu Chi General Hospital|||1||f||||t|f|f||||||No|No plan to share data with other researchers|2017-10-10 21:13:08.896571|2017-10-10 21:13:08.896571
NCT03097354|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-30|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|May 29, 2017|Actual|2017-05-29|May 29, 2017|Actual|2017-05-29||Observational|AF-CIDI||Assignment of Alcohol Drinks to CIDI Drink Categories|Validation of the Assignment of Alcoholic Drinks to Predefined Drink Groups in the Composite International Diagnostic Interview (CIDI)|Completed||N/A|174|Actual|Technische Universität Dresden|||2||f||||f|f|f||||||Undecided||2017-10-10 21:13:09.007552|2017-10-10 21:13:09.007552
NCT03097341|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-22|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects|A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Xisomab 3G3 in Healthy Adult Subjects|Recruiting||Phase 1|21|Anticipated|Aronora, Inc.||2|||f||||t|t|f||||||Undecided|undecided|2017-10-10 21:13:09.14472|2017-10-10 21:13:09.14472
NCT03097315|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-15|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|AZALEA||Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis|Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis|Active, not recruiting||Phase 3|38|Anticipated|Clearside Biomedical, Inc.||1|||f||||f|t|t|f|f||||||2017-10-10 21:13:09.353699|2017-10-10 21:13:09.353699
NCT03097302|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-24|||June 6, 2013|Actual|2013-06-06|March 2017|2017-03-01|July 31, 2014|Actual|2014-07-31|July 31, 2014|Actual|2014-07-31||Observational|||Tomographic Analysis of Anterior, Posterior, Total Corneal Refractive Power Changes After Laser-assisted Keratotomy|Tomographic Analysis of Anterior, Posterior and Total Corneal Refractive Power Changes After Femtosecond Laser-assisted Keratotomy After Laser Lens Surgery|Completed||N/A|23|Actual|University Clinic Frankfurt|||1||f||||f|f|f||||||Yes|Via a Publication in a reviewed journal.|2017-10-10 21:13:09.484944|2017-10-10 21:13:09.484944
NCT03097289|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-11|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution|An In Vivo Recovery and Survival Study of Platelets Collected on the Trima Accel System and Stored in InterSol Solution|Recruiting||N/A|40|Anticipated|Terumo BCT||1|||f||||f|f|t|t|f||||||2017-10-10 21:13:09.545282|2017-10-10 21:13:09.545282
NCT03097276|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-05-02|||April 17, 2017|Actual|2017-04-17|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|GESPACE||Management of Patients With High C-reactive Protein After Scheduled Resection of Colorectal Cancer|Management of Patients With High C-reactive Protein After Scheduled Resection of Colorectal Cancer: Pilot Study|Recruiting||N/A|75|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f|||||f|f|||f|||||2017-10-10 21:13:09.648749|2017-10-10 21:13:09.648749
NCT03097263|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-03-27|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|MARLO||Is the Walking Velocity an Efficient Outcome of Rehabilitation Program in Non- Specific Low Back Pain Patient|Is the Walking Velocity an Efficient Outcome of Rehabilitation Program in Non- Specific Low Back Pain Patient|Completed||N/A|127|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:13:09.727862|2017-10-10 21:13:09.727862
NCT03097250|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-12|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Observational|||MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria|MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria|Recruiting||N/A|10|Anticipated|Boston Children’s Hospital|||2||f|||||f|f||||||||2017-10-10 21:13:09.820846|2017-10-10 21:13:09.820846
NCT03097237|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2017-03-24|||September 2016||2016-09-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|RyeWeight||High Fiber Rye Foods for Weight and Body Fat Reduction||Recruiting||N/A|260|Anticipated|Swedish University of Agricultural Sciences||2|||f||||||||||||||2017-10-10 21:13:09.903912|2017-10-10 21:13:09.903912
NCT03097224|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-24|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|July 1, 2019|Anticipated|2019-07-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Prehabilitation in Frail Colon Cancer|Prehabilitation Before Surgery in Colorectal Cancer With Improved Fast Track Rehabilitation : Part 2|Recruiting||N/A|40|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f|||||f|f||||||Undecided||2017-10-10 21:13:10.00334|2017-10-10 21:13:10.00334
NCT03097211|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-03-27|||July 17, 2006|Actual|2006-07-17|March 2017|2017-03-01|October 20, 2006||2006-10-20|October 20, 2006|Actual|2006-10-20||Interventional|||Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg|A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study in Healthy Volunteers to Investigate the Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics When Administered in Combination With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg|Completed||Phase 1|38|Actual|Bial - Portela C S.A.||4|||f||||f|f|f||||||Undecided||2017-10-10 21:13:10.276916|2017-10-10 21:13:10.276916
NCT03097198|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-24|||December 2016||2016-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Plum-blossom Needle vs. Tropicamide Eye Drops on Juvenile Myopia|Effect of Plum-blossom Needle vs. Tropicamide Eye Drops on Juvenile Myopia: A Cross-over Single-blind Randomized Study|Recruiting||N/A|98|Anticipated|Wenzhou Medical University||2|||f|||||f|f||||||Undecided|The IPD sharing plan is undecided yet.|2017-10-10 21:13:10.414729|2017-10-10 21:13:10.414729
NCT03097185|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-04-28|||June 3, 2010|Actual|2010-06-03|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Analysis of Graft Function Following Autologous Islet Transplantation|Analysis of Graft Function Following Autologous Islet Transplantation|Enrolling by invitation||N/A|100|Anticipated|Baylor Research Institute|||1||f||||t|f|f||||Samples Without DNA|"     Each subject will provide samples of blood at specific timepoints as outlined in the protocol   "|Undecided||2017-10-10 21:13:10.574391|2017-10-10 21:13:10.574391
NCT03097172|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-08-08|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|GRAVITY||The Effect of GRAVITY on Physiological Measurements During Invasive Coronary Angiography and Intervention|The Effect of GRAVITY on Physiological Measurements During Invasive Coronary Angiography and Intervention|Recruiting||N/A|50|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust|||2||f||||f|f|f||||||||2017-10-10 21:13:10.640385|2017-10-10 21:13:10.640385
NCT03097159|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-05-17|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|BPB||Comparison of Costoclavicular Brachial Plexus Block and Supraclavicular Brachial Plexus Block|Comparison of Costoclavicular Brachial Plexus Block and Supraclavicular Brachial Plexus Block|Recruiting||N/A|86|Anticipated|Ajou University School of Medicine|||2||f||||t|f|f||||||No||2017-10-10 21:13:10.751697|2017-10-10 21:13:10.751697
NCT03097146|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-29|||April 11, 2017|Actual|2017-04-11|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Managing Aftercare for Stroke (MAS): MAS-II - A Longitudinal Complex-interventional Study in Post-rehabilitation Stroke Patients|Managing Aftercare for Stroke (MAS): MAS-II - A Longitudinal Complex-interventional Study in Post-rehabilitation Stroke Patients|Recruiting||N/A|100|Anticipated|Charite University, Berlin, Germany||1|||f|||||f|f||||||||2017-10-10 21:13:10.845771|2017-10-10 21:13:10.845771
NCT03097133|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-09-22|||June 15, 2017|Actual|2017-06-15|September 2017|2017-09-01|September 24, 2019|Anticipated|2019-09-24|September 23, 2019|Anticipated|2019-09-23||Interventional|Aspire II||A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide|A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide|Recruiting||Phase 3|224|Anticipated|Janssen Research & Development, LLC||2|||f||||t|t|f||||||||2017-10-10 21:13:10.979377|2017-10-10 21:13:10.979377
NCT03097120|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2017-03-24|||January 1995||1995-01-01|March 2017|2017-03-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|ERA||The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.|The Estrogen Replacement and Atherosclerosis Trial|Completed||Phase 3|309|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||||2017-10-10 21:13:11.256049|2017-10-10 21:13:11.256049
NCT03097107|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-06|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|April 15, 2018|Anticipated|2018-04-15|March 1, 2018|Anticipated|2018-03-01||Interventional|||Evaluate the Safety and Efficacy of Saroglitazar Magnesium in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL|Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL|Recruiting||Phase 2|124|Anticipated|Zydus Discovery DMCC||4|||f||||t|t|f||||||Undecided|See above.|2017-10-10 21:13:11.380454|2017-10-10 21:13:11.380454
NCT03097094|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-31|||March 24, 2017|Actual|2017-03-24|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Precision Allergy: Separate Allergies to Male and Female Dogs|Precision Allergy: Separate Allergies to Male and Female Dogs|Recruiting||N/A|24|Anticipated|Copenhagen Studies on Asthma in Childhood||2|||f||||f|f|f||||||No||2017-10-10 21:13:11.654525|2017-10-10 21:13:11.654525
NCT03097081|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-24|||November 2016||2016-11-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|January 2019|Anticipated|2019-01-01||Interventional|ORNOT||ORthosis vs No Orthosis After Surgically Treated Traumatic Thoracolumbar Fractures|Orthosis Versus no Orthosis After Dorsally Fixated Traumatic Thoracolumbar Fractures|Recruiting||N/A|45|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-10-10 21:13:11.756138|2017-10-10 21:13:11.756138
NCT03097068|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-08|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis|Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis|Recruiting||Phase 4|10|Anticipated|Vitreo-Retinal Associates, Michigan||1|||f||||f|t|f|||f|||No||2017-10-10 21:13:11.855918|2017-10-10 21:13:11.855918
NCT03097055|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-06|||March 30, 2017|Actual|2017-03-30|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ANAIS||Effect of Acupuncture Intervention on Improving Neurological Function and Antiinflammation in Patients With Acute Ischemic Stroke|Effect of Acupuncture Intervention on Improving Neurological Function and Antiinflammation in Patients With Acute Ischemic Stroke|Recruiting||N/A|40|Anticipated|China Medical University, Taiwan||2|||f||||f|f|f||||||No||2017-10-10 21:13:11.940498|2017-10-10 21:13:11.940498
NCT03097042|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-02|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Two Different Catheter Withdrawal Technique|Comparison of Two Different Catheter Withdrawal Technique During Embryo Transfer|Active, not recruiting||N/A|200|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t|f|f||||||||2017-10-10 21:13:12.062828|2017-10-10 21:13:12.062828
NCT02566434|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-04-24|||July 2015||2015-07-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|Met||Methionine Tolerance in Healthy Human Adults|Methionine Tolerance in Healthy Human Adults|Active, not recruiting||N/A|15|Actual|Texas A&M University||1|||f||||f||||||||||2017-10-10 22:52:21.800854|2017-10-10 22:52:21.800854
NCT03097016|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-28|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment|A Phase 1, Open-label, Single-dose Study to Assess the Pharmacokinetics (PK) of CC-122 in Subjects With Mild, Moderate and Severe Renal Impairment|Recruiting||Phase 1|48|Anticipated|Celgene||1|||f||||f|t|f||||||||2017-10-10 21:13:12.247002|2017-10-10 21:13:12.247002
NCT03097003|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-28|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|OTELO||A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium|An Observational Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium|Recruiting||N/A|250|Anticipated|Celgene|||1||f||||f|f|f||||||||2017-10-10 21:13:12.347127|2017-10-10 21:13:12.347127
NCT03096990|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-28|||April 21, 2017|Actual|2017-04-21|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|APOLO||A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium|An Observational Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium|Recruiting||N/A|150|Anticipated|Celgene|||1||f||||f|f|f||||||||2017-10-10 21:13:12.494938|2017-10-10 21:13:12.494938
NCT03096977|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-30|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Use of the Nine Holes Peg Test in Multiple Sclerosis: Participation of Elementary Neurological Components in the Functional Evaluation of Manual Dexterity|Use of the Nine Holes Peg Test in Multiple Sclerosis: Participation of Elementary Neurological Components in the Functional Evaluation of Manual Dexterity|Recruiting||N/A|30|Anticipated|Brugmann University Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:13:12.632689|2017-10-10 21:13:12.632689
NCT03096964|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-03-24|||March 2014||2014-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2014|Actual|2014-10-01||Interventional|Pole walking||Nordic Walking Training for Older People|Effects of Nordic Walking Training in Energetic, Mechanical and Neuromuscular Parameters of Elderly. A Randomized Clinical Trail|Completed||N/A|32|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||No||2017-10-10 21:13:12.844341|2017-10-10 21:13:12.844341
NCT03096951|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-24|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|July 1, 2019|Anticipated|2019-07-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Prehabilitation in Colorectal Cancer|Prehabilitation Before Surgery in Colorectal Cancer With Improved Fast Track Rehabilitation : Part 1|Recruiting||N/A|70|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f|||||f|f||||||Undecided||2017-10-10 21:13:12.967513|2017-10-10 21:13:12.967513
NCT03096938|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 1, 2021|Anticipated|2021-05-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||Cell-free DNA Methylation Markers for Cancer Screening|Cell-free DNA Methylation Markers for Cancer Screening|Not yet recruiting||N/A|15000|Anticipated|Sun Yat-sen University||2|||f||||f|f|f||||||||2017-10-10 21:13:13.097835|2017-10-10 21:13:13.097835
NCT03096925|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-24|||April 3, 2017|Actual|2017-04-03|March 2017|2017-03-01|June 15, 2019|Anticipated|2019-06-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Non-cardiac Chest Pain: Effect of Cognitive Therapy Administered as Guided Self-help|Non-cardiac Chest Pain: Effect of Cognitive Therapy Administered as Guided Self-help|Recruiting||N/A|160|Anticipated|Sorlandet Hospital HF||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:13.176883|2017-10-10 21:13:13.176883
NCT03096912|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-03-31|||July 2016||2016-07-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma|A Phase II Single Arm Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well-Differentiated or Dedifferentiated Liposarcoma|Recruiting||Phase 2|30|Anticipated|Assaf-Harofeh Medical Center||1|||f||||f|t|f|||f|||No||2017-10-10 21:13:13.276398|2017-10-10 21:13:13.276398
NCT03096899|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-20|||January 2016||2016-01-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma|An Observational Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma|Recruiting||N/A|80|Anticipated|The Rogosin Institute|||1||f||||f|t|f||||||No||2017-10-10 21:13:13.385931|2017-10-10 21:13:13.385931
NCT03096886|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-27|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|||Novel Neural Circuit Biomarkers of Depression Response to CCBT|Novel Neural Circuit Biomarkers of Depression Response to Computer-augmented CBT|Recruiting||N/A|90|Anticipated|University of Pennsylvania||3|||f||||t|f|f||||||||2017-10-10 21:13:13.479117|2017-10-10 21:13:13.479117
NCT03096873|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-24|||March 3, 2016|Actual|2016-03-03|March 2017|2017-03-01|June 5, 2016|Actual|2016-06-05|June 3, 2016|Actual|2016-06-03||Interventional|||Effectiveness of Combined Resistance and Aerobic Exercise Training on Obesity in Adolescent Girls||Completed||N/A|40|Actual|Pusan National University||2|||f|||||f|f||||||||2017-10-10 21:13:13.61772|2017-10-10 21:13:13.61772
NCT03096847|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-10-03|||October 24, 2016|Actual|2016-10-24|October 2017|2017-10-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer|A National Phase IIIb, Multi-center, Open Label Study for Women and Men With Hormone-receptor Positive, HER-2 Negative Locally Advanced or Metastatic Breast Cancer Treated With Ribociclib (LEE011) in Combination With Letrozole|Recruiting||Phase 3|500|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 21:13:13.800372|2017-10-10 21:13:13.800372
NCT03096483|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-07-11|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|||Clinical Evaluation of the OEC Elite Vascular Mobile Fluoroscopy System|Clinical Evaluation of the OEC Elite Vascular Mobile Fluoroscopy System|Terminated||N/A|12|Actual|GE Healthcare||1||Sponsor determination|f||||f|f|t|t|f|t|||||2017-10-10 21:13:17.210909|2017-10-10 21:13:17.210909
NCT03096834|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-06-21|||March 20, 2017|Actual|2017-03-20|June 2017|2017-06-01|March 22, 2019|Anticipated|2019-03-22|March 22, 2019|Anticipated|2019-03-22||Interventional|LIBERTY||A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies|A 12-week Double-blind, Randomized, Multicenter Study Comparing the Efficacy and Safety of Once Monthly Subcutaneous AMG 334 Against Placebo in Adult Episodic Migraine Patients Who Have Failed Prophylactic Migraine Treatments|Recruiting||Phase 3|220|Anticipated|Novartis||2|||f||||f|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:13:14.114009|2017-10-10 21:13:14.114009
NCT03096821|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-29|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|EXALT||Extended Analysis for Leukemia/Lymphoma Treatment|A Prospective Investigator-initiated Translational Study Evaluating Individualized Treatment Regiments Based on Respective Biomarker Analyses for Refractory Leukemia and Lymphoma Patients|Recruiting||N/A|98|Anticipated|Medical University of Vienna||1|||f||||t|f|f||||||Undecided||2017-10-10 21:13:14.369399|2017-10-10 21:13:14.369399
NCT03096808|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-27|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Adaptive Radiotherapy for Head and Neck Cancer|A Prospective Non-Inferiority Trial of the Use of Adaptive Radiotherapy for Head and Neck Cancer Undergoing Radiation Therapy|Recruiting||Phase 2|65|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||f|f||||||||2017-10-10 21:13:14.488553|2017-10-10 21:13:14.488553
NCT03096795|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-06-13|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 3, 2018|Anticipated|2018-12-03|December 3, 2018|Anticipated|2018-12-03||Interventional|||Safety and Tolerability of MEDI3506 in Healthy Subjects and in Subjects With Chronic Obstructive Pulmonary Disease|Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI3506 Administered as Single Ascending Doses in Healthy Adult Subjects With a History of Mild Atopy and as Multiple Ascending Doses in Subjects COPD|Recruiting||Phase 1|80|Anticipated|MedImmune LLC||10|||f||||f|f|f||||||Yes|Clinical Study Report|2017-10-10 21:13:14.662954|2017-10-10 21:13:14.662954
NCT03096782|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-27|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Cord Blood (CB) Ex-vivo Mesenchymal Stem Cell (MSC) Expansion + Fucosylation|Cord Blood Ex-vivo Mesenchymal Stem Cell (MSC) Expansion Plus Fucosylation to Enhance Homing and Engraftment|Not yet recruiting||Phase 2|25|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:13:14.793644|2017-10-10 21:13:14.793644
NCT03096769|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-24|||February 2, 2017|Actual|2017-02-02|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Ergonomics in Robotic Surgery|Ergonomics in Robotic Surgery|Recruiting||N/A|6|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||No||2017-10-10 21:13:14.964692|2017-10-10 21:13:14.964692
NCT03096756|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-04-03|||July 26, 2016|Actual|2016-07-26|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study of the Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study Designed to Compare the Safety and Pharmacokinetics of Orally Administered Superoxide Dismutase Mimetic GC4702 With Intravenously Administered Superoxide Dismutase Mimetic GC4419 (Part 1), With Assessment of Food Effect (Part 2), in Healthy Volunteers|Completed||Phase 1|48|Actual|Galera Therapeutics, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:13:15.050175|2017-10-10 21:13:15.050175
NCT03096743|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-03-24|||January 10, 2017|Actual|2017-01-10|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Evaluating Raised Intracranial Pressure Using MR Elastography|Evaluating Raised Intracranial Pressure Using MR Elastography|Recruiting||N/A|100|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:13:15.158584|2017-10-10 21:13:15.158584
NCT03096730|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-24|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia|The Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Gynecological Surgery|Recruiting||N/A|150|Anticipated|Tianjin Medical University General Hospital||5|||f||||t|t|f|||f|||Yes|data not entered|2017-10-10 21:13:15.249831|2017-10-10 21:13:15.249831
NCT03096717|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-30|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|February 28, 2019|Anticipated|2019-02-28|December 1, 2018|Anticipated|2018-12-01|3 Months|Observational [Patient Registry]|||Dysplasia in Inflammatory Chronic Idiopathic Colitis Long-standing|Incidence of Dysplasia and Colorectal Cancer in Patients With Chronic Idiopathic Inflammatory Colitis Treated With Biologics, Mesalamine, and Immunosuppressive Drug Combinations|Recruiting||N/A|300|Anticipated|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis|||1||f||||t|f|f||||Samples Without DNA|"     colonic biopsies   "|Yes||2017-10-10 21:13:15.354735|2017-10-10 21:13:15.354735
NCT03096704|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-30|||January 30, 2017|Actual|2017-01-30|March 2017|2017-03-01|May 15, 2017|Anticipated|2017-05-15|April 30, 2017|Anticipated|2017-04-30||Observational|||Vitamine d Dosage and Constipation|Vitamine D Deficiency in Slow Transit Time Constipation|Recruiting||N/A|50|Anticipated|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis|||1||f||||t|f|f||||||Undecided||2017-10-10 21:13:15.421637|2017-10-10 21:13:15.421637
NCT03096691|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-03-29|||February 1, 2016|Actual|2016-02-01|March 2017|2017-03-01|March 30, 2017|Anticipated|2017-03-30|March 30, 2017|Anticipated|2017-03-30||Interventional|||Use of Pessary in Case of Cervical Insufficiency and Short Cervix|Use of Pessary in Case of Cervical Insufficiency and Short Cervix|Recruiting||N/A|2|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t|f|t|f|f|t|||No||2017-10-10 21:13:15.488693|2017-10-10 21:13:15.488693
NCT03096678|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-04-09|||January 1, 2010|Actual|2010-01-01|April 2017|2017-04-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2020|Anticipated|2020-12-31|5 Years|Observational [Patient Registry]|||Prognosis of Patients With Compete Left Bundle Branch Block|Morphological and Functional Changes, Risk Stratification and Prognosis of Patients With Compete Left Bundle Branch Block|Recruiting||N/A|500|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||2||f||||f|f|f||||||Undecided||2017-10-10 21:13:15.567072|2017-10-10 21:13:15.567072
NCT03096665|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-14|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Effectiveness of Point of Care Blood Analysis Obtained From Skin Puncture Blood|Correlation Between the Point of Care Blood Analysis Obtained From Skin Puncture Blood and Conventional Blood Analysis Obtained From Venous and Arterial Blood|Enrolling by invitation||N/A|250|Anticipated|Hanyang University|||1||f||||t|f|f||||||Undecided||2017-10-10 21:13:15.664276|2017-10-10 21:13:15.664276
NCT03096652|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-24|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||A Modified Approach for Morbid Obese With Gynecologic Cancer|Gynecologic Cancer: a Modified Approach for Morbid Obese Patients|Recruiting||N/A|100|Anticipated|Mansoura University||2|||f||||f||||||||No||2017-10-10 21:13:15.729834|2017-10-10 21:13:15.729834
NCT03096639|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-20|||September 20, 2017|Anticipated|2017-09-20|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|August 30, 2018|Anticipated|2018-08-30||Interventional|RESCUE2||Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing|Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing|Recruiting||N/A|88|Anticipated|Lungpacer Medical Inc.||2|||f||||t|f|t|t|f|t|||||2017-10-10 21:13:15.93205|2017-10-10 21:13:15.93205
NCT03096626|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-29|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|||Association Between Depression and Iron Metabolism in Hemodialysis Patients|Association Between Depression and Iron Metabolism in Hemodialysis Patients|Completed||N/A|152|Actual|University of Hyogo|||1||f||||f|f|f||||||No||2017-10-10 21:13:16.120899|2017-10-10 21:13:16.120899
NCT03096613|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-03-29|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|THEME-HF||Levothyroxine Replacement for Subclinical Hypothyroidism and Chronic Heart Failure|Efficacy and Safety of Levothyroxine (L-T4) Replacement on Exercise Capability in Chronic Systolic Heart Failure Patients With Subclinical Hypothyroidism: A 24-week, Multi-center, Open Label, Randomized, Parallel Group Trial|Recruiting||Phase 4|124|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:13:16.186002|2017-10-10 21:13:16.186002
NCT03096600|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-05-24|||February 9, 2017|Actual|2017-02-09|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Evaluation of Fast Track Rehabilitaion in Mini-invasive Lombar Arthrodesis|Evaluation of Fast Track Rehabilitaion in Mini-invasive Lombar Arthrodesis|Recruiting||N/A|30|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||No||2017-10-10 21:13:16.294314|2017-10-10 21:13:16.294314
NCT03096587|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-08-21|||April 15, 2017|Actual|2017-04-15|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|RCT||Effect Of XP Endo Finisher Versus Ultrasonic Activated Irrigation On Post-operative Pain In Endodontic Treatment of Symptomatic Irreversible Pulpitis|Effect Of Using XP Endo Finisher Versus Ultrasonic Activated Irrigation On Post-operative Pain In Single Visit Endodontic Treatment of Teeth With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial|Recruiting||N/A|44|Anticipated|Cairo University||2|||f||||f|f|f|||f|||||2017-10-10 21:13:16.364186|2017-10-10 21:13:16.364186
NCT03096561|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-24|||November 14, 2016|Actual|2016-11-14|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|Kai+||Measurement of Serum Potassium Rate During Accidental Hypothermia.|A Comparative Study of Serum Potassium Rate Between Peripheral and Central Venous Sample Collection in Patients With Hypothermia Related Cardiac Arrest|Recruiting||N/A|12|Anticipated|University Hospital, Grenoble||1|||f|||||f|f||||||No||2017-10-10 21:13:16.5649|2017-10-10 21:13:16.5649
NCT03096548|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-24|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2021|Anticipated|2021-01-01||Interventional|||Sun Safety Ink! A Sun Safety Program for the Tattoo Community|Sun Safety Ink! A Sun Safety Program for the Tattoo Community|Recruiting||N/A|1820|Anticipated|Klein Buendel, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:13:16.680646|2017-10-10 21:13:16.680646
NCT03096535|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-04-10|||April 2, 2017|Actual|2017-04-02|April 2017|2017-04-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|COLDBAT||Cold Induced Activation of Brown Adipose Tissue in Humans|Cold Induced Activation of Brown Fat in Humans Assessed With PET/MR Scans and Skin-temperature Measure - A Cross-over Randomized Controlled Trial.|Recruiting||N/A|15|Anticipated|Rigshospitalet, Denmark||2|||f||||f|f|f||||||No||2017-10-10 21:13:16.796488|2017-10-10 21:13:16.796488
NCT03096522|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-26|2017-03-29|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|January 31, 2018|Anticipated|2018-01-31||Interventional|||Randomized Trial on the Effect of Topical Phenytoin on Healing After Fistulotomy|A Randomized Controlled Trial on the Effect of Topical Phenytoin 2% on Wound Healing After Fistulotomy|Recruiting||N/A|38|Anticipated|Mansoura University||2|||f||||t|f|f||||||No||2017-10-10 21:13:16.896344|2017-10-10 21:13:16.896344
NCT03096509|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-23|||January 19, 2017|Actual|2017-01-19|March 2017|2017-03-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Participatory Action Research to Evaluate the Delivery of the MISSION ABC Service Model and Assess Health Service and Clinical Outcomes|MISSION ABC: Modern Innovative Solutions to Improve Outcomes in Asthma, Breathlessness and COPD - Participatory Action Research to Evaluate the Delivery of the MISSION ABC Service Model and Assess Health Service and Clinical Outcomes|Recruiting||N/A|70|Anticipated|Portsmouth Hospitals NHS Trust|||1||f||||t|f|f||||||Undecided||2017-10-10 21:13:16.999247|2017-10-10 21:13:16.999247
NCT03096470|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-29|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|||Closed Reduction With Anesthesia and no Anesthesia for Developmental Dislocation of the Hip < 6 Months|Clinical Analysis of Two Methods for Closed Reduction of Developmental Dislocation of the Hip by Prolonged Traction < 6 Months----An Multicenter Prospective Observational Study|Completed||N/A|30|Actual|The Fuzhou No 2 Hospital|||2||f||||t|f|f||||||Yes||2017-10-10 21:13:17.284629|2017-10-10 21:13:17.284629
NCT03096457|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-24|||April 15, 2017|Anticipated|2017-04-15|March 2017|2017-03-01|October 15, 2018|Anticipated|2018-10-15|April 15, 2018|Anticipated|2018-04-15||Interventional|||Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia|Topical Paromomycin Cream For Bolivian Cutaneous Eishmaniasis: A Controlled Study|Not yet recruiting||Phase 2/Phase 3|80|Anticipated|Fundacion Nacional de Dermatologia||3|||f||||f|f|f||||||No||2017-10-10 21:13:17.369686|2017-10-10 21:13:17.369686
NCT03096444|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-23|||May 23, 2017|Actual|2017-05-23|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 19, 2017|Actual|2017-07-19||Interventional|||Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine|Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine|Terminated||Phase 2|13|Actual|University of Miami||5||Efficacy was not seen after interim analysis|f||||f|t|f||||||||2017-10-10 21:13:17.488092|2017-10-10 21:13:17.488092
NCT03096431|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-06|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Impact of Cognitive Rehab and Physical Activity on Cognition in Patients With Metastatic Brain Tumors Undergoing RT|Does Cognitive Rehabilitation and Physical Activity Impact Executive Functioning Following Radiation Therapy for Cerebral Metastases? A Pilot Study|Recruiting||N/A|76|Anticipated|Virginia Commonwealth University||3|||f||||f|f|f||||||||2017-10-10 21:13:17.612011|2017-10-10 21:13:17.612011
NCT03096418|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-10|||March 13, 2017|Actual|2017-03-13|August 2017|2017-08-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2018|Anticipated|2018-03-15||Interventional|||Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response|Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response|Recruiting||N/A|20|Anticipated|University of Wisconsin, Madison||1|||f|||||f|f||||||||2017-10-10 21:13:17.715575|2017-10-10 21:13:17.715575
NCT03096405|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-05-24|||February 1, 2014|Actual|2014-02-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|March 31, 2016|Actual|2016-03-31||Observational|||Impact MRSA -PCR on Patient Management|Impact MRSA -PCR on Patient Management|Completed||N/A|50|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||No||2017-10-10 21:13:17.812497|2017-10-10 21:13:17.812497
NCT03096392|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-08|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control|A Randomized Controlled Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro Alone to Further Improve Glycemic Control in Type 1 Diabetes Mellitus Subjects With Good Glycemic Control|Recruiting||Phase 2|46|Anticipated|Diasome Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 21:13:17.885991|2017-10-10 21:13:17.885991
NCT03096379|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-24|||December 30, 2014|Actual|2014-12-30|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|December 30, 2018|Anticipated|2018-12-30||Observational|||MRI Differentiating Gut TB and Crohn's|Differentiating Gut Tuberculosis and Crohn's Disease Via Magnetic Resonance Enterography|Recruiting||N/A|150|Anticipated|The University of Hong Kong|||1||f||||f|f|f||||||No||2017-10-10 21:13:18.027707|2017-10-10 21:13:18.027707
NCT03096366|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-09|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Does Blood Flow Restriction Training Improve Quadriceps Function After Arthroscopic Knee Surgery?|Does Blood Flow Restriction Training Improve Quadriceps Function After Arthroscopic Knee Surgery? A Randomized Clinical Trial|Not yet recruiting||N/A|150|Anticipated|The University of Texas Health Science Center, Houston||2|||f|||||f|t|f|f||||||2017-10-10 21:13:18.121485|2017-10-10 21:13:18.121485
NCT03096353|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-29|2017-10-03|||August 1, 2017|Actual|2017-08-01|September 22, 2017|2017-09-22|October 17, 2019|Anticipated|2019-10-17|October 17, 2018|Anticipated|2018-10-17||Observational|||Sensory and Opioid Mechanisms of Affective Touch|Sensory and Opioid Mechanisms of Affective Touch|Recruiting||N/A|30|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f||||||||||||||2017-10-10 21:13:18.278247|2017-10-10 21:13:18.278247
NCT03096340|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-30|||March 23, 2017|Actual|2017-03-23|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer|A Phase 1 With Expansion Cohort, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Intravenously Infused IT-141 in Subjects With Recurrent or Refractory Solid Tumors|Recruiting||Phase 1|45|Anticipated|Intezyne Technologies, Inc.||1|||f||||f|t|f||||||Undecided||2017-10-10 21:13:18.372109|2017-10-10 21:13:18.372109
NCT03096327|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-09|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|October 31, 2017|Anticipated|2017-10-31|September 30, 2017|Anticipated|2017-09-30||Interventional|TEAM||TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)|TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)|Recruiting||Phase 4|180|Anticipated|PharmEvo Pvt Ltd||2|||f||||t|f|f|||f|||||2017-10-10 21:13:18.529476|2017-10-10 21:13:18.529476
NCT03096314|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-18|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|VIOLET||Vitamin D to Improve Outcomes by Leveraging Early Treatment|Vitamin D to Improve Outcomes by Leveraging Early Treatment|Recruiting||Phase 3|3000|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||Yes|Data will be collected electronically and stored at the Clinical Coordinating Center at MGH. A de-identified database of all data will be available for use 3 years after the primary publication. Data can be accessed at that point via the NHLBI BioLINCC data repository.|2017-10-10 21:13:18.66951|2017-10-10 21:13:18.66951
NCT03095014|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-22|||January 2010|Actual|2010-01-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Interventional|||Myomectomy During Cesarean Section|Cesarean Myomectomy : Safety and Risk of Intrauterine Synechiae|Completed||Phase 1|76|Actual|Zagazig University||2|||f||||t|f|f||||||No||2017-10-10 21:13:33.112908|2017-10-10 21:13:33.112908
NCT03096288|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-27|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity|Impact of the PCSK9 Inhibitor Evolocumab on the Pharmacodynamic Effects of Clopidogrel in Patients With Atherosclerotic Cardiovascular Disease and High On-Treatment Platelet Reactivity|Recruiting||Phase 4|90|Anticipated|University of Florida||2|||f||||t|t|f|||f|||||2017-10-10 21:13:18.992083|2017-10-10 21:13:18.992083
NCT03096275|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-04|||March 16, 2017|Actual|2017-03-16|April 2017|2017-04-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|CommittedTA||Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis|Comparison of the Efficacy of Mycophenolate Mofetil Combined With Methotrexate and Cyclophosphamide for the Treatment of Takayasu's Arteritis|Recruiting||Phase 3|150|Anticipated|Chinese SLE Treatment And Research Group||2|||f||||t|f|f||||||No||2017-10-10 21:13:19.092178|2017-10-10 21:13:19.092178
NCT03096262|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-12|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Transforming Robot-mediated Telerehabilitation: Citizen Science for Rehabilitation|Transforming Robot-mediated Telerehabilitation: Citizen Science for Rehabilitation|Not yet recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:13:19.224773|2017-10-10 21:13:19.224773
NCT03096249|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-24|||November 21, 2016|Actual|2016-11-21|March 2017|2017-03-01|July 30, 2017|Anticipated|2017-07-30|May 30, 2017|Anticipated|2017-05-30||Interventional|||The Influence of Oxytocin on Socio-communicative Sensitivity|Monitoring the Influence of Oxytocin on Socio-communicative Sensitivity Using Fast Periodic Visual Stimulation|Recruiting||Phase 1/Phase 2|30|Anticipated|Katholieke Universiteit Leuven||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:19.330752|2017-10-10 21:13:19.330752
NCT03096236|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-15|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|March 1, 2019|Anticipated|2019-03-01||Observational|RESET||Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD|Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD|Recruiting||N/A|20|Anticipated|Kliniken Ludwigsburg-Bietigheim gGmbH|||1||f||||t|f|f||||||||2017-10-10 21:13:19.436428|2017-10-10 21:13:19.436428
NCT03096223|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-14|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis|A Phase 1, Open-Label, Multiple-Dose Study of KHK4083 in Subjects With Atopic Dermatitis|Active, not recruiting||Phase 1|20|Anticipated|Kyowa Hakko Kirin Co., Ltd||1|||f||||t|f|f||||||||2017-10-10 21:13:19.50239|2017-10-10 21:13:19.50239
NCT03096210|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-23|||March 11, 2013|Actual|2013-03-11|March 2017|2017-03-01|March 2, 2015|Actual|2015-03-02|November 28, 2014|Actual|2014-11-28||Interventional|||Titanium-Prepared Platelet Rich Fibrin in the Sinus Lifting Procedure|Comparison of the Clinic, Radiographic and Histological Effects of Allograft and T-PRF (Titanium-Prepared Platelet Rich Fibrin) Materials in the Sinus Lifting Procedure. Preliminary Results From a Pilot Randomised Controlled Trial|Completed||N/A|18|Actual|Kırıkkale University||2|||f|||||f|f||||||No||2017-10-10 21:13:19.579685|2017-10-10 21:13:19.579685
NCT03096197|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-08-18|||March 30, 2017|Actual|2017-03-30|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Exoskeleton and Spinal Cord Stimulation for SCI|Exoskeleton and Spinal Cord Stimulation for SCI|Recruiting||N/A|24|Anticipated|Kessler Foundation||2|||f||||t|f|t|f||f|||||2017-10-10 21:13:19.652587|2017-10-10 21:13:19.652587
NCT03096184|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-03-29|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|May 1, 2019|Anticipated|2019-05-01|October 31, 2018|Anticipated|2018-10-31||Interventional|||A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers|A Non-randomized Phase II Study of Apatinib Mesylate Tablets Plus Tegafur Gimeracil Oteracil Potassium Capsules in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck|Not yet recruiting||Phase 2|38|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||1|||f||||t|f|f||||||No||2017-10-10 21:13:19.914382|2017-10-10 21:13:19.914382
NCT03096171|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-08-09|||March 28, 2017|Actual|2017-03-28|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 28, 2017|Anticipated|2017-12-28||Interventional|||Flourishing App: An Evaluation With High School Students|Flourishing App: An Evaluation With High School Students|Recruiting||N/A|60|Anticipated|Hospital Israelita Albert Einstein||2|||f||||t|f|f||||||||2017-10-10 21:13:20.10179|2017-10-10 21:13:20.10179
NCT03096158|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-13|||April 1, 2017|Actual|2017-04-01|March 2017|2017-03-01|October 1, 2018|Anticipated|2018-10-01|April 1, 2018|Anticipated|2018-04-01||Interventional|CEFREET||Cardiac and Endothelial Function Response to Early Exercise Training After Coronary Artery Bypass Surgery|Cardiac and Endothelial Function Response to Early Exercise Training (CEFREET Study) After Coronary Artery Bypass Surgery: a Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||4|||f||||f|f|f||||||No||2017-10-10 21:13:20.229149|2017-10-10 21:13:20.229149
NCT03096145|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-25|2017-09-05|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers|Pilot Study Phase - Nonsmoker Interventions to Increase Use of Quitline Services Among Racially Diverse Low Income Smokers|Recruiting||N/A|60|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 21:13:20.375382|2017-10-10 21:13:20.375382
NCT03096132|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-18|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|June 2021|Anticipated|2021-06-01||Interventional|||FRESH-DOSE: Families Responsibility Education Support Health—Dual Options for Sustained Effectiveness|Effect of Treatment Dose on Childhood Obesity|Recruiting||N/A|160|Anticipated|University of California, San Diego||2|||f||||t|f|f||||||||2017-10-10 21:13:20.50782|2017-10-10 21:13:20.50782
NCT03096119|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-09|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Observational|Asia BP@Home||A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)|A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)|Recruiting||N/A|1600|Anticipated|Jichi Medical University|||1||f||||f|f|f||||||No||2017-10-10 21:13:20.652199|2017-10-10 21:13:20.652199
NCT03096106|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-03|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|||Visual Assessment for Pressure-time Curve|The Reliability and Validity of Visual Assessment for Pressure-time Curve|Completed||N/A|200|Actual|Capital Medical University|||1||f||||t||||||||||2017-10-10 21:13:20.744463|2017-10-10 21:13:20.744463
NCT03096093|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-06-21|||April 25, 2017|Actual|2017-04-25|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|October 2018|Anticipated|2018-10-01||Interventional|||Investigation of a Therapeutic Vaccine (ACIT-1) in Late Stage Cancer|A Phase I Clinical Study to Determine the Optimal Dose for the Safe Immune Restoration and Immune Response of Allogeneic Cell Immunotherapy (ACIT-1) in Adult Cancer Patients|Recruiting||Phase 1/Phase 2|34|Anticipated|Cancer Vaccines Limited||2|||f||||t|t|f|||t|||No||2017-10-10 21:13:20.828222|2017-10-10 21:13:20.828222
NCT03096080|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-28|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)|A Phase 1, Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)|Recruiting||Phase 1|18|Anticipated|Kadmon Corporation, LLC||3|||f||||f|t|f||||||||2017-10-10 21:13:20.948523|2017-10-10 21:13:20.948523
NCT03096067|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-01|||March 29, 2017|Actual|2017-03-29|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Treatment of Patellar Tendinopathy|Treatment of Patellar Tendinopathy; Influence of Load Magnitude on Clinical Outcome, Tendon Structure and Function|Enrolling by invitation||N/A|44|Anticipated|Bispebjerg Hospital||2|||f||||t|f|f||||||||2017-10-10 21:13:21.070936|2017-10-10 21:13:21.070936
NCT03096054|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-21|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|November 6, 2020|Anticipated|2020-11-06|November 6, 2020|Anticipated|2020-11-06||Interventional|||A CR-UK Phase I Trial of LY3143921|A Cancer Research UK (CR-UK) Phase I Trial of LY3143921 a Cdc7 Inhibitor in Adult Patients With Advanced Solid Tumours|Recruiting||Phase 1|68|Anticipated|Cancer Research UK||2|||f||||t|f|f||||||||2017-10-10 21:13:21.190492|2017-10-10 21:13:21.190492
NCT03096041|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-19|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|TRIPLE-A||Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors|Phase 3 Study Randomized Against Placebo, Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors in Adjuvant Treatment of Breast Cancer (TRIPLE-A)|Recruiting||N/A|216|Anticipated|Centre Francois Baclesse||2|||f||||f|f|f||||||||2017-10-10 21:13:21.319022|2017-10-10 21:13:21.319022
NCT03096028|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-08-16|||July 1, 2018|Anticipated|2018-07-01|August 2017|2017-08-01|February 28, 2022|Anticipated|2022-02-28|December 31, 2020|Anticipated|2020-12-31||Observational|||Developmental Origins of Mental Health Disorders|Developmental Origins of Neurocognitive and Behavioral Endophenotypes and Common Mental Health Disorders in Young Adults of a Prospective Birth Cohort|Not yet recruiting||N/A|700|Anticipated|Kem Hospital, Pune, India|||1||f||||t|f|f||||||||2017-10-10 21:13:21.427889|2017-10-10 21:13:21.427889
NCT03096015|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-24|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Intensive Interdisciplinary Treatment Program for Individuals With Stroke-Induced Aphasia|Intensive Interdisciplinary Treatment Program for Individuals With Stroke-Induced Aphasia|Completed||N/A|19|Actual|Boston University Charles River Campus||1|||f||||f|f|f||||||No||2017-10-10 21:13:21.545156|2017-10-10 21:13:21.545156
NCT03096002|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-23|||May 1, 2017|Anticipated|2017-05-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Small Steps for Big Changes: A Lifestyle Program to Reduce the Risk of Developing Type 2 Diabetes|Small Steps for Big Changes: A Lifestyle Program to Reduce the Risk of Developing Type 2 Diabetes in the Community|Not yet recruiting||N/A|500|Anticipated|University of British Columbia|||1||f||||f||||||||No||2017-10-10 21:13:21.639224|2017-10-10 21:13:21.639224
NCT03095989|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-04-26|||January 2015||2015-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Online Mindfulness Intervention for People With ALS and Their Caregivers|An Online Mindfulness Intervention for People With ALS and Their Caregivers|Recruiting||N/A|100|Anticipated|Harvard University||2|||f||||f||||||||No||2017-10-10 21:13:21.760326|2017-10-10 21:13:21.760326
NCT03095976|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-07|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration for Periodontal Intrabony Defects and Grade II Furcation Defects.|Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration for Periodontal Intrabony Defects and Grade II Furcation Defects.|Recruiting||Phase 4|20|Anticipated|Indiana University||1|||f||||t|f|f|||f|||||2017-10-10 21:13:21.875949|2017-10-10 21:13:21.875949
NCT03095963|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-24|||January 1, 2014||2014-01-01|March 2017|2017-03-01|October 25, 2016|Actual|2016-10-25|October 25, 2016|Actual|2016-10-25||Interventional|||Interaction Between Levothyroxine and Probiotics in Hypothyroid Patients|Effects of Probiotics Assumption on Serum Thyroid Hormone and TSH Levels in Hypothyroid Patients on Levothyroxine Treatment|Completed||N/A|80|Actual|Azienda USL Modena||2|||f|||||f|f||||||Undecided||2017-10-10 21:13:21.976743|2017-10-10 21:13:21.976743
NCT03095950|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by French-speaking Population|Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin: A Randomized Controlled Trial Among French-speaking Population|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:22.055303|2017-10-10 21:13:22.055303
NCT03095937|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-24|||September 1, 2016|Actual|2016-09-01|March 2017|2017-03-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Observational|RHD||Evaluation of Fetal Cardiac Function in Rheumatic Heart Disease (RHD) Patients|Different Modalities for Evaluation of Fetal Cardiac Function in Pregnant Women With Rheumatic Heart Disease (RHD) Patients|Recruiting||N/A|152|Anticipated|Assiut University|||1||f||||t|f|f||||||Undecided||2017-10-10 21:13:22.182893|2017-10-10 21:13:22.182893
NCT03095924|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by French-speaking Patients|Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin: A Randomized Controlled Trial Among French-speaking Patients|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:22.265088|2017-10-10 21:13:22.265088
NCT03095911|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by English-speaking Population|Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin: A Randomized Controlled Trial Among English-speaking Population|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:22.408874|2017-10-10 21:13:22.408874
NCT03095898|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-06-05|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 15, 2018|Anticipated|2018-07-15|April 15, 2018|Anticipated|2018-04-15||Interventional|||Electroacupuncture Analgesia for Colonoscopy|Electroacupuncture Analgesia for Colonoscopy: A Prospective and Randomized Study|Not yet recruiting||N/A|180|Anticipated|American University of Beirut Medical Center||3|||f||||f|f|f||||||No||2017-10-10 21:13:22.517987|2017-10-10 21:13:22.517987
NCT03095885|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-24|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria|A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria|Completed||N/A|22|Actual|Allena Pharmaceuticals||1|||f||||f||||||||No||2017-10-10 21:13:22.611516|2017-10-10 21:13:22.611516
NCT03095872|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-31|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|CO2||"Comparison of the Effect of Vaseline and Bepanthen® Wund- Und Heilsalbe on the Wound Healing Following Laser Therapy"|"Comparison of the Effect of Vaseline and Bepanthen® Wund- Und Heilsalbe on the Wound Healing Following Fractional Ablative Laser Treatment of Photo-damaged Skin"|Recruiting||Phase 3|37|Anticipated|RWTH Aachen University||1|||f||||f|f|f|||f|||No||2017-10-10 21:13:22.720645|2017-10-10 21:13:22.720645
NCT03095859|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-24|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|PIRATE||Post-operative, Inpatient Rehabilitation After Lung Transplant Evaluation|Post-operative, Inpatient Rehabilitation After Lung Transplant Evaluation: A Feasibility Study|Not yet recruiting||N/A|40|Anticipated|The Alfred||2|||f||||f|f|f||||||No|IPD will not be shared outside of this trial.|2017-10-10 21:13:22.832082|2017-10-10 21:13:22.832082
NCT03095846|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-10|||April 2, 2017|Actual|2017-04-02|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|COLDBAT_WS||Cold Induced Activation of Brown Adipose Tissue in Winter Swimmers|Cold Induced Activation of Brown Fat in Winter Swimmers|Recruiting||N/A|20|Anticipated|Rigshospitalet, Denmark||2|||f||||f|f|f||||||No||2017-10-10 21:13:22.947482|2017-10-10 21:13:22.947482
NCT03095833|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-24|||February 27, 2015|Actual|2015-02-27|March 2017|2017-03-01|November 19, 2015|Actual|2015-11-19|November 19, 2015|Actual|2015-11-19||Interventional|||Food Intake Decisions|Food Decisions and Reward System: Modulation by Olfaction and Taste|Terminated||N/A|65|Actual|Hospices Civils de Lyon||2||Insufficient on-site staff to manage study|f|||||f|f||||||||2017-10-10 21:13:23.058522|2017-10-10 21:13:23.058522
NCT03095820|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-24|||September 1, 2015|Actual|2015-09-01|March 2017|2017-03-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Multi-domain Lifestyle Modification With Contingency Management for Geriatric Depression|Community-Based Multi-domain Lifestyle Modification With Contingency Management for Geriatric Depression: A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Ajou University School of Medicine||2|||f|||||f|f||||||||2017-10-10 21:13:23.173414|2017-10-10 21:13:23.173414
NCT03095807|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-22|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity|Investigation on Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity|Completed||Phase 1|34|Actual|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 21:13:23.290653|2017-10-10 21:13:23.290653
NCT03095794|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-06|||January 31, 2015|Actual|2015-01-31|July 2017|2017-07-01|July 18, 2016|Actual|2016-07-18|July 18, 2016|Actual|2016-07-18||Interventional|||Social Decision-making (SOCIAL-DECISION)|Brain Mechanism of Social Decision-making|Terminated||N/A|145|Actual|Hospices Civils de Lyon||1||Insufficient on-site staff to manage study|f|||||f|f||||||||2017-10-10 21:13:23.44079|2017-10-10 21:13:23.44079
NCT03095781|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-05|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|June 2023|Anticipated|2023-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer|Phase Ib Trial of Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Malignancies|Recruiting||Phase 1|50|Anticipated|Emory University||1|||f||||t|t|f||||||||2017-10-10 21:13:23.538679|2017-10-10 21:13:23.538679
NCT03095768|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-16|||April 13, 2017|Actual|2017-04-13|June 2017|2017-06-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|BLENDS||Lifestyle Education and Nutrition Demonstration|Blending Lifestyle Education and Nutrition Demonstration for Seniors in the Warrensville Heights Community|Completed||N/A|37|Actual|The Cleveland Clinic||1|||f||||f|f|f||||||No||2017-10-10 21:13:23.69223|2017-10-10 21:13:23.69223
NCT03095755|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-30|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|May 2023|Anticipated|2023-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Ischemic Conditioning as an Intervention to Improve Motor Function in Chronic Stroke|Ischemic Conditioning as an Intervention to Improve Motor Function in Chronic Stroke|Recruiting||N/A|50|Anticipated|Medical College of Wisconsin||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:23.817549|2017-10-10 21:13:23.817549
NCT03095742|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-09-18|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 20, 2020|Anticipated|2020-03-20|September 20, 2019|Anticipated|2019-09-20||Interventional|MICA||Bedside Monitoring of Cerebral Energy State During the Peri-cardiac Arrest Period|Bedside Monitoring of Cerebral Energy State During the Peri-cardiac Arrest Period - Blood Pressure Targets in Post Resuscitation Care|Recruiting||N/A|80|Anticipated|Odense University Hospital||2|||f||||t|f|f||||||||2017-10-10 21:13:23.921439|2017-10-10 21:13:23.921439
NCT03095729|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-05|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|VENTIPSY||Cognitive Consequences of an Activation of the Cortical Drive to Breath (VENTIPSY)|Cognitive Consequences of an Activation of the Cortical Drive to Breath|Recruiting||N/A|82|Anticipated|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil|||3||f|||||f|f||||||||2017-10-10 21:13:24.021667|2017-10-10 21:13:24.021667
NCT03095716|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-30|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Laparoscopic Surgery in Elderly Patients|Impact of Intraperitoneal Pressure and Warmed, Humidified CO2 Gas on Clinical Outcomes After Laparoscopic Surgery for Uterine Prolapse in Patients Aged ˃75 Years: A Observational Study|Recruiting||N/A|20|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 21:13:24.139234|2017-10-10 21:13:24.139234
NCT03095703|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-07-03|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Sirolimus and Familial Adenomatous Polyposis (FAP)|Sirolimus for the Treatment of Severe Intestinal Polyposis in Patients With Familial Adenomatous Polyposis (FAP): a Pilot Study|Recruiting||Phase 2|5|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t|f|f|||f|||||2017-10-10 21:13:24.283603|2017-10-10 21:13:24.283603
NCT03095690|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-24|||January 7, 2016|Actual|2016-01-07|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|DOPPA||Volumetric Bone Mineral Density and it's Relationship With Osteoporotic Fractures in Parkinson's Disease|Determinants of Volumetric Bone Mineral Density at the Tibia and Radius and it's Relationship With Osteoporotic Fractures in Idiopathic Parkinson's Disease|Recruiting||N/A|200|Anticipated|Centre Hospitalier Régional d'Orléans||1|||f||||f||||||||No||2017-10-10 21:13:24.411586|2017-10-10 21:13:24.411586
NCT03095677|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-03-30|||April 8, 2016|Actual|2016-04-08|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|APNEX||Acute and Chronic Effects of Dynamic Apnea in Healthy Untrained Subjects|Acute and Chronic Effects of Dynamic Apnea in Healthy Untrained Subjects|Recruiting||N/A|32|Anticipated|Centre Hospitalier Régional d'Orléans||2|||f||||f||||||||No||2017-10-10 21:13:24.529819|2017-10-10 21:13:24.529819
NCT03095664|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-30|||November 2016||2016-11-01|March 2017|2017-03-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Interventional|||Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors|Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors|Recruiting||N/A|286|Anticipated|Brazilian National Cancer Institute||2|||f||||f||||||||No||2017-10-10 21:13:26.782877|2017-10-10 21:13:26.782877
NCT03095651|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-27|2017-06-14|||April 12, 2017|Actual|2017-04-12|June 2017|2017-06-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)|A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamic Effect of MK-5160 in Subjects With Type 1 and Type 2 Diabetes Mellitus|Recruiting||Phase 1|48|Anticipated|Merck Sharp & Dohme Corp.||8|||f||||f|t|f||||||||2017-10-10 21:13:26.916888|2017-10-10 21:13:26.916888
NCT03095638|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-04|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Interventional|||Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir|A 2-Part, Phase I, Single Dose, Crossover Relative Bioavailability Study of Both TIVICAY 10 mg Conventional Tablets and 5 mg Dispersible Tablets Compared to Conventional TIVICAY Tablets in Fasted Healthy Adult Subjects|Completed||Phase 1|38|Actual|ViiV Healthcare||8|||f||||f|t|f||||||||2017-10-10 21:13:27.054997|2017-10-10 21:13:27.054997
NCT03095625|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||October 1, 2015|Actual|2015-10-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30|90 Days|Observational [Patient Registry]|||Role of Thromboelastography in Septic Shock|Role of Thromboelastography in Septic Shock: a Prospective Observational Study|Recruiting||N/A|100|Anticipated|University of Turin, Italy|||1||f||||t|f|f||||Samples Without DNA|"     whole blood   "|No||2017-10-10 21:13:27.188826|2017-10-10 21:13:27.188826
NCT03095612|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||May 1, 2018|Anticipated|2018-05-01|March 2017|2017-03-01|May 1, 2021|Anticipated|2021-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|||Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)|An Investigator-Sponsored, Phase 1/2 Trial of the Oral XPO1 Inhibitor Selinexor (KPT-330) in Combination With Docetaxel for Previously Treated, Advanced KRAS Mutant Non-small Cell Lung Cancer (NSCLC)|Not yet recruiting||Phase 1/Phase 2|59|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t|t|f|||f|||No||2017-10-10 21:13:27.284826|2017-10-10 21:13:27.284826
NCT03095599|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-23|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|IVACFLUS-0203||Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3|A Phase 2/3 Double Blinded, Randomized, Placebo-Controlled Study in Healthy Adult Volunteers in Vietnam to Examine the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine (IVACFLU-S) Produced by IVAC|Recruiting||Phase 2/Phase 3|888|Anticipated|Institute of Vaccines and Medical Biologicals, Vietnam||2|||f||||t|f|f||||||No||2017-10-10 21:13:27.385685|2017-10-10 21:13:27.385685
NCT03095586|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-15|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by English-speaking Patients|Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin: A Randomized Controlled Trial Among English-speaking Patients|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:27.49944|2017-10-10 21:13:27.49944
NCT03095573|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-29|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 28, 2019|Anticipated|2019-02-28|October 31, 2018|Anticipated|2018-10-31||Interventional|||Comparison Between Axial- and Lateral-viewing Capsule Endoscopy in Celiac Disease|Prospective Randomized Comparison Between Axial- and Lateral-viewing Capsule Endoscopy Systems in Celiac Patients: a Pilot Study|Recruiting||N/A|25|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f|f|t|f|f|t|||Undecided||2017-10-10 21:13:27.64309|2017-10-10 21:13:27.64309
NCT03095560|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-23|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||BTs Nirvana and Post-stroke Rehab|Role of Body Shadow in Improving Virtual Reality Rehabilitation: Preliminary Data From BTS Nirvana|Completed||N/A|20|Actual|"IRCCS Centro Neurolesi Bonino-Pulejo"||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:27.904465|2017-10-10 21:13:27.904465
NCT03094273|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-30|||February 25, 2013|Actual|2013-02-25|March 2017|2017-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Observational|||Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi|Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi|Completed||N/A|138|Actual|New York University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 21:13:39.322322|2017-10-10 21:13:39.322322
NCT03095547|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-28|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Drug/Drug Interactions With F901318|An Open Label Assessment of the Effect of Coadministration of Posaconazole or Pantoprazole on Systemic Exposure of F901318 and the Effect of F901318 on the Single Dose Pharmacokinetics of Tacrolimus and Cyclosporine A in Healthy Male and Female Subjects|Not yet recruiting||Phase 1|48|Anticipated|F2G Ltd.||4|||f||||f|f|f||||||No||2017-10-10 21:13:28.006175|2017-10-10 21:13:28.006175
NCT03095534|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Translating 3-Step Workout for Life in a Local Senior Living Community|Translating 3-Step Workout for Life in a Local Senior Living Community: A Feasibility Study|Enrolling by invitation||N/A|18|Anticipated|Indiana University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:13:28.175483|2017-10-10 21:13:28.175483
NCT03095521|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-06-02|||February 22, 2017|Actual|2017-02-22|June 2017|2017-06-01|May 7, 2017|Actual|2017-05-07|May 7, 2017|Actual|2017-05-07||Interventional|||A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat|"A Prospective, Multi-center, Open, Randomized Clinical Study in Parallel Groups, for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol], 1 mg + 5 mg (Sandoz d.d., Slovenia), and ANTI-ANGIN® FORMULA, Lozenges, 0,2 mg + 2 mg + 50 mg (LLC Valeant, Russia) in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat."|Completed||Phase 3|227|Actual|Sandoz||2|||f||||f|f|f||||||No||2017-10-10 21:13:28.307872|2017-10-10 21:13:28.307872
NCT03095508|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-02|||February 22, 2017|Actual|2017-02-22|June 2017|2017-06-01|May 8, 2017|Actual|2017-05-08|May 8, 2017|Actual|2017-05-08||Interventional|||Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat|"Prospective, Multicenter, Open, Randomized, Parallel, Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray [Menthol], 0,5 mg + 2 mg / 1 ml (Sandoz d.d., Slovenia), and ANTI-ANGIN® FORMULA, Topical Metered Spray, 0,12 mg + 0,24 mg / Dose (OOO Valeant, Russia) in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat"|Completed||Phase 3|228|Actual|Sandoz||2|||f||||f|f|f||||||No||2017-10-10 21:13:28.454971|2017-10-10 21:13:28.454971
NCT03095495|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-10|||January 2018|Anticipated|2018-01-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue|Heated Humidified High Flow Nasal Cannula (HHHFNC) For Acute Moderate to Severe RSV-Bronchiolitis in Infants Younger Than 3 Months Old: Early Versus Rescue|Not yet recruiting||N/A|350|Anticipated|Hamad Medical Corporation||2|||f||||f|f|f||||||||2017-10-10 21:13:28.604207|2017-10-10 21:13:28.604207
NCT03095482|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||tDCS-Augmented Exposure Therapy for Pathological Fear|tDCS-Augmented Exposure Therapy for Pathological Fear|Recruiting||N/A|60|Anticipated|University of Texas at Austin||3|||f||||f|f|f||||||Undecided||2017-10-10 21:13:28.750792|2017-10-10 21:13:28.750792
NCT03095469|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-06-07|||August 20, 2017|Anticipated|2017-08-20|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|EODOPWCHD||Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention|Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention:A Double-Blinded, Randomised Controlled Trial|Not yet recruiting||Early Phase 1|200|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:13:28.887218|2017-10-10 21:13:28.887218
NCT03095456|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-25|||March 20, 2017|Actual|2017-03-20|July 2017|2017-07-01|October 9, 2017|Anticipated|2017-10-09|October 2, 2017|Anticipated|2017-10-02||Interventional|||Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD|A Phase 3b, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Study to Compare Once Daily Nebulized Revefenacin With Spiriva Once Daily Delivered Via the HandiHaler® on Lung Function in Subjects With COPD and a Low PIFR|Recruiting||Phase 3|200|Anticipated|Theravance Biopharma R & D, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:13:29.02685|2017-10-10 21:13:29.02685
NCT03095443|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-08-15|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|DDM||Decreasing Delirium Through Music|Decreasing Delirium Through Music|Recruiting||N/A|60|Anticipated|Indiana University||3|||f||||f|f|f||||||||2017-10-10 21:13:29.148323|2017-10-10 21:13:29.148323
NCT03095430|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-23|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|December 31, 2016|Actual|2016-12-31||Observational|ESPTR||Modulation of General Anesthesia Using Entropy and Surgical Pleth Index|Modulation of General Anesthesia Using Entropy and Surgical Pleth Index|Completed||N/A|72|Actual|Romanian Society of Anesthesia and Intensive Care|||2||f||||t|f|f||||||No||2017-10-10 21:13:29.26537|2017-10-10 21:13:29.26537
NCT03095417|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-10-04|||September 25, 2017|Actual|2017-09-25|October 2017|2017-10-01|June 1, 2023|Anticipated|2023-06-01|June 1, 2022|Anticipated|2022-06-01||Interventional|IMPROVE||Improving the Recovery and Outcome Every Day After the ICU|Decreasing Alzheimer's Disease and Related Dementias After Delirium- Exercise and Cognitive Training|Recruiting||N/A|344|Anticipated|Indiana University||4|||f||||t|f|f||||||||2017-10-10 21:13:29.366076|2017-10-10 21:13:29.366076
NCT03095404|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-06|||September 1, 2018|Anticipated|2018-09-01|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|December 31, 2019|Anticipated|2019-12-31||Interventional|||Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery|Optimum Dosage of Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery|Not yet recruiting||Early Phase 1|50|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 21:13:29.517995|2017-10-10 21:13:29.517995
NCT03095391|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||June 6, 2017|Anticipated|2017-06-06|March 2017|2017-03-01|October 1, 2017|Anticipated|2017-10-01|September 15, 2017|Anticipated|2017-09-15||Interventional|||The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™|A Phase 2b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ in Healthy Subjects and Patients With Varying Degrees of Renal Impairment|Not yet recruiting||N/A|32|Anticipated|FAST BioMedical||4|||f||||t|f|t|t|f||||No||2017-10-10 21:13:29.659855|2017-10-10 21:13:29.659855
NCT03095378|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||March 10, 2014|Actual|2014-03-10|March 2017|2017-03-01|March 10, 2017|Actual|2017-03-10|February 10, 2017|Actual|2017-02-10||Interventional|||Evaluation of Root Coverage by Connective Graft and Different Root Conditioning Methods|Evaluation of Root Coverage by Subepithelial Connective Graft Associated to Root Conditioning by Citric Acid Plus Tetracycline and Antimicrobial Photodynamic Therapy: A Randomized Clinical Trial|Completed||N/A|14|Actual|University of Sao Paulo||3|||f||||t|f|f||||||No||2017-10-10 21:13:29.801574|2017-10-10 21:13:29.801574
NCT03095365|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-05|||March 14, 2017|Actual|2017-03-14|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|September 1, 2017|Actual|2017-09-01||Interventional|||Dry Needling and Pain Education in the Treatment of Chronic Neck Pain|Dry Needling and Pain Neuroscience Education in Chronic Pain Patients|Completed||N/A|60|Actual|Universidad Rey Juan Carlos||3|||f|||||f|f||||||||2017-10-10 21:13:29.912971|2017-10-10 21:13:29.912971
NCT03095352|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-10-03|||September 9, 2017|Actual|2017-09-09|October 2017|2017-10-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2021|Anticipated|2021-09-01||Interventional|||A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease|A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease|Recruiting||Phase 2|84|Anticipated|University of California, San Francisco||2|||||||t|t|f||||||||2017-10-10 21:13:30.041188|2017-10-10 21:13:30.041188
NCT03095339|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||February 21, 2011|Actual|2011-02-21|March 2017|2017-03-01|January 31, 2015|Actual|2015-01-31|November 24, 2014|Actual|2014-11-24||Interventional|EFECAB||EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso|EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso|Completed||N/A|58|Actual|University of Oklahoma||2|||f||||f|f|f||||||Yes|De-identified data will be made available at the time of publication as per NIH requirements|2017-10-10 21:13:30.309658|2017-10-10 21:13:30.309658
NCT03095326|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-28|||September 1, 2013|Actual|2013-09-01|March 2017|2017-03-01|February 1, 2014|Actual|2014-02-01|February 1, 2014|Actual|2014-02-01||Interventional|||Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia|Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia|Completed||Phase 4|56|Actual|Fakultas Kedokteran Universitas Indonesia||2|||f||||f|f|f||||||No||2017-10-10 21:13:30.45193|2017-10-10 21:13:30.45193
NCT03095313|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-03-24|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 31, 2023|Anticipated|2023-12-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes|18-F Sodium Fluoride (18F-NaF) Positron Emission Tomography (PET) for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes|Not yet recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center||1|||f||||f|t|t|f||f|||No||2017-10-10 21:13:30.589856|2017-10-10 21:13:30.589856
NCT03095300|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-23|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|Optiprone||Prone Positioning During High Flow Oxygen Therapy in Acute Hypoxemic Respiratory Failure|Prone Positioning During High Flow Oxygen Therapy in Patients With Acute Hypoxemic Respiratory Failure: a Pilot Physiological Trial|Not yet recruiting||N/A|15|Anticipated|Catholic University of the Sacred Heart||1|||f||||f|f|f|||f|||Undecided||2017-10-10 21:13:30.712409|2017-10-10 21:13:30.712409
NCT03095274|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-08-23|||April 11, 2017|Actual|2017-04-11|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|DUNE||Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin|A Phase II Study of Durvalumab (MEDI4736) Plus Tremelimumab for the Treatment of Patients With Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin (the DUNE Trial)|Recruiting||Phase 2|126|Anticipated|Grupo Espanol de Tumores Neuroendocrinos||2|||f||||f|f|f||||||||2017-10-10 21:13:30.96121|2017-10-10 21:13:30.96121
NCT03095261|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-03-23|||September 2016||2016-09-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Incentives in Cardiac Rehabilitation|A Web-based Exercise Intervention With Financial Incentives for Cardiac Rehabilitation Graduates: A One Year Crossover Study Design|Recruiting||N/A|100|Anticipated|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 21:13:31.156167|2017-10-10 21:13:31.156167
NCT03095248|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-09|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|SEL-TH-1601||Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors|Phase 2 Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors|Recruiting||Phase 2|34|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t|t|f||||||No||2017-10-10 21:13:31.27241|2017-10-10 21:13:31.27241
NCT03095235|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-04|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Dietary Riboflavin (Vitamin B-2) and Cornea Cross-Linking|Dietary Riboflavin (Vitamin B-2) and Cornea Cross-Linking|Recruiting||N/A|24|Anticipated|University of Missouri-Columbia||1|||f||||f|f|f||||||||2017-10-10 21:13:31.401813|2017-10-10 21:13:31.401813
NCT03095222|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-08|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|July 1, 2018|Anticipated|2018-07-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury|Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury|Recruiting||Phase 4|20|Anticipated|University of Kansas Medical Center||2|||f||||f|t|f|||f|||||2017-10-10 21:13:31.516812|2017-10-10 21:13:31.516812
NCT03095209|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-06|||February 24, 2017|Actual|2017-02-24|March 2017|2017-03-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery|Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery|Recruiting||N/A|40|Anticipated|Fox Chase Cancer Center|||1||f||||t|t|f|||f|||No||2017-10-10 21:13:31.613546|2017-10-10 21:13:31.613546
NCT03095196|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-24|||September 1, 2012|Actual|2012-09-01|April 2017|2017-04-01|September 1, 2015|Actual|2015-09-01|September 1, 2014|Actual|2014-09-01||Observational|||Multipolar CRT-d and Diabetes|Multipolar Pacing by Cardiac Resynchronization Therapy With a Defibrillator as Treatment in Type 2 Diabetes Mellitus Failing Heart Patients: Impact on Responders Rate, and Clinical Outcomes.|Completed||N/A|190|Actual|"University of Campania Luigi Vanvitelli"|||2||f||||t|t|t|f|f|f|||No||2017-10-10 21:13:31.723898|2017-10-10 21:13:31.723898
NCT03095183|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-23|||August 24, 2016|Actual|2016-08-24|March 2017|2017-03-01|February 21, 2017|Actual|2017-02-21|February 21, 2017|Actual|2017-02-21||Interventional|||Do Traditional or Flavored Tongue Depressors Make for Easier Posterior Oropharynx Exams in Pediatric Patients|Do Traditional or Flavored Tongue Depressors Make for Easier Posterior|Completed||N/A|96|Actual|Brooke Army Medical Center||2|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:13:31.811229|2017-10-10 21:13:31.811229
NCT03095170|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-14|||March 23, 2017|Actual|2017-03-23|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|PEACEOFMND||Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder|Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder|Recruiting||N/A|150|Anticipated|University of Florida||3|||f||||f|f|f||||||||2017-10-10 21:13:31.902742|2017-10-10 21:13:31.902742
NCT03095157|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-23||||||March 2017|2017-03-01||||July 1, 2019|Anticipated|2019-07-01||Interventional|||The Emerging Role of Resolvins in the Prevention of Chronic Pain After Thoracic Surgery|The Emerging Role of Resolvins in the Prevention of Chronic Pain After Thoracic Surgery|Not yet recruiting||N/A|80|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:13:32.011473|2017-10-10 21:13:32.011473
NCT03095144|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-03-28|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Spinal Anesthesia and General Anesthesia for Pyloromyotomy - Surgical Outcomes a Comparison Retrospective Study|A Retrospective Comparative Study, Post Operative Outcomes of Pyloromyotomy Procedure Under Spinal Anesthesia Compared to General Anesthesia|Not yet recruiting||N/A|100|Anticipated|Bnai Zion Medical Center|||2||f||||t|f|t|f|f|f|||Undecided||2017-10-10 21:13:32.076952|2017-10-10 21:13:32.076952
NCT03095131|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-23|||February 22, 2016|Actual|2016-02-22|March 2017|2017-03-01|December 7, 2016|Actual|2016-12-07|June 23, 2016|Actual|2016-06-23||Interventional|||Assessment of the Clinical Efficacy of the Heart Spectrum Blood Pressure Monitor for Diagnosis of Atrial Fibrillation|Assessment of the Clinical Efficacy of the Heart Spectrum Blood Pressure Monitor for Diagnosis of Atrial Fibrillation: An Unblinded Clinical Trial|Completed||N/A|62|Actual|Ostar Meditech Corp||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:13:32.184094|2017-10-10 21:13:32.184094
NCT03095105|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-29|||January 24, 2006|Actual|2006-01-24|March 2017|2017-03-01|March 2, 2006|Actual|2006-03-02|March 2, 2006|Actual|2006-03-02||Interventional|||Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects|An Open-label, Parallel-group Study to Compare the Pharmacokinetic Profile in Healthy Elderly Subjects Versus Healthy Young Subjects After Single and Repeated Oral Administration of BIA 6-512 (Trans-resveratrol)|Completed||Phase 1|25|Actual|Bial - Portela C S.A.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:32.354067|2017-10-10 21:13:32.354067
NCT03095092|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||May 23, 2005|Actual|2005-05-23|March 2017|2017-03-01|July 7, 2005|Actual|2005-07-07|July 7, 2005|Actual|2005-07-07||Interventional|||Effect of Food on BIA 6-512 (Trans-resveratrol)|The Effect of Food on the Pharmacokinetics of a Single 400 mg Oral Dose of BIA 6-512 (Trans-resveratrol) in Healthy Subjects|Completed||Phase 1|24|Actual|Bial - Portela C S.A.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:32.466893|2017-10-10 21:13:32.466893
NCT03095079|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||October 2016||2016-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma|a Phase II Trial With Continuous Intravenous Infusion of Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma|Recruiting||Phase 2|70|Anticipated|Beijing Cancer Hospital||1|||f||||f||||||||||2017-10-10 21:13:32.573843|2017-10-10 21:13:32.573843
NCT03095066|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-22|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury (TBI).|Recruiting||Phase 2|150|Anticipated|Avanir Pharmaceuticals||2|||f||||t|t|f||||||||2017-10-10 21:13:32.699013|2017-10-10 21:13:32.699013
NCT03095053|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-10-04|||March 23, 2017|Actual|2017-03-23|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||CCS Versus Blastocyst Morphology Selection|Conventional Blastocyst Morphology Versus Comprehensive Chromosome Screening Selection: a Randomized Control Superiority Trial|Recruiting||N/A|150|Anticipated|Antalya IVF||2|||f||||f|f|f||||||||2017-10-10 21:13:32.894236|2017-10-10 21:13:32.894236
NCT03095040|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|November 2019|Anticipated|2019-11-01||Interventional|||CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma|The Efficacy and Safety of CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma: a Randomized, Double-blind, Double Dummy, Multicenter Study|Not yet recruiting||Phase 2/Phase 3|390|Anticipated|AnewPharma||3|||f||||f|f|f||||||No||2017-10-10 21:13:32.994515|2017-10-10 21:13:32.994515
NCT03095027|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-08-25|||April 19, 2017||2017-04-19||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:13:33.074755|2017-10-10 21:13:33.074755
NCT03095001|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-11|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion|Chinese PLA Generation Hospital|Recruiting||Phase 2|70|Anticipated|Chinese PLA General Hospital||2|||f||||t|t|f|||t|||Yes||2017-10-10 21:13:33.28619|2017-10-10 21:13:33.28619
NCT03094988|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-01|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||COgnitive and Physical Exercise (COPE) Prehabilitation Pilot Feasibility Study|COgnitive and Physical Exercise (COPE) Prehabilitation to Improve Outcomes in Surgical Patients: A Pilot Feasibility Study|Recruiting||N/A|30|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:13:33.403124|2017-10-10 21:13:33.403124
NCT03094975|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-04-07|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Observational|||A Multicenter Registry Study of Aneurysmal SAH|A Multicenter Registry Study of Aneurysmal Subarachnoid Hemorrhage|Not yet recruiting||N/A|2000|Anticipated|Changhai Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:13:33.502871|2017-10-10 21:13:33.502871
NCT03094962|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-22|||January 21, 2015|Actual|2015-01-21|March 2017|2017-03-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||Development of a Musculoskeletal Model of the PIP Joint|Development of Parametric Musculoskeletal Models to Investigate the Anatomy and the Function of the PIP|Recruiting||N/A|10|Anticipated|University of Southampton||1|||f||||f|f|f||||||No||2017-10-10 21:13:33.584546|2017-10-10 21:13:33.584546
NCT03094949|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-23|||July 1, 2008|Actual|2008-07-01|March 2017|2017-03-01|September 1, 2017|Anticipated|2017-09-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||Comparison Between Partial Nephrectomy and Ablation for Renal Tumor|Comparison Between Laparoscopic Partial Nephrectomy and Ultrasound Guided Percutaneous Microwave Ablation for T1a Renal Tumor|Recruiting||N/A|200|Anticipated|Chinese PLA General Hospital||2|||f||||t|f|f||||||Yes||2017-10-10 21:13:33.675991|2017-10-10 21:13:33.675991
NCT03094936|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-03-22|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Trial for Weight Regain Post-RYGB: APC Versus APC Plus Endoscopic Suture Technique|Randomized Clinical Trial for Weight Regain Post-RYGB:Argon Plasma Coagulation Versus Argon Plasma Coagulation Plus Endoscopic Suture Technique|Recruiting||N/A|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|t|f|f|t|||No||2017-10-10 21:13:33.768893|2017-10-10 21:13:33.768893
NCT03094923|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||January 12, 2010|Actual|2010-01-12|March 2017|2017-03-01|January 18, 2014|Actual|2014-01-18|March 17, 2011|Actual|2011-03-17||Interventional|||Effects of Respiratory Muscle Training on Postoperative Pulmonary Complications of Cardiac Surgery|Effects of Preoperative Inspiratory Muscle Training on Functional Capacity and Pulmonary Complications in Coronary Artery Bypass Graft Surgery|Completed||N/A|32|Actual|University of the State of Santa Catarina||2|||f||||t|f|f||||||No||2017-10-10 21:13:33.87985|2017-10-10 21:13:33.87985
NCT03094910|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-23|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|RaynAUT||Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon|RaynAUT - Thermography and the Autonomic Nervous System in Raynaud's Phenomenon - Investigation of the Autonomic Nervous System in Patients With Raynaud's Phenomenon, Glaucoma, and Autonomic Neuropathy.|Recruiting||N/A|160|Anticipated|Herlev Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:13:33.950467|2017-10-10 21:13:33.950467
NCT03094897|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-11|||April 20, 2017|Anticipated|2017-04-20|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics|Phase 1 Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics|Not yet recruiting||Early Phase 1|30|Anticipated|Wuxi No. 4 People's Hospital||1|||f||||t|t|t|f|f|f|||No||2017-10-10 21:13:34.056036|2017-10-10 21:13:34.056036
NCT03094884|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-06-06|||February 24, 2017|Actual|2017-02-24|June 2017|2017-06-01|November 1, 2021|Anticipated|2021-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer|Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer|Recruiting||Phase 1|40|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|f|||f|||No||2017-10-10 21:13:34.149069|2017-10-10 21:13:34.149069
NCT03094871|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||FACE-PC: Family-Centered Care for Older Adults With Depression and Chronic Medical Conditions in Primary Care|FACE-PC: Family-Centered Care for Older Adults With Depression and Chronic Medical Conditions in Primary Care|Recruiting||N/A|60|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:34.242222|2017-10-10 21:13:34.242222
NCT03094858|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-26|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|SMARTpath||Evaluation of a Smartphone Intervention to Reduce Sedentary Behavior|Evaluation of a Smartphone Intervention to Reduce Sedentary Behavior|Not yet recruiting||N/A|300|Anticipated|University of Oklahoma||2|||f||||f|f|f||||||||2017-10-10 21:13:34.330077|2017-10-10 21:13:34.330077
NCT03094845|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-23|||September 28, 2016|Actual|2016-09-28|March 2017|2017-03-01|January 23, 2017|Actual|2017-01-23|January 12, 2017|Actual|2017-01-12||Interventional|||Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients|Assessment of Safety and Clinical Tolerability of hdmASIT+TM Administered Subcutaneously in House Dust Mite-induced Allergic Rhinoconjunctivitis Patients|Completed||Phase 2|36|Actual|ASIT Biotech S.A.||2|||f|||||f|f||||||||2017-10-10 21:13:34.418871|2017-10-10 21:13:34.418871
NCT03094819|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-06-19|||March 2016||2016-03-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||PROTECT2: Diabetes Care - Eye Exam|PROTECT2: Diabetes Care - Eye Exam|Recruiting||N/A|4500|Anticipated|University of Oklahoma||3|||f||||f||||||||No||2017-10-10 21:13:34.607736|2017-10-10 21:13:34.607736
NCT03094806|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-03-23|||October 2013||2013-10-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPD|Vibratory/Positive Expiratory Pressure Device and Hospital Length of Stay for Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Completed||N/A|91|Actual|New York Methodist Hospital||2|||f||||f||||||||||2017-10-10 21:13:34.69749|2017-10-10 21:13:34.69749
NCT03094793|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-03-28|||May 2015||2015-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|COGNIT-AIC||Impact of Interictal Electroencephalographic Abnormalities on the Stability of Attention in the Epilepsies|Impact of Interictal Electroencephalographic Abnormalities on the Stability of Attention in the Epilepsies in Adults and Children|Recruiting||N/A|900|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 21:13:34.784736|2017-10-10 21:13:34.784736
NCT03094780|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-03-23|||July 2016||2016-07-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Quality of Life Intervention for Patients Receiving Radiation Therapy for Advanced Cancer Treatment and Their Caregivers|A Structured Multidisciplinary Quality of Life Intervention for Patients Receiving Radiation Therapy for Advanced Cancer Treatment & Their Caregivers: A Telemedicine Project|Recruiting||N/A|80|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 21:13:34.872697|2017-10-10 21:13:34.872697
NCT03094767|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-03-22|||October 2016||2016-10-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation Program|Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation Program|Recruiting||N/A|60|Anticipated|União Educacional do Norte||2|||f||||f||||||||Undecided||2017-10-10 21:13:34.973025|2017-10-10 21:13:34.973025
NCT03094754|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-28|||March 13, 2017|Actual|2017-03-13|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Excision Size and Location on the Postoperative Pain After Nevi Excision in Children|Effect of Excised Surface Area/Body Surface Area Ratio and Location of Excision on the Postoperative Pain After Nevi Excision in Children: Observational Study|Recruiting||N/A|100|Anticipated|Ajou University School of Medicine|||1||f|||||f|f||||||||2017-10-10 21:13:35.080679|2017-10-10 21:13:35.080679
NCT03094741|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-04|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of a Mobile Digital Solution for Cancer Care and Research|Evaluation of a Mobile Digital Solution for Cancer Care and Research: A Feasibility Study|Recruiting||N/A|30|Anticipated|John Wayne Cancer Institute||1|||f||||f|f|f||||||No||2017-10-10 21:13:35.153569|2017-10-10 21:13:35.153569
NCT03094728|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-23|||January 1, 2015|Actual|2015-01-01|March 2017|2017-03-01|June 1, 2016|Actual|2016-06-01|January 1, 2016|Actual|2016-01-01||Observational|||Role of Human Leukocyte Antigen Matching in Liver Transplantation and Its Relation to Outcomes|Role of Human Leukocyte Antigen Matching in Liver Transplantation and Its Relation to Outcomes|Completed||N/A|24|Actual|Ain Shams University|||1||f||||t|f|f||||||Undecided||2017-10-10 21:13:35.244727|2017-10-10 21:13:35.244727
NCT03094715|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-22|||October 1, 2017|Anticipated|2017-10-01|March 2017|2017-03-01|March 31, 2021|Anticipated|2021-03-31|October 31, 2020|Anticipated|2020-10-31||Interventional|Tension||Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window|Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window: a Randomized, Controlled Trial|Not yet recruiting||N/A|714|Anticipated|University Hospital Heidelberg||2|||f||||t|f|t|f|f|t|||Undecided||2017-10-10 21:13:35.346158|2017-10-10 21:13:35.346158
NCT03094702|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-25|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||SPRINT Trial Type Blood Pressure Measurements in Patients After Kidney Transplantation|Influence of SPRINT Trial Type Blood Pressure Measurements on Hypertension Diagnosis in Patients After Kidney Transplantation|Recruiting||N/A|150|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||1||f||||f|f|f||||||Undecided||2017-10-10 21:13:35.461825|2017-10-10 21:13:35.461825
NCT03094689|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-04-27|||January 2017||2017-01-01|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Cold Water Immersion in the Recovery of Markers of Muscle Damage of 10km Street Runners|Cold Water Immersion in the Recovery of Clinical, Biochemical, Functional and Neuromuscular Markers of Muscle Damage of 10km Street Runners: Clinical, Randomized and Blinded Trial|Active, not recruiting||N/A|30|Actual|Universidade Federal do Rio Grande do Norte||3|||f||||||||||||||2017-10-10 21:13:35.55087|2017-10-10 21:13:35.55087
NCT03094676|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-28|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|February 28, 2018|Anticipated|2018-02-28|August 30, 2017|Anticipated|2017-08-30||Interventional|||Effects of Massage in Different Moments of Application on Autonomic Cardiac Modulation and Cardiorespiratory Parameters|Effects of Massage as a Recuperative Technique in Different Moments of Application on Autonomic Cardiac Modulation and Cardiorespiratory Parameters|Recruiting||N/A|40|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||5|||f||||f|f|f||||||No||2017-10-10 21:13:35.622431|2017-10-10 21:13:35.622431
NCT03094663|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-23|||February 28, 2017|Actual|2017-02-28|March 2017|2017-03-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|IPACK||Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)|Analgesia After Total Knee Arthroplasty: Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI). A Double-Blinded Randomized Controlled Trial|Recruiting||N/A|86|Anticipated|Hospital for Special Surgery, New York||2|||f||||t|f|f||||||No||2017-10-10 21:13:35.709952|2017-10-10 21:13:35.709952
NCT03094650|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-23|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Immersive Virtual Reality for Stroke Motor Rehabilitation|The Use of Immersive Virtual Reality for Upper Limb Neurorehabilitation in Stroke Survivors|Completed||N/A|10|Actual|Mindmaze SA||1|||f|||||f|f||||||||2017-10-10 21:13:35.822375|2017-10-10 21:13:35.822375
NCT03094637|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Azacitidine and Pembrolizumab for Patients With Myelodysplastic Syndrome (MDS)|A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients With Myelodysplastic Syndrome (MDS)|Not yet recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:13:35.900023|2017-10-10 21:13:35.900023
NCT03094624|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-04|||January 13, 2013|Actual|2013-01-13|September 2017|2017-09-01|July 13, 2018|Anticipated|2018-07-13|June 13, 2018|Anticipated|2018-06-13||Interventional|||Auditory Deficits in Congenital Amusia (AMUSIE CONGENITALE)|Auditory Perceptual and Memory Deficits in Congenital Amusia: Studies of Cerebral Correlates With MEG, Anatomical MRI and Functional MRI|Recruiting||N/A|280|Anticipated|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 21:13:36.012705|2017-10-10 21:13:36.012705
NCT03094611|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Interventional|||Study of Low Dose Inotuzumab Ozogamicin in Patients With Relapsed and Refractory CD22 Positive Acute Lymphocytic Leukemia|Phase II Study of Low Dose Inotuzumab Ozogamicin in Patients With Relapsed and Refractory CD22 Positive Acute Lymphocytic Leukemia|Not yet recruiting||Phase 2|48|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:13:36.108889|2017-10-10 21:13:36.108889
NCT03094598|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-03-23|||October 1996||1996-10-01|March 2017|2017-03-01|December 1996|Actual|1996-12-01|December 1996|Actual|1996-12-01||Interventional|INFO-I||Outpatients' Knowledge About and Attitude Toward Randomised Clinical Trials|The INFO-I Trial: A Randomised Trial Assessing the Impact of Written Information on Outpatients' Knowledge About and Attitude Toward Randomised Clinical Trials|Completed||N/A|428|Actual|Copenhagen Trial Unit, Center for Clinical Intervention Research||4|||f||||f||||||||No|No plan for data sharing|2017-10-10 21:13:36.193449|2017-10-10 21:13:36.193449
NCT03094585|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-03-23|||September 1997||1997-09-01|March 2017|2017-03-01||||September 1997|Actual|1997-09-01||Interventional|INFO-II||The INFO-II Trial: Nurses Knowledge About and Attitude Towards Clinical Trials|Nurses Knowledge About and Attitude Towards Clinical Trials. A Randomised Trial|Completed||N/A|||Copenhagen Trial Unit, Center for Clinical Intervention Research||3|||f||||f||||||||No|No plan for data sharing|2017-10-10 21:13:36.277472|2017-10-10 21:13:36.277472
NCT03094572|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-21|||July 13, 2017|Actual|2017-07-13|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluation of the Visual Motor Task's Impact on the Behavior of a Neuronal and Spinal Network in Hemiplegic Patients|Evaluation of the Visual Motor Task's Impact on the Behavior of a Neuronal and Spinal Network in Hemiplegic Patients|Recruiting||N/A|64|Anticipated|Centre d'Investigation Clinique et Technologique 805||7|||f||||f|f|f||||||||2017-10-10 21:13:36.357098|2017-10-10 21:13:36.357098
NCT03094559|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-12|||March 7, 2017|Actual|2017-03-07|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI)|Correlation Between FlowMet™, ABI, SPP, TBI, TcPO2 and Angiography|Withdrawn||N/A|0|Actual|The Cleveland Clinic||1||Investigator leaving institution|f||||t|f|f||||||No|No plan to share IPD|2017-10-10 21:13:36.448812|2017-10-10 21:13:36.448812
NCT03094546|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-29|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|SmartAge||Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline|Effect of Polyamine-enriched Dietary Supplementation on Cognitive Function and Biomarkers in Elderly Individuals With Subjective Cognitive Decline|Recruiting||Phase 2|100|Anticipated|Charite University, Berlin, Germany||2|||f||||t|f|f||||||Undecided||2017-10-10 21:13:36.540297|2017-10-10 21:13:36.540297
NCT03094533|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-18|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|November 30, 2018|Anticipated|2018-11-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||TIVA and VIMA on Blood Glucose and Insulin Levels in Lung Lobectomy Patients|The Effect of Total Intravenous Anesthesia and Volatile Induction and Maintenance Anesthesia on Perioperative Blood Glucose and Insulin Levels in Patients Undergoing Lung Lobectomy|Recruiting||N/A|60|Anticipated|Yeungnam University College of Medicine||2|||f||||t|f|f||||||Yes||2017-10-10 21:13:36.841018|2017-10-10 21:13:36.841018
NCT03094520|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-29|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|GEST||Cognitive Embodiment Activation by tDCS|Effects of Transcranial Direct Current Stimulation (tDCS) on Gestural-verbal Brain Associations: the Role of Cognitive Embodiment|Recruiting||N/A|24|Anticipated|Charite University, Berlin, Germany||2|||f|||||f|f||||||||2017-10-10 21:13:37.01814|2017-10-10 21:13:37.01814
NCT03094507|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-28|||April 19, 2017|Actual|2017-04-19|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|SSAT073||The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers|The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers|Recruiting||Phase 1|20|Anticipated|St Stephens Aids Trust||2|||f||||f|f|f||||||Yes|Only authorised representatives of the sponsor (such as monitors and auditors) and individuals who are authorised on the signature and delegation log will have access to the participants' personal data. This could typically be: doctors, nurses, pharmacists, laboratory staff and data manager within the Trust/Care organisation. It is also possible that the regulatory authorities may wish to access this data. The access given to participants' data is explained in the participant information sheet, so consent will have been given to these individuals outside the care organisation.|2017-10-10 21:13:37.158297|2017-10-10 21:13:37.158297
NCT03094494|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-28|||November 1, 2012|Actual|2012-11-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections|Double Carbapenem as Rescue Strategy for the Treatment of Severe Carbapenemase-Producing Klebsiella Pneumoniae Infections: A Two-Center Matched Case-Control Study|Completed||N/A|144|Actual|Policlinico Universitario Agostino Gemelli|||2||f||||f|f|f||||||Yes||2017-10-10 21:13:37.296004|2017-10-10 21:13:37.296004
NCT03094481|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-28|||October 21, 2016|Actual|2016-10-21|March 2017|2017-03-01|March 1, 2019|Anticipated|2019-03-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Interscalene vs. Superficial Cervical Block vs. Combination for Analgesia After Clavicle Fracture|Comparison of Interscalene vs. Superficial Cervical Block vs. Combination of Both Blocks for Analgesia After Operative Repair of Midshaft and Lateral Clavicle Fractures|Recruiting||N/A|120|Anticipated|Sunnybrook Health Sciences Centre||6|||f||||f|f|f||||||No||2017-10-10 21:13:37.387765|2017-10-10 21:13:37.387765
NCT03094468|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-23|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis|A Multicenter, Randomized, Double-blind, Parallel, Vehicle-controlled Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Onychomycosis|Not yet recruiting||Phase 3|840|Anticipated|Polichem S.A.||2|||f||||f|t|f||||||Undecided||2017-10-10 21:13:37.542537|2017-10-10 21:13:37.542537
NCT03094455|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-07-26|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|April 29, 2018|Anticipated|2018-04-29|November 29, 2017|Anticipated|2017-11-29||Interventional|Tele-UPCAT||AOT and ICT for Hemiplegia|Action-Observation Therapy (AOT) and Information and Communications Technologies (ICT) for Home Rehabilitation of Hemiplegia|Recruiting||N/A|20|Anticipated|IRCCS Fondazione Stella Maris||2|||f||||t|f|f||||||||2017-10-10 21:13:37.638204|2017-10-10 21:13:37.638204
NCT03094442|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-10|||December 2016||2016-12-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?|Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?|Recruiting||N/A|54|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No||2017-10-10 21:13:37.769289|2017-10-10 21:13:37.769289
NCT03094429|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-04-06|||March 29, 2017|Actual|2017-03-29|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults|An Adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®,a D-Amino Acid Oxidase Inhibitor, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults|Recruiting||Phase 2/Phase 3|287|Anticipated|SyneuRx International (Taiwan) Corp||3|||f||||t|t|f||||||||2017-10-10 21:13:37.909102|2017-10-10 21:13:37.909102
NCT03094416|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-06-16|||April 21, 2017|Actual|2017-04-21|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors|An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors|Recruiting||Phase 4|60|Anticipated|IBSA Institut Biochimique SA||1|||f||||f|t|f|||f|||No||2017-10-10 21:13:38.051843|2017-10-10 21:13:38.051843
NCT03094403|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-03|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|March 31, 2017|Actual|2017-03-31||Interventional|||To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel|A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Azeliac Acid Gel and Active Treatments to a Placebo Control in the Treatment of Moderate Facial Rosacea.|Completed||Phase 1|1000|Actual|Taro Pharmaceuticals USA||3|||f||||f|t|f|||t|||No||2017-10-10 21:13:38.168727|2017-10-10 21:13:38.168727
NCT03094390|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-07|||April 4, 2017|Actual|2017-04-04|July 2017|2017-07-01|November 15, 2017|Anticipated|2017-11-15|October 31, 2017|Anticipated|2017-10-31||Observational|||Total Thoracic Fluid Content in Prediction of Failure of Weaning From Mechanical Ventilation|The Impact of Total Thoracic Fluid Content Measured by Cardiometry on Prediction of Failure of Weaning From Mechanical Ventilation|Recruiting||N/A|32|Anticipated|Cairo University|||1||f||||f|f|f||||||||2017-10-10 21:13:38.285331|2017-10-10 21:13:38.285331
NCT03094377|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-23|||March 1, 2015|Actual|2015-03-01|March 2017|2017-03-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Effect of Multisensory Stimulation on Upper Extremity Motor Recovery in Stroke Patient: a Preliminary Testing||Completed||N/A|12|Actual|Tung Wah College||2|||f||||t|f|f||||||Yes|Share all the available data as requested|2017-10-10 21:13:38.385185|2017-10-10 21:13:38.385185
NCT03094364|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-08|||November 2015||2015-11-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis|Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis|Recruiting||N/A|36|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-10 21:13:38.495697|2017-10-10 21:13:38.495697
NCT03094351|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-29|||July 29, 2017|Actual|2017-07-29|July 2017|2017-07-01|December 1, 2024|Anticipated|2024-12-01|December 1, 2024|Anticipated|2024-12-01||Interventional|RATLE vs CTLE||Robot Assisted Thoraco-Laparoscopic Esophagectomy Versus Conventional Thoraco-Laparoscopic Esophagectomy|Robot Assisted Thoraco-laparoscopic Esophagectomy Versus Conventional Thoraco-laparoscopic Esophagectomy for Patients With Squamous Cell Esophageal Cancer: a Multicenter Open-label, Randomized Controlled Trial|Recruiting||Phase 3|300|Anticipated|Shanghai Chest Hospital||2|||f||||f|f|f||||||||2017-10-10 21:13:38.595809|2017-10-10 21:13:38.595809
NCT03094338|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-23|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|July 1, 2017|Anticipated|2017-07-01||Observational|||A Stress Survey in Nurse Anesthetist Students|A Stress Survey in Nurse Anesthetist Students|Enrolling by invitation||N/A|30|Anticipated|Siriraj Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:13:38.738656|2017-10-10 21:13:38.738656
NCT03094325|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-08-09|||March 23, 2017|Actual|2017-03-23|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|OPIE||On-pump Intraoperative Echocardiography|On-pump Intraoperative Echocardiography (OPIE)|Enrolling by invitation||N/A|10|Anticipated|New York University School of Medicine||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:13:38.832446|2017-10-10 21:13:38.832446
NCT03094312|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-06-26|||June 23, 2017|Actual|2017-06-23|June 2017|2017-06-01|January 23, 2022|Anticipated|2022-01-23|January 23, 2022|Anticipated|2022-01-23||Interventional|ISD SEEG||Evaluation of the Risk of Cognitive Deficit After Surgery of Epilepsy by Dynamic Spectral Imaging (ISD) of the Cognitive Functions in Patients Explored in StereoElectroEncephaloGraphy (SEEG)|Evaluation of the Risk of Cognitive Deficit After Surgery of Epilepsy by Dynamic Spectral Imaging (ISD) of the Cognitive Functions in Patients Explored in StereoElectroEncephaloGraphy (SEEG)|Recruiting||N/A|90|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||No||2017-10-10 21:13:38.92955|2017-10-10 21:13:38.92955
NCT03094299|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-23|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Diaphragm Ultrasound in Weaning From Mechanical Ventilation|The Efficacy of Ultrasound Assessment of Diaphragmatic Function in Guiding Weaning From Mechanical Ventilation in Critically Ill Patients With Abdominal Sepsis|Recruiting||N/A|30|Anticipated|Cairo University|||1||f|||||f|f||||||||2017-10-10 21:13:39.042239|2017-10-10 21:13:39.042239
NCT03094286|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-25|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Durvalumab in Solid Tumors|A PHASE II EXPLORATORY STUDY OF DURVALUMAB (MEDI4736) IN HIV-1 PATIENTS WITH ADVANCED SOLID TUMORS|Recruiting||Phase 2|20|Anticipated|Spanish Lung Cancer Group||1|||f||||t|f|f||||||No||2017-10-10 21:13:39.146822|2017-10-10 21:13:39.146822
NCT03094260|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Light Therapy and Binge Eating Disorder Treatment (BED Light Study)|Interest of Light Therapy in the Treatment of Binge Eating Disorder: Prospective Controlled Randomized Double-blind Trial|Not yet recruiting||N/A|56|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:13:39.406601|2017-10-10 21:13:39.406601
NCT03094247|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Feeding Malnourished Children Different Types of Fatty Acids to Promote Neurocognitive Development|Improved Polyunsaturated Ready-to-use Therapeutic Food for Improved Neurocognitive Outcomes in Severe Acute Malnutrition|Not yet recruiting||N/A|3700|Anticipated|Washington University School of Medicine||3|||f||||f|f|f||||||Undecided||2017-10-10 21:13:39.572087|2017-10-10 21:13:39.572087
NCT03094234|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-01|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|March 28, 2020|Anticipated|2020-03-28|March 28, 2019|Anticipated|2019-03-28||Interventional|||8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding in Patients With Child A Cirrhosis|8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding in Patients With Child A Cirrhosis|Recruiting||N/A|72|Anticipated|West China Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:13:39.703914|2017-10-10 21:13:39.703914
NCT03094221|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-03-23|||January 13, 2015|Actual|2015-01-13|March 2017|2017-03-01|December 1, 2015|Actual|2015-12-01|December 1, 2015|Actual|2015-12-01||Observational|||Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias|Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias|Completed||N/A|20|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-10 21:13:39.83703|2017-10-10 21:13:39.83703
NCT03094208|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-22|||June 16, 2017|Anticipated|2017-06-16|March 2017|2017-03-01|August 15, 2018|Anticipated|2018-08-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||The Effects of Dual Task Balance Training In Individuals With Above Knee Amputation|Investigation of the Effects of Dual Task Balance Training In Indıvıduals With Above Knee Amputation|Not yet recruiting||N/A|20|Anticipated|Hacettepe University||2|||f|||||f|f||||||Undecided||2017-10-10 21:13:39.937177|2017-10-10 21:13:39.937177
NCT03094195|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-26|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|November 29, 2018|Anticipated|2018-11-29|November 29, 2018|Anticipated|2018-11-29||Interventional|EMPHENE||Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)|A Double-blind, Placebo-controlled, Randomized Dose Ranging Trial to Determine the Safety and Efficacy of Three Dose Levels of EMA401 in Reducing 24-hour Average Pain Intensity Score in Patients With Post-herpetic Neuralgia|Recruiting||Phase 2|360|Anticipated|Novartis||4|||f||||t|t|f||||||||2017-10-10 21:13:40.054518|2017-10-10 21:13:40.054518
NCT03094182|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy of Intravenous Iron Therapy in Maintaining Hemoglobin Concentration on Patients Undergoing Bimaxillary Orthognathic Surgery|Efficacy of Intravenous Iron Therapy in Maintaining Hemoglobin Concentration on Patients Undergoing Bimaxillary Orthognathic Surgery|Recruiting||N/A|58|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:13:40.187925|2017-10-10 21:13:40.187925
NCT03094169|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-05-18|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|August 1, 2019|Anticipated|2019-08-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||AVID100 in Advanced Epithelial Carcinomas|Phase 1a/2a Dose Escalation Trial to Determine Safety, Tolerance, MTD, and Preliminary Antineoplastic Activity of AVID100, in Patients With Advanced or Metastatic Solid Tumors of Epithelial Origin|Recruiting||Phase 1|30|Anticipated|Formation Biologics||1|||f||||f|t|f||||||No||2017-10-10 21:13:40.30598|2017-10-10 21:13:40.30598
NCT03094156|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-29|||April 26, 2006|Actual|2006-04-26|March 2017|2017-03-01|July 11, 2006|Actual|2006-07-11|July 11, 2006|Actual|2006-07-11||Interventional|||Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics|A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study in Healthy Volunteers to Investigate the Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics When Administered in Combination With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Entacapone 200 mg|Completed||Phase 1|39|Actual|Bial - Portela C S.A.||5|||f||||f|f|f||||||Undecided||2017-10-10 21:13:40.40181|2017-10-10 21:13:40.40181
NCT03094143|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-08-08|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|EVoLVeD||Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS|Early Valve Replacement Guided by Biomarkers of Left Ventricular Decompensation in Asymptomatic Patients With Severe Aortic Stenosis|Recruiting||N/A|1000|Anticipated|University of Edinburgh||4|||f||||f|f|f||||||||2017-10-10 21:13:40.530891|2017-10-10 21:13:40.530891
NCT03094130|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin by French-speaking Population|Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin: A Randomized Controlled Trial Among French-speaking Population|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:40.63181|2017-10-10 21:13:40.63181
NCT03094117|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin by French-speaking Patients|Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin: A Randomized Controlled Trial Among French-speaking Patients|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:40.76152|2017-10-10 21:13:40.76152
NCT03094104|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin by English-speaking Population|Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin: A Randomized Controlled Trial Among English-speaking Population|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:41.589964|2017-10-10 21:13:41.589964
NCT03094091|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-15|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin by English-speaking Patients|Interpretation of Health News Items Reporting Results of Phase I/II (Non-randomized) Trials With or Without Spin: A Randomized Controlled Trial Among English-speaking Patients|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:41.713375|2017-10-10 21:13:41.713375
NCT03094078|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-15|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin by English-speaking Patients|Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin: A Randomized Controlled Trial Among English-speaking Patients|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:41.831422|2017-10-10 21:13:41.831422
NCT03094065|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin By French-speaking Patients|Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin: A Randomized Controlled Trial Among French-speaking Patients|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:41.941344|2017-10-10 21:13:41.941344
NCT03094052|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-30|||January 4, 2017|Actual|2017-01-04|March 2017|2017-03-01|December 2, 2020|Anticipated|2020-12-02|December 1, 2018|Anticipated|2018-12-01||Interventional|||Diarrhea Prophylaxis in Patients With HER2+ Breast Cancer Treated With Trastuzumab and Neratinib, Followed by Neratinib Monotherapy|An Open Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early Stage HER2+ Breast Cancer Treated With Adjuvant Trastuzumab and Neratinib Followed by Neratinib Monotherapy, and Intensive Anti-diarrhea Prophylaxis|Recruiting||Phase 2|23|Anticipated|University of California, San Francisco||1|||||||t|t|||||||||2017-10-10 21:13:42.055945|2017-10-10 21:13:42.055945
NCT03094039|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-27|||April 27, 2017|Actual|2017-04-27|March 2017|2017-03-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|INSPIRE-CDH||Initiation of Resuscitation While Attached to the Cord With Congenital Diaphragmatic Hernia|Initiation of Resuscitative Care While on Placental Circulation for Infants With Congenital Diaphragmatic Hernia - a Randomized Pilot Trial|Recruiting||N/A|30|Anticipated|University of Alberta||2|||f||||f|f|f||||||No||2017-10-10 21:13:42.198658|2017-10-10 21:13:42.198658
NCT03094026|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-09-12|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|cTAG||Cognitive Training Intervention and Attitudes Towards Genetics|Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation|Recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 21:13:42.327497|2017-10-10 21:13:42.327497
NCT03094013|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-15|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|August 1, 2019|Anticipated|2019-08-01|March 31, 2019|Anticipated|2019-03-31||Observational|||Psychosocial Factors of Burn Related Injuries and Perceived Gaps in Service Delivery|Psychosocial Factors of Burn Related Injuries and Perceived Gaps in Service Delivery During the Rehabilitation Period: A Mixed Methods Study|Recruiting||N/A|300|Anticipated|St. Louis University|||1||f||||f|f|f||||||No||2017-10-10 21:13:42.447973|2017-10-10 21:13:42.447973
NCT03094000|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-03-22|||October 1, 2015|Actual|2015-10-01|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Mindfulness Training Effect on Self-monitoring Adherence and Group CBT Outcomes for Binge Eating Disorders|A Randomized Controlled Trial Examining Mindfulness Training Effect on Self-monitoring Adherence and Group Cognitive-behavioral Treatment Outcomes Among Women Suffering From Eating Disorders|Active, not recruiting||N/A|40|Anticipated|Shalvata Mental Health Center||2|||f||||t|f|f||||||No||2017-10-10 21:13:42.705879|2017-10-10 21:13:42.705879
NCT03093987|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-05|||April 10, 2017|Anticipated|2017-04-10|April 2017|2017-04-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Critical Care Ultrasound Oriented Shock Treatment in ICU|Critical Care Ultrasound Oriented Shock Treatment in ICU|Not yet recruiting||N/A|180|Anticipated|West China Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:13:42.839469|2017-10-10 21:13:42.839469
NCT03093974|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-10-02|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|PROMIS-I||Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium|A Double-blind Placebo-controlled Multicentre Clinical Trial to Investigate the Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-CF Bronchiectasis Chronically Infected With P.Aeruginosa|Recruiting||Phase 3|264|Anticipated|Zambon SpA||2|||f||||f|f|f||||||||2017-10-10 21:13:42.958998|2017-10-10 21:13:42.958998
NCT03093961|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-06-12|||March 10, 2017|Actual|2017-03-10|June 2017|2017-06-01|April 2023|Anticipated|2023-04-01|October 2018|Anticipated|2018-10-01||Interventional|||REDUCE LAP-HFREF TRIAL|A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure With Reduced Ejection Fraction|Recruiting||N/A|10|Anticipated|Corvia Medical||1|||f||||f|f|t|t|f||||||2017-10-10 21:13:43.090223|2017-10-10 21:13:43.090223
NCT03093948|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-22|||March 21, 2017|Actual|2017-03-21|April 2017|2017-04-01|September 17, 2020|Anticipated|2020-09-17|March 16, 2020|Anticipated|2020-03-16||Interventional|||Effect of Remote Ischemic Post-conditioning on Out-of-hospital Cardiac Arrest|Effect of Remote Ischemic Post-conditioning on Neurologic and Cardiac Recovery in Out-of-hospital Cardiac Arrest|Recruiting||N/A|118|Anticipated|Chonnam National University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:13:43.210987|2017-10-10 21:13:43.210987
NCT03093935|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-27|||May 10, 2017|Anticipated|2017-05-10|March 2017|2017-03-01|June 20, 2018|Anticipated|2018-06-20|February 15, 2018|Anticipated|2018-02-15||Interventional|PSSP||StimRouter™ for Pain Management in Post-stroke Shoulder Pain|StimRouter™ Neuromodulation System: Implanted Peripheral Nerve Stimulation for Pain Management When Treating Patients With Chronic Post-stroke Shoulder-pain|Not yet recruiting||N/A|50|Anticipated|Bioness Inc||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:13:43.337481|2017-10-10 21:13:43.337481
NCT03093922|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-26|||March 22, 2017|Actual|2017-03-22|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer|Atezolizumab in Combination With Gemcitabine and Cisplatin As First-Line Treatment in Metastatic Urothelial Cancer: A Multicenter Randomized Phase II Study of Two Alternative Dosing Schedules|Recruiting||Phase 2|31|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f||||||||2017-10-10 21:13:43.462907|2017-10-10 21:13:43.462907
NCT03093909|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-10-04|||April 2018|Anticipated|2018-04-01|October 2017|2017-10-01|April 2023|Anticipated|2023-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases|Phase I Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases|Not yet recruiting||Phase 1|44|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:13:43.658703|2017-10-10 21:13:43.658703
NCT03093896|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-03-22|||April 2016||2016-04-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Consumption of Almonds and Snack Mix Daily for 6 Months on Cognitive Function in Older Adults|The Effect of Consumption of Almonds and Snack Mix Daily for 6 Months on Performance on a Battery of Computerized Cognitive Tests (CANTAB) in Older Adults|Recruiting||N/A|72|Anticipated|Tufts University||3|||f||||f||||||||Yes||2017-10-10 21:13:43.823442|2017-10-10 21:13:43.823442
NCT03093883|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-06-29|||April 20, 2017|Actual|2017-04-20|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers|Open-label, Randomized, Crossover-design Bioequivalence Study With Comparing a Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection of Vifor AG in Healthy Male Volunteers|Recruiting||Phase 1|46|Anticipated|Azad Pharma AG||2|||f||||f|f|f||||||No||2017-10-10 21:13:43.978636|2017-10-10 21:13:43.978636
NCT03093870|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-27|||May 24, 2017|Anticipated|2017-05-24|March 2017|2017-03-01|January 21, 2019|Anticipated|2019-01-21|January 21, 2019|Anticipated|2019-01-21||Interventional|TreeTopp||Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy|Not yet recruiting||Phase 2/Phase 3|482|Anticipated|Aslan Pharmaceuticals||2|||f||||t|t|f||||||No||2017-10-10 21:13:44.089494|2017-10-10 21:13:44.089494
NCT03093857|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-28|||June 1, 2014|Actual|2014-06-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|TAAA||Investigation of the Cerebrospinal Fluid and Further Tissue Samples for Biomarker Indicating Spinal Ischemia and Organ Failure in Patients With Thoracoabdominal Aortic Aneurysm|Investigation of the Cerebrospinal Fluid and Further Tissue Samples for Biomarker Indicating Spinal Ischemia and Organ Failure in Patients With Thoracoabdominal Aortic Aneurysm|Recruiting||N/A|100|Anticipated|RWTH Aachen University|||1||f||||f|f|f||||||Undecided||2017-10-10 21:13:44.252135|2017-10-10 21:13:44.252135
NCT03093844|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders|Safety and Efficacy of Miltenyi CliniMACS® CD34 Reagent System for Transplant Protocol Utilizing Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders|Not yet recruiting||N/A|50|Anticipated|University of Colorado, Denver||1|||f||||t|f|t|f|f||||||2017-10-10 21:13:44.348796|2017-10-10 21:13:44.348796
NCT03093831|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||July 8, 2016||2016-07-08|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma|A Phase II Investigator Sponsored Multi-Centre Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma|Recruiting||Phase 2|21|Anticipated|National Cancer Centre, Singapore||1|||f||||f||||||||No||2017-10-10 21:13:44.505336|2017-10-10 21:13:44.505336
NCT03093818|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-17|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PREPARE||PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions|PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions|Recruiting||N/A|8100|Anticipated|Leiden University Medical Center||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:13:44.643641|2017-10-10 21:13:44.643641
NCT03093805|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-31|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Topical Vitamin D in Acute Graft Versus Host Disease of the Skin|Clinical Effectiveness of Calcipotriene in Acute Graft Versus Host Disease of the Skin: A Pilot Study|Recruiting||N/A|10|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f|f|f||||||No||2017-10-10 21:13:44.824015|2017-10-10 21:13:44.824015
NCT03093792|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||September 1, 2013|Actual|2013-09-01|March 2017|2017-03-01|May 1, 2015|Actual|2015-05-01|May 1, 2015|Actual|2015-05-01||Interventional|Curves2||Effects of Diet Manipulation on Women in the Curves Program|Effects of a Carbohydrate Restricted, High Protein, High Fat Diet on Weight Loss and Health Outcomes in Women Participating in the Curves Fitness and Weight Loss Program|Completed||N/A|86|Actual|Texas A&M University||4|||f||||t|f|f||||||No||2017-10-10 21:13:44.937361|2017-10-10 21:13:44.937361
NCT03093779|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||December 9, 2016|Actual|2016-12-09|March 2017|2017-03-01|August 30, 2020|Anticipated|2020-08-30|August 30, 2020|Anticipated|2020-08-30||Observational|HIL||Mechanisms of Health Literacy and Information Accessibility in the Deaf|Mechanisms of Health Literacy and Information Accessibility in the Deaf|Recruiting||N/A|900|Anticipated|University of Michigan|||2||f||||f|f|f||||||Undecided||2017-10-10 21:13:45.053944|2017-10-10 21:13:45.053944
NCT03093766|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-23|||August 7, 2017|Actual|2017-08-07|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|BIAS||Balance Study on ICU-acquired Hypernatremia and Sodium Handling (BIAS)|Balance Study on ICU-acquired Hypernatremia and Sodium Handling|Recruiting||N/A|110|Anticipated|Medical Centre Leeuwarden|||1||f||||f|f|f||||||||2017-10-10 21:13:45.167101|2017-10-10 21:13:45.167101
NCT03024411|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-01-13|||July 2016||2016-07-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Music and/or Video Games During Labor|Music and/or Video Games for Pain Management During Induction of Labor|Recruiting||N/A|220|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-10 21:26:50.99136|2017-10-10 21:26:50.99136
NCT03093753|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-03|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of a Beverage Comprised of Compounds From Olives on Post-prandial Blood Glucose Responses in Healthy Volunteers|Effect of a Beverage Comprised of Compounds From Olives on Post-prandial Blood Glucose Responses in Healthy Volunteers|Active, not recruiting||N/A|70|Actual|University of Leeds||14|||f||||f||||||||||2017-10-10 21:13:45.275229|2017-10-10 21:13:45.275229
NCT03093740|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-10-04|||February 1, 2018|Anticipated|2018-02-01|October 2017|2017-10-01|January 31, 2021|Anticipated|2021-01-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant|Use of Direct-acting Antiviral Therapy to Prevent Spread of HCV Infection for Patients Receiving a HCV Positive Kidney Transplant as a HCV Negative Recipient|Not yet recruiting||Phase 4|30|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f|||f|||||2017-10-10 21:13:45.403078|2017-10-10 21:13:45.403078
NCT03093727|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-23|||September 27, 2013|Actual|2013-09-27|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01|1 Year|Observational [Patient Registry]|||Characterization of Pulmonary Langerhans Cell Histiocytosis|Functional and Genetical Characterization of Pulmonary Langerhans Cell Histiocytosis: Diagnostic and Therapeutical Implications.|Recruiting||N/A|20|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f|||||f|f||||||||2017-10-10 21:13:45.495643|2017-10-10 21:13:45.495643
NCT03093714|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-22|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects|A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate Safety, Pharmacokinetics (PK) and Pharmacodynamics(PD) of FDL169 in Cystic Fibrosis (CF) Subjects Homozygous for the F508del-CFTR Mutation|Recruiting||Phase 1|24|Anticipated|Flatley Discovery Lab LLC||4|||f||||t|f|f||||||||2017-10-10 21:13:45.567157|2017-10-10 21:13:45.567157
NCT03093701|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-20|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|||TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)|A Phase IIa Trial of TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO): A Double-masked, Randomized Trial to Evaluate Efficacy and Tolerability|Recruiting||Phase 2|66|Anticipated|Taiwan Liposome Company||3|||f||||f|t|f||||||||2017-10-10 21:13:45.703538|2017-10-10 21:13:45.703538
NCT03093688|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-29|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor|Phace I and II Study of Immunotherapy Strategy Used iNKT Cells and CD8+T Cells in Patients With Advanced Tumor|Recruiting||Phase 1/Phase 2|40|Anticipated|Shanghai Public Health Clinical Center||1|||f||||f|f|f||||||No||2017-10-10 21:13:45.902336|2017-10-10 21:13:45.902336
NCT03093675|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-27|||October 23, 2013|Actual|2013-10-23|March 2017|2017-03-01|December 9, 2014|Actual|2014-12-09|December 9, 2014|Actual|2014-12-09||Interventional|||Robotic Assisted Surgery for Treatment of Gynecological Diseases: Pilot Study|Robotic Assisted Surgery for Treatment of Gynecological Diseases: Pilot Study|Completed||N/A|150|Actual|SOFAR S.p.A.||1|||f||||f|f|f||||||No||2017-10-10 21:13:46.019651|2017-10-10 21:13:46.019651
NCT03093662|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||Preoxygenation With Nasal Cannula and Noninvasive Positive Pressure Ventilation|Analysis of Preoxygenation Combining Nasal Cannula With Noninvasive Positive Pressure Ventilation: A Randomized Crossover Trial|Completed||N/A|37|Actual|Brooke Army Medical Center||2|||f||||f|f|t|f|f||||No||2017-10-10 21:13:46.147929|2017-10-10 21:13:46.147929
NCT03093649|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-22|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma|Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Patients With Nasopharyngeal Carcinoma Undergoing Intensity Modulated Radiation Therapy: A Randomised Controlled Trial|Not yet recruiting||N/A|320|Anticipated|Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 21:13:46.244799|2017-10-10 21:13:46.244799
NCT03093636|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-10|||April 14, 2017|Actual|2017-04-14|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|DSS||Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes|Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes|Recruiting||N/A|132|Anticipated|University of Virginia||2|||f||||f|f|t|t|f||||Yes|pending|2017-10-10 21:13:46.365154|2017-10-10 21:13:46.365154
NCT03093623|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-04-09|||October 2014||2014-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Physical Activity and Abstain From Smoking on the Precancerous Lesion|The Effect of Physical Activity and Abstain From Smoking on the Regression of Precancerous Lesion.|Recruiting||N/A|446|Anticipated|Taipei Medical University||2|||f||||t||||||||No||2017-10-10 21:13:46.504664|2017-10-10 21:13:46.504664
NCT03093610|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-02|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Evaluation of Fluid Output Threshold for Safe Chest Tube Removal - A Potential Way to Decrease Length of Stay in Hospital and to Improve Postoperative Care After Lung Surgery?|Evaluation of Fluid Output Threshold for Safe Chest Tube Removal - A Potential Way to Decrease Length of Stay in Hospital and to Improve Postoperative Care After Lung Surgery?|Not yet recruiting||N/A|304|Anticipated|University Hospital Inselspital, Berne||2|||f||||t|f|f||||||No|No IPD will be shared, All participant Data will be encrypted|2017-10-10 21:13:46.691901|2017-10-10 21:13:46.691901
NCT03093597|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-05-01|||March 27, 2017|Actual|2017-03-27|January 2017|2017-01-01|March 27, 2018|Anticipated|2018-03-27|September 27, 2017|Anticipated|2017-09-27||Interventional|||Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin|Evaluating Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer Use in Patients With Dry Skin|Recruiting||N/A|40|Anticipated|University of Arizona||4|||f||||f|f|f||||||No||2017-10-10 21:13:46.788359|2017-10-10 21:13:46.788359
NCT03093584|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-27|||April 2014|Actual|2014-04-01|March 2017|2017-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|AA_EW_Anxi||Auricular Stimulation vs. Expressive Writing for Exam Anxiety|Auricular Acupuncture (AA) vs. Expressive Writing in Treatment of Pre-exam Anxiety - Randomised Crossover Study in Medical Students|Completed||N/A|37|Actual|University Medicine Greifswald||3|||f||||f|f|f||||||Undecided||2017-10-10 21:13:46.918982|2017-10-10 21:13:46.918982
NCT03093571|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-03-27|||April 2015|Actual|2015-04-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|AAvsPMR||Auricular Stimulation vs. Relaxation for Pre-exam Anxiety|Auricular Acupuncture vs. Progressive Muscle Relaxation in Treatment of Pre-exam Anxiety - Randomised Crossover Study in Medical Students|Completed||N/A|47|Actual|University Medicine Greifswald||3|||f||||f|f|f||||||Undecided||2017-10-10 21:13:47.001709|2017-10-10 21:13:47.001709
NCT03093558|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-07-24|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|March 20, 2018|Anticipated|2018-03-20||Interventional|||Pilot Atrial Fibrillation Information Technology Trial|Pilot Atrial Fibrillation Information Technology Trial|Enrolling by invitation||N/A|200|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 21:13:47.084418|2017-10-10 21:13:47.084418
NCT03093545|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-03-31|||March 2015||2015-03-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients|Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients|Completed||N/A|60|Actual|Mahidol University||2|||f||||f|f|f||||||No|No plan to provide individual participant data (IPD). However, other researcher could request IPD from principal investigator.|2017-10-10 21:13:47.159926|2017-10-10 21:13:47.159926
NCT03093532|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-22|||September 8, 2015|Actual|2015-09-08|March 2017|2017-03-01|September 8, 2017|Anticipated|2017-09-08|July 30, 2017|Anticipated|2017-07-30||Interventional|AHEAD2||A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities|A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities|Active, not recruiting||N/A|150|Actual|University of Illinois at Chicago||3|||f||||t|f|f||||||No||2017-10-10 21:13:47.250292|2017-10-10 21:13:47.250292
NCT03093519|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-03|||March 3, 2017|Actual|2017-03-03|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease|A Phase 1 Randomized, Double-blind, Placebo-controlled, Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease|Active, not recruiting||Phase 1|5|Anticipated|Kyowa Hakko Kirin Co., Ltd||2|||f||||f|f|f||||||||2017-10-10 21:13:49.107876|2017-10-10 21:13:49.107876
NCT03093506|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-03-22|||September 2011||2011-09-01|March 2017|2017-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Performance|Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Performance|Completed||Early Phase 1|25|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-10-10 21:13:49.231946|2017-10-10 21:13:49.231946
NCT03093493|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-29|||August 25, 2017|Actual|2017-08-25|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01|1 Year|Observational [Patient Registry]|||Genetics of Ehlers-Danlos Syndrome|Determine the Causative Genetic Variations in Patients With Ehlers-Danlos Syndrome|Recruiting||N/A|60|Anticipated|Boston University|||2||f||||f|f|f||||Samples With DNA|"     Blood and saliva for DNA extraction to use in genetic testing of children and adults with EDS     and their relatives will be collected. Medical records from other institutions and notes from     visits in Dr. Holick's clinic will be reviewed to obtain the following information: previous     diagnosis at other institutions, age, clinical signs and symptoms of EDS, Joints     Hypermobility Syndrome (JHS), other metabolic or genetic disorders and laboratory results,     radiology reports and images, and genetic testing that support these diagnoses. Subjects'     peripheral vein blood, saliva and pictures will be taken. A clinical evaluation will be     performed to document clinical signs for EDS. No clinical interventions will be performed. No     patients' identifiers will be reported.   "|||2017-10-10 21:13:49.348966|2017-10-10 21:13:49.348966
NCT03093467|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-01|||May 29, 2017|Actual|2017-05-29|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|March 2018|Anticipated|2018-03-01||Interventional|ASCENSO||Effectiveness of an Internet-based Intervention for the Treatment of Depression|Effectiveness of an Internet-based Intervention for the Treatment of Depression: Towards the Improvement of the Management of Depression|Recruiting||N/A|200|Anticipated|Instituto Milenio para Investigación en Depresión y Personalidad||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:49.535077|2017-10-10 21:13:49.535077
NCT03093454|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-05-08|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effects of Lavender Oil on Postoperative Pain, Sleep Quality and Mood|Effects of Lavender Oil on Postoperative Pain, Sleep Quality and Mood|Not yet recruiting||Phase 3|40|Anticipated|Duke University||2|||f||||t|t|f||||||No||2017-10-10 21:13:49.653828|2017-10-10 21:13:49.653828
NCT03093441|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-27|||July 31, 2017|Anticipated|2017-07-31|March 2017|2017-03-01|December 8, 2017|Anticipated|2017-12-08|December 8, 2017|Anticipated|2017-12-08||Interventional|||A Comparison of High-intensity Interval Training Protocols on Health and Fitness|A Comparison of High-intensity Interval Training Protocols on Cardiometabolic Markers, Physical Performance, and Psychosocial Markers in College Females|Not yet recruiting||N/A|72|Anticipated|Oakland University||3|||f||||f|f|f||||||No||2017-10-10 21:13:49.750898|2017-10-10 21:13:49.750898
NCT03093428|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-06-18|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|June 2024|Anticipated|2024-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC|A Randomized, Phase II Study Evaluating the Addition of Pembrolizumab (MK-3475) to Radium-223 in Metastatic Castration Resistant Prostate Cancer (mCRPC)|Recruiting||Phase 2|45|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||No||2017-10-10 21:13:49.837365|2017-10-10 21:13:49.837365
NCT03093259|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-10-04|||October 1, 2017|Actual|2017-10-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|June 30, 2018|Anticipated|2018-06-30||Interventional|||ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis|Phase IIa Study to Evaluate the Safety and Efficacy of ABX464 Versus Placebo in Subjects With Moderate to Severe Active Ulcerative Colitis Who Have Failed or Are Intolerant to Immunomodulators, Anti-TNFα, Vedolizumab and/or Corticosteroids|Recruiting||Phase 2|30|Anticipated|Abivax S.A.||2|||f||||t|f|f||||||||2017-10-10 21:13:51.671478|2017-10-10 21:13:51.671478
NCT03093415|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-30|||May 30, 2017|Actual|2017-05-30|May 2017|2017-05-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|||Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care|A Prospective Cohort Study Comparing the Effectiveness of Zepatier for the Treatment of Hepatitis C in an Academic Center Population to People Who Inject Drugs (PWIDs) in a Safety Net Clinic Setting Engaged in Either a Medication Assisted Therapy (MAT) or Syringe Exchange Program|Enrolling by invitation||Phase 4|100|Anticipated|Oregon Health and Science University||3|||f||||t|t|f|||f|||Yes|All electronic data will be maintained encrypted in the Red Cap repository, devoid of HIPPA identifiers. Only the primary investigator and co-investigator will have access to the master spreadsheet linking study ID and personal identifiers. Andrew Seaman, co-investigator and primary study contact, will be listed as the repository guardian. He will be responsible for ensuring data are released according to OHSU policy and the IRB approved repository protocol, executing a repository sharing agreement in case data are released for future research, ensuring the security and confidentiality of all stored data, ensuring the security and confidentiality of data, and tracking acquisitions and releases of data. The repository guardian will be responsible for verifying that future releases are done in concordance with pre-proposed limits and the original consent. Data transport at the time of any future IRB approved data sharing will be approved by an updated RSA and separate IRB approval.|2017-10-10 21:13:49.969693|2017-10-10 21:13:49.969693
NCT03093389|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||May 11, 2005|Actual|2005-05-11|March 2017|2017-03-01|July 29, 2005|Actual|2005-07-29|July 29, 2005|Actual|2005-07-29||Interventional|||Tolerability and Steady-state Pharmacokinetics of BIA 6-512|A Double-blind, Randomised, Placebo-controlled, Rising Multiple-dose Study to Investigate the Tolerability and Steady-state Pharmacokinetics of BIA 6-512 (Trans-resveratrol) in Healthy Volunteers|Completed||Phase 1|40|Actual|Bial - Portela C S.A.||4|||f||||f|f|f||||||Undecided||2017-10-10 21:13:50.408012|2017-10-10 21:13:50.408012
NCT03093376|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-17|||March 30, 2017|Actual|2017-03-30|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Neurally Targeted Interventions to Reduce Early Childhood Anxiety|Neurally Targeted Interventions to Reduce Early Childhood Anxiety|Recruiting||N/A|40|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 21:13:50.524857|2017-10-10 21:13:50.524857
NCT03093363|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-03-21|||October 31, 2016|Actual|2016-10-31|March 2017|2017-03-01|April 30, 2017|Anticipated|2017-04-30|April 30, 2017|Anticipated|2017-04-30||Interventional|||Impact of a Hospital Pharmacist's Intervention on FENO (Fractional Exhaled Nitric Oxide) in Asthmatic Patients|Study of the Impact of a Hospital Pharmacist's Intervention in Collaboration With Pneumologists on Bronchial Inflammation of Outpatient Asthmatic Patients Seen in University Hospital of Liege|Active, not recruiting||N/A|68|Actual|University Hospital of Liege||2|||f|||||f|f||||||Undecided||2017-10-10 21:13:50.646984|2017-10-10 21:13:50.646984
NCT03093350|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-17|||August 1, 2017|Anticipated|2017-08-01|April 2017|2017-04-01|August 1, 2024|Anticipated|2024-08-01|November 1, 2019|Anticipated|2019-11-01||Interventional|TACTIC||TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer|Tumor Associated Antigen (TAA) Specific Cytotoxic T Lymphocytes Administered in Patients With Breast Cancer|Not yet recruiting||Phase 2|22|Anticipated|Baylor College of Medicine||1|||f||||t|t|f|||f|||No||2017-10-10 21:13:50.755664|2017-10-10 21:13:50.755664
NCT03093337|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-21|||December 1, 2007|Actual|2007-12-01|March 2017|2017-03-01|July 8, 2017|Anticipated|2017-07-08|December 1, 2013|Actual|2013-12-01||Interventional|VPI||Psychomotor Therapy for Very Premature Infants|Early Post Hospital Discharge Psychomotor Therapy Intervention Program: Effect on the Development in Very Preterm Infants at 2-years Corrected Age|Recruiting||N/A|162|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-10 21:13:50.875374|2017-10-10 21:13:50.875374
NCT03093324|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-15|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2|A Phase 3 Study in Subjects With Relapsing Remitting Multiple Sclerosis to Evaluate the Tolerability of ALKS 8700 and Dimethyl Fumarate|Recruiting||Phase 3|420|Anticipated|Alkermes, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:13:51.061111|2017-10-10 21:13:51.061111
NCT03093311|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-18|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|January 30, 2019|Anticipated|2019-01-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Near Infrared Spectroscopy for Detection of Cerebral Desaturation After Positioning for Neurosurgical Procedures|Near Infrared Spectroscopy for Detection of Cerebral Desaturation After Positioning for Neurosurgical Procedure|Recruiting||N/A|100|Anticipated|University Hospital Hradec Kralove||2|||f||||f|f|f||||||Yes||2017-10-10 21:13:51.295995|2017-10-10 21:13:51.295995
NCT03093298|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-21|||December 12, 2014|Actual|2014-12-12|March 2017|2017-03-01|December 13, 2016|Actual|2016-12-13|December 13, 2016|Actual|2016-12-13||Interventional|||The Endocrine Secretome After Gastric Bypass Surgery|Searching for Altered Gene Expression in the Endocrine Secretome Following Roux-en-Y Gastric Bypass Surgery|Completed||N/A|28|Actual|University Hospital, Gentofte, Copenhagen||1|||f||||f|f|f||||||Undecided||2017-10-10 21:13:51.395522|2017-10-10 21:13:51.395522
NCT03093285|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-21|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Dysthyroidism and Female Sexual Function|OBSERVATIONAL STUDY FOR EVALUATIING THE EFFECT OF RESTORING Euthyroidism ON FEMALE SEXUAL FUNCTION|Recruiting||N/A|60|Anticipated|University of Florence|||1||f||||f||||||||||2017-10-10 21:13:51.465224|2017-10-10 21:13:51.465224
NCT03093272|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-01|||June 23, 2017|Actual|2017-06-23|August 2017|2017-08-01|August 31, 2024|Anticipated|2024-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer|A Phase 2 Study of Docetaxel Plus Apalutamide in Castration-Resistant Prostate Cancer Patients Post Abiraterone Acetate|Recruiting||Phase 2|33|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:13:51.56007|2017-10-10 21:13:51.56007
NCT03093246|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-15|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis|Evaluation of Omega-3 Polyunsaturated Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Generalized Aggressive Periodontitis: Randomized Controlled Clinical Trial|Recruiting||Phase 2/Phase 3|38|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f|||||f|f|||f|||Undecided||2017-10-10 21:13:51.760446|2017-10-10 21:13:51.760446
NCT03093233|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-27|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|August 30, 2016|Actual|2016-08-30|April 4, 2016|Actual|2016-04-04||Observational|RETRACE-II||Multicenter Analysis of Oral Anticoagulant-associated ICH - Part Two|German-wide Multicenter Analysis of Oral Anticoagulant-associated Intracerebral Hemorrhage - Part Two (RETRACE-II)|Completed||N/A|1369|Actual|University of Erlangen-Nürnberg Medical School|||1||f|||||f|f||||||||2017-10-10 21:13:51.853235|2017-10-10 21:13:51.853235
NCT03093220|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-22|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|March 31, 2018|Anticipated|2018-03-31||Observational|||Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis|Molecular Typing of Adult Community-acquired Pneumonia in China|Recruiting||N/A|500|Anticipated|Peking University People's Hospital|||1||f||||t|f|f||||Samples With DNA|"     1. Lower respiratory tract specimens including sputum, endotracheal aspiration and          bronchoalveolar lavage fluid.        2. Peripheral whole blood samples   "|No||2017-10-10 21:13:52.054968|2017-10-10 21:13:52.054968
NCT03093207|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-05-15|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis|Evaluation of Omega-3 Polyunsaturated Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Generalized Aggressive Periodontitis: Randomized Controlled Clinical Trial|Recruiting||Phase 2/Phase 3|34|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f|||||f|f|||f|||Undecided||2017-10-10 21:13:52.163093|2017-10-10 21:13:52.163093
NCT03093194|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-04-03|||April 10, 2017|Anticipated|2017-04-10|April 2017|2017-04-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Vaginal Antimicrobacterial Preparation Before Cesarean Secation for Endometritis Prevention|Vaginal Antimicrobacterial Preparation Before Cesarean Secation for Endometritis Prevention|Not yet recruiting||N/A|1040|Anticipated|Rambam Health Care Campus||2|||f||||f|f|f||||||No||2017-10-10 21:13:52.282898|2017-10-10 21:13:52.282898
NCT03093181|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-09-15|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|August 28, 2017|Actual|2017-08-28|August 28, 2017|Actual|2017-08-28||Interventional|||Investigation of the Cosmetic Benefit Provided by Regular Application of a Moisturising Cream in People With Blemish Prone Skin|A Randomised, Parallel-group, Evaluator-blind, No-treatment and Positive Controlled, Single-site, Proof of Concept Clinical Study to Evaluate the Cosmetic Benefit Provided by 8 Weeks of Twice-daily Topical Application of a Developmental Moisturising Cream With Niacinamide in Healthy Subjects With Sensitive, Oily, Blemish-prone Skin|Completed||N/A|132|Actual|GlaxoSmithKline||3|||f||||f|f|f||||||||2017-10-10 21:13:52.373396|2017-10-10 21:13:52.373396
NCT03093168|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-27|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|September 2019|Anticipated|2019-09-01||Interventional|||BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma|A Phase I Clinical Trial of T-Cells Targeting B-Cell Maturation Antigen for Subjects With BCMA-positive Multiple Myeloma|Recruiting||Phase 1|10|Anticipated|The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine||1|||f||||t|f|f||||||Yes||2017-10-10 21:13:52.474019|2017-10-10 21:13:52.474019
NCT03093155|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-17|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab|A Randomized Phase II Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab in Recurrent or Persistent Platinum-resistant/Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers|Recruiting||Phase 2|88|Anticipated|Yale University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:13:52.597701|2017-10-10 21:13:52.597701
NCT03093142|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-12|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||The Treatment Effectiveness of Combined tDCs and Neurofeedback (NF) for Patients With Cognitive Deficits After Stroke|The Treatment Effectiveness of Combined tDCs and Neurofeedback (NF) for Patients With Cognitive Deficits After Stroke|Recruiting||N/A|60|Anticipated|Kowloon Hospital, Hong Kong||3|||f||||t|f|f||||||No||2017-10-10 21:13:52.73576|2017-10-10 21:13:52.73576
NCT03093129|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-28|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|NeoART-V||Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)|Phase II Randomised, Double Blind, Placebo Controlled Trial of Neoadjuvant Artesunate in Stage II/III Colorectal Cancer in Vietnamese Patients|Not yet recruiting||Phase 2|200|Anticipated|The 108 Military Central Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:13:52.859851|2017-10-10 21:13:52.859851
NCT03093116|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-09|||February 27, 2017|Actual|2017-02-27|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|January 2021|Anticipated|2021-01-01||Interventional|TRIDENT-1||A Study of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements|A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)|Recruiting||Phase 1/Phase 2|450|Anticipated|TP Therapeutics, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:13:53.006397|2017-10-10 21:13:53.006397
NCT03093103|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-22|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|EMPA-REIN||Empagliflozin and Renal Oxygenation in Healthy Volunteers|Effects of the SGLT2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-diabetic Subjects|Recruiting||Phase 2|45|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:13:53.224963|2017-10-10 21:13:53.224963
NCT03093090|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-06-27|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: Furosemide|Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: Furosemide|Not yet recruiting||Phase 1|8|Anticipated|Yale University||4|||f||||f|t|f|||t|||No||2017-10-10 21:13:53.336489|2017-10-10 21:13:53.336489
NCT03093077|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-03-22|||November 2016||2016-11-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Kinematics After Total Knee Arthroplasty|Kinematics Following Total Knee Arthroplasty Performed With Different Surgical Alignment Techniques|Active, not recruiting||N/A|56|Anticipated|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-10 21:13:53.469767|2017-10-10 21:13:53.469767
NCT03093064|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-15|||April 1, 2017|Actual|2017-04-01|February 2017|2017-02-01|April 1, 2022|Anticipated|2022-04-01|April 1, 2022|Anticipated|2022-04-01||Interventional|IRIS||Inflammatory Response In Schizophrenia|The Role of Inflammation in Brain and Cognitive Function in Mental Disorders|Active, not recruiting||Phase 1|60|Anticipated|King's College London||2|||f||||t|t|f|||t|||||2017-10-10 21:13:53.552646|2017-10-10 21:13:53.552646
NCT03093051|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-22|||October 2017|Anticipated|2017-10-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Observational|JUPITER||Termination Therapy for Ventricular Tachyarrhythmias|Unpinning Pulse Termination Therapy for Ventricular Tachyarrhythmias|Not yet recruiting||N/A|50|Anticipated|Cardialen, Inc.|||1||f||||t|f|f||||||No||2017-10-10 21:13:53.659212|2017-10-10 21:13:53.659212
NCT03093038|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-03-22|||May 2014||2014-05-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Interventional|RSA-DELTA-TT||Early Stability of the Delta-TT Cup With Polyethylene Insert Versus a Ceramic Insert. A RSA Study.|Early Stability of the Delta-TT Cup With Polyethylene Insert Compared to the Delta-TT Cup With Ceramic Insert. A Randomised RSA Study|Active, not recruiting||N/A|65|Anticipated|JointResearch||3|||f||||f||||||||Undecided||2017-10-10 21:13:53.748273|2017-10-10 21:13:53.748273
NCT03093025|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-31|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Patients With Major Depressive Disorder With an Inadequate Response to Current Antidepressant Treatment|Recruiting||Phase 2|180|Anticipated|Taisho Pharmaceutical R&D Inc.||3|||f|||||t|f||||||||2017-10-10 21:13:53.860718|2017-10-10 21:13:53.860718
NCT03093012|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-27|||August 2015|Actual|2015-08-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|NIRS||Individual Blood Pressure Optimization Based on Cerebral Autoregulation After Implantation of Continuous-flow LVAD|Individual Blood Pressure Optimization Based on Cerebral Blood Flow Autoregulation After Implantation of Continuous-flow Left Ventricular Assist Device|Recruiting||N/A|130|Anticipated|Baylor College of Medicine|||1||f|||||f|f||||||Yes|This study will collect retrospective and prospective clinical data regarding the Principal Investigator's patient population to allow for data analysis seeking basic trends and to prepare academic reports, including journal manuscripts and presentations for scientific organizations.|2017-10-10 21:13:53.980938|2017-10-10 21:13:53.980938
NCT03092999|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-17|||March 28, 2017|Actual|2017-03-28|July 2017|2017-07-01|July 17, 2017|Actual|2017-07-17|July 17, 2017|Actual|2017-07-17||Interventional|||Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)|Investigation of Pharmacokinetics, Safety, and Tolerability of Vilaprisan (BAY1002670) in Subjects With Hepatic Impairment (Classified as Child-Pugh A or B) Compared to Sex, Age, and Weight-matched Healthy Subjects Following a Single Oral Dose|Completed||Phase 1|36|Actual|Bayer||3|||f||||f|f|f||||||||2017-10-10 21:13:54.056567|2017-10-10 21:13:54.056567
NCT03092986|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-27|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer|Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer|Not yet recruiting||Phase 3|60|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||t|t|t|f||f|||No||2017-10-10 21:13:54.143302|2017-10-10 21:13:54.143302
NCT03092973|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-27|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Carotid Intima Media Thickness (CIMT) in Epistaxis|Carotid Intima Media Thickness in Patients With Epistaxis: a Surrogate Marker for Generalised Atherosclerosis|Recruiting||N/A|100|Anticipated|University of Zurich|||2||f||||f|f|f||||||No|The participant data will no longer be used by us or other researchers after the project is finished.|2017-10-10 21:13:54.221538|2017-10-10 21:13:54.221538
NCT03092960|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-06-21|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|July 1, 2020|Anticipated|2020-07-01|December 31, 2019|Anticipated|2019-12-31||Interventional|HOMBRE||The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men|The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men|Recruiting||N/A|424|Anticipated|Palo Alto Medical Foundation||2|||f||||t|f|f||||||||2017-10-10 21:13:54.309502|2017-10-10 21:13:54.309502
NCT03092947|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-27|||November 1, 2014|Actual|2014-11-01|March 2017|2017-03-01|February 28, 2016|Actual|2016-02-28|October 31, 2015|Actual|2015-10-31||Observational|RFR||Preoperative Prediction of Acute Kidney Injury After Cardiac Surgery|Use of Preoperative Renal Functional Reserve to Predict Risk of Acute Kidney Injury After Cardiac Surgery|Completed||N/A|110|Actual|University of Giessen|||1||f||||f|f|f||||Samples With DNA|"     Collection of only residual material (blood, urine) for International Renal Research     Institute   "|No||2017-10-10 21:13:54.398169|2017-10-10 21:13:54.398169
NCT03092934|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-22|||May 17, 2017|Actual|2017-05-17|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||A Study of AK-01 in Solid Tumors|A Phase I/II Open-Label Multicenter Study to Evaluate the Safety and Efficacy of AK-01 as Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|90|Anticipated|AurKa Pharma Inc.||2|||f||||f|f|f||||||||2017-10-10 21:13:54.467449|2017-10-10 21:13:54.467449
NCT03092921|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-08-06|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|August 3, 2017|Actual|2017-08-03||Interventional|||The Evaluation of a Mask Seal/Mask for the Treatment of Obstructive Sleep Apnea (OSA)|The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea (OSA)|Completed||N/A|18|Actual|Fisher and Paykel Healthcare||2|||f||||t|f|f||||||||2017-10-10 21:13:54.585375|2017-10-10 21:13:54.585375
NCT03021434|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-06-28|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||Trial of Low-cost Microbiological Water Test Kits|Cluster Randomized Trial of Low-cost Microbiological Water Test Kits|Completed||N/A|572|Actual|London School of Hygiene and Tropical Medicine||3|||f||||f||||||||No||2017-10-10 21:27:21.132054|2017-10-10 21:27:21.132054
NCT03092908|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-31|||March 22, 2017|Actual|2017-03-22|March 2017|2017-03-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Mature Vinegar Prophylaxis Against Recurrent Calcium Oxalate Nephrolithiasis|Mature Vinegar Prophylaxis Against Recurrent Calcium Oxalate Nephrolithiasis - a Prospective Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f|||||f|f||||||||2017-10-10 21:13:54.682904|2017-10-10 21:13:54.682904
NCT03092895|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-15|||April 27, 2017|Actual|2017-04-27|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of SHR-1210 in Combination With Apatinib or FOLFOX4 Regimen in Subjects With Advanced Primary Liver Cancer（PLC）|A Phase 2 Study of SHR-1210 (PD-1 Antibody) in Combination With Apatinib or FOLFOX4 Regimen in Subjects With Advanced Primary Liver Cancer（PLC）|Recruiting||Phase 2|36|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:13:54.919154|2017-10-10 21:13:54.919154
NCT03092882|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-11|||March 3, 2017|Actual|2017-03-03|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c|Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c|Active, not recruiting||N/A|607|Actual|Evidation Health||2|||f||||f|f|f||||||||2017-10-10 21:13:55.049137|2017-10-10 21:13:55.049137
NCT03092869|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-25|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|FEET_BALANCE||Effects of Feet and Ankle Mobilization on Balance of Older Adults|Effects of Feet and Ankle Mobilization on Balance of Older Adults|Recruiting||N/A|20|Anticipated|University of Valencia||2|||f||||f|f|f||||||Undecided||2017-10-10 21:13:55.140761|2017-10-10 21:13:55.140761
NCT03092856|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-20|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|July 19, 2021|Anticipated|2021-07-19|July 19, 2020|Anticipated|2020-07-19||Interventional|||Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer|Phase II Randomized Double Blind Trial of PF-04518600, an OX40 Antibody, in Combination With Axitinib Versus Axitinib in Immune-Checkpoint Inhibitor Exposed Patients With Metastatic Renal Cell Carcinoma|Recruiting||Phase 2|104|Anticipated|University of Southern California||2|||f||||t|t|f||||||||2017-10-10 21:13:55.240718|2017-10-10 21:13:55.240718
NCT03092843|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|December 30, 2021|Anticipated|2021-12-30|May 30, 2020|Anticipated|2020-05-30||Observational|||Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM|Functional Capacity and Quality of Life Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy|Recruiting||N/A|175|Anticipated|The Cleveland Clinic|||2||f||||f|f|f||||||No||2017-10-10 21:13:55.39128|2017-10-10 21:13:55.39128
NCT03092830|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-27|||September 7, 2017|Anticipated|2017-09-07|January 2017|2017-01-01|August 7, 2020|Anticipated|2020-08-07|August 7, 2020|Anticipated|2020-08-07||Observational|||Molecular Characterization of Cutaneous Tumors|Molecular Characterization of Cutaneous Tumors|Not yet recruiting||N/A|500|Anticipated|Rabin Medical Center|||1||f||||t|f|f||||Samples With DNA|"     DNA or RNA which will be produced from skin biopsy specimens of SCC,BCC   "|No||2017-10-10 21:13:55.476954|2017-10-10 21:13:55.476954
NCT03092817|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-06-29|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|April 1, 2022|Anticipated|2022-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)|A Randomized Double Blind Placebo Controlled Trial of Adjunctive Dexamethasone for the Treatment of HIV-infected Adults With Tuberculous Meningitis|Recruiting||Phase 3|520|Anticipated|Oxford University Clinical Research Unit, Vietnam||2|||f||||t|f|f||||||Yes|The Oxford University Clinical Research Unit recognizes the ethical obligation to ensure that optimal use is made of the data and specimens that the investigators collect for our research and the value of sharing individual level data. The investigators aim to ensure that data generated from all our research are collected, curated, managed and shared in a way that maximizes their benefit. When sharing data the investigators have an obligation to ensure that the interests of research participants, researchers and other stakeholders are appropriately protected. The Oxford University Clinical Research Unit data sharing policy and the data request form outline the default procedures for data sharing.|2017-10-10 21:13:55.579536|2017-10-10 21:13:55.579536
NCT03092804|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||August 1, 2016|Actual|2016-08-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Observational|||The Brain Structure and Neural Network Changing the Before and After Ventriculo-peritoneal Shunting in the Normal Pressure Hydrocephalus Patients|The Brain Structure and Neural Network Changing the Before and After Ventriculo-peritoneal Shunting in the Normal Pressure Hydrocephalus Patients|Recruiting||N/A|60|Anticipated|Peking Union Medical College Hospital|||2||f||||f|f|t|f|f||||No||2017-10-10 21:13:55.768567|2017-10-10 21:13:55.768567
NCT03092791|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-06-08|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|June 13, 2019|Anticipated|2019-06-13|March 8, 2018|Anticipated|2018-03-08||Interventional|||IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults|A Randomized, Observer-Blind, Controlled Phase 1/2 Trial to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses of a Stand-alone Trivalent, Inactivated Poliomyelitis Vaccine From Sabin Strains in Healthy Infants, With a Safety and Tolerability Age-Step Down Lead-in in Healthy Adults Followed by Healthy Toddlers|Recruiting||Phase 1/Phase 2|340|Anticipated|Takeda||8|||f||||t|f|f||||||||2017-10-10 21:13:55.876116|2017-10-10 21:13:55.876116
NCT03092778|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-12|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|April 10, 2019|Anticipated|2019-04-10|April 10, 2019|Anticipated|2019-04-10||Interventional|||Cryoablation for Obesity Management|Percutaneous Image Guided Cryoablation of the Vagus Nerve for Management of Mild-Moderate Obesity|Recruiting||N/A|20|Anticipated|Emory University||1|||f||||f|f|f|||f|||||2017-10-10 21:13:56.027353|2017-10-10 21:13:56.027353
NCT03092765|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-24|2017-07-06|||March 23, 2017|Actual|2017-03-23|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|||Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid|A Clinical Phase 2 Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid|Recruiting||Phase 2|80|Anticipated|Eisai Inc.||8|||f||||t|f|f||||||||2017-10-10 21:13:56.146877|2017-10-10 21:13:56.146877
NCT03092752|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-27|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|||Clinical Characteristics and Practice Patterns of T2DM Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV|Clinical Characteristics and Practice Patterns of Type 2 Diabetes Mellitus (T2D) Patients Treated With Oral Antidiabetic Drugs (OAD) in Japan: Analysis of Medical and Health Care Database of the Medical Data Vision (MDV)|Completed||N/A|8000|Actual|Boehringer Ingelheim|||1||f|||||t|f|||t|||||2017-10-10 21:13:56.323397|2017-10-10 21:13:56.323397
NCT03092739|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-08-01|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Observational|||A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens|A Non-Interventional Multinational Study to Assess PD-L1 Expression in Cytological Versus Histological Non-Small Cell or Small Cell Lung Cancer Specimens|Recruiting||N/A|200|Anticipated|Hoffmann-La Roche|||1||f||||f|f|f||||Samples With DNA|"     Formalin fixed, paraffin embedded tumor tissue; formalin fixed paraffin embedded cytological     samples (cell blocks) from the same participant will be retained until end of the study.   "|||2017-10-10 21:13:56.406091|2017-10-10 21:13:56.406091
NCT03092726|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-21|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia|A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia|Recruiting||Phase 2|178|Anticipated|Astellas Pharma Inc||2|||f||||t|t|f||||||||2017-10-10 21:13:56.516443|2017-10-10 21:13:56.516443
NCT03092713|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-19|||January 2, 2017|Actual|2017-01-02|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Combined Cognitive and Vocational Interventions After Mild-to-moderate TBI: a Randomized Controlled Trial|The Effect Evaluation of Combined Cognitive and Vocational Interventions After Mild-to-moderate Traumatic Brain Injury: a Randomized Controlled Trial and Qualitative Process Evaluation|Recruiting||N/A|125|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:13:56.665398|2017-10-10 21:13:56.665398
NCT03092700|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-05-05|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|READ-COG BPCO||Pulmonary Rehabilitation, Dyspnoea and Emotional Cognition in COPD|Effects of Pulmonary Rehabilitation on Dyspnoea Affective Dimension and Emotional Cognition in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|48|Anticipated|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil|||1||f||||f|f|f||||||||2017-10-10 21:13:56.775547|2017-10-10 21:13:56.775547
NCT03092674|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-23|2017-09-04|||December 20, 2017|Anticipated|2017-12-20|May 2017|2017-05-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2022|Anticipated|2022-06-01||Interventional|||Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome|"A Randomized Phase II/III Trial of Novel Therapeutics Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Intergroup Less-Intense AML Platform Trial"|Not yet recruiting||Phase 2/Phase 3|1670|Anticipated|National Cancer Institute (NCI)||4|||f||||f|t|f||||||||2017-10-10 21:13:56.923963|2017-10-10 21:13:56.923963
NCT03092661|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-07-06|||March 27, 2017|Actual|2017-03-27|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|January 31, 2018|Anticipated|2018-01-31||Observational|BOSS||Baby Oxygen Saturation Study|Reference Data for Neonatal Oxygen Saturation - a Pilot Study.|Recruiting||N/A|40|Anticipated|NHS Greater Glasgow and Clyde|||1||f|||||f|f||||||||2017-10-10 21:13:57.077639|2017-10-10 21:13:57.077639
NCT03092648|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 28, 2019|Anticipated|2019-02-28|December 30, 2018|Anticipated|2018-12-30||Interventional|||Autologous Bronchial Basal Cells Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD)|Autologous Bronchial Basal Cells Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 1/Phase 2|20|Anticipated|Nanfang Hospital of Southern Medical University||2|||f|||||f|f||||||No||2017-10-10 21:13:57.163943|2017-10-10 21:13:57.163943
NCT03092635|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-06-13|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy|Pilot Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in ER+, Metastatic Breast Cancer Patients Receiving Endocrine Therapy|Recruiting||Phase 1|20|Anticipated|Medical University of South Carolina||1|||f||||t|t|f||||||No||2017-10-10 21:13:57.742503|2017-10-10 21:13:57.742503
NCT03092622|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-19|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia|Effects of Aerobic Interval Training on Cardiac Function, With Special Focus on Pulmonary Pressures and Right Sided Function, in Patients With Chronic Obstructive Pulmonary Disease and Hypoxemia|Recruiting||N/A|12|Anticipated|Norwegian University of Science and Technology||1|||f||||f|f|f||||||No||2017-10-10 21:13:57.852341|2017-10-10 21:13:57.852341
NCT03092609|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-13|||September 15, 2017|Anticipated|2017-09-15|September 2017|2017-09-01|September 14, 2020|Anticipated|2020-09-14|September 14, 2020|Anticipated|2020-09-14||Interventional|||Neuroplasticity in an Extended Amygdala Network as a Target Mechanism for Attention Bias Modification Outcome|Neuroplasticity in an Extended Amygdala Network as a Target Mechanism for Attention Bias Modification Outcome|Not yet recruiting||N/A|100|Anticipated|Northern Michigan University||2|||f||||f|f|f||||||||2017-10-10 21:13:57.940725|2017-10-10 21:13:57.940725
NCT03092076|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-21|||May 20, 2015|Actual|2015-05-20|March 2017|2017-03-01|June 16, 2016|Actual|2016-06-16|October 24, 2015|Actual|2015-10-24||Interventional|IGPPT||The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese|The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese|Completed||Phase 1|51|Actual|Guangdong General Hospital||3|||f||||f|f|f||||||Yes||2017-10-10 21:14:02.395476|2017-10-10 21:14:02.395476
NCT03092596|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-03-22|||February 2, 2017|Actual|2017-02-02|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|September 2019|Anticipated|2019-09-01||Interventional|||Integrated Care (iCare) at Mount Sinai to Improve Substance Use Diagnosis and Treatment Practices in HIV Clinic Settings|A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings|Enrolling by invitation||N/A|120|Anticipated|Icahn School of Medicine at Mount Sinai||4|||f||||t|f|f||||||Undecided||2017-10-10 21:13:58.03575|2017-10-10 21:13:58.03575
NCT03092583|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-27|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|METYLAS||Analysis of DNA Methylation in Spondyloarthritis|Analysis of DNA Methylation in Spondyloarthritis|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f|f|f||||||No||2017-10-10 21:13:58.149293|2017-10-10 21:13:58.149293
NCT03092570|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-29|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|MADECCS||Manual Dexterity Control After Cerebellar Stimulation|Assessment of Cerebellar Stimulation Effect on Motor Learning in Ageing Population and Stroke Patients|Not yet recruiting||N/A|60|Anticipated|Centre Hospitalier St Anne||6|||f||||f|f|f||||||No||2017-10-10 21:13:58.272928|2017-10-10 21:13:58.272928
NCT03092557|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-07-24|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||A New Ultrasonographic Tool to Assess Regional Pulmonary Strain|A Pilot Study of a New Ultrasonographic Tool to Assess Regional Pulmonary Strain in Patients Under General Anesthesia|Recruiting||N/A|10|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f|f|f||||||||2017-10-10 21:13:58.420743|2017-10-10 21:13:58.420743
NCT03092544|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-03-29|||February 2015||2015-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients|Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients|Active, not recruiting||Phase 4|57|Actual|Multiple Sclerosis Center of Northeastern New York||5|||f||||f||||||||No||2017-10-10 21:13:58.556859|2017-10-10 21:13:58.556859
NCT03092531|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|STEPS||Positive Steps to Enhance Problem Solving Skills|Adaptive Intervention Strategies Trial for Strengthening Adherence to Antiretroviral HIV Treatment Among Youth|Not yet recruiting||N/A|192|Anticipated|Brown University||2|||f||||t|f|f||||||||2017-10-10 21:13:58.667574|2017-10-10 21:13:58.667574
NCT03092479|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-21|||January 20, 2017|Actual|2017-01-20|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Behavioral Support Intervention After Bariatric Surgery|A Randomized Trial of a Pilot Behavioral Support Intervention After Bariatric Surgery|Active, not recruiting||N/A|50|Actual|Geisinger Clinic||2|||f||||f|f|f||||||||2017-10-10 21:13:59.236993|2017-10-10 21:13:59.236993
NCT03092466|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-21|||February 26, 2017|Actual|2017-02-26|March 2017|2017-03-01|February 23, 2019|Anticipated|2019-02-23|February 23, 2018|Anticipated|2018-02-23||Interventional|||Early Femoral Block in Elderly With Hip Fracture|A Prospective, Randomized, Double-blind, Multicenter Trial on the Effects of the Early Femoral Nerve Block in Elderly With Hip Fracture|Recruiting||N/A|600|Anticipated|ASST Gaetano Pini-CTO||2|||f||||t|f|f||||||Undecided||2017-10-10 21:13:59.368249|2017-10-10 21:13:59.368249
NCT03092453|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-12|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Dendritic Cell Vaccination in Patients With Advanced Melamona|Mature Dendritic Cell Vaccination Against Mutated Antigens in Patients With Advanced Melanoma|Recruiting||Phase 1|12|Anticipated|University of Pennsylvania||1|||||||f|t|f||||||||2017-10-10 21:13:59.488277|2017-10-10 21:13:59.488277
NCT03092440|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-31|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||"Validity Assessment of the LabForGames Warning Serious Game"|"Validity Assessment of the LabForGames Warning Serious Game"|Not yet recruiting||N/A|45|Anticipated|Université Paris-Sud|||3||f||||f|f|f||||||||2017-10-10 21:13:59.584605|2017-10-10 21:13:59.584605
NCT03092427|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-07-24|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|PERMAJI||Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)|Evaluation of the Effectiveness of a Probiotic Treatment on Clinical Activity, Relapse Rates and Modification of the Intestinal Microbiota in Patients With Juvenile Idiopathic Arthritis (JIA)|Recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:13:59.67279|2017-10-10 21:13:59.67279
NCT03092414|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-25|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions|CMV Criteria in the Detection of Gastric Diseases Using Linked Color Imaging|Not yet recruiting||N/A|2000|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t|f|f||||||No||2017-10-10 21:13:59.765233|2017-10-10 21:13:59.765233
NCT03092401|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-27|||October 1, 2015|Actual|2015-10-01|March 2017|2017-03-01|March 31, 2017|Anticipated|2017-03-31|March 31, 2017|Anticipated|2017-03-31||Observational|HPS||Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study|Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study.|Active, not recruiting||N/A|142|Actual|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 21:13:59.853218|2017-10-10 21:13:59.853218
NCT03092388|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-30|||February 2015||2015-02-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea|Evaluation Eines Leg Fluid Shift Und Erörterung Der hämodynamischen Und Respiratorischen Auswirkungen Auf Patienten Mit Chronischer Herzinsuffizienz Und Obstruktiver Oder Zentraler Schlafapnoe|Completed||N/A|40|Actual|Heart and Diabetes Center North-Rhine Westfalia||2|||f||||f||||||||No||2017-10-10 21:13:59.922634|2017-10-10 21:13:59.922634
NCT03092375|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-24|||April 20, 2017|Actual|2017-04-20|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|May 1, 2018|Anticipated|2018-05-01||Interventional|||Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects|A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects With Chronic Hepatitis C Previously Treated With an NS5A Inhibitor + Sofosbuvir Therapy|Recruiting||Phase 3|225|Anticipated|University of Florida||4|||f||||f|t|f||||||||2017-10-10 21:14:00.05091|2017-10-10 21:14:00.05091
NCT03092362|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-24|||November 2016||2016-11-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|BVAR-Afib||Beat-to-beat Variability in Persistent Atrial Fibrillation|Beat-to-beat Variability in Persistent Atrial Fibrillation|Recruiting||N/A|150|Anticipated|Heart and Diabetes Center North-Rhine Westfalia|||1||f||||f||||||||No||2017-10-10 21:14:00.300942|2017-10-10 21:14:00.300942
NCT03092349|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||January 2017|Actual|2017-01-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|VECTOPT||SonR Based Stimulation-VECtor OPTimisation in CRT Patients|Effect of SonR Based Stimulation-VECtor OPTimisation in Patients With Chronically Implanted Cardiac Resynchronization Devices|Recruiting||N/A|50|Anticipated|Heart and Diabetes Center North-Rhine Westfalia|||1||f||||f||||||||No||2017-10-10 21:14:00.38089|2017-10-10 21:14:00.38089
NCT03092336|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||May 2011|Actual|2011-05-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of Different Protocols of Physical Training on Levels of Muscle Strength and Functional Capacity|Effects of Different Protocols of Physical Training on Levels of Muscle Strength and Functional Capacity on Patients With Peripheral Artery Disease: a Randomized Clinical Trial|Recruiting||N/A|73|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||Undecided||2017-10-10 21:14:00.479066|2017-10-10 21:14:00.479066
NCT03092310|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-20|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index|Feasibility Evaluation of an Artificial Pancreas With an Enhanced Model Predictive Control (eMPC) Controller and a Health Monitoring System (HMS) With a Glucose Prediction Trust Index|Recruiting||N/A|20|Anticipated|William Sansum Diabetes Center||1|||f||||f|f|t|t|f||||No||2017-10-10 21:14:00.713847|2017-10-10 21:14:00.713847
NCT03092297|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-05-18|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|INOX ICU-2||Insufficient Cellular Oxygen in ICU Patients With Anaemia|Insufficient Cellular Oxygen in ICU Patients With Anaemia: the INOX ICU-2 Study|Recruiting||N/A|240|Anticipated|Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research|||1||f||||t||||||Samples Without DNA|"     Blood samples will be taken for measurement of: troponin, creatinine kinase, creatinine,     hemoglobin, lactate, central venous oxygen saturation, arterial saturation, arterial oxygen     tension, and venous oxygen tension. Remaining plasma will be frozen and stored for further     evaulation   "|Undecided|to be decided|2017-10-10 21:14:00.815884|2017-10-10 21:14:00.815884
NCT03092284|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-03-24|||September 2015||2015-09-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|CSCC_ASCII||Allogeneic Stem Cell Therapy in Heart Failure|Allogeneic Adipose Tissue-derived Stromal/Stem Cell Therapy in Patients With Ischemic Heart Disease and Heart Failure: A Phase II Danish Multicentre Study|Recruiting||Phase 2|81|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||Yes|Data can be share for scientific collaboration|2017-10-10 21:14:00.921636|2017-10-10 21:14:00.921636
NCT03092271|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||April 3, 2017|Anticipated|2017-04-03|March 2017|2017-03-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2021|Anticipated|2021-08-31||Interventional|Step2Health||Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults|Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults|Recruiting||N/A|300|Anticipated|University of California, Los Angeles||2|||f||||t|f|f||||||No|Only fully anonymized and de-identified data as approved by the Institutional Review Board. The study principal investigator will collaborate with National Institute of Mental Health to finalize public use dataset procedures, ensure that the rights and privacy of all individual research participants are protected, and that Protected Personal Health Information is protected as required by law and approved by the study Institutional Review Board. The plan is for a limited access database of anonymized and de-identified data to be created. This data set will be available after study papers are completed and accepted for publication.|2017-10-10 21:14:01.014363|2017-10-10 21:14:01.014363
NCT03092258|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-18|||April 27, 2017|Actual|2017-04-27|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Do we Prepare Patients for Their Digital Legacy? A Survey of Palliative Care Professionals in the West Midlands|Do we Prepare Patients for Their Digital Legacy? A Survey of Palliative Care Professionals in the West Midlands|Recruiting||N/A|600|Anticipated|The Royal Wolverhampton Hospitals NHS Trust|||1||f||||f|f|f||||||||2017-10-10 21:14:01.127372|2017-10-10 21:14:01.127372
NCT03092245|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-10|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|VIPER-SHOCK||Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial|Efficacy and Safety of OctaplasLG® Administration vs. Crystalloids (Standard) in Patients With Septic Shock - a Randomized, Controlled, Open-label Investigator-initiated Pilot Trial|Recruiting||Phase 2|40|Anticipated|Rigshospitalet, Denmark||2|||f||||f|f|f||||||No||2017-10-10 21:14:01.209198|2017-10-10 21:14:01.209198
NCT03092232|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-10|||March 16, 2017|Actual|2017-03-16|August 2017|2017-08-01|July 17, 2017|Actual|2017-07-17|July 13, 2017|Actual|2017-07-13||Interventional|||Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571|A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Single Escalating Oral Doses Of Pf-06865571 In Healthy Adult Subjects|Completed||Phase 1|17|Actual|Pfizer||3|||f||||f|t|f||||||||2017-10-10 21:14:01.321102|2017-10-10 21:14:01.321102
NCT03092219|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||December 20, 2016||2016-12-20||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:14:01.413235|2017-10-10 21:14:01.413235
NCT03092206|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-16|||April 18, 2017|Actual|2017-04-18|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|TAF-IR||Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication|Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication: The TAF-IR Study|Completed||Phase 1|30|Actual|Technische Universität München||3|||f||||f|f|f|||f|||||2017-10-10 21:14:01.45838|2017-10-10 21:14:01.45838
NCT03092193|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-02|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazole|Clinical Pharmacokinetics of Cytochrome P450: Influence on the Pharmacokinetics of Naproxen (CYP2C8 and CYP2C9) and Associated Naproxen-esomeprazole (CYP2C19)|Recruiting||Phase 4|20|Anticipated|University of Sao Paulo||2|||f||||t|f|f|||f|||No||2017-10-10 21:14:01.553427|2017-10-10 21:14:01.553427
NCT03092180|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-24|||January 2005||2005-01-01|March 2017|2017-03-01|January 2026|Anticipated|2026-01-01|January 2018|Anticipated|2018-01-01||Observational|||Optimizing Treatment on Idiopathic Inflammatory Myopathies|Optimizing Treatment on Idiopathic Inflammatory Myopathies|Recruiting||N/A|60|Anticipated|University of Sao Paulo|||2||f||||t||||||Samples With DNA|"     Serum and muscle biopsies      NOTE: This is a observational study. Subjects in the study will receive a routine care that     has been established in our Instituition (diagnostic, therapeutic, biospecimen analysis and     retention).   "|No||2017-10-10 21:14:01.644108|2017-10-10 21:14:01.644108
NCT03092167|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-24|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Physical Training in Patients With Idiopathic Inflammatory Myopathies|Physical Training in Patients With Idiopathic Inflammatory Myopathies|Recruiting||N/A|40|Anticipated|University of Sao Paulo||3|||f||||t|f|f||||||No||2017-10-10 21:14:01.731697|2017-10-10 21:14:01.731697
NCT03092154|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-24|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis|Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis|Recruiting||N/A|40|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 21:14:01.825099|2017-10-10 21:14:01.825099
NCT03092141|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-24|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Physical Training in Patients With Relapsing Polychondritis|Physical Training in Patients With Relapsing Polychondritis|Recruiting||N/A|12|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 21:14:01.958149|2017-10-10 21:14:01.958149
NCT03092128|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment|Retrospective Study Based on Pharmacokinetics, Somatic Mutations and Genetic Polymorphisms Related to Individual Variations of Drug Effect and Adverse Drug Reaction of Imatinib in Gastrointestinal Stromal Tumor Treatment.|Recruiting||N/A|200|Anticipated|Sun Yat-sen University|||1||f||||t|f|||||Samples With DNA|"     1. FFPE samples of tissue needle biopsy were used for KIT and PDGFRA mutation detection.        2. EDTA-whole blood was centrifuged at 4000rpm*10min,plasma was separated within four hours          for somatic mutation detection.The remaining samples were used for germline mutation          detection. All the blood samples were frozen in -80℃ until analysis.   "|No||2017-10-10 21:14:02.075753|2017-10-10 21:14:02.075753
NCT03092115|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-06-08|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|September 1, 2018|Anticipated|2018-09-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Youth mHealth Adherence Intervention for HIV+ YMSM|Feasibility Testing of a Novel mHealth Intervention to Improve Adherence to Antiretroviral Therapy Among HIV+ Men Who Have Sex With Men (MSM) Youth|Recruiting||N/A|10|Anticipated|Children's Hospital of Philadelphia||1|||f||||f|f|f||||||No|individual participant data will not be shared with other researchers. If shared, datasets will be deidentified of participant health information.|2017-10-10 21:14:02.166574|2017-10-10 21:14:02.166574
NCT03092102|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||May 15, 2017|Anticipated|2017-05-15|March 2017|2017-03-01|May 15, 2018|Anticipated|2018-05-15|January 15, 2018|Anticipated|2018-01-15||Interventional|||The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects|A Phase I, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects|Not yet recruiting||Phase 1|84|Anticipated|Sunshine Lake Pharma Co., Ltd.||3|||f||||t|t|f||||||No||2017-10-10 21:14:02.243718|2017-10-10 21:14:02.243718
NCT03092089|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-16|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Sonothrombolysis in Patients With STEMI|Sonothrombolysis in Patients With an ST-segment Elevation Myocardial Infarction. A Prospective Single-arm Study.|Recruiting||Phase 2|15|Anticipated|University of Alberta||1|||f||||f|t|f|||t|||||2017-10-10 21:14:02.30701|2017-10-10 21:14:02.30701
NCT03091712|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-08|||May 5, 2017|Actual|2017-05-05|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Insulin Degludec Titration Using Mobile Insulin Dosing System|Insulin Degludec Titration Using Mobile Insulin Dosing System|Recruiting||N/A|240|Anticipated|Glooko||2|||f||||f|f|t|t|f|f|||No||2017-10-10 21:14:06.275686|2017-10-10 21:14:06.275686
NCT03092063|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-05-01|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 31, 2021|Anticipated|2021-03-31|July 1, 2020|Anticipated|2020-07-01||Interventional|||Using Multifamily Groups to Improve Self-Management of Type 2 Diabetes|Using Multifamily Groups to Improve Family-Centered Self-Management of Type 2 Diabetes Among Mexican-Americans|Recruiting||N/A|330|Anticipated|University of California, Los Angeles||6|||f||||f|f|f||||||Undecided||2017-10-10 21:14:02.479268|2017-10-10 21:14:02.479268
NCT03092050|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-21|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Group Therapy for Depressed Dementia Caregivers|Group Therapy for Depressed Caregivers of Alzheimer's Disorder and Related Dementias|Recruiting||N/A|50|Anticipated|University of California, San Francisco||2|||f|||||f|f||||||||2017-10-10 21:14:02.572796|2017-10-10 21:14:02.572796
NCT03092037|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-07|||March 23, 2017|Actual|2017-03-23|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics|Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics|Recruiting||N/A|350|Anticipated|University of Colorado, Denver|||2||f||||f|f|f||||||No||2017-10-10 21:14:02.672732|2017-10-10 21:14:02.672732
NCT03092024|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-07-11|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|SPIN-HAND-F||Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study|Feasibility Trial of an Internet-based Exercise Program to Improve Hand Function in Patients With Scleroderma: A Scleroderma Patient-centered Intervention Network (SPIN) Study|Recruiting||N/A|36|Anticipated|Lady Davis Institute||2|||f||||f|f|f||||||||2017-10-10 21:14:02.7644|2017-10-10 21:14:02.7644
NCT03092011|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-07-18|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy|Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy|Not yet recruiting||Phase 4|90|Anticipated|The Cooper Health System||2|||f||||f|t|f||||||||2017-10-10 21:14:03.034026|2017-10-10 21:14:03.034026
NCT03091998|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-07-25|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|CD-NP/LVAD||Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support|A Phase I Trial to Determine Safety and Efficacy of Chronic Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support|Withdrawn||Phase 1|0|Actual|Mayo Clinic||2||No funding available|f||||t|t|f|||f|||||2017-10-10 21:14:03.162393|2017-10-10 21:14:03.162393
NCT03091985|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-21|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|BDM||Influence of the Brownie Breast Shield on the Dynamics of Milk Removal|Influence of the Brownie Breast Shield on the Dynamics of Milk Removal|Active, not recruiting||N/A|72|Anticipated|Medela AG||2|||f||||f|f|f||||||||2017-10-10 21:14:03.265104|2017-10-10 21:14:03.265104
NCT03091972|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-21|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|LIBCAAF||Liner Ablation Using Contact-force in Atrial Fibrillation|Left Atrial Liner Block Using Contact-force Catheter in Ablation for Atrial Fibrillation|Recruiting||N/A|200|Anticipated|Korea University Anam Hospital||2|||f||||t|f|f||||||Yes||2017-10-10 21:14:03.351052|2017-10-10 21:14:03.351052
NCT03091959|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-05-22|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|PATTERNS||Profiling Implantable Cardiac Device Diagnostics Trends During Clinical Events .|Profiling of Implantable Cardiac Device Diagnostics Trends During Clinical Events for Co-morbid Conditions in Indian Patients- PATTERNS Study|Recruiting||N/A|300|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||1||f|||||f|f||||||No|All patient identifiers will be anonymized and only the final results will be shared if there is a need.|2017-10-10 21:14:03.465442|2017-10-10 21:14:03.465442
NCT03091946|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-18|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|November 1, 2017|Anticipated|2017-11-01||Interventional|||Glycemic and Insulinemic Impact of Oats With Additional Dried Fruits, Nuts and Seeds Soaked Overnight|Glycemic and Insulinemic Impact of Oats With Additional Dried Fruits, Nuts and Seeds Soaked Overnight in Skim Milk Versus Cream of Rice With Additional Dried Fruits, Nuts and Seeds|Recruiting||N/A|40|Anticipated|PepsiCo Global R&D||2|||f||||f|f|f||||||||2017-10-10 21:14:03.599143|2017-10-10 21:14:03.599143
NCT03091933|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-28|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|GLIDE||Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)|An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Anti-minor Histocompatibility Complex (MiHA) Donor T-lymphocytes Expanded ex Vivo, in Patients With a Hematologic Malignancy, With Molecular or Clinical Relapse After Hematopoietic Stem Cell Transplantation From a Matched Donor|Recruiting||Phase 1/Phase 2|20|Anticipated|Ciusss de L'Est de l'Île de Montréal||1|||f||||t|f|f||||||Undecided|De-identified individual participant data for all primary and secondary outcome measures will be made available within 6 months of study end|2017-10-10 21:14:03.702465|2017-10-10 21:14:03.702465
NCT03091907|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-04|||August 5, 2017|Actual|2017-08-05|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Long-term Consequences of Necrotizing Enterocolitis in the Newborn Period|Long-term Consequences of Necrotizing Enterocolitis in the Newborn Period: Follow-up at School Age, a Case-control Study|Recruiting||N/A|750|Anticipated|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-10 21:14:03.937135|2017-10-10 21:14:03.937135
NCT03016390|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||April 2016||2016-04-01|January 2017|2017-01-01||||April 2017|Anticipated|2017-04-01||Observational|||Electromagnetic Interference and Automobile Remote Keyless Entry in Cardiovascular Implantable Electronic Device (CIED) Patients||Active, not recruiting||N/A|100|Anticipated|Chiang Mai University|||1||f||||||||||||||2017-10-10 21:28:09.679793|2017-10-10 21:28:09.679793
NCT03091894|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy|Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy: A Prospective Randomized Controlled Study|Not yet recruiting||N/A|50|Anticipated|Zagazig University||2|||f||||f|f|f||||||No||2017-10-10 21:14:04.048151|2017-10-10 21:14:04.048151
NCT03091881|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-24|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 1, 2017|Anticipated|2017-11-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Granisetron in Diabetic Parturients Decrease Spinal Induced Hypotension|Attenuation of Spinal Induced Hypotension With Granisetron in Type I Diabetic Parturients|Not yet recruiting||Phase 4|68|Anticipated|Suez Canal University||2|||f||||f|f|f|||f|||No||2017-10-10 21:14:04.14457|2017-10-10 21:14:04.14457
NCT03091868|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||November 3, 2004|Actual|2004-11-03|March 2017|2017-03-01|February 28, 2005|Actual|2005-02-28|February 28, 2005|Actual|2005-02-28||Interventional|||Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics|A Double-blind, Randomised, Placebo-controlled Study in Healthy Volunteers to Investigate the Tolerability and Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics When Administered in Combination With a Single-dose of Levodopa/Carbidopa 100/25 mg or With a Single-dose of Levodopa/Carbidopa 100/25 mg Plus a Single-dose of Entacapone 200 mg|Completed||Phase 1|80|Actual|Bial - Portela C S.A.||4|||f||||f||f||||||Undecided||2017-10-10 21:14:04.277631|2017-10-10 21:14:04.277631
NCT03091855|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-05|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Observational|PLUG||PLUG Dementia Trial|Impact of Percutaneous Left Atrial Appendage Closure on the Cognitive Decline and Dementia in Patients With Atrial Fibrillation (PLUG Dementia Trial)|Recruiting||N/A|80|Anticipated|Intermountain Health Care, Inc.|||1||f||||f|f|f||||||No||2017-10-10 21:14:04.415541|2017-10-10 21:14:04.415541
NCT03091842|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-19|||November 20, 2017|Anticipated|2017-11-20|August 2017|2017-08-01|November 20, 2023|Anticipated|2023-11-20|November 20, 2022|Anticipated|2022-11-20||Interventional|||Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer|Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors|Not yet recruiting||N/A|300|Anticipated|University of Southern California||3|||f||||t|f|f||||||||2017-10-10 21:14:04.532092|2017-10-10 21:14:04.532092
NCT03091829|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|||Chest Pain Unit II Register|Chest Pain Unit II Register - CPU II Register|Recruiting||N/A|2000|Anticipated|Stiftung Institut fuer Herzinfarktforschung|||1||f||||f|f|f||||||No||2017-10-10 21:14:04.677323|2017-10-10 21:14:04.677323
NCT03091816|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-12|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|November 20, 2020|Anticipated|2020-11-20|November 20, 2019|Anticipated|2019-11-20||Interventional|||Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer|Dynamic Perfusion Computed Tomography Changes After Stereotactic Body Radiation Therapy for Localized Non-small Cell Lung Cancer|Not yet recruiting||N/A|7|Anticipated|University of Southern California||1|||f||||t|f|t|f|||||||2017-10-10 21:14:04.772395|2017-10-10 21:14:04.772395
NCT03091803|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-01|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|April 4, 2020|Anticipated|2020-04-04|April 4, 2019|Anticipated|2019-04-04||Interventional|||QSM and Regional DCE MRI Permeability Using GOCART Technique|Evaluation of Regional Gadolinium Retention in the Brain Using QSM With Correlation to Regional DCE MRI Permeability Using GOCART Technique in Intracranial Neoplasm Patients Receiving Gadobenate Dimeglumine (MultiHance) or Gadoterate Meglumine (Dotarem)|Recruiting||N/A|40|Anticipated|University of Southern California||2|||f||||t|f|t|f||t|||||2017-10-10 21:14:04.891379|2017-10-10 21:14:04.891379
NCT03091790|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-04-04|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Mesh Type in Ventral Hernia Repair|Mesh Type in Ventral Hernia Repair|Recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t|f|f||||||Undecided||2017-10-10 21:14:05.511866|2017-10-10 21:14:05.511866
NCT03091777|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-24|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis|A Multicenter, Randomized, Double-Blind, Vehicle Controlled Study Evaluating the Therapeutic Equivalence and Safety of GDC-229 (Investigational Metronidazole 0.75% Vaginal Gel) and Metronidazole 0.75% Vaginal Gel in the Treatment of Bacterial Vaginosis|Recruiting||Phase 3|738|Anticipated|Gage Development Company, LLC||3|||f||||f|t|f|||f|||No||2017-10-10 21:14:05.632223|2017-10-10 21:14:05.632223
NCT03091764|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||July 1, 2016|Actual|2016-07-01|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30|1 Year|Observational [Patient Registry]|||Evaluation of a Patient-Reported Symptom Index for NMIBC|Psychometric Evaluation of a Patient-Reported Symptom Index for Non-Muscle Invasive Bladder Cancer: Field Testing|Recruiting||N/A|450|Anticipated|University of Sydney|||3||f||||f|f|f||||||No||2017-10-10 21:14:05.730764|2017-10-10 21:14:05.730764
NCT03091751|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-26|2017-04-13||August 2005|Actual|2005-08-01|June 2017|2017-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||Thirteen subjects with 2 prior pharmacokinetic assessments with AlphaNine (PK1, PK2) had a third PK assessment with BeneFIX (PK3). Nine subjects had PK3 analysis with BeneFIX as part of a previous study. In total, 22 subjects treated with BeneFIX (PK3) were analyzed jointly and compared to 25 subjects treated with AlphaNine (PK2).|Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B|Efficacy and Safety of Factor IX (FIX) Contained in AlphaNine® and Its Pharmacokinetic Comparison With BeneFIX® in Patients With Severe Hereditary Haemophilia B|Completed||Phase 2|13|Actual|Grifols Biologicals Inc.||1|||f|||||t||||t|||||2017-10-10 21:14:05.844828|2017-10-10 21:14:05.844828
NCT03091738|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-07|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Ramelteon for Treatment of Insomnia in Cirrhosis|Ramelteon for Treatment of Insomnia in Cirrhosis|Recruiting||Phase 4|10|Anticipated|Virginia Commonwealth University||1|||f||||f|f|f||||||||2017-10-10 21:14:06.103472|2017-10-10 21:14:06.103472
NCT03091725|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-05-17|||April 25, 2017|Actual|2017-04-25|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||A Role for FGF21 in Postprandial Nutrient Homeostasis After RYGB|A Role for FGF21 in Postprandial Nutrient Homeostasis After RYGB|Recruiting||N/A|24|Anticipated|Washington University School of Medicine||2|||f||||t|f|f||||||||2017-10-10 21:14:06.199476|2017-10-10 21:14:06.199476
NCT03091699|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-10|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effects of Exercise and Nicotine on Cognition in Smokers|The Acute Effects of Moderate Intensity Exercise and Nicotine on Cognition in Smokers|Recruiting||Phase 3|34|Anticipated|Western University, Canada||2|||f|||||f|f|||f|||||2017-10-10 21:14:06.397454|2017-10-10 21:14:06.397454
NCT03091686|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-17|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Health Action Process Approach and Movement Patterns in Adult Office Workers|Sedentary Behaviour and Diabetes Information as a Source of Motivation to Reduce Daily Sitting Time in Adult Office Workers: An Experimental Study Using the Health Action Process Approach|Recruiting||N/A|252|Anticipated|Western University, Canada||3|||f||||f|f|f||||||||2017-10-10 21:14:06.508694|2017-10-10 21:14:06.508694
NCT03091673|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-05-08|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Glucose Response of G-Pen™ (Glucagon Injection) in Pediatric T1D Patients|A Phase 3 Study to Evaluate the Glucose Response of G-Pen™ (Glucagon Injection) in Pediatric Patients With Type 1 Diabetes|Recruiting||Phase 3|24|Anticipated|Xeris Pharmaceuticals||2|||f||||f|t|f||||||No||2017-10-10 21:14:06.607489|2017-10-10 21:14:06.607489
NCT03091660|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-07-12|||February 7, 2017|Actual|2017-02-07|July 2017|2017-07-01|February 2025|Anticipated|2025-02-01|February 2022|Anticipated|2022-02-01||Interventional|||S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer|S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer|Recruiting||Phase 3|969|Anticipated|Southwest Oncology Group||3|||f||||t|t|f||||||||2017-10-10 21:14:06.785096|2017-10-10 21:14:06.785096
NCT03091647|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-06-29|||July 1, 2016|Actual|2016-07-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Acupressure for Cancer-Related Fatigue|Acupressure Intervention to Improve Fatigue and Physical Functioning of Chinese Immigrant Breast Cancer Survivors|Recruiting||N/A|124|Anticipated|Georgetown University||2|||f||||f|f|f||||||||2017-10-10 21:14:07.09595|2017-10-10 21:14:07.09595
NCT03091634|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-07-24|||May 6, 2017|Actual|2017-05-06|April 2017|2017-04-01|December 1, 2018|Anticipated|2018-12-01|November 1, 2018|Anticipated|2018-11-01||Interventional|TROTEASOTXZC||The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome.|The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treating qi Stagnation and Blood Stasis Syndrome: a Multicenter, Double-blind, Randomized and Placebo-controlled Trial|Recruiting||Phase 2|120|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 21:14:07.186944|2017-10-10 21:14:07.186944
NCT03091621|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-27|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism|Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism|Recruiting||N/A|1000|Anticipated|Nihon University|||1||f||||f||||||||||2017-10-10 21:14:07.288076|2017-10-10 21:14:07.288076
NCT03091608|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-24|||March 25, 2017|Anticipated|2017-03-25|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|8 Weeks|Observational [Patient Registry]|||Surveillance for Early Liver Injuries Caused by Xianlin Gubao Granule|A Registry Study to Surveil Early Liver Injuries Caused by Xianlin Gubao Granule (XLGB Granule)|Not yet recruiting||N/A|1000|Anticipated|Beijing 302 Hospital|||1||f|||||f|f||||Samples With DNA|"     serum, plasma, histology and urine.   "|Undecided||2017-10-10 21:14:07.369495|2017-10-10 21:14:07.369495
NCT03091595|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-27|||February 7, 2017|Actual|2017-02-07|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||E4/DRSP Ovarian Function Inhibition Study|A Single-center, Randomized, Open-label, Two-arm Study to Evaluate the Ovarian Function Inhibition of a Monophasic Combined Oral Contraceptive (COC) Containing 15 mg Estetrol (E4) and 3 mg Drospirenone (DRSP) and a Monophasic COC Containing 20mcg Ethinylestradiol (EE)/3 mg DRSP (YAZ®), Administered Orally Once Daily in a 24/4 Day Regimen for Three Consecutive Cycles|Recruiting||Phase 2|80|Anticipated|Estetra||2|||f||||f|f|f||||||Undecided||2017-10-10 21:14:07.433453|2017-10-10 21:14:07.433453
NCT03091582|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-07-19|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Brief Inpatient Psychotherapy for Depression|Pilot Testing of a Rapid-Onset Psychological Therapy Intervention for Depressed Medical Inpatients|Recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:14:09.531352|2017-10-10 21:14:09.531352
NCT03091556|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||March 25, 2017|Anticipated|2017-03-25|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|8 Weeks|Observational [Patient Registry]|||Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.|A Registry Study to Surveil Early Liver Injuries Caused by Xianlin Gubao Pill (XLGB Pill).|Not yet recruiting||N/A|1000|Anticipated|Beijing 302 Hospital|||1||f|||||f|f||||Samples With DNA|"     Samples With DNA   "|Undecided||2017-10-10 21:14:09.746795|2017-10-10 21:14:09.746795
NCT03091543|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||May 4, 2004|Actual|2004-05-04|March 2017|2017-03-01|July 23, 2004|Actual|2004-07-23|July 23, 2004|Actual|2004-07-23||Interventional|||Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics|A Double-blind, Randomised, Crossover, Placebo-controlled Study in Healthy Volunteers to Investigate the Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics When Administered in Combination With a Single-dose of Levodopa/Benserazide 100/25 mg|Completed||Phase 1|20|Actual|Bial - Portela C S.A.||5|||f||||f|f|f||||||Undecided||2017-10-10 21:14:09.825953|2017-10-10 21:14:09.825953
NCT03091530|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-28|||January 1, 2018|Anticipated|2018-01-01|March 2017|2017-03-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Glenohumeral Rotation After Throwing: RCT Comparing the Sleeper Stretch to the 90/90 Hip Lift With Balloon Blow Exercise|Restoration of Glenohumeral Internal Rotation Deficit (GIRD) After Throwing: A Randomized Clinical Trail Comparing the Sleeper Stretch to the 90/90 Hip Lift With Balloon Blow Exercise|Not yet recruiting||N/A|50|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 21:14:09.953055|2017-10-10 21:14:09.953055
NCT03091517|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-06-23|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes|A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes|Recruiting||N/A|100|Anticipated|Duke-NUS Graduate Medical School||1|||f||||f|f|f||||||No|We do not plan to make individual participant data available to other researchers.|2017-10-10 21:14:10.027372|2017-10-10 21:14:10.027372
NCT03091504|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-26|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula|Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula|Not yet recruiting||N/A|40|Anticipated|Rush University Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:14:10.107316|2017-10-10 21:14:10.107316
NCT03091491|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-06|||April 7, 2017|Actual|2017-04-07|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer|Randomised Phase 2 Study of Nivolumab Versus Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer|Recruiting||Phase 2|184|Anticipated|National Cancer Centre, Singapore||2|||f||||f|f|f||||||||2017-10-10 21:14:10.198917|2017-10-10 21:14:10.198917
NCT03091478|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-07-31|||April 12, 2017|Actual|2017-04-12|July 2017|2017-07-01|May 30, 2022|Anticipated|2022-05-30|May 30, 2020|Anticipated|2020-05-30||Interventional|||Pembrolizumab in Patients With Leptomeningeal Disease|Pembrolizumab in Patients With Leptomeningeal Disease|Recruiting||Phase 2|18|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:14:10.310916|2017-10-10 21:14:10.310916
NCT03091465|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-21|||December 20, 2016|Actual|2016-12-20|March 2017|2017-03-01|April 17, 2017|Anticipated|2017-04-17|April 17, 2017|Anticipated|2017-04-17||Observational|Spazo-2||Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib|Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib|Recruiting||N/A|500|Anticipated|Spanish Oncology Genito-Urinary Group|||1||f|||||f|f||||||||2017-10-10 21:14:10.402072|2017-10-10 21:14:10.402072
NCT03091452|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-21|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|CASE-AF||CArdioSurgEry Atrial Fibrillation Register|CArdioSurgEry Atrial Fibrillation Register - CASE-AF Register|Recruiting||N/A|400|Anticipated|Stiftung Institut fuer Herzinfarktforschung|||1||f||||f|f|f||||||No||2017-10-10 21:14:10.838303|2017-10-10 21:14:10.838303
NCT03091439|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-18|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis|A Phase 2, Multicenter, Open-label, Randomized, Comparator-controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis Known or Suspected to be Due to Gram-positive Organisms|Terminated||Phase 2|1|Actual|Allergan||2||Business decision outlined by the corporation.|f|||||t|f||||||||2017-10-10 21:14:10.925565|2017-10-10 21:14:10.925565
NCT03091426|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-07-18|||March 8, 2017|Actual|2017-03-08|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis|A Randomized, Double-blind, Placebo-controlled Study to Assess the Pharmacodynamics, Safety, Tolerability and Efficacy of Omiganan BID in Patients With Mild to Moderate Atopic Dermatitis|Recruiting||Phase 2|80|Anticipated|Cutanea Life Sciences, Inc.||4|||f||||f|f|f||||||||2017-10-10 21:14:11.032904|2017-10-10 21:14:11.032904
NCT03091413|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-28|||March 17, 2017|Actual|2017-03-17|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Correlation Between Pi Max and Diaphragm Maximum Inspiratory Excursion Detected With Ultrasound During Weaning|Correlation Between Pi Max and Diaphragm Maximum Inspiratory Excursion Detected With Ultrasound During Weaning|Recruiting||N/A|20|Anticipated|Corporacion Parc Tauli|||1||f|||||f|f||||||||2017-10-10 21:14:11.151548|2017-10-10 21:14:11.151548
NCT03091400|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-04|||March 28, 2017|Actual|2017-03-28|April 2017|2017-04-01|March 13, 2018|Anticipated|2018-03-13|March 13, 2018|Anticipated|2018-03-13||Interventional|||Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)|Phase Two Randomized Controlled Crossover Trial of Atomoxetine to Treat Memory Impairment Due to Multiple Sclerosis|Recruiting||Phase 2|24|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|t|f||||||||2017-10-10 21:14:11.239509|2017-10-10 21:14:11.239509
NCT03091387|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Observational|||Utility of Spontaneous Breathing Trial (SBT) Using ET-CPAP, in Predicting Extubation Failure in Neonates|Utility of Spontaneous Breathing Trial (SBT) Using ET-CPAP, in Predicting Extubation Failure in Neonates|Not yet recruiting||N/A|110|Anticipated|Aga Khan University|||1||f||||f|f|f||||||No||2017-10-10 21:14:11.344108|2017-10-10 21:14:11.344108
NCT03091374|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-25|||December 2016||2016-12-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Recombinant Human Growth Hormone on HIV Persistence|A Proof-of-concept Study to Assess the Effect of Recombinant Human Growth Hormone on the Size of the Replication-competent Viral Reservoir in HIV-infected Individuals on Suppressive Antiretroviral Therapy|Recruiting||Phase 2|22|Anticipated|McGill University Health Center||1|||f||||t||||||||||2017-10-10 21:14:11.429472|2017-10-10 21:14:11.429472
NCT03090633|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-20|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|April 2027|Anticipated|2027-04-01|April 2024|Anticipated|2024-04-01||Interventional|||Fetoscopic Repair of Isolated Fetal Spina Bifida|Study of Fetoscopic Repair of Myelomeningocele in Fetuses With Isolated Spina Bifida|Recruiting||N/A|10|Anticipated|Johns Hopkins University||1|||f||||t|f|t|f|f||||Undecided||2017-10-10 21:14:17.695872|2017-10-10 21:14:17.695872
NCT03091361|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-03-24|||June 2016||2016-06-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Observational|||Post Market Clinical Followup of MolecuLight i:X's PPV to Predict Presence of Bacteria in Wounds|A Prospective, Single-blind Evaluation of the Positive Predictive Value (PPV) of the MolecuLight i:X™ Imaging Device to Predict the Presence of Bacteria in Chronic Wounds|Completed||N/A|36|Actual|MolecuLight Inc.|||1||f||||f||||||||No||2017-10-10 21:14:11.524894|2017-10-10 21:14:11.524894
NCT03091348|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-21|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Subcutaneous vs. Intramuscular Testosterone|Subcutaneous Testosterone Therapy in Men Compared to Intramuscular Testosterone Therapy in Men|Recruiting||Phase 4|20|Anticipated|Men's Health Boston||2|||f|||||t|f||||||||2017-10-10 21:14:11.623427|2017-10-10 21:14:11.623427
NCT03091335|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-01|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|May 30, 2018|Anticipated|2018-05-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Music-listening During Deep Brain Stimulation to Relieve Anxiety|The Effects of Music Listening on Intra-operative Anxiety in Patients Undergoing Awake Deep Brain Stimulation for Movement Disorders.|Recruiting||N/A|10|Anticipated|The Cleveland Clinic||2|||f||||f|f|f||||||No||2017-10-10 21:14:11.739871|2017-10-10 21:14:11.739871
NCT03091322|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-05-15|||February 12, 2017|Actual|2017-02-12|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||"BIO|MASTER.Edora Family Study"|"BIO|MASTER.Edora Family Study"|Recruiting||N/A|115|Anticipated|Biotronik SE & Co. KG|||4||f|||||f|f||||||||2017-10-10 21:14:11.82829|2017-10-10 21:14:11.82829
NCT03091309|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|||Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease|Counseling to Optimize Medication Adherence in Expectant Mothers With Inflammatory Bowel Disease (COACH-IBD)|Not yet recruiting||N/A|220|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f|f|f||||||||2017-10-10 21:14:11.924019|2017-10-10 21:14:11.924019
NCT03091296|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-21|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||Diurnal Testosterone Concentration|Diurnal Testosterone Concentrations in Men With and Without Testosterone Deficiency|Recruiting||N/A|24|Anticipated|Men's Health Boston|||2||f|||||f|f||||||||2017-10-10 21:14:12.061549|2017-10-10 21:14:12.061549
NCT03091283|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|July 1, 2017|Anticipated|2017-07-01|June 1, 2017|Anticipated|2017-06-01||Observational|||Time Management in Nurse Anaesthetist Students|A Survey Study of Time Management in Nurse Anaesthetist Students|Not yet recruiting||N/A|30|Anticipated|Siriraj Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:14:12.154693|2017-10-10 21:14:12.154693
NCT03091270|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-21|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|||ZOOMit-fMRI Identifies Motor Functional Cortex|The Application of ZOOMit-fMRI to Identify Motor Functional Cortex|Recruiting||N/A|60|Anticipated|Beijing Neurosurgical Institute|||2||f||||||||||||||2017-10-10 21:14:12.274329|2017-10-10 21:14:12.274329
NCT03091257|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-05-08|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma|An Open-label, Pilot Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1|60|Anticipated|Massachusetts General Hospital||3|||f||||t|t|f||||||No||2017-10-10 21:14:12.455645|2017-10-10 21:14:12.455645
NCT03091244|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-21|||March 25, 2017|Anticipated|2017-03-25|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|8 Weeks|Observational [Patient Registry]|||Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.|A Registry Study to Surveil Early Liver Injuries Caused by Xianlin Gubao Capsule (XLGB Capsule)|Not yet recruiting||N/A|1000|Anticipated|Beijing 302 Hospital|||1||f|||||f|f||||Samples With DNA|"     serum, plasma, histology and urine.   "|Undecided||2017-10-10 21:14:12.606154|2017-10-10 21:14:12.606154
NCT03091231|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-05|||May 15, 2017|Actual|2017-05-15|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Multiparametric Ultrasound-Study for the Detection of Prostate Cancer|Multiparametric Ultrasound - Contrast Enhanced Ultrasound and Shear Wave Elastography Compared to Radical Prostatectomy Specimens in 50 Patients|Recruiting||N/A|50|Anticipated|Martini-Klinik am UKE GmbH|||1||f||||f|f|f||||||||2017-10-10 21:14:12.734445|2017-10-10 21:14:12.734445
NCT03091218|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-21|||March 25, 2017|Anticipated|2017-03-25|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|8 Weeks|Observational [Patient Registry]|||Surveillance for Early Liver Injuries Caused by Runzao Zhiyang Capsule.|A Registry Study to Surveil Early Liver Injuries Caused by Runzao Zhiyang Capsule (RZZY Capsule).|Not yet recruiting||N/A|1000|Anticipated|Beijing 302 Hospital|||1||f||||t|f|f||||Samples With DNA|"     serum, plasma, histology and urine.   "|Undecided||2017-10-10 21:14:12.8535|2017-10-10 21:14:12.8535
NCT03091205|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-12|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|April 15, 2019|Anticipated|2019-04-15|April 15, 2019|Anticipated|2019-04-15||Observational|Maze||Proper Extent of Maze Intercaval Lesion|Proper Extent of Maze Intercaval Lesion|Not yet recruiting||N/A|50|Anticipated|Baylor Research Institute|||1||f|||||f|f||||||||2017-10-10 21:14:12.958443|2017-10-10 21:14:12.958443
NCT03091179|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-04-24|||March 17, 2017|Actual|2017-03-17|April 2017|2017-04-01|June 12, 2018|Anticipated|2018-06-12|March 12, 2018|Anticipated|2018-03-12||Interventional|||Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Short Laryngologic Surgery|The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Short Laryngologic Surgical Procedures.|Recruiting||N/A|40|Anticipated|Stanford University||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:14:13.306548|2017-10-10 21:14:13.306548
NCT03091166|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||December 2016||2016-12-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Perioperative Dexmedetomidine Administration on Outcomes in Cardiac Surgery Patients|The Effect of Prophylactic Dexmedetomidine Administration on the Incidence and Severity of Development of Multiple Organ Dysfunction Syndrome in Patients Undergoing Surgery With Cardiopulmonary Bypass|Recruiting||Phase 4|130|Anticipated|Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy||2|||f||||f||||||||Undecided||2017-10-10 21:14:13.406666|2017-10-10 21:14:13.406666
NCT03091153|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-05-17|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Deprescribing in a Long Term Care Facility|Impact of a Deprescribing Intervention on Nursing Home Residents: a Randomized Controlled Trial|Recruiting||N/A|66|Anticipated|Memorial University of Newfoundland||2|||f||||f|f|f||||||No||2017-10-10 21:14:13.507396|2017-10-10 21:14:13.507396
NCT03091140|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-21|||December 25, 2016|Actual|2016-12-25|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Alterations in Muscle's Functional Characteristics After Parathyroid Surgery for Primary Hyperparathyroidism.|Alterations in Muscle's Functional Characteristics After Parathyroid Surgery for Primary Hyperparathyroidism.|Recruiting||N/A|200|Anticipated|Aristotle University Of Thessaloniki|||4||f||||f|f|f||||||No||2017-10-10 21:14:13.603305|2017-10-10 21:14:13.603305
NCT03091127|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-10-04|||March 14, 2017|Actual|2017-03-14|October 2017|2017-10-01|March 17, 2020|Anticipated|2020-03-17|March 17, 2020|Anticipated|2020-03-17||Observational|||Real-world Use of Carfilzomib Among Patients With Relapsed MM in Europe|Real-world Evidence of the Use of Carfilzomib Among Patients With Relapsed Multiple Myeloma in Europe|Recruiting||N/A|1000|Anticipated|Amgen|||1||f||||f|f|f||||||||2017-10-10 21:14:13.756517|2017-10-10 21:14:13.756517
NCT03091114|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-05-04|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Observational|||Predictive Factors for Failure of Internal Fixations of Lower Limb Fractures|Predictive Factors for Failure of Internal Fixations of Lower Limb Fractures: a Prospective Cohort Study|Recruiting||N/A|300|Anticipated|University of Witten/Herdecke|||1||f||||f|f|f||||||Yes|All data on predictive factors and outcomes will be made available. Published as supplemental material open access (anticipated 12/2018).|2017-10-10 21:14:13.950081|2017-10-10 21:14:13.950081
NCT03091101|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-18|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Impact of Scleral Contact Lens Wear on Corneal Nerves in Keratoconus|Impact of Scleral Contact Lens Wear on Corneal Sensitivity, Nerve Morphology and Inflammation in Keratoconic Eyes|Recruiting||N/A|15|Anticipated|University of Waterloo||1|||f||||f|f|f|||f|||Undecided||2017-10-10 21:14:14.034182|2017-10-10 21:14:14.034182
NCT03091088|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||February 1, 2011|Actual|2011-02-01|March 2017|2017-03-01|December 30, 2016|Actual|2016-12-30|July 1, 2013|Actual|2013-07-01||Interventional|Osteo_women||Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women|Efecto de Dos Tipos de Ejercicio físico Para Prevenir la Osteoporosis en Mujeres Postmenopausicas, un Ensayo Clinico Aleatorizado|Completed||N/A|36|Actual|University of Valencia||2|||f||||f|f|f||||||Undecided||2017-10-10 21:14:14.147525|2017-10-10 21:14:14.147525
NCT03091075|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-09-14|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|ORCT||Oxandrolone Rotator Cuff Trial|Ability of Oral Steroid (Oxandrolone) to Halt Fatty Infiltration and Aid Rotator Cuff Healing: A Double-Blind, Randomized Clinical Trial|Not yet recruiting||Phase 2|144|Anticipated|University of Southern California||2|||f||||f|t|f|||t|||||2017-10-10 21:14:14.233692|2017-10-10 21:14:14.233692
NCT03091062|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-10-03|||March 30, 2017|Actual|2017-03-30|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of an Airway Clearance System|Evaluation of the Effectiveness of the Monarch™ Airway Clearance System as Determined by Mucus Production|Recruiting||N/A|10|Anticipated|Hill-Rom||1|||f||||f|f|f|||f|||||2017-10-10 21:14:14.36609|2017-10-10 21:14:14.36609
NCT03091049|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-21|||November 1, 2014|Actual|2014-11-01|March 2017|2017-03-01|January 10, 2018|Anticipated|2018-01-10|January 1, 2018|Anticipated|2018-01-01||Observational|||RAOLA Observational: Local Anesthesia During Cardiac Catheterization|Trans-radial Cardiac Catheterization Local Anesthesia: an Observational Study|Recruiting||N/A|800|Anticipated|Hippocration General Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:14:14.459863|2017-10-10 21:14:14.459863
NCT03091036|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-07|||July 2015||2015-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|CCP||Impact of a Health Intervention on Some Indicators in the Care of Chronic Complex Patient (CCP).|Impact of a Proactive and Integrated Health Intervention Between Different Assistance Levels Over Some Indicators in the Care of Chronic Complex Patient (CCP)|Completed||N/A|28|Actual|Hospital Universitario 12 de Octubre||1|||f||||f|f|f||||||No||2017-10-10 21:14:14.537113|2017-10-10 21:14:14.537113
NCT03091023|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-03-21|||March 2016||2016-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Quantitative Identification of Implantation Receptivity by Single Cell Transcriptome Analysis|Non-invasive Transcriptomic Signature at the Single Cell Level in Endometrial Fluid as a Novel Diagnostic Test of Human Endometrial Receptivity|Active, not recruiting||N/A|70|Anticipated|Igenomix||2|||f||||f||||||||No||2017-10-10 21:14:14.616431|2017-10-10 21:14:14.616431
NCT03091010|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-15|||April 8, 2017|Actual|2017-04-08|March 2017|2017-03-01|April 8, 2019|Anticipated|2019-04-08|April 8, 2019|Anticipated|2019-04-08||Interventional|||A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.|A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis A Randomized Controlled Trial.|Recruiting||N/A|130|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f|f|f||||||No||2017-10-10 21:14:14.696692|2017-10-10 21:14:14.696692
NCT03090997|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-29|||November 15, 2017|Anticipated|2017-11-15|August 2017|2017-08-01|August 20, 2020|Anticipated|2020-08-20|November 30, 2019|Anticipated|2019-11-30||Interventional|||Effect of Resveratrol and Vitamin C on Insulin Resistance Among Postmenopausal Women|Effect of Resveratrol and Vitamin C on Insulin Resistance and Antioxidant Capacity in Postmenopausal Women. A Randomized Clinical Trial|Not yet recruiting||N/A|270|Anticipated|Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes||3|||f||||t|f|f||||||||2017-10-10 21:14:14.781534|2017-10-10 21:14:14.781534
NCT03090984|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-11|||May 8, 2017|Actual|2017-05-08|August 2017|2017-08-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|c-phact||Evaluation of Contact Phase Activation During Hemodialysis|Evaluation of Contact Phase Activation During Hemodialysis Using Different Dialysis Membranes: a Prospective Randomized Crossover Study|Completed||N/A|10|Actual|Universitair Ziekenhuis Brussel||3|||f||||f|f|f|||f|||||2017-10-10 21:14:14.872027|2017-10-10 21:14:14.872027
NCT03090971|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-20|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|March 23, 2017|Anticipated|2017-03-23||Interventional|||Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1|Clinical Assessment of the Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With Neurofibromatosis Type 1|Active, not recruiting||Phase 2|7|Anticipated|Fundação Educacional Serra dos Órgãos||1|||f||||t|t|f|||f|||No||2017-10-10 21:14:15.092339|2017-10-10 21:14:15.092339
NCT03090958|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-20|||August 1, 2015|Actual|2015-08-01|March 2017|2017-03-01|January 3, 2017|Actual|2017-01-03|January 3, 2017|Actual|2017-01-03||Interventional|AQ||AllyQuest: Engaging HIV+ YMSM in Care Through Social Networking and Gamification|AllyQuest: Engaging HIV+ YMSM in Care Through Social Networking and Gamification|Completed||N/A|20|Actual|University of North Carolina, Chapel Hill||1|||f||||f|f|f||||||No||2017-10-10 21:14:15.192429|2017-10-10 21:14:15.192429
NCT03090945|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-18|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 1, 2020|Anticipated|2020-12-01|March 1, 2020|Anticipated|2020-03-01|6 Months|Observational [Patient Registry]|TRIAGE||Pediatric Acute Gastrointestinal Bleeding Registry|Pediatric Acute Bleeding Registry: Identification of Clinical, Laboratory and Endoscopic Risk Factors Associated With Pediatric Upper Gastrointestinal Bleeding|Recruiting||N/A|300|Anticipated|Boston Children’s Hospital|||1||f||||f|f|f||||||||2017-10-10 21:14:15.283875|2017-10-10 21:14:15.283875
NCT03090932|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||January 18, 2016|Actual|2016-01-18|March 2017|2017-03-01|July 1, 2018|Anticipated|2018-07-01|January 18, 2018|Anticipated|2018-01-18||Observational|||Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS|Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS|Recruiting||N/A|25|Anticipated|University of Michigan|||1||f||||f|f|f||||Samples With DNA|"     Innate lymphoid cells from whole blood   "|Undecided||2017-10-10 21:14:15.398537|2017-10-10 21:14:15.398537
NCT03090919|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-03-20|||January 3, 2017|Actual|2017-01-03|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|INFUSE||The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis|The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis|Recruiting||N/A|50|Anticipated|University of Kentucky||2|||f||||t|f|f||||||No||2017-10-10 21:14:15.47774|2017-10-10 21:14:15.47774
NCT03090906|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-05-03|||April 2015||2015-04-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|March 2017|Actual|2017-03-01||Interventional|||Soft Tissue Volume Gain and Stability Comparing Palate and Tuberosity|Clinical and Histological Analysis of Soft Tissue Volume Gain and Stability Around Dental Implants Using Autogenous Subepithelial Connective Tissue Grafts Harvested From the Palate or Tuberosity. A Randomized Controlled Clinical Study|Active, not recruiting||N/A|32|Actual|Universitat Internacional de Catalunya||2|||f||||f|f|f||||||No||2017-10-10 21:14:15.595807|2017-10-10 21:14:15.595807
NCT03090880|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-03-21|||April 2017|Anticipated|2017-04-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|December 2020|Anticipated|2020-12-01||Interventional|PROVE||Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)|Long-term Prophylaxis of Venous Thromboembolism With Low-molecular-weight Heparin in Patients With Metastatic Lung Cancer|Not yet recruiting||Phase 3|800|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||Undecided||2017-10-10 21:14:15.774165|2017-10-10 21:14:15.774165
NCT03090867|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-25|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|PARTICIPATE||Participation of Relative or Surrogate in the Patient's Care in Reanimation|Participation of Relative or Surrogate in the Patient's Care in Reanimation|Not yet recruiting||N/A|140|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:14:15.93967|2017-10-10 21:14:15.93967
NCT03090854|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Observational|CHOLINE||Cholinergic Markers Alzheimer's Disease|Cholinergic Markers as Predictive Tools of Therapeutic Response in Alzheimer's Disease (CHOLINE)|Not yet recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||||2017-10-10 21:14:16.047716|2017-10-10 21:14:16.047716
NCT03090841|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-03-21|||December 2016||2016-12-01|March 2017|2017-03-01|June 2023|Anticipated|2023-06-01|December 2022|Anticipated|2022-12-01||Observational|BIO-CCMV||Biomarkers of Cytomegalovirus Fetal Infection and Disease|Biomarkers of Fetal Infection and Disease Following Maternal HCMV Infection|Recruiting||N/A|265|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     -  Amniotic fluid (2ml)        -  Fetal blood (2 ml)        -  Maternal blood (5 ml)        -  Cord blood (50 ml)        -  Neonatal blood (2 ml)        -  Neonatal urine (2 ml   "|No||2017-10-10 21:14:16.139437|2017-10-10 21:14:16.139437
NCT03090828|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-21|||September 2017|Anticipated|2017-09-01|February 2017|2017-02-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Interventional|PIC-R||Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease|Economic Evaluation of an Interactive Community-based Patient Education Platform Kidney Dialysis and Transplantation|Not yet recruiting||N/A|1600|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f|f|f||||||Undecided|JPAL plans to share the de-identified patient database|2017-10-10 21:14:16.240876|2017-10-10 21:14:16.240876
NCT03090815|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-20|||February 2016||2016-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma|Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma|Recruiting||N/A|100|Anticipated|The University of Hong Kong|||3||f||||f||||||||||2017-10-10 21:14:16.329468|2017-10-10 21:14:16.329468
NCT03090802|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-05-23|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|MAMAS||MAMAS: Mentoring Adolescent Mothers at School|Re-enrolling Young South African Mothers in School as a Social Vaccine Against HIV Transmission|Not yet recruiting||N/A|480|Anticipated|Drexel University||2|||f||||f|f|f||||||Yes|Persons requesting permission to access non-biological data (behavioral assessments) will communicate with the project PI, Dr. Ali Groves, who will provide/decline permission. Persons requesting permission to access biological data (biological assessments and specimens) will communicate with the site PI, Dr. Daya Moodley, who will provide/decline permission. If permission is granted, the relevant research staff will be alerted to the release of samples/data as requested. A list of the participant samples/data being released will be provided to the PI, and the person requesting the data. Both will acknowledge release and receipt of samples/data. Data that will be provided with the samples will be limited to demographic data, no personal participant information will be provided; only participant identifiers will be used to identify the specific sample/data requested.|2017-10-10 21:14:16.447424|2017-10-10 21:14:16.447424
NCT03090789|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-21|||January 1, 2001|Actual|2001-01-01|March 2017|2017-03-01|January 1, 2030|Anticipated|2030-01-01|January 1, 2030|Anticipated|2030-01-01|15 Years|Observational [Patient Registry]|FA-COMS||FA Clinical Outcome Measures|Clinical Outcome Measures in Friedreich's Ataxia|Recruiting||N/A|1500|Anticipated|Children's Hospital of Philadelphia|||1||f||||f|f|f||||Samples With DNA|"     Optional sample collection offered to study participants; whole blood and/or cheek swab may     be collected as a one-time procedure.   "|No||2017-10-10 21:14:16.547464|2017-10-10 21:14:16.547464
NCT03090776|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-24|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Prevention of Post Mastectomy With Intraoperative Ketamine|Prevention of Post-Mastectomy Pain With Perioperative Ketamine Administration: A Randomized, Placebo-controlled Trial|Not yet recruiting||Early Phase 1|200|Anticipated|Brigham and Women's Hospital||2|||f||||f|t|f|||t|||No||2017-10-10 21:14:16.677506|2017-10-10 21:14:16.677506
NCT03090763|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|June 1, 2019|Anticipated|2019-06-01|May 1, 2018|Anticipated|2018-05-01||Observational|||"Role of Circulating MicroRNAs in Pathogenesis of Aneurysms of the Abdominal and Thoracic Aorta - Study Micro AAA"|"Role of Circulating MicroRNAs in Pathogenesis of Aneurysms of the Abdominal and Thoracic Aorta - Study Micro AAA"|Recruiting||N/A|200|Anticipated|Charles University, Czech Republic|||2||f||||f|f|f||||||No||2017-10-10 21:14:16.757717|2017-10-10 21:14:16.757717
NCT03090750|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-24|||July 16, 2015|Actual|2015-07-16|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|December 19, 2016|Actual|2016-12-19||Interventional|||Effects of Aromatherapy on Anxiety in Invasive Radiologic Procedure|What is the Effect of Using Aromatherapy to Reduce Anxiety in Patients Undergoing Invasive Radiologic Procedures?|Active, not recruiting||Phase 1|31|Actual|Carolinas Healthcare System||3|||f|||||t|f||||||||2017-10-10 21:14:16.841484|2017-10-10 21:14:16.841484
NCT03090737|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-10-04|||May 26, 2017|Actual|2017-05-26|October 2017|2017-10-01|December 6, 2020|Anticipated|2020-12-06|April 29, 2020|Anticipated|2020-04-29||Interventional|CheckMate 907||Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer|An Open-label, Single-arm Phase II Safety Study of Nivolumab in Participants With Advanced or Metastatic Non-small Cell Lung Cancer Who Have Progressed During or After Receiving at Least One Prior Systemic Regimen (CheckMate 907: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 907)|Recruiting||Phase 2|50|Anticipated|Bristol-Myers Squibb||1|||f||||f|f|f||||||||2017-10-10 21:14:16.916691|2017-10-10 21:14:16.916691
NCT03090724|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||June 13, 2008|Actual|2008-06-13|March 2017|2017-03-01|August 12, 2008|Actual|2008-08-12|August 12, 2008|Actual|2008-08-12||Interventional|||Pharmacokinetics of BIA 5-453 and Its Metabolites|Single-dose and Steady-state Pharmacokinetics of BIA 5-453 and Its Metabolites in Healthy Male Elderly Subjects Compared With Those in Healthy Male Young Subjects|Completed||Phase 1|25|Actual|Bial - Portela C S.A.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:14:17.031459|2017-10-10 21:14:17.031459
NCT03090711|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-14|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|SSS||Sleep as a Model to Understand and Manipulate Cortical Activity in Order to Promote Functional Recovery After Stroke|Sleep as a Model to Understand and Manipulate Cortical Activity in Order to Promote Neuroplasticity and Functional Recovery After Stroke|Recruiting||N/A|60|Anticipated|University Hospital Inselspital, Berne||4|||f||||f|f|f||||||||2017-10-10 21:14:17.111891|2017-10-10 21:14:17.111891
NCT03090698|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-20|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Outcomes of Injections in Patients Waiting for Total Knee Replacement|Viscosupplementation in Patients With Severe Osteoarthritis of the Knee|Recruiting||Phase 4|120|Anticipated|Universidade Federal Fluminense||3|||f|||||t|f|||t|||Undecided||2017-10-10 21:14:17.211967|2017-10-10 21:14:17.211967
NCT03090685|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-09|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Effects of Auriculotherapy on Pain and Functional Capacity of Individuals With Chikungunya Fever|Effects of Auriculotherapy on Pain and Functional Capacity of Individuals With Chikungunya Fever|Active, not recruiting||N/A|50|Anticipated|Universidade Federal do Ceara||2|||f||||t|f|f||||||No||2017-10-10 21:14:17.306176|2017-10-10 21:14:17.306176
NCT03090672|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-27|||March 11, 2017|Actual|2017-03-11|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|August 31, 2019|Anticipated|2019-08-31||Interventional|BRT||Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease|Use of Cellular and Biocellular Therapy in Musculoskeletal Pain, Dysfunction, Degenerative or Inflammatory Disease|Recruiting||N/A|300|Anticipated|Regeneris Medical||3|||f||||t|f|t|f|f|f|||||2017-10-10 21:14:17.408961|2017-10-10 21:14:17.408961
NCT03090659|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-07-05|||October 2, 2015|Actual|2015-10-02|July 2017|2017-07-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|LEGEND-2||LCAR-B38M-02 Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma|A Clinical Study of Legend Biotech BCMA-chimeric Antigen Receptor Technology in Treating Relapsed/Refractory (R/R) Multiple Myeloma Patients|Enrolling by invitation||Phase 1/Phase 2|100|Anticipated|Nanjing Legend Biotech Co.||1|||f||||t|f|f||||||||2017-10-10 21:14:17.524935|2017-10-10 21:14:17.524935
NCT03090646|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-09-05|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|April 1, 2023|Anticipated|2023-04-01|April 1, 2023|Anticipated|2023-04-01||Interventional|||Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance|Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance|Recruiting||N/A|320|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-10 21:14:17.587994|2017-10-10 21:14:17.587994
NCT03090620|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-06-09|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|TAAT||Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome|A Randomized Trial Comparing Physostigmine vs Lorazepam for Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome|Recruiting||Phase 4|28|Anticipated|University of Colorado, Denver||2|||f||||f|t|f|||f|||No||2017-10-10 21:14:17.826453|2017-10-10 21:14:17.826453
NCT03090607|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|NECTAR||Novel Endoluminal Clinical TreAtment of Reflux|A 12-month Double-blind, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Efficacy of Endoluminal Aluvra™ for the Treatment of Gastroesophageal Reflux Disease|Not yet recruiting||N/A|100|Anticipated|Impleo Medical Inc.||2|||||||t|f|t|t|f||||||2017-10-10 21:14:17.905708|2017-10-10 21:14:17.905708
NCT03090594|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|September 17, 2017|Anticipated|2017-09-17||Interventional|||Transbronchial Cryobiopsy in Lung Transplant Patients|Diagnostic Performance and Complications of Transbronchial Cryobiopsy in Lung Transplant Patients According to the Number of Samples Obtained|Recruiting||N/A|50|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||f|f|f||||||No||2017-10-10 21:14:17.966709|2017-10-10 21:14:17.966709
NCT03090581|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-27|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Transbronchial Biopsies With Cryoprobe in Patients With Lung Transplantation.|Prospective Study of Transbronchial Biopsies With Cryoprobe in Patients With Lung Transplantation Admitted to an Intensive Care Unit.|Recruiting||N/A|132|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||f|f|f||||||No|no.|2017-10-10 21:14:18.056652|2017-10-10 21:14:18.056652
NCT03090568|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||July 15, 2008|Actual|2008-07-15|March 2017|2017-03-01|August 14, 2008|Actual|2008-08-14|August 14, 2008|Actual|2008-08-14||Interventional|||Bioavailability Study of BIA 5-453|Comparative Bioavailability Study of BIA 5-453 Under Fasted and Fed Conditions|Completed||Phase 1|12|Actual|Bial - Portela C S.A.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:14:18.238432|2017-10-10 21:14:18.238432
NCT03090555|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||January 5, 2004|Actual|2004-01-05|March 2017|2017-03-01|April 27, 2011|Actual|2011-04-27|May 31, 2006|Actual|2006-05-31||Interventional|TMACS||Translational Manipulation Under Interscalene Block for Adhesive Capsulitis of the Shoulder (TMACS)|The Effectiveness of Translational Manipulation Under Interscalene Block for Treatment of Adhesive Capsulitis of the Shoulder: A Randomized Clinical Trial|Completed||N/A|18|Actual|Brooke Army Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:14:18.335722|2017-10-10 21:14:18.335722
NCT03090542|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-19|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 15, 2017|Anticipated|2017-12-15|September 15, 2017|Anticipated|2017-09-15||Interventional|GLOCK-pilot||GPur- Luminating Oral Cholesterol Kinetics Pilot Study|39 Day Randomized, Open Label, Two Arm Cross Over Study of Clinoptilolite (Gpur) in Healthy Adult Subjects Not Requiring or Receiving Lipid Lowering Therapy|Recruiting||N/A|22|Anticipated|Canadian Collaborative Research Network||2|||f||||t|f|f||||||||2017-10-10 21:14:18.43753|2017-10-10 21:14:18.43753
NCT03090529|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-20|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|EnRIcH||The Role of Exercise Training in the Treatment of Resistant Hypertension|The Role of Exercise Training in the Treatment of Resistant Hypertension|Recruiting||N/A|60|Anticipated|Aveiro University||2|||f||||t|f|f||||||No||2017-10-10 21:14:18.535233|2017-10-10 21:14:18.535233
NCT03090516|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-23|||August 10, 2016|Actual|2016-08-10|March 2017|2017-03-01|March 10, 2018|Anticipated|2018-03-10|March 10, 2018|Anticipated|2018-03-10||Interventional|||Clinical Study on Improving the Cognitive Function of Patients With Mild to Moderate Alzheimer's Disease by Using Ginkgo Biloba Dispersible Tablets|Clinical Study on Improving the Cognitive Function of Patients With Mild to Moderate Alzheimer's Disease by Using Ginkgo Biloba Dispersible Tablets|Recruiting||Phase 2/Phase 3|240|Anticipated|The First Affiliated Hospital with Nanjing Medical University||3|||f|||||f|f||||||||2017-10-10 21:14:18.648554|2017-10-10 21:14:18.648554
NCT03090503|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|PAFIP3_3Y||Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up|Open Flexible-dose Randomized Study of the Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: A 3-year Follow-up|Enrolling by invitation||Phase 4|200|Anticipated|Fundación Marques de Valdecilla||2|||f||||f|f|f||||||No||2017-10-10 21:14:18.760262|2017-10-10 21:14:18.760262
NCT03090490|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADARFEP_10Y||10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals|Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-episode Non-affective Psychosis Individuals: a 10-year Follow-up|Enrolling by invitation||N/A|68|Anticipated|Fundación Marques de Valdecilla||2|||f||||f|f|f||||||No||2017-10-10 21:14:18.861199|2017-10-10 21:14:18.861199
NCT03090477|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-26|||March 24, 2017|Actual|2017-03-24|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients|Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients. A Randomised Control Trial|Recruiting||N/A|98|Anticipated|UCSI University||2|||f||||f|f|f||||||No||2017-10-10 21:14:18.955765|2017-10-10 21:14:18.955765
NCT03090451|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-18|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Exercise Physiology Study|Evaluating the Dynamics of Insulin and Non-insulin Mediated Effects on Glucose During Aerobic Exercise in Subjects With Type 1 Diabetes|Recruiting||N/A|26|Anticipated|Oregon Health and Science University||2|||f||||f|f|f|||f|||||2017-10-10 21:14:19.278012|2017-10-10 21:14:19.278012
NCT03090438|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||May 2017|Anticipated|2017-05-01|October 2016|2016-10-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||IVF Outcomes After Varicocele Repair|The Effect of Preliminary Varicocele Repair on IVF Outcomes in Male Factor Infertility|Not yet recruiting||N/A|250|Anticipated|Shaare Zedek Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:14:19.404313|2017-10-10 21:14:19.404313
NCT03090425|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|Ikarius||Inflammatory/Familial Dilated Cardiomyopathy: Is There a Link to Autoimmune Diseases? TP9a|Inflammatory/Familial Dilated Cardiomyopathy: Is There a Link to Autoimmune Diseases? TP9a of the KNHI Associated to the DZHK|Active, not recruiting||N/A|320|Actual|Philipps University Marburg Medical Center|||1||f||||t|f|f||||||Yes||2017-10-10 21:14:19.494788|2017-10-10 21:14:19.494788
NCT03090412|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-10-05|||March 30, 2017|Actual|2017-03-30|October 2017|2017-10-01|November 2, 2021|Anticipated|2021-11-02|November 2, 2020|Anticipated|2020-11-02||Interventional|||Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer|A Randomized Multicenter Phase II Study Using (2-1[Heyloxyethyl]-2-Devinylpyropheophorbide-a) (HPPH) With PDT Versus Standard of Care Surgery for Patients With T1/T2 N0 Squamous Cell Carcinoma of the Oral Cavity|Recruiting||Phase 2|114|Anticipated|Roswell Park Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 21:14:19.558962|2017-10-10 21:14:19.558962
NCT03090399|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-03-20|||January 2012|Actual|2012-01-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|July 2015|Actual|2015-07-01||Interventional|||Fluid ORiented Therapy for yoUNg Asa 1patients|Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery|Completed||N/A|60|Actual|Policlinico Universitario Agostino Gemelli||2|||f||||t||||||||Yes||2017-10-10 21:14:19.67237|2017-10-10 21:14:19.67237
NCT03090386|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-23|||February 25, 2017|Actual|2017-02-25|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Observational|||Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients|Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients|Recruiting||N/A|40|Anticipated|Mayo Clinic|||1||f||||f|f|f||||||||2017-10-10 21:14:19.739472|2017-10-10 21:14:19.739472
NCT03090373|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Effect of Surface Acoustic Waves on the Prevention of Colonization in Longterm Indwelling Urinary Caatheters|The Effect of Surface Acoustic Waves on the Prevention of Bacterial Colonization in Longterm Indwelling Urinary Catheters|Enrolling by invitation||N/A|63|Anticipated|Rosenblum, Jonathan I., DPM||2|||f||||t|f|f||||||No|Data will NOT be shared beyond the investigators of this study.|2017-10-10 21:14:19.807607|2017-10-10 21:14:19.807607
NCT03090360|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-20|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Growth of Infants Fed a New Term Infant Formula|Growth of Infants Fed a New Term Infant Formula With a Prebiotic|Recruiting||N/A|350|Anticipated|Nestlé||3|||f||||t|f|f||||||No||2017-10-10 21:14:19.8921|2017-10-10 21:14:19.8921
NCT03090347|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|||Effects of Dietary Nutrients on Liver and Adipose Tissue Metabolism|The Effect of Short-term Overconsumption of Specific Dietary Nutrients on Liver and Adipose Tissue Metabolism|Recruiting||N/A|100|Anticipated|University of Oxford||1|||f||||f|f|f||||||Yes|Following completion of the study, all individual data obtained from participants may potentially be shared with other researchers, both here in the United Kingdom and abroad, in appropriate circumstances. If data is to be shared with other researchers, it will be done so under fully anonymised conditions.|2017-10-10 21:14:19.989415|2017-10-10 21:14:19.989415
NCT03090334|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-30|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis|A B-D-Glucan Driven Antifungal Stewardship Approach to Manage Empirical Therapy in Patients at Very High Risk for Invasive Candidiasis: a Randomized Controlled Trial|Recruiting||N/A|180|Anticipated|University of Bologna||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:14:20.089282|2017-10-10 21:14:20.089282
NCT03090321|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-18|||March 2015||2015-03-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2017|Anticipated|2017-12-01||Interventional|MHC||MyHeart Counts Cardiovascular Health Study|MyHeart Counts Cardiovascular Health Study|Recruiting||N/A|2000000|Anticipated|Stanford University||5|||f||||f||||||||Yes|Individual user data will not be shared, deidentified user data will be shared if the user has indicated that this is ok with them.|2017-10-10 21:14:20.18851|2017-10-10 21:14:20.18851
NCT03090308|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-20|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01|15 Days|Observational [Patient Registry]|||Pulmonary Contusion Flail Chest Complex|Impact of Pulmonary Contusion in Patient's Outcome When Associated With Traumatic Flail Chest: An Observational Study|Completed||N/A|20|Actual|Assiut University|||1||f||||f|f|f||||||Yes||2017-10-10 21:14:20.297909|2017-10-10 21:14:20.297909
NCT03090295|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||March 13, 2017|Actual|2017-03-13|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Palpation and ACCURO for Placing Spinal in C-section|Does the Use of Both Palpation and Accuro as Compared to Palpation Alone or Use of Accuro Alone in a Single Patient Increase the First Pass Success Rate in Placing Spinals or Combined Spinal Epidurals for Cesarean Sections.|Recruiting||N/A|55|Anticipated|University of Virginia||1|||f||||f|f|t|f||f|||No||2017-10-10 21:14:20.371581|2017-10-10 21:14:20.371581
NCT03090282|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-23|||March 2, 2016|Actual|2016-03-02|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Subgingival Microbiome Following Mechanical Treatment and it's Effect on Peri-implant Sub-mucosa in Aggressive Periodontitis Patients|Subgingival Microbiome Following Mechanical Treatment and it's Effect on Peri-implant Sub-mucosa in Aggressive Periodontitis Patients|Recruiting||N/A|12|Anticipated|Peking University|||1||f||||f|f|f||||Samples With DNA|"     some bacteria DNA from subgingival. No need for human DNA.   "|Undecided|haven't decided yet|2017-10-10 21:14:20.473264|2017-10-10 21:14:20.473264
NCT03090269|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-04|||December 31, 2017|Anticipated|2017-12-31|June 2017|2017-06-01|May 26, 2018|Anticipated|2018-05-26|February 26, 2018|Anticipated|2018-02-26||Interventional|ANRS STIMAGO||Methylphenidate for Cocaine Dependence|Pilot Study to Evaluate the Benefits and the Risks of Methylphenidate for the Treatment of Cocaine Dependence|Not yet recruiting||Phase 2|20|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t|f|f|||f|||||2017-10-10 21:14:20.568032|2017-10-10 21:14:20.568032
NCT03089164|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-11|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|March 19, 2018|Anticipated|2018-03-19|March 19, 2018|Anticipated|2018-03-19||Observational|||Postural Changes During Right Heart Catheterization|Assessing the Influence of Postural Changes During Right Heart Catheterization for the Evaluation of Pulmonary Hypertension|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f|f|f||||||No||2017-10-10 21:14:20.668842|2017-10-10 21:14:20.668842
NCT03089151|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-17|||June 2, 2016|Actual|2016-06-02|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|June 1, 2017|Anticipated|2017-06-01||Interventional|DGEM||Denver Garden Environment and Microbiome Study Disease|A Pilot Randomized Controlled Trial of Gardening as an Intervention to Reduce Risk of Cancer and Heart|Active, not recruiting||N/A|30|Anticipated|University of Colorado, Boulder||2|||f||||t|f|f||||||No||2017-10-10 21:14:20.747821|2017-10-10 21:14:20.747821
NCT03089138|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-19|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome|Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled Phase 2b Study|Not yet recruiting||Phase 2|120|Anticipated|Beijing Da-an Bio-technology Co., Ltd.||3|||f|||||f|f||||||Undecided||2017-10-10 21:14:20.849076|2017-10-10 21:14:20.849076
NCT03089125|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-06-08|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|February 28, 2022|Anticipated|2022-02-28|February 1, 2021|Anticipated|2021-02-01||Interventional|||Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer|Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:14:20.931639|2017-10-10 21:14:20.931639
NCT03089112|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||March 30, 2017|Anticipated|2017-03-30|March 2017|2017-03-01|October 31, 2017|Anticipated|2017-10-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501|A Randomized, Open-label, Crossover Study to Investigate the Pharmacokinetic Drug Interactions and the Safety Between HGP1607 and HGP1501 in Healthy Male Volunteers|Not yet recruiting||Phase 1|30|Anticipated|Hanmi Pharmaceutical Company Limited||6|||f|||||f|f||||||||2017-10-10 21:14:21.04943|2017-10-10 21:14:21.04943
NCT03089099|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-27|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer|Development of a Prognostic Model for High Volume Metastatic Castration-Resistant Prostate Cancer Patients by Sequentially Analyzing the Expression of Molecular Markers in Circulating Tumor Cells|Recruiting||N/A|100|Anticipated|Fudan University|||1||f||||f|f|f|||t|||No||2017-10-10 21:14:21.163719|2017-10-10 21:14:21.163719
NCT03089086|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|July 31, 2020|Anticipated|2020-07-31|June 30, 2018|Anticipated|2018-06-30||Interventional|B Part of It||South Australian Meningococcal B Vaccine Herd Immunity Study|South Australian Meningococcal B Vaccine Herd Immunity Study|Recruiting||Phase 4|44000|Anticipated|University of Adelaide||2|||f||||t|t|f|||f|||No||2017-10-10 21:14:21.2482|2017-10-10 21:14:21.2482
NCT03089060|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-17|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|||"Silicone Finger Cap (Silikonfingerling)"|"Clinical Trial on the Semi-occlusive Treatment of Traumatic Substance Defects of the Fingertip in Children and Adults With a Novel Silicone Finger Cap. (Klinische Prüfung Zur Semiokklusiven Behandlung Von Traumatischen Substanzdefekten im Bereich Der Fingerendglieder Mittels Silikonfingerorthesen (Silikonfingelingen) Bei Kindern Und Erwachsenen)"|Not yet recruiting||N/A|22|Anticipated|Orthopädie- und Rehatechnik Dresden GmbH||2|||f||||t|f|f||||||No||2017-10-10 21:14:21.430369|2017-10-10 21:14:21.430369
NCT03089047|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Rejuvenated RBC and VO2 Max in Healthy Subjects|A Pilot Study on the Impact of Rejuvenated Autologous Blood Transfusion on VO2 Max in Healthy Subjects|Not yet recruiting||Phase 4|10|Anticipated|Duke University||2|||f|||||t|f|||f|||||2017-10-10 21:14:21.509647|2017-10-10 21:14:21.509647
NCT03090256|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-26|||April 11, 2017||2017-04-11||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:14:21.593217|2017-10-10 21:14:21.593217
NCT03090243|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-25|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 28, 2018|Anticipated|2018-03-28|March 28, 2018|Anticipated|2018-03-28||Observational|||The Effects of Virtual Colonoscopy on Intraocular Pressure|The Effects of Virtual Colonoscopy on Intraocular Pressure|Not yet recruiting||N/A|100|Anticipated|Rabin Medical Center|||1||f||||f|f|t|f|f|f|||No|there is no plan to share individual participant data|2017-10-10 21:14:21.6304|2017-10-10 21:14:21.6304
NCT03090230|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-20|||April 17, 2017|Anticipated|2017-04-17|March 2017|2017-03-01|July 17, 2024|Anticipated|2024-07-17|June 17, 2019|Anticipated|2019-06-17||Interventional|||Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta|A Prospective, Multicenter, Non-Blinded, Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta|Not yet recruiting||N/A|50|Anticipated|Bolton Medical||1|||f||||t|f|t|t|f||||No||2017-10-10 21:14:21.688518|2017-10-10 21:14:21.688518
NCT03090217|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-08-21|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|May 31, 2018|Anticipated|2018-05-31||Interventional|PPPVSSR||Pelvic Physiotherapy in the Prevention of Vaginal Stenosis Secondary to the Radiotherapy|Pelvic Physiotherapy in the Prevention of Vaginal Stenosis Secondary to Radiotherapy of Gynecological Cancer: a Randomized Controlled Trial|Recruiting||N/A|160|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 21:14:21.767993|2017-10-10 21:14:21.767993
NCT03090204|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-06|||November 25, 2016|Actual|2016-11-25|March 2017|2017-03-01|November 25, 2017|Anticipated|2017-11-25|November 25, 2017|Anticipated|2017-11-25||Interventional|||Strain Analysis as a Right Ventricle Contractility Marker|Strain Analysis as a Right Ventricle Contractility Marker|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:14:21.901691|2017-10-10 21:14:21.901691
NCT03090178|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-06-06|||June 2, 2017|Actual|2017-06-02|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ACTISLEEP||Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy|Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on Real-world Data Collection With a Smartphone Application and a Validated Actigraphy Wristband|Recruiting||N/A|30|Anticipated|Ad scientiam||2|||f|||||f|f||||||||2017-10-10 21:14:23.258806|2017-10-10 21:14:23.258806
NCT03090165|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-23|||March 2, 2017|Actual|2017-03-02|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Ribociclib and Bicalutamide in AR+ TNBC|A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024|Recruiting||Phase 1/Phase 2|58|Anticipated|Big Ten Cancer Research Consortium||1|||f||||t|t|f||||||||2017-10-10 21:14:23.361344|2017-10-10 21:14:23.361344
NCT03090152|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-20|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Minimal Opioid Use After Total Hip Replacement (THR)|Minimal Opioid Use After Total Hip Replacement (THR): a Blinded Randomized Placebo-controlled Study|Recruiting||Phase 4|180|Anticipated|Hospital for Special Surgery, New York||3|||f|||||f|f||||||||2017-10-10 21:14:23.510513|2017-10-10 21:14:23.510513
NCT03090139|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-04-19|||March 28, 2017|Actual|2017-03-28|April 2017|2017-04-01|June 29, 2018|Anticipated|2018-06-29|January 30, 2018|Anticipated|2018-01-30||Observational|||Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets|Indicators of Sub-Optimal Response to Anti-Tumor Necrosis Factor (TNF) Therapy in Patients With Crohn's Disease (CD) and Ulcerative Colitis (UC): A Retrospective Chart Review in the Emerging Market (EM) Region (EXPLORE)|Recruiting||N/A|2000|Anticipated|Takeda|||1||f||||f|f|f||||||||2017-10-10 21:14:23.676752|2017-10-10 21:14:23.676752
NCT03090126|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-05|||March 17, 2017|Actual|2017-03-17|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|QoVNI||Assessment of Therapeutic Education About Non Invasive Ventilation in Patients With Chronic Respiratory Failure (QoVNI)|Assessment of Therapeutic Education About Non Invasive Ventilation in Patients With Chronic Respiratory|Recruiting||N/A|50|Anticipated|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil|||1||f|||||f|f||||||||2017-10-10 21:14:23.81488|2017-10-10 21:14:23.81488
NCT03090113|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-18|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SPACE||Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism|A Random, Double-blind, Parallel, Placebo-controlled, Multi-center Study of Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism|Not yet recruiting||Phase 4|2416|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||Undecided||2017-10-10 21:14:23.915988|2017-10-10 21:14:23.915988
NCT03090100|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-10-03|||April 27, 2017|Actual|2017-04-27|October 2017|2017-10-01|November 23, 2018|Anticipated|2018-11-23|September 28, 2018|Anticipated|2018-09-28||Interventional|ECLIPSE||A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis|A Phase 3, Multicenter, Randomized, Double-blind Study Evaluating the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis|Recruiting||Phase 3|1040|Anticipated|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 21:14:24.046093|2017-10-10 21:14:24.046093
NCT03090087|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-24|||March 22, 2017|Actual|2017-03-22|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo|The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo|Recruiting||Phase 2|20|Anticipated|University of Aarhus||1|||f||||t|f|f||||||Yes|The project results will be published in recognized international journals. Both positive, negative and inconclusive results will be published.|2017-10-10 21:14:24.427293|2017-10-10 21:14:24.427293
NCT03090074|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-27|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|March 19, 2021|Anticipated|2021-03-19|March 19, 2020|Anticipated|2020-03-19||Interventional|LOWinCHIP||Moderate or Extensive Carbohydrate Reduction in Risk Patients|To Lower Glucose Levels and Reduce Weight by Exclusion of Carbohydrates and Inclusion of Psychological Behavioral Support|Recruiting||N/A|200|Anticipated|University Hospital, Linkoeping||4|||f||||f|f|f||||||No|It is not planned to be shared|2017-10-10 21:14:24.537001|2017-10-10 21:14:24.537001
NCT03090061|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-01|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Reliability of Light Induced Fluorescence Intraoral Camera Versus Visual-Tactile Method in Assessment of Marginal Integrity of Resin Composite Restorations: Diagnostic Invivo Study|Reliability of Light Induced Fluorescence Intraoral Camera Versus Visual-Tactile Method in Assessment of Marginal Integrity of Resin Composite Restorations: Diagnostic Invivo Study|Enrolling by invitation||N/A|29|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 21:14:24.622506|2017-10-10 21:14:24.622506
NCT03090048|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-08-28|||September 20, 2017|Anticipated|2017-09-20|March 2017|2017-03-01|February 20, 2018|Anticipated|2018-02-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||Vitamin A and Azithromycin for Acne Vulgaris|Treatment of Acne for Cases Resistant to Currently Available Measures Via Vitamin A With or Without Azithromycin in Topical Formulations|Not yet recruiting||Early Phase 1|30|Anticipated|Manchanda Medical Clinic||3|||f||||t|f|f||||||||2017-10-10 21:14:24.695541|2017-10-10 21:14:24.695541
NCT03090035|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-22|||January 1, 2014|Actual|2014-01-01|April 2017|2017-04-01|December 31, 2014|Actual|2014-12-31|July 1, 2014|Actual|2014-07-01||Interventional|||Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment|Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses in Chronic Hepatitis C Treatment|Completed||Phase 3|98|Actual|Sheikh Zayed Medical College||1|||f||||t|f|f|||f|||No||2017-10-10 21:14:24.797865|2017-10-10 21:14:24.797865
NCT03090022|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|April 1, 2020|Anticipated|2020-04-01|September 1, 2018|Anticipated|2018-09-01||Interventional|H-PACS||Hernia-Prophylaxis in Acute Care Surgery H-PACS|Prophylactic Mesh Implantation in Patients Undergoing Requiring Emergency Laparatomy for the Prevention of Incisional Hernia:A Randomized Controlled Trial|Recruiting||N/A|118|Anticipated|University Hospital Inselspital, Berne||2|||f||||t|f|f||||||||2017-10-10 21:14:24.897385|2017-10-10 21:14:24.897385
NCT03090009|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-30|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Microbiome Shift in Peri-mucositis by Anti-inflammatory Drugs|The Use of Non-Steroidal Anti-Inflammatory Drugs as a Tool of Positive Change in Peri-Implants Mucositis Microbiome|Not yet recruiting||Early Phase 1|100|Anticipated|Hadassah Medical Organization||2|||f||||f|t|f|||f|||No||2017-10-10 21:14:25.036875|2017-10-10 21:14:25.036875
NCT03089996|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-18|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|December 1, 2020|Anticipated|2020-12-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Evaluation of Clinical Approaches to Accelerate Orthodontic Tooth Movement|Piezocision and Corticotomy to Accelerate Orthodontic Tooth Movement: A Randomized Controlled Trial|Recruiting||N/A|45|Anticipated|Pontifícia Universidade Católica de Minas Gerais||3|||f|||||f|f||||||||2017-10-10 21:14:25.138867|2017-10-10 21:14:25.138867
NCT03089983|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-18|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|HARAPAN II||Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings|Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings|Not yet recruiting||Phase 4|500|Anticipated|Yale University||5|||f||||t|f|f|||f|||No||2017-10-10 21:14:25.226974|2017-10-10 21:14:25.226974
NCT03089970|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-24|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Observational|||Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients|Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients|Recruiting||N/A|78|Anticipated|University of California, Davis|||3||f||||f|f|f||||Samples Without DNA|"     Exhaled breath condensate   "|No||2017-10-10 21:14:25.348232|2017-10-10 21:14:25.348232
NCT03089957|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-08-12|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS)|Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS) A Randomized Controlled Trial|Recruiting||N/A|840|Anticipated|Peking University Third Hospital||2|||f||||t|f|f||||||||2017-10-10 21:14:25.447489|2017-10-10 21:14:25.447489
NCT03089944|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-22|2017-09-29|||April 28, 2017|Actual|2017-04-28|September 2017|2017-09-01|December 21, 2018|Anticipated|2018-12-21|April 27, 2018|Anticipated|2018-04-27||Interventional|||A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis|A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis|Recruiting||Phase 3|270|Anticipated|AbbVie||1|||t||||f|t|f||||||||2017-10-10 21:14:25.601879|2017-10-10 21:14:25.601879
NCT03089931|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-10-03|||November 11, 2012|Actual|2012-11-11|October 2017|2017-10-01|April 30, 2018|Anticipated|2018-04-30|October 30, 2017|Anticipated|2017-10-30|6 Months|Observational [Patient Registry]|LBP||Change of Lumbar Symptom After Surgical Treatment for Patients With Cervical Stenosis|Change of Lumbar Symptom After Surgical Treatment for Patients With Cervical Stenosis|Recruiting||N/A|143|Anticipated|Seoul National University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:14:27.546783|2017-10-10 21:14:27.546783
NCT03089918|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-08-25|||May 17, 2017|Actual|2017-05-17|August 2017|2017-08-01|December 8, 2017|Anticipated|2017-12-08|December 8, 2017|Anticipated|2017-12-08||Interventional|||A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain|An Open-Label Microdosing Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain|Recruiting||Phase 1|23|Anticipated|Janssen Research & Development, LLC||2|||f||||f|f|f||||||||2017-10-10 21:14:27.623122|2017-10-10 21:14:27.623122
NCT03089905|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-20|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|TREX||A Study to Compare the Long-term Outcomes After Two Different Anaesthetics|Neurodevelopmental Outcome After Standard Dose Sevoflurane Versus Low-dose Sevoflurane/Dexmedetomidine/Remifentanil Anaesthesia in Young Children- The TREX Trial|Recruiting||Phase 3|450|Anticipated|Murdoch Childrens Research Institute||2|||f||||t|t|f|||f|||||2017-10-10 21:14:27.712796|2017-10-10 21:14:27.712796
NCT03089892|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||October 19, 2016|Actual|2016-10-19|March 2017|2017-03-01|September 20, 2018|Anticipated|2018-09-20|September 20, 2018|Anticipated|2018-09-20||Observational|||A Perspective Study of Cancer-related Fatigue in Gynecologic Cancer Patients Under Chemotherapy|A Perspective Study of Cancer-related Fatigue in Gynecologic Cancer Patients Under Chemotherapy|Recruiting||N/A|60|Anticipated|Tri-Service General Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:14:27.919604|2017-10-10 21:14:27.919604
NCT03089879|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-21|2017-09-11|||March 16, 2017|Actual|2017-03-16|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study|A Phase 1, Open Label, Non-randomized, Single Center Study to Evaluate the Safety and Immunogenicity of 1 Booster Vaccination With (GVGH Shigella Sonnei 1790GAHB) Vaccine Administered Intramuscularly in Healthy Adults Previously Primed With Three Doses of the Same Vaccine in Study H03_01TP Compared to 1 Vaccination With (1790GAHB) Administered Intramuscularly Either to Subjects Who Received Placebo in the H03_01TP Study or naïve Subjects Who Were Not Part of H03_01TP Study|Completed||Phase 1|35|Actual|GlaxoSmithKline||1|||f|||||f|f||||||||2017-10-10 21:14:29.357216|2017-10-10 21:14:29.357216
NCT03089866|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-08|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 16, 2017|Actual|2017-04-16||Observational|||Effect of Sedation on Cognitive Performance in the Elderly|Effect of Sedation on Cognitive Performance in the Elderly (Pilot Study)|Active, not recruiting||N/A|20|Actual|University of Alabama at Birmingham|||1||f||||t|t|f|||f|||||2017-10-10 21:14:29.4672|2017-10-10 21:14:29.4672
NCT03089853|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-20|||July 14, 2016|Actual|2016-07-14|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Smart Telehealth Exercise Intervention to Reduce COPD Readmissions|Smart Telehealth Exercise Intervention to Reduce COPD Readmissions|Recruiting||N/A|40|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|f||||||No||2017-10-10 21:14:29.565787|2017-10-10 21:14:29.565787
NCT03089840|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-03-20|||February 24, 2017|Actual|2017-02-24|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Normothermic Liver Preservation Trial|Assessing the Safety and Efficacy of a Portable Ex Vivo Oxygenated, Normothermic Liver Perfusion System (OrganOx Metra™ ) Prior to Liver Transplantation|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Alberta||1|||f||||t|f|f||||||||2017-10-10 21:14:29.718408|2017-10-10 21:14:29.718408
NCT03089827|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||May 21, 2014|Actual|2014-05-21|March 2017|2017-03-01|January 2025|Anticipated|2025-01-01|April 2022|Anticipated|2022-04-01||Observational|||Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease|Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease|Enrolling by invitation||N/A|60|Anticipated|Wake Forest University Health Sciences|||1||f||||f|f|f||||||No||2017-10-10 21:14:29.847629|2017-10-10 21:14:29.847629
NCT03089814|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-03|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|March 15, 2018|Anticipated|2018-03-15|February 15, 2018|Anticipated|2018-02-15||Interventional|||Changes in Tissue Microcirculation During Ischemic Conditioning: Pilot Study|Changes in Tissue Microcirculation During Ischemic Conditioning: Pilot Study|Recruiting||N/A|20|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:14:29.921852|2017-10-10 21:14:29.921852
NCT03089801|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-17|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Tablet-Enabled Video Telehealth to Enhance Veterans' Access and Care|Making Connections: Tablet-Enabled Video Telehealth to Enhance Veterans' Access and Care|Enrolling by invitation||N/A|5000|Anticipated|VA Palo Alto Health Care System|||2||f||||f|f|f||||||No||2017-10-10 21:14:30.023386|2017-10-10 21:14:30.023386
NCT03089788|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-15|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Methodological Study to Compare the Effect of Different Methods of Measuring Cat Allergy Symptoms in Patients That Have Immunized Their Cats With FEL-CMV.|Methodological Study to Compare the Effect of Different Methods of Measuring Cat Allergy Symptoms in Patients That Have Immunized Their Cats With FEL-CMV.|Recruiting||N/A|10|Anticipated|University of Zurich||1|||f||||f|f|f||||||No||2017-10-10 21:14:30.140384|2017-10-10 21:14:30.140384
NCT03089775|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-13|||March 14, 2017|Actual|2017-03-14|July 2017|2017-07-01|May 24, 2017|Actual|2017-05-24|May 24, 2017|Actual|2017-05-24||Interventional|BBI||Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis|A Randomized, Controlled Study to Evaluate the Effect of Topically Applied BBI-2000 (5%) on Allergic Responses in Subjects With Contact Hypersensitivity to Diphencyprone|Completed||Phase 1|47|Actual|Brickell Biotech, Inc.||3|||f||||f|f|f||||||||2017-10-10 21:14:30.225424|2017-10-10 21:14:30.225424
NCT03089762|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-23|||February 12, 2012|Actual|2012-02-12|March 2017|2017-03-01|December 30, 2014|Actual|2014-12-30|December 30, 2014|Actual|2014-12-30||Interventional|||Intra-articular Injection in the Knee of Adipose Derived Stromal Cells and Platelet Rich Plasma for Osteoarthritis|Intra-articular Injection in the Knee of Adipose Derived Stromal Cells and Platelet Rich Plasma for Osteoarthritis|Completed||Phase 1|10|Actual|Bioheart, Inc.||1|||f|||||f|f||||||||2017-10-10 21:14:30.321137|2017-10-10 21:14:30.321137
NCT03089749|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||May 2015||2015-05-01|March 2017|2017-03-01|May 2022|Anticipated|2022-05-01|May 2017|Anticipated|2017-05-01||Observational|CHAT CNS||Characterization of Human Autoantibody Titers After Central Nervous System Insult|Characterization of Human Autoantibody Titers After Central Nervous System Insult|Recruiting||N/A|100|Anticipated|University of Utah|||4||f||||f||||||Samples Without DNA|"     Plasma   "|Undecided||2017-10-10 21:14:30.489962|2017-10-10 21:14:30.489962
NCT03089736|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-29|||January 1, 2015|Actual|2015-01-01|March 2017|2017-03-01|March 19, 2017|Actual|2017-03-19|December 31, 2016|Actual|2016-12-31||Interventional|HNC||Pain Related to Head and Neck Cancer (HNC); Implementation and Evaluation of Self-care Measure Due to the Same Illness|Pain Related to Head and Neck Cancer (HNC); Implementation and Evaluation of Self-care Measure Due to the Same Illness During Radiotherapy (RT)|Completed||N/A|62|Actual|Linkoeping University||2|||f||||f|f|f||||||No||2017-10-10 21:14:30.599111|2017-10-10 21:14:30.599111
NCT03089723|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-07-21|||July 30, 2017|Anticipated|2017-07-30|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Saline Lavage X Saline Lavage and Osteonil® Mini in Rizarthritis|Comparative Study of the Intraarticular Treatment of Carpometacarpal Joint Ostearthritis of the Thumb With Lavage With Saline Solution, or Lavage and Injection of Hyaluronic Acid and Mannitol.|Recruiting||N/A|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 21:14:30.709072|2017-10-10 21:14:30.709072
NCT03089710|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-20|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mini-fluid Challenge in Predicting Fluid Responsiveness During Prone Position Spine Surgery|The Effectiveness of Mini-fluid Challenge in Predicting Fluid Responsiveness During Prone Position Spine Surgery|Not yet recruiting||N/A|60|Anticipated|National Taiwan University Hospital||1|||f|||||f|f||||||Undecided||2017-10-10 21:14:30.864393|2017-10-10 21:14:30.864393
NCT03089697|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-26|||March 7, 2017|Actual|2017-03-07|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Phase IIa Clinical Study of N-Rephasin® SAL200|A Randomized, Double-blind, Placebo-controlled, Multicenter Phase IIa Clinical Study to Evaluate Safety and to Explore Efficacy of N-Rephasin® SAL200, in Patients With Persistent Staphylococcus Aureus Bacteremia|Recruiting||Phase 2|50|Anticipated|Intron Biotechnology, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:14:30.968192|2017-10-10 21:14:30.968192
NCT03089684|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-23|||January 1, 2011|Actual|2011-01-01|March 2017|2017-03-01|December 31, 2012|Actual|2012-12-31|December 31, 2012|Actual|2012-12-31||Observational|||Correspondence of Folate Dietary Intake and Biomarker Data|Correspondence of Dietary Intake and Biomarker Data|Completed||N/A|4878|Actual|National Institute of Health and Nutrition|||1||f||||f|f|f||||||Undecided||2017-10-10 21:14:31.074749|2017-10-10 21:14:31.074749
NCT03089671|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-31|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Ureteric Visualization: Vitamin B Vs 5% Dextrose in Water|Optimal Ureteric Visualization At the Time of Pelvic Reconstructive Surgery: Vitamin B Versus 5% Dextrose in Water|Not yet recruiting||N/A|250|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f|f|f||||||||2017-10-10 21:14:31.136632|2017-10-10 21:14:31.136632
NCT03089645|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-19|||March 21, 2017|Actual|2017-03-21|September 2017|2017-09-01|August 15, 2022|Anticipated|2022-08-15|August 15, 2022|Anticipated|2022-08-15||Interventional|||MEDI5083 Alone and in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors|A Phase 1 First Time in Human Study to Evaluate the Safety, Pharmacokinetics and Immunogenicity of MEDI5083 Alone and in Combination With Durvalumab in Selected Advanced Solid Tumors|Recruiting||Phase 1|204|Anticipated|MedImmune LLC||2|||f||||f|t|f||||||||2017-10-10 21:14:31.341788|2017-10-10 21:14:31.341788
NCT03089632|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-28|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 1, 2018|Anticipated|2018-06-01||Interventional|||The Effect of Gluten-free Diet in Type 1 Diabetics With Dyspepsia Symptoms|The Effect of Gluten-free Diet on Upper Gastrointestinal Symptoms in Type 1 Diabetic Patients With Dyspepsia-like Symptoms|Not yet recruiting||N/A|30|Anticipated|McMaster University||1|||f||||f|f|f||||||||2017-10-10 21:14:31.457601|2017-10-10 21:14:31.457601
NCT03089619|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-17|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Alveolar Management Following Teeth Extraction|A Method for Measuring Volume Changes of the Alveolar Ridge During Dental Implantation Using 3D Scanning|Recruiting||Phase 4|24|Anticipated|University Medicine Greifswald||2|||f||||t|f|f||||||No|IPD will not be shared in accordance with medical data protection regulations.|2017-10-10 21:14:31.567547|2017-10-10 21:14:31.567547
NCT03089606|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-29|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pembrolizumab TX-naive Distant Mets Melanoma and Use of AMT (PET) at Baseline as Imaging Biomarker|Pembrolizumab in Systemic Treatment-Naïve Distant Metastatic Melanoma and Exploration of Use of 11Cmethyl-L-tryptophan (AMT) PET at Baseline as a Predictive Imaging Biomarker of Response|Recruiting||Phase 2|25|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:14:31.693091|2017-10-10 21:14:31.693091
NCT03089593|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-20|||March 27, 2017|Actual|2017-03-27|June 2017|2017-06-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|||Thermogenic Effect of Ginger|Double-blind Placebo-controlled Clinical Trial of Thermogenic Effect of Ginger (Zingiber Officinale) in Eutrophic Women|Completed||N/A|20|Actual|Federal University of Minas Gerais||2|||f||||t|f|f||||||Undecided||2017-10-10 21:14:31.789894|2017-10-10 21:14:31.789894
NCT03089580|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-31|||March 25, 2017|Actual|2017-03-25|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Intense Pulsed Light Study for Dry Eye Disease|Intense Pulsed Light Study for Dry Eye Disease|Recruiting||N/A|30|Anticipated|University of Michigan||2|||f||||t|f|t|f||f|||No||2017-10-10 21:14:31.8643|2017-10-10 21:14:31.8643
NCT03089567|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||June 15, 2017|Anticipated|2017-06-15|March 2017|2017-03-01|July 15, 2018|Anticipated|2018-07-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish|Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish|Not yet recruiting||Early Phase 1|90|Anticipated|Yale University||3|||f||||f|t|f|||f|||Undecided||2017-10-10 21:14:31.950188|2017-10-10 21:14:31.950188
NCT03089554|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-04-22|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|December 31, 2028|Anticipated|2028-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies|Integration of Precision Medicine Into Cancer Therapeutics, Part 2: A Therapeutic Phase 2 Sub-study Evaluating Genomic Testing in Human Cancer and Outcomes of Targeted Therapies Recommended by an Institutional Multidisciplinary Molecular Tumor Board in Patients With Poor Prognosis Cancer|Recruiting||Phase 2|93|Anticipated|University of Kentucky||1|||f||||t|t|f|||f|||||2017-10-10 21:14:32.038521|2017-10-10 21:14:32.038521
NCT03089541|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-06-27|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|January 1, 2018|Anticipated|2018-01-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Electronic Cigarette Use in Young Adult Men and Women|Electronic Cigarette Use in Young Adult Men and Women|Recruiting||N/A|30|Anticipated|Yale University||1|||f||||t|f|f||||||No||2017-10-10 21:14:32.128187|2017-10-10 21:14:32.128187
NCT03089528|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-09-09|||April 1, 2017|Actual|2017-04-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Videolaryngoscopy for Intubation in Patients With Diabetes|Videolaryngoscopy Versus Direct Laryngoscopy for Tracheal Intubation in Patients With Diabetes Mellitus|Recruiting||N/A|60|Anticipated|Diskapi Teaching and Research Hospital||2|||f||||f|f|f||||||||2017-10-10 21:14:32.20968|2017-10-10 21:14:32.20968
NCT03089515|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-07|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust|Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust|Recruiting||N/A|60|Anticipated|New York University School of Medicine||2|||f||||f|f|f|||f|||||2017-10-10 21:14:32.305384|2017-10-10 21:14:32.305384
NCT03089502|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-27|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|April 1, 2019|Anticipated|2019-04-01|July 1, 2018|Anticipated|2018-07-01||Interventional|CORE||Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity|A Randomized Control Trial of the Efficacy of a Cardio-Oncology Rehabilitation Exercise Program to Improve Cardiorespiratory Fitness in Women With Breast Cancer and Treatment Related Cardiotoxicity (CORE Study).|Not yet recruiting||N/A|38|Anticipated|University Health Network, Toronto||2|||f||||f|f|f||||||Yes|Individual data of the primary and secondary outcomes will be made available to other researchers as a supplementary file to be accompanied by any publications generated by this clinical trial. Individual data will also be made available upon request for research purposes|2017-10-10 21:14:32.507119|2017-10-10 21:14:32.507119
NCT03089489|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-17|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 8, 2024|Anticipated|2024-03-08|March 8, 2022|Anticipated|2022-03-08||Observational|||Lung PGD Biomarkers in Organ Donors|Role of Lung Surfactant Proteins in Donor Lung to Predict Primary Graft Dysfunction in Lung Recipients|Not yet recruiting||N/A|50|Anticipated|University Hospital of Mont-Godinne|||2||f||||f|f|f||||Samples With DNA|"     Lung and blood samples in organ donors   "|No||2017-10-10 21:14:32.613981|2017-10-10 21:14:32.613981
NCT03086122|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-15|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||The Impact of Obstructive Sleep Apnea in Erectile Dysfunction|The Impact of Obstructive Sleep Apnea in Erectile Dysfunction|Recruiting||N/A|140|Anticipated|Sociedad Española de Neumología y Cirugía Torácica||3|||f||||f||||||||No||2017-10-10 21:15:03.600594|2017-10-10 21:15:03.600594
NCT03089476|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-11|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy|Hypothesis: Skin Barrier Dysfunction With Altered Expression of Skin Barrier Proteins and Lipids Predicts Early Food Sensitizations in Infants at High Risk of Atopy|Recruiting||N/A|100|Anticipated|National Jewish Health||2|||f||||f|f|f|||t|||||2017-10-10 21:14:32.703601|2017-10-10 21:14:32.703601
NCT03089463|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-20|||April 3, 2017|Anticipated|2017-04-03|March 2017|2017-03-01|October 1, 2018|Anticipated|2018-10-01|April 3, 2018|Anticipated|2018-04-03||Observational|||Foot Assessment in People With Diabetes: A Quantitative Diagnostic Approach|Foot Assessment in People With Diabetes: A Quantitative Diagnostic Approach|Recruiting||N/A|153|Anticipated|Staffordshire University|||1||f||||t|f|f||||||No||2017-10-10 21:14:32.836095|2017-10-10 21:14:32.836095
NCT03089450|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-03-26|||March 22, 2017|Actual|2017-03-22|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent|A Multicenter, Subject-blinded, Randomized Study to Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent in Patients Undergoing Drug-eluting Stent Procedure After Coronary Angiography|Recruiting||N/A|112|Anticipated|CGBio Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:14:32.964974|2017-10-10 21:14:32.964974
NCT03089437|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-05-12|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia|The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia|Recruiting||N/A|12|Anticipated|University of Texas at Austin||2|||f||||f|f|f||||||No||2017-10-10 21:14:33.055937|2017-10-10 21:14:33.055937
NCT03089424|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Photobiomodulation Therapy on Low Back Pain|Effects of Photobiomodulation Therapy in Patients With Chronic Non-specific Low Back Pain: a Randomized Placebo-controlled Trial|Not yet recruiting||N/A|148|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 21:14:33.151514|2017-10-10 21:14:33.151514
NCT03089411|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|July 15, 2017|Anticipated|2017-07-15|July 15, 2017|Anticipated|2017-07-15||Observational|||Collection of Additional Data Followed the Study IFM 2013-04|"Collection of Additional Data Followed the Study A Phase III Study of Velcade (Bortezomib) Thalidomide Dexaméthasone (VTD) Versus Velcade (Bortezomib) Cyclophosphamide Dexaméthasone (VCD) as an Induction Treatment Prior to Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma"|Active, not recruiting||N/A|340|Actual|Nantes University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:14:33.255163|2017-10-10 21:14:33.255163
NCT03089398|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-21|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2024|Anticipated|2024-03-01|March 2024|Anticipated|2024-03-01||Interventional|||Hybrid Coronary Revascularization Trial|Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention|Not yet recruiting||N/A|2354|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|f|t|f|f||||||2017-10-10 21:14:33.461583|2017-10-10 21:14:33.461583
NCT03089385|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||February 22, 2016|Actual|2016-02-22|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis|Development, Validation, and Implementation of a Clinical Decision Tool for Blood Pressure Management in Patients on Hemodialysis|Recruiting||N/A|90|Anticipated|University Health Network, Toronto||2|||f|||||f|f||||||||2017-10-10 21:14:33.765546|2017-10-10 21:14:33.765546
NCT03089372|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20||||||March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Repeating Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) for Erectile Dysfunction (ED)|Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) in Patients With Vasculogenic Erectile Dysfunction (ED): Evaluation of the Efficacy of Re-treatment.|Active, not recruiting||N/A|36|Actual|Institute for the Study of Urological Diseases, Greece||2|||f||||f|f|f||||||No||2017-10-10 21:14:33.849792|2017-10-10 21:14:33.849792
NCT03089359|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||May 4, 2015|Actual|2015-05-04|March 2017|2017-03-01|December 30, 2017|Anticipated|2017-12-30|July 1, 2017|Anticipated|2017-07-01||Observational|PRIUS||Prehospital Recognition and Identification of Unspecific Symptoms|Prehospital Recognition and Identification of Unspecific Symptoms|Recruiting||N/A|500|Anticipated|Karolinska Institutet|||1||f||||f|f|f||||||No||2017-10-10 21:14:33.940021|2017-10-10 21:14:33.940021
NCT03089346|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-22|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ASTHMAGRI||Assessment of Bronchial Thickness Using MRI in Asthma|Assessment of Bronchial Thickness Using MRI in Asthma|Recruiting||N/A|30|Anticipated|University Hospital, Bordeaux||1|||f||||f|f|f||||||No||2017-10-10 21:14:34.023756|2017-10-10 21:14:34.023756
NCT03089333|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-04|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects|Effects of Dapagliflozin, an SGLT2 Inhibitor, on Hemodynamic Parameters, Target Organ Damage and Obesity Profile in Resistant Hypertensive Subjects|Recruiting||Phase 4|20|Anticipated|University of Campinas, Brazil||2|||f||||f|f|f||||||Undecided||2017-10-10 21:14:34.121574|2017-10-10 21:14:34.121574
NCT03089320|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-07|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2024|Anticipated|2024-08-01|August 2020|Anticipated|2020-08-01||Interventional|FIRST||Financial Incentives, Randomization With Stepped Treatment Trial|Financial Incentives, Randomization With Stepped Treatment Trial|Not yet recruiting||N/A|348|Anticipated|Yale University||2|||f||||t|f|f||||||||2017-10-10 21:14:34.226885|2017-10-10 21:14:34.226885
NCT03089307|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20||||||March 2017|2017-03-01|September 13, 2016|Actual|2016-09-13|September 13, 2016|Actual|2016-09-13||Interventional|||6 vs 12 Sessions in Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) for Erectile Dysfunction (ED)|Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) for Erectile Dysfunction (ED): Comparison of 6 Sessions Once a Week vs 12 Sessions Twice Per Week|Completed||N/A|44|Actual|Institute for the Study of Urological Diseases, Greece||2|||f||||f|f|f||||||No||2017-10-10 21:14:34.336914|2017-10-10 21:14:34.336914
NCT03088982|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-23|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|FDPM||Preventing Decompensation Among Multimorbid Outpatients in Residential Care. A Cohort Study With a Six-month Follow-up.|Running Title: The Patient's Pain Seems to be a Reliable Risk Factor for Decompensation Among Multimorbid Patients in Residential Care.|Completed||N/A|64|Actual|University Hospital, Brest|||1||f||||f|f|f||||||No||2017-10-10 21:14:36.367184|2017-10-10 21:14:36.367184
NCT03089294|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||May 30, 2016|Actual|2016-05-30|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Low Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: Standardisation of Treatment Protocol|Low Intensity Extracorporeal Shock Wave Treatment Patients With Vasculogenic Erectile Dysfunction: Standardisation of Treatment Protocol|Recruiting||N/A|88|Anticipated|Institute for the Study of Urological Diseases, Greece||4|||f||||f|f|f||||||No||2017-10-10 21:14:34.415013|2017-10-10 21:14:34.415013
NCT03089281|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-09-29|||August 1, 2017|Actual|2017-08-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|SMART CRT||Strategic Management to Optimize Response To Cardiac Resynchronization Therapy|Strategic Management to Optimize Response To Cardiac Resynchronization Therapy|Recruiting||N/A|726|Anticipated|Boston Scientific Corporation||2|||f|||||f|t|f|f|t|||||2017-10-10 21:14:34.527889|2017-10-10 21:14:34.527889
NCT03089268|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-24|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|January 2027|Anticipated|2027-01-01|January 2027|Anticipated|2027-01-01|10 Years|Observational [Patient Registry]|SERRACOLON||Molecular and Histological Characteristics of Serrated Lesions of the Colon|Molecular and Histological Characteristics of Serrated Lesions of the Colon: Development of an Individual Risk Profile Applicable to Population-based Colorectal Cancer Screening Programs|Not yet recruiting||N/A|700|Anticipated|Hospital Universitario La Fe|||1||f||||f|f|f||||Samples With DNA|"     colonic polyp or colorectal cancer samples   "|Undecided||2017-10-10 21:14:35.195229|2017-10-10 21:14:35.195229
NCT03089255|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||April 3, 2017|Anticipated|2017-04-03|March 2017|2017-03-01|December 30, 2017|Anticipated|2017-12-30|September 30, 2017|Anticipated|2017-09-30|3 Months|Observational [Patient Registry]|EvaTIP||Assessment of the Impact of TIP Score on Thromboprophylaxis in Patients With Non-surgical Lower Leg Trauma.|Prospective Study to Assess the Foreseeable Impact of TIP Score on Thromboprophylaxis in Patients With Isolated Non-surgical Lower Limb Trauma Compared to the Physicians' Judgment in Standard Practice.|Not yet recruiting||N/A|180|Anticipated|University Hospital, Angers|||1||f||||t|f|f||||||No||2017-10-10 21:14:35.324644|2017-10-10 21:14:35.324644
NCT03089242|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-28|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|MIRAKI||MicroRNAs in Acute Kidney Injury|MicroRNAs in Acute Kidney Injury (MIRAKI) - a Pilotstudy -|Recruiting||N/A|150|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f|f|f||||Samples With DNA|"     Blood and urine   "|||2017-10-10 21:14:35.405949|2017-10-10 21:14:35.405949
NCT03089229|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-20|||March 26, 2017|Anticipated|2017-03-26|March 2017|2017-03-01|July 31, 2017|Anticipated|2017-07-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis|A Study to Evaluate the Efficacy and Safety of HAT01H, a Novel Topical Therapeutic: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients With Moderate to Severe Atopic Dermatitis|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Haus Bioceuticals||2|||f||||t|f|f||||||Yes||2017-10-10 21:14:35.485509|2017-10-10 21:14:35.485509
NCT03089216|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||April 1, 2016|Actual|2016-04-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|November 30, 2016|Actual|2016-11-30||Interventional|||Combined Bleaching Technique: Efficacy and Tooth Sensitivity|Combined Bleaching Technique: Efficacy and Tooth Sensitivity - A Randomized, Double Blind Clinical Trial|Active, not recruiting||Phase 4|108|Actual|Universidade Federal de Goias||4|||f||||t|f|f||||||No||2017-10-10 21:14:35.575671|2017-10-10 21:14:35.575671
NCT03089203|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-23|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|September 8, 2021|Anticipated|2021-09-08|September 8, 2020|Anticipated|2020-09-08||Interventional|||CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer|PHASE I STUDY OF PSMA-TGFβRDN CAR MODIFIED T CELLS IN PATIENTS WITH ADVANCED CASTRATE RESISTANT PROSTATE CANCER|Recruiting||Phase 1|18|Anticipated|University of Pennsylvania||3|||||||t|t|f||||||Undecided||2017-10-10 21:14:35.694588|2017-10-10 21:14:35.694588
NCT03089190|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-30|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SLIM8||Acute Effects of DC7-2, a Meat Derived Octapeptide, on Appetite|SLIM8 - Acute Effects of DC7-2 on Appetite|Recruiting||N/A|30|Anticipated|University of Copenhagen||4|||f||||t|f|f||||||||2017-10-10 21:14:35.80311|2017-10-10 21:14:35.80311
NCT03089177|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-17|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|CAPs||Community Activation for Prevention (CAPs): A Study of Community Gardening|Community Activation for Prevention (CAPs): A Randomized Controlled Trial of Community Gardening|Recruiting||N/A|312|Anticipated|University of Colorado, Boulder||2|||f||||t|f|f||||||No|The investigators will store all Individual Participant Data in a HIPPA compliant database separate from the study database. All analysis will be conducted on an analytic data set, stripped of indirect and direct identifiers.|2017-10-10 21:14:35.912776|2017-10-10 21:14:35.912776
NCT03089034|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-07-24|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|SCOPAH||Singapore Cohort of Patients With Advanced Heart Failure|Singapore Cohort of Patients With Advanced Heart Failure|Recruiting||N/A|300|Anticipated|Duke-NUS Graduate Medical School|||1||f||||f|f|f||||||||2017-10-10 21:14:36.027923|2017-10-10 21:14:36.027923
NCT03089021|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-19|||December 20, 2016|Actual|2016-12-20|September 2017|2017-09-01|December 28, 2017|Anticipated|2017-12-28|November 1, 2017|Anticipated|2017-11-01||Interventional|||Maitland Mobilization Versus Mulligan Mobilization in Sub-Acute and Chronic Non-Specific Neck Pain|Maitland Mobilization Versus Mulligan Mobilization in Sub-Acute and Chronic Non-Specific Neck Pain|Enrolling by invitation||N/A|22|Anticipated|Dammam University||2|||f||||t|f|f||||||||2017-10-10 21:14:36.114903|2017-10-10 21:14:36.114903
NCT03089008|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-03-23|||January 1999||1999-01-01|March 2017|2017-03-01|December 2007|Actual|2007-12-01|July 2000|Actual|2000-07-01||Interventional|||Eccentric Exercise in Treatment of Achilles Tendinopathy|Eccentric Exercise in Treatment of Achilles Tendinopathy|Completed||N/A|45|Actual|Copenhagen Trial Unit, Center for Clinical Intervention Research||2|||f||||f||||||||No|No plan to share data.|2017-10-10 21:14:36.200372|2017-10-10 21:14:36.200372
NCT03088995|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-08-17|||April 1, 2017|Actual|2017-04-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Observational|OPDEP||Pilot Study of HIV and Hepatitis B and C Screening in Surgery|Pre-operative Screening for HIV and Viral Hepatitis B and C: Pilot Study in Stomatology|Recruiting||N/A|1000|Anticipated|Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida|||1||f||||t|f|f||||||||2017-10-10 21:14:36.28431|2017-10-10 21:14:36.28431
NCT03088969|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-03-24|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|RTWSE||Validation of the French Version RTWSE (Return To Work Self Efficacy Scale)|Validation of the French Version of the Questionnaires of Self-efficacy Received From the People With a Chronic Low Back Pain After Return to the Work (10 and 19 Items)|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||1||f|||||f|f||||||||2017-10-10 21:14:36.4395|2017-10-10 21:14:36.4395
NCT03088956|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-09-14|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|March 27, 2019|Anticipated|2019-03-27|February 27, 2019|Anticipated|2019-02-27||Observational|||Cognitive Change in Behavioral Variant Frontotemporal Dementia (FTD)|A Study to Model Rates of Change on Neuropsychological Test Measures in Subjects Diagnosed With Behavioral Variant Frontotemporal Dementia and Healthy Subjects|Not yet recruiting||N/A|70|Anticipated|Biogen|||2||f||||f|f|f||||Samples With DNA|"     Whole blood samples   "|||2017-10-10 21:14:36.554775|2017-10-10 21:14:36.554775
NCT03088943|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-10|||February 14, 2017|Actual|2017-02-14|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Intraoperative Diastolic Function by TDI and STE|Assessment of Diastolic Function Using Intraoperative Transesophageal Echocardiography: Comparison of Mitral Annular Plane Velocity and Systolic Excursion Measured by Tissue Doppler Imaging vs. Speckle-Tracking|Active, not recruiting||N/A|28|Anticipated|University Hospital, Ghent||3|||f||||f|f|f||||||Undecided|undecided|2017-10-10 21:14:36.711335|2017-10-10 21:14:36.711335
NCT03088917|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-06-22|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|August 1, 2018|Anticipated|2018-08-01|January 1, 2018|Anticipated|2018-01-01||Observational|Track&Trace||'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'|'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat' A Prospective Cohort Study Assessing the Impact of Loss to Follow-up on Liver Fibrosis in Chronic Hepatitis C.|Not yet recruiting||N/A|100|Anticipated|Radboud University|||1||f||||f|f|f||||Samples With DNA|"     blood serum samples will be saved in the biobank after participation   "|Undecided|Possibly individual data on primary and secondary outcomes can be requested from reserachers or shared via digital research environment|2017-10-10 21:14:36.880674|2017-10-10 21:14:36.880674
NCT03088904|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-10-03|||September 2014|Actual|2014-09-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|SLVP028||Genetic and Environmental Factors in the Response to Influenza Vaccination|Genetic and Environmental Factors in the Response to Influenza Vaccination|Recruiting||Phase 4|120|Anticipated|Stanford University||3|||f||||t|t|f|||f|||||2017-10-10 21:14:36.96741|2017-10-10 21:14:36.96741
NCT03088891|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-03-19|||October 2015||2015-10-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ALTAX||Effect of an Antioxidant-rich Diet During Moderate Altitude Training|The Effect of an Increased Intake of Antioxidant-rich Foods on Training Adaptation, Redox-balance and Inflammation Among Elite Athletes During a Moderate Altitude Training Camp|Completed||N/A|35|Actual|University of Oslo||2|||f||||f||||||||||2017-10-10 21:14:37.071183|2017-10-10 21:14:37.071183
NCT03088878|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-22|||August 1, 2017|Anticipated|2017-08-01|March 2017|2017-03-01|August 1, 2022|Anticipated|2022-08-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||A Study of the Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies|A Phase 1b/2 Study of the ROR1-Targeting Monoclonal Antibody, Cirmtuzumab, and the Bruton Tyrosine Kinase Inhibitor, Ibrutinib, in Patients With B-Cell Lymphoid Malignancies|Not yet recruiting||Phase 1/Phase 2|156|Anticipated|University of California, San Diego||4|||f||||t|t|f||||||No||2017-10-10 21:14:37.17528|2017-10-10 21:14:37.17528
NCT03088865|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-19|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of an Internal Hospital Practice: The Effect of Altered Test Tubes Sampling Order on Blood Culture Contamination Rates|Evaluation of an Internal Hospital Practice: The Effect of Altered Sampling Protocol on Blood Culture Contamination Rates: An Open, Randomized, Prospective Study|Not yet recruiting||N/A|800|Anticipated|Hadassah Medical Organization||2|||f|||||f|f||||||||2017-10-10 21:14:37.271866|2017-10-10 21:14:37.271866
NCT03088852|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-03-23|||May 10, 2017|Anticipated|2017-05-10|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards|Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards|Not yet recruiting||Phase 4|330|Anticipated|HaEmek Medical Center, Israel||2|||f||||f|f|f||||||No||2017-10-10 21:14:37.327718|2017-10-10 21:14:37.327718
NCT03088839|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-17|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 1, 2018|Anticipated|2018-04-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)|Observational Case-Control Study to Identify Circulating miR-218 as a Possible Non-invasive Biomarker of Amyotrophic Lateral Sclerosis (ALS)|Not yet recruiting||N/A|60|Anticipated|Neuromed IRCCS|||2||f||||f|f|f||||||No||2017-10-10 21:14:37.397814|2017-10-10 21:14:37.397814
NCT03088826|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-08-18|||August 18, 2017|Actual|2017-08-18|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Analgesic Efficacy of (MSIR)/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet)|Comparison of Analgesic Efficacy of Morphine Sulfate Immediate Release (MSIR)/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet) for Acute Pain in Emergency Department Patients|Recruiting||Phase 2|180|Anticipated|Maimonides Medical Center||2|||f||||f|t|f||||||||2017-10-10 21:14:37.448772|2017-10-10 21:14:37.448772
NCT03088813|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-29|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|September 2023|Anticipated|2023-09-01|March 2022|Anticipated|2022-03-01||Interventional|||Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer|RESILIENT: A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection (ONIVYDE®) Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Progressed on or After Platinum-based First-Line Therapy|Not yet recruiting||Phase 3|482|Anticipated|Ipsen||2|||f||||t|t|f||||||||2017-10-10 21:14:37.529071|2017-10-10 21:14:37.529071
NCT03088787|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|COaRt||Feasibility of Continuous Noninvasive Finger Arterial Blood Pressure Measurement for Detection and Staging of Aortic Stenosis|Feasibility of Continuous Noninvasive Finger Arterial Blood Pressure Measurement for Detection and Staging of Aortic Stenosis|Not yet recruiting||N/A|100|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f|f|t|f|f|f|||Yes||2017-10-10 21:14:37.69437|2017-10-10 21:14:37.69437
NCT03088774|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-15|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparing Satisfaction With a Participatory Driven Web-application and a Standard Website|Comparing Satisfaction With a Participatory Driven Web-application and a Standard Website for Patients With Low Back Pain: a Study Protocol of a Randomised Controlled Trial|Not yet recruiting||N/A|200|Anticipated|Aalborg Universitetshospital||2|||f||||f|f|f||||||||2017-10-10 21:14:37.752092|2017-10-10 21:14:37.752092
NCT03088761|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-04-12|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|October 1, 2017|Anticipated|2017-10-01|September 30, 2017|Anticipated|2017-09-30||Observational|||Cuff Pressure in Infants|Changes in the Cuff Pressure in Infants in the Absence of Nitrous Oxide|Not yet recruiting||N/A|20|Anticipated|Istanbul Science University|||1||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:14:37.830789|2017-10-10 21:14:37.830789
NCT03088748|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-13|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Kinematics in Posterior Cruciate Retaining and Bi-Cruciate Retaining Total Knee Replacements Using Mobile Fluoroscopy|Kinematics in Posterior Cruciate Retaining and Bi-Cruciate Retaining Total Knee Replacements Using Mobile Fluoroscopy|Recruiting||N/A|84|Anticipated|The University of Tennessee, Knoxville|||2||f||||t|f|t|f|f|f|||No||2017-10-10 21:14:37.997861|2017-10-10 21:14:37.997861
NCT03088735|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-22|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Transfer Strategy in an Oocyte Donation Programme|Pilot Study of the Best Transfer Strategy in an Oocyte Donation Programme: an Intention to Treat Randomized Controlled Trial|Recruiting||N/A|250|Anticipated|Institut Universitari Dexeus||2|||f||||f|f|f||||||No||2017-10-10 21:14:38.151232|2017-10-10 21:14:38.151232
NCT03088722|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-17|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||A Study Comparing Implant Provision by Community Health Extension Workers With Nurses and Midwives in Nigeria|Task-sharing to Expand Access to Contraceptive Implants: A Study Comparing Implant Provision by Community Health Extension Workers With Nurses and Midwives in Nigeria|Completed||N/A|7903|Actual|Marie Stopes International||2|||f|||||f|f||||||||2017-10-10 21:14:38.25339|2017-10-10 21:14:38.25339
NCT03088683|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-03-16|||January 2017||2017-01-01|March 2017|2017-03-01|April 20, 2017|Anticipated|2017-04-20|April 1, 2017|Anticipated|2017-04-01||Interventional|||Comparison of Liver Trauma in Two Retractors Used in Sleeve Gastrectomy|Comparison of Liver Trauma in Two Retractors Used in Sleeve Gastrectomy: A Prospective Multicenter Clinical Trial|Recruiting||N/A|60|Anticipated|Umraniye Education and Research Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:14:38.54003|2017-10-10 21:14:38.54003
NCT03088670|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-03-18|||April 23, 2013|Actual|2013-04-23|March 2017|2017-03-01|October 3, 2014|Actual|2014-10-03|March 30, 2014|Actual|2014-03-30||Interventional|||Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.|Evaluate Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.|Completed||Phase 3|299|Actual|SatRx LLC||2|||f||||f|f|f||||||No||2017-10-10 21:14:38.641835|2017-10-10 21:14:38.641835
NCT03088657|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-17|||September 2015||2015-09-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01|1 Year|Observational [Patient Registry]|||Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study|Mood Disorder Cohort Research Consortium (MDCRC) in Korea|Recruiting||N/A|500|Anticipated|Korea University Anam Hospital|||1||f||||f||||||Samples With DNA|"     blood 10cc   "|No||2017-10-10 21:14:38.792027|2017-10-10 21:14:38.792027
NCT03088644|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-25|||March 24, 2017|Actual|2017-03-24|August 2017|2017-08-01|April 25, 2018|Anticipated|2018-04-25|April 25, 2018|Anticipated|2018-04-25||Interventional|||A Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor Positron Emission Tomography (PET) Tracer 18F-JNJ-64413739|An Open-label Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor PET Tracer 18F-JNJ-64413739|Recruiting||Phase 1|31|Anticipated|Janssen-Cilag International NV||4|||f||||f|f|f||||||||2017-10-10 21:14:38.909098|2017-10-10 21:14:38.909098
NCT03088631|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-18|2017-04-30|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||Metformin in Intracytoplasmic Sperm Injection Cycles|Role of Metformin in Prevention of Premature Luteinization in Intracytoplasmic Sperm Injection Cycles|Recruiting||Phase 2|150|Anticipated|Assiut University||2|||f||||f|f|f||||||Yes||2017-10-10 21:14:39.009858|2017-10-10 21:14:39.009858
NCT03088618|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-16|||August 2016||2016-08-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of Surgical Material for Nasal Septoplasty|A Multi-center, Non-randomized, Open, Single-arm Confirmatory Clinical Study to Evaluate the Safety and Efficacy of Surgical Material for Nasal Septoplasty in Septal Deformity Patients With Nasal Obstruction|Recruiting||N/A|22|Anticipated|T&R Biofab Co., Ltd.||1|||f||||t||||||||Undecided||2017-10-10 21:14:39.120345|2017-10-10 21:14:39.120345
NCT03088605|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-05|||February 20, 2017|Actual|2017-02-20|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Safety and Efficacy of TOP1630 for Dry Eye Syndrome|A Single-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of TOP1630 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Syndrome|Completed||Phase 2|170|Anticipated|Topivert Pharma Ltd||2|||f||||f|t|f||||||||2017-10-10 21:14:39.273163|2017-10-10 21:14:39.273163
NCT03088592|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-16|||February 1, 2016|Actual|2016-02-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|DBSMER||Electrophysiological Recordings of Deep Brain Stimulation in the Basal Ganglia|Electrophysiological Recordings of Deep Brain Stimulation in the Basal Ganglia|Recruiting||N/A|30|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:14:39.39238|2017-10-10 21:14:39.39238
NCT03088579|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-16|||April 2, 2013|Actual|2013-04-02|March 2017|2017-03-01|June 1, 2018|Anticipated|2018-06-01|March 1, 2018|Anticipated|2018-03-01||Observational|||Intraoperative Brachytherapy for Central Nervous System Lesions: A Validation Study of a Radioactive Seed Loading Device|Intraoperative Brachytherapy for Central Nervous System Lesions: A Validation Study of a Radioactive Seed Loading Device|Recruiting||N/A|150|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix|||1||f||||f|f|f||||||No||2017-10-10 21:14:39.512405|2017-10-10 21:14:39.512405
NCT03088566|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-25|||August 15, 2017|Anticipated|2017-08-15|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|November 15, 2017|Anticipated|2017-11-15||Interventional|||Implementation of the D-Foot at the Department of Prosthetics and Orthotics|Implementation of the D-Foot at the Department of Prosthetics and Orthotics|Not yet recruiting||N/A|80|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f|f|f||||||No||2017-10-10 21:14:39.648409|2017-10-10 21:14:39.648409
NCT03088553|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-05-15|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|GANEX||Observational Study Comparing the Efficacy of Ganciclovir as a Function of Blood Exposure to the Drug During a Curative or Preemptive Treatment|Etude Observationnelle Comparant l'efficacité du GANciclovir en Fonction de l'EXposition Sanguine au médicament|Recruiting||N/A|138|Anticipated|Rennes University Hospital|||1||f||||||f||||||||2017-10-10 21:14:39.742035|2017-10-10 21:14:39.742035
NCT03088540|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-26|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)|A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus Platinum Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic PD L1+Non-small Cell Lung Cancer|Recruiting||Phase 3|300|Anticipated|Regeneron Pharmaceuticals||2|||f||||t|t|f|||t|||||2017-10-10 21:14:39.833661|2017-10-10 21:14:39.833661
NCT03088527|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-16|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer|A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer|Not yet recruiting||Phase 1|40|Anticipated|Radius Pharmaceuticals, Inc.||1|||f|||||t|f||||||||2017-10-10 21:14:40.051443|2017-10-10 21:14:40.051443
NCT03088514|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-22|||March 23, 2017|Actual|2017-03-23|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|NITRATE-TOD||Investigation of Dietary Nitrate Effects in Hypertension-induced Target Organ Damage|Investigation of Dietary Nitrate Effects in Hypertension-induced Target Organ Damage|Recruiting||Phase 2|160|Anticipated|Queen Mary University of London||4|||f||||t|f|f||||||||2017-10-10 21:14:40.124515|2017-10-10 21:14:40.124515
NCT03088501|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|PERTH||Participant Engagement and Retention Trial in a Public Hospital (PERTH): An RCT Protocol|Participant Engagement and Retention Trial in a Public Hospital (PERTH): An RCT Protocol|Not yet recruiting||N/A|795|Anticipated|Public Health Foundation of India||3|||f||||f|f|f||||||||2017-10-10 21:14:40.241699|2017-10-10 21:14:40.241699
NCT03088488|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-16|||June 1, 2015|Actual|2015-06-01|March 2017|2017-03-01|April 21, 2016|Actual|2016-04-21|March 15, 2016|Actual|2016-03-15||Observational|||Vitamin D and Periodontitis|Relationship of Bone Metabolism Biomarkers and Serum 25-Hydroxy Vitamin D in Patients With Chronic Periodontitis|Completed||N/A|60|Actual|T.C. ORDU ÜNİVERSİTESİ|||2||f||||f|f|f||||||Undecided||2017-10-10 21:14:40.314578|2017-10-10 21:14:40.314578
NCT03088475|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-16|||January 1, 2018|Anticipated|2018-01-01|March 2017|2017-03-01|December 30, 2019|Anticipated|2019-12-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||A Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Blood Glucose Control|A Randomised Controlled Trial on a Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Glycaemic Control|Not yet recruiting||N/A|128|Anticipated|National University, Singapore||2|||f||||t|f|f||||||No||2017-10-10 21:14:40.399781|2017-10-10 21:14:40.399781
NCT03088462|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-18|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|July 31, 2020|Anticipated|2020-07-31|April 28, 2020|Anticipated|2020-04-28||Interventional|||LiveWell: A Mobile Intervention for Bipolar Disorder|LiveWell: A Mobile Intervention for Bipolar Disorder|Recruiting||N/A|200|Anticipated|Northwestern University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:14:40.483958|2017-10-10 21:14:40.483958
NCT03088449|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-09-27|||March 2013||2013-03-01|September 2017|2017-09-01|July 30, 2019|Anticipated|2019-07-30|July 30, 2017|Actual|2017-07-30||Observational|PANTS||Personalising Anti-TNF Therapy in Crohns Disease (PANTS)|Investigation of the Clinical,Serological and Genetic Factors That Determine Primary Non-response, Loss of Response and Adverse Drug Reactions to Anti-TNF Drugs in Patients With Active Luminal Crohn's Disease|Active, not recruiting||N/A|1750|Actual|NIHR Exeter Clinical Research Facility|||1||f||||t|f|f||||Samples With DNA|"     DNA, RNA, STOOL, SERUM will be collected over the 3 years period from multiple time points.   "|||2017-10-10 21:14:40.597469|2017-10-10 21:14:40.597469
NCT03088436|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||January 1, 2014|Actual|2014-01-01|March 2017|2017-03-01|January 15, 2015|Actual|2015-01-15|January 15, 2015|Actual|2015-01-15||Observational|||Feasibility Study of Supine Breast MRI : Comparison With Prone MRI and Comfort Assessment|Feasibility Study of Supine Breast MRI : Comparison With Prone MRI and Comfort Assessment|Completed||N/A|47|Actual|Institut de Cancérologie de Lorraine|||1||f|||||f|f||||||||2017-10-10 21:14:40.668881|2017-10-10 21:14:40.668881
NCT03088423|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-17|||October 1, 2011|Actual|2011-10-01|March 2017|2017-03-01|February 1, 2015|Actual|2015-02-01|April 1, 2013|Actual|2013-04-01||Observational|||HCC Response Assessment by MRI After SBRT|Tumor Response Assessment by MRI Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma|Completed||N/A|35|Actual|Institut de Cancérologie de Lorraine|||1||f|||||f|f||||||||2017-10-10 21:14:40.729179|2017-10-10 21:14:40.729179
NCT03088410|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-16|||April 1, 2016|Actual|2016-04-01|March 2017|2017-03-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|MOCHA||Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gabarone, Botawana|The Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV-exposed Uninfected in Botswana|Recruiting||Phase 4|450|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||t|t|f|||t|||No||2017-10-10 21:14:40.787525|2017-10-10 21:14:40.787525
NCT03088397|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-08-29|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|POCO||Effectiveness of a Patient Decision Aid in Immediate Postpartum Contraceptive Counseling|Effectiveness of a Patient Decision Aid in Immediate Postpartum Contraceptive Counseling|Recruiting||N/A|120|Anticipated|Montefiore Medical Center||3|||f||||f|f|f||||||||2017-10-10 21:14:40.880589|2017-10-10 21:14:40.880589
NCT03088384|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-17|||November 28, 2016|Actual|2016-11-28|March 2017|2017-03-01|November 27, 2018|Anticipated|2018-11-27|November 27, 2018|Anticipated|2018-11-27||Observational|||Ketamine Infusion Therapy for PTSD in Combat Veterans|The Effect of Therapeutic Ketamine Infusions on the Symptoms of Post-Traumatic Stress Disorder in Combat Veterans|Recruiting||N/A|30|Anticipated|Klarisana Physician Services PLLC|||1||f||||t|t|f|||f|||No||2017-10-10 21:14:40.986136|2017-10-10 21:14:40.986136
NCT03088371|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-16|||April 10, 2014|Actual|2014-04-10|March 2017|2017-03-01|September 22, 2016|Actual|2016-09-22|June 14, 2016|Actual|2016-06-14||Interventional|||Psoas Sciatic Blockade for Knee Arthroplasty|Psoas Sciatic Blockade Could be a Sole Anaesthetic Technique for Total Knee Arthroplasty|Completed||N/A|80|Actual|Menoufia University||2|||f||||f|f|f||||||No||2017-10-10 21:14:41.120423|2017-10-10 21:14:41.120423
NCT03088358|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-18|||August 2013||2013-08-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement|A Multicenter, Randomized, Pilot, Dose-Ranging Clinical Study to Evaluate Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement|Completed||Phase 2|200|Actual|TeaRx LLC||4|||f||||f|f|f||||||No||2017-10-10 21:14:41.769895|2017-10-10 21:14:41.769895
NCT03088345|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-16|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|April 2018|Anticipated|2018-04-01||Interventional|VAMP||Early Use of Vasopressin in Post-Fontan Management|Use of Arginine Vasopressin in Early Postoperative Management After Fontan Palliation|Recruiting||Phase 2/Phase 3|20|Anticipated|Medical College of Wisconsin||2|||f||||t|t|f|||t|||No||2017-10-10 21:14:41.898756|2017-10-10 21:14:41.898756
NCT03088332|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-06|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Evaluating the Efficacy and Results of Endoscopic Gastroplasty Performed Using Overstitch in Patients With Obesity.|Prospective Multicenter Study to Evaluate the Efficacy and Results of Endoscopic Gastroplasty Performed Using Overstitch in Patients With Class I and II Obesity.|Recruiting||N/A|30|Anticipated|Kaiser Clinic and Hospital||1|||f||||f|f|f||||||Yes||2017-10-10 21:14:42.035295|2017-10-10 21:14:42.035295
NCT03088319|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-06-22|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|October 11, 2019|Anticipated|2019-10-11|October 11, 2019|Anticipated|2019-10-11||Observational|serene||Post-natal Depression and Chronic Stress|Chronic Stress Protection for Post-natal Depression Prevention: An Exploratory Study|Recruiting||N/A|260|Anticipated|Institut de Recherche Biomedicale des Armees|||1||f||||t|f|f||||||No||2017-10-10 21:14:42.136147|2017-10-10 21:14:42.136147
NCT03088306|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-08-15|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|IPaRO||Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients|Comparative Effectiveness of Multi-modal Pain Management Versus Standard Intra- and Post-operative Analgesia: Randomized Controlled Clinical Trial to Reduce Post-operative Pain and Opioid Use Among Patients Undergoing Lumbar Spine Surgery|Recruiting||Early Phase 1|50|Anticipated|Johns Hopkins University||2|||f||||f|t|f|||f|||||2017-10-10 21:14:42.220203|2017-10-10 21:14:42.220203
NCT03088293|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|CIRIS||Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)|A Multicenter Randomized Open-label Trial Comparing the Efficacy and Safety of Infliximab Versus Cyclophosphamide in Subjects With Idiopathic Refractory Scleritis|Not yet recruiting||Phase 2|50|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 21:14:42.359426|2017-10-10 21:14:42.359426
NCT03088280|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-17|||June 30, 2015|Actual|2015-06-30|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen|Prospective Randomized Study to Evaluate the Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg vs. 6mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen|Recruiting||Phase 4|200|Anticipated|Hospital Geral de Fortaleza||2|||f||||f|t|f|||f|||No|patient data are confidential e will not be share with other researchers.|2017-10-10 21:14:42.469446|2017-10-10 21:14:42.469446
NCT03088267|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-28|||February 11, 2017|Actual|2017-02-11|April 2017|2017-04-01|September 30, 2017|Anticipated|2017-09-30|February 25, 2017|Actual|2017-02-25||Interventional|||Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School Study|Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children Wit|Active, not recruiting||Phase 3|18|Actual|Tris Pharma, Inc.||2|||f||||f|t|f|||f|||No||2017-10-10 21:14:42.551523|2017-10-10 21:14:42.551523
NCT03088254|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-17|||October 2016||2016-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin|A Multi-center, Randomized, Double-blind, Parellel Phase III Clinical Trial to Evaluate the Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients With Dyslipidemia and Hypertension|Recruiting||Phase 3|126|Anticipated|Jeil Pharmaceutical Co., Ltd.||3|||f||||f|f|f||||||No||2017-10-10 21:14:42.629959|2017-10-10 21:14:42.629959
NCT03088241|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-09-30|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|SESOTHO||"Switch Either Near Suppression Or THOusand"|Switch to Second-line Versus WHO-guided Standard of Care for Unsuppressed Patients on First-line ART With Viremia Below 1000 Copies/mL - a Multicenter, Parallel-group, Open-label, Randomized Clinical Study in Rural Lesotho|Recruiting||N/A|80|Anticipated|Swiss Tropical & Public Health Institute||2|||f||||t|f|f||||||||2017-10-10 21:14:42.903349|2017-10-10 21:14:42.903349
NCT03088228|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-26|||February 2, 2015|Actual|2015-02-02|September 2017|2017-09-01|December 31, 2016|Actual|2016-12-31|August 15, 2016|Actual|2016-08-15|6 Months|Observational [Patient Registry]|||Maternal Periodontal Status and Cytokines in Preeclampsia|Maternal Periodontal Status and Gingival Crevicular Fluid Levels of Interleukin-6, Interleukin-35, and Interleukin-37 in Preeclampsia|Completed||N/A|80|Actual|Yuzuncu Yıl University|||3||f||||f|f|f||||Samples Without DNA|"     gingival crevicular flud was analyzed   "|||2017-10-10 21:14:43.137738|2017-10-10 21:14:43.137738
NCT03088202|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-08|||March 22, 2017|Actual|2017-03-22|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|PALLiON||PALLiON - PALLiative Care In ONcology|PALLiON - PALLiative Care In ONcology - a Cluster-randomized Trial to Improve the Care for Cancer Patients With a Short Life Expectancy|Recruiting||N/A|600|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:14:43.328592|2017-10-10 21:14:43.328592
NCT03088189|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-05|||May 9, 2017|Actual|2017-05-09|June 2017|2017-06-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2022|Anticipated|2022-03-31||Observational|||Effect of Parental Peri-conceptional Vitamin B12 Supplementation on Infant Neurocognitive Development in Offspring|Effect of Parental Peri-conceptional Vitamin B12 Supplementation on Infant Neurocognitive Development in Offspring|Recruiting||N/A|250|Anticipated|Kem Hospital, Pune, India|||3||f||||t|f|f||||||No||2017-10-10 21:14:43.613361|2017-10-10 21:14:43.613361
NCT03088176|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-23|||June 25, 2017|Anticipated|2017-06-25|June 2017|2017-06-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma|A Phase 1b Trial of Talimogene Laherparepvec in Combination With Dabrafenib and Trametinib in Advanced Melanoma With an Activating BRAF Mutation|Recruiting||Phase 1|20|Anticipated|West Cancer Center||1|||f||||f|t|f|||f|||No|Data will be de-identified before publication or sharing with external entities or researchers|2017-10-10 21:14:43.729785|2017-10-10 21:14:43.729785
NCT03088163|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-22|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Value of Diffusion-weighted Imaging in Evaluating the Early Efficacy of Liver Metastasis in Colorectal Cancer|The Value of DWI-MRI(Diffusion-weighted Imaging) in Evaluating the Early Efficacy of Liver Metastasis in Colorectal Cancer|Recruiting||N/A|100|Anticipated|Fudan University||1|||f||||f|f|f||||||No||2017-10-10 21:14:43.8644|2017-10-10 21:14:43.8644
NCT03088150|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-07-14|||July 13, 2017|Actual|2017-07-13|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|July 2022|Anticipated|2022-07-01||Interventional|COLLISION||COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation|COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation, a Phase III Single-blind Prospective Randomized Controlled Trial|Recruiting||N/A|618|Anticipated|VU University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:14:43.959944|2017-10-10 21:14:43.959944
NCT03088137|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-15|||February 8, 2017|Actual|2017-02-08|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|February 28, 2018|Anticipated|2018-02-28||Interventional|||Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment|Multicentre Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment|Recruiting||Phase 3|140|Anticipated|IVFarma LLC||2|||f||||t|f|f||||||||2017-10-10 21:14:44.091382|2017-10-10 21:14:44.091382
NCT03088124|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-16|||April 28, 2017|Actual|2017-04-28|August 2017|2017-08-01|April 28, 2022|Anticipated|2022-04-28|April 28, 2022|Anticipated|2022-04-28||Interventional|||Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer|Active Surveillance With or Without a 6 Months Apalutamide Treatment in Low Risk Prostate Cancer: A Phase II Randomized Multicenter Trial|Recruiting||Phase 2|206|Anticipated|Institut Paoli-Calmettes||2|||f||||f|f|f||||||||2017-10-10 21:14:44.22369|2017-10-10 21:14:44.22369
NCT03088111|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-07-25|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2021|Anticipated|2021-01-01||Interventional|||An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis|A Phase 4, Open Label Field Study to Evaluate the Clinical Benefit, Safety, and Pharmacokinetics of Anthim (Obiltoxaximab) When Used in the Treatment of Suspected, Probable, or Confirmed Cases of Inhalational Anthrax Due to B. Anthracis|Not yet recruiting||Phase 4|100|Anticipated|Elusys Therapeutics||1|||f||||f|t|f||||||||2017-10-10 21:14:44.365345|2017-10-10 21:14:44.365345
NCT03088098|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-22|||May 15, 2016||2016-05-15|March 2017|2017-03-01|June 15, 2022|Anticipated|2022-06-15|May 15, 2017|Anticipated|2017-05-15||Interventional|TAVI/LAAO||Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI|Randomized Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in Atrial Fibrillation Undergoing Transfemoral Transcatheter Aortic Valve Implantation: The TAVI LAAO Trial|Recruiting||N/A|80|Anticipated|University of Zurich||2|||f||||f||||||||No||2017-10-10 21:14:44.473291|2017-10-10 21:14:44.473291
NCT03086941|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-03-23|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Blind Versus Fiberoptic Intubation Through I-GEL|The Use of Supraglottic I-Gel Airway as a Conduit for Fiberoptic Guided and Blind Intubation in Children|Recruiting||N/A|88|Anticipated|Cairo University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:14:57.05475|2017-10-10 21:14:57.05475
NCT03088085|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-22|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|May 1, 2017|Anticipated|2017-05-01|May 1, 2017|Anticipated|2017-05-01||Interventional|||The Effectiveness of Self-thoracic Spine Mobilization on Improving Sleep Quality in Patients Who Have Shoulder Pain|The Effectiveness of Self-thoracic Spine Mobilization on Improving Sleep Quality in Patients Who Have Shoulder Pain|Recruiting||N/A|40|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:14:44.588148|2017-10-10 21:14:44.588148
NCT03088072|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-07-07|||March 23, 2017|Actual|2017-03-23|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|November 30, 2018|Anticipated|2018-11-30||Interventional|||A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure|A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure|Recruiting||Phase 4|75|Anticipated|Scripps Health||1|||f||||t|t|f|||f|||||2017-10-10 21:14:44.680982|2017-10-10 21:14:44.680982
NCT03088059|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-02|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|UPSTREAM||Biomarker-based Study in R/M SCCHN|A Pilot Study of Personalized Biomarker-based Treatment Strategy or Immunotherapy in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck|Not yet recruiting||Phase 2|257|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||5|||f||||t|f|f||||||||2017-10-10 21:14:44.815448|2017-10-10 21:14:44.815448
NCT03088046|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-16|||February 2014|Actual|2014-02-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome|Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome|Completed||N/A|15|Actual|Institut Universitari Dexeus||1|||f||||f|f|f||||||No||2017-10-10 21:14:44.92307|2017-10-10 21:14:44.92307
NCT03088033|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-10-04|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|July 2024|Anticipated|2024-07-01|December 2020|Anticipated|2020-12-01||Interventional|REDUCELAPHF II||REDUCE LAP-HF TRIAL II|A Study to Evaluate the Corvia Medical, Inc. IASD® System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure|Recruiting||N/A|380|Anticipated|Corvia Medical||2|||f||||t|f|t|t|||||||2017-10-10 21:14:45.019379|2017-10-10 21:14:45.019379
NCT03088020|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-22|||June 24, 2013|Actual|2013-06-24|March 2017|2017-03-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31|10 Years|Observational [Patient Registry]|||International Congenital Central Hypoventilation Syndrome (CCHS) Registry|International Congenital Central Hypoventilation Syndrome (CCHS) REDCap Registry|Recruiting||N/A|400|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f|f|f||||||||2017-10-10 21:14:45.239586|2017-10-10 21:14:45.239586
NCT03088007|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-16|||August 1, 2014|Actual|2014-08-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|October 1, 2016|Actual|2016-10-01||Observational|EVAL'ID||Importance of Multidimensional Assessments in Accompanying Schooling of Children With Mild to Moderate Intellectual Disability.|Importance of Multidimensional Assessments in Accompanying Schooling of Children With Mild to Moderate Intellectual Disability.|Completed||N/A|150|Actual|Hospices Civils de Lyon|||2||f||||f|f|f||||||No||2017-10-10 21:14:45.34473|2017-10-10 21:14:45.34473
NCT03087994|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-10-03|||June 1, 2017|Actual|2017-06-01|March 2017|2017-03-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||The Influence of Obesity on Level of Depression and Cognitive and Executive Functions|The Influence of Obesity on Level of Depression and Cognitive and Executive Functions|Recruiting||N/A|90|Anticipated|Rabin Medical Center||3|||f||||f|f|f||||||||2017-10-10 21:14:45.457205|2017-10-10 21:14:45.457205
NCT03087981|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-09-13|||October 2017|Anticipated|2017-10-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Observational|PANDA||Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition|A Multicenter Prospective Observational Study to Analyze Various ICP Derived Parameters and Clinical Status in Neurosurgical Critical Patients Through Big Data Acquisition|Recruiting||N/A|120|Anticipated|RenJi Hospital|||1||f||||f|f|f||||||||2017-10-10 21:14:45.561567|2017-10-10 21:14:45.561567
NCT03087968|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-13|||July 31, 2016|Anticipated|2016-07-31|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|September 13, 2017|Actual|2017-09-13||Interventional|||Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124|Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124|Withdrawn||Early Phase 1|0|Actual|HepQuant, LLC||2||No longer a sub-study - Changing to an independent parallel study|||||t|t|t|t|f||||||2017-10-10 21:14:45.652008|2017-10-10 21:14:45.652008
NCT03087955|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-16|||October 11, 2016|Actual|2016-10-11|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|April 2020|Anticipated|2020-04-01||Interventional|OXA002||Prospective Study on Efficacy and Safety of SCYX-7158 in Patients Infected by Human African Trypanosomiasis Due to T.b. Gambiense|Efficacy and Safety Study of SCYX-7158 in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Gambiense: a Multicentre, Open-label, Prospective Study|Recruiting||Phase 2/Phase 3|360|Anticipated|Drugs for Neglected Diseases||1|||f||||t|f|f||||||Yes|Only for patients from OXA002 participating also in the DiTECT-HAT-WP4, some data (all anonymised) will be shared with L'Institut de Recherche pour le Dévelopment, sponsor of the DiTECT-HAT-WP4 study.|2017-10-10 21:14:45.785577|2017-10-10 21:14:45.785577
NCT03087942|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-30|||June 7, 2017|Anticipated|2017-06-07|May 2017|2017-05-01|April 7, 2018|Anticipated|2018-04-07|April 7, 2018|Anticipated|2018-04-07||Interventional|||Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects|An Open-label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics of Fevipiprant (QAW039) in Patients With End-stage Renal Disease on Hemodialysis and Optionally in Patients With Severe to Moderate and Mild Renal Impairment Compared to Matched Healthy Volunteers Including a Cross-over Assessment in End-stage Renal Disease Patients on the Effect of Dialysis on Fevipiprant Pharmacokinetics|Not yet recruiting||Phase 1|60|Anticipated|Novartis||4|||f||||f|t|f||||||No||2017-10-10 21:14:45.891268|2017-10-10 21:14:45.891268
NCT03087929|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-17|||September 20, 2013|Actual|2013-09-20|March 2017|2017-03-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Observational|||Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon|Phase II Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon|Completed||N/A|12|Actual|Sunnybrook Health Sciences Centre|||1||f||||f|f|f||||||No||2017-10-10 21:14:45.985404|2017-10-10 21:14:45.985404
NCT03087903|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA|A Phase 2 Study of Grape Seed Extract (GSE) Product in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising Prostate Specific Antigen (PSA)|Not yet recruiting||Phase 2|41|Anticipated|University of Colorado, Denver||1|||f||||t|f|f||||||||2017-10-10 21:14:46.087474|2017-10-10 21:14:46.087474
NCT03087890|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-05|||March 30, 2017|Actual|2017-03-30|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30||Interventional|CoTrimResist||Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria|Randomized Clinical Trial to Assess Whether the Duration of Cotrimoxazole Preventive Therapy in HIV Patients With CD4 Counts >350 CD4 Cells/µL by Antiretroviral Treatment Influences the Rate of Carriage of Multidrug-resistant Bacteria|Recruiting||Phase 4|500|Anticipated|University of Bergen||2|||f||||t|f|f|||f|||||2017-10-10 21:14:46.173892|2017-10-10 21:14:46.173892
NCT03086785|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-21|||November 24, 2016|Actual|2016-11-24|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer|Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer|Recruiting||Phase 2|120|Anticipated|Hebei Medical University Fourth Hospital||1|||f|||||f|f||||||||2017-10-10 21:14:46.306239|2017-10-10 21:14:46.306239
NCT03086772|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-03-21|||May 2014||2014-05-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effects of Tai Chi on Multisite Pain and Brain Functions in Older Adults|Effects of Tai Chi on Multisite Pain and Brain Functions in Older Adults|Active, not recruiting||N/A|54|Actual|University of Massachusetts, Boston||2|||f||||t||||||||No||2017-10-10 21:14:46.384302|2017-10-10 21:14:46.384302
NCT03086759|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-21|||January 2, 2017|Actual|2017-01-02|March 2017|2017-03-01|March 2, 2018|Anticipated|2018-03-02|March 2, 2018|Anticipated|2018-03-02||Interventional|||Intra-Articular Platelet Rich Plasm Use in Osteoarthritis of Knee.|Intra-Articular Use of Platelet Rich Plasma Versus Corticosteroid: A Clinical Trials in Osteoarthritis of Knee.|Recruiting||Phase 4|99|Anticipated|Federal University of São Paulo||3|||f|||||f|f||||||||2017-10-10 21:14:46.45928|2017-10-10 21:14:46.45928
NCT03086746|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-07-11|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 1, 2019|Anticipated|2019-06-01|May 1, 2019|Anticipated|2019-05-01|6 Months|Observational [Patient Registry]|VINDICATE-MI||VItamin D as a Novel Determinant of Injurious Cardiac Remodelling After acuTE Myocardial Infarction|VItamin D as a Novel Determinant of Injurious Cardiac Remodelling After acuTE Myocardial Infarction|Not yet recruiting||N/A|800|Anticipated|University of Leeds|||1||f||||f|f|f||||Samples Without DNA|"     EDTA and serum   "|||2017-10-10 21:14:46.541889|2017-10-10 21:14:46.541889
NCT03086733|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-23|||December 5, 2016|Actual|2016-12-05|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|Metcore||Phase II Lung Metcore - Preoperative Metformin for Lung Cancer|Phase II Study of Single Agent Pre-operative Metformin in Patients With Clinical Stage I - IIIA NSCLC Proceeding to Surgical Resection. 'Lung Metcore Study'|Recruiting||Phase 2|50|Anticipated|University Health Network, Toronto||1|||f||||t|f|f|||t|||Undecided||2017-10-10 21:14:46.608985|2017-10-10 21:14:46.608985
NCT03086720|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-16|||July 2012||2012-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Deproteinization as a Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions|Effect of Sodium Hypochlorite Pre-treatment on the Retention of Restorations for Non-carious Cervical Lesions: A Randomized Controlled Trial|Active, not recruiting||N/A|30|Anticipated|Federal University of Pelotas||2|||f|||||f|f||||||No||2017-10-10 21:14:46.701189|2017-10-10 21:14:46.701189
NCT03086707|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-14|||January 21, 2017|Actual|2017-01-21|September 2017|2017-09-01|October 20, 2017|Anticipated|2017-10-20|August 14, 2017|Actual|2017-08-14||Interventional|||Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure|A 2-arm, Open Label, Prefatory Study to Explore Changes in Nasal Mucociliary Clearance Between Smokers and Never Smokers and to Standardize Nasal Scraping Procedure|Active, not recruiting||N/A|14|Actual|Philip Morris Products S.A.||2|||f||||f|f|f||||||||2017-10-10 21:14:46.798331|2017-10-10 21:14:46.798331
NCT03086694|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-04-27|||April 5, 2017|Actual|2017-04-05|August 2016|2016-08-01|December 31, 2019|Anticipated|2019-12-31|August 25, 2019|Anticipated|2019-08-25||Observational|||Goal-Directed Fluid Therapy for Patients Undergoing Oro-Maxillofacial Surgery|Kaohsiung Medical University Chung-Ho Memorial Hospital|Enrolling by invitation||N/A|60|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:14:46.867513|2017-10-10 21:14:46.867513
NCT03086681|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-16|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|ECWHCCFLACC||Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma|A Multicenter, Randomized Controlled Clinical Trial Comparing Endostar With Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Carcinoma|Not yet recruiting||Phase 3|120|Anticipated|First Affiliated Hospital of Guangxi Medical University||2|||f||||t|f|f||||||No||2017-10-10 21:14:48.586814|2017-10-10 21:14:48.586814
NCT03087877|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-07-25|||February 3, 2017||2017-02-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:14:48.69916|2017-10-10 21:14:48.69916
NCT03087864|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-27|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|PERFECT||PDL-1 Targeting in Resectable Oesophageal Cancer|PDL-1 Targeting in Resectable Oesophageal Cancer: a Phase II Feasibility Study of Atezolizumab and Chemoradiation.|Recruiting||Phase 2|40|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t|f|f|||f|||No||2017-10-10 21:14:48.744549|2017-10-10 21:14:48.744549
NCT03087851|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-17|||March 13, 2017|Actual|2017-03-13|March 2017|2017-03-01|October 1, 2020|Anticipated|2020-10-01|April 1, 2020|Anticipated|2020-04-01||Interventional|ZOLARMAB||Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis|Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis|Recruiting||Phase 4|60|Anticipated|Aarhus University Hospital||3|||f||||t|t|f|||t|||Undecided||2017-10-10 21:14:48.838652|2017-10-10 21:14:48.838652
NCT03087838|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-05-03|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|September 1, 2017|Anticipated|2017-09-01|August 1, 2017|Anticipated|2017-08-01||Observational|||Postoperative Delirium in Adult Patients After Elective Craniotomy Under General Anaesthesia|Postoperative Delirium in Adult Patients After Elective Craniotomy Under General Anaesthesia: a Prospective Cohort Study|Recruiting||N/A|800|Anticipated|Capital Medical University|||2||f||||t|f|f||||||No||2017-10-10 21:14:48.947885|2017-10-10 21:14:48.947885
NCT03087825|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-07-05|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Preoxygenation Method With a Calibrated Leak|Effect of Preoxygenation With Spontaneous Breathing or Noninvasive Positive Pressure Ventilation With or Without a Calibrated Leak. An Experimental Study in Healthy Volunteers|Completed||N/A|20|Actual|University Hospital, Caen||2|||f||||f|f|f||||||||2017-10-10 21:14:49.020418|2017-10-10 21:14:49.020418
NCT03087812|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-03-16|||December 2015||2015-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy|Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy|Enrolling by invitation||N/A|24|Anticipated|Clinical Research Office of the Endourological Society|||1||f||||f||||||||||2017-10-10 21:14:49.09223|2017-10-10 21:14:49.09223
NCT03087799|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-02|||March 3, 2017|Actual|2017-03-03|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Brief Behavioral Treatment for Sleep Problems in IBS Study|Brief Behavioral Treatment for Sleep Problems in Irritable Bowel Syndrome: a Pilot Study|Recruiting||N/A|40|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:14:49.159477|2017-10-10 21:14:49.159477
NCT03087786|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-09-18|||March 21, 2017|Actual|2017-03-21|September 2017|2017-09-01|November 15, 2017|Anticipated|2017-11-15|August 12, 2017|Actual|2017-08-12||Interventional|||Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations|Randomized, Parallel-Group, Assessor Blind Study To Evaluate Oral Mucosal Effects In Healthy Adult Smokers Associated With 3 Week Use Of Nicotine Bi-tartrate 4mg Mint Lozenges Relative To The Use Of Nicotine Polacrilex 4mg Mint Lozenges|Active, not recruiting||Phase 3|100|Actual|Niconovum USA||2|||f||||f|t|f||||||||2017-10-10 21:14:49.240593|2017-10-10 21:14:49.240593
NCT03087773|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-08-02|||May 11, 2017|Actual|2017-05-11|August 2017|2017-08-01|April 2, 2020|Anticipated|2020-04-02|November 2, 2019|Anticipated|2019-11-02||Interventional|EMMY||Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction|Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction|Recruiting||Phase 3|476|Anticipated|Medical University of Graz||2|||f||||t|f|f||||||||2017-10-10 21:14:49.323983|2017-10-10 21:14:49.323983
NCT03087760|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-03-21|||January 18, 2017|Actual|2017-01-18|March 2017|2017-03-01||||July 18, 2019|Anticipated|2019-07-18||Interventional|||Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer|Phase II Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer|Recruiting||Phase 2|41|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t|t|f||||||||2017-10-10 21:14:49.556763|2017-10-10 21:14:49.556763
NCT03087747|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-21|||January 1, 2015|Actual|2015-01-01|March 2017|2017-03-01|June 1, 2019|Anticipated|2019-06-01|December 31, 2018|Anticipated|2018-12-31|1 Year|Observational [Patient Registry]|||Percutaneous Transhepatic Cholangiography (PTHC) in Acute Cholecystitis and Clinical Outcomes|Percutaneous Drainage in a Setting of Acute Cholecystitis Severity Grade III and Correlation With Clinical Outcomes|Recruiting||N/A|50|Anticipated|University of Split, School of Medicine|||2||f||||||||||||||2017-10-10 21:14:49.654151|2017-10-10 21:14:49.654151
NCT03087734|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-03-22|||March 27, 2017|Anticipated|2017-03-27|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of a New Model of Metallic Bar and Stabilizer for Use in MIRPE|Evaluation of a New Model of Metallic Bar and Stabilizer for Use in the Minimally Invasive Repair of Pectus Excavatum|Recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 21:14:49.759647|2017-10-10 21:14:49.759647
NCT03087721|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-16|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|September 29, 2018|Anticipated|2018-09-29||Interventional|Intraining-MET||High-intensity Interval, Low Volume Training in Metabolic Syndrome|Efficacy of High-intensity Interval, Low-volume Training Compared to Continuous Aerobic Exercise on Insulin Resistance, Skeletal Muscle Composition and Endocrine Function in Adults With Metabolic Syndrome: a Randomized Controlled Clinical Trial (Intraining-MET)|Recruiting||N/A|60|Anticipated|Universidad de Antioquia||2|||f||||f|f|f||||||Yes||2017-10-10 21:14:49.860971|2017-10-10 21:14:49.860971
NCT03087708|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer|A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-small Cell Lung Cancer (Adenocarcinoma)|Not yet recruiting||Phase 3|204|Anticipated|Alliance for Clinical Trials in Oncology||3|||f||||t|t|f|||t|||||2017-10-10 21:14:49.96863|2017-10-10 21:14:49.96863
NCT03087695|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-16|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|January 16, 2019|Anticipated|2019-01-16|January 16, 2018|Anticipated|2018-01-16||Observational|||Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma|Effect of the Plasma EBV DNA Concentration Change During Chemoradiotherapy on Tumor Control and Patient Survival in Advanced Nasopharyngeal Carcinoma|Recruiting||N/A|200|Anticipated|Taichung Veterans General Hospital|||1||f||||f|f|f||||Samples With DNA|"     The patients will be collected blood sample once per week during chemoradiotherapy period.     Plasma will be extracted from these blood sample. Plasma EBV DNA concentrations will be     measured by a real-time quantitative polymerase chain reaction.   "|No|No plan to make individual participant data (IPD) available|2017-10-10 21:14:50.100493|2017-10-10 21:14:50.100493
NCT03087682|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-21|||February 1, 2013|Actual|2013-02-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|March 15, 2014|Actual|2014-03-15||Observational|OCT||Pituitary Gland Enlargement Was First Diagnosed by Optical Coherence Tomography (OCT)|Pituitary Gland Enlargement Was First Diagnosed by OCT Before There Were Any Changes at All in the Computerized and Automated Eighty Degrees Peripheral Visual Fields|Completed||N/A|2|Actual|Dr. S.S. Michel Clinic|||1||f||||f|f|f||||||No||2017-10-10 21:14:50.212282|2017-10-10 21:14:50.212282
NCT03087669|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-21|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|ECOH3||Central and Cerebral Circulation in Early Stages After LVAD Implantation|Evaluation of Central and Cerebral Circulation in Early Stages After Implantation of Left Ventricular Assist Device (LVAD)|Recruiting||N/A|20|Anticipated|Sahlgrenska University Hospital, Sweden||1|||f||||f|f|f||||||No||2017-10-10 21:14:50.303749|2017-10-10 21:14:50.303749
NCT03087656|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-04-18|||March 29, 2017|Actual|2017-03-29|April 2017|2017-04-01|February 23, 2019|Anticipated|2019-02-23|February 23, 2019|Anticipated|2019-02-23||Interventional|||Antibiotics to Decrease Post ERCP Cholangitis|Randomized Trial of Short Antibiotic Course to Decrease Post ERCP Cholangitis|Recruiting||Phase 4|200|Anticipated|University of Southern California||2|||f||||t|t|f|||t|||Yes||2017-10-10 21:14:50.440884|2017-10-10 21:14:50.440884
NCT03087630|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-16|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|EPIC||Evaluating Personalized Information and Choices|Informing Alcohol-Related Risk Intervention With the Prototype Willingness Model: Evaluating Personalized Information and Choices|Active, not recruiting||N/A|1204|Actual|University of Washington||4|||f|||||f|f||||||No|A select number of researchers will have access to unidentified participant data at the close of the study.|2017-10-10 21:14:50.693847|2017-10-10 21:14:50.693847
NCT03087617|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-16|||August 2017|Anticipated|2017-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Personalized Smoking Cessation Tool Based on Patient Lung CT Image|Personalized Smoking Cessation Tool Based on Patient Lung CT Image|Not yet recruiting||N/A|400|Anticipated|Imbio||4|||f||||f|f|t|t|f|f|||No||2017-10-10 21:14:50.786726|2017-10-10 21:14:50.786726
NCT03087604|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-06-01|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Loss of Resistance, w/wo Stimulation, For Epidural Placement|Loss of Resistance With Nerve Stimulation Versus Loss of Resistance Alone; Effect on Success of Thoracic Epidural Placement.|Recruiting||Phase 4|100|Anticipated|Wake Forest University Health Sciences||2|||f||||f|t|f|||f|||Undecided||2017-10-10 21:14:50.886649|2017-10-10 21:14:50.886649
NCT03087591|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-05-02|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery|Safety and Immunologic Activity of Multiple Infusions of APN401|Recruiting||Phase 1|10|Anticipated|Wake Forest University Health Sciences||1|||f|||||t|f||||||||2017-10-10 21:14:50.994827|2017-10-10 21:14:50.994827
NCT03087578|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-23|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|September 30, 2018|Anticipated|2018-09-30|July 1, 2018|Anticipated|2018-07-01||Interventional|||Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder|Comparison of Electroacupuncture to Mirabegron on Symptoms of Overactive Bladder in Women Who Have Failed Anti-Cholinergic Therapy|Not yet recruiting||N/A|80|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f|f|f|||f|||No||2017-10-10 21:14:51.11133|2017-10-10 21:14:51.11133
NCT03087565|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-04-11|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Urinary and Sexual Functions After Subtotal Versus Total Abdominal Hysterectomy|Urinary and Sexual Functions After Subtotal Versus Total Abdominal Hysterectomy|Recruiting||N/A|200|Anticipated|Cairo University||2|||f||||t|f|f||||||Yes||2017-10-10 21:14:51.208954|2017-10-10 21:14:51.208954
NCT03087552|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-03-21|||March 11, 2017|Actual|2017-03-11|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|November 30, 2020|Anticipated|2020-11-30|1 Month|Observational [Patient Registry]|SOFTLY-II||Mini-invasive Balloon Aortic Valvuloplasty|Safety and Feasibility of Transradial Mini-invasive Balloon Aortic Valvuloplasty|Recruiting||N/A|204|Anticipated|University Hospital of Ferrara|||1||f||||t|f|f||||||Undecided||2017-10-10 21:14:51.317412|2017-10-10 21:14:51.317412
NCT03087539|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-16|||May 2013||2013-05-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 14, 2016|Actual|2016-12-14||Interventional|||Exploratory P2 Trial to Evaluate Efficacy and Safety of Clotinab® (Abciximab) in Acute MI Patients|Exploratory Phase II Clinical Trial to Evaluate the Efficacy and Safety of Clotinab® (Abciximab) in Acute Myocardial Infarction Patients: Multicenter, Randomized, Double Blind, Placebo-controlled and Parallel Group Trial|Active, not recruiting||Phase 2|146|Anticipated|ISU Abxis Co., Ltd.||2|||f||||f||||||||Undecided|No comment|2017-10-10 21:14:51.414263|2017-10-10 21:14:51.414263
NCT03087526|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-16|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|October 31, 2019|Anticipated|2019-10-31|April 30, 2019|Anticipated|2019-04-30||Interventional|DIACCIMEX||NIPD on CFTC for Triplet Repeat Diseases|Non Invasive Prenatal Diagnosis on Isolated Circulating Fetal Trophoblastic Cells (CFTC) for Triplet Repeat Diseases|Not yet recruiting||N/A|55|Anticipated|University Hospital, Montpellier||1|||f||||t|f|f||||||Undecided|NC|2017-10-10 21:14:51.674739|2017-10-10 21:14:51.674739
NCT03087513|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-01|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||A Randomized Controlled Cross Over Study Comparing Sugammadex and Placebo|Effect of Reversal of Neuromuscular Blockade on the Amplitude of Motor Evoked Potentials: A Randomized Controlled Cross Over Study Comparing Sugammadex and Placebo|Not yet recruiting||Phase 4|36|Anticipated|University Health Network, Toronto||2|||f|||||t|f|||f|||||2017-10-10 21:14:51.787668|2017-10-10 21:14:51.787668
NCT03087500|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-07-20|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||Physiological Abnormalities Associated With Down Syndrome|Physiologic Biomarkers Within the Functional Spectrum of Down Syndrome|Not yet recruiting||N/A|180|Anticipated|University of Arkansas|||2||f||||f|f|f||||Samples Without DNA|"     -  Biomarkers of oxidative stress (GSH/GSSG)        -  Biomarkers of reduced methylation capacity (SAM/SAH)        -  Biomarkers of mitochondrial energetics        -  Metabolomics (Urine, Blood)        -  Salivary inflammatory cytokines (IL-1, IL2, IL-6, TNFα)        -  DNA methylation array (epigenetic profile); total DNA methylation        -  Folate Receptor Autoantibody (Blocking and Binding)        -  Thyroid Function (Thyroid Stimulating Hormone, T3, Reverse T3 and free and total T4)        -  Microbiome Analysis (Stool)   "|||2017-10-10 21:14:51.872053|2017-10-10 21:14:51.872053
NCT03087474|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-10-03|||December 4, 2015|Actual|2015-12-04|October 2017|2017-10-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Treatment of Venous Thromboembolism in Real-Life Patients|Treatment of Venous Thromboembolism in Real-Life Patients: A Nationwide, Population-Based Study|Active, not recruiting||N/A|89383|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 21:14:52.045015|2017-10-10 21:14:52.045015
NCT03087461|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-19|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in Ontario|Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in Ontario|Not yet recruiting||N/A|24|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f|f|f||||||No||2017-10-10 21:14:52.116374|2017-10-10 21:14:52.116374
NCT03087448|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-29|||September 9, 2017|Actual|2017-09-09|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)|A Phase I/II Study of Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|69|Anticipated|University of California, San Francisco||1|||f||||t|t|f|||t|||||2017-10-10 21:14:52.231004|2017-10-10 21:14:52.231004
NCT03087435|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-21|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|August 30, 2017|Anticipated|2017-08-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Well-Being in Medical Residents|Generation of a New Instrument to Measure Well-being in Medical Residents|Not yet recruiting||N/A|20|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||t|f|f||||||No||2017-10-10 21:14:52.363345|2017-10-10 21:14:52.363345
NCT03087422|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-16|||August 1, 2016|Actual|2016-08-01|March 2017|2017-03-01|December 15, 2017|Anticipated|2017-12-15|September 1, 2017|Anticipated|2017-09-01||Interventional|||Text Message (SMS) to Help Cancer Patients in Chemotherapy Treatment|An Intervention Based on Text Message (SMS) to Help Cancer Patients in Chemotherapy Treatment|Recruiting||N/A|80|Anticipated|Federal University of Pelotas||2|||f||||f|f|f|||f|||No||2017-10-10 21:14:52.467558|2017-10-10 21:14:52.467558
NCT03087409|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-06-01|||July 2016||2016-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up|High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up of a Randomized Phase III Study|Active, not recruiting||N/A|885|Anticipated|University Medical Center Groningen|||1||f||||f||||||||No||2017-10-10 21:14:52.595215|2017-10-10 21:14:52.595215
NCT03087396|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-06|||March 10, 2017|Actual|2017-03-10|August 2017|2017-08-01|March 2024|Anticipated|2024-03-01|March 2021|Anticipated|2021-03-01||Observational|||A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Foot/Ankle|A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Foot/Ankle|Recruiting||N/A|250|Anticipated|Zimmer Biomet|||1||f||||f|f|t|f|f|f|||||2017-10-10 21:14:52.714255|2017-10-10 21:14:52.714255
NCT03087383|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-15|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Identification of Genetic Polymorphisms Related to Propofol Requirement and Recovery Through Genome-wide Association Study (GWAS) in Total Intravenous Anesthesia for Clipping of Unruptured Cerebral Aneurysm in Korean Population|Identification of Genetic Polymorphisms Related to Propofol Requirement and Recovery Through Genome-wide Association Study (GWAS) in Total Intravenous Anesthesia for Clipping of Unruptured Cerebral Aneurysm in Korean Population|Recruiting||N/A|500|Anticipated|Yonsei University|||2||f||||f|f|f||||Samples With DNA|"     Blood obtained from enrolled patients before surgery   "|No||2017-10-10 21:14:52.880994|2017-10-10 21:14:52.880994
NCT03087370|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-23|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome|A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome|Not yet recruiting||N/A|100|Anticipated|X4 Pharmaceuticals|||1||f||||f|f|f||||Samples With DNA|"     Blood or buccal swab for the purposes of identifying a CXCR4 mutation.   "|Yes||2017-10-10 21:14:52.999895|2017-10-10 21:14:52.999895
NCT03087357|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-22|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|VALUE||VAlidation of a Lower Cost aneUploidy scrEen|The VALUE Study - Women & Infants as the Coordinating Center|Not yet recruiting||N/A|2650|Anticipated|Women and Infants Hospital of Rhode Island|||2||f||||f|f|f||||Samples With DNA|"     Residual plasma samples, only with permission of enrolled women   "|No||2017-10-10 21:14:53.110736|2017-10-10 21:14:53.110736
NCT03087344|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-15|||March 31, 2017|Anticipated|2017-03-31|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis|Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis|Not yet recruiting||N/A|19|Anticipated|VA Connecticut Healthcare System||1|||f||||t|f|t|f|f|f|||Undecided|once all data is collected, possibly share individual data|2017-10-10 21:14:53.219058|2017-10-10 21:14:53.219058
NCT03087331|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||An Evaluation of the Effect of Community-based Pharmacist Intervention on Patients With Chronic Pain|An Evaluation of the Effect of Community-based Pharmacist Intervention on Patients With Chronic Pain|Recruiting||N/A|30|Anticipated|University of Waterloo||1|||f||||f||||||||No||2017-10-10 21:14:53.322266|2017-10-10 21:14:53.322266
NCT03087318|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-27|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|S4H||Sport as a Treatment in Chronic Diseases and Healthcare Sustainability|Sport as a Treatment in Chronic Diseases and Healthcare Sustainability: Sport 4 Health|Not yet recruiting||N/A|60|Anticipated|University Hospital, Grenoble||3|||f||||f|f|f||||||No||2017-10-10 21:14:53.417806|2017-10-10 21:14:53.417806
NCT03087305|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-21|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|July 1, 2018|Anticipated|2018-07-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Incidence of SCLN Metastasis in Patients Referred for EBUS-TBNA|Incidence of Supraclavicular Lymph Node Metastasis in Patients Referred for EBUS-TBNA for Presumed Primary Lung Cancer by Interventional Pulmonologists.|Not yet recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||||No||2017-10-10 21:14:53.539872|2017-10-10 21:14:53.539872
NCT03087292|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-22|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|June 15, 2017|Anticipated|2017-06-15|June 15, 2017|Anticipated|2017-06-15||Interventional|||Low Intensity Resistance Training With Vascular Occlusion in Coronary Heart Disease Patients|Effect of Low Intensity Resistance Training With Vascular Occlusion on Muscle Hypertrophy, Neuromuscular Adaptations and Selected Cardiovascular Parameters in Patients With Coronary Heart Disease|Recruiting||N/A|30|Anticipated|University Medical Centre Ljubljana||2|||f|||||f|f||||||||2017-10-10 21:14:53.642304|2017-10-10 21:14:53.642304
NCT03087279|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-06-22|||August 15, 2012|Actual|2012-08-15|June 2017|2017-06-01|May 31, 2015|Actual|2015-05-31|May 31, 2015|Actual|2015-05-31||Interventional|ICAN||Assessing Impact of Active Learning on Student Outcomes: Texas Initiatives for Children's Activity and Nutrition (ICAN)|A Cluster Randomized Control Trial to Assess the Impact of Active Learning on Child Activity, Attention Control, and Academic Outcomes: The Texas I-CAN Trial|Completed||N/A|2716|Actual|University of Texas at Austin||3|||f||||t|f|f||||||No||2017-10-10 21:14:53.781706|2017-10-10 21:14:53.781706
NCT03087266|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-21|||June 1, 2016|Actual|2016-06-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|PERIO-DIA||Acute-phase Response & Periodontal Treatment in Diabetes Affected Patients|Acute-phase Response Following Full-mouth Versus Quadrant Non-surgical Periodontal Treatment in Diabetes-affected Subjects: A Randomized Clinical Trial|Recruiting||N/A|38|Anticipated|University of Pisa||2|||f|||||f|f||||||||2017-10-10 21:14:53.8636|2017-10-10 21:14:53.8636
NCT03087253|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-08-17|||November 15, 2017|Anticipated|2017-11-15|August 2017|2017-08-01|March 2023|Anticipated|2023-03-01|March 2022|Anticipated|2022-03-01|4 Years|Observational [Patient Registry]|||The LD Lync Study - Natural History Study of Genetic Lipodystrophy Syndromes|Prospective Multicenter Natural History Study of Genetic Lipodystrophy Syndromes to Determine Prevalence, Incidence and Predictors of Diabetes and Severe Hypertriglyceridemia, and Their Complications|Not yet recruiting||N/A|500|Anticipated|University of Michigan|||1||f||||f|f|f||||||||2017-10-10 21:14:53.967163|2017-10-10 21:14:53.967163
NCT03087240|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-03|||February 28, 2017|Actual|2017-02-28|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|PREPARA II||Dental Prophylaxis and Rheumatoid Arthritis|Influence of Dental Prophylaxis on Disease Activity of Rheumatoid Arthritis|Recruiting||N/A|70|Anticipated|University Hospital Heidelberg||2|||f||||f|f|f||||||No||2017-10-10 21:14:54.033673|2017-10-10 21:14:54.033673
NCT03087227|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-07|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|November 30, 2018|Anticipated|2018-11-30||Interventional|NEUTROSIS||Shared Health Information System for Febrile Neutropenia|Evaluation of a Shared Health Information System for Home-hospital Management of Febrile NEUTROpenia After Cytotoxic Chemotherapy|Recruiting||N/A|200|Anticipated|University of Paris 13||2|||f||||t|f|f||||||||2017-10-10 21:14:54.151985|2017-10-10 21:14:54.151985
NCT03087214|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-23|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Observational|||Human Movement Patterns on the Thailand-Myanmar Border|Movement and Migration Patterns Among a Cohort of Villagers From the Thailand-Myanmar Border|Recruiting||N/A|50|Anticipated|University of Oxford|||1||f||||f|f|f||||||Yes||2017-10-10 21:14:54.254978|2017-10-10 21:14:54.254978
NCT03087201|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-17|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|CANNA-TICS||CANNAbinoids in the Treatment of TICS (CANNA-TICS)|A Randomized Multi-centre Double-blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders|Not yet recruiting||Phase 3|96|Anticipated|Hannover Medical School||2|||f||||t|f|f||||||||2017-10-10 21:14:54.31809|2017-10-10 21:14:54.31809
NCT03087188|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-15|||September 9, 2015|Actual|2015-09-09|March 2017|2017-03-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Observational|InhaliPAD||Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet|Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet|Completed||N/A|114|Actual|RWTH Aachen University|||1||f|||||f|f||||||Undecided||2017-10-10 21:14:54.407271|2017-10-10 21:14:54.407271
NCT03087175|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-05-19|||December 2016||2016-12-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|GUARDIANCORY||MGuard Stent and Microcirculation|Impact of Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) on Coronary Microcirculation's Lesions in Patients With Non ST-segment Elevation Myocardial Infarction (NSTE-ACS): Assessment by Index of Microcirculatory Resistance (IMR)|Recruiting||N/A|52|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:14:54.477219|2017-10-10 21:14:54.477219
NCT03087149|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-13|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|May 31, 2019|Anticipated|2019-05-31||Interventional|MOSVID||Monitored vs Standard Supplementation of Vitamin D in Preterm Infants|Supplementation of Vitamin D in Preterm Infants- Monitored Therapy vs Standard Therapy. A Randomized Controlled Trial|Recruiting||N/A|138|Anticipated|Princess Anna Mazowiecka Hospital, Warsaw, Poland||2|||f||||t|f|f||||||Yes||2017-10-10 21:14:54.861382|2017-10-10 21:14:54.861382
NCT03087136|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-26|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|EMOCEMP||A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil|A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil|Recruiting||N/A|100|Anticipated|Pontificia Universidade Católica do Rio Grande do Sul|||1||f||||f|f|f||||||||2017-10-10 21:14:55.009635|2017-10-10 21:14:55.009635
NCT03087123|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-15|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Pre-PLACE||Physical and Social Environmental Influence on Children's Exercise: Preparation (Pre-PLACE)|Physical and Social Environmental Influence on Children's Exercise: Preparation (Pre-PLACE)|Not yet recruiting||N/A|24|Anticipated|Pennington Biomedical Research Center||3|||f||||t|f|f||||||No||2017-10-10 21:14:55.155917|2017-10-10 21:14:55.155917
NCT03087110|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-07-04|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|SCUBI-CP||Stem Cells in Umbilical Blood Infusion for CP|Safety Study of Sibling Cord Blood Cell Infusion to Children With Cerebral Palsy|Active, not recruiting||Phase 1|12|Actual|Murdoch Childrens Research Institute||1|||f||||t|f|f||||||||2017-10-10 21:14:55.265974|2017-10-10 21:14:55.265974
NCT03087097|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-03-15|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Fecal Microbiota Transplantation for Severe Acute Malnutrition|Fecal Microbiota Transplantation for Severe Acute Malnutrition: A Randomized, Placebo-controlled, Pilot Study|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Microbiome Health Research Institute||2|||f|||||f|f||||||Undecided||2017-10-10 21:14:55.369146|2017-10-10 21:14:55.369146
NCT03087084|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-19|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|October 15, 2018|Anticipated|2018-10-15|October 15, 2018|Anticipated|2018-10-15||Interventional|REST-HF||RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF)|RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF)|Not yet recruiting||N/A|25|Anticipated|Medtronic BRC||1|||f||||f|f|f||||||No||2017-10-10 21:14:55.466758|2017-10-10 21:14:55.466758
NCT03087071|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-10|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Panitumumab in Combination With Trametinib in Cetuximab-Refractory Stage IV Colorectal Cancer|A Phase II Enrichment Study of Panitumumab as a Single Agent or in Combination With Trametinib in Cetuximab-Refractory Stage IV Colorectal Cancer Patients|Not yet recruiting||Phase 2|84|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:14:55.562383|2017-10-10 21:14:55.562383
NCT03087058|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-10-02|||May 1, 2017|Actual|2017-05-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|July 2020|Anticipated|2020-07-01||Interventional|EMERALD||Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia|A Phase 2, Open-Label, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer for Oral Suspension in Children and Adolescents 2 to < 18 Years of Age With Chronic Kidney Disease and Hyperkalemia|Recruiting||Phase 2|54|Anticipated|Relypsa, Inc.||3|||f||||t|t|f||||||||2017-10-10 21:14:55.731938|2017-10-10 21:14:55.731938
NCT03087045|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-07|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||Behavioral Manifestations of Listening Effort|Behavioral Manifestations of Listening Effort|Enrolling by invitation||N/A|20|Anticipated|University of Miami|||1||f||||f|f|f||||||No||2017-10-10 21:14:55.975743|2017-10-10 21:14:55.975743
NCT03087032|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-16|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|May 20, 2019|Anticipated|2019-05-20|March 20, 2019|Anticipated|2019-03-20||Interventional|||Effects of Adding Liraglutide vs Insulin Glargine to Prandial Insulin in Type 2 Diabetes Patients|Effects of Adding Liraglutide vs Insulin Glargine to Prandial Insulin in Type 2 Diabetes Patients Treated With Premixed Insulin: a Randomized Clinical Trial|Recruiting||Phase 4|304|Anticipated|The First Affiliated Hospital of Xiamen University||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:14:56.093662|2017-10-10 21:14:56.093662
NCT03087019|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-18|||April 25, 2017|Actual|2017-04-25|August 2017|2017-08-01|October 31, 2024|Anticipated|2024-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma|A Phase II Trial of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma|Recruiting||Phase 2|44|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 21:14:56.263493|2017-10-10 21:14:56.263493
NCT03087006|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-08-22|||July 1, 2018|Anticipated|2018-07-01|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Automatic Self Transcending Meditation (ASTM) in Patients With Dry Eye Disease|Automatic Self Transcending Meditation (ASTM) Plus Treatment As Usual (TAU) Versus TAU Alone in Patients With Dry Eye Disease (DED): a Single Blind Randomized Controlled Longitudinal Study|Not yet recruiting||N/A|256|Anticipated|Lawson Health Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:14:56.444202|2017-10-10 21:14:56.444202
NCT03086993|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-07-25|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|May 2023|Anticipated|2023-05-01|January 2023|Anticipated|2023-01-01||Interventional|||Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma|Randomized, Controlled Study to Compare the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment Given Sequentially Following Cisplatin/Gemcitabine Versus Cisplatin/Gemcitabine in Patients With IntraHepatic Cholangiocarcinoma|Not yet recruiting||Phase 2/Phase 3|295|Anticipated|Delcath Systems Inc.||2|||||||t|t|f||||||||2017-10-10 21:14:56.605513|2017-10-10 21:14:56.605513
NCT03086980|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-08-22|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Automatic Self Transcending Meditation (ASTM) Versus Usual Care in Patients With Glaucoma|Automatic Self Transcending Meditation (ASTM) Versus Usual Care in Patients With Glaucoma|Recruiting||N/A|142|Anticipated|Lawson Health Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:14:56.710536|2017-10-10 21:14:56.710536
NCT03086967|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-16|||June 2013|Actual|2013-06-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours|Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours|Completed||N/A|104|Actual|Carolinas Healthcare System||2|||f||||f||||||||No||2017-10-10 21:14:56.845404|2017-10-10 21:14:56.845404
NCT03086954|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-21|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|EECPL||Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma|Open, Single Arm,Multicenter Phase 2 Clinical Study to Evaluating the Efficacy and Safety of the Chimeric Antigen Receptor T Cell Immunotherapy (CAR-T) for CD19 Positive Lymphoma|Not yet recruiting||Phase 1|24|Anticipated|Sinobioway Cell Therapy Co., Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:14:56.93383|2017-10-10 21:14:56.93383
NCT03086928|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-16|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||One Year Clinical Evaluation of E-max CAD and Lava Ultimate Laminate Veneers|One Year Clinical Evaluation of E-max CAD and Lava Ultimate Laminate Veneers With Butt Joint Preparation|Not yet recruiting||N/A|16|Anticipated|Cairo University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:14:57.156263|2017-10-10 21:14:57.156263
NCT03086915|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-08-04|||March 5, 2017|Actual|2017-03-05|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|July 30, 2017|Actual|2017-07-30||Observational|PAMPE||Myorelaxation Practice in Paediatric Anesthesia|Myorelaxation Practice in Paediatric Anesthesia: Retrospective Study|Completed||N/A|1650|Actual|Brno University Hospital|||1||f||||t|f|f||||||||2017-10-10 21:14:57.246182|2017-10-10 21:14:57.246182
NCT03086902|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-10-04|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|PVC||Comparision of PVC Ablation Techniques|Cryo Ablation vs. Radiofrequency Catheter Ablation for Ventricular Premature Contractions|Not yet recruiting||N/A|88|Anticipated|Sheba Medical Center||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:14:57.326344|2017-10-10 21:14:57.326344
NCT03086889|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-16|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Immersive Virtual Reality Based Training for Rehabilitation of Subacute Stroke|Immersive Virtual Reality Based Training for Motor Function Rehabilitation of Upper Limbs After Subacute Stroke：Study Protocol of a Randomized Clinical Trial|Not yet recruiting||N/A|60|Anticipated|Second Affiliated Hospital of Wenzhou Medical University||2|||f||||||f||||||||2017-10-10 21:14:57.41922|2017-10-10 21:14:57.41922
NCT03086876|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-16|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|May 31, 2021|Anticipated|2021-05-31|September 30, 2020|Anticipated|2020-09-30||Interventional|||Evaluation of Parent Intervention for Challenging Behaviour in Children With Intellectual Disabilities (EPICC-ID)|Clinical and Cost Effectiveness of a Parent Mediated Intervention to Reduce Challenging Behaviour in Pre-schoolers With Moderate to Severe Learning Disability: a Randomised Controlled Trial|Not yet recruiting||N/A|258|Anticipated|University College, London||2|||f||||t|f|f||||||||2017-10-10 21:14:57.503948|2017-10-10 21:14:57.503948
NCT03086863|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-04-03|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|EAPSSP||Electroacupuncture for Poststroke Patients With Shoulder Pain|Effectiveness and Safety of Electroacupuncture for Poststroke Patients With Shoulder Pain: Study Protocol for a Multicenter, Randomized, Patient and Assessor Blinded, Sham Controlled, Parallel, Clinical Trial|Recruiting||N/A|60|Anticipated|Kyunghee University||2|||f|||||f|f||||||||2017-10-10 21:14:57.586235|2017-10-10 21:14:57.586235
NCT03086850|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-04|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|November 1, 2020|Anticipated|2020-11-01|April 1, 2020|Anticipated|2020-04-01||Interventional|PASOS||Long-term Effect of the Physical Activity Promotion on the Clinical Characteristics and Vascular Risk in Patients With Mild-moderate Obstructive Sleep Apnea|Randomized, Parallel and Controled Clinical Trial to Assess the Effect of the Physical Activity Promotion During 12 Months on the Clinical Characteristics and Vascular Risk in Patients With Mild-moderate Obstructive Sleep Apnea|Recruiting||N/A|144|Anticipated|Hospital Universitario La Paz||2|||f||||f|f|f||||||No||2017-10-10 21:14:57.701233|2017-10-10 21:14:57.701233
NCT03086837|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-25|||September 18, 2017|Anticipated|2017-09-18|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|SCAMPI||The Smart City Active Mobile Phone Intervention (SCAMPI)|The Smart City Active Mobile Phone Intervention (SCAMPI) Study: a Randomized Controlled Trial to Promote Physical Activity Through Active Transportation|Not yet recruiting||N/A|400|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 21:14:57.812682|2017-10-10 21:14:57.812682
NCT03086824|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-03-16|||December 12, 2014|Actual|2014-12-12|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Safety Evaluation of MR-guided Focused Ultrasound Treatment for Palliative Pain Control of Bone Metastases|A Safety Evaluation of MR-guided Focused Ultrasound Treatment for Palliative Pain Control of Bone Metastases|Active, not recruiting||Phase 4|20|Anticipated|Taipei Medical University Shuang Ho Hospital||1|||f||||f||||||||Yes||2017-10-10 21:14:57.899024|2017-10-10 21:14:57.899024
NCT03086811|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-05|||October 25, 2011|Actual|2011-10-25|June 2017|2017-06-01|July 21, 2013|Actual|2013-07-21|July 21, 2013|Actual|2013-07-21||Interventional|MI-FI||"Improved Mother Infant Feeding Interaction (MI-FI) at 12 Months With Very Early Parent Training"|"Improved Mother Infant Feeding Interaction (MI-FI) at 12 Months With Very Early Parent"|Completed||N/A|166|Actual|Rambam Health Care Campus||2|||f||||t|f|f||||||Undecided|The investigators plan to publish results of the research project in peer reviewed journals. However, individual data collected, such as video taping of family meals will not be shared.|2017-10-10 21:14:57.989665|2017-10-10 21:14:57.989665
NCT03086798|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-04-27|||March 31, 2017|Actual|2017-03-31|August 2016|2016-08-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Comparison of Different Tools to Facilitate Nasotracheal Tube Placement Under Video-laryngoscope Use|Comparison Techniques of Magill Forceps and Cuff Inflation to Facilitate Nasotracheal Tube Placement Under Video-laryngoscope Use|Enrolling by invitation||N/A|200|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:14:58.066544|2017-10-10 21:14:58.066544
NCT03086668|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-04-27|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|August 6, 2019|Anticipated|2019-08-06||Interventional|||Fingers Hook Technique to Facilitate Nasotracheal Intubation|Tube-Videostylet Assembly for Nasotracheal Intubation Assisted by a Fingers-Hook Technique|Enrolling by invitation||N/A|80|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:14:58.165684|2017-10-10 21:14:58.165684
NCT03086655|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-05-05|||October 1, 2019|Anticipated|2019-10-01|May 2017|2017-05-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Tel-Me-Box: Testing a New, Real-time Strategies for Monitoring HIV Medication Adherence in India|Tel-Me-Box: Validating and Testing a Novel, Low-cost, Real-time Monitoring Device With Hair Level Analysis Among Adherence-challenged Patients|Not yet recruiting||N/A|120|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||No||2017-10-10 21:14:58.264495|2017-10-10 21:14:58.264495
NCT03086135|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-06-21|||March 9, 2017|Actual|2017-03-09|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Performance of a New Implant System for Bone Conduction Hearing|Clinical Performance of a New Implant System for Bone Conduction Hearing|Recruiting||N/A|30|Anticipated|Cochlear Bone Anchored Solutions||1|||f||||f|f|t|t|f|f|||No||2017-10-10 21:15:03.43698|2017-10-10 21:15:03.43698
NCT03086642|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-16|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2026|Anticipated|2026-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Study of Talimogene Laherparepvec in Pancreatic Cancer|A Phase I Study of Talimogene Laherparepvec Administered Endoscopically for the Treatment of Locally Advanced or Metastatic Pancreas Cancer Refractory to at Least One Chemotherapy Regimen|Not yet recruiting||Phase 1|16|Anticipated|Columbia University||2|||f||||t|t|f||||||Undecided||2017-10-10 21:14:58.37992|2017-10-10 21:14:58.37992
NCT03086629|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-03-16|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Improving Quality of Life Through the Routine Use of the Patient Concerns Inventory for Head and Neck Cancer Patients|Improving Quality of Life Through the Routine Use of the Patient Concerns Inventory for Head and Neck Cancer Patients (PCI-QoL)|Recruiting||N/A|416|Anticipated|Aintree University Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:14:58.480828|2017-10-10 21:14:58.480828
NCT03086616|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-07|||May 23, 2017|Actual|2017-05-23|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With DIPG|A Phase I and Early Efficacy Study of Convection Enhanced Delivery of Irinotecan Liposome Injection Using Real Time Imaging With Gadolinium in Children With Diffuse Intrinsic Pontine Glioma|Recruiting||Phase 1|19|Anticipated|University of California, San Francisco||1|||f||||t|t|f||||||||2017-10-10 21:14:58.574289|2017-10-10 21:14:58.574289
NCT03086603|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-15|||March 2016||2016-03-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Observation of Principal Hemodynamic Variables After Spinal Anesthesia With Non Invasive Hemodynamic Monitoring|Prospective Observational Study About Variation of Principal Hemodynamic Parameters, Collected With Non-invasive Monitoring, in Patients Undergoing Spinal Anesthesia for Primary Elective Hip Arthroplasty.|Completed||N/A|30|Actual|Istituto Ortopedico Rizzoli|||1||f||||f||||||||No||2017-10-10 21:14:58.822743|2017-10-10 21:14:58.822743
NCT03086590|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-31|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|||EVALUATION OF RESPIRATORY MECHANICS AND FUNCTIONALITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE|BODY COMPOSITION, PERIPHERAL MUSCULAR FORCE, KINEMATIC THORACIC-ABDOMINAL, VENTILATORY METABOLIC RESPONSE, DIAPHRAGM MOBILITY AND THICKNESS PREDICTION OF OBSTRUCTION LEVEL OF COPD?|Not yet recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco|||4||f||||||||||||||2017-10-10 21:14:58.900828|2017-10-10 21:14:58.900828
NCT03086577|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-05-02|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|February 21, 2018|Anticipated|2018-02-21||Observational|||Pain in Chronic Leg- and Foot Ulcers|Pain in Patients With Chronic Leg and Foot Ulcers - a Cross Sectional Study|Recruiting||N/A|360|Anticipated|University College of Southeast Norway|||1||f||||f|f|f||||||No||2017-10-10 21:14:58.995805|2017-10-10 21:14:58.995805
NCT03086564|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-08-02|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)|A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment|Recruiting||Phase 1/Phase 2|70|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t|f|f|||f|||||2017-10-10 21:14:59.103501|2017-10-10 21:14:59.103501
NCT03086551|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-29|||April 1, 2016|Actual|2016-04-01|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|March 30, 2018|Anticipated|2018-03-30||Interventional|||Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke|Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke|Recruiting||N/A|16|Anticipated|University of Michigan||2|||||||t|f|t|f|||||No||2017-10-10 21:14:59.242057|2017-10-10 21:14:59.242057
NCT03086538|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-21|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study|Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study|Not yet recruiting||Phase 2|29|Anticipated|Samsung Medical Center||1|||f|||||t|f|||f|||||2017-10-10 21:14:59.369981|2017-10-10 21:14:59.369981
NCT03086525|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-22|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|November 2017|Anticipated|2017-11-01||Observational|||Influence of Beliefs on the Development of Musculoskeletal Pain.|The Influence of Beliefs (Fear of Movement, Pain-related Fear, Self-efficacy, and Pain Acceptance) in the Development and/or Perpetuation of Muasculoskeletal Pain. Protocol|Not yet recruiting||N/A|650|Anticipated|University of Malaga|||1||f||||t|f|f||||||No||2017-10-10 21:14:59.452882|2017-10-10 21:14:59.452882
NCT03086512|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-08|||April 21, 2017|Actual|2017-04-21|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||A Study Comparing Computerized Tomographic Progression of Bone Bridging After Subtalar Fusion Using Fully and Partially Threaded Screws|A Randomized Prospective Pivotal Study Comparing Computerized Tomographic Progression of Bone Bridging After Subtalar Fusion Using Fully and Partially Threaded Screws|Recruiting||N/A|90|Anticipated|St. Paul's Hospital, Canada||2|||f|||||f|t|f|f|t|||||2017-10-10 21:14:59.555807|2017-10-10 21:14:59.555807
NCT03086499|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-04-06|||March 25, 2017|Actual|2017-03-25|March 2017|2017-03-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Observational|PECTUS-cluster||Clustering Among the Clinical Profiles of Patients With Pectus Excavatum|Clustering Among the Clinical Profiles of Patients With Pectus Excavatum|Completed||N/A|55|Actual|University Hospital, Montpellier|||1||f||||f|f|f||||||Undecided|NC|2017-10-10 21:14:59.669828|2017-10-10 21:14:59.669828
NCT03086330|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-28|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|September 6, 2018|Anticipated|2018-09-06|June 20, 2018|Anticipated|2018-06-20||Interventional|SUSTAIN 9||Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus|Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus. A 30-week Randomised, Double-blind, Placebo-controlled Trial|Recruiting||Phase 3|300|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 21:15:01.383953|2017-10-10 21:15:01.383953
NCT03086486|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-15|||October 2017|Anticipated|2017-10-01|March 2017|2017-03-01|January 2022|Anticipated|2022-01-01|April 2021|Anticipated|2021-04-01||Interventional|||Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary TB, XDR-TB, Pre- XDR-TB or Non-responsive/Intolerant MDR-TB (ZeNiX)|A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)|Not yet recruiting||Phase 3|180|Anticipated|Global Alliance for TB Drug Development||4|||f||||t|t|f||||||Undecided||2017-10-10 21:14:59.762976|2017-10-10 21:14:59.762976
NCT03086473|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-21|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Early Caffeine in Preterm Neonates|A Randomized, Placebo-controlled Trial of Early Caffeine in Preterm Neonates|Recruiting||Phase 4|88|Anticipated|Children's Hospital Los Angeles||2|||f||||f|t|f|||t|||No||2017-10-10 21:14:59.906083|2017-10-10 21:14:59.906083
NCT03086460|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-22|||August 28, 2017|Anticipated|2017-08-28|March 2017|2017-03-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Dose Ranging Study of CHF 1531 in Asthmatic Subjects|A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects|Not yet recruiting||Phase 2|60|Anticipated|Chiesi Farmaceutici S.p.A.||6|||f||||f|t|f||||||No||2017-10-10 21:15:00.076039|2017-10-10 21:15:00.076039
NCT03086447|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-06-27|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Interventional|||Evaluation of Astigmatic Contact Lenses|Evaluation of Astigmatic Contact Lenses|Completed||N/A|267|Actual|Johnson & Johnson Vision Care, Inc.||2|||f|||||f|t|f|f|t|||||2017-10-10 21:15:00.178702|2017-10-10 21:15:00.178702
NCT03086434|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-15|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Intertribal Talking Circle for the Prevention of Substance Abuse in Native Youth|Intertribal Talking Circle for the Prevention of Substance Abuse in Native Youth|Enrolling by invitation||N/A|630|Anticipated|Florida State University||2|||f||||t|f|f||||||Yes|This study and project will be presented to the other researchers and at national conferences and submitted for publication after study completion.|2017-10-10 21:15:00.285723|2017-10-10 21:15:00.285723
NCT03086421|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-12|||July 11, 2017|Actual|2017-07-11|March 2017|2017-03-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2024|Anticipated|2024-09-30||Observational|||Social Emotional Development in Young Children With Cancer|Social Emotional Development in Young Children With Cancer|Recruiting||N/A|64|Anticipated|St. Jude Children's Research Hospital|||2||f||||f|f|f||||||||2017-10-10 21:15:00.365846|2017-10-10 21:15:00.365846
NCT03086395|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-16|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD)|Phase II Study of Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD)|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||1||Funding Unavailable|f||||t|t|f|||f|||||2017-10-10 21:15:00.555797|2017-10-10 21:15:00.555797
NCT03086382|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-04-20|||February 27, 2017|Actual|2017-02-27|April 2017|2017-04-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|||A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects|A Randomized, Open-Label, Single-Dose, 2-Period Crossover Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects|Completed||Phase 1|24|Actual|UCB Pharma||2|||f||||f|f|f|||f|||||2017-10-10 21:15:00.648209|2017-10-10 21:15:00.648209
NCT03086369|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-10-03|||June 22, 2017|Actual|2017-06-22|October 2017|2017-10-01|October 1, 2020|Anticipated|2020-10-01|December 2, 2019|Anticipated|2019-12-02||Interventional|||A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer|A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer|Recruiting||Phase 1/Phase 2|186|Anticipated|Eli Lilly and Company||4|||f||||f|t|f||||||||2017-10-10 21:15:00.734241|2017-10-10 21:15:00.734241
NCT03086356|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-20|||May 10, 2017|Actual|2017-05-10|September 2017|2017-09-01|September 12, 2017|Actual|2017-09-12|September 12, 2017|Actual|2017-09-12||Interventional|||Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Idarucizumab (BI 655075) Administered Alone or With Dabigatran Etexilate in Chinese Healthy Subjects|Open Label Phase I Trial in Healthy Chinese Male and Female Volunteers to Investigate Pharmacokinetics and Pharmacodynamics of Idarucizumab to Reverse Dabigatran Anticoagulant Activity|Completed||Phase 1|12|Actual|Boehringer Ingelheim||1|||f||||f|f|f||||||||2017-10-10 21:15:00.879818|2017-10-10 21:15:00.879818
NCT03086343|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-20|2017-09-29|||May 9, 2017|Actual|2017-05-09|September 2017|2017-09-01|March 26, 2021|Anticipated|2021-03-26|July 7, 2019|Anticipated|2019-07-07||Interventional|SELECT-CHOICE||A Phase 3 Study to Compare ABT-494 to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs|A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs) on Stable Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs)|Recruiting||Phase 3|550|Anticipated|AbbVie||2|||f||||t|t|f||||||||2017-10-10 21:15:00.968004|2017-10-10 21:15:00.968004
NCT03086317|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-09|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Standard vs Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism|USAT-CDT Trial: Standard vs Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism|Recruiting||N/A|80|Anticipated|Emory University||2|||f||||t|f|t|f|f||||No||2017-10-10 21:15:01.686769|2017-10-10 21:15:01.686769
NCT03086304|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-06-07|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|TAESRIOGS||Effects of Transcutaneous Acupoint Electrical Stimulation on Intestinal Obstruction After Gastrointestinal Surgery|Effects of Transcutaneous Acupoint Electrical Stimulation on Intestinal Obstruction After Gastrointestinal Surgery in Adults:Single-Blinded, Randomised Controlled Trial|Not yet recruiting||N/A|430|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:01.8274|2017-10-10 21:15:01.8274
NCT03086291|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-21|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy|A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy|Not yet recruiting||Phase 1|9|Anticipated|Samsung Medical Center||1|||f||||t|t|f|||f|||||2017-10-10 21:15:01.93829|2017-10-10 21:15:01.93829
NCT03086278|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-06-26|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|April 1, 2018|Anticipated|2018-04-01|February 28, 2018|Anticipated|2018-02-28||Interventional|||A Phase 1 Study of AST 008 in Healthy Subjects|A Randomized, Combined SAD/MAD Phase 1 Study of the Safety, Pharmacokinetics and Pharmacodynamics of AST 008 in Healthy Subjects|Not yet recruiting||Phase 1|44|Anticipated|Exicure, Inc.||2|||f|||||t|f|||t|||||2017-10-10 21:15:02.009813|2017-10-10 21:15:02.009813
NCT03086265|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-04-24|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|June 14, 2018|Anticipated|2018-06-14|March 28, 2018|Anticipated|2018-03-28||Interventional|||Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery|The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery|Recruiting||N/A|60|Anticipated|Stanford University||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:15:02.087311|2017-10-10 21:15:02.087311
NCT03086252|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-07-26|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study|Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study|Recruiting||N/A|25|Anticipated|Emory University||1|||f||||t|f|f||||||||2017-10-10 21:15:02.198504|2017-10-10 21:15:02.198504
NCT03086239|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-17|2017-09-29|||May 10, 2017|Actual|2017-05-10|September 2017|2017-09-01|March 25, 2020|Anticipated|2020-03-25|July 5, 2019|Anticipated|2019-07-05||Interventional|||A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer|An Open-Label Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer|Recruiting||Phase 1|60|Anticipated|AbbVie||2|||f||||f|f|f||||||||2017-10-10 21:15:02.290995|2017-10-10 21:15:02.290995
NCT03086226|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-21|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan|A Randomized, Double Blind Phase II Proof-of-Concept Superiority Trial of Fosravuconazole 200 mg or 300 mg Weekly Dose Versus Itraconazole 400 mg Daily, All Three Arms in Combination With Surgery, in Patients With Eumycetoma in Sudan|Recruiting||Phase 2|138|Anticipated|Drugs for Neglected Diseases||3|||f||||t|f|f||||||Yes|Through Drugs for Neglected Diseases Initiative (DNDi) and open data sharing platforms. The data may be obtained by sending a request to DNDi|2017-10-10 21:15:02.384709|2017-10-10 21:15:02.384709
NCT03086213|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-15|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Comparative Study of Nonintubated Uniport Thoracoscopic Surgery Using Thoracic Paravertebral Nerve Block Versus Intercostal Nerve Block for Peripheral Solitary Pulmonary Nodule Patients|the Safety and Effectiveness of the Effects on the Perioperative Pain Control Comparing Between the Thoracic Paravertebral Nerve Block Using the Camera Guided and the Intrathoracic Intercostals Nerve Block for the Management of Nonintubated Local Regional Analgesia in Uniport Thoracoscopic Surgery for the Undetermined Solitary Nodules Patients|Recruiting||N/A|48|Anticipated|Shenzhen Third People's Hospital||2|||f||||t|f|f||||||No|there is not a plan to make individual participant data available to other researcher.|2017-10-10 21:15:02.50127|2017-10-10 21:15:02.50127
NCT03086187|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-03-15|||March 2011||2011-03-01|March 2017|2017-03-01|July 2012|Actual|2012-07-01|August 2011|Actual|2011-08-01||Interventional|HEP||"The Effects of the Novel Unloading Device HEPHAISTOS on Bone, Muscles and Vessels"|The Effects of a 56day Unilateral Muscular Unloading Intervention With a Novel Device That Allows Normal Ambulation While Reducing Muscle Activation Drastically, on Muscles, Bones and Vessels|Completed||N/A|11|Actual|DLR German Aerospace Center||1|||f||||t||||||||Undecided||2017-10-10 21:15:02.872298|2017-10-10 21:15:02.872298
NCT03086174|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-22|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Tolerability and Pharmacokinetics of JS001 in Combination With Axitinib in Patients With Kidney Cancer and Melanoma|A Phase Ib,Open,Mono-center,Dose-escalation,Tolerability and Pharmacokinetic Study of Recombinant Humanized Anti-PD-1 mAb for Injection in Combination With Axitinib in Patients With Advanced Kidney Cancer and Melanoma|Recruiting||Phase 1|24|Anticipated|Shanghai Junshi Bioscience Co.,Ltd.||1|||f||||t|f|f||||||||2017-10-10 21:15:03.012365|2017-10-10 21:15:03.012365
NCT03086161|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-15|||November 23, 2015|Actual|2015-11-23|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Mood and Excess Weight Gain in Adolescent Pregnancy|Mood and Excess Weight Gain in Adolescent Pregnancy|Recruiting||N/A|50|Anticipated|Colorado State University||2|||f||||f|f|f||||||No||2017-10-10 21:15:03.170233|2017-10-10 21:15:03.170233
NCT03086148|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-07-14|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Ketamine and Postoperative Depressive Symptom|The Effect of Ketamine on Postoperative Depressive Symptom in Patients Undergoing Supratentorial Tumor Resection.|Recruiting||N/A|314|Anticipated|Beijing Tiantan Hospital||2|||f|||||f|f||||||||2017-10-10 21:15:03.306726|2017-10-10 21:15:03.306726
NCT03086109|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-03-16|||October 1, 2013|Actual|2013-10-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||The Prevalence of Bone Degenerative Diseases in Beijing - a Cross-sectional Study|The Prevalence of Bone Degenerative Diseases in Beijing - a Cross-sectional Study|Recruiting||N/A|850|Anticipated|Beijing Jishuitan Hospital|||1||f|||||f|f||||||||2017-10-10 21:15:03.729149|2017-10-10 21:15:03.729149
NCT03086096|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-11|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01|12 Months|Observational [Patient Registry]|CIREL||CIRSE Registry for LifePearl Microspheres|CIRSE Registry for LifePearl Microspheres|Recruiting||N/A|500|Anticipated|Cardiovascular and Interventional Radiological Society of Europe|||1||f||||t|f|f||||||No||2017-10-10 21:15:03.83615|2017-10-10 21:15:03.83615
NCT03086083|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-03-24|||October 21, 2013|Actual|2013-10-21|March 2017|2017-03-01|August 28, 2015|Actual|2015-08-28|March 13, 2015|Actual|2015-03-13||Interventional|||Bilateral Brain Stimulation in Trauma Therapy|Bilateral Brain Stimulation in Trauma Therapy: a Randomized Clinical Trial|Completed||N/A|40|Actual|Ciclo de Mutação||2|||f||||f|f|f||||||No||2017-10-10 21:15:03.96705|2017-10-10 21:15:03.96705
NCT03086070|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-19|||January 1, 2010|Actual|2010-01-01|July 2017|2017-07-01|June 30, 2010|Actual|2010-06-30|April 30, 2010|Actual|2010-04-30||Interventional|||Omeprazole 20 mg in Patients With Laryngopharyngeal reﬂux and Comorbid Chronic Rhinosinusitis|Omeprazole 20 mg in Patients With Laryngopharyngeal reﬂux and Comorbid Chronic Rhinosinusitis - a Randomized, Double Blind, Placebo Controlled Trial|Completed||Phase 4|60|Actual|Children's Hospital Srebrnjak||2|||f||||f|f|f|||f|||||2017-10-10 21:15:04.104166|2017-10-10 21:15:04.104166
NCT03086057|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-13|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Optimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization Design|Optimizing Pre-exposure Prophylaxis (PrEP) Uptake & Adherence Among MSW Using a 2-stage Randomization Design|Recruiting||N/A|106|Anticipated|Brown University||4|||f||||t|f|f||||||Yes|It is anticipated that this data will be presented annually on data collected after the second year when sufficient baseline data is collected. It is anticipated that most of the papers and data-based projects/presentations will happen in year 3, when all of the baseline data is collected, and the 3 month outcome has occurred for all participants. Sharing of the findings will involve a primary paper describing the study outcome and a paper that describes the intervention, as well as submitting to lead workshops on the intervention approach at relevant national meetings and conferences. Raw data for additional analysis will be available to outside individuals through contacting the MPIs. Information regarding the availability of data for analysis will be listed on the MPIs' web pages. Contact information for the MPIs will be listed in all manuscripts and publications as another means to access data.|2017-10-10 21:15:04.20642|2017-10-10 21:15:04.20642
NCT03086044|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-04-05|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Transplanting Hepatitis C Positive Thoracic Organs|Transplanting Thoracic Organs From Hepatitis C Positive Donors to Hepatitis C Uninfected Recipients|Recruiting||Phase 4|32|Anticipated|Brigham and Women's Hospital||2|||f||||t|t|f|||f|||No||2017-10-10 21:15:04.326592|2017-10-10 21:15:04.326592
NCT03086031|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-07-11|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Manual-Based Vocational Rehabilitation Program for Patients With Acquired Brain Injury|A Randomised Controlled Trial of a Manual-Based Vocational Rehabilitation Program for Patients With Acquired Brain Injury|Not yet recruiting||N/A|84|Anticipated|Brain Injury Center BOMI, Roskilde, Denmark||2|||f|||||f|f||||||||2017-10-10 21:15:04.461039|2017-10-10 21:15:04.461039
NCT03086018|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-15|||March 13, 2017|Actual|2017-03-13|March 2017|2017-03-01|May 31, 2017|Anticipated|2017-05-31|May 17, 2017|Anticipated|2017-05-17||Interventional|||A Comparative, Controlled, Clinical Investigation and Quality Control of a New Hearing Aid|A Comparative, Controlled, Clinical Investigation and Quality Control of a New Hearing Aid in Comparison to the Currently Marketed Device|Recruiting||N/A|30|Anticipated|Bernafon AG||1|||f||||f|f|t|t|f|f|||No|Individual data will not be shared.|2017-10-10 21:15:04.609364|2017-10-10 21:15:04.609364
NCT03086005|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-05-10|||October 12, 2011|Actual|2011-10-12|May 2017|2017-05-01|July 23, 2015|Actual|2015-07-23|May 4, 2015|Actual|2015-05-04||Interventional|||Study to Assess the Effect of Metformin Supplementation on IVF Outcome in Patients With Polycystic Ovarian Syndrome.|A Multicenter, Prospective, Randomized Study to Assess the Effect of Metformin Supplementation on IVF Outcome and Intrafollicular Environment in Patients With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization/Embryo Transfer|Completed||Phase 3|24|Actual|Asan Medical Center||2|||f||||f||||||||No||2017-10-10 21:15:04.715295|2017-10-10 21:15:04.715295
NCT03085992|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-03-15|||March 2012||2012-03-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|TRUST||Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer|Open-label Phase II Study of Induction Treatment With Folfoxiri Plus Bevacizumab Followed by Preoperative Chemoradiotherapy Plus Bevacizumab in Patients With Locally Advanced, Resectable Rectal Cancer.|Active, not recruiting||Phase 2|49|Actual|Azienda Ospedaliero, Universitaria Pisana||1|||f||||t||||||||Undecided||2017-10-10 21:15:04.822955|2017-10-10 21:15:04.822955
NCT03085979|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-15|||October 2008|Actual|2008-10-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||Mixed Urinary Incontinence Surgical Trial|Surgical Management of Mixed Urinary Incontinence|Completed||N/A|198|Actual|Ain Shams Maternity Hospital||3|||f||||t|f|f||||||No||2017-10-10 21:15:04.916788|2017-10-10 21:15:04.916788
NCT03085966|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-15|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|December 27, 2019|Anticipated|2019-12-27|October 27, 2019|Anticipated|2019-10-27||Interventional|||Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC|Study of Autologous Immune Cell Therapy in Combination With the Luteinizing Hormone Releasing Hormone Agonists (LHRH-a) in Patients With Metastatic Castration-resistant Prostate Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|Cellular Biomedicine Group Ltd.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:15:04.993351|2017-10-10 21:15:04.993351
NCT03085953|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-20|||April 2013||2013-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|June 2016|Actual|2016-06-01||Interventional|SERVe||Study for the Employment Retention of Veterans|Study for the Employment Retention of Veterans|Active, not recruiting||N/A|511|Actual|Oregon Health and Science University||2|||f||||f||||||||No||2017-10-10 21:15:05.100539|2017-10-10 21:15:05.100539
NCT03085940|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-29|||January 20, 2017|Actual|2017-01-20|September 2017|2017-09-01|September 30, 2017|Actual|2017-09-30|September 30, 2017|Actual|2017-09-30||Interventional|||Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis|Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis|Completed||N/A|37|Actual|Indonesia University||2|||f|||||f|f||||||||2017-10-10 21:15:05.179483|2017-10-10 21:15:05.179483
NCT03085927|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-12|||September 15, 2016|Actual|2016-09-15|March 2017|2017-03-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|PINPOINT||Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents|Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents|Recruiting||N/A|184|Anticipated|Indiana University||2|||f||||t|f|f||||||No||2017-10-10 21:15:05.279493|2017-10-10 21:15:05.279493
NCT03085914|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-16|||May 2, 2017|Actual|2017-05-02|August 2017|2017-08-01|October 2022|Anticipated|2022-10-01|April 2021|Anticipated|2021-04-01||Interventional|||A Study of Epacadostat in Combination With a PD-1 Inhibitor and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207)|A Phase 1/2, Open-Label, Dose-Escalation, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With a PD-1 Inhibitor and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207)|Recruiting||Phase 1/Phase 2|332|Anticipated|Incyte Corporation||5|||||||t|t|f||||||||2017-10-10 21:15:05.393946|2017-10-10 21:15:05.393946
NCT03085901|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-03-15|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Comparison of Clinical Outcomes of Toric Intraocular Lens|Comparison of Clinical Outcomes of Toric Intraocular Lens|Completed||N/A|40|Actual|Samsung Medical Center||2|||f|||||f|f||||||No||2017-10-10 21:15:05.550373|2017-10-10 21:15:05.550373
NCT03085888|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-31|||February 28, 2017|Actual|2017-02-28|August 2017|2017-08-01|May 2025|Anticipated|2025-05-01|July 2019|Anticipated|2019-07-01|5 Years|Observational [Patient Registry]|||The STRIVE Study: Breast Cancer Screening Cohort|The STRIVE Study: Breast Cancer Screening Cohort for Training and Validation of the GRAIL Test|Enrolling by invitation||N/A|120000|Anticipated|GRAIL, Inc.|||1||f||||f||||||||||2017-10-10 21:15:05.619009|2017-10-10 21:15:05.619009
NCT03085875|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-10|||March 16, 2017|Actual|2017-03-16|March 2017|2017-03-01|July 31, 2027|Anticipated|2027-07-31|March 13, 2027|Anticipated|2027-03-13||Observational|||Healthy Pregnancy Study|Healthy Pregnancy Study|Recruiting||N/A|100000|Anticipated|Scripps Translational Science Institute|||1||f||||f|f|f||||||Undecided||2017-10-10 21:15:05.707077|2017-10-10 21:15:05.707077
NCT03085862|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-15|||April 1, 2015|Actual|2015-04-01|March 2017|2017-03-01|November 30, 2015|Actual|2015-11-30|November 20, 2015|Actual|2015-11-20||Observational|||Lung Ultrasonography and Extravascular Lung Water|Lung Ultrasonography for Detecting Extravascular Lung Water Overload in Intensive Care Patients Early After Surgery: a Preliminary Study|Completed||N/A|60|Actual|General Hospital Sveti Duh|||1||f||||f|f|f||||||Undecided||2017-10-10 21:15:05.779606|2017-10-10 21:15:05.779606
NCT03085849|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-15|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|||SGI-110 Plus Durvalumab/Tremelimumab in SCLC|A Phase I Study Evaluating the Safety and Efficacy of SGI-110 Followed by Combined Durvalumab Plus Tremelimumab in Subjects With Extensive-stage Small Cell Lung Cancer (ES-SCLC)|Recruiting||Phase 1|22|Anticipated|Columbia University||1|||f||||t|t|f||||||Undecided||2017-10-10 21:15:05.845939|2017-10-10 21:15:05.845939
NCT03085836|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-18|||April 25, 2017|Actual|2017-04-25|September 2017|2017-09-01|August 17, 2017|Actual|2017-08-17|August 17, 2017|Actual|2017-08-17||Interventional|||A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants|An Open-Label, Single-center, Parallel, Phase 1 Study to Determine the Pharmacokinetics of Single- and Multiple- Oral Doses of TAK-438 10 mg and 20 mg in Healthy Adult Chinese Subjects|Completed||Phase 1|33|Actual|Takeda||3|||f||||f|f|f||||||||2017-10-10 21:15:05.946631|2017-10-10 21:15:05.946631
NCT03085823|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-03-15|||September 2016||2016-09-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01|24 Months|Observational [Patient Registry]|EASTBOURNE||The All-comers Sirolimus-coated Balloon European Registry|The All-comers Sirolimus-coated Balloon European Registry|Recruiting||N/A|900|Anticipated|Fatebenefratelli and Ophthalmic Hospital|||1||f||||f||||||||||2017-10-10 21:15:06.051541|2017-10-10 21:15:06.051541
NCT03085810|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-16|2017-09-25|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|January 19, 2022|Anticipated|2022-01-19|January 19, 2022|Anticipated|2022-01-19||Interventional|||Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)|An Open-Label, Single-Arm Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis|Recruiting||Phase 3|600|Anticipated|Hoffmann-La Roche||1|||f|||||t|f|||t|||||2017-10-10 21:15:06.154142|2017-10-10 21:15:06.154142
NCT03085784|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-20|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|ARRT||Intravitreal Aflibercept Injection for Radiation Retinopathy Trial|Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)|Not yet recruiting||Phase 2|30|Anticipated|Greater Houston Retina Research||2|||f||||f|t|f||||||No||2017-10-10 21:15:08.94186|2017-10-10 21:15:08.94186
NCT03085771|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-15|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|December 12, 2022|Anticipated|2022-12-12|December 12, 2020|Anticipated|2020-12-12||Interventional|DESIRED||Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes|Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes|Recruiting||Phase 2|30|Anticipated|Karolinska University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:15:09.098489|2017-10-10 21:15:09.098489
NCT03085758|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-15|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|AdrenOSS-2||Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB|A Double-Blind, Placebo-Controlled, Randomized, Multicenter, Proof of Concept and Dose-Finding Phase II Clinical Trial to Investigate the Safety, Tolerability and Efficacy of ADRECIZUMAB in Patients With Septic Shock and Elevated Adrenomedullin|Not yet recruiting||Phase 2|300|Anticipated|Adrenomed AG||3|||f||||t|f|f||||||No||2017-10-10 21:15:09.270135|2017-10-10 21:15:09.270135
NCT03085745|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-14|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|May 19, 2018|Anticipated|2018-05-19|February 19, 2018|Anticipated|2018-02-19||Interventional|IWCToxin||Sensorimotor Mapping in Patients With Writer's Cramp|Corticomotor Plasticity as a Biomarker for Functional Improvement After Botulinium Treatment in Writer's Cramp|Recruiting||N/A|15|Anticipated|University Hospital, Grenoble||1|||f||||t|f|f||||||Undecided||2017-10-10 21:15:09.412877|2017-10-10 21:15:09.412877
NCT03085732|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-20|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|May 31, 2017|Anticipated|2017-05-31||Interventional|||The Effect of Intraabdominal Saline Irrigation in Abdominal Hysterectomies|The Effect of Intraabdominal Saline Irrigation on Infectious Morbidities and Gastrointestinal Outcomes in Patients Undergoing Abdominal Hysterectomies for Benign Causes|Recruiting||N/A|100|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:15:09.530037|2017-10-10 21:15:09.530037
NCT03085719|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-25|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|October 31, 2024|Anticipated|2024-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN|Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 2|26|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 21:15:09.619968|2017-10-10 21:15:09.619968
NCT03085706|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-15|||October 2010|Actual|2010-10-01|March 2017|2017-03-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis|Transplantation of Autologous Peripheral Blood Mononuclear Cells in the Subarachnoid Space for Amyotrophic Lateral Sclerosis: a Safety Analysis of 14 Patients|Completed||N/A|14|Actual|The First Affiliated Hospital of Dalian Medical University||1|||f||||t|f|f||||||Undecided||2017-10-10 21:15:09.750682|2017-10-10 21:15:09.750682
NCT03085693|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-03-20|||August 2016||2016-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|LAAEX||Impact of Left Atrial Appendage Closure on Physical Capacity.|Impact of Left Atrial Appendage Closure With a Closure Device on Quality of Life, Physical Capacity and Expression of Atrial Natriuretic Peptide and Brain Natriuretic|Recruiting||N/A|40|Anticipated|University of Leipzig|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 21:15:09.852366|2017-10-10 21:15:09.852366
NCT03085680|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-27|||August 11, 2017|Actual|2017-08-11|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|July 1, 2019|Anticipated|2019-07-01||Interventional|SPICE||Curcumin and Function in Older Adults|Does Dietary Supplementation With Curcumin Maintain or Improve Physical and Cognitive Function in Aging Adults at Increased Risk for Disability?|Recruiting||Phase 2/Phase 3|24|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 21:15:09.933303|2017-10-10 21:15:09.933303
NCT03085667|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-03-14|||January 2011||2011-01-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Observational|||Impact of Implantation of an LAA Occluder on ANP and BNP Level and Quality of Life|Impact of Implantation of an LAA Occluder on ANP and BNP Level and Quality of Life|Completed||N/A|25|Actual|University of Leipzig|||1||f||||f||||||Samples Without DNA|"     Serum   "|No||2017-10-10 21:15:10.047261|2017-10-10 21:15:10.047261
NCT03085654|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-03-14|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety|Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety|Recruiting||Early Phase 1|160|Anticipated|University of Electronic Science and Technology of China||6|||f|||||f|f||||||No||2017-10-10 21:15:10.131559|2017-10-10 21:15:10.131559
NCT03085641|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-21|||June 15, 2017|Anticipated|2017-06-15|March 2017|2017-03-01|April 1, 2018|Anticipated|2018-04-01|December 31, 2017|Anticipated|2017-12-31||Interventional|RELAX||Treatment of Central Sleep Apnoea in Patients With Heart Failure With Nasal High Flow Therapy (nHFT)|Treatment of Central Sleep Apnoea and Cheyne Stokes Respiration in Patients With Heart Failure: Nasal High-flow Oxygen Therapy?|Not yet recruiting||N/A|10|Anticipated|University Medical Center Groningen||1|||f||||t|f|f||||||No||2017-10-10 21:15:10.233259|2017-10-10 21:15:10.233259
NCT03085628|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-14|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Sex- and Context-dependent Effects of Oxytocin on Social Reward Processing||Recruiting||N/A|252|Anticipated|University of Electronic Science and Technology of China||2|||f|||||f|f||||||Undecided||2017-10-10 21:15:10.318311|2017-10-10 21:15:10.318311
NCT03085615|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-26|||March 15, 2017|Actual|2017-03-15|July 2017|2017-07-01|December 1, 2019|Anticipated|2019-12-01|September 1, 2019|Anticipated|2019-09-01||Interventional|FEDOX||Feeding the Critically Ill During Phases of Altered Redox Status|Feeding the Critically Ill During Phases of Altered Redox Status (FEDOX): a Prospective Randomized Trial|Recruiting||N/A|40|Anticipated|University of Illinois at Chicago||2|||f||||t|f|f||||||||2017-10-10 21:15:10.519367|2017-10-10 21:15:10.519367
NCT03085602|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-29|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|November 15, 2018|Anticipated|2018-11-15||Interventional|||Neuroimaging Studies of Smoking and Treatment|Smoking Cessation, Cognitive Control and Reward Processing: An fMRI Pilot Study|Recruiting||N/A|56|Anticipated|University of Kansas Medical Center||3|||f|||||f|f|||f|||||2017-10-10 21:15:10.667596|2017-10-10 21:15:10.667596
NCT03085589|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-06-26|||August 2016||2016-08-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|April 2021|Anticipated|2021-04-01||Observational|||MOWI Amulet Mobile Health Technology Validation|Mobile Health Obesity Wellness Intervention in Rural Older Adults (MOWI): Amulet Technology Development & Validation|Recruiting||N/A|60|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||No||2017-10-10 21:15:10.769063|2017-10-10 21:15:10.769063
NCT03085576|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-07-03|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30|12 Months|Observational [Patient Registry]|NATURE-AF||NATional TUnisian REgistry of Atrial Fibrillation|National Tunisian Registry of Atrial Fibrillation|Active, not recruiting||N/A|910|Actual|Dacima Consulting|||1||f||||t|f|f||||||||2017-10-10 21:15:10.863281|2017-10-10 21:15:10.863281
NCT03085563|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-18|||May 24, 2017|Actual|2017-05-24|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department|A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department|Recruiting||Phase 4|500|Anticipated|University of Colorado, Denver||2|||f|||||t|f|||f|||||2017-10-10 21:15:10.952865|2017-10-10 21:15:10.952865
NCT03085550|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|||Platelet Rich Plasma and Autologous Fat Graft for Diabetic Ulcer|A Randomised Controlled Trial to Compare Platelet-Rich Plasma and Autologous Fat Graft for Diabetic Ulcer|Not yet recruiting||N/A|30|Anticipated|University College, London||3|||f|||||f|f|||f|||||2017-10-10 21:15:11.095463|2017-10-10 21:15:11.095463
NCT03085537|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-21|||October 1, 2016|Actual|2016-10-01|March 2017|2017-03-01|December 30, 2018|Anticipated|2018-12-30|September 30, 2018|Anticipated|2018-09-30|1 Day|Observational [Patient Registry]|PRE-HVNI||Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Digital Diagnosis Platform|Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Pressure and Flow-time Signals Analysis Integrated on Digital Diagnosis Platform.|Recruiting||N/A|70|Anticipated|Corporacion Parc Tauli|||1||f||||||||||||Undecided||2017-10-10 21:15:11.240527|2017-10-10 21:15:11.240527
NCT03085524|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|TIDE||The Impact of Diabetes on REvascularization|The Impact of Diabetes on REvascularization|Recruiting||N/A|500|Anticipated|Vanderbilt University Medical Center|||2||f||||f|f|f||||Samples With DNA|"     Leukoctyes   "|||2017-10-10 21:15:11.348131|2017-10-10 21:15:11.348131
NCT03085511|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-03|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|Egg_breakfast||High Quality Protein for Assisting With Weight Loss|Does Higher Protein Quality Reduce Energy Intake When Following a Weight Loss Diet Plan? -- Nonpilot, Powered Crossover|Not yet recruiting||N/A|40|Anticipated|Texas Tech University||2|||f||||f|f|f||||||||2017-10-10 21:15:11.463356|2017-10-10 21:15:11.463356
NCT03085498|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-14|||November 1, 2017|Anticipated|2017-11-01|March 2017|2017-03-01|October 1, 2018|Anticipated|2018-10-01|July 7, 2018|Anticipated|2018-07-07||Observational|||Sportcheck Follow-Up|Sportcheck Follow-Up: Physical Fitness, Cardiovascular and Psychosocial Health in Primary School Childen|Not yet recruiting||N/A|250|Anticipated|University of Basel|||1||f||||t||||||||Undecided||2017-10-10 21:15:11.592407|2017-10-10 21:15:11.592407
NCT03085485|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-09|||March 16, 2017|Actual|2017-03-16|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor|A Randomized, Double-blind, Phase 2, Placebo Controlled Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The Topic Trial)|Recruiting||Phase 2|40|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f||||||||2017-10-10 21:15:11.672081|2017-10-10 21:15:11.672081
NCT03085472|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-15|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|January 1, 2023|Anticipated|2023-01-01|February 1, 2019|Anticipated|2019-02-01||Observational|||Chongqing Intracerebral Hemorrhage Study|Chongqing Intracerebral Hemorrhage Study|Recruiting||N/A|1000|Anticipated|First Affiliated Hospital of Chongqing Medical University|||2||f||||t|f|f||||||Undecided||2017-10-10 21:15:11.811913|2017-10-10 21:15:11.811913
NCT03085459|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-14|||January 12, 2015|Actual|2015-01-12|March 2017|2017-03-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29||Observational|||Effects of Nursing Staff on Empiric Antibiotic in Septic Shock|The Effect of Nursing Staff on Empiric Antibiotic Treatment Within the First Hour in Patients With Septic Shock: A Retrospective Study|Completed||N/A|214|Actual|Southeast University, China|||4||f||||t|f|f||||||No||2017-10-10 21:15:11.910938|2017-10-10 21:15:11.910938
NCT03085446|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-06-15|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Insomnia in Older Adults: Impact of Personalized, Diet-Induced Alterations in the Microbiota|Two-armed, Single-blind Randomized Clinical Trial for Older Adults With Insomnia|Recruiting||N/A|100|Anticipated|University of Haifa||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:11.994568|2017-10-10 21:15:11.994568
NCT03085433|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-03-19|||March 17, 2017|Actual|2017-03-17|March 2017|2017-03-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|SPERM||Sperm Selection by Microfluidic Separation Improves Embryo Quality in Patients With a History of Poor Embryo Quality|Sperm Selection by Microfluidic Separation Improves Embryo Quality in Patients With a History of Poor Embryo Quality|Recruiting||Phase 3|62|Anticipated|University of California, San Francisco||2|||f||||t|f|t|t|||||Undecided||2017-10-10 21:15:12.13158|2017-10-10 21:15:12.13158
NCT03085420|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-10-04|||May 3, 2017|Actual|2017-05-03|October 2017|2017-10-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|||Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient|Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient|Enrolling by invitation||N/A|50|Anticipated|Shriners Hospitals for Children||2|||f||||f|f|f||||||||2017-10-10 21:15:12.234474|2017-10-10 21:15:12.234474
NCT03085407|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-10-03|||December 1, 2013|Actual|2013-12-01|October 2017|2017-10-01|January 1, 2018|Anticipated|2018-01-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Acute Biliary Pancreatitis - Optimal Time for Cholecystectomy|Acute Biliary Pancreatitis - Optimal Time for Cholecystectomy: A Prospective Randomized Study|Active, not recruiting||N/A|2|Actual|South Valley University||2|||f||||t|f|f||||||||2017-10-10 21:15:12.334872|2017-10-10 21:15:12.334872
NCT03085381|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-03-19|||December 2016||2016-12-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Phase I Study of Quadrivalent HPV Recombinant Vaccine|A Randomized, Double-Blind and Placebo-Controlled Phase I Study to Evaluate the Safety and Primary Immunogenicity of the Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Subjects Aged 9-45 Years|Active, not recruiting||Phase 1|90|Anticipated|Shanghai Bovax Biotechnology Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:15:12.515176|2017-10-10 21:15:12.515176
NCT03085368|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-07-26|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|March 1, 2021|Anticipated|2021-03-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin|A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib and Paclitaxel vs Herceptin and Paclitaxel With Sequential and Synchronous Anthracycline|Recruiting||Phase 2/Phase 3|482|Anticipated|Peking Union Medical College Hospital||4|||f||||t|f|f|||f|||||2017-10-10 21:15:12.601853|2017-10-10 21:15:12.601853
NCT03085355|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-19|2017-03-21|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Evaluation of the Effect of the OMT Exercises Education for Pain in Participants With Cervical Pain|Evaluation of the Effects of the Association of the Osteopathic Manipulative Treatment to Exercises, Education for Pain in Participants With Cervical Pain - Pragmatic Clinical Trial Randomized|Not yet recruiting||N/A|40|Anticipated|Instituto Brasileiro de Osteopatia||2|||f||||t|f|f||||||No||2017-10-10 21:15:12.694767|2017-10-10 21:15:12.694767
NCT03085342|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-04|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluation of Hepatic Fibrosis on Multiparametric MRI|Evaluation of Hepatic Fibrosis on Multiparametric MRI Including Portal Flow Measurement Using Dual-input Software: Preliminary Study|Recruiting||N/A|50|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:15:12.79102|2017-10-10 21:15:12.79102
NCT03085329|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-20|||February 10, 2017|Actual|2017-02-10|March 2017|2017-03-01|February 9, 2019|Anticipated|2019-02-09|October 31, 2018|Anticipated|2018-10-31||Interventional|||A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants|A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants|Recruiting||N/A|220|Anticipated|Seattle Children's Hospital||2|||f||||t|f|t|f|f|f|||Yes|The data will be available for download via Globus sharing services from the Seattle-PAP shared endpoint.|2017-10-10 21:15:12.901989|2017-10-10 21:15:12.901989
NCT03085316|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-25|||October 26, 2015|Actual|2015-10-26|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|BVFP IDE||Laryngeal Pacing Study|Electrical Stimulation of Laryngeal Muscles to Restore Glottal Opening in Patients With Bilateral Vocal Fold Paralysis|Enrolling by invitation||N/A|10|Anticipated|Vanderbilt University Medical Center||1|||f||||f|f|||||||||2017-10-10 21:15:13.009834|2017-10-10 21:15:13.009834
NCT03085303|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-12|||March 16, 2017|Actual|2017-03-16|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AD‐Blue||Treatment of Atopic Dermatitis by a Full‐Body Blue Light Device|Treatment of Atopic Dermatitis by a Full‐Body Blue Light Device|Recruiting||N/A|150|Anticipated|Philips Light and Health||3|||f||||f|f|f||||||||2017-10-10 21:15:13.103392|2017-10-10 21:15:13.103392
NCT03085290|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-15|||June 26, 2017|Actual|2017-06-26|August 2017|2017-08-01|September 20, 2018|Anticipated|2018-09-20|March 20, 2018|Anticipated|2018-03-20||Interventional|AVAnS||Allogeneic Versus Autologous Serum Eye Drops|Allogeneic Versus Autologous Serum Eye Drops: a Double-blind Randomized Cross Over Trial|Enrolling by invitation||N/A|18|Anticipated|Sanquin Research & Blood Bank Divisions||2|||f||||f|f|f||||||||2017-10-10 21:15:13.403071|2017-10-10 21:15:13.403071
NCT03085277|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-26|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|March 31, 2019|Anticipated|2019-03-31||Interventional|PreColos-RCT||Bovine Colostrum for Preterm Newborns|Bovine Colostrum Versus Preterm Formula as the First Supplemental Nutrition for Very Preterm Infants, a Randomized, Controlled Trial|Recruiting||N/A|352|Anticipated|Rigshospitalet, Denmark||2|||f||||t|f|f||||||||2017-10-10 21:15:13.569927|2017-10-10 21:15:13.569927
NCT03085264|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-28|||April 7, 2017|Actual|2017-04-07|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|March 7, 2019|Anticipated|2019-03-07||Interventional|CCAT||Community Health Worker Care Transitions Study|Implementing 30-day Post- Discharge Community Health Worker Pairings for Patients at High-Risk for Readmission (C-CAT Study)|Recruiting||N/A|1200|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||||2017-10-10 21:15:13.834727|2017-10-10 21:15:13.834727
NCT03085251|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-25|||March 16, 2017|Actual|2017-03-16|September 2017|2017-09-01|June 1, 2017|Actual|2017-06-01|April 3, 2017|Actual|2017-04-03||Interventional|||Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS)|Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS)|Completed||N/A|109|Actual|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm||1|||f|||||f|f||||||||2017-10-10 21:15:13.952573|2017-10-10 21:15:13.952573
NCT03085238|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-24|||March 9, 2017|Actual|2017-03-09|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian Cancer|Safety and Performance of Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian Cancer|Recruiting||N/A|22|Anticipated|MTrap, Inc.||1|||f||||t|f|t|t|f|t|||No||2017-10-10 21:15:14.039348|2017-10-10 21:15:14.039348
NCT03085225|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-05-12|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|May 5, 2021|Anticipated|2021-05-05|May 5, 2020|Anticipated|2020-05-05||Interventional|TRAMUNE||Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.|Trabectedin Combined With Durvalumab (MEDI4736) in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. A Phase Ib Study.|Recruiting||Phase 1|50|Anticipated|Institut Bergonié||1|||f||||t|f|f||||||No||2017-10-10 21:15:14.175732|2017-10-10 21:15:14.175732
NCT03085212|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-15|||April 21, 2017|Actual|2017-04-21|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|SPA||Strategies for Pregnancy Achievement|Strategies for Pregnancy Achievement (SPA): a Pilot Study|Recruiting||N/A|40|Anticipated|Ohio State University||2|||f||||f|f|f||||||||2017-10-10 21:15:14.341176|2017-10-10 21:15:14.341176
NCT03085199|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-15|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Laparoscopic Reinforcement Suture (LARS) of Duodenal Stump A Prospective Single Arm Phase II Study|Laparoscopic Reinforcement Suture (LARS) on Staple-line of Duodenal Stump Using Barbed Suture in Laparoscopic Gastrectomy for Gastric Cancer: A Prospective Single Arm Phase II Study|Recruiting||N/A|100|Anticipated|Inje University||1|||f||||f|f|f||||||No||2017-10-10 21:15:14.484256|2017-10-10 21:15:14.484256
NCT03085186|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-28||||||August 2017|2017-08-01||||||||Expanded Access|||Treatment With Crizotinib Single Patient Expanded Access IND 134375|Treatment With Crizotinib Single Patient Expanded Access IND 134375|No longer available||N/A|||University of Pittsburgh||||||t|||||||||||||2017-10-10 21:15:14.619728|2017-10-10 21:15:14.619728
NCT03085173|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-09-08|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||"A Trial of Armored CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies"|"A Phase I Trial of CD19-Targeted EGFRt/19-28z/4-1BBL Armored Chimeric Antigen Receptor (CAR) Modified T Cells in Patients With Relapsed or Refractory CD19+ Hematologic Malignancies"|Recruiting||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:15:14.698435|2017-10-10 21:15:14.698435
NCT03085147|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-24|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Dye for the Detection of Cancer of the Tongue and Mouth|A Phase I/II Study of the Fluorescent PARP1 Binding Imaging Agent PARPi-FL in Patients With Oral Squamous Cell Carcinomas|Recruiting||Phase 1/Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:15:14.97686|2017-10-10 21:15:14.97686
NCT03085134|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-14|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|CINNAMON||Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides|Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose (FSMP) Containing 2 Human Milk Oligosaccharides (HMOs)|Recruiting||N/A|174|Anticipated|Nestlé||2|||f||||f|f|f||||||No||2017-10-10 21:15:15.186989|2017-10-10 21:15:15.186989
NCT03085121|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-21|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Femoral Extramedullary Versus Intramedullary Alignment Systems in Total Knee Arthroplasty|A Comparative Study of Femoral Extramedullary and Intramedullary Alignment Systems in Total Knee Arthroplasty|Not yet recruiting||N/A|100|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||4|||f||||f|f|f||||||No||2017-10-10 21:15:15.566639|2017-10-10 21:15:15.566639
NCT03085108|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-25|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|December 27, 2017|Anticipated|2017-12-27|December 27, 2017|Anticipated|2017-12-27||Observational|||A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment|Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide|Recruiting||N/A|120|Anticipated|Janssen Scientific Affairs, LLC|||2||f||||f|f|f||||||||2017-10-10 21:15:15.669087|2017-10-10 21:15:15.669087
NCT03085095|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-18|||March 3, 2017|Actual|2017-03-03|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|September 30, 2019|Anticipated|2019-09-30||Interventional|HERO||A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer|HERO: A Multinational Phase 3 Randomized, Open-label, Parallel Group Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer|Recruiting||Phase 3|1125|Anticipated|Myovant Sciences GmbH||2|||f||||t|t|f|||f|||||2017-10-10 21:15:15.773838|2017-10-10 21:15:15.773838
NCT03085082|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-20|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|September 1, 2017|Anticipated|2017-09-01||Observational|||Study of the Relationship Between Blood Groups,RH and Skeletal Malocclusion : a Cross Sectional Study|Study of the Relationship Between Blood Groups,RH and Skeletal Malocclusion in a Group of Egyptian Population: a Cross Sectional Study|Not yet recruiting||N/A|300|Anticipated|Cairo University|||3||f||||t|f|f||||||No||2017-10-10 21:15:15.960119|2017-10-10 21:15:15.960119
NCT03085069|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-03-20|||January 2017||2017-01-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study to Evaluate SHR-1210 as Second-line Therapy in Patients With NSCLC|An Open-label, Single-arm, Multi-center, Phase 2 Study to Evaluate SHR-1210(Anti-PD-1 Antibody) as Second-line Therapy in Patients With Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|120|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||4|||f||||f||||||||Undecided||2017-10-10 21:15:16.043461|2017-10-10 21:15:16.043461
NCT03085056|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-10-03|||March 15, 2017|Actual|2017-03-15|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer|A Pilot Study of Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer|Recruiting||Early Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f|||t|||||2017-10-10 21:15:16.138995|2017-10-10 21:15:16.138995
NCT03085043|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-06-02|||April 20, 2016|Actual|2016-04-20|June 2017|2017-06-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01||Interventional|||Magnetic Resonance Imaging as a Comprehensive Staging Tool for the Evaluation of High-Risk Prostate Carcinoma|Magnetic Resonance Imaging as a Comprehensive Staging Tool for the Evaluation of High-Risk Prostate Carcinoma|Recruiting||N/A|86|Anticipated|M.D. Anderson Cancer Center||1|||f|||||f|f||||||||2017-10-10 21:15:16.233215|2017-10-10 21:15:16.233215
NCT03085030|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-04-04|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Can Antioxidants Affect Pregnancy Rate in Patients With Expected Low Number of Egg Retrieval in IVF Cycles?|Effect of Some Antioxidants on the Conception Rate in Poor Responders in IVF Cycles (a Randomized Controlled Trial)|Recruiting||Phase 4|593|Anticipated|Cairo University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:16.312118|2017-10-10 21:15:16.312118
NCT03085017|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-06-07|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|August 7, 2018|Anticipated|2018-08-07|June 7, 2018|Anticipated|2018-06-07||Interventional|||Effectiveness of BoneSeal® on Bone Hemostats in Patients Undergoing Cardiothoracic Surgery|Effectiveness of BoneSeal® on Bone Hemostats in Patients Undergoing Cardiothoracic Surgery|Recruiting||N/A|60|Anticipated|Loma Linda University||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:15:16.398647|2017-10-10 21:15:16.398647
NCT03085004|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-28|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts|CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts: a Prospective, Randomized, Double-blind, Multi-center Clinical Trial|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Milton S. Hershey Medical Center||2|||f||||t|t|f||||||||2017-10-10 21:15:16.493541|2017-10-10 21:15:16.493541
NCT03084991|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-08-14|||May 17, 2017|Actual|2017-05-17|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|April 2019|Anticipated|2019-04-01||Observational|||OCT Registry in Patients With STEMI During PPCI|OPTical Coherence Tomography IMAging in Patients With ST-segment Elevation myocardiaL Infarction During Primary PCI|Recruiting||N/A|4500|Anticipated|Harbin Medical University|||2||f|||||f|f||||||||2017-10-10 21:15:16.586784|2017-10-10 21:15:16.586784
NCT03084978|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-14|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Conscious Sedation vs General Anesthesia in TAVR Patients|Randomized Prospective Study in Transcatheter Aortic Valve Replacement Patients- Conscious Sedation VS. General Anesthesia Examining the Effect on Operative Time|Not yet recruiting||N/A|80|Anticipated|Montefiore Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:15:16.852899|2017-10-10 21:15:16.852899
NCT03084965|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-10-03|||May 12, 2017|Actual|2017-05-12|October 2017|2017-10-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|||Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan|Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan|Recruiting||N/A|1300|Anticipated|AstraZeneca|||1||f||||f|f|f||||||||2017-10-10 21:15:16.966912|2017-10-10 21:15:16.966912
NCT03084952|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-15|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients|A Phase 2, Randomized, Unicentric Clinical Trial With Dose Scaling for Safety, Tolerability and Efficacy Assessment of 18-Methoxycoronaridine Administered to Cutaneous Leishmaniasis Patients|Not yet recruiting||Phase 2|52|Anticipated|Infan Industria Quimica Farmaceutica Nacional||7|||f|||||f|f||||||||2017-10-10 21:15:17.049965|2017-10-10 21:15:17.049965
NCT03084913|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-20|||January 1, 2015|Actual|2015-01-01|March 2017|2017-03-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate Cancer|Comparing Diets for Weight Loss and Improvement in Cancer Biomarkers in Men With Prostate Cancer|Completed||N/A|30|Actual|The Miriam Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:15:17.455208|2017-10-10 21:15:17.455208
NCT03084900|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-08|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|CHICAT1||Patient-Centered Decision Support to Improve Diabetes Management in Pre-Teens and Adolescents With Type 1 Diabetes|Patient-Centered Decision Support to Improve Diabetes Management in Pre-Teens and Adolescents With Type 1 Diabetes|Recruiting||N/A|255|Anticipated|Indiana University||2|||f||||f|f|f||||||||2017-10-10 21:15:17.550968|2017-10-10 21:15:17.550968
NCT03084887|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-03-14|||November 10, 2016|Actual|2016-11-10|November 2016|2016-11-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|STEDC||Study of Tissue Expansion Devices Complications|Intervention Study of Common Complications About Patients Placed Tissue Expansion Devices|Recruiting||N/A|208|Anticipated|Xijing Hospital||2|||f||||f|f|||||||Undecided||2017-10-10 21:15:17.639965|2017-10-10 21:15:17.639965
NCT03084874|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-14|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy of a Coaching Program to Promote Physical Activity and Reduce Sedentary Behavior After a COPD Hospitalization|Efficacy of a Coaching Program to Promote Physical Activity and Reduce Sedentary Behavior After a COPD Exacerbation That Require Hospitalization|Recruiting||N/A|66|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f|f|f||||||No|IPD will not be shared|2017-10-10 21:15:17.730554|2017-10-10 21:15:17.730554
NCT03084861|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-14|||February 24, 2017|Actual|2017-02-24|March 2017|2017-03-01|April 7, 2019|Anticipated|2019-04-07|March 17, 2019|Anticipated|2019-03-17||Interventional|||A Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy|A Multicenter, Randomized, Open-label, Two-arms Phase I/II Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy|Recruiting||Phase 1/Phase 2|42|Anticipated|Banc de Sang i Teixits||2|||f||||f|f|f||||||No||2017-10-10 21:15:17.836411|2017-10-10 21:15:17.836411
NCT03084848|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-03-14|||May 18, 2016|Actual|2016-05-18|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|APEX-ADO||Executive Training and Brain in Adolescent|Cerebral Bases of the Cognitive Learning in the Executive Control In the Adolescence|Recruiting||N/A|60|Anticipated|Centre Hospitalier St Anne||2|||f||||f||||||||No||2017-10-10 21:15:17.937859|2017-10-10 21:15:17.937859
NCT03084822|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-17|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|June 2018|Anticipated|2018-06-01||Interventional|FAITH!||Cardiovascular Health Promotion Among African-Americans by FAITH!|Cardiovascular Health Promotion Among African-Americans by FAITH! (Fostering African-American Improvement in Total Health): Engaging the Community Through Mobile Technology-assisted Education|Active, not recruiting||N/A|50|Actual|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 21:15:18.149979|2017-10-10 21:15:18.149979
NCT03084809|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-14|||May 6, 2012|Actual|2012-05-06|March 2017|2017-03-01|September 15, 2014|Actual|2014-09-15|September 15, 2014|Actual|2014-09-15||Interventional|||Chemotherapy Combined With CIK Treating Colon Cancer|Clinical Efficacy of Chemotherapy Combined With Cytokine-induced Killer in Treatment of Patients With Colon Cancer|Completed||Phase 4|46|Actual|China Meitan General Hospital||2|||f||||f|f|f|||f|||Undecided|whether individual participant data (IPD) could be shared must obtain the consent of the subjects|2017-10-10 21:15:18.232783|2017-10-10 21:15:18.232783
NCT03084094|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-13|||October 17, 2016|Actual|2016-10-17|March 2017|2017-03-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Neuromodulation and Its Therapeutic Potentiality in Different Populations|Transcranial Direct Current Stimulation and Its Therapeutic Potentiality in Different Populations|Active, not recruiting||N/A|45|Anticipated|Universidade Federal do Rio Grande do Norte||3|||f||||f|f|f||||||No||2017-10-10 21:15:25.810692|2017-10-10 21:15:25.810692
NCT03084796|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-14|||July 28, 2017|Anticipated|2017-07-28|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease|A 6-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 5259 pMDI (HFA Glycopyrronium Bromide Via Pressurized Metered Dose Inhaler) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Not yet recruiting||Phase 2|702|Anticipated|Chiesi Farmaceutici S.p.A.||6|||f||||f|t|f||||||No||2017-10-10 21:15:18.317933|2017-10-10 21:15:18.317933
NCT03084783|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-10-04|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 1, 2020|Anticipated|2020-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|DexEnceph||Dexamethasone in Herpes Simplex Virus Encephalitis|Dexamethasone in Herpes Simplex Virus Encephalitis : a Randomised Controlled Trial|Not yet recruiting||Phase 3|30|Anticipated|University Hospital, Grenoble||2|||f||||t|f|f||||||||2017-10-10 21:15:18.419104|2017-10-10 21:15:18.419104
NCT03084770|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-14|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2023|Anticipated|2023-03-31||Observational|ASPEN||Asymptomatic Small Pancreatic Endocrine Neoplasms.|A Prospective Evaluation of the Management of Sporadic Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤ 2 cm|Recruiting||N/A|1000|Anticipated|IRCCS San Raffaele|||2||f||||f|f|f||||||No||2017-10-10 21:15:18.532916|2017-10-10 21:15:18.532916
NCT03084757|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-14|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|SHIVA02||SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control|SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control|Not yet recruiting||N/A|370|Anticipated|Institut Curie||1|||f||||f|f|f||||||No||2017-10-10 21:15:18.647192|2017-10-10 21:15:18.647192
NCT03084744|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-22|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|May 1, 2025|Anticipated|2025-05-01|May 1, 2025|Anticipated|2025-05-01||Interventional|||Schema Therapy for Chronic Depression|Senzoku Intervention of Schema Therapy for Aid and Recovery From Chronic Depression (SISTAR*CD)|Not yet recruiting||N/A|64|Anticipated|Institute for Health Economics and Policy, Japan||2|||f||||t|f|f||||||Yes|IPD will be available to other researchers within 3 years after the publication of the primary paper.|2017-10-10 21:15:18.710882|2017-10-10 21:15:18.710882
NCT03084731|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-03-14|||February 1, 2018|Anticipated|2018-02-01|December 2016|2016-12-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|MDCF||'Pre-Proof of Concept (Pre-POC)' Clinical Trials to Optimize Lead Microbiota-directed Complementary Food (MDCF) Prototypes for Their Ability to Repair Microbiota Immaturity and Establish Their Organoleptic Acceptability|Microbiota Directed Complementary Food (MDCF) Translational Trial|Not yet recruiting||N/A|180|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||f|f|f||||||No||2017-10-10 21:15:18.806601|2017-10-10 21:15:18.806601
NCT03084718|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-14|||July 28, 2017|Anticipated|2017-07-28|March 2017|2017-03-01|April 13, 2018|Anticipated|2018-04-13|April 13, 2018|Anticipated|2018-04-13||Interventional|||An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects|An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.|Not yet recruiting||Phase 2|585|Anticipated|Chiesi Farmaceutici S.p.A.||5|||f||||f|t|f||||||No||2017-10-10 21:15:18.88423|2017-10-10 21:15:18.88423
NCT03084705|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Wearable Device for Motivating Hand Use After Stroke|An Interactive, Wearable Device for Measuring and Motivating Hand Use After Stroke|Not yet recruiting||N/A|22|Anticipated|University of California, Irvine||2|||f||||f|f|f||||||No||2017-10-10 21:15:18.969563|2017-10-10 21:15:18.969563
NCT03084692|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-17|||April 14, 2017|Actual|2017-04-14|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Interventional|ASSURE||Therapeutic Yoga and Resistance Exercise for Lung Cancer|Feasibility and Preliminary Efficacy of a Combined Therapeutic Yoga and Resistance Exercise Intervention for Individuals With Lung Cancer and Their Caregivers|Recruiting||N/A|20|Anticipated|University of Alberta||1|||f||||f|f|f||||||Undecided|Undecided at this time.|2017-10-10 21:15:19.051756|2017-10-10 21:15:19.051756
NCT03084679|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-03-24|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Characterization of Myocardial Interstitial Fibrosis and Cardiomyocyte Hypertrophy by Cardiac MRI in Heart Failure|Characterization of Myocardial Interstitial Fibrosis and Cardiomyocyte Hypertrophy by Cardiac MRI In Heart Failure: Implication on Early Remodeling and on the Transition to Heart Failure|Not yet recruiting||N/A|100|Anticipated|University of Campinas, Brazil||4|||f||||t|f|f|||f|||No|No plan to Share individual participant data.|2017-10-10 21:15:19.164478|2017-10-10 21:15:19.164478
NCT03084666|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-21|||July 2, 2014|Actual|2014-07-02|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 13, 2018|Anticipated|2018-01-13||Interventional|||Remote Ischemic Preconditioning Living Donor Renal Transplant Protocol|Remote Ischemic Preconditioning Living Donor Renal Transplant Protocol|Recruiting||N/A|150|Anticipated|University of Alabama at Birmingham||2|||f||||t|f|t|f|f|t|||Undecided||2017-10-10 21:15:19.304169|2017-10-10 21:15:19.304169
NCT03084653|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-14|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|June 2015|Actual|2015-06-01||Observational|||Choosing the Technique for First Abdominal Entry in Laparoscopy|Choosing the Technique for First Abdominal Entry in Laparoscopy: A Questionnaire-based Observational Study.|Completed||N/A|263|Actual|Umraniye Education and Research Hospital|||1||f|||||f|f||||||||2017-10-10 21:15:19.396128|2017-10-10 21:15:19.396128
NCT03084640|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-28|||May 4, 2017|Actual|2017-05-04|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Phase 1b Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Subjects With Advanced Melanoma|A Multicenter, Two Part, Phase 1b Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Subjects With Advanced Melanoma|Recruiting||Phase 1/Phase 2|76|Anticipated|Checkmate Pharmaceuticals||4||||||||t|f||||||||2017-10-10 21:15:19.473566|2017-10-10 21:15:19.473566
NCT03084627|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-09-04|||July 4, 2016|Actual|2016-07-04|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|June 30, 2017|Actual|2017-06-30||Interventional|MONCAP||Evaluation of the Efficiency of Tailored Dietary Advice in Improving the Nutrient Adequacy of the Diet of French Pregnant Women|Evaluation of the Efficiency of Tailored Dietary Advice in Improving the Nutrient Adequacy of the Diet of French Pregnant Women|Active, not recruiting||N/A|80|Actual|Groupe Hospitalier Paris Saint Joseph||2|||f||||t|f|f||||||||2017-10-10 21:15:19.571276|2017-10-10 21:15:19.571276
NCT03084614|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-15|2017-07-13|||March 28, 2017|Actual|2017-03-28|July 12, 2017|2017-07-12|March 31, 2022|Anticipated|2022-03-31|February 27, 2019|Anticipated|2019-02-27||Observational|||CD8 Reactivity to Microorganisms in Blood and Breast Milk|CD8 Reactivity to Microorganisms in Blood and Breast Milk|Recruiting||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||2||f||||||||||||||2017-10-10 21:15:19.642427|2017-10-10 21:15:19.642427
NCT03084601|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-14|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|3-mixtatin||Evaluation of Postoperative Pain After Using 3MIX-TATIN Versus Calcium Hydroxide Iodoform Paste In Necrotic Primary Molars Treated by Lesion Sterilization and Tissue Repair Therapy|Evaluation of Postoperative Pain After Using 3MIX-TATIN Versus Calcium Hydroxide Iodoform Paste In Necrotic Primary Molars Treated by Lesion Sterilization and Tissue Repair Therapy: A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|92|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:15:19.727888|2017-10-10 21:15:19.727888
NCT03084588|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-23|||July 2016||2016-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Methadone and Interscalene Block for Shoulder Surgery|Methadone and Interscalene Block for Shoulder Surgery|Recruiting||Phase 4|100|Anticipated|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||No||2017-10-10 21:15:19.809553|2017-10-10 21:15:19.809553
NCT03084575|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-20|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Thermal Radiofrequency Versus Neurolytic Saddle Rhizotomyfor Severe Pereneal Cancer Pain|The Role of Selective Thermal Radiofrequency Saddle Rhizotomy In Managing Interactable Malignant Perineal Pain: A Comparative Study|Enrolling by invitation||Phase 2|40|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:15:19.890169|2017-10-10 21:15:19.890169
NCT03084562|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-11|||May 3, 2017|Actual|2017-05-03|March 2017|2017-03-01|February 3, 2018|Anticipated|2018-02-03|January 3, 2018|Anticipated|2018-01-03||Observational|REDUCE||Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT|Descriptive Study Comparing Regadenoson Versus Dipyridamole in Use as Pharmacological Stress Agent Before a Myocardial Perfusion Imaging by Single Photon Emission Computed Tomography (SPECT)|Recruiting||N/A|800|Anticipated|Hospices Civils de Lyon|||2||f||||f|f|f||||||||2017-10-10 21:15:19.964687|2017-10-10 21:15:19.964687
NCT03084536|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-08|||June 7, 2017|Actual|2017-06-07|June 2017|2017-06-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery|PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery|Recruiting||Phase 2|160|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||No||2017-10-10 21:15:20.127539|2017-10-10 21:15:20.127539
NCT03084523|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-08-04|||April 26, 2017|Actual|2017-04-26|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|February 27, 2019|Anticipated|2019-02-27||Interventional|||Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI|Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI|Enrolling by invitation||Phase 1|80|Anticipated|University of Utah||2|||f||||t|t|f|||t|||||2017-10-10 21:15:20.227174|2017-10-10 21:15:20.227174
NCT03084510|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-03-14|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||REPRISE China - Clinical Evaluation in China|Reprise China: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Clinical Evaluation in China|Not yet recruiting||N/A|50|Anticipated|Boston Scientific Corporation||1|||f||||f|f|f||||||No||2017-10-10 21:15:20.306339|2017-10-10 21:15:20.306339
NCT03084497|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-14|||August 2016||2016-08-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Effects of Infant Massage on Development of Down Syndrome Babies|Effects and Effectiveness of Infant Massage in Motor, Cognitive, Language and Social Developmental in Babies With Syndrome of Down Aged Between 4 and 8 Months|Completed||N/A|32|Actual|University of Seville||2|||f||||f|f|f||||||No||2017-10-10 21:15:20.392524|2017-10-10 21:15:20.392524
NCT03084484|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-14|||May 2013|Actual|2013-05-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|PERIO-KIWI||Kiwifruit Effect on Periodontal Inflammation Kiwifruit Effect on Periodontal Inflammation|The Effect of Twice Daily Kiwifruit Consumption on Periodontal and Systemic Conditions Before and After Treatment: a Randomized Clinical Trial|Completed||N/A|50|Actual|University of Pisa||2|||f|||||f|f||||||||2017-10-10 21:15:20.619463|2017-10-10 21:15:20.619463
NCT03084471|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-22|||April 17, 2017|Actual|2017-04-17|September 2017|2017-09-01|April 29, 2022|Anticipated|2022-04-29|April 29, 2022|Anticipated|2022-04-29||Interventional|STRONG||An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.|An Open-Label, Multi-Centre, Safety Study of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.|Recruiting||Phase 3|1200|Anticipated|AstraZeneca||2|||f||||t|t|f|||t|||||2017-10-10 21:15:20.752047|2017-10-10 21:15:20.752047
NCT03084458|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-21|||February 14, 2017|Actual|2017-02-14|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Does Activity Feedback Increase ICD Patient Activity Levels?|Does Activity Feedback Increase ICD Patient Activity Levels?|Recruiting||N/A|50|Anticipated|East Carolina University||2|||f||||f|f|f||||||No||2017-10-10 21:15:21.27155|2017-10-10 21:15:21.27155
NCT03084445|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-03-14|||September 2013||2013-09-01|March 2017|2017-03-01|December 31, 2021|Anticipated|2021-12-31|December 2020|Anticipated|2020-12-01|3 Days|Observational [Patient Registry]|||Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort|Impact of Exposure to Environmental Pollutants on Birth Outcomes in an Israeli Cohort|Recruiting||N/A|1500|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||Samples Without DNA|"     whole blood, serum, white cells, red blood cells, urine, breast milk, meconium   "|||2017-10-10 21:15:21.375804|2017-10-10 21:15:21.375804
NCT03084432|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-14|||December 1, 2014|Actual|2014-12-01|March 2017|2017-03-01|September 1, 2016|Actual|2016-09-01|June 1, 2016|Actual|2016-06-01||Observational|||Effect of Caffeine on Preterm Infants' Bone Mineral Content|Assessment of Bone Mineral Content for Preterm Neonates Treated With Caffeine Using Dual Energy X-ray Absorptiometry : an Observational Study|Completed||N/A|42|Actual|Ain Shams University|||2||f|||||f|f||||||No||2017-10-10 21:15:21.473196|2017-10-10 21:15:21.473196
NCT03084419|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-14|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|APRIL||APRIL (AbatacePt in RA-ILD)|Safety of Abatacept in Rheumatoid Arthritis Associated Interstitial Lung Disease: A Feasibility Trial|Not yet recruiting||Phase 2|30|Anticipated|Cambridge University Hospitals NHS Foundation Trust||1|||f||||f|t|f|||t|||No||2017-10-10 21:15:21.545124|2017-10-10 21:15:21.545124
NCT03084406|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-14|||February 13, 2017|Actual|2017-02-13|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|CV-ATOD||Efficacy of Centervention-ATOD: An Implementation Tool for Dissemination of Evidence-based Programs for Substance Abuse|Web-Based Tool for the Dissemination of Evidence-based Interventions for ATOD|Recruiting||N/A|935|Anticipated|3-C Institute for Social Development||2|||f||||f|f|f||||||||2017-10-10 21:15:21.65459|2017-10-10 21:15:21.65459
NCT03084393|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-23|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||POCD: Correlations With the Gene Polymorphism and the Concentrations of Plasma Homocysteine, Folic Acid and Vitamin B12.|Postoperative Cognitive Dysfunction: Correlations With the Gene Polymorphism and the Concentrations of Plasma Homocysteine, Folic Acid and Vitamin B12.|Recruiting||N/A|1000|Anticipated|Xuzhou Medical University|||2||f|||||f|f||||Samples With DNA|"     blood   "|Yes|within six months after the trial complete|2017-10-10 21:15:21.763926|2017-10-10 21:15:21.763926
NCT03084380|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-17|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)|Phase I Trial of Anti-GPC3 Chimeric T Cells for Subjects With GPC3-Positive Advanced Hepatocellular Carcinoma|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Xinqiao Hospital of Chongqing||1|||f||||t|f|f||||||Yes||2017-10-10 21:15:21.856898|2017-10-10 21:15:21.856898
NCT03084367|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-07-17|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|DEFINE PCI||Physiologic Assessment of Coronary Stenosis Following PCI|DEFINE PCI: Physiologic Assessment of Coronary Stenosis Following PCI|Recruiting||N/A|500|Anticipated|Volcano Corporation|||1||f||||f|f|f||||||||2017-10-10 21:15:21.956308|2017-10-10 21:15:21.956308
NCT03084354|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-07-10|||July 25, 2016|Actual|2016-07-25|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Women's Experiences of Maternity Bladder Care|Women's Experiences of Maternity Bladder Care|Completed||N/A|9|Actual|University of Southampton|||1||f||||t|f|f||||||||2017-10-10 21:15:22.196086|2017-10-10 21:15:22.196086
NCT03084341|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-03-13|||March 13, 2017|Actual|2017-03-13|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effectiveness of Two Stretching Techniques on Healthy Volunteers With Shortened Hamstrings|Effectiveness of Two Stretching Techniques on Healthy Volunteers With Shortened Hamstrings|Recruiting||N/A|96|Anticipated|Universidad San Jorge||3|||f||||t|f|f||||||Yes||2017-10-10 21:15:22.273067|2017-10-10 21:15:22.273067
NCT03084328|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-12|||January 20, 2012|Actual|2012-01-20|April 2017|2017-04-01|March 10, 2017|Actual|2017-03-10|December 20, 2014|Actual|2014-12-20||Observational|||Vitamin D Replacement in Nonalcoholic Fatty Liver Disease|Vitamin D Replacement in Nonalcoholic Fatty Liver Disease|Completed||N/A|48|Actual|The Cleveland Clinic|||2||f||||f|f|f|||t|||No|No plan to share data, needs HIPPA clearance and specific IRB approval, we did not plan on original data being shared|2017-10-10 21:15:22.376515|2017-10-10 21:15:22.376515
NCT03084315|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-13|||November 15, 2016|Actual|2016-11-15|March 2017|2017-03-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Changes in Biomarkers Associated With Use of Electronic Cigarettes|Changes in Biomarkers Associated With Use of Electronic Cigarettes Among African American Menthol and Nonmenthol Smokers|Recruiting||N/A|300|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:15:22.462638|2017-10-10 21:15:22.462638
NCT03084302|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-13|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|May 31, 2020|Anticipated|2020-05-31|December 31, 2019|Anticipated|2019-12-31||Observational|MoM Health||Monitoring Movement and Health Study|Sedentary Behavior in Pregnancy and Cardiovascular Health: the Monitoring Movement and Health (MoM Health) Study|Recruiting||N/A|120|Anticipated|University of Pittsburgh|||1||f||||f|f|f||||||Yes|Individual participant data will be shared with secondary investigators after the following process. 1) Secondary investigators will submit a proposal to the principal investigator that will be reviewed by all Coinvestigators. 2) If all investigators approve, the secondary investigator will obtain institutional review board approval to conduct the proposed analyses, and 3) a deidentified dataset including only requested variables will be provided to the secondary researcher.|2017-10-10 21:15:22.549565|2017-10-10 21:15:22.549565
NCT03084289|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-05|||March 28, 2017|Actual|2017-03-28|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of Administration|A Phase I Study to Assess the Safety and Immunogenicity of Novel Routes of Administration of Plasmodium Falciparum Malaria Vaccine Candidate ChAd63 Encoding ME-TRAP.|Recruiting||Phase 1|15|Anticipated|University of Oxford||5|||f||||t|f|f||||||No||2017-10-10 21:15:22.640752|2017-10-10 21:15:22.640752
NCT03084276|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-24|||January 16, 2017|Actual|2017-01-16|March 2017|2017-03-01|March 21, 2017|Actual|2017-03-21|March 17, 2017|Actual|2017-03-17||Interventional|||Effect of Meal Composition on the Responses to Meal Ingestion|Factors That Determine the Responses to Meal Ingestion: Meal Composition|Completed||N/A|12|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f|||||f|f||||||||2017-10-10 21:15:22.725157|2017-10-10 21:15:22.725157
NCT03084263|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-23|||May 1, 2017|Anticipated|2017-05-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Arthroscopic Assisted Open Reduction Internal Fixation Versus Open Reduction Internal Fixation in Ankle Fractures|A Comparison Study of Arthroscopic Assisted Open Reduction Internal Fixation (AORIF) Versus Open Reduction Internal Fixation (ORIF) in Ankle Fractures: Does AORIF Improve Functional Outcomes?|Withdrawn||N/A|0|Actual|Spectrum Health Hospitals||2||Withdrawn (No Participants Enrolled)|f||||f|f|f||||||No||2017-10-10 21:15:22.797355|2017-10-10 21:15:22.797355
NCT03084250|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-02|||March 10, 2017|Actual|2017-03-10|May 2017|2017-05-01|December 1, 2023|Anticipated|2023-12-01|April 1, 2023|Anticipated|2023-04-01||Interventional|||The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC|A Prospective, Randomized, Open-label Study of the Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC|Active, not recruiting||Phase 4|150|Anticipated|Shanghai Nanhui Nanhua Hospital||2|||f|||||f|f||||||||2017-10-10 21:15:22.875647|2017-10-10 21:15:22.875647
NCT03084237|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-29|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|August 2021|Anticipated|2021-08-01|January 2021|Anticipated|2021-01-01||Interventional|||Clinical Study to Compare the Efficacy and to Evaluate the Safety and Immunogenicity of Trastuzumab Biosimilar HLX02 and EU-sourced Herceptin® in HER2-Positive, Locally Recurrent or Previously Untreated Metastatic Breast Cancer|Double-blind, Randomized, Multicenter, Phase III Clinical Study to Compare the Efficacy and to Evaluate the Safety and Immunogenicity of Trastuzumab Biosimilar HLX02 and EU-sourced Herceptin® in HER2-Positive, Locally Recurrent or Previously Untreated Metastatic Breast Cancer|Recruiting||Phase 3|608|Anticipated|Shanghai Henlius Biotech||2|||f|||||f|f||||||||2017-10-10 21:15:22.967382|2017-10-10 21:15:22.967382
NCT03084224|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-30|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2017|Anticipated|2017-12-01|8 Years|Observational [Patient Registry]|||Implementation of Molecular Diagnostic Pathways|Implementation of Molecular Diagnostic Pathways in Neurological and Neurodegenerative Diseases|Not yet recruiting||N/A|1|Anticipated|Neuromed IRCCS|||1||f||||f|f|f||||Samples With DNA|"     Samples with Parkinson's Disease   "|No||2017-10-10 21:15:23.059859|2017-10-10 21:15:23.059859
NCT03084211|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-06-27|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Prescribed Light Exercise for ED Patients With MTBI|A Randomized Controlled Trial Comparing Prescribed Light Exercise to Standard Management for Emergency Department Patients With Acute Mild Traumatic Brain Injury.|Recruiting||N/A|300|Anticipated|Mount Sinai Hospital, Canada||2|||f||||t|f|f||||||No|No IDP will be shared with other researchers.|2017-10-10 21:15:23.148263|2017-10-10 21:15:23.148263
NCT03084198|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-04-24|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure|Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure|Not yet recruiting||N/A|16|Anticipated|Shanghai East Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:15:23.235385|2017-10-10 21:15:23.235385
NCT03084185|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-12|||December 2012||2012-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .|Evaluation of the Role of Plasma Biomarkers for Portal Hypertension Progression and Oxidative Damage in Decompensation of Cirrhotic Patient.|Recruiting||N/A|200|Anticipated|University of Modena and Reggio Emilia|||1||f||||f|f|f||||||||2017-10-10 21:15:23.337561|2017-10-10 21:15:23.337561
NCT03084172|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-21|||October 1, 2015|Actual|2015-10-01|March 2017|2017-03-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Observational|SCREENING||Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai|Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai|Recruiting||N/A|2000000|Anticipated|Shanghai Changzheng Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:15:23.423383|2017-10-10 21:15:23.423383
NCT03084159|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-06-15|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Multi-disciplinary Participatory Design of a Process to Deliver a CKD Diagnosis in Primary Care|Multi-disciplinary Participatory Design of a Process to Deliver a CKD Diagnosis in Primary Care|Recruiting||N/A|50|Anticipated|University of Michigan||3|||f||||f|f|f||||||No||2017-10-10 21:15:23.566655|2017-10-10 21:15:23.566655
NCT03084146|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-13|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||The Role of Food Sensitivity in Psoriasis|The Role of Food Sensitivity in Psoriasis: a 12-week Prospective Correlational Study of the Impact of an Individualized Elimination Diet on Disease Severity|Recruiting||N/A|70|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 21:15:23.652008|2017-10-10 21:15:23.652008
NCT03084133|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-05-05|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|June 3, 2019|Anticipated|2019-06-03|May 3, 2018|Anticipated|2018-05-03||Interventional|EDUCANCOLAGE||Impact of EDUcation Strategy on Patients With COLorectal CANCER or Advanced Adenoma in the Detection of Colorectal Cancer of Their First-degree Relatives|Impact of EDUcation Strategy on Patients With COLorectal CANCER or Advanced Adenoma in the Detection of Colorectal Cancer of Their First-degree Relatives - Randomized, Multicenter Cluster Test|Recruiting||N/A|168|Anticipated|University Hospital, Tours||2|||f||||t|f|f||||||||2017-10-10 21:15:23.747077|2017-10-10 21:15:23.747077
NCT03084120|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-13|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2022|Anticipated|2022-08-01||Interventional|SMOOTHIE||Effect of the Maternal Obesity and/or the By-pass on the Growth and the Nutritional Balance of the Child|Effect of the Maternal Obesity and/or the By-pass on the Growth and the Nutritional Balance of the Child|Not yet recruiting||N/A|240|Anticipated|University Hospital, Angers||4|||f||||f|f|f||||||No||2017-10-10 21:15:23.881827|2017-10-10 21:15:23.881827
NCT03084107|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-19|||August 1, 2011||2011-08-01|June 2017|2017-06-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Interventional|||Eldercare Technology in a Silver Culture Village|LES_Cloud - Advanced Eldercare Technology and Creative Space|Completed||N/A|39|Actual|Chang Gung Memorial Hospital||1|||f||||||||||||||2017-10-10 21:15:25.735393|2017-10-10 21:15:25.735393
NCT03083548|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-19|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|May 2025|Anticipated|2025-05-01|May 2025|Anticipated|2025-05-01||Observational|||The Nor-Hand Study|The Nor-Hand Study: An Observational Cohort of Hand Osteoarthritis Patients|Recruiting||N/A|300|Anticipated|Diakonhjemmet Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:15:30.545596|2017-10-10 21:15:30.545596
NCT03084081|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-28|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|UH3||An Innovative Treatment for Cervical Precancer (UH3)|A Randomized Controlled Trial Comparing Cure Rates of Cervical Intraepithelial Neoplasia Grade 2 and Higher (CIN2+) Treated With CO2-based Cryotherapy, CropPen, and Thermoablation (UH3)|Recruiting||N/A|1152|Anticipated|The Cleveland Clinic||3|||f||||t|f|f|||f|||||2017-10-10 21:15:25.895379|2017-10-10 21:15:25.895379
NCT03084068|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-14|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|September 1, 2019|Anticipated|2019-09-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Use of Human Dehydrated Umbilical Cord Allograft in Supraspinatus Tendon Repair|A Prospective, Randomized Controlled Trial for Rotator Cuff Repair - Efficacy of Supraspinatus Tendon Repair Using a Human Dehydrated Umbilical Cord Patch|Enrolling by invitation||N/A|50|Anticipated|MiMedx Group, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:15:26.011509|2017-10-10 21:15:26.011509
NCT03084055|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-03-13|||May 2016||2016-05-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||A Two-arm Intervention Study With Parallel Process Evaluation to Assess the Feasibility, Acceptability and Fidelity of the eMotion Online Intervention for People With Depressive Symptoms.|A Two-arm Intervention Study With Parallel Process Evaluation to Assess the Feasibility, Acceptability and Fidelity of the eMotion Online Intervention for People With Depressive Symptoms.|Recruiting||N/A|120|Anticipated|University of Exeter||2|||f||||f||||||||Undecided||2017-10-10 21:15:26.085313|2017-10-10 21:15:26.085313
NCT03084042|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-13|||July 2016||2016-07-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Emotional Brain Networks & Cognitive Functioning in Depression and Anxiety|Emotional Brain Networks & Cognitive Functioning in Depression and Anxiety|Recruiting||N/A|105|Anticipated|University of Electronic Science and Technology of China|||3||f|||||f|f||||None Retained|"     saliva   "|No||2017-10-10 21:15:26.174834|2017-10-10 21:15:26.174834
NCT03084029|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-03-13|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||The Neural Basis of Oxytocin's Effects on Empathy|The Neural Basis of Oxytocin's Effects on Empathy|Recruiting||Early Phase 1|80|Anticipated|University of Electronic Science and Technology of China||4|||f||||f|f|f||||||No||2017-10-10 21:15:26.276181|2017-10-10 21:15:26.276181
NCT03084016|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-20|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|ABBA||Asthma Breath Biomarker Assessment|Exhaled Breath Biomarkers in Acute Asthma: A Feasibility Study|Recruiting||N/A|100|Anticipated|University of East Anglia|||2||f||||f|f|f||||Samples Without DNA|"     Serum   "|No||2017-10-10 21:15:26.383333|2017-10-10 21:15:26.383333
NCT03084003|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-13|||February 18, 2016|Actual|2016-02-18|March 2017|2017-03-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||Effects of Almond Consumption on Cardiovascular, Metabolomic, and Microbiome Profiles in Millennials|Effects of Almond Consumption on Cardiovascular, Metabolomic, and Microbiome Profiles in Millennials: Implications of Systemic Glucoregulatory Mechanisms|Active, not recruiting||N/A|74|Anticipated|University of California, Merced||2|||f||||f|f|f||||||No||2017-10-10 21:15:26.466995|2017-10-10 21:15:26.466995
NCT03083990|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2017-03-17|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||Compare IBI305 and Bevacizumab on Pharmacokinetics/Safety/Immunogenicity on Healthy Male|Compare IBI305 to Avastin on the Pharmacokinetics, Safety, Tolerance and Immunogenicity of a Single Dose In Healthy Male Subjects: a Randomized Double-blind Parallel Controlled Phase I Clinical Study|Recruiting||Phase 1|100|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:15:26.715463|2017-10-10 21:15:26.715463
NCT03083977|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-15|||June 22, 2017|Actual|2017-06-22|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Examining the Effects of Processed Music on Chronic Pain|Examining the Effects of Processed Music on Chronic Pain|Recruiting||N/A|40|Anticipated|Indiana University||1|||f||||f|f|f||||||||2017-10-10 21:15:26.84102|2017-10-10 21:15:26.84102
NCT03083964|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-13|||January 18, 2017|Actual|2017-01-18|March 2017|2017-03-01|September 30, 2020|Anticipated|2020-09-30|December 31, 2019|Anticipated|2019-12-31||Interventional|APP-ME||Addressing Place and People Micro Environments in Weight Loss Disparities|APP-ME: Addressing Place and People MicroEnvironments in Weight Loss Disparities|Recruiting||N/A|300|Anticipated|Indiana University||2|||f||||f|f|f||||||No||2017-10-10 21:15:26.936503|2017-10-10 21:15:26.936503
NCT03083951|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-24|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|CMELL||Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)|Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)|Not yet recruiting||Phase 4|84|Anticipated|Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta||2|||f||||t|f|f||||||||2017-10-10 21:15:27.041988|2017-10-10 21:15:27.041988
NCT03083938|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-28|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Trial of Omental Roll-up Technique on Pancreato-jejunostomy Anastomosis for Reducing Perioperative Complication in Patients Undergoing Pancreatoduodenectomy|Prospective Randomized Controlled Trial of Omental Roll-up Technique on Pancreato-jejunostomy Anastomosis for Reducing Perioperative Complication in Patients Undergoing Pancreatoduodenectomy|Recruiting||N/A|60|Anticipated|Mahidol University||2|||f||||f|f|f||||||||2017-10-10 21:15:27.130059|2017-10-10 21:15:27.130059
NCT03083925|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-13|||May 23, 2016|Actual|2016-05-23|March 2017|2017-03-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2017|Anticipated|2017-06-01||Observational|VIATORR-CX||Viatorr CX Case-control Study for Complications of Portal Hypertension|Viatorr Control Expansion Compared to Bare-metal and Regular Viatorr for Complications of Portal Hypertension|Recruiting||N/A|40|Anticipated|University Hospital, Bonn|||3||f||||f|f|f||||Samples With DNA|"     blood, stool, DNA   "|No||2017-10-10 21:15:27.234948|2017-10-10 21:15:27.234948
NCT03083912|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-20|||March 2016||2016-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01|3 Months|Observational [Patient Registry]|PROT-e-GER||Effect of High Protein, High-calorie Oral Nutritional Supplementation in Malnourished Elderly in Nursing Homes.|Effect of High Protein, High-calorie Nutritional Supplementation in Malnourished Elderly in Nursing Homes. A Prospective, Observational, Multicentric Study (PROT-e-GER Study)|Recruiting||N/A|285|Anticipated|Hospital Viamed Valvanera, Spain|||1||f||||f||||||||||2017-10-10 21:15:27.321886|2017-10-10 21:15:27.321886
NCT03083899|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-20|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|September 30, 2019|Anticipated|2019-09-30||Interventional|DiaTast||The Diabetes Patient Takes Responsibility|DiaTast - Patient Reported Experience in a New Out-patient Structure.|Recruiting||N/A|500|Anticipated|Hospital of South West Jutland||2|||f||||f|f|f||||||||2017-10-10 21:15:27.428511|2017-10-10 21:15:27.428511
NCT03083886|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-20|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|March 1, 2020|Anticipated|2020-03-01|January 1, 2019|Anticipated|2019-01-01||Interventional|SPINE CARE||Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure|Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure - Randomized Clinical Trial|Recruiting||N/A|3096|Anticipated|Brigham and Women's Hospital||3|||f|||||f|f||||||||2017-10-10 21:15:27.532406|2017-10-10 21:15:27.532406
NCT03083873|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-17|||January 9, 2017|Actual|2017-01-09|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of LN-145 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck|A Phase 2 Study to Evaluate the Safety and Efficacy of Cell Transfer Therapy Using Autologous Tumor Infiltrating Lymphocytes (LN-145) Followed by IL-2 in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 2|47|Anticipated|Iovance Biotherapeutics, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:15:27.625015|2017-10-10 21:15:27.625015
NCT03083860|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-15|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.|Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.|Not yet recruiting||N/A|100|Anticipated|Brainmarc Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:27.712605|2017-10-10 21:15:27.712605
NCT03083847|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-07-26|||June 5, 2017|Actual|2017-06-05|July 17, 2017|2017-07-17|June 15, 2018|Anticipated|2018-06-15|December 30, 2017|Anticipated|2017-12-30||Interventional|||Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Trial to Determine Safety and Development of Protective Efficacy After Exposure to Only Pre-erythrocytic Stages of Plasmodium Falciparum|Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Dose Escalation Trial to Determine Safety and Development of Protective Efficacy After Exposure to Only Pre-erythrocytic Stages of Plasmodium Falciparum|Recruiting||Phase 1|230|Anticipated|National Institutes of Health Clinical Center (CC)||4|||t|||||t|f||||||||2017-10-10 21:15:27.784321|2017-10-10 21:15:27.784321
NCT03083834|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-21|||March 14, 2017|Actual|2017-03-14|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients|Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients|Recruiting||N/A|50|Anticipated|Bnai Zion Medical Center||3|||f||||f|f|f||||||||2017-10-10 21:15:27.885129|2017-10-10 21:15:27.885129
NCT03083808|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-08-08|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase II Trial of Continuation Therapy in Advanced NSCLC|A Phase II Trial of Chemotherapy Plus Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Previously Treated With PD-1 or PD-L1 Inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029|Recruiting||Phase 2|35|Anticipated|Big Ten Cancer Research Consortium||1|||f||||t|t|f|||t|||||2017-10-10 21:15:28.05703|2017-10-10 21:15:28.05703
NCT03083795|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-17|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Social Relationships on Psychological Distress and Disease Progression in Patients With Diabetes|Evaluating the Effectiveness of Social Relationships on Psychological Distress and Disease Progression in Patients With Diabetes: A Randomized Controlled Trial|Not yet recruiting||N/A|48|Anticipated|BCDiabetes.Ca||2|||f||||f|f|f||||||Undecided|At the end of the study, anonymized participant data may be shared with other researchers wishing to undergo similar studies to assist with study design and implementation.|2017-10-10 21:15:28.169427|2017-10-10 21:15:28.169427
NCT03083769|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-13|||January 2007||2007-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation and Liver Transplantation.||Recruiting||N/A|1500|Anticipated|Southern Medical University, China|||4||f||||f|f|f||||Samples With DNA|"     Human genomic DNA was extracted from leukocytes in patients' peripheral blood.   "|No||2017-10-10 21:15:28.378773|2017-10-10 21:15:28.378773
NCT03083756|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-13|||August 2014||2014-08-01|March 2017|2017-03-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Observational|SIMPLICITY||Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients|Prospective Observational Study for the Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients|Completed||N/A|577|Actual|Sociedad Española de Trasplante|||1||f||||f||||||||No||2017-10-10 21:15:28.562787|2017-10-10 21:15:28.562787
NCT03083743|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-13|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection|A Randomized, Double-blind, Placebo-controlled in Parallel, Multicenter Phase III Trial of Recombinant Human Apo-2 Ligand for Injection（Dulanermin for Injection）in the Treatment of Advanced Non-small Cell Lung Cancer|Active, not recruiting||Phase 3|417|Actual|Shanghai Gebaide Biotechnology Co., Ltd.||2|||f||||t|f|f|||f|||||2017-10-10 21:15:28.714694|2017-10-10 21:15:28.714694
NCT03083730|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-07-19|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis|Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis|Recruiting||N/A|40|Anticipated|Rockefeller University||1|||f||||f|f|f||||||||2017-10-10 21:15:28.839373|2017-10-10 21:15:28.839373
NCT03083717|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-13|||April 20, 2017|Anticipated|2017-04-20|March 2017|2017-03-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|||Application of Nanotechnology and Chemical Sensors for Diagnosis of Decompensated Heart Failure by Respiratory Samples|Application of Nanotechnology and Chemical Sensors for Diagnosis of Decompensated Heart Failure by Respiratory Samples|Not yet recruiting||N/A|150|Anticipated|Rambam Health Care Campus|||3||f||||f|f|f||||||No||2017-10-10 21:15:28.949981|2017-10-10 21:15:28.949981
NCT03083704|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-06|||February 26, 2017|Actual|2017-02-26|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa|A Phase 1 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Second Generation Andexanet Alfa Administered to Healthy Subjects|Active, not recruiting||Phase 1|153|Actual|Portola Pharmaceuticals||11|||f||||f|t|f||||||||2017-10-10 21:15:29.049977|2017-10-10 21:15:29.049977
NCT03083691|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-11|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|March 2019|Anticipated|2019-03-01||Interventional|||BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer|A Phase II Trial of Nivolumab in Combination With Ipilimumab to Evaluate Efficacy and Safety Relapsed in Lung Cancer and to Evaluate Biomarkers Predictive for Response to Immune Checkpoint Inhibition|Enrolling by invitation||Phase 2|106|Anticipated|Lung Cancer Group Cologne||2|||f||||t|f|f||||||No||2017-10-10 21:15:29.175511|2017-10-10 21:15:29.175511
NCT03083678|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Afatinib in Locally Advanced and Metastatic Chordoma|A Phase 2, Single Arm, European Multi-center Trial Evaluating the Efficacy of Afatinib as First-line or Later-line Treatment in Advanced Chordoma.|Not yet recruiting||Phase 2|40|Anticipated|Leiden University Medical Center||1|||f||||f|f|f|||f|||||2017-10-10 21:15:29.267932|2017-10-10 21:15:29.267932
NCT03083652|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-08|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients|Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients|Recruiting||N/A|40|Anticipated|Hospital Clinic of Barcelona||2|||f|||||f|f|||f|||||2017-10-10 21:15:29.533445|2017-10-10 21:15:29.533445
NCT03083639|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-16|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|May 13, 2017|Actual|2017-05-13|May 13, 2017|Actual|2017-05-13||Interventional|||A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy Participants|A Phase 1, Randomized, Open-label, 2-way Cross-over Study to Evaluate the Bioequivalence Between a Single Oral Dose of Esomeprazole 40 mg Capsules and Esomeprazole 40 mg Tablets in Healthy Subjects|Completed||Phase 1|52|Anticipated|Takeda||2|||f||||f|t|f|||f|||||2017-10-10 21:15:29.667491|2017-10-10 21:15:29.667491
NCT03083626|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-18|||May 1, 2015|Actual|2015-05-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||The Effects of Water Temperature on the Cold Pressor Test|The Effects of Water Temperature on the Cold Pressor Test in Patients With Opioid-Induced Hyperalgesia in Comparison to Healthy Controls|Completed||N/A|20|Actual|Georgetown University|||2||f|||||f|f||||||No||2017-10-10 21:15:29.798872|2017-10-10 21:15:29.798872
NCT03083613|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-14|||May 2015||2015-05-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma|Phase II Trial of Raltitrexed and Paclitaxel as Second-line Chemotherapy for Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|Recruiting||Phase 2|40|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||No||2017-10-10 21:15:29.905861|2017-10-10 21:15:29.905861
NCT03083600|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-06-19|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Protein Hydrolysates on HbA1c Levels in Pre-diabetics|A Randomized, Double-blind, Placebo-controlled, Study to Assess Efficacy and Safety of Protein Hydrolysates in the Reduction and Maintenance of HbA1c Levels in a Pre-diabetic Population|Recruiting||N/A|56|Anticipated|Atlantia Food Clinical Trials||7|||f||||f|f|f||||||No||2017-10-10 21:15:30.017058|2017-10-10 21:15:30.017058
NCT03083587|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-05|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|FABS||Frequent Activity Snacks Breaks|Frequent Activity Snacks Breaks - Interrupting Sedentary Behaviour|Recruiting||N/A|20|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||No||2017-10-10 21:15:30.153931|2017-10-10 21:15:30.153931
NCT03083574|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-03-13|||September 2014||2014-09-01|March 2017|2017-03-01|September 2023|Anticipated|2023-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)|A Phase II Study to Assess the Safety and the Efficacy of Extracorporeal Photopheresis Using the Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)|Recruiting||Phase 2|100|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-10 21:15:30.267552|2017-10-10 21:15:30.267552
NCT03083561|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-23|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||A Study of LY3337641 in Japanese and Caucasian Healthy Participants|A Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3337641 in Japanese and Caucasian Healthy Subjects|Completed||Phase 1|50|Actual|Eli Lilly and Company||4|||f||||f|t|f||||||||2017-10-10 21:15:30.4479|2017-10-10 21:15:30.4479
NCT03083535|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-17|||January 2016||2016-01-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy of AloeVera Gel Gum Massaging and Adjunct to Scaling and Root Planing in Chronic Periodontitis Patients|To Evaluate the Efficacy of Aloe Vera Gel in Gingival Massaging and as an Adjunct to Scaling and Root Planing in Patients With Chronic Periodontitis|Active, not recruiting||N/A|120|Anticipated|Government College of Dentistry, Indore||3|||f||||t||||||||Undecided||2017-10-10 21:15:30.657842|2017-10-10 21:15:30.657842
NCT03083522|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-17|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|OJS||Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and Feet|Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and Feet - A Randomized, Double-blinded, Placebo Controlled, Multi-center Pilot Study|Not yet recruiting||Phase 3|60|Anticipated|Gachon University Gil Oriental Medical Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:15:30.766572|2017-10-10 21:15:30.766572
NCT03083509|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-07-31|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|July 29, 2016|Actual|2016-07-29|July 29, 2016|Actual|2016-07-29||Interventional|||A Physiological Profile of Recovery From Resistance, Endurance, and Mixed Exercise Types|A Physiological Profile of Recovery From Mechanical, Metabolic, and Mixed Exercise Stressors|Completed||N/A|24|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 21:15:30.851938|2017-10-10 21:15:30.851938
NCT03083496|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-14|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|June 2017|Anticipated|2017-06-01||Interventional|||Clinical Evaluation of Different Potassium Oxalate Concentrations in Dentin Hypersensitivity Treatment|Clinical Evaluation of Different Potassium Oxalate Concentrations in Dentin: A Randomized Clinical Trial|Recruiting||N/A|32|Anticipated|Federal University of Uberlandia||2|||f||||f|f|f||||||No||2017-10-10 21:15:30.943589|2017-10-10 21:15:30.943589
NCT03083483|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-11|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Utilizing Transcranial Direct Current Stimulation and Gaze Training to Enhance Laparoscopic Technical Skills Training|Utilizing Transcranial Direct Current Stimulation and Gaze Training to Enhance Laparoscopic Technical Skills Training|Recruiting||N/A|249|Anticipated|Duke University||10|||f|||||f|t|f||f|||||2017-10-10 21:15:31.025394|2017-10-10 21:15:31.025394
NCT03083470|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-19|||May 18, 2017|Actual|2017-05-18|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of SOR007 Ointment for Actinic Keratosis|Phase 2 Dose-Rising Study of SOR007 Ointment for Actinic Keratosis|Recruiting||Phase 2|32|Anticipated|DFB Soria, LLC||5|||f||||f|t|f||||||No||2017-10-10 21:15:31.150359|2017-10-10 21:15:31.150359
NCT03083457|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-20|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PEEP-RM||Physiological Effects of Lung Recruitment During General Anesthesia and Low-tidal Volume Ventilation|Physiological Effects of Positive End-expiratory Pressure With or Without Recruiting Maneuvers in Patients Receiving Low-tidal Volume Ventilation During General Anesthesia for Open Abdominal Surgery. A Randomized, Cross-over Study|Recruiting||N/A|30|Anticipated|Catholic University of the Sacred Heart||6|||f||||f|f|f||||||Undecided||2017-10-10 21:15:31.409889|2017-10-10 21:15:31.409889
NCT03083444|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-17|||April 15, 2017|Anticipated|2017-04-15|March 2017|2017-03-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Observational|||P Gingivalis Oral Infection, Intimamedia Thickening in Infants, Atherosclerosis|Early P Gingivalis Oral Infection and Ultrasound Detection of Intimamedia Thickening in Radial Arteries of Young Children|Not yet recruiting||N/A|30|Anticipated|Creighton University|||1||f||||t|f|f||||||No||2017-10-10 21:15:31.572755|2017-10-10 21:15:31.572755
NCT03083431|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-13|||January 2018|Anticipated|2018-01-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|May 2020|Anticipated|2020-05-01||Interventional|ROPROP||Propranolol for Prevention of Threshold Retinopathy of Prematurity|Propranolol for Prevention of Threshold Retinopathy of Prematurity|Not yet recruiting||Phase 2|276|Anticipated|Charite University, Berlin, Germany||2|||f||||t|t|f|||f|||Yes|Anonymized data set containing gestational age, birth weight, gender, intervention (propranolol or placebo), outcome (retinopathy of prematurity, maximum stage), date and type of treatment for retinopathy if any|2017-10-10 21:15:31.654753|2017-10-10 21:15:31.654753
NCT03083418|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-03-13|||October 2016||2016-10-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effect of EDP on Diaphragmatic Function and Neural Respiratory Drive in Patient With AECOPD|The Effect of External Diaphragmatic Pacemaker(EDP) on Diaphragmatic Function and Neural Respiratory Drive in Patient With Acute Exacerbation of Chronic Obstructive Pulmonary Disease(AECOPD)|Recruiting||N/A|40|Anticipated|Zhujiang Hospital||2|||f||||t||||||||No||2017-10-10 21:15:31.74694|2017-10-10 21:15:31.74694
NCT03083405|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-05-08|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|||Evaluation of Selected Disorders With Sleep Bruxism|Evaluation of the Quality of Sleep, Endothelial Function, Cardiovascular Risk, Thyroid Function, a Function of Masticatory Muscles and Psycho-emotional State of Patients With Sleep Bruxism|Enrolling by invitation||N/A|100|Anticipated|Wroclaw Medical University|||4||f||||f|t|f|||f|||Undecided||2017-10-10 21:15:31.85781|2017-10-10 21:15:31.85781
NCT03083392|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-13|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Endosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis|Endosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis|Not yet recruiting||N/A|20|Anticipated|Western Galilee Hospital-Nahariya||1|||f||||f||||||||||2017-10-10 21:15:31.977255|2017-10-10 21:15:31.977255
NCT03083379|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-23|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|||Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy|A Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy in Healthy Adult Human Subjects|Completed||N/A|30|Actual|University of Virginia||2|||f||||f|f|f||||||No||2017-10-10 21:15:32.082481|2017-10-10 21:15:32.082481
NCT03083366|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-03-13|||September 1, 2016|Actual|2016-09-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||Sacral Nerve Stimulation in Improving Bladder After Acute Traumatic Spinal Cord Injury|The Effectiveness of Early Sacral Nerve Stimulation in Improving Bladder- Related Complications and Quality of Life After Acute Traumatic Spinal Cord Injury|Active, not recruiting||N/A|60|Anticipated|University of Utah||2|||f||||t||||||||No||2017-10-10 21:15:32.196853|2017-10-10 21:15:32.196853
NCT03083353|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-05-01|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Enhancing Cue Exposure Treatment for Smoking Reduction With Isradipine|Enhancing Cue Exposure Treatment for Smoking Reduction With Isradipine|Recruiting||Early Phase 1|60|Anticipated|University of Texas at Austin||2|||f||||f|t|f|||f|||No||2017-10-10 21:15:32.319193|2017-10-10 21:15:32.319193
NCT03083340|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-05-01|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Implementation of a Self-Help Depression Program Among Orthopedic Patients|Implementation of a Self-Help Depression Program Among Orthopedic Patients|Recruiting||N/A|50|Anticipated|University of Texas at Austin||1|||f||||f|f|f||||||No||2017-10-10 21:15:32.432182|2017-10-10 21:15:32.432182
NCT03083327|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-08|||July 30, 2017|Anticipated|2017-07-30|May 2017|2017-05-01|May 1, 2022|Anticipated|2022-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|||Prophylactic Early PN in HPT/BMT|Prophylactic Early Parenteral Nutrition in Patients Undergoing Hematopoietic Cell Transplantation: A Multi-centre Randomised Controlled Trial.|Not yet recruiting||N/A|408|Anticipated|University of Sydney||2|||f||||t|f|f||||||Undecided||2017-10-10 21:15:32.524433|2017-10-10 21:15:32.524433
NCT03083314|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-17|||June 12, 2014|Actual|2014-06-12|March 2017|2017-03-01|June 2, 2017|Anticipated|2017-06-02|June 2, 2017|Anticipated|2017-06-02||Interventional|||Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment|SELECTIVE AXILLARY LYMPH NODE DISSECTION VS COMPLETE AXILLARY DISSECTION: A RANDOMISED CLINICAL TRIAL TO ASSESS THE PREVENTION OF LYMPHEDEMA IN BREAST CANCER TREATMENT|Recruiting||N/A|158|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f|f|f||||||No||2017-10-10 21:15:32.608152|2017-10-10 21:15:32.608152
NCT03083301|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-13|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Cardiac Resynchronization Therapy: Relevance of the Surgical Approach in the Implantation of the Left Ventricular Probe|Cardiac Resynchronization Therapy: Relevance of the Surgical Approach in the Implantation of the Left Ventricular Probe|Not yet recruiting||N/A|155|Anticipated|Brugmann University Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:15:32.700708|2017-10-10 21:15:32.700708
NCT03083288|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-03-14|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01||||February 22, 2019|Anticipated|2019-02-22||Interventional|||Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer|Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer|Recruiting||Phase 1|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t|t|f||||||||2017-10-10 21:15:32.794928|2017-10-10 21:15:32.794928
NCT03083275|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-13|||January 3, 2016|Actual|2016-01-03|March 2017|2017-03-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|TRANS2||Resistance Training in Older Adults With Limitations in Mobility|An Exploratory Study to Evaluate the Relationship Between Measures of Lower-extremity Peak Torque, Velocity, Power, Fatigue, and Measures of Physical Function in Response to Resistance Training in Older Adults With Limitations in Mobility|Completed||N/A|70|Actual|Tufts University||2|||f||||f|f|f||||||No||2017-10-10 21:15:32.879936|2017-10-10 21:15:32.879936
NCT03083262|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-05|||January 31, 2017|Actual|2017-01-31|September 2017|2017-09-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Observational|||High Tone Pelvic Floor Dysfunction|Retrospective Chart Review to Investigate an Association Between Vulvovaginal Atrophy and High Tone Pelvic Floor Dysfunction (HTPFD)|Completed||N/A|80|Actual|St. Louis University|||1||f||||f|f|f||||||||2017-10-10 21:15:32.946674|2017-10-10 21:15:32.946674
NCT03083249|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-17|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Gardasil Knowledge|Gardasil Anonymous Survey|Enrolling by invitation||N/A|100|Anticipated|St. Louis University|||1||f||||f|f|f||||||||2017-10-10 21:15:33.013854|2017-10-10 21:15:33.013854
NCT03083223|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-13|||May 12, 2013|Actual|2013-05-12|March 2017|2017-03-01|September 15, 2015|Actual|2015-09-15|December 10, 2013|Actual|2013-12-10||Observational|||Positions and Peripheral Oxygen Saturation|Comparison of Five Different Positions on Peripheral Oxygen Saturation and Vital Signs in Patients With Lung Disease|Completed||N/A|109|Actual|Ege University|||1||f||||f|f|f||||||Yes|The subjects were placed consecutively in random order in the five different positions, SSPB-45°, SSPB-60°, SPB-90°, LRSB-45°, and LLSB-45°, by drawing lots. Oxygen saturation (SaO2) and vital signs (pulse rate, respiratory rate, systolic blood pressure, diastolic blood pressure and body temperature) were measured in each position at 10, 25 and 40 minutes. Oxygen saturation and vital signs were measured with a finger pulse oximeter|2017-10-10 21:15:33.153884|2017-10-10 21:15:33.153884
NCT03083210|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-16|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET||Active, not recruiting||Phase 4|28|Anticipated|Samsung Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:15:33.229761|2017-10-10 21:15:33.229761
NCT03083197|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-05-08|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|START||Scrub Typhus Antibiotic Resistance Trial|The Scrub Typhus Antibiotic Resistance Trial (START) Comparing Doxycycline and Azithromycin Treatment Modalities in Areas of Reported Antimicrobial Resistance for Scrub Typhus|Not yet recruiting||Phase 4|177|Anticipated|University of Oxford||3|||f||||f|f|f|||f|||Undecided||2017-10-10 21:15:33.304574|2017-10-10 21:15:33.304574
NCT03083184|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-17|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Interventional|ETERNITY||"Evaluation of the Efficacy of an inTerdialytic Ethanol 40% v/v - enoxapaRin 1000 U/mL Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients"|"Evaluation of the Efficacy of an inTerdialytic Ethanol 40% v/v - enoxapaRin 1000 U/mL Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients: a mulTi-centre, Randomized, Single Blind, Parallel Group studY (ETERNITY)"|Not yet recruiting||Phase 3|400|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:15:33.422936|2017-10-10 21:15:33.422936
NCT03083171|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-20|||January 4, 2017|Actual|2017-01-04|March 2017|2017-03-01|June 25, 2017|Anticipated|2017-06-25|June 25, 2017|Anticipated|2017-06-25||Interventional|||Adrecizumab-LPS Study|A Randomized Double-blind Placebo-controlled Phase I Study on the Safety, Tolerability and Pharmacokinetics/-Dynamics of Escalating Single Intravenous Doses of ADRECIZUMAB (HAM8101) in Healthy Male Subjects During Experimental Endotoxemia.|Active, not recruiting||Phase 1|24|Actual|Adrenomed AG||4|||f||||t|f|f||||||Undecided||2017-10-10 21:15:33.553163|2017-10-10 21:15:33.553163
NCT03083158|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-13|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HVP01||Immunity to Hepatitis B Vaccine|Identification of Age-dependent Mechanism of Vaccine-induced Immunity to a Single Dose of Hepatitis B Vaccine Using a Systems Biology Approach - a Demonstration Project|Recruiting||Phase 4|20|Anticipated|University of British Columbia||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:33.649647|2017-10-10 21:15:33.649647
NCT03083145|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-13|||February 1, 2016|Actual|2016-02-01|March 2017|2017-03-01|June 1, 2016|Actual|2016-06-01|May 15, 2016|Actual|2016-05-15||Interventional|||Protein Source, Nutrition Messaging, and Food Intake|Evaluating How Breakfast Protein Source Affects Satiety, Glucose and Food Preference|Completed||N/A|40|Actual|University of Arkansas, Fayetteville||2|||f||||f|f|f||||||No||2017-10-10 21:15:33.76747|2017-10-10 21:15:33.76747
NCT03083132|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-28|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|April 30, 2018|Anticipated|2018-04-30||Interventional|||Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)|Modafinil as a Novel Therapy for the Treatment of Freezing of Gait in Parkinson's Disease|Enrolling by invitation||Early Phase 1|20|Anticipated|University of Arkansas||2|||f|||||t|f||||||||2017-10-10 21:15:33.851728|2017-10-10 21:15:33.851728
NCT03083119|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-13|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|August 20, 2017|Anticipated|2017-08-20|April 20, 2017|Anticipated|2017-04-20||Interventional|||Efficacy and Safety of Xuesaitong Soft Capsule for Coronary Heart Disease Unstable Angina|The Methylation Regulation Mechanism of Blood Stasis Relevant miRNA Expression on Coronary Heart Disease|Recruiting||Phase 2|70|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:33.925571|2017-10-10 21:15:33.925571
NCT03083106|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-12|||March 3, 2017||2017-03-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:15:34.020102|2017-10-10 21:15:34.020102
NCT03083093|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-04|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|September 1, 2018|Anticipated|2018-09-01|April 1, 2018|Anticipated|2018-04-01||Observational|InShapeIII||CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients|Identification of CTEPH on Standard Computerised Tomography Pulmonary Angiography Performed in the Work-up of Suspected Pulmonary Embolism|Recruiting||N/A|100|Anticipated|Leiden University Medical Center|||2||f||||f|f|f||||||Undecided|this has to be planned|2017-10-10 21:15:34.06647|2017-10-10 21:15:34.06647
NCT03083080|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-20|||March 27, 2017|Anticipated|2017-03-27|February 2017|2017-02-01|March 26, 2019|Anticipated|2019-03-26|March 26, 2019|Anticipated|2019-03-26||Interventional|||VATS Block for Uniportal Video-assisted Thoracoscopic Surgery|Ultrasound-guided Peripheral Nerve Block for Non-intubated Uniportal Video-assisted Thoracoscopic Surgery|Not yet recruiting||N/A|30|Anticipated|Taipei Medical University WanFang Hospital||1|||f|||||f|f||||||||2017-10-10 21:15:34.175812|2017-10-10 21:15:34.175812
NCT03083067|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-16|||March 10, 2016|Actual|2016-03-10|March 2017|2017-03-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|SIRCAP||Salvational Intervention for Reducing AECOPD Under Severe Air Pollution|A Prospective Study of Salvational Intervention With ICS/LABA for Reducing Chronic Obstructive Pulmonary Disease Exacerbation Under Severe Air Pollution (SIRCAP) in Beijing|Recruiting||N/A|764|Anticipated|Peking University First Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:15:34.262457|2017-10-10 21:15:34.262457
NCT03083054|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-16|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia|Cellular Immunotherapy as a Treatment Option for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Campinas, Brazil||1|||f||||t|f|f||||||No||2017-10-10 21:15:34.425192|2017-10-10 21:15:34.425192
NCT03083041|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-13|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|August 31, 2018|Anticipated|2018-08-31|February 27, 2018|Anticipated|2018-02-27||Interventional|||A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)|A Phase II Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung|Not yet recruiting||Phase 2|118|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:34.495298|2017-10-10 21:15:34.495298
NCT03083028|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-12|||August 2010||2010-08-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|CROSSBAT 5Y||Combined Randomised and Observational Study of Surgery for Type B Ankle Fracture Treatment|Combined Randomised and Observational Study of Surgery for Type B Ankle Fracture Treatment|Active, not recruiting||N/A|160|Actual|The University of New South Wales||2|||f||||f|f|f||||||||2017-10-10 21:15:34.604472|2017-10-10 21:15:34.604472
NCT03083015|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-19|||December 6, 2012|Actual|2012-12-06|March 2017|2017-03-01|December 2, 2015|Actual|2015-12-02|December 2, 2015|Actual|2015-12-02||Interventional|RCT||Pulp Revascularization Versus MTA Apexification|A Comparative Study Between Pulp Revascularization and MTA Apexification in Necrotic Immature Anterior Teeth, A Randomized Controlled Trial|Completed||N/A|66|Actual|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 21:15:34.67001|2017-10-10 21:15:34.67001
NCT03083002|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-12|||May 2013||2013-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis|Study of Hepatocellular Carcinoma Risk in Patient With Liver Cirrhosis|Recruiting||N/A|250|Anticipated|University of Modena and Reggio Emilia|||1||f||||f|f|f||||Samples With DNA|"     Liver tissue   "|||2017-10-10 21:15:34.754317|2017-10-10 21:15:34.754317
NCT03082989|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-10|||March 13, 2017|Actual|2017-03-13|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30|1 Day|Observational [Patient Registry]|ERIS||Evolving Routine Standards of FFR Use|Prospective Study Evaluating the Routine Standard Use of Fractional Flow Reserve and Disagreement With Guideline Recommendations: a Nationwide Study|Recruiting||N/A|832|Anticipated|University Hospital of Ferrara|||2||f||||f|f|f||||||||2017-10-10 21:15:34.829154|2017-10-10 21:15:34.829154
NCT03082976|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-10-04|||July 16, 2017|Actual|2017-07-16|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|PREDICT||Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region|PREDICT: Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region. A Prospective, Multi-centre, Epidemiological Observational Study Designed to Evaluate the Prevalence of BRCA1 and BRCA2 Mutations in Current and Newly Diagnosed Ovarian Cancer Patients Across Different Countries in the Gulf Region. This Study Study Will Also Describe the Epidemiological Features for the Disease for the Enrolled Patients.|Recruiting||N/A|120|Anticipated|AstraZeneca|||1||f||||f|f|f||||||||2017-10-10 21:15:35.055042|2017-10-10 21:15:35.055042
NCT03082963|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-02|||April 4, 2017|Actual|2017-04-04|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation|Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation|Recruiting||N/A|10|Anticipated|University of Miami||1|||f||||t|f|t|f|f||||No||2017-10-10 21:15:35.138089|2017-10-10 21:15:35.138089
NCT03082950|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-19|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||HPV Infections, Cancer of the Vulva and Therapeutical Success|Influence of Hpv Infections on Therapeutical Outcome of Patients Suffering From Vulvar Cancer and Ist Preinvasive Lesions|Recruiting||N/A|100|Anticipated|University of Luebeck|||2||f||||f|f|f||||Samples With DNA|"     Tumor tissue samples are analyzed according to their hpv status   "|||2017-10-10 21:15:35.231204|2017-10-10 21:15:35.231204
NCT03082937|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-13|||January 31, 2017|Actual|2017-01-31|March 2017|2017-03-01|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Interventional|||An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects|An Open Label, Single-Dose, Single Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-A4250 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Albireo||1|||f||||f|f|f||||||||2017-10-10 21:15:35.333102|2017-10-10 21:15:35.333102
NCT03082924|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-03-10|||July 2016||2016-07-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||Surface EMGdi Evaluate the Efficacy of Pulmonary Rehabilitation in Patients With COPD: a Multi Center Prospective Study|Surface Diaphragm EMG Evaluate the Clinical Efficacy of Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease: a Multi Center Prospective Randomized Controlled Study|Recruiting||N/A|500|Anticipated|Zhujiang Hospital||4|||f||||t||||||||Undecided||2017-10-10 21:15:35.416476|2017-10-10 21:15:35.416476
NCT03082911|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-20|||March 13, 2017|Actual|2017-03-13|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||A Telephone Intervention to Improve Participation in a Screening Program.|Effectiveness of a Brief Telephone Intervention to Improve Participation in a Colorectal Cancer Screening Program: a Randomized Controlled Trial|Active, not recruiting||N/A|432|Actual|Corporacion Parc Tauli||2|||f||||f|f|f||||||||2017-10-10 21:15:35.530968|2017-10-10 21:15:35.530968
NCT03082898|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-07|||November 2016||2016-11-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1)|Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1)|Recruiting||N/A|24|Anticipated|Vanderbilt University||2|||f||||t||||||||Yes||2017-10-10 21:15:35.623856|2017-10-10 21:15:35.623856
NCT03082885|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-12|||March 18, 2017|Anticipated|2017-03-18|March 2017|2017-03-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF.|A Randomized Controlled Trial to Evaluate Efficacy and Safety of Thymosin-α1 Administration in Patients With HBV-related Acute-on-chronic Liver Failure|Not yet recruiting||N/A|120|Anticipated|Sun Yat-sen University||2|||f|||||f|f||||||No||2017-10-10 21:15:35.745564|2017-10-10 21:15:35.745564
NCT03082872|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-12|||January 1, 2009|Actual|2009-01-01|March 2017|2017-03-01|January 30, 2015|Actual|2015-01-30|January 30, 2015|Actual|2015-01-30||Interventional|||Cemented K-wire Fixation vs Open Transfixion Pinning|Randomized Comparison Between Cemented K-wire Fixation vs Open Transfixion Pinning for the Treatment of Shaft Fractures of Middle Phalanges|Completed||N/A|98|Actual|The Second Hospital of Qinhuangdao||2|||f||||t|f|f||||||No|No plan to share the IPD data|2017-10-10 21:15:35.831342|2017-10-10 21:15:35.831342
NCT03082859|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-03-10|||July 2016||2016-07-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Acute Exercise and Free-living Glycaemic Control in Type 2 Diabetes|A Comparison of the Acute Impact of High-intensity Interval Training, Reduced-exertion High-intensity Interval Training and Moderate-intensity Continuous Aerobic Exercise on Free-living Glycaemic Control in Type 2 Diabetes|Recruiting||N/A|14|Anticipated|University of Ulster||4|||f||||f||||||||No||2017-10-10 21:15:35.917492|2017-10-10 21:15:35.917492
NCT03082833|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-12|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy|Samsung Medical Center|Active, not recruiting||Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:15:36.132162|2017-10-10 21:15:36.132162
NCT03082820|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-17|||February 3, 2015||2015-02-03|March 2017|2017-03-01|November 5, 2016|Actual|2016-11-05|November 5, 2016|Actual|2016-11-05||Observational|||Pain-related Evoked Potentials in Unilateral Peripheral Nerve Injuries|Evaluation of Pain-related Evoked Potentials (PREP) for the Objectivization of Neuropathic Pain|Completed||N/A|64|Actual|Ruhr University of Bochum|||2||f||||f|f|f||||||No||2017-10-10 21:15:36.212945|2017-10-10 21:15:36.212945
NCT03082807|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-17|||February 25, 2011|Actual|2011-02-25|March 2017|2017-03-01|December 15, 2012|Actual|2012-12-15|September 20, 2012|Actual|2012-09-20||Interventional|||Dietary Guide in Active Older Adult Men|Investigating the Effects of Negative Calorie Diet Compared With Low-calorie Diet Under Exercise Condition on Weight Loss and Lipid Profile in Overweight/Obese Middle-aged and Older Men|Completed||N/A|37|Actual|P.L.Shupik National Medical Academy of Post-Graduate Education||2|||f||||t|f|f||||||||2017-10-10 21:15:36.311916|2017-10-10 21:15:36.311916
NCT03082794|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-17|||February 20, 2011|Actual|2011-02-20|March 2017|2017-03-01|December 27, 2012|Actual|2012-12-27|September 20, 2012|Actual|2012-09-20||Interventional|||Dietary Effects on Weight Loss and Lipid Profile in Sedentary Men|Investigating the Effects of Negative Calorie Diet Compared With Low-Calorie Diet on Weigh Loss and Lipid Profile in Sedentary Overweight/Obese Middle-Aged and Older Men|Completed||N/A|104|Actual|P.L.Shupik National Medical Academy of Post-Graduate Education||2|||f|||||f|f||||||||2017-10-10 21:15:36.41339|2017-10-10 21:15:36.41339
NCT03082781|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-17|||October 10, 2012|Actual|2012-10-10|March 2017|2017-03-01|August 15, 2013|Actual|2013-08-15|June 20, 2013|Actual|2013-06-20||Interventional|||Dietary Choice in Active Older Adult Women|A Comparative Assessment of Weight Loss and Anti-lipid Effects of Negative Calorie Diet and Low-calorie Diet in Overweight/Obese Middle-aged and Older Women Under Exercise Condition|Completed||N/A|66|Actual|P.L.Shupik National Medical Academy of Post-Graduate Education||2|||f||||t|f|f||||||||2017-10-10 21:15:36.511924|2017-10-10 21:15:36.511924
NCT03082768|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-27|||March 3, 2017|Actual|2017-03-03|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects|An Open Label, Brain Positron Emission Tomography, Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects|Recruiting||Early Phase 1|7|Anticipated|Molecular NeuroImaging||1|||f|||||t|f||||||||2017-10-10 21:15:36.626216|2017-10-10 21:15:36.626216
NCT03082755|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-18|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease|Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease|Recruiting||Phase 4|136|Anticipated|University of Texas at Austin||2|||f||||t|t|f|||f|||||2017-10-10 21:15:36.737164|2017-10-10 21:15:36.737164
NCT03082742|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-16|||August 2015||2015-08-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients|The Effect of Thiazide and Loop Diuretic on Mineral and Bone Disorder in Chronic Kidney Disease Patients|Recruiting||N/A|52|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 21:15:36.87849|2017-10-10 21:15:36.87849
NCT03082729|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-14|||April 24, 2017|Actual|2017-04-24|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|March 2019|Anticipated|2019-03-01||Interventional|VIP-A||Vascular Inflammation in Psoriasis - Apremilast|A Phase IV, Open Label Study of the Effects of Apremilast on Vascular Inflammation and Cardiometabolic Function in Psoriasis|Recruiting||Phase 4|70|Anticipated|University of Pennsylvania||1|||f||||f|t|f|||f|||No||2017-10-10 21:15:37.049132|2017-10-10 21:15:37.049132
NCT03082716|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-08-01|||September 19, 2016|Actual|2016-09-19|August 2017|2017-08-01|January 20, 2019|Anticipated|2019-01-20|December 19, 2018|Anticipated|2018-12-19||Interventional|||Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery|Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery|Recruiting||Phase 2|274|Anticipated|King Faisal Specialist Hospital & Research Centre, Jeddah||2|||f||||t|f|f|||f|||||2017-10-10 21:15:37.192644|2017-10-10 21:15:37.192644
NCT03082703|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-13|||March 24, 2016|Actual|2016-03-24|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|December 1, 2016|Actual|2016-12-01||Interventional|||Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease|Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease|Completed||N/A|30|Actual|University of Alabama at Birmingham||2|||f||||f|f|f||||||No||2017-10-10 21:15:37.323432|2017-10-10 21:15:37.323432
NCT03082690|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-08-15|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study|Phase 1 Study of the Safety, Toxicity, Pharmacokinetics, Pharmacodynamics and Luminal Distribution of Single-dose DuoGel Through Rectal Administration|Not yet recruiting||Phase 1|16|Anticipated|Johns Hopkins University||1|||f||||t|t|f||||||||2017-10-10 21:15:37.391269|2017-10-10 21:15:37.391269
NCT03082677|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-19|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies|Open Label Phase II Study of Ixazomib for the Prevention of Recurrent or Late Acute and Chronic Graft-versus-Host Disease at 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies|Recruiting||Phase 2|46|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:15:37.484994|2017-10-10 21:15:37.484994
NCT03082664|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-16|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients|Topical Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Obstetric Patients|Recruiting||N/A|200|Anticipated|University of Arizona||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:15:37.601414|2017-10-10 21:15:37.601414
NCT03082651|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-13|||August 1, 2016|Actual|2016-08-01|March 2017|2017-03-01|December 30, 2017|Anticipated|2017-12-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Alternate Run Study|The Run Alternate Study|Active, not recruiting||N/A|300|Anticipated|University of British Columbia||4|||f||||f|f|f||||||No||2017-10-10 21:15:37.696442|2017-10-10 21:15:37.696442
NCT03082638|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-13|||January 18, 2017|Actual|2017-01-18|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Identification of Gulf War Illness (GWI) Biomarkers|Identification of Lipid Biomarkers of Inflammation and Metabolic Disturbances in Gulf War Illness (GWI)|Recruiting||N/A|100|Anticipated|Roskamp Institute Inc.|||2||f||||f|f|f||||Samples With DNA|"     Blood samples will be analyzed for lipids, proteins, DNA, RNA and breakdown products to     identify biomarkers for GWI   "|No||2017-10-10 21:15:37.812762|2017-10-10 21:15:37.812762
NCT03082625|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-16|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Topical Magnesium and Muscle Cramps in Dialysis Patients.|Topical Magnesium Supplementation for the Treatment of Muscle Cramps in Dialysis Patients|Not yet recruiting||Phase 2|40|Anticipated|Sir Charles Gairdner Hospital||2|||f||||f|f|f||||||Undecided|The plan at this stage is to have unidentified information available in a secure web-based environment.|2017-10-10 21:15:37.90046|2017-10-10 21:15:37.90046
NCT03082612|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-06-23|||December 2017|Anticipated|2017-12-01|June 2017|2017-06-01|April 28, 2018|Anticipated|2018-04-28|April 28, 2018|Anticipated|2018-04-28||Interventional|||Overcoming Psychological Distress Through Hymns|Overcoming Psychological Distress Through Hymns Intervention Among Late Stage African American Cancer Patients and Their FCGs|Not yet recruiting||N/A|40|Anticipated|Emory University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:37.983928|2017-10-10 21:15:37.983928
NCT03082599|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-16|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Symfony Toric Intraocular Lens Visual Outcomes|Visual Outcomes of an Extended Depth of Focus (EDOF) Intraocular Lens (IOL)|Recruiting||N/A|120|Anticipated|Carolina Eyecare Physicians, LLC||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:15:38.089884|2017-10-10 21:15:38.089884
NCT03082586|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-04-10|||November 20, 2016|Actual|2016-11-20|April 2017|2017-04-01|January 20, 2019|Anticipated|2019-01-20|January 20, 2018|Anticipated|2018-01-20||Interventional|||Radiation Dose Escalation in Esophageal Cancer|Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Cisplatin and Paclitaxel in Patients With Esophageal Cancer|Recruiting||N/A|18|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||6|||f||||t|f|f||||||No||2017-10-10 21:15:38.205988|2017-10-10 21:15:38.205988
NCT03082573|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-16|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel|Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Were Treated With H.P. Acthar Gel After an Incomplete Response to Combinations of DMARDs and Biologic DMRADs|Recruiting||Phase 4|30|Anticipated|Iraj Sabahi Research Inc.||2|||f||||f|t|f||||||Undecided||2017-10-10 21:15:38.319157|2017-10-10 21:15:38.319157
NCT03082560|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-13|||February 10, 2017|Actual|2017-02-10|March 2017|2017-03-01|February 10, 2018|Anticipated|2018-02-10|February 10, 2018|Anticipated|2018-02-10||Observational|||Design and Validation of a New Assessment Tool for Lichen Planopilaris|Design and Validation of a New Assessment Tool for Lichen Planopilaris, the Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital|||1||f|||||f|f||||||No||2017-10-10 21:15:38.444887|2017-10-10 21:15:38.444887
NCT03082547|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-12|||August 1, 2016|Actual|2016-08-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01|3 Months|Observational [Patient Registry]|||A Clinical Observation on Neuropsychology and Electrophysiology in Headache Patinets With Myofascial Trigger Points|A Clinical Observation on Neuropsychology and Electrophysiology in Headache Patinets With Myofascial Trigger Points|Recruiting||N/A|100|Anticipated|The First Affiliated Hospital with Nanjing Medical University|||2||f|||||f|f||||||||2017-10-10 21:15:38.53307|2017-10-10 21:15:38.53307
NCT03082534|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-28|||March 28, 2017|Actual|2017-03-28|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 27, 2019|Anticipated|2019-05-27||Interventional|||Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma|An Open-label, Non-randomized, Multi-arm, Phase II Trial to Evaluate the Efficacy of Pembrolizumab Combined With Cetuximab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)|Recruiting||Phase 2|83|Anticipated|University of California, San Diego||4|||f||||t|t|f|||f|||No||2017-10-10 21:15:38.606284|2017-10-10 21:15:38.606284
NCT03082521|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-10|||March 15, 2017|Anticipated|2017-03-15|March 2017|2017-03-01|October 1, 2023|Anticipated|2023-10-01|March 15, 2021|Anticipated|2021-03-15|4 Years|Observational [Patient Registry]|BAbAR||Better Antibiotic Prescribing Through Action Research|Better Antibiotic Prescribing Through Action Research|Not yet recruiting||N/A|170|Anticipated|Universiteit Antwerpen|||1||f||||f|f|f||||||No||2017-10-10 21:15:38.722735|2017-10-10 21:15:38.722735
NCT03082508|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-03-13|||August 2017|Anticipated|2017-08-01|March 2017|2017-03-01|January 2024|Anticipated|2024-01-01|January 2020|Anticipated|2020-01-01||Interventional|AUGMENT-HFII||A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure|A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure|Not yet recruiting||N/A|240|Anticipated|LoneStar Heart, Inc.||2|||f||||t|f|t|t|f||||No||2017-10-10 21:15:38.806606|2017-10-10 21:15:38.806606
NCT03082495|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-06|||June 26, 2017|Actual|2017-06-26|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|EXERT||Exercise During and After Neoadjuvant Rectal Cancer Treatment|A Phase II Randomized Controlled Trial of Aerobic Exercise in Rectal Cancer Patients During and After Neoadjuvant Chemoradiotherapy|Recruiting||N/A|60|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 21:15:38.895134|2017-10-10 21:15:38.895134
NCT03082482|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-06-13|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 19, 2017|Actual|2017-05-19||Interventional|AVAST-HIV||Smartphone-delivered Automated Video-assisted Smoking Treatment for People Living With HIV|Smartphone-delivered Automated Video-assisted Smoking Treatment for People Living With HIV: Project AVAST - HIV|Active, not recruiting||N/A|20|Actual|University of Oklahoma||2|||f||||f|f|f||||||No||2017-10-10 21:15:39.001472|2017-10-10 21:15:39.001472
NCT03082469|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-03-10|||March 15, 2017|Anticipated|2017-03-15|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|PACIFIC||Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal|Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal: A Prospective Study.|Not yet recruiting||Phase 4|30|Anticipated|Technische Universität München||2|||f||||f|f|f||||||No|n.a.|2017-10-10 21:15:39.107708|2017-10-10 21:15:39.107708
NCT03082456|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-12|||June 1, 2015|Actual|2015-06-01|January 2017|2017-01-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Molecular Breast Imaging in Screening Breast Cancer|Molecular Breast Imaging in Screening Breast Cancer|Recruiting||N/A|1800|Anticipated|Chang Gung Memorial Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:15:39.200117|2017-10-10 21:15:39.200117
NCT03082443|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-12|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||Group Intervention in the Nutritional Profile, Stress and Quality of Life in Patients in Cardiopulmonary Rehabilitation|The Effectiveness of a Group Intervention in the Nutritional Profile, Stress and Quality of Life in Patients in Cardiopulmonary Rehabilitation: a Randomized Clinical Trial|Not yet recruiting||N/A|116|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||t|f|f||||||||2017-10-10 21:15:39.280791|2017-10-10 21:15:39.280791
NCT03082430|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-10|||January 19, 2017|Actual|2017-01-19|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||GO PRP: Assessing the Efficacy of Intra Articular Injection of Platelets Rich Plasma for Gonarthrosis Treatment in Routine Care|Study GO-PRP: Assessing the Efficacy of Intra Articular Injection of Platelets Rich Plasma for Gonarthrosis Treatment in Routine Care|Enrolling by invitation||N/A|60|Anticipated|Hospital St. Joseph, Marseille, France||1|||f||||f|f|f||||||No||2017-10-10 21:15:39.339038|2017-10-10 21:15:39.339038
NCT03082417|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-10|||March 1, 2016|Actual|2016-03-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|November 1, 2017|Anticipated|2017-11-01||Interventional|PAINFREE||The PAINFREE Initiative, a Stepped Wedge Cluster Randomized Trial|Improving PAIN Control Following FRactures; Towards an Elder-friendly Emergency Department|Recruiting||N/A|500|Anticipated|McGill University Health Center||3|||f||||t||||||||Undecided||2017-10-10 21:15:39.401301|2017-10-10 21:15:39.401301
NCT03082404|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-12|||April 3, 2017|Anticipated|2017-04-03|March 2017|2017-03-01|June 2, 2017|Anticipated|2017-06-02|May 2, 2017|Anticipated|2017-05-02||Interventional|||Inspiratory Muscle Training in Chronic Kidney Disease|Effects of High-intensity Inspiratory Muscle Training in Chronic Kidney Disease: Randomized Clinical Trial|Not yet recruiting||N/A|25|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t|f|f||||||No||2017-10-10 21:15:39.487189|2017-10-10 21:15:39.487189
NCT03082391|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-20|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|February 20, 2020|Anticipated|2020-02-20|February 20, 2019|Anticipated|2019-02-20||Interventional|||Heavy Weight Versus Medium Weight Mesh in Ventral Hernia Repair|Long-term Results of Heavy Weight Versus Medium Weight Mesh in Ventral Hernia Repair|Recruiting||Phase 4|352|Anticipated|The Cleveland Clinic||2|||f||||f|f|f||||||No|IPD data will not be shared, rather the results of the aggregate groups of patients will be shared.|2017-10-10 21:15:39.727324|2017-10-10 21:15:39.727324
NCT03082378|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-16|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Central Obesity and Hepatocellular Carcinoma|Central Obesity and the Prognosis of Hepatocellular Carcinoma After Microwave Ablation|Recruiting||N/A|200|Anticipated|Chinese PLA General Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:15:39.845659|2017-10-10 21:15:39.845659
NCT03082365|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-16||||||March 2017|2017-03-01||||March 30, 2018|Anticipated|2018-03-30||Observational|||Oral Findings in Chronic Kidney Disease|"Prevalence of Oral Findings in Adult Patients With Chronic Kidney Disease '' Cross Sectional 2 "|Not yet recruiting||N/A|225|Anticipated|Cairo University|||2||f||||t||||||||Undecided||2017-10-10 21:15:39.93678|2017-10-10 21:15:39.93678
NCT03082352|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-07-11|||December 2017|Anticipated|2017-12-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations|Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations|Not yet recruiting||Phase 1|30|Anticipated|Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited||2|||f||||t|f|f||||||||2017-10-10 21:15:40.054191|2017-10-10 21:15:40.054191
NCT03082339|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-06-26|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31|2 Weeks|Observational [Patient Registry]|||Cortisone and QTc-Interval|Influence of Cortisone on QTc-interval|Recruiting||N/A|60|Anticipated|Asklepios Neurological Clinic Bad Salzhausen|||2||f||||f|f|f||||||Undecided||2017-10-10 21:15:40.152265|2017-10-10 21:15:40.152265
NCT03082326|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-07-28|||April 5, 2016||2016-04-05|March 2017|2017-03-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Observational|||The CCUS Based Characteristic of Hemodynamic and Lung Pathology in Early Stage of Shock in ICU: The Epidemic and Prognostic Value|The Critical Care Ultrasound Based Characteristic of Hemodynamic and Lung Pathology in Early Stage of Shock in ICU: The Epidemic and Prognostic Value|Completed||N/A|181|Actual|West China Hospital|||1||f||||t|f|f||||||||2017-10-10 21:15:40.25004|2017-10-10 21:15:40.25004
NCT03082313|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-16|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Movement-based Infant Intervention|Movement-based Intervention to Promote Positive Neurodevelopmental Outcomes in Infants at Risk for Developmental Delay|Not yet recruiting||N/A|12|Anticipated|University of Southern California||1|||f||||f|f|f||||||No||2017-10-10 21:15:40.35438|2017-10-10 21:15:40.35438
NCT03082300|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-07-26|||March 24, 2017|Actual|2017-03-24|July 2017|2017-07-01|June 19, 2017|Actual|2017-06-19|May 12, 2017|Actual|2017-05-12||Interventional|||A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations|A Phase 1, Randomized, 2-period Crossover Study to Assess Bioequivalence of a Tablet Formulation Versus a Capsule Formulation of ASP8273 in Subjects With Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations|Terminated||Phase 1|3|Actual|Astellas Pharma Inc||3||Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.|f||||f|t|f||||||||2017-10-10 21:15:40.458606|2017-10-10 21:15:40.458606
NCT03082287|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-27|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool|ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool|Recruiting||N/A|500|Anticipated|American Laboratory Products Company|||4||f||||f|f|t|t|f|f|Samples Without DNA|"     Stool   "|No||2017-10-10 21:15:40.602299|2017-10-10 21:15:40.602299
NCT03082274|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-28|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|October 30, 2018|Anticipated|2018-10-30|April 30, 2018|Anticipated|2018-04-30||Observational|PRIORITY||Prospective Validation of Prostate Biomarkers for Repeat Biopsy|Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study|Enrolling by invitation||N/A|1000|Actual|MDx Health|||1||f||||f|f|f||||Samples With DNA|"     Serum and plasma from each subject will be collected and stored for up to 10 years for future     research.   "|||2017-10-10 21:15:40.717199|2017-10-10 21:15:40.717199
NCT03082261|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-08-28|||March 3, 2017|Actual|2017-03-03|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|November 30, 2018|Anticipated|2018-11-30||Interventional|TRIUMPH||Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses When Utilizing a Multiple Waveform Enabled Neurostimulator|Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses When Utilizing a Multiple Waveform Enabled Neurostimulator|Recruiting||N/A|267|Anticipated|St. Jude Medical||1|||f||||f|f|t|f|f|t|||||2017-10-10 21:15:40.810701|2017-10-10 21:15:40.810701
NCT03082248|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-10|||September 2017|Anticipated|2017-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Second Opinion in Spinal Surgery Indications: Cost-Effectiveness Evaluation|Second Opinion in Spinal Surgery Indications: Cost-Effectiveness Evaluation|Not yet recruiting||N/A|190|Anticipated|Hospital Israelita Albert Einstein||2|||f||||f|f|f||||||Undecided|We are happy to share our data with researchers that would like to use it on an individual participant data|2017-10-10 21:15:41.058632|2017-10-10 21:15:41.058632
NCT03082235|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-05-22|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742 in Healthy Adult Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742 in Healthy Adult Subjects|Recruiting||Phase 1|48|Anticipated|Eisai Inc.||12|||f||||f|t|f||||||No||2017-10-10 21:15:41.184702|2017-10-10 21:15:41.184702
NCT03082222|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-15|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions|An Open, Multicentric, Non-Interventional Observational Study Investigating Retention, Seizure Control and Tolerability in Epilepsy Patients With Partial Onset Seizures Receiving Eslicarbazepine Acetate (ESL) in Different Therapy Situations|Recruiting||N/A|200|Anticipated|Eisai Inc.|||2||f||||t||||||||||2017-10-10 21:15:41.315164|2017-10-10 21:15:41.315164
NCT03082209|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-14|2017-09-29|||March 29, 2017|Actual|2017-03-29|September 2017|2017-09-01|February 27, 2020|Anticipated|2020-02-27|November 16, 2018|Anticipated|2018-11-16||Interventional|||A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously Treated Solid Tumors and Hematologic Malignancies|An Open-Label, Phase 1, First-In-Human Study of Safety and Tolerability of TRAIL Receptor Agonist ABBV-621 in Subjects With Previously Treated Solid Tumors and Hematologic Malignancies|Recruiting||Phase 1|92|Anticipated|AbbVie||5|||f||||f|t|f||||||||2017-10-10 21:15:41.414381|2017-10-10 21:15:41.414381
NCT03082196|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-05-02|||March 30, 2017|Actual|2017-03-30|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|May 30, 2019|Anticipated|2019-05-30||Interventional|||Efficacy Of A PVP-I Fluoride Varnish|Phase 2 Efficacy Evaluation Of Advantage Anti-Caries Varnish|Active, not recruiting||Phase 2|285|Actual|Advantage Dental Services, LLC||2|||f||||f|t|f||||||No||2017-10-10 21:15:41.959491|2017-10-10 21:15:41.959491
NCT03082183|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-06-21|||March 28, 2017|Actual|2017-03-28|June 2017|2017-06-01|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Interventional|||DDI Strong CYP3A4 Inducer|Effects of Rifampicin on the Pharmacokinetics of BI 425809 Following Oral Administration in Healthy Male Subjects (an Open-label, Two-period, Fixed-sequence Trial)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||1|||f|||||f|f||||||||2017-10-10 21:15:42.071261|2017-10-10 21:15:42.071261
NCT03082170|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-13|2017-05-10|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 20, 2018|Anticipated|2018-03-20|November 20, 2017|Anticipated|2017-11-20||Interventional|||The Effect of Obstructive Sleep Apnea Operations on the Swallowing Function|Quality of Postoperative Swallowing After Tongue Base and Palate Surgeries for Obstructive Sleep Apnea.|Not yet recruiting||N/A|120|Anticipated|Rambam Health Care Campus||2|||f||||t|f|f||||||Undecided|The data collected are summarized information regarding the swallowing quality of patients as recorded in the FEES test and as reported by the patient in the SDQ questionnaire.|2017-10-10 21:15:42.171431|2017-10-10 21:15:42.171431
NCT03082157|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-13|||October 16, 2017|Anticipated|2017-10-16|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Mighty Men: A Faith-Based Weight Loss Program to Address Cancer Disparities|Mighty Men: A Faith-Based Weight Loss Program to Address Cancer Disparities|Not yet recruiting||N/A|448|Anticipated|Vanderbilt University||2|||f||||f|f|f||||||||2017-10-10 21:15:42.274041|2017-10-10 21:15:42.274041
NCT03082144|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-10|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|June 2018|Anticipated|2018-06-01||Interventional|||Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors|Involved-field Radiotherapy Combined With Concurrent Intrathecal-MTX Versus Intrathecal-Ara-C for Leptomeningeal Metastases From Solid Tumor: A Randomized Phase II Clinical Trial|Recruiting||Phase 2|70|Anticipated|First Hospital of Jilin University||2|||f||||t|f|f||||||||2017-10-10 21:15:42.377995|2017-10-10 21:15:42.377995
NCT03082131|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-06-20|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Resistant Starch Wheat for Improved Metabolic Health|Resistant Starch Wheat for Improved Metabolic Health: A Proof of Concept Study in Human Subjects|Recruiting||N/A|60|Anticipated|USDA, Western Human Nutrition Research Center||2|||f||||f|f|f||||||No||2017-10-10 21:15:42.501709|2017-10-10 21:15:42.501709
NCT03082118|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-08-18|||March 9, 2017|Actual|2017-03-09|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|VESICAL||Vesair Continued Access Trial|Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence|Recruiting||N/A|90|Anticipated|Solace Therapeutics, Inc.||1|||f||||f|f|t|t|f||||||2017-10-10 21:15:42.620718|2017-10-10 21:15:42.620718
NCT03082105|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-10|||December 1, 2013|Actual|2013-12-01|March 2017|2017-03-01|March 9, 2014|Actual|2014-03-09|March 9, 2014|Actual|2014-03-09||Interventional|||Snow Physical Properties and Human Ventilatory Response|Evaluation of Air Pocket Factors That Contribute to the Development of Hypoxia and Hypercapnia|Completed||N/A|12|Actual|Institute of Mountain Emergency Medicine||3|||f||||f|f|f||||||No||2017-10-10 21:15:42.755788|2017-10-10 21:15:42.755788
NCT03082092|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-09-21|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Pre-operative Intravenous Steroid in Total Knee Replacement for Pain Relief and Recovery|Pre-operative Intravenous Steroid in Unilateral Primary Total Knee Replacement for Pain Relief and Recovery: A Double-Blind Randomized Controlled Trial|Recruiting||Phase 4|50|Anticipated|Queen Elizabeth Hospital, Hong Kong||2|||f||||f|f|f|||f|||||2017-10-10 21:15:42.861405|2017-10-10 21:15:42.861405
NCT03082079|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-14|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|September 30, 2021|Anticipated|2021-09-30|August 1, 2021|Anticipated|2021-08-01||Interventional|||Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)|Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm) :a Randomized Controlled Trial|Not yet recruiting||N/A|90|Anticipated|Nanfang Hospital of Southern Medical University||2|||f|||||f|f||||||Undecided||2017-10-10 21:15:42.986519|2017-10-10 21:15:42.986519
NCT03082066|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-28|||March 15, 2017|Actual|2017-03-15|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Observational|||Soft Tissue and Bone Diameter in Children and Adults for Intraosseus Access|Assessment of Soft Tissue and Bone Diameter for Intraosseus Access in Children and Adults|Recruiting||N/A|500|Anticipated|Medical University Innsbruck|||2||f||||f|f|f||||||||2017-10-10 21:15:43.100594|2017-10-10 21:15:43.100594
NCT03082053|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-10|||January 31, 2017|Actual|2017-01-31|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours|A Phase Ib Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours|Recruiting||Phase 1|42|Anticipated|Aslan Pharmaceuticals||2|||f||||f|f|f||||||||2017-10-10 21:15:43.226963|2017-10-10 21:15:43.226963
NCT03082040|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-11|||October 26, 2016|Actual|2016-10-26|March 2017|2017-03-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||A Home-based Breathing Training on Menopausal Symptoms|Effects of a Home-based Breathing Training on Menopausal Symptoms Among Community Menopausal Women|Recruiting||N/A|160|Anticipated|Ministry of Science and Technology, Taiwan||2|||f|||||f|f||||||Undecided||2017-10-10 21:15:43.333817|2017-10-10 21:15:43.333817
NCT03082014|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-16|||August 1, 2017|Anticipated|2017-08-01|March 2017|2017-03-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|TREAT-SVDs||Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function|EffecTs of Amlodipine and Other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases|Not yet recruiting||Phase 3|105|Anticipated|Ludwig-Maximilians - University of Munich||3|||f||||f|t|f|||f|||No||2017-10-10 21:15:43.496593|2017-10-10 21:15:43.496593
NCT03082001|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-11|||January 1, 2011|Actual|2011-01-01|March 2017|2017-03-01|April 30, 2012|Actual|2012-04-30|April 30, 2012|Actual|2012-04-30||Interventional|||Sucrose to Reduce Pain During Initiation of Venipuncture in Extremely Low Birth Weight Babies|A Study to Assess the Role of Two Different Concentrations of Sucrose to Reduce Pain During Initiation of Venipuncture in Extremely Low Birth Weight Babies|Completed||Phase 3|60|Actual|Lady Hardinge Medical College||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:43.632797|2017-10-10 21:15:43.632797
NCT03081988|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-03-11|||October 19, 2015|Actual|2015-10-19|March 2017|2017-03-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2018|Anticipated|2018-10-30|3 Years|Observational [Patient Registry]|||Prediction Model of Response for CCRT in Esophageal Cancer|Prediction Model of Response for Combined Chemo-Radio-therapy Based on Clinical and Molecular Biology|Recruiting||N/A|140|Anticipated|Kyungpook National University|||2||f||||t|f|f||||Samples With DNA|"     esophageal cancer tissue and paired normal tissue serum, plasma, buffy coat (DNA), whole     blood (RNA)   "|Undecided||2017-10-10 21:15:43.706406|2017-10-10 21:15:43.706406
NCT03081975|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-16|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||NBI Does Not Increase ADR Compared to HD White Light Colonoscopy in Screening and Surveillance Colonoscopies|NBI Does Not Increase Adenoma Detection Rate Compared to HD White Light Colonoscopy in Screening and Surveillance Colonoscopies|Recruiting||N/A|500|Anticipated|Jena University Hospital||2|||f||||||||||||No||2017-10-10 21:15:43.787847|2017-10-10 21:15:43.787847
NCT03081962|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-25|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of a Combination of Bundles on Surgical-site Infection After Elective Colorectal Surgery|Effect of Intraperitoneal Irrigation With Antibiotic Solution, Triclosan-impregnated Sutures for Fascial Closure and Mupirocin Ointment Over the Skin Staples, on Surgical-site Infection After Laparoscopic Colorectal Surgery|Recruiting||Phase 3|102|Anticipated|Hospital General Universitario Elche||2|||f||||t|f|f||||||Undecided||2017-10-10 21:15:43.870002|2017-10-10 21:15:43.870002
NCT03081949|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-09|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|PEACE||Peripartum Cardiomyopathy in Nigeria Registry|Peripartum Cardiomyopathy in Nigeria (PEACE) A Registry to Study the Demographics, Social and Clinical Characteristics, Pathophysiology and Outcomes of Peripartum Cardiomyopathy in Nigeria|Recruiting||Phase 4|500|Anticipated|Aminu Kano Teaching Hospital||2|||f||||f|f|f||||||No|We intend to publish the results in peer reviewed scientific journals.|2017-10-10 21:15:43.953817|2017-10-10 21:15:43.953817
NCT03081936|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-03-10|||November 2015||2015-11-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Comparative A1 vs A2 Formula and Breast Feeding on Alimentation and Gastrointestinal Digestion for the Infant|Comparative Effects of A1 Versus A2®Cow Milk Based Formula and Breast Feeding on Alimentation and Gastrointestinal Digestion for the Infant: a Pilot Double-blinded, Randomized, Controlled Parallel Study|Completed||Phase 4|33|Actual|a2 Milk Company Ltd.||3|||f||||f||||||||No||2017-10-10 21:15:44.057916|2017-10-10 21:15:44.057916
NCT03081923|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-15|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|APACHE||Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors|An Open Label, Randomized, Phase 2 Study of the Anti-Programmed Death-Ligand 1 (PD-L1) Durvalumab, Alone or in Combination With Tremelimumab, in Patients With Advanced and Relapsed Germ Cell Tumors|Recruiting||Phase 2|120|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f|f|f||||||No||2017-10-10 21:15:44.142796|2017-10-10 21:15:44.142796
NCT03081910|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-17|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 1, 2036|Anticipated|2036-06-01|July 15, 2021|Anticipated|2021-07-15||Interventional|MAGENTA||Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen|Phase 1 Therapy of Manufactured Autologous T-Cells Expressing a Second Generation Chimeric Antigen Receptor (CAR) for Treatment of T-Cell Malignancies Expressing CD5 Antigen|Not yet recruiting||Phase 1|21|Anticipated|Baylor College of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:15:44.220663|2017-10-10 21:15:44.220663
NCT02556151|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-08-23|||April 2015||2015-04-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Neuromodulation Therapy for Fecal Incontinence|Neuromodulation Therapy for Fecal Incontinence|Recruiting||N/A|48|Anticipated|Augusta University||3|||f||||t||||||||||2017-10-10 22:54:29.13133|2017-10-10 22:54:29.13133
NCT03081897|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-06-04|||July 2016||2016-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|SPRANC||Regional Anaesthesia and Substance P in Head and Neck Cancer|Influence of Regional Anaesthesia on the Expression of Substance P During Unilateral Neck Dissection Due to Head and Neck Cancer|Recruiting||N/A|40|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||Undecided||2017-10-10 21:15:44.33357|2017-10-10 21:15:44.33357
NCT03081884|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-05-02|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|January 2027|Anticipated|2027-01-01|January 2027|Anticipated|2027-01-01||Interventional|EDRN-FACBC||Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease|Validation of FACBC as an Early Indicator of Sub-clinical Metastatic Disease Among High-risk Prostate Cancer Patients With Presumed Localized Disease|Recruiting||Phase 2|88|Anticipated|Emory University||1|||f||||f|t|f||||||No||2017-10-10 21:15:44.417383|2017-10-10 21:15:44.417383
NCT03081871|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-09|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|mCVRS||Mobile Cardiovascular Risk Service Trial|Design and Testing of a Mobile Cardiovascular Risk Service With Patient Partners|Enrolling by invitation||N/A|100|Anticipated|University of Iowa||2|||f||||f|f|f||||||||2017-10-10 21:15:46.321065|2017-10-10 21:15:46.321065
NCT03081845|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-10|||September 13, 2016|Actual|2016-09-13|March 2017|2017-03-01|January 20, 2017|Actual|2017-01-20|October 14, 2016|Actual|2016-10-14||Interventional|||A1 Versus A2® Milk on the Gastrointestinal Physiology, Symptoms and Cognitive Behaviour for the Preschool Children|Comparative Effects of A1 Versus A2® Milk on the Gastrointestinal Physiology, Symptoms and Cognitive Behaviour for the Preschool Children: a Double-blinded Randomized Controlled Cross-over Study|Completed||Phase 4|80|Actual|a2 Milk Company Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:15:46.525568|2017-10-10 21:15:46.525568
NCT03081832|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-05-02|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|OT2SUITE||Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.|Long Term Evaluation of Infants Aged From 3 to 4 Years Old Included in the Ancient Study (Repeated Administrations of Oxytocin in Infants With Prader Willi Syndrome Aged From 0 to 6 Months) and Comparison With Not Treated and Age-matched Prader Willi Syndrome Infants (OT2SUITE)|Recruiting||N/A|36|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-10 21:15:46.647552|2017-10-10 21:15:46.647552
NCT03081819|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-19|||March 30, 2017|Actual|2017-03-30|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer|A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer|Recruiting||Phase 1|18|Anticipated|Kyunghee University Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:15:46.821453|2017-10-10 21:15:46.821453
NCT03081793|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-18|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Observational|||Estimation of Average and Beat-to-beat Heart Rate With a Novel Wrist-worn PPG Device in Surgery Patients|Estimation of Average and Beat-to-beat Heart Rate With a Novel Wrist-worn PPG Device in Surgery Patients|Completed||N/A|30|Actual|Tampere University Hospital|||2||f||||f|f|f||||||||2017-10-10 21:15:46.990282|2017-10-10 21:15:46.990282
NCT03081780|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-10-04|||April 27, 2017|Actual|2017-04-27|September 2017|2017-09-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2021|Anticipated|2021-01-01||Interventional|||Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML|Open Label Dose Escalation Trial of an Adaptive Natural Killer (NK) Cell Infusion (FATE-NK100) With Subcutaneous IL-2 in Adults With Refractory or Relapsed Acute Myelogenous Leukemia (AML)|Recruiting||Phase 1|29|Anticipated|Masonic Cancer Center, University of Minnesota||1|||||||t|t|f||||||||2017-10-10 21:15:47.089577|2017-10-10 21:15:47.089577
NCT03081767|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-13|||March 29, 2017|Actual|2017-03-29|March 2017|2017-03-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Standard PET/CT vs. Digital PET/CT|Comparison of Standard PET/CT vs. Digital PET/CT|Recruiting||N/A|270|Anticipated|Stanford University||1|||f||||t|f|f||||||No||2017-10-10 21:15:47.205241|2017-10-10 21:15:47.205241
NCT03081754|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-10|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Correlation of Uterine and Umbilical Arteries Doppler With Placental Pathology in IUGR|Study of Placental Bed of Growth Restricted Fetuses: Correlation of Doppler Velocimetries of Uterine and Umbilical Arteries With Placental Pathology|Completed||N/A|75|Actual|Cairo University|||2||f||||t|f|f||||Samples Without DNA|"     The general shapes of placentas were assessed and weightedby trimming the membranes and     umbilical cord. The diameters and thickness of placentas were noted cord insertion site. The     maternal surface at a distance of 1-2 cm in bread loaf manner and examined for the pale     areas. Whole thickness villous tissue blocks were obtained from three zones ;central,     peripheral and intermediate zones      Placental bed biopsies were obtained at Caesarean sections .. The specimens were fixed in     buffered formalin. The tissues were processed and stained with Haematoxlyin and Eosin.     Microscopic study of placenta was carried out utilizing a set of standard criteria for     villous and intervillous lesions . For studying these criteria 8 random microscopic fields     were chosen and 100 villi were counted in each field   "|Yes||2017-10-10 21:15:47.309109|2017-10-10 21:15:47.309109
NCT03081390|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-27|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Migraine and CVD Risk in Women|Mechanisms of Increased Cardiovascular Disease Risk in Women With Migraine|Recruiting||N/A|30|Anticipated|University of Pennsylvania||4|||f||||f|f|f||||||||2017-10-10 21:15:50.35367|2017-10-10 21:15:50.35367
NCT03081741|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-05-22|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|March 18, 2020|Anticipated|2020-03-18|December 1, 2017|Anticipated|2017-12-01||Observational|||Circulating Tumor DNA in Surgical Lung Cancer Patients|A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Lung Cancer Patients|Recruiting||N/A|500|Anticipated|Shenzhen Gene Health Bio Tech Co., Ltd.|||1||f|||||f|f||||Samples With DNA|"     Blood samples and FFPE tissue sections were collected from each patient.   "|No||2017-10-10 21:15:47.53522|2017-10-10 21:15:47.53522
NCT03081728|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-09-21|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Incidence Of Hemidiaphragmatic Paralysis After Usg Guided Low Dose Interscalene Brachial Plexus Block|Incidence Of Hemidiaphragmatic Paralysis With Patient Controlled Infusion Of Low Volume Of Ropivacaine After Usg Guided Low Dose Interscalene Brachial Plexus Block|Recruiting||Early Phase 1|40|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t|f|f|||f|||||2017-10-10 21:15:47.648897|2017-10-10 21:15:47.648897
NCT03081715|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-08-03|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|February 27, 2018|Anticipated|2018-02-27||Interventional|||PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer|A Phase II Trial of PD-1 Knockout Engineered T Cells for the Treatment of Advanced Esophageal Cancer|Recruiting||Phase 2|21|Anticipated|Hangzhou Cancer Hospital||1|||f|||||f|f||||||||2017-10-10 21:15:47.755976|2017-10-10 21:15:47.755976
NCT03081702|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-10|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|October 1, 2022|Anticipated|2022-10-01|May 1, 2022|Anticipated|2022-05-01||Interventional|||A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer|A Phase I/II Trial Investigating the Tolerability, Toxicity and Efficacy of Hydroxychloroquine and Itraconazole in Patients With Advanced Platinum-resistant Epithelial Ovarian Cancer (EOC) (HYDRA-1 Study)|Not yet recruiting||Phase 1/Phase 2|52|Anticipated|University Health Network, Toronto||1|||f||||t|f|f||||||No||2017-10-10 21:15:47.881094|2017-10-10 21:15:47.881094
NCT03081689|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-25|||April 15, 2017|Actual|2017-04-15|March 2017|2017-03-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients|NEO -ADJUVANT CHEMO/IMMUNOTHERAPY FOR THE TREATMENT OF RESECTABLE STAGE IIIA NON SMALL CELL LUNG CANCER (NSCLC): A PHASE II MULTICENTER EXPLORATORY STUDY|Recruiting||Phase 2|46|Anticipated|Spanish Lung Cancer Group||1|||f||||t|f|f||||||No||2017-10-10 21:15:47.972646|2017-10-10 21:15:47.972646
NCT03081676|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-06-01|||March 8, 2017|Actual|2017-03-08|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|HNF1A-Clamp||The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea|The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea|Recruiting||N/A|20|Anticipated|University Hospital, Gentofte, Copenhagen||6|||f||||t|f|f||||||Undecided||2017-10-10 21:15:48.192861|2017-10-10 21:15:48.192861
NCT03081663|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-19|||July 11, 2017|Actual|2017-07-11|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Quadriceps Sparing Versus Standard Total Knee Arthroplasty|Cost and Patient Satisfaction After Total Knee Arthroplasty: Standard Medial Para-patellar Versus Quadriceps Sparing Mid-vastus Surgical Approach|Recruiting||N/A|40|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:15:48.304686|2017-10-10 21:15:48.304686
NCT03081650|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-15|||August 16, 2016|Actual|2016-08-16|February 2017|2017-02-01|December 1, 2017|Anticipated|2017-12-01|August 16, 2017|Anticipated|2017-08-16||Interventional|||The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy|The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy as Well as Stand-alone Therapy in Patients With Respiratory Insufficiency|Recruiting||N/A|30|Anticipated|Lutheran Hospital, Indiana||1|||f||||f|f|f||||||No||2017-10-10 21:15:48.400877|2017-10-10 21:15:48.400877
NCT03081637|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-31|||January 1, 2004|Actual|2004-01-01|May 2017|2017-05-01|March 2, 2017|Actual|2017-03-02|December 31, 2014|Actual|2014-12-31||Observational|||FLNA in HCC Patients|Filamin A Expression in HCC Patients|Completed||N/A|115|Actual|University of Milan|||1||f|||||f|f||||Samples Without DNA|"     Surgical specimen from patients resected for HCC.   "|||2017-10-10 21:15:48.501137|2017-10-10 21:15:48.501137
NCT03081624|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-21|||December 17, 2016|Actual|2016-12-17|March 2017|2017-03-01|July 17, 2018|Anticipated|2018-07-17|July 17, 2017|Anticipated|2017-07-17|1 Day|Observational [Patient Registry]|||Evaluation of Neurological Status and School Readiness in Preterm Preschoolers|Evaluation of Neurological Status and School Readiness of Preterm Children in Preschool Period|Active, not recruiting||N/A|60|Anticipated|Gazi University|||2||f||||t|f|f||||||Undecided|Haven't decided yet.|2017-10-10 21:15:48.550476|2017-10-10 21:15:48.550476
NCT03081611|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-12|2017-03-15|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|May 31, 2019|Anticipated|2019-05-31|March 31, 2019|Anticipated|2019-03-31||Interventional|RAMCAN||RAM Cannula VS Short Nasal Prongs for Delivering NIPPV in Preterm Infants|RAM Cannula for Delivering Nasal Intermittent Positive Pressure Ventilation (NIPPV) in Preterm Infants: Non Inferiority Randomized Control Trial|Not yet recruiting||N/A|200|Anticipated|Rambam Health Care Campus||2|||f||||t|f|f||||||No||2017-10-10 21:15:48.609061|2017-10-10 21:15:48.609061
NCT03081598|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-10|||May 29, 2017|Actual|2017-05-29|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome|A Phase 2, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PBI-4050 in Type 2 Diabetes Mellitus Patients With Metabolic Syndrome|Recruiting||Phase 2|268|Anticipated|ProMetic Pharma SMT Limited||4|||f||||f|f|f||||||||2017-10-10 21:15:48.688343|2017-10-10 21:15:48.688343
NCT03081585|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-15|||June 9, 2015|Actual|2015-06-09|March 2017|2017-03-01|June 10, 2016|Actual|2016-06-10|June 10, 2016|Actual|2016-06-10||Observational|||Food Reward Processing in the Human Brain|Integration of Homeostatic Signaling and Food Reward Processing in the Human Brain|Completed||N/A|23|Actual|University of Heidelberg Medical Center|||1||f||||f|f|f||||||No||2017-10-10 21:15:48.79338|2017-10-10 21:15:48.79338
NCT03081572|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-03|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Platelet Function on Abacavir and Tenofovir|Differences in Platelet Function in Patients on Abacavir Versus Tenofovir Based Antiretroviral Regimens|Not yet recruiting||N/A|44|Anticipated|University of California, Los Angeles|||2||f||||f|f|f|||f|Samples Without DNA|"     Plasma   "|No|There is no plan to share individual participant data|2017-10-10 21:15:48.868393|2017-10-10 21:15:48.868393
NCT03081559|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-10|||November 9, 2016|Actual|2016-11-09|March 2017|2017-03-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Improving Engagement in HIV Care for High-risk Women|Improving Engagement in HIV Care for High-risk Women|Recruiting||N/A|286|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||Undecided||2017-10-10 21:15:48.935599|2017-10-10 21:15:48.935599
NCT03081546|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-05-08|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease|Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease|Enrolling by invitation||N/A|80|Anticipated|University of Colorado, Denver|||2||f|||||f|f||||||||2017-10-10 21:15:49.016428|2017-10-10 21:15:49.016428
NCT03081533|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-10|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Circle Dances for Elderly Caregivers|Circle Dances in Elderly Caregivers of Patients With Alzheimer's Disease: A Controlled and Randomized Study|Recruiting||N/A|40|Anticipated|Universidade Federal de Sao Carlos||2|||f||||f|f|f||||||Yes|The individual participant data collected in this study, such as age, gender, cognitive status, contact telephone and address is available in a database in order to facilitate the recruitment process of the population for the development of new studies.|2017-10-10 21:15:49.080428|2017-10-10 21:15:49.080428
NCT03081520|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-07-03|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Affective Responses Following Aerobic Exercise With Different Intensities|Affective Responses Following Aerobic Exercise With Different Intensities|Not yet recruiting||N/A|30|Anticipated|Telemark University College||3|||f||||f|f|f||||||||2017-10-10 21:15:49.285956|2017-10-10 21:15:49.285956
NCT03081507|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-05-11|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|June 1, 2018|Anticipated|2018-06-01||Interventional|MARHABA||Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City|Muslim Americans Reaching for Health and Building Alliances (MARHABA): Patient Navigation Intervention to Increase Breast and Cervical Cancer Screening Among Muslim Women in New York City|Recruiting||N/A|540|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:15:49.392041|2017-10-10 21:15:49.392041
NCT03081481|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-07|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer|Multi-Centre, Ph IIb Study, Evaluating Safety & Efficacy of Targeted Intraprostatic Admin of PRX302 to Treat Men With Histologically Proven, Clinically Significant, Localised Prostate Cancer Associated With MRI Lesion|Recruiting||Phase 2|40|Anticipated|Sophiris Bio Corp||1|||f||||t|t|f||||||No||2017-10-10 21:15:49.633982|2017-10-10 21:15:49.633982
NCT03081468|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-05|||May 18, 2017|Actual|2017-05-18|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|||The PUPIL Study - Automated, Quantitative Pupil Assessment Using Binocular OCT|A Prospective Single-Site Non-Interventional Study to Evaluate the Diagnostic Accuracy and Repeatability of Pupil Measurements Using a Prototype Binocular Optical Coherence Tomography System.|Recruiting||N/A|100|Anticipated|University College, London|||2||f|||||f|f||||||||2017-10-10 21:15:49.748504|2017-10-10 21:15:49.748504
NCT03081455|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-07|||February 13, 2017|Actual|2017-02-13|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|July 7, 2017|Actual|2017-07-07||Observational|||Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes|A Prospective Evaluation of the Impact of a Process Engineering Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes in Community-Based Obstetrics and Gynecology Settings|Completed||N/A|145|Actual|Myriad Genetic Laboratories, Inc.|||1||f|||||f|f||||Samples With DNA|"     Whole blood and saliva   "|||2017-10-10 21:15:49.845866|2017-10-10 21:15:49.845866
NCT03081442|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-02|||March 11, 2017|Actual|2017-03-11|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar|Benefits of Use of 600 Microgram Misoprostol Vaginally Prior To Insertion Of An Intrauterine Device in Patients With Cesarean Scar: A Randomized Controlled Trial|Recruiting||Phase 4|120|Anticipated|Cairo University||2|||f||||t|t|f|||f|||No||2017-10-10 21:15:49.93083|2017-10-10 21:15:49.93083
NCT03081429|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-14|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Observational|||A Prospective Cohort Study of Perioperative Covert Stroke and Postoperative Cognitive Dysfunction|A Prospective Cohort Study of Perioperative Covert Stroke and Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Noncardiac Surgery|Recruiting||N/A|1100|Anticipated|Beijing Tiantan Hospital|||2||f|||||f|f||||||||2017-10-10 21:15:50.055064|2017-10-10 21:15:50.055064
NCT03081416|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-10|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2016|Actual|2016-09-01||Interventional|THINK||"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"|"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"|Recruiting||Phase 3|60|Anticipated|Brooke Army Medical Center||2|||f||||t|f|f|||f|||No||2017-10-10 21:15:50.134002|2017-10-10 21:15:50.134002
NCT03081403|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-12|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|SENSISKIN||Quantitative Sensory Testing in Subjects With Sensitive Skin or Not|Quantitative Sensory Testing in Subjects With Sensitive Skin or Not|Recruiting||N/A|42|Anticipated|University Hospital, Brest||2|||f||||f|f|f||||||No||2017-10-10 21:15:50.256568|2017-10-10 21:15:50.256568
NCT03081364|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-04-13|||September 2015||2015-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|1 Month|Observational [Patient Registry]|PROMeNADe||Patient Registry Of Magnetic Resonance Imaging in Non-Approved DEvices|Patient Registry Of Magnetic Resonance Imaging in Non-Approved DEvices|Enrolling by invitation||N/A|3000|Anticipated|Saint Luke's Health System|||1||f||||f||||||||No|There is no plan to share the IPD|2017-10-10 21:15:50.484693|2017-10-10 21:15:50.484693
NCT03081351|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-10|||June 1, 2016|Actual|2016-06-01|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Extended Retroperitoneal Lymphadenectomy and Nerve Plexus Clearance Versus Standard Lymphadenectomy in Pancreaticoduodenectomy|Extended Retroperitoneal Lymphadenectomy and Nerve Plexus Clearance Versus Standard Lymphadenectomy in Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head in a Chinese Population:A Multicenter, Open-label, Randomized Controlled Clinical Trial.|Recruiting||N/A|480|Anticipated|Shanghai Zhongshan Hospital||2|||f|||||f|f||||||No||2017-10-10 21:15:50.583963|2017-10-10 21:15:50.583963
NCT03081338|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-08-07|||May 2015||2015-05-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|ALS-CarE||A Programme for Amyotrophic Lateral Sclerosis Care in Europe|A Programme for Amyotrophic Lateral Sclerosis Care in Europe|Active, not recruiting||N/A|115|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||f|f|f||||||||2017-10-10 21:15:50.708003|2017-10-10 21:15:50.708003
NCT03081325|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-30|||March 2015||2015-03-01|March 2017|2017-03-01|July 20, 2017|Actual|2017-07-20|June 2017|Actual|2017-06-01||Interventional|immunotherapy||A Preliminary Study About Recurrent Spontaneous Abortion and Repeated Implantation Failure IVF-ET Patients Treated by Active Immunotherapy With Small Amount of Lymphocytes|A Preliminary Study About Recurrent Spontaneous Abortion and Repeated Implantation Failure IVF-ET Patients Treated by Active Immunotherapy With Small Amount of Lymphocytes|Completed||Phase 1/Phase 2|100|Anticipated|Nanjing University||1|||f||||||||||||||2017-10-10 21:15:50.84969|2017-10-10 21:15:50.84969
NCT03081312|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-10|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Observational|FCG-NBC||A Study of Family Caregivers' Needs, Burden of Care and Quality of Life Over the Course of a Cancer Illness|A Study of Family Caregivers' Needs, Burden of Care and Quality of Life Over the Course of a Cancer Illness|Recruiting||N/A|510|Anticipated|National University, Singapore|||1||f||||f|f|f||||||No||2017-10-10 21:15:50.937239|2017-10-10 21:15:50.937239
NCT03081299|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-10|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Characterization of Bio-psychosocial Pain Profiles in the Perioperative Period|Characterization of Bio-psychosocial Pain Profiles in the Perioperative Period|Recruiting||N/A|1500|Anticipated|Defense and Veterans Center for Integrative Pain Management|||6||f||||f|f|f||||||No||2017-10-10 21:15:51.0145|2017-10-10 21:15:51.0145
NCT03081286|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-10|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Treatment of Postmastectomy Pain Syndrome With Fat Grafting|Treatment of Postmastectomy Pain Syndrome With Fat Grafting: A Double-blinded Randomized Controlled Trial|Enrolling by invitation||N/A|40|Anticipated|Odense University Hospital||2|||f||||t|f|f||||||||2017-10-10 21:15:51.092301|2017-10-10 21:15:51.092301
NCT03081273|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-24|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Corynebacterium Spp Bone and Joint Infection: Retrospective Study of Microbiological, Diagnostic and Therapeutic Features|Corynebacterium Spp Bone and Joint Infection: Retrospective Study of Microbiological, Diagnostic and Therapeutic Features|Completed||N/A|49|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:15:51.18945|2017-10-10 21:15:51.18945
NCT03081260|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-07|||April 3, 2017|Actual|2017-04-03|August 2017|2017-08-01|October 3, 2019|Anticipated|2019-10-03|October 3, 2019|Anticipated|2019-10-03||Interventional|||Long-term Evaluation Protocol (12 Months Postoperative) of Total Knee Prostheses Anatomic With Resurfaced Patella Versus Non-resurfaced Patella in Patients Requiring Total Knee Arthroplasty|Long-term Evaluation Protocol (12 Months Postoperative) of Total Knee Prostheses Anatomic With Resurfaced Patella Versus Non-resurfaced Patella in Patients Requiring Total Knee Arthroplasty Prospective, Monocentric, Randomized, Open-label Study|Recruiting||N/A|250|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:15:51.256716|2017-10-10 21:15:51.256716
NCT03081234|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-10-02|||March 31, 2018|Anticipated|2018-03-31|October 2017|2017-10-01|November 17, 2025|Anticipated|2025-11-17|November 17, 2025|Anticipated|2025-11-17||Interventional|EarLEE-2||Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer|A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative, Intermediate Risk Early Breast Cancer|Not yet recruiting||Phase 3|4000|Anticipated|Novartis||2|||f||||t|t|f||||||||2017-10-10 21:15:51.41577|2017-10-10 21:15:51.41577
NCT03081221|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-15|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01|1 Day|Observational [Patient Registry]|||Verification of Endotracheal Tube Placement With Ultrasonography (USG)|Verification of Endotracheal Tube Placement With Ultrasonography (USG) in Patients|Recruiting||N/A|60|Anticipated|Cukurova University|||1||f||||f|f|f||||||Undecided||2017-10-10 21:15:51.504412|2017-10-10 21:15:51.504412
NCT03081195|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-15|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|SMART||SMART Africa (Strengthening Mental Health Research and Training)|SMART Africa: Addressing African Youth Mental Health by Scaling Family and Community-Level EBPs|Not yet recruiting||N/A|7366|Anticipated|NYU Silver School of Social Work||3|||f||||t|f|f||||||No|There will be no individual participant data that will be shared.|2017-10-10 21:15:51.747258|2017-10-10 21:15:51.747258
NCT03081182|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-04-19|||March 16, 2017|Actual|2017-03-16|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||Pediatric Longitudinal Cohort Study of Chronic Pancreatitis|Pediatric Longitudinal Cohort Study of Chronic Pancreatitis (INSPPIRE 2)|Recruiting||N/A|860|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||Samples With DNA|"     Specimens collected at participating sites.   "|||2017-10-10 21:15:51.992717|2017-10-10 21:15:51.992717
NCT03081169|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-27|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|February 15, 2019|Anticipated|2019-02-15|February 15, 2019|Anticipated|2019-02-15||Interventional|||Timing of VTE Prophylaxis in TBI|Timing of Venous Thromboembolism Prophylaxis in Traumatic Brain Injury|Recruiting||Phase 4|200|Anticipated|Loyola University||2|||f||||t|t|f|||f|||No||2017-10-10 21:15:52.11894|2017-10-10 21:15:52.11894
NCT03081156|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-10|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD|An Investigator Initiated, Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of Glycopyrrolate/Formoterol on Exercise Tolerance and Dynamic Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease.|Recruiting||Phase 4|50|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||f|t|f||||||No||2017-10-10 21:15:52.242258|2017-10-10 21:15:52.242258
NCT03081143|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-10|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|March 20, 2021|Anticipated|2021-03-20|March 20, 2021|Anticipated|2021-03-20||Interventional|RAMIRIS||Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy|Ramucirumab Plus Irinotecan / Leucovorin / 5-FU Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed One Prior Line of Palliative Chemotherapy|Recruiting||Phase 2|111|Anticipated|Krankenhaus Nordwest||2|||f||||t|f|f||||||||2017-10-10 21:15:52.356729|2017-10-10 21:15:52.356729
NCT03081130|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-09|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Intravenous Laser Irradiation Effect on Treatment Resistant Thin Endometrium|Effects of Intravenous Laser Irradiation on Treatment Resistant Thin Endometrium in Women Undergoing Frozen Thawed Embryo Transfer Cycles|Recruiting||N/A|60|Anticipated|Kaohsiung Veterans General Hospital.|||2||f||||f|f|f||||Samples Without DNA|"     blood samples   "|No||2017-10-10 21:15:52.457794|2017-10-10 21:15:52.457794
NCT03081117|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Intranasal Insulin for the Treatment of HAND|Clinical Trial of Intranasal Insulin for the Treatment of HIV-associated Neurocognitive Disorder (HAND)|Recruiting||Phase 1/Phase 2|40|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||||2017-10-10 21:15:52.561532|2017-10-10 21:15:52.561532
NCT03081104|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-04-08|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Operative Hysteroscopy and Ultrasound Guided Vacuum Aspiration Versus Blind Vacuum Aspiration for the Treatment of Missed Abortion|Comparative Study Between Operative Hysteroscopy Versus the Ultrasound Guided Vacuum Aspiration Versus the Blind Vacuum Aspiration for the Treatment of the Missed Abortion|Recruiting||N/A|300|Anticipated|Cairo University||3|||f||||t|f|f||||||Yes||2017-10-10 21:15:52.661514|2017-10-10 21:15:52.661514
NCT03081091|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-14|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||Effects of Acupuncture on Pain and Quality of Life of People Affected With Chronic Widespread Pain.|Effects of Acupuncture on Pain and Quality of Life of People Affected With Chronic Widespread Pain. Study Protocol for a Randomized, Triple-blinded, Placebo Controlled Trial.|Recruiting||N/A|100|Anticipated|University of Girona||2|||f|||||f|f||||||||2017-10-10 21:15:52.763705|2017-10-10 21:15:52.763705
NCT03081078|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-02|||May 15, 2017|Anticipated|2017-05-15|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Community-based Caring Contact on Post-discharge Young Adults With Self-harm|Effects of Community-based Caring Contact on Post-discharge Young Adults With Self-harm - a Multi-center Randomized Controlled Trial|Not yet recruiting||N/A|108|Anticipated|The University of Hong Kong||3|||f||||t|f|f||||||No||2017-10-10 21:15:52.860737|2017-10-10 21:15:52.860737
NCT03081065|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-03-08|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|PREDI-DEP||Mediterranean Diet and Recurrence of Depression|Nutritional Intervention With Mediterranean Diet in the Prevention of Recurrence of Depression|Not yet recruiting||N/A|750|Anticipated|University of Las Palmas de Gran Canaria||3|||f||||f|f|f||||||No||2017-10-10 21:15:52.960479|2017-10-10 21:15:52.960479
NCT03081052|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-23|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|iNO vs iEPO||Inhaled Pulmonary Vasodilator Therapy in Left Ventricular Assist Device (LVAD) Implantation, Heart Transplantation, and Lung Transplantation: Prospective, Randomized, Double-Blinded Study|Inhaled Pulmonary Vasodilator Therapy in Left Ventricular Assist Device (LVAD) Implantation, Heart Transplantation, and Lung Transplantation: Prospective, Randomized, Double-Blinded Study|Recruiting||Phase 4|424|Anticipated|Duke University||4|||f||||f|t|f|||f|||No||2017-10-10 21:15:53.045748|2017-10-10 21:15:53.045748
NCT03081039|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-25|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|December 31, 2022|Anticipated|2022-12-31|April 28, 2022|Anticipated|2022-04-28||Interventional|||A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma|A Phase III, Multicenter, Open-Label, Randomized Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablated Intra-Hepatic Cholangiocarcinoma|Not yet recruiting||Phase 3|48|Anticipated|University of Louisville||2|||f||||t|t|f||||||No||2017-10-10 21:15:53.164235|2017-10-10 21:15:53.164235
NCT03081026|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-07-27|||May 1, 2017|Actual|2017-05-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||Transphyseal Vs. Physeal Sparing ACL Reconstruction in Skeletally Immature Patients: Risk of Subsequent Lower Extremity Growth Deformity|Transphyseal Vs. Physeal Sparing ACL Reconstruction in Skeletally Immature Patients: Risk of Subsequent Lower Extremity Growth Deformity|Recruiting||N/A|100|Anticipated|Duke University|||3||f||||f|f|f||||||||2017-10-10 21:15:53.263217|2017-10-10 21:15:53.263217
NCT03081013|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-15|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FIT-TEEN||Randomized Controlled Trial of a Physical Activity Program for Teenagers|Randomized Controlled Trial of a Physical Activity Program for Teenagers (FIT-TEEN)|Recruiting||N/A|312|Anticipated|Duke-NUS Graduate Medical School||2|||f||||t|f|f||||||Yes|Upon request from the principal investigator, individual participant data will be available to other researchers for secondary analysis purposes, such as meta-analyses, reanalysis or replication of results. Any data that will be shared will be de-identified so privacy of the participants will be protected.|2017-10-10 21:15:53.371589|2017-10-10 21:15:53.371589
NCT03081000|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-08-27|||October 2015||2015-10-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|March 2016|Actual|2016-03-01||Observational|||Perioperative Hypothermia: A Multi-center Study of Incidence, Risk Factors and Preventive Measures.|Perioperative Hypothermia: A Multi-center Study of Incidence, Risk Factors and Preventive Measures.|Completed||N/A|4000|Actual|KK Women's and Children's Hospital|||1||f||||t||||||||||2017-10-10 21:15:53.509604|2017-10-10 21:15:53.509604
NCT03080987|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-29|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|June 23, 2018|Anticipated|2018-06-23|June 23, 2018|Anticipated|2018-06-23||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese Participants|A 2-Part Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese Subjects|Recruiting||Phase 1|48|Anticipated|Janssen Research & Development, LLC||6|||f||||f|f|f|||f|||||2017-10-10 21:15:53.602396|2017-10-10 21:15:53.602396
NCT03080974|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-09-29|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 1, 2022|Anticipated|2022-04-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma|Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma|Recruiting||Phase 2|10|Anticipated|University of Louisville||1|||f||||t|t|f|||f|||||2017-10-10 21:15:53.725874|2017-10-10 21:15:53.725874
NCT03080961|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-28|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SAFE||The VIBLOK SAfety and perFormancE Trial|The VIBLOK SAfety and perFormancE Trial|Recruiting||N/A|48|Anticipated|CLJI Worldwide||1|||f||||t|f|f||||||||2017-10-10 21:15:53.81837|2017-10-10 21:15:53.81837
NCT03080948|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-08-09|||March 9, 2017|Actual|2017-03-09|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Risk Stratification Among Individuals Who Have Many Moles on Their Skin|Cutaneous Melanoma Risk Stratification of Individuals With a High-Risk Nevus Phenotype|Enrolling by invitation||N/A|150|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f|||||f|f|||f|Samples With DNA|"     saliva   "|||2017-10-10 21:15:53.931016|2017-10-10 21:15:53.931016
NCT03080935|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-07-31|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|October 22, 2022|Anticipated|2022-10-22|October 22, 2022|Anticipated|2022-10-22||Interventional|||Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries|A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries|Recruiting||Phase 3|1600|Anticipated|Amgen||1|||f||||f|t|f|||t|||||2017-10-10 21:15:54.035667|2017-10-10 21:15:54.035667
NCT03080922|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-30|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML|Treatment of Relapsed/Refractory Acute Myeloblastic Leukemia(AML) by Infusion of Donor High Dose Allogeneic Mismatched Hematopoietic Stem Cells After Chemotherapy|Recruiting||Phase 1/Phase 2|10|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||1|||f||||t|f|f||||||Undecided||2017-10-10 21:15:54.278392|2017-10-10 21:15:54.278392
NCT03080909|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-19|||March 28, 2017|Actual|2017-03-28|June 2017|2017-06-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|ENDORSE||Encapsulated Nutrients' Acute Effects on Appetite; ENcapsulated, lipiD, aminO, pRobiotic, SatiEty|Encapsulated Nutrients' Acute Effects on Appetite|Completed||N/A|33|Actual|University of Copenhagen||2|||f||||t|f|f||||||No|No IPD will be shared|2017-10-10 21:15:54.375592|2017-10-10 21:15:54.375592
NCT03080896|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-06-27|||April 10, 2017|Actual|2017-04-10|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|COMBO||Video-Laryngoscope Alone or With Bronchoscope for Predicted Difficult Intubation|Comparison of Video-Laryngoscope Versus a Combination of a Video-Laryngoscope and Disposable Bronchoscope for Predicted Difficult Airway Intubation of Anesthetized Patients for Oral Cavity, Pharynx or Larynx Surgery|Recruiting||N/A|80|Anticipated|University of Louisville||2|||f||||f|f|t|f|f||||Undecided|individual patients data will not be shared. Results or the studies findings will be published|2017-10-10 21:15:54.458569|2017-10-10 21:15:54.458569
NCT03080883|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-05-01|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|||Apixaban in Preventing Secondary Cancer Related Blood Clots in Cancer Patients Who Have Completed Anticoagulation Therapy|A Phase III, Randomized, Controlled, Double-Blind Study Evaluating the Safety of Two Doses of Apixaban for Secondary Prevention of Cancer Related Venous Thrombosis in Subjects Who Have Completed at Least Six Months of Anticoagulation Therapy|Not yet recruiting||Phase 3|370|Anticipated|Academic and Community Cancer Research United||2|||f||||t|t|f||||||||2017-10-10 21:15:54.549631|2017-10-10 21:15:54.549631
NCT03080870|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-14|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|JOYofART||JOYof ART - an Intervention Study|JOY of ART - an Intervention Study for Older Adults and Their Family Caregivers|Recruiting||N/A|120|Anticipated|University of Eastern Finland||2|||f||||f|f|f||||||No||2017-10-10 21:15:54.68349|2017-10-10 21:15:54.68349
NCT03080857|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-06-19|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Computer Simulated Atrial Fibrillation Tool|Computer Simulated Atrial Fibrillation Tool to Reduce Hospitalizations and Emergency Department Visits|Not yet recruiting||N/A|75|Anticipated|Nova Scotia Health Authority||1|||f||||f|f|f||||||No||2017-10-10 21:15:54.771327|2017-10-10 21:15:54.771327
NCT03080844|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-05-17|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|COPE||Neuroimaging Studies of Practice and Smoking|Smoking Cessation and Brain Activation: How Practice Changes the Brain|Recruiting||N/A|110|Anticipated|University of Kansas Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:15:54.860011|2017-10-10 21:15:54.860011
NCT03080831|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-05-01|||March 9, 2017|Actual|2017-03-09|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|TOPMAST-1||TOnicity of Perioperative Maintenance SoluTions|TOnicity of Perioperative Maintenance SoluTions - Part 1: Thoracic Surgery|Recruiting||Phase 4|68|Anticipated|University Hospital, Antwerp||2|||f||||f|f|f|||f|||Undecided|Anonymized data available on reasonable request|2017-10-10 21:15:54.931593|2017-10-10 21:15:54.931593
NCT03080818|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-09|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Probiotic on Psychological and Cognitive Effects|Evaluation of a Probiotic on Psychological and Cognitive Effects in Middle and Older Adults|Recruiting||N/A|200|Anticipated|Kent State University||2|||f||||f|f|f||||||No||2017-10-10 21:15:55.029488|2017-10-10 21:15:55.029488
NCT03080805|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-07|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer|A Randomised, Open-label, Parallel Controlled, Multicentre, Phase 3 Clinical Trial of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer:|Not yet recruiting||Phase 3|240|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f|||||t|f|||t|||||2017-10-10 21:15:55.11998|2017-10-10 21:15:55.11998
NCT03080792|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-05-24|||November 2016||2016-11-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PRESENT-P||Pre-Exercise for Allogeneic Stem Cell Transplant Patients|Pre-Exercise for Allogeneic Stem Cell Transplant Patients: a Pilot Study|Recruiting||N/A|30|Anticipated|University Hospital Heidelberg||1|||f||||f||||||||No||2017-10-10 21:15:55.356177|2017-10-10 21:15:55.356177
NCT03080779|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-09-29|||February 3, 2017|Actual|2017-02-03|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|July 2018|Anticipated|2018-07-01||Observational|||Long Term Outcomes After Accidental Dural Puncture ADP Study|The Incidence of Chronic Headache and Low Back Pain After Accidental Dural Puncture (ADP) With a Tuohy Needle and Epidural Blood Patch in the Obstetric Population: A Prospective 2-group Cohort Multicentre Study|Recruiting||N/A|270|Anticipated|University Hospitals, Leicester|||2||f||||f||||||||||2017-10-10 21:15:55.492218|2017-10-10 21:15:55.492218
NCT03080766|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-09|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 28, 2021|Anticipated|2021-02-28|November 30, 2020|Anticipated|2020-11-30||Interventional|||The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype|The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype|Recruiting||Phase 2|20|Anticipated|The University of Hong Kong||1|||f||||t|f|f||||||Undecided||2017-10-10 21:15:55.597766|2017-10-10 21:15:55.597766
NCT03080753|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|||Treatment of Anal Incontinence With Intersphincteric Implants|Treatment of Anal Incontinence Using Intersphincteric Implants (SphinKeeper)|Not yet recruiting||N/A|52|Anticipated|Region Skane||1|||f||||f|f|f||||||||2017-10-10 21:15:55.690518|2017-10-10 21:15:55.690518
NCT03080740|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis|The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet for the Treatment of Bacterial Vaginosis|Recruiting||Phase 4|300|Anticipated|Guangzhou Yipinhong Pharmaceutical CO.,LTD||2|||f||||t||||||||Undecided||2017-10-10 21:15:55.791695|2017-10-10 21:15:55.791695
NCT03080727|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-16|||April 13, 2017|Anticipated|2017-04-13|March 2017|2017-03-01|August 31, 2017|Anticipated|2017-08-31|May 19, 2017|Anticipated|2017-05-19||Observational|||Intraobserver and Interobserver Reproducibility on Hip Clinical Assessment|Intraobserver and Interobserver Reproducibility on Hip Clinical Assessment|Recruiting||N/A|20|Anticipated|Federal University of Rio Grande do Sul|||1||f||||t|f|f||||||||2017-10-10 21:15:55.893362|2017-10-10 21:15:55.893362
NCT03080714|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-08-03|||March 13, 2017|Actual|2017-03-13|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Triton Agreement and Precision Study|Topcon DRI OCT Triton Agreement and Precision Study|Active, not recruiting||N/A|150|Anticipated|Topcon Medical Systems, Inc.||3|||f||||f|f|t|t|f|f|||||2017-10-10 21:15:55.958602|2017-10-10 21:15:55.958602
NCT03080701|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-27|||March 23, 2017|Actual|2017-03-23|June 2017|2017-06-01|September 4, 2017|Anticipated|2017-09-04|September 4, 2017|Anticipated|2017-09-04||Interventional|||Financial Incentives to Increase Colorectal Cancer Screening in Priority Populations|Systems of Support (SOS) to Increase Colon Cancer Screening Disparities Supplement|Recruiting||N/A|1150|Anticipated|Kaiser Permanente||3|||f||||f|f|f||||||No||2017-10-10 21:15:56.043802|2017-10-10 21:15:56.043802
NCT03080688|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-09|||April 15, 2016|Actual|2016-04-15|March 2017|2017-03-01|April 16, 2016|Actual|2016-04-16|April 15, 2016|Actual|2016-04-15||Observational|||Prizma Pulse Oximeter Evaluation|Prizma Pulse Oximeter Evaluation|Completed||N/A|12|Actual|G Medical Innovations Ltd.|||1||f||||f|f|t|t|||||No||2017-10-10 21:15:56.145064|2017-10-10 21:15:56.145064
NCT03080675|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-03-09|||November 2016||2016-11-01|March 2017|2017-03-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Interventional|||Trial of a Nutritional Blend to Prevent Cognitive Decline in Older Adults|Trial of a Nutritional Blend to Prevent Cognitive Decline in Older Adults|Recruiting||N/A|2080|Anticipated|Nestlé||2|||f||||f||||||||No||2017-10-10 21:15:56.219428|2017-10-10 21:15:56.219428
NCT03080662|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-14|||January 22, 2015|Actual|2015-01-22|March 2017|2017-03-01|March 15, 2018|Anticipated|2018-03-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Impact of Inspiratory Muscle Training on Daily Physical Activity (INAF)|Impact of Inspiratory Muscle Training on Daily Physical Activity (INAF)|Recruiting||N/A|20|Anticipated|Parc de Salut Mar||2|||f||||f|f|f||||||No||2017-10-10 21:15:56.339362|2017-10-10 21:15:56.339362
NCT03080649|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-03-14|||August 31, 2011|Actual|2011-08-31|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2016|Actual|2016-04-30||Interventional|||Laser in Caries Treatment - Patients´View, Pulpal Reactions and Survival of Fillings|Laser in Caries Treatment - Patients´View, Pulpal Reactions and Survival of Fillings. A Randomized Controlled Trial.|Active, not recruiting||N/A|25|Actual|Public Dental Health in Uppsala Region||2|||f||||f|f|f||||||No|IPD are not planned to be shared|2017-10-10 21:15:56.420191|2017-10-10 21:15:56.420191
NCT03080636|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-09|||January 1, 2014|Actual|2014-01-01|March 2017|2017-03-01|February 20, 2015|Actual|2015-02-20|December 24, 2014|Actual|2014-12-24||Interventional|||Sex and Exercise-mode Differences in Post Exercise Blood Pressure and Heart Rate Variability Responses During Workday|Sex and Exercise-mode Differences in Post Exercise Blood Pressure and Heart Rate Variability Responses During Workday|Completed||N/A|20|Actual|Federal University of Uberlandia||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:56.510884|2017-10-10 21:15:56.510884
NCT03080623|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-09|||May 1, 2018|Anticipated|2018-05-01|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|June 30, 2020|Anticipated|2020-06-30||Observational|||Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion|Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion|Not yet recruiting||N/A|1872|Anticipated|Peking University|||1||f||||t|f|f||||Samples Without DNA|"     Breast biopsy pathology   "|No||2017-10-10 21:15:56.609721|2017-10-10 21:15:56.609721
NCT03080610|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-09|||January 1, 2006|Actual|2006-01-01|March 2017|2017-03-01|December 1, 2015|Actual|2015-12-01|December 1, 2015|Actual|2015-12-01||Observational|||The Occurrence of Post Dural Puncture Headache After Epidural Blood Patch|Factors Influencing the Occurrence of Post Dural Puncture Headache in Patients Undergoing Cesarean Section After Epidural Blood Patch|Completed||N/A|74|Actual|Siriraj Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:15:56.689836|2017-10-10 21:15:56.689836
NCT03080597|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-20|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PrEP for HBCUs||PrEP for HBCUs (Study 2)|PrEP for HBCUs (Study 2)|Recruiting||N/A|20|Anticipated|Duke University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:15:56.756591|2017-10-10 21:15:56.756591
NCT03080584|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-15|||November 12, 2016|Actual|2016-11-12|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31||Interventional|||Effect of 12 Weeks of Acupuncture on AMH and COH in Low Responder Patients|Effect of 12 Weeks of Acupuncture on AMH and Ovarian Reserve in Women With Low Ovarian Reserve. A Pilot Study|Recruiting||N/A|50|Anticipated|Dansk Fertilitetsklinik||1|||f||||f|f|f||||||No||2017-10-10 21:15:56.85219|2017-10-10 21:15:56.85219
NCT03080571|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-14|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Intraarterial Stem Cells in Subacute Ischemic Stroke|To Evaluate the Safety, Feasibility and Clinical Outcome of Intraarterial Infusion of Bone Marrow Derived Mononuclear Cells in Subacute Ischaemic Stroke Patients|Completed||Phase 1|20|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t|t|f|||f|||No||2017-10-10 21:15:56.941211|2017-10-10 21:15:56.941211
NCT03080558|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-14|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|INDIE||Estimation of Vascularization After Treatment of Deep Rectovaginal Endometriosis Node by Rectal Shaving|Estimation of Vascularization After Treatment of Deep Rectovaginal Endometriosis Node by Rectal Shaving, Using Indocyanine Green Injection. Feasibility Study|Not yet recruiting||Phase 4|30|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 21:15:57.021187|2017-10-10 21:15:57.021187
NCT03080545|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-09|||March 15, 2017|Anticipated|2017-03-15|March 2017|2017-03-01|November 15, 2017|Anticipated|2017-11-15|October 25, 2017|Anticipated|2017-10-25||Interventional|||Enstilar in Combination With Biologic Agents|An Open-Label, Study Evaluating Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% QD in Psoriasis Patients Being Treated With Biologic Agents|Not yet recruiting||Phase 4|25|Anticipated|Psoriasis Treatment Center of Central New Jersey||1|||f||||f|t|f|||f|||No||2017-10-10 21:15:57.116111|2017-10-10 21:15:57.116111
NCT03080532|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-09|||May 2016||2016-05-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|February 2017|Actual|2017-02-01||Observational|DIAGRAM||Diet Interactions With Human Gut Microbiota. The Potential Role of Mediterranean Diet Adherence. DIAGRAM, a Pilot Study|Diet Interactions With Human Gut Microbiota. The Potential Role of Mediterranean Diet Adherence. DIAGRAM, a Pilot Study|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 21:15:57.191531|2017-10-10 21:15:57.191531
NCT03080519|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-14|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2024|Anticipated|2024-04-01|April 2022|Anticipated|2022-04-01||Interventional|ETRAS-China||Endovascular Therapy for Renal Artery Stenosis in China|A Multicenter Registry of Endovascular Therapy for Renal Artery Stenosis in China|Not yet recruiting||N/A|5000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:15:57.290391|2017-10-10 21:15:57.290391
NCT03080506|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-09|||March 13, 2017|Anticipated|2017-03-13|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Abdominal Binder Following Cesarean Delivery|Effect of Elastic Abdominal Binder on Pain and Functional Recovery After Cesarean Delivery: a Randomized Controlled Trial|Not yet recruiting||N/A|170|Anticipated|Chiang Mai University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:57.429435|2017-10-10 21:15:57.429435
NCT03080493|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-13|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|GABA||Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial|Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial|Recruiting||Phase 4|120|Anticipated|University of California, Davis||2|||f|||||t|f||||||||2017-10-10 21:15:57.51477|2017-10-10 21:15:57.51477
NCT03080480|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-07|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Pioglitazone Therapy for Chronic Granulomatous Disease|Efficacy and Safety of Pioglitazone Therapy for Chronic Granulomatous Disease Patients With Severe Infection.|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|Children's Hospital of Fudan University||1|||f||||t|f|f||||||No||2017-10-10 21:15:57.621211|2017-10-10 21:15:57.621211
NCT03080129|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-24|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Microbiome and Sarcopenia in Patients With Liver Cirrhosis|Microbiome and Sarcopenia in Patients With Liver Cirrhosis: A Prospective Controlled Cohort Study|Recruiting||N/A|120|Anticipated|Medical University of Graz||2|||f||||f|f|f||||||No||2017-10-10 21:16:00.321658|2017-10-10 21:16:00.321658
NCT03080467|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-14|||June 13, 2017|Actual|2017-06-13|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|||Long-Term Outcome of Pediatric Traumatic Wound Repair: Suture Versus Tissue Adhesive|Long-term Outcome of the Primary Wound Repair of Traumatic Skin Lacerations in the Head Area in Pediatric Patients: Suture Versus Tissue Adhesive|Recruiting||N/A|400|Anticipated|University Children's Hospital, Zurich|||2||f||||t|f|f||||||||2017-10-10 21:15:57.707024|2017-10-10 21:15:57.707024
NCT03080454|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||September 2016||2016-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke|The Effect of Treatment With the PathMaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients With Severe Hand Spasticity After Stroke|Recruiting||N/A|23|Anticipated|Northwell Health||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:57.793545|2017-10-10 21:15:57.793545
NCT03080441|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-09|||November 11, 2016|Actual|2016-11-11|March 2017|2017-03-01|May 1, 2017|Anticipated|2017-05-01|April 1, 2017|Anticipated|2017-04-01||Interventional|||Minimization of Intradialytic Hypotension Using Cardiography-Guided Intervention|Minimization of Intradialytic Hypotension Using Cardiography-Guided Intervention|Enrolling by invitation||Phase 4|35|Anticipated|Nimedical||3|||f|||||t|t|f||t|||No|There is no current plan to share IPD with other researchers|2017-10-10 21:15:57.885673|2017-10-10 21:15:57.885673
NCT03080428|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-25|||May 2017|Anticipated|2017-05-01|August 2017|2017-08-01|May 2023|Anticipated|2023-05-01|June 2018|Anticipated|2018-06-01||Interventional|OPTIGEN||Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer|Prospective Multicenter Randomized Study Assessing Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer With Uncertainty on the Indication of Chemotherapy Using Standard Assessments.|Withdrawn||N/A|0|Actual|UNICANCER||4||The study has been withdrawn because of lack of funding|f||||f|f|f||||||||2017-10-10 21:15:57.95489|2017-10-10 21:15:57.95489
NCT03080415|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-31|||March 18, 2017|Actual|2017-03-18|March 2017|2017-03-01|June 15, 2018|Anticipated|2018-06-15|September 15, 2017|Anticipated|2017-09-15||Interventional|||Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir|The Safety and Efficacy of Sofosbuvir & Daclatasvir Combined Therapy for Treatment of Egyptian Children and Adolescents With Chronic Hepatitis C (HCV)-Genotype 4|Enrolling by invitation||Phase 3|40|Anticipated|Yassin Abdelghaffar Charity Center for Liver Disease and Research||1|||f||||f|f|f||||||No||2017-10-10 21:15:58.033936|2017-10-10 21:15:58.033936
NCT03080402|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-09|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Mechanical Perturbation Training for ACL Injury Prevention|Mechanical Perturbation Training for ACL Injury Prevention|Recruiting||N/A|24|Anticipated|University of Delaware||2|||f||||f|f|f||||||No|There is currently no IPD sharing plan.|2017-10-10 21:15:58.125554|2017-10-10 21:15:58.125554
NCT03080389|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-04-18|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections|Are Extended Urine Cultures More Sensitive Than Standard Urine Cultures in Diagnosing Urinary Tract Infections in Patients With Urgency and Frequency?|Recruiting||N/A|26|Anticipated|The Cleveland Clinic|||1||f||||f||||||Samples Without DNA|"     Urine specimens will be retained.   "|No|Patient information will not be shared with outside researchers.|2017-10-10 21:15:58.229059|2017-10-10 21:15:58.229059
NCT03080376|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-09-22|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Home Exercise Intervention in Childhood Obesity|Home Exercise Intervention in Childhood Obesity: Randomized Clinical Trial Comparing Print-based Versus Web-based Platform|Completed||N/A|51|Actual|Cardenal Herrera University||3|||f||||t|f|f||||||||2017-10-10 21:15:58.315735|2017-10-10 21:15:58.315735
NCT03080363|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-06|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|May 15, 2017|Actual|2017-05-15||Interventional|||Analgesic Efficacy of Ultrasound Guided Quadratus Lumborum Block During ESWL|Is Painless ESWL Possible? Analgesic Efficacy of Ultrasound Guided Quadratus Lumborum Block During Extracorporeal Shockwave Lithotripsy|Completed||Phase 4|40|Actual|Ataturk University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:15:58.395317|2017-10-10 21:15:58.395317
NCT03080350|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2017-03-09|||January 2017||2017-01-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|April 2017|Anticipated|2017-04-01||Interventional|||Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope|Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope - a Double-blind Randomized Prospective Study|Recruiting||Phase 4|108|Anticipated|Azienda Sanitaria dell'Alto Adige||2|||f||||f|t|f||||||No||2017-10-10 21:15:58.470891|2017-10-10 21:15:58.470891
NCT03080337|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-18|||March 17, 2017|Actual|2017-03-17|July 2017|2017-07-01|May 1, 2021|Anticipated|2021-05-01|March 3, 2021|Anticipated|2021-03-03||Interventional|||Group vs. Traditional Diabetes Prenatal Care|Group Prenatal Care Compared to Traditional Prenatal Care for Women With Pre-gestational Diabetes: A Randomized Clinical Trial.|Recruiting||N/A|190|Anticipated|University of Wisconsin, Madison||2|||f||||f|f|f||||||||2017-10-10 21:15:58.584738|2017-10-10 21:15:58.584738
NCT03080324|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2017-03-09|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room|Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the ER - a Double-blind Randomized Prospective Study|Recruiting||Phase 4|108|Anticipated|Azienda Sanitaria dell'Alto Adige||2|||f||||f|t|f||||||No||2017-10-10 21:15:58.666756|2017-10-10 21:15:58.666756
NCT03080311|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-06-21|||February 12, 2017|Actual|2017-02-12|March 2017|2017-03-01|February 12, 2019|Anticipated|2019-02-12|February 12, 2019|Anticipated|2019-02-12||Interventional|||A Study of APG-1252 in Patients With SCLC or Other Solid Tumors|A Phase I Study of the Safety, Pharmacokinetic and Pharmacodynamic Properties of Intravenously Administered APG-1252 in Patients With Small Cell Lung Cancer (SCLC) or Other Solid Tumors|Recruiting||Phase 1|50|Anticipated|Ascentage Pharma Group Inc.||1|||f||||t|t|f||||||No||2017-10-10 21:15:58.755218|2017-10-10 21:15:58.755218
NCT03079934|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-03-08|||May 2013|Actual|2013-05-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Observational|||Vascular Healing After BVS-implantation|Vascular Healing After Implantation of Bioresorbable Vascular Scaffold in Different Clinical Settings and Follow-up Time Points|Completed||N/A|200|Actual|Klinikum der Universitaet Muenchen|||1||f||||f||||||||No||2017-10-10 21:16:02.141334|2017-10-10 21:16:02.141334
NCT03080298|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-15|||March 14, 2016|Actual|2016-03-14|August 2017|2017-08-01|July 25, 2017|Actual|2017-07-25|April 4, 2017|Actual|2017-04-04||Interventional|||Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire|International, Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2a Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire|Completed||Phase 2|119|Actual|Ivix LLX||2|||f||||f|f|f||||||||2017-10-10 21:15:58.841426|2017-10-10 21:15:58.841426
NCT03080285|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-14|||July 2014||2014-07-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|OPTA||Efficacy of Over-glasses Patch Treatment for Amblyopia in Children : OPTA Study|Efficacy of Over-glasses Patch Treatment for Amblyopia in Children :OPTA Study, A Prospective Randomized Clinical Trial|Completed||N/A|107|Actual|Pusan National University Hospital||2|||f||||f||||||||No||2017-10-10 21:15:58.928264|2017-10-10 21:15:58.928264
NCT03080272|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-10|||March 3, 2017|Actual|2017-03-03|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||"Do we Achieve the Goal of No Worse Than Mild Pain in Daily Clinical Practice?"|"The Goal of no Worse Than Mild Pain in Daily Clinical Practice: Individual Responder Analysis - a Cross-sectional Prospective Cohort Study of Surgical Patients at Zealand University Hospital, Koege"|Recruiting||N/A|200|Anticipated|Zealand University Hospital|||5||f||||t||||||||Undecided|no plan|2017-10-10 21:15:59.004116|2017-10-10 21:15:59.004116
NCT03080259|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-03-09|||May 2016||2016-05-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|January 2020|Anticipated|2020-01-01||Interventional|||Primary Care Prevention of Stimulant Diversion by High School Students With ADHD|Primary Care Prevention of Stimulant Diversion by High School Students With ADHD|Enrolling by invitation||N/A|450|Anticipated|University of Pittsburgh||2|||f||||f||||||||Yes|The investigators will make de-identified data available to potential scientific collaborators upon request as allowed by local Institutional Review Board (IRB) regulations and after the main findings of the study have been accepted for publication. The investigators will honor requests to use data for research or teaching purposes only and that include a commitment to protect the privacy and confidentiality of the data per IRB requirements. Depending upon the size of the request, the investigators will charge, as needed, reasonable costs associated with preparation of datasets and assistance with dataset utilization.|2017-10-10 21:15:59.11077|2017-10-10 21:15:59.11077
NCT03080246|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-03-08|||December 2015||2015-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|STARS||Effects of Strength Training on Musculoskeletal Overuse Injuries in Female Runners|Effects of Strength Training on Musculoskeletal Overuse Injuries in Female Runners|Recruiting||N/A|150|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:15:59.295025|2017-10-10 21:15:59.295025
NCT03080233|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-09|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Validation of Clinical Decision Support Tool for Acute Stroke Diagnosis (InstaDx)|Validation of Clinical Decision Support Tool Information Technology Application for Stroke Diagnosis|Active, not recruiting||N/A|210|Actual|Aga Khan University|||1||f||||t||||||||No|This may be shared on request only.|2017-10-10 21:15:59.420267|2017-10-10 21:15:59.420267
NCT03080220|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-11|2017-03-16|||September 1, 2016|Actual|2016-09-01|March 2017|2017-03-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Examining the Effects of Three Soft Tissue Treatments on Functional Movement and Functional Performance Enhancement|Effects of Pre-Event Soft Tissue Treatment on Functional Movement and Functional Performance|Completed||N/A|48|Actual|Rocky Mountain University of Health Professions||3|||f||||f|f|f||||||No|There is no plan to share individual participant data at this point.|2017-10-10 21:15:59.510139|2017-10-10 21:15:59.510139
NCT03080207|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-14|||January 17, 2017|Actual|2017-01-17|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Platelet Rich Plasma, Complex Decongestive Physiotherapy and Low Level Laser in Treatment of Lower Extremity Lymphoedema|Comparison of Efficacy of Platelets / Platelet Enriched Plasma Regard (PRP) Method, Complex Decongestive Physiotherapy and Low Level Laser in Treatment of Lower Extremity Lymphoedema|Recruiting||N/A|45|Anticipated|Istanbul University||3|||f||||f|f|f||||||No||2017-10-10 21:15:59.635557|2017-10-10 21:15:59.635557
NCT03080194|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-04-22|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia|The Effect of a Community-based Long-acting Antipsychotic-treated Management Model on the Violence Risk of Patients With Schizophrenia: a 1-year, Open-label Randomized Controlled Study|Not yet recruiting||Phase 4|150|Anticipated|Huazhong University of Science and Technology||2|||f||||f|t|f|||f|||Undecided||2017-10-10 21:15:59.768203|2017-10-10 21:15:59.768203
NCT03080181|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-14|||May 2013|Actual|2013-05-01|March 2017|2017-03-01|January 28, 2017|Actual|2017-01-28|December 30, 2016|Actual|2016-12-30||Interventional|||Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment|Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment: Correlation With Disease Activity, Insulin Sensitivity and Secretion Parameters|Completed||Phase 4|24|Actual|University of Palermo||1|||f||||f|t|f|||f|||No||2017-10-10 21:15:59.878827|2017-10-10 21:15:59.878827
NCT03080168|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-08|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|August 30, 2020|Anticipated|2020-08-30|April 30, 2020|Anticipated|2020-04-30||Observational|AIM||"The AIM Study: Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety"|Assessing Actigraphy-Determined Movement Variability as a Novel Objective Marker|Recruiting||N/A|115|Anticipated|VA Office of Research and Development|||1||f||||t|f|f|||f|||||2017-10-10 21:15:59.956149|2017-10-10 21:15:59.956149
NCT03080155|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-18|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer|Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer|Recruiting||N/A|680|Anticipated|Real Imaging Ltd.||1|||f|||||f|f||||||||2017-10-10 21:16:00.100992|2017-10-10 21:16:00.100992
NCT03080142|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-26|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery|Transversus Abdominus Plane (TAP) Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery: A Prospective Randomized Control Trial|Recruiting||Phase 4|100|Anticipated|University of California, Davis||2|||f||||f|t|f||||||No||2017-10-10 21:16:00.206446|2017-10-10 21:16:00.206446
NCT03080116|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-08|||April 30, 2017|Anticipated|2017-04-30|February 2017|2017-02-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2022|Anticipated|2022-04-30||Interventional|ARNEO||Neoadjuvant Degarelix +/- Apalutamide (ARN-509) Followed by Radical Prostatectomy|Neoadjuvant Degarelix +/- Apalutamide (ARN-509) Followed by Radical Prostatectomy for Intermediate and High-risk Prostate Cancer: a Randomized, Placebo-controlled Trial|Not yet recruiting||Phase 2|84|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f|t|f|||f|||||2017-10-10 21:16:00.464569|2017-10-10 21:16:00.464569
NCT03080103|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-08-12|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|ACTUAA||Appendectomy Versus Conservative Treatment for Uncomplicated Acute Appendicitis|A Prospective Non-randomized Controlled, Multicenter, Multidisciplinary Trial Comparing Appendectomy and Conservative Treatment for Patients With Uncomplicated Acute Appendicitis (the ACTUAA STUDY).|Recruiting||N/A|600|Anticipated|Associazione Chirurghi Ospedalieri Italiani|||2||f||||t|f|f||||Samples With DNA|"     Specimens of the appendix   "|||2017-10-10 21:16:00.599683|2017-10-10 21:16:00.599683
NCT03080090|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-27|||April 12, 2017|Actual|2017-04-12|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||YMCA Exercise Intervention for Smoking Cessation Study|YMCA Exercise Intervention for Smoking Cessation Study|Recruiting||N/A|150|Anticipated|University of Texas at Austin||2|||f||||f|f|f||||||||2017-10-10 21:16:00.839729|2017-10-10 21:16:00.839729
NCT03080077|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||June 2016||2016-06-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|CXL||Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia|Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia|Recruiting||Phase 3|200|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||No||2017-10-10 21:16:00.965283|2017-10-10 21:16:00.965283
NCT03080064|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-14|||July 16, 2015|Actual|2015-07-16|March 2017|2017-03-01|June 27, 2016|Actual|2016-06-27|June 27, 2016|Actual|2016-06-27||Interventional|AHA||Health Coach Intervention Pilot Study|Supporting Healthful Lifestyles During Pregnancy: A Health Coach Intervention Pilot Study|Completed||N/A|30|Actual|Harvard Pilgrim Health Care||1|||f||||f|f|f||||||No||2017-10-10 21:16:01.095254|2017-10-10 21:16:01.095254
NCT03080051|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-10-05|||August 2016||2016-08-01|October 2017|2017-10-01|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|||Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain|Phase 0 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Progressive Supranuclear Palsy or Alzheimer's Disease Compared to Healthy Volunteers|Completed||Early Phase 1|6|Actual|Molecular NeuroImaging||1|||f||||||||||||||2017-10-10 21:16:01.178307|2017-10-10 21:16:01.178307
NCT03080038|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-14|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|March 30, 2020|Anticipated|2020-03-30|December 31, 2019|Anticipated|2019-12-31||Interventional|SQUEEZE||SQUEEZE Trial: A Trial to Determine Whether Septic Shock Reversal is Quicker in Pediatric Patients Randomized to an Early Goal Directed Fluid Sparing Strategy vs. Usual Care|SQUEEZE Trial: A Trial to Determine Whether Septic Shock Reversal is Quicker in Pediatric Patients Randomized to an Early Goal Directed Fluid Sparing Strategy vs. Usual Care|Recruiting||N/A|400|Anticipated|McMaster University||2|||f||||t|f|f||||||Yes|The final trial data set will be made public.|2017-10-10 21:16:01.309648|2017-10-10 21:16:01.309648
NCT03080025|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-03-08|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|SIDE||Social Interaction and Compassion in Depression|The Effects of a Cognitively-based Compassion Training on Health and Social Interaction in Depressed Patients and Their Partners|Recruiting||N/A|216|Anticipated|Heidelberg University||2|||f||||f||||||||Yes||2017-10-10 21:16:01.478187|2017-10-10 21:16:01.478187
NCT03080012|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-21|||March 7, 2017|Actual|2017-03-07|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs|An Observational Study of Salivary Versus Blood Concentrations of Various Anti-Tuberculosis Drugs in Tuberculosis Patients|Recruiting||N/A|25|Anticipated|University Medical Center Groningen|||1||f||||f||||||||Undecided|Encoded data can be shared for scientific use up to 15 years after study completion.|2017-10-10 21:16:01.595368|2017-10-10 21:16:01.595368
NCT03079999|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Study of Aspirin in Patients With Vestibular Schwannoma|Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas|Not yet recruiting||Phase 2|300|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f|||||t|f|||f|||||2017-10-10 21:16:01.681666|2017-10-10 21:16:01.681666
NCT03079986|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-07-03|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|June 30, 2021|Anticipated|2021-06-30|April 30, 2021|Anticipated|2021-04-30||Interventional|CLAP||Chyle Leak After Pancreatic Surgery|Chyle Leak After Pancreatic Surgery - CLAP|Recruiting||N/A|86|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f|f|f||||||||2017-10-10 21:16:01.765862|2017-10-10 21:16:01.765862
NCT03079973|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-28|||May 15, 2017|Anticipated|2017-05-15|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s|A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis|Not yet recruiting||Phase 3|470|Anticipated|Polichem S.A.||2|||f||||f|t|f||||||Undecided||2017-10-10 21:16:01.853164|2017-10-10 21:16:01.853164
NCT03079960|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-14|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Data-Driven Characterization of Neuronal Markers During Deep Brain Stimulation for Patients With Parkinson's Disease|Data-Driven Characterization of Neuronal Markers During Deep Brain Stimulation for Patients With Parkinson's Disease|Not yet recruiting||N/A|20|Anticipated|University Hospital Freiburg||1|||f||||f|f|f||||||Undecided||2017-10-10 21:16:01.930307|2017-10-10 21:16:01.930307
NCT03079947|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-22|||January 2017||2017-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients|Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in Non-hodgkin Lymphoma Patients|Recruiting||N/A|300|Anticipated|Peking Union Medical College Hospital|||1||f||||t|f|f||||Samples With DNA|"     circulating DNA from plasma   "|Undecided||2017-10-10 21:16:02.055417|2017-10-10 21:16:02.055417
NCT03079921|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-16|||January 20, 2017|Actual|2017-01-20|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Adrenergic System in Islet Transplantation|Adrenergic Contribution to Glucose Counterregulation in Islet Transplantion|Recruiting||N/A|45|Anticipated|University of Pennsylvania||5|||f||||t|f|f|||f|||Undecided||2017-10-10 21:16:02.223085|2017-10-10 21:16:02.223085
NCT03079908|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-17|||August 15, 2017|Actual|2017-08-15|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of da Vinci Simulator vs LapSim Simulator|Comparison of the da Vinci Skills Simulator and the LapSim Laparoscopy Simulator for Conventional Laparoscopic Skills Improvement: a Prospective, Randomized Trial|Recruiting||N/A|75|Anticipated|Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital||3|||f||||f|f|t|f|f|t|||||2017-10-10 21:16:02.333651|2017-10-10 21:16:02.333651
NCT03079895|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-24|||April 13, 2017|Anticipated|2017-04-13|February 2017|2017-02-01|December 13, 2017|Anticipated|2017-12-13|December 13, 2017|Anticipated|2017-12-13||Interventional|||Thrive Care: Internet CBT for Depression|The Thrive Care Study: Computer-Delivered Cognitive Behavioral Therapy as Care Augmentation for Depressed Primary Care Patients|Not yet recruiting||N/A|300|Anticipated|Kaiser Permanente||2|||f||||f|f|f||||||No||2017-10-10 21:16:02.414852|2017-10-10 21:16:02.414852
NCT03079882|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-10|||July 2016||2016-07-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Observational|||VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health|VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health|Recruiting||N/A|100|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f|f|f|||f|||No||2017-10-10 21:16:02.498602|2017-10-10 21:16:02.498602
NCT03079869|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-08|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients|"Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients: A Phase 4 Real World Experience Study From Kaiser Permanente Southern California"|Not yet recruiting||Phase 4|55|Anticipated|Kaiser Permanente||1|||f||||f|t|f|||f|||No||2017-10-10 21:16:02.603605|2017-10-10 21:16:02.603605
NCT03079856|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-24|||September 25, 2017|Anticipated|2017-09-25|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER|Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER|Not yet recruiting||N/A|80|Anticipated|University of Michigan||2|||f||||t|f|f||||||||2017-10-10 21:16:02.670351|2017-10-10 21:16:02.670351
NCT03079843|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-28|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|September 1, 2020|Anticipated|2020-09-01|April 1, 2020|Anticipated|2020-04-01||Interventional|PM-SNS||Particulate Matter, Blood Pressure, and the Sympathetic Nervous System|Particulate Matter, Blood Pressure, and the Sympathetic Nervous System: Impact of Near-roadway Exposures and N-95 Facemasks|Recruiting||N/A|50|Anticipated|University of Michigan||2|||f||||t|f|f||||||No||2017-10-10 21:16:02.746436|2017-10-10 21:16:02.746436
NCT03079830|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-07|||October 2016||2016-10-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|PPMAMIAVS||Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery|Efficacy of Ropivacaine Wound Infiltration for Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery|Recruiting||Phase 3|90|Anticipated|University Medical Centre Ljubljana||2|||f||||t||||||||||2017-10-10 21:16:02.825412|2017-10-10 21:16:02.825412
NCT03079817|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-21|||January 17, 2017|Actual|2017-01-17|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Proprioception and Meditation|The Effects of Yoga Based Meditation on Proprioception in Individuals With Parkinson's Disease|Recruiting||N/A|40|Anticipated|University of Miami||2|||f|||||f|f||||||||2017-10-10 21:16:02.903585|2017-10-10 21:16:02.903585
NCT03079804|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-08|||January 30, 2017|Actual|2017-01-30|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|April 30, 2017|Anticipated|2017-04-30||Interventional|||Comparison Between Two Mobilization Techniques of Ankle on Balance in Patients With Chronic Ankle Instability|Comparison Between Two Mobilization Techniques With and Without Ankle Thrust on Balance in Patients With Chronic Ankle Instability|Recruiting||N/A|24|Anticipated|Universidade Federal do Ceara||3|||f||||f|f|f||||||No||2017-10-10 21:16:02.973026|2017-10-10 21:16:02.973026
NCT03079791|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-03-08|||July 2016||2016-07-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01|2 Years|Observational [Patient Registry]|IMPROVE-OCT||Impact of Level and Quality of Immunosuppression on Onset and Pattern of Cardiac Allograft Vasculopathy Evaluated by OCT|Prospective Registry of Impact of Level and Quality of Immunosuppression on Onset and Pattern of Cardiac Allograft Vasculopathy Evaluated by OCT.|Recruiting||N/A|100|Anticipated|Klinikum der Universitaet Muenchen|||1||f||||f||||||||Undecided||2017-10-10 21:16:03.045522|2017-10-10 21:16:03.045522
NCT03079778|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-09-01|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|August 2023|Anticipated|2023-08-01|August 2022|Anticipated|2022-08-01||Interventional|TACERT||Transarterial Chemoembolization (TACE) With or Without Stereotactic Body Radiotherapy (SBRT) in Hepatocellular Carinoma|Transarterial Chemoembolization (TACE) With or Without Stereotactic Body Radiotherapy (SBRT) in Hepatocellular Carinoma|Not yet recruiting||N/A|116|Anticipated|Lawson Health Research Institute||2|||f||||t|f|f|||f|||||2017-10-10 21:16:03.112515|2017-10-10 21:16:03.112515
NCT03079765|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-08|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Training Educators to Conduct Functional Behavior Assessment Via Telehealth|Training Educators to Implement Behavioral Assessment and Treatment Procedures in School Settings Via Telehealth|Recruiting||N/A|12|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||No|Individual participant data will only be disseminated via professional meetings and peer-reviewed publications. Data will be de-identified to maintain confidentiality of participants. Data will not be shared with anyone else.|2017-10-10 21:16:03.179689|2017-10-10 21:16:03.179689
NCT03079752|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-13|||March 18, 1994|Actual|1994-03-18|March 2017|2017-03-01|April 30, 1998|Actual|1998-04-30|September 12, 1996|Actual|1996-09-12||Interventional|||The Prenatal/Early Infancy Project: An Adolescent Follow-up|The Prenatal/Early Infancy Project: An Adolescent Follow-up|Completed||N/A|629|Actual|University of Colorado, Denver||4|||f||||t|f|f||||||Yes|The investigators are in the process of archiving the primary data published for this trial with the University of Michigan Consortium for Political and Social Research.|2017-10-10 21:16:03.256492|2017-10-10 21:16:03.256492
NCT03079739|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-12|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|August 31, 2024|Anticipated|2024-08-31|August 31, 2019|Anticipated|2019-08-31|5 Years|Observational [Patient Registry]|HALE-BOPP||Long-term Outcome of Deferred Lesion Based on FFR|The Prospective Assessment of Long-term Outcome of Deferred Coronary Lesions Based on FFR Evaluation|Recruiting||N/A|811|Anticipated|University Hospital of Ferrara|||1||f||||t|f|f||||||||2017-10-10 21:16:05.297418|2017-10-10 21:16:05.297418
NCT03079726|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-13|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|FRAILCIED||Use of Device Data to Predict Frailty in Individuals|Use of Device Data to Predict Frailty in Individuals With Cardiovascular Implantable Electrical Devices: Pilot Study|Enrolling by invitation||N/A|50|Anticipated|University of Colorado, Denver|||2||f||||f|f|f||||||||2017-10-10 21:16:05.391831|2017-10-10 21:16:05.391831
NCT03079713|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-10|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|Eyebrator||Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections|Comparison of Handheld Vibrator to Topical Eye Drops as Anesthesia for Intravitreal Injections|Recruiting||N/A|110|Anticipated|Wills Eye||3|||f||||t|f|f||||||No||2017-10-10 21:16:05.47437|2017-10-10 21:16:05.47437
NCT03079700|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-09|||August 1, 2012|Actual|2012-08-01|March 2017|2017-03-01|December 31, 2012|Actual|2012-12-31|December 31, 2012|Actual|2012-12-31||Observational|||Immune Modulation From Trichuris Suis|Mucosal and Systemic Immune Modulation From Trichuris Suis in a Self-infected Individual|Completed||N/A|1|Actual|University of Aarhus|||1||f||||f|f|f||||Samples With DNA|"     Blood cell and intestinal biopsies   "|No||2017-10-10 21:16:05.572972|2017-10-10 21:16:05.572972
NCT03079687|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-14||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.|A Multiple Patient Expanded Access Program for Olaparib Tablets for the Maintenance Treatment Following Response (Complete Response or Partial Response) to Platinum-based Chemotherapy in Patients With Platinum-sensitive Relapsed High-grade Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.|Approved for marketing||N/A|||AstraZeneca||||||||t|||||||||||2017-10-10 21:16:05.645608|2017-10-10 21:16:05.645608
NCT03079674|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-05-09|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2019|Anticipated|2019-02-01|12 Months|Observational [Patient Registry]|CR-NICE||China Registry of Non-disabling Ischemic Cerebrovascular Events|China Registry of Non-disabling Ischemic Cerebrovascular Events: A Prospective Multi-center, National Registry Trail|Not yet recruiting||N/A|10000|Anticipated|The First Affiliated Hospital of Zhengzhou University|||1||f|||||f|f||||Samples With DNA|"     The faecal samples, plasma, serum and whole blood are retained to establish the biological     samples library of NICE.   "|Undecided||2017-10-10 21:16:05.728358|2017-10-10 21:16:05.728358
NCT03079661|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-04-07|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|PolluBPCO||Impact of Air Quality on Exacerbations of COPD in the Somme|Impact of Air Quality on Exacerbations of COPD in the Somme|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f|||||f|f||||||||2017-10-10 21:16:06.097771|2017-10-10 21:16:06.097771
NCT03079648|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-13|||February 14, 2017|Actual|2017-02-14|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride|A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride|Recruiting||N/A|100|Anticipated|Chonbuk National University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:16:06.180563|2017-10-10 21:16:06.180563
NCT03079635|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-16|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 1, 2017|Actual|2017-06-01||Interventional|||Breakfast and Energy Expenditure in Young Women|The Effect of Breakfast Intake on Energy Expenditure and Hunger in Young Women|Completed||N/A|29|Actual|University of Arkansas, Fayetteville||2|||f||||f|f|f||||||||2017-10-10 21:16:06.285351|2017-10-10 21:16:06.285351
NCT03079622|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-03-07|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks|Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks: A Randomized Trial|Completed||N/A|146|Actual|Washington University School of Medicine||2|||f||||f||||||||No|There is no plan to share data, except de-identified data within our division.|2017-10-10 21:16:06.362658|2017-10-10 21:16:06.362658
NCT03079609|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-07|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ViBaVa||The Search for Viral and Bacterial Etiology of Varicocele|The Search for Viral and Bacterial Etiology of Varicocele|Recruiting||N/A|40|Anticipated|Medical University of Warsaw||2|||f|||||f|f||||||Undecided||2017-10-10 21:16:06.452915|2017-10-10 21:16:06.452915
NCT03079596|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-08-31|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy|Comparison of ERAS (Early Recovery After Surgery) Protocol With Conventional Protocol After Laparoscopic Total Gastrectomy: A Prospective Randomized Controlled Trial (Phase II Study)|Recruiting||N/A|100|Anticipated|Seoul National University Bundang Hospital||2|||f||||t|f|f||||||||2017-10-10 21:16:06.55699|2017-10-10 21:16:06.55699
NCT03079583|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|BAZIRI||The Efficacy of Zinc-biofortified Rice in Bangladeshi Children|The Efficacy of Zinc-biofortified Rice in Improving Zinc Status in Young Bangladeshi Children, a Double Blind Randomized Controlled Trial|Not yet recruiting||N/A|470|Anticipated|Swiss Federal Institute of Technology||2|||f||||f|f|f||||||||2017-10-10 21:16:06.679969|2017-10-10 21:16:06.679969
NCT03079570|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-13|||August 23, 2016|Actual|2016-08-23|March 2017|2017-03-01|September 8, 2016|Actual|2016-09-08|September 8, 2016|Actual|2016-09-08||Observational|||Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels|A Pilot Study Examining Differences in Critical Flicker Fusion Thresholds Between Young and Old Subjects With Normal Ocular Health at Photopic, Mesopic, and Scotopic Luminance Levels|Completed||N/A|9|Actual|ORA, Inc.|||1||f||||f|f|f||||||No||2017-10-10 21:16:06.828847|2017-10-10 21:16:06.828847
NCT03079557|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-30|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|ReBOO||Feasibility Pilot for the ReBOO-trial|A Non-randomised, Open Feasibility Pilot for the 'REpurposing BOtulinum Toxin in Treatment of Obesity in Adolescents' (ReBOO) Trial|Active, not recruiting||Phase 2|10|Actual|St. Olavs Hospital||1|||f||||t|f|f|||f|||No||2017-10-10 21:16:06.947658|2017-10-10 21:16:06.947658
NCT03079544|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-13|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|December 30, 2022|Anticipated|2022-12-30|December 30, 2022|Anticipated|2022-12-30||Observational|||Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients|Social Media-based Patient Education and Active Self-report on Incidence and Outcomes of Adverse Events in Natural Killer/T-cell Lymphoma (NK/TCL) Patients|Recruiting||N/A|200|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 21:16:07.063299|2017-10-10 21:16:07.063299
NCT03079531|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-07-11|||July 14, 2017|Anticipated|2017-07-14|July 2017|2017-07-01|January 1, 2019|Anticipated|2019-01-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea|An Open Label Phase 1b Study of Secukinumab in Patients With Moderate to Severe Papulopustular Rosacea|Recruiting||Phase 1/Phase 2|24|Anticipated|Stanford University||1|||f|||||t|f|||f|||||2017-10-10 21:16:07.157844|2017-10-10 21:16:07.157844
NCT03079518|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-04-18|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|Iron Turtle||Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency|Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency: Effects Upon Phosphate and FGF23 Metabolism|Recruiting||Phase 2|24|Anticipated|RWTH Aachen University||2|||f||||f|f|f|||f|||No|IPD will not be shared due to publication afterwards|2017-10-10 21:16:07.271838|2017-10-10 21:16:07.271838
NCT03079505|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-12|||August 3, 2017|Actual|2017-08-03|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2018|Anticipated|2018-08-01||Interventional|DANIN||Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia|Dasatinib Versus Nilotinib as Upfront Therapy for Treatment Naïve Chronic Myeloid Leukemia Chronic Phase|Recruiting||Phase 3|50|Anticipated|Hamad Medical Corporation||2|||f||||t|t|f|||t|||||2017-10-10 21:16:07.376714|2017-10-10 21:16:07.376714
NCT03079492|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-08|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31|2 Days|Observational [Patient Registry]|||MRI of Neonate With HIE Before and During the Moderate Hypothermia|Magnetic Resonance Imaging of Neonates With Hypoxic Ischemic Encephalopathy Before and During Moderate Hypothermia|Not yet recruiting||N/A|30|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||1||f||||f|f|f||||||No||2017-10-10 21:16:07.506113|2017-10-10 21:16:07.506113
NCT03079479|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-23|||September 2015||2015-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Observational|||Impact on Muscle Strength, Quality of Life and Functionality in Individuals Submitted to Hip Arthroplasty: a Prospective Study.|Impact on Muscle Strength, Quality of Life and Functionality in Individuals Submitted to Hip Arthroplasty|Recruiting||N/A|55|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo|||4||f||||t||||||||||2017-10-10 21:16:07.579534|2017-10-10 21:16:07.579534
NCT03079466|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-13|||March 9, 2017|Actual|2017-03-09|March 2017|2017-03-01|July 15, 2017|Anticipated|2017-07-15|June 10, 2017|Anticipated|2017-06-10||Interventional|||Effect of CPAP Treatment on the Elderly With Mild to Moderate Sleep Apnea|Effect of CPAP Treatment on the Elderly With Mild to Moderate Sleep Apnea|Active, not recruiting||N/A|96|Actual|Hospital Universitario Doctor Peset||2|||f||||t|f|f||||||Yes||2017-10-10 21:16:07.670515|2017-10-10 21:16:07.670515
NCT03079453|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-03-20|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||An Approach to Reduce Uvula Edema After Tonsillectomy|An Approach to Reduce Uvula Edema After Tonsillectomy|Completed||Phase 4|30|Actual|Bezmialem Vakif University||2|||f||||f|t|f|||f|||No||2017-10-10 21:16:07.738264|2017-10-10 21:16:07.738264
NCT03079440|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-18|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|May 2019|Anticipated|2019-05-01||Interventional|||TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors|Phase 2 Study of Temozolomide Plus Capecitabine in Patients With Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors|Recruiting||Phase 2|31|Anticipated|Asan Medical Center||1|||f||||f|f|f|||f|||||2017-10-10 21:16:07.818404|2017-10-10 21:16:07.818404
NCT03079427|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-09|2017-09-18|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma|Randomized Phase 2 Study of Capecitabine vs Gemcistabine Plus Cisplatin in Patients With Resected Extrahepatic Cholangiocarcinoma With Regional Lymph Node Metastasis|Recruiting||Phase 2|100|Anticipated|Asan Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:16:07.915827|2017-10-10 21:16:07.915827
NCT03079414|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-25|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Observational|EPS ARREST||The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest|The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest|Recruiting||N/A|100|Anticipated|Western University, Canada|||1||f||||f|f|f||||Samples With DNA|"     DNA will be collected on patients identified to possess bundle branch reentrant ventricular     tachycardia on invasive electrophysiology study.   "|No|There is no current plan to share IPD with other researchers.|2017-10-10 21:16:08.190506|2017-10-10 21:16:08.190506
NCT03079388|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-05-08|||February 27, 2017|Actual|2017-02-27|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)|Randomized Control Trial of the Use of Supplementary Food and Measures to Control Inflammation in Malnourished Pregnant Women to Improve Birth Outcomes|Recruiting||N/A|1514|Anticipated|Washington University School of Medicine||2|||f|||||f|f||||||||2017-10-10 21:16:08.493347|2017-10-10 21:16:08.493347
NCT03079375|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-15|||September 1, 2013|Actual|2013-09-01|March 2017|2017-03-01|October 24, 2015|Actual|2015-10-24|April 24, 2015|Actual|2015-04-24||Interventional|||The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You|The Impact of Pharmaceutical Medication Review, Medication Interview Before Discharge and Follow-up: A Randomized Controlled Trial|Completed||N/A|1499|Actual|Odense University Hospital||3|||f||||f|f|f||||||Yes|Only during data analysis between clinical pharmacists. Personal identification number is converted to an anonymous identification number.|2017-10-10 21:16:08.611976|2017-10-10 21:16:08.611976
NCT03079362|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-05|||January 15, 2007|Actual|2007-01-15|April 2017|2017-04-01|December 3, 2015|Actual|2015-12-03|December 3, 2015|Actual|2015-12-03||Observational|||SDR Monitoring in Children With Cerebral Palsy|SDR Monitoring in Children With Cerebral Palsy - a Retrospective Cohort Study|Completed||N/A|148|Actual|Charite University, Berlin, Germany|||1||f||||f|f|f||||||No||2017-10-10 21:16:08.704139|2017-10-10 21:16:08.704139
NCT03079349|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-13|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|July 1, 2016|Actual|2016-07-01||Interventional|||Online Distance Learning Outcomes Compared to Traditional Classroom Learning in Medicine|Randomized Controlled Study of a Remote Flipped Classroom Neuro-Otology Curriculum|Completed||N/A|274|Actual|Carrick Institute for Graduate Studies||2|||f||||f|f|f||||||No||2017-10-10 21:16:08.795909|2017-10-10 21:16:08.795909
NCT03079336|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-08|||January 2017||2017-01-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|IMPLEMENT2_0||Implementation of Psychological Treatment in Generalized Anxiety|Design Development in Randomized Clinical Trials - Psychological Treatment in Generalized Anxiety|Recruiting||N/A|80|Anticipated|University of Zurich||2|||f||||t||||||||No||2017-10-10 21:16:08.878309|2017-10-10 21:16:08.878309
NCT03079323|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-08|||February 6, 2017|Actual|2017-02-06|February 2017|2017-02-01|February 1, 2025|Anticipated|2025-02-01|February 1, 2025|Anticipated|2025-02-01||Interventional|PART||Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer|Phase II Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer Using Arc Therapy (IMAT/VMAT)|Recruiting||Phase 2|137|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f|f|f||||||No||2017-10-10 21:16:08.984546|2017-10-10 21:16:08.984546
NCT03079310|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-13|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Spinal Cord Stimulation for Gait in Parkinson Disease|Thoracic Dorsal Spinal Cord Stimulation for the Treatment of Gait and Balance Impairments in Parkinson Disease|Enrolling by invitation||Phase 1/Phase 2|25|Anticipated|Western University, Canada||1|||f||||f|f|f||||||No||2017-10-10 21:16:09.089817|2017-10-10 21:16:09.089817
NCT03079297|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-13|||March 9, 2017|Actual|2017-03-09|March 2017|2017-03-01|June 30, 2022|Anticipated|2022-06-30|March 1, 2022|Anticipated|2022-03-01||Interventional|||Rapid Antidepressant Effects of Leucine|A Pilot Double-Blind Randomized Placebo-Controlled Crossover Study to Investigate Rapid Antidepressant Effects of Leucine|Recruiting||Phase 2|40|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|t|f|||f|||No||2017-10-10 21:16:09.182186|2017-10-10 21:16:09.182186
NCT03079284|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-29|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Holding, Stress, and Bonding During Therapeutic Hypothermia|The Effects of Holding on Stress and Bonding in Mother-Infant Dyads During Therapeutic Hypothermia|Recruiting||N/A|10|Anticipated|Maine Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:16:09.292723|2017-10-10 21:16:09.292723
NCT03079271|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-03-07|||November 2016||2016-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||An Open Label Comparing the Short Term Efficacy of Lacrisert|An Open Label Comparing the Short Term Efficacy of Lacrisert|Recruiting||Phase 4|50|Anticipated|Virginia Eye Consultants||1|||f||||||||||||||2017-10-10 21:16:09.380458|2017-10-10 21:16:09.380458
NCT03079258|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-09|||April 23, 2017|Actual|2017-04-23|September 2017|2017-09-01|January 3, 2019|Anticipated|2019-01-03|November 30, 2018|Anticipated|2018-11-30||Interventional|||Physical Activity and Vascular Health During Pregnancy|Can Physical Activity During Pregnancy Improve Maternal and Offspring Vascular Health?|Recruiting||N/A|20|Anticipated|Liverpool John Moores University||2|||f||||f|f|f||||||||2017-10-10 21:16:09.464525|2017-10-10 21:16:09.464525
NCT03079245|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-08|||May 1, 2009|Actual|2009-05-01|March 2017|2017-03-01|April 30, 2012|Actual|2012-04-30|April 30, 2012|Actual|2012-04-30||Interventional|iNAP||Improving Antimicrobial Prescribing Practices in the Neonatal ICU|Improving Antimicrobial Prescribing Practices in the Neonatal Intensive Care Unit|Completed||N/A|6184|Actual|Columbia University||4|||f||||f|f|f||||||No||2017-10-10 21:16:09.558072|2017-10-10 21:16:09.558072
NCT03079232|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-03-28|||March 28, 2017|Actual|2017-03-28|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|GALAXY||Optical Coherence Microscopy in Dermato-oncology|In Vivo Imaging Innovation : Optical Coherence Microscopy in Dermato-oncology|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||No||2017-10-10 21:16:09.678548|2017-10-10 21:16:09.678548
NCT03079219|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-22|||March 23, 2017|Actual|2017-03-23|March 2017|2017-03-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients|A Randomized Study to Determine the Efficacy and Tolerability of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients|Recruiting||Phase 3|120|Anticipated|Chinese University of Hong Kong||2|||f||||f|f|f||||||Undecided||2017-10-10 21:16:09.767202|2017-10-10 21:16:09.767202
NCT03079206|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-07|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Basophile Activation Testing (BAT) in Hazelnut Allergy (Hazelnut BAT Study)|Correlation of the in Vivo Food Provocation Test With the in Vitro Basophile Activation Test in Hazelnut Allergic Patients|Recruiting||N/A|65|Anticipated|University of Zurich||1|||f||||f|f|f||||||No||2017-10-10 21:16:09.876736|2017-10-10 21:16:09.876736
NCT03079193|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-03-08|||January 2011||2011-01-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01|6 Months|Observational [Patient Registry]|||Post Thyroidectomy Endoscopic Laryngeal Examination :Is it Mandatory?|Post Thyroidectomy Endoscopic Laryngeal Examination :Is it Mandatory?|Completed||N/A|100|Actual|Khamis Mushayt General Hospital|||2||f||||t||||||||Undecided||2017-10-10 21:16:09.964678|2017-10-10 21:16:09.964678
NCT03079180|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-07|||February 13, 2017|Actual|2017-02-13|March 2017|2017-03-01|July 28, 2017|Anticipated|2017-07-28|July 28, 2017|Anticipated|2017-07-28||Interventional|TAGE||Tendon Adaptations to Training - Effect of Ageing|Effect of Different Strength Training Intensities on Achilles and Patellar Tendon Adaptations With Aging|Enrolling by invitation||N/A|60|Anticipated|Université de Technologie de Compiegne||3|||f||||f|f|f||||||No||2017-10-10 21:16:10.031017|2017-10-10 21:16:10.031017
NCT03079167|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-07|||May 14, 2016|Actual|2016-05-14|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PAEAN||PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns|Preventing Adverse Outcomes of Neonatal Hypoxic Ischaemic Encephalopathy With Erythropoietin: A Phase III Randomised Placebo Controlled Multicentre Clinical Trial|Recruiting||Phase 3|300|Anticipated|University of Sydney||2|||f||||t||||||||No||2017-10-10 21:16:10.127132|2017-10-10 21:16:10.127132
NCT03079154|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-13|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|September 28, 2017|Anticipated|2017-09-28|June 16, 2017|Anticipated|2017-06-16||Interventional|||The Influence of Mindfulness on the Link Between Consumer Culture Values and Well-being|A Pilot RCT Intervention to Test the Impact of High and Low-intensity Mindfulness-based Cognitive Therapy (MBCT) on Self, Values, and Well-being|Not yet recruiting||N/A|180|Anticipated|University of Sussex||3|||f||||f|f|f||||||No||2017-10-10 21:16:10.29049|2017-10-10 21:16:10.29049
NCT03079141|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-08|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|June 2019|Anticipated|2019-06-01||Interventional|SPECT||Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy|Study on Half-dose Photodynamic Therapy Versus Eplerenone in Chronic CenTRAl Serous Chorioretinopathy (SPECTRA Trial)|Recruiting||Phase 4|107|Anticipated|Leiden University Medical Center||2|||f||||t|t|f|||f|||No|No plan.|2017-10-10 21:16:10.387552|2017-10-10 21:16:10.387552
NCT03079128|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-22|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of a Commercial Program on Weight Loss and Health Outcomes 2|Evaluation of a Commercial Program on Weight Loss and Health Outcomes 2|Active, not recruiting||N/A|150|Actual|University of Pittsburgh||1|||f||||f|f|f||||||||2017-10-10 21:16:10.617677|2017-10-10 21:16:10.617677
NCT03079115|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-08|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 30, 2018|Anticipated|2018-12-30|October 30, 2018|Anticipated|2018-10-30||Interventional|PICAS||High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting|Efficacy of Two Different Doses of Atorvastatin for Prevention of Periprocedural Ischemic Brain Damage in Chinese Patients Undergoing Carotid Artery Stenting (CAS)|Not yet recruiting||Phase 4|130|Anticipated|Beijing Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:16:10.718463|2017-10-10 21:16:10.718463
NCT03079102|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-25|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|November 17, 2019|Anticipated|2019-11-17|August 20, 2019|Anticipated|2019-08-20||Interventional|iNOOHCA||Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest|Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest|Recruiting||Phase 2|130|Anticipated|University of Pittsburgh||2|||f||||t|t|f||||||||2017-10-10 21:16:10.820756|2017-10-10 21:16:10.820756
NCT03079089|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-19|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|June 15, 2022|Anticipated|2022-06-15|June 15, 2020|Anticipated|2020-06-15||Interventional|LY-SET-HAPLO||Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders|Sequential Chemotherapy Prior Conditioning Reduced Intensity: Study Routine Care in Haploidentical Allogeneic Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders|Recruiting||N/A|40|Anticipated|Association for Training, Education, and Research in Hematology, Immunology, and Transplantation||1|||f||||f|f|f||||||||2017-10-10 21:16:10.971232|2017-10-10 21:16:10.971232
NCT03079076|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-16|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 16, 2017|Actual|2017-05-16||Interventional|TLIP||Ultrasound Guided Modified Thoracolumbar Interfascial Plane Block for Spinal Surgery|Ultrasound Guided Modified Thoracolumbar Interfascial Plane Block for Spinal Surgery: A New Approach|Completed||Phase 4|40|Actual|Ataturk University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:16:11.066134|2017-10-10 21:16:11.066134
NCT03079063|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-08|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency|Randomized, Multicenter, Single-dose, Cross-over, Double-blind Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency|Recruiting||Phase 3|50|Anticipated|AryoGen Pharmed Co.||2|||f||||t|f|f||||||Undecided||2017-10-10 21:16:11.167324|2017-10-10 21:16:11.167324
NCT03079050|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-09-14|||February 27, 2017|Actual|2017-02-27|February 2017|2017-02-01|July 30, 2017|Actual|2017-07-30|July 30, 2017|Actual|2017-07-30||Interventional|||An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan|An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan|Completed||Phase 4|33|Actual|American University of Beirut Medical Center||1|||f||||f|t|f|||t|||||2017-10-10 21:16:11.284014|2017-10-10 21:16:11.284014
NCT03079037|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Observational|||Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3|Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3|Recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||||||2017-10-10 21:16:11.373738|2017-10-10 21:16:11.373738
NCT03079024|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-26|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|May 19, 2021|Anticipated|2021-05-19|May 19, 2020|Anticipated|2020-05-19||Interventional|Mini-COTES||Minnesota Community-Based Cognitive Training in Early Psychosis|Minnesota Community-Based Cognitive Training in Early Psychosis|Recruiting||N/A|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f|f|f||||||Undecided||2017-10-10 21:16:11.448446|2017-10-10 21:16:11.448446
NCT03079011|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-04-19|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|April 15, 2024|Anticipated|2024-04-15|April 15, 2022|Anticipated|2022-04-15||Interventional|PADA-1||PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection|Randomized, Open Label, Multicentric Phase III Trial to Evaluate the Safety and Efficacy of Palbociclib in Combination With HTdriven by ctDNA ESR1 Mutation Monitoring in ER+, HER2-negative Metastatic Breast Cancer Patients|Recruiting||Phase 3|800|Anticipated|UNICANCER||3|||f||||t|f|f||||||||2017-10-10 21:16:11.550314|2017-10-10 21:16:11.550314
NCT03078998|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-08|||April 1, 2016|Actual|2016-04-01|March 2017|2017-03-01|July 15, 2017|Anticipated|2017-07-15|December 14, 2016|Actual|2016-12-14||Interventional|LMBE||Leap Motion Based Exercises in Upper Extremity Rehabilitation of The Children|The Investigation of Effectiveness of Leap Motion Based Exercises in Upper Extremity Rehabilitation of The Children|Active, not recruiting||N/A|60|Actual|Istanbul University||3|||f||||f|f|f||||||No||2017-10-10 21:16:11.670026|2017-10-10 21:16:11.670026
NCT03078985|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-08-08|||March 30, 2017|Actual|2017-03-30|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|2016-IMR||Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter II|Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter|Recruiting||N/A|35|Anticipated|Heartcenter Leipzig GmbH||1|||f||||f|f|f||||||||2017-10-10 21:16:11.745269|2017-10-10 21:16:11.745269
NCT03078972|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-13|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Observational|IRONMAN||Effect of mechanIcal circulatoRy Support ON Exercise Capacity aMong pAtieNts With Heart Failure|Effective Mechanical Circulatory Support on Exercise Capacity in Heart Failure|Recruiting||N/A|60|Anticipated|University of Colorado, Denver|||3||f||||t|f|f||||Samples Without DNA|"     Approximately 20cc of blood will be collected during testing.   "|No||2017-10-10 21:16:11.846274|2017-10-10 21:16:11.846274
NCT03078959|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-08|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|April 15, 2017|Anticipated|2017-04-15|March 30, 2017|Anticipated|2017-03-30||Observational|||Prognostic Value of PD-L1 in NSCLC|The Prognostic Value of the Expression of Programmed Death Ligand 1 (PD-L1) in Early Stage Non-small-cell Lung Cancer|Active, not recruiting||N/A|350|Actual|Fondazione Ricerca Traslazionale|||1||f||||f|f|f||||Samples With DNA|"     Formalin fixed paraffin embedded specimen were collected from 350 patients who underwent     surgical resection of early stage NSCLC. Tumors samples were included in a tissue microarray.   "|No||2017-10-10 21:16:11.929211|2017-10-10 21:16:11.929211
NCT03078946|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-13|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Dexmedetomidine Versus Morphine and Midazolam in Prevention and Treatment of Delirium After Adult Cardiac Surgery|Dexmedetomidine Versus Morphine and Midazolam in Prevention and Treatment of Delirium After Adult Cardiac Surgery; a Randomized, Double-blind Clinical Trial|Completed||Phase 4|60|Actual|Ain Shams University||2|||f|||||t|f||||||||2017-10-10 21:16:11.991462|2017-10-10 21:16:11.991462
NCT03078933|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-05|||March 20, 2017|Actual|2017-03-20|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers|A Randomized, Prospective, Multi-Center Feasibility Study of APT001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers|Recruiting||N/A|100|Anticipated|Origin Inc.||5|||f||||t|f|t|f|||||Undecided||2017-10-10 21:16:12.071423|2017-10-10 21:16:12.071423
NCT03078920|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-10|||March 23, 2017|Actual|2017-03-23|August 2017|2017-08-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|||Benefits of a Contralateral Routing of Signals (CROS) System in Unilateral CI-recipients|Subjective and Objective Benefits of a Contralateral Routing of Signals (CROS) System in Unilateral Cochlear Implant Recipients|Completed||N/A|13|Actual|Advanced Bionics AG||1|||f||||f|f|f||||||||2017-10-10 21:16:12.205356|2017-10-10 21:16:12.205356
NCT03078907|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-10-03|||October 31, 2017|Anticipated|2017-10-31|October 2017|2017-10-01|December 28, 2019|Anticipated|2019-12-28|December 28, 2019|Anticipated|2019-12-28||Interventional|TRACE||Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.|A Multi-center, Double-blind, Placebo-controlled Phase 4 Study in Patients With Pulmonary Arterial Hypertension to Assess the Effect of Selexipag on Daily Life Physical Activity and Patient's Self-reported Symptoms and Their Impacts|Not yet recruiting||Phase 4|100|Anticipated|Actelion||2|||f||||f|t|f||||||||2017-10-10 21:16:12.293648|2017-10-10 21:16:12.293648
NCT03078894|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-29|||March 17, 2017|Actual|2017-03-17|March 2017|2017-03-01|May 1, 2017|Anticipated|2017-05-01|May 1, 2017|Anticipated|2017-05-01||Observational|||A Pilot Study Examining for the Presence of Fecal Coliforms and Tropical Diseases in Peru|A Pilot Study Examining for the Presence of Fecal Coliforms in Peruvian Water Sources and the Association of Tropical Diseases Within Peru|Recruiting||N/A|100|Anticipated|BioRed LLC|||2||f||||f|f|f||||||Undecided||2017-10-10 21:16:12.404661|2017-10-10 21:16:12.404661
NCT03078881|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-06-22|||March 10, 2017|Actual|2017-03-10|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|LUSTRO||Clinical Assessment Study in Crigler-Najjar Syndrome|LUSTRO: A Clinical Assessment Study in Crigler-Najjar Syndrome|Recruiting||N/A|18|Anticipated|Audentes Therapeutics|||1||f||||f|f|f||||||No||2017-10-10 21:16:12.504314|2017-10-10 21:16:12.504314
NCT03078868|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-13|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15||Interventional|DWMRI||Utility of Diffusion-weighted MR Imaging|Utility of Diffusion-weighted MR Imaging in Guiding Selective Percutaneous Drainage of Postoperative Intra-abdominal Abscesses After Colorectal Resection|Recruiting||N/A|20|Anticipated|University of Chicago||1|||f||||f|f|t|f|||||No|N/A-data won't be shared|2017-10-10 21:16:12.583111|2017-10-10 21:16:12.583111
NCT03078855|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Interventional|ILyAD||A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma|ILyAD (Indolent Lymphoma And Vitamin D): A Phase III Double Blind, Prospective Randomized Trial to Evaluate the Supplemental Effect of Vitamin D (Cholecalciferol) on Progression-free Survival in Patients With Low Tumor-burden Indolent Non-Hodgkin Lymphoma Treated With Rituximab Therapy|Recruiting||Phase 3|210|Anticipated|University of Rochester||2|||f||||t|f|f||||||||2017-10-10 21:16:12.673858|2017-10-10 21:16:12.673858
NCT03078842|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-18|||January 23, 2017|Actual|2017-01-23|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|ZTDT||Zinc Dosing Trial - Does Dose Reduction Reduce Side Effects But Retain Efficacy in Diarrhoea Management|Establishing the Optimal Dose of Therapeutic Zinc Supplementation for the Treatment of Acute Diarrhea in Under Five Children - a Dose Response Trial in a South Asian and a Sub-Saharan African Setting|Recruiting||N/A|4500|Anticipated|World Health Organization||3|||f||||t|f|f||||||Yes|The exact mechanism of data sharing has not yet been decided among the researchers. But the study is funded by an Organization (Bill & Melinda Gates Foundation) that requires data sharing.|2017-10-10 21:16:12.770997|2017-10-10 21:16:12.770997
NCT03078829|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-07|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Observational|||The Relation of GnRH Treatment to QTc Interval in Transgender Females|The Relation of GnRH Treatment to QTc Interval in Transgender Female Youth: A Time Series Study|Recruiting||N/A|23|Anticipated|University of California, San Francisco|||1||f||||f|f|f||||||No||2017-10-10 21:16:12.872861|2017-10-10 21:16:12.872861
NCT03078816|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-05-01|||March 3, 2017|Actual|2017-03-03|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|DBSVop||Thalamic Deep Brain Stimulation for Secondary Dystonia in Children and Young Adults|Thalamic Deep Brain Stimulation for Secondary Dystonia in Children and Young Adults|Recruiting||Phase 1|15|Anticipated|University of California, San Francisco||1|||f||||t|f|t|f|f||||Undecided||2017-10-10 21:16:12.959264|2017-10-10 21:16:12.959264
NCT03078803|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-05-01|||March 28, 2017|Actual|2017-03-28|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Fecal Transplant for Crohn's Disease|A Prospective Multicenter Randomized Controlled Trial Comparing Fecal Microbiota Transplantation (FMT) to Placebo in the Treatment of Mild to Moderate Crohn's Disease|Recruiting||Phase 2|126|Anticipated|University of Alberta||2|||f||||t|f|f||||||No||2017-10-10 21:16:13.09607|2017-10-10 21:16:13.09607
NCT03078790|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-10|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Implementing a Paced Deep Breathing Module to Decrease Preoperative Anxiety in Gynecological Surgery Patients|Implementing a Paced Deep Breathing Module to Decrease Preoperative Anxiety in Gynecological Surgery Patients|Not yet recruiting||N/A|45|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 21:16:13.207986|2017-10-10 21:16:13.207986
NCT03078777|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-07|||May 2017|Anticipated|2017-05-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||The Effect Dialysis on the Pharmacokinetics of Fexofenadine|The Effect Dialysis on the Pharmacokinetics of Fexofenadine|Not yet recruiting||Phase 4|30|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||No||2017-10-10 21:16:13.27708|2017-10-10 21:16:13.27708
NCT03078764|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-06-15|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand|The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand|Recruiting||N/A|60|Anticipated|University of Michigan||2|||f||||f|f|f||||||No||2017-10-10 21:16:13.351066|2017-10-10 21:16:13.351066
NCT03078751|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-09-26|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|September 13, 2023|Anticipated|2023-09-13|September 13, 2023|Anticipated|2023-09-13||Interventional|EarLEE-1||Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer|A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative, High Risk Early Breast Cancer|Recruiting||Phase 3|2000|Anticipated|Novartis||2|||f||||t|t|f||||||||2017-10-10 21:16:13.504516|2017-10-10 21:16:13.504516
NCT03078738|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-08|||February 8, 2017|Actual|2017-02-08|March 2017|2017-03-01|February 12, 2018|Anticipated|2018-02-12|February 2018|Anticipated|2018-02-01||Interventional|||Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects|A First-in-Human Randomized, Double-blind, Placebo-controlled, Fed-fasted, Gender, Single and Multiple Ascending Oral Dose Study, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OMT-28 in Healthy Subjects|Recruiting||Phase 1|92|Anticipated|Omeicos Therapeutics GmbH||7|||f||||t|f|f||||||No||2017-10-10 21:16:13.950863|2017-10-10 21:16:13.950863
NCT03078725|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-13|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|May 10, 2018|Anticipated|2018-05-10|March 10, 2018|Anticipated|2018-03-10||Interventional|GLAM||Failure Rate of GLyburide And Metformin Among Gestational Diabetics|Failure Rate of GLyburide And Metformin Among Gestational Diabetics|Not yet recruiting||Phase 4|190|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|t|f|||f|||No||2017-10-10 21:16:14.07901|2017-10-10 21:16:14.07901
NCT03078712|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-13|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Interventional|ANDROMEDA||Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study|Early Goal Directed Therapy Using a Physiological Holistic View. A Multicenter Study in Latin America: The ANDROMEDA-SHOCK Study|Recruiting||N/A|400|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||t|f|f||||||Undecided||2017-10-10 21:16:14.181933|2017-10-10 21:16:14.181933
NCT03078699|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-07|||January 1, 2005|Actual|2005-01-01|March 2017|2017-03-01|September 1, 2016|Actual|2016-09-01|January 1, 2014|Actual|2014-01-01||Interventional|||Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment|Prospective Ⅱ Study of Stereotactic Body Radiation Therapy for Thymoma and Thymic Carcinoma: Therapeutic Effect and Toxicity Assessment|Completed||N/A|32|Actual|Third Military Medical University||1|||f|||||f|f||||||No||2017-10-10 21:16:14.343809|2017-10-10 21:16:14.343809
NCT03078686|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-31|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|June 22, 2019|Anticipated|2019-06-22|January 22, 2019|Anticipated|2019-01-22||Interventional|SAAA||Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata|Biocellular Regenerative Therapy in Treating Scaring Alopecias and Alopecia Areata: Use of High Density Platelet-Rich Plasma Concentrates and Cell-Enriched Emulsified Adipose-Derived Tissue Stromal Vascular Fraction (AD-tSVF)|Recruiting||N/A|60|Anticipated|Regeneris Medical||4|||f||||t|f|f||||||Undecided||2017-10-10 21:16:14.444686|2017-10-10 21:16:14.444686
NCT03078673|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-05-24|||June 20, 2017|Anticipated|2017-06-20|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Interventional|CPMST||Cross Country Poling Specific Motor Skill- and Strength Training.|Motor Skill- and Strength Training; Importance for Technique, Work Economy and Time Performance in Cross Country Poling|Recruiting||N/A|45|Anticipated|Telemark University College||3|||f||||f|f|f||||||Yes|planned published in a peer reviewed journal|2017-10-10 21:16:14.641845|2017-10-10 21:16:14.641845
NCT03078660|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-07|||January 13, 2016|Actual|2016-01-13|March 2017|2017-03-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Interventional|||Pilot Trial to Test a Nutrition Application for Making Smart and Healthy Choices|Pilot Trial to Test a Nutrition Application for Making Smart and Healthy Choices When Purchasing Food in Grocery Stores|Completed||N/A|38|Actual|University of Puerto Rico||2|||f||||f|f|f||||||No|No plan yet|2017-10-10 21:16:14.796976|2017-10-10 21:16:14.796976
NCT03078647|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-14|||September 13, 2017|Actual|2017-09-13|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Profound Dermal and SubQ Cartridges for the Treatment of Cellulite|Clinical Study to Evaluate the Safety and Efficacy Performance of the Profound System Using the Dermal and Sub-dermal (SubQ) Cartridges for the Treatment of Cellulite|Recruiting||N/A|60|Anticipated|Syneron Medical||1|||f||||f|f|t|f||f|||||2017-10-10 21:16:14.905466|2017-10-10 21:16:14.905466
NCT03078634|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-04-24|||March 16, 2017|Actual|2017-03-16|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|MANTRA||The Multi-disciplinary Treatment of Functional Gut Disorders Study|The MANTRA Study: The Multi-disciplinary Treatment of Functional Gut Disorders Study|Recruiting||N/A|234|Anticipated|St Vincent's Hospital Melbourne||2|||f||||t|f|f||||||No||2017-10-10 21:16:15.029037|2017-10-10 21:16:15.029037
NCT03078621|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-03-07|||September 2016||2016-09-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|October 2020|Anticipated|2020-10-01||Interventional|||Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy|Safety and Efficacy of Transplantation of Specific Populations of Stem Cells and Mesenchymal Stem Cells for the Treatment of Cerebral Palsy|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Stem Cells Arabia||1|||f||||f||||||||Undecided||2017-10-10 21:16:15.15972|2017-10-10 21:16:15.15972
NCT03078595|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-21|||July 16, 2015|Actual|2015-07-16|August 2017|2017-08-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Observational|||Gingival Bleeding and Von Willebrand Disease Typ 2 and 3|Is Gingival Bleeding a Symptom of Patients With Type 2 and 3 Von Willebrand Disease? A Case-Control Study|Completed||N/A|48|Actual|Goethe University|||2||f|||||f|f||||||||2017-10-10 21:16:15.358711|2017-10-10 21:16:15.358711
NCT03078582|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-10|||March 8, 2017|Actual|2017-03-08|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase 2 Safety and Efficacy Study of RA101495 to Treat PNH Patients|Phase 2 Multicenter, Open-Label, Uncontrolled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of RA101495 in Subjects With Paroxysmal Nocturnal Hemoglobinuria|Recruiting||Phase 2|20|Anticipated|Ra Pharmaceuticals||1|||f||||f|f|f||||||||2017-10-10 21:16:15.449153|2017-10-10 21:16:15.449153
NCT03078569|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-08|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF|Transdermal Testosterone for Poor Responders Undergoing IVF|Recruiting||Phase 4|30|Anticipated|Wolfson Medical Center||2|||f||||f|t|f|||f|||No||2017-10-10 21:16:15.545282|2017-10-10 21:16:15.545282
NCT03078556|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-05|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Interventional|||Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine|An Open-label, Randomized, Single Dose, Crossover, Pivotal Bioequivalence Study of Fixed-dose Combination Tablets of Dolutegravir and Lamivudine Versus Dolutegravir and Lamivudine Single Entities and Food Effect Assessment in Healthy Volunteers|Completed||Phase 1|154|Actual|ViiV Healthcare||6|||f||||f|t|f||||||||2017-10-10 21:16:15.636713|2017-10-10 21:16:15.636713
NCT03078543|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-28|||June 28, 2017|Actual|2017-06-28|June 2017|2017-06-01|December 30, 2029|Anticipated|2029-12-30|December 30, 2028|Anticipated|2028-12-30||Interventional|ANTHEM||Ten Year Implant Survivorship of the ANTHEM™ Total Knee System|A Prospective, Multicentre, Cohort Study Assessing the Safety and Efficacy of the ANTHEM™ Total Knee System in Patients Following a Total Knee Arthroplasty|Recruiting||N/A|196|Anticipated|Smith & Nephew, Inc.||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:16:15.753502|2017-10-10 21:16:15.753502
NCT03078530|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-10|||September 13, 2013|Actual|2013-09-13|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Probiotic (Visbiome) for Gulf War Illness|Probiotic (Visbiome) for Gulf War Illness|Recruiting||Phase 2/Phase 3|60|Anticipated|VA Salt Lake City Health Care System||2|||f||||t|t|f||||||No||2017-10-10 21:16:15.871293|2017-10-10 21:16:15.871293
NCT03078517|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-17|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of the LMA Protector and the I-gel|Comparison of the LMA Protector and the I-gel in Anesthetized Patients.|Recruiting||N/A|76|Anticipated|SMG-SNU Boramae Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:16:15.961213|2017-10-10 21:16:15.961213
NCT03078504|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-08|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy|Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy|Recruiting||N/A|15|Anticipated|St. Louis University||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:16:16.044981|2017-10-10 21:16:16.044981
NCT03078491|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-25|||March 30, 2017|Actual|2017-03-30|April 2017|2017-04-01|January 1, 2022|Anticipated|2022-01-01|July 31, 2021|Anticipated|2021-07-31||Interventional|TANGO||Technological Advances in Glucose Management in Older Adults|Technological Advances in Glucose Management in Older Adults|Recruiting||N/A|168|Anticipated|Joslin Diabetes Center||2|||f||||t|f|f||||||No||2017-10-10 21:16:16.124486|2017-10-10 21:16:16.124486
NCT03078478|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-28|||March 13, 2017|Actual|2017-03-13|September 2017|2017-09-01|October 10, 2018|Anticipated|2018-10-10|September 10, 2018|Anticipated|2018-09-10||Interventional|||A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs|A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs|Active, not recruiting||Phase 3|1590|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 21:16:16.254013|2017-10-10 21:16:16.254013
NCT03078088|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-27|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Airway Alkalinization and Nasal Colonization|Airway Alkalinization and Nasal Colonization|Not yet recruiting||Phase 1|64|Anticipated|University of Iowa||2|||f||||t|t|f||||||Undecided||2017-10-10 21:16:20.096492|2017-10-10 21:16:20.096492
NCT03078465|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-12|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|May 30, 2021|Anticipated|2021-05-30|May 30, 2021|Anticipated|2021-05-30||Interventional|PL-PLATELET||Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCI|Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Percutaneous Coronary Intervention: The PL-PLATELET Randomized Trial|Recruiting||Phase 3|1050|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t|t|f|||t|||||2017-10-10 21:16:16.772905|2017-10-10 21:16:16.772905
NCT03078452|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-03-10|||February 14, 2017|Actual|2017-02-14|March 2017|2017-03-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy|Comparison of Quality of Bone Marrow Biopsy and Patient Convenience and Pain Control by a Battery Powered Drill Versus Conventional Methods in Patients With Plasma Cell Disorders|Recruiting||N/A|100|Anticipated|Emory University||2|||f||||f|f|t|f|||||Undecided||2017-10-10 21:16:16.86293|2017-10-10 21:16:16.86293
NCT03078439|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-03-07|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Day|Observational [Patient Registry]|EPIPAGE2||EPIPAGE2 Cohort Study Follow up at Five and a Half Years|Epidemiologic Study on Small-for-gestational-age Children (EPIPAGE2 Cohort Study) - Follow up at Five and a Half Years|Recruiting||N/A|5201|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples With DNA|"     DNA from saliva samples collected from 5 years and a half children   "|No||2017-10-10 21:16:16.95295|2017-10-10 21:16:16.95295
NCT03078426|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-07|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|PIC'IRM||Lung MRI in the Management of Idiopathic Pulmonary Fibrosis|LUNG MRI in the Management of Idiopathic Pulmonary Fibrosis : PIC'IRM|Recruiting||N/A|60|Anticipated|University Hospital, Bordeaux||4|||f||||f|f|f||||||No||2017-10-10 21:16:17.568244|2017-10-10 21:16:17.568244
NCT03078413|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-02|||March 3, 2017|Actual|2017-03-03|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Late Function After Surgery for Transposition of the Great Arteries|Late Function After Surgery for Transposition of the Great Arteries|Enrolling by invitation||N/A|45|Anticipated|Indiana University|||1||f||||f|f|f||||||No||2017-10-10 21:16:17.706313|2017-10-10 21:16:17.706313
NCT03078400|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-06-15|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|November 30, 2018|Anticipated|2018-11-30||Interventional|||Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer|An Open-label Phase 1 Trial of the Safety and Efficacy of Daily Subcutaneous SPL-108 Injections When Used In Combination With Paclitaxel In Patients With Platinum-resistant, CD44+, Advanced Ovarian Epithelial Cancer|Recruiting||Phase 1|18|Anticipated|Splash Pharmaceuticals, Inc.||2|||f||||f|t|f||||||No||2017-10-10 21:16:17.81591|2017-10-10 21:16:17.81591
NCT03078387|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-08|||August 31, 2006|Actual|2006-08-31|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|January 29, 2013|Actual|2013-01-29||Observational|||The Extreme Significance of Bilateral Embolic Retinal Phenomena That Can be Life Saving|Bilateral Retinal Embolic Phenomena Always Necessitates Immediate and Intensive Investigation. Careful, Documented, Ophthalmic Examination is All we Require to Initiate Life Saving Investigations.|Active, not recruiting||N/A|2|Actual|Dr. S.S. Michel Clinic|||1||f|||||f|f||||||Yes|Color photographs of patients with bilateral retinal emboli and relevant medical conditions will be shared.|2017-10-10 21:16:17.924122|2017-10-10 21:16:17.924122
NCT03078374|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-06-30|||January 11, 2017|Actual|2017-01-11|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|January 11, 2018|Anticipated|2018-01-11||Interventional|||MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)|A Safety and Feasibility Study of Low-intensity Anticoagulation With HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)|Enrolling by invitation||N/A|15|Anticipated|Institute for Clinical and Experimental Medicine||1|||f||||t|f|f||||||||2017-10-10 21:16:18.013153|2017-10-10 21:16:18.013153
NCT03078361|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-18|||April 28, 2014|Actual|2014-04-28|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|July 14, 2016|Actual|2016-07-14||Interventional|||Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening)|Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) Project|Active, not recruiting||N/A|159|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:16:18.103896|2017-10-10 21:16:18.103896
NCT03078348|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-06-16|||June 19, 2011|Actual|2011-06-19|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 23, 2015|Actual|2015-10-23||Interventional|IACCT||Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks|Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks|Active, not recruiting||N/A|330|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:16:18.199974|2017-10-10 21:16:18.199974
NCT03078335|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-21|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|March 22, 2018|Anticipated|2018-03-22|March 22, 2018|Anticipated|2018-03-22||Interventional|GloveCare||Glove-based Care in the NICU to Prevent Late Onset Sepsis|Non-Sterile Glove Based Care to Prevent Late Onset Sepsis in The NICU - Cluster Crossover Randomized Controlled Pilot Study|Recruiting||N/A|900|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f|f|f||||||No||2017-10-10 21:16:18.296258|2017-10-10 21:16:18.296258
NCT03078322|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-08-03|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression|Double-Blind, Placebo-Controlled, Phase 2 Trial to Test Efficacy and Safety of AV-101 (L‑4‑Chlorokynurenine) as Adjunct to Current Antidepressant Therapy in Patients With Major Depressive Disorder (MDD)|Not yet recruiting||Phase 2|180|Anticipated|VistaGen Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:16:18.42623|2017-10-10 21:16:18.42623
NCT03078309|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-07|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients|A Controlled Study of the Effect of Cannabis on Visual Functions in Healthy Subjects and in Retinitis Pigmentosa Patients|Not yet recruiting||Early Phase 1|50|Anticipated|Hadassah Medical Organization||2|||f||||f|f|f||||||No||2017-10-10 21:16:18.505083|2017-10-10 21:16:18.505083
NCT03078296|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-10|||January 2017||2017-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Observational|||Burnout Among Members of AAGL|Burnout and Associated Factors Among Members of the American Association of Gynecologic Laparoscopists|Enrolling by invitation||N/A|500|Anticipated|George Washington University|||1||f||||f||||||||||2017-10-10 21:16:18.614846|2017-10-10 21:16:18.614846
NCT03078283|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-08|||March 15, 2017|Anticipated|2017-03-15|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Food Effects on the Gut Microbiota|Effects of High-fiber Snack Foods on Human Gut Microbes|Enrolling by invitation||N/A|16|Anticipated|Washington University School of Medicine||1|||f||||f|f|f||||||Yes|Individual data will be shared after completion of the study, to the extent that this can be accomplished without violating the confidentiality of participants (some of whom would be easily identifiable from their clinical metadata).|2017-10-10 21:16:18.687861|2017-10-10 21:16:18.687861
NCT03078270|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-10|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|September 12, 2017|Anticipated|2017-09-12|September 12, 2017|Anticipated|2017-09-12||Interventional|||A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder|A Controlled Study of the Efficacy of Botulinum Toxin A (Botox) for the Treatment of Social Anxiety Disorder (SAD)|Recruiting||Phase 4|40|Anticipated|George Washington University||2|||f||||f|t|f|||t|||No|Data sharing is not planned on being shared with other investigators|2017-10-10 21:16:18.765911|2017-10-10 21:16:18.765911
NCT03078257|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-07|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|DPABIAP||Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients|Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients|Recruiting||Phase 1|90|Anticipated|The First Affiliated Hospital with Nanjing Medical University||5|||f||||f||||||||||2017-10-10 21:16:18.878788|2017-10-10 21:16:18.878788
NCT03078244|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-08|||November 2016||2016-11-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|SPIRIT||Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension|Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension|Enrolling by invitation||N/A|1500|Anticipated|George Clinical Pty Ltd|||1||f||||f||||||||||2017-10-10 21:16:18.98088|2017-10-10 21:16:18.98088
NCT03078231|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-07|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool|Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool|Enrolling by invitation||N/A|85|Anticipated|Eyenuk, Inc.|||1||f||||||||||||||2017-10-10 21:16:19.032571|2017-10-10 21:16:19.032571
NCT03078218|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-03-07|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|OXYNAT||Health-economic Impact of Pulse Oximetry Systematic Screening of Critical Congenital Heart Disease in Asymptomatic Newborns|Health-economic Impact of Pulse Oximetry Systematic Screening of Critical Congenital Heart Disease in Asymptomatic Newborns|Not yet recruiting||N/A|34704|Anticipated|University Hospital, Bordeaux||2|||f||||f|f|f||||||No||2017-10-10 21:16:19.092684|2017-10-10 21:16:19.092684
NCT03078205|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-10|||May 1, 2016|Actual|2016-05-01|March 2017|2017-03-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Observation on the Curative Effect of Assisted Reproduction by TCM Multi-channel Interventional Therapy|TCM Multi-channel Interventional Therapy for Assisting Reproduction|Recruiting||Phase 2|100|Anticipated|Chengdu University of Traditional Chinese Medicine||3|||f||||t|f|f||||||||2017-10-10 21:16:19.296746|2017-10-10 21:16:19.296746
NCT03078192|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-29|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|November 14, 2019|Anticipated|2019-11-14|November 14, 2019|Anticipated|2019-11-14||Interventional|XenonMRI||Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging|Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging|Recruiting||Phase 2|122|Anticipated|Duke University||2|||f||||f|t|f|||f|||||2017-10-10 21:16:19.374642|2017-10-10 21:16:19.374642
NCT03078179|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-04|||June 5, 2017|Actual|2017-06-05|August 2017|2017-08-01|December 10, 2017|Anticipated|2017-12-10|August 28, 2017|Anticipated|2017-08-28||Interventional|||Effect of Lactobacillus Rhamnosus GG and Bifidobacterium Longum in Children Aged 3 to 5 Years of Villavicencio and Pasto|Effect of Lactobacillus Rhamnosus GG and Bifidobacterium Longum in Children Aged 3 to 5 Years of Villavicencio and Pasto|Recruiting||N/A|100|Anticipated|Cooperative University of Colombia||2|||f|||||f|f|||f|||||2017-10-10 21:16:19.45949|2017-10-10 21:16:19.45949
NCT03078166|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-07|||December 20, 2016|Actual|2016-12-20|March 2017|2017-03-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31|2 Years|Observational [Patient Registry]|G-CHF||Global Congestive Heart Failure Registry|Global Congestive Heart Failure Registry|Recruiting||N/A|25000|Anticipated|Hamilton Health Sciences Corporation|||1||f||||f|f|f||||||Undecided||2017-10-10 21:16:19.550429|2017-10-10 21:16:19.550429
NCT03078153|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-21|||April 1, 2017|Actual|2017-04-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Social Media Support and Financial Incentives on PrEP Adherence|The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in Young MSM of Color in Washington, DC|Recruiting||N/A|120|Anticipated|George Washington University||3|||f||||f|f|f|||f|||No||2017-10-10 21:16:19.655036|2017-10-10 21:16:19.655036
NCT03078140|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-13|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation|The Study to Compare Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation|Not yet recruiting||N/A|85|Anticipated|ChaingMai University||2|||f||||t|f|f||||||No||2017-10-10 21:16:19.741138|2017-10-10 21:16:19.741138
NCT03078127|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-09-20|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|November 30, 2017|Anticipated|2017-11-30||Interventional|REACT-CF||Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis|Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis (REACT-CF)|Recruiting||N/A|10|Anticipated|University of North Carolina, Chapel Hill||4|||f||||f|f|t|f||t|||||2017-10-10 21:16:19.820818|2017-10-10 21:16:19.820818
NCT03078114|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-10|||May 2012||2012-05-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Central Mechanism of Manual Therapy for Low Back Pain|Central Mechanism of Manual Therapy for Low Back Pain|Completed||N/A|29|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 21:16:19.921398|2017-10-10 21:16:19.921398
NCT03078101|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-11|||April 15, 2017|Actual|2017-04-15|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|EMPRA||EMPRA (EMPagliflozin and RAs in Kidney Disease)|Effect of Empagliflozin on the Renin-angiotensin System in Patients With Chronic|Recruiting||Phase 2|48|Anticipated|Medical University of Vienna||4|||f||||f|f|f||||||||2017-10-10 21:16:19.993433|2017-10-10 21:16:19.993433
NCT03078075|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-06-20|||May 5, 2017|Actual|2017-05-05|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|ADAPT-2||Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder|NIDA CTN Protocol 0068: Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder|Recruiting||Phase 3|370|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t|t|f|||f|||Yes|Data from this study will be available to researchers on the website https://datashare.nida.nih.gov/ after the study is complete and the data is analyzed. This website will not include information that can identify individual study participants.The following information will be posted: Study protocol, reference to study publication of primary outcome, data sets (SAS and ASCII ), annotated case report forms, define file (also known as Data Dictionary), study-specific de-identification notes. Prior to downloading any study data, the user will be prompted to complete a registration agreement for data use. Users will have to register a name and valid e-mail address in order to download data and to accept their responsibility for using data in accordance with the NIDA Data Share Agreement.|2017-10-10 21:16:20.179279|2017-10-10 21:16:20.179279
NCT03078049|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-26|||March 31, 2017|Actual|2017-03-31|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|April 30, 2017|Actual|2017-04-30||Observational|||Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data|Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data|Completed||N/A|11971|Actual|AstraZeneca|||2||f||||f|f|f||||||Yes|"2 abstracts
1 manuscript"|2017-10-10 21:16:20.404821|2017-10-10 21:16:20.404821
NCT03078036|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-14|||March 13, 2017|Actual|2017-03-13|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|BREAKOUT||International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study|BREAKOUT -International Breast Cancer Biomarker, Standard of Care and Real World Outcomes Study|Recruiting||N/A|197|Anticipated|AstraZeneca|||1||f||||f|f|f||||Samples With DNA|"     Whole Blood and Archived Tumor Specimen (e.g. tumor tissue)   "|||2017-10-10 21:16:22.49333|2017-10-10 21:16:22.49333
NCT03078023|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-14|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Sponge and Eosinophil Peroxidase (EPO) Staining|Is EPO Staining on Esophageal Sponge Samples a Simple Reliable Method of Accessing Esophageal Eosinophilia?|Recruiting||N/A|25|Anticipated|Mayo Clinic||1|||f||||t|f|f||||||No||2017-10-10 21:16:23.329585|2017-10-10 21:16:23.329585
NCT03078010|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-27|||February 10, 2017|Actual|2017-02-10|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant|Rational Use of Broad-spectrum Antibiotics as Empiric Antibiotic Therapy in Febrile Neutropenia in Recipients of Allogeneic Hematopoietic Cell Transplantation|Recruiting||Phase 2|144|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f|||t|||||2017-10-10 21:16:23.432024|2017-10-10 21:16:23.432024
NCT03077997|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-24|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|December 10, 2017|Anticipated|2017-12-10|September 15, 2017|Anticipated|2017-09-15||Interventional|||Internet Intervention for Diabetes Distress|Acceptability and Clinical Feasibility of an Internet-delivered Intervention for Psychological Distress in Patients With Type 2 Diabetes|Recruiting||N/A|42|Anticipated|Silver Cloud Health||1|||f||||f|f|f||||||No||2017-10-10 21:16:23.554383|2017-10-10 21:16:23.554383
NCT03077984|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-03-13|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study on the Clinical Efficacy of Chinese Medicine Treatment of Sequelae of Apoplexy||Enrolling by invitation||N/A|1660|Anticipated|Shaanxi Hospital of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-10 21:16:23.671045|2017-10-10 21:16:23.671045
NCT03077971|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-07|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Effectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple Sclerosis|Effectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple Sclerosis: A Feasibility Randomised Controlled Trial|Recruiting||N/A|54|Anticipated|University of Nottingham||3|||f||||f|f|f||||||No||2017-10-10 21:16:23.736312|2017-10-10 21:16:23.736312
NCT03077958|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-03-07|||February 18, 2017|Actual|2017-02-18|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|June 2018|Anticipated|2018-06-01||Interventional|Att16SM||Total Knee Replacement With the Attune vs. the Press Fit Condylar (PFC) Sigma.|Total Knee Replacement With the Attune vs. the Press Fit Condylar (PFC) Sigma. Randomised Study of 50 Attune and 50 PFC Sigma Total Knee Replacements (TKRs)|Recruiting||N/A|100|Anticipated|Sahlgrenska University Hospital, Sweden||1|||f||||f|f|f||||||Undecided|Data will be shared with the sponsor (DePuy).|2017-10-10 21:16:23.830412|2017-10-10 21:16:23.830412
NCT03077945|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-13|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||A Cognitive Behavioral Stress Intervention for Women Who Smoke||Recruiting||N/A|60|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||Undecided||2017-10-10 21:16:23.919073|2017-10-10 21:16:23.919073
NCT03077932|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-05-23|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|BetterOFF||An App to Aid in Transitioning Off Opiate Replacement Therapy|A Smartphone App to Facilitate Buprenorphine Discontinuation|Recruiting||N/A|65|Anticipated|Butler Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:16:24.043509|2017-10-10 21:16:24.043509
NCT03077919|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-07|||May 25, 2016|Actual|2016-05-25|March 2017|2017-03-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness|A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms|Recruiting||N/A|240|Anticipated|RTI International||2|||f||||f||f||||||No||2017-10-10 21:16:24.149698|2017-10-10 21:16:24.149698
NCT03077906|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-08|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Study of Gastro-oesophageal Reflux in Patients Having Had Bariatric Surgery|Study of Gastro-oesophageal Reflux in Patients Having Had Bariatric Surgery|Not yet recruiting||N/A|400|Anticipated|Brugmann University Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:16:24.45328|2017-10-10 21:16:24.45328
NCT03077893|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-27|||March 9, 2017|Actual|2017-03-09|March 2017|2017-03-01|December 26, 2017|Anticipated|2017-12-26|December 26, 2017|Anticipated|2017-12-26||Interventional|||Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy|A Multi-Center, Sham-Controlled, Double-Blind Randomized Withdrawal Study of PEMF Therapy to Evaluate Vibration Perception Threshold and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy in the Lower Extremity|Active, not recruiting||N/A|40|Anticipated|Regenesis Biomedical, Inc.||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:16:24.611384|2017-10-10 21:16:24.611384
NCT03077880|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-07|||January 15, 2017|Actual|2017-01-15|March 2017|2017-03-01|July 15, 2018|Anticipated|2018-07-15|January 15, 2018|Anticipated|2018-01-15||Observational|STR||Influence of Thickness of the Peri-implant Soft Tissue on Marginal Bone Remodeling|Influence Of Thickness Of the Peri-implant Soft Tissue On Marginal Bone Remodeling Around Bone Level Implant: A Multicenter Observational Clinical Study|Recruiting||N/A|100|Anticipated|International Piezosurgery Academy|||2||f||||f|f|f||||||No||2017-10-10 21:16:24.753549|2017-10-10 21:16:24.753549
NCT03077867|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-07|||January 15, 2017|Actual|2017-01-15|March 2017|2017-03-01|January 15, 2021|Anticipated|2021-01-15|January 15, 2018|Anticipated|2018-01-15||Interventional|SYNBIO||Comparison Synthetic Hydroxyapatite and Inorganic Bovine Bone in Sinus Floor Elevation|Comparison of Histological and Radiographic Evidence After Sinus Lift With Synthetic Nano-hydroxyapatite and Inorganic Bovine Bone.|Recruiting||N/A|88|Anticipated|International Piezosurgery Academy||4|||f||||f|f|f||||||No||2017-10-10 21:16:24.872572|2017-10-10 21:16:24.872572
NCT03077854|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-03-07|||June 2016||2016-06-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial|A Single-Blind Randomized Trial of Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Locally Advanced Non-Small Cell and Small Cell Lung Cancer|Recruiting||N/A|64|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:16:24.98384|2017-10-10 21:16:24.98384
NCT03077841|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-29|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Optimizing Preventative Adjuvant Linac-Based Radiation: the OPAL Trial - Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer|Optimizing Preventative Adjuvant Linac-based Radiation: the OPAL Trial A Phase II Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|f|f||||||||2017-10-10 21:16:25.109088|2017-10-10 21:16:25.109088
NCT03077828|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-04-22|||April 21, 2017|Actual|2017-04-21|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|November 2019|Anticipated|2019-11-01||Interventional|||Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma|Phase II Trial of Pembrolizumab in Combination With ICE Salvage Chemotherapy for Relapsed/Refractory Hodgkin Lymphoma|Recruiting||Phase 2|40|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 21:16:25.247595|2017-10-10 21:16:25.247595
NCT03077815|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-12|||March 27, 2017|Anticipated|2017-03-27|March 2017|2017-03-01|July 31, 2018|Anticipated|2018-07-31|July 1, 2018|Anticipated|2018-07-01||Interventional|||Systematically Intermittent Arm Exercise for Improving Maturation of Hemodialysis Arteriovenous Shunt: Study Protocol for a Randomized Controlled Trial|National Taiwan University Hospital|Not yet recruiting||N/A|150|Anticipated|National Taiwan University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:16:25.461874|2017-10-10 21:16:25.461874
NCT03077802|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-07-18|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultrasound Guided Central Venous Catheterization: Seldinger vs. Modified Seldinger Technique|Comparison of Two Needle Insertion Techniques on Success Rate and Complications During Ultrasound Guided Central Venous Catheterization: Seldinger vs. Modified Seldinger Technique|Recruiting||N/A|308|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:16:25.548073|2017-10-10 21:16:25.548073
NCT03077789|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-08|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|Conglau||Prospective Study of the Diagnostic and Therapeutic Management of Congenital Glaucoma in France|Prospective Study of the Diagnostic and Therapeutic Management of Congenital Glaucoma in France|Recruiting||N/A|250|Anticipated|University Hospital, Lille||1|||f||||f|f|f||||||No||2017-10-10 21:16:25.661225|2017-10-10 21:16:25.661225
NCT03077776|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-02|||April 14, 2017|Actual|2017-04-14|May 2017|2017-05-01|July 2025|Anticipated|2025-07-01|January 2025|Anticipated|2025-01-01||Interventional|TRACERX-TNBC||Tracking Triple-negative Breast Cancer Evolution Through Therapy|Tracking Triple-negative Breast Cancer Evolution Through Therapy|Active, not recruiting||N/A|250|Anticipated|UNICANCER||1|||f||||t|f|f||||||Undecided||2017-10-10 21:16:25.763433|2017-10-10 21:16:25.763433
NCT03077763|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-03-17|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Haem and Nitrite Study - The Effects of Haemoglobin NO-blockade on Nitrite-induced Forearm Vessel Dilatation|The Effects of Free Haemoglobin NO-blockade on Nitrite Forearm Vessel Dilatation Under Normoxia and Hypoxia in Healthy Volunteers|Recruiting||Phase 1|41|Anticipated|University of East Anglia||2|||f||||f||||||||No||2017-10-10 21:16:25.871628|2017-10-10 21:16:25.871628
NCT03077750|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-07|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum|A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the Efficacy, Tolerability, and Safety of VBP-245 in Pediatric Subjects for the Treatment of Molluscum Contagiosum|Recruiting||Phase 2|110|Anticipated|Veloce BioPharma LLC||2|||f||||t|t|f||||||No||2017-10-10 21:16:25.963199|2017-10-10 21:16:25.963199
NCT03077737|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-06-06|||April 21, 2017|Actual|2017-04-21|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Reducing Tobacco Use Disparities Among Low-Income Adults|Reducing Tobacco Use Disparities Among Adults In Safety Net Community Health Centers|Enrolling by invitation||N/A|530|Anticipated|Northwestern University||2|||f||||f|f|f||||||No||2017-10-10 21:16:26.074193|2017-10-10 21:16:26.074193
NCT03077724|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-10|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|August 2017|Anticipated|2017-08-01||Interventional|FORTUNE||Fish Oil to Reduce Tobacco Use iN Expectant Mothers Study|Fish Oil to Reduce Tobacco Use iN Expectant Mothers Study|Active, not recruiting||Phase 2|40|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||No|This is a pilot and feasibility trial. We are not planning to share IPD with other researchers|2017-10-10 21:16:26.185668|2017-10-10 21:16:26.185668
NCT03077711|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-31|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs|Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs|Recruiting||Phase 4|130|Anticipated|NorthShore University HealthSystem||2|||f||||t|t|f|||f|||No|The investigators are currently only recruiting at one institution and only researchers on the original institutional review board will have access to data. Only the principal investigator and research coordinator will have the data to be analyzed.|2017-10-10 21:16:26.277071|2017-10-10 21:16:26.277071
NCT03077685|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma|Phase IIa Trial Evaluating the Safety of Intratumoral Injection of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma|Recruiting||Phase 2|30|Anticipated|NanOlogy, LLC||3|||||||t|t|f||||||||2017-10-10 21:16:26.575812|2017-10-10 21:16:26.575812
NCT03077672|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-10|||February 10, 2017|Actual|2017-02-10|March 2017|2017-03-01|February 10, 2018|Anticipated|2018-02-10|February 10, 2018|Anticipated|2018-02-10||Observational|MBOSS||Mitochondrial DNA as a Biomarker of Sepsis Severity|Mitochondrial DNA as a Biomarker of Sepsis Severity|Recruiting||N/A|600|Anticipated|Weill Medical College of Cornell University|||2||f||||f|f|f||||Samples With DNA|"     Plasma, Leukocyte Pellet, Mitochondrial DNA   "|Yes|Upon reasonable request, de-identified participant data will be able available to individuals six-months after publication of all data.|2017-10-10 21:16:26.685759|2017-10-10 21:16:26.685759
NCT03077659|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-10-04|||September 6, 2017|Actual|2017-09-06|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer|Phase IIa Dose Escalation Trial of NanoPac® Focal Therapy for Prostate Cancer in Subjects Undergoing Radical Prostatectomy|Recruiting||Phase 2|30|Anticipated|NanOlogy, LLC||3|||||||t|t|f||||||||2017-10-10 21:16:26.786025|2017-10-10 21:16:26.786025
NCT03077646|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-07|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|IF||Pediatric Inpatient Firearms Study|Pediatric Inpatient Firearms Study|Recruiting||N/A|225|Anticipated|Montefiore Medical Center||3|||f||||f|f|f||||||No|There is no plan to share individual participant data with other researchers. The data will only be available to study personnel approved on this study.|2017-10-10 21:16:27.022511|2017-10-10 21:16:27.022511
NCT03077633|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 1, 2022|Anticipated|2022-03-01|October 1, 2021|Anticipated|2021-10-01||Interventional|||Cerclage for Twins With Short Cervix|Cervical Cerclage for Twin Pregnancy With Sonographic Cervical Length 0.1 to 15.0 mm: A Randomized Clinical Trial|Not yet recruiting||Phase 2/Phase 3|152|Anticipated|Mednax Center for Research, Education and Quality||2|||f||||t|f|f|||f|||||2017-10-10 21:16:27.151295|2017-10-10 21:16:27.151295
NCT03077607|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-09-28|||December 19, 2016|Actual|2016-12-19|September 2017|2017-09-01|December 23, 2017|Anticipated|2017-12-23|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors|A Phase 1 Open-label, Two-arm,Drug-drug Interaction Study To Evaluate The Effect Of Itraconazole And Rifampin On The Pharmacokinetics Of Talazoparib In Patients With Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-10 21:16:27.405354|2017-10-10 21:16:27.405354
NCT03077594|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-07|||September 26, 2016|Actual|2016-09-26|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Characterization of the Neo-squamous Epithelial Barrier|Prospective Characterization of the Neo-squamous Epithelial Barrier Following Successful Endoscopic Therapy in Barrett's Esophagus|Recruiting||N/A|40|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||No||2017-10-10 21:16:27.518884|2017-10-10 21:16:27.518884
NCT03077581|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-07|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|June 15, 2017|Anticipated|2017-06-15|June 5, 2017|Anticipated|2017-06-05||Interventional|Maha1||Comparison of Three Techniques for Analgesia After Abdominoplasty|The Efficacy of Three Different Surgically Infiltrated Local Anesthetic Techniques in Abdominoplasty|Active, not recruiting||N/A|48|Anticipated|Mansoura University||3|||f||||t|f|f||||||Undecided||2017-10-10 21:16:27.598946|2017-10-10 21:16:27.598946
NCT03077568|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-03-07|||December 2016||2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation of a Web Application That Supports Behavior Change in Work Related Stress|Evaluation of a Web Application That Supports Behavior Change in Work Related Stress - a Randomized Controlled Trial|Enrolling by invitation||N/A|238|Anticipated|Mälardalen University||2|||f||||f||||||||No|No plan to share data|2017-10-10 21:16:27.675019|2017-10-10 21:16:27.675019
NCT03077555|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-31|||January 21, 2017|Actual|2017-01-21|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception|Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception Containing Estradiol Hemihydrate Compared to Ethinyl Estradiol|Recruiting||Phase 4|80|Anticipated|Mahidol University||2|||f||||f|f|f|||f|||||2017-10-10 21:16:27.779295|2017-10-10 21:16:27.779295
NCT03077542|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-10|2017-09-20|||April 6, 2017|Actual|2017-04-06|September 15, 2017|2017-09-15|August 31, 2026|Anticipated|2026-08-31|September 30, 2025|Anticipated|2025-09-30||Interventional|||Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease|Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease|Recruiting||Phase 1/Phase 2|84|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f|||||t|f||||||||2017-10-10 21:16:27.87877|2017-10-10 21:16:27.87877
NCT03077529|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-02|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||GOS and Microbial Fermentation in Aging|Impact of Galacto-oligosaccharides on Microbial Fermentation Capacity and Markers of Frailty in Healthy Adults and Elderly|Recruiting||N/A|40|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:16:27.97647|2017-10-10 21:16:27.97647
NCT03077516|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-03-07|||November 2016||2016-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease|Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease|Enrolling by invitation||N/A|250|Anticipated|LDR Spine USA|||1||f||||f||||||||No||2017-10-10 21:16:28.061289|2017-10-10 21:16:28.061289
NCT03077503|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-07|||September 1, 2015|Actual|2015-09-01|March 2017|2017-03-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Comparison of Dexmedetomidine and Fentanyl to Prevent Hemodynamic Response to Skull Pins Application|Comparison of Dexmedetomidine and Fentanyl to Prevent Hemodynamic Response to Skull Pins Application in Neurosurgery:Double Blind Randomized Controlled Trial|Completed||Phase 4|60|Actual|Khon Kaen University||2|||f|||||t|f|||f|||||2017-10-10 21:16:28.168151|2017-10-10 21:16:28.168151
NCT03077490|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-07|||March 4, 2015|Actual|2015-03-04|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|March 30, 2016|Actual|2016-03-30||Observational|KIDS||Comparison of Single Versus Multicenter Outcomes for Pelvic Organ Prolapse Repair Using a Mesh-capturing Device|Comparison of Single Versus Multicenter Outcomes for Pelvic Organ Prolapse Repair Using a Mesh-capturing Device|Completed||N/A|319|Actual|Karolinska Institutet|||1||f||||f|f|t|f||t|||No||2017-10-10 21:16:28.279746|2017-10-10 21:16:28.279746
NCT03077477|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-07|||April 15, 2017|Anticipated|2017-04-15|March 2017|2017-03-01|December 15, 2017|Anticipated|2017-12-15|November 15, 2017|Anticipated|2017-11-15||Interventional|||Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers|Phase 1 Double-Blind, Placebo Controlled, Dose-Escalation Safety, Pharmacokinetic and Pharmacodynamic Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers|Not yet recruiting||Phase 1|48|Anticipated|Aminex Therapeutics, Inc.||3|||||||f|t|f||||||No|No sharing of IPD at this time|2017-10-10 21:16:28.370967|2017-10-10 21:16:28.370967
NCT03077464|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-07|||June 1, 2014|Actual|2014-06-01|March 2017|2017-03-01|May 15, 2015|Actual|2015-05-15|July 28, 2014|Actual|2014-07-28||Interventional|||Behaviorally Oriented Nutrition Education at a Russian Summer Camp|Behaviorally Oriented Nutrition Education at a Russian Summer Camp: A Quasi-experimental Superiority Trial|Completed||N/A|40|Actual|Kansas State University||2|||f||||f|f|f||||||No||2017-10-10 21:16:28.469051|2017-10-10 21:16:28.469051
NCT03077438|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-29|||February 24, 2017|Actual|2017-02-24|September 2017|2017-09-01|October 13, 2017|Anticipated|2017-10-13|October 13, 2017|Anticipated|2017-10-13||Interventional|||Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years|Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age|Active, not recruiting||Phase 3|1000|Actual|Sanofi||2|||f||||f|t|f||||||||2017-10-10 21:16:28.678754|2017-10-10 21:16:28.678754
NCT03077425|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-07-05|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|April 2021|Anticipated|2021-04-01|October 2020|Anticipated|2020-10-01||Interventional|CHALO||Obesity and Caries in Young South Asian Children: A Common Risk Factor Approach|Obesity and Caries in Young South Asian Children: A Common Risk Factor Approach|Not yet recruiting||N/A|377|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:16:28.883967|2017-10-10 21:16:28.883967
NCT03077412|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-09-18|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease|Recruiting||Phase 2|75|Anticipated|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:16:28.978295|2017-10-10 21:16:28.978295
NCT03077399|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-03-14|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|SCALA||Validation Study of SCALA, Scale for Lateropulsion|Clinical Validation of SCALA, a New Rating Scale for Assessing Lateropulsion After Stroke|Not yet recruiting||N/A|100|Anticipated|University Hospital, Grenoble|||2||f||||t|f|f||||||No||2017-10-10 21:16:29.110389|2017-10-10 21:16:29.110389
NCT03077386|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-06|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Community Health Worker Intervention for Patients With Complex Chronic Disease|Community Health Worker Intervention for Patients With Complex Chronic Disease Seen in Primary Care|Not yet recruiting||N/A|1200|Anticipated|University of Calgary||2|||f||||f|f|f||||||No||2017-10-10 21:16:29.196558|2017-10-10 21:16:29.196558
NCT03077373|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-07|||January 16, 2017|Actual|2017-01-16|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of a Brief Intervention on Reduction of Systolic Blood Pressure|The Efficacy of a Computerized Brief Intervention Targeting Physical Activity, Sedentary Behavior, and Smoking Cessation on the Reduction of Systolic Blood Pressure in Individuals Aged 40 to 65 Years|Recruiting||N/A|538|Anticipated|University Medicine Greifswald||2|||f||||f||||||||Undecided||2017-10-10 21:16:29.335883|2017-10-10 21:16:29.335883
NCT03077360|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-09-05|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|January 31, 2021|Anticipated|2021-01-31|August 1, 2020|Anticipated|2020-08-01||Interventional|||Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans|Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans|Recruiting||N/A|69|Anticipated|University of Colorado, Denver||3|||f||||t|f|f||||||||2017-10-10 21:16:29.427024|2017-10-10 21:16:29.427024
NCT03077347|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-25|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 1, 2022|Anticipated|2022-12-01|December 1, 2022|Anticipated|2022-12-01||Interventional|||The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in Schizophrenia|The Effects of Transcranial Direct Current Stimulation on the Neuronal Mechanisms of Cognitive Control in Schizophrenia|Recruiting||N/A|100|Anticipated|University of California, Davis||2|||f||||f|f|t|t||f|||Yes|"Select data from this study may be submitted to the National Institute of Mental Health Data Archive (NDA). NDA is a data repository run by the National Institute of Mental Health (NIMH) that allows researchers studying mental illness to collect and share de-identified information with each other. The data repository is accessible only to qualified investigators. All subject data will be de-identified (subject names will not be used) and each subject will have a separate identifier called a Global Unique Identifier (GUID) to remove any possibility that the identities of the subjects cannot be readily ascertained or otherwise associated with the data by the repository staff or secondary data users (45 Code of Federal Regulations, 46.102)."|2017-10-10 21:16:29.512683|2017-10-10 21:16:29.512683
NCT03077334|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-09|||October 7, 2014|Actual|2014-10-07|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Observational|||Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer|Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer-Prospective Cohort Study|Recruiting||N/A|100|Anticipated|Yonsei University|||2||f||||f|f|f||||||Undecided||2017-10-10 21:16:29.595107|2017-10-10 21:16:29.595107
NCT03077321|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-09-13|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Improving Access to a Primary Care Based Positive Parenting Program|Improving Access to a Primary Care Based Positive Parenting Program|Not yet recruiting||N/A|200|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 21:16:29.681064|2017-10-10 21:16:29.681064
NCT03077308|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-18|||January 2, 2017|Actual|2017-01-02|May 2017|2017-05-01|July 31, 2019|Anticipated|2019-07-31|January 23, 2017|Actual|2017-01-23||Observational|||Rare Diseases Clinical Research Network: Neurophysiological Correlates|Rett Syndrome, MECP2 Duplication, and Rett-Related Disorders Consortium, Rare Disease Clinical Research Network: Neurophysiologic Correlates|Recruiting||N/A|250|Anticipated|University of Alabama at Birmingham|||4||f||||t|f|f||||||Yes|Data will be submitted to NDAR/dbGAP.|2017-10-10 21:16:29.777891|2017-10-10 21:16:29.777891
NCT03077295|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-04-20|||April 5, 2017|Actual|2017-04-05|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|January 2018|Anticipated|2018-01-01||Interventional|||The Big Breakfast Study|Role of Breakfast Size and Composition for Appetite Control and Energy Balance|Recruiting||N/A|20|Anticipated|University of Aberdeen||2|||f||||t|f|f||||||No||2017-10-10 21:16:30.095339|2017-10-10 21:16:30.095339
NCT03077282|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-02|||August 3, 2017|Anticipated|2017-08-03|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer|Quality Control and Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer|Not yet recruiting||Phase 1|24|Anticipated|Thammasat University||2|||f||||t|f|f||||||||2017-10-10 21:16:30.235675|2017-10-10 21:16:30.235675
NCT03077269|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-09|||May 1, 2016|Actual|2016-05-01|March 2017|2017-03-01|December 31, 2024|Anticipated|2024-12-31|May 1, 2022|Anticipated|2022-05-01||Observational|||Understanding Coagulation and Inflammation in Burns|Understanding Coagulation and Inflammation in Burns|Recruiting||N/A|250|Anticipated|University of Rochester|||1||f||||t|f|f||||Samples Without DNA|"     plasma and microparticles   "|No||2017-10-10 21:16:30.328572|2017-10-10 21:16:30.328572
NCT03077256|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-13|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|October 1, 2018|Anticipated|2018-10-01|July 1, 2018|Anticipated|2018-07-01|6 Months|Observational [Patient Registry]|||Burst Biologics Foot and Ankle Registry|Multicenter Prospective Registry to Evaluate Use and Outcomes of Burst Biologics Products in Foot and Ankle Surgery|Recruiting||N/A|300|Anticipated|Smart-Surgical Inc. dba Burst Biologics|||1||f||||t|f|f||||||No||2017-10-10 21:16:30.422885|2017-10-10 21:16:30.422885
NCT03077243|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-03-06|||August 2016||2016-08-01|March 2017|2017-03-01|August 2046|Anticipated|2046-08-01|April 2019|Anticipated|2019-04-01||Interventional|||P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC|LCCC 1612: P53 Mutational Status and Circulating Free HPV DNA for the Management of HPV-associated Oropharyngeal Squamous Cell Cancers|Recruiting||Phase 2|80|Anticipated|UNC Lineberger Comprehensive Cancer Center||3|||f||||t|t|f||||||||2017-10-10 21:16:30.519564|2017-10-10 21:16:30.519564
NCT03077230|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-19|||May 2015||2015-05-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer Screening|Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer Screening|Completed||N/A|62|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 21:16:30.645919|2017-10-10 21:16:30.645919
NCT03077217|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-03-06|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy|Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy: A Randomized Open Controlled Study|Not yet recruiting||Phase 4|120|Anticipated|Shanghai Changzheng Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:16:30.737854|2017-10-10 21:16:30.737854
NCT03077204|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-24|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||BIO4 Clinical Case Study: Cervical Spine|Clinical and Radiographic Outcomes of BIO4 Bone Matrix in Patients Undergoing 1 or 2-Level Anterior Cervical Discectomy and Fusion Surgery|Recruiting||Phase 4|20|Anticipated|Seton Healthcare Family||1|||f||||f|t|t|f|f|t|||No||2017-10-10 21:16:30.819969|2017-10-10 21:16:30.819969
NCT03076996|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-07-19|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||YouthPower Action Feasibility Study of Online Support Group Intervention Among Adolescents Living With HIV in Nigeria|YouthPower Action Feasibility Study of Online Support Group Intervention Among Adolescents Living With HIV in Nigeria|Recruiting||N/A|50|Anticipated|FHI 360||1|||f||||f|f|f||||||||2017-10-10 21:16:32.579679|2017-10-10 21:16:32.579679
NCT03077191|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-06|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|December 31, 2025|Anticipated|2025-12-31|June 30, 2020|Anticipated|2020-06-30|66 Months|Observational [Patient Registry]|Ipomammella||Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience|Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy Without Boost: Results of a Homogeneous Single Institution Experience|Recruiting||N/A|500|Anticipated|IRCCS San Raffaele|||1||f||||f|f|f||||||No|Individual Participant Data will not be shared with other researchers.|2017-10-10 21:16:30.954485|2017-10-10 21:16:30.954485
NCT03077178|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-28|||October 15, 2017|Anticipated|2017-10-15|March 2017|2017-03-01|March 15, 2023|Anticipated|2023-03-15|March 15, 2022|Anticipated|2022-03-15||Interventional|SARCOLD||Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over|Evaluation of the Impact of Locoregional Treatment of Soft Tissue Sarcoma on the Functional Status of Patients Aged 70 Years and Over|Not yet recruiting||N/A|100|Anticipated|Institut Bergonié||1|||f||||f|f|f||||||||2017-10-10 21:16:31.079517|2017-10-10 21:16:31.079517
NCT03077165|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-15|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Dose-response Relationship Study of S42909 on Leg Ulcer Healing|A 10-week Randomized, Double-blind, Placebo-controlled, Prospective, International, Multicentre, Phase IIa Study of S42909 on Leg Ulcer Healing.|Recruiting||Phase 2|204|Anticipated|Ilkos Therapeutic Inc.||6|||f||||f|t|f||||||||2017-10-10 21:16:31.196063|2017-10-10 21:16:31.196063
NCT03077152|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-09|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Patient Factors Associated With Prescription of Antibiotics for Inappropriate Indication in Patients With AECOPD|Patient Factors Associated With Prescription of Antibiotics for Inappropriate Indication in Patients With AECOPD|Recruiting||N/A|143|Anticipated|Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:16:31.365967|2017-10-10 21:16:31.365967
NCT03077139|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-19|||November 29, 2012|Actual|2012-11-29|September 2017|2017-09-01|March 23, 2017|Actual|2017-03-23|March 23, 2017|Actual|2017-03-23||Interventional|CRT in PH||Cardiac Resynchronization Therapy in Pulmonary Hypertension|Cardiac Resynchronization Therapy in Pulmonary Hypertension|Completed||N/A|6|Actual|Ochsner Health System||1|||f||||f|f|f|||f|||||2017-10-10 21:16:31.472966|2017-10-10 21:16:31.472966
NCT03077126|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-09|||April 11, 2013|Actual|2013-04-11|March 2017|2017-03-01|September 18, 2015|Actual|2015-09-18|June 29, 2015|Actual|2015-06-29||Interventional|||Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer|Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer: A Pilot Study|Completed||N/A|10|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|f|f||||||||2017-10-10 21:16:31.551793|2017-10-10 21:16:31.551793
NCT03077113|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-09|||October 15, 2012|Actual|2012-10-15|March 2017|2017-03-01|August 23, 2016|Actual|2016-08-23|April 16, 2015|Actual|2015-04-16||Interventional|||Pilot Study of Regional Lung Ventilation|Pilot Study of Regional Lung Ventilation: Comparing Ventilation Images Computed From 4D CTs vs. Traditional Nuclear Medicine Ventilation Images|Completed||N/A|3|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|f|f||||||||2017-10-10 21:16:31.649818|2017-10-10 21:16:31.649818
NCT03077100|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-06|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Identification of Pathogens in the Neonatal Intensive Care Unit (NICU)|Identification of Pathogens and Their Antibiogram in the Neonatal Intensive Care Unit (NICU)|Not yet recruiting||N/A|2000|Anticipated|Hillel Yaffe Medical Center|||1||f||||t|f|f||||||No||2017-10-10 21:16:31.736531|2017-10-10 21:16:31.736531
NCT03077087|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-24|||April 10, 2017|Actual|2017-04-10|February 2017|2017-02-01|August 28, 2018|Anticipated|2018-08-28|April 10, 2018|Anticipated|2018-04-10||Interventional|Integra||Single-Stage Integra Reconstruction in Burns|Single-Stage Integra Reconstruction in Burns|Recruiting||N/A|10|Anticipated|HealthPartners Institute||1|||f||||f|f|t|f|f|f|||No|We do not plan to share IPD|2017-10-10 21:16:31.831506|2017-10-10 21:16:31.831506
NCT03077074|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-20|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Brain Responses to Visual Food Cues in Response to a Low Carbohydrate Diet|Brain Responses to Visual Food Cues in Response to a Low Carbohydrate Diet|Recruiting||N/A|40|Anticipated|Hadassah Medical Organization||1|||f|||||f|f||||||No||2017-10-10 21:16:31.963205|2017-10-10 21:16:31.963205
NCT03077061|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-04-25|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|April 1, 2023|Anticipated|2023-04-01|April 1, 2023|Anticipated|2023-04-01||Interventional|||Peri-implantitis - Reconstructive Surgical Therapy|Reconstructive Surgical Therapy of Peri-implantitis-related Osseous Defects. A Multicenter Randomized Controlled Clinical Trial|Recruiting||N/A|140|Anticipated|Göteborg University||2|||f||||f|f|f|||f|||No||2017-10-10 21:16:32.046681|2017-10-10 21:16:32.046681
NCT03077048|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-31|||March 30, 2017|Actual|2017-03-30|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|CKD||Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients|Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis CKD Patients - A Randomized, Controlled, Open-labelled Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fresenius Kabi||2|||f||||f|f|f||||||No||2017-10-10 21:16:32.156732|2017-10-10 21:16:32.156732
NCT03077035|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-19|||October 1, 2015|Actual|2015-10-01|March 2017|2017-03-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Using ICDAS II and KaVo DIAGNOdent Pen Detecting Tooth Pit and Fissure Level Incipent Caries Progression||Recruiting||N/A|300|Anticipated|Fourth Military Medical University||2|||f||||||||||||||2017-10-10 21:16:32.308505|2017-10-10 21:16:32.308505
NCT03077022|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-24|||February 1, 2016|Actual|2016-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Femoroacetabular Impingement (FAI): The Effectiveness of Physical Therapy|Effectiveness of Physical Therapy (PT) Alone vs PT Followed by Surgery to Alleviate the Symptoms of Femoroacetabular Impingement (FAI)|Active, not recruiting||N/A|150|Anticipated|University of Colorado, Denver|||1||f|||||f|f|||f|||Undecided||2017-10-10 21:16:32.391188|2017-10-10 21:16:32.391188
NCT03077009|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-03-06|||March 20, 2017|Anticipated|2017-03-20|February 2017|2017-02-01|March 20, 2020|Anticipated|2020-03-20|March 20, 2020|Anticipated|2020-03-20||Interventional|||Functional Improvement and UTC of the Achilles Tendon After Sodium Hyaluronate Injection for Plantaris Syndrome|Functional Improvement and Ultrasound Tissue Characterisation of the Achilles Tendon Following Sodium Hyaluronate Injection for Plantaris Friction Syndrome|Recruiting||Phase 4|33|Anticipated|Fortius Clinic||1|||f||||f|t|f|||f|||No||2017-10-10 21:16:32.465743|2017-10-10 21:16:32.465743
NCT03076983|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-21|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Assessment of the Capability of PulmoVista 500 to Continuously Monitor Changes of Ventilation Over Time|Assessment of the Capability of PulmoVista 500 to Continuously Monitor Changes of Ventilation Over Time|Recruiting||N/A|80|Anticipated|Drägerwerk AG & Co. KGaA|||2||f||||t|f|f||||||No||2017-10-10 21:16:32.667982|2017-10-10 21:16:32.667982
NCT03076970|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-10|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|||Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Subjects|A Randomized, Double-Blind, Three Period, Cross-Over Study to Evaluate the Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan (Imitrex) in Healthy Male and Female Subjects|Completed||Phase 1|42|Actual|CoLucid Pharmaceuticals||3|||f||||f|t|f||||||No||2017-10-10 21:16:32.761468|2017-10-10 21:16:32.761468
NCT03076957|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-03-06|||December 2016||2016-12-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.|A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. in Patients With Previously Treated Advanced Colorectal Cancer|Recruiting||Phase 1/Phase 2|24|Anticipated|Chong Kun Dang Pharmaceutical||1|||f||||f||||||||Undecided||2017-10-10 21:16:32.854299|2017-10-10 21:16:32.854299
NCT03076944|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-27|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of Desensitization Protocols in Reduction of Dentin Hypersensitivity|Evaluation of Desensitization Protocols in Reduction of Dentin Hypersensitivity: A Randomized Clinical Trial|Recruiting||N/A|32|Anticipated|Federal University of Uberlandia||3|||f||||f|f|f||||||No||2017-10-10 21:16:32.930844|2017-10-10 21:16:32.930844
NCT03076931|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-03-06|||August 2016||2016-08-01|March 2017|2017-03-01||||August 2022|Anticipated|2022-08-01||Interventional|||Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction|Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction|Recruiting||N/A|64|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||||||||||||2017-10-10 21:16:33.015711|2017-10-10 21:16:33.015711
NCT03076918|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-15|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Flexithera||Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy|A Phase II Study Evaluating the Non-inferiority of the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy (PDT)|Recruiting||N/A|47|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:16:33.100877|2017-10-10 21:16:33.100877
NCT03076905|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Pharmacokinetics of IV Formulation|F901318 - A Phase I, Single Intravenous Dose, Safety, Tolerability and Pharmacokinetics Study in Healthy Male and Female Subjects|Not yet recruiting||Phase 1|8|Anticipated|F2G Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:16:33.180828|2017-10-10 21:16:33.180828
NCT03076892|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-11|||September 2016||2016-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PHOS-ISTOS||Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS|A Phase II Study Evaluating the Non-inferiority and Better Tolerability of the Device PHOS-ISTOS Compared to the Conventional Photodynamic Therapy (PDT)|Recruiting||N/A|47|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 21:16:33.242443|2017-10-10 21:16:33.242443
NCT03076879|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-09-25|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|June 19, 2017|Actual|2017-06-19|March 22, 2017|Actual|2017-03-22||Interventional|||Increasing Participation in Cervical Cancer Screening and Risk for Beliefs/Attitudes Among Women at Risk|The Effect of Nursing Interventions on Women's Cervical Cancer Risk for Beliefs / Attitudes and Attendance to Screening Programme; Study Protocol for a Randomized Controlled Trial|Completed||N/A|114|Actual|Selcuk University||2|||f||||f|f|f||||||||2017-10-10 21:16:33.323293|2017-10-10 21:16:33.323293
NCT03076866|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-13|||January 1, 2001|Actual|2001-01-01|March 2017|2017-03-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01|20 Years|Observational [Patient Registry]|PPCRNice||Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism|Suivi Prospectif Des Patients Presentant un Rhumatisme Inflammatoire Chronique|Recruiting||N/A|1000|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f|f|f||||||Undecided||2017-10-10 21:16:33.401674|2017-10-10 21:16:33.401674
NCT03076853|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-06|||April 3, 2016|Actual|2016-04-03|March 2017|2017-03-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|MATRIX-DPRS||Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System|Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System|Completed||N/A|511|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f|f|f||||||No||2017-10-10 21:16:33.46947|2017-10-10 21:16:33.46947
NCT03076840|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-20|||February 17, 2016|Actual|2016-02-17|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||The Immediate Effect of Kinesio Tape on Hamstring Muscle Length in Female Students of University of Dammam|The Immediate Effect of Kinesio Tape on Hamstring Muscle Length in Female Students of University of Dammam|Recruiting||N/A|96|Anticipated|Dammam University||3|||f||||t|f|f||||||Undecided|only coded data|2017-10-10 21:16:33.534332|2017-10-10 21:16:33.534332
NCT03076827|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-03-06|||October 2015||2015-10-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Comparison Between Morning Surgery and Afternoon Surgery According to Cortisol Circadian Rhythm.|Comparison of Cortisol and Cytokines in Morning and Afternoon Surgerys According to Circadian Rhythm of Cortisol|Completed||N/A|44|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||Yes||2017-10-10 21:16:33.608266|2017-10-10 21:16:33.608266
NCT03076814|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-03-06|||March 2012||2012-03-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Functional Muscle Ischemia With Tadalafil Treatment in Becker Muscular Dystrophy||Completed||N/A|20|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-10 21:16:33.676317|2017-10-10 21:16:33.676317
NCT03076801|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-04-20|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|CHOIR||Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?|Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?: A Pilot Randomized Controlled Trial|Not yet recruiting||N/A|50|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||No||2017-10-10 21:16:33.735431|2017-10-10 21:16:33.735431
NCT03076775|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-06-08|||June 8, 2017|Actual|2017-06-08|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|E-ALPS||Euglycemia After Antenatal Late Preterm Steroids|Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study|Recruiting||N/A|560|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|f||||||No|Data collected as a part of this trial will only be available to the study team. Protected health information will only be available to the recruiting site in order to complete data abstraction.|2017-10-10 21:16:34.110755|2017-10-10 21:16:34.110755
NCT03076762|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-06|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparative Study Suburothelial and Trigonal Botulinum Toxin A Injection in Treatment of Interstitial Cystitis|Comparative Study of the Efficacy and Safety Between Suburothelial and Trigonal Intravesical Botulinum Toxin A Injection in Treatment of Interstitial Cystitis Refractory to Conventional Treatment - A Prospective, Randomized, Clinical Trial|Recruiting||Phase 2|60|Anticipated|Buddhist Tzu Chi General Hospital||2|||f||||t|t|f|||t|||No|No plan to share IPD|2017-10-10 21:16:34.260189|2017-10-10 21:16:34.260189
NCT03076749|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-09|||February 2013||2013-02-01|February 2012|2012-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Predictive Models for Betalactam Allergy|Designing Predictive Models for Betalactam Allergy Using the Drug Allergy and Hypersensitivity Database®|Completed||N/A|1200|Actual|University Hospital, Montpellier|||1||f||||t||||||||No||2017-10-10 21:16:34.419592|2017-10-10 21:16:34.419592
NCT03076736|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-28|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|SPA||Singing for People With Aphasia|Singing for People With Aphasia (SPA): A Pilot Randomised Controlled Trial of a Group Singing Intervention to Improve Wellbeing|Recruiting||N/A|48|Anticipated|University of Exeter||2|||f||||t|f|f||||||No||2017-10-10 21:16:34.537246|2017-10-10 21:16:34.537246
NCT03076723|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-03-13|||March 2017|Anticipated|2017-03-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus|Using Cerebrospinal Fluid Dynamics to Identify Shunt Responders in Idiopathic Normal Pressure Hydrocephalus and to Optimize Postoperative Clinical Improvement While Minimizing Overdrainage Related Complications - A Double Blind Randomized Study|Not yet recruiting||N/A|150|Anticipated|Umeå University||2|||f|||||f|f||||||No||2017-10-10 21:16:34.687338|2017-10-10 21:16:34.687338
NCT03076710|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-03|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|EXPAREL||Post-Operative Pain Management Following Spine Surgery|Two-Stage, Pilot, Prospective, Observational Study of Post-Operative Pain Management Following Spine Surgery|Recruiting||N/A|40|Anticipated|University of Miami|||2||f||||f|t|f|||f|||||2017-10-10 21:16:34.827666|2017-10-10 21:16:34.827666
NCT03076697|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-24|||April 16, 2015|Actual|2015-04-16|August 2017|2017-08-01|August 30, 2025|Anticipated|2025-08-30|June 30, 2023|Anticipated|2023-06-30||Observational|||Smartphone Screening for Eye Diseases|Smartphone Screening for Eye Diseases|Enrolling by invitation||N/A|550|Anticipated|University of Michigan|||4||f||||f|f|f||||||||2017-10-10 21:16:34.97719|2017-10-10 21:16:34.97719
NCT03076684|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-10|||March 3, 2017|Actual|2017-03-03|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Gender Differences in the Metabolic Effects of Uric Acid|Gender Differences in the Metabolic Effects of Uric Acid|Recruiting||Early Phase 1|36|Anticipated|University of Missouri-Columbia||3|||f||||f|t|f|||f|||No||2017-10-10 21:16:35.095026|2017-10-10 21:16:35.095026
NCT03076671|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-22|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|February 28, 2021|Anticipated|2021-02-28||Interventional|MTMD||More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease|More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease|Recruiting||N/A|632|Anticipated|University of Colorado, Denver||3|||f||||f|f|f||||||||2017-10-10 21:16:35.226496|2017-10-10 21:16:35.226496
NCT03076658|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-03-06|||September 2016||2016-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers|Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers|Recruiting||N/A|60|Anticipated|University of Colorado, Denver||1|||f||||f||||||||Yes|Researchers, at the end of the study, can make data request to Principle Investigator and then requested data can be obtained via RedCap.|2017-10-10 21:16:35.387024|2017-10-10 21:16:35.387024
NCT03076632|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-26|||April 1, 2017|Anticipated|2017-04-01|September 2017|2017-09-01|September 26, 2017|Anticipated|2017-09-26|September 26, 2017|Actual|2017-09-26||Interventional|||Interactions Between Neurostimulation and Physical Exercise|Acute Interactions Between Electromagnetic Stimulation and Physical Exercise|Withdrawn||N/A|0|Actual|Bronx VA Medical Center||3||Funding obtained to conduct expanded study - to be posted to ClinicalTrials.gov.|f||||f|f|f||||||||2017-10-10 21:16:35.647927|2017-10-10 21:16:35.647927
NCT03076619|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-03-10|||November 2003||2003-11-01|March 2017|2017-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||A Clinical Study of Fundus Findings in Toxaemia of Pregnancy|A Clinical Study of Fundus Findings in Toxaemia of Pregnancy (Pregnancy Induced Hypertension)|Completed||N/A|300|Actual|B. J. Medical College, Ahmedabad|||1||f||||f||||||||No||2017-10-10 21:16:35.742261|2017-10-10 21:16:35.742261
NCT03076606|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|March 20, 2019|Anticipated|2019-03-20|March 20, 2019|Anticipated|2019-03-20||Interventional|AVIGE||Nurses Ability to Assess Visual Acuity in Geriatric Consultation|Nurses Ability to Assess Visual Acuity in Geriatric Consultation|Not yet recruiting||N/A|204|Anticipated|University Hospital, Caen||1|||f||||f|f|f||||||No||2017-10-10 21:16:35.836443|2017-10-10 21:16:35.836443
NCT03076593|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-06|||February 14, 2017|Actual|2017-02-14|March 2017|2017-03-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Observational|||GAPcare Fall Prevention Pilot Survey|GAPcare: The Geriatric Acute and Post-acute Care Coordination Program - Pilot Survey|Recruiting||N/A|100|Anticipated|Rhode Island Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:16:35.914865|2017-10-10 21:16:35.914865
NCT03076580|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-06|||July 1, 2015|Actual|2015-07-01|March 2017|2017-03-01|December 31, 2021|Anticipated|2021-12-31|July 1, 2018|Anticipated|2018-07-01||Observational|AOCC||"An Integrative-Omics Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China"|An Integrative-omics Study to Identify New Biomarkers of Cardiomyopathy Patients in China|Recruiting||N/A|2000|Anticipated|Beijing Institute of Heart, Lung and Blood Vessel Diseases|||3||f||||t|f|f||||Samples With DNA|"     If a blood specimen is obtained, it will be separated and stored at -80 ℃ as plasma, viable     cells, and extracted DNA. If a saliva specimen is obtained, it is stored for DNA. If a tissue     specimen is obtained, it will be cut into small pieces and stored at liquid nitrogen.   "|Undecided||2017-10-10 21:16:36.032601|2017-10-10 21:16:36.032601
NCT03076541|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-04|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|PLMS||Cardiovascular Variability, Heart Rate Response, and Electromyogram Power Associated With Periodic Leg Movements.|Cardiovascular Variability, Heart Rate Response, and Electromyogram Power Associated With Periodic Leg Movements.|Completed||N/A|50|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f|f|f||||||||2017-10-10 21:16:36.373859|2017-10-10 21:16:36.373859
NCT03076528|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-19|||November 6, 2016|Actual|2016-11-06|April 2017|2017-04-01|November 6, 2019|Anticipated|2019-11-06|November 6, 2019|Anticipated|2019-11-06||Interventional|||An Innovative Virtually Supervised Exercise for Dialysis Patients|An Innovative Virtually Supervised Exercise for Dialysis Patients|Recruiting||Phase 2|100|Anticipated|Baylor College of Medicine||2|||f||||f|f|f||||||Undecided|Only de-identified data and associated results will be published in peer-review papers or scientific abstracts.|2017-10-10 21:16:36.471489|2017-10-10 21:16:36.471489
NCT03076515|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-05-30|||April 2, 2017|Actual|2017-04-02|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Migraine Treatment With Nerivio Migra Neurostimulation Device|A Prospective, Randomized, Double-blind, Sham Controlled Multi-center Clinical Trial, Migraine Headache Treatment With Nerivio Migra Neurostimulation Device|Recruiting||N/A|160|Anticipated|Theranica||2|||f||||t|f|t|t|f||||No||2017-10-10 21:16:36.56649|2017-10-10 21:16:36.56649
NCT03076502|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-10|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer|The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer|Not yet recruiting||N/A|500|Anticipated|RenJi Hospital|||1||f||||t|f|f||||Samples With DNA|"     Peripheral blood samples; Portal vein blood samples; Tumor tissue samples   "|No||2017-10-10 21:16:36.697252|2017-10-10 21:16:36.697252
NCT03076489|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-07-25|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Hed-O-Shift||Hed-O-Shift: Hedonic and Neurocognitive Processes in Relation to Dietary Habits and Weight Status|Hed-O-Shift: Hedonic and Neurocognitive Processes in Relation to Dietary Habits and Weight Status|Recruiting||N/A|40|Anticipated|Rennes University Hospital||2|||f|||||f|f||||||||2017-10-10 21:16:36.789175|2017-10-10 21:16:36.789175
NCT03076476|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-03-06|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EMPIRE-BVS||Coronary Microcirculatory and Bioresorbable Vascular Scaffolds|Evaluation of Microcirculatory Protection In Percutaneous REvascularisation With Bioresorbable Vascular Scaffolds Versus Metallic Drug-eluting Stents: a Device- and Implant Technique-based Comparison|Recruiting||N/A|50|Anticipated|Papworth Hospital NHS Foundation Trust||3|||f||||t|f|f||||||No||2017-10-10 21:16:36.876962|2017-10-10 21:16:36.876962
NCT03076463|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-09-15|||March 10, 2017|Actual|2017-03-10|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|July 7, 2017|Actual|2017-07-07||Interventional|GRAPOM||Grape Pomace Polyphenols and Cardiometabolic Risk|Long-term Effects of Grape Polyphenols as Modulators of Metabolic Syndrome in Humans|Recruiting||N/A|50|Anticipated|National Research Council, Spain||2|||f||||f|f|f||||||||2017-10-10 21:16:36.986156|2017-10-10 21:16:36.986156
NCT03076450|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-29|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Evaluation of POC Lung Ultrasound Combined With Pressure-volume Curve to Titration Adjust PEEP for ARDS Lung Recruitment|Clinical Evaluation of Point-of-care Lung Ultrasound Combined With Pressure-volume Curve to Titration Adjust PEEP for ARDS Lung Recruitment|Recruiting||N/A|30|Anticipated|Shanghai Pudong New Area Gongli Hospital||2|||f||||t|f|f|||f|||Yes||2017-10-10 21:16:37.076943|2017-10-10 21:16:37.076943
NCT03076437|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-07|||January 15, 2016|Actual|2016-01-15|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies|Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies|Recruiting||Phase 1/Phase 2|36|Anticipated|Shenzhen Institute for Innovation and Translational Medicine||1|||f||||t|f|f||||||No||2017-10-10 21:16:37.168454|2017-10-10 21:16:37.168454
NCT03076424|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-27|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|NI-MWG||The Effect of Nutrient Intake on the Microbiome, Weight, and Glucoregulation (NI-MWG)|Is Weight Change and Glucoregulation Related to Dietary Intake, the Gut Microbiome or the Interaction Between The Two Variables?|Recruiting||N/A|18|Anticipated|North Dakota State University|||3||f||||f||||||Samples Without DNA|"     plasma/serum samples and fecal samples will be collected from each patient.   "|||2017-10-10 21:16:37.259872|2017-10-10 21:16:37.259872
NCT03076411|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-03-06|||January 11, 2012|Actual|2012-01-11|March 2017|2017-03-01|June 16, 2015|Actual|2015-06-16|December 19, 2013|Actual|2013-12-19||Observational|||Pepsin in Patients With Functional Dyspepsia|A Non-interventional, Observational Study With a Fixed Combination of Pepsin and Amino Acid Hydrochloride in Patients With Functional Dyspepsia|Completed||N/A|97|Actual|Nordmark Arzneimittel GmbH & Co. KG|||1||f||||f|f|f||||||No||2017-10-10 21:16:37.376172|2017-10-10 21:16:37.376172
NCT03076398|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-03-09|||February 19, 2015|Actual|2015-02-19|March 2017|2017-03-01|April 19, 2017|Anticipated|2017-04-19|April 19, 2017|Anticipated|2017-04-19||Observational|||Development of Anaesthesia Electronic Medical Record|Feasibility Study and Prototype Computerised Program Development of Anaesthesia Electronic Medical Record|Recruiting||N/A|397|Anticipated|Siriraj Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:16:37.448637|2017-10-10 21:16:37.448637
NCT03076385|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-06|||December 2015||2015-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects|A Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of H10N8 Antigen mRNA in Healthy Adult Subjects|Active, not recruiting||Phase 1|201|Actual|Moderna Therapeutics||2|||f||||t||||||||No||2017-10-10 21:16:37.515379|2017-10-10 21:16:37.515379
NCT03076372|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-06-07|||February 22, 2017|Actual|2017-02-22|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study Evaluating MM-310 in Patients With Solid Tumors|A Phase-1 Study Evaluating the Safety, Pharmacology and Preliminary Activity of MM-310 in Patients With Solid Tumors|Recruiting||Phase 1|34|Anticipated|Merrimack Pharmaceuticals||1|||f||||f|t|f||||||No||2017-10-10 21:16:37.590082|2017-10-10 21:16:37.590082
NCT03076359|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||June 10, 2015|Actual|2015-06-10|March 2017|2017-03-01|May 30, 2019|Anticipated|2019-05-30|May 30, 2019|Anticipated|2019-05-30||Interventional|PLHIV||Traditional Healers as Adherence Partners for Persons Living With HIV in Rural Mozambique|Traditional Healers as Adherence Partners for PLHIV in Rural Mozambique|Recruiting||N/A|340|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:16:37.687812|2017-10-10 21:16:37.687812
NCT03076346|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-10-02|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Observational|||Neural Biomarkers of Clozapine Response|Neural Biomarkers of Clozapine Response|Recruiting||N/A|40|Anticipated|University of Pittsburgh|||1||f|||||f|f||||||||2017-10-10 21:16:37.768035|2017-10-10 21:16:37.768035
NCT03076333|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-10-03|||April 2018|Anticipated|2018-04-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas|Utility of PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Treatment of High Grade Sarcomas|Not yet recruiting||N/A|30|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-10 21:16:37.831906|2017-10-10 21:16:37.831906
NCT03076320|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-27|||March 27, 2017|Anticipated|2017-03-27|March 2017|2017-03-01|January 31, 2018|Anticipated|2018-01-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne|Molecular and Clinical Study of the Effect of Zaxcell Versus Effezel in the Inflammatory and Scarring Process of Moderate and Severe Acne|Recruiting||Phase 1/Phase 2|82|Anticipated|University of Guadalajara||2|||f||||f|f|f||||||||2017-10-10 21:16:37.898228|2017-10-10 21:16:37.898228
NCT03076307|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-19|||October 18, 2016|Actual|2016-10-18|July 2017|2017-07-01|July 19, 2017|Actual|2017-07-19|May 20, 2017|Actual|2017-05-20||Interventional|||DAT SPECT and Procedural Motor Skills in Parkinson's Disease|Correlation of Procedural Motor Skills Impairment and 123I-FP-CIT SPECT Uptake in Patients With Early Parkinson's Disease: a Case-control Study|Completed||N/A|9|Actual|University Hospital, Geneva||2|||f||||f|f|f||||||||2017-10-10 21:16:37.998877|2017-10-10 21:16:37.998877
NCT03076294|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-06|||January 2017||2017-01-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Repetitive Transcranial Magnetic Stimulation Associated With Manual Therapy in Knee Ostearthritis Pain||Recruiting||Phase 2|15|Anticipated|Universidade Federal de Pernambuco||3|||f||||t||||||||||2017-10-10 21:16:38.076708|2017-10-10 21:16:38.076708
NCT03076281|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-14|||April 3, 2017|Actual|2017-04-03|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery|A Phase II Study of Metformin, Doxycycline, or a Combination of Both Agents in Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 2|72|Anticipated|Thomas Jefferson University||3|||f||||t|t|f|||t|||||2017-10-10 21:16:40.108547|2017-10-10 21:16:40.108547
NCT03076268|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-09|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|September 15, 2018|Anticipated|2018-09-15|March 15, 2018|Anticipated|2018-03-15||Interventional|TMP-HV RCT||TMP-Visitas al Hogar|Treinta Millones de Palabras-Visitas al Hogar Pilot Randomized Controlled Trial|Enrolling by invitation||N/A|90|Anticipated|University of Chicago||2|||f||||f|f|f||||||||2017-10-10 21:16:40.223312|2017-10-10 21:16:40.223312
NCT03076255|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-24|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Head and Neck Maskless Immobilization Device in Immobilizing Patients With Intracranial Tumors Undergoing Radiation Therapy|A Single Institution Pilot Study Using a Head and Neck Maskless Immobilization Device (MID) for Patients With Intracranial Tumors|Recruiting||N/A|24|Anticipated|Thomas Jefferson University||1|||f||||t|f|t|f|f|t|||||2017-10-10 21:16:40.289139|2017-10-10 21:16:40.289139
NCT03076242|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-05|||October 23, 2014|Actual|2014-10-23|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01|3 Years|Observational [Patient Registry]|||Genetic Evaluation of Men - The GEM Registry|Genetic Evaluation of Men - The GEM Registry|Recruiting||N/A|1000|Anticipated|Thomas Jefferson University|||1||f||||t|f|f||||||||2017-10-10 21:16:40.381201|2017-10-10 21:16:40.381201
NCT03076229|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-06|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Relationship Education:Project Harmony|A Randomized Control Trial of Relationship Education: Project Harmony|Recruiting||N/A|1200|Anticipated|University of Central Florida||2|||f||||f|f|f||||||No||2017-10-10 21:16:40.467984|2017-10-10 21:16:40.467984
NCT03076047|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-14|||March 31, 2017|Anticipated|2017-03-31|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Capnography in the Post-Anesthesia Care Unit (PACU)|Preliminary Characterization of the Capnography Profile of Obstructive Sleep Apnea (OSA) Patients in the Post-Anesthesia Care Unit (PACU)|Recruiting||N/A|30|Anticipated|University of South Florida|||1||f||||f|f|t|f|f||||No||2017-10-10 21:16:42.609985|2017-10-10 21:16:42.609985
NCT03076216|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-01|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|OncoPaC-1||A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.|An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Subjects With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With Gemcitabine or Gemcitabine+Nab-paclitaxel Chemotherapies|Not yet recruiting||N/A|20|Anticipated|OncoSil Medical Limited||1|||f||||t|f|t|t|f||||||2017-10-10 21:16:40.551925|2017-10-10 21:16:40.551925
NCT03076190|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-07-17|||August 2015||2015-08-01|March 2017|2017-03-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||My Surgical Success: A Randomized Controlled Pilot Study of a Pre-surgical Psychological Intervention|"Feasibility and Preliminary Efficacy of an Internet-based Pre-surgical Pain Psychology Intervention: A Randomized Controlled Pilot Study of My Surgical Success"|Completed||N/A|80|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 21:16:40.786033|2017-10-10 21:16:40.786033
NCT03076177|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-03-06|||October 2014||2014-10-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effectiveness of Kinesio Taping Method for Knee Osteoarthritis.|The Effectiveness of Kinesio Taping Method for Knee Osteoarthritis. Randomized Double Blinded Clinical Trial.|Recruiting||N/A|200|Anticipated|Lithuanian University of Health Sciences||2|||f||||t||||||||No||2017-10-10 21:16:40.8547|2017-10-10 21:16:40.8547
NCT03076164|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-25|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib|A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib|Recruiting||Phase 1/Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||t|t|f|||t|||||2017-10-10 21:16:41.059631|2017-10-10 21:16:41.059631
NCT03076151|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-17|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|IMPAKT||Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation|Interventional Multicentre Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation|Not yet recruiting||Phase 4|30|Anticipated|University Hospital, Limoges||1|||f||||f|f|f||||||||2017-10-10 21:16:41.187769|2017-10-10 21:16:41.187769
NCT03076138|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-09|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|November 6, 2017|Anticipated|2017-11-06||Interventional|||Gene-activated Bone Substitute for Maxillofacial Bone Regeneration|"The Clinical Trial of the Safety and Efficacy of the Medical Device Bone Substitute Based on Octacalcium Phosphate and Biologically Active Nucleic Acids for Bone Tissue Regeneration (Nucleostim-VEGF)"|Enrolling by invitation||N/A|20|Actual|Histograft Co., Ltd.||1|||f||||f|f|f||||||Yes|Detailed results of the study will be published in a specialized peer-reviewed scientific journal with an open access|2017-10-10 21:16:41.322738|2017-10-10 21:16:41.322738
NCT03076125|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-03-05|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|July 31, 2018|Anticipated|2018-07-31|December 20, 2017|Anticipated|2017-12-20||Interventional|SCORRE||Stroke COunseling for Risk REduction|Stroke Counseling for Risk Reduction in Young Adult African Americans|Recruiting||N/A|116|Anticipated|Georgia State University||2|||f||||f|f|f||||||No||2017-10-10 21:16:41.459661|2017-10-10 21:16:41.459661
NCT03076112|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-25|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|October 1, 2018|Anticipated|2018-10-01||Interventional|||Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin|Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin|Recruiting||Phase 3|170|Anticipated|Seoul National University Bundang Hospital||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:16:42.023523|2017-10-10 21:16:42.023523
NCT03076099|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-06|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Dexmedetomidine on Post-operative Blood Pressure in Bain Arteriovenous Malformation Embolization|Effects of Dexmedetomidine on Post-operative Blood Pressure in Patients Undergoing Brain Arteriovenous Malformation Embolization|Recruiting||N/A|30|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t|f|f||||||No|the IPD will not be shared with others, since following investigations based on this trial is about to start.|2017-10-10 21:16:42.167778|2017-10-10 21:16:42.167778
NCT03076086|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-17|||May 12, 2017|Actual|2017-05-12|May 2017|2017-05-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Investigation of Secreted Phosphoproteins and PiP3 (Phosphoinositolphospat 3) in Sputum|Investigation of Secreted Phosphoproteins and PiP3 (Phosphoinositolphospat 3) in Sputum Samples of Healthy Smokers and Non Smokers|Enrolling by invitation||N/A|20|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f|||||f|f||||||No||2017-10-10 21:16:42.296824|2017-10-10 21:16:42.296824
NCT03076073|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-07-30|||May 20, 2017|Actual|2017-05-20|March 2017|2017-03-01|November 1, 2018|Anticipated|2018-11-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Ultrasonography of the Patellar Tendon and Achilles Tendon in Children Adolescent and Adults|Ultrasonography of the Patellar Tendon and Achilles Tendon in Children Adolescent and Adults|Recruiting||N/A|100|Anticipated|Meir Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:16:42.381435|2017-10-10 21:16:42.381435
NCT03076060|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-06|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|September 1, 2017|Anticipated|2017-09-01||Interventional|Ketomig||Very Low Calories Ketogenic Diet in Migraine.|Randomised Controlled Crossover Double-blind Study on Very Low Calories Ketogenic Diet in Overweighted Migraine Patients.|Recruiting||N/A|35|Anticipated|University of Roma La Sapienza||2|||f||||t|f|f||||||No|We do not share data.|2017-10-10 21:16:42.494334|2017-10-10 21:16:42.494334
NCT03076034|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-29|||January 26, 2015|Actual|2015-01-26|June 2017|2017-06-01|November 1, 2018|Anticipated|2018-11-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk|Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk|Recruiting||N/A|150|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f|f|t|t|f|t|||||2017-10-10 21:16:42.702638|2017-10-10 21:16:42.702638
NCT03076021|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-06|||July 26, 2016|Actual|2016-07-26|March 2017|2017-03-01|July 26, 2026|Anticipated|2026-07-26|July 26, 2026|Anticipated|2026-07-26||Interventional|||Effects of Isotretinoin on CYP2D6 Activity|Effects of Isotretinoin on CYP2D6 Activity|Recruiting||Phase 4|50|Anticipated|University of Washington||1|||f||||f|t|f|||f|||Yes|After completion of the study, we plan to follow NIGMS/NIH and University of Washington requirements for data sharing.|2017-10-10 21:16:42.784356|2017-10-10 21:16:42.784356
NCT03076008|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||October 1, 2016|Actual|2016-10-01|March 2017|2017-03-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|TT-TG Outcome||The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction|The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction|Recruiting||N/A|160|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||||Undecided|We are currently undecided|2017-10-10 21:16:42.86508|2017-10-10 21:16:42.86508
NCT03075995|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-04-12|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||To Discuss the Best Mode for Taking Lapatinib Under the Influence of the Diet|To Discuss the Best Mode for Taking Lapatinib Under the Influence of the Diet|Recruiting||N/A|10|Anticipated|Sun Yat-sen University||1|||f||||t|f|f||||||No||2017-10-10 21:16:42.945916|2017-10-10 21:16:42.945916
NCT03075969|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-24|||March 3, 2017|Actual|2017-03-03|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia|An International Field Study for the Reliability and Validity of the Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia (EORTC QLQ-CML24)|Recruiting||N/A|324|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f|f|f||||||||2017-10-10 21:16:43.037326|2017-10-10 21:16:43.037326
NCT03075956|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-07|||January 31, 2017|Actual|2017-01-31|February 2017|2017-02-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Interventional|||Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers|An Open-label, Single Center, Randomized, Two Period Study to Characterize the Safety, Tolerability and Pharmacokinetics (PK) of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers|Completed||Phase 1|31|Actual|Estetra||4|||f||||f|f|f||||||||2017-10-10 21:16:43.28311|2017-10-10 21:16:43.28311
NCT03075943|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Algues||Brown Seaweed Extract on Glycemic Control and Body Weight|Efficacy of a Brown Seaweed Extract on Glycemic Control and Body Weight in Overweight Pre-diabetic Subjects.|Recruiting||N/A|72|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 21:16:43.502992|2017-10-10 21:16:43.502992
NCT03075930|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-09|||January 12, 2017|Actual|2017-01-12|March 2017|2017-03-01|January 2023|Anticipated|2023-01-01|January 2022|Anticipated|2022-01-01|12 Months|Observational [Patient Registry]|AFAB-Registry||Atrial Fibrillation Ablation Registry|A Registry With the Aim to Identify Characteristics of Atrial Conduction and Risk of Recurrence in Patients With Atrial Fibrillation Undergoing Ablation for Atrial Fibrillation|Recruiting||N/A|1250|Anticipated|Maastricht University Medical Center|||2||f||||f||||||Samples With DNA|"     Probes of blood for common gene variant analysis   "|Yes|This study is planned as a Single Center Study. But it could be possible to extend it to other centers. In this case data will be shared with the participating centers.|2017-10-10 21:16:43.628084|2017-10-10 21:16:43.628084
NCT03075917|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-09|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|ARCTEnfants||Validation of an Allergic Rhinitis Control Test in Children|Validation of an Allergic Rhinitis Control Test in Children|Not yet recruiting||N/A|200|Anticipated|University Hospital, Montpellier||1|||f||||t|f|f||||||No||2017-10-10 21:16:43.75331|2017-10-10 21:16:43.75331
NCT03075904|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-28|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||A Safety Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)|A Phase 1b, Multicenter, Open-Label, Safety, Tolerability, and Activity Study of SYNT001 in Subjects With Chronic Pemphigus (Vulgaris or Foliaceus)|Recruiting||Phase 1|16|Anticipated|Syntimmune, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:16:43.831341|2017-10-10 21:16:43.831341
NCT03075891|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-25|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|February 15, 2018|Anticipated|2018-02-15|November 15, 2017|Anticipated|2017-11-15||Interventional|ANSWER||Oracea Soolantra Association in Patients With Severe Rosacea|Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea|Recruiting||Phase 4|270|Anticipated|Galderma||2|||f||||f|t|f||||||||2017-10-10 21:16:43.921818|2017-10-10 21:16:43.921818
NCT03075878|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)|A Phase 1b, Multicenter, Open-Label, Safety, Tolerability, and Activity Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)|Recruiting||Phase 1|16|Anticipated|Syntimmune, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:16:44.062749|2017-10-10 21:16:44.062749
NCT03075865|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-02|||June 28, 2017|Actual|2017-06-28|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|December 31, 2017|Anticipated|2017-12-31||Observational|OmniMax||A Cohort Study for Clinical Evaluation of OmniMax MMF System|The OmniMax MMF System: A Cohort Study for Clinical Evaluation|Recruiting||N/A|50|Anticipated|Zimmer Biomet|||1||f||||f|f|t|f|f|f|||||2017-10-10 21:16:44.165139|2017-10-10 21:16:44.165139
NCT03075852|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-23|||May 26, 2017|Actual|2017-05-26|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||Comparision of Retinal Surgery by Three-dimensional Heads-up Display to the Standard Operating Microscope|Comparative Analysis of Three-dimensional Heads-up Display Surgical Platform to Standard Operating Microscope for Vitreoretinal Surgery|Recruiting||N/A|100|Anticipated|Wills Eye|||2||f||||f|f|t|f|f||||No||2017-10-10 21:16:44.32066|2017-10-10 21:16:44.32066
NCT03075839|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-10|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Impact of Switching to Non-Menthol Cigarettes Among Smokers|Impact of Switching to Non-Menthol Cigarettes Among Smokers|Recruiting||N/A|30|Anticipated|Yale University||1|||f||||t|f|f||||||||2017-10-10 21:16:44.436659|2017-10-10 21:16:44.436659
NCT03075826|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-09|||March 15, 2016|Actual|2016-03-15|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms|A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms|Recruiting||Phase 2|50|Anticipated|Weill Medical College of Cornell University||1|||f||||t|t|f||||||No||2017-10-10 21:16:44.537711|2017-10-10 21:16:44.537711
NCT03075813|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-04-25|||March 6, 2017|Actual|2017-03-06|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|Early 2RIS||Early Recognition and Response to Increases in Surgical Site Infections Using Optimized Statistical Process Control Charts: The Early 2RIS Study|Early Recognition and Response to Increases in Surgical Site Infections Using Optimized Statistical Process Control Charts|Recruiting||N/A|29|Anticipated|Duke University||2|||f||||f|f|f||||||No||2017-10-10 21:16:44.661452|2017-10-10 21:16:44.661452
NCT03075800|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-08|||June 7, 2011|Actual|2011-06-07|March 2017|2017-03-01|March 31, 2015|Actual|2015-03-31|March 31, 2015|Actual|2015-03-31||Interventional|ACT+IMR||Integration of Illness Management and Recovery Within ACT|Integration of Illness Management and Recovery Within ACT|Completed||N/A|101|Actual|University of Washington||2|||f||||f|f|f||||||No||2017-10-10 21:16:44.791231|2017-10-10 21:16:44.791231
NCT03075787|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-04|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|OSAS||Cardiovascular Variability and Heart Rate Response Associated With Obstructive Sleep Apnea|Cardiovascular Variability and Heart Rate Response Associated With Obstructive Sleep Apnea|Enrolling by invitation||N/A|60|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f|f|f||||||||2017-10-10 21:16:44.889221|2017-10-10 21:16:44.889221
NCT03075774|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-08|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|1 Week|Observational [Patient Registry]|||Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery|FibCard Study: Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery|Not yet recruiting||N/A|3000|Anticipated|Société Française d'Anesthésie et de Réanimation|||1||f|||||f|f||||||||2017-10-10 21:16:45.013984|2017-10-10 21:16:45.013984
NCT03075761|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-03-03|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|PACT||Physical Activity in Children at Risk of Post-thrombotic Syndrome (PACT)|Physical Activity in Children at Risk of Post-thrombotic Syndrome: A Pilot Randomized Controlled Trial|Recruiting||N/A|44|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:16:45.084196|2017-10-10 21:16:45.084196
NCT03075748|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-03|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|January 2025|Anticipated|2025-01-01|April 2024|Anticipated|2024-04-01||Interventional|||Visceral Manifold Study for the Repair of TAAA|Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms|Not yet recruiting||N/A|15|Anticipated|University of South Florida||2|||f||||t|f|t|f|f||||Yes|De-identified data will be shared with Sanford Health|2017-10-10 21:16:45.208482|2017-10-10 21:16:45.208482
NCT03075735|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-27|||January 15, 2013|Actual|2013-01-15|July 2017|2017-07-01|December 15, 2018|Anticipated|2018-12-15|May 2018|Anticipated|2018-05-01|36 Months|Observational [Patient Registry]|||Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)|Prospective Multicentre Cohort Study of the Prevalence and Clinical Impact of Germline Deleterious Mutations in DNA Repair Genes of Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)|Active, not recruiting||N/A|408|Actual|Centro Nacional de Investigaciones Oncologicas CARLOS III|||1||f||||f|f|f||||Samples With DNA|"     Whole blood, plasma, serum, archival FFPE and fresh tumour samples   "|||2017-10-10 21:16:45.312359|2017-10-10 21:16:45.312359
NCT03075722|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-04-18|||March 9, 2017|Actual|2017-03-09|April 2017|2017-04-01|April 15, 2017|Actual|2017-04-15|March 30, 2017|Actual|2017-03-30||Interventional|||The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA): Comfort & Performance Trial|The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA): Comfort & Performance Trial|Completed||N/A|14|Actual|Fisher and Paykel Healthcare||1|||f||||t|f|f||||||No|IPD will not be shared with anyone|2017-10-10 21:16:45.394798|2017-10-10 21:16:45.394798
NCT03075709|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-01|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Observational|||The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan|The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan|Enrolling by invitation||N/A|800|Anticipated|University of Saskatchewan|||4||f||||f|f|f||||||No||2017-10-10 21:16:45.470954|2017-10-10 21:16:45.470954
NCT03075696|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-09-25|||February 21, 2017|Actual|2017-02-21|September 2017|2017-09-01|March 6, 2020|Anticipated|2020-03-06|March 6, 2020|Anticipated|2020-03-06||Interventional|||A Dose Escalation Study of RO7082859, Administered After a Fixed, Single Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma|A Multicenter, Open-Label, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Escalating Doses of RO7082859, Administered After a Fixed, Single Dose of Obinutuzumab (Gazyva®/Gazyvaro™) in Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma|Recruiting||Phase 1|110|Anticipated|Hoffmann-La Roche||3|||f|||||f|f||||||||2017-10-10 21:16:45.549834|2017-10-10 21:16:45.549834
NCT03075683|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-03|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|IBIS||Internet-based CBT for Insomnia in Chronic Pain|Internet-based Cognitive Behavioural Therapy for Insomnia in Chronic Pain: a Randomised Controlled Trial|Recruiting||N/A|100|Anticipated|Uppsala University||2|||f|||||f|f||||||No||2017-10-10 21:16:45.658309|2017-10-10 21:16:45.658309
NCT03075657|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-05-18|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|May 30, 2018|Anticipated|2018-05-30||Interventional|||Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia|Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia|Recruiting||Phase 4|120|Anticipated|All India Institute of Medical Sciences, Bhubaneswar||4|||f||||f|f|f|||f|||No||2017-10-10 21:16:45.878811|2017-10-10 21:16:45.878811
NCT03075644|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-10-05|||March 3, 2017|Actual|2017-03-03|October 2017|2017-10-01|October 5, 2018|Anticipated|2018-10-05|September 28, 2018|Anticipated|2018-09-28||Interventional|||A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency|A Multicentre, Randomised, Open-labelled, Parallel-group, Activecontrolled Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency|Active, not recruiting||Phase 3|60|Anticipated|Novo Nordisk A/S||2|||f||||f|f|f||||||||2017-10-10 21:16:45.984476|2017-10-10 21:16:45.984476
NCT03075631|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-03|||December 2015||2015-12-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|APPRENTICE2||Acute Pancreatitis Patient Registry To Examine Novel Therapies In Clinical Experiences 2|Acute Pancreatitis Patient Registry To Examine Novel Therapies In Clinical Experiences 2|Recruiting||N/A|5000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Specimens will be collected to look at biological measures.   "|Undecided|The results will be shared with the other IRB approved sites associated with this study.|2017-10-10 21:16:46.23633|2017-10-10 21:16:46.23633
NCT03075618|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-03|||July 2015||2015-07-01|March 2017|2017-03-01|July 2025|Anticipated|2025-07-01|July 2025|Anticipated|2025-07-01||Observational|APPRENTICE||Acute Pancreatitis Patient Registry To Examine Novel Therapies In Clinical Experiences (APPRENTICE)|Acute Pancreatitis Patient Registry To Examine Novel Therapies In Clinical Experiences (APPRENTICE)|Recruiting||N/A|5000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Samples will be obtained to study DNA.   "|Undecided|Findings will be shared with co-collaborators and the Collaborative Alliance for Pancreatic Education and Research.|2017-10-10 21:16:46.32937|2017-10-10 21:16:46.32937
NCT03075605|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-03|||May 20, 2008|Actual|2008-05-20|March 2017|2017-03-01|April 20, 2020|Anticipated|2020-04-20|April 20, 2020|Anticipated|2020-04-20||Observational|PROOF||PROOF: Pancreatitis-associated Risk Of Organ Failure|PROOF: Pancreatitis-associated Risk Of Organ Failure|Recruiting||N/A|2500|Anticipated|University of Pittsburgh|||3||f||||t|f|f||||Samples With DNA|"     Serum and DNA and urine samples will be collected and stored without personal identifiers     (e.g. using a unique laboratory number or bar code) for future research involving pancreatic     diseases to include pancreatitis and pancreatic cancer. Stored biospecimens collected for     htis protocol may be shared in a de-identified manner with outside investigators with the     approval of the principal investigator.   "|Undecided|If shared, all individual identifiers will be removed.|2017-10-10 21:16:46.417124|2017-10-10 21:16:46.417124
NCT03075592|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-08|||April 22, 2009|Actual|2009-04-22|March 2017|2017-03-01|April 22, 2020|Anticipated|2020-04-22|April 22, 2020|Anticipated|2020-04-22||Observational|PEPSI||Post-ERCP Pancreatitis Severity Indication (PEPSI) Study|Post-ERCP Pancreatitis Severity Indication (PEPSI) Study|Recruiting||N/A|800|Anticipated|University of Pittsburgh|||1||f|||||f|f||||Samples With DNA|"     Participant samples will be stored for an indefinite period of time in the Genomics and     Proteomics Core Laboratories or in the laboratory of Dr. Whitcomb or appropriate core     facility at the University of Pittsburgh. The samples will remain within the research studies     of Dr. Whitcomb. Only authorized samples will be made available to other studies following     IRB guidelines. The primary investigator, Dr. David Whitcomb, will have control over the     blood samples.   "|||2017-10-10 21:16:46.506853|2017-10-10 21:16:46.506853
NCT03075579|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-12|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|ADHDstress||Atomoxetine, Diurnal Profiles of Cortisol and α-amylase|Atomoxetine, Diurnal Profiles of Cortisol and α-amylase, Possible Biological Markers of Treatment Success|Recruiting||N/A|50|Anticipated|Praxis für kleine und grosse Leute|||1||f||||f|t|t|f||t|Samples Without DNA|"     Saliva samples   "|No||2017-10-10 21:16:46.595755|2017-10-10 21:16:46.595755
NCT03075566|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-03-03|||September 2014||2014-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Coronary Artery Disease: a Case- Control Study|Clinical and Biochemical Markers in Coronary Artery Disease|Recruiting||N/A|517|Anticipated|University of Monastir|||1||f||||t|t|f||||Samples With DNA|"     Serum, Plasma, DNA   "|No||2017-10-10 21:16:46.700148|2017-10-10 21:16:46.700148
NCT03075553|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-22|||May 17, 2017|Actual|2017-05-17|March 2017|2017-03-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma|Phase 2 Single-Arm, Open-Label Study of Nivolumab in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)|Recruiting||Phase 2|39|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:16:46.783339|2017-10-10 21:16:46.783339
NCT03075540|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-06|||May 24, 2016|Actual|2016-05-24|February 2017|2017-02-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer|Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer: Using Mental Models to Develop Culturally Targeted Media|Recruiting||N/A|90|Anticipated|Georgetown University||1|||f||||f|f|f||||||No||2017-10-10 21:16:46.925675|2017-10-10 21:16:46.925675
NCT03075527|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-04-20|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma|A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma|Recruiting||Phase 2|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 21:16:47.028695|2017-10-10 21:16:47.028695
NCT03075514|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-14|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|KEATING||Ketogenic Diets as an Adjuvant Therapy in Glioblastoma|Ketogenic Diets as an Adjuvant Therapy in Glioblastoma: A Randomised Pilot Trial|Recruiting||N/A|12|Anticipated|University of Liverpool||2|||f||||f|f|f||||||||2017-10-10 21:16:47.142309|2017-10-10 21:16:47.142309
NCT03075501|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-07-10|||December 2015||2015-12-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Interactions Between Drug Effects and Environments|Drug Contextual Conditioning With in Humans: Causes and Consequences|Active, not recruiting||Phase 4|110|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-10 21:16:47.28442|2017-10-10 21:16:47.28442
NCT03075488|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-15|||March 31, 2017|Anticipated|2017-03-31|March 2017|2017-03-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Ultrasound Prescan vs Conventional Landmark-guided Technique in Spinal Anesthesia in Orthopedic Obese Patients|Ultrasound Pre-procedural Scan vs Conventional Landmark-guided Technique in Spinal Anesthesia in Orthopedic Obese Patients|Not yet recruiting||N/A|90|Anticipated|Istituto Ortopedico Rizzoli||2|||f||||f|f|t|f||t|||No||2017-10-10 21:16:47.390532|2017-10-10 21:16:47.390532
NCT03075475|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-16|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Effectiveness Study of a Treatment to Improve the Mental Health of Children and Adolescents|Study of Effectiveness of a Treatment to Improve the Mental Health of Children and Adolescents Affected by Armed Conflict in Kachin State, Myanmar|Recruiting||N/A|260|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f|f|f||||||||2017-10-10 21:16:47.491384|2017-10-10 21:16:47.491384
NCT03075462|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-23|||March 9, 2017|Actual|2017-03-09|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients|An Open, Non-randomised, Multi-centre Phase I Study to Assess the Safety and Efficacy of Fluzoparib Given in Combination With Apatinib in Patients With Recurrent Ovarian Cancer or Triple Negative Breast Cancer|Recruiting||Phase 1|76|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:16:47.595154|2017-10-10 21:16:47.595154
NCT03075449|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-08|2017-03-08|||May 2016||2016-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Real World Data on Management of Male LUTS|Real World Data Exploring the Practices of Primary Care Providers in the Managment of Male Lower Urinary Tract Symptoms|Completed||N/A|430|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 21:16:47.704539|2017-10-10 21:16:47.704539
NCT03075436|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-07|2017-04-18|||March 7, 2017|Actual|2017-03-07|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Impact of Enhanced, Demand-side Sanitation and Hygiene Promotion on Sustained Behavior Change and Health in Ethiopia|The Impact of Enhanced, Demand-side Sanitation and Hygiene Promotion on Sustained Behavior Change and Health in Ethiopia|Recruiting||N/A|13500|Anticipated|Emory University||2|||f||||f|f|f||||||||2017-10-10 21:16:47.769755|2017-10-10 21:16:47.769755
NCT03075423|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-08|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|SUNIFORECAST||Randomized Phase-II Study of Nivolumab Plus Ipilimumab Versus Sunitinib in Untreated and Advanced Non-clear Cell RCC|A Phase 2, Randomized, Open-Label Study of Nivolumab Combined With Ipilimumab Versus Sunitinib Monotherapy in Subjects With Previously Untreated and Advanced (Unresectable or Metastatic) Non-clear Cell Renal Cell Carcinoma (nccRCC)|Not yet recruiting||Phase 2|306|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:16:47.873778|2017-10-10 21:16:47.873778
NCT03075410|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-09-08|||April 2, 2017|Actual|2017-04-02|September 2017|2017-09-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|||First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects|A Double Blind, Placebo-controlled First Time in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK3036656 in Healthy Adult Volunteers|Completed||Phase 1|31|Actual|GlaxoSmithKline||12|||f||||f|f|f||||||||2017-10-10 21:16:47.997312|2017-10-10 21:16:47.997312
NCT03075397|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-03|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CellspermVIH||VIH-1 Colo-rectal Transmission by Infected Semen Cells and Effects of Seminal Plasma ex Vivo (CellspermVIH)|VIH-1 Colo-rectal Transmission by Infected Semen Cells and Effects of Seminal Plasma ex Vivo|Recruiting||N/A|30|Anticipated|University Hospital, Toulouse||1|||f||||f|f|f||||||Yes|"The duplicated part of the CRFs will then be sent to Mrs DEJUC at the IRST in Rennes, the remaining part will be kept in the investigating center.
All the data of the study transcribed by the investigator in the CRFs will be transmitted electronically to the person in charge of the data of the INSERM / IRSET 1085 unit. Upon receipt, the data will be entered simply by typing and re-reading on the Excel spreadsheet. The files will be locked by password and backed up daily with storage for 3 months on the server of the INSERM 1085 unit managed by the IT department of the University of Rennes 1. The set Data is saved every evening, with storage for 4 weeks, then archived monthly on tape."|2017-10-10 21:16:48.158714|2017-10-10 21:16:48.158714
NCT03075384|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-08|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Treatment of Unilateral Complicated Zygomatic Complex Fractures Using Computer-Assisted Navigation System|Application of Computer-Assisted Navigation System in the Treatment of Unilateral Complicated Zygomatic Complex Fractures: A Randomized Controlled Trial|Completed||N/A|20|Actual|West China College of Stomatology|||1||f||||t|f|f||||||Undecided||2017-10-10 21:16:48.273982|2017-10-10 21:16:48.273982
NCT03075371|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-09|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa|Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa|Recruiting||N/A|25|Anticipated|University of Heidelberg Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:16:48.367645|2017-10-10 21:16:48.367645
NCT03075358|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-06|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effects of Lidocaine Spray for Reducing Pain During Endometrial Aspiration Biopsy : a Randomized Controlled Trial|Effects of Lidocaine Spray for Reducing Pain During Endometrial Aspiration Biopsy : a Randomized Controlled Trial|Recruiting||Phase 3|240|Anticipated|Chiang Mai University||3|||f||||f|t|f|||f|||Undecided||2017-10-10 21:16:48.46143|2017-10-10 21:16:48.46143
NCT03075345|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-04|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Acceptance and Commitment Therapy in the Treatment of Obesity: Pilot.|Testing the Added Benefit of Acceptance and Commitment Therapy (ACT) in the Treatment of Obesity: a Pilot Randomised Controlled Trial.|Not yet recruiting||N/A|48|Anticipated|University of Sheffield||2|||f||||t|f|f||||||No||2017-10-10 21:16:48.558882|2017-10-10 21:16:48.558882
NCT03075150|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-05-24|||December 15, 2016|Actual|2016-12-15|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PVI||PVI as a Parameter to Predict Fluid Responsiveness|Validation of PVI as a Parameter to Predict Fluid Responsiveness|Recruiting||N/A|100|Anticipated|University of California, Davis|||2||f||||f|f|t|f|f||||No||2017-10-10 21:16:50.805367|2017-10-10 21:16:50.805367
NCT03075332|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-08|||February 19, 2016|Actual|2016-02-19|February 2017|2017-02-01|July 23, 2016|Actual|2016-07-23|June 21, 2016|Actual|2016-06-21||Interventional|PVHA||Detraining in People Living With HIV/AIDS|Detraining in the Components of Physical Aptitude in People Living With HIV/ AIDS|Completed||N/A|2|Actual|Universidade Federal do Rio Grande do Norte||1|||f||||f|f|f||||||Undecided|It is not done sharing since the individuals involved in the people are vulnerable and the secrecy is rescued|2017-10-10 21:16:48.636797|2017-10-10 21:16:48.636797
NCT03075319|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-09|||March 1, 2015|Actual|2015-03-01|March 2017|2017-03-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29||Interventional|||Use of Perioperative Photograph as a Motivation for Increasing Range of Motion After Primary Total Knee Arthroplasty|Use of Perioperative Photograph as a Motivation for Increasing Range of Motion After Primary Total Knee Arthroplasty: Randomized Controlled Trial|Completed||N/A|60|Actual|Thammasat University||2|||f||||t|f|f||||||No||2017-10-10 21:16:48.725776|2017-10-10 21:16:48.725776
NCT03075306|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-08|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|CHAMPION||Randomized Trial of a Healthy Weight Intervention for Youth With Serious Emotional Disturbance|Randomized Trial of a Healthy Weight Intervention for Youth With Serious Emotional Disturbance|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|Johns Hopkins University||2|||f|||||f|f||||||Yes|via NIMH|2017-10-10 21:16:48.80622|2017-10-10 21:16:48.80622
NCT03075293|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-06|||March 26, 2017|Anticipated|2017-03-26|March 2017|2017-03-01|April 1, 2018|Anticipated|2018-04-01|July 1, 2017|Anticipated|2017-07-01||Observational|||Pain Management of Children With Appendicitis in the Emergency Department (ER)|Pain Management of Children With Appendicitis in the Emergency Department (ER)|Not yet recruiting||N/A|500|Anticipated|Hillel Yaffe Medical Center|||1||f||||t|f|f||||||No||2017-10-10 21:16:48.879503|2017-10-10 21:16:48.879503
NCT03075280|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-04-06|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Pre-ERCP High Carbohydrate Drinks Improve Patients Recovery|Pre-ERCP Carbohydrate Drinks Improve Patients Recovery: an ERAS Protocol Attempts in ERCP|Recruiting||N/A|1500|Anticipated|Hepatopancreatobiliary Surgery Institute of Gansu Province||2|||f||||t|f|f||||||No||2017-10-10 21:16:48.947325|2017-10-10 21:16:48.947325
NCT03075267|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-08-18|||April 17, 2017|Actual|2017-04-17|August 2017|2017-08-01|September 28, 2017|Anticipated|2017-09-28|September 28, 2017|Anticipated|2017-09-28||Interventional|||Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects|A Phase I, Randomized, Double-Blind, Parallel-Group, Study to Assess the Pharmacokinetics and Safety of Two Doses of PT010 and a Single Dose of PT003 in Healthy Chinese Adult Subjects Following A Single Administrations and After Chronic Administration for 7 Days|Recruiting||Phase 1|90|Anticipated|Pearl Therapeutics, Inc.||3|||f||||f|t|f|||t|||||2017-10-10 21:16:49.084996|2017-10-10 21:16:49.084996
NCT03075254|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-21|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|April 30, 2022|Anticipated|2022-04-30|March 30, 2020|Anticipated|2020-03-30||Interventional|||Central Mechanisms of Chronic Pain and Fatigue Subtitle: Functional Imaging of Brain and Spinal Cord|Central Mechanisms of Chronic Pain and Fatigue Subtitle: Functional Imaging of Brain and Spinal Cord|Recruiting||N/A|200|Anticipated|University of Florida||3|||f||||t|f|f||||||Undecided||2017-10-10 21:16:49.209884|2017-10-10 21:16:49.209884
NCT03075241|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-08-23|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Z-Drugs for Sleep Disorders in Alzheimer's Disease|Z-Drugs for the Treatment of Sleep Disorders in Alzheimer's Disease: a Randomised, Double-blind, Placebo-controlled Study|Recruiting||Phase 3|60|Anticipated|Brasilia University Hospital||3|||f||||f|f|f|||f|||||2017-10-10 21:16:49.314559|2017-10-10 21:16:49.314559
NCT03075228|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-07-11|||April 25, 2017|Actual|2017-04-25|July 2017|2017-07-01|July 4, 2017|Actual|2017-07-04|July 4, 2017|Actual|2017-07-04||Observational|DUPLO||Comparison of the Microbial Composition in Lean and Obese Subjects|DUPLO Study: Comparison of the Microbial Composition of the Upper Gastrointestinal Tract in Lean and Obese Subjects|Terminated||N/A|10|Actual|NIZO Food Research|||2|Low recruitment rate; high proportion of screening failures.|f||||f|f|f||||Samples Without DNA|"     serum, fecal samples, small intestinal samples   "|||2017-10-10 21:16:49.428756|2017-10-10 21:16:49.428756
NCT03075215|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-05|2017-09-29|||April 14, 2017|Actual|2017-04-14|March 2017|2017-03-01|August 1, 2022|Anticipated|2022-08-01|February 1, 2021|Anticipated|2021-02-01|12 Months|Observational [Patient Registry]|SMART Registry||Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry|Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)|Recruiting||N/A|2000|Anticipated|Boston Scientific Corporation|||1||f||||f|f|t|t|f|t|||||2017-10-10 21:16:49.533685|2017-10-10 21:16:49.533685
NCT03075202|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-04|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|June 1, 2017|Anticipated|2017-06-01|June 1, 2017|Anticipated|2017-06-01||Observational|||Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia|Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia: A Prospective 3-month Pilot Study|Recruiting||N/A|20|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f|||t|||No|Individual participant data may be available to some collaborating researchers, but not all.|2017-10-10 21:16:50.335676|2017-10-10 21:16:50.335676
NCT03075189|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-05-18|||March 7, 2017|Actual|2017-03-07|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Increased Focus on Protein Intake Among Geriatric Patients|Increased Focus on Protein Intake Among Geriatric Patients During Hospitalization: Serving and Acceptance of Protein Enriched Meals in the Morning and Before Bedtime, as Well as Nutritional Guidance by a Clinical Dietician.|Recruiting||N/A|38|Anticipated|University of Copenhagen||2|||f||||t|f|f||||||No||2017-10-10 21:16:50.430629|2017-10-10 21:16:50.430629
NCT03075176|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-04-17|||February 13, 2017|Actual|2017-02-13|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy|Outcomes of Topography-guided LASIK and Photorefractive Keratectomy Compared to Wavefront Optimized LASIK and Photorefractive Keratectomy|Recruiting||N/A|400|Anticipated|University of Utah||4|||f||||f|f|t|f|f|t|||No||2017-10-10 21:16:50.566204|2017-10-10 21:16:50.566204
NCT03075163|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-24|||October 18, 2016|Actual|2016-10-18|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Post-Operative Therapy for Nausea or Vomiting|Optimization of Post-Operative Therapy for Nausea or Vomiting|Active, not recruiting||N/A|300|Actual|University of California, Davis||2|||f||||f|f|f||||||No||2017-10-10 21:16:50.68301|2017-10-10 21:16:50.68301
NCT03075137|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-23|||June 10, 2017|Anticipated|2017-06-10|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||Effect of External Counter Pulsation on Ischemic Stroke|Effect of External Counter Pulsation on IschemicStroke (ECP-STROKE)|Not yet recruiting||Phase 3|380|Anticipated|Eighth Affiliated Hospital, Sun Yat-sen University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:16:50.925859|2017-10-10 21:16:50.925859
NCT03075124|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-23|||June 8, 2017|Anticipated|2017-06-08|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|May 28, 2018|Anticipated|2018-05-28||Interventional|ECP-CAD||Effect of External Counter Pulsation on Coronary Artery Disease|Effect of External Counter Pulsation on Coronary Artery Disease (ECP-CAD)|Recruiting||Phase 3|380|Anticipated|Eighth Affiliated Hospital, Sun Yat-sen University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:16:51.03917|2017-10-10 21:16:51.03917
NCT03075111|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-25|||November 7, 2015|Actual|2015-11-07|March 2017|2017-03-01|December 1, 2018|Anticipated|2018-12-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Host-based Immunoassay for Differentiating Bacterial From Viral Infections (Post-marketing Study of ImmunoXpert™)|Field Study of Host-based Immunoassay for Differentiating Bacterial From Viral Infections (Post-marketing Study of ImmunoXpert™)|Recruiting||N/A|4500|Anticipated|MeMed Diagnostics Ltd.|||1||f||||f|f|f||||None Retained|"     Serum and plasma samples   "|No||2017-10-10 21:16:51.171209|2017-10-10 21:16:51.171209
NCT03075098|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-08|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Colposcopy in Detection of Oral Epithelial Dysplasia|Diagnostic Accuracy Of Colposcopic Examination in Patients With Oral Dysplastic Lesion (Diagnostic Accuracy Study)|Not yet recruiting||N/A|25|Anticipated|Cairo University||1|||f||||t|f|f||||||No||2017-10-10 21:16:51.261949|2017-10-10 21:16:51.261949
NCT03075085|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-13|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|May 30, 2019|Anticipated|2019-05-30||Interventional|||Developing and Testing Implementation Strategies for Evidence-Based Obesity Prevention in Childcare|Developing and Testing Implementation Strategies for Evidence-Based Obesity Prevention in Childcare|Not yet recruiting||N/A|410|Anticipated|University of Arkansas||2|||f||||f|f|f||||||||2017-10-10 21:16:51.3477|2017-10-10 21:16:51.3477
NCT03075072|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-19|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|March 30, 2022|Anticipated|2022-03-30|March 30, 2021|Anticipated|2021-03-30||Interventional|||Whole Brain Radiation Versus Stereotactic Radiation (SRS) in Patients With 5-15 Brain Metastases: A Phase III, Randomized Clinical Trial|Whole Brain Radiation Versus Stereotactic Radiation (SRS) in Patients With 5-15 Brain Metastases: A Phase III, Randomized Clinical Trial|Recruiting||Phase 3|196|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|f|f||||||No||2017-10-10 21:16:51.493248|2017-10-10 21:16:51.493248
NCT03075059|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-04|||February 2016||2016-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Child Life Intervention to Decrease Anxiety in Patients and Caregivers for Outpatient Surgical Intervention|Child Life Intervention to Decrease Anxiety in Patients and Caregivers for Outpatient Surgical Intervention|Recruiting||N/A|44|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||No||2017-10-10 21:16:51.61575|2017-10-10 21:16:51.61575
NCT03075046|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-08|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|February 20, 2019|Anticipated|2019-02-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial|Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial|Not yet recruiting||N/A|40|Anticipated|Centro de Atenção ao Assoalho Pélvico||3|||f||||t|f|f||||||No||2017-10-10 21:16:51.706747|2017-10-10 21:16:51.706747
NCT03075033|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-08|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||SOS Versus Awake Fiberoptic Intubation|The Shikani Optical Stylet As An Alternative To Awake Fiberoptic Intubation In Patients At Risk Of Secondary Cervical Spine Injury - A Randomized Controlled Trial.|Completed||N/A|60|Actual|Faculty of Medicine, University of Alexandria||2|||f||||f|f|f||||||No||2017-10-10 21:16:51.789938|2017-10-10 21:16:51.789938
NCT03075020|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-03-10|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Carbon Monoxide Migraine-inducing Effects in Patients With Migraine Without Aura.|Basic Research on Carbon Monoxide's Headache Inducing Characteristics in a Humane Experimental Headache Model|Recruiting||N/A|12|Anticipated|Danish Headache Center||2|||f||||t|f|f||||||No||2017-10-10 21:16:51.882951|2017-10-10 21:16:51.882951
NCT03075007|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-06|2017-06-05|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Brain Vascular Disease in Aging and Dementia|White Matter Hyperintensities in Aging and Dementia|Recruiting||N/A|20|Anticipated|Columbia University|||1||f||||f|f|f|||f|||No||2017-10-10 21:16:51.983022|2017-10-10 21:16:51.983022
NCT03074994|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-03-08|||October 2016||2016-10-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||The Comparative Efficacy of Peri-articular and Intraarticular Tranexamic Acid in Total Knee Arthroplasty|The Comparative Efficacy of Peri-articular and Intraarticular Tranexamic Acid in Total Knee Arthroplasty: A Prospective, Double-Blind Randomized, Controlled Trial|Recruiting||Phase 2|108|Anticipated|Thammasat University||3|||f||||t||||||||No||2017-10-10 21:16:52.085826|2017-10-10 21:16:52.085826
NCT03074981|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-05-06|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 30, 2019|Anticipated|2019-08-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Novel Methods for Management of Complicated Wounds|Novel Methods for Management of Complicated Wounds|Not yet recruiting||N/A|50|Anticipated|Sheba Medical Center||1|||f||||f|f|f|||f|||No||2017-10-10 21:16:52.21053|2017-10-10 21:16:52.21053
NCT03074968|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-04-24|||March 8, 2017|Actual|2017-03-08|April 2017|2017-04-01|January 13, 2018|Anticipated|2018-01-13|December 13, 2017|Anticipated|2017-12-13||Interventional|||Effect of Benzydamine Hydrochloride to Postoperative Sore Throat in Pediatric Patients|Effect of Benzydamine Hydrochloride to Postoperative Sore Throat in Pediatric Patients: a Randomized Controlled Trial|Recruiting||Phase 4|142|Anticipated|Seoul National University Hospital||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:16:52.295844|2017-10-10 21:16:52.295844
NCT03074955|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-05|||August 16, 2013|Actual|2013-08-16|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Preventive Effect of Leg Wrapping Combined With Trendelenburg Position on Hypotension Induced by Propofol|Preventive Effect of Leg Wrapping Combined With Trendelenburg Position on Hypotension Induced by Propofol|Recruiting||N/A|156|Anticipated|Seoul St. Mary's Hospital||3|||f|||||f|f||||||No||2017-10-10 21:16:52.405683|2017-10-10 21:16:52.405683
NCT03074942|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-09|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab|Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab: a Pilot Study|Recruiting||Phase 2|30|Anticipated|Sociedad Española de Neumología y Cirugía Torácica||1|||f||||f|f|f||||||No||2017-10-10 21:16:52.526252|2017-10-10 21:16:52.526252
NCT03074929|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-03|||November 1, 2017|Anticipated|2017-11-01|March 2017|2017-03-01|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||Improving Childhood Obesity-Related Behavior Change Through Better Risk Communication|Improving Childhood Obesity-Related Behavior Change Through Better Risk Communication|Not yet recruiting||N/A|50|Anticipated|Seattle Children's Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:16:52.663508|2017-10-10 21:16:52.663508
NCT03074916|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-10-04|||March 8, 2017|Actual|2017-03-08|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Outcomes of Motion-preserving Surgery and Arthrodesis at the Distal Interphalangeal (DIP) Joint|Outcomes of Motion-preserving Surgery and Arthrodesis at the Distal Interphalangeal (DIP) Joint|Recruiting||N/A|68|Anticipated|Schulthess Klinik|||2||f||||f|f|f||||||||2017-10-10 21:16:52.739296|2017-10-10 21:16:52.739296
NCT03074903|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-27|||April 16, 2016|Actual|2016-04-16|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|July 27, 2017|Actual|2017-07-27||Observational|||Does Skyla Insertion Timing Impact Bleeding?|Does Skyla Insertion Timing Impact Bleeding?|Active, not recruiting||N/A|132|Actual|Rutgers, The State University of New Jersey|||2||f||||f|f|t|f|f|t|||||2017-10-10 21:16:52.810763|2017-10-10 21:16:52.810763
NCT03074890|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-03-05|||January 2015||2015-01-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|PHM||Evaluating of the Hospital Universitario de Canarias Massive Transfusion Protocol|Observational Study to Assess the Safety and Clinical Effectiveness of the Hospital Universitario de Canarias Massive Transfusion Protocol|Recruiting||N/A|30|Anticipated|Hospital Universitario de Canarias||2|||f||||f||||||||Undecided||2017-10-10 21:16:52.884102|2017-10-10 21:16:52.884102
NCT03074877|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-03|||June 1, 2014|Actual|2014-06-01|March 2017|2017-03-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|SKY||Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care|Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care|Recruiting||N/A|1000|Anticipated|RTI International||3|||f||||f|f|f||||||No||2017-10-10 21:16:52.982591|2017-10-10 21:16:52.982591
NCT03074864|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-05|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|TREND||Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC|Intercalated Combination of Erlotinib and Radiotherapy for Patients With EGFR-mutant, Unresectable, Locally Advanced Non-small-cell Lung Cancer|Active, not recruiting||Phase 2/Phase 3|90|Anticipated|Guangdong General Hospital||1|||f||||f|t|f|||f|||Undecided||2017-10-10 21:16:53.111886|2017-10-10 21:16:53.111886
NCT03074851|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-03-08|||December 2011||2011-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2012|Actual|2012-02-01||Interventional|||Activating Media for Salt Reduction|Activating Mass Media for Salt Reduction Program by Using Media Reporters as Research Investigators in a Randomized Controlled Trial|Completed||N/A|516|Actual|The George Institute for Global Health, China||2|||f||||f||||||||Undecided||2017-10-10 21:16:53.189971|2017-10-10 21:16:53.189971
NCT03074838|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-03|||December 1, 2012|Actual|2012-12-01|March 2017|2017-03-01|December 31, 2013|Actual|2013-12-31|December 31, 2013|Actual|2013-12-31||Interventional|||Inflammatory Response to Aortic Valve Replacement|Reduced Inflammatory Response Using Transcatheter Aortic Valve Replacement as Compared to Conventional Surgery|Completed||N/A|36|Actual|Oslo University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:16:53.264597|2017-10-10 21:16:53.264597
NCT03074825|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-23|||May 9, 2017|Actual|2017-05-09|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma|Efficacy and Safety of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma: a Single-arm, Open-label, Multi-site, Exploratory Phase Ib Study|Recruiting||Phase 1|29|Anticipated|Chipscreen Biosciences, Ltd.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:16:53.342451|2017-10-10 21:16:53.342451
NCT03074812|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-03-03|||February 2016||2016-02-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation|Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation|Recruiting||N/A|80|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 21:16:53.438226|2017-10-10 21:16:53.438226
NCT03074799|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-08|||October 1, 2015|Actual|2015-10-01|March 2017|2017-03-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Interventional|SOAR||Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index Cases|Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index Cases|Recruiting||N/A|1000|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||Yes|Study is ongoing; plans for data sharing are in process|2017-10-10 21:16:53.532269|2017-10-10 21:16:53.532269
NCT03074786|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-05|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 30, 2020|Anticipated|2020-12-30|December 2018|Anticipated|2018-12-01||Interventional|||Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)|A Phase 2a Crossover Trial Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population|Withdrawn||Phase 2|0|Actual|International Partnership for Microbicides, Inc.||2||Study was transferred to partner who will conduct under its own IND|f||||t|t|f||||||||2017-10-10 21:16:53.611335|2017-10-10 21:16:53.611335
NCT03074773|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-07-18|||October 30, 2016|Actual|2016-10-30|July 2017|2017-07-01|April 15, 2017|Actual|2017-04-15|March 30, 2017|Actual|2017-03-30||Interventional|||The Effect of Paravertebral Block With Dexamethasone on Intraoperative and Postoperative Analgesia in Children Undergoing Surgery for Coarctation of Aorta|Paravertebral Block in Coarctation of the Aorta|Completed||Phase 1|50|Actual|Cairo University||2|||f||||f|f|f|||f|||||2017-10-10 21:16:53.867041|2017-10-10 21:16:53.867041
NCT03074760|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-04|2017-03-29|||March 16, 2017|Actual|2017-03-16|March 2017|2017-03-01|May 1, 2017|Anticipated|2017-05-01|May 1, 2017|Anticipated|2017-05-01||Observational|||A Study of Acequias Contamination & Association of Infectious Diseases in Peru|A Study of Acequias Contamination & Association of Infectious Diseases in Peru|Recruiting||N/A|450|Anticipated|BioRed LLC|||2||f||||f|f|f||||||Undecided||2017-10-10 21:16:54.065498|2017-10-10 21:16:54.065498
NCT03074747|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-09|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|March 2017|Anticipated|2017-03-01||Observational|COQ||Comparison of Four Questionnaires for OSA Screening in China|The Comparison of Different Questionnaires for Preoperative Screening and Perioperative Risk Prediction in Obstructive Sleep Apnea Patients in China|Not yet recruiting||N/A|1200|Anticipated|Beijing Tongren Hospital|||1||f||||f||||||||No||2017-10-10 21:16:54.252482|2017-10-10 21:16:54.252482
NCT03074734|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-03-03|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|April 2018|Anticipated|2018-04-01||Interventional|TackSHSWP5||Health Effects of Secondhand Smoke Exposure in Outdoor Smoking Areas in Patients With COPD and Asthma ( TackSHSWP5 )|Exposure to Secondhand Smoke in Exempted Areas/Outside Areas and Acute Health Effects in Patients With Chronic Lung Disease|Active, not recruiting||N/A|60|Anticipated|Institut Català d'Oncologia||1|||f||||t|f|f||||||No||2017-10-10 21:16:54.374596|2017-10-10 21:16:54.374596
NCT03074721|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-02|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|PCI Suite||PCI Suite: Road Map Fusion Imaging in Coronary Diagnostics and Therapy|PCI Suite: Road Map Fusion Imaging in Coronary Diagnostics and Therapy|Recruiting||N/A|130|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||f|f|f||||||No||2017-10-10 21:16:54.50144|2017-10-10 21:16:54.50144
NCT03074708|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-03-08|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery|Zhujiang Hospital of the Southern Medical University|Recruiting||N/A|200|Anticipated|Zhujiang Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:16:54.628957|2017-10-10 21:16:54.628957
NCT03074695|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-03|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||DPE Technique in Labor Epidural for Morbidly Obese Women|A Randomized Controlled Trial for Epidural Labor Analgesia: Comparison of Dural Puncture Epidural With Standard Labor Epidural Techniques|Recruiting||Phase 4|130|Anticipated|Duke University||4|||f||||f|t|f|||t|||||2017-10-10 21:16:54.755384|2017-10-10 21:16:54.755384
NCT03074682|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-03|||March 15, 2017|Anticipated|2017-03-15|March 2017|2017-03-01|August 31, 2017|Anticipated|2017-08-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||Novel Device for Rapid Fluid Administration|Fluid Administration With LifeFlow vs Push/Pull|Not yet recruiting||N/A|30|Anticipated|Yale University||3|||f||||f|f|t|f|f|t|||Undecided||2017-10-10 21:16:54.903038|2017-10-10 21:16:54.903038
NCT03074669|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-05-09|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|May 15, 2017|Anticipated|2017-05-15||Interventional|||Online Acceptance and Commitment Therapy for Reducing Anxiety|Internet-delivered Acceptance and Commitment Therapy for Reducing Anxiety Symptoms|Active, not recruiting||N/A|80|Anticipated|West University of Timisoara||2|||f||||f|f|f||||||No|Data will be process only at the group level. No individual data will be shared to third parties.|2017-10-10 21:16:54.996667|2017-10-10 21:16:54.996667
NCT03074656|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-03|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 1, 2022|Anticipated|2022-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|NOR-DRUM||The Norwegian Drug Monitoring Study|A NORwegian Multicentre Randomised Controlled Trial Assessing the Effectiveness of Tailoring Infliximab Treatment by Therapeutic DRUg Monitoring - The NOR-DRUM Study|Recruiting||N/A|600|Anticipated|Diakonhjemmet Hospital||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:16:55.106968|2017-10-10 21:16:55.106968
NCT03074643|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-05-16|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|UPLIFT||Utilizing Protein During Weight Loss to Impact Physical Function|Long-term Effects of Weight Loss and Supplemental Protein on Physical Function|Recruiting||N/A|225|Anticipated|Wake Forest University Health Sciences||3|||f||||t|f|f|||t|||No||2017-10-10 21:16:55.233561|2017-10-10 21:16:55.233561
NCT03074630|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-03-09|||May 2016||2016-05-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|DICE||Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)|Dapagliflozin on Cholesterol Metabolism in DM2: Dissecting Its Effect on Dyslipidemia by Using Stable Isotope Based Cholesterol and Glucose Fluxes|Recruiting||Phase 4|12|Anticipated|VU University Medical Center||1|||f||||f||||||||No||2017-10-10 21:16:55.369573|2017-10-10 21:16:55.369573
NCT03074617|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-03|||January 31, 2017|Actual|2017-01-31|March 2017|2017-03-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Electromagnetic Field Effects of Mobile Communication (LTE) on Sleep in the Context of Genetic Variation|Electromagnetic Field Effects of Mobile Communication (LTE) on Sleep in the Context of Genetic Variation|Recruiting||N/A|40|Anticipated|University of Zurich||2|||f|||||f|f||||||||2017-10-10 21:16:55.474414|2017-10-10 21:16:55.474414
NCT03074604|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-03|||February 28, 2017|Actual|2017-02-28|March 2017|2017-03-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|CANON||Carbon Dioxide Surgical Field Flooding and Aortic No-touch Off-pump Coronary Artery Bypass Grafting to Reduce Neurological Injuries After Surgical Coronary Revascularization (CANON): a Randomised, Controlled, Investigator and Patient Blinded Single Center Superiority Trial With Three Parallel Arms.|Carbon Dioxide Surgical Field Flooding and Aortic No-touch Off-pump Coronary Artery Bypass Grafting to Reduce Neurological Injuries After Surgical Coronary Revascularization (CANON): a Randomised, Controlled, Investigator and Patient Blinded Single Center Superiority Trial With Three Parallel Arms.|Recruiting||N/A|360|Anticipated|Collegium Medicum w Bydgoszczy||3|||f||||f|f|f||||||Undecided||2017-10-10 21:16:55.561069|2017-10-10 21:16:55.561069
NCT03074591|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-23|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|FAIR-HFpEF||Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction|Effect of IV Iron (Ferric Carboxymaltose, Ferinject) on Exercise Tolerance, Symptoms and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) and Iron Deficiency With and Without Anaemia.|Recruiting||Phase 2|200|Anticipated|Charite University, Berlin, Germany||2|||f||||t|f|f||||||||2017-10-10 21:16:55.682688|2017-10-10 21:16:55.682688
NCT03074578|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-03|||November 8, 2016|Actual|2016-11-08|March 2017|2017-03-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Interventional|COREV||Is There a Desensitization During Sleep After Exposure to a Violent Verbal Input ?|Y a T-il Une désensibilisation Pendant le Sommeil après la réception de Violence Verbale ?|Recruiting||N/A|32|Anticipated|Centre National de la Recherche Scientifique, France||2|||f||||f|f|f||||||No||2017-10-10 21:16:55.841375|2017-10-10 21:16:55.841375
NCT03074565|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-07-11|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ultrasonic Versus Ultrasonic+ for Effective Sanative Therapy|Comparison of Ultrasonic Versus Hand Instrumentation Plus Ultrasonic for Effective Sanative Therapy|Enrolling by invitation||N/A|150|Anticipated|Brock University||2|||f||||f|f|f||||||||2017-10-10 21:16:55.942023|2017-10-10 21:16:55.942023
NCT03074552|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-06-29|||July 25, 2017|Anticipated|2017-07-25|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Probiotic Prophylaxis for Microbiome Modulation and VAP or Infections Prevention in Multitrauma Patients|Probiotic Prophylaxis for Microbiome Modulation and Ventilator Associated Pneumonia (VAP) or Severe Infections Prevention in Multitrauma Patients: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial|Not yet recruiting||N/A|254|Anticipated|Aristotle University Of Thessaloniki||2|||f||||f|f|f||||||||2017-10-10 21:16:56.04188|2017-10-10 21:16:56.04188
NCT03074539|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-08|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Sleep Disorder Breathing in Chronic Thromboembolic Pulmonary Hypertension|Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension - a Prospective, Descriptive Cohort Study|Recruiting||N/A|50|Anticipated|Medical University of Vienna||3|||f||||f|f|f||||||Undecided||2017-10-10 21:16:56.145722|2017-10-10 21:16:56.145722
NCT03074526|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-03-03|||January 23, 2017|Actual|2017-01-23|March 2017|2017-03-01|November 1, 2017|Anticipated|2017-11-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||Protocol for the Clinical Evaluation of Lyophilized Amniotic Fluid in the Treatment of Knee Osteoarthritis|Prospective, Double Blinded Randomized Multi-Center Controlled Trial Evaluating the 2 Different Doses of Lyophilized Amniotic Fluid Compared to a Saline Placebo Injection in the Treatment of Subjects With Osteoarthritic (OA) Knee Pain|Recruiting||N/A|180|Anticipated|MiMedx Group, Inc.||3|||f||||t|f|f||||||No||2017-10-10 21:16:56.25617|2017-10-10 21:16:56.25617
NCT03074513|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-08|||March 3, 2017|Actual|2017-03-03|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Atezolizumab and Bevacizumab in Rare Solid Tumors|A Phase II, Single-Arm Open-Label Study Of The Combination Of Atezolizumab And Bevacizumab In Rare Solid Tumors|Recruiting||Phase 2|160|Anticipated|M.D. Anderson Cancer Center||8|||f||||f|t|f||||||||2017-10-10 21:16:56.37318|2017-10-10 21:16:56.37318
NCT03074500|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-04-18|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|September 30, 2017|Anticipated|2017-09-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Kinesiotaping in Lateral Epicondylitis|A Randomized Controlled Trial Comparing the Effects of Kinesiology Taping With Exercise, Sham Taping With Exercise and Exercise Alone for Lateral Epicondylitis|Recruiting||N/A|30|Anticipated|Marmara University||3|||f||||f|f|f|||f|||No||2017-10-10 21:16:56.513697|2017-10-10 21:16:56.513697
NCT03074487|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-08|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|SINATRA||Evaluating Monitoring Techniques for Postoperative Spinal Cord Ischemia|Exploratory Study Regarding the Use of Neurophysiological Monitoring Techniques to Detect Spinal Cord Ischemia in Patients After Thoracoabdominal Aortic Aneurysm Repair|Recruiting||N/A|100|Anticipated|Maastricht University Medical Center|||1||f||||f|f|f||||||Undecided||2017-10-10 21:16:56.65695|2017-10-10 21:16:56.65695
NCT03074474|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-03|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Ventral Hernia Study Using OviTex Reinforced Bioscaffold|A Prospective, Single Arm, Multi-center Study Evaluating the Short-term Clinical Outcomes of Ventral Hernias Treated With OviTex Reinforced Bioscaffold.|Recruiting||N/A|100|Anticipated|Tela Bio Inc||1|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:16:56.759165|2017-10-10 21:16:56.759165
NCT03074461|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-05-31|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|CSAR||Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial|Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial|Recruiting||N/A|80|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f|f|f||||||No|There is no plan to make individual participant data available to third parties beyond the study team.|2017-10-10 21:16:56.865138|2017-10-10 21:16:56.865138
NCT03074448|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-03-03|||May 2014||2014-05-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Aquanet Bowel Cleansing Device Versus Oral Sodium Picosulfate for Pre-endoscopy Bowel Preparation|Aquanet Bowel Cleansing Device Versus Oral Sodium Picosulfate for Pre-endoscopy Bowel Preparation: Propensity Score Analysis for Interventional Effectiveness Evaluation|Completed||Phase 3|314|Actual|Kaiser Clinic and Hospital||2|||f||||t||||||||||2017-10-10 21:16:56.979129|2017-10-10 21:16:56.979129
NCT03074435|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-03-08|||April 2016||2016-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|October 2017|Anticipated|2017-10-01||Interventional|REACT||Insecticide Resistance Management in Burkina Faso and Côte d'Ivoire|Insecticide Resistance Management in Burkina Faso and Côte d'Ivoire: Research on Vector Control Strategies|Enrolling by invitation||Phase 3|18000|Anticipated|Institut de Recherche pour le Developpement||5|||f||||f||||||||No||2017-10-10 21:16:57.067163|2017-10-10 21:16:57.067163
NCT03074422|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-08|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2019|Anticipated|2019-07-30||Interventional|ERST||Effectiveness and Reliability of Hypnosis in Stereotaxy|Effectiveness and Reliability of Hypnosis in Stereotaxy|Not yet recruiting||N/A|22|Anticipated|University Hospital, Geneva||2|||f||||f|f|f||||||Undecided||2017-10-10 21:16:57.161169|2017-10-10 21:16:57.161169
NCT03074409|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-05|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|July 30, 2017|Anticipated|2017-07-30||Interventional|||The Modulatory Effect of Oxytocin on Interoception|The Modulatory Effect of Oxytocin on Interoception|Recruiting||N/A|84|Anticipated|University of Electronic Science and Technology of China||2|||f|||||f|f||||||||2017-10-10 21:16:57.316954|2017-10-10 21:16:57.316954
NCT03074396|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-03-07|||February 1, 2016|Actual|2016-02-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 20, 2016|Actual|2016-12-20||Interventional|||Usefulness of a Mobile Information Management System for Haemodialysis Patient|Usefulness of a Mobile Information Management System for Haemodialysis Patients and the Prospect of Participatory Medicine|Completed||N/A|14|Actual|Inje University||1|||f||||t|f|f||||||No||2017-10-10 21:16:57.409707|2017-10-10 21:16:57.409707
NCT03074383|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-22|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Improvement of Care for Outpatients With Type 2 Diabetes Through Self-Care Multidisciplinary Workshop for Diabetes|Improvement of Care for Outpatients With Type 2 Diabetes at the Porto Alegre Clinic Hospital Through Self-Care Multidisciplinary Workshop for Diabetes: a Randomized Controlled Trial|Recruiting||N/A|96|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||||2017-10-10 21:16:57.481586|2017-10-10 21:16:57.481586
NCT03074370|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-03-03|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Observational|||Evaluation of Smile Esthetics in Orthodontically Treated Patients With Bimaxillary-dentoalveolar Protrusion|Evaluation of Smile Esthetics in Orthodontically Treated Adult Female Patients With Bimaxillary-dentoalveolar Protrusion: A Retrospective Cohort Study|Not yet recruiting||N/A|19|Anticipated|Cairo University|||1||f|||||f|f||||||Undecided||2017-10-10 21:16:57.576007|2017-10-10 21:16:57.576007
NCT03074357|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-28|||March 30, 2017|Actual|2017-03-30|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||Urine, DNA and Clinical Information Collection From Patients With Alport Nephropathy.|Urine, DNA and Retrospective Clinical Information Collection From Patients With Alport Nephropathy.|Recruiting||N/A|80|Anticipated|Novartis|||1||f||||f|f|f||||Samples With DNA|"     Urine Saliva for DNA   "|||2017-10-10 21:16:57.63864|2017-10-10 21:16:57.63864
NCT03074344|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-08|||May 2016||2016-05-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|DEDCO||Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye|Study on the Effectiveness of Eye-drops Containing Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Patients With Mild to Moderate Dry Eye|Completed||N/A|40|Actual|"Azienda Ospedaliera Universitaria Policlinico G. Martino"||2|||f||||f||||||||No||2017-10-10 21:16:57.716895|2017-10-10 21:16:57.716895
NCT03074318|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-09-28|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|September 15, 2020|Anticipated|2020-09-15|October 15, 2018|Anticipated|2018-10-15||Interventional|||Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery|A Phase I/II Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma|Recruiting||Phase 1/Phase 2|28|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f||||||||2017-10-10 21:16:57.92131|2017-10-10 21:16:57.92131
NCT03074292|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-07|||December 2013||2013-12-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia||Active, not recruiting||N/A|120|Actual|Ain Shams University||3|||f|||||f|f|||f|||||2017-10-10 21:17:00.29894|2017-10-10 21:17:00.29894
NCT03074279|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-03|||July 1, 2011|Actual|2011-07-01|March 2017|2017-03-01|July 31, 2018|Anticipated|2018-07-31|December 31, 2017|Anticipated|2017-12-31||Observational|PRERIES||Risk Factors of SUDEP|Risk Factors in Sudden Unexpected Death in Epilepsy of the Adults and Children: A Matched Case-control Study|Recruiting||N/A|408|Anticipated|University Hospital, Montpellier|||2||f||||t|f|f||||||Yes|NC|2017-10-10 21:17:00.374256|2017-10-10 21:17:00.374256
NCT03074266|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-07-31|||June 8, 2017|Actual|2017-06-08|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical Performance of the Investigational Hemochron® MCS 7000 Whole Blood Microcoagulation System (MCS)|Clinical Performance of the Investigational Hemochron® MCS 7000 Whole Blood Microcoagulation System|Enrolling by invitation||N/A|140|Anticipated|Accriva Diagnostics|||2||f||||f||t|t||f|||||2017-10-10 21:17:00.485602|2017-10-10 21:17:00.485602
NCT03074253|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-07|||December 1, 2014|Actual|2014-12-01|March 2017|2017-03-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|CIBER||Cardiovascular Imaging and Biomarker Analyses (CIBER)|Cardiovascular Imaging and Biomarker Analyses (CIBER)|Recruiting||N/A|500|Anticipated|Universitätsmedizin Mannheim|||1||f||||f|f|f||||Samples Without DNA|"     One peripheral blood withdraws in EDTA, citrate, ammonium heparin, serum tubes within 24     hours before cardiac imaging.   "|No||2017-10-10 21:17:00.565859|2017-10-10 21:17:00.565859
NCT03074240|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-28|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|TAPB||Comparison of Ultrasound-guided Transversus Abdominis Plane Block (TAPB)Versus Rectus Sheath Block (RSB)|A Prospective and Randomized Comparison of Ultrasound-guided Transversus Abdominis Plane Versus Rectus Sheath Blocks as a Primary Anesthetic for Umbilical Hernia Repair in Adults|Recruiting||N/A|60|Anticipated|University of Florida||2|||f||||f|f|f|||f|||||2017-10-10 21:17:00.664386|2017-10-10 21:17:00.664386
NCT03074227|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-28|||October 1, 2017|Anticipated|2017-10-01|March 2017|2017-03-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|FAIS||The FAIS-Trial: Faecal Transplantation in Adolescents With Refractory Irritable Bowel Syndrome|The FAIS-Trial: Faecal Transplantation in Adolescents With Refractory Irritable Bowel Syndrome|Not yet recruiting||N/A|30|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t|f|f||||||No||2017-10-10 21:17:00.760406|2017-10-10 21:17:00.760406
NCT03074214|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-09|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|August 31, 2019|Anticipated|2019-08-31|February 28, 2019|Anticipated|2019-02-28||Observational|GOODI||Prognostic Value of Copeptin for Infarct Size and Prognosis in Patients With ST-elevation Myocardial Infarction|Study of Prognostic Value of Copeptin for Myocardial Infarct Size and 6-month Prognosis in Patients With ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: GOOD I Study|Recruiting||N/A|275|Anticipated|Shengjing Hospital|||1||f||||f|f|f||||Samples Without DNA|"     A venous blood sample will be collected at before, immediately after, and 3 days after PPCI     and 6-month visit for biomarker analysis and storage for future studies.   "|No|We will not share IPD to protect our data very well.|2017-10-10 21:17:00.841259|2017-10-10 21:17:00.841259
NCT03074201|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-03|||October 1, 2015|Actual|2015-10-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP|Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP|Recruiting||N/A|50|Anticipated|Stanford University||1|||f|||||f|t|f|||||||2017-10-10 21:17:00.941182|2017-10-10 21:17:00.941182
NCT03074188|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-07||||||March 2017|2017-03-01||||May 30, 2018|Anticipated|2018-05-30|1 Day|Observational [Patient Registry]|||Prevalence of Oral Findings in Chronic Kidney Disease|"Prevalence of Oral Findings in Adult Patients With Chronic Kidney Disease Cross Sectional"|Not yet recruiting||N/A|225|Anticipated|Cairo University|||2||f||||t||||||||Undecided||2017-10-10 21:17:01.030551|2017-10-10 21:17:01.030551
NCT03074175|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-07|||July 1, 2017|Anticipated|2017-07-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer：Multicenter Controlled Study.(RadimiR-01)|Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer：Multicenter Controlled Study.|Not yet recruiting||N/A|240|Anticipated|Xinqiao Hospital of Chongqing||2|||f|||||f|f||||||||2017-10-10 21:17:01.108906|2017-10-10 21:17:01.108906
NCT03074162|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-07-04|||April 20, 2017|Actual|2017-04-20|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Comparison of the Bioavailability of Diclofenac in a Diclofenac+Capsaicin Combination Gel to a Reference Product of Diclofenac Gel in Healthy Volunteers|A SINGLE CENTER, MULTIPLE DOSE, OPEN-LABEL, RANDOMIZED, THREE-PERIOD CROSSOVER STUDY TO DETERMINE THE RELATIVE BIOAVAILABILITY OF DICLOFENAC IN THE TOPICAL GEL COMBINATION PRODUCT (DICLOFENAC 2% + CAPSAICIN 0.075%) COMPARED TO DICLOFENAC MONO GEL 2% AND VOLTAROL® 12 HOUR EMULGEL 2.32% GEL IN AT LEAST 42 HEALTHY MALES AND FEMALES|Completed||Phase 1|48|Actual|Boehringer Ingelheim||3|||f||||f|f|f||||||||2017-10-10 21:17:01.296781|2017-10-10 21:17:01.296781
NCT03074149|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-05|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|February 15, 2021|Anticipated|2021-02-15|February 15, 2021|Anticipated|2021-02-15||Observational|INDULGEIPF||Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF)|Investigating Diopathic Pulmonary Fibrosis in Greece|Recruiting||N/A|200|Anticipated|Boehringer Ingelheim|||1||f|||||f|f||||||||2017-10-10 21:17:01.393832|2017-10-10 21:17:01.393832
NCT03074136|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-04-20|||February 10, 2017|Actual|2017-02-10|April 2017|2017-04-01|December 15, 2017|Anticipated|2017-12-15|September 15, 2017|Anticipated|2017-09-15||Interventional|||Application of Photodynamic Therapy and Diode Laser for Endodontic Therapy of Young Permanent Teeth|Application Success of Photodynamic Therapy and Diode Laser During Endodontic Therapy of Young Permanent Teeth|Recruiting||Phase 2|45|Anticipated|Association of Paediatric and Preventive Dentists of Serbia||3|||f||||t|f|f||||||No||2017-10-10 21:17:01.479756|2017-10-10 21:17:01.479756
NCT03074123|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-08-21|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|August 1, 2017|Actual|2017-08-01||Interventional|||Cortisol Response to Low Dose Cosyntropin Stimulation Test in the Late Afternoon|Cortisol Response to Low Dose Cosyntropin Stimulation Test in the Late Afternoon|Active, not recruiting||N/A|20|Anticipated|Bnai Zion Medical Center||1|||f|||||f|f||||||||2017-10-10 21:17:01.608433|2017-10-10 21:17:01.608433
NCT03074110|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-09|||November 11, 2016|Actual|2016-11-11|March 2017|2017-03-01|November 1, 2017|Anticipated|2017-11-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||Isocapnic Hyperventilation - an Alternative Method|Isocapnic Hyperventilation for Enhancing Recovery After Inhalation Anaesthesia - an Alternative Method|Recruiting||N/A|20|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f|f|f||||||No||2017-10-10 21:17:01.709174|2017-10-10 21:17:01.709174
NCT03074097|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-03|||March 5, 2015|Actual|2015-03-05|March 2017|2017-03-01|April 28, 2016|Actual|2016-04-28|February 1, 2016|Actual|2016-02-01||Interventional|||Epidural Analgesia Vs Rectus Sheath Block: Postoperative Analgesia and Proinflammatory Cytokines|Effect of Epidural Analgesia Versus Rectus Sheath Block on Postoperative Pain and Proinflammatory Cytokines in Patients Undergoing Malignant Urological Surgery|Completed||Phase 2|60|Actual|Assiut University||2|||f||||t|f|f|||f|||Yes||2017-10-10 21:17:01.814368|2017-10-10 21:17:01.814368
NCT03074084|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-03-03|||June 2016||2016-06-01|March 2017|2017-03-01|December 31, 2025|Anticipated|2025-12-31|December 2017|Anticipated|2017-12-01||Observational|||Acute Abdomen in Adults- a Prospective Study on Emergency Department Admissions|Acute Abdomen in Adults- a Prospective Study on Causes of Abdominal Pain Leading to Emergency Department Admission in Tampere University Hospital|Recruiting||N/A|1000|Anticipated|Tampere University Hospital|||1||f||||f||||||Samples Without DNA|"     urine sample, blood sample   "|||2017-10-10 21:17:01.909226|2017-10-10 21:17:01.909226
NCT03074071|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-03|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Enhancing Hope Among Patients With Poor-Prognosis Breast Cancer and Oncologists|Enhancing Hope Among Patients With Poor-Prognosis Breast Cancer and Oncologists|Not yet recruiting||N/A|120|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:17:02.014134|2017-10-10 21:17:02.014134
NCT03074058|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-20|||June 10, 2015|Actual|2015-06-10|March 2017|2017-03-01|August 21, 2015|Actual|2015-08-21|August 4, 2015|Actual|2015-08-04||Interventional|||Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet|Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet - Randomized, Open-label, Two-way Crossover Study to Establish the Bioequivalence Between BAY 77-1931 Orally Disintegrating Tablet 500 mg and Fosrenol Chewable Tablet 500 mg Administered in Japanese Healthy Male Adult Subjects|Completed||Phase 1|20|Actual|Bayer||2|||f||||f||||||||||2017-10-10 21:17:02.098459|2017-10-10 21:17:02.098459
NCT03074045|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-07-19|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|September 1, 2022|Anticipated|2022-09-01|September 1, 2022|Anticipated|2022-09-01||Interventional|||LCS16 vs. COC User Satisfaction and Tolerability Study|Multi-center, Randomized, Open-label, Parallel-group Study to Evaluate User Satisfaction With and Tolerability of the Low-dose Levonorgestrel (LNG) Intrauterine Delivery System (IUS) With 16 μg LNG/Day Initial in Vitro Release Rate (LCS16) in Comparison to a Combined Oral Contraceptive (COC) Containing 30 μg Ethinyl Estradiol and 3 mg Drospirenone (Yarina®) in Young Nulliparous and Parous Women (18 - 29 Years) Over 12 Months of Use (With an Option for Extended Use of LCS16 for up to 5 Years)|Active, not recruiting||Phase 3|123|Actual|Bayer||2|||f||||f|f|f||||||||2017-10-10 21:17:02.187052|2017-10-10 21:17:02.187052
NCT03074032|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-07-08|||June 30, 2014|Actual|2014-06-30|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer|Phase I Open-label Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer (mCRPC)|Completed||Phase 1|17|Actual|Avionco LLC||4|||f||||t|f|f||||||||2017-10-10 21:17:02.28543|2017-10-10 21:17:02.28543
NCT03074019|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-12|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Actual|2017-08-31||Interventional|||Pilot Study on the Effect of a XOS95 on the Human Gut Microbiome|A Randomized, Double-blind, Placebo-controlled, Parallel Group, Pilot Study on the Effect of a Novel Prebiotic, XOS95, on the Human Gut Microbiome|Active, not recruiting||N/A|75|Anticipated|Prenexus Health||3|||f||||f|f|f||||||||2017-10-10 21:17:02.363199|2017-10-10 21:17:02.363199
NCT03074006|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Dose Escalation and Proof-of-Concept Studies of TEW-7197 Monotherapy in Patients With Myelodysplastic Syndrome (MDS)|Phase 1/2 Study of TEW-7197 Monotherapy in Patients With Low or Intermediate Myelodysplastic Syndromes|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|MedPacto, Inc.||2|||f|||||t|f||||||||2017-10-10 21:17:02.444659|2017-10-10 21:17:02.444659
NCT03073993|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-03-02|||October 2015||2015-10-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Nasogastric Versus Orogastric Route of Feeding in Preterm (<32 Weeks) Neonates|Nasogastric Versus Orogastric Route of Feeding in Preterm (<32 Weeks) Neonates|Completed||N/A|160|Actual|Max Super Speciality Hospital||2|||f||||t||||||||No||2017-10-10 21:17:02.529775|2017-10-10 21:17:02.529775
NCT03073980|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-02|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|December 1, 2019|Anticipated|2019-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Assessing Efficacy of Intravenous Acetaminophen vs. Fentanyl for Perioperative Pain Control During Oocyte Retrievals|Assessing Efficacy of Intravenous Acetaminophen vs. Fentanyl for Perioperative Pain Control During Oocyte Retrievals|Not yet recruiting||Phase 4|174|Anticipated|Massachusetts General Hospital||3|||f||||t|t|f||||||||2017-10-10 21:17:02.606971|2017-10-10 21:17:02.606971
NCT03073954|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-13|||July 1, 2017|Anticipated|2017-07-01|January 2017|2017-01-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Working Memory Training in COPD Patients: the Cogtrain-Trial|The Feasibility of Working Memory Training in COPD Patients and the Efficacy on Cognitive Performance, Self-Control and Stress Response|Not yet recruiting||N/A|75|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:17:02.834137|2017-10-10 21:17:02.834137
NCT03073941|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-16|||December 2016||2016-12-01|June 2017|2017-06-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Multicenter Prospective Randomized Control Study on Persona Total Knee System vs NexGen|A Multicenter Prospective Randomized Control Study on Persona Total Knee System vs NexGen Total Knee System in Total Knee Arthroplasty|Recruiting||N/A|314|Anticipated|Zimmer Biomet||2|||f||||f||||||||No||2017-10-10 21:17:03.047752|2017-10-10 21:17:03.047752
NCT03073928|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-08-25|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|SPBvsISB||Comparison of Paracoracoid Subscapularis Plane Block to Interscalene Block for Arthroscopic Shoulder Surgery|Comparison of Paracoracoid Subscapularis Plane Block to Interscalene Block for Arthroscopic Shoulder Surgery|Recruiting||N/A|120|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:17:03.179943|2017-10-10 21:17:03.179943
NCT03073915|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-03|||August 2013|Actual|2013-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|4 Months|Observational [Patient Registry]|||Evaluation of the Risk of VTE Among Patients Hospitalized in Non-surgical Departments|The Risk for VTE Among Patients in the Medical Wards - Prospective Observational Study.|Active, not recruiting||N/A|4000|Anticipated|Hadassah Medical Organization|||1||f|||||f|f||||||Undecided||2017-10-10 21:17:03.303689|2017-10-10 21:17:03.303689
NCT03073902|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-02|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.|Clinical Research for the Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.|Not yet recruiting||N/A|60|Anticipated|Xinqiao Hospital of Chongqing||1|||f|||||f|f||||||||2017-10-10 21:17:03.362489|2017-10-10 21:17:03.362489
NCT03073889|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-03-02|||June 2016||2016-06-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||A Comparison Between Scalp Nerve Block and Scalp Infiltration|A Comparison Between Scalp Nerve Block and Scalp Infiltration on the Circulatory and Stress Response for Aneurysm Clipping Using an Enhanced Recovery After Surgery Programme|Recruiting||N/A|45|Anticipated|Wuhan University||3|||f||||f||||||||No||2017-10-10 21:17:03.442475|2017-10-10 21:17:03.442475
NCT03073876|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-02|||December 1, 2005|Actual|2005-12-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|October 8, 2009|Actual|2009-10-08||Interventional|||Detecting an Early Response to Donepezil With Measures of Visual Attention|Detecting an Early Response to Donepezil With Measures of Visual Attention|Active, not recruiting||Phase 4|24|Actual|Winthrop University Hospital||2|||f||||f|t|f|||f|||No||2017-10-10 21:17:03.552362|2017-10-10 21:17:03.552362
NCT03073863|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-27|||April 3, 1998|Actual|1998-04-03|April 2017|2017-04-01|May 1, 2007|Actual|2007-05-01|May 1, 2007|Actual|2007-05-01||Interventional|TNTpost-hoc||Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study|Statin Intensity, Achieved LDL Cholesterol, and Cardiovascular Outcome in Statin Therapy in Patients With Coronary Artery Disease (Post-hoc Study of TNT Trial)|Completed||Phase 4|10001|Actual|Korea University Guro Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:17:03.657182|2017-10-10 21:17:03.657182
NCT03073850|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-04|||February 23, 2017|Actual|2017-02-23|May 2017|2017-05-01|August 23, 2021|Anticipated|2021-08-23|February 23, 2018|Anticipated|2018-02-23||Interventional|ATEMS-AF||Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation|Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation|Recruiting||Phase 4|750|Anticipated|Korea University Guro Hospital||3|||f|||||f|f|||f|||||2017-10-10 21:17:03.738927|2017-10-10 21:17:03.738927
NCT03073837|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-15|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|April 18, 2017|Actual|2017-04-18||Interventional|||Rudolph: Nasal Microbiota With Red and Sore Nose|RUDOLPH Study Nasal Microbiota and Concurrent Nose Soreness Associated With Common Cold Infection - a Pilot Using the HRV-16 Challenge Model in Healthy Subjects|Completed||N/A|10|Actual|Kimberly-Clark Corporation||1|||f||||f|f|f||||||||2017-10-10 21:17:03.839475|2017-10-10 21:17:03.839475
NCT03073824|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-04-13|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||A Long-term Evaluation of a Novel Intravaginal Device|An Open-label Long-term Evaluation of a Novel Intravaginal Device in Female Patients Experiencing Sexual and Bladder Function Issues|Recruiting||N/A|60|Anticipated|Joylux, Inc.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:17:03.913517|2017-10-10 21:17:03.913517
NCT03073811|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-07-13|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|February 28, 2022|Anticipated|2022-02-28|September 30, 2021|Anticipated|2021-09-30||Interventional|||Nutritional Perihabilitation in Older Veterans Undergoing Surgery|Nutritional (High Protein) Perihabilitation in Older Veterans Undergoing Surgery|Recruiting||N/A|105|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:17:04.012873|2017-10-10 21:17:04.012873
NCT03073785|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-23|||September 16, 2016|Actual|2016-09-16|February 2017|2017-02-01|September 16, 2020|Anticipated|2020-09-16|September 16, 2019|Anticipated|2019-09-16||Interventional|||Hypofractionated Stereotactic Body Radiation Therapy and Fluorouracil or Capecitabine With or Without Zoledronic Acid in Treating Patients With Locally Advanced Pancreatic Cancer|A Randomized Phase II Study of the Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy and 5FU or Capecitabine With and Without Zometa in Patients With Locally Advanced Pancreatic Adenocarcinoma|Recruiting||Phase 2|40|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-10-10 21:17:04.425374|2017-10-10 21:17:04.425374
NCT03073772|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-02|||April 1, 2010|Actual|2010-04-01|February 2017|2017-02-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Interventional|RECO||Rehabilitation for Improved Cognition|Effects on Cognitive Function, Estimated as a Global Brain Score, by Cognitive and Physical Fitness Training Added to a Multimodal Rehabilitation Program for Patients With Exhaustion Disorder|Completed||N/A|161|Actual|Umeå University||3|||f||||f|f|f||||||No||2017-10-10 21:17:04.577754|2017-10-10 21:17:04.577754
NCT03073759|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-03-02|||March 2016||2016-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Transcranial Direct Current Stimulation on Peripheral Neuropathy|Effect of Transcranial Direct Current Stimulation on Proprioceptive and Vibratory Sensation: Potential Benefit for Patients With Peripheral Neuropathy|Recruiting||N/A|10|Anticipated|Johns Hopkins University||1|||f||||f||||||||No||2017-10-10 21:17:04.688238|2017-10-10 21:17:04.688238
NCT03073746|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-16|||September 7, 2016|Actual|2016-09-07|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|August 9, 2017|Actual|2017-08-09||Interventional|GHST||Google Health Search Trial|Accuracy of Differential Diagnosis From Google Health Search and Impact on Clinical Encounters|Completed||N/A|330|Actual|Johns Hopkins University||3|||f||||f|f|f||||||||2017-10-10 21:17:04.765259|2017-10-10 21:17:04.765259
NCT03073720|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-18|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Observational|||Follicular Fluid, Bioavailable Vitamin D and Embryo Quality Markers|Correlation Between Follicular Fluid Levels of Bioavailable Vitamin D and Embryo Quality Markers: Euploid Status, Morphokinetics and Mitochondrial DNA Content Among UAE Women Undergoing an IVF Cycle|Not yet recruiting||N/A|30|Anticipated|IVI Middle East Fertility Clinic|||1||f||||f|f|f||||Samples With DNA|"     follicular fluid,serum sample   "|||2017-10-10 21:17:04.970196|2017-10-10 21:17:04.970196
NCT03073707|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-06-15|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Reservoir of Invasive Salmonellosis in Children, DRC|The Potential Role of the Household Environment as the Reservoir for Invasive Salmonellosis in Children, Kisangani, DR Congo.|Completed||N/A|96|Actual|Institute of Tropical Medicine, Belgium|||1||f||||f|f|f||||||No||2017-10-10 21:17:05.070301|2017-10-10 21:17:05.070301
NCT03073694|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-02||||||March 2017|2017-03-01|April 2025|Anticipated|2025-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis|Phase II Single-Blind Randomized Trial Comparing Morbidity of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis|Not yet recruiting||Phase 2|100|Anticipated|University of Kansas Medical Center||2|||f||||t|t|f||||||No||2017-10-10 21:17:05.159155|2017-10-10 21:17:05.159155
NCT03073681|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-01|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Satisfaction & Spectacle Independence With ReSTOR 2.5 & ReSTOR 3.0 IOLs|Patient-Reported Satisfaction and Spectacle Independence With the ReSTOR 2.5 Combined With the ReSTOR 3.0 IOL in Cataract Surgery|Recruiting||N/A|100|Anticipated|MDbackline, LLC|||2||f||||f|f|t|f|f|f|||||2017-10-10 21:17:05.254809|2017-10-10 21:17:05.254809
NCT03073668|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-05-17|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Pericardial Resection to Treat Heart Failure|The Effects of Pericardiotomy on Diastolic Reserve in Humans|Recruiting||N/A|15|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 21:17:05.33876|2017-10-10 21:17:05.33876
NCT03073655|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-09|||January 2016||2016-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effects of Kinesio Tape Application With Different Verbal Input Given to With Patients With Rotator Cuff Tear|Istanbul University, Faculty of Health Science, Division of Physiotherapy and Rehabilitation|Completed||N/A|87|Actual|Istanbul University||3|||f||||t||||||||Yes||2017-10-10 21:17:05.415511|2017-10-10 21:17:05.415511
NCT03073642|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-05-01|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 1, 2019|Anticipated|2019-07-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effects of Pain Therapeutic Education and Hydrotherapy on Physical Function, Pain and Sleep of Women With Fibromyalgia|Effects of Pain Therapeutic Education and Hydrotherapy on Pain, Depression, Anxiety, Quality of Life and Quality of Sleep of Women With Fibromyalgia|Not yet recruiting||N/A|60|Anticipated|Universidade Federal de Sao Carlos||2|||f||||f|f|f||||||No|All results shall be disclosed in a form that no individual volunteers shall be identified.|2017-10-10 21:17:05.486321|2017-10-10 21:17:05.486321
NCT03073629|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-08|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Assessing Outcomes in ED Patients With RV Failure|Implementation of a Clinical Pathway to Improve Outcomes in Emergency Department Patients With Right Ventricular Failure|Recruiting||N/A|40|Anticipated|Indiana University||2|||f||||f|f|f||||||No||2017-10-10 21:17:05.663374|2017-10-10 21:17:05.663374
NCT03073616|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-02|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|ECO_NUSS||Lung Ultrasound for the Postoperative Diagnosis of Pneumothorax in Children|Is Lung Ultrasound the Technique of Choice for the Diagnosis of Pneumothorax Following the Nuss Procedure for Pectus Excavatum?|Not yet recruiting||N/A|66|Anticipated|Istituto Giannina Gaslini|||1||f||||f|f|f||||||Undecided||2017-10-10 21:17:05.754908|2017-10-10 21:17:05.754908
NCT03073590|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-08-30|||January 27, 2016|Actual|2016-01-27|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Improving Anemia Status of Female Garment Workers in Bangladesh: An Evaluation of Pilot Intervention in Four Factories|Improving Anemia Status of Female Garment Workers in Bangladesh: An Evaluation of Pilot Intervention in Four Factories|Active, not recruiting||N/A|1310|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||f|f|f||||||||2017-10-10 21:17:05.997458|2017-10-10 21:17:05.997458
NCT03073577|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-02|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Islet Transplantation Using PKX-001|Clinical Study Using Antiaging Glycopeptide (PKX-001) in Islet Transplantation|Recruiting||Phase 1|10|Anticipated|University of Alberta||1|||f||||t|f|f||||||No||2017-10-10 21:17:06.123908|2017-10-10 21:17:06.123908
NCT03073564|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-02|||December 1, 2015|Actual|2015-12-01|March 2017|2017-03-01|August 31, 2018|Anticipated|2018-08-31|October 1, 2017|Anticipated|2017-10-01||Interventional|||Effect of Expiratory Positive Pressure on Dynamic Hyperinflation and Ability to Exercise With Upper Limbs in COPD|Effect of Expiratory Positive Airway Pressure on Dynamic Hyperinflation and Ability to Exercise With Upper Limbs in COPD Patients|Recruiting||N/A|19|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f|f|f||||||Undecided||2017-10-10 21:17:06.252777|2017-10-10 21:17:06.252777
NCT03073551|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-03-02|||July 27, 2010|Actual|2010-07-27|March 2017|2017-03-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||The Impact of Activity Promoting Video Games on Glycemic Control in Gestational Diabetes Mellitus|The Impact of Activity Promoting Video Games on Glycemic Control in Gestational Diabetes Mellitus|Completed||N/A|150|Actual|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||No||2017-10-10 21:17:06.383841|2017-10-10 21:17:06.383841
NCT03073538|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-02|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Screening of Gonococcal and Chlamydial Infections in the Third Trimester|Screening of Gonococcal and Chlamydial Infections in the Third Trimester|Enrolling by invitation||N/A|1000|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f|f|f||||||No||2017-10-10 21:17:06.483007|2017-10-10 21:17:06.483007
NCT03073525|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-26|||May 25, 2017|Actual|2017-05-25|September 2017|2017-09-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)|A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers|Recruiting||Phase 2|25|Anticipated|Gradalis, Inc.||2|||||||t|t|f||||||||2017-10-10 21:17:06.575943|2017-10-10 21:17:06.575943
NCT03073512|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-07|||June 2, 2016|Actual|2016-06-02|March 2017|2017-03-01|June 2, 2018|Anticipated|2018-06-02|June 2, 2018|Anticipated|2018-06-02||Interventional|||The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Preterm Birth|The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Preterm Birth|Enrolling by invitation||N/A|88|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f|f|f||||||No||2017-10-10 21:17:06.749159|2017-10-10 21:17:06.749159
NCT03073499|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-03-02|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||A Clinical Trial to Evaluate the Sensitivity of a Number of Clinical and Psychological Outcome Measures for Cancer Patients Being Treated at the Hospital Day Care Unit or (Partially) at Home|A Single-centre, Non-randomized, Prospective, Open Clinical Trial to Evaluate the Sensitivity of a Number of Clinical and Psychological Outcome Measures for Cancer Patients Being Treated at the Hospital Day Care Unit or (Partially) at Home|Recruiting||N/A|50|Anticipated|General Hospital Groeninge||2|||f||||f|f|f||||||No||2017-10-10 21:17:06.827282|2017-10-10 21:17:06.827282
NCT03073473|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-09-06|||February 28, 2017|Actual|2017-02-28|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Observational|||Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers|Quantitative Targeted Proteomics Detected by Mass Spectrometry With Whole Genome (DNA) and Whole Transcriptome (RNA) Sequencing in Advanced Cancers|Recruiting||N/A|640|Anticipated|Cota Inc.|||3||f||||f|f|f||||||||2017-10-10 21:17:07.144117|2017-10-10 21:17:07.144117
NCT03073460|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-07|||June 2, 2016|Actual|2016-06-02|February 2017|2017-02-01|June 2, 2018|Anticipated|2018-06-02|June 2, 2018|Anticipated|2018-06-02||Interventional|||The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Labour at Term|The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Labour at Term|Enrolling by invitation||N/A|144|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f|f|f||||||No||2017-10-10 21:17:07.316299|2017-10-10 21:17:07.316299
NCT03073447|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-04-06|||March 20, 2017|Actual|2017-03-20|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|WAMIF||WAMIF : Young Women Presenting Acute Myocardial Infarction in France|Prospective Registry in Young Women Presenting Acute Myocardial Infarction in France: Clinical, Morphological and Biological Descriptive Analysis: WAMIF Study|Recruiting||N/A|200|Anticipated|French Cardiology Society||1|||f||||f|f|f||||||No||2017-10-10 21:17:07.400645|2017-10-10 21:17:07.400645
NCT03073434|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-02|||March 1, 2016|Actual|2016-03-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|||Pregnancy Outcomes in Renal Transplant Recipients|Pregnancy Outcomes in Renal Transplant Recipients|Active, not recruiting||N/A|17|Actual|St. Michael's Hospital, Toronto|||1||f||||f|f|f||||||No||2017-10-10 21:17:07.534404|2017-10-10 21:17:07.534404
NCT03073421|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-02|||June 29, 2012|Actual|2012-06-29|March 2017|2017-03-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Interventional|P3||Positive Pregnancy Program|"A Qualitative Evaluation of the Positive Pregnancy Program, an Inter-professional Multidisciplinary Program for the Care of HIV-positive Pregnant Women"|Completed||N/A|25|Actual|St. Michael's Hospital, Toronto||1|||f||||f|f|f||||||No||2017-10-10 21:17:07.611321|2017-10-10 21:17:07.611321
NCT03073408|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-03|||March 6, 2017|Anticipated|2017-03-06|March 2017|2017-03-01|September 15, 2017|Anticipated|2017-09-15|September 15, 2017|Anticipated|2017-09-15||Interventional|||Design of a Closed-loop Controller Based on the Bispectral Index (BIS) Effectiveness of the Smith Predictor|Design of a Closed-loop Controller for the Administration of Propofol Based on the Bispectral Index (BIS). Effectiveness of the Smith Predictor and Comparison With Manual Control|Not yet recruiting||N/A|50|Anticipated|Hospital Universitario de Canarias||2|||f||||f|f|f||||||No||2017-10-10 21:17:07.68486|2017-10-10 21:17:07.68486
NCT03073395|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-03|||July 21, 2017|Actual|2017-07-21|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|||Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer|Preliminary Investigation of Uptake in PSMA Expressing Cancer, Biodistribution and Excretion of the Novel Radio Tracer [68Ga]P16-093 by PET/CT|Recruiting||Early Phase 1|30|Anticipated|Five Eleven Pharma, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:17:07.779406|2017-10-10 21:17:07.779406
NCT03073382|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-09-05|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Observational|||Fetal Myelomeningocele|Risk Factors Associated With Spontaneous Preterm Delivery Status Post Open Fetal Myelomeningocele Repair|Completed||N/A|56|Actual|University of Nebraska|||1||f||||f|f|f||||||||2017-10-10 21:17:07.862337|2017-10-10 21:17:07.862337
NCT03073369|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-14|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease|Targeting the Interactions Between Disordered Iron Homeostasis and Mineral Metabolism in Chronic Kidney Disease (Aim 1)|Not yet recruiting||Phase 4|40|Anticipated|University of Alabama at Birmingham||2|||f||||f|t|f||||||||2017-10-10 21:17:07.936051|2017-10-10 21:17:07.936051
NCT03073356|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-28|||March 17, 2017|Actual|2017-03-17|January 2017|2017-01-01|May 1, 2018|Anticipated|2018-05-01|February 28, 2018|Anticipated|2018-02-28||Interventional|||Ketones in Heart Failure - Effects on Cardiac Efficiency|Effects of Ketones on Cardiac Function and Oxygen Consumption in Heart Failure Patients With Reduced Ejection Fraction and Healthy Test Subjects|Recruiting||Phase 2|40|Anticipated|University of Aarhus||4|||f||||t|f|f||||||||2017-10-10 21:17:08.04037|2017-10-10 21:17:08.04037
NCT03073343|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-02|||November 12, 2013|Actual|2013-11-12|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine|A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) and Elevated Alanine Aminotransferase (ALT)|Recruiting||N/A|48|Anticipated|Southern California Institute for Research and Education||2|||f||||f|f|f||||||No|IPD will not be shared with anyone outside authorized research personnel.|2017-10-10 21:17:08.149837|2017-10-10 21:17:08.149837
NCT03073317|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-08|||December 1, 2016|Actual|2016-12-01|March 2017|2017-03-01|December 20, 2019|Anticipated|2019-12-20|April 30, 2019|Anticipated|2019-04-30||Interventional|PREPARE||PREPARE, Prematurity Reduction by Pre-eclampsia Care|PREPARE, Prematurity Reduction by Pre-eclampsia Care|Recruiting||N/A|800|Anticipated|Instituto Fernandes Figueira||2|||f||||t||||||||Undecided||2017-10-10 21:17:08.379486|2017-10-10 21:17:08.379486
NCT03073304|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-02|||February 24, 2017|Actual|2017-02-24|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|ILP-Prime||A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion.|A Randomized Controlled Study With the Aim to Compare Crystalloid Prime Solution With a Prime Solution Containing Packed Red Blood Cells in Relation to the Patient's Regional Metabolic Needs and Immunological Influence During Isolated Limb Perfusion|Recruiting||N/A|20|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f|f|f||||||No||2017-10-10 21:17:08.539153|2017-10-10 21:17:08.539153
NCT03073291|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-03|||June 2016||2016-06-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Intervening to Prevent Youth Access to Marijuana Phase II|Intervening to Prevent Youth Access to Marijuana Phase II|Enrolling by invitation||N/A|150|Anticipated|Klein Buendel, Inc.||2|||f||||f||||||||No|At the conclusion of the project Klein Buendel Inc. will initiate a data sharing plan to make data from this project publicly available via archive files and publish reports describing study procedures in detail in peer-reviewed academic journals. Public data sets will be de-identified so that they are free of all identifiers that would permit linkages to individual research participants and of variables that could lead to deductive disclosure of the identity of individual participants. Individuals wishing to use this data will be required to fill out the KB Data Sharing Request Form, which asks for information on the type of data being requested, anticipated data use, research questions, study design, variables, analysis plan, and IRB approval.|2017-10-10 21:17:08.620365|2017-10-10 21:17:08.620365
NCT03073278|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-09-26|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|March 31, 2024|Anticipated|2024-03-31|March 31, 2022|Anticipated|2022-03-31||Interventional|||Focal Radiotherapy for Previously Treated Prostate Cancer Patients|Phase I Feasibility Trial of Stereotactic Re-irradiation of Prostate Cancer Recurrence Within the Definitively Irradiated Prostate|Recruiting||N/A|36|Anticipated|Royal North Shore Hospital||3|||f||||t|f|f||||||||2017-10-10 21:17:08.694045|2017-10-10 21:17:08.694045
NCT03073265|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-17|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Apixaban Validation Study - Additional Study on Fresh Samples|Validation Study Protocol - Additional Study on Fresh Samples STA - Apixaban Calibrator & STA - Apixaban Control|Recruiting||N/A|60|Anticipated|Diagnostica Stago|||1||f|||||f|t|t|f|f|Samples Without DNA|"     Plasma samples   "|||2017-10-10 21:17:08.769576|2017-10-10 21:17:08.769576
NCT03073252|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-02|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|S47||The Acute Effect of Egg-Based High Protein Meal on Hypertensive Response to Exercise|The Acute Effect of Egg-Based High Protein Meal on Hypertensive Response to Exercise|Recruiting||N/A|35|Anticipated|Purdue University||2|||f||||f|f|f||||||No|no plans to share data with other researchers|2017-10-10 21:17:08.840091|2017-10-10 21:17:08.840091
NCT03073239|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-03-02|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|ALSParadigm||Amyotrophic Lateral Sclerosis: a New Paradigm|Amyotrophic Lateral Sclerosis: a New Paradigm|Recruiting||N/A|40|Anticipated|Conde, Bebiana, M.D.|||1||f||||f|f|f||||Samples With DNA|"     blood to test als mutations   "|Yes|Research results will be shared with the scientific community through the publication of 2 to 3 papers in medical journals, as well as through the participation in national and international conferences. Whenever requested by the participants, the individual data resulting from clinical examinations will be provided.|2017-10-10 21:17:08.923975|2017-10-10 21:17:08.923975
NCT03073226|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-02|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|ELITE||A Prospective Study Comparing the Accuracy of Olympus Lucera Spectrum Technology vs Olympus Lucera Elite Technology in the in Vivo Diagnosis of Barrett's Oesophagus and Colorectal Polyps: The ELITE Study|A Prospective Study Comparing the Accuracy of Olympus Lucera Spectrum Technology vs Olympus Lucera Elite Technology in the in Vivo Diagnosis of Barrett's Oesophagus and Colorectal Polyps: The ELITE Study|Recruiting||N/A|250|Anticipated|Portsmouth Hospitals NHS Trust||4|||f||||t|f|f||||||No|No current plan|2017-10-10 21:17:09.014259|2017-10-10 21:17:09.014259
NCT03073213|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-10-02|||April 13, 2017|Actual|2017-04-13|October 2017|2017-10-01|June 17, 2019|Anticipated|2019-06-17|June 17, 2019|Anticipated|2019-06-17||Interventional|||A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris|A Phase 1, Single- and Multiple-Dose Study to Assess the Safety and Pharmacokinetics of Ixekizumab (LY2439821) (Anti-IL-17 Humanized Antibody) in Chinese Patients With Psoriasis Vulgaris|Recruiting||Phase 1|45|Anticipated|Eli Lilly and Company||3|||f||||f|t|f|||t|||||2017-10-10 21:17:09.269588|2017-10-10 21:17:09.269588
NCT03073200|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-10-02|||March 28, 2017|Actual|2017-03-28|October 2017|2017-10-01|February 3, 2021|Anticipated|2021-02-03|April 3, 2019|Anticipated|2019-04-03||Interventional|Ixora-peds||Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis|Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis|Recruiting||Phase 3|195|Anticipated|Eli Lilly and Company||2|||f||||t|t|f||||||||2017-10-10 21:17:09.421159|2017-10-10 21:17:09.421159
NCT03073187|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-02|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Sleep Quality in High School Students With Asthma|A Pilot Study to Improve Sleep Quality in Urban High School Students With Asthma|Enrolling by invitation||N/A|84|Anticipated|Columbia University|||5||f||||f|f|f||||||No||2017-10-10 21:17:09.902556|2017-10-10 21:17:09.902556
NCT03073174|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-07|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|August 31, 2018|Anticipated|2018-08-31|April 1, 2018|Anticipated|2018-04-01||Observational|||Dietary Intakes and Periodontal Health: A Follow-Up Study|Dietary Intakes and Periodontal Outcomes After Sanative Therapy: A Follow-Up Study|Enrolling by invitation||N/A|79|Anticipated|Brock University|||1||f||||f|f|f||||Samples With DNA|"     Saliva is being collected at time of hygiene appointment.   "|No||2017-10-10 21:17:10.028125|2017-10-10 21:17:10.028125
NCT03073161|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-03-03|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|August 31, 2018|Anticipated|2018-08-31|April 30, 2018|Anticipated|2018-04-30||Observational|||Flavonoid Intake and Periodontal Healing|Flavonoid Intake and Periodontal Outcomes After Sanative Therapy|Recruiting||N/A|150|Anticipated|Brock University|||1||f||||f|f|f||||Samples With DNA|"     Saliva is being collected for before and after sanative therapy for analysis of inflammatory     markers.   "|No||2017-10-10 21:17:10.116009|2017-10-10 21:17:10.116009
NCT03073135|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-05-08|||May 1, 2017|Actual|2017-05-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||Group Psychodrama for Skin Picking|Randomized Controlled Trial of Group Psychodrama for Skin Picking|Recruiting||N/A|40|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||No||2017-10-10 21:17:10.283972|2017-10-10 21:17:10.283972
NCT03073122|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-03-13|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Observational|BCAS-Adult||The Boston Circulatory Arrest Study: Antecedents and Correlates of Well-Being in Adults With Congenital Heart Disease|The Boston Circulatory Arrest Study: Antecedents and Correlates of Well-Being in Adults With Congenital Heart Disease|Not yet recruiting||N/A|150|Anticipated|Boston Children’s Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:17:10.397319|2017-10-10 21:17:10.397319
NCT03073096|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-20|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||LYMPHA: Eliminating the Burden of Lymphedema in Patients Requiring Nodal Dissection|Performing a Lymphatic-venous Anastomosis at Time of Nodal Dissection in Patients Requiring Complete Axillary or Groin Dissection for the Prevention of Lymphedema|Recruiting||N/A|20|Anticipated|Ottawa Hospital Research Institute||1|||f||||f|f|f||||||||2017-10-10 21:17:10.596749|2017-10-10 21:17:10.596749
NCT03073083|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-04-04|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|December 2029|Anticipated|2029-12-01|September 2029|Anticipated|2029-09-01||Interventional|Grafttype||Graft Selection in Anatomic Anterior Cruciate Ligament Reconstruction|Graft Selection in Anatomic Anterior Cruciate Ligament Reconstruction: Patella, Hamstrings or Quadriceps Tendon Autograft|Recruiting||N/A|519|Anticipated|Orthopedisch Centrum Oost Nederland||3|||f||||t|f|f||||||No||2017-10-10 21:17:10.70989|2017-10-10 21:17:10.70989
NCT03073070|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-03-02|||April 30, 2017|Anticipated|2017-04-30|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||RBC Lifespan Measurement in Diabetic Children|Red Blood Cell Lifespan Measurement in Diabetic Children|Not yet recruiting||Phase 1|16|Anticipated|University of Iowa||2|||f||||t|t|f||||||||2017-10-10 21:17:10.832324|2017-10-10 21:17:10.832324
NCT03073057|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-03-02|||January 2016|Actual|2016-01-01|February 2016|2016-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler|Pharmacokinetic Pilot Study Comparing Three Formulations of Budesonide/Formoterol Easyhaler 160/4.5 Microg/Inhalation and Symbicort Turbuhaler: A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|20|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-10-10 21:17:10.926572|2017-10-10 21:17:10.926572
NCT03073044|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-02|||September 1, 2015|Actual|2015-09-01|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|September 1, 2016|Actual|2016-09-01||Observational|||Translation and Validation of BELA-p-K for QoL Evaluation in PD Patients|Italian Validation of the Belastungfragebogen Parkinson Kurzversion (BELA-P-K): a Disease-specific Questionnaire for Evaluation of the Subjective Perception of Quality of Life.|Completed||N/A|100|Actual|Ospedale Generale Di Zona Moriggia-Pelascini|||1||f||||t|f|f||||||No||2017-10-10 21:17:11.021867|2017-10-10 21:17:11.021867
NCT03073031|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-03-02|||January 10, 2017|Actual|2017-01-10|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy|The Use of PRO-CTCAE by Patients Receiving Immunotherapy for the Treatment of Malignant Melanoma|Recruiting||N/A|140|Anticipated|Odense University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:17:11.122892|2017-10-10 21:17:11.122892
NCT03073018|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-03-07|||April 1998||1998-04-01|March 2017|2017-03-01|November 2003|Actual|2003-11-01|June 2003|Actual|2003-06-01||Interventional|PREVEND-IT||Prevention of Renal and Vascular Endstage Disease Intervention Trial|Prevention of Renal and Vascular Endstage Disease Intervention Trial|Completed||Phase 3|864|Actual|University Medical Center Groningen||4|||f||||||||||||Undecided||2017-10-10 21:17:11.228455|2017-10-10 21:17:11.228455
NCT03073005|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-07-13|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|Sim VAD||Use of Simulation to Improve VAD Self-management|Use of Simulation to Improve Ventricular Assist Device Self-management|Enrolling by invitation||N/A|150|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 21:17:11.326844|2017-10-10 21:17:11.326844
NCT03072992|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-05-14|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||"Curcumin in Combination With Chemotherapy in Advanced Breast Cancer"|Study of Efficacy of Curcumin in Combination With Chemotherapy in Patients With Advanced Breast Cancer: Randomized, Double Blind, Placebo Controlled Clinical Trial|Recruiting||Phase 2|75|Anticipated|National Center of Oncology, Armenia||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:17:11.408119|2017-10-10 21:17:11.408119
NCT03072979|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-02|||January 21, 2017|Actual|2017-01-21|March 2017|2017-03-01|December 31, 2018||2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)|Reduction in Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)|Recruiting||N/A|18|Anticipated|National University Hospital, Singapore|||1||f||||t|f|f||||||Undecided||2017-10-10 21:17:11.521557|2017-10-10 21:17:11.521557
NCT03072966|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-15|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Development of Distress Management Algorithms Using Mobile Device Based Health Logs in Breast Cancer Survivors|Development of Distress Management Algorithms Using Mobile Device Based Health Logs in Breast Cancer Survivors|Recruiting||N/A|150|Anticipated|Asan Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:17:11.592056|2017-10-10 21:17:11.592056
NCT03072953|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-31|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum|A Phase 2a, Open-label, Proof of Concept Study to Determine the Efficacy and Safety of Etrasimod (APD334) in Patients With Pyoderma Gangrenosum|Recruiting||Phase 2|8|Anticipated|Arena Pharmaceuticals||1|||f|||||t|f|||t|||||2017-10-10 21:17:11.684684|2017-10-10 21:17:11.684684
NCT03072940|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-07|||February 2014|Actual|2014-02-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|ALICE||Brain Imaging in the Idiopathic REM Sleep Behavior Disorder (ALICE)|3 T Multimodal MRI in Idiopathic RBD|Completed||N/A|42|Actual|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil|||2||f|||||f|f||||||||2017-10-10 21:17:11.783891|2017-10-10 21:17:11.783891
NCT03072914|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-02|||June 2014|Actual|2014-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome|Effects of Remote Ischemic Preconditioning With Postconditioning in Patients Undergoing Superficial Temporal Artery-middle Cerebral Artery (STA-MCA) Anastomosis|Recruiting||N/A|170|Anticipated|Seoul National University Hospital||2|||f|||||f|f||||||||2017-10-10 21:17:11.976218|2017-10-10 21:17:11.976218
NCT03072901|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-03-02|||December 2010||2010-12-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01|12 Months|Observational [Patient Registry]|||Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity|Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity|Terminated||N/A|244|Actual|GI Dynamics|||1|GID terminated the Registry due to evolving registry requirements|f||||f|f|t|f|f|t|||No||2017-10-10 21:17:12.052143|2017-10-10 21:17:12.052143
NCT03072888|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-05-05|||March 31, 2016|Actual|2016-03-31|May 2017|2017-05-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||Effects of Transcutaneous Electrical Nerve Stimulation (TENS) Following Hysterectomy|The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Pain and Quality of Recovery After Abdominal Hysterectomy|Completed||N/A|50|Actual|Tokat Gaziosmanpasa University||2|||f||||t|f|f||||||No||2017-10-10 21:17:12.121191|2017-10-10 21:17:12.121191
NCT03072875|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-02|||December 18, 2015|Actual|2015-12-18|February 2017|2017-02-01|December 17, 2017|Anticipated|2017-12-17|December 17, 2017|Anticipated|2017-12-17||Interventional|CAMS-RAS||CAMS-RAS: for Suicide Prevention|CAMS Relational Agent System for Suicide Prevention|Enrolling by invitation||N/A|65|Anticipated|Evidence-Based Practice Institute, Seattle, WA||1|||f||||t|f|f||||||Yes|Requests for use of data will be considered on a case-by-case basis. Interested researchers may send data requests to research@ebpi.org.|2017-10-10 21:17:12.199372|2017-10-10 21:17:12.199372
NCT03072862|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-30|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|August 2021|Anticipated|2021-08-01||Observational|||Evaluation of the Benefits for Overall Health Following Cochlear Implant Treatment in the Elderly Population|Cochlear Implant and Healthy Aging: A Multinational, Multicentre Observational Study|Not yet recruiting||N/A|100|Anticipated|Cochlear|||1||f||||f||||||||||2017-10-10 21:17:12.271766|2017-10-10 21:17:12.271766
NCT03072849|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||April 2015||2015-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Observational|||Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation|Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation|Recruiting||N/A|40|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||t||||||||||2017-10-10 21:17:12.366171|2017-10-10 21:17:12.366171
NCT03072836|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-04-11|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|February 15, 2018|Anticipated|2018-02-15|February 15, 2018|Anticipated|2018-02-15||Interventional|FLORACROHN||Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis|Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis|Recruiting||N/A|108|Anticipated|Central Hospital, Nancy, France||3|||f||||f|f|f||||||No||2017-10-10 21:17:12.457184|2017-10-10 21:17:12.457184
NCT03072823|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-02|||January 27, 2016|Actual|2016-01-27|March 2017|2017-03-01|October 31, 2018|Anticipated|2018-10-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases|Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases: a Double-blind Placebo-controlled Therapeutic Trial|Recruiting||N/A|60|Anticipated|China Medical University Hospital||2|||f||||t|f|f||||||||2017-10-10 21:17:12.527523|2017-10-10 21:17:12.527523
NCT03072797|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-16|||March 16, 2017|Actual|2017-03-16|March 2017|2017-03-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|BHAS||Beijing Hospital Atherosclerosis Study|Beijing Hospital Atherosclerosis Study|Recruiting||N/A|3000|Anticipated|Beijing Hospital|||1||f|||||f|f|||f|Samples With DNA|"     Blood, 10 mL (whole blood, plasma, serum)   "|||2017-10-10 21:17:12.707543|2017-10-10 21:17:12.707543
NCT03072784|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-07|||February 1, 2015|Actual|2015-02-01|March 2017|2017-03-01|August 25, 2016|Actual|2016-08-25|April 20, 2016|Actual|2016-04-20||Interventional|||Aortic Cross Clamping Time, and Postoperative Respiratory Function|Implication of Aortic Cross Clamping Time Upon Postoperative Respiratory Function in Adult Patients Undergoing Open Heart Surgery|Completed||N/A|53|Actual|Assiut University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:17:12.792965|2017-10-10 21:17:12.792965
NCT03072771|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-02|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|September 30, 2021|Anticipated|2021-09-30|January 31, 2019|Anticipated|2019-01-31||Interventional|||Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)|A Pilot Trial of Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With DLBCL|Recruiting||Phase 1|15|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:17:12.861047|2017-10-10 21:17:12.861047
NCT03072758|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-31|||March 30, 2017|Actual|2017-03-30|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|September 15, 2017|Anticipated|2017-09-15||Interventional|||Men's Club: Impact of Male Partner Involvement on Initiation and Sustainment of Exclusive Breastfeeding Among Postpartum Women|Men's Club: Impact of Male Partner Involvement on Initiation and Sustainment of Exclusive Breastfeeding Among Postpartum Women|Enrolling by invitation||N/A|200|Actual|University of Nevada, Las Vegas||2|||f||||t|f|f||||||No||2017-10-10 21:17:12.993825|2017-10-10 21:17:12.993825
NCT03072745|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||January 1, 2011|Actual|2011-01-01|March 2017|2017-03-01|June 1, 2012|Actual|2012-06-01|May 1, 2012|Actual|2012-05-01||Interventional|||Insomnia and Cognitive Performance in Chronic Pain|Distinct Effect of Insomnia on Cognitive Performance in Individuals With Complex Chronic Pain|Completed||N/A|22|Actual|Uppsala University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:17:13.069909|2017-10-10 21:17:13.069909
NCT03072732|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-23|||November 3, 2016||2016-11-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:17:13.160532|2017-10-10 21:17:13.160532
NCT03072719|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-07-10|2017-03-07||March 1, 2012||2012-03-01|July 2017|2017-07-01|June 12, 2012|Actual|2012-06-12|June 1, 2012|Actual|2012-06-01||Interventional|||The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Immediate and Short Term Relief From Dentinal Hypersensitivity|Completed||Phase 3|120|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 21:17:13.366086|2017-10-10 21:17:13.366086
NCT03072706|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-10|||October 2, 2017|Anticipated|2017-10-02|August 2017|2017-08-01|October 3, 2019|Anticipated|2019-10-03|October 3, 2018|Anticipated|2018-10-03||Interventional|EXACT||Evaluation of X-ray, Acetabular Guides and CT in THR|Evaluation of X-ray, Acetabular Guides and CT in THR|Not yet recruiting||N/A|54|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust||2|||f||||t|f|f||||||||2017-10-10 21:17:14.059609|2017-10-10 21:17:14.059609
NCT03072693|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||September 1, 2017|Anticipated|2017-09-01|March 2017|2017-03-01|July 31, 2020|Anticipated|2020-07-31|December 31, 2019|Anticipated|2019-12-31||Interventional|DAVID-HF||RATIONALE AND DESIGN OF A DAILY AMBULATORY REMOTE MONITORING SYSTEM VS CONVENTIONAL THERAPY FOR THE POST-DISCHAGE MANAGEMENT OF ACUTE DECOMPENSATED HEART FAILURE|RATIONALE AND DESIGN OF A DAILY AMBULATORY REMOTE MONITORING SYSTEM VS CONVENTIONAL THERAPY FOR THE POST-DISCHAGE MANAGEMENT OF ACUTE DECOMPENSATED HEART FAILURE|Not yet recruiting||N/A|876|Anticipated|The University of Hong Kong||3|||f||||t|f|f||||||No||2017-10-10 21:17:14.1774|2017-10-10 21:17:14.1774
NCT03072680|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy of a Positive Psychology Intervention Through a Mobile App|Efficacy of a Positive Psychology Intervention Through a Mobile App: a Randomized Controlled Trial|Not yet recruiting||N/A|150|Anticipated|University of Valencia||3|||f||||f|f|f||||||No||2017-10-10 21:17:14.277953|2017-10-10 21:17:14.277953
NCT03072667|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-06||||||March 2017|2017-03-01||||||||Expanded Access|||Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease|Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease|Available||N/A|||St. Louis University||||||t||t|||||||||||2017-10-10 21:17:14.414465|2017-10-10 21:17:14.414465
NCT03072654|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-06|||November 1, 2014|Actual|2014-11-01|March 2017|2017-03-01|March 2, 2017|Actual|2017-03-02|March 1, 2017|Actual|2017-03-01||Observational|||Tracheal Anatomy After Thyroidectomy|Thyroidectomy Improves Tracheal Anatomy and Airflow in Patients With Nodular Goiter: A Prospective Cohort Study|Completed||N/A|72|Actual|University of Southern Denmark|||1||f||||f|f|f||||||No||2017-10-10 21:17:14.519043|2017-10-10 21:17:14.519043
NCT03072641|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-06|||June 3, 2010|Actual|2010-06-03|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Using Probiotics to Reactivate Tumor Suppressor Genes in Colon Cancer|Using Probiotics to Reactivate Tumor Suppressor Genes in Colon Cancer|Completed||N/A|20|Actual|Vastra Gotaland Region||2|||f||||f|f|f||||||No||2017-10-10 21:17:14.581138|2017-10-10 21:17:14.581138
NCT03072628|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||January 11, 2017|Actual|2017-01-11|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||E-cigarettes, Nicotine Inhaler, and Blood Vessel Function|The Effects of Electronic Cigarettes on Endothelial Function and Oxidative Stress|Recruiting||N/A|120|Anticipated|University of California, Los Angeles||4|||f||||f|f|f|||f|||No||2017-10-10 21:17:14.666204|2017-10-10 21:17:14.666204
NCT03072615|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||April 1, 2013|Actual|2013-04-01|March 2017|2017-03-01|February 29, 2016|Actual|2016-02-29|November 30, 2015|Actual|2015-11-30||Observational|TIPS-SWE||Role of SWE-change After TIPS in the Prediction of Prognosis After TIPS|Role of SWE-change After TIPS in the Prediction of Prognosis After TIPS|Completed||N/A|83|Actual|University Hospital, Bonn|||2||f||||f|f|f||||Samples Without DNA|"     Plasma and serum samples   "|No||2017-10-10 21:17:14.787125|2017-10-10 21:17:14.787125
NCT03072602|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-06|||August 26, 2016|Actual|2016-08-26|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Racial Differences in the Natriuretic Peptide Response to Glucose Challenge|A Study of Racial Differences in Natriuretic Peptides Response to Glucose Challenge|Recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||2|||f||||f|f|f||||||No||2017-10-10 21:17:14.884021|2017-10-10 21:17:14.884021
NCT03072589|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-06|||August 1, 2017|Anticipated|2017-08-01|March 2017|2017-03-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation|A Phase 1 Open Label Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation|Not yet recruiting||Phase 1|21|Anticipated|University of Virginia||1|||f||||t|t|f||||||No||2017-10-10 21:17:15.015213|2017-10-10 21:17:15.015213
NCT03072576|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-07|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Accuracy and Feasibility of Xpert Ultra|A Multicentre Study of the Diagnostic Accuracy and Feasibility of the Xpert Ultra for Detection of TB and Rifampin Resistance in Adults Suspected of Having Pulmonary TB|Recruiting||N/A|1200|Anticipated|Foundation for Innovative New Diagnostics, Switzerland|||1||f||||t|f|f||||||Undecided||2017-10-10 21:17:15.116783|2017-10-10 21:17:15.116783
NCT03072563|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||March 7, 2017|Anticipated|2017-03-07|February 2017|2017-02-01|March 7, 2019|Anticipated|2019-03-07|March 7, 2019|Anticipated|2019-03-07||Observational|CPR GDM||The Use of the CPR to Predict Adverse Outcomes in GDM Pregnancies|The Use of the Cerebro-placental Ratio to Predict Adverse Outcomes in Pregnancies Complicated by Gestational Diabetes|Recruiting||N/A|207|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f|f|f||||||No||2017-10-10 21:17:15.238242|2017-10-10 21:17:15.238242
NCT03072550|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-24|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail)|A Multi Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.|Recruiting||N/A|30|Anticipated|DeviceFarm, Inc.||1|||f||||f|f|t|t|f|f|||||2017-10-10 21:17:15.324086|2017-10-10 21:17:15.324086
NCT03072537|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-01|||January 1, 1998|Actual|1998-01-01|March 2017|2017-03-01|January 1, 2028|Anticipated|2028-01-01|January 1, 2028|Anticipated|2028-01-01|18 Years|Observational [Patient Registry]|CrescNet||CrescNet - Wachstumsnetzwerk [Growth Monitoring Network]|CrescNet - Computer-guided, Population-based Screening System for Growth Disorders|Recruiting||N/A|1000000|Anticipated|University of Leipzig|||1||f|||||f|f||||||No||2017-10-10 21:17:15.444709|2017-10-10 21:17:15.444709
NCT03072524|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-01|||March 1, 2016|Actual|2016-03-01|March 2017|2017-03-01|July 1, 2018|Anticipated|2018-07-01|December 31, 2017|Anticipated|2017-12-31||Observational|||The Prehospital Selection of Acute Stroke Patients|Validation of Prehospital Stroke Scale (FAST PLUS TEST) to Predict Patients With Large Arterial Vessel Intracranial Occlusion.|Recruiting||N/A|400|Anticipated|University Hospital Ostrava|||1||f||||f|f|f||||||No||2017-10-10 21:17:15.552988|2017-10-10 21:17:15.552988
NCT03072511|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-09-20|||December 13, 2016|Actual|2016-12-13|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SPOTLIGHT||Smoking Cessation Intervention|Pilot Trial of a Smoking Cessation Intervention Informed by Construal Level Theory|Recruiting||Phase 4|180|Anticipated|University of Florida||2|||f||||f|t|f|||f|||||2017-10-10 21:17:15.695751|2017-10-10 21:17:15.695751
NCT03072498|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-08-08|||April 6, 2017|Actual|2017-04-06|August 2017|2017-08-01|March 5, 2019|Anticipated|2019-03-05|March 5, 2019|Anticipated|2019-03-05||Observational|||Collection of Samples From Patients With MDS|Collection of Bone Marrow, Peripheral Blood (PB), Epithelial Tissue, and Saliva Samples From Patients With Myelodysplastic Syndromes (MDS) to Identify MDS-Specific Antigens (MSA) for Use in Cellular Immunotherapy.|Recruiting||N/A|24|Anticipated|PersImmune, Inc|||1||f||||f|f|f||||Samples With DNA|"     We intend to obtain cells from bone marrow, peripheral blood, epithelial tissue, and saliva     from patients who are likely to be candidates for MDS treatment in the near future.   "|||2017-10-10 21:17:15.794891|2017-10-10 21:17:15.794891
NCT03072485|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-01|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|July 1, 2017|Anticipated|2017-07-01||Interventional|||Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers|Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers|Recruiting||Phase 1|10|Anticipated|Stanford University||2|||f||||t|t|f||||||No||2017-10-10 21:17:15.874725|2017-10-10 21:17:15.874725
NCT03072472|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-05-05|||February 14, 2017|Actual|2017-02-14|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|B-ADENOMA||BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities|BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities|Recruiting||N/A|3222|Anticipated|South Tyneside NHS Foundation Trust||2|||f||||t|f|f||||||No||2017-10-10 21:17:15.975681|2017-10-10 21:17:15.975681
NCT03072459|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-08-08|||February 20, 2017|Actual|2017-02-20|July 2017|2017-07-01|May 15, 2018|Anticipated|2018-05-15|February 15, 2018|Anticipated|2018-02-15||Observational|NAVIO||A Retrospective Study of the Navio|A Retrospective Study of the Navio◊ Robotic-assisted Surgical System|Recruiting||N/A|128|Anticipated|Smith & Nephew, Inc.|||1||f||||f|f|f||||||||2017-10-10 21:17:16.142736|2017-10-10 21:17:16.142736
NCT03072446|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents.|Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents.|Not yet recruiting||N/A|30|Anticipated|University Hospital Southampton NHS Foundation Trust||1|||f||||t|f|t|f|f|t|||No|No individual participant data will be available to other researchers.|2017-10-10 21:17:16.225149|2017-10-10 21:17:16.225149
NCT03072433|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-01|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Intervention for Primary Caregivers to Improve Outcomes in Children With Severe Malnutrition|The Effect of an Intervention Program for Primary Caregivers on the Development of Children With Severe Malnutrition: A Cluster Randomized Controlled Clinical Trial|Recruiting||N/A|256|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||No||2017-10-10 21:17:16.316795|2017-10-10 21:17:16.316795
NCT03072420|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-07-06|||July 21, 2015|Actual|2015-07-21|July 2017|2017-07-01|July 24, 2015|Actual|2015-07-24|July 24, 2015|Actual|2015-07-24||Interventional|||Characterization of Fingertips Using MRI Images (FINGERS-COMPRESSION)|Characterization of Fingertips Using MRI Images : Development of Mechanically Faithful Models Dedicated to Manipulation.|Completed||N/A|8|Actual|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 21:17:16.433268|2017-10-10 21:17:16.433268
NCT03072407|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-13|||November 24, 2015|Actual|2015-11-24|March 2017|2017-03-01|November 15, 2016|Actual|2016-11-15|November 2, 2016|Actual|2016-11-02||Interventional|||MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Group, MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM|Completed||Phase 1|40|Actual|PegBio Co., Ltd.||5|||f||||f|f|f||||||No||2017-10-10 21:17:16.512778|2017-10-10 21:17:16.512778
NCT03072394|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-07|||January 10, 2015|Actual|2015-01-10|March 2017|2017-03-01|January 10, 2021|Anticipated|2021-01-10|November 20, 2020|Anticipated|2020-11-20||Interventional|RAOLA||Local Anesthesia in Radial Catheterization|Anesthetic Ointment vs Local Injectable Anesthetic in Trans-radial Cardiac Catheterization: The RAOLA Study|Recruiting||Phase 4|444|Anticipated|Hippocration General Hospital||2|||f||||f|t|f|||f|||No||2017-10-10 21:17:16.650967|2017-10-10 21:17:16.650967
NCT03072381|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-03-01|||May 2016||2016-05-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PEAK Platelet Rich Plasma Injection Treatment for Chronic Lateral Epicondylosis|The Clinical, Biomechanical, and Tissue Regenerating Effects of a Single PEAK Platelet Rich Plasma Injection for the Treatment of Chronic Lateral Epicondylosis: a Randomized Controlled Trial|Recruiting||Phase 2|50|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 21:17:16.748243|2017-10-10 21:17:16.748243
NCT03072368|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-01|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Iris Colors in Neonates: Do They Really Change? Prevalence, Predicting Factors and Associated Characteristics|Iris Colors in Neonates: Do They Really Change? Prevalence, Predicting Factors and Associated Characteristics|Not yet recruiting||N/A|200|Anticipated|Hillel Yaffe Medical Center||4|||f||||t|f|f||||||No||2017-10-10 21:17:16.838253|2017-10-10 21:17:16.838253
NCT03072355|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-01|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Reliability and Validity of a Shoulder Fatigue Test|Reliability and Validity of a Shoulder Fatigue Test Using Two Tools: Elastic Resistance and Isokinetic Dynamometer.|Not yet recruiting||N/A|30|Anticipated|São Paulo State University||2|||f||||t|f|f||||||No||2017-10-10 21:17:16.924086|2017-10-10 21:17:16.924086
NCT03072342|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-07|||April 16, 2013|Actual|2013-04-16|February 2017|2017-02-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||PERIODONTITIS AND VASCULAR DYSFUNCTION|INTENSIVE TREATMENT FOR PERIODONTAL DISEASE: A MODEL OF AND THERAPY OF INFLAMMATORY VASCULAR DYSFUNCTION|Recruiting||N/A|190|Anticipated|University College, London||2|||f|||||f|f||||||||2017-10-10 21:17:17.015634|2017-10-10 21:17:17.015634
NCT03072329|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-03-06|||October 2016||2016-10-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|February 20, 2017|Actual|2017-02-20||Interventional|||Neurostimulation in Pudendal Nerve Block|Neurostimulation in Pudendal Nerve Block: is That Really Necessary?|Completed||N/A|150|Actual|Hôpital d'enfants Béchir-Hamza||1|||f||||f||||||||No||2017-10-10 21:17:17.098249|2017-10-10 21:17:17.098249
NCT03072316|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-03-31|||January 14, 2016||2016-01-14|March 2017|2017-03-01|January 14, 2018|Anticipated|2018-01-14|January 14, 2018|Anticipated|2018-01-14||Observational|||Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast Reconstruction|Case Control Study to Evaluate the Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast Reconstruction|Recruiting||N/A|300|Anticipated|Royal Marsden NHS Foundation Trust|||4||f||||f||||||||||2017-10-10 21:17:17.165921|2017-10-10 21:17:17.165921
NCT03072303|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-19|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Pregnancy in Osteogenesis Imperfecta (OI) Registry|Pregnancy in Osteogenesis Imperfecta (OI) Registry|Recruiting||N/A|100|Anticipated|University of South Florida|||1||f||||f|f|f||||||No||2017-10-10 21:17:17.269104|2017-10-10 21:17:17.269104
NCT03072290|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-01|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Corticosteroid Injection in Carpal Tunnel Syndrome|Comparison of Different Dose of Steroid Injection in Carpal Tunnel Syndrome|Recruiting||N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f|||||f|f||||||||2017-10-10 21:17:17.358963|2017-10-10 21:17:17.358963
NCT03072277|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-25|||December 2015||2015-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|August 2019|Anticipated|2019-08-01||Interventional|DHANI-2||Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2)|Maternal Docosa-Hexaenoic Acid (DHA) Supplementation and Offspring Neurodevelopment in India (DHANI-2)|Active, not recruiting||Phase 3|957|Actual|Public Health Foundation of India||2|||f||||t|f|f||||||||2017-10-10 21:17:17.438704|2017-10-10 21:17:17.438704
NCT03072264|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-03-01|||October 2016||2016-10-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randomized Clinical Trial of a Mindfulness Based Intervention in Generalized Anxiety Disorder|Randomized Clinical Trial Comparing Mindfulness, Pharmacological Treatment, and Control Group in Generalized Anxiety Disorder (GAD)|Recruiting||N/A|192|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||Undecided||2017-10-10 21:17:19.507791|2017-10-10 21:17:19.507791
NCT03072251|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-16|||February 5, 2017|Actual|2017-02-05|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Participation of Breast Milk Feeding Mothers in Research|Participation of Breast Milk Feeding Mothers in Research|Recruiting||N/A|5000|Anticipated|Pennington Biomedical Research Center|||1||f||||f|f|f||||||||2017-10-10 21:17:19.642635|2017-10-10 21:17:19.642635
NCT03072238|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-09-21|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|September 9, 2023|Anticipated|2023-09-09|May 12, 2020|Anticipated|2020-05-12||Interventional|IPATential150||Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Testing Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Asymptomatic or Mildly Symptomatic, Previously Untreated, Metastatic Castrate-Resistant Prostate Cancer|Recruiting||Phase 3|850|Anticipated|Hoffmann-La Roche||2|||f||||t|t|f||||||||2017-10-10 21:17:19.761865|2017-10-10 21:17:19.761865
NCT03072225|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-03-01|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|Spchim||Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine|Randomized Controlled Clinical Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine|Not yet recruiting||Phase 2|120|Anticipated|Guangzhou University of Traditional Chinese Medicine||2|||f||||t|f|f||||||No||2017-10-10 21:17:20.562789|2017-10-10 21:17:20.562789
NCT03072212|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-03-02|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||HIV and Stroke Outcomes in Uganda|Impact of HIV on Stroke Characteristics and Outcomes in Uganda|Recruiting||N/A|200|Anticipated|Mbarara University of Science and Technology|||2||f||||f|f|f||||||No|Data will be directly entered into a database and analysed|2017-10-10 21:17:20.656552|2017-10-10 21:17:20.656552
NCT03072199|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-06-08|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|October 1, 2018|Anticipated|2018-10-01|May 1, 2018|Anticipated|2018-05-01||Interventional|RITA-MI||Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study|Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study|Recruiting||Phase 1/Phase 2|24|Anticipated|Papworth Hospital NHS Foundation Trust||1|||f||||t|f|f|||f|||No||2017-10-10 21:17:20.748707|2017-10-10 21:17:20.748707
NCT03072160|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-03|2017-07-26|||June 16, 2017|Actual|2017-06-16|June 15, 2017|2017-06-15|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer|Phase II Trial of Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer|Recruiting||Phase 2|32|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f|||||t|f||||||||2017-10-10 21:17:20.971314|2017-10-10 21:17:20.971314
NCT03072147|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-15|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Teriparatide as a Chondroregenerative Therapy in OA|Evaluating Teriparatide as a Chondroregenerative Therapy in Human Osteoarthritis|Recruiting||Phase 2|80|Anticipated|University of Rochester||2|||f||||f|t|f|||t|||||2017-10-10 21:17:21.067271|2017-10-10 21:17:21.067271
NCT03072134|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-24|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|April 1, 2019|Anticipated|2019-04-01|March 30, 2019|Anticipated|2019-03-30||Interventional|||Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma|Neural Stem Cell Oncolytic Adenoviral Virotherapy of Newly Diagnosed Malignant Glioma|Recruiting||Phase 1|36|Anticipated|Northwestern University||2|||f||||t|t|f||||||No||2017-10-10 21:17:21.176571|2017-10-10 21:17:21.176571
NCT03072121|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-30|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization|Study of Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy|Not yet recruiting||Phase 4|440|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||Undecided||2017-10-10 21:17:21.285492|2017-10-10 21:17:21.285492
NCT03072108|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-01|||June 24, 2016|Actual|2016-06-24|March 2017|2017-03-01|September 10, 2018|Anticipated|2018-09-10|April 30, 2018|Anticipated|2018-04-30||Interventional|||Dietary Supplement for Joint: the OLE Study|Effect of Oleuropein-based Dietary Supplement (Bonolive™) Versus Placebo on Knee Joint Functionality and Cartilage Catabolism in Ageing Population|Recruiting||N/A|138|Anticipated|Nestlé||2|||f||||f|f|f||||||No||2017-10-10 21:17:21.409035|2017-10-10 21:17:21.409035
NCT03072095|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-27|||April 17, 2017|Actual|2017-04-17|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|August 3, 2017|Actual|2017-08-03||Interventional|||Colorectal Cancer Screening in a Community Health Setting|Patient-Centered Outreach to Increase Colorectal Cancer Screening in a Community Health Setting|Enrolling by invitation||N/A|320|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 21:17:21.631509|2017-10-10 21:17:21.631509
NCT03072082|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-30|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization|Study of Curative Effect Evaluation of DanLou Tablet on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy|Not yet recruiting||Phase 4|440|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||Undecided||2017-10-10 21:17:21.761663|2017-10-10 21:17:21.761663
NCT03072069|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-06|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Analysis of Autonomic Function During Anesthesia Using Response Surface Model|Analysis of Autonomic Function During Anesthesia Using Response Surface Model|Recruiting||N/A|30|Anticipated|National Central University|||1||f||||t||||||||Undecided|If individual participant data collected in this study are to be made available to other researchers after the end of the study, vital signs and heart rate variability are to be shared, when data will be available.|2017-10-10 21:17:21.92229|2017-10-10 21:17:21.92229
NCT03072056|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-30|||January 9, 2017|Actual|2017-01-09|August 2017|2017-08-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|||A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers|A Phase 1, Open-Label, 3-Period, Single-Ascending Dose, Crossover Study in Healthy Subjects to Compare PK Properties of MIN-101 and Its Metabolites Poor and Extensive Metabolizers as Defined by Cytochrome P450 2D6 Genotype|Completed||Phase 1|23|Actual|Minerva Neurosciences||6|||f||||f|f|f|||f|||||2017-10-10 21:17:22.029265|2017-10-10 21:17:22.029265
NCT03072043|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-05-05|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms|A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination With Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms|Recruiting||Phase 1/Phase 2|60|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|t|f||||||||2017-10-10 21:17:22.130722|2017-10-10 21:17:22.130722
NCT03072030|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-11|||August 3, 2017|Actual|2017-08-03|April 2017|2017-04-01|July 1, 2019|Anticipated|2019-07-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi|"01 - GamEvac-Combi-2016  International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi - Combined Vector-Based Vaccine Against Ebola Virus Disease, 0.5 ml+0.5 ml/Dose "|Recruiting||Phase 4|2000|Anticipated|Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation||2|||f||||f|f|f||||||||2017-10-10 21:17:22.259086|2017-10-10 21:17:22.259086
NCT03072017|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-13|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|MBAT||Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults|Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults: Phase 1 Open Label Pilot|Completed||N/A|20|Actual|University of Pennsylvania||1|||f||||f|f|f||||||||2017-10-10 21:17:22.408806|2017-10-10 21:17:22.408806
NCT03072004|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-01|||January 27, 2017|Actual|2017-01-27|March 2017|2017-03-01|March 1, 2019|Anticipated|2019-03-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Low Level Laser Therapy Effects in Peripheral Nerves Patient With Leprosy.|Evaluation of Low Level Laser Therapy Effects in Peripheral Nerves Patient Affected With Leprosy : Randomized Controlled Trial|Recruiting||N/A|92|Anticipated|Federal University of Uberlandia||2|||f||||t|f|f||||||No|This project doesn´t have a plan to make individual participant data available to other researchers. The datas are available only for our researcher group.|2017-10-10 21:17:22.512137|2017-10-10 21:17:22.512137
NCT03071991|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-03-06|||January 2017||2017-01-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|||Effect of Preincisional Bupivakain Infiltration on Postoperative Narcotic Medication Requirement|Effect of Preincisional Bupivakain Infiltration on Postoperative Narcotic Medication in Laparoscopic Sleeve Gastrectomy|Recruiting||N/A|40|Anticipated|Umraniye Education and Research Hospital|||2||f||||||||||||No||2017-10-10 21:17:22.636676|2017-10-10 21:17:22.636676
NCT03071978|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-03-01|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Observational|||Application of Right Atrial Left Ventricular Fusion Pacing in Patients With CRT Indications|Application of Right Atrial Left Ventricular Fusion Pacing in Patients With CRT (Cardiac Resynchronization Therapy) Indications|Recruiting||N/A|60|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||2||f||||f|f|f||||||Undecided||2017-10-10 21:17:22.74638|2017-10-10 21:17:22.74638
NCT03071965|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-06-16|||May 12, 2017|Actual|2017-05-12|June 2017|2017-06-01|April 15, 2021|Anticipated|2021-04-15|April 15, 2021|Anticipated|2021-04-15||Interventional|||Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)|Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)|Enrolling by invitation||Phase 2|73|Anticipated|Neurotech Pharmaceuticals||2|||f|||||t|f||||||||2017-10-10 21:17:22.88338|2017-10-10 21:17:22.88338
NCT03071952|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-03-01|||September 2016||2016-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Assessment of AAIR Pacing Treatment for Heart Failure Patients With Chronotropic Incompetence|Assessment of AAIR Pacing Treatment for Heart Failure Patients With Chronotropic Incompetence|Recruiting||N/A|30|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||No||2017-10-10 21:17:23.006889|2017-10-10 21:17:23.006889
NCT03071939|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-07-05|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|February 15, 2019|Anticipated|2019-02-15|January 5, 2019|Anticipated|2019-01-05||Interventional|EIPSP||Cognate Patient Care Insight Scale|Pilot Study of a New Insight Assessment Tool|Not yet recruiting||N/A|119|Anticipated|Hôpital le Vinatier||1|||f||||f|f|f||||||||2017-10-10 21:17:23.090449|2017-10-10 21:17:23.090449
NCT03071926|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-10|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Metronomic PLD in Patients With Primary Endocrine Resistant ABC|Efficacy and Safety of Metronomic Pegylated Liposomal Doxorubicin in Patients With Primary Endocrine Resistant Advanced Breast Cancer|Recruiting||Phase 2|46|Anticipated|Fudan University||1|||f||||f|f|f||||||||2017-10-10 21:17:23.198208|2017-10-10 21:17:23.198208
NCT03071913|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-09-06|||September 5, 2017|Actual|2017-09-05|February 2017|2017-02-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||Blood Brain Barrier Differences in Patients With Brain Tumors Undergoing Surgery|Pilot Study to Assess Heterogeneity of the Blood Brain Barrier in Patients With CNS Malignancy|Recruiting||N/A|81|Anticipated|Mayo Clinic|||1||f||||t||||||||||2017-10-10 21:17:23.305698|2017-10-10 21:17:23.305698
NCT03071900|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-01|||June 22, 2016|Actual|2016-06-22|March 2017|2017-03-01|April 20, 2017|Anticipated|2017-04-20|March 15, 2017|Anticipated|2017-03-15||Interventional|||CTC Detection Rate in SCCHN With a in Vivo Device|Enumeration and Molecular Characterization of Circulating Tumor Cells (CTCs) Using a in Vivo Device in Squamous Cell Carcinoma of Head and Neck (SCCHN)|Recruiting||N/A|50|Anticipated|Nanjing Tongren Hospital||2|||f|||||f|f||||||||2017-10-10 21:17:23.411933|2017-10-10 21:17:23.411933
NCT03071887|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-01|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Resilience Intervention for Older, HIV-Infected Women|Developing a Resilience Intervention for Older, HIV-Infected Women|Not yet recruiting||N/A|40|Anticipated|Massachusetts General Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:17:23.500299|2017-10-10 21:17:23.500299
NCT03071874|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-27|||September 27, 2017|Anticipated|2017-09-27|September 2017|2017-09-01|July 25, 2024|Anticipated|2024-07-25|July 25, 2020|Anticipated|2020-07-25||Interventional|||Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas|A Single Arm Phase II Study Of The Dual mTORC1/mTORC2 Inhibitor Vistusertib (AZD2014) Provided On An Intermittent Schedule For Sporadic Patients With Grade II-III Meningiomas That Recur Or Progress After Surgery And Radiation|Recruiting||Phase 2|30|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 21:17:23.587858|2017-10-10 21:17:23.587858
NCT03071861|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-05|||November 1, 2017|Anticipated|2017-11-01|May 2017|2017-05-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|MEND||Mild Encephalopathy in the Newborn Treated With Darbepoetin|Mild Encephalopathy in the Newborn Treated With Darbepoetin (MEND)|Not yet recruiting||Phase 2|40|Anticipated|University of New Mexico||2|||f||||t|t|f||||||No||2017-10-10 21:17:23.689266|2017-10-10 21:17:23.689266
NCT03071848|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-09-29|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Observational|||A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical Cancer|Retrospective Multicenter Observational Study to Evaluate Safety and Effectiveness of Bevacizumab (Avastin®) in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Patients With Advanced Cervical Cancer|Recruiting||N/A|120|Anticipated|Hoffmann-La Roche|||1||f||||f||||||||||2017-10-10 21:17:23.79593|2017-10-10 21:17:23.79593
NCT03071835|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-08-25|||June 23, 2016|Actual|2016-06-23|August 2017|2017-08-01|December 31, 2029|Anticipated|2029-12-31|December 31, 2028|Anticipated|2028-12-31||Observational|HYPERION||A Comparative Study of Subjects Past Their Final Follow-ON Visit|A Comparative Study of Subjects tHree to Nine Years Past thEiR fInal Follow- ON Visit|Enrolling by invitation||N/A|200|Anticipated|University of Miami|||1||f||||f|f|f||||Samples With DNA|"     Genetic testing will consist of collecting tissue and/or blood stored for future use.   "|||2017-10-10 21:17:23.89005|2017-10-10 21:17:23.89005
NCT03071822|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-04-21|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|February 28, 2022|Anticipated|2022-02-28|July 31, 2021|Anticipated|2021-07-31||Interventional|||Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas|Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone (PIGLETS Regimen) as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas (PTCLs)|Recruiting||Phase 4|50|Anticipated|The University of Hong Kong||1|||f||||f|f|f|||f|||||2017-10-10 21:17:23.967054|2017-10-10 21:17:23.967054
NCT03071809|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-09-25|||June 30, 2017|Actual|2017-06-30|June 2017|2017-06-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01||Observational|||"Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and Healthy Controls"|"Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and Healthy Controls"|Recruiting||N/A|400|Anticipated|Lexent Bio, Inc.|||2||f||||f|f|f||||Samples With DNA|"     Whole Blood FFPE (optional)   "|||2017-10-10 21:17:24.243852|2017-10-10 21:17:24.243852
NCT03071796|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-06-22|||March 7, 2017|Actual|2017-03-07|June 2017|2017-06-01|June 20, 2017|Actual|2017-06-20|June 15, 2017|Actual|2017-06-15||Interventional|||Influences of Multivitamin Supplementation on Health Parameters|Influence of Liquid Multivitamin Supplementation on Life Quality, Mood, Perception of Stress and Health-related Vital and Blood Parameters and the Immune System|Completed||N/A|80|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f|f|f||||||No||2017-10-10 21:17:24.348325|2017-10-10 21:17:24.348325
NCT03071783|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-08|||April 2016||2016-04-01|April 2016|2016-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|SVEA||Intra-operative Feed Back on Traction Force During Vacuum Extraction: Safe Vacuum Extraction Alliance|Intra-operative Feed Back on Traction Force During Vacuum Extraction: a Randomized Control Study of Mid and Low Metal Cup Deliveries.|Recruiting||N/A|6000|Anticipated|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 21:17:24.45365|2017-10-10 21:17:24.45365
NCT03071770|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-06-06|||March 31, 2017|Actual|2017-03-31|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|May 9, 2017|Actual|2017-05-09||Interventional|||Japanese Bridging Study of Ivosidenib (AG-120) in Healthy Subjects|A Phase 1, Single-Dose, Open-Label Trial to Evaluate the Pharmacokinetics and Safety of AG-120 in Healthy Male Japanese Subjects Relative to Healthy Male Caucasian Subjects|Active, not recruiting||Phase 1|60|Actual|Agios Pharmaceuticals, Inc.||1|||f||||f|t|f||||||No||2017-10-10 21:17:24.580095|2017-10-10 21:17:24.580095
NCT03071757|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-02|2017-09-29|||April 3, 2017|Actual|2017-04-03|September 2017|2017-09-01|October 27, 2019|Anticipated|2019-10-27|February 15, 2019|Anticipated|2019-02-15||Interventional|||A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors|A Multicenter, Phase 1, Open-Label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|100|Anticipated|AbbVie||4|||f||||f|t|f||||||||2017-10-10 21:17:24.680063|2017-10-10 21:17:24.680063
NCT03071744|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-05-01|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 12, 2018|Anticipated|2018-03-12|March 12, 2018|Anticipated|2018-03-12||Interventional|||Lazanda in Cancer Patients Receiving Palliative Radiation|Phase II, Open-Label Study to Evaluate Lazanda in Cancer Patients Receiving Palliative Radiation|Recruiting||Phase 2|15|Anticipated|University of California, San Diego||1|||f||||t|t|f|||t|||No||2017-10-10 21:17:24.814367|2017-10-10 21:17:24.814367
NCT03071731|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-09|||April 13, 2017|Actual|2017-04-13|May 2017|2017-05-01|March 15, 2018|Anticipated|2018-03-15|March 15, 2018|Anticipated|2018-03-15||Interventional|Glittre||Glittre ADL-test: Responsiveness to Acute Bronchodilation in Chronic Obstructive Pulmonary Disease (COPD)|Glittre Activities of Daily Life-test: Responsiveness to Acute Bronchodilation in Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|34|Anticipated|Laval University||2|||f||||t|f|f||||||Yes|Participant data sets on characterization (muscle and pulmonary function, cardiopulmonary exercise testing) and medical history collected during the recruitment interview will be made available to other researchers after the end of the study, upon request. Data will be obtained through electronical denominalized files.|2017-10-10 21:17:24.918802|2017-10-10 21:17:24.918802
NCT03071718|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-18|||June 2016||2016-06-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|DINAMIC||Diet-induced Arrangement of the Gut Microbiome for Improvement of Cardiometabolic Health|Diet-induced Arrangement of the Gut Microbiome for Improvement of Cardiometabolic Health|Recruiting||N/A|80|Anticipated|Federico II University||2|||f||||t||||||||||2017-10-10 21:17:25.095674|2017-10-10 21:17:25.095674
NCT03071705|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-01|||March 2016||2016-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma|Effect of Metformin in Combination With Tyrosine Kinase Inhibitors (TKI) on Clinical, Biochemical and Nutritional in Patients With Non-Small Cell Lung Carcinoma (NSCLC): Randomized Clinical Trial|Recruiting||N/A|120|Anticipated|Instituto Nacional de Cancerologia de Mexico||2|||f||||f||||||||Undecided|Data will be uploaded to a repository in an anonimized manner to preserve patient confidentiality.|2017-10-10 21:17:25.242927|2017-10-10 21:17:25.242927
NCT03071692|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-23|||March 23, 2017|Actual|2017-03-23|June 2017|2017-06-01|May 2022|Anticipated|2022-05-01|April 2022|Anticipated|2022-04-01||Interventional|PROMINENT||Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)|Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)|Recruiting||Phase 3|10000|Anticipated|Kowa Research Institute, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:17:25.387393|2017-10-10 21:17:25.387393
NCT03071679|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-19|||February 6, 2017|Actual|2017-02-06|May 2017|2017-05-01|March 7, 2017|Actual|2017-03-07|March 7, 2017|Actual|2017-03-07||Interventional|||Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers|A Randomized, Evaluator-blinded, Vehicle-controlled Study to Explore the Pharmacodynamic Effects of Omiganan and Omiganan in Combination With Imiquimod in Healthy Volunteers|Completed||Phase 1|16|Actual|Cutanea Life Sciences, Inc.||5|||f||||f|f|f||||||||2017-10-10 21:17:25.659182|2017-10-10 21:17:25.659182
NCT03071666|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-27|||March 27, 2017|Actual|2017-03-27|March 2017|2017-03-01|December 31, 2021|Anticipated|2021-12-31|June 28, 2021|Anticipated|2021-06-28||Interventional|VitaPreg||Vitamin B12 Supplementation During Pregnancy on Cognitive Development|Supplementation of Vitamin B12 in Pregnancy and Postpartum on Growth and Cognitive Functioning in Early Childhood: A Randomized, Placebo Controlled Trial|Recruiting||Phase 2/Phase 3|600|Anticipated|Centre For International Health||2|||f||||t|f|f||||||Undecided|Individual participant data will be shared with other researchers upon request after completion of the study (data collection) and after publication of the main outcomes. And if the ethical review boards approve the use of the data for other purposes that what is described in the proposal.|2017-10-10 21:17:25.76885|2017-10-10 21:17:25.76885
NCT03071653|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-01|||November 24, 2016|Actual|2016-11-24|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|November 2019|Anticipated|2019-11-01||Interventional|LCSD||Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study|Left Cardiac Sympathetic Denervation (LCSD) for Cardiomyopathy Feasibility Pilot Study|Recruiting||Phase 2|30|Anticipated|University of Cape Town||2|||f||||f|f|f||||||||2017-10-10 21:17:25.926663|2017-10-10 21:17:25.926663
NCT03071640|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-13|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|August 2018|Anticipated|2018-08-01||Observational|||Improving Quality of Life and Function for Older Cancer Patients Receiving Radiotherapy|Improving Quality of Life and Function for Older Cancer Patients Receiving Radiotherapy. Part IC: A Prospective Observational Study|Recruiting||N/A|325|Anticipated|Sykehuset Innlandet HF|||1||f||||f|f|f||||||No||2017-10-10 21:17:26.045007|2017-10-10 21:17:26.045007
NCT03071627|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin By French-speaking Population|Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin: A Randomized Controlled Trial Among French-speaking Population|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:17:26.132297|2017-10-10 21:17:26.132297
NCT03071614|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-09-15|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin By English-speaking Population|Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin: A Randomized Controlled Trial Among English-speaking Population|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:17:26.236275|2017-10-10 21:17:26.236275
NCT03071601|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-20|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|April 2, 2018|Anticipated|2018-04-02|March 1, 2018|Anticipated|2018-03-01||Interventional|||Prospective Evaluation of Topical Analgesia for Laceration Repair in the Emergency Department|Prospective Evaluation of Topical Analgesia Using a Lidocaine/Prilocaine Cream for Laceration Repair in the Emergency Department|Not yet recruiting||Phase 4|126|Anticipated|Centre Hospitalier le Mans||2|||f||||t|f|f|||f|||||2017-10-10 21:17:26.346742|2017-10-10 21:17:26.346742
NCT03071588|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-01|||July 2014|Actual|2014-07-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Assessment of a New Protocol for Indirect Pulp Capping Procedures|Assessment of a New Protocol for Indirect Pulp Capping Procedures|Active, not recruiting||N/A|86|Actual|King's College London||2|||f||||t|f|f||||||No||2017-10-10 21:17:26.467706|2017-10-10 21:17:26.467706
NCT03071575|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-01|||March 9, 2017|Anticipated|2017-03-09|March 2017|2017-03-01|October 27, 2017|Anticipated|2017-10-27|October 27, 2017|Anticipated|2017-10-27||Interventional|||Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age|Assessing Immunogenicity of Measles-Rubella Vaccine at 6 and 9 Months of Age|Not yet recruiting||Phase 4|620|Anticipated|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-10 21:17:26.56541|2017-10-10 21:17:26.56541
NCT03071562|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-07-12|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||A Randomized Pilot Trial Evaluating the Impact of a Yoga Intervention on Cognition in Older Adults Infected With HIV|A Randomized Pilot Trial Evaluating the Impact and Feasibility of a Yoga-Mindfulness Intervention on Cognition, Quality of Life, Balance, Walking Speed, Medication Adherence, and Depression in Older Adults Infected With HIV|Recruiting||N/A|30|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||||2017-10-10 21:17:26.699225|2017-10-10 21:17:26.699225
NCT03071549|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-01|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne|Clinical and Dermoscopic Study Using a Combination of Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Mild to Moderate Acne , A Split Face, Double Blinded, Randomised Controlled Trial|Completed||Phase 3|34|Actual|Cairo University||2|||f||||t|f|f||||||No||2017-10-10 21:17:26.819045|2017-10-10 21:17:26.819045
NCT03071536|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-10-02|||March 25, 2017|Actual|2017-03-25|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|FOSTIK||Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation|Furosemide Stress Test as a Marker of Postoperative Kidney Allograft Function|Recruiting||N/A|50|Anticipated|King Chulalongkorn Memorial Hospital||1|||f||||t|f|f||||||||2017-10-10 21:17:26.904368|2017-10-10 21:17:26.904368
NCT03071510|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-19|||May 18, 2017|Actual|2017-05-18|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|IO-CTNG||Evaluation of the Atlas Genetics io® CTNG System|IO-CTNG: A Multi-Centre Evaluation of the Atlas Genetics io® CTNG System Used in Centralised and Point of Care Settings|Recruiting||N/A|5000|Anticipated|Atlas Genetics Limited|||1||f||||f|f|f||||||||2017-10-10 21:17:27.078804|2017-10-10 21:17:27.078804
NCT03071497|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-03-09|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX|Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX|Recruiting||N/A|300|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:17:27.188211|2017-10-10 21:17:27.188211
NCT03071484|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-01|||October 2016||2016-10-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Transcranial Direct Current Stimulation in Treatment of Cognitive Deficits in Early Stages of Psychosis|Evaluation of the Efficacy of Transcranial Direct Current Stimulation in the Treatment of Cognitive Symptomatology in the Early Stages of Psychosis: Study Protocol of a Double-blind Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|Instituto Bairral de Psiquiatria||2|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:17:27.294816|2017-10-10 21:17:27.294816
NCT03071471|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-01|||June 2014||2014-06-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|2 Years|Observational [Patient Registry]|MID-C||Feasibility Evaluation Study of the MID-C Device|Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Adolescent Idiopathic Scoliosis (AIS)|Completed||N/A|7|Actual|Apifix|||1||f||||f|f|f||||||No||2017-10-10 21:17:27.386344|2017-10-10 21:17:27.386344
NCT03071458|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-03-01|||January 2008||2008-01-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|MUTHEC||Mutational Landscape in Hepatocellular Carcinoma|Translating Molecular Classifications and Genetic Alterations of Hepatocellular Carcinoma in Clinical Care (MUTHEC Project)|Completed||N/A|808|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples With DNA|"     224 tumor (HCC) and 224 non tumor samples from liver transplantation 129 tumor (HCC) and 129     non tumor samples from radio frequency ablation 342 tumor (HCC) and 342 non tumor samples     from liver resection 40 tumor (HCC) and 35 non tumor samples from biopsies of advanced HCC     277 plasmas of 78 patients for circulating tumor DNA analysis   "|No||2017-10-10 21:17:27.457283|2017-10-10 21:17:27.457283
NCT03071445|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-01|||April 2012|Actual|2012-04-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|2 Years|Observational [Patient Registry]|MID-C||Feasibility Study of MID-C for AIS|Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Adolescent Idiopathic Scoliosis (AIS)|Completed||N/A|13|Actual|Apifix|||1||f||||f|f|f||||||No||2017-10-10 21:17:27.682451|2017-10-10 21:17:27.682451
NCT03071432|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-01|||August 30, 2016|Actual|2016-08-30|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Interventional|QUANCAN||QUANtification of Cardiovascular Autonomic Neuropathy (CAN) and the Effects of Anaesthesia on Haemodynamics and Cerebral Perfusion|QUANtification of Cardiovascular Autonomic Neuropathy (CAN) and the Effects of Anaesthesia on Haemodynamics and Cerebral Perfusion|Recruiting||N/A|100|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||f|f|f||||||No||2017-10-10 21:17:27.795943|2017-10-10 21:17:27.795943
NCT03071419|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-03|||December 2016||2016-12-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Nutrition and Parenting Program for Fathers and Their Pre-school Age Children|Father-Focused Nutrition and Parenting Program to Help Prevent Childhood Obesity in Preschool Age Children|Recruiting||N/A|120|Anticipated|University of Connecticut||2|||f||||t||||||||No||2017-10-10 21:17:27.902882|2017-10-10 21:17:27.902882
NCT03071406|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-10-04|||March 3, 2017|Actual|2017-03-03|October 2017|2017-10-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|||Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma|A Phase 2, Randomized, Multi-institutional Study of Nivolumab and Ipilimumab Versus Nivolumab, Ipilimumab and Stereotactic Body Radiation Therapy for Metastatic Merkel Cell Carcinoma|Recruiting||Phase 2|50|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|t|f|||f|||||2017-10-10 21:17:28.045833|2017-10-10 21:17:28.045833
NCT03071393|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-10|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury|Acute Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury|Recruiting||N/A|30|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 21:17:28.205438|2017-10-10 21:17:28.205438
NCT03071380|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-01|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)|Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f|t|f|||f|||Undecided||2017-10-10 21:17:28.360132|2017-10-10 21:17:28.360132
NCT03071367|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-06|||August 20, 2012|Actual|2012-08-20|March 2017|2017-03-01|June 20, 2014|Actual|2014-06-20|February 20, 2014|Actual|2014-02-20||Interventional|||A Comparison of Clinical Simulation and Classical Learning for Airway Management in Medical Students|Title: A Comparison of Clinical Simulation and Classical Learning for Airway Management in Medical Students: a Randomized Controlled Trial|Completed||N/A|102|Actual|Fundación Santa Fe de Bogota||2|||f||||f|f|f||||||No||2017-10-10 21:17:28.472448|2017-10-10 21:17:28.472448
NCT03071354|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-08|||May 1, 2017|Anticipated|2017-05-01|August 2017|2017-08-01|February 1, 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Improving Muscle Function in Nutritionally at Risk, Elderly Patients|Phase II, Multi-center, Randomized Control Trial of Beta- Hydroxy-Methyl-Butyrate (HMB) in Improving Physical Muscle Function, in Nutritionally at Risk, Elderly Patients|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||2||Principal Investigator is Moving Institutions|f||||f|f|f|||f|||||2017-10-10 21:17:28.551967|2017-10-10 21:17:28.551967
NCT03071341|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-01|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I|An Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Patients With Mucopolysaccharidosis I Who Were Previously Enrolled in Studies With AGT-181|Enrolling by invitation||Phase 1/Phase 2|11|Anticipated|ArmaGen, Inc||1|||f||||f|f|f||||||No||2017-10-10 21:17:28.650124|2017-10-10 21:17:28.650124
NCT03071328|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-09-14|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Prostate Cancer|INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Prostate Cancer|Recruiting||Early Phase 1|15|Anticipated|Duke University||3|||f||||f|t|f|||t|||||2017-10-10 21:17:28.743009|2017-10-10 21:17:28.743009
NCT03071315|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-09|||January 20, 2013|Actual|2013-01-20|March 2017|2017-03-01|January 30, 2015|Actual|2015-01-30|January 30, 2015|Actual|2015-01-30||Observational|||Economic Evaluation Comparing CCT With MMT in Hai Phong City, Vietnam|Economic Evaluation Comparing Center-based Compulsory Drug Treatment With Community-based Methadone Maintenance Treatment in Hai Phong City, Vietnam|Completed||N/A|522|Actual|The University of New South Wales|||2||f||||f|f|f||||||No||2017-10-10 21:17:28.853763|2017-10-10 21:17:28.853763
NCT03071302|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-02-28|||August 1, 2015|Actual|2015-08-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Evaluation of Tomographic and Genetic Aspects of Keratoconus Patients Compared to Sounds Corneas|Evaluation of Tomographic and Genetic Aspects of Keratoconus Patients Compared to Sounds Corneas|Completed||N/A|210|Actual|Sao Jose do Rio Preto Medical School||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:17:28.978435|2017-10-10 21:17:28.978435
NCT03071289|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-07-11|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|March 31, 2025|Anticipated|2025-03-31|March 31, 2025|Anticipated|2025-03-31||Interventional|||A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer|Observation Versus Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer: A Phase 3 Prospective Multi-institutional Randomised Controlled Trial|Recruiting||Phase 3|540|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 21:17:29.146463|2017-10-10 21:17:29.146463
NCT03071276|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-13|||January 14, 2016|Actual|2016-01-14|March 2017|2017-03-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia|A Phase I/II Study of the Selective Inhibitor of Nuclear Export Selinexor (KPT-330) in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Leukemia or Myelodysplastic Syndrome|Recruiting||Phase 2|39|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-10 21:17:29.303418|2017-10-10 21:17:29.303418
NCT03071263|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-10-02|||February 13, 2017|Actual|2017-02-13|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|AMBER||Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease|A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease|Recruiting||Phase 2|290|Anticipated|Relypsa, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:17:29.470524|2017-10-10 21:17:29.470524
NCT03071237|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-01|||March 4, 2017|Anticipated|2017-03-04|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|IPA-Origin||The Origin of Infrapyloric Artery|The Origin of Infrapyloric Artery: an Observational Trial|Recruiting||N/A|442|Anticipated|Peking University|||1||f||||f|f|f||||||No||2017-10-10 21:17:29.771397|2017-10-10 21:17:29.771397
NCT03071211|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-03|||January 26, 2017|Actual|2017-01-26|February 2017|2017-02-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Catheter Management After Pelvic Reconstructive Surgery|Catheter Management After Pelvic Reconstructive Surgery: a Randomized Controlled Trial|Recruiting||N/A|96|Anticipated|Hartford Hospital||3|||f||||f|f|f||||||Undecided|At this time, it is undecided if IPD will be made available to other researchers at the end of this study.|2017-10-10 21:17:29.980347|2017-10-10 21:17:29.980347
NCT03071198|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-06|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy|Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy for T3-4N0-2M0 Middle and Lower Rectal Cancer|Recruiting||N/A|1|Anticipated|Harbin Medical University||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:17:30.116703|2017-10-10 21:17:30.116703
NCT03071185|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-07|||January 20, 2017|Actual|2017-01-20|March 2017|2017-03-01|April 30, 2017|Anticipated|2017-04-30|April 30, 2017|Anticipated|2017-04-30||Interventional|||The Efficacy and Safety of Lower Limb Nerve Blocks in Postoperative Analgesia for the Free Flap Donor Sites|The Efficacy and Safety of Lower Limb Nerve Blocks in Postoperative Analgesia for the Free Flap Donor Sites|Recruiting||N/A|40|Anticipated|China Medical University, China||2|||f||||f|f|f||||||No||2017-10-10 21:17:30.233372|2017-10-10 21:17:30.233372
NCT03071172|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-28|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET|Clinical Study of Recombinant Human Follitropin for Injection Assisted in Controlled Ovarian Hyperstimulation Assisted IVF-ET|Not yet recruiting||Phase 3|252|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 21:17:30.340767|2017-10-10 21:17:30.340767
NCT03071159|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-03-01|||March 10, 2017|Anticipated|2017-03-10|February 2017|2017-02-01|March 10, 2018|Anticipated|2018-03-10|March 10, 2018|Anticipated|2018-03-10||Interventional|||An Evaluation of the FreeStyle Libre Flash Glucose Monitoring System|A Medium-term Evaluation of the Use, the Identified Problems, the Usability and the Effect on the Metabolic Control of the FreeStyle Flash Libre Glucose Monitoring System|Not yet recruiting||N/A|90|Anticipated|Jessa Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:17:30.487235|2017-10-10 21:17:30.487235
NCT03071146|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-02|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 4, 2017|Actual|2017-05-04||Observational|REALITY III||Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System|A Prospective Study of the Performance of the Bard LifeStent 5F Vascular Stent System|Active, not recruiting||N/A|30|Actual|C. R. Bard|||1||f||||f|f|f||||||||2017-10-10 21:17:30.563287|2017-10-10 21:17:30.563287
NCT03071133|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-09-26|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|November 20, 2019|Anticipated|2019-11-20|November 20, 2019|Anticipated|2019-11-20||Observational|||Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy|Asunaprevir/Daclatasvir/Beclabuvir Fixed-Dose Combination Safety Surveillance in Japanese Patients With Chronic Hepatitis C (HCV) or Japanese Patients With Compensated Cirrhosis|Recruiting||N/A|1000|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:17:30.651813|2017-10-10 21:17:30.651813
NCT03071120|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-06-02|||February 3, 2017|Actual|2017-02-03|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Parent-Mediated Intervention for Families With Children With Autism and Feeding Challenges|Parent-Mediated Intervention for Families With Children With Autism and Feeding Challenges|Recruiting||N/A|17|Anticipated|University of Wisconsin, Madison||1|||f||||f|f|f||||||No||2017-10-10 21:17:30.735976|2017-10-10 21:17:30.735976
NCT03071107|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-02-28|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|FITNESS||Frailty Intervention Trial in End-Stage Patients on Dialysis|Frailty Intervention Trial in End-Stage Patients on Dialysis: A Feasibility Study|Not yet recruiting||N/A|50|Anticipated|University Hospital Birmingham NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 21:17:30.845044|2017-10-10 21:17:30.845044
NCT03071094|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-07-04|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)|A Phase I/IIa Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)|Recruiting||Phase 1/Phase 2|30|Anticipated|Transgene||1|||f||||t|t|f|||f|||||2017-10-10 21:17:30.919984|2017-10-10 21:17:30.919984
NCT03071081|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-07-06|||February 8, 2017|Actual|2017-02-08|July 2017|2017-07-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|||Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects|A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of TOP1288 Oral Single Ascending and Multiple Doses in Healthy Volunteers|Completed||Phase 1|36|Anticipated|Topivert Pharma Ltd||6|||f||||t|f|f||||||||2017-10-10 21:17:31.003197|2017-10-10 21:17:31.003197
NCT03071068|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-06-09|||December 2016||2016-12-01|June 2017|2017-06-01||||April 2018|Anticipated|2018-04-01||Interventional|||A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)|A Phase 2, Single-masked, Multicentre Study to Evaluate the Safety and Efficacy of 2 Dose Levels of THR-317 for the Treatment of Diabetic Macular Oedema (DME)|Recruiting||Phase 2|50|Anticipated|ThromboGenics||2|||f||||||||||||||2017-10-10 21:17:31.102117|2017-10-10 21:17:31.102117
NCT03071055|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-02-28|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|June 1, 2018|Anticipated|2018-06-01||Interventional|||Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF|Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF Therapy Comparing Syringe Preparation Time Using Ranibizumab Vial and Pre-filled Syringe|Not yet recruiting||Phase 2|20|Anticipated|Southeast Clinical Research Associates, LLC||2|||f||||f|t|f||||||No||2017-10-10 21:17:31.229761|2017-10-10 21:17:31.229761
NCT03071042|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2017-02-28|||October 2015||2015-10-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma|A Phase I Dose Escalation Clinical Trial of Apatinib Tablets Plus Docetaxel as Second-line Treatment in Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma|Recruiting||Phase 1|12|Anticipated|Sir Run Run Shaw Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:17:31.33507|2017-10-10 21:17:31.33507
NCT03071029|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-05-05|||July 2016||2016-07-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||PAFP Provider Feedback Trial in Nepal|Applying Behavioural Insights to Improve Take up of Post-abortion Family Planning: In-depth Study in Nepal|Completed||N/A|12000|Actual|Marie Stopes International||2|||f||||f||||||||||2017-10-10 21:17:31.425763|2017-10-10 21:17:31.425763
NCT03071016|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-10-05|||March 4, 2017|Actual|2017-03-04|October 2017|2017-10-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30|6 Months|Observational [Patient Registry]|FOREFRONT||Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian Patients|Usage of Dapagliflozin - a Sodium Glucose Co-transporter Inhibitor, in the managEment of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian Patients|Recruiting||N/A|2000|Anticipated|AstraZeneca|||1||f||||f|f|f||||None Retained|"     no samples retained   "|||2017-10-10 21:17:31.829066|2017-10-10 21:17:31.829066
NCT03071003|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-28|||October 27, 2016|Actual|2016-10-27|February 2017|2017-02-01|June 13, 2017|Anticipated|2017-06-13|April 26, 2017|Anticipated|2017-04-26||Interventional|||A Study of SENS 401 in Healthy Subjects|A Randomised Double Blind, Multiple Dose, Pharmacokinetic and Safety Study of SENS 401 in Healthy Subjects|Active, not recruiting||Phase 1|36|Actual|Simbec Research||3|||f||||f|f|f||||||No||2017-10-10 21:17:32.066363|2017-10-10 21:17:32.066363
NCT03070990|ClinicalTrials.gov processed this data on October 10, 2017|2017-03-01|2017-07-18|||April 24, 2017|Actual|2017-04-24|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma|An Open-label, Randomized, Phase 1 Safety and Pharmacokinetic Study of Enfortumab Vedotin (ASG-22CE) in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma|Recruiting||Phase 1|16|Anticipated|Astellas Pharma Inc||2|||f||||t|t|f|||t|||||2017-10-10 21:17:32.205358|2017-10-10 21:17:32.205358
NCT03070977|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-03-03|||November 2016||2016-11-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|May 2018|Anticipated|2018-05-01||Interventional|||Interprofessional Training in a Psychiatric Study Unit|Interprofessional Training in a Psychiatric Study Unit|Recruiting||N/A|190|Anticipated|Psychiatric Research Unit, Region Zealand, Denmark||2|||f||||f||||||||No||2017-10-10 21:17:32.377068|2017-10-10 21:17:32.377068
NCT03070964|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-10-05|||November 2016||2016-11-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma|A Phase II Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma|Recruiting||Phase 2|60|Anticipated|PharmaMar||1|||f||||t||||||||||2017-10-10 21:17:32.52939|2017-10-10 21:17:32.52939
NCT03070769|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-03|||June 1, 2012|Actual|2012-06-01|March 2017|2017-03-01|December 12, 2016|Actual|2016-12-12|June 1, 2016|Actual|2016-06-01||Observational|||Inflammatory Markers in Obstructive Sleep Apnea (OSA) Patients.|Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients|Completed||N/A|1053|Actual|University of Crete|||2||f|||||f|f||||||Undecided||2017-10-10 21:17:35.444421|2017-10-10 21:17:35.444421
NCT03070951|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-09-21|||May 23, 2017|Actual|2017-05-23|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|April 2019|Anticipated|2019-04-01||Interventional|PRIMROSE 2||Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids|A Phase 3, Multicentre, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Daily Oral Administration of OBE2109 Alone and in Combination With Add-back Therapy for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women|Recruiting||Phase 3|500|Anticipated|ObsEva SA||5|||f||||t|t|f||||||||2017-10-10 21:17:32.765413|2017-10-10 21:17:32.765413
NCT03070938|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-29|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|PuraPlyAM||PuraPly™ Antimicrobial Wound Matrix and Wound Management|A Prospective, Observational Study of the Use of PuraPly™ Antimicrobial in the Management of Wounds|Recruiting||N/A|100|Anticipated|Organogenesis|||1||f||||f|f|t|f|f|f|||||2017-10-10 21:17:33.039779|2017-10-10 21:17:33.039779
NCT03070925|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-08-29|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Observational|||Prospective PuraPly™ AM Case Series Study|A Prospective, Observational Study of the Use of PuraPly™ Antimicrobial (PuraPly AM) in the Management of Wounds|Completed||N/A|43|Actual|Organogenesis|||1||f||||f|f|t|f|f|f|||||2017-10-10 21:17:33.172773|2017-10-10 21:17:33.172773
NCT03070912|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-07-04|||September 30, 2017|Anticipated|2017-09-30|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|WITECMO-H||Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients|Study of the Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients of a Veino Arterial or Veinous ECMO|Not yet recruiting||N/A|130|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||||2017-10-10 21:17:33.282199|2017-10-10 21:17:33.282199
NCT03070899|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-09-19|||April 20, 2017|Actual|2017-04-20|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|July 2019|Anticipated|2019-07-01||Interventional|PRIMROSE 1||Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids|A Phase 3, Multicentre, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Daily Oral Administration of OBE2109 Alone and in Combination With Add-back Therapy for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women|Recruiting||Phase 3|500|Anticipated|ObsEva SA||5|||f||||t|t|f||||||||2017-10-10 21:17:33.393653|2017-10-10 21:17:33.393653
NCT03070886|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-02-28|||January 16, 2017|Actual|2017-01-16|February 2017|2017-02-01||||May 2026|Anticipated|2026-05-01||Interventional|||Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery|Phase II-III Trial of Adjuvant Radiotherapy Following Radical Prostatectomy With or Without Adjuvant Docetaxel|Recruiting||Phase 2/Phase 3|612|Anticipated|NRG Oncology||2|||f||||f|t|f|||f|||||2017-10-10 21:17:33.746447|2017-10-10 21:17:33.746447
NCT03070873|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-28|||January 1, 2010|Actual|2010-01-01|February 2017|2017-02-01|January 30, 2014|Actual|2014-01-30|January 30, 2014|Actual|2014-01-30||Interventional|mesh||Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift|Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift|Completed||N/A|258|Actual|Nanjing Medical University||3|||f||||t|f|t|f|f|t|||Yes||2017-10-10 21:17:33.947516|2017-10-10 21:17:33.947516
NCT03070860|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-05-16|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|GOCAPXE||What's Happen Under the Calcification Process in Pseudoxanthoma Elasticum|Glucidic Metabolism, Ossification and Arterial Calcification During PseudoXanthoma Elasticum (PXE)|Recruiting||N/A|17|Anticipated|University Hospital, Angers||1|||f||||f||||||||Undecided||2017-10-10 21:17:34.072115|2017-10-10 21:17:34.072115
NCT03070847|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-28|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Low vs. Very Low Dose of Prophylactic Tranexamic Acid for Bleeding Reduction During Rhinoplasty|Impact of Prophylactic Tranexamic Acid on Intra and Postoperational Bleeding Reduction in Patients Undergoing Rhinoplasty Surgery. Low (10mg/kg) and Very Low (5mg/kg) Dose Comparison|Recruiting||Phase 4|50|Anticipated|Centre of Postgraduate Medical Education||2|||f||||f|f|f|||f|||||2017-10-10 21:17:34.758506|2017-10-10 21:17:34.758506
NCT03070834|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-23|||July 1, 2017|Actual|2017-07-01|January 2017|2017-01-01|January 1, 2020|Anticipated|2020-01-01|July 1, 2019|Anticipated|2019-07-01||Interventional|RIPT||RIPT Feasibility Trial|Retrievable Inferior Vena Cava Filter for Primary Pulmonary Embolism Prophylaxis in At-Risk Trauma Patients: RIPT Feasibility Trial|Recruiting||N/A|42|Anticipated|Lawson Health Research Institute||2|||f|||||f|t|f||t|||||2017-10-10 21:17:34.869605|2017-10-10 21:17:34.869605
NCT03070821|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-28|||January 30, 2013|Actual|2013-01-30|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Therapy of Alzheimer's Disease With Neurofeedback|Neurofeedback and Follow-up With Real-time fMRI to Investigate Cognitive Function in Patients of Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD)|Completed||N/A|30|Actual|University Hospital, Aachen||3|||f||||f|f|f||||||No||2017-10-10 21:17:34.966412|2017-10-10 21:17:34.966412
NCT03070808|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-03|||March 15, 2017|Anticipated|2017-03-15|February 2017|2017-02-01|September 15, 2018|Anticipated|2018-09-15|March 15, 2018|Anticipated|2018-03-15||Observational|||The Influence of Significant Weight Lost on the Quality of Voice|The Influence of Significant Weight Lost on the Quality of Voice|Not yet recruiting||N/A|50|Anticipated|Kaplan Medical Center|||1||f|||||f|f||||||Undecided||2017-10-10 21:17:35.076091|2017-10-10 21:17:35.076091
NCT03070795|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-07|||February 23, 2017|Actual|2017-02-23|March 2017|2017-03-01|August 20, 2017|Anticipated|2017-08-20|June 20, 2017|Anticipated|2017-06-20||Interventional|||Outcomes of Early Versus Delayed Oral Feeding After Cesarean Section in Korle-bu Teaching Hospital|Outcomes of Early Versus Delayed Oral Feeding After Elective Cesarean Section in a Teaching Hospital in Ghana.|Recruiting||N/A|170|Anticipated|University of Ghana Medical School||2|||f||||t|f|f||||||Undecided||2017-10-10 21:17:35.163497|2017-10-10 21:17:35.163497
NCT03070782|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-31|||March 7, 2017|Actual|2017-03-07|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Patients With Hyperlipoproteinemia(a) and Cardiovascular Disease|A Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) Administered Subcutaneously to Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease (CVD)|Recruiting||Phase 2|270|Anticipated|Ionis Pharmaceuticals, Inc.||6|||f||||t|t|f||||||||2017-10-10 21:17:35.26749|2017-10-10 21:17:35.26749
NCT03070756|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-02-28|||October 2016||2016-10-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Extended Evaluation of the Efficacy of a Proactive FOT-based Auto-CPAP Algorithm|Extended Evaluation of the Efficacy of a Proactive FOT-based Auto-CPAP Algorithm in Patients With Predominantly Obstructive Sleep Apnea|Recruiting||N/A|64|Anticipated|Heinen und Löwenstein GmbH & Co. KG||1|||f||||f||||||||No||2017-10-10 21:17:35.53656|2017-10-10 21:17:35.53656
NCT03070743|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-02-28|||July 2015||2015-07-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Observational|PCDR-BIAAD||Posterior Compression Distraction Reduction Technique System in the Treatment of BI-AAD||Recruiting||N/A|20|Anticipated|Xuanwu Hospital, Beijing|||1||f||||t||||||||Undecided||2017-10-10 21:17:35.626733|2017-10-10 21:17:35.626733
NCT03070730|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-04-13|2017-04-12||August 15, 2011|Actual|2011-08-15|April 2017|2017-04-01|July 28, 2014|Actual|2014-07-28|December 18, 2012|Actual|2012-12-18||Interventional||Participants that were enrolled in the study were not randomized. They did not meet eligibility criteria, or decided not to participate.|Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist|A Double-Blinded, Placebo-Controlled Study To Assess Hemodynamic Changes, Orthostatic Tolerance, Out-Patient Fatigue And Quality Of Life In Neuropathic And Non-Neuropathic POTS Patients In Response To Adrenoreceptor Agonist And Antagonist|Terminated||Phase 1/Phase 2|8|Actual|Beth Israel Deaconess Medical Center|The trial was terminated early due to difficulties in the recruitment process. Subjects were found to be ineligible, or decided not to participate in the study.|3||Recruitment was slow and subjects declined participation after signing the ICF.|f||||f||||||||Yes|NIH Grant Policy on Sharing of Unique Research Resources including the Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources.|2017-10-10 21:17:35.733685|2017-10-10 21:17:35.733685
NCT03070717|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-02-28|||June 12, 2014|Actual|2014-06-12|February 2017|2017-02-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2019|Anticipated|2019-05-15||Observational|HELP||High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)|High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)|Active, not recruiting||N/A|153|Actual|Novartis|||1||f||||f||||||Samples With DNA|"     Whole blood, Serum   "|||2017-10-10 21:17:39.507219|2017-10-10 21:17:39.507219
NCT03070704|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-01|||August 16, 2017|Anticipated|2017-08-16|August 2017|2017-08-01|August 16, 2019|Anticipated|2019-08-16|March 1, 2019|Anticipated|2019-03-01||Observational|||Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India|A Multi-centre, Prospective, Open-label, Single-arm, Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India|Withdrawn||N/A|0|Actual|Novo Nordisk A/S|||1|Request for the study waived by Indian Health Authorities|f||||f|t|f|||f|||||2017-10-10 21:17:39.62991|2017-10-10 21:17:39.62991
NCT03070691|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-06|2017-05-03||||||February 2017|2017-02-01||||||||Interventional|||Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)|A Randomized, Double-blind, Vehicle-controlled, Multicenter Trial of Topically Administered LDE225 Cream (0.75% Bid) to Evaluate Clearance of Basal Cell Carcinoma in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome|Withdrawn||Phase 2/Phase 3|0|Actual|Novartis||2|||f|||||f|f||||||||2017-10-10 21:17:39.810557|2017-10-10 21:17:39.810557
NCT03070678|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-06-06|||March 14, 2017|Actual|2017-03-14|June 2017|2017-06-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|||Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects|Open-label, Cross Over, Single-sequence, Two Periods Phase 1 Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose Mefenamic Acid, a Known UGT1A9 Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Single-dose Sotagliflozin in Healthy Male and Female Subjects|Completed||Phase 1|16|Actual|Sanofi||1|||f||||f|t|f||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:17:39.992635|2017-10-10 21:17:39.992635
NCT03070665|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-04-24|||April 1, 2017|Actual|2017-04-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|October 1, 2018|Anticipated|2018-10-01||Interventional|||Blood Pressure During ESD is Related With the Postoperative Bleeding|Increasing Blood Pressure During Gastric ESD May Control the Risk of Postoperative Bleeding: a Prospective Randomized Trial|Recruiting||N/A|296|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:17:40.077444|2017-10-10 21:17:40.077444
NCT03070652|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-10|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|July 31, 2019|Anticipated|2019-07-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||What Are the Effects of Supporting Early Parenting by Increasing the Understanding of the Infant?|What Are the Effects of Supporting Early Parenting by Increasing the Understanding of the Infant? A Randomized Community Based Trial|Recruiting||N/A|2730|Anticipated|University of Aarhus||2|||f||||||||||||||2017-10-10 21:17:40.190242|2017-10-10 21:17:40.190242
NCT03070639|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-21|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Enhancing Safe Sleep Practices of Urban Low-Income Mothers|Enhancing Safe Sleep Practices of Urban Low-Income Mothers|Completed||N/A|214|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||f||||||||||2017-10-10 21:17:40.284958|2017-10-10 21:17:40.284958
NCT03070626|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-03-24|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Preoperative Loading With Carbohydrates in Lung Cancer Surgery|Preoperative Loading With Carbohydrates in Lung Cancer Surgery|Recruiting||N/A|104|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:17:40.365413|2017-10-10 21:17:40.365413
NCT03070236|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-15|||October 13, 2017|Anticipated|2017-10-13|September 2017|2017-09-01|February 25, 2022|Anticipated|2022-02-25|February 25, 2020|Anticipated|2020-02-25||Interventional|||PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions|PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions|Not yet recruiting||N/A|1200|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|f|f||||||||2017-10-10 21:17:44.012771|2017-10-10 21:17:44.012771
NCT03070613|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-07-13|||April 23, 2017|Actual|2017-04-23|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery|Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery|Enrolling by invitation||Early Phase 1|50|Anticipated|University of Oxford||1|||f||||f|f|f||||||||2017-10-10 21:17:40.456703|2017-10-10 21:17:40.456703
NCT03070600|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-02-27|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|April 2021|Anticipated|2021-04-01|May 2020|Anticipated|2020-05-01||Interventional|PrIMA||PrEP Implementation for Mothers in Antenatal Care|Delivering PrEP in Pregnancy|Not yet recruiting||Phase 4|4000|Anticipated|University of Washington||2|||f||||f|t|f|||f|||||2017-10-10 21:17:40.527948|2017-10-10 21:17:40.527948
NCT03070587|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-02|||December 2016||2016-12-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study of Loving-Kindness Meditation for Social Anxiety Disorder|Effect of Mindfulness and Loving Kindness Meditation on Symptoms of Social Anxiety Disorder|Recruiting||N/A|60|Anticipated|Komazawa University||2|||f||||f||||||||No||2017-10-10 21:17:40.612553|2017-10-10 21:17:40.612553
NCT03070574|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-19|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2024|Anticipated|2024-09-01|September 2020|Anticipated|2020-09-01||Interventional|MesaCAPP||Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome|Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome - MesaCAPP|Recruiting||Phase 2|540|Anticipated|Medical University of Vienna||3|||f||||f|f|f|||f|||||2017-10-10 21:17:40.715016|2017-10-10 21:17:40.715016
NCT03070561|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-02-28|||January 14, 2014|Actual|2014-01-14|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluating Peanut Immunotherapy Dissolving Film in Healthy Subjects|Evaluating the Placement of a Peanut Immunotherapy Dissolving Film in Healthy Subjects|Completed||Early Phase 1|9|Actual|Johns Hopkins University||1|||f||||f|t|f||||||No||2017-10-10 21:17:40.823854|2017-10-10 21:17:40.823854
NCT03070548|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-23|||September 27, 2016|Actual|2016-09-27|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 1, 2017|Actual|2017-06-01||Interventional|||A Study of Talazoparib in Patients With Advanced Solid Tumors|A Phase 1 Open-label Study Of 14c-labeled Talazoparib In Patients With Advanced Solid Tumors|Completed||Phase 1|2|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 21:17:40.915713|2017-10-10 21:17:40.915713
NCT03070535|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-02-27|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||APOE Genotype and Diet Influences on Alzheimer's Biomarkers|APOE Genotype and Diet Influences on Alzheimer's Biomarkers|Recruiting||N/A|80|Anticipated|University of Washington||2|||f||||t|f|f||||||Undecided||2017-10-10 21:17:41.000811|2017-10-10 21:17:41.000811
NCT03070522|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-28|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|PIPE||Prednisone in Cystic Fibrosis Pulmonary Exacerbations|Randomized Controlled Trial of Prednisone in Cystic Fibrosis Pulmonary Exacerbations|Not yet recruiting||Phase 3|84|Anticipated|The Hospital for Sick Children||2|||f||||t|f|f||||||No||2017-10-10 21:17:41.083488|2017-10-10 21:17:41.083488
NCT03070509|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-12|||May 12, 2017|Actual|2017-05-12|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients|Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients|Recruiting||Phase 4|20|Anticipated|North Dakota State University||2|||f||||f|t|f|||f|||No||2017-10-10 21:17:41.16609|2017-10-10 21:17:41.16609
NCT03070496|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-07-27|||March 7, 2017|Actual|2017-03-07|February 2017|2017-02-01|March 7, 2022|Anticipated|2022-03-07|March 7, 2022|Anticipated|2022-03-07||Interventional|HIBISCUS-STEMI||Multicenter Cohort of STEMI Patients|CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in ST Elevation Myocardial Infarction|Recruiting||N/A|500|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:17:41.248179|2017-10-10 21:17:41.248179
NCT03070483|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-24|||January 1, 2018|Anticipated|2018-01-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|BBC||Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study|Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study|Not yet recruiting||Phase 2|15|Anticipated|Loyola University||1|||f||||t|t|f|||t|||||2017-10-10 21:17:41.358037|2017-10-10 21:17:41.358037
NCT03070470|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-30|||March 14, 2017|Actual|2017-03-14|August 2017|2017-08-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||CiPA Phase 1 ECG Biomarker Validation Study|Comprehensive in Vitro Proarrhythmia Assay (CiPA) Clinical Phase 1 ECG Biomarker Validation Study (CiPA Phase 1 ECG Biomarker Study)|Completed||Phase 1|57|Actual|Food and Drug Administration (FDA)||6|||f||||f|t|f|||f|||||2017-10-10 21:17:41.561457|2017-10-10 21:17:41.561457
NCT03070457|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-02-28|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Safety of an Early Discharge Protocol After Sleeve Gastrectomy|Safety of an Early Discharge Protocol After Sleeve Gastrectomy. Randomised Clinical Trial|Not yet recruiting||N/A|60|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t|f|f||||||Undecided||2017-10-10 21:17:42.072889|2017-10-10 21:17:42.072889
NCT03070444|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-07|||November 12, 2009|Actual|2009-11-12|January 2017|2017-01-01|June 10, 2021|Anticipated|2021-06-10|June 10, 2021|Anticipated|2021-06-10||Interventional|||Vacuum-formed Retainer Versus Bonded Retainer to Prevent Relapse After Orthodontic Treatment|Vacuum-formed Retainer Versus Bonded Retainer to Prevent Relapse After Orthodontic Treatment - A Randomized Controlled Trial About Stability and Patients' Perceptions|Active, not recruiting||N/A|104|Actual|Region Gävleborg||2|||f||||f||||||||Undecided||2017-10-10 21:17:42.176546|2017-10-10 21:17:42.176546
NCT03070431|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-02-27|||January 15, 2017|Actual|2017-01-15|February 2017|2017-02-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|PRE-MODE||High-precision Radiotherapy of Motor Deficits Due to Metastatic Spinal Cord Compression|High-precision Radiotherapy of Motor Deficits Due to Metastatic Spinal Cord Compression|Recruiting||N/A|44|Anticipated|University of Schleswig-Holstein||1|||f||||t|f|f||||||Undecided||2017-10-10 21:17:42.295023|2017-10-10 21:17:42.295023
NCT03070418|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-02-28|||June 2010||2010-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|MIDHST||Mini Incision Dynamic Hip Screw Technique|Mini Incision Dynamic Hip Screw Technique|Completed||N/A|65|Actual|Issa, Abdulhamid Sayed, M.D.||1|||f||||t||||||||Yes||2017-10-10 21:17:42.412709|2017-10-10 21:17:42.412709
NCT03070405|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-02|||October 2016||2016-10-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects|An Open-label, Randomized, Crossover Study to Evaluate the Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects|Active, not recruiting||Phase 1|20|Anticipated|Inje University||2|||f||||||||||||No||2017-10-10 21:17:42.498277|2017-10-10 21:17:42.498277
NCT03070379|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-02|||February 20, 2017|Actual|2017-02-20|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Topical Pharyngeal Anesthesia in Sedated Esophagogastroduodenoscopy|The Application of Topical Pharyngeal Anesthesia in the Esophagogastroduodenoscopy Under Sedation|Recruiting||N/A|300|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t|f|f||||||No||2017-10-10 21:17:42.772683|2017-10-10 21:17:42.772683
NCT03070366|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-28|||September 2016||2016-09-01|February 2017|2017-02-01|October 2021|Anticipated|2021-10-01|September 2020|Anticipated|2020-09-01||Interventional|OMET||Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC|Randomized Phase II Trial Comparing Chemotherapy Combined With Stereotactic Radiotherapy and Stereotactic Radiotherapy Alone, for Treatment of Oligometastases in Squamous Cell Cancers of the Upper Aerodigestive Tract|Recruiting||Phase 2|78|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||2|||f||||t||||||||Yes|The Data Monitoring Committee will meet every year either by a physical meeting or by conference call. Data on the recruitment, toxicity and autonomy are submitted every year.|2017-10-10 21:17:42.872866|2017-10-10 21:17:42.872866
NCT03070353|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-02-28|||July 1, 2015|Actual|2015-07-01|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury|Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury|Completed||Phase 2/Phase 3|10|Actual|Ramathibodi Hospital||1|||f||||f|f|f||||||No|IPD will be provided if directly contact with investigator|2017-10-10 21:17:42.982725|2017-10-10 21:17:42.982725
NCT03070340|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-19|||February 28, 2017|Actual|2017-02-28|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery|Comparison of Breast Magnetic Resonance Imaging (MRI) and Contrast Enhanced Mammography (CEDM) to Evaluate Residual Disease Extent After Neoadjuvant Therapy (NAT)|Recruiting||N/A|125|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||f|f||||||Undecided||2017-10-10 21:17:43.064264|2017-10-10 21:17:43.064264
NCT03070327|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-07|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma|A Phase I Trial of B-cell Maturation Antigen (BCMA) Targeted EGFRt/BCMA-41BBz Chimeric Antigen Receptor (CAR) Modified T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma (MM)|Recruiting||Phase 1|36|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:17:43.177459|2017-10-10 21:17:43.177459
NCT03070314|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-28|||February 20, 2017|Actual|2017-02-20|February 2017|2017-02-01|November 30, 2017|Anticipated|2017-11-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Echinaforce Junior Bioavailability Trial|Bioavailability of an Echinacea Product (Echinaforce® Junior) in Children With a Common Cold, Aged 4-12 Years After Intake of a Daily Dosage|Recruiting||Phase 4|18|Anticipated|Bioforce AG||1|||f||||t|f|f||||||No||2017-10-10 21:17:43.297919|2017-10-10 21:17:43.297919
NCT03070301|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-25|||February 27, 2017|Actual|2017-02-27|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors|A Phase II Trial of LEE011 in Combination With Everolimus in the Treatment of Advanced Well Differentiated Neuroendocrine Tumors of Foregut Origin|Recruiting||Phase 2|42|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:17:43.398594|2017-10-10 21:17:43.398594
NCT03070288|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-28|||January 2015||2015-01-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|||RGB(Red- Green-Blue) Measurement of the Nasal Mucosal Image|RGB(Red- Green-Blue) Measurement of the Nasal Mucosal Image: A New Diagnostic Parameter for Allergic Rhinitis|Completed||N/A|146|Actual|Bezmialem Vakif University|||2||f||||||||||||No||2017-10-10 21:17:43.527394|2017-10-10 21:17:43.527394
NCT03070275|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-02-28|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|Implant_bone||Dental Implant Placement in Adjunction With Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs)|Preservation of Alveolar Crestal Bone From Implant Placement to Implant Exposure Using Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs)|Active, not recruiting||Phase 1/Phase 2|20|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||No||2017-10-10 21:17:43.653078|2017-10-10 21:17:43.653078
NCT03070262|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-02-28|||January 2017||2017-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|CAEC||The Efficacy and Safety of Caffeic Acid for Esophageal Cancer|Caffeic Acid for Advanced Esophageal Squamous Cell Cancer: A Randomized, Double-blind, and Multicenter Trial in Chinese Patients|Enrolling by invitation||Phase 3|300|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology||2|||f||||t||||||||Undecided||2017-10-10 21:17:43.774574|2017-10-10 21:17:43.774574
NCT03070249|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-25|||April 13, 2017|Actual|2017-04-13|April 2017|2017-04-01|October 10, 2017|Anticipated|2017-10-10|April 25, 2017|Actual|2017-04-25||Observational|||Compassion Fatigue in ED Providers|Compassion Fatigue Among Emergency Department Healthcare Providers|Active, not recruiting||N/A|100|Actual|University of Florida|||1||f||||f|f|f||||||No||2017-10-10 21:17:43.915984|2017-10-10 21:17:43.915984
NCT03070223|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-01|||February 28, 2017|Actual|2017-02-28|May 2017|2017-05-01|February 28, 2023|Anticipated|2023-02-28|February 28, 2023|Anticipated|2023-02-28||Observational|PREPARE||PREPARE (A5361s) Substudy of REPRIEVE (A5332)|Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)|Recruiting||N/A|600|Anticipated|AIDS Clinical Trials Group|||2||f||||t|t|f||||||No||2017-10-10 21:17:44.13999|2017-10-10 21:17:44.13999
NCT03070210|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-04|||January 25, 2017|Actual|2017-01-25|March 2017|2017-03-01|July 25, 2019|Anticipated|2019-07-25|January 25, 2019|Anticipated|2019-01-25||Interventional|||Clinical Trial to Evaluate the Endoscopic Ultrasound Guided Celiac Plexus Block for Treatment of Pain in Chronic Pancreatitis|A Randomized, Controlled Trial of Endoscopic Ultrasound Guided Celiac Plexus Blockade (EUS-CPB) With Standard Plexus Injection vs. Direct Celiac Ganglia Block for Treatment of Pain in Chronic Pancreatitis.|Recruiting||N/A|86|Anticipated|The Cleveland Clinic||2|||f||||t|f|f||||||No||2017-10-10 21:17:44.385699|2017-10-10 21:17:44.385699
NCT03070197|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-18|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|||Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes)|Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease|Recruiting||N/A|400|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||t|f|f||||||||2017-10-10 21:17:44.517313|2017-10-10 21:17:44.517313
NCT03070184|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-05-03|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Response of Natriuretic Peptide to Exercise and Beta-blockers|Racial Differences in the Natriuretic Peptide Response to Exercise and Beta-blockers|Recruiting||Phase 1|80|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f||||||Undecided||2017-10-10 21:17:44.687226|2017-10-10 21:17:44.687226
NCT03070171|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-07-18|||March 21, 2017|Actual|2017-03-21|July 2017|2017-07-01|June 20, 2017|Actual|2017-06-20|June 16, 2017|Actual|2017-06-16||Interventional|||Pradaxa Tablet BE Study in Japan|Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male Subjects (an Open-label, Randomised, Single-dose, Replicate Design in a Two-treatment, Four-period, Two-sequence Crossover Study)|Completed||Phase 1|160|Actual|Boehringer Ingelheim||2|||f|||||f|f||||||||2017-10-10 21:17:44.834883|2017-10-10 21:17:44.834883
NCT03070158|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-02-28|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Affective Bonding in Mothers and Their Premature Newborn|Efficacy of a Nursing Intervention in the Mother-premature Infant Affective Bond|Not yet recruiting||N/A|148|Anticipated|Universidad Industrial de Santander||2|||f||||t|f|f||||||No||2017-10-10 21:17:44.940067|2017-10-10 21:17:44.940067
NCT03070145|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-26|||August 17, 2017|Anticipated|2017-08-17|June 2017|2017-06-01|February 25, 2022|Anticipated|2022-02-25|February 25, 2020|Anticipated|2020-02-25||Interventional|||Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy|Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy: A Pilot Study|Not yet recruiting||N/A|40|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|f|f||||||No||2017-10-10 21:17:45.225948|2017-10-10 21:17:45.225948
NCT03070132|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-23|||April 30, 2018|Anticipated|2018-04-30|May 2017|2017-05-01|May 13, 2021|Anticipated|2021-05-13|May 13, 2021|Anticipated|2021-05-13||Interventional|||Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia|A Phase 3 Placebo-Controlled, Double-Blind Randomized Withdrawal Study to Evaluate the Efficacy and Safety of BIIB074 in Subjects With Trigeminal Neuralgia|Not yet recruiting||Phase 3|88|Anticipated|Biogen||2|||f||||t|t|f||||||||2017-10-10 21:17:45.34863|2017-10-10 21:17:45.34863
NCT03070106|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-06-27|||March 5, 2017|Actual|2017-03-05|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|||Diabetes: Functional Medicine Approach vs. Usual Care|Assessment of Diabetes Control, Cost of Care, and Quality of Life Utilizing a Functional Medicine Approach in Addition to Usual Care vs. Usual Care Alone|Recruiting||N/A|90|Anticipated|The Cleveland Clinic||2|||f||||t|f|f||||||No||2017-10-10 21:17:45.597542|2017-10-10 21:17:45.597542
NCT03070093|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-26||||||September 2017|2017-09-01||||||||Expanded Access|||Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)|A Multicenter, Open-label Treatment Protocol of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)|Available||N/A|||Astellas Pharma Inc||||||||t|||||||||||2017-10-10 21:17:45.7167|2017-10-10 21:17:45.7167
NCT03070080|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-04|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|October 1, 2017|Anticipated|2017-10-01||Interventional|||Restrictive Versus Conservative Fluid Therapy in Colorectal Surgery|Restrictive Versus Conservative Fluid Therapy in Colorectal Surgery: Hemodynamics and Kidney Function Outcomes|Recruiting||N/A|60|Anticipated|Assiut University||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:17:45.873845|2017-10-10 21:17:45.873845
NCT03070067|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-15|||April 1, 2015|Actual|2015-04-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||SpecTRA; A Study of the Validation of Protein Biomarkers in Transient Ischemic Attack|Spectrometry for TIA Rapid Assessment (SpecTRA) Project: Study 2—Validation of Clinical Features and Protein Biomarkers|Completed||N/A|1150|Actual|Vancouver Island Health Authority|||3||f||||t|f|f||||Samples Without DNA|"     Human plasma collected within 24 hours of symptom onset; MRI; Holter +\- Extended Cardiac     Monitoring   "|||2017-10-10 21:17:45.979574|2017-10-10 21:17:45.979574
NCT03070054|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-10-04|||June 2016|Actual|2016-06-01|October 2017|2017-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||LIA in Hip Arthroscopy Patients|LIA in Hip Arthroscopy Patients: An Extra-Capsular Approach|Enrolling by invitation||Early Phase 1|74|Anticipated|University of Utah||2|||f||||t|t|f|||t|||||2017-10-10 21:17:46.071072|2017-10-10 21:17:46.071072
NCT03070041|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-02|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Impact of Baby-friendly Hospital Initiative to Breastfeeding, Breastfeeding Counselling and Breastfeeding Attitudes|Vauvamyönteisyysohjelman Vaikutus Imetykseen, Imetysohjaukseen ja Imetysasenteisiin / The Impact of Baby-friendly Hospital Initiative to Breastfeeding, Breastfeeding Counselling and Breastfeeding Attitudes|Not yet recruiting||N/A|520|Anticipated|University of Turku||1|||f||||f|f|f||||||No||2017-10-10 21:17:46.163783|2017-10-10 21:17:46.163783
NCT03070028|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-02-28|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Minimally Invasive Treatment Methods for Pilonidal Disease|Randomized Prospective Comparison of Crystallized Phenol and Platelet Rich Plasma Applications in Treatment of Pilonidal Sinus Disease|Not yet recruiting||N/A|200|Anticipated|Uşak University||2|||f||||f|f|f||||||No||2017-10-10 21:17:46.231769|2017-10-10 21:17:46.231769
NCT03070015|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-02-28|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Effects of a Commercially Available Weight Loss Program on Body Weight in Overweight Men and Women|The Effects of a Commercially Available Weight Loss Program on Body Weight in Overweight Men and Women|Completed||N/A|84|Actual|Nutrisystem, Inc.||2|||f||||f|f|f||||||No|There is no plan to make individual participant data available to other researchers.|2017-10-10 21:17:46.315652|2017-10-10 21:17:46.315652
NCT03070002|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-23|||March 23, 2017|Actual|2017-03-23|March 2017|2017-03-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells|A Phase II, Open Label Study to Evaluate Denosumab in Patients With ER and/or PR-Positive, HER2-Negative Metastatic Breast Cancer (MBC) With Bone Metastases and Detectable Circulating Tumor Cells (CTCs)|Recruiting||Phase 2|42|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 21:17:46.415827|2017-10-10 21:17:46.415827
NCT03069989|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-10-02|||June 13, 2017|Actual|2017-06-13|October 2017|2017-10-01|December 21, 2018|Anticipated|2018-12-21|December 21, 2018|Anticipated|2018-12-21||Interventional|||Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging|A Study of Single Doses to Evaluate the Safety, Tolerability, Pharmacokinetics and Target Engagement of Nebulised GSK3008348 in Idiopathic Pulmonary Fibrosis Patients, Using Positron Emission Tomography (PET) Imaging|Recruiting||Phase 1|17|Anticipated|GlaxoSmithKline||4|||f||||f|f|f||||||||2017-10-10 21:17:46.551129|2017-10-10 21:17:46.551129
NCT03069976|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-03|||January 2016||2016-01-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||"Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children"|" Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Modification With Antibiotics in Children"|Recruiting||N/A|20|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||No||2017-10-10 21:17:46.686674|2017-10-10 21:17:46.686674
NCT03069963|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-09|||February 24, 2017|Actual|2017-02-24|June 2017|2017-06-01|April 23, 2017|Actual|2017-04-23|April 23, 2017|Actual|2017-04-23||Interventional|||PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects|A Randomized, Open Label, 2-Treatment Crossover Study to Compare by pH Metry, the Antacid Activity of the To-be-registered Product (250 mg Sodium Alginate/187.5 mg Calcium Carbonate/106.5 mg Sodium Hydrogen Carbonate, Chewable Tablets) Versus the Registered Gaviscon Double Action Tablets, in Healthy Adult Subject|Completed||Phase 1|24|Actual|Sanofi||2|||f||||f|f|f||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:17:46.799004|2017-10-10 21:17:46.799004
NCT03069950|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-19|||February 28, 2017|Actual|2017-02-28|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver|A Randomized, Multicenter Phase II Study of Panitumumab Plus FOLFIRI With or Without Hepatic Arterial Infusion as Second-Line Treatment in Patients With Wild Type RAS Who Have Unresectable Hepatic Metastases From Colorectal Cancer|Recruiting||Phase 2|80|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f|||t|||||2017-10-10 21:17:46.891465|2017-10-10 21:17:46.891465
NCT03069937|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-22|||March 1, 2017|Actual|2017-03-01|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.|A Phase II Study of Docetaxel Before Medical Castration With Degarelix in Patients With Newly Diagnosed Metastatic Prostatic Adenocarcinoma.|Recruiting||Phase 2|53|Anticipated|Medical University of South Carolina||1|||f||||t|f|f||||||No||2017-10-10 21:17:47.038905|2017-10-10 21:17:47.038905
NCT03069924|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-29|||July 1, 2017|Actual|2017-07-01|February 2017|2017-02-01|January 2021|Anticipated|2021-01-01|April 2020|Anticipated|2020-04-01||Interventional|||Gain-framed Messages and NRT for Lung Cancer Screening Patients|Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs|Recruiting||N/A|616|Anticipated|Medical University of South Carolina||4|||f|||||f|f|||f|||||2017-10-10 21:17:47.13525|2017-10-10 21:17:47.13525
NCT03069911|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-02-28|||February 27, 2017|Actual|2017-02-27|February 2017|2017-02-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Randomized Controlled Trial of OnabotulinumtoxinA for Depression in Parkinson Disease|Randomized Controlled Trial of OnabotulinumtoxinA for Depression in Parkinson Disease|Recruiting||Phase 1|60|Anticipated|Johns Hopkins University||2|||f||||t|t|f|||f|||No|Deidentified group data will be shared between the two study sites (Johns Hopkins and NIH)|2017-10-10 21:17:47.243719|2017-10-10 21:17:47.243719
NCT03069898|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-08-15|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|April 2020|Anticipated|2020-04-01||Interventional|||TRUE Dads: Evaluation of an Intervention Focusing on Father Involvement, Co-parenting, and Employment|Evaluation of the TRUE Dads Intervention|Recruiting||N/A|2400|Anticipated|It's My Community Initiative||2|||f||||f|f|f||||||||2017-10-10 21:17:47.351399|2017-10-10 21:17:47.351399
NCT03069885|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-27|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||iNPWT in Immediate Breast Reconstruction|Incisional Negative Pressure Wound Therapy (Prevena™) vs. Conventional Post-operative Dressing After Immediate Breast Reconstruction; a Randomized Controlled Clinical Trial|Not yet recruiting||N/A|60|Anticipated|University of Aarhus||2|||f||||t|f|f||||||No||2017-10-10 21:17:47.434591|2017-10-10 21:17:47.434591
NCT03069872|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-02|||April 5, 2017|Actual|2017-04-05|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer|Access to Fast Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer|Enrolling by invitation||N/A|7000|Anticipated|University of Aarhus||1|||f||||t|f|f||||||No||2017-10-10 21:17:47.544754|2017-10-10 21:17:47.544754
NCT03069859|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-06|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|TAPPH-1||Use of TXA to Prevent Postpartum Hemorrhage|Prophylactic Use of Tranexamic Acid for Preventing Postpartum Hemorrhage: A Randomized, Double-blinded, Placebo-controlled Pilot Trial|Not yet recruiting||Phase 2|58|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t|f|f|||f|||No||2017-10-10 21:17:47.629812|2017-10-10 21:17:47.629812
NCT03069846|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-24|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|July 31, 2017|Anticipated|2017-07-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope|Collecting Spectral Signatures of Melanoma, Squamous Cell Carcinoma, Basal Cell Carcinoma, Benign Lesions and Normal Tissues Using Spectra-Scope|Not yet recruiting||N/A|150|Anticipated|Speclipse Australia Pty Ltd||1|||f||||t|f|f||||||No||2017-10-10 21:17:47.769818|2017-10-10 21:17:47.769818
NCT03069833|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-25|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Computer Aided Diagnosis of Colorectal Neoplasms During Colonoscopic Examination|Computer Aided Diagnosis of Colorectal Neoplasms During Colonoscopic Examination|Recruiting||N/A|300|Anticipated|Tri-Service General Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:17:47.872595|2017-10-10 21:17:47.872595
NCT03069820|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-27|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury|Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury After Therapy With Docetaxel and Cisplatin for Nasopharyngeal Carcinoma|Recruiting||Phase 4|120|Anticipated|Second Affiliated Hospital of Nanchang University||1|||f||||t|f|f||||||No||2017-10-10 21:17:47.953386|2017-10-10 21:17:47.953386
NCT03069807|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-02-27|||September 2016|Actual|2016-09-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CATAPULT||Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent Tuberculosis|Can Latent Tuberculosis Infection (LTBI) in Recent Migrants be Treated Effectively and Safely in Primary Care? A Cluster Randomised Controlled Trial.|Recruiting||N/A|780|Anticipated|Queen Mary University of London||2|||f||||f|f|f||||||No||2017-10-10 21:17:48.037239|2017-10-10 21:17:48.037239
NCT03069794|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-06-03|||January 20, 2017|Actual|2017-01-20|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Spinal Surgery on Stable Force Platform Parameters Estimating the Posture and the Balance of the Patients Reached of Spinal Pathologies|Effect of Spinal Surgery on Stable Force Platform Parameters Estimating the Posture and the Balance of the Patients Reached of Spinal Pathologies|Recruiting||N/A|190|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||t|f|f||||||Undecided||2017-10-10 21:17:48.122713|2017-10-10 21:17:48.122713
NCT03069781|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-02|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effects of 17β-estradiol on Skeletal Muscle|The Effects of 17β-estradiol on Skeletal Muscle Mass Following Immobilization|Not yet recruiting||Early Phase 1|20|Anticipated|McMaster University||2|||f||||f|t|f|||f|||No||2017-10-10 21:17:48.205369|2017-10-10 21:17:48.205369
NCT03069768|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-07-20|||April 27, 2017|Actual|2017-04-27|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|mSMART-v||Stage Ib Trial of mSMART With Varenicline|Stage Ib Trial of mSMART With Varenicline|Recruiting||Phase 1|20|Anticipated|Duke University||2|||f||||f|t|f||||||||2017-10-10 21:17:48.285439|2017-10-10 21:17:48.285439
NCT03069755|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-02-27|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Perioperative Mortality Rate in Indian Trauma Patients|What is the Perioperative Mortality Rate and What is the Association Between Type of Acute Surgical Intervention and Perioperative Mortality Among Adult Trauma Patients in an Urban Indian Setting?|Active, not recruiting||N/A|16047|Actual|Karolinska Institutet|||1||f||||t|f|f||||||No||2017-10-10 21:17:48.383133|2017-10-10 21:17:48.383133
NCT03069742|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-05-10|||November 2016||2016-11-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting|Web-based Decision Aids for Breast Cancer Risk Assessment and Increasing Breast Cancer Chemoprevention in the Primary Care Setting: Randomized Controlled Trial|Recruiting||N/A|350|Anticipated|Columbia University||2|||f||||f||||||||Undecided||2017-10-10 21:17:48.440607|2017-10-10 21:17:48.440607
NCT03069729|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-14|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|July 1, 2019|Anticipated|2019-07-01||Observational|||Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)|Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)|Recruiting||N/A|380|Anticipated|VisionQuest Biomedical LLC|||3||f||||f|f|f||||||||2017-10-10 21:17:48.539056|2017-10-10 21:17:48.539056
NCT03069716|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-17|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|mHealth||A Mobile Health Intervention in Pulmonary Arterial Hypertension|A Mobile Health Intervention in Pulmonary Arterial Hypertension|Recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:17:48.620628|2017-10-10 21:17:48.620628
NCT03069703|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-21|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|May 2021|Anticipated|2021-05-01|November 2020|Anticipated|2020-11-01||Interventional|PNEUMOVAS||Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy|Multicenter Randomized Controlled Trial Comparing Immunogenicity and Safety of Two Innovative Anti-pneumococcal Vaccine Strategies to Standard Vaccination Regimen in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy|Not yet recruiting||Phase 2|120|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t|f|f||||||No||2017-10-10 21:17:48.864051|2017-10-10 21:17:48.864051
NCT03069690|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-27|||October 1, 2016|Actual|2016-10-01|February 2017|2017-02-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|HABIT||Optimizing Health From Pregnancy Through One Year Postpartum|Optimizing Health From Pregnancy Through One Year Postpartum: A Sequential Multiple Assignment Randomized Trial (SMART) of Perinatal Lifestyle Interventions|Recruiting||N/A|300|Anticipated|University of Pittsburgh||4|||f||||f|f|f||||||No||2017-10-10 21:17:49.029836|2017-10-10 21:17:49.029836
NCT03069677|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-07-25|||April 12, 2017|Actual|2017-04-12|July 2017|2017-07-01|May 6, 2018|Anticipated|2018-05-06|March 6, 2018|Anticipated|2018-03-06||Interventional|||Music vs Midazolam During Preop Nerve Block Placement|Music vs Midazolam During Preoperative Nerve Block Placement: A Prospective, Randomized Controlled Study|Recruiting||Phase 3|200|Anticipated|University of Pennsylvania||2|||f||||f|t|f|||f|||||2017-10-10 21:17:49.126893|2017-10-10 21:17:49.126893
NCT03069664|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-27|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer|Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer|Not yet recruiting||N/A|40|Anticipated|Helsinki University Central Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:17:49.228809|2017-10-10 21:17:49.228809
NCT03069651|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-08-14|||December 2016||2016-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Virtual Care in CF (VIRTUAL-CF) Study|A Prospective Randomised Pilot Study of Videoconferencing in Adults With Cystic Fibrosis Receiving Intravenous Antibiotics for Acute Pulmonary Exacerbations (VIRTUALCF)|Recruiting||N/A|100|Anticipated|Heart of England NHS Trust||2|||f||||f||||||||||2017-10-10 21:17:49.342907|2017-10-10 21:17:49.342907
NCT03069638|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-02-27|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population|Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population|Recruiting||Phase 4|109|Anticipated|University of Oulu||2|||f||||f|f|f||||||No||2017-10-10 21:17:49.451401|2017-10-10 21:17:49.451401
NCT03069625|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-05|||August 31, 2017|Actual|2017-08-31|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Sit-to-stand Test in Cystic Fibrosis Children and Adolescents|Sit-to-stand Test Use in Children and Adolescents With Cystic Fibrosis : Correlations With 6-Minute Walking Test, Quadriceps and Respiratory Muscle Strength and Health Related Quality of Life|Recruiting||N/A|40|Anticipated|Groupe Hospitalier du Havre||2|||f|||||f|f||||||||2017-10-10 21:17:49.575167|2017-10-10 21:17:49.575167
NCT03069612|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-06|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|August 28, 2017|Actual|2017-08-28|August 28, 2017|Actual|2017-08-28||Interventional|||rTMS Treatment for Cannabis Use Disorders in Psychosis|Evaluating Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Dependence and Working Memory in Patients With Early Psychosis|Terminated||N/A|4|Actual|Centre for Addiction and Mental Health||2||Terminated|f||||f|f|f||||||||2017-10-10 21:17:49.707007|2017-10-10 21:17:49.707007
NCT03069599|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-02|||February 15, 2017|Actual|2017-02-15|May 2017|2017-05-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|IRE Immuno||Immune Response After Pancreatic Cancer Treatment|Differential Immunologic Signature After Pancreatic Cancer Treatment: Does Irreversible Electroporation Lead to a Prolonged and Potent T-cell Mediated Immune Response Compared to Surgical Resection?|Recruiting||N/A|30|Anticipated|University Hospital Inselspital, Berne|||3||f||||f||||||||||2017-10-10 21:17:49.814542|2017-10-10 21:17:49.814542
NCT03069586|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-02-27|||May 2015||2015-05-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect Low Pressure Pneumoperitoneum and Pulmonary Recruitment on Postoperative Pain|The Effect of Low Pressure Pneumoperitoneum and Pulmonary Recruitment Manoeuvre on Postoperative Pain After Laparoscopic Cholecystectomy|Recruiting||N/A|80|Anticipated|General Hospital Groeninge||2|||f||||f||||||||No||2017-10-10 21:17:49.933636|2017-10-10 21:17:49.933636
NCT03069573|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-27|||January 1, 2015|Actual|2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01|4 Years|Observational [Patient Registry]|||Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients|Phenotypic Characterization of Pediatric Patients With Esophageal Eosinophilia and Biomarkers Investigation for the Diagnosis of Eosinophilic Esophagitis|Recruiting||N/A|500|Anticipated|Federal University of Uberlandia|||3||f||||t||||||Samples With DNA|"     blood, saliva, esophageal tissue, esophageal mucus   "|Yes|The phenotypic characterization by demographic,symptom, endoscopy, histology data description and the presence of potential biomarkers will be published and shared in this platform|2017-10-10 21:17:50.049923|2017-10-10 21:17:50.049923
NCT03069560|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-07-20|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|C-SIAM||Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts|Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts|Recruiting||N/A|15|Anticipated|University Hospital, Brest||1|||f|||||f|f||||||||2017-10-10 21:17:50.139583|2017-10-10 21:17:50.139583
NCT03069547|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-19|||April 10, 2017|Actual|2017-04-10|April 2017|2017-04-01|November 1, 2019|Anticipated|2019-11-01|August 1, 2019|Anticipated|2019-08-01||Interventional|COMPETE||Comparison of Exercise Therapies for Patellofemoral Pain|Comparative Effectiveness of Therapeutic Hip and Knee Exercise for Atellofemoral Pain: A Pragmatic Randomised Trial|Recruiting||N/A|200|Anticipated|Frederiksberg University Hospital||2|||f||||f|f|f||||||Yes|All IPD will be shared once the study is finalised and results pulished. IPD can be obtained by contacting the responsible party|2017-10-10 21:17:50.224423|2017-10-10 21:17:50.224423
NCT03069534|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-27|||June 1, 2009|Actual|2009-06-01|September 2009|2009-09-01|March 1, 2020|Anticipated|2020-03-01|June 1, 2019|Anticipated|2019-06-01||Interventional|rhIL-2||Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB|Study of Adjunctive rhIL-2 Therapy in Patients With MDR-TB That Improves Efficiency and Shortens Course|Recruiting||Phase 2/Phase 3|500|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||f|t|f||||||||2017-10-10 21:17:50.336484|2017-10-10 21:17:50.336484
NCT03069521|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-27|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Study to Evaluate the Safety of the EndoArt™ for Treatment of Subjects Suffering From Corneal Edema|Prospective, Feasibility Study to Evaluate the Safety of the EndoArt™ for Treatment of Subjects Suffering From Corneal Edema|Not yet recruiting||N/A|12|Anticipated|Eye-yon Medical||1|||f||||f|f|f||||||No||2017-10-10 21:17:50.433867|2017-10-10 21:17:50.433867
NCT03069508|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-27|||February 13, 2017|Actual|2017-02-13|February 2017|2017-02-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Clemizole HCl for Subjects With Hepatocellular Carcinoma|A Phase IIa, Open Label Pilot Study of Clemizole Hydrochloride Given Orally Thrice a Day, for Subjects With Hepatocellular Carcinoma That Are Either Awaiting Transplantation or Have an Unresectable Lesion|Enrolling by invitation||Phase 2|12|Anticipated|Eiger Group International, Inc.||4|||f||||f|t|f|||t|||No||2017-10-10 21:17:50.503324|2017-10-10 21:17:50.503324
NCT03069495|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-21|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Role of Circulating Innate Lymphoid Cells in Allergic Disorders|Role of Circulating Innate Lymphoid Cells in Allergic Disorders|Recruiting||N/A|48|Anticipated|University of Nebraska|||3||f||||f|f|f||||None Retained|"     A one time blood draw   "|||2017-10-10 21:17:50.596308|2017-10-10 21:17:50.596308
NCT03069482|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-08-17|||May 15, 2017|Actual|2017-05-15|January 2017|2017-01-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness|Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness|Recruiting||N/A|90|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 21:17:50.675459|2017-10-10 21:17:50.675459
NCT03069469|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-05-25|||February 16, 2017|Actual|2017-02-16|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of DCC-3014 in Patients With Advanced Malignancies|Multi-center, Phase 1, Open-Label Study of DCC-3014 to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Advanced Malignancies|Recruiting||Phase 1|55|Anticipated|Deciphera Pharmaceuticals LLC||1|||||||f|t|f||||||No||2017-10-10 21:17:50.817942|2017-10-10 21:17:50.817942
NCT03069456|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-27|||April 2016||2016-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparative Population Pharmacodynamic Modeling for Sevoflurane Effects Using ADMS and Bispectral Index|Comparative Population Pharmacodynamic Modeling for Sevoflurane Effects Using Anesthetic Depth Monitoring for Sedation (ADMS) and Bispectral Index System (BIS)|Recruiting||N/A|30|Anticipated|Chonnam National University Hospital||2|||f||||f||||||||No||2017-10-10 21:17:50.913699|2017-10-10 21:17:50.913699
NCT03069443|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-06-27|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|June 15, 2018|Anticipated|2018-06-15|December 31, 2017|Anticipated|2017-12-31||Interventional|POTENT||Isometric Handgrip Home Training to Lower Blood Pressure in Hypertensive Older adulTs|Isometric Handgrip Home Training to Lower Blood Pressure in Hypertensive Older adulTs: a 20-week Assessor-blindEd raNdomized Controlled Trial|Recruiting||N/A|50|Anticipated|Aalborg Universitetshospital||2|||f||||f|f|f||||||No|Data from the study will be made available on a public server|2017-10-10 21:17:51.000406|2017-10-10 21:17:51.000406
NCT03069430|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-06|||August 1, 2016|Actual|2016-08-01|March 2017|2017-03-01|April 1, 2017|Anticipated|2017-04-01|April 1, 2017|Anticipated|2017-04-01||Observational|||A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I|Self Management for Families and Youth: Phase I|Recruiting||N/A|45|Anticipated|Medical University of South Carolina|||1||f||||t|f|f||||||No|IPD will only be available to study mentors and the biostatistician.|2017-10-10 21:17:51.101352|2017-10-10 21:17:51.101352
NCT03069417|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-27|||September 11, 2016||2016-09-11|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|June 2017|Anticipated|2017-06-01||Interventional|INSPireD||Support for Perinatal Adherence and Depression|Project INSPireD: Integrating Nuanced Support for Perinatal Adherence and Depression|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 21:17:51.168733|2017-10-10 21:17:51.168733
NCT03069404|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-04-21|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Observational|||INSTrUCT-SCI: INdependent Observational STUdy of Cell Transplantation in SCI|INSTrUCT-SCI: INdependent Observational STUdy of Cell Transplantation in SCI, an Investigator Initiated Trial|Not yet recruiting||N/A|12|Anticipated|University of Zurich|||1||f|||||f|f||||||||2017-10-10 21:17:51.266853|2017-10-10 21:17:51.266853
NCT03069391|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-27|||March 4, 2017|Anticipated|2017-03-04|February 2017|2017-02-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|iPACES™||The Interactive Physical and Cognitive Exercise System|The Interactive Physical and Cognitive Exercise System (iPACES™): A Neuro-exergame for Preventing Alzheimer's and Ameliorating Cognitive Impairment|Recruiting||N/A|100|Anticipated|Union College, New York||2|||f||||t|f|t|t|f|f|||No||2017-10-10 21:17:51.328889|2017-10-10 21:17:51.328889
NCT03069378|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-05|||March 3, 2017|Actual|2017-03-03|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma|A Phase II Study of Talimogene Laherparepvec (T-VEC) Administered Concurrently With the Anti-PD1 Monoclonal Antibody Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma|Recruiting||Phase 2|26|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:17:51.433481|2017-10-10 21:17:51.433481
NCT03069365|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-29|||March 29, 2017|Actual|2017-03-29|September 2017|2017-09-01|May 11, 2018|Anticipated|2018-05-11|March 16, 2018|Anticipated|2018-03-16||Interventional|Expedition-5||A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment|A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection (EXPEDITION-5)|Recruiting||Phase 3|120|Anticipated|AbbVie||3|||t||||f|t|f||||||||2017-10-10 21:17:51.542181|2017-10-10 21:17:51.542181
NCT03069352|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-09-29|||May 24, 2017|Actual|2017-05-24|September 2017|2017-09-01|April 4, 2020|Anticipated|2020-04-04|October 20, 2019|Anticipated|2019-10-20||Interventional|||A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naïve Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy|A Randomized, Double-Blind, Placebo Controlled Study of Venetoclax Co-Administered With Low Dose Cytarabine Versus Low Dose Cytarabine in Treatment Naïve Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy|Recruiting||Phase 3|175|Anticipated|AbbVie||2|||t||||t|t|f||||||||2017-10-10 21:17:51.718337|2017-10-10 21:17:51.718337
NCT03068806|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-02-27|||December 1, 2014|Actual|2014-12-01|February 2017|2017-02-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Brain Imaging, Attention, and Auditory Processing in Schizophrenia|Predictive Coding Abnormalities in Psychosis: EEG and fMRI|Recruiting||N/A|169|Anticipated|San Francisco Veterans Affairs Medical Center|||2||f||||f|f|f||||||No||2017-10-10 21:17:56.272954|2017-10-10 21:17:56.272954
NCT03069339|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-04-19|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||CARVEDILOL, ENDOSCOPIC VARICEAL LIGATION OR COMBINATION OF BOTH FOR PREVENTION OF FIRST VARICEAL BLEED IN CHILD'S B & C CIRRHOSIS|CARVEDILOL, ENDOSCOPIC VARICEAL LIGATION OR COMBINATION OF BOTH FOR PREVENTION OF FIRST VARICEAL BLEED IN CHILD'S B & C CIRRHOSIS: A RANDOMIZED CONTROLLED TRIAL|Recruiting||N/A|330|Anticipated|Institute of Liver and Biliary Sciences, India||3|||f||||f|f|f||||||No||2017-10-10 21:17:51.91578|2017-10-10 21:17:51.91578
NCT03069326|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-10|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis|Evaluation of Ruxolitinib And Thalidomide Combination as a Therapy for Patients With Myelofibrosis|Recruiting||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:17:52.00145|2017-10-10 21:17:52.00145
NCT03069300|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-08|||October 1, 2015|Actual|2015-10-01|February 2017|2017-02-01|June 1, 2018|Anticipated|2018-06-01|January 1, 2018|Anticipated|2018-01-01||Interventional|NACAH||N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis|The Mechanism of Action of N-acetylcysteine for Reducing the Risk of Infection in Alcoholic Hepatitis|Recruiting||Phase 3|42|Anticipated|Imperial College London||2|||f||||f|f|f||||||Yes|contact investigators|2017-10-10 21:17:52.167028|2017-10-10 21:17:52.167028
NCT03069287|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-08-14|||March 19, 2017|Actual|2017-03-19|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Integrating Family Caregiver Support Into Cancer Clinical Trials|Integrating Family Caregiver Support Into Cancer Clinical Trials|Active, not recruiting||N/A|20|Anticipated|John Wayne Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 21:17:52.249075|2017-10-10 21:17:52.249075
NCT03069274|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-28|2017-03-02|||October 5, 2015|Actual|2015-10-05|March 2017|2017-03-01|November 8, 2016|Actual|2016-11-08|June 15, 2016|Actual|2016-06-15||Interventional|||Sugar-sweetened Beverage Intake Substitution by Water to Prevent Overweight in Mexican Children|Impact of a Randomized School-based Intervention on Sugar-sweetened Beverage Intake Substitution by Water to Prevent Excessive Weight in Mexican Scholars|Completed||N/A|314|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t|f|f||||||No||2017-10-10 21:17:52.320801|2017-10-10 21:17:52.320801
NCT03069261|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-04-03|||August 1, 2016|Actual|2016-08-01|February 2017|2017-02-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Observational|||Intraoperative Indocyanine Green Laser Angiography; Postoperative Outcomes for Autologous Tissue Flaps|Intraoperative Indocyanine Green Laser (ICG) Angiography; Evaluation of Postoperative Outcomes for Breast Reconstruction With Autologous Tissue Flaps|Enrolling by invitation||N/A|200|Anticipated|University of Aarhus|||2||f||||t|f|f||||||||2017-10-10 21:17:52.388095|2017-10-10 21:17:52.388095
NCT03069248|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-01|||June 1, 2000|Actual|2000-06-01|February 2017|2017-02-01|September 17, 2009|Actual|2009-09-17|September 17, 2009|Actual|2009-09-17||Interventional|||Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon|Treatment of Follicular Non-Hodgkin's Lymphoma With High Dose Therapy and Stem Cell Support Followed by Consolidative Immunotherapy With Rituximab and Alpha Interferon|Completed||Phase 2|36|Actual|Sunnybrook Health Sciences Centre||1|||f||||f|t|f|||f|||No||2017-10-10 21:17:52.443914|2017-10-10 21:17:52.443914
NCT03069235|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-01|||February 8, 2012|Actual|2012-02-08|March 2017|2017-03-01|November 30, 2013|Actual|2013-11-30|November 30, 2013|Actual|2013-11-30||Interventional|EBF||Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program|Operational Research to Promote Breastfeeding Among HIV Infected Women Attending the Prevention of Mother to Child Transmission (PMTCT) Program in Mulago Hospital, Kampala, Uganda|Completed||N/A|218|Actual|Johns Hopkins University||3|||f||||f|f|f||||||No||2017-10-10 21:17:52.517161|2017-10-10 21:17:52.517161
NCT03069222|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-01|||April 1, 2016|Actual|2016-04-01|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|||Longitudinal Assessment of Spinal Cord Structural Plasticity Using DTI in SCI Patients|Longitudinal Assessment of Spinal Cord Structural Plasticity Using DTI in SCI Patients|Recruiting||N/A|30|Anticipated|Kessler Foundation|||2||f||||f|f|f||||||No||2017-10-10 21:17:52.726558|2017-10-10 21:17:52.726558
NCT03069209|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-02-25|||January 2015||2015-01-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|June 2021|Anticipated|2021-06-01||Interventional|||Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF)|Transplantation of Specific Populations of Bone Marrow-Derived Stem Cells and Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure.|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Stem Cells Arabia||1|||f||||f||||||||Undecided||2017-10-10 21:17:52.861144|2017-10-10 21:17:52.861144
NCT03069196|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-11|||June 10, 2016|Actual|2016-06-10|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|PICTURE||Prevalence and Incidence of Complications of Type One Diabetes in pUne at a Tertiary Care centRE|A Study to Assess Prevalence and Incidence of Long-term Complications of Type 1 Diabetes in a Tertiary Clinic in Pune.|Recruiting||N/A|400|Anticipated|Kem Hospital, Pune, India|||1||f||||f|f|f||||Samples With DNA|"     For future biochemical tests : Plasma, Serum and Urine samples are stored. To do DNA     extraction at a later stage Packed cells are stored.   "|Undecided||2017-10-10 21:17:52.94649|2017-10-10 21:17:52.94649
NCT03069183|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-07|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|HIPFIB||The Efficacy of Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block on Early Post-operative Analgesia After Total Hip Arthroplasty|The Efficacy of Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block on Early Post-operative Analgesia After Total Hip Arthroplasty|Not yet recruiting||Phase 2/Phase 3|132|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:17:53.057447|2017-10-10 21:17:53.057447
NCT03069170|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-02-25|||July 2016||2016-07-01|April 2016|2016-04-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|||Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.|Safety and Efficacy of Immuno-modulation and Autologous Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Multiple Sclerosis.|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Stem Cells Arabia||2|||f||||f||||||||Undecided||2017-10-10 21:17:53.169249|2017-10-10 21:17:53.169249
NCT03069157|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-10|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of the Effect of Lung Recruitment and Positive End- Expiratory Pressure (PEEP) on Anesthesia Induced Atelectasis Using Lung Ultrasound|Evaluation of the Effect of Lung Recruitment and Positive End- Expiratory Pressure (PEEP) on Anesthesia Induced Atelectasis Using Lung Ultrasound in Children Undergoing Major Abdominal Surgery.|Recruiting||N/A|40|Anticipated|Kasr El Aini Hospital||2|||f|||||f|f||||||No||2017-10-10 21:17:53.269569|2017-10-10 21:17:53.269569
NCT03069144|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-02-27|||January 6, 2012|Actual|2012-01-06|February 2017|2017-02-01|May 28, 2012|Actual|2012-05-28|April 11, 2012|Actual|2012-04-11||Interventional|||Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis|Efficacy and Safety of HAT1, a Novel Topical Therapeutic: An Open Label Pilot Study of HAT1 Compared to Calcipotriol in Patients With Chronic Plaque Psoriasis|Completed||Phase 1/Phase 2|28|Actual|Haus Bioceuticals||2|||f||||t|f|f||||||Yes||2017-10-10 21:17:53.378756|2017-10-10 21:17:53.378756
NCT03069131|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-06|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|November 2020|Anticipated|2020-11-01||Interventional|ProPILARifax||Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites|A Multicenter, Double-blind, Placebo-controlled Randomized Clinical Trial Comparing Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites : Using or Not Using Rifaximin|Not yet recruiting||Phase 3|160|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t|f|f||||||No||2017-10-10 21:17:53.47943|2017-10-10 21:17:53.47943
NCT03069118|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-08|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||90-Day Online Substance Use Program|Effectiveness of a Remote Behavioral Intervention and Coaching Support for Risky Substance Users in a Randomized Control Trial|Recruiting||N/A|200|Anticipated|Workit Health||2|||f||||f|f|f||||||No||2017-10-10 21:17:53.607778|2017-10-10 21:17:53.607778
NCT03069105|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer|An Exploratory Study of Caregiver Burden Among Family Caregivers of Cancer Patients|Not yet recruiting||N/A|122|Anticipated|John Wayne Cancer Institute|||1||f||||f|f|f||||||No||2017-10-10 21:17:53.726361|2017-10-10 21:17:53.726361
NCT03069092|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-15|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|CardioRACE||Comparison of the Cardiovascular Benefits of Resistance, Aerobic, and Combined Exercise|Comparison of the Cardiovascular Benefits of Resistance, Aerobic, and Combined Exercise|Recruiting||N/A|400|Anticipated|Iowa State University||4|||f||||t|f|f||||||||2017-10-10 21:17:53.842751|2017-10-10 21:17:53.842751
NCT03069079|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-03-31|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|GOSH||Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study|Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study|Recruiting||N/A|50|Anticipated|Queen Mary University of London||1|||f||||f||||||||No||2017-10-10 21:17:53.958719|2017-10-10 21:17:53.958719
NCT03069066|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-02|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring)|Prospective Study of Bioresorbable Vascular Scaffold Treatment With Scoring Balloon Pre-dilatation in Patients With In-stent Restenosis|Recruiting||Phase 4|100|Anticipated|Spanish Society of Cardiology||1|||f||||f|f|f||||||||2017-10-10 21:17:54.099386|2017-10-10 21:17:54.099386
NCT03069053|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-25|||July 1, 2016|Actual|2016-07-01|February 2017|2017-02-01|February 20, 2017|Actual|2017-02-20|December 15, 2016|Actual|2016-12-15|14 Years|Observational [Patient Registry]|HistologyIC||Clinical Features and Histologic Findings in Bladder Pain Syndrome/Interstitial Cystitis|Clinical Features and Histologic Findings in Bladder Pain Syndrome/Interstitial Cystitis (BPS/IS): New Findings on Useful Correlations|Completed||N/A|57|Actual|IRCCS Policlinico S. Matteo|||1||f||||f|f|f||||Samples Without DNA|"     bladder biopsy   "|No||2017-10-10 21:17:54.274111|2017-10-10 21:17:54.274111
NCT03069040|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-01|||November 1, 2011|Actual|2011-11-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Nerve Sparing Radical Hysterectomy VS Radical Hysterectomy: Safety and Clinical Efficacy|The Randomized Controlled Trial of Nerve Sparing Hysterectomy Radical Hysterectomy and Radical Hysterectomy|Active, not recruiting||N/A|50|Anticipated|Southern Medical University, China||2|||f||||t|f|f||||||No||2017-10-10 21:17:54.359969|2017-10-10 21:17:54.359969
NCT03069027|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-03-01|||August 15, 2016|Actual|2016-08-15|February 2017|2017-02-01|May 1, 2017|Anticipated|2017-05-01|April 15, 2017|Anticipated|2017-04-15||Interventional|||Efficacy of External Nasal Nerve Block in Prevention of Postoperative Agitation Following Nasal Surgeries|Efficacy of External Nasal Nerve Block on Postoperative Agitation Following Nasal Surgeries Under General Anesthesia. Randomized, Controlled Trial|Recruiting||N/A|100|Anticipated|Al Jedaani Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:17:54.458927|2017-10-10 21:17:54.458927
NCT03069014|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-03-01|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|October 31, 2019|Anticipated|2019-10-31|October 10, 2019|Anticipated|2019-10-10||Interventional|||Study of LM11A-31-BHS in Mild-moderate AD Patients|A 6-months Prospective, Multi-center, Double-blind, Placebo-controlled, Randomized, Adaptive-trial-design Study to Evaluate Safety, Tolerability and Exploratory Endpoints of Either Placebo or Two Different Oral Doses of LM11A-31-BHS in Patients With Mild to Moderate Probable Alzheimer's Disease|Recruiting||Phase 1/Phase 2|120|Anticipated|PharmatrophiX Inc.||3|||f||||t|f|f||||||No||2017-10-10 21:17:54.56249|2017-10-10 21:17:54.56249
NCT03069001|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV|Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Egyptian Patients With HCV|Completed||Phase 4|90|Actual|Ain Shams University||2|||f|||||t|f||||||||2017-10-10 21:17:54.771355|2017-10-10 21:17:54.771355
NCT03068988|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-03|||January 1, 2012|Actual|2012-01-01|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2014|Actual|2014-12-31||Interventional|||Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions|Mesenchymal Stem Cells in the Reconstruction Surgery of the Supraspinatus Muscle Lesions|Active, not recruiting||Phase 1|50|Actual|Hospital Znojmo||2|||f||||f|f|f|||f|||||2017-10-10 21:17:54.866193|2017-10-10 21:17:54.866193
NCT03068975|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-27|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Alvimopan Use in Polytraumatized Patients|A Double Blind, Randomized, Parallel Design Study to Evaluate the Effectiveness of Post-operative Dose of Alvimopan(Entereg) in Preventing Post-operative Ileus in Poly-traumatized Patients|Not yet recruiting||Phase 4|180|Anticipated|University of Puerto Rico||2|||f||||t|t|f|||t|||Yes||2017-10-10 21:17:54.973905|2017-10-10 21:17:54.973905
NCT03068962|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-27|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|REBOC||Examination of the Distribution of Nitrate Reducing Bacteria in the Human Oral Cavity|Examination of the Distribution of Nitrate Reducing Bacteria in the Human Oral Cavity|Not yet recruiting||N/A|20|Anticipated|University of Reading||3|||f||||t|f|f||||||||2017-10-10 21:17:55.096436|2017-10-10 21:17:55.096436
NCT03068949|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||October 28, 2015|Actual|2015-10-28|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Comparison of Three Licensed Influenza Vaccines|A Comparison of CD4 T Cell Induction and Antibody Responses Between a Pure Hemagglutinin Influenza Vaccine (rHA, Protein Sciences Corp) and Licensed Subvirion Influenza Vaccine Made in Eggs (Sanofi) or Cell Culture (Novartis) in Healthy Adults.|Recruiting||Phase 4|135|Anticipated|University of Rochester||3|||f||||f|t|f|||f|||Yes|Data will be shared with the CEIRS (Centers of Excellence for Influenza Research and Surveillance) network|2017-10-10 21:17:55.192355|2017-10-10 21:17:55.192355
NCT03068936|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-27|||March 2017|Anticipated|2017-03-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma|Intensity Modulated Radiotherapy Plus Cisplatin Versus Intensity Modulated Radiotherapy in Patients With Stage 2 Nasopharyngeal Carcinoma: A Phase 3 Multicenter, Open-label, Randomized, Non-inferior Clinical Trial|Not yet recruiting||Phase 3|716|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t|f|f||||||No||2017-10-10 21:17:55.274743|2017-10-10 21:17:55.274743
NCT03068923|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-01|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Observational|TOP||Thrombosis Outcomes in Pediatric Venous Thromboembolism|Predicting and Preventing Poor Outcomes of Venous Thromboembolism in Children|Recruiting||N/A|200|Anticipated|University of Texas Southwestern Medical Center|||1||f||||t|f|f||||Samples With DNA|"     Plasma and DNA samples   "|No||2017-10-10 21:17:55.348762|2017-10-10 21:17:55.348762
NCT03068910|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||July 2016||2016-07-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|CRM008||Hyperandrogenemia and Altered Day-night LH Pulse Patterns|Hyperandrogenemia and Altered Day-night LH Pulse Patterns|Recruiting||Phase 1|32|Anticipated|University of Virginia||2|||f||||t|t|f||||||Undecided|We do not have current plans to share IPD|2017-10-10 21:17:55.454356|2017-10-10 21:17:55.454356
NCT03068897|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-02|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain|Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain: A Randomized Trial|Recruiting||Phase 4|320|Anticipated|Montefiore Medical Center||4|||f||||t|t|f|||f|||No|IPD will not be available|2017-10-10 21:17:55.5911|2017-10-10 21:17:55.5911
NCT03068884|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-02|||March 1, 2017|Actual|2017-03-01|February 2017|2017-02-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Dopamine Dorsolateral Prefrontal Cortex Behavioural Flexibility|Dopaminergic Contribution to Behavioural Flexibility as Modulated by Transcranial Direct-current Stimulation of the Dorsolateral Prefrontal Cortex|Recruiting||N/A|24|Anticipated|Sheffield Hallam University||4|||f||||f|f|f||||||No||2017-10-10 21:17:55.708367|2017-10-10 21:17:55.708367
NCT03068871|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-24|||February 28, 2017|Anticipated|2017-02-28|February 2017|2017-02-01|May 23, 2017|Anticipated|2017-05-23|May 23, 2017|Anticipated|2017-05-23||Interventional|||A Comparison of Two Psycho-educational Group Interventions for Tinnitus Patients|A Comparison of Two Psycho-educational Group Interventions for Tinnitus Patients|Not yet recruiting||N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 21:17:55.790853|2017-10-10 21:17:55.790853
NCT03068858|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-08-30|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Real-time Feedback of SYNTAX Score Category During Coronary Angiographies to Improve Appropriateness of Coronary Revascularization for Patients With Stable Coronary Artery Diseases: a Before-and-after Controlled Study||Recruiting||N/A|2400|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t||||||||||2017-10-10 21:17:55.856492|2017-10-10 21:17:55.856492
NCT03068845|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-04-25|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|June 2019|Anticipated|2019-06-01||Interventional|ACADEMIC||Arteriovenous Fistula: Conventional Angioplasty vs Drug Eluting Balloon-assisted Maturation Intervention Clinical Trial|Arteriovenous Fistula: Conventional Angioplasty vs Drug Eluting Balloon-assisted Maturation Intervention Clinical Trial|Not yet recruiting||Phase 3|124|Anticipated|Singapore General Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:17:55.941897|2017-10-10 21:17:55.941897
NCT03068832|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-10-04|||December 31, 2017|Anticipated|2017-12-31|October 2017|2017-10-01|May 31, 2022|Anticipated|2022-05-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors|A Pilot Study to Assess the Safety, Feasibility, and Preliminary Efficacy of a Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors|Not yet recruiting||Phase 1|10|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:17:56.072298|2017-10-10 21:17:56.072298
NCT03068819|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-10-04|||December 31, 2017|Anticipated|2017-12-31|October 2017|2017-10-01|November 30, 2024|Anticipated|2024-11-30|November 30, 2024|Anticipated|2024-11-30||Interventional|||Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant|A Pilot Study of Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant in Children and Young Adults|Not yet recruiting||Phase 1|24|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 21:17:56.167535|2017-10-10 21:17:56.167535
NCT03068793|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-02-27|||October 1, 2013|Actual|2013-10-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Reward Processing in Schizophrenia|Multimodal Neural Investigation of Reward Processing in Schizophrenia|Recruiting||N/A|80|Anticipated|San Francisco Veterans Affairs Medical Center|||2||f||||f|f|f||||||No||2017-10-10 21:17:56.400428|2017-10-10 21:17:56.400428
NCT03068780|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-28|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|EASE||Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa|Double Blind, Randomised, Vehicle Controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa|Recruiting||Phase 3|164|Anticipated|Amryt Pharma||2|||f||||t|f|f||||||||2017-10-10 21:17:56.516364|2017-10-10 21:17:56.516364
NCT03068767|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-25|||September 2016||2016-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Relationship Between Vitamin D and Hepatitis B Virus Replication|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Recruiting||N/A|300|Anticipated|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation||2|||f||||||||||||No||2017-10-10 21:17:56.61382|2017-10-10 21:17:56.61382
NCT03068754|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-22|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis|A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis|Recruiting||Phase 2|213|Anticipated|Mallinckrodt||2|||f||||t|t|f||||||||2017-10-10 21:17:56.6983|2017-10-10 21:17:56.6983
NCT03068741|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-24|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|PITSTOP||Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)|Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)|Not yet recruiting||Phase 4|2040|Anticipated|Sunnybrook Health Sciences Centre||4|||f||||t|f|f||||||Yes|We will accept proposals from other researchers to access the anonymous study data (and only as permitted and/or approved by our Research Ethics Boards) one year following the publication of the main study findings.|2017-10-10 21:17:58.857773|2017-10-10 21:17:58.857773
NCT03068728|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-24|||May 13, 2014|Actual|2014-05-13|February 2017|2017-02-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Analysis of Hemostatic Agents Compared to Physiologic Hemostasis|Analysis of Hemostatic Agents Compared to Physiologic Hemostasis|Enrolling by invitation||N/A|144|Anticipated|St. Louis University||6|||f||||f|f|t|f||f|||Undecided||2017-10-10 21:17:58.972459|2017-10-10 21:17:58.972459
NCT03068715|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-24|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|aTBS||Accelerated Theta Burst in Treatment-Resistant Depression|Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study|Recruiting||N/A|40|Anticipated|Stanford University||2|||f|||||f|t|f|f|f|||No||2017-10-10 21:17:59.06797|2017-10-10 21:17:59.06797
NCT03068702|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-01|||August 21, 2016|Actual|2016-08-21|February 2017|2017-02-01|February 21, 2017|Actual|2017-02-21|January 12, 2017|Actual|2017-01-12||Observational|OCTA||New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)|New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy|Completed||N/A|2|Actual|Dr. S.S. Michel Clinic|||1||f||||f|f|f||||||No||2017-10-10 21:17:59.16394|2017-10-10 21:17:59.16394
NCT03068689|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-08-30|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Remote Ischaemic PreConditioning (RIPC) in Partial Nephrectomy for the Prevention of Ischemia/Reperfusion Injury|Remote Ischaemic PreConditioning (RIPC) in Partial Nephrectomy for the Prevention of Ischemia/Reperfusion Injury|Not yet recruiting||N/A|40|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f|f|f||||||||2017-10-10 21:17:59.240508|2017-10-10 21:17:59.240508
NCT03068676|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-24|||February 8, 2017|Actual|2017-02-08|April 2017|2017-04-01|May 2, 2018|Anticipated|2018-05-02|February 8, 2018|Anticipated|2018-02-08||Interventional|||Internet-delivered Treatments for Depression and Anxiety in Primary Care (SUMMA)|A Pilot Study Investigating the Feasibility of Implementing Internet-delivered Treatments for Depression and Anxiety in Primary Care|Recruiting||N/A|96|Anticipated|Silver Cloud Health||2|||f||||f|f|f||||||No||2017-10-10 21:17:59.336335|2017-10-10 21:17:59.336335
NCT03068663|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-07-18|||May 23, 2017|Actual|2017-05-23|July 2017|2017-07-01|November 30, 2019|Anticipated|2019-11-30|May 31, 2019|Anticipated|2019-05-31||Observational|MICA||Microbiota and the Lung Cancer|Characterization of Microbiota (Intestinal, From Lungs, and Upper Airways) in Patients With Non-small Cell Lung Carcinoma: Observational Study|Recruiting||N/A|40|Anticipated|Centre Jean Perrin|||2||f||||f|f|f||||Samples With DNA|"     Blood, saliva, faecal samples, tumour/peritumoural tissue, lung tissue, bronchoalveolar     lavage fluid.   "|||2017-10-10 21:17:59.462549|2017-10-10 21:17:59.462549
NCT03068650|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-06-13||||||June 2017|2017-06-01||||||||Expanded Access|CDX-110||Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut|Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut (CDX-110)|Available||N/A|||Celldex Therapeutics|||||||t||||||||||||2017-10-10 21:17:59.571198|2017-10-10 21:17:59.571198
NCT03068637|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-01|||August 23, 2016|Actual|2016-08-23|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma|Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma|Recruiting||N/A|210|Anticipated|Carevive Systems, Inc.||1|||f||||f|f|f||||||No||2017-10-10 21:17:59.626678|2017-10-10 21:17:59.626678
NCT03068624|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-11|||September 8, 2017|Actual|2017-09-08|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4 for Patients With Metastatic Uveal Melanoma|Phase Ib Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4 for Patients With Metastatic Uveal Melanoma|Recruiting||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:17:59.715185|2017-10-10 21:17:59.715185
NCT03068611|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-05-15|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Development and Pilot Testing of a Multimodal Web-based Program to Address Heavy Drinking During Smoking Cessation|Development and Pilot Testing of a Multimodal Web-based Program to Address Heavy Drinking During Smoking Cessation|Recruiting||N/A|120|Anticipated|Brown University||2|||f||||f|f|f||||||No||2017-10-10 21:17:59.999591|2017-10-10 21:17:59.999591
NCT03068598|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-10|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|August 1, 2017|Anticipated|2017-08-01|July 1, 2017|Anticipated|2017-07-01||Interventional|SSLEEM||Suicide Sleep Monitoring (Ssleem)|Connected Sleep Recording Device for Suicidal Patients, Acceptability Study - Suicide Sleep Monitoring (Ssleem)|Recruiting||N/A|20|Anticipated|University Hospital, Brest||1|||f||||f|f|f||||||No||2017-10-10 21:18:00.113126|2017-10-10 21:18:00.113126
NCT03068585|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2017-02-26|||February 2010|Actual|2010-02-01|June 2011|2011-06-01|July 1, 2011|Actual|2011-07-01|June 1, 2011|Actual|2011-06-01||Interventional|Neovasculgen||Efficiency, Safety and Portability of Neovasculgen|Phase 3 Study of Efficiency, Safety and Portability of Gene Therapy Drug Neovasculgen (DNA Encoding the 165-amino-acid Isoform of Human Vascular Endothelial Growth Factor (pCMV - VEGF165) for Peripheral Arterial Disease Complex Treatment|Completed||Phase 2/Phase 3|100|Actual|Human Stem Cell Institute, Russia||2|||f||||f||||||||No||2017-10-10 21:18:00.205539|2017-10-10 21:18:00.205539
NCT03068572|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-18|||January 15, 2017|Actual|2017-01-15|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|October 30, 2017|Anticipated|2017-10-30||Observational|||Diagnostic Value of Linked Color Imaging for Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and GERD|A Study on the Diagnosis of Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and Gastroesophageal Reflux Disease Using Linked Color Imaging|Recruiting||N/A|90|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences|||2||f||||t|f|f||||||||2017-10-10 21:18:00.307303|2017-10-10 21:18:00.307303
NCT03068559|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-04-06|||December 20, 2012|Actual|2012-12-20|March 2017|2017-03-01|September 15, 2016|Actual|2016-09-15|December 15, 2014|Actual|2014-12-15||Observational|DYSPHAGIA||Consequences of an Initial Treatment for Head and Neck Cancer on Swallowing Function: Impact on Nutritional Status|Consequences of an Initial Treatment for Head and Neck Cancer on Swallowing Function: Impact on Nutritional Status|Completed||N/A|240|Actual|Centre Antoine Lacassagne|||1||f||||f|f|f||||||No||2017-10-10 21:18:00.416058|2017-10-10 21:18:00.416058
NCT03068533|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-01|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||8% L-Arginine/Calcium Carbonate Toothpaste in Comparison to Strontium Acetate Toothpaste for Hypersensitive Dentin|The Use of 8% L-Arginine/Calcium Carbonate Containing Toothpaste in Comparison to Strontium Acetate Containing Toothpaste in Management of Hypersensitive Dentine in Chronic Periodontitis Patients : A Randomized-controlled Clinical Trial|Not yet recruiting||N/A|46|Anticipated|Cairo University||2|||f|||||f|f||||||Undecided||2017-10-10 21:18:00.579299|2017-10-10 21:18:00.579299
NCT03068520|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-20|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease Progression?|Imaging After Stereotactic Radiosurgery for Brain Metastases or Primary Tumor Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease ?|Recruiting||N/A|140|Anticipated|Assuta Medical Center||3|||f||||f|f|f||||||No||2017-10-10 21:18:00.672564|2017-10-10 21:18:00.672564
NCT03068507|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-08|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||The Impact of Trimodal Prehabilitation Strategy on Patients Undergoing Thoracoscopic Lobectomy|The Impact of Trimodal Prehabilitation Strategy on Perioperative Functional Capability and Prognosis of Patients Undergoing Thoracoscopic Lobectomy for Lung Cancer：a Randomized Controlled Trail|Not yet recruiting||N/A|100|Anticipated|Peking Union Medical College Hospital||2|||f|||||f|f||||||Yes||2017-10-10 21:18:00.814245|2017-10-10 21:18:00.814245
NCT03068494|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-05|||February 28, 2017|Actual|2017-02-28|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|August 31, 2017|Anticipated|2017-08-31|3 Years|Observational [Patient Registry]|COBIS III||Korean Coronary Bifurcation Stenting (COBIS) Registry III|Multicenter, Retrospective Korean Coronary Bifurcation Stenting (COBIS) Registry III|Recruiting||N/A|3000|Anticipated|Samsung Medical Center|||1||f||||f|f|f||||||||2017-10-10 21:18:00.946325|2017-10-10 21:18:00.946325
NCT03068481|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-02-26||||||February 2017|2017-02-01||||January 2018|Anticipated|2018-01-01||Interventional|||A Phase I Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease.||Recruiting||Phase 1|||Kissei Pharmaceutical Co., Ltd.||5|||f||||||||||||||2017-10-10 21:18:01.039562|2017-10-10 21:18:01.039562
NCT03068455|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-10-03|||April 7, 2017|Actual|2017-04-07|October 2017|2017-10-01|February 17, 2023|Anticipated|2023-02-17|November 8, 2020|Anticipated|2020-11-08||Interventional|CheckMate 915||An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma|A Phase 3, Randomized Study of Adjuvant Immunotherapy With Nivolumab Combined With Ipilimumab Versus Nivolumab Monotherapy After Complete Resection of Stage IIIb/c/d or Stage IV Melanoma|Recruiting||Phase 3|900|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 21:18:01.330326|2017-10-10 21:18:01.330326
NCT03068273|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-02-24|||May 2015||2015-05-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|Pilot Hosp CGM||Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign (Pilot)||Recruiting||N/A|56|Anticipated|Scripps Whittier Diabetes Institute||2|||f||||t|f|f||||||No||2017-10-10 21:18:03.394395|2017-10-10 21:18:03.394395
NCT03068442|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-02|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition|Amyloid Deposition and Preexisting Vulnerable Carotid Plaque Features Predicting Cognitive Improvement After Surgery|Recruiting||Phase 2|45|Anticipated|University of Utah||1|||f||||t|t|f||||||Yes|"All data will be made freely and publicly available on ClinicalTrials.gov within 12 months of the end of the funding period (and any no-cost extension).
Carotid intraplaque hemorrhage
Carotid plaque inflammation on histology
Age, stroke status, male sex, smoking and vitamin D level
Statin, antiplatelet, or antihypertensive use
Ipsilateral brain inflammation measured by PET
Carotid stenosis and perfusion parameters
Cognitive score"|2017-10-10 21:18:02.051634|2017-10-10 21:18:02.051634
NCT03068429|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-07-19|||December 1, 2016|Actual|2016-12-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|February 20, 2019|Anticipated|2019-02-20||Interventional|FEARCON||Fear Conditioned Response in Healthy Subjects and in OCD Patients Pre and Post Treatment With Sertraline.|Fear Conditioning, Extinction and Recall in Healthy Subjects and in Obsessive-compulsive Disorder Patients Pre and Post Treatment With Sertraline.|Recruiting||Phase 4|48|Anticipated|University of Sao Paulo||1|||f||||t|f|f|||f|||||2017-10-10 21:18:02.16128|2017-10-10 21:18:02.16128
NCT03068416|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-10-02|||September 18, 2017|Actual|2017-09-18|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy|CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy - a Phase II Trial.|Recruiting||Phase 2|15|Anticipated|Uppsala University||1|||f||||f|f|f||||||||2017-10-10 21:18:02.285995|2017-10-10 21:18:02.285995
NCT03068403|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-07-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|RECT||Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT|Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT|Not yet recruiting||N/A|20|Anticipated|University Hospital, Bordeaux||2|||f||||f|f|f||||||||2017-10-10 21:18:02.397734|2017-10-10 21:18:02.397734
NCT03068390|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-24|||February 24, 2017|Actual|2017-02-24|February 2017|2017-02-01|August 21, 2021|Anticipated|2021-08-21|August 21, 2021|Anticipated|2021-08-21||Interventional|RICHH||Rural Intervention for Caregivers' Heart Health|Rural Intervention for Caregivers' Heart Health (RICHH)|Recruiting||N/A|280|Anticipated|University of Kentucky||2|||f||||f|f|f||||||No||2017-10-10 21:18:02.52084|2017-10-10 21:18:02.52084
NCT03068377|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-02-26|||March 20, 2017|Anticipated|2017-03-20|February 2017|2017-02-01|August 20, 2017|Anticipated|2017-08-20|June 20, 2017|Anticipated|2017-06-20||Interventional|||The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow|The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow|Not yet recruiting||Phase 2/Phase 3|60|Anticipated|LycoRed Ltd.||2|||f|||||f|f||||||||2017-10-10 21:18:02.632502|2017-10-10 21:18:02.632502
NCT03068364|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-27|2017-03-08|||November 3, 2016|Actual|2016-11-03|March 2017|2017-03-01|February 17, 2017|Actual|2017-02-17|February 17, 2017|Actual|2017-02-17||Observational|||Biological and Electrocardiographic Biomarkers for Risk Stratification in Hypertension.|Additive Value of Biological and Electrocardiographic Biomarkers for Risk Stratification in Hypertension|Completed||N/A|1600|Actual|Hospices Civils de Lyon|||1||f||||f|f|f||||||||2017-10-10 21:18:02.735901|2017-10-10 21:18:02.735901
NCT03068338|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-08|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Robotic Sock Technology for Prevention of Deep Vein Thrombosis and Joint Contracture|Robotic Sock Technology for Prevention of Deep Vein Thrombosis and Joint Contracture|Recruiting||N/A|30|Anticipated|National University Hospital, Singapore||2|||f|||||f|f||||||||2017-10-10 21:18:02.941339|2017-10-10 21:18:02.941339
NCT03068325|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-02-28|||April 2016|Actual|2016-04-01|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|TF-EAT||Trauma-Focused Equine-Assisted Therapy (TF-EAT) for Veterans With PTSD|Trauma-Focused Equine-Assisted Therapy (TF-EAT) for Veterans With PTSD|Recruiting||N/A|60|Anticipated|Research Foundation for Mental Hygiene, Inc.||1|||f||||||||||||||2017-10-10 21:18:03.051269|2017-10-10 21:18:03.051269
NCT03068312|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-07-28|||July 18, 2017|Actual|2017-07-18|July 2017|2017-07-01|September 25, 2018|Anticipated|2018-09-25|September 25, 2018|Anticipated|2018-09-25||Interventional|||A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation|A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Are 6 Years of Age and Older and Have Either a 3849 + 10KB C→T or D1152H-CFTR Mutation|Recruiting||Phase 3|50|Anticipated|Vertex Pharmaceuticals Incorporated||2|||f||||f|t|f|||t|||||2017-10-10 21:18:03.139969|2017-10-10 21:18:03.139969
NCT03068299|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-24|||October 1, 2017|Anticipated|2017-10-01|February 2017|2017-02-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Effects of Dance on Cognition, Frailty, and Burden in Elderly Caregivers Living in Rural Communities|Effects of Dance on Cognition, Frailty, and Burden in Elderly Caregivers Living in Rural Communities|Not yet recruiting||N/A|58|Anticipated|Universidade Federal de Sao Carlos||2|||f||||t|f|f||||||No|No participant data will be shared with other research. However, the analyzed results will be published in papers.|2017-10-10 21:18:03.212448|2017-10-10 21:18:03.212448
NCT03068286|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-01|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|June 1, 2018|Anticipated|2018-06-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||iCBT for Long-term Conditions in IAPT|Tailored Internet-delivered Cognitive Behavioural Therapy for Depression and Anxiety in Patients With a Long-term Condition (Chronic Pain, COPD and Diabetes).|Recruiting||N/A|105|Anticipated|Silver Cloud Health||3|||f||||f|f|f||||||No||2017-10-10 21:18:03.294011|2017-10-10 21:18:03.294011
NCT03068260|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-01|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section.|Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section. A Double Blind, Randomized, Placebo Controlled Trial.|Not yet recruiting||Phase 4|72|Anticipated|Zealand University Hospital||2|||f||||t|t|f|||f|||No||2017-10-10 21:18:03.479009|2017-10-10 21:18:03.479009
NCT03068247|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-28|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Neurobiology of Treatment Responses in MDD|Neurobiology of Non-Specific and Specific Treatment Responses in Major Depression|Not yet recruiting||Phase 3|80|Anticipated|University of Utah||2|||f||||t|t|f|||f|||||2017-10-10 21:18:03.564736|2017-10-10 21:18:03.564736
NCT03068234|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-24|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis|A Randomized, Double-blinded, Placebo Controlled Study to Evaluate Clinical Efficacy and Safety of Pirfenidone for Skin Fibrosis in Systemic Sclerosis|Not yet recruiting||Phase 2/Phase 3|72|Anticipated|RenJi Hospital||2|||f|||||f|f||||||Undecided||2017-10-10 21:18:03.645352|2017-10-10 21:18:03.645352
NCT03068221|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-26|||March 1, 2017|Anticipated|2017-03-01|January 2017|2017-01-01|August 30, 2017|Anticipated|2017-08-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Clinical Sciences Research Proposal- The Effect of Physical Exercise on PCOS Overweight Female Adolescents|Clinical Sciences Research Proposal- The Effect of Physical Exercise on Poly Cystic Ovary Syndrome Overweight Female Adolescents|Not yet recruiting||N/A|30|Anticipated|Meir Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:18:03.735971|2017-10-10 21:18:03.735971
NCT03068208|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-26|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians|Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study|Not yet recruiting||N/A|15|Anticipated|Chulalongkorn University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:18:03.807062|2017-10-10 21:18:03.807062
NCT03068195|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-02-24|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Efficacy and Safety of Microwave Ablation in BosniakⅠ~ⅡF Cystic Renal Lesions|Efficacy and Safety of Microwave Ablation in BosniakⅠ~ⅡF Cystic Renal Lesions: Clinical Outcomes of a Randomised Controlled Trial|Recruiting||N/A|300|Anticipated|RenJi Hospital||3|||f||||t||||||||No||2017-10-10 21:18:03.883599|2017-10-10 21:18:03.883599
NCT03068182|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-08-06|||September 1, 2015|Actual|2015-09-01|February 2017|2017-02-01|January 25, 2017|Actual|2017-01-25|September 25, 2016|Actual|2016-09-25||Interventional|||Effects of Arm Crank Versus Treadmill Exercises on Heart Rate Variability in Adult Subjects.|Cardiovascular Responses to Arm Crank Exercise Versus to Treadmill Exercise in Adult Subjects|Completed||N/A|130|Actual|Dammam University||2|||f||||t|f|f|||f|||||2017-10-10 21:18:04.106233|2017-10-10 21:18:04.106233
NCT03068169|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-06-07|||June 15, 2017|Anticipated|2017-06-15|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|September 1, 2018|Anticipated|2018-09-01||Observational|ECG-shirt||Biomedical Shirt-based ECG Monitoring|Biomedical Shirt-based ECG Monitoring in Relevant Clinical Situations|Recruiting||N/A|220|Anticipated|Medical University of Warsaw|||1||f||||f|f|f||||||Yes|Data will be available for meta-analysis|2017-10-10 21:18:04.233986|2017-10-10 21:18:04.233986
NCT03068156|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-26|||January 31, 2017|Actual|2017-01-31|February 2017|2017-02-01|March 2, 2018|Anticipated|2018-03-02|January 30, 2018|Anticipated|2018-01-30||Interventional|||Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians|Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study|Recruiting||N/A|15|Anticipated|Chulalongkorn University||2|||f||||t|f|f|||t|||Undecided||2017-10-10 21:18:04.381685|2017-10-10 21:18:04.381685
NCT03068143|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-24|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|PTMIBT||Postoperative Temperature Monitoring In Brain Trauma|A Muti-centre Prospective Observational Study on Postoperative Temperature Monitoring In Patients With Brain Trauma|Recruiting||N/A|150|Anticipated|RenJi Hospital|||1||f|||||f|f||||||||2017-10-10 21:18:04.52243|2017-10-10 21:18:04.52243
NCT03068130|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-07-31|||April 18, 2017|Actual|2017-04-18|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|RANGER||Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER|An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension|Recruiting||Phase 3|414|Anticipated|Reata Pharmaceuticals, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:18:04.660848|2017-10-10 21:18:04.660848
NCT03068117|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-03-01|||March 2014||2014-03-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|RESPECT-Meso||Malignant Mesothelioma - Can we Improve Quality of Life|"A Multicentre, Non-blinded, Randomised Controlled Trial to Assess the Impact of Regular Early SPEcialist Symptom Control Treatment on Quality of Life in Malignant Mesothelioma - RESPECT-Meso"|Active, not recruiting||N/A|319|Actual|Portsmouth Hospitals NHS Trust||2|||f||||f||||||||No||2017-10-10 21:18:05.266468|2017-10-10 21:18:05.266468
NCT03068104|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-02-26|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Unmet Need for Massive Transfusion in Indian Trauma Patients|What is the Difference Between Predicted Need for Massive Transfusion and Actual Transfusion in Adult Trauma Patients in an Urban Indian Setting?|Active, not recruiting||N/A|16047|Actual|Karolinska Institutet|||1||f||||t|f|f||||||No||2017-10-10 21:18:05.439864|2017-10-10 21:18:05.439864
NCT03068091|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-07-01|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Assessment of Lung Movement With Computed Tomography (CT)|Assessment of Lung Movement With CT in Healthy Subjects and Patients With ILD|Recruiting||N/A|40|Anticipated|University of Missouri-Columbia||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:18:05.524423|2017-10-10 21:18:05.524423
NCT03068078|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-03-07|||May 2016||2016-05-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|ReDuCtion||A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes|A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes: a Six-month Study of Changes in Metabolism, Liver- and Cardiovascular Function (ReDuCtion)|Recruiting||N/A|135|Anticipated|Odense University Hospital||2|||f||||t||||||||No||2017-10-10 21:18:05.622993|2017-10-10 21:18:05.622993
NCT03068065|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-28|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Interventional|||Antidiabetic Effects on Intrahepatic Fat|Comparison of Efficacy of Liraglutide, Metformin and Gliclazide MR on Hepatic Lipid Content in Patients With Type 2 Diabetes (T2DM) and Non-alcoholic Fatty Liver (NAFLD)|Completed||Phase 4|87|Actual|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||3|||f||||t||||||||Undecided||2017-10-10 21:18:05.725474|2017-10-10 21:18:05.725474
NCT03068052|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-27|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|August 8, 2017|Actual|2017-08-08||Interventional|||Behavioral Economic Incentives and Cancer Health Risk Assessment|Behavioral Economic Incentives and Cancer Health Risk Assessment|Enrolling by invitation||N/A|2000|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 21:18:05.835758|2017-10-10 21:18:05.835758
NCT03068026|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-25|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Influence of the VitaBreath on Exercise Tolerance in COPD|Influence of the VitaBreath Device on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease|Not yet recruiting||N/A|24|Anticipated|North Tyneside General Hospital||2|||f||||f|f|f|||f|||No||2017-10-10 21:18:06.016101|2017-10-10 21:18:06.016101
NCT03068013|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2017-02-24|||January 2017||2017-01-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|CALM-IT||Managing Cancer and Living Meaningfully (CALM) Adapted to Italian Cancer Care Setting|Efficacy of a Brief Manualized Intervention Managing Cancer and Living Meaningfully (CALM) Adapted to Italian Cancer Care Setting. Study Protocol for a Randomized Controlled Trial|Enrolling by invitation||N/A|198|Anticipated|Università degli Studi di Ferrara||2|||f||||t||||||||No||2017-10-10 21:18:06.114557|2017-10-10 21:18:06.114557
NCT03068000|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-07-03|||March 3, 2017|Actual|2017-03-03|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|August 9, 2018|Anticipated|2018-08-09||Interventional|||Effect of Judo Training Compared to Ball Games on Motor Skills, Physical Fitness, Quality of Life and Cardiovascular Parameters in Children and Adolescents|Effect of Judo Training Compared to Ball Games on Motor Skills, Physical Fitness, Quality of Life and Cardiovascular Parameters in Children and Adolescents: Randomized Crinical Trial|Recruiting||N/A|66|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f|f|f||||||||2017-10-10 21:18:06.239084|2017-10-10 21:18:06.239084
NCT03067987|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-09-25|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|March 22, 2018|Anticipated|2018-03-22|December 22, 2017|Anticipated|2017-12-22||Interventional|||Safety and Efficacy of Low Intensity Shockwave for the Treatment of Erectile Dysfunction|Safety and Efficacy of Low Intensity Shockwave for the Treatment of Erectile Dysfunction- Comparison of Two Treatment Schedule|Recruiting||N/A|80|Anticipated|University of Miami||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:18:06.343585|2017-10-10 21:18:06.343585
NCT03067974|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-08-24|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study|Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study|Not yet recruiting||Early Phase 1|10|Anticipated|University of Arizona||1|||f||||f|f|f||||||||2017-10-10 21:18:06.453559|2017-10-10 21:18:06.453559
NCT03067961|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-05-23|||December 2016||2016-12-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2017|Anticipated|2017-06-01||Interventional|TYGER||Investigating Typhoid Fever Pathogenesis|Investigating the Role of Typhoid Toxin in the Pathogenesis of Enteric Fever: A Double-blinded, Randomised, Outpatient Human Challenge Study.|Recruiting||N/A|40|Anticipated|University of Oxford||2|||f||||t||||||||No||2017-10-10 21:18:06.534275|2017-10-10 21:18:06.534275
NCT03067948|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-16|||February 9, 2017|Actual|2017-02-09|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|June 30, 2017|Actual|2017-06-30||Interventional|PROACT||Improving Identification of Mental Health/Substance Use Disorders in HIV Primary Care: Pilot Clinical Response|Improving Identification of Mental Health/Substance Use Disorders in HIV Primary Care: Pilot Clinical Response|Completed||N/A|60|Actual|Johns Hopkins University||1|||f||||f|f|f||||||||2017-10-10 21:18:06.626428|2017-10-10 21:18:06.626428
NCT03067935|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-13||||||June 2017|2017-06-01||||||||Expanded Access|||Individual Patient Expanded Access-Glembatumumab Vedotin||Available||N/A|||Celldex Therapeutics|||||f|t|||||||||||||2017-10-10 21:18:06.689699|2017-10-10 21:18:06.689699
NCT03067922|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-24|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|September 6, 2018|Anticipated|2018-09-06|March 6, 2018|Anticipated|2018-03-06|6 Months|Observational [Patient Registry]|||Postmastectomy Pain Syndrome in an Indian Cancer Hospital|Post Mastectomy Pain Syndrome at an Indian Tertiary Cancer Centre: Incidence, Pain Severity, Impact on Daily Function and Quality of Life|Recruiting||N/A|120|Anticipated|Tata Memorial Centre|||1||f||||t|f|f||||||No||2017-10-10 21:18:06.741183|2017-10-10 21:18:06.741183
NCT03067909|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-02-28|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|||Antithrombotic Therapy in Patients Undergoing CIED Surgery - HEMATOMA NO MORE Registry|THE Management of AntiThrOMbotic therApy in Patients Undergoing Electrophysiological Device Surgery: Italian NatiOnal Multicenter Observational REgistry (HEMATOMA NO MORE)|Recruiting||N/A|1000|Anticipated|Azienda Ospedaliera Universitaria Senese|||1||f||||t|f|f||||||Yes|IPD will be made available on demand to other researchers.|2017-10-10 21:18:06.831554|2017-10-10 21:18:06.831554
NCT03067896|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2017-02-25|||June 2015||2015-06-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Dexmedetomidine Versus Magnesium Sulphate for Caesarean Delivery|Effect of Adding Dexmedetomidine Versus Magnesium Sulphate to Intrathecal Bupivacaine on Spinal Block and Neonatal Outcome in Uncomplicated Caesarean Delivery|Recruiting||Phase 3|78|Anticipated|Assiut University||3|||f||||||||||||Undecided||2017-10-10 21:18:06.904102|2017-10-10 21:18:06.904102
NCT03067883|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-28|||November 9, 2016|Actual|2016-11-09|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients|Evaluation of Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir Plus Ribavirin Based Therapy for Chronic Hepatitis C With or Without Compensated Cirrhosis in Haemodialysis Patients|Recruiting||Phase 2|40|Anticipated|Ain Shams University||1|||f||||f|t||||f|||Undecided||2017-10-10 21:18:06.980829|2017-10-10 21:18:06.980829
NCT03067870|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-02-28|||November 2016||2016-11-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|||Transplantation of Autologous Bone Marrow Derived Stem Cells in Patients With Rheumatoid Arthritis|Transplantation of Autologous Purified Bone Marrow Derived Specific Populations of Stem Cells and Mesenchymal Stem Cells in Patients With Rheumatoid Arthritis|Active, not recruiting||Phase 1|100|Anticipated|Stem Cells Arabia||1|||f||||t||||||||Undecided||2017-10-10 21:18:07.161277|2017-10-10 21:18:07.161277
NCT03067857|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-03-01|||September 2016||2016-09-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|||Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease|Autologous Purified Bone-Marrow-Derived Stem Cell Therapy for Motor Neuron Disease|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Stem Cells Arabia||1|||f||||f||||||||Undecided||2017-10-10 21:18:07.242415|2017-10-10 21:18:07.242415
NCT03067844|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-13|||April 25, 2017|Actual|2017-04-25|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|PACMAN-AMI||Vascular Effects of Alirocumab in Acute MI-Patients|Effects of the PCSK9 Antibody AliroCuMab on Coronary Atherosclerosis in PatieNts With Acute Myocardial Infarction: A Serial, Multivessel, Intravascular Ultrasound, Near-Infrared Spectroscopy And Optical Coherence Tomography Imaging Study|Recruiting||Phase 3|220|Anticipated|University Hospital Inselspital, Berne||2|||f||||t|f|f||||||||2017-10-10 21:18:07.329597|2017-10-10 21:18:07.329597
NCT03067831|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-25|2017-03-01|||September 2015||2015-09-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy|Safety and Efficacy of Purified Autologous Bone Marrow-Derived Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy.|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Stem Cells Arabia||1|||f||||t||||||||Undecided||2017-10-10 21:18:07.461067|2017-10-10 21:18:07.461067
NCT03067818|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-15|||June 20, 2017|Actual|2017-06-20|August 2017|2017-08-01|February 28, 2019|Anticipated|2019-02-28|January 15, 2019|Anticipated|2019-01-15||Interventional|||Mechanisms of Arm Recovery in Stroke Patients With Hand Paralysis|Mechanisms of Arm Recovery in Stroke Patients With Hand Paralysis|Recruiting||N/A|26|Anticipated|George Mason University||3|||f||||f|f|f||||||||2017-10-10 21:18:07.554082|2017-10-10 21:18:07.554082
NCT03067805|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-02|||February 2016||2016-02-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|||Influence of Oxytocin on Romantic Jealousy||Recruiting||N/A|160|Anticipated|University of Electronic Science and Technology of China||2|||f||||||||||||||2017-10-10 21:18:07.69405|2017-10-10 21:18:07.69405
NCT03067792|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-28|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|October 17, 2016|Actual|2016-10-17|October 17, 2016|Actual|2016-10-17||Interventional|||FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer||Completed||Phase 3|52|Actual|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:18:07.810703|2017-10-10 21:18:07.810703
NCT03067779|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-07-25|||June 26, 2017|Actual|2017-06-26|February 2017|2017-02-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|eCRIC||Is There a Digital Divide in Chronic Kidney Disease (CKD)?|Is There a Digital Divide in Chronic Kidney Disease (CKD)?|Recruiting||N/A|1200|Anticipated|Duke University||1|||f|||||f|f||||||||2017-10-10 21:18:07.90678|2017-10-10 21:18:07.90678
NCT03067766|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-18|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comic Art Creation as Supportive Care in Cancer Patients and Caregivers|A Pilot Study to Test the Feasibility of Comic Art Creation for Symptom Management in Cancer Supportive Care|Recruiting||N/A|20|Anticipated|City of Hope Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:18:08.030117|2017-10-10 21:18:08.030117
NCT03067753|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-24|||December 2016||2016-12-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis||Recruiting||Phase 2|28|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||No||2017-10-10 21:18:08.146545|2017-10-10 21:18:08.146545
NCT03067714|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-08-18|||March 30, 2017|Actual|2017-03-30|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|TEMPO||A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy|A Randomised, Double-blind, Controlled, Parallel-group, Multi-country Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy|Recruiting||Phase 3|700|Anticipated|Nutricia Research||2|||f||||t|f|f||||||||2017-10-10 21:18:08.471717|2017-10-10 21:18:08.471717
NCT03067688|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-04-16|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia|A Randomized, Double-blind, Active-controlled, Multicenter Phase3 Trial to Evaluate the Efficacy and Safety of Co-administrated Temisartan/Amlodipine and Rosuvastatin in Subjects With Hypertension and Hyperlipidemia|Recruiting||Phase 3|180|Anticipated|Yuhan Corporation||3|||f||||f|f|f||||||No||2017-10-10 21:18:08.659736|2017-10-10 21:18:08.659736
NCT03067675|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-03|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|August 30, 2017|Anticipated|2017-08-30||Observational|||Triton Reference Database|Topcon DRI OCT Triton Reference Database Study|Active, not recruiting||N/A|500|Anticipated|Topcon Medical Systems, Inc.|||1||f||||f|f|t|t|f|f|||||2017-10-10 21:18:08.773681|2017-10-10 21:18:08.773681
NCT03067662|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-23|||September 27, 2012||2012-09-27|February 2017|2017-02-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Interventional|GDM-FIT||Aerobic Exercise in Women With Gestational Diabetes|Efficacy of Supervised Physical Exercise in Metabolic Control of Women With Gestational Diabetes|Recruiting||N/A|48|Anticipated|Universita di Verona||2|||f||||t|f|f||||||No||2017-10-10 21:18:08.85952|2017-10-10 21:18:08.85952
NCT03067649|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-07|||February 2010|Actual|2010-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Parents' Adherence to Treatment Recommendations|Parents' Adherence to Treatment Recommendations: Do It for the Children|Completed||N/A|194|Actual|Vanderbilt University||2|||f||||f|f|f||||||No|No plan to share the data at this time|2017-10-10 21:18:08.964156|2017-10-10 21:18:08.964156
NCT03067636|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-13|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 20, 2020|Anticipated|2020-12-20|June 1, 2020|Anticipated|2020-06-01||Interventional|||Retraining Body and Brain to Conquer Compulsions|Retraining the Body and Brain to Conquer Compulsions|Recruiting||N/A|90|Anticipated|Monash University||3|||f||||f|f|f||||||No||2017-10-10 21:18:09.031214|2017-10-10 21:18:09.031214
NCT03067623|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-02|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|February 27, 2019|Anticipated|2019-02-27|December 31, 2018|Anticipated|2018-12-31||Interventional|||Autologous Platelet-Rich Plasma (PRP) and Endometrial Thickness|Intrauterine Infusion of Autologous Platelet-Rich Plasma (PRP) in Women With Thin Endometrium Undergoing Embryo-transfer.|Recruiting||Phase 2|200|Anticipated|University Magna Graecia||1|||f||||f|t|f|||f|||No||2017-10-10 21:18:09.127287|2017-10-10 21:18:09.127287
NCT03067610|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-06-21|||January 20, 2017|Actual|2017-01-20|June 2017|2017-06-01|December 31, 2026|Anticipated|2026-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|INFIELD||Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer|A Prospective Phase II Study of Involved Field Elective Volume De-Intensification for Oropharyngeal and Laryngeal Squamous Cell Carcinoma Treated With Intensity Modulated Radiation Therapy|Recruiting||Phase 2|72|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t|t|f||||||No||2017-10-10 21:18:09.222141|2017-10-10 21:18:09.222141
NCT03067584|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-05-31|||May 9, 2017|Actual|2017-05-09|February 2017|2017-02-01|May 31, 2027|Anticipated|2027-05-31|May 31, 2027|Anticipated|2027-05-31||Observational|||Genetic Study of Familial Acute Lymphoblastic Leukemia|Genetic Study of Familial Acute Lymphoblastic Leukemia|Recruiting||N/A|100|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     Blood and tumor/tissue for DNA testing.   "|||2017-10-10 21:18:09.417676|2017-10-10 21:18:09.417676
NCT03067571|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-13|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||Daratumumab in Subjects With Relapsed/Refractory Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome|An Open-label, Phase 2 Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome|Not yet recruiting||Phase 2|36|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:18:09.491375|2017-10-10 21:18:09.491375
NCT03067558|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-07-27|||April 5, 2017|Actual|2017-04-05|July 2017|2017-07-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Observational|||Acute Respiratory Infection Diagnostic Aids (ARIDA) Controlled Accuracy Evaluation Protocol|Acute Respiratory Infection Diagnostic Aids (ARIDA) for Children Under Five Years When Used in a Controlled Setting in Ethiopia: Study Protocol for Controlled Accuracy Evaluation|Terminated||N/A|150|Actual|Malaria Consortium|||3|Device incorrect colour-coded classification of fast breathing for RR|f||||f|f|f||||||||2017-10-10 21:18:09.5799|2017-10-10 21:18:09.5799
NCT03067545|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-22|||March 22, 2017|Actual|2017-03-22|March 2017|2017-03-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Do Simple Running Technique Changes Reduce Pain and Change Injury Causing Mechanics|Do Simple Running Technique Changes Reduce Pain and Change Injury Causing Mechanics in Runners With Common Running Related Injuries?|Recruiting||N/A|15|Anticipated|University of Salford||1|||f||||f|f|f||||||No||2017-10-10 21:18:09.674754|2017-10-10 21:18:09.674754
NCT03067532|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-02-26|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||Assessment of Educational Effect of Home-made Robotic Surgery Simulator for Novice Robotic Surgeons|Assessment of Educational Effect of Home-made Robotic Surgery Simulator for Novice Robotic Surgeons|Recruiting||N/A|66|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:18:09.753585|2017-10-10 21:18:09.753585
NCT03067519|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-01|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|January 31, 2016|Actual|2016-01-31|December 31, 2015|Actual|2015-12-31||Interventional|||Fast Track Surgery for Abdominal Surgery in Rwanda|Fast Track Surgery for Abdominal Surgery in Rwanda: a Randomized Controlled Trial|Completed||N/A|62|Actual|University of Rwanda||2|||f||||f|f|f||||||No||2017-10-10 21:18:09.823983|2017-10-10 21:18:09.823983
NCT03066973|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-13|||May 1, 2016|Actual|2016-05-01|March 2017|2017-03-01|July 30, 2016|Actual|2016-07-30|June 30, 2016|Actual|2016-06-30||Interventional|||BREATHING EXERCISES FOR LABOR PAIN AND DURATION|THE EFFECTIVENESS OF BREATHING EXERCISES TO LABOR PAIN and DURATION: A RANDOMIZED CONTROLLED TRIAL|Completed||N/A|250|Actual|Ataturk University||2|||f||||f|f|f||||||Yes|it will be submitted as an article|2017-10-10 21:18:14.096903|2017-10-10 21:18:14.096903
NCT03067506|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-07-10|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Observational|||Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology|A Single Center Pilot Study to Evaluate Real Time Passive and Active High-Frequency Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology|Completed||N/A|30|Actual|Takeda|||1||f||||f|f|f||||||||2017-10-10 21:18:09.886373|2017-10-10 21:18:09.886373
NCT03067493|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-26|2017-03-22|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|RAMEC||RFA Combined With Neo-MASCT for Primary HCC: a Phase II Trial|Radiofrequency Ablation Combined With Neo-MASCT for Primary Hepatocellular Carcinoma: a Randomised, Multicentre Phase II Trial|Not yet recruiting||Phase 2|98|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||No||2017-10-10 21:18:09.960462|2017-10-10 21:18:09.960462
NCT03067480|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-07-25|||June 6, 2017|Actual|2017-06-06|February 2017|2017-02-01|July 1, 2018|Anticipated|2018-07-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients|Comparison of 3 Versus 6-Month Use of Professional Continuous Glucose Monitoring in the Treatment of Poorly Controlled, Non-Insulin Using T2DM Patients in a Primary Care Setting|Recruiting||N/A|25|Anticipated|East Tennessee State University||2|||f||||f|f|t|f||t|||||2017-10-10 21:18:10.052983|2017-10-10 21:18:10.052983
NCT03067467|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-23|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|HPCIM||Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)|Investigating Metabolic Characteristics of Intracranial Malignancy In Vivo Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)|Not yet recruiting||Early Phase 1|16|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|t|f||||||No||2017-10-10 21:18:10.134765|2017-10-10 21:18:10.134765
NCT03067454|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-21|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Early Mobilization of Spiral Metacarpal Fractures Compared With Operative Treatment|Early Mobilization of Spiral Metacarpal Fractures Compared With Operative Treatment - a Prospective Randomized Trial|Recruiting||N/A|42|Anticipated|Uppsala University||2|||f||||f|f|f||||||No||2017-10-10 21:18:10.201322|2017-10-10 21:18:10.201322
NCT03067441|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-02-24|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)|A Multicenter Open-Label Extension (OLE) Study To Assess The Long-Term Safety and Efficacy of Bempedoic Acid (ETC-1002) 180 MG|Enrolling by invitation||Phase 3|1300|Anticipated|Esperion Therapeutics||1|||f||||t|t|f||||||No||2017-10-10 21:18:10.29714|2017-10-10 21:18:10.29714
NCT03067428|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-24|||January 31, 2017|Actual|2017-01-31|February 2017|2017-02-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|FRUITLESS||Effects of Fructose Restriction on Liver Steatosis|Effects of Fructose Restriction on Liver Steatosis|Recruiting||N/A|44|Anticipated|Maastricht University Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 21:18:10.382756|2017-10-10 21:18:10.382756
NCT03067415|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-07-18|||March 30, 2017|Actual|2017-03-30|February 2017|2017-02-01|September 30, 2017|Anticipated|2017-09-30|September 10, 2017|Anticipated|2017-09-10||Interventional|||Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily|A Multi Center, Randomized, Double-blind, Parallel Design, Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily in Primary Open Angle Glaucoma or Ocular Hypertension Patients.|Recruiting||Phase 2|98|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f|f|f||||||||2017-10-10 21:18:10.46591|2017-10-10 21:18:10.46591
NCT03067402|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-15|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|June 10, 2022|Anticipated|2022-06-10|June 20, 2021|Anticipated|2021-06-20||Interventional|ROSSTAR||Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline|Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline|Not yet recruiting||N/A|1100|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:18:10.556973|2017-10-10 21:18:10.556973
NCT03067389|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-08-31|||February 6, 2016|Actual|2016-02-06|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Observational|||Combined Breast Cancer Risk Study|Evaluation of a Combined Breast Cancer Risk Derived From a Polygenic Risk Score and the Tyrer-Cuzick Model|Recruiting||N/A|500|Anticipated|Myriad Genetic Laboratories, Inc.|||2||f||||f|f|f||||Samples With DNA|"     Whole blood and saliva   "|||2017-10-10 21:18:10.759701|2017-10-10 21:18:10.759701
NCT03067376|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-02-23|||August 2016||2016-08-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the Body|An Open-label, Single-dose Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Identification of Metabolite Structures for [14C]-CORT125134 in Healthy Subjects|Completed||Phase 1|9|Actual|Corcept Therapeutics||1|||f||||f||||||||Undecided||2017-10-10 21:18:10.93037|2017-10-10 21:18:10.93037
NCT03067363|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-21|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||First in Human Single Ascending Dose Study of MOR107|Assessment of Safety, Tolerability and Pharmacokinetics of Single Ascending Subcutaneous Doses of MOR107 in Healthy Male Subjects and Pharmacodynamics in Healthy Male Subjects on a Low Sodium Diet|Recruiting||Phase 1|72|Anticipated|LanthioPep BV||11|||f||||f|f|f||||||No||2017-10-10 21:18:11.085682|2017-10-10 21:18:11.085682
NCT03067350|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-28|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|VORIGENE||Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients|Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients|Recruiting||N/A|60|Anticipated|University Hospital, Grenoble|||1||f||||f|f|f||||||No||2017-10-10 21:18:11.265891|2017-10-10 21:18:11.265891
NCT03067337|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-24|||August 30, 2015|Actual|2015-08-30|February 2017|2017-02-01|December 30, 2016|Actual|2016-12-30|August 30, 2016|Actual|2016-08-30||Interventional|||Evaluation Between Zirconia and Stainless Steel Crowns|Clinical Evaluation Between Zirconia Crowns and Stainless Steel Crowns in Primary Molars Teeth|Completed||N/A|120|Actual|King Abdulaziz University||2|||f||||f|f|t|f|f||||No||2017-10-10 21:18:11.372847|2017-10-10 21:18:11.372847
NCT03067324|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-24|||January 11, 2017|Actual|2017-01-11|February 2017|2017-02-01|July 1, 2021|Anticipated|2021-07-01|December 31, 2020|Anticipated|2020-12-31|3 Months|Observational [Patient Registry]|ISLET CHIP||Quality Control of Pancreatic Islet Intended to Islet Graft Cells Intended to Stabilot Islet Graft Protocol|Quality Control of Pancreatic Islet Intended to Islet Graft|Recruiting||N/A|40|Anticipated|University Hospital, Grenoble|||1||f||||f|f|f||||Samples Without DNA|"     pancreatic islet cells   "|No||2017-10-10 21:18:11.471693|2017-10-10 21:18:11.471693
NCT03067311|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-02|||October 3, 2016|Actual|2016-10-03|May 2017|2017-05-01|October 3, 2018|Anticipated|2018-10-03|October 3, 2018|Anticipated|2018-10-03||Interventional|I-CAT||Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy|Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy (I-CAT)|Recruiting||N/A|40|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||No||2017-10-10 21:18:11.625955|2017-10-10 21:18:11.625955
NCT03067298|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-20|||October 2016||2016-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|PREDICTION2||Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening|Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening|Recruiting||N/A|1000|Anticipated|CHU de Quebec-Universite Laval|||1||f||||f||||||Samples With DNA|"     maternal serum, maternal plasma (cell-free DNA), maternal urine   "|||2017-10-10 21:18:11.758921|2017-10-10 21:18:11.758921
NCT03067285|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-07-31|||September 1, 2017|Anticipated|2017-09-01|February 2017|2017-02-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|DREAM||A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study|A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study|Not yet recruiting||Phase 4|64|Anticipated|Fundacion SEIMC-GESIDA||2|||f||||f|f|f||||||||2017-10-10 21:18:11.861127|2017-10-10 21:18:11.861127
NCT03067272|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-10-02|||February 24, 2017|Actual|2017-02-24|October 2017|2017-10-01|September 2022|Anticipated|2022-09-01|December 31, 2017|Anticipated|2017-12-31||Interventional|BLOC||Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception|Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception|Recruiting||N/A|50|Anticipated|Femasys Inc.||1|||f||||f|f|t|t|||||||2017-10-10 21:18:11.995245|2017-10-10 21:18:11.995245
NCT03067259|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-01|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|February 1, 2019|Anticipated|2019-02-01|February 5, 2018|Anticipated|2018-02-05||Interventional|POCD||Post Operative Cognitive Dysfunction|Impact of Anesthesia Surgical Procedure on the Development of Long-term Cognitive Dysfunction|Enrolling by invitation||N/A|974|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t|f|f||||||No||2017-10-10 21:18:12.138869|2017-10-10 21:18:12.138869
NCT03067246|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-07-31|||January 2017||2017-01-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||A Comparison of the VBM Intubating Laryngeal Tube and the I-Gel|A Comparison of Two Supraglottic Devices, the VBM Intubating Laryngeal Tube and I-Gel|Recruiting||N/A|20|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 21:18:12.24033|2017-10-10 21:18:12.24033
NCT03067233|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-02-28|||April 5, 2016|Actual|2016-04-05|February 2017|2017-02-01|April 8, 2016|Actual|2016-04-08|April 8, 2016|Actual|2016-04-08||Interventional|AEP||Automated Embedded Polysomnography (AEP)|Automated Embedded Polysomnography|Completed||N/A|10|Actual|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil||1|||f|||||f|f||||||||2017-10-10 21:18:12.337529|2017-10-10 21:18:12.337529
NCT03067220|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-08|||May 1, 2016|Actual|2016-05-01|June 2017|2017-06-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Can A Virtual Clinic Review Replace A Surgical Clinic Visit After Discharge?|Can A Virtual Clinic Review Replace A Surgical Clinic Visit After Discharge?|Completed||N/A|209|Actual|Connolly Hospital Blanchardstown||2|||f||||f|f|f||||||No||2017-10-10 21:18:12.405887|2017-10-10 21:18:12.405887
NCT03067207|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-23|||November 4, 2016|Actual|2016-11-04|February 2017|2017-02-01|June 15, 2017|Anticipated|2017-06-15|June 1, 2017|Anticipated|2017-06-01||Interventional|||In-Person vs e-Health Mindfulness-Based Intervention for Adolescents With Chronic Illness|A Randomized-Control Trial of an In-Person vs e-Health Mindfulness-Based Intervention for Adolescents With Chronic Illness|Active, not recruiting||N/A|60|Anticipated|The Hospital for Sick Children||2|||f||||f|f|f||||||No||2017-10-10 21:18:12.491481|2017-10-10 21:18:12.491481
NCT03067194|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-24|||December 2016||2016-12-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients|Open-label, Multicenter, Randomized Study to Assess the Efficacy and Safety of Celecoxib 200mg Capsule QD and Celecoxib 100mg BID in Hand Osteoarthritis Patients|Recruiting||Phase 4|150|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||Undecided||2017-10-10 21:18:12.574963|2017-10-10 21:18:12.574963
NCT03067181|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-06-02|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors|A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors|Recruiting||Phase 3|1680|Anticipated|Children's Oncology Group||5|||f||||f|t|f||||||||2017-10-10 21:18:12.677366|2017-10-10 21:18:12.677366
NCT03067168|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-12|||May 17, 2017|Actual|2017-05-17|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||A Trial of Levator Muscle Blocks Following Posterior Colporrhaphy Surgery to Reduce Post-operative Pain.|A Multicenter, Double Blinded, Randomized Controlled Trial of Levator Muscle Blocks Following Posterior Colporrhaphy Surgery to Reduce Post-operative Pain.|Recruiting||N/A|128|Anticipated|The Christ Hospital||2|||f||||t|f|f|||t|||||2017-10-10 21:18:12.866104|2017-10-10 21:18:12.866104
NCT03067155|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-03-21|||October 2016||2016-10-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.|CMV Specific T Cell Therapy for the Treatment of Relapsing or Therapy Refractory CMV Infection After Allogeneic Stem Cell Transplantation With a CMV-positive Donor.|Recruiting||Phase 2|20|Anticipated|University Hospital, Ghent||2|||f||||f||||||||No||2017-10-10 21:18:12.956155|2017-10-10 21:18:12.956155
NCT03067142|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-23|||January 5, 2017|Actual|2017-01-05|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|PH1||Proteomics of Primary Hyperoxaluria Type 1|"Pilot Study: Proteomics of Primary Hyperoxaluria Type 1 (PH1): A Rare Calcium Oxalate Stone Disease"|Active, not recruiting||N/A|93|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||3||f||||f|f|f||||||Undecided||2017-10-10 21:18:13.070867|2017-10-10 21:18:13.070867
NCT03067129|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-09-29|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|April 27, 2022|Anticipated|2022-04-27|September 19, 2019|Anticipated|2019-09-19||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection|An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection|Recruiting||Phase 3|110|Anticipated|AbbVie||4|||t||||f|t|f||||||||2017-10-10 21:18:13.14507|2017-10-10 21:18:13.14507
NCT03067116|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-28|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Posturography Changes During Pregnancy|Posturography Changes During Pregnancy|Enrolling by invitation||N/A|10|Anticipated|Caps Research Network|||1||f||||f|f|f||||||No||2017-10-10 21:18:13.259477|2017-10-10 21:18:13.259477
NCT03067103|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-05-01|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||Comparison of Peritonsillar Infiltration of Tramadol Ketamine and Placebo on Pediatric Posttonsillectomy Pain|Comparison of Effect of Peritonsillar Infiltration of Ketamine and Tramadol on Pediatric Posttonsillectomy Pain: A Double-blinded Randomized Placebo-controlled Clinical Trial|Not yet recruiting||Phase 4|108|Anticipated|Universidade Federal de Goias||3|||f||||f|f|f|||f|||No||2017-10-10 21:18:13.326599|2017-10-10 21:18:13.326599
NCT03067090|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-04-21|||April 21, 2017|Actual|2017-04-21|April 2017|2017-04-01|March 15, 2019|Anticipated|2019-03-15|September 15, 2018|Anticipated|2018-09-15||Observational|||Aquamid Reconstruction for Osteoarthritis of the Knee|Prospective Study of Aquamid Reconstruction in Patients With Osteoarthritis of the Knee|Recruiting||N/A|50|Anticipated|A2 Reumatologi Og Idrætsmedicin|||1||f||||t|f|f||||||Undecided||2017-10-10 21:18:13.414387|2017-10-10 21:18:13.414387
NCT03067077|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-29|||March 12, 2017|Actual|2017-03-12|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||A Prospective, Contralateral, Eye to Eye Comparison of SMILE Surgery to LASIK Surgery|A Prospective, Randomized Comparison of SMILE Surgery to Wavefront-guided LASIK Surgery|Recruiting||Phase 4|70|Anticipated|Stanford University||2|||f||||f|f|t|f||f|||No||2017-10-10 21:18:13.522797|2017-10-10 21:18:13.522797
NCT03067064|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-01|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01|1 Day|Observational [Patient Registry]|MIH||Prevelance of Molar Incisor Hypomineralization Among a Group of Egyptian Children|Prevelance of Molar Incisors Hypomineralization Among a Group of Egyptian Children|Enrolling by invitation||N/A|610|Anticipated|Cairo University|||1||f|||||f|f||||||No||2017-10-10 21:18:13.618552|2017-10-10 21:18:13.618552
NCT03067051|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-27|||March 21, 2017|Actual|2017-03-21|April 2017|2017-04-01|August 31, 2019|Anticipated|2019-08-31|June 1, 2019|Anticipated|2019-06-01||Interventional|||Clinical Study to Assess the Safety and Adequacy of Effectiveness of the SpectraCure P18 System|Open-label Clinical Study to Assess the Safety and Adequacy of Effectiveness of the SpectraCure P18 System (Interstitial Multiple Diode Lasers and IDOSE® Software) and Verteporfin for Injection (VFI) for the Treatment of Recurrent Prostate Cancer|Recruiting||Phase 1|36|Anticipated|SpectraCure AB||1|||f|||||t|t|f|f||||||2017-10-10 21:18:13.678|2017-10-10 21:18:13.678
NCT03067038|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-02-23|||October 2014||2014-10-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Single Incision Versus Three Port Laparoscopic Cholecystectomy|Single Incision Versus Three Port Laparoscopic Cholecystectomy in Symptomatic Gallstones: A Prospective Randomized Study|Completed||N/A|2|Actual|South Valley University||2|||f||||f||||||||No||2017-10-10 21:18:13.750134|2017-10-10 21:18:13.750134
NCT03067025|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-06-26|||July 15, 2017|Anticipated|2017-07-15|June 2017|2017-06-01|June 15, 2018|Anticipated|2018-06-15|June 15, 2018|Anticipated|2018-06-15||Observational|||Sleep, Physical Activity and Multiple Sclerosis Symptoms in Pediatric Multiple Sclerosis|Sleep, Physical Activity and Multiple Sclerosis Symptoms in Pediatric Multiple Sclerosis|Recruiting||N/A|60|Anticipated|The Hospital for Sick Children|||2||f|||||f|f||||||||2017-10-10 21:18:13.812267|2017-10-10 21:18:13.812267
NCT03067012|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-16|||September 1, 2015|Actual|2015-09-01|March 2017|2017-03-01|July 30, 2017|Anticipated|2017-07-30|July 5, 2016|Actual|2016-07-05||Interventional|ONCOMETAB||Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients|Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery (Long Limb Uncut Roux-en Y Gastrojejunostomy) for Obese Gastric Cancer|Active, not recruiting||N/A|20|Actual|Seoul National University Bundang Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:18:13.875255|2017-10-10 21:18:13.875255
NCT03066999|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-10|||March 7, 2017|Actual|2017-03-07|April 2017|2017-04-01|January 1, 2018|Anticipated|2018-01-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||DirectVision for Urinary Catheterization|Assessment of the Effectiveness and Ease of Use of DirectVision- a Direct Visualization System for Urinary Catheterization: Results of a Single Center Prospective Study|Recruiting||N/A|100|Anticipated|The Pur Clinic||2|||f||||t|f|t|f||f|||No|We will keep the IPD within the research group|2017-10-10 21:18:13.929656|2017-10-10 21:18:13.929656
NCT03066986|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-23|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|Jumpvax||Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)|A Dose Ranging Study of Sting Challenge and Specific lgE, and IgG4 Responses to Jack Jumper Ant (JJA) [Myrmecia Pilosula] Venom Immunotherapy (VIT) With and Without Delta-inulin as an Adjuvant.|Recruiting||Phase 1/Phase 2|40|Anticipated|Central Adelaide Local Health Network Incorporated||4|||f||||t||||||||Yes|IPD will be shared with collaborating institutions/organisations, specifically Royal Hobart Hospital JJA Program and Vaxine Pty Ltd, Flinders Medical Centre. We are prepared to share de-identidied data with other researchers. We do not expect any substantive results to be available until February 2018. Enquries for obtaining data should be directed to the primary investigator R Heddle.|2017-10-10 21:18:14.007765|2017-10-10 21:18:14.007765
NCT03066960|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-06-07|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Radiofrequency Neurotomy for Chronic Facet Joint Related Neck Pain|Long-term Efficacy of Radiofrequency Neurotomy for Chronic Zygapophysial (Facet) Joint Related Neck Pain|Not yet recruiting||N/A|44|Anticipated|Oslo University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:18:14.153297|2017-10-10 21:18:14.153297
NCT03066947|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-20|||May 5, 2017|Actual|2017-05-05|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|||BriaVax™ in Metastatic or Locally Recurrent Breast Cancer|A Phase I/IIa Study of the Whole-Cell Vaccine BriaVax™ in Metastatic or Locally Recurrent Breast Cancer Patients|Recruiting||Phase 1/Phase 2|40|Anticipated|BriaCell Therapeutics Corporation||1|||f||||f|t|f||||||||2017-10-10 21:18:16.058433|2017-10-10 21:18:16.058433
NCT03066934|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-03-01|||November 2016||2016-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01|5 Days|Observational [Patient Registry]|SAFE-NIV||A Multicentered Study on Efficiency of Noninvasive Ventilation Procedures|A Multicentered Study on Efficiency of Noninvasive Ventilation Procedures|Recruiting||N/A|200|Anticipated|Akdeniz University|||1||f||||t||||||||No||2017-10-10 21:18:16.188715|2017-10-10 21:18:16.188715
NCT03066908|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-09-13|||February 20, 2017|Actual|2017-02-20|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|CRS||Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS|A Prospective, Single Arm, Multicenter Study of the Sinopsys® Lacrimal Stent Used for Transcaruncular-Ethmoid Sinus Access and Saline Irrigation in Patients With Moderate to Severe Chronic Rhinosinusitis|Recruiting||N/A|66|Anticipated|Sinopsys Surgical||1|||f||||t|f|t|t|f||||||2017-10-10 21:18:16.379201|2017-10-10 21:18:16.379201
NCT03066895|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-10-03|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||BGS Neonatal Pilot Study|Development and Testing of BabyGentleStick™ Vibrated Needle System for Heel Lance- Neonatal Pilot Study|Not yet recruiting||N/A|20|Anticipated|Actuated Medical, Inc.||2|||f||||t|f|t|t|f|f|||||2017-10-10 21:18:16.494932|2017-10-10 21:18:16.494932
NCT03066882|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-23|||May 10, 2012|Actual|2012-05-10|February 2017|2017-02-01|October 30, 2016|Actual|2016-10-30|September 20, 2015|Actual|2015-09-20||Interventional|||Dietary Effects on Weight Loss and Lipid Profile in Sedentary Women|Comparison Effects of Negative Calorie Diet and Low-calorie Diet on Weight Loss and Lipid Profile in Sedentary Overweight/Obese Middle-aged and Older Women|Completed||N/A|37|Actual|P.L.Shupik National Medical Academy of Post-Graduate Education||2|||f||||t|f|f||||||||2017-10-10 21:18:16.566245|2017-10-10 21:18:16.566245
NCT03066869|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-09-26|||March 22, 2017|Actual|2017-03-22|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis|Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis|Recruiting||Phase 4|20|Anticipated|Ocular Immunology and Uveitis Foundation||1|||f||||f|t|f||||||||2017-10-10 21:18:16.640502|2017-10-10 21:18:16.640502
NCT03066856|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-28|||December 1, 2015|Actual|2015-12-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Dietary Intervention and BRCA Penetrance|Lifestyle and the Penetrance of BRCA Mutation|Recruiting||N/A|600|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||t|f|f||||||No|Individual participant data are not available to other researchers. The data software is blinded and protected.|2017-10-10 21:18:16.721941|2017-10-10 21:18:16.721941
NCT03066843|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-03-13|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Photodynamic Therapy Incubation Times for Actinic Keratosis|A Randomized Controlled Trial Evaluating 5-aminolevulinic Acid Photodynamic Therapy With Different Incubation Times for the Treatment of Actinic Keratosis|Recruiting||N/A|60|Anticipated|Northwestern University||2|||f||||t|f|f||||||No||2017-10-10 21:18:16.803291|2017-10-10 21:18:16.803291
NCT03066817|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-08|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients|A Pilot Study of Role of Vitamin D in Regulation of Bone Homeostasis in Orthopaedic Polytrauma Patients|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|New York City Health and Hospitals Corporation||2|||f||||t|t|f|||t|||No|Individual participant data are not planned to be shared.|2017-10-10 21:18:17.329731|2017-10-10 21:18:17.329731
NCT03066804|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-29|||September 29, 2017|Anticipated|2017-09-29|August 2017|2017-08-01|December 4, 2019|Anticipated|2019-12-04|September 11, 2019|Anticipated|2019-09-11||Interventional|PARALLAX||A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients|A 24-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Effect of LCZ696 on NT-proBNP, Symptoms, Exercise Function and Safety Compared to Individualized Medical Management of Comorbidities in Patients With Heart Failure and Preserved Ejection Fraction|Recruiting||Phase 3|2200|Anticipated|Novartis||2|||t||||t|t|f||||||||2017-10-10 21:18:17.41832|2017-10-10 21:18:17.41832
NCT03066791|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-10|||November 30, 2016|Actual|2016-11-30|July 2017|2017-07-01|October 23, 2017|Anticipated|2017-10-23|October 23, 2017|Anticipated|2017-10-23||Interventional|||Turmeric and Curcumin on Sebum Production|Pilot Study on the Effects of Oral Curcumin and Turmeric on Sebum Production|Recruiting||N/A|30|Anticipated|University of California, Davis||3|||f||||||||||||||2017-10-10 21:18:17.525057|2017-10-10 21:18:17.525057
NCT03066765|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-28|||February 25, 2016|Actual|2016-02-25|February 2017|2017-02-01|September 25, 2017|Anticipated|2017-09-25|August 25, 2017|Anticipated|2017-08-25||Interventional|||LTR for Treatment of Obstructive Sleep Apnea|Non-Randomized, Single Arm Study of the New Linguaflex Tongue Retractor for the Treatment of Obstructive Sleep Apnea|Active, not recruiting||N/A|20|Anticipated|Linguaflex, Inc.||1|||f||||f|f|f||||||No||2017-10-10 21:18:18.160678|2017-10-10 21:18:18.160678
NCT03066752|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-22|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes|Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes|Recruiting||N/A|14|Anticipated|The Hospital for Sick Children|||2||f||||f||||||||||2017-10-10 21:18:18.232832|2017-10-10 21:18:18.232832
NCT03066739|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-28|||March 1, 2017|Actual|2017-03-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia|Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia|Recruiting||Phase 2|105|Anticipated|University of California, Irvine||3|||f||||f|t|f|||t|||Undecided||2017-10-10 21:18:18.312156|2017-10-10 21:18:18.312156
NCT03066726|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-07-19|||May 15, 2017|Actual|2017-05-15|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|March 15, 2018|Anticipated|2018-03-15||Observational|CPR||Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?|Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?|Recruiting||N/A|3000|Anticipated|Rutgers, The State University of New Jersey|||2||f||||t|f|f||||||||2017-10-10 21:18:18.449239|2017-10-10 21:18:18.449239
NCT03066713|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-23|||January 31, 2017|Actual|2017-01-31|February 2017|2017-02-01|May 25, 2017|Anticipated|2017-05-25|May 25, 2017|Anticipated|2017-05-25||Interventional|||Post-prandial Glucose Response From Phytochemical Rich Potato Products|Post-prandial Glucose Response From Phytochemical Rich Potato Products|Recruiting||N/A|24|Anticipated|Purdue University||4|||f||||f|f|f||||||Undecided||2017-10-10 21:18:18.566935|2017-10-10 21:18:18.566935
NCT03066700|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|August 31, 2017|Anticipated|2017-08-31|June 1, 2017|Anticipated|2017-06-01||Observational|||Prognostic Factors in Malignant GI Bleeding Treated With Hemostatic Powder|Prognostic Factors of Outcome in Patient With Malignant Gastrointestinal Bleeding Treated With a Novel Hemostatic Power|Not yet recruiting||N/A|100|Anticipated|King Chulalongkorn Memorial Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:18:18.653709|2017-10-10 21:18:18.653709
NCT03066687|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-22|||March 14, 2017|Actual|2017-03-14|June 2017|2017-06-01|May 12, 2017|Actual|2017-05-12|May 12, 2017|Actual|2017-05-12||Interventional|||A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants|Randomized, Open-Label, 2-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Subjects|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 21:18:18.724679|2017-10-10 21:18:18.724679
NCT03066674|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-18|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Effect of the Hands- on McKenzie Program on Low Back Pain|Effect of the Hands- on McKenzie Program on Derangement Syndrome in Sub-acute and Chronic Low Back Pain|Completed||N/A|38|Actual|Imam Abdulrahman Bin Faisal University||2|||f||||t|f|f||||||||2017-10-10 21:18:18.805303|2017-10-10 21:18:18.805303
NCT03066661|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-04-20||||||April 2017|2017-04-01||||||||Expanded Access|||Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions|Expanded Access to Entrectinib (RXDX-101) for the Treatment of Cancers With NTRK, ROS1, or ALK Gene Fusions|Available||N/A|||Ignyta, Inc.|||||||||||||||||||2017-10-10 21:18:18.886428|2017-10-10 21:18:18.886428
NCT03066648|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-09-12|||July 6, 2017|Actual|2017-07-06|September 2017|2017-09-01|June 11, 2019|Anticipated|2019-06-11|June 11, 2019|Anticipated|2019-06-11||Interventional|||Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS|Phase 1b, Multi-arm, Open-label Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome|Recruiting||Phase 1|70|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 21:18:18.965724|2017-10-10 21:18:18.965724
NCT03066635|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-19|||April 18, 2017|Actual|2017-04-18|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues|Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues|Recruiting||Phase 1/Phase 2|10|Anticipated|Norwegian University of Science and Technology||2|||f|||||f|f||||||||2017-10-10 21:18:19.110488|2017-10-10 21:18:19.110488
NCT03066622|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-02|||July 2016|Actual|2016-07-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Olanzapine||Olanzapine for Acute Headaches|Oral Rapidly Dissolving Olanzapine for Acute Primary Headache in the Emergency Department Setting: A Feasibility Trial|Recruiting||N/A|124|Anticipated|HealthPartners Institute||2|||f||||f||||||||||2017-10-10 21:18:19.23502|2017-10-10 21:18:19.23502
NCT03066596|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-29|||March 7, 2017|Actual|2017-03-07|March 2017|2017-03-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|PRAGMATIC||Promoting Asthma Guidelines and Management Through Technology-Based Intervention and Care Coordination|Promoting Asthma Guidelines and Management Through Technology-Based Intervention and Care Coordination|Recruiting||N/A|512|Anticipated|Montefiore Medical Center||1|||f||||f|f|f||||||Yes|Investigators will share de-identified data using Data Sharing Agreement process after the study is completed and main study aims manuscripts have been published.|2017-10-10 21:18:19.437738|2017-10-10 21:18:19.437738
NCT03066583|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-02-28|||January 2016||2016-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|Prolotherapy||Effectiveness of Trephination With Platelet Rich Plasma or Placebo in a Primary Meniscal Tear Treatment|Prospective, Randomised, Double Blinded Trial Comparing Effectiveness of Platelet Rich Plasma or Placebo in a Primary Meniscal Tear Treatment|Recruiting||Phase 2/Phase 3|60|Anticipated|Centre of Postgraduate Medical Education||2|||f||||t||||||||Undecided||2017-10-10 21:18:19.531406|2017-10-10 21:18:19.531406
NCT03066570|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-08-31|||June 1, 2017|Actual|2017-06-01|February 2017|2017-02-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|PDN&GEXP||Graded Exposure in Patients With Painful Diabetic Neuropathy|Graded Exposure in Patients With Painful Diabetic Neuropathy|Recruiting||N/A|20|Anticipated|Maastricht University Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:18:19.61033|2017-10-10 21:18:19.61033
NCT03066557|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-23|||March 15, 2017|Anticipated|2017-03-15|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma|Study of the Combination of Transcatheter Arterial Chemoembolization (TACE) With Apatinib in Patients With Hepatocellular Carcinoma Trial|Not yet recruiting||N/A|80|Anticipated|Jiangsu Cancer Institute & Hospital||2|||f||||t|f|f||||||Yes|Within six months after the trial complete|2017-10-10 21:18:19.688826|2017-10-10 21:18:19.688826
NCT03066544|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-10|||November 30, 2016|Actual|2016-11-30|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Status Migrainosus - Differentiating Between Responders and Non-responders|Status Migrainosus - Differentiating Between Responders and Non-responders in the Setup of Real-life Clinical Practice|Recruiting||Phase 1/Phase 2|50|Anticipated|Hartford HealthCare||4|||f||||f|t|f|||t|||No||2017-10-10 21:18:19.800152|2017-10-10 21:18:19.800152
NCT03066531|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-23|||January 1, 2014|Actual|2014-01-01|February 2017|2017-02-01|January 1, 2016|Actual|2016-01-01|January 1, 2016|Actual|2016-01-01||Interventional|MOTIVOB-ACT||MOTIVOB-(Acceptance and Commitment Therapy Group Intervention for Obesity)Section|Acting Flexible, Acting Resistant: the Upsides of an ACT Choice. A Randomized Comparison of Acceptance and Commitment Therapy Group Intervention and Cognitive Behavioral Therapy Group for the Treatment of Obese Patients|Completed||N/A|156|Actual|Istituto Auxologico Italiano||2|||f||||f|f|f||||||Undecided||2017-10-10 21:18:19.924026|2017-10-10 21:18:19.924026
NCT03066518|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-23|||January 15, 2016|Actual|2016-01-15|February 2017|2017-02-01|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Interventional|||Effect of Melatonin on Sleep Quality in Patients Dementia|A Randomized Placebo-controlled Trial Evaluating the Effect of Melatonin on Sleep Quality in Patients With Dementia|Completed||Phase 4|40|Actual|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||t|f|f||||||Undecided||2017-10-10 21:18:20.015163|2017-10-10 21:18:20.015163
NCT03066505|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-19|||February 23, 2016|Actual|2016-02-23|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|February 28, 2018|Anticipated|2018-02-28||Interventional|MeRT-USC-009||A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With ADHD|A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With Attention Deficit Hyperactivity Disorder.|Active, not recruiting||N/A|9|Actual|Newport Brain Research Laboratory||2|||f||||f||t|f||f|||No||2017-10-10 21:18:20.111593|2017-10-10 21:18:20.111593
NCT03066492|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-20|||September 2, 2015|Actual|2015-09-02|February 2017|2017-02-01|May 1, 2017|Actual|2017-05-01|May 1, 2016|Actual|2016-05-01||Interventional|||Evaluation of a Hospital Discharge Clinic to Improve Care Coordination and Reduce Rehospitalization in Low Income Adults|Evaluation of a Novel Hospital Discharge Clinic to Improve Care Coordination and Reduce Rehospitalization Among Low Income Adults|Completed||N/A|654|Actual|Northwestern University||2|||f||||f|f|f||||||No||2017-10-10 21:18:20.197932|2017-10-10 21:18:20.197932
NCT03066479|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-15|||August 4, 2015|Actual|2015-08-04|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Comparing Fitbit® Quality of Measured Sleep to Sleep Measured by Polysomnography in the Sleep Lab|Comparing Fitbit® Quality of Measured Sleep to Sleep Measured by Polysomnography in the Sleep Lab|Completed||N/A|20|Actual|Nationwide Children's Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:18:20.279416|2017-10-10 21:18:20.279416
NCT03066466|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-04-06|||April 10, 2017|Anticipated|2017-04-10|April 2017|2017-04-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|||Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT|Randomized Study of Atorvastatin Prophylaxis as a Supplement to Standard of Care Prophylaxis to Prevent Chronic Graft Versus Host Disease Allogeneic Stem Cell Transplantation From Matched Unrelated Donors|Recruiting||Phase 3|207|Anticipated|Loyola University||2|||f||||t|t|f|||f|||No||2017-10-10 21:18:20.51063|2017-10-10 21:18:20.51063
NCT03066453|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-21|||June 13, 2017|Actual|2017-06-13|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TOBRAMUC||Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis|Evaluation of an Antibiotic Treatment With 14 Days of Intravenous Tobramycin Versus the Same Antibiotic Associated With 5 Days of Intravenous Tobramycin Followed by Tobramycin Aerosol for 9 Days in Cystic Fibrosis.|Recruiting||Phase 3|97|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||||2017-10-10 21:18:20.683117|2017-10-10 21:18:20.683117
NCT03066427|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-21|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|May 31, 2020|Anticipated|2020-05-31|January 31, 2020|Anticipated|2020-01-31||Interventional|INMUNOSUN||Study to Evaluate Efficacy and Safety of Sunitinib in Patients With Renal Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment|Phase II Study to Evaluate Efficacy and Safety of Sunitinib Therapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment (INMUNOSUN Study)|Recruiting||Phase 2|23|Anticipated|Spanish Oncology Genito-Urinary Group||1|||f||||f|f|f||||||||2017-10-10 21:18:20.954303|2017-10-10 21:18:20.954303
NCT03066414|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-27|||February 2015||2015-02-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|ReVAs||Respiratory Variations For Assessing Blood Withdrawal|Respiratory Variations in Diameters of the Inferior Vena Cava and the Internal Jugular Vein to Assess Blood Withdrawal in Patients With Genetic Hemochromatosis|Completed||N/A|27|Actual|University Hospital, Lille|||1||f||||f||||||||No||2017-10-10 21:18:21.086697|2017-10-10 21:18:21.086697
NCT03066401|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-27|||January 2015||2015-01-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|ReVAs2||Respiratory Variations for Assessing Blood Withdrawal 2|Respiratory Variations in Diameters of the Inferior Vena Cava and the Internal Jugular Vein to Assess Blood Withdrawal in Patients With Dysmetabolic Hyperferritinemia|Terminated||N/A|5|Actual|University Hospital, Lille|||1|insufficient inclusion rate|f||||f||||||||No||2017-10-10 21:18:21.175674|2017-10-10 21:18:21.175674
NCT03066388|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-23|||April 2012||2012-04-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Accuracy of Pulse Pressure Variations Measured by a Non Invasive Digital Device to Predict Fluid Responsiveness|Accuracy of Pulse Pressure Variations Measured by a Non Invasive Digital Device to Predict Fluid Responsiveness in Patients With Systemic Inflammatory Response Syndrome|Terminated||N/A|6|Actual|University Hospital, Lille||1||insufficient inclusion rate|f||||t||||||||No||2017-10-10 21:18:21.277316|2017-10-10 21:18:21.277316
NCT03066375|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-27|||May 2012||2012-05-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|ReVaPreF2||Respiratory Variations For Predicting Fluid Responsiveness 2|Diagnostic Accuracy of the Inferior Vena Cava Collapsibility to Predict Fluid Responsiveness in Spontaneously Breathing Patients With Sepsis, Acute Circulatory Failure, and Irregular Cardiac Rhythm|Completed||N/A|55|Actual|University Hospital, Lille||1|||f||||t|f|f||||||No||2017-10-10 21:18:21.391009|2017-10-10 21:18:21.391009
NCT03066362|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-27|||November 2011||2011-11-01|February 2017|2017-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|ReVaPreF||Respiratory Variations for Predicting Fluid Responsiveness|Respiratory Variations of the Inferior Vena Cava and Femoral Artery Flow to Predict Fluid Responsiveness in Spontaneously Breathing Patients With Sepsis, Acute Circulatory Failure, and Regular Cardiac Rhythm|Completed||N/A|90|Actual|University Hospital, Lille||1|||f||||t|f|f||||||No||2017-10-10 21:18:21.490764|2017-10-10 21:18:21.490764
NCT03066349|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-28|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31|3 Months|Observational [Patient Registry]|EMAQOLIVMIVF||IVM Versus IVF: Differences in Patients' Emotional Adjustment and Quality of Life|Conventional Ovarian Stimulation vs. in Vitro Oocyte Maturation (IVM) Followed by in Vitro Fertilisation (IVF): Differences in Patients' Emotional Adjustment and Quality of Life|Not yet recruiting||N/A|200|Anticipated|Universitair Ziekenhuis Brussel|||2||f||||f||||||||No||2017-10-10 21:18:21.593683|2017-10-10 21:18:21.593683
NCT03066336|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-05-21|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus|A Pilot Evaluation of the Effect of the Erchonia LunulaLaser for the Treatment of Toenail Onychomycosis|Recruiting||N/A|54|Anticipated|Erchonia Corporation||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:18:21.673901|2017-10-10 21:18:21.673901
NCT03066323|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-07-27|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Effect of Tea Extract on Post Prandial Blood Glucose|Effect of Tea Extract on Post Prandial Blood Glucose|Completed||N/A|166|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-10 21:18:21.770817|2017-10-10 21:18:21.770817
NCT03066310|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-23|||February 17, 2017|Actual|2017-02-17|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Urine-DNA Biomarkers in Detecting Bladder Cancer|Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Cancer in Patients With Gross Hematuria for Cystoscope.|Recruiting||N/A|200|Anticipated|Xiangya Hospital of Central South University|||2||f||||t|f|f||||Samples With DNA|"     Voided urine samples were collected prior to the cystoscopy and stored at 4 ℃，within 12 hours     after collection ,urine samples were processed in paticipant laboratories. Blood samples was     collected. Tissue samples was collected( optional).   "|Undecided||2017-10-10 21:18:21.879512|2017-10-10 21:18:21.879512
NCT03066297|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-27|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|February 15, 2027|Anticipated|2027-02-15|February 15, 2027|Anticipated|2027-02-15|5 Years|Observational [Patient Registry]|OREX-IA||Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer|A Prospective Study to Optimize the Extent of Pulmonary Resection According to the Decision-Making Algorithm in Patients With Clinical Stage IA Non-Small Cell Lung Cancer|Recruiting||N/A|1000|Anticipated|Samsung Medical Center|||3||f||||f|f|f||||||No||2017-10-10 21:18:22.002491|2017-10-10 21:18:22.002491
NCT03066284|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||March 14, 2016|Actual|2016-03-14|February 2017|2017-02-01|March 13, 2019|Anticipated|2019-03-13|March 13, 2017|Anticipated|2017-03-13||Observational|||A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes|A Qualitative Study on the Experiences and Expectations of Children and Adolescents Having Type 1 Diabetes Towards Insulin Pump Therapy and Its Effect on Their Quality of Life in Kuwait|Recruiting||N/A|20|Anticipated|Dasman Diabetes Institute|||1||f||||t||||||||No||2017-10-10 21:18:22.132023|2017-10-10 21:18:22.132023
NCT03066271|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-04|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|PRIME||Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer|PRIME - Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer|Recruiting||N/A|40|Anticipated|Rigshospitalet, Denmark||2|||f||||f|f|f||||||No||2017-10-10 21:18:22.231169|2017-10-10 21:18:22.231169
NCT03003143|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-23|||November 2016||2016-11-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|||Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients|Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients - A Pilot Study|Recruiting||N/A|10|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 21:30:13.693457|2017-10-10 21:30:13.693457
NCT03066258|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-01|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|August 2018|Anticipated|2018-08-01||Interventional|||RGX-314 Gene Therapy for Neovascular AMD Trial|A Phase I, Open-label, Multiple-cohort, Dose-escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With RGX-314 in Subjects With Neovascular AMD (nAMD)|Recruiting||Phase 1|18|Anticipated|Regenxbio Inc.||3|||f||||t|t|f||||||||2017-10-10 21:18:22.37201|2017-10-10 21:18:22.37201
NCT03066245|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||October 3, 2016|Actual|2016-10-03|February 2017|2017-02-01|July 15, 2019|Anticipated|2019-07-15|May 15, 2019|Anticipated|2019-05-15||Interventional|||Use of Stem Cells Cultured on a Scaffold for the Treatment of Aneurysmal Bone Cysts (ABC)|Autologous Bone Tissue Constructed On Biodegradable Polymer for the Treatment of Aneurysmal Bone Cysts|Recruiting||Phase 1/Phase 2|4|Anticipated|University of Jordan||1|||f||||t|f|f||||||Undecided||2017-10-10 21:18:22.509997|2017-10-10 21:18:22.509997
NCT03066232|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-22|||May 11, 2015|Actual|2015-05-11|February 2017|2017-02-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Delirium in Home-dwelling Old People Receiving Home Nursing Care|Delirium in Home-dwelling Old People Receiving Home Nursing Care|Active, not recruiting||N/A|211|Actual|Oslo University Hospital|||1||f||||f|f|f||||Samples With DNA|"     EDTA blood samples serum   "|No||2017-10-10 21:18:22.615569|2017-10-10 21:18:22.615569
NCT03066219|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-23|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Safety and Efficacy of BRM421 for Dry Eye Syndrome|A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model|Not yet recruiting||Phase 2|150|Anticipated|BRIM Biotechnology Inc.||2|||f|||||t|f||||||||2017-10-10 21:18:22.695072|2017-10-10 21:18:22.695072
NCT03066206|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-17|||March 17, 2017|Actual|2017-03-17|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Poziotinib in EGFR Exon 20 Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase II Study of Poziotinib in EGFR Exon 20 Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:18:22.783393|2017-10-10 21:18:22.783393
NCT03066193|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-01|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome|Examining the Efficacy of a Therapeutic Combination of Dronabinol (Synthetic Δ9-tetrahydracannabinol) and Palmitoylethanolamide for Tourette Syndrome|Recruiting||Phase 3|18|Anticipated|Yale University||2|||f||||f|t|f||||||No||2017-10-10 21:18:22.91095|2017-10-10 21:18:22.91095
NCT03066180|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Study of Non-Ablative Radiofrequency Treatment for Stress Urinary Incontinence|Pilot Study of Non-Ablative Radiofrequency Treatment for Stress Urinary Incontinence|Not yet recruiting||N/A|36|Anticipated|Viveve Inc.||2|||f||||f|f|t|f||t|||No||2017-10-10 21:18:23.041579|2017-10-10 21:18:23.041579
NCT03066167|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||November 2010|Actual|2010-11-01|January 2017|2017-01-01|April 30, 2017|Anticipated|2017-04-30|March 5, 2017|Anticipated|2017-03-05||Observational|||Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal Cancer|Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal Cancer|Active, not recruiting||N/A|64|Actual|Vastra Gotaland Region|||2||f||||t||||||||No||2017-10-10 21:18:23.163682|2017-10-10 21:18:23.163682
NCT03066154|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-02-22|||September 2016||2016-09-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|DOP||Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer|Weekly ModraDoc/r in Combination With Hormonal Treatment and High-dose Intensity-modulated Radiation Therapy in Patients With High-risk Early Stage Prostate Cancer|Recruiting||Phase 1|24|Anticipated|The Netherlands Cancer Institute||1|||f||||t|f|f||||||No||2017-10-10 21:18:23.310116|2017-10-10 21:18:23.310116
NCT03066141|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-22|||February 14, 2017|Actual|2017-02-14|February 2017|2017-02-01|February 14, 2018|Anticipated|2018-02-14|February 14, 2018|Anticipated|2018-02-14|1 Year|Observational [Patient Registry]|||Evaluation of Association Between Obstructive Sleep Apnea and the Severity of Coronary Artery Disease|The Prevalence and Influence of Obstructive Sleep Apnea in Coronary Artery Disease in Modern Age: Findings in A Large Cohort Study|Active, not recruiting||N/A|600|Anticipated|Chinese Pulmonary Vascular Disease Research Group|||2||f||||t|f|f||||||No||2017-10-10 21:18:23.443541|2017-10-10 21:18:23.443541
NCT03066128|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-08-11|||February 24, 2017|Actual|2017-02-24|March 2017|2017-03-01|September 27, 2018|Anticipated|2018-09-27|March 27, 2018|Anticipated|2018-03-27||Interventional|STREAM||Point-of-care Viral Load Testing to Enable Streamlined Care and Task Shifting for Chronic HIV Care|Point-of-care Viral Load Testing to Enable Streamlined Care and Task Shifting for Chronic HIV Care|Enrolling by invitation||N/A|390|Anticipated|University of Washington||2|||f||||f|f|f||||||||2017-10-10 21:18:23.533485|2017-10-10 21:18:23.533485
NCT03066115|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-23|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow Regulation|Contributions of Nitric Oxide Synthase, Cyclooxygenase, and Reactive Oxygen Species to Regional Cerebrovascular Control During Hypoxia and Hypercapnia|Not yet recruiting||Phase 1|25|Anticipated|University of Wisconsin, Madison||2|||f||||t|t|f||||||No||2017-10-10 21:18:23.637277|2017-10-10 21:18:23.637277
NCT03066102|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-27|||March 6, 2017|Anticipated|2017-03-06|February 2017|2017-02-01|August 31, 2017|Anticipated|2017-08-31|July 1, 2017|Anticipated|2017-07-01||Interventional|||Muscle Fatigue and Scapular Sensorimotor System|Muscle Fatigue and Scapular Sensorimotor System|Not yet recruiting||N/A|30|Anticipated|National Yang Ming University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:18:23.753057|2017-10-10 21:18:23.753057
NCT03066089|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-02-22|||December 14, 2015|Actual|2015-12-14|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study|Open Labeled, Interventional, Two Armed, Single Centric Study to Assess the Efficacy of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study|Recruiting||Phase 4|100|Anticipated|Chemical Resources||2|||f||||f|f|f||||||No||2017-10-10 21:18:23.822225|2017-10-10 21:18:23.822225
NCT03066076|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-22|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|June 1, 2019|Anticipated|2019-06-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy|Prospective Randomized Clinical Trial of Total Thyroidectomy (Tx) Versus Thionamides (Anti-Thyroid Drugs) in Patients With Moderate-to-Severe Graves' Ophthalmopathy - a 1-year Follow-up|Recruiting||Phase 3|60|Anticipated|Medical University of Vienna||2|||f||||t|t|f|||f|||No|No IPD sharing|2017-10-10 21:18:23.905844|2017-10-10 21:18:23.905844
NCT03066063|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-27|||March 2018||2018-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:18:24.015769|2017-10-10 21:18:24.015769
NCT03066050|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-30|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Long Term Follow Up for CTSN Mitral Valve Repair Studies|Long-Term Follow-Up For Participants Of: Evaluation Of Outcomes Following Mitral Valve Repair/Replacement In SMR and Surgical Interventions For MMR Trials|Enrolling by invitation||N/A|469|Anticipated|Icahn School of Medicine at Mount Sinai|||4||f||||t|f|f||||||||2017-10-10 21:18:24.063353|2017-10-10 21:18:24.063353
NCT03066037|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-22|||January 1, 2009|Actual|2009-01-01|February 2017|2017-02-01|November 13, 2016|Actual|2016-11-13|June 30, 2016|Actual|2016-06-30||Observational|RetroBlock||Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective Study|Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective Study|Completed||N/A|83|Actual|Charite University, Berlin, Germany|||1||f||||t|f|f||||||No|Data sharing can be requested and will be evaluated by Charité data safety authorities.|2017-10-10 21:18:24.382162|2017-10-10 21:18:24.382162
NCT03066024|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-22|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|||Electroencephalogram Dynamics in Children During Different Levels of Anesthetic Depth|Electroencephalogram Dynamics in Children During Different Levels of Anesthetic Depth|Completed||N/A|94|Actual|Charite University, Berlin, Germany|||1||f||||f|f|f||||||No||2017-10-10 21:18:24.498293|2017-10-10 21:18:24.498293
NCT03066011|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-10-02|||March 16, 2017|Actual|2017-03-16|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Registry of Patients Treated With Systemic Mold-Active Triazoles|Observational Disease Registry of Patients Treated With Systemic Mold-Active Triazoles|Recruiting||N/A|2000|Anticipated|Astellas Pharma Inc|||3||f||||f||||||||||2017-10-10 21:18:24.58781|2017-10-10 21:18:24.58781
NCT03065998|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-22|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction|Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction: Medical and Cognitive Effects|Recruiting||Early Phase 1|140|Anticipated|Ministry of Health, Israel||2|||f|||||f|f||||||Undecided||2017-10-10 21:18:24.779185|2017-10-10 21:18:24.779185
NCT03065985|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma.|A Phase II Prospective Randomised Clinical Study of Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Inoperable Pancreatic Ductal Adenocarcinoma|Withdrawn||Phase 2|0|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2||Change in methodology|f|||||f|t|f|f|f|||||2017-10-10 21:18:24.872154|2017-10-10 21:18:24.872154
NCT03065972|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-02-22|||February 2016||2016-02-01|February 2017|2017-02-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|ELDERLY||Hemodialysis in the Elderly (70yrs & Older)|A Randomized Controlled Comparative Study on Efficacy and Cost-effectiveness of Autologous Arteriovenous Fistulas Versus Hemodialysis Access Grafts in Elderly Patients|Recruiting||N/A|270|Anticipated|The Methodist Hospital System||2|||f||||t||||||||Undecided|The Investigators plan to write a manuscript once all the participant information has been compiled.|2017-10-10 21:18:24.966844|2017-10-10 21:18:24.966844
NCT03065959|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-29|||June 28, 2017|Actual|2017-06-28|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility|A Phase 1b Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility|Recruiting||Phase 1|60|Anticipated|Astellas Pharma Inc||2|||f||||f|t|f||||||||2017-10-10 21:18:25.108193|2017-10-10 21:18:25.108193
NCT03065946|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-10|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|THAW||Therapeutic Hypothermia and eArly Waking|Therapeutic Hypothermia and eArly Waking|Recruiting||N/A|50|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust|||1||f||||t|f|f||||||Yes||2017-10-10 21:18:25.232192|2017-10-10 21:18:25.232192
NCT03065933|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-03-15|2017-03-15||January 2012||2012-01-01|March 2017|2017-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||No data besides region of enrollment was collected on these participants before the study terminated.|An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-on, Open-Label Study|An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-On, Open-Label Study|Terminated||Phase 4|5|Actual|Mclean Hospital||1|||f||||t|t|f|||f|||Yes|IPD to be shared via clinicaltrials.gov, publication, or personal request.|2017-10-10 21:18:25.344774|2017-10-10 21:18:25.344774
NCT03065920|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-02-27|||April 2016||2016-04-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01|12 Months|Observational [Patient Registry]|ASAP||African Severe Asthma Program: A Research Network for Characterisation of Severe Asthma in Africans (ASAP)|African Severe Asthma Program|Recruiting||N/A|1676|Anticipated|Makerere University|||1||f||||t||||||Samples With DNA|"     Replicative single nucleotide polymorphisms (SNP) genotying: Subjects enrolled into the study     will be invited to participate in genetic research by providing a blood sample.      DNA will be extracted from the blood samples.Part of the DNA will be used for replicative     severe asthma associated SNPs genotying of SNPs previously reported to be associated with     severe asthma. The remaining samples will be biobanked for future genetic and pharmacogenetic     studies.   "|Yes||2017-10-10 21:18:25.506791|2017-10-10 21:18:25.506791
NCT03065049|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-23|||September 30, 2016|Actual|2016-09-30|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|TREC||Transforming Recovery Through Exercise and Community|Peer-Facilitated Physical Activity Intervention Delivered During Methadone Maintenance|Recruiting||N/A|20|Anticipated|Butler Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:18:35.101758|2017-10-10 21:18:35.101758
NCT03065907|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-08-22|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|November 1, 2019|Anticipated|2019-11-01||Interventional|TRAVIT||Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy|Timing of Low Vision Rehabilitation in Anti-VEGF Therapy: a Randomized, Controlled Trial|Not yet recruiting||N/A|44|Anticipated|Johns Hopkins University||2|||f|||||f|f||||||||2017-10-10 21:18:25.636555|2017-10-10 21:18:25.636555
NCT03065894|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-04-18|||March 29, 2017|Actual|2017-03-29|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Risk Stratification in Primary Care Combined With Stratified-specific Physical Therapy Care for Low Back Pain|Does Risk Stratification in Primary Care Combined With Stratified-specific Physical Therapy Care Improve Clinical Outcomes for Patients With Nonspecific Low Back Pain Compared to Those Who Receive Only Current Care?|Enrolling by invitation||N/A|1322|Anticipated|University of Vermont Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:18:25.727839|2017-10-10 21:18:25.727839
NCT03065881|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-03-06|||February 13, 2017|Actual|2017-02-13|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|REACT||RETeval All Comers Trial (REACT)|RETeval All Comers Trial (REACT)|Recruiting||N/A|1000|Anticipated|LKC Technologies, Inc.||2|||f|||||f|t|f|f|t|||||2017-10-10 21:18:25.846338|2017-10-10 21:18:25.846338
NCT03065868|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-02-27|||December 9, 2015|Actual|2015-12-09|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp|Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp (Randomized Controlled Study)|Recruiting||Phase 4|60|Anticipated|Kyungpook National University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:18:25.948767|2017-10-10 21:18:25.948767
NCT03065855|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-23|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Removal Time of Urinary Catheter After Laparoscopic Anterior Resection of the Rectum|Amonocenter, Prospective, Randomized Clinical Trial to Investigate the Removal Time of Urinary Catheter After Laparoscopic Anterior Resection of the Rectum.|Not yet recruiting||N/A|220|Anticipated|Peking Union Medical College Hospital||2|||f||||f|f|f||||||Yes|Other researchers have access to data in the form of published papers|2017-10-10 21:18:26.051571|2017-10-10 21:18:26.051571
NCT03065842|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-27|||February 17, 2017|Actual|2017-02-17|February 2017|2017-02-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|SAC||A Pre and Post Test Intervention Design to Prevent Abortion and Contraceptive-use Stigma Among School Youths in Kenya|Cluster Randomized Trial: A Pre and Post Test Intervention Program to Prevent Abortion and Contraceptive-use Stigma Among School Youths in Kenya|Recruiting||N/A|800|Anticipated|Karolinska Institutet||2|||f||||t|f|f||||||Undecided||2017-10-10 21:18:26.16933|2017-10-10 21:18:26.16933
NCT03065829|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-18|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|ASSIST||Self-Management Behaviors of Caregivers of the Chronically Critically Ill|The Mediating Effects of Decentering on Self-Management Behaviors in Caregivers of Critically Chronically Ill Patients|Recruiting||N/A|20|Anticipated|Case Western Reserve University||2|||f||||t|f|f||||||||2017-10-10 21:18:26.316639|2017-10-10 21:18:26.316639
NCT03065816|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-06-13|||February 9, 2017|Actual|2017-02-09|June 2017|2017-06-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|||Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects|A Randomized, Open-label, 2-Treatment Crossover Study to Compare by Scintigraphy, the Antireflux Activity of the To-be-Registered Product (250 mg Sodium Alginate/187.5 mg Calcium Carbonate/106.5 mg Sodium Hydrogen Carbonate) Chewable Tablets Versus the Registered Gaviscon Double Action Tablets, in Healthy Adult Subjects|Completed||Phase 1|34|Actual|Sanofi||2|||f||||f|f|f||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:18:26.424933|2017-10-10 21:18:26.424933
NCT03065803|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-22|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|May 1, 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Buccal Plate Expansion Technique Versus Guided Bone Regeneration Technique in Socket Preservation in the Aesthetic Zone.|Clinical Assessment of Buccal Plate Expansion Technique Versus Guided Bone Regeneration Technique in Socket Preservation in The Esthetic Zone: A Randomized Controlled Clinical Trial|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||Yes|the data will be available for other scientists after the end of the study on www.clinicaltrials.gov , all data will be shared except patient contact or private data|2017-10-10 21:18:26.532403|2017-10-10 21:18:26.532403
NCT03065790|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-23|||February 6, 2017|Actual|2017-02-06|February 2017|2017-02-01||||February 6, 2019|Anticipated|2019-02-06||Observational|||Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide|Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide|Recruiting||N/A|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t|f|f||||||||2017-10-10 21:18:26.619458|2017-10-10 21:18:26.619458
NCT03065777|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-22|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Postoperative Pain Associated With Three Endodontic Rotary Systems|Evaluation of Postoperative Pain After Single Visit Root Canal Treatment Associated With The Three Rotary Systems; ONE ENDO, F6 SkyTper and ProTaper Universal. (Randomized Controlled Clinical Trial)|Recruiting||N/A|57|Anticipated|Cairo University||3|||f||||t|f|f||||||No||2017-10-10 21:18:26.701748|2017-10-10 21:18:26.701748
NCT03065764|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-14|||January 20, 2017|Actual|2017-01-20|August 2017|2017-08-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer|89Zirconium-labeled Pembrolizumab as Predictive Imaging Biomarker of Response and Toxicity in Pembrolizumab Treated Patients With Non-small-cell Lung Cancer - a Feasibility Study|Active, not recruiting||Phase 2|10|Anticipated|VU University Medical Center||1|||f||||f|f|f|||f|||||2017-10-10 21:18:26.803044|2017-10-10 21:18:26.803044
NCT03065751|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-03-14|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|January 2021|Anticipated|2021-01-01||Interventional|EXCHANGE||Plasmaexchange in Early Septic Shock|Prospective, Randomized, Multicenter, Open-label, Controlled, Parallel-group Trial Investigating the Efficacy of add-on Plasma-exchange as an Adjunctive Strategy Against Septic Shock|Recruiting||N/A|352|Anticipated|Hannover Medical School||2|||f||||t|f|t|f|f|f|||Yes|pre-defined substudies with primary responsibilities for each individual center|2017-10-10 21:18:26.89245|2017-10-10 21:18:26.89245
NCT03065738|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-09|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|February 1, 2018|Anticipated|2018-02-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Effect of RO On GB During TKR Severe Varus Deformity|Effect Of Reduction Osteotomy On Gap Balancing During Total Knee Replacement For Severe Varus Deformity|Recruiting||N/A|30|Anticipated|Assiut University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:18:26.973996|2017-10-10 21:18:26.973996
NCT03065725|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-06-26|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|January 2024|Anticipated|2024-01-01|January 2019|Anticipated|2019-01-01||Observational|||Early Versus Late FDG-PET/CT in Bladder Cancer|Is Late FDG-PET/CT Imaging Better Than Early FDG-PET/CT Imaging to Distinguish Between Malign and Inflammatory Changes in Lymph Nodes in Patients With Muscle Invasive Bladder Cancer Scheduled for Radical Cystectomy?|Recruiting||N/A|200|Anticipated|Aarhus University Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:18:27.067654|2017-10-10 21:18:27.067654
NCT03065712|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-27|||February 22, 2017|Actual|2017-02-22|February 2017|2017-02-01|February 20, 2020|Anticipated|2020-02-20|February 22, 2019|Anticipated|2019-02-22||Interventional|||Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET|Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET and Predictive Measure for Endocrine Therapy Response in Patients With Newly Diagnosed Metastatic Breast Cancer|Recruiting||Phase 2|15|Anticipated|University of Texas Southwestern Medical Center||1|||||||t|t|f||||||No||2017-10-10 21:18:27.153151|2017-10-10 21:18:27.153151
NCT03065699|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-24|||July 9, 2017|Actual|2017-07-09|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|DIALIVE _ACLF||Safety and Performance Trial of DIALIVE Liver Dialysis Device in Acute On Chronic Liver Failure Patients|A Multi-centre, Randomised Controlled Study, to Evaluate the Safety and Performance of The DIALIVE Liver Dialysis Device (LDD) in Patients With Acute on Chronic Liver Failure (ACLF) Versus Standard of Care (SOC)|Recruiting||N/A|24|Anticipated|Yaqrit Ltd||2|||f||||t|f|f||||||||2017-10-10 21:18:27.253012|2017-10-10 21:18:27.253012
NCT03065686|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-23|2017-02-23|||September 23, 2016|Actual|2016-09-23|February 2017|2017-02-01|October 14, 2020|Anticipated|2020-10-14|October 14, 2020|Anticipated|2020-10-14||Interventional|GENEPIC||Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing|Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing GENEPIC|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f|||||f|f||||||||2017-10-10 21:18:27.388014|2017-10-10 21:18:27.388014
NCT03065673|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-07|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|March 17, 2018|Anticipated|2018-03-17||Interventional|||Potassium Oxalate and Placebo and Post-bleaching Sensitivity|Evaluation of Tooth Sensitivity Related to in Office Bleaching in a Randomized Clinical Trial: Effect of Potassium Oxalate and Placebo|Not yet recruiting||N/A|50|Anticipated|Universidade Federal de Sergipe||2|||f||||f|f|f||||||||2017-10-10 21:18:27.469808|2017-10-10 21:18:27.469808
NCT03065660|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-10-04|||September 20, 2017|Actual|2017-09-20|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|MifeMiso||Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage|A Randomised Placebo-controlled Trial of Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage|Recruiting||Phase 3|710|Anticipated|University of Birmingham||2|||f||||t|f|f|||f|||||2017-10-10 21:18:27.558443|2017-10-10 21:18:27.558443
NCT03065647|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-17|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 31, 2018|Anticipated|2018-08-31||Interventional|EROCA||ECPR for Refractory Out-Of-Hospital Cardiac Arrest|Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest (EROCA)|Enrolling by invitation||N/A|30|Anticipated|University of Michigan||2|||f||||t|f|t|f|||||No||2017-10-10 21:18:27.679666|2017-10-10 21:18:27.679666
NCT03065634|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-22|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|RELIANCE||Return to Work and Living Healthy After Head and Neck Cancer|Return to Work and Living Healthy After Head and Neck Cancer|Recruiting||N/A|144|Anticipated|University of Leipzig||2|||f||||t|f|f||||||Undecided||2017-10-10 21:18:27.775374|2017-10-10 21:18:27.775374
NCT03065621|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-08-21|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|November 2019|Anticipated|2019-11-01||Interventional|NeoRHEA||Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)|Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer|Recruiting||Phase 2|100|Anticipated|Jules Bordet Institute||1|||f||||f|f|f|||f|||||2017-10-10 21:18:27.869784|2017-10-10 21:18:27.869784
NCT03065608|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-22|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Evaluation of C-reactive Protein Level in the Group of Patient With Pain Form of Temporomandibular Joint Dysfunction|Evaluation of C-reactive Protein Level in the Group of Patient With Pain Form of Temporomandibular Joint Dysfunction|Completed||N/A|72|Actual|Jagiellonian University|||2||f||||f|f|f||||||No||2017-10-10 21:18:27.978359|2017-10-10 21:18:27.978359
NCT03065595|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-22|||October 5, 2016|Actual|2016-10-05|February 2017|2017-02-01|February 14, 2017|Actual|2017-02-14|December 30, 2016|Actual|2016-12-30||Interventional|||The Effect of Ophiocephalus Striatus Extract on Levels of IGF-1, Albumin, and MNA Score in Elderly With Malnutrition|The Effect of Ophicephalus Striatus Extract on Levels of Insulin-like Growth Factor-1 (IGF-1), Albumin, and Mini Nutritional Assessment Score in Elderly Patients With Malnutrition: A Double Blind Randomized Controlled Trial|Completed||Phase 4|90|Actual|Indonesia University||2|||f||||t|f|f||||||Yes|The research findings will be disseminated via publication of results, submission of information to public accessible databases, or meetings|2017-10-10 21:18:28.035738|2017-10-10 21:18:28.035738
NCT03064503|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-08|||February 20, 2017|Actual|2017-02-20|February 2017|2017-02-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|MARVEL||Myocardial Fibrosis, Function and Aging|Myocardial Fibrosis and Changes of Myocardial Function Related to Aging|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:18:40.559587|2017-10-10 21:18:40.559587
NCT03065582|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-22|||June 2015||2015-06-01|February 2017|2017-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects|The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects|Active, not recruiting||N/A|32|Actual|Henry Ford Health System||1|||f||||t||||||||No|No individual participant data will be available to other researchers.|2017-10-10 21:18:28.116948|2017-10-10 21:18:28.116948
NCT03065569|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-06-30|||May 7, 2017|Actual|2017-05-07|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Comparison of Epidural Techniques for Labour Analgesia|A Comparison of Epidural Techniques for Labour Analgesia|Recruiting||N/A|150|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 21:18:28.211673|2017-10-10 21:18:28.211673
NCT03065556|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-10-05|||January 26, 2017|Actual|2017-01-26|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)|A Double-Blind, Randomized, Multicenter, Vehicle-Controlled, Parallel Group Study to Determine the Efficacy and Safety of 188-0551 in Subjects With Plaque Psoriasis Receiving Up To Four Weeks of Twice-Daily Treatment|Recruiting||Phase 2|88|Anticipated|Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:18:28.50031|2017-10-10 21:18:28.50031
NCT03065543|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-22|||January 1, 2006|Actual|2006-01-01|February 2017|2017-02-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2016|Actual|2016-12-31|5 Years|Observational [Patient Registry]|TERCETZabrze||Hyperlipidemia Therapy TERCET Zabrze Registry|Hyperlipidemia Therapy in tERtiary Cardiological cEnTer Zabrze Registry|Recruiting||N/A|25000|Anticipated|Silesian Centre for Heart Diseases|||1||f||||f|f|f||||||No||2017-10-10 21:18:28.620526|2017-10-10 21:18:28.620526
NCT03065530|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-09-20|||February 7, 2017|Actual|2017-02-07|September 2017|2017-09-01|September 20, 2017|Actual|2017-09-20|August 2, 2017|Actual|2017-08-02||Interventional|||Intravenous Dexmedetomidine for Cesarean Section|Efficacy and Safety of Dexmedetomidine Combined With Butorphanol Tartrate for Postoperative Analgesia and Breastfeeding in Cesarean Section|Completed||Phase 4|114|Actual|The First Affiliated Hospital with Nanjing Medical University||4|||f||||f|f|f||||||||2017-10-10 21:18:28.758156|2017-10-10 21:18:28.758156
NCT03065517|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-22|||March 1, 2018|Anticipated|2018-03-01|February 2017|2017-02-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|VillageWhere||VillageWhere: Innovative Mobile Technology for Youth With Conduct Disorder and Their Parents|Using Mobile Technology to Enhance MST Outcomes|Not yet recruiting||N/A|200|Anticipated|Evidence-Based Practice Institute, Seattle, WA||2|||f||||t|f|f||||||Yes|Requests for use of data will be considered on a case-by-case basis. Interested researchers may send data requests to research@ebpi.org.|2017-10-10 21:18:28.90753|2017-10-10 21:18:28.90753
NCT03065504|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-17|||November 2016||2016-11-01|July 2017|2017-07-01|October 23, 2017|Anticipated|2017-10-23|October 23, 2017|Anticipated|2017-10-23||Interventional|||Turmeric and Turmeric-containing Tablets and Sebum Production|Pilot Study on the Effects of Oral Turmeric and Turmeric-containing Tablets on Sebum Production|Recruiting||N/A|30|Anticipated|University of California, Davis||3|||f||||f||||||||||2017-10-10 21:18:29.040346|2017-10-10 21:18:29.040346
NCT03065491|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-22|||November 15, 2016|Actual|2016-11-15|February 2017|2017-02-01|February 17, 2017|Actual|2017-02-17|February 15, 2017|Actual|2017-02-15||Interventional|||Effect of Red Yeast Rice, Phytosterols and L-tyrosol on Lipid Profile and Endothelial Function|Effect of Red Yeast Rice, Phytosterols and L-tyrosol on Lipid Profile and Endothelial Function: a Double-blind, Placebo-controlled, Randomized Clinical Trial|Completed||N/A|50|Actual|University of Bologna||2|||f||||f|f|f||||||No||2017-10-10 21:18:29.159261|2017-10-10 21:18:29.159261
NCT03065478|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-22|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|STEFANO||Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy|An Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving Chemotherapy-induced peripherAl NeurOpathy in Patients With Colon or Breast Cancer After End of Adjuvant Therapy|Recruiting||N/A|150|Anticipated|Swiss Medical Food AG|||2||f||||f|f|f||||||No||2017-10-10 21:18:29.274118|2017-10-10 21:18:29.274118
NCT03065465|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-02-22|||November 2015||2015-11-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage|Randomized Controlled Trial (RCT) of Standard Endoscopic Hemostasis Compared to OVESCO for Severe Non-variceal UGI Hemorrhage|Recruiting||N/A|45|Anticipated|CURE Digestive Diseases Research Center||2|||f||||f||||||||No||2017-10-10 21:18:29.396139|2017-10-10 21:18:29.396139
NCT03065452|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-28|||November 2014|Actual|2014-11-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|CLE/EOS||Sagittal Imbalance and Lumbar Stenosis Surgery: Decompression Without Implant|Sagittal Imbalance and Lumbar Stenosis Surgery: Decompression Without Implant|Completed||N/A|72|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||f|f|f||||||No||2017-10-10 21:18:29.539766|2017-10-10 21:18:29.539766
NCT03065439|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-04|||June 4, 2017|Actual|2017-06-04|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|November 15, 2017|Anticipated|2017-11-15||Interventional|||The Association Between STarT Back Tool Subgroups and Postural Stability|The Association Between STarT Back Tool Subgroups of Patients With Low Back Pain and Postural Stability Under Conditions of Sensory Deprivation and Cognitive Load|Recruiting||N/A|100|Anticipated|Aalborg Universitetshospital||2|||f||||f|f|f||||||No|The data analysed will be available from the corresponding author on reasonable request.|2017-10-10 21:18:29.623941|2017-10-10 21:18:29.623941
NCT03065426|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-12|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|Biobehavioral||Microbiome and Bariatric Surgery|Mechanisms That Predict Weight Trajectory After Bariatric Surgery: The Interactive Roles of Behavior and Biology|Recruiting||N/A|144|Anticipated|North Dakota State University|||2||f||||f||||||Samples With DNA|"     Fecal   "|Yes|To the extent required by NIH and permitted by appropriate laws and rules. It will be available after the conclusion of the study and when the data have been cleaned.|2017-10-10 21:18:29.741448|2017-10-10 21:18:29.741448
NCT03064516|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-03|||March 10, 2017|Actual|2017-03-10|May 2017|2017-05-01|December 20, 2019|Anticipated|2019-12-20|December 20, 2017|Anticipated|2017-12-20||Interventional|||Endocrowns vs.Ceramic Onlays Used in Endodontically Treated Teeth- Randomized Clinical Study|Endocrowns vs.Ceramic Onlays With Filling and Fiber Pins Used in Endodontically Treated Teeth- Randomized Clinical Study|Recruiting||N/A|68|Anticipated|Universidade Ibirapuera||2|||f|||||f|f||||||||2017-10-10 21:18:40.486869|2017-10-10 21:18:40.486869
NCT03065413|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|December 2035|Anticipated|2035-12-01|December 2025|Anticipated|2025-12-01||Observational|OCEANUS||It is a Prospective Study Aiming to Identify Incidence and Prevalence of Cardiovascular Diseases, Changes in Physical Activity, Dietary Habits and Anxiety Depression Levels Through a Period of Time in the Naval Personnel (PrOspeCtive HEllenic NAval PersoNnel StUdy in CardiovaScular Diseases)|The PrOspeCtive HEllenic NAval PersoNnel StUdy in CardiovaScular Diseases (OCEANUS Study)|Recruiting||N/A|3000|Anticipated|Naval Hospital, Athens|||1||f||||f|f|f||||||Undecided||2017-10-10 21:18:29.834962|2017-10-10 21:18:29.834962
NCT03065400|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-27|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||PD-1 Inhibition in Advanced Myeloproliferative Neoplasms|PD-1 Inhibition in Advanced Myeloproliferative Neoplasms|Recruiting||Phase 2|34|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|t|f||||||No||2017-10-10 21:18:29.92868|2017-10-10 21:18:29.92868
NCT03065387|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-07-10|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Study of the Pan-ERBB Inhibitor Neratinib Given in Combination With Everolimus, Palbociclib or Trametinib in Advanced Cancer Subjects With EGFR Mutation/Amplification, HER2 Mutation/Amplification or HER3/4 Mutation|Phase I Study of the Pan-ERBB Inhibitor Neratinib Given in Combination With Everolimus, Palbociclib or Trametinib in Advanced Cancer Subjects With EGFR Mutation/Amplification, HER2 Mutation/Amplification or HER3/4 Mutation|Not yet recruiting||Phase 1|120|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:18:30.083182|2017-10-10 21:18:30.083182
NCT03065374|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-15|||August 21, 2017|Anticipated|2017-08-21|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Treatment for Clostridium-difficile Infection With IMM529|A Phase I/II, Randomized, Double Blind, Placebo-controlled Clinical Study of IMM529 for the Treatment of Clostridium-difficile Infection (CDI).|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|Immuron Ltd.||2|||f||||f|f|f||||||||2017-10-10 21:18:30.220819|2017-10-10 21:18:30.220819
NCT03065361|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-02-24|||August 2014||2014-08-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Assessing Manual Components of Brazilian Children and Adolescents on Hemodialysis|Assessing the Handgrip Strength, Fine Motor Skills, and Hand Sensitivity of Brazilian Children and Adolescents on Hemodialysis|Completed||N/A|42|Actual|Federal University of Minas Gerais|||2||f||||f||||||||Undecided||2017-10-10 21:18:30.315511|2017-10-10 21:18:30.315511
NCT03065348|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-06|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|March 1, 2019|Anticipated|2019-03-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Perioperative Multimodal Care for Cystectomy Frail Patient|A Multimodal Pre- and Intraoperative Approach for Frail Cystectomy Patients. A Prospective Single-arm Matched Case Feasibility Study|Recruiting||N/A|31|Anticipated|University Hospital Inselspital, Berne||1|||f||||f|f|f|||f|||No||2017-10-10 21:18:30.389381|2017-10-10 21:18:30.389381
NCT03065335|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-24|2017-06-30|||May 25, 2017|Actual|2017-05-25|April 13, 2017|2017-04-13|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder|Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder|Recruiting||Phase 1|100|Anticipated|National Institutes of Health Clinical Center (CC)||7|||t|||||t|f||||||||2017-10-10 21:18:30.541519|2017-10-10 21:18:30.541519
NCT03065322|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-11|||February 13, 2017|Actual|2017-02-13|September 2017|2017-09-01|January 11, 2020|Anticipated|2020-01-11|January 11, 2020|Anticipated|2020-01-11||Observational|||The Impact of Obstructive Sleep Apnoea in Women With Polycystic Ovary Syndrome.|The Impact of Obstructive Sleep Apnoea in Women With Polycystic Ovary Syndrome: A Cross-sectional Study|Recruiting||N/A|38|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust|||1||f||||f||||||||||2017-10-10 21:18:30.676117|2017-10-10 21:18:30.676117
NCT03065309|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-12|||February 25, 2017|Actual|2017-02-25|September 2017|2017-09-01|March 1, 2017|Actual|2017-03-01|February 28, 2017|Actual|2017-02-28||Interventional|||Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults|Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults|Completed||Phase 3|15|Actual|Brasilia University Hospital||1|||f||||f|f|f||||||||2017-10-10 21:18:30.782203|2017-10-10 21:18:30.782203
NCT03065296|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-16|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Standardized Home Exercise Prescription Education|Standardized Home Exercise Prescription: Education of Family Medicine Residents|Recruiting||N/A|27|Anticipated|University of Florida||1|||f||||f|f|f||||||No|No individual participant data (IPD) will be shared.|2017-10-10 21:18:30.86402|2017-10-10 21:18:30.86402
NCT03065283|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-03-01|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Diaphragm-releasing Techniques on the Lumbar Spine and Diaphragmatic Function in Healthy Women|Effects of Diaphragm-releasing Techniques on the Lumbar Spine and Diaphragmatic Function in Healthy Women: a Randomized Clinical Trial|Completed||N/A|4|Actual|Universidade Federal do Ceara||2|||f||||f|f|f||||||No||2017-10-10 21:18:30.955047|2017-10-10 21:18:30.955047
NCT03065270|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-24|||September 2011||2011-09-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy of Unstable Shoes for Instability and Lumbopelvic Pain|Efficacy of Masai Barefoot Technology (MBT) for Decreasing Pain and Improvement of Lumbopelvic Pain|Completed||N/A|24|Actual|Universidad Europea de Madrid||2|||f||||t|f|f||||||No||2017-10-10 21:18:31.024586|2017-10-10 21:18:31.024586
NCT03065257|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-21|||March 15, 2017|Actual|2017-03-15|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|March 2020|Anticipated|2020-03-01||Observational|||Endoscopic Resection Multicenter Registry|Endoscopic Resection: A Retrospective and Prospective Multicenter Registry|Recruiting||N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|No IPD Sharing|2017-10-10 21:18:31.093815|2017-10-10 21:18:31.093815
NCT03065244|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-21|||February 17, 2017|Actual|2017-02-17|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|January 2020|Anticipated|2020-01-01||Interventional|KIDCARE||KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)|KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)|Recruiting||Phase 3|250|Anticipated|University of California, San Diego||2|||f||||t|t|f|||t|||No||2017-10-10 21:18:31.200414|2017-10-10 21:18:31.200414
NCT03065231|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-01|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|January 1, 2023|Anticipated|2023-01-01|January 1, 2022|Anticipated|2022-01-01||Interventional|||Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage|Lumbar Drainage Compared With Extraventricular Drainage of Cerebral Spinal Fluid in Treatment of Patients With Subarachnoid Hemorrhage - a Prospective Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|University of California, San Diego||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:18:31.309697|2017-10-10 21:18:31.309697
NCT03065218|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-10|||October 2016||2016-10-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer Patients|Evaluation of 99mTc Sestamibi Scans In Patients Who Have Differentiated Thyroid Cancer, Elevated Serum Thyroglobulin Levels, and Negative Diagnostic Imaging Studies|Recruiting||N/A|15|Anticipated|Washington Hospital Center||1|||f||||t||||||||No||2017-10-10 21:18:31.422157|2017-10-10 21:18:31.422157
NCT03065205|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-02-24|||February 16, 2017|Actual|2017-02-16|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Breathing Counts: Evaluating Adherence in the Presence of Asthma Navigation Support|Breathing Counts: Evaluating Adherence in the Presence of Asthma Navigation Support|Recruiting||N/A|100|Anticipated|University of Colorado, Denver||1|||f||||f|f|t|f|f||||No||2017-10-10 21:18:31.55326|2017-10-10 21:18:31.55326
NCT03065192|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-28|||May 11, 2017|Actual|2017-05-11|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease|An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa|Recruiting||Phase 1|16|Anticipated|Voyager Therapeutics||1|||f||||t|t|f||||||||2017-10-10 21:18:31.682313|2017-10-10 21:18:31.682313
NCT03065179|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-03-16|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|January 31, 2020|Anticipated|2020-01-31|January 2020|Anticipated|2020-01-01||Interventional|RADVAX||Trial of SBRT in Combination With Nivolumab/Ipilimumab in RCC / Kidney Cancer Patients|Phase II Trial of Stereotactic Body Radiation Therapy in Combination With Nivolumab Plus Ipilimumab in Patients With Metastatic Renal Cell Cancer|Recruiting||Phase 2|25|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t|t|f||||||No||2017-10-10 21:18:31.865028|2017-10-10 21:18:31.865028
NCT03065166|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-10-03|||September 2016||2016-09-01|October 2017|2017-10-01|July 2017|Actual|2017-07-01|April 2017|Actual|2017-04-01||Interventional|RZN||Dried Cabernet Grapes and Cardiovascular Risk Markers|Effects of CabernayZyns (Dried Cabernet Grapes) Intake on Vascular Function and Platelet Reactivity in Postmenopausal Women|Completed||N/A|20|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 21:18:31.999187|2017-10-10 21:18:31.999187
NCT03065153|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-21|||April 1, 2015|Actual|2015-04-01|February 2017|2017-02-01|December 1, 2017|Anticipated|2017-12-01|July 1, 2017|Anticipated|2017-07-01||Observational|||Interaction Between Trunk and Gait Performance in Both Healthy Adults and Stroke Patients|Interaction Between Trunk and Gait Performance in Both Healthy Adults and Stroke Patients|Recruiting||N/A|60|Anticipated|Universiteit Antwerpen|||2||f||||f|f|f||||||Undecided||2017-10-10 21:18:32.120973|2017-10-10 21:18:32.120973
NCT03065140|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-02-21|||September 2016||2016-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|MISTY||Muscle Fat Compartments and Turnover as Determinant of Insulin Sensitivity|Muscle Fat Compartments and Turnover as Determinant of Insulin Sensitivity - the MISTY Study|Recruiting||N/A|50|Anticipated|University of Aberdeen||2|||f||||t|f|f||||||No||2017-10-10 21:18:32.208994|2017-10-10 21:18:32.208994
NCT03065127|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-04-24|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Investigating Therapies for Freezing of Gait|Investigating Therapies for Freezing of Gait Targeting the Cognitive, Limbic, and Sensorimotor Domains|Active, not recruiting||N/A|17|Actual|Sun Life Financial Movement Disorders Research and Rehabilitation Centre||3|||f||||f|f|f||||||No||2017-10-10 21:18:32.319004|2017-10-10 21:18:32.319004
NCT03065114|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||December 1, 2014|Actual|2014-12-01|February 2017|2017-02-01|November 30, 2015|Actual|2015-11-30|November 30, 2015|Actual|2015-11-30||Observational|||Retrospective Study on Clinical Results of Preimplantation Genetic Screening at Different Embryo Stage|Institute of Medicine, Chung Shan Medical University|Completed||N/A|500|Actual|Chung Shan Medical University|||1||f|||||f|f||||||Undecided||2017-10-10 21:18:32.419059|2017-10-10 21:18:32.419059
NCT03065101|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-06|||October 5, 2016|Actual|2016-10-05|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Trigen InterTAN vs Sliding Hip Screw RCT|Functional Advantages of TRIGEN™ INTERTAN™ Over Sliding Hip Screw in Subjects With Trochanteric Hip Fracture: A Randomised Controlled Trial|Recruiting||N/A|180|Anticipated|Smith & Nephew, Inc.||2|||f||||f||||||||||2017-10-10 21:18:32.495422|2017-10-10 21:18:32.495422
NCT03065088|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-10-04|||February 28, 2017|Actual|2017-02-28|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|PreventIT||The PreventIT Trial in Young Older Adults, Comparing Two Lifestyle-integrated Exercise Interventions|The PreventIT Feasibility Randomised Controlled Trial in Young Older Adults, Comparing Two Lifestyle-integrated Exercise Interventions Delivered by Use of ICT or an Instructor, With a Control Group|Active, not recruiting||N/A|181|Actual|Norwegian University of Science and Technology||3|||f||||t|f|f||||||||2017-10-10 21:18:32.596205|2017-10-10 21:18:32.596205
NCT03065075|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-24|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|EPOV||Effect of Phenazopyridine on Prolapse Surgery Voiding Trials|Effect of Phenazopyridine on Prolapse Surgery Voiding Trials|Recruiting||Phase 3|152|Anticipated|University of Massachusetts, Worcester||2|||f||||f|t|f|||f|||No||2017-10-10 21:18:34.823821|2017-10-10 21:18:34.823821
NCT03065062|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-03-13|||February 28, 2017|Actual|2017-02-28|March 2017|2017-03-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors|Phase I Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors|Recruiting||Phase 1|96|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 21:18:34.932665|2017-10-10 21:18:34.932665
NCT03065036|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-03-10|||March 2010|Actual|2010-03-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|POAG||Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG|A Prospective, Multi-Center Evaluation of the Hydrus Aqueous Implant (Standard and Low-Profile) for Lowering Intraocular Pressure (IOP) in Subjects With Mild to Advanced Primary Open Angle Glaucoma (POAG) With or Without a Cataract|Completed||Phase 1/Phase 2|120|Actual|Ivantis, Inc.||2|||f||||f||||||||No||2017-10-10 21:18:35.226941|2017-10-10 21:18:35.226941
NCT03065023|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-29|||April 25, 2017|Actual|2017-04-25|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase I/II Trial of Intralesional Administration of RGT100|A Phase I/II, Multicenter, Open-label, Clinical Trial of Intratumoral/Intralesional Administration of RGT100 in Subjects With Advanced or Recurrent Tumors|Recruiting||Phase 1/Phase 2|54|Anticipated|Rigontec GMBH||2|||f||||f|f|f||||||||2017-10-10 21:18:35.324932|2017-10-10 21:18:35.324932
NCT03065010|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-24|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer|A Multicenter Open-label Non-comparative 2-Stage Phase 1a/1b Study to Assess the Safety and Pharmacokinetics of Oral BCD-115 (JSC BIOCAD, Russia) in Combination With Endocrine Therapy in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer|Recruiting||Phase 1|36|Anticipated|Biocad||1|||f|||||f|f||||||||2017-10-10 21:18:35.443493|2017-10-10 21:18:35.443493
NCT03064997|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-21|||January 12, 2016|Actual|2016-01-12|February 2017|2017-02-01|June 1, 2016|Actual|2016-06-01|March 1, 2016|Actual|2016-03-01||Interventional|||Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children|Assessment of the Impact of Prebiotic Synergy 1 on the Intestine Permeability, Clinical Symptoms, and Selected Biochemical and Nutritional Parameters in the Children With Celiac Disease on a Gluten-free Diet|Completed||N/A|34|Actual|Polish Academy of Sciences||2|||f||||f|f|f||||||No||2017-10-10 21:18:35.529226|2017-10-10 21:18:35.529226
NCT03064984|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-22|||January 30, 2017|Actual|2017-01-30|February 2017|2017-02-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy|Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy - A Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t|f|f||||||No||2017-10-10 21:18:35.623474|2017-10-10 21:18:35.623474
NCT03064971|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-22|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|June 15, 2021|Anticipated|2021-06-15|March 15, 2021|Anticipated|2021-03-15||Interventional|||Enhancing Quitline Services for African American Smokers|Enhancing Quitline Services for African American Smokers: RCT of an Evidence-Based DVD|Recruiting||N/A|1050|Anticipated|Case Comprehensive Cancer Center||3|||f||||t|f|f||||||||2017-10-10 21:18:35.761873|2017-10-10 21:18:35.761873
NCT03064958|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-24|||September 13, 2016|Actual|2016-09-13|May 2017|2017-05-01|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29||Interventional|||The Acute Effect of Spices on Vascular Health|The Postprandial Effects of a High Fat Meal Containing Spices on Endothelial Function: a Pilot Study|Completed||N/A|6|Actual|Penn State University||3|||f||||f||||||||No||2017-10-10 21:18:35.986574|2017-10-10 21:18:35.986574
NCT03064945|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-15|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||The Effectiveness and Safety of LIVIA® Transcutaneous Electrical Nerve Stimulation (TENS) in Women Suffering From Primary Dysmenorrhea.|A Randomized, Controlled, Multi-Center, CROSSOVER, Prospective, Double-blind Clinical Study to Assess the Effectiveness and Safety of Livia® Transcutaneous Electrical Nerve Stimulation (TENS) in Women Suffering From Primary Dysmenorrhea|Not yet recruiting||Phase 2|63|Anticipated|iPulse Medical Ltd. (Livia)||2|||f||||t|f|f|||f|||||2017-10-10 21:18:36.093567|2017-10-10 21:18:36.093567
NCT03064932|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-21|||January 25, 2017|Actual|2017-01-25|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of a Spice Blend on Cardiovascular Risk Factors and Diet Satisfaction|The Effect of Chronic Consumption of Popular Spices on Risk Factors for Cardiovascular Disease (CVD), Inflammation & Immune Function, and Diet Satisfaction|Recruiting||N/A|80|Anticipated|Penn State University||3|||f||||f|f|f||||||No||2017-10-10 21:18:36.197027|2017-10-10 21:18:36.197027
NCT03064919|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-21|||June 25, 2015|Actual|2015-06-25|February 2017|2017-02-01|May 1, 2018|Anticipated|2018-05-01|January 2, 2018|Anticipated|2018-01-02||Interventional|CTSI||Developing Novel Methods to Teach Children to Recognize Internal Signals of Hunger|Developing Novel Methods to Teach Children to Recognize Internal Signals of Hunger and Fullness|Recruiting||N/A|40|Anticipated|Penn State University||1|||f||||f|f|f||||||No||2017-10-10 21:18:36.341232|2017-10-10 21:18:36.341232
NCT03064906|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-25|||March 18, 2017|Actual|2017-03-18|April 2017|2017-04-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|IDE2||Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)|Evaluating Meal Performance and Effect of Moderate Intensity Exercise in Patients With Type 1 Diabetes With the Insulet Automated Glucose Control System: IDE 2|Completed||N/A|24|Actual|Insulet Corporation||1|||f||||f|f|t|f|f||||No||2017-10-10 21:18:36.500676|2017-10-10 21:18:36.500676
NCT03064893|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-07-05|||February 6, 2017|Actual|2017-02-06|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|February 2020|Anticipated|2020-02-01||Interventional|REaCT-ADM||The Use of Alloderm Versus Dermacell in Immediate Implant Based Breast Reconstruction|A Randomised Controlled Trial Comparing the Use of Alloderm Versus Dermacell in Immediate Implant Based Breast Reconstruction|Recruiting||N/A|56|Anticipated|Ottawa Hospital Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:18:36.612651|2017-10-10 21:18:36.612651
NCT03064880|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-07|||March 15, 2017|Anticipated|2017-03-15|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Preoperative Goal-directed Fluid Therapy and Physiological Changes Following One-lung Ventilation|Does Preoperative Maximization Fluid Strategies for Goal-directed Therapy Affect Physiological Changes Following One-lung Ventilation|Not yet recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f|||||f|f||||||Undecided||2017-10-10 21:18:36.730368|2017-10-10 21:18:36.730368
NCT03064867|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-08-18|||June 26, 2017|Actual|2017-06-26|August 2017|2017-08-01|March 15, 2020|Anticipated|2020-03-15|November 15, 2018|Anticipated|2018-11-15||Interventional|||Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma|Phase I Trial of Venetoclax in Combination With R-ICE (V+RICE) Chemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma|Recruiting||Phase 1|18|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:18:36.843901|2017-10-10 21:18:36.843901
NCT03064854|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-08-23|||May 24, 2017|Actual|2017-05-24|August 2017|2017-08-01|November 6, 2019|Anticipated|2019-11-06|November 6, 2019|Anticipated|2019-11-06||Interventional|||PDR001 in Combination With Platinum-doublet Chemotherapy in PD-L1 Unselected, Metastatic NSCLC Patients (ElevatION:NSCLC-101 Trial)|Phase Ib, Multicenter, Open Label Study of PDR001 in Combination With Platinum-doublet Chemotherapy in PD-L1 Unselected, Metastatic NSCLC Patients (ElevatION:NSCLC-101 Trial)|Recruiting||Phase 1|170|Anticipated|Novartis||4|||f||||f|t|f||||||||2017-10-10 21:18:36.996352|2017-10-10 21:18:36.996352
NCT03064841|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-10-03|||March 9, 2017|Actual|2017-03-09|October 2017|2017-10-01|October 16, 2017|Anticipated|2017-10-16|October 16, 2017|Anticipated|2017-10-16||Observational|||Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China|Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China: A Nationwide Cross-sectional Study|Recruiting||N/A|1500|Anticipated|Boehringer Ingelheim|||1||f||||f|t|f|||t|||||2017-10-10 21:18:37.167295|2017-10-10 21:18:37.167295
NCT03064828|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-22|||January 2017||2017-01-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Colorectal Polyps Screening With Low-dose CT Colonoscopy|Colorectal Adenoma Screening by Low-dose CT Colonoscopy With Computer-aided Detection|Active, not recruiting||N/A|100|Anticipated|Xijing Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:18:37.330629|2017-10-10 21:18:37.330629
NCT03064815|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-27|||June 2009||2009-06-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SpACE||The SpACE Study - Small Bowel Crohn's Disease and Spondyloarthropathies|Prevalence of Small Bowel Inflammatory Crohn's Disease Lesions in Patients With Spondyloarthropathies (SpA): A Prospective Capsule Endoscopy-Based Study|Completed||N/A|67|Actual|McGill University Health Center||2|||f||||f||||||||Yes|Patients will be told of the results of all blood work and diagnostic tests. Data will be presented at scientific conferences as well as published in scientific journals.|2017-10-10 21:18:37.423163|2017-10-10 21:18:37.423163
NCT03064802|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-09-22|||March 24, 2017|Actual|2017-03-24|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01|12 Months|Observational [Patient Registry]|||Burst Biologics Spinal Fusion Registry|Multicenter Prospective Registry to Evaluate Use and Outcomes of Burst Biologics Products in Spinal Fusion Surgery|Recruiting||N/A|450|Anticipated|Smart-Surgical Inc. dba Burst Biologics|||1||f||||t|f|f|||f|||||2017-10-10 21:18:37.564273|2017-10-10 21:18:37.564273
NCT03064789|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-21|||December 29, 2016|Actual|2016-12-29|February 2017|2017-02-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|||Epidemiological Study in Subjects With Vulvovaginal Candidiases|Estudio epidemiológico de la evolución clínica y microbiológica en Pacientes Tratadas Por un Episodio Agudo de Candidiasis Vulvovaginal|Recruiting||N/A|43|Anticipated|Instituto Palacios|||1||f|||||f|f||||||No||2017-10-10 21:18:37.697101|2017-10-10 21:18:37.697101
NCT03064776|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-03-09|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|m-RESIST||Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia|Pilot Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia: Acceptability, Usability, Satisfaction and Perceived Quality of Life Reported by Patients and Caregivers|Recruiting||N/A|45|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f|f|f||||||Undecided||2017-10-10 21:18:37.827279|2017-10-10 21:18:37.827279
NCT03064763|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-26|||March 7, 2017|Actual|2017-03-07|June 2017|2017-06-01|September 23, 2021|Anticipated|2021-09-23|June 6, 2019|Anticipated|2019-06-06||Interventional|||Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma|A Phase 1, Multi-center, Open-Label, Dose De-escalation Study to Evaluate the Safety and Efficacy of Talimogene Laherparepvec in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma|Recruiting||Phase 1|18|Anticipated|Amgen||1|||f||||f|t|f|||t|||||2017-10-10 21:18:37.953003|2017-10-10 21:18:37.953003
NCT03064750|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|CONTRAPOP||Pelvic Floor Exercise Before Surgery in Women With Pelvic Organ Prolapse|Pelvic Floor Exercise Before Surgery in Women With Pelvic Organ Prolapse|Recruiting||N/A|150|Anticipated|St. Olavs Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:18:38.279706|2017-10-10 21:18:38.279706
NCT03064737|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-08-17|||September 2017|Anticipated|2017-09-01|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|May 2020|Anticipated|2020-05-01||Interventional|Proglegio||Bacterial and Human Biomarkers of Prognostic Value for Severe Legionnaire's Disease|Bacterial and Human Biomarkers of Prognostic Value for Severe Legionnaire's Disease|Not yet recruiting||N/A|300|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:18:38.484141|2017-10-10 21:18:38.484141
NCT03064724|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-22|||August 2012||2012-08-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Practice-based Intervention for Vietnamese and Korean Patients|Practice-based Intervention for Vietnamese and Korean Patients|Completed||N/A|47|Actual|Asian Health Services||1|||f||||f||||||||||2017-10-10 21:18:38.58275|2017-10-10 21:18:38.58275
NCT03064711|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Activity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics in Post-Polio Patients|Comparison of Activity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics Between Post-Polio Patients and Healthy Controls: A Pilot Study|Completed||N/A|24|Actual|Hadassah Medical Organization|||||f|||||f|f||||||||2017-10-10 21:18:38.678184|2017-10-10 21:18:38.678184
NCT03064698|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-22|||June 3, 2016|Actual|2016-06-03|February 2017|2017-02-01|June 3, 2018|Anticipated|2018-06-03|June 3, 2018|Anticipated|2018-06-03||Observational|||Uterine Artery Doppler Changes|Uterine Artery Doppler Changes From the Second Trimester of Pregnancy to the Postpartum Period in a Group of High Risk Women|Enrolling by invitation||N/A|32|Anticipated|St. Michael's Hospital, Toronto|||2||f||||f|f|f||||||No||2017-10-10 21:18:38.764057|2017-10-10 21:18:38.764057
NCT03064685|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-01|||November 22, 2016|Actual|2016-11-22|March 2017|2017-03-01|March 3, 2017|Anticipated|2017-03-03|March 2, 2017|Anticipated|2017-03-02||Observational|||Risk Factors and Outcomes of Pyogenic Liver Abscess in Adult Liver Recipients: A Match Case Control Study|Risk Factors and Outcomes of Pyogenic Liver Abscess in Adult Liver Recipients: A Match Case Control Study|Recruiting||N/A|126|Anticipated|Hospital Italiano de Buenos Aires|||2||f||||t|f|f||||||No||2017-10-10 21:18:38.852749|2017-10-10 21:18:38.852749
NCT03064672|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-24|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||Transcervical Balloon Catheters in GBS Carriers, Is It Safe? A Randomized Controlled Trial|Transcervical Balloon Catheters in GBS Carriers, Is It Safe? A Randomized Controlled Trial|Not yet recruiting||N/A|500|Anticipated|Hadassah Medical Organization||2|||f||||f|f|t|f|f|f|||No|The data of the mother and the baby will be checked and recorded. At the end of the study, all the data are gonna be analyzed. In case of a severe bad outcome, the data will be checked during the study to make sure that the study is not the cause.|2017-10-10 21:18:38.96393|2017-10-10 21:18:38.96393
NCT03064659|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-05-22|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|January 2017|Actual|2017-01-01|1 Month|Observational [Patient Registry]|||Driving Pressure And EFL in Adult Cardiac Surgery|Driving Pressure And Limitation of Expiratory Flow: Evaluation of Postoperative Pulmonary Complications in Elective Adult Cardiac Surgery.|Completed||N/A|200|Actual|Ospedale San Raffaele|||1||f|||||f|f||||||||2017-10-10 21:18:39.076173|2017-10-10 21:18:39.076173
NCT03064646|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-10|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|February 2027|Anticipated|2027-02-01|February 2022|Anticipated|2022-02-01||Interventional|PRONAR||Organ Preservation in Locally Advanced Rectal Cancer|ORGAN PRESERVATION AFTER NEOADJUVANT TREATMENT FOR LOCALLY ADVANCED RECTAL CANCER|Recruiting||N/A|30|Anticipated|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||1|||f||||t|f|f||||||No|It is planned to share global data analysis|2017-10-10 21:18:39.199239|2017-10-10 21:18:39.199239
NCT03064633|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-28|||March 8, 2017|Actual|2017-03-08|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Dexamethasone Versus Dexmedetomidine|Dexamethasone Versus Dexmedetomidine as Local Anesthetic Adjuvants in Ultrasound Guided Transversus Abdominis Plane Block for Total Abdominal Hysterectomies|Recruiting||Phase 4|54|Anticipated|Fayoum University Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:18:39.33741|2017-10-10 21:18:39.33741
NCT03064620|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-02-22|||April 2014||2014-04-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|August 2020|Anticipated|2020-08-01||Observational|PICRcarriage||PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study|PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study|Recruiting||N/A|12800|Anticipated|Sheba Medical Center|||3||f||||t||||||Samples Without DNA|"     S. aureus and S. pneumoniae   "|No||2017-10-10 21:18:39.515015|2017-10-10 21:18:39.515015
NCT03064607|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-07-25|||November 5, 2010|Actual|2010-11-05|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|February 1, 2019|Anticipated|2019-02-01||Observational|||Neurodegeneration in Newborns After Anesthetics|Measurement of Biomarkers of Neurodegeneration in Newborns After Exposure to Anesthetics|Recruiting||N/A|130|Anticipated|University of Pennsylvania|||1||f||||f|f|f||||Samples Without DNA|"     Plasma   "|||2017-10-10 21:18:39.665472|2017-10-10 21:18:39.665472
NCT03064594|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-24|||February 9, 2017|Actual|2017-02-09|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Comparison of Laparoscopic Cornuostomy and Wedge Resection for Interstitial Pregnancy|Comparison of Laparoscopic Cornuostomy and Wedge Resection for Interstitial Pregnancy|Recruiting||N/A|40|Anticipated|Far Eastern Memorial Hospital|||2||f|||||f|f||||||||2017-10-10 21:18:39.779597|2017-10-10 21:18:39.779597
NCT03064581|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-02-21|||January 2008||2008-01-01|February 2017|2017-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Pap Test Intervention to Enhance Decision Making Among Pacific Islander Women|A Pap Test Intervention to Enhance Decision Making Among Pacific Islander Women|Completed||N/A|1014|Actual|California State University, Fullerton||2|||f||||t||||||||Yes|After completion of each data collection activity, all program project datasets will be de-identified and then made available for secondary analysis on the California State University, Fullerton, Health Promotion Research Institute website. A consultant, who is experienced in large multi-site controlled trials, will assist with the protocols (in years 2 and 3) required for dataset documentation and distribution. Researchers will be able to access the data, documentation, and surveys by registering on the website, obtaining approval from the Health Promotion Research Institute steering committee, and downloading the files. Care will be taken to ensure that respondents cannot be identified from the information in the public-use dataset. The final dataset will be stripped of identifiers (i.e., individual respondent identifying information, such as names and phone numbers, will be removed) prior to release for sharing.|2017-10-10 21:18:39.891998|2017-10-10 21:18:39.891998
NCT03064568|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-24|||October 14, 2016|Actual|2016-10-14|February 2017|2017-02-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy|Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy|Recruiting||Phase 4|50|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f|t|f|||t|||No||2017-10-10 21:18:40.000815|2017-10-10 21:18:40.000815
NCT03064555|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-06-13|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01|2 Months|Observational [Patient Registry]|PRECISE||Acute Physiological Response to Exercise in End Stage Renal Disease|Acute Physiological Response to Exercise in End Stage Renal Disease|Recruiting||N/A|55|Anticipated|Coventry University|||2||f||||f|f|f||||Samples Without DNA|"     Serum and plasma from whole blood samples.   "|No||2017-10-10 21:18:40.188839|2017-10-10 21:18:40.188839
NCT03064542|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-08-22|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01|6 Months|Observational [Patient Registry]|TRIBUTE||The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure|The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure|Recruiting||N/A|40|Anticipated|Clinical Nutrition Research Centre, Singapore|||1||f||||f|f|f||||Samples With DNA|"     Blood samples for thyroid function, liver and kidney function, fasting glucose, insulin and     lipids, analysis of fat metabolism and protein profiles.      Urine samples for fat metabolism and protein profiles.   "|||2017-10-10 21:18:40.315816|2017-10-10 21:18:40.315816
NCT03064529|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-21|||January 2016||2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Novel Approach to Inpatient Pediatric Physical Activity Measurement - The 6th Vital Sign|A Novel Approach to Inpatient Pediatric Physical Activity Measurement - The 6th Vital Sign|Recruiting||N/A|75|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||No||2017-10-10 21:18:40.401125|2017-10-10 21:18:40.401125
NCT03064490|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-07-31|||July 28, 2017|Actual|2017-07-28|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|PROCEED||Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)|Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)|Recruiting||Phase 2|38|Anticipated|Duke University||1|||f||||f|t|f|||f|||||2017-10-10 21:18:40.645153|2017-10-10 21:18:40.645153
NCT03064477|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-10|||September 14, 2014|Actual|2014-09-14|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System|Cost-efficacy and Acceptability of the Unified Protocol for the Treatment of Emotional Disorders in the Spanish Public Mental Health System Using a Group Format|Recruiting||N/A|200|Anticipated|Universitat Jaume I||2|||f||||t|f|f||||||No|IPD will not be shared with other researchers.|2017-10-10 21:18:40.734287|2017-10-10 21:18:40.734287
NCT03064464|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||December 15, 2016|Actual|2016-12-15|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|||CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome|Community-associated Staphylococcus Aureus Infections in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome|Recruiting||N/A|5400|Anticipated|Sir Run Run Shaw Hospital|||3||f||||f|f|f||||Samples With DNA|"     bacterial isolates   "|Undecided||2017-10-10 21:18:40.84584|2017-10-10 21:18:40.84584
NCT03064451|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-06-27|||February 22, 2017|Actual|2017-02-22|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|October 31, 2018|Anticipated|2018-10-31||Interventional|RAPID-AF||Repetitive Activation Patterns and Focal Impulses Identification and Ablation in Persistent AF|Repetitive Activation Patterns and Focal Impulses Identification and Ablation in Persistent AF Using the RHYTHMFINDER-192|Recruiting||N/A|40|Anticipated|Biosense Webster, Inc.||1|||f||||t|f|f||||||Undecided||2017-10-10 21:18:40.929899|2017-10-10 21:18:40.929899
NCT03064438|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-24|||April 15, 2017|Anticipated|2017-04-15|February 2017|2017-02-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Efficacy of Accu-D1 in the Treatment of Acne Rosacea|Efficacy of Accu-D1 in the Treatment of Acne Rosacea|Not yet recruiting||Phase 2|36|Anticipated|Accuitis, Inc.||2|||f||||f|t|f|||f|||No||2017-10-10 21:18:41.019843|2017-10-10 21:18:41.019843
NCT03064425|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Understanding HIV Susceptibility in the Female Genital Tract|Understanding HIV Susceptibility in the Female Genital Tract|Completed||N/A|150|Actual|St. Michael's Hospital, Toronto||1|||f||||f|f|f||||||No||2017-10-10 21:18:41.093695|2017-10-10 21:18:41.093695
NCT03064412|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-07-20|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Pregnancy on Androgenic Steroids in Different Genetic Panels|Effect of Pregnancy on Androgenic Steroids in Different Genetic Panels|Completed||N/A|70|Actual|St. Michael's Hospital, Toronto||1|||f||||f|f|f||||||||2017-10-10 21:18:41.157229|2017-10-10 21:18:41.157229
NCT03064399|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||February 28, 2017|Anticipated|2017-02-28|February 2017|2017-02-01|February 28, 2020|Anticipated|2020-02-28|May 28, 2019|Anticipated|2019-05-28||Interventional|||Microfracture Technique for Talar Articular Cartilage Lesions With or Without Lateral Ligament Repairment|Microfracture Technique for the Treatment of Articular Cartilage Lesions of the Talus With or Without Lateral Ligament Repairment|Not yet recruiting||N/A|40|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine||2|||f|||||f|f||||||||2017-10-10 21:18:41.215962|2017-10-10 21:18:41.215962
NCT03064386|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||February 28, 2017|Anticipated|2017-02-28|February 2017|2017-02-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Comparative Study of Postieror Ankle Fracture|Comparative Study of Postieror Malleolar Fracture With Plate and Screw Fixation|Not yet recruiting||N/A|50|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine||2|||f|||||f|f||||||||2017-10-10 21:18:41.4473|2017-10-10 21:18:41.4473
NCT03064373|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||December 17, 2008|Actual|2008-12-17|February 2017|2017-02-01|June 17, 2023|Anticipated|2023-06-17|December 17, 2022|Anticipated|2022-12-17||Observational|||Mother to Newborn Transmission of Staphylococcus Aureus and Dynamics of S.Aureus Carriage During the First Years Life|Mother to Newborn Transmission of Staphylococcus Aureus and the Dynamics of S. Aureus Carriage During the First Years of Life|Recruiting||N/A|600|Anticipated|Sheba Medical Center|||1||f||||t|f|f||||Samples Without DNA|"     S. aureus and S. pneumoniae   "|No||2017-10-10 21:18:41.559395|2017-10-10 21:18:41.559395
NCT03064360|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-08-24|||February 13, 2017|Actual|2017-02-13|August 2017|2017-08-01|November 1, 2018|Anticipated|2018-11-01|July 31, 2018|Anticipated|2018-07-31||Observational|||Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring|Early Prediction of Major Adverse Cardiovascular Event Surrogates Using Remote Monitoring With Biosensors, Biomarkers, and Patient-Reported Outcomes|Recruiting||N/A|200|Anticipated|Cedars-Sinai Medical Center|||1||f||||t|f|f||||||||2017-10-10 21:18:42.133355|2017-10-10 21:18:42.133355
NCT03064347|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-24|||February 22, 2017|Actual|2017-02-22|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|TEND||Targeted Enteral Nutrient Delivery: A Prospective Randomized Study|Targeted Enteral Nutrient Delivery: A Prospective Randomized Study|Recruiting||N/A|20|Anticipated|University of Southern California||8|||f||||f|f|f||||||No||2017-10-10 21:18:42.259056|2017-10-10 21:18:42.259056
NCT03064334|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-07-04|||September 5, 2017|Anticipated|2017-09-05|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Patients' Views on Outcomes Following Total Knee Arthroplasty: a Focus-group Study|Patients' Views on Outcomes Following Total Knee Arthroplasty: a Focus-group Study|Not yet recruiting||N/A|10|Anticipated|University of Salford|||1||f||||f|f|f||||||||2017-10-10 21:18:42.390719|2017-10-10 21:18:42.390719
NCT03064321|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 30, 2020|Anticipated|2020-03-30|March 30, 2019|Anticipated|2019-03-30||Interventional|DSTT-I||Diabetes Sleep Treatment Trial for Insomnia|Self-Management, Insomnia, and Glucose Control in Adults With Diabetes|Not yet recruiting||N/A|40|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||||2017-10-10 21:18:42.51653|2017-10-10 21:18:42.51653
NCT03063775|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-21|||January 9, 2017|Actual|2017-01-09|February 2017|2017-02-01|May 1, 2018|Anticipated|2018-05-01|January 9, 2018|Anticipated|2018-01-09||Interventional|SocketSeal||Proof of Concept: Socket Seal|Proof of Concept: Intra-oral Soft Tissue Preservation of Extraction Sockets in Anterior Upper Jaw|Recruiting||N/A|50|Anticipated|Medical University of Graz||5|||f||||t|f|f|||f|||No||2017-10-10 21:18:46.887932|2017-10-10 21:18:46.887932
NCT03064308|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-06-26|||June 26, 2017|Anticipated|2017-06-26|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|POETold||The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery|The Assessment of the Feasibility of a Home Based Post-operative Exercise Training Programme Targeting Physical and Cognitive Function in Older Patients Undergoing Major Body Surgery|Not yet recruiting||N/A|30|Anticipated|University of Nottingham||2|||f||||t|f|f||||||No||2017-10-10 21:18:42.609205|2017-10-10 21:18:42.609205
NCT03064295|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-01|||March 1, 2017|Anticipated|2017-03-01|March 2017|2017-03-01|January 1, 2025|Anticipated|2025-01-01|January 1, 2025|Anticipated|2025-01-01||Observational|||Whole-Heart Myocardial Blood Flow Quantification Using MRI|Whole-Heart Myocardial Blood Flow Quantification Using Magnetic Resonance Imaging|Recruiting||N/A|160|Anticipated|Cedars-Sinai Medical Center|||3||f||||f||t|f|||||No||2017-10-10 21:18:42.747582|2017-10-10 21:18:42.747582
NCT03064282|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-08-28|||September 20, 2017|Anticipated|2017-09-20|August 2017|2017-08-01|February 20, 2018|Anticipated|2018-02-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||Prostatic Hyperplasia Treatment and Cancer Prevention|Treatment of Prostatic Hyperplasia With Topical Papaverine|Not yet recruiting||Early Phase 1|40|Anticipated|Manchanda Medical Clinic||2|||f||||f|f|f|||f|||||2017-10-10 21:18:42.874917|2017-10-10 21:18:42.874917
NCT03064256|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-21|||November 14, 2014|Actual|2014-11-14|February 2017|2017-02-01|January 16, 2017|Actual|2017-01-16|December 21, 2015|Actual|2015-12-21||Interventional|||Aerobic Physical Training and Heart Rate Variability in Hypertersion|EFFECT OF AEROBIC PHYSICAL TRAINING WITH DETERMINED INTENSITY FOR THE PROTOCOL OF DOUBLE EXHAUSTIVE EFFORTS IN THE AUTONOMICAL MODULATION OF THE HEART FREQUENCY OF PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION|Completed||N/A|63|Actual|University of Campinas, Brazil||2|||f||||t|f|f|||f|||||2017-10-10 21:18:43.064475|2017-10-10 21:18:43.064475
NCT03064243|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-02-22|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 1, 2018|Anticipated|2018-09-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||A Phase II Study of Apatinib in STS Patients|Effectiveness and Safety of Apatinib for the Patients With Advanced Soft Tissue Sarcoma|Not yet recruiting||Phase 2|53|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||1|||f|||||f|f||||||||2017-10-10 21:18:43.15027|2017-10-10 21:18:43.15027
NCT03064230|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-24|||January 1, 2016|Actual|2016-01-01|February 2017|2017-02-01|May 30, 2016|Actual|2016-05-30|May 30, 2016|Actual|2016-05-30||Observational|Wsport||Promotion of Wellbeing in Women Athletes|Promotion and Protection of the Well Being of Women Athletes Through the Female Athlete Triad Screening|Completed||N/A|200|Actual|Campus Bio-Medico University|||2||f||||f|f|f||||||No||2017-10-10 21:18:43.228684|2017-10-10 21:18:43.228684
NCT03064217|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-14|||May 25, 2017|Actual|2017-05-25|July 2017|2017-07-01|July 30, 2020|Anticipated|2020-07-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Intraoral Imaging at Clinical Crown Lengthening|The Use of Intraoral Imaging at Clinical Crown Lengthening Procedures|Recruiting||N/A|34|Anticipated|University of Maryland Baltimore Dental School||2|||f||||f|f|f||||||||2017-10-10 21:18:43.31245|2017-10-10 21:18:43.31245
NCT03064204|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-05-04|||February 9, 2017|Actual|2017-02-09|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||The Pathogenesis of OSA in People Living With HIV|The Pathogenesis of OSA in People Living With HIV|Recruiting||N/A|44|Anticipated|University of California, San Diego|||2||f||||f|f|f||||||||2017-10-10 21:18:43.418012|2017-10-10 21:18:43.418012
NCT03064191|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-09|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|April 13, 2018|Anticipated|2018-04-13|March 13, 2018|Anticipated|2018-03-13||Interventional|||Influence of Intra Canal Medications on Postoperative Flare-up in Endodontic Re-treatment Cases|Influence of Calcium Hydroxide Chlorhexidine Combination vs. Calcium Hydroxide as an Intra Canal Medicaments on Postoperative Flare -up Following Two-Visits Endodontic Retreatment Cases: Single Blinded Randomized Clinical Trial|Not yet recruiting||N/A|24|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 21:18:43.511521|2017-10-10 21:18:43.511521
NCT03064178|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-21|||May 10, 2014|Actual|2014-05-10|February 2017|2017-02-01|August 15, 2016|Actual|2016-08-15|March 7, 2016|Actual|2016-03-07||Observational|||Use of Pain Medication Following Periodontal Procedures|Anticipated Versus Actual Pain Associated With Periodontal Surgery and Use of Pain Medication|Completed||N/A|213|Actual|Brock University|||1||f||||f|f|f||||||No||2017-10-10 21:18:43.623435|2017-10-10 21:18:43.623435
NCT03064165|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-21|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Postoperative Analgesia After Elective Hip Surgery - Effect of Obturator Nerve Blockade|Postoperative Analgesia After Elective Hip Surgery - Effect of Obturator|Not yet recruiting||Phase 4|60|Anticipated|University of Aarhus||2|||f||||t|f|f|||f|||Undecided|Data will be shared through the Danish Data Archive.|2017-10-10 21:18:43.708313|2017-10-10 21:18:43.708313
NCT03064152|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-21|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery|Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery|Not yet recruiting||N/A|100|Anticipated|Brigham and Women's Hospital||2|||f||||t|f|t|f|f||||No||2017-10-10 21:18:43.801312|2017-10-10 21:18:43.801312
NCT03064139|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-07-11|||February 2018|Anticipated|2018-02-01|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Mindful Walking Intervention for Knee Osteoarthritis|Mind Your Walk Intervention for Community-based Management of Knee OA: A Feasibility Study|Not yet recruiting||N/A|80|Anticipated|Boston University Charles River Campus||2|||f||||f|f|f||||||||2017-10-10 21:18:43.892372|2017-10-10 21:18:43.892372
NCT03064100|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-07-18|||March 21, 2017|Actual|2017-03-21|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Pilot Evaluation of the FilmArray® Childhood Systemic Infection (CSI) Panel|Pilot Evaluation of the FilmArray® Childhood Systemic Infection (CSI) Panel|Enrolling by invitation||N/A|1500|Anticipated|BioFire Diagnostics, LLC|||1||f||||f|f|f|||f|Samples With DNA|"     Plasma and Whole Blood   "|||2017-10-10 21:18:44.387512|2017-10-10 21:18:44.387512
NCT03064087|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-19|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|February 28, 2018|Anticipated|2018-02-28||Observational|VALHUDES||Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples|Validation of Human Papillomavirus Assays and Collection Devices for HPV Testing on Self-samples and First-void Urine Samples (VALHUDES)|Not yet recruiting||N/A|500|Anticipated|Belgian Scientific Institute of Public Health|||1||f||||t|f|t|f|f||Samples With DNA|"     First-void urine sample, vaginal self-sample and cervical cell sample collected by a     gynecologist. No human DNA is extracted from the samples but the samples can contain HPV DNA.   "|||2017-10-10 21:18:44.459069|2017-10-10 21:18:44.459069
NCT03064074|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-09-14|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta|Multicenter Study to Evaluate Safety of Fresolimumab in Adults With Moderate-to-severe Osteogenesis Imperfecta|Recruiting||Phase 1|16|Anticipated|Baylor College of Medicine||4|||f||||t|t|f||||||||2017-10-10 21:18:44.54403|2017-10-10 21:18:44.54403
NCT03064061|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-02-21|||March 2017||2017-03-01|January 2017|2017-01-01|June 2019||2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Impact of Virtual Reality Before Oocytes Retrieval on Anxiety and Pregnancy Rate|Impact of a Virtual Reality Experience, Before Oocytes Retrieval for In-vitro Fertilisation Treatment, on Anxiety and on the Pregnancy Rate|Not yet recruiting||N/A|600|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f|||||f|f||||||||2017-10-10 21:18:44.64068|2017-10-10 21:18:44.64068
NCT03064048|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-21|||April 15, 2017|Anticipated|2017-04-15|February 2017|2017-02-01|December 31, 2023|Anticipated|2023-12-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD|Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD)|Recruiting||N/A|16|Anticipated|Baylor College of Medicine||2|||f||||t|f|f||||||Yes|According to the policy of the National Institutes of Health (one of the study sponsors) research data may be put in a secure, limited-access database known as dbGaP. The data will include any genetic test results as well as other information about medical problems. There will be NO identifiers included (no name, data of birth, address, social security number, etc.). Access to this information is restricted by the National Institutes of Health. Only doctors and scientists who get approval from the National Institutes of Health can access this de-identified data.|2017-10-10 21:18:44.712862|2017-10-10 21:18:44.712862
NCT03064035|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-24|||April 5, 2017|Actual|2017-04-05|February 2017|2017-02-01|April 15, 2020|Anticipated|2020-04-15|April 15, 2020|Anticipated|2020-04-15||Interventional|kcentra||Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal|A Prospective, Randomized Study of Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal at a Large Tertiary Care Medical Center|Recruiting||Phase 4|48|Anticipated|HealthPartners Institute||2|||f||||f|t|f|||t|||No||2017-10-10 21:18:44.814022|2017-10-10 21:18:44.814022
NCT03064022|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-05|||February 2009|Actual|2009-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|PreMGS||Preterm Infant Multicentre Growth Study|Preterm Infant Multicentre Growth Study|Recruiting||N/A|1400|Anticipated|University of Calgary|||3||f||||f||||||||||2017-10-10 21:18:44.899444|2017-10-10 21:18:44.899444
NCT03064009|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-03-10|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|||Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures|Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures|Recruiting||N/A|5000|Anticipated|University of Washington|||1||f||||f|f|f||||||No||2017-10-10 21:18:44.988269|2017-10-10 21:18:44.988269
NCT03063996|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-07|||February 7, 2017|Actual|2017-02-07|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access|Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access Research Study|Recruiting||N/A|84|Anticipated|HealthPartners Institute||2|||f||||f|f|f||||||No|We do not plan to share individual personnel data|2017-10-10 21:18:45.114334|2017-10-10 21:18:45.114334
NCT03063983|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-03-09|||January 2, 2017|Actual|2017-01-02|March 2017|2017-03-01|January 31, 2022|Anticipated|2022-01-31|January 2, 2019|Anticipated|2019-01-02||Interventional|GLATO2017||Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma|A Study Multicenter Randomized to Assess the Efficacy and Toxicity of Adding Metronomic Therapy to the Standard Treatment of Patients With High Grade Malignant Osteosarcoma With Metastatic Lung Disease at Diagnosis and Primary Resectable Tumor: A Study by the Latin American Group for Treatment of Osteosarcoma|Recruiting||Phase 2|158|Anticipated|Grupo de Apoio ao Adolescente e a Crianca com Cancer||2|||f||||f|t|f|||f|||Undecided||2017-10-10 21:18:45.195986|2017-10-10 21:18:45.195986
NCT03063970|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-27|||January 13, 2017|Actual|2017-01-13|February 2017|2017-02-01|March 31, 2018|Anticipated|2018-03-31|December 2017|Anticipated|2017-12-01||Interventional|LOTUS||Lycra Orthosis as Therapy for the Upper Limb After Stroke|Dynamic Lycra Orthosis as an Adjunct to Upper Limb Rehabilitation After Stroke: A Randomised Controlled Feasibility Trial|Recruiting||N/A|51|Anticipated|Glasgow Caledonian University||2|||f||||f|f|f||||||No||2017-10-10 21:18:45.428787|2017-10-10 21:18:45.428787
NCT03063957|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-21|||June 30, 2015|Actual|2015-06-30|February 2017|2017-02-01|February 28, 2019|Anticipated|2019-02-28|August 31, 2018|Anticipated|2018-08-31||Observational|||Identification/Characterization of Changes in Microscopic Colitis|Identification and Characterization of Microbial and Immunologic Changes in Microscopic Colitis|Recruiting||N/A|300|Anticipated|Massachusetts General Hospital|||2||f||||f|f|f||||Samples With DNA|"     Tissue, blood, stool   "|No|Only de-identified information may be shared with other collaborators and entities involved in generating data.|2017-10-10 21:18:45.56343|2017-10-10 21:18:45.56343
NCT03063944|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-10-03|||March 17, 2017|Actual|2017-03-17|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||STAT Inhibitor OPB-111077 and Decitabine in Treating Patients With Acute Myeloid Leukemia That Is Refractory or Newly Diagnosed and Ineligible for Intensive Chemotherapy|Phase I Trial of OPB-111077 in Combination With Decitabine for the Treatment of AML Refractory to or Ineligible for Intensive Chemotherapy|Active, not recruiting||Phase 1|7|Actual|Thomas Jefferson University||1|||||||t|t|f||||||||2017-10-10 21:18:45.660831|2017-10-10 21:18:45.660831
NCT03063931|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-24|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|||Pain and Magnesium|Effect of the Oral Route of Magnesium on Pre and Post-mastectomy on the Post-surgery Pain|Not yet recruiting||Phase 2|100|Anticipated|University Hospital, Clermont-Ferrand||2|||f|||||f|f||||||||2017-10-10 21:18:45.754006|2017-10-10 21:18:45.754006
NCT03063918|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-28|||April 28, 2017|Actual|2017-04-28|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors|Pilot Study of a Personalized Dietary Intervention to Manage Bowel Dysfunction in Rectal Cancer Survivors|Recruiting||N/A|10|Anticipated|City of Hope Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:18:45.863442|2017-10-10 21:18:45.863442
NCT03063905|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-21|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Effects of Opioid Taper on Opioid-Induced Hyperalgesia|The Effects of Opioid Taper on Opioid-Induced Hyperalgesia|Recruiting||N/A|30|Anticipated|Georgetown University|||2||f||||f|f|f||||||No||2017-10-10 21:18:45.986589|2017-10-10 21:18:45.986589
NCT03063879|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-30|||April 1, 2017|Actual|2017-04-01|February 2017|2017-02-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Interventional|SD-CRF||Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir|Efficacy and Safety of Sofosbuvir and Daclatasvir in Treating Patients With Hepatitis C and Renal Failure.|Recruiting||Phase 4|100|Anticipated|Tehran University of Medical Sciences||1|||f||||f|f|f||||||No||2017-10-10 21:18:46.18189|2017-10-10 21:18:46.18189
NCT03063866|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-25|||February 21, 2017|Actual|2017-02-21|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Randomised Controlled Study of Popofol Versus Midazolam as Sedation in Endoscopy With Advanced Liver Disease.|Randomised Controlled Study Comparing Use of Popofol Plus Fentanyl Versus Midazolam Plus Fentanyl as Sedation in Diagnostic Endoscopy in Patients With Advanced Liver Disease.|Recruiting||Phase 4|100|Anticipated|Tanta University||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:18:46.282049|2017-10-10 21:18:46.282049
NCT03063853|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-04-23|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ROCD||Removal of Surgical Staples After Cesarean Delivery. POD4 or POD8. Randomized Control Trial.|Removal of Surgical Staples After Cesarean Delivery. POD4 or POD8. Randomized Control Trial.|Recruiting||N/A|104|Anticipated|Wolfson Medical Center||2|||f||||||||||||No||2017-10-10 21:18:46.400158|2017-10-10 21:18:46.400158
NCT03063840|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-02-23|||July 2016||2016-07-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels|To Evaluate the Safety and Efficacy of Microwave Ablation for the Treatment of Malignant|Enrolling by invitation||N/A|40|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:18:46.48896|2017-10-10 21:18:46.48896
NCT03063827|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-09|||January 2010|Actual|2010-01-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients|Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients - An Investigation of Sensory Receptor Expressionsbetween Responders and Non-responders|Completed||N/A|36|Actual|Buddhist Tzu Chi General Hospital|||2||f||||t|t|f|||f|||No|IPD is not planned to share with other researchers|2017-10-10 21:18:46.568347|2017-10-10 21:18:46.568347
NCT03063814|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-21|||September 1, 2015|Actual|2015-09-01|February 2017|2017-02-01|January 1, 2016|Actual|2016-01-01|January 1, 2016|Actual|2016-01-01||Interventional|ACL01||Effects of App-based Versus Personal On-site Instruction on Neuromuscular Activity in Injury Prevention Exercises|Immediate Effects of App-based Versus Personal On-site Instruction on Neuromuscular Activity in Injury Prevention Exercises: Randomized Controlled Trial|Completed||N/A|47|Actual|National Research Centre for the Working Environment, Denmark||2|||f||||f|f|f||||||Undecided||2017-10-10 21:18:46.650312|2017-10-10 21:18:46.650312
NCT03063801|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-21|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Study on the Transfusional Management of the Patients With Congenital Heart Disease Carried Out in Adulthood.|Observational Retrospective Study on the Transfusional Management of the Patients With Congenital Heart Disease Carried Out in Adulthood.|Not yet recruiting||N/A|300|Anticipated|Brugmann University Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:18:46.729143|2017-10-10 21:18:46.729143
NCT03063788|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-23|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Imaging the HIV Reservoir|Imaging the HIV Reservoir|Not yet recruiting||Phase 1|10|Anticipated|Bayside Health||3|||f||||f|f|f|||t|||No||2017-10-10 21:18:46.813395|2017-10-10 21:18:46.813395
NCT03063762|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-09-25|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|August 29, 2020|Anticipated|2020-08-29|March 16, 2020|Anticipated|2020-03-16||Interventional|||Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)|An Open-Label, Multi-Center, Randomized, Dose-Escalation, Phase 1b Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 in Combination With Atezolizumab ± Bevacizumab in Patients With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma|Recruiting||Phase 1|190|Anticipated|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 21:18:46.980195|2017-10-10 21:18:46.980195
NCT03063749|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-15|||March 30, 2017|Actual|2017-03-30|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Observational|ONYX PAS||RESOLUTE ONYX Post-Approval Study|A Post-approval Study of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System|Recruiting||N/A|510|Anticipated|Medtronic Vascular|||2||f|||||f|t|t||f|||||2017-10-10 21:18:47.136118|2017-10-10 21:18:47.136118
NCT03063736|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-06|||October 2017|Anticipated|2017-10-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Entolimod, an Adjuvant for Vaccine Augmentation|Entolimod, an Adjuvant for Vaccine Augmentation|Not yet recruiting||Early Phase 1|40|Anticipated|Baylor College of Medicine||2|||f||||f|t|f||||||||2017-10-10 21:18:47.356678|2017-10-10 21:18:47.356678
NCT03063723|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-21|||January 1, 2016|Actual|2016-01-01|February 2017|2017-02-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Observational|||Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs|Dynamic Changes of the Frequency of Classic and Inflammatory Monocytes Subsets and Natural Killer Cells in Chronic Hepatitis C Patients Treated by Direct-acting Antiviral Agents|Completed||N/A|25|Actual|Third Affiliated Hospital, Sun Yat-Sen University|||2||f||||t|f|f|||f|Samples With DNA|"     peripheral blood   "|No|Individual participant data (IPD) is not available to other researchers.|2017-10-10 21:18:47.451809|2017-10-10 21:18:47.451809
NCT03063710|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-19||||||September 2017|2017-09-01||||||||Expanded Access|||Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan|Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients|Temporarily not available||N/A|||AstraZeneca|||||f|||t|||||||||||2017-10-10 21:18:47.547576|2017-10-10 21:18:47.547576
NCT03063697|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-02-21|||November 2015||2015-11-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|DELIGHT||Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure|Prospective, Multi-center, Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure|Enrolling by invitation||N/A|20000|Anticipated|Chong Kun Dang Pharmaceutical|||1||f||||f||||||||No||2017-10-10 21:18:47.613647|2017-10-10 21:18:47.613647
NCT03063684|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-09-09|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus|Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus|Recruiting||N/A|20|Anticipated|Hadassah Medical Organization||2|||f||||f|f|f|||f|||||2017-10-10 21:18:47.674015|2017-10-10 21:18:47.674015
NCT03063671|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-07|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Dexmedetomidine,Ketamine and Their Combination to Bupivicaine on Thoracic Epidural Analgesia|Effect of Adding Dexmedetomidine, Ketamine and Their Combination to Bupivicaine on Thoracic Epidural Analgesia for Post-mastectomy Pain|Recruiting||Phase 2/Phase 3|20|Anticipated|Assiut University||4|||f||||t|f|f||||||||2017-10-10 21:18:47.751933|2017-10-10 21:18:47.751933
NCT03063658|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-23|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Comparison of the Effectiveness of Preemptive Paracetamol and Ibuprofen in Acute Postoperative Pain|Comparison of the Postoperative Analgesia Effectiveness of Preemptive Intravenous Ibuprofen and Paracetamol in Patients Undergoing Laparoscopic Cholecystectomy|Active, not recruiting||Phase 4|108|Actual|Ankara University||2|||f||||f|t|f|||f|||No||2017-10-10 21:18:47.842605|2017-10-10 21:18:47.842605
NCT03063645|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-06-26|||March 11, 2017|Actual|2017-03-11|June 2017|2017-06-01|May 5, 2017|Actual|2017-05-05|April 7, 2017|Actual|2017-04-07||Interventional|||Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production|A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production|Completed||Phase 1|17|Actual|Accera, Inc.||3|||f||||f|t|f||||||No||2017-10-10 21:18:47.927057|2017-10-10 21:18:47.927057
NCT03063619|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-22|2017-05-10|||May 30, 2017|Anticipated|2017-05-30|April 2017|2017-04-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2019|Anticipated|2019-05-15||Interventional|||Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast|A Randomized, Double-Blind, Placebo-Controlled Study of 4-hydroxytamoxifen Topical Gel in Women With Mammographically Dense Breast|Not yet recruiting||Phase 2|152|Anticipated|National Cancer Institute (NCI)||2|||f||||t|t|f||||||||2017-10-10 21:18:48.135155|2017-10-10 21:18:48.135155
NCT03063606|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-09-06|||September 5, 2017|Anticipated|2017-09-05|February 2017|2017-02-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment|Behavioral and Pharmacologic Treatment of Binge Eating and Obesity|Enrolling by invitation||Phase 2/Phase 3|72|Anticipated|Yale University||2|||f||||f|t|f||||||||2017-10-10 21:18:48.260909|2017-10-10 21:18:48.260909
NCT03063593|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-14|||April 29, 2016|Actual|2016-04-29|September 2017|2017-09-01|April 29, 2031|Anticipated|2031-04-29|April 29, 2029|Anticipated|2029-04-29||Observational|||UK Infinity, Post-Market Clinical Follow-up Study|UK Multi-Centre, Observational, Post-Market Clinical Follow-up of the INFINITY® Total Ankle System|Recruiting||N/A|500|Anticipated|Wright Medical Technology|||1||f||||f|f|f||||||||2017-10-10 21:18:48.342719|2017-10-10 21:18:48.342719
NCT03063580|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-06-01|||February 27, 2017|Actual|2017-02-27|June 2017|2017-06-01|May 12, 2017|Actual|2017-05-12|May 12, 2017|Actual|2017-05-12||Interventional|||Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin|A Phase 1, Single-center, Open-label, 2-period, Single Sequence Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose Rifampicin on the Pharmacokinetics and Pharmacodynamics of Single Dose Sotagliflozin in Healthy Male and Female Subjects|Completed||Phase 1|16|Actual|Sanofi||1|||f||||f|t|f||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:18:48.451578|2017-10-10 21:18:48.451578
NCT03063567|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-24|||August 2014||2014-08-01|February 2017|2017-02-01|December 19, 2017|Anticipated|2017-12-19|April 1, 2017|Anticipated|2017-04-01||Interventional|||Investigation of Predictive Indices to Objectively Guide Choice of CPAP Interface|Selecting the Appropriate CPAP Interface: Investigation of Predictive Indices to Objectively Guide the Choice of Interface|Active, not recruiting||N/A|100|Anticipated|Singapore General Hospital||3|||f||||||||||||Undecided||2017-10-10 21:18:48.527782|2017-10-10 21:18:48.527782
NCT03063554|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-20|||October 18, 2016|Actual|2016-10-18|February 2017|2017-02-01|October 1, 2018|Anticipated|2018-10-01|September 1, 2018|Anticipated|2018-09-01||Interventional|BILPAL||EUS BD vs ERCP TP for Pancreatic Cancer|Endoscopic Ultrasound-Guided Biliary Drainage (EUS-BD) Compared to Standard Transpapillary Biliary Drainage (ERCP-TP) for Palliation of Jaundice in Unresectable Cancer of the Head of the Pancreas (BILPAL TRIAL)|Recruiting||N/A|120|Anticipated|Weill Medical College of Cornell University||2|||f||||t|f|f||||||No||2017-10-10 21:18:48.588379|2017-10-10 21:18:48.588379
NCT03063541|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-22|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|PROTECT-U||Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms|Prospective Randomized Open-label Trial to Evaluate Risk faCTor Management in Patients With Unruptured Intracranial Aneurysms|Recruiting||Phase 3|776|Anticipated|Universitätsmedizin Mannheim||2|||f||||t|f|f|||f|||||2017-10-10 21:18:48.680165|2017-10-10 21:18:48.680165
NCT03063528|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-09-18|||January 5, 2017|Actual|2017-01-05|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|HM2B||Healthy Motivations for Moms-to-be Study|Healthy Motivations for Moms-to-be Study|Recruiting||N/A|135|Anticipated|University of South Carolina||2|||f||||f||||||||||2017-10-10 21:18:48.768569|2017-10-10 21:18:48.768569
NCT03063515|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-08-30|||April 19, 2017|Actual|2017-04-19|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|AchE||AchE Inhibitor and Insulin|Using Acetylcholinesterase Inhibitors to Promote Insulin Secretion in Human Beings|Recruiting||Phase 1|12|Anticipated|University of Miami||2|||f||||f|t|f|||f|||||2017-10-10 21:18:48.864779|2017-10-10 21:18:48.864779
NCT03063502|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-01|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Observational|||Pre-analytical Sample Handling Conditions and Their Effects on the Human Urine Metabolome|Pre-analytical Sample Handling Conditions and Their Effects on the Human Urine Metabolome|Completed||N/A|13|Actual|USDA Beltsville Human Nutrition Research Center|||1||f||||f|f|f||||||No||2017-10-10 21:18:48.942377|2017-10-10 21:18:48.942377
NCT03063489|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-21|||February 2015||2015-02-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability|Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers|Completed||Phase 1|15|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||t||||||||Yes||2017-10-10 21:18:48.99509|2017-10-10 21:18:48.99509
NCT03063476|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-06-01|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|May 18, 2017|Actual|2017-05-18|May 18, 2017|Actual|2017-05-18||Interventional|||The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)|The Effect of Acute Lysine Administration on α-aminoadipic Acid|Completed||Phase 1|2|Actual|Vanderbilt University Medical Center||1|||f||||f|t|f||||||Yes||2017-10-10 21:18:49.070885|2017-10-10 21:18:49.070885
NCT03063463|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-11|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Observational|||Mechanisms of Weight Loss in Patients Diagnosed With Achalasia|Mechanisms of Weight Loss in Patients Diagnosed With Achalasia: A Prospective Observational Study|Recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center|||2||f||||f|f|f||||Samples With DNA|"     Serum sample will be collected for future genomic analysis.   "|No||2017-10-10 21:18:49.136765|2017-10-10 21:18:49.136765
NCT03063450|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-05|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|June 2021|Anticipated|2021-06-01||Interventional|CONFIRM||CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma|CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma (CONFIRM): A Phase III Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Nivolumab in Relapsed Mesothelioma|Recruiting||Phase 3|336|Anticipated|University of Southampton||2|||f||||t|f|f|||f|||||2017-10-10 21:18:49.46603|2017-10-10 21:18:49.46603
NCT03063437|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-21|||April 15, 2017|Anticipated|2017-04-15|February 2017|2017-02-01|April 15, 2018|Anticipated|2018-04-15|December 30, 2017|Anticipated|2017-12-30||Interventional|||A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization|Phase II Randomized, Double Blind, Placebo-controlled, Parallel Group Trial of Encapsulated Fecal Microbiota Transplantation for Vancomycin Resistant Enterococcus Decolonization|Not yet recruiting||Phase 2|46|Anticipated|Microbiome Health Research Institute||2|||f||||t|f|f||||||No||2017-10-10 21:18:49.620512|2017-10-10 21:18:49.620512
NCT03063424|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-20|||June 2011||2011-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HYVES||Hyperventilation Versus Exercise Testing Sensitivity in Exercise Induced Asthma|Hyperventilation Versus Exercise Testing Sensitivity in Exercise Induced Asthma|Recruiting||N/A|40|Anticipated|Université de Sherbrooke||2|||f||||f|f|f||||||Undecided||2017-10-10 21:18:49.73956|2017-10-10 21:18:49.73956
NCT03062670|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-20|||January 31, 2017|Actual|2017-01-31|February 2017|2017-02-01|February 15, 2018|Anticipated|2018-02-15|November 1, 2017|Anticipated|2017-11-01||Interventional|||Team-Based Delivery of Care in Outpatient Settings|Team-Based Delivery of Care in Outpatient Settings: An Experimental Investigation|Enrolling by invitation||N/A|30|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||No||2017-10-10 21:18:58.085766|2017-10-10 21:18:58.085766
NCT03063411|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-20|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Testing Whether a Short Training Program Designed to Improve Cognitive Skills Improves 4-year-olds' Maths Skills|Testing a Short Executive Function Training Intervention to Improve Mathematical Reasoning in a Diverse Sample of Children Before They Start School|Recruiting||N/A|195|Anticipated|University of Sheffield||2|||f||||f|f|f||||||Undecided||2017-10-10 21:18:49.844765|2017-10-10 21:18:49.844765
NCT03063398|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-24|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|PAPPEI||Post Acute Pancreatitis Pancreatic Exocrine Insufficiency|PAPPEI: Post Acute Pancreatitis Pancreatic Exocrine Insufficiency|Recruiting||N/A|180|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Blood and fecal samples will be collected for future Pancreatitis studies concerning EPI or     genetics.   "|||2017-10-10 21:18:49.95164|2017-10-10 21:18:49.95164
NCT03063385|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-07-13|||September 2012||2012-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|August 2016|Actual|2016-08-01||Interventional|||Puerto Rico Cuidalos Parent-adolescent Program|Testing a Latino Web-based Parent-adolescent Sexual Communication Intervention|Completed||N/A|680|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 21:18:50.062918|2017-10-10 21:18:50.062918
NCT03063372|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-01|||February 28, 2017|Actual|2017-02-28|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Pomegranate Supplementation and Well-Being Among Medical Students and Residents|Pomegranate Supplementation and Well-Being Among Medical Students and Residents|Enrolling by invitation||N/A|50|Anticipated|University of Mississippi Medical Center||2|||f||||t|f|f||||||No|We do not plan to share IPD.|2017-10-10 21:18:50.170749|2017-10-10 21:18:50.170749
NCT03063359|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-20|||March 31, 2017|Anticipated|2017-03-31|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|FINDOL||Intranasal Fentanyl Versus Oral Morphine Sulfate in the Treatment of Pain in Pediatric Trauma|Non-inferiority of Intranasal Fentanyl Versus Oral Morphine Sulfate in the Treatment of Pain in Pediatric Trauma : a Controled Randomized , Single Blind Study|Not yet recruiting||Phase 3|82|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||Undecided||2017-10-10 21:18:50.287888|2017-10-10 21:18:50.287888
NCT03063346|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-01|||June 6, 2016|Actual|2016-06-06|March 2017|2017-03-01|February 20, 2017|Actual|2017-02-20|February 9, 2017|Actual|2017-02-09||Interventional|||The Effect of a Protein Hydrolysate on Muscle Strength Recovery|The Effect of a Protein Hydrolysate on Muscle Strength Recovery in Athletes|Completed||N/A|48|Actual|BioActor||3|||f||||f||||||||Undecided||2017-10-10 21:18:50.398083|2017-10-10 21:18:50.398083
NCT03063333|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-16|||May 18, 2017|Anticipated|2017-05-18|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Long-term Effect of Hypnosis in Spinal Cord Injury Patients|Long-term Effect of Hypnosis in Spinal Cord Injury Patients|Not yet recruiting||N/A|75|Anticipated|Central Jutland Regional Hospital||3|||f||||t|f|f||||||No||2017-10-10 21:18:50.48372|2017-10-10 21:18:50.48372
NCT03063320|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-23|||January 25, 2017|Actual|2017-01-25|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Spice Consumption on Postprandial Vascular Function|The Effect of Chronic Consumption of Popular Spices on Postprandial Vascular Function|Recruiting||N/A|30|Anticipated|Penn State University||3|||f||||f|f|f||||||No||2017-10-10 21:18:50.585245|2017-10-10 21:18:50.585245
NCT03063307|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-05-16|||September 20, 2016|Actual|2016-09-20|May 2017|2017-05-01|May 31, 2020|Anticipated|2020-05-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Effectiveness of Silver Diamine Fluoride in Arresting Dental Caries|Effectiveness of Silver Diamine Fluoride in Arresting Dental Caries in Deciduous Molars: a Controlled and Randomized Clinical Trial|Recruiting||N/A|118|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||No||2017-10-10 21:18:50.701382|2017-10-10 21:18:50.701382
NCT03063294|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-31|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|CTAC||Coordination Toolkit and Coaching Project|Improving PACT Coordination Across Settings and Services (QUE 15-276)|Enrolling by invitation||N/A|1788|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 21:18:50.831276|2017-10-10 21:18:50.831276
NCT03063281|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-21|||November 2012|Actual|2012-11-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2013|Actual|2013-05-01||Observational|Ficolupus2||Anti-ficolin-2 Autoantibodies in Lupus Nephritis|Association Between the Presence of Autoantibodies Targeting Ficolin-2 and Active Nephritis in Patients With Systemic Lupus Erythematosus|Completed||N/A|213|Actual|University Hospital, Grenoble|||2||f||||f|f|f||||Samples Without DNA|"     one serum per patient   "|Undecided|Further analysis of serum collection is ongoing. IPD availability will be decided by the sponsor at completion and publication.|2017-10-10 21:18:50.922547|2017-10-10 21:18:50.922547
NCT03063255|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-10|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|December 1, 2019|Anticipated|2019-12-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Comparison of Obturator Nerve Blockade and Neuromuscular Blockade|Comparison of Obturator Nerve Blockade and Neuromuscular Blockade for the Prevention of Adductor Spasm in Patients Undergoing Transurethral Resection of Bladder Tumors.|Recruiting||N/A|60|Anticipated|University of Florida||2|||f||||f|f|f|||f|||No||2017-10-10 21:18:51.15651|2017-10-10 21:18:51.15651
NCT03063242|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-03-03|||February 23, 2017|Actual|2017-02-23|March 2017|2017-03-01|February 15, 2020|Anticipated|2020-02-15|February 15, 2020|Anticipated|2020-02-15||Interventional|||Sargramostim for Myeloid Dendritic Cell Deficiency|Sargramostim to Reverse Myeloid Dendritic Cell Deficiency|Recruiting||Phase 2|15|Anticipated|University of Florida||3|||f||||f|f|f||||||No||2017-10-10 21:18:51.252708|2017-10-10 21:18:51.252708
NCT03063229|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-02-20|||June 2016||2016-06-01|February 2016|2016-02-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|EBFIT||Energy Balance Following Islet Transplantation|Energy Balance Following Islet Transplantation|Recruiting||N/A|60|Anticipated|University of Edinburgh||3|||f||||f||||||||No||2017-10-10 21:18:51.373984|2017-10-10 21:18:51.373984
NCT03063216|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-21|||January 1, 2009|Actual|2009-01-01|February 2017|2017-02-01|December 31, 2029|Anticipated|2029-12-31|December 31, 2019|Anticipated|2019-12-31|10 Years|Observational [Patient Registry]|||Shanghai Pediatric Cataract Study|Visual Outcome Evaluation and Genetic Analysis: Shanghai Pediatric Cataract Study|Recruiting||N/A|10000|Anticipated|Evidence Based Cataract Study Group|||2||f||||f|f|f||||Samples With DNA|"     Samples of blood, aqueous humor, anterior capsular membranes and lens tissues from pediatric     cataract patients.   "|Undecided||2017-10-10 21:18:51.555349|2017-10-10 21:18:51.555349
NCT03063203|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-07-17|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|July 31, 2025|Anticipated|2025-07-31|July 31, 2023|Anticipated|2023-07-31||Interventional|||Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia|An Open Label, Multicenter, Phase II Trial Testing Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia|Recruiting||Phase 2|60|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:18:51.653919|2017-10-10 21:18:51.653919
NCT03063190|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-15|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 31, 2018|Anticipated|2018-03-31||Interventional|RLS||Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease|Evaluation of Cholecalciferol Supplementation in Chronic Kidney Disease Patients With Restless Leg Syndrome|Recruiting||Phase 4|100|Anticipated|University of Sao Paulo General Hospital||4|||f||||t|f|f|||f|||No||2017-10-10 21:18:51.776238|2017-10-10 21:18:51.776238
NCT03063177|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-23|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of How Different Dosages of Spinal Manipulation Modulate Spinal Stiffness in Participants With Back Pain|Evaluation of the Associations Between Spinal Manipulative Therapy Dosage and the Related Spinal Stiffness Modulation in Participants With Chronic Thoracic Pain|Not yet recruiting||N/A|75|Anticipated|Université du Québec à Trois-Rivières||3|||f||||f|f|f||||||No||2017-10-10 21:18:51.861457|2017-10-10 21:18:51.861457
NCT03063164|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-05-29|||February 14, 2017|Actual|2017-02-14|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||A Comparison of LASIK Outcomes Using Two Femtosecond Lasers|A Prospective, Randomized, Fellow Eye Comparison of Fellow Eyes Undergoing LASIK With the Intralase IFS150 Versus the Visumax|Recruiting||N/A|50|Anticipated|Stanford University||2|||f||||f|f|t|f||f|||No||2017-10-10 21:18:51.955819|2017-10-10 21:18:51.955819
NCT03063151|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-26|||February 14, 2016|Actual|2016-02-14|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Direction Modulation of Muscle Synergies After a Stroke|Direction Modulation of Muscle Synergies After a Stroke|Recruiting||N/A|32|Anticipated|University of Haifa||2|||f||||||||||||No||2017-10-10 21:18:52.063758|2017-10-10 21:18:52.063758
NCT03063138|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-18|||August 1, 2015|Actual|2015-08-01|September 2017|2017-09-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|3D-DFU||Evaluation of 3D Imaging Ulcer Camera|Evaluation of Three-dimensional Measurements of Wounds Using a Newly Developed 3D Camera|Completed||N/A|48|Actual|Odense University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:18:52.147883|2017-10-10 21:18:52.147883
NCT03063125|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-03|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|||Hypogonadism in Bladder Cancer|Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer|Recruiting||N/A|25|Anticipated|University of Kansas Medical Center|||1||f||||f|f|f||||||||2017-10-10 21:18:52.223417|2017-10-10 21:18:52.223417
NCT03063112|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-26|||October 1, 2016|Actual|2016-10-01|February 2017|2017-02-01|May 1, 2017|Anticipated|2017-05-01|April 10, 2017|Anticipated|2017-04-10||Interventional|RF||Radiofrequency and Chemical Neurolysis of Thoracic Splanchnic Nerve for Abdominal Cancer Pain|Comparative Study Between Radiofrequency Thermocoagulation and Chemical Neurolysis of Thoracic Splanchnic Nerve Bilaterally for the Management of Abdominal Cancer Pain|Recruiting||N/A|79|Anticipated|South Egypt Cancer Institute||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:18:52.292911|2017-10-10 21:18:52.292911
NCT03063099|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-09-14|||February 8, 2017|Actual|2017-02-08|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||ReNu™ Injection to Treat Hip Osteoarthritis Study|A Pilot Study of ReNu™ Hip Injection: Monitoring the Response of Hip Function and Pain in Patient With Osteoarthritis|Recruiting||N/A|10|Anticipated|NuTech Medical, Inc||1|||f||||f|f|f||||||||2017-10-10 21:18:52.384262|2017-10-10 21:18:52.384262
NCT03063086|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-04-24|||May 13, 2017|Anticipated|2017-05-13|April 2017|2017-04-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma.|A Randomized, Double-blind, Double-dummy, Active-controlled, 3-period Complete Cross-over Study to Assess the Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma|Not yet recruiting||Phase 2|114|Anticipated|Novartis||6|||f||||f|t|f|||f|||||2017-10-10 21:18:52.507461|2017-10-10 21:18:52.507461
NCT03063073|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-23|||February 25, 2017|Anticipated|2017-02-25|February 2017|2017-02-01|June 15, 2017|Anticipated|2017-06-15|May 30, 2017|Anticipated|2017-05-30||Interventional|pec`s||Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block|Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Patient Undergoing Breast Cancer Surgery :A Comparative Study|Not yet recruiting||Phase 3|60|Anticipated|South Egypt Cancer Institute||2|||f||||t|t|f|||f|||Yes||2017-10-10 21:18:52.587345|2017-10-10 21:18:52.587345
NCT03063060|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-21|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|||The Impact of Vitamin D Deficiency on Hypocalcaemia Following Total Thyroidectomy|The Impact of Vitamin D Deficiency on Hypocalcaemia Following Total Thyroidectomy|Not yet recruiting||N/A|60|Anticipated|Hillel Yaffe Medical Center|||1||f||||f|f|f||||||Undecided||2017-10-10 21:18:52.684803|2017-10-10 21:18:52.684803
NCT03063047|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-13|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|||"CSD1603: A Crossover Study to Evaluate the Exposure to Tar and Nicotine From 100s Menthol Cigarette Products"|"CSD1603: A Crossover Study to Evaluate the Exposure to Tar and Nicotine From 100s Menthol Cigarette Products"|Completed||N/A|29|Actual|RAI Services Company||2|||f||||f|f|f||||||No||2017-10-10 21:18:52.746168|2017-10-10 21:18:52.746168
NCT03063034|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-13|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|||"CSD1602: A Crossover Study to Evaluate the Exposure to Tar and Nicotine From Two King Size Menthol Cigarette Products"|"CSD1602: A Crossover Study to Evaluate the Exposure to Tar and Nicotine From Two King Size Menthol Cigarette Products"|Completed||N/A|39|Actual|RAI Services Company||2|||f||||f|f|f||||||No||2017-10-10 21:18:52.815424|2017-10-10 21:18:52.815424
NCT03063021|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-20|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|FIGHT-RP1||The FIGHT-RP1 Study|A Phase 1 Open Label Dose Ranging Study to Assess the Safety and Tolerability of N-Acetylcysteine (NAC) in Patients With Retinitis Pigmentosa (FIGHT-RP1 Study)|Recruiting||Phase 1|50|Anticipated|Johns Hopkins University||2|||f|||||t|f||||||Undecided||2017-10-10 21:18:52.90971|2017-10-10 21:18:52.90971
NCT03063008|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-23|||January 16, 2012|Actual|2012-01-16|February 2017|2017-02-01|December 1, 2013|Actual|2013-12-01|September 1, 2013|Actual|2013-09-01||Interventional|||Transforaminal Lumbar Interbody Fusion in PEEK Oblique Cages With and Without Titanium Coating|"Randomized Evaluation of Bone Ingrowth After Intervertebral Body Fusion With Either MectaLIF® PEEK or MectaLIF® TiPEEK Oblique"|Completed||N/A|40|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:18:52.995071|2017-10-10 21:18:52.995071
NCT03062995|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-08-10|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|MAESTRO||A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy|A Randomised, Double-blind, Controlled, Parallel-group, Multi-country Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy|Not yet recruiting||Phase 3|1700|Anticipated|Nutricia Research||2|||f||||t|f|f||||||||2017-10-10 21:18:53.057105|2017-10-10 21:18:53.057105
NCT03062982|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-20|||December 21, 2016|Actual|2016-12-21|February 2017|2017-02-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Interventional|||Food-Effect and Metabolism Study in Healthy Subjects|A Phase I, Open-label, 2-sequence, Cross-over, Pharmacokinetic (PK) Study to Evaluate the Effect of the Food and to Identify the Metabolism of Fluzoparib in Healthy Subjects|Completed||Phase 1|16|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:18:53.115971|2017-10-10 21:18:53.115971
NCT03062969|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-20|||January 1, 2014|Actual|2014-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|February 28, 2016|Actual|2016-02-28||Observational|||The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies|The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies|Completed||N/A|383|Actual|Institut Universitari Dexeus|||2||f||||f|f|f||||||No||2017-10-10 21:18:53.188836|2017-10-10 21:18:53.188836
NCT03062956|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-20|||January 16, 2017|Actual|2017-01-16|February 2017|2017-02-01|July 30, 2017|Anticipated|2017-07-30|June 15, 2017|Anticipated|2017-06-15||Interventional|||A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491|Randomized, Placebo-Controlled Study of Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-491 in Healthy Adult Volunteers|Recruiting||Phase 1|56|Anticipated|MyoKardia, Inc.||2|||f||||t|t|f||||||No||2017-10-10 21:18:53.253426|2017-10-10 21:18:53.253426
NCT03062943|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-02-20|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|LAM||A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)|A Pilot Study of Nintedanib for LymphAngioleioMyomatosis (LAM)|Recruiting||Phase 2|30|Anticipated|IRCCS Multimedica||1|||f||||f||||||||No||2017-10-10 21:18:55.178266|2017-10-10 21:18:55.178266
NCT03062930|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-02-20|||August 2016||2016-08-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Remediation of the Non-Paretic Arm in Stroke|Remediation of the Non-Paretic Arm to Improve Functional Independence in Chronic Stroke Survivors|Recruiting||N/A|20|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||Yes|Scholar Sphere|2017-10-10 21:18:55.290745|2017-10-10 21:18:55.290745
NCT03062917|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-20|||October 2, 2015|Actual|2015-10-02|February 2017|2017-02-01|April 30, 2017|Anticipated|2017-04-30|April 30, 2017|Anticipated|2017-04-30||Interventional|RSV-SAM||Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis|Validation of Nasal and Bronchial Absorption Sampling Methods for the Assessment of RSV Bronchiolitis in Babies and Children|Recruiting||N/A|80|Anticipated|Imperial College Healthcare NHS Trust||5|||f||||f|f|f||||||Undecided|Participants consented that blood or nasal samples taken during this study can be used in the future for any ethically-approved studies.|2017-10-10 21:18:55.391544|2017-10-10 21:18:55.391544
NCT03062904|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-20|||February 2014||2014-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VACUVOL||Search of a Paradoxical Fall in Maximum Expiratory Flow After Bronchodilation in Healthy Subjects|Search of a Paradoxical Fall in Maximum Expiratory Flow After Bronchodilation in Healthy Subjects|Recruiting||N/A|65|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 21:18:55.480654|2017-10-10 21:18:55.480654
NCT03062891|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-08-31|||November 2016||2016-11-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|STOP-Pilot||Sleep Treatment Outcome Predictors: A Pilot Study (STOP-pilot)|Sleep Treatment Outcome Predictors: A Pilot Study (STOP-pilot)|Enrolling by invitation||N/A|240|Anticipated|King's College London||2|||f||||f||||||||||2017-10-10 21:18:55.578014|2017-10-10 21:18:55.578014
NCT03062878|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-20|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function|The Effects of Anthracycline-based Chemotherapy on Spontaneous Baroreflex Sensitivity, Carotid Artery Stiffness, and Endothelial-dependent Vascular Function.|Recruiting||N/A|60|Anticipated|Kansas State University|||3||f||||f|f|f||||||No||2017-10-10 21:18:55.687694|2017-10-10 21:18:55.687694
NCT03062865|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-20|||November 2016||2016-11-01|January 2017|2017-01-01|February 2025|Anticipated|2025-02-01|November 2024|Anticipated|2024-11-01|5 Years|Observational [Patient Registry]|ART||French National Registry: ART REGISTRY (Observational Study)|"ART REGISTRY : Rheumatoid Arthritis and Anti-TNF"|Recruiting||N/A|1500|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||No||2017-10-10 21:18:55.782384|2017-10-10 21:18:55.782384
NCT03062852|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-21|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PERMIS||Preventing Drug Errors Related to Caregiver Interruptions|Prévention Des Erreurs médicamenteuses liées Aux Interruptions de tâches Des Soignants Lors de la préparation et de l'Administration Des médicaments : Essai contrôlé randomisé Multicentrique en Clusters|Not yet recruiting||N/A|15000|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 21:18:55.86486|2017-10-10 21:18:55.86486
NCT03062839|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-31|||September 1, 2017|Anticipated|2017-09-01|February 2017|2017-02-01|June 30, 2019|Anticipated|2019-06-30|February 28, 2019|Anticipated|2019-02-28||Interventional|||Melatonin as Adjuvant Treatment for ADHD in Adults|Melatonin as Adjuvant Treatment for ADHD in Adults|Not yet recruiting||Phase 3|120|Anticipated|Hospital Israelita Albert Einstein||2|||f||||t|f|f||||||||2017-10-10 21:18:55.958372|2017-10-10 21:18:55.958372
NCT03062826|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-08|||January 11, 2017|Actual|2017-01-11|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2018|Anticipated|2018-06-30||Observational|||EROSION II: OCT Guided PPCI in STEMI|A Prospective，Multicenter，Optical Coherence Tomography Guided Reperfusion Strategy in Patients With STEMI（EROSION II）|Recruiting||N/A|340|Anticipated|Harbin Medical University|||1||f||||f|f|f||||||||2017-10-10 21:18:56.152968|2017-10-10 21:18:56.152968
NCT03062813|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-22|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|March 31, 2020|Anticipated|2020-03-31|February 1, 2020|Anticipated|2020-02-01||Interventional|TOHBVGN||Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)|The Therapy of Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis : A Multicenter, Prospective, Randomized, Controlled, Single-blind Trial.|Recruiting||Phase 4|112|Anticipated|Guangdong General Hospital||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:18:56.283189|2017-10-10 21:18:56.283189
NCT03062800|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-20|||December 2016||2016-12-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)|Study of Thalidomide With First-line Chemotherapy and as Maintenance Treatment of Advanced Nonsquamous NSCLC With Epidermal Growth Factor Receptor Wild-Type or Unknown Mutation Status: A Multicenter, Randomized, Prospective Clinical Trial|Recruiting||Phase 2|232|Anticipated|Qilu Hospital of Shandong University||2|||f||||t||||||||No||2017-10-10 21:18:56.417121|2017-10-10 21:18:56.417121
NCT03062787|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-09-27|||April 5, 2017|Actual|2017-04-05|September 2017|2017-09-01|October 13, 2017|Anticipated|2017-10-13|October 13, 2017|Anticipated|2017-10-13||Interventional|EEFFEK||Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee|Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee (EEFFEK Study)|Active, not recruiting||N/A|60|Actual|Pharmascience Inc.||2|||f||||f|f|f||||||||2017-10-10 21:18:56.543109|2017-10-10 21:18:56.543109
NCT03062774|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-20|||November 15, 2014|Actual|2014-11-15|February 2017|2017-02-01|October 8, 2016|Actual|2016-10-08|September 13, 2016|Actual|2016-09-13||Interventional|||Continuous Multiple Dose PB-119 Injection in Health Volunteers|The Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of Continuous Multiple Dose PB-119 Injection in Health Volunteers|Completed||Phase 1|36|Actual|PegBio Co., Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:18:56.645606|2017-10-10 21:18:56.645606
NCT03062761|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-30|||April 27, 2017|Actual|2017-04-27|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|TENUTO||A Clinical Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants|A Randomized, Controlled, Double Blind, Parallel Group, Multi-country Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants|Recruiting||Phase 2|336|Anticipated|Nutricia Research||2|||f||||f|f|f||||||||2017-10-10 21:18:56.722115|2017-10-10 21:18:56.722115
NCT03062748|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-20|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index|Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index|Enrolling by invitation||N/A|196|Anticipated|Milton S. Hershey Medical Center|||1||f||||f|f|f||||||||2017-10-10 21:18:56.85891|2017-10-10 21:18:56.85891
NCT03062735|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-20|||February 6, 2017|Actual|2017-02-06|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|PEAK||Efficacy of Inspiratory Muscle Training on Elite Swimmers|Protocol for a Randomized Controlled Trial Evaluating the Efficacy of Inspiratory Muscle Training on Swimming Performance, Airway Dysfunction and Perceived Breathlessness in Elite Swimmers|Recruiting||N/A|40|Anticipated|Universidade do Porto||2|||f||||f|f|f||||||No||2017-10-10 21:18:56.942595|2017-10-10 21:18:56.942595
NCT03062722|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-22|||January 1, 2015|Actual|2015-01-01|February 2017|2017-02-01|July 1, 2016|Actual|2016-07-01|December 1, 2015|Actual|2015-12-01||Interventional|||Efficacy of Keyhole Approach to Carpal Tunnel Syndrome Under Ambulatory Strategy|Efficacy of Keyhole Approach to Carpal Tunnel Syndrome Under Ambulatory|Completed||N/A|55|Actual|University of Guadalajara||1|||f||||t|f|f||||||No||2017-10-10 21:18:57.641372|2017-10-10 21:18:57.641372
NCT03062709|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-05-15|||March 12, 2017|Actual|2017-03-12|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|March 30, 2017|Actual|2017-03-30||Interventional|||A Study of Tobacco Smoke and Children With Respiratory Illnesses|Urine Cotinine in Children and Parental Behavior Modification: A Pilot Study|Completed||N/A|3|Actual|Maine Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:18:57.74342|2017-10-10 21:18:57.74342
NCT03062696|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-07|||May 19, 2017|Actual|2017-05-19|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||A Pilot Study of Cognitive-Behavioral Therapy for Rumination Disorder (CBT-RD)|A Pilot Study of Cognitive-Behavioral Therapy for Rumination Disorder (CBT-RD)|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||||2017-10-10 21:18:57.868366|2017-10-10 21:18:57.868366
NCT03062683|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-03|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Serum Lactate in Convulsive Syncopes Compared to Non-convulsive Syncopes|Serum Lactate in Convulsive Syncopes Compared to Non-convulsive Syncopes|Recruiting||N/A|100|Anticipated|RWTH Aachen University|||2||f||||f|f|f||||Samples Without DNA|"     repeated blood samples (2-5 ml)   "|No||2017-10-10 21:18:57.98348|2017-10-10 21:18:57.98348
NCT03062657|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|||An Investigation of the Metal Concentration in Patients Implanted With the PRESTIGE LP™ Cervical Disc at Two Contiguous Levels in the Cervical Spine|An Investigation of the Metal Concentration in Patients Implanted With the PRESTIGE LP™ Cervical Disc at Two Contiguous Levels in the Cervical Spine|Not yet recruiting||N/A|30|Anticipated|Medtronic Spinal and Biologics||1|||f||||t|f|t|f||t|||||2017-10-10 21:18:58.179013|2017-10-10 21:18:58.179013
NCT03062644|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-21|||April 5, 2017|Actual|2017-04-05|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|STARDOM2||Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.|A Randomized, Double-Blind, Multicenter, Placebo- and Active Comparator-Controlled Study to Evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Abdominal Hysterectomy Surgery Under General Anaesthesia (STARDOM2).|Recruiting||Phase 3|1100|Anticipated|Mundipharma Research GmbH & Co KG||6|||f||||f|f|f||||||||2017-10-10 21:18:58.255568|2017-10-10 21:18:58.255568
NCT03062631|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-05-11||||||February 2017|2017-02-01||||||||Expanded Access|||Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome|Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome|Available||N/A|||University of California, Davis||||||t||t|||||||||||2017-10-10 21:18:58.369653|2017-10-10 21:18:58.369653
NCT03062618|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-10-03|||February 20, 2017|Actual|2017-02-20|October 2017|2017-10-01|January 9, 2018|Anticipated|2018-01-09|January 9, 2018|Anticipated|2018-01-09||Interventional|||A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis|Randomized, Double Blind, Placebo Controlled, Incomplete Crossover Single Oral Dose Escalation of PRCL-02 in Normal Healthy Volunteers (Part A) and Multiple Oral Dose Escalation in Normal Healthy Volunteers (Part B) and in Chronic Plaque Psoriasis Patients (Part C)|Recruiting||Phase 1|50|Anticipated|PRCL Research Inc.||6|||f||||f|t|f|||t|||||2017-10-10 21:18:58.447658|2017-10-10 21:18:58.447658
NCT03062605|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-02-22|||May 21, 2011|Actual|2011-05-21|February 2017|2017-02-01|February 17, 2012|Actual|2012-02-17|February 11, 2012|Actual|2012-02-11||Interventional|||Reducing Bacteria That Cause Tooth Decay|Reducing Microbial Levels in High Caries Risk Adults|Completed||Phase 3|36|Actual|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 21:18:58.72567|2017-10-10 21:18:58.72567
NCT03062592|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-22|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||FFAR Agonist on Incretins, Insulin, Lipids and Inflammation|Effects of a Naturally Occurring Dual FFAR Agonist on Incretins, Insulin Secretion, Lipids and Inflammation in Obesity and Type 2 Diabetes|Completed||N/A|8|Actual|Odense University Hospital||3|||f||||t|f|f||||||No||2017-10-10 21:18:58.818864|2017-10-10 21:18:58.818864
NCT03062579|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-20|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|April 1, 2018|Anticipated|2018-04-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD|Single-center, Open Label Trial of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active Neuromyelitis Optica Spectrum Disorders (NMOSD)|Active, not recruiting||Phase 1/Phase 2|10|Anticipated|Tianjin Medical University General Hospital||1|||f|||||t|f|||f|||No||2017-10-10 21:18:58.916336|2017-10-10 21:18:58.916336
NCT03062566|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-02-20|||February 15, 2017|Actual|2017-02-15|October 2016|2016-10-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|PreTBI III||Prognostic Potential of Prehospital Biomarkers in TBI Patients|Prognostic Potential of Prehospital S100B, Glial Fibrillary Acidic Protein (GFAP) and Neuron Specific Annuals (NSE) Levels in Patients Suffering Severe Traumatic Brain Injury (TBI)|Recruiting||N/A|90|Anticipated|University of Aarhus|||1||f||||t||||||Samples With DNA|"     Blood samples   "|No||2017-10-10 21:18:59.00967|2017-10-10 21:18:59.00967
NCT03062553|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-06-23|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|tACS||Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation|Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation|Not yet recruiting||N/A|150|Anticipated|University of British Columbia||3|||f||||t|f|f||||||No|All data will be reviewed in the aggregate. Individual data will not be analyzed or shared with participants.|2017-10-10 21:18:59.127706|2017-10-10 21:18:59.127706
NCT03062540|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-24|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|HONOR||Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD|A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily at Bedtime in Patients With Military-Related PTSD|Recruiting||Phase 3|550|Anticipated|Tonix Pharmaceuticals, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:18:59.252666|2017-10-10 21:18:59.252666
NCT03062527|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-20|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|May 1, 2015|Actual|2015-05-01|February 6, 2015|Actual|2015-02-06||Interventional|||Effect of Glycemic Index on Physical Capacity in Runners|Effects of Low and Versus Moderate Glycemic Index Diets on Physical Capacity and Body Composition in Endurance- Trained Runners|Completed||N/A|36|Actual|Poznan University of Life Sciences||2|||f||||f|f|f||||||Undecided|Shared data will be exclusively related to the level recorded indicators (body composition, aerobic capacity, performance in 12-min running test), without personal data. Depending on the requirements of the journal, the data obtained will be attached to scientific publications, deposited in a public repository or provided by principal investigator when requested.|2017-10-10 21:18:59.439885|2017-10-10 21:18:59.439885
NCT03062514|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-20|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial to Evaluate the Safety and Effectiveness of Vagus Nerve Stimulation for Children With Refractory Epilepsy|Vagus Nerve Stimulation for Pediatric Intractable Epilepsy (VNS-PIE)|Not yet recruiting||N/A|84|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t|f|f||||||Undecided||2017-10-10 21:18:59.53537|2017-10-10 21:18:59.53537
NCT03062501|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-20|||November 2016||2016-11-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|HELPS||Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis|Protocol for the Administration of Hydroxyurea During Painful Vaso-occlusive Crisis in Sickle Cell Anemia|Recruiting||Phase 2|30|Anticipated|Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti||2|||f||||f||||||||No||2017-10-10 21:18:59.606558|2017-10-10 21:18:59.606558
NCT03062488|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-15|||August 24, 2017|Anticipated|2017-08-24|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Emergence Agitation and Pain Scores in Pediatrics When Comparing Single-modal vs Multi-modal Analgesia for ENT Surgery|Emergence Agitation and Pain Scores in Pediatric Patients Following Sevoflurane Anesthesia When Comparing Single-modal Versus Multi-modal Analgesia for Routine Ear-nose-throat (ENT) Surgery, a Multi-center Double-blinded Study|Not yet recruiting||Early Phase 1|150|Anticipated|Nemours Children's Clinic||3|||f||||t|t|f||||||||2017-10-10 21:18:59.688549|2017-10-10 21:18:59.688549
NCT03062475|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-23|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes Mellitus|The Efficacy of Lifestyle Intervention in Preventing the the Recurrence of Gestational Diabetes Mellitus|Not yet recruiting||N/A|660|Anticipated|Peking University First Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:18:59.780565|2017-10-10 21:18:59.780565
NCT03062462|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-03-20|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Low-dose of Ticagrelor and Double Standard-dose Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With Coronary Heart Disease|Low-dose of Ticagrelor and Double Standard-dose Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With Coronary Heart Disease|Recruiting||Phase 2/Phase 3|60|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f|||||f|f||||||||2017-10-10 21:18:59.871751|2017-10-10 21:18:59.871751
NCT03062449|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-05-05|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|LSPI-2||Phase IIa L-serine Trial for eAD|A Phase IIa Proof of Concept, Randomized, Double-blind, Placebo-controlled Study of the Effects of L-serine on Early Stage Alzheimer's Disease Patients|Recruiting||Phase 2|40|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f|t|f||||||No||2017-10-10 21:18:59.981675|2017-10-10 21:18:59.981675
NCT03062436|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-07-20|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission|Stopping Imatinib Therapy in CML Patients With Sustained Molecular Remission|Not yet recruiting||N/A|25|Anticipated|Command Hospital, India||1|||f||||f|f|f||||||||2017-10-10 21:19:00.100206|2017-10-10 21:19:00.100206
NCT03062423|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-20|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)|Comparative Open-label,Randomized, Fed, Three Way Three Sequence Two Treatment Partial Replicate Crossover Bioequivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)|Completed||Phase 1|36|Actual|Genuine Research Center, Egypt||3|||f||||f|t|f|||f|||Undecided||2017-10-10 21:19:00.175495|2017-10-10 21:19:00.175495
NCT03062410|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-08-08|||May 4, 2017|Actual|2017-05-04|August 2017|2017-08-01|February 4, 2020|Anticipated|2020-02-04|November 4, 2019|Anticipated|2019-11-04||Interventional|QUANARIE||Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma|Heath Related Quality of Life Assessment for Patients With Advanced or Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitor Using Electronic Patient Reported Outcome in Daily Clinical Practice.|Recruiting||N/A|56|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f|f|f||||||||2017-10-10 21:19:00.264343|2017-10-10 21:19:00.264343
NCT03062397|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-20|||November 2016||2016-11-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke|A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke|Recruiting||Phase 2|110|Anticipated|Jeil Pharmaceutical Co., Ltd.||3|||f||||t||||||||No||2017-10-10 21:19:00.372965|2017-10-10 21:19:00.372965
NCT03062384|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-02-19|||May 2016||2016-05-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|ALPHA||AT-001 for Long-term Preservation of Brain Health in Aging|AT-001 for Long-term Preservation of Brain Health in Aging: The ALPHA Study|Recruiting||N/A|60|Anticipated|University of Kentucky||2|||f||||f|f|f||||||No||2017-10-10 21:19:00.473464|2017-10-10 21:19:00.473464
NCT03062371|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-20|||April 2015||2015-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|August 2017|Anticipated|2017-08-01||Interventional|||Early Intervention Playgroup|Early Intervention Playgroup|Recruiting||N/A|75|Anticipated|Florida Gulf Coast University||3|||f||||f||||||||||2017-10-10 21:19:00.567956|2017-10-10 21:19:00.567956
NCT03062358|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-21|2017-10-04|||April 27, 2017|Actual|2017-04-27|October 2017|2017-10-01|December 23, 2019|Anticipated|2019-12-23|December 23, 2019|Anticipated|2019-12-23||Interventional|||Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)|A Phase III Randomized Double-blind Study of Pembrolizumab Plus Best Supportive Care vs. Placebo Plus Best Supportive Care as Second-Line Therapy in Asian Subjects With Previously Systemically Treated Advanced Hepatocellular Carcinoma (KEYNOTE-394)|Recruiting||Phase 3|330|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t|f|f||||||||2017-10-10 21:19:00.677027|2017-10-10 21:19:00.677027
NCT03062345|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-22|||January 26, 2017|Actual|2017-01-26|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||In Home VR Therapy|Multi-user Virtual Training for Upper Extremity in the Home|Recruiting||N/A|15|Anticipated|Shirley Ryan AbilityLab||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:00.901127|2017-10-10 21:19:00.901127
NCT03062332|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-06-06|||February 27, 2017|Actual|2017-02-27|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Gut Microbiota of Bipolar and Depression|Altered Fecal Microbiota Composition in Patients With Major Depressive Disorder and Bipolar Disorder|Recruiting||N/A|240|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||6||f||||f|f|f||||Samples With DNA|"     blood and stool sample   "|No||2017-10-10 21:19:01.117433|2017-10-10 21:19:01.117433
NCT03060941|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-17|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PACES||Promoting Activity in Cancer Survivors|Promoting Activity in Cancer Survivors|Not yet recruiting||N/A|500|Anticipated|University of Texas Southwestern Medical Center||16|||f||||f|f|f||||||No||2017-10-10 21:19:15.529132|2017-10-10 21:19:15.529132
NCT03062319|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-13|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2021|Anticipated|2021-01-31||Interventional|ATIS-NVAF||Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis|Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis|Recruiting||Phase 4|400|Anticipated|National Cerebral and Cardiovascular Center||2|||f||||t|f|f||||||||2017-10-10 21:19:01.228065|2017-10-10 21:19:01.228065
NCT03062306|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-19|||May 31, 2017|Anticipated|2017-05-31|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|CPR||Chest Compression and Cerebral Oxygenation During Cardiopulmonary Resuscitation|Can Sufficient Cerebral Oxygenation be Provided in a Synchronized Manner With Chest Compression During Cardiopulmonary Resuscitation?|Recruiting||N/A|20|Anticipated|Nevsehir Public Hospital|||1||f|||||f|f||||||||2017-10-10 21:19:01.34943|2017-10-10 21:19:01.34943
NCT03062293|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-02-20|||September 2016||2016-09-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Newcastle Low Back Pain Intervention Study|Newcastle Low Back Pain Intervention Study|Active, not recruiting||N/A|14|Actual|Northumbria University||1|||f||||f||||||||No|NO IPD will be available to researchers outside of the research team.|2017-10-10 21:19:01.420298|2017-10-10 21:19:01.420298
NCT03062280|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-07-17|||August 18, 2016|Actual|2016-08-18|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH|A Phase III Extension Study of Efficacy, Safety and Tolerability of Chronocort® in the Treatment of Congenital Adrenal Hyperplasia|Recruiting||Phase 3|110|Anticipated|Diurnal Limited||1|||f||||t||||||||||2017-10-10 21:19:01.513821|2017-10-10 21:19:01.513821
NCT03062267|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-23|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|April 1, 2019|Anticipated|2019-04-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness|Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness|Not yet recruiting||N/A|52|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:19:01.606375|2017-10-10 21:19:01.606375
NCT03062254|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy|Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy|Not yet recruiting||Phase 2|10|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||1|||f||||f|f|f||||||||2017-10-10 21:19:01.705364|2017-10-10 21:19:01.705364
NCT03062241|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-22|||January 23, 2017|Actual|2017-01-23|February 2017|2017-02-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|CONTRA-HF||Ablation of Atrial Fibrillation in Heart Failure Patients|Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure|Recruiting||N/A|330|Anticipated|Medical University of Silesia||2|||f||||t|f|f||||||No||2017-10-10 21:19:01.798355|2017-10-10 21:19:01.798355
NCT03062228|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-19|||April 28, 2016|Actual|2016-04-28|February 2017|2017-02-01|March 15, 2017|Anticipated|2017-03-15|March 15, 2017|Anticipated|2017-03-15||Observational|KBTH-HBWS||KBTH-GIRHL Healthy Birth Weight Study: A Cross-Section|Korle Bu Teaching Hospital - Global Innovations for Reproductive Health & Life Healthy Birth Weight Study: A Cross-Section|Recruiting||N/A|162|Anticipated|IWK Health Centre|||1||f||||f|f|f||||||Yes|Individual participant data (IPD) in the form of spreadsheet datasets and statistical code are available other researchers from the corresponding author (email allan.kember@dal.ca to request). Consent to share IPD was not obtained from participants, but the presented data are anonymised and risk of identification is very low. In addition, the potential benefits of sharing these data outweigh the potential harms because the high burden of stillbirth and low birth weight in low- and middle-income countries demands urgent investigation by researchers around the world in order to identify and modify risk factors for these conditions.|2017-10-10 21:19:01.967804|2017-10-10 21:19:01.967804
NCT03062215|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-19|||August 2, 2016|Actual|2016-08-02|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|CAiCBT||Efficacy of a Culturally Adapted Cognitive Behavioural Internet-delivered Treatment for Depression|Assessing the Efficacy of a Culturally Adapted Cognitive Behavioural Internet-delivered Treatment for Depression: Protocol for a Randomised Controlled Trial|Recruiting||N/A|90|Anticipated|Silver Cloud Health||2|||f||||f|f|f||||||No||2017-10-10 21:19:02.117714|2017-10-10 21:19:02.117714
NCT03062202|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-08-18|||December 12, 2016||2016-12-12|August 2017|2017-08-01|September 25, 2017|Anticipated|2017-09-25|September 25, 2017|Anticipated|2017-09-25||Interventional|ICBT@STEP3||Internet-delivered Cognitive Behaviour Therapy at Step 3 of IAPT|The Potential Impact of Using Internet-delivered CBT (iCBT) for People in IAPT Services as a Prequel to High Intensity Therapy (HIT) for Depression and Anxiety Disorders.|Recruiting||N/A|126|Anticipated|Silver Cloud Health||3|||f||||t|f|f||||||||2017-10-10 21:19:02.24538|2017-10-10 21:19:02.24538
NCT03062189|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-24|||January 2015||2015-01-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Binge Drinking Among Youngs is a Risk Factor for Alcohol Use Disorders|Binge Drinking Among Young Students is a Risk Factor for the Development of Alcohol Use Disorders: Results From an Epidemiologic-observational Study|Completed||N/A|2704|Actual|Catholic University of the Sacred Heart|||1||f||||f||||||||No||2017-10-10 21:19:02.391294|2017-10-10 21:19:02.391294
NCT03062176|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-18|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|E-HART||Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With End-stage Renal Disease (E-HART)|Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With End-stage Renal Disease (E-HART)|Recruiting||Phase 2|20|Anticipated|Virginia Commonwealth University||1|||f||||t|t|f|||f|||||2017-10-10 21:19:02.473557|2017-10-10 21:19:02.473557
NCT03062163|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-20|||January 23, 2017|Actual|2017-01-23|February 2017|2017-02-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers|Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers|Completed||N/A|66|Actual|Chulalongkorn University||2|||f||||t|f|f||||||No||2017-10-10 21:19:02.568529|2017-10-10 21:19:02.568529
NCT03062150|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-22|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|MISO||Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression|Effects of Mineralocorticoid Receptor Stimulation on Cognitive Bias and Social Cognition in Patients With Major Depression and Healthy Controls: What's the Role of NMDA Receptors?|Recruiting||N/A|232|Anticipated|Charite University, Berlin, Germany||4|||f||||t|f|f||||||No||2017-10-10 21:19:02.655283|2017-10-10 21:19:02.655283
NCT03062137|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-30|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Observational|||Finding the Optimal Location for Saturation Measurement During Flexible Bronchoscopy|Optimal Location of Saturation Measurement During Flexible Fiberoptic Bronchoscopy|Completed||N/A|116|Actual|Rabin Medical Center|||1||f||||t||||||||No||2017-10-10 21:19:02.76883|2017-10-10 21:19:02.76883
NCT03062124|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-27|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Evaluating Suspected Intraductal Papillary Mucinous Neoplasms (IPMN) With SpyGlass Pancreatoscopy|Evaluating Suspected Intraductal Papillary Mucinous Neoplasms (IPMN) With SpyGlass Pancreatoscopy|Not yet recruiting||N/A|60|Anticipated|Helsinki University Central Hospital|||1||f||||f|f|f||||Samples With DNA|"     -  Tissue biopsies collected from suspected IPMN (Intraductal Papillary Mucinous Neoplasm)          lesions        -  Flushing fluid from pancreatic duct   "|No||2017-10-10 21:19:02.84463|2017-10-10 21:19:02.84463
NCT03062111|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-10|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)|Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP): a Prospective Study Comparing Outcomes|Not yet recruiting||N/A|100|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 21:19:02.921605|2017-10-10 21:19:02.921605
NCT03062098|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-10-03|||May 15, 2017|Anticipated|2017-05-15|October 2017|2017-10-01|September 1, 2017|Anticipated|2017-09-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||Optimizing the Technique of Embryo Transfer in IVF Using Better Imaging Guidance|Optimizing the Technique of Embryo Transfer in IVF Using Better Imaging Guidance|Withdrawn||N/A|0|Actual|Rambam Health Care Campus||1||Primary investigator retired, rest of staff cannot continue|f||||f|f|f||||||||2017-10-10 21:19:03.012469|2017-10-10 21:19:03.012469
NCT03062085|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-26|||January 1, 2015|Actual|2015-01-01|February 2017|2017-02-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2025|Anticipated|2025-12-31|5 Years|Observational [Patient Registry]|||Shanghai High Myopia Study|Visual Outcome Evaluation and Genetic Analysis: Shanghai High Myopia Study|Recruiting||N/A|60000|Anticipated|Shanghai High Myopia Study Group|||3||f||||t|f|f||||Samples With DNA|"     Blood samples from HMC, ARC and anisometropia patients collected before the cataract surgery.     Aqueous humor and capsular membranes samples from HMC, ARC and ametropic cataract patients     collected during the cataract surgery.   "|Undecided|Undecided.|2017-10-10 21:19:03.080572|2017-10-10 21:19:03.080572
NCT03062072|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-05|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Observational|ECHO||Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients|Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients (ECHO)|Recruiting||N/A|300|Anticipated|National Cancer Center, Korea|||1||f|||||f|f||||Samples With DNA|"     serum, plasma, buffy coat   "|||2017-10-10 21:19:03.186017|2017-10-10 21:19:03.186017
NCT03062059|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-14|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence|The Effectiveness and Safety of Intravesical Gemcitabine Instillation During Operation to Prevent Intravesical Recurrence After Radical Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma: Prospective, Phase II Study|Recruiting||Phase 2|134|Anticipated|National Cancer Center, Korea||2|||f|||||f|f|||f|||||2017-10-10 21:19:03.295019|2017-10-10 21:19:03.295019
NCT03062046|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-06-27|||January 27, 2017|Actual|2017-01-27|June 2017|2017-06-01|May 31, 2019|Anticipated|2019-05-31|December 31, 2018|Anticipated|2018-12-31||Interventional|VISTAX||Evaluation of Ablation Index and VISITAG™ (ABI-173)|Evaluation of Ablation Index and VISITAG™ Use for Pulmonary Vein Isolation (PVI) in Patients With Paroxysmal Atrial Fibrillation (PAF)|Recruiting||Phase 4|330|Anticipated|Biosense Webster, Inc.||1|||f|||||f|f||||||Yes||2017-10-10 21:19:03.401723|2017-10-10 21:19:03.401723
NCT03062033|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-04|||April 4, 2017|Actual|2017-04-04|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01|12 Months|Observational [Patient Registry]|RE-Kinect||Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents|Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents|Recruiting||N/A|70|Anticipated|Neurocrine Biosciences|||2||f||||f||||||||||2017-10-10 21:19:03.504321|2017-10-10 21:19:03.504321
NCT03062020|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-02-19|||November 16, 2016|Actual|2016-11-16|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|November 2020|Anticipated|2020-11-01||Interventional|||New Tool to Predict Risk of Spontaneous Preterm Birth in Asymptomatic High-risk Women|New Tool to Predict Risk of Spontaneous Preterm Birth in Asymptomatic High-risk Women|Recruiting||N/A|258|Anticipated|Hospital Clinic of Barcelona||2|||f||||f|f|f||||||No||2017-10-10 21:19:03.612079|2017-10-10 21:19:03.612079
NCT03062007|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-20|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With Trastuzumab|Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With Trastuzumab|Recruiting||Phase 1|40|Anticipated|Biointegrator LLC||1|||f||||t|f|f||||||No||2017-10-10 21:19:03.719902|2017-10-10 21:19:03.719902
NCT03061994|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-05-26|||October 2016||2016-10-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|MAC||Metabolomic Study of All-age Cardiomyopathy|Metabolomic Study of Patients With Cardiomyopathy in China|Recruiting||N/A|1000|Anticipated|Beijing Institute of Heart, Lung and Blood Vessel Diseases|||2||f||||f||||||||No||2017-10-10 21:19:03.825838|2017-10-10 21:19:03.825838
NCT03000010|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2016-12-18|||July 2012||2012-07-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Interventional|WV||Wound Vac Bandage Comparison After Spinal Fusion|Incisional Vacuum-assisted Closure Therapy After Posterior Spinal Fusion for Pediatric Neuromuscular Scoliosis|Recruiting||Phase 4|50|Anticipated|University of Michigan||2|||f||||f||||||||No||2017-10-10 21:30:45.059396|2017-10-10 21:30:45.059396
NCT03061981|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-12|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects|A Phase I, First In Human, Double Blind, Placebo Controlled, Single Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Interaction Effect With Metformin Following A Single Oral Dose Of DA-1241 In Healthy Male Subjects|Recruiting||Phase 1|60|Anticipated|Dong-A ST Co., Ltd.||4|||f||||f|t|f||||||No||2017-10-10 21:19:03.911453|2017-10-10 21:19:03.911453
NCT03061968|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-12|2017-02-22|||May 2010|Actual|2010-05-01|February 2017|2017-02-01|February 2017|Anticipated|2017-02-01|December 2011|Actual|2011-12-01||Interventional|||Study of Applying Acupressure in Low-birth Weight Premature|Study of Appling Acupressure in Low-birth Weight Premature|Enrolling by invitation||N/A|60|Anticipated|China Medical University Hospital||2|||f||||f||||||||No||2017-10-10 21:19:03.997878|2017-10-10 21:19:03.997878
NCT03061955|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-22|||October 1, 2016|Actual|2016-10-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|March 31, 2017|Actual|2017-03-31||Observational|||Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)|Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)|Active, not recruiting||N/A|27|Anticipated|Advocate Health Care|||1||f||||f|f|f||||||||2017-10-10 21:19:04.059283|2017-10-10 21:19:04.059283
NCT03061942|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-17|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Arthroscopic Rotator Cuff Repair With Synovectomy|Arthroscopic Rotator Cuff Repair With Synovectomy; Prospective Randomized Controlled Study|Recruiting||N/A|60|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:19:04.121592|2017-10-10 21:19:04.121592
NCT03061929|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-08-07|||March 24, 2017|Actual|2017-03-24|August 2017|2017-08-01|May 21, 2018|Anticipated|2018-05-21|December 29, 2017|Anticipated|2017-12-29||Observational|||Human Milk Composition in Indian Mothers|Human Milk Composition in Indian Mothers|Recruiting||N/A|258|Anticipated|Abbott Nutrition|||3||f||||f|f|f||||||||2017-10-10 21:19:04.190753|2017-10-10 21:19:04.190753
NCT03061916|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-19|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|November 1, 2017|Anticipated|2017-11-01|May 1, 2017|Anticipated|2017-05-01||Interventional|||Cinnamon and Ginger in Comparison to Chlorhexidine Gluconate 0.2% on Oral Streptococcus Mutans|Antimicrobial Effects of Aqueous Extracts of Cinnamon and Ginger in Comparison to Chlorhexidine Gluconate 0.2% on Oral Streptococcus Mutans|Not yet recruiting||Phase 3|21|Anticipated|Cairo University||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:19:04.416339|2017-10-10 21:19:04.416339
NCT03061903|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-07-19|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|March 1, 2018|Anticipated|2018-03-01||Interventional|Prevena||Closed Incision Negative Pressure Therapy vs Standard of Care|Closed Incision Negative Pressure Therapy vs. Standard of Care for Surgical Incision Management in High-Risk Patients Following Total Hip Arthroplasty: A Randomized Controlled Trial|Not yet recruiting||N/A|116|Anticipated|Columbia University||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:19:04.549487|2017-10-10 21:19:04.549487
NCT03061890|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-06-26|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31|7 Years|Observational [Patient Registry]|DINE||Developmental Impact of NICU Exposures (DINE)|Developmental Impact of Neonatal Intensive Care Unit (NICU) Exposures: Environmental Influences on Child Health Outcomes (ECHO)|Recruiting||N/A|854|Anticipated|Albert Einstein College of Medicine, Inc.|||4||f||||f|f|f||||Samples With DNA|"     Urine, hair, teeth, saliva for DNA (optional) samples retained, with potential for extraction     of DNA from saliva with separate consent   "|Yes|"All efforts, within reason, are made to keep protected health information (PHI) private, including data gathered for research studies. Using or sharing (disclosure) such data must follow federal privacy rules. All PHI about children in the study will be entered into REDCap, a secure, web-based data collection platform. Study patients will be identified only by a study identification (ID) number. Access to the REDCap study database is restricted to study personnel, password protected and behind a Medical Center firewall. The study child's name and medical record number will appear only on the Screening Log which contains no other PHI. Only the study team will have access to the Screening Log."|2017-10-10 21:19:04.707584|2017-10-10 21:19:04.707584
NCT03061877|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-24|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Observational|ADAR||Anxiety Depression and Rheumatoid Arthritis|The Effect of Anxiety and Depression on Treatment Response in Rheumatoid Arthritis|Not yet recruiting||N/A|134|Anticipated|Sichuan Provincial People's Hospital|||2||f|||||f|f||||||||2017-10-10 21:19:04.875252|2017-10-10 21:19:04.875252
NCT03061864|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-19|||August 2016||2016-08-01|February 2017|2017-02-01|August 2019||2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||The Periviable Birth Plan|The Periviable Birth Plan: A Randomized Control Trial Evaluating an Intervention to Decrease Maternal Anxiety and Stress|Recruiting||N/A|54|Anticipated|Albany Medical College||2|||f||||f||||||||No||2017-10-10 21:19:04.949411|2017-10-10 21:19:04.949411
NCT03061851|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-02-22|||January 25, 2017|Actual|2017-01-25|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||The Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus|A Multicenter, Prospective, Randomized, Controlled Clinical Trial of the Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus|Recruiting||N/A|400|Anticipated|Qingdao Zhixin Health Technology Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:19:05.046949|2017-10-10 21:19:05.046949
NCT03061838|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-20|||October 27, 2016|Actual|2016-10-27|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera®|Multicenter Double-blind Randomized Clinical Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Biosimilar Drug Ritumax® Compared to Original Drug MabThera® in Patients With Rheumatoid Arthritis|Recruiting||Phase 1|120|Anticipated|Biointegrator LLC||2|||f||||f|f|f||||||No||2017-10-10 21:19:05.160706|2017-10-10 21:19:05.160706
NCT03061825|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-13|||May 24, 2017|Actual|2017-05-24|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01|2 Years|Observational [Patient Registry]|||Zenith Alpha™ Abdominal Endovascular Graft|Post-Market Study for Zenith Alpha™ Abdominal Endovascular Graft|Recruiting||N/A|100|Anticipated|Cook Group Incorporated|||1||f|||||f|f||||||||2017-10-10 21:19:05.256014|2017-10-10 21:19:05.256014
NCT03061812|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-09-29|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|May 2, 2020|Anticipated|2020-05-02|September 19, 2019|Anticipated|2019-09-19||Interventional|TAHOE||Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)|A Randomized, Open-label, Multicenter, Phase 3 Study of Rovalpituzumab Tesirine Compared With Topotecan for High DLL3 Expressing Small Cell Lung Cancer (SCLC) Subjects With First Relapse/Recurrence Following Front-Line Platinum-Based Chemotherapy (TAHOE)|Recruiting||Phase 3|411|Anticipated|AbbVie||2|||f||||t|t|f||||||||2017-10-10 21:19:05.374384|2017-10-10 21:19:05.374384
NCT03061799|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-19|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy and Safety of HPC-03 for Postmenopausal Symptom|Efficacy and Safety of HPC-03(Extracts of Angelica Gigas Nakai, Cnidium Rhizome, and Cinnamon Bark) for Postmenopausal Symptom|Recruiting||N/A|150|Anticipated|Severance Hospital||2|||f||||||||||||No||2017-10-10 21:19:05.739786|2017-10-10 21:19:05.739786
NCT03061786|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-22|||January 2017||2017-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Prognosis of Acute Kidney Injury:China Collaborative Study on AKI（CCS-AKI）Study|Prognosis of Acute Kidney Injury:China Collaborative Study on AKI（CCS-AKI）Study|Recruiting||N/A|1000000|Anticipated|Guangdong General Hospital|||2||f||||||||||||||2017-10-10 21:19:05.856131|2017-10-10 21:19:05.856131
NCT03061773|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-19|||March 1, 2014|Actual|2014-03-01|February 2017|2017-02-01|September 30, 2015|Actual|2015-09-30|September 1, 2015|Actual|2015-09-01||Interventional|||Physical Training on Patients With Breast Cancer|Benefits of Physical Exercise in Patients With Breast Cancer|Completed||N/A|2|Actual|Federal University of Maranhao||2|||f|||||f|f||||||No||2017-10-10 21:19:05.933803|2017-10-10 21:19:05.933803
NCT03061760|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-21|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy|Could Urinary Bladder Hypertrophy Influence on Urge Urine Incontinence Development in Patients After Radical Prostatectomy: A Multi-center Study|Not yet recruiting||N/A|250|Anticipated|Collegium Medicum w Bydgoszczy|||5||f||||f|f|f||||||No|The summary of all the results will be provided on ClinicalTrials.gov . Individual patient data may be provided after individual request to the extant needed for the requesting researcher.|2017-10-10 21:19:06.029117|2017-10-10 21:19:06.029117
NCT03061747|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-02-18|||June 1, 2016|Actual|2016-06-01|February 2017|2017-02-01|April 30, 2017|Anticipated|2017-04-30|April 15, 2017|Anticipated|2017-04-15||Observational|IMPLANTED||Multi-centre Observational Registry on Patients With Implantable Devices Remotely Monitored|Italian Multi-centre Observational Registry on Patients With impLANTable Devices Remotely monitorED|Recruiting||N/A|1000|Anticipated|Azienda Ospedaliera Cardinale G. Panico|||1||f|||||f|f||||||||2017-10-10 21:19:06.135792|2017-10-10 21:19:06.135792
NCT03061734|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-09-03|||February 18, 2017|Actual|2017-02-18|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Oral ALLOD-2 vs. Components and vs. Placebo in the Acute Treatment of Migraine (ANODYNE-1)|Single Center, Phase 2B, Randomized, Double Blind, Placebo, Individual Components, and 2-Dose Comparator-Controlled Study to Assess the Efficacy and Safety of a Single Dose of Oral ALLOD-2 in the Acute Treatment of Moderate to Severe Migraine (ANODYNE-1)|Recruiting||Phase 2/Phase 3|150|Anticipated|Allodynic Therapeutics, LLC||5|||f||||f|t|f||||||||2017-10-10 21:19:06.22355|2017-10-10 21:19:06.22355
NCT03061721|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-15|||April 6, 2017|Actual|2017-04-06|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|EVIDENCES II||Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis|A Phase 2, Prospective, Multicenter, Double-blind, Randomized Study of Saroglitazar Magnesium 1 mg, 2 mg or 4 mg Versus Placebo in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis|Recruiting||Phase 2|104|Anticipated|Zydus Discovery DMCC||4|||f|||||t|f||||||Undecided||2017-10-10 21:19:06.342948|2017-10-10 21:19:06.342948
NCT03061708|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-21|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|AZD2014||Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy|Phase II Trial of Single Agent AZD2014 in RICTOR Amplified or Over-expressed GC Patients as Second-line Therapy|Active, not recruiting||Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:19:06.490481|2017-10-10 21:19:06.490481
NCT03061695|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-19|||February 28, 2017|Anticipated|2017-02-28|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Application of Digitized Respiratory Sounds for Confirmation of the Position of the Balloon of Endobronchial Blockers|The Application of the Spectral Analysis and Characteristic Parameters of Digitized Respiratory Sounds in the Confirmation of the Position of the Balloon of Endobronchial Blockers - an Observational Study|Not yet recruiting||N/A|30|Anticipated|National Taiwan University Hospital|||1||f|||||f|f||||||Undecided||2017-10-10 21:19:06.561444|2017-10-10 21:19:06.561444
NCT03061682|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-02-19|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Implantation of Add on Lens for Age Related Macular Degeneration Patients With Low Vision|Implantation of Add on Lens for Age Related Macular Degeneration Patients With Low Vision|Not yet recruiting||N/A|20|Anticipated|Rabin Medical Center||1|||f|||||f|t|f|f|f|||||2017-10-10 21:19:06.618751|2017-10-10 21:19:06.618751
NCT03061669|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-05-28|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Respiratory Monitoring During Right Heart|Respiratory Monitoring During Right Heart Catheterization to Differentiate Between Various Types of Pulmonary Hypertension; The Effects of the Cardiovascular System on the Lung Mechanical Properties|Recruiting||N/A|50|Anticipated|Rambam Health Care Campus|||1||f||||f|f|f||||||No||2017-10-10 21:19:06.688197|2017-10-10 21:19:06.688197
NCT03061656|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-20|||January 1, 2009|Actual|2009-01-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2013|Actual|2013-12-31||Interventional|||Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma|High-dose 131I-MIBG Treatment Incorporated Into Tandem High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With High-risk Neuroblastoma|Active, not recruiting||Phase 2|40|Anticipated|Samsung Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:19:06.761873|2017-10-10 21:19:06.761873
NCT03061643|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-25|||February 8, 2017|Actual|2017-02-08|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma|SAMSUNG MEDICAL CENTER|Active, not recruiting||Phase 2|51|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||t|||||2017-10-10 21:19:06.845418|2017-10-10 21:19:06.845418
NCT03061630|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-04-25|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder|SAMSUNG MEDICAL CENTER|Active, not recruiting||Phase 2|48|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||t|||||2017-10-10 21:19:06.919115|2017-10-10 21:19:06.919115
NCT03061617|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-21|||July 2016||2016-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Comparison of Different Ventilation Mode During One-lung Ventilation|Comparison of Pressure-controlled Ventilation With Volume-controlled Ventilation During One-lung Ventilation|Completed||N/A|64|Actual|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-10 21:19:06.991699|2017-10-10 21:19:06.991699
NCT03061604|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-02-19|||November 2014||2014-11-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding|A Randomized Control Study to Determine the Efficacy and Safety of Combining Hemospray With Medical Standard of Care Treatment in the Management of Acute Variceal Bleeding in Cirrhotic Patients.|Recruiting||N/A|120|Anticipated|Theodor Bilharz Research Institute||2|||f||||t||||||||Undecided|If data will be shared to other researchers , The patients personal data will be removed|2017-10-10 21:19:07.063902|2017-10-10 21:19:07.063902
NCT03061591|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-19|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.|Efficacy of Wholistic Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis A Randomized, Double Blinded, Placebo Controlled Study|Not yet recruiting||Phase 2|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:19:07.168516|2017-10-10 21:19:07.168516
NCT03061578|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-06-29|||January 26, 2017|Actual|2017-01-26|June 2017|2017-06-01|May 11, 2017|Actual|2017-05-11|March 11, 2017|Actual|2017-03-11||Observational|TFI-LH16||Evaluation of Dry Eye by Tear Film Imager in a Low Humidity Environmental Exposure Chamber (TFI-LH16)|A Clinical Study to Evaluate Innovative Tear Film Imaging for the Evaluation of Dry Eye and Its Correlation to Traditional Signs and Symptoms of Dry Eye Syndrome in a Low Humidity Environmental Exposure Chamber (LH-EEC)|Completed||N/A|29|Actual|Adom Advanced Optical Technologies Ltd.|||3||f||||f|f|f||||||||2017-10-10 21:19:07.253439|2017-10-10 21:19:07.253439
NCT03061565|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-17|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|October 31, 2017|Anticipated|2017-10-31||Observational|||Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury|Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury A Follow-up Study of an International Randomised Controlled Trial|Recruiting||N/A|603|Anticipated|Australian and New Zealand Intensive Care Research Centre|||2||f||||f|f|f||||||||2017-10-10 21:19:07.349341|2017-10-10 21:19:07.349341
NCT03061552|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-20|2017-02-28|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life|Influence of Dry Weight Adjustment by Inferior Vena Cava Sonography in Hemodialysis Patients on Quality of Life During Treatment|Not yet recruiting||N/A|20|Anticipated|Hadassah Medical Organization||2|||f||||f|f|f||||||No||2017-10-10 21:19:07.434427|2017-10-10 21:19:07.434427
NCT03061539|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-02|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|January 2024|Anticipated|2024-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature|Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature|Not yet recruiting||Phase 2|175|Anticipated|University College, London||1|||f|||||t|f|||f|||||2017-10-10 21:19:07.502375|2017-10-10 21:19:07.502375
NCT03061526|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-23|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Spectral-domain Optical Coherence Tomography Findings in Retinal Vessel Occlusion|Spectral-domain Optical Coherence Tomography Findings in Retinal Vessel Occlusion - A Pilot Study of Detecting Ischemia in OCT|Not yet recruiting||N/A|100|Anticipated|Technische Universität Dresden|||1||f||||f|f|f||||||No||2017-10-10 21:19:07.58344|2017-10-10 21:19:07.58344
NCT03061513|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-24|2017-02-22||February 28, 2012|Actual|2012-02-28|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers|Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers|Completed||Phase 2|11|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||No||2017-10-10 21:19:07.655726|2017-10-10 21:19:07.655726
NCT03061500|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-19|||October 15, 2016|Actual|2016-10-15|February 2017|2017-02-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Observational|||Prognostic Value of Proadrenomedullin in Intra-abdominal Sepsis|Proadrenomedullin as a Severity Score and Prognostic Marker in Intra-abdominal Sepsis|Recruiting||N/A|100|Anticipated|Instituto de Investigación Hospital Universitario La Paz|||1||f||||f|f|f||||||No||2017-10-10 21:19:07.926562|2017-10-10 21:19:07.926562
NCT03061487|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-23|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|April 27, 2018|Anticipated|2018-04-27|February 26, 2018|Anticipated|2018-02-26||Observational|INSTANT||Influence of Statins in Artery Aneurysms|The Influence of Statin Treatment on Aneurysmatic Disease|Recruiting||N/A|20|Anticipated|University of Cantanzaro|||2||f||||t|f|f||||||No||2017-10-10 21:19:08.003825|2017-10-10 21:19:08.003825
NCT03061474|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-03|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|NEAT||Nicotinamide as an Early Alzheimer's Disease Treatment|A Double-Blind-Randomized, Placebo-Controlled Adaptive Design Trial of Nicotinamide in Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease Dementia|Not yet recruiting||Phase 2|48|Anticipated|University of California, Irvine||2|||||||t|t|f||||||Yes||2017-10-10 21:19:08.091775|2017-10-10 21:19:08.091775
NCT03061461|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-23|||February 23, 2017|Actual|2017-02-23|February 2017|2017-02-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Radial Extracorporeal Shock Wave Therapy for Chronic Soft Tissue Wounds|A Prospective, Randomized, Double-blind, Placebo Controlled, Parallel Group, Single Center Trial to Assess the Efficacy and Safety of Radial Extracorporeal Shock Wave Therapy in Subjects With Chronic Soft Tissue Wounds|Recruiting||N/A|50|Anticipated|Kuala Lumpur General Hospital||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:19:08.339033|2017-10-10 21:19:08.339033
NCT03061448|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-08-17|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Internet-based Exposure Therapy for Panic Disorder|Internet-based Exposure Therapy for Panic Disorder: A Randomized Controlled Pilot Study|Completed||N/A|61|Actual|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 21:19:08.472281|2017-10-10 21:19:08.472281
NCT03061435|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Vulvar-AIN||Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.|Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.|Not yet recruiting||N/A|110|Anticipated|Sunnybrook Health Sciences Centre||3|||f||||f|f|f||||||||2017-10-10 21:19:08.567837|2017-10-10 21:19:08.567837
NCT03061422|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-22|||March 3, 2017|Anticipated|2017-03-03|February 2017|2017-02-01|November 30, 2018|Anticipated|2018-11-30|October 1, 2017|Anticipated|2017-10-01||Interventional|||Effect of Xylitol-Containing Chewing Gum With/Without Bicarbonate Versus Paraffin Pellet on Salivary pH|Effect of Xylitol-Containing Chewing Gum With/Without Bicarbonate Versus Paraffin Pellet on Salivary pH in High Caries Risk Patients (A Randomized Clinical Trial)|Not yet recruiting||N/A|36|Anticipated|Cairo University||3|||f||||t|f|f||||||Undecided||2017-10-10 21:19:08.667559|2017-10-10 21:19:08.667559
NCT03061409|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-02-17|||May 2016||2016-05-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Vitamin and Mineral Supplementation Improves Micronutrient Status in Older Adults||Recruiting||N/A|60|Anticipated|Tufts University||2|||f||||f||||||||No||2017-10-10 21:19:08.764935|2017-10-10 21:19:08.764935
NCT03061396|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-03-01|||March 10, 2017|Anticipated|2017-03-10|March 2017|2017-03-01|December 28, 2017|Anticipated|2017-12-28|September 28, 2017|Anticipated|2017-09-28||Interventional|||The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints|The Different Effectiveness of Single Acupoint vs Matching Acupoints in Chemotherapy-induced Nausea and Vomiting：A Multicenter, Randomized, Controlled Clinical Trial|Not yet recruiting||N/A|208|Anticipated|Tianjin University of Traditional Chinese Medicine||2|||f|||||f|f||||||||2017-10-10 21:19:08.882492|2017-10-10 21:19:08.882492
NCT03061383|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-22|||March 3, 2017|Anticipated|2017-03-03|February 2017|2017-02-01|November 30, 2018|Anticipated|2018-11-30|October 3, 2018|Anticipated|2018-10-03||Interventional|DH||Reduction of Dentine Hypersensitivity Using 8% Arginine Based Toothpaste and 8% Strontium Acetate Based Toothpaste (DH)|Reduction of Dentine Hypersensitivity Using 8% Arginine Based Toothpaste and 8% Strontium Acetate Based Toothpaste: Randomized Controlled Clinical Trial|Not yet recruiting||N/A|51|Anticipated|Cairo University||3|||f||||t|f|f||||||Yes|publishing the data at egyptian dental journal|2017-10-10 21:19:08.980989|2017-10-10 21:19:08.980989
NCT03061370|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-17|||January 1, 2010|Actual|2010-01-01|February 2017|2017-02-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2017|Actual|2017-01-01||Observational|||Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer|An Investigation of the Prevalence and Clinical Impact of Sarcopenia and Visceral Obesity Among Patients With Upper Gastrointestinal Malignancies|Active, not recruiting||N/A|500|Anticipated|St. James's Hospital, Ireland|||1||f||||f|f|f||||||No||2017-10-10 21:19:09.095176|2017-10-10 21:19:09.095176
NCT03061357|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-17|||August 6, 2015|Actual|2015-08-06|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|July 31, 2016|Actual|2016-07-31||Interventional|||Physical Activity Intervention Among College Students|Incorporating Wearable Technology Into Physical Activity Instructional Program: A Cluster Randomized Trial in University Settings|Completed||N/A|187|Actual|Texas Tech University||2|||f||||f|f|f||||||No||2017-10-10 21:19:09.209957|2017-10-10 21:19:09.209957
NCT03061344|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-02-17|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|LBMG||Liquid Buccal Mucosa Graft Urethroplasty|Endoscopic Buccal Mucosal Graft Urethroplasty or Bladder Neck Reconstruction|Not yet recruiting||Phase 1|10|Anticipated|State University of New York - Upstate Medical University||1|||f||||f|t|f||||||No||2017-10-10 21:19:09.305449|2017-10-10 21:19:09.305449
NCT03061331|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-04-12|||January 31, 2017|Actual|2017-01-31|February 2017|2017-02-01|October 5, 2017|Anticipated|2017-10-05|September 7, 2017|Anticipated|2017-09-07||Interventional|||Lumacaftor/Ivacaftor Combination Therapy in Subjects With CF Who Have an A455E CFTR Mutation|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of Lumacaftor/Ivacaftor Combination Therapy in Subjects With Cystic Fibrosis Who Have an A455E-CFTR Mutation|Active, not recruiting||Phase 2|20|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||f|t|f|||t|||||2017-10-10 21:19:09.42326|2017-10-10 21:19:09.42326
NCT03061318|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-17|||April 8, 2015|Actual|2015-04-08|February 2017|2017-02-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|CT-DS||Validation of a Multi-Genetic Test for the Diagnosis of Indeterminate Thyroid Nodules|Validation of a Multi-Genetic Test for the Diagnosis of Indeterminate Thyroid Nodules|Recruiting||N/A|4000|Anticipated|Pontificia Universidad Catolica de Chile|||1||f||||f|f|f||||Samples Without DNA|"     Thyroid Nodule Fine Needle Aspiration   "|No||2017-10-10 21:19:09.532552|2017-10-10 21:19:09.532552
NCT03061305|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-17|||November 2016|Actual|2016-11-01|February 2017|2017-02-01||||April 2020|Anticipated|2020-04-01|3 Years|Observational [Patient Registry]|||Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection|Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection|Recruiting||N/A|100000|Anticipated|Strata Oncology|||1||f||||f|f|f||||Samples With DNA|"     leftover tumor tissue, DNA, RNA   "|No||2017-10-10 21:19:09.668137|2017-10-10 21:19:09.668137
NCT03061292|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-21|||July 25, 2016|Actual|2016-07-25|February 2017|2017-02-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Cardiac Implantable Electronic Device Implantation With and Without Pectoral Nerve Block|A Randomized, Controlled Trial on Patients Undergoing Cardiac Implantable Electronic Device Implantation With Local Anaesthesia and Sedation With and Without Pectoral Nerve Block|Recruiting||N/A|120|Anticipated|Changi General Hospital||2|||f|||||f|f||||||Undecided||2017-10-10 21:19:09.756873|2017-10-10 21:19:09.756873
NCT03061279|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-04-09|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|March 1, 2021|Anticipated|2021-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Clinical Trial Evaluating Acutrak Headless Compression Screw Fixation of Medial Malleolus Fractures|Randomized Clinical Trial Evaluating Acutrak Headless Compression Screw Fixation of Medial Malleolus Fractures|Recruiting||N/A|500|Anticipated|Stanford University||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:19:09.84778|2017-10-10 21:19:09.84778
NCT03061266|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-21|||March 9, 2016|Actual|2016-03-09|February 2017|2017-02-01|March 8, 2017|Anticipated|2017-03-08|March 8, 2017|Anticipated|2017-03-08||Interventional|||The Application of the E-health Education on Shared Care Program for Patients With Type 2 Diabetes|The Application of the E-health Education on Shared Care Program for Patients With Type 2 Diabetes - Taking Local Teaching Hospital for Example|Recruiting||N/A|110|Anticipated|China Medical University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:19:09.990435|2017-10-10 21:19:09.990435
NCT03061253|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-17|||April 21, 2017|Anticipated|2017-04-21|February 2017|2017-02-01|April 20, 2020|Anticipated|2020-04-20|November 21, 2019|Anticipated|2019-11-21||Interventional|ISME-NRT||E-cigarettes and Cardiovascular Function|Impact on Cardiovascular Function in Smokers Making a Quit Attempt Using E-cigarettes Compared With Smokers Making a Quit Attempt With Prescription Nicotine-Replacement Therapy|Not yet recruiting||N/A|258|Anticipated|Sheffield Hallam University||3|||f||||f|f|f||||||||2017-10-10 21:19:10.152251|2017-10-10 21:19:10.152251
NCT03061240|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-11|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|SPA||Smart Pain Assesment Tool Based on Internet of Things|Smart Pain Assesment Tool Based on Internet of Things|Not yet recruiting||N/A|50|Anticipated|University of Turku||1|||f||||f|f|f||||||||2017-10-10 21:19:10.276904|2017-10-10 21:19:10.276904
NCT03061227|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-15|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge|Metabolic and Central Nervous System Characterisation of the Phenotype of Non-suppressed (Rising) Glucagon After Glucose Challenge|Recruiting||N/A|30|Anticipated|University Hospital Tuebingen||2|||f||||f|f|f||||||No||2017-10-10 21:19:10.385975|2017-10-10 21:19:10.385975
NCT03061214|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-09-26|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|November 19, 2018|Anticipated|2018-11-19|September 24, 2018|Anticipated|2018-09-24||Interventional|SUSTAIN||Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)|Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes. A 30-week Randomised, Double-blind, Double-dummy, Active-controlled, Parallel-group, Multi-centre and Multi-national Trial|Recruiting||Phase 3|1050|Anticipated|Novo Nordisk A/S||4|||f||||f|t|f|||t|||||2017-10-10 21:19:10.528173|2017-10-10 21:19:10.528173
NCT03061201|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-08-15|||June 2, 2017|Actual|2017-06-02|August 2017|2017-08-01|January 30, 2022|Anticipated|2022-01-30|November 15, 2021|Anticipated|2021-11-15||Interventional|||Dose-Ranging Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 in Subjects With Severe Hemophilia A|A Phase 1/2, Open-Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 (Recombinant AAV2/6 Human Factor 8 Gene Therapy) in Adult Subjects With Severe Hemophilia A|Recruiting||Phase 1/Phase 2|20|Anticipated|Sangamo Therapeutics||1|||f||||t|t|f||||||||2017-10-10 21:19:10.793142|2017-10-10 21:19:10.793142
NCT03061188|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-01|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|September 2020|Anticipated|2020-09-01||Interventional|||Nivolumab and Veliparib in Treating Patients With Recurrent or Refractory Stage IV Solid Tumors That Cannot Be Removed by Surgery or Lymphoma With or Without Alterations in DNA Repair Genes|Phase I/Ib Study of Nivolumab and Veliparib in Patients With Advanced Solid Tumors and Lymphoma With and Without Alterations in Selected DNA Repair Genes|Recruiting||Phase 1|50|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 21:19:10.881954|2017-10-10 21:19:10.881954
NCT03061175|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-17|||July 2015||2015-07-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy|Facilitating Informed Decisions for Contralateral Prophylactic Mastectomy|Recruiting||N/A|140|Anticipated|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-10 21:19:11.07709|2017-10-10 21:19:11.07709
NCT03061162|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-13|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|March 1, 2022|Anticipated|2022-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|||Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis|Phase II Study of Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis|Recruiting||N/A|40|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||f|f|f||||||No||2017-10-10 21:19:11.272792|2017-10-10 21:19:11.272792
NCT03061149|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-17|||March 30, 2009|Actual|2009-03-30|February 2017|2017-02-01|November 12, 2016|Actual|2016-11-12|February 15, 2014|Actual|2014-02-15||Interventional|||The Effectiveness of Physical Therapy Modalities in Carpal Tunnel Syndrome|The Effects of Nerve and Tendon Gliding Exercises Combined With Low-level Laser or Ultrasound Therapy in Carpal Tunnel Syndrome|Completed||N/A|70|Actual|Poznan University of Medical Sciences||2|||f||||f|f|f||||||No||2017-10-10 21:19:11.368674|2017-10-10 21:19:11.368674
NCT03061136|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-08-28|||October 2016||2016-10-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|KGB||Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia|Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia|Withdrawn||Phase 4|0|Actual|Palo Alto Veterans Institute for Research||4||Delays in equipment procurement prevented the start of the study in time|f||||f||||||||||2017-10-10 21:19:11.471788|2017-10-10 21:19:11.471788
NCT03061123|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-20|||September 2015||2015-09-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF|Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular Atrial Fibrillation|Active, not recruiting||N/A|91|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-10 21:19:11.619434|2017-10-10 21:19:11.619434
NCT03057535|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-15|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||Impact of NaHCO3- on Exercise Hyperpnea|Effect of Induced Metabolic Alkalosis by Sodium Bicarbonate Administration on the Ventilatory Response to Exercise in Healthy Adults|Completed||Early Phase 1|20|Actual|McGill University||2|||f||||f||||||||No||2017-10-10 21:19:49.068444|2017-10-10 21:19:49.068444
NCT03061097|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-31|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|RACE||Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization|Randomized Controlled Trial of Autologous Microbiome Reconstitution to Prevent Colonization by Antibiotic rEsistant Bacteria|Enrolling by invitation||Phase 1|180|Anticipated|Microbiome Health Research Institute||2|||f||||t|t|f||||||||2017-10-10 21:19:11.84299|2017-10-10 21:19:11.84299
NCT03061084|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-21|||August 27, 2015|Actual|2015-08-27|February 2017|2017-02-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Prospective Cohort of Transitional Urology Patients|Long Term Assessment and Outcome of Adult Patients With Congenital Genitourinary Abnormalities.|Recruiting||N/A|200|Anticipated|The Methodist Hospital System|||1||f||||f|f|f||||||No||2017-10-10 21:19:11.939422|2017-10-10 21:19:11.939422
NCT03061071|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-29|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea|A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)|Recruiting||N/A|120|Anticipated|NightBalance||2|||f||||f|f|t|t|f|f|||No||2017-10-10 21:19:12.018435|2017-10-10 21:19:12.018435
NCT03061058|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-09-13|||April 1, 2013|Actual|2013-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC|An Open-label, Randomized, Phase III, Multicenter Clinical Trial Comparing the Efficacy and Safety of Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for Advanced Gastric Cancer|Recruiting||Phase 3|240|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||f|f|f|||f|||||2017-10-10 21:19:12.164364|2017-10-10 21:19:12.164364
NCT03061045|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-15|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|July 1, 2019|Anticipated|2019-07-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus|Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus|Not yet recruiting||Phase 4|500|Anticipated|Johns Hopkins University||1|||f||||t|t|f|||f|||No||2017-10-10 21:19:12.298021|2017-10-10 21:19:12.298021
NCT03061032|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-17|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|HepCC-2||Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients|Open-label Study of Efficacy and Safety of Generic Sofosbuvir/Ledipasvir±Ribavirin in Iranian Patients With Hepatitis C Virus Genotype 1 Infection|Not yet recruiting||Phase 3|200|Anticipated|Iran Hepatitis Network||4|||f||||t|t|f|||f|||Undecided||2017-10-10 21:19:12.380881|2017-10-10 21:19:12.380881
NCT03061019|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-18|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|August 7, 2017|Anticipated|2017-08-07||Interventional|PERSIST-B||Comparison of Two Oral Myofunctional Reeducation Methods for Children With Obstructive Sleep Apnea|Comparison of Two Oral Myofunctional Reeducation Methods for Children With Obstructive Sleep Apnea Before Adenotonsillectomy : a Randomized Controlled Trial.|Enrolling by invitation||N/A|60|Anticipated|Université de Montréal||3|||f||||f|f|f||||||Undecided||2017-10-10 21:19:14.387715|2017-10-10 21:19:14.387715
NCT03061006|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-04-05|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|CAF||Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation|Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation (CAF Trial)|Recruiting||Phase 4|120|Anticipated|Intermountain Health Care, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:19:14.53251|2017-10-10 21:19:14.53251
NCT03060993|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-18|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|April 30, 2018|Anticipated|2018-04-30|January 1, 2018|Anticipated|2018-01-01||Interventional|||CAN BREATHE in COPD Trial|Effect of Inhaled Vaporized Cannabis on Pulmonary Function, Breathlessness and Exercise Tolerance in Symptomatic Patients With Advanced Chronic Obstructive Pulmonary Disease (COPD)|Not yet recruiting||Phase 2|16|Anticipated|McGill University||2|||f||||t|t|f|||f|||No||2017-10-10 21:19:14.663758|2017-10-10 21:19:14.663758
NCT03060980|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-10-04|||March 3, 2017|Actual|2017-03-03|October 2017|2017-10-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin|A Phase 3b, Randomized, Active Comparator, Open-label, Multicenter Study to Compare the Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and to Glimepiride as Add-on Therapy to Metformin in Patients With Type 2 Diabetes|Recruiting||Phase 3|930|Anticipated|Intarcia Therapeutics||3|||f||||t|t|f||||||||2017-10-10 21:19:14.812355|2017-10-10 21:19:14.812355
NCT03060967|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-05-11|||June 2017|Anticipated|2017-06-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|MOODDIS||Assessment of Hedonic and Motivational States in Major Depression ( MOODDIS)|Use of an Innovative and Easy-to-use Tool Based on the Perception of Visual Food Stimuli for Assessing Hedonic and Motivational States in Major Depression.|Not yet recruiting||N/A|72|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f|f|f||||||No||2017-10-10 21:19:15.279589|2017-10-10 21:19:15.279589
NCT03060954|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-09-21|||November 28, 2017|Anticipated|2017-11-28|February 2017|2017-02-01|April 30, 2018|Anticipated|2018-04-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Non-Inferiority Study Comparing MINI WELL READY ® and FineVision ® in Patients With Cataract Surgery|Multicentre, Controled, Randomised, Singleblind, Two-armed, Non Inferiority Trial Evaluating the Visual Performance,Quality of Vision After Bilateral Implantation of MINI WELL READY®, or FINEVISION® in Patients With Cataract Surgery|Not yet recruiting||N/A|66|Anticipated|SIFI MedTech Srl||2|||f||||t|f|f||||||||2017-10-10 21:19:15.386582|2017-10-10 21:19:15.386582
NCT03060928|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-27|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Evaluation of Tendon-to-Bone Healing Potential in Arthroscopic Rotator Cuff Repair Through Biological Stimulation|Evaluation of Tendon-to-Bone Healing Potential in Arthroscopic Rotator Cuff Repair Through Biological Stimulation|Not yet recruiting||N/A|240|Anticipated|ASST Gaetano Pini-CTO||3|||f||||t|f|f||||||Undecided||2017-10-10 21:19:15.763569|2017-10-10 21:19:15.763569
NCT03060915|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-27|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Actigraphy Sleep Parameters in Obstructive Sleep Apnea Patient's|Comparison of Actigraphy Sleep Parameters vs Polysomnography Sleep Parameters in OSA Patient's|Recruiting||N/A|100|Anticipated|Hospital Clinic of Barcelona||1|||f||||f|f|f||||||No||2017-10-10 21:19:15.939761|2017-10-10 21:19:15.939761
NCT03060902|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-01|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder|Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder|Not yet recruiting||N/A|200|Anticipated|University of Oregon||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:16.053004|2017-10-10 21:19:16.053004
NCT03060889|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-21|||February 2016||2016-02-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa|Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa: A Randomized Controlled Trial|Completed||Phase 3|86|Actual|Ain Shams University||2|||f||||t||||||||Undecided||2017-10-10 21:19:16.146773|2017-10-10 21:19:16.146773
NCT03060876|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-02-21|||June 2016|Actual|2016-06-01|June 2016|2016-06-01|June 2025|Anticipated|2025-06-01|June 2021|Anticipated|2021-06-01|5 Years|Observational [Patient Registry]|HHR||Hanover Humerus Registry|Prospective Register Study of Patients After Proximal Humerus and Humerus Shaft Fracture for Data Collection of Healing Process, Quality of Life and Shoulder Function According to the Treatment Method - Hanover Humerus Register (HHR)|Recruiting||N/A|1000|Anticipated|Hannover Medical School|||1||f||||t||||||||||2017-10-10 21:19:16.228273|2017-10-10 21:19:16.228273
NCT03060863|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-22|||September 1, 2015|Actual|2015-09-01|February 2017|2017-02-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||ABC Brain Games Self-Regulation Intervention|Targeting Self-Regulation to Promote Adherence and Health Behaviors in Children|Recruiting||N/A|200|Anticipated|University of Michigan||5|||f||||t|f|f||||||No||2017-10-10 21:19:16.350719|2017-10-10 21:19:16.350719
NCT03060850|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-29|||March 17, 2017|Actual|2017-03-17|September 2017|2017-09-01|February 14, 2020|Anticipated|2020-02-14|February 14, 2019|Anticipated|2019-02-14||Interventional|||A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL|A Phase I Study of AC0010 in Patients With Relapsed or Refractory CLL/SLL, MCL, DLBCL and Other Non-Hodgkin B-Cell Lymphoma|Recruiting||Phase 1|184|Anticipated|Hangzhou ACEA Pharmaceutical Research Co.,Ltd.||1|||f||||f|f|f||||||||2017-10-10 21:19:16.511422|2017-10-10 21:19:16.511422
NCT03060837|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-03|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|September 1, 2017|Anticipated|2017-09-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Investigate the Renal Movement by Single Lung Ventilation in Patients Administered RIRS for Kidney Stones.|To Investigate the Effect of Reducing Renal Movement by Single Lung Ventilation in Patients Administered Retrograde Infrarenal Surgery (RIRS) for Kidney Stones on Operative and Postoperative Parameters|Recruiting||N/A|80|Anticipated|Kahramanmaras Sutcu Imam University||2|||f||||f|f|f||||||No||2017-10-10 21:19:16.657001|2017-10-10 21:19:16.657001
NCT03060824|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-06|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|||Changes in Plasma Osmolality Related to the Use of Cardiopulmonary Bypass With Hyperosmolar Prime.|Changes in Plasma Osmolality Related to the Use of Cardiopulmonary Bypass With Hyperosmolar Prime, an Observational Study.|Recruiting||N/A|30|Anticipated|Umeå University|||1||f||||f|f|f||||||Undecided|Data will be shared after reviewing final results after study completion at this site and through publication in a scientific journal.|2017-10-10 21:19:16.79088|2017-10-10 21:19:16.79088
NCT03060811|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-24|||September 22, 2016|Actual|2016-09-22|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|December 22, 2016|Actual|2016-12-22||Observational|TMED||Mediterranean Diet, Trimethylamine N-oxide (TMAO) and Anti-oxidants in Healthy Adults|Mediterranean Diet, Trimethylamine N-oxide (TMAO) and Anti-oxidants in Healthy Adults|Completed||N/A|50|Actual|Federico II University|||1||f||||f|f|f||||||No||2017-10-10 21:19:16.894558|2017-10-10 21:19:16.894558
NCT03060798|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-02-21|||August 2, 2016|Actual|2016-08-02|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||The Change of Tissue Oxygen Saturation Following Volatile Anesthesia|The Change of Tissue Oxygen Saturation Measured by Dynamic Near Infrared Spectroscopy Following Volatile Anesthesia in Healthy Population|Recruiting||N/A|57|Anticipated|Pusan National University Hospital|||1||f||||t|t|t|f|f|f|||No||2017-10-10 21:19:16.957313|2017-10-10 21:19:16.957313
NCT03060785|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-24|||March 8, 2016|Actual|2016-03-08|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women|Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women|Recruiting||Phase 1|16|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||No||2017-10-10 21:19:17.041323|2017-10-10 21:19:17.041323
NCT03060772|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-09-07|||October 10, 2017|Anticipated|2017-10-10|September 2017|2017-09-01|March 20, 2019|Anticipated|2019-03-20|March 20, 2019|Anticipated|2019-03-20||Interventional|APPEAL||A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)|A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)|Not yet recruiting||Phase 2|36|Anticipated|Emory University||3|||f||||t|t|f||||||||2017-10-10 21:19:17.275132|2017-10-10 21:19:17.275132
NCT03060759|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-04-27|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|March 14, 2018|Anticipated|2018-03-14|December 31, 2017|Anticipated|2017-12-31||Interventional|||Light Therapy as Treatment for Fatigue in Multiple Sclerosis|Light Therapy as Treatment for Fatigue in Multiple Sclerosis|Recruiting||N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:19:17.445301|2017-10-10 21:19:17.445301
NCT02996708|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||January 2014||2014-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Assessment of the Benefit of Teleconsultations for Children With Autism Spectrum Disorders||Recruiting||N/A|102|Anticipated|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||||No||2017-10-10 21:31:16.638355|2017-10-10 21:31:16.638355
NCT03060746|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-15|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects|Helicobacter Pylori Sample Collection Protocol PRE-THERAPY|Recruiting||N/A|280|Anticipated|DiaSorin Inc.|||1||f|||||f|||||Samples Without DNA|"     Human Stool   "|||2017-10-10 21:19:17.602375|2017-10-10 21:19:17.602375
NCT03060733|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-15|||February 14, 2017|Actual|2017-02-14|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects|Helicobacter Pylori Sample Collection Protocol POST-THERAPY|Recruiting||N/A|100|Anticipated|DiaSorin Inc.|||1||f|||||f|||||Samples Without DNA|"     Human Stool   "|||2017-10-10 21:19:17.712498|2017-10-10 21:19:17.712498
NCT03060720|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-17|||February 2017||2017-02-01|February 2017|2017-02-01|February 2022|Anticipated|2022-02-01|February 2020|Anticipated|2020-02-01||Observational|||Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy|Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy|Not yet recruiting||N/A|375|Anticipated|Dana-Farber Cancer Institute|||1||f||||t||||||||No||2017-10-10 21:19:17.783367|2017-10-10 21:19:17.783367
NCT03060707|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-04-24|||March 23, 2017|Actual|2017-03-23|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|RCVB||Continuous Infusion Versus Intermittent Bolus Injection of Rocuronium|Comparison of Hourly Rocuronium Consumption Using Continuous Infusion Versus Intermittent Bolus Injection: a Randomized Controlled Trial|Recruiting||Phase 4|70|Anticipated|Seoul National University Hospital||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:19:17.856552|2017-10-10 21:19:17.856552
NCT03060694|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-19|2017-03-16|||September 2016||2016-09-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|February 2017|Actual|2017-02-01|1 Day|Observational [Patient Registry]|||Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements|Screening Inpatients With Type 2 Diabetes for Nonalcoholic Fatty Liver Disease Using Controlled Attenuation Parameter and Liver Stiffness Measurements|Active, not recruiting||N/A|58|Actual|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||2||f||||f||||||||No||2017-10-10 21:19:17.934739|2017-10-10 21:19:17.934739
NCT03060681|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-03-07|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|February 20, 2018|Anticipated|2018-02-20|February 20, 2018|Anticipated|2018-02-20||Interventional|TLIP||Thoracolumber Oterfacial Plane Block for Spine Surgery|Thoracolumbar Interfacial Plane Block for Analgesia After Spine Surgery|Recruiting||N/A|40|Anticipated|Mansoura University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:19:18.016852|2017-10-10 21:19:18.016852
NCT03060668|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-21|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Optimized Caloric-proteic Nutrition in Critically Ill Patients|Optimized Caloric-proteic Nutrition in Critically Ill Patients: Impact on Short and Long-term Outcomes|Recruiting||N/A|294|Anticipated|Hospital Sao Domingos||2|||f||||t|f|f||||||No||2017-10-10 21:19:18.086799|2017-10-10 21:19:18.086799
NCT03060655|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-02-21|||August 2016||2016-08-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of PLGA-Mg Material in Clinical Orthopedics|Randomized, Double Blind Trial of Study of PLGA-Mg Material in Clinical Orthopedics|Recruiting||Phase 2|40|Anticipated|Hebei Medical University Third Hospital||2|||f||||t||||||||Yes||2017-10-10 21:19:18.189253|2017-10-10 21:19:18.189253
NCT03060642|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-24|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2020|Anticipated|2020-04-01||Observational|BETRNet2||The Microenvironment in Barrett's Esophagus|Application of the Microbiome and Microenvironment to Novel Non-Endoscopic Screening and Surveillance in Barrett's Esophagus|Not yet recruiting||N/A|150|Anticipated|Columbia University|||2||f||||f|f|t|t|f|f|Samples With DNA|"     Saliva Gastric Aspirate Tissue from the Esophagus   "|||2017-10-10 21:19:18.279878|2017-10-10 21:19:18.279878
NCT03060616|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-06|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Validation of Hemorrhoidal Bleeding Score|Validation of Hemorrhoidal Bleeding Score|Recruiting||N/A|100|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||No||2017-10-10 21:19:18.606514|2017-10-10 21:19:18.606514
NCT03060603|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-23|||February 23, 2017|Actual|2017-02-23|February 2017|2017-02-01|March 30, 2017|Anticipated|2017-03-30|March 25, 2017|Anticipated|2017-03-25||Observational|||Proliferative Effects of Erythropoietin on Human Endometrium|Proliferative Effects of Erythropoietin on Human Endometrium|Recruiting||N/A|20|Anticipated|Fatih Sultan Mehmet Training and Research Hospital|||1||f||||f||||||||Yes||2017-10-10 21:19:18.676247|2017-10-10 21:19:18.676247
NCT03060590|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-25|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Roles of Uremic Toxins in Uremic Sacropenia|Association of Uremic Toxins and Sacropenia in Hemodialysis Patients|Recruiting||N/A|300|Anticipated|Tungs’ Taichung Metroharbour Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:19:18.81529|2017-10-10 21:19:18.81529
NCT03060577|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-09-14|||March 24, 2017|Actual|2017-03-24|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|January 2018|Anticipated|2018-01-01||Interventional|||An Extension Trial of Inclisiran Compared to Evolocumab in Participants With Cardiovascular Disease and High Cholesterol|An Open Label, Active Comparator Extension Trial to Assess the Effect of Long Term Dosing of Inclisiran and Evolocumab Given as Subcutaneous Injections in Participants With High Cardiovascular Risk and Elevated LDL-C (ORION-3)|Recruiting||Phase 2|490|Anticipated|The Medicines Company||2|||f||||t|t|f||||||||2017-10-10 21:19:18.909118|2017-10-10 21:19:18.909118
NCT02994433|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-14|||July 2016||2016-07-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Interventional|||NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits|NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits|Recruiting||Phase 1|40|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 21:31:37.758443|2017-10-10 21:31:37.758443
NCT03060564|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-17|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Reconstruction Of Acute Coracoclavicular Ligament Disruption With and Without Tendon Graft|A Randomized, Prospective Trial Comparing Reconstruction Of Acute Coracoclavicular Ligament Disruption With and Without Tendon Graft|Not yet recruiting||N/A|150|Anticipated|Cedars-Sinai Medical Center||2|||f||||f|f|f|||t|||No||2017-10-10 21:19:19.125434|2017-10-10 21:19:19.125434
NCT03060551|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-21|||October 2016||2016-10-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|March 2017|Anticipated|2017-03-01||Interventional|||Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients|Safety, Tolerability and Potential Efficacy of Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients|Active, not recruiting||Phase 1|50|Anticipated|Seoul St. Mary's Hospital||1|||f||||f||||||||No||2017-10-10 21:19:19.199543|2017-10-10 21:19:19.199543
NCT03060538|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-09-20|||March 5, 2017|Actual|2017-03-05|September 2017|2017-09-01|June 22, 2018|Anticipated|2018-06-22|June 22, 2018|Anticipated|2018-06-22||Interventional|||A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus|A Phase Ib, Randomized, Blinded, Placebo-Controlled, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous BFKB8488A in Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 1|140|Anticipated|Genentech, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:19:19.267473|2017-10-10 21:19:19.267473
NCT03060525|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-07-17|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|DWW2||Deaf Weight Wise 2.0: A Healthy Lifestyle Intervention With Deaf Adults Who Are Overweight or Obese|Deaf Weight Wise 2.0: Clinical Trial of a Healthy Lifestyle Intervention With Deaf Adults Ages 21 to 70|Recruiting||N/A|132|Anticipated|University of Rochester||4|||f||||t||||||||||2017-10-10 21:19:19.489403|2017-10-10 21:19:19.489403
NCT03060512|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-09-07|||March 2, 2017|Actual|2017-03-02|September 2017|2017-09-01|August 23, 2017|Actual|2017-08-23|August 23, 2017|Actual|2017-08-23||Interventional|||To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation|A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment|Completed||Phase 4|273|Actual|AstraZeneca||2|||f||||f|t|f||||||||2017-10-10 21:19:19.621685|2017-10-10 21:19:19.621685
NCT03060499|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-02|||October 13, 2016|Actual|2016-10-13|April 2017|2017-04-01|October 13, 2018|Anticipated|2018-10-13|October 13, 2017|Anticipated|2017-10-13||Observational|TECH||Post Thyroidectomy Myocardial Function|Post Thyroidectomy Myocardial Function|Recruiting||N/A|50|Anticipated|Aristotle University Of Thessaloniki|||1||f||||f|f|f||||||No||2017-10-10 21:19:19.845602|2017-10-10 21:19:19.845602
NCT03060486|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-21|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|January 17, 2017|Actual|2017-01-17|January 10, 2017|Actual|2017-01-10||Interventional|||A New Approach for Controlling Hemostasis During Canal Treatment: a Pilot Study|A New Approach for Controlling Hemostasis During Canal Treatment: a Pilot Study|Completed||N/A|33|Actual|Azienda Ospedaliero-Universitaria Careggi||1|||f|||||f|t|f|f|t|||No||2017-10-10 21:19:19.946605|2017-10-10 21:19:19.946605
NCT03060473|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-26|||February 23, 2017|Actual|2017-02-23|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|TREAT||Treatment of ppROM With Erythromycin vs. Azithromycin Trial|TREAT: Treatment of ppROM With Erythromycin vs. Azithromycin Trial|Recruiting||Phase 3|324|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t|t|f|||t|||||2017-10-10 21:19:20.030626|2017-10-10 21:19:20.030626
NCT03060460|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-04-28|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|ACCESS-II||Ultrasound Guided Insertion of Sheath Before Angiography or Angioplasty|Randomized Evaluation of Traditional Versus Ultrasound Guided Insertion of Sheath Before Angiography or Angioplasty|Recruiting||N/A|600|Anticipated|Aarhus University Hospital Skejby||3|||f||||t|f|f||||||No|Anonymous data can be shared|2017-10-10 21:19:20.15366|2017-10-10 21:19:20.15366
NCT03060434|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-08-26|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pentoxifylline and Lumbar Radiculopathy|Prospective Controlled Crossover Study of the Role of Pentoxifylline in the Management of Lumbar Radiculopathy|Recruiting||Phase 4|70|Anticipated|St Joseph University, Beirut, Lebanon||2|||f||||f|f|f||||||||2017-10-10 21:19:20.37035|2017-10-10 21:19:20.37035
NCT03060421|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-31|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|||Evaluation of the Safety of Intraarticular Aquamid Reconstruction Injection for Knee Osteoarthritis in Humans|Evaluation of the Safety of Intraarticular Aquamid Reconstruction Injection for Knee Osteoarthritis in Humans|Completed||N/A|91|Actual|Frederiksberg University Hospital|||1||f||||f|f|f||||||||2017-10-10 21:19:20.483476|2017-10-10 21:19:20.483476
NCT03060408|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-21|||June 2016||2016-06-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|||Comparison of Fluid Requirements in Pancreatectomy: Laparotomy vs. Laparoscopy|Comparison of Intraoperative Basal Fluid Requirements in Distal Pancreatectomy - Laparotomy vs. Laparoscopy: A Retrospective Cohort Study|Completed||N/A|304|Actual|Seoul National University Bundang Hospital|||2||f||||||||||||||2017-10-10 21:19:20.567586|2017-10-10 21:19:20.567586
NCT03060395|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-07|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of A2 Milk on Gastrointestinal Function in Non-lactose Milk Intolerance|Effects of A2 Milk on Gastrointestinal Function of Volunteers Affected by Non-lactose Milk Intolerance|Recruiting||N/A|50|Anticipated|University of Reading||2|||f||||f|f|f||||||||2017-10-10 21:19:20.637592|2017-10-10 21:19:20.637592
NCT03060382|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-06-22|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Treatment of Knee Osteoarthritis With Balanced Buttress Absorbable Spacer|The Treatment of Knee Osteoarthritis With Balanced Buttress Absorbable Spacer|Recruiting||Phase 3|150|Anticipated|Hebei Medical University Third Hospital||2|||f||||t|f|f||||||Yes||2017-10-10 21:19:20.765566|2017-10-10 21:19:20.765566
NCT03060369|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-02-21|||June 2012|Actual|2012-06-01|February 2017|2017-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||BWH Critical Care Study of CareGuide for Evaluation of Emerging or Established Shock|BWH Critical Care Study of CareGuide for Evaluation of Emerging or Established Shock|Active, not recruiting||N/A|50|Anticipated|Brigham and Women's Hospital|||2||f||||f|f|f||||||Undecided||2017-10-10 21:19:20.854882|2017-10-10 21:19:20.854882
NCT03060356|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-17|||December 21, 2016|Actual|2016-12-21|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)|Clinical Trial of Autologous cMET Redirected T Cells Administered Intravenously in Patients With Melanoma & Breast Carcinoma|Recruiting||Early Phase 1|10|Anticipated|University of Pennsylvania||2||||||||t|f||||||Undecided||2017-10-10 21:19:20.93885|2017-10-10 21:19:20.93885
NCT03060343|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-18|||November 28, 2016|Actual|2016-11-28|February 2017|2017-02-01|November 28, 2019|Anticipated|2019-11-28|November 28, 2018|Anticipated|2018-11-28||Interventional|||Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)|Preliminary Clinical Study of Autologous T Cells Modified Chimeric Antigen Receptor (CAR) Targeting PD-L1 and CD80/CD86 (Zeushield Cytotoxic T Lymphocytes) for the Treatment of Recurrent or Refractory Non Small Cell Lung Cancer|Recruiting||Early Phase 1|10|Anticipated|Second Xiangya Hospital of Central South University||1|||f|||||f|f||||||Undecided||2017-10-10 21:19:21.031592|2017-10-10 21:19:21.031592
NCT03060330|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-01|||April 26, 2017|Actual|2017-04-26|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Laparoscopic Ventral Mesh Rectopexy Combined With or Without Stapled Trans-anal Rectal Resection for Obstructed Defecation Syndrome|Obstructed Defecation Caused by Rectal Prolapse and Rectocele: Laparoscopic Ventral Rectopexy Alone Versus Laparoscopic Ventral Rectopexy Combined With Stapled Trans-anal Rectal Resection|Recruiting||N/A|40|Anticipated|Renmin Hospital of Wuhan University||2|||f||||f|f|f||||||No||2017-10-10 21:19:21.128204|2017-10-10 21:19:21.128204
NCT03060317|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-07-17|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|July 12, 2017|Actual|2017-07-12|July 12, 2017|Actual|2017-07-12||Observational|||Validation of the Russian Version of Coma Recovery Scale-Revised (CRS-R)|Validation of the Russian Version of Coma Recovery Scale-Revised (CRS-R)|Completed||N/A|60|Actual|Research Center of Neurology, Russia|||1||f||||t|f|f||||||||2017-10-10 21:19:21.203364|2017-10-10 21:19:21.203364
NCT03060304|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-18|2017-02-22|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.|The Effect of Tamoxifen on Endometrial Thickness and Pregnancy Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.|Not yet recruiting||Phase 4|100|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 21:19:21.277558|2017-10-10 21:19:21.277558
NCT03060291|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-09-17|||February 21, 2017|Actual|2017-02-21|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Prevention of Substance Use in At-Risk Students: A Family-Centered Web Program|Prevention of Substance Use in At-Risk Students: A Family-Centered Web Program|Recruiting||N/A|300|Anticipated|University of Oregon||3|||f||||f|f|f||||||||2017-10-10 21:19:21.361352|2017-10-10 21:19:21.361352
NCT03060278|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-06-13|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 19, 2017|Actual|2017-05-19||Interventional|AVAST-FRC||Smartphone-delivered Automated Video-assisted Smoking Treatment for Patrons of a Food Resource Center|Smartphone-delivered Automated Video-assisted Smoking Treatment for Patrons of a Food Resource Center: Project AVAST - FRC|Active, not recruiting||Phase 4|20|Actual|University of Oklahoma||2|||f||||f|f|f||||||No||2017-10-10 21:19:21.458811|2017-10-10 21:19:21.458811
NCT03060265|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-17|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Protective Analgesia in Caesarean Section Using Intravenous Paracetamol|Protective Analgesia in Caesarean Section Using Intravenous Paracetamol: A Prospective Randomised Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Bnai Zion Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:19:21.539377|2017-10-10 21:19:21.539377
NCT03060252|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-25|||March 25, 2017|Anticipated|2017-03-25|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|8 Weeks|Observational [Patient Registry]|||Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill|A Registry Study to Surveil Early Liver Injuries Caused by Zhuanggu Guanjie Pill (ZGGJ Pill)|Not yet recruiting||N/A|1000|Anticipated|Beijing 302 Hospital|||1||f||||t||||||Samples With DNA|"     serum, plasma, histology and urine.   "|Undecided||2017-10-10 21:19:21.608071|2017-10-10 21:19:21.608071
NCT03060239|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-25|||April 11, 2017|Actual|2017-04-11|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|NIRS-RBD||Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRS|Exploration of the Mechanism of Movement Improvement During Rapid Eye Movement (REM) Sleep Behaviour Disorder (RBD) in Parkinson's Disease Using Near-infrared Spectroscopy (NIRS)|Recruiting||N/A|13|Anticipated|Clinique Beau Soleil||1|||f|||||f|f||||||||2017-10-10 21:19:21.668221|2017-10-10 21:19:21.668221
NCT03060226|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-17|||February 9, 2017|Actual|2017-02-09|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PAESCART||Prediction of Appearance of Late Cutaneous Side Effects After RadioTherapy|Prediction of Appearance of Late Cutaneous Side Effects After RadioTherapy|Recruiting||N/A|20|Anticipated|Centre Francois Baclesse||2|||f||||f|f|f||||||No||2017-10-10 21:19:21.733604|2017-10-10 21:19:21.733604
NCT03060213|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-08-04|||March 6, 2017|Actual|2017-03-06|August 2017|2017-08-01|July 15, 2017|Actual|2017-07-15|July 15, 2017|Actual|2017-07-15||Interventional|||Fun For Wellness: Online Well-Being Promotion Intervention in a Patient Sample|Fun For Wellness Online Intervention to Promote Multidimensional Well-Being: A Randomized Controlled Trial in a Community-Based Patient Sample|Completed||N/A|19|Actual|University of Miami||2|||f||||f|f|f||||||||2017-10-10 21:19:21.802594|2017-10-10 21:19:21.802594
NCT03055650|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-25|||December 7, 2015||2015-12-07||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:20:06.856089|2017-10-10 21:20:06.856089
NCT03060200|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-07-12|||February 17, 2017|Actual|2017-02-17|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Reducing Depressive Symptomatology With a Smartphone App|Reducing Depressive Symptomatology With a Smartphone App: A Protocol for a Randomized, Placebo-Controlled Clinical Trial|Recruiting||N/A|220|Anticipated|Babes-Bolyai University||3|||f||||f|f|f||||||||2017-10-10 21:19:21.890863|2017-10-10 21:19:21.890863
NCT03060187|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-17|||February 2010|Actual|2010-02-01|February 2017|2017-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Proposal and Clinical Evaluation of a Comprehensive Airway Exam Score|"The KU Score: Proposal and Clinical Evaluation of a Comprehensive Airway Exam Score; an Observational Study"|Completed||N/A|2000|Actual|University of Kansas Medical Center|||1||f||||f|f|f||||||||2017-10-10 21:19:21.976774|2017-10-10 21:19:21.976774
NCT03060174|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-07-11|||May 2014||2014-05-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|DelPOCD||Study of Prevention of Postoperative Delirum to Reduce Incidence of Postoperative Cognitive Dysfunction|The Influence of Non-medication-based Prophylaxis of Postoperative Delirium on Postoperative Delirium and Cognitive Deficit|Recruiting||N/A|638|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 21:19:22.034269|2017-10-10 21:19:22.034269
NCT03060161|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-17|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HRM||Health in the Right Measure: Promoting Healthy Food and Regular Physical Activity Practice for UFRJ Servers|Health in the Right Measure: Promoting Healthy Food and Regular Physical Activity Practice for UFRJ Server|Not yet recruiting||N/A|60|Anticipated|Universidade Federal do Rio de Janeiro||1|||f||||f|f|f||||||No||2017-10-10 21:19:22.117958|2017-10-10 21:19:22.117958
NCT03060148|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-07|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Spinal Cord Stimulation in Heart Failure|The Treatment of Spinal Cord Stimulation in Severe Heart Failure|Not yet recruiting||N/A|15|Anticipated|Chang Gung Memorial Hospital||2|||f||||t|f|t|t|f|t|||No||2017-10-10 21:19:22.342955|2017-10-10 21:19:22.342955
NCT03060135|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-13|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparing the Efficacy of Several Popular Online Interventions to Reduce Hazardous Alcohol Consumption|Comparing the Efficacy of Several Popular Online Interventions to Reduce Hazardous Alcohol Consumption: Randomized Controlled Trial|Active, not recruiting||N/A|878|Actual|Centre for Addiction and Mental Health||3|||f||||f|f|f||||||No||2017-10-10 21:19:22.443387|2017-10-10 21:19:22.443387
NCT03060122|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-11|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Combining CES Alpha-Stim and InterX for Optimized Rehabilitation Following Extremity Immobilization|The Clinical Feasibility of Combining Cranial Electrotherapy Stimulation (CES Alpha-Stim) and Non-invasive Interactive Neurostimulation (InterX) for Optimized Rehabilitation Following Extremity Immobilization|Not yet recruiting||N/A|94|Anticipated|Brooke Army Medical Center||3|||f||||f|f|f|||f|||||2017-10-10 21:19:22.539581|2017-10-10 21:19:22.539581
NCT03060109|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-09-28|||June 21, 2016|Actual|2016-06-21|September 2017|2017-09-01|September 10, 2017|Actual|2017-09-10|September 10, 2017|Actual|2017-09-10||Observational|FIRST DOWN||Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development With Philips Point of Care System|Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development With Philips Point of Care System (FIRST DOWN)|Terminated||N/A|317|Actual|Banyan Biomarkers, Inc|||1|"Diagnostic platform no longer under development; study termination not related to any safety   issues"|f||||f|f|f||||||||2017-10-10 21:19:23.16823|2017-10-10 21:19:23.16823
NCT03060096|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-01|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|Telehealth||Stepped-Care Telehealth for Distress in Rural Cancer Survivors|Stepped-Care Telehealth for Distress in Rural Cancer Survivors|Not yet recruiting||N/A|120|Anticipated|Wake Forest University Health Sciences||4|||f||||t|f|f||||||||2017-10-10 21:19:23.257144|2017-10-10 21:19:23.257144
NCT03060083|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-21|||February 8, 2017|Actual|2017-02-08|February 2017|2017-02-01|November 30, 2017|Anticipated|2017-11-30|October 31, 2017|Anticipated|2017-10-31||Interventional|||Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day|A Randomized Trial to Compare Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day|Recruiting||Phase 2/Phase 3|74|Anticipated|University of Vermont||2|||f||||f|t|f||||||No||2017-10-10 21:19:23.375188|2017-10-10 21:19:23.375188
NCT03060070|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-07-01|||March 10, 2017|Actual|2017-03-10|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|June 25, 2017|Actual|2017-06-25||Interventional|||Ketamine Versus Dexmedetomidine With Local Anesthetic in TAP Block|Comparison of the Analgesic Effect of Ketamine Versus Dexmedetomidine Added to Local Anesthetic in TAP Block for Lower Abdominal Cancer Surgery|Completed||Phase 2/Phase 3|90|Actual|Assiut University||3|||f|||||f|f|||f|||||2017-10-10 21:19:23.499301|2017-10-10 21:19:23.499301
NCT03060057|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-05-04|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|March 30, 2024|Anticipated|2024-03-30|March 30, 2019|Anticipated|2019-03-30||Observational|U-Propel||"Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - U-Propel Study"|"Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - U-Propel Study"|Recruiting||N/A|200|Anticipated|United Orthopedic Corporation|||1||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:19:23.61274|2017-10-10 21:19:23.61274
NCT03060044|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-03-02|||July 2016|Actual|2016-07-01|August 2016|2016-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus|Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus 50/500 µg/Inhalation: A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|64|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||Undecided||2017-10-10 21:19:23.722194|2017-10-10 21:19:23.722194
NCT03060031|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-16|||January 25, 2017|Actual|2017-01-25|February 2017|2017-02-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain|Effects of Oxytocin Administration on Social Influence Effects on Pain|Recruiting||Phase 1|70|Anticipated|University of Colorado, Boulder||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:23.833479|2017-10-10 21:19:23.833479
NCT03060018|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-08-18|||August 17, 2017|Actual|2017-08-17|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|August 1, 2018|Anticipated|2018-08-01||Interventional|OxiVenT||Transcutaneous Partial Oxygen and Carbon Dioxide Pressures Compared With Blood Gas Values|Agreement of Transcutaneous Partial Oxygen and Carbon Dioxide Pressure With Arterial and Capillary Blood Gas Values. A Single Centre Prospective Non-randomized Trial in Critically Ill Neonates.|Recruiting||N/A|120|Anticipated|University Children's Hospital, Zurich||1|||f||||f|f|f||||||||2017-10-10 21:19:23.967051|2017-10-10 21:19:23.967051
NCT03060005|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-05-14|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?|Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?|Recruiting||N/A|80|Anticipated|Tung Wah Hospital||4|||f||||f|f|f||||||||2017-10-10 21:19:24.06573|2017-10-10 21:19:24.06573
NCT03059992|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-10-05|||April 1, 2017|Actual|2017-04-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|FURI||Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases|Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)|Recruiting||Phase 3|60|Anticipated|Scynexis, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:19:24.220765|2017-10-10 21:19:24.220765
NCT03059979|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-16|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )|Hit Hard and Early. The Effect of High Dose Methylprednisolone on Nailfold Capillary Changes and Biomarkers in Early SSc: a 12-week Randomised Explorative Double-blind Placebo-controlled Trial.|Enrolling by invitation||Early Phase 1|30|Actual|Radboud University||2|||f||||t||||||||Undecided||2017-10-10 21:19:24.388258|2017-10-10 21:19:24.388258
NCT03059966|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-16|||March 2014||2014-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Evaluation of the Inflammatory and Healing Profile After Root Coverage With Emdogain®|Evaluation of the Inflammatory and Healing Profile After Root Coverage With Emdogain®|Completed||Phase 4|16|Actual|Rio de Janeiro State University||2|||f||||f|t|f|||f|||No||2017-10-10 21:19:24.538564|2017-10-10 21:19:24.538564
NCT03059953|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-04-07|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|APRAISAL||A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)|A Non-interventional, Prospective, Observational Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)|Recruiting||N/A|300|Anticipated|Genesis Pharma S.A.|||1||f|||||f|f||||||||2017-10-10 21:19:24.630033|2017-10-10 21:19:24.630033
NCT03059940|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-16|||June 16, 2017|Actual|2017-06-16|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer|Optimizing Effectiveness of Smoking Cessation Intervention During Low Dose CT Screening for Lung Cancer|Recruiting||Early Phase 1|1260|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:19:24.721812|2017-10-10 21:19:24.721812
NCT03059927|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-19|||March 1, 2017|Actual|2017-03-01|February 2017|2017-02-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Interventional|||The Effect of Three Prosthesis Designs in Total Knee Arthroplasty|The Effect of Three Prosthesis Designs on Implant Stability and Survival, Knee Function, and Clinical Course in Knee Arthroplasty: a Randomized Trial|Recruiting||N/A|216|Anticipated|Lovisenberg Diakonale Hospital||3|||f||||f|f|f||||||No||2017-10-10 21:19:24.889073|2017-10-10 21:19:24.889073
NCT03059914|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-10|||August 10, 2017|Actual|2017-08-10|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||A Histomorphometric Analysis Following Sinus Augmentation Using Two Different Bone Graft Materials.|A Histomorphometric Analysis of New Bone Formation Following Sinus Augmentation Using Two Different Bone Graft Materials. A Pilot Study in Humans.|Recruiting||N/A|20|Anticipated|Loma Linda University||2|||f||||f|f|t|f|f|t|||||2017-10-10 21:19:25.025595|2017-10-10 21:19:25.025595
NCT03059901|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-07-24|||August 4, 2015|Actual|2015-08-04|July 2017|2017-07-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Caminamos: A Smartphone App to Connect With Walking Partners|Caminamos: A Location-based Smartphone App for Latinas to Connect With Nearby Walking Partners|Completed||N/A|60|Actual|Klein Buendel, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:19:25.149037|2017-10-10 21:19:25.149037
NCT03059888|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-15|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Trial of Orencia in Patients With Myasthenia Gravis|Pilot Trial of Orencia in Myasthenia Gravis Patients Inadequately Responsive to Conventional Immunotherapy|Recruiting||Early Phase 1|20|Anticipated|Johns Hopkins University||1|||f||||t|t|f|||f|||||2017-10-10 21:19:25.303821|2017-10-10 21:19:25.303821
NCT03059875|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-09|||January 2014||2014-01-01|June 2017|2017-06-01|April 30, 2022|Anticipated|2022-04-30|December 2018|Anticipated|2018-12-01||Interventional|||Place of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter)|Place of Comprehensive Geriatric Assessment (CGA) in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter): Comparison Between CGA Before Surgery (Strategy A) vs. After Surgery (Strategy B)|Recruiting||N/A|390|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 21:19:25.429065|2017-10-10 21:19:25.429065
NCT03059862|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-28|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Interventional|Aryl-IMMUNE||The Role of Dietary Tryptophan on Aryl Hydrocarbon Receptor Activation|The Role of Tryptophan on Aryl Hydrocarbon Receptor Activation: a Randomized, Double Blind, Placebo-controlled, Crossover Design Pilot Trial|Not yet recruiting||N/A|20|Anticipated|McMaster University||2|||f||||t|f|f||||||||2017-10-10 21:19:25.582963|2017-10-10 21:19:25.582963
NCT03059849|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-16|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|September 1, 2018|Anticipated|2018-09-01|May 1, 2018|Anticipated|2018-05-01||Interventional|BEAT-IBD||Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD|Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD|Not yet recruiting||Phase 4|290|Anticipated|McMaster University||2|||f||||f|t|f|||f|||No||2017-10-10 21:19:25.721069|2017-10-10 21:19:25.721069
NCT03059836|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||February 28, 2017|Anticipated|2017-02-28|February 2017|2017-02-01|March 28, 2018|Anticipated|2018-03-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||n3 PUFA and Muscle-disuse Atrophy in Young Women|Effects of n3 PUFA Supplementation on the Attenuation of Muscle Disuse Atrophy in Young Women|Not yet recruiting||N/A|20|Anticipated|McMaster University||2|||f||||f|f|f||||||No||2017-10-10 21:19:25.819594|2017-10-10 21:19:25.819594
NCT03059823|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-19|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase 1 Study of MGA012 in Patients With Advanced Solid Tumors|A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of MGA012 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|125|Anticipated|MacroGenics||3|||f||||f|t|f||||||||2017-10-10 21:19:25.915894|2017-10-10 21:19:25.915894
NCT03058718|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-16|||January 1, 2014|Actual|2014-01-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|July 1, 2016|Actual|2016-07-01||Interventional|||Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis|Effectiveness of Procalcitonin-Guided Antibiotic Therapy in Acute Exacerbations of Bronchiectasis: a Randomized Controlled Trial|Completed||N/A|210|Actual|Qilu Hospital of Shandong University||2|||f|||||f|f||||||||2017-10-10 21:19:26.011974|2017-10-10 21:19:26.011974
NCT03058705|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-07-18|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Near Infrared Fluorescence Imaging for Bladder Cancer Detection|Pilot Study: Assessing Near Infrared Fluorescence Imaging Medical Technology for the Detection of Bladder Cancer|Not yet recruiting||N/A|10|Anticipated|University of Rochester||1|||f||||f|f|f|||t|||||2017-10-10 21:19:26.094159|2017-10-10 21:19:26.094159
NCT03058692|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-10-05|||October 26, 2017|Anticipated|2017-10-26|February 2, 2017|2017-02-02|September 1, 2018|Anticipated|2018-09-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Two Doses of Multimeric-001 (M-001) Followed by Two Doses of an Influenza A/H7N9 Vaccine|A Phase II, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial to Assess the Safety, Reactogenicity and Immunogenicity of Two Doses of Multimeric-001 (M-001) Followed by Two Doses of an Influenza A/H7N9 Vaccine Administered With or Without MF59 Adjuvant|Not yet recruiting||Phase 2|240|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f|||||t|f|||f|||||2017-10-10 21:19:26.173364|2017-10-10 21:19:26.173364
NCT03058666|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-08|||March 29, 2017|Actual|2017-03-29|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 1, 2018|Anticipated|2018-12-01||Interventional|||Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients|Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients|Recruiting||Phase 3|658|Anticipated|ONY||2|||f||||t|t|t|t|f||||||2017-10-10 21:19:26.379739|2017-10-10 21:19:26.379739
NCT03058653|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-24|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of a Mini-fluid Bolus to Identify Fluid Responsiveness|Use of a Mini-fluid Bolus to Identify Fluid Responsiveness|Not yet recruiting||N/A|100|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||1|||f||||f|f|f||||||No|No plan to make IPD available|2017-10-10 21:19:26.531609|2017-10-10 21:19:26.531609
NCT03059810|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-02|||January 27, 2017||2017-01-27||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:19:26.60265|2017-10-10 21:19:26.60265
NCT03059797|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-15|||December 2017|Anticipated|2017-12-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)|A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Compare the Efficacy and Safety of Anlotinib Versus Placebo in Patients With Small Cell Lung Cancer(ALTER1202)|Recruiting||Phase 2|90|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||f|f|f|||f|||||2017-10-10 21:19:26.63776|2017-10-10 21:19:26.63776
NCT03059784|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-02-20|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||APP-based Multifaceted Management After PCI|Mobile Application-based Multifaceted Management to Improve Long-term Care After Percutaneous Coronary Intervention|Not yet recruiting||N/A|1100|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||f|f|f||||||Yes|management methods,outcomes including medication use, events of patients can be available on request.|2017-10-10 21:19:26.737519|2017-10-10 21:19:26.737519
NCT03059771|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-21|||February 28, 2017|Actual|2017-02-28|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Mobile Enhancement of Motivation in Schizophrenia|Mobile Enhancement of Motivation in Schizophrenia: A Pilot Trial of a Personalized Text Message Intervention for Motivation Deficits|Recruiting||N/A|40|Anticipated|Indiana University||2|||f||||f|f|f||||||||2017-10-10 21:19:26.803805|2017-10-10 21:19:26.803805
NCT03059758|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-20|||July 26, 2014|Actual|2014-07-26|February 2017|2017-02-01|July 26, 2020|Anticipated|2020-07-26|June 26, 2020|Anticipated|2020-06-26||Interventional|||Deductive Reasoning and Math Learning Difficulty|Deductive Reasoning and Math Learning Difficulty: an fMRI Study in Children|Recruiting||N/A|120|Anticipated|Hospices Civils de Lyon||1|||f|||||f|f||||||||2017-10-10 21:19:26.883839|2017-10-10 21:19:26.883839
NCT03059745|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-06-19|||June 2004||2004-06-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Use of Robotics for Cholecystectomy; Retrospective Review of Outcomes, Set Up and Learning Curves|Evolution of Robotic Cholecystectomy; the U.C. Davis Experience.|Recruiting||N/A|500|Anticipated|University of California, Davis|||1||f||||f||||||||No||2017-10-10 21:19:27.128721|2017-10-10 21:19:27.128721
NCT03059732|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-16|||December 1, 2016|Actual|2016-12-01|November 2016|2016-11-01|August 31, 2017|Anticipated|2017-08-31|February 28, 2017|Anticipated|2017-02-28||Observational|||Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus Japan|Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus Japan|Recruiting||N/A|700|Anticipated|King Chulalongkorn Memorial Hospital|||2||f|||||f|f||||||||2017-10-10 21:19:27.267753|2017-10-10 21:19:27.267753
NCT03059719|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||April 8, 2015|Actual|2015-04-08|February 2017|2017-02-01|October 27, 2016|Actual|2016-10-27|September 30, 2016|Actual|2016-09-30||Interventional|||Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus|A Randomized, Open, Comparative to the Positive-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects Newly Diagnosed as Type 2 Diabetes Mellitus|Completed||Phase 1|36|Actual|PegBio Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:19:27.371444|2017-10-10 21:19:27.371444
NCT03059706|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-08-22|||March 23, 2017|Actual|2017-03-23|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effect of Intra-Articular Injection of RegenoGel-OSP™(Self-Plasma) to Treat Pain Following Arthroscopic Surgery|Randomized, Open-Labal, Placebo-Controlled Trial of the Effect of Intra-Articular Injection of RegenoGel-OSP™ (Slef-Plasma) to Treat Pain Following Arthroscopic Surgery|Recruiting||N/A|36|Anticipated|Kaplan Medical Center||2|||f|||||f|f||||||||2017-10-10 21:19:27.460134|2017-10-10 21:19:27.460134
NCT03059693|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-16|||February 29, 2016|Actual|2016-02-29|February 2017|2017-02-01|July 24, 2016|Actual|2016-07-24|June 13, 2016|Actual|2016-06-13||Interventional|||Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis|Efficacy and Safety of HAT1, a Novel Topical Therapeutic: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients With Moderate to Severe Atopic Dermatitis|Completed||Phase 1/Phase 2|48|Actual|Haus Bioceuticals||2|||f||||t|f|f||||||Yes||2017-10-10 21:19:27.568532|2017-10-10 21:19:27.568532
NCT03059680|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-05-23|||January 2012||2012-01-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Effects of Implementing a High Potassium Diet in Heart Failure Patients|Safety and Physiologic Effects of Implementing a High Potassium Diet in Heart Failure Patients|Completed||N/A|30|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||No||2017-10-10 21:19:27.71002|2017-10-10 21:19:27.71002
NCT03059667|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-08|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Immunotherapy as Second-line in Patient With Small Cell Lung Cancer|A Randomized Non-comparative Phase II Study of Anti-PDL1 ATEZOLIZUMAB (MPDL3280A) or Chemotherapy as Second-line Therapy in Patients With Small Cell Lung Cancer (SCLC)|Recruiting||Phase 2|70|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||f|f|f||||||No||2017-10-10 21:19:27.804337|2017-10-10 21:19:27.804337
NCT03059654|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-20|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Ultrasound-guided Percutaneous Dilatation Tracheostomy: Does it Have a Role in Obese Patients?|Ultrasound-guided Percutaneous Dilatation Tracheostomy: Does it Have a Role in Obese Patients?|Recruiting||N/A|60|Anticipated|Suez Canal University||2|||f||||f||||||||||2017-10-10 21:19:28.011586|2017-10-10 21:19:28.011586
NCT03059641|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-03-06|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Observational|||Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China|Mutation Profile Detection, Therapeutic Resistance and Clonal Evolution Assessed With Liquid Biopsy of Advanced NSCLC Patients in China|Recruiting||N/A|500|Anticipated|Geneplus-Beijing Co. Ltd.|||1||f||||f|f|f||||Samples With DNA|"     whole blood (including plasma, white cells), tissue   "|No||2017-10-10 21:19:28.128304|2017-10-10 21:19:28.128304
NCT03059628|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-07-25|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|IFACAP||Evaluation of a Personalized Normative Feedback Repeatedly Delivered Via a Mobile Application After a Brief Therapeutic Intervention on Alcohol-related Risks:|Evaluation of a Personalized Normative Feedback Repeatedly Delivered Via a Mobile Application After a Brief Therapeutic Intervention on Alcohol-related Risks: a Multi Center Randomized Open Study in Young Adults Admitted to Emergency Room for Acute Alcohol Intoxication (AAI).|Not yet recruiting||N/A|580|Anticipated|Rennes University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:19:28.301395|2017-10-10 21:19:28.301395
NCT03059615|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-16|||April 2, 2017|Anticipated|2017-04-02|February 2017|2017-02-01|December 2, 2019|Anticipated|2019-12-02|April 2, 2019|Anticipated|2019-04-02||Interventional|||A Phase 2a, Open-Label, Dose-Escalation Study of IV Nerofe in Subjects With AML and MDS|A Phase 2a, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Intravenously Administered Nerofe in Subjects With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Not yet recruiting||Phase 2|22|Anticipated|Immune System Key Ltd||1|||f||||t|f|f||||||No||2017-10-10 21:19:28.451258|2017-10-10 21:19:28.451258
NCT03059602|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-22|||May 12, 2016|Actual|2016-05-12|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Biopsychosocial Impact on Caregivers in Patients Undergoing Joint and Spine Surgery|Characterizing the Biopsychosocial Impact on Caregivers in Patients Undergoing Joint Replacement and Cervical/Thoracic/Lumbar Spine Surgery: A Pilot Study|Recruiting||N/A|150|Anticipated|Defense and Veterans Center for Integrative Pain Management|||3||f||||f|f|f||||||No||2017-10-10 21:19:28.57665|2017-10-10 21:19:28.57665
NCT03059589|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-16|||March 15, 2017|Anticipated|2017-03-15|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01|4 Years|Observational [Patient Registry]|||Registry of Food Allergy Oral Immunotherapy Treatment|National Registry of Food Allergy Treatment|Not yet recruiting||N/A|500|Anticipated|Food Allergy Support Team|||1||f||||f||||||||Undecided||2017-10-10 21:19:28.661694|2017-10-10 21:19:28.661694
NCT03059576|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-23|||December 2012|Actual|2012-12-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|March 2013|Actual|2013-03-01||Observational|MTR||Circadian System Heritability Assessed in Free Living Conditions|Circadian System Heritability Assessed in Free Living Conditions in a Twin Mediterranean Population|Completed||N/A|106|Actual|Universidad de Murcia|||1||f||||f|f|f||||||No||2017-10-10 21:19:28.748763|2017-10-10 21:19:28.748763
NCT03059563|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-16|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users|Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users|Not yet recruiting||Phase 1|36|Anticipated|University of California, Los Angeles||2|||f|||||t|f||||||||2017-10-10 21:19:28.831831|2017-10-10 21:19:28.831831
NCT03059056|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||February 2, 2017|Actual|2017-02-02|February 2017|2017-02-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Interventional|||Pharmacokinetic Evaluation of Empagliflozin|Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS: Compared With Other Ethnic Populations|Completed||Phase 1|6|Actual|British University In Egypt||1|||f|||||t|f|||t|||Yes|Publication of data in a scientific journal|2017-10-10 21:19:34.806844|2017-10-10 21:19:34.806844
NCT03059550|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-16|||March 1, 2013|Actual|2013-03-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|May 31, 2015|Actual|2015-05-31||Observational|REHABDIAB||Screening for Glucose Metabolism Disorders in Cardiac Rehabilitation|Screening for Glucose Metabolism Disorders in Cardiac Rehabilitation After an Acute Coronary Syndrome (REHABDIAB [REHABilitation for Coronary Disease and DIABetes])|Recruiting||N/A|350|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||t|f|f||||||Undecided||2017-10-10 21:19:28.950212|2017-10-10 21:19:28.950212
NCT03059537|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-06-22|||March 13, 2017|Actual|2017-03-13|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|September 30, 2017|Anticipated|2017-09-30||Interventional|VABAD||Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea|Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea|Recruiting||Phase 4|70|Anticipated|Zealand University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:19:29.040403|2017-10-10 21:19:29.040403
NCT03059524|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-02-16|||January 2017||2017-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Dynamic Monitoring of Circulating microRNA Changes in Patients With or Without Multiple Organ Failure|Dynamic Monitoring of Circulating microRNA Changes in Patients With or Without Multiple Organ Failure|Recruiting||N/A|200|Anticipated|University of Electronic Science and Technology of China|||3||f||||||||||Samples Without DNA|"     Whole blood extraction from subjects subsequently separated to plasma.   "|||2017-10-10 21:19:29.166142|2017-10-10 21:19:29.166142
NCT03059511|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-03-13|||March 3, 2017|Actual|2017-03-03|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants|Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants: A Single Center, Open-label, Prospective Study|Recruiting||Phase 1|42|Anticipated|University Children's Hospital, Zurich||2|||f||||t|t|f|||f|||||2017-10-10 21:19:29.248121|2017-10-10 21:19:29.248121
NCT03059498|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-06-08|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||PECS Block: Plasma Bupivacaine Level|Determining Plasma Bupivacaine Levels Following Pectoral Nerve Blocks: A Prospective Observational Study|Recruiting||Early Phase 1|20|Anticipated|Wake Forest University Health Sciences||2|||f||||f|t|f|||f|||Undecided||2017-10-10 21:19:29.328777|2017-10-10 21:19:29.328777
NCT03059485|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-06-30|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||DC/AML Fusion Cell Vaccine vs DC/AML Fusion Cell Vaccine Plus Durvalumab vs Observation in Patients Who Achieve a Chemotherapy-induced Remission|A Randomized Phase II Clinical Trial of Dendritic Cell/AML Fusion Cell Vaccine Versus DC/AML Fusion Cell Vaccine in Conjunction With Durvalumab, Versus Observation in Patients Who Achieve a Chemotherapy-induced Remission|Recruiting||Phase 2|105|Anticipated|Dana-Farber Cancer Institute||3|||f||||t|t|f||||||||2017-10-10 21:19:29.424943|2017-10-10 21:19:29.424943
NCT03059472|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-06-05|||January 20, 2017|Actual|2017-01-20|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Strong Hearts for New York: A Rural Heart Disease Prevention Study|Strong Hearts for New York: A Rural Community CVD Prevention Program|Active, not recruiting||N/A|182|Actual|Cornell University||2|||f||||f|f|f||||||||2017-10-10 21:19:29.54514|2017-10-10 21:19:29.54514
NCT03059459|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||December 4, 2015|Actual|2015-12-04|February 2017|2017-02-01|December 4, 2017|Anticipated|2017-12-04|December 4, 2017|Anticipated|2017-12-04||Observational|||Effect of Atmospheric Pollution on Obstructive Lung Diseases|Effect of Atmospheric Pollution Due to Particulate Matter on Obstructive Lung Diseases in San Nicolas, Buenos Aires Province, Argentina|Active, not recruiting||N/A|117|Actual|National Council of Scientific and Technical Research, Argentina|||1||f||||t|f|f||||||No||2017-10-10 21:19:29.676156|2017-10-10 21:19:29.676156
NCT03059446|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-04-22|||February 14, 2017|Actual|2017-02-14|April 2017|2017-04-01|October 31, 2019|Anticipated|2019-10-31|July 21, 2019|Anticipated|2019-07-21||Interventional|||Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis|Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)|Enrolling by invitation||Phase 2|200|Anticipated|Tobira Therapeutics, Inc.||1|||f||||f|t|f|||f|||||2017-10-10 21:19:29.739977|2017-10-10 21:19:29.739977
NCT03059433|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-27|||April 21, 2017|Actual|2017-04-21|April 2017|2017-04-01|November 1, 2020|Anticipated|2020-11-01|November 1, 2020|Anticipated|2020-11-01||Observational|AVID||Randomized Trial of a Social Networks Intervention|Leveraging School Environments to Shape Social Networks and Reduce Adolescent Substance Use—A Pilot Randomized Trial of a Social Networks Intervention|Enrolling by invitation||N/A|525|Anticipated|University of California, Los Angeles|||3||f||||f|f|f||||||No|"Participants will be assigned a study ID number to link their name, address, and phone number to their survey responses. This ID will be used for all data collection.
The computer file linking the personal identifiers and the study ID number will be kept separate from the survey data. Personally identifying information pertaining to individual participants will not be shared or made available to other researchers. Any data request will be made to the Principal Investigator and any data shared will be encrypted and will not include any personal identifying information."|2017-10-10 21:19:29.967586|2017-10-10 21:19:29.967586
NCT03059420|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||February 1, 2004|Actual|2004-02-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies|Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies|Recruiting||N/A|20000|Anticipated|Boston Children’s Hospital|||1||f||||f|f|f||||Samples With DNA|"     Following specimens may be submitted: saliva, blood, discarded tissue   "|No||2017-10-10 21:19:30.064052|2017-10-10 21:19:30.064052
NCT03059407|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-23|||May 25, 2017|Actual|2017-05-25|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Impact of Therapy Dog Presence on Pediatric Echocardiogram|Impact of Animal Assisted Therapy on Quality, Completeness, and Patient and Parental Satisfaction in Children Undergoing Clinical Echocardiography|Recruiting||N/A|160|Anticipated|Duke University||3|||f||||f|f|f||||||No||2017-10-10 21:19:30.15723|2017-10-10 21:19:30.15723
NCT03059394|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-20|||March 2014|Actual|2014-03-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Observational|||Validation of Rehab Assessments in Myositis Patients|Validation of Manual Muscle Testing and the Myositis Activity Profile Assessments in Patients With Inflammatory Myositis|Completed||N/A|50|Actual|University of Zurich|||1||f||||f|f|f||||||Undecided|The dataset analyzed in the current study is available from the corresponding author(s) on reasonable request.|2017-10-10 21:19:30.234485|2017-10-10 21:19:30.234485
NCT03059381|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-04|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|February 2023|Anticipated|2023-02-01|February 2022|Anticipated|2022-02-01||Observational|FYC02T||Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures|Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures|Recruiting||N/A|500|Anticipated|Eisai Inc.|||1||f||||f||||||||||2017-10-10 21:19:30.303878|2017-10-10 21:19:30.303878
NCT03059368|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-16|||August 2013|Actual|2013-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|||New Bone Fixation Plate for the Repair of Tibial Avulsion Fracture of Posterior Cruciate Ligament of the Knee|New Bone Fixation Plate for the Repair of Tibial Avulsion Fracture of Posterior Cruciate Ligament of the Knee: a Prospective, Open-label, Self-controlled, Clinical Trial|Completed||N/A|20|Actual|Cangzhou Central Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:19:30.39204|2017-10-10 21:19:30.39204
NCT03059355|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-25|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|June 2026|Anticipated|2026-06-01|June 2025|Anticipated|2025-06-01||Interventional|CERES||Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs to Evaluate Cytokine Suppression in Patients With Chronic Inflammation Due to Metabolic Syndrome.|A Phase I/II, Randomized, Placebo-controlled Comparative Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs to Evaluate Cytokine Suppression in Patients With Chronic Inflammation Due to Metabolic Syndrome.|Not yet recruiting||Phase 1/Phase 2|37|Anticipated|University of Miami||9|||f||||f|t|f||||||||2017-10-10 21:19:30.45942|2017-10-10 21:19:30.45942
NCT03059342|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-16|||December 3, 2012|Actual|2012-12-03|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|December 31, 2019|Anticipated|2019-12-31||Observational|||Functional Follow-up After Single Event Multilevel Surgery in Children Spastic Diplegic Cerebral Palsy|Short and Longterm Evolution of Self-care and Functional Mobility After Single Event Multilevel Surgery in Children and Adolescents With Spastic Diplegic Cerebral Palsy|Active, not recruiting||N/A|34|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f|f|f||||||No||2017-10-10 21:19:30.553363|2017-10-10 21:19:30.553363
NCT03059329|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-04|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|February 2023|Anticipated|2023-02-01|February 2021|Anticipated|2021-02-01||Observational|FYC01S||Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures|Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures|Recruiting||N/A|3750|Anticipated|Eisai Inc.|||1||f||||f||||||||||2017-10-10 21:19:32.576632|2017-10-10 21:19:32.576632
NCT03059316|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-07-18|||June 10, 2016|Actual|2016-06-10|July 2017|2017-07-01|April 21, 2017|Actual|2017-04-21|April 10, 2017|Actual|2017-04-10||Interventional|||The Effects of Nitroglycerin Versus Labetalol on the Perfusion During Hypotensive Anesthesia|Department of Anestheia and Intensive Care Unit,Cairo University|Completed||Early Phase 1|80|Actual|Cairo University||2|||f||||t|f|f|||f|||||2017-10-10 21:19:32.723522|2017-10-10 21:19:32.723522
NCT03059303|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-08-11|||February 20, 2017|Actual|2017-02-20|August 2017|2017-08-01|October 17, 2017|Anticipated|2017-10-17|October 17, 2017|Anticipated|2017-10-17||Interventional|||Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)|Phase 1, Open-label, Partially Randomized, Parallel-group Study in Healthy Adult Subjects to Assess the Relative Bioavailability of Single-dose Simeprevir (SMV), Odalasvir (ODV), and AL-335 Administered as a Fixed-dose Combination (FDC) Compared With the Single Agents Administered Together, and to Assess the Effect of Multiple-dose Lansoprazole or Omeprazole on the Single-dose Pharmacokinetics of SMV, ODV, and AL-335 Administered as an FDC|Recruiting||Phase 1|120|Anticipated|Janssen Research & Development, LLC||13|||f||||f|t|f||||||||2017-10-10 21:19:32.820117|2017-10-10 21:19:32.820117
NCT03059290|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-16|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Incidence of Post-Operative Pain After Single Visit Root Canal Treatment in Necrotic Teeth Using Two Different Rotary Systems (Protaper Nex t& Neolix File)|Incidence of Post-Operative Pain After Single Visit Root Canal Treatment in Necrotic Teeth Using Two Different Rotary Systems (Protaper Nex t& Neolix File)|Not yet recruiting||N/A|50|Anticipated|Cairo University||1|||f|||||f|f||||||||2017-10-10 21:19:32.982765|2017-10-10 21:19:32.982765
NCT03059277|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-24|||March 30, 2017|Anticipated|2017-03-30|February 2017|2017-02-01|March 30, 2019|Anticipated|2019-03-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab|Efficacy of Intravitreal Aflibercept Injection (IAI) Administered in a Treat and Extend Fashion in Patients With Center Involved Diabetic Macular Edema (DME) Previously Managed With 0.3 mg Intravitreal Ranibizumab|Not yet recruiting||Phase 4|24|Anticipated|Southeast Clinical Research Associates, LLC||1|||f||||f|t|f|||f|||No|Site will not be sharing IPD.|2017-10-10 21:19:33.077229|2017-10-10 21:19:33.077229
NCT03059264|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-16|||December 14, 2016|Actual|2016-12-14|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31|1 Year|Observational [Patient Registry]|TREAT_CDM||Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy|Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy|Recruiting||N/A|150|Anticipated|University of Utah|||2||f||||t|f|f||||Samples With DNA|"     Blood   "|No||2017-10-10 21:19:33.168912|2017-10-10 21:19:33.168912
NCT03059251|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-17|2017-06-14|||August 18, 2017|Anticipated|2017-08-18|June 2017|2017-06-01|November 15, 2022|Anticipated|2022-11-15|November 15, 2022|Anticipated|2022-11-15||Observational|||Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina|An Observational Study of the Safety and Effectiveness of Obinutuzumab in Patients With Chronic Lymphocytic Leukemia Treated in Argentina|Not yet recruiting||N/A|50|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 21:19:33.278492|2017-10-10 21:19:33.278492
NCT03059238|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-21|||September 2016||2016-09-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure|Study of Parecoxib Versus Celecoxib Versus Oxycodone on Perioperative Pain Control of Transcatheter Chemoembolization Procedure for Patients With Hepatocelullar Carcinoma|Recruiting||Phase 3|258|Anticipated|Sun Yat-sen University||3|||f|||||f|f||||||No||2017-10-10 21:19:33.374935|2017-10-10 21:19:33.374935
NCT03059225|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-16|||June 2014||2014-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Synchronous rTMS and Computer-integrated Speech Training Applied in Aphasic Patients and the Neuroimaging Study|Synchronous rTMS and Computer-integrated Speech Training Applied in Aphasic Patients|Recruiting||N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||No||2017-10-10 21:19:33.48135|2017-10-10 21:19:33.48135
NCT03059212|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-16|||October 2014||2014-10-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Role of Primary Motor Cortex for Facilitation of Working Memory in PD|The Role of Primary Motor Cortex for Facilitation of Working Memory in PD|Recruiting||N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||No||2017-10-10 21:19:33.586759|2017-10-10 21:19:33.586759
NCT03059199|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-02-16|||August 2016||2016-08-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||HAT TRICK: An Innovative Health Promotion Program for Men|HAT TRICK: Examining the Feasibility of a Gender Sensitive Intervention Focused on Physical Activity, Healthy Eating and Connectedness in Male Hockey Fans|Recruiting||N/A|60|Anticipated|University of British Columbia||1|||f||||f||||||||No|Only the principal investigators and UBC research team members will have access to the raw data. CO-I's external to UBC will not require access to raw participant data. Any data that are shared will be aggregate data and have all identifiers removed. All of these individuals have training in issues concerning privacy, confidentiality, and are aware of their responsibilities to maintain these.|2017-10-10 21:19:33.793133|2017-10-10 21:19:33.793133
NCT03059186|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-07-15|||June 6, 2017|Actual|2017-06-06|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Gratitude Intervention in Improving Well-being and Coping in People Living With Inflammatory Bowel Disease|A Randomised Controlled Trial of a Brief Gratitude Intervention in Improving Well-being and Coping in People Living With Inflammatory Bowel Disease|Recruiting||N/A|152|Anticipated|University of Sheffield||2|||f|||||f|f||||||||2017-10-10 21:19:33.892241|2017-10-10 21:19:33.892241
NCT03059173|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-06-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|MYOPK||Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome|Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome During Induction of Ovulation With Clomiphene Citrate|Not yet recruiting||Phase 3|276|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:19:33.984848|2017-10-10 21:19:33.984848
NCT03059160|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-16|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|August 1, 2018|Anticipated|2018-08-01|April 1, 2018|Anticipated|2018-04-01||Interventional|UX007||Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.|Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.|Not yet recruiting||Phase 2|10|Anticipated|Sheba Medical Center||1|||f||||f|f|f||||||Yes|the final results of the study will be shared with ultragenix pharmaceutical and with other RETT syndrome researchers|2017-10-10 21:19:34.086411|2017-10-10 21:19:34.086411
NCT03059147|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-07-26|||March 27, 2017|Actual|2017-03-27|July 2017|2017-07-01|October 1, 2022|Anticipated|2022-10-01|October 1, 2022|Anticipated|2022-10-01||Interventional|SRX||A Study of Single Agent SF1126 Inhibitor in Patients With Advanced Hepatocellular Carcinoma|A Phase I Study of Single Agent SF1126, a Dual PI3 Kinase and Bromodomain Inhibitor, in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A-B7 Cirrhosis|Recruiting||Phase 1|14|Anticipated|SignalRX Pharmaceuticals, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:19:34.179945|2017-10-10 21:19:34.179945
NCT03059134|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||April 28, 2015|Actual|2015-04-28|February 2017|2017-02-01|April 27, 2016|Actual|2016-04-27|April 27, 2016|Actual|2016-04-27||Interventional|||Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan|Therapeutic Efficacy and Safety of Mirabegron , a β3-Adrenoceptor Agonist, Treatment on Patients With Overactive Bladder Syndrome in Taiwan - Predictive Factors for the First Line Use and the Dose Effectiveness Relationship|Completed||Phase 3|168|Actual|Buddhist Tzu Chi General Hospital||4|||f||||t|t|f|||f|||No|IPD was not planned to share|2017-10-10 21:19:34.26902|2017-10-10 21:19:34.26902
NCT03059121|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-15|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Observational|||The Cleveland Cardiometabolic Cohort|Observational Study of Cardiometabolic Risk in HIV Infected Subjects After Initiation of Antiretroviral Therapy: The Cleveland Cardiometabolic Cohort|Recruiting||N/A|60|Anticipated|University Hospitals Cleveland Medical Center|||1||f||||f||||||Samples With DNA|"     Urine, plasma, feces   "|No||2017-10-10 21:19:34.361483|2017-10-10 21:19:34.361483
NCT03059108|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-05-01|||February 20, 2017|Actual|2017-02-20|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of B+ Surface on Early Loading|Evaluation of B+ Surface on Early Loading|Recruiting||N/A|30|Anticipated|Universidad de Granada||2|||f||||f|f|f||||||||2017-10-10 21:19:34.451954|2017-10-10 21:19:34.451954
NCT03059095|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-21|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Study of Yoga and Mindfulness for Psychological and Physical Wellness|Study of Yoga and Mindfulness for Psychological and Physical Wellness|Enrolling by invitation||N/A|150|Anticipated|University of South Florida||1|||f||||f|f|f||||||No||2017-10-10 21:19:34.545557|2017-10-10 21:19:34.545557
NCT03059082|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-15|||December 2016||2016-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CIRNA||A Critical Illness Recovery Navigator for Alcohol|A Critical Illness Recovery Navigator for Alcohol: a Pilot Clinical Trial|Recruiting||N/A|70|Anticipated|University of Colorado, Denver||3|||f||||f||||||||||2017-10-10 21:19:34.615885|2017-10-10 21:19:34.615885
NCT03059069|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||June 1, 2016|Actual|2016-06-01|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients|The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients|Recruiting||Phase 4|60|Anticipated|Yonsei University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:34.724501|2017-10-10 21:19:34.724501
NCT03059043|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-06-27|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 22, 2019|Anticipated|2019-03-22|March 22, 2018|Anticipated|2018-03-22||Interventional|||Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation|Prospective, Multicenter,Randomized Clinical Investigation of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation to Treat High Myopia: A Pilot Study|Recruiting||N/A|60|Anticipated|Wenzhou Medical University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:34.875084|2017-10-10 21:19:34.875084
NCT03059030|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-17|||March 16, 2017|Actual|2017-03-16|May 2017|2017-05-01|April 1, 2024|Anticipated|2024-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia|Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia|Recruiting||N/A|20|Anticipated|Northwestern University||1|||f||||t|f|t|f|f||||Undecided||2017-10-10 21:19:34.986169|2017-10-10 21:19:34.986169
NCT03059017|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||February 5, 2017|Actual|2017-02-05|February 2017|2017-02-01|February 5, 2017|Actual|2017-02-05|February 5, 2017|Actual|2017-02-05||Interventional|||In Vivo Investigation of Novel Nano-vesicles of Salbutamol Sulphate|Novel Nano-vesicles of Salbutamol Sulphate in Metered Dose Inhalers: Formulation, Characterization, In Vitro and In Vivo Evaluation|Completed||Phase 1|20|Actual|British University In Egypt||2|||f|||||t|f|||f|||Yes|Share of the results by Publication|2017-10-10 21:19:35.096752|2017-10-10 21:19:35.096752
NCT03059004|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-16|||July 1, 2017|Anticipated|2017-07-01|February 2017|2017-02-01|November 1, 2021|Anticipated|2021-11-01|November 1, 2020|Anticipated|2020-11-01||Interventional|TeMPO||Comparing Different Types of Physical Therapy for Treating People With a Meniscal Tear and Osteoarthritis|Treatment of Meniscal Problems in Osteoarthritis|Not yet recruiting||N/A|860|Anticipated|Brigham and Women's Hospital||4|||f||||t|f|f||||||Undecided||2017-10-10 21:19:35.172228|2017-10-10 21:19:35.172228
NCT03058991|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-04-28|||October 2016||2016-10-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|DOAN||Cognitive and Emotional Skills to Aid Smoking Prevention|Rescuing Cognitive and Emotional Regulatory Processes to Aid Smoking Prevention|Recruiting||N/A|150|Anticipated|Boston University Charles River Campus||3|||f||||f||||||||No||2017-10-10 21:19:35.296138|2017-10-10 21:19:35.296138
NCT03058978|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-16|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Assessing Ovarian Function During Prolonged Implant Use|Assessing Ovarian Function During Prolonged Implant Use|Not yet recruiting||N/A|210|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 21:19:35.393035|2017-10-10 21:19:35.393035
NCT03058965|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-15|||November 2016||2016-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain|Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Probable Alzheimer's Disease or Progressive Supranuclear Palsy Compared With Healthy Volunteers|Recruiting||Early Phase 1|9|Anticipated|Molecular NeuroImaging||1|||f||||||||||||||2017-10-10 21:19:35.495891|2017-10-10 21:19:35.495891
NCT03058952|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-06-19|||July 3, 2017|Anticipated|2017-07-03|June 2017|2017-06-01|April 1, 2021|Anticipated|2021-04-01|October 1, 2020|Anticipated|2020-10-01||Interventional|GROW||Groups for Regaining Our Wellbeing|Evaluation of a Mindfulness-Based Intervention for Gulf War Illness|Not yet recruiting||N/A|308|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Yes|A de-identified, anonymized dataset will be created and shared. Only de-identified data, with no individually identifiable patient information, will be shared.|2017-10-10 21:19:35.667594|2017-10-10 21:19:35.667594
NCT03058939|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-08|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer|Assessing the REsponse Rate of Weekly Neo-adjuvanT pacliTAxel (Taxol) in Nigerian Women With Breast Cancer (ARETTA)|Not yet recruiting||Phase 2|60|Anticipated|University of Chicago||6|||f||||t|t|f|||t|||||2017-10-10 21:19:35.779241|2017-10-10 21:19:35.779241
NCT03058926|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-04-20|||January 19, 2017|Actual|2017-01-19|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer|Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer|Recruiting||N/A|25000|Anticipated|M.D. Anderson Cancer Center|||3||f||||f|f|f||||Samples With DNA|"     Blood and urine examined for biomarker evaluation.   "|||2017-10-10 21:19:35.909945|2017-10-10 21:19:35.909945
NCT03058913|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-16|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01|1 Year|Observational [Patient Registry]|||OEIS Outcome Data Registry|OEIS (Outpatient Endovascular and Interventional Society) Outcome Data Registry|Recruiting||N/A|600000|Anticipated|Outpatient Endovascular and Interventional Society|||1||f||||f|f|f||||||No||2017-10-10 21:19:36.006783|2017-10-10 21:19:36.006783
NCT03058900|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-17|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|FLORA||Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis|Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Peripheral Psoriatic Arthritis: A 6-month, Double-Blinded, Randomized Placebo-Controlled Trial|Recruiting||N/A|80|Anticipated|Odense University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:19:36.091697|2017-10-10 21:19:36.091697
NCT03058887|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-02-15|||June 2016||2016-06-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effects of Exercise in Patients With Systemic Sclerosis|Investigating the Effectiveness and Feasibility of Exercise on Microcirculatory Parameters and Quality of Life in Systemic Sclerosis Patients Experiencing Raynaud's Phenomenon.|Recruiting||N/A|36|Anticipated|Sheffield Hallam University||3|||f||||f||||||||||2017-10-10 21:19:36.236989|2017-10-10 21:19:36.236989
NCT03058874|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-26|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|LUST ABPM||Effect of Dry-weight Probing Guided by Lung-Ultrasound on Ambulatory Aortic Blood Pressure and Arterial Stiffness in Hemodialysis Patients (LUST Sub-Study)|The Effect of a Dry-weight Probing Guided by Lung Ultrasound on Ambulatory Aortic Blood Pressure and Ambulatory Arterial Stiffness in Hemodialysis Patients. A LUST Sub-study.|Recruiting||N/A|50|Anticipated|"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"||2|||f||||f|f|f||||||No||2017-10-10 21:19:36.350524|2017-10-10 21:19:36.350524
NCT03058848|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-09-26|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|September 15, 2017|Actual|2017-09-15||Interventional|PKU Start||Evaluation of PKU Start|A Study to Evaluate the Acceptability of a New Phenylalanine Free Infant Formula for Use in the Dietary Management of Phenylketonuria in Infants From Birth to 2 Year of Age With Regard to Product Tolerance and Adherence.|Completed||N/A|10|Actual|Vitaflo International, Ltd||1|||f||||f|f|f||||||||2017-10-10 21:19:36.567477|2017-10-10 21:19:36.567477
NCT03058835|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-24|||September 2016||2016-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project|IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project|Recruiting||Phase 4|31|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f|t|||||||No||2017-10-10 21:19:36.650315|2017-10-10 21:19:36.650315
NCT03058822|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-16|||February 2017||2017-02-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in Vial|A Randomized, Open-label, Parallel-group, Single Subcutaneous Dose, Relative Bioavailability Study of the Pharmacokinetics of Lulizumab (BMS-931699) From Prefilled Syringe (Process A) Compared to Drug in Vial (Process A) in Healthy Participants|Not yet recruiting||Phase 1|60|Anticipated|Bristol-Myers Squibb||6|||f||||||||||||||2017-10-10 21:19:36.762392|2017-10-10 21:19:36.762392
NCT03058809|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-20|||September 2017|Anticipated|2017-09-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood|Evaluation of the Saftey and Efficacy of the Viatar™ Oncopheresis System in Removing Circulating Tumor Cells From Whole Blood|Not yet recruiting||N/A|150|Anticipated|Viatar LLC||1|||f||||f|f|t|t||t|||Undecided||2017-10-10 21:19:36.848176|2017-10-10 21:19:36.848176
NCT03058796|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-06-05|||June 19, 2017|Anticipated|2017-06-19|June 2017|2017-06-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2021|Anticipated|2021-02-28||Interventional|||Contralaterally Controlled Functional Electrical Stimulation Plus Video Games for Hand Therapy After Stroke|Contralaterally Controlled FES Plus Video Games for Hand Therapy After Stroke|Not yet recruiting||Phase 2|52|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 21:19:36.915491|2017-10-10 21:19:36.915491
NCT03058783|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-02-16|||August 2017|Anticipated|2017-08-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects|A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects|Not yet recruiting||Phase 3|348|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||t|t|f||||||Yes||2017-10-10 21:19:37.011208|2017-10-10 21:19:37.011208
NCT03058770|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-21|||February 16, 2017|Actual|2017-02-16|February 2017|2017-02-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Sensorimotor Retraining in Chronic Stroke|Study of the Effect of a Sensorimotor Retraining Program in Chronic Stroke|Recruiting||N/A|50|Anticipated|University of Valencia||2|||f|||||f|f||||||||2017-10-10 21:19:37.097164|2017-10-10 21:19:37.097164
NCT03058757|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-21|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation|The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation in Non-muscle Invasive Bladder Cancer Patients: Prospective, Randomized, Phase II Study|Recruiting||Phase 2|78|Anticipated|National Cancer Center, Korea||2|||f|||||f|f||||||No||2017-10-10 21:19:37.239161|2017-10-10 21:19:37.239161
NCT03058744|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-08|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis|A Phase 1b Open Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 1|94|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||Yes||2017-10-10 21:19:37.341289|2017-10-10 21:19:37.341289
NCT03058731|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-16|||February 2, 2016|Actual|2016-02-02|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Observational|||ACELL Mesh for Paraesophageal Hernia Repair|Comparison of Symptomatic and Radiographic Outcomes of Paraesophageal Hernia Repair With and Without MatriStem Surgical Matrix|Recruiting||N/A|70|Anticipated|University of South Florida|||2||f||||f|f|t|f||f|||No||2017-10-10 21:19:37.455045|2017-10-10 21:19:37.455045
NCT03058640|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-31|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Effects of Karate in Adolescents With Down Syndrome|The Effects of Participation in Karate on Health Outcomes in Adolescents With Down Syndrome|Recruiting||N/A|30|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 21:19:37.556517|2017-10-10 21:19:37.556517
NCT03058614|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-07-18|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 30, 2022|Anticipated|2022-06-30|December 31, 2021|Anticipated|2021-12-31||Interventional|CEUS||Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management|Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient|Not yet recruiting||Phase 2|1046|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||||2017-10-10 21:19:37.758342|2017-10-10 21:19:37.758342
NCT03058601|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-17|||January 4, 2016||2016-01-04|May 2017|2017-05-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Observational|||Outcomes in UK ACS Patients Prescribed Ticagrelor|Health Outcomes of Patients With Acute Coronary Syndromes Prescribed Ticagrelor in UK Primary Care: a Retrospective Cohort Study|Completed||N/A|1650|Actual|AstraZeneca|||1||f||||||||||||||2017-10-10 21:19:37.836316|2017-10-10 21:19:37.836316
NCT03058588|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-02|||February 9, 2017|Actual|2017-02-09|February 2017|2017-02-01|February 9, 2021|Anticipated|2021-02-09|February 9, 2021|Anticipated|2021-02-09||Observational|||Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes|Next Generation Sequencing (NGS) Approach to Study Known and New Germline Mutations in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes|Recruiting||N/A|20|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia|||1||f||||f|f|f||||Samples With DNA|"     Tumor DNA of index case will be extracted from 10 ml of PB collected at diagnosis in EDTA     tubes. Mononuclear cells from PB (PBMC)will be separated and isolated by Ficoll gradient.     Tumor DNA will be extracted possibly soon after the isolation. Tumor DNA of affected     relative/-s will be extracted from PBMC isolated at diagnosis, or during the patients     monitoring, and stored at -80°C. Tumor DNA previously extracted and stored at -20°C may be     used in event of no PB or bone marrow sample available.      Germline DNA of index case and relatives will be extracted by buccal epithelial cells     isolated by Isohelix SK-2 DNA Buccal Swab Collection Kit by Therapak Corporation, Isohelix     SK-2 DNA Buccal Swab Collection Kit.   "|No||2017-10-10 21:19:37.899511|2017-10-10 21:19:37.899511
NCT03058575|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-20|||January 16, 2017|Actual|2017-01-16|February 2017|2017-02-01|September 28, 2017|Anticipated|2017-09-28|July 28, 2017|Anticipated|2017-07-28||Interventional|||Effects of a Novel Food Product Containing Microbiota Accessible Carbohydrates on the Human Microbiome|A Randomized, Controlled, Crossover Study to Evaluate the Effects of a Novel Food Product Containing Microbiota Accessible Carbohydrates on the Human Microbiome and Associated Parameters|Recruiting||N/A|30|Anticipated|Access Business Group||2|||f||||f|f|f||||||No||2017-10-10 21:19:37.97207|2017-10-10 21:19:37.97207
NCT03058562|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-08|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome|A Randomized, Placebo-Controlled, Single-Dose Crossover Study of ABX-1431 HCl in Adult Patients With Tourette Syndrome (TS) and Chronic Motor Tic Disorder|Recruiting||Phase 1|20|Anticipated|Abide Therapeutics||4|||f||||f|f|f||||||No||2017-10-10 21:19:38.198131|2017-10-10 21:19:38.198131
NCT03058549|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-18|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Impact Evaluation of Family Expectations: A Program to Strengthen the Relationships of Disadvantaged Expectant Couples|Family Expectations: Impact Evaluation of Program for Expectant Couples|Recruiting||N/A|2710|Anticipated|Public Strategies||2|||f|||||f|f||||||||2017-10-10 21:19:38.330592|2017-10-10 21:19:38.330592
NCT03058536|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-03-13|||February 21, 2017|Actual|2017-02-21|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PRECEPET||Progesterone and Cervical Pessary in Twins|Progesterone and Cervical Pessary in Twins : A Prospective and Randomized Study to Prevent Preterm Birth (PRECEPT)|Recruiting||Phase 2/Phase 3|312|Anticipated|University of Sao Paulo||4|||f||||f|t|t|f||f|||No||2017-10-10 21:19:38.426203|2017-10-10 21:19:38.426203
NCT03058523|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-02|||March 21, 2017|Actual|2017-03-21|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|FLAVOUR||Flavour Programming: Fruit and Vegetable Palatability|Flavour Programming: Fruit and Vegetable Format Palatability|Recruiting||N/A|60|Anticipated|University of Aberdeen|||2||f||||f||||||Samples With DNA|"     Tongue and cheek cells from buccal swabs   "|No||2017-10-10 21:19:38.533545|2017-10-10 21:19:38.533545
NCT03058510|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-21|||January 17, 2016|Actual|2016-01-17|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|ORBID-OA||Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion|Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion|Recruiting||N/A|30|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||f|f|f||||||No||2017-10-10 21:19:38.619371|2017-10-10 21:19:38.619371
NCT03058497|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-02-20|||May 2014||2014-05-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|LASER||Laminar Airflow in Severe Asthma for Exacerbation Reduction|A Multi-centre Randomised, Double Blind, Placebo-controlled, Parallel Group Trial of the Effectiveness of the Nocturnal Use of a Temperature Controlled Laminar Airflow (TLA) Device (Airsonett®) in Adults With Poorly-controlled, Severe Allergic Asthma|Completed||N/A|240|Actual|Portsmouth Hospitals NHS Trust||2|||f||||t|f|f||||||No||2017-10-10 21:19:38.735639|2017-10-10 21:19:38.735639
NCT03058484|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-20|||May 1, 2015|Actual|2015-05-01|February 2017|2017-02-01|March 30, 2016|Actual|2016-03-30|March 30, 2016|Actual|2016-03-30||Interventional|||Community Health Workers and Prevention of Mother-to-Child HIV Transmission in Tanzania|Short-term Effectiveness of a Community Health Worker Intervention for HIV-infected Pregnant Women in Tanzania to Improve Treatment Adherence and Retention in Care: A Cluster-Randomized Trial|Completed||N/A|1830|Actual|University of California, Berkeley||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:38.824474|2017-10-10 21:19:38.824474
NCT03058471|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-21|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Starting Methotrexate Early in Chikungunya Arthritis|Efficacy of Starting Methotrexate Early in Chikungunya Arthritis:A 24 Week Randomized Controlled Open Label Crossover Trial|Active, not recruiting||N/A|60|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||Yes|all study data can be available after the study completion. Contact the auther.|2017-10-10 21:19:38.906671|2017-10-10 21:19:38.906671
NCT03058458|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-09-19|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A First Time in Human Study of PIN201104 in Healthy Volunteers and Patients With Asthma|A First-time-in-human, Randomised, Double-blind, Placebo-controlled, Parallel-group Study in Healthy Volunteers and Patients With Asthma to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending and Repeat Doses of PIN201104|Recruiting||Phase 1|84|Anticipated|Peptinnovate||4|||f|||||f|f||||||||2017-10-10 21:19:38.992774|2017-10-10 21:19:38.992774
NCT03058445|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-15|||January 2017||2017-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||"Assessing Validity of M-Mode Time-to-Turbulence T2T Echo Use to Confirm CVC Tip Position"|"Assessing Validity of M-Mode Time-to-Turbulence T2T Echo Use to Confirm CVC Tip Position"|Recruiting||N/A|25|Anticipated|South Tyneside NHS Foundation Trust||1|||f||||t|f|f||||||No||2017-10-10 21:19:39.087358|2017-10-10 21:19:39.087358
NCT03058432|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-16|||January 2017||2017-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma||Recruiting||Phase 2|122|Anticipated|Zhejiang Cancer Hospital||2|||f||||||||||||||2017-10-10 21:19:39.177972|2017-10-10 21:19:39.177972
NCT03058419|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-06-07|||March 14, 2017|Actual|2017-03-14|June 2017|2017-06-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects|An Open-label Drug Interaction Study in Healthy Subjects to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||1|||f||||f|f|f||||||||2017-10-10 21:19:39.256827|2017-10-10 21:19:39.256827
NCT03058406|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-08-04|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Observational|HAL03T||A Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas|Special Use Investigation of HALAVEN (HAL03T) - Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas|Recruiting||N/A|160|Anticipated|Eisai Inc.|||1||f||||f|f|f||||||||2017-10-10 21:19:39.367216|2017-10-10 21:19:39.367216
NCT03058393|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-07-11|||April 17, 2017|Actual|2017-04-17|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Analyzing Challenging Clinical Discussions in Orthopaedics|Effectiveness of Teach-back in Orthopedic Treatment Decision Discussions|Recruiting||N/A|110|Anticipated|Duke University||1|||f||||f|f|f||||||||2017-10-10 21:19:39.441783|2017-10-10 21:19:39.441783
NCT03058380|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-07-11|||August 17, 2017|Anticipated|2017-08-17|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Observational|||Stated-Preferences in Knee Arthroplasty|Examining Stated-Preferences in Knee Arthroplasty: Unicompartmental Knee Arthroplasty (UKA) or Total Knee Arthroplasty (TKA)|Not yet recruiting||N/A|500|Anticipated|Duke University|||1||f||||f|f|f||||||||2017-10-10 21:19:39.529643|2017-10-10 21:19:39.529643
NCT03058367|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-07-19|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Benefit and Tolerability of IQP-AE-103 in Weight Loss|Double-blind, Randomised, Three-armed, Placebo-controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects|Recruiting||N/A|108|Anticipated|InQpharm Group||3|||f||||f|f|f||||||||2017-10-10 21:19:39.611083|2017-10-10 21:19:39.611083
NCT03058354|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-17|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Study to Investigate TIVA With Propofol on Postoperative Pain and Side Effects|Retrospective Study to Investigate Total Intravenous Anaesthesia (TIVA) With Propofol on Postoperative Pain and Side Effects After Surgery|Recruiting||N/A|6000|Anticipated|The University of Hong Kong|||2||f||||f|f|f||||||No||2017-10-10 21:19:39.706444|2017-10-10 21:19:39.706444
NCT03058341|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-15|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Total Intravenous Anaesthesia With Propofol on Postoperative Pain After Bilateral Third Molar Surgery|Effects of Intraoperative Total Intravenous Anaesthesia With Propofol Versus Inhalational Anaesthesia on Postoperative Pain After Bilateral Third Molar Surgery|Active, not recruiting||Phase 4|110|Anticipated|The University of Hong Kong||2|||f||||t|f|f||||||Undecided||2017-10-10 21:19:39.797209|2017-10-10 21:19:39.797209
NCT03058328|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-15|||January 2017||2017-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.|Post-surgery Systemic Inflammation and Neuro-immune Interactions|Enrolling by invitation||N/A|28|Anticipated|Karolinska University Hospital|||1||f||||f||||||Samples Without DNA|"     Whoole blood from which PBMCs (Peripheral Blood Monocytic Cells), plasma, serum will be     stored.   "|||2017-10-10 21:19:39.87964|2017-10-10 21:19:39.87964
NCT03058315|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-11|||April 1, 2017|Actual|2017-04-01|February 2017|2017-02-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|||Disease Perception and Recovery From Low Back Pain|A Prospective Cohort Study With 52 Weeks Follow-up Investigating the Influence of Disease Perception on Functional Outcome Among Patients Referred From General Practice to Secondary Care for Treatment of Low Back Pain.|Recruiting||N/A|800|Anticipated|Central Jutland Regional Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:19:39.944942|2017-10-10 21:19:39.944942
NCT03058302|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-10|||January 2017||2017-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Effectiveness and Implementation of a Mental Health Intervention With Conflict-affected Communities in Ukraine|Study of Effectiveness and Implementation of Different Versions of the CETA Mental Health Intervention Among Internally Displaced Persons (IDPs) and Veterans in Ukraine|Recruiting||N/A|324|Anticipated|Johns Hopkins Bloomberg School of Public Health||3|||f||||f||||||||No|De-identified data may be shared with other collaborators and researchers. Data that is not de-identified will never be shared.|2017-10-10 21:19:40.052037|2017-10-10 21:19:40.052037
NCT03058289|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-25|||February 9, 2017|Actual|2017-02-09|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|July 2019|Anticipated|2019-07-01||Interventional|IT-01||A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6|A Phase 1/2 Safety Study of Intratumorally Administered INT230-6 in Adult Subjects With Advanced Refractory Cancers|Recruiting||Phase 1/Phase 2|60|Anticipated|Intensity Therapeutics, Inc.||9|||f||||f|t|f||||||||2017-10-10 21:19:40.171666|2017-10-10 21:19:40.171666
NCT03058276|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-15|||January 1, 2016|Actual|2016-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||New Therapeutic Strategies for Inhibitory Control in Alcoholism|New Therapeutic Strategies for Inhibitory Control Improvement of Alcohol-dependent Patients|Recruiting||N/A|105|Anticipated|Hospital Universitario 12 de Octubre||4|||f||||f|f|f||||||No||2017-10-10 21:19:40.313504|2017-10-10 21:19:40.313504
NCT03058263|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-08-15|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|February 28, 2017|Actual|2017-02-28|February 1, 2017|Actual|2017-02-01||Interventional|||Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose|The Effectiveness of Neostigmine on the Recovery of Rocuronium-Induced Neuromuscular Blockade: A Comparison Between Partial Dose and TOF Ratio-Based Adjustment Dose|Completed||Phase 1/Phase 2|66|Actual|Indonesia University||2|||f|||||f|f||||||||2017-10-10 21:19:40.419331|2017-10-10 21:19:40.419331
NCT03058250|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-15|||December 2012|Actual|2012-12-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|March 2014|Actual|2014-03-01||Interventional|||Trial Comparing Routine Intraoperative Transesophageal Echocardiography During Radical Cystectomy to Standard of Care|Randomized Control Trial Comparing Routine Intraoperative Transesophageal Echocardiography During Radical Cystectomy to Standard of Care|Completed||N/A|80|Actual|University of Chicago||2|||f||||t|f|f||||||No||2017-10-10 21:19:40.520714|2017-10-10 21:19:40.520714
NCT03058237|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-28|||January 23, 2017|Actual|2017-01-23|July 2017|2017-07-01|July 5, 2017|Actual|2017-07-05|July 5, 2017|Actual|2017-07-05||Interventional|||A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers|A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers|Completed||Phase 1|40|Actual|Indivior Inc.||14|||f||||f|f|f||||||||2017-10-10 21:19:40.590454|2017-10-10 21:19:40.590454
NCT03058224|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-03|||February 16, 2017|Actual|2017-02-16|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia|Randomized, Double-blind, Placebo-controlled Exploratory Trial to Investigate Efficacy and Safety of IGN-ES001 in Patients With Chronic Widespread Pain With or Without Fibromyalgia|Recruiting||N/A|230|Anticipated|IgNova GmbH||2|||f||||f|f|f||||||||2017-10-10 21:19:40.752108|2017-10-10 21:19:40.752108
NCT03058211|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-15|||October 1, 2017|Anticipated|2017-10-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|October 31, 2017|Anticipated|2017-10-31|3 Years|Observational [Patient Registry]|NEUMOCAR||Myocardial Injury and Severe Pneumococcal Pneumonia|Myocardial Injury in Severe Pneumococcal Pneumonia as a Cause of Mortality From Acute Cardiovascular Events|Not yet recruiting||N/A|40|Anticipated|Hospital Universitari Joan XXIII de Tarragona.|||2||f||||f|f|f||||||No||2017-10-10 21:19:40.908278|2017-10-10 21:19:40.908278
NCT03058198|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-15|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma|The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma and Its Correlation to EGFRvIII|Recruiting||N/A|40|Anticipated|Huashan Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:19:40.988347|2017-10-10 21:19:40.988347
NCT03058185|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-05-02|||July 11, 2013|Actual|2013-07-11|May 2017|2017-05-01|July 11, 2023|Anticipated|2023-07-11|July 11, 2023|Anticipated|2023-07-11|10 Years|Observational [Patient Registry]|OPALE||Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Obeservatory for PAtients With Laminopathies and Emerinopathies)|Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Obeservatory for PAtients With Laminopathies and Emerinopathies)|Recruiting||N/A|800|Anticipated|Pitié-Salpêtrière Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:19:41.07954|2017-10-10 21:19:41.07954
NCT03058172|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-15|||April 15, 2016|Actual|2016-04-15|February 2017|2017-02-01|April 15, 2019|Anticipated|2019-04-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Study of Olfaction / Vision Interactions in Expert and Novice Populations|Study of Olfaction / Vision Interactions in Expert and Novice Populations|Recruiting||N/A|120|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:19:41.150423|2017-10-10 21:19:41.150423
NCT03058159|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-06|||March 5, 2015|Actual|2015-03-05|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|May 24, 2017|Actual|2017-05-24||Interventional|||Sleep Inertia and Functional Connectivity|Sleep Inertia and Functional Connectivity Between Brain Regions at Awakening : a Functional Magnetic Resonance Imaging (fMRI) Study|Completed||N/A|44|Actual|Hospices Civils de Lyon||2|||f|||||f|f||||||||2017-10-10 21:19:41.222507|2017-10-10 21:19:41.222507
NCT03058146|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-17|||February 1, 2016|Actual|2016-02-01|February 2017|2017-02-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2021|Anticipated|2021-04-30||Interventional|||Independent Walking for Brain Health|A Novel Mobile Health Exercise Intervention in Aging: Brain Perfusion and Cognition|Recruiting||N/A|60|Anticipated|University of California, San Diego||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:41.281179|2017-10-10 21:19:41.281179
NCT03058133|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-26|||May 20, 2016|Actual|2016-05-20|April 2017|2017-04-01|May 20, 2018|Anticipated|2018-05-20|April 20, 2018|Anticipated|2018-04-20||Interventional|Face-Voice||Gender in Face-Voice Integration|Neural Correlates of Multimodal Face/Voice Processing in a Gender Task.|Recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:19:41.480178|2017-10-10 21:19:41.480178
NCT03058120|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-15|||February 19, 2014|Actual|2014-02-19|February 2017|2017-02-01|May 8, 2015|Actual|2015-05-08|May 8, 2015|Actual|2015-05-08||Interventional|||Henry Ford Heart Score Randomized Trial: Rapid Discharge of Patients Evaluated for Possible Myocardial Infarction|Henry Ford Heart Score Randomized Trial: Rapid Discharge of Patients Evaluated for Possible Myocardial Infarction|Completed||N/A|105|Actual|Henry Ford Health System||2|||f||||f|f|f||||||No||2017-10-10 21:19:41.581135|2017-10-10 21:19:41.581135
NCT03058094|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-26|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|January 1, 2020|Anticipated|2020-01-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI|A Phase III, Open-Label, Randomized Multicenter Study to Compare AC0010 and Pemetrexed/Cisplatin in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI|Not yet recruiting||Phase 3|366|Anticipated|Hangzhou ACEA Pharmaceutical Research Co.,Ltd.||2|||f||||f|f|f|||f|||No||2017-10-10 21:19:42.795842|2017-10-10 21:19:42.795842
NCT03058081|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-09-18|||August 1, 2017|Actual|2017-08-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|AiRehab||Effect of High Flow Nasal During Exercise in COPD Patients|Acute Effects of High Flow Nasal Support During Exercise in Patients With COPD After Severe Exacerbation|Recruiting||N/A|19|Anticipated|Groupe Hospitalier du Havre||2|||f||||f|f|f||||||||2017-10-10 21:19:42.924705|2017-10-10 21:19:42.924705
NCT03057522|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-15|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Step Rate in Recreational Runners|The Effect of a Home Training Program on Preferred Step Rate in Recreational Runners|Recruiting||N/A|40|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||No|No IPD will be shared with other researchers|2017-10-10 21:19:49.146756|2017-10-10 21:19:49.146756
NCT03058068|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-20|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|September 2028|Anticipated|2028-09-01|September 2027|Anticipated|2027-09-01||Interventional|HAPI||Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis|A Phase I, Randomized and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis - HAPI|Not yet recruiting||Phase 1|18|Anticipated|University of Miami||5|||||||t|t|f||||||||2017-10-10 21:19:43.026363|2017-10-10 21:19:43.026363
NCT03058055|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-03-08|||July 15, 2016|Actual|2016-07-15|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|BEST||Brain Exercises for Synaptic Plasticity|Brain Exercises for Synaptic Plasticity: the BEST Study|Active, not recruiting||N/A|45|Actual|University of Kentucky||3|||f||||f|f|f||||||No||2017-10-10 21:19:43.150195|2017-10-10 21:19:43.150195
NCT03058042|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-06-26|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 30, 2017|Anticipated|2017-12-30|August 1, 2017|Anticipated|2017-08-01||Interventional|||Outpatient and Home Pelvic Floor Training for Stress Urinary Incontinence|Outpatient Pelvic Floor Muscle Training Versus Home Pelvic Floor Muscle Training for Stress Urinary Incontinence: Randomized Controlled Trial|Not yet recruiting||N/A|48|Anticipated|Federal University of São Paulo||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:43.241715|2017-10-10 21:19:43.241715
NCT03058029|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-06-20|||February 22, 2017|Actual|2017-02-22|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|LIGHT-UP||Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and Metformin-treated Type 2 Diabetes|A Randomize, Double-blind, Placebo-controlled, Parallel-group Study Assessing the Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and Met Forming-treated Type 2 Diabetes|Recruiting||N/A|420|Anticipated|Gelesis, Inc.||3|||f||||f|f|f||||||Undecided||2017-10-10 21:19:43.340423|2017-10-10 21:19:43.340423
NCT03058016|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-15|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 1, 2022|Anticipated|2022-04-01|April 1, 2022|Anticipated|2022-04-01||Interventional|||Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study|Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study|Not yet recruiting||N/A|500|Anticipated|Galilee CBR||1|||f||||f|f|f||||||No||2017-10-10 21:19:43.452981|2017-10-10 21:19:43.452981
NCT03058003|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-17|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Correlation Between Central Sensitization Inventory and Posturographic Data|Correlation Between Central Sensitization Inventory and Posturographic Data|Enrolling by invitation||N/A|300|Anticipated|Caps Research Network|||2||f||||f|f|f||||||No||2017-10-10 21:19:43.531264|2017-10-10 21:19:43.531264
NCT03057990|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-04-13|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS) That Has Relapsed or Refractory to Azanucleosides|A Phase 1 Study of Pyrimethamine, a STAT3 Inhibitor, for the Treatment of Intermediate/ High-risk Myelodysplastic Syndromes (MDS) That Has Relapsed or is Refractory to Azanucleosides|Not yet recruiting||Phase 1|6|Anticipated|University of Kansas Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:19:43.642914|2017-10-10 21:19:43.642914
NCT03057977|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-10-03|||March 6, 2017|Actual|2017-03-06|October 2017|2017-10-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)|Efficacy and Safety of Empagliflozin Compared to Placebo in Patients With Heart Failure With Reduced Ejection Fraction|Recruiting||Phase 3|2850|Anticipated|Boehringer Ingelheim||2|||f||||t|t|f||||||||2017-10-10 21:19:43.745286|2017-10-10 21:19:43.745286
NCT03057964|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-13|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|March 29, 2018|Anticipated|2018-03-29|March 29, 2018|Anticipated|2018-03-29||Interventional|||PDL and Fractional Photothermolysis for Postsurgical Scars|The Effect of Combined Treatment of PDL and Fractional Photothermolysis on the Cosmetic Appearance of Postsurgical Scars|Enrolling by invitation||N/A|150|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 21:19:44.323375|2017-10-10 21:19:44.323375
NCT03057951|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-10-03|||March 2, 2017|Actual|2017-03-02|October 2017|2017-10-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)|A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)|Recruiting||Phase 3|4126|Anticipated|Boehringer Ingelheim||2|||f||||t|t|f||||||||2017-10-10 21:19:44.460468|2017-10-10 21:19:44.460468
NCT03057938|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-15|||March 15, 2017|Anticipated|2017-03-15|February 2017|2017-02-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Interventional|||Subjects With Subjective Cognitive Decline: 18F-Florbetaben Positron Emission Tomography Study|Subjects With Subjective Cognitive Decline: 18F-Florbetaben Positron Emission Tomography Study|Not yet recruiting||Phase 2|30|Anticipated|Fundacion Clinic per a la Recerca Biomédica||1|||f||||f|t|f|||f|||||2017-10-10 21:19:45.311857|2017-10-10 21:19:45.311857
NCT03057925|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-06-17|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ultrasound-guided Percutaneous Microwave Ablation for Benign Thyroid Nodules|Ultrasound-guided Percutaneous Microwave Ablation for Benign Thyroid Nodules|Recruiting||N/A|60|Anticipated|First Affiliated Hospital of Wenzhou Medical Univeristy||2|||f||||t|f|f||||||No||2017-10-10 21:19:45.386924|2017-10-10 21:19:45.386924
NCT03057912|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-06-07|||January 15, 2018|Anticipated|2018-01-15|June 2017|2017-06-01|January 15, 2019|Anticipated|2019-01-15|November 15, 2018|Anticipated|2018-11-15||Interventional|||A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ|A Safety and Efficacy Study of Transcription Activator-like Effector Nucleases and Clustered Regularly Interspaced Short Palindromic Repeat/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ|Not yet recruiting||Phase 1|60|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:19:45.466904|2017-10-10 21:19:45.466904
NCT03057899|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-17|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy of Fenugreek Seed and Lespedeza Cuneata in TDS|Efficacy and Safety of a Mixed Extract of Fenugreek Seed and Lespedeza Cuneata in the Treatment of Testosterone Deficiency Syndrome: A Randomized, Double-blind, Placebo-Controlled Clinical Trial|Completed||Phase 4|88|Actual|Pusan National University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:19:45.656777|2017-10-10 21:19:45.656777
NCT03057886|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-15|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01|1 Day|Observational [Patient Registry]|||Study to Evaluate the Accuracy of the New Monitor of Temperature in Comparison With the Consecrated Thermometers by Literature|"COMPARATIVE STUDY BETWEEN THE USE OF THE SPOT ON THERMOMETER AND THE ORAL AND ESOPHAGEAL THERMOMETERS IN SPINAL AND GENERAL ANESTHESIA"|Not yet recruiting||N/A|210|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo|||1||f||||t|f|t|f|f|t|||No|We will publish the data and result after the conclusion of study.|2017-10-10 21:19:45.791235|2017-10-10 21:19:45.791235
NCT03057873|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-04-06|||February 13, 2017|Actual|2017-02-13|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of a High Protein, High Fiber Dietary Supplement on Weight and Fat Loss|A Double Blind, Placebo Controlled Parallel Study to Investigate the Effect of a High Protein, High Fiber Dietary Supplement on Weight and Fat Loss in Healthy Overweight Adults|Recruiting||N/A|200|Anticipated|Beachbody||2|||f|||||f|f||||||||2017-10-10 21:19:45.889505|2017-10-10 21:19:45.889505
NCT03057860|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-15|||February 1, 2016|Actual|2016-02-01|February 2017|2017-02-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2021|Anticipated|2021-01-31|2 Years|Observational [Patient Registry]|TREATgermany||TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis|TREATgermany: German National Clinical Registry: Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis|Recruiting||N/A|600|Anticipated|Technische Universität Dresden|||1||f||||f|f|f||||||No||2017-10-10 21:19:46.071973|2017-10-10 21:19:46.071973
NCT03057847|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-07|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection|Management of Hepatitis C Virus (HCV) Infection in Pregnant Women With Opioid Use Disorder (OUD): the Potential of an Integrated Medical Home Model: Phase IV Trial of Sofosbuvir/Velpatasvir (SOF/VEL) in Postpartum Women With Chronic HCV|Not yet recruiting||Phase 4|75|Anticipated|University of Pittsburgh||1|||f||||f|t|f|||f|||||2017-10-10 21:19:46.180074|2017-10-10 21:19:46.180074
NCT03057834|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-07|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|UNITS||The Urinary Incontinence Treatment Study|Exploring the Role of Sarcopenia and Functional Impairment on the Non-Surgical Management of Urinary Incontinence in Older Women|Recruiting||N/A|100|Anticipated|Wake Forest University Health Sciences||2|||f||||t|f|f||||||No||2017-10-10 21:19:46.309817|2017-10-10 21:19:46.309817
NCT03057821|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-21|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Propionibacterium Acnes in Shoulder Arthroplasty|Does Hydrogen Peroxide Skin Preparation Reduce Propionibacterium Acnes in Shoulder Arthroplasty?|Enrolling by invitation||N/A|60|Anticipated|University of Utah||2|||f||||f|f|f||||||||2017-10-10 21:19:46.425966|2017-10-10 21:19:46.425966
NCT03057808|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-15|||February 6, 2017|Actual|2017-02-06|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|January 2020|Anticipated|2020-01-01||Interventional|||Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight)|Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women|Recruiting||N/A|450|Anticipated|University of Tennessee||3|||f||||f|f|f||||||||2017-10-10 21:19:46.522248|2017-10-10 21:19:46.522248
NCT03057795|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-15|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma|A Phase 2 Study of Nivolumab and Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplantation in Patients With High-Risk Classical Hodgkin Lymphoma|Recruiting||Phase 2|65|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:19:46.658262|2017-10-10 21:19:46.658262
NCT03057782|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-02-15|||October 2016||2016-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|||Innovative Approaches to Assessment of Pain Control and Sedation in the NICU|Innovative Approaches to Assessment of Pain Control and Sedation in the NICU|Recruiting||N/A|50|Anticipated|Boston Children’s Hospital|||4||f||||f||||||||No||2017-10-10 21:19:46.837161|2017-10-10 21:19:46.837161
NCT03057769|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-15|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin|Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin: A Multi-center, Double-blind, Randomized Controlled Trial|Recruiting||N/A|3300|Anticipated|Fourth Military Medical University||2|||f||||t|f|f||||||No||2017-10-10 21:19:46.991258|2017-10-10 21:19:46.991258
NCT03057756|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-17|||September 11, 2015|Actual|2015-09-11|February 2017|2017-02-01|March 1, 2021|Anticipated|2021-03-01|April 4, 2019|Anticipated|2019-04-04|15 Months|Observational [Patient Registry]|TB-MR||Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance|Nine Months' Short Course Regimen Protocol for the Treatment of Multidrug Resistance-tuberculosis (MDR-TB) Patients in Gabon|Recruiting||N/A|30|Anticipated|Centre de Recherche Médicale de Lambaréné|||1||f||||f|f|f||||||No||2017-10-10 21:19:47.237994|2017-10-10 21:19:47.237994
NCT03057743|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-16|2017-02-16|||April 5, 2016|Actual|2016-04-05|February 2017|2017-02-01||||April 5, 2019|Anticipated|2019-04-05||Observational|||Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer|Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer|Recruiting||N/A|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t|f|t|f|f||||||2017-10-10 21:19:47.368256|2017-10-10 21:19:47.368256
NCT03057730|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-02-15|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|August 2021|Anticipated|2021-08-01|June 2021|Anticipated|2021-06-01||Interventional|||A Clinical Trial Testing Root Coverage With Acellular Dermal Matrix in Thin and Thick Gingival Biotypes|Acellular Dermal Matrix Combined With Coronally Advanced Flap in the Treatment of Multiple Recession Defects in Thin Versus Thick Periodontal Biotype Population: A Controlled Clinical Investigation|Recruiting||Phase 4|50|Anticipated|Tufts University School of Dental Medicine||2|||f||||f||||||||No||2017-10-10 21:19:47.457014|2017-10-10 21:19:47.457014
NCT02993861|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Pharmacokinetics of Anti-epileptic Drugs in Obese Children|Pharmacokinetics of Anti-epileptic Drugs in Obese Children|Recruiting||N/A|96|Anticipated|Duke University|||4||f||||t||||||||||2017-10-10 21:31:43.889554|2017-10-10 21:31:43.889554
NCT03057717|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-15|||August 20, 2010|Actual|2010-08-20|February 2017|2017-02-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Interventional|||The Effect of Antenatal Corticosteroids on the Fetal Thymus - a Possible Role in Fetal Immune Programming|The Effect of Antenatal Corticosteroids on the Fetal Thymus - a Possible Role in Fetal Immune|Completed||N/A|86|Actual|St. Michael's Hospital, Toronto||1|||f||||f|f|f||||||No||2017-10-10 21:19:47.566057|2017-10-10 21:19:47.566057
NCT03057704|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-07-29|||December 5, 2016|Actual|2016-12-05|February 2017|2017-02-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Comparison of Two Techniques of IV Lidocaine on Propofol Injection Pain|Comparison of Two Techniques of Administering IV Lidocaine in Reducing Propofol Injection Pain|Completed||Phase 4|50|Actual|Wake Forest University Health Sciences||2|||f||||t|t|f|||t|||||2017-10-10 21:19:47.644029|2017-10-10 21:19:47.644029
NCT03057691|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-26|||March 2017|Anticipated|2017-03-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Observational|||The Impact of Depression and/or Anxiety on PCI Patients|The Impact of Major Depressive and/or Generalized Anxiety Disorder on Patients With Acute Myocardial Infarction After Percutaneous Coronary Interventions|Not yet recruiting||N/A|5000|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||5||f||||f||||||||||2017-10-10 21:19:47.7426|2017-10-10 21:19:47.7426
NCT03057678|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-08-30|||October 2018|Anticipated|2018-10-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|PPF||Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery|Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery|Not yet recruiting||N/A|10|Anticipated|Vanderbilt University Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:19:47.857825|2017-10-10 21:19:47.857825
NCT03057665|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-24|||October 2010||2010-10-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Atomic Magnetometer for Fetal Biomagnetism|Atomic Magnetometer for Fetal Biomagnetism|Enrolling by invitation||N/A|35|Anticipated|University of Wisconsin, Madison|||1||f||||f|f|f||||||No||2017-10-10 21:19:47.964263|2017-10-10 21:19:47.964263
NCT03057652|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-15|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training|Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training|Recruiting||N/A|75|Anticipated|The University of Texas Health Science Center, Houston||6|||f||||f|f|t|f|f|f|||||2017-10-10 21:19:48.090506|2017-10-10 21:19:48.090506
NCT03057639|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-08-19|||February 3, 2017|Actual|2017-02-03|August 2017|2017-08-01|February 3, 2020|Anticipated|2020-02-03|August 3, 2019|Anticipated|2019-08-03||Observational|||Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With Cancer|Adolescent and Young Adult (AYA) Cancers Clinical Model: An Evaluation of the AYA Clinical Care Model by Assessment of Clinical, Psychosocial, and Health Economic Factors Related to AYA Patient Outcomes|Recruiting||N/A|850|Anticipated|University of Southern California|||1||f||||t|f|f||||||||2017-10-10 21:19:48.312795|2017-10-10 21:19:48.312795
NCT03057626|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-06-06|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma|LEAHRN (Late Effects After High-Risk Neuroblastoma) Study|Recruiting||N/A|400|Anticipated|Children's Oncology Group|||1||f||||t||||||||||2017-10-10 21:19:48.424933|2017-10-10 21:19:48.424933
NCT03057613|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-15|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|January 15, 2022|Anticipated|2022-01-15|January 15, 2020|Anticipated|2020-01-15||Interventional|||The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck|A Phase II Study of the Addition of Pembrolizumab to Postoperative Radiotherapy in Resected High Risk Cutaneous Squamous Cell Cancer of the Head and Neck|Recruiting||Phase 2|37|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:19:48.512105|2017-10-10 21:19:48.512105
NCT03057600|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-15|||May 9, 2017|Actual|2017-05-09|September 2017|2017-09-01|May 1, 2020|Anticipated|2020-05-01|October 31, 2018|Anticipated|2018-10-31||Interventional|||Study of CB-839 in Combination w/ Paclitaxel in Patients of African Ancestry and Non-African Ancestry With Advanced TNBC|A Multicenter Phase 2 Study of the Glutaminase Inhibitor CB-839 in Combination With Paclitaxel in Patients With Advanced Triple Negative Breast Cancer (TNBC) Including Patients of African Ancestry and Non-African Ancestry|Recruiting||Phase 2|112|Anticipated|Calithera Biosciences, Inc||4|||f||||f|t|f||||||||2017-10-10 21:19:48.600724|2017-10-10 21:19:48.600724
NCT03057587|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-15|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||The Newborn Project: Examining the Oxygenation of Brain Tissue During General Anesthesia|The Newborn Project: A Prospective Observational Study Examining the Oxygenation of Brain Tissue During General Anesthesia Using Near Infrared Spectroscopy Technology|Not yet recruiting||N/A|200|Anticipated|Boston Children’s Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:19:48.730688|2017-10-10 21:19:48.730688
NCT03057574|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-08-29|||February 9, 2017|Actual|2017-02-09|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|GIVF||Gonapure® in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI|An Interventional Study to Assess the Efficacy and Safety of Gonapure® in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI|Recruiting||Phase 4|200|Anticipated|MinaPharm Pharmaceuticals||1|||f||||t|f|f||||||||2017-10-10 21:19:48.797856|2017-10-10 21:19:48.797856
NCT03057561|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-02-15|||October 1, 2016|Actual|2016-10-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Efficacy of Dotarem® (Gd-DOTA) Versus Magnevist® (Gd-DTPA) for Late Gadolinium Enhancement Cardiac Magnetic Resonance|Efficacy of Dotarem® (Gd-DOTA) Versus Magnevist® (Gd-DTPA) for Late Gadolinium Enhancement Cardiac Magnetic Resonance and Relationship to Outcomes: A Pilot Study|Enrolling by invitation||N/A|120|Anticipated|The Methodist Hospital System||2|||f||||f||||||||Undecided||2017-10-10 21:19:48.900459|2017-10-10 21:19:48.900459
NCT03057548|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-24|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PIVoTAL||Comparison of Pulmonary Vein Ablation With or Without Left Atrial Posterior Wall Ablation for Persistent AF (PIVoTAL)|Left Atrial Posterior Wall Isolation in Conjunction With Pulmonary Vein Isolation for Treatment of Persistent Atrial Fibrillation (PIVoTAL) Trial|Recruiting||N/A|100|Anticipated|Sacramento EP Research||2|||f||||f|f|f||||||No||2017-10-10 21:19:48.97173|2017-10-10 21:19:48.97173
NCT03057509|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|October 2019|Anticipated|2019-10-01||Interventional|||A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors|A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors|Not yet recruiting||Phase 1|30|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 21:19:49.214199|2017-10-10 21:19:49.214199
NCT03057496|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-09-07|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Collision Warning Device for Blind and Visually Impaired|Wearable Collision Warning Device for Blind and Visually Impaired: Clinical Trial (As Part of: 'Development of a Vision Assistive Device for Veterans With Traumatic Brain Injury-Associated Visual Dysfunctions')|Not yet recruiting||N/A|90|Anticipated|Massachusetts Eye and Ear Infirmary||1|||f||||f|f|t|f||f|||||2017-10-10 21:19:49.333898|2017-10-10 21:19:49.333898
NCT03057483|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-11|||April 6, 2017|Actual|2017-04-06|July 2017|2017-07-01|December 6, 2017|Anticipated|2017-12-06|September 6, 2017|Anticipated|2017-09-06||Observational|FLU-05-IB||Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute|Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (Split Virion and Inactivated) Produced at Butantan Institute|Recruiting||N/A|900|Anticipated|Butantan Institute|||5||f||||f|f|f||||||||2017-10-10 21:19:49.430971|2017-10-10 21:19:49.430971
NCT03057470|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-02-17|||May 2016||2016-05-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|FIT||Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT)|Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes: The FIT Study|Recruiting||Phase 4|18|Anticipated|LMC Diabetes & Endocrinology Ltd.||4|||f||||f||||||||No|Only overall study data will be shared|2017-10-10 21:19:49.550463|2017-10-10 21:19:49.550463
NCT03057457|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-30|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population|The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population|Recruiting||N/A|530|Anticipated|BioPorto Diagnostics|||1||f||||f|f|t|t|f|f|||No||2017-10-10 21:19:49.651014|2017-10-10 21:19:49.651014
NCT03057444|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-28|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RSDD||Resistant Starch, Gut Bacteria and Diabetes|Influence of Resistant Starch Type III on Butyrate-producing Gut Bacteria and Diabetes Parameter in (Pre-) Diabetes|Recruiting||N/A|16|Anticipated|University of Hohenheim||1|||f||||f|f|f||||||No||2017-10-10 21:19:49.730903|2017-10-10 21:19:49.730903
NCT03057431|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-07-04|||March 9, 2017|Actual|2017-03-09|July 2017|2017-07-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2021|Anticipated|2021-02-28||Interventional|NOSTONE||Randomized Double-blind Placebo-controlled Trial Assessing the Efficacy of Standard and Low Dose Hydrochlorothiazide Treatment in the Prevention of Recurrent Nephrolithiasis|Randomized Double-blind Placebo-controlled Trial Assessing the Efficacy of Standard and Low Dose Hydrochlorothiazide Treatment in the Prevention of Recurrent Nephrolithiasis|Recruiting||Phase 3|416|Anticipated|University Hospital Inselspital, Berne||4|||f||||f|f|f||||||||2017-10-10 21:19:51.588753|2017-10-10 21:19:51.588753
NCT03057418|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-22|||June 2013|Actual|2013-06-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim|Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim Multiple Doses in Patients With Recurrent/Refractory В-cell, CD20-positive Non-Hodgkin Lymphoma of Low Tumor Grade or With Follicular Lymphoma|Completed||Phase 1|7|Actual|Biointegrator LLC||1|||f||||t||||||||No||2017-10-10 21:19:51.739761|2017-10-10 21:19:51.739761
NCT03057405|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-28|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Observational|||Intra-operative (IO) Navigation and IO-CBCT for 3D Orbital Reconstruction|Intra-operative (IO) Navigation and IO-CBCT for 3D Orbital Reconstruction in Post-traumatic and Post-ablative Defects. Evaluation of the Potential of a Fully Integrated Brainlab Iplan System.|Active, not recruiting||N/A|40|Anticipated|AZ Sint-Jan AV|||3||f||||f|f|f||||||No||2017-10-10 21:19:51.819964|2017-10-10 21:19:51.819964
NCT03057392|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-04-18|||May 2013||2013-05-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Head Out Water Immersion for Hemodynamic Stability During Dialysis|The Effect of Head Out Water Immersion During Dialysis on Clinical Parameters, Hemodynamic Parameters, and Hormonal Parameters in 10 Hemodialysis Patients|Completed||N/A|10|Actual|Assaf-Harofeh Medical Center||2|||f||||t||||||||||2017-10-10 21:19:51.880766|2017-10-10 21:19:51.880766
NCT03057379|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-27|||February 27, 2017|Actual|2017-02-27|February 2017|2017-02-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2018|Anticipated|2018-12-15||Interventional|||HPV IIS Reminder/Recall- New York State|State Immunization Information Systems to Improve HPV Vaccination Rates|Enrolling by invitation||N/A|45000|Anticipated|University of California, Los Angeles||4|||f||||f|f|f||||||Undecided||2017-10-10 21:19:51.967411|2017-10-10 21:19:51.967411
NCT03057366|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-06-06|||May 11, 2017|Actual|2017-05-11|June 2017|2017-06-01|May 3, 2019|Anticipated|2019-05-03|May 4, 2018|Anticipated|2018-05-04||Interventional|||A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors|A Phase 1 Study to Assess Mass Balance, Pharmacokinetics, and Metabolism of [14C]-Pevonedistat in Patients With Advanced Solid Tumors|Recruiting||Phase 1|6|Anticipated|Takeda||1|||f||||t|f|f||||||||2017-10-10 21:19:52.046276|2017-10-10 21:19:52.046276
NCT03057353|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-15|||May 2012|Actual|2012-05-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Observational|||Risk Factors for Ligamentum Flavum Hypertrophy in Lumbar Spinal Stenosis Patients|Risk Factors for Ligamentum Flavum Hypertrophy in Lumbar Spinal Stenosis Patients From Xinjiang Uygur Autonomous Region of China: a Retrospective, Single-center, Case Analysis|Active, not recruiting||N/A|104|Actual|Sixth Affiliated Hospital of Xinjiang Medical University|||1||f||||t|f|t|f|f||||Undecided||2017-10-10 21:19:52.153768|2017-10-10 21:19:52.153768
NCT03057340|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-17|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells|The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting|Not yet recruiting||Phase 1|30|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||1|||f||||f|f|f||||||No||2017-10-10 21:19:52.217846|2017-10-10 21:19:52.217846
NCT03057314|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-02-15|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Improving the Function and Welfare of Late-stage Solid Cancer Subjects by ACC Administered Orally and Concomitantly With Inhalation|An Exploratory, Open Label Study to Improve the Function and Welfare of Late-stage Solid Cancer Subjects (With or Without Lung Involvement) by Amorphous Calcium Carbonate (ACC) Treatment, Administered Orally and Concomitantly With Inhalation|Not yet recruiting||Phase 1|20|Anticipated|Amorphical Ltd.||1|||f||||f||||||||No||2017-10-10 21:19:52.46926|2017-10-10 21:19:52.46926
NCT03057301|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-15|||April 1, 2016|Actual|2016-04-01|February 2017|2017-02-01|March 1, 2017|Anticipated|2017-03-01|March 1, 2017|Anticipated|2017-03-01||Observational|||Assessment of Home Tonometry in Glaucoma|Assessment of Home Tonometry in Glaucoma|Recruiting||N/A|100|Anticipated|NHS Lothian|||1||f||||f|f|t|t|f|f|||No||2017-10-10 21:19:52.549546|2017-10-10 21:19:52.549546
NCT03057288|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-12|||February 3, 2017|Actual|2017-02-03|May 2017|2017-05-01|February 28, 2019|Anticipated|2019-02-28|February 3, 2019|Anticipated|2019-02-03||Interventional|FIDECHO||Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer|Prospective Study Evaluating the Feasibility of Fiducial Markers Placement Under Echoendoscopy (EUS) Guidance for Patients With Esophageal or Rectal Cancer With an Indication of Radiotherapy|Recruiting||N/A|40|Anticipated|Société Française d'Endoscopie Digestive||1|||f||||f|f|f|||f|||Undecided||2017-10-10 21:19:52.638896|2017-10-10 21:19:52.638896
NCT03057275|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-05-03|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|September 30, 2017|Anticipated|2017-09-30||Observational|||Performance of the Monica Novii Wireless Patch System in Pre-term Labor|Performance of the Monica Novii Wireless Patch System in Pre-term Labor|Recruiting||N/A|60|Anticipated|Monica Healthcare Ltd|||2||f||||f|f|t|f|f|f|||No||2017-10-10 21:19:52.734916|2017-10-10 21:19:52.734916
NCT03057262|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-19|||February 2014|Actual|2014-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|February 2014|Actual|2014-02-01||Observational|||The Efficiency of Anterior Repositioning Splint for the Management of Temporomandibular Joint Dysunction|The Efficiency of Anterior Repositioning Splint for the Management of Pain Related to Temporomandibular Joint Disc Displacement With Reduction|Completed||N/A|112|Actual|Jagiellonian University|||2||f||||f|f|t|f|f|f|||No||2017-10-10 21:19:52.834344|2017-10-10 21:19:52.834344
NCT03057249|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-23|||January 1, 2013|Actual|2013-01-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|July 1, 2017|Anticipated|2017-07-01||Observational|DIRTSURGERY||Skin Perfusion After Abdominal Surgery|The Impact of a Selected Surgical Procedure on Skin Blood Perfusion of the Abdominal Wall Evaluated by Dynamic Infrared Thermography (DIRT)|Recruiting||N/A|60|Anticipated|University Hospital of North Norway|||1||f||||f|f|f||||||No|The study is based on qualitative evaluation of individual thermographic images that are not suitable for public sharing|2017-10-10 21:19:52.907392|2017-10-10 21:19:52.907392
NCT03057236|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-17|||March 1, 2014|Actual|2014-03-01|February 2017|2017-02-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Interventional|||Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients|A Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Patients Undergoing Antiviral Therapy for Chronic Hepatitis C|Completed||N/A|20|Actual|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||No||2017-10-10 21:19:52.998374|2017-10-10 21:19:52.998374
NCT03057223|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-17|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|July 1, 2021|Anticipated|2021-07-01|March 31, 2021|Anticipated|2021-03-31||Interventional|3DJP16||Three-Dimensional Printing of Patient-Specific Titanium Plates in Jaw Surgery: A Pilot Study|Three-Dimensional Printing of Patient-Specific Titanium Plates in Jaw Surgery: An Open-Label, Prospective Pilot Clinical Study|Recruiting||N/A|48|Anticipated|The University of Hong Kong||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:19:53.100977|2017-10-10 21:19:53.100977
NCT03057210|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-18|||September 18, 2017|Anticipated|2017-09-18|September 2017|2017-09-01|December 22, 2017|Anticipated|2017-12-22|December 18, 2017|Anticipated|2017-12-18||Interventional|||Effects of Massage on Post-exercise Recovery on Functional Performance|Effects of Massage on Post-exercise Recovery on Functional, Clinical and Metabolic Outcomes|Not yet recruiting||N/A|40|Anticipated|São Paulo State University||5|||f||||t|f|f||||||||2017-10-10 21:19:53.204155|2017-10-10 21:19:53.204155
NCT03057197|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-23|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|December 30, 2017|Anticipated|2017-12-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||The Influence of Needle-insertion Depth on Successful Epidurogram and Clinical Outcome in Caudal Epidural Injections|The Influence of Needle-insertion Depth on Successful Epidurogram and Clinical Outcome in Caudal Epidural Injections: A Randomized Clinical Trial|Recruiting||N/A|170|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:19:53.299444|2017-10-10 21:19:53.299444
NCT03057184|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-17|||February 12, 2017|Actual|2017-02-12|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 12, 2017|Anticipated|2017-12-12||Interventional|PROCENDIAS||Behavioral Problems Related to Attendance Adult Day Care Centers|Behavioral Intervention to Reduce Resistance in Those Attending Adult Day Care Centers: PROCENDIAS Study. A Randomized Clinical Trial|Active, not recruiting||N/A|120|Actual|Fundacion para la Investigacion y Formacion en Ciencias de la Salud||2|||f||||t|f|f||||||Undecided||2017-10-10 21:19:53.362468|2017-10-10 21:19:53.362468
NCT03057171|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA|A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA|Recruiting||N/A|50|Anticipated|Yonsei University|||4||f||||f|f|f||||Samples With DNA|"     EGD, forcep biopsy   "|No||2017-10-10 21:19:53.436801|2017-10-10 21:19:53.436801
NCT03057158|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-23|||May 1, 2017|Actual|2017-05-01|February 2017|2017-02-01|January 18, 2019|Anticipated|2019-01-18|January 18, 2019|Anticipated|2019-01-18||Observational|GENIE||Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study|Epigenomics in Insulin Resistance Associated Overactive Bladder.|Recruiting||N/A|450|Anticipated|Duke University|||3||f||||f|f|f||||Samples With DNA|"     Urine and blood samples.   "|No||2017-10-10 21:19:53.504329|2017-10-10 21:19:53.504329
NCT03057145|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-01|||March 10, 2017|Actual|2017-03-10|August 2017|2017-08-01|February 25, 2023|Anticipated|2023-02-25|February 25, 2020|Anticipated|2020-02-25||Interventional|||Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors|Phase 1 Combination Study of Prexasertib (LY2606368), CHK1 Inhibitor, and Olaparib, PARP Inhibitor, in Patients With Advanced Solid Tumors|Recruiting||Phase 1|24|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:19:53.601254|2017-10-10 21:19:53.601254
NCT03057132|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-02-15|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula|A Pilot Study Evaluating the Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula|Terminated||N/A|1|Actual|3M||1||Slow enrollment of patients|f||||f||||||||No||2017-10-10 21:19:53.704709|2017-10-10 21:19:53.704709
NCT03057119|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-08-28|||October 15, 2017|Anticipated|2017-10-15|August 2017|2017-08-01|March 30, 2021|Anticipated|2021-03-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||Feasibility of SBIRT-PN|Feasibility of Screening, Brief Intervention, Referral to Treatment With Peer Navigation (SBIRT-PN) for Underserved HIV+ Adults 50+ in Primary Care Settings.|Not yet recruiting||N/A|100|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 21:19:53.781951|2017-10-10 21:19:53.781951
NCT03057093|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||January 1, 2011|Actual|2011-01-01|February 2017|2017-02-01|January 15, 2017|Actual|2017-01-15|September 30, 2013|Actual|2013-09-30||Observational|T-infarction||TIII Over TI in Subjects With Myocardial Infarction|Assessment of T Wave Changes of Patients With Acute Non-ST-elevation Myocardial Infarction|Completed||N/A|903|Actual|University of Cologne|||2||f||||t|f|f||||||No||2017-10-10 21:19:54.130125|2017-10-10 21:19:54.130125
NCT03057080|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-14|||June 1, 2009|Actual|2009-06-01|February 2017|2017-02-01|December 1, 2016|Actual|2016-12-01|June 1, 2015|Actual|2015-06-01||Interventional|||The Role of Percutaneous Angioplasty in Ischemic Leg Ulcer Healing|Peripheral Angioplasty as the First Choice Revascularization Procedure to Promote Ischemic Leg Ulcer Healing|Completed||N/A|161|Actual|University of Crete||1|||f|||||f|f||||||No||2017-10-10 21:19:54.207345|2017-10-10 21:19:54.207345
NCT03057067|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-05-25|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Embolization of Pelvic Varicosities in Patients With Pelvic Congestion Syndrome|Embolization of Pelvic Varicosities in Patients With Pelvic Congestion Syndrome|Recruiting||N/A|30|Anticipated|St. Olavs Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:19:54.304043|2017-10-10 21:19:54.304043
NCT03057054|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-10-05|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant|The Effectiveness of Lactobacillus Plantarum (LBP) in Preventing Acute Graft-Versus-Host Disease (GvHD) in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)|Not yet recruiting||Phase 3|500|Anticipated|Children's Oncology Group||2|||f||||t|t|f||||||||2017-10-10 21:19:54.396788|2017-10-10 21:19:54.396788
NCT03057041|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-03|||March 23, 2017|Actual|2017-03-23|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration|Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration: A Randomized Controlled Trial|Recruiting||N/A|106|Anticipated|University of Hawaii||2|||f||||f|f|f|||f|||No||2017-10-10 21:19:54.512235|2017-10-10 21:19:54.512235
NCT03057028|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-05-18|||April 2016||2016-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension|Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension|Recruiting||Phase 1|10|Anticipated|Virginia Commonwealth University||1|||f||||f||||||||Undecided||2017-10-10 21:19:54.592328|2017-10-10 21:19:54.592328
NCT03057015|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-11|||May 22, 2017|Anticipated|2017-05-22|May 2017|2017-05-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Addition of Clonidine to Ropivacaine in Adductor Canal Block|Addition of Clonidine to Ropivacaine in Adductor Canal Block for Postoperative Pain Relief in Total Knee Arthroplasty: A Prospective Randomized Double Blind Placebo Controlled Trial|Not yet recruiting||Phase 4|80|Anticipated|University of Vermont||2|||f||||t|t|f|||t|||Undecided||2017-10-10 21:19:54.67639|2017-10-10 21:19:54.67639
NCT03057002|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-14|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|HPHCM||UTSW HP [13-C] Pyruvate Injection in HCM|Detection of Regional Myocardial Metabolic Changes in Patients With Hypertrophic Cardiomyopathy Using Hyperpolarized Carbon 13 Magnetic Resonance Spectroscopic Imaging (MRSI)|Not yet recruiting||N/A|10|Anticipated|University of Texas Southwestern Medical Center|||2||f||||f|t|f||||||No||2017-10-10 21:19:54.761114|2017-10-10 21:19:54.761114
NCT03056989|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-01|||May 31, 2017|Actual|2017-05-31|September 2017|2017-09-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Interventional|||A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis|A Phase 1, Single-Center, Open-Label Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis|Completed||Phase 1|5|Actual|Spyryx Biosciences, Inc.||3|||f|||||f|f||||||||2017-10-10 21:19:54.836779|2017-10-10 21:19:54.836779
NCT03056976|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||July 2016||2016-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CEAIMPLANT||Cost-effectiveness of Implant Treatment for the Edentulous Mandible|Cost-effectiveness of Implant Treatment for the Edentulous Mandible|Enrolling by invitation||N/A|48|Actual|Universidade Federal de Goias||3|||f||||f||||||||No||2017-10-10 21:19:54.915022|2017-10-10 21:19:54.915022
NCT03056963|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-07-17|||March 17, 2017|Actual|2017-03-17|July 2017|2017-07-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||Guided Imagery Training and Self-Referential Processing|Guided Imagery Training and Self-Referential Processing|Completed||N/A|86|Actual|University of Texas at Austin||2|||f||||f|f|f||||||||2017-10-10 21:19:55.007332|2017-10-10 21:19:55.007332
NCT03056950|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||March 2016||2016-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||BFR DISTRAD NON OP: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture|BFR DISTRAD NON OP: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture|Recruiting||N/A|52|Anticipated|Brooke Army Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:19:55.098524|2017-10-10 21:19:55.098524
NCT03056937|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||February 1, 2016|Actual|2016-02-01|February 2017|2017-02-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Effects of Bariatric Surgery on Inspiratory Metaboreflex in Obese Subjects|Effects of Bariatric Surgery on Inspiratory Metaboreflex in Metabolically Healthy Obese and Obese Subjects With Metabolic Syndrome|Recruiting||N/A|45|Anticipated|University of Cruz Alta|||3||f||||f|f|f||||||No||2017-10-10 21:19:55.200809|2017-10-10 21:19:55.200809
NCT03056924|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-07-10|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab|Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in Inflammatory Bowel Disease Patients Treated With Vedolizumab|Recruiting||N/A|400|Anticipated|Boston Medical Center|||4||f||||t|t|f|||t|||||2017-10-10 21:19:55.307437|2017-10-10 21:19:55.307437
NCT03056911|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Clinical Effects of Ozone Therapy in Cervical Disc Hernia|Clinical Effects of Ozone Therapy in Cervical Disc Hernia|Recruiting||N/A|43|Anticipated|Sakarya University|||1||f||||f|f|f||||||Undecided||2017-10-10 21:19:55.453689|2017-10-10 21:19:55.453689
NCT03056898|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||September 21, 2016|Actual|2016-09-21|February 2017|2017-02-01|December 30, 2016|Actual|2016-12-30|September 23, 2016|Actual|2016-09-23||Observational|||Health Professional Dietary Habits and Blood Omega-3 Fatty Acid Concentrations|Health Professional Dietary Habits and Blood Omega-3 Fatty Acid Concentrations|Completed||N/A|387|Actual|DSM Nutritional Products, Inc.|||1||f||||f|f|f||||||No||2017-10-10 21:19:55.543363|2017-10-10 21:19:55.543363
NCT03056885|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-14|||November 2, 2015|Actual|2015-11-02|February 2017|2017-02-01|January 15, 2016|Actual|2016-01-15|November 25, 2015|Actual|2015-11-25||Interventional|||Inflammatory Local Response During OLV: Protective vs Conventional Ventilation Strategy|Does a Protective One Lung Ventilation Strategy Reduce the Inflammatory Cytokine Local Response After Pulmonary Resection?|Completed||N/A|28|Actual|University of Roma La Sapienza||2|||f||||f|f|f||||||No||2017-10-10 21:19:55.614554|2017-10-10 21:19:55.614554
NCT03056859|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-09|||February 17, 2017|Actual|2017-02-17|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Compass Device CVC Trial|Central Venous Catheterization in Obese Patients With Compass Device|Recruiting||N/A|40|Anticipated|University of New Mexico|||1||f||||f||||||||Undecided|Deidentified study data may be shared with other researchers, pending final decision by study PI and sponsor|2017-10-10 21:19:55.791331|2017-10-10 21:19:55.791331
NCT03056846|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-09-14|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SAS||Probiotics on Stress-associated Gastrointestinal Function in University Students|Probiotics (Lactobacillus Gasseri KS-13, Bifidobacterium Bifidum G9-1, Bifidobacterium Longum MM-2) on Stress-associated Gastrointestinal Function in University Students: a Randomized, Double-blind, Placebo-controlled Clinical Trial|Recruiting||N/A|730|Anticipated|University of Florida||4|||f||||f|f|f||||||||2017-10-10 21:19:55.883689|2017-10-10 21:19:55.883689
NCT03056833|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-06-15|||June 10, 2017|Actual|2017-06-10|June 2017|2017-06-01|February 1, 2019|Anticipated|2019-02-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer|Phase I Trial of Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer|Recruiting||Phase 1|40|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:19:55.995271|2017-10-10 21:19:55.995271
NCT03056820|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-14|||May 2010|Actual|2010-05-01|February 2017|2017-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Comparison of Apnea Tolerance in Two Positions of Patients With BMI 30-40|Comparison of Apnea Tolerance in Two Positions of Patients With Body Mass Index (BMI) 30-40|Completed||N/A|74|Actual|University of Kansas Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:19:56.080896|2017-10-10 21:19:56.080896
NCT03056807|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-14|||October 2008|Actual|2008-10-01|February 2017|2017-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Evaluation of Apnea Tolerance in Bariatric Patients Following Rapid-sequence Induction of Anesthesia|Evaluation of Apnea Tolerance in Bariatric Patients Following Rapid-sequence Induction of Anesthesia|Completed||N/A|65|Actual|University of Kansas Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:19:56.147632|2017-10-10 21:19:56.147632
NCT03056794|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-16|||September 2015||2015-09-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01|5 Years|Observational [Patient Registry]|||Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies|Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies (North American Mitochondrial Disease Consortium, Rare Diseases Clinical Research Network, Project 7413)|Recruiting||N/A|150|Anticipated|University Hospitals Cleveland Medical Center|||1||f||||t||||||Samples With DNA|"     Blood sample for DNA and biochemical analysis. Saliva, buccal swab, urine sample, blood     sample, or skin sample for NAMDC biorepository (optional).   "|Yes|Data to be submitted to dbGap, as well as NAMDC researchers and the RDCRN.|2017-10-10 21:19:56.216529|2017-10-10 21:19:56.216529
NCT03056781|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-14|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Emotional Response in Psychiatric and Control Participants|Emotional Response in Psychiatric and Control Participants|Recruiting||N/A|225|Anticipated|University of California, Irvine||2|||f||||||||||||||2017-10-10 21:19:56.312975|2017-10-10 21:19:56.312975
NCT03056768|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-14|||August 30, 2014|Actual|2014-08-30|February 2017|2017-02-01|July 24, 2016|Actual|2016-07-24|October 5, 2015|Actual|2015-10-05||Interventional|THISCE||Taiwan Health Promotion Intervention Study for Elders|Taiwan Health Promotion Intervention Study for Elders|Completed||N/A|1080|Actual|Taipei Veterans General Hospital, Taiwan||2|||f|||||f|f||||||No||2017-10-10 21:19:56.389329|2017-10-10 21:19:56.389329
NCT03056755|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-10-03|||August 14, 2017|Actual|2017-08-14|October 2017|2017-10-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|BYLieve||Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant|A Phase II, Multicenter, Open-label, Two-cohort, Non-comparative Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole in Patients With PIK3CA Mutant, Hormone Receptor (HR) Positive, HER2-negative Advanced Breast Cancer (aBC), Who Have Progressed on or After CDK 4/6 Inhibitor Treatment|Recruiting||Phase 2|160|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:19:56.454198|2017-10-10 21:19:56.454198
NCT03056742|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-04-05|||February 20, 2017|Anticipated|2017-02-20|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|April 2018|Anticipated|2018-04-01||Interventional|||A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease|A Single Arm, Open Label, Multicentric, Clinical Study Assessing the Efficacy and Safety of Stempeucel® (ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients With CLI Due to Buerger's Disease|Withdrawn||Phase 2|0|Actual|Stempeutics Research Pvt Ltd||1||"Form 46 from DCGI for the manufacturing & commercial marketing of Stempeucel® directs   Stempeutics to conduct PMS study. Hence this study is being terminated."|f||||t|f|f||||||No||2017-10-10 21:19:56.572367|2017-10-10 21:19:56.572367
NCT03056716|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-16|||June 2009|Actual|2009-06-01|February 2017|2017-02-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|SD-CD||Silastic Versus Conventional Drain in Thoracic Surgery|Silastic Versus Conventional Drain for Postoperative Drainage in Thoracic Surgery.|Completed||N/A|118|Actual|T.C. Dumlupınar Üniversitesi||2|||f||||f|f|f|||t|||Yes|Patient data except for the names and ID numbers will be shared.|2017-10-10 21:19:56.929047|2017-10-10 21:19:56.929047
NCT03056703|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-15|||February 2014||2014-02-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Mille||Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets|An Open Label, Randomized, Two-Way Crossover Trial to Assess the Bioequivalence of a Single Oral Dose of a 1000 mg Fast Release Aspirin Tablet Versus Two 500 mg Fast Release Aspirin Tablets in Healthy Male and Female Subjects|Completed||Phase 1|38|Anticipated|Bayer||2|||f||||f||||||||||2017-10-10 21:19:57.017655|2017-10-10 21:19:57.017655
NCT03056690|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-14|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia|A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia|Recruiting||Phase 2|178|Anticipated|Astellas Pharma Inc||2|||f||||t|t|f||||||||2017-10-10 21:19:57.119339|2017-10-10 21:19:57.119339
NCT03056677|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-02|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|MWPS||Modified Whey Protein and Effect on Post Meal Glucose Levels Study|Does Modified Whey Protein Lower Post Meal Glucose Levels|Recruiting||N/A|30|Anticipated|University of Aberdeen||3|||f||||f|f|f||||||No||2017-10-10 21:19:57.273466|2017-10-10 21:19:57.273466
NCT03056664|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-02-14|||January 2017||2017-01-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease|The Safety and Efficiacy of Local MSC Injection in the Treatment of Fistulas in Patients With Perianal Crohn's Disease|Not yet recruiting||Phase 2/Phase 3|3|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||3|||f||||t||||||||||2017-10-10 21:19:57.367989|2017-10-10 21:19:57.367989
NCT03056651|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-14|||April 2016||2016-04-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|DayCare-HF||Day-care Unit for Patients With Refractory Heart Failure|Day-care Unit for Patients With Refractory Heart Failure - a Single-centre Study|Enrolling by invitation||N/A|200|Anticipated|Silesian Centre for Heart Diseases||1|||f||||f||||||||||2017-10-10 21:19:57.452706|2017-10-10 21:19:57.452706
NCT03056638|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-09-08|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer|Phase III Randomized Trial Comparing Short Course Androgen Deprivation Therapy and Ultra-Hypofractionated SBRT Versus SBRT Alone For Intermediate Prostate Cancer|Recruiting||Phase 3|200|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f||||||||2017-10-10 21:19:57.539078|2017-10-10 21:19:57.539078
NCT03056625|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-09-19|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|December 24, 2017|Anticipated|2017-12-24|August 31, 2017|Actual|2017-08-31||Interventional|EVAL||Efficacy of Vitamin A Fortified Rice in Lactating Thai Women|Efficacy of Vitamin A Fortified Rice in Lactating Thai Women|Recruiting||N/A|70|Anticipated|Prince of Songkla University||2|||f||||f|f|f||||||||2017-10-10 21:19:57.659924|2017-10-10 21:19:57.659924
NCT03056612|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-19|||March 2, 2017|Actual|2017-03-02|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|PREDICT||Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study|Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study|Recruiting||N/A|1200|Anticipated|European Foundation for Study of Chronic Liver Failure|||2||f||||f|f|f||||Samples With DNA|"     peripheral serum, plasma, PBMC/PMN, urine, hair (in case of alcohol abuse), ascites (if any),     stool, saliva   "|No||2017-10-10 21:19:57.780525|2017-10-10 21:19:57.780525
NCT03056599|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-16|||December 15, 2016|Actual|2016-12-15|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO™ Device in Soft Tissue Sarcoma|Feasibility of Assessing Drug Response to Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma Patients Undergoing Surgery.|Recruiting||Phase 1|12|Anticipated|Presage Biosciences||1|||f||||t|t|t|t|f|f|||No||2017-10-10 21:19:58.066245|2017-10-10 21:19:58.066245
NCT03056586|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-03-06|||March 20, 2017|Anticipated|2017-03-20|March 2017|2017-03-01|December 20, 2019|Anticipated|2019-12-20|December 20, 2018|Anticipated|2018-12-20||Interventional|pfgp||The Effect of Pessary Post Vaginal Prolapse Repair, for One Month, to Reduce the Recurrence Rate of Prolapse|The Recurrence Rate of Genital Prolapse Post Repair With the Use of PESSARY for One Month Post Operative|Not yet recruiting||N/A|100|Anticipated|Meir Medical Center||2|||f|||||f|t|f|f|f|||||2017-10-10 21:19:58.189069|2017-10-10 21:19:58.189069
NCT03056573|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-08|||March 14, 2017|Actual|2017-03-14|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|Portico ALT||Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access|Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access|Recruiting||Phase 2/Phase 3|90|Anticipated|St. Jude Medical||2|||f||||f|f|f||||||||2017-10-10 21:19:58.266358|2017-10-10 21:19:58.266358
NCT03056560|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-14|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluating a Video Bystander Program for First-Year College Students|TakeCARE: A Video Bystander Program to Prevent Sexual Violence on College Campuses|Recruiting||N/A|1000|Anticipated|Southern Methodist University||2|||f||||f|f|f||||||No||2017-10-10 21:19:58.387487|2017-10-10 21:19:58.387487
NCT03056547|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-07-19|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|BIODYSPNEE||Biomarkers in Dyspnea|Biomarkers in Dyspnea|Not yet recruiting||N/A|37|Anticipated|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil||1|||f|||||f|f||||||||2017-10-10 21:19:58.483554|2017-10-10 21:19:58.483554
NCT03056534|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-06|||November 30, 2017|Anticipated|2017-11-30|September 2017|2017-09-01|March 30, 2023|Anticipated|2023-03-30|March 30, 2022|Anticipated|2022-03-30||Observational|R3-PAS||R3 Delta Ceramic Acetabular System PAS U.S.|Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - US|Not yet recruiting||N/A|183|Anticipated|Smith & Nephew, Inc.|||1||f||||f|f|t|f|f|f|||||2017-10-10 21:19:58.564038|2017-10-10 21:19:58.564038
NCT03056521|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-02-16|||June 2016||2016-06-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|epps||Effect of Preoperative Information About Pain on Postoperative Pain Experience and Patient Satisfaction|Effect of Preoperative Information About Pain on Postoperative Pain Experience and Patient Satisfaction in Adult Elective Orthopedic Patients: A Randomized Controlled Trial|Recruiting||N/A|340|Anticipated|Makerere University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:19:58.637563|2017-10-10 21:19:58.637563
NCT03056508|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-14|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|LEAD||Lifestyle, Exercise and Diet: The LEAD Study|Nutrition, Exercise and Lifestyle: Team 6 of the Canadian Consortium on Neurodegeneration in Aging (CCNA)|Not yet recruiting||N/A|66|Anticipated|Rotman Research Institute at Baycrest||2|||f||||f|f|f||||||Yes|data will be uploaded to shared CCNA database - LORIS|2017-10-10 21:19:58.731411|2017-10-10 21:19:58.731411
NCT03056495|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-07-12|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|VostatAD01||Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease|Multicenter, Open-label Phase Ib Dose-escalation and Dose-confirmational Study for the Tolerability and Safety of N-hydroxy-N'-Phenyl-octanediamide (Vorinostat) in Patients With Mild Alzheimer's Disease|Not yet recruiting||Phase 1|44|Anticipated|German Center for Neurodegenerative Diseases (DZNE)||1|||f||||t|t|f|||t|||||2017-10-10 21:19:58.881166|2017-10-10 21:19:58.881166
NCT03056482|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-05-25|||May 21, 2017|Actual|2017-05-21|May 2017|2017-05-01|July 1, 2019|Anticipated|2019-07-01|April 1, 2019|Anticipated|2019-04-01||Interventional|HaVOC||Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)|Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized Controlled Trial|Recruiting||Phase 4|80|Anticipated|Queen's University||3|||f||||t|f|f|||f|||No||2017-10-10 21:19:58.973706|2017-10-10 21:19:58.973706
NCT03056469|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-14|||September 2016||2016-09-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|March 2020|Anticipated|2020-03-01||Interventional|||Patient-Reported Outcomes Integrated in the Follow-up of Patients With Hematological Cancer|Patient-Reported Outcomes Integrated in the Follow-up of Patients With Hematological Cancer|Recruiting||N/A|225|Anticipated|Zealand University Hospital||3|||f||||f||||||||No||2017-10-10 21:19:59.090792|2017-10-10 21:19:59.090792
NCT03056456|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-15|2017-06-28|||February 23, 2017|Actual|2017-02-23|June 2017|2017-06-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||A Study of LY900014 Administered by an Insulin Pump in Type 1 Diabetes Participants|A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy|Completed||Phase 1|30|Actual|Eli Lilly and Company||2|||f||||f|t|f|||t|||||2017-10-10 21:19:59.176111|2017-10-10 21:19:59.176111
NCT03056443|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-17|||February 8, 2016|Actual|2016-02-08|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients|Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients: A Randomized Clinical Trial|Recruiting||N/A|200|Anticipated|West Virginia University||2|||f||||f|f|t|f|f||||No||2017-10-10 21:19:59.257773|2017-10-10 21:19:59.257773
NCT03056430|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-07-31|||January 2016||2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neuroanatomical and Functional Changes in Response to an Intensive Balance Training|Neuroanatomical and Functional Changes in Response to an Intensive Balance Training|Recruiting||N/A|60|Anticipated|German Center for Neurodegenerative Diseases (DZNE)||2|||f||||f||||||||||2017-10-10 21:19:59.338898|2017-10-10 21:19:59.338898
NCT03056417|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-14|||January 10, 2017|Actual|2017-01-10|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Impact of Lifestyle Changes on Telomeric Activity in Patients With Chronic Pain|Impact of Lifestyle Changes Via the Complete Health Improvement Program on Telomerase Activity and Telomere Length in Patients With Chronic Pain|Enrolling by invitation||N/A|60|Anticipated|Ohio University||2|||f||||f|f|f||||||No||2017-10-10 21:19:59.409942|2017-10-10 21:19:59.409942
NCT03056404|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-02-14|||January 2016||2016-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|HYPERSENS||Research for Specific Proteins of Interest for the Serological Diagnosis of Bird Fancier's Lung|Research for Specific Proteins of Interest for the Serological Diagnosis of Bird Fancier's Lung|Recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:19:59.500153|2017-10-10 21:19:59.500153
NCT03056391|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-14|||October 2016||2016-10-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PACKNOW||Effect of Paracetamol on Renal Function in Plasmodium Knowlesi Malaria|Effect of Paracetamol on Renal Function in Plasmodium Knowlesi Malaria: A Randomised Controlled Clinical Trial|Recruiting||Phase 3|200|Anticipated|Menzies School of Health Research||2|||f||||t||||||||No||2017-10-10 21:19:59.592717|2017-10-10 21:19:59.592717
NCT03056378|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-05-03|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|Pooled RBCs||POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units|Phase I Clinical Trial of Pooled Red Blood Cells for Transfusion|Not yet recruiting||Phase 1|60|Anticipated|New York Blood Center||2|||f|||||t|f||||||||2017-10-10 21:19:59.763194|2017-10-10 21:19:59.763194
NCT03056365|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-08-21|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|January 1, 2019|Anticipated|2019-01-01||Interventional|SAMBA||Advanced Nurses vs. General Practitioners for the Management of Outpatient Alcohol Detox: a Safety and Cost Comparison|Advanced Nurses vs. General Practitioners for the Management of Outpatient Alcohol Detoxification: a Randomized Clinical Trial Comparing Safety and Costs|Recruiting||N/A|1262|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||||2017-10-10 21:19:59.975717|2017-10-10 21:19:59.975717
NCT03056352|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-04-28|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Metoclopramide for Post-Traumatic Headache. A Pilot Study|Metoclopramide for Post-Traumatic Headache. A Pilot Study|Recruiting||Early Phase 1|30|Anticipated|Montefiore Medical Center||1|||f||||t|t|f|||f|||No||2017-10-10 21:20:00.185007|2017-10-10 21:20:00.185007
NCT03056339|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-16|||June 21, 2017|Actual|2017-06-21|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Umbilical & Cord Blood (CB)- Derived CAR-Engineered NK Cells for B Lymphoid Malignancies|Dose Escalation Study Phase I/II of Umbilical and Cord Blood-Derived CAR-Engineered NK Cells in Conjunction in Patients With Relapsed/Refractory B-Lymphoid Malignancies|Recruiting||Phase 1/Phase 2|36|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:20:00.275652|2017-10-10 21:20:00.275652
NCT03056326|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-14|||November 2016||2016-11-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CHF6333 FIH||A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects|A Phase I, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF 6333 After Single and Repeated Ascending Doses in Healthy Male Subjects|Recruiting||Phase 1|72|Anticipated|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||No||2017-10-10 21:20:00.398246|2017-10-10 21:20:00.398246
NCT03056313|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-19|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|April 15, 2019|Anticipated|2019-04-15|April 15, 2019|Anticipated|2019-04-15||Interventional|PAF||The Proactive Support of Labor Study|The Proactive Support of Labor Study|Recruiting||N/A|250|Anticipated|Norwegian University of Science and Technology||2|||f|||||f|f||||||||2017-10-10 21:20:00.502724|2017-10-10 21:20:00.502724
NCT03056300|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-06-27|||January 11, 2017|Actual|2017-01-11|June 2017|2017-06-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies||Completed||N/A|50|Actual|Ethicon, Inc.||1|||f||||f|f|f||||||Yes||2017-10-10 21:20:00.606719|2017-10-10 21:20:00.606719
NCT03056287|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-14|||January 1, 2016|Actual|2016-01-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Exercise and Brain Stimulation for Post-stroke Depression|Treating Depression and Enhancing Locomotor Recovery Post-stroke|Recruiting||N/A|50|Anticipated|Medical University of South Carolina||4|||f||||t|f|f||||||No||2017-10-10 21:20:00.687702|2017-10-10 21:20:00.687702
NCT03056274|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-02-14|||April 2017|Anticipated|2017-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|METRIC||Metformin in Intrahepatic Cholestasis of Pregnancy|METformin in Intrahepatic Cholestasis of Pregnancy (METRIC) Study|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Epsom and St Helier University Hospitals NHS Trust||2|||f||||t|t|f|||f|||No||2017-10-10 21:20:00.783008|2017-10-10 21:20:00.783008
NCT03056261|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-17|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Combined General-epidural vs General Anaesthesia on Postoperative Gastrointestinal Surgery|The Effect of Combined General-epidural vs General Anaesthesia on Postoperative Intestinal Function Recovery and Infection in Neonates and Infants Undergoing Gastrointestinal Surgery: a Prospective, Randomised, Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Bnai Zion Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:20:00.894118|2017-10-10 21:20:00.894118
NCT03056248|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-14|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|January 1, 2018|Anticipated|2018-01-01|December 30, 2017|Anticipated|2017-12-30||Interventional|LSCAKI||Lithium in Acute Kidney Injury|Lithium in Cardiac Surgery Related Acute Kidney Injury: A Pilot Study|Not yet recruiting||Phase 4|50|Anticipated|Lifespan||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:20:00.978061|2017-10-10 21:20:00.978061
NCT03056235|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-14|||December 2016||2016-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Evaluate the Efficacy of ELAPR002f and ELAPR002g in Females and Males With Atrophic Acne Scars|A Randomized, Within-subject, Placebo-controlled, Single-blind Study to Evaluate the Efficacy of ELAPR002f and ELAPR002g in Females and Males With Atrophic Acne Scars|Recruiting||N/A|30|Anticipated|Elastagen Pty Ltd||3|||f||||t||||||||No||2017-10-10 21:20:01.075372|2017-10-10 21:20:01.075372
NCT03056222|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-17|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|CF²||CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation|CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation|Recruiting||N/A|350|Anticipated|I-Med-Pro GmbH||2|||f||||f|f|t|f|f|t|||||2017-10-10 21:20:01.172984|2017-10-10 21:20:01.172984
NCT03056209|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-14|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 1, 2017|Anticipated|2017-09-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers|A Dose Block-randomized, Double-blind, Placebo-controlled, Single-dose, Dose-escalation, Phase I Clinical Study|Not yet recruiting||Phase 1|10|Anticipated|KT&G Life Sciences Corp||3|||f||||t|f|f||||||No||2017-10-10 21:20:01.291192|2017-10-10 21:20:01.291192
NCT03056196|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-14|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 1, 2018|Anticipated|2018-03-01|February 28, 2018|Anticipated|2018-02-28||Observational|||Two-Site Compression POINt-OF-CARE Ultrasonography for DVT|Age-Adjusted D-Dimer and Two-Site Compression POINt-OF-CARE Ultrasonography to Rule Out Acute Deep Vein Thrombosis|Not yet recruiting||N/A|500|Anticipated|Jewish General Hospital|||1||f||||f|f|f||||||No|Not going to share patients data|2017-10-10 21:20:01.39271|2017-10-10 21:20:01.39271
NCT03056183|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||September 1, 2017|Anticipated|2017-09-01|February 2017|2017-02-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Care Transitions for Patients With Depression|Care Transitions for Medically Ill Patients With Depression|Not yet recruiting||N/A|300|Anticipated|Cedars-Sinai Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:20:01.473925|2017-10-10 21:20:01.473925
NCT03056170|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-07-06|||November 13, 2015|Actual|2015-11-13|July 2017|2017-07-01|June 20, 2017|Actual|2017-06-20|April 19, 2017|Actual|2017-04-19||Interventional|COMBI-STIM||Neurophysiological Impact of a Fronto-temporal tDCS Stimulation in Healthy Subjects: a Multimodal Imaging Approach|Neurophysiological Impact of a Fronto-temporal Transcranial Direct Current Stimulation (tDCS) in Healthy Subjects: a Multimodal Imaging Approach|Completed||N/A|37|Actual|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:20:01.588101|2017-10-10 21:20:01.588101
NCT03056157|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-31|||September 5, 2017|Anticipated|2017-09-05|May 2017|2017-05-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|AD-E||Psychosocial Rehabilitation After Military Trauma With Adaptive Disclosure|Psychosocial Rehabilitation After Moral Injury and Loss With Adaptive Disclosure|Not yet recruiting||N/A|186|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 21:20:01.729732|2017-10-10 21:20:01.729732
NCT03056144|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-08-08|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Whole Body Vibration Therapy in Children With Spinal Muscular Atrophy|Effect of Whole Body Vibration Therapy on Muscle Function, Gross Motor Function and Bone Mineral Density in Children With Spinal Muscular Atrophy - a Feasibility Study|Recruiting||N/A|10|Anticipated|The Hong Kong Polytechnic University||1|||f||||f|f|f||||||||2017-10-10 21:20:01.941847|2017-10-10 21:20:01.941847
NCT03056131|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-13|||October 2015||2015-10-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Diacutaneous Fibrolysis, Effects on Tension Type Headache|Diacutaneous Fibrolysis, Effects on Tension Type Headache|Enrolling by invitation||N/A|82|Anticipated|Universidad de Zaragoza||2|||f||||f||||||||No||2017-10-10 21:20:02.132747|2017-10-10 21:20:02.132747
NCT03056118|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-14|||May 2, 2011|Actual|2011-05-02|February 2017|2017-02-01|September 7, 2015|Actual|2015-09-07|June 1, 2015|Actual|2015-06-01||Interventional|OPTIMA-C||Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents|Optimal Duration of Clopidogrel After Implantation of Second-Generation Drug-Eluting Stents (OPTIMA-C)|Completed||Phase 4|1368|Actual|Gangnam Severance Hospital||4|||f||||t|f|f||||||Yes|If PI and scientific committee approve to share individual participant data to other researchers.|2017-10-10 21:20:02.204727|2017-10-10 21:20:02.204727
NCT03056105|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-05-24|||February 3, 2013|Actual|2013-02-03|May 2017|2017-05-01|February 4, 2014|Actual|2014-02-04|February 4, 2014|Actual|2014-02-04||Observational|||The Psychobiological Effects of Participation in a One-Month Insight Meditation Retreat|The Psychobiological Effects of a One-Month Insight Meditation Retreat, a Sub-study of The Shamatha Project: A Longitudinal, Randomized Waitlist Control Study of Cognitive, Emotional, and Neural Effects of Intensive Meditation Training|Completed||N/A|66|Actual|University of California, Davis|||2||f||||f|f|f||||Samples With DNA|"     whole blood, peripheral blood mononucleocytes, plasma, serum   "|Undecided||2017-10-10 21:20:02.320985|2017-10-10 21:20:02.320985
NCT03056092|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-13|||February 28, 2017|Anticipated|2017-02-28|February 2017|2017-02-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|COVERT||Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab|Cytokine and Visual Outcome Variations in Eyes Receiving a Variable Dosing Ranibizumab Treatment: The COVERT Study|Not yet recruiting||Phase 4|168|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f|t|f|||f|||No||2017-10-10 21:20:02.475602|2017-10-10 21:20:02.475602
NCT03056079|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-13|||February 28, 2017|Anticipated|2017-02-28|February 2017|2017-02-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|COVARIANT||Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept|Cytokine and Visual Outcome Variations in Eyes Receiving a Variable Dosing Aflibercept Treatment: The COVARIANT Study|Not yet recruiting||Phase 4|168|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f|t|f|||f|||No||2017-10-10 21:20:02.59892|2017-10-10 21:20:02.59892
NCT03056066|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-10-03|||July 31, 2017|Actual|2017-07-31|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Accuracy of Spircare Device as Compared to the Conventional Plethysmograph|Accuracy of Spircare Device as Compared to the Conventional Plethysmograph|Enrolling by invitation||N/A|90|Anticipated|Spircare Ltd.|||1||f||||f|f|f||||||||2017-10-10 21:20:02.725039|2017-10-10 21:20:02.725039
NCT03056053|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-16|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|May 5, 2017|Actual|2017-05-05|April 21, 2017|Actual|2017-04-21||Interventional|||Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder|Multi-center, Single-arm, Open-label Study in Patients With Insomnia Disorder to Validate the Insomnia Daytime Symptoms and Impacts Questionnaire™ (IDSIQ™)|Completed||Phase 2|113|Actual|Actelion||1|||f||||f|f|f||||||||2017-10-10 21:20:02.817571|2017-10-10 21:20:02.817571
NCT03056040|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-09-21|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||ALXN1210 Versus Eculizumab in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab|A Phase 3, Randomized, Open-Label, Active-Controlled Study of ALXN1210 Versus Eculizumab in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab|Active, not recruiting||Phase 3|197|Actual|Alexion Pharmaceuticals||2|||f||||t|t|f||||||||2017-10-10 21:20:02.965685|2017-10-10 21:20:02.965685
NCT03056027|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-16|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|February 28, 2018|Anticipated|2018-02-28|October 30, 2017|Anticipated|2017-10-30||Observational|||Testicular Vascular Evaluation in Patients Undergoing Inguinal Hernia Repair|Evaluation of the Impact of Open or Laparoscopic Preperitoneal Inguinal Hernia Repair on Arterial and Venous Testicular Vascularization by Means of Ecocolordoppler Ultrasound Examination|Recruiting||N/A|40|Anticipated|Istituto Auxologico Italiano|||2||f||||f|f|f||||||No||2017-10-10 21:20:03.216065|2017-10-10 21:20:03.216065
NCT03056014|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-22|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Antioxidant Use in Diabetes to Reduce Oxidative Stress|Supplementation of N-acetylcysteine and Arachonic Acid in Type 1 Diabetes to Determine Changes in Oxidative Stress|Not yet recruiting||Early Phase 1|126|Anticipated|University of Maryland||6|||f||||t|t|f|||f|||No||2017-10-10 21:20:03.351509|2017-10-10 21:20:03.351509
NCT03056001|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-10-04|||May 1, 2017|Actual|2017-05-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma|A Pilot Study Evaluating the Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab in Patients With Metastatic or Unresectable Soft Tissue Sarcoma|Recruiting||Phase 2|30|Anticipated|Carolinas Healthcare System||1|||f||||t|t|f||||||||2017-10-10 21:20:03.474531|2017-10-10 21:20:03.474531
NCT03055988|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-10-03|||March 29, 2017|Actual|2017-03-29|October 2017|2017-10-01|February 23, 2018|Anticipated|2018-02-23|February 2, 2018|Anticipated|2018-02-02||Interventional|||Cardiovascular Function in COPD Patients|An Exploratory, Randomised, Double-blind, Double-dummy, Active-controlled, Two Period Cross-over Study to Investigate the Effect of 6 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (FDC) Delivered by the Respimat® Inhaler With Fluticasone Propionate + Salmeterol FDC Delivered by the Accuhaler® Inhaler, on Left Ventricular Function and Arterial Stiffness in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 4|74|Anticipated|Boehringer Ingelheim||2|||f||||f|f|f||||||||2017-10-10 21:20:03.609128|2017-10-10 21:20:03.609128
NCT03055975|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-16|||January 30, 2013|Actual|2013-01-30|February 2017|2017-02-01|October 30, 2018|Anticipated|2018-10-30|May 30, 2017|Anticipated|2017-05-30||Observational|||Prevalence of Bacteria Following Endodontic Treatment|Prevalence and Phenotype of Oral Enterococcus Faecalis|Recruiting||N/A|200|Anticipated|King's College London|||2||f||||t|f|f||||||Undecided|IPD is not planned to be made available to other researchers as of yet|2017-10-10 21:20:03.788099|2017-10-10 21:20:03.788099
NCT03055962|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-14|||February 14, 2017|Actual|2017-02-14|April 2017|2017-04-01|April 11, 2017|Actual|2017-04-11|March 29, 2017|Actual|2017-03-29||Interventional|||Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects|A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects|Completed||Phase 1|16|Actual|Eisai Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:20:03.912883|2017-10-10 21:20:03.912883
NCT03055949|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-02-14|||May 2014||2014-05-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ERP||Safety and Efficacy of an Early Rehabilitation Program in Surgical Intensive Care Unit|Safety and Efficacy of an Early Rehabilitation Program in Surgical Intensive Care Unit (SICU)|Completed||N/A|131|Actual|Asan Medical Center||2|||f||||t||||||||No||2017-10-10 21:20:04.03595|2017-10-10 21:20:04.03595
NCT03055923|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-19|||November 2016||2016-11-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|EXHALE Pilot||EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.|A Cross-sectional, Feasibility Study to Explore the Use of a New Device (Inflammacheck™) in Measuring the Level of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) in Patients With Asthma, COPD, and Healthy Volunteers. The EXHALE Pilot|Recruiting||N/A|90|Anticipated|Portsmouth Hospitals NHS Trust|||3||f||||f||||||||||2017-10-10 21:20:04.230364|2017-10-10 21:20:04.230364
NCT03055910|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-15|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31|1 Day|Observational [Patient Registry]|F(FR)²||Fractional Flow Reserve Fax Registry|A Fax-based Registry Regarding Clinical Indications, Complication Rates and Management Consequences of Invasive Fractional Flow Reserve Measurements|Not yet recruiting||N/A|2000|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f|f|f||||||No||2017-10-10 21:20:04.543421|2017-10-10 21:20:04.543421
NCT03055897|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-25|||May 3, 2016||2016-05-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:20:04.683691|2017-10-10 21:20:04.683691
NCT03055871|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-02|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|March 2020|Anticipated|2020-03-01||Interventional|||Parents and Children Active Together Study|Parents and Children Active Together: Examining Motivational, Regulatory, and Habitual Intervention Approaches|Recruiting||N/A|240|Anticipated|University of Victoria||3|||f||||f|f|f||||||Undecided||2017-10-10 21:20:04.878295|2017-10-10 21:20:04.878295
NCT03055858|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-09-14|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|December 2018|Anticipated|2018-12-01||Interventional|ADO II AS||AMPLATZER Duct Occluder II Additional Sizes|AMPLATZER Duct Occluder II Additional Sizes (ADO II AS) Clinical Study|Recruiting||N/A|50|Anticipated|St. Jude Medical||1|||f||||t|f|t|t|f||||||2017-10-10 21:20:05.007544|2017-10-10 21:20:05.007544
NCT03055845|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-06-22|||March 27, 2017|Actual|2017-03-27|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Single Ascending Dose Study of Safety and Tolerability of STA363 Compared to Placebo in 15 Patients With Chronic Discogenic Low Back Pain|A Prospective, Randomised, Double-blinded, Placebo-controlled, Single Ascending Dose Study Investigating the Safety and Local Tolerability of STA363 Compared to Placebo in 15 Patients With Chronic Discogenic Low Back Pain|Recruiting||Phase 1|15|Anticipated|Stayble Therapeutics||4|||f||||t|f|f||||||||2017-10-10 21:20:05.160638|2017-10-10 21:20:05.160638
NCT03055832|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-25|||February 9, 2017||2017-02-09||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:20:05.271401|2017-10-10 21:20:05.271401
NCT03055819|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-16|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|April 1, 2021|Anticipated|2021-04-01|July 1, 2017|Anticipated|2017-07-01||Interventional|LIFT||Evaluation of Patient and Physician Satisfaction With the Zift eLevatIon of Facial Tissue Clinical Study|Evaluation of Patient and Physician Satisfaction With the Zift eLevatIon of Facial Tissue Clinical Study|Recruiting||N/A|20|Anticipated|Zift, LLC||1|||f||||f|f|t|t|||||No||2017-10-10 21:20:05.329174|2017-10-10 21:20:05.329174
NCT03055806|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-20|||February 28, 2017|Actual|2017-02-28|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|November 17, 2017|Anticipated|2017-11-17||Interventional|||IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)|A Phase 2b, 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of 3 Different Dose Levels of IX-01 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (PE)|Active, not recruiting||Phase 2|220|Anticipated|Ixchelsis Limited||4|||f||||f|t|f||||||||2017-10-10 21:20:05.439747|2017-10-10 21:20:05.439747
NCT03055793|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-09-06|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|SKIRON||Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice|A Real Life, on International, Multicenter Study to Assess the Efficacy and Quality of Life in Greek Asthmatic Patients Who Will be on Fixed Dose Bodesonide Formoterol Combination Treatment|Completed||N/A|1400|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f|f|f||||||||2017-10-10 21:20:05.627045|2017-10-10 21:20:05.627045
NCT03055780|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||July 1, 2015|Actual|2015-07-01|February 2017|2017-02-01|October 1, 2016|Actual|2016-10-01|May 30, 2016|Actual|2016-05-30||Observational|||Diagnostic Accuracy to Detect Hemodynamically Significant Stenosis by Non-invasive SURECardio CT-FFR|Clinical Trial for SURECardio CT-FFR|Completed||N/A|59|Actual|Toshiba Medical Systems Corporation, Japan|||1||f|||||f|t|t|f|f|||No||2017-10-10 21:20:05.705491|2017-10-10 21:20:05.705491
NCT03055767|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-01|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population|Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Randomized Double Blinded Placebo Cross-over Study in the Pediatric Pain Population|Recruiting||Phase 2|26|Anticipated|University of California, Irvine||2|||f||||t|t|f||||||No||2017-10-10 21:20:05.778512|2017-10-10 21:20:05.778512
NCT03055754|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-04-04|||May 2016||2016-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|February 2017|Actual|2017-02-01||Interventional|||Endoscopic Argon Plasma Coagulation Vs. Control For Weight Regain After Gastric Surgery|Endoscopic Argon Plasma Coagulation Vs. Observation In The Management Of Weight Regain After Gastric Bypass Surgery: A Randomized Controlled Trial|Active, not recruiting||N/A|42|Actual|Kaiser Clinic and Hospital||2|||f||||||||||||Yes||2017-10-10 21:20:05.924184|2017-10-10 21:20:05.924184
NCT03055741|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-04-07|||December 28, 2016|Actual|2016-12-28|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IIb, Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil|Recruiting||Phase 2|180|Anticipated|Daehwa Pharmaceutical Co., Ltd.||3|||f||||t||||||||No||2017-10-10 21:20:06.027974|2017-10-10 21:20:06.027974
NCT03055728|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-14|||May 9, 2013|Actual|2013-05-09|February 2017|2017-02-01|January 24, 2018|Anticipated|2018-01-24|January 24, 2018|Anticipated|2018-01-24||Observational|||Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis|Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis|Recruiting||N/A|600|Anticipated|Georgetown University|||2||f||||f|f|f||||Samples Without DNA|"     Throat swabs of the posterior oropharynx will be tested for rapid antigen test and throat     culture.   "|No||2017-10-10 21:20:06.167037|2017-10-10 21:20:06.167037
NCT03055715|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-05-24|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Changes in Radical Radiotherapy of Locally Advanced NSCLC|Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Change in the Curative-intended, Radical Radiotherapy of Locally Advanced NSCLC|Recruiting||N/A|700|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||1||f||||t|f|f||||||Undecided||2017-10-10 21:20:06.275332|2017-10-10 21:20:06.275332
NCT03055702|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||November 1, 2016|Actual|2016-11-01|February 2017|2017-02-01|March 30, 2018|Anticipated|2018-03-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients|Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Type 2 Diabetes Mellitus Appointment Attendance in a Primary Care Clinic|Recruiting||N/A|270|Anticipated|The University of Hong Kong||2|||f||||t|f|f||||||Undecided||2017-10-10 21:20:06.476552|2017-10-10 21:20:06.476552
NCT03055689|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-12|||January 30, 2017|Actual|2017-01-30|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Bowel Preparation for Repeat Colonoscopy After Preparation Failure (RepeatPrep Study)|Nurse-led Educational Telephone Intervention for Bowel Preparation for Repeat Colonoscopy After Preparation Failure (RepeatPrep Study)|Recruiting||N/A|590|Anticipated|Parc de Salut Mar||2|||f||||f|f|f||||||No||2017-10-10 21:20:06.577958|2017-10-10 21:20:06.577958
NCT03055676|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||January 2017||2017-01-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|||A Randomized Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy|A Randomized Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy|Recruiting||N/A|332|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||Yes|After this multicenter randomized clinical trail complete, the results of this study will be submitted to and published in a peer-reviewing journal. Other researchers can assess our article through electronic database, such as Medline/PubMed.|2017-10-10 21:20:06.682433|2017-10-10 21:20:06.682433
NCT03055663|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-08-18|||February 20, 2017|Actual|2017-02-20|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Sedation Using Virtual Reality During Surgery Under Spinal Anesthesia|A Comparison of Patient Satisfaction Between Sedation Using Medication and Sedation Using Virtual Reality During Surgery Under Spinal Anesthesia: A Randomized Controlled Trial|Recruiting||N/A|37|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:20:06.777698|2017-10-10 21:20:06.777698
NCT03055637|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||February 19, 2017|Anticipated|2017-02-19|February 2017|2017-02-01|May 19, 2017|Anticipated|2017-05-19|May 19, 2017|Anticipated|2017-05-19||Interventional|||Evaluation of the Incidence of Palatal Fistula in Furlow Double-opposing Z-plasty vs. Two-flap Palatoplasty for Cleft Palate Repair|Evaluation of the Incidence of Palatal Fistula in Furlow Double-opposing Z-plasty vs. Two-flap Palatoplasty for Cleft Palate Repair|Not yet recruiting||N/A|32|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 21:20:06.889973|2017-10-10 21:20:06.889973
NCT03055624|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-01|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 1, 2022|Anticipated|2022-03-01|March 1, 2022|Anticipated|2022-03-01||Interventional|||Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia|Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia|Recruiting||N/A|20|Anticipated|University of California, San Diego||1|||f||||f|f|t|f|f||||No||2017-10-10 21:20:06.957741|2017-10-10 21:20:06.957741
NCT03055611|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-09-18|||May 9, 2017|Actual|2017-05-09|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|PREVENT||A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B|A 24-month Prospective, Non-interventional, Multicentre Study to Evaluate the Real-World Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B|Recruiting||N/A|100|Anticipated|Swedish Orphan Biovitrum|||2||f||||f||||||||||2017-10-10 21:20:07.05086|2017-10-10 21:20:07.05086
NCT03055598|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-06-06|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Ferric Citrate in ESRD Pilot Project|Effect of Auryxia on ESA Utilization in ESRD Patients With High Ferritin & Low Transferrin Saturation: A Pilot Project|Recruiting||Phase 4|30|Anticipated|Baylor College of Medicine||1|||f||||f|t|f|||f|||No||2017-10-10 21:20:07.176343|2017-10-10 21:20:07.176343
NCT03055585|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-26|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|AWED||Applying Wolbachia to Eliminate Dengue|A Non-blinded Cluster Randomised Controlled Trial to Assess the Efficacy of Wolbachia-infected Mosquito Deployments to Reduce Dengue Incidence in Yogyakarta, Indonesia|Not yet recruiting||N/A|10000|Anticipated|Gadjah Mada University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:20:07.278372|2017-10-10 21:20:07.278372
NCT03055572|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||October 1, 2017|Anticipated|2017-10-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Olfactory Training in Chronic Rhinosinusitis|Olfactory Training for Olfactory Dysfunction in Chronic Rhinosinusitis|Not yet recruiting||N/A|150|Anticipated|Emory University||3|||f||||f|f|f||||||No||2017-10-10 21:20:07.436575|2017-10-10 21:20:07.436575
NCT03055559|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||June 2016||2016-06-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|TPG||Trial Protocol GlobiFer - Oral Iron Repletion|Oral Iron Repletion With Globifer Forte® After 12 Weeks of Treatment|Recruiting||N/A|60|Anticipated|Gedeon Richter Slovakia, s.r.o.||1|||f||||f||||||||No||2017-10-10 21:20:07.501994|2017-10-10 21:20:07.501994
NCT03055546|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-02-27|||February 2016||2016-02-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Intranasal Oxytocin on Emotion Regulation|Effects of Intranasal Oxytocin on Emotion Regulation|Recruiting||Early Phase 1|80|Anticipated|University of Electronic Science and Technology of China||2|||f|||||f|f||||||No||2017-10-10 21:20:07.575963|2017-10-10 21:20:07.575963
NCT03055533|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-03-10|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Headsprout Reading Program in Children With Autism Spectrum Disorder and Reading Delay|A Feasibility Study of Headsprout Reading Program in Children With Autism Spectrum Disorder and Reading Delay|Recruiting||N/A|18|Anticipated|Emory University||2|||f||||f|f|f||||||No||2017-10-10 21:20:07.672559|2017-10-10 21:20:07.672559
NCT03055520|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-13|||June 2009|Actual|2009-06-01|February 2017|2017-02-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Arithmetic Training With the Kumon Method for Cognition in Schizophrenia|Arithmetic Calculation Training With the Kumon Errorless Learning Method for Cognitive Rehabilitation of Patients With Schizophrenia: a Randomized Controlled Trial|Completed||N/A|51|Actual|University of Sao Paulo||2|||f|||||f|f||||||Undecided||2017-10-10 21:20:07.758347|2017-10-10 21:20:07.758347
NCT03055507|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-05-02|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Effect of Post-operative Ibuprofen After Surgery for Chronic Rhinosinusitis|Effect of Post-operative Ibuprofen After Surgery for Chronic Rhinosinusitis: A Prospective, Pilot, Cohort Study|Recruiting||Phase 2/Phase 3|60|Anticipated|University of Washington||2|||f||||t|t|f|||f|||No|There is no plan to share IPD|2017-10-10 21:20:07.824297|2017-10-10 21:20:07.824297
NCT03055494|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-06-22|||April 18, 2017|Actual|2017-04-18|June 2017|2017-06-01|April 5, 2019|Anticipated|2019-04-05|June 22, 2018|Anticipated|2018-06-22||Interventional|ObePso-S||Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Explore Changes in Subcutaneous Adipose Tissue and Modulation of Skin Inflammation After 12 Weeks of Treatment With Secukinumab, Compared to Placebo, and up to 52 Weeks of Treatment With Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis|Recruiting||Phase 4|75|Anticipated|Novartis||2|||f||||f|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:20:07.910872|2017-10-10 21:20:07.910872
NCT03055481|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-15|||February 20, 2017|Anticipated|2017-02-20|February 2017|2017-02-01|February 20, 2020|Anticipated|2020-02-20|February 20, 2019|Anticipated|2019-02-20||Interventional|||A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice|A Prospective Multicenter Non-inferiority Randomized Controlled Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice|Not yet recruiting||N/A|300|Anticipated|Nagoya University||2|||f||||t|f|f||||||||2017-10-10 21:20:07.997766|2017-10-10 21:20:07.997766
NCT02993848|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|2 Years|Observational [Patient Registry]|NASCon||North American Scapula Consortium|North American Scapula Consortium|Enrolling by invitation||N/A|170|Anticipated|North American Scapula Consortium|||2||f||||f||||||||No||2017-10-10 21:31:43.973111|2017-10-10 21:31:43.973111
NCT03055468|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-10|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||The Efficacy of Peer Support Model for Depression Care in Patients With Diabetes Mellitus|Developing a Peer Support Model for Depression Care in Patients With Diabetes Mellitus, and Testing it's Efficacy on Patient Outcomes; a Randomized Control Trial Protocal|Not yet recruiting||N/A|130|Anticipated|Makerere University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:20:08.066118|2017-10-10 21:20:08.066118
NCT03055455|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-14|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Neuroimaging and Neuromonitoring in Critically Ill Children With Sepsis|Neuroimaging and Neuromonitoring in Critically Ill Children With Sepsis|Recruiting||N/A|50|Anticipated|Children's Hospital of Philadelphia|||1||f||||f|f|f||||||No||2017-10-10 21:20:09.948902|2017-10-10 21:20:09.948902
NCT03055442|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-13|||October 2016||2016-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Myo-inositol/D-chiro-inositol Ratio in Follicular Fluid|Altered Myo-inositol/D-chiro-inositol Ratio in Follicular Fluid of Women Undergoing in Vitro Fertilization Has Detrimental Effects on Oocyte and Embryo Quality|Completed||N/A|34|Actual|Lo.Li.Pharma s.r.l|||1||f|||||f|f||||||||2017-10-10 21:20:10.066486|2017-10-10 21:20:10.066486
NCT03055429|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-09-06|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Enhancing Care of the Aged and Dying in Prisons|Enhancing Care of the Aged and Dying in Prisons Phase II|Recruiting||N/A|624|Anticipated|Klein Buendel, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:20:10.148845|2017-10-10 21:20:10.148845
NCT03055416|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-24|||September 2016||2016-09-01|July 2017|2017-07-01|April 30, 2018|Anticipated|2018-04-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Mobile Phone Intervention for Physical Activity Maintenance in African American Men (MobileMen)|Mobile Phone Intervention for Physical Activity Maintenance in African American Men (MobileMen)|Recruiting||N/A|34|Anticipated|Klein Buendel, Inc.||1|||f||||f||||||||||2017-10-10 21:20:10.244317|2017-10-10 21:20:10.244317
NCT03055403|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-17|||February 17, 2017|Actual|2017-02-17|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Continuous Intravenous Injection, Dose Escalation, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of M201-A in Healthy Japanese Subjects|Recruiting||Phase 1|56|Anticipated|Kitasato University||2|||f||||f|f|f||||||No||2017-10-10 21:20:10.335664|2017-10-10 21:20:10.335664
NCT03055390|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-04-03|||February 11, 2017|Actual|2017-02-11|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women|Study the Effect of Intravenous Hyoscine Butylbromide Injection on the Duration and Progress of First Stage Labour in High Risk Women|Recruiting||Phase 4|300|Anticipated|Cairo University||3|||f||||t|t|f|||f|||Undecided||2017-10-10 21:20:10.439486|2017-10-10 21:20:10.439486
NCT03055377|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-02-15|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|February 28, 2022|Anticipated|2022-02-28|November 30, 2021|Anticipated|2021-11-30||Interventional|||N-Acetylcysteine for Youth Cannabis Use Disorder|N-Acetylcysteine for Youth Cannabis Use Disorder|Not yet recruiting||Phase 2/Phase 3|192|Anticipated|Medical University of South Carolina||2|||f||||t|t|f||||||No||2017-10-10 21:20:10.538724|2017-10-10 21:20:10.538724
NCT03055364|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-24|||May 24, 2017|Actual|2017-05-24|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Observational|||Cognitive Function After Treatment of Primary CNS Malignancy|Observational Study Evaluating Neurocognitive Function in Patients With Primary CNS Malignancy Receiving Radiation Treatment to the Brain|Recruiting||N/A|160|Anticipated|Mayo Clinic|||1||f||||f|f|f||||||||2017-10-10 21:20:10.617648|2017-10-10 21:20:10.617648
NCT03055351|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-10|||February 17, 2017|Actual|2017-02-17|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Stop&Go: an Intervention Program to Promote Healthy and Active Lifestyles Among Patients With Substance Use Disorders|Stop&Go: an Intervention Program to Promote Healthy and Physically Active Lifestyles Among Patients With Substance Use Disorders [Proyecto STOP & GO: Parar de Consumir y Motivar Para el Cambio]|Enrolling by invitation||N/A|120|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f|f|f||||||||2017-10-10 21:20:10.687599|2017-10-10 21:20:10.687599
NCT03055338|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-09-28|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|January 29, 2018|Anticipated|2018-01-29|January 12, 2018|Anticipated|2018-01-12||Interventional|||An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia|Recruiting||Phase 2|215|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||f|t|f||||||||2017-10-10 21:20:10.782017|2017-10-10 21:20:10.782017
NCT03055325|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-15|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|POSINI||Post-surgery Systemic Inflammation and Neuro-immune Interactions|Post-surgery Systemic Inflammation and Neuro-immune Interactions|Enrolling by invitation||N/A|28|Anticipated|Karolinska University Hospital|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|Undecided||2017-10-10 21:20:11.106698|2017-10-10 21:20:11.106698
NCT03055312|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-09-08|||December 2016||2016-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|SYSUCC-007||Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer|A Randomized, Multicenter,Phase III Study of Bicalutamide Versus Chemotherapy in First Line Treatment of AR Positive Metastatic Triple Negative Breast Cancer|Recruiting||Phase 3|262|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 21:20:11.201234|2017-10-10 21:20:11.201234
NCT03055299|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-05-01|||February 20, 2017|Actual|2017-02-20|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|COMEX||COMEX Study for Dialysis Patients|Comprehensive Exercise (COMEX) Program for Dialysis Patients Pilot Study|Recruiting||N/A|40|Anticipated|University of Pittsburgh||1|||f||||f|f|f||||||||2017-10-10 21:20:11.334909|2017-10-10 21:20:11.334909
NCT03055286|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-03-06|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients|A Phase 1b Clinical Study of CWP232291 in Combination With Cytarabine in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|40|Anticipated|JW Pharmaceutical||1|||f||||f|t|f||||||||2017-10-10 21:20:11.452464|2017-10-10 21:20:11.452464
NCT03055273|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-08-16|||June 2016||2016-06-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|SOCIABLE||SOCIABLE Seniors Optimizing Community Integration to Advance Better Living With ESRD|SOCIABLE Seniors Optimizing Community Integration to Advance Better Living With ESRD|Completed||N/A|12|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 21:20:11.57083|2017-10-10 21:20:11.57083
NCT03055260|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-21|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Low Intensity Blood Flow Restriction Training Study|Effect of Low Intensity Blood Flow Restriction Training on Lower Extremity Strength and Hypertrophy|Not yet recruiting||N/A|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|t|f||f|||Yes|Research coordinator/statistician will have access to blinded, individual data for the purpose of record keeping and analysis.|2017-10-10 21:20:11.668942|2017-10-10 21:20:11.668942
NCT03055247|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-05-26|||November 2015||2015-11-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Interventional|XCGD-MOBI||Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD|A Multicentric, Exploratory, Non-randomised, Non-controlled, Prospective, Open-label Phase II Study Evaluating Safety and Efficacy of IBU, G-CSF and Plerixafor as Stem Cell Mobilization Regimen in Patients Affected by X-CGD|Recruiting||Phase 2|3|Anticipated|IRCCS San Raffaele||1|||f||||f||||||||||2017-10-10 21:20:11.77467|2017-10-10 21:20:11.77467
NCT03055234|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-04-07|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)|A Phase 3, Multicenter, Randomized, Placebo-controlled Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Sickle Cell Disease|Withdrawn||Phase 3|0|Actual|United Therapeutics||2||Business decision|f||||t|t|f||||||No||2017-10-10 21:20:11.936873|2017-10-10 21:20:11.936873
NCT03055221|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-27|2017-03-20||June 10, 2005|Actual|2005-06-10|June 2017|2017-06-01|February 25, 2014|Actual|2014-02-25|February 25, 2014|Actual|2014-02-25||Interventional|TRUST-2||TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)|TRUST-2: An Open-label Continuation Trial of the Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 4|20|Actual|United Therapeutics||1|||f||||f|t|f||||||No||2017-10-10 21:20:12.020493|2017-10-10 21:20:12.020493
NCT03055208|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-16|||February 8, 2017|Actual|2017-02-08|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|February 2020|Anticipated|2020-02-01||Interventional|Gamma-GBM||Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma|Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma|Recruiting||Phase 2|50|Anticipated|Universitätsmedizin Mannheim||1|||f||||f|f|f|||f|||No||2017-10-10 21:20:12.397567|2017-10-10 21:20:12.397567
NCT03055182|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-16|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|OXYLOM||Oxygenation of Paravertebral Muscles During Exercise in Chronic Low Back Pain Patients|Oxygenation of Paravertebral Muscles During Exercise in Chronic Low Back Pain Patients|Recruiting||N/A|36|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:20:12.672149|2017-10-10 21:20:12.672149
NCT03055169|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-06|||April 2012|Actual|2012-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|READIAB-G4||TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure|TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure|Recruiting||N/A|1000|Anticipated|University Hospital, Lille|||1||f||||f||||||Samples With DNA|"     blood, plasma, mononuclear cells, DNA   "|No||2017-10-10 21:20:12.869222|2017-10-10 21:20:12.869222
NCT03055156|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-02-13|||October 2015||2015-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms|Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms|Enrolling by invitation||N/A|600|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 21:20:12.993046|2017-10-10 21:20:12.993046
NCT03055143|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-15|||September 3, 2008|Actual|2008-09-03|February 2017|2017-02-01|November 28, 2009|Actual|2009-11-28|November 28, 2009|Actual|2009-11-28||Interventional|||Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer|A Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study Of Doxorubicin Hydrochloride Liposome Injection, 2 mg/ml (50 mg/m2 Dose) of Sun Pharma Advanced Research Company Limited, India, And Caelyx® (Doxorubicin Hydrochloride) Liposome Injection, 2 mg/ml (50 mg/m2 Dose) of Schering-Plough, Belgium, in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer, Under Fed (Normal Breakfast) Conditions.|Completed||Phase 1|29|Actual|Sun Pharma Advanced Research Company Limited||2|||f||||f|f|f|||f|||No||2017-10-10 21:20:13.092561|2017-10-10 21:20:13.092561
NCT03055130|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-15|||July 2015|Actual|2015-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01|1 Week|Observational [Patient Registry]|||HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study|HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study|Recruiting||N/A|160|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University|||2||f||||||||||||||2017-10-10 21:20:13.171346|2017-10-10 21:20:13.171346
NCT03055117|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-15|||February 16, 2017|Actual|2017-02-16|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Individual Versus Group-based Exercise Rehabilitation for Shoulder Disorders: a Randomised Controlled Trial|Individual Versus Group-based Exercise Rehabilitation for Shoulder Disorders|Recruiting||N/A|180|Anticipated|Regional Hospital West Jutland||3|||f||||f|f|f||||||No||2017-10-10 21:20:13.259285|2017-10-10 21:20:13.259285
NCT03055104|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-13|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31|6 Months|Observational [Patient Registry]|||Management and Treatment of Patients With Severe Malnutrition in Intensive Care Unit: a Registry|Management and Treatment of Patients With Severe Malnutrition in Intensive Care Unit: a Registry|Recruiting||N/A|80|Anticipated|Peking University Third Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:20:13.364333|2017-10-10 21:20:13.364333
NCT03055091|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-10|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|POME-Xylitol||Xylitol for the Prevention of Acute Otitis Media Episodes in Children|Xylitol for the Prevention of Acute Otitis Media Episodes in Children 2-4: A Pragmatic RCT|Recruiting||N/A|472|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 21:20:13.461652|2017-10-10 21:20:13.461652
NCT03055078|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-04-06|||January 2017||2017-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia|Evaluation of Safety and Efficacy in Patients With Aplastic Anemia by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells|Recruiting||Phase 1|10|Anticipated|Hebei Medical University||1|||f||||f||||||||No||2017-10-10 21:20:13.569198|2017-10-10 21:20:13.569198
NCT03055052|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-15|||January 2017||2017-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Effects of a Formula With Modified Protein Levels and Fat Blend in Preterm Infants|Clinical Effects of a Formula With Modified Protein Levels and Fat Blend in Preterm Infants|Recruiting||N/A|252|Anticipated|Nestlé||2|||f||||t||||||||No||2017-10-10 21:20:13.740274|2017-10-10 21:20:13.740274
NCT03055039|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-04|||February 19, 2016|Actual|2016-02-19|September 2017|2017-09-01|May 31, 2016|Actual|2016-05-31|March 2, 2016|Actual|2016-03-02||Observational|||Epidemiology of Pain in the Delivery Room|Epidemiology of New Born Child Pain in the Delivery Room|Completed||N/A|63|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||||2017-10-10 21:20:13.822991|2017-10-10 21:20:13.822991
NCT03055026|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-22|||May 3, 2017|Actual|2017-05-03|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|PRO-LAPSII||Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.|Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer: a Randomized, Double Blind, Placebo-controlled Study.|Recruiting||Phase 3|646|Anticipated|Fadoi Foundation, Italy||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:20:13.881464|2017-10-10 21:20:13.881464
NCT03055000|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-14|2017-07-20|||February 15, 2017|Actual|2017-02-15|July 12, 2017|2017-07-12|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Study in Healthy Volunteers to Evaluate the Safety and Immunogenicity of AGS-v, a Universal Mosquito-Borne Disease Vaccine|Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study in Healthy Volunteers to Evaluate the Safety and Immunogenicity of AGS-v, a Universal Mosquito-Borne Disease Vaccine|Recruiting||Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)||3|||t|||||t|f||||||||2017-10-10 21:20:14.629894|2017-10-10 21:20:14.629894
NCT03054987|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-17|||September 2016||2016-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction|Randomized Trial Comparing Endoscopic Ultrasound-guided Biliary Drainage (EUS-BD) and Endoscopic Retrograde Cholangiopancreatography (ERCP) for Malignant Distal Biliary Obstruction|Recruiting||N/A|70|Anticipated|Florida Hospital||2|||f||||f||||||||||2017-10-10 21:20:14.739829|2017-10-10 21:20:14.739829
NCT03054974|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-02-15|||January 2013||2013-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TCM Clinical Practice Rehabilitation of Post-stroke Spasticity|Traditional Chinese Medicine Clinical Practice Rehabilitation of Post-stroke Spasticity|Recruiting||N/A|1208|Anticipated|The First Affiliated Hospital with Nanjing Medical University||4|||f||||f||||||||No||2017-10-10 21:20:14.834751|2017-10-10 21:20:14.834751
NCT03054961|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-13|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|February 9, 2024|Anticipated|2024-02-09|February 9, 2022|Anticipated|2022-02-09||Observational|||Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study|Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study - MULTICHANNEL NIRS for Epilepsy Seizure Detection|Recruiting||N/A|40|Anticipated|Medical College of Wisconsin|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:20:14.950682|2017-10-10 21:20:14.950682
NCT03054948|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-13|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||SMOFLipid in Intralipid Intolerant|Safety and Efficacy of SMOFlipid in Patients Intolerant to Intralipid.|Recruiting||Phase 4|60|Anticipated|Mayo Clinic||2|||f||||f|t|f||||||||2017-10-10 21:20:15.177229|2017-10-10 21:20:15.177229
NCT02993835|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-05-15|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Iron Bioavailability From Fortified Food|Iron Bioavailability From Fortified Food in Healthy Women|Completed||N/A|23|Actual|Nestlé||3|||f||||f||||||||No||2017-10-10 21:31:44.063336|2017-10-10 21:31:44.063336
NCT03054935|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-08|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Observational|REECD||Resting Energy Expenditure Evaluation in Subjects With Crohn's Disease|The Effects of Disease Activity on Resting Energy Expenditure in Subjects With Crohn's Disease: A Cross-sectional Study|Recruiting||N/A|150|Anticipated|Federico II University|||1||f|||||f|f||||||||2017-10-10 21:20:15.291711|2017-10-10 21:20:15.291711
NCT03054922|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-17|||January 2017||2017-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables||Enrolling by invitation||N/A|180|Anticipated|Nationwide Children's Hospital||3|||f||||f|f|f||||||No||2017-10-10 21:20:15.411834|2017-10-10 21:20:15.411834
NCT03054909|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-06-13|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer|QUILT-2.021: Randomized Study of Single Course of Intraperitoneal (IP) ALT-803 Followed by Subcutaneous (SQ) Maintenance ALT-803 Versus Subcutaneous (SQ) Maintenance ALT-803 Only After 1st Line Chemotherapy for Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Not yet recruiting||Phase 1|28|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t|t|f|||f|||||2017-10-10 21:20:15.500814|2017-10-10 21:20:15.500814
NCT03054896|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-15|||March 8, 2017|Actual|2017-03-08|March 2017|2017-03-01|September 1, 2023|Anticipated|2023-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter's Syndrome|Venetoclax Plus Dose-adjusted EPOCH-R for Richter's Syndrome|Recruiting||Phase 2|20|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 21:20:15.600646|2017-10-10 21:20:15.600646
NCT03054883|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-13|||April 1, 2012|Actual|2012-04-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy|Observational Study for Patients With Newly Diagnosed Mantle Cell Lymphoma (MCL) Not Eligible for High-dose Therapy According to the Protocol Alternating R-CHOP and R-cytarabine Chemotherapy Regimen (3+3 Cycles)|Completed||N/A|73|Actual|Czech Lymphoma Study Group|||1||f||||f|f|f||||Samples With DNA|"     Isolation of DNA from leukemized peripheral blood or infiltrated bone marrow will be used for     set up of patient-specific primers for detection of minimal residual disease after induction.   "|No||2017-10-10 21:20:15.709072|2017-10-10 21:20:15.709072
NCT03054857|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-02-13|||June 2015||2015-06-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of Dexmedetomidine Infusion on Post-operative Cognitive Function and Oxidative Stress in Cardiac Surgery|The Effect of Dexmedetomidine Infusion on Post-operative Cognitive Function and Oxidative Stress in Patients Undergo Cardiopulmonary Bypass Machine Facilitated Elective Cardiac Surgery|Completed||Phase 4|100|Actual|Chulalongkorn University||2|||f||||t||||||||Undecided||2017-10-10 21:20:15.886674|2017-10-10 21:20:15.886674
NCT03054844|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-18|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||PREMIX vs PREMED Intranasal Lidocaine and Midazolam|Comparison of Two Methods Using Intranasal Lidocaine to Alleviate Discomfort Associated With Administration of Intranasal Midazolam in Children.|Recruiting||Phase 2|50|Anticipated|Columbia University||2|||f||||t|t|f|||f|||No||2017-10-10 21:20:15.981276|2017-10-10 21:20:15.981276
NCT03054831|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-08-21|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||The Effect of General Anesthesia on Pharmacokinetics of Oxycodone in Pediatric|The Effect of General Anesthesia on Pharmacokinetics and Pharmacogenomics of Liquid Oxycodone in Pediatric Surgical Patients|Not yet recruiting||Phase 4|40|Anticipated|Boston Children’s Hospital||4|||f||||t|f|f||||||||2017-10-10 21:20:16.124366|2017-10-10 21:20:16.124366
NCT03054818|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-13|||October 2016||2016-10-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word（STONE）|Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word|Recruiting||N/A|4000|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.|||1||f||||||||||||Undecided||2017-10-10 21:20:16.235778|2017-10-10 21:20:16.235778
NCT03054792|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-19|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|June 2019|Anticipated|2019-06-01||Interventional|||Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas|Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas: Feasibility Steps Toward Personalized Medicine.|Enrolling by invitation||Phase 1|18|Anticipated|The Hospital for Sick Children||1|||f||||t|f|f||||||No|No IPD data will be shared with other researchers|2017-10-10 21:20:16.568143|2017-10-10 21:20:16.568143
NCT03054779|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-02-13|||September 2014|Actual|2014-09-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|COMITII||Canola Oil Multi-center Intervention Trial II|Canola Oil Multi-center Intervention Trial II (COMIT II): Effects of Oleic Acid Enriched and Regular Canola Oil on Body Composition and Lipid Metabolism in Participants With Metabolic Syndrome Risk Factors|Completed||N/A|28|Actual|Penn State University||3|||f||||f||||||||||2017-10-10 21:20:16.654026|2017-10-10 21:20:16.654026
NCT03054571|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-17|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Correlation Between Somatic Growth and Number of Erupted Deciduous Teeth|Correlation Between Somatic Growth and Number of Erupted Deciduous Teeth|Not yet recruiting||N/A|91|Anticipated|Cairo University|||1||f||||f|f|f||||||Undecided|publishing through an national journal|2017-10-10 21:20:18.234127|2017-10-10 21:20:18.234127
NCT03054766|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-13|||February 20, 2017|Anticipated|2017-02-20|February 2017|2017-02-01|February 28, 2020|Anticipated|2020-02-28|June 30, 2019|Anticipated|2019-06-30||Interventional|||Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO|The Randomized Double-blind Controlled Clinical Trial of Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion|Not yet recruiting||N/A|64|Anticipated|Beijing Hospital||2|||f||||t|f|f|||t|||Yes|share the results of the study,and one can send message to yuxiaobing@sina.come for information|2017-10-10 21:20:16.760261|2017-10-10 21:20:16.760261
NCT03054753|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-07|||March 31, 2017|Actual|2017-03-31|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01||Interventional|SENSABDUKT||Prospective Sensor Controlled Compliance Analysis of Shoulder Abduction Splint After Rotator Cuff Repair|Prospective Sensor Controlled Compliance Analysis of Shoulder Abduction Splint After Rotator Cuff Repair|Enrolling by invitation||N/A|50|Anticipated|Balgrist University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:20:16.880277|2017-10-10 21:20:16.880277
NCT03054740|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-28|||February 27, 2017|Actual|2017-02-27|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Vapocoolant Spray Used Prior to Intravenous (IV) Insertions|Will Patients Perceive a Vapocoolant Spray to be Effective in Reducing Pain and Increasing Satisfaction With Insertion at an Intravenous Site?|Recruiting||Phase 4|30|Anticipated|Aultman Health Foundation||2|||f||||t|t|f||||||No||2017-10-10 21:20:16.964784|2017-10-10 21:20:16.964784
NCT03054727|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-07-11|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|SPOT||Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )|Long Term Natural History of PTS and Other Adverse Outcomes After Venous Thromboembolism in the Optimev Study (SPOT)|Not yet recruiting||N/A|2400|Anticipated|Association des Médecins Vasculaires Hospitaliers|||2||f||||t||||||||||2017-10-10 21:20:17.069924|2017-10-10 21:20:17.069924
NCT03054714|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-21|||November 1, 2011|Actual|2011-11-01|February 2017|2017-02-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Long-term Hemodialysis Catheter Removal and Delayed Replacement, Versus Exchange Over a Guidewire to Treat Catheter Related Blood Stream Infection|Prospective, Randomized Study of Long-term Hemodialysis Catheter Removal, Versus Guidewire Exchange to Treat Catheter Related Blood Stream Infection|Completed||N/A|798|Actual|Ain Shams University||2|||f|||||f|f||||||||2017-10-10 21:20:17.191254|2017-10-10 21:20:17.191254
NCT03054701|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-09|||March 7, 2017|Actual|2017-03-07|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|May 17, 2017|Actual|2017-05-17||Interventional|||Effects of Hip and Knee Exercises on Knee Pain in Young Adult Females With Long-standing Patellofemoral Pain|The Acute Effects of Hip and Knee Exercises on Pain Sensitivity in Young Adult Females With Long-standing Patellofemoral Pain - a Randomized Crossover Study.|Completed||N/A|30|Actual|Aalborg University||2|||f||||t|f|f||||||No|IPD data will be available on request after manuscript has been published.|2017-10-10 21:20:17.266605|2017-10-10 21:20:17.266605
NCT03054688|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-26|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|VAST||Somnotouch-NIBP Compared to Standard Ambulatory 24 Hours Blood Pressure Measurement|Somnotouch-NIBP Compared to Standard Ambulatory 24 Hours Blood Pressure Measurement|Recruiting||N/A|50|Anticipated|University Hospital, Basel, Switzerland||1|||f||||f|f|f||||||No||2017-10-10 21:20:17.389921|2017-10-10 21:20:17.389921
NCT03054675|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-13|||June 1, 2013|Actual|2013-06-01|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|PLF||Perioperative Lung Function Monitoring After Anatomic Lung Resections|Perioperative Lung Function Monitoring After Anatomic Lung Resections|Completed||N/A|328|Actual|University Hospital Inselspital, Berne|||4||f||||f|f|f||||||No||2017-10-10 21:20:17.498395|2017-10-10 21:20:17.498395
NCT03054662|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-17|||January 16, 2017|Actual|2017-01-16|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.|Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.|Recruiting||N/A|200|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f|f|f||||||No||2017-10-10 21:20:17.615668|2017-10-10 21:20:17.615668
NCT03054649|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-07-21|||June 3, 2016||2016-06-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:20:17.734663|2017-10-10 21:20:17.734663
NCT03054636|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-06-12|||January 2017||2017-01-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|SPA||Short-term Perfusion Angiography Pilot Study (SPA)|Short-term 2D Perfusion Angiography Pilot Study|Recruiting||N/A|110|Anticipated|Volcano Corporation|||1||f||||||||||||||2017-10-10 21:20:17.7902|2017-10-10 21:20:17.7902
NCT03054623|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-13|||September 20, 2016|Actual|2016-09-20|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|September 20, 2018|Anticipated|2018-09-20||Observational|DRIL||Hemodynamic Assessment of Distal Revascularization Interval Ligation|Prospective Hemodynamic Assessment of Distal Revascularization Interval Ligation|Recruiting||N/A|10|Anticipated|University of South Florida|||1||f||||f|f|f||||||No||2017-10-10 21:20:17.868201|2017-10-10 21:20:17.868201
NCT03054610|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-15|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis.|Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis.|Recruiting||Phase 1|60|Anticipated|Universidad Autonoma de Nuevo Leon||3|||f||||t||||||||No||2017-10-10 21:20:17.985465|2017-10-10 21:20:17.985465
NCT03054597|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-10-04|||February 2012||2012-02-01|October 2017|2017-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Use of Eye Exercises to Improve Vision|Novel Way to Strengthen Eye Muscle and Enhance Peripheral Vision|Completed||N/A|19|Actual|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 21:20:18.100771|2017-10-10 21:20:18.100771
NCT03054584|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-10-03|||June 26, 2017|Actual|2017-06-26|October 2017|2017-10-01|April 1, 2019|Anticipated|2019-04-01|December 31, 2017|Anticipated|2017-12-31||Observational|||Genetic Basis of Melanocytic Nevi|Genetic Basis of Melanocytic Nevi|Recruiting||N/A|50|Anticipated|University of California, Davis|||1||f|||||f|f||||||||2017-10-10 21:20:18.172261|2017-10-10 21:20:18.172261
NCT03054558|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-16|||December 2015|Actual|2015-12-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|JZ||JZ Thickness as a Predictor of Recurrent Unexplained First Trimesteric Pregnancy Loss.|Predictive Value of Junctional Zone Thickness in Combination With Three Dimensional Power Doppler and Uterine Artery Vascular Indices in Patients With Recurrent Unexplained Pregnancy Loss; A New Diagnostic Tool.|Recruiting||N/A|100|Anticipated|Cairo University|||2||f||||||||||||||2017-10-10 21:20:18.283106|2017-10-10 21:20:18.283106
NCT03054545|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-23|||May 8, 2017|Anticipated|2017-05-08|February 2017|2017-02-01|April 30, 2019|Anticipated|2019-04-30|May 8, 2018|Anticipated|2018-05-08||Interventional|||Iguratimod as Treatment for Refractory Lupus Nephritis|Evaluation of Clinical Efficacy and Immunologic Response After Iguratimod Therapy in Refractory Lupus Nephritis|Not yet recruiting||N/A|30|Anticipated|RenJi Hospital||1|||f|||||f|f||||||||2017-10-10 21:20:18.491229|2017-10-10 21:20:18.491229
NCT03054532|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-15|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|July 2021|Anticipated|2021-07-01|January 2021|Anticipated|2021-01-01||Interventional|||Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma|Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma|Not yet recruiting||Phase 2|22|Anticipated|Singapore General Hospital||1|||f||||t|t|f|||t|||No||2017-10-10 21:20:18.58386|2017-10-10 21:20:18.58386
NCT03054519|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-06-19|||May 1, 2017|Actual|2017-05-01|April 2017|2017-04-01|September 30, 2023|Anticipated|2023-09-30|September 30, 2022|Anticipated|2022-09-30||Interventional|PERMET||Improve PAD PERformance With METformin|Improve PAD Performance With Metformin: The PERMET Trial|Recruiting||Phase 3|212|Anticipated|Northwestern University||2|||f||||t|t|f|||t|||Undecided||2017-10-10 21:20:18.687036|2017-10-10 21:20:18.687036
NCT03054506|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-25|||March 7, 2017|Actual|2017-03-07|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation|A Randomized, Single Center, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation|Recruiting||N/A|53|Anticipated|Massachusetts General Hospital||3|||f||||f|f|t|f|f||||No||2017-10-10 21:20:18.793412|2017-10-10 21:20:18.793412
NCT03054493|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-14|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Observational|NNSH||Prevalence of NNSH in a Group of Egyptian Children Aged 3-8 Years Old in Giza Governorate: A Cross Sectional Study.|Prevalence of Non-Nutritive Sucking Habits in a Group of Egyptian Children Aged 3-8 Years Old in Giza Governorate: A Cross Sectional Study.|Enrolling by invitation||N/A|1023|Actual|Cairo University|||1||f||||||||||||No||2017-10-10 21:20:18.902361|2017-10-10 21:20:18.902361
NCT03054480|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-02-15|||August 1, 2016|Actual|2016-08-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|December 31, 2016|Actual|2016-12-31||Interventional|||Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis|A Comparative Study for Efficacy and Safety Between Fractional Micro-Needle Radiofrequency (FRM) and Intradermal Botulinum Toxin A for the Treatment of Primary Axillary Hyperhidrosis|Completed||N/A|40|Actual|Mae Fah Luang University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:20:18.974054|2017-10-10 21:20:18.974054
NCT03054467|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-03-20|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|April 28, 2019|Anticipated|2019-04-28|April 28, 2019|Anticipated|2019-04-28||Interventional|SCARLET||Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina|Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Symptoms, Function, and Quality of Life in Patients With Coronary Vasospastic Angina|Not yet recruiting||Phase 4|150|Anticipated|Kosin University Gospel Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:20:19.075714|2017-10-10 21:20:19.075714
NCT03054454|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-15|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||A Podiatry Led MDT Intervention to Reduce the Burden of Foot Disease in Patients With End Stage Kidney Failure|A Podiatry-led Multidisciplinary Intervention to Reduce the Burden of Foot Disease in People With Diabetes and End-stage Kidney Failure|Not yet recruiting||N/A|32|Anticipated|South Tees Hospitals NHS Foundation Trust||2|||f||||t|f|f||||||No||2017-10-10 21:20:19.159|2017-10-10 21:20:19.159
NCT03054441|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-11|2017-07-23|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01|7 Days|Observational [Patient Registry]|||Actigraphs for Detection of Asymmetries|Detection of Asymmetries in Upper Limb Use Through Actigraphs|Recruiting||N/A|100|Anticipated|IRCCS Fondazione Stella Maris|||2||f||||f|f|f||||||||2017-10-10 21:20:19.256537|2017-10-10 21:20:19.256537
NCT03054428|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-22|||April 7, 2017|Actual|2017-04-07|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy and Safety of Dupilumab in Patients ≥12 to <18 Years of Age, With Moderate-to-Severe Atopic Dermatitis|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Dupilumab Monotherapy in Patients ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis|Recruiting||Phase 3|240|Anticipated|Regeneron Pharmaceuticals||3|||f||||t|t|f||||||||2017-10-10 21:20:19.37129|2017-10-10 21:20:19.37129
NCT03054415|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-15|||May 5, 2017|Actual|2017-05-05|February 2017|2017-02-01|November 5, 2019|Anticipated|2019-11-05|November 5, 2018|Anticipated|2018-11-05||Interventional|ANOSAIN||Anorectal Function and Neuronal-glial-epithelial Unit in Healthy Subjects|Anorectal Function and Neuronal-glial-epithelial Unit in Healthy Subjects|Recruiting||N/A|16|Anticipated|Rennes University Hospital||1|||f||||f|f|f||||||||2017-10-10 21:20:19.522857|2017-10-10 21:20:19.522857
NCT03054207|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-08|||June 2015||2015-06-01|February 2017|2017-02-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|IMPACT/R||Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients|Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients|Terminated||Phase 1|21|Actual|University Hospital, Geneva||4||difficulty to recruit|f||||f||||||||||2017-10-10 21:20:21.098262|2017-10-10 21:20:21.098262
NCT03054389|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-06-26|||March 31, 2017|Actual|2017-03-31|June 2017|2017-06-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Observational|||Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews|Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews|Completed||N/A|27|Actual|Baxalta US Inc.|||2||f||||f||||||||||2017-10-10 21:20:19.722014|2017-10-10 21:20:19.722014
NCT03054376|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-05-01|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|August 31, 2019|Anticipated|2019-08-31|March 1, 2019|Anticipated|2019-03-01||Interventional|||Vascular Health With Immobilization and Exercise Training|Impact of Training on Skeletal Muscle Vascular and Metabolic Changes With Limb Immobilization|Recruiting||N/A|24|Anticipated|University of Copenhagen||2|||f||||f|f|f||||||No||2017-10-10 21:20:19.799089|2017-10-10 21:20:19.799089
NCT03054363|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer|Phase IB/II Open-label Single Arm Study to Evaluate Safety and Efficacy of Tucatinib in Combination With Palbociclib and Letrozole in Subjects With Hormone Receptor Positive and HER2-positive Metastatic Breast Cancer|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|University of Colorado, Denver||1|||f||||t|t|f|||f|||||2017-10-10 21:20:19.904001|2017-10-10 21:20:19.904001
NCT03054350|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-06-28|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)|Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)|Active, not recruiting||Phase 2|48|Anticipated|Akebia Therapeutics||4|||f||||||||||||||2017-10-10 21:20:20.002429|2017-10-10 21:20:20.002429
NCT03054337|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-09-29|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|August 28, 2017|Actual|2017-08-28|July 5, 2017|Actual|2017-07-05||Interventional|||Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)|Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)|Completed||Phase 2|51|Actual|Akebia Therapeutics||4|||f||||||||||||||2017-10-10 21:20:20.142122|2017-10-10 21:20:20.142122
NCT03054324|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-12|||September 2, 2016|Actual|2016-09-02|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|FFRB||Validation of a Predictive Model of Coronary Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis|FFRB Study: Validation of a Predictive Model of Coronary Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis|Recruiting||N/A|120|Anticipated|National Heart Centre Singapore|||1||f||||f|f|f||||||No||2017-10-10 21:20:20.275322|2017-10-10 21:20:20.275322
NCT03054311|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-10|||January 2004||2004-01-01|February 2017|2017-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Lifestyle Matters: An Occupational Approach Towards Health and Well-being in Later Life|Lifestyle Matters: An Occupational Approach Towards Health and Well-being in Later Life|Completed||N/A|28|Actual|University of Sheffield||1|||f||||f|f|f||||||No||2017-10-10 21:20:20.355853|2017-10-10 21:20:20.355853
NCT03054298|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-08|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||CAR T Cells in Mesothelin Expressing Cancers|Phase I Study of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers|Recruiting||Phase 1|30|Anticipated|University of Pennsylvania||5|||f||||t|t|f||||||Undecided||2017-10-10 21:20:20.446291|2017-10-10 21:20:20.446291
NCT03054285|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-14|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?|Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?|Not yet recruiting||Phase 4|2300|Anticipated|Loyola University||2|||f||||t|t|f|||f|||No|There is no plan to share individual participant data.|2017-10-10 21:20:20.547052|2017-10-10 21:20:20.547052
NCT03054272|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-01|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|February 1, 2017|Actual|2017-02-01||Observational|||Visual Perception Exploration Using Eye-tracking Technology in a Cannot Intubate/Cannot Oxygenate Simulation|Visual Perception Exploration Using Eye-tracking Technology in a Cannot Intubate/Cannot Oxygenate Simulation|Completed||N/A|14|Actual|Université de Montréal|||2||f||||f|f|f||||||No||2017-10-10 21:20:20.639514|2017-10-10 21:20:20.639514
NCT03054259|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-24|||March 13, 2017|Actual|2017-03-13|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ROOTS||Rituximab Objective Outcome Measures Trial in SLE|A Feasibility Randomised Placebo-controlled Trial With Objective Outcome Measures to Evaluate the Efficacy of Biosimilar Rituximab in Musculoskeletal and Mucocutaneous Systemic Lupus Erythematosus|Recruiting||Phase 2|30|Anticipated|University of Leeds||2|||f|||||f|f|||f|||||2017-10-10 21:20:20.721704|2017-10-10 21:20:20.721704
NCT03054246|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-23|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||Chewing Side Preference and Hemispheric Laterality in Healthy Adults|Chewing Side Preference is Associated With Hemispheric Laterality in Healthy Adults|Completed||N/A|75|Actual|Hacettepe University||1|||f||||t|f|f||||||No||2017-10-10 21:20:20.826169|2017-10-10 21:20:20.826169
NCT03054233|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-15|||July 2016|Actual|2016-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of Successful Spinal Needle Insertion Between Obese and Non-obese Pregnant Women|Comparison of Successful Spinal Needle Insertion Between Obese and Non-obese Pregnant Women in Crossed Leg Sitting Position Undergoing Caesarean Section|Completed||N/A|136|Actual|Indonesia University||2|||f||||||||||||Undecided||2017-10-10 21:20:20.907547|2017-10-10 21:20:20.907547
NCT03054220|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-10|||July 2016|Actual|2016-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6|Risk of Phenoconversion in Genetic Extensive Metabolizers Healthy Volunteers Carriers of One Fully-Functional and One Non-Functional Allele Versus Carriers of Two Fully-Functional Alleles|Active, not recruiting||N/A|34|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 21:20:21.014737|2017-10-10 21:20:21.014737
NCT03054194|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-04-17|||January 31, 2017|Actual|2017-01-31|April 2017|2017-04-01|May 18, 2017|Anticipated|2017-05-18|March 2, 2017|Actual|2017-03-02||Interventional|||Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730|Active, not recruiting||Phase 1|8|Actual|Eisai Inc.||6|||f||||t|t|f||||||No||2017-10-10 21:20:21.179343|2017-10-10 21:20:21.179343
NCT03054181|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-08-02|||December 22, 2016|Actual|2016-12-22|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Observational|FIGARO||Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)|Facilitated Immunoglobulin Administration Registry and Outcomes Study|Recruiting||N/A|100|Anticipated|GWT-TUD GmbH|||1||f||||f|f|f||||||||2017-10-10 21:20:21.284388|2017-10-10 21:20:21.284388
NCT03054168|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-21|||December 15, 2016|Actual|2016-12-15|February 2017|2017-02-01|December 15, 2019|Anticipated|2019-12-15|September 15, 2018|Anticipated|2018-09-15||Interventional|||Systemic Hormones and Muscle Protein Synthesis|The Regulation of Skeletal Muscle Protein Synthesis by Systemic Hormones and Its Influence on Ageing and Anabolic Resistance|Recruiting||Phase 3|32|Anticipated|University of Nottingham||4|||f||||t|f|f||||||Undecided||2017-10-10 21:20:21.392906|2017-10-10 21:20:21.392906
NCT03054155|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-11|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser|Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser|Recruiting||N/A|20|Anticipated|Wayne State University||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:20:21.50343|2017-10-10 21:20:21.50343
NCT03054142|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-16|||January 2017||2017-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||China Collaborative Study on Epidemiology of Acute Kidney Injury|China Collaborative Study on Epidemiology of Acute Kidney Injury|Recruiting||N/A|1000000|Anticipated|Guangdong General Hospital|||2||f||||f||||||||No||2017-10-10 21:20:21.591952|2017-10-10 21:20:21.591952
NCT03054129|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-08-19|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Efficacy of Balance Training in Patients With Rotator Cuff Disease|Efficacy of Balance Training in Patients With Rotator Cuff Disease: A Randomized Controlled Trial|Recruiting||N/A|42|Anticipated|Dokuz Eylul University||2|||f|||||f|f||||||||2017-10-10 21:20:21.670263|2017-10-10 21:20:21.670263
NCT03054116|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-19|||April 1, 2013|Actual|2013-04-01|February 2017|2017-02-01|August 31, 2014|Actual|2014-08-31|August 31, 2014|Actual|2014-08-31||Observational|||Airflow Perturbation Device (APD) for the Evaluation of Pulmonary and Sleep Disorders|Airflow Perturbation Device (APD) for the Evaluation of Pulmonary and Sleep Disorders|Completed||N/A|199|Actual|Walter Reed National Military Medical Center|||1||f||||f|f|f||||||No||2017-10-10 21:20:21.743309|2017-10-10 21:20:21.743309
NCT03054103|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-10|||May 3, 2016|Actual|2016-05-03|February 2017|2017-02-01|November 11, 2016|Actual|2016-11-11|November 5, 2016|Actual|2016-11-05||Interventional|||Sedation Methods During Cataract Surgery|A Comparison of Midazolam vs. Midazolam/Ketamine for Conscious Sedation in Patients Undergoing Phacoemulsification Under Topical Anesthesia|Completed||Phase 4|105|Actual|Wake Forest University Health Sciences||3|||f||||t|t|f|||t|||No||2017-10-10 21:20:21.795252|2017-10-10 21:20:21.795252
NCT03054090|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-02-10|||May 2015||2015-05-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|HVH||Heart of Virginia Healthcare|Restoring Primary Care in Virginia: PCOR Learning as a Pathway to Value|Enrolling by invitation||N/A|300|Anticipated|Virginia Commonwealth University||1|||f||||t||||||||No||2017-10-10 21:20:21.871436|2017-10-10 21:20:21.871436
NCT03054064|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-22|||February 21, 2017|Actual|2017-02-21|February 2017|2017-02-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA|Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA|Recruiting||N/A|40|Anticipated|Parker Hannifin Corporation||1|||f|||||f|t|f|f|f|||||2017-10-10 21:20:22.28927|2017-10-10 21:20:22.28927
NCT03054051|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-03-31|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Mobile Phone Game to Prevent HIV Among Young Africans|A Mobile Phone Game to Prevent HIV Among Young Africans|Recruiting||N/A|90|Anticipated|Emory University||2|||f||||f|f|f||||||No||2017-10-10 21:20:22.558816|2017-10-10 21:20:22.558816
NCT03054038|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-17|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer|Phase I Trial of Combination Afatinib and Necitumumab in EGFR Mutation Positive NSCLC With Acquired Resistance to First or Third Generation EGFR TKIs|Recruiting||Phase 1|60|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:20:22.743788|2017-10-10 21:20:22.743788
NCT03054025|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-10|||September 2, 2015|Actual|2015-09-02|February 2017|2017-02-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Smart Phone Application in Increasing Physical Activity in Breast Cancer Survivors|Facilitating Motivational Readiness and Adoption of Physical Activity by Breast Cancer Survivors With a Smart Phone Application|Recruiting||N/A|48|Anticipated|Thomas Jefferson University||1|||f||||f|f|f||||||||2017-10-10 21:20:22.843977|2017-10-10 21:20:22.843977
NCT03054012|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-14|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Accuracy and Outcome of Computer-assisted Surgery for Bony Micro-vascular Reconstruction in the Head and Neck Region||Active, not recruiting||N/A|30|Anticipated|AZ Sint-Jan AV|||1||f||||f|f|f||||||No||2017-10-10 21:20:22.942442|2017-10-10 21:20:22.942442
NCT03053999|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-13|||October 9, 2012|Actual|2012-10-09|February 2017|2017-02-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Observational|||Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)|Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)|Recruiting||N/A|53|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||||||2017-10-10 21:20:23.023349|2017-10-10 21:20:23.023349
NCT03053986|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-12|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|April 1, 2017|Anticipated|2017-04-01|March 1, 2017|Anticipated|2017-03-01||Interventional|||Effect of Apple Polyphenols on Vascular Oxidative Stress and Endothelium Function Study (APP trial_2016)|A Double-blind, Placebo-controlled, Randomized Clinical Trial on the Metabolic and Vascular Effects of a Dietary Supplementation With Apple Polyphenols in Overweight Subjects|Recruiting||N/A|62|Anticipated|University of Bologna||2|||f||||f|f|f||||||Undecided||2017-10-10 21:20:23.131063|2017-10-10 21:20:23.131063
NCT03053973|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-12|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 1, 2020|Anticipated|2020-12-01|June 1, 2020|Anticipated|2020-06-01||Interventional|RECAPTURE||The Effects of Nocturnal Non-invasive Ventilation in Stable COPD|Nocturnal Non-Invasive Ventilation in COPD Patients With Stable Hypercapnic Respiratory Failure: Why and in Which Patient Might This be Effective?|Not yet recruiting||N/A|116|Anticipated|University Medical Center Groningen||2|||f||||t|f|t|f|f|f|||Undecided||2017-10-10 21:20:23.235752|2017-10-10 21:20:23.235752
NCT03053960|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-05|||March 2018|Anticipated|2018-03-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer|Predictability of Carcinomatous Invasion of the Maxilla or Mandible: An Assessment of Radiologic Modalities With Histologic Correlation|Withdrawn||N/A|0|Actual|Thomas Jefferson University||1||Terminated by IRB|f||||t|f|f||||||||2017-10-10 21:20:23.381386|2017-10-10 21:20:23.381386
NCT03053947|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-02-15|||February 16, 2017|Actual|2017-02-16|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pain Free Laceration Repairs Using Intra-nasal Ketamine|Pain Free Laceration Repairs Using Intra-nasal Ketamine: A Dose Escalation Clinical Trial|Recruiting||Phase 2|40|Anticipated|St. Justine's Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:20:23.499194|2017-10-10 21:20:23.499194
NCT03053934|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-08-15|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of Online Video Counselling|Evaluation of Online Video Counselling|Recruiting||N/A|400|Anticipated|Swinburne University of Technology||2|||f||||f|f|f||||||||2017-10-10 21:20:23.60886|2017-10-10 21:20:23.60886
NCT03053921|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-12|||August 19, 2015|Actual|2015-08-19|January 2017|2017-01-01|June 15, 2016|Actual|2016-06-15|March 23, 2016|Actual|2016-03-23||Interventional|||Placental Membrane for Root Coverage|Treatment of Gingival Recession Using a Coronally Advanced Flap Procedure With or Without Placental Membrane|Completed||N/A|15|Actual|Meenakshi Ammal Dental College and Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:20:23.714314|2017-10-10 21:20:23.714314
NCT03053908|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Orexin and Tau Pathology in Cognitively Normal Elderly|Orexin and Tau Pathology in Cognitively Normal Elderly (A New Prevention Strategy for Alzheimer's Disease)|Not yet recruiting||N/A|30|Anticipated|New York University School of Medicine||1|||f||||t|f|f|||f|||||2017-10-10 21:20:23.824717|2017-10-10 21:20:23.824717
NCT03053895|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-02-12|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|February 28, 2020|Anticipated|2020-02-28|September 30, 2019|Anticipated|2019-09-30||Interventional|DECIDE||Bedside Versus Operating Room Burr-Hole Drainage of Chronic Subdural Hematoma (DECIDE)|Bedside Versus Operating Room Burr-Hole Drainage of Chronic Subdural Hematoma (DECIDE)|Not yet recruiting||N/A|486|Anticipated|Hamilton Health Sciences Corporation||2|||f||||t|f|f||||||No||2017-10-10 21:20:23.934057|2017-10-10 21:20:23.934057
NCT03053882|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-02-12|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy of Peppermint and Green Tea in Malodor|Comparative Study of the Effects of Green Tea and Peppermint Herbal Mouthwash on Halitosis.|Completed||N/A|88|Actual|Shahid Beheshti University of Medical Sciences||2|||f|||||f|f||||||||2017-10-10 21:20:24.027875|2017-10-10 21:20:24.027875
NCT03053869|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-05-15|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|April 30, 2018|Anticipated|2018-04-30||Interventional|B-Free||Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free)|Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free): A Single Centre Pilot Study to Determine the Feasibility of a Multi-centre, Randomized, Cluster Crossover Trial|Not yet recruiting||Phase 1|480|Anticipated|McMaster University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:20:24.108878|2017-10-10 21:20:24.108878
NCT03053856|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-14|||February 14, 2017|Anticipated|2017-02-14|February 2017|2017-02-01|August 13, 2021|Anticipated|2021-08-13|May 13, 2021|Anticipated|2021-05-13||Interventional|||Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients|Phase II, Single-arm Study of Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Treated With Neoadjuvant Concurrent Chemoradiotherapy Followed by Curative Resection|Not yet recruiting||Phase 2|37|Anticipated|Samsung Medical Center||1|||f||||t|t|f|||f|||No||2017-10-10 21:20:24.226608|2017-10-10 21:20:24.226608
NCT03053843|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-12|||March 6, 2017|Anticipated|2017-03-06|February 2017|2017-02-01|March 6, 2020|Anticipated|2020-03-06|March 6, 2020|Anticipated|2020-03-06||Interventional|PREDIMAR||Mediterranean Diet Plus Extravirgin Olive Oil in the Prevention of Recurrent Arrhythmias. The PREDIMAR (PREvención Con DIeta Mediterránea de Arritmias Recurrentes) Trial|Randomized Trial of Mediterranean Diet Plus Extravirgin Olive Oil in the Prevention of Recurrent Arrhythmias. The PREDIMAR (PREvención Con DIeta Mediterránea de Arritmias Recurrentes) Trial|Not yet recruiting||N/A|640|Anticipated|Fundación de investigación HM||2|||f||||f|f|f||||||Undecided||2017-10-10 21:20:24.347812|2017-10-10 21:20:24.347812
NCT03053830|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-20|||January 31, 2017|Actual|2017-01-31|July 2017|2017-07-01|January 30, 2020|Anticipated|2020-01-30|January 30, 2020|Anticipated|2020-01-30||Interventional|Ket-MDD||Open Label Ketamine Treatment for Major Depressive Disorder in Veterans|An Open Label Study of the Effects of Ketamine on a Veteran Clinical Population With Major Depressive Disorder (MDD)|Recruiting||Phase 2|25|Anticipated|VA Connecticut Healthcare System||1|||f||||t|t|f|||t|||||2017-10-10 21:20:24.485363|2017-10-10 21:20:24.485363
NCT03053817|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-10|||December 2015||2015-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||The Impact of Structured Exercise on Brain Health in HIV Positive Individuals|The Impact of Structured Exercise on Brain Health in HIV Positive Individuals|Recruiting||N/A|30|Anticipated|McGill University||2|||f||||f||||||||Undecided||2017-10-10 21:20:24.594735|2017-10-10 21:20:24.594735
NCT03053804|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-02-14|||March 2015||2015-03-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction|Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment, Outcome, and Prognosis Prediction|Recruiting||N/A|75|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||No||2017-10-10 21:20:24.70799|2017-10-10 21:20:24.70799
NCT03053791|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-02-10|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|DBS-SCI||Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait|A Phase I/II Open-label Single Center Trial to Evaluate Safety and Preliminary Efficacy of Unilateral Deep Brain Stimulation of the Mesencephalic Locomotor Region in Patients With Incomplete Spinal Cord Injury|Recruiting||N/A|5|Anticipated|University of Zurich||1|||f||||t|f|f||||||No||2017-10-10 21:20:24.781756|2017-10-10 21:20:24.781756
NCT03053778|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-14|||November 1, 2016|Actual|2016-11-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Heart Valve Clinic Study|The Heart Valve Clinic Study - Reduction of Readmission After Heart Valve Surgery|Recruiting||N/A|1350|Anticipated|Odense University Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:20:24.886005|2017-10-10 21:20:24.886005
NCT03053765|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-02-10|||August 2012||2012-08-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Optimizing Fidelity of Interpersonal Psychotherapy|Optimizing Fidelity of Interpersonal Psychotherapy for Depression|Enrolling by invitation||N/A|80|Anticipated|University of Iowa||4|||f||||f||||||||||2017-10-10 21:20:24.960197|2017-10-10 21:20:24.960197
NCT03053752|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-10|||May 2013|Actual|2013-05-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Transcutaneous Electric Nerve Stimulation in Sleep of Patients With Parkinson's Disease|Transcutaneous Electric Nerve Stimulation in Sleep of Patients With Parkinson's Disease|Completed||N/A|14|Actual|Universidade Federal de Pernambuco||1|||f||||t||||||||||2017-10-10 21:20:25.030298|2017-10-10 21:20:25.030298
NCT03053739|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-02-12|||December 2016||2016-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BosSilSS||To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis|Randomized Controlled Trial to Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis|Recruiting||Phase 4|50|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 21:20:25.093835|2017-10-10 21:20:25.093835
NCT03053726|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-14|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluate the Effectiveness and Safety of Variable Frequency Stimulation Compared With Constent Frequency Stimulation for Patients With Idiopathic Parkinson's Disease||Not yet recruiting||N/A|106|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t|f|f||||||Undecided||2017-10-10 21:20:25.178804|2017-10-10 21:20:25.178804
NCT03053713|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-05-01|||April 4, 2017|Actual|2017-04-04|February 2017|2017-02-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis|The Effect of Diet Modification on Clinical Disease Activity, the Gut Microbiome and Immune Responses in Patients With Ulcerative Colitis|Enrolling by invitation||N/A|102|Anticipated|University of British Columbia||2|||f||||f|f|f||||||No||2017-10-10 21:20:25.258598|2017-10-10 21:20:25.258598
NCT03053700|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-23|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea|Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea- a Prospective Study|Not yet recruiting||Phase 4|12|Anticipated|Rabin Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:20:25.340719|2017-10-10 21:20:25.340719
NCT03053687|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-27|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy|Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy- a Randomized Double Blind, Placebo Controlled Trial|Not yet recruiting||N/A|64|Anticipated|Rabin Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:20:25.419381|2017-10-10 21:20:25.419381
NCT03053674|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-13|||February 20, 2017|Anticipated|2017-02-20|February 2017|2017-02-01|July 1, 2017|Anticipated|2017-07-01|April 1, 2017|Anticipated|2017-04-01||Interventional|||Impact of Explanation Given to Parents on Rate of Post-partum Influenza Vaccination|Impact of Explanation Given to Parents on Rate of Post-partum Influenza Vaccination|Not yet recruiting||N/A|208|Anticipated|Hillel Yaffe Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:20:25.488898|2017-10-10 21:20:25.488898
NCT03053661|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-02-12|||August 2013||2013-08-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|IRECT-01||Immune Response Evaluation to Curative Conventional Therapy|Immune Response Evaluation to Curative Conventional Therapy of Stage III/IV Head and Neck Squamous Cell Carcinoma Patients|Active, not recruiting||N/A|22|Actual|University of Ulm|||2||f||||f||||||Samples With DNA|"     serum, plasma, peripheral blood mononuclear cells, tumor tissue (fresh frozen), formalin     fixed paraffin embedded tumor tissue   "|No||2017-10-10 21:20:25.554681|2017-10-10 21:20:25.554681
NCT03053648|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-02-14|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|March 31, 2017|Anticipated|2017-03-31|March 3, 2017|Anticipated|2017-03-03||Interventional|||Self-acupressure for Insomnia|Self-acupressure for Insomnia: A Pilot Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|The Hong Kong Polytechnic University||2|||f|||||f|f||||||||2017-10-10 21:20:25.607479|2017-10-10 21:20:25.607479
NCT03053635|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-23|||December 21, 2016|Actual|2016-12-21|February 2017|2017-02-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients|A Phase Ib Trial of Intravesical Photodynamic Therapy in Patients With Non-muscle Invasive Bladder Cancer at High Risk of Progression Who Are Refractory to Bacillus Calmette-Guerin Therapy and Who Are Medically Unfit for/Refuse Cystectomy|Recruiting||Phase 1|9|Anticipated|Theralase Inc.||1|||f|||||f|f||||||Undecided||2017-10-10 21:20:25.709524|2017-10-10 21:20:25.709524
NCT03053622|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-13|2017-10-02|||April 24, 2017|Actual|2017-04-24|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of Mirikizumab (LY3074828) Injection in Healthy Participants|A Phase 1, Single-Dose Study to Assess the Relative Bioavailability, Absolute Bioavailability, and Tolerability of LY3074828 Formulations in Healthy Subjects|Active, not recruiting||Phase 1|72|Actual|Eli Lilly and Company||4|||f||||f|t|f|||t|||||2017-10-10 21:20:25.791336|2017-10-10 21:20:25.791336
NCT03053609|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-10|||January 2006|Actual|2006-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|CR-GER||Gastroesophageal Reflux and Cardiorespiratory Problems|Association Between Cardiorespiratory and Gastroesophageal Reflux Events in Infants.|Completed||N/A|72|Actual|University of Turin, Italy|||1||f||||f|f|f||||||No||2017-10-10 21:20:25.862818|2017-10-10 21:20:25.862818
NCT03053596|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-05-17|||November 2016||2016-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry)|LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable Hepacellular Carcinoma|Recruiting||N/A|100|Anticipated|Terumo Europe N.V.|||1||f||||f||||||||Undecided||2017-10-10 21:20:25.923455|2017-10-10 21:20:25.923455
NCT03053583|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-02-10|||April 1, 2016|Actual|2016-04-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|September 1, 2016|Actual|2016-09-01||Interventional|||Comparison of Classical Miller, Wis-Hipple and C-MAC Size 1 Blades|Comparison of Laryngoscopy View by Classical Miller, Wis-Hipple and C-MAC Straight Size 1 Blades in Young Children|Completed||N/A|99|Actual|State University of New York at Buffalo||3|||f||||f||||||||No||2017-10-10 21:20:26.002355|2017-10-10 21:20:26.002355
NCT03053570|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-12|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study Comparing Pulmonary Vein Isolation With the Cryoballoon and Radiofrequency Energy(Contact Force) in the Treatment of Persistent Atrial Fibrillation (AF) (Cryo Vs CF in PerAF)|Study Comparing Pulmonary Vein Isolation With the Cryoballoon and Radiofrequency Energy(Contact Force) in the Treatment of Persistent Atrial Fibrillation (PerAF)|Recruiting||N/A|200|Anticipated|China Cardiometabolic Registries||2|||f|||||f|f||||||||2017-10-10 21:20:26.066113|2017-10-10 21:20:26.066113
NCT03053544|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-04-17|||December 2016||2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer|Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer: An Internal Pilot Study|Recruiting||Phase 2|15|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||Yes|Results from this internal pilot will be disseminated to participants and stakeholders by means of publication and presentation where appropriate.|2017-10-10 21:20:26.220083|2017-10-10 21:20:26.220083
NCT03053531|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-05-04|||February 3, 2017|Actual|2017-02-03|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|HERO-ED||Hearing Resources and Outcomes in the Emergency Department (HERO-ED)|Hearing Resources and Outcomes in the Emergency Department (HERO-ED)|Recruiting||N/A|25|Anticipated|New York University School of Medicine||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:20:26.299175|2017-10-10 21:20:26.299175
NCT03053505|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-03-29|||January 2017||2017-01-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|FMTREAT||A Novel Faecal Microbiota Transplantation System for Treatment of Primary and Recurrent Clostridium Difficile Infection|Two-arm, Interventional, Prospective, Open-label, Multi-center Trial to Evaluate the Safety & Effectiveness of FMT for Treatment of Adult Patients With Primary or Recurrent CDI, Using a Novel, Standardized Microbiota Transplantation System|Recruiting||N/A|150|Anticipated|Sejtterapia Kozpont Kft.||3|||f||||f||||||||Undecided||2017-10-10 21:20:26.444113|2017-10-10 21:20:26.444113
NCT03053492|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-28|||January 10, 2017|Actual|2017-01-10|February 2017|2017-02-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|DDPSBIR||Functional Viability Duck Duck Punch|Establishing the Functional Viability and Dose-response of Duck, Duck Punch: A Stroke Rehabilitation Computer Game|Recruiting||N/A|66|Anticipated|Medical University of South Carolina||2|||f||||f|f|t|f|f|f|||Yes|At the conclusion of the study, de-identified data will be available to other researchers and may be obtained by emailing the PI|2017-10-10 21:20:28.28874|2017-10-10 21:20:28.28874
NCT03053479|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-10|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|October 30, 2024|Anticipated|2024-10-30|October 15, 2019|Anticipated|2019-10-15||Interventional|SAME||Comparison of the Efficacy of Sacrocolpopexy, the Amreich-Richter Procedure and Transvaginal Mesh|Comparison of the Efficacy of Three Surgical Methods in the Treatment of POP: Sacrocolpopexy,the Amreich-Richter Procedure and Transvaginal Mesh|Recruiting||N/A|462|Anticipated|Charles University, Czech Republic||3|||f||||f|f|f||||||No|IPD sharing not planned|2017-10-10 21:20:28.407359|2017-10-10 21:20:28.407359
NCT03053466|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-25|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|February 2018|Anticipated|2018-02-01||Interventional|||CBT-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors|A Phase 1 Multicenter, Dose Escalation Study of CBT-501 in Subjects With Select Advanced or Relapsed/Recurrent Solid Tumors|Recruiting||Phase 1|50|Anticipated|CBT Pharmaceuticals, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:20:28.52474|2017-10-10 21:20:28.52474
NCT03053453|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-14|||December 6, 2016|Actual|2016-12-06|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of PRO After TKA Under Spinal Anesthesia|Evaluation of the Patient Reported Outcomes After Sensor-guided Total Knee Arthroplasty Under Spinal Anesthesia With Limited Motor-block.|Recruiting||Phase 4|125|Anticipated|New York University School of Medicine||2|||f||||f|t|f|||f|||||2017-10-10 21:20:28.6411|2017-10-10 21:20:28.6411
NCT03053440|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-08-08|||January 25, 2017|Actual|2017-01-25|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)|A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Inhibitors BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)|Recruiting||Phase 3|167|Anticipated|BeiGene||3|||f||||t|t|f||||||||2017-10-10 21:20:28.749594|2017-10-10 21:20:28.749594
NCT03053427|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-06-16|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients|Gabapentin Enacarbil Post-marketing Clinical Study A Randomized, Double-blind, Placebo-controlled, Parallel-group Study in Subjects With Restless Legs Syndrome.|Recruiting||Phase 4|360|Anticipated|Astellas Pharma Inc||2|||f||||f|t|f|||t|||Undecided||2017-10-10 21:20:29.261936|2017-10-10 21:20:29.261936
NCT03053414|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-10|||February 20, 2017|Anticipated|2017-02-20|February 2017|2017-02-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Vitamin D Repletion and Maintenance in IBD: How Much and How Often|A Vitamin D Dosing Strategy for Adequate Repletion and Maintenance in IBD Patients With Minimal Disease Activity|Recruiting||N/A|80|Anticipated|Cedars-Sinai Medical Center||4|||f||||f|f|f|||f|||No||2017-10-10 21:20:29.465698|2017-10-10 21:20:29.465698
NCT03053401|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-12|||July 2016||2016-07-01|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|January 31, 2018|Anticipated|2018-01-31||Interventional|||Ultrasound Guided Adductor Canal Block Versus Femoral Nerve Block for Anterior Cruciate Ligament Repair in Pediatrics|Ultrasound Guided Single Shot Adductor Canal Block (ACB) Versus Single Shot Femoral Nerve Block (FNB) for Postoperative Analgesia After Arthroscopic Anterior Cruciate Ligament (ACL) Repair in Pediatrics|Recruiting||N/A|50|Anticipated|Akron Children's Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:20:29.563423|2017-10-10 21:20:29.563423
NCT03053388|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-12|2017-03-13|||March 5, 2017|Actual|2017-03-05|February 2017|2017-02-01|August 19, 2017|Anticipated|2017-08-19|August 19, 2017|Anticipated|2017-08-19||Interventional|||Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis|Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis|Recruiting||Phase 3|120|Anticipated|Advanced Inhalation Therapies Ltd||2|||f||||t|f|f||||||No||2017-10-10 21:20:29.693369|2017-10-10 21:20:29.693369
NCT03053375|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-11|||February 8, 2017|Actual|2017-02-08|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||The Effect of Pulsed Electromagnetic Field Therapy on Patients With Low Back Pain|The Effect of Pulsed Electromagnetic Field Therapy on Patients With Low Back Pain|Recruiting||N/A|80|Anticipated|University of Bridgeport||4|||f||||f|f|t|f|f|f|||Yes||2017-10-10 21:20:29.765956|2017-10-10 21:20:29.765956
NCT03053362|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-10|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||THINC-it Vortioxetine - Sensitivity to Change|An Open-Label Clinical Trial Evaluating Sensitivity to Change in Cognition Using the THINC-it Following Treatment With Vortioxetine in Major Depressive Disorder|Not yet recruiting||Phase 2/Phase 3|150|Anticipated|Brain and Cognition Discovery Foundation||2|||f||||f|t|f|||t|||No||2017-10-10 21:20:29.841692|2017-10-10 21:20:29.841692
NCT03053349|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-18|||February 18, 2017|Actual|2017-02-18|February 2017|2017-02-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01|12 Months|Observational [Patient Registry]|||Ex Vivo Lung Perfusion in Bergamo Lung Transplant Program|Ex Vivo Lung Perfusion in Bergamo Lung Transplant Program: A Prospective Observational Study|Recruiting||N/A|10|Anticipated|Papa Giovanni XXIII Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:20:29.913461|2017-10-10 21:20:29.913461
NCT03053336|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-08-16|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||App-technology to Increase Physical Activity Among Patients With Type 2 Diabetes|App-technology to Enhance Self-care for Patients With Diabetes Type 2 - A Randomized Controlled Trial|Recruiting||N/A|250|Anticipated|Karolinska Institutet||2|||f|||||f|f||||||||2017-10-10 21:20:29.987293|2017-10-10 21:20:29.987293
NCT03053323|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-13|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preconception and Pregnancy Obesity Treatment and Prevention Among Women With a History of Depression|Preconception and Pregnancy Obesity Treatment and Prevention Among Women With a History of Depression|Recruiting||N/A|24|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:20:30.135863|2017-10-10 21:20:30.135863
NCT03053310|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-15|||January 25, 2017|Actual|2017-01-25|February 2017|2017-02-01|February 28, 2025|Anticipated|2025-02-28|February 28, 2024|Anticipated|2024-02-28||Observational|GEROP||Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer|Determination of the Value of Geriatric Screening to Predict Postoperative Morbidity in an Older Head and Neck Cancer Population (GEROP)|Recruiting||N/A|94|Anticipated|AZ Sint-Jan AV|||2||f||||f|f|f||||||No||2017-10-10 21:20:30.220824|2017-10-10 21:20:30.220824
NCT03053297|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-26|||March 2, 2017|Actual|2017-03-02|September 2017|2017-09-01|November 1, 2021|Anticipated|2021-11-01|November 1, 2021|Anticipated|2021-11-01|3 Years|Observational [Patient Registry]|PANORAMA||Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)|Global PANORAMA Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC.|Recruiting||N/A|2650|Anticipated|AstraZeneca|||2||f||||f|f|f||||||||2017-10-10 21:20:30.308049|2017-10-10 21:20:30.308049
NCT03053284|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-14|||April 2017|Anticipated|2017-04-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Pasireotide in Hyperinsulinemic Hypoglycemia|Pasireotide for Prevention of Hypoglycemia in Patients With Hyperinsulinemic Hypoglycemia|Not yet recruiting||Phase 2|4|Anticipated|Montefiore Medical Center||2|||f||||f|t|f||||||No||2017-10-10 21:20:30.808807|2017-10-10 21:20:30.808807
NCT03053271|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-08-11|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ATR-101 for the Treatment of Cushing's Syndrome|Recruiting||Phase 2|16|Anticipated|Millendo Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:20:30.929211|2017-10-10 21:20:30.929211
NCT03053258|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-10|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Observational|VAP-VOC||Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP)|Pilot Study to Evaluate Diagnostic Breath Analysis for Early Detection of Ventilator Acquired Pneumonia (VAP)|Recruiting||N/A|50|Anticipated|Landon Pediatric Foundation|||1||f||||f||||||Samples Without DNA|"     Exhaled breath saved for re-test in thirty days   "|No||2017-10-10 21:20:31.09905|2017-10-10 21:20:31.09905
NCT03053245|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-23|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 1, 2022|Anticipated|2022-02-01|February 1, 2022|Anticipated|2022-02-01||Interventional|m-CCRP||Mobile Critical Care Recovery Program for Acute Respiratory Failure Survivors|Mobile Critical Care Recovery Program for Acute Respiratory Failure Survivors|Recruiting||N/A|620|Anticipated|Indiana University||2|||f||||t|f|f||||||No|There is no plan to make individual participant data (IPD) available to other researchers.|2017-10-10 21:20:31.184099|2017-10-10 21:20:31.184099
NCT03053232|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-10|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Purse String Suture Device vs. Endoclip for Immediate Endoscopic Procedure Associated Gastrointestinal Perforation|Purse String Suture Device Versus Endoclip in the Treatment of Immediate Endoscopic Procedure Associated Gastrointestinal Perforation|Recruiting||N/A|100|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f|||||f|f||||||No||2017-10-10 21:20:31.304368|2017-10-10 21:20:31.304368
NCT03053219|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-29|||November 2016||2016-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment|An Open-Label, Non-Randomized, Single-Center Study to Preliminary Evaluation of Safety and Efficacy of Patients Who Participant in [14C] AC0010 Trail and Subsequent Receiving AC0010 Treatment|Recruiting||Phase 1|7|Anticipated|Hangzhou ACEA Pharmaceutical Research Co.,Ltd.||1|||f||||f||||||||||2017-10-10 21:20:31.405543|2017-10-10 21:20:31.405543
NCT03053206|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-10|||February 15, 2017|Anticipated|2017-02-15|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia|RESPONSE TO CYTARABINE, DAUNORUBICIN AND ETOPOSIDE (ADE) AT FIRST RELASPE IN CHILDHOOD AML|Not yet recruiting||Phase 2|84|Anticipated|All India Institute of Medical Sciences, New Delhi||1|||f||||f|f|f||||||No||2017-10-10 21:20:31.494792|2017-10-10 21:20:31.494792
NCT03053193|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-10-04|||April 28, 2017|Actual|2017-04-28|October 2017|2017-10-01|December 2027|Anticipated|2027-12-01|April 2027|Anticipated|2027-04-01|10 Years|Observational [Patient Registry]|FLEX||MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles|MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)|Recruiting||N/A|2000|Anticipated|Agendia|||1||f||||f|f|f||||Samples With DNA|"     Tumor tissue acquired as part of a standard of care biopsy or surgical procedure will be sent     to Agendia for testing.   "|||2017-10-10 21:20:31.584558|2017-10-10 21:20:31.584558
NCT03053180|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-08-02|||March 23, 2017|Actual|2017-03-23|August 2017|2017-08-01|December 10, 2017|Anticipated|2017-12-10|December 10, 2017|Anticipated|2017-12-10||Observational|CITRIN||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, + Dasabuvir Without Ribavirin in Patients With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation- An Observational, Multi-Center Study|Active, not recruiting||N/A|60|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:20:31.745608|2017-10-10 21:20:31.745608
NCT03053167|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-13|||December 2016||2016-12-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients|Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients: An Open-label, Single-arm, Multicenter Phase II Study|Recruiting||Phase 2|100|Anticipated|China Medical University, China||1|||f||||t||||||||||2017-10-10 21:20:31.863028|2017-10-10 21:20:31.863028
NCT03053154|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-05-11|||September 2016||2016-09-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Observational|||Relationship Between Pelvic Tilt and Sit to Stand Task in Stroke Patients|Influence Of Pelvic Inclination On Sit To Stand Task In Stroke Patients|Completed||N/A|45|Actual|Cairo University|||3||f||||||||||||||2017-10-10 21:20:31.983097|2017-10-10 21:20:31.983097
NCT03053141|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-05-02|||May 2016||2016-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|RHAPSODY||RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)|RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)|Recruiting||N/A|40|Anticipated|Boston Scientific Corporation|||1||f||||f|f|||||||||2017-10-10 21:20:32.059328|2017-10-10 21:20:32.059328
NCT03053128|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-06-09|||November 2016||2016-11-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|December 2019|Anticipated|2019-12-01||Interventional|CSWT||Implication of Cardiac Shock Wave Therapy on Coronary Heart Disease|Implication of Cardiac Shock Wave Therapy on Coronary Heart Disease: A Prospective Randomized Double-blind Control Trial|Recruiting||N/A|30|Anticipated|Beijing Hospital||2|||f||||t||||||||No||2017-10-10 21:20:32.142448|2017-10-10 21:20:32.142448
NCT03053115|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-03-20|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|February 2019|Anticipated|2019-02-01||Interventional|LEVOLIO||Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients|Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients: Effects on Peripheral Tissues. A Prospective, Randomized, Controlled, Double-blind Study|Recruiting||Phase 2/Phase 3|260|Anticipated|Azienda USL Modena||2|||f|||||f|f||||||||2017-10-10 21:20:32.240135|2017-10-10 21:20:32.240135
NCT03053102|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-06|||March 31, 2017|Actual|2017-03-31|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Treatment Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)|A Phase 2 Open-Label Proof of Concept Study to Assess the Efficacy, Safety, and Pharmacokinetics of ACH-0144471 in Untreated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)|Recruiting||Phase 2|12|Anticipated|Achillion Pharmaceuticals||1|||f|||||t|f|||t|||||2017-10-10 21:20:32.333097|2017-10-10 21:20:32.333097
NCT03053089|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-27|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I|A Two-Stage, Phase 1/2, Open-Label Study of the Human Insulin Receptor Monoclonal Antibody-Human Alpha-L-iduronidase (HIRMAb-IDUA) Fusion Protein, AGT-181 in Patients With Mucopolysaccharidosis I (MPS I, Hurler Syndrome)|Active, not recruiting||Phase 1/Phase 2|21|Actual|ArmaGen, Inc||2|||f||||f|f|f||||||No||2017-10-10 21:20:32.41181|2017-10-10 21:20:32.41181
NCT03053076|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-07|||February 10, 2017|Actual|2017-02-10|April 2017|2017-04-01|May 15, 2017|Anticipated|2017-05-15|May 15, 2017|Anticipated|2017-05-15||Interventional|||Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates|Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates|Recruiting||Phase 1|200|Anticipated|Guangdong Women and Children Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:20:32.496789|2017-10-10 21:20:32.496789
NCT03053037|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-03|||August 5, 2016|Actual|2016-08-05|March 2017|2017-03-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2022|Anticipated|2022-04-30||Interventional|AS-RCT||Apical Size and Root Canal Treatment Success Trial (AS-RCT Trial)|Impact of Final Apical Size Preparation on Root Canal Treatment Success: A Clinical, Microbiological and Volumetric Evaluation|Recruiting||N/A|204|Anticipated|University of Washington||2|||f||||f|f|f||||||No||2017-10-10 21:20:34.439261|2017-10-10 21:20:34.439261
NCT03053024|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-21|||April 14, 2017|Actual|2017-04-14|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants|An Observational Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in China|Recruiting||N/A|50|Anticipated|Xian-Janssen Pharmaceutical Ltd.|||2||f||||f|f|f||||||||2017-10-10 21:20:34.541584|2017-10-10 21:20:34.541584
NCT03053011|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-20|||February 13, 2017|Actual|2017-02-13|February 2017|2017-02-01|February 12, 2019|Anticipated|2019-02-12|February 12, 2018|Anticipated|2018-02-12||Interventional|BRASSARD||Evaluation of the Awakening Capability by a Vibrating Bracelet (BRASSARD)|Alarm Relay Bracelet for Simplification and Security Respiratory Assistance at Home: Evaluation of the Nocturnal Awakening Capability in Ventilated Patients and Healthy Volunteers|Recruiting||N/A|40|Anticipated|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche||1|||f||||t|f|f||||||||2017-10-10 21:20:34.673293|2017-10-10 21:20:34.673293
NCT03052998|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-15|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|February 1, 2018|Anticipated|2018-02-01|December 31, 2017|Anticipated|2017-12-31||Interventional|OAETREAT||Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy|Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial|Not yet recruiting||Phase 4|110|Anticipated|Universiteit Antwerpen||2|||f||||t|t|f|||f|||Yes|will be available at an ERC website|2017-10-10 21:20:34.756492|2017-10-10 21:20:34.756492
NCT03052985|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-14|||February 14, 2017|Actual|2017-02-14|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|10 Years|Observational [Patient Registry]|VIGI-MESH||Materiovigilance After Urinary Incontinence or Prolapse Surgery|Observatory of Materiovigilance After Surgery of Urinary Incontinence or Prolapse in Women.|Recruiting||N/A|10000|Anticipated|Poitiers University Hospital|||1||f|||||f|f||||||No||2017-10-10 21:20:34.842041|2017-10-10 21:20:34.842041
NCT03052972|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-04-13|||March 23, 2017|Actual|2017-03-23|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Flortaucipir 18F PET Imaging in BIOCARD Study|Flortaucipir (18F) PET Imaging in the BIOCARD Study|Recruiting||Phase 1|100|Anticipated|Avid Radiopharmaceuticals||2|||f|||||t|f||||||||2017-10-10 21:20:34.927401|2017-10-10 21:20:34.927401
NCT03052959|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-15|||June 2018|Anticipated|2018-06-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||BETTER HEALTH: Durham|Building on Existing Tools To Improve Chronic Disease Prevention and Screening in Public Health: Durham|Not yet recruiting||N/A|120|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||No||2017-10-10 21:20:35.006235|2017-10-10 21:20:35.006235
NCT03052946|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-20|||February 28, 2017|Anticipated|2017-02-28|February 2017|2017-02-01|March 30, 2018|Anticipated|2018-03-30|November 30, 2017|Anticipated|2017-11-30||Interventional|Bulking||Bulking Agent Versus Electrostimulation Therapy in Anal Incontinence|A Prospective Randomized Study Between the Use of Bulking Agent and the Endoanal Electrostimulation Therapy in Patients With Mild or Moderate Anal Incontinence|Not yet recruiting||Phase 2/Phase 3|60|Anticipated|University of Sao Paulo||2|||f||||f|f|f||||||No||2017-10-10 21:20:35.114687|2017-10-10 21:20:35.114687
NCT03052933|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-13|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Copanlisib and Gemcitabine in Relapsed/Refractory PTCL|Prospective, Multicenter, Open-labeled, Phase I/II Study of the Efficacy and Safety of Copanlisib (BAY 80-6946) and Gemcitabine Combination in Patients With Relapsed/Refractory Peripheral T-cell or NK/T-cell Lymphoma|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|Chonnam National University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:20:35.193799|2017-10-10 21:20:35.193799
NCT03052920|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-27|||June 13, 2017|Actual|2017-06-13|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|February 2020|Anticipated|2020-02-01||Interventional|||Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial|Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial|Recruiting||N/A|40|Anticipated|Washington University School of Medicine||1|||f||||t|f|t|f|f||||||2017-10-10 21:20:35.296337|2017-10-10 21:20:35.296337
NCT03052907|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-13|||November 2012||2012-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Breast Screening & Patient Navigation (BSPAN2): Evaluating a De-Centralized Regional Delivery System for Rural Underserved|Breast Screening & Patient Navigation (BSPAN2): Evaluating a De-Centralized Regional Delivery System for Rural Underserved|Active, not recruiting||N/A|20000|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:20:35.431024|2017-10-10 21:20:35.431024
NCT03052894|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-23|||January 26, 2017|Actual|2017-01-26|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Validation of a Muscle Relaxation Monitor|Validation of a Device to Monitor Muscle Relaxation During Surgery|Recruiting||N/A|20|Anticipated|University of Miami||2|||f||||f|f|t|f|||||||2017-10-10 21:20:35.516387|2017-10-10 21:20:35.516387
NCT03052881|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-02-09|||May 2016||2016-05-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|R2D2||Robotic Retinal Dissection Device Trial|Robotic Retinal Dissection Device Trial|Recruiting||N/A|16|Anticipated|University of Oxford||2|||f||||t||||||||No|Anonymised data may be shared with other researchers as per Study Protocol and Research Participant Consent form.|2017-10-10 21:20:35.606022|2017-10-10 21:20:35.606022
NCT03052868|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-13|||July 2011||2011-07-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Analysis of Neurocognitive Elements of Attention After Chemotherapy|Analysis of Neurocognitive Elements of Attention After Chemotherapy|Completed||N/A|75|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:20:35.683454|2017-10-10 21:20:35.683454
NCT03052855|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-09|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|BICS||Inflammatory Biomarkers and Brain Metabolites, a Study Based on Magnetic Resonance Spectroscopy|Title: Inflammatory Biomarkers and Brain Metabolites, a Study Based on Magnetic Resonance Spectroscopy.|Recruiting||N/A|69|Anticipated|University Hospital, Montpellier||1|||f||||f|f|f||||||No||2017-10-10 21:20:35.744767|2017-10-10 21:20:35.744767
NCT03052842|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-06-14|||February 9, 2017|Actual|2017-02-09|February 2017|2017-02-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|||A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application|A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects|Completed||Phase 2|30|Actual|C3 Jian, LLC||3|||f||||f|t|f||||||||2017-10-10 21:20:35.823271|2017-10-10 21:20:35.823271
NCT03052829|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-03-09|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 14, 2019|Anticipated|2019-02-14|September 30, 2018|Anticipated|2018-09-30||Interventional|||Physical Activity and Pacemaker Study|Reducing Sedentary Time in Individuals With Pacemakers - Tracking By Pacemaker-Based Accelerometry|Recruiting||N/A|50|Anticipated|Medical College of Wisconsin||2|||f||||f|f|f|||f|||Yes|Step-count data from the pedometers that the subjects wear along with the activity level as measured by the subject's pacemaker will be shared with the collaborating researchers at Medtronic and at UW-Milwaukee. This data will be obtained via phone conversations with the subject and via in-clinic or remote interrogations of the implanted pacemakers. The data will become available on an ongoing basis during the study duration as participants are contacted per the study protocol.|2017-10-10 21:20:35.899858|2017-10-10 21:20:35.899858
NCT03052816|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-01|||January 30, 2017|Actual|2017-01-30|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|ICET||Ice T Postoperative Multimodal Pain Regimen in FPMRS Surgery|ICE-T Postoperative Multimodal Pain Regimen Compared to the Standard Regimen in Same Day Vaginal Pelvic Reconstructive Surgery: a Randomized Controlled Trial|Active, not recruiting||Phase 4|66|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:20:35.972813|2017-10-10 21:20:35.972813
NCT03052803|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-16|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 1, 2017|Anticipated|2017-12-01|February 1, 2017|Actual|2017-02-01||Observational|FFR-DS||Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries|Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries : FRACTIONAL FLOW RESERVE - DEVICE STUDY (FFR-DS)|Enrolling by invitation||N/A|30|Anticipated|University Hospital, Caen|||1||f||||f|f|t|f|f|f|||||2017-10-10 21:20:36.051971|2017-10-10 21:20:36.051971
NCT03052790|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-01|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Comparison of Implant Positioning With Robotic Aided Surgery and Traditional Jig Positioning in Total Knee Arthroplasty|Comparison of Implant Positioning With Robotic Aided Surgery and Traditional Jig Positioning in Total Knee Arthroplasty|Not yet recruiting||N/A|200|Anticipated|The University of Texas Health Science Center, Houston||2|||f|||||f|t|f|f|f|||||2017-10-10 21:20:36.12779|2017-10-10 21:20:36.12779
NCT03052777|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-10-02|||February 21, 2017|Actual|2017-02-21|October 2017|2017-10-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors|Improving Quality of Life in Hematologic Cancer Survivors by Closing the Exercise Intention—Behavior Gap: a Phase II Randomized Controlled Trial of a Theory-based, Telephone-delivered Exercise Counselling Intervention|Completed||N/A|51|Actual|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 21:20:36.215423|2017-10-10 21:20:36.215423
NCT03052764|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-27|||December 12, 2016|Actual|2016-12-12|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|LO-BOT||Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence (LO-BOT)|Recruiting||Phase 4|240|Anticipated|Allergan||2|||f||||f||||||||||2017-10-10 21:20:36.379692|2017-10-10 21:20:36.379692
NCT03052751|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-27|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|September 14, 2018|Anticipated|2018-09-14|July 6, 2018|Anticipated|2018-07-06||Interventional|||Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis.|A Multicenter, Randomized, Investigator- and Subject-Blind, Placebo-Controlled, Treatment Sequence Study Evaluating the Safety, Tolerability, and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis|Recruiting||Phase 2|42|Anticipated|UCB Pharma||2|||f||||t|t|f||||||||2017-10-10 21:20:36.569192|2017-10-10 21:20:36.569192
NCT03052738|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-29|||January 15, 2016|Actual|2016-01-15|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Medical Marijuana in the Pediatric Central Nervous System Tumor Population|Medical Marijuana in the Pediatric Central Nervous System Tumor Population|Recruiting||N/A|150|Anticipated|University of Colorado, Denver|||1||f||||t|f|f||||Samples Without DNA|"     Peripheral Blood   "|||2017-10-10 21:20:36.696433|2017-10-10 21:20:36.696433
NCT03052725|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-07-13|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|September 5, 2018|Anticipated|2018-09-05|August 31, 2017|Anticipated|2017-08-31||Interventional|||A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma|An Open-Label Extension Study of Reslizumab 110-mg Fixed, Subcutaneous Dosing in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma|Recruiting||Phase 3|360|Anticipated|Teva Pharmaceutical Industries||1|||f||||f|t|f||||||||2017-10-10 21:20:36.775606|2017-10-10 21:20:36.775606
NCT03052712|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-10|||November 13, 2015|Actual|2015-11-13|February 2017|2017-02-01|November 13, 2018|Anticipated|2018-11-13|November 13, 2018|Anticipated|2018-11-13||Interventional|GREFEXII||Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies (GREFEX II)|Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies (GREFEX II)|Recruiting||N/A|1170|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:20:37.234818|2017-10-10 21:20:37.234818
NCT03052699|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-02-10|||September 2015||2015-09-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|CeVag||Medium and Long-term Complications of the Patients Having Had a Vaginal Caesarian in Hospital René Dubos|Medium and Long-term Complications of the Patients Having Had a Vaginal Caesarian in Hospital René Dubos|Completed||N/A|26|Actual|Centre Hospitalier René Dubos|||1||f||||f||||||||No||2017-10-10 21:20:37.353581|2017-10-10 21:20:37.353581
NCT03052686|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-02-10|||January 2000||2000-01-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|RUVO||Retrospective Study of 110 Cases of Uterine Rupture to Determine Obstetric and Neonatal Complications|Retrospective Study of 110 Cases of Uterine Rupture to Determine Obstetric and Neonatal Complications|Completed||N/A|110|Actual|Centre Hospitalier René Dubos|||1||f||||f||||||||No||2017-10-10 21:20:37.441677|2017-10-10 21:20:37.441677
NCT03052673|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-04-25|||February 20, 2017|Actual|2017-02-20|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Ketamine for Pain Relief in Bariatric Surgery|Per-operative Low-Dose Ketamine For Postoperative Pain Relief In Patients Undergoing Bariatric Surgery: A Randomised Study|Recruiting||Phase 4|76|Anticipated|Sir Ganga Ram Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:20:37.555567|2017-10-10 21:20:37.555567
NCT03052660|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|I-PROMOTE||Impact of Preoperative Midazolam on Outcome of Elderly Patients|Impact of Preoperative Midazolam on Outcome of Elderly Patients: a Multicentre Randomised Controlled Trial|Not yet recruiting||Phase 4|614|Anticipated|RWTH Aachen University||2|||f||||f|f|f||||||||2017-10-10 21:20:37.717717|2017-10-10 21:20:37.717717
NCT03052647|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-13|||June 1, 2016|Actual|2016-06-01|February 2017|2017-02-01|March 1, 2018|Anticipated|2018-03-01|November 30, 2017|Anticipated|2017-11-30||Interventional|||Comparison of Adhesive Latch Device to Subcuticular Skin Closure at the Time of Cesarean Section|Comparison of Adhesive Latch Device to Subcuticular Skin Closure at the Time of Cesarean Section|Recruiting||N/A|32|Anticipated|Rubino Ob-Gyn Group||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:20:37.920696|2017-10-10 21:20:37.920696
NCT03052634|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-02-20|||November 2016||2016-11-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|||RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Breast Cancer||Recruiting||Phase 1/Phase 2|165|Anticipated|RemeGen||2|||f||||t||||||||Undecided||2017-10-10 21:20:38.026393|2017-10-10 21:20:38.026393
NCT03052621|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-02-13|||January 1994||1994-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|||Revisiting Omental Transposition in Locally Advance and Locally Recurrent Breast Cancer|Revisiting Omental Transposition in Locally Advance and Locally Recurrent Breast Cancer|Completed||N/A|40|Actual|Queen Sirikit Centre for Breast Cancer|||2||f||||t|f|f||||||||2017-10-10 21:20:38.131684|2017-10-10 21:20:38.131684
NCT03052608|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-09-28|||April 14, 2017|Actual|2017-04-14|September 2017|2017-09-01|October 23, 2023|Anticipated|2023-10-23|February 17, 2020|Anticipated|2020-02-17||Interventional|||A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC|A Phase 3, Randomized, Open-label Study Of Lorlatinib (Pf-06463922) Monotherapy Versus Crizotinib Monotherapy In The First-line Treatment Of Patients With Advanced Alk-positive Non-small Cell Lung Cancer|Recruiting||Phase 3|280|Anticipated|Pfizer||2|||t||||t|t|f||||||||2017-10-10 21:20:38.234628|2017-10-10 21:20:38.234628
NCT03052595|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-13|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 31, 2021|Anticipated|2021-12-31|June 30, 2020|Anticipated|2020-06-30||Observational|MS-MIDY||Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance|Multiple Sclerosis: The Role of Mitochondrial Dysfunction in Insulin Resistance|Recruiting||N/A|70|Anticipated|Slovak Academy of Sciences|||2||f||||f|f|f||||Samples With DNA|"     MicroRNA, DNA   "|Undecided||2017-10-10 21:20:38.618272|2017-10-10 21:20:38.618272
NCT03052582|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-09|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Whole Milk Compared With Skimmed Milk and Effect on Lipids|Whole Milk Compared With Skimmed Milk and Effect on Lipids - A Randomized, Controlled Cross-over Study|Completed||N/A|18|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 21:20:38.724532|2017-10-10 21:20:38.724532
NCT03052569|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-14||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access to RXDX-105 for Cancers With RET Alterations|Expanded Access to RXDX-105 for the Treatment of Cancers With RET Alterations|Temporarily not available||N/A|||Ignyta, Inc.|||||||||||||||||||2017-10-10 21:20:38.799973|2017-10-10 21:20:38.799973
NCT03052556|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-10|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|MUCOHPV||Human Papillomavirus and Cervical Dysplasia in Women With Cystic Fibrosis|Prevalence and Persistence of Human Papillomavirus (HPV) and of Cervical Dysplasia in a Cohort of Women With Cystic Fibrosis|Not yet recruiting||N/A|92|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||No||2017-10-10 21:20:38.864698|2017-10-10 21:20:38.864698
NCT03052543|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-06-08|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Outcomes of an Intraoperative Bispectral Index Monitor|A Pilot Study to Determine the Outcomes of an Intraoperative Bispectral Index Monitor|Not yet recruiting||N/A|60|Anticipated|Boston Children’s Hospital|||2||f||||f||||||||No||2017-10-10 21:20:38.961681|2017-10-10 21:20:38.961681
NCT03052530|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-07-31|||May 5, 2017|Actual|2017-05-05|July 2017|2017-07-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|||Sapphire II PRO US Clinical Study|Sapphire II PRO - A Prospective, Open Label, Multi-center, Single Arm, Observational Study Designed to Evaluate the Acute Safety and Device Procedural Success of the Sapphire II PRO 1.0 and 1.25 mm PTCA Dilatation Catheters.|Completed||N/A|61|Actual|OrbusNeich||1|||f||||f|f|t|t|||||||2017-10-10 21:20:39.051288|2017-10-10 21:20:39.051288
NCT03052517|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-05-05|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|July 15, 2022|Anticipated|2022-07-15|July 15, 2022|Anticipated|2022-07-15||Interventional|||Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment|A 2-treatment Period, Randomized, Placebo-controlled, Multicenter Parallel-group Study to Assess the Safety of QAW039 When Added to Existing Asthma Therapy in GINA Steps 3, 4 and 5 Patients With Uncontrolled Asthma.|Recruiting||Phase 3|2314|Anticipated|Novartis||3|||f|||||f|f||||||Yes|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:20:39.143194|2017-10-10 21:20:39.143194
NCT03052504|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-21|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy|Prospective Versus Retrospective Study of Comorbidity and Complications in Relation to Radical Cystectomy and Nephrectomy|Recruiting||N/A|156|Anticipated|Aarhus University Hospital|||4||f||||t|f|f||||||No||2017-10-10 21:20:39.266463|2017-10-10 21:20:39.266463
NCT03052491|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-09|||March 12, 2016|Actual|2016-03-12|February 2017|2017-02-01|August 24, 2016|Actual|2016-08-24|August 24, 2016|Actual|2016-08-24||Interventional|||Effects of a 10 Component Dietary Supplement on Health and the Quality of Life|Effects of a Multi-Pathway Dietary Supplement (Stem Cell 100+) on Indices of Health and Life Expectancy|Completed||N/A|15|Actual|Centagen, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:20:39.354685|2017-10-10 21:20:39.354685
NCT03052478|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-13|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|September 30, 2019|Anticipated|2019-09-30|March 31, 2019|Anticipated|2019-03-31||Interventional|||Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression|Phase II, Single-arm Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression|Recruiting||Phase 2|28|Anticipated|Samsung Medical Center||1|||f||||t|f|f||||||Undecided||2017-10-10 21:20:39.469202|2017-10-10 21:20:39.469202
NCT03052465|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-13|||November 16, 2015|Actual|2015-11-16|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|MIC2||Magnetic Resonance Imaging of Motility in Crohn's 2|Reduced Intestinal Motility in Inflammatory Crohn's Disease|Recruiting||N/A|35|Anticipated|University of Nottingham||1|||f||||f|f|f||||||No||2017-10-10 21:20:39.709363|2017-10-10 21:20:39.709363
NCT03052452|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-07-27|||May 23, 2017|Actual|2017-05-23|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||My Nutritional Health App Testing|My Nutritional Health App Testing|Recruiting||N/A|100|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 21:20:39.837807|2017-10-10 21:20:39.837807
NCT03052439|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-08-10|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Diet Reintroduction Study in Irritable Bowel Syndrome|Charting a Course to a Less Restrictive Diet for IBS|Recruiting||N/A|30|Anticipated|University of Michigan||5|||f||||f|f|f||||||||2017-10-10 21:20:39.911769|2017-10-10 21:20:39.911769
NCT03052426|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-16|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Occupational Therapy's Role in Promoting Community Wellness Utilizing Sit-Stand Workstations|Occupational Therapy's Role in Promoting Community Wellness: A Multi-modal Approach to Combat Sedentary Behavior in the Workplace Utilizing Sit-Stand Workstations|Active, not recruiting||N/A|18|Actual|West Virginia University||3|||f||||f|f|f||||||No|There is not a plan to share individual participant data.|2017-10-10 21:20:40.015487|2017-10-10 21:20:40.015487
NCT03052413|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-10|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females|Study to Evaluate Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals for Treatment of Hair Loss and Thinning in Females|Recruiting||N/A|60|Anticipated|Sadick Research Group||2|||f||||f|f|f||||||||2017-10-10 21:20:40.106191|2017-10-10 21:20:40.106191
NCT03052400|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-13|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus|Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus|Recruiting||Phase 2|60|Anticipated|Charles Drew University of Medicine and Science||2|||f||||t|t|f||||||Yes|Data sharing as per NIH funding requirements|2017-10-10 21:20:40.212455|2017-10-10 21:20:40.212455
NCT03052218|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-02|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|PUPICYP||Evaluation of Pupillometry for cyp2d6 Phenotyping in Children Treated With Tramadol|Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated With Tramadol|Recruiting||N/A|53|Anticipated|University Hospital, Geneva||1|||f||||t|f|f||||||No||2017-10-10 21:20:42.394217|2017-10-10 21:20:42.394217
NCT03052387|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-20|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Vertical Augmentation Using Onlay Versus Inlay Autogenous Graft With Simultaneous Implant Placement.|Assessment of Vertical Bone Augmentation Using Autogenous Onlay Versus Inlay Grafting Techniques With Simultaneous Implant Placement in the Anterior Maxillary Area on Patient's Esthetic Satisfaction : A Randomized Clinical Trial|Not yet recruiting||N/A|12|Anticipated|Cairo University||2|||f||||f|f|f||||||No|assessment of vertical ridge augmentation using autogenous Onlay versus Inlay Bone Grafting techniques in the anterior maxilla.|2017-10-10 21:20:40.327222|2017-10-10 21:20:40.327222
NCT03052374|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-01|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|January 1, 2022|Anticipated|2022-01-01|March 31, 2020|Anticipated|2020-03-31||Interventional|VID-KIDS||"Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants (VID-KIDS)"|"Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants (VID-KIDS)"|Recruiting||N/A|400|Anticipated|University of Calgary||2|||f||||f|f|f||||||Undecided||2017-10-10 21:20:40.437652|2017-10-10 21:20:40.437652
NCT03052361|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-08-01|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Triage Administration of Ondansetron for Gastroenteritis in Children|Triage Administration of Ondansetron for Gastroenteritis in Children; a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|248|Anticipated|St. Justine's Hospital||2|||f||||f|f|f||||||||2017-10-10 21:20:40.52839|2017-10-10 21:20:40.52839
NCT03052348|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-09-22|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|August 30, 2018|Anticipated|2018-08-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.|A Multicentre Study Evaluating the Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Standard of Care in the Treatment of Severe Atopic Dermatitis, a Phase II Randomized, Clinical Trial|Not yet recruiting||N/A|78|Anticipated|Red Cross War Memorial Childrens Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:20:40.82443|2017-10-10 21:20:40.82443
NCT03052335|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-03|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Efficiency of Colon Capsule Endoscopy in Colon Cancer Screening|The Comparison of the Efficiency of Colon Capsule Endoscopy and Optical Colonoscopy in Patients With Positive Immunochemical Fecal Occult Blood Test|Recruiting||N/A|230|Anticipated|Military University Hospital, Prague||1|||f|||||f|f|||f|||||2017-10-10 21:20:41.008777|2017-10-10 21:20:41.008777
NCT03052322|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-05-30|||January 31, 2017|Actual|2017-01-31|May 2017|2017-05-01|August 9, 2018|Anticipated|2018-08-09|May 9, 2018|Anticipated|2018-05-09||Interventional|Auriel-RA||MSB11022 in Moderate to Severe Rheumatoid Arthritis|A Multicenter, Randomized, Double-blind, Phase III Trial to Evaluate the Safety, Immunogenicity, and Efficacy of MSB11022 Compared With Humira® in Patients With Moderately to Severely Active Rheumatoid Arthritis|Active, not recruiting||Phase 3|288|Actual|Merck KGaA||2|||f||||t|t|f||||||||2017-10-10 21:20:41.154455|2017-10-10 21:20:41.154455
NCT03052309|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-26|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Observational|||BIOLUX P-III BENELUX All-Comers Registry|BIOTRONIK - A Prospective, International, Multi-centre, Post-market All-comers Registry to Assess the Clinical Performance of the Passeo-18 Lux Paclitaxel Releasing Balloon Catheter in Popliteal Arteries - III BENELUX|Recruiting||N/A|100|Anticipated|Biotronik AG|||1||f||||f|f|f||||||||2017-10-10 21:20:41.433311|2017-10-10 21:20:41.433311
NCT03052296|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-26|||March 22, 2017|Actual|2017-03-22|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||BIOLUX P-III SPAIN All-Comers Registry|BIOTRONIK - A Prospective, National, Multi-centre, Post-market Registry to Assess the Clinical Performance of the Passeo-18 Lux Paclitaxel Releasing Balloon Catheter in Long Femoropopliteal Artery Lesions - III SPAIN|Recruiting||N/A|150|Anticipated|Biotronik AG|||1||f||||f|f|f||||||||2017-10-10 21:20:41.64306|2017-10-10 21:20:41.64306
NCT03052283|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-13|||January 26, 2017|Actual|2017-01-26|February 2017|2017-02-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2019|Anticipated|2019-01-31||Observational|||Symptom Score to Assess Abdominal Involvement in Patients With Cystic Fibrosis|Evaluation and Validation of a New Questionnaire to Identify and Quantify Abdominal Symptoms in Patients With Cystic Fibrosis: the JenAbdomen-CF Score|Recruiting||N/A|1000|Anticipated|University of Jena|||2||f||||f|f|f||||Samples Without DNA|"     Stool   "|No||2017-10-10 21:20:41.81416|2017-10-10 21:20:41.81416
NCT03052270|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-13|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies|"Comparison of Vaginal Progesterone With Arabin Cervical Pessary and Vaginal Progesterone Alone in the Prevention of Preterm Delivery in Singleton Pregnancies With Incidental Premature Shortening of Cervical Length"|Recruiting||N/A|200|Anticipated|University of Illinois at Chicago||2|||f||||f|f|f||||||Undecided||2017-10-10 21:20:41.94645|2017-10-10 21:20:41.94645
NCT03052257|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-06-05|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|March 1, 2021|Anticipated|2021-03-01|July 1, 2019|Anticipated|2019-07-01||Interventional|MAGIC||Improve Glaucoma Medication Adherence|Improving Glaucoma Medication Adherence|Not yet recruiting||N/A|400|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:20:42.05426|2017-10-10 21:20:42.05426
NCT03052244|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-02-09|||March 15, 2017|Anticipated|2017-03-15|February 2017|2017-02-01|March 15, 2020|Anticipated|2020-03-15|March 15, 2020|Anticipated|2020-03-15||Interventional|||tDCS and VI to Treat Neuropathic Pain and Function in SCI|tDCS Stimulation Combined With VI as a Possible Therapy for Enhancing Functional Ability in SCI With Neuropathic Pain|Not yet recruiting||N/A|100|Anticipated|Loewenstein Hospital||2|||f||||t|f|t|f|||||No||2017-10-10 21:20:42.186631|2017-10-10 21:20:42.186631
NCT03052231|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-02-09|||March 2016||2016-03-01|September 2016|2016-09-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|MOMMI3CFCM||Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center|Evaluating the Feasibility of Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center|Completed||N/A|80|Actual|Landon Pediatric Foundation||2|||f||||f||||||||Yes|Share with iCAN|2017-10-10 21:20:42.294012|2017-10-10 21:20:42.294012
NCT03052192|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-02-09|||November 2016||2016-11-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|FAM-CPH||Biological Aging, Medication, Malnutrition and Inflammation Among Acutely Ill and Healthy Elderly.|Biological Aging, Medication, Malnutrition and Inflammation Among Acutely Ill and Healthy Elderly.|Recruiting||N/A|212|Anticipated|Hvidovre University Hospital|||3||f||||t||||||Samples With DNA|"     Whole blood, plasma, serum, buffy coat.   "|No||2017-10-10 21:20:43.051706|2017-10-10 21:20:43.051706
NCT03052179|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-15|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|January 31, 2019|Anticipated|2019-01-31|October 1, 2018|Anticipated|2018-10-01||Interventional|CABRIO||The Clinical and Biological Effects Of The Use Of Probiotic VSL#3 In Patients With Oral Lichen Planus|The Clinical and Biological Effects Of The Use Of Probiotic VSL#3 In Patients With Oral Lichen Planus : a Proof-of-concept Study|Not yet recruiting||N/A|30|Anticipated|University College, London||2|||f||||t|f|f||||||No|the data will be kept anynomous. This data only accessible by the party mention in the protocols|2017-10-10 21:20:43.182416|2017-10-10 21:20:43.182416
NCT03052166|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-18|||April 18, 2017|Actual|2017-04-18|September 2017|2017-09-01|November 9, 2019|Anticipated|2019-11-09|October 9, 2018|Anticipated|2018-10-09||Observational|ACCRUE||Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging|A Prospective Multi-center Case Collection Study of Breast Imaging Examinations From Asymptomatic Women to Evaluate the Non-inferiority of QT Ultrasound Compared to Digital Mammography-Digital Breast Tomography (DM-DBT)|Recruiting||N/A|350|Anticipated|QT Ultrasound LLC|||2||f||||f|f|f|||f|||||2017-10-10 21:20:43.284494|2017-10-10 21:20:43.284494
NCT03052153|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-09-27|||March 17, 2017|Actual|2017-03-17|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Intraoperative Echocardiographic Evaluation of Pulmonary Vein Velocities and Outcomes in Lung Transplantation|Intraoperative Echocardiographic Evaluation of Pulmonary Vein Velocities and Outcomes in Lung Transplantation|Recruiting||N/A|100|Anticipated|Ohio State University|||1||f||||f|f|f||||||||2017-10-10 21:20:43.370455|2017-10-10 21:20:43.370455
NCT03052140|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-08-25|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|August 9, 2017|Actual|2017-08-09|August 9, 2017|Actual|2017-08-09||Interventional|||Lamelleye vs Comparator for the Treatment of Dry Eye Disease|Post-approval Study to Assess Lamelleye vs Comparator for the Treatment of Dry Eye Disease in Adults|Completed||N/A|31|Actual|Glasgow Caledonian University||2|||f||||f|f|f||||||||2017-10-10 21:20:43.461259|2017-10-10 21:20:43.461259
NCT03052127|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-11|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Phase 1B/2 Study in Subjects With Small to Medium Primary Choroidal Melanoma|A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety of Light-activated AU-011 for the Treatment of Subjects With Small to Medium Primary Choroidal Melanoma|Recruiting||Phase 1/Phase 2|24|Anticipated|Aura Biosciences||5|||f||||f|t|f||||||||2017-10-10 21:20:43.547526|2017-10-10 21:20:43.547526
NCT03052114|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||October 2015||2015-10-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Electrical Impedance Tomography of Stroke and Brain Injury|Imaging Stroke, Epilepsy and Evoked Potentials in the Brain Using Electrical Impedance Tomography|Recruiting||N/A|150|Anticipated|University College, London|||2||f||||f||||||||Undecided||2017-10-10 21:20:43.655659|2017-10-10 21:20:43.655659
NCT03052101|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-13|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis|Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis|Recruiting||N/A|200|Anticipated|University of Cincinnati|||1||f||||f||||||||||2017-10-10 21:20:43.832591|2017-10-10 21:20:43.832591
NCT03052088|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-10|||February 6, 2017|Actual|2017-02-06|February 2017|2017-02-01|July 1, 2019|Anticipated|2019-07-01|December 1, 2018|Anticipated|2018-12-01||Observational|AutoPilot||Diagnostic Accuracy of a Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients|Multi-center, Prospective, Study to Validate the Accuracy and Assess the Clinical Utility of a Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the Emergency Department|Recruiting||N/A|1222|Anticipated|MeMed Diagnostics Ltd.|||1||f||||t|f|f||||Samples Without DNA|"     Serum samples   "|No||2017-10-10 21:20:43.907459|2017-10-10 21:20:43.907459
NCT03052075|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-02-10|||September 3, 2014|Actual|2014-09-03|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism|Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism|Recruiting||N/A|250|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||||||2017-10-10 21:20:43.987319|2017-10-10 21:20:43.987319
NCT03052062|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-07-12|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Tolerance Study of the Dietary Supplement Lipidrive (ECPH1-03)|Lipidrive Dietary Supplement Tolerance Study Based on Blood, Urine, and Hemodynamic Biological Parameters.|Recruiting||Phase 1/Phase 2|20|Anticipated|Valbiotis||1|||f||||t|f|f||||||||2017-10-10 21:20:44.078254|2017-10-10 21:20:44.078254
NCT03052049|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-12|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|March 1, 2023|Anticipated|2023-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|||Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres|Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)|Recruiting||N/A|30|Anticipated|Northwestern University||1|||f||||t|f|t|f|f||||||2017-10-10 21:20:44.228974|2017-10-10 21:20:44.228974
NCT03051685|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-12|||July 20, 2015|Actual|2015-07-20|September 2017|2017-09-01|November 10, 2015|Actual|2015-11-10|August 14, 2015|Actual|2015-08-14||Interventional|||Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults||Completed||Phase 1|16|Actual|Dr. Reddy's Laboratories Limited||4|||f||||f|t|f||||||||2017-10-10 21:20:48.949416|2017-10-10 21:20:48.949416
NCT03052023|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-12|||November 2016||2016-11-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Comparative Study Between Lap. Dual Approach, Lap. Trans Abdominal Pre-peritoneal and Lichtenstein Procedures|Inguinal Hernioplasty: Comparative Study Between Laparoscopic Dual Approach, Laparoscopic Trans Abdominal Preperitoneal and Lichtenstein Procedures. A Prospective Randomized Controlled Trial|Recruiting||N/A|75|Anticipated|Assiut University||3|||f||||f||||||||||2017-10-10 21:20:44.540202|2017-10-10 21:20:44.540202
NCT03052010|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-09|||February 6, 2017|Actual|2017-02-06|February 2017|2017-02-01|August 2021|Anticipated|2021-08-01|February 2021|Anticipated|2021-02-01||Interventional|||The Partners Scale-Up Project|Delivery of Integrated PrEP and ART for Couples in Kenya|Recruiting||Phase 4|4800|Anticipated|University of Washington||1|||f||||t|f|f||||||Yes|Data from the Partners Scale-Up Project will be available at end of the Project by contacting the International Clinical Research Center at the University of Washington (icrc@uw.edu)|2017-10-10 21:20:44.623525|2017-10-10 21:20:44.623525
NCT03051997|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-22|||April 15, 2017|Anticipated|2017-04-15|January 2017|2017-01-01|July 31, 2021|Anticipated|2021-07-31|January 31, 2021|Anticipated|2021-01-31||Interventional|||Increasing Caregiver Engagement in Juvenile Drug Courts|Behavioral Incentives to Increase Caregiver Engagement in Juvenile Drug Courts|Not yet recruiting||N/A|374|Anticipated|Medical University of South Carolina||2|||f||||f|f|f||||||No||2017-10-10 21:20:44.715234|2017-10-10 21:20:44.715234
NCT03051984|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-13|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty|Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty|Recruiting||N/A|48|Anticipated|University of Vermont||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:20:44.796735|2017-10-10 21:20:44.796735
NCT03051971|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-09|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Medicated Aerosol Delivery Using A Jet Nebulizer Versus A Vibrating Mesh Nebulizer in COPD Exacerbation|A Pilot Study of Medicated Aerosol Delivery Using A Jet Nebulizer Versus A Vibrating Mesh Nebulizer in COPD Exacerbation|Not yet recruiting||N/A|100|Anticipated|Medstar Health Research Institute||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:20:44.872248|2017-10-10 21:20:44.872248
NCT03051958|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-09|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Internet-based Mindfulness and Exposure Treatment for Atopic Dermatitis|Internet-based Mindfulness and Exposure Treatment for Atopic Dermatitis: Randomized Controlled Trial|Not yet recruiting||N/A|140|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||No|Karolinska Institutet requires that a formal assessment if the data can be made public must be conducted before publishing individual level data|2017-10-10 21:20:44.964687|2017-10-10 21:20:44.964687
NCT03051945|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-15|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|March 1, 2021|Anticipated|2021-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|||Endogenous Opioid Modulation by Ketamine|Endogenous Opioid Modulation by Ketamine|Enrolling by invitation||Phase 3|40|Anticipated|University of Utah||2|||f||||t|t|f|||t|||No||2017-10-10 21:20:45.05699|2017-10-10 21:20:45.05699
NCT03051932|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-05|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|IVTylenol||Effects of Intravenous Acetaminophen in Patients Undergoing Thoracoscopic Surgery|Effects of Intravenous Acetaminophen in Patients Undergoing Thoracoscopic Surgery|Not yet recruiting||N/A|100|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:20:47.060437|2017-10-10 21:20:47.060437
NCT03051919|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-02-18|||March 2014||2014-03-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Reinforcement Method in Laparoscopic Sleeve Gastrectomy|Staple Line Reinforcement Methods in Laparoscopic Sleeve Gastrectomy: Comparison of Burst Pressures and Leaks|Completed||N/A|118|Actual|Fatih Sultan Mehmet Training and Research Hospital|||4||f||||t||||||Samples Without DNA|"     resected stomachs   "|Undecided||2017-10-10 21:20:47.149806|2017-10-10 21:20:47.149806
NCT03051906|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-09|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|June 2024|Anticipated|2024-06-01|June 2021|Anticipated|2021-06-01||Interventional|DUCRO-HN||Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer|Anti PD-L1 Durvalumab Combined With Cetuximab and Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: a Phase II Study|Not yet recruiting||Phase 2|69|Anticipated|Azienda Ospedaliero-Universitaria Careggi||1|||f||||f|t|f|||f|||Yes|Clinical and biologic (translational) individual data will be available after the end of study|2017-10-10 21:20:47.215426|2017-10-10 21:20:47.215426
NCT03051893|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-02-09|||February 2011||2011-02-01|February 2017|2017-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations|A Two-part Open Label, Randomised, Single Dose, Crossover Study in Healthy Volunteers to: (Part A) Compare the Pharmacokinetics of up to 6 Chronocort® Formulations, and (Part B) Determine the Dose Proportionality of a Selected Chronocort® Formulation at Three Dose Levels With an Additional Comparison With the Selected Formulation Dosed on Two Occasions Over a 24 Hour Period|Completed||Phase 1|28|Actual|Diurnal Limited||3|||f||||f||||||||No||2017-10-10 21:20:47.289268|2017-10-10 21:20:47.289268
NCT03051880|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-02-09|||November 2016||2016-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors|The Preventive Effect of Topical EGF Cream for Dermatologic Adverse Events Related to EGFR Inhibitors|Recruiting||N/A|40|Anticipated|The Catholic University of Korea||2|||f||||t||||||||Undecided||2017-10-10 21:20:47.369642|2017-10-10 21:20:47.369642
NCT03051867|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-09|||January 15, 2009|Actual|2009-01-15|February 2017|2017-02-01|December 18, 2011|Actual|2011-12-18|December 18, 2010|Actual|2010-12-18||Observational|||Vitamin D Status and Metabolism in Human Pregnancy|Vitamin D Status and Metabolism in Pregnant and Nonpregnant Control Women Consuming Controlled and Equivalent Intakes of Vitamin D|Completed||N/A|47|Actual|Cornell University|||2||f||||f|f|f||||Samples With DNA|"     blood, urine, cord blood, placental tissue   "|No||2017-10-10 21:20:47.466843|2017-10-10 21:20:47.466843
NCT03051854|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-06-04|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Prevention of Violence Against Children|Prevalence, Consequences and Prevention of Violence Against Children in Southwestern Uganda|Recruiting||N/A|720|Anticipated|University of Konstanz||2|||f||||t|f|f||||||Undecided||2017-10-10 21:20:47.569265|2017-10-10 21:20:47.569265
NCT03051841|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-05-11|||January 2017||2017-01-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|January 2018|Anticipated|2018-01-01||Interventional|||CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma|A Phase I, Open-Label, Multi-Center Study of CKD-581 in Combination With Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma|Recruiting||Phase 1|18|Anticipated|Chong Kun Dang Pharmaceutical||1|||f||||f||||||||Undecided||2017-10-10 21:20:47.651147|2017-10-10 21:20:47.651147
NCT03051828|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-02-09|||August 2015||2015-08-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|ESCRIME||Physical Evaluation and Quality of Life in the Practice of Fencing in Breast Cancer Support|Practice of Fencing in Breast Cancer Care|Completed||N/A|30|Actual|Centre Hospitalier René Dubos|||1||f||||f||||||||No||2017-10-10 21:20:47.7385|2017-10-10 21:20:47.7385
NCT03051815|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-07-21|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Observational|||Influence of Craniofacial Restriction on Rebound of Obstructive Sleep Apnea Following Weight Gain|Influence of Craniofacial Restriction on Rebound of Obstructive Sleep Apnea Following Weight Gain|Not yet recruiting||N/A|20|Anticipated|Chinese University of Hong Kong|||1||f||||f||||||||||2017-10-10 21:20:47.808454|2017-10-10 21:20:47.808454
NCT03051802|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-09|||January 27, 2017|Actual|2017-01-27|February 2017|2017-02-01|July 27, 2018|Anticipated|2018-07-27|July 27, 2018|Anticipated|2018-07-27||Interventional|||Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and Lung|Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and Lung|Recruiting||N/A|10|Anticipated|University Health Network, Toronto||1|||f||||f|f|f||||||No||2017-10-10 21:20:47.879833|2017-10-10 21:20:47.879833
NCT03051789|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-28|||February 28, 2017|Actual|2017-02-28|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|CCg||Cups or Cash for Girls Trial to Reduce Sexual and Reproductive Harm and School Dropout|Menstrual Cups and Cash Transfer to Reduce Sexual and Reproductive Harm and School Dropout in Adolescent Schoolgirls in Western Kenya: a Cluster Randomised Controlled Trial|Recruiting||N/A|3864|Anticipated|Liverpool School of Tropical Medicine||4|||f||||t|f|f|||f|||Yes|A link will be provided from LSTM and study-specific website to study resources including the protocol, participant information sheets, SOPs, publications and the database. A data repository is being established at LSTM and will be entrusted with storing data when ready. The investigators policy to data sharing will be published on the study website. A final database containing all research data will be made fully publicly available in an unrestricted format once the findings have been published. The only limits to data sharing will be to safeguard participants' confidentiality. The proposed procedures for data sharing will be set out and explained to the research participants as part of the informed consent process. External users will be bound by data sharing agreements in line with The MRC Data Sharing Policy. External users will be required to accept terms and conditions of use using a declaration tick box.|2017-10-10 21:20:48.065422|2017-10-10 21:20:48.065422
NCT03051776|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-10-05|||January 3, 2016|Actual|2016-01-03|October 2017|2017-10-01|March 30, 2016|Actual|2016-03-30|March 30, 2016|Actual|2016-03-30||Interventional|||Kinesio Taping Versus Compression Garments for Breast Cancer-Related Lymphedema|Kinesio Taping Versus Compression Garments in the Treatment of Breast Cancer-Related Lymphedema. Randomized Crossover Trial.|Completed||N/A|30|Actual|Hospital Universitario 12 de Octubre||2|||f||||f|f|f||||||||2017-10-10 21:20:48.219575|2017-10-10 21:20:48.219575
NCT03051763|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-05-01|||January 19, 2017|Actual|2017-01-19|May 2017|2017-05-01|May 19, 2019|Anticipated|2019-05-19|January 19, 2019|Anticipated|2019-01-19||Observational|PEGASUS||The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension|PEGASUS - The Effects of Commercial Air Travel on Patients Suffering From Pulmonary Hypertension: A Prospective, Multicentric Analysis|Recruiting||N/A|1000|Anticipated|University of Giessen|||1||f||||t||||||||No||2017-10-10 21:20:48.310278|2017-10-10 21:20:48.310278
NCT03051750|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-29|||February 1, 2016|Actual|2016-02-01|February 2017|2017-02-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|||Comparison of Techniques for Breast Cancer-Related Lymphedema.|Complex Physical Therapy Plus Pressotherapy Versus Kinesio Taping in Breast Cancer-Related Lymphedema. Randomized Crossover Trial.|Completed||N/A|42|Actual|Hospital Universitario 12 de Octubre||2|||f||||f|f|f||||||No||2017-10-10 21:20:48.438591|2017-10-10 21:20:48.438591
NCT03051737|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-05-22|||September 2017|Anticipated|2017-09-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|PRED-URG||Development and Validation of a Regional Multi-scale System for the Prediction of the Patient Flow in the Emergencies and the Need for Hospitalization|Development and Validation of a Regional Multi-scale System in Ile-de-France for the Prediction of the Patient Flow in the Emergency Department and the Need for Hospitalization|Not yet recruiting||N/A|18000000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||No||2017-10-10 21:20:48.537299|2017-10-10 21:20:48.537299
NCT03051724|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-09|||February 6, 2017|Actual|2017-02-06|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Telemedicine for CPAP Therapy Control in OSA|Telemedicine for CPAP Therapy Control in OSA Patients With Limited Internet Knowledge|Recruiting||N/A|60|Anticipated|Hospital Clinic of Barcelona||2|||f||||t|f|f||||||No||2017-10-10 21:20:48.62191|2017-10-10 21:20:48.62191
NCT03051711|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-29|||December 2016||2016-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions|An Open Label Study of GBT440 to Evaluate the Effect on Oxygenation in Healthy Subjects at Rest and Maximal Exercise Under Hypoxic Conditions|Recruiting||Phase 1|20|Anticipated|Global Blood Therapeutics||2|||f||||f||||||||||2017-10-10 21:20:48.707223|2017-10-10 21:20:48.707223
NCT03051698|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-09|||November 16, 2016|Actual|2016-11-16|February 2017|2017-02-01|November 16, 2018|Anticipated|2018-11-16|November 16, 2018|Anticipated|2018-11-16||Interventional|CAST||C1-inhibitor in Allergic ASThma Patients|Effect of Intravenous Administration of C1-inhibitor on Inflammation and Coagulation After Bronchial Instillation of House Dust Mite Allergen and Lipopolysaccharide in Allergic Asthma Patients|Recruiting||Phase 4|60|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||f|t|f||||||Undecided||2017-10-10 21:20:48.810299|2017-10-10 21:20:48.810299
NCT03051672|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-14|||April 14, 2017|Actual|2017-04-14|April 2017|2017-04-01|August 25, 2024|Anticipated|2024-08-25|August 25, 2020|Anticipated|2020-08-25||Interventional|||Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC|A Phase II Study Of Pembrolizumab In Combination With Palliative Radiotherapy For Metastatic Hormone Receptor Positive Breast Cancer|Recruiting||Phase 2|27|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 21:20:49.032843|2017-10-10 21:20:49.032843
NCT03051659|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-22|||March 22, 2017|Actual|2017-03-22|March 2017|2017-03-01|August 25, 2024|Anticipated|2024-08-25|August 25, 2020|Anticipated|2020-08-25||Interventional|||A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer|A Randomized Phase II Study Of Eribulin Mesylate With Or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer|Recruiting||Phase 2|88|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||No||2017-10-10 21:20:49.124214|2017-10-10 21:20:49.124214
NCT03051633|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-09|||April 15, 2014|Actual|2014-04-15|February 2017|2017-02-01|February 28, 2019|Anticipated|2019-02-28|December 20, 2018|Anticipated|2018-12-20||Interventional|||Substance Use Prevention Campaign for American Indian Youth|Substance Use Prevention Campaign for American Indian Youth|Active, not recruiting||N/A|548|Actual|Colorado State University||2|||f||||f|f|f||||||No||2017-10-10 21:20:49.307741|2017-10-10 21:20:49.307741
NCT03051620|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-06-26|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|July 1, 2019|Anticipated|2019-07-01|February 1, 2019|Anticipated|2019-02-01||Observational|PROSA||Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate|Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate|Recruiting||N/A|140|Anticipated|Aarhus University Hospital|||1||f||||t|t|f||||||Undecided||2017-10-10 21:20:49.370154|2017-10-10 21:20:49.370154
NCT03051594|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-10|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|March 30, 2018|Anticipated|2018-03-30|March 1, 2018|Anticipated|2018-03-01||Interventional|||Reliability of Fluorescent Camera and Caries Detection Dye Versus the Visual Tactile Method|Reliability of Fluorescent Camera and Caries Detection Dye Versus the Visual Tactile Method in Determining Caries Excavation Endpoint Using Microbiological Assessment (Randomized Clinical Trial)|Recruiting||N/A|20|Anticipated|Cairo University||3|||f||||t|f|t|f|||||Yes|publishing the data at egyptian dental journal|2017-10-10 21:20:49.638563|2017-10-10 21:20:49.638563
NCT03051581|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma|18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma|Not yet recruiting||N/A|80|Anticipated|Beijing Cancer Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:20:49.82364|2017-10-10 21:20:49.82364
NCT03051568|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma|Evaluating Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography /Computed Tomography With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma|Not yet recruiting||N/A|80|Anticipated|Beijing Cancer Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:20:49.905039|2017-10-10 21:20:49.905039
NCT03051555|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma|18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma|Not yet recruiting||N/A|60|Anticipated|Beijing Cancer Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:20:49.995259|2017-10-10 21:20:49.995259
NCT03051542|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma|Evaluating Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography / Computed Tomography With Liver SUVmax-based Criteria for Prognosis of Patients With NK/T-cell Lymphoma|Not yet recruiting||N/A|60|Anticipated|Beijing Cancer Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:20:50.106879|2017-10-10 21:20:50.106879
NCT03051529|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-02-09|||January 2009||2009-01-01|February 2017|2017-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Combined Spinal- Epidural Anesthesia in Patients With Dilated Cardiomyopathy|Combined Spinal- Epidural Anesthesia (CSE) for Vascular and Orthopedic Operations in Patients With Dilated Cardiomyopathy|Completed||N/A|24|Actual|Assiut University|||1||f||||t||||||||No||2017-10-10 21:20:50.204206|2017-10-10 21:20:50.204206
NCT03051516|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-13|||September 14, 2017|Anticipated|2017-09-14|July 2017|2017-07-01|December 21, 2021|Anticipated|2021-12-21|December 21, 2021|Anticipated|2021-12-21||Interventional|||HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions|HPV Vaccine to Interrupt Progression of Vulvar and Anal Neoplasia (VIVA) Trial: A Randomized, Double-Blind, Placebo-Controlled Trial|Recruiting||Phase 4|345|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t|t|f||||||||2017-10-10 21:20:50.291175|2017-10-10 21:20:50.291175
NCT03051503|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-22|||February 2, 2017|Actual|2017-02-02|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy of Transdermal Fentanyl Patches in Relief of Acute Postoperative Pain After Mastectomy|Efficacy of Transdermal Fentanyl Patches in Relief of Acute Postoperative Pain After Mastectomy|Recruiting||Phase 4|60|Anticipated|South Egypt Cancer Institute||2|||f||||t|t|f|||t|||Yes||2017-10-10 21:20:50.411721|2017-10-10 21:20:50.411721
NCT03051477|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-04-05|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Dose Escalating Trial of Mistletoe Extract in Patients With Advanced Solid Tumors|A Phase I Dose Escalating Trial of Mistletoe Extract in Patients With Advanced Solid Tumors|Recruiting||Phase 1|58|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||No||2017-10-10 21:20:50.681506|2017-10-10 21:20:50.681506
NCT03051464|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-20|||April 25, 2017|Actual|2017-04-25|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|||No Surgery Trial / Two Dose-escalation Strategies|A Pilot Study of Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in Rectal Cancer Patients.|Recruiting||N/A|40|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||t|f|f||||||||2017-10-10 21:20:50.774776|2017-10-10 21:20:50.774776
NCT03051451|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-08-31||||||August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|Metfluo||Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity|Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Efficacy of Two Fixed Dose Combination of Metformin/Fluoxetin 1000/40 mg vs. 1700/40 mg in the Management of Overweight and Obesity|Suspended||Phase 2|150|Anticipated|Laboratorios Silanes S.A. de C.V.||3||Business decision|f||||f|f|f||||||||2017-10-10 21:20:50.873386|2017-10-10 21:20:50.873386
NCT03051425|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||March 28, 2016|Actual|2016-03-28|February 2017|2017-02-01|February 8, 2017|Actual|2017-02-08|January 10, 2017|Actual|2017-01-10||Interventional|||Immune Benefits of Consumption of Dairy Yogurt in Elderly|Immune Benefits of Consumption of Dairy Yogurt Containing Functional Probiotics Among Individuals Over 60 Years Old|Completed||N/A|200|Actual|Yonsei University||2|||f|||||f|f||||||||2017-10-10 21:20:51.071428|2017-10-10 21:20:51.071428
NCT03051412|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-26|||February 22, 2017|Actual|2017-02-22|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Pain Mechanisms in Young Adolescent Females With Longstanding Patellofemoral Pain|Differences in Pain Sensitivity in Young Females With Longstanding Patellofemoral Pain, Recovered Females With a History of PFP, and Healthy Controls.|Recruiting||N/A|108|Anticipated|Aalborg University|||3||f|||||f|f||||||Undecided||2017-10-10 21:20:51.183681|2017-10-10 21:20:51.183681
NCT03051399|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-13|||July 6, 2015|Actual|2015-07-06|February 2017|2017-02-01|November 30, 2016|Actual|2016-11-30|January 31, 2016|Actual|2016-01-31||Interventional|||Clinical Evaluation of the Effects of EpiCor on Digestive Comfort|Clinical Evaluation of the Effects of EpiCor Brand Yeast Fermentate (Made Using Saccharomyces Cerevisiae) on Digestive Comfort, Intestinal Barrier Function and Prebiotic Modulation of the Gut Microbiota.|Completed||N/A|80|Actual|ProDigest||2|||f||||f|f|f||||||No||2017-10-10 21:20:51.274606|2017-10-10 21:20:51.274606
NCT03051373|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-10|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|April 30, 2019|Anticipated|2019-04-30||Interventional|||Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract|Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract|Not yet recruiting||Phase 2|108|Anticipated|Chinese PLA General Hospital||2|||f|||||f|f||||||||2017-10-10 21:20:51.453549|2017-10-10 21:20:51.453549
NCT03051360|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-08|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|January 1, 2020|Anticipated|2020-01-01|December 31, 2019|Anticipated|2019-12-31||Interventional|||PCSK9 Inhibitors in the Progression of Aortic Stenosis|Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor in Aortic Stenosis|Not yet recruiting||Phase 2|140|Anticipated|Seoul National University Hospital||2|||f||||t|t|f||||||Undecided||2017-10-10 21:20:51.538959|2017-10-10 21:20:51.538959
NCT03051347|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-02|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments|AAD-PEPR: Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments|Recruiting||N/A|90|Anticipated|Northwestern University||2|||f||||f|f|f||||||Yes||2017-10-10 21:20:51.624696|2017-10-10 21:20:51.624696
NCT03051334|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||January 1, 2007|Actual|2007-01-01|February 2017|2017-02-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Ascending Aortic Dilation in BiAV After TAVR|Changes in Ascending Aorta Size After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis: A Pilot Study With Echocardiographic Follow-up|Recruiting||N/A|100|Anticipated|Seoul National University Hospital|||2||f||||||||||||||2017-10-10 21:20:51.706424|2017-10-10 21:20:51.706424
NCT03051321|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-24|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Maintaining Lower Levels of Care Through Automated Perineal Hygiene|Maintaining Lower Levels of Care Through Automated Perineal Hygiene|Recruiting||N/A|40|Anticipated|SchwabCare||1|||f||||t|f|f||||||No||2017-10-10 21:20:51.787508|2017-10-10 21:20:51.787508
NCT03051308|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-02-08|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|July 1, 2017|Anticipated|2017-07-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation|University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation: Effects on Calcium Sensing and Vitamin D Receptor During Cold Ischemia|Recruiting||N/A|7|Anticipated|SB Istanbul Education and Research Hospital||5|||f||||t|f|f||||||Undecided||2017-10-10 21:20:51.872414|2017-10-10 21:20:51.872414
NCT03051295|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-10|||June 8, 2016|Actual|2016-06-08|February 2017|2017-02-01|December 13, 2016|Actual|2016-12-13|December 13, 2016|Actual|2016-12-13||Interventional|RCDENT2017||Dentists' Understanding of Diagnostic Test Results and Treatment Efficacy.|The Influence of Different Formats for Presenting Diagnostic Test Results and Treatment Efficacy on Dentists' Understanding and on Their Reported Clinical Management.|Completed||N/A|101|Actual|Rio de Janeiro State University||4|||f||||f|f|f||||||No||2017-10-10 21:20:51.968505|2017-10-10 21:20:51.968505
NCT03051282|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-04-14|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Genetic Determinants of ACEI Prodrug Activation|Genetic Determinants of ACEI Prodrug Activation|Recruiting||Phase 4|36|Anticipated|University of Michigan||2|||f|||||t|f||||||||2017-10-10 21:20:52.035384|2017-10-10 21:20:52.035384
NCT03051269|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-08|||May 2016||2016-05-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Calcium Electroporation for Head and Neck Cancer|Calcium Electroporation for Head and Neck Cancer|Recruiting||Phase 1|6|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||No||2017-10-10 21:20:52.110979|2017-10-10 21:20:52.110979
NCT03051256|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Safety, Tolerability, PK, and Symptom Response of REL-1017 (d-Methadone) in Major Depressive Disorder|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, 3 Arm Study to Assess the Safety, Tolerability, Pharmacokinetics, and Symptom Response of REL-1017 (d-Methadone) in the Treatment of Patients With Major Depressive Disorder|Not yet recruiting||Phase 2|45|Anticipated|Relmada Therapeutics, Inc.||3|||f||||f|t|f||||||||2017-10-10 21:20:52.21035|2017-10-10 21:20:52.21035
NCT03051243|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department|Safety and Efficacy of Linagliptin Therapy in the Setting of Internal Medicine Department Type 2 Diabetes Mellitus|Not yet recruiting||Phase 3|60|Anticipated|Rabin Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:20:52.422604|2017-10-10 21:20:52.422604
NCT03051230|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-08|||April 1, 2012|Actual|2012-04-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|January 2, 2015|Actual|2015-01-02||Observational|PREDHSO||Vascular Cell Activation, Cell-Derived Microparticles and In Vitro Fertilisation, and In Vitro Fertilisation|Vascular Cell Activation Throughout Ovarian Hyperstimulation for In Vitro Fertilisation: Role of Cell-Derived Microparticles in the Adverse Outcomes|Completed||N/A|50|Actual|Poissy-Saint Germain Hospital|||1||f||||f|f|f||||Samples Without DNA|"     After platelet removal, serum samples will be frozen stored before being processed   "|Undecided||2017-10-10 21:20:52.532071|2017-10-10 21:20:52.532071
NCT03051217|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-27|||February 21, 2017|Actual|2017-02-21|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis|Phase 2/3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis|Recruiting||Phase 2/Phase 3|125|Anticipated|UCB Pharma||3|||f||||f|f|f|||f|||||2017-10-10 21:20:52.67704|2017-10-10 21:20:52.67704
NCT03051204|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-10|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|November 2017|Anticipated|2017-11-01||Observational|OptiCal||OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome|OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome|Not yet recruiting||N/A|175|Anticipated|University of California, Los Angeles|||1||f||||f|f|f||||||No|All participants data will be de-identified by the research coordinator in standing with HIPAA regulations.|2017-10-10 21:20:52.871372|2017-10-10 21:20:52.871372
NCT03051191|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-19|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Pathogenic Mechanisms of Cancer and Cardiovascular Diseases|Exploring the Pathogenic Mechanisms Shared by Cancer and Cardiovasuclar Diseases|Recruiting||N/A|66|Anticipated|Sakakibara Heart Institute|||6||f||||f|f|f||||Samples With DNA|"     plasma containing cell free DNA   "|No||2017-10-10 21:20:52.946522|2017-10-10 21:20:52.946522
NCT03051178|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-27|||November 30, 2017|Anticipated|2017-11-30|September 2017|2017-09-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||Wearable Sensor for Responsive DBS for ET|Wearable Sensor Driven Closed-loop Deep Brain Stimulation for Essential Tremor|Not yet recruiting||N/A|60|Anticipated|University of Florida||1|||f||||t|f|f|||f|||||2017-10-10 21:20:53.05115|2017-10-10 21:20:53.05115
NCT03051152|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|LELEGA||D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric Adenocarcinoma|Limited Versus Extended Lymphadenectomy in High Risk Elderly With Gastric Adenocarcinoma: a Randomized Controlled Trial|Not yet recruiting||N/A|500|Anticipated|Italian Research Group for Gastric Cancer||2|||f||||f|f|f||||||Yes||2017-10-10 21:20:53.231792|2017-10-10 21:20:53.231792
NCT03050788|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-21|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma|Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma|Recruiting||N/A|500|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:20:56.043663|2017-10-10 21:20:56.043663
NCT03051139|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-02-20|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|December 2017|Anticipated|2017-12-01||Interventional|||A Strategy to Improve Implementation of LTVV for Patients w/ ARDS|A Cluster Randomized Controlled Trial of a Multi-component Strategy to Improve Implementation of Low Tidal Volume Ventilation for Patients With Acute Respiratory Distress Syndrome|Not yet recruiting||N/A|264|Anticipated|Northwestern University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:20:53.335603|2017-10-10 21:20:53.335603
NCT03051126|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-08|||July 9, 2009|Actual|2009-07-09|February 2017|2017-02-01|July 1, 2024|Anticipated|2024-07-01|July 1, 2024|Anticipated|2024-07-01||Observational|||Establishment of a Parathyroid Tissue Bank|Establishment of a Parathyroid Tissue Bank|Recruiting||N/A|10000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||Samples With DNA|"     Up to 40cc of blood will be collected from all patients during routine blood draws at     follow-up appointments through the care cycle.   "|||2017-10-10 21:20:53.451664|2017-10-10 21:20:53.451664
NCT03051113|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||August 2016||2016-08-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Identification of Neuromas by High Resolution Ultrasound in Patients With Peripheral Nerve Injury and Amputations|Identification of Neuromas by High Resolution Ultrasound in Patients With Peripheral Nerve Injury and Amputations|Recruiting||N/A|60|Anticipated|Danish Pain Research Center|||1||f||||t|f|f||||||No||2017-10-10 21:20:53.54264|2017-10-10 21:20:53.54264
NCT03051100|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Triplet Therapy With Bempedoic Acid (ETC 1002) 180 mg, Ezetimibe 10 mg, and Atorvastatin 20 mg in Patients With Elevated LDL C|Recruiting||Phase 2|60|Anticipated|Esperion Therapeutics||2|||f||||f|f|f||||||No||2017-10-10 21:20:53.6188|2017-10-10 21:20:53.6188
NCT03051087|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-08|||October 2016||2016-10-01|February 2017|2017-02-01||||January 2018|Anticipated|2018-01-01||Interventional|||To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®|A Multicenter, Randomized, Treated-controlled, Parallel, Open Label Study to Compare and Evaluate the Efficacy and Safety of Ganilever PFS and Orgalutran® in Infertility Women for Assisted Reproductive Technologies|Recruiting||Phase 4|288|Anticipated|LG Life Sciences||2|||f||||f||||||||||2017-10-10 21:20:53.746197|2017-10-10 21:20:53.746197
NCT03051074|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-06-27|||December 2016||2016-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Examining the Effects of Reduced Environmental Stimulation on Anxiety|Examining the Effects of Reduced Environmental Stimulation on Anxiety|Recruiting||N/A|100|Anticipated|Laureate Institute for Brain Research, Inc.||2|||f||||f||||||||No||2017-10-10 21:20:53.839584|2017-10-10 21:20:53.839584
NCT03051061|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-19|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|November 1, 2017|Anticipated|2017-11-01|June 1, 2017|Anticipated|2017-06-01|1 Year|Observational [Patient Registry]|ACHDAF||Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation|Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation:A Single-center,Retrospective,Observational Study|Recruiting||N/A|1000|Anticipated|Henan Institute of Cardiovascular Epidemiology|||1||f||||t|f|f|||f|||Yes||2017-10-10 21:20:53.937745|2017-10-10 21:20:53.937745
NCT03051048|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-03|||January 1, 2004|Actual|2004-01-01|June 2017|2017-06-01|January 30, 2018|Anticipated|2018-01-30|January 30, 2017|Actual|2017-01-30||Observational|MOODY||System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study)|System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study)|Enrolling by invitation||N/A|8000|Actual|Nanjing First Hospital, Nanjing Medical University|||2||f||||t|f|f||||||No||2017-10-10 21:20:54.023115|2017-10-10 21:20:54.023115
NCT03051022|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-08-15|||May 1, 2016|Actual|2016-05-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|November 30, 2016|Actual|2016-11-30||Interventional|||Comparison Between Dexamethasone and Morphine as an Adjuvant to Bupivacaine for Post-operative Analgesia|The Comparison Between Dexamethasone and Morphine as an Adjuvant to Epidural Bupivacaine for Post-operative Analgesia in Lower Extremity Surgery|Completed||N/A|64|Actual|Indonesia University||2|||f||||||||||||||2017-10-10 21:20:54.225268|2017-10-10 21:20:54.225268
NCT03051009|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-05-02|||January 11, 2017|Actual|2017-01-11|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects|A Multi-Centre Trial Investigating the Long Term Safety and Tolerability of Desmopressin (FE 992026) Orally Disintegrating Tablets for the Treatment of Nocturia Due to Nocturnal Polyuria in Japanese Subjects|Recruiting||Phase 3|400|Anticipated|Ferring Pharmaceuticals||8|||f||||f|f|f||||||||2017-10-10 21:20:54.318882|2017-10-10 21:20:54.318882
NCT03050996|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-08|||June 1, 2016|Actual|2016-06-01|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|May 30, 2017|Anticipated|2017-05-30||Observational|||Retrograde Perfusion Sphinterometry and Autologous Sling to Improve Urinary Continence in Robotic Radical Prostatectomy|Intraoperative Evaluation or Retrograde Leack Point Pressure During Robot Assisted Radical Prostatectomy for Proper Autologous Suburethral Sling Tensioning to Improve Early Urinary Continence Recovery|Recruiting||N/A|50|Anticipated|Istituto Auxologico Italiano|||1||f||||f|f|f||||||No||2017-10-10 21:20:54.414394|2017-10-10 21:20:54.414394
NCT03050983|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-08-28|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|February 15, 2018|Anticipated|2018-02-15|August 5, 2017|Actual|2017-08-05||Observational|IPI||Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.|Observational Investigation to Determine Clinical Impact of Continuous Surveillance Monitoring (SM) on General Care Floors With a Nested Study to Determine the Clinical Utility of IPI (Integrated Pulmonary Index).|Active, not recruiting||N/A|440|Actual|Medtronic - MITG|||2||f||||f|f|f|||t|||||2017-10-10 21:20:54.493435|2017-10-10 21:20:54.493435
NCT03050970|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-31|||February 11, 2017|Actual|2017-02-11|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Observational|PELICAN||Infant Minor Head Trauma Clinical Decision Rule|Performance of a Minor Head Trauma Clinical Decision Rule Dedicated to Children Younger Than Two Years: A National Prospective Multicenter Study|Recruiting||N/A|10000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||||||2017-10-10 21:20:54.575636|2017-10-10 21:20:54.575636
NCT03050957|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-09|||May 2013|Actual|2013-05-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging|Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging|Completed||Phase 2|38|Actual|Hospital de Mataró||2|||f||||t|f|f||||||No||2017-10-10 21:20:54.674879|2017-10-10 21:20:54.674879
NCT03050944|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-13|||June 2013|Actual|2013-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Observational|MedDietIVF||Association of the Mediterranean Diet With Fertility Outcomes|Association of the Mediterranean Diet With Fertility Outcomes: a Study Among Couples Undergoing in Vitro Fertilization Treatment|Completed||N/A|250|Actual|Harokopio University|||2||f||||t|f|f||||Samples Without DNA|"     Blood, follicular fluid   "|No||2017-10-10 21:20:54.740888|2017-10-10 21:20:54.740888
NCT03050931|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-31|||May 30, 2017|Actual|2017-05-30|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Electrical Impedance Tomography of Epilepsy|Imaging Stroke, Epilepsy and Evoked Potentials in the Brain Using Electrical Impedance Tomography|Recruiting||N/A|50|Anticipated|University College, London|||2||f||||f||||||||||2017-10-10 21:20:54.840126|2017-10-10 21:20:54.840126
NCT03050918|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-20|||February 20, 2017|Actual|2017-02-20|February 2017|2017-02-01|October 28, 2018|Anticipated|2018-10-28|October 28, 2017|Anticipated|2017-10-28||Interventional|||Discharge Follow-up Phone Call Program|A Pragmatic, Randomized, Controlled Trial Examining the Effectiveness of a Hospital Discharge Follow-up Phone Call Program|Recruiting||N/A|3556|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:20:54.921732|2017-10-10 21:20:54.921732
NCT03050905|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-08-13|||June 22, 2017|Actual|2017-06-22|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B|An Open-Label, Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus (HCV) Infection Genotype 2K/1B- NINJA Study|Recruiting||Phase 4|10|Anticipated|HaEmek Medical Center, Israel||1|||f||||f|f|f||||||||2017-10-10 21:20:55.001813|2017-10-10 21:20:55.001813
NCT03050892|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-08|||February 29, 2016|Actual|2016-02-29|February 2017|2017-02-01|May 1, 2018|Anticipated|2018-05-01|March 1, 2017|Anticipated|2017-03-01||Observational|ISIDORE||Impact of Donor and Recipient ST2 / IL-33 Pathway After Heart Transplantation|Impact of Donor and Recipient ST2 / IL-33 Pathway on Recipient Survival and Acute Rejection After Heart Transplantation|Recruiting||N/A|50|Anticipated|Groupe Hospitalier Pitie-Salpetriere|||1||f||||f|f|f||||Samples Without DNA|"     Serum   "|No||2017-10-10 21:20:55.101505|2017-10-10 21:20:55.101505
NCT03050866|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-03-13|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|CABA-V7||Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)|A Single Arm Phase 2 Multicenter Study Determining the Response to Cabazitaxel in Metastatic Prostate Cancer (mCRPC) Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)|Recruiting||Phase 2|100|Anticipated|Erasmus Medical Center||1|||f||||f|f|f||||||Undecided|Information can be shared by importing it into another databases|2017-10-10 21:20:55.253996|2017-10-10 21:20:55.253996
NCT03050853|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-25|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||The Appeal and Impact of E-cigarettes in Smokers With SMI|The Appeal and Impact of E-cigarettes in Smokers With Serious Mental Illness|Recruiting||N/A|240|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t|f|f|||f|||||2017-10-10 21:20:55.355745|2017-10-10 21:20:55.355745
NCT03050840|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-07-05|||February 13, 2017|Actual|2017-02-13|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Gamification and Energetic Behavior Changes|Gamification and Energetic Behavior Changes in Adolescent-Parent Dyads With Obesity|Recruiting||N/A|100|Anticipated|Children's Hospital of Philadelphia||2|||f||||f|f|f||||||||2017-10-10 21:20:55.452452|2017-10-10 21:20:55.452452
NCT03050827|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-25|||May 1, 2014|Actual|2014-05-01|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy|Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy|Recruiting||Phase 3|60|Anticipated|Eastern Virginia Medical School||2|||f||||t|t|f|||f|||||2017-10-10 21:20:55.519331|2017-10-10 21:20:55.519331
NCT03050814|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-10|2017-08-04|||April 5, 2017|Actual|2017-04-05|August 2017|2017-08-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004|A Randomized Phase II Trial of Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in Patients With Previously Untreated Metastatic Colorectal Cancer|Suspended||Phase 2|81|Anticipated|National Institutes of Health Clinical Center (CC)||3||"This study has a stopping rule when death occurs within 30 days of receiving investigational   drug;study is closed until further discussion w FDA"|t|||||t|f||||||||2017-10-10 21:20:55.805162|2017-10-10 21:20:55.805162
NCT03050775|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||July 5, 2016|Actual|2016-07-05|February 2017|2017-02-01|February 5, 2017|Actual|2017-02-05|February 5, 2017|Actual|2017-02-05||Interventional|||Evaluating Adult Patient Temperatures During Lower Spinal Surgery|Comparing Patient Temperatures in Adults During Lower Spinal Surgery Using Either a Heated Ventilator Circuit or a Standard Ventilator Circuit With a Heat-Moisture Exchanger|Completed||N/A|92|Actual|Mayo Clinic||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:20:56.132996|2017-10-10 21:20:56.132996
NCT03050762|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-10|||October 5, 2011|Actual|2011-10-05|February 2017|2017-02-01|October 2026|Anticipated|2026-10-01|October 2026|Anticipated|2026-10-01||Observational|||Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease|Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease|Recruiting||N/A|15000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||||||2017-10-10 21:20:56.207809|2017-10-10 21:20:56.207809
NCT03050749|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||January 18, 2017|Actual|2017-01-18|February 2017|2017-02-01|October 9, 2017|Anticipated|2017-10-09|February 27, 2017|Anticipated|2017-02-27||Interventional|FLASH2||Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars|A Prospective, Open-label, Non-comparative, Multicentre, Post-market Clinical Follow-up Study of the Princess® VOLUME Performance and Safety for Correction of Facial Lipoatrophy, Morphological Asymmetry of the Face, or Debilitating Scars|Active, not recruiting||N/A|60|Anticipated|Croma-Pharma GmbH||1|||f||||f|f|f||||||No||2017-10-10 21:20:56.312694|2017-10-10 21:20:56.312694
NCT03050736|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-08|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression|An Open Label Trial of Dianhydrogalactitol (VAL-083) and Radiation Therapy in Treatment of Newly Diagnosed GBM Patients With An Unmethylated Promoter of the Methylguanine-DNA Methyltransferase (MGMT) Gene|Recruiting||Phase 2|30|Anticipated|DelMar Pharmaceuticals, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:20:56.390177|2017-10-10 21:20:56.390177
NCT03050723|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||December 12, 2016|Actual|2016-12-12|February 2017|2017-02-01|July 17, 2017|Anticipated|2017-07-17|February 27, 2017|Anticipated|2017-02-27||Interventional|FLASH 1||Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars|A Prospective, Open-label, Non-comparative, Multicentre, Post-market Clinical Follow-up Study of the Princess® FILLER Performance and Safety for Correction of Facial Lipoatrophy, Morphological Asymmetry of the Face, or Debilitating Scars|Active, not recruiting||N/A|60|Anticipated|Croma-Pharma GmbH||1|||f||||f||f||||||No||2017-10-10 21:20:56.517308|2017-10-10 21:20:56.517308
NCT03050710|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-02-09|||December 27, 2016|Actual|2016-12-27|February 2017|2017-02-01|October 10, 2017|Anticipated|2017-10-10|July 18, 2017|Anticipated|2017-07-18||Interventional|VINO||Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds|A Prospective, Open-label, Multicenter, Post-market Study Evaluating Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds|Active, not recruiting||N/A|60|Anticipated|Croma-Pharma GmbH||1|||f||||f|f|f||||||No||2017-10-10 21:20:56.610277|2017-10-10 21:20:56.610277
NCT03050697|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-08|||September 25, 2016||2016-09-25||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:20:56.688496|2017-10-10 21:20:56.688496
NCT03050684|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-02-08|||November 2016||2016-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||Does Vaginal Washing Affect the Success Rate of the Labour Induction?|Does Vaginal Washing Before Inserting Dinoprostone Affect the Success Rate of the Labour Induction?|Active, not recruiting||N/A|200|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||f||||||||||2017-10-10 21:20:56.736892|2017-10-10 21:20:56.736892
NCT03050671|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-03-24|||January 18, 2017|Actual|2017-01-18|March 2017|2017-03-01|July 1, 2017|Anticipated|2017-07-01|May 1, 2017|Anticipated|2017-05-01||Interventional|||Effects of External Leg Compression Devices on Healing and Blood Clotting|Intermittent Pneumatic Compression in the Lower Limbs: Systemic and Local Effects in Coagulation Status, Microcirculation, Tissue Metabolic Activity and Collagen Production.|Enrolling by invitation||N/A|10|Anticipated|Karolinska University Hospital||2|||f|||||f|f||||||||2017-10-10 21:20:56.832445|2017-10-10 21:20:56.832445
NCT03050658|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-10|||February 7, 2017|Actual|2017-02-07|February 2017|2017-02-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|BBA||Bathing Babies and Allergy|Skin Integrity After Newborns' First Bath And Development of Eczema and Allergy at 2 Years|Recruiting||N/A|144|Anticipated|University of Virginia|||1||f||||f||||||Samples Without DNA|"     skin swabs   "|No||2017-10-10 21:20:56.917163|2017-10-10 21:20:56.917163
NCT03050645|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-02-10|||June 2011||2011-06-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Metabolic Risk and Life Style Factors in Women With Previous Gestational Diabetes Mellitus (GDM)|Diabetes, Metabolic Risk Factors, Autoimmunity and Self-reported Life Style Factors in Women With Previous Gestational Diabetes Mellitus (GDM)|Recruiting||N/A|200|Anticipated|University of Southern Denmark|||2||f||||f||||||Samples With DNA|"     blood samples   "|Undecided||2017-10-10 21:20:57.009728|2017-10-10 21:20:57.009728
NCT03050632|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-04-28|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|CEO||Effects of Cognitive and Emotional Functioning on Treatment Outcomes|An Investigation of the Effects of Cognitive and Emotional Functioning on Treatment Outcomes|Not yet recruiting||N/A|154|Anticipated|Boston University Charles River Campus||2|||f||||f|f|f||||||No||2017-10-10 21:20:57.112818|2017-10-10 21:20:57.112818
NCT03050606|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-06-28|||February 15, 2017|Actual|2017-02-15|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness and Cost-effectiveness of Modified Pilates Method Versus Aerobic Exercise in Patients With Fibromyalgia|Effectiveness and Cost-effectiveness of Modified Pilates Method Versus Aerobic Exercise in the Treatment of Patients With Fibromyalgia: a Randomized Controlled Trial|Recruiting||N/A|98|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t|f|f||||||No||2017-10-10 21:20:57.281524|2017-10-10 21:20:57.281524
NCT03050593|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||February 2013||2013-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|DIAMONDHFpEF||Developing Imaging And plasMa biOmarkers iN Describing Heart Failure With Preserved Ejection Fraction (DIAMONDHFpEF)|Prospective, Observational, Single-centre, Cohort Study Aimed at Developing Imaging and Plasma Biomarkers in Heart Failure With Preserved Ejection Fraction|Completed||N/A|280|Actual|University of Leicester|||3||f||||f|f|f||||Samples With DNA|"     EDTA Plasma, serum, urine, DNA   "|No||2017-10-10 21:20:57.395105|2017-10-10 21:20:57.395105
NCT03050580|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-10|||January 1, 2013|Actual|2013-01-01|February 2017|2017-02-01|June 30, 2015|Actual|2015-06-30|November 30, 2014|Actual|2014-11-30||Interventional|||"An Evaluation of the Treatment Group Model for Abused Women in Shelters in Hong Kong"|"An Evaluation of the Treatment Group Model for Abused Women in Shelters in Hong Kong"|Completed||N/A|122|Actual|The University of Hong Kong||2|||f|||||f|f||||||Undecided||2017-10-10 21:20:57.474261|2017-10-10 21:20:57.474261
NCT03050567|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-05-15|||March 17, 2017|Actual|2017-03-17|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Observational|||Reproducibility Study of Transcranial Doppler|Reproducibility Study of Transcranial Doppler Microembolic Signals Detection in the Middle Cerebral Artery|Recruiting||N/A|40|Anticipated|University of Edinburgh|||2||f||||||||||||||2017-10-10 21:20:57.573853|2017-10-10 21:20:57.573853
NCT03050554|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-20|||March 13, 2017|Actual|2017-03-13|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Stereotactic Body Radiation Therapy (SBRT) Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)|Phase I/II Study of the Safety, Tolerability, and Efficacy of Stereotactic Body Radiation Therapy (SBRT) Combined With Concurrent and Adjuvant Avelumab for Definitive Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|56|Anticipated|University of California, San Diego||1|||f||||t|t|f||||||No||2017-10-10 21:20:57.649818|2017-10-10 21:20:57.649818
NCT03050528|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-05-02|||February 6, 2017|Actual|2017-02-06|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|ExACT||The Effectiveness of Exercise Combined With Acceptance and Commitment Therapy for Chronic Pain|The ExACT Trial: The Effectiveness of Exercise Combined With Acceptance and Commitment Therapy Compared to a Standalone Supervised Exercise Intervention for Chronic Pain. A Randomised Controlled Trial|Recruiting||N/A|160|Anticipated|University College Dublin||2|||f||||f|f|f||||||Undecided||2017-10-10 21:20:57.826676|2017-10-10 21:20:57.826676
NCT03050515|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-08|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections|Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract|Not yet recruiting||Early Phase 1|20|Anticipated|University of California, Irvine||1|||f||||t|f|f|||f|||No||2017-10-10 21:20:57.941492|2017-10-10 21:20:57.941492
NCT03050502|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-08|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|HemoTxRCT||The Management of Traumatic Hemothoraces|The Management of Traumatic Hemothoraces in Blunt Thoracic Injured Patients: A Randomized Clinical Trial|Not yet recruiting||N/A|200|Anticipated|University of Calgary||2|||f||||f|f|f||||||No||2017-10-10 21:20:58.017694|2017-10-10 21:20:58.017694
NCT03050489|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||September 15, 2015|Actual|2015-09-15|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG|AMIRI-CABG: Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG|Recruiting||N/A|100|Anticipated|St. Petersburg State Pavlov Medical University|||3||f||||t|f|f||||Samples Without DNA|"     Serum from central vein.   "|No||2017-10-10 21:20:58.109942|2017-10-10 21:20:58.109942
NCT03050476|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-08|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|February 2022|Anticipated|2022-02-01|February 2019|Anticipated|2019-02-01||Interventional|APPIRED-III||Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase|Preventing Oxidative Stress-induced Ischemic Injury- and Systemic Inflammation Complications During and After Invasive Cardiac Surgery With Alkaline Phosphatase (APPIRED III)|Not yet recruiting||Phase 2/Phase 3|1050|Anticipated|Alloksys Life Sciences B.V.||2|||f||||t|f|f||||||No||2017-10-10 21:20:58.24006|2017-10-10 21:20:58.24006
NCT03050463|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-02-27|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer|Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions|Recruiting||N/A|170|Anticipated|Stanford University|||3||f||||||||||Samples With DNA|"     blood and saliva   "|||2017-10-10 21:20:58.368812|2017-10-10 21:20:58.368812
NCT03050450|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-02-08|||August 10, 2016|Actual|2016-08-10|February 2017|2017-02-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors|A Phase 1 Study of Lenalidomide in Combination With Vorinostat in Pediatric Patients With High Grade or Progressive Central Nervous System Tumors|Recruiting||Phase 1|20|Anticipated|Johns Hopkins All Children's Hospital||5|||f||||t||||||||Yes||2017-10-10 21:20:58.473249|2017-10-10 21:20:58.473249
NCT03050437|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-02-09|||March 2013||2013-03-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI|A Randomized, Open Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Pemetrexed Until Progression Versus Pemetrexed Alone Until Progression in Non-small Cell Lung Cancer Patients Who Have Progressed on First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)|Recruiting||Phase 2|96|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 21:20:58.579551|2017-10-10 21:20:58.579551
NCT03049722|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-02-09|||February 2015||2015-02-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Investigation Plan for the AVOPT Data Collection Clinical Study|Clinical Investigation Plan for the AVOPT Data Collection|Completed||N/A|30|Actual|Biotronik Canada Inc||1|||f||||||||||||||2017-10-10 21:21:06.660942|2017-10-10 21:21:06.660942
NCT03050424|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-11|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|January 1, 2019|Anticipated|2019-01-01|October 1, 2018|Anticipated|2018-10-01||Interventional|ICE-T||Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial|Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial|Recruiting||Phase 2|40|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t|f|f|||f|||No||2017-10-10 21:20:58.659522|2017-10-10 21:20:58.659522
NCT03050411|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-02-09|||May 2016||2016-05-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|||Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer|A Study of Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer|Recruiting||Phase 1|30|Anticipated|Peking University Third Hospital||1|||f||||||||||||||2017-10-10 21:20:58.773934|2017-10-10 21:20:58.773934
NCT03050398|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-16|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|December 16, 2019|Anticipated|2019-12-16|December 16, 2019|Anticipated|2019-12-16||Interventional|||A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib|A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib|Recruiting||Phase 3|140|Anticipated|Novartis||1|||f||||f|t|f||||||Undecided||2017-10-10 21:20:58.870487|2017-10-10 21:20:58.870487
NCT03050385|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-08|||October 2016||2016-10-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Cognitive Rehabilitation During Transcranial Direct Current Stimulation|COgnitive REhabilitation During Transcranial Direct Current Stimulation for Major or Mild Neurocognitive Disorder Patients|Recruiting||N/A|20|Anticipated|National Center of Neurology and Psychiatry, Japan||2|||f||||t||||||||No||2017-10-10 21:20:59.072312|2017-10-10 21:20:59.072312
NCT03050372|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-02-09|||November 2016||2016-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Low Field Magnetic Stimulation (LFMS) on Measures of Sleep|Double-Blind, Sham-Controlled Crossover Pilot Study of Low Field Magnetic Stimulation (LFMS) on Subjective and Objective Measures of Sleep|Recruiting||N/A|20|Anticipated|Medical University of South Carolina||2|||f||||f||||||||Undecided|This process is still being discussed by investigators. Once plan is complete it will likely include protocol and primary outcome measures which may be accessed through peer reviewed publications.|2017-10-10 21:20:59.146942|2017-10-10 21:20:59.146942
NCT03050359|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-26|||April 5, 2017|Actual|2017-04-05|September 2017|2017-09-01|October 19, 2018|Anticipated|2018-10-19|September 21, 2018|Anticipated|2018-09-21||Interventional|||Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection|A Randomized Double-Blind, Double-Dummy, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 20 mg Compared to Lansoprazole 30 mg Once- or Twice-Daily in the Treatment of Endoscopically Confirmed Duodenal Ulcer Subjects With or Without Helicobacter Pylori Infection|Recruiting||Phase 3|770|Anticipated|Takeda||4|||f||||f|f|f||||||||2017-10-10 21:20:59.226262|2017-10-10 21:20:59.226262
NCT03050346|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-06-20|||January 2016||2016-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|B-MORE-Pilot||Breathing-Induced Myocardial Oxygenation Reserve|Breathing-Induced Myocardial Oxygenation Reserve - Pilot Study (B-MORE-Pilot)|Recruiting||N/A|160|Anticipated|McGill University Health Center|||2||f||||f||||||||Undecided||2017-10-10 21:20:59.470372|2017-10-10 21:20:59.470372
NCT03050333|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-09|||April 25, 2013|Actual|2013-04-25|February 2017|2017-02-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|||Efficacy and Safety of Endoscopic Resection|Efficacy and Safety of Endoscopic Resection|Recruiting||N/A|3000|Anticipated|Fundacion Miguel Servet|||1||f||||f|f|f||||||Undecided||2017-10-10 21:20:59.767463|2017-10-10 21:20:59.767463
NCT03050307|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-24|||April 17, 2017|Actual|2017-04-17|May 2017|2017-05-01|April 19, 2019|Anticipated|2019-04-19|March 22, 2019|Anticipated|2019-03-22||Interventional|||Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection|A Randomized Double-Blind, Double-Dummy, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 20mg Compared to Lansoprazole 30mg Once- or Twice-Daily in the Treatment of Endoscopically Confirmed Gastric Ulcer Subjects With or Without Helicobacter Pylori Infection|Recruiting||Phase 3|830|Anticipated|Takeda||4|||f||||f|f|f||||||||2017-10-10 21:20:59.982428|2017-10-10 21:20:59.982428
NCT03050294|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-07|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating Treatment Resistant Dermatitis TaroIIR|Study to Evaluate Resistant Disease/Max Adherence to Topical Treatments in Patients With Atopic Dermatitis and Psoriasis|Active, not recruiting||Phase 4|24|Anticipated|Wake Forest University Health Sciences||2|||f||||f|t|f|||f|||||2017-10-10 21:21:00.308044|2017-10-10 21:21:00.308044
NCT03050281|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-02-08|||April 2016||2016-04-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Simulation and Cadaver Workshop for Medical Students|Utility, Feasibility, and Cost-effectiveness of Using a Combined Cadaver and Simulation Laboratory Experience During the OB-GYN and Surgical Medical School Clerkships|Recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:21:00.417374|2017-10-10 21:21:00.417374
NCT03050255|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-02-08|||November 2016||2016-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|IPFO2||Short-term Effects of Supplemental Oxygen in Patients With IPF|Short-term Effects of Supplemental Oxygen During Walking in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis|Recruiting||N/A|50|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||6|||f||||f||||||||Undecided||2017-10-10 21:21:00.669279|2017-10-10 21:21:00.669279
NCT03050242|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)|Benefits of Intramuscular Glycopyrrolate Premedication on Intubation With Rigid-videostylet (OptiScope® PM 201, KoMAC Co., Ltd, Seoul, Republic of Korea)|Recruiting||N/A|78|Anticipated|Kangbuk Samsung Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:00.804997|2017-10-10 21:21:00.804997
NCT03050229|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-02-10|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)||Recruiting||Phase 4|176|Anticipated|Jichi Medical University||2|||f||||t||||||||||2017-10-10 21:21:00.936213|2017-10-10 21:21:00.936213
NCT03050216|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-10-04|||May 16, 2017|Actual|2017-05-16|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML|QUILT-3.033: Haploidentical Donor Natural Killer (NK) Cell Infusion With Subcutaneous ALT-803 in Adults With Refractory or Relapsed Acute Myelogenous Leukemia|Recruiting||Phase 2|24|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f||||||||2017-10-10 21:21:01.133797|2017-10-10 21:21:01.133797
NCT03050203|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-09|||September 2, 2015|Actual|2015-09-02|February 2017|2017-02-01|July 30, 2016|Actual|2016-07-30|June 16, 2016|Actual|2016-06-16||Interventional|kit||Custom Pack in Spine Surgery|Surgical Field Custom Pack's Efficacy on Soft Tissue Dissecting Time Reduction, on Relative Risks and Materials Wasted, in Patients Undergoing Spine Surgery: Randomized Controlled Trial|Completed||N/A|37|Actual|Istituto Ortopedico Rizzoli||2|||f||||f|f|f||||||No||2017-10-10 21:21:01.227308|2017-10-10 21:21:01.227308
NCT03050190|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-15|||July 2013||2013-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies|A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies|Recruiting||Phase 1/Phase 2|200|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||t|f|f||||||Undecided||2017-10-10 21:21:01.309453|2017-10-10 21:21:01.309453
NCT03050177|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-02-08|||September 1, 2016|Actual|2016-09-01|January 2017|2017-01-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Bioequivalence Study of Gefitinib Tablets Under Fed Conditions|Single-dose, Open-label, Randomized, 2-way Crossover Bioequivalence Study of Gefitinib Tablets Under Fed Conditions in Chinese Healthy Male Subjects|Completed||Phase 1|38|Actual|Hunan Kelun Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:21:01.398299|2017-10-10 21:21:01.398299
NCT03050164|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-02-08|||September 8, 2016|Actual|2016-09-08|January 2017|2017-01-01|November 4, 2016|Actual|2016-11-04|November 4, 2016|Actual|2016-11-04||Interventional|||Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions|Single-dose, Open-label, Randomized, 2-way Crossover Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions in Chinese Healthy Male Subjects|Completed||Phase 1|38|Actual|Hunan Kelun Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:21:01.478358|2017-10-10 21:21:01.478358
NCT03050151|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-17|||March 9, 2017|Actual|2017-03-09|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis|An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis|Recruiting||Phase 1|168|Anticipated|Regeneron Pharmaceuticals||4|||f||||f|t|t|f|f||||||2017-10-10 21:21:01.558435|2017-10-10 21:21:01.558435
NCT03050138|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-10|||April 2016||2016-04-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|DABI-PTS||Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran|The Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran- a Cross-Sectional Assessment of RE-COVER Study Patients|Recruiting||N/A|300|Anticipated|Oslo University Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:21:01.719565|2017-10-10 21:21:01.719565
NCT03050125|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-01|||February 7, 2017|Actual|2017-02-07|May 2017|2017-05-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|SAFFRON||The Impact of Hypo-osmolar Drops on Contact Lens Comfort|The Impact of Hypo-osmolar Drops on Contact Lens Comfort|Completed||N/A|20|Actual|University of Waterloo||3|||f||||f|f|f|||f|||No||2017-10-10 21:21:01.831938|2017-10-10 21:21:01.831938
NCT03050112|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Long-term Quality of Life of Patients With a Congenital Heart Disease, Treated by Surgery in Adulthood at the Brugmann Hospital.|Long-term Quality of Life of Patients With a Congenital Heart Disease, Treated by Surgery in Adulthood at the Brugmann Hospital.|Not yet recruiting||N/A|250|Anticipated|Brugmann University Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:21:01.922207|2017-10-10 21:21:01.922207
NCT03050099|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-28|||December 1, 2013|Actual|2013-12-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|June 30, 2015|Actual|2015-06-30||Observational|||SpecTRA; An Observational Study of the Verification of Protein Biomarkers in Transient Ischemic Attack.|Spectrometry for TIA Rapid Assessment (SpecTRA) Project: Study 1 Cohort 1A and 1B—Verification of Protein Biomarkers|Completed||N/A|560|Actual|Vancouver Island Health Authority|||3||f||||t|f|f||||Samples Without DNA|"     Human plasma collected within 24 hours of symptom onset; MRI; Holter +/- Extended Cardiac     Monitoring   "|No||2017-10-10 21:21:02.002751|2017-10-10 21:21:02.002751
NCT03050086|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-13|||March 29, 2017|Actual|2017-03-29|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Open Label Phase 2 Feasibility Study of BPX-01Topical Minocycline Gel in Rosacea|An Open Label Phase 2 Feasibility Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in Treatment of Moderate to Severe Papulopustular Rosacea (BPX-01-C05)|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|BioPharmX, Inc.||1|||||||f|t|f||||||||2017-10-10 21:21:02.078052|2017-10-10 21:21:02.078052
NCT03050073|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-24|||March 1, 2017|Actual|2017-03-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|30 Days|Observational [Patient Registry]|||Choroidal Thickness Association With Primary Angle Closure|Choroidal Thickness Association With Primary Angle Closure|Active, not recruiting||N/A|30|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||Undecided||2017-10-10 21:21:02.143487|2017-10-10 21:21:02.143487
NCT03050060|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-06-12|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, and Nivolumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer|ImmunoRad: Stratified Phase II Trial of Image Guided Hypofractionated Radiotherapy With Concurrent Nelfinavir and Nivolumab in Advanced Melanoma, Lung Cancer, and Renal Cell Carcinoma|Recruiting||Phase 2|120|Anticipated|University of Washington||1|||f||||f|t|f||||||||2017-10-10 21:21:02.194169|2017-10-10 21:21:02.194169
NCT03050047|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-09|||September 2016|Actual|2016-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors|A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of BCD-100 (JSC BIOCAD, Russia) in Patients With Advanced Solid Tumors|Recruiting||Phase 1|30|Anticipated|Biocad||1|||f|||||f|f||||||||2017-10-10 21:21:02.284943|2017-10-10 21:21:02.284943
NCT03050034|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||February 27, 2017|Anticipated|2017-02-27|February 2017|2017-02-01|February 27, 2018|Anticipated|2018-02-27|October 27, 2017|Anticipated|2017-10-27||Interventional|LiMS||Role of Wireless Monitoring in Internal Medicine Unit for Ongoing Assessment of Acute Instable Patients|Role of Wireless Monitoring in Internal Medicine Unit for Ongoing Assessment of Acute Instable Patients: Impact on Outcomes, Length of Stay and Costs.|Not yet recruiting||N/A|296|Anticipated|Azienda Socio Sanitaria Territoriale del Garda||2|||f||||t|f|f||||||No||2017-10-10 21:21:02.35678|2017-10-10 21:21:02.35678
NCT03050021|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||April 1, 2013|Actual|2013-04-01|February 2017|2017-02-01|August 30, 2015|Actual|2015-08-30|August 30, 2013|Actual|2013-08-30||Observational|||Risk Factors for Delirium in Critically Ill Surgical Patients|Risk Factors for Delirium in Critically Ill Surgical Patients|Completed||N/A|251|Actual|Asan Medical Center|||2||f||||f|f|f||||||No||2017-10-10 21:21:02.461555|2017-10-10 21:21:02.461555
NCT03050008|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-13|||January 2016||2016-01-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|USFREE||Efficacy of FLACS USFREE Compared to Traditional Surgery Using Ultrasound.|Randomized, Controlled Trial in Patients With Senile Cataract to Evaluate the Efficacy of Ultrasound-free Femtosecond Laser (FLACS) Cataract Surgery (USFREE), Compared to Traditional Phacoemulsification Surgery Using Ultrasound.|Completed||N/A|71|Actual|Alfredo Tranjan Centro Oftalmologico||2|||f||||f||||||||Undecided|Information not yet provided.|2017-10-10 21:21:02.576435|2017-10-10 21:21:02.576435
NCT03049995|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-06-01|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|SE2020||Stress Echo 2020 - The International Stress Echo Study|The International Stress Echo Study in Ischemic and Non-ischemic Heart Disease|Recruiting||N/A|300|Anticipated|Fatebenefratelli Hospital|||10||f||||f||||||Samples With DNA|"     Blood and saliva will be collected in patients of GENESprotocol.   "|No||2017-10-10 21:21:02.655541|2017-10-10 21:21:02.655541
NCT03049982|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-09|||February 7, 2017|Actual|2017-02-07|February 2017|2017-02-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||A Study for Obstructive Sleep Apnea Using a New At-Home Sleep Test|A Study for Obstructive Sleep Apnea Using a New At-Home Sleep Test|Recruiting||N/A|150|Anticipated|Zephyr Sleep Technologies||1|||f||||t|f|f||||||No||2017-10-10 21:21:02.778573|2017-10-10 21:21:02.778573
NCT03049969|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-04|||February 7, 2017|Actual|2017-02-07|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS)|Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS)|Recruiting||N/A|100|Anticipated|New York University School of Medicine||1|||f||||f|f|t|t|f|f|||||2017-10-10 21:21:02.85221|2017-10-10 21:21:02.85221
NCT03049956|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-07|||November 1, 2016|Actual|2016-11-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||OVEMP in Myasthenia|Diagnostic Accuracy of Repetitive Ocular Vestibular Evoked Myogenic Potentials in Myasthenia Gravis (OMG Study)|Recruiting||N/A|200|Anticipated|University of Zurich||1|||f||||f|f|f||||||No||2017-10-10 21:21:02.933481|2017-10-10 21:21:02.933481
NCT03049943|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-09|||May 5, 2014|Actual|2014-05-05|February 2017|2017-02-01|September 16, 2014|Actual|2014-09-16|September 16, 2014|Actual|2014-09-16||Interventional|||Low Level Laser Therapy for Hyposalivation|Different Low Level Laser Protocols for Therapy of Hyposalivation|Completed||N/A|30|Actual|University of Zagreb||2|||f||||t|f|f||||||No||2017-10-10 21:21:03.000669|2017-10-10 21:21:03.000669
NCT03049930|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-04-13|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Intraoperative Low-dose Ketamine Infusion as the Main Analgesic in Burn Patients|Intraoperative Low-dose Ketamine Infusion as the Main Analgesic in Burn Patients|Not yet recruiting||Phase 4|46|Anticipated|Loyola University||2|||f||||f|t|f|||f|||No|There is no plan to share individual participant data|2017-10-10 21:21:03.06425|2017-10-10 21:21:03.06425
NCT03049917|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-09|||January 31, 2017|Actual|2017-01-31|February 2017|2017-02-01|April 1, 2018|Anticipated|2018-04-01|February 1, 2018|Anticipated|2018-02-01||Interventional|FIT||Financial Incentives to Increase Pediatric HIV Testing|Financial Incentives to Increase Pediatric HIV Testing|Recruiting||N/A|800|Anticipated|University of Washington||5|||f||||f|f|f||||||Yes|Open to collaboration. Please contact the study PIs for requests for data sharing.|2017-10-10 21:21:03.141935|2017-10-10 21:21:03.141935
NCT03049904|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-29|||February 19, 2017|Actual|2017-02-19|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research|American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research|Recruiting||N/A|90|Anticipated|University of Washington||2|||f||||t|f|f||||||No||2017-10-10 21:21:03.217637|2017-10-10 21:21:03.217637
NCT03049891|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||November 2015||2015-11-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Pediatric Decentralization of ART in South Africa|Impact of Decentralization on Retention of Pediatric Patients Initiated on ART at a Large Referral Hospital in Eastern Cape, South Africa|Completed||N/A|1583|Actual|Columbia University|||4||f||||f||||||||||2017-10-10 21:21:03.300844|2017-10-10 21:21:03.300844
NCT03048994|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-02-07|||January 2011||2011-01-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|CGH-GLU||Glutamine Supplementation in Critically Ill Patients With Severe Sepsis|A Randomized Controlled Trial of Glutamine Supplementation in Critically Ill Adults With Severe Sepsis: A Pilot Study|Completed||N/A|39|Actual|Changi General Hospital||2|||f||||t||||||||No||2017-10-10 21:21:12.594097|2017-10-10 21:21:12.594097
NCT03049878|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-07|||February 21, 2013|Actual|2013-02-21|February 2017|2017-02-01|September 10, 2016|Actual|2016-09-10|September 20, 2015|Actual|2015-09-20||Interventional|||Efficacy of Preoperative Administration of Paracetamol-codeine on Pain Following Impacted Mandibular Third Molar Surgery|Efficacy of Preoperative Administration of Paracetamol-codeine on Pain Following Impacted Mandibular Third Molar Surgery: a Randomized, Split-mouth, Placebo-controller, Double-blind Clinical Trial|Completed||Phase 4|32|Actual|University of Roma La Sapienza||2|||f||||t|f|f||||||No||2017-10-10 21:21:05.388734|2017-10-10 21:21:05.388734
NCT03049865|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-09|||February 9, 2017|Anticipated|2017-02-09|February 2017|2017-02-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|GASP||Gait Speed at Discharge as a Marker for Readmission|Gait Speed at Discharge as a Marker for Readmission - The GASP Study|Not yet recruiting||N/A|1000|Anticipated|Karolinska University Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:21:05.470153|2017-10-10 21:21:05.470153
NCT03049852|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-09|||April 15, 2017|Anticipated|2017-04-15|February 2017|2017-02-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|Pterygium||Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium|A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium|Not yet recruiting||Phase 2|74|Anticipated|Cloudbreak Therapeutics, LLC||2|||f||||t|t|f||||||No||2017-10-10 21:21:05.530169|2017-10-10 21:21:05.530169
NCT03049839|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-02-09|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|PREDICOL||Evaluation of a Community Health Program for the Prevention of Type 2 Diabetes and Other Cardio-metabolic Risk Factors in Adults: Districts of Barranquilla and Bogota, Colombia - January 2017 - December 2019|Evaluation of a Community Health Program for the Prevention of Type 2 Diabetes and Other Cardio-metabolic Risk Factors in Adults: Districts of Barranquilla and Bogota, Colombia - January 2017 - December 2019|Not yet recruiting||N/A|650|Anticipated|Universidad del Norte||3|||f||||t|f|f||||||No||2017-10-10 21:21:05.600966|2017-10-10 21:21:05.600966
NCT03049826|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-05-10|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|NUTRIENT||Nutritional Status in Children Treated With Advanced Nutrition Therapy|Nutritional Status in Children Treated With Advanced Nutrition Therapy|Recruiting||N/A|100|Anticipated|University of Oslo||3|||f||||f|f|f||||||No||2017-10-10 21:21:05.72486|2017-10-10 21:21:05.72486
NCT03049813|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-06-02|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Virtual Reality Job Interview Training in Severe Mental Illness|Virtual Reality Job Interview Training: An Enhancement to Supported Employment in Severe Mental Illness|Recruiting||N/A|180|Anticipated|Northwestern University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:21:05.803337|2017-10-10 21:21:05.803337
NCT03049800|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-06-26|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|June 12, 2021|Anticipated|2021-06-12|June 12, 2020|Anticipated|2020-06-12||Interventional|||Is Cognitive Training Neuroprotective in Early Psychosis?|Is Cognitive Training Neuroprotective in Early Psychosis?|Recruiting||N/A|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f|f|t|f|f|f|||Yes||2017-10-10 21:21:05.900845|2017-10-10 21:21:05.900845
NCT03049787|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-02-08|||March 2016||2016-03-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|||Formal Physical Therapy (PT) vs. Home PT for Adhesive Capsulitis|The Effectiveness of Traditional Physical Therapy Versus Home Exercise in Conjunction With Glenohumeral and Subacromial Corticosteroid Injection for the Treatment of Shoulder Adhesive Capsulitis|Active, not recruiting||N/A|72|Anticipated|Boston Medical Center||2|||f||||f||||||||||2017-10-10 21:21:05.997564|2017-10-10 21:21:05.997564
NCT03049774|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-08|||February 28, 2017|Anticipated|2017-02-28|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor|A Retrospective Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor|Not yet recruiting||N/A|2000|Anticipated|Angde Biotech Pharmaceutical Co., Ltd.|||1||f|||||f|f||||||||2017-10-10 21:21:06.160705|2017-10-10 21:21:06.160705
NCT03049761|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-09|||January 9, 2017|Actual|2017-01-09|February 2017|2017-02-01|March 13, 2017|Anticipated|2017-03-13|February 23, 2017|Anticipated|2017-02-23||Interventional|||Water Flosser vs String Floss vs Manual Toothbrush Safety|Evaluation of the Safety of a Water Flosser on Gingival and Epithelial Tissue at Different Pressure Settings|Active, not recruiting||N/A|105|Anticipated|All Sum Research Center Ltd.||3|||f||||f|f|t|f|f|f|||No||2017-10-10 21:21:06.251478|2017-10-10 21:21:06.251478
NCT03049748|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-02-09|||January 30, 2017|Actual|2017-01-30|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Self-Management App for Patients With Left-Ventricular Assist Devices|A Preliminary Evaluation of Mobile Care App as Self-Management Tool in Patients With Left-Ventricular Assist Devices - Phase 2|Recruiting||N/A|80|Anticipated|University of Michigan||2|||f||||f|f|f||||||Undecided|Data sharing will be made available for research to those who request it once analyses of specific aims have been conducted and findings have been published. All data will be de-identified. Persons interested in using the data will need to submit a request in writing, stating their intended use. Data will be made available at cost. Requirements for sharing will include acknowledgement in all publications of the funding source and of the study authors. Data sets will be accompanied by a data dictionary for all study variables, both derived and raw data. We will consider the most cost-effective means for sharing data after a data-sharing agreement has been reached. For example, data may be copied to a CD or DVD, be posted on a password protected and secure web site, or made available through a third party data archive service. We will also share research findings through publications and presentations at scholarly research meetings.|2017-10-10 21:21:06.341962|2017-10-10 21:21:06.341962
NCT03049735|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-07|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids|LIBERTY 1: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy & Safety Study of Relugolix Co-Administered With/Without Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids|Recruiting||Phase 3|390|Anticipated|Myovant Sciences GmbH||3|||f||||t||||||||||2017-10-10 21:21:06.459838|2017-10-10 21:21:06.459838
NCT03049709|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-02|||May 1, 2015|Actual|2015-05-01|June 2017|2017-06-01|October 30, 2017|Anticipated|2017-10-30|May 31, 2017|Actual|2017-05-31||Observational|MEASURE-cBP2||Non-invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis|Non-invasive Automated Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis - Comparison With Non-Invasive Reference Values|Recruiting||N/A|100|Anticipated|Universitätsmedizin Mannheim|||2||f||||t|f|f|||f|||No||2017-10-10 21:21:06.728827|2017-10-10 21:21:06.728827
NCT03049696|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Does Participation in a Pre-Operative Physical Activity Program Improve Patient Outcomes and Quality of Life?|An Integrated Surgical and Physical Activity Program to Identify Bariatric Surgery Quality Indicators and Evaluate Patient Outcomes and Quality of Life|Not yet recruiting||N/A|48|Anticipated|University of Manitoba||2|||f||||f|f|f||||||||2017-10-10 21:21:06.816408|2017-10-10 21:21:06.816408
NCT03049683|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-02-08|||October 2016||2016-10-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 1, 2017|Anticipated|2017-03-01||Observational|||Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials|Clinical Utility of Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials During Monaural Stimulation|Enrolling by invitation||N/A|60|Anticipated|Chonbuk National University|||2||f||||f||||||||No||2017-10-10 21:21:06.927843|2017-10-10 21:21:06.927843
NCT03049670|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-02-08|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|Klorsept||The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study|The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study|Not yet recruiting||N/A|50|Anticipated|Carmel Medical Center|||1||f|||||f|f||||||Undecided||2017-10-10 21:21:06.990794|2017-10-10 21:21:06.990794
NCT03049657|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-18|||February 2, 2016|Actual|2016-02-02|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|March 31, 2017|Actual|2017-03-31||Interventional|||Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention|Randomized Clinical Trial to Compare the Efficacy of Angiolite Stent Versus a Second-generation Drug-eluting Stent Such as Xience in Patients With Indication of Percutaneous Coronary Intervention|Active, not recruiting||N/A|220|Actual|Cardiva2 S.L.||2|||f||||f|f|f||||||||2017-10-10 21:21:07.056048|2017-10-10 21:21:07.056048
NCT03049644|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-09|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||A Trial Comparing Mechanical Diagnosis and Treatment to Manual Therapy|Management of Chronic Lower Back Pain: A Randomized Controlled Trial Comparing Mechanical Diagnosis and Treatment to Manual Therapy Utilizing a Point of Care Methodology|Recruiting||N/A|20|Anticipated|Canandaigua VA Medical Center||2|||f||||f|f|f||||||Yes|We will publish results of study in a journal as a pilot study.|2017-10-10 21:21:07.14453|2017-10-10 21:21:07.14453
NCT03049631|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-19|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|RRB2||Red Raspberry Polyphenols on Gut Microbiome|The Reciprocal Interactions Between Red Raspberry Polyphenols and Gut Microbiome Composition Affect Insulin Sensitivity|Recruiting||N/A|30|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:07.235924|2017-10-10 21:21:07.235924
NCT03049618|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-22|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|March 10, 2020|Anticipated|2020-03-10|March 10, 2019|Anticipated|2019-03-10||Interventional|||Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475|A Phase IIa Trial of sEphB4-HSA in Combination With Anti PD-1 Antibody (Pembrolizumab, MK3475) in Patients With Non-small Cell Lung and Head/Neck Cancer|Recruiting||Phase 2|50|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 21:21:07.331843|2017-10-10 21:21:07.331843
NCT03049592|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-02-07|||March 2016||2016-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HIBISCUS||High-risk Obstetrical Patient Intervention Utilizing the Contraceptive CHOICE Project Script|High-risk Obstetrical Patient Intervention to Promote Birth Interval Spacing Utilizing the Contraceptive CHOICE Project Script to Reduce Unintended Subsequent Pregnancies|Recruiting||N/A|50|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 21:21:07.496553|2017-10-10 21:21:07.496553
NCT03049579|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-09|||January 8, 2016|Actual|2016-01-08|February 2017|2017-02-01|May 2, 2016|Actual|2016-05-02|April 10, 2016|Actual|2016-04-10||Interventional|||Immune System Stimulation by Probiotic Food Supplementation|Immune System Stimulation by Probiotic Food Supplementation: a Double-blind, Randomized, Controlled, Parallel-designed, Prospective Trial|Completed||N/A|136|Actual|Hangzhou Wei Chuan Foods Co., Ltd.||2|||f|||||f|f||||||No||2017-10-10 21:21:07.5958|2017-10-10 21:21:07.5958
NCT03049566|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-03-06|||February 10, 2014|Actual|2014-02-10|March 2017|2017-03-01|December 30, 2014|Actual|2014-12-30|December 30, 2014|Actual|2014-12-30||Observational|||Low-dose Acetylsalicylic Acid Before Non-cardiac Surgery|Discontinuation of Low-dose Acetylsalicylic Acid Before Elective Non-cardiac Surgery: a Preoperative Monocentric Cross-sectional Study|Completed||N/A|805|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f|f|f||||||No||2017-10-10 21:21:07.796099|2017-10-10 21:21:07.796099
NCT03049553|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-02|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Interventional|||Trial23 - Randomized Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls|Trial23 - Randomized Method Study on HPV-testing and Cytology Triage in Women Offered HPV-vaccination as Girls in Denmark|Active, not recruiting||N/A|7000|Anticipated|University of Copenhagen||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:07.901796|2017-10-10 21:21:07.901796
NCT03049358|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-11|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer|Olfactory Training For Post Radiation Olfactory Loss In Patients With Paranasal Sinus and Nasopharyngeal Carcinoma|Not yet recruiting||Phase 1|120|Anticipated|Stanford University||2|||f||||t|t|f||||||||2017-10-10 21:21:09.573851|2017-10-10 21:21:09.573851
NCT03049540|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-09-04|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|May 31, 2021|Anticipated|2021-05-31||Interventional|SERVE||Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function|Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function - a Multi-center, Double-blind, Randomized, Placebo-controlled Clinical Trial - SERVE Trial|Not yet recruiting||Phase 3|98|Anticipated|University Hospital Inselspital, Berne||2|||f|||||f|f||||||||2017-10-10 21:21:08.045504|2017-10-10 21:21:08.045504
NCT03049527|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-06|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||CKDu in Sugarcane Workers in Guatemala|Understanding Occupational and Non-occupational Risks Associated With CKDu in Sugarcane Workers in Guatemala|Completed||N/A|531|Actual|University of Colorado, Denver||1|||f||||f|f|f|||f|||No||2017-10-10 21:21:08.201303|2017-10-10 21:21:08.201303
NCT03049514|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||December 23, 2016|Actual|2016-12-23|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|RECANAL||Study of Arterial Recanalization of the Central Retinal Artery Occlusions|Study of Arterial Recanalization of the Central Retinal Artery Occlusions|Recruiting||N/A|70|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f|||||f|f||||||||2017-10-10 21:21:08.291609|2017-10-10 21:21:08.291609
NCT03049501|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||July 2013||2013-07-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Caring for the Caregiver Network|A Tailored Technology Intervention for Diverse Caregivers of AD Patients|Recruiting||N/A|240|Anticipated|University of Miami||2|||f||||t|f|f||||||||2017-10-10 21:21:08.364135|2017-10-10 21:21:08.364135
NCT03049488|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-21|||February 22, 2017|Actual|2017-02-22|September 12, 2017|2017-09-12|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults|VRC 317: A Phase I Randomized, Open-Label Clinical Trial to Evaluate Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults|Recruiting||Phase 1|100|Anticipated|National Institutes of Health Clinical Center (CC)||3|||t|||||t|f||||||||2017-10-10 21:21:08.467485|2017-10-10 21:21:08.467485
NCT03049475|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-09-21|||March 13, 2017|Actual|2017-03-13|September 15, 2017|2017-09-15|October 31, 2021|Anticipated|2021-10-31|October 31, 2021|Anticipated|2021-10-31||Observational|||Pathophysiology of Acute Pain in Patients With Sickle Cell Disease|Pathophysiology of Acute Pain in Patients With Sickle Cell Disease|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||2||f||||||||||||||2017-10-10 21:21:08.592055|2017-10-10 21:21:08.592055
NCT03049462|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-06-30|||March 13, 2017|Actual|2017-03-13|May 4, 2017|2017-05-04|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta 3-Adrenergic Receptor Agonists|The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta-3-Adrenergic Receptor Agonists|Recruiting||Phase 1|75|Anticipated|National Institutes of Health Clinical Center (CC)||3|||t|||||t|f||||||||2017-10-10 21:21:08.704025|2017-10-10 21:21:08.704025
NCT03049449|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-09|2017-10-04|||March 17, 2017|Actual|2017-03-17|June 22, 2017|2017-06-22|June 30, 2022|Anticipated|2022-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas|T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas|Recruiting||Phase 1|76|Anticipated|National Institutes of Health Clinical Center (CC)||2|||t|||||t|f||||||||2017-10-10 21:21:08.81805|2017-10-10 21:21:08.81805
NCT03049436|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||February 1, 2017|Actual|2017-02-01|January 2017|2017-01-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Observational|UMACHAPA||Adapted Physical Activity in a Chemotherapy Ambulatory Care Unit: Feasibility and Impact on Fatigue, Anxiety and Depression in Cancer Patients|Adapted Physical Activity in a Chemotherapy Ambulatory Care Unit: Feasibility and Impact on Fatigue, Anxiety and Depression in Cancer Patients|Recruiting||N/A|250|Anticipated|CHU de Reims|||1||f|||||f|f||||||||2017-10-10 21:21:08.95539|2017-10-10 21:21:08.95539
NCT03049423|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|August 2016|Actual|2016-08-01||Observational|||MRI Appearance of Injured Ligament and Tendon of the Ankle in Different Postures|MRI Appearance of Injured Ligament and Tendon of the Ankle in Different Postures: Study Protocol for a Single-center, Diagnostic Clinical Trial|Active, not recruiting||N/A|60|Actual|The First Hospital of Hebei Medical University|||2||f||||t|f|f||||||Undecided||2017-10-10 21:21:09.057141|2017-10-10 21:21:09.057141
NCT03049410|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-04|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|February 15, 2020|Anticipated|2020-02-15|November 30, 2019|Anticipated|2019-11-30||Interventional|iROC||Trial to Compare Robotically Assisted Radical Cystectomy With Open Radical Cystectomy|A Phase III Multicentre Randomised Controlled Trial to Compare the Efficacy of Robotically Assisted Radical Cystectomy (RARC) and Intracorporeal Urinary Diversion With Open Radical Cystectomy (ORC) in Patients With Bladder Cancer|Recruiting||N/A|320|Anticipated|University College, London||2|||f||||t|f|f||||||||2017-10-10 21:21:09.14021|2017-10-10 21:21:09.14021
NCT03049397|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-10|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer|Family Functioning and Bereavement Outcomes Following the Enhancing Connections Program in Palliative Care|Recruiting||N/A|99|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|f|f||||||||2017-10-10 21:21:09.254283|2017-10-10 21:21:09.254283
NCT03049384|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-25|||March 9, 2017|Actual|2017-03-09|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Tailored Exercise Interventions to Reduce Fatigue in Cancer Survivors|Tailored Exercise Interventions to Reduce Fatigue in Cancer Survivors|Recruiting||N/A|52|Anticipated|University of Calgary||2|||f||||f|f|f||||||||2017-10-10 21:21:09.343408|2017-10-10 21:21:09.343408
NCT03049371|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-09|||January 2013|Actual|2013-01-01|January 2017|2017-01-01|November 2022|Anticipated|2022-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Exploration of the Neo-Vagina Study|Thai Red Cross AIDS Research Center|Recruiting||N/A|100|Anticipated|Thai Red Cross AIDS Research Centre||1|||f||||t|f|f||||||No||2017-10-10 21:21:09.491529|2017-10-10 21:21:09.491529
NCT03049345|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-07|||July 1, 2016|Actual|2016-07-01|February 2017|2017-02-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Gastric Cancer Sentinel Lymph Node Mapping|Gastric Cancer Sentinel Lymph Node Sampling: Refining Patient Selection for Organ Sparing Resection of Early Gastric Cancer in a North American Context|Enrolling by invitation||N/A|40|Anticipated|McGill University Health Center||1|||f||||f|f|f||||||No||2017-10-10 21:21:09.686261|2017-10-10 21:21:09.686261
NCT03049332|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||July 2014|Actual|2014-07-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Self- and Family-management Intervention in HIV+ Chinese Women|Self- and Family-management Intervention in HIV+ Chinese Women|Completed||N/A|82|Actual|Yale University||1|||f||||f|f|f||||||No||2017-10-10 21:21:09.778577|2017-10-10 21:21:09.778577
NCT03049319|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-06-02|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||MED in UVB Devices in the Presence and Absence of UV Filter|Comparing Minimal Erythema Dose (MED) in UVB Devices in the Presence and Absence of UV Filter|Recruiting||N/A|10|Anticipated|Wake Forest University Health Sciences||1|||f||||t|f|t|f|f|t|||Undecided||2017-10-10 21:21:09.865739|2017-10-10 21:21:09.865739
NCT03049306|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-16|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|ProSAT||Propranolol for Sleep Apnea Therapy|Propranolol for Sleep Apnea Therapy|Recruiting||Phase 2|94|Anticipated|Johns Hopkins University||3|||f||||f|t|f|||f|||||2017-10-10 21:21:09.966141|2017-10-10 21:21:09.966141
NCT03049293|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-07-18|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Measurement of Midazolam Levels in Follicular Fluid|Measurement of Midazolam Levels in Follicular Fluid and Correlation of Midazolam Levels in Follicular Fluid and Oocyte Quality, Fertilization Rate, Embryo Development Pattern and Euploid Status|Not yet recruiting||Early Phase 1|34|Anticipated|IVI Middle East Fertility Clinic||2|||f||||f|f|f|||f|||||2017-10-10 21:21:10.086923|2017-10-10 21:21:10.086923
NCT03049280|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-11|||April 17, 2017||2017-04-17||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:21:10.17301|2017-10-10 21:21:10.17301
NCT03049267|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-19|||February 2, 2017|Actual|2017-02-02|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|SMASH||Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis|Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis: A Randomised Double-blind Placebo Controlled Trial|Active, not recruiting||Phase 2|20|Anticipated|Erasmus Medical Center||2|||f||||f|t|f|||t|||||2017-10-10 21:21:10.211248|2017-10-10 21:21:10.211248
NCT03049254|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-11|||January 2016||2016-01-01|September 2017|2017-09-01|December 2031|Anticipated|2031-12-01|December 2022|Anticipated|2022-12-01||Observational|||Mayo AVC Registry and BioBank|The Mayo Clinic Arrhythmogenic Ventricular Cardiomyopathy Registry|Enrolling by invitation||N/A|6000|Anticipated|Mayo Clinic|||2||f||||f||||||Samples With DNA|"     For participants who volunteer and consent to the biobank arm, a baseline blood sample,     saliva sample and buccal scrapings will be collected and stored for analyses in the future.     The investigators will initially test for exisiting and novel pathogenic variants using next     generation whole exome sequencing, which is not approved for clinical diagnosis. However,     technologies are rapidly evolving, and samples may be used for whole genome and epigenome     analyses. Blood will also be stored for measuring known blood-biomarkers of disease     progression (such as high-sensitivity cardiac troponins, natriuretic peptides,     high-sensitivity CRP and cytokines). Blood will also be stored for high throughput 'omics     (transcriptomics, metabolomics and proteomics) to develop new biomarkers for diagnosis and     disease progression.   "|||2017-10-10 21:21:10.295749|2017-10-10 21:21:10.295749
NCT03049241|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-09|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|LENGTH-FATIG||Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults|Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults|Not yet recruiting||N/A|50|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-10 21:21:10.477058|2017-10-10 21:21:10.477058
NCT03049228|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-07-19|||March 21, 2017|Actual|2017-03-21|July 2017|2017-07-01|April 2, 2018|Anticipated|2018-04-02|April 1, 2018|Anticipated|2018-04-01|1 Day|Observational [Patient Registry]|31P||In and ex Vivo Mitochondrial Function of the Heart|Cardiac Mitochondrial Function: Comparison of in and ex Vivo Measurements|Enrolling by invitation||N/A|45|Anticipated|Maastricht University Medical Center|||3||f||||t|f|f||||Samples With DNA|"     From a fasting blood sample will DNA be extracted from leucocytes to study genetic variants     that may affect results.   "|||2017-10-10 21:21:10.59255|2017-10-10 21:21:10.59255
NCT03049215|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 31, 2020|Anticipated|2020-12-31|March 31, 2020|Anticipated|2020-03-31||Interventional|Axios||Lumen Apposing Metal Stents vs Lumen Apposing Metal Stent Plus Double Pigtail Stent for Endoscopic Drainage of Pancreatic Fluid Collections|Lumen Apposing Metal Stents vs Lumen Apposing Metal Stent Plus Double Pigtail Stent for Endoscopic Drainage of Pancreatic Fluid Collections: a Randomized Controlled Trial|Enrolling by invitation||N/A|101|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|t|f||f|||||2017-10-10 21:21:10.726719|2017-10-10 21:21:10.726719
NCT03049202|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-07|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 31, 2025|Anticipated|2025-12-31|June 1, 2020|Anticipated|2020-06-01||Observational|BRONCOSCAPIS||BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study|BROnchoalveolar Investigations of Never-smokers With CHronic Obstructive Lung Disease From the Swedish CardioPulmonary bioImage Study|Recruiting||N/A|1000|Anticipated|Karolinska Institutet|||5||f||||t|f|f||||Samples With DNA|"     Mouth wash, bronchoalveolar lavage (BAL) cells, BAL fluid, bronchial wash (BW) cells, BW     fluid, bronchial biopsies, airway epithelial brushings, serum, plasma, blood cells, and urine     are collected and stored.   "|No||2017-10-10 21:21:10.813561|2017-10-10 21:21:10.813561
NCT03049020|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-02-08|||October 2014||2014-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Efficacy of Laparoscopic Sacrocolpopexy in the Treatment of Pelvic Organ Prolapse in Women With or Without Avulsion of the Levator Ani Muscle|The Efficacy of Laparoscopic Sacrocolpopexy in the Treatment of Pelvic Organ Prolapse in Women With or Without Avulsion of the Levator Ani Muscle|Recruiting||N/A|120|Anticipated|Charles University, Czech Republic|||2||f||||f||||||||||2017-10-10 21:21:12.357255|2017-10-10 21:21:12.357255
NCT03049176|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-18|||March 13, 2017|Actual|2017-03-13|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|April 2018|Anticipated|2018-04-01||Observational|SAFER||The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)|The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples|Recruiting||N/A|160|Anticipated|University of California, San Francisco|||2||f||||t|f|f||||||Yes|De-identified data will be made available at the end of the study on an online repository.|2017-10-10 21:21:11.090923|2017-10-10 21:21:11.090923
NCT03049163|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-02-08|||October 2016||2016-10-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison the Topical Anesthesia and Retrobulbar Anesthesia for 27-gauge Vitrectomy for Vitreous Floaters||Recruiting||N/A|30|Anticipated|The Eye Hospital of Wenzhou Medical University||2|||f||||f|f|f||||||No||2017-10-10 21:21:11.212094|2017-10-10 21:21:11.212094
NCT03049150|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|PRE-RENAL||PREdicting RENAL Injury In Patient After Hip Fracture Surgery|The Use of Urinary MALDI-MS in Predicting Post-Operative Acute Kidney Injury in Patients After Fixation of Fractured Neck of Femur.|Not yet recruiting||N/A|20|Anticipated|University of Edinburgh|||1||f||||f|f|f||||Samples Without DNA|"     Urine   "|No||2017-10-10 21:21:11.295159|2017-10-10 21:21:11.295159
NCT03049137|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Computer Guided Versus Conventional Augmentation Using Bone Ring|Evaluation of Computer-Guided Versus Conventional Simultaneous Implant Placement With Ridge Augmentation Using an Autogenous Bone Ring Graft With PRF on Patient's Esthetic Satisfaction|Not yet recruiting||N/A|10|Anticipated|Cairo University||2|||f||||f|f|f||||||No|Evaluation of The Comparative Effectiveness of Computer Guided Surgical stents in Anterior Ridge Defects with Bone Ring Graft and PRF|2017-10-10 21:21:11.357366|2017-10-10 21:21:11.357366
NCT03049111|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-13|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 1, 2022|Anticipated|2022-03-01|March 1, 2022|Anticipated|2022-03-01||Interventional|MiteScreen||Screening Inhaled Allergen Challenge for Dermatophagoides Farinae|Screening Inhaled Allergen Challenge for Dermatophagoides Farinae|Not yet recruiting||Early Phase 1|100|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t|t|f||||||||2017-10-10 21:21:11.559282|2017-10-10 21:21:11.559282
NCT03049098|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||July 14, 2016|Actual|2016-07-14|February 2017|2017-02-01|January 25, 2017|Actual|2017-01-25|July 18, 2016|Actual|2016-07-18||Observational|||Visual Perception Exploration Using Eye-tracking Technology in High-fidelity Medical Simulation|Visual Perception Exploration Using Eye-tracking Technology in High-fidelity Medical Simulation|Completed||N/A|21|Actual|Université de Montréal|||2||f||||f|f|f||||||No||2017-10-10 21:21:11.690469|2017-10-10 21:21:11.690469
NCT03049085|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-07|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting|Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting: A Double-blind, Placebo-controlled, Randomized Trial|Active, not recruiting||Phase 4|300|Anticipated|Medinet Heart Centre||2|||f|||||t|f|||f|||||2017-10-10 21:21:11.810703|2017-10-10 21:21:11.810703
NCT03049072|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-07|||January 2017||2017-01-01|February 2017|2017-02-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01|10 Years|Observational [Patient Registry]|||Ion Therapy Patient Registry|Prospective Patient Registry for the Evaluation of Efficacy and Safety of Ion Therapy at MedAustron|Recruiting||N/A|800|Anticipated|EBG MedAustron GmbH|||1||f||||||||||||||2017-10-10 21:21:11.929059|2017-10-10 21:21:11.929059
NCT03049059|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||June 1, 2016|Actual|2016-06-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|December 1, 2016|Actual|2016-12-01||Interventional|||A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma|A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma|Completed||Phase 2|30|Actual|Mae Fah Luang University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:21:12.035839|2017-10-10 21:21:12.035839
NCT03049046|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-01|||April 7, 2017|Actual|2017-04-07|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|January 30, 2018|Anticipated|2018-01-30||Interventional|CC100B||CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS|Protocol CC100B. CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS|Recruiting||Phase 1|21|Anticipated|Chemigen, LLC||4|||f|||||t|f||||||||2017-10-10 21:21:12.153051|2017-10-10 21:21:12.153051
NCT03049033|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-04-27|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||NMT for Parkinson's Disease|Neurologic Music Therapy for Enhancing Fine Motor Control in Parkinson's Disease|Recruiting||N/A|80|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||Yes|De-identified data will be made available to the scientific community upon request.|2017-10-10 21:21:12.263968|2017-10-10 21:21:12.263968
NCT03049007|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-08|||February 7, 2017|Actual|2017-02-07|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|November 2018|Anticipated|2018-11-01||Observational|TABS||The Aarhus Bereavement Study|The Aarhus Bereavement Study - a Prospective Study on Natural and Prolonged Grief Reactions in the Adult Population|Recruiting||N/A|1500|Anticipated|University of Aarhus|||2||f||||t|f|f||||||||2017-10-10 21:21:12.469738|2017-10-10 21:21:12.469738
NCT03048981|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-05|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|FOILP||Effects of Fish Oil on Platelet Function and Coagulation|Effects of Fish Oil on Platelet Function and Coagulation|Completed||N/A|12|Actual|Region Skane||1|||f||||f|f|f||||||Yes|IPD will be available upon reasonable request|2017-10-10 21:21:12.704599|2017-10-10 21:21:12.704599
NCT03048968|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of a Walking Assist Robot on Gait Function and Brain Activity in Stroke Patients and Elderly Adults|The Effect of a Walking Assist Robot on Gait, Sit-to-Stand Movement and Brain Activity in Stroke Patients and Elderly Adults|Not yet recruiting||N/A|23|Anticipated|Samsung Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:21:12.801156|2017-10-10 21:21:12.801156
NCT03048955|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-06|||February 8, 2017|Actual|2017-02-08|June 2017|2017-06-01|July 31, 2025|Anticipated|2025-07-31|July 31, 2022|Anticipated|2022-07-31||Interventional|ASCEND||Assessing Superion Clinical Endpoints vs. Decompression|A 2 and 5 Year Comparative Evaluation of Clinical Outcomes in the Treatment of Moderate Lumbar Spinal Stenosis With the Superion® Indirect Decompression System (IDS) vs. Direct Decompression Surgery for FDA Actual Conditions of Use Study|Recruiting||N/A|358|Anticipated|VertiFlex, Incorporated||2|||f||||f|f|t|f||t|||No||2017-10-10 21:21:12.9087|2017-10-10 21:21:12.9087
NCT03048942|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-02-06|||November 2014||2014-11-01|February 2017|2017-02-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|CONCEPT||Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer|A Randomised Phase II Pilot Study of 3 Weekly Cabazitaxel Versus Weekly Paclitaxel Chemotherapy in the First Line Treatment of HER2 Negative Breast Cancer|Recruiting||Phase 2|90|Anticipated|University Hospitals Bristol NHS Foundation Trust||2|||f||||t||||||||No||2017-10-10 21:21:13.017787|2017-10-10 21:21:13.017787
NCT03048929|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-08|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|K01||Inflammation and Threat Sensitivity in PTSD|Effects of Inflammation on Neural Mechanisms of Threat Sensitivity in Posttraumatic Stress Disorder|Not yet recruiting||Early Phase 1|80|Anticipated|University of California, San Francisco||2|||f||||f|t|f|||t|||||2017-10-10 21:21:13.129777|2017-10-10 21:21:13.129777
NCT03048916|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-08|||August 1, 2010|Actual|2010-08-01|February 2017|2017-02-01|July 31, 2013|Actual|2013-07-31|July 31, 2012|Actual|2012-07-31||Interventional|||Dysphagia After Different Swallowing Therapies|Acute Stroke Patients With Dysphagia After Different Swallowing Therapies: Videofluoroscopy Findings and Brain Plasticity in Magnetic Resonance Imaging|Completed||N/A|58|Actual|Chang Gung Memorial Hospital||3|||f||||f|f|f||||||No||2017-10-10 21:21:13.212698|2017-10-10 21:21:13.212698
NCT03048903|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-07|||February 2016||2016-02-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure|The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function|Recruiting||Phase 2|400|Anticipated|Shanghai Changzheng Hospital||2|||f||||f||||||||No||2017-10-10 21:21:13.306366|2017-10-10 21:21:13.306366
NCT03048890|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-02-21|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|VascTrac||VascTrac Peripheral Arterial Disease (PAD) Study|VascTrac PAD ResearchKit Study|Not yet recruiting||N/A|2000|Anticipated|Palo Alto Veterans Institute for Research|||2||f||||f||||||||Undecided|If users consent, their data may or may not be shared with their personal physicians for direct patient care.|2017-10-10 21:21:13.395422|2017-10-10 21:21:13.395422
NCT03048877|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer|A Randomized, Double-Blind, Placebo-Controlled Study of Apatinib in Locally Advanced or Metastatic Radioactive Iodine-refractory Differentiated Thyroid Cancer|Recruiting||Phase 3|118|Anticipated|Peking Union Medical College Hospital||2|||f|||||f|f||||||||2017-10-10 21:21:13.465185|2017-10-10 21:21:13.465185
NCT03048864|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-04-06|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Questionnaire for Metabolic Screening|Use of Metabolic Evaluations for Patients With Renal Calculi and the Risk of Recurrence|Not yet recruiting||N/A|500|Anticipated|University of British Columbia|||1||f||||t|f|f||||||No||2017-10-10 21:21:13.542738|2017-10-10 21:21:13.542738
NCT03048851|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-02-08|||August 2015||2015-08-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of New Protocols in the Treatment of Upper Limb Dysfunctions in Patients With Cerebral Palsy|Immediate and Maintaining Efficacy of New Protocols in the Treatment of Upper Limb Dysfunctions in Patients With Cerebral Palsy|Recruiting||N/A|125|Anticipated|Chang Gung Memorial Hospital||5|||f||||t||||||||No||2017-10-10 21:21:13.600398|2017-10-10 21:21:13.600398
NCT03048838|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||A Couple-based HIV Prevention Intervention to Promote HIV Protection Among Latino Male Couples|A Couple-based HIV Prevention Intervention to Promote HIV Protection Among Latino Male Couples|Active, not recruiting||N/A|300|Anticipated|Temple University||2|||f||||f|f|f||||||No||2017-10-10 21:21:13.867863|2017-10-10 21:21:13.867863
NCT03048825|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-07-25|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 30, 2021|Anticipated|2021-12-30|June 30, 2021|Anticipated|2021-06-30||Interventional|CLEAR-SYNERGY||Colchicine and Spironolactone in Patients With STEMI / SYNERGY Stent Registry|A 2x2 Factorial Randomized Controlled Trial of Colchicine and Spironolactone in Patients With ST-elevation Myocardial Infarction (STEMI) / SYNERGY Stent Registry - CLEAR-SYNERGY (OASIS-9)|Not yet recruiting||Phase 3|4000|Anticipated|Population Health Research Institute||4|||f||||t|t|t|f|f|f|||||2017-10-10 21:21:13.968945|2017-10-10 21:21:13.968945
NCT03048812|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-09|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|SIMODA||Attachment Types for Single-implant Mandibular Overdentures: a Crossover Clinical Trial|Clinical Outcomes Using Different Attachment Types for Single-implant Mandibular Overdentures: a Crossover Clinical Trial|Enrolling by invitation||N/A|22|Actual|Universidade Federal de Goias||2|||f||||t|f|f||||||No||2017-10-10 21:21:14.10818|2017-10-10 21:21:14.10818
NCT02993068|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-17|||April 18, 2017|Actual|2017-04-18|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)|Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)|Recruiting||N/A|3000|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|f|f||||||||2017-10-10 21:31:52.194556|2017-10-10 21:31:52.194556
NCT03048799|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-08|||December 5, 2016|Actual|2016-12-05|February 2017|2017-02-01|December 5, 2018|Anticipated|2018-12-05|June 30, 2017|Anticipated|2017-06-30||Interventional|||Radiofrequency in the Treatment of Urinary Incontinence After Radical Prostatectomy|Radiofrequency in the Treatment of Urinary Incontinence After Radical Prostatectomy: Randomized Clinical Trial|Recruiting||N/A|62|Anticipated|Centro de Atenção ao Assoalho Pélvico||2|||f||||t|f|f||||||No||2017-10-10 21:21:14.205993|2017-10-10 21:21:14.205993
NCT03048786|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-10|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Mobile-based Peer Mentoring for Smoking Cessation|Mobile-based Peer Mentoring for Smoking Cessation: A Pilot Study|Not yet recruiting||N/A|204|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||No||2017-10-10 21:21:14.303314|2017-10-10 21:21:14.303314
NCT03048773|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-07|||February 20, 2017|Anticipated|2017-02-20|August 2016|2016-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Extracorporeal Shockwave Therapy for Knee Osteoarthritis|Extracorporeal Shockwave Therapy for Knee Osteoarthritis|Not yet recruiting||N/A|100|Anticipated|Taoyuan General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:21:14.411296|2017-10-10 21:21:14.411296
NCT03048760|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-10|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|MR-Lung||Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients|Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients|Not yet recruiting||N/A|35|Anticipated|The Christie NHS Foundation Trust||1|||f||||f|f|f||||||Yes|The contoured data sets will be fully anonymised, and used in house and shared with Elekta to assist with the development of automatic contouring / tumour tracking software, comparing CT to cone beam CT (CBCT) tracking (standard of care) with MR to MR tracking (experimental).|2017-10-10 21:21:14.495548|2017-10-10 21:21:14.495548
NCT03048747|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-03-09|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH|A Multicenter, Uncontrolled, Open-label, Dose-titration Trial to Investigate the Efficacy and Safety of Tolvaptan Tablets in Patients With Hyponatremia in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)|Recruiting||Phase 3|16|Anticipated|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 21:21:14.588264|2017-10-10 21:21:14.588264
NCT03048721|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-15|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||Skin Tape Harvesting for Transcriptomics Analysis|Skin Tape Harvesting for Transcriptomics Analysis|Recruiting||N/A|15|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 21:21:14.753663|2017-10-10 21:21:14.753663
NCT03048708|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-09|||June 2011||2011-06-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|December 2013|Actual|2013-12-01||Interventional|ThyrBar||Thyroid in Bariatric Surgery|Changes in Thyroid Function Tests and Texture Following Bariatric Surgery Induced Weight Loss|Completed||N/A|20|Actual|University Hospitals Coventry and Warwickshire NHS Trust||2|||f||||f||||||||No||2017-10-10 21:21:14.839578|2017-10-10 21:21:14.839578
NCT03048695|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-05-18|||May 18, 2017|Actual|2017-05-18|January 2017|2017-01-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia|Cognitive Remediation of Executive Dysfunction - Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia|Recruiting||N/A|100|Anticipated|Sykehuset Innlandet HF||2|||f||||f|f|f||||||||2017-10-10 21:21:14.91292|2017-10-10 21:21:14.91292
NCT03048682|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-13|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery|Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery|Recruiting||N/A|100|Anticipated|The Cleveland Clinic||2|||f||||f|f|f||||||No|There no plan to make individual participant data available to other researchers|2017-10-10 21:21:15.043699|2017-10-10 21:21:15.043699
NCT03048669|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||November 2016||2016-11-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo|Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo|Recruiting||N/A|6000|Anticipated|Ohio State University||2|||f||||f|f|f||||||Yes|The final dataset will include self-reported demographic and behavioral data from interviews with the subjects, clinical and laboratory data from the mother-infant pair, and blood specimens provided. Although the final dataset will be stripped of identifiers prior to release for sharing, we believe that there remains the possibility of deductive disclosure of subjects with unusual characteristics. Thus, we will make the data and associated documentation available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for the proposed research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed and results publish.|2017-10-10 21:21:15.15528|2017-10-10 21:21:15.15528
NCT03048656|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||January 18, 2017|Actual|2017-01-18|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|January 25, 2017|Actual|2017-01-25||Interventional|||The Postural Control in Individuals With the Structural Leg-length Discrepancy|Does the Structural Leg-length Discrepancy Affect the Postural Control? Preliminary Study|Completed||N/A|38|Actual|Poznan University of Medical Sciences||2|||f||||f|f|f||||||No||2017-10-10 21:21:15.25706|2017-10-10 21:21:15.25706
NCT03048643|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-05|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|CATS-CARE||Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis|CATS-CARE: Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis|Recruiting||N/A|20|Anticipated|University of Kentucky||2|||f||||f|f|f||||||No||2017-10-10 21:21:15.343292|2017-10-10 21:21:15.343292
NCT03048630|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-07|||September 1, 2012|Actual|2012-09-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2016|Actual|2016-12-31||Interventional|KHOEDEP||Reducing Chemical Exposures in Nail Salons|Reducing Chemical Exposures in Nail Salons Using an Owner-to-Worker Intervention|Active, not recruiting||N/A|347|Actual|Cancer Prevention Institute of California||2|||f||||f|f|f||||||No||2017-10-10 21:21:15.475942|2017-10-10 21:21:15.475942
NCT03048617|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-10-04|||February 13, 2017|Actual|2017-02-13|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|RePOWER||An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)|A Prospective Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)|Recruiting||N/A|300|Anticipated|Stealth BioTherapeutics Inc.|||1||f||||f||||||||||2017-10-10 21:21:15.552349|2017-10-10 21:21:15.552349
NCT03048604|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-06-25|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnoea (BLAST OSA)|A Multicentre, Prospective, Open-label, Non-randomized, Single Arm Treatment Study to Assess the Safety, Performance and Initial Efficacy Trends of the Genio(TM) Bilateral Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnoea.|Recruiting||N/A|25|Anticipated|Nyxoah S.A.||1|||f|||||f|f||||||||2017-10-10 21:21:15.745898|2017-10-10 21:21:15.745898
NCT03048591|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-20|||February 21, 2017|Anticipated|2017-02-21|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Exploratory Study of Electroacupuncture in the Treatment of Peripheral Neuropathy Induced by Platinum Based Chemotherapy Drugs|The Exploratory Study of Electroacupuncture in the Treatment of Peripheral Neuropathy Induced by Platinum Based Chemotherapy Drugs|Not yet recruiting||N/A|36|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f|||||f|f||||||||2017-10-10 21:21:15.837581|2017-10-10 21:21:15.837581
NCT03048578|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-22|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|July 2019|Anticipated|2019-07-01||Interventional|||Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery|Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery|Recruiting||Phase 4|132|Anticipated|New York University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 21:21:15.911033|2017-10-10 21:21:15.911033
NCT03048565|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Trial of an Online Mindfulness Based Programme for Informal Caregivers of People With Chronic Illnesses|An Exploratory Randomised Pilot Trial Examining the Potential Effectiveness of an Online Mindfulness Based Stress Reduction Programme for Informal Caregivers of People With Chronic Illnesses.|Recruiting||N/A|80|Anticipated|University of Dublin, Trinity College||2|||f||||f|f|f||||||||2017-10-10 21:21:16.019222|2017-10-10 21:21:16.019222
NCT03048552|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-03-09|||November 17, 2016|Actual|2016-11-17|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3|Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3|Enrolling by invitation||N/A|136|Anticipated|New York State Psychiatric Institute||2|||f||||t|f|f||||||||2017-10-10 21:21:16.101313|2017-10-10 21:21:16.101313
NCT03048539|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-04|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Comparison of Quality of Life Between Patients Underwent Transoral Endoscopic Thyroid Surgery and Conventional Surgery|Comparison of Quality of Life Between Patients Underwent Transoral Endoscopic Thyroid Surgery and Conventional Surgery|Recruiting||N/A|38|Anticipated|Khon Kaen University|||2||f||||t|f|f||||||Undecided||2017-10-10 21:21:16.178791|2017-10-10 21:21:16.178791
NCT03048526|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-07-03|||December 15, 2016|Actual|2016-12-15|July 2017|2017-07-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|||Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease|Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease|Completed||N/A|48|Actual|Novaliq GmbH||2|||f|||||f|f||||||||2017-10-10 21:21:16.264123|2017-10-10 21:21:16.264123
NCT03048513|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-08|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|July 1, 2017|Anticipated|2017-07-01|July 1, 2017|Anticipated|2017-07-01||Observational|||Clinical Presentation of Melioidosis in Head and Neck Region|Clinical Presentation of Melioidosis in Head and Neck Region|Recruiting||N/A|48|Anticipated|Khon Kaen University|||1||f||||t|f|f||||||Undecided||2017-10-10 21:21:16.362068|2017-10-10 21:21:16.362068
NCT03048500|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|February 2021|Anticipated|2021-02-01|August 2020|Anticipated|2020-08-01||Interventional|||Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery|Parallel Proof of Concept Phase 2 Study of Nivolumab and Metformin Combination Treatment in Advanced Non-small Cell Lung Cancer With and Without Prior Treatment With PD-1/PD-L1 Inhibitors|Not yet recruiting||Phase 2|51|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 21:21:16.462137|2017-10-10 21:21:16.462137
NCT03048487|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-02-07|||September 2016||2016-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Protein Consumption in Critically Ill Patients|Protein Consumption in Critically Ill Patients: A Retrospective Study|Active, not recruiting||N/A|2250|Anticipated|Nestlé|||1||f||||f||||||||No||2017-10-10 21:21:16.591392|2017-10-10 21:21:16.591392
NCT03048474|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-13|||September 2016||2016-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|INITIATE||Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma|Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma: a Phase II Study. Acronym: INITIATE|Recruiting||Phase 2|33|Anticipated|The Netherlands Cancer Institute||1|||f||||t||||||||||2017-10-10 21:21:16.689121|2017-10-10 21:21:16.689121
NCT03048461|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-27|||January 13, 2018|Anticipated|2018-01-13|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia|A Randomized, Double-blind, Placebo-controlled Clinical Trial Investigating the Effect of Autologous Platelet-rich Plasma in Subjects With Androgenetic Alopecia.|Not yet recruiting||Phase 2|30|Anticipated|Northwestern University||2|||f||||f|f|t|f|||||||2017-10-10 21:21:16.79039|2017-10-10 21:21:16.79039
NCT03048448|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-05-30|||June 5, 2017|Anticipated|2017-06-05|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects|An Open-label, Single-dose, Parallel-group Study to Assess the Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects|Not yet recruiting||Phase 1|40|Anticipated|Novartis||1|||f||||f|t|f||||||Undecided||2017-10-10 21:21:16.87003|2017-10-10 21:21:16.87003
NCT03048435|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-06-20|||February 27, 2017|Actual|2017-02-27|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|||Cervical Ca PROs in Clinical Practice|Feasibility and Acceptability of Measuring Cervical Cancer Specific Patient-Reported Outcomes in Clinical Practice|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||2||f||||f|f|f||||||||2017-10-10 21:21:16.974129|2017-10-10 21:21:16.974129
NCT03048422|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-18|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|VESTED||Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants|Phase III Study of the Virologic Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants|Not yet recruiting||Phase 3|549|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t|t|f||||||||2017-10-10 21:21:17.082531|2017-10-10 21:21:17.082531
NCT03048409|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-07-25|||July 24, 2017|Actual|2017-07-24|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|March 15, 2018|Anticipated|2018-03-15||Observational|RAP||Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula|Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-based Formula|Active, not recruiting||N/A|30|Anticipated|Nestlé|||1||f||||f|f|f||||||||2017-10-10 21:21:17.219375|2017-10-10 21:21:17.219375
NCT03048396|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-02-08|||October 2016||2016-10-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Acceptance of Uterus Transplantation|Transplantation of an Uterus for Treatment of an Absolute Uterine Infertility|Enrolling by invitation||N/A|10|Anticipated|University Women's Hospital Tübingen||1|||f||||f||||||||No||2017-10-10 21:21:17.285847|2017-10-10 21:21:17.285847
NCT03048383|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-06-29|2017-05-06||July 2012||2012-07-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis|Randomized, Single-blind Comparison of Three Commercially Available Botulinum Neuromodulators in the Management of Facial Synkinesis|Completed||Phase 4|71|Actual|University of Utah|Re-enrollment of patients already treated with botulinum toxin for synkinesis (treated as unique patients); small sample size of patients/treatments.|3|||f||||t||||||||||2017-10-10 21:21:17.360461|2017-10-10 21:21:17.360461
NCT03048370|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-07|||January 2017||2017-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia|Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia|Not yet recruiting||N/A|40|Anticipated|Centre for Addiction and Mental Health||8|||f||||f||||||||No||2017-10-10 21:21:17.633396|2017-10-10 21:21:17.633396
NCT03048357|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-13|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|November 1, 2017|Anticipated|2017-11-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Effectiveness of Freedom Bed Compared to Manual Turning in Prevention of Pressure Injuries in Persons With Limited Mobility Due to Traumatic Brain Injury and/or Spinal Cord Injury.|Effectiveness of the Freedom Bed, Automatic Continuous Lateral Rotation Therapy System as Compared to a Standard Hospital Mattress With Manual Caregiver Turning Every 2 Hours for Prevention of Pressure Injuries in Persons With Limited Mobility Due to Traumatic Brain Injury and/or Spinal Cord Injury.|Active, not recruiting||N/A|8|Anticipated|Northeast Center for Rehabilitation and Brain Injury||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:21:17.722659|2017-10-10 21:21:17.722659
NCT03048344|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-15|||December 2, 2016|Actual|2016-12-02|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Phase I, Three-part Study to Determine the Maximum Tolerated Dose/Recommended Dose, Compare Bioavailability in the Fed and Fasted States, and Evaluate Safety and Tolerability of ORH-2014 in Subjects With Advanced Hematological Disorders|A Phase I, Three-part Study to Determine the Maximum Tolerated Dose/Recommended Dose (Part 1), Compare Bioavailability in the Fed and Fasted States (Part 2), and Evaluate Safety and Tolerability (Part 3) of a Novel Oral Arsenic Trioxide Formulation (ORH-2014), in Subjects With Advanced Hematological Disorders|Recruiting||Phase 1|50|Anticipated|Orsenix LLC||3||||||||t|f||||||||2017-10-10 21:21:17.791983|2017-10-10 21:21:17.791983
NCT03048331|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-25|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|FES||Functional Electrical Stimulation (FES) and Reconstructive Tetraplegia Hand and Arm Surgery|The Effect of Functional Electrical Stimulation (FES) in Tetraplegia Reconstructive Surgery of the Upper Limbs - A Pilot Study|Recruiting||N/A|30|Anticipated|Swiss Paraplegic Centre Nottwil||2|||f||||f|f|f||||||No||2017-10-10 21:21:17.894372|2017-10-10 21:21:17.894372
NCT03048318|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-28|||October 1, 2015|Actual|2015-10-01|January 2017|2017-01-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Antegrade Arterial and Portal Flushing Versus Portal Flushing Only in LDLT|Antegrade Arterial and Portal Flushing Versus Portal Flushing Only of the Liver Graft in Living Donor Liver Transplantation and Its Effects on Biliary Complications and Graft Function: A Randomized Control Study|Completed||Phase 4|85|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||t|f|f||||||Yes||2017-10-10 21:21:18.123666|2017-10-10 21:21:18.123666
NCT03048305|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-07|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|January 2023|Anticipated|2023-01-01|January 2019|Anticipated|2019-01-01||Observational|||Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue|Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue|Not yet recruiting||N/A|200|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     Whole blood and tumor tissue   "|Undecided||2017-10-10 21:21:18.233657|2017-10-10 21:21:18.233657
NCT03047928|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-07|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma|Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Herlev Hospital||1|||f||||t|||||f|||||2017-10-10 21:21:21.817027|2017-10-10 21:21:21.817027
NCT03048292|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||June 2016||2016-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|NYC MIST||New York City Mobile Interventional Stroke Team|Reducing Disparities in Mechanical Embolectomy Access for Patients of New York City Via a Mobile Interventional Stroke Team: Systems of Care and Time-To-Treatment|Enrolling by invitation||N/A|300|Anticipated|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||Samples With DNA|"     Blood Clot; Saliva   "|No||2017-10-10 21:21:18.3144|2017-10-10 21:21:18.3144
NCT03048279|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||September 5, 2001|Actual|2001-09-05|February 2017|2017-02-01|September 1, 2026|Anticipated|2026-09-01|September 1, 2026|Anticipated|2026-09-01||Observational|||Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2|Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2|Recruiting||N/A|1500|Anticipated|M.D. Anderson Cancer Center|||2||f||||f|f|f||||||||2017-10-10 21:21:18.460266|2017-10-10 21:21:18.460266
NCT03048266|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||November 5, 2015|Actual|2015-11-05|February 2017|2017-02-01|November 1, 2025|Anticipated|2025-11-01|November 1, 2025|Anticipated|2025-11-01||Observational|||Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients|Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Patients|Recruiting||N/A|629|Anticipated|M.D. Anderson Cancer Center|||2||f||||f|f|f||||||||2017-10-10 21:21:18.565927|2017-10-10 21:21:18.565927
NCT03048253|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-09-29|||March 29, 2016|Actual|2016-03-29|February 2017|2017-02-01|October 28, 2019|Anticipated|2019-10-28|October 10, 2017|Anticipated|2017-10-10||Observational|||A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c|Recombinant Human GM-CSF Herpes Simplex Virus Injection (OrienX010) Standard Injection in Tumor Treatment Scheme Failed M1c Ⅳ Period Malignant Melanoma Spread to the Liver Open I-c Phase of Clinical Trial|Recruiting||N/A|30|Anticipated|OrienGene Biotechnology Ltd.|||1||f||||f|f|f||||||||2017-10-10 21:21:18.671689|2017-10-10 21:21:18.671689
NCT03048240|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-05-17|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|INDYGO||INtraoperative photoDYnamic Therapy of GliOblastoma|A Pilot Study of the Feasibility of Intraoperative Photodynamic Therapy of Glioblastoma.|Recruiting||N/A|10|Anticipated|University Hospital, Lille||1|||f||||t|f|f||||||No||2017-10-10 21:21:18.769765|2017-10-10 21:21:18.769765
NCT03048227|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-07|||March 1, 2017|Anticipated|2017-03-01|January 2017|2017-01-01|December 31, 2019|Anticipated|2019-12-31|December 1, 2019|Anticipated|2019-12-01||Interventional|CGMIP||Can Continuous Glucose Measurements Help Diabetic Patients Treated With an Implantated Pump?|Assessement of the Influence of Continuous Glucose Measurement on Glucose Control of Type 1 Diabetic Patients Treated by Implanted Insulin Pump|Not yet recruiting||Phase 2|28|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f||||||Undecided|NC|2017-10-10 21:21:18.884252|2017-10-10 21:21:18.884252
NCT03048214|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-07|||April 2016|Actual|2016-04-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Effect of Nerve Block Versus General Anaesthesia for Distal Radial Fracture Surgery|Effect of Infraclavicular Nerve Block Versus General Anaesthesia for Acute Postoperative Pain After Distal Radial Fracture Surgery|Active, not recruiting||N/A|70|Anticipated|The University of Hong Kong||2|||f||||t|f|f||||||No||2017-10-10 21:21:19.062663|2017-10-10 21:21:19.062663
NCT03048201|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-03-27|||March 24, 2017|Actual|2017-03-24|March 2017|2017-03-01|March 2030|Anticipated|2030-03-01|March 2030|Anticipated|2030-03-01||Interventional|||Post-market Registry Study on the Physica System Total Knee Replacement|Post-market Registry Study on the Physica System Total Knee Replacement|Recruiting||N/A|500|Anticipated|Limacorporate S.p.a||3|||f||||f|f|t|f|f|f|||No||2017-10-10 21:21:19.160931|2017-10-10 21:21:19.160931
NCT03048175|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||April 19, 2007|Actual|2007-04-19|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|June 15, 2009|Actual|2009-06-15||Interventional|OTTO-SYST||Acute Inflammation After Wisdom Tooth Removal|Systemic Inflammation After Wisdom Tooth Removal: a Case-control Study|Completed||N/A|40|Actual|University of Pisa||2|||f||||f|f|f||||||No||2017-10-10 21:21:19.442246|2017-10-10 21:21:19.442246
NCT03048162|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-05-15|||February 13, 2017|Actual|2017-02-13|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||The Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index|The Evaluation of the Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index|Completed||N/A|93|Actual|Tokat Gaziosmanpasa University||3|||f||||t|f|f||||||Undecided||2017-10-10 21:21:19.566046|2017-10-10 21:21:19.566046
NCT03048149|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-03-08|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Observational|||Clinical and Biological Efficacy of Hazelnut Oral Immunotherapy|Clinical and Biological Efficacy of Hazelnut Oral Immunotherapy|Completed||N/A|100|Actual|Lille Catholic University|||1||f||||f|f|f||||||No||2017-10-10 21:21:19.715416|2017-10-10 21:21:19.715416
NCT03048136|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-08-01|||March 9, 2018|Anticipated|2018-03-09|August 2017|2017-08-01|September 29, 2019|Anticipated|2019-09-29|September 29, 2019|Anticipated|2019-09-29||Interventional|CheckMate 955||A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer|A Phase Ib/II Safety Trial of Nivolumab in Combination With Ipilimumab Administered in Participants With Chemotherapy-naive Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) (CheckMate 955: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 955)|Not yet recruiting||Phase 3|124|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 21:21:19.789271|2017-10-10 21:21:19.789271
NCT03048123|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||October 1, 2015|Actual|2015-10-01|February 2017|2017-02-01|January 24, 2017|Actual|2017-01-24|October 1, 2016|Actual|2016-10-01||Interventional|||HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B|The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Compared With Transarterial Chemoembolization in Patients With Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B|Completed||Phase 2|79|Actual|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:21:19.969005|2017-10-10 21:21:19.969005
NCT03047915|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-02-08|||June 2016||2016-06-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Music in the Emergency Department (ED)|The Effects of a Music Intervention on Older Adults in the Emergency Department|Recruiting||N/A|150|Anticipated|Columbia University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:21.906672|2017-10-10 21:21:21.906672
NCT03048110|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-07-28|||February 15, 2017|Actual|2017-02-15|July 2017|2017-07-01|July 19, 2017|Actual|2017-07-19|May 4, 2017|Actual|2017-05-04||Interventional|||Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction|A Phase I, Non-randomized, Open-label, Fixed-sequence Study to Investigate the Effect of a Probe CYP3A4 Inhibitor and Inducer on the Pharmacokinetics of BAY1841788 (ODM 201) in Healthy Male Volunteers|Completed||Phase 1|15|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 21:21:20.090604|2017-10-10 21:21:20.090604
NCT03048097|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-07|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82|Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82 Myocardial Perfusion Imaging for Evaluation of Cardiac Sarcoidosis|Recruiting||Phase 2|15|Anticipated|Yale University||1|||f||||f|t|f|||f|||No||2017-10-10 21:21:20.193867|2017-10-10 21:21:20.193867
NCT03048084|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||June 1, 2017|Anticipated|2017-06-01|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|December 2018|Anticipated|2018-12-01||Interventional|STING||Seizure Treatment in Glioma|A Randomized Controlled Trial Comparing a Treatment Strategy With Levetiracetam and Valproic Acid in Glioma Patients With a First Seizure|Not yet recruiting||Phase 4|120|Anticipated|Leiden University Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:21:20.302765|2017-10-10 21:21:20.302765
NCT03048071|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-07|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Morbimortality of Contegra Duct Replacements Versus Homografts in Pulmonary Position|Morbimortality of Contegra Duct Replacements Versus Homografts in Pulmonary Position: a Comparative Study|Not yet recruiting||N/A|84|Anticipated|Brugmann University Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:21:20.401369|2017-10-10 21:21:20.401369
NCT03048058|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-08|||May 5, 2016|Actual|2016-05-05|February 2017|2017-02-01|July 19, 2017|Anticipated|2017-07-19|January 19, 2017|Actual|2017-01-19||Interventional|||Internet Surveys and Their Impact on Adherence for Rosacea|Internet Surveys and Their Impact on Adherence and Quality of Life to Mirvaso for Rosacea|Active, not recruiting||N/A|20|Actual|Wake Forest University Health Sciences||2|||f||||f|f|f||||||No||2017-10-10 21:21:20.51756|2017-10-10 21:21:20.51756
NCT03048045|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-09|||June 2015||2015-06-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Observational|SYSPERIO10||Long-term Results After Systematic Periodontal Therapy|Long-term Results After Systematic Periodontal Therapy|Enrolling by invitation||N/A|100|Anticipated|Goethe University|||1||f||||f||||||||No||2017-10-10 21:21:20.607137|2017-10-10 21:21:20.607137
NCT03048032|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-07|||April 2015||2015-04-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|LEDA||Lithuanian Echocardiography Study of Dyspnea in Acute Settings|Diagnostic and Prognostic Value of Cardiac Biomarkers and Echocardiography for Patients Hospitalized Due to Acute Dyspnea: Prospective Observational Multicenter Cohort Study|Recruiting||N/A|2000|Anticipated|Vilnius University|||2||f||||f|f|f||||Samples Without DNA|"     plasma   "|Yes|Individual participant data will be made available to other researchers via GREAT (Global REsearch on Acute Conditions Team) database|2017-10-10 21:21:20.688692|2017-10-10 21:21:20.688692
NCT03048019|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-06-29|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|May 1, 2018|Anticipated|2018-05-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention|Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention|Not yet recruiting||N/A|60|Anticipated|Inova Health Care Services|||2||f|||||t|f||||||||2017-10-10 21:21:20.855495|2017-10-10 21:21:20.855495
NCT03048006|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-22|2017-03-22||January 2011||2011-01-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Post-marketing Surveillance Study for Evaluation of Dotarem Safety|Evaluation of Dotarem Safety|Completed||N/A|44456|Actual|Guerbet|||1||f||||f||||||||||2017-10-10 21:21:20.969437|2017-10-10 21:21:20.969437
NCT03047993|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-07-07|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||CB-839 + Azacitidine for Treatment of Myelodysplastic Syndrome (MDS)|Phase Ib/II Study of the Glutaminase Inhibitor CB-839 in Combination With Azacitidine in Patients With Advanced Myelodysplastic Syndrome|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:21:21.311121|2017-10-10 21:21:21.311121
NCT03047980|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-11|||January 2017||2017-01-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome|Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome|Recruiting||Phase 2/Phase 3|10|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||t||||||||||2017-10-10 21:21:21.444947|2017-10-10 21:21:21.444947
NCT03047967|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-06|||February 2017|Anticipated|2017-02-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns|Effets du Tabagisme in Utero Sur la fonctionnalité de l'épithelium Respiratoire et Sur la Fonction Ventilatoire du Nouveau-né.|Not yet recruiting||N/A|60|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f|||||f|f||||||Undecided||2017-10-10 21:21:21.568599|2017-10-10 21:21:21.568599
NCT03047954|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-07|||July 2003||2003-07-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis|Multicentre, Randomised, Double Blind, Placebo-controlled Study of the Efficacy and Safety of Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis|Completed||Phase 3|179|Actual|Vifor Inc.||2|||f||||f||||||||No||2017-10-10 21:21:21.646554|2017-10-10 21:21:21.646554
NCT03047941|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-03-14|||February 13, 2017|Actual|2017-02-13|March 2017|2017-03-01|October 31, 2017|Anticipated|2017-10-31|September 30, 2017|Anticipated|2017-09-30|1 Month|Observational [Patient Registry]|||Determination of Optimal Cutoff Value for Screening Severe Hypoxemic OSA (Obstructive Sleep Apnea) Patients|Determination of Optimal Cutoff Value of 4 Tests (DES-OSA, STOP-Bang, OSA50, P-SAP) for Screening Severe Hypoxemic OSA (Obstructive Sleep Apnea) Patients|Recruiting||N/A|150|Anticipated|Astes|||1||f||||t|f|f||||||No||2017-10-10 21:21:21.731834|2017-10-10 21:21:21.731834
NCT03047889|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-02-07|||April 2016||2016-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast|A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast|Recruiting||N/A|4200|Anticipated|Chinese Academy of Medical Sciences|||1||f||||f||||||||No||2017-10-10 21:21:22.098789|2017-10-10 21:21:22.098789
NCT03047876|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-05-25|||September 20, 2017|Anticipated|2017-09-20|February 2017|2017-02-01|March 19, 2018|Anticipated|2018-03-19|March 19, 2018|Anticipated|2018-03-19||Observational|||Brain Vascular Reactivity to Hypothermic Circulatory Arrest With Antegrade Cerebral Perfusion During Aortic Arch Surgery|Brain Vascular Reactivity to Hypothermic Circulatory Arrest With Antegrade Cerebral Perfusion During Aortic Arch Surgery in Neonates and Infants.|Not yet recruiting||N/A|20|Anticipated|Alder Hey Children's NHS Foundation Trust|||1||f||||t|f|f||||||No||2017-10-10 21:21:22.227926|2017-10-10 21:21:22.227926
NCT03047863|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-02-08|||November 2016||2016-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors|The Therapeutic Effect of Topical EGF Cream for Dermatologic Adverse Events Related to EGFR Inhibitors|Recruiting||N/A|20|Anticipated|The Catholic University of Korea||2|||f||||t||||||||Undecided||2017-10-10 21:21:24.101151|2017-10-10 21:21:24.101151
NCT03047850|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-05-30|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|September 30, 2017|Anticipated|2017-09-30|1 Day|Observational [Patient Registry]|||Comparison of Delta Pulse Pressure and Delta Down Before and After Sternotomy|Comparison of Delta Pulse Pressure and Delta Down Before and After Sternotomy|Recruiting||N/A|200|Anticipated|Astes|||1||f||||t|f|f||||||No||2017-10-10 21:21:24.212634|2017-10-10 21:21:24.212634
NCT03047837|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-10-02|||March 15, 2017|Actual|2017-03-15|October 2017|2017-10-01|March 15, 2020|Anticipated|2020-03-15|September 15, 2019|Anticipated|2019-09-15||Interventional|ASAMET||A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients.|A Randomized, Phase II, Double-blind, Placebo-controlled, Multicenter, 2x2 Factorial Design Biomarker Tertiary Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients. The ASAMET Trial|Recruiting||Phase 2|160|Anticipated|Ente Ospedaliero Ospedali Galliera||4|||f||||f|f|f||||||||2017-10-10 21:21:24.295491|2017-10-10 21:21:24.295491
NCT03047824|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-03-09|||May 2014||2014-05-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|May 2014|Actual|2014-05-01||Interventional|GlucoClearIT||Effects of GlucoClear CGM System on the Performance of Insulin Therapy in Critically Ill Patients|A Study on the Effects of the Use of GlucoClear CGM System on the Performance of Insulin Therapy in Critically Ill Patients|Completed||N/A|100|Actual|Erasme University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:21:24.418839|2017-10-10 21:21:24.418839
NCT03047811|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-08|||August 26, 2016|Actual|2016-08-26|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors|The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors|Recruiting||N/A|15|Anticipated|Fudan University||1|||f||||f|f|f||||||No||2017-10-10 21:21:24.511742|2017-10-10 21:21:24.511742
NCT03047798|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||June 1, 2014|Actual|2014-06-01|February 2017|2017-02-01|October 31, 2014|Actual|2014-10-31|September 30, 2014|Actual|2014-09-30||Interventional|||The Effect of Mouthrinses Containing Bamboo Salt, Magnolia Bark and Centella Asiatica on Reducing Plaque and Gingivitis|Comparative Effects of Aqueous Single-phase and Oil-water Two-phase Mouthrinses Containing Bamboo Salt, Magnolia Bark and Centella Asiatica Extracts on Reducing Gingivitis: a Randomized Clinical Trial|Completed||Phase 3|34|Actual|Seoul National University||3|||f||||f|f|f||||||No||2017-10-10 21:21:24.609701|2017-10-10 21:21:24.609701
NCT03047785|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-05-16|||June 13, 2017|Anticipated|2017-06-13|May 2017|2017-05-01|October 13, 2017|Anticipated|2017-10-13|July 13, 2017|Anticipated|2017-07-13||Observational|CHARIOT||"Is the Current Threshold for Diagnosis of Abnormality, Including Non ST Elevation Myocardial Infarction, Using Raised Highly Sensitive Troponin Appropriate for a Hospital Population? The CHARIOT Study"|"Is the Current Threshold for Diagnosis of Abnormality, Including Non ST Elevation Myocardial Infarction, Using Raised Highly Sensitive Troponin Appropriate for a Hospital Population? The CHARIOT Study"|Not yet recruiting||N/A|20000|Anticipated|University Hospital Southampton NHS Foundation Trust|||1||f||||f|f|f||||||No||2017-10-10 21:21:24.724924|2017-10-10 21:21:24.724924
NCT03047772|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||March 6, 2017|Anticipated|2017-03-06|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|TEAM-AMI||Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients|The Randomized Double-blind Placebo-Controlled Multi-center Clinical Trial of Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in Acute Myocardial Infarction Patients|Not yet recruiting||Phase 2|124|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||8|||f|||||f|f|||f|||||2017-10-10 21:21:24.803031|2017-10-10 21:21:24.803031
NCT03047759|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-02-07|||July 21, 2016|Actual|2016-07-21|August 2016|2016-08-01|August 19, 2016|Actual|2016-08-19|August 2016|Actual|2016-08-01||Interventional|||Comparison of Two Interdental Cleaners||Completed||N/A|70|Actual|All Sum Research Center Ltd.||2|||f||||||||||||No||2017-10-10 21:21:24.916829|2017-10-10 21:21:24.916829
NCT03047746|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-05|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Unrelated And Partially Matched Related Donor PSCT w/ TCR αβ Depletion for Patients With BMF|Unrelated And Partially Matched Related Donor Peripheral Blood Stem Cell Transplantation (PSCT) With TCR αβ + T Cell And B Cell Depletion For Patients With Acquired And Inherited Bone Marrow Failure|Recruiting||N/A|20|Anticipated|Children's Hospital of Philadelphia||2|||f||||t|f|t|t|f||||No||2017-10-10 21:21:24.995688|2017-10-10 21:21:24.995688
NCT03047733|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-07|||July 21, 2015|Actual|2015-07-21|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo|Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo: A Randomized Controlled Non-inferiority Trial|Completed||N/A|12|Actual|Ajou University School of Medicine||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:21:25.29601|2017-10-10 21:21:25.29601
NCT03047707|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||S-Shearwave Elastography for Assessment of Hepatic Fibrosis|Diagnostic Performance of S-Shearwave Elastography for Hepatic Fibrosis Evaluation: a Multicenter Prospective Study|Not yet recruiting||N/A|628|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:21:25.569395|2017-10-10 21:21:25.569395
NCT03047694|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-09-19|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|SemantiMATT||A Lexico-semantic Program on Tactile Tablet for Patients With Alzheimer's Disease|Contribution of a Semantic Therapy on a Tactile Tablet in the Alzheimer's Disease, Early and Late Onset|Not yet recruiting||N/A|72|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:21:25.661882|2017-10-10 21:21:25.661882
NCT03047681|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-08|2017-02-08|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01||Observational|TAVR||Tryptase Level as a Marker of Complications in Transcatheter Aortic Valve Replacement|Tryptase Levels as a Marker of Mast Cell Activity and the Prognostic Implication in Patients Post Transcatheter Aortic Valve Replacement|Recruiting||N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||f|f|f||||Samples Without DNA|"     tryptase level in serum   "|No|Only the principle investigator will have access to IPD|2017-10-10 21:21:25.780975|2017-10-10 21:21:25.780975
NCT03047668|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-02-06|||May 2013||2013-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|POLYPHEM||POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 Diabetes|POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 Diabetes|Recruiting||N/A|200|Anticipated|German Institute of Human Nutrition||4|||f||||f||||||||||2017-10-10 21:21:25.875955|2017-10-10 21:21:25.875955
NCT03047655|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-02-22|||January 9, 2017|Actual|2017-01-09|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|GesundLeben||Effects of Short-term Interventions for a Healthy Lifestyle on the Human Lipidome in Subjects With Metabolic Syndrome||Recruiting||N/A|100|Anticipated|German Institute of Human Nutrition||2|||f||||f||||||||Undecided||2017-10-10 21:21:25.983124|2017-10-10 21:21:25.983124
NCT03047642|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-02-20|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance Characteristics|Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance Characteristics in Africa and Latin America|Not yet recruiting||N/A|1500|Anticipated|Foundation for Innovative New Diagnostics, Switzerland||1|||f||||t||||||||Yes|As appropriate data will be made available to the scientific community and/or commercial partners to support product development activities.|2017-10-10 21:21:26.083814|2017-10-10 21:21:26.083814
NCT03047629|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-06-27|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RASMET||Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation|A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation|Recruiting||Phase 1/Phase 2|50|Anticipated|Enterin Inc.||2|||f||||f|t|f||||||Undecided|Anonymized data may be shared with other clinical researchers outside of this study that are involved in similar research at non-participating institutions.|2017-10-10 21:21:26.163223|2017-10-10 21:21:26.163223
NCT03047616|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-31|||November 22, 2016|Actual|2016-11-22|July 2017|2017-07-01||||November 22, 2021|Anticipated|2021-11-22||Observational|||A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer|A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer|Recruiting||N/A|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t|f|f||||Samples With DNA|"     will collect blood and urine specimens from patients receiving immunotherapy as part of their     standard of care for the treatment of NSCLC   "|||2017-10-10 21:21:26.300514|2017-10-10 21:21:26.300514
NCT03047603|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-25|||May 1, 2016|Actual|2016-05-01|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|February 1, 2018|Anticipated|2018-02-01||Observational|||Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC|Evaluation of Diagnostic and Differential Diagnostic Significance of a Combination of PIVKA-II and Other Tumor Markers in Hepatocellular Carcinoma|Recruiting||N/A|2500|Anticipated|Eastern Hepatobiliary Surgery Hospital|||4||f||||t|f|f||||||||2017-10-10 21:21:26.371808|2017-10-10 21:21:26.371808
NCT03047590|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-02|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Comparison of Affect-based, Self-selected, and Traditional Exercise Prescriptions|Comparison of Affect-based, Self-selected, and Traditional Exercise Prescriptions|Recruiting||N/A|164|Anticipated|Duke University||4|||f||||f|f|f||||||Yes|The investigators retain ownership of all study data, but are willing to share anonymized data for transparency purposes at the conclusion of the study. Data may be requested by contacting the Principal Investigator.|2017-10-10 21:21:26.469639|2017-10-10 21:21:26.469639
NCT03047577|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-05-10|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|June 30, 2021|Anticipated|2021-06-30|February 28, 2021|Anticipated|2021-02-28||Interventional|ICU-BI||Brief Intervention for ICU Patients With Alcohol Use Disorders|Brief Intervention for ICU Patients With Alcohol Use Disorders- a Randomized Controlled Trial|Recruiting||N/A|600|Anticipated|Helsinki University||2|||f||||f|f|f||||||No||2017-10-10 21:21:26.565677|2017-10-10 21:21:26.565677
NCT03047564|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-06|||February 1, 2012|Actual|2012-02-01|February 2017|2017-02-01|December 1, 2020|Anticipated|2020-12-01|February 28, 2015|Actual|2015-02-28||Interventional|||Metal Ion Concentration Between Coated and Uncoated TKA|Metal Ion Concentration and Clinical Outcome Between Coated and Uncoated TKA|Active, not recruiting||N/A|120|Actual|Technische Universität Dresden||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:26.66647|2017-10-10 21:21:26.66647
NCT03047551|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-02-06|||July 2016||2016-07-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|TASvTVS||Transabdominal and Transvaginal Sonography in Medical Abortion|Is Transabdominal Sonography Comparable to Transvaginal Sonography for Eligibility Assessment Prior to Medical Abortion? A Randomized Controlled Trial.|Recruiting||N/A|830|Anticipated|Columbia University||2|||f||||t||||||||No||2017-10-10 21:21:26.749742|2017-10-10 21:21:26.749742
NCT03047538|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-08|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|FILIP||Fixed Combination for Lipid and Blood Pressure Control|Fixed Combination for Lipid and Blood Pressure Control. Randomized Cross-over Study|Not yet recruiting||Phase 4|160|Anticipated|Charles University, Czech Republic||2|||f||||t|t|f|||f|||No||2017-10-10 21:21:26.881385|2017-10-10 21:21:26.881385
NCT03047525|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-08|||February 20, 2017|Anticipated|2017-02-20|February 2017|2017-02-01|December 1, 2020|Anticipated|2020-12-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Study of DC-CTL Combined With CIK for Advanced Solid Tumor|The Opening and Negative Controlled Clinical Study of Autologous Multiple Targets DC-CTL Combined With CIK for Advanced Solid Tumor|Recruiting||Phase 1/Phase 2|200|Anticipated|Harbin Medical University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:26.976604|2017-10-10 21:21:26.976604
NCT03047512|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study of an Internet-based Program for Prevention and Early Intervention of Adolescent Depression|Pilot Study of an Internet-based Program for Prevention and Early Intervention of Adolescent Depression|Not yet recruiting||N/A|200|Anticipated|CES University||2|||f||||f|f|f||||||No||2017-10-10 21:21:27.053522|2017-10-10 21:21:27.053522
NCT03047499|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-08|||February 15, 2017|Anticipated|2017-02-15|February 2017|2017-02-01|November 15, 2017|Anticipated|2017-11-15|October 15, 2017|Anticipated|2017-10-15|6 Months|Observational [Patient Registry]|||Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty|Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleftlip Repair by Modified Millard Cheiloplasty|Recruiting||N/A|2|Anticipated|Cairo University|||3||f||||t|t|f||||||||2017-10-10 21:21:27.262677|2017-10-10 21:21:27.262677
NCT03047486|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-10|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|Smartguard||Smartguard Use in Real Life : a Longitudinal Study in Patients With Type 1 Diabetes|Smartguard Use in Real Life : a Longitudinal Study in Patients With Type 1 Diabetes|Not yet recruiting||N/A|30|Anticipated|University Hospital, Caen|||1||f||||f||||||||No||2017-10-10 21:21:27.355224|2017-10-10 21:21:27.355224
NCT03047473|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-06|||March 10, 2017|Actual|2017-03-10|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|SEJ||Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme|Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme|Recruiting||Phase 2|30|Anticipated|Clinique Neuro-Outaouais||1|||f|||||t|f|||t|||||2017-10-10 21:21:27.437747|2017-10-10 21:21:27.437747
NCT03047460|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-02-06|||April 2016||2016-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|January 2017|Actual|2017-01-01||Observational|||Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting|Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting|Recruiting||N/A|10|Anticipated|Clinique Neuro-Outaouais|||2||f||||f||||||||Yes|the data will pooled with 3 other centers to augment the power of the study|2017-10-10 21:21:27.530782|2017-10-10 21:21:27.530782
NCT03047447|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-04-24|2017-02-13||February 25, 2016|Actual|2016-02-25|April 2017|2017-04-01|November 30, 2016|Actual|2016-11-30|September 30, 2016|Actual|2016-09-30||Interventional|||Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies|Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies|Completed||N/A|30|Actual|Bristlecone Behavioral Health, Inc.||3|||f||||t|f|f||||||Undecided||2017-10-10 21:21:27.627915|2017-10-10 21:21:27.627915
NCT03047434|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||November 9, 2016|Actual|2016-11-09|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|Purple Rain||Characterization of Postoperative Pain in Shoulder Arthroscopy and Knee Arthroscopy and Assessment of the Defense and Veterans Pain Rating Scale for Persistent Pot-Surgical Pain|Characterization of Postoperative Pain in Shoulder Arthroscopy and Knee Arthroscopy and Assessment of the Defense and Veterans Pain Rating Scale for Persistent Pot-Surgical Pain|Recruiting||N/A|250|Anticipated|Defense and Veterans Center for Integrative Pain Management|||1||f||||f|f|f||||||No||2017-10-10 21:21:28.107844|2017-10-10 21:21:28.107844
NCT03047421|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-08|||January 1, 2016|Actual|2016-01-01|February 2017|2017-02-01|October 31, 2017|Anticipated|2017-10-31|September 30, 2017|Anticipated|2017-09-30|1 Month|Observational [Patient Registry]|||Influence of Different Methods of Measurement in the Accuracy of DES-OSA and P-SAP Scores|Influence of Different Methods of Measurement in the Accuracy of DES-OSA and P-SAP Scores|Recruiting||N/A|1500|Anticipated|Astes|||1||f||||t|f|f||||||No||2017-10-10 21:21:28.186336|2017-10-10 21:21:28.186336
NCT03047408|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-06|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Evolution of RBD in PD|Evolution of REM Sleep Behavior Disorder in Parkinson's Disease Patients RBD Diagnosed Three Years Earlier|Not yet recruiting||N/A|50|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 21:21:28.285325|2017-10-10 21:21:28.285325
NCT03047395|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-29|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|November 30, 2021|Anticipated|2021-11-30|November 30, 2021|Anticipated|2021-11-30||Interventional|||A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis|A Multicenter, Open Label Study to Assess the Safety and Efficacy of rIsankizuMab for MaInTenance in Moderate to Severe pLaquE Type pSoriaSis (LIMMITLESS)|Enrolling by invitation||Phase 3|2000|Anticipated|AbbVie||1|||f||||t|t|f||||||||2017-10-10 21:21:28.426858|2017-10-10 21:21:28.426858
NCT03047382|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-02-08|||July 2014||2014-07-01|April 2016|2016-04-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|||Electronic Alerting Tool to Help Prevent Acute Kidney Injury|'Preventable Acute Kidney Injury (AKI) Should Never Occur.' The Use of a Novel Electronic Prediction Alerting Tool to Deliver an Individualised Care Package for Hospital In-patients at Risk of AKI|Completed||N/A|30298|Actual|Western Sussex Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 21:21:28.912343|2017-10-10 21:21:28.912343
NCT03047200|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-02-14|||July 2008||2008-07-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression|Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression|Withdrawn||Phase 1|0|Actual|Baylor Research Institute||1||There were not patients that meet inclusion/exclusion criteria. Site decided to close study.|f||||t||||||||||2017-10-10 21:21:30.339122|2017-10-10 21:21:30.339122
NCT03047369|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-04-19|||December 8, 2016|Actual|2016-12-08|April 2017|2017-04-01|December 8, 2026|Anticipated|2026-12-08|December 8, 2026|Anticipated|2026-12-08|10 Years|Observational [Patient Registry]|MDBP||The Myelin Disorders Biorepository Project|New Diagnostic Approaches in Leukodystrophy: The Myelin Disorders Biorepository and Natural History Project|Recruiting||N/A|12000|Anticipated|Children's Hospital of Philadelphia|||1||f||||f|f|f||||Samples With DNA|"     Enrolled participants (and immediate relatives) will submit blood samples to be processed and     stored in a secure biorepository.   "|Yes|Fully de-identified data may be shared with collaborating scientists, clinicians, and data management services.|2017-10-10 21:21:28.993556|2017-10-10 21:21:28.993556
NCT03047356|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-06|||March 4, 2016|Actual|2016-03-04|February 2017|2017-02-01|April 6, 2016|Actual|2016-04-06|April 6, 2016|Actual|2016-04-06||Interventional|||Sleep Intervention|"Effects of If-then Plans (Implementation Intentions) on Adolescent Sleep"|Completed||N/A|151|Actual|University of Manchester||3|||f||||f|f|f||||||Undecided||2017-10-10 21:21:29.085487|2017-10-10 21:21:29.085487
NCT03047343|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-07|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Evolution of Two Cohorts of Children (Univentricular and Bi-ventricular Heart) After Strapping of the Pulmonary Artery|Evolution of Two Cohorts of Children (Univentricular and Bi-ventricular Heart) After Strapping of the Pulmonary Artery|Not yet recruiting||N/A|79|Anticipated|Brugmann University Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:21:29.158726|2017-10-10 21:21:29.158726
NCT03047330|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-07-14|||July 15, 2017|Anticipated|2017-07-15|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Menopausal Sleep Fragmentation and Body Fat Gain|Menopausal Sleep Fragmentation: Impact on Body Fat Gain Biomarkers in Women|Recruiting||Phase 4|58|Anticipated|Brigham and Women's Hospital||2|||f|||||t|f||||||||2017-10-10 21:21:29.239599|2017-10-10 21:21:29.239599
NCT03047317|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-06-26|||February 15, 2017|Actual|2017-02-15|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|March 8, 2017|Actual|2017-03-08||Interventional|||A Pharmacokinetic Study of MABp1 in Healthy Volunteers|A Phase I Pharmacokinetic Study of MABp1 in Healthy Volunteers|Completed||Phase 1|6|Actual|XBiotech, Inc.||1|||f||||f|t|f||||||No||2017-10-10 21:21:29.444298|2017-10-10 21:21:29.444298
NCT03047304|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-13|||February 14, 2017|Anticipated|2017-02-14|February 2017|2017-02-01|March 10, 2018|Anticipated|2018-03-10|February 10, 2018|Anticipated|2018-02-10||Interventional|||Magnesium Effect on Embryonal PR Interval|Magnesium Effect on Embryonal PR Interval|Not yet recruiting||N/A|25|Anticipated|Rambam Health Care Campus||1|||f||||f|f|f||||||Undecided||2017-10-10 21:21:29.535602|2017-10-10 21:21:29.535602
NCT03047291|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-05-01|||January 1, 2014||2014-01-01|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|March 1, 2017|Actual|2017-03-01||Interventional|||Effect of Probiotic Lactobacillus Reuteri in the Treatment of Mucositis and Periimplantitis|Clinical and Microbiological Evaluation of the Effect of Probiotic Lactobacillus Reuteri Prodentis in the Treatment of Mucositis and Periimplantitis|Active, not recruiting||Phase 4|44|Anticipated|Universitat Internacional de Catalunya||2|||f||||t|f|f||||||No||2017-10-10 21:21:29.621793|2017-10-10 21:21:29.621793
NCT03047278|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-07|||November 1, 2015|Actual|2015-11-01|February 2017|2017-02-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Influence of OCT2 Inhibitor Cetirizine and Type 2 Diabetes on Gabapentin Kinetics Disposition in Patients With Neuropathic Pain|Influence of Organic Cation Transporter 2 (OCT2) Inhibitor Cetirizine and Type 2 Diabetes on Gabapentin Kinetics Disposition in Patients With Neuropathic Pain|Enrolling by invitation||Phase 4|30|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f|||||t|f|||f|||Undecided||2017-10-10 21:21:29.715593|2017-10-10 21:21:29.715593
NCT03047265|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-09|||February 4, 2017|Actual|2017-02-04|February 2017|2017-02-01|June 1, 2027|Anticipated|2027-06-01|December 1, 2025|Anticipated|2025-12-01||Interventional|||Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Phase II Randomized Trial Comparing Paclitaxel Combined With DDP Plus Concurrent Chemoradiotherapy With DDP Plus Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Active, not recruiting||Phase 2|164|Anticipated|Sun Yat-sen University||2|||f|||||f|f||||||||2017-10-10 21:21:29.813981|2017-10-10 21:21:29.813981
NCT03047252|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-10-03|||December 19, 2016|Actual|2016-12-19|October 2017|2017-10-01|May 31, 2018|Anticipated|2018-05-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||SWORD Phoenix Versus Standard of Care in the Rehabilitation After Total Knee Replacement|Efficacy of Home-based Rehabilitation With SWORD Phoenix Versus Standard of Care After Total Knee Replacement: a Randomised Controlled Trial|Recruiting||N/A|40|Anticipated|Sword Health, SA||2|||f||||f|f|f||||||||2017-10-10 21:21:29.904882|2017-10-10 21:21:29.904882
NCT03047239|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-10-03|||January 15, 2018|Anticipated|2018-01-15|October 2017|2017-10-01|October 31, 2020|Anticipated|2020-10-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||TF for the Prediction of Visual Field Progression|A Prospective Study Investigating the Relationship Between SENSIMED Triggerfish® Ocular Dimensional Profiles and Disease Progression in Patients With Open Angle Glaucoma|Not yet recruiting||N/A|322|Anticipated|Sensimed AG||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:21:29.990758|2017-10-10 21:21:29.990758
NCT03047213|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-09-04|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations|An Open Label, Multicenter, Single Arm Phase II Study to Evaluate the Activity and Tolerability of the Novel mTOR Inhibitor, MLN0128 (TAK-228), in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract Whose Tumors Harbor a TSC1 and/or a TSC2 Mutation|Recruiting||Phase 2|209|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 21:21:30.173782|2017-10-10 21:21:30.173782
NCT03047187|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-01|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|SHOPS||The Functional Status of Anterior Cruciate Ligament Reconstruction (ACLR) Patients at Discharge From Rehabilitation|What is the Functional Status of Anterior Cruciate Ligament Reconstruction (ACLR) Patients at Discharge From Rehabilitation|Not yet recruiting||N/A|25|Anticipated|University of Salford|||1||f|||||f|f||||||No||2017-10-10 21:21:30.427205|2017-10-10 21:21:30.427205
NCT03047174|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-07-05|||May 9, 2017|Actual|2017-05-09|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|RAREST-01||Radiotherapy Related Skin Toxicity: Mepitel® vs. Standard Care in Patients With Locally Advanced Head-and-Neck Cancer|Radiotherapy Related Skin Toxicity: Mepitel® Film vs. Standard Care in Patients With Locally Advanced Head-and-Neck Cancer|Recruiting||N/A|168|Anticipated|University of Schleswig-Holstein||2|||f||||f|f|f||||||||2017-10-10 21:21:30.519114|2017-10-10 21:21:30.519114
NCT03047161|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-02|||February 7, 2017|Actual|2017-02-07|May 2017|2017-05-01|February 5, 2022|Anticipated|2022-02-05|February 5, 2021|Anticipated|2021-02-05||Observational|fMCG||Electrophysiology of Fetal Arrhythmia|Electrophysiology of Fetal Arrhythmia|Recruiting||N/A|150|Anticipated|University of Wisconsin, Madison|||2||||||f|f|t|f|f||Samples Without DNA|"     fetal magnetocardiography and fetal echocardiography recordings   "|No||2017-10-10 21:21:30.708823|2017-10-10 21:21:30.708823
NCT03047148|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-18|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Immediate Post-operative Recovery After Regional vs. General Anesthesia|Immediate Post-operative Outcome After Regional vs. General Anesthesia|Not yet recruiting||N/A|3000|Anticipated|University of Zurich|||2||f||||f|f|f||||||No|No IPD planned.|2017-10-10 21:21:30.824286|2017-10-10 21:21:30.824286
NCT03047135|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-12|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 1, 2022|Anticipated|2022-03-01|March 1, 2021|Anticipated|2021-03-01||Interventional|||Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis|Phase II Study of Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis|Recruiting||Phase 2|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:21:30.920703|2017-10-10 21:21:30.920703
NCT03047122|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-03-20|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Detection of Breast Lesions by Automatic Breast US|Detection of Breast Lesions by Automatic Breast US (Comparison to Current Hand Held US and Pathological Findings When Exist).|Recruiting||N/A|1200|Anticipated|Assuta Medical Center|||1||f||||f|f|f||||||No||2017-10-10 21:21:31.044294|2017-10-10 21:21:31.044294
NCT03047109|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-02-10|||February 7, 2017|Actual|2017-02-07|February 2017|2017-02-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ephedrine and Phenylephrine for Spinal Hypotension|Ephedrine Versus Phenylephrine Infusion for Prevention of Spinal Hypotension During Cesarean Section: Effect on Maternal Cardiodynamics and Fetal Circulation: Randomized Double-blind Study|Recruiting||Phase 2/Phase 3|100|Anticipated|Assiut University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:21:31.139193|2017-10-10 21:21:31.139193
NCT03047096|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-08|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Intra-Articular, Single-shot Injection of Hyaluronic Acid and Corticosteroids in Knee Osteoarthritis|Intra-Articular, Single-shot Injection of Hyaluronic Acid and Corticosteroids in Knee Osteoarthritis|Recruiting||Phase 1|120|Anticipated|Zhongda Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:21:31.246589|2017-10-10 21:21:31.246589
NCT03047083|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-29|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Observational|||Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review|Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia With and Without FLT3 Mutation|Completed||N/A|1042|Actual|Astellas Pharma Inc|||6||f||||f||||||||||2017-10-10 21:21:31.341018|2017-10-10 21:21:31.341018
NCT03047070|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-23|||February 9, 2017|Actual|2017-02-09|June 2017|2017-06-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Interventional|||Lidocaine in Nasal Sinuscopy|Lidocaine Infusion in Functional Endoscopic Sinus Surgery|Recruiting||Phase 2|30|Anticipated|Assiut University||2|||f||||t|f|f||||||No||2017-10-10 21:21:31.449284|2017-10-10 21:21:31.449284
NCT03047057|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-23|||February 9, 2017|Actual|2017-02-09|June 2017|2017-06-01|August 20, 2017|Anticipated|2017-08-20|August 20, 2017|Anticipated|2017-08-20||Interventional|||Ileus After Radical Cystectomy|Lidocaine Infusion in Radical Cystectomy|Recruiting||Phase 2|30|Anticipated|Assiut University||2|||f||||t|f|f||||||No||2017-10-10 21:21:31.544432|2017-10-10 21:21:31.544432
NCT03047044|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-03-23|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|January 30, 2019|Anticipated|2019-01-30|January 15, 2019|Anticipated|2019-01-15||Interventional|||The Comparison of Postoperative Pain After Lumbar Fusion Surgery in Intravenous Patient-controlled Analgesia Between Conventional Mode and Optimizing B.I Mode With 'PAINSTOP' Equipment|The Comparison of Postoperative Pain After Lumbar Fusion Surgery in Intravenous Patient-controlled Analgesia Between Conventional Mode and Optimizing B.I Mode With 'PAINSTOP' Equipment|Recruiting||N/A|68|Anticipated|Yonsei University||2|||f||||t|f|f||||||No||2017-10-10 21:21:31.636256|2017-10-10 21:21:31.636256
NCT03047031|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-07|2017-10-03|||April 6, 2017|Actual|2017-04-06|October 2017|2017-10-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis|An Active Surveillance to Monitor the Real World Safety in Indian Patients Prescribed Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis|Recruiting||N/A|100|Anticipated|Boehringer Ingelheim|||1||f||||f|f|f||||||||2017-10-10 21:21:31.731968|2017-10-10 21:21:31.731968
NCT02989766|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-09-22|||May 2015||2015-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Self-Guided Breastfeeding Program|Preparing Mothers for Feeding Their Newborns: A Self-Guided Program for Pregnant Women|Active, not recruiting||N/A|340|Anticipated|St. Louis University||2|||f||||f||||||||||2017-10-10 21:32:23.583923|2017-10-10 21:32:23.583923
NCT03047005|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-08-28|||August 28, 2017|Actual|2017-08-28|February 2017|2017-02-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy|Behavioral and Pharmacologic Treatment of Binge Eating and Obesity|Enrolling by invitation||Phase 2/Phase 3|88|Anticipated|Yale University||2|||f||||f|t|f||||||||2017-10-10 21:21:31.913326|2017-10-10 21:21:31.913326
NCT03046992|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-07-01|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Clinical Trial of YH25448 in Patients With EGFR Mutation Positive Advanced NSCLC|A Phase I/II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-Tumor Activity of YH25448 in Patients With EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|290|Anticipated|Yuhan Corporation||1|||f||||t|f|f||||||||2017-10-10 21:21:32.035523|2017-10-10 21:21:32.035523
NCT03046979|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-06|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|HCC||Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)|Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)|Recruiting||Phase 2|30|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||f||||||||Undecided|the plan to share IPD is under consideration.|2017-10-10 21:21:32.142938|2017-10-10 21:21:32.142938
NCT03046966|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Manikin To Patient Intubation: Does It Translate?|Manikin To Patient Intubation: Does It Translate?|Not yet recruiting||N/A|95|Anticipated|University of Arkansas||2|||f||||f|f|f||||||||2017-10-10 21:21:32.244169|2017-10-10 21:21:32.244169
NCT03046953|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-09|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|January 2020|Anticipated|2020-01-01||Interventional|AVAIL-T||Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma|A Phase 2a Trial of Avelumab, an Anti-PDL1 Antibody, in Relapsed and Refractory Peripheral T-cell Lymphoma|Not yet recruiting||Phase 2|35|Anticipated|University of Birmingham||1|||f||||f|f|f||||||No||2017-10-10 21:21:32.325254|2017-10-10 21:21:32.325254
NCT03046940|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-06-08|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|||The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication|The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication|Completed||N/A|120|Actual|Philipps University Marburg Medical Center||3|||f|||||f|f||||||||2017-10-10 21:21:32.404228|2017-10-10 21:21:32.404228
NCT03046927|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-08-29|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|PCR||Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes|Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes|Recruiting||Phase 2/Phase 3|40|Anticipated|University of Massachusetts, Worcester||2|||f||||t|t|f|||f|||||2017-10-10 21:21:32.483106|2017-10-10 21:21:32.483106
NCT03046914|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-07|||February 24, 2016|Actual|2016-02-24|February 2017|2017-02-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction|A Prospective Study to Prove the Usefulness of HLA-B*5801 Screening Test for the Prevention of Allopurinol-induced Severe Cutaneous Adverse Reaction in Patient With Chronic Kidney Disease|Recruiting||N/A|600|Anticipated|Seoul National University Hospital||1|||f|||||f|f||||||||2017-10-10 21:21:32.583955|2017-10-10 21:21:32.583955
NCT03046901|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-07|||December 7, 2016|Actual|2016-12-07|February 2017|2017-02-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients|Oral Vancomycin Treatment in Recurrent Primary Sclerosing Cholangitis in Liver Transplant Recipients|Recruiting||N/A|20|Anticipated|Ochsner Health System||1|||f||||||||||||||2017-10-10 21:21:32.792053|2017-10-10 21:21:32.792053
NCT03046888|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-10|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||ROBOTIC PYELOLITHIOTOMY VERSUS PERCUTANEOUS NEPHROLITHOTOMY (PCNL).|ROBOTIC PYELOLITHIOTOMY VERSUS PERCUTANEOUS NEPHROLITHOTOMY (PCNL).|Not yet recruiting||N/A|40|Anticipated|University Hospital Roskilde||2|||f||||t|f|f||||||No||2017-10-10 21:21:32.918562|2017-10-10 21:21:32.918562
NCT03046875|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-07|||October 2016||2016-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TSCS||The Biophysical Impact of Transcutaneous Spinal Cord Stimulation Within a Single Session|The Biophysical Impact of Transcutaneous Spinal Cord Stimulation Within a Single Session|Recruiting||N/A|12|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||t||||||||No||2017-10-10 21:21:33.004006|2017-10-10 21:21:33.004006
NCT03046862|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-25|||February 25, 2017|Actual|2017-02-25|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer|Biomarker-oriented Study of Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer|Recruiting||Phase 2|31|Anticipated|Seoul National University Hospital||1|||f||||t|t|f|||f|||No||2017-10-10 21:21:33.111303|2017-10-10 21:21:33.111303
NCT03046836|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-09-25|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||Oxytocin, Alcohol Craving, and Intimate Partner Aggression|Effects of Oxytocin on Alcohol Craving and Intimate Partner Aggression|Recruiting||Phase 2|200|Anticipated|Medical University of South Carolina||2|||f||||t|t|f||||||||2017-10-10 21:21:33.296603|2017-10-10 21:21:33.296603
NCT03046641|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-02-17|||November 2014|Actual|2014-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||Exercise Duration Models, in Middle-aged Men|The Study of Various Models of Exercise Duration on Weight Loss and Lipid Profile in Sedentary Overweight/Obese Middle-aged Men|Completed||N/A|82|Actual|P.L.Shupik National Medical Academy of Post-Graduate Education||2|||f||||f|f|f||||||No||2017-10-10 21:21:34.935413|2017-10-10 21:21:34.935413
NCT03046823|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-02-06|||June 2014||2014-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Imaging-based Diagnosis of Diffuse Coronary Artery Disease and Quantification of Cardiac Remodeling in Obesity|Imaging-based Diagnosis of Diffuse Coronary Artery Disease and Quantification of Cardiac Remodeling in Obesity|Recruiting||N/A|100|Anticipated|National Heart Centre Singapore|||1||f||||f||||||Samples Without DNA|"     blood specimen for future research   "|Undecided||2017-10-10 21:21:33.393228|2017-10-10 21:21:33.393228
NCT03046810|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-04-24|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|TRIAD-A||Treatment of Incontinence Associated Dermatitis - Automated|Treatment of Incontinence Associated Dermatitis - Automated|Recruiting||N/A|40|Anticipated|SchwabCare||1|||f||||t|f|f||||||No|No plan to share individual participant data at this time|2017-10-10 21:21:33.472892|2017-10-10 21:21:33.472892
NCT03046797|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-03-03|||February 5, 2017|Actual|2017-02-05|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|Obese-FOB||Boussignac Valve and Fibroptic Intubation in Morbidly Obese Patients, Can it be a Solution?|Boussignac Valve and Fibroptic Intubation in Morbidly Obese Patients, Can it be a Solution?|Recruiting||N/A|40|Anticipated|Mansoura University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:21:33.584156|2017-10-10 21:21:33.584156
NCT03046784|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-04-13|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|May 31, 2017|Anticipated|2017-05-31|March 31, 2017|Actual|2017-03-31||Observational|||Non-invasive Haemodynamic Monitoring in Pregnancy|Non-invasive Haemodynamic Monitoring in Pregnancy : Comparison Between Ultrasound and Nexfin Technology|Active, not recruiting||N/A|55|Actual|Hospital Nord|||1||f||||f|f|f||||||No||2017-10-10 21:21:33.690909|2017-10-10 21:21:33.690909
NCT03046771|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-06|||January 19, 2017|Actual|2017-01-19|February 2017|2017-02-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Transport PLUS Intervention|Randomized Controlled Trial Evaluating Efficacy of EMS Providers Performing Discharge Comprehension and Home Fall Hazard Assessments|Recruiting||N/A|100|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|f||||||No||2017-10-10 21:21:33.787067|2017-10-10 21:21:33.787067
NCT03046758|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-28|||February 24, 2017|Actual|2017-02-24|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 2017|Anticipated|2017-11-01||Interventional|||The Safety and Pharmacokinetics of Intraperitoneal Administration in Patients Undergoing Appendectomy for Uncomplicated Appendicitis|The Safety and Pharmacokinetics of Intraperitoneal Administration of Granulocyte-macrophage Colony-stimulating Factor, Fosfomycin, and Metronidazole in Patients Undergoing Appendectomy for Uncomplicated Appendicitis|Recruiting||Phase 2|14|Anticipated|Herlev Hospital||1|||f|||||f|f|||f|||||2017-10-10 21:21:33.897595|2017-10-10 21:21:33.897595
NCT03046745|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-23|||August 2016||2016-08-01|February 2017|2017-02-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Observational|||Gastric Cancer Registry for Epidemiology and Molecular Risk Factor|Analysis and Prediction of Epidemiology and Molecular Biologic Risks of Gastric Cancer by Multicenter Registry|Recruiting||N/A|18000|Anticipated|Kyungpook National University|||2||f||||t||||||Samples Without DNA|"     Serum: pepsinogen I and II, Helicobacter pylori IgG Antibody, serum TFF3 Gastric mucosal     specimen: tumor and normal mucosa   "|Undecided||2017-10-10 21:21:34.01613|2017-10-10 21:21:34.01613
NCT03046732|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-04-27|||July 2016||2016-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||"Implementing Explore Transplant- A Pilot Study"|"Reducing Barriers in Access to Kidney Transplantation: Implementing the Explore Transplant Education Program to Increase Patient Knowledge and to Facilitate Informed Decision Making- A Pilot Study"|Active, not recruiting||N/A|227|Actual|University Health Network, Toronto||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:34.148533|2017-10-10 21:21:34.148533
NCT03046719|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-05|||September 2016||2016-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal|Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal|Completed||N/A|30|Actual|Indonesia University||2|||f||||||||||||||2017-10-10 21:21:34.274463|2017-10-10 21:21:34.274463
NCT03046706|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-09-27|||June 20, 2017|Actual|2017-06-20|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||The Role of Vocal Rest After Removal of Benign Lesions From Vocal Cord|Is Voice Rest Contributes to the Quality of Voice After Surgery to Remove Benign Vocal Cord Lesion?|Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||t|f|f||||||||2017-10-10 21:21:34.392029|2017-10-10 21:21:34.392029
NCT03046693|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-09-05|||January 16, 2017|Actual|2017-01-16|September 2017|2017-09-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|NAION||Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)|Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) : Pattern Electroretinography Study|Completed||Phase 4|38|Actual|Indonesia University||2|||f||||t|f|f|||f|||||2017-10-10 21:21:34.510982|2017-10-10 21:21:34.510982
NCT03046680|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-05|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|December 30, 2017|Anticipated|2017-12-30|June 1, 2017|Anticipated|2017-06-01||Interventional|||Health Coaching Based Treatment Versus Usual Treatment of Systemic Arterial Hypertension and Comorbidities|Health Coaching Based Treatment Versus Usual Treatment of Systemic Arterial Hypertension and Comorbidities|Recruiting||N/A|150|Anticipated|Universidade Federal de Goias||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:34.62732|2017-10-10 21:21:34.62732
NCT03046667|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-05|||February 8, 2017|Anticipated|2017-02-08|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|NEWDRINK||Effect of 6 Weeks Daily Consumption of a Cereal-based Juice Beverage on Gastrointestinal Health|Effect of 6 Weeks Daily Consumption of a Cereal-based Juice Beverage on Gastrointestinal Health|Recruiting||N/A|56|Anticipated|University of Copenhagen||2|||f||||f|f|f||||||Yes|After full anonymization the data may be shared pending acceptance by sponsor approximately 24 months after completion.|2017-10-10 21:21:34.724675|2017-10-10 21:21:34.724675
NCT03046654|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-03-29|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|March 1, 2020|Anticipated|2020-03-01||Interventional|||Cervical Cerclage Position Throughout the Pregnancy.|Cervical Cerclage Position Throughout Pregnancy, it`s Distance From the Inner and Outer Cervical os`, and Implications of the Position on Pregnancy Outcomes.|Recruiting||N/A|40|Anticipated|Rambam Health Care Campus||1|||f||||f|f|f||||||Undecided||2017-10-10 21:21:34.845689|2017-10-10 21:21:34.845689
NCT03046628|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-05|||February 2017||2017-02-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Lower Extremity Tissue Perfusion With Polarized Laser Light|A Feasibility Study of Using Technology Based on Polarized Laser Light and Speed Camera for Non-invasive Tissue Perfusion Assessment of the Lower Extremities|Not yet recruiting||N/A|30|Anticipated|Meir Medical Center||1|||f||||||||||||||2017-10-10 21:21:35.043341|2017-10-10 21:21:35.043341
NCT03046615|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-24|||February 13, 2017|Actual|2017-02-13|March 2017|2017-03-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Intraoperative Non-invasive Eye Movement Monitoring|Intraoperative Non-invasive Eye Movement Monitoring|Enrolling by invitation||N/A|5|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||Undecided||2017-10-10 21:21:35.135195|2017-10-10 21:21:35.135195
NCT03046602|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-05-24|||March 1, 2017|Actual|2017-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 1, 2017|Actual|2017-03-01||Observational|||Parental Real-life Experience During the Neonatal Transfer|Parental Real-life Experience During the Neonatal Transfer From Intensive Care Unit to Maternity Service of St Joseph Hospital|Recruiting||N/A|30|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||No||2017-10-10 21:21:35.223588|2017-10-10 21:21:35.223588
NCT03046589|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-07-27|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|February 1, 2018|Anticipated|2018-02-01||Interventional|||DP13 SAD & MAD in Healthy Male Subjects|A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Oral Dose, Safety, Tolerability, Pharmacodynamic, and Pharmacokinetic Study of DP13 in Healthy Male Subjects|Recruiting||Phase 1|48|Anticipated|Damian Pharma AG||6|||f||||f|f|f|||f|||||2017-10-10 21:21:35.298312|2017-10-10 21:21:35.298312
NCT03046576|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-07-18|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|September 30, 2015|Actual|2015-09-30|September 30, 2015|Actual|2015-09-30||Observational|||Prognostic Value of Plasma DPP4 Activity in ST-elevation Myocardial Infarction Patients|The Association Between Plasma DPP4 Activity And Prognosis of Patients With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention|Completed||N/A|625|Actual|Chinese PLA General Hospital|||1||f|||||f|f||||||||2017-10-10 21:21:35.398868|2017-10-10 21:21:35.398868
NCT03046563|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-22|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|November 2016|Actual|2016-11-01||Interventional|||The Applying of Acupressure and Abdominal Massage to Improving Constipation in Stroke Patients.|The Effectiveness of the Applying of Acupressure and Abdominal Massage to Improving Constipation in Stroke Patients.|Enrolling by invitation||N/A|40|Anticipated|China Medical University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:21:35.461239|2017-10-10 21:21:35.461239
NCT03046550|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-05|||March 20, 2017|Actual|2017-03-20|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults|A Phase I, Double-Blind, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults|Active, not recruiting||Phase 1|24|Actual|Nanotherapeutics, Inc.||3|||f||||t|t|f||||||Undecided||2017-10-10 21:21:35.54022|2017-10-10 21:21:35.54022
NCT03046537|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-12|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Detection of PCOS by Sensors Array|Detection of PCOS and Ovulation Timing by NA-Nose|Not yet recruiting||N/A|200|Anticipated|Meir Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:21:35.623121|2017-10-10 21:21:35.623121
NCT03046524|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-06|||October 6, 2015|Actual|2015-10-06|February 2017|2017-02-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Observational|||Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior|Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center|||2||f||||f|f|f||||||||2017-10-10 21:21:35.680098|2017-10-10 21:21:35.680098
NCT03046511|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-05|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2022|Anticipated|2022-01-31||Interventional|||Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.|Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter. Comparison Between Post - Surgical Intraperitoneal Vs. Intravenous Pre- Surgical Administration|Not yet recruiting||Phase 3|200|Anticipated|Carmel Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:21:35.7555|2017-10-10 21:21:35.7555
NCT03046498|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-06|||February 2, 2017|Actual|2017-02-02|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Addressing Diabetes Together|Addressing Diabetes Together: Implementation of a Regional Partnership for Population Health Management in Southeast Minnesota|Recruiting||N/A|5500|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 21:21:35.820795|2017-10-10 21:21:35.820795
NCT03046485|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-29|2017-02-06|||May 2007||2007-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Use of Self-management Group to Improve Quality of Life in Patients With Low Vision|A Randomized Controlled Trial to Assess if Attending an Interactive, Self-management Group, 'Living With Vision Loss', in Addition to Having Vision Rehabilitation in Our Clinic, Improves Patients' Quality of Life|Withdrawn||N/A|0|Actual|Massachusetts Eye and Ear Infirmary||2||Investigator left institution|f||||f|f|f||||||No||2017-10-10 21:21:35.89749|2017-10-10 21:21:35.89749
NCT03046472|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-07|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Physical Therapy Treatment Once a Month Versus Once a Week for Posture Improvement in Children and Adolescents|Physical Therapy Treatment Once a Month Versus Physical Treatment Once a Week for Posture Improvement in Children and Adolescents Who Suffer From Posture Problem or Low Back Pain|Recruiting||N/A|50|Anticipated|Assuta Hospital Systems||2|||f||||f|f|f||||||No||2017-10-10 21:21:35.981013|2017-10-10 21:21:35.981013
NCT03046459|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-21|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Interventional|||A First-in-Human Study of BNZ132-1-40|A First-in-human Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of BNZ132-1-40|Completed||Phase 1|18|Actual|Bioniz Therapeutics||1|||f||||f|t|f||||||No||2017-10-10 21:21:36.0579|2017-10-10 21:21:36.0579
NCT03046082|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-07|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Anaerobic Antibiotic Usage for Pneumonia in the Medical Intensive Care Unit|Anaerobic Antibiotic Usage for Pneumonia in the Medical Intensive Care Unit|Completed||N/A|192|Actual|Henry Ford Health System|||1||f||||f|f|f||||||Undecided||2017-10-10 21:21:39.172298|2017-10-10 21:21:39.172298
NCT03046446|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-08-31|||February 21, 2017|Actual|2017-02-21|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee|An Open-label Study to Assess the Safety of Repeat Administration of FX006 to Patients With Osteoarthritis of the Knee|Active, not recruiting||Phase 3|200|Anticipated|Flexion Therapeutics, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:21:36.124192|2017-10-10 21:21:36.124192
NCT03046433|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-05-08|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|March 2022|Anticipated|2022-03-01||Observational|||Children-Adult Asthma Cohort Study in China|Children-Adult Asthma Cohort Study in China|Not yet recruiting||N/A|4000|Anticipated|Beijing Children's Hospital|||1||f||||t|f|f||||||No||2017-10-10 21:21:36.219069|2017-10-10 21:21:36.219069
NCT03046420|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-04-13|||January 26, 2017|Actual|2017-01-26|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|August 31, 2017|Anticipated|2017-08-31||Observational|||Hypertension in Long-Term Care Facilities|Hypertension Prevalence, Treatment Patterns and Outcomes in Long-Term Care Facilities|Recruiting||N/A|100|Anticipated|Louisiana State University Health Sciences Center in New Orleans|||1||f||||f|f|f||||||No||2017-10-10 21:21:36.281991|2017-10-10 21:21:36.281991
NCT03046407|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-04-06|||April 2017|Anticipated|2017-04-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells|Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells|Recruiting||Early Phase 1|10|Anticipated|Chinese Academy of Sciences||1|||f||||t|f|f||||||Undecided||2017-10-10 21:21:36.373577|2017-10-10 21:21:36.373577
NCT03046394|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-05-03|||February 6, 2017|Actual|2017-02-06|May 2017|2017-05-01|May 3, 2017|Actual|2017-05-03|February 10, 2017|Actual|2017-02-10||Interventional|ProSto||Comparison Between Three Types of Prosthetic Feet|Comparison Between Three Types of Prosthetic Feet: a Randomized Double-blind Controlled Single-subject Multiple-rater Trial|Completed||N/A|1|Actual|University Rehabilitation Institute, Republic of Slovenia||3|||f||||t|f|f||||||No||2017-10-10 21:21:36.475696|2017-10-10 21:21:36.475696
NCT03046381|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-07-19|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|TOCISCH||Tocilizumab in Patients With Schnitzler's Syndrome|A Pilot Open-label Study to Assess the Efficacy and Safety of Tocilizumab in Patients With Active Schnitzler's Syndrome|Recruiting||Phase 2|12|Anticipated|Charite University, Berlin, Germany||1|||f||||t|f|f||||||||2017-10-10 21:21:36.553821|2017-10-10 21:21:36.553821
NCT03046368|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-04|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Personalization of Cover Letter and Response Rate|Personalization of Cover Letter and Response Rate - a Randomized Controlled Trial in the Danish Health and Morbidity Survey|Enrolling by invitation||N/A|25000|Actual|University of Southern Denmark||11|||f||||t|f|f||||||Undecided||2017-10-10 21:21:36.644312|2017-10-10 21:21:36.644312
NCT03046355|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-07-12|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|September 1, 2019|Anticipated|2019-09-01|May 1, 2019|Anticipated|2019-05-01||Interventional|GROW||Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women|Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women: A Randomized Controlled Trial (GROW Trial)|Recruiting||N/A|320|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|f||||||||2017-10-10 21:21:36.921675|2017-10-10 21:21:36.921675
NCT03046342|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-05|||March 10, 2015|Actual|2015-03-10|January 2017|2017-01-01|March 10, 2019|Anticipated|2019-03-10|March 10, 2019|Anticipated|2019-03-10||Observational|GE||Gastroenteritis in Pediatric Population of Qatar|Epidemiology of Acute Gastroenteritis in the Pediatric Population in Qatar: Causes, Risk Factors, Burden of Disease, Sources and Preventable Measures|Recruiting||N/A|3000|Anticipated|Hamad Medical Corporation|||1||f|||||f|f||||||No||2017-10-10 21:21:37.093678|2017-10-10 21:21:37.093678
NCT03046329|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||June 1, 2015|Actual|2015-06-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans|Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans: Pilot Testing the Impact of Continuing Education and Care Planning on Symptom Management|Completed||N/A|90|Actual|Carevive Systems, Inc.||1|||f||||f|f|f||||||No||2017-10-10 21:21:37.195677|2017-10-10 21:21:37.195677
NCT03046316|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-06-05|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|March 1, 2019|Anticipated|2019-03-01||Interventional|LOCAL||Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy|Local Consolidative Therapy (LCT) in Patients With Advanced Stage Non-small Cell Lung Cancer Who do Not Progress After Front Line Systemic Therapy|Not yet recruiting||N/A|150|Anticipated|Guangdong Association of Clinical Trials||2|||f||||t|f|f||||||No||2017-10-10 21:21:37.280705|2017-10-10 21:21:37.280705
NCT03046303|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-05|||February 20, 2017|Anticipated|2017-02-20|February 2017|2017-02-01|January 30, 2019|Anticipated|2019-01-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Radical Gastrectomy Within Enhanced Recovery Programs(ERAS): a Prospective Randomized Controlled Trial|Radical Gastrectomy Within Enhanced Recovery Programs: a Prospective Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|First Hospital of Jilin University||2|||f|||||f|f||||||No||2017-10-10 21:21:37.404659|2017-10-10 21:21:37.404659
NCT03046290|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-07|||January 2017||2017-01-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Pudendal Block Versus Penian Block For Circumcision In Children|Pudendal Block Versus Penian Block For Circumcision In Children: A Double Blind Randomised Controlled Trial|Recruiting||N/A|60|Anticipated|Université Libre de Bruxelles||2|||f||||f||||||||No||2017-10-10 21:21:37.506644|2017-10-10 21:21:37.506644
NCT03046277|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-03-21|||March 22, 2017|Actual|2017-03-22|March 2017|2017-03-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Observational|||Short- and Long-Term Renal Outcomes Following Lung Transplantation|Short- and Long-Term Renal Outcomes Following Lung Transplantation- A Single-Centre Experience|Recruiting||N/A|120|Anticipated|University of Giessen|||1||f||||f|f|f||||Samples With DNA|"     Collection of only residual material (blood, urine) was done for Deutsche Zentrum für     Lungenforschung Biobank.   "|No||2017-10-10 21:21:37.628059|2017-10-10 21:21:37.628059
NCT03045159|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-02-03|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Strong Families Strong Forces: Supporting Active Duty Families With Very Young Children|Supporting Military Families With Young Children Throughout the Deployment Lifecycle|Recruiting||N/A|300|Anticipated|Boston University||2|||f||||t||||||||Undecided||2017-10-10 21:23:33.12351|2017-10-10 21:23:33.12351
NCT03046264|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-06-02|||September 1, 2013|Actual|2013-09-01|June 2017|2017-06-01|October 30, 2017|Anticipated|2017-10-30|May 31, 2017|Actual|2017-05-31||Observational|MEASURE-cBP1||Invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis|Non-invasive Automated Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis - Comparison With Invasive Reference Values|Active, not recruiting||N/A|100|Anticipated|Universitätsmedizin Mannheim|||1||f||||t|f|f||||||No||2017-10-10 21:21:37.724011|2017-10-10 21:21:37.724011
NCT03046251|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-03|||August 2015|Actual|2015-08-01|February 2017|2017-02-01||||December 2018|Anticipated|2018-12-01||Interventional|NAPPREMS||Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis|Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis|Recruiting||Phase 4|100|Anticipated|State University of New York at Buffalo||2|||f||||f||||||||No||2017-10-10 21:21:37.801977|2017-10-10 21:21:37.801977
NCT03046238|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-23|||February 2, 2017|Actual|2017-02-02|February 2017|2017-02-01|April 2, 2017|Anticipated|2017-04-02|April 2, 2017|Anticipated|2017-04-02||Interventional|||Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients|Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Patient Undergoing Breast Cancer Surgery :A Comparative Study|Recruiting||Phase 3|60|Anticipated|South Egypt Cancer Institute||2|||f||||t|t|f|||t|||Yes||2017-10-10 21:21:37.922|2017-10-10 21:21:37.922
NCT03046199|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-03|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|DISCO||Detection of COPD in Primary Care|Detection of COPD in Primary Care|Not yet recruiting||N/A|4260|Anticipated|Rennes University Hospital||4|||f||||f|f|f||||||No||2017-10-10 21:21:38.224522|2017-10-10 21:21:38.224522
NCT03046186|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-06|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Physiological Effects of Gastric Sleeve Operation|Effect of Gastric Sleeve Operation on Absorption and Metabolism of Glucose and Protein as Well as Gut-hormonal Response - A Comparison With Roux-en-Y Gastric Bypass|Recruiting||N/A|36|Anticipated|Hvidovre University Hospital|||3||f||||t|f|f||||Samples Without DNA|"     Blood and urine samples during mixed meal test with double tracer tecnique using iv tracers     ([D2] Phenylalanine, [ring-D4]Tyrosine, [6,6-2H2]Glucose, [1,1,2,3,3-2H5]Glycerol, [15N2]Urea     and labelled oral tracers ([U13C6]glucose, intrinsically [ring-D5]Phenylalanine).   "|No||2017-10-10 21:21:38.326028|2017-10-10 21:21:38.326028
NCT03046173|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-05|||May 2014||2014-05-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|January 2016|Actual|2016-01-01||Interventional|||Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach|Osteogenic Effects of Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach With Simultaneous Implant Placement: a Single-center Randomized Controlled Trial|Active, not recruiting||N/A|20|Actual|Deyang Stomatological Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:21:38.447337|2017-10-10 21:21:38.447337
NCT03046160|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-07|||April 2016||2016-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effect of Scapulothoracic Mobilization on Cervical Pain and Range of Motion in Patients With Neck Pain and Scapular Dyskinesia||Recruiting||N/A|34|Anticipated|Dammam University||2|||f||||||||||||||2017-10-10 21:21:38.539809|2017-10-10 21:21:38.539809
NCT03046147|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-02-06|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|||The Effect of Roux-en-Y Gastric Bypass on Bone Turnover|Bone Mineral Density and Markers of Bone Turnover After Roux-en-Y Gastric Bypass|Recruiting||N/A|20|Anticipated|Hvidovre University Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Plasma and serum   "|No||2017-10-10 21:21:38.655069|2017-10-10 21:21:38.655069
NCT03046134|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-07-21|||March 3, 2017|Actual|2017-03-03|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01|14 Days|Observational [Patient Registry]|COPDCAP||Burden of Hospitalized Pneumonia in Korea COPD Population|Burden of Hospitalized Pneumonia and Its Clinical Characteristics in Korea COPD Population: A Prospective, Multi-center, Cohort Study|Recruiting||N/A|384|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine|||1||f||||f|f|f||||||||2017-10-10 21:21:38.738917|2017-10-10 21:21:38.738917
NCT03046121|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-04|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|February 28, 2022|Anticipated|2022-02-28|July 31, 2021|Anticipated|2021-07-31||Interventional|||A Family-centered Intervention for Acutely-ill Persons With Dementia|Reducing Disability Via a Family-centered Intervention for Acutely-ill Persons With Alzheimer's Disease and Related Dementias|Not yet recruiting||N/A|438|Anticipated|Penn State University||2|||f||||t|f|f||||||No||2017-10-10 21:21:38.862925|2017-10-10 21:21:38.862925
NCT03046108|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-02-09|||August 2015||2015-08-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Blind and Ultrasound Guided Injection in Morton Neuroma|Comparison Between Blind and Ultrasound Guided Injection in Morton Neuroma|Recruiting||Phase 4|100|Anticipated|Complejo Hospitalario Universitario de Granada||6|||f||||f||||||||Yes|our idea is to publish the short term results and the long term results in order to influence management of this pathology. Tables and statistical analysis will be available for review and metaanalysis.|2017-10-10 21:21:38.956452|2017-10-10 21:21:38.956452
NCT03046095|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-04|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|HYPAT||The Regulation of Human Skeletal Muscle Mass by Contractile Perturbation|The Regulation of Human Skeletal Muscle Mass by Contractile Perturbation|Not yet recruiting||N/A|16|Anticipated|McMaster University||2|||f||||f|f|f||||||No|The individual participant data will not be available to other researchers.|2017-10-10 21:21:39.086819|2017-10-10 21:21:39.086819
NCT03046069|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-09-01|||February 20, 2017|Actual|2017-02-20|September 2017|2017-09-01|November 28, 2017|Anticipated|2017-11-28|November 28, 2017|Anticipated|2017-11-28||Observational|||FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey|FF/UMEC/VI: Qualitative Interviews and Discrete Choice Experiment(s) Evaluating the Perceived Benefits of the Features of FF/UMEC/VI (Single Inhaler Triple Therapy) Treatment in the UK, US and Germany|Recruiting||N/A|573|Anticipated|GlaxoSmithKline|||5||f||||f|f|f||||||||2017-10-10 21:21:39.226665|2017-10-10 21:21:39.226665
NCT03046056|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-06|2017-10-05|||April 11, 2017|Actual|2017-04-11|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)|Recruiting||Phase 2|100|Anticipated|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:21:39.324751|2017-10-10 21:21:39.324751
NCT03046043|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||AF Ablation Based on High Density Voltage Mapping and CFAE|Ablation of Persistent Atrial Fibrillation Based on High Density Voltage Mapping and Complex Fractionated Atrial Electrogram|Not yet recruiting||N/A|50|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||t|f|f||||||Undecided||2017-10-10 21:21:39.43705|2017-10-10 21:21:39.43705
NCT03046030|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-03|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Mechanistic Studies on Video-guided Acupuncture Imagery Treatment of Pain|Mechanistic Studies on Video-guided Acupuncture Imagery Treatment of Pain|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 21:21:39.507843|2017-10-10 21:21:39.507843
NCT03046017|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-07|||January 2018|Anticipated|2018-01-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|||Neuromodulation of Placebo Effect on Chronic Pain Patients|Neuromodulation of Placebo Effect on Chronic Pain Patients|Not yet recruiting||N/A|90|Anticipated|Massachusetts General Hospital||3|||f||||t|f|f||||||||2017-10-10 21:21:39.578492|2017-10-10 21:21:39.578492
NCT03046004|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-09-15|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|September 14, 2017|Actual|2017-09-14||Interventional|InforMa||Effect of Information About the Benefits and Harms of Mammography on Women's Decision Making|The Effect of Receiving Information About the Benefits and Harms of Mammography Screening on Women's Decision Making|Active, not recruiting||N/A|400|Actual|Institut de Recerca Biomèdica de Lleida||2|||f||||f|f|f||||||||2017-10-10 21:21:39.656758|2017-10-10 21:21:39.656758
NCT03045991|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-02-05|||September 2016||2016-09-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Effects and Mechanism of the Sequential Combination of Exercise and Cognitive Training in Stroke Patients|The Effects and Mechanism of the Sequential Combination of Exercise and Cognitive Training on Cognitive Function in Stroke Patients With Cognitive Decline: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 21:21:39.754768|2017-10-10 21:21:39.754768
NCT03045978|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-07|||September 2015||2015-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Association of Hormones and Peptides With Nutritional Consequences in Children With Feeding Difficulty.|The Role of Ghrelin, Leptin, Adiponectin, Neuropeptide Y, Orexin A, Insulin Like Growth Factor-1(IGF-1), IGFBP-1, IGFBP-3, Corticotrophin-releasing Hormone in Feeding and Nutritional Consequences in Children With Feeding Difficulty.|Recruiting||N/A|120|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||Samples Without DNA|"     Venous blood is collected in Serum separation tubes and kept at 4 °C for 1 before being     centrifuged, and the serum is stored at -80 °C.   "|No||2017-10-10 21:21:39.906238|2017-10-10 21:21:39.906238
NCT03045965|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-22|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 2050|Anticipated|2050-12-01|June 2021|Anticipated|2021-06-01||Interventional|HOPPSA||Hysterectomy and OPPortunistic SAlpingectomy|Hysterectomy and Opportunistic Salpingectomy|Recruiting||N/A|4400|Anticipated|Göteborg University||2|||f||||f|f|f||||||||2017-10-10 21:21:39.967808|2017-10-10 21:21:39.967808
NCT03045952|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-02-07|||January 2013||2013-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Percutaneous Microwave Ablation Under Ultrasound Guidance for Liver Cancer: a Multicenter Analysis|Percutaneous Microwave Ablation Under Ultrasound Guidance for Primary Liver Cancer: a Multicenter Analysis|Recruiting||N/A|2000|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||No||2017-10-10 21:21:40.05411|2017-10-10 21:21:40.05411
NCT03045939|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-07-11|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|DoubleCRIB||Cervical Ripening With the Double Balloon Device for 6 Hours Compared With 12 Hours|Cervical Ripening With the Double Balloon Device for 6 Hours Compared With 12 Hours. A Randomized Multicenter Controlled Trial|Recruiting||N/A|200|Anticipated|Bnai Zion Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:21:40.162475|2017-10-10 21:21:40.162475
NCT03045926|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-07-13|||August 2016||2016-08-01|July 2017|2017-07-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea|Assessment of Elemental Impurities Level After Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea|Completed||Phase 1|35|Actual|Ipsen||1|||f||||f||||||||||2017-10-10 21:21:40.27525|2017-10-10 21:21:40.27525
NCT03045913|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-03|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|June 1, 2019|Anticipated|2019-06-01|December 31, 2017|Anticipated|2017-12-31|12 Months|Observational [Patient Registry]|||Genoss DES Prospective Multicenter Registry|Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of GENOSS Sirolimus-eluting Stent in Patients With Coronary Artery Disease (GENOSS Registry)|Recruiting||N/A|2000|Anticipated|Yonsei University|||1||f||||t|f|f||||||No||2017-10-10 21:21:40.379502|2017-10-10 21:21:40.379502
NCT03045900|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-03|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|October 15, 2017|Anticipated|2017-10-15|August 15, 2017|Anticipated|2017-08-15||Interventional|||Measurements of Color Matching and Blending Effect|Measurements of Color Matching and Blending Effect of Translucent and Shaded Bulk-fill Resin Composites [Ex-vivo and In-vivo Study]|Not yet recruiting||N/A|48|Anticipated|Cairo University||2|||f|||||f|f||||||Undecided||2017-10-10 21:21:40.535341|2017-10-10 21:21:40.535341
NCT03045887|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-28|||February 6, 2017|Actual|2017-02-06|August 2017|2017-08-01|August 16, 2017|Actual|2017-08-16|August 11, 2017|Actual|2017-08-11||Interventional|||Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes|A Single-centre, Double-blind (Sponsor Open), Placebo Controlled Two Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 as a Dry Powder in Healthy Participants Who Smoke Cigarettes|Completed||Phase 1|37|Actual|GlaxoSmithKline||10|||f||||f|f|f||||||||2017-10-10 21:23:23.320507|2017-10-10 21:23:23.320507
NCT03045874|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-16|||February 23, 2017|Actual|2017-02-23|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Community Partnership for Healthy Sleep|Community Partnership for Healthy Sleep|Recruiting||N/A|70|Anticipated|Yale University|||3||f||||f||||||||No||2017-10-10 21:23:23.668965|2017-10-10 21:23:23.668965
NCT03045861|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-28|||March 17, 2017|Actual|2017-03-17|September 2017|2017-09-01|November 13, 2017|Anticipated|2017-11-13|November 13, 2017|Anticipated|2017-11-13||Interventional|||Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults|A Phase 2a, Multicenter, Randomized, Adaptive, Open-label, Dose Ranging Study to Evaluate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Cobicistat-boosted GSK2838232 Monotherapy Over 10 Days in HIV-1 Infected Treatment-naive Adults|Recruiting||Phase 2|40|Anticipated|GlaxoSmithKline||4|||f||||f|t|f||||||||2017-10-10 21:23:23.769255|2017-10-10 21:23:23.769255
NCT03045848|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-05-11|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|October 31, 2020|Anticipated|2020-10-31|12 Months|Observational [Patient Registry]|||Biofreedom Prospective Multicenter Observational Registry|Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of Biofreedom Stent in Patients With Coronary Artery Disease (Biofreedom Registry)|Not yet recruiting||N/A|2000|Anticipated|Wonju Severance Christian Hospital|||1||f||||t|f|f||||||Undecided||2017-10-10 21:23:23.918267|2017-10-10 21:23:23.918267
NCT03045835|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-25|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Baska ® Mask Versus Endotracheal Tube in Laparoscopic Cholecystectomy|Baska ® Mask Versus Endotracheal Tube in Laparoscopic Cholecystectomy : A Prospective Randomized Trial|Recruiting||N/A|180|Anticipated|University of Malaya||2|||f||||t|f|f||||||||2017-10-10 21:23:24.118022|2017-10-10 21:23:24.118022
NCT03045822|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-03|||March 18, 2014|Actual|2014-03-18|February 2017|2017-02-01|January 16, 2017|Actual|2017-01-16|February 28, 2016|Actual|2016-02-28||Interventional|||BIA and Cardiac Implantable Electronic Devices|Evaluation of the Impact of Bioimpedance Analysis in Patients With Cardiac Implantable Electronic Devices|Completed||Phase 4|200|Actual|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 21:23:24.197347|2017-10-10 21:23:24.197347
NCT03045809|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-17|||July 5, 2016|Actual|2016-07-05|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|March 14, 2017|Actual|2017-03-14||Observational|WISH||Women's Improvement of Sexual Health (WISH) Demonstration Project|Improving HIV Prevention and Sexual and Reproductive Health Care in High Risk Women in Rwanda Using Lessons Learnt From Previous Rinda Ubuzima Projects|Active, not recruiting||N/A|705|Actual|University of Liverpool|||1||f||||f|f|f||||Samples With DNA|"     The only samples to be retained are two vaginal swabs per participant. If funding permits,     DNA will be extracted for qPCR testing of select urogenital organisms.   "|Undecided|The University of Liverpool and project investigators support open access but university-wide systems are not yet accessible and open access has not yet been negotiated with the Rwandan authorities.|2017-10-10 21:23:24.262827|2017-10-10 21:23:24.262827
NCT03045796|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-05-10|||March 1, 2017|Actual|2017-03-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Hypoxemia in Maintenance Hemodialysis Patients|Cardiac Output and Central-Venous Oxygen Saturation in Maintenance Hemodialysis Patients|Recruiting||N/A|15|Anticipated|University of Illinois at Urbana-Champaign|||1||f||||||||||||||2017-10-10 21:23:24.342517|2017-10-10 21:23:24.342517
NCT03045783|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-02-04|||December 2016||2016-12-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|PUoA-EIoTA||Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices|Efficacy and Safety of Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices: A Multicenter Randomized Controlled Trial|Active, not recruiting||N/A|912|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||No||2017-10-10 21:23:24.417029|2017-10-10 21:23:24.417029
NCT03045770|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-04|||February 10, 2017|Anticipated|2017-02-10|January 2017|2017-01-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA|A Randomized, Parallel Control Trial to Compare mFOLFOX Versus mFOLFIRI Versus FOLFPTX (a Combination of Paclitaxel, Fluorouracil) as First-line Treatment in Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction|Not yet recruiting||N/A|150|Anticipated|Fujian Cancer Hospital||3|||f|||||f|f||||||Undecided||2017-10-10 21:23:24.515126|2017-10-10 21:23:24.515126
NCT03045757|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-21|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|||Evaluating Dysphagia in Neonates With CHD|Evaluating Oral Motor Skills of Neonates Requiring Congenital Heart Surgery and the Impact on Oral Feeding Readiness|Recruiting||N/A|60|Anticipated|Advocate Health Care|||2||f||||f|f|f||||||No||2017-10-10 21:23:24.61324|2017-10-10 21:23:24.61324
NCT03045744|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-08|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Long-term PAS in Rehabilitation After SCI|Long-term Paired Associative Stimulation in Rehabilitation of Spinal Cord Injury Patients|Enrolling by invitation||N/A|5|Anticipated|Helsinki University Central Hospital||1|||f|||||f|f||||||||2017-10-10 21:23:24.687475|2017-10-10 21:23:24.687475
NCT03045731|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-02-04|||January 2016||2016-01-01|January 2017|2017-01-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2019|Anticipated|2019-09-30||Observational|||An US Mathematical Model in Predicting Renal Transplant Rejection|An US Mathematical Model in Predicting Renal Transplant Rejection|Recruiting||N/A|180|Anticipated|Shanghai Zhongshan Hospital|||1||f||||||||||||||2017-10-10 21:23:24.765314|2017-10-10 21:23:24.765314
NCT03045718|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-05|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|December 1, 2019|Anticipated|2019-12-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Effects of Horticultural Therapy on Elderly at Risk of Cognitive Decline|Effects of Horticultural Therapy on Elderly at Risk of Cognitive Decline|Enrolling by invitation||N/A|100|Anticipated|National University Hospital, Singapore||2|||f||||f|f|f||||||No|Individual data will not be shared, in the interests of subject confidentiality|2017-10-10 21:23:24.836501|2017-10-10 21:23:24.836501
NCT03045692|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-06|||February 13, 2017|Anticipated|2017-02-13|February 2017|2017-02-01|April 30, 2019|Anticipated|2019-04-30|February 28, 2019|Anticipated|2019-02-28||Interventional|||Assessment of Kidney Function for Drug Dosage Adjustments in Critically Ill Patients|Reliable Methods to Assess Kidney Function for Drug Dosage Adjustments in Critically Ill Patients - Comparison of Timed Clearance of Creatinine and Creatinine Based Estimated GFR|Not yet recruiting||N/A|172|Anticipated|Samsung Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:23:24.988898|2017-10-10 21:23:24.988898
NCT03045679|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-04-24|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 1, 2019|Anticipated|2019-12-01|March 1, 2018|Anticipated|2018-03-01||Interventional|MGBvsRYGB||One-anastomosis Gastric Bypass/Mini-Gastric Bypass Versus Roux-en Y Gastric Bypass|The Evidence of One-anastomosis Gastric Bypass/Mini-Gastric Bypass Versus Roux-en Y Gastric Bypass in Metabolic Surgery - a Prospective Randomized Controlled Trial|Not yet recruiting||N/A|100|Anticipated|Sana Klinikum Offenbach||2|||f||||f|f|f||||||No||2017-10-10 21:23:25.08429|2017-10-10 21:23:25.08429
NCT03045666|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-04-04|||April 15, 2017|Anticipated|2017-04-15|January 2017|2017-01-01|May 1, 2018|Anticipated|2018-05-01|February 28, 2018|Anticipated|2018-02-28||Interventional|||Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.|The Impact of Macitentan Therapy and Rehabilitation Program on Peak Oxygen Consumption in Patients With Severe Pulmonary Arterial Hypertension|Not yet recruiting||N/A|48|Anticipated|Soroka University Medical Center||2|||f|||||f|f||||||Undecided||2017-10-10 21:23:25.172061|2017-10-10 21:23:25.172061
NCT03045653|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 3, 2018|Anticipated|2018-01-03|October 10, 2017|Anticipated|2017-10-10||Interventional|||Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer|Efficacy and Safety of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Endocrine Therapy Resisted Breast Cancer|Not yet recruiting||Phase 2|30|Anticipated|Sun Yat-sen University||1|||f|||||f|f|||f|||||2017-10-10 21:23:25.246063|2017-10-10 21:23:25.246063
NCT03045640|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-02-03|||October 2014||2014-10-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|FSIECD||Family Strengthening Intervention for Early Childhood Development (ECD)|Adapting a Family Strengthening Intervention (FSI) to Improve Early Childhood Development (ECD) Outcomes|Completed||N/A|55|Actual|Harvard School of Public Health||1|||f||||t||||||||||2017-10-10 21:23:28.09336|2017-10-10 21:23:28.09336
NCT03045627|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-03|||January 2017||2017-01-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients|A Multi-center Randomized Open-label Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of Acute Myeloid Leukemia Patients|Recruiting||Phase 2|120|Anticipated|Shandong University||2|||f||||t||||||||Undecided||2017-10-10 21:23:28.170522|2017-10-10 21:23:28.170522
NCT03045614|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-02-06|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Observational|||Prevalence of Kidney Disease, Hemodynamic Predictors and Long-Term Renal Outcome in Pulmonary Hypertension|Prevalence of Kidney Disease, Hemodynamic Predictors and Long-Term Renal Outcome in Pulmonary Hypertension - A Single Centre, Retrospective Analysis|Recruiting||N/A|1700|Anticipated|University of Giessen|||1||f||||f|f|f||||Samples With DNA|"     Collection of only residual material (blood, urine) for Deutsche Zentrum für Lungenforschung     Biobank.   "|No||2017-10-10 21:23:28.307935|2017-10-10 21:23:28.307935
NCT03045601|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-25|||February 21, 2017|Actual|2017-02-21|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Diagnostic Accuracy of CT-FFR Compared to Invasive Coronar Angiography With Fractional Flow Reserve|Diagnostic Accuracy of Coronary Computed Tomographic Angiography Derived Fractional Flow Reserve Compared to Invasive Coronar Angiography With Fractional Flow Reserve|Recruiting||N/A|200|Anticipated|St. Olavs Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:23:28.394323|2017-10-10 21:23:28.394323
NCT03045588|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-02-06|||October 1, 2016|Actual|2016-10-01|September 2016|2016-09-01|September 1, 2019|Anticipated|2019-09-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||The Effects of a Train High, Sleep Low Strategy|The Effects of a Train High, Sleep Low Strategy on Performance, Substrate Utilization and Muscular Adaptations in Moderately Trained Cyclists|Active, not recruiting||N/A|24|Anticipated|University of Aarhus||2|||f||||t|f|f||||||No||2017-10-10 21:23:28.47969|2017-10-10 21:23:28.47969
NCT03045575|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-03|||August 2, 2016|Actual|2016-08-02|February 2017|2017-02-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer|Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer|Recruiting||N/A|60|Anticipated|University of California, San Francisco|||1||f||||f|f|f||||||No||2017-10-10 21:23:28.541921|2017-10-10 21:23:28.541921
NCT03045562|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-03|||January 20, 2017|Actual|2017-01-20|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|SISTEMI||Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI|Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute ST Segment Elevation Myocardial Infarction After Primary PCI|Recruiting||Phase 4|536|Anticipated|Green Valley Group of China||2|||f||||t|f|f||||||||2017-10-10 21:23:28.629562|2017-10-10 21:23:28.629562
NCT03045549|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-10-03|||December 19, 2016|Actual|2016-12-19|October 2017|2017-10-01|March 30, 2018|Anticipated|2018-03-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||SWORD Phoenix Versus Standard of Care in the Rehabilitation After Total Hip Replacement|Efficacy of Home-based Rehabilitation With SWORD Phoenix Versus Standard of Care After Total Hip Replacement: a Pragmatic Clinical Trial|Recruiting||N/A|54|Anticipated|Sword Health, SA||2|||f||||f|f|f||||||||2017-10-10 21:23:28.719977|2017-10-10 21:23:28.719977
NCT03045536|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-04-24|||January 1, 2016|Actual|2016-01-01|February 2017|2017-02-01|April 1, 2019|Anticipated|2019-04-01|March 1, 2018|Anticipated|2018-03-01||Observational|EFeRe||Evaluation of Partial and Total Femoral Replacement|Evaluation of Partial and Total Femoral Replacement Treated in a Single Orthopedic Centre|Recruiting||N/A|30|Anticipated|Technische Universität München|||1||f||||f|f|f||||||No||2017-10-10 21:23:28.800184|2017-10-10 21:23:28.800184
NCT03045523|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-08-01|||January 2017||2017-01-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis|A Phase IIa, Randomized, Double-blind, Placebo-controlled Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis Harbouring One F508del CFTR Mutation and a Second Gating (Class III) Mutation|Active, not recruiting||Phase 2|37|Actual|Galapagos NV||3|||f||||f||||||||||2017-10-10 21:23:30.104168|2017-10-10 21:23:30.104168
NCT03045510|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-06|||December 1, 2016|Actual|2016-12-01|January 2017|2017-01-01|July 30, 2020|Anticipated|2020-07-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent|A Single-center Prospective Clinical Trial of the Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk Myelodysplastic Syndrome Patients With Transfusion Dependent|Recruiting||Phase 2|50|Anticipated|Shandong University||1|||f||||t||||||||Undecided||2017-10-10 21:23:30.24105|2017-10-10 21:23:30.24105
NCT03045497|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-03|||December 12, 2012|Actual|2012-12-12|February 2017|2017-02-01|December 5, 2013|Actual|2013-12-05|December 5, 2013|Actual|2013-12-05||Interventional|||Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads|Contrast-Enhanced Ultrasound for the Evaluation of Transarterial Chemoembolization With Drug Eluting Beads|Completed||Phase 1|15|Actual|Thomas Jefferson University||1|||||||f|t|f||||||||2017-10-10 21:23:30.321321|2017-10-10 21:23:30.321321
NCT03045484|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-02-03|||May 2016||2016-05-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy|Comparison of Controlled-release Oxycodone to Control Chemoradiotherapy-induced Moderate or Severe Oral Mucositis Pain in Nasopharyngeal Carcinoma Patients|Recruiting||N/A|130|Anticipated|Sun Yat-sen University||2|||f||||f||||||||Undecided||2017-10-10 21:23:30.405381|2017-10-10 21:23:30.405381
NCT03045471|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-06|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma|The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma|Not yet recruiting||N/A|50|Anticipated|Shanghai Public Health Clinical Center|||2||f||||f|t|f|||f|||Undecided||2017-10-10 21:23:30.494824|2017-10-10 21:23:30.494824
NCT03045458|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-06|||September 1, 2010|Actual|2010-09-01|February 2017|2017-02-01|June 1, 2011|Actual|2011-06-01|October 1, 2010|Actual|2010-10-01||Interventional|||Associations of Alveolar Bone Loss and Interleukin-1β Levels in One and Two Stage Surgical Procedures|Associations of Alveolar Bone Loss, Clinical Parameters and Interleukin-1β Levels in One and Two Stage Surgical Procedures: A Randomized Prospective Trial|Completed||N/A|40|Actual|Firat University||2|||f||||f|f|t|f|||||No|Individual participant data can not be used another purpose such as meta-analyses, reanalysis, or replication of results.|2017-10-10 21:23:30.565597|2017-10-10 21:23:30.565597
NCT03045445|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-04|2017-05-30|||May 30, 2017|Actual|2017-05-30|May 2017|2017-05-01|December 20, 2018|Anticipated|2018-12-20|August 20, 2018|Anticipated|2018-08-20||Interventional|||"Double Low-Dose DECT for HCC Imaging"|"Comparison of Image Quality Between Double Low-Dose Dual Energy Liver CT and Standard Contrast Enhanced Liver CT in Patients at High-risk of HCC: Prospective, Randomized Single Center Study"|Recruiting||N/A|68|Anticipated|Seoul National University Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:23:30.642781|2017-10-10 21:23:30.642781
NCT03045432|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-05|2017-02-05|||August 1, 2007|Actual|2007-08-01|January 2017|2017-01-01|June 30, 2009|Actual|2009-06-30|July 31, 2008|Actual|2008-07-31||Interventional|||Shoulder Passive Range of Motion and Positioning Exercise on Hemiplegic Stroke Patients|Passive Range of Motion and Position Training for Stroke Patients With Hemiplegia to Prevent Shoulder Injury or Pain- Ultrasonographic Study|Completed||N/A|104|Actual|Chang Gung Memorial Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:23:30.726001|2017-10-10 21:23:30.726001
NCT03045419|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-03|||December 29, 2009|Actual|2009-12-29|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|November 24, 2013|Actual|2013-11-24||Observational|||Added Value of Gadoxetic Acid-enhanced Liver MRI|Added Value of Gadoxetic Acid-enhanced Liver Magnetic Resonance Imaging for Diagnosis of Small (10-19 mm) or Atypical Hepatic Nodules at Contrast-enhanced Computed Tomography: A Prospective Study|Completed||N/A|130|Actual|Seoul National University Hospital|||2||f||||t||f||||||No||2017-10-10 21:23:30.896695|2017-10-10 21:23:30.896695
NCT03045406|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-28|||April 13, 2017|Actual|2017-04-13|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|CARAVAGGIO||Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer|Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer: A Prospective Randomized Open Blinded End-Point (Probe) Study|Recruiting||Phase 3|1168|Anticipated|Fadoi Foundation, Italy||2|||f||||t|f|f||||||||2017-10-10 21:23:30.980787|2017-10-10 21:23:30.980787
NCT03045393|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-04-30|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|December 1, 2020|Anticipated|2020-12-01|March 1, 2019|Anticipated|2019-03-01||Interventional|IMGN853||Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC|Pilot Study of Mirvetuximab Soravtansine (IMGN853) in Folate Receptor Alpha (FRα)-Expressing, Triple Negative Breast Cancer (TNBC) With Residual Disease Post Standard Neoadjuvant Chemotherapy|Recruiting||Phase 1|15|Anticipated|Duke University||1|||f||||f|t|f||||||||2017-10-10 21:23:31.083361|2017-10-10 21:23:31.083361
NCT03045380|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Video Game Based Physical Activity Training in Persons With Multiple Sclerosis|Effect of Video Game Based Physical Activity Training on Upper Extremity Functions, Walking, Balance and Cognitive Functions in Persons With Multiple Sclerosis|Recruiting||N/A|51|Anticipated|Dokuz Eylul University||3|||f||||f|f|f||||||No||2017-10-10 21:23:31.212927|2017-10-10 21:23:31.212927
NCT03045367|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-03|||June 22, 2015|Actual|2015-06-22|February 2017|2017-02-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31|180 Days|Observational [Patient Registry]|||Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery|Mid-term Clinical Assessment and Correlation Between Metamorphopsia, Visual Acuity and Foveal Thickness in Idiopathic Epiretinal Membrane and Cataract Surgery|Completed||N/A|30|Actual|Clinica Oculistica dell'Università di Torino|||1||f||||t|f|f||||||Undecided||2017-10-10 21:23:31.329725|2017-10-10 21:23:31.329725
NCT03045354|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-07-05|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|June 2017|Actual|2017-06-01||Interventional|||Dietary Carbohydrate Consumption at Breakfast on Food Intake, Glycemic Response, and Subjective Appetite|The Effect of Carbohydrate-Containing Foods at Breakfast on Food Intake, Glycemic Response, and Subjective Appetite in Normal Weight and Overweight/Obese Children|Active, not recruiting||N/A|22|Actual|Ryerson University||5|||f||||f|f|f||||||||2017-10-10 21:23:31.397591|2017-10-10 21:23:31.397591
NCT03045341|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-03-02|||February 27, 2017|Actual|2017-02-27|February 2017|2017-02-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment|Behavioral and Pharmacologic Treatment of Binge Eating and Obesity|Recruiting||Phase 2/Phase 3|160|Anticipated|Yale University||4|||f||||f|t|f||||||||2017-10-10 21:23:31.489743|2017-10-10 21:23:31.489743
NCT03045328|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-10-02|||September 26, 2017|Actual|2017-09-26|October 2017|2017-10-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL|An Open Label Phase 2 Trial of Venetoclax With Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Recruiting||Phase 2|20|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 21:23:31.608433|2017-10-10 21:23:31.608433
NCT03045315|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-07|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|||LXR and Oocyte Meiosis Resumption|Are LXRs Involved in Regulation of Human Oocyte Meiosis Resumption?|Recruiting||N/A|250|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 21:23:31.730444|2017-10-10 21:23:31.730444
NCT03045302|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-07-25|||January 26, 2017|Actual|2017-01-26|July 2017|2017-07-01|June 2, 2017|Actual|2017-06-02|May 17, 2017|Actual|2017-05-17||Interventional|DOPAACRO 002||Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly|A Phase IIa, Open-label, Single-arm, Two Stage, Multi-centre Study to Investigate the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Repeated Subcutaneous Administration of BIM23B065 in Subjects With Acromegaly|Terminated||Phase 2|4|Actual|Ipsen||1||"Early termination is a sponsor decision. No new safety signal or serious adverse event has been   observed."|f||||f|f|f||||||||2017-10-10 21:23:31.816507|2017-10-10 21:23:31.816507
NCT03045289|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-07-31|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer|Whole-Food, Plant-Based Nutrition and Group Education Among Women With Metastatic Breast Cancer: A Pilot Study of Recruitment, Retention, and Preliminary Changes in Biomarkers and Symptoms.|Not yet recruiting||N/A|60|Anticipated|University of Rochester||2|||f||||t|f|f||||||||2017-10-10 21:23:31.945958|2017-10-10 21:23:31.945958
NCT03045276|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-07|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|January 2023|Anticipated|2023-01-01|January 2022|Anticipated|2022-01-01||Interventional|U-REAACT||Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial|Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial|Recruiting||N/A|400|Anticipated|Children's Hospital of Philadelphia||2|||f||||t|f|f||||||||2017-10-10 21:23:32.046238|2017-10-10 21:23:32.046238
NCT03045263|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-04-21|||February 2, 2017|Actual|2017-02-02|February 2017|2017-02-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|PRT||Pivotal Response Treatment (PRT) Telemedicine|Pivotal Response Treatment Telemedicine|Recruiting||N/A|12|Anticipated|Yale University||2|||f||||t|f|f||||||||2017-10-10 21:23:32.196245|2017-10-10 21:23:32.196245
NCT03045250|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-03|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|CCM||Corneal Confocal Microscopy in Patients With Type 1 Diabetes|Corneal Confocal Microscopy in Patients With Type 1 Diabetes|Not yet recruiting||N/A|100|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t|f|t|f|f||||||2017-10-10 21:23:32.294827|2017-10-10 21:23:32.294827
NCT03045237|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-04-08|||November 1, 2015|Actual|2015-11-01|April 2017|2017-04-01|August 31, 2018|Anticipated|2018-08-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Healthy Bellies - Intervention Program During Pregnancy on Women and Newborn|Sporty Bellies - Intervention Program During Pregnancy on Women and Newborn|Recruiting||N/A|410|Anticipated|University of Minho||2|||f|||||f|f||||||Undecided||2017-10-10 21:23:32.400222|2017-10-10 21:23:32.400222
NCT03045224|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||August 2008||2008-08-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|August 2014|Actual|2014-08-01|2 Years|Observational [Patient Registry]|PTAReg||PTA-Registry, a Prospective, Multicenter Study With 24-Month Follow-up|Endovascular Treatment in Patients With Peripheral Artery Disease: Real Life Effectiveness Off the Road of Studies PTA-Registry, a Prospective, Multicenter Study With 24-Month Follow-up|Completed||N/A|1760|Actual|Vascular Center Berlin|||1||f||||t|f|f||||||No||2017-10-10 21:23:32.498948|2017-10-10 21:23:32.498948
NCT03045211|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-03|||September 2016||2016-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Post-Physical Therapy Extension of In-Home Dynamic Standing Table Use in Parkinson Disease||Recruiting||N/A|24|Anticipated|University of Michigan||2|||f||||f||||||||No||2017-10-10 21:23:32.557581|2017-10-10 21:23:32.557581
NCT03045198|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-04-05|||March 2012||2012-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Azithromycin on Fatty Acids in CF|Effect of Azithromycin on Lipoproteins and Docosahexaenoic Acid in Patients With Cystic Fibrosis|Enrolling by invitation||Phase 4|20|Anticipated|University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn)||1|||f||||f|t|f|||f|||Undecided||2017-10-10 21:23:32.812938|2017-10-10 21:23:32.812938
NCT03045185|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-06|||January 1, 2013|Actual|2013-01-01|February 2017|2017-02-01|January 1, 2017|Actual|2017-01-01|January 1, 2015|Actual|2015-01-01||Interventional|||Regenerative Endodontic Treatment of Traumatised Teeth|A Prospective Clinical Study of Regenerative Endodontic Treatment of Traumatised Non-vital Immature Teeth Using Bi-antibiotic Paste|Completed||N/A|15|Actual|University of Leeds||1|||f||||f|f|f||||||No|Not planning on IPD|2017-10-10 21:23:32.908322|2017-10-10 21:23:32.908322
NCT03045172|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-03|||November 2016||2016-11-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Platelet Rich Plasma (PRP) for Vulvar Lichen Sclerosus|A Double Blind Placebo Controlled Trial of Autologous Platelet Rich Plasma (PRP) Intradermal Injections for the Treatment of Vulvar Lichen Sclerosus|Recruiting||N/A|30|Anticipated|Center for Vulvovaginal Disorders||2|||f||||f|f|f||||||No||2017-10-10 21:23:33.000352|2017-10-10 21:23:33.000352
NCT03045146|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-10-04|||January 31, 2017|Actual|2017-01-31|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|March 31, 2017|Actual|2017-03-31||Observational|FRAME||FRench Acute Cerebral Multimodal Imaging to Select Patient for MEchanical Thrombectomy|FRench Acute Cerebral Multimodal Imaging to Select Patient for MEchanical Thrombectomy|Recruiting||N/A|220|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||||2017-10-10 21:23:33.229574|2017-10-10 21:23:33.229574
NCT03045120|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-12|||March 29, 2017|Actual|2017-03-29|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|January 2021|Anticipated|2021-01-01||Observational|||Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States|Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States|Recruiting||N/A|200|Anticipated|Bristol-Myers Squibb|||3||f||||f||||||Samples With DNA|"     biomarker analyses will be collected for metabolic panels   "|||2017-10-10 21:23:33.445105|2017-10-10 21:23:33.445105
NCT03045107|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-05-01|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|July 30, 2020|Anticipated|2020-07-30|January 31, 2020|Anticipated|2020-01-31||Interventional|||Intracorporeal or Extracorporeal Anastomosis After Laparoscopic Right Colectomy.|Intracorporeal or Extracorporeal Ileocolic Anastomosis After Laparoscopic Right Colectomy.|Recruiting||N/A|140|Anticipated|University of Turin, Italy||2|||f||||t|f|f||||||No||2017-10-10 21:23:33.617168|2017-10-10 21:23:33.617168
NCT03045094|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-06|||February 20, 2017|Anticipated|2017-02-20|February 2017|2017-02-01|March 1, 2018|Anticipated|2018-03-01|October 31, 2017|Anticipated|2017-10-31||Observational|||Neck Movement Implicate the Tracheal Tube-tip Displacement in Pediatric Surgery|Neck Flexion and Extension Implicate the Tracheal Tube-tip Displacement in Children Undergoing Head and Neck Surgeries|Not yet recruiting||N/A|180|Anticipated|Beijing Tsinghua Chang Gung Hospital|||1||f||||f|f|f||||||Yes||2017-10-10 21:23:33.770559|2017-10-10 21:23:33.770559
NCT03045081|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-15|||April 2016||2016-04-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PTSM||PainTracker Self-Manager: a Web-based Platform to Promote and Track Chronic Pain Self-management|PainTracker Self-Manager: Development and Testing of a Web-based Platform to Promote and Track Chronic Pain Self-management and Other Treatment Outcomes|Active, not recruiting||N/A|100|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 21:23:33.866003|2017-10-10 21:23:33.866003
NCT03045068|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-04-21|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|April 11, 2018|Anticipated|2018-04-11||Interventional|CPB||Platelet Transfusion During Neonatal Open Heart Surgery|Platelet Transfusion During Neonatal Open Heart Surgery|Recruiting||N/A|44|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|f||||||No||2017-10-10 21:23:33.944755|2017-10-10 21:23:33.944755
NCT03045055|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|RICPETAIS||Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke|A Proof-of-Concept Pilot Study Assessing Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke|Not yet recruiting||Phase 1/Phase 2|120|Anticipated|Capital Medical University||2|||f||||t|f|f||||||Yes||2017-10-10 21:23:34.078889|2017-10-10 21:23:34.078889
NCT03045042|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-03-17|||April 2017|Anticipated|2017-04-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|BIOPOMPE||Search for Serum/Plasma Biomarkers in Pompe's Disease|Search for Serum/Plasma Biomarkers in Pompe's Disease|Not yet recruiting||N/A|35|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||t|f|f||||Samples Without DNA|"     Plasma and serum samples   "|No||2017-10-10 21:23:34.170693|2017-10-10 21:23:34.170693
NCT03045029|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-29|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|52 Weeks|Observational [Patient Registry]|ADAPT||ADAPT - A Patient Registry of the Real-world Use of Orenitram®|ADAPT - A Patient Registry of the Real-world Use of Orenitram®|Recruiting||N/A|300|Anticipated|United Therapeutics|||1||f||||f|t|f||||||||2017-10-10 21:23:34.277167|2017-10-10 21:23:34.277167
NCT03045016|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-08|||April 21, 2017|Actual|2017-04-21|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|PRAZOSTRESS||Efficacy of Prazosin in Preventing Post-traumatic Stress Disorder|Preliminary Study About the Efficacy of an α1 Blocker (Prazosin) in Preventing the Occurrence of Post-traumatic Stress Disorder (PTSD) in Patients With Acute Stress|Recruiting||Phase 2|24|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:23:34.442307|2017-10-10 21:23:34.442307
NCT03045003|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-07|||January 1, 2014|Actual|2014-01-01|February 2017|2017-02-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|RESIL||Testing Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients|Testing the Feasibility and Efficacy of Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients: A Phase II TriaL|Completed||N/A|86|Actual|University of Lausanne||2|||f||||f|f|f||||||No||2017-10-10 21:23:34.537171|2017-10-10 21:23:34.537171
NCT03044990|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-03|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Observational|PACS-RI||Prognosis of Patients With Acute Coronary Syndrome Complicated With Renal Insufficiency(PACS-RI)|Study on the Prognosis of Patients With Acute Coronary Syndrome Complicated With Renal Insufficiency: a Prospective, Multicenter, Observational Study|Recruiting||N/A|2000|Anticipated|Henan Institute of Cardiovascular Epidemiology|||1||f||||t||||||||||2017-10-10 21:23:34.606699|2017-10-10 21:23:34.606699
NCT03044977|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-31|||May 7, 2017|Actual|2017-05-07|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors|Phase 1 Trial Using 131I MIBG and 90Y DOTATOC in a Dosimetrically Determined Optimal Combination for Therapy of Selected Patients With Midgut Neuroendocrine Tumors.|Recruiting||Early Phase 1|20|Anticipated|University of Iowa||8|||f||||t|t|f||||||Yes|Information will be distributed via clinicaltrials.gov and shared as per the filed NIH data sharing plan|2017-10-10 21:23:34.682138|2017-10-10 21:23:34.682138
NCT03044964|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-03|||January 10, 2017|Actual|2017-01-10|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|REPTAR||Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention (REPTAR)|Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention|Recruiting||Phase 4|40|Anticipated|Stern Cardiovascular Foundation, Inc.||2|||f||||f||||||||No||2017-10-10 21:23:34.796089|2017-10-10 21:23:34.796089
NCT03044951|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-06|||November 2016||2016-11-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|CRYO-AF||Comparison of RF and crYoballoon ablatiOn Therapy of AF（CRYO-AF）|Cryoballoon Versus Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation: A Multi-center, Prospective, Randomized, Controlled Study|Recruiting||N/A|600|Anticipated|Ruijin Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:23:34.89475|2017-10-10 21:23:34.89475
NCT03044938|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-02|||August 6, 2016|Actual|2016-08-06|February 2017|2017-02-01|November 21, 2016|Actual|2016-11-21|August 6, 2016|Actual|2016-08-06||Interventional|||Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy Subjects|Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy Subjects: Randomized, Double-blind, and Crossover Study|Completed||Phase 4|15|Actual|Universidade Ibirapuera||2|||f||||t|f|f||||||No||2017-10-10 21:23:34.979181|2017-10-10 21:23:34.979181
NCT03044925|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-06|||November 1, 2016|Actual|2016-11-01|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|RECREATION||Remote Magnetic Navigation-guided Ablation Versus Cryoablation for Persistent Atrial Fibrillation (RECREATION Study)|Remote Magnetic Navigation-guided Ablation Versus Cryoablation for Persistent Atrial Fibrillation: A Prospective, Controlled Study|Active, not recruiting||N/A|200|Anticipated|Ruijin Hospital||2|||f|||||f|f||||||Undecided||2017-10-10 21:23:35.077127|2017-10-10 21:23:35.077127
NCT03044912|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-07|||November 16, 2015|Actual|2015-11-16|February 2017|2017-02-01|August 1, 2019|Anticipated|2019-08-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan|Therapeutic Efficacy and Safety of Mirabegron , a β3-Adrenoceptor Agonist, Treatment on Patients With Overactive Bladder Syndrome in Taiwan - Comparison of Therapeutic Efficacy and Safety Between 25mg and 50mg|Recruiting||Phase 3|574|Anticipated|Buddhist Tzu Chi General Hospital||2|||f||||t|t|f|||f|||No|IPD is not planned to be available|2017-10-10 21:23:35.166367|2017-10-10 21:23:35.166367
NCT03044899|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-03|||February 1, 2016|Actual|2016-02-01|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30|30 Days|Observational [Patient Registry]|ASOS||African Surgical Outcomes Study (ASOS)|African Surgical Outcomes Study (ASOS): An African, Multi-centre Seven Day Evaluation of Patient Care and Clinical Outcomes for Patients Undergoing Surgery|Completed||N/A|11422|Actual|University of KwaZulu|||1||f||||f|f|f||||||Undecided||2017-10-10 21:23:35.264312|2017-10-10 21:23:35.264312
NCT03044886|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-10|||January 2013||2013-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effects of Vitamin D on Moderate to Severe Periodontitis|Effects of Vitamin D on Chronic Periodontitis|Completed||N/A|323|Actual|Beijing Chao Yang Hospital||3|||f||||f||||||||No||2017-10-10 21:23:35.492396|2017-10-10 21:23:35.492396
NCT03044873|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-04-13|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|March 27, 2017|Actual|2017-03-27|March 14, 2017|Actual|2017-03-14||Interventional|||Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin|Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin|Completed||Phase 1|20|Actual|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 21:23:35.577601|2017-10-10 21:23:35.577601
NCT03044860|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-14|||March 2011||2011-03-01|February 2017|2017-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Anatomical and Physiological Characterisation of the Gut Endocrine Cells in Healthy and in Patients With Type 2 Diabetes|Enteroendocrine Cells in Healthy Individuals and Patients With Type 2 Diabetes|Completed||N/A|24|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||Undecided||2017-10-10 21:23:35.656516|2017-10-10 21:23:35.656516
NCT03044847|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-06|||July 2016||2016-07-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China|The Cohort Study for Chronic Obstructive Pulmonary Diseases (COPD) in China---- Observation of the Disease Outcome and Identification of Prognostic Biomarkers for the Disease Outcome|Recruiting||N/A|3800|Anticipated|Beijing Chao Yang Hospital|||2||f||||t||||||Samples With DNA|"     whole blood   "|Yes||2017-10-10 21:23:35.725428|2017-10-10 21:23:35.725428
NCT03044834|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-03|||January 2017||2017-01-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|PPB||Review of the Paediatric Pleuropulmonary Blastoma French Series|Review of the Paediatric Pleuropulmonary Blastoma French Series|Recruiting||N/A|40|Anticipated|Rennes University Hospital|||1||f||||f||||||||||2017-10-10 21:23:35.819898|2017-10-10 21:23:35.819898
NCT03044821|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-02-03|||May 2016||2016-05-01|February 2017|2017-02-01||||May 2020|Anticipated|2020-05-01||Interventional|||Open Myelomeningocele Repair With High Maternal BMI|Open Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 And 40.0|Recruiting||N/A|15|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 21:23:35.99933|2017-10-10 21:23:35.99933
NCT03044808|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-09-18|||February 2, 2016|Actual|2016-02-02|September 2017|2017-09-01|April 19, 2017|Actual|2017-04-19|April 19, 2017|Actual|2017-04-19||Interventional|||Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery|Randomized Double Blind Prospective Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery|Completed||Phase 4|60|Actual|Odense University Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:23:36.078294|2017-10-10 21:23:36.078294
NCT03044795|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-06-01|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|REPAIR||Response to PARP Inhibitor Predicted by the RAD51 Assay|Phase II Study With PARP Inhibitor Veliparib (ABT-888) in Patients With Increased Risk of Homologous Recombination Deficiency to Determine the Value of an (Ex-vivo) RAD51 Assay as a Biomarker|Not yet recruiting||Phase 2|100|Anticipated|University Medical Center Groningen||2|||f||||t|f|f||||||No||2017-10-10 21:23:36.165151|2017-10-10 21:23:36.165151
NCT03044782|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-02-03|||August 2016||2016-08-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|1 Year|Observational [Patient Registry]|||Barriers to Care and QOL for CCCA Patients|Barriers to Healthcare and Quality of Life for Central Centrifugal Cicatricial Alopecia Patients|Enrolling by invitation||N/A|50|Anticipated|Northwestern University|||1||f||||f||||||||Undecided||2017-10-10 21:23:36.289965|2017-10-10 21:23:36.289965
NCT03044769|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-02|||April 1, 2016||2016-04-01|February 2017|2017-02-01|April 1, 2026|Anticipated|2026-04-01|January 1, 2020|Anticipated|2020-01-01|10 Years|Observational [Patient Registry]|CLADatabase||Congenital Lung Anomalies (CLA) Swiss Database|Follow up of Congenital Lung Anomalies (CLA) With Antenatal Diagnosis - a Swiss Multicentric Database|Recruiting||N/A|100|Anticipated|University Hospital, Geneva|||2||f||||f|f|f||||Samples With DNA|"     To create a biobank with the different samples of patients undergoing surgery, healthy edge     of resections being considered as control tissue. Leukocyte DNA will be compared with lung     tissue DNA.   "|Undecided||2017-10-10 21:23:36.388531|2017-10-10 21:23:36.388531
NCT03044756|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-06|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|December 30, 2017|Anticipated|2017-12-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Omitting GnRH-antagonist Dose on the Day of Ovulation Trigger|Impact of Omitting GnR-antagonist on Ovulation Trigger Day in the Fresh Autologous IVF/ICSI Cycles|Recruiting||Phase 2/Phase 3|100|Anticipated|Assiut University||2|||f||||t|f|f||||||No|The regulations in Assiut University do not allow protected patient data sharing|2017-10-10 21:23:36.531353|2017-10-10 21:23:36.531353
NCT03044743|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-04-28|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|||PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies|A Phase I/II Trial of PD-1 Knockout EBV-CTLs for Advanced Stage EBV Associated Malignancies|Recruiting||Phase 1/Phase 2|20|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||f|f|f||||||Undecided||2017-10-10 21:23:36.624591|2017-10-10 21:23:36.624591
NCT03044730|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-06-06|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|March 2021|Anticipated|2021-03-01||Interventional|||Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery|Phase II Study of Pembrolizumab and Capecitabine for Advanced Triple Negative and Hormone-Refractory Breast Cancer|Recruiting||Phase 2|30|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 21:23:36.769745|2017-10-10 21:23:36.769745
NCT03044717|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-06|||February 2, 2017|Actual|2017-02-02|September 2017|2017-09-01|January 29, 2018|Anticipated|2018-01-29|January 29, 2018|Anticipated|2018-01-29||Observational|||Nutrition Education in Fellows|How Nutrition Education in Cardiology Fellows and Faculty Affects Clinical Practice Over a Six-Month Period|Recruiting||N/A|15|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-10 21:23:36.884667|2017-10-10 21:23:36.884667
NCT03044704|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-27|||February 6, 2017|Actual|2017-02-06|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|January 31, 2018|Anticipated|2018-01-31||Observational|ANGLE||Haemodynamic and Geometric Factors in Atherosclerosis|Influence of Haemodynamic and Geometric Factors on the Onset and Progression of Atherosclerosis|Recruiting||N/A|100|Anticipated|Medical University Innsbruck|||1||f||||f|f|f||||||||2017-10-10 21:23:36.976171|2017-10-10 21:23:36.976171
NCT03044691|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-09-18|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|December 28, 2019|Anticipated|2019-12-28|August 28, 2019|Anticipated|2019-08-28||Interventional|||The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care|The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care|Recruiting||N/A|1334|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 21:23:37.063145|2017-10-10 21:23:37.063145
NCT03044678|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-06|||January 1, 2010|Actual|2010-01-01|February 2017|2017-02-01|January 1, 2015|Actual|2015-01-01|January 1, 2015|Actual|2015-01-01||Interventional|||School Based Prevention for Childhood Anxiety|School Based Prevention for Childhood Anxiety|Completed||N/A|109|Actual|Arizona State University||2|||f||||t|f|f||||||No||2017-10-10 21:23:37.17445|2017-10-10 21:23:37.17445
NCT03044665|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-23|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|February 15, 2022|Anticipated|2022-02-15|January 15, 2022|Anticipated|2022-01-15||Interventional|||RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)|RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)|Recruiting||N/A|3780|Anticipated|Yonsei University||2|||f||||f|f|f||||||No||2017-10-10 21:23:37.2723|2017-10-10 21:23:37.2723
NCT03044652|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-11|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol|Prospective, Open-label, Multicenter, Multinational, Randomized Trial to Investigate the Non-inferiority of Treatment With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol in a Panel of Post-menopausal Women Suffering From the Symptoms of Vulvovaginal Dryness in a Parallel Group Design|Completed||Phase 4|172|Actual|Dr. August Wolff GmbH & Co. KG Arzneimittel||2|||f||||f||||||||||2017-10-10 21:23:37.381978|2017-10-10 21:23:37.381978
NCT03044639|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-02|||April 1, 2010|Actual|2010-04-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|October 31, 2016|Actual|2016-10-31||Interventional|||Parenteral Lipid Emulsions and the Liver Function|Four Parenteral Lipid Emulsions and the Liver Function|Completed||Phase 4|64|Actual|Stanley Dudrick's Memorial Hospital||4|||f||||f|f|f||||||No||2017-10-10 21:23:37.486994|2017-10-10 21:23:37.486994
NCT03044613|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-14|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Nivolumab or Nivolumab/Ipilimumab Prior to Chemoradiation Plus Nivolumab With II/III Gastro/Esophageal Cancer|Phase IB Trial of Induction Nivolumab or Nivolumab/Ipilimumab Prior to Concurrent Chemoradiation Plus Nivolumab in Patients With Operable Stage II/III Esophageal/ Gastroesophageal Junction Cancer|Recruiting||Phase 1|32|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:23:37.717286|2017-10-10 21:23:37.717286
NCT03044600|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-03|||November 7, 2012|Actual|2012-11-07|February 2017|2017-02-01|November 1, 2022|Anticipated|2022-11-01|November 1, 2022|Anticipated|2022-11-01||Observational|||Gene Expression in Hyperparathyroidism|Gene Expression in Hyperparathyroidism: Identifying Molecular Differences in MEN1 Patients Versus Young MEN1 Negative Patients|Recruiting||N/A|130|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||Samples With DNA|"     Parathyroid tissue previously obtained during surgery.   "|||2017-10-10 21:23:37.864102|2017-10-10 21:23:37.864102
NCT03044587|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-08-08|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|January 2024|Anticipated|2024-01-01|October 2018|Anticipated|2018-10-01||Interventional|NIFE||Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer|Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer - An Open Label, Non-comparative, Randomized, Multicenter Phase II Trial|Not yet recruiting||Phase 2|92|Anticipated|AIO-Studien-gGmbH||2|||f||||f|f|f||||||||2017-10-10 21:23:37.953674|2017-10-10 21:23:37.953674
NCT03044574|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|July 31, 2018|Anticipated|2018-07-31|January 31, 2018|Anticipated|2018-01-31||Interventional|IPCSUPER||Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism|Trial to Assess the Effectiveness of Intermittent Pneumatic Compression in the Prevention of Postoperative Venous Thromboembolism in Surgical Patients at Extremely High Risk|Recruiting||N/A|400|Anticipated|Pirogov Russian National Research Medical University||2|||f||||t|f|t|f|f|t|||Undecided||2017-10-10 21:23:38.09898|2017-10-10 21:23:38.09898
NCT03044548|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-02-02|||December 2016||2016-12-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 2017|Anticipated|2017-12-01||Interventional|||Improving the Quality of Care for Children With Acute Malnutrition in Uganda|Improving the Quality of Care for Children With Acute Malnutrition: Cluster Randomised Controlled Trial in West Nile Region, Uganda|Recruiting||N/A|700|Anticipated|WHO Collaborating Centre for Maternal and Child Health, Trieste||2|||f||||f||||||||No||2017-10-10 21:23:38.408151|2017-10-10 21:23:38.408151
NCT03044535|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-08-15|||October 26, 2016|Actual|2016-10-26|August 2017|2017-08-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2021|Anticipated|2021-02-28||Observational|MCS A-QOL||Mechanical Support Measures of Adjustment and QOL|Mechanical Circulatory Support: Measures of Adjustment and Quality of Life|Recruiting||N/A|700|Anticipated|Northwestern University|||3||f||||t|f|f||||||||2017-10-10 21:23:38.526992|2017-10-10 21:23:38.526992
NCT03044522|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-09-20|||November 14, 2016|Actual|2016-11-14|September 2017|2017-09-01|November 21, 2017|Anticipated|2017-11-21|October 31, 2017|Anticipated|2017-10-31||Interventional|||Use of a Nurse Pain Educator for Patients With Chronic Pain|A Multicenter Study Comparing the Patient Outcomes Associated With Use of a Nurse Pain Educator for Patients With Chronic Pain|Active, not recruiting||N/A|200|Anticipated|NEMA Research, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:23:38.660729|2017-10-10 21:23:38.660729
NCT03044509|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-06-01|||May 12, 2017|Actual|2017-05-12|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01|2 Months|Observational [Patient Registry]|CITRUS||Diagnosis of Tuberculosis in Swiss Children|Evaluation and Validation of Novel Immunodiagnostic Tests for Childhood Tuberculosis Infection and Disease in Switzerland. The CITRUS (ChIldhood TubeRcUlosis in Switzerland) Study.|Recruiting||N/A|190|Anticipated|University Children's Hospital Basel|||3||f||||f||||||Samples Without DNA|"     For each child a total blood volume of 7.5 ml will be required for this study.   "|No||2017-10-10 21:23:38.752003|2017-10-10 21:23:38.752003
NCT03044496|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-07|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|||NIRS Measurement After SCP Block|Near-infrared Spectroscopy to Assess Changes in Tissue Oxygenation Following Supraclavicular Plexus Block in Patients Undergoing Vascular Surgery|Recruiting||N/A|25|Anticipated|Marienhospital Stuttgart|||1||f||||f|f|f||||||No||2017-10-10 21:23:38.996785|2017-10-10 21:23:38.996785
NCT03044483|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-03-08|||January 24, 2017|Actual|2017-01-24|March 2017|2017-03-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Observational|||Establishing Normal Ranges of Microcirculatory Function as Determined by CytoCam-IDF Imaging|Establishing Normal Ranges of Microcirculatory Function as Determined by CytoCam-IDF Imaging|Recruiting||N/A|150|Anticipated|University Hospitals, Leicester|||3||f||||f|f|f||||||No||2017-10-10 21:23:39.076404|2017-10-10 21:23:39.076404
NCT03044470|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||June 1, 2016|Actual|2016-06-01|February 2017|2017-02-01|September 5, 2016|Actual|2016-09-05|August 31, 2016|Actual|2016-08-31||Interventional|||Role of Cryotherapy in Reduction of Post Operative Endodontic Pain Following Single Visit Root Canal Therapy|Role of Cryotherapy in Reduction of Post Operative Endodontic Pain Following Single Visit Root Canal Therapy|Completed||N/A|40|Actual|Mamata Dental College||2|||f||||f|f|f||||||Undecided||2017-10-10 21:23:39.180966|2017-10-10 21:23:39.180966
NCT03044457|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-02-06|||August 1, 2017|Anticipated|2017-08-01|February 2017|2017-02-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Forgotten Joint Score After Reversed Gap Technique|Forgotten Joint Score After Reversed Gap Technique vs. Gap Technique|Not yet recruiting||N/A|100|Anticipated|University of Jena||2|||f||||f|f|f||||||No||2017-10-10 21:23:39.250071|2017-10-10 21:23:39.250071
NCT03044444|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-04-10|||March 13, 2017|Actual|2017-03-13|April 2017|2017-04-01|October 1, 2017|Anticipated|2017-10-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||The Effect of a Citrus Extract on Exercise Performance in Moderately Trained Athletes|Establishing the Effect of Long-term Citrus Extract Supplementation on Exercise-specific Performance in Moderately Trained Athletes|Recruiting||N/A|93|Anticipated|BioActor||3|||f||||f|f|f||||||No||2017-10-10 21:23:39.31677|2017-10-10 21:23:39.31677
NCT03044405|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-02|||May 1, 2016|Actual|2016-05-01|February 2017|2017-02-01|September 1, 2016|Actual|2016-09-01|August 23, 2016|Actual|2016-08-23||Interventional|fluidres||Focused Assessed Echocardiography to Predict Fluid Responsiveness|Focused Assessed Echocardiography to Predict Fluid Responsiveness for Non-cardiac Hypotensive Spontaneously Breathing Patients After Major Abdominal Surgery|Completed||N/A|40|Actual|Lithuanian University of Health Sciences||1|||f||||f|f|f||||||No||2017-10-10 21:23:39.581695|2017-10-10 21:23:39.581695
NCT03044392|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-02|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|||"Determination of the Optimal Next Bolus Interval for Programmed Intermittent Bolus Epidural Analgesia"|"Determination of the Optimal Next Bolus Interval for Programmed Intermittent Bolus Epidural Analgesia: A Randomized Controlled Trial"|Not yet recruiting||Phase 4|105|Anticipated|IWK Health Centre||3|||f|||||f|f||||||||2017-10-10 21:23:39.667888|2017-10-10 21:23:39.667888
NCT03044379|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-02-06|||September 29, 2015|Actual|2015-09-29|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Dapivirine Gel Rectal Safety and PK Study|A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults|Withdrawn||Phase 1|0|Actual|International Partnership for Microbicides, Inc.||2||Current program is on hold, not for safety reason|f||||f||||||||No||2017-10-10 21:23:39.748042|2017-10-10 21:23:39.748042
NCT03044366|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-02-07|||December 2016||2016-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||General Anesthesia Management in 15 Preterm Infant|General Anesthesia Management in 15 Preterm Infant Undergoing Diode Laser Photocoagulation for Retinopathy of Prematurity: A Retrospective Study|Completed||N/A|15|Actual|Inonu University|||2||f||||f||||||||Yes||2017-10-10 21:23:39.825729|2017-10-10 21:23:39.825729
NCT03044340|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-15|||January 12, 2017|Actual|2017-01-12|January 2017|2017-01-01|January 18, 2018|Anticipated|2018-01-18|January 18, 2018|Anticipated|2018-01-18||Interventional|||Vascular and Neurologic Exploration of Small Nervous Fiber by Sudoscanner and QST|Vascular and Neurologic Exploration of Small Nervous Fiber by Sudoscanner|Recruiting||N/A|25|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||f|f|f||||||No||2017-10-10 21:23:40.051746|2017-10-10 21:23:40.051746
NCT03044327|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-07|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers|Development of Novel Non-invasive Inflammometry Following LPS Challenge in Healthy Volunteers|Enrolling by invitation||N/A|15|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f|||||f|f||||||No||2017-10-10 21:23:40.131911|2017-10-10 21:23:40.131911
NCT03044314|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-07-21|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|OVATION||Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension|OUTPATENT VASODILATOR ASSESSMENT USING ILOPROST IN PULMONARY HYPERTENSION (The OVATION Study)|Recruiting||Phase 4|50|Anticipated|Duke University||1|||f||||f|t|f|||f|||||2017-10-10 21:23:40.200822|2017-10-10 21:23:40.200822
NCT03044301|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-02-02|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)||Completed||N/A|97|Actual|Crossject||4|||f||||||||||||||2017-10-10 21:23:40.310706|2017-10-10 21:23:40.310706
NCT03044288|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-29|||January 23, 2017|Actual|2017-01-23|May 2017|2017-05-01|February 9, 2017|Actual|2017-02-09|February 9, 2017|Actual|2017-02-09||Interventional|||Evaluation of the Effect of Output on Skin Covered by a New Adhesive|Evaluation of the Effect of Output on Skin Covered by a New Adhesive|Completed||N/A|6|Actual|Coloplast A/S||1|||f||||f|f|f||||||No||2017-10-10 21:23:40.379973|2017-10-10 21:23:40.379973
NCT03044275|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-29|||January 16, 2017|Actual|2017-01-16|May 2017|2017-05-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|||The Influence of Output on Skin Covered by Adhesive With Topfilm|The Influence of Output on Skin Covered by Adhesive With Topfilm|Completed||N/A|15|Actual|Coloplast A/S||1|||f||||f|f|f||||||No||2017-10-10 21:23:40.46895|2017-10-10 21:23:40.46895
NCT03044262|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-29|||January 9, 2017|Actual|2017-01-09|May 2017|2017-05-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|||Evaluation of the Influence of New Adhesives of Output on Skin|Evaluation of the Influence of Output on Skin Covered by Newly Developed Adhesives|Completed||N/A|15|Actual|Coloplast A/S||1|||f||||f||||||||No||2017-10-10 21:23:40.542278|2017-10-10 21:23:40.542278
NCT03044249|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-27|||May 4, 2017|Actual|2017-05-04|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of MP-101 in the Treatment of Psychosis in Alzheimer's Disease|Tolerability, Pharmacokinetics, and Efficacy of MP-101 in the Treatment of Psychosis in Patients With Alzheimer's Disease|Recruiting||Phase 2|200|Anticipated|Mediti Pharma Inc.||2|||f||||f|t|f||||||||2017-10-10 21:23:40.610565|2017-10-10 21:23:40.610565
NCT03044236|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-28|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|GIRD||"Effect of a Novel Stretching Technique on Shoulder Range of Motion and Voluntary Contraction in Overhead Athletes With Glenohumeral Internal Rotation Deficits GIRD"|Effect of a Novel Stretching Technique on Shoulder Range of Motion and Maximum Voluntary Contraction in Overhead Athletes With Glenohumeral Internal Rotation Deficits: A Randomized Control Trial|Not yet recruiting||N/A|50|Anticipated|Loma Linda University||2|||f||||f|f|f||||||||2017-10-10 21:23:40.722653|2017-10-10 21:23:40.722653
NCT03044223|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-02|||August 2014||2014-08-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|MIPSA||Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis|Phenotypical Und Functional Characterization of Macrophages in Critically Ill Patients With Pseudomonas Aeruginosa Induced Sepsis|Recruiting||N/A|100|Anticipated|University of Ulm|||1||f||||f||||||Samples Without DNA|"     blood, plasma   "|No||2017-10-10 21:23:40.790779|2017-10-10 21:23:40.790779
NCT03044197|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-25|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy|Assessing the Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Guided Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy Outcomes Study: The ASTROS Trial|Recruiting||N/A|80|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:23:41.039074|2017-10-10 21:23:41.039074
NCT03044184|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-04|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|TRANSACT||Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial|Randomized, Double-blind, Placebo-controlled Trial to Investigate the Effectiveness of Early Intravenous Tranexamic Acid in Limiting Hematoma Expansion in Patients With Spontaneous Intracerebral Hemorrhage|Not yet recruiting||Phase 3|220|Anticipated|Kwong Wah Hospital||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:23:41.176005|2017-10-10 21:23:41.176005
NCT03044171|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-03-16|||August 1, 2016|Actual|2016-08-01|March 2017|2017-03-01|February 23, 2017|Actual|2017-02-23|January 23, 2017|Actual|2017-01-23||Interventional|||Evaluation of the Effect of Fluoride and Laser Application on the Prevention of Sensitivity in Bleached Teeth|Effect of Sodium Fluoride at 1.1%, Associated or Not With the Low-level Light Therapy in the Prevention of Post-bleaching Sensitivity: a Randomized, Double-blind, Controlled Trial|Completed||Phase 1|25|Actual|Universidade Federal do Para||2|||f||||f|f|f||||||No||2017-10-10 21:23:41.304953|2017-10-10 21:23:41.304953
NCT03044158|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-02|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|XPEL TB||Xpert Omni Performance Evaluation|Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial|Not yet recruiting||N/A|8000|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||Undecided|Provided upon request|2017-10-10 21:23:41.407792|2017-10-10 21:23:41.407792
NCT03044145|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-03|||September 20, 2016|Actual|2016-09-20|January 2017|2017-01-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|CFI-EA||The Cultural Formulation Interview-Engagement Aid|The Cultural Formulation Interview-Engagement Aid for Mental Health Treatment|Enrolling by invitation||N/A|33|Anticipated|New York State Psychiatric Institute||3|||f||||f|f|f||||||No||2017-10-10 21:23:41.558875|2017-10-10 21:23:41.558875
NCT03044132|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||January 15, 2017|Actual|2017-01-15|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers|A Prospective Trial Measuring the Clinical Outcomes for DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers|Recruiting||N/A|50|Anticipated|LifeNet Health||1|||f||||f|f|f||||||No||2017-10-10 21:23:41.644064|2017-10-10 21:23:41.644064
NCT03044119|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-04|||March 20, 2017|Anticipated|2017-03-20|February 2017|2017-02-01|September 20, 2018|Anticipated|2018-09-20|April 20, 2018|Anticipated|2018-04-20||Interventional|||The Effect of Platelet Rich Fibrin Matrix With and Without Peripheral Blood Mesenchymal Stem Cells on Implant Stability|A Comparative Evaluation of the Effect of Platelet Rich Fibrin Matrix With and Without Peripheral Blood Mesenchymal Stem Cells on Implant Stability : A Randomized Controlled Clinical Trial|Not yet recruiting||Phase 1|15|Anticipated|KLE Society's Institute of Dental Sciences||2|||f||||t|f|f||||||Yes|in the form of research publication|2017-10-10 21:23:41.742197|2017-10-10 21:23:41.742197
NCT03044106|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-04-17|||March 4, 2017|Actual|2017-03-04|April 2017|2017-04-01|January 22, 2018|Anticipated|2018-01-22|June 2017|Anticipated|2017-06-01||Interventional|CLRTHam||Cranial Laser Reflex Technique for Hamstring Function|The Effects of Cranial Laser Reflex Technique on Hamstring Flexibility, Strength, and Pain Pressure Threshold: a Pilot Study|Recruiting||N/A|44|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|t|f||f|||No||2017-10-10 21:23:41.814903|2017-10-10 21:23:41.814903
NCT03044093|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-02-02|||January 2017||2017-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion|Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion|Recruiting||Phase 4|200|Anticipated|Rambam Health Care Campus||2|||f||||||||||||No||2017-10-10 21:23:41.915758|2017-10-10 21:23:41.915758
NCT03044080|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-03|||January 1, 2015|Actual|2015-01-01|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot|Effects of Repeated Use of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot in Stroke Patients: A Randomized Clinical Trial|Recruiting||Phase 4|20|Anticipated|Parc de Salut Mar||2|||f||||f|f|f||||||No||2017-10-10 21:23:42.026731|2017-10-10 21:23:42.026731
NCT03044067|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-02|||September 2017|Anticipated|2017-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Pain Neuroscience Education in Fibromyalgia|The Effects of Pain Neuroscience Education Plus Exercise in the Management of Fibromyalgia: A Randomized Controlled Trial|Not yet recruiting||N/A|24|Anticipated|University of Malaga||2|||f||||t|f|f||||||No||2017-10-10 21:23:42.215852|2017-10-10 21:23:42.215852
NCT03044054|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-26|||January 2017||2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|HIFU-003||Treatment of Breast Fibroadenoma Targeted Tissue With HIFU|Treatment of Breast Fibroadenoma Targeted Tissue With High Intensity Focused Ultrasound (HIFU)|Recruiting||N/A|100|Anticipated|Theraclion||1|||f||||t||||||||No||2017-10-10 21:23:42.303964|2017-10-10 21:23:42.303964
NCT03044041|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-02-02|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison Between Low Dose and High Dose Intra-articular Tranexamic Acid in Total Knee Arthroplasty|Topical Intra‐Articular High Doses Compared With Low Doses of Tranexamic Acid to Reduce Blood Loss in Primary Total Knee Arthroplasty: A Double‐Blind Randomized Controlled Trial|Recruiting||Phase 4|80|Anticipated|Thammasat University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:23:42.420187|2017-10-10 21:23:42.420187
NCT03044028|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-22|||January 2017||2017-01-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Neuromuscular Electrical Stimulation (NMES) for Improving Outcomes Following Total Knee Arthroplasty (TKA)|Prospective Evaluation of Neuromuscular Electrical Stimulation (NMES) for Improving Outcomes Following Total Knee Arthroplasty (TKA)|Active, not recruiting||N/A|66|Anticipated|The Cleveland Clinic||3|||f||||t||||||||No||2017-10-10 21:23:42.505357|2017-10-10 21:23:42.505357
NCT03044015|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-02-02|||January 2017||2017-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|APROP||Primary Care Based Intervention for the Secondary Prevention of Osteoporotic Fractures|a Primary Care Based Intervention for the Secondary Prevention of Osteoporotic Fractures|Recruiting||N/A|1800|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||No||2017-10-10 21:23:42.603461|2017-10-10 21:23:42.603461
NCT03044002|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-09-25|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|BIO4AMB||BIOTRONIK 4French for AMBulatory Peripheral Intervention|BIOTRONIK 4French for AMBulatory Peripheral Intervention. A Multicenter, Controlled Trial Comparing 4French Versus 6French Femoral Access for Endovascular Treatment of Lower-extremity Peripheral Artery Disease in an Ambulatory Setting: BIO4AMB|Recruiting||N/A|792|Anticipated|Biotronik AG|||2||f||||f|f|||||||||2017-10-10 21:23:42.669064|2017-10-10 21:23:42.669064
NCT03043989|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-03-29|||March 21, 2017|Actual|2017-03-21|March 2017|2017-03-01|February 15, 2022|Anticipated|2022-02-15|February 15, 2020|Anticipated|2020-02-15||Interventional|||Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin|Two Independent Phase 1b Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin|Recruiting||Phase 1|35|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t|t|f|||f|||No||2017-10-10 21:23:42.73763|2017-10-10 21:23:42.73763
NCT03043976|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-02-02|||October 2015||2015-10-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|STEP in PH||Using Step Count to Enhance Daily Physical Activity in Pulmonary Hypertension||Recruiting||N/A|42|Anticipated|Imperial College Healthcare NHS Trust||3|||f||||f||||||||||2017-10-10 21:23:42.820269|2017-10-10 21:23:42.820269
NCT03043963|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-03-31|||February 10, 2017|Actual|2017-02-10|March 2017|2017-03-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Mechanisms Underlying the Blood Pressure Lowering Effect of Sleep|Mechanisms Underlying the Blood Pressure Lowering Effect of Sleep Extension|Recruiting||N/A|188|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:23:42.906264|2017-10-10 21:23:42.906264
NCT03043950|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-26|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Observational|VALIDATE||Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI in First Line (VALIDATE)|A Non-interventional Study to Assess the Safety and Efficacy of First Line Therapy With Vectibix® in Combination With FOLFIRI and to Validate a Prognostic Score in Adult Patients With RAS Wild-type Metastatic Colorectal Cancer in a Real World Setting (VALIDATE)|Recruiting||N/A|1240|Anticipated|iOMEDICO AG|||3||f|||||f|f||||||||2017-10-10 21:23:42.971275|2017-10-10 21:23:42.971275
NCT03043937|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-18|||January 2015||2015-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|2 Years|Observational [Patient Registry]|||Cardiac Diseases With Pregnancy in Benisuef Localities|Cardiac Diseases With Pregnancy in Benisuef Localities|Completed||N/A|400|Actual|Beni-Suef University|||2||f||||t||||||||||2017-10-10 21:23:43.069175|2017-10-10 21:23:43.069175
NCT03043924|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|MRI-PCOS||Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)|Functional Study of the Hypothalamus in High-resolution Magnetic Resonance Imaging (MRI) in Women With Polycystic Ovary Syndrome (PCOS): a Comparative Study|Not yet recruiting||N/A|52|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:23:43.691425|2017-10-10 21:23:43.691425
NCT03043911|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-09|||February 2016||2016-02-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|SafetyNet||Improved Patient Safety Through Continuous Bi-channel RR and SpO2 Monitoring With Masimo Patient SafetyNet|Improved Patient Safety Through Continuous Bi-channel Respiratory Rate and Oxygen Saturation Monitoring With Masimo Patient SafetyNet|Active, not recruiting||N/A|300|Anticipated|Baylor Research Institute|||1||f||||f||||||||||2017-10-10 21:23:43.831869|2017-10-10 21:23:43.831869
NCT03043898|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-21|||October 23, 2017|Anticipated|2017-10-23|September 2017|2017-09-01|April 23, 2020|Anticipated|2020-04-23|April 23, 2020|Anticipated|2020-04-23||Observational|||Mapping Sound Propagation Through the Human Lung for Better Diagnosis|Mapping Sound Propagation Through the Human Lung for Better Diagnosis|Not yet recruiting||N/A|100|Anticipated|University of Cambridge|||4||f||||f|f|f||||||||2017-10-10 21:23:43.91522|2017-10-10 21:23:43.91522
NCT03043885|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-03|||January 5, 2015|Actual|2015-01-05|February 2017|2017-02-01|March 1, 2017|Anticipated|2017-03-01|May 9, 2016|Actual|2016-05-09||Interventional|||Ridge Preservation With Platelet Rich Fibrin Augmented With Freeze Dried Bone Allograft|Ridge Preservation With Platelet Rich Fibrin Augmented With Freeze Dried Bone Allograft: A Comparative Clinical, Histological, and Micro-computed Tomography Study|Active, not recruiting||N/A|40|Actual|University of California, San Francisco||4|||f||||t|f|t|f|f|t|||Undecided||2017-10-10 21:23:44.044088|2017-10-10 21:23:44.044088
NCT03043872|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-15|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|March 29, 2019|Anticipated|2019-03-29||Interventional|Caspian||Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian)|A Phase III, Randomized, Multicenter,Open-Label, Comparative Study to Determine the Efficacy of Durvalumab or Durvalumab and Tremelimumab in Combination With Platinum-Based Chemotherapy for the First-Line Treatment in Patients With Extensive Disease (Stage IV) Small-Cell Lung Cancer (SCLC)|Recruiting||Phase 3|795|Anticipated|AstraZeneca||3|||f||||t|t|f||||||||2017-10-10 21:23:44.244143|2017-10-10 21:23:44.244143
NCT03043859|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-01|||May 9, 2017|Actual|2017-05-09|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Trial to Evaluate the Effectiveness of the Pure Prairie Living Program|A Randomized Controlled Trial to Evaluate the Effectiveness of the Pure Prairie Living Program - A Lifestyle Intervention|Active, not recruiting||N/A|50|Actual|University of Alberta||2|||f||||f|f|f||||||No|Not anticipated|2017-10-10 21:23:45.133449|2017-10-10 21:23:45.133449
NCT03043846|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-03|||November 30, 2016|Actual|2016-11-30|February 2017|2017-02-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|TICOSPA||Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)|Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)|Recruiting||N/A|160|Anticipated|Association de Recherche Clinique en Rhumatologie|||2||f||||f|f|f||||||No||2017-10-10 21:23:45.214398|2017-10-10 21:23:45.214398
NCT03043833|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-23|||January 18, 2017|Actual|2017-01-18|February 2017|2017-02-01|August 18, 2017|Anticipated|2017-08-18|August 18, 2017|Anticipated|2017-08-18||Interventional|||Internet-Delivered Cognitive Behavior Therapy for Anxiety and Depression Amongst French Canadians|Improving Access to Treatment for Anxiety and Depression Among French Canadians Using an Internet-Delivered Cognitive Behavior Therapy: A Randomized Controlled Trial|Recruiting||N/A|64|Anticipated|Universite de Moncton||2|||f||||f|f|f||||||Undecided|There is currently in place a memorandum of understanding with Macquarie University, our collaborators. This agreement allows for the sharing of data once personally identifiable information has been removed.|2017-10-10 21:23:45.384524|2017-10-10 21:23:45.384524
NCT03043820|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-02-02|||August 2016||2016-08-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|December 2018|Anticipated|2018-12-01||Interventional|RAPSODI||Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder|Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder to Reduce Symptoms and Improve Cognition|Recruiting||Phase 3|154|Anticipated|UMC Utrecht||2|||f||||t||||||||Undecided||2017-10-10 21:23:45.472949|2017-10-10 21:23:45.472949
NCT03043807|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-06|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy|A Phase II Study of Definitive Therapy for Newly Diagnosed Men With Oligometastatic Prostate Cancer After Prostatectomy|Recruiting||Phase 2|33|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:23:45.581398|2017-10-10 21:23:45.581398
NCT03043794|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-09|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 1, 2024|Anticipated|2024-08-01|August 1, 2022|Anticipated|2022-08-01||Interventional|||Study of Stereotactic Radiotherapy for Breast Cancer|A Phase II Study of Preoperative Single Fraction Stereotactic Body Radiotherapy to the Intact Breast in Early Stage Low Risk Breast Cancer: Analysis of Radiation Response|Recruiting||Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|f|t|f|f|f|||||2017-10-10 21:23:45.68088|2017-10-10 21:23:45.68088
NCT03043781|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-20|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|PIEBA||The Programmed Intermittent Epidural Bolus Adrenaline Study|The Programmed Intermittent Epidural Bolus Adrenaline Study|Recruiting||N/A|150|Anticipated|University Hospital, Akershus||2|||f||||f|f|f|||f|||No|No plan to share individual participant data.|2017-10-10 21:23:45.758931|2017-10-10 21:23:45.758931
NCT03043768|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-02-02|||March 2016||2016-03-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|CAPTURE PD||Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease|Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease (CAPTURE PD)|Recruiting||N/A|104|Anticipated|GWT-TUD GmbH|||2||f||||f||||||Samples Without DNA|"     3mm skin biopsies (punch biopsies)   "|||2017-10-10 21:23:45.835874|2017-10-10 21:23:45.835874
NCT03043755|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-03|||July 2016|Actual|2016-07-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|PARAST||PECS and Parasternal Block for Breast Surgery|Observational Study to Evaluated Efficacy of Parasternal and PECS Blocks Association in Breast Surgery|Completed||N/A|32|Actual|Istituti Ospitalieri di Cremona|||1||f||||f|f|f||||||No||2017-10-10 21:23:45.933755|2017-10-10 21:23:45.933755
NCT03043742|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-02-02|||June 2016||2016-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Stem Cell Heart Injections During Laser Revascularization Surgery for Treatment of Chronic Ischemic Heart Disease|Prospective Controlled Trial of Intra-Myocardial Infusion of Bone Marrow Derived Autologous CD133+ Selected Cells During Trans-Myocardial Laser Revascularization (TMR) in Patients With Chronic Ischemic Heart Disease|Recruiting||Phase 1|10|Anticipated|University of Kentucky||1|||f||||t||||||||Undecided|to be determined per principal investigator and statistician|2017-10-10 21:23:45.984002|2017-10-10 21:23:45.984002
NCT03043729|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-16|||March 6, 2017|Actual|2017-03-06|June 2017|2017-06-01|February 2022|Anticipated|2022-02-01|August 2021|Anticipated|2021-08-01||Interventional|||mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer|mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer: a Randomized Phase-II-trial|Recruiting||Phase 2|209|Anticipated|AIO-Studien-gGmbH||2|||f||||f|f|f||||||No||2017-10-10 21:23:46.063752|2017-10-10 21:23:46.063752
NCT03043703|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-04-13|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||AirSense 10 for Her RDI Validation Study|Evaluation of a Respiratory Disturbance Index Determined by the ResMed AirSense 10 for Her|Not yet recruiting||N/A|129|Anticipated|ResMed||1|||f|||||f|f||||||||2017-10-10 21:23:46.234318|2017-10-10 21:23:46.234318
NCT03043690|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-08|||February 11, 2017|Anticipated|2017-02-11|February 2017|2017-02-01|March 30, 2017|Anticipated|2017-03-30|March 3, 2017|Anticipated|2017-03-03||Observational|||A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms|Clinical Efficacy of an Ammonium Succinate-based Dietary Supplement in Women With Menopausal Symptoms: a Pooled Analysis of the Data From Two Randomized, Multicenter, Double-blinded Placebo-controlled Clinical Trials.|Not yet recruiting||N/A|227|Anticipated|I.M. Sechenov First Moscow State Medical University|||2||f||||f|f|f||||||No||2017-10-10 21:23:46.305923|2017-10-10 21:23:46.305923
NCT03043677|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-10|||December 1, 2017|Anticipated|2017-12-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Observational|||Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells|Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells|Not yet recruiting||N/A|45|Anticipated|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa|||3||f||||f|t|f||||Samples Without DNA|"     Cell culture supernatants   "|||2017-10-10 21:23:46.449457|2017-10-10 21:23:46.449457
NCT03043664|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-07-31|||July 1, 2017|Actual|2017-07-01|May 2017|2017-05-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|PLANET||Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors|Phase Ib/II Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors|Recruiting||Phase 1/Phase 2|26|Anticipated|Duke University||1|||||||f|t|f|||f|||||2017-10-10 21:23:46.513971|2017-10-10 21:23:46.513971
NCT03043651|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-10-05|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF)|An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301|Recruiting||Phase 3|310|Anticipated|United Therapeutics||1|||f||||f|t|f||||||||2017-10-10 21:23:46.640515|2017-10-10 21:23:46.640515
NCT03043638|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-06|||July 1, 2008|Actual|2008-07-01|January 2017|2017-01-01|June 20, 2011|Actual|2011-06-20|June 20, 2011|Actual|2011-06-20||Interventional|PRP||Efficiency of PRP on Acellular Dermal Matrix Application in the Treatment of Multiple Adjacent Gingival Recessions|Efficiency of Platelet-Rich Plasma (PRP) on Acellular Dermal Matrix Application With Coronally Advanced Flap in the Treatment of Multiple Adjacent Gingival Recessions:a Double-masked Randomized Controlled Clinical Trial|Completed||N/A|12|Actual|Okmeydani Training and Research Hospital||2|||f||||f|f|f||||||Yes|When needed data can be shared via email.|2017-10-10 21:23:46.836273|2017-10-10 21:23:46.836273
NCT03043625|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-03|||October 1, 2016|Actual|2016-10-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|January 30, 2017|Actual|2017-01-30||Interventional|||Visceral Manipulation Treatment to Patients With Non-specific Neck Pain With Functional Dyspepsia|Effect of Visceral Manipulation on Electromyographic Activity of the Upper Trapezius Muscle, Cervical Range and Pain in Patients With Non-specific Neck Pain With Functional Dyspepsia: A Randomized, Double-blinded, Sham-controlled, Study|Completed||N/A|60|Actual|University of Nove de Julho||2|||f||||t|f|f||||||No|The data will not be shared with other researchers. The results of the study will be published as a manuscript in a scientific journal.|2017-10-10 21:23:46.90728|2017-10-10 21:23:46.90728
NCT03043612|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-30|||June 10, 2015|Actual|2015-06-10|June 2017|2017-06-01|June 30, 2017|Actual|2017-06-30|June 16, 2017|Actual|2017-06-16||Interventional|||Ureteral Stent Study|Cook Ureteral Stent Study|Completed||N/A|56|Actual|Cook Group Incorporated||2|||f|||||f|f||||||||2017-10-10 21:23:46.990367|2017-10-10 21:23:46.990367
NCT03043599|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-10-04|||February 13, 2017|Actual|2017-02-13|October 2017|2017-10-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer|Consolidative Ipilimumab and Nivolumab With Thoracic Radiotherapy After Platinum Based Chemotherapy for Patients With Extensive-Stage Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|52|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 21:23:47.061272|2017-10-10 21:23:47.061272
NCT03043586|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-02|||December 2016||2016-12-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Treatment Patterns and Treatment Outcomes for Acromegaly|Treatment Patterns and Treatment Outcomes in a New York City Based Cohort of 520 Patients With Acromegaly|Recruiting||N/A|520|Anticipated|Columbia University|||1||f||||f||||||Samples Without DNA|"     Blood will be sampled for fasting measurements of GH (Growth Hormone) and IGF-I (insulin     Growth Factor 1) and patients will undergo an OGTT Oral Glucose tolerance Test) with blood     drawn before and 60, 90 and 120 minutes after a 75 g. dextrose drink.   "|Undecided||2017-10-10 21:23:48.795153|2017-10-10 21:23:48.795153
NCT03043573|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-08-03|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|PATH-MCI||Problem Adaptation Therapy for Mild Cognitive Impairment and Depression|Problem Adaptation Therapy for Mild Cognitive Impairment and Depression|Recruiting||N/A|40|Anticipated|Weill Medical College of Cornell University||2|||f||||t|f|f||||||||2017-10-10 21:23:48.918779|2017-10-10 21:23:48.918779
NCT03043560|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-29|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|May 15, 2019|Anticipated|2019-05-15|April 15, 2019|Anticipated|2019-04-15||Interventional|||Study to Treat Major Depressive Disorder With a New Medication|Developing Neuronal KCNQ Channel Modulators for Mood Disorders|Recruiting||Phase 2|48|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|t|f||||||||2017-10-10 21:23:49.043716|2017-10-10 21:23:49.043716
NCT03043547|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|January 2021|Anticipated|2021-01-01||Interventional|NALIRICC||Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies|A Randomized Phase II Trial of Nal-IRI and 5-Fluorouracil Compared to 5-Fluorouracil in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies|Not yet recruiting||Phase 2|100|Anticipated|AIO-Studien-gGmbH||2|||f||||f|f|f||||||||2017-10-10 21:23:49.139057|2017-10-10 21:23:49.139057
NCT03043534|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-07|2017-04-19||November 12, 2015|Actual|2015-11-12|July 2017|2017-07-01|October 12, 2016|Actual|2016-10-12|October 12, 2016|Actual|2016-10-12||Interventional|||Pre-Shave Gel and Brush in Pseudofolliculitis Barbae|The Impact of a Pre-Shave Gel and Brush in Males With Pseudofolliculitis Barbae|Completed||N/A|29|Actual|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-10 21:23:49.237835|2017-10-10 21:23:49.237835
NCT03043521|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-03|||May 13, 2015|Actual|2015-05-13|February 2017|2017-02-01|August 12, 2015|Actual|2015-08-12|August 12, 2015|Actual|2015-08-12||Interventional|||Pharmacodynamic Properties of CJ-12420 on Evening Dosing|Phase I Study to Investigate Pharmacodynamics of CJ-12420 Compared to Dexlansoprazole With Evening Dosing|Completed||Phase 1|24|Actual|CJ HealthCare Corporation||4|||f||||f|f|f||||||No||2017-10-10 21:23:49.484984|2017-10-10 21:23:49.484984
NCT03043508|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-03|||April 10, 2015|Actual|2015-04-10|February 2017|2017-02-01|April 1, 2025|Anticipated|2025-04-01|April 1, 2025|Anticipated|2025-04-01||Observational|||Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)|Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)|Recruiting||N/A|510|Anticipated|M.D. Anderson Cancer Center|||2||f||||f|f|f||||||||2017-10-10 21:23:49.571876|2017-10-10 21:23:49.571876
NCT03043495|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-03|||October 1, 2016|Actual|2016-10-01|February 2017|2017-02-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Dexamethasone Dose in Low Volume Bupivacaine USG Supraclavicular Block|The Optimal Dose Of Dexamethasone To Be Used As An Adjuvant To Low Volume Bupivacaine Ultrasound Guided Supraclavicular Brachial Plexus Block. A Randomized Controlled Double Blinded Dose Ranging Study|Recruiting||Phase 4|40|Anticipated|Cairo University||4|||f||||t|t|f||||||No||2017-10-10 21:23:49.66452|2017-10-10 21:23:49.66452
NCT03043482|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-03|||January 24, 2017|Actual|2017-01-24|February 2017|2017-02-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105|A Phase 1, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105 Following Oral Administration in Healthy and Hemodialysis Subjects|Recruiting||Phase 1|76|Anticipated|Vidasym, Inc.||3|||f||||f|t|f||||||No||2017-10-10 21:23:49.848672|2017-10-10 21:23:49.848672
NCT03043469|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-04|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|March 1, 2017|Anticipated|2017-03-01||Observational|||Dysfunctional Breathing: Characterisation and Assessment|Dysfunctional Breathing: Multidimensional Characterisation and Assessment Tool|Not yet recruiting||N/A|141|Anticipated|Brunel University|||4||f||||f|f|f||||||No||2017-10-10 21:23:49.97666|2017-10-10 21:23:49.97666
NCT03043456|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-07|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 1, 2017|Anticipated|2017-09-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Patient Satisfaction and Microbial Changes in Complete Dentures.|Evaluation of Patient Satisfaction and Microbiological Changes in Injectable Thermoplastic Resin and Conventional Acrylic Resin Complete Dentures|Not yet recruiting||N/A|24|Anticipated|Cairo University||2|||f||||f|f|f||||||No|Data will be available through contact by email of the principle investigator. (gazar_fantasy@yahoo.com)|2017-10-10 21:23:50.204756|2017-10-10 21:23:50.204756
NCT03043443|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-16|||January 25, 2017|Actual|2017-01-25|June 2017|2017-06-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Melatonin Use for Sleep Problems in Alcohol Dependent Patients|Melatonin for Alcohol Use Disorder Patients With Sleeping Problems|Recruiting||N/A|60|Anticipated|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||No||2017-10-10 21:23:50.287289|2017-10-10 21:23:50.287289
NCT03043430|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-02|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients|Anxiolysis for Emergency Department Procedures in Pediatric Patients Using Intranasal Ketamine Compared With Intranasal Midazolam: A Randomized Controlled Trial|Recruiting||Phase 4|80|Anticipated|Brooke Army Medical Center||2|||f||||t|t|f|||t|||No||2017-10-10 21:23:50.375487|2017-10-10 21:23:50.375487
NCT03043417|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-07-04|||May 2014||2014-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Stigma Intervention Among Primary Health Workers in Toronto|Exploring Stigma, Discrimination, and Recovery-based Perspectives Toward Mental Illness and Substance Use Problems|Active, not recruiting||N/A|270|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-10 21:23:50.470103|2017-10-10 21:23:50.470103
NCT03043404|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-04-05|||December 3, 2013|Actual|2013-12-03|April 2017|2017-04-01|January 17, 2019|Anticipated|2019-01-17|December 10, 2013|Actual|2013-12-10||Interventional|||Performance and Safety of the Lotus™ Valve With a FLEXible Delivery System|REPRISE II FLEX: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LotuS™ ValvE With a FLEXible Delivery System - Confirmation of Performance and Safety|Active, not recruiting||N/A|4|Actual|Boston Scientific Corporation||1|||f||||f|f|f||||||No||2017-10-10 21:23:50.552241|2017-10-10 21:23:50.552241
NCT03043391|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children|Phase Ib Study of Oncolytic Polio/Rhinovirus Recombinant Against Recurrent Malignant Glioma in Children|Not yet recruiting||Phase 1|12|Anticipated|Duke University||1|||f||||t|t|f||||||||2017-10-10 21:23:50.653398|2017-10-10 21:23:50.653398
NCT03043378|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-10|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic|Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic|Not yet recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||||||2017-10-10 21:23:50.746404|2017-10-10 21:23:50.746404
NCT03043365|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-03|2017-07-06|||June 15, 2017|Actual|2017-06-15|June 13, 2017|2017-06-13|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults|Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults|Recruiting||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||2|||t|||||t|f||||||||2017-10-10 21:23:50.825911|2017-10-10 21:23:50.825911
NCT03043352|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-02-03|||April 20, 2015|Actual|2015-04-20|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Evaluation of the Effectiveness and Impact of Community Case Management of Severe Acute Malnutrition|Evaluation of the Effectiveness and Impact of Community Case Management of Severe Acute Malnutrition Through Lady Health Workers As Compared To a Facility Based Program: A Cluster Randomized Controlled Trial|Completed||N/A|762|Actual|Aga Khan University||2|||f||||t|f|f||||||Yes||2017-10-10 21:23:50.912778|2017-10-10 21:23:50.912778
NCT03043339|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|COMET-DR||Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt|Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt|Recruiting||N/A|200|Anticipated|Emory University|||2||f||||t|f|f||||Samples With DNA|"     Specimens collected through anal swabs and stool samples will be stored until DNA extraction     can occur. DNA analysis of the microbiome will occur; DNA of the participants will not be     examined.   "|||2017-10-10 21:23:50.990629|2017-10-10 21:23:50.990629
NCT03043326|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-02|||January 23, 2017|Actual|2017-01-23|January 2017|2017-01-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2020|Anticipated|2020-01-31||Observational|||Demonstration Project on the Feasibility to Implement PrEP in MSM and TG Women|Demonstration Project on the Feasibility to Implement a Pre-Exposure Oral Prophylaxis Program in Men Who Have Sex With Other Men and Transgender Women at Risk of Acquiring HIV|Recruiting||N/A|1000|Anticipated|Asociación Civil Impacta Salud y Educación, Peru|||1||f||||t|t|f|||f|||No||2017-10-10 21:23:51.09699|2017-10-10 21:23:51.09699
NCT03043313|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-03|||June 23, 2017|Actual|2017-06-23|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|MOUNTAINEER||Tucatinib (ONT-380) and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer (MOUNTAINEER)|A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer|Recruiting||Phase 2|35|Anticipated|Academic and Community Cancer Research United||1|||f||||t|t|f|||f|||||2017-10-10 21:23:51.206282|2017-10-10 21:23:51.206282
NCT03043300|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|ABROAD||A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US|A Pilot Study to Assess the Intestinal MicroBiota Diversification States and Changes in U.S. Travelers After Return From Short-Term Travel to an Overseas South(East) Asian Destination|Recruiting||N/A|10|Anticipated|Emory University|||1||f||||t|f|f||||Samples With DNA|"     Every stool specimen will be collected by the participant and placed in a kit and stored for     deoxyribonucleic acid (DNA) extraction and sequencing. Specimens will be batched for     analysis.   "|||2017-10-10 21:23:51.292562|2017-10-10 21:23:51.292562
NCT03043287|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-03|||May 12, 2017|Actual|2017-05-12|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)|Voiding Efficiency, a Predictor of CIC|Recruiting||N/A|1000|Anticipated|Allergan|||1||f||||f||||||||||2017-10-10 21:23:51.406786|2017-10-10 21:23:51.406786
NCT03043274|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-02-03|||January 2017||2017-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size|Periprocedural Cangrelor in Patients With ST-Elevation Myocardial Infarction to Reduce Development of Myocardial Necrosis|Recruiting||N/A|60|Anticipated|University of Kentucky||2|||f||||f||||||||Undecided||2017-10-10 21:23:51.582532|2017-10-10 21:23:51.582532
NCT03043261|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-11|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EMERGE||Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation|Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation|Not yet recruiting||Phase 4|30|Anticipated|Duke University||1|||f||||f|f|f|||f|||||2017-10-10 21:23:51.70854|2017-10-10 21:23:51.70854
NCT03043248|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-06-01|||February 6, 2017|Actual|2017-02-06|June 2017|2017-06-01|May 21, 2017|Actual|2017-05-21|May 13, 2017|Actual|2017-05-13||Interventional|||TRK-700 Drug-Drug Interaction Study With Digoxin and Midazolam|TRK-700 Drug-Drug Interaction Study With Digoxin and Midazolam in Healthy Adults|Completed||Phase 1|48|Anticipated|Toray Industries, Inc||2|||f||||f|f|f||||||||2017-10-10 21:23:51.78131|2017-10-10 21:23:51.78131
NCT03043235|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-02|||January 8, 2014|Actual|2014-01-08|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity|Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity|Recruiting||N/A|120|Anticipated|University of Alabama at Birmingham|||4||f||||f|f|f||||Samples With DNA|"     DNA will be used to identify ancestry. This information is needed to understand why African     Americans and Caucasians have different risks for developing certain diseases.   "|No||2017-10-10 21:23:51.862978|2017-10-10 21:23:51.862978
NCT03043222|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-08-18|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men|The Effect of Prostatic Urethral Lift (PUL) Versus Prostate Arterial Embolization (PAE), Two Novel Minimally Invasive Treatment Options on Health-related Quality of Life (HRQoL) in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostate Hyperplasia (BPH): A Prospective, Single Center, Comparative Trial.|Not yet recruiting||N/A|100|Anticipated|St. Louis University||2|||f||||f|f|t|t|f||||||2017-10-10 21:23:51.944644|2017-10-10 21:23:51.944644
NCT03043209|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-11|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Observational|||Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy|Genomic Sequencing in Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy|Not yet recruiting||N/A|25|Anticipated|The Cleveland Clinic|||1||f||||f|f|f||||Samples With DNA|"     leftover of myectomy tissue and peripheral blood   "|||2017-10-10 21:23:52.07923|2017-10-10 21:23:52.07923
NCT03043196|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-02|||June 2015||2015-06-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||1.2% Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis|1.2% Rosuvastatin Gel As A Local Drug Delivery Agent In Smokers With Chronic Periodontitis- A Randomized Controlled Clinical Trial.|Completed||Phase 2/Phase 3|60|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||f||||||||Undecided||2017-10-10 21:23:52.15293|2017-10-10 21:23:52.15293
NCT03043183|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-03|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 30, 2021|Anticipated|2021-09-30|March 1, 2021|Anticipated|2021-03-01||Interventional|||Enhanced Recovery After Surgery(ERAS) for Gastric Cancer and Perioperative Nutritional Status|The Effect of Perioperative Nutritional Status on Enhanced Recovery After Surgery for Gastric Cancer|Not yet recruiting||N/A|1400|Anticipated|First Hospital of Jilin University||2|||f|||||f|f||||||||2017-10-10 21:23:52.2389|2017-10-10 21:23:52.2389
NCT03043170|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-10-02|||March 1, 2017|Actual|2017-03-01|October 2017|2017-10-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|DiPS||Diagnostic Investigation and Prediction of Shock|Diagnostic Investigation and Prediction of Shock (The DiPS Study)|Recruiting||N/A|354|Anticipated|Cardiff University|||1||f||||f|f|f||||||||2017-10-10 21:23:52.299883|2017-10-10 21:23:52.299883
NCT03043157|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-12|||February 15, 2017|Actual|2017-02-15|September 2017|2017-09-01|March 2, 2017|Actual|2017-03-02|March 2, 2017|Actual|2017-03-02||Interventional|||Rocuronium Effective Dose for Laparoscopic Cholecystectomy|Rocuronium ED50 for Excellent Laparoscopic Conditions for Cholecistectomy: Dose-finding Adaptative Clinical Trial|Completed||Phase 3|30|Actual|Brasilia University Hospital||1|||f||||f|f|f||||||||2017-10-10 21:23:52.390995|2017-10-10 21:23:52.390995
NCT03043144|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-06-22|||February 15, 2017|Actual|2017-02-15|June 2017|2017-06-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Observational|TASTE ESRD||Taste And Smell TEsting in End Stage Renal Disease|TASTE ESRD: Taste And Smell TEsting in End Stage Renal Disease|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center|||1|Investigator leaving the institution|f||||f|f|f||||||Undecided||2017-10-10 21:23:52.463172|2017-10-10 21:23:52.463172
NCT03043131|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2017-02-01|||February 10, 2017||2017-02-10|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparative Analysis Between Ringer's Lactate vs Plasma Lyte-A as Cardiopulmonary Bypass Prime|Comparative Analysis Between Ringer's Lactate vs Acetate Containing Balanced Crystalloid Solution (Plasma Lyte-A) as Cardiopulmonary Bypass Prime|Not yet recruiting||Phase 3|60|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||Undecided||2017-10-10 21:23:52.556966|2017-10-10 21:23:52.556966
NCT03043118|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-02-01|||February 2015||2015-02-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|December 2016|Actual|2016-12-01||Interventional|CTS||Children's Taste Study to Increase Vegetable Intake in Preschoolers|A Pilot Study to Test the Influence of Vegetable Flavor Variety Using Herbs and Spices on Preschool Children's Vegetable Intake|Active, not recruiting||N/A|48|Actual|Penn State University||2|||f||||f||||||||No||2017-10-10 21:23:52.660299|2017-10-10 21:23:52.660299
NCT03043105|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-03|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial|Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Multicentric Castleman's Disease: a Prospective, Single-center, Single-arm, Phase-II Pilot Trial|Recruiting||Phase 2|55|Anticipated|Peking Union Medical College Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:23:52.754874|2017-10-10 21:23:52.754874
NCT03043092|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-05-12|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|CRITIDOP||Transcranial Doppler Ultrasound in Critically Ill Patients With Cardiovascular Comorbidities|Transcranial Doppler Ultrasound and Arterial Diseases: Description of Ultrasound Patterns in a Critically Ill Population Without Neurological Disorders.|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||No||2017-10-10 21:23:52.860815|2017-10-10 21:23:52.860815
NCT03043079|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-01|||April 2016|Actual|2016-04-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultrasound Assessment of Ventral Hernia Defects|Ultrasound Assessment of Ventral Hernia Defects|Recruiting||N/A|60|Anticipated|University of Pennsylvania||3|||f||||f|f|f||||||No|There is no plan to share individual participant data to outside researchers at the end of the study. Any data shared will be de-identified.|2017-10-10 21:23:52.948182|2017-10-10 21:23:52.948182
NCT03043066|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-02-01|||March 1, 2016|Actual|2016-03-01|January 2017|2017-01-01|October 1, 2016|Actual|2016-10-01|July 31, 2016|Actual|2016-07-31||Interventional|||Serum TRAP-5b Levels in Patients With Generalized Chronic Periodontitis|The Effect of Non-surgical Periodontal Therapy With or Without Systemic Administration of Amoxicillin and Metronidazole on Serum Levels of TRAP-5b in Patients With Generalized Chronic Periodontitis - A Comparative Clinical Study|Completed||N/A|30|Actual|Meenakshi Ammal Dental College and Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:23:53.030895|2017-10-10 21:23:53.030895
NCT03043053|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-07-17|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2021|Anticipated|2021-04-01||Interventional|||The Effects of Oxytocin in Obese Adults|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Repeat Doses of Intranasal Oxytocin in Obese Adults|Recruiting||Phase 2|100|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||||2017-10-10 21:23:53.108149|2017-10-10 21:23:53.108149
NCT03043040|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-01|||July 1, 2014|Actual|2014-07-01|February 2017|2017-02-01|March 31, 2017|Anticipated|2017-03-31|March 31, 2017|Anticipated|2017-03-31||Interventional|||Prevention of Suicidal Behaviour With Telemedicine Techniques|Prevention of Suicidal Behaviour in High Risk Patients With Telemedicine Techniques|Active, not recruiting||N/A|651|Actual|Osakidetza||2|||f||||f|f|f||||||No||2017-10-10 21:23:53.194945|2017-10-10 21:23:53.194945
NCT03043027|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-24|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Interventional|||Efficacy of Liposomal Bupivacaine for Pain Control After Percutaneous Nephrostolithotomy|Efficacy of Liposomal Bupivacaine for Pain Control After Percutaneous Nephrostolithotomy|Withdrawn||Phase 3|0|Actual|Northwell Health||3||cost of medicine too expensive to continue without funding|f||||t|t|f||||||||2017-10-10 21:23:53.262631|2017-10-10 21:23:53.262631
NCT03043014|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-23|||April 15, 2017|Anticipated|2017-04-15|January 2017|2017-01-01|June 15, 2019|Anticipated|2019-06-15|March 1, 2019|Anticipated|2019-03-01||Interventional|BPCEN||Cervical Preparation of Abortions Under Paracervical Block in the First Trimester:|Cervical Preparation of Abortions Under Paracervical Block in the First Trimester: A Randomized Clinical Trial|Not yet recruiting||N/A|110|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f|f|f||||||No||2017-10-10 21:23:53.35535|2017-10-10 21:23:53.35535
NCT03043001|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-30|||January 1, 2014|Actual|2014-01-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Memantine in Bipolar Patients With Alcoholism|Using Memantine in Treating Bipolar Disorder Comorbid With Alcoholism|Enrolling by invitation||Phase 3|60|Anticipated|National Cheng-Kung University Hospital||1|||f||||f|f|f|||f|||||2017-10-10 21:23:53.428582|2017-10-10 21:23:53.428582
NCT03042988|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-01|||January 30, 2017|Actual|2017-01-30|June 2017|2017-06-01|July 30, 2021|Anticipated|2021-07-30|January 30, 2021|Anticipated|2021-01-30||Interventional|||Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension|Overnight Trials to Compare the Effects of Controlled Heat Stress Versus Sham Control on Nocturnal Supine Hypertension in Autonomic Failure Patients|Recruiting||N/A|20|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f|||f|||No||2017-10-10 21:23:53.519428|2017-10-10 21:23:53.519428
NCT03042975|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-20|||January 23, 2017|Actual|2017-01-23|September 2017|2017-09-01|February 28, 2022|Anticipated|2022-02-28|February 28, 2022|Anticipated|2022-02-28||Observational|||Imaging Genetics of Spasmodic Dysphonia|Imaging Genetics of Spasmodic Dysphonia|Recruiting||N/A|298|Anticipated|Massachusetts Eye and Ear Infirmary|||3||f||||f|f|f||||Samples With DNA|"     Blood samples will be collected, the DNA will be extracted and banked for genetic studies   "|||2017-10-10 21:23:53.627283|2017-10-10 21:23:53.627283
NCT03042962|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-20|||August 1, 2015|Actual|2015-08-01|September 2017|2017-09-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Observational|||Brain Networks in Dystonia|Brain Networks in Dystonia|Enrolling by invitation||N/A|140|Anticipated|Massachusetts Eye and Ear Infirmary|||2||f||||f|f|f||||Samples With DNA|"     Blood samples will be collected, the DNA will be extracted and banked for genetic studies   "|||2017-10-10 21:23:53.733218|2017-10-10 21:23:53.733218
NCT03042949|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-08|||February 15, 2017|Anticipated|2017-02-15|February 2017|2017-02-01|April 1, 2018|Anticipated|2018-04-01|February 15, 2018|Anticipated|2018-02-15||Interventional|||An Optical System for Measuring Blood Pressure|Correlation of Blood Pressure Measurements Using an Optical System for Measuring Blood Pressure|Not yet recruiting||N/A|100|Anticipated|Meir Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:23:53.811403|2017-10-10 21:23:53.811403
NCT03042936|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-01|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Diabetes Prevention Program in Youth|Insulin Superheroes Club: Diabetes Prevention Program in Youth (12-month Supplement to the CDC DPP for Adults)|Active, not recruiting||N/A|33|Actual|University of Tennessee Health Science Center||1|||f||||f||||||||No||2017-10-10 21:23:53.87768|2017-10-10 21:23:53.87768
NCT03042923|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-01|||April 2016||2016-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Intestinal Permeability and Endometriosis|Intestinal Permeability and Endometriosis|Recruiting||N/A|30|Anticipated|University of Tennessee|||2||f||||f||||||||No||2017-10-10 21:23:53.966191|2017-10-10 21:23:53.966191
NCT03042910|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-08-18|||October 13, 2016|Actual|2016-10-13|August 2017|2017-08-01|June 22, 2017|Actual|2017-06-22|May 30, 2017|Actual|2017-05-30||Interventional|||A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors|A Phase 1, Open-label Study To Assess The Effects Of Talazoparib On Cardiac Repolarization In Patients With Advanced Solid Tumors|Completed||Phase 1|39|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 21:23:54.070468|2017-10-10 21:23:54.070468
NCT03042897|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-09-12|||November 20, 2017|Anticipated|2017-11-20|June 2017|2017-06-01|November 20, 2019|Anticipated|2019-11-20|November 20, 2018|Anticipated|2018-11-20||Interventional|||Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer|Endometrial Cancer and Obesity: An Exercise and Diet Intervention for Weight Loss|Not yet recruiting||N/A|25|Anticipated|University of Southern California||1|||f||||t|f|f||||||||2017-10-10 21:23:54.329604|2017-10-10 21:23:54.329604
NCT03042884|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-12|||February 13, 2017|Actual|2017-02-13|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Wearable Exercise Trackers in Cancer Rehabilitation|Wearable Exercise Trackers in Cancer Rehabilitation|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 21:23:54.449945|2017-10-10 21:23:54.449945
NCT03042871|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-02-05|||April 2015||2015-04-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|SMILE||Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization|Dosing Strategy of Intravitreal Ranibizumab for Myopia Choroidal Neovascularization: a Single Center Randomized Prospective Study|Recruiting||Phase 4|60|Anticipated|Zhongshan Ophthalmic Center, Sun Yet-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:23:54.551405|2017-10-10 21:23:54.551405
NCT03042858|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-01|||January 2017||2017-01-01|January 2017|2017-01-01|December 2036|Anticipated|2036-12-01|December 2035|Anticipated|2035-12-01||Observational|HxPPV||Natural History of Infants With Patent Processus Vaginalis|Natural History of Infants With Patent Processus Vaginalis|Recruiting||N/A|3000|Anticipated|Children's Mercy Hospital Kansas City|||2||f||||f||||||||Yes|The data coordination site will have contact information for all subjects so that long-term follow-up can be done. Each contributing site will only have access to their own subjects' information.|2017-10-10 21:23:54.655366|2017-10-10 21:23:54.655366
NCT03042845|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-05-25|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|JUDGE||Randomized Comparison of JUDkins vs tiGEr Catheter in Coronary Angiography Via the Right Radial Artery: the JUDGE Study|Randomized Comparison of JUDkins vs tiGEr Catheter in Coronary Angiography Via the Right Radial Artery: the JUDGE Study|Completed||N/A|640|Actual|University Hospital of Patras||2|||f||||f|f|f||||||Undecided||2017-10-10 21:23:54.756751|2017-10-10 21:23:54.756751
NCT03042832|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-02-01|||September 2015||2015-09-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|LOCI||Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention|Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention in Substance Abuse Treatment Programs|Recruiting||N/A|396|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 21:23:54.848023|2017-10-10 21:23:54.848023
NCT03042819|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-05-29|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|November 16, 2020|Anticipated|2020-11-16|May 16, 2020|Anticipated|2020-05-16||Interventional|||Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas|A Phase 1b Trial of Selinexor Plus Doxorubicin in Advanced Soft Tissue Sarcomas (STS)|Recruiting||Phase 1|25|Anticipated|University Health Network, Toronto||1|||f||||t|f|f|||t|||No||2017-10-10 21:23:54.949132|2017-10-10 21:23:54.949132
NCT03042806|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-31|||February 2, 2017|Actual|2017-02-02|July 2017|2017-07-01|February 2, 2018|Anticipated|2018-02-02|July 2, 2017|Actual|2017-07-02||Interventional|MaPAct||Validation of a Questionnaire for Physical Activity in COPD: Maugeri Physical Activity Questionnaire (MaPAct)|Validation of a Questionnaire Evaluating the Physical Activities in COPD Patients: the Maugeri Physical Activity Questionnaire - MaPAct|Recruiting||N/A|195|Anticipated|Fondazione Salvatore Maugeri||1|||f||||t|f|f||||||||2017-10-10 21:23:55.066599|2017-10-10 21:23:55.066599
NCT03042793|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-03|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Vaccination With PD-L1 Peptide Against Multiple Myeloma|Vaccination With PD-L1 Peptide With Montanide Against Multiple Myeloma After High Dose Chemotherapy With Stem Cell Support. A Phase I First-in-human Study.|Recruiting||Phase 1|10|Anticipated|Herlev Hospital||1|||f||||t|f|f||||||||2017-10-10 21:23:55.173183|2017-10-10 21:23:55.173183
NCT03042780|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-28|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas|Phase II Trial of FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas|Recruiting||Phase 2|28|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 21:23:55.28497|2017-10-10 21:23:55.28497
NCT03042767|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-26|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Anti-LPS Antibody Treatment for Pediatric NAFLD|Anti-LPS Antibody in Pediatric Nonalcoholic Fatty Liver Disease|Recruiting||Phase 2|40|Anticipated|Emory University||2|||f||||t|t|f||||||||2017-10-10 21:23:55.44614|2017-10-10 21:23:55.44614
NCT03042754|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||June 6, 2011|Actual|2011-06-06|January 2017|2017-01-01|December 1, 2022|Anticipated|2022-12-01|December 1, 2022|Anticipated|2022-12-01||Interventional|||Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals|Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals|Recruiting||N/A|936|Anticipated|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||f|f|f||||||No|only for auditing/monitoring process as needed|2017-10-10 21:23:55.584529|2017-10-10 21:23:55.584529
NCT03042741|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-27|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|May 18, 2018|Anticipated|2018-05-18|February 18, 2018|Anticipated|2018-02-18||Interventional|V6||Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity|Phase II Trial of Daily Dose of Oral Vaccine Against Atherosclerosis|Recruiting||Phase 3|300|Anticipated|Immunitor LLC||2|||f||||f|f|f||||||Undecided|Data will be shared without identification of participants|2017-10-10 21:23:55.71618|2017-10-10 21:23:55.71618
NCT03042728|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-29|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program|Impact of Inclusion of a Dog as Part of the Fibromyalgia Treatment Program on Patient's Physical and Mental Health Functioning - A Randomized Controlled Trial|Recruiting||N/A|230|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-10 21:23:55.846014|2017-10-10 21:23:55.846014
NCT03042715|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-09-23|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Observational|||Psychological Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)|Psychological Intervention to Promote Coping for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)|Completed||N/A|6|Actual|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-10 21:23:55.964564|2017-10-10 21:23:55.964564
NCT03042702|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-08-18|||February 9, 2017|Actual|2017-02-09|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer|A Phase 2 Study of Kevetrin (Thioureidobutyronitrile) in Subjects With Platinum-Resistant/Refractory Ovarian Cancer|Recruiting||Phase 2|10|Anticipated|Cellceutix Corporation||2|||f||||t|t|f||||||||2017-10-10 21:23:56.069576|2017-10-10 21:23:56.069576
NCT03042689|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-02|||January 2017||2017-01-01|February 2017|2017-02-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of Regorafenib in Patients With Advanced Myeloid Malignancies|Phase I Study of Regorafenib in Patients With Advanced Myeloid Malignancies|Not yet recruiting||Phase 1|28|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-10 21:23:56.170892|2017-10-10 21:23:56.170892
NCT03042676|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-03-03|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2027|Anticipated|2027-12-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|AFF||Electronic Database for the Follow up of the ATG_FamilyStudy|Observational, Electronic Database With a Prospective Phase and Retrospective Phase for the Follow up of the ATG_FamilyStudy|Not yet recruiting||N/A|100|Anticipated|St. Orsola Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:23:56.28272|2017-10-10 21:23:56.28272
NCT03042663|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-19|||March 1, 2016|Actual|2016-03-01|June 2017|2017-06-01|October 4, 2017|Anticipated|2017-10-04|September 1, 2017|Anticipated|2017-09-01||Interventional|||Effect of Stellate Ganglion Block on Blood Flow in the Cannulated Radial Artery|Effect of Stellate Ganglion Block on Blood Flow in the Cannulated Radial Artery in Septic Shock Patients on Vasopressors, A Feasibility Study|Recruiting||N/A|34|Anticipated|Cairo University||1|||f||||f|f|f||||||No||2017-10-10 21:23:56.366256|2017-10-10 21:23:56.366256
NCT03042650|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-02-01|||July 2016||2016-07-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Intensive Referral to Reduce Smoking in Probationers|Intensive Referral to Reduce Smoking in Probationers|Recruiting||N/A|150|Anticipated|University of Nebraska||2|||f||||t||||||||Undecided||2017-10-10 21:23:56.523571|2017-10-10 21:23:56.523571
NCT03042637|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-02-01|||January 2012|Actual|2012-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome|Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome|Active, not recruiting||N/A|26|Actual|Southeast Renal Research Institute|||1||f||||t|f|f||||||No||2017-10-10 21:23:56.626595|2017-10-10 21:23:56.626595
NCT03042624|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-02|||January 24, 2017|Actual|2017-01-24|February 2017|2017-02-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis: Randomized, Double-blind Controlled Trial|Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis: Randomized, Double-blind Controlled Trial|Recruiting||N/A|50|Anticipated|University of Milan||2|||f||||f|f|f||||||No||2017-10-10 21:23:56.700277|2017-10-10 21:23:56.700277
NCT03042611|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-09-27|||February 24, 2017|Actual|2017-02-24|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|August 30, 2018|Anticipated|2018-08-30||Interventional|ANGEL||Efficacy and Safety Trial of Apatinib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Patients With Gastric Cancer|A Prospective, Randomized, Double-Blinded, Placebo-Controlled, Multinational, Multicenter, Parallel-group, Phase III Study to Evaluate the Efficacy and Safety of Apatinib Plus Best Supportive Care (BSC) Compared to Placebo Plus BSC in Patients With Advanced or Metastatic Gastric Cancer|Recruiting||Phase 3|459|Anticipated|LSK BioPartners Inc.||2|||f||||t|t|f||||||||2017-10-10 21:23:56.813157|2017-10-10 21:23:56.813157
NCT03042598|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-02-02|||January 14, 2017|Actual|2017-01-14|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|BVAM||Biphasic Ventilation Airway Management Clinical Trial|Is Biphasic Ventilation Airway Management Utilizing Biphasic Cuirass Ventilation a Feasible Method to Provide Ventilation During the Apneic Phase for Patients Undergoing Emergent Rapid Sequence Intubation in the Emergency Department?|Recruiting||N/A|15|Anticipated|University Medical Center of Southern Nevada||1|||f||||t||||||||No|Individual Participant Data (IPD) will not be shared|2017-10-10 21:23:57.083576|2017-10-10 21:23:57.083576
NCT03042585|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-02-02|||June 2006||2006-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL|Phase I Study of Autologous Transplant Conditioned by Dose-Escalated Total Body Irradiation (TBI) and Standard Doses of Cyclophosphamide and Palifermin (Kepivance) for High Risk Non-Hodgkins Lymphoma|Recruiting||N/A|24|Anticipated|Loyola University||4|||f||||t||||||||No||2017-10-10 21:23:57.184646|2017-10-10 21:23:57.184646
NCT03042572|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-05-02|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|SAIL||Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs|Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs; A Double-blind, Randomized, Placebo-controlled Trial|Not yet recruiting||Phase 2/Phase 3|60|Anticipated|UMC Utrecht||2|||f||||t|f|f||||||Undecided|Study outcomes will be published in international peer-reviewed journals and individual participant data (IPD) will become available on request.|2017-10-10 21:23:57.837131|2017-10-10 21:23:57.837131
NCT03042559|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-09|||February 14, 2017|Actual|2017-02-14|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|HRE||Protonics Knee Brace Versus Hamstring Resisted Exercise (HRE) on Individuals With Patellofemoral Pain Syndrome|The Effects of Protonics Knee Brace Versus Hamstring Resisted Exercise on Individuals With Patellofemoral Pain Syndrome|Recruiting||N/A|50|Anticipated|Loma Linda University||2|||f||||f|f|t|f|f||||No||2017-10-10 21:23:57.964981|2017-10-10 21:23:57.964981
NCT03042546|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-05-01|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Calcium Sulfate Spacer in Open Tibia Fractures|Calcium Sulfate Spacer in Open Tibia Fractures With Sub-segmental Bone Loss to Decrease the Need for Secondary Surgery|Recruiting||Phase 4|100|Anticipated|University of Washington||3|||f||||f|t|f||||||No|there is no plan to share individual data|2017-10-10 21:23:58.055382|2017-10-10 21:23:58.055382
NCT03042533|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-05-01|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Union Rate of Transverse Tibia Fracture|Union Rates of Transverse Tibia Fractures Managed With Internal Fracture Compression Through an Intramedullary Rod Compared to Standard Backslapping or Backslapping With Dynamic Locking|Recruiting||N/A|100|Anticipated|University of Washington||3|||f||||f|f|t|f|f||||No|Currently there is no plan|2017-10-10 21:23:58.138836|2017-10-10 21:23:58.138836
NCT03042520|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-02-28|||August 2016||2016-08-01|December 2016|2016-12-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|LONGHEAD||Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment|Long-term Hepatic and Extra-hepatic Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Interferon-free Treatment (LONGHEAD Study)|Recruiting||N/A|200|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||2||f||||f||||||||No||2017-10-10 21:23:58.364272|2017-10-10 21:23:58.364272
NCT03042507|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-06-02|||January 20, 2012|Actual|2012-01-20|June 2017|2017-06-01|January 1, 2020|Anticipated|2020-01-01|December 29, 2012|Actual|2012-12-29||Interventional|CBIT JR||Psychosocial Intervention for Young Children With Chronic Tics|Psychosocial Intervention for Young Children With Chronic Tics|Active, not recruiting||N/A|15|Actual|Weill Medical College of Cornell University||1|||f||||t|f|f||||||Yes||2017-10-10 21:23:58.494971|2017-10-10 21:23:58.494971
NCT03042494|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-08|||May 15, 2016|Actual|2016-05-15|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 25, 2017|Actual|2017-05-25||Interventional|||Effect of Prebiotic Intake on Gut Microbiota in Healthy Adults|Effect of Prebiotic Intake on Gut Microbiota in Healthy Adults|Recruiting||N/A|50|Anticipated|University of Calgary||2|||f||||f|f|f||||||No||2017-10-10 21:23:58.583495|2017-10-10 21:23:58.583495
NCT03042481|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-02|||April 2016||2016-04-01|January 2017|2017-01-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Observational|||Off-therapy Response After Stopping Entecavir or Tenofovir|Comparison and Prediction of Off-therapy Response in Patients of Chronic Hepatitis B Treated With Entecavir or Tenofovir and Achieved Criteria of Stopping Therapy by APASL Guideline|Recruiting||N/A|400|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||||||||||||2017-10-10 21:23:58.677479|2017-10-10 21:23:58.677479
NCT03042468|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-01|||December 2016||2016-12-01|February 2017|2017-02-01|September 2021|Anticipated|2021-09-01|December 2020|Anticipated|2020-12-01||Interventional|||Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC|Phase I Dose-escalation Study of Fractionated Dose 177Lu-PSMA-617 for Progressive Metastatic Castration Resistant Prostate Cancer|Recruiting||Phase 1|46|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-10 21:23:58.774265|2017-10-10 21:23:58.774265
NCT03042455|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-01|||August 31, 2015|Actual|2015-08-31|January 2017|2017-01-01|July 31, 2017|Anticipated|2017-07-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||Combined Repetitive Transcranial Magnetic Stimulation and Robot-Assisted Upper Arm Training in Subacute Stroke Patients|Combined Repetitive Transcranial Magnetic Stimulation and Robot-Assisted Upper Arm Training in Subacute Stroke Patients : Randomized Controlled Trial|Recruiting||N/A|99|Anticipated|Yonsei University||3|||f||||f|f|f||||||Undecided||2017-10-10 21:23:58.890461|2017-10-10 21:23:58.890461
NCT03042442|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-01|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2017|Anticipated|2017-06-30||Observational|CDNPAN||Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy|Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy|Recruiting||N/A|89|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy|||2||f||||t|f|f||||Samples Without DNA|"     Venous blood samples and pancreatic cancer tissue (from EUS FNA and surgery) will be     collected from patients with pancreatic cancer adenocarcinoma at the time of diagnosis. The     blood sample will be immediately prepared by centrifugation at 5000 × g for 5 min. The plasma     samples were stored at −80 °C until use. Tissue will be embedded in paraffin.      Point-of-care bio-markers will be assessed by using western blot analyses and     immunohistochemistry.      The participant will be explicitly asked for consent for storing the plasma sample.   "|No||2017-10-10 21:23:59.001872|2017-10-10 21:23:59.001872
NCT03042429|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-03|||January 1, 2007|Actual|2007-01-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|NB2004-HR||Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients|Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-risk Neuroblastoma|Completed||Phase 3|360|Actual|University of Cologne||2|||f||||t|f|f||||||No||2017-10-10 21:23:59.117862|2017-10-10 21:23:59.117862
NCT03042416|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-05-01|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety|18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety|Recruiting||Phase 3|400|Anticipated|University of Alberta||1|||f||||f|f|f||||||No||2017-10-10 21:23:59.218273|2017-10-10 21:23:59.218273
NCT03042390|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-07|||December 23, 2016|Actual|2016-12-23|December 2016|2016-12-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Observational|CoDAR||Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice|Multicenter Retrospective Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice|Completed||N/A|762|Actual|Fundacion SEIMC-GESIDA|||1||f||||f||||||||||2017-10-10 21:23:59.436677|2017-10-10 21:23:59.436677
NCT03042377|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-15|||March 1, 2015|Actual|2015-03-01|August 2017|2017-08-01|August 30, 2015|Actual|2015-08-30|July 30, 2015|Actual|2015-07-30||Interventional|||Postoperative Pain in Single-visit and Multiple-visit Retreatment Cases|The Clinical Comparative Evaluation Of Postoperative Pain In Single-Visit And Multiple-Visit Pretreatment Cases: A Prospective Randomized Clinical Trial|Completed||Phase 4|80|Actual|Istanbul Medipol University Hospital||4|||f||||f|f|f||||||||2017-10-10 21:23:59.580398|2017-10-10 21:23:59.580398
NCT03042364|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-01|||October 1, 2016|Actual|2016-10-01|October 2016|2016-10-01|December 31, 2017|Anticipated|2017-12-31|May 1, 2017|Anticipated|2017-05-01||Interventional|||Cytokine Profile of the Uterine Secretome After Therapeutic Endometrial Scratching|Cytokine Profile of the Uterine Secretome After Therapeutic Endometrial Scratching|Recruiting||N/A|250|Anticipated|University of Aarhus||2|||f|||||f|f||||||Undecided||2017-10-10 21:23:59.729717|2017-10-10 21:23:59.729717
NCT03042351|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-02-01|||March 2016||2016-03-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Pilot Study for the Urinary Incontinence Treatment|Pilot Study for the Urinary Incontinence Treatment by Using a Pelvic Floor Muscles Restorative Device (E-NNA®)|Completed||N/A|36|Actual|Instituto Palacios||1|||f||||f||||||||No||2017-10-10 21:23:59.881294|2017-10-10 21:23:59.881294
NCT03042338|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-08-02|||March 31, 2017|Actual|2017-03-31|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|CET||Central Executive Training for ADHD|Evaluating the Feasibility of Central Executive Training for Children With ADHD|Recruiting||N/A|30|Anticipated|Florida State University||2|||f||||t|f|f||||||||2017-10-10 21:23:59.995043|2017-10-10 21:23:59.995043
NCT03042325|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-21|||July 30, 2017|Anticipated|2017-07-30|June 2017|2017-06-01|January 15, 2018|Anticipated|2018-01-15|January 15, 2018|Anticipated|2018-01-15||Interventional|||Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus|Prospective, Multi-center, Open-label, Phase IV Study to Evaluate the Safety and Efficacy of Alogliptin as Monotherapy or Add on Therapy in Indian Patients With Type 2 Diabetes Mellitus|Not yet recruiting||Phase 4|300|Anticipated|Takeda||1|||f||||f|f|f||||||||2017-10-10 21:24:00.172113|2017-10-10 21:24:00.172113
NCT03042312|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-06-11|||April 11, 2017|Actual|2017-04-11|June 2017|2017-06-01|April 11, 2019|Anticipated|2019-04-11|April 11, 2018|Anticipated|2018-04-11||Interventional|||Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy|PSMA-directed EndoRadiotherapy of Castration-resISTant Prostate Cancer (PERCIST): A Phase II Clinical Trial|Recruiting||Phase 2|200|Anticipated|Excel Diagnostics and Nuclear Oncology Center||2|||f||||t|t|f||||||No||2017-10-10 21:24:00.279679|2017-10-10 21:24:00.279679
NCT03042299|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-28|||February 3, 2017|Actual|2017-02-03|June 2017|2017-06-01|March 11, 2017|Actual|2017-03-11|March 11, 2017|Actual|2017-03-11||Interventional|||A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation|A Randomized, Open Label, 2-Period, 2-Treatment, Cross-over Phase 1 Study to Evaluate the Bio-equivalence of Single Oral Dose of TAK-536 Pediatric Formulation and TAK-536 Commercial Formulation in Healthy Adult Male Subjects|Completed||Phase 1|28|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 21:24:00.409888|2017-10-10 21:24:00.409888
NCT03042286|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-01-31|||March 2015||2015-03-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|STATIN||SAPhIRE Statin Adverse Drug Reaction|Study of Pharmacogenomic and Pharmacokinetic Risk Factors Associated With Statin Induced Muscle ADRs (Adverse Drug Reactions) in Singapore Population|Recruiting||N/A|1500|Anticipated|National Heart Centre Singapore|||1||f||||f||||||Samples With DNA|"     For patients who are sensitive about having genetic material collected, investigators will     provide the option of not having their DNA analyzed in the informed consent form.   "|No||2017-10-10 21:24:00.503676|2017-10-10 21:24:00.503676
NCT03042273|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-08-17|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|||High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection|A Randomised, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of High Strength Cranberry (Pacran®) in Women With Recurrent Urinary Tract Infections (Cystitis)|Recruiting||N/A|300|Anticipated|Swisse Wellness Pty Ltd||2|||f||||f|f|f||||||||2017-10-10 21:24:00.57936|2017-10-10 21:24:00.57936
NCT03042260|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-04-10|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous|Prophylactic Trimethoprim-Sulfamethoxazole for the Prevention of Serious Infections in Patients With Systemic Lupus Erythematosus: a Randomized Placebo Controlled Trial|Recruiting||Phase 4|310|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t|f|f||||||No|Undecided|2017-10-10 21:24:00.696828|2017-10-10 21:24:00.696828
NCT03042247|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-07-29|||January 24, 2017|Actual|2017-01-24|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|July 31, 2017|Anticipated|2017-07-31||Observational|||Prospective Comparison Between FDG-PET/MR and FDG-PET/CT in Classical Hodgkin Lymphoma and DLBC Non-Hodgkin Lymphoma|Prospective Comparison Between FDG-positron Emission Tomography (FDG-PET)/Magnetic Resonance and FDG-PET/Computed Tomography for Staging, Interim Assessment and Restaging in Classical Hodgkin Lymhoma and DLBC Non-Hodgkin Lymphoma|Recruiting||N/A|50|Anticipated|Federico II University|||1||f||||f|f|f||||||||2017-10-10 21:24:00.837237|2017-10-10 21:24:00.837237
NCT03042234|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-01|||February 2, 2017|Anticipated|2017-02-02|February 2017|2017-02-01|February 2, 2018|Anticipated|2018-02-02|June 30, 2017|Anticipated|2017-06-30||Interventional|||Influence of High-intensity Interval Training in Obese Adolescents With and Without Insulin Resistance ()|Influence of High-intensity Interval Training on the Anaerobic Threshold and Substrates Oxidation in Obese Adolescents With and Without Insulin Resistance|Not yet recruiting||N/A|20|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||3|||f||||||||||||||2017-10-10 21:24:00.927263|2017-10-10 21:24:00.927263
NCT03040596|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-01|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Inhaled Corticosteroids on Vocal Fold Nodules in Children|The Effect of Inhaled Corticosteroids on Vocal Fold Nodules in Children: A Pilot Study|Recruiting||Phase 1|12|Anticipated|University of Pittsburgh||2|||f||||f|t|f|||f|||No||2017-10-10 21:24:16.02358|2017-10-10 21:24:16.02358
NCT03042221|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-29|||April 20, 2016|Actual|2016-04-20|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|||Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR TKI Therapy|Early Rebiopsy to Identify Mechanisms and Biomarkers of Tumor Cell Survival Following Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Targeted Therapy|Recruiting||N/A|20|Anticipated|University of Colorado, Denver|||1||f||||t|f|f||||Samples Without DNA|"     Tumor tissue   "|||2017-10-10 21:24:01.111384|2017-10-10 21:24:01.111384
NCT03042208|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-01|||January 2, 2015|Actual|2015-01-02|February 2017|2017-02-01|October 30, 2015|Actual|2015-10-30|October 30, 2015|Actual|2015-10-30||Interventional|||Weight Watchers and Families|Ripple Effect of a Nationally Available Weight Loss Program on Untreated Family Members|Completed||N/A|260|Actual|University of Connecticut||2|||f||||f|f|f||||||No||2017-10-10 21:24:01.21805|2017-10-10 21:24:01.21805
NCT03042195|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-02-01|||December 2016||2016-12-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SpPN-HNC||Supplementary Postoperative Parenteral Nutrition for Head and Neck Cancer Patients|Supplementary Postoperative Parenteral Nutrition for Head and Neck Cancer Patients - A Randomized Trial|Recruiting||N/A|40|Anticipated|University of Copenhagen||2|||f|||||f|f||||||No||2017-10-10 21:24:01.320484|2017-10-10 21:24:01.320484
NCT03042182|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-08|||February 20, 2017|Actual|2017-02-20|April 2017|2017-04-01|April 20, 2019|Anticipated|2019-04-20|February 20, 2019|Anticipated|2019-02-20||Interventional|cholangio||Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma|Open Label Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma|Recruiting||Phase 1/Phase 2|20|Anticipated|Immunitor LLC||1|||f||||t|f|f||||||No||2017-10-10 21:24:01.437645|2017-10-10 21:24:01.437645
NCT03042169|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|SURGIGAST||Palliative Gastric Resection Plus Chemotherapy Versus Chemotherapy Alone in Stage IV Gastric Cancer|Palliative Gastric Resection Plus Chemotherapy Versus Chemotherapy Alone in Stage IV Gastric Cancer - a Multicenter Prospective Open-labeled, Two-armed, Randomized Controlled Phase III Trial|Not yet recruiting||Phase 3|424|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:24:01.571533|2017-10-10 21:24:01.571533
NCT03042156|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-02-01|||January 2017||2017-01-01|February 2017|2017-02-01||||December 2018|Anticipated|2018-12-01||Observational|||Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy|Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy|Not yet recruiting||N/A|30|Anticipated|University Health Network, Toronto|||1||f||||t||||||||||2017-10-10 21:24:01.67299|2017-10-10 21:24:01.67299
NCT03042143|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||September 2017|Anticipated|2017-09-01|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|REALIST||Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)|Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST): An Open Label Dose Escalation Phase 1 Trial Followed by a Randomized, Double-blind, Placebo-controlled Phase 2 Trial|Not yet recruiting||Phase 1/Phase 2|75|Anticipated|Belfast Health and Social Care Trust||2|||f||||t|f|f||||||Yes||2017-10-10 21:24:01.745261|2017-10-10 21:24:01.745261
NCT03042130|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-05|||February 15, 2017|Anticipated|2017-02-15|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency|Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency|Not yet recruiting||Phase 4|60|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t|t|f||||||No||2017-10-10 21:24:01.857111|2017-10-10 21:24:01.857111
NCT03042104|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01||Interventional|EARLY TAVR||Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis|Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis|Recruiting||N/A|1109|Anticipated|Edwards Lifesciences||2|||f||||t|f|t|f|f||||||2017-10-10 21:24:02.026801|2017-10-10 21:24:02.026801
NCT03042091|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-25|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|January 2018|Anticipated|2018-01-01||Interventional|||Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery|Combined Mechanical and Oral Antibiotic Bowel Preparation Versus Oral Antibiotics Alone for the Reduction of Surgical Site Infection Following Elective Colorectal Resection|Recruiting||Early Phase 1|224|Anticipated|Thomas Jefferson University||2|||f||||f|t|f|||t|||||2017-10-10 21:24:02.134474|2017-10-10 21:24:02.134474
NCT03042078|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-02|||January 2012||2012-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ZFA-PSVT||Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia|Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia|Recruiting||N/A|2200|Anticipated|Tongji Hospital||2|||f||||t||||||||No||2017-10-10 21:24:02.245811|2017-10-10 21:24:02.245811
NCT03042065|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-01|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SIBILANT||Salbutamol in the Pediatric Emergencies: Nebulization Estimated Via AerogeN or Jet|Salbutamol in the Pediatric Emergencies: Nebulization Estimated Via AerogeN or Jet|Not yet recruiting||N/A|60|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||f|f|f||||||No||2017-10-10 21:24:02.349286|2017-10-10 21:24:02.349286
NCT03042052|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-01|||January 1, 2014|Actual|2014-01-01|February 2017|2017-02-01|June 1, 2016|Actual|2016-06-01|May 1, 2016|Actual|2016-05-01||Observational|NDOTOX||Toxin Retrospective Study|Retrospective Study With Botulinic Toxin in Neurogenic Detrusor Overactivity|Completed||N/A|292|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f|t|f|||f|||No||2017-10-10 21:24:02.425879|2017-10-10 21:24:02.425879
NCT03042039|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-08|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|April 30, 2016|Actual|2016-04-30||Observational|CAREWELL||Multi-level Integration for Patients With Complex Needs Facilitated by ICTs. A Shared Approach, Mutual Learning and Evaluation Are Expected to Create Synergies Among the Partners and to Bring Forward Integration of Care in Europe|CareWell - Multi-level Integration for Patients With Complex Needs|Active, not recruiting||N/A|1712|Actual|Him SA|||1||f||||t|f|f||||||||2017-10-10 21:24:02.505531|2017-10-10 21:24:02.505531
NCT03042026|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-05|||June 1, 2012|Actual|2012-06-01|January 2017|2017-01-01|June 1, 2027|Anticipated|2027-06-01|June 1, 2022|Anticipated|2022-06-01||Observational|||Developing a Simple Recognition System of Acromegaly|Developing a Simple Recognition System of Acromegaly|Recruiting||N/A|80|Anticipated|National Taiwan University Hospital|||2||f||||f|f|f||||||No||2017-10-10 21:24:02.60812|2017-10-10 21:24:02.60812
NCT03042013|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-07-07|||February 28, 2017|Actual|2017-02-28|July 2017|2017-07-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study|An Open-label, Multicenter, Rollover Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study|Withdrawn||Phase 2|0|Actual|Astellas Pharma Inc||1||Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.|f||||f|t|f||||||||2017-10-10 21:24:02.66757|2017-10-10 21:24:02.66757
NCT03042000|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-02|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.|A Multicenter, Prospective, Randomized Clinical Trial to Investigate the Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.|Not yet recruiting||N/A|1200|Anticipated|Peking Union Medical College Hospital||6|||f||||t|f|f||||||Undecided||2017-10-10 21:24:02.729498|2017-10-10 21:24:02.729498
NCT03041987|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-02-02|||January 1, 2012|Actual|2012-01-01|February 2017|2017-02-01|December 31, 2026|Anticipated|2026-12-31|December 31, 2021|Anticipated|2021-12-31||Observational|C-STRIDE||Chinese Cohort Study of Chronic Kidney Disease|Chinese Cohort Study of Chronic Kidney Disease|Recruiting||N/A|5000|Anticipated|Peking University First Hospital|||1||f||||t||||||Samples With DNA|"     Blood samples Urine samples DNA   "|Undecided||2017-10-10 21:24:03.002371|2017-10-10 21:24:03.002371
NCT03041974|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-02-01|||March 2011||2011-03-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Observational|IMIB||Impact of Microparticles in Blood on Transfused Patient Outcomes|Cell-derived Microparticles in Red Blood Cell (RBC) Concentrates, and Their Potential Impact on Outcomes of Transfused Patients in Critical Care: a Prospective Multicentre National Cohort Study of Patients Included in the ABLE Trial|Completed||N/A|280|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 21:24:03.15918|2017-10-10 21:24:03.15918
NCT03041961|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-15|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||Aronia Berry Consumption on Vascular Function|Effects of Aronia Berry (Chokeberry) Extract on Vascular Function in Healthy Men: a 3 Month Randomized Controlled Trial.|Completed||N/A|66|Anticipated|King's College London||3|||f||||f|f|f||||||||2017-10-10 21:24:03.253269|2017-10-10 21:24:03.253269
NCT03041948|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||September 1, 2015|Actual|2015-09-01|February 2017|2017-02-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Hernia Repair|Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Hernia Repair|Recruiting||N/A|88|Anticipated|Alberta Children's Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:24:03.385074|2017-10-10 21:24:03.385074
NCT03041935|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||September 1, 2015|Actual|2015-09-01|February 2017|2017-02-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Orchiopexy Repair|Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Orchiopexy Repair|Recruiting||N/A|88|Anticipated|Alberta Children's Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:24:03.551597|2017-10-10 21:24:03.551597
NCT03041922|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-02|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01|1 Day|Observational [Patient Registry]|||Estimation of Changes in Soft Tissue Rigidity of the Buttocks in Sitting Under Weight Bearing Compared to Sitting Without Weight Bearing|Estimation of Changes in Soft Tissue Rigidity of the Buttocks in Sitting Under Weight Bearing Compared to Sitting Without Weight Bearing|Not yet recruiting||N/A|15|Anticipated|HaEmek Medical Center, Israel|||1||f||||t|f|f||||||No||2017-10-10 21:24:03.723299|2017-10-10 21:24:03.723299
NCT03041909|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-03|||August 2016||2016-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001|An Open Label Single Arm Extension Study to Further Evaluate the Safety, Tolerability and Treatment Response of GBT440 in Patients With Sickle Cell Disease Who Participated in the Phase 1 Study GBT440-001|Active, not recruiting||Phase 2|16|Anticipated|Global Blood Therapeutics||1|||f||||f||||||||Yes||2017-10-10 21:24:03.81281|2017-10-10 21:24:03.81281
NCT03041896|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-02-02|||July 2016||2016-07-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|||Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion|Retrospective Evaluation of the Clinical and Radiographic Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion.|Enrolling by invitation||N/A|5000|Anticipated|Paradigm Spine|||3||f||||f||||||||Yes|There are no benefits to the subject as this data is being collected to obtain additional clinical evidence to support publications and marketing.|2017-10-10 21:24:03.902327|2017-10-10 21:24:03.902327
NCT03041883|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-01|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Corneal Collagen Crosslinking to Increase the Resistance of the Support Graft of the KPro Type I Against Corneal Melting|Corneal Collagen Crosslinking to Increase the Resistance of the Graft Used as a Support for the Boston Keratoprosthesis Type I Against Corneal Melting|Recruiting||Phase 1/Phase 2|40|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||Undecided||2017-10-10 21:24:03.988466|2017-10-10 21:24:03.988466
NCT03041870|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|SERODOM||Relationship Between Serotonin and Brain Response to Social Dominance and Emotion Perception.|Relationship Between Serotonin and Brain Response to Social Dominance Perception and Emotion: a Combined [11C]DASB-PET/fMRI Study in Humans|Not yet recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:24:04.112818|2017-10-10 21:24:04.112818
NCT03041857|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-09-28|||December 2013|Actual|2013-12-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Observational|||Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy|Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy|Completed||N/A|30|Actual|Institute for Biomechanics, ETH Zürich|||3||f||||f||||||||||2017-10-10 21:24:04.218298|2017-10-10 21:24:04.218298
NCT03041844|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-22|||January 2017||2017-01-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|August 2021|Anticipated|2021-08-01||Interventional|||Enhanced Ultrasound Treatment of Chronic Wounds With Monitoring of Healing and Quality of Life Outcomes||Recruiting||Phase 2|120|Anticipated|Drexel University||2|||f||||f||||||||Undecided||2017-10-10 21:24:04.29984|2017-10-10 21:24:04.29984
NCT03041831|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-06-26|||August 15, 2016|Actual|2016-08-15|June 2017|2017-06-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Observational|||MOWI Qualitative Assessment|Mobile Health Obesity Wellness Intervention in Rural Older Adults (MOWI): Qualitative Assessment|Completed||N/A|41|Actual|Dartmouth-Hitchcock Medical Center|||4||f||||t||||||||No||2017-10-10 21:24:04.394139|2017-10-10 21:24:04.394139
NCT03041818|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-20|||March 14, 2017|Actual|2017-03-14|February 2017|2017-02-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||Development of Horse-Riding Program Model for Children With Cerebral Palsy|Development of Horse-Riding Program Model for Children With Cerebral Palsy|Active, not recruiting||N/A|12|Actual|The Catholic University of Korea||1|||f||||t|f|f||||||||2017-10-10 21:24:04.479135|2017-10-10 21:24:04.479135
NCT03041805|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-02|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|CAPSIVS||Caprini Score in Venous Surgery: a Prospective Cohort Study|A Prospective Cohort Register Study for Validation of Caprini Score in Patients Undergoing Varicose Vein Surgery|Recruiting||N/A|3000|Anticipated|Pirogov Russian National Research Medical University|||1||f||||f|f|f||||||No||2017-10-10 21:24:04.577186|2017-10-10 21:24:04.577186
NCT03041792|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-10-03|||February 20, 2017|Actual|2017-02-20|October 2017|2017-10-01|December 8, 2017|Anticipated|2017-12-08|December 8, 2017|Anticipated|2017-12-08||Interventional|||Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects|A 6-week, Randomized, Double-blind, Placebo-controlled, Two-arm, Parallel Methodology Study To Assess The Effect Of Liraglutide On Food Intake In Obese Subjects|Recruiting||Phase 1|60|Anticipated|Pfizer||2|||f||||f|t|f||||||||2017-10-10 21:24:04.680762|2017-10-10 21:24:04.680762
NCT03041779|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-02-01|||October 2015||2015-10-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SuPPerP||Comparison Between Rectal Suppository Acetaminophen and Diclofenac Sodium as Analgesia for Postpartum Perineal Tear|A Single Blinded, Open-labelled, Randomized Control Trial Comparing Acetaminophen Rectal Suppository With Diclofenac Rectal Suppository as Analgesia for Perineal Injury Following Childbirth|Completed||Phase 2|909|Actual|Clinical Research Centre, Malaysia||2|||f||||f||||||||Undecided||2017-10-10 21:24:04.771629|2017-10-10 21:24:04.771629
NCT03041766|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-31|||December 6, 2016|Actual|2016-12-06|January 2017|2017-01-01|July 30, 2017|Anticipated|2017-07-30|April 6, 2017|Anticipated|2017-04-06||Interventional|||Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions|Safety and Immunogenicity Evaluation of the Vaccine Candidate Sm14 in Combination With the Adjuvant Glucopyranosyl Lipid A (GLA-SE) in Adults Living in Endemic Regions for S. Mansoni and S. Haematobium in Senegal. A Comparative, Randomized, Open-label Trial|Active, not recruiting||Phase 2|30|Actual|Oswaldo Cruz Foundation||2|||f||||t||||||||No||2017-10-10 21:24:04.873155|2017-10-10 21:24:04.873155
NCT03041753|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-02-02|||September 2015||2015-09-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|RISKS||Reperfusion Injury After Stroke Study|"Reperfusion Injury After Cerebral Ischemia: an in Vivo Study Using Neuro-imaging Markers"|Recruiting||N/A|140|Anticipated|Azienda Ospedaliero-Universitaria Careggi|||1||f||||t||||||Samples Without DNA|"     Blood; thrombus eventually taken during endovascular procedure   "|Undecided||2017-10-10 21:24:04.979555|2017-10-10 21:24:04.979555
NCT03041740|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-21|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|July 2019|Anticipated|2019-07-01||Interventional|FFLOAT||Fluid Filled Lung Oxygenation Assistance Trial|A Pilot Study to Evaluate the Safety of Perflurooctylbromide (PFOB) Partial Liquid Ventilation (PLV) for Up to 10 Days in Neonates With Severe Bronchopulmonary Dysplasia (BPD)|Recruiting||Early Phase 1|20|Anticipated|Children's Hospital of Philadelphia||2|||f||||t|t|f||||||||2017-10-10 21:24:05.076376|2017-10-10 21:24:05.076376
NCT03041727|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-02|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|February 1, 2018|Anticipated|2018-02-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Physiotherapist Approach to Shoulder's Diseases, Differences Between Fascial Manipulation and Standard Exercises|Physiotherapist Approach to Shoulder's Diseases, Differences Between Fascial Manipulation and Standard Exercise|Recruiting||N/A|70|Anticipated|Azienda Ospedaliera Bolognini di Seriate Bergamo||2|||f||||f|f|f||||||No||2017-10-10 21:24:05.174687|2017-10-10 21:24:05.174687
NCT03041714|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-07-20|||April 7, 2017|Actual|2017-04-07|April 5, 2017|2017-04-05|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Observational|||Neurophysiologic Study of Patient With Essential Tremor and Dystonic Tremor|Neurophysiologic Study of Patients With Essential Tremor and Dystonic Tremor|Recruiting||N/A|78|Anticipated|National Institutes of Health Clinical Center (CC)|||3||f||||||||||||||2017-10-10 21:24:05.260917|2017-10-10 21:24:05.260917
NCT03041701|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-10-03|||July 7, 2017|Actual|2017-07-07|September 28, 2017|2017-09-28|October 31, 2021|Anticipated|2021-10-31|January 1, 2021|Anticipated|2021-01-01||Interventional|||Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma|A Phase I/II Trial of the Insulin-Like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in Patients With Embryonal and Alveolar Rhabdomyosarcoma|Recruiting||Phase 1/Phase 2|24|Anticipated|National Institutes of Health Clinical Center (CC)||2|||t|||||t|f||||||||2017-10-10 21:24:05.33624|2017-10-10 21:24:05.33624
NCT03041688|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-02|2017-09-04|||October 13, 2017|Anticipated|2017-10-13|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||MDM2 Inhibitor AMG-232 and Decitabine in Treating Patients With Relapsed, Refractory, or Newly-Diagnosed Acute Myeloid Leukemia|A Phase 1B Study of AMG-232 in Combination With Decitabine in Acute Myeloid Leukemia|Not yet recruiting||Phase 1|40|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:24:05.434516|2017-10-10 21:24:05.434516
NCT03041675|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-05|||February 13, 2017|Anticipated|2017-02-13|February 2017|2017-02-01|August 31, 2017|Anticipated|2017-08-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Effects of Laser Acupuncture Therapy on Paralytic Ileus|Effects of Laser Acupuncture Therapy on Paralytic Ileus|Recruiting||N/A|94|Anticipated|China Medical University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:24:05.525341|2017-10-10 21:24:05.525341
NCT03041662|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||October 31, 2011|Actual|2011-10-31|February 2017|2017-02-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|PSC||Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)|Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)|Completed||N/A|620|Actual|Karolinska University Hospital|||1||f||||f|f|f||||||Undecided||2017-10-10 21:24:05.608233|2017-10-10 21:24:05.608233
NCT03041649|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-02-01|||November 2016||2016-11-01|February 2017|2017-02-01|November 2025|Anticipated|2025-11-01|November 2024|Anticipated|2024-11-01||Interventional|MicKeyVMini||Mic-Key Versus Mini One Family Preference Comparison|Mic-Key Versus Mini: A Prospective, Randomized Trial for Family Preference Comparing Low Profile Balloon Gastrostomy Buttons|Recruiting||N/A|220|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||No||2017-10-10 21:24:05.664162|2017-10-10 21:24:05.664162
NCT03041636|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-09-07|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Administration of Jakafi (Ruxolitinib) to Patients With Previously Untreated High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)|Administration of Jakafi (Ruxolitinib) to Patients With Previously Untreated High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): A Phase II Clinical Trial|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:24:05.740795|2017-10-10 21:24:05.740795
NCT03041623|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-05-17|||December 2016||2016-12-01|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01|3 Years|Observational [Patient Registry]|JIPS||Japanese Idiopathic Interstitial Pneumonias Registry|Japanese Idiopathic Interstitial Pneumonias Registry|Recruiting||N/A|800|Anticipated|North East Japan Study Group|||1||f||||f||||||||||2017-10-10 21:24:05.852444|2017-10-10 21:24:05.852444
NCT03041610|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-02-02|||February 13, 2017|Anticipated|2017-02-13|February 2017|2017-02-01|January 31, 2020|Anticipated|2020-01-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Pedometer-Based Walking Intervention in Patients With Chronic Heart Failure With Reduced Ejection Fraction|Effect of Pedometer-Based Walking Intervention on Functional Capacity and Neurohumoral Modulation in Patients With Chronic Heart Failure With Reduced Ejection Fraction: a Multicenter Randomized Controlled Trial|Not yet recruiting||N/A|200|Anticipated|Charles University, Czech Republic||2|||f||||f|f|f||||||No||2017-10-10 21:24:06.283349|2017-10-10 21:24:06.283349
NCT03041597|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-01|||September 1, 2009|Actual|2009-09-01|February 2017|2017-02-01|December 31, 2015|Actual|2015-12-31|December 31, 2013|Actual|2013-12-31||Interventional|||Dental Implant Supported Removable Dental Prostheses|An Randomized Controlled Trial Comparing Immediate Loading With Conventional Loading Using Cone-anchored Implant Supported Removable Dental Prostheses, a Two Year Follow up|Completed||N/A|15|Actual|Katholieke Universiteit Leuven||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:24:06.34917|2017-10-10 21:24:06.34917
NCT03041584|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-01|||January 2009|Actual|2009-01-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2012|Actual|2012-06-01||Interventional|||Dental Implants Placed by Using a Drill Guide Versus Non-guided Placement. Follow-up Study|Implant-centered Outcomes of Guided Surgery, a 3-year Follow-up: An RCT Comparing Guided Surgery With Non-guided Implant Placement|Completed||N/A|60|Actual|Katholieke Universiteit Leuven||6|||f||||f|f|f||||||Undecided||2017-10-10 21:24:06.412064|2017-10-10 21:24:06.412064
NCT03041571|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-16|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|May 1, 2018|Anticipated|2018-05-01||Observational|||Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students|Patients to People: Examining the Effects of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes in Medical Students. A Qualitative Study|Recruiting||N/A|28|Anticipated|University of Florida|||2||f||||f|f|f||||||No||2017-10-10 21:24:07.968394|2017-10-10 21:24:07.968394
NCT03041558|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||September 2013||2013-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluating Trauma-Informed, Evidence-Informed Interventions for Latino Families Experiencing Domestic Violence|SafeCare+: Implementing & Evaluating Trauma-Informed, Evidence-Informed Interventions for Latino Families Experiencing Domestic Violence & Child Maltreatment|Recruiting||N/A|160|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 21:24:08.058063|2017-10-10 21:24:08.058063
NCT03041545|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-31|||June 1, 2015|Actual|2015-06-01|January 2017|2017-01-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Tracking Physical Activity Throughout Chemotherapy for Breast Cancer|Tracking Physical Activity Throughout Chemotherapy for Breast Cancer|Recruiting||N/A|30|Anticipated|University of California, San Diego|||1||f||||f|f|f||||||No||2017-10-10 21:24:08.144301|2017-10-10 21:24:08.144301
NCT03041532|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-01|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|October 2017|Anticipated|2017-10-01||Interventional|||Impact of Proximal Colon Retroflexion in Colorectal Cancer Screening Programme|Impact of Proximal Colon Retroflexion in Colorectal Cancer Screening Programme: Randomized Trial|Not yet recruiting||N/A|956|Anticipated|Hospital del Río Hortega||2|||f|||||f|f||||||||2017-10-10 21:24:08.221334|2017-10-10 21:24:08.221334
NCT03041519|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-01-31|||October 2011||2011-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|ZFOVA||Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias|Multi-center, Randomized, Controlled, Prospective Trial to Compare the Feasibility, Safety, and Efficacy of Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias.|Recruiting||N/A|300|Anticipated|Tongji Hospital||2|||f||||t||||||||No||2017-10-10 21:24:08.289387|2017-10-10 21:24:08.289387
NCT03041506|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-05|||February 15, 2017|Anticipated|2017-02-15|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Interscalene Nerve Block vs. Sedation for Shoulder Dislocation Reduction|US Guided Interscalene Block Compared With Sedation for Shoulder Dislocation Reduction in the ER|Not yet recruiting||N/A|90|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f|f|f||||||No|We do not plan to share individual participant data (IPD).|2017-10-10 21:24:08.383645|2017-10-10 21:24:08.383645
NCT03041493|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-06-21|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Investigation of the Effects of Electronic Cigarettes on Vascular Health|Investigation of the Effects of Electronic Cigarettes on Vascular Health|Recruiting||N/A|60|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f|||||f|f||||||||2017-10-10 21:24:08.491011|2017-10-10 21:24:08.491011
NCT03041480|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-01|||February 2, 2015|Actual|2015-02-02|January 2017|2017-01-01|November 26, 2015|Actual|2015-11-26|August 23, 2015|Actual|2015-08-23||Observational|||Serum Lipid Levels and Lp-PLA2 in Chronic Periodontitis|The Association Between Periodontal Status, Serum Lipid Levels and Lipoprotein Associated Lipophosphase A2(Lp-PLA2) in Chronic Periodontitis Subjects and Healthy Controls: A Case Control Study|Completed||N/A|75|Actual|Meenakshi Ammal Dental College and Hospital|||3||f||||t|f|f||||||No||2017-10-10 21:24:08.574588|2017-10-10 21:24:08.574588
NCT03041467|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-05-02|||April 25, 2017||2017-04-25||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:24:08.646509|2017-10-10 21:24:08.646509
NCT03041454|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-10|||May 16, 2017|Actual|2017-05-16|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||Testing New Formats for the Presentation of Research Evidence to Health Care Managers and Policy Makers|A Randomized Trial to Compare the Effects of a Novel Versus Traditional Systematic Review Format on the Ability of Health Care Managers and Policy Makers to Understand and Apply Evidence|Recruiting||N/A|308|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 21:24:08.682994|2017-10-10 21:24:08.682994
NCT03041441|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-09-15|||September 14, 2017|Actual|2017-09-14|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 24, 2017|Anticipated|2017-12-24||Interventional|||Non-invasive Estimation of CSF Pressure Using MRI in Patients With Spontaneous Intracranial Hypotension|Non-invasive Estimation of CSF Pressure Using MRI in Patients With Spontaneous Intracranial Hypotension|Recruiting||N/A|10|Anticipated|Duke University||1|||f||||f|f|t|t||f|||||2017-10-10 21:24:08.864005|2017-10-10 21:24:08.864005
NCT03041428|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-07|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|UPV-ECMO||Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)|Effect of Ultraprotective Ventilation on the Lung Inflammatory Response in Patients With Acute Pulmonary Edema Treated With Venoarterial Extracorporeal Oxygenation|Recruiting||N/A|20|Anticipated|Fundación para la Investigación Biosanitaria del Principado de Asturias||1|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:24:08.95785|2017-10-10 21:24:08.95785
NCT03041402|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-02-01|||March 2013||2013-03-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||New Setting of Neurally Adjusted Ventilatory Assist During Mask Noninvasive Ventilation|New Setting of Neurally Adjusted Ventilatory Assist During Postextubation Prophylactic Noninvasive Ventilation Through a Mask: a Physiologic Study|Completed||N/A|14|Actual|Southeast University, China||3|||f||||f||||||||No||2017-10-10 21:24:09.144295|2017-10-10 21:24:09.144295
NCT03041389|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-01|||January 1, 2014|Actual|2014-01-01|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|January 1, 2016|Actual|2016-01-01||Interventional|ACCORD-PD||Computerized Cognitive Behavioral Therapy Trial for Insomnia in Parkinson Disease|A Computerized Cognitive Behavioral Therapy Randomized, Controlled, Pilot Trial for Insomnia in Parkinson Disease (The ACCORD-PD Study)|Completed||N/A|40|Actual|The Cleveland Clinic||2|||f||||f|f|f||||||No|No IPD made available to other researchers.|2017-10-10 21:24:09.239172|2017-10-10 21:24:09.239172
NCT03041376|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-02|||February 13, 2017|Anticipated|2017-02-13|February 2017|2017-02-01|January 31, 2020|Anticipated|2020-01-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Pedometer-Based Walking Intervention in Patients With Chronic Heart Failure With Preserved Ejection Fraction|Effect of Pedometer-Based Walking Intervention on Functional Capacity and Neurohumoral Modulation in Patients With Chronic Heart Failure With Preserved Ejection Fraction: a Multicenter Randomized Controlled Trial|Not yet recruiting||N/A|200|Anticipated|Charles University, Czech Republic||2|||f||||f|f|f||||||No||2017-10-10 21:24:09.32502|2017-10-10 21:24:09.32502
NCT03041363|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-18|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|March 29, 2025|Anticipated|2025-03-29|March 29, 2022|Anticipated|2022-03-29||Interventional|||Treatment Development of Triheptanoin (G1D)|Treatment Development of Triheptanoin (C7) for Glucose Transporter Type I Deficiency (G1D): A Phase I Maximum Tolerable Dose Trial|Recruiting||Phase 1|36|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t|t|f||||||No||2017-10-10 21:24:09.414367|2017-10-10 21:24:09.414367
NCT03041350|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-01-31|||January 2013||2013-01-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SWALS||Smartphone Video-assisted Advanced Life Support of Patients With Out-of-hospital Cardiac Arrest by EMS Under Physician Direction|Smartphone Video-assisted Advanced Life Support of Patients With Out-of-hospital Cardiac Arrest by EMS Under Physician Direction|Completed||N/A|300|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 21:24:09.514323|2017-10-10 21:24:09.514323
NCT03041337|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-31|||June 1, 2015|Actual|2015-06-01|January 2017|2017-01-01|January 1, 2025|Anticipated|2025-01-01|January 1, 2020|Anticipated|2020-01-01|10 Years|Observational [Patient Registry]|RIGHT-Net||Right Heart International NETwork During Exercise in Different Clinical Conditions|Morphological and Functional Response of the Right Heart and Pulmonary Circulation|Recruiting||N/A|1000|Anticipated|Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona|||2||f||||t|f|f||||||No||2017-10-10 21:24:09.592341|2017-10-10 21:24:09.592341
NCT03041324|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-09-14|||May 11, 2017|Actual|2017-05-11|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II|A Phase I, Multicenter, Open-label, Single-dose, Dose-ranging Study to Assess the Safety and Tolerability of SB-913, a rAAV2/6-based Gene Transfer in Subjects With Mucopolysaccharidosis II (MPS II)|Recruiting||Phase 1|9|Anticipated|Sangamo Therapeutics||3|||f||||t|t|f||||||||2017-10-10 21:24:09.684795|2017-10-10 21:24:09.684795
NCT03041311|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-09-15|||April 7, 2017|Actual|2017-04-07|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Extensive Stage Small Cell Lung Cancer (SCLC)|Phase 2 Study of Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib in Patients With Untreated Extensive Stage Small Cell Lung Cancer|Recruiting||Phase 2|100|Anticipated|G1 Therapeutics, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:24:09.790702|2017-10-10 21:24:09.790702
NCT03041298|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-22|2017-03-22||September 2011||2011-09-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Observational|||Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography|Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography|Completed||N/A|1537|Actual|Guerbet|||1||f||||f||||||||No||2017-10-10 21:24:10.010483|2017-10-10 21:24:10.010483
NCT03041285|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-30|||August 31, 2017|Actual|2017-08-31|April 2017|2017-04-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer|Phase I Study of Idronoxil Combined With Radiation Treatment in Men With Metastatic Prostate Cancer|Recruiting||Phase 1|12|Anticipated|Royal North Shore Hospital||2|||f||||t|f|f||||||||2017-10-10 21:24:10.299115|2017-10-10 21:24:10.299115
NCT03041272|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-24|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|AIMS||Aggressive Incidents in Medical Settings Study|Aggressive Incidents in Medical Settings Study|Enrolling by invitation||N/A|12|Anticipated|Yale University|||1||f||||f||||||||No||2017-10-10 21:24:10.471342|2017-10-10 21:24:10.471342
NCT03041246|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-01|||February 1, 2017|Anticipated|2017-02-01|February 2017|2017-02-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Manual Fascial Manipulation in Pregnant Women|The Influence of Manual Fascial Manipulation on the Function of the Pelvic Floor in Pregnant Women|Not yet recruiting||N/A|80|Anticipated|Sheba Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:24:10.612245|2017-10-10 21:24:10.612245
NCT03041233|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-01|||March 27, 2017|Anticipated|2017-03-27|February 2017|2017-02-01|March 27, 2020|Anticipated|2020-03-27|March 27, 2020|Anticipated|2020-03-27|12 Months|Observational [Patient Registry]|||ABLATOR Brazil - Ablation Observational Study (Registry)|ABLATOR Brazil - Ablation Observational Study (Registry)|Not yet recruiting||N/A|400|Anticipated|St. Jude Medical|||1||f||||f|f|f||||||Undecided||2017-10-10 21:24:10.685251|2017-10-10 21:24:10.685251
NCT03041220|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-05|||December 2016||2016-12-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Low Versus High Transverse|Best Incision Site for Obese Patients - Low Versus High Transverse.|Withdrawn||N/A|0|Actual|University of Nebraska|||1|Per PI|f||||f||||||||||2017-10-10 21:24:10.744872|2017-10-10 21:24:10.744872
NCT03041207|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-27|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|July 1, 2019|Anticipated|2019-07-01|January 1, 2019|Anticipated|2019-01-01||Observational|VAIN2||Decreasing Antibiotic Use in Infants With Suspected Ventilator-associated Infection|Decreasing Antibiotic Use in Infants With Suspected Ventilator-associated Infection|Enrolling by invitation||N/A|586|Anticipated|Virginia Commonwealth University|||3||f||||f|f|f||||||No||2017-10-10 21:24:10.810546|2017-10-10 21:24:10.810546
NCT03041194|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-21|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Dietary Impact on Urinary pH in Women With Interstitial Cystitis|Title A Pilot Study to Evaluate the Dietary Impact on Urinary pH in Interstitial Cystitis Pilot Study to Evaluate the Dietary Impact on Urinary pH in Interstitial Cystitis|Completed||N/A|17|Actual|St. Louis University|||1||f||||f||||||||||2017-10-10 21:24:10.896771|2017-10-10 21:24:10.896771
NCT03041181|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-31|||January 27, 2017|Actual|2017-01-27|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Docetaxel Plus Nivolumab or Docetaxel Alone in Patients With Advanced NSCLC Previously Treated With a PD-1 or PD-L1 Inhibitor|Randomized Phase II Trial of Docetaxel Plus Nivolumab or Docetaxel Alone in Patients With Advanced Squamous or Non-squamous NSCLC and Previous Clinical Benefit on Treatment With a PD-1 or PD-L1 Inhibitor: Hoosier Cancer Research Network LUN15-233|Recruiting||Phase 2|58|Anticipated|Hoosier Cancer Research Network||2|||f||||t|t|f|||t|||||2017-10-10 21:24:10.956811|2017-10-10 21:24:10.956811
NCT03041168|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-02-01|||January 2017||2017-01-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors|Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors|Enrolling by invitation||N/A|1000|Anticipated|Thomas Jefferson University|||1||f||||f|f|t|t|f|t|||No||2017-10-10 21:24:11.084786|2017-10-10 21:24:11.084786
NCT03041155|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-15|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|||Respiratory Muscle Training in Hemodialysis Patients|Respiratory Muscle Training in Hemodialysis Patients: Effects on Physiologic Parameters and Endothelium-related Biomarkers|Completed||N/A|48|Actual|Universidade Federal do Ceara||2|||f||||f|f|f||||||||2017-10-10 21:24:11.151039|2017-10-10 21:24:11.151039
NCT03041142|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-02|||October 1, 2015|Actual|2015-10-01|February 2017|2017-02-01|July 3, 2016|Actual|2016-07-03|April 1, 2016|Actual|2016-04-01||Interventional|PANPES||Program of Physical, Nutritional and Psychological Activities With Overweight Schoolchildren|Effects of an Interdisciplinary Intervention Program on Cardiovascular Risk Factors in Children With Overweight and Obesity|Completed||N/A|33|Actual|Universidade Federal do vale do São Francisco||2|||f||||t|f|f||||||No||2017-10-10 21:24:11.228543|2017-10-10 21:24:11.228543
NCT03041129|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-28|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 1, 2022|Anticipated|2022-06-01|June 1, 2021|Anticipated|2021-06-01||Observational|PLUM||Post-Prandial Liver Glucose Metabolism in Polycystic Ovarian Syndrome (PCOS) and Understanding Standard of Care Medications|Post-Prandial Liver Glucose Metabolism in Polycystic Ovarian Syndrome (PCOS) and Understanding Standard of Care Medications|Not yet recruiting||N/A|100|Anticipated|University of Colorado, Denver|||4||f||||f|f|f||||Samples With DNA|"     DNA for hepatic steatosis related genes   "|No||2017-10-10 21:24:11.328757|2017-10-10 21:24:11.328757
NCT03041116|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-09-13|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|PKAN||Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Patients|Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), A Phosphopantothenate Replacement Therapy, in Pantothenate Kinase-Associated Neurodegeneration (PKAN) Patients: A Randomized, Double Blind, Placebo Controlled Study With an Open Label Extension|Recruiting||Phase 3|82|Anticipated|Retrophin, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:24:11.443601|2017-10-10 21:24:11.443601
NCT03041103|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-10-03|||January 31, 2017|Actual|2017-01-31|October 2017|2017-10-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Acceptability and Tolerance of a Protein and Micronutrient Fortified Food|Acceptability and Tolerance of a Protein and Micronutrient Fortified Nutritious Food Product in Californian Adults and Children|Completed||N/A|20|Actual|University of California, Davis||2|||f||||f|f|f||||||||2017-10-10 21:24:11.564661|2017-10-10 21:24:11.564661
NCT03041090|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-01-31|||March 2016||2016-03-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|Lucerno device||Patterns and Prevalence of FDG Extravasation in PET/CT Scans|Patterns and Prevalence of FDG (Fluorodeoxyglucose) Extravasation in PET (Positron Emission Tomography)/CT (Computed Tomography)Scans|Recruiting||N/A|250|Anticipated|St. Louis University||1|||f||||f||||||||Yes|Coded data will be shared with our industry sponsor, Lucerno Dynamics|2017-10-10 21:24:11.672309|2017-10-10 21:24:11.672309
NCT03041077|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-17|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||Influence of Instaflex Advanced Supplement on Joint Function|Influence of Instaflex Advanced Supplement on Joint Function: A Randomized, Placebo-controlled Community Trial|Recruiting||N/A|66|Anticipated|Appalachian State University||2|||f||||f|f|f||||||No|No IPD sharing plan|2017-10-10 21:24:11.772296|2017-10-10 21:24:11.772296
NCT03041064|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-02-03|||May 2016||2016-05-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Multiday Beach Study|A Single Center, Randomized, Split Body and Split Face, Double-Blinded, Multiple Sun Exposure Evaluation of Sunscreens of SPF 50+ and Above Under Actual Use Conditions|Completed||N/A|55|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||Undecided||2017-10-10 21:24:11.866581|2017-10-10 21:24:11.866581
NCT03041051|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-01|||December 2015|Actual|2015-12-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 1, 2017|Anticipated|2017-03-01||Interventional|||Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients|Study of the Immunogenicity and Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Adults|Active, not recruiting||Phase 4|40|Actual|Aghia Sophia Children's Hospital of Athens||2|||f||||t||||||||No||2017-10-10 21:24:11.96003|2017-10-10 21:24:11.96003
NCT03041038|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-09-08|||December 2016||2016-12-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||The Efficacy and Safety of Secukinumab in Patients With Ichthyoses|A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses|Recruiting||Phase 2|36|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 21:24:12.025349|2017-10-10 21:24:12.025349
NCT03041012|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-04-05|||January 20, 2017|Actual|2017-01-20|January 2017|2017-01-01|August 20, 2019|Anticipated|2019-08-20|January 20, 2019|Anticipated|2019-01-20||Interventional|eCLEAR||Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART|Early Administration of Latency Reversing Therapy and Broadly Neutralizing Antibodies to Limit the Establishment of the HIV-1 Reservoir During Initiation of Antiretroviral Treatment - a Randomized Controlled Trial|Recruiting||Phase 2|60|Anticipated|University of Aarhus||4|||f||||t|f|f||||||Undecided|No plan available|2017-10-10 21:24:12.271355|2017-10-10 21:24:12.271355
NCT03040986|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-07-10|||July 21, 2017|Anticipated|2017-07-21|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations|A Phase II Study of Selumetinib (AZD6244) for the Treatment of Advanced Pancreas Cancer Harboring KRAS G12R Mutations|Not yet recruiting||Phase 2|180|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:24:13.005376|2017-10-10 21:24:13.005376
NCT03040973|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-22|||July 4, 2017|Actual|2017-07-04|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Roll-over Study for Patients With cMET-dependent Malignancies Who Previously Completed a Novartis Capmatinib Study|An Open-label, Multi-center, Long-term Safety Follow-up, Roll-over Study in Patients Who Have Completed a Prior Novartis-sponsored Capmatinib (INC280) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Capmatinib|Recruiting||Phase 4|40|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:24:13.104185|2017-10-10 21:24:13.104185
NCT03040947|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-04-05|||March 2016||2016-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|BikeMRI||CMR Sequence and Imaging Protocol Development|Cardiovascular Magnetic Resonance (CMR) Sequence and Imaging Protocol Development|Recruiting||N/A|200|Anticipated|National Heart Centre Singapore|||2||f||||f|f|f||||Samples With DNA|"     Blood samples will be collected from all participants before and after the CMR scan.   "|No||2017-10-10 21:24:13.272325|2017-10-10 21:24:13.272325
NCT03040934|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-01|||July 2017|Anticipated|2017-07-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Firehawk™ Coronary Stent System in the Treatment of Total Coronary Artery Occlusion Lesion(s)|A Prospective, Open Label, Multi-center Trial of Firehawk™ Coronary Stent System in the Treatment of Total Coronary Artery Occlusion Lesion(s) by Optical Coherent Tomography (OCT) and Coronary Angiography|Not yet recruiting||N/A|196|Anticipated|Shanghai MicroPort Medical (Group) Co., Ltd.||2|||f||||t|f|f||||||No||2017-10-10 21:24:13.365816|2017-10-10 21:24:13.365816
NCT03040921|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-08-08|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|July 1, 2020|Anticipated|2020-07-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Uterine Transposition: Feasibility Study|Uterine Transposition: Feasibility Study|Recruiting||N/A|10|Anticipated|Hospital Erasto Gaertner||1|||f||||t|f|f||||||||2017-10-10 21:24:13.477209|2017-10-10 21:24:13.477209
NCT03040908|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-09|||September 1, 2017|Anticipated|2017-09-01|February 2017|2017-02-01|September 30, 2019|Anticipated|2019-09-30|September 1, 2019|Anticipated|2019-09-01||Observational|HEMODREP||New Hemolysis Parameters in Sickle Cell Disease|Evaluation de la capacité Physique Sous Maximale au Moyen du Test de Marche de 6 Minutes Des Enfants et Adultes Jeunes Suivis Pour drépanocytose et Nouveaux paramètres d'hémolyse : Vers Une prédiction Des Complications Vasculaires ?|Not yet recruiting||N/A|150|Anticipated|Queen Fabiola Children's University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:24:13.567659|2017-10-10 21:24:13.567659
NCT03040895|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-31|||February 10, 2016|Actual|2016-02-10|January 2017|2017-01-01|June 20, 2018|Anticipated|2018-06-20|June 20, 2018|Anticipated|2018-06-20||Interventional|ICDP RCT||Effect Evaluation of The International Child Development Programme (ICDP)|Effect Evaluation of The International Child Development Programme (ICDP)|Recruiting||N/A|1000|Anticipated|Norwegian Institute of Public Health||2|||f|||||f|f||||||No||2017-10-10 21:24:13.630783|2017-10-10 21:24:13.630783
NCT03040882|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-01|||July 1, 2016|Actual|2016-07-01|January 2017|2017-01-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||Cotton Sock in Pediatric Patients With Leg-foot Splint|Effectiveness of Cotton Sock in Pediatric Patients With Leg-foot Splint After Surgery for Correction of the Foot, in Reducing the Incidence of Cutaneous Lesions. Randomized Controlled Trial.|Completed||N/A|100|Actual|Istituto Ortopedico Rizzoli||2|||f||||f|f|f||||||No||2017-10-10 21:24:13.733528|2017-10-10 21:24:13.733528
NCT03040869|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-02-01|||February 1, 2017|Anticipated|2017-02-01|February 2017|2017-02-01|July 31, 2020|Anticipated|2020-07-31|January 31, 2020|Anticipated|2020-01-31|3 Months|Observational [Patient Registry]|||Risk Facotors in Young CHD Patients|Risk Factors Investigation in Young Patients With Coronary Artery Disease and Their Clinical Follow-up|Not yet recruiting||N/A|1000|Anticipated|Shanghai Zhongshan Hospital|||2||f||||t|f|f||||||Undecided|laboratory test|2017-10-10 21:24:13.845043|2017-10-10 21:24:13.845043
NCT03040856|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-03-21|||May 1, 2017|Anticipated|2017-05-01|February 2017|2017-02-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy|The Effect of Alpha Linolenic Acid (ALA) Supplementation on Essential Fatty Acids Profile During Pregnancy Compared to Common Supplements and the Epigenetic Effect on the Newborn|Not yet recruiting||N/A|150|Anticipated|Sheba Medical Center||3|||f||||f|f|f|||f|||No||2017-10-10 21:24:13.918353|2017-10-10 21:24:13.918353
NCT03040843|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-09-20|||January 2017||2017-01-01|September 2017|2017-09-01|June 2017||2017-06-01|June 2017|Actual|2017-06-01||Observational|||Documentation of Altered Mental Status|Documentation of Altered Mental Status|Completed||N/A|1200|Actual|Nevsehir Public Hospital|||1||f||||||||||||||2017-10-10 21:24:14.028804|2017-10-10 21:24:14.028804
NCT03040830|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-01|||November 1, 2015|Actual|2015-11-01|January 2017|2017-01-01|January 1, 2017|Actual|2017-01-01|October 30, 2016|Actual|2016-10-30||Interventional|||Effect of Timing Progesterone Luteal Support on Embryo Transfer|Does the Time of Starting Progesterone (P4) Luteal Support (LS) Affects Embryo Transfer (ET) in Long Agonist Protocol Down-regulated ICSI Cycles?|Completed||Phase 4|150|Actual|Mansoura Integrated Fertility Center||2|||f|||||f|f||||||||2017-10-10 21:24:14.14261|2017-10-10 21:24:14.14261
NCT03040817|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-26|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 16, 2019|Anticipated|2019-12-16|August 16, 2019|Anticipated|2019-08-16||Interventional|||Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China|Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China|Recruiting||N/A|50|Anticipated|Zhongda Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:24:14.237137|2017-10-10 21:24:14.237137
NCT03040804|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-06|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|RTHS||Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa|A Phase I Study of Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa|Recruiting||N/A|20|Anticipated|Montefiore Medical Center||1|||f||||t|f|t|f|f|f|||||2017-10-10 21:24:14.365893|2017-10-10 21:24:14.365893
NCT03040791|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-19|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|ImmunoProst||Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)|Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)|Not yet recruiting||Phase 2|29|Anticipated|Hospital Moinhos de Vento||1|||f||||t|t|f|||t|||||2017-10-10 21:24:14.474041|2017-10-10 21:24:14.474041
NCT03040778|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-02|||February 15, 2017||2017-02-15|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)|Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment|Not yet recruiting||Phase 3|100|Anticipated|University of Washington||2|||f||||t||||||||No||2017-10-10 21:24:14.586818|2017-10-10 21:24:14.586818
NCT03040765|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-07-24|||September 2017|Anticipated|2017-09-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|DOHA||Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis|Denosumab Versus Zoledronic Acid for Patients With Beta-Thalassemia Major-Induced Osteoporosis|Not yet recruiting||Phase 3|20|Anticipated|Hamad Medical Corporation||2|||f||||t|f|f|||f|||||2017-10-10 21:24:14.738533|2017-10-10 21:24:14.738533
NCT03040752|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor|Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor: A Randomized Controlled Trial|Completed||Phase 4|200|Actual|Cairo University||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:24:14.871211|2017-10-10 21:24:14.871211
NCT03040739|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-04|||July 8, 2016|Actual|2016-07-08|September 2017|2017-09-01|June 15, 2017|Actual|2017-06-15|January 1, 2017|Actual|2017-01-01|1 Day|Observational [Patient Registry]|||Treatment of Acetabulum Fracture With O'ARM Surgical Imaging|Treatment of Acetabulum Fracture With O'ARM Surgical Imaging|Completed||N/A|56|Actual|Groupe Hospitalier Paris Saint Joseph|||2||f||||f|f|f||||||||2017-10-10 21:24:14.969378|2017-10-10 21:24:14.969378
NCT03040726|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-11|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Netupitant and Palonosetron (AKYNZEO) for Chronic Nausea and Vomiting in Cancer Patients|Fixed-Dose Netupitant and Palonosetron for Chronic Nausea and Vomiting in Cancer Patients|Recruiting||Phase 2/Phase 3|42|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:24:15.050322|2017-10-10 21:24:15.050322
NCT03040713|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-25|||April 11, 2017|Actual|2017-04-11|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Flortaucipir PET Imaging in Subjects With FTD|18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia|Recruiting||Phase 1|25|Anticipated|Avid Radiopharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 21:24:15.166207|2017-10-10 21:24:15.166207
NCT03040700|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-31|||November 2014||2014-11-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Interventional|FAMOUS||Follow-up of Patients With Multivessel Coronary Artery Disease After CABG|"Long-term Follow-up of Patients With Multivessel Coronary Artery Disease Undergoing CABG - Comparison Between Functional, Anatomical, or Medical Only-Based Evaluation to Prevent Cardiovascular Events - The FAMOUS Trial"|Recruiting||N/A|600|Anticipated|Ministry of Health, Brazil||3|||f||||t||||||||No||2017-10-10 21:24:15.260448|2017-10-10 21:24:15.260448
NCT03040687|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-07-07|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|April 2017|Actual|2017-04-01||Interventional|||Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge|Protective Efficacy of Orally Delivered Bovine Serum Immunoglobulin (BSIgG) Specific for the Colonization Factor CS6 Following Challenge With the CS6-expressing Enterotoxigenic E. Coli (ETEC) Strain B7A|Active, not recruiting||Phase 1|60|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||f||||||||||2017-10-10 21:24:15.360889|2017-10-10 21:24:15.360889
NCT03040674|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-07-20|||January 3, 2017|Actual|2017-01-03|July 2017|2017-07-01|April 5, 2018|Anticipated|2018-04-05|January 3, 2018|Anticipated|2018-01-03||Observational|||An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease|An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease|Recruiting||N/A|200|Anticipated|Lung Institute|||1||f||||t|f|f||||||||2017-10-10 21:24:15.451864|2017-10-10 21:24:15.451864
NCT03040661|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-29|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|May 1, 2018|Anticipated|2018-05-01|February 1, 2018|Anticipated|2018-02-01||Interventional|Figure 8||Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture|Randomized Trial of Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture|Recruiting||N/A|100|Anticipated|Inova Health Care Services||2|||f|||||f|f||||||||2017-10-10 21:24:15.534402|2017-10-10 21:24:15.534402
NCT03040648|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-01-31|||April 1, 2016|Actual|2016-04-01|January 2017|2017-01-01|January 1, 2017|Actual|2017-01-01|December 30, 2016|Actual|2016-12-30||Interventional|||Detection of Intravascular Penetration During Cervical Transforaminal Epidural Block|Detection of Intravascular Penetration During Cervical Transforaminal Epidural Block: a Comparison of Digital Subtraction Angiography and Real Time Fluoroscopy|Completed||N/A|128|Actual|Kyungpook National University||2|||f||||t|f|f||||||No||2017-10-10 21:24:15.608339|2017-10-10 21:24:15.608339
NCT03040635|ClinicalTrials.gov processed this data on October 10, 2017|2017-02-01|2017-10-02|||March 22, 2017|Actual|2017-03-22|October 2017|2017-10-01|October 6, 2017|Anticipated|2017-10-06|October 6, 2017|Anticipated|2017-10-06||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7034067 in Healthy Japanese Participants|An Investigator/Subject Blind, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of RO7034067 in Healthy Japanese Subjects|Recruiting||Phase 1|32|Anticipated|Hoffmann-La Roche||4|||f||||f|t|f||||||||2017-10-10 21:24:15.679835|2017-10-10 21:24:15.679835
NCT03040622|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-06-30|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial|The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial|Recruiting||N/A|30|Anticipated|Inova Health Care Services|||1||f|||||f|t|f|f||||||2017-10-10 21:24:15.774766|2017-10-10 21:24:15.774766
NCT03040609|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-07-31|||July 20, 2017|Actual|2017-07-20|November 2016|2016-11-01|December 20, 2019|Anticipated|2019-12-20|July 20, 2019|Anticipated|2019-07-20||Observational|PLH-Vision||Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision)|Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision)|Recruiting||N/A|310|Anticipated|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||||||2017-10-10 21:24:15.880408|2017-10-10 21:24:15.880408
NCT03040583|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-20|||September 2016||2016-09-01|January 2017|2017-01-01|September 2030|Anticipated|2030-09-01|September 2030|Anticipated|2030-09-01|20 Years|Observational [Patient Registry]|ASSESS||The ASSESS National Multi-center Prospective Cohort|Assessment of Systemic Complications (Signs) and Evolution From Patients With Sjögren's Syndrome (ASSESS)|Recruiting||N/A|395|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||No||2017-10-10 21:24:16.19364|2017-10-10 21:24:16.19364
NCT03040570|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-31|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|Oxy-PICU||Conservative Versus Liberal Oxygenation Targets in Critically Ill Children|A Randomised Pilot Multiple Centre Trial of Conservative Versus Liberal Oxygenation Targets in Critically Ill Children|Not yet recruiting||N/A|120|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 21:24:16.294764|2017-10-10 21:24:16.294764
NCT03040557|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2017-02-02|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|April 1, 2018|Anticipated|2018-04-01|February 1, 2017|Actual|2017-02-01||Interventional|||Flexible Footwear and Insole in Heel Pain|Therapeutic Effect of Flexible Footwear and Insoles on Clinical Aspects, Functional and Biomechanical of the Individuals With Heel Pain|Recruiting||Phase 1/Phase 2|75|Anticipated|University of Sao Paulo||2|||f||||t|f|f||||||No||2017-10-10 21:24:16.44543|2017-10-10 21:24:16.44543
NCT03040544|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-01-31|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|NOVICE||"Randomized Study to Investigate Laparoscopic Skills by Physicians in the First Year of Further Education After Completing the Lübeck Toolbox Curriculum (NOVICE Study)"|"Randomized Study to Investigate Laparoscopic Skills by Physicians in the First Year of Further Education After Completing the Lübeck Toolbox Curriculum (NOVICE Study)"|Recruiting||N/A|12|Anticipated|University of Schleswig-Holstein||2|||f|||||f|f||||||||2017-10-10 21:24:16.564161|2017-10-10 21:24:16.564161
NCT03040531|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-03-01|||January 19, 2017|Actual|2017-01-19|March 2017|2017-03-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis|Metabolic, Endocrine, and Central Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis|Recruiting||Phase 2/Phase 3|200|Anticipated|University of Messina||2|||f||||t|f|f||||||No||2017-10-10 21:24:16.655772|2017-10-10 21:24:16.655772
NCT03040518|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-01-31|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Game of Stones: A Research Study That Texts Men to Help Them Lose Weight|Feasibility Study of How Best to Engage Obese Men in Narrative SMS (Short Message System) and Incentive Interventions for Weight Loss, to Inform a Future Effectiveness and Cost-effectiveness Trial|Not yet recruiting||N/A|105|Anticipated|University of Stirling||3|||f||||f|f|f||||||No||2017-10-10 21:24:16.771458|2017-10-10 21:24:16.771458
NCT03040505|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-07|||April 5, 2017|Actual|2017-04-05|September 2017|2017-09-01|May 30, 2021|Anticipated|2021-05-30|April 30, 2020|Anticipated|2020-04-30||Observational|FutureProSchiz||Future Mental Projections in Schizophrenia|Future Mental Projections in Schizophrenia|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||2||f||||f|f|f||||||||2017-10-10 21:24:16.874773|2017-10-10 21:24:16.874773
NCT03040492|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-31|||October 31, 2012|Actual|2012-10-31|January 2017|2017-01-01|June 6, 2018|Anticipated|2018-06-06|May 1, 2015|Actual|2015-05-01||Observational|||Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk|Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risks in Alabama Population|Active, not recruiting||N/A|200|Actual|University of Alabama at Birmingham|||1||f||||f|f|f||||None Retained|"     Biospecimens retained for further analysis of polymorphisms   "|No||2017-10-10 21:24:16.954836|2017-10-10 21:24:16.954836
NCT03040479|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-25|||March 14, 2017|Actual|2017-03-14|July 2017|2017-07-01|July 17, 2017|Actual|2017-07-17|July 17, 2017|Actual|2017-07-17||Interventional|||Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function|A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function|Completed||Phase 1|24|Actual|CoLucid Pharmaceuticals||3|||f||||f|t|f||||||||2017-10-10 21:24:17.015903|2017-10-10 21:24:17.015903
NCT03040466|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-07-25|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope|Randomized Controlled Trial Comparing Disposable to Reusable Flexible Ureteroscope for Treatment of Upper Urinary Tract Stone|Not yet recruiting||N/A|360|Anticipated|University of California, San Francisco||3|||f||||t|f|t|f||f|||||2017-10-10 21:24:17.102716|2017-10-10 21:24:17.102716
NCT03040453|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-01|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|IRAL||Immunological Response After Ablative Therapy in the Liver|Comparison of Immunological Response After Microwave Ablation and Irreversible Electroporation of Hepatocellular Carcinoma|Recruiting||N/A|40|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||No||2017-10-10 21:24:17.229918|2017-10-10 21:24:17.229918
NCT03040440|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||June 1, 2016|Actual|2016-06-01|January 2017|2017-01-01|December 30, 2016|Actual|2016-12-30|December 15, 2016|Actual|2016-12-15||Interventional|||Comparison of the Cuff Pressure of TaperGuard and Cylindrical- Endotracheal Tube During Laparoscopic Surgery|Comparison of the Cuff Pressure of TaperGuard Endotracheal Tube and Cylindrical- Endotracheal Tube During Laparoscopic Surgery|Completed||N/A|64|Actual|Kyungpook National University||2|||f||||t|f|f||||||Yes||2017-10-10 21:24:17.355567|2017-10-10 21:24:17.355567
NCT03040427|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-01|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis|The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis|Recruiting||Phase 4|40|Anticipated|The Cleveland Clinic||1|||f||||f|t|f||||||No||2017-10-10 21:24:17.468154|2017-10-10 21:24:17.468154
NCT03040414|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-09|||December 1, 2017|Anticipated|2017-12-01|February 2017|2017-02-01|June 29, 2020|Anticipated|2020-06-29|December 31, 2019|Anticipated|2019-12-31||Interventional|||A Crossover Study Comparing Two Automated Insulin Delivery System Algorithms in Adolescents and Young Adults With Type 1 Diabetes|A Crossover Study Comparing Two Automated Insulin Delivery System Algorithms (PID vs. PID + Fuzzy Logic) in Adolescents and Young Adults With Type 1 Diabetes|Not yet recruiting||N/A|112|Anticipated|HealthPartners Institute||2|||f||||t|f|t|t|f||||Undecided||2017-10-10 21:24:17.633644|2017-10-10 21:24:17.633644
NCT03040401|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-04-28|||February 15, 2017|Actual|2017-02-15|January 2017|2017-01-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)|A Phase I/II, Open-Label, Multicenter Study of the Safety, Efficacy and Immune Response of Histamine Dihydrochloride and Low-dose Interleukin-2 in Chronic Myelomonocytic Leukemia (CMML)|Recruiting||Phase 1/Phase 2|15|Anticipated|Vastra Gotaland Region||3|||f||||f|f|f||||||No||2017-10-10 21:24:17.851813|2017-10-10 21:24:17.851813
NCT03040388|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-08|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|August 8, 2019|Anticipated|2019-08-08|August 8, 2019|Anticipated|2019-08-08||Observational|||Exploring Effects of Electroconvulsive Therapy on the Human Brain in Depression - The Danish ECT/MRI Study|Predicting Effects and Risk of Relapse Into Depression - The Danish ECT/MRI Project|Recruiting||N/A|60|Anticipated|University of Copenhagen|||1||f||||f||||||Samples With DNA|"     Whole blood samples are kept in the biobank until the last enrolled patient has been     examined. They will be then analysed for S100B-protein concentration and destroyed. Whole     blood, serum and plasma samples are kept in the biobank until the last enrolled patient has     been examined. They will then be analysed for concentrations of BDNF and VEGF and destroyed.     Extra whole blood samples are stored in the psychiatric biobank for the future research (as     part of another protocol - PSV-2001-04, I-Suite 00422 - ID nr 2001-54-798)   "|||2017-10-10 21:24:18.010684|2017-10-10 21:24:18.010684
NCT03040375|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-31|||November 2014||2014-11-01|November 2014|2014-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Integrating Infant Feeding Counselling With Psychosocial Stimulation to Improve Child Growth and Development in Urban Slum of Bangladesh|Integrating Infant Feeding Counselling With Psychosocial Stimulation|Completed||N/A|365|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f||||||||No||2017-10-10 21:24:18.170636|2017-10-10 21:24:18.170636
NCT03040362|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-05-10|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|May 6, 2017|Actual|2017-05-06|May 6, 2017|Actual|2017-05-06||Interventional|||Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration|A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Lasmiditan Following Single Oral Dose Administration in Healthy Male and Female Subjects|Completed||Phase 1|8|Actual|CoLucid Pharmaceuticals||1|||f||||f|t|f||||||No||2017-10-10 21:24:18.247264|2017-10-10 21:24:18.247264
NCT03040349|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-31|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|TiTAN||Tobacco Treatment TrAining Network in Greece & Cyprus|Evaluation of the Primary Care Tobacco Treatment TrAining Network in Greece & Cyprus|Not yet recruiting||N/A|300|Anticipated|University of Crete||1|||f||||f|f|f||||||No||2017-10-10 21:24:18.324515|2017-10-10 21:24:18.324515
NCT03040336|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-06-06|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|November 30, 2017|Anticipated|2017-11-30|July 31, 2017|Anticipated|2017-07-31||Interventional|||Piloting Prehabilitation Before Abdominal Surgery|Pilot Testing Prehabilitation Services Aimed at Improving Outcomes of Frail Veterans Following Major Abdominal Surgery|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 21:24:18.434761|2017-10-10 21:24:18.434761
NCT03040323|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-04-25|||December 22, 2016|Actual|2016-12-22|April 2017|2017-04-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses|Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses|Recruiting||Phase 4|300|Anticipated|Indiana University||2|||f||||t|t|f|||t|||No||2017-10-10 21:24:18.534294|2017-10-10 21:24:18.534294
NCT03040310|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-03-06|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Personalized Back Rx Exercise Program as a Treatment for Discogenic Low Back Pain|Personalized Back Rx Exercise Program With Coaching, Social Support, and Sensor-assisted Assessments as a Treatment for Discogenic Low Back Pain: A Prospective Pilot Study|Active, not recruiting||N/A|98|Actual|Hospital for Special Surgery, New York||1|||f|||||f|f||||||||2017-10-10 21:24:18.614477|2017-10-10 21:24:18.614477
NCT03040297|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-01|||November 2016||2016-11-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Parallel Oxygen Delivery Through a Tracheal Gas Insufflation (TGI) and a T-piece, on Blood Gases and Respiratory Rate, in ICU Tracheostomized Patients|Effect of Parallel Oxygen Delivery Through a Tracheal Gas Insufflation (TGI) and a T-piece on Blood Gases and Respiratory Rate in ICU Tracheostomized Patients as an Extra Supporting Method During Weaning From Mechanical Ventilation.|Recruiting||N/A|11|Anticipated|Attikon Hospital||3|||f||||t|f|f||||||No||2017-10-10 21:24:18.691931|2017-10-10 21:24:18.691931
NCT03040284|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-31|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|HEMAPIC||Non Invasive Measurements of Intracranial Pressure After Aneurysmal Subarachnoid Hemorrhage|Non Invasive Measurements of Intracranial Pressure After Aneurysmal Subarachnoid Hemorrhage|Recruiting||N/A|140|Anticipated|University Hospital, Clermont-Ferrand||1|||f|||||f|f||||||||2017-10-10 21:24:18.798261|2017-10-10 21:24:18.798261
NCT03040271|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-31|||February 10, 2009|Actual|2009-02-10|January 2017|2017-01-01|June 10, 2013|Actual|2013-06-10|June 10, 2013|Actual|2013-06-10||Interventional|||Interventions to Promote Healthy Eating and Physical Activity in Lebanese School Children Targeting Overweight and Obesity.|Interventions to Promote Healthy Eating and Physical Activity in Lebanese School Children Targeting Overweight and Obesity.|Completed||N/A|2276|Actual|American University of Beirut Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:24:18.880241|2017-10-10 21:24:18.880241
NCT03040258|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-31|||March 10, 2008|Actual|2008-03-10|January 2017|2017-01-01|March 10, 2010|Actual|2010-03-10|March 10, 2010|Actual|2010-03-10||Interventional|||Interventions to Promote Healthy Eating and Physical Activity in Lebanese School Children Targeting Overweight and Obesity- Pilot Study|Interventions to Promote Healthy Eating and Physical Activity in Lebanese School Children Targeting Overweight and Obesity-Pilot Study|Completed||N/A|374|Actual|American University of Beirut Medical Center||2|||f||||t|f|f||||||No||2017-10-10 21:24:18.94687|2017-10-10 21:24:18.94687
NCT03040245|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-01|||June 2015||2015-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|WHIPLASH||Measuring the Impact of the French Version of the Whiplash Book|Measuring the Impact of the French Version of the Whiplash Book on Both Treatment Approach and Fears and Beliefs Among Emergency Physicians|Completed||N/A|95|Actual|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-10 21:24:19.011647|2017-10-10 21:24:19.011647
NCT03040232|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-31|||January 2016||2016-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Outcomes Following Patellar Dislocation in Young Athletes|Clinical Outcomes Following Patellar Dislocation in Young Athletes|Recruiting||N/A|100|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No||2017-10-10 21:24:19.096668|2017-10-10 21:24:19.096668
NCT03040219|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-03-11|||April 1, 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Folic Acid Supplementation as an Appetizer in Primary Malnourished Egyptian Infants and Children|Folic Acid Supplementation as an Appetizer in Primary Malnourished Egyptian Infants and Children|Not yet recruiting||Phase 4|100|Anticipated|Ain Shams University||2|||f||||t|t|f|||t|||Undecided||2017-10-10 21:24:19.173626|2017-10-10 21:24:19.173626
NCT03040206|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-06|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Observational|||Risk Stratification of Nodal PTCL|Multicenter Study to Assess the Prognostic Significances of NCCN-IPI and Post-treatment PET Results in Patients With Newly Diagnosed Nodal PTCL|Active, not recruiting||N/A|405|Actual|Chonbuk National University Hospital|||1||f||||t|f|f||||||||2017-10-10 21:24:19.251762|2017-10-10 21:24:19.251762
NCT03040193|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-06-28|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|NEBULA||Nebulized Lignocaine for Topical Airway Anesthesia During Flexible Bronchoscopy: A Randomized Controlled Trial|Nebulized Lignocaine for Topical Airway Anesthesia During Flexible Bronchoscopy: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t|f|f||||||Undecided||2017-10-10 21:24:19.32722|2017-10-10 21:24:19.32722
NCT03040180|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-30|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|nECT||Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer|Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Randomized Clinical Phase II Trial|Recruiting||Phase 2|40|Anticipated|Zealand University Hospital||2|||f||||t||||||||Undecided|Undecided|2017-10-10 21:24:19.453921|2017-10-10 21:24:19.453921
NCT03040167|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-07-18|||October 2017|Anticipated|2017-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|BPCAM||The Pectoral Block for Breast Augmentation Surgery|The Pectoral Block for Breast Augmentation Surgery: a Volunteers' and Patients' Study.|Not yet recruiting||Phase 4|20|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t|f|f||||||||2017-10-10 21:24:19.624895|2017-10-10 21:24:19.624895
NCT03040154|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||June 2016||2016-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Engaging Immigrants in Preventive Parenting Interventions|Engaging Immigrants in Preventive Parenting Interventions|Completed||N/A|215|Actual|Children's Hospital Los Angeles||2|||f||||f||||||||No||2017-10-10 21:24:19.767948|2017-10-10 21:24:19.767948
NCT03040141|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-30|||June 2017|Anticipated|2017-06-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study to Evaluate the Efficacy and Safety of Intravenous VIS410 in Addition to Oseltamivir (Tamiflu®) Compared With Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support|Phase 2b, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of Intravenous VIS410 in Addition to Oseltamivir (Tamiflu®) Compared With Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support|Not yet recruiting||Phase 2|390|Anticipated|Visterra, Inc.||3|||f||||t|t|f||||||No||2017-10-10 21:24:19.841601|2017-10-10 21:24:19.841601
NCT03040128|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-30|||June 27, 2013|Actual|2013-06-27|January 2017|2017-01-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Use of Minocycline in Intracerebral Hemorrhage|Minocycline and Matrix Metalloproteinase Inhibition in Acute Intracerebral Hemorrhage: A Pilot Trial|Completed||Phase 1/Phase 2|20|Actual|University of Tennessee Health Science Center||2|||||||t|t|f||||||No||2017-10-10 21:24:19.913602|2017-10-10 21:24:19.913602
NCT03040115|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-30|||August 2015||2015-08-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|||Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome|Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome|Recruiting||N/A|100|Anticipated|University of Cincinnati|||1||f||||t||||||||||2017-10-10 21:24:19.977166|2017-10-10 21:24:19.977166
NCT03040102|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-03-21|||March 9, 2017|Actual|2017-03-09|March 2017|2017-03-01|February 25, 2022|Anticipated|2022-02-25|February 25, 2020|Anticipated|2020-02-25||Interventional|||Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers|Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers|Recruiting||N/A|300|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:24:20.070179|2017-10-10 21:24:20.070179
NCT03040089|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-30|||March 9, 2016|Actual|2016-03-09|January 2017|2017-01-01|September 26, 2016|Actual|2016-09-26|July 15, 2016|Actual|2016-07-15||Interventional|||Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 595 nm|Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Laser Therapy Using 1,064 nm and 595 nm on Patients With Melasma: A Prospective, Multi-center, Split Face, 2% Hydroquinone Cream-controlled Clinical Trial|Completed||N/A|40|Actual|LUTRONIC Corporation||2|||f||||f|f|f||||||No||2017-10-10 21:24:20.177818|2017-10-10 21:24:20.177818
NCT03040076|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-06-28|||December 2016||2016-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Testing if Reductions in Negative Affect Yield Decreased Emotional Eating Symptoms|Testing if Reductions in Negative Affect Yield Decreased Emotional Eating Symptoms: A Cognitive Bias Intervention|Active, not recruiting||N/A|80|Anticipated|Florida State University||2|||f||||f||||||||No||2017-10-10 21:24:20.377042|2017-10-10 21:24:20.377042
NCT03040063|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||August 1, 2016|Actual|2016-08-01|January 2017|2017-01-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|EVAR-P||Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery|Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery and Acute Limb Ischemia|Recruiting||N/A|30|Anticipated|Charles University, Czech Republic||2|||f||||f|f|f||||||No||2017-10-10 21:24:20.506878|2017-10-10 21:24:20.506878
NCT03040050|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-31|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|January 1, 2025|Anticipated|2025-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Rapid PCR to Guide Antibiotic Therapy at the Time of Prostate Biopsy|Rapid PCR to Guide Antibiotic Therapy at the Time of Prostate Biopsy|Recruiting||N/A|136|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f|||||f|f||||||||2017-10-10 21:24:20.608798|2017-10-10 21:24:20.608798
NCT03040037|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-01-31|||December 2016||2016-12-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|||Cryoballoon Atrial Fibrillation Ablation Registry|Prospective Registry of Atrial Fibrillation Cryoballoon Ablation in the Russian Federation|Recruiting||N/A|1500|Anticipated|Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health|||1||f||||||||||||||2017-10-10 21:24:20.713569|2017-10-10 21:24:20.713569
NCT03040024|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-30|||March 17, 2017|Actual|2017-03-17|March 2017|2017-03-01|January 9, 2019|Anticipated|2019-01-09|January 9, 2019|Anticipated|2019-01-09||Interventional|||Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients|A Randomized Placebo-controlled Pilot Study of Single-dose Intraoperative Ketamine for the Prevention of Delirium in Otolaryngeal Cancer Surgery Patients|Recruiting||Phase 4|60|Anticipated|Emory University||3|||f||||f|t|f|||f|||||2017-10-10 21:24:20.806056|2017-10-10 21:24:20.806056
NCT03040011|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-13|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|July 6, 2018|Anticipated|2018-07-06|March 6, 2018|Anticipated|2018-03-06||Interventional|||Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block for Pain Control After Vaginal Reconstructive Surgery|Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block With Bupivacaine and Dexamethasone for Improved Pain Control After Vaginal Reconstructive Surgery: A Three-Arm Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|75|Anticipated|University of Pittsburgh||3|||f||||f|t|f|||f|||No||2017-10-10 21:24:20.950375|2017-10-10 21:24:20.950375
NCT03039998|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-01-30|||March 2013||2013-03-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|||Validity of Biological Material Sampling in Patients With Hospital-acquired Pneumonia|Validity of Biological Material Sampling in Patients With Hospital-acquired Pneumonia|Completed||N/A|56|Actual|University Hospital Olomouc|||1||f||||f||||||Samples Without DNA|"     endotracheal aspirate, gastric aspirate, oropharyngeal swab, protected specimen brushing   "|No||2017-10-10 21:24:21.088949|2017-10-10 21:24:21.088949
NCT03039985|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-31|||February 2015||2015-02-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||All-ceramic Crowns in Patients With Sleep Bruxism|All-ceramic Crowns in Patients With Sleep Bruxism - a Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|Heidelberg University||4|||f||||||||||||||2017-10-10 21:24:21.173325|2017-10-10 21:24:21.173325
NCT03039972|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-10-01|||January 25, 2017|Actual|2017-01-25|October 2017|2017-10-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01|1 Day|Observational [Patient Registry]|||Hydration Status and Kidney Disease in Patients With Pulmonary Hypertension|Hydration Status and Kidney Disease in Patients With Pulmonary Hypertension - A Cross-sectional Single-center Study|Recruiting||N/A|500|Anticipated|University of Giessen|||1||f||||f|f|f||||Samples With DNA|"     Collection of only residual material (blood, urine) for Deutsche Zentrum für Lungenforschung     Biobank   "|||2017-10-10 21:24:21.275718|2017-10-10 21:24:21.275718
NCT03039959|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-10-01|||January 25, 2017|Actual|2017-01-25|October 2017|2017-10-01|October 1, 2017|Actual|2017-10-01|August 15, 2017|Actual|2017-08-15|1 Day|Observational [Patient Registry]|||Evaluation of Renal Function in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization|Evaluation of Renal Function, Intrarenal Hemodynamics, and Neurohormonal Status in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization - A Prospective Cross-sectional Single-center Study|Completed||N/A|205|Actual|University of Giessen|||1||f||||f|f|f||||Samples With DNA|"     Only residual material will be reserved for the Deutsche Zentrum für Lungenforschung Biobank   "|||2017-10-10 21:24:21.380869|2017-10-10 21:24:21.380869
NCT03039946|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-27|||January 2017||2017-01-01|January 2017|2017-01-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Automated Closed-Loop Versus Restrictive Fluid Therapy in Abdominal Surgery|Automated Closed-Loop Versus Restrictive Fluid Therapy in Abdominal Surgery: a Pilot Randomized Controlled Trial|Completed||N/A|40|Actual|Erasme University Hospital||2|||f||||||||||||||2017-10-10 21:24:21.466457|2017-10-10 21:24:21.466457
NCT03039933|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-29|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Intervention to Reduce Fear of Hypoglycemia and Optimize Type 1 Diabetes Outcomes|Intervention to Reduce Fear of Hypoglycemia and Optimize Type 1 Diabetes Outcomes|Recruiting||N/A|88|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 21:24:21.559324|2017-10-10 21:24:21.559324
NCT03039920|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-09-10|||May 2015|Actual|2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effects of Electronic Cigarette Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers|The Effects of Electronic Cigarette Smoking on the Arterial Wall and Endothelial Glycocalyx Properties of Smokers|Active, not recruiting||N/A|90|Anticipated|University of Athens||2|||f||||f||||||||||2017-10-10 21:24:21.647467|2017-10-10 21:24:21.647467
NCT03039907|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-01-31|||April 2, 2017|Anticipated|2017-04-02|January 2017|2017-01-01|July 1, 2021|Anticipated|2021-07-01|April 1, 2021|Anticipated|2021-04-01|2 Years|Observational [Patient Registry]|||Return to Physical Activities After Total Knee Arthroplasty|A Critical Assessment of the Factors That Promote or Limit the Return to Recreational, Work, and Physical Fitness Activities After Primary Total Knee Arthroplasty|Not yet recruiting||N/A|150|Anticipated|Cincinnati Sportsmedicine Research and Education Foundation|||1||f||||t||||||||Yes||2017-10-10 21:24:21.731078|2017-10-10 21:24:21.731078
NCT03039725|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-21|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|August 1, 2019|Anticipated|2019-08-01|July 1, 2019|Anticipated|2019-07-01||Observational|||Vaccination Compliance|Vaccination Rates in Obstetric Opioid-Addicted Patients|Enrolling by invitation||N/A|100|Anticipated|St. Louis University|||1||f||||f|f|f||||||||2017-10-10 21:24:23.425938|2017-10-10 21:24:23.425938
NCT03039712|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-03-10|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|Micra CED||Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers|Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers|Active, not recruiting||N/A|7000|Anticipated|Medtronic|||2||f||||f||||||||No||2017-10-10 21:24:23.505254|2017-10-10 21:24:23.505254
NCT03039894|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-01|||October 1, 2016|Actual|2016-10-01|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|GG||Grade Book Game Evaluation Among 6th Grade Students|Improving School Engagement Among Early Adolescents: Evaluation of a Team-based Social Network Intervention|Active, not recruiting||N/A|100|Actual|University of California, Los Angeles|||2||f||||f|f|f||||||No|"Participants have been assigned a study ID number to link their name, address, phone number, grade book and behavior data, and survey responses. This ID will be used for all survey data collection and to identify all grade book and behavior data.
The computer file linking the personal identifiers and the study ID number will be kept separate from the survey, grade book, and behavior data. Personally identifying information pertaining to individual participants will not be shared or made available to other researchers. Any data request will be made to the Faculty Sponsor (Mitchell Wong, MD PhD) or to the principle investigator (Ashley Lewis-Hunter, MD) and any data shared will be encrypted and will not include any personal identifying information."|2017-10-10 21:24:21.817779|2017-10-10 21:24:21.817779
NCT03039881|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-30|||January 9, 2015|Actual|2015-01-09|January 2017|2017-01-01|January 8, 2018|Anticipated|2018-01-08|January 8, 2018|Anticipated|2018-01-08||Observational|||Evaluation of Non-Invasive Respiratory Volume Monitor|Blinded Observational Study to Evaluate a Non-Invasive Respiratory Volume Monitor in the Post-Anesthesia Care Unit and on the General Hospital Floor|Recruiting||N/A|150|Anticipated|Tufts Medical Center|||1||f||||||t|f|||||No||2017-10-10 21:24:21.895084|2017-10-10 21:24:21.895084
NCT03039868|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-21|||October 7, 2017|Anticipated|2017-10-07|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Use of Pap Smear Derived Cells to Analyze the Expression of SLC6A14 and GPR81 Genes|Use of Pap Smear Derived Cells to Analyze the Expression of SLC6A14 and GPR81 Genes|Not yet recruiting||N/A|400|Anticipated|Texas Tech University Health Sciences Center|||2||f||||f||||||Samples Without DNA|"     RNA will be extracted from Pap smear cells for further analysis.   "|||2017-10-10 21:24:21.971362|2017-10-10 21:24:21.971362
NCT03039855|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-09-19|||January 2017||2017-01-01|September 2017|2017-09-01|January 2024|Anticipated|2024-01-01|January 2019|Anticipated|2019-01-01||Interventional|TIARA-II||Tiara™ Transcatheter Mitral Valve Replacement Study|Tiara™ Transcatheter Mitral Valve Replacement Study (TIARA-II)|Recruiting||N/A|115|Anticipated|Neovasc Inc.||1|||f||||t||||||||||2017-10-10 21:24:22.030946|2017-10-10 21:24:22.030946
NCT03039842|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-07-06|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder|Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder|Enrolling by invitation||Phase 3|300|Anticipated|National Cheng-Kung University Hospital||4|||f||||t|f|f|||f|||||2017-10-10 21:24:22.165776|2017-10-10 21:24:22.165776
NCT03039829|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-30|||January 2016||2016-01-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|NB9||Safety of Different Forms of Creatine|Short-Term Safety and Dose Effects of Different Forms of Creatine|Completed||N/A|38|Actual|Texas A&M University||3|||f||||t||||||||No||2017-10-10 21:24:22.262429|2017-10-10 21:24:22.262429
NCT03039816|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-30|||May 2013||2013-05-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|CPARGPDBPC||Cellulose Powder Against Grass Pollen Allergic Rhinitis|A Nasally Applied Cellulose Powder in Seasonal Allergic Rhinitis in Adults With Grass Pollen Allergy: A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study|Completed||Phase 2/Phase 3|108|Actual|Nasaleze International Ltd||2|||f||||f||||||||No||2017-10-10 21:24:22.341189|2017-10-10 21:24:22.341189
NCT03039803|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2017-01-30|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Impact of Double-layer Versus Single-layer Uterine Closure Suture in Cesarean Section on the Development of Postoperative Uterine Scar Deficiency|Impact of Double-layer Versus Single-layer Uterine Closure Suture in Cesarean Section on the Development of Postoperative Uterine Scar Deficiency: A Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Medical University of Vienna||2|||f||||||||||||||2017-10-10 21:24:22.423255|2017-10-10 21:24:22.423255
NCT03039790|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-06|||February 21, 2017|Actual|2017-02-21|July 2017|2017-07-01|December 30, 2023|Anticipated|2023-12-30|December 30, 2023|Anticipated|2023-12-30||Interventional|||Long-Term Immunogenicity of the Norovirus GI.I/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Adults|A Phase 2, Long-Term Immunogenicity Follow-up Trial of Adult and Elderly Subjects Who Have Previously Received an Intramuscular Injection of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine|Recruiting||Phase 2|800|Anticipated|Takeda||1|||f||||f|t|f||||||||2017-10-10 21:24:22.507289|2017-10-10 21:24:22.507289
NCT03039777|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-13|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|March 1, 2017|Actual|2017-03-01|February 28, 2017|Actual|2017-02-28||Observational|||Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients|Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients|Completed||N/A|28|Actual|Benha University|||1||f||||f|f|f||||||||2017-10-10 21:24:22.610445|2017-10-10 21:24:22.610445
NCT03039764|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-30|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Effects of Virtual Reality Based Rehabilitation in Acute Stroke Patients in an Inpatient Rehab Setting|The Comparison Study of Virtual Reality Rehabilitation With Standard Occupational Therapy Versus Standard Occupational Therapy|Not yet recruiting||N/A|30|Anticipated|Montefiore Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 21:24:23.167911|2017-10-10 21:24:23.167911
NCT03039751|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-13|||January 2017||2017-01-01|January 2017|2017-01-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|ReGenHeart||Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris|Clinical Development and Proof of Principle Testing of New Regenerative Adenovirus Vascular Endothelial Growth Factor (VEGF-D) Therapy for Cost-effective Treatment of Refractory Angina. A Phase II Randomized, Double-blinded, Placebo-controlled Study (ReGenHeart)|Not yet recruiting||Phase 2|180|Anticipated|Kuopio University Hospital||2|||f||||t||||||||No|Data wil be shared to Partners of ReGenHeart Consortium|2017-10-10 21:24:23.244328|2017-10-10 21:24:23.244328
NCT03039738|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-06-05|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Surveillance Monitoring as an Alternative to Telemetry|A Prospective Evaluation of Surveillance Monitoring as an Alternative to Telemetry in Patients Scheduled for Telemetry Without American Heart Association (AHA) Indication|Enrolling by invitation||N/A|280|Anticipated|Medtronic - MITG||2|||f||||f|f|t|f||f|||No||2017-10-10 21:24:23.338333|2017-10-10 21:24:23.338333
NCT03039699|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-28|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children|International Multicenter, Double-blind, Randomized, Parallel Group Placebo-Controlled Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children|Recruiting||Phase 4|286|Anticipated|Materia Medica Holding||2|||f||||f||||||||||2017-10-10 21:24:23.572088|2017-10-10 21:24:23.572088
NCT03039673|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-10|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|MIROCALS||MIROCALS: Modifying Immune Response and OutComes in ALS|Efficacy and Safety of Low-dose IL-2 (Ld-IL-2) as a Treg Enhancer for Controlling Neuro-inflammation in Newly Diagnosed Amyotrophic Lateral Sclerosis (ALS) Patients: A Randomized, Double-blind, Placebo- Controlled, Phase-II Proof of Concept/ Proof of Mechanism Clinical Trial|Recruiting||Phase 2|216|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t|f|f||||||||2017-10-10 21:24:24.050002|2017-10-10 21:24:24.050002
NCT03039660|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-10-03|||January 17, 2017|Actual|2017-01-17|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Feasibility and Efficacy Study of Student Wellness Online Course for Medical Students|Evidence-Based Online Curriculum to Improve Sleep in Medical Students: A Multisite Trial to Assess Efficacy and Feasibility of RefreshMD|Active, not recruiting||N/A|200|Anticipated|Stanford University||2|||f||||||||||||||2017-10-10 21:24:24.213505|2017-10-10 21:24:24.213505
NCT03039647|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-30|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2022|Anticipated|2022-01-01||Observational|||Insulin Resistance and Accelerated Cognitive Aging|Insulin Resistance and Accelerated Cognitive Aging|Recruiting||N/A|160|Anticipated|Stanford University|||2||f||||f|f|f||||||No||2017-10-10 21:24:24.29371|2017-10-10 21:24:24.29371
NCT03039634|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-05|||August 2016||2016-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA|A Multicenter, Double-blind, Nontreatment, Long-term, Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA of a Topical Silver Particle Solution Followed by Laser for the Treatment of Facial Acne Vulgaris|Recruiting||N/A|165|Anticipated|Sienna Labs|||1||f||||f||||||||||2017-10-10 21:24:25.895063|2017-10-10 21:24:25.895063
NCT03039621|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-28|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children|International Multicenter Double-blind Placebo-Controlled Parallel-Group Randomized Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children|Recruiting||Phase 4|288|Anticipated|Materia Medica Holding||2|||f||||||||||||||2017-10-10 21:24:26.02374|2017-10-10 21:24:26.02374
NCT03039608|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-21|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|November 10, 2018|Anticipated|2018-11-10|August 10, 2018|Anticipated|2018-08-10||Interventional|||Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm|Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm：a Randomized Controlled Trial|Recruiting||N/A|72|Anticipated|Shanghai Zhongshan Hospital||2|||f|||||f|f||||||||2017-10-10 21:24:26.13858|2017-10-10 21:24:26.13858
NCT03039595|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-13|||March 29, 2017|Actual|2017-03-29|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||Ploidy and Stroma in Early Rectal Cancer|An Observational Study to Correlate the Results of Ploidy and Stroma Analysis With Prognosis in Early Rectal Cancer|Recruiting||N/A|150|Anticipated|Oxford University Hospitals NHS Trust|||1||f||||f|f|f||||Samples Without DNA|"     Specimens of early rectal cancer removed by transanal endoscopic microsurgery, which are     routinely retained, will be further analysed.   "|||2017-10-10 21:24:26.231861|2017-10-10 21:24:26.231861
NCT03039582|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-10|||September 1, 2014|Actual|2014-09-01|February 2017|2017-02-01|January 19, 2017|Actual|2017-01-19|January 31, 2016|Actual|2016-01-31||Observational|AVD and OASR||Short Anovaginal Distance is Associated With Obstetric Anal Sphincter Rupture|Short Anovaginal Distance is Associated With Obstetric Anal Sphincter Rupture|Completed||N/A|151|Actual|Ostergotland County Council, Sweden|||3||f||||f|f|f||||||No||2017-10-10 21:24:26.338806|2017-10-10 21:24:26.338806
NCT03039569|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-03-07|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients|Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients|Recruiting||N/A|100|Anticipated|University of Nebraska Lincoln||2|||f||||f|f|f||||||No||2017-10-10 21:24:26.422155|2017-10-10 21:24:26.422155
NCT03039556|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-31|||September 2015||2015-09-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CDA-SR||Step-reduction in Older Men and Women|The Influence of Acute Physical Inactivity on Metabolic Function in Older Men and Women|Completed||N/A|22|Actual|McMaster University||1|||f||||||||||||||2017-10-10 21:24:26.524644|2017-10-10 21:24:26.524644
NCT03039543|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-04|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Neuromuscular Blockade During Transurethral Resection of Bladder Cancer|The Effect of Neuromuscular Blockade During Transurethral Resection of Bladder Cancer on Surgical Condition and Recovery Profiles : A Prospective, Randomized and Controlled Trial|Recruiting||Phase 4|108|Anticipated|Seoul National University Bundang Hospital||2|||f||||f|t|f|||t|||||2017-10-10 21:24:26.614742|2017-10-10 21:24:26.614742
NCT03039530|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-06-29|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Group CBT for PPD in the Public Health Setting|Impact of Public Health Nurse Delivered Group CBT for Postpartum Depression on Women and Their Children: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 21:24:26.74291|2017-10-10 21:24:26.74291
NCT03039517|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-09|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|January 2021|Anticipated|2021-01-01||Interventional|||Post Thrombotic Syndrome Prevention Study|Post Thrombotic Syndrome Prevention Study|Recruiting||N/A|84|Anticipated|New York University School of Medicine||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:24:26.986788|2017-10-10 21:24:26.986788
NCT03039504|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-06-30|||January 31, 2017|Actual|2017-01-31|June 2017|2017-06-01|June 28, 2017|Actual|2017-06-28|June 28, 2017|Actual|2017-06-28||Interventional|||Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction|Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction|Completed||N/A|106|Actual|Research Center, LLC||2|||f||||f|f|f||||||||2017-10-10 21:24:27.107025|2017-10-10 21:24:27.107025
NCT03039491|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-08|||September 1, 2015|Actual|2015-09-01|January 2017|2017-01-01|June 30, 2019|Anticipated|2019-06-30|March 30, 2019|Anticipated|2019-03-30||Interventional|||Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults|Immune Response to Pneumococcal Vaccination in Aging HIV Positive Individuals|Recruiting||Early Phase 1|160|Anticipated|Medical University of South Carolina||8|||f||||f|t|f|||t|||Yes|The data will be made available once analysis is completed through publications in peer reviewed journals.|2017-10-10 21:24:27.231865|2017-10-10 21:24:27.231865
NCT03039478|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-30|||February 24, 2017|Actual|2017-02-24|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Effect of Different Concentrations of Xylitol and Erythritol on Gut Peptide Release and Gastric Emptying in Humans|Effect of Different Concentrations of Xylitol and Erythritol on the Release of Gastrointestinal Peptides and on Gastric Emptying Rates in Healthy Normal Weight Humans|Recruiting||N/A|24|Anticipated|University Hospital, Basel, Switzerland||6|||f||||t|f|f||||||||2017-10-10 21:24:27.377416|2017-10-10 21:24:27.377416
NCT03039465|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-30|||April 18, 2016|Actual|2016-04-18|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|TEP||A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients|A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients|Recruiting||N/A|50|Anticipated|HealthCare Global Enterprise Ltd.||1|||f||||f|f|f||||||No|Overall results of the study would be made public but individual patient data would be not be made available|2017-10-10 21:24:27.5035|2017-10-10 21:24:27.5035
NCT03039452|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-30|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||High Intensity Interval Training in Osteoarthritis, Effects on Metabolomics|Feasibility and Initial Effects of High Intensity Interval Training on Knee Osteoarthritis: an Exploratory Evaluation on Metabolomics|Recruiting||N/A|15|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-10 21:24:27.600663|2017-10-10 21:24:27.600663
NCT03039439|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-30|||November 24, 2015|Actual|2015-11-24|January 2017|2017-01-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Observational|||Molecular and IHC Profiling of PTH Tumors to Evaluate Targeted Agents|Molecular and Immunohistochemical Profiling of Tumor From Patients With Parathyroid Tumors for Evaluation of Targeted Agents|Recruiting||N/A|310|Anticipated|M.D. Anderson Cancer Center|||3||f||||f|f|f||||Samples With DNA|"     All patients with a known diagnoses of PHPT operated/treated in the Department of Surgical     Oncology of MDACC or at a collaborating site.   "|||2017-10-10 21:24:27.714513|2017-10-10 21:24:27.714513
NCT03039413|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-10-03|||September 28, 2016|Actual|2016-09-28|October 2017|2017-10-01|January 30, 2020|Anticipated|2020-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|||Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy|Targeting a Genomic Biomarker for PET Imaging and Staging of Urothelial Cancer: A Preliminary Evaluation|Recruiting||Early Phase 1|30|Anticipated|Thomas Jefferson University||1|||||||t|t|f||||||||2017-10-10 21:24:27.890998|2017-10-10 21:24:27.890998
NCT03039400|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-30|||November 2016||2016-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Physiotherapist-guided Home Exercise in Moderate to Severe MS|Physiotherapist-guided Home Exercise in Moderate to Severe Multiple Sclerosis|Recruiting||N/A|45|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-10-10 21:24:27.980386|2017-10-10 21:24:27.980386
NCT03039387|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-01-30|||September 2016||2016-09-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients|The Effect of Transcranial Direct Current Stimulation (tDCS) on Cognitive Control and Emotion Regulation in Depressed Patients|Recruiting||N/A|44|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||No||2017-10-10 21:24:28.06601|2017-10-10 21:24:28.06601
NCT03039374|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-03|||September 2014||2014-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||External Phase MRI in Diagnosis of OASI|The Use of External Phase Array MRI, 3D Endoanal Ultrasound, and Manometry in the Diagnosis of Obstetric Anal Sphincter Injuries|Enrolling by invitation||N/A|80|Anticipated|University of Turku|||1||f||||f||||||||No||2017-10-10 21:24:28.147608|2017-10-10 21:24:28.147608
NCT03039361|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-30|||January 2015||2015-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|||Equine Assisted Psychotherapy for PTSD|Equine Assisted Psychotherapy for PTSD|Active, not recruiting||N/A|20|Actual|University of New Mexico||2|||f||||f||||||||No|Individual participant data will be provided in Lobo vault after finalization of the study.|2017-10-10 21:24:28.220889|2017-10-10 21:24:28.220889
NCT03039348|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-01-30|||December 2016||2016-12-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Opting for Breast Reconstruction After Mastectomy or Not: Search for Influencing Factors|Keuze Voor Wel of Geen Borstreconstructie na Mastectomie: Onderzoek Naar beïnvloedende Factoren|Enrolling by invitation||N/A|100|Anticipated|Universitair Ziekenhuis Brussel|||2||f||||f||||||||Undecided|undecided|2017-10-10 21:24:28.291925|2017-10-10 21:24:28.291925
NCT03039335|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||December 15, 2016|Actual|2016-12-15|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency|The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: Assessing the Association Between Diagnostic Delay and Worsened Clinical Status|Recruiting||N/A|90|Anticipated|Biocerna LLC|||1||f||||f||||||||No||2017-10-10 21:24:28.376043|2017-10-10 21:24:28.376043
NCT03039322|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||December 22, 2014|Actual|2014-12-22|January 2017|2017-01-01|December 30, 2015|Actual|2015-12-30|December 30, 2015|Actual|2015-12-30||Observational|||Golgi Protein for HCC Diagnosis|Golgi Protein 73 for Diagnosis of HCC in Egyptian Patients|Completed||N/A|90|Actual|Ain Shams University|||2||f|||||f|f||||||||2017-10-10 21:24:28.460786|2017-10-10 21:24:28.460786
NCT03039309|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-30|||August 2016||2016-08-01|January 2017|2017-01-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01|2 Years|Observational [Patient Registry]|ESDUK||Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom|Endoscopic Submucosal Dissection in the Treatment of Early Gastrointestinal Neoplasia: A UK Cohort Study to Assess Effectiveness and Safety|Recruiting||N/A|500|Anticipated|Portsmouth Hospitals NHS Trust|||1||f||||f||||||||Undecided||2017-10-10 21:24:28.528109|2017-10-10 21:24:28.528109
NCT03039296|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-25|||February 3, 2017|Actual|2017-02-03|January 2017|2017-01-01|December 31, 2021|Anticipated|2021-12-31|January 1, 2019|Anticipated|2019-01-01|4 Years|Observational [Patient Registry]|EPCSIV||EuroPainClinics® Study IV (Prospective Observational Study)|EuroPainClinics® Study IV (Prospective Observational Study)|Recruiting||N/A|150|Anticipated|Europainclinics z.ú.|||2||f||||t|f|f||||||||2017-10-10 21:24:28.604068|2017-10-10 21:24:28.604068
NCT03039283|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-07-28|||March 14, 2017|Actual|2017-03-14|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Retrospective CI532 Hearing Performance|Retrospective Post-market Hearing Performance Outcome in a Cohort of CI532 Recipients|Recruiting||N/A|150|Anticipated|Cochlear|||1||f||||f||||||||||2017-10-10 21:24:28.801448|2017-10-10 21:24:28.801448
NCT03039270|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-01-31|||January 18, 2016|Actual|2016-01-18|January 2017|2017-01-01|April 15, 2016|Actual|2016-04-15|March 31, 2016|Actual|2016-03-31||Interventional|||Evaluation of Sensitivity With and Without Sonic Activation of a Desensitizing Gel Before in Office Bleaching in Adults|Sensitivity Absolute Risk Evaluation With and Without Sonic Activation of a Desensitizing Gel Previously to in Office Bleaching in Adults.|Completed||N/A|31|Actual|Federal University of Amazonas||2|||f||||t|f|f||||||No||2017-10-10 21:24:28.896642|2017-10-10 21:24:28.896642
NCT03039257|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-02-13|||February 2, 2017|Actual|2017-02-02|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates|Single, High Dose Vitamin A Replacement in Patients Undergoing Hematopoietic Stem Cell Transplantation and Its Role on MBI-LCBI Rates|Recruiting||N/A|28|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f|f|f||||||No||2017-10-10 21:24:28.9969|2017-10-10 21:24:28.9969
NCT03039244|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-31|||September 1, 2014|Actual|2014-09-01|January 2017|2017-01-01|September 1, 2017|Anticipated|2017-09-01|December 1, 2016|Actual|2016-12-01||Interventional|||Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers|Evaluation of Antimicrobial Photodynamic Therapy in Multiples Episodes as an Adjunct to Non-surgical Periodontal Treatment in Smokers|Active, not recruiting||N/A|20|Actual|University of Sao Paulo||2|||f||||t|f|f||||||Undecided||2017-10-10 21:24:29.098262|2017-10-10 21:24:29.098262
NCT03039231|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-07|||January 2017||2017-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD)|Investigation of the Freespira Breathing System in the Treatment of PTSD|Recruiting||N/A|55|Anticipated|Palo Alto Health Sciences, Inc.||1|||f||||f||||||||No||2017-10-10 21:24:29.200758|2017-10-10 21:24:29.200758
NCT03039218|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-08-08|||February 7, 2017|Actual|2017-02-07|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Dornier Aries 2 Extracorporeal Shock Wave Device for the Treatment of Mild Erectile Dysfunction (ED)|A Randomized, Double-Blind, Placebo-Controlled, Open-Label Extension Clinical Trial of the Dornier Aries 2 Extracorporeal Shock Wave Device for the Treatment of Mild Erectile Dysfunction (ED)|Recruiting||N/A|100|Anticipated|Dornier MedTech Systems||2|||f||||t|f|t|t|f||||||2017-10-10 21:24:29.308653|2017-10-10 21:24:29.308653
NCT03039205|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-05-01|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 15, 2018|Anticipated|2018-12-15|November 30, 2018|Anticipated|2018-11-30||Interventional|||Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor|Evaluation of Platelet Aggregation and Adenosine Levels in Patients With Coronary Artery Disease and Chronic Kidney Dysfunction Taking Dual Antiplatelet Therapy With Aspirin and Clopidogrel or Ticagrelor|Not yet recruiting||Phase 2|112|Anticipated|University of Sao Paulo||4|||f||||f|f|f||||||Undecided||2017-10-10 21:24:29.437295|2017-10-10 21:24:29.437295
NCT03039192|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-22|||June 9, 2017|Actual|2017-06-09|September 2017|2017-09-01|September 9, 2019|Anticipated|2019-09-09|September 9, 2019|Anticipated|2019-09-09||Interventional|Aspire I||A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adults at Imminent Risk for Suicide|A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide|Recruiting||Phase 3|224|Anticipated|Janssen Research & Development, LLC||2|||f||||t|t|f||||||||2017-10-10 21:24:29.628961|2017-10-10 21:24:29.628961
NCT03039179|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-04-20|2017-02-01||July 1, 2014|Actual|2014-07-01|April 2017|2017-04-01|August 31, 2015|Actual|2015-08-31|July 31, 2015|Actual|2015-07-31||Interventional|SCHIUMABIMB||Polyurethane Foam on the Heel for Prevention in Children|Effectiveness of Polyurethane Foam in Preventing the Onset of Pressure Sores in a Pediatric Orthopedic Population: Randomized Controlled Trial|Completed||N/A|80|Actual|Istituto Ortopedico Rizzoli||2|||f||||f|f|f||||||No||2017-10-10 21:24:29.850491|2017-10-10 21:24:29.850491
NCT03039166|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-04-13|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|October 2022|Anticipated|2022-10-01|February 2022|Anticipated|2022-02-01||Interventional|||Metabolic and Structural Characterization of Hub's Vulnerability in Neurological Diseases Assessed by Ultra High Field Structural and Functional MRI|Metabolic and Structural Characterization of Hub's Vulnerability in Neurological Diseases Assessed by Ultra High Field Structural and Functional MRI|Not yet recruiting||N/A|260|Anticipated|Assistance Publique Hopitaux De Marseille||6|||f||||f|f|f||||||No||2017-10-10 21:24:30.088136|2017-10-10 21:24:30.088136
NCT03039153|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-03-22|||March 21, 2017|Actual|2017-03-21|March 2017|2017-03-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|peripress||Pressure Ulcers in Knee Replacement Surgery|The Peripheral Nerve Blocks Analgesia in Patients Undergoing Knee Replacement Surgery is a Risk Factor for the Development of Pressure Sores at the Heel? Retrospective Cohort Study|Recruiting||N/A|440|Anticipated|Istituto Ortopedico Rizzoli|||1||f||||f|f|f||||||No||2017-10-10 21:24:30.196887|2017-10-10 21:24:30.196887
NCT03039140|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-17|||May 14, 2015|Actual|2015-05-14|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors|A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study|Suspended||N/A|20|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 21:24:30.293823|2017-10-10 21:24:30.293823
NCT03039127|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-01|||June 2016||2016-06-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Immunostimulating Interstitial Laser Thermotherapy in Breast Cancer|Interstitial Laser Thermotherapy (imILT) as a Treatment Option in Breast Cancer Patients Not Suitable for Surgical Excision|Recruiting||N/A|5|Anticipated|Clinical Laserthermia Systems AB||1|||f||||f||||||||No||2017-10-10 21:24:30.389569|2017-10-10 21:24:30.389569
NCT03039114|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-29|||February 15, 2017|Actual|2017-02-15|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)|An Open-Label, Dose-Finding, and Cohort-Expansion Phase 1 Study Evaluating Safety and Efficacy of INCB050465 in Combination With Bendamustine and Obinutuzumab in Subjects With Relapsed or Refractory Follicular Lymphoma (CITADEL-102)|Recruiting||Phase 1|45|Anticipated|Incyte Corporation||1|||f||||f|t|f||||||||2017-10-10 21:24:30.480407|2017-10-10 21:24:30.480407
NCT03039101|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-06|||September 6, 2017|Actual|2017-09-06|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects|Double Blind Study of Leukotriene Antagonism in the Nasal Recruitment of CD49d Expressing Neutrophils in Atopic Subjects|Recruiting||N/A|20|Anticipated|Nationwide Children's Hospital||2|||f||||f|f|f||||||||2017-10-10 21:24:30.643892|2017-10-10 21:24:30.643892
NCT03039088|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-30|||October 2, 2014|Actual|2014-10-02|January 2017|2017-01-01|October 4, 2016|Actual|2016-10-04|October 4, 2016|Actual|2016-10-04||Observational|PREDICT_SpA||PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients|PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients|Completed||N/A|527|Actual|Association de Recherche Clinique en Rhumatologie|||2||f||||f|f|f||||||No||2017-10-10 21:24:30.740785|2017-10-10 21:24:30.740785
NCT03039075|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-01-30|||November 2016||2016-11-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|CQM-2016||Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes|Comparison of Metformin Hydrochloride Sustained-release Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes|Recruiting||Phase 4|240|Anticipated|Chongqing Medical University||2|||f||||t||||||||No||2017-10-10 21:24:30.811913|2017-10-10 21:24:30.811913
NCT03039062|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-03-29|||July 2016||2016-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy|Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy. - an Open , Multicenter, Non-interventional Clinical Trial|Recruiting||N/A|180|Anticipated|Chinese Academy of Medical Sciences|||3||f||||t||||||Samples With DNA|"     Serum miR-122 and serum ALT, AST,ALP and total bilirubin level   "|No||2017-10-10 21:24:30.895304|2017-10-10 21:24:30.895304
NCT03039049|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-05|||March 2014||2014-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT|GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Mid-luteal Bolus of GnRHa: a Randomised Controlled Trial.|Completed||Phase 3|328|Actual|Centre Hospitalier Universitaire Ibn Rochd||2|||f||||t||||||||||2017-10-10 21:24:30.970397|2017-10-10 21:24:30.970397
NCT03039036|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-13|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|February 1, 2021|Anticipated|2021-02-01||Interventional|||Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction|A Randomized Clinical Trial of Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction|Recruiting||N/A|110|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 21:24:31.055822|2017-10-10 21:24:31.055822
NCT03039023|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-05-08|||September 2016||2016-09-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|EGGS||Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans|Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans (EGGS)|Recruiting||N/A|70|Anticipated|The Cleveland Clinic||4|||f||||f||||||||No||2017-10-10 21:24:31.244533|2017-10-10 21:24:31.244533
NCT03039010|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|July 31, 2018|Anticipated|2018-07-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Validation of Data for Dental Health in the SKaPa Registry for Children and Adolescents|Validation of Data for Dental Health in the SKaPa Registry for Children and Adolescents|Recruiting||N/A|150|Anticipated|Malmö University|||1||f||||f|f|f||||||No||2017-10-10 21:24:31.363206|2017-10-10 21:24:31.363206
NCT03038269|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-20|||December 2013||2013-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||tDCS and Robotic Training in Adults With Cerebral Palsy|Transcranial Direct Current Stimulation and Robotic Training in Adults With Cerebral Palsy|Recruiting||N/A|22|Anticipated|Burke Medical Research Institute||2|||f||||f||||||||||2017-10-10 21:24:37.012295|2017-10-10 21:24:37.012295
NCT03038997|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-02-03|||November 2014||2014-11-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Early Detection of Cardiac Toxicity in Childhood Cancer Survivors|Early Detection of Cardiac Toxicity in Childhood Cancer Survivors|Recruiting||N/A|50|Anticipated|Children's Research Institute|||1||f||||f|f|f||||Samples Without DNA|"     A blood specimen equal to 1 teaspoonful will be collected for future analysis to be used to     identify serum biomarkers in myocardial fibrosis, and to validate the potential use for     diagnostic purposes.   "|No||2017-10-10 21:24:31.44023|2017-10-10 21:24:31.44023
NCT03038984|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-30|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|August 2026|Anticipated|2026-08-01|August 2026|Anticipated|2026-08-01||Interventional|||Are Rates of Colectomies, Resections, Mortalities and Cancer Reduced by Home Monitoring of IBD Patients ?|Are Rates of Colectomies, Resections, Mortalities and Cancer Reduced by Home Monitoring of IBD Patients Tightly on Demand or Every 3 Months by Fecal Calprotectin and Disease Activity?|Active, not recruiting||N/A|120|Actual|Nordsjaellands Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:24:31.538942|2017-10-10 21:24:31.538942
NCT03038971|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-22|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections|A Single-Center, Double-Blinded, Placebo-Controlled, Phase 1 Evaluation of the Safety of Ragweed Mix Given in Four Monthly Doses by Intralymphatic Node Injections for Inducing Tolerance in Subjects With Ragweed Induced Allergic Conjunctivitis and Allergic Rhinitis|Active, not recruiting||Phase 1|70|Anticipated|Woodmont Pharmaceuticals, Inc.||3|||f||||f|t|f||||||Undecided||2017-10-10 21:24:31.620643|2017-10-10 21:24:31.620643
NCT03038958|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-30|||April 2016||2016-04-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Comparison of Hyperbaric Prilocaine With Chloroprocaine for Intrathecal Anaesthesia in Day Case Knee Arthroscopy|Comparison of Hyperbaric Prilocaine With Chloroprocaine for Intrathecal Anaesthesia in Day Case Knee Arthroscopy|Completed||Phase 4|80|Actual|Centre Hospitalier Universitaire Saint Pierre||2|||f||||f||||||||No||2017-10-10 21:24:31.715251|2017-10-10 21:24:31.715251
NCT03038945|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-23|||October 2016||2016-10-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Barbed vs Standard Suture for Laparoscopic Vaginal Cuff Closure|Barbed vs Standard Suture for Laparoscopic Vaginal Cuff Closure|Completed||N/A|150|Actual|CES University||2|||f||||f||||||||No||2017-10-10 21:24:31.812062|2017-10-10 21:24:31.812062
NCT03038932|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-02|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Etiology of Eczema Herpeticum (EH)|Integrated Extreme Trait Analysis to Understand the Etiology of Eczema Herpeticum (ADRN-06)|Recruiting||N/A|72|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||f|f|f||||Samples With DNA|"     Blood and Skin Tissue   "|||2017-10-10 21:24:31.913556|2017-10-10 21:24:31.913556
NCT03038919|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||October 2016||2016-10-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|RAS-ICU||Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness|Pilot Randomized, Controlled Trial of Testosterone Therapy in Chronic Critically Ill Patients and Its Potential Effects on Weaning From Mechanical Ventilation and Intensive Care Unit-acquired Weakness|Recruiting||Phase 2/Phase 3|30|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:24:32.018211|2017-10-10 21:24:32.018211
NCT03038906|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-29|||January 2017||2017-01-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Observational|PRIMROSE||Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS|Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS|Recruiting||N/A|290|Anticipated|University of Washington|||1||f||||f||||||||No||2017-10-10 21:24:32.141881|2017-10-10 21:24:32.141881
NCT03038893|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-01-31|||August 1, 2016|Actual|2016-08-01|January 2017|2017-01-01|January 30, 2017|Actual|2017-01-30|November 30, 2016|Actual|2016-11-30||Interventional|||Point of Care Ultrasound For The Diagnosis Of Deep Venous Thrombosis And Its Effect On Length Of Hospital Stay|Point of Care Ultrasound For The Diagnosis Of Deep Venous Thrombosis And Its Effect On Length Of Hospital Stay|Completed||N/A|25|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||Undecided||2017-10-10 21:24:32.238474|2017-10-10 21:24:32.238474
NCT03038880|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-08-16|||January 27, 2017|Actual|2017-01-27|August 2017|2017-08-01|June 26, 2018|Anticipated|2018-06-26|April 8, 2018|Anticipated|2018-04-08||Interventional|STAIRWAY||Study to Evaluate RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (nAMD)|STAIRWAY: Simultaneous Blockade of Angiopoietin-2 and VEGF-A With the Bispecific Antibody RO6867461 (RG7716) for Extended Durability in the Treatment of Neovascular Age-Related Macular Degeneration|Active, not recruiting||Phase 2|76|Actual|Hoffmann-La Roche||3|||f|||||t|f||||||||2017-10-10 21:24:32.315681|2017-10-10 21:24:32.315681
NCT03038867|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-30|||December 12, 2016|Actual|2016-12-12|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Impact of Duloxetine on Male Fertility|Impact of Duloxetine on Male Fertility|Recruiting||Phase 4|70|Anticipated|Weill Medical College of Cornell University||2|||f||||f|t|f|||f|||||2017-10-10 21:24:32.481629|2017-10-10 21:24:32.481629
NCT03038854|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-07-19|||February 8, 2017|Actual|2017-02-08|July 2017|2017-07-01|February 1, 2022|Anticipated|2022-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Growing Up Milk (GUM) Intake and Nutrient Status of Toddlers|Effects of Milk Intake on Nutrient Status and Neurocognitive Development in Toddlers: a Partially Randomized and Controlled Trial|Recruiting||N/A|310|Anticipated|Nestlé||4|||f||||f|f|f||||||||2017-10-10 21:24:32.580221|2017-10-10 21:24:32.580221
NCT03038841|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-20|||February 1, 2017|Actual|2017-02-01|January 2017|2017-01-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31|12 Weeks|Observational [Patient Registry]|||Mobile Health Technology for Palliative Care Patients|Mobile Health Technologies for Palliative Care Patients at the Interface of In-patient to Out-patient Care: A Feasibility Study Aiming to Early Predict Deterioration of Patient's Health Status|Recruiting||N/A|30|Anticipated|University of Zurich|||1||f||||f|f|f||||||No||2017-10-10 21:24:32.693979|2017-10-10 21:24:32.693979
NCT03038828|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-07-18|||April 2015||2015-04-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|PAW||Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts|Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected|Recruiting||Phase 1|15|Anticipated|CEL-SCI Corporation||2|||f||||f||||||||||2017-10-10 21:24:32.790725|2017-10-10 21:24:32.790725
NCT03038815|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-01|||February 1, 2017|Anticipated|2017-02-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|June 30, 2017|Anticipated|2017-06-30||Interventional|||The Influence of Stability Boots on Gait Pattern in Healthy Adults|The Influence of Stability Boots on Gait Pattern in Healthy Adults|Not yet recruiting||N/A|20|Anticipated|Institute for Biomechanics, ETH Zürich||3|||f||||f|f|f||||||No||2017-10-10 21:24:32.933288|2017-10-10 21:24:32.933288
NCT03038802|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-10|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|HBV003||A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection|A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Vaxine Pty Ltd||2|||f||||f|f|f||||||Undecided||2017-10-10 21:24:33.074213|2017-10-10 21:24:33.074213
NCT03038776|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-31|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|FLU007||Recombinant H7 Hemagglutinin Influenza Vaccine Trial|A Randomised, Controlled, Phase 1 Study in Healthy Adults to Evaluate the Immunogenicity and Safety of a Recombinant H7 Hemagglutinin Influenza Vaccine|Recruiting||Phase 1|150|Anticipated|Vaxine Pty Ltd||6|||f||||f||||||||No||2017-10-10 21:24:33.299737|2017-10-10 21:24:33.299737
NCT03038763|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-06-09|||May 11, 2017|Actual|2017-05-11|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers|Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers|Recruiting||N/A|180|Anticipated|University of Pennsylvania|||2||f||||f|f|f||||||No||2017-10-10 21:24:33.415577|2017-10-10 21:24:33.415577
NCT03038750|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-15|||August 14, 2017|Actual|2017-08-14|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|CADBIO||Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers|Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers|Recruiting||N/A|220|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||3||f||||f|f|f||||||||2017-10-10 21:24:33.540258|2017-10-10 21:24:33.540258
NCT03038737|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-30|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparative Study of Biting Force of Injection Molded PEEK and Bre.Flex for Removable Partial Dentures.|Comparative Study Of Biting Force Of Injection Molded PEEK and Bre.Flex Materials For Bounded Removable Partial Dentures (Randomized Clinical Trial)|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:24:33.699827|2017-10-10 21:24:33.699827
NCT03038724|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-30|||August 11, 2015|Actual|2015-08-11|January 2017|2017-01-01|December 15, 2015|Actual|2015-12-15|November 28, 2015|Actual|2015-11-28||Interventional|PETTSEQ||Randomised Study Comparing Two HIV Screening Strategies|Randomised Study Comparing Two HIV Screening Strategies in the Emergency Department Using an Electronic Tablet Questionnaire: The PETTSEQ Study (PErformance of Two Testing Strategies by Electronic Questionnaire)|Completed||N/A|160|Actual|University of Lausanne Hospitals||2|||f||||f|f|f||||||No||2017-10-10 21:24:33.776708|2017-10-10 21:24:33.776708
NCT03038711|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-08-30|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|August 10, 2017|Actual|2017-08-10|August 10, 2017|Actual|2017-08-10||Interventional|||A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers|A Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects|Completed||Phase 1|213|Actual|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 21:24:33.847315|2017-10-10 21:24:33.847315
NCT03038698|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-04|||May 15, 2017|Anticipated|2017-05-15|January 2017|2017-01-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Observational|PAASII||Paediatric and Adult African Spirometry II|Paediatric and Adult African Spirometry II: A Determination of Reference Equation in South African Children and Adults|Not yet recruiting||N/A|4000|Anticipated|University of KwaZulu|||1||f||||f|f|f||||||No|All results of the study will be published in a peer-reviewed journal|2017-10-10 21:24:33.940496|2017-10-10 21:24:33.940496
NCT03038685|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-02|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|STROKECOACH||A Personalized, Digital Coaching Program After Stroke|A Personalized, Digital Coaching Program With Teleconsultancy to Improve Secondary Prevention After Ischemic Stroke: a Pilot, Multicenter Pre/Post Study.|Recruiting||N/A|175|Anticipated|University Hospital, Antwerp||2|||f||||t|f|f||||||No||2017-10-10 21:24:34.002076|2017-10-10 21:24:34.002076
NCT03038672|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-31|2017-09-04|||December 8, 2017|Anticipated|2017-12-08|May 2017|2017-05-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas|A Randomized Phase 2 Study of Varlilumab (CDX-1127) in Combination With Nivolumab in Patients With Relapsed or Refractory Aggressive B-Cell Lymphomas|Not yet recruiting||Phase 2|106|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 21:24:34.117115|2017-10-10 21:24:34.117115
NCT03038659|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-01-31|||July 1, 2016|Actual|2016-07-01|January 2017|2017-01-01|January 29, 2017|Actual|2017-01-29|January 1, 2017|Actual|2017-01-01||Observational|||Role of Intima-media Thickness in Determining Arteriogenic Erectile Dysfunction|Predictive Value of Measuring Intima-media Thickness of Cavernosal Artery in Diagnosis of Arteriogenic Erectile Dysfunction by Penile Duplex|Completed||N/A|70|Actual|Adam International Hospital|||1||f||||f|f|f||||||No|Erectile dysfunction|2017-10-10 21:24:34.232891|2017-10-10 21:24:34.232891
NCT03038646|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-08-30|||November 30, 2016|Actual|2016-11-30|August 2017|2017-08-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|||A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects|A Phase 1, Open-Label, Randomised, 3-Treatment, 3-Period, Single-Dose, Crossover Study in Healthy Subjects to Compare the Pharmacokinetic Properties of Modified Release (MR) Formulations of MIN-101 Followed by Food Effect Testing of a Selected Formulation|Completed||Phase 1|14|Actual|Minerva Neurosciences||4|||f||||f||||||||||2017-10-10 21:24:34.283789|2017-10-10 21:24:34.283789
NCT03038633|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-01-30|||May 2014|Actual|2014-05-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia|A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia|Completed||Phase 1|2|Actual|Milton S. Hershey Medical Center||4|||f||||f|f|f|||t|||Undecided|Data under review|2017-10-10 21:24:34.370372|2017-10-10 21:24:34.370372
NCT03038620|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-05-17|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|||Impact of Liraglutide 3.0 on Body Fat Distribution|Impact of Liraglutide 3.0 on Body Fat Distribution, Visceral Adiposity, and Cardiometabolic Risk Markers In Overweight and Obese Adults at High Risk for Cardiovascular Disease|Recruiting||Phase 4|356|Anticipated|University of Texas Southwestern Medical Center||2|||f|||||t|f||||||Undecided||2017-10-10 21:24:34.43756|2017-10-10 21:24:34.43756
NCT03038607|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-01-29|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Aspirin in Asymmetrically Intrauterine Growth|Effect of Low-dose Aspirin on Fetal Weight of Idiopathic Asymmetrically Intrauterine Growth Restricted Fetuses With Abnormal Umbilical Doppler Indices|Completed||Phase 2|60|Actual|Assiut University||2|||f||||f|f|f||||||Yes||2017-10-10 21:24:34.690278|2017-10-10 21:24:34.690278
NCT03038594|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-04-12|||November 2015||2015-11-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients|Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients|Recruiting||Phase 2/Phase 3|62|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||No||2017-10-10 21:24:34.767842|2017-10-10 21:24:34.767842
NCT03038581|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-01-28|||October 2015||2015-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Observational|||Comparison of Self-inflicted Deep Wrist Injuries to Traumatic Deep Wrist Injuries|Comparison of Self-inflicted Deep Wrist Injuries to Traumatic Deep Wrist Injuries|Enrolling by invitation||N/A|100|Anticipated|University of Schleswig-Holstein|||2||f||||f|f|f||||||No||2017-10-10 21:24:34.92849|2017-10-10 21:24:34.92849
NCT03038568|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-07-10|||January 27, 2017|Actual|2017-01-27|July 2017|2017-07-01|January 27, 2019|Anticipated|2019-01-27|January 27, 2019|Anticipated|2019-01-27||Observational|||Assessing How Normal Variations in CT Scanning Affects Its Interpretation|Stability of Radiomic Features for Abdominal Tumors on Contrast Enhanced CT|Recruiting||N/A|100|Anticipated|Memorial Sloan Kettering Cancer Center|||18||f|||||f|f||||||||2017-10-10 21:24:35.006533|2017-10-10 21:24:35.006533
NCT03038555|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-28|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|COACS||China Obstetrics Alliance Cohort Study|The Study of Prevention and Intervention Strategy of Gestational Diseases Based on Cohort|Enrolling by invitation||N/A|900|Anticipated|The Third Affiliated Hospital of Guangzhou Medical University|||2||f||||||||||Samples With DNA|"     Store the blood samples (serum, blood and plasma) of both the experimental group and control     group and their children.      These additional samples were be centrifuged and treated and stored in a collection of     biological samples of total serum and plasma and blood at the Biobank of The Third Affiliated     Hospital of Guangzhou Medical University at -80 ° C   "|||2017-10-10 21:24:35.12753|2017-10-10 21:24:35.12753
NCT03038542|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-30|||May 2016||2016-05-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Quit4hlth: Enhancing Tobacco and Cancer Control Through Framed Text Messages|Quit4hlth: Enhancing Tobacco and Cancer Control Through Framed Text Messages|Active, not recruiting||N/A|600|Actual|Medical University of South Carolina||2|||f||||f|f|f||||||||2017-10-10 21:24:35.216431|2017-10-10 21:24:35.216431
NCT03038529|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-02-26|||January 1, 2015|Actual|2015-01-01|February 2017|2017-02-01|November 30, 2016|Actual|2016-11-30|October 30, 2016|Actual|2016-10-30||Interventional|||Variable Approaches of Intradiscal O3-O2 Injection|Variable Approaches of Intradiscal O3-O2 Injection for Management of Low Back Pain: Could it Make a Difference? a Prospective Double Blind Randomized Clinical Trial.|Completed||N/A|60|Actual|Assiut University||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:24:35.284048|2017-10-10 21:24:35.284048
NCT03038516|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-24|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|Palliative-D||'Palliative-D' Vitamin D to Palliative Cancer Patients|'Palliative-D' Vitamin D Supplementation to Palliative Cancer Patients - A Double Blind, Randomised Controlled Trial|Not yet recruiting||Phase 2|254|Anticipated|Stockholm County Council, Sweden||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:24:35.363598|2017-10-10 21:24:35.363598
NCT03038503|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-28|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||What Should be the Next Vasopressor for Severe Septic Shock? Methylene Blue or Terlipressin|What Should be the Next Vasopressor for Severe Septic Shock Patients? Methylene Blue or Terlipressin|Recruiting||Phase 3|60|Anticipated|Ramathibodi Hospital||3|||f||||f||||||||No||2017-10-10 21:24:35.46157|2017-10-10 21:24:35.46157
NCT03038490|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-01-30|||December 1, 2016|Actual|2016-12-01|January 2017|2017-01-01|March 31, 2020|Anticipated|2020-03-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers|The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for the Treatment of Pressure Ulcers|Recruiting||N/A|90|Anticipated|Our Lady of Maryknoll Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:24:35.560501|2017-10-10 21:24:35.560501
NCT03038477|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-06-14|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection|A Study of Durvalumab (MEDI4736), as an Adjuvant Therapy, Compared to Observation Alone, in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma (BR PDA) Following Neoadjuvant Therapy and Successful Surgical Resection|Recruiting||Phase 2|114|Anticipated|University of Colorado, Denver||2|||f||||t|t|f||||||No||2017-10-10 21:24:35.649059|2017-10-10 21:24:35.649059
NCT03038464|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-04-24|||November 1, 2016|Actual|2016-11-01|January 2017|2017-01-01|May 1, 2019|Anticipated|2019-05-01|April 1, 2019|Anticipated|2019-04-01||Observational|SyPJI||Synovial Aspiration and Serological Testing in Two-stage Revision Arthroplasty of Prosthetic Joint Infection|Benefit of Synovial Aspiration and Serological Testing in Two-stage Revision Arthroplasty of Prosthetic Joint Infection|Recruiting||N/A|40|Anticipated|Technische Universität München|||1||f||||f|f|f||||||Undecided||2017-10-10 21:24:35.739232|2017-10-10 21:24:35.739232
NCT03038451|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-02-16|||March 20, 2013|Actual|2013-03-20|February 2017|2017-02-01|February 14, 2017|Actual|2017-02-14|February 14, 2017|Actual|2017-02-14||Interventional|||Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients|Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients: Open-label, Local, Phase IV Study|Completed||Phase 4|43|Actual|Neutec Ar-Ge San ve Tic A.Ş||1|||f||||f||||||||Undecided||2017-10-10 21:24:35.813292|2017-10-10 21:24:35.813292
NCT03038438|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-01-30|||June 2017||2017-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:24:35.89225|2017-10-10 21:24:35.89225
NCT03038425|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-05-08|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Does Continuous Adductor Canal Nerve Block Improve the Quality of Recovery for Outpatient Total Knee Arthroplasty Patients?|Does Continuous Adductor Canal Nerve Block Improve the Quality of Recovery for Outpatient Total Knee Arthroplasty Patients?|Recruiting||N/A|80|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|f||||||Undecided||2017-10-10 21:24:35.937351|2017-10-10 21:24:35.937351
NCT03038412|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-30|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|||Clinical Assessment of Caries and Dental Plaque Based on Auto-fluorescence Imaging System|Clinical Detection and Quantification of Caries and Dental Plaque Based on Auto-fluorescence Imaging System: An Observational Study|Enrolling by invitation||N/A|60|Anticipated|The Dental Hospital of Zhejiang University School of Medicine|||1||f||||||||||||Undecided||2017-10-10 21:24:36.055441|2017-10-10 21:24:36.055441
NCT03038399|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-23|||January 2017||2017-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)|A 24-month Phase II Open-label, Multicenter Long-term Extension Study to Assess the Long‑Term Safety and Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)|Enrolling by invitation||Phase 2|48|Anticipated|ReveraGen BioPharma, Inc.||4|||f||||t||||||||||2017-10-10 21:24:36.123224|2017-10-10 21:24:36.123224
NCT03038386|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2017-01-28|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DEteCT||Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration|Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration|Recruiting||N/A|100|Anticipated|Meander Medical Center||1|||f||||t||||||||Undecided||2017-10-10 21:24:36.269523|2017-10-10 21:24:36.269523
NCT03038373|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-02|||April 2012||2012-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery|Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery-focused on Beta Cell Function and Insulin Sensitivity Changes|Active, not recruiting||N/A|80|Anticipated|Dasman Diabetes Institute|||4||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, PBMC, fat tissues, muscle tissues, remnant surgical tissue.   "|||2017-10-10 21:24:36.354759|2017-10-10 21:24:36.354759
NCT03038360|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-30|||September 10, 2014|Actual|2014-09-10|January 2017|2017-01-01|September 10, 2017|Anticipated|2017-09-10|February 10, 2017|Anticipated|2017-02-10||Observational|CardioSAVE||Prospective Study With AMI Patients Undergoing PCI|CardioSAVE: A 12-months Prospective Longitudinal Controlled Study for the Validation of a Novel Predictive Model and a Diagnostic Tool, for the Risk Stratification of AMI Patients Undergoing PCI|Recruiting||N/A|600|Anticipated|Firalis SA|||1||f||||t|f|f||||Samples Without DNA|"     Blood and urine samples   "|No||2017-10-10 21:24:36.420408|2017-10-10 21:24:36.420408
NCT03038347|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-27|||December 2017|Anticipated|2017-12-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Training of Cross-cultural Competencies in Psychotherapists|Evaluation of an Internet-based Training Program to Improve Cross-cultural Competencies in Psychotherapists|Not yet recruiting||N/A|108|Anticipated|Philipps University Marburg Medical Center||3|||f||||f|f|f||||||No||2017-10-10 21:24:36.490238|2017-10-10 21:24:36.490238
NCT03038334|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-27|||February 20, 2017|Anticipated|2017-02-20|January 2017|2017-01-01|October 20, 2019|Anticipated|2019-10-20|August 20, 2019|Anticipated|2019-08-20||Interventional|||Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease|Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease|Not yet recruiting||N/A|100|Anticipated|Metabolic Therapy Inc.||1|||f||||t|f|f||||||Undecided||2017-10-10 21:24:36.58779|2017-10-10 21:24:36.58779
NCT03038321|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-05-19|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?|Solifenacin vs Levofloxacin vs Lornoxicam for Management of Intravesical Instillation of Bacillus Calmette-Guerin (BCG) Side Effects A Single Blinded Randomised Controlled Study|Active, not recruiting||Phase 4|150|Actual|Mansoura University||3|||f||||t|f|f|||f|||Yes|meta-analyses by contact the Prof. Hassan Abol-Enein, MD, Phd (Study Chair)|2017-10-10 21:24:36.654329|2017-10-10 21:24:36.654329
NCT03038308|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-01-30|||September 16, 2016|Actual|2016-09-16|January 2017|2017-01-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole|Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole: A Dose Escalation Study of Efficacy and Tolerability|Recruiting||Phase 1/Phase 2|26|Anticipated|Columbia University||1|||f||||t|t|f|||f|||Undecided||2017-10-10 21:24:36.752843|2017-10-10 21:24:36.752843
NCT03038295|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-01|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||a Prospective Cohort Study for Propranolol Treatment in Retinopathy of Prematurity|Safety and Efficacy of Propranolol Treatment in Newborns With Retinopathy of Prematurity:a Prospective Cohort Study|Not yet recruiting||Phase 2|100|Anticipated|Guangdong Women and Children Hospital||4|||f||||t|f|f||||||No||2017-10-10 21:24:36.832342|2017-10-10 21:24:36.832342
NCT03038282|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-27|||February 20, 2017|Anticipated|2017-02-20|January 2017|2017-01-01|October 20, 2019|Anticipated|2019-10-20|August 20, 2019|Anticipated|2019-08-20||Interventional|||Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients|Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients|Not yet recruiting||N/A|100|Anticipated|Metabolic Therapy Inc.||3|||f||||t|f|f|||f|||Undecided|Sharing data will be available upon written request.|2017-10-10 21:24:36.938234|2017-10-10 21:24:36.938234
NCT03038256|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-02|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 1, 2022|Anticipated|2022-12-01|April 1, 2020|Anticipated|2020-04-01||Interventional|EXPLORE||Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial|Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by 4 Cycles XELOX Pre- a Delayed TME Compared With 6 Cycles XELOX post-a Regular Timing TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized, Open-Label Trial|Not yet recruiting||Phase 2|508|Anticipated|Peking University People's Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:24:37.099151|2017-10-10 21:24:37.099151
NCT03038243|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-06-05|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults|A Phase 2a/2b, Randomized, Double-blinded, Placebo-controlled, Trial to Assess the Safety, Immunogenicity and Efficacy of Inactivated Shigella Flexneri 2a Whole Cell (Sf2aWC) Vaccine Administered With and Without Double Mutant E. Coli Heat Labile Toxin (dmLT) in Healthy Adult Subjects|Recruiting||Phase 2|72|Anticipated|PATH||3|||f||||t|t|f||||||No||2017-10-10 21:24:37.193771|2017-10-10 21:24:37.193771
NCT03038230|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-03|||April 2016||2016-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||MCLA-117 in Acute Myelogenous Leukemia|A Phase 1, Multinational Study of MCLA-117 in Acute Myelogenous Leukemia|Recruiting||Phase 1|50|Anticipated|Merus N.V.||1|||f||||t||||||||Yes|Individual participant data are made available only to the individual patient upon specific request of that individual patient or its treating physician.|2017-10-10 21:24:37.300591|2017-10-10 21:24:37.300591
NCT03038217|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-02-02|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer|Investigation of the Value of ctDNA Analysis in the Diagnosis, Treatment, and Surveillance of Patients With Surgically Resectable Colorectal Cancer|Not yet recruiting||Phase 3|300|Anticipated|Peking Union Medical College Hospital||4|||f||||t|f|f||||||Undecided||2017-10-10 21:24:37.433982|2017-10-10 21:24:37.433982
NCT03038204|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-28|||February 2016||2016-02-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Observational|PMA||The Papillary Muscle Approximation Provide Stability of Mitral Valve Repair for Ischemic Mitral Regurgitation|The Papillary Muscle Approximation Provide Stability of Mitral Valve Repair for Ischemic Mitral Regurgitation|Active, not recruiting||N/A|100|Anticipated|The Federal Centre of Cardiovascular Surgery, Russia|||2||f||||t||||||||Yes||2017-10-10 21:24:37.540748|2017-10-10 21:24:37.540748
NCT03038191|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-05-30|||March 8, 2017|Actual|2017-03-08|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|||Epi-collect: Data Collection During Video EEG Monitoring and at Patient's Home|Epi-collect: Data Collection During Video EEG Monitoring and at Patient's Home|Recruiting||N/A|50|Anticipated|Medial Research Ltd.|||1||f||||f||||||||No||2017-10-10 21:24:37.625463|2017-10-10 21:24:37.625463
NCT03038178|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-26|||October 2016||2016-10-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease|An Open-label Study of Efficacy, Safety and Tolerability of Liposomal Amikacin for Inhalation (LAI) Once Daily in Addition to Standard Multi-antibiotic Therapy in the Treatment of Mycobacterium Abscessus Lung Disease|Recruiting||Phase 2|30|Anticipated|Oregon Health and Science University||1|||f||||t||||||||No||2017-10-10 21:24:37.694883|2017-10-10 21:24:37.694883
NCT03038165|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-31|||November 2016|Actual|2016-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Hemodynamic Parameters Changes in the Course of Hemodialysis Sessions in Patients With Intradialytic Hypertension|Hemodynamic Parameters Changes in the Course of Hemodialysis Sessions in Patients With Intradialytic Hypertension|Recruiting||N/A|22|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||f|f|f||||||No||2017-10-10 21:24:37.799883|2017-10-10 21:24:37.799883
NCT03038152|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-19|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study the Use of Magseed and Sentimag to Localize Axillary Lymph Nodes|A Prospective, Open Label Study of the Use of Magseed® and Sentimag® to Localize Axillary Lymph Nodes With Biopsy-Proven Metastases in Breast Cancer Patients|Recruiting||Phase 4|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|f|t|f|f||||||2017-10-10 21:24:37.878873|2017-10-10 21:24:37.878873
NCT03038139|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-10-02|||November 2016||2016-11-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Postural Correction Exercises for Forward Head Posture|Changes in Spinal Muscular Activation and Creaniovertebral Angle After Postural Correction Program for Forward Head Posture|Enrolling by invitation||N/A|60|Actual|Dammam University||2|||f||||t||||||||||2017-10-10 21:24:37.973691|2017-10-10 21:24:37.973691
NCT03038126|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-01-30|||May 2014||2014-05-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|CCHT in CKD||Care Coordination/Home Telehealth to Safeguard Care in CKD|Care Coordination/Telehealth to Address Patient Safety and Poor Outcomes in CKD|Recruiting||N/A|130|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-10 21:24:38.04855|2017-10-10 21:24:38.04855
NCT03038113|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-21|||February 6, 2017|Actual|2017-02-06|September 2017|2017-09-01|November 13, 2018|Anticipated|2018-11-13|November 13, 2018|Anticipated|2018-11-13||Interventional|||A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B|A Randomized, Sponsor-Open, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of Subcutaneous Administration of RO7062931 With Single Ascending Doses in Healthy Volunteers and Multiple Doses and Modified Regimens in Virologically Suppressed Patients With Chronic Hepatitis B Virus Infection|Recruiting||Phase 1|160|Anticipated|Hoffmann-La Roche||2|||f||||f|f|f||||||||2017-10-10 21:24:38.139705|2017-10-10 21:24:38.139705
NCT03037918|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-27|||February 3, 2017|Anticipated|2017-02-03|January 2017|2017-01-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Effect of Yakult Ingestion on Diet-induced Insulin Resistance in Humans|Effect of Yakult Ingestion on Diet-induced Insulin Resistance in Humans. A Large-cohort, Mechanistic Follow-up Study.|Recruiting||N/A|60|Anticipated|Loughborough University||2|||f|||||f|f||||||||2017-10-10 21:24:40.780106|2017-10-10 21:24:40.780106
NCT03038100|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-08-04|||March 8, 2017|Actual|2017-03-08|August 2017|2017-08-01|July 1, 2025|Anticipated|2025-07-01|December 1, 2021|Anticipated|2021-12-01||Interventional|IMagyn050||A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase III, Multicenter, Randomized, Study of Atezolizumab Versus Placebo Administered in Combination With Paclitaxel, Carboplatin, and Bevacizumab to Patients With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 3|1300|Anticipated|Hoffmann-La Roche||2|||f||||t|t|f||||||||2017-10-10 21:24:38.28232|2017-10-10 21:24:38.28232
NCT03038087|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-10-03|||February 23, 2017|Actual|2017-02-23|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Test the SENSE Device in Patients With Intracranial Hemorrhage|An Early Feasibility Study to Evaluate the User Interfaces and Sensitivity of the SENSE Device in Patients With Intracranial Hemorrhage|Recruiting||N/A|10|Anticipated|Sense Diagnostics, LLC||1|||f||||f|f|t|t|||||||2017-10-10 21:24:39.165759|2017-10-10 21:24:39.165759
NCT03038074|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-05-09|||December 2016||2016-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:24:39.254504|2017-10-10 21:24:39.254504
NCT03038061|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-28|2017-07-28|||December 1, 2015|Actual|2015-12-01|July 2017|2017-07-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|UDLaS||Ultrasound Detection of Position of Diaphragm During Laparoscopic Surgery|Ultrasound Detection of Presence of Diaphragm in the Region of Lung Monitoring Using Electrical Impedance Tomography During Laparoscopic Surgery|Recruiting||N/A|20|Anticipated|Czech Technical University in Prague||1|||f||||f|f|f||||||||2017-10-10 21:24:39.30011|2017-10-10 21:24:39.30011
NCT03038048|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-07-21|||January 27, 2017|Actual|2017-01-27|July 2017|2017-07-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|||30g vs 33g Needle for Intravitreal Injections|Intravitreal Injection Using 33-gauge Versus 30-gauge Needles: Comparison of Patients' Experience|Completed||N/A|50|Actual|Wills Eye||2|||f||||f|f|f||||||||2017-10-10 21:24:39.40539|2017-10-10 21:24:39.40539
NCT03038035|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-01-26|||December 2016||2016-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|ATHENE||The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study|The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study : Assessing the Safety and Efficacy of Neuroaid II (MLC901) in Patients With Mild to Moderate Alzheimer's Disease Stable on Cholinesterase Inhibitors or Memantine: A Randomized, Double Blind, Placebo Controlled Trial|Recruiting||Phase 2|150|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-10 21:24:39.499344|2017-10-10 21:24:39.499344
NCT03038022|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-27|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|January 15, 2018|Anticipated|2018-01-15|September 25, 2017|Actual|2017-09-25||Interventional|||Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)|A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo Controlled Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia|Active, not recruiting||Phase 2|116|Actual|Madrigal Pharmaceuticals, Inc.||2|||f||||t|t|f|||t|||||2017-10-10 21:24:39.600864|2017-10-10 21:24:39.600864
NCT03038009|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-02-04|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|DACAB-GI-2||Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft|Evaluation of the Efficacy and Safety of Different Duration of Proton Pump Inhibitor for Prevention of Upper Gastrointestinal Mucosal Injury in Patients Taking 12-month Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery|Not yet recruiting||Phase 4|208|Anticipated|Ruijin Hospital||2|||f|||||f|f||||||No||2017-10-10 21:24:39.683776|2017-10-10 21:24:39.683776
NCT03037996|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-10-05|||January 23, 2017|Actual|2017-01-23|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|4 Months|Observational [Patient Registry]|Anesthesia||To Develop a Validated Program and Use it to Evaluate Patients Post-operatively|The Develop a Validated Si-2-AQ and Use it to Evaluate Patients Postoperatively|Enrolling by invitation||N/A|450|Actual|Siriraj Hospital|||1||f||||t|f|f||||||||2017-10-10 21:24:39.78835|2017-10-10 21:24:39.78835
NCT03037983|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-27|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation|Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation|Recruiting||N/A|24|Anticipated|VA Office of Research and Development||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:24:39.856209|2017-10-10 21:24:39.856209
NCT03037970|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-30|||January 30, 2017|Anticipated|2017-01-30|January 2017|2017-01-01|October 15, 2017|Anticipated|2017-10-15|August 15, 2017|Anticipated|2017-08-15||Interventional|ABSOLVE||Evaluation of ABSOLVE in Diabetic Foot Ulcers|A Prospective Randomized Controlled Blinded Study to Evaluate the Safety and Efficacy of rhPDGF-BB Saturated Collagen Wound Dressings on Diabetic Foot Ulcers|Recruiting||Phase 2|40|Anticipated|Lynch Biologics LLC||2|||f||||f|f|f||||||Undecided||2017-10-10 21:24:39.96844|2017-10-10 21:24:39.96844
NCT03037957|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-07-05|||January 9, 2017|Actual|2017-01-09|July 2017|2017-07-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Observational|||A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients|A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients|Completed||N/A|704|Actual|Luminex Molecular Diagnostics|||1||f||||f|f|f||||||||2017-10-10 21:24:40.11781|2017-10-10 21:24:40.11781
NCT03037944|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2017-01-28|||March 1, 2016|Actual|2016-03-01|January 2017|2017-01-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|LNG-IUDvsCOCs||Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri|Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri|Recruiting||Early Phase 1|32|Anticipated|Ain Shams Maternity Hospital||2|||f||||t|t|t|t|f|f|||No||2017-10-10 21:24:40.227072|2017-10-10 21:24:40.227072
NCT03037892|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-02-01|||June 2015||2015-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy|A Prospective Randomized Comparative Study to Evaluate the Use of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy|Recruiting||N/A|90|Anticipated|King Hamad University Hospital, Bahrain||3|||f||||t||||||||||2017-10-10 21:24:40.983105|2017-10-10 21:24:40.983105
NCT03037879|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-17|||April 13, 2017|Actual|2017-04-13|March 2017|2017-03-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Treating Cognitive Deficits in Spinal Cord Injury|Treating Cognitive Deficits in Traumatic Spinal Cord Injury: A Randomized Clinical Trial|Recruiting||N/A|104|Anticipated|James J. Peters Veterans Affairs Medical Center||4|||f||||f|f|f||||||Undecided||2017-10-10 21:24:41.151494|2017-10-10 21:24:41.151494
NCT03037866|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-26|||May 2015||2015-05-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Primary Prevention of Sexual Violence Among College Students|Primary Prevention of Sexual Violence Among College Students|Active, not recruiting||N/A|4000|Anticipated|National Health Promotion Associates, Inc.||2|||f||||t||||||||No||2017-10-10 21:24:41.256961|2017-10-10 21:24:41.256961
NCT03037853|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-08|||April 2015||2015-04-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|A2H||Anatomic Altas of the Whole Human Body|Anatomic Altas of the Whole Human Body|Completed||N/A|20|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 21:24:41.337122|2017-10-10 21:24:41.337122
NCT03037840|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-02-02|||July 2016||2016-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients|Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients In Vivo|Not yet recruiting||N/A|200|Anticipated|Southern Medical University, China|||2||f||||t||||||||Undecided||2017-10-10 21:24:41.39532|2017-10-10 21:24:41.39532
NCT03037827|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-02-01|||January 30, 2017|Actual|2017-01-30|February 2017|2017-02-01|December 30, 2017|Anticipated|2017-12-30|September 30, 2017|Anticipated|2017-09-30||Interventional|SLEDGE||The Effect of Laser Power and Fiber Traction Speed on the Outcomes of Endovenous Laser Ablation|Three Different Regimens of Endovenous Laser Ablation With Equal Linear Endovenous Energy Density (The SLEDGE Study): a Prospective, Randomized Multicenter Trial|Recruiting||N/A|750|Anticipated|Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia||3|||f||||f|f|f||||||Yes|Data collection will take place at the Russian Registry of Treatment of Chronic Venous Diseases (RRT CVD). Access to the data will be available after completion of the study. To access the data will need to send a request to RRT CVD administrator. Register in Russian. Registry now listed in the database ClinicalTrials.gov, ID NCT03035747 (see references)|2017-10-10 21:24:41.469589|2017-10-10 21:24:41.469589
NCT03037814|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-07-17|||October 28, 2017|Anticipated|2017-10-28|July 2017|2017-07-01|December 25, 2022|Anticipated|2022-12-25|April 25, 2022|Anticipated|2022-04-25||Interventional|||Clinical Performance of Restorative Materials in Primary Teeth|Clinical Performance of Restorative Materials in Class II Cavities of Primary Molar Teeth|Not yet recruiting||N/A|100|Anticipated|Hacettepe University||4|||f||||f|f|f||||||||2017-10-10 21:24:41.564671|2017-10-10 21:24:41.564671
NCT03037801|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-29|2017-06-01|||March 1, 2017|Actual|2017-03-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Intrapulmonary Percussive Ventilation for Children With Bronchiolitis on Non-Invasive Ventilation Support|Prospective Randomized Controlled Study of the Use of Intrapulmonary Percussive Ventilation (IPV) for Children With Bronchiolitis Admitted to the Pediatric Intensive Care Unit (PICU) and Are on Non-Invasive Ventilation Support|Recruiting||N/A|50|Anticipated|Soroka University Medical Center||2|||f|||||f|t|f||t|||No||2017-10-10 21:24:41.646241|2017-10-10 21:24:41.646241
NCT03037788|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-11|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis|Pharmacokinetics, Local and Systemic Tolerability and Local Efficacy of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in a Placebo Controlled, Double Blind Study in Subjects With Axillary Hyperhidrosis|Completed||Phase 1|29|Actual|Dr. August Wolff GmbH & Co. KG Arzneimittel||4|||f||||f||||||||||2017-10-10 21:24:41.717516|2017-10-10 21:24:41.717516
NCT03037775|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-27|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EPAPHemo||The Influence of Electronic and Traditional Cigarettes Smoking on Hemodynamic Parameters|The Influence of Electronic and Traditional Cigarettes Smoking on Hemodynamic Parameters and Sympathetic Nerves Activity in Healthy People|Recruiting||N/A|50|Anticipated|Medical University of Warsaw||1|||f||||f||||||||No||2017-10-10 21:24:41.794852|2017-10-10 21:24:41.794852
NCT03037762|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-27|||October 2014||2014-10-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01|3 Months|Observational [Patient Registry]|FEES-Registry||Findings and Side-effects of Flexible Endoscopic Evaluation of Swallowing - the FEES-Registry|Findings and Side-effects of Flexible Endoscopic Evaluation of Swallowing - the FEES-Registry|Recruiting||N/A|2000|Anticipated|University Hospital Muenster|||1||f||||f||||||||No||2017-10-10 21:24:41.889196|2017-10-10 21:24:41.889196
NCT03037749|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-01-27|||March 2015||2015-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence|Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence|Recruiting||N/A|70|Anticipated|University of New Mexico||2|||f||||f||||||||||2017-10-10 21:24:43.950726|2017-10-10 21:24:43.950726
NCT03037736|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-27|||May 1, 2017|Anticipated|2017-05-01|January 2017|2017-01-01|May 1, 2020|Anticipated|2020-05-01|April 1, 2019|Anticipated|2019-04-01||Interventional|OPPS||Outpatient Performed Pterygium Surgery Study|Outpatient Performed Pterygium Surgery Study|Not yet recruiting||Phase 4|190|Anticipated|University of California, San Francisco||3|||f||||t|t|f|||f|||Undecided||2017-10-10 21:24:44.047233|2017-10-10 21:24:44.047233
NCT03037723|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-30|||September 2013||2013-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prone Whole-Breast RadiationTherapy Versus Supine Whole-Breast Radiation Therapy Imaging|Prospective Trial of Prone Whole-Breast RadiationTherapy Versus Supine Whole-Breast Radiation Therapy With and Without Respiratory Gating, a Dosimetric Comparison|Recruiting||N/A|100|Anticipated|State University of New York - Upstate Medical University||1|||f||||f||||||||No||2017-10-10 21:24:44.123731|2017-10-10 21:24:44.123731
NCT03037710|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-08-15|||June 2015||2015-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|LINK-HF||Link-HF, Phase II: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation|Link-HF, Phase II: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation|Active, not recruiting||N/A|100|Actual|University of Utah|||1||f||||f||||||||||2017-10-10 21:24:44.199801|2017-10-10 21:24:44.199801
NCT03037697|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-27|||January 2017||2017-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy of Axial Stability on Improving Gait and Balance Performance in Children With Dyskinetic Cerebral Palsy|Efficacy of Axial Stability on Improving Gait and Balance Performance in Children With Dyskinetic Cerebral Palsy|Recruiting||N/A|40|Anticipated|Umm Al-Qura University||2|||f||||t||||||||Undecided||2017-10-10 21:24:44.277937|2017-10-10 21:24:44.277937
NCT03037684|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-03-28|||March 27, 2017|Actual|2017-03-27|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain|Selective Activation of Unmyelinated Skin Nerve Fibres Using Slow Depolarising Transcutaneous Electrical Stimulation in Patients With Neuropathic Pain or Chronic Postoperative Pain|Recruiting||N/A|40|Anticipated|Swiss Paraplegic Centre Nottwil|||2||f||||f|f|f||||||No||2017-10-10 21:24:44.366405|2017-10-10 21:24:44.366405
NCT03037671|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population|Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric Hematopoietic Stem Cell Transplant Population|Not yet recruiting||N/A|30|Anticipated|University of Colorado, Denver|||1||f||||t|f|f||||||||2017-10-10 21:24:44.465373|2017-10-10 21:24:44.465373
NCT03037658|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-04-26|||September 2013||2013-09-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Physical Activity Incentives|Physical Activity Incentives|Completed||N/A|450|Actual|Stanford University||5|||f||||f|f|f||||||Yes|The researchers will share de-identified participant data with other researchers.|2017-10-10 21:24:44.557848|2017-10-10 21:24:44.557848
NCT03037645|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-04|||April 28, 2017|Actual|2017-04-28|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Safety, PK, PD, and Antitumor Activity of SNS-062 in B Lymphoid Cancers|A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study of the Noncovalent, Reversible Bruton's Tyrosine Kinase Inhibitor, SNS-062, in Patients With B-Lymphoid Malignancies|Recruiting||Phase 1/Phase 2|124|Anticipated|Sunesis Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 21:24:44.644126|2017-10-10 21:24:44.644126
NCT03037632|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-30|||June 7, 2016|Actual|2016-06-07|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|January 2019|Anticipated|2019-01-01||Interventional|||DCM Precision Medicine Study|Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry|Recruiting||N/A|6500|Anticipated|Ohio State University||2|||f||||t|f|f||||||No||2017-10-10 21:24:44.859877|2017-10-10 21:24:44.859877
NCT03037619|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-12|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Fitbit and Social Support in Knee Replacement Patients & Buddies|Influence of Wearable Activity Monitors and Social Support on Physical Activity After Knee Replacement|Recruiting||N/A|30|Anticipated|Northwestern University||2|||f||||f|f|f||||||||2017-10-10 21:24:45.054974|2017-10-10 21:24:45.054974
NCT03037606|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-08-23|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|June 1, 2018|Anticipated|2018-06-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets|Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets on Intragastric and Intraesophageal Acidity|Active, not recruiting||Phase 4|48|Anticipated|Neutec Ar-Ge San ve Tic A.Ş||2|||f||||f|f|f||||||||2017-10-10 21:24:45.175896|2017-10-10 21:24:45.175896
NCT03037593|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-15|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women|A Randomized Single-Center Study of the Effects of High-Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High-Risk Pregnant Women|Not yet recruiting||Phase 1/Phase 2|300|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||Undecided||2017-10-10 21:24:45.300718|2017-10-10 21:24:45.300718
NCT03037580|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-10-05|||August 15, 2017|Actual|2017-08-15|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF)|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)|Recruiting||Phase 3|310|Anticipated|United Therapeutics||2|||f||||t|t|f||||||||2017-10-10 21:24:45.408464|2017-10-10 21:24:45.408464
NCT03037567|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-23|||January 27, 2017|Actual|2017-01-27|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of a Commercial Program on Weight Loss and Health Outcomes|Evaluation of a Commercial Program on Weight Loss and Health Outcomes|Active, not recruiting||N/A|152|Actual|University of North Carolina, Chapel Hill||1|||f||||f|f|f||||||No||2017-10-10 21:24:45.630403|2017-10-10 21:24:45.630403
NCT03037554|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-27|||March 15, 2017|Anticipated|2017-03-15|January 2017|2017-01-01|March 15, 2018|Anticipated|2018-03-15|March 15, 2018|Anticipated|2018-03-15||Interventional|||The Effects of Lateralized Thermal Sleepwear on Sleep, Skin Temperature and Skin Moisture in Menopausal Women|The Effects of Sleepwear With Lateralized Thermal Characteristics on Sleep, Proximal Skin Temperature and Sternal Skin Moisture in Menopausal Women|Not yet recruiting||N/A|16|Anticipated|St. Peter's Hospital, Albany, NY||2|||f||||f|f|f||||||No||2017-10-10 21:24:45.710896|2017-10-10 21:24:45.710896
NCT03037541|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-01-31|2017-01-31||January 5, 2011|Actual|2011-01-05|January 2017|2017-01-01|October 29, 2013|Actual|2013-10-29|October 29, 2013|Actual|2013-10-29||Interventional|||Cryosurgery and Cream Combination for Actinic Keratosis|A Single-Center, Randomized, Single-Blinded, Placebo-Controlled Trial on the Efficacy of Cryosurgery and 5-Fluorouracil 0.5% Cream Combination Therapy for the Treatment of Actinic Keratosis|Completed||Phase 3|60|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-10 21:24:45.800273|2017-10-10 21:24:45.800273
NCT03037528|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-05-04|||January 27, 2017|Actual|2017-01-27|May 2017|2017-05-01|May 1, 2021|Anticipated|2021-05-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes|Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes|Recruiting||N/A|144|Anticipated|University of Michigan||8|||f||||f|f|f||||||No||2017-10-10 21:24:46.19119|2017-10-10 21:24:46.19119
NCT03037515|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-27|||February 15, 2017|Anticipated|2017-02-15|January 2017|2017-01-01|November 16, 2017|Anticipated|2017-11-16|August 15, 2017|Anticipated|2017-08-15||Interventional|||Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery|A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery|Not yet recruiting||Phase 4|120|Anticipated|Henry Ford Health System||2|||f||||f|t|f||||||||2017-10-10 21:24:46.315562|2017-10-10 21:24:46.315562
NCT03037502|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-20|||June 1, 2018|Anticipated|2018-06-01|April 2017|2017-04-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Tailoring a Lifestyle Intervention to Address Obesity Disparities Among Men|Tailoring a Lifestyle Intervention to Address Obesity Disparities Among Men|Not yet recruiting||N/A|236|Anticipated|Vanderbilt University||2|||f||||f|f|f||||||No||2017-10-10 21:24:46.449315|2017-10-10 21:24:46.449315
NCT03037489|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-08-24|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients|An Open-Label, One-Arm Phase II Extension Study to Evaluate Safety and Tolerability of MIV-711 in Patients With Knee Joint Osteoarthritis|Active, not recruiting||Phase 2|50|Actual|Medivir||1|||f||||t||||||||||2017-10-10 21:24:46.568444|2017-10-10 21:24:46.568444
NCT03037476|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-04-06|||January 2017||2017-01-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Personalized Health Assessment Related to Medications (Project PHARM)|Personalized Health Assessment Related to Medications (Project PHARM)|Recruiting||N/A|1050|Anticipated|University of Washington||3|||f||||t||||||||No||2017-10-10 21:24:46.658662|2017-10-10 21:24:46.658662
NCT03037463|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-08|||January 2017||2017-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Measuring Parkinson's Disease With Tear Fluid|Identification of Tear Biomarkers for Parkinson's Disease Patients|Recruiting||N/A|130|Anticipated|University of Southern California|||2||f||||||||||||||2017-10-10 21:24:46.867376|2017-10-10 21:24:46.867376
NCT03037450|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-30|||March 30, 2017|Anticipated|2017-03-30|January 2017|2017-01-01|March 30, 2019|Anticipated|2019-03-30|March 30, 2019|Anticipated|2019-03-30||Interventional|MICORNE||Miniinvasive Corneal Neurotization. A Pilot Study.|Miniinvasive Corneal Neurotization. A Pilot Study.|Not yet recruiting||N/A|5|Anticipated|University Hospital, Strasbourg, France||1|||f||||f|f|f||||||No||2017-10-10 21:24:46.936155|2017-10-10 21:24:46.936155
NCT03037437|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-27|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer|Modulation of Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer|Not yet recruiting||Phase 2|68|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t|t|f||||||||2017-10-10 21:24:47.007955|2017-10-10 21:24:47.007955
NCT03037424|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-23|||February 22, 2017|Actual|2017-02-22|February 2017|2017-02-01|March 30, 2019|Anticipated|2019-03-30|January 30, 2019|Anticipated|2019-01-30||Interventional|FIBRES||FIBrinogen REplenishment in Surgery|Prospective, Multi-center, Randomized, Active-control, Non-inferiority Study Comparing Fibrinogen Concentrate With Cryoprecipitate for the Treatment of Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients|Recruiting||Phase 3|1200|Anticipated|University Health Network, Toronto||2|||f|||||f|f||||||No||2017-10-10 21:24:47.100879|2017-10-10 21:24:47.100879
NCT03037411|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|REGAL||A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries|A Real World Evaluation of the ELUVIA Drug Eluting Stent in All-Comers With Superficial Femoral Artery and Proximal Popliteal Artery Disease|Recruiting||N/A|500|Anticipated|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-10 21:24:47.255754|2017-10-10 21:24:47.255754
NCT03037398|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-02-01|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CLOVER||Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation||Recruiting||N/A|12|Anticipated|Boston Scientific Corporation||2|||f||||f||||||||No||2017-10-10 21:24:47.394371|2017-10-10 21:24:47.394371
NCT03037385|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-30|||March 17, 2017|Actual|2017-03-17|June 2017|2017-06-01|March 2023|Anticipated|2023-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Phase 1 Study of BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors|A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors|Recruiting||Phase 1|115|Anticipated|Blueprint Medicines Corporation||1|||f||||f|t|f||||||||2017-10-10 21:24:47.469026|2017-10-10 21:24:47.469026
NCT03037372|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-26|||June 1, 2017|Anticipated|2017-06-01|January 2017|2017-01-01|December 31, 2022|Anticipated|2022-12-31|June 30, 2022|Anticipated|2022-06-30||Interventional|STAR||Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial|Statin Adjunct Therapy Among HAART-treated Adults in Sub-Saharan Africa: Equivalence of Atorvastatin and Rosuvastatin|Not yet recruiting||Phase 3|320|Anticipated|Makerere University||4|||f||||t|f|f|||f|||Yes|Data will be shared with the Infectious Diseases Institute, according to the IDI data sharing policy|2017-10-10 21:24:47.572591|2017-10-10 21:24:47.572591
NCT03037359|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-07-11|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31|24 Weeks|Observational [Patient Registry]|||A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products|A Multicenter, Non-interventional, Observational, Prospective Study to Assess Hypotension in Patients With Primary Immunodeficiency Disease Treated With Bivigam™ (Human 10%) or Other Commercial Human 10% Immune Globulin (Intravenous) (IGIV) Products During Infusion and up to 72 Hours Post Infusion|Recruiting||N/A|200|Anticipated|Biotest Pharmaceuticals Corporation|||2||f||||f|t|f|||f|||||2017-10-10 21:24:47.677357|2017-10-10 21:24:47.677357
NCT03037333|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-27|||August 16, 2017|Actual|2017-08-16|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|EMERG-TV-PAC||Analysis in the EMERGEncy Between TransVenous Cardiac PACIng Guided by Fluoroscopy Versus Echocardiogram|Prospective Analysis in the EMERGEncy Between TransVenous Cardiac PACIng Guided by Fluoroscopy Versus Echocardiogram|Recruiting||N/A|150|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 21:24:47.864556|2017-10-10 21:24:47.864556
NCT03037320|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-31|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|CAF and SVIT||Comparison of Coronally Advanced Flap and Semilunar Incision Vestibular Technique for Multiple Gingival Recessions in Maxillary Teeth - A Randomized Controlled Trial|Comparison of Coronally Advanced Flap and Semilunar Incision Vestibular Technique for Multiple Gingival Recessions in Maxillary Teeth - A Randomized Controlled|Recruiting||N/A|50|Anticipated|Indira Gandhi Institute of Dental Science||2|||f||||t|f|f||||||Undecided||2017-10-10 21:24:47.965231|2017-10-10 21:24:47.965231
NCT03037307|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-07-03|||February 13, 2017|Actual|2017-02-13|July 2017|2017-07-01|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Interventional|||A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive|A Bite Force Study Assessing Two Currently Marketed Denture Adhesive Products Compared to No-Adhesive Control.|Completed||N/A|43|Actual|GlaxoSmithKline||3|||f|||||f|f||||||||2017-10-10 21:24:48.044|2017-10-10 21:24:48.044
NCT03037294|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-26|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|August 30, 2019|Anticipated|2019-08-30|April 30, 2018|Anticipated|2018-04-30||Interventional|KneeT||Protein Turnover in the Osteoarthritic Knee|Protein Turnover in the Osteoarthritic Knee; the Impact of Preoperative Protein Intake and Intra-articular Corticosteroid Injections|Recruiting||N/A|39|Anticipated|Maastricht University Medical Center||3|||f||||t|f|f|||f|||No||2017-10-10 21:24:48.119139|2017-10-10 21:24:48.119139
NCT03037281|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-06|||April 7, 2016|Actual|2016-04-07|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Release of Nociceptin From Granulocytes in Sepsis|Does the Release Profile of Nociceptin From Immunocytes Differ in Healthy Volunteers and Critically Ill Patients With Sepsis?|Recruiting||N/A|40|Anticipated|University of Leicester|||2||f||||f|f|f||||||No||2017-10-10 21:24:48.212499|2017-10-10 21:24:48.212499
NCT03037268|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-07-31|||December 2017|Anticipated|2017-12-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|PORT||Quality and Diagnostic Utility of Mydriatic Fundus Plenoptic Photography|Quality and Diagnostic Utility of Mydriatic Fundus Plenoptic Photography: The Plenoptic Ophthalmoscopy Reliability Trial|Suspended||N/A|20|Anticipated|Wills Eye|||1|Device is being refined by the engineers|f||||f||||||||||2017-10-10 21:24:48.311491|2017-10-10 21:24:48.311491
NCT03037255|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-27|||January 2003||2003-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2013|Actual|2013-12-01|8 Years|Observational [Patient Registry]|||Association of Long-term Conditions With Survival Following Heart Attack in England and Wales|Association of Long-term Conditions With Survival Following Acute Myocardial Infarction in England and Wales|Active, not recruiting||N/A|693633|Actual|University of Leeds|||1||f||||f||||||||No||2017-10-10 21:24:48.391467|2017-10-10 21:24:48.391467
NCT03037242|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-03-06|||January 2017||2017-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Outcomes of Meniscus Root Repair Using a Transtibial Pullout Technique|Multi-Center Prospective Clinical and Radiographic Outcomes of Meniscus Root Repair Using a Transtibial Pullout Technique|Recruiting||N/A|45|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 21:24:48.467946|2017-10-10 21:24:48.467946
NCT03037229|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-27|||December 29, 2016|Actual|2016-12-29|January 2017|2017-01-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|ST LEUIS||Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction|Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction|Recruiting||N/A|30|Anticipated|Mayo Clinic|||2||f||||f|f|t|f|f|t|||No||2017-10-10 21:24:48.551157|2017-10-10 21:24:48.551157
NCT03037216|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-08-01|||December 15, 2016|Actual|2016-12-15|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans|Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans|Active, not recruiting||N/A|10|Anticipated|Joslin Diabetes Center||1|||f||||f|f|f||||||||2017-10-10 21:24:48.642464|2017-10-10 21:24:48.642464
NCT03037203|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-10-03|||January 2017||2017-01-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness|A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness|Recruiting||Phase 2|49|Anticipated|Jazz Pharmaceuticals||3|||f||||f||||||||||2017-10-10 21:24:48.721956|2017-10-10 21:24:48.721956
NCT03037190|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-30|||December 2015|Actual|2015-12-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|Diabglut||Preservation of Residual Beta Cell Mass and Prevention of Celiac Disease in Children With Recent Onset Type 1 Diabetes|Investigation Whether a Gluten Free Diet After the Onset of Type 1 Diabetes (T1D) Can Better Preserve the Remaining Beta Cell Mass and at the Same Time Prevent the Development of Celiac Disease (CD) in These Patients.|Recruiting||N/A|160|Anticipated|Lund University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:24:48.834166|2017-10-10 21:24:48.834166
NCT03037177|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-01-27|||January 2013||2013-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|||Mediastinal Grey Zone Lymphoma From the LYSA|Mediastinal Grey Zone Lymphoma: Clinico-pathological Characteristics and Outcomes of 99 Patients From the LYSA|Completed||N/A|99|Actual|Hospices Civils de Lyon|||3||f||||||||||Samples Without DNA|"     clinical characteristics and outcomes of a large retrospective series of 99 cases centrally     reviewed by a panel of hematopathologists.   "|||2017-10-10 21:24:48.94572|2017-10-10 21:24:48.94572
NCT03037164|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-06-05|||May 11, 2017|Actual|2017-05-11|June 2017|2017-06-01|March 30, 2019|Anticipated|2019-03-30|November 30, 2018|Anticipated|2018-11-30||Interventional|RedeS||Study of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS)|A Randomized, Double-Blind, Controlled, Parallel Group Study With the INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS Study) and Treatment Use Open-Label Extension Study|Recruiting||Phase 3|600|Anticipated|Cerus Corporation||2|||||||t|f|t|t|f||||||2017-10-10 21:24:49.0252|2017-10-10 21:24:49.0252
NCT03037151|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-08-09|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|January 19, 2022|Anticipated|2022-01-19|January 19, 2022|Anticipated|2022-01-19||Interventional|||Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV|Safety and Fibrosis Improvement of Grazoprevir and Elbasvir for HCV GT1 and GT6 With or Without HIV|Not yet recruiting||Phase 3|100|Anticipated|The HIV Netherlands Australia Thailand Research Collaboration||4|||f||||f|f|f||||||||2017-10-10 21:24:49.135474|2017-10-10 21:24:49.135474
NCT03037138|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-27|||November 12, 2016|Actual|2016-11-12|January 2017|2017-01-01|January 1, 2017|Actual|2017-01-01|December 5, 2016|Actual|2016-12-05||Interventional|||Use Of Blood Flow Rate Profiling For Postdialysis Washed-Out Patients|Use Of Blood Flow Rate Profiling For Postdialysis Washed-Out Patients|Completed||N/A|27|Actual|Benha University||1|||f||||f|f|f|||f|||No||2017-10-10 21:24:49.230056|2017-10-10 21:24:49.230056
NCT03037125|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-31|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|January 1, 2018|Anticipated|2018-01-01|August 15, 2017|Anticipated|2017-08-15||Interventional|||The Evaluation Of Bone Width Gain Following Split Crest Technique With Or Without Platelet Rich Fibrin( PRF)|The Evaluation Of Bone Width Gain Following Split Crest Technique With Or Without PRF In Conjunction With Simultaneous Implant Placement In Narrow Alveolar Ridges: A Randomized Controlled Clinical Trial|Not yet recruiting||N/A|14|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 21:24:49.421649|2017-10-10 21:24:49.421649
NCT03037112|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-03-09|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse|Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse|Recruiting||N/A|1656|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||t|f|f||||||Yes|We will create a clean, de-identified copy of our final dataset that will be available to other researcher groups, upon request, within 9 months of the end of the final year of funding. Prior to data sharing, we will remove or convert all identifying information (date of birth will be converted to age and other identifiers will be removed). There may remain the possibility of deductive disclosure of subjects with unusual characteristics. Thus, we will make the data and associated documentation available to users under a data-sharing agreement.|2017-10-10 21:24:49.500913|2017-10-10 21:24:49.500913
NCT03037099|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-01-27|||January 2017|Actual|2017-01-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|HEALD-GI||Healthy Eating and Active Living for Diabetes: Glycemic Index|Enhancing Glycemic Index Knowledge and Application Among Adults With Type-2 Diabetes Mellitus|Recruiting||N/A|66|Anticipated|Athabasca University||2|||f||||f|f|f||||||No||2017-10-10 21:24:49.608765|2017-10-10 21:24:49.608765
NCT03037086|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-03-14|||October 15, 2015|Actual|2015-10-15|March 2017|2017-03-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Observational|MEDI-APEX||Asia PDL1 Study Among NSCLC Patients|A Retrospective Non-Interventional Study of PD-L1 Prevalence and Clinical Outcomes for Non-Small Cell Lung Cancer in Asia-Pacific|Completed||N/A|659|Actual|AstraZeneca|||1||f||||f||||||Samples With DNA|"     Tumour tissue samples   "|||2017-10-10 21:24:49.728683|2017-10-10 21:24:49.728683
NCT03037073|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-07|||February 7, 2017|Actual|2017-02-07|February 2017|2017-02-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Duloxetine for Succinylcholine-induced Postoperative Myalgia|Effect of Duloxetine on Succinylcholine-induced Postoperative Myalgia in Direct Microlaryngoscopic Surgeries: Randomized Controlled Double-blind Study|Recruiting||Phase 2/Phase 3|70|Anticipated|Assiut University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:24:49.830197|2017-10-10 21:24:49.830197
NCT03037060|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-09-22|||December 2016||2016-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study|Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study|Recruiting||N/A|25|Anticipated|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-10-10 21:24:49.934909|2017-10-10 21:24:49.934909
NCT03037047|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-27|||May 11, 2016|Actual|2016-05-11|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris|Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris: a Parallel, Double Blind, Randomized, Controlled, Multi-center Trial.|Recruiting||Phase 4|320|Anticipated|Green Valley Group of China||2|||f||||t|f|f||||||Undecided||2017-10-10 21:24:50.05182|2017-10-10 21:24:50.05182
NCT03037034|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-30|||January 1, 2015|Actual|2015-01-01|January 2017|2017-01-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Novel Endoscopic Resection of Upper Gastrointestinal Subepithelial Tumors Originating From the Muscularis Propria|Novel Endoscopic Resection of Upper Gastrointestinal Subepithelial Tumors Originating From the Muscularis Propria: a Promising Forcep Strip Method|Completed||N/A|11|Actual|Korea University Anam Hospital||1|||f|||||f|f||||||No||2017-10-10 21:24:50.166108|2017-10-10 21:24:50.166108
NCT03037021|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-06-16|||May 31, 2017|Actual|2017-05-31|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines|Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines, Nurse Care Managers and Peer Mentors in Primary Care and Emergency Departments in Central North Carolina|Recruiting||N/A|500|Anticipated|Duke University|||4||f||||||||||||||2017-10-10 21:24:50.266937|2017-10-10 21:24:50.266937
NCT03037008|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-01-26|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Perineal Ultrasound in Men Before and After Radical Prostatectomy|Comparison of Perineal Ultrasound in Men Before and After Radical Prostatectomy and in Incontinent Men After Radical Prostatectomy Before and After Operative Treatment With Male Sling|Not yet recruiting||N/A|100|Anticipated|Kantonsspital Winterthur KSW||2|||f|||||f|t|f||f|||No||2017-10-10 21:24:50.420272|2017-10-10 21:24:50.420272
NCT03036995|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-03-23|||March 20, 2017|Actual|2017-03-20|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|Rapid Vitiligo||Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO|Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO RAPID VITILIGO|Recruiting||Phase 2|80|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||||2017-10-10 21:24:50.534668|2017-10-10 21:24:50.534668
NCT03036982|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-06-23|||January 1, 2016||2016-01-01|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|April 30, 2017|Actual|2017-04-30||Observational|||Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma|Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma|Active, not recruiting||N/A|500|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||Yes|Will make deidentified data available for other researchers|2017-10-10 21:24:50.638234|2017-10-10 21:24:50.638234
NCT03036969|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-31|||May 2016||2016-05-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Observational|EPICS-8||EPICS-8: Reasons for Emergency Department Utilization by Patients With Non-urgent Conditions|Emergency Processes in Clinical Structures - EPICS-8: Gründe für Die Inanspruchnahme Der Notaufnahme Durch Patienten Mit Blauer, grüner Oder Gelber Triagekategorie Und Ambulantem Behandlungsbedarf|Recruiting||N/A|5000|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||No||2017-10-10 21:24:50.719413|2017-10-10 21:24:50.719413
NCT03036956|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-06-02|||January 2017||2017-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|PRECIOUS||The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan|The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan|Recruiting||N/A|500|Anticipated|Abbott|||1||f||||f||||||||No||2017-10-10 21:24:50.822279|2017-10-10 21:24:50.822279
NCT03036943|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-07-21|||February 15, 2017|Actual|2017-02-15|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|FRONTIER||Fluciclovine (18F) Imaging of Breast Cancer|An Open-labelled Study to Characterise Fluciclovine (18F) Uptake Measured by positRon emissiON Tomography In Breast cancER|Recruiting||N/A|45|Anticipated|University of Oxford||1|||f||||f|f|f||||||||2017-10-10 21:24:50.957677|2017-10-10 21:24:50.957677
NCT03036930|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-30|2017-09-29|||June 23, 2017|Actual|2017-06-23|September 2017|2017-09-01|February 1, 2020|Anticipated|2020-02-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papillomavirus-Related Cancer in Adult Women After Kidney Transplant|Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial|Recruiting||Phase 2|180|Anticipated|National Cancer Institute (NCI)||1|||f||||t|t|f||||||||2017-10-10 21:24:51.067382|2017-10-10 21:24:51.067382
NCT03036917|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-06-28|||May 2018|Anticipated|2018-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|coffee-cup||Cognitive Function Before and After Opioid Reduction in Patients With Chronic Pain|Cognitive Function Before and After Opioid Reduction in Patients With Chronic Pain A Prospective Cohort Study|Not yet recruiting||N/A|50|Anticipated|Zealand University Hospital|||1||f||||t||||||||No||2017-10-10 21:24:51.219665|2017-10-10 21:24:51.219665
NCT03036904|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-07-14|||February 6, 2017|Actual|2017-02-06|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|February 2018|Anticipated|2018-02-01||Interventional|V+DA-EPOCH-R||Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas|Phase I Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas|Recruiting||Phase 1|18|Anticipated|Weill Medical College of Cornell University||1|||f||||t|t|f||||||||2017-10-10 21:24:51.336665|2017-10-10 21:24:51.336665
NCT03036891|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-01-30|||March 1, 2017|Anticipated|2017-03-01|January 2017|2017-01-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Naloxegol for Opioid-Related Gastroparesis|Naloxegol for Opioid-Related Gastroparesis: A Double-Blind Study With an Open Label Extension|Not yet recruiting||Phase 2|24|Anticipated|Temple University||2|||f||||f|t|f||||||No||2017-10-10 21:24:51.502892|2017-10-10 21:24:51.502892
NCT03036878|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-14|||January 12, 2017|Actual|2017-01-12|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||ReNu™ Marrow Stimulation Augmentation|Evaluation of the ReNu™ Amniotic Suspension Allograft After Marrow Stimulation in the Treatment of Osteochondral Defects|Recruiting||N/A|8|Anticipated|NuTech Medical, Inc||1|||f||||f|f|f||||||||2017-10-10 21:24:51.608327|2017-10-10 21:24:51.608327
NCT03036852|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-21|||March 22, 2017|Actual|2017-03-22|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|SOF/VEL ESRD||Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease|A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir for 12 Weeks in Subjects With Chronic HCV Infection Who Are on Dialysis for End Stage Renal Disease|Recruiting||Phase 2|100|Anticipated|Gilead Sciences||1|||f||||t|t|f|||t|||||2017-10-10 21:24:51.845097|2017-10-10 21:24:51.845097
NCT03036839|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-21|||June 27, 2017|Actual|2017-06-27|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection Who Are on Dialysis for End Stage Renal Disease|A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects With Genotype 1, 4, 5 and 6 Chronic HCV Infection Who Are on Dialysis for End Stage Renal Disease|Recruiting||Phase 2|100|Anticipated|Gilead Sciences||3|||f||||t|t|f|||t|||||2017-10-10 21:24:51.977381|2017-10-10 21:24:51.977381
NCT03036826|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-27|||October 2017|Anticipated|2017-10-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|September 2019|Anticipated|2019-09-01||Observational|||Computer-based Dosage Calculation for Antibiotics|Computer-basierte Dosierungsregime Von Antiinfektiva Unter Der Behandlung Mit Einem Kontinuierlichen Nierenersatztherapieverfahren|Not yet recruiting||N/A|180|Anticipated|University Hospital Tuebingen|||3||f||||t||||||Samples With DNA|"     blood   "|Undecided||2017-10-10 21:24:52.088144|2017-10-10 21:24:52.088144
NCT03036813|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-10-03|||December 2016|Actual|2016-12-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|GBT_HOPE||Study to Evaluate the Effect of GBT440 Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)|A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease|Recruiting||Phase 3|400|Anticipated|Global Blood Therapeutics||3|||f||||t|t|f||||||||2017-10-10 21:24:52.195154|2017-10-10 21:24:52.195154
NCT03036800|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-07-25|||September 2017|Anticipated|2017-09-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|September 2020|Anticipated|2020-09-01||Interventional|STRIVE||Saxenda in Obesity Services (STRIVE Study)|EFFECTIVENESS AND COST OF INTEGRATING A PROTOCOL WITH USE OF LIRAGLUTIDE 3.0 MG INTO AN OBESITY SERVICE: (STRIVE Study)|Not yet recruiting||Phase 4|400|Anticipated|University of Leicester||2|||f||||t|f|f||||||||2017-10-10 21:24:52.41759|2017-10-10 21:24:52.41759
NCT03036787|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-20|||February 9, 2014|Actual|2014-02-09|February 2017|2017-02-01|July 20, 2017|Anticipated|2017-07-20|February 2, 2017|Actual|2017-02-02||Observational|||Is There Any Differences in Motor and Cognitive Development Between Preterm and Early Preterm Infants?|Is There Any Differences in Motor And Cognitive Development Between Preterm (<37 Weeks) and Early Preterm (<32 Weeks) Infants? Two Years Follow Up Study|Active, not recruiting||N/A|40|Anticipated|Gazi University|||2||f||||t||||||||Undecided|We have no decided yet|2017-10-10 21:24:52.569582|2017-10-10 21:24:52.569582
NCT03036774|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-04-19|||February 14, 2017|Actual|2017-02-14|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|ECHODIABETE||Gastric Volume and Diabetes|Quantitative Ultrasound Assessment of Gastric Volume in Diabetic and Non Diabetic Patients Scheduled for a General Anesthesia|Recruiting||N/A|245|Anticipated|Hopital Foch||2|||f||||f|f|f||||||No||2017-10-10 21:24:52.64266|2017-10-10 21:24:52.64266
NCT03036761|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-28|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|Migauric||Interest of Auriculotherapy in Prophylaxis of Migraine and Headache in Patients With Migraines|Interest of Auriculotherapy in Prophylaxis of Migraine and Headache in Patients With Migraines|Recruiting||N/A|90|Anticipated|Hopital Foch||2|||f||||f||||||||||2017-10-10 21:24:52.83895|2017-10-10 21:24:52.83895
NCT03036748|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-26|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Increased Activity of ENaC in Proteinuric Kidney Transplant Recipients|Increased Activity of ENaC in Proteinuric Kidney Transplant Recipients|Not yet recruiting||N/A|20|Anticipated|University of Southern Denmark||2|||f|||||f|f||||||||2017-10-10 21:24:52.92745|2017-10-10 21:24:52.92745
NCT03036735|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-01-31|||May 2015||2015-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Rates of Middle Meatus Synechiae Formation Post ESS|Rates of Middle Meatus (MM) Synechiae Formation Post Endoscopic Sinus Surgery (ESS)|Terminated||N/A|10|Actual|Steward St. Elizabeth's Medical Center of Boston, Inc.||1||Sponsor withdrew funds|f||||f||||||||Yes||2017-10-10 21:24:53.015|2017-10-10 21:24:53.015
NCT03036722|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-05-02|||May 10, 2017|Anticipated|2017-05-10|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|February 2018|Anticipated|2018-02-01||Interventional|FLAX||Flaxseed Consumption and Bone Metabolism in Postmenopausal Women.|Effect of Phytoestrogen-rich Flaxseeds on Decreasing Bone Turnover in Postmenopausal Women Aged Between 50 -70 Years.|Not yet recruiting||N/A|44|Anticipated|University of Reading||2|||f||||f|f|f||||||Undecided||2017-10-10 21:24:53.109773|2017-10-10 21:24:53.109773
NCT03036709|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-01-25|||August 2016||2016-08-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Therapeutic Efficacy of mAb VRC01 During ATI in Early Treatment During Acute HIV Infection|Safety and Therapeutic Efficacy of the Broadly Neutralizing HIV-1 Specific Monoclonal Antibody VRC01 During Analytic Treatment Interruption in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection|Recruiting||Phase 2|24|Anticipated|South East Asia Research Collaboration with Hawaii||2|||f||||t||||||||Undecided||2017-10-10 21:24:53.211667|2017-10-10 21:24:53.211667
NCT03036696|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-09-26|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|April 29, 2018|Anticipated|2018-04-29|April 29, 2018|Anticipated|2018-04-29||Observational|BEACH||The BEACH Interview Study- Pregnant and Lactating Mothers|The Breastfeeding and Early Child Health (BEACH) Interview Study|Recruiting||N/A|120|Anticipated|University of Florida|||2||f||||f|f|f||||Samples With DNA|"     Non-invasive biospecimens include stool, saliva, blood, urine, human milk, and vaginal swab.   "|||2017-10-10 21:24:53.32596|2017-10-10 21:24:53.32596
NCT03036683|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-05-01|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Transcranial Direct Current Stimulation in Offenders|The Effect of Transcranial Direct Current Stimulation on Risk-taking and Aggression in Offenders|Recruiting||N/A|60|Anticipated|University of Pennsylvania||2|||f||||f|f|f|||f|||No||2017-10-10 21:24:53.420258|2017-10-10 21:24:53.420258
NCT03036670|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-09-19|||September 2016||2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|EGPA Cohort||Eosinophilic Granulomatosis With Polyangiitis Cohort|Eosinophilic Granulomatosis With Polyangiitis Cohort|Recruiting||N/A|50|Anticipated|Portsmouth Hospitals NHS Trust|||1||f||||f||||||||||2017-10-10 21:24:53.523518|2017-10-10 21:24:53.523518
NCT03036657|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-01-25|||October 2015||2015-10-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Local Effects of Acupuncture and Nerve Conduction Studies|Local Effects of Acupuncture on the Median and Ulnar Nerves in Patients With Carpal Tunnel Syndrome|Recruiting||N/A|60|Anticipated|Oregon Health and Science University||3|||f||||f||||||||||2017-10-10 21:24:53.609498|2017-10-10 21:24:53.609498
NCT03036644|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-02-06|||January 15, 2017|Actual|2017-01-15|February 2017|2017-02-01|October 30, 2018|Anticipated|2018-10-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Comparison of Electronic Cigarettes and Tobacco Cigarettes on Cardiovascular Function and Oxidative Stress|Effects of Electronic Cigarette Vaporization at High Temperature in Comparison to Tobacco Smoking on Cardiovascular Function and Oxidative Stress in Electronic Cigarette Users and Regular Tobacco Smokers|Recruiting||N/A|60|Anticipated|Université Libre de Bruxelles||6|||f||||t|f|f||||||No||2017-10-10 21:24:53.70944|2017-10-10 21:24:53.70944
NCT03036631|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-03-02|||October 2016||2016-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01|3 Months|Observational [Patient Registry]|ISST||Ideal Sedation for Stroke Thrombectomy|Ideal Sedation for Stroke Thrombectomy|Recruiting||N/A|40|Anticipated|Neurovascular Research Foundation|||2||f||||f||||||||||2017-10-10 21:24:53.820474|2017-10-10 21:24:53.820474
NCT03036618|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-26|||August 2016||2016-08-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|February 2017|Anticipated|2017-02-01||Interventional|||Effects of Quinoa Consumption on Markers of Cardiovascular Risk and Gastrointestinal Health|Effects of Quinoa Consumption on Markers of Cardiovascular Risk and Gastrointestinal Health|Recruiting||N/A|30|Anticipated|Newcastle University||2|||f||||f||||||||Undecided||2017-10-10 21:24:53.893793|2017-10-10 21:24:53.893793
NCT03036605|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-06-06|||March 15, 2017|Actual|2017-03-15|June 2017|2017-06-01|May 15, 2017|Actual|2017-05-15|April 1, 2017|Actual|2017-04-01||Interventional|||The Effect of Dexamethasone Added to Bupivacain in Nasal Surgery|The Postoperative Analgesic Effect of Dexamethasone Added to Topical Bupivacaine in Endoscopic Nasal Surgery|Completed||Phase 4|60|Actual|Ataturk University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:24:53.997264|2017-10-10 21:24:53.997264
NCT03036592|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-26|||November 1, 2016|Actual|2016-11-01|January 2017|2017-01-01|June 30, 2021|Anticipated|2021-06-30|May 31, 2020|Anticipated|2020-05-31||Interventional|ONTIME-MT||MTNR1B SNP*Food Timing Interaction on Glucose Control|MTNR1B SNP*Food Timing Interaction on Glucose Control in a Late Eater Mediterranean Population|Recruiting||N/A|1000|Anticipated|Universidad de Murcia||3|||f||||t|f|f||||||No||2017-10-10 21:24:54.103563|2017-10-10 21:24:54.103563
NCT03036579|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-26|||November 2015||2015-11-01|January 2017|2017-01-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Celtra Duo Computer Assisted Design/Computer Assisted Machining (CAD/CAM) Dental Crown Study|Clinical Evaluation of Chairside Computer Assisted Design/Computer Assisted Machining (CAD/CAM) Zirconia-reinforced Lithium Silicate Ceramic Crowns|Active, not recruiting||N/A|100|Actual|University of Michigan||2|||f||||f|f|t|f|||||No||2017-10-10 21:24:54.213581|2017-10-10 21:24:54.213581
NCT03036566|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-28|||March 2014||2014-03-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Lithium Disilicate (CAD/CAM) Fixed Partial Dentures (FPD) Clinical Study|Clinical Evaluation of Chairside Computer Assisted Design/Computer Assisted Machining (CAD/CAM) Lithium Disilicate Fixed Partial Dentures (FPD)|Active, not recruiting||N/A|30|Actual|University of Michigan||1|||f||||f|f|t|f|||||No||2017-10-10 21:24:54.30124|2017-10-10 21:24:54.30124
NCT03036553|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-07-12|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Observational|||Influence of Beliefs on the Prognosis of Chronic Musculoskeletal Pain.|The Influence of Beliefs (Fear of Movement, Pain-related Fear, Self-efficacy, and Pain Acceptance) on the Prognosis of Chronic Musculoskeletal Pain: a Prospective Cohort Study. Study Protocol|Not yet recruiting||N/A|307|Anticipated|University of Malaga|||1||f||||t|f|f||||||||2017-10-10 21:24:54.382705|2017-10-10 21:24:54.382705
NCT03036540|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-26|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Upper Limb Thrombosis Associated With Midline Catheter|Symptomatic and Asymptomatic Thrombosis in Midline Catheter|Recruiting||N/A|400|Anticipated|University Hospital, Motol|||1||f||||f|f|f||||||No|The patients with the inseertion of midline catheter during admission in hospital are followed-up for the possible complications including symptoms and signs of symptomatic and asymptomatic upper limb thrombosis using sonography examinations|2017-10-10 21:24:54.461334|2017-10-10 21:24:54.461334
NCT03036527|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-30|||September 2014||2014-09-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Recovery of Bladder and Sexual Function After Spinal Cord Injury|Effects of Activity Dependent Plasticity on Recovery of Bladder and Sexual Function After Human Spinal Cord Injury|Recruiting||N/A|30|Anticipated|University of Louisville||3|||f||||t||||||||No||2017-10-10 21:24:54.549039|2017-10-10 21:24:54.549039
NCT03036514|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-05-02|||April 5, 2017|Actual|2017-04-05|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia After Back Surgery.|Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia (PCIA) With Morphine for Postoperative Pain After Back Surgery. A Single Center Case-control Study.|Recruiting||N/A|25|Anticipated|University Hospital, Antwerp||2|||f||||f|f|f||||||No||2017-10-10 21:24:54.660833|2017-10-10 21:24:54.660833
NCT03036501|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-03-16|||January 3, 2017|Actual|2017-01-03|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||A Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-Labeled RO7034067 in Healthy Male Participants|Open-label Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-Labeled RO7034067 in Healthy Male Subjects|Completed||Phase 1|6|Anticipated|Hoffmann-La Roche||1|||f||||f||||||||||2017-10-10 21:24:54.78227|2017-10-10 21:24:54.78227
NCT03036475|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-02-15|||March 1, 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|Sienna||Sienna and Sentimag in Sentinel Lymph Node Biopsy|Sentinel Lymph Node Biopsy Using a Magnetic Tracer Versus Standard Radio-isotope Technique in Early Breast Cancer|Not yet recruiting||N/A|52|Anticipated|Kwong Wah Hospital||1|||f|||||f|t|f|f||||No||2017-10-10 21:24:55.666757|2017-10-10 21:24:55.666757
NCT03036462|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-08-28|||February 7, 2017|Actual|2017-02-07|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|FAIR-HF2||Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality|Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality - FAIR-HF2|Recruiting||Phase 4|1200|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t|f|f|||f|||||2017-10-10 21:24:55.736904|2017-10-10 21:24:55.736904
NCT03035162|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-04|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Dual-hemisphere Transcranial Direct Current Stimulation on Lower Limb Motor Functions After Stroke|Dual-hemisphere Transcranial Direct Current Stimulation on Lower Limb Motor Functions After Stroke|Recruiting||N/A|18|Anticipated|Mahidol University||2|||f|||||f|t|f|||||No||2017-10-10 21:25:10.805479|2017-10-10 21:25:10.805479
NCT03036449|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-02-03|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|OREANE||Efficacy of a Multifaceted Intervention to Reduce Medication Administration Errors in Neonatal Intensive Care Units|Efficacy of Tools Associated With a Multifaceted Education Intervention Directed to Health Professionals to Reduce Medication Preparation and Administration Error Rates in Neonatal Intensive Care Units|Not yet recruiting||N/A|5300|Anticipated|University Hospital, Bordeaux|||3||f||||f||||||||||2017-10-10 21:24:55.932129|2017-10-10 21:24:55.932129
NCT03036436|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-27|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|IMPETUS||The IMPETUS Cancer Trial. A Technology Delivered Physical Activity Intervention in Cancer|Investigating the Feasibility and Acceptability of a Technology Delivered Physical Activity (PA) Intervention in Cancer: The IMPETUS Cancer Trial. (IMproving Physical Activity and Exercise With Technology Use in Cancer Survivors)|Recruiting||N/A|60|Anticipated|University of Dublin, Trinity College||1|||f||||f||||||||Undecided||2017-10-10 21:24:56.030328|2017-10-10 21:24:56.030328
NCT03036423|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-01-26|||September 2016||2016-09-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|CTC||Cognitive Training for Older Caregivers|Cognitive Training to Protect Immune Systems of Older Caregivers|Recruiting||N/A|240|Anticipated|University of Rochester||2|||f||||t||||||||No||2017-10-10 21:24:56.13459|2017-10-10 21:24:56.13459
NCT03036410|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-09-05|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|August 21, 2017|Actual|2017-08-21|August 21, 2017|Actual|2017-08-21||Interventional|PhoneCIHA||Evaluation of Different Phone Solutions in CI and Hearing Aid Users and Bimodal Recipients|Evaluation of Different Phone Solutions in CI and Hearing Aid Users and Bimodal Recipients|Completed||N/A|25|Actual|Advanced Bionics AG||4|||f||||f|f|f||||||||2017-10-10 21:24:56.232492|2017-10-10 21:24:56.232492
NCT03036397|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-06-30|||March 3, 2017|Actual|2017-03-03|March 8, 2017|2017-03-08|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Fear and Anxiety in Humans|Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Fear and Anxiety in Humans|Recruiting||Phase 1|47|Anticipated|National Institutes of Health Clinical Center (CC)||2|||t|||||t|f||||||||2017-10-10 21:24:56.335427|2017-10-10 21:24:56.335427
NCT03036384|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-26|||March 2016||2016-03-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery|Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery : a Dose-finding Study Bases on the Continual Reassessment Method (CRM)|Completed||Phase 2|40|Actual|Centre Hospitalier Universitaire Saint Pierre||10|||f||||t||||||||No||2017-10-10 21:24:56.552565|2017-10-10 21:24:56.552565
NCT03036371|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-03-28|||March 28, 2017|Actual|2017-03-28|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Pilot Study of the Impact of Exercise on Hippocampal Function|Pilot Study of the Impact of Exercise on Hippocampal Behavior|Recruiting||N/A|30|Anticipated|New York State Psychiatric Institute||1|||f||||f|f|f||||||No|This is a pilot study intended to assess the feasibility of an at-home exercise protocol in a patient population, and to measure within-patient changes from baseline to post-exercise in order to calculate sample sizes needed for a full study. Therefore, the investigators do not plan to share the data of this small pilot study with other researchers.|2017-10-10 21:24:56.701435|2017-10-10 21:24:56.701435
NCT03036358|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2017-01-26|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting|The Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Emergency Department Setting.|Recruiting||N/A|30|Anticipated|Ohio State University||2|||f||||f||||||||Yes||2017-10-10 21:24:56.798991|2017-10-10 21:24:56.798991
NCT03036345|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-07-10|||January 2017||2017-01-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Cerebral Perfusion in the Beach Chair Position|Prediction of Post-operative Cognitive Decline Following Shoulder Surgery in the Beach Chair Position: The Value of Cerebral Oximetry|Recruiting||N/A|200|Anticipated|Brisbane Hand and Upper Limb Research Institute||1|||f||||f||||||||||2017-10-10 21:24:56.919638|2017-10-10 21:24:56.919638
NCT03036332|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-27|||June 1, 2015|Actual|2015-06-01|January 2017|2017-01-01|December 10, 2016|Actual|2016-12-10|December 10, 2016|Actual|2016-12-10||Interventional|||Exercise Training and Metabolic Syndrome|Effects of Aerobic Interval Training on Clinical Biomarkers and Quality of Life in Metabolic Syndrome|Completed||N/A|53|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||t|f|f||||||No||2017-10-10 21:24:57.076824|2017-10-10 21:24:57.076824
NCT03036319|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-25|||June 2016||2016-06-01|January 2017|2017-01-01|April 2026|Anticipated|2026-04-01|April 2026|Anticipated|2026-04-01||Interventional|PCN||Patient-Centered NeuroRehabilitation (PCN)|Patient-Centered NeuroRehabilitation|Recruiting||N/A|75|Anticipated|University of Michigan||7|||f||||f||||||||No||2017-10-10 21:24:57.172167|2017-10-10 21:24:57.172167
NCT03036306|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-10-03|||January 2017||2017-01-01|October 2017|2017-10-01|October 2, 2017|Actual|2017-10-02|October 2, 2017|Actual|2017-10-02||Interventional|||Dose Ranging Study to Evaluate the Safety and Tolerability of SCX-001 Cream in Healthy Volunteers With Induced Dermal Incisions|A Randomized, Placebo Controlled, Double-blind, Dose Ranging Study to Evaluate the Safety and Tolerability of SCX-001 Cream in Healthy Volunteers With Induced Dermal Incisions|Completed||Phase 1|24|Actual|ScarX Corp||3|||f||||f||||||||||2017-10-10 21:24:57.347836|2017-10-10 21:24:57.347836
NCT03036293|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-28|||February 8, 2017|Actual|2017-02-08|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial of Tenoten® in the Treatment of Anxiety in Patients With Somatoform, Stress-related and Other Neurotic Disorders|International Multicenter, Double-blind, Randomized Parallel Group Placebo-controlled Clinical Trial of Efficacy and Safety of Different Dosing Regimens of Tenoten® in the Treatment of Anxiety in Patients With Somatoform, Stress-related and Other Neurotic Disorders|Recruiting||Phase 4|390|Anticipated|Materia Medica Holding||4|||f||||f|f|f||||||||2017-10-10 21:24:57.468362|2017-10-10 21:24:57.468362
NCT03036280|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-03-15|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|August 2020|Anticipated|2020-08-01||Interventional|MissionAD2||A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease_|A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease|Recruiting||Phase 3|1330|Anticipated|Eisai Inc.||2|||f||||t||||||||Undecided||2017-10-10 21:24:57.692249|2017-10-10 21:24:57.692249
NCT03036267|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-29|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|September 22, 2017|Actual|2017-09-22|September 22, 2017|Actual|2017-09-22||Interventional|||Feasibility of the BREATHE Asthma Intervention Trial|Self-care Decision-making: Feasibility of the BREATHE Asthma Intervention Trial|Completed||N/A|46|Actual|Columbia University||2|||f||||t|f|f||||||||2017-10-10 21:24:58.053891|2017-10-10 21:24:58.053891
NCT03036254|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-10|||October 28, 2017|Anticipated|2017-10-28|August 2017|2017-08-01|November 30, 2021|Anticipated|2021-11-30|November 30, 2021|Anticipated|2021-11-30||Interventional|||Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk|Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk|Recruiting||N/A|154|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|t|f|||||||2017-10-10 21:24:58.15802|2017-10-10 21:24:58.15802
NCT03036241|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-06-22|||January 23, 2013|Actual|2013-01-23|June 2017|2017-06-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|DRECOREST2||Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae)|Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study (Dialysis Fistulae)|Completed||N/A|39|Actual|Helsinki University Central Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:24:58.309583|2017-10-10 21:24:58.309583
NCT03036228|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-14|||January 2017||2017-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|MASTIFF||MTH1, A Phase I, Study on Tumors Inhibition, First in Human, First in Class|MTH1, A Phase I, Study on Tumors Inhibition, First in Human, First in Class|Recruiting||Phase 1|20|Anticipated|Thomas Helleday Foundation||1|||f||||t||||||||||2017-10-10 21:24:58.423096|2017-10-10 21:24:58.423096
NCT03036215|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-05-15|||May 8, 2017|Actual|2017-05-08|January 2017|2017-01-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|TMDPACT||Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology|Tailored Self-Management of TMD Pain Using Health Information Technology|Recruiting||N/A|80|Anticipated|HealthPartners Institute||2|||f||||f|f|f||||||No||2017-10-10 21:24:58.552823|2017-10-10 21:24:58.552823
NCT03036202|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-06-29|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Pharmacokinetics of Epinephrine During Cardiac Arrest|Pharmacokinetic Study of Epinephrine During Cardiac Arrest Determining T1/2 and Time to Peak Concentration|Recruiting||N/A|10|Anticipated|Haukeland University Hospital|||1||f||||t|t|f|||f|Samples Without DNA|"     Blood samples with determination of medical concentration in plasma   "|No|There is no plan to make individual data available to other researchers. The data will be presented pooled and anonymously|2017-10-10 21:24:58.662133|2017-10-10 21:24:58.662133
NCT03036189|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-26|||November 1, 2017|Anticipated|2017-11-01|January 2017|2017-01-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01||Interventional|||Improving Chronic Illness Management With the Apsaalooke Nation: The Baa Nnilah Project|Improving Chronic Illness Management With the Apsaalooke Nation: The Baa Nnilah Project|Not yet recruiting||N/A|200|Anticipated|Montana State University||2|||f||||f|f|f||||||No||2017-10-10 21:24:58.749258|2017-10-10 21:24:58.749258
NCT03036176|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-27|||February 2011||2011-02-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|August 2012|Actual|2012-08-01||Interventional|||Family Centered Developmental Intervention on Severely Acutely Malnourished Children|"Effects of a Play-based Family Centered Psychomotor/Psychosocial Stimulation on Recovery of Severely Malnourished Children of 6-60 Months of Age During Nutritional Rehabilitation in the Jimma Zone of Ethiopia"|Completed||N/A|339|Actual|Hasselt University||2|||f||||f||||||||||2017-10-10 21:24:58.810738|2017-10-10 21:24:58.810738
NCT03036163|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-01-26|||January 2016||2016-01-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Phase 1 Study of PBTZ169|Open-label Prospective Noncomparative Study of Safety, Tolerability and Pharmacokinetics of PBTZ169 After Single and Multiple Fasting Oral Administration in Increasing Doses in Healthy Volunteers|Completed||Phase 1|35|Actual|Nearmedic Plus LLC||7|||f||||t||||||||No||2017-10-10 21:24:58.912493|2017-10-10 21:24:58.912493
NCT03036150|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-19|||February 2, 2017|Actual|2017-02-02|September 2017|2017-09-01|November 27, 2020|Anticipated|2020-11-27|November 27, 2020|Anticipated|2020-11-27||Interventional|Dapa-CKD||A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease|A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease|Recruiting||Phase 3|4000|Anticipated|AstraZeneca||2|||f||||t|t|f||||||||2017-10-10 21:24:59.061322|2017-10-10 21:24:59.061322
NCT03036137|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-27|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|September 1, 2017|Anticipated|2017-09-01|May 31, 2017|Anticipated|2017-05-31||Interventional|||Impact of Neurostimulation on Patterns of Brain Electrical Activity in Patients With Tinnitus|IMPACT OF TRANSCRANIAL DIRECT CURRENT STIMULATION ON THE STANDARDS OF CEREBRAL ELECTRIC ACTIVITY IN PATIENTS WITH CHRONIC TINNITUS: CLINICAL TRIAL, DOUBLE BLIND, PLACEBO-CONTROLLED|Not yet recruiting||Phase 2|54|Anticipated|Federal University of Paraíba||2|||f||||f|f|f||||||No||2017-10-10 21:25:01.381837|2017-10-10 21:25:01.381837
NCT03036124|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-19|||February 8, 2017|Actual|2017-02-08|September 2017|2017-09-01|December 5, 2019|Anticipated|2019-12-05|December 5, 2019|Anticipated|2019-12-05||Interventional|Dapa-HF||Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure|Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure With Reduced Ejection Fraction|Recruiting||Phase 3|4500|Anticipated|AstraZeneca||2|||f||||t|t|f||||||||2017-10-10 21:25:01.701885|2017-10-10 21:25:01.701885
NCT03036111|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-28|||February 1, 2017|Actual|2017-02-01|January 2017|2017-01-01|April 1, 2018|Anticipated|2018-04-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Effect of Topical Trimebutine on Pain After Hemorrhoidectomy|Effect of Trimebutine on Postoperative Pain After Milligan-Morgan Hemorrhoidectomy: A Randomized Controlled Trial|Suspended||N/A|42|Anticipated|Mansoura University||2||Unavailability of Triembutine maleate|f||||f|f|f||||||||2017-10-10 21:25:02.962691|2017-10-10 21:25:02.962691
NCT03036098|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-27|2017-10-05|||March 24, 2017|Actual|2017-03-24|October 2017|2017-10-01|December 23, 2022|Anticipated|2022-12-23|April 26, 2020|Anticipated|2020-04-26||Interventional|CheckMate901||Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer|A Phase 3, Open-label, Randomized Study of Nivolumab Combined With Ipilimumab, or With Standard of Care Chemotherapy, Versus Standard of Care Chemotherapy in Participants With Previously Untreated Unresectable or Metastatic Urothelial Cancer|Recruiting||Phase 3|897|Anticipated|Bristol-Myers Squibb||4|||f||||t|t|f||||||||2017-10-10 21:25:03.086327|2017-10-10 21:25:03.086327
NCT03036085|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-25|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Liposomal Bupivacaine for Pain Control Following Thoracic Surgery.|Liposomal Bupivacaine Versus Bupivacaine for Postoperative Analgesia Following Video-assisted Thoracoscopic Surgery.|Not yet recruiting||Phase 2/Phase 3|200|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f|||f|||No||2017-10-10 21:25:03.722584|2017-10-10 21:25:03.722584
NCT03036072|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-26|||May 2016||2016-05-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Delayed Rewarming for Neuroprotection in Infants Following Cardiopulmonary Bypass Surgery|Delayed Rewarming for Neuroprotection in Infants Following Cardiopulmonary Bypass Surgery|Recruiting||N/A|47|Anticipated|Maine Medical Center||2|||f||||t||||||||No||2017-10-10 21:25:03.863942|2017-10-10 21:25:03.863942
NCT03036059|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-05-24|||May 19, 2017|Actual|2017-05-19|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Twice Yearly Treatment for the Control of LF|Cluster Randomized Community-based Trial of Annual Versus Biannual Single-dose Ivermectin Plus Albendazole Against Wuchereria Bancrofti Infection in Human and Mosquito Populations|Recruiting||Phase 4|1440|Anticipated|Noguchi Memorial Institute for Medical Research||2|||f||||f|f|f|||f|||No|IPD will not be shared publicly. Researchers interested in the data can contact the principal investigator directly. No personal identifying information will be shared.|2017-10-10 21:25:03.958362|2017-10-10 21:25:03.958362
NCT03036046|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-26|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|SAFEGUARDFP||Safety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia|An Open Label Phase IIa Clinical Study to Evaluate the Safety and Pharmacokinetics of Oral F901318 (Combined With Fluconazole and Posaconazole) in AML|Not yet recruiting||Phase 1/Phase 2|18|Anticipated|F2G Ltd.||3|||f||||f|f|f||||||No||2017-10-10 21:25:04.064479|2017-10-10 21:25:04.064479
NCT03036033|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-27|||January 26, 2017|Actual|2017-01-26|January 2017|2017-01-01|July 25, 2017|Anticipated|2017-07-25|May 25, 2017|Anticipated|2017-05-25||Interventional|T-SET||The SaeboGlove Evaluation Trial|The SaeboGlove Evaluation Trial in Stroke|Recruiting||N/A|12|Anticipated|NHS Greater Glasgow and Clyde||1|||f||||f|f|f||||||No||2017-10-10 21:25:04.139696|2017-10-10 21:25:04.139696
NCT03036020|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-01-27|||October 2014||2014-10-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|NASPP||The Norwegian Acute Stroke Prehospital Project|The Norwegian Acute Stroke Prehospital Project|Completed||N/A|100|Actual|Norwegian Air Ambulance Foundation||1|||f||||f||||||||No||2017-10-10 21:25:04.237916|2017-10-10 21:25:04.237916
NCT03036007|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-06-19|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Physiotherapy After Anterior Cervical Spine Surgery|Physiotherapy After Anterior Cervical Spine Surgery for Cervical Disc Disease. A Prospective Randomised Study to Compare Internet-based Neck-specific Exercise With Prescribed Physical Activity|Recruiting||N/A|140|Anticipated|Linkoeping University||2|||f||||f|f|f||||||No||2017-10-10 21:25:04.318677|2017-10-10 21:25:04.318677
NCT03035994|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-04-17|||July 2016||2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Effect of Altered Mechanical Loading in ACLR|Effect of Altered Mechanical Loading on Lower Extremity Biomechanics and Biochemical Markers in Individuals With an Anterior Cruciate Ligament Reconstruction|Completed||N/A|30|Actual|University of North Carolina, Chapel Hill||4|||f||||f|f|f||||||No||2017-10-10 21:25:04.470681|2017-10-10 21:25:04.470681
NCT03035981|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-26|||August 2014||2014-08-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Gastric Emptying of Rice With Different Starch Properties|Assessment of Gastric Emptying and Fullness of Rice With Different Starch Properties|Completed||N/A|12|Actual|Purdue University||7|||f||||f||||||||No||2017-10-10 21:25:04.548893|2017-10-10 21:25:04.548893
NCT03035968|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||December 2, 2015|Actual|2015-12-02|January 2017|2017-01-01|March 1, 2018|Anticipated|2018-03-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Vojta Therapy in Early Stroke Rehabilitation|Improvement of Postural Control and Motor Function by Vojta Therapy in Early Stroke Rehabilitation of Stroke Patients - a Pilot Study and New Approach in Stroke Rehabilitation|Recruiting||N/A|40|Anticipated|Klinikum Frankfurt Höchst||2|||f||||f|f|f||||||No||2017-10-10 21:25:04.639698|2017-10-10 21:25:04.639698
NCT03035955|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-04-17|2017-02-28||December 2010||2010-12-01|April 2017|2017-04-01|February 2, 2012|Actual|2012-02-02|February 2, 2012|Actual|2012-02-02||Interventional|||Azelaic Acid on Demodex Counts in Rosacea|The Effect of Azelaic Acid (Financea Gel 15%) on Demodex Folliculorum Counts in Adult Subjects With Mild to Moderate Papulopustular Rosacea|Completed||Phase 2/Phase 3|20|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-10 21:25:04.755329|2017-10-10 21:25:04.755329
NCT03035942|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-27|||January 2, 2017|Actual|2017-01-02|January 2017|2017-01-01|July 1, 2017|Anticipated|2017-07-01|May 1, 2017|Anticipated|2017-05-01||Interventional|||Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration|Role of Dexamethasone or Ondansetron in the Quality of Recovery After Intrathecal Morphine Administration in Patients Undergoing Lower Limb Surgery.|Recruiting||Phase 4|135|Anticipated|Pontificia Universidade Catolica de Sao Paulo||3|||f||||t|f|f||||||No||2017-10-10 21:25:04.987434|2017-10-10 21:25:04.987434
NCT03035929|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-30|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Diagnosing Natriuretic Peptide Deficiency|Diagnosing Natriuretic Peptide Deficiency: A Pilot Study|Active, not recruiting||Phase 1|10|Anticipated|Vanderbilt University Medical Center||1|||f||||f|t|f|||f|||||2017-10-10 21:25:05.099589|2017-10-10 21:25:05.099589
NCT03035903|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-03|||February 13, 2017|Actual|2017-02-13|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MEDGEM||Energy Cost for Holding a MedGem® Indirect Calorimeter|Energy Cost for Holding a MedGem® Indirect Calorimeter|Recruiting||N/A|40|Anticipated|Pennington Biomedical Research Center||2|||f||||f|f|f||||||No|The data will be not be shared outside of Weight Watchers and the Investigators listed on the protocol for this study.|2017-10-10 21:25:05.259031|2017-10-10 21:25:05.259031
NCT03035890|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-09|||January 23, 2017|Actual|2017-01-23|February 2017|2017-02-01|October 31, 2018|Anticipated|2018-10-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer|Use of Response-Adapted Hypofractionated Radiation Therapy to Potentiate the Systemic Immune Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer|Recruiting||N/A|33|Anticipated|West Virginia University||1|||f||||t|f|f||||||No||2017-10-10 21:25:05.360871|2017-10-10 21:25:05.360871
NCT03035877|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-18|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|April 15, 2021|Anticipated|2021-04-15|January 15, 2021|Anticipated|2021-01-15||Interventional|||Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse|Treatment of Justice-Involved Emerging Adults With Substance Use Disorders|Recruiting||N/A|240|Anticipated|Oregon Social Learning Center||2|||f||||t|f|f||||||||2017-10-10 21:25:05.456965|2017-10-10 21:25:05.456965
NCT03035864|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-26|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A 8 Weeks Study With 4 Weeks of Follow-up to Evaluate Preliminary Efficacy and Safety of Recombinant Human Nerve Growth Factor Eye Drops Solution Versus Vehicle in Patients After Cataract and Refractive Surgery|A 8 Weeks, Phase II, Single-centre, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 4 Weeks of Follow-up to Evaluate Preliminary Efficacy and Safety of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drops Solution Versus Vehicle in Patients After Cataract and Refractive Surgery|Recruiting||Phase 2|150|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||f|f|f||||||No||2017-10-10 21:25:05.553001|2017-10-10 21:25:05.553001
NCT03035851|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-26|||January 2017||2017-01-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|June 2020|Anticipated|2020-06-01||Interventional|BIM2||Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias|Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias: Harnessing Translational Physiology|Not yet recruiting||N/A|264|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 21:25:05.772319|2017-10-10 21:25:05.772319
NCT03035838|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-05-01|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|NK1||Importance of Substance P in Intracranial Pressure Elevation Following Traumatic Brain Injury|Importance of Substance P in Intracranial Pressure Elevation Following Traumatic Brain Injury|Not yet recruiting||Early Phase 1|15|Anticipated|University of Cambridge||1|||f||||t|f|f|||f|||No||2017-10-10 21:25:05.869794|2017-10-10 21:25:05.869794
NCT03035825|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-07-25|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients|A Randomized Controlled Trial for Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients With Xerostomia|Recruiting||N/A|70|Anticipated|Dental Innovation Foundation Under Royal Patronage||2|||f||||t|f|f||||||||2017-10-10 21:25:05.953385|2017-10-10 21:25:05.953385
NCT03035812|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-07-25|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|January 1, 2018|Anticipated|2018-01-01||Interventional|AlcalUN||Alkalinization by Urologists & Nephrologists|Prospective Evaluation of Oral Alkalinization by Urologists and Nephrologists: Evolution of the Extracellular Compartment|Recruiting||Phase 4|100|Anticipated|Club des Jeunes Néphrologues||1|||f||||f|f|f||||||||2017-10-10 21:25:06.041555|2017-10-10 21:25:06.041555
NCT03035799|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-25|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms|A Randomized Trial Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms|Not yet recruiting||N/A|40|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:25:06.177224|2017-10-10 21:25:06.177224
NCT03035786|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-26|||November 2016||2016-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01|1 Day|Observational [Patient Registry]|||Airway Code Calls - Survey of Management|Airway Code Calls - Survey of Management|Recruiting||N/A|300|Anticipated|Singapore General Hospital|||1||f||||f||||||||No||2017-10-10 21:25:06.262281|2017-10-10 21:25:06.262281
NCT03035773|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-26|||October 2015||2015-10-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|SSCP||Simplifying Survivorship Care Planning|Simplifying Survivorship Care Planning; Comparing the Efficacy and Patient-Centeredness of Three Care Delivery Models|Recruiting||N/A|375|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||f||||||||No||2017-10-10 21:25:06.370875|2017-10-10 21:25:06.370875
NCT03035760|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-14|||May 12, 2017|Actual|2017-05-12|July 19, 2017|2017-07-19|January 3, 2018|Anticipated|2018-01-03|January 2, 2018|Anticipated|2018-01-02||Interventional|||Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers|A Phase 1 Open Label, Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers|Recruiting||Phase 1|36|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f|||||t|f|||f|||||2017-10-10 21:25:06.48753|2017-10-10 21:25:06.48753
NCT03035747|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-01|||July 2016|Actual|2016-07-01|February 2017|2017-02-01|July 2036|Anticipated|2036-07-01|July 2036|Anticipated|2036-07-01|12 Months|Observational [Patient Registry]|RRT CVD||Ongoing Registry of Treatment of Chronic Venous Diseases|Russian Registry of Treatment of Chronic Venous Diseases|Recruiting||N/A|1000|Anticipated|Medalp Private Surgery Clinic|||1||f|||||f|f||||||||2017-10-10 21:25:06.584545|2017-10-10 21:25:06.584545
NCT03035734|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-26|||January 2017||2017-01-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants|A Randomized Study to Evaluate the Bioavailability of BMS-986141 From a Form B Tablet Formulation Relative to the Form A Reference Tablet in Healthy Participants|Not yet recruiting||Phase 1|16|Anticipated|Bristol-Myers Squibb||4|||f||||||||||||||2017-10-10 21:25:06.676476|2017-10-10 21:25:06.676476
NCT03035721|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-28|||June 2014||2014-06-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Clinical Evaluation of a Low Protein Content Formula in the First Months of Life: a RCT|Clinical Evaluation of a Low Protein Content Formula Fed to Full Term Healthy Infants in the First Months of Life: a Randomized Controlled Trial|Completed||N/A|150|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||3|||f||||f||||||||Undecided||2017-10-10 21:25:06.761442|2017-10-10 21:25:06.761442
NCT03035708|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-07-20|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|July 7, 2018|Anticipated|2018-07-07|July 1, 2018|Anticipated|2018-07-01||Interventional|||Human Laboratory Study of Varenicline for Alcohol Use Disorder|Human Laboratory Study of Varenicline for Alcohol Use Disorder|Recruiting||Phase 1/Phase 2|48|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||2|||f||||f|t|f|||f|||||2017-10-10 21:25:06.863299|2017-10-10 21:25:06.863299
NCT03035695|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-26|||May 2012|Actual|2012-05-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Studying Safety & Efficacy of Axiostat® Dressing in Acute Hemorrhage Due to Trauma-Comparative Study|Pre Hospital Hemorrhagic Control Effectiveness of Axiostat® Dressing Versus Conventional Method in Acute Hemorrhage Due to Trauma|Completed||N/A|104|Actual|Axio Biosolutions Pvt. Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:25:06.963764|2017-10-10 21:25:06.963764
NCT03035682|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-31|||January 23, 2017|Actual|2017-01-23|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|July 23, 2018|Anticipated|2018-07-23||Interventional|||The Impact of a mHealth Application on Outpatient Physical Therapy HEP Adherence and Outcomes: A RCT|The Impact of a mHealth Application on Outpatient Physical Therapy HEP Adherence and Outcomes: A Randomized Clinical Trial|Enrolling by invitation||N/A|120|Anticipated|Aultman Health Foundation||2|||f||||f|f|f||||||Undecided||2017-10-10 21:25:07.052855|2017-10-10 21:25:07.052855
NCT03035669|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-01-25|||November 2016||2016-11-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MFN&SOCCOG||Effects of Mindfulness Training on Emotion Regulation and Social Cognition.|Effects of Mindfulness Training on Emotion Regulation and Social Cognition, a Psychophysiological and Neuroimaging Randomized Controled Study.|Recruiting||N/A|60|Anticipated|Humboldt-Universität zu Berlin||2|||f||||f||||||||No||2017-10-10 21:25:07.130525|2017-10-10 21:25:07.130525
NCT03035656|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-08-08|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 15, 2020|Anticipated|2020-09-15|September 15, 2020|Anticipated|2020-09-15||Interventional|||Effects of Intra-Operative Ropivaciane Epidural Injection on Post-Operative Outcomes Following Elective Lumbar Fusion|Effects of Intra-Operative Ropivaciane Epidural Injection on Post-Operative Outcomes Following Elective Lumbar Fusion|Not yet recruiting||Phase 4|228|Anticipated|Horizon Health Network||2|||f||||t|f|f|||f|||||2017-10-10 21:25:07.233083|2017-10-10 21:25:07.233083
NCT03035643|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-03-07|||March 5, 2017|Actual|2017-03-05|March 2017|2017-03-01|February 21, 2022|Anticipated|2022-02-21|February 21, 2022|Anticipated|2022-02-21||Interventional|||Device: Ascyrus Medical Dissection Stent (AMDS)|Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility Study|Recruiting||N/A|10|Anticipated|Ascyrus Medical LLC.||1|||f||||t|f|f||||||No||2017-10-10 21:25:07.327318|2017-10-10 21:25:07.327318
NCT03035630|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-08|||May 23, 2017|Actual|2017-05-23|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma|Randomized Phase II Trial Comparing Sequential First-line Sunitinib and Second-line Avelumab vs First-line Avelumab and Second-line Sunitinib for Metastatic Renal Cell Carcinoma: SUAVE Trial. Hoosier Cancer Research Network GU15-223|Recruiting||Phase 2|150|Anticipated|Hoosier Cancer Research Network||2|||f||||t|t|f||||||||2017-10-10 21:25:07.412508|2017-10-10 21:25:07.412508
NCT03035617|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-26|||November 15, 2015|Actual|2015-11-15|January 2017|2017-01-01|May 30, 2017|Anticipated|2017-05-30|April 30, 2017|Anticipated|2017-04-30||Interventional|HAPPIEST||Study to Evaluate Reduction in Pain After Laparoscopic Hernia Repair With Mesh Soaked in Bupivacaine Solution|Post-Operative Pain After Laparoscopic Ventral Hernia Repair, Impact of Mesh Impregnation With Bupivacaine Solution vs. Normal Saline Solution|Recruiting||N/A|100|Anticipated|Aga Khan University||2|||f||||f||||||||No||2017-10-10 21:25:07.524451|2017-10-10 21:25:07.524451
NCT03035604|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-10-02|||January 24, 2017|Actual|2017-01-24|October 2017|2017-10-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2021|Anticipated|2021-01-01||Observational|||Malnutrition in Older Cancer Patients|Malnutrition in Older Cancer Patients|Recruiting||N/A|284|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||||||2017-10-10 21:25:07.618379|2017-10-10 21:25:07.618379
NCT03035591|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-04-27|||December 22, 2016|Actual|2016-12-22|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BETIDES||ODM-207 in Patients With Advance Solid Tumours|Safety and Pharmacokinetics of ODM-207 in Patients With Selected Advanced Solid Tumours: an Open-label, Non-randomised, Uncontrolled, Multicentre, First-in-human Study With Cohort Expansion|Recruiting||Phase 1/Phase 2|144|Anticipated|Orion Corporation, Orion Pharma||1|||f|||||f|f|||f|||||2017-10-10 21:25:07.701959|2017-10-10 21:25:07.701959
NCT03035578|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-27|||June 1, 2017|Anticipated|2017-06-01|January 2017|2017-01-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population|Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|The Hospital for Sick Children||1|||f||||f|f|f||||||No||2017-10-10 21:25:07.771632|2017-10-10 21:25:07.771632
NCT03035565|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-09|||February 22, 2017|Actual|2017-02-22|February 2017|2017-02-01|August 2021|Anticipated|2021-08-01|December 2019|Anticipated|2019-12-01||Interventional|Memoir-HF||Cognitive Intervention to Improve Memory in Heart Failure Patients|Cognitive Intervention to Improve Memory in Heart Failure Patients|Recruiting||N/A|260|Anticipated|Indiana University||3|||f||||t|f|f||||||Yes||2017-10-10 21:25:07.847296|2017-10-10 21:25:07.847296
NCT03033173|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-24|||January 2013|Actual|2013-01-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Ratio of the Cross Sectional Area of Median Nerve to Ulnar Nerve in Diagnosing Carpal Tunnel Syndrome||Completed||N/A|74|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||2||f||||||||||||||2017-10-10 21:25:31.839503|2017-10-10 21:25:31.839503
NCT03035552|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-26|||September 15, 2016|Actual|2016-09-15|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||CTICU Pacifier Activated Music Player and Mother's Voice|Randomized Controlled Trial to Improve Oral Feeding Outcomes in Infants With Complex Congenital Heart Disease Using Pacifier Activated Device-Training With Mother's Voice|Enrolling by invitation||N/A|75|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||No||2017-10-10 21:25:07.933192|2017-10-10 21:25:07.933192
NCT03035539|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2017-07-14|||May 2012||2012-05-01|July 2017|2017-07-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Rehabilitation of Patients With Atrial Fibrillation|Rehabilitation of Patients With Atrial Fibrillation|Completed||N/A|58|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-10-10 21:25:08.021302|2017-10-10 21:25:08.021302
NCT03035526|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||January 2000|Actual|2000-01-01|January 2017|2017-01-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Observational|||Sex Hormones and Pericardial Adipose Tissue|Do Endogenous Sex Hormones Affect Pericardial Adipose Tissue Volume of Males in The Multi-Ethnic Study of Atherosclerosis (MESA)?|Completed||N/A|3213|Actual|Gulhane School of Medicine|||1||f||||t|f|f||||||||2017-10-10 21:25:08.107038|2017-10-10 21:25:08.107038
NCT03035513|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-27|||January 2017||2017-01-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|POCS-DTI||Diffusion Tensor Imaging in Epilepsy With Continuous Spikes and Waves During Sleep|Diffusion Tensor Imaging of the Thalamo-cortical Network in Epilepsy With Continuous Spikes and Waves During Sleep|Recruiting||N/A|45|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-10 21:25:08.153183|2017-10-10 21:25:08.153183
NCT03035500|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-18|||July 2008||2008-07-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Long-Term Follow-Up in Patients With Prostate Cancer After Surgery|Long-term Follow-up After Prostate Cancer|Active, not recruiting||N/A|2500|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 21:25:08.224577|2017-10-10 21:25:08.224577
NCT03035487|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-08-02|||December 2016||2016-12-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2016|Actual|2016-12-01||Interventional|||Urology of Virginia Case Series|Urology of Virginia Case Series|Active, not recruiting||N/A|9|Anticipated|Exact Imaging||1|||f||||f||||||||||2017-10-10 21:25:08.295872|2017-10-10 21:25:08.295872
NCT03035474|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-21|||April 21, 2017|Actual|2017-04-21|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01||Interventional|CONNECT-HF||Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure|Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)|Recruiting||N/A|8000|Anticipated|Duke University||4|||f||||t|f|f||||||||2017-10-10 21:25:08.372581|2017-10-10 21:25:08.372581
NCT03035461|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-07-27|||March 15, 2017|Actual|2017-03-15|July 2017|2017-07-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|PANDA||Patient's Feelings After Receiving a Diagnosis of Age-related Macular Degeneration|Ressenti du Patient au Moment de l'Annonce du Diagnostic de DMLA|Recruiting||N/A|250|Anticipated|Centre Hospitalier Intercommunal Creteil|||1||f||||f|f|f||||||||2017-10-10 21:25:08.814329|2017-10-10 21:25:08.814329
NCT03035448|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-19|||February 13, 2017|Actual|2017-02-13|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Communication Strategies to Introduce Psychology Services|A Randomized Controlled Trial of Communication Strategies to Introduce Psychology Services in the Palliative Care Setting|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 21:25:08.890324|2017-10-10 21:25:08.890324
NCT03035435|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-25|||January 2016||2016-01-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|||Fast-track Rehabilitation After Total Knee or Hip Arthroplasty|Fast-track Rehabilitation After Total Knee or Hip Arthroplasty: an Observational Prospective Case-control Study|Completed||N/A|58|Actual|Fondazione Don Carlo Gnocchi Onlus|||2||f||||||||||||||2017-10-10 21:25:08.981991|2017-10-10 21:25:08.981991
NCT03035422|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-01-27|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|SET-HAPLO||Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia|Sequential Chemotherapy Prior to Reduced Intensity Conditioning: Interventional Study in Haploidentical Hematopoietic Stem Cells Transplantation for Patients With Refractory Acute Myeloid Leukemia|Not yet recruiting||N/A|24|Anticipated|Association for Training, Education, and Research in Hematology, Immunology, and Transplantation||1|||f||||f||||||||No||2017-10-10 21:25:09.063571|2017-10-10 21:25:09.063571
NCT03035409|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-10-05|||February 8, 2017|Actual|2017-02-08|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer|Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer|Recruiting||Phase 2|38|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:25:09.163904|2017-10-10 21:25:09.163904
NCT03035396|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-07-10|||December 29, 2016||2016-12-29||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:25:09.270059|2017-10-10 21:25:09.270059
NCT03035383|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-01-25|||October 1, 2013|Actual|2013-10-01|January 2017|2017-01-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Interventional|||Purse String Suture for the Closure of Large Thyroidectomy Resulted in Better Cosmetics|Purse String Suture for the Closure of Large Thyroidectomy Resulted in Better Cosmetics|Completed||N/A|30|Actual|Dr Cipto Mangunkusumo General Hospital||2|||f||||f|f|f||||||No|No plan to share IPD.|2017-10-10 21:25:09.30992|2017-10-10 21:25:09.30992
NCT03035370|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-27|||September 2016||2016-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Viaskin Pertussis Vaccine Trial|A Phase I Dose Escalation Randomized, Double-blind, Placebo-controlled Safety and Immunogenicity Trial of the Reactivation of Pertussis Toxin Immunity With the Viaskin Epicutaneous Delivery System in Healthy Adults|Active, not recruiting||Phase 1|60|Actual|DBV Technologies||3|||f||||t||||||||||2017-10-10 21:25:09.392747|2017-10-10 21:25:09.392747
NCT03035357|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-04-20|||March 1, 2017|Anticipated|2017-03-01|April 2017|2017-04-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Neoadjuvant Listeria or Daratumumab in Prostate Cancer|A Pilot Presurgical Study of Daratumumab (CD38 Antagonist) in Men With High-Risk Localized Prostate Cancer Followed by Radical Prostatectomy|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||PI's Request|f||||f|t|f||||||||2017-10-10 21:25:09.48974|2017-10-10 21:25:09.48974
NCT03035344|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-01-26|||May 2015||2015-05-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|May 2017|Anticipated|2017-05-01||Observational|||Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)|Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia|Recruiting||N/A|25|Anticipated|Aristotle University Of Thessaloniki|||2||f||||f|f|f||||Samples With DNA|"     blood, urine, bone marrow   "|Undecided||2017-10-10 21:25:09.571074|2017-10-10 21:25:09.571074
NCT03035331|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-08-23|||March 27, 2017|Actual|2017-03-27|January 2017|2017-01-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma|Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation and Anti-PD-1 Antibody (Pembrolizumab) for Patients With Non-Hodgkin Lymphoma|Recruiting||Phase 1/Phase 2|44|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:25:09.652264|2017-10-10 21:25:09.652264
NCT03035318|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-25|||September 2014||2014-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:25:09.772998|2017-10-10 21:25:09.772998
NCT03035305|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-25|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali|Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Kolokani Circle, Koulikoro Region, Mali, August-November 2016: Interventional Matched-pair Clustered Cohort|Completed||N/A|36717|Actual|Alliance for International Medical Action||2|||f||||f|f|f||||||No||2017-10-10 21:25:09.814502|2017-10-10 21:25:09.814502
NCT03035292|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-26|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2017|Anticipated|2017-08-01||Observational|||Choroidal Reflectance Camera for the Detection of Congenital Cataracts|Proof of Concept Trial of a Novel Imaging System to Assess and Document Choroidal Reflectance in Infants for the Detection of Cataract and Media Opacities.|Recruiting||N/A|260|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f|f|f||||||No||2017-10-10 21:25:09.921988|2017-10-10 21:25:09.921988
NCT03035279|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-09-29|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|December 22, 2020|Anticipated|2020-12-22|July 1, 2020|Anticipated|2020-07-01||Interventional|||A Study of SC-006 in Subjects With Advanced Cancer|An Open Label Study of SC-006 in Subjects With Advanced Cancer|Recruiting||Phase 1|108|Anticipated|AbbVie||1|||f||||f|t|f||||||||2017-10-10 21:25:10.014433|2017-10-10 21:25:10.014433
NCT03035266|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-04-05|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|December 12, 2018|Anticipated|2018-12-12|July 12, 2018|Anticipated|2018-07-12||Interventional|||The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery|The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery; A Randomized Control Trial|Recruiting||N/A|40|Anticipated|Keller Army Community Hospital||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:25:10.111536|2017-10-10 21:25:10.111536
NCT03035253|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-25|||December 2016||2016-12-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer|A Phase 1b Study of OMP-305B83 Plus FOLFIRI as Second Line Therapy in Subjects With Metastatic Colorectal Cancer|Recruiting||Phase 1|30|Anticipated|OncoMed Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-10 21:25:10.207221|2017-10-10 21:25:10.207221
NCT03035240|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-05-03|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Finances First: A Health Intervention in Low Income Single Mother Households|Finances First: A Health Intervention in Low Income Single Mother Households. A Prospective, Randomized, Controlled Trial to Assess the Effect of Financial Education on Health Outcomes in Single Mother Households.|Recruiting||N/A|440|Anticipated|Creighton University||2|||f||||f|f|f||||||No|Individual participant data will only be shared with local Creighton Investigators listed on the study and the ICF. Individual participant data will not be shared outside of Creighton University.|2017-10-10 21:25:10.310817|2017-10-10 21:25:10.310817
NCT03035227|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-25|||January 23, 2017|Actual|2017-01-23|January 2017|2017-01-01|July 31, 2019|Anticipated|2019-07-31|December 31, 2018|Anticipated|2018-12-31||Interventional|ABLATE-CRT||Catheter Ablation of Arrhythmias to Improve CRT Response|Catheter Ablation of Arrhythmias to Improve CRT Response|Enrolling by invitation||Phase 4|189|Anticipated|University of Kansas Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:25:10.386487|2017-10-10 21:25:10.386487
NCT03035214|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-19|||February 19, 2017|Actual|2017-02-19|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia|Single Arm Study on Treatment Algorithm to Justify Steroid Use in Selected Preterm Neonates to Prevent Bronchopulmonary Dysplasia|Recruiting||Phase 2|30|Anticipated|Maadi Military Hospital||1|||f|||||t|f||||||No||2017-10-10 21:25:10.469211|2017-10-10 21:25:10.469211
NCT03035201|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-03-13|||September 2016||2016-09-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|COSMOS-Mind||COcoa Supplement and Multivitamin Outcomes Study for the Mind|COcoa Supplement and Multivitamin Outcomes Study-Mind|Enrolling by invitation||N/A|2000|Anticipated|Wake Forest University Health Sciences||4|||f||||t|f|f|||f|||Yes|COSMOS-Mind and COSMOS (parent trial, PI: Manson and Sesso) have data transfer procedures and protocols in place which use password protection and encryption, to permit seamless and secure exchange of information. Safety monitoring will be completed through the parent trial. The COSMOS-Mind staff will send all adverse events reported to them to the parent trial for reporting and follow-up. This data will be sent electronically only to approved users through a protected network.|2017-10-10 21:25:10.54699|2017-10-10 21:25:10.54699
NCT03035188|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-25|||January 2017||2017-01-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|NICCI||Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma|A Phase II, Single-armed, Multicenter Trial of Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma|Not yet recruiting||Phase 2|65|Anticipated|SRH Wald-Klinikum Gera GmbH||1|||f||||f||||||||No||2017-10-10 21:25:10.636056|2017-10-10 21:25:10.636056
NCT03035175|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||May 2014||2014-05-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Using Video Laryngoscopy for Neonatal Intubation|A Randomized Control Trial: Does Guidance Using Video Laryngoscopy Improve Residents' Success in Neonatal Intubation?|Completed||N/A|48|Actual|University of Rochester||2|||f||||f|f|f||||||No||2017-10-10 21:25:10.722952|2017-10-10 21:25:10.722952
NCT03035149|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-26|||May 2005||2005-05-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Exercise Capacity and Dyspnea in Obese Patients With Metabolic Syndrome: Effects of Weight Loss|Exercise Capacity and Dyspnea in Obese Patients With Metabolic Syndrome: Effects of Weight Loss|Completed||N/A|68|Actual|University of Ottawa||2|||f||||f|f|f||||||No||2017-10-10 21:25:10.90999|2017-10-10 21:25:10.90999
NCT03035136|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-29|||January 15, 2017|Actual|2017-01-15|January 2017|2017-01-01|July 15, 2017|Anticipated|2017-07-15|June 15, 2017|Anticipated|2017-06-15|1 Day|Observational [Patient Registry]|||Retrospective Study on Epidemiology of Colorectal Lesions|Retrospective Study on Epidemiology of Colorectal Lesions|Active, not recruiting||N/A|2500|Anticipated|Lyell McEwin Hospital|||2||f||||t|f|f||||||No||2017-10-10 21:25:10.989642|2017-10-10 21:25:10.989642
NCT03035110|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-05-03|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings|A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings|Recruiting||N/A|30|Anticipated|University of Essex||1|||f||||f|f|f||||||No||2017-10-10 21:25:11.16223|2017-10-10 21:25:11.16223
NCT03035097|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-25|||February 2013||2013-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01|1 Day|Observational [Patient Registry]|||Deployment-Related Lung Disease Research Database and Biorepository|Deployment-Related Lung Disease Research Database and Biorepository|Recruiting||N/A|500|Anticipated|National Jewish Health|||1||f||||f||||||Samples With DNA|"     If patients consent to having blood and tissue collected for the biorepository, the samples     will be collected during a clinic visit. Two DNA PAXgene tubes will be used to collect 17ml     of blood and two RNA PAXgene tubes would be used to collect 5 ml of blood. In addition,     excess bronchoalveolar lavage (BAL) fluid from a clinically-indicated bronchoscopy would also     be collected. Blood and BAL fluid will be frozen and stored in -80 degree C freezers in the     Occupational Medicine Laboratory until processed. If a patient will have a surgical or     transbronchial biopsy as part of his or her clinical evaluation, any excess lung tissue that     has been formalin-fixed and paraffin-embedded will also be collected and stored in the     Occupational Medicine facilities.   "|Undecided||2017-10-10 21:25:11.228735|2017-10-10 21:25:11.228735
NCT03035084|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-25|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena?|Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena? A Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|King Faisal Specialist Hospital & Research Center||4|||f||||f||||||||Undecided||2017-10-10 21:25:11.293101|2017-10-10 21:25:11.293101
NCT03035071|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-26|||May 1, 2010|Actual|2010-05-01|January 2017|2017-01-01|April 18, 2016|Actual|2016-04-18|November 19, 2014|Actual|2014-11-19||Interventional|MIOMIE||Morbidity in Open Versus Minimally Invasive Esophagectomy|Morbidity In Open Versus Minimally Invasive Hybrid Esophagectomy|Completed||N/A|26|Actual|Austrian Society Of Surgical Oncology||2|||f|||||f|f||||||||2017-10-10 21:25:11.383318|2017-10-10 21:25:11.383318
NCT03035058|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-07|||February 2017||2017-02-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|September 2020|Anticipated|2020-09-01||Interventional|||Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease|A Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Vedolizumab IV for the Treatment of Primary Sclerosing Cholangitis, With Underlying Inflammatory Bowel Disease|Withdrawn||Phase 3|0|Actual|Takeda||3|||f||||t||||||||||2017-10-10 21:25:11.453992|2017-10-10 21:25:11.453992
NCT03035045|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-26|||November 2016|Actual|2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Oral Paracetamol Premedication Effect on Maternal Pain in Amniocentesis|Oral Paracetamol Premedication Effect on Maternal Pain in Amniocentesis: A Randomized Double Blind Placebo-controlled Trial|Active, not recruiting||N/A|240|Anticipated|Rajavithi Hospital||2|||f||||||||||||||2017-10-10 21:25:11.529042|2017-10-10 21:25:11.529042
NCT03035019|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-25|||July 1, 2016|Actual|2016-07-01|January 2017|2017-01-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Reducing Stress in Primary Care Patients|Reducing Stress in Primary Care Patients|Recruiting||N/A|950|Anticipated|University of Pittsburgh||1|||f||||t|f|f||||||Undecided||2017-10-10 21:25:11.68038|2017-10-10 21:25:11.68038
NCT03035006|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-05-21|||April 14, 2017|Actual|2017-04-14|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis|A Phase I/II, Dose-escalation Study of Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis|Recruiting||Phase 1/Phase 2|40|Anticipated|Taiwan Liposome Company||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:25:11.751629|2017-10-10 21:25:11.751629
NCT03034993|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-26|2017-09-10|||July 21, 2017|Actual|2017-07-21|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|August 30, 2018|Anticipated|2018-08-30||Interventional|||Self-Management Using Text Messaging in a Homeless Population|Improving Self-Management of Chronic Conditions Among Homeless Persons: a Community-Based Participatory Approach Using Text Messaging|Recruiting||N/A|60|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 21:25:11.825744|2017-10-10 21:25:11.825744
NCT03034980|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-09|||December 20, 2016|Actual|2016-12-20|August 2017|2017-08-01|September 15, 2017|Anticipated|2017-09-15|July 1, 2017|Actual|2017-07-01||Observational|||Influence of Training Intensity in Coronary Artery Disease|Influence of Training Intensity on Exercise Capacity and Risk Profile in Coronary Artery Disease|Recruiting||N/A|343|Anticipated|Hasselt University|||1||f||||f|f|f||||||||2017-10-10 21:25:12.004308|2017-10-10 21:25:12.004308
NCT03034954|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-15|||October 2016||2016-10-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PCN1||Patient Centered-Rehabilitation ver111090.1|Effects of 3mA HD-tDCS on Associative and Working Memory in Cognitively Intact Older Adults|Recruiting||N/A|30|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 21:25:12.634592|2017-10-10 21:25:12.634592
NCT03034941|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-25|||April 2014||2014-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients|Short Term Weight Loss With Liraglutide and Metformin Before IVF in Infertile Obese PCOS Patients|Completed||Phase 4|35|Actual|University Medical Centre Ljubljana||3|||f||||f||||||||Yes|Data are going to be available for other researchers if needed after the evaluation of this study.|2017-10-10 21:25:12.746686|2017-10-10 21:25:12.746686
NCT03034928|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-17|||February 14, 2017||2017-02-14||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:25:12.850314|2017-10-10 21:25:12.850314
NCT03034902|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-31|||February 3, 2017||2017-02-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:25:13.93332|2017-10-10 21:25:13.93332
NCT03034889|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-26|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|ANFOLKI-36||Anesthesia Related Neurocognitive Deficits in Children|Neurocognitive Development in Children Who Received General Anesthesia Before the Age of 3 Years: A Historic-prospective, Controlled, Single Center Cross-section Trial|Enrolling by invitation||N/A|1400|Anticipated|University of Erlangen-Nürnberg Medical School|||2||f||||f||||||||||2017-10-10 21:25:13.966457|2017-10-10 21:25:13.966457
NCT03034876|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-25|||March 1, 2017|Anticipated|2017-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Utility of NGAL to Diagnose AKI in Critically Ill Children|Acute Kidney Injury Based on Neutrophil Gelatinase-Associated Lipocalcin (NGAL) in a Pediatric Intensive Care Unit of Tertiary Care Hospital Karachi, Pakistan|Not yet recruiting||N/A|140|Anticipated|Aga Khan University|||1||f||||f||||||Samples Without DNA|"     Plasma of participants will be analyzed for creatinine and Neutrophil Gelatinase-Associated     Lipocalcin (NGAL   "|No||2017-10-10 21:25:14.032931|2017-10-10 21:25:14.032931
NCT03034863|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-08-08|||July 3, 2017|Actual|2017-07-03|August 2017|2017-08-01|February 28, 2020|Anticipated|2020-02-28|November 1, 2019|Anticipated|2019-11-01||Interventional|SAFER||SAFER: A Brief Intervention Involving Family Members in Suicide Safety Planning|SAFER: A Brief Intervention Involving Family Members in Suicide Safety Planning|Recruiting||N/A|120|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:25:14.086582|2017-10-10 21:25:14.086582
NCT03034850|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-24|||April 2015||2015-04-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Thrombin Generation and Platelet Activation in CRS/HIPEC|Thrombin Generation and Platelet Activation in Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy|Completed||N/A|27|Actual|Ziekenhuis Oost-Limburg|||1||f||||f||||||||Yes|All de-identified data will be available 6 months after inclusion of the last patient by contacting the principle investigator (svanpoucke@gmail.com). Once the results of the study are available and published, all data will be part of the publication.|2017-10-10 21:25:14.191179|2017-10-10 21:25:14.191179
NCT03034837|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-24|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness and Economic Evaluation of Glass Ionomer Material Using as Dental Sealant|Economic Evaluation of ART Sealant in Preventing Pit and Fissure Caries in Permanent First Molars in an Asia Population|Recruiting||Phase 4|630|Anticipated|Zhengzhou University||2|||f||||||||||||No||2017-10-10 21:25:14.31839|2017-10-10 21:25:14.31839
NCT03034824|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-02-22|||January 2014||2014-01-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Er,Cr:YSGG, Diode Lasers on GCF Cytokines Levels|Comparison Of Er,Cr:YSGG and Diode Laser on the Periodontal Parameters and Cytokines Levels in Patients With Generalized Aggressive Periodontitis|Completed||N/A|26|Actual|Yuzuncu Yıl University||3|||f||||f||||||||No||2017-10-10 21:25:14.429263|2017-10-10 21:25:14.429263
NCT03034811|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-31|||February 8, 2017|Actual|2017-02-08|August 2017|2017-08-01|July 2029|Anticipated|2029-07-01|September 2027|Anticipated|2027-09-01||Interventional|||Persona Partial Knee Clinical Outcomes Study|Persona Partial Knee Clinical Outcomes Study|Recruiting||N/A|600|Anticipated|Zimmer Biomet||1|||f||||f|f|t|f|f|t|||||2017-10-10 21:25:14.514744|2017-10-10 21:25:14.514744
NCT03034798|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-26|||January 14, 2015|Actual|2015-01-14|January 2017|2017-01-01|July 28, 2016|Actual|2016-07-28|July 28, 2016|Actual|2016-07-28||Observational|||Suspending Basal Insulin Levels for Exercise in Adults With Type 1 Diabetes|The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous vs. Circuit-based Exercise in Individuals With Type 1 Diabetes on CSII|Completed||N/A|12|Actual|York University|||1||f||||f|f|f||||||No||2017-10-10 21:25:14.70226|2017-10-10 21:25:14.70226
NCT02986035|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-01-30|||October 2016||2016-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|ECA||Effectiveness of ECA Cream on Calcifying Shoulder Tendinitis|Effectiveness of ECA Cream on Calcifying Shoulder Tendinitis|Completed||N/A|10|Actual|Consorci Sanitari del Maresme||1|||f||||t||||||||No||2017-10-10 21:33:04.161252|2017-10-10 21:33:04.161252
NCT03034785|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-18|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Flexible Electronics for Early Assessment|Young Hands at Work and Play: Flexible Electronics for Early Assessment of Force Modulation and Planning in Children Born Prematurely|Recruiting||N/A|120|Anticipated|Wyss Institute at Harvard University||2|||f|||||f|f||||||||2017-10-10 21:25:14.756178|2017-10-10 21:25:14.756178
NCT03034772|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-23|||February 8, 2017|Actual|2017-02-08|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|February 1, 2018|Anticipated|2018-02-01||Interventional|DAWN||Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration|A Randomized Controlled Trial Comparing the Effect of Topical Dorzolamide-Timolol Versus Placebo Combined With Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Injections in Patients With Neovascular Age-Related Macular Degeneration Who Are Incomplete Anti-VEGF Responders|Recruiting||Phase 2/Phase 3|50|Anticipated|Wills Eye||2|||f||||f|f|f||||||No||2017-10-10 21:25:14.84692|2017-10-10 21:25:14.84692
NCT03034759|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-04-26|||June 1, 2017|Anticipated|2017-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A New Wizard for Insulin Sensitivity Estimation From SAP: a Randomized Controlled Trial in Adolescents With T1D|A New Wizard for Insulin Sensitivity Estimation From SAP: a Randomized Controlled Trial in Adolescents With T1D|Not yet recruiting||N/A|32|Anticipated|Yale University||1|||f||||f|f|f||||||||2017-10-10 21:25:14.950315|2017-10-10 21:25:14.950315
NCT03034746|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-27|||September 2013||2013-09-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Impact of Physical Activity on Successful Aging|Impact of Physical Activity on Successful Aging: Multidisciplinary Analysis of Mechanisms and Outcomes|Completed||N/A|90|Actual|Universita di Verona||4|||f||||t||||||||No||2017-10-10 21:25:16.618817|2017-10-10 21:25:16.618817
NCT03034733|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-05-03|||February 15, 2017|Actual|2017-02-15|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Dexamethasone on Pain After Total Knee Replacement Surgery|The Effect of Intravenous Single-dose Dexamethasone on Pain After Total Knee Replacement Surgery|Recruiting||Phase 4|96|Anticipated|University of Oulu||3|||f||||f|f|f||||||No||2017-10-10 21:25:16.72004|2017-10-10 21:25:16.72004
NCT03034720|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-11|||March 9, 2017|Actual|2017-03-09|May 2017|2017-05-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Collaborative Care Model for the Treatment of Persistent Symptoms After Concussion Among Youth|Collaborative Care Model for the Treatment of Persistent Symptoms After Concussion Among Youth|Recruiting||N/A|200|Anticipated|Seattle Children's Hospital||2|||f||||t|f|f||||||||2017-10-10 21:25:16.84684|2017-10-10 21:25:16.84684
NCT03034707|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-24|||April 2016||2016-04-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Interference of Biotin Supplementation in Biotin-streptavidin Platforms for Hormone Testing|Interference of Biotin Supplementation in Biotin-streptavidin Platforms for Hormone Testing|Active, not recruiting||N/A|12|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||No||2017-10-10 21:25:16.94199|2017-10-10 21:25:16.94199
NCT03034694|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2017-01-25|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting|The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting|Recruiting||N/A|45|Anticipated|Ohio State University||2|||f||||f||||||||Yes||2017-10-10 21:25:17.027383|2017-10-10 21:25:17.027383
NCT03034681|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-31|||January 2011||2011-01-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Lumbosciatic Syndrome: Vojta Therapy vs. TENS|Lumbosciatic Syndrome: a Quasi-experimental Study on the Effectiveness of the Vojta Therapy vs. Transcutaneous Electrical Nerve Stimulation|Completed||N/A|12|Actual|Universidad Rey Juan Carlos||2|||f||||f||||||||||2017-10-10 21:25:17.105297|2017-10-10 21:25:17.105297
NCT03034668|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-08|||November 2016||2016-11-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Botanical Supplement Muscle Function and Lean Body Mass|The Acute and Chronic Influence of a Botanical Supplement on Muscle Function and Lean Body Mass|Recruiting||N/A|114|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f||||||||No||2017-10-10 21:25:17.18046|2017-10-10 21:25:17.18046
NCT03034655|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||January 1, 2016|Actual|2016-01-01|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|ReFOVeRe||Reducing Rate of Falls in Older People by Means of Vestibular Rehabilitation (ReFOVeRe Study)|Reducing Rate of Falls in Older People With the Improvement of Balance by Means of Vestibular Rehabilitation (ReFOVeRe Study): Optimizing Costs|Recruiting||N/A|220|Anticipated|Hospital Clinico Universitario de Santiago||4|||f||||f|f|f||||||No||2017-10-10 21:25:17.276084|2017-10-10 21:25:17.276084
NCT03034642|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-24|||October 2015||2015-10-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Modulation of Steroid Immunosuppression by Alveolar Efferocytosis|Modulation of Steroid Immunosuppression by Alveolar Efferocytosis|Recruiting||N/A|60|Anticipated|University of Michigan||2|||f||||f||||||||Yes|de-identified participant data will be made available at study completion|2017-10-10 21:25:17.383719|2017-10-10 21:25:17.383719
NCT03034629|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Reliability and Timing of Exercise on TMS-based Plasticity Measures.|Assessing the Reliability and Influence of Timing of Exercise on Transcranial Magnetic Stimulation (TMS) Neuroplasticity Measures.|Not yet recruiting||N/A|40|Anticipated|University of Miami||1|||f||||f||||||||No||2017-10-10 21:25:18.666724|2017-10-10 21:25:18.666724
NCT03034616|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-26|||January 2017||2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|OLIVA||Ovarian Laparoscopic In Vivo Activation of Ovary for Premature Ovarian Insufficiency|in Vivo Activation of Ovarian Cortex in Premature Ovarian Insufficiency|Not yet recruiting||N/A|30|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||No||2017-10-10 21:25:18.732486|2017-10-10 21:25:18.732486
NCT03034603|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-26|||August 2014||2014-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Safety and Efficacy Test of Nutri-PEITC Jelly in Head and Neck Cancer Patients|The Safety and Efficacy Test of Nutri-PEITC Jelly in Head and Neck Cancer Patients|Recruiting||N/A|96|Anticipated|Dental Innovation Foundation Under Royal Patronage||2|||f||||t||||||||No||2017-10-10 21:25:18.806211|2017-10-10 21:25:18.806211
NCT03034590|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-01-25|||August 2014||2014-08-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||How to Identify Fatigue in Stroke Patients|How to Identify Fatigue in Stroke Patients: Validity of the Post-stroke Fatigue Case Definition|Completed||N/A|70|Actual|Herlev Hospital|||1||f||||t||||||||No||2017-10-10 21:25:18.8988|2017-10-10 21:25:18.8988
NCT03034564|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-25|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2020|Anticipated|2020-01-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease|Recruiting||Phase 4|70|Anticipated|The Cooper Health System||2|||f||||||||||||||2017-10-10 21:25:19.057873|2017-10-10 21:25:19.057873
NCT03034551|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-30|||January 30, 2017|Actual|2017-01-30|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Mobile App With Patient Financial Incentives for Adherence to Heart Failure Medications & Daily Self-Weighing|Randomized Controlled Trial of a Mobile App With Patient Financial Incentives for Tracking and Improving Adherence to Medications & Daily Self-Weighing to Reduce Heart Failure Readmissions|Recruiting||N/A|400|Anticipated|Wellth Inc.||2|||f||||t|f|f||||||No||2017-10-10 21:25:19.14168|2017-10-10 21:25:19.14168
NCT03034538|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-26|||April 8, 2016|Actual|2016-04-08|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|April 1, 2018|Anticipated|2018-04-01||Interventional|||An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease|An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease|Recruiting||Phase 4|20|Anticipated|The Cooper Health System||2|||f||||f|t|f||||||No||2017-10-10 21:25:19.234547|2017-10-10 21:25:19.234547
NCT03034525|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-25|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Observational|||Assessing the Risk of Pulmonary Embolism in Patients After Hospitalization for First Episode of Syncope|Assessing the Risk of Pulmonary Embolism in Patients After Hospitalization for First Episode of Syncope|Not yet recruiting||N/A|7000|Anticipated|Rambam Health Care Campus|||1||f|||||f|f||||||No||2017-10-10 21:25:19.309536|2017-10-10 21:25:19.309536
NCT03034512|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-25|||January 2014||2014-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|Alpers||Alpers Huttenlocher Natural History Study|Natural History Study of Alpers Huttenlocher Syndrome|Recruiting||N/A|50|Anticipated|Columbia University|||2||f||||f|f|f||||||Yes|This study is a sub project under the North American Mitochondrial Disease Consortium. The de-identified data can be shared if investigators have Institutional Review Board (IRB) approval for a project that might include data from this study and if the NAMDC administration approves of the project|2017-10-10 21:25:19.36146|2017-10-10 21:25:19.36146
NCT03034499|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-29|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|June 1, 2019|Anticipated|2019-06-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Single Versus Multi-port Robotic Assisted Sacrocolpopexy for Repair of Vaginal Apex Prolapse|Single Versus Multi-port Robotic Assisted Sacrocolpopexy for Repair of Vaginal Apex Prolapse|Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||f|f|f||||||Undecided||2017-10-10 21:25:19.535094|2017-10-10 21:25:19.535094
NCT03034486|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-07-28|||February 17, 2017|Actual|2017-02-17|July 2017|2017-07-01|March 20, 2017|Actual|2017-03-20|March 17, 2017|Actual|2017-03-17||Interventional|||The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930|A Single Sequence, 3-period, Multiple-dose Study to Evaluate the Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930 in Healthy Male Volunteers|Completed||Phase 1|15|Actual|Chong Kun Dang Pharmaceutical||1|||f||||f|f|f||||||||2017-10-10 21:25:19.619682|2017-10-10 21:25:19.619682
NCT03034473|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-24|||August 2011||2011-08-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|TransValid-A||Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.|Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC II-IV, With a 5-FU-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.|Active, not recruiting||N/A|200|Actual|University Medical Center Goettingen||1|||f||||f||||||||No||2017-10-10 21:25:19.705282|2017-10-10 21:25:19.705282
NCT03034460|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-25|||April 2016||2016-04-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy and Safety of CD5024 1% in Acne Vulgaris|Efficacy and Safety of CD5024 1% in Acne Vulgaris|Completed||Phase 2|70|Actual|Galderma R&D||4|||f||||f||||||||||2017-10-10 21:25:19.833812|2017-10-10 21:25:19.833812
NCT03034447|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-27|||December 2016||2016-12-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Sleep Apnea in Asthmatic Children and Teenagers|Obstructive Sleep Apnea in Asthmatic Children: Does the Sex Matter?|Recruiting||N/A|80|Anticipated|Federal University of São Paulo||1|||f||||f|f|f||||||Undecided||2017-10-10 21:25:19.930329|2017-10-10 21:25:19.930329
NCT03034434|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-03-29|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|June 1, 2018|Anticipated|2018-06-01|2 Days|Observational [Patient Registry]|||Cervical Recuperation After Vaginal Delivery|Sonography Evaluation of Cervical Recuperation After Vaginal Delivery|Recruiting||N/A|300|Anticipated|Rambam Health Care Campus|||1||f||||f|f|f||||||Undecided||2017-10-10 21:25:20.040254|2017-10-10 21:25:20.040254
NCT03034421|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-01-25|||September 2016||2016-09-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Prevention of Pneumothorax Following Endoscopic Valve Therapy in Patients With Severe Emphysema|Prevention of Pneumothorax Following Endoscopic Valve Therapy in Patients With Severe Emphysema|Recruiting||N/A|130|Anticipated|Heidelberg University||2|||f||||||||||||||2017-10-10 21:25:20.120772|2017-10-10 21:25:20.120772
NCT03034408|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-01-25|||July 2016||2016-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects|Effects of Nalmefene and Baclofen on Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects: A Randomized, Placebo-controlled Study|Recruiting||Phase 2|60|Anticipated|University Hospital, Geneva||2|||f||||t||||||||No||2017-10-10 21:25:20.213253|2017-10-10 21:25:20.213253
NCT03034395|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-30|||January 30, 2017|Actual|2017-01-30|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma|Pilot Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma|Recruiting||N/A|60|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-10 21:25:20.307132|2017-10-10 21:25:20.307132
NCT03034382|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-05-19|||January 2016||2016-01-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Morphine and/or Nalbuphine as Adjuvants in Ultrasound Guided Interscalene Block: for Shoulder Surgeries|Adjuvants to Ultrasonic Guided Interscalene Block In Arthroscopic Rotator Cuff Repair; Morphine and/or Nalbuphine|Recruiting||Phase 2|80|Anticipated|Assiut University||4|||f||||||||||||Undecided||2017-10-10 21:25:20.382732|2017-10-10 21:25:20.382732
NCT03034369|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-13|||March 2015||2015-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Caring for the Whole Person|Caring for the Whole Person: A Patient-Centered Assessment of Integrated Care Models in Vulnerable Populations|Active, not recruiting||N/A|6000|Anticipated|Providence Health & Services|||1||f||||f||||||||No||2017-10-10 21:25:20.479766|2017-10-10 21:25:20.479766
NCT03034356|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-14|||October 1, 2017|Anticipated|2017-10-01|June 2017|2017-06-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2022|Anticipated|2022-09-30||Interventional|||Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia|Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia|Not yet recruiting||N/A|50|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Yes|A de-identified, anonymized dataset will be created and shared.|2017-10-10 21:25:20.584217|2017-10-10 21:25:20.584217
NCT03034343|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-24|||October 2016||2016-10-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effectiveness of a Brief Psychological Mindfulness Based Intervention for the Treatment of Depression in Primary Care|Effectiveness of a Brief Psychological Mindfulness Based Intervention for the Treatment of Depression in Primary Care: Face-to-face Application, Treatment as Usual and Application Through ICTs|Recruiting||N/A|120|Anticipated|Universitat Jaume I||3|||f||||f||||||||Undecided||2017-10-10 21:25:20.674605|2017-10-10 21:25:20.674605
NCT03034330|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-31|||January 2017||2017-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|||A Two-Tier Care Management Program to Empower Stroke Caregivers in Hong Kong|A Two-Tier Care Management Program to Empower Stroke Caregivers in Hong Kong: A Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|The University of Hong Kong||2|||f||||f||||||||Yes|Data collected in this study will be published and submitted to academic journals to share with other researchers.|2017-10-10 21:25:20.792823|2017-10-10 21:25:20.792823
NCT03034317|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-25|||February 2017||2017-02-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|PARADIGM||NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)|Multi-Center, Concurrent-Controlled, On-Label Study of the NeuRx Diaphragm Pacing System (DPS) in Participants With Amyotrophic Lateral Sclerosis (ALS)|Not yet recruiting||N/A|108|Anticipated|Synapse Biomedical||2|||f||||t|f|t|f|f||||No||2017-10-10 21:25:20.897069|2017-10-10 21:25:20.897069
NCT03034304|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-25|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2019|Anticipated|2019-12-01||Interventional|||A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors|A Single-center, I Phase Clinical Study for Evaluating the Safety and Efficacy of Multiple-antigen Specific Cell Therapy in Vitro Combined With Anti-PD1 Technology (MASCT-I) in Patients With Advanced Solid Tumors and Preliminarily Assessing the Antitumor Effectiveness of MASCT-I Alone and in Combination With Chemotherapy Drugs|Not yet recruiting||Phase 1|36|Anticipated|SYZ Cell Therapy Co..||1|||f||||f||||||||Undecided||2017-10-10 21:25:20.975892|2017-10-10 21:25:20.975892
NCT03034291|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-27|||May 2012||2012-05-01|January 2017|2017-01-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Cacao Consumption in Patients With Insulin Resistance|Controlled Clinical Trial of the Effect of Cocoa Consumption in Patients With Insulin Resistance|Completed||N/A|92|Actual|Universidad de Antioquia||2|||f||||f|f|f||||||No||2017-10-10 21:25:21.142407|2017-10-10 21:25:21.142407
NCT03034278|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-08|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Observational|||Self-reported Usage Patterns of Opioid Analgesic Medications After Surgery|Improving Opioid Prescription Safety After Surgery|Recruiting||N/A|853|Anticipated|University of Colorado, Denver|||1||f||||f|f|f||||||No||2017-10-10 21:25:21.223848|2017-10-10 21:25:21.223848
NCT03034265|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-07-24|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||New Biomarkers and Difficult-to-treat Hypertension|Identification of New Biomarkers for the Classification and Monitoring of Difficult-to-treat Arterial Hypertension: Prospective Observational Study|Completed||N/A|24|Actual|University Hospital Inselspital, Berne|||1||f||||f|f|f||||Samples Without DNA|"     blood, urine   "|||2017-10-10 21:25:21.325475|2017-10-10 21:25:21.325475
NCT03034252|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-01-25|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|RELiSa||Retrospective Evaluation of Liposarcoma|Retrospective Evaluation of Liposarcoma|Completed||N/A|100|Actual|Technische Universität München|||1||f||||f|f|f||||||Undecided||2017-10-10 21:25:21.405793|2017-10-10 21:25:21.405793
NCT03034239|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-05-08|||March 20, 2017|Actual|2017-03-20|January 2017|2017-01-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||The Effect of Insect Protein on Performance and Hypertrophy|The Effect of Insect Protein on Performance and Hypertrophy During Eight Weeks of Resistance Training|Completed||N/A|18|Actual|University of Aarhus||2|||f||||t|f|f||||||||2017-10-10 21:25:21.476181|2017-10-10 21:25:21.476181
NCT03034226|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-14|||January 2017||2017-01-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Comparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control Subjects|A Comparison Between Counter Regulatory Responses in Type 1 Diabetic Patients Versus Healthy Control Subjects With and Without Antecedent Hypoglycemia|Recruiting||N/A|18|Anticipated|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-10 21:25:21.566526|2017-10-10 21:25:21.566526
NCT03034200|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-28|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Phase 2 Study of ONC201 in Neuroendocrine Tumors|Phase 2 Study of ONC201 in Neuroendocrine Tumors|Recruiting||Phase 2|24|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:25:21.780206|2017-10-10 21:25:21.780206
NCT03034187|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-02-24|||April 1999||1999-04-01|February 2017|2017-02-01|January 2028|Anticipated|2028-01-01|January 2025|Anticipated|2025-01-01||Observational|SFP-PROSTATE||Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate|Radiation Induced Toxicity in Prostate Cancer|Recruiting||N/A|10000|Anticipated|University Medical Center Groningen|||1||f||||f||||||||Yes|Sharing data between physicians at the Department of Radiotherapy|2017-10-10 21:25:21.890887|2017-10-10 21:25:21.890887
NCT03034174|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-05-01|||January 15, 2017|Actual|2017-01-15|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2017|Anticipated|2017-09-01||Observational|||Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients|Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients: an Observational, Prospective Study|Recruiting||N/A|70|Anticipated|Medical University of Lublin|||1||f||||f||||||Samples With DNA|"     Patients' arterial blood samples.   "|No||2017-10-10 21:25:21.980385|2017-10-10 21:25:21.980385
NCT03034148|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-02-15|||March 2015||2015-03-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ACCTHEROMA||Platelet Acetyl Coenzyme A Carboxylase Phosphorylation in Coronary Artery Disease|Prospective Evaluation of Acetyl-Coenzyme A Carboxylase Phosphorylation State in Platelets in Atherothrombotic Coronary Artery Disease.|Completed||N/A|188|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||No||2017-10-10 21:25:22.163132|2017-10-10 21:25:22.163132
NCT03034135|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-11|||March 9, 2017|Actual|2017-03-09|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma|A Phase II, Multicenter, Open-Label, Single-Arm Study to Evaluate the Safety, Tolerability, and Efficacy of DIsulfiram and Copper Gluconate in Recurrent Glioblastoma|Recruiting||Phase 2|20|Anticipated|Cantex Pharmaceuticals||1|||f|||||t|f||||||||2017-10-10 21:25:22.259789|2017-10-10 21:25:22.259789
NCT03034122|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CrEAM-HD||Is Caffeine an Environmental Modifier in Huntington's Disease?|Is Caffeine an Environmental Modifier in Huntington's Disease?|Not yet recruiting||N/A|100|Anticipated|University Hospital, Lille|||1||f||||t||||||||No||2017-10-10 21:25:22.385548|2017-10-10 21:25:22.385548
NCT03034109|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||January 2017||2017-01-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|TDCS-PSMWD||Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits|Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits|Recruiting||N/A|12|Anticipated|Stony Brook University||3|||f||||f||||||||No||2017-10-10 21:25:22.479422|2017-10-10 21:25:22.479422
NCT03034096|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-04-24|||January 2017||2017-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|GA-CARES||General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial|General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial: Pragmatic Randomized Trial of Propofol vs Volatile Inhalational Anesthesia|Recruiting||Phase 4|2000|Anticipated|Stony Brook University||2|||f||||t||||||||No||2017-10-10 21:25:22.612406|2017-10-10 21:25:22.612406
NCT03034083|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||An Evaluation of Healthy Marriage and Relationship Education Program: Elevate|Elevate: Taking Your Relationship to the Next Level|Not yet recruiting||Phase 2|340|Anticipated|University of Georgia||2|||f||||f||||||||No||2017-10-10 21:25:22.731137|2017-10-10 21:25:22.731137
NCT03034070|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-25|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|TFE-TVE||Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer.|Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer. Comparison of Diagnostic Performance of GE mDixon and FSE, for Bone and Node Staging in Patients With Prostate Cancer.|Recruiting||N/A|30|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||No||2017-10-10 21:25:22.814145|2017-10-10 21:25:22.814145
NCT03034057|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-10-03|||August 23, 2017|Actual|2017-08-23|October 2017|2017-10-01|May 22, 2019|Anticipated|2019-05-22|May 22, 2019|Anticipated|2019-05-22||Interventional|||Sayana Press UK Self-Injection Study|Phase Iv Open Label Single Group One Year Study Of Home Self-injection With Sayana (Registered) Press In Adult Women Of Reproductive Age - A Pragmatic Clinical Trial|Recruiting||Phase 4|160|Anticipated|Pfizer||1|||f||||f|f|f||||||||2017-10-10 21:25:22.909515|2017-10-10 21:25:22.909515
NCT02983656|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-07-03|||November 2016||2016-11-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine||Active, not recruiting||N/A|360|Anticipated|Zhejiang Provincial Center for Disease Control and Prevention|||1||f||||f||||||||||2017-10-10 21:33:25.096753|2017-10-10 21:33:25.096753
NCT03034031|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-30|||January 2017||2017-01-01|January 2017|2017-01-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Observational|MISTIC||MR Imaging Study of TBI in Children|Classifying Neuro-imaging Measures Predicting Rehabilitation Outcome Following Pediatric Closed Head Injuries.|Not yet recruiting||N/A|60|Anticipated|Sheba Medical Center|||1||f||||f|f|f||||||Undecided||2017-10-10 21:25:23.070978|2017-10-10 21:25:23.070978
NCT03034018|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-07-14|||May 25, 2017|Actual|2017-05-25|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia|A Double-blind, Randomized, Placebo-controlled Study to Determine the Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia in Midlife Women|Recruiting||Phase 4|80|Anticipated|Brigham and Women's Hospital||2|||f|||||t|f||||||||2017-10-10 21:25:23.139427|2017-10-10 21:25:23.139427
NCT03034005|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-07-11|||March 27, 2017|Actual|2017-03-27|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|RECONSTRUCT||The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma|The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma|Recruiting||Phase 4|60|Anticipated|Bispebjerg Hospital||2|||f||||t|f|f|||f|||||2017-10-10 21:25:23.218036|2017-10-10 21:25:23.218036
NCT03033992|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-25|||January 2017||2017-01-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma|Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma|Recruiting||N/A|25|Anticipated|Pediatric Brain Tumor Consortium||1|||f||||t||||||||||2017-10-10 21:25:23.302572|2017-10-10 21:25:23.302572
NCT03033979|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-26|||January 1, 2015|Actual|2015-01-01|January 2017|2017-01-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Prolonged Laryngeal Mask Airway ProSealTM Use|Prolonged Use of the Laryngeal Mask Airway ProSealTM: a Report of Seven Cases Lasting 5-11 Hours|Completed||N/A|7|Actual|Schulthess Klinik|||1||f||||f|f|f||||||No||2017-10-10 21:25:23.42654|2017-10-10 21:25:23.42654
NCT03033966|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-26|||February 10, 2016|Actual|2016-02-10|January 2017|2017-01-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|||Evaluation of Cerebral Oxygenation and Hemodynamics in Patients With Cerebral Venous Thrombosis|Evaluation of Cerebral Oxygenation and Hemodynamics in Patients With Cerebral Venous Thrombosis|Completed||N/A|17|Actual|National Institute of Mental Health and Neuro Sciences, India|||1||f||||f|f|t|f||t|||No|May be shared on individual requests|2017-10-10 21:25:23.483066|2017-10-10 21:25:23.483066
NCT03033953|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-24|||August 2014||2014-08-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Native Whey or Milk Supplementation on Adaptations to 12 Weeks of Strength Training in Young and Elderly|Effects of Native Whey and Milk Supplementation on Changes in Muscle Mass and Strength After 12 Weeks of Strength Training in Young and Elderly|Completed||N/A|66|Actual|Norwegian School of Sport Sciences||2|||f||||f||||||||Undecided||2017-10-10 21:25:23.56102|2017-10-10 21:25:23.56102
NCT03033940|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-27|||October 2016||2016-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Total Knee Arthroplasty Videofluoroscopy|Kinematics Analysis: Comparison Between the Cruciate Retaining, Fixed Bearing Primary Total Knee Arthroplasty ATTUNE TM Knee System and the Fixed Bearing PFC Sigma Curved Total Knee Arthroplasty|Recruiting||N/A|19|Anticipated|Institute for Biomechanics, ETH Zürich|||2||f||||f||||||||||2017-10-10 21:25:23.922563|2017-10-10 21:25:23.922563
NCT03033927|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-04-19|||January 24, 2017|Actual|2017-01-24|April 2017|2017-04-01|January 24, 2019|Anticipated|2019-01-24|January 24, 2019|Anticipated|2019-01-24||Observational|||Predicting Effective Therapy in Pancreatic Cancer|Circulating Tumor Cell and Tumor Tissue Models for Predicting Effective Pancreatic Cancer Response|Recruiting||N/A|80|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f|||||f|f||||Samples With DNA|"     Sodium heparin tube collections will be performed at baseline, at each restaging CT scan and     at time of first disease progression. K3-EDTA tubes will be collected at baseline and at     disease progression.      In patients who are planning an EGD for the purpose of obtaining a tumor biopsy, portal vein     sampling will be offered. Under EUS guidance, a 19-gauge EUS fine needle will be advanced     transhepatically into the portal vein and as many as four 7.5 mL K3-EDTA samples of blood     will be aspirated, as previously described. Research biopsy will be performed at baseline     and, if feasible, at disease progression.   "|||2017-10-10 21:25:24.000109|2017-10-10 21:25:24.000109
NCT03033914|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-08-15|||January 25, 2017|Actual|2017-01-25|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma|Phase I of Nivolumab and A(B)VD in the Front-line Setting for High Risk Hodgkin Lymphoma|Recruiting||Phase 1|26|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f|||||t|f||||||||2017-10-10 21:25:24.096963|2017-10-10 21:25:24.096963
NCT03033901|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-07|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Observational|C-SAS||Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome|Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome|Recruiting||N/A|259|Anticipated|James A. Haley Veterans Administration Hospital|||1||f||||f||||||||||2017-10-10 21:25:24.239062|2017-10-10 21:25:24.239062
NCT03033888|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-25|||April 2016||2016-04-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CHECC-uP||Community-Based Cervical Cancer Prevention and Education Among Women Living With HIV|Community-Based Cervical Cancer Prevention and Education Among Women Living With HIV|Recruiting||N/A|122|Anticipated|Johns Hopkins University||2|||f||||||||||||No||2017-10-10 21:25:24.399422|2017-10-10 21:25:24.399422
NCT03033875|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-06-15|||May 18, 2017|Actual|2017-05-18|June 2017|2017-06-01|November 30, 2020|Anticipated|2020-11-30|November 30, 2020|Anticipated|2020-11-30||Interventional|||Testing Tele-Savvy, an On-line Psychoeducation Program for Dementia Family Caregivers|Testing Tele-Savvy, an On-line Psychoeducation Program for Dementia Family Caregivers|Recruiting||N/A|75|Anticipated|Emory University||2|||f||||t|f|f||||||||2017-10-10 21:25:24.489961|2017-10-10 21:25:24.489961
NCT03033862|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-06-29|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|||Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds|Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds|Not yet recruiting||N/A|60|Anticipated|Inova Health Care Services|||2||f||||||||||||||2017-10-10 21:25:24.599208|2017-10-10 21:25:24.599208
NCT03033849|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-09-11|||January 2017||2017-01-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013|User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013|Completed||N/A|189|Actual|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm||1|||f||||||||||||||2017-10-10 21:25:24.715525|2017-10-10 21:25:24.715525
NCT03033836|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-09|||December 2015||2015-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|TRANSViiV||Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women|Pilot Study of Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women|Recruiting||Phase 4|60|Anticipated|The Huesped Foundation||1|||f||||f||||||||||2017-10-10 21:25:24.803175|2017-10-10 21:25:24.803175
NCT03033823|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-24|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|MAGMA||MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)|Multicenter Randomized Placebo Controlled Trial Assessing the Efficacy of Oral Adjuvant Magnesium Supplementation in the Treatment of Alcohol Withdrawal Syndrome|Not yet recruiting||Phase 3|450|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 21:25:24.932307|2017-10-10 21:25:24.932307
NCT03033810|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|FiGARO||FFR Versus iFR in Assessment of Hemodynamic Lesion Significance|FFR Versus iFR in Assessment of Hemodynamic Lesion Significance Using Gene Polymorphisms and Lesion Morphology Assessed by OCT (FiGARO Trial)|Recruiting||N/A|200|Anticipated|General University Hospital, Prague|||1||f||||f||||||Samples With DNA|"     Genetic analysis of polymorphisms in gene for Hemoxygenase-1 and endothelial nitric oxide     synthase. Patient's DNA will be isolated from peripheral blood leukocytes using standard     techniques.   "|No||2017-10-10 21:25:25.085217|2017-10-10 21:25:25.085217
NCT03033797|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-14|||March 8, 2016|Actual|2016-03-08|August 2017|2017-08-01|March 24, 2018|Anticipated|2018-03-24|March 10, 2018|Anticipated|2018-03-10||Interventional|||Augmentative and Alternative Communication in Games With Virtual Reality in Intellectual Disabilities|Augmentative and Alternative Communication in Games With Virtual Reality in Intellectual Disabilities|Recruiting||N/A|165|Anticipated|Faculdade de Medicina do ABC||2|||f||||f|f|f||||||||2017-10-10 21:25:25.202004|2017-10-10 21:25:25.202004
NCT03033784|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-07|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Autism Oxytocin Brain Project|Target Engagement for Intranasal Oxytocin in Autism Spectrum Disorders, an fMRI Dose Response Study|Recruiting||Phase 2|80|Anticipated|Emory University||2|||f||||f|t|f||||||||2017-10-10 21:25:25.29521|2017-10-10 21:25:25.29521
NCT03033771|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-25|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Dragon Study Europe|Evaluation of the Safety and Performance of the Multilayer Flow Modulator (MFM) for the Treatment of Chronic Type B Aortic Dissection|Recruiting||N/A|35|Anticipated|Cardiatis||1|||f||||t|f|f||||||No||2017-10-10 21:25:25.402519|2017-10-10 21:25:25.402519
NCT03033758|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-28|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|BOREAS||Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice.|Observational Study to Evaluate the Clinical Efficacy and Improved Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol, in Approximately 2000 Patients With Asthma|Recruiting||N/A|2000|Anticipated|Elpen Pharmaceutical Co. Inc.|||1||f||||t||||||||No||2017-10-10 21:25:25.502281|2017-10-10 21:25:25.502281
NCT03033745|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-10-02|||February 1, 2017|Actual|2017-02-01|October 2017|2017-10-01|January 19, 2018|Anticipated|2018-01-19|January 12, 2018|Anticipated|2018-01-12||Interventional|||Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)|An Open-label Multicenter Study to Evaluate the Safety and Tolerability of Higher Infusion Parameters of Immune Globulin Subcutaneous (Human), 20% Liquid (Hizentra®) in Subjects With Primary Immunodeficiency|Recruiting||Phase 4|51|Anticipated|CSL Behring||3|||f||||t|t|f||||||||2017-10-10 21:25:25.585315|2017-10-10 21:25:25.585315
NCT03033719|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-24|||July 4, 2017|Actual|2017-07-04|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|April 2020|Anticipated|2020-04-01||Interventional|CELL||Colectomy for Cancer in the Elderly by Laparoscopy or Laparotomy|Multicenter Randomized Trial Comparing Laparoscopy and Laparotomy for Colon Cancer Surgery in Patients Older Than 75 Years|Recruiting||N/A|276|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:25:25.858992|2017-10-10 21:25:25.858992
NCT03033706|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-04-20|||March 25, 2017|Actual|2017-03-25|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Intraoperative Goal Directed Fluid Management in Supratentorial Brain Tumor Craniotomy|Intraoperative Goal Directed Fluid Management Guided by Pulse Pressure Variation in Supratentorial Brain Tumor Craniotomy: a Randomized Controlled Study|Recruiting||N/A|50|Anticipated|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 21:25:25.967971|2017-10-10 21:25:25.967971
NCT03033693|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-09|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|DEPTH||Study of the Depth of Anesthesia on Postoperative Clinical Outcome in Patients With Supratentorial Tumor|Study of the Depth of Anesthesia on Postoperative Clinical Outcome in Patients With Supratentorial Tumor|Recruiting||N/A|3004|Anticipated|Beijing Tiantan Hospital||2|||f|||||f|f||||||||2017-10-10 21:25:26.068345|2017-10-10 21:25:26.068345
NCT03033680|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA|Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA|Not yet recruiting||Phase 1/Phase 2|4|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 21:25:26.161997|2017-10-10 21:25:26.161997
NCT03033667|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-25|||September 2014||2014-09-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Conventional Fasting Versus Lipid/Carbohydrate Infusion for Coronary Bypass Patients|Comparative Study Between Conventional Fasting Versus Overnight Infusion of Lipid or Carbohydrate on Free Fatty Acid and Insulin in Obese Patients Undergoing Elective First Time On-pump Coronary Artery Bypass Grafting|Completed||N/A|63|Actual|Cairo University||3|||f||||f||||||||Yes||2017-10-10 21:25:26.222582|2017-10-10 21:25:26.222582
NCT03033654|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-26|||February 2015|Actual|2015-02-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Two Consecutive Sunscreen Applications Optimize Sun Protection|Two Consecutive Sunscreen Applications Optimize Sun Protection|Completed||N/A|31|Actual|Bispebjerg Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:25:26.294816|2017-10-10 21:25:26.294816
NCT03033641|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-06-27|||December 5, 2016|Actual|2016-12-05|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|December 15, 2017|Anticipated|2017-12-15||Interventional|FIND CAN||"FIND CAN Trial: CF-172"|"Feasibility of the CARTOFINDER™ 4D LAT Algorithm to Identify Ablation Target in Subjects With Atrial Fibrillation (FIND CAN Trial: CF-172)"|Recruiting||N/A|25|Anticipated|Biosense Webster, Inc.||1|||f||||f|f|f||||||No||2017-10-10 21:25:26.360028|2017-10-10 21:25:26.360028
NCT03033628|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-14|||April 1, 2017|Anticipated|2017-04-01|February 2017|2017-02-01|January 1, 2018|Anticipated|2018-01-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||"Pain Perception of Dental Local Anesthesia Using DentalVibe Comfort System in a Group of Egyptian Children"|"Pain Perception of Maxillary Infiltration Injection of Dental Local Anesthesia Using DentalVibe Comfort System Compared to Maxillary Infiltration Injection Alone in a Group of Egyptian Children: A Randomized Clinical Trial"|Not yet recruiting||N/A|21|Anticipated|Cairo University||2|||f||||f|f|t|f||t|||No||2017-10-10 21:25:26.438768|2017-10-10 21:25:26.438768
NCT03033615|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2017-06-26|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||PixelShine vs. Iterative Reconstruction (IR) Processing of CT Images|Prospective Review of CT Imaging Data Comparing Quality of Low-Radiation-Dose Images Post-Processed With Iterative Reconstruction Software vs. Machine Learning (AlgoMedica PixelShine) Software|Not yet recruiting||N/A|20|Anticipated|AlgoMedica, Inc.||2|||f||||t|f|t|f|f|t|||No||2017-10-10 21:25:26.499657|2017-10-10 21:25:26.499657
NCT03033602|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-01-25|||October 2015||2015-10-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Brief Treatment for Posttraumatic Stress Disorder|Brief Treatment for PTSD: Enhancing Retention and Engagement|Recruiting||N/A|150|Anticipated|Boston VA Research Institute, Inc.||2|||f||||t||||||||||2017-10-10 21:25:26.577841|2017-10-10 21:25:26.577841
NCT03033589|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-01-26|||May 2016||2016-05-01|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength|Femoral Nerve Block Versus. Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament Reconstruction: Evaluation of Post-Operative Pain and Strength|Recruiting||N/A|80|Anticipated|Henry Ford Health System||2|||f||||f||||||||||2017-10-10 21:25:26.677688|2017-10-10 21:25:26.677688
NCT03033563|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-01-24|||January 1, 2012|Actual|2012-01-01|January 2017|2017-01-01|December 31, 2014|Actual|2014-12-31|December 1, 2014|Actual|2014-12-01||Observational|||ICSI Outcome of Ejaculated Versus Extracted Testicular Spermatozoa|ICSI Outcome of Ejaculated Versus Extracted Testicular Spermatozoa in Cryptozoospermic or Severe Oligozoospermic Men|Completed||N/A|430|Actual|Adam International Hospital|||1||f||||f|f|f||||||No||2017-10-10 21:25:28.290082|2017-10-10 21:25:28.290082
NCT03033550|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-09-11|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Integrating Primary & Secondary Interventions for Cervical Cancer Prevention in Primary Care Settings|A Single-arm Proof of Concept, Open Trial Clinical Study Investigating the Feasibility and Efficacy of Integrating Behavioral and Mobile Health Educational Interventions for Primary and Secondary Prevention in the Primary Care Setting|Active, not recruiting||N/A|100|Anticipated|Boston Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:25:28.36592|2017-10-10 21:25:28.36592
NCT03033537|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-24|||July 1, 2015|Actual|2015-07-01|January 2017|2017-01-01|January 20, 2016|Actual|2016-01-20|January 1, 2016|Actual|2016-01-01|2 Years|Observational [Patient Registry]|||Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction|Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction: A Pilot Study|Completed||N/A|20|Actual|Adam International Hospital|||2||f|||||f|f||||||No||2017-10-10 21:25:28.458902|2017-10-10 21:25:28.458902
NCT03033524|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-25|||February 2016||2016-02-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma|A Multicenter, 3-Arm, Open-Label, Phase Ⅱa Clinical Trial to Evaluate the Safety and Efficacy of TTAC-0001, a Fully Human Monoclonal Antibody in Patients With Recurrent Glioblastoma|Active, not recruiting||Phase 2|12|Actual|PharmAbcine||3|||f||||t||||||||Undecided||2017-10-10 21:25:28.538577|2017-10-10 21:25:28.538577
NCT03033511|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-29|||February 7, 2017|Actual|2017-02-07|September 2017|2017-09-01|April 1, 2020|Anticipated|2020-04-01|November 14, 2019|Anticipated|2019-11-14||Interventional|MERU||A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects With Extensive Stage Small Cell Lung Cancer (MERU)|Recruiting||Phase 3|740|Anticipated|AbbVie||2|||f||||t|t|f||||||||2017-10-10 21:25:28.65832|2017-10-10 21:25:28.65832
NCT03033498|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-29|||May 24, 2017|Actual|2017-05-24|September 2017|2017-09-01|December 16, 2017|Anticipated|2017-12-16|December 16, 2017|Anticipated|2017-12-16||Interventional|||A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease|A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of 24 Hour and 72 Hour Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease|Recruiting||Phase 1|24|Anticipated|AbbVie||4|||f||||f|t|f||||||||2017-10-10 21:25:29.036135|2017-10-10 21:25:29.036135
NCT03033485|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-24|||December 2017|Anticipated|2017-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||18F‐Labeled Picolinamide PET Imaging of Melanoma Diagnosis|18F‐Labeled Picolinamide PET-CT in the Management of Patients With Melanoma: The Radiation Dosimetry and Diagnostic Applications in Melanoma Patients|Not yet recruiting||N/A|50|Anticipated|Xijing Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:25:29.117099|2017-10-10 21:25:29.117099
NCT03033472|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-26||||||January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Preoperative Clindamycin on Postoperative Endodontic Pain|Effect of Preoperative Single-dose Clindamycin on Postoperative Endodontic Pain in Patients With Symptomatic Apical Periodontitis: A Randomized Controlled Trial|Not yet recruiting||Phase 2/Phase 3|72|Anticipated|Cairo University||2|||f||||||||||||||2017-10-10 21:25:29.192301|2017-10-10 21:25:29.192301
NCT03033459|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-25|||September 2016||2016-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Prenatal Lactation-Focused Motivational Interviewing|Enhancing Breastfeeding Initiation, Exclusivity, and Duration: Effects of Prenatal Lactation-Focused Motivational Interviewing|Recruiting||N/A|80|Anticipated|West Virginia University||2|||f||||f||||||||Undecided|Data will be available upon request to the PI (Daniel McNeil, PhD) upon completion of the study, by emailing dmcneil@wvu.edu AND sehayes@mix.wvu.edu|2017-10-10 21:25:29.272258|2017-10-10 21:25:29.272258
NCT03033446|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-03-03|||December 2016||2016-12-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma|A Phase II Open-Label, Single Centre, Non-Randomised Trial Of Y90-Radioembolization In Combination With Nivolumab In Asian Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 2|40|Anticipated|National Cancer Centre, Singapore||1|||f||||f||||||||Undecided||2017-10-10 21:25:29.37004|2017-10-10 21:25:29.37004
NCT03033433|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-01-24|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients|An Open-label Phase I Study to Assess the Safety and Tolerability Profile of Three Escalating Doses of DCB-DM101 in Healthy Volunteers and Optimum Dose of DCB-DM101 as add-on Treatment in Type 2 Diabetes Mellitus (T2DM) Patients|Recruiting||Phase 1|24|Anticipated|VitNovo, Inc.||1|||f||||t||||||||No||2017-10-10 21:25:29.47224|2017-10-10 21:25:29.47224
NCT03033420|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-06-15|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|July 2019|Anticipated|2019-07-01||Interventional|RADMIS||Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials|Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials|Recruiting||N/A|400|Anticipated|Psychiatric Centre Rigshospitalet||2|||f||||f|f|f||||||No||2017-10-10 21:25:29.544202|2017-10-10 21:25:29.544202
NCT03033407|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-24|||October 2014||2014-10-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Evaluate the Efficacy of Diabetes Management Based on Ubiquitous Healthcare System|A Randomized, Controlled, Open-label Study to Evaluate the Efficacy of the S-Diabetes Care Program Based on Ubiquitous Healthcare System in Patients With Type 2 Diabetes|Completed||N/A|148|Actual|Kangbuk Samsung Hospital||2|||f||||||||||||No||2017-10-10 21:25:29.631762|2017-10-10 21:25:29.631762
NCT03033394|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-24|||February 20, 2017|Anticipated|2017-02-20|January 2017|2017-01-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Observational|||Beta-lactam Pharmacokinetics in Secondary Care|Defining Adult Beta-lactam Antimicrobial Pharmacokinetics Across the Secondary Care Setting|Not yet recruiting||N/A|250|Anticipated|Imperial College London|||1||f|||||f|f||||Samples Without DNA|"     Plasma   "|No||2017-10-10 21:25:29.696591|2017-10-10 21:25:29.696591
NCT03033381|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-24|||April 2016||2016-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|IHR||A Comparison of Testicular Volume and Blood Flow in Patients With Inguinal Hernia, Hydrocele, and Cord Cyst|A Comparison of Preoperative and Postoperative Testicular Volume and Blood Flow in Patients With Inguinal Hernia, Hydrocele, and Cord Cyst: A Prospective Cohort Study|Completed||N/A|23|Actual|Kocatepe University||2|||f||||f||||||||No||2017-10-10 21:25:29.812594|2017-10-10 21:25:29.812594
NCT03033368|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-22|2017-01-24|||July 2015||2015-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Rilpivirine in Virologically Suppressed Adolescents|Treatment Switch From Efavirenz to Rilpivirine in Virologically-suppressed HIV-infected Thai Adolescents|Enrolling by invitation||Phase 2/Phase 3|100|Actual|Mahidol University||1|||f||||f||||||||Yes|Investigator plan to the clinical data|2017-10-10 21:25:29.934883|2017-10-10 21:25:29.934883
NCT03033355|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-02-12|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Central Nervous System Changes Following BotulinumtoxinA Injection in the Bladder|A Prospective Study of Higher Neural Control Changes Following Intradetrusor Injection of BotulinumtoxinA in Patients With Multiple Sclerosis and Lower Urinary Tract Symptoms.|Active, not recruiting||N/A|50|Anticipated|The Methodist Hospital System|||2||f||||f|f|f||||||No||2017-10-10 21:25:30.145568|2017-10-10 21:25:30.145568
NCT03033342|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-03|||August 2, 2016|Actual|2016-08-02|September 2017|2017-09-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Single Dose Escalation and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4|A Randomized, Double-Blind, Placebo Controlled Three-Part Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of MRX 4 Administered Orally to Healthy Volunteers in Single Ascending and Multiple Ascending Dose Cohorts, and to Evaluate Drug Interactions With Omeprazole|Completed||Phase 1|122|Actual|MicuRx||6|||f||||t||||||||||2017-10-10 21:25:30.267411|2017-10-10 21:25:30.267411
NCT03033329|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-24|||October 2016||2016-10-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Single Dose Escalation and Multiple Dose Escalation Trial of an Intravenous Formulation of MRX-4|A Randomized, Double-Blind, Placebo Controlled Three-Part Study of the Safety, Tolerability, and Pharmacokinetics of MRX 4 Administered Intravenously to Healthy Volunteers in Single Ascending and Multiple Ascending Dose Cohorts, and Bioavailability of Oral MRX-4 Versus Intravenous Administration|Enrolling by invitation||Phase 1|90|Anticipated|MicuRx||5|||f||||t||||||||No||2017-10-10 21:25:30.375721|2017-10-10 21:25:30.375721
NCT03033316|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|AMETHYST||A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma|A Phase I-IIa, Open Label, Multi-Center, Dose Escalating Study to Evaluate the Safety of Intravenous Pegylated Liposomal Dexamethasone Sodium Phosphate (Oncocort) as Monotherapy in Patients With Previously Treated Progressive Multiple Myeloma|Not yet recruiting||Phase 1/Phase 2|35|Anticipated|Enceladus Pharmaceuticals BV||1|||f||||t||||||||No||2017-10-10 21:25:30.476319|2017-10-10 21:25:30.476319
NCT03033303|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-04-19|||January 23, 2017|Actual|2017-01-23|April 2017|2017-04-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma|Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin for Consolidation of First Remission of Patients With High-Risk Neuroblastoma: A Phase II Study|Recruiting||Phase 2|59|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:25:30.58431|2017-10-10 21:25:30.58431
NCT03033290|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-01-24|||January 30, 2017|Anticipated|2017-01-30|January 2017|2017-01-01|March 26, 2018|Anticipated|2018-03-26|March 26, 2018|Anticipated|2018-03-26||Interventional|||Traditional Chinese Medicine on Gut Microbiota and Allergic Diseases|Effect of Traditional Chinese Medicine on Gut Microbiota, Physical Constitution, and Allergic Diseases|Not yet recruiting||Phase 3|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:25:30.692325|2017-10-10 21:25:30.692325
NCT03033277|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-24|||February 2016|Actual|2016-02-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI)|Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI)|Recruiting||Phase 1/Phase 2|320|Anticipated|Chinese Academy of Sciences||2|||f||||t|f|f||||||No||2017-10-10 21:25:30.797832|2017-10-10 21:25:30.797832
NCT03033264|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-03-29|||January 2017||2017-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.|A Comparison Between Labor Induction With Dinoprostone and a Cervical Ripening Balloon in Women With a BMI>30 as Oppose With a BMI<30.|Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||4|||f||||f|f|f||||||No||2017-10-10 21:25:30.903657|2017-10-10 21:25:30.903657
NCT03033251|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-07-27|||July 21, 2017|Actual|2017-07-21|July 2017|2017-07-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|HiFOLD||High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease|High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease|Recruiting||N/A|30|Anticipated|St. Michael's Hospital, Toronto||3|||f||||f|f|f||||||||2017-10-10 21:25:31.009978|2017-10-10 21:25:31.009978
NCT03033238|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-01-25|||January 2003||2003-01-01|January 2017|2017-01-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Observational|MOST||Multicenter Bone and Joint Health Study|Multicenter Osteoarthritis Study (MOST) Second Renewal|Recruiting||N/A|4526|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     Existing Cohort biospecimens were collected at enrollment, 30-month and 60-month follow-up.     New Cohort biospecimens will be collected at 144-month which will be their enrollment visit).   "|Yes|Anonymized clinical data is shared via MOST Online (http:\\most.ucsf.edu); 144-month through 168-month follow-up data is planned for release in 2021|2017-10-10 21:25:31.121823|2017-10-10 21:25:31.121823
NCT03033225|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-04-05|||January 5, 2017|Actual|2017-01-05|April 2017|2017-04-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|VERTPAC-02||EUS-guided PDT in Pancreatic Tumors|EUS-guided Verteporfin PDT in Solid Pancreatic Tumors (VERTPAC-02)|Recruiting||Phase 2|15|Anticipated|Mayo Clinic||1|||f||||f|t|f|||f|||No||2017-10-10 21:25:31.259971|2017-10-10 21:25:31.259971
NCT03033212|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-26|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|February 2021|Anticipated|2021-02-01||Interventional|||Single-Level TLIF: Post-Fusion Rehabilitation|Single-Level TLIF: Post-Fusion Rehabilitation|Recruiting||N/A|66|Anticipated|Rush University Medical Center||3|||f||||f|f|f||||||||2017-10-10 21:25:31.40287|2017-10-10 21:25:31.40287
NCT03033199|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia|A Multi-center Randomized Clinical Trial of Regulating Gut Microbiota by Probiotic Agents in Management of Immune Thrombocytopenia|Recruiting||Phase 2|60|Anticipated|Shandong University||2|||f||||t||||||||No||2017-10-10 21:25:31.555059|2017-10-10 21:25:31.555059
NCT03033186|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-05-30|||May 16, 2017|Actual|2017-05-16|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|September 1, 2018|Anticipated|2018-09-01||Observational|Foresight||Everolimus TDM to Predict Long Term Toxicity|Foreseeing the Moments of Occurrence of Everolimus Long-term Side Effects by Follow up of Trough Blood Concentrations|Recruiting||N/A|40|Anticipated|Maastricht University Medical Center|||1||f||||f||||||Samples Without DNA|"     Whole blood and drop of blood   "|No||2017-10-10 21:25:31.69893|2017-10-10 21:25:31.69893
NCT03033147|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25||||||January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Preoperative Amoxicillin/Clavulanic Acid Combination on Postoperative Endodontic Pain|Effect of Preoperative, Single-dose Amoxicillin/Clavulanic Acid Combination on Postoperative Endodontic Pain in Patients With Symptomatic Apical Periodontitis: A Double-Blind Randomized Controlled Trial.|Not yet recruiting||Phase 2/Phase 3|72|Anticipated|Cairo University||2|||f|||||||||f|||||2017-10-10 21:25:32.024908|2017-10-10 21:25:32.024908
NCT03033134|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-11|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|February 2018|Anticipated|2018-02-01||Interventional|SALUTE||A Study to Evaluate the Safety and Effectiveness of the Left Atrial Appendage Closure Therapy Using BSJ003W|A Study to Evaluate the Safety and Effectiveness of the Left Atrial Appendage Closure Therapy Using BSJ003W for Patients With Non-valvular Atrial Fibrillation at Increased Risk of ThromboEmbolism in Japanese Medical Environment (SALUTE)|Active, not recruiting||N/A|54|Actual|Boston Scientific Japan K.K.||1|||f|||||f|t|f||t|||||2017-10-10 21:25:32.120447|2017-10-10 21:25:32.120447
NCT03033121|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-23|||January 1, 2016||2016-01-01|January 2017|2017-01-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|GH 3 wk dose||Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children|More Favorable Metabolic Impact of Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children|Completed||Phase 3|32|Actual|University of Palermo||2|||f||||t||||||||No||2017-10-10 21:25:32.232138|2017-10-10 21:25:32.232138
NCT03033108|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-02|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease|A Phase 2a Multicenter, Randomized, Masked Study Evaluating the Pharmacodynamics of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease|Recruiting||Phase 2|30|Anticipated|Acucela Inc.||3|||f||||f||||||||No||2017-10-10 21:25:32.331311|2017-10-10 21:25:32.331311
NCT03033095|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-01-23|||July 2016||2016-07-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|PRESA||Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers|Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis Disease During 6 Months by Combinatorial Analysis of Serum Biomarkers|Recruiting||N/A|50|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 21:25:32.409386|2017-10-10 21:25:32.409386
NCT03033082|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-01-24|||January 1, 2014|Actual|2014-01-01|January 2017|2017-01-01|June 30, 2014|Actual|2014-06-30|June 1, 2014|Actual|2014-06-01||Observational|||Evaluation of Marital and Sexual Satisfaction of Wives to Erectile Dysfunction Males|Evaluation of Marital and Sexual Satisfaction of Wives to Erectile Dysfunction Males Using Intra Corporeal Injection (Ici). In Correlation to Personality Profile|Completed||N/A|70|Actual|Adam International Hospital|||2||f|||||f|f||||||Yes|Contact the authors|2017-10-10 21:25:32.501291|2017-10-10 21:25:32.501291
NCT03033069|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-05-26|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder|A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole as Monotherapy or as Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder|Recruiting||Phase 2|332|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||f|t|f||||||No||2017-10-10 21:25:32.567802|2017-10-10 21:25:32.567802
NCT03033056|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-02|||August 20, 2017|Anticipated|2017-08-20|August 2017|2017-08-01|August 1, 2021|Anticipated|2021-08-01|August 1, 2021|Anticipated|2021-08-01||Observational|||Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders|Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders (Community Anxiety Response Study)|Not yet recruiting||N/A|159|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f|f|f||||||||2017-10-10 21:25:32.717177|2017-10-10 21:25:32.717177
NCT03033043|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-03-07|||March 17, 2017|Anticipated|2017-03-17|March 2017|2017-03-01|April 17, 2024|Anticipated|2024-04-17|May 17, 2019|Anticipated|2019-05-17||Interventional|||Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection|A Prospective, Multicenter, Non-Blinded, Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection|Not yet recruiting||N/A|80|Anticipated|Bolton Medical||1|||f||||t|f|t|t|f||||No||2017-10-10 21:25:32.797168|2017-10-10 21:25:32.797168
NCT03033030|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||February 2014|Actual|2014-02-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Observational|TOMUS||Tomosynthesis (TS) or Ultrasound (US) in Mammography-negative Dense Breasts (TOMUS). National Multicenter Trial|Tomosynthesis (TS) or Ultrasound (US) in Mammography-negative Dense Breasts (TOMUS). National Multicenter Trial|Recruiting||N/A|8000|Anticipated|University of Genova|||1||f||||t|f|f||||||||2017-10-10 21:25:32.88046|2017-10-10 21:25:32.88046
NCT03033017|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-09-20|||July 2016||2016-07-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Predictors of Time to Viremia With an Analytic Treatment Interruption|Predictors of Time to Viremia With an Analytic Treatment Interruption|Recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples With DNA|"     Lymph node biopsy: Inguinal lymph node biopsies will be collected per institutional     guidelines   "|||2017-10-10 21:25:33.005105|2017-10-10 21:25:33.005105
NCT03033004|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-04|||January 2017||2017-01-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Cryolipolisis for Abdomen and Flank Fat Reduction|Cryolipolisis for Subcutaneous Abodomen and Flank Fat Reduction|Recruiting||N/A|60|Anticipated|Universidade Cidade de Sao Paulo||3|||f||||f||||||||||2017-10-10 21:25:33.091599|2017-10-10 21:25:33.091599
NCT02983084|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-22|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Orthodontic Archwire Comparison Trial||Recruiting||N/A|105|Anticipated|Ormco Corporation||3|||f||||f||||||||No||2017-10-10 21:33:29.971895|2017-10-10 21:33:29.971895
NCT03032991|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-23|||January 2016||2016-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|GD-BRAIN||Early Biomarkers of Neurodevelopment in Offspring of Diabetic Mothers|Early Biomarkers of Neurodevelopment in Offspring of Diabetic Mothers (GD-BRAIN)|Recruiting||N/A|174|Anticipated|Universidad de Murcia|||2||f||||f||||||Samples Without DNA|"     Saliva, urine   "|||2017-10-10 21:25:33.181226|2017-10-10 21:25:33.181226
NCT03032978|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-07-27|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Calcium Silicate Versus Calcium Hydroxide in Two-step Indirect Pulp Treatment|Clinical and Microbiological Evaluation of Calcium Silicate Versus Calcium Hydroxide in Two-step Indirect Pulp Treatment: Randomized Clinical Trial|Not yet recruiting||N/A|102|Anticipated|Cairo University||2|||f||||f|f|f|||f|||||2017-10-10 21:25:33.270838|2017-10-10 21:25:33.270838
NCT03032952|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-24|||February 2016||2016-02-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Efficacy of a Mobile Application for Treating Depression and Anxiety Symptoms|The Efficacy of a Mobile Application for Treating Depression and Anxiety Symptoms in University Students|Completed||N/A|168|Actual|University College, London||2|||f||||f||||||||No||2017-10-10 21:25:33.412531|2017-10-10 21:25:33.412531
NCT03032939|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||December 18, 2007|Actual|2007-12-18|January 2017|2017-01-01|January 30, 2015|Actual|2015-01-30|January 30, 2012|Actual|2012-01-30||Observational|||The Effect of Tracheal Intubation on AC and DC Components of a Photoplethysmograph|The Effect of Tracheal Intubation Induced Autonomic Response on Photoplethysmography|Completed||N/A|35|Actual|University of California, San Francisco|||1||f||||f|f|f||||||No|only a unique study number such as, IP01, that is unrelated to any patient identifiers will be used|2017-10-10 21:25:33.480561|2017-10-10 21:25:33.480561
NCT03032926|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-06-02|||February 2014||2014-02-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|October 2015|Actual|2015-10-01||Observational|||A Pilot Study of Fear Extinction Learning in Anxious Youth|Enhancing Specificity and Predictability of CBT Outcome for Pediatric Anxiety Disorders: A Pilot Test of a Potential Biomarker for Treatment Response Across Development|Active, not recruiting||N/A|9|Actual|Weill Medical College of Cornell University|||1||f||||t|f|f||||||No||2017-10-10 21:25:33.526729|2017-10-10 21:25:33.526729
NCT03032913|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-07-25|||February 15, 2017|Actual|2017-02-15|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|PANC-CTC||Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC|Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC|Recruiting||N/A|40|Anticipated|University Hospital, Bordeaux|||2||f||||f|f|f||||||||2017-10-10 21:25:33.587323|2017-10-10 21:25:33.587323
NCT03032900|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-23|||January 2017||2017-01-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|RESECHO||Right Ventricular Dysfunction Incidence After Major Lung Resection|Right Ventricular Dysfunction Incidence After Major Lung Resection, a Prospective Study.|Not yet recruiting||N/A|160|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||Undecided|NC|2017-10-10 21:25:33.662069|2017-10-10 21:25:33.662069
NCT03032887|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-28|||March 2016||2016-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Reducing Visitors- and Personnel-associated Infection Risk on Perinatal Care Station|Reducing Visitors- and Personnel-associated Infection Risk by Special Agitation Incl. Voice Prompts for Hand Disinfection on Perinatal Care Stations|Recruiting||N/A|300|Anticipated|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||Undecided||2017-10-10 21:25:33.729361|2017-10-10 21:25:33.729361
NCT03032874|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-01-27|||January 1, 2014|Actual|2014-01-01|January 2017|2017-01-01|July 30, 2016|Actual|2016-07-30|July 30, 2016|Actual|2016-07-30||Observational|||Community Based Screening for Colorectal Cancer in an Underserved High Risk Population in Nigeria|Colorectal Cancer Control in Low Resource Countries: Results From a Prospective Cohort Study of Patients at High-risk for Colorectal Cancer|Completed||N/A|100|Actual|Obafemi Awolowo University Teaching Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Colonic polyps and colorectal cancer specimen   "|Undecided|Each request will be review on their merit by the team and approval of the Ethic and Research Committee that approve the study|2017-10-10 21:25:35.489713|2017-10-10 21:25:35.489713
NCT03032861|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-04-25|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?|Influence of the Prebiotic Effect of Orange Juice on the Bioavailability of Flavanones After Chronic Intake of Orange Juice.|Completed||N/A|10|Actual|São Paulo State University||1|||f||||t||||||||Undecided|There is still no decision regarding if the individual participant data (IPD) will be available to other researchers.|2017-10-10 21:25:35.560496|2017-10-10 21:25:35.560496
NCT03032848|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-23|||November 26, 2013|Actual|2013-11-26|January 2017|2017-01-01|December 26, 2016|Actual|2016-12-26|December 20, 2016|Actual|2016-12-20||Interventional|||Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients|Randomized, Blinded Trial Comparing Vaginal Estrogens on Pelvic Organ Prolapse Patients|Completed||Phase 4|69|Actual|Universidade Federal do Paraná||4|||f||||t|f|f||||||Yes||2017-10-10 21:25:35.655687|2017-10-10 21:25:35.655687
NCT03032835|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-25|||January 2017||2017-01-01|January 2017|2017-01-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|20 Years|Observational [Patient Registry]|PCB||Partners Calciphylaxis Biobank|Partners Calciphylaxis Biobank and Patient Registry|Recruiting||N/A|300|Anticipated|Massachusetts General Hospital|||1||f||||f|f|f||||Samples With DNA|"     Plasma, serum, DNA and tissue samples (e.g. skin)   "|No||2017-10-10 21:25:35.740693|2017-10-10 21:25:35.740693
NCT03032822|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-24|||September 2016||2016-09-01|January 2017|2017-01-01||||August 5, 2017|Anticipated|2017-08-05||Observational|||Opioid Consumption in Cystectomy Patients|Opioid Consumption After Hospital Discharge in Cystectomy Patients|Recruiting||N/A|80|Anticipated|Ohio State University|||1||f||||f||||||||No|Efforts will be made to keep patient information confidential. individual participant data will only be available to researchers who are approved by the Institutional Review Board (IRB) to participate in study enrollment, follow up and data analysis.|2017-10-10 21:25:35.817137|2017-10-10 21:25:35.817137
NCT03032809|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-25|||January 2017||2017-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|VWI||Magnetic Resonance Imaging of Intracranial Vasculopathies|High Resolution Vessel Wall Imaging by Magnetic Resonance Imaging of Intracranial Vasculopathies|Not yet recruiting||N/A|50|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||No||2017-10-10 21:25:35.885708|2017-10-10 21:25:35.885708
NCT03032796|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-02-02|||January 2017||2017-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|BBT||Characterizing the Synergistic Effects of Physical and Cognitive Training on Attention and Working Memory|Characterizing the Synergistic Effects of Physical and Cognitive Training on Attention and Working Memory|Recruiting||N/A|100|Anticipated|University of California, San Francisco||4|||f||||f||||||||No||2017-10-10 21:25:35.958387|2017-10-10 21:25:35.958387
NCT03032783|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-04-24|||January 31, 2017|Actual|2017-01-31|April 2017|2017-04-01|July 24, 2020|Anticipated|2020-07-24|July 24, 2020|Anticipated|2020-07-24||Interventional|||A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity|A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity|Recruiting||Phase 2|42|Anticipated|Thomas Jefferson University||1|||f||||t|f|t|f|f|t|||||2017-10-10 21:25:36.046912|2017-10-10 21:25:36.046912
NCT03032770|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-03-12|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|March 31, 2019|Anticipated|2019-03-31|January 31, 2019|Anticipated|2019-01-31||Observational|||Early Prediction of Placenta Accreta by Ultrasound and Color Doppler|Early Prediction of Placenta Accreta by 2 Dimensional Transvaginal Ultrasound and Color Doppler|Recruiting||N/A|148|Anticipated|Assiut University|||2||f||||t|f|t|f|f|f|||Undecided||2017-10-10 21:25:36.15779|2017-10-10 21:25:36.15779
NCT03032757|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-04-07|||April 15, 2017|Anticipated|2017-04-15|April 2017|2017-04-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Lysosomal Movement and Anabolic Resistance|Defining the Role of Lysosomal Movement in Age-associated Anabolic Resistance in Human Skeletal Muscle|Recruiting||N/A|26|Anticipated|University of Birmingham||4|||f|||||f|f||||||||2017-10-10 21:25:36.312871|2017-10-10 21:25:36.312871
NCT03032744|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-24|||January 17, 2017|Actual|2017-01-17|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Project IMPACT in Schools to Prevent Asthma Symptoms|Intervention and Management Program for Asthma Control and Treatment in Schools|Recruiting||N/A|60|Anticipated|State University of New York at Buffalo||2|||f||||f|f|f||||||No||2017-10-10 21:25:36.390999|2017-10-10 21:25:36.390999
NCT03032731|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-23|||January 16, 2017|Actual|2017-01-16|January 2017|2017-01-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Trial of a New Online Programme for Physical Activity and Healthy Eating.|Trial of a Self-directed Behaviour Change Intervention for Physical Activity and Healthy Eating.|Recruiting||N/A|60|Anticipated|University of Bath||2|||f||||f|f|f||||||No||2017-10-10 21:25:36.505108|2017-10-10 21:25:36.505108
NCT03032718|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-03-08|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|VANISH||Whole-body Vibration Training to Reduce the Symptoms of Chemotherapy-induced Peripheral Neuropathy|Effects of Individually Tailored Whole-body Vibration Training on the Symptoms of Chemotherapy-induced Peripheral Neuropathy: a Randomized-controlled Trial|Recruiting||N/A|44|Anticipated|University of Basel||2|||f||||f|f|f||||||No||2017-10-10 21:25:36.609821|2017-10-10 21:25:36.609821
NCT03032705|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-07-24|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|||Clinical Evaluation of Kerr SonicFill™ 2 vs 3M ESPE Filtek™ Supreme Ultra Universal Restorative|Clinical Evaluation of Kerr SonicFill™ 2 vs 3M ESPE Filtek™ Supreme Ultra Universal Restorative|Recruiting||N/A|44|Anticipated|Tufts University School of Dental Medicine||2|||f||||f|f|t|f|f||||||2017-10-10 21:25:36.714951|2017-10-10 21:25:36.714951
NCT03032692|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-12|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|||Motor Task Performance Under Visual and Auditory Feedback Post Stroke: a Randomized Crossover Trial|Motor Task Performance Under Visual and Auditory Feedback Post Stroke: a Randomized Crossover Trial|Completed||N/A|30|Actual|Sword Health, SA||2|||f||||f|f|f||||||No|Individual Participant Data will not be made available to other researchers|2017-10-10 21:25:36.820452|2017-10-10 21:25:36.820452
NCT03032679|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-02|||February 2, 2017|Actual|2017-02-02|February 2017|2017-02-01|February 1, 2019|Anticipated|2019-02-01|October 31, 2017|Anticipated|2017-10-31||Observational|||Pain and Impact of Chronic Pain on Function After Total Knee Replacements|Postoperative Pain Severity, Incidence Of Chronic Pain And Its Impact On Daily Function Following Total Knee Replacements (TKR) At A Tertiary Cancer Institute|Recruiting||N/A|140|Anticipated|Tata Memorial Centre|||1||f||||t|f|f||||||No||2017-10-10 21:25:36.933419|2017-10-10 21:25:36.933419
NCT03032666|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-05|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|September 15, 2017|Anticipated|2017-09-15|August 15, 2017|Anticipated|2017-08-15||Interventional|||Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial|Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial|Recruiting||Phase 4|10|Anticipated|American University of Beirut Medical Center||1|||f||||t|t|f|||t|||No||2017-10-10 21:25:37.029296|2017-10-10 21:25:37.029296
NCT03032653|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-30|||January 2017||2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Immediate Weight-Bearing Ankle Study|Immediate Unprotected Weight-Bearing and Range of Motion After Open Reduction and Internal Fixation of Unstable Ankle Fractures. A Historical Control Group Comparative Study|Not yet recruiting||N/A|80|Anticipated|Simon Fraser Orthopaedic Fund||2|||f||||f||||||||No||2017-10-10 21:25:37.119803|2017-10-10 21:25:37.119803
NCT03032640|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-03-09|||January 2017||2017-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|ISTAR-micro||Interactions of Human Gut Microbiota With Intestinal Sweet Taste Receptors|Interactions of Human Gut Microbiota With Intestinal Sweet Taste Receptors|Recruiting||N/A|90|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida||4|||f||||t||||||||No||2017-10-10 21:25:37.240988|2017-10-10 21:25:37.240988
NCT03030807|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-03-07|||October 2016||2016-10-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Pulmonary Hypertension in Hypersensitivity Pneumonitis|Recognition of Pulmonary Hypertension in Patients With Hypersensitivity Pneumonitis|Enrolling by invitation||N/A|400|Anticipated|Medical University of Graz|||1||f||||||||||||||2017-10-10 21:25:53.040057|2017-10-10 21:25:53.040057
NCT03032627|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-23|||December 2016||2016-12-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Identifying Targets of Maladaptive Metabolic Responses in Heart Failure|Identifying Targets of Maladaptive Metabolic Responses in Heart Failure|Enrolling by invitation||N/A|165|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida||1|||f||||t||||||||No||2017-10-10 21:25:37.352807|2017-10-10 21:25:37.352807
NCT03032601|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-05-15|||January 5, 2017|Actual|2017-01-05|May 2017|2017-05-01|January 5, 2020|Anticipated|2020-01-05|January 5, 2019|Anticipated|2019-01-05||Interventional|MSNAC||Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis|Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis|Recruiting||N/A|30|Anticipated|Thomas Jefferson University||2|||f||||f|f|f||||||No|There is no plan to make individual participant data (IPD) available to other researchers.|2017-10-10 21:25:37.512192|2017-10-10 21:25:37.512192
NCT03032575|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-06|||January 2017||2017-01-01|January 2017|2017-01-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection|SEARCH Thailand and Thai Red Cross AIDS Research Centre|Recruiting||N/A|100|Anticipated|Thai Red Cross AIDS Research Centre||1|||f||||t||||||||||2017-10-10 21:25:37.696426|2017-10-10 21:25:37.696426
NCT03032562|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||December 1, 2016|Actual|2016-12-01|January 2017|2017-01-01|February 28, 2020|Anticipated|2020-02-28|December 31, 2019|Anticipated|2019-12-31||Observational|||Respiratory Muscle Strength and Function in Neuromuscular Disorders and Chronic Obstructive Pulmonary Disease|Multimodal Measurement of Respiratory Muscle Strength and Function: Validation of Volitional and Non-volitional Tests With Regard to Nocturnal Hypoventilation in Patients With Neuromuscular Disorders and Chronic Obstructive Pulmonary Disease|Recruiting||N/A|200|Anticipated|Westfälische Wilhelms-Universität Münster|||2||f||||f|f|f||||||No||2017-10-10 21:25:37.76788|2017-10-10 21:25:37.76788
NCT03032549|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-23|||January 1, 2016|Actual|2016-01-01|January 2017|2017-01-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Interventional|NB10||Safety of a Ready to Drink Supplement|Short-Term Safety and Dose Effects of a Ready to Drink Pre-Workout Supplement|Completed||N/A|28|Actual|Texas A&M University||2|||f||||t|f|f||||||No||2017-10-10 21:25:37.844491|2017-10-10 21:25:37.844491
NCT03032523|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-24|||October 2016||2016-10-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)|Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)|Recruiting||N/A|40|Anticipated|Stanford University||2|||f||||f||||||||Undecided||2017-10-10 21:25:38.143566|2017-10-10 21:25:38.143566
NCT03032510|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-09-22|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|IGNITE3||Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections|A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of IV Eravacycline Compared With Ertapenem in Complicated Urinary Tract Infections|Active, not recruiting||Phase 3|1200|Anticipated|Tetraphase Pharmaceuticals, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:25:38.222426|2017-10-10 21:25:38.222426
NCT03032497|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-07-06|||June 5, 2017|Actual|2017-06-05|January 2017|2017-01-01|September 30, 2018|Anticipated|2018-09-30|July 31, 2018|Anticipated|2018-07-31||Interventional|||Brain-Computer Interface (BCI)-Based Feedback for Chronic Pain Management|Feasibility of a Brain-Computer Interface (BCI)-Based Adaptive Sensing and Feedback for Chronic Pain Management|Recruiting||N/A|30|Anticipated|Tan Tock Seng Hospital||1|||f||||t|f|f||||||||2017-10-10 21:25:38.450428|2017-10-10 21:25:38.450428
NCT03032484|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-07|||May 18, 2017|Actual|2017-05-18|August 2017|2017-08-01|April 10, 2021|Anticipated|2021-04-10|April 10, 2021|Anticipated|2021-04-10||Interventional|||TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma|A Phase 2 Investigator Initiated Study to Determine the Efficacy and Safety of TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma|Recruiting||Phase 2|24|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t|t|f||||||||2017-10-10 21:25:38.555505|2017-10-10 21:25:38.555505
NCT03032471|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-10-03|||July 20, 2017|Actual|2017-07-20|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Observational|||Swiss SOS MoCA - DCI Study|Impact of Delayed Cerebral Ischemia (DCI) on the Neuropsychological Outcome After Aneurysmal Subarachnoid Hemorrhage - a SWISS SOS Multicentre Observational Study|Recruiting||N/A|240|Anticipated|Swiss SOS Study Group|||2||f||||t||||||||||2017-10-10 21:25:38.654593|2017-10-10 21:25:38.654593
NCT03032458|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-19|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Pethidine, Ketorolac And Xylocaine Gel As Analgesics For Pain Control In Shockwave Lithotripsy|Efficacy of Pethidine, Ketorolac And Xylocaine Gel As Analgesics For Pain Control In Shockwave Lithotripsy Single Blinded Randomized Controlled Trial|Active, not recruiting||Phase 4|165|Actual|Mansoura University||3|||f||||t||||||||Yes|meta-analyses by contact the Prof. Hassan Abol-Enein, MD, Phd (Study Chair) or Prof. Khaled Z. Sheir, MD ( Study Central Contact Backup)|2017-10-10 21:25:38.790941|2017-10-10 21:25:38.790941
NCT03032445|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-24|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|BEER||Beer for Endurance Exercise Recovery|Potential Impacts of Beer on Post-Race Ultramarathon Athletes|Enrolling by invitation||N/A|1000|Anticipated|State University of New York - Upstate Medical University||2|||f||||f|f|f|||f|||No||2017-10-10 21:25:38.884282|2017-10-10 21:25:38.884282
NCT03032432|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-20|||November 17, 2017|Anticipated|2017-11-17|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|DEG||A Dynamic Elastic Garment (DEG) in Patients With Rotator Cuff Tendinopathy|A Single-blinded Randomized Controlled Trial Comparing Patients Who Receive a Corticosteroid Injection for Nontraumatic Degenerative Rotator Cuff Tears or Tendinopathy and Scheduled Use of a Dynamic Elastic Garment to Patients Who Receive a Corticosteroid Injection Alone.|Not yet recruiting||Phase 3|60|Anticipated|Loma Linda University||2|||f||||f|f|f|||f|||||2017-10-10 21:25:38.960279|2017-10-10 21:25:38.960279
NCT03032419|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-06-09|||February 6, 2017|Actual|2017-02-06|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|VIPV-06||Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months|Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine, IPV-Al SSI, in Comparison to Non-adjuvanted Full Dose IPV SSI, in Infants Vaccinated at 6, 10, 14 Weeks and 9 Months of Age|Active, not recruiting||Phase 3|1000|Anticipated|Statens Serum Institut||2|||f||||t|f|f||||||Yes||2017-10-10 21:25:39.046588|2017-10-10 21:25:39.046588
NCT03032406|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||January 23, 2017|Actual|2017-01-23|January 2017|2017-01-01||||January 23, 2022|Anticipated|2022-01-23||Interventional|||CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer|CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer|Recruiting||Phase 2|60|Anticipated|Abramson Cancer Center of the University of Pennsylvania||4|||f||||t|t|f||||||||2017-10-10 21:25:39.147281|2017-10-10 21:25:39.147281
NCT03032393|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-04|||February 3, 2017|Actual|2017-02-03|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Posture and Timed Up and Go|The Effects of Posture on Timed up and go|Recruiting||N/A|30|Anticipated|Youngstown State University||2|||f||||f|f|f||||||No||2017-10-10 21:25:39.232016|2017-10-10 21:25:39.232016
NCT03032380|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-30|||July 30, 2017|Actual|2017-07-30|August 2017|2017-08-01|February 1, 2019|Anticipated|2019-02-01|January 1, 2019|Anticipated|2019-01-01||Interventional|APEKS-NP||Clinical Study of S-649266 for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens|A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens|Recruiting||Phase 3|300|Anticipated|Shionogi Inc.||2|||f||||t|t|f||||||||2017-10-10 21:25:39.308422|2017-10-10 21:25:39.308422
NCT03032367|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-07-26|||November 10, 2016|Actual|2016-11-10|July 2017|2017-07-01|January 11, 2017|Actual|2017-01-11|December 9, 2016|Actual|2016-12-09||Interventional|||TASK-002: Bioequivalence of Bedaquiline 400mg Administered in Crushed Form Compared to Tablet Form in Healthy Male and Female Adults Under Fed Conditions (BDQ Crush Study)|TASK-002: Bioequivalence of Bedaquiline 400mg Administered in Crushed Form Compared to Tablet Form in Healthy Male and Female Adults Under Fed Conditions (BDQ Crush Study)|Completed||Early Phase 1|24|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group||2|||f||||f|f|f|||f|||||2017-10-10 21:25:39.431961|2017-10-10 21:25:39.431961
NCT03032354|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-07-06|||July 15, 2017|Anticipated|2017-07-15|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Probiotics in Newly Recognized Type 1 Diabetes|Effect of Lactobacillus Rhamnosus GG and Bifidobacterium Lactis BB 12 on Beta-cell Function in Children With Newly Diagnosed Type 1 Diabetes - a Randomized Controlled Trial|Not yet recruiting||Phase 4|96|Anticipated|Medical University of Warsaw||2|||f||||f|f|f||||||||2017-10-10 21:25:39.51769|2017-10-10 21:25:39.51769
NCT03032341|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-03-07|||January 17, 2017|Actual|2017-01-17|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MAT||Mobility Assessment Using Surrogates in Elderly Participants|Mobility Assessment Using Surrogates in Elderly Participants|Recruiting||N/A|120|Anticipated|Wake Forest University Health Sciences|||2||f||||f|f|f||||||No||2017-10-10 21:25:39.627734|2017-10-10 21:25:39.627734
NCT03032328|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-01-25|||June 2016||2016-06-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Vitamin D Deficiency and Dysautonomia|Comprehensive Assessment of Vascular and Autonomic Function in Children With Low Vitamin D|Recruiting||N/A|80|Anticipated|Wake Forest University Health Sciences||1|||f||||f||||||||No||2017-10-10 21:25:39.693778|2017-10-10 21:25:39.693778
NCT03032315|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||October 1, 2016|Actual|2016-10-01|January 2017|2017-01-01|December 27, 2016|Actual|2016-12-27|December 27, 2016|Actual|2016-12-27||Interventional|||Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers|Clinical Trial to Compare the Pharmacokinetics of TAH Tablet(80/10/12.5mg) in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers|Completed||Phase 1|44|Actual|IlDong Pharmaceutical Co Ltd||2|||f||||f|f|f||||||Undecided||2017-10-10 21:25:39.767469|2017-10-10 21:25:39.767469
NCT03032302|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-10-03|||October 1, 2017|Actual|2017-10-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Micronutrient Supplement Effects on Cognitive Outcomes in Post-Acute TBI|Micronutrient Intervention Effects on Cognitive Outcomes in Post-Acute Traumatic Brain Injury|Recruiting||N/A|60|Anticipated|Sheffield Hallam University||3|||f||||f|f|f||||||||2017-10-10 21:25:39.832945|2017-10-10 21:25:39.832945
NCT03032289|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-25|||January 1, 2010|Actual|2010-01-01|January 2017|2017-01-01|December 31, 2013|Actual|2013-12-31|December 31, 2013|Actual|2013-12-31|3 Years|Observational [Patient Registry]|||Association Between Active Transport and Acute Myocardial Infarction|Association Between Active Transport and Acute Myocardial Infarction: Cross Sectional Ecological Study Using National Registry and Census Data|Completed||N/A|100482|Actual|University of Leeds|||1||f|||||f|f||||||||2017-10-10 21:25:39.925404|2017-10-10 21:25:39.925404
NCT03032276|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-23|||July 2016||2016-07-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|SMPNS||Safe Motherhood Promotion and Newborn Survival|Impact and Operational Assessment of an Integrated Safe Motherhood and Newborn Health Promotion Package: a Community-based Cluster Randomized Controlled Trial|Active, not recruiting||N/A|50400|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f||||||||No||2017-10-10 21:25:39.987297|2017-10-10 21:25:39.987297
NCT03032263|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-23|||March 2016||2016-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Video vs. Direct Laryngoscopy in Pediatric Nasal Intubation|A Comparison of Direct Laryngoscopy and Video Laryngoscopy Using the C-Mac in Pediatric Nasal Intubations|Recruiting||N/A|70|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-10 21:25:40.074574|2017-10-10 21:25:40.074574
NCT03032250|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-16|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer|Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer Caregivers|Recruiting||N/A|40|Anticipated|Wake Forest University Health Sciences||1|||f||||t|f|f||||||||2017-10-10 21:25:40.152137|2017-10-10 21:25:40.152137
NCT03032237|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-21|||April 4, 2017|Actual|2017-04-04|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|ConsuMEER||Increase Protein Intake of Older Meal Service Clients With Readymade Protein-rich Meals and Foods|Testing the Effectiveness and Acceptance of Home-delivered Protein-rich Meals and Foods on the Intake of Community-dwelling Older Adults.|Completed||N/A|100|Actual|HAN University of Applied Sciences||2|||f||||f|f|f||||||||2017-10-10 21:25:40.26534|2017-10-10 21:25:40.26534
NCT03032224|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-02-23|||October 2005|Actual|2005-10-01|February 2017|2017-02-01|March 30, 2017|Anticipated|2017-03-30|November 2010|Actual|2010-11-01||Observational|||Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal Cancer|Analysis of Sarcopenia and Body Composition in Relation to Outcome in a Cohort of Patients With Esophageal Cancer or Cancer of the Gastroesophageal Junction Before and After Surgery With Curative Intent|Active, not recruiting||N/A|76|Actual|Vastra Gotaland Region|||1||f||||t||||||||No||2017-10-10 21:25:40.463562|2017-10-10 21:25:40.463562
NCT03032211|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-01-23|||December 31, 2017|Anticipated|2017-12-31|January 2017|2017-01-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|OPTIMALBALANCE||Optimal Balance Alfapump® System Feasibility Study|A Feasibility Clinical Study of Osmotic Pump Treatment in Fluid Management to Achieve Optimal Fluid Balance in NYHA Class III and Ambulatory NYHA Class IV Heart Failure Patients Who Have an Estimated Glomerular Filtration Rate of > 15 to < 60 mL/Min/1.73m2|Withdrawn||Phase 1|0|Actual|Sequana Medical AG||1||Change in company strategy|f||||t|f|t|t|f|f|||Undecided|Study cancelled, therefore not applicable at time of answering this remark.|2017-10-10 21:25:40.54499|2017-10-10 21:25:40.54499
NCT03032198|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-17|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"|"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"|Recruiting||N/A|110|Anticipated|Seno Medical Instruments Inc.||1|||f||||f|f|f||||||||2017-10-10 21:25:40.614684|2017-10-10 21:25:40.614684
NCT03032185|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-01-23|||January 2017||2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Postmenopausal Women|Evaluation of Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Autonomic and Psychophysical Parameters in Postmenopausal Women|Recruiting||Phase 1/Phase 2|30|Anticipated|Secretaria Municipal de Saúde de Rolante||2|||f||||t||||||||Yes||2017-10-10 21:25:40.703029|2017-10-10 21:25:40.703029
NCT03032172|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-09-05|||March 2, 2017|Actual|2017-03-02|September 2017|2017-09-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|Jewelfish||A Study of RO7034067 in Adult and Pediatric Participants With Spinal Muscular Atrophy|An Open-Label Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of RO7034067 in Adult and Pediatric Patients With Spinal Muscular Atrophy|Recruiting||Phase 2|24|Anticipated|Hoffmann-La Roche||1|||f||||t|t|f||||||||2017-10-10 21:25:40.785074|2017-10-10 21:25:40.785074
NCT03032159|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-01-23|||August 2015||2015-08-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|T2B||Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities|Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities|Enrolling by invitation||N/A|276|Anticipated|Seattle Children's Hospital||2|||f||||f||||||||No||2017-10-10 21:25:40.880116|2017-10-10 21:25:40.880116
NCT03032146|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-24|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of a Cardiac Rehabilitation Program on Active Participation in the Community and Exercise Habits|The Effect of a Cardiac Rehabilitation Program on Active Participation in the Community and Exercise Habits Six Months After a Coronary Event|Not yet recruiting||N/A|100|Anticipated|HaEmek Medical Center, Israel||2|||f||||f|f|f||||||No||2017-10-10 21:25:40.973361|2017-10-10 21:25:40.973361
NCT03032133|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-02-06|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pain Control After Total Knee Arthroplasty|Pain After Total Knee Arthroplasty With Either Regional or Local Pain Katheter|Recruiting||N/A|140|Anticipated|Technische Universität Dresden||2|||f||||f|f|f||||||No||2017-10-10 21:25:41.051702|2017-10-10 21:25:41.051702
NCT03032120|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-01|||July 2012||2012-07-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Postprandial Response of Fresh-squeezed and Processed Orange Juice of Lean and Obese Subjects|Postprandial Response of Fresh-squeezed and Processed Orange Juice on Appetite-related Biomarkers and Antioxidant-status in Lean and Obese Subjects|Completed||N/A|36|Actual|São Paulo State University||3|||f||||t||||||||No|There was no plan to share individual participant data (IPD) to other researchers.|2017-10-10 21:25:41.157558|2017-10-10 21:25:41.157558
NCT03032107|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-03-24|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|July 1, 2024|Anticipated|2024-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||A Study Of Pembrolizumab In Combination With Trastuzumab-DM1|A Phase 1b Study Of Pembrolizumab In Combination With Trastuzumab-DM1 In Metastatic HER2-Positive Breast Cancer|Recruiting||Phase 1|27|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 21:25:41.286851|2017-10-10 21:25:41.286851
NCT03032094|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-24|||October 2014||2014-10-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Connective Tissue Grafting for Single Tooth Recession & the Impact of the Thickness of the Palatal Harvest Tissue|Connective Tissue Grafting for Single Tooth Recession Defects & the Impact of the Thickness of the Palatal Harvest Tissue: A Pilot Study|Completed||N/A|42|Actual|Columbia University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:25:41.458685|2017-10-10 21:25:41.458685
NCT03032081|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-21|||March 2, 2017|Actual|2017-03-02|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||High Intensity Interval Training in Heart Failure|High Intensity Interval Training in Heart Failure: The Gold Standard of Future Patient Care|Withdrawn||N/A|0|Actual|Georgia State University||2||PI relocated, unable to complete the study. No replacement PI identified.|f||||t|f|f||||||||2017-10-10 21:25:41.569997|2017-10-10 21:25:41.569997
NCT03032068|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-22|||July 2016||2016-07-01|May 2017|2017-05-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|||Home Monitoring After Primary Total Knee Arthroplasty|Feasibility of Home Monitoring After Primary Total Knee Arthroplasty|Completed||N/A|10|Actual|The Cleveland Clinic||1|||f||||f||||||||No||2017-10-10 21:25:41.705147|2017-10-10 21:25:41.705147
NCT03032055|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-01-23|||January 2016||2016-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|Presev2||Validation of a Predictive Score of Acute Chest Syndrome|Validation of a Predictive Score of Acute Chest Syndrome|Recruiting||N/A|800|Anticipated|Soutien aux Actions contre les Maladies du Globule Rouge|||2||f||||t||||||Samples With DNA|"     serum and DNA in Africa   "|No||2017-10-10 21:25:41.840363|2017-10-10 21:25:41.840363
NCT03032042|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-23|||January 2017||2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Intestinal Microbiome Post-Azythromycin/Albendazole Treatment||Not yet recruiting||Phase 4|100|Anticipated|Francis I. Proctor Foundation||4|||f||||t||||||||||2017-10-10 21:25:41.965697|2017-10-10 21:25:41.965697
NCT03032016|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-01-24|||April 2015|Actual|2015-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||European VOD Registry|A Multi-centre, Multinational, Prospective Observational Registry to Collect Safety and Outcome Data in Patients Diagnosed With Severe Hepatic VOD Following Hematopoietic Stem Cell Transplantation (HSCT) and Treated With Defitelio® or Supportive Care (Control Group)|Recruiting||N/A|600|Anticipated|European Group for Blood and Marrow Transplantation|||2||f||||f||f||||||No||2017-10-10 21:25:42.223297|2017-10-10 21:25:42.223297
NCT03032003|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-23|||February 15, 2017|Anticipated|2017-02-15|January 2017|2017-01-01|May 31, 2018|Anticipated|2018-05-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Prophylactic Use of Cranberries in Recurrent Bacterial Cystitis in Women|Prophylactic Use of Cranberries in Recurrent Bacterial Cystitis in Women: A Randomized, Comparative, Study.|Not yet recruiting||N/A|160|Anticipated|University of Thessaly||2|||f|||||f|f||||||||2017-10-10 21:25:42.590136|2017-10-10 21:25:42.590136
NCT03031990|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-02-16|||January 2017||2017-01-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Stress and Fertility: How to Lower Stress When Trying to Conceive|Yoga and Infertility: The Impact of Yoga on Anxiety Reduction in Patients Undergoing in Vitro Fertilization or Elective Oocyte Freezing|Recruiting||N/A|300|Anticipated|Fertility Centers of Illinois||2|||f||||f||||||||No||2017-10-10 21:25:42.661433|2017-10-10 21:25:42.661433
NCT03031977|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-23|||September 2016||2016-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Visceral Mobilization and Functional Constipation in Stroke Survivors|Visceral Mobilization and Functional Constipation in Stroke Survivors: a Randomized, Controlled, Double-blind, Clinical Trial|Completed||N/A|30|Actual|University of Sorocaba||2|||f||||t||||||||||2017-10-10 21:25:42.777279|2017-10-10 21:25:42.777279
NCT03031964|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-03-24|||December 2016||2016-12-01|March 2017|2017-03-01|October 2028|Anticipated|2028-10-01|October 2026|Anticipated|2026-10-01||Observational|||Survivorship, Radiographic, and Functional Outcomes of the Multihole Revision Acetabular Cup|Survivorship, Clinical and Functional Outcomes of the Multihole Revision Acetabular Cup|Recruiting||N/A|180|Anticipated|The Cleveland Clinic|||1||f||||f||||||||No||2017-10-10 21:25:42.839808|2017-10-10 21:25:42.839808
NCT03031951|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-03-25|||September 2016||2016-09-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|Champ4Life||Lifestyle Intervention Program for Former Elite Athletes|Lifestyle Intervention Program for Former Elite Athletes|Recruiting||N/A|100|Anticipated|Faculdade de Motricidade Humana||2|||f||||f||||||||Undecided||2017-10-10 21:25:42.930938|2017-10-10 21:25:42.930938
NCT03031938|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-10-02|||October 31, 2017|Anticipated|2017-10-31|October 2017|2017-10-01|October 9, 2021|Anticipated|2021-10-09|April 12, 2021|Anticipated|2021-04-12||Interventional|||Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies|A Protocol To Monitor From Birth To Age 15 Months The Neurological Development Of Infants With Exposure In-utero In Tanezumab Clinical Studies At All Investigational Sites|Not yet recruiting||Phase 3|10|Anticipated|Pfizer||1|||f||||t|t|f||||||||2017-10-10 21:25:43.043979|2017-10-10 21:25:43.043979
NCT03031925|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-24|||January 31, 2017|Anticipated|2017-01-31|January 2017|2017-01-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|ANLUP||Detection of Annexin A2 in Systemic Lupus Erythematosus|Detection of Annexin A2 in Systemic Lupus Erythematosus|Not yet recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f|||||f|f||||||||2017-10-10 21:25:43.128662|2017-10-10 21:25:43.128662
NCT03031912|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-26|||June 30, 2017|Anticipated|2017-06-30|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola|A Phase 2 Randomized, Multi-Center Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of the V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine Candidate in HIV-Infected Adults and Adolescents|Not yet recruiting||Phase 2|200|Anticipated|Dalhousie University||4|||f||||t|f|f||||||No||2017-10-10 21:25:43.203935|2017-10-10 21:25:43.203935
NCT03031886|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-08-01|||January 20, 2016|Actual|2016-01-20|January 2017|2017-01-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||Energy Flux and Fat Oxidation Using Low and High Glycaemic Index Foods|Energy Flux and Fat Oxidation Using Low and High Glycaemic Index Foods|Completed||N/A|20|Actual|Clinical Nutrition Research Centre, Singapore||2|||f||||f|f|f||||||||2017-10-10 21:25:43.407598|2017-10-10 21:25:43.407598
NCT03031860|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-02-04|||September 2016||2016-09-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Observational|||Semi-quantitative Cough Strength Score (SCSS)|Semi-quantitative Cough Strength Score: Prediction of Extubation Outcome in Mechanically Ventilated Trauma Patients|Recruiting||N/A|60|Anticipated|Assiut University|||1||f||||f|f|f||||||Yes||2017-10-10 21:25:44.049549|2017-10-10 21:25:44.049549
NCT03031847|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-05-01|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Cardiac Resynchronization in the Elderly|Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy (Randomized Trial)|Recruiting||N/A|50|Anticipated|University of Pittsburgh||2|||f||||t|f|t|f|f||||No||2017-10-10 21:25:44.124672|2017-10-10 21:25:44.124672
NCT03031834|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-24|||January 1999||1999-01-01|January 2017|2017-01-01||||May 2001|Actual|2001-05-01||Interventional|||Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus|Efficacy of Administration of Angiotensin Converting Enzyme Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus|Completed||Phase 4|||Aristotle University Of Thessaloniki|||||f||||||||||||No||2017-10-10 21:25:44.219886|2017-10-10 21:25:44.219886
NCT03031821|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 1, 2023|Anticipated|2023-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|PRIME||Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome|A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The Prime Study|Not yet recruiting||Phase 3|300|Anticipated|Canadian Urologic Oncology Group||2|||f||||t|f|f||||||||2017-10-10 21:25:44.286275|2017-10-10 21:25:44.286275
NCT03031808|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-30|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant on Sore Throat and Hemodynamics|Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant; Impact on Postoperative Sore Throat and Haemodynamics|Not yet recruiting||Phase 4|100|Anticipated|Ostfold Hospital Trust||3|||f||||t||||||||No|No sharing plan so far.|2017-10-10 21:25:44.595471|2017-10-10 21:25:44.595471
NCT03031782|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-03|||June 6, 2017|Anticipated|2017-06-06|May 2017|2017-05-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2020|Anticipated|2020-12-30||Interventional|||Secukinumab Safety and Efficacy in JPsA and ERA|A Three-part Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Secukinumab Treatment in Juvenile Idiopathic Arthritis Subtypes of Psoriatic and Enthesitis-related Arthritis|Not yet recruiting||Phase 3|80|Anticipated|Novartis||2|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:25:44.804843|2017-10-10 21:25:44.804843
NCT03031769|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-09-29|||December 21, 2016|Actual|2016-12-21|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Observational|SPACE||Symptoms and Physical Activity in COPD Patients in Europe|Symptoms and Physical Activity in COPD Patients in Europe|Completed||N/A|2176|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 21:25:44.914534|2017-10-10 21:25:44.914534
NCT03031756|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-25|||January 2015||2015-01-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy of Glycine Powder Air-Polishing Combined With Scaling and Root Planing in the Treatment of Periodontitis and Halitosis|Efficacy of Glycine Powder Air-Polishing Combined With Scaling and Root Planing in the Treatment of Periodontitis and Halitosis: A Randomized Clinical Study|Completed||N/A|60|Actual|Near East University, Turkey||2|||f||||f||||||||No||2017-10-10 21:25:44.99669|2017-10-10 21:25:44.99669
NCT03031392|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-05-10|||July 1, 2016|Actual|2016-07-01|January 2017|2017-01-01|April 2, 2017|Actual|2017-04-02|April 1, 2017|Actual|2017-04-01||Observational|||Sensitivity and Specificity of Peri-Implantitis-Related Parameters|Sensitivity and Specificity of Peri-Implantitis-Related Parameters: A Case-Control Study|Completed||N/A|141|Actual|Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain|||2||f||||f|f|f||||||No||2017-10-10 21:25:47.833422|2017-10-10 21:25:47.833422
NCT03031743|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-01-23|||January 2014||2014-01-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Observational|||The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan|Nested Case-control Analysis of the Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan|Completed||N/A|88|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-10 21:25:45.09773|2017-10-10 21:25:45.09773
NCT03031730|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-25|2017-09-12|||October 27, 2017|Anticipated|2017-10-27|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||MDM2 Inhibitor AMG-232, Carfilzomib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase 1 Dose-Escalation and Exploratory Dose Expansion Study of AMG 232 in Combination With Carfilzomib, Lenalidomide, and Dexamethasone in Relapsed and/or Refractory Myeloma|Not yet recruiting||Phase 1|40|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:25:45.188507|2017-10-10 21:25:45.188507
NCT03031717|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-23|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|June 30, 2017|Anticipated|2017-06-30|April 30, 2017|Anticipated|2017-04-30||Observational|||Follow-up and Survival of Cirrhotic and Non Cirrhotic Patients With Portal Vein Thrombosis Treated With Transjugular Intrahepatic Portosystemic Shunt|Follow-up and Survival of Cirrhotic and Non Cirrhotic Patients With Portal Vein Thrombosis Treated With Transjugular Intrahepatic Portosystemic Shunt|Active, not recruiting||N/A|15|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||||||||||||2017-10-10 21:25:45.367339|2017-10-10 21:25:45.367339
NCT03031704|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-23|||January 9, 2017|Actual|2017-01-09|January 2017|2017-01-01|January 9, 2022|Anticipated|2022-01-09|January 9, 2021|Anticipated|2021-01-09|24 Months|Observational [Patient Registry]|MUCO-DUO||French Register of Duodenal Adenomas Characterization and Evaluation of Endoscopic Mucosectomy|French Register of Duodenal Adenomas Characterization and Evaluation of Endoscopic Mucosectomy|Recruiting||N/A|120|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f|f|f||||||No||2017-10-10 21:25:45.439312|2017-10-10 21:25:45.439312
NCT03031691|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-05-31|||January 2017||2017-01-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|May 2017|Actual|2017-05-01||Interventional|||A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer|A Phase 1b Dose Escalation Study of the Safety and Pharmacodynamics of Brontictuzumab in Combination With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer|Active, not recruiting||Phase 1|7|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 21:25:45.527192|2017-10-10 21:25:45.527192
NCT03031678|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-06-12|||December 2016||2016-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Electric-Acoustic Stimulation Extended Follow-up Post Approval Study|Office of Device Evaluation Lead-MED-EL EAS Extended f/u Study|Enrolling by invitation||N/A|68|Anticipated|Med-El Corporation||1|||f||||f|f|t|f|f||||||2017-10-10 21:25:45.62655|2017-10-10 21:25:45.62655
NCT03031665|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-05-01|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2021|Anticipated|2021-04-30||Observational|||Sex, Hormones and Gamma-Aminobutyric Acid (GABA) in Stress Induced Anhedonia in Depression|Sex, Hormones and GABA in Stress Induced Anhedonia in Depression|Recruiting||N/A|144|Anticipated|Mclean Hospital|||3||f||||f|f|f||||||No||2017-10-10 21:25:45.726286|2017-10-10 21:25:45.726286
NCT03031652|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-24|||March 1, 2016|Actual|2016-03-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|August 31, 2016|Actual|2016-08-31||Observational|||Clinical Analysis of Ocular Parameters Contributing to Intraoperative Pain During Standard Phacoemulsification|Clinical Analysis of Ocular Parameters Contributing to Intraoperative Pain During Standard Phacoemulsification|Completed||N/A|142|Actual|Kyungpook National University|||1||f||||f|f|f||||||No||2017-10-10 21:25:45.825539|2017-10-10 21:25:45.825539
NCT03031639|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-24|||January 13, 2017|Actual|2017-01-13|January 2017|2017-01-01|July 13, 2020|Anticipated|2020-07-13|January 13, 2020|Anticipated|2020-01-13|6 Months|Observational [Patient Registry]|||Khon Kaen University's Thyroidectomy Registry|Khon Kaen University's Thyroidectomy Registry|Recruiting||N/A|98|Anticipated|Khon Kaen University|||2||f||||f|f|f||||||No||2017-10-10 21:25:45.914214|2017-10-10 21:25:45.914214
NCT03031626|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-23|||September 1, 2016|Actual|2016-09-01|January 2017|2017-01-01|December 15, 2018|Anticipated|2018-12-15|September 1, 2018|Anticipated|2018-09-01||Interventional|||Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome|Comparison of Therapeutic Oxygen Versus Medical Air for the Treatment of Central Sleep Apnea in Infants and Children With Prader Willi Syndrome: A Proof of Concept Study|Recruiting||Phase 4|10|Anticipated|The Hospital for Sick Children||2|||f||||t|f|f||||||Undecided||2017-10-10 21:25:46.01824|2017-10-10 21:25:46.01824
NCT03031613|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of PEEP on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical Prostatectomy|Effects of Positive End Expiratory Pressure (PEEP) on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical Prostatectomy|Recruiting||N/A|50|Anticipated|Gangnam Severance Hospital||2|||f||||t||||||||No||2017-10-10 21:25:46.124422|2017-10-10 21:25:46.124422
NCT03031600|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-25|||May 1, 2017|Anticipated|2017-05-01|January 2017|2017-01-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||Pilot Validation of a Hemodilution Technique to Estimate Blood Volume in Vivo|Pilot Validation of a Hemodilution Technique to Estimate Blood Volume in Vivo|Not yet recruiting||N/A|33|Anticipated|Uniformed Services University of the Health Sciences||2|||f||||t|f|f||||||No||2017-10-10 21:25:46.209037|2017-10-10 21:25:46.209037
NCT03031587|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-23|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|VAIMTH-IRM||Validation of Thermometric Cardiac Imaging by MRI|Validation of Thermometric Cardiac Imaging by MRI|Not yet recruiting||N/A|100|Anticipated|University Hospital, Bordeaux||1|||f||||f|f|f||||||No||2017-10-10 21:25:46.290412|2017-10-10 21:25:46.290412
NCT03031574|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-09-21|||January 23, 2017|Actual|2017-01-23|September 2017|2017-09-01|September 7, 2017|Actual|2017-09-07|August 29, 2017|Actual|2017-08-29||Interventional|||A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-D4010 in Healthy Subjects|A Phase 1, Single-Center, Single-Dose, 2-Way Crossover, Randomized Food-Effect and Non-Randomized Gender- and Age- Effect Pharmacokinetic Study of SUVN-D4010 Orally Administered in Healthy Subjects|Completed||Phase 1|28|Actual|Suven Life Sciences Limited||3|||f||||t|t|f||||||||2017-10-10 21:25:46.380477|2017-10-10 21:25:46.380477
NCT03031561|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-09-05|||March 1, 2012|Actual|2012-03-01|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|August 6, 2015|Actual|2015-08-06||Interventional|||Ultrasound Imaging Technique in Detecting Breast Microcalcifications in Patients Undergoing Biopsy for a Breast Abnormality|Breast Microcalcifications Identified With MicroPure as a Marker for Malignancy Compared to Grayscale Ultrasound and Mammography (Using Biopsy as the Reference Standard)|Active, not recruiting||N/A|85|Actual|Thomas Jefferson University||1|||f||||f|f|f||||||||2017-10-10 21:25:46.458868|2017-10-10 21:25:46.458868
NCT03031548|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-04-13|||February 16, 2017|Actual|2017-02-16|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|POCUS||Intra-op POCUS for Identification of Endotracheal Tube Position in the Pediatric Population|Intraoperative Point-of Care Ultrasound for Identification of Endotracheal Tube Position in the Pediatric Population|Recruiting||N/A|100|Anticipated|Loma Linda University|||2||f||||f|f|f||||||No||2017-10-10 21:25:46.536719|2017-10-10 21:25:46.536719
NCT03031535|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-11|||January 2017||2017-01-01|January 2017|2017-01-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers|A Two-Part, Phase 1, Randomized, Crossover Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intranasal Octreotide (DP1038) Versus Subcutaneous Sandostatin® Injection in Healthy Adult Volunteers|Completed||Phase 1|32|Actual|Dauntless Pharmaceuticals||6|||f||||f||||||||No||2017-10-10 21:25:46.631916|2017-10-10 21:25:46.631916
NCT03031522|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-23|||November 2014|Actual|2014-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||EGFR Molecular Classification In Vivo|Molecular Imaging to Identify EGFR-TKIs Benefit Non-small Cell Lung Carcinoma Patients|Recruiting||N/A|100|Anticipated|Harbin Medical University||6|||f|||||f|f||||||Undecided||2017-10-10 21:25:46.735556|2017-10-10 21:25:46.735556
NCT03031509|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-06-02|||December 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells（hAECs）|Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells（hAECs）|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|Shanghai East Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:25:46.819674|2017-10-10 21:25:46.819674
NCT03031496|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-04-24|||March 17, 2017|Actual|2017-03-17|April 2017|2017-04-01|April 10, 2017|Actual|2017-04-10|April 10, 2017|Actual|2017-04-10||Interventional|||Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions|An Open-label, Randomized, Single-dose, Two-period Cross-over Study to Evaluate Bioequivalence of GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Fixed Dose Combination Tablets Versus Reference Product in Healthy Adult Participants Under Fasting Conditions|Completed||Phase 1|42|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 21:25:46.921278|2017-10-10 21:25:46.921278
NCT03031483|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-04-28|||April 3, 2017|Actual|2017-04-03|January 2017|2017-01-01|February 2029|Anticipated|2029-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma|A Phase II Trial Addressing Feasibility and Activity of Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma|Recruiting||Phase 2|68|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||f|f|f||||||||2017-10-10 21:25:47.026357|2017-10-10 21:25:47.026357
NCT03031470|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-01-23|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy and Safety Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Orthotopic Liver Transplantation Patients|A Multicenter, Open-label, Randomized Pilot Clinical Study of Efficacy and Safety of Reparixin for Prevention of Early Allograft Dysfunction in Patients Undergoing Orthotopic Liver Transplantation|Active, not recruiting||Phase 2|100|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||t||||||||||2017-10-10 21:25:47.166976|2017-10-10 21:25:47.166976
NCT03031457|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-04-25|||January 30, 2017|Actual|2017-01-30|April 2017|2017-04-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||Microsurgical Breast Reconstruction & VTE|Microsurgical Breast Reconstruction - Identifying Procedure-Specific Risk Factors for Venous Thromboembolism|Recruiting||N/A|74|Anticipated|Stanford University|||2||f||||f|f|f||||||No||2017-10-10 21:25:47.280513|2017-10-10 21:25:47.280513
NCT03031444|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2017-01-23|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PARECEC||Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis|A Multicenter Study of Prognosis and the Efficacy Comparison of Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Patients(Clinical Risk Score≥3) of Resectable Colorectal Liver Metastasis|Recruiting||Phase 2/Phase 3|154|Anticipated|Beijing Cancer Hospital||2|||f||||f||||||||No||2017-10-10 21:25:47.394049|2017-10-10 21:25:47.394049
NCT03031431|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-07-25|||July 2016||2016-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Electricity-free Infant Warmer for Newborn Thermoregulation in Rwanda|Electricity-free Infant Warmer for Newborn Thermoregulation in Rwanda|Recruiting||N/A|204|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-10 21:25:47.524689|2017-10-10 21:25:47.524689
NCT03031418|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-22|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|November 1, 2017|Anticipated|2017-11-01||Observational|||Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)|Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study Including Impact on Decision-making and Health Economics.|Recruiting||N/A|1000|Anticipated|Exosome Diagnostics, Inc.|||2||f|||||f|f||||Samples Without DNA|"     Random first catch urine sample > 20mL   "|Undecided||2017-10-10 21:25:47.648223|2017-10-10 21:25:47.648223
NCT03031405|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-23|||January 15, 2017|Actual|2017-01-15|January 2017|2017-01-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||The Effect of Oxytocin on the Acquisition and Consolidation of Trauma-Associated Memories|The Effect of Oxytocin on the Acquisition and Consolidation of Trauma-Associated Memories: A Model to Understand the Development of Posttraumatic Stress Disorder|Recruiting||N/A|130|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 21:25:47.749207|2017-10-10 21:25:47.749207
NCT03031366|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-05-01|||February 13, 2017|Actual|2017-02-13|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Novel Approach for Transjugular Intrahepatic Portocaval Shunt Creation Using Real-time Three Dimensional Roadmap|A Novel Approach for Transjugular Intrahepatic Portocaval Shunt Creation Using Real-time Three Dimensional Roadmap|Recruiting||N/A|15|Anticipated|West China Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:25:47.994779|2017-10-10 21:25:47.994779
NCT03031353|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2017-09-14|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Misoprostol Before Elective Caesarean Section for Decreasing the Neonatal Respiratory Morbidity|Misoprostol Before Elective Caesarean Section for Decreasing the Neonatal Respiratory Morbidity: A Randomized Controlled Trial|Recruiting||N/A|170|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 21:25:48.07789|2017-10-10 21:25:48.07789
NCT03031340|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-01-24|||May 2012||2012-05-01|May 2012|2012-05-01||||September 2012|Actual|2012-09-01||Interventional|||Double Blinded, Randomized, Placebo Controlled Study in Evaluating the Role of Pregabalin in Reducing Opioid Requirement in Spinal Fusion Surgeries of Two or More Vertebrae|Double Blinded, Randomized, Placebo Controlled Study in Evaluating the Role of Pregabalin in Reducing Opioid Requirement in Spinal Fusion Surgeries of Two or More Vertebrae|Terminated||Phase 3|3|Actual|Montefiore Medical Center||2||Incidence of AE|f||||t||||||||||2017-10-10 21:25:48.195293|2017-10-10 21:25:48.195293
NCT03031327|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-02-06|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A 2 Weeks Study to Evaluate Tolerability, Safety, Permanence on the Ocular Surface and Efficacy of Two Concentrations of Lubricin Eye Drops Versus Sodium Hyaluronate 0.18% Eye Drops in Patients With Ocular Discomfort Following Refractive Surgery|A 2 Week, Randomized, Double-masked, Controlled, Parallel Group Study to Evaluate Tolerability, Safety, Permanence on the Ocular Surface and Efficacy of Two Concentrations of Lubricin (20 and 50 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients With Ocular Discomfort Following Refractive Surgery|Not yet recruiting||N/A|30|Anticipated|Dompé Farmaceutici S.p.A||3|||f||||f|f|f||||||No||2017-10-10 21:25:48.278577|2017-10-10 21:25:48.278577
NCT03031314|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-27|||October 2014|Actual|2014-10-01|January 2017|2017-01-01|January 1, 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of Knotless Barbed Suture and Standard Suture in Knee Replacement Patients||Completed||N/A|1000|Actual|Washington Hospital Healthcare System||2|||f||||||||||||||2017-10-10 21:25:48.408523|2017-10-10 21:25:48.408523
NCT03031301|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-05-29|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week|A Prospective, Multicenter, Randomized, Double-blind, Sham-controlled Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week|Recruiting||N/A|190|Anticipated|Vibrant Ltd.||2|||f||||t|f|t|t|f|f|||Undecided||2017-10-10 21:25:48.677779|2017-10-10 21:25:48.677779
NCT03031288|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-06|||January 1, 2017||2017-01-01|September 2017|2017-09-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|FeedGERD||Effects of Vented Base Feeding Bottle in Preterm Infants With GERD Symptoms.|Vented Base Feeding Bottle in Preterm Infants With GERD Symptoms: Effects on Respiration-swallow Patterns and Reflux.|Recruiting||N/A|30|Anticipated|University of Turin, Italy||2|||f||||t||||||||||2017-10-10 21:25:48.809744|2017-10-10 21:25:48.809744
NCT03031275|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-22|||January 2014||2014-01-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Interventional|||Long-term Follow Up of Adult Patients Treated With Extracorporeal Membrane Oxygenation for Respiratory Failure||Completed||N/A|31|Actual|Karolinska University Hospital||1|||f||||||||||||||2017-10-10 21:25:48.960697|2017-10-10 21:25:48.960697
NCT03031262|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-23|||February 8, 2017|Actual|2017-02-08|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Efficacy and Safety of Chidamide in CBF Leukemia|Efficacy and Safety of Chidamide in CBF Leukemia|Recruiting||Phase 1/Phase 2|250|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:25:49.113282|2017-10-10 21:25:49.113282
NCT03031249|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-23|||February 8, 2017|Actual|2017-02-08|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia|Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|250|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:25:49.257867|2017-10-10 21:25:49.257867
NCT03031236|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-01-22|||May 2015||2015-05-01|November 2016|2016-11-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Reduce Childhood Maltreatment and Promote Development|Effect of Integrated Management of Childhood Maltreatment, Maternal Depression, Psychosocial Stimulation and Nutritional Intervention on Child Development - A Randomized Controlled Trial|Completed||N/A|306|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f||||||||No||2017-10-10 21:25:49.431487|2017-10-10 21:25:49.431487
NCT03031223|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-01-21|||August 2016||2016-08-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|January 2017|Actual|2017-01-01||Interventional|||Evaluation of Sensory-motor Response to Low-level Laser Therapy for the Treatment of Spinal Injuries|Evaluation of Sensory-motor Response to Low-level Laser Therapy for the Treatment of Spinal Injuries - Protocol for a Randomized, Controlled, Clinical Trial|Recruiting||N/A|30|Anticipated|University of Nove de Julho||2|||f||||t||||||||Undecided||2017-10-10 21:25:49.631394|2017-10-10 21:25:49.631394
NCT03031210|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-06-11|||June 11, 2017|Actual|2017-06-11|June 2017|2017-06-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.|Treatment of Non-severe Community Acquired Pneumonia With Twice Daily Compared to Thrice Daily Regimen- A Non-inferiority Pragmatic Randomized-controlled Trial.|Recruiting||Phase 2/Phase 3|1370|Anticipated|St. Justine's Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:25:49.792901|2017-10-10 21:25:49.792901
NCT03031197|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-04-24|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SAAV||Supporting Adolescent Adherence in Vietnam (SAAV)|The Supporting Adolescent Adherence in Vietnam (SAAV) Study|Not yet recruiting||N/A|80|Anticipated|University of New England||2|||f||||f|f|t|f|f|t|||Undecided|Undecided.|2017-10-10 21:25:49.979711|2017-10-10 21:25:49.979711
NCT03031184|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-05-02|||January 2017||2017-01-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|SYMBAD||Study of Mirtazapine or Carbamazepine for Agitation in Dementia|A Pragmatic, Multi Centre, Double-blind, Placebo Controlled Randomised Trial to Assess the Safety, Clinical and Cost Effectiveness of Mirtazapine or Carbamazepine in Patients With Alzheimer's Disease (AD) and Agitated Behaviours|Recruiting||Phase 3|471|Anticipated|University of Sussex||3|||f||||t||||||||Undecided|No plans to routinely disseminate this data. The Trial Management Group (and in future, the funder) may consider individual requests made in writing.|2017-10-10 21:25:50.115757|2017-10-10 21:25:50.115757
NCT03031171|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-01-21|||April 2010||2010-04-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Community Engaged Colon Cancer Screening Patient Navigator Program|Community Engaged Colon Cancer Screening Patient Navigator Program|Completed||N/A|415|Actual|University of Nevada, Reno||2|||f||||f|f|f||||||No||2017-10-10 21:25:50.268049|2017-10-10 21:25:50.268049
NCT03031158|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-05-01|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Hip-spine Intervention for Older Adults With Chronic Low Back Pain|Pilot Trial of a Hip-spine Intervention for Older Adults With a Primary Complaint of Low Back Pain|Recruiting||N/A|24|Anticipated|University of Delaware||2|||f||||f|f|f||||||No||2017-10-10 21:25:50.395579|2017-10-10 21:25:50.395579
NCT03031145|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-09-22|||April 3, 2017|Actual|2017-04-03|September 2017|2017-09-01|February 15, 2021|Anticipated|2021-02-15|February 15, 2021|Anticipated|2021-02-15||Interventional|Kitty Nose||Investigation of the Impact of Smoking Status on Allergen-induced Nasal Airway Inflammation Using a Cat Hair (Felis Domesticus) Extract Nasal Allergen Challenge Model|Investigation of the Impact of Smoking Status on Allergen-induced Nasal Airway Inflammation Using a Cat Hair (Felis Domesticus) Extract Nasal Allergen Challenge Model|Recruiting||Phase 1|45|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f|t|f||||||||2017-10-10 21:25:50.497461|2017-10-10 21:25:50.497461
NCT03031132|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-17|||June 2016||2016-06-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of a High Protein Breakfast on Appetite and Sleep in Young Adults|The Effects of a High Protein Breakfast on Appetite and Sleep in Young Adults|Suspended||N/A|13|Actual|Purdue University||3||Transferring study to another University|f||||t||||||||No||2017-10-10 21:25:50.621472|2017-10-10 21:25:50.621472
NCT03031119|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-09-05|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Multiple Ascending Dose and DDI Study|A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess Safety, Tolerability, And Pharmacokinetics Of Multiple Oral Doses Of Pf-06835919 In Healthy Adult Subjects (Part A); And An Open-label Study To Assess Multiple Oral Doses Of Pf-06835919 On Atorvastatin Pharmacokinetics (Part B)|Completed||Phase 1|62|Actual|Pfizer||3|||f||||f|f|f||||||||2017-10-10 21:25:50.794497|2017-10-10 21:25:50.794497
NCT03031106|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-05-03|||January 2017||2017-01-01|May 2017|2017-05-01||||July 2018|Anticipated|2018-07-01||Observational|||Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease|Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease; Focus on the Patient's Preferences and Life Situation|Recruiting||N/A|300|Anticipated|Aalborg Universitetshospital|||1||f||||f||||||||Undecided||2017-10-10 21:25:50.968775|2017-10-10 21:25:50.968775
NCT03031093|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-06-13|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Aerosol Therapy in Obese COPD Patients.|Aerosol Therapy With Positive Expiratory Pressure (PEP Valve) in Obese COPD Patients. Aerosol Deposition Pattern and Predictive Values.|Recruiting||N/A|60|Anticipated|Universidade Federal do Rio Grande do Norte||8|||f||||t|f|f||||||Yes|The final papers might be submitted together with individual data, in order to improve the evaluation process from the journal editors. Although, there will not be personal identifications. No name, photos, or any other kind of identification will be allowed in this data base.|2017-10-10 21:25:51.075066|2017-10-10 21:25:51.075066
NCT03031080|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-23|||March 1, 2017|Anticipated|2017-03-01|January 2017|2017-01-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|BOND||BOND Study: the Benefit Of Night Splinting in Dupuytrens'|The Effectiveness of Night Splinting After Collagenase Injection for Dupuytren's Contracture|Not yet recruiting||N/A|60|Anticipated|Royal Liverpool and Broadgreen University Hospitals NHS Trust||2|||f||||f|f|f||||||No||2017-10-10 21:25:51.1922|2017-10-10 21:25:51.1922
NCT03031067|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-21|||October 2016||2016-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|PIO||Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Marginal Graft|Comparison Between Hypothermic Oxygenated Perfusion and Static Cold Storage of Organ From Extended Criteria Donors|Recruiting||N/A|20|Anticipated|University of Bologna||4|||f||||t||||||||Yes|Individual participant data will be performed by application of a single code.|2017-10-10 21:25:51.281818|2017-10-10 21:25:51.281818
NCT03031054|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-03-01|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||The Effect of Hyaluronic Acid for Carpal Tunnel Syndrome|The Effect of Hyaluronic Acid in Patients With Carpal Tunnel Syndrome|Recruiting||N/A|60|Anticipated|Tri-Service General Hospital||2|||f||||t|f|f|||f|||Yes||2017-10-10 21:25:51.451963|2017-10-10 21:25:51.451963
NCT03031041|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-04-25|||January 25, 2017|Actual|2017-01-25|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Comparison of Difference Hydrodissection for CTS|Comparison of Difference Hydrodissection Technique in Patients With Carpal Tunnel Syndrome|Recruiting||N/A|40|Anticipated|Tri-Service General Hospital||2|||f||||t|f|f||||||Yes||2017-10-10 21:25:51.5493|2017-10-10 21:25:51.5493
NCT03031028|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-01-21|||July 2016||2016-07-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.|The Study of Outpatient Ketogenic Diet on Seizure Rate, Nutritional Status and Some Biochemical Factors in Children and Adolescent With Refractory Epilepsy.|Recruiting||Phase 2|30|Anticipated|Tehran University of Medical Sciences||1|||f||||t||||||||Undecided||2017-10-10 21:25:51.635103|2017-10-10 21:25:51.635103
NCT03031015|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-21|||January 1, 2011|Actual|2011-01-01|January 2017|2017-01-01|May 1, 2014|Actual|2014-05-01|May 1, 2014|Actual|2014-05-01||Interventional|CKFPFF||Cemented K-wire Fixation vs Plating for Finger Fractures|Randomized Comparison of Cemented K-wire Fixation and Plating of Shaft Fractures of Proximal Phalanges|Completed||N/A|131|Actual|The Second Hospital of Qinhuangdao||2|||f||||t|f|f||||||No|No plan to share the IPD data.|2017-10-10 21:25:51.719135|2017-10-10 21:25:51.719135
NCT03030989|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-26|||January 2017||2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients|A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients|Recruiting||Phase 2|200|Anticipated|University of Chicago||2|||f||||f|t|f||||||Undecided||2017-10-10 21:25:51.877929|2017-10-10 21:25:51.877929
NCT03030976|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-04|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)|An Open-labeled, Uncontrolled, Single-arm Pilot Study to Evaluate Cellular Immunotherapy Using CD19-targeted Chimeric Antigen Receptor Engineered T Cells in Patients With CD19+ B Cell Systemic Lupus Erythematosus (SLE)|Recruiting||Phase 1|5|Anticipated|Shanghai GeneChem Co., Ltd.||2|||f||||f|f|f||||||Undecided||2017-10-10 21:25:51.95448|2017-10-10 21:25:51.95448
NCT03030963|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-03-06|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Equal Ratio Ventilation on Blood Loss During Posterior Lumbar Interbody Fusion Surgery|Effect of Equal Ratio Ventilation on Blood Loss During Posterior Lumbar Interbody Fusion Surgery: A Randomized Controlled Trial|Recruiting||N/A|32|Anticipated|Gangnam Severance Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:25:52.035428|2017-10-10 21:25:52.035428
NCT03030950|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-04-20|||March 25, 2017|Actual|2017-03-25|April 2017|2017-04-01|November 1, 2017|Anticipated|2017-11-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Perineural Dexmedetomidine in Adductor Canal Block|Effects of Peri-neural Dexmedetomidine on the Pharmacodynamic Profile of Bupivacaine-induced Adductor Canal Block in Patients Undergoing Arthroscopic Medial Meniscectomy|Recruiting||Phase 4|16|Anticipated|Cairo University||2|||f||||f|f|f||||||No||2017-10-10 21:25:52.120099|2017-10-10 21:25:52.120099
NCT03030937|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-22|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|December 30, 2018|Anticipated|2018-12-30|July 31, 2018|Anticipated|2018-07-31||Interventional|||Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA|A Randomized, Parallel Control, Exploratory Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in Subjects With Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction|Not yet recruiting||Phase 2|74|Anticipated|Fujian Cancer Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:25:52.205271|2017-10-10 21:25:52.205271
NCT03030924|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-09-19|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|July 3, 2019|Anticipated|2019-07-03|July 3, 2019|Anticipated|2019-07-03||Observational|||Wearable Suicidal Early Warning System for Adolescents|Physiologic Parameters for Monitoring Adolescent Suicidality|Recruiting||N/A|100|Anticipated|Oregon Health and Science University|||1||f||||t|f|f||||||||2017-10-10 21:25:52.325852|2017-10-10 21:25:52.325852
NCT03030911|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-07|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Dexmedetomidine vs Midazolam on Resting Energy Expenditure in Critically Ill Patients|The Effect of Dexmedetomidine vs Midazolam on Resting Energy Expenditure in Critically Ill Patients: Randomized Controlled Study|Recruiting||Phase 4|30|Anticipated|Cairo University||2|||f||||f|f|f||||||||2017-10-10 21:25:52.401304|2017-10-10 21:25:52.401304
NCT03030898|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-21|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|December 28, 2017|Anticipated|2017-12-28|April 25, 2017|Anticipated|2017-04-25||Interventional|||Analysis of Respiratory Variations of the Right Internal Jugular Vein as a Predictor of Fluid Responsiveness During Mechanical Ventilation|Analysis of Respiratory Variations of the Internal Jugular Vein as a Predictor of Fluid Responsiveness During Mechanical Ventilation|Active, not recruiting||N/A|50|Actual|Military Hospital of Tunis||1|||f|||||f|f||||||||2017-10-10 21:25:52.500678|2017-10-10 21:25:52.500678
NCT03030885|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-04-19|||January 19, 2017|Actual|2017-01-19|April 2017|2017-04-01|January 19, 2020|Anticipated|2020-01-19|January 19, 2020|Anticipated|2020-01-19||Interventional|||Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)|A Phase 1, Open-Label, Dose Ascending Study to Evaluate the Safety and Tolerability of the Therapeutic Radiopharmaceutical 131I-MIP-1095 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)|Recruiting||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f|||||t|f||||||||2017-10-10 21:25:52.57327|2017-10-10 21:25:52.57327
NCT03030859|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-22|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis|Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis|Not yet recruiting||N/A|98|Anticipated|Vanderbilt-Ingram Cancer Center||3|||f||||t||||||||Undecided||2017-10-10 21:25:52.713124|2017-10-10 21:25:52.713124
NCT03030846|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-20|||September 2015||2015-09-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Investigation the Effects of Stabilization Exercises on Pain, Disability and Activity of Pelvic Floor Muscles in Patients With Postpartum Lumbopelvic Pain|Zahra Teymuri, Zahedan University of Medical Sciences|Completed||N/A|36|Actual|Zahedan University of Medical Sciences||2|||f||||f||||||||No||2017-10-10 21:25:52.796526|2017-10-10 21:25:52.796526
NCT03030833|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-08-31|||February 6, 2017|Actual|2017-02-06|January 2017|2017-01-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Observational|||Dysfunctional Hemoglobin Pulse Oximetry|Dysfunctional Hemoglobin Pulse Oximeter|Completed||N/A|36|Actual|Nonin Medical, Inc|||1||f||||f|f|t|f||t|||||2017-10-10 21:25:52.887716|2017-10-10 21:25:52.887716
NCT03030820|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-14|||October 2016||2016-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Oral Gut Liver Axis in Cirrhosis|Oral Gut Liver Axis in Cirrhosis|Recruiting||N/A|60|Anticipated|Virginia Commonwealth University||1|||f||||f||||||||||2017-10-10 21:25:52.950574|2017-10-10 21:25:52.950574
NCT03030794|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-04-04|||December 2016||2016-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Alleviating Headache and Pain in GWI With Neuronavigation Guided rTMS|Alleviating Headache and Pain in GWI With Neuronavigation Guided rTMS|Recruiting||N/A|90|Anticipated|Veterans Medical Research Foundation||2|||f||||t||||||||No||2017-10-10 21:25:54.760766|2017-10-10 21:25:54.760766
NCT03030781|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-01-21|||August 2016||2016-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging.|Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging.|Completed||N/A|35|Actual|King Fahad Medical City|||1||f||||f||||||||No||2017-10-10 21:25:54.89318|2017-10-10 21:25:54.89318
NCT03030768|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-20|||February 2016||2016-02-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Observational|SCIP||Safer Conception Intervention for HIV-1 Serodiscordant Couples|Pilot of an mHealth-enhanced, Safer Conception Intervention to Reduce HIV-1 Risk Among Kenyan HIV-1 Serodiscordant Couples|Recruiting||N/A|80|Anticipated|University of Washington|||1||f||||f||||||Samples Without DNA|"     Plasma   "|Yes|De-identified individual participant data for all outcome measures will be made available after study completion|2017-10-10 21:25:54.945256|2017-10-10 21:25:54.945256
NCT03030755|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-22|||May 2016||2016-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Corneal Elastography and Patient Specific Modeling|Corneal Elastography and Patient Specific Modeling|Recruiting||N/A|60|Anticipated|The Cleveland Clinic|||1||f||||f||||||||No||2017-10-10 21:25:55.075416|2017-10-10 21:25:55.075416
NCT03030742|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-07-14|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|||Postpartum Opioid Prescribing Patterns and Patient Utilization|Postpartum Opioid Prescribing Patterns and Patient Utilization|Recruiting||N/A|700|Anticipated|Northwestern University|||2||f||||t|f|f||||||||2017-10-10 21:25:55.156579|2017-10-10 21:25:55.156579
NCT03030729|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-24||||||January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Observational|||Macular Thickness Measurements Using Retinal-thickness OCT|Macular Thickness Measurements Using RTOCT|Not yet recruiting||N/A|160|Anticipated|Notal Vision Ltd|||4||f||||f||||||||||2017-10-10 21:25:55.260661|2017-10-10 21:25:55.260661
NCT03030716|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-24|||June 25, 2016|Actual|2016-06-25|January 2017|2017-01-01|December 10, 2016|Actual|2016-12-10|December 10, 2016|Actual|2016-12-10||Interventional|||Multiple Daily Condensed Tannin Supplementation and Iron Bioavailability: The Tannin Dose Response Trial|Long-term, Multiple Daily Condensed Tannin Supplementation in Increasing Concentrations Does Not Affect Iron Status or Bioavailability: Results From the Tannin-dose Response Trial.|Completed||N/A|11|Actual|Kansas State University||3|||f||||f|f|f||||||No||2017-10-10 21:25:55.322221|2017-10-10 21:25:55.322221
NCT03030703|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-01-24|||November 11, 2016|Actual|2016-11-11|January 2017|2017-01-01|December 10, 2016|Actual|2016-12-10|December 10, 2016|Actual|2016-12-10||Interventional|||Cystatin SN Binds to Phytic Acid and Predicts Non-heme Iron Bioavailability|Salivary Cystatin SN Binds to Phytic Acid and is a Predictor of Non-heme Iron Bioavailability With Phytic Acid Supplementation|Completed||N/A|7|Actual|Kansas State University||1|||f||||f|f|f||||||No||2017-10-10 21:25:55.39799|2017-10-10 21:25:55.39799
NCT03030690|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-01-21|||November 2016||2016-11-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Clinical Assessment of Glass Carbomer Cement|A Clinical Assessment of Class II Glass Carbomer Cement Restorations Compared to Resin Modified Glass Ionomer Cement and Composite Resin Restorations in Primary Molars.|Enrolling by invitation||N/A|150|Anticipated|King Abdulaziz University||3|||f||||f||||||||No||2017-10-10 21:25:55.482511|2017-10-10 21:25:55.482511
NCT03030677|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-24|||November 2016||2016-11-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|ETCI||Establishing Technique for PECS2 Catheter Insertion|Establishing Technique for PECS Type 2 (Serratus Block) Catheter Insertion With Ultrasound Guidence|Active, not recruiting||N/A|40|Anticipated|Kasr El Aini Hospital||2|||f||||t||||||||||2017-10-10 21:25:55.574754|2017-10-10 21:25:55.574754
NCT03030664|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-07-28|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|BIOWELL||Effect of L. Reuteri on Bowel Movements in Children (BIOWELL Study)|Randomised Controlled Trial With Two Parallel Arms Testing the Effect of L. Reuteri on Bowel Movements in Children Aged 6 Months to 4 Years|Recruiting||N/A|58|Anticipated|Centre Hospitalier Intercommunal Creteil||2|||f||||f|f|f||||||||2017-10-10 21:25:55.770409|2017-10-10 21:25:55.770409
NCT03030651|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-07-12|||May 8, 2017|Actual|2017-05-08|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|April 15, 2018|Anticipated|2018-04-15||Interventional|||Effect of Breastfeeding Education and Support Intervention on Timely Initiation and Exclusive Breastfeeding|Effect of Breastfeeding Education and Support Intervention on Timely Initiation and Exclusive Breastfeeding in Southwest Ethiopia: a Cluster Randomized Controlled Trial.|Recruiting||N/A|432|Anticipated|Jimma University||2|||f||||f|f|f||||||||2017-10-10 21:25:55.905481|2017-10-10 21:25:55.905481
NCT03030638|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-10-03|||February 1, 2017|Actual|2017-02-01|October 2017|2017-10-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Drug Utilization Study for Olodaterol|Drug Utilization Study for Olodaterol|Recruiting||N/A|20000|Anticipated|Boehringer Ingelheim|||2||f||||f|f|f||||||||2017-10-10 21:25:56.007216|2017-10-10 21:25:56.007216
NCT03030625|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-21|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|CaP-VMAT-DIL||VMAT for Dominant Intraprostatic Lesion|Dose Intensification With a Focal Boost to Dominant Intraprostatic Lesion Using Volumetric Modulated Arc Therapy /Image Guided Radiotherapy in Patients With Localized Prostate Cancer|Not yet recruiting||N/A|27|Anticipated|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa||1|||f||||f|f|f||||||No||2017-10-10 21:25:56.115246|2017-10-10 21:25:56.115246
NCT03030612|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-08-22|||December 2016||2016-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||ARGX-110 With AZA in AML or High Risk MDS|A Phase I/II, Open-label, Dose-Escalating Study With a Proof of Concept Cohort to Evaluate the Safety, Tolerability and Efficacy of ARGX-110 in Combination With Azacytidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)|Recruiting||Phase 1/Phase 2|36|Anticipated|arGEN-X BVBA||1|||f||||t||||||||||2017-10-10 21:25:56.221438|2017-10-10 21:25:56.221438
NCT03030599|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-10-03|||January 2017||2017-01-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy|A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy|Recruiting||Phase 3|130|Anticipated|Jazz Pharmaceuticals||2|||f||||f||||||||||2017-10-10 21:25:56.313477|2017-10-10 21:25:56.313477
NCT03030586|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-23|2017-04-13|||November 2016||2016-11-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|ADDIA||ADDIA Proof-of-Performance Clinical Study|A Multi-centre Proof-of-performance Clinical Study to Validate Blood-based Biomarker Candidates for the Diagnosis of Alzheimer's Disease|Recruiting||N/A|800|Anticipated|Amoneta Diagnostics SAS|||3||f||||||||||Samples With DNA|"     Blood   "|No||2017-10-10 21:25:56.520531|2017-10-10 21:25:56.520531
NCT03030573|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2017-02-05|||November 2015||2015-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Reconstruction of the Bile Duct With the Round Ligament|Reconstruction of Postcholecystectomy Bile Duct Injury and Bile Duct Defects With the Round Ligament|Recruiting||N/A|20|Anticipated|Beaujon Hospital||1|||f||||t||||||||No||2017-10-10 21:25:56.628717|2017-10-10 21:25:56.628717
NCT03030560|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-22|2017-02-10|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|Lidocaine||Postoperative Analgesia, Intravenous Lidocaine Infusion|Analgesic Consumption and Serum Cortisol Level After Spinal Fusion Surgery in Patients Receiving Intraoperative Lidocaine Intravenous Infusion: Double Blind Randomized Study|Completed||Phase 2|40|Actual|Assiut University||2|||f||||f|t|f|||f|||Yes||2017-10-10 21:25:56.702496|2017-10-10 21:25:56.702496
NCT03030547|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-21|||March 2016||2016-03-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Identification of Factors Associated With Physical Activity Levels in Adult Muscle Diseases|Erişkin Kas hastalıklarında Fiziksel Aktivite Ile ilişkili faktörlerin Belirlenmesi|Recruiting||N/A|80|Anticipated|Hacettepe University||2|||f||||f||||||||No||2017-10-10 21:25:56.779596|2017-10-10 21:25:56.779596
NCT03030534|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-22|||October 2016||2016-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|January 2017|Actual|2017-01-01||Interventional|||Research Protocol On Developing an Integrated Technology-Moderated Institutional Health Promotion Model|Research Protocol On Developing an Integrated Technology-Moderated Institutional Health Promotion Model (ITIHPM)for Use in Nigeria Universities|Active, not recruiting||N/A|69|Anticipated|University of KwaZulu||2|||f||||t||||||||Undecided|All data that will be beneficial to other researchers will be sheared through journal publication and workshops. No identifying data will be published.|2017-10-10 21:25:56.87245|2017-10-10 21:25:56.87245
NCT03030521|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-24|||January 30, 2017|Actual|2017-01-30|February 2017|2017-02-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Observational|||The Roles of Intraluminal Pressure and the Dilation of Tunica Media in the Development of Aortic Dissection|The Roles of Intraluminal Pressure and the Dilation of Tunica Media in the Development of Aortic Dissection|Completed||N/A|8|Actual|Wuhan Asia Heart Hospital|||2||f||||t||||||||No|The investigators will not share participant data with other researchers.|2017-10-10 21:25:56.95828|2017-10-10 21:25:56.95828
NCT03030508|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-22|||January 2016||2016-01-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Observational|||Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients|Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients|Enrolling by invitation||N/A|300|Anticipated|Shanghai Changzheng Hospital|||1||f||||t|f|f||||Samples With DNA|"     tissue,blood,urine and stool sample   "|No||2017-10-10 21:25:57.027455|2017-10-10 21:25:57.027455
NCT03030495|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-22|||December 2016||2016-12-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|IMPACT-FFR||Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR|IMaging and Physiologic Predictors of Atherosclerotic Progression in Deferred Lesions With Contemporary Medical Treatment Based on Fractional Flow Reserve-guided Strategy|Recruiting||N/A|1400|Anticipated|Samsung Medical Center|||2||f||||t||||||||Yes|After publication of first manuscript and trial results, the de-identified data will be shared by permission of principle investigator, when asked|2017-10-10 21:25:57.115163|2017-10-10 21:25:57.115163
NCT03030482|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-21|2017-01-24|||February 1, 2017||2017-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|REaLAX||Evaluation of Touch Massage on Anxiety in Critically Ill Patients|Evaluation of Touch Massage on Anxiety in Critically Ill Patients : a Randomised Controlled Trial Study (REaLAX)|Not yet recruiting||N/A|70|Anticipated|Versailles Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:25:57.343151|2017-10-10 21:25:57.343151
NCT03030469|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-29|||December 2016||2016-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Electronic Defaults to Reduce Opioid Prescribing in Dentistry Practices|A Cluster-randomized Trial of Modifying Electronic Health Record Defaults to Reduce the Prescribed Quantity of Opioid Analgesics in Dentistry Practices|Enrolling by invitation||N/A|10000|Anticipated|Montefiore Medical Center||3|||f||||f||||||||||2017-10-10 21:25:57.421837|2017-10-10 21:25:57.421837
NCT03030456|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-01-20|||September 2016||2016-09-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||Whole Body Vibrations on Functional Capacity, Muscular Strength, and Biochemical Profile in Elders|Evaluation of the Effects of Whole Body Vibration Training on Functional Capacity, Muscle Strength, and Biochemical Profile in Elderly Women|Enrolling by invitation||N/A|68|Anticipated|University of Santa Cruz do Sul||2|||f||||f||||||||No||2017-10-10 21:25:57.508264|2017-10-10 21:25:57.508264
NCT03030443|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-22|||April 4, 2017|Actual|2017-04-04|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Observational|PAC||Patient Preferences in Anesthesia for Abortion Care|Patient Preferences in Anesthesia for Abortion Care|Recruiting||N/A|30|Anticipated|University of New Mexico|||2||f||||f||||||||No||2017-10-10 21:25:57.591607|2017-10-10 21:25:57.591607
NCT03030430|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-21|||March 15, 2016||2016-03-15|January 2017|2017-01-01|June 30, 2017|Anticipated|2017-06-30|February 20, 2017|Anticipated|2017-02-20||Interventional|||Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects|Randomized, Double-blind, Single-dose, 3-arm Parallel Design Comparative Pharmacokinetic(PK) and Safety Study of BAT1706 Versus European Union(EU)-Sourced Avastin® and United State (US)-Sourced Avastin® Administered in Healthy Subjects|Recruiting||Phase 1|129|Anticipated|Bio-Thera Solutions||3|||f||||||||||||||2017-10-10 21:25:57.677975|2017-10-10 21:25:57.677975
NCT03030404|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-06-30|||January 11, 2017||2017-01-11|January 23, 2017|2017-01-23|December 31, 2026|Anticipated|2026-12-31|December 31, 2026|Anticipated|2026-12-31||Observational|||Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer|Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer|Recruiting||N/A|240|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:25:57.869858|2017-10-10 21:25:57.869858
NCT03030391|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-09-13|||January 10, 2017||2017-01-10|July 19, 2017|2017-07-19|September 9, 2019|Anticipated|2019-09-09|September 9, 2019|Anticipated|2019-09-09||Interventional|||Novel Positron Emission Tomography (PET) Radiotracer to Image Phosphodiesterase-4B (PDE4B)|Evaluation of a Novel Positron Emission Tomography (PET) Radiotracer to Image Phosphodiesterase-4B (PDE4B)|Recruiting||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:25:57.95625|2017-10-10 21:25:57.95625
NCT03030378|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-24|2017-08-08|||August 11, 2017|Anticipated|2017-08-11|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors|A Phase 1 Study of Pembrolizumab (MK-3475) in Combination With Recombinant Interleukin-12 in Patients With Solid Tumors|Not yet recruiting||Phase 1|36|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:25:58.041817|2017-10-10 21:25:58.041817
NCT03030365|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-21|||February 15, 2017|Anticipated|2017-02-15|January 2017|2017-01-01|February 15, 2020|Anticipated|2020-02-15|February 15, 2019|Anticipated|2019-02-15||Observational|||Orientation in AD Patients: PET-MR Study|The Orientation System, the Default-network and Brain Metabolism in Patients With Early Stage Alzheimer's Disease: a Multimodal Functional Study.|Not yet recruiting||N/A|30|Anticipated|Assuta Medical Center|||3||f||||f||||||||Undecided|Only in the case where publication of coded data is required\encouraged by the Journal for publication|2017-10-10 21:25:58.155589|2017-10-10 21:25:58.155589
NCT03030352|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-20|||February 2014||2014-02-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Promoting Children's Mental Health: The Effects of a Parenting Program|How to Talk so Kids Will Listen & Listen so Kids Will Talk: A Randomized Controlled Trial Assessing the Impact of the French Workshop Format in the General Population|Recruiting||N/A|256|Anticipated|Université de Montréal||2|||f||||f||||||||||2017-10-10 21:25:58.262399|2017-10-10 21:25:58.262399
NCT03030339|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-03|||August 2016||2016-08-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|GloVitAS-P||Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children|Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children Exposed to Multiple Vitamin A Intervention Programs|Completed||N/A|123|Actual|University of California, Davis|||3||f||||f||||||Samples With DNA|"     Serum, plasma, red and white cells, dried blood spots, breast milk   "|Undecided|To be determined.|2017-10-10 21:25:58.37701|2017-10-10 21:25:58.37701
NCT03030326|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-09-13|||September 13, 2017|Anticipated|2017-09-13|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|April 30, 2020|Anticipated|2020-04-30||Interventional|ASANX||Biofeedback for Asthma Comorbid With Anxiety or Depression|Biofeedback for Asthma Comorbid With Anxiety or Depression|Not yet recruiting||N/A|20|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||||2017-10-10 21:25:58.491552|2017-10-10 21:25:58.491552
NCT03030313|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-06-09|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Respiration Rate Monitoring in COPD Patients|Assessment of the Temporal Changes in Nightly Respiration Rate in Combination With a Daily Symptom Reporting Application for Facilitating Early Treatment of Symptoms in COPD Patients|Active, not recruiting||N/A|50|Actual|ResMed||1|||f||||f||||||||No||2017-10-10 21:25:58.588278|2017-10-10 21:25:58.588278
NCT03030300|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-24|||January 2008||2008-01-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy||Completed||Phase 4|170|Actual|Qianfoshan Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:25:58.670676|2017-10-10 21:25:58.670676
NCT03030287|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-05-01|||December 2016||2016-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer|A Phase 1b Study of OMP-305B83 Plus Weekly Paclitaxel in Subjects With Platinum Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Recruiting||Phase 1|30|Anticipated|OncoMed Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-10 21:25:58.761699|2017-10-10 21:25:58.761699
NCT03030274|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-14|||July 6, 2017|Actual|2017-07-06|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|PRELIEVE||The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients|Prospective, Non-randomized, Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients With Reduced Ejection Fraction or in Heart Failure Patients With Preserved Ejection Fraction|Recruiting||N/A|30|Anticipated|Occlutech International AB||1|||f|||||f|f||||||||2017-10-10 21:25:58.890999|2017-10-10 21:25:58.890999
NCT03030261|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-10-04|||December 31, 2017|Anticipated|2017-12-31|October 2017|2017-10-01|March 31, 2026|Anticipated|2026-03-31|June 30, 2021|Anticipated|2021-06-30||Interventional|||Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma|A Phase II Study of Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma|Not yet recruiting||Phase 2|40|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:25:58.964336|2017-10-10 21:25:58.964336
NCT03030079|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-20|||January 2017||2017-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Electrical Stimulus Therapy for Chronic Phantom Limb Pain|Exploratory Study of Electrical Stimulus as a Treatment Option for Chronic Phantom Limb Pain|Recruiting||Early Phase 1|10|Anticipated|University of Colorado, Denver||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:26:00.490688|2017-10-10 21:26:00.490688
NCT03030248|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||June 1, 2017|Anticipated|2017-06-01|January 2017|2017-01-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Treatment of Clostridium Difficile in Colonized Patients in the Hematology Oncology Population|Randomized Double Blind Controlled Trial for the Treatment of Nucleic Acid Amplification Test (NAAT)+/Toxin Enzyme Immunoassay (EIA)- Clostridium Difficile in the Hematology Oncology Population|Not yet recruiting||Phase 4|30|Anticipated|Medical College of Wisconsin||2|||f||||t|t|f|||t|||Undecided|Participant data to be shared would consist of age categories, genders, treatment groups, Clostridium difficile status, microbiome profile and metabolic profile. The data will be anonymized to prevent the identification of individual patients from the data provided. The data would be made available through contacting the principal investigator directly.|2017-10-10 21:25:59.06873|2017-10-10 21:25:59.06873
NCT03030235|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-06-07|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|PRESERVED-HF||Dapagliflozin in Type 2 Diabetes or Pre-diabetes, and PRESERVED Ejection Fraction Heart Failure|Effects of Dapagliflozin on Biomarkers, Symptoms and Functional Status in Patients With Type 2 Diabetes or Pre-diabetes, and PRESERVED Ejection Fraction Heart Failure|Recruiting||Phase 4|320|Anticipated|Saint Luke's Health System||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:25:59.14121|2017-10-10 21:25:59.14121
NCT03030222|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-07-14|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|EMBRACE-HF||Empagliflozin Impact on Hemodynamics in Patients With Diabetes and Heart Failure|Empagliflozin Evaluation by Measuring Impact on Hemodynamics in Patients With Diabetes and Heart Failure|Recruiting||Phase 4|60|Anticipated|Saint Luke's Health System||2|||f||||t|t|f|||f|||||2017-10-10 21:25:59.235284|2017-10-10 21:25:59.235284
NCT03030209|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2017-01-23|||January 2000||2000-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Risk Factors for the Development of Diabetes Mellitus After Distal Pancreatectomy|Risk Factors for the Development of Diabetes Mellitus After Distal Pancreatectomy|Recruiting||N/A|800|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:25:59.332837|2017-10-10 21:25:59.332837
NCT03030196|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-05-22|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Denosumab and Male Infertility: a RCT|Denosumab and Male Infertility: a Randomized Controlled Double-blinded Intervention Study|Recruiting||Phase 2|95|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||No||2017-10-10 21:25:59.416237|2017-10-10 21:25:59.416237
NCT03030183|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-09-26|||April 17, 2017|Actual|2017-04-17|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase 2 Safety and Efficacy Study of RA101495 to Treat PNH Patients Who Have an Inadequate Response to Eculizumab|A Phase 2 Multicenter, Open-Label, Uncontrolled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of RA101495 in Subjects With Paroxysmal Nocturnal Hemoglobinuria Who Have an Inadequate Response to Eculizumab|Recruiting||Phase 2|8|Anticipated|Ra Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 21:25:59.531583|2017-10-10 21:25:59.531583
NCT03030170|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-07|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Interventional|REPLAY||REinforcement of the Pancreas in distaL pAncreatectomY (REPLAY)|Does the Strengthening of the Pancreas in Distal Pancreatectomy Using Endo GIA Reload Reinforced Reduce the Occurrence of Pancreatic Fistula? Multicenter Randomized Prospective Open Study|Not yet recruiting||Phase 3|200|Anticipated|Rennes University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:25:59.602112|2017-10-10 21:25:59.602112
NCT03030157|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01||||December 2019|Anticipated|2019-12-01||Interventional|||Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma|Prospective Randomized Phase II Trial: Single Instillation Versus Long-term Prophylactic Intravesical Instillation of Pirarubicin in the Prevention of Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma|Recruiting||Phase 2|220|Anticipated|RenJi Hospital||2|||f||||f||||||||||2017-10-10 21:25:59.69314|2017-10-10 21:25:59.69314
NCT03030144|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-28|||April 18, 2017|Actual|2017-04-18|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|November 2, 2017|Anticipated|2017-11-02||Interventional|||P-INC: Project Incontinence- Effectiveness of Nursing Recommendations|Effectiveness of Nursing Recommendations for the Management of Urinary Incontinence in Nursing Homes: a Cluster-randomized Controlled Trial|Active, not recruiting||N/A|147|Anticipated|Medical University of Graz||2|||f|||||f|f||||||||2017-10-10 21:25:59.905011|2017-10-10 21:25:59.905011
NCT03030131|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-08|||January 12, 2017|Actual|2017-01-12|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|IONESCO||Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer|A Phase II Prospective Immune Neoadjuvant Therapy Study od Durvalumab (MEDI4736) in Early Stage Non-small Cell Lung Cancer|Recruiting||Phase 2|81|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||1|||f||||f|f|f||||||||2017-10-10 21:25:59.994722|2017-10-10 21:25:59.994722
NCT03030118|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-09-11|||December 31, 2017|Anticipated|2017-12-31|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|September 2021|Anticipated|2021-09-01||Interventional|SMILE||Study of Anti-Malarials in Incomplete Lupus Erythematosus|Study of Anti-Malarials in Incomplete Lupus Erythematosus|Not yet recruiting||Phase 2|240|Anticipated|Milton S. Hershey Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 21:26:00.127423|2017-10-10 21:26:00.127423
NCT03030105|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-26|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled, Single-dose, 6-Period Crossover Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers|Active, not recruiting||Phase 1|38|Actual|Tetra Discovery Partners||6|||f||||f||||||||No||2017-10-10 21:26:00.26413|2017-10-10 21:26:00.26413
NCT03030092|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Maximal Strength Training Following Hip Fracture Surgery: Impact on Muscle Mass, Balance, Walking Efficiency and Bone Density||Enrolling by invitation||N/A|40|Anticipated|Molde University College||2|||f||||f||||||||No||2017-10-10 21:26:00.398388|2017-10-10 21:26:00.398388
NCT03030053|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2017-02-20|||February 2016||2016-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CoCo_Chronic||The Effects of Flavonoid Supplementation on Cognition and Neural Mechanisms in Healthy Older Adults|Mechanistic Assessment of the Acute and Chronic Cognitive Effects of Flavanol/Anthocyanin Intervention in Humans - Chronic Trial|Recruiting||N/A|70|Anticipated|University of Reading||2|||f||||f||||||||Yes|To achieve the aim of data sharing with the wider community data will be submitted for inclusion in the Biotechnology and Biological Sciences Research Council (BBSRC)-funded Code Analysis, Repository & Modelling for E-Neuroscience (CARMEN) depository for neurophysiological datasets (http://www.carmen.org.uk). Data will also be accessible by making a direct request to the PI, and will be transferred to the recipient. Publications will be in open access journals where possible. If not possible, due to the need to reach the widest possible audience, pre-publication manuscripts arising from the project will be deposited in the free and publicly searchable University of Reading research database (CentAUR: http://centaur.reading.ac.uk). All data will be made available in an anonymised format upon request following publication of main findings. It is envisaged that the entire datasets will be available 6 months following the end of the project and maintained for a period of at least 10 years.|2017-10-10 21:26:00.686342|2017-10-10 21:26:00.686342
NCT03030040|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-26|||January 26, 2017|Actual|2017-01-26|January 2017|2017-01-01|March 1, 2018|Anticipated|2018-03-01|December 1, 2017|Anticipated|2017-12-01||Interventional|MindSHINE2||A Randomised Controlled Trial of Self-help Mindfulness-based Cognitive Therapy for Health Workers|A Randomised Controlled Trial of a Mindfulness-based Cognitive Therapy Self-help Intervention for UK National Health Service Employees|Enrolling by invitation||N/A|90|Anticipated|Canterbury Christ Church University||2|||f||||f|f|f||||||No||2017-10-10 21:26:00.80152|2017-10-10 21:26:00.80152
NCT03030027|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-05-22|||January 9, 2017|Actual|2017-01-09|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CTC||Connecting Through Caregiving: Reappraising Intergeneration Relationships|Connecting Through Caregiving: Reappraising Intergeneration Relationships for Dementia Caregivers|Recruiting||N/A|80|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||No||2017-10-10 21:26:00.917665|2017-10-10 21:26:00.917665
NCT03030014|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-06|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Dental Educational Program on Oral Hygiene Status Among Institutionalized Deaf Children|Effect of Dental Educational Program on Oral Hygiene Status Among Institutionalized Deaf Children. A Randomized Controlled Trial.|Not yet recruiting||N/A|238|Anticipated|Cairo University||2|||f|||||f|f||||||||2017-10-10 21:26:01.004804|2017-10-10 21:26:01.004804
NCT03030001|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-20|||February 15, 2017|Anticipated|2017-02-15|January 2017|2017-01-01|February 1, 2019|Anticipated|2019-02-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies|PD-1 Antibody Expressing Chimeric Antigen Receptor T Cells for Mesothelin Positive Advanced Malignancies|Recruiting||Phase 1/Phase 2|40|Anticipated|Ningbo Cancer Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:26:01.07218|2017-10-10 21:26:01.07218
NCT03029988|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-03|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.|An Exploratory Evaluation of Technetium Tc 99m Tilmanocept by Intravenous (IV) Injection in Subjects With Liver Metastases From Colorectal Carcinoma Patients Using SPECT/CT Imaging Compared to FDG PET/CT Imaging.|Recruiting||Phase 1|12|Anticipated|Navidea Biopharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 21:26:01.172429|2017-10-10 21:26:01.172429
NCT03029975|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-05-01|||February 1, 2017|Actual|2017-02-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||The Influence of Regular Beef Consumption and Protein Density of the Diet on Training-induced Gains in Muscle Strength and Performance in Healthy Adults|The Influence of Regular Beef Consumption and Protein Density of the Diet on Training-induced Gains in Muscle Strength and Performance in Healthy Adults|Recruiting||N/A|50|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||t|f|f||||||No||2017-10-10 21:26:01.279835|2017-10-10 21:26:01.279835
NCT03029962|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-09-12|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|Girl2Girl||Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls|Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls|Recruiting||N/A|840|Anticipated|Center for Innovative Public Health Research||2|||f||||f||||||||||2017-10-10 21:26:01.371767|2017-10-10 21:26:01.371767
NCT03029949|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-04-24|||April 25, 2017|Anticipated|2017-04-25|April 2017|2017-04-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||Acceptance and Commitment Therapy With Vestibular Rehabilitation for Chronic Dizziness|Acceptance and Commitment Therapy With Vestibular Rehabilitation for Chronic Dizziness: a Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Nagoya City University||2|||f|||||f|f||||||Undecided||2017-10-10 21:26:01.466655|2017-10-10 21:26:01.466655
NCT03029936|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||July 1, 2016|Actual|2016-07-01|January 2017|2017-01-01|August 1, 2017|Anticipated|2017-08-01|July 30, 2017|Anticipated|2017-07-30||Observational|||Obesity-asthma Endophenotype and Diaphragm Mobility in Adolescence|Obesity-asthma Endophenotype: Assessment of Diaphragm Mobility and Muscle Inflammation Markers in the Adolescence|Enrolling by invitation||N/A|100|Actual|Universidade Federal de Pernambuco|||4||f||||f|f|f||||Samples Without DNA|"     Serum   "|No||2017-10-10 21:26:01.57517|2017-10-10 21:26:01.57517
NCT03029923|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-28|||February 1, 2017|Anticipated|2017-02-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|PACES||Integrated Smoking Cessation and Mood Management for ACS Patients|Integrated Smoking Cessation and Mood Management for ACS Patients (PACES Phase IV Vanguard R56 Trial)|Withdrawn||N/A|0|Actual|The Miriam Hospital||2||Funding for this pilot transitioned into funding for a fully powered study.|f||||f|f|f||||||||2017-10-10 21:26:01.644809|2017-10-10 21:26:01.644809
NCT03029910|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-23|||January 2017||2017-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Eccentric Training and Cryotherapy Vs Eccentric Training and Whole Body Vibration in Achilles Tendinopathy|Eccentric Training and Cryotherapy Vs Eccentric Training and Whole Body Vibration in Achilles Tendinopathy|Recruiting||N/A|40|Anticipated|Universidad Europea de Madrid||2|||f||||f||||||||No||2017-10-10 21:26:01.721985|2017-10-10 21:26:01.721985
NCT03029897|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-31|||April 2017|Anticipated|2017-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|VigiP-SEP||E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis|Impact of E-reporting by Patients With Relapsing-remitting Multiple Sclerosis on the Reporting of Adverse Drug Reactions in France: a Randomized Controlled Trial.|Not yet recruiting||N/A|160|Anticipated|University Hospital, Caen||2|||f||||f|f|f||||||No||2017-10-10 21:26:01.810579|2017-10-10 21:26:01.810579
NCT03029871|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||January 13, 2017|Actual|2017-01-13|January 2017|2017-01-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|NSCLC||Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer|Phase 1 Trial of Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Combination With Stereotactic Body Radiation Therapy (SBRT) in Clinical Stage 1 (T1B-T2A) Non-Small Cell Lung Cancer|Recruiting||Phase 1|9|Anticipated|Henry Ford Health System||1|||f||||t||||||||No||2017-10-10 21:26:01.99606|2017-10-10 21:26:01.99606
NCT03029858|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|ATHENE||PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC Patients|Programmed Death-ligand 1(PD-L1) and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced Non-small Cell Lung Cancer (NSCLC) Patients|Not yet recruiting||N/A|155|Anticipated|Guangdong Association of Clinical Trials|||1||f||||f||||||Samples With DNA|"     Tumor Formaldehyde Fixed-Paraffin Embedded (FFPE) tissue specimen collection • Tumor FFPE     tissue specimen will be at least collected at baseline, disease progression and Response     (optional) in sufficient amount (10 FFPE slices, thickness 4um, tumor cells≥25% and the area     of necrotic tissues＜10%).      Blood specimen collection(optional)      • The plasma specimen requirements for 10 ml blood will be collected at least at baseline,     disease progression, and every 6 weeks, which is for detecting tumor mutation burden by     QIAGEN Mix-561-Match Panel (561genes).   "|No||2017-10-10 21:26:02.080581|2017-10-10 21:26:02.080581
NCT03029845|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-28|||January 2017||2017-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Propranolol for Treating Fibromyalgia Pain|Propranolol for Treating Fibromyalgia Pain: Pilot Study|Recruiting||Phase 1|30|Anticipated|University of Utah||3|||f||||t||||||||||2017-10-10 21:26:02.182634|2017-10-10 21:26:02.182634
NCT03029832|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-06|||April 27, 2017|Actual|2017-04-27|September 2017|2017-09-01|August 25, 2022|Anticipated|2022-08-25|November 15, 2020|Anticipated|2020-11-15||Interventional|||A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy|A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Moxr0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Patients With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy|Active, not recruiting||Phase 2|5|Actual|Genentech, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:26:02.284324|2017-10-10 21:26:02.284324
NCT03029819|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||iQuit Mindfully: Text Messaging for Smoking Cessation|iQuit Mindfully: A Randomized Controlled Trial of Mindfulness-based Smoking Cessation Enhanced With Mobile Technology|Recruiting||N/A|70|Anticipated|Georgia State University||2|||f||||t||||||||||2017-10-10 21:26:02.420884|2017-10-10 21:26:02.420884
NCT03029806|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Lysine-specific Demethylase 1 and Salt-sensitivity in Humans|Lysine-specific Demethylase 1 and Salt-sensitivity in Humans|Not yet recruiting||N/A|88|Anticipated|Brigham and Women's Hospital||4|||f||||f||||||||Yes|IPD will be shared first thru the publication of research results in peer-review scientific journals by the study investigator. IPD will be made available upon reasonable request from bona fide research organizations in an effort to provide broader impact and enrich public health knowledge. Research volunteer PHI will not be shared, and all participant data will be de-identified and coded. Only encrypted and secure network exchanges will be used for data transfer. Cost sharing my be required in order prepare datasets.|2017-10-10 21:26:02.512388|2017-10-10 21:26:02.512388
NCT03029793|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-20|||May 2016||2016-05-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer|Combination of Molecular Biomarkers and Functional Imaging in Predicting Pathologic Response and Clinical Outcomes in Squamous Esophageal Cancer Patients Who Undergo Trimodality Therapy|Recruiting||N/A|200|Anticipated|Fourth Military Medical University|||1||f||||f||||||||No||2017-10-10 21:26:02.593871|2017-10-10 21:26:02.593871
NCT03029780|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-09-26|||February 9, 2017|Actual|2017-02-09|September 2017|2017-09-01|February 21, 2021|Anticipated|2021-02-21|December 12, 2017|Anticipated|2017-12-12||Interventional|CheckMate 800||An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma|Phase II, Randomized, Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma|Recruiting||Phase 2|100|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 21:26:02.678022|2017-10-10 21:26:02.678022
NCT03029767|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-03-06|||February 20, 2017|Actual|2017-02-20|February 2017|2017-02-01|August 20, 2017|Anticipated|2017-08-20|August 20, 2017|Anticipated|2017-08-20||Interventional|||Effect of Exercise on Selected Anthropometric,Biochemical and Physiological Variables Among Hypertensive Patients|Effect of Aerobic and Resistance Exercise on Selected Anthropometric Biochemical and Physiological Variables Among Hypertensive Patients in Hawassa University Referral Hospital, Southern Ethiopia: a Parallel Randomized Controlled Trial|Recruiting||N/A|84|Anticipated|Mekelle University||4|||f||||t|f|f|||f|||Yes|Abstract of the study and consent format|2017-10-10 21:26:02.809041|2017-10-10 21:26:02.809041
NCT03029754|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||January 20, 2017|Actual|2017-01-20|January 2017|2017-01-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Effect of Passive Leg Raise for Pediatric Peripheral IV Placement|Effect of Passive Leg Raise for Pediatric Peripheral IV Placement|Enrolling by invitation||N/A|80|Anticipated|University of Saskatchewan||2|||f||||f|f|f||||||No||2017-10-10 21:26:02.914773|2017-10-10 21:26:02.914773
NCT03029741|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-04-12|||February 21, 2017|Actual|2017-02-21|April 2017|2017-04-01|March 23, 2017|Actual|2017-03-23|March 23, 2017|Actual|2017-03-23||Interventional|||Bioavailability of AZD0284 and IV Microtracer Study|A Phase I Study To Assess The Absolute Bioavailability Of A Single Oral Dose Of AZD0284 And To Assess The Pharmacokinetics Of A Single Intravenous Microdose Of [14C]AZD0284 In Healthy Subjects.|Completed||Phase 1|6|Actual|AstraZeneca||1|||f||||f|f|f||||||No||2017-10-10 21:26:02.979449|2017-10-10 21:26:02.979449
NCT03029728|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-13|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Observational|BioHAE||Biomarker for Hereditary Angioedema Disease Type 1|Biomarker for Hereditary Angioedema Disease Type 1: An International, Multicenter, Epidemiological Protocol|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectrometry 7,5 ml     EDTA blood and/or a dry blood spot filter card are taken. To proof the correct diagnosis in     those patients where up to the enrollment in the study no genetic testing has been done,     sequencing of hereditary angioedema disease type 1 will be done.   "|||2017-10-10 21:26:03.195394|2017-10-10 21:26:03.195394
NCT03029715|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-20|||February 2014||2014-02-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Anaesthesia for Laparoscopic Sleeve Gastrectomy|Comparative Study Between Inhalational Anaesthesia and Total Intravenous Anaesthesia (TIVA) With Dexmedetomidine for Morbidly Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy|Completed||N/A|100|Actual|Menoufia University||2|||f||||f||||||||No||2017-10-10 21:26:03.285147|2017-10-10 21:26:03.285147
NCT03029702|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-08|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|March 30, 2021|Anticipated|2021-03-30|June 30, 2020|Anticipated|2020-06-30||Interventional|MATCh-GDM||Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus|Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus|Not yet recruiting||Phase 4|60|Anticipated|University of Pittsburgh||2|||f||||f|t|f|||f|||||2017-10-10 21:26:03.384726|2017-10-10 21:26:03.384726
NCT03029689|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-07-31|||July 28, 2017|Actual|2017-07-28|January 2017|2017-01-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY|Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME|Recruiting||Phase 3|60|Anticipated|Fundacio Lluita Contra la SIDA||2|||f||||f|f|f||||||||2017-10-10 21:26:03.496855|2017-10-10 21:26:03.496855
NCT03029676|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-20|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Assessment of POCD After TURBT Under Spinal Anesthesia|The Assessment of Postoperative Cognitive Dysfunction After Transurethral Resection of Bladder Tumor Under Spinal Anesthesia|Recruiting||Phase 4|200|Anticipated|Medical University of Warsaw||2|||f||||f|f|f||||||No||2017-10-10 21:26:03.618416|2017-10-10 21:26:03.618416
NCT03029663|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-23|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|ComTUR||Complications of Transurethral Resection of the Bladder Tumour|Complications of Transurethral Resection of the Bladder Tumour: A Prospective Analysis of Incidence and Predictive Factors|Recruiting||N/A|750|Anticipated|Medical University of Warsaw|||1||f||||||||||||||2017-10-10 21:26:03.72976|2017-10-10 21:26:03.72976
NCT03029650|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-18|||November 2016||2016-11-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Scopolamine Patch Pharmacokinetics in Healthy Adults||Active, not recruiting||Phase 4|29|Actual|University of Iowa||2|||f||||f||||||||||2017-10-10 21:26:03.794415|2017-10-10 21:26:03.794415
NCT03029637|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-19|||June 2017|Anticipated|2017-06-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||No-preparation Resin Bonded Bridges for the Replacement of Single Missing Teeth|No-preparation Resin Bonded Bridges for the Replacement of Single Missing Teeth|Not yet recruiting||N/A|90|Anticipated|The University of Hong Kong||2|||f||||f|f|f||||||No||2017-10-10 21:26:03.873881|2017-10-10 21:26:03.873881
NCT03029624|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-07-10|||April 3, 2017|Actual|2017-04-03|July 2017|2017-07-01|August 31, 2018|Anticipated|2018-08-31|December 30, 2017|Anticipated|2017-12-30||Interventional|||eCoin Tibial Nerve Stimulation for OAB|Subcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence|Recruiting||N/A|50|Anticipated|Valencia Technologies Corporation||1|||f||||t|f|t|t|f|t|||||2017-10-10 21:26:03.977854|2017-10-10 21:26:03.977854
NCT03029611|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-26|||April 3, 2017|Actual|2017-04-03|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|June 1, 2018|Anticipated|2018-06-01||Interventional|||IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery|A Phase II Study of Concurrent IGFBP-2 Vaccination and Neoadjuvant Chemotherapy to Increase the Rate of Pathologic Complete Response at the Time of Cytoreductive Surgery|Recruiting||Phase 2|38|Anticipated|University of Washington||1|||f||||f|t|f||||||||2017-10-10 21:26:04.116123|2017-10-10 21:26:04.116123
NCT03029598|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-09-26|||March 14, 2017|Actual|2017-03-14|September 2017|2017-09-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Anti-PD-1 Therapy in Combination With Platinum Chemotherapy for Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Recruiting||Phase 1/Phase 2|27|Anticipated|University of Washington||1|||f||||f|t|f||||||||2017-10-10 21:26:04.245096|2017-10-10 21:26:04.245096
NCT03029585|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-22|||April 19, 2017|Actual|2017-04-19|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer|Phase II Study of Four Dose Levels of Intraperitoneal NanoPac® Plus IV Carboplatin and Paclitaxel in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery|Recruiting||Phase 2|61|Anticipated|NanOlogy, LLC||5|||f||||t|t|f||||||||2017-10-10 21:26:04.371232|2017-10-10 21:26:04.371232
NCT03029572|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-19|||February 2009||2009-02-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Micro-nutritional Status and Gut Microbiota in Morbidly Obese Patients Before and After Gastric Bypass|Micro-nutritional Status and Gut Microbiota in Morbidly Obese Patients Before and After Gastric Bypass With and Without Micro-nutritional Supplementation|Completed||N/A|90|Actual|University Hospital, Geneva||2|||f||||f||||||||No||2017-10-10 21:26:04.503646|2017-10-10 21:26:04.503646
NCT03029546|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-20|||November 2015||2015-11-01|January 2017|2017-01-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Effect of Glucose Load on Expression of Advanced Glycation End Products in Women Screened for Gestational Diabetes|The Effect of Acute Glucose Loading on Level of Expression of Advanced Glycation End Products in Women Screened for Gestational Diabetes During Pregnancy|Recruiting||N/A|105|Anticipated|Ohio State University|||2||f||||t||||||||No||2017-10-10 21:26:04.716704|2017-10-10 21:26:04.716704
NCT03029533|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-20|||February 2017||2017-02-01|January 2017|2017-01-01||||November 2017|Anticipated|2017-11-01||Interventional|||Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer|An Open Label, Randomized, Single Dose, Parallel-group, Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following Subcutaneous Administration of DWJ108J in Patients With Prostate Cancer|Not yet recruiting||Phase 1|44|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||||2017-10-10 21:26:04.801351|2017-10-10 21:26:04.801351
NCT03029520|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-24|||July 2015||2015-07-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Post-Obturation Pain Following the Use of the AH Plus and iRoot SP Sealers|Termoplastik Kor tekniğini Iki farklı Kanal patı Ile kullanıp Tedavi sonrası Hassasiyet ve kök Ucundan taşma miktarının değerlendirilmesi: Randomize kontrollü Klinik çalışma|Completed||N/A|160|Actual|Cukurova University||4|||f||||t||||||||Yes|The study will be shared at Turkish Council of Higher education thesis center|2017-10-10 21:26:04.868817|2017-10-10 21:26:04.868817
NCT03029507|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-05-09|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|March 2020|Anticipated|2020-03-01||Interventional|||An ACT-enhanced Weight Management and Fitness Program for Navy Personnel|An Acceptance and Commitment Therapy (ACT)-Enhanced Weight Management and Fitness Program for Navy Personnel|Not yet recruiting||N/A|280|Anticipated|Veterans Medical Research Foundation||2|||f||||f|f|f||||||No||2017-10-10 21:26:04.94935|2017-10-10 21:26:04.94935
NCT03029494|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||October 1, 2015|Actual|2015-10-01|January 2017|2017-01-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|ROStrO-TMD||Oxidative Stress and Opiorphin in Temporomandibular Disorders|The Role of Oxidative Stress and Opiorphin in Temporomandibular Disorders|Recruiting||N/A|80|Anticipated|Croatian Science Foundation||3|||f||||t|f|t||f||||No||2017-10-10 21:26:05.062156|2017-10-10 21:26:05.062156
NCT03029481|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-23||||||January 2017|2017-01-01||||||||Expanded Access|||Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma|Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma|Available||N/A|||Jonsson Comprehensive Cancer Center||||||t||t|||||||||||2017-10-10 21:26:05.170094|2017-10-10 21:26:05.170094
NCT03029455|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-01|||November 2016||2016-11-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis|A Phase 1, Randomized, Double Blind, Placebo Controlled, Dose Escalation, and Bioavailability Study Evaluating the Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Subjects With Cystic Fibrosis|Completed||Phase 1|163|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||t||||||||||2017-10-10 21:26:05.31553|2017-10-10 21:26:05.31553
NCT03029442|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-28|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01||Interventional|||The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury|The Efficacy of Denosumab to Prevent Bone Loss in Ambulatory and Non-ambulatory Motor-Incomplete Patients With Subacute Spinal Cord Injury|Not yet recruiting||Phase 4|32|Anticipated|James J. Peters Veterans Affairs Medical Center||4|||f||||t|t|f||||||No|An IPD is not desired by the investigators and is not part of the regulatory guidelines at the participating institutions|2017-10-10 21:26:05.447681|2017-10-10 21:26:05.447681
NCT03029429|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-23|||December 1, 2017|Anticipated|2017-12-01|January 2017|2017-01-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Theophylline Treatment for Pseudohypoparathyroidism|Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism|Not yet recruiting||Phase 2|34|Anticipated|Vanderbilt University Medical Center||2|||f||||t|t|f||||||No||2017-10-10 21:26:05.554789|2017-10-10 21:26:05.554789
NCT03029416|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-08-03|||December 15, 2017|Anticipated|2017-12-15|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension|A Randomized Phase 2 Study of Two Radiation Dose Schedules of Stereotactic Body Radiotherapy (SBRT) to Lung Metastases < 5cm in Dimension|Not yet recruiting||Phase 2|50|Anticipated|University of Kentucky||2|||f||||t|f|f|||f|||||2017-10-10 21:26:05.658192|2017-10-10 21:26:05.658192
NCT03029403|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-20|||March 13, 2017|Anticipated|2017-03-13|January 2017|2017-01-01|September 13, 2022|Anticipated|2022-09-13|March 13, 2022|Anticipated|2022-03-13||Interventional|||Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer|A Phase 2 Study of Pembrolizumab (MK-3475), DPX-Survivac Vaccine and Low Dose of Cyclophosphamide Combination in Patients With Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Not yet recruiting||Phase 2|42|Anticipated|University Health Network, Toronto||4|||f||||t|f|f||||||No||2017-10-10 21:26:05.743991|2017-10-10 21:26:05.743991
NCT03029390|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-23|||March 2016||2016-03-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes|Effect of Administration of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Patients With Prediabetes|Recruiting||Phase 4|28|Anticipated|University of Guadalajara||2|||f||||f||||||||||2017-10-10 21:26:05.855664|2017-10-10 21:26:05.855664
NCT03029377|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-03-06|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Noradrenergic and Stress-Related Etiologies of Chronic Fatigue Syndrome|Noradrenergic and Stress-Related Etiologies of Chronic Fatigue Syndrome|Recruiting||N/A|210|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:26:05.969851|2017-10-10 21:26:05.969851
NCT03029364|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-08-24|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|June 30, 2019|Anticipated|2019-06-30||Observational|||Body Composition and Lipid Metabolism at Rest and During Exercise: A Cross-Sectional and Prospective Analysis.|Body Composition and Lipid Metabolism at Rest and During Exercise: A Cross-Sectional and Prospective Analysis.|Not yet recruiting||N/A|200|Anticipated|University of Bath|||1||f||||f||||||Samples With DNA|"     Plasma, serum and buffy coat layer extraction from blood samples. Skeletal muscle and adipose     tissue (fat) samples. Urine sample for immediate analysis and disposal.   "|||2017-10-10 21:26:06.076389|2017-10-10 21:26:06.076389
NCT03029351|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-23|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|1981 GLP||GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes|GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes|Not yet recruiting||Phase 4|90|Anticipated|University at Buffalo||2|||f||||f|t|f|||t|||No||2017-10-10 21:26:06.214006|2017-10-10 21:26:06.214006
NCT03029338|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-20|||November 2016||2016-11-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma|CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma|Recruiting||Phase 1|10|Anticipated|Institute of Hematology & Blood Diseases Hospital||1|||f||||||||||||Undecided||2017-10-10 21:26:06.306696|2017-10-10 21:26:06.306696
NCT03029325|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-31|||June 1993||1993-06-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|||Molecular and Genetic Analysis of Lung Cancer|Molecular and Genetic Analysis of Lung Cancer|Recruiting||N/A|10000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     Blood and tissue samples   "|||2017-10-10 21:26:06.388876|2017-10-10 21:26:06.388876
NCT03029312|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-23|||January 17, 2012|Actual|2012-01-17|January 2017|2017-01-01|January 18, 2016|Actual|2016-01-18|November 18, 2015|Actual|2015-11-18||Interventional|||Whole Body Vibration Training in Children With Osteogenesis Imperfecta and Limited Mobility|Whole Body Vibration as an Osteogenic Treatment for Children With Osteogenesis Imperfecta With Limited Mobility: A Randomised Controlled Pilot Trial|Completed||N/A|24|Actual|Birmingham Women's and Children's NHS Foundation Trust||2|||f||||f|f||||f|||Yes|Anonymised data available on request, subject to Ethical and R&D guidelines|2017-10-10 21:26:06.456125|2017-10-10 21:26:06.456125
NCT03029299|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-09-22|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|September 15, 2017|Actual|2017-09-15||Interventional|||Implementation Assessment and Clinical Utility of the FilmArray® Respiratory Panel (RP) EZ in a CLIA-waived Setting|Implementation Assessment and Clinical Utility of the FilmArray® Respiratory Panel (RP) EZ in a CLIA-waived Setting|Completed||N/A|83|Actual|BioFire Diagnostics, LLC||2|||f||||f|f|t|f|||||||2017-10-10 21:26:06.539936|2017-10-10 21:26:06.539936
NCT03029286|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-30|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2|ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2|Recruiting||N/A|1250|Anticipated|Georgetown University||2|||f||||t|f|f||||||||2017-10-10 21:26:06.629797|2017-10-10 21:26:06.629797
NCT03029273|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-20|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLC|Pilot Study of Affinity-enhanced Anti-NY-ESO-1 TCR Engineered Autologous T Cells in NSCLC Patients|Recruiting||Phase 1|20|Anticipated|Guangzhou Institute of Respiratory Disease||1|||f|||||f|f||||||Undecided||2017-10-10 21:26:06.707694|2017-10-10 21:26:06.707694
NCT03029260|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-07-12|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|||Effects of Nervous System Mobilization|Effect of Nervous System Mobilization on Heat, Cold and Mechanical Pain Thresholds and Lower Limb Flexibility|Recruiting||N/A|60|Anticipated|Aveiro University||2|||f||||||||||||||2017-10-10 21:26:06.794186|2017-10-10 21:26:06.794186
NCT03029247|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-09-25|||July 27, 2017|Actual|2017-07-27|September 2017|2017-09-01|June 20, 2018|Anticipated|2018-06-20|May 21, 2018|Anticipated|2018-05-21||Interventional|||A Phase IIA Study of Blood Pressure Comparing Daprodustat to an Erythropoiesis-stimulating Agent in Subjects With Anemia of Chronic Kidney Disease on Hemodialysis|A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent|Recruiting||Phase 2|62|Anticipated|GlaxoSmithKline||2|||f||||f|t|f||||||||2017-10-10 21:26:06.878443|2017-10-10 21:26:06.878443
NCT03029234|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-10-04|||March 31, 2017|Actual|2017-03-31|October 2017|2017-10-01|May 14, 2021|Anticipated|2021-05-14|January 8, 2019|Anticipated|2019-01-08||Interventional|||A Study of Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Subjects With Relapsed and Refractory Multiple Myeloma|An Open-label, Single-arm, Phase 3 Study of Carfilzomib in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma in China|Recruiting||Phase 3|120|Anticipated|Amgen||1|||f||||f|t|f|||t|||||2017-10-10 21:26:07.008044|2017-10-10 21:26:07.008044
NCT03029221|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-20|||July 2016||2016-07-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|July 2020|Anticipated|2020-07-01||Observational|||Local Evaluation of Real Relationships||Recruiting||N/A|1340|Anticipated|Children's Aid Society in Clearfield County|||4||f||||f||||||||No||2017-10-10 21:26:07.245486|2017-10-10 21:26:07.245486
NCT03029208|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-07-17|||May 11, 2017|Actual|2017-05-11|July 2017|2017-07-01|November 15, 2019|Anticipated|2019-11-15|November 15, 2019|Anticipated|2019-11-15||Interventional|||A Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin (rhEPO) in Subjects With Anemia Associated With Chronic Kidney Disease (CKD) Who Are Initiating Dialysis|A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis|Recruiting||Phase 3|300|Anticipated|GlaxoSmithKline||2|||f||||t|t|f||||||||2017-10-10 21:26:07.360823|2017-10-10 21:26:07.360823
NCT03029195|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-10-02|||December 2016||2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|EgyCleft||Nasoalveolar Molding for Egyptian Cleft Lip Palate Infants|Efficacy of Nasoalveolar Molding Therapy for Treatment of Unilateral Cleft Lip and Palate in Egyptian Infants|Recruiting||N/A|45|Anticipated|Alexandria University||3|||f||||f||||||||||2017-10-10 21:26:07.70039|2017-10-10 21:26:07.70039
NCT03029182|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-13|||October 2016||2016-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited Mobility|Simulated-Altitude as an Adjunct to Optimize Aerobic Exercise in Obese Breast Cancer Survivors With Limited Ambulatory Function: Pilot Randomized Trial|Recruiting||N/A|30|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 21:26:07.813573|2017-10-10 21:26:07.813573
NCT03029169|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-02-14|||February 2017||2017-02-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|PRASE||Propafenone Versus Amiodarone in Septic Shock|Prospective Randomized Study of Efficacy and Safety of 1c Class Antiarrhythmic Agent (Propafenone) in Septic Shock|Not yet recruiting||Phase 4|100|Anticipated|Charles University, Czech Republic||2|||f||||t|f|f||||||No||2017-10-10 21:26:07.924973|2017-10-10 21:26:07.924973
NCT03029156|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-01-19|||August 2015|Actual|2015-08-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of the Aeroneb in Acute Severe Asthma|Effectiveness of the Aeroneb Compared to a Jet Nebulizer Fort the Delivery of Bronchodilator Therapy of Acute Severe Asthma|Recruiting||N/A|68|Anticipated|Tufts Medical Center||2|||f||||f||||||||No||2017-10-10 21:26:08.041166|2017-10-10 21:26:08.041166
NCT03029130|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-23|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Catheter Extension Trial for Early Vesicovaginal Fistula Repair Failures|Does Extending Catheterization Improve Outcomes in Early Vesicovaginal Fistula Repair Failures? A Prospective Randomized Controlled Trial|Enrolling by invitation||N/A|232|Anticipated|Evangel VVF Centre||2|||f||||t|f|f||||||No||2017-10-10 21:26:08.382517|2017-10-10 21:26:08.382517
NCT03029117|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-25|||February 1, 2016|Actual|2016-02-01|January 2017|2017-01-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01|3 Months|Observational [Patient Registry]|||Effect of Rheumatic Heart Disease on Maternal and Fetal Outcomes|Prospective Cohort Study Compares Effect of Corrected and Uncorrected Rheumatic Heart Valve of Pregnant Women on Maternal and Fetal Outcomes|Completed||N/A|125|Anticipated|Assiut University|||1||f||||t|f|f||||||No||2017-10-10 21:26:08.465222|2017-10-10 21:26:08.465222
NCT03029104|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-07-14|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||COLLAGEN CROSS-LINKING WITH ULTRAVIOLET-A IN ASYMMETRIC CORNEAS|COLLAGEN CROSS-LINKING WITH ULTRAVIOLET-A IN ASYMMETRIC CORNEAS|Recruiting||Phase 2|3000|Anticipated|Cxlusa||3|||f||||f|t|||||||||2017-10-10 21:26:08.541298|2017-10-10 21:26:08.541298
NCT03029091|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-20|||January 19, 2017|Actual|2017-01-19|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|September 2018|Anticipated|2018-09-01||Interventional|||An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)|A Preliminary Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) With or Without a Connective Tissue Disorder|Recruiting||Phase 2|15|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t|t|f||||||No||2017-10-10 21:26:08.689015|2017-10-10 21:26:08.689015
NCT03029078|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-20|||November 1, 2014|Actual|2014-11-01|January 2017|2017-01-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|FEDEX||FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?|FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?|Recruiting||Phase 4|20|Anticipated|Centre d'Investigation Clinique et Technologique 805||1|||f||||f|f|f||||||No||2017-10-10 21:26:08.786332|2017-10-10 21:26:08.786332
NCT03029065|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-01-23|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01|6 Months|Observational [Patient Registry]|CSF||Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis|Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis|Not yet recruiting||N/A|50|Anticipated|Shandong Cancer Hospital and Institute|||1||f||||t||||||Samples With DNA|"     Anticoagulated whole blood, anticoagulated cerebrospinal fluid and tumor tissue were     collected. DNA was extracted from tumor tissues, genomic DNA was extracted from leukocytes,     and cfDNA was extracted from plasma and cerebrospinal fluid.   "|No||2017-10-10 21:26:08.875319|2017-10-10 21:26:08.875319
NCT03029052|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-09|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|CONCIVILLE||Medication Reconciliation at Discharge: Impact on Patient's Care|A Comparative Pilot Study in an Infectious Disease Department Assessing the Impact of Medication Reconciliation at Discharge Associated With a Patient's Counseling Session, Both Provided by a Pharmacist, on Patient's Care After Discharge|Recruiting||N/A|120|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||t|f|f||||||No||2017-10-10 21:26:08.949874|2017-10-10 21:26:08.949874
NCT03029039|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-04-07|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31|1 Day|Observational [Patient Registry]|PlatISSep||Platelet-associated Inflammation in Severe Sepsis|Platelet-associated Inflammation in Severe Sepsis|Recruiting||N/A|135|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||3||f||||f|f|f||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 21:26:09.039394|2017-10-10 21:26:09.039394
NCT03029026|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-19|||September 2016||2016-09-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|ATTRact-AS||The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.|A sTudy invesTigating the Role of Occult cArdiaC Amyloid in The Elderly With Aortic Stenosis|Recruiting||N/A|250|Anticipated|Queen Mary University of London|||3||f||||f||||||Samples With DNA|"     Blood and urine samples will be biobanked for all patients (n=250). Endomyocardial biopsy     specimens will be snap frozen and biobanked for those patients undergoing sAVR (n=50).   "|||2017-10-10 21:26:09.156813|2017-10-10 21:26:09.156813
NCT03029013|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer|A Phase II Clinical Trial Study on Apatinib and Chemotherapy Sequential Treatment With Advanced Metastatic Cervical Cancer|Recruiting||N/A|30|Anticipated|Third Military Medical University||1|||f||||||||||||||2017-10-10 21:26:09.283261|2017-10-10 21:26:09.283261
NCT03029000|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-01|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|April 11, 2018|Anticipated|2018-04-11|April 11, 2018|Anticipated|2018-04-11||Interventional|GRANIX||Study of the Effect of a 5-day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Donors|A Single-Arm Study of the Effect of a 5-day Regimen of Tbo-Filgrastim 10 g/kg of Body Weight Administered Subcutaneously on Peripheral Stem Cell Mobilization in Healthy Donors|Recruiting||Phase 3|60|Anticipated|Teva Pharmaceutical Industries||1|||f||||f|t|f||||||||2017-10-10 21:26:09.356396|2017-10-10 21:26:09.356396
NCT03028987|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-08-10|2017-07-11||November 19, 2014|Actual|2014-11-19|July 2017|2017-07-01|November 18, 2015|Actual|2015-11-18|November 18, 2015|Actual|2015-11-18||Interventional|||Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)|Project 1. The Role of CD4+ Memory Phenotype, Memory, and Effector T-Cells in Vaccination and Infection - Influenza-specific DR1501+ and DR0701+ T-cells|Terminated||Phase 4|10|Actual|Stanford University||2||LAIV was no longer recommended by ACIP|f||||f||||||||||2017-10-10 21:26:09.476208|2017-10-10 21:26:09.476208
NCT03028974|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-10-03|||September 17, 2014|Actual|2014-09-17|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)|Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection|Active, not recruiting||Phase 4|72|Actual|Stanford University||7|||f||||f||||||||||2017-10-10 21:26:09.737998|2017-10-10 21:26:09.737998
NCT03028961|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-03-09|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|BMTSLPRCT||Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant|Randomized Clinical Study Comparing the Effectiveness of the Stanford Letter to the Traditional Advance Directive in Bone Marrow Transplant Recipients|Recruiting||N/A|126|Anticipated|Stanford University||2|||f||||t|f|f||||||||2017-10-10 21:26:09.830907|2017-10-10 21:26:09.830907
NCT03028948|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-21|||March 13, 2017|Actual|2017-03-13|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Stage 0-III Melanoma|Internet Intervention for Sun Protection and Skin Self-check Behaviors|Recruiting||N/A|420|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||||2017-10-10 21:26:09.921278|2017-10-10 21:26:09.921278
NCT03028935|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-08-03|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Exercise and Nutrition Program in Improving Physical Activity and Dietary Behavior in Non-Active, Overweight, or Obese Latinas|Fuerte y Sanas: Exercise and Nutrition Program in Improving Physical Activity and Dietary Behavior in Non-Active, Overweight, or Obese Latinas|Active, not recruiting||N/A|15|Actual|OHSU Knight Cancer Institute||1|||f||||f||||||||||2017-10-10 21:26:10.065706|2017-10-10 21:26:10.065706
NCT03028922|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-19|||October 2016||2016-10-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|November 2017|Anticipated|2017-11-01||Interventional|||A 1-year Clinical Investigation on the the CREOS™ XENOGAIN Bone Graft SUBSTITUTE|A Prospective, Multi-centre Study Evaluating Creos™ Xenogain Bone Graft Substitute in Horizontal Ridge Augmentation in the Premolar and Molar Region of the Mandible|Recruiting||N/A|42|Anticipated|Nobel Biocare||1|||f||||f||||||||||2017-10-10 21:26:10.13607|2017-10-10 21:26:10.13607
NCT03028909|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-04-05|||July 24, 2017|Anticipated|2017-07-24|April 2017|2017-04-01|July 26, 2019|Anticipated|2019-07-26|July 26, 2019|Anticipated|2019-07-26||Interventional|||Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.|A Phase 2b, Randomized, Double-blind, Single-dose, Active-controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Influenza Caused by Type A Strains|Withdrawn||Phase 2|0|Actual|MedImmune LLC||3||Study is withdrawn due to company decision.|f||||f||||||||||2017-10-10 21:26:10.234485|2017-10-10 21:26:10.234485
NCT03028896|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-19|||April 2, 2015|Actual|2015-04-02|January 2017|2017-01-01|January 19, 2017|Actual|2017-01-19|March 4, 2016|Actual|2016-03-04||Interventional|||90° Rotation Technique for LMA FlexibleTM Insertion|Comparison of Standard Versus 90° Rotation Technique for LMA FlexibleTM Insertion|Completed||N/A|138|Actual|Seoul National University Bundang Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 21:26:10.332819|2017-10-10 21:26:10.332819
NCT03028883|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-03-03|||January 2, 2017|Actual|2017-01-02|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Observational|||Buprenorphine Dose Adjustments and Gestational Age|Relationship Between Buprenorphine Dose Adjustments and Gestational Age in the Treatment of Opioid-Maintained Pregnant Women|Enrolling by invitation||N/A|50|Anticipated|St. Louis University|||1||f||||f||||||||No||2017-10-10 21:26:10.392956|2017-10-10 21:26:10.392956
NCT03028532|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-06-01|||March 13, 2017|Actual|2017-03-13|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting|Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting|Active, not recruiting||Phase 1|10|Anticipated|University of Utah||1|||f||||t|t|f||||||No||2017-10-10 21:26:14.855136|2017-10-10 21:26:14.855136
NCT03028857|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-07-13|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|January 2027|Anticipated|2027-01-01|January 2027|Anticipated|2027-01-01||Interventional|||Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal|Double-blind Trial of Phosphatidylcholine Supplementation During Pregnancy: Impact on Attention and Social Withdrawal at 4 Years of Age|Recruiting||Phase 1|600|Anticipated|University of Colorado, Denver||2|||f||||t|t|f||||||||2017-10-10 21:26:10.633067|2017-10-10 21:26:10.633067
NCT03028844|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-18|||April 2016||2016-04-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||The Effect of a Musical Intervention on Stress Response to Venepuncture|The Effect of a Musical Intervention on Stress Response to Venepuncture|Completed||N/A|20|Actual|University College Cork||2|||f||||f||||||||No||2017-10-10 21:26:12.386185|2017-10-10 21:26:12.386185
NCT03028831|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Fiber to Reduce Colon Cancer in Alaska Native People|Randomized Controlled Trial of Resistant Starch to Reduce Colon Cancer Risk in Alaska Native People.|Not yet recruiting||N/A|60|Anticipated|University of Pittsburgh||2|||f||||t||||||||Yes|we will use a public deposit when all the data analysis is completed|2017-10-10 21:26:12.466479|2017-10-10 21:26:12.466479
NCT03028818|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-19|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01|30 Days|Observational [Patient Registry]|||Fever Observational Study|An Observational Study of the Epidemiology of Fever Due to Infection in Critically Ill Children Following an Unplanned Admission to a Paediatric Intensive Care Unit|Enrolling by invitation||N/A|3960|Anticipated|Intensive Care National Audit & Research Centre|||1||f||||t|f|f||||||Undecided||2017-10-10 21:26:12.562009|2017-10-10 21:26:12.562009
NCT03028805|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01||||June 2018|Anticipated|2018-06-01||Interventional|EPICPath||Study of Automated Care Pathway for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Early Patient Identification and Care Pathway for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial of Informatics Enhanced Hospital Admission|Not yet recruiting||N/A|1000|Anticipated|University of California, San Francisco||4|||f||||f||||||||||2017-10-10 21:26:12.636981|2017-10-10 21:26:12.636981
NCT03028792|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-18|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|October 30, 2019|Anticipated|2019-10-30|September 1, 2019|Anticipated|2019-09-01||Interventional|||Attention Training for Underserved Youth With Anxiety|Attention Training for Underserved Youth With Anxiety|Not yet recruiting||N/A|52|Anticipated|University of California, Los Angeles||2|||f||||f|f|f||||||Yes|The proposed research will include data from approximately 52 subjects who are participating in a RCT examining the effectiveness of promotora delivered ABM vs. and active control condition for rural Latino youth with anxiety. The final dataset will include self-reported demographic, clinical symptom, functional impairment, and mental health service use data from questionnaires and interviews with the participants. The dataset will be stripped of identifiers prior to release for sharing. We will make the data and available to users under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed. This data will be a part of the NIMH data sharing repository - National Database for Clinical Trials Related to Mental Illness, and made available after study completion.|2017-10-10 21:26:12.738175|2017-10-10 21:26:12.738175
NCT03028779|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-19|||November 2016||2016-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Implementation of Fast-track Surgery Program for Total Hip and Knee Replacement and the Evaluation of the Risks and Benefits for the Patient|Implementation of Fast-track Surgery Program for Total Hip and Knee Replacement and the Evaluation of the Risks and Benefits for the Patient|Recruiting||N/A|150|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||No||2017-10-10 21:26:12.83338|2017-10-10 21:26:12.83338
NCT03028766|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-27|||June 22, 2017|Actual|2017-06-22|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|WISTERIA||WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer|A Phase I Trial of WEE1 Inhibition With Chemotherapy and Radiotherapy as Adjuvant Treatment, and a Window of Opportunity Trial With Cisplatin in Patients With Head and Neck Cancer|Recruiting||Phase 1|42|Anticipated|University of Birmingham||2|||f||||f|f|f|||f|||||2017-10-10 21:26:12.976854|2017-10-10 21:26:12.976854
NCT03028753|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-18|||August 2016||2016-08-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Interventional|||Accuracy of Bladder Scanners in Post-operative Voiding Trials|Accuracy of Bladder Scanners in Post-operative Voiding Trials|Recruiting||N/A|110|Anticipated|Tufts Medical Center||1|||f||||f||||||||||2017-10-10 21:26:13.076875|2017-10-10 21:26:13.076875
NCT03028740|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-07|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|October 31, 2024|Anticipated|2024-10-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH|AURORA: A Phase 3 Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis|Recruiting||Phase 3|2000|Anticipated|Tobira Therapeutics, Inc.||2|||f||||t|t|f||||||No||2017-10-10 21:26:13.278918|2017-10-10 21:26:13.278918
NCT03028727|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-01-19|||March 2013||2013-03-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Diode Laser Therapy As An Adjunct To Scaling And Root Planing|Diode Laser Therapy As An Adjunct To Non-Surgical Management Of Chronic Periodontitis - A Pilot Study|Completed||N/A|40|Actual|KLE Society's Institute of Dental Sciences||2|||f||||t||||||||No||2017-10-10 21:26:13.378958|2017-10-10 21:26:13.378958
NCT02982525|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-02|||November 28, 2016|Actual|2016-11-28|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|April 20, 2017|Actual|2017-04-20||Interventional|Mussel||Mussel Intake and Vitamin D Status in Humans|Effect of Mussel Intake on Vitamin D Status Study|Active, not recruiting||N/A|20|Anticipated|University of Aberdeen||4|||f||||f||||||||No||2017-10-10 21:33:35.068258|2017-10-10 21:33:35.068258
NCT03028714|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-03-09|||January 26, 2017|Actual|2017-01-26|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||The Impact of Online Quiz-games on Nutrition Knowledge and Related Outcomes Among University Students.|The Impact of an Educational Intervention on Nutrition Knowledge, Dietary Habits, BMI and Physical Activity, in University Students in the United Kingdom (UK).|Recruiting||N/A|130|Anticipated|Kingston University||2|||f||||f|f|f||||||Yes||2017-10-10 21:26:13.483191|2017-10-10 21:26:13.483191
NCT03028701|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-03-10|||September 2015|Actual|2015-09-01|January 2017|2017-01-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|COPD||Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD|Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|33|Actual|Neutec Ar-Ge San ve Tic A.Ş||1|||f||||f||||||||No||2017-10-10 21:26:13.631173|2017-10-10 21:26:13.631173
NCT03028688|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-07|||June 21, 2017|Actual|2017-06-21|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||HIFLO ENDO-High Flow Nasal Cannula in GI Endoscopy|HIFLO ENDO- Use of High Flow Nasal Cannula Oxygenation to Increase Patient Safety During Upper GI Endoscopy|Recruiting||N/A|262|Anticipated|University of Maryland||2|||f||||t|f|f||||||||2017-10-10 21:26:13.759506|2017-10-10 21:26:13.759506
NCT03028675|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-07-13|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||pH Imaging in Multiple Sclerosis|pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic Stress|Recruiting||Phase 4|20|Anticipated|New York University School of Medicine||2|||f||||f|t|f|||t|||||2017-10-10 21:26:13.876992|2017-10-10 21:26:13.876992
NCT03028662|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-02-07|||January 2016||2016-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||New Therapeutic Strategies for the Treatment of Alcohol Use Disorders|New Therapeutic Strategies for the Treatment of Alcohol Use Disorders|Recruiting||N/A|115|Anticipated|Hospital Universitario 12 de Octubre||3|||f||||f||||||||No||2017-10-10 21:26:13.983768|2017-10-10 21:26:13.983768
NCT03028649|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-18|||January 2010||2010-01-01|January 2017|2017-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Effect of β-hydroxy-β-methylbutyrate Supplementation on Physical Capacity and Body Composition in Trained Athletes|The Effect of β-hydroxy-β-methylbutyrate (HMB) Supplementation on Physical Capacity and Body Composition in Trained Athletes|Completed||Phase 3|58|Actual|Poznan University of Medical Sciences||2|||f||||f||||||||Undecided|Shared data will be exclusively related to the level recorded indicators (body composition, aerobic and anaerobic capacity indicators, levels of biochemical markers), without personal data. The data obtained will be attached to scientific publications, depending on the requirements of the journal|2017-10-10 21:26:14.088644|2017-10-10 21:26:14.088644
NCT03028636|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-18|||September 2016||2016-09-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|1 Year|Observational [Patient Registry]|LIBERATEPRO||LIBERATE - PRO: Eclipse™ System Registry|LIBERATE - PRO: An Extended Use Registry to Further Develop Understanding of the Long Term Use of the Eclipse™ System for Fecal Incontinence in Women Via Patient Reported Outcomes|Enrolling by invitation||N/A|70|Anticipated|Pelvalon, Inc.|||1||f||||f||||||||No||2017-10-10 21:26:14.184114|2017-10-10 21:26:14.184114
NCT03028623|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-05-02|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery|A Randomized Controlled Trial of Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery|Recruiting||N/A|36|Anticipated|University of Virginia||2|||f||||f|f|f||||||No||2017-10-10 21:26:14.258874|2017-10-10 21:26:14.258874
NCT03028610|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-07-11|||January 2016||2016-01-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Pregnancy Outcome Following Global Fibroid Ablation Using the Acessa™ System|Pregnancy Outcome Following Global Fibroid Ablation Using the Acessa™ System|Recruiting||N/A|25|Anticipated|University Women's Hospital Tübingen||1|||f||||f||||||||||2017-10-10 21:26:14.33614|2017-10-10 21:26:14.33614
NCT03028597|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-29|||January 2017||2017-01-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Interventional|||Using Values Affirmation to Reduce the Effects of Perceived Discrimination on Hypertension Disparities|Using Values Affirmation to Reduce the Effects of Perceived Discrimination on Hypertension Disparities|Recruiting||N/A|1330|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 21:26:14.409194|2017-10-10 21:26:14.409194
NCT03028584|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-09-06|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|January 31, 2018|Anticipated|2018-01-31||Observational|||Survivorship Care Plans in a Community Oncology Practice|Feasibility of Delivering Electronic Health Record (EHR)-Based Survivorship Care Plans and Planning to Cancer Survivors in a Community Oncology Practice|Not yet recruiting||N/A|30|Anticipated|University of Wisconsin, Madison|||2||f||||t||||||||||2017-10-10 21:26:14.508497|2017-10-10 21:26:14.508497
NCT03028571|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-06-01|||February 17, 2017|Actual|2017-02-17|June 2017|2017-06-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||Autonomic Blockade and Endogenous Glucose Production|Acute Sympathetic Blockade and Endogenous Glucose Production|Recruiting||Phase 1|12|Anticipated|Vanderbilt University Medical Center||2|||f|||||t|f||||||||2017-10-10 21:26:14.613444|2017-10-10 21:26:14.613444
NCT03028558|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-23|||January 2017||2017-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Biology of the Oral Epithelium of E-Cigarette Smokers|Biology of the Oral Epithelium of E-Cigarette Smokers|Recruiting||N/A|125|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||Samples With DNA|"     Specimens collected may include blood, urine and oral epithelium samples from consenting     subjects. Subjects will include both e-cigarette smoking individuals and healthy control     subjects.   "|Undecided||2017-10-10 21:26:14.693372|2017-10-10 21:26:14.693372
NCT03028545|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-02|||January 4, 2017|Actual|2017-01-04|February 2017|2017-02-01|January 31, 2019|Anticipated|2019-01-31|September 29, 2018|Anticipated|2018-09-29||Interventional|EPR||Representations and Strategies for Recovery|Representations, Strategies and Identity Redefinition in the Recovery Process: Exploratory Study|Recruiting||N/A|80|Anticipated|Hôpital le Vinatier||4|||f||||f|f|f||||||No||2017-10-10 21:26:14.765369|2017-10-10 21:26:14.765369
NCT03028519|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-19|||January 2016||2016-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer|Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer|Recruiting||N/A|70|Anticipated|University of Oklahoma||1|||f||||t||||||||||2017-10-10 21:26:14.94626|2017-10-10 21:26:14.94626
NCT03028506|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-21|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Meal Composition and the Influence on Pre-prandial Blood Glucose Values|Meal Composition and Frequency in Type 1 Diabetic Women and the Influence on Pre-prandial Blood Glucose Values and Fetal Weight.|Completed||N/A|50|Actual|St. Louis University|||1||f||||f|f|f||||||||2017-10-10 21:26:15.137388|2017-10-10 21:26:15.137388
NCT03028493|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-01|||January 18, 2017|Actual|2017-01-18|August 2017|2017-08-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Increasing the Accessibility of a Falls Prevention Intervention for Community Dwelling Older Adults With Low Vision|Increasing the Accessibility of a Falls Prevention Intervention for Community Dwelling Older Adults With Low Vision|Active, not recruiting||N/A|9|Actual|University of Alabama at Birmingham||2|||f||||t|f|f||||||||2017-10-10 21:26:15.210171|2017-10-10 21:26:15.210171
NCT03028480|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-26|||January 2017||2017-01-01|January 2017|2017-01-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Observational|||Long Term Special Drug Use Investigation of Mepolizumab|Nucala® Subcutaneous Injection Special Drug Use Investigation (Long-Term)|Active, not recruiting||N/A|1|Anticipated|GlaxoSmithKline|||1||f||||f||||||||||2017-10-10 21:26:15.303156|2017-10-10 21:26:15.303156
NCT03028454|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-07-25|||January 2017||2017-01-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|June 2017|Actual|2017-06-01||Interventional|||Effects of Ginger on Muscle Soreness and Dysfunction Stemming From Downhill Running|Effects of Ginger on Muscle Soreness and Dysfunction Stemming From Downhill Running|Recruiting||N/A|60|Anticipated|Old Dominion University||2|||f||||f||||||||||2017-10-10 21:26:15.533722|2017-10-10 21:26:15.533722
NCT03028441|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-03-02||||||January 17, 2017|2017-01-17||||December 8, 2018|Anticipated|2018-12-08||Interventional|||Phase I Trial of Measles Vectored Chikungungya Vaccine|A Phase 1, Double Blinded, Placebo Controlled, Dose Comparison Trial to Evaluate the Safety, Immunogenicity and Schedule of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults|Not yet recruiting||Phase 1|180|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f|||||t|f|||f|||||2017-10-10 21:26:15.627919|2017-10-10 21:26:15.627919
NCT03028428|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-02-03|||December 2016||2016-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intra-articular Injection of MSCs in Treatment of Knee OA|Clinical Research on Intra-articular Injection of Human Autologous MSCs in Treatment of Knee OA|Active, not recruiting||Phase 2|1|Anticipated|Affiliated Hospital of Jiangsu University||2|||f||||||||||||||2017-10-10 21:26:15.74892|2017-10-10 21:26:15.74892
NCT03028415|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-10-04|||July 28, 2017|Actual|2017-07-28|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||AMPLEX Ankle Fusion|A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX® Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle|Recruiting||N/A|480|Anticipated|Ferring Pharmaceuticals||2|||f||||t|f|t|t|||||||2017-10-10 21:26:15.842707|2017-10-10 21:26:15.842707
NCT03028402|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-02-07|||April 2016||2016-04-01|February 2017|2017-02-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||Adjacent Segment Mechanics in Cervical Arthrodesis Patients|Adjacent Segment Mechanics in Cervical Arthrodesis Patients|Recruiting||N/A|110|Anticipated|University of Pittsburgh|||5||f||||f||||||||No||2017-10-10 21:26:16.025766|2017-10-10 21:26:16.025766
NCT03028389|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-19|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|LRIP-D||Effects of Limb Remote Ischemic Preconditioning for Prevention of Delirium in Elderly Patients After Non-cardiac Surgery|Effects of Limb Remote Ischemic Preconditioning for Prevention of Delirium in Elderly Patients After Non-cardiac Surgery:a Randomised, Double-blind, Placebo-controlled Trial|Not yet recruiting||N/A|611|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t|f|f||||||No||2017-10-10 21:26:16.133488|2017-10-10 21:26:16.133488
NCT03028376|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-10-04|||February 15, 2017|Actual|2017-02-15|October 2016|2016-10-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|PreTBI II||Biomarkers in Prehospital Prediction of Need for Neurosurgical Observation or Intervention in TBI Patients|S100B and Glial Fibrillary Acidic Protein (GFAP) in Prehospital Prediction of Need for Neurosurgical Observation or Intervention in Patients Suffering Moderate Traumatic Brain Injury (TBI)|Recruiting||N/A|100|Anticipated|University of Aarhus|||1||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-10 21:26:16.222942|2017-10-10 21:26:16.222942
NCT03028363|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-05|||December 27, 2016|Actual|2016-12-27|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris|A Randomized, Double-blind, Vehicle Controlled, Efficacy and Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris|Active, not recruiting||Phase 3|759|Actual|Dermira, Inc.||2|||f||||f||||||||||2017-10-10 21:26:16.331426|2017-10-10 21:26:16.331426
NCT03028350|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-12|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)|A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects With Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)|Recruiting||Phase 2|76|Anticipated|Cumberland Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 21:26:16.513404|2017-10-10 21:26:16.513404
NCT03028337|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-29|||January 18, 2017|Actual|2017-01-18|September 2017|2017-09-01|January 18, 2022|Anticipated|2022-01-18|January 18, 2022|Anticipated|2022-01-18||Interventional|||Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases|Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases: a Randomized Phase II Clinical Trial|Recruiting||Phase 2|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|f|f||||||||2017-10-10 21:26:16.63737|2017-10-10 21:26:16.63737
NCT03028324|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)|Investigating the Use of Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)|Not yet recruiting||N/A|10|Anticipated|University of Miami||1|||f||||f||||||||No||2017-10-10 21:26:16.72466|2017-10-10 21:26:16.72466
NCT03028311|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||January 9, 2017|Actual|2017-01-09|January 2017|2017-01-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment|Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment|Recruiting||N/A|12|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|t|f|f||||||2017-10-10 21:26:16.806388|2017-10-10 21:26:16.806388
NCT03028298|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-19|||December 2016||2016-12-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Sildenafil for DCI|Sildenafil for the Treatment of Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage|Recruiting||Phase 1|24|Anticipated|University of Mississippi Medical Center||2|||f||||t||||||||No||2017-10-10 21:26:16.901733|2017-10-10 21:26:16.901733
NCT03028285|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-20|||April 2016||2016-04-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers|"Open Randomized Study of the Safety, Tolerability, and Pharmacokinetic Parameters of UNIFUZOL® (Solution for Infusions, 1.4%, Manufactured by NTFFPOLYSAN  Ltd.,Russia) in Healthy Volunteers at Different Rates of Administration (Phase I)"|Recruiting||Phase 1|48|Anticipated|Scientific Technological Pharmaceutical Firm Polysan, Ltd.||3|||f||||f||||||||Undecided||2017-10-10 21:26:16.988559|2017-10-10 21:26:16.988559
NCT03028272|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-19|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft vs. Fascia for Tympanoplasty|Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft Versus Fascia for Tympanoplasty: A Randomized Prospective Trial|Enrolling by invitation||N/A|50|Anticipated|University of Missouri-Columbia||2|||f||||f|f|f||||||No|The investigators do not intend to share individual participant data to other researchers. Analyzed data will be published in peer-review journal.|2017-10-10 21:26:17.088679|2017-10-10 21:26:17.088679
NCT03028259|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-19|||June 2014||2014-06-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|May 2015|Actual|2015-05-01||Observational|||Glucose Variability|Does Plasma Glucose Variability in Obese Diabetic Pregnancies Influence Maternal or Neonatal Outcomes?|Enrolling by invitation||N/A|243|Anticipated|St. Louis University|||1||f||||f||||||||No||2017-10-10 21:26:17.161529|2017-10-10 21:26:17.161529
NCT03028246|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-08-01|||January 12, 2017||2017-01-12|August 2017|2017-08-01|January 15, 2019|Anticipated|2019-01-15|January 15, 2019|Anticipated|2019-01-15||Interventional|||A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects|A Feasibility Safety Study Using the ExAblate 4000 System in the Management of Benign Centrally-Located Intracranial Tumors Which Require Clinical Intervention in Pediatric and Young Adult Subjects|Recruiting||N/A|10|Anticipated|InSightec||1|||f||||t||||||||||2017-10-10 21:26:17.220873|2017-10-10 21:26:17.220873
NCT03028233|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-19|||September 2014||2014-09-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|||Healthy Kids & Families: Overcoming Social, Environmental and Family Barriers to Childhood Obesity Prevention|Healthy Kids & Families: Overcoming Social, Environmental and Family Barriers to Childhood Obesity Prevention|Recruiting||N/A|480|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||No||2017-10-10 21:26:17.305363|2017-10-10 21:26:17.305363
NCT03028220|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-09-01|||January 2016||2016-01-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|February 2017|Actual|2017-02-01||Interventional|I HART CGM||Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose Data|Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous|Completed||N/A|40|Actual|Imperial College London||2|||f||||f||||||||||2017-10-10 21:26:17.561042|2017-10-10 21:26:17.561042
NCT03028207|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-04-21|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||A Cross-sectional Study on COPD Prevalence|New Study on the Prevalence of COPD in Spain EPI-Scan-II Study|Recruiting||N/A|10200|Anticipated|GlaxoSmithKline|||2||f||||f|f|f||||||No||2017-10-10 21:26:17.678028|2017-10-10 21:26:17.678028
NCT03028194|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-20|||October 1, 2015|Actual|2015-10-01|January 2017|2017-01-01|December 11, 2016|Actual|2016-12-11|October 31, 2016|Actual|2016-10-31||Interventional|||Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia|Effects of Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia: A Randomized, Controlled Trial|Completed||N/A|442|Actual|Saint Thomas Hospital, Panama||2|||f||||f|f|f||||||No||2017-10-10 21:26:17.862763|2017-10-10 21:26:17.862763
NCT03028181|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-20|||January 2014||2014-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||The Evaluation of Pro/Antioxidative Profile and Diagnostic Parameters in the Patients With Pancreatic Disease|The Evaluation of Pro/Antioxidative Profile and Diagnostic Parameters in the Patients With Acute Pancreatitis|Completed||N/A|34|Actual|Wroclaw Medical University|||4||f||||f||||||Samples With DNA|"     The blood samples taking into tubes containing heparin, EDTA and serum clotting activator to     obtain plasma, erythrocyte lysate and serum.   "|No||2017-10-10 21:26:18.003388|2017-10-10 21:26:18.003388
NCT03028168|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-20|||August 2012||2012-08-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Yôga and Breathing Techniques Training in Patients With Heart Failure and Preserved Ejection Fraction|Yôga and Breathing Techniques Training in Patients With Heart Failure and Preserved Ejection Fraction: Study Protocol for a Randomized Clinical Trial|Recruiting||N/A|33|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||Undecided||2017-10-10 21:26:18.113081|2017-10-10 21:26:18.113081
NCT03028155|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-01-19|||November 2016||2016-11-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|COBOX||Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' Treatment|Concentration-based Versus Body Surface Area-based Peroperative Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery in Colorectal Peritoneal Carcinomatosis' Treatment - Randomized Non-blinded Phase III Clinical Trial|Recruiting||Phase 3|60|Anticipated|Hasselt University||2|||f||||f||||||||No||2017-10-10 21:26:18.261224|2017-10-10 21:26:18.261224
NCT03028142|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-09|||January 2017||2017-01-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||The Effects of RPL554 in Addition to Tiotropium in COPD Patients||Completed||Phase 2|30|Anticipated|Verona Pharma plc||3|||f||||f||||||||||2017-10-10 21:26:18.383852|2017-10-10 21:26:18.383852
NCT03028129|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-08-30|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Prevention of Tuberculosis in Prisons|Primary Prophylaxis for Prevention of TB in Prison's Populations|Not yet recruiting||Phase 4|728|Anticipated|Federal University of Mato Grosso do Sul||2|||f||||f|f|f|||f|||||2017-10-10 21:26:18.514457|2017-10-10 21:26:18.514457
NCT03028116|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-20|||May 2016||2016-05-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|VSI||Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine|A Randomized, Blinded, Placebo-controlled Study of Phase I Allantoic Split Inactivated Seasonal Influenza Vaccine in Healthy Adults|Completed||Phase 1|44|Actual|Research Institute for Biological Safety Problems||2|||f||||t|f|f||||||Undecided||2017-10-10 21:26:18.699888|2017-10-10 21:26:18.699888
NCT03028103|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-06-19|||March 27, 2017|Actual|2017-03-27|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, the Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and the Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma Subjects|An Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize the Effects of a Moderate CYP3A Inhibitor on the Pharmacokinetics of Tazemetostat (EPZ-6438) (Part A), the Effects of Tazemetostat on the Pharmacokinetics of CYP2C8 and CYP2C19 Substrates, and the Effect of Increased Gastric pH on the Pharmacokinetics of Tazemetostat (Part B) in Subjects With B-cell Lymphoma|Recruiting||Phase 1|28|Anticipated|Epizyme, Inc.||1|||f||||f|t|f||||||No||2017-10-10 21:26:18.841964|2017-10-10 21:26:18.841964
NCT03028090|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-18|||November 2013||2013-11-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|MODUS||Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System|A Two-Arm Prospective, Multi-Centered Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System|Completed||N/A|182|Actual|C. R. Bard|||1||f||||||||||||||2017-10-10 21:26:18.972912|2017-10-10 21:26:18.972912
NCT03028077|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-18|||October 2014||2014-10-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of GS-3K8 and GINst15 on Acute Respiratory Illness|The Efficacy and Safety of GS-3K8 and GINst15 on Acute Respiratory Illness in Healthy Subjects|Completed||N/A|45|Actual|Chonbuk National University Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:26:19.050395|2017-10-10 21:26:19.050395
NCT03028064|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|POCGIB||Point of Care Testing of Platelet Function in Patients With Acute Upper Gastrointestinal Bleeding|Point of Care Testing of Platelet Function in Patients With Acute Upper Gastrointestinal Bleeding|Recruiting||N/A|476|Anticipated|Chinese University of Hong Kong|||1||f||||||||||||Undecided||2017-10-10 21:26:19.148455|2017-10-10 21:26:19.148455
NCT03028051|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-24|||September 2014||2014-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Chronic Pain, Life Style Factors and Quality of Life|Chronic Pain, Life Style Factors and Quality of Life|Completed||N/A|477|Actual|Helsinki University Central Hospital|||1||f||||f||||||Samples Without DNA|"     Blood samples frozen for possible further biochemical analysis (vitamin D, S-PTH, S-TSH,     cytokines, P-Ca++)   "|No||2017-10-10 21:26:19.230023|2017-10-10 21:26:19.230023
NCT03028038|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-26|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|May 2017|Actual|2017-05-01||Interventional|||Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion|Evaluation of Efficacy of Injectable Platelet-Rich Plasma (PRP) in Reducing Alveolar Bone Resorption Following Rapid Maxillary Expansion (RME): A Cone Beam Computed Tomography (CBCT) Assessment|Active, not recruiting||Phase 1|16|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 21:26:19.303951|2017-10-10 21:26:19.303951
NCT03028025|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-10|||February 16, 2017|Actual|2017-02-16|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Comparing TR Band to Statseal in Conjunction With TR Band|A Prospective Randomized Study Comparing the Incidence of Radial Artery Occlusion (RAO) and the Time To Hemostasis (TTH) When Using a Hemostasis Band Alone and in Conjunction With a Disc Comprised of Potassium Ferrate (StatSeal Advanced) Following Transradial Percutaneous Coronary Intervention (PCI)|Recruiting||N/A|180|Anticipated|VA Long Beach Healthcare System||2|||f|||||f|t|f|f||||||2017-10-10 21:26:19.416908|2017-10-10 21:26:19.416908
NCT03028012|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-06-21|||May 2, 2017|Actual|2017-05-02|June 2017|2017-06-01|March 20, 2018|Anticipated|2018-03-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone|Double-blind, Prospective Comparison of Medications Used in Trigger Point Injections - Ketorolac, Lidocaine, or Dexamethasone|Recruiting||Phase 4|90|Anticipated|University of Utah||3|||f||||t|t|f||||||No||2017-10-10 21:26:19.576381|2017-10-10 21:26:19.576381
NCT03027999|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-08-29|||May 5, 2017|Actual|2017-05-05|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|SIERRA||Efficiency of a Tight Monitoring by a Nurse Practitioner of Rheumatoid Arthritis (RA) Patients in Remission|Efficiency of a Tight Monitoring by a Nurse Practitioner of Rheumatoid Arthritis (RA) Patients in Remission (or Low Disease Activity) Under Rituximab to Detect Early Relapse of the Disease|Recruiting||N/A|88|Anticipated|University Hospital, Rouen||2|||f||||f|f|f||||||||2017-10-10 21:26:19.759128|2017-10-10 21:26:19.759128
NCT03027804|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-19|||August 5, 2017|Anticipated|2017-08-05|July 2017|2017-07-01|August 5, 2017|Anticipated|2017-08-05|August 5, 2017|Anticipated|2017-08-05|5 Years|Observational [Patient Registry]|ROFDA||Ross Operation Failure Database|Database on Ross Operation Failures and Outcomes|Enrolling by invitation||N/A|15000|Anticipated|Centre Cardiologique du Nord|||1||f||||f||||||||||2017-10-10 21:26:21.212015|2017-10-10 21:26:21.212015
NCT03027986|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-08-29|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|PROTOMEN||Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy|Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy|Not yet recruiting||N/A|116|Anticipated|University Hospital, Rouen||2|||f||||f|f|f||||||||2017-10-10 21:26:19.928105|2017-10-10 21:26:19.928105
NCT03027973|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-18|||February 2017||2017-02-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|||Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding|Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding: A Pilot Randomized Control Trial|Not yet recruiting||Phase 1|60|Anticipated|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 21:26:20.052255|2017-10-10 21:26:20.052255
NCT03027960|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-27|||June 27, 2017|Actual|2017-06-27|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|EMPA||Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects|Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects|Enrolling by invitation||Phase 2|50|Anticipated|Yale University||2|||f||||f|t|f|||f|||No||2017-10-10 21:26:20.153478|2017-10-10 21:26:20.153478
NCT03027947|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-05-04|||March 16, 2017|Actual|2017-03-16|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Spinal Root and Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees|Spinal Root and Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees|Recruiting||N/A|10|Anticipated|University of Pittsburgh||1|||f||||t|f|t|f|f||||Yes|The investigators may share data with researchers at other centers for the purpose of data analysis and collaboration.|2017-10-10 21:26:20.234033|2017-10-10 21:26:20.234033
NCT03027934|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-18|||August 28, 2017|Anticipated|2017-08-28|July 2017|2017-07-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response|A Single Center, Randomized, Open Label, Crossover Study With Ticagrelor and Prasugrel to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response|Not yet recruiting||Phase 4|12|Anticipated|CirQuest Labs, LLC||2|||f||||f|t|f|||f|||||2017-10-10 21:26:20.321138|2017-10-10 21:26:20.321138
NCT03027921|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-19|||February 2017||2017-02-01|January 2017|2017-01-01||||February 2018|Anticipated|2018-02-01||Interventional|DECHO2||Validation in a Non-targeted Population of Single Ultrasound Doppler Signs of Liver Fibrosis|Validation in a Non-targeted Population (Screening) of Single Ultrasound Doppler Signs of Liver Fibrosis|Not yet recruiting||N/A|1500|Anticipated|University Hospital, Angers||1|||f||||||||||||||2017-10-10 21:26:20.388036|2017-10-10 21:26:20.388036
NCT03027908|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-18|||October 2016||2016-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study to Measure the Effect of Two Fluoride Toothpastes on Gingival Health Over a Six Month Period|A Study to Measure the Effect of Two Fluoride Toothpastes on Gingival Health Over a Six Month Period|Active, not recruiting||N/A|240|Anticipated|Unilever R&D||2|||f||||f||||||||No||2017-10-10 21:26:20.459155|2017-10-10 21:26:20.459155
NCT03027895|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Endoscopic Ultrasound-guided Drainage of Walled Off Necrosis (WON)|Endoscopic Ultrasound-guided Drainage of Walled Off Necrosis (WON)|Not yet recruiting||N/A|60|Anticipated|Changhai Hospital||2|||f||||t||||||||No||2017-10-10 21:26:20.540258|2017-10-10 21:26:20.540258
NCT03027882|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-04-24|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||Determining the Reliability and Validity of the Swing Test|Determining the Reliability and Validity of the Swing Test|Recruiting||N/A|50|Anticipated|Shenandoah University|||1||f||||||||||||||2017-10-10 21:26:20.602152|2017-10-10 21:26:20.602152
NCT03027869|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-05|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Normal_tDCS||Normal Brain Imaging Database for Brain Disorder Studies|Normal Brain Imaging Database for Brain Disorder Studies|Recruiting||N/A|40|Anticipated|University of Manitoba||3|||f|||||f|t|f|f|t|||||2017-10-10 21:26:20.677741|2017-10-10 21:26:20.677741
NCT03027856|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-17|||September 2016||2016-09-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|September 2018|Anticipated|2018-09-01||Interventional|BIFSORB P-II||The BIFSORB Pilot Study II|A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions - The BIFSORB Pilot Study II|Recruiting||N/A|20|Anticipated|Aarhus University Hospital Skejby||1|||f||||t||||||||||2017-10-10 21:26:20.758737|2017-10-10 21:26:20.758737
NCT03027843|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-19|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|August 2019|Anticipated|2019-08-01||Interventional|||The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder|A Pilot Study of the Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder|Not yet recruiting||Phase 4|80|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 21:26:20.870415|2017-10-10 21:26:20.870415
NCT03027830|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-20|||March 2014|Actual|2014-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||iFR Pressure Wires in Assessment of the Provisional Side-branch Intervention Strategy for Bifurcation Lesions|Physiological and Clinical Assessment of the Provisional Side-branch Intervention Strategy for Coronary Bifurcation Lesions Using iFR Pressure Wires|Completed||N/A|50|Actual|Nova-Med Medical Research Association||2|||f||||t|f|f||||||No||2017-10-10 21:26:20.944706|2017-10-10 21:26:20.944706
NCT03027817|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-20|||November 2014||2014-11-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Cardiac Output and Other Hemodynamic Changes With Prone Position in Cervical Myelopathy Patients Undergoing Surgery|Cardiac Output and Other Hemodynamic Changes With Prone Position in Cervical Myelopathy Patients Undergoing Surgery|Completed||N/A|30|Actual|National Institute of Mental Health and Neuro Sciences, India|||1||f||||f||||||||No|There is no plan to share IPD with other researchers. If required, the Sponsor-Investigator may be contacted via email shared on this portal.|2017-10-10 21:26:21.009042|2017-10-10 21:26:21.009042
NCT03027791|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SoHELP||Sodium Healthy Living Project|Sodium Healthy Living Project|Not yet recruiting||N/A|50|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||No||2017-10-10 21:26:21.297637|2017-10-10 21:26:21.297637
NCT03027778|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-19|||February 2015||2015-02-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|November 2015|Actual|2015-11-01||Interventional|||Intradialytic Pedalling Exercise and Vascular Hemodynamic Parameters Among Prevalent Hemodialysis Population|Intradialytic Pedalling Exercise and Vascular Hemodynamic Parameters Among Prevalent Hemodialysis Population|Active, not recruiting||N/A|40|Anticipated|McGill University Health Center||2|||f||||t||||||||No||2017-10-10 21:26:21.395176|2017-10-10 21:26:21.395176
NCT03027765|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-20|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Observational|||Prevalence of Constructed Space Maintainers in a Group of Egyptian Children|Prevalence of Constructed Space Maintainers in a Group of Egyptian Children Attending Pediatric Dentistry Department, Faculty of Oral and Dental Medicine Cairo University. A Cross-Sectional Study|Not yet recruiting||N/A|1500|Anticipated|Cairo University|||2||f||||f||||||||No||2017-10-10 21:26:21.480818|2017-10-10 21:26:21.480818
NCT03027752|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-31|||December 2016||2016-12-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pilot Study of Autoarterial Remodeling of Bifurcation of the Common Carotid Artery|The New Technique of Carotid Endarterectomy With Autoarterial Remodeling of Bifurcation of the Common Carotid Artery.|Recruiting||N/A|200|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 21:26:21.557067|2017-10-10 21:26:21.557067
NCT03027739|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-19|||November 2016||2016-11-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|CCFMPCA||CART-19 Cells For MRD Positive CD19+ ALL|CART-19 Cells For Patients With Minimal Residual Disease (MRD) Positive CD19+ Acute Lymphoblastic Leukemia|Recruiting||Phase 2/Phase 3|20|Anticipated|Fujian Medical University||1|||f||||f||||||||No||2017-10-10 21:26:21.650029|2017-10-10 21:26:21.650029
NCT03027726|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-03-08|||March 7, 2017|Actual|2017-03-07|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|September 30, 2018|Anticipated|2018-09-30||Interventional|PREDIKID||Prevention of Diabetes in Overweight/Obese Preadolescent Children|Prevention of Diabetes in Overweight/Obese Preadolescent Children Through a Family-based Intervention Program Including Supervised Exercise; the PREDIKID Study|Recruiting||N/A|84|Anticipated|Basque Country University||2|||f||||f|f|f||||||||2017-10-10 21:26:21.735041|2017-10-10 21:26:21.735041
NCT03027713|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2017-01-19|||June 2009||2009-06-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|NAVA||Diaphragmatic Activity During Weaning With NAVA, a Pilot Study (NAVA: Neurally Adjusted Ventilatory Assist)|Diaphragmatic Activity During a Postoperative Rapid Weaning Protocol With Neurally Adjusted Ventilatory Assist in Healthy Lung Patients, a Pilot Study.|Completed||N/A|40|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f|f|f||||||Yes|Shared data will be anonymous|2017-10-10 21:26:21.826169|2017-10-10 21:26:21.826169
NCT03027700|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-07-28|||January 26, 2017|Actual|2017-01-26|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Methods to Detect Liver Fibrosis|Comparison of Non-invasive Methods to Detect and Quantify Liver Fibrosis|Recruiting||N/A|32|Anticipated|Children's Hospital Medical Center, Cincinnati||4|||f||||f|f|f||||||||2017-10-10 21:26:21.901769|2017-10-10 21:26:21.901769
NCT03027687|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-19|||November 2016||2016-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Repetitive tDCS on Cigarette Consumption: EMA and EEG Study|The Longitudinal Effects of Repetitive tDCS on Cigarette Consumption: An EMA and EEG Study|Recruiting||N/A|60|Anticipated|Erasmus Medical Center||2|||f||||f||||||||No||2017-10-10 21:26:22.007531|2017-10-10 21:26:22.007531
NCT03027674|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-19|||August 2016||2016-08-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud|"Color Doppler Ultrasound Comparison of Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud: A Randomized, Double-blind, Placebo-controlled Pilot Study"|Completed||Early Phase 1|10|Actual|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||No||2017-10-10 21:26:22.105429|2017-10-10 21:26:22.105429
NCT03027661|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-30|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.|Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.|Not yet recruiting||N/A|46|Anticipated|University of Tennessee||2|||f||||f|f|f||||||No||2017-10-10 21:26:22.200127|2017-10-10 21:26:22.200127
NCT03027635|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-20|||December 2016||2016-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|PETRA||PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis|Tunnelated Peritoneal Catheter Versus Repeated Large Volume Paracentesis for Diuretic Resistant Ascites in Patients With Cirrhosis: An Investigator Initiated, Open, Parallel Arm Randomized Controlled Trial|Active, not recruiting||N/A|32|Actual|Copenhagen University Hospital, Hvidovre||2|||f||||t||||||||Undecided|Due to Danish Legislation only anonymized data may be available upon request|2017-10-10 21:26:22.38824|2017-10-10 21:26:22.38824
NCT03027622|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-13|||January 2016||2016-01-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Observational|||The Effects of Active Surveillance Protocol on Long Term Quality of Life in Patients With Mild Pericoronitis|The Effects of Active Surveillance Protocol on Long Term Quality of Life in Patints With Mild Pericoronitis|Completed||N/A|55|Actual|Ankara University|||1||f||||f||||||||Undecided||2017-10-10 21:26:22.474482|2017-10-10 21:26:22.474482
NCT03027609|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-02|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Aerucin® in P. Aeruginosa Pneumonia|Placebo-controlled, Double-blind, Randomized Study of Aerucin® as Adjunct Therapy to Antibiotics in the Treatment of P. Aeruginosa Pneumonia|Recruiting||Phase 2|108|Anticipated|Aridis Pharmaceuticals, Inc.||2|||f||||t|t|f||||||No||2017-10-10 21:26:22.542997|2017-10-10 21:26:22.542997
NCT03027596|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|RIC in burns||Remote Ischemic Conditioning to Reduce Burn Wound Progression|Remote Ischemic Conditioning to Reduce Burn Wound Progression|Recruiting||N/A|140|Anticipated|BG Trauma Center Tuebingen||2|||f||||f||||||||Undecided||2017-10-10 21:26:22.650505|2017-10-10 21:26:22.650505
NCT03027583|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-28|||March 1, 2017|Actual|2017-03-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Probiotic Intervention on Intestinal Permeability|The Effect of 6 Weeks Supplementation of Probiotic on Exercise-induced Intestinal Permeability in Trained Subjects - a Randomized, Double-blind, Placebo-controlled, Two Armed Parallel Group Trial.|Recruiting||N/A|126|Anticipated|Chr Hansen||2|||f||||f|f|f||||||No||2017-10-10 21:26:22.745879|2017-10-10 21:26:22.745879
NCT03027570|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-16|||March 2, 2017|Actual|2017-03-02|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||The Impact of Incorporating an Exergame Activity Application in a Treatment Regimen for Overweight Children|The Impact of Incorporating an Exergame Activity Application in a Treatment Regimen for Overweight Children|Active, not recruiting||N/A|100|Actual|Bait Balev Hospital||2|||f||||t|f|f||||||||2017-10-10 21:26:22.838327|2017-10-10 21:26:22.838327
NCT03027557|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-06-27|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|March 30, 2019|Anticipated|2019-03-30|March 1, 2019|Anticipated|2019-03-01||Interventional|DENOCINA||Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.|Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.|Enrolling by invitation||Phase 3|60|Anticipated|Aalborg Universitetshospital||3|||f||||t|t|f|||t|||||2017-10-10 21:26:22.967199|2017-10-10 21:26:22.967199
NCT03027544|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-19|||September 1, 2014|Actual|2014-09-01|January 2017|2017-01-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|TRBM||Tomotherapy for Refractory Brain Metastases|Tomotherapy for Refractory Brain Metastases: a Single Arm, Single Center Phase II Trial|Recruiting||N/A|150|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f|f|f||||||No|the baseline characteristics and treatment plan can be shared with other researchers when the research paper has been published. The IPD will be sent by email if applied.|2017-10-10 21:26:23.101106|2017-10-10 21:26:23.101106
NCT03027531|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||February 1, 2012|Actual|2012-02-01|January 2017|2017-01-01|June 30, 2013|Actual|2013-06-30|June 30, 2013|Actual|2013-06-30||Interventional|eKISS||eKISS: Electronic KIOSK Intervention for Safer-Sex|eKISS Electronic KIOSK Intervention for Safer-Sex: A Pilot Randomized Controlled Trial of an Interactive Computer-based Intervention for Sexual Health in Adolescents and Young Adults|Completed||N/A|272|Actual|University of Washington||2|||f||||f|f|f||||||No||2017-10-10 21:26:23.188456|2017-10-10 21:26:23.188456
NCT03027518|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-27|||February 6, 2017|Anticipated|2017-02-06|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||WILD 5 Wellness: A 30-Day Intervention|WILD 5 Wellness: A 30-Day Intervention|Enrolling by invitation||N/A|100|Anticipated|Beloit College||2|||f|||||f|f||||||||2017-10-10 21:26:23.263763|2017-10-10 21:26:23.263763
NCT03027505|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|MUAC-Only||Integrated Treatment Protocol for Acute Malnutrition: A Non Inferiority Trial in Burkina Faso|Effectiveness of an Integrated Treatment Protocol for Acute Malnutrition: A Non Inferiority Trial in Passore Province (Northern Region), Burkina Faso|Recruiting||N/A|12000|Anticipated|Alliance for International Medical Action||1|||f||||t||||||||No||2017-10-10 21:26:23.339313|2017-10-10 21:26:23.339313
NCT03027492|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-17|||January 2001||2001-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Gynaecological Disorders in Not-celiac Wheat Sensitivity|Gynaecological Disorders in Patients With Not-celiac Wheat Sensitivity|Recruiting||N/A|150|Anticipated|University of Palermo||6|||f||||f||||||||No||2017-10-10 21:26:23.43137|2017-10-10 21:26:23.43137
NCT03027479|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-03-08|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|METERMUS-IMC||Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss|Study of Differences in Skeletal Muscle Energy Metabolism Alterations in Women With Weight Loss and Ovarian and/or Endometrial Cancer Based on the Body Mass Index|Recruiting||N/A|50|Anticipated|University Hospital, Tours||2|||f||||f|f|f||||||No||2017-10-10 21:26:23.531088|2017-10-10 21:26:23.531088
NCT03027466|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-23|||January 6, 2017||2017-01-06|September 14, 2017|2017-09-14|January 2, 2018|Anticipated|2018-01-02|January 2, 2018|Anticipated|2018-01-02||Interventional|||Integrating Use of Self-Affirmation Content Into a Mobile App to Promote Quit Attempts With Text-Based Smoking Cessation Intervention Messaging|Integrating Use of Self-Affirmation Content Into a Mobile App to Promote Quit Attempts With Text-Based Smoking Cessation Intervention Messaging|Not yet recruiting||Early Phase 1|5000|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:26:23.617893|2017-10-10 21:26:23.617893
NCT03027453|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||January 2016||2016-01-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01|3 Months|Observational [Patient Registry]|B-SPATIAL||Berlin - SPecific Acute Treatment in Ischemic or hAemorrhagic Stroke With Long Term Follow-up|Berlin - Specific Acute Treatment in Ischemic or Haemorrhagic Stroke With Long Term Follow-up|Recruiting||N/A|9000|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||No||2017-10-10 21:26:23.698407|2017-10-10 21:26:23.698407
NCT03027440|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-20|2017-10-03|||January 6, 2017||2017-01-06|September 26, 2017|2017-09-26|November 30, 2021|Anticipated|2021-11-30|November 30, 2021|Anticipated|2021-11-30||Observational|||The Developmental Origins of Suicide Mortality|The Developmental Origins of Suicide Mortality|Active, not recruiting||N/A|52966|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:26:23.778927|2017-10-10 21:26:23.778927
NCT03027427|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-06-30|||January 12, 2017||2017-01-12|January 13, 2017|2017-01-13|December 31, 2026|Anticipated|2026-12-31|August 31, 2026|Anticipated|2026-08-31||Observational|||Prospective Evaluation and Molecular Profiling in People With Gastric Tumors|Prospective Evaluation and Molecular Profiling in Patients With Gastric Tumors|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:26:23.845938|2017-10-10 21:26:23.845938
NCT03027414|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-04|||January 12, 2017||2017-01-12|July 12, 2017|2017-07-12|January 1, 2023|Anticipated|2023-01-01|January 1, 2023|Anticipated|2023-01-01||Observational|||Effect of Transcranial Magnetic Stimulation to the Dorsolateral Prefrontal Cortex on Anxiety Potentiated Startle|The Effect of Transcranial Magnetic Stimulation to the Dorsolateral Prefrontal Cortex on Anxiety Potentiated Startle|Recruiting||N/A|184|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:26:23.923118|2017-10-10 21:26:23.923118
NCT03027401|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-28|||January 10, 2017||2017-01-10|February 3, 2017|2017-02-03|August 1, 2035|Anticipated|2035-08-01|August 1, 2035|Anticipated|2035-08-01||Observational|||Clinical Sequencing of Cancer and Tissue Repository: ClinOmics|Clinical Sequencing of Cancer and Tissue Repository: ClinOmics|Not yet recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:26:24.006816|2017-10-10 21:26:24.006816
NCT03027388|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-06-30|||January 5, 2017||2017-01-05|May 11, 2017|2017-05-11|August 30, 2020|Anticipated|2020-08-30|August 30, 2020|Anticipated|2020-08-30||Interventional|||Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma|Phase 0 Trial of LB100, A Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma|Not yet recruiting||Early Phase 1|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:26:24.087184|2017-10-10 21:26:24.087184
NCT03027362|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression|Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression: a Randomized Controlled Trial|Not yet recruiting||N/A|28|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 21:26:24.282055|2017-10-10 21:26:24.282055
NCT03027349|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-02-14|||January 2011||2011-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism||Completed||N/A|180|Actual|Azienda USL Modena|||2||f||||f||||||||||2017-10-10 21:26:24.346586|2017-10-10 21:26:24.346586
NCT03027336|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-19|||January 2016||2016-01-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|Coleosoma||Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects|Randomized Controlled Clinical Trial for Assessing Tolerability and Effectiveness of Formula Coleosoma 29 in Patients With Dyslipidemia|Completed||Phase 2|39|Actual|Azienda Ospedaliero-Universitaria di Parma||2|||f||||t||||||||No||2017-10-10 21:26:24.410411|2017-10-10 21:26:24.410411
NCT03027323|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|WASHCAN||Washington Study of AxoTrack-Guided Central Venous Cannulation|Washington Study of AxoTrack-Guided Central Venous Cannulation|Not yet recruiting||N/A|30|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 21:26:24.499414|2017-10-10 21:26:24.499414
NCT03027310|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-26|||January 6, 2017||2017-01-06|August 23, 2017|2017-08-23|January 1, 2022|Anticipated|2022-01-01|January 1, 2022|Anticipated|2022-01-01||Observational|||Clinical and Physiological Studies of Tremor Syndromes|Clinical and Physiological Studies of Tremor Syndromes|Recruiting||N/A|450|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:26:24.566153|2017-10-10 21:26:24.566153
NCT03027284|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-09-28|||February 3, 2017|Actual|2017-02-03|September 2017|2017-09-01|June 4, 2018|Anticipated|2018-06-04|June 4, 2018|Anticipated|2018-06-04||Interventional|||A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer|A Phase I Study of Merestinib Monotherapy or in Combination With Other Anti-Cancer Agents in Japanese Patients With Advanced and/or Metastatic Cancer|Recruiting||Phase 1|18|Anticipated|Eli Lilly and Company||3|||f||||f|f|f||||||||2017-10-10 21:26:24.635772|2017-10-10 21:26:24.635772
NCT03027258|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-02|||September 2016||2016-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|mHealth||Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome|Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome|Recruiting||N/A|300|Anticipated|University of Nevada, Las Vegas||1|||f||||t||||||||No||2017-10-10 21:26:24.728961|2017-10-10 21:26:24.728961
NCT03027245|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-19|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|IRENE||Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy|Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy|Recruiting||N/A|400|Anticipated|Eisai Inc.|||1||f||||t||||||||No||2017-10-10 21:26:24.806827|2017-10-10 21:26:24.806827
NCT03027232|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-25|||January 2007||2007-01-01|January 2017|2017-01-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|||Control of Leukocyte Function||Recruiting||N/A|100|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||Samples Without DNA|"     Blood is collected from all subjects in the same fashion. Purpose: isolation of immune cells     for in vitro studies of cell function.      This is an observational study in human beings in predefined groups of individuals who are     healthy and volunteer to donate blood for laboratory science studies. Subjects in the study     receive neither diagnostic, therapeutic, nor other interventions, and the investigator does     not assign specific interventions to any of the subjects of the study.   "|No||2017-10-10 21:26:24.929313|2017-10-10 21:26:24.929313
NCT03027219|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-10|||January 31, 2017|Actual|2017-01-31|July 2017|2017-07-01|January 30, 2018|Anticipated|2018-01-30|January 25, 2018|Anticipated|2018-01-25||Observational|||Blood Flow Change After Free Flap Surgery in Diabetic Patients|Prospective Observational Study of the Changes of Blood Flow of Arterial Anastomosis-site of Free Flap in Diabetic Patients Who Undergoing Free Flap Transfer|Recruiting||N/A|44|Anticipated|Asan Medical Center|||1||f||||f|f|f||||||||2017-10-10 21:26:25.131137|2017-10-10 21:26:25.131137
NCT03027206|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-19|||June 2015||2015-06-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|RPCPPWP||Respiratory Physiotherapy Change Premature Pain With Pneumonia|Effects of Vibration Techniques and Expiratory Flow Acceleration in Premature Pain Parameters With Pneumonia|Completed||Early Phase 1|28|Actual|Amazon University||2|||f||||t||||||||No||2017-10-10 21:26:25.224337|2017-10-10 21:26:25.224337
NCT03027193|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-02-13|||January 2017||2017-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccine ChAdOx2 HAV in Healthy Adult Volunteers|A Phase I Clinical Trial to Determine the Safety and Immunogenicity of the Candidate Mycobacterium Avium Subspecies Paratuberculosis (MAP) Vaccine ChAdOx2 HAV in Healthy Adult Volunteers|Recruiting||Phase 1|18|Anticipated|University of Oxford||3|||f||||||||||||||2017-10-10 21:26:25.315903|2017-10-10 21:26:25.315903
NCT03027180|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-20|||November 2016||2016-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Pressure Levels on Lung Expansion|DIFFERENT LEVELS OF NONINVASIVE POSITIVE AIRWAY PRESSURE FOR LUNG EXPANSION ON PATIENTS WITH PLEURAL DRAINAGE: A STUDY VIA COMPUTED TOMOGRAPHY|Completed||N/A|4|Actual|Universidade Cidade de Sao Paulo||3|||f||||f||||||||No||2017-10-10 21:26:25.415959|2017-10-10 21:26:25.415959
NCT03027167|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-05-10|||January 2017||2017-01-01|May 2017|2017-05-01|January 2023|Anticipated|2023-01-01|January 2019|Anticipated|2019-01-01||Interventional|PDAS||Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty|Outcomes Study to Determine the Incidence of Symptomatic DVT/PE in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty|Withdrawn||Phase 4|0|Actual|Washington University School of Medicine||2|||f||||f||||||||Undecided||2017-10-10 21:26:25.496071|2017-10-10 21:26:25.496071
NCT03027154|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-19|2017-01-19|||October 2016||2016-10-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for Children|For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 Dose Certain Phase III Clinical Research in Children Under the Age of 18 Years Old|Recruiting||Phase 3|96|Anticipated|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.||4|||f||||f||||||||No||2017-10-10 21:26:25.588498|2017-10-10 21:26:25.588498
NCT03027141|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-05-04|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Self-Face Recognition After Face Transplantation|Pilot Study: Self-Face Recognition After Face Transplantation|Enrolling by invitation||N/A|5|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:26:25.715035|2017-10-10 21:26:25.715035
NCT03027128|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-23|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors|Open-label, Phase 1 Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors|Recruiting||Phase 1|16|Anticipated|NantKwest, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:26:25.795197|2017-10-10 21:26:25.795197
NCT03027115|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-05-15|||January 13, 2017|Actual|2017-01-13|May 2017|2017-05-01|January 27, 2018|Anticipated|2018-01-27|January 13, 2018|Anticipated|2018-01-13||Interventional|||Hernia Surgery Urinary Retention|Post-operative Urinary Retention: A Prospective Randomized Study Identifying Patients at Risk and Reducing the Incidence Using Tamsulosin Pretreatment|Recruiting||Phase 4|140|Anticipated|Memorial Health University Medical Center||2|||f||||t|t|f|||f|||No|There is no plan to share IPD.|2017-10-10 21:26:25.890173|2017-10-10 21:26:25.890173
NCT03027102|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-27|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia|Phase I Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia|Recruiting||Phase 1|24|Anticipated|University Health Network, Toronto||2|||f|||||f|f||||||||2017-10-10 21:26:25.982846|2017-10-10 21:26:25.982846
NCT03027089|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter Study|Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA) in Chinese Patients -Multicenter Study|Recruiting||N/A|560|Anticipated|Chinese PLA General Hospital|||1||f||||t||||||||No||2017-10-10 21:26:26.067849|2017-10-10 21:26:26.067849
NCT03027076|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-28|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01|6 Months|Observational [Patient Registry]|||Microbiome of Urologic Chronic Pelvic Pain Syndrome|Microbiome Studies of Urologic Chronic Pelvic Pain Syndrome|Withdrawn||N/A|0|Actual|Johns Hopkins University|||4|Funding for project not secured|f||||f||||||Samples Without DNA|"     1. Urine from male and female participants        2. Expressed prostatic secretions (EPS) from male participants   "|||2017-10-10 21:26:26.146538|2017-10-10 21:26:26.146538
NCT03027063|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.|Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer Who Will be Treated With Anthracyclines|Not yet recruiting||Phase 2|30|Anticipated|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 21:26:26.241271|2017-10-10 21:26:26.241271
NCT03027050|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-19|||November 2015||2015-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||T-PRF Provides Advantages on Periodontal Healing: A Split Mouth Clinical Study|T-PRF Contributes to Periodontal Healing|Completed||N/A|33|Actual|Ataturk University||2|||f||||t||||||||No||2017-10-10 21:26:26.347911|2017-10-10 21:26:26.347911
NCT03027037|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-20|||November 2015||2015-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|PEARLS||Perinatal Emotion and Relationships Longitudinal Study|Perinatal Emotion and Relationships Longitudinal Study|Recruiting||N/A|180|Anticipated|University of Colorado, Boulder|||2||f||||f||||||||No||2017-10-10 21:26:26.436678|2017-10-10 21:26:26.436678
NCT03027024|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-12|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Clinical Study to Investigate Visual Performance of IOL: FineVision HP|Clinical Study to Investigate Visual Performance of Hydrophobic Trifocal IOL: FineVision HP|Recruiting||N/A|20|Anticipated|Physiol||1|||f||||f|f|f||||||||2017-10-10 21:26:26.526767|2017-10-10 21:26:26.526767
NCT03027011|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-03-09|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Remote Ischemic Preconditioning on Brain Injury in Carotid Endarterectomy|Effect of Remote Ischemic Preconditioning on Brain Injury in Carotid Endarterectomy|Recruiting||N/A|40|Anticipated|The Affiliated Hospital of Xuzhou Medical University||2|||f||||t|f|f||||||No|IPD will be available when this trial is finished and the article have been published|2017-10-10 21:26:26.640171|2017-10-10 21:26:26.640171
NCT03026998|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-07-10|||March 19, 2017|Actual|2017-03-19|July 2017|2017-07-01|January 2032|Anticipated|2032-01-01|January 2032|Anticipated|2032-01-01||Interventional|DepiSCARRH||MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)|MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma|Recruiting||N/A|190|Anticipated|Institut Curie||1|||f||||f|f|f||||||||2017-10-10 21:26:26.755831|2017-10-10 21:26:26.755831
NCT03026985|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-09-23|||January 25, 2017|Actual|2017-01-25|September 2017|2017-09-01|September 19, 2017|Actual|2017-09-19|September 19, 2017|Actual|2017-09-19||Observational|||Acute Skeletal Muscle Wasting and Relation to Physical Function in Patients Requiring ECMO|Acute Skeletal Muscle Wasting and Relation to Physical Function in Patients Requiring Extracorporeal Membrane Oxygenation (ECMO)|Completed||N/A|25|Actual|The Alfred|||1||f||||f||||||||||2017-10-10 21:26:26.846314|2017-10-10 21:26:26.846314
NCT03026972|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-20|||March 15, 2017|Anticipated|2017-03-15|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|AEC/BCO2||A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried|A Phase ⅠStudy of the Human Body Tolerance Research of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried|Not yet recruiting||Phase 1|175|Anticipated|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.||3|||f||||f|f|f||||||No||2017-10-10 21:26:26.938898|2017-10-10 21:26:26.938898
NCT03026959|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-01-18|||November 2016||2016-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Mindfulness and Maternal Mental Health|The Role of Mindfulness Skills Training in Maternal Mental Health: A Randomized Controlled Trial|Recruiting||N/A|124|Anticipated|Lakehead University||2|||f||||f||||||||Undecided||2017-10-10 21:26:27.098601|2017-10-10 21:26:27.098601
NCT03026946|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-29|||May 29, 2017|Actual|2017-05-29|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|ALICsA||Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema|Efficacy of Oral Alitretinoin Versus Oral Cyclosporine in Patients With Severe Recurrent Vesicular Hand Eczema. A Randomized Prospective Open-label Trial With Blinded Outcome Assessment|Recruiting||Phase 3|76|Anticipated|University Medical Center Groningen||2|||f||||f|f|f||||||No|Data will be published anonymously and will not be possible to trace back to individual participants.|2017-10-10 21:26:27.227665|2017-10-10 21:26:27.227665
NCT03026933|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-19|||May 2014||2014-05-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ROMANTIC||Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled|A Multi-center, Randomized, Double Blind, Parallel Phase III Study to Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled|Completed||Phase 3|215|Actual|Kuhnil Pharmaceutical Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:26:27.344311|2017-10-10 21:26:27.344311
NCT03026920|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-19|||June 2016||2016-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Pelvic and Acetabular Fracture in Old People|Different Surgical Methods for Pelvic or Acetabular Fracture of Old Man|Recruiting||Phase 4|40|Anticipated|Hebei Medical University Third Hospital||1|||f||||f||||||||No||2017-10-10 21:26:27.413083|2017-10-10 21:26:27.413083
NCT03026907|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-01-18|||May 2016||2016-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ALIAZ||Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema|Efficacy of Oral Alitretinoin Versus Oral Azathioprine in Patients With Severe Chronic Non-hyperkeratotic Hand Eczema. A Randomized Prospective Open-label Trial With Blinded Outcome Assessment|Recruiting||Phase 3|116|Anticipated|University Medical Center Groningen||2|||f||||f||||||||No|Data will be published anonymously and will not be possible to trace back to individual participants.|2017-10-10 21:26:27.497712|2017-10-10 21:26:27.497712
NCT03026894|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-19|||November 2015||2015-11-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Association of Force Distribution and Bone Resorption|Association of Occlusal Force Distribution and Bone Resorption in Implant Supported Overdentures|Completed||N/A|46|Actual|University of Malaya||2|||f||||t||||||||No||2017-10-10 21:26:27.594462|2017-10-10 21:26:27.594462
NCT03026881|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-03-05|||January 2017||2017-01-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients|An Open, Non-randomised, Multi-centre Phase I Study to Assess the Safety and Efficacy of Fluzoparib Given in Combination With Apatinib and Paclitaxel in the 2nd Line Treatment of Patients With Recurrent or Metastatic Gastric Cancer|Recruiting||Phase 1|24|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:26:27.668361|2017-10-10 21:26:27.668361
NCT03026868|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-06-22|||February 2015|Actual|2015-02-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|||Novel Quadrilateral Surface Plate for Acetabular Fracture|Randomized Trails of Different Fixations for Acetabular Fracture Involving Quadrilateral Surface|Recruiting||N/A|80|Anticipated|Hebei Medical University Third Hospital||1|||f||||t||||||||No||2017-10-10 21:26:27.769752|2017-10-10 21:26:27.769752
NCT03026855|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-17|||June 2014||2014-06-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers|To Demonstrate the Safety and Efficacy of Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers|Completed||Phase 1|24|Actual|TotipotentRX Cell Therapy Pvt. Ltd.||1|||f||||f||||||||No||2017-10-10 21:26:27.843937|2017-10-10 21:26:27.843937
NCT03026673|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-07-21|||January 18, 2017|Actual|2017-01-18|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|||Retrospective Review of NSAIDS in the Postpartum Period|Hypertension and NSAIDS in the Postpartum Period|Withdrawn||N/A|0|Actual|St. Louis University|||1|staff shortage|f||||f|f|f||||||||2017-10-10 21:26:31.540211|2017-10-10 21:26:31.540211
NCT03026842|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|October 2024|Anticipated|2024-10-01|December 2023|Anticipated|2023-12-01||Interventional|||Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)|A Prospective, Randomized, Controlled Trial of Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Patients With Acute Myeloid Leukemia With t(8;21)|Active, not recruiting||Phase 4|180|Anticipated|First Hospital of Jilin University||2|||f||||||||||||No||2017-10-10 21:26:27.957881|2017-10-10 21:26:27.957881
NCT03026829|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-10-03|||October 3, 2017|Actual|2017-10-03|October 2017|2017-10-01|July 30, 2018|Anticipated|2018-07-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Sound Therapy for Tinnitus Relief in Cochlear Implant Users|"Cochlear Active Relief From Tinnitus (CART) Sound Therapy for Tinnitus Relief in Nucleus® Cochlear Implant Users With Tinnitus"|Recruiting||N/A|50|Anticipated|Cochlear||1|||f|||||f|f||||||||2017-10-10 21:26:28.105867|2017-10-10 21:26:28.105867
NCT03026816|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-08-10|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|January 2023|Anticipated|2023-01-01|January 2022|Anticipated|2022-01-01||Interventional|E-STAND||Epidural Stimulation After Neurologic Damage|Epidural Stimulation for Spinal Cord Injury|Recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f|f|t|f|f||||||2017-10-10 21:26:28.297978|2017-10-10 21:26:28.297978
NCT03026803|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-03-16|2017-01-19||November 2006||2006-11-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer|A Phase II Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer|Terminated||Phase 2|4|Actual|City of Hope Medical Center|Due to Sorafenib becoming a first line treatment for HCC, the designed treatment became less competitive. The company Sanofi decided not to continue support. Study was terminated after accrual of 4 of the 32 planned patients.|1||"Due to Sorafenib became first line treatment for HCC, the designed treatment became less   competitive. The company Sanofi decided not to continue to support"|f||||t||||||||||2017-10-10 21:26:28.454019|2017-10-10 21:26:28.454019
NCT03026790|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-04-19|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Comparative Effectiveness of Patient-Centered Strategies to Improve Pain Management and Opioid Safety for Veterans|Comparative Effectiveness of Patient-Centered Strategies to Improve Pain Management and Opioid Safety for Veterans|Not yet recruiting||Phase 2|1400|Anticipated|University of Minnesota - Clinical and Translational Science Institute||4|||f||||t|f|f|||f|||Yes|Data sharing procedures have not been finalized. At a minimum, a complete, cleaned, de-identified copy of the final dataset used in conducting the final analyses of the study will be created and made available within one year after the completion of the study, pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. Depending on feasibility and guidance from VA Office of Research Oversight, a Limited Dataset (LDS) may be created and shared. We have not yet determined how to operationalize data sharing for this study. In the interim, contact the PI for questions or requests.|2017-10-10 21:26:28.705809|2017-10-10 21:26:28.705809
NCT03026777|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-26|||January 2017||2017-01-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|PrePARE||Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation|Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial|Recruiting||Phase 4|500|Anticipated|Louisiana State University Health Sciences Center in New Orleans||2|||f||||t||||||||||2017-10-10 21:26:28.802949|2017-10-10 21:26:28.802949
NCT03026764|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-07-25|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Inpatient vs Outpatient Total Hip Replacement|Patient Satisfaction and Costs Associated With Total Hip Arthroplasty|Recruiting||N/A|750|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 21:26:28.904523|2017-10-10 21:26:28.904523
NCT03026751|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-25|||May 5, 2017|Actual|2017-05-05|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|||Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing|Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing|Recruiting||N/A|285|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Next-generation sequencing will occur looking at target genes in the marrow to identify     mutations.      DNA will be sequenced to allow us to determine acquired mutations in haematopoietic tissue.   "|||2017-10-10 21:26:29.018919|2017-10-10 21:26:29.018919
NCT03026738|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Anterior Versus Posterior Laparoscopic Mesh Rectopexy For Rectal Prolapse; a Randomized Controlled Trial.|Anterior Versus Posterior Laparoscopic Mesh Rectopexy For Rectal Prolapse; a Randomized Controlled Trial.|Not yet recruiting||N/A|30|Anticipated|Assiut University||2|||f|||||f|t|f|f||||Undecided||2017-10-10 21:26:29.096589|2017-10-10 21:26:29.096589
NCT03026725|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-04-11|||November 2016||2016-11-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effect of Tri Calcium Phosphate on Efficacy and Sensitivity With Vital Tooth Whitening Using 20% Carbamide Peroxide|Effect of Tri Calcium Phosphate Paste on Efficacy and Postoperative Sensitivity Associated With At-Home Vital Tooth Whitening Using 20% Carbamide Peroxide 'A Randomized Controlled Study'|Completed||N/A|24|Actual|Damascus University||2|||f||||t||||||||No||2017-10-10 21:26:31.093673|2017-10-10 21:26:31.093673
NCT03026712|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-17|||February 2016||2016-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|hARMonies||Hemiparetic Arm Robotic Mobilization With Non Invasive Electrical Stimulation|Association of Dual Transcranial Electrical Stimulation (tDCS) to Upper Limb Robotic Therapy in Individuals With Chronic Stroke|Enrolling by invitation||N/A|80|Anticipated|I.R.C.C.S. Fondazione Santa Lucia||2|||f||||t||||||||No||2017-10-10 21:26:31.208229|2017-10-10 21:26:31.208229
NCT03026699|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-06-09|||May 5, 2017|Actual|2017-05-05|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Refining and Testing the Electronic Social Network Assessment Program (eSNAP)|Refining and Testing the Electronic Social Network Assessment Program (eSNAP)|Recruiting||N/A|20|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||4||f||||f|f|f||||||||2017-10-10 21:26:31.378178|2017-10-10 21:26:31.378178
NCT03026634|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-31|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01|1 Month|Observational [Patient Registry]|HTx-HDZ-SDB-1||Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation|Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation - a Prospective Single Center Trial|Recruiting||N/A|110|Anticipated|Heart and Diabetes Center North-Rhine Westfalia|||1||f||||f||||||Samples Without DNA|"     plasma, serum and urine samples   "|No||2017-10-10 21:26:31.776932|2017-10-10 21:26:31.776932
NCT03026621|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Examining the Change in Microbiome Diversity and Urine Metabolites After Lignite Extract Use|Examining the Change in Microbiome Diversity and Urine Metabolites After Lignite Extract Use|Recruiting||N/A|20|Anticipated|Seraphic Group Inc||2|||f||||||||||||||2017-10-10 21:26:31.906596|2017-10-10 21:26:31.906596
NCT03026608|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-17|||September 2012||2012-09-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Green Cart Program Evaluation|Impact of a Public-Private Mobile Market to Improve Fruit & Vegetable Access|Completed||N/A|201|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No|No plan to share individual data|2017-10-10 21:26:32.004866|2017-10-10 21:26:32.004866
NCT03026595|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-19|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Profile of the Depression and it's Intervention Strategy in Patients With Parkinson's Disease in China|The Profile of the Depression and it's Intervention Strategy in Patients With Parkinson's Disease in China|Not yet recruiting||N/A|500|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||||Undecided||2017-10-10 21:26:32.196536|2017-10-10 21:26:32.196536
NCT03026582|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-01|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Observational|SPIBDUS||Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease|Intestinal Ultrasound Role in the Management of Pediatric Inflammatory Bowel Disease: A Prospective Longitudinal Cohort Study|Recruiting||N/A|150|Anticipated|Schneider Children's Medical Center, Israel|||1||f||||t||||||||||2017-10-10 21:26:32.271094|2017-10-10 21:26:32.271094
NCT03026569|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-20|||May 2012||2012-05-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Orange Juice Consumption in Patients With Hepatitis C|Orange Juice as Dietary Source of Antioxidants for Patients With Hepatitis C Under Antiviral Therapy|Completed||N/A|43|Actual|São Paulo State University||2|||f||||f||||||||||2017-10-10 21:26:32.357888|2017-10-10 21:26:32.357888
NCT03026556|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-22|||December 29, 2016|Actual|2016-12-29|September 2017|2017-09-01|August 23, 2017|Actual|2017-08-23|August 23, 2017|Actual|2017-08-23||Observational|||The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis|Safety and Effectiveness Study Comparing Dabigatran, Rivaroxaban & Apixaban in Non-valvular Atrial Fibrillation Patients Enrolled in the US Department of Defense Military Health System|Completed||N/A|35130|Actual|Boehringer Ingelheim|||2||f|||||t|f||||||||2017-10-10 21:26:32.466393|2017-10-10 21:26:32.466393
NCT03026543|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-18|||October 2014||2014-10-01|January 2017|2017-01-01||||October 2017|Anticipated|2017-10-01||Interventional|||Effect of Pulmonary Recruitment Maneuver (PRM) on Pain and Nausea After Laparoscopic Cholecystectomy|A Prospective, Blinded, Randomized Clinical Trial Investigating the Effect on Postoperative Pain and Nausea, When Performing a Ventilator-piloted PRM at the End of Laparoscopic Cholecystectomy|Recruiting||N/A|200|Anticipated|Region Östergötland||2|||f||||||||||||||2017-10-10 21:26:32.558595|2017-10-10 21:26:32.558595
NCT03026530|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-18|||November 2014||2014-11-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Pulmonary Recruitment Maneuver (PRM) on Pain and Nausea After Laparoscopic Bariatric Surgery|Effect of Pulmonary Recruitment Maneuver (PRM) on Pain and Nausea After Laparoscopic Bariatric Surgery|Completed||N/A|200|Actual|Region Östergötland||2|||f||||||||||||||2017-10-10 21:26:32.660607|2017-10-10 21:26:32.660607
NCT03026517|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-11|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Clinical Trial of Phenformin in Combination With Dabrafenib and Trametinib for Patients With BRAF-mutated Melanoma|Phase I Trial of Phenformin With Dabrafenib and Trametinib in Patients With BRAFV600E/K-mutated Melanoma|Recruiting||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:26:32.769635|2017-10-10 21:26:32.769635
NCT03026504|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-09-07|||March 9, 2017|Actual|2017-03-09|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Baricitinib in Relapsing Giant Cell Arteritis|Baricitinib in Relapsing Giant Cell Arteritis (GCA): A Phase II, Single-institution, Open-label Pilot Study|Recruiting||Phase 2|15|Anticipated|Mayo Clinic||1|||f||||f|t|f||||||||2017-10-10 21:26:32.885866|2017-10-10 21:26:32.885866
NCT03026491|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-08-08|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|April 1, 2017|Actual|2017-04-01|March 1, 2017|Actual|2017-03-01||Observational|||Chewing in Children With Repaired Esophageal Atresia-tracheoesophageal Fistula|Chewing Function in Children With Repaired Esophageal Atresia-tracheoesophageal Fistula|Completed||N/A|35|Actual|Hacettepe University|||2||f||||t||||||||||2017-10-10 21:26:32.972553|2017-10-10 21:26:32.972553
NCT03026478|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-21|||May 6, 2016|Actual|2016-05-06|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus|A Comparative Study on Clinical Efficacy of Clobetasol and Betamethasone in Orabase in Combination With Clotrimazole, in Oral Lichen Planus|Recruiting||Phase 2|30|Anticipated|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||t||||||||||2017-10-10 21:26:33.041598|2017-10-10 21:26:33.041598
NCT03026465|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-08-16|||February 16, 2017|Actual|2017-02-16|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|VISTA||Vessel Injury in Relation With Strut Thickness Assessed by OCT|Vessel Injury in Relation With Strut Thickness Assessed by OCT (VISTA): A Comparison of Vascular Injury Induced by a Polymer Free Sirolimus and Probucol Eluting Stent and a Biodegradable-polymer Biolimus-eluting Stent|Recruiting||Phase 4|50|Anticipated|Fundacion Investigacion Interhospitalaria Cardiovascular||2|||f||||t|f|f||||||||2017-10-10 21:26:33.151343|2017-10-10 21:26:33.151343
NCT03026452|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-17|||January 2013||2013-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer||Recruiting||Phase 1/Phase 2|400|Anticipated|First Affiliated Hospital of Zhejiang University||1|||f||||||||||||||2017-10-10 21:26:33.29755|2017-10-10 21:26:33.29755
NCT03026439|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-23|||September 2014||2014-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|SOON||Searching Chronic Obstructive Pulmonary Disease Onset|The Boundaries of Early Chronic Obstructive Pulmonary Disease: Searching COPD Onset|Recruiting||N/A|240|Anticipated|Pontificia Universidad Catolica de Chile|||4||f||||f||||||||Yes||2017-10-10 21:26:33.409999|2017-10-10 21:26:33.409999
NCT03026426|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-05-16|||January 2017||2017-01-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|LATIN-MHPeru||Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in Peru|A Randomized Controlled Trial to Evaluate the Effectiveness of a Mobile Technology Intervention in the Treatment of Depressive Symptoms in People With Diabetes or Hypertension in Peru|Recruiting||Phase 3|432|Anticipated|Universidad Peruana Cayetano Heredia||2|||f||||t||||||||Yes|Data goes open 6 months after the study finishes.|2017-10-10 21:26:33.529514|2017-10-10 21:26:33.529514
NCT03026413|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-06-28|||March 2015||2015-03-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|FORCE-PVA||The Comparison Between the PVAM and CPVI for the Patients of PAF|The Comparison Between the Pulmonary Vein Antrum Modification by SmartTouch Ablation Catheter With Contact Force Monitoring and Circumferential Pulmonary Vein Isolation by That Without Contact Force Monitoring Plus Lasso Catheter for the Patients of Paroxysmal Atrial Fibrillation: a Randomized Controlled Trial|Completed||N/A|180|Actual|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||No||2017-10-10 21:26:33.688318|2017-10-10 21:26:33.688318
NCT03026400|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-02|||August 2014||2014-08-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|October 2015|Actual|2015-10-01||Interventional|||Sub vs Trans-umbilical Incision: A Patient's Satisfaction-centered Trial|Sub vs Trans-umbilical Incision: A Patient's Satisfaction-centered Randomised Trial|Active, not recruiting||N/A|54|Actual|Université de Sherbrooke||2|||f||||t||||||||No||2017-10-10 21:26:33.772742|2017-10-10 21:26:33.772742
NCT03026387|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-19|||February 2017||2017-02-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|SUI-PREDICT||Evaluation of the Risk Associated With Impulsivity and Other Neuropsychological Factors on Suicidal Relapse Within Hospital Emergencies|Evaluation of the Risk Associated With Impulsivity and Other Neuropsychological Factors on Suicidal Relapse Within Hospital Emergencies|Not yet recruiting||N/A|500|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:26:33.844106|2017-10-10 21:26:33.844106
NCT03026374|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-17|||June 2017||2017-06-01|January 2017|2017-01-01||||June 2022|Anticipated|2022-06-01||Interventional|||Effect of a Mentor-based, Supportive-expressive Program on Survival in Metastatic Breast Cancer||Not yet recruiting||N/A|204|Anticipated|The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:26:33.935527|2017-10-10 21:26:33.935527
NCT03026361|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-18|||January 2010||2010-01-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity|Molecular Mechanisms of Precancerous and Cancerous Lesions of the Oral Cavity|Completed||N/A|71|Actual|University of Zagreb|||3||f||||t||||||||No||2017-10-10 21:26:34.052723|2017-10-10 21:26:34.052723
NCT03026348|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-09-12|||January 2017||2017-01-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2017|Actual|2017-04-01||Interventional|||Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults|Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults|Active, not recruiting||Phase 2|300|Actual|Novavax||12|||f||||f||||||||||2017-10-10 21:26:34.196987|2017-10-10 21:26:34.196987
NCT03026335|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-17|||September 2011||2011-09-01|January 2017|2017-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|CREST||Childhood Resiliency Effects for School-wide Treatment in Belize City|Childhood Resiliency Effects for School-wide Treatment in Belize City|Completed||N/A|6296|Actual|University of North Texas, Denton, TX||2|||f||||f||||||||No||2017-10-10 21:26:34.319054|2017-10-10 21:26:34.319054
NCT03026322|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-08-28|||March 14, 2017|Actual|2017-03-14|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|PreVent||Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial|Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial|Recruiting||N/A|350|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:26:34.402369|2017-10-10 21:26:34.402369
NCT03026309|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-18|||March 2017||2017-03-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility|PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility|Not yet recruiting||N/A|60|Anticipated|Assuta Medical Center|||2||f||||f||||||Samples With DNA|"     whole blood.   "|No||2017-10-10 21:26:34.557722|2017-10-10 21:26:34.557722
NCT03026296|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-17|||August 2016||2016-08-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Healthy Life Centers - Municipal Health Care Service for Lifestyle Changes - a Multicenter Intervention Study|Healthy Life Centers - Municipal Health Care Service for Lifestyle Changes - a Multicenter Intervention Study on Changes Among Participants and Moderators for Changes Such as the Centers Capacity and Competence and the Participants Motivation|Recruiting||N/A|1200|Anticipated|Norwegian University of Science and Technology||1|||f||||f||||||||No||2017-10-10 21:26:34.63892|2017-10-10 21:26:34.63892
NCT03026283|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-03|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|VFFRCTA||The Value of CT Fractional Flow Reserve|The Value of Fractional Flow Reserve Derived From Coronary CTA and in the Triage of Low to Intermediate Risk Chest Pain Patients: Design: Single Center Prospective Clinical Trial; Target Disease: Coronary Artery Disease|Enrolling by invitation||N/A|576|Anticipated|Northwell Health||1|||f||||f||||||||No||2017-10-10 21:26:34.7689|2017-10-10 21:26:34.7689
NCT03026270|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Therapeutical Paraffin in the Malleability of Burned Skin|Effect of Therapeutical Paraffin Wax Bath in the Malleability of Burned Skin|Not yet recruiting||N/A|60|Anticipated|University of Sao Paulo||2|||f||||t||||||||Undecided||2017-10-10 21:26:34.866602|2017-10-10 21:26:34.866602
NCT03026257|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-08-22|||February 13, 2017|Actual|2017-02-13|August 2017|2017-08-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Interventional|||Clinical Assessment of a HYDRAGLYDE® Regimen|Clinical Assessment of a Regimen of AIR OPTIX® Plus HYDRAGLYDE® Silicone Hydrogel Lenses and HYDRAGLYDE® Containing Lens Care Solutions|Completed||N/A|323|Actual|Alcon Research||2|||f||||f|f|t|f|f||||||2017-10-10 21:26:34.944027|2017-10-10 21:26:34.944027
NCT03026244|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-17|||November 2016||2016-11-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Milk Protein and Prebiotics in Combination With Vitamin D on Innate Immunity in Elderly People|A Nutritional Intervention Study to Evaluate the Effect of Milk Protein and Prebiotics in Combination With Vitamin D on Innate Immunity in Elderly People|Active, not recruiting||N/A|30|Actual|NIZO Food Research||2|||f||||f||||||||No||2017-10-10 21:26:35.073526|2017-10-10 21:26:35.073526
NCT03026231|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-04-18|||July 15, 2017|Anticipated|2017-07-15|April 2017|2017-04-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|||Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients|A Prospective, Randomized Placebo Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Weekly Administration of Lyophilized PRIM-DJ2727 Given Orally in Subjects With Parkinson's Disease|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t|t|f||||||||2017-10-10 21:26:35.169594|2017-10-10 21:26:35.169594
NCT03026218|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-17|||February 2017||2017-02-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|October 2018|Anticipated|2018-10-01||Interventional|||Group and Mobile Care for Gestational Diabetes|Group and Mobile Care for Gestational Diabetes|Not yet recruiting||N/A|120|Anticipated|University of Maryland||4|||f||||||||||||||2017-10-10 21:26:35.29085|2017-10-10 21:26:35.29085
NCT03026205|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|ARMS-I||ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)|Evaluation of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Orally Administered ARMS-I Administered in Healthy Adults, Aged 18-45 Years|Recruiting||Phase 2|20|Anticipated|University of Toledo Health Science Campus||1|||f||||t||||||||No||2017-10-10 21:26:35.375793|2017-10-10 21:26:35.375793
NCT03026192|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-18|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure|Use of Near Infrared Spectroscopy in Preterm Infants to Determine Patent Ductus Arteriosus Closure Following Medical Treatment|Recruiting||N/A|40|Anticipated|Albany Medical College|||2||f||||t||||||||No||2017-10-10 21:26:35.473792|2017-10-10 21:26:35.473792
NCT03026179|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-01-19|||July 2013||2013-07-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Education of Parents About Discipline in a Way That is Culturally Sensitive|Education of Parents About Discipline in a Way That is Culturally Sensitive|Completed||N/A|108|Actual|Vanderbilt University Medical Center||1|||f||||f||||||||||2017-10-10 21:26:35.556567|2017-10-10 21:26:35.556567
NCT03026166|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-09-29|||April 14, 2017|Actual|2017-04-14|September 2017|2017-09-01|April 15, 2020|Anticipated|2020-04-15|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer|A Phase 1/2 Study on the Safety of Rovalpituzumab Tesirine Administered in Combination With Nivolumab or Nivolumab and Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer|Recruiting||Phase 1|90|Anticipated|AbbVie||3|||f||||f|t|f||||||||2017-10-10 21:26:35.622969|2017-10-10 21:26:35.622969
NCT03026153|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-17|||October 2016||2016-10-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|March 16, 2017|Actual|2017-03-16||Interventional|||Biologics Anchoring Study|Biologics Anchoring Study|Recruiting||N/A|100|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-10 21:26:35.745492|2017-10-10 21:26:35.745492
NCT03026140|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-23|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|NICHE||Nivolumab, Ipilimumab and COX2-inhibition in Early Stage Colon Cancer: an Unbiased Approach for Signals of Sensitivity|Nivolumab, Ipilimumab and COX2-inhibition in Early Stage Colon Cancer: an Unbiased Approach for Signals of Sensitivity: The NICHE TRIAL|Recruiting||Phase 2|60|Anticipated|The Netherlands Cancer Institute||2|||f||||f||||||||No||2017-10-10 21:26:35.830198|2017-10-10 21:26:35.830198
NCT03026127|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-23|||December 2016||2016-12-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CRISP||A Novel Cognitive Reappraisal Intervention for Suicide Prevention|A Novel Cognitive Reappraisal Intervention for Suicide Prevention|Recruiting||N/A|40|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||Yes|Data sharing plan of the NIMH.|2017-10-10 21:26:35.925204|2017-10-10 21:26:35.925204
NCT03026114|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-19|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01|1 Day|Observational [Patient Registry]|TURKHEF||Clinical Characteristics and Management of TURKish Adult Outpatients With HEart Failure|Clinical Characteristics and Management of TURKish Adult Outpatients With HEart Failure|Not yet recruiting||N/A|2000|Anticipated|Muğla Sıtkı Koçman University|||1||f||||f||||||||No||2017-10-10 21:26:36.013583|2017-10-10 21:26:36.013583
NCT03026101|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Understanding the Pathophysiology of Migraine Pain|Understanding the Role of the External Carotid Artery in the Pathophysiology of Migraine Pain|Not yet recruiting||N/A|20|Anticipated|Montefiore Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:26:36.097303|2017-10-10 21:26:36.097303
NCT03025906|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-01|||February 16, 2017|Actual|2017-02-16|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus|Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China|Recruiting||Phase 2|120|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t|f|f||||||||2017-10-10 21:26:37.381131|2017-10-10 21:26:37.381131
NCT03026075|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-12|||December 22, 2016|Actual|2016-12-22|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|MCS||Evaluation of the Performance of the Motus Cleansing System (MCS)|Evaluation of the Performance of the Motus Cleansing System|Completed||N/A|47|Actual|Motus GI Medical Technologies Ltd||1|||f||||t||||||||Undecided||2017-10-10 21:26:36.300414|2017-10-10 21:26:36.300414
NCT03026062|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-10-05|||May 18, 2017|Actual|2017-05-18|October 2017|2017-10-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Trial of Durvalumab (MEDI4736) and Tremelimumab Administered in Combination Versus Sequentially in Recurrent Platinum-Resistant Epithelial Ovarian Cancer|Randomized Phase II Trial of Durvalumab (MEDI4736) and Tremelimumab Administered in Combination Versus Sequentially in Recurrent Platinum-Resistant Epithelial Ovarian Cancer|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:26:36.372781|2017-10-10 21:26:36.372781
NCT03026049|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-30|||March 9, 2017|Actual|2017-03-09|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|STEVECO||Stent Versus Conservative Treatment in Patients With Deep Venous Obstruction|A Randomized Controlled Trial Comparing Venous Stenting With Conservative Treatment in Patients With Deep Venous Obstruction|Recruiting||N/A|130|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:26:36.463721|2017-10-10 21:26:36.463721
NCT03026036|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-20|||April 2016||2016-04-01|January 2017|2017-01-01|April 2021|Anticipated|2021-04-01|February 2021|Anticipated|2021-02-01||Observational|||Neuroimaging Studies of Reward Processing in Depression|Neuroimaging Studies of Reward Processing in Depression|Recruiting||N/A|114|Anticipated|Mclean Hospital|||3||f||||f||||||Samples With DNA|"     blood samples, saliva samples   "|Yes||2017-10-10 21:26:36.63204|2017-10-10 21:26:36.63204
NCT03026023|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-10-04|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|June 30, 2021|Anticipated|2021-06-30|December 31, 2020|Anticipated|2020-12-31||Interventional|||Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant|A Proof of Concept Study for Preemptive Treatment With Grazoprevir and Elbasvir in Donor HCV-positive to Recipient HCV-negative Cardiac Transplant|Suspended||Phase 4|11|Anticipated|Massachusetts General Hospital||1||Funding source yet to be established - study not yet active|f||||t|t|f|||f|||||2017-10-10 21:26:36.728889|2017-10-10 21:26:36.728889
NCT03026010|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-19|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|July 11, 2017|Actual|2017-07-11|July 11, 2017|Actual|2017-07-11||Observational|||Central Blood Pressure|Early Detection of Central Blood Pressure and Arterial Stiffness (Pulse Wave Analysis) Can be a Predictor of Gestational Hypertension/Preeclampsia.|Completed||N/A|100|Anticipated|St. Louis University|||1||f||||f||||||||||2017-10-10 21:26:36.809131|2017-10-10 21:26:36.809131
NCT03025997|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-04-11|||January 24, 2017|Actual|2017-01-24|March 2017|2017-03-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Lipid Encapsulation for Ileal Brake Activation|The Effect of Orally Applied Encapsulated Lipids in Yoghurt on Satiety and Food Intake: a Randomized Single-blind Placebo-controlled Study With Cross-over Design|Completed||N/A|33|Actual|Maastricht University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:26:36.866605|2017-10-10 21:26:36.866605
NCT03025984|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-31|||December 2016||2016-12-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Texting for Diabetes|Adherence to a Diabetes Care Regimen Following Text Message Intervention in Pregnant Women With Diabetes|Recruiting||N/A|250|Anticipated|St. Louis University||2|||f||||f||||||||No||2017-10-10 21:26:36.938081|2017-10-10 21:26:36.938081
NCT03025971|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-17|||March 2014||2014-03-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2016|Actual|2016-07-01||Interventional|||Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation|Efficacy and Safety Evaluation for The Interventional Aortic Valve Bioprosthesis and Delivery System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation With Elevated Surgical Risk|Active, not recruiting||N/A|82|Anticipated|JC Medical, Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:26:37.017495|2017-10-10 21:26:37.017495
NCT03025958|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma||Recruiting||Phase 2|30|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||No||2017-10-10 21:26:37.093737|2017-10-10 21:26:37.093737
NCT03025945|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-17|||October 2013||2013-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo|Pseudophakic Cystoid Macular Edema Prevention and Risk Factors; Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo|Completed||N/A|1497|Actual|Intuor Technologies, Inc.||2|||f||||f||||||||No||2017-10-10 21:26:37.172226|2017-10-10 21:26:37.172226
NCT03025932|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-17|||January 2016||2016-01-01|January 2017|2017-01-01||||January 2020|Anticipated|2020-01-01||Observational|||Recurrence Rate After Laparoscopic Repair of Large Hiatal Hernia|Clinical vs. Radiological Recurrence Rate After Laparoscopic Repair of Large Hiatal Hernia With Mesh and Anterior Fundoplication|Enrolling by invitation||N/A|50|Actual|Spital Limmattal Schlieren|||1||f||||f||||||||No||2017-10-10 21:26:37.23805|2017-10-10 21:26:37.23805
NCT03025919|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-03|||January 2017||2017-01-01|May 2017|2017-05-01|December 2017||2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)|Using 2h-glycosuria Combined With Fasting Plasma Glucose , Advanced Glycation End-product Alone or in Combination With Fasting Plasma Glucose in Diabetes Screening in Chinese Natural Population|Recruiting||N/A|20000|Anticipated|Zhongda Hospital|||1||f||||t||||||||||2017-10-10 21:26:37.308171|2017-10-10 21:26:37.308171
NCT03024983|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-18|||September 2015||2015-09-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Pasta and Other Durum Wheat-based Products: Effects on Post-prandial Glucose Metabolism|Pasta and Other Durum Wheat-based Products: Effects on Post-prandial Glucose Metabolism|Completed||N/A|18|Actual|University of Parma||6|||f||||f||||||||No||2017-10-10 21:26:45.255958|2017-10-10 21:26:45.255958
NCT03025893|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-07-31|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|STELLAR||A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme|A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme: the STELLAR Study|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|VU University Medical Center||2|||f||||t|f|f|||f|||||2017-10-10 21:26:37.474663|2017-10-10 21:26:37.474663
NCT03025880|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-08-23|||June 28, 2017|Actual|2017-06-28|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|October 2019|Anticipated|2019-10-01||Interventional|PANGEA-Breast||Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC|A Multicenter Phase II Trial to Evaluate the Efficacy and Safety of Pembrolizumab and Gemcitabine in Patients With HER2-negative Advanced Breast Cancer (ABC)|Recruiting||Phase 2|65|Anticipated|Spanish Breast Cancer Research Group||1|||f||||f|f|f|||f|||||2017-10-10 21:26:37.600292|2017-10-10 21:26:37.600292
NCT03025867|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-04-13||||||April 2017|2017-04-01||||||||Expanded Access|||Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer|Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer|Approved for marketing||N/A|||Tesaro, Inc.|||||||||||||||||||2017-10-10 21:26:37.718593|2017-10-10 21:26:37.718593
NCT03025854|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-18|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|January 2023|Anticipated|2023-01-01|January 2019|Anticipated|2019-01-01||Observational|||Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma|Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma|Not yet recruiting||N/A|600|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     Whole blood and tumor tissue   "|Undecided||2017-10-10 21:26:37.78177|2017-10-10 21:26:37.78177
NCT03025841|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-03-15|||December 2016|Actual|2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|CEFTAREA||Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Augmented Renal Clearance|Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Augmented Renal Clearance|Recruiting||Phase 1|24|Anticipated|Poitiers University Hospital||1|||f||||||||||||||2017-10-10 21:26:37.864831|2017-10-10 21:26:37.864831
NCT03025828|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-17|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Adrenocorticotropic Hormone in Membranous Nephropathy|Changes in Autoreactive Memory B Cells as Biomarker of Response to Adrenocorticotropic Hormone in Patients With Membranous Nephropathy|Recruiting||Phase 4|25|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f|t|f||||||||2017-10-10 21:26:37.946086|2017-10-10 21:26:37.946086
NCT03025815|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-08-16|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effects of the Oral Stimulation Program in Extreme Preterm Infants|Effects of the Oral Stimulation Program in Extreme Preterm Infants: A Randomized Clinical Trial|Completed||N/A|74|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 21:26:38.056123|2017-10-10 21:26:38.056123
NCT03025802|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|1 Year|Observational [Patient Registry]|FAPIC||Fast Assay for Pathogen Identification and Characterization - Prospective Study|Fast Assay for Pathogen Identification and Characterization - Prospective Study|Not yet recruiting||N/A|250|Anticipated|Hasselt University|||1||f||||f||||||Samples With DNA|"     Whole blood   "|No||2017-10-10 21:26:38.144095|2017-10-10 21:26:38.144095
NCT03025789|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-08-14|||November 2016||2016-11-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|November 2019|Anticipated|2019-11-01||Interventional|||Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage|An Open-label Study Assessing Effectiveness, Safety and Compliance With Fexinidazole in Patients With Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage|Recruiting||Phase 3|174|Anticipated|Drugs for Neglected Diseases||1|||f||||t||||||||||2017-10-10 21:26:38.238557|2017-10-10 21:26:38.238557
NCT03025776|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-25|||September 2016||2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FSIFall2016||One vs. Two Hand Use After Stroke: Role of Task Requirements||Recruiting||N/A|48|Anticipated|Cleveland State University|||2||f||||f||||||||||2017-10-10 21:26:38.361715|2017-10-10 21:26:38.361715
NCT03025763|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-17|||November 2014||2014-11-01|January 2017|2017-01-01|June 2029|Anticipated|2029-06-01|June 2019|Anticipated|2019-06-01||Observational|||Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones|Craniosynostosis Network|Recruiting||N/A|4000|Anticipated|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||Samples With DNA|"     Saliva, blood, white blood cells, DNA, RNA, and generated induced pluripotent stem cells   "|Yes|Clinical results from chromosomal analysis and DNA mutation analysis performed in CLIA approved laboratories with standard clinical genetic counseling will be given to the patient upon request. Individual research results will be made available to the individual from the PI or their primary care physician (PCP) who has obtained preliminary results from the PI from our non-CLIA laboratory, as long as the PCP can confirm and validate the lab results through a CLIA approved lab before the results are given to the subjects.|2017-10-10 21:26:38.439278|2017-10-10 21:26:38.439278
NCT03025750|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-05-30|||January 19, 2017|Actual|2017-01-19|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|VIPV-07||Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age|Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine, IPV-Al SSI, in Comparison to Non-adjuvanted Full Dose IPV SSI, in Infants Vaccinated at 2, 4 and 6 Months of Age|Active, not recruiting||Phase 3|800|Actual|Statens Serum Institut||2|||f||||t|f|f||||||No||2017-10-10 21:26:38.60911|2017-10-10 21:26:38.60911
NCT03025737|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01|5 Years|Observational [Patient Registry]|||Semmelweis Sport Study|Semmelweis Sport - Complex Cardiovascular Screening of Elite, Recreational, Young and Master Athletes|Recruiting||N/A|150|Anticipated|Semmelweis University Heart and Vascular Center|||2||f||||f||||||Samples With DNA|"     Samples with DNA, serum, plasma   "|No||2017-10-10 21:26:38.702679|2017-10-10 21:26:38.702679
NCT03025724|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-16|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ|Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ|Not yet recruiting||N/A|40|Anticipated|Rhode Island Hospital||2|||f||||t||||||||No||2017-10-10 21:26:38.77696|2017-10-10 21:26:38.77696
NCT03025711|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-16|||March 2017||2017-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|KNOWHER||Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine|Use Of Pertuzumab And Trastuzumab Emtansine In Adult Patients With Her2-Positive Metastatic Or Locally Recurrent Unresectable Breast Cancer|Not yet recruiting||N/A|700|Anticipated|Puerta de Hierro University Hospital|||2||f||||f||||||||No||2017-10-10 21:26:38.869766|2017-10-10 21:26:38.869766
NCT03025698|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-08-25|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|March 25, 2024|Anticipated|2024-03-25|March 25, 2024|Anticipated|2024-03-25||Interventional|||A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia|A Phase II, Open-label, Non-controlled, Intra-patient Dose-escalation Study to Characterize the Pharmacokinetics After Oral Administration of Eltrombopag in Pediatric Patients With Refractory, Relapsed or Treatment Naive Severe Aplastic Anemia or Recurrent Aplastic Anemia|Recruiting||Phase 2|60|Anticipated|Novartis||3|||f||||t|t|f||||||||2017-10-10 21:26:38.951832|2017-10-10 21:26:38.951832
NCT03025685|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-22|||September 2016||2016-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||"Radial Ultra Support Technique (RUS Technique)"|"Radial Ultra Support Technique (RUS) Versus Anchoring Technique to Enhance Guiding Catheter Support: a Prospective Randomized Pilot Study"|Completed||N/A|54|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||No||2017-10-10 21:26:39.056436|2017-10-10 21:26:39.056436
NCT03025672|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-16|||April 2015||2015-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Evaluation of the Cost of a Nosocomial Infection With Clostridium Difficile||Completed||N/A|10445|Actual|Lille Catholic University|||2||f||||t||||||||No||2017-10-10 21:26:39.125936|2017-10-10 21:26:39.125936
NCT03025659|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-06|||May 28, 2017|Actual|2017-05-28|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||Lactate Acidosis in Postoperative Hearts|Characterization of Lactic Acidosis in Pediatric Postoperative Cardiac Patients|Recruiting||N/A|120|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-10 21:26:39.177296|2017-10-10 21:26:39.177296
NCT03025646|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-18|||January 2017||2017-01-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Feasibility of Implementing a Mental Health Care Program and Home-based Training for Mothers of Children With Autism Spectrum Disorder in an Urban Population in Bangladesh|Feasibility of Implementing a Mental Health Care Program and Home-based Training for Mothers of Children With Autism Spectrum Disorder in an Urban Population in Bangladesh|Not yet recruiting||N/A|78|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||1|||f||||f||||||||No||2017-10-10 21:26:39.247314|2017-10-10 21:26:39.247314
NCT03025633|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-22|||November 2016|Actual|2016-11-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Explaining the Invisible|Explaining the Invisible - A Study to Evaluate the Effectiveness of Delivering Radiotherapy Treatment Information in a Visual Manner Using the PEARL System|Recruiting||N/A|154|Anticipated|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 21:26:39.319872|2017-10-10 21:26:39.319872
NCT03025620|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-18|||November 2006||2006-11-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|February 2011|Actual|2011-02-01||Interventional|||Dietary Intake of Alpha-linolenic Acid in Elderly|Investigation of the Relationship Between Alpha-linolenic Acid and Arterial, Biochemical, Biological Parameters in Older Persons With History of Cardiovascular Events and/or Moderate Cognitive Impairment|Completed||N/A|254|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:26:39.389993|2017-10-10 21:26:39.389993
NCT03025607|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-06-22|||May 3, 2017|Actual|2017-05-03|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Mobile Phone-based Program for Adults With Prediabetes|A Mixed Methods Pilot Randomized Controlled Trial of a Mobile Phone-based Health Program Among Adults With Prediabetes|Recruiting||N/A|156|Anticipated|University of Michigan||3|||f||||f|f|f||||||No||2017-10-10 21:26:39.47251|2017-10-10 21:26:39.47251
NCT03025594|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-23|||January 2017||2017-01-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|Toxin||Gonyautoxins Local Periarticular Injection for Pain Management After Total Knee Arthroplasty|Gonyautoxins Local Periarticular Injection for Pain Management After Total Knee Arthroplasty: A Double Blind Randomized Study|Recruiting||Phase 3|64|Anticipated|University of Chile||2|||f||||t||||||||Yes|First, a formal letter must be send to the Ethical Committee of Hospital Clinico Universidad de Chile. If the committee gives its consent, the principal investigator will send IPD to whom request it.|2017-10-10 21:26:39.553763|2017-10-10 21:26:39.553763
NCT03025581|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|NIPROM||Does Nipple Stimulation Shorten Time to Vaginal Birth in Women With Term PROM?|Does Nipple Stimulation Shorten Time to Vaginal Birth in Women With Term PROM? (NIPROM Study)|Not yet recruiting||N/A|80|Anticipated|Hillel Yaffe Medical Center||2|||f||||f||||||||No||2017-10-10 21:26:39.654457|2017-10-10 21:26:39.654457
NCT03025568|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-17|||March 2017||2017-03-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Retention of Peek and Bre.Flex Materials Maxillary Bilateral Bounded Removable Partial Dentures|Comparative Study of Retention of Peek and Bre.Flex Materials Maxillary Bilateral Bounded Removable Partial Dentures .(Randomized Clinical Trial).|Not yet recruiting||N/A|17|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:26:39.7352|2017-10-10 21:26:39.7352
NCT03025555|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-02-01|||March 30, 2017|Anticipated|2017-03-30|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Patient Satisfaction and Dimensional Accuracy of Bre Flex and Peek for Removable Partial Dentures|COMPARISON OF PATIENT SATISFACTION AND DIMENSIONAL ACCURACY OF INJECTION MOLDED PEEK AND BRE-FLEX MATERIALS FOR BOUNDED REMOVABLE PARTIAL DENTURES (Randomized Clinical Trial)|Not yet recruiting||N/A|12|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:26:39.794371|2017-10-10 21:26:39.794371
NCT03025373|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-09-20|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Virtual Reality Stimulation to Enhance Cognitive Function of Intensive Care Unit Patients|Virtual Reality Stimulation to Enhance Cognitive Function of Intensive Care Unit Patients|Recruiting||N/A|100|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-10 21:26:41.303256|2017-10-10 21:26:41.303256
NCT03025542|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-29|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis|A Multicenter, Randomized, Subject-Blind, Investigator-Blind Study to Evaluate the Time Course of Pharmacodynamic Response, Safety and Pharmacokinetics of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis|Active, not recruiting||Phase 2|49|Actual|UCB Pharma||2|||f||||t||||||||||2017-10-10 21:26:39.981848|2017-10-10 21:26:39.981848
NCT03025529|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-20|||February 2015||2015-02-01|September 2017|2017-09-01|November 28, 2016|Actual|2016-11-28|November 28, 2016|Actual|2016-11-28||Interventional|||Transcranial Stimulation for Essential Tremor|Transcranial Stimulation for Essential Tremor|Terminated||N/A|8|Actual|Beth Israel Deaconess Medical Center||3||Investigator leaving institution|f||||f||||||||||2017-10-10 21:26:40.115235|2017-10-10 21:26:40.115235
NCT03025516|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-18|||May 29, 2017|Actual|2017-05-29|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Performance Evaluation of TB Breath- and Cough-testing Platforms|Performance Evaluation of Two Diagnostic Technologies for TB Detection Based Upon Breath Testing|Recruiting||N/A|360|Anticipated|Find|||1||f||||f||||||Samples With DNA|"     All consenting patients are expected to provide the following samples: 2x breath/cough     samples, which will be collected directly into enclosed diagnostic devices and destroyed     immediately following diagnosis; blood samples for HIV testing, which will be de-identified     and stored until study completion; urine samples; and 3x sputum samples, collected at     enrollment and during an 8-week follow-up, de-identified and used for liquid culture, solid     culture, AFB smear, and DNA extraction for Xpert testing. Except for the breath samples, all     samples will be de-identified and stored until study completion.   "|||2017-10-10 21:26:40.22576|2017-10-10 21:26:40.22576
NCT03025503|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-01-16|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Nipple Stimulation for Labor Induction|Nipple Stimulation for Labor Induction: Efficiency, Safety and Satisfaction Measures|Not yet recruiting||N/A|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||Undecided||2017-10-10 21:26:40.326562|2017-10-10 21:26:40.326562
NCT03025490|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-16|||January 2017||2017-01-01|November 2016|2016-11-01||||February 2019|Anticipated|2019-02-01||Interventional|||The Use of Capnography and Integrated Pulmonary Index in the Electrophysiology Laboratory|The Use of Capnography and Integrated Pulmonary Index in the Electrophysiology Laboratory|Not yet recruiting||N/A|450|Anticipated|Hadassah Medical Organization||2|||f||||||||||||No||2017-10-10 21:26:40.41528|2017-10-10 21:26:40.41528
NCT03025477|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-16|||May 2016||2016-05-01|December 2016|2016-12-01|May 2029|Anticipated|2029-05-01|May 2018|Anticipated|2018-05-01||Interventional|CHIMOVIP||Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer|Randomized Study Assessing Two Strategies of First Line: a Strategy With Intraperitoneal Chemotherapy and a Strategy With Total Intravenous Strategy, in Patients With Epithelial Advanced Ovarian Cancer|Recruiting||Phase 2|84|Anticipated|Groupe Hospitalier Diaconesses Croix Saint-Simon||2|||f||||t||||||||||2017-10-10 21:26:40.524413|2017-10-10 21:26:40.524413
NCT03025464|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-26|||August 2016||2016-08-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Validation of Sleep Apnea Screening Device Phase II|Wireless Sensor Patch for Educing Barriers to In-home Sleep Apnea Screening, Phase II|Not yet recruiting||Phase 2|100|Anticipated|University of Michigan||1|||f||||f||||||||No||2017-10-10 21:26:40.676678|2017-10-10 21:26:40.676678
NCT03025451|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-16|||May 2011||2011-05-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Retrospective Evaluation of Athens Complete Health Improvement Program (CHIP) Database|Retrospective Evaluation of Athens Complete Health Improvement Program (CHIP) Database|Completed||N/A|512|Actual|Ohio University||1|||f||||f||||||||No||2017-10-10 21:26:40.757947|2017-10-10 21:26:40.757947
NCT03025438|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Observational|||Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation|Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation|Not yet recruiting||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:26:40.863705|2017-10-10 21:26:40.863705
NCT03025425|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Palliation of Dyspnea With Mouth Piece Ventilation in AECOPD|Palliation of Dyspnea With Mouth Piece Ventilation in Acute Exacerbation of COPD Without Respiratory Insufficiency|Recruiting||N/A|44|Anticipated|Tampere University Hospital||1|||f||||f||||||||||2017-10-10 21:26:40.942637|2017-10-10 21:26:40.942637
NCT03025412|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-20|||April 19, 2017|Actual|2017-04-19|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Comparison of Endoscopic Surgery and Exercise Therapy in Patients With Longstanding Achilles Tendinopathy|A Comparison of Endoscopic Surgery and Conservative Treatment in Patients With Longstanding Mid-portion Achilles Tendinopathy|Recruiting||N/A|85|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||Undecided||2017-10-10 21:26:41.038202|2017-10-10 21:26:41.038202
NCT03025399|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-19|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy|Multi Center Clinical Study of Chinese Medicine Intervention on Early Diabetic Microvascular Complications: Multi Centers Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy|Not yet recruiting||Early Phase 1|384|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||Undecided||2017-10-10 21:26:41.140607|2017-10-10 21:26:41.140607
NCT03025386|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|EVODA-ICMN||Establish a Concordance Between the Mismatch Negativity Amplitude and a Score of Logatoms Discrimination|Establish a Concordance Between the Mismatch Negativity Amplitude and a Score of Logatoms Discrimination, Both Highlighting Capacities of Auditory Discrimination, in Adult Cochlear Implant Users|Active, not recruiting||N/A|47|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:26:41.239323|2017-10-10 21:26:41.239323
NCT03024970|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-08-15|||January 2017||2017-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:26:45.392038|2017-10-10 21:26:45.392038
NCT03025347|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-18|||December 2014||2014-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Exercise on Appetite and Gut Peptides in Men With Variants of the Obesity-linked FTO rs9939609 Polymorphism|Effect of Exercise on Appetite, Energy Intake and Gut Peptides in Men With Variants of the Obesity-linked FTO rs9939609 Polymorphism|Completed||N/A|24|Actual|Loughborough University||2|||f||||f||||||||No||2017-10-10 21:26:41.449564|2017-10-10 21:26:41.449564
NCT03025334|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-05-31|||March 22, 2017|Actual|2017-03-22|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|tDCS-PD-fMRI||tDCS on Parkinson's Disease Cognition|Transcranial Direct Current Stimulation Treatment of Cognitive Dysfunction in Parkinson's Disease|Recruiting||N/A|24|Anticipated|University of Manitoba||3|||f|||||f|t|f|f|t|||||2017-10-10 21:26:41.535031|2017-10-10 21:26:41.535031
NCT03025321|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Interventional|||Effects of Repetitive tDCS on Relapse in Cocaine Addiction: EMA Study|The Effects of Repetitive tDCS on Relapse in Cocaine Addiction: An Ecological Momentary Assessment (EMA) Study|Not yet recruiting||N/A|80|Anticipated|Erasmus Medical Center||2|||f||||t||||||||||2017-10-10 21:26:41.614705|2017-10-10 21:26:41.614705
NCT03025295|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-18|||July 2016||2016-07-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effect of Orexin on Delayed Emergence of General Anesthesia in Dexmedetomidine|The Effect of Orexin on Delayed Emergence of General Anesthesia in Dexmedetomidine|Recruiting||N/A|40|Anticipated|General Hospital of Ningxia Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:26:41.916564|2017-10-10 21:26:41.916564
NCT03025282|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-04|||November 3, 2016|Actual|2016-11-03|April 2017|2017-04-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|||Safety and Efficacy of CD10367 in Psoriasis Vulgaris|Exploratory Study to Evaluate the Safety and Efficacy of CD10367 in Subjects With Psoriasis|Completed||Phase 2|24|Actual|Galderma R&D||6|||f||||f||||||||||2017-10-10 21:26:42.002514|2017-10-10 21:26:42.002514
NCT03025269|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-08-16|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis|Effect of Ocrelizumab on Gray Matter Pathology, Leptomeningeal Inflammation and Cognitive Dysfunction in Multiple Sclerosis|Not yet recruiting||N/A|30|Anticipated|University at Buffalo|||1||f||||f||||||||||2017-10-10 21:26:42.09111|2017-10-10 21:26:42.09111
NCT03025256|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Study of Concurrent Intravenous and Intrathecal Nivolumab for Patients With Leptomeningeal Disease (LMD)|A Phase I/Ib Study of Concurrent Intravenous and Intrathecal Nivolumab for Patients With Leptomeningeal Disease (LMD)|Not yet recruiting||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:26:42.17736|2017-10-10 21:26:42.17736
NCT03025243|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Printing Layer Thickness on the Accuracy of Computer Aided Surgical Guides|The Effect of Printing Layer Thickness on the Accuracy of Computer Aided Surgical Guides : A Randomized Clinical Trial|Not yet recruiting||N/A|24|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:26:42.26376|2017-10-10 21:26:42.26376
NCT03025230|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-11|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Dry Needling Versus Intramuscular Stimulation in the Management of the Myofascial Trigger Points|Effectiveness of Dry Needling and Intramuscular Electrostimulation in the Treatment of Myofascial Trigger Points in Patients With Neck Pain|Completed||N/A|80|Actual|University of Alcala||2|||f||||t|f|f||||||||2017-10-10 21:26:42.332904|2017-10-10 21:26:42.332904
NCT03025217|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-18|||September 2014||2014-09-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|August 2015|Actual|2015-08-01||Interventional|TLC||Total Lifestyle Coaching Pilot Study (TLC)|Total Lifestyle Coaching Pilot Study (TLC)|Completed||N/A|31|Actual|Massachusetts General Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:26:42.411448|2017-10-10 21:26:42.411448
NCT03025204|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-26|||February 2016||2016-02-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Enamel Matrix Proteins in the Treatment of Intrabony Defects in Patients With Aggressive and Chronic Periodontitis|Enamel Matrix Proteins in the Treatment of Intrabony Defects in Patients With Aggressive and Chronic Periodontitis: Randomized Clinical Trial|Recruiting||Phase 4|45|Anticipated|University of Campinas, Brazil||3|||f||||||||||||||2017-10-10 21:26:42.481078|2017-10-10 21:26:42.481078
NCT03025191|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|January 2021|Anticipated|2021-01-01||Interventional|||Prison Connect-STI/HIV Prevention Intervention for Couples Affected by Incarceration|Development and Acceptability Evaluation of a Novel STI/HIV Prevention Intervention for Couples Affected by Incarceration|Recruiting||N/A|32|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 21:26:42.570534|2017-10-10 21:26:42.570534
NCT03025178|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-20|||March 8, 2017|Actual|2017-03-08|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Optimal Insertion Depth of Left Internal Jugular Vein Catheter in Infants|External Validation of Predictive Formula for Optimal Insertion Depth of Left Internal Jugular Venous Catheter in Infants|Recruiting||N/A|46|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:26:42.671508|2017-10-10 21:26:42.671508
NCT03025165|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-18|||February 2017||2017-02-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|||A Comparison of Different Community Models of ART Delivery Amongst Stable HIV+ Patients in Two Urban Settings in Zambia|A Comparison of Different Community Models of ART Delivery Amongst Stable HIV+ Patients in Two Urban Settings in Zambia|Not yet recruiting||N/A|3120|Anticipated|HIV Prevention Trials Network||3|||f||||f||||||||No||2017-10-10 21:26:42.744004|2017-10-10 21:26:42.744004
NCT03025152|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-19|||October 2016||2016-10-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer|Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-blinded, Parallel-group, Placebo-controlled Trial|Recruiting||N/A|130|Anticipated|Jiangxi University of Traditional Chinese Medicine||2|||f||||t||||||||No|The investigators do not plan to share individual participant data.|2017-10-10 21:26:42.822066|2017-10-10 21:26:42.822066
NCT03025139|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-03-21|||February 20, 2017|Actual|2017-02-20|January 2017|2017-01-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|PTW||Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)|Improving Outcomes for Younger Breast Cancer Survivors: A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors|Recruiting||N/A|360|Anticipated|Jonsson Comprehensive Cancer Center||3|||f||||t|f|f||||||||2017-10-10 21:26:42.932638|2017-10-10 21:26:42.932638
NCT03025126|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-16|||March 2016||2016-03-01|January 2017|2017-01-01||||August 2017|Anticipated|2017-08-01||Interventional|HEAD||Human Empowerment Aging and Disability (HEAD): New Technologies for Neurorehabilitation|Human Empowerment Aging and Disability (HEAD): New Technologies for Neurorehabilitation|Recruiting||N/A|100|Anticipated|Fondazione Don Carlo Gnocchi Onlus||2|||f||||||||||||||2017-10-10 21:26:43.0543|2017-10-10 21:26:43.0543
NCT03025113|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-20|||September 1, 2017|Anticipated|2017-09-01|January 2017|2017-01-01|June 29, 2018|Anticipated|2018-06-29|March 30, 2018|Anticipated|2018-03-30||Interventional|||Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine in Osteomuscular Treatment|Phase III, National, Multicenter, Randomized, Double-blind, Double-Masked, Compare the Efficacy of Ketoprofen + Cyclobenzaprine Association Versus Cyclobenzaprine (Miosan®) in the Treatment of Osteomuscular Pain in Adults|Not yet recruiting||Phase 3|414|Anticipated|EMS||2|||f||||t|f|f||||||||2017-10-10 21:26:43.141362|2017-10-10 21:26:43.141362
NCT03025100|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-03-30|||February 2016|Actual|2016-02-01|December 2016|2016-12-01|March 4, 2017|Actual|2017-03-04|March 4, 2017|Actual|2017-03-04||Observational|||VTE Prophylaxis Guidelines in Hospitalized Elders|Adherence to Venous Thromboembolism Prophylaxis Guidelines in Hospitalized Elders|Completed||N/A|120|Anticipated|Duke University|||1||f||||||||||||||2017-10-10 21:26:43.211701|2017-10-10 21:26:43.211701
NCT03025087|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-07-31|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Hydroxychloroquine and Cognitive Function After Surgery|Hydroxychloroquine and Cognitive Function After Surgery|Recruiting||Phase 4|30|Anticipated|Duke University||5|||f||||f|t|f|||f|||||2017-10-10 21:26:43.277634|2017-10-10 21:26:43.277634
NCT03025074|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-01-19|||July 2013||2013-07-01|January 2017|2017-01-01|December 2099|Anticipated|2099-12-01|December 2099|Anticipated|2099-12-01|1 Day|Observational [Patient Registry]|||Blood Collection Biorepository for Liver Disease Research|Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases|Recruiting||N/A|1000|Anticipated|State University of New York at Buffalo|||1||f||||t||||||Samples With DNA|"     Serum, Plasma, Buffy Coat, Liver tissue (Core Needle Biopsy)   "|Yes|The Biorepository was created to provide high quality specimens to future researchers to advance their clinical and translational research.|2017-10-10 21:26:43.362519|2017-10-10 21:26:43.362519
NCT03025061|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-03-31|||February 24, 2017|Actual|2017-02-24|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|CERS||Within-day and Between-day Repeatability of the Breath Pattern in Healthy Children and in Children With Asthma|Within-day and Between-day Repeatability of the Breath Pattern in Healthy Children and in Children With Moderate or Severe Asthma|Recruiting||N/A|120|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||3||f||||t||||||||No||2017-10-10 21:26:43.440896|2017-10-10 21:26:43.440896
NCT03025048|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-02-01|||September 2016||2016-09-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2016|Actual|2016-11-01||Observational|||A Holistic Dietary Intervention for Persons With Spinal Cord Injury|PILOT: A Holistic Dietary Intervention for Persons With Spinal Cord Injury|Active, not recruiting||N/A|13|Actual|Sunnaas Rehabilitation Hospital|||1||f||||f||||||||No||2017-10-10 21:26:43.537526|2017-10-10 21:26:43.537526
NCT03025035|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-06-07|||June 8, 2017|Anticipated|2017-06-08|June 2017|2017-06-01|January 30, 2023|Anticipated|2023-01-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Pembrolizumab in Advanced BRCA-mutated Breast Cancer|Open Label, Phase II Pilot Study of Immune Checkpoint Inhibition With Pembrolizumab in Advanced BRCA-mutated Breast Cancers|Recruiting||Phase 2|20|Anticipated|Cedars-Sinai Medical Center||1|||f||||t|t|f||||||Undecided|Undecided|2017-10-10 21:26:43.597555|2017-10-10 21:26:43.597555
NCT03025022|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-05-09|||January 17, 2017|Actual|2017-01-17|May 2017|2017-05-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects|An Open-Label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects|Completed||Phase 1|8|Actual|Janssen Research & Development, LLC||1|||f||||f|t|||||||||2017-10-10 21:26:44.198719|2017-10-10 21:26:44.198719
NCT03025009|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-10-02|||March 13, 2017|Actual|2017-03-13|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of LY3192767 in Healthy Participants|A Single-Site, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Glucodynamic Effects of LY3192767 in Healthy Subjects|Active, not recruiting||Phase 1|85|Actual|Eli Lilly and Company||5|||f||||f|t|f|||t|||||2017-10-10 21:26:44.302369|2017-10-10 21:26:44.302369
NCT03024996|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-09-14|||January 3, 2017|Actual|2017-01-03|September 2017|2017-09-01|April 13, 2024|Anticipated|2024-04-13|May 24, 2022|Anticipated|2022-05-24||Interventional|IMmotion010||A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy|A Phase III, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Atezolizumab (Anti−PD-L1 Antibody) as Adjuvant Therapy in Patients With Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy|Recruiting||Phase 3|664|Anticipated|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-10 21:26:44.428855|2017-10-10 21:26:44.428855
NCT03024957|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity|Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity in Patients Undergoing Major Abdominal Cancer Surgeries|Recruiting||Phase 1/Phase 2|30|Anticipated|Assiut University||3|||f||||f||||||||No||2017-10-10 21:26:45.438975|2017-10-10 21:26:45.438975
NCT03024944|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-04-17|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|TAUPET||TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind|TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind|Not yet recruiting||Phase 2|30|Anticipated|Columbia University||1|||f||||f|t|f||||||Undecided||2017-10-10 21:26:45.55702|2017-10-10 21:26:45.55702
NCT03024931|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2018|Anticipated|2018-01-01||Observational|MrBurn||Metabolic Rate in Burns|In Vivo Cellular and Physiological Response to Severe Burns Injuries|Not yet recruiting||N/A|10|Anticipated|Chelsea and Westminster NHS Foundation Trust|||1||f||||f||||||||No|no, we do not plan to share participant data with other researchers.|2017-10-10 21:26:45.648009|2017-10-10 21:26:45.648009
NCT03024918|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-19|||April 2016||2016-04-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Observational|TWINSHARE||Unequal Placental Sharing in Monochorionic Diamniotic Twins: an Observational Study|Unequal Placental Sharing in Monochorionic Diamniotic Twins: an Observational Study to Investigate Prediction and Outcome: the TWINSHARE Study|Recruiting||N/A|393|Anticipated|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||Samples With DNA|"     placental samples   "|Undecided||2017-10-10 21:26:45.733267|2017-10-10 21:26:45.733267
NCT03024905|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-07-21|||January 16, 2017|Actual|2017-01-16|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|EWH||Project to Use Community Health Workers to Reduce Maternal Deaths|Enhancing All Community Health Workers on Maternal and Newborn Health: Rorya Tanzania|Recruiting||N/A|17000|Anticipated|Bruyere Research Institute||4|||f||||f||||||||||2017-10-10 21:26:45.850093|2017-10-10 21:26:45.850093
NCT03024892|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-02-05|||November 2015||2015-11-01|October 2015|2015-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Intra-gallbladder or Systemic Indocyanide Green Injection Facilitate Cholecystectomy.|Intra-gallbladder or Systemic Indocyanide Green Injection Facilitate Cholecystectomy in Acute Cholecystitis , Gallstone and Gallbladder Polyp Patients.|Recruiting||N/A|600|Anticipated|Chang Gung Memorial Hospital||4|||f||||t||||||||Yes||2017-10-10 21:26:45.969043|2017-10-10 21:26:45.969043
NCT03024879|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-01-16|||March 2014||2014-03-01|January 2017|2017-01-01||||March 2017|Anticipated|2017-03-01||Interventional|||The Effect of Motilin on the Frequency and Amount of Food Intake|Influence of Erythromycin on ad Libitum Food Intake and the Evaluation of Motilin in Food Timing in Healthy Volunteers and Patients|Enrolling by invitation||Phase 4|15|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 21:26:46.090646|2017-10-10 21:26:46.090646
NCT03024866|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-15|||October 2016||2016-10-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|||Electronic Brachytherapy (eBx)-Mohs Matched Pair - Cohort Study A Multi-Center Retrospective-Prospective Matched Pairs Cohort Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx Compared to Non-melanoma Skin Cancer Patients Treated With Mohs Surgery|Electronic Brachytherapy (eBx)-Mohs Matched Pair - Cohort Study A Multi-Center Retrospective-Prospective Matched Pairs Cohort Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx Compared to Non-melanoma Skin Cancer Patients Treated With Mohs Surgery|Recruiting||N/A|500|Anticipated|Xoft, Inc.|||2||f||||f||||||||||2017-10-10 21:26:46.16352|2017-10-10 21:26:46.16352
NCT03024853|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-16|||March 2015||2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of Different Versions of the Best Possible Self Intervention|Efficacy of Different Versions of the Best Possible Self Intervention: a Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|University of Valencia||4|||f||||f||||||||No||2017-10-10 21:26:46.254759|2017-10-10 21:26:46.254759
NCT03024840|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-15|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Anaesthetic and Pediatric Living Related Liver Transplantation|The Effect of Sevoflurane or Propofol on Brain Injury and Neurocognitive in Pediatric Living Related Liver Transplantation|Enrolling by invitation||N/A|60|Anticipated|Tianjin First Central Hospital||2|||f||||t||||||||No||2017-10-10 21:26:46.363194|2017-10-10 21:26:46.363194
NCT03024814|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-01-14|||October 2016||2016-10-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Prophylactic Acetaminophen for Prevention Intraventricular Hemorrhage in Premature Infants|Prophylactic Acetaminophen for Prevention Intraventricular Hemorrhage in Premature Infants|Recruiting||Phase 3|300|Anticipated|King Saud Medical City||2|||f||||t||||||||No||2017-10-10 21:26:46.588731|2017-10-10 21:26:46.588731
NCT03024801|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-17|2017-01-18|||February 2012||2012-02-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2014|Actual|2014-05-01||Interventional|||Effectiveness of Autologous Platelet-rich Plasma on Knee Cartilage Injury|Effectiveness of Autologous Platelet-rich Plasma on Knee Cartilage Injury: a Randomized, Controlled, Open-label Clinical Trial|Completed||N/A|50|Actual|Chinese PLA General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:26:46.670388|2017-10-10 21:26:46.670388
NCT03024788|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-03|||January 2017||2017-01-01|May 2017|2017-05-01|December 2020||2020-12-01|June 2020|Anticipated|2020-06-01||Observational|||Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)|Determination of Cut-off Value of Advanced Glycation End-product and Glycosylated Haemoglobin in Type 2 Diabetes Diagnosis in China|Active, not recruiting||N/A|6000|Actual|Zhongda Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:26:46.741761|2017-10-10 21:26:46.741761
NCT03024775|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Response to Different Wheat Genotypes in Not-celiac Wheat Sensitivity|Clinical Response and Cytokines Production After Challenge With Different Wheat Genotypes in Patients With Not-celiac Wheat Sensitivity.|Not yet recruiting||N/A|50|Anticipated|University of Palermo||4|||f||||f||||||||No||2017-10-10 21:26:46.798756|2017-10-10 21:26:46.798756
NCT03024762|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-01-22|||July 2015|Actual|2015-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Interventional|ASPA||Active Search for Pediatric HIV/AIDS (ASPA)|Active Search for Pediatric HIV/AIDS (ASPA)|Active, not recruiting||N/A|870|Anticipated|Research for Development International||2|||f||||t||||||||Yes|Data can be made available to other researchers through an application addressed to the sponsor (Research for Development International) and this via the Principal Investigator (Dr Yumo Habakkuk).|2017-10-10 21:26:46.890201|2017-10-10 21:26:46.890201
NCT03024749|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-06-04|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31|12 Months|Observational [Patient Registry]|SUIT-SAVM||Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas|Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas: Multicenter Prospective Cohort Study|Recruiting||N/A|380|Anticipated|Xuanwu Hospital, Beijing|||1||f||||t||||||||Undecided||2017-10-10 21:26:46.970306|2017-10-10 21:26:46.970306
NCT03024736|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-07-21|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Neonatal and Maternal Effects of Buprenorphine and Methadone|Neonatal and Maternal Effects of Buprenorphine and Methadone in the Treatment of Opioid-Maintained Pregnant Women: A Retrospective Cohort Study|Enrolling by invitation||N/A|50|Anticipated|St. Louis University|||1||f||||f||||||||||2017-10-10 21:26:47.05367|2017-10-10 21:26:47.05367
NCT03024723|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-03-17|||April 2015||2015-04-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Nasal Continuous Positive Airway Pressure and Airway Patency in Obese Patient|Comparison of Upper Airway Patency Using Continuous Positive Airway Pressure Ventilation Via a Nasal Mask With a Face Mask During Induction of Anesthesia on Obese Patients|Completed||N/A|32|Actual|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-10 21:26:47.107421|2017-10-10 21:26:47.107421
NCT03024710|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-01-19|||January 2011||2011-01-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Promotion of Complimentary Feeding Practices in Bangladesh|Promotion of Complimentary Feeding Practices Through Health Messages: a Community-based Clustered Randomized Trial in Rural Bangladesh|Completed||N/A|360|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f||||||||Yes|As per icddr,b data policy study data will be shared with research administration for use future by others after following legal permission|2017-10-10 21:26:47.173929|2017-10-10 21:26:47.173929
NCT03024697|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-09-06|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Single-shot Pectoral Plane(PECs) Block Versus Continuous Local Anaesthetic Infusion Analgesia or Both PECS Block and Local Anaesthetic Infusion After Breast Surgery: A Prospective Randomised, Double-blind Trial|Single-shot Pectoral Plane (PECs) Blocks Versus Continuous Local Anaesthetic Infusion Analgesia or Both PECs Block and Local Anaesthetic Infusion After Non-ambulatory Breast Cancer Surgery: A Prospective, Randomised, Double-blind Trial|Completed||Phase 4|45|Actual|Mater Misericordiae University Hospital||3|||f||||f|f|f||||||||2017-10-10 21:26:47.273708|2017-10-10 21:26:47.273708
NCT03024684|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|SHOT||Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment|Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment: a Double-blind Randomized Placebo-controlled Trial|Recruiting||Phase 4|240|Anticipated|Chiayi Christian Hospital||2|||f||||t||||||||No||2017-10-10 21:26:47.385968|2017-10-10 21:26:47.385968
NCT03024671|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-03|||February 10, 2017|Actual|2017-02-10|May 2017|2017-05-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Epicutaneous Testing of Cosmetics|Epicutaneous Testing of Cosmetic Products to Determine Skin Compatibility|Recruiting||N/A|180|Anticipated|University Hospital Inselspital, Berne||1|||f|||||f|f||||||No|single centered study|2017-10-10 21:26:47.484837|2017-10-10 21:26:47.484837
NCT03024658|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-14|||May 2015||2015-05-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Positive End Expiratory Pressure at the Time of Induction in Morbidly Obese Patients|Single Minute of Positive End Expiratory Pressure at the Time of Induction: Effect on Arterial Blood Gases and Hemodynamics in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery|Completed||N/A|70|Actual|Sri Aurobindo Institute of Medical Sciences||2|||f||||f||||||||Yes|data was recorded on a planned proforma. Masterchart was prepared on completion which is available for sharing.|2017-10-10 21:26:47.560106|2017-10-10 21:26:47.560106
NCT03024645|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-18|||February 1, 2017|Anticipated|2017-02-01|January 2017|2017-01-01|June 1, 2019|Anticipated|2019-06-01|September 1, 2018|Anticipated|2018-09-01||Interventional|BeAMom||Be a Mom: Effectiveness of a Web-based Preventive Intervention for Postpartum Depression|Be a Mom: A Randomized Controlled Trial of the Effectiveness of a Web-based Preventive Intervention for Postpartum Depression.|Not yet recruiting||N/A|1000|Anticipated|University of Coimbra||3|||f||||f|f|f||||||Undecided|After the conclusion of the trial, the investigators plan to share the results of the study both with scientific community and health professionals.|2017-10-10 21:26:47.662264|2017-10-10 21:26:47.662264
NCT03024632|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-09-02|||January 2017|Anticipated|2017-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Previous Cesarean Sections|Trial of Labor After 3 or More Previous Cesarean Sections|Withdrawn||N/A|0|Actual|St. Louis University|||2|Closed study. Study is retrospective in nature and never enrolled any subjects.|f||||f||||||||||2017-10-10 21:26:47.756422|2017-10-10 21:26:47.756422
NCT03024619|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-21|||October 2016||2016-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Interstitial Cystitis and Urinary pH|A Pilot Study of the Correlation Between Symptoms of Interstitial Cystitis and Urinary pH|Enrolling by invitation||N/A|40|Anticipated|St. Louis University|||1||f||||f||||||||||2017-10-10 21:26:47.81209|2017-10-10 21:26:47.81209
NCT03024593|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-16||||||January 2017|2017-01-01||||September 2018|Anticipated|2018-09-01||Interventional|||An Examination of the Effects of Health-related Internet Use in Individuals With Pathological Health Anxiety|An Examination of the Effects of Health-related Internet Use in Individuals With Pathological Health Anxiety in a Randomized Controlled Trial|Not yet recruiting||N/A|80|Anticipated|Johannes Gutenberg University Mainz||2|||f||||||||||||||2017-10-10 21:26:47.930971|2017-10-10 21:26:47.930971
NCT03024580|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-16|||March 2017||2017-03-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|MEGA||A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer|A Pilot Study Evaluating Megestrol Acetate Modulation in Advanced Breast Cancer With Positive Hormonal Receptor|Not yet recruiting||Phase 2|20|Anticipated|Instituto Nacional de Cancer, Brazil||6|||f||||f||||||||No||2017-10-10 21:26:48.000216|2017-10-10 21:26:48.000216
NCT03024567|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|TS4||Randomized Study on Salt Intake and Energy Metabolism|Effects of Increased Salt Intake on Energy Metabolism in Healthy Volunteers - a Randomized Clinical Study|Recruiting||N/A|28|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||No||2017-10-10 21:26:49.806288|2017-10-10 21:26:49.806288
NCT03024554|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-16|||April 2014||2014-04-01|January 2017|2017-01-01|April 2022|Anticipated|2022-04-01|April 2018|Anticipated|2018-04-01||Interventional|STREAMLINER||Evaluation of Safety and Efficacy of the Bifurcated Multilayer Flow Modulator (BMFM®).|Evaluation of Safety and Efficacy of the Bifurcated Multilayer Flow Modulator (BMFM®).|Recruiting||N/A|40|Anticipated|Cardiatis||1|||f||||t||||||||No||2017-10-10 21:26:49.89145|2017-10-10 21:26:49.89145
NCT03024541|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-01-13|||June 2016||2016-06-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Longitudinal Analysis of Drug Burden Index|Longitudinal Analysis of Cumulative Exposure to Anticholinergic and Sedative Drugs Measured With the Drug Burden Index|Completed||N/A|9985|Actual|University of Groningen|||2||f||||f||||||||Undecided|Not Applicable: Permission to use the data should be obtained from the LASA and/or InterRAI researchers|2017-10-10 21:26:49.997438|2017-10-10 21:26:49.997438
NCT03024528|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-20|||January 2017||2017-01-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|POL-CPOT||Validation of the Polish Version of CPOT|Validation of the Polish Version of CPOT (Critical Care Pain Observation Tool) to Assess Pain Intensity in Adult, Intubated ICU Patients, POL-CPOT.|Completed||N/A|71|Actual|Pomeranian Medical University Szczecin|||2||f||||f||||||||No||2017-10-10 21:26:50.084821|2017-10-10 21:26:50.084821
NCT03024515|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-01-15|||January 2017||2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Opioids Titration Study in Advanced Cancer Patients in Hong Kong|A Pilot Randomized Open-labeled Study Comparing a Structured Titration Method of immediate-and Sustained- Release Oxycodone Versus Opioids Titration of Investigators' Choice in Advanced Cancer Patients in Hong Kong|Not yet recruiting||N/A|60|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-10 21:26:50.167804|2017-10-10 21:26:50.167804
NCT03024502|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-29|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|EPP-AFG-VVC||Patients With Vulvovaginal Candidiasis|Randomized Clinical Trial of a Mucoadhesive Gel Containing EPP-AF in Patients Diagnosed With Vulvovaginal Candidiasis|Not yet recruiting||Phase 1/Phase 2|90|Anticipated|University of Sao Paulo||3|||f||||t||||||||No||2017-10-10 21:26:50.255159|2017-10-10 21:26:50.255159
NCT03024489|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-03|||July 19, 2017|Actual|2017-07-19|September 2017|2017-09-01|December 2026|Anticipated|2026-12-01|December 2024|Anticipated|2024-12-01||Interventional|||Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma|A Phase I/II Dose Escalation Study of the CDK4/6 Inhibitor, Palbociclib in Combination With Cetuximab and Intensity Modulated Radiation Therapy (IMRT) for Locally Advanced Unresectable Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1/Phase 2|33|Anticipated|Mahidol University||1|||f||||t|t|f|||t|||||2017-10-10 21:26:50.339005|2017-10-10 21:26:50.339005
NCT03024476|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-06-12|||September 1, 2016|Actual|2016-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance|Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance: Prospective, Randomized, Open, Blinded Outcome Evaluation, and Feasibility Trial|Recruiting||Phase 2|60|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:26:50.446143|2017-10-10 21:26:50.446143
NCT03024463|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-16|||February 2017||2017-02-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Observational|||The Clinical Significance of Internal Mammary Lymph Node Irradiation in Axillary Lymph Node Positive Breast Cancer Patients||Not yet recruiting||N/A|100|Anticipated|Shandong Cancer Hospital and Institute|||1||f||||||||||||||2017-10-10 21:26:50.552414|2017-10-10 21:26:50.552414
NCT03024450|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-21|||January 2012||2012-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01|8 Years|Observational [Patient Registry]|||Trastuzumab Based Therapy in HER2 Positive AGC|Efficacy and Prognostic Factors of Trastuzumab Based Therapy in HER2 Positive Advanced Gastric Cancer: a Single Center Prospective Observational Study|Completed||N/A|98|Actual|Shanghai Zhongshan Hospital|||1||f||||f||||||Samples Without DNA|"     spicimen with paraffin-embedded obtained by gastroscope or surgery   "|No||2017-10-10 21:26:50.708384|2017-10-10 21:26:50.708384
NCT03024437|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-06-07|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma|A Phase I/II Study to Evaluate the Safety, Pharmacodynamics and Efficacy of Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|62|Anticipated|Indiana University||3|||f||||t|t|f||||||||2017-10-10 21:26:50.801727|2017-10-10 21:26:50.801727
NCT03024424|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-04-26|||March 2016||2016-03-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD|Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD|Active, not recruiting||N/A|200|Anticipated|University of Utah||2|||f||||f||||||||No||2017-10-10 21:26:50.907917|2017-10-10 21:26:50.907917
NCT03024398|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|Sentimetre||Evaluation of the Fluorescent Green of Indocyanine in the Detection of Sentinel Lymph Node in Endometrial Cancer||Not yet recruiting||N/A|50|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:26:51.113406|2017-10-10 21:26:51.113406
NCT03024385|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-05-05|||March 20, 2017|Actual|2017-03-20|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|||Interconception Care at the University of Mississippi Medical Center|Interconception Care at the University of Mississippi Medical Center: An Innovative and Unique Collaborative Continuous Quality Improvement Project Between the Departments of Pediatrics and Family Medicine|Enrolling by invitation||N/A|1625|Anticipated|University of Mississippi Medical Center|||1||f||||f||||||||No||2017-10-10 21:26:51.179766|2017-10-10 21:26:51.179766
NCT03024372|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-02-16|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|August 2024|Anticipated|2024-08-01|February 2024|Anticipated|2024-02-01||Interventional|||Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation|A Prospective Randomized Single Blinded Study of Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation|Recruiting||N/A|164|Anticipated|University of South Florida||2|||f||||f|f|t|f|||||No||2017-10-10 21:26:51.273127|2017-10-10 21:26:51.273127
NCT03024359|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|||Monounsaturated Fatty Acids and Brown/Beige Adipose Tissue in Humans|Effect of Monounsaturated Fatty Acids Consumption in Brown/Beige Adipose Tissue Activity in Human Adults|Recruiting||Early Phase 1|80|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||No||2017-10-10 21:26:51.398607|2017-10-10 21:26:51.398607
NCT03024333|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-09-21|||September 2018|Anticipated|2018-09-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Effect of Different Viscous Foods and Liquids on Swallowing Sounds|Effect of Different Viscous Foods and Liquids on Swallowing Sounds|Not yet recruiting||N/A|38|Anticipated|University of Nebraska|||1||f||||t||||||||||2017-10-10 21:26:51.515181|2017-10-10 21:26:51.515181
NCT03024320|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-08-28|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Scale Up Evaluation of a Physical Activity Program for Adults With Physical Disability|Scale Up Evaluation of a Physical Activity Program for Adults With Physical Disability|Not yet recruiting||N/A|649|Anticipated|University of Alabama at Birmingham||3|||f||||f|f|f||||||||2017-10-10 21:26:51.607089|2017-10-10 21:26:51.607089
NCT03024307|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-01-22|||January 18, 2017|Actual|2017-01-18|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of OPCSP on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases|Evaluation of an Outpatient Pharmacy Clinical Services Program on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases|Recruiting||N/A|600|Anticipated|RenJi Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:26:51.701895|2017-10-10 21:26:51.701895
NCT03024294|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Care Pathway for Patients Undergoing VATS Lobectomy or Segmentectomy|Care Pathway for Patients Undergoing VATS Lobectomy or Segmentectomy|Recruiting||N/A|50|Anticipated|Brigham and Women's Hospital||1|||f||||||||||||||2017-10-10 21:26:51.803452|2017-10-10 21:26:51.803452
NCT03024281|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-15|||July 2016||2016-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Surveillance of Azole Resistance in Aspergillus Isolates in Taiwan|Surveillance of Azole Resistance in Aspergillus|Recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:26:51.891628|2017-10-10 21:26:51.891628
NCT03024268|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-19|||January 2016||2016-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure|MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure - Evaluation of Morphologic and Functional Changes in a Randomized Setting|Recruiting||N/A|80|Anticipated|University of Leipzig||2|||f||||f||||||||Undecided||2017-10-10 21:26:51.974742|2017-10-10 21:26:51.974742
NCT03024255|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-07-13|||December 2016||2016-12-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis|A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 3 Concentrations of Topically Applied BBI-4000 (Sofpironium Bromide) Gel in Subjects With Axillary Hyperhidrosis|Active, not recruiting||Phase 2|220|Anticipated|Brickell Biotech, Inc.||4|||f||||f||||||||||2017-10-10 21:26:52.086023|2017-10-10 21:26:52.086023
NCT03024242|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-23|||July 2014||2014-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Tight Vaginoscopy: a Simplified Novel Technique for a Better Vaginal Surgery||Completed||Phase 2|34|Actual|Assiut University||1|||f||||f||||||||Yes||2017-10-10 21:26:52.188369|2017-10-10 21:26:52.188369
NCT03024229|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-05-09|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|January 15, 2019|Anticipated|2019-01-15|September 15, 2018|Anticipated|2018-09-15||Interventional|RENALIFE||Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine|The Importance of Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine Before Renal Transplantation|Recruiting||N/A|40|Anticipated|University Hospital, Tours||1|||f||||f|f|f||||||No||2017-10-10 21:26:52.258892|2017-10-10 21:26:52.258892
NCT03024216|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-05-02|||January 2017||2017-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients Who Have Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer|Phase Ib Study Assessing Different Sequencing Regimens of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients Who Have Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer|Recruiting||Phase 1|34|Anticipated|University of Hawaii||2|||f||||t||||||||Undecided||2017-10-10 21:26:52.354391|2017-10-10 21:26:52.354391
NCT03024203|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-01-15|||August 2016||2016-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Comparison of Cognitive Training Approaches in Psychotic Disorders|A Comparison of Cognitive Training Approaches in Psychotic Disorders|Recruiting||N/A|60|Anticipated|Queen's University||2|||f||||f||||||||No||2017-10-10 21:26:52.475115|2017-10-10 21:26:52.475115
NCT03024190|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-13|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Kinesiotaping Combined With Therapeutic Exercise in Upper Extremity Spasticity and Function in Subacute Stroke Patients|The Clinical Effect and Sonographic Findings of Kinesiotaping Combined With Therapeutic Exercise in Upper Extremity Spasticity and Function in Subacute Stroke Patients|Not yet recruiting||N/A|40|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||Undecided|undecided|2017-10-10 21:26:52.684582|2017-10-10 21:26:52.684582
NCT03024177|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-21||||||April 2017|2017-04-01||||April 2017|Actual|2017-04-01||Interventional|||A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection|Withdrawn||Phase 2|0|Actual|Aviragen Therapeutics||2||Study is withdrawn due to company decision|f||||t||||||||||2017-10-10 21:26:52.822376|2017-10-10 21:26:52.822376
NCT03024164|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-08-22|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31|1 Year|Observational [Patient Registry]|REACH||Stroke Registration of Young Adults in China|Stroke Registration of Young Adults in China|Not yet recruiting||N/A|3000|Anticipated|First Hospital of Jilin University|||5||f||||f||||||Samples Without DNA|"     EDTA-blood and serum will be collected for future analysis   "|||2017-10-10 21:26:52.930254|2017-10-10 21:26:52.930254
NCT03024151|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-03-24|||December 2016||2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients|The Effects of T4 Mono Replacement Versus T4/T3 Combination Replacement on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients; Prospective, Randomized, Double Blind, T4 Comparative Clinical Study|Recruiting||N/A|150|Anticipated|Inje University||2|||f||||f||||||||||2017-10-10 21:26:53.057521|2017-10-10 21:26:53.057521
NCT03024138|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-07|||December 2016||2016-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|REACT||Repeat CT for Evaluation of Inter- and Intrafraction Changes During Curative Thoracic Radiotherapy|Repeat CT for Evaluation of Inter- and Intrafraction Changes During Curative Thoracic Radiotherapy; An Exploratory Pilot Study (REACT)|Recruiting||N/A|80|Anticipated|University Medical Center Groningen|||1||f||||t||||||||||2017-10-10 21:26:53.156795|2017-10-10 21:26:53.156795
NCT03024125|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-01-17|||May 2016||2016-05-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|August 2016|Actual|2016-08-01||Interventional|||High vs Normal Protein Diets, Resistance Exercise, Lean Mass and Strength Gains|Effect of Normal and High Protein Diets in Lean Mass, Adiposity, and Strength in Postmenopausal Women Practitioners of Resistance Exercise|Active, not recruiting||N/A|20|Actual|Federal University of Uberlandia||2|||f||||t||||||||No||2017-10-10 21:26:53.236446|2017-10-10 21:26:53.236446
NCT03024099|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-13|||February 2016||2016-02-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Interventional|||Effects of Weekly Hippotherapy Frequency on Children With Cerebral Palsy||Enrolling by invitation||N/A|20|Actual|University of Brasilia||2|||f||||t||||||||No||2017-10-10 21:26:53.412682|2017-10-10 21:26:53.412682
NCT03024086|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-15|||December 2016||2016-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia|Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study (PART 1)|Recruiting||Phase 3|124|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||t||||||||No||2017-10-10 21:26:53.496034|2017-10-10 21:26:53.496034
NCT03024073|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-14|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Assessment of Near Vision Capacity in Different Light Intensities|Assessment of Near Vision Capacity in Different Light Intensities and Temperatures in Patients Who Underwent Pseudophakic Presbyopic Correction|Recruiting||N/A|80|Anticipated|Democritus University of Thrace|||2||f||||f||||||||No||2017-10-10 21:26:53.584986|2017-10-10 21:26:53.584986
NCT03024060|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-07|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp|A RANDOMIZED, VEHICLE-CONTROLLED PHASE 3 STUDY TO PROVE THE SAFETY AND EFFICACY OF LEVULAN KERASTICK (AMINOLEVULINIC ACID HCl) FOR TOPICAL SOLUTION, 20% AND 10 J/CM2 OF BLUE LIGHT DELIVERED AT 10 MW/CM2 OR 20 MW/CM2 BY A NEW LIGHT SOURCE FOR THE TREATMENT OF ACTINIC KERATOSES ON THE FACE OR SCALP|Not yet recruiting||Phase 3|135|Anticipated|DUSA Pharmaceuticals, Inc.||3|||f||||f|t|t|t|f||||No||2017-10-10 21:26:53.672423|2017-10-10 21:26:53.672423
NCT03024047|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01||||August 2018|Anticipated|2018-08-01||Observational|||Cohort Description of Younger With AV-block||Not yet recruiting||N/A|1255|Anticipated|University of Aarhus|||1||f||||t||||||||||2017-10-10 21:26:53.882275|2017-10-10 21:26:53.882275
NCT03024034|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-09-06|||March 2, 2017|Actual|2017-03-02|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase 1 TP-271 Oral PK Single Ascending Dose Study|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral TP-271 in Healthy Adult Subjects, Including 1 Cross-over Arm|Active, not recruiting||Phase 1|56|Anticipated|Tetraphase Pharmaceuticals, Inc.||7|||f||||t|t|f||||||||2017-10-10 21:26:53.993997|2017-10-10 21:26:53.993997
NCT03024021|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-19|||September 2016||2016-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia|The Effect of Cerebral Oxymetry in Determining Neurological Outcome in Patients Treated With Therapeutic Hypothermia|Recruiting||N/A|30|Anticipated|Tepecik Training and Research Hospital|||1||f||||f||||||||||2017-10-10 21:26:54.100718|2017-10-10 21:26:54.100718
NCT03024008|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-15|||January 2017||2017-01-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II|Phase I/II Open Label Single Center Clinical Study Aimed to Evaluate the Safety and Efficacy of BonoFill-II in Reconstructing Bone in the Extremities|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|BonusBio Group Ltd||1|||f||||f||||||||No||2017-10-10 21:26:54.211802|2017-10-10 21:26:54.211802
NCT03023995|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-13|||August 2015||2015-08-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Coronally Advanced Flap With Connective Tissue Graft and PRF for Recession Coverage||Completed||Phase 3|10|Actual|Dr. D. Y. Patil Dental College & Hospital||2|||f||||f||||||||No||2017-10-10 21:26:54.314212|2017-10-10 21:26:54.314212
NCT03023982|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-17|||February 2017||2017-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Pectoralis and Serratus Nerves Block in Thoracic Surgery|Ultrasound Guided PECs II (Pectoralis and Serratus Nerves) Block in Patients Undergoing a Thoracic Surgery|Not yet recruiting||Phase 2|168|Anticipated|Soroka University Medical Center||2|||f||||t||||||||Undecided|will be decided later|2017-10-10 21:26:54.395114|2017-10-10 21:26:54.395114
NCT03023969|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-02-05|||August 2015||2015-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Implication of Two Doses of O2-O3 Upon the Pain Alleviation in Patients With Low Back Pain|Implication of Two Different Doses of Intradiscal O2-O3 Injection Upon the Pain Alleviation in Patients With Low Back Pain: A Randomized, Single-blind Study|Completed||N/A|60|Actual|Assiut University||2|||f||||f||||||||Undecided||2017-10-10 21:26:54.48249|2017-10-10 21:26:54.48249
NCT03023956|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-22|||July 2016||2016-07-01|January 2017|2017-01-01|January 3, 2017|Actual|2017-01-03|December 2016|Actual|2016-12-01||Observational|||Outcome of Proximal Humerus Fractures :Anatomic Neck Fractures vs Surgical Neck Fractures||Completed||N/A|31|Actual|Zhoupu Hospital, Pudong New Area, Shanghai, China|||2||f||||||||||||||2017-10-10 21:26:54.566084|2017-10-10 21:26:54.566084
NCT03023943|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-06-27|||February 3, 2017|Actual|2017-02-03|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of IASTM and Proprioception|The Effects of Instrument Assisted Soft Tissue Mobilization on Proprioception|Recruiting||N/A|30|Anticipated|Youngstown State University||1|||f|||||f|f||||||||2017-10-10 21:26:54.628773|2017-10-10 21:26:54.628773
NCT03023930|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-25|||April 3, 2017|Actual|2017-04-03|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|July 2020|Anticipated|2020-07-01||Interventional|||Opioid Use Disorder in the Emergency Department: CTN 0069|Opioid Use Disorder in the Emergency Department: Clinical Trials Network-0069|Recruiting||N/A|2000|Anticipated|Yale University||1|||f||||t|f|f||||||||2017-10-10 21:26:54.705825|2017-10-10 21:26:54.705825
NCT03023917|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-10-04|||June 30, 2017|Actual|2017-06-30|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||The Study on Umbilical Cord Milking to Prevent and Decrease the Severity of Anemia in Preterms|The Study on Umbilical Cord Milking to Prevent and Decrease the Severity of Anemia in preterms--a Multi-center Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:26:54.823094|2017-10-10 21:26:54.823094
NCT03023904|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-24|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2019|Anticipated|2019-07-30||Interventional|||Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads|Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads|Not yet recruiting||Phase 2|47|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:26:54.916166|2017-10-10 21:26:54.916166
NCT03023891|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-06-13|||February 15, 2017|Actual|2017-02-15|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids|Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids|Recruiting||Phase 1|50|Anticipated|Vanderbilt University Medical Center||1|||f||||f|t|f|||f|||||2017-10-10 21:26:54.994635|2017-10-10 21:26:54.994635
NCT03023865|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-01-13|||January 2017||2017-01-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Individualized Management for Long Gap Esophageal Atresia|Individualized Diagnosis and Treatment for Long Gap Esophageal Atresia Based on the Principle of Biological Growth Under Stress|Not yet recruiting||N/A|30|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||Yes|Share with the period of stress applied,gap distance between two esophageal segments,stress pressure.etc|2017-10-10 21:26:55.346022|2017-10-10 21:26:55.346022
NCT03023852|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-05-24|||February 14, 2017|Actual|2017-02-14|May 2017|2017-05-01|April 14, 2017|Actual|2017-04-14|April 14, 2017|Actual|2017-04-14||Interventional|||A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult Participants|A Phase 1, Open-label, Randomized, Crossover Study in Two Panels of Healthy Adult Subjects to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation|Completed||Phase 1|45|Actual|Janssen-Cilag International NV||8|||f||||f|f|f||||||||2017-10-10 21:26:55.442391|2017-10-10 21:26:55.442391
NCT03023839|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-17|||February 2015||2015-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|July 2015|Actual|2015-07-01||Observational|||Incidence and Risk Factors for Delirium in Severely Injured Patients|Incidence and Risk Factors for Delirium in Severely Injured Patients|Completed||N/A|179|Actual|Asan Medical Center|||1||f||||f||||||||Undecided||2017-10-10 21:26:55.539423|2017-10-10 21:26:55.539423
NCT03023826|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-16|2017-06-19|||January 15, 2017|Actual|2017-01-15|June 2017|2017-06-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Interventional|||A Study of LY3202626 in Healthy Participants|Relative Bioavailability and Food Effect Study in Healthy Subjects Administered Two Different Formulations of LY3202626|Completed||Phase 1|30|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 21:26:55.632266|2017-10-10 21:26:55.632266
NCT03023813|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-07-07|||February 22, 2017|Actual|2017-02-22|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Individualizing Disease Prevention for Middle-Aged Adults|Individualizing Disease Prevention for Middle-Aged Adults|Recruiting||N/A|30|Anticipated|The Cleveland Clinic|||1||f||||f||||||||||2017-10-10 21:26:55.718924|2017-10-10 21:26:55.718924
NCT03023787|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-20|||August 2016||2016-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers|A Randomized, Double-Blinded, Safety and Pharmacokinetic Study of Escalating Single Doses of Hepalatide in Healthy Volunteers|Completed||Phase 1|35|Actual|Shanghai HEP Pharmaceatical Co., Ltd.||2|||f||||t||||||||No||2017-10-10 21:26:55.892539|2017-10-10 21:26:55.892539
NCT03023774|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-13|||June 2016||2016-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Use of Gcsf in Patients With Recurrent Ivf/Icsi Failure|Effects of Granulocyte Colony-stimulating Factor (GCSF)-Neupogen on Cases With Thin Endometrium or Previous Implantation Failure in ICSI Cycles|Completed||N/A|20|Actual|Ain Shams Maternity Hospital||1|||f||||t||||||||Yes|Female 35 years maximum have failed icsi due to low endometrium thickness|2017-10-10 21:26:55.976425|2017-10-10 21:26:55.976425
NCT03023761|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Management of Post Endodontic Re-treatment Pain With Low‑Level Laser Therapy|Management of Post Endodontic Re-treatment Pain With Low‑Level Laser Therapy|Recruiting||N/A|61|Anticipated|Shahid Beheshti University||2|||f||||f||||||||Undecided||2017-10-10 21:26:56.04156|2017-10-10 21:26:56.04156
NCT03023748|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-01-14|||September 2011||2011-09-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravenous Paricalcitol in Chronic Hemodialysis Patients|Providing Intravenous Paricalcitol Treatment to the Sick and Poor Chronic Hemodialysis Patients With Severe Secondary Hyperparathyroidism Resistant to Existing Vitamin D Analogs|Active, not recruiting||Phase 4|30|Anticipated|The University of Hong Kong||1|||f||||t||||||||No||2017-10-10 21:26:56.13516|2017-10-10 21:26:56.13516
NCT03023735|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-20|||August 2016||2016-08-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||Trial of Strategies to Communicate Genetic Information to Different Ethnic Subpopulations|Trial of Strategies to Communicate Genetic Information to Different Ethnic and Racial Subpopulations|Recruiting||N/A|300|Anticipated|Stanford University|||1||f||||t||||||||Undecided||2017-10-10 21:26:56.237476|2017-10-10 21:26:56.237476
NCT03023722|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-08-09|||May 11, 2017|Actual|2017-05-11|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer|An Open-label, Phase II Study of Intravenous Anetumab Ravtansine (BAY 94-9343), an Anti-mesothelin Antibody Drug Conjugate, in Pretreated Mesothelin-expressing Advanced Pancreatic Cancer|Recruiting||Phase 2|30|Anticipated|Yale University||1|||f||||t|t|f||||||||2017-10-10 21:26:56.313014|2017-10-10 21:26:56.313014
NCT03023709|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-03-30|2017-01-19||September 2015||2015-09-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)|Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers. U19-HIPC Vaccination and Infection: Indicators of Immunological Health and Responsiveness|Terminated||Phase 4|3|Actual|Stanford University||2||Due to the ACIP guidelines halting the use of LAIV|f||||f||||||||No||2017-10-10 21:26:56.431187|2017-10-10 21:26:56.431187
NCT03023696|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-07-14|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Can Prophylactic Foraminotomy Prevent C5 Palsy|A Randomized, Prospective Study Determining the Impact of Prophylactic Bilateral Foraminotomy During Cervical Decompression on C5 Palsy|Recruiting||N/A|480|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 21:26:56.793568|2017-10-10 21:26:56.793568
NCT03023683|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-18|2017-01-18||October 2012||2012-10-01|January 2017|2017-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)|U19 Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza|Completed||Phase 4|18|Actual|Stanford University||2|||f||||f||||||||No||2017-10-10 21:26:56.912595|2017-10-10 21:26:56.912595
NCT03023670|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Lung Protection and Pediatric Cardiac Surgery|Ventilatory Patterns During Cardiopulmonary Bypass In Pediatric Cardiac Surgery|Not yet recruiting||Phase 2|60|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:26:57.190357|2017-10-10 21:26:57.190357
NCT03023657|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-06-26|||June 23, 2017|Actual|2017-06-23|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|DAME||Detection of Arousal With Facial Micro-expression in Severe Brain-damaged Patient|Detection of Arousal With Facial Micro-expression in Severe Brain-damaged Patient|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||No||2017-10-10 21:26:57.28451|2017-10-10 21:26:57.28451
NCT03023488|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-05-24|2017-01-18||February 2016||2016-02-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional||Patients undergoing F-URS and laser lithotripsy for kidney stones in accordance with the EAU guidelines on Urolithiasis|Effects of Flexible Ureteroscopy on Renal Blood Flow|Effects Of Flexible Ureteroscopy On Renal Blood Flow|Completed||N/A|46|Actual|Marmara University||1|||f||||f||||||||Undecided||2017-10-10 21:26:58.964811|2017-10-10 21:26:58.964811
NCT03023644|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-24|||February 21, 2017|Actual|2017-02-21|February 2017|2017-02-01|September 30, 2019|Anticipated|2019-09-30|February 20, 2019|Anticipated|2019-02-20||Interventional|||Improving Neurodevelopmental Outcomes in Children With Congenital Heart Disease: An Intervention Study|Improving Neurodevelopmental Outcomes in Children With Congenital Heart Disease: An Intervention Study|Recruiting||N/A|100|Anticipated|Boston Children’s Hospital||2|||f||||t|f|f||||||Yes|We will share the final research data, including the computerized dataset upon which publications were based. The final dataset may also include both raw data and derived variables. Data products from this study will be made available without cost to researchers and analysts. User registration will be required in order to access or download files. As part of the registration process, users must agree to the conditions of use governing access to the public release data, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgement of the data resource. We are aware of the need to protect human subject information and Protected Health Information in accordance with HIPPA standards and in other situations where data sharing may not be appropriate or allowed. Data sharing will occur in a timely fashion.|2017-10-10 21:26:57.391755|2017-10-10 21:26:57.391755
NCT03023631|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-24|||April 23, 2017|Actual|2017-04-23|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||HPV Antibody Response After GARDASIL 9 Vaccination in Participants After Allogeneic Stem Cell Transplantation|Human Papillomavirus Antibody Response After GARDASIL 9 Vaccination in Participants After Allogeneic Stem Cell Transplantation|Recruiting||Phase 4|48|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:26:57.486802|2017-10-10 21:26:57.486802
NCT03023618|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-01-17|||January 2012||2012-01-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Fluid Oriented Therapy During Major Abdominal Surgery|Effect Of Stroke Volume Optimization On Complication Rate Of Patients Undergoing Pancreatic Surgery|Completed||N/A|180|Actual|Policlinico Universitario Agostino Gemelli||2|||f||||t||||||||Yes||2017-10-10 21:26:57.581326|2017-10-10 21:26:57.581326
NCT03023605|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-17|||October 2016||2016-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|APEED||Analysis of a Training Intervention for Pulmonary Embolism Diagnosis in Emergency Department (APEED)|Adherence to Clinical Guidelines in the Diagnosis of Pulmonary Embolism in an Emergency Department. Analysis of the Clinical Impact of a Training Intervention (APEED)|Recruiting||N/A|440|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||Undecided||2017-10-10 21:26:57.655974|2017-10-10 21:26:57.655974
NCT03023592|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-15|2017-01-15|||February 2017||2017-02-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of Iguratimod in Sjögren's Syndrome|A Preliminary Efficacy Study of Iguratimod in Patients With Sjögren's Syndrome|Recruiting||Phase 1/Phase 2|30|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-10 21:26:57.754245|2017-10-10 21:26:57.754245
NCT03023579|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-14|||January 2016||2016-01-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Interventional|||The Star Excursion Balance Test: Analysis of Children With Cerebral Palsy||Completed||N/A|8|Actual|Inje University||1|||f||||||||||||||2017-10-10 21:26:57.840631|2017-10-10 21:26:57.840631
NCT03023566|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-13|||February 9, 2017|Actual|2017-02-09|March 2017|2017-03-01|February 8, 2018|Anticipated|2018-02-08|February 8, 2018|Anticipated|2018-02-08||Observational|||Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI|Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI in Pediatric and Neonatal Patient Population (<18years)|Recruiting||N/A|250|Anticipated|Phoenix Children's Hospital|||1||f||||f|t|||||||No||2017-10-10 21:26:57.893066|2017-10-10 21:26:57.893066
NCT03023553|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-03-27|2017-01-18||December 2012||2012-12-01|March 2017|2017-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||In LAIV Group, 13 subjects initially consented. One subject was determined ineligible due to age. Twelve subjects completed the LAIV Group.|The Human Mucosal Immune Responses to Influenza Virus (SLVP026)|The Human Mucosal Immune Responses to Influenza Virus: A Systems Biology Approach. Innate Immune Responses to Influenza Virus in Single Human Nasal Epithelial Cells|Completed||Phase 4|13|Actual|Stanford University||2|||f||||f||||||||Yes|The NIH Human Immunology Project Consortium (HIPC) data repositories (ImmPORT) may store the results of the research assays results. Genetic data that is developed in this study may be made available to other researchers through the National Center for Biotechnology Information (NCBI) databases. Results from research assays will be labeled with a unique identification code and the volunteer identity (except for age) will not be disclosed.|2017-10-10 21:26:57.977843|2017-10-10 21:26:57.977843
NCT03023540|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-04-13|||March 7, 2017|Actual|2017-03-07|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|PLEO-CMT-FU||Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A|International, Multi-center, Double Blind 9-month Follow-up Extension Study Assessing the Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A|Recruiting||Phase 3|323|Anticipated|Pharnext SA||2|||f||||t|t|f||||||Undecided||2017-10-10 21:26:58.318743|2017-10-10 21:26:58.318743
NCT03023527|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-09|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|August 2022|Anticipated|2022-08-01|May 2022|Anticipated|2022-05-01||Interventional|||Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma||Recruiting||Phase 1|40|Anticipated|PETHEMA Foundation||2|||f||||f||||||||||2017-10-10 21:26:58.521648|2017-10-10 21:26:58.521648
NCT03023514|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-18|||March 2015||2015-03-01|January 2017|2017-01-01||||June 2016|Actual|2016-06-01||Interventional|||Lipoic Acid Supplementation in IVF||Completed||Phase 4|172|Actual|Lo.Li.Pharma s.r.l||2|||f||||||||||||||2017-10-10 21:26:58.640018|2017-10-10 21:26:58.640018
NCT03023501|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-13|||March 2014||2014-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Gabapentin on Postoperative Morphine Consumption After Sleeve Gastrectomy|The Effect of Gabapentin on Postoperataive Pain ,Morphine Sparing Effect and Preoperative Anxiety in Bariatric Surgical Patients|Completed||Phase 2|50|Actual|King Saud University||2|||f||||t||||||||Yes||2017-10-10 21:26:58.873893|2017-10-10 21:26:58.873893
NCT03022773|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-30|||June 2015||2015-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Macular Pigment Measurements in Eye & Other Tissues|Macular Pigment Measurements in Eye & Other Tissues|Recruiting||N/A|500|Anticipated|University of Utah||1|||f||||f||||||||||2017-10-10 21:27:06.487692|2017-10-10 21:27:06.487692
NCT03023475|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Two Different Endoscopic Radial Artery Harvesting Devices|Prospective Randomized Comparison of Two Different Endoscopic Radial Artery Harvesting Devices|Not yet recruiting||N/A|100|Anticipated|Kerckhoff Klinik||2|||f||||f||||||||No||2017-10-10 21:26:59.288669|2017-10-10 21:26:59.288669
NCT03023462|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|||Effectiveness of a Quadratus Lumborum 3 Block vs. a TAP-block for Inguinal Hernia Repair|Effectiveness of a Quadratus Lumborum 3 Block vs. a TAP-block for Inguinal Hernia Repair|Not yet recruiting||Phase 4|50|Anticipated|Ostfold Hospital Trust||2|||f||||t|f|f|||f|||||2017-10-10 21:26:59.381074|2017-10-10 21:26:59.381074
NCT03023449|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-05-01|||April 4, 2017|Actual|2017-04-04|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|DOMINO||Diffuse Optical Monitoring With Inhaled Nitric Oxide|Diffuse Optical Monitoring With Inhaled Nitric Oxide|Recruiting||Phase 2|40|Anticipated|University of Pennsylvania||2|||f||||f|t|f||||||No||2017-10-10 21:26:59.485774|2017-10-10 21:26:59.485774
NCT03023436|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-02-04|||January 2016||2016-01-01|February 2017|2017-02-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis|Multicenter Study on Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy and Chemotherapy for Gastric Cancer With Peritoneal Metastasis|Recruiting||Phase 3|220|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||No||2017-10-10 21:26:59.583397|2017-10-10 21:26:59.583397
NCT03023410|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-14|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Using Intraoperative Sensing Technology to Evaluate Revision Total Knee Arthroplasty|Using Intraoperative Sensing Technology to Evaluate Revision Total Knee Arthroplasty|Recruiting||N/A|200|Anticipated|Orthosensor, Inc.|||2||f||||f||||||||||2017-10-10 21:27:00.12024|2017-10-10 21:27:00.12024
NCT03023397|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-09-22|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|Mitey Nose||Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.|Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.|Recruiting||Phase 1|45|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f|t|f||||||||2017-10-10 21:27:00.211036|2017-10-10 21:27:00.211036
NCT03023384|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-01|||December 2016||2016-12-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01|5 Years|Observational [Patient Registry]|ICAML2015||Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML|Feasibility Study of the Use of Intermediate Doses of Cytarabine Associated With Autologous Hematopoietic Stem Cells as Consolidation Treatment of Young Adults With Low- or Intermediate-risk de Novo Acute Myeloid Leukemia|Recruiting||N/A|547|Anticipated|International Consortium on Acute Leukemias|||1||f||||t||||||Samples With DNA|"     Whole blood and Bone Marrow Aspirate   "|No||2017-10-10 21:27:00.313304|2017-10-10 21:27:00.313304
NCT03023371|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-23|||December 2016||2016-12-01|January 2017|2017-01-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01|10 Years|Observational [Patient Registry]|||National Registry of IgG4-RD in China|National Registry of IgG4-RD in China|Recruiting||N/A|900|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||Samples With DNA|"     Peripheral blood samples from IgG4-RD patients will be saved for DNA extration and study.   "|Yes||2017-10-10 21:27:00.446739|2017-10-10 21:27:00.446739
NCT03023358|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-01-13|||February 2017||2017-02-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients|Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients|Not yet recruiting||Phase 3|174|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||No||2017-10-10 21:27:00.525052|2017-10-10 21:27:00.525052
NCT03023345|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|FOSTINE||Trans-rectal Focal Microwave Ablation of the Index Tumor in Patients With Low-risk Prostate Cancer|Evaluation of the Feasibility and Tolerance of Trans-rectal Focal Microwave Ablation of the Index Tumor in Patients With Low-risk Prostate Cancer|Not yet recruiting||N/A|5|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||No||2017-10-10 21:27:00.649061|2017-10-10 21:27:00.649061
NCT03023332|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|June 2020|Anticipated|2020-06-01||Interventional|||Tailored Health Self-Management Interventions for Highly Distressed Family Caregivers|Tailored Health Self-Management Interventions for Highly Distressed Family Caregivers|Not yet recruiting||N/A|360|Anticipated|Case Western Reserve University||4|||f||||t||||||||No||2017-10-10 21:27:00.743522|2017-10-10 21:27:00.743522
NCT03023319|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-08-22|||January 2017||2017-01-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors|Phase I Study of the Non-receptor Kinase Inhibitor Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors|Recruiting||Phase 1|24|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-10 21:27:00.814974|2017-10-10 21:27:00.814974
NCT03023306|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-02-21|||February 17, 2017|Actual|2017-02-17|February 2017|2017-02-01|December 16, 2018|Anticipated|2018-12-16|December 16, 2018|Anticipated|2018-12-16||Interventional|||Preemptive Versus Preventive Antiemetics|Effectiveness of Preemptive Versus Preventive Antiemetic Treatment in Patients Undergoing Thyroidectomy. A Randomized Double Blind Trial.|Recruiting||N/A|115|Anticipated|University of Athens||2|||f|||||f|f||||||No||2017-10-10 21:27:00.900508|2017-10-10 21:27:00.900508
NCT03023293|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-17|||February 2017||2017-02-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01||Observational|||Effects and Mechanisms of n-3 PUFAs and Irisin on the Incidence of Abnormal Glucose Metabolism After GDM|Effects and Mechanisms of n-3 Polyunsaturated Fatty Acids and Irisin on the Incidence of Abnormal Glucose Metabolism After Gestational Diabetes Mellitus|Not yet recruiting||N/A|1285|Anticipated|Sun Yat-sen University|||1||f||||f||||||Samples Without DNA|"     the status of n-3 polyunsaturated fatty acids and irisin in plasma/serum/eryhrocyte membrane.   "|Undecided||2017-10-10 21:27:00.980448|2017-10-10 21:27:00.980448
NCT03023280|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-01-13|||September 2014||2014-09-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Radiofrequency Ablation in Patients With Large Cervical Heterotopic Gastric Mucosa and Globus Sensation||Completed||N/A|10|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 21:27:01.058075|2017-10-10 21:27:01.058075
NCT03023267|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-03-29|||April 20, 2017|Anticipated|2017-04-20|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||The Contribution of Parent-infant Interaction While Singing During Kangaroo Care, on Preterm-infants' Autonomic Stability and Parental Anxiety Reduction|Open Randomized Study on the Effect of Applying Music Therapy by Therapist in the Neonatal Intensive Care Unit (NICU).|Not yet recruiting||N/A|50|Anticipated|Meir Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:27:01.121662|2017-10-10 21:27:01.121662
NCT03023254|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-01-13|||March 2017||2017-03-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|PAP||An Exploratory Study to Assess the Efficacy of the Avène Hydrotherapy|An Exploratory Study to Assess the Efficacy of the Avène Hydrotherapy on Chronic Pruritus in Adults With Plaque Psoriasis|Not yet recruiting||N/A|70|Anticipated|Pierre Fabre Dermo Cosmetique||2|||f||||f||||||||No||2017-10-10 21:27:01.201199|2017-10-10 21:27:01.201199
NCT03023241|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-13|||December 2004||2004-12-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis|Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis|Recruiting||N/A|300|Anticipated|Cantonal Hospital, Frauenfeld||1|||f||||f||||||||No||2017-10-10 21:27:01.276892|2017-10-10 21:27:01.276892
NCT03023228|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-01-13|||May 2010||2010-05-01|January 2017|2017-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Diabetes To Go: An Inpatient Diabetes Survival Skills Education Program|Diabetes To Go: A Pilot Feasibility and Preliminary Efficacy Evaluation of an Inpatient Diabetes Self-management Survival Skills Education Program|Completed||N/A|125|Actual|Medstar Health Research Institute||1|||f||||f||||||||No||2017-10-10 21:27:01.362346|2017-10-10 21:27:01.362346
NCT03023215|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-13|||October 2012||2012-10-01|January 2017|2017-01-01||||October 2018|Anticipated|2018-10-01||Interventional|||Meditation for Breast Biopsy|Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy|Active, not recruiting||N/A|84|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 21:27:01.447417|2017-10-10 21:27:01.447417
NCT03023202|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-13|||March 2016||2016-03-01|January 2017|2017-01-01||||March 2021|Anticipated|2021-03-01|5 Years|Observational [Patient Registry]|||UWCCC Molecular Tumor Board Registry|UWCCC Precision Medicine Molecular Tumor Board Registry|Recruiting||N/A|500|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||Samples With DNA|"     Subjects will be asked to give one blood sample and up to two tissue samples (one at     diagnossi & one at progression of treatment, which are both standard clinical procedures).        -  Drawing 8 tsp of blood at the first clinic visit, DNA extraction from this blood,          additional testing on this blood.        -  Retention of residual tumor tissue for future research.        -  Collection of residual fresh tumor tissue [that was biopsied for clinical reasons], and          performing of genetic analyses/retention for future research.        -  Banking of data, blood, and biopsy tissue for future research.        -  Distribution of banked data/blood/biopsied tissue for research projects.   "|||2017-10-10 21:27:01.536286|2017-10-10 21:27:01.536286
NCT03023189|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-13|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|EXARHOSE||Efficacity and Safety of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding|Efficacy and Safety of Early Administration of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding Due to Portal Hypertension: a Multicenter, Randomized, Double Blind, Placebo-controlled Trial|Not yet recruiting||Phase 4|500|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 21:27:01.619317|2017-10-10 21:27:01.619317
NCT03023176|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-03|2017-01-18||September 2013||2013-09-01|April 2017|2017-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013|Protective Mechanisms Against a Pandemic Respiratory Virus: B-cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 5, 2013|Completed||Phase 4|20|Actual|Stanford University||1|||f||||f||||||||No||2017-10-10 21:27:01.729552|2017-10-10 21:27:01.729552
NCT03023163|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-13|||December 2016||2016-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||A Longitudinal Examination of Aging With a Spinal Cord Injury: Cardiovascular, Cerebrovascular and Cognitive Consequences|A Longitudinal Examination of Aging With a Spinal Cord Injury: Cardiovascular, Cerebrovascular and Cognitive Consequences|Recruiting||N/A|110|Anticipated|James J. Peters Veterans Affairs Medical Center|||4||f||||f||||||||||2017-10-10 21:27:01.95287|2017-10-10 21:27:01.95287
NCT03023150|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-13|||October 2016||2016-10-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert|Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation|Active, not recruiting||N/A|50|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||Undecided||2017-10-10 21:27:02.099359|2017-10-10 21:27:02.099359
NCT03022383|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01||||February 2017|Anticipated|2017-02-01||Interventional|||TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus|TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus|Enrolling by invitation||N/A|15|Anticipated|Topcon Medical Systems, Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:27:13.234809|2017-10-10 21:27:13.234809
NCT03023137|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-04-06|2017-02-02||May 2011||2011-05-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Interventional|W&D||Walking and Dietary Modification for Recurrent Early Miscarriages|Walking and Dietary Modification for Women With Consecutive Early Miscarriages: a Randomized Study|Completed||N/A|480|Actual|Hospital dos Servidores do Estado do Rio de Janeiro|"An important limitation of this study is that it did not assess the exact composition of the participants’ diet.
Another limitation is that the use of heparin use was not controlled in this study."|2|||f||||f|f|f||||||Yes||2017-10-10 21:27:02.203772|2017-10-10 21:27:02.203772
NCT03023124|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-22|||August 2017|Anticipated|2017-08-01|January 2017|2017-01-01|March 2024|Anticipated|2024-03-01|March 2021|Anticipated|2021-03-01||Interventional|STRADA||Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor|Solitary Fibrous Tumor: Phase II Study on Trabectedin Versus Adriamycin Plus Dacarbazine in Advanced Patients|Not yet recruiting||Phase 2|50|Anticipated|Italian Sarcoma Group||2|||f||||t|f|f||||||||2017-10-10 21:27:03.015317|2017-10-10 21:27:03.015317
NCT03023111|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-18|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Miltefosine and GM-CSF in Cutaneous Leishmaniasis|Miltefosine and GM-CSF in Cutaneous Leishmaniasis: a Randomized and Controlled Trial|Not yet recruiting||Phase 3|300|Anticipated|Hospital Universitário Professor Edgard Santos||3|||f||||t|t|f||||||No||2017-10-10 21:27:03.149477|2017-10-10 21:27:03.149477
NCT03023098|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-13|||January 2013||2013-01-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|DRECOREST1||Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study|Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study|Completed||N/A|57|Actual|Helsinki University Central Hospital||2|||f||||f||||||||No||2017-10-10 21:27:03.290775|2017-10-10 21:27:03.290775
NCT03023085|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-13|||August 2016||2016-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects|A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects|Recruiting||Phase 1/Phase 2|80|Anticipated|Braintree Laboratories||1|||f||||f||||||||No||2017-10-10 21:27:03.417572|2017-10-10 21:27:03.417572
NCT03023072|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-10-03|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Evaluation of an Incontinence Product||Suspended||N/A|90|Anticipated|Hill-Rom|||2|Product availability|f||||f||||||||||2017-10-10 21:27:03.539045|2017-10-10 21:27:03.539045
NCT03023059|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-05-02|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose Ranging Study of Carbidopa-levodopa|Proof of Concept and Dose Ranging Study of Carbidopa-levodopa in Neovascular AMD|Recruiting||Phase 2|52|Anticipated|Snyder, Robert W., M.D., Ph.D., P.C.||1|||f||||f|t|f||||||No||2017-10-10 21:27:03.662832|2017-10-10 21:27:03.662832
NCT03023046|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-06-16|||February 23, 2017|Actual|2017-02-23|June 2017|2017-06-01|December 1, 2022|Anticipated|2022-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|A Phase II Study of Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) as Front-Line Therapy for Adults With Acute Lymphoblastic Leukemia/Lymphoma|Recruiting||Phase 2|28|Anticipated|University of Washington||1|||f||||f|t|f||||||||2017-10-10 21:27:03.810019|2017-10-10 21:27:03.810019
NCT03023033|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-01-13|||October 2014||2014-10-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|SAFI||Supporting Attendance for Facility Delivery and Infant Health|Enhancing Retention in PMTCT/MNCH Services and Facility Delivery in Tabora, Tanzania|Completed||N/A|1505|Actual|Elizabeth Glaser Pediatric AIDS Foundation||3|||f||||f||||||||Yes|The dataset has been given to the USAID, the study sponsor. There is a plan to made these data publically available from 2018|2017-10-10 21:27:04.156496|2017-10-10 21:27:04.156496
NCT03023020|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-07-18|||April 4, 2017|Actual|2017-04-04|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|MASTER DAPT||Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen|Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen|Recruiting||N/A|4300|Anticipated|ECRI bv||2|||f||||t|f|f||||||||2017-10-10 21:27:04.316374|2017-10-10 21:27:04.316374
NCT03023007|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|PECS||Study Evaluating the Efficacy of Loco-regional Anaesthesia PECS on Chronic Pain of a Mastectomy|Study Evaluating the Efficacy of Loco-regional Anaesthesia PECS on the Rate of Chronic Pains 6 Month After a Mastectomy Associated or Not With Axillary Node Dissection and/or a Reconstruction Prosthesis.|Not yet recruiting||N/A|194|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||No||2017-10-10 21:27:04.551105|2017-10-10 21:27:04.551105
NCT03022994|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-07-09|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|January 2017|Actual|2017-01-01||Observational|||Duodenal and Rectal Histology in Non-celiac Wheat Sensitivity and Irritable Bowel Syndrome Patients|Duodenal and Rectal Histology in Non-celiac Wheat Sensitivity and Irritable Bowel Syndrome Patients|Completed||N/A|80|Actual|University of Palermo|||2||f||||f||||||Samples Without DNA|"     Biopsy specimens obtained from the bulb and the second duodenal portion and the rectum.   "|||2017-10-10 21:27:04.671061|2017-10-10 21:27:04.671061
NCT03022981|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-10-04|||January 26, 2017|Actual|2017-01-26|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|||Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection|A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection|Recruiting||Phase 2|200|Anticipated|Gilead Sciences||5|||f||||t|t|f||||||||2017-10-10 21:27:04.79177|2017-10-10 21:27:04.79177
NCT03022968|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-02-20|||January 10, 2017|Actual|2017-01-10|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|TEPTAU||Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD)|Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD)|Recruiting||Phase 2|24|Anticipated|University Hospital, Tours||3|||f||||t|f|f||||||No||2017-10-10 21:27:04.969891|2017-10-10 21:27:04.969891
NCT03022955|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of Cocoa on Gastrointestinal Function|Effects of Cocoa Solids on Gastrointestinal Transit, Postprandial Sensation and Gastrointestinal Well-being: a Randomized, Controlled Trial in Healthy Volunteers|Recruiting||N/A|16|Anticipated|University Hospital, Basel, Switzerland||4|||f||||f||||||||Undecided||2017-10-10 21:27:05.093337|2017-10-10 21:27:05.093337
NCT03022942|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy of Costal Mobilization Techniques and Manual Diaphragm Release Technique in Patients COPD|Efficacy of Costal Mobilization Techniques and Diaphragm Release in Thoracoabdominal Kinematics, Diaphragm Mobility and Submaximal Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial|Not yet recruiting||N/A|30|Anticipated|Universidade Federal de Pernambuco||3|||f||||t||||||||Undecided||2017-10-10 21:27:05.192153|2017-10-10 21:27:05.192153
NCT03022929|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-10-04|||January 2017||2017-01-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MITIGATE||A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings|A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings|Recruiting||N/A|380|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-10-10 21:27:05.285064|2017-10-10 21:27:05.285064
NCT03022916|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-01-12|||September 2015||2015-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Real-World Evaluation of the Effect of Jublia on Nail Polish||Recruiting||N/A|5|Anticipated|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-10 21:27:05.395339|2017-10-10 21:27:05.395339
NCT03022903|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-01-17|||September 2015||2015-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis|Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis|Recruiting||N/A|10|Anticipated|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-10 21:27:05.481416|2017-10-10 21:27:05.481416
NCT03022890|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-05-11|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy|Pilot Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy|Recruiting||N/A|40|Anticipated|Butler Hospital||2|||f||||t|f|f||||||||2017-10-10 21:27:05.576055|2017-10-10 21:27:05.576055
NCT03022877|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-12|||June 2017||2017-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Acute and Chronic Protective Effects of Peri-interventional Administration of Levosimendan in ST Elevation Myocardial Infarctions|Acute and Chronic Protective Effects of Peri-interventional Administration of Levosimendan in ST Elevation Myocardial Infarctions|Not yet recruiting||N/A|129|Anticipated|RWTH Aachen University||3|||f||||f||||||||No||2017-10-10 21:27:05.668668|2017-10-10 21:27:05.668668
NCT03022864|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-17|||October 2016||2016-10-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01|3 Months|Observational [Patient Registry]|||Accurate Diagnosis System for Postoperative Chronic Pain Based on fMRI|Establishment of Accurate Diagnosis and Treatment System for Postoperative Chronic Pain Based on Functional Magnetic Resonance Imaging|Enrolling by invitation||N/A|100|Anticipated|RenJi Hospital|||2||f||||f||||||||No||2017-10-10 21:27:05.765383|2017-10-10 21:27:05.765383
NCT03022851|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-08-14|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Prophet Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension|Prospective, Non-randomized, Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension|Recruiting||N/A|30|Anticipated|Occlutech International AB||1|||f||||t|f|f||||||||2017-10-10 21:27:05.830273|2017-10-10 21:27:05.830273
NCT03022838|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-02-28|||February 28, 2017|Actual|2017-02-28|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effects of Caffeine Withdrawal on Migraine|The Effects of Caffeine Withdrawal on Migraine - a Randomized, Double-blind, Crossover Study|Recruiting||Phase 2/Phase 3|80|Anticipated|Nordlandssykehuset HF||2|||f||||f|f|f||||||No||2017-10-10 21:27:05.909672|2017-10-10 21:27:05.909672
NCT03022825|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-08-16|||June 2, 2017|Actual|2017-06-02|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|March 2019|Anticipated|2019-03-01||Interventional|||QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer|QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer|Recruiting||Phase 2/Phase 3|100|Anticipated|Altor BioScience||1|||f||||f|t|f||||||||2017-10-10 21:27:06.002473|2017-10-10 21:27:06.002473
NCT03022812|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-22|||April 6, 2017|Actual|2017-04-06|May 2017|2017-05-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Neck-specific Exercise in Chronic Whiplash|Is E-health a Way to Increase Ability and Health and Make Health Care More Effective in Chronic Whiplash? A Prospective Randomized Controlled Multicenter Trial|Recruiting||N/A|140|Anticipated|Linkoeping University||2|||f||||f|f|f||||||No||2017-10-10 21:27:06.136541|2017-10-10 21:27:06.136541
NCT03022799|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-12|||October 2016||2016-10-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||KM-819 for Patients With Parkinson's Disease|A First in Human, Randomized, Double-blind, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following Single and Multiple Oral Doses of KM-819 in Healthy Young Adult and Elderly Subjects With Exploration of Food Effect|Recruiting||Phase 1|88|Anticipated|Kainos Medicine Inc.||2|||f||||t||||||||Undecided|Individual identifiable personal information will not be shared. All individuals will be coded by a 4-digit study code.|2017-10-10 21:27:06.290406|2017-10-10 21:27:06.290406
NCT03022786|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Dermatitis||Improving Value of Care for Patients With Severe Stasis Dermatitis|Improving Value of Care for Patients With Severe Stasis Dermatitis|Not yet recruiting||N/A|150|Anticipated|University Hospitals Cleveland Medical Center||3|||f||||t||||||||No||2017-10-10 21:27:06.398289|2017-10-10 21:27:06.398289
NCT03022760|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-01-11|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|PRIMA||Return to Work Among Patients With Stress Related Mental Disorders - An Intervention in the Swedish Primary Care|Return to Work Among Patients With Stress Related Mental Disorders - An Intervention in the Swedish Primary Care (PRIMA)|Recruiting||N/A|500|Anticipated|Vastra Gotaland Region||2|||f||||||||||||||2017-10-10 21:27:06.565558|2017-10-10 21:27:06.565558
NCT03022747|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol|Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol Clinical Study in Children 1-19 Years on Maintenance Therapy for Acute Lymphoblastic Leukemia.|Recruiting||Phase 2|60|Anticipated|Vastra Gotaland Region||2|||f||||t||||||||No||2017-10-10 21:27:06.650949|2017-10-10 21:27:06.650949
NCT03022734|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-12|||September 2016||2016-09-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis|A Phase II Study of Neoadjuvant Systemic Chemotherapy With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis|Recruiting||Phase 2|40|Anticipated|Yonsei University||1|||f||||f||||||||No||2017-10-10 21:27:06.747537|2017-10-10 21:27:06.747537
NCT03022721|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||September 2016||2016-09-01|January 2017|2017-01-01|September 2028|Anticipated|2028-09-01|September 2027|Anticipated|2027-09-01||Observational|HEIST-DiC||Heidelberg Study on Diabetes and Complications|Heidelberg Study on Diabetes and Complications|Recruiting||N/A|500|Anticipated|Heidelberg University|||3||f||||f||||||Samples With DNA|"     Plasma, serum, PBMC, whole blood, urine. There is a possibility of DNA extraction from PBMC   "|No|No sharing of individual participant data is planned.|2017-10-10 21:27:06.820868|2017-10-10 21:27:06.820868
NCT03022708|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-22|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|July 2018|Anticipated|2018-07-01||Interventional|Xplore2||Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study|Prospective, Non-randomized, Open Label Clinical Study to Assess the Feasibility of the Bioabsorbable Pulmonary Valved Conduit in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction|Recruiting||N/A|10|Anticipated|Xeltis||1|||f||||t|f|t|t|f||||||2017-10-10 21:27:06.904774|2017-10-10 21:27:06.904774
NCT03022695|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-01-19|||October 2013||2013-10-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|HIFU||Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)|Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)|Completed||N/A|27|Actual|University Women's Hospital Tübingen||1|||f||||||||||||||2017-10-10 21:27:08.829829|2017-10-10 21:27:08.829829
NCT03022682|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||February 2015||2015-02-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|IDEO||Inflammation, Diabetes, Ethnicity and Obesity Cohort|Development of a Multi-Ethnic, Multimodal Obesity Cohort|Recruiting||N/A|145|Anticipated|University of California, San Francisco|||1||f||||||||||Samples With DNA|"     Serum, plasma, Adipose tissue, stool   "|||2017-10-10 21:27:08.969749|2017-10-10 21:27:08.969749
NCT03022669|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||December 2016||2016-12-01|January 2017|2017-01-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Mobile Health Strategies for Veterans|Mobile Health Strategies for Veterans With Coronary Heart Disease|Recruiting||Phase 2|225|Anticipated|University of California, San Francisco||3|||f||||f||||||||Undecided||2017-10-10 21:27:09.039774|2017-10-10 21:27:09.039774
NCT03022656|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|A RCT Brace||A Randomized Clinical Trial of Brace Treatment|A Randomized Clinical Trial of Brace Treatment|Active, not recruiting||N/A|128|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 21:27:09.128009|2017-10-10 21:27:09.128009
NCT03022643|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-07-05|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Social & Behavioral Rhythms in Chronic Pain|Social & Behavioral Rhythms in Chronic Pain|Completed||N/A|62|Actual|University of Utah||3|||f||||t||||||||||2017-10-10 21:27:09.193958|2017-10-10 21:27:09.193958
NCT03022630|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-09-15|||February 6, 2017|Actual|2017-02-06|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|COMPASS||Palliative Care for Non-Malignant Diseases (COMPASS Trial)|The Creation of Models for Palliative Assessments to Support Severe Illness (COMPASS) Investigation: Testing Early and Ongoing Implementation of Palliative Care for Incurable Non-malignant Diseases|Enrolling by invitation||N/A|400|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:27:09.279539|2017-10-10 21:27:09.279539
NCT03022617|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis||Not yet recruiting||Phase 4|20|Anticipated|University of Alabama at Birmingham||1|||f||||f||||||||No||2017-10-10 21:27:09.373112|2017-10-10 21:27:09.373112
NCT03022604|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-20|||June 2015||2015-06-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|NB6||Assessment of a Pre-Workout Supplement|Pharmacokinetic, Hemodynamic and Ergogenic Assessment of a Pre-Workout Dietary Supplement|Completed||N/A|19|Actual|Texas A&M University||3|||f||||t||||||||No||2017-10-10 21:27:09.448268|2017-10-10 21:27:09.448268
NCT03022591|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|||Short Cervix - Twins|Management of Twins With Short Cervix at a Single Institution: A Retrospective Review|Enrolling by invitation||N/A|200|Anticipated|St. Louis University|||1||f||||f||||||||No||2017-10-10 21:27:09.522859|2017-10-10 21:27:09.522859
NCT03022578|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-09-12|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Study of Laser Interstitial Thermal Therapy (LITT) in Recurrent Glioblastoma|Phase II Study of Laser Interstitial Thermal Therapy (LITT) in Recurrent Glioblastoma|Not yet recruiting||Phase 2|34|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|t|f|||||||2017-10-10 21:27:09.577479|2017-10-10 21:27:09.577479
NCT03022370|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-11|||October 2015||2015-10-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Stepping Stones and Creating Futures Intervention Trial|Stepping Stones and Creating Futures Intervention Trial|Active, not recruiting||Phase 3|1357|Actual|University of KwaZulu||2|||f||||f||||||||No||2017-10-10 21:27:13.317794|2017-10-10 21:27:13.317794
NCT03022565|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-10-03|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|October 2024|Anticipated|2024-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Vorinostat in Patients With Class 2 High Risk Uveal Melanoma|Proof of Concept Study of Vorinostat, A Histone Deacetylase Inhibitor, in Patients With Class 2 High Risk Uveal Melanoma|Not yet recruiting||Early Phase 1|10|Anticipated|University of Miami||1|||f||||t|t|f||||||||2017-10-10 21:27:09.764784|2017-10-10 21:27:09.764784
NCT03022552|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-13|||August 2016||2016-08-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01|6 Months|Observational [Patient Registry]|HARP||Women's Heart Attack Research Program: Platelet Sub-Study (HARP)|Women's Heart Attack Research Program: Platelet Sub-Study (HARP); Platelet Collection for Women With Myocardial Infarction|Recruiting||N/A|200|Anticipated|New York University School of Medicine|||3||f||||t||||||Samples With DNA|"     Blood Collection   "|Yes|De-identified data will be shared after the end of the study.|2017-10-10 21:27:09.87587|2017-10-10 21:27:09.87587
NCT03022539|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-11|||December 2016||2016-12-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|RACE||Repeat CT Scans for Evaluation of Inter- and Intrafraction Motion and it's Effect on Radiotherapy Dose Distribution During Curative Radiotherapy for Pelvic Tumours||Recruiting||N/A|40|Anticipated|University Medical Center Groningen|||1||f||||t||||||||||2017-10-10 21:27:09.990268|2017-10-10 21:27:09.990268
NCT03022526|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01||||June 2018|Anticipated|2018-06-01||Interventional|COPE||CSE v. Epidural for Postpartum Depression|Combined Spinal Epidural v. Epidural Labor Analgesia for Postpartum Depression Symptoms (COPE Trial): Pilot Randomized Control Trial|Recruiting||N/A|46|Anticipated|University of Pittsburgh||2|||f||||f||||||||Undecided||2017-10-10 21:27:10.102913|2017-10-10 21:27:10.102913
NCT03022513|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Fibromyalgia-like Joint/Muscle Pain and Synovitis in Non-celiac Wheat Sensitivity Patients|Fibromyalgia-like Joint/Muscle Pain and Synovitis in Non-celiac Wheat Sensitivity Patients|Not yet recruiting||N/A|150|Anticipated|University of Palermo||3|||f||||f||||||||No||2017-10-10 21:27:10.248005|2017-10-10 21:27:10.248005
NCT03022500|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-09-10|||May 18, 2017|Actual|2017-05-18|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|January 2020|Anticipated|2020-01-01||Interventional|||Pulmonary sarcomatoid_MEDI4736+Treme|Phase II Study of Durvalumab + Tremelimumab in Pulmonary Sarcomatoid Carcinoma|Recruiting||Phase 2|18|Anticipated|Seoul National University Hospital||1|||f||||f|f|f||||||||2017-10-10 21:27:10.374358|2017-10-10 21:27:10.374358
NCT03022487|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||July 2016||2016-07-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|MINERVA||Multicentre Investigation of Novel Electrocardiogram Risk Markers in Ventricular Arrhythmia Prediction|Multicentre Investigation of Novel Electrocardiogram Risk Markers in Ventricular Arrhythmia Prediction (MINERVA)|Recruiting||N/A|440|Anticipated|University of Leicester|||1||f||||||||||||||2017-10-10 21:27:10.512393|2017-10-10 21:27:10.512393
NCT03022474|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-03-24|||January 2012||2012-01-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|KICOG||Kindergarten-based Intervention for Childhood Obesity in Guangzhou(KICOG)|Kindergarten-based Intervention for Childhood Obesity in Guangzhou(KICOG)|Completed||N/A|984|Actual|Guangzhou Women and Children's Medical Center||2|||f||||t||||||||No||2017-10-10 21:27:10.616321|2017-10-10 21:27:10.616321
NCT03022461|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||June 2016||2016-06-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|HM3 CE LTFU||HeartMate 3 CE Mark Study Long Term Follow-up|HeartMate 3 CE Mark Study Long Term Follow-up Clinical Investigation Plan|Recruiting||N/A|30|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-10 21:27:10.700407|2017-10-10 21:27:10.700407
NCT03022448|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-09-05|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|E-TRAB||"Geriatric Assessmen of Elderly Unsuited Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)"|"Geriatric Assessmen of Elderly Unsuited Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)"|Recruiting||N/A|110|Anticipated|GWT-TUD GmbH|||1||f||||f||||||||||2017-10-10 21:27:10.816965|2017-10-10 21:27:10.816965
NCT03022435|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-05-18|2017-01-17||October 2012|Actual|2012-10-01|May 2017|2017-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012|Protective Mechanisms Against a Pandemic Respiratory Virus: B-cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 4, 2012|Completed||Phase 4|22|Actual|Stanford University||5|||f||||f||||||||No||2017-10-10 21:27:10.903484|2017-10-10 21:27:10.903484
NCT03022422|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-08-15|2017-01-17||September 2011||2011-09-01|August 2017|2017-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Numbers listed in the tables reflect individual twins and not twin pairs. In Group D, one twin of an identical pair consented but was not eligible, so this participant did not receive vaccine. Because of this, the other twin of this identical pair did not come in for a study visit.|T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011|Protective Mechanisms Against a Pandemic Respiratory Virus: B-Cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 3, 2011|Completed||Phase 4|63|Actual|Stanford University||6|||f||||f|||||f|||||2017-10-10 21:27:11.477395|2017-10-10 21:27:11.477395
NCT03022396|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-08-15|2017-01-17||September 2010||2010-09-01|August 2017|2017-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||All numbers reflect the number of individual participants, not the number of twin pairs. Ie, in Group A there were 16 participants who were part of 8 twin pairs.|T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010|Protective Mechanisms Against a Pandemic Respiratory Virus: B- Cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 2, 2010|Completed||Phase 4|82|Actual|Stanford University||6|||f||||f||||||||||2017-10-10 21:27:12.368785|2017-10-10 21:27:12.368785
NCT03022344|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-17|||November 2014||2014-11-01|January 2017|2017-01-01|October 2021|Anticipated|2021-10-01|June 2021|Anticipated|2021-06-01||Interventional|DD2plaque||DD2-Coronary Plaque Morphology and Plaque Progression|Coronary Plaque Morphology and Plaque Progression in Patients With Newly Diagnosed Type-2 Diabetes Mellitus|Active, not recruiting||N/A|200|Anticipated|Sydvestjysk Hospital||2|||f||||f||||||||No||2017-10-10 21:27:13.546227|2017-10-10 21:27:13.546227
NCT03022331|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||VCRC Longitudinal Protocol for Aortitis|VCRC Longitudinal Protocol for Aortitis|Not yet recruiting||N/A|250|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     Blood and urine samples, including genetic information (DNA), will be collected from patients     with aortitis in this study.   "|||2017-10-10 21:27:13.634363|2017-10-10 21:27:13.634363
NCT03022318|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-05-02|||May 2, 2017|Actual|2017-05-02|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Carbidopa-levodopa in Neovascular AMD|Short Term Effects of Carbidopa-levodopa in Neovascular AMD|Recruiting||Phase 2|52|Anticipated|Snyder, Robert W., M.D., Ph.D., P.C.||2|||f||||f|t|f||||||No||2017-10-10 21:27:13.709767|2017-10-10 21:27:13.709767
NCT03022305|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-01-12|||November 2015||2015-11-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Pelvic Alignment and Shoulder Function|The Effects of Pelvic Alignment on Shoulder Range of Motion and Torque Production|Completed||N/A|42|Actual|University of North Georgia||3|||f||||f||||||||No||2017-10-10 21:27:13.81582|2017-10-10 21:27:13.81582
NCT03022292|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-04-26|||March 30, 2017|Actual|2017-03-30|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Interventional|IAI-OCTA||The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy|The IAI-OCTA Study or; Microvascular Structure and Morphology of Neovascular Membranes in Age Related Macular Degeneration (AMD) After Intravitreal Aflibercept Injection (IAI) Therapy Using OCT-Angiography Analysis|Recruiting||Phase 4|30|Anticipated|University of California, Los Angeles||1|||f||||f|f|t|f|f|f|||No||2017-10-10 21:27:13.897171|2017-10-10 21:27:13.897171
NCT03022279|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-03-10|||January 6, 2017|Actual|2017-01-06|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Nerve Blocks vs Local Injections for Post-op Pain Prevention in Laparoscopic Cholecystectomy in Children|Transversus Abdominis Plane Block vs. Local Wound Infiltration for Elective Laparoscopic Cholecystectomy in Children and Adolescents: A Prospective Randomized-Controlled Trial|Enrolling by invitation||Phase 4|150|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 21:27:14.009043|2017-10-10 21:27:14.009043
NCT03022266|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-27|||January 2017||2017-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Behavioral Economics-Based Telehealth Intervention to Improve Post-MI Medication Adherence|A Behavioral Economics-Based Telehealth Intervention to Improve Post-MI Medication Adherence|Recruiting||N/A|140|Anticipated|Wellth Inc.||2|||f||||t||||||||No||2017-10-10 21:27:14.101006|2017-10-10 21:27:14.101006
NCT03022253|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2017-04-26|||March 2016||2016-03-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates|Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial|Recruiting||Phase 3|44|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||No||2017-10-10 21:27:14.228023|2017-10-10 21:27:14.228023
NCT03022240|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Neurobiological and Cognitive Changes Following Exposure to Either Sevoflurane- or Propofol-based Anesthesia in Children|Neurobiological, Cognitive-affective and Behavioral Changes Following Exposure to Either Sevoflurane- or Propofol-based Anesthesia in Children Undergoing MRI|Recruiting||Phase 4|50|Anticipated|University of Calgary||2|||f||||t||||||||Undecided||2017-10-10 21:27:14.378968|2017-10-10 21:27:14.378968
NCT03022227|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-28|||May 2015|Actual|2015-05-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Interventional|TELERIC1||Feasibility of Remote Cochlear Implant Users' Follow-up|Comparison of Remote Versus Standard On-site Care for Long Term Follow-up of Adult Cochlear Implant Users: a Prospective Controlled Feasibility Study|Completed||N/A|30|Actual|Hôpital Rothschild||2|||f||||f||||||||||2017-10-10 21:27:14.492731|2017-10-10 21:27:14.492731
NCT03022214|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-02|||March 22, 2017|Actual|2017-03-22|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ADAPT||ADAPT: Efficacy of a Dietary Supplement During and After Exercise|ADAPT: Efficacy of a Dietary Supplement to Increase Resilience and Inhibit the Oxidative Stress Response During and After Exercise|Recruiting||N/A|40|Anticipated|University of Aberdeen||2|||f||||f|f|f||||||No||2017-10-10 21:27:14.557298|2017-10-10 21:27:14.557298
NCT03022201|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-01-13|||May 2013||2013-05-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease|Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease Evaluated by Real-time Ultrasonography: A Randomized Double-blinded Clinical Trial|Completed||Phase 3|40|Actual|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 21:27:14.649503|2017-10-10 21:27:14.649503
NCT03022188|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-15|||January 2017||2017-01-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2019|Anticipated|2019-01-01||Observational|||Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma|Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma: Clinical and Morphological Findings, and Therapeutic Options (IPANEMA)|Not yet recruiting||N/A|100|Anticipated|Société Française d'Endoscopie Digestive|||1||f||||f||||||||No||2017-10-10 21:27:14.737499|2017-10-10 21:27:14.737499
NCT03022175|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-10-04|||December 2016||2016-12-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|July 2017|Actual|2017-07-01||Interventional|||A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunteers|A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of SPR741 in Healthy Volunteers|Completed||Phase 1|64|Actual|Spero Therapeutics||2|||f||||f||||||||||2017-10-10 21:27:14.818976|2017-10-10 21:27:14.818976
NCT03022162|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-04-25|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast Cancer|Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast Cancer : A Prospective Observational Study|Not yet recruiting||N/A|200|Anticipated|Tata Memorial Centre|||1||f||||t||||||||No||2017-10-10 21:27:14.991562|2017-10-10 21:27:14.991562
NCT03022149|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-12|||February 2016||2016-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|RIPSVD||Remote Ischemic Preconditioning for Subcortical Vascular Dementia|Remote Ischemic Preconditioning for Subcortical Vascular Dementia|Active, not recruiting||N/A|52|Actual|Tianjin Medical University General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:27:15.084306|2017-10-10 21:27:15.084306
NCT03022136|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-13|||February 2017||2017-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|LTDEP||To Map Human Lower Thoracic Dermatomes by Epidural Block|Observation Study of Thoracic Dermatomes|Not yet recruiting||N/A|50|Anticipated|Tongji Hospital||1|||f||||f||||||||Yes|Damatomes of sensory loss to cold of each patient. Investigators can contact us by e-mail.|2017-10-10 21:27:15.253284|2017-10-10 21:27:15.253284
NCT03022123|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-13|||November 2016||2016-11-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma|The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Initial Treatment of Patients With Diffuse Large B-cell Lymphoma|Recruiting||N/A|270|Anticipated|Hebei Medical University Fourth Hospital||2|||f||||t||||||||No||2017-10-10 21:27:15.331929|2017-10-10 21:27:15.331929
NCT03022110|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||February 2017||2017-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts|Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts: A Multi-center Randomized Controlled Trial|Not yet recruiting||N/A|106|Anticipated|Changhai Hospital||2|||f||||t||||||||No||2017-10-10 21:27:15.418698|2017-10-10 21:27:15.418698
NCT03022097|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-10-05|||January 24, 2017|Actual|2017-01-24|October 2017|2017-10-01|December 12, 2018|Anticipated|2018-12-12|December 12, 2018|Anticipated|2018-12-12||Interventional|AVANT||Study to Patients With Stable COPD to Assess the Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate (DUAKLIR)|A 24-week Treatment, Randomised, Parallel-group, Double Blinded, Double-Dummy, Multicenter Study to Assess the Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Compared With Individual Components and Placebo and Aclidinium Bromide Compared With Placebo When Administered to Patients With Stable Chronic Obstructive Pulmonary Disease.|Recruiting||Phase 3|1060|Anticipated|AstraZeneca||4|||f||||f|f|f||||||||2017-10-10 21:27:15.495208|2017-10-10 21:27:15.495208
NCT03022084|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-11|||January 2017||2017-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Clinical Trial of Sound-Based Versus Behavioral Therapy for Tinnitus|Clinical Trial of Sound-Based Versus Behavioral Therapy for Tinnitus|Recruiting||N/A|200|Anticipated|VA National Center for Rehabilitative Auditory Research||2|||f||||t||||||||Undecided||2017-10-10 21:27:15.720472|2017-10-10 21:27:15.720472
NCT03022071|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-01-12|||February 2017||2017-02-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|MOP||Mechanisms of Change in Psychotherapy|What Works for Whom and How? Mechanisms of Change in Psychotherapy|Not yet recruiting||N/A|100|Anticipated|Oslo University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:27:15.813597|2017-10-10 21:27:15.813597
NCT03022058|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-06-22|||June 22, 2017|Actual|2017-06-22|June 2017|2017-06-01|January 5, 2018|Anticipated|2018-01-05|January 5, 2018|Anticipated|2018-01-05||Interventional|||Evaluation of the EarEEG System for Detection of Hypoglycaemia-induced Changes in the EEG in Subjects With Type 1 Diabetes|Evaluation of the EarEEG System for Detection of Hypoglycaemia-induced Changes in the EEG in Subjects With Type 1 Diabetes: A Non-controlled, Exploratory Study|Recruiting||N/A|20|Anticipated|Odense University Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:27:15.885055|2017-10-10 21:27:15.885055
NCT03022045|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-09-29|||January 26, 2017|Actual|2017-01-26|September 2017|2017-09-01|January 14, 2021|Anticipated|2021-01-14|December 21, 2017|Anticipated|2017-12-21||Interventional|||A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis|A Phase 3, Randomized, Open-Label Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis|Active, not recruiting||Phase 3|16|Anticipated|AbbVie||2|||f||||t|f|f||||||||2017-10-10 21:27:15.96905|2017-10-10 21:27:15.96905
NCT03022032|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-01|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The HOPE Trial:Helping Our Patients Excel|The HOPE Trial:Helping Our Patients Excel|Recruiting||N/A|110|Anticipated|Dana-Farber Cancer Institute||5|||f||||t|f|f||||||No||2017-10-10 21:27:16.090412|2017-10-10 21:27:16.090412
NCT03022019|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-03-28|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||ReNovaCell in Non-segmental Vitiligo|Autologous Cell Suspension Grafting Using ReNovaCell in Non-segmental Vitiligo Patients: a Randomized Controlled Study|Enrolling by invitation||N/A|20|Anticipated|Netherlands Institute for Pigment Disorders||2|||f||||||||||||||2017-10-10 21:27:16.201382|2017-10-10 21:27:16.201382
NCT03022006|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-11|||January 15, 2017|Actual|2017-01-15|April 2017|2017-04-01||||March 2019|Anticipated|2019-03-01||Interventional|||Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C|Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C|Recruiting||Phase 4|60|Anticipated|Norte Study Group||1|||f||||||||||||||2017-10-10 21:27:16.289573|2017-10-10 21:27:16.289573
NCT03021993|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-06-12|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|April 2019|Anticipated|2019-04-01||Interventional|||Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer|Phase II Trial of Nivolumab, an Anti-PD-1 Monoclonal Antibody, as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer|Recruiting||Phase 2|19|Anticipated|Medical University of South Carolina||1|||f||||t|t|f||||||No||2017-10-10 21:27:16.376947|2017-10-10 21:27:16.376947
NCT03021980|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|SuperFIT||Systems of Underprivileged Preschoolers in Their Home and Preschool EnviRonment: Family Intervention Trial|Development and Evaluation of SuperFIT: Systems of Underprivileged Preschoolers in Their Home and Preschool EnviRonment: Family Intervention Trial.|Not yet recruiting||N/A|438|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:27:16.47453|2017-10-10 21:27:16.47453
NCT03021967|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-05-15|||July 2014|Actual|2014-07-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Perceptions of Health Professionals Confronted With Palliative Situations|Preliminary Study: Perceptions of Doctors and Caregivers Confronted With Adult Patients in Advanced or Terminal Stage of a Severe, Progressive and Incurable Pathology in the Services of the Hospitals University of Strasbourg Including Beds Identified Palliative Care|Completed||N/A|20|Actual|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:27:16.583981|2017-10-10 21:27:16.583981
NCT03021954|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||November 2016||2016-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Role of Platelet Rich Plasma Towards the Repair of Pelvic Floor Muscle Damage in Primipara|The Role of Platelet Rich Plasma Towards the Repair of Pelvic Floor Muscle Damage in Primipara|Recruiting||Phase 2/Phase 3|90|Anticipated|Dr Cipto Mangunkusumo General Hospital||2|||f||||t||||||||No||2017-10-10 21:27:16.669316|2017-10-10 21:27:16.669316
NCT03021941|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease|A Multicenter, Open Label, Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) (Taliglucerase Alfa) In Pediatric Subjects With Type 1 Gaucher Disease|Not yet recruiting||Phase 4|15|Anticipated|Pfizer||1|||f||||f|t|f||||||||2017-10-10 21:27:16.779522|2017-10-10 21:27:16.779522
NCT03021928|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-06-20|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|August 2021|Anticipated|2021-08-01|June 2021|Anticipated|2021-06-01||Interventional|START||Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation|Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation|Recruiting||Phase 3|1000|Anticipated|University of Texas at Austin||4|||f||||f|t|f|||t|||No||2017-10-10 21:27:16.868269|2017-10-10 21:27:16.868269
NCT03021915|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-02-16|||October 2016||2016-10-01|February 2017|2017-02-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure|Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure|Recruiting||N/A|50|Anticipated|OvaScience, Inc.||1|||f||||t||||||||No||2017-10-10 21:27:17.060919|2017-10-10 21:27:17.060919
NCT03021902|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-08-10|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|NEXIS||Nutrition and Exercise in Critical Illness|Nutrition and Exercise in Critical Illness (The NEXIS Trial): A Randomized Trial of Combined Cycle Ergometry and Amino Acids in the ICU|Not yet recruiting||Phase 2|142|Anticipated|Clinical Evaluation Research Unit at Kingston General Hospital||2|||f||||t|t|t|f|f|f|||||2017-10-10 21:27:17.151372|2017-10-10 21:27:17.151372
NCT03021889|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-08-22|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Nutritional Therapy Improves Dyslipidemia in HIV Infected Teenagers With Antiretroviral Treatment|Nutritional Therapy Improves Dyslipidemia in HIV Infected Teenagers With Antiretroviral Treatment: a Randomized Controlled Trial|Completed||N/A|20|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 21:27:17.303148|2017-10-10 21:27:17.303148
NCT03021876|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2017-01-12|||April 2016||2016-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients|L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients|Recruiting||Phase 2/Phase 3|80|Anticipated|Kochi University||2|||f||||t||||||||No||2017-10-10 21:27:17.384357|2017-10-10 21:27:17.384357
NCT03021863|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-29|||January 2017||2017-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|ResponseQT||How Frequently and in What Format Are Research Trial Results Disseminated to Participants (ResponseQT)|How Frequently and in What Format Are Research Trial Results Disseminated to Participants? A Survey of Trialists and Response Questionnaire Trial|Enrolling by invitation||N/A|20000|Anticipated|ThinkWell||9|||f||||f||||||||Yes|De-Identified, aggregated data upon request to investigators due to data protection laws|2017-10-10 21:27:17.465928|2017-10-10 21:27:17.465928
NCT03021850|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-15|||April 2016||2016-04-01|January 2017|2017-01-01||||February 2017|Anticipated|2017-02-01||Interventional|||Different Therapeutical Modalities Associated to Hamstring Flexibility Training|Comparison Between Different Therapeutical Modalities Associated to Hamstring Flexibility Training: Randomized Clinical Trial|Active, not recruiting||N/A|34|Anticipated|Federal University of Health Science of Porto Alegre||3|||f||||||||||||||2017-10-10 21:27:17.56788|2017-10-10 21:27:17.56788
NCT03021837|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-13|||August 24, 2012|Actual|2012-08-24|September 2017|2017-09-01|March 17, 2015|Actual|2015-03-17|March 17, 2015|Actual|2015-03-17||Observational|||The Effect of Steroids on Maternal Glucose Levels|The Effect of Steroids for Fetal Lung Maturity on Maternal Glucose Levels|Completed||N/A|200|Actual|St. Louis University|||1||f||||f||||||||||2017-10-10 21:27:17.658317|2017-10-10 21:27:17.658317
NCT03021824|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||October 2016||2016-10-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|SAGE||Severe ARDS: Generating Evidence|Severe ARDS: Generating Evidence. A U.S. Multicenter Observational Study.|Recruiting||N/A|1500|Anticipated|Montefiore Medical Center|||1||f||||f||||||||Yes||2017-10-10 21:27:17.773114|2017-10-10 21:27:17.773114
NCT03021811|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-08-15|||October 2015||2015-10-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||EUREKA Italy - Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds Management|EUREKA Italy - The Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds Management: a Reproducibility Study|Completed||N/A|100|Actual|KLOX Technologies Inc.||1|||f||||f||||||||||2017-10-10 21:27:18.033841|2017-10-10 21:27:18.033841
NCT03021421|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-01-12|||January 2015||2015-01-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|CTRTIKA||Comparison of Two Regional Technics In Knee Artroplasty|The Effect of Unilateral Spinal Anaesthesia and Psoas Compartment With Sciatic Block on the Postoperative Pain Management in Total Knee Artroplastic Surgery|Completed||Early Phase 1|60|Actual|T.C. ORDU ÜNİVERSİTESİ||2|||f||||t||||||||Yes||2017-10-10 21:27:21.24325|2017-10-10 21:27:21.24325
NCT03021798|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-07-30|||February 8, 2017|Actual|2017-02-08|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|SARA-OBS||An OBServational Clinical Trial (SARA-OBS) in Sarcopenia and Sarcopenic Obesity in Patients Aged 65 Years and Over|Characterising SARcopenia and Sarcopenic Obesity in Patients Aged 65 Years and Over at Risk of Mobility Disability. An OBServational Clinical Trial (SARA-OBS)|Recruiting||N/A|300|Anticipated|Biophytis|||1||f||||f||||||||||2017-10-10 21:27:18.114855|2017-10-10 21:27:18.114855
NCT03021785|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-03|||September 2017|Anticipated|2017-09-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration|A Multi-center, Open-label Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-Related Macular Degeneration|Recruiting||Phase 1|36|Anticipated|Jiangsu T-Mab Biopharma Co.,Ltd||3|||f||||f|f|f||||||||2017-10-10 21:27:18.233563|2017-10-10 21:27:18.233563
NCT03021772|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-26|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Neostigmine Versus Dexamethasone as Adjuvants to Lidocaine During Intravenous Local Anesthesia|Efficacy of Neostigmine Versus Dexamethasone as Adjuvants to Lidocaine During Intravenous Local Anesthesia for Forearm Orthopedic Surgeries|Active, not recruiting||Phase 2/Phase 3|60|Actual|Assiut University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:27:18.358414|2017-10-10 21:27:18.358414
NCT03021759|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-05-01|||February 21, 2017|Actual|2017-02-21|May 2017|2017-05-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|PRESCRIBE||Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence|Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence|Completed||N/A|4774|Actual|University of Pennsylvania||3|||f||||f|f|f||||||||2017-10-10 21:27:18.443578|2017-10-10 21:27:18.443578
NCT03021746|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||March 2016||2016-03-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|March 2021|Anticipated|2021-03-01||Interventional|||Fostering Sustainability Through Diabetes Self-Management Support|Fostering Sustainability Through Diabetes Self-Management Support|Recruiting||N/A|525|Anticipated|University of Michigan||3|||f||||t||||||||No||2017-10-10 21:27:18.531815|2017-10-10 21:27:18.531815
NCT03021733|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-15|||February 2012||2012-02-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||A Pilot Cohort Study of Surgical and Non-surgical Management of Rotator Cuff Tears|A Pilot Cohort Study of Surgical and Non-surgical Management of Rotator Cuff Tears|Completed||N/A|222|Actual|University of Michigan|||2||f||||f||||||||||2017-10-10 21:27:18.631465|2017-10-10 21:27:18.631465
NCT03021720|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-12|||November 2016||2016-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|SPARQLE||Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial|Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial|Recruiting||N/A|52|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||No||2017-10-10 21:27:18.733414|2017-10-10 21:27:18.733414
NCT03021707|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-10-05|||March 7, 2017||2017-03-07||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:27:18.83748|2017-10-10 21:27:18.83748
NCT03021694|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||February 2017||2017-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Testing of Micellar Casein, Blended Micellar Casein and Native Whey|Testing of Micellar Casein, Blended Micellar Casein and Native Whey, Versus Native Whey to Determine Post-ingestion Aminoacidemia, Glycemia, and Insulinemia in Young Adult Men|Not yet recruiting||N/A|10|Anticipated|McMaster University||3|||f||||f||||||||No||2017-10-10 21:27:18.881252|2017-10-10 21:27:18.881252
NCT03021681|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-22|||November 2016||2016-11-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||An Exploratory Study on the Treatment of Chronic Obstructive Pulmonary Disease With Autologous Bronchial Basal Cell Transplantation|Huai'an First People 's Hospital,Nanjing Medical University|Recruiting||N/A|20|Anticipated|Huai'an No.1 People's Hospital||1|||f||||f||||||||No||2017-10-10 21:27:18.968295|2017-10-10 21:27:18.968295
NCT03021668|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-12|||November 2016||2016-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections|A Randomized Control Trial of Prevena Peel & Place Dressing Versus Standard Closure for Patients Undergoing Pancreaticoduodenectomy Who Have Undergone Neoadjuvant Chemotherapy or Biliary Stent Placement|Recruiting||Phase 1/Phase 2|144|Anticipated|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 21:27:19.066331|2017-10-10 21:27:19.066331
NCT03021655|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-15|||December 2016||2016-12-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||A Pilot Randomized Control Trial to Help Youth Smokers to Quit Smoking:|Effectiveness of Using Adventure-based Training and WhatsApp Group to Relieve Emotion and Pressure so as to Quit Smoking: A Pilot Randomized Control Trial|Recruiting||N/A|300|Anticipated|The University of Hong Kong||3|||f||||f||||||||No||2017-10-10 21:27:19.164254|2017-10-10 21:27:19.164254
NCT03021642|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||January 2016||2016-01-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers|A Phase I, Open-label, Randomized, Cross-over Trial to Investigate the Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers|Completed||Phase 1|24|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-10 21:27:19.265746|2017-10-10 21:27:19.265746
NCT03021629|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-07-13|||July 2013||2013-07-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Comparison of Vitamin D Status and Vitamin D Receptor Polymorphisms in Patients With High Myopia and Primary Open-angle Glaucoma|Comparison of Vitamin D Status and Vitamin D Receptor Polymorphisms in Patients With High Myopia and Primary Open-angle Glaucoma|Completed||N/A|500|Actual|Tianjin Medical University Eye Hospital|||3||f||||t||||||Samples Without DNA|"     blood   "|||2017-10-10 21:27:19.356328|2017-10-10 21:27:19.356328
NCT03020849|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-27|||January 2011||2011-01-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Predictors of Hypofibrinogenemia in Severe Trauma|Can we Define a Clinical Score for Predicting of Hypofibrinogenemia in Severe Trauma|Completed||N/A|1038|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:27:27.324985|2017-10-10 21:27:27.324985
NCT03021616|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers|Evaluation of Energy Drink Consumption on Electrocardiographic, Vascular and Hematologic Parameters in Young Healthy Volunteers: A Randomized, Double Blind, Active-Controlled, Crossover Study|Not yet recruiting||N/A|50|Anticipated|David Grant U.S. Air Force Medical Center||3|||f||||t||||||||Undecided||2017-10-10 21:27:19.44631|2017-10-10 21:27:19.44631
NCT03021603|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-20|||March 1, 2017|Anticipated|2017-03-01|January 2017|2017-01-01|May 1, 2018|Anticipated|2018-05-01|April 30, 2018|Anticipated|2018-04-30||Interventional|||Evaluation on the Effects of a Brief Hope Intervention to the Symptoms in the Palliative Care Patients|A Brief Hope Intervention to Increase the Hope Level and to Improve the Physical and Mental Health of Patients Receiving Palliative Care: a Randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|The Hong Kong Polytechnic University||2|||f||||f|f|f||||||Yes|Publication of results in May 2018|2017-10-10 21:27:19.571776|2017-10-10 21:27:19.571776
NCT03021590|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-03|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|January 31, 2022|Anticipated|2022-01-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori|Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori|Recruiting||Phase 4|100|Anticipated|Damascus Hospital||2|||f||||t|f|f||||||||2017-10-10 21:27:19.643264|2017-10-10 21:27:19.643264
NCT03021577|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-25|||January 25, 2017|Actual|2017-01-25|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ORACLE||Comparison of Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation in PCI|Comparison of Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation in Percutaneous Coronary Intervention (PCI)|Recruiting||N/A|40|Anticipated|Columbia University||2|||f||||f|f|t|f|f|f|||||2017-10-10 21:27:19.737895|2017-10-10 21:27:19.737895
NCT03021564|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-03-28|||January 2017||2017-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ACIR||Unexpected Cardiac Arrest in Intensive Care Unit|Etude Observationnelle Multicentrique Prospective Sur l'épidémiologie, Les Facteurs de Risques et Les conséquences Des Arrêts Cardiaques Inattendus Survenant en Réanimation|Recruiting||N/A|1000|Anticipated|Groupe Hospitalier de la Rochelle Ré Aunis|||1||f||||f||||||||Undecided||2017-10-10 21:27:19.836154|2017-10-10 21:27:19.836154
NCT03021551|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-24|||September 15, 2016|Actual|2016-09-15|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||ORI: Early Warning for Desaturation in Morbidly Obese Patients|Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients|Recruiting||N/A|40|Anticipated|University of California, Davis|||1||f||||f|f|t|f|f||||No||2017-10-10 21:27:20.090221|2017-10-10 21:27:20.090221
NCT03021538|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-19|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|May 2022|Anticipated|2022-05-01|March 2021|Anticipated|2021-03-01||Interventional|BELT||Bypass vs. Ecmo in Lung Transplantation (BELT)|Randomized Clinical Trial of Intraoperative Extracorporeal Membrane Oxygenation (ECMO) Versus Cardiopulmonary Bypass (CPB) in Lung Transplantation|Recruiting||N/A|80|Anticipated|The Cleveland Clinic||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:27:20.179832|2017-10-10 21:27:20.179832
NCT03021525|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-08-28|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|iPEGASUS||Individualized Perioperative Hemodynamic Goal-directed Therapy in Major Abdominal Surgery (iPEGASUS-trial)|Individualized Perioperative Hemodynamic Goal-directed Therapy in Major Abdominal Surgery (iPEGASUS-trial) - A Multi-center, Prospective, Randomized Trial|Recruiting||N/A|380|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f|f|f||||||||2017-10-10 21:27:20.268085|2017-10-10 21:27:20.268085
NCT03021512|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-13|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Functional Assessment of ADL in Patients Who Underwent Bifocal and Trifocal Presbyopic Correction|Retrospective Functional Assessment of Activities of Daily Living (ADL) in Patients Who Underwent Bilateral Implantation of Aspheric Bifocal Intraocular Lenses or Aspheric Trifocal Intraocular Lenses|Recruiting||N/A|80|Anticipated|Democritus University of Thrace|||2||f||||f||||||||No||2017-10-10 21:27:20.365645|2017-10-10 21:27:20.365645
NCT03021486|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-29|||June 5, 2017|Actual|2017-06-05|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Haloperidol and/or Chlorpromazine for Refractory Agitated Delirium|Haloperidol and/or Chlorpromazine for Refractory Agitated Delirium in the Palliative Care Unit|Recruiting||Phase 2/Phase 3|54|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-10 21:27:20.679729|2017-10-10 21:27:20.679729
NCT03021473|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-24|||May 5, 2016|Actual|2016-05-05|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||ORI: Early Warning for Desaturation and Clinical Lab Correlations in Critically Ill Patients|Oxygen Reserve Index: Utility as Early Warning for Desaturation and Clinical Laboratory Correlations in Critically Ill Patients|Active, not recruiting||N/A|40|Anticipated|University of California, Davis|||1||f||||f|f|t|f|f||||No||2017-10-10 21:27:20.835741|2017-10-10 21:27:20.835741
NCT03021460|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-06-20|||January 31, 2017|Actual|2017-01-31|June 2017|2017-06-01|February 1, 2021|Anticipated|2021-02-01|February 1, 2021|Anticipated|2021-02-01||Interventional|||Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery|A Phase II Study of Pembrolizumab in Combination With Ibrutinib in the Treatment of Unresectable or Metastatic Melanoma|Suspended||Phase 2|51|Anticipated|Mayo Clinic||1||Reassess the safety of the drug concentration/combination involving ibrutinib and pembrolizumab|f||||t|t|f||||||||2017-10-10 21:27:20.964676|2017-10-10 21:27:20.964676
NCT03021447|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Prediction of Postoperative Pain by Injection Pain of Propofol||Not yet recruiting||N/A|70|Anticipated|Ajou University School of Medicine|||1||f||||f||||||||No||2017-10-10 21:27:21.064813|2017-10-10 21:27:21.064813
NCT03021408|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|Tr-T-VR||Effectiveness of Different Approaches for the Rehabilitation of Gait in Patients With Parkinson's Disease|Evaluation of the Effectiveness of Three Different Approaches for the Rehabilitation of Gait in Patients With Parkinson's Disease: Treadmill Versus Treadmill-plus Versus Virtual Reality|Recruiting||N/A|60|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini||3|||f||||f||||||||No||2017-10-10 21:27:21.329934|2017-10-10 21:27:21.329934
NCT03021395|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-23|||February 8, 2017|Actual|2017-02-08|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Efficacy of Decitabine in Clearance of MRD|Efficacy of Decitabine in Clearance of MRD|Recruiting||Phase 1/Phase 2|300|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:27:21.434475|2017-10-10 21:27:21.434475
NCT03021382|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-11|||July 2016||2016-07-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Comparisons of Morphological Measurement Between Coronary Computed Tomography and Optical Coherence Tomography||Completed||N/A|72|Actual|Kobe University|||2||f||||||||||||||2017-10-10 21:27:21.542645|2017-10-10 21:27:21.542645
NCT03021369|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-08-16|||September 2016||2016-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Two Different Pleural Drainage Systems|Vergleich Zweier Thoraxdrainage-Systeme in Der Herzchirurgie|Recruiting||N/A|400|Anticipated|Kerckhoff Klinik||2|||f||||f||||||||||2017-10-10 21:27:21.635358|2017-10-10 21:27:21.635358
NCT03021356|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-11|||September 2012||2012-09-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|July 2014|Actual|2014-07-01||Interventional|||Comparison of TrIfecta and Perimount Magna Ease|Prospective Randomized Comparison of TrIfecta and Perimount Magna Ease|Completed||N/A|100|Actual|Kerckhoff Klinik||2|||f||||f||||||||No||2017-10-10 21:27:21.7415|2017-10-10 21:27:21.7415
NCT03021343|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-01-11|||October 2012||2012-10-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|END-AF||Effect of Colchicine on the Incidence of Atrial Fibrillation in Open Heart Surgery Patients|Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial|Completed||Phase 3|360|Actual|Jordan Collaborating Cardiology Group||2|||f||||t||||||||Yes|yes|2017-10-10 21:27:21.829999|2017-10-10 21:27:21.829999
NCT03021330|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-04-23|||February 8, 2017|Actual|2017-02-08|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML|Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML|Recruiting||Phase 3|1000|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:27:21.923546|2017-10-10 21:27:21.923546
NCT03021317|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-17|||February 2017||2017-02-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|ACTHAR||Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses|Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses|Not yet recruiting||Phase 4|18|Anticipated|University of Chicago||1|||f||||f||||||||No||2017-10-10 21:27:22.036872|2017-10-10 21:27:22.036872
NCT03021291|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GLOW-EX||Extension Study of Gelesis100 on Body Weight|An Open-label Study Assessing the Effect of Gelesis100 on Weight Loss and Weight Maintenance in Overweight and Obese Subjects Who Completed the GLOW Study (G-04)|Not yet recruiting||N/A|150|Anticipated|Gelesis, Inc.||1|||f||||t||||||||Undecided||2017-10-10 21:27:22.263708|2017-10-10 21:27:22.263708
NCT03021278|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-07-27|||January 2017||2017-01-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Tactile Acuity in Experimentally Induced Acute Low Back Pain|Lumbar Tactile Acuity in Experimentally Induced Acute Low Back Pain|Completed||N/A|57|Actual|The Jerzy Kukuczka Academy of Physical Education in Katowice||3|||f||||f||||||||||2017-10-10 21:27:22.436075|2017-10-10 21:27:22.436075
NCT03021265|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-22|||January 20, 2017|Actual|2017-01-20|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|||To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension|The Special Drug Use-results Survey on Long-term Use of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed Dose Combination Tablets in Patients With Hypertension|Recruiting||N/A|500|Anticipated|Boehringer Ingelheim|||1||f||||f|f|f||||||||2017-10-10 21:27:22.543318|2017-10-10 21:27:22.543318
NCT03021252|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-19|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|RETORNUS-2||Respiratory Muscle Training in Stroke Swallowing Disorders|The RETORNUS-2 Study: Impact of Respiratory Muscle Training on Swallowing Disorders in Stroke Patients|Recruiting||N/A|108|Anticipated|Parc de Salut Mar||2|||f||||f|f|f||||||||2017-10-10 21:27:22.61944|2017-10-10 21:27:22.61944
NCT03021239|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-11|||March 2016||2016-03-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|Ramp-it-Up||Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life|Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: A Multicenter Study|Recruiting||N/A|40|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-10 21:27:22.714354|2017-10-10 21:27:22.714354
NCT03021226|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||July 2016||2016-07-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|September 2020|Anticipated|2020-09-01||Interventional|||Evaluation of the Brothers United Fatherhood Program|An Impact Evaluation of the Brothers United Fatherhood Program, a Community-Based Responsible Fatherhood Initiative|Recruiting||N/A|2625|Anticipated|Economic Opportunity Planning Association dba Pathway, Inc.||4|||f||||f||||||||No||2017-10-10 21:27:22.820135|2017-10-10 21:27:22.820135
NCT03021213|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Treating Heart Failure With Enhanced External Counterpulsation (EECP)|Treating Heart Failure With Enhanced External Counterpulsation (EECP): Prospective, Multi-centric Observational Cohort Study|Recruiting||N/A|160|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||No||2017-10-10 21:27:22.911921|2017-10-10 21:27:22.911921
NCT03021200|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-06-28|||July 12, 2016|Actual|2016-07-12|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 30, 2017|Anticipated|2017-06-30||Interventional|||Laser Fluorescence in Cancer Surgical Treatment|Use of Laser Fluorescence With Spy Elite, Pinpoint and Firefly Robotic Platform Systems in Cancer Surgical Treatment|Recruiting||N/A|270|Anticipated|Instituto do Cancer do Estado de São Paulo||3|||f||||t||||||||No||2017-10-10 21:27:22.987547|2017-10-10 21:27:22.987547
NCT03021187|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-08-18|||February 2, 2017|Actual|2017-02-02|August 2017|2017-08-01|August 19, 2018|Anticipated|2018-08-19|January 14, 2018|Anticipated|2018-01-14||Interventional|PIONEER 8||Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin|Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin. A 52-week, Randomised, Double-blind, Placebo-controlled Trial (PIONEER 8 - Insulin add-on)|Active, not recruiting||Phase 3|720|Anticipated|Novo Nordisk A/S||4|||f||||f|t|f||||||||2017-10-10 21:27:23.124725|2017-10-10 21:27:23.124725
NCT03021174|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-07-07|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Exercise and Nutrition Interventions During Chemotherapy|A Feasibility Pilot Study on the Effects of Exercise on Chemotherapy-induced Peripheral Neuropathy and Interoceptive Brain Circuitry|Recruiting||N/A|40|Anticipated|University of Rochester||2|||f||||t|f|f||||||||2017-10-10 21:27:23.500981|2017-10-10 21:27:23.500981
NCT03021161|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|December 2017|Anticipated|2017-12-01||Interventional|prob&asthma||The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers|The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers: A Randomized Controlled Trial.|Not yet recruiting||Phase 4|200|Anticipated|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 21:27:23.580402|2017-10-10 21:27:23.580402
NCT03021148|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-11|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|||Self-reported Gluten Sensitivity in High-school Students|Prevalence of Self-reported Gluten Sensitivity in a Population of High-school Students|Completed||N/A|500|Actual|University of Palermo|||1||f||||f||||||||No||2017-10-10 21:27:23.68213|2017-10-10 21:27:23.68213
NCT03021135|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-01-12|||February 2017||2017-02-01|January 2017|2017-01-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Conventional Endoscopic Mucosal Resection vs Underwater Resection for Colorectal Non-pedunculated Colorectal Lesions|Conventional Endoscopic Mucosal Resection (With Submucosal Injection) Versus Underwater Endoscopic Mucosal Resection (Without Submucosal Injection) for Colorectal Non-pedunculated Colorectal Lesions|Not yet recruiting||Phase 3|324|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||t||||||||Yes||2017-10-10 21:27:23.758248|2017-10-10 21:27:23.758248
NCT03021122|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-09-22|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Reducing Medication Errors and Time to Drugs Delivery During Pediatric Cardiopulmonary Resuscitation: a Multicenter RCT|Reducing Medication Errors and Time to Vasoactive Drugs Preparation and Delivery During Pediatric Cardiopulmonary Resuscitation: a Multicenter, Prospective, Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Pediatric Clinical Research Platform||2|||f||||f|f|f||||||||2017-10-10 21:27:23.836892|2017-10-10 21:27:23.836892
NCT03021109|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-01-12|||December 2016||2016-12-01|January 2017|2017-01-01||||September 2017|Anticipated|2017-09-01||Interventional|||Assessment of Volume Status by Bedside Ultrasound in Children With Acute Gastroenteritis|Assessment of Volume Status by Measurement of Caval Index by Bedside Ultrasound in Children With Acute Gastroenteritis|Recruiting||N/A|150|Anticipated|Derince Training and Research Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:27:23.929844|2017-10-10 21:27:23.929844
NCT03021096|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-28|||January 27, 2017|Actual|2017-01-27|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|TSA Pain||Natural History of Pain After Shoulder Arthroplasty Conducted With Multimodal Analgesia|Natural History of Pain After Shoulder Arthroplasty Conducted With Multimodal Analgesia|Recruiting||N/A|100|Anticipated|Hospital for Special Surgery, New York|||1||f||||t||||||||||2017-10-10 21:27:25.525751|2017-10-10 21:27:25.525751
NCT03021083|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-06-03|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|IONSYS Pilot||IONSYS Feasibility Study|Evaluating the Feasibility of Using Transdermal Patient-controlled Fentanyl After Spinal Fusions|Not yet recruiting||Phase 4|10|Anticipated|Hospital for Special Surgery, New York||1|||f||||t|f|t|f||t|||No||2017-10-10 21:27:25.604207|2017-10-10 21:27:25.604207
NCT03021070|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|AFYA||Afya Credit Incentives for Improved Maternal and Child Health Outcomes in Kenya|Afya Credit Incentives for Improved Maternal and Child Health Outcomes in Kenya|Not yet recruiting||N/A|7200|Anticipated|Stockholm Environment Institute||2|||f||||t||||||||Yes||2017-10-10 21:27:25.687137|2017-10-10 21:27:25.687137
NCT03021057|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||November 2016||2016-11-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas|PD-1 Blockade With Pembrolizumab in Relapsed/Refractory Mature T-cell and NK-cell Lymphomas|Active, not recruiting||Phase 2|33|Anticipated|The University of Hong Kong||1|||f||||f||||||||||2017-10-10 21:27:25.777106|2017-10-10 21:27:25.777106
NCT03021044|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-14|||January 2017||2017-01-01|May 2017|2017-05-01|September 2023|Anticipated|2023-09-01|September 2018|Anticipated|2018-09-01||Interventional|HULK||Physical Activity Intervention for Patients With Reduced Physical Performance After Acute Coronary Syndrome|Physical Activity Intervention for Patients With Reduced Physical Performance After Acute Coronary Syndrome: a Randomized Clinical Trial (The HULK Pilot Study).|Recruiting||N/A|226|Anticipated|University Hospital of Ferrara||2|||f||||t||||||||No||2017-10-10 21:27:25.847279|2017-10-10 21:27:25.847279
NCT03021031|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|January 2023|Anticipated|2023-01-01|January 2022|Anticipated|2022-01-01|5 Years|Observational [Patient Registry]|||Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core|Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core|Enrolling by invitation||N/A|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||||||||||||2017-10-10 21:27:25.946754|2017-10-10 21:27:25.946754
NCT03021018|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-14|||February 6, 2017|Actual|2017-02-06|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting|A Multicenter, Open-Label, Randomized, Parallel-Group, Active-Controlled Study to Assess the Efficacy and Safety of Brivaracetam Administered Intravenously as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting|Recruiting||Phase 2|60|Anticipated|UCB Pharma||3|||f||||f|t|f||||||||2017-10-10 21:27:26.009754|2017-10-10 21:27:26.009754
NCT03021005|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-12|2017-08-15|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Provision of HIV Self-Test Kit to Emergency Department Patients|Provision of HIV Self-Test Kit to Increase Uptake of HIV Testing Among Emergency Department Patients Who Decline Emergency Department-Based HIV Screening.|Active, not recruiting||N/A|202|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 21:27:26.136241|2017-10-10 21:27:26.136241
NCT03020979|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-30|||January 2017||2017-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites|A Phase II, Single-Arm, Open-Label, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Apatinib in Patients With Refractory Malignant Ascites|Recruiting||Phase 2|120|Anticipated|First Affiliated Hospital Bengbu Medical College||1|||f||||||||||||||2017-10-10 21:27:26.491374|2017-10-10 21:27:26.491374
NCT03020966|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-03-27|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|April 16, 2018|Anticipated|2018-04-16|February 16, 2018|Anticipated|2018-02-16||Interventional|IV Tylenol||IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty|IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty: a Randomized, Blinded Trial|Recruiting||Phase 4|154|Anticipated|Hospital for Special Surgery, New York||2|||f|||||t|f|||f|||||2017-10-10 21:27:26.567975|2017-10-10 21:27:26.567975
NCT03020953|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-11|||January 2017||2017-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Anabolic Effects of Estrogen on Skeletal Muscles||Not yet recruiting||N/A|30|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 21:27:26.688944|2017-10-10 21:27:26.688944
NCT03020940|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-11|||January 2017||2017-01-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||The Clinical Trial of Cefuroxime Axetil Dispersible Tablets|100000 Cases Real World Research of the Safety and Efficacy Revaluation of Cefuroxime Axetil Dispersible Tablets After Listing|Not yet recruiting||N/A|100000|Anticipated|Jiangsu Famous Medical Technology Co., Ltd.|||1||f||||f||||||||Undecided||2017-10-10 21:27:26.78198|2017-10-10 21:27:26.78198
NCT03020927|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-01-11|||April 2016||2016-04-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ParentRIT||Therapist and Parent Delivered Reciprocal Imitation Training for Young Children With Autism Spectrum Disorder||Recruiting||N/A|30|Anticipated|Ohio State University||2|||f||||f||||||||No||2017-10-10 21:27:26.850959|2017-10-10 21:27:26.850959
NCT03020914|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-16|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AVD||Effects of Audiovisual Distraction on Desaturation and Airway Intervention in OSA-patients|Effects of Audiovisual Distraction Versus Standard Sedation on Desaturation and Airway Intervention in OSA-patients Undergoing Total Knee Arthroplasty Under Neuraxial Anesthesia|Enrolling by invitation||N/A|60|Anticipated|Hospital for Special Surgery, New York||2|||f||||f||||||||No||2017-10-10 21:27:26.939576|2017-10-10 21:27:26.939576
NCT03020901|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||the Clinical Trial of Teicoplanin for Injection|100000cases Real World Research of the Safety, Efficacy Reassessment, and Bacterial Resistance Monitoring of Teicoplanin for Injection After Listing|Not yet recruiting||N/A|100000|Anticipated|Jiangsu Famous Medical Technology Co., Ltd.|||1||f||||f||||||||Undecided||2017-10-10 21:27:27.016943|2017-10-10 21:27:27.016943
NCT03020888|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-30|||January 2017||2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Magseed Magnetic Marker Localization|A Prospective, Open Label, Post Marketing Study of Magseed and Sentimag in Patients Undergoing Surgical Excision of a Breast Lesion That Requires Preoperative Radiographic Localization|Recruiting||N/A|120|Anticipated|Endomagnetics Inc||1|||f||||f||||||||No||2017-10-10 21:27:27.078526|2017-10-10 21:27:27.078526
NCT03020875|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-03-06|||January 2017||2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||IV vs Oral Acetaminophen in Spine Fusion Perioperative Care|Single-Center, Randomized Controlled Trial of Intravenous v Oral Acetaminophen Administration in Perioperative Care of 1 and 2 Level XLIFs Supplemented With Bilateral Pedicle Screw Stabilization: a Comparative Effectiveness Study|Enrolling by invitation||Phase 4|166|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||Undecided||2017-10-10 21:27:27.169536|2017-10-10 21:27:27.169536
NCT03020862|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-13|||December 2013||2013-12-01|June 2014|2014-06-01|August 2015|Actual|2015-08-01|April 2014|Actual|2014-04-01||Interventional|COPD||Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients|Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients|Completed||N/A|15|Actual|University of Aarhus||2|||f||||t||||||||No||2017-10-10 21:27:27.244242|2017-10-10 21:27:27.244242
NCT03020836|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-12|||April 2015||2015-04-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluating Effective Methods for Referral for Smoking Cessation Counseling and High Blood Pressure Follow-up|Evaluating Effective Methods for Referral for Smoking Cessation Counseling and High Blood Pressure Follow-up|Completed||N/A|473|Actual|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 21:27:27.380042|2017-10-10 21:27:27.380042
NCT03020823|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-02-16|||April 30, 2017|Anticipated|2017-04-30|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer|An Open-Label, Phase II Study to Evaluate the Efficacy and Safety of SCB01A in Subjects With Recurrent or Metastatic Squamous Cell Head and Neck Cancer Who Have Failed Platinum-Based Treatment|Withdrawn||Phase 2|0|Actual|SynCore Biotechnology Co., Ltd.||1||withdrawal by sponsor|f||||t|t|f||||||No||2017-10-10 21:27:27.441319|2017-10-10 21:27:27.441319
NCT03020810|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-06-26||||||June 2017|2017-06-01||||||||Expanded Access|||Dupilumab Compassionate Use Study|Dupilumab Compassionate Use Study|Available||N/A|||University of Pittsburgh|||||||||||||||||||2017-10-10 21:27:27.508417|2017-10-10 21:27:27.508417
NCT03020797|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-11|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)||Recruiting||N/A|60|Anticipated|Stony Brook University||2|||f||||t||||||||No||2017-10-10 21:27:27.556195|2017-10-10 21:27:27.556195
NCT03020784|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-07-31|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Safety and Tolerability of PF-06818883 in Healthy Subjects|A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo-controlled, Single-ascending Dose Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Pf-06818883 Following Single Intravenous Administration In Healthy Subjects|Terminated||Phase 1|30|Actual|Pfizer||2|||f|||||t|f||||||||2017-10-10 21:27:27.643057|2017-10-10 21:27:27.643057
NCT03020771|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-13|||December 2014||2014-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans|Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans, Prepared in Cell Culture and Inactivated With Formalin, and Administered Subcutaneously or Intramuscularly With Two Different Doses|Active, not recruiting||Phase 1|60|Actual|Tubitak||6|||f||||t||||||||||2017-10-10 21:27:27.718052|2017-10-10 21:27:27.718052
NCT03020758|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Effect of Dried Fruit on Cardiometabolic Risk Factors|The Effect of Bioactives in Dried Plums, Figs, Dates, and Raisins Compared With a High Carbohydrate Snack on Risk Factors for Cardiometabolic Disease|Not yet recruiting||N/A|50|Anticipated|Penn State University||2|||f||||f||||||||No||2017-10-10 21:27:27.803231|2017-10-10 21:27:27.803231
NCT03020732|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-13|||February 2013||2013-02-01|January 2017|2017-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Gingival Recession Treatment With Concentrated Growth Factor(CGF)|Concentrated Growth Factor Membrane Versus Subepithelial Connective Tissue Grafts in Treatment of Multiple Gingival Recession Defects: a Split-mouth Randomized Clinical Trial|Completed||N/A|9|Actual|Gazi University||2|||f||||f||||||||Undecided|there is no plan to make IPD. IPD will be formed if necessary.|2017-10-10 21:27:28.182988|2017-10-10 21:27:28.182988
NCT03020719|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-20|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|GROW||The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis|A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis|Recruiting||Phase 2|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|t|f||||||||2017-10-10 21:27:28.316453|2017-10-10 21:27:28.316453
NCT03020706|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-11|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Magnesium Sulphate on Neostigmine|Effect of Magnesium Sulphate on Neostigmine-induced Reversal of Neuromuscular Block by Rocuronium|Recruiting||N/A|166|Anticipated|Gachon University Gil Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:27:28.543216|2017-10-10 21:27:28.543216
NCT03020693|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-11|||December 2016||2016-12-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Effectiveness of Invasive Electrostimulation Combined With an Exercise Program in Plantar Fasciitis|Effectiveness of Invasive Electrostimulation Combined With an Exercise Program in Plantar. A Clinical Trial|Active, not recruiting||N/A|60|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||||||||||||2017-10-10 21:27:28.66469|2017-10-10 21:27:28.66469
NCT03020680|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-01-12|||April 2016||2016-04-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Bioavailability of Ubiquinone and Ubiquinol in Older Adults|The Effect of Redox Status on Bioavailability of Ubiquinone and Ubiquinol in 10 Older Adults|Recruiting||Phase 1|10|Anticipated|Tufts University||2|||f||||f||||||||Undecided||2017-10-10 21:27:28.756372|2017-10-10 21:27:28.756372
NCT03020667|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-01-11|||April 2016||2016-04-01|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|May 2021|Anticipated|2021-05-01||Observational|||Japanese Post-Market Cohort Study|An Observational Cohort Study in Japan to Assess the Patterns of Product Use and Changes in Health Status Associated With the Use of HeatSticks With the THS 2.2 Tobacco Heating System|Recruiting||N/A|4760|Anticipated|Philip Morris Products S.A.|||3||f||||f||||||Samples With DNA|"     Blood: long-term storage of bio-banking samples for further analysis of gene expression (only     if additional consent is given).   "|No||2017-10-10 21:27:28.838166|2017-10-10 21:27:28.838166
NCT03020641|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-03-15|||January 2017||2017-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Peritoneal Damage in Laparoscopic Surgery|Characterization of Changes in Peritoneal Cells Gene Expression After Standard Versus Low Pressure Laparoscopic Cholecystectomy and Its Clinical Correlation|Recruiting||N/A|100|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||t||||||||No||2017-10-10 21:27:29.05022|2017-10-10 21:27:29.05022
NCT03020628|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-17|||October 2016||2016-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months|A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess the Immunogenicity and Safety of 'NBP607-QIV(Quadrivalent Inactivated Cell Culture-derived Influenza Vaccine)' in Children Aged 6~35 Months|Recruiting||Phase 3|201|Anticipated|SK Chemicals Co.,Ltd.||2|||f||||t||||||||No||2017-10-10 21:27:29.141789|2017-10-10 21:27:29.141789
NCT03020615|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-01|||May 12, 2017|Actual|2017-05-12|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies|Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies|Recruiting||Phase 2|50|Anticipated|St. Jude Children's Research Hospital||2|||f||||t|t|f||||||||2017-10-10 21:27:29.307692|2017-10-10 21:27:29.307692
NCT03020602|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||BPM31510 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Previously Treated With Bevacizumab|A Phase I Study of BPM31510 Plus Vitamin K in Subjects With Glioblastoma That Has Recurred on a Bevacizumab-Containing Regimen|Recruiting||Phase 1|10|Anticipated|Stanford University||1|||f||||t||||||||No||2017-10-10 21:27:29.465152|2017-10-10 21:27:29.465152
NCT03020589|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-03-21|||January 2017||2017-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|TAC3A5||Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients|Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients|Recruiting||Phase 4|260|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No|No participant data will be shared outside the research team.|2017-10-10 21:27:29.57713|2017-10-10 21:27:29.57713
NCT03020563|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-24|||August 23, 2017|Actual|2017-08-23|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?|Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?|Recruiting||Phase 4|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|t|f|||f|||||2017-10-10 21:27:29.763168|2017-10-10 21:27:29.763168
NCT03020550|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-22|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Correlates of GERD Symptom Severity|Physiologic and Behavioral Correlates of GERD Symptom Severity|Recruiting||N/A|24|Anticipated|Massachusetts General Hospital|||1||f||||t|f|f||||||Undecided||2017-10-10 21:27:29.840887|2017-10-10 21:27:29.840887
NCT03020537|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-04-03|2017-01-13||October 2013||2013-10-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||B-cell Immunity to Influenza (SLVP017)- Year 5, 2013|U19 Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire- Year 5, 2013|Completed||Phase 4|8|Actual|Stanford University||2|||f||||f||||||||No||2017-10-10 21:27:29.917193|2017-10-10 21:27:29.917193
NCT03020524|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-04-19|||January 2017||2017-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Autologous CD4 T-Cells in HIV (C34-CXCR4)|A Pilot Study to Evaluate the Safety and Tolerability of Escalating Doses of Autologous CD4 T-Cells Modified With Lentiviral Vector Expressing an HR2, C34-peptide Conjugated to the CXCR4 N-terminus in HIV-infected Subjects|Recruiting||Early Phase 1|9|Anticipated|University of Pennsylvania||3|||f||||||||||||||2017-10-10 21:27:30.256101|2017-10-10 21:27:30.256101
NCT03020511|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-07-09|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Interventional|||Effects of Ancient Grains-based Diet in a Closed Community|Effects of Ancient Grains-based Diet in a Closed Community|Completed||N/A|30|Actual|University of Palermo||1|||f||||f||||||||||2017-10-10 21:27:30.354068|2017-10-10 21:27:30.354068
NCT03020498|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-04-03|2017-01-13||September 2010||2010-09-01|April 2017|2017-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)|Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire - Years 2 (2010) & 3 (2011)|Completed||Phase 4|91|Actual|Stanford University||3|||f||||f||||||||No||2017-10-10 21:27:30.458714|2017-10-10 21:27:30.458714
NCT03020485|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-11|||December 2014||2014-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants|The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants|Completed||N/A|46|Actual|Clinical Nutrition Research Centre, Singapore||2|||f||||f||||||||No||2017-10-10 21:27:31.115594|2017-10-10 21:27:31.115594
NCT03020472|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-03-17|2017-01-12||November 2008||2008-11-01|March 2017|2017-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|SLVP016||Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age|U19 Year 6: Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age, SLVP016|Terminated||Phase 4|6|Actual|Stanford University||1||Due to low enrollment|f||||f||||||||No||2017-10-10 21:27:31.210478|2017-10-10 21:27:31.210478
NCT03019926|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-17|||February 2017||2017-02-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Observational|LUPOBS||Lupus and Observance|Lupus and Observance|Not yet recruiting||N/A|200|Anticipated|University Hospital Center of Martinique|||1||f||||f||||||||No||2017-10-10 21:27:36.81849|2017-10-10 21:27:36.81849
NCT03020459|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||January 2017||2017-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Internal Limiting Membrane Peeling-reposition to Treat Idiopathic Macular Holes|Comparing the Surgical Outcomes of Internal Limiting Membrane Peeling-reposition Versus Peeling in Idiopathic Macular Holes: A Randomized Controlled Trial|Not yet recruiting||N/A|30|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Yes||2017-10-10 21:27:31.44416|2017-10-10 21:27:31.44416
NCT03020446|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-04-11|||July 2014||2014-07-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Sorbion||Effectiveness of Sorbion in the Treatment of Venous Leg Ulcers The Protocol Elements|Effectiveness of Sorbion in the Treatment of Venous Leg Ulcers The Protocol Elements|Terminated||N/A|3|Actual|University of Toledo Health Science Campus||1||Provider of product no longer wished to continue with site.|f||||f||||||||||2017-10-10 21:27:31.531314|2017-10-10 21:27:31.531314
NCT03020433|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-01-11|||March 2016||2016-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity|Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity|Recruiting||Early Phase 1|24|Anticipated|The Cleveland Clinic||4|||f||||f||||||||No||2017-10-10 21:27:31.619836|2017-10-10 21:27:31.619836
NCT03020420|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-03-24|||March 2015||2015-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Cicatricell||Clinical Trial To Study The Anti-scarring Effect Of Cicatricell|Clinical Trial To Study The Anti-scarring Effect Of Cicatricell|Recruiting||N/A|68|Anticipated|University of Toledo Health Science Campus||2|||f||||f||||||||No||2017-10-10 21:27:31.732442|2017-10-10 21:27:31.732442
NCT03020407|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-01|||January 18, 2017|Actual|2017-01-18|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|||The Randomized Controlled Trial of Inferior Vena Cava Ultrasound-guided Fluid Management in Septic Shock Resuscitation|The Randomized Controlled Trial of Inferior Vena Cava Ultrasound-guided Fluid Management in Septic Shock Resuscitation|Recruiting||N/A|254|Anticipated|Chulalongkorn University||2|||f||||t|f|f||||||No||2017-10-10 21:27:31.824298|2017-10-10 21:27:31.824298
NCT03020394|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||NPPV vs IPPV in Severe Chronic Obstructive Pulmonary Disease Exacerbation|Comparison of Noninvasive Positive Ventilation (NPPV) and Invasive Positive Ventilation (IPPV) in Severe Chronic Obstructive Pulmonary Disease Exacerbation (AECOPD)|Not yet recruiting||N/A|208|Anticipated|China-Japan Friendship Hospital||2|||f||||f||||||||No||2017-10-10 21:27:31.940592|2017-10-10 21:27:31.940592
NCT03020381|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-04-22|||December 2007||2007-12-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study|Gait as Predictor of Cognitive Decline, Dementia, and Risk of Falls in MCI. A Cohort Study|Recruiting||N/A|400|Anticipated|Lawson Health Research Institute|||3||f||||f||||||Samples With DNA|"     APOEε4 carrier status will be determined by PCR of genomic DNA extracted from anticoagulated     blood. Carrier status is determined by dichotomizing into ε4- (ε2/ε3 heterozygote or ε2/ε3     homozygote) and ε4+ (ε4 homozygote or ε4 heterozygote) for consistency with previous studies.   "|Undecided||2017-10-10 21:27:32.031937|2017-10-10 21:27:32.031937
NCT03020368|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-03-21|||January 2017||2017-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint|"Effectiveness and Safety of Breeded Leech Medileech by BioRepro GmbH for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint: a Randomized Controlled Clinical Trial"|Recruiting||N/A|52|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 21:27:32.118717|2017-10-10 21:27:32.118717
NCT03020355|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-11|||February 2017||2017-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of Blood Loss in Using vs Not Using Placental Cord Drainage After Spontaneous Vaginal Delivery|Comparison of Blood Loss in Using vs Not Using Placental Cord Drainage After Spontaneous Vaginal Delivery|Not yet recruiting||N/A|200|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||f||||||||Yes||2017-10-10 21:27:32.208675|2017-10-10 21:27:32.208675
NCT03020342|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-01-11|||May 2016||2016-05-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC|A New Biomarker for Detection of Minimal Residual Tumor in Hepatitis-B Virus Related Hepatocellular Carcinoma After Curative Therapies: The Cell-free Circulating HBV-host Chimera DNA Fragment|Recruiting||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     Tumor (T) and non-Tumor (NT) tissue, and peripheral blood.   "|Undecided||2017-10-10 21:27:32.279099|2017-10-10 21:27:32.279099
NCT03020329|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Phase II Study of Induction Chemotherapy (Taxol+Cisplatin+Fluorouracil) Plus Concurrent Chemoradiotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Not yet recruiting||Phase 2|37|Anticipated|Sun Yat-sen University||1|||f||||t||||||||No||2017-10-10 21:27:32.374744|2017-10-10 21:27:32.374744
NCT03020316|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-11|||April 2016||2016-04-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||"Peer Mentored Approaches for Women With Coronary Artery Disease (4-Steps)"|"Peer Mentored Approaches for Women With Coronary Artery Disease (4-Steps)"|Recruiting||N/A|150|Anticipated|Weill Medical College of Cornell University||3|||f||||f||||||||Undecided||2017-10-10 21:27:32.51673|2017-10-10 21:27:32.51673
NCT03020303|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-07-24|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|September 2023|Anticipated|2023-09-01|April 2023|Anticipated|2023-04-01||Interventional|ACHIEVE||Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease|Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease|Recruiting||Phase 3|2750|Anticipated|Population Health Research Institute||2|||f||||t|f|f|||f|||||2017-10-10 21:27:32.624338|2017-10-10 21:27:32.624338
NCT03020290|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-11|||December 2016||2016-12-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|STELLASUPERA||Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents|Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents|Recruiting||N/A|50|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:27:32.736986|2017-10-10 21:27:32.736986
NCT03020277|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|SMARTAUTISM||Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)|Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)|Not yet recruiting||N/A|100|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 21:27:32.856867|2017-10-10 21:27:32.856867
NCT03020264|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|HYPOAGE||Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life|Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life|Not yet recruiting||N/A|250|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 21:27:32.957521|2017-10-10 21:27:32.957521
NCT03020251|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-12|||January 2017||2017-01-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|Rexochir||Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer|Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer|Not yet recruiting||N/A|90|Anticipated|Centre Jean Perrin||2|||f||||f||||||||No||2017-10-10 21:27:33.07021|2017-10-10 21:27:33.07021
NCT03020238|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||January 2013||2013-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2016|Actual|2016-01-01||Interventional|||Impact of Nerve-sparing Radical Hysterectomy on Patients' Urinary Dynamics|Impact of Nerve-sparing Radical Hysterectomy on Patients' Urinary Dynamics: a Randomized Controlled Trial|Completed||N/A|120|Actual|Peking Union Medical College Hospital||2|||f||||t||||||||Yes|IPD will be shared with authorised researchers via online database.|2017-10-10 21:27:33.183244|2017-10-10 21:27:33.183244
NCT03020225|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-07-12|||December 2016||2016-12-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|February 2017|Actual|2017-02-01||Interventional|Mankai||Protein Bioavailability of Wolffia Globosa (Mankai); Acute Test Meal Effects|Protein Bioavailability of Wolffia Globosa (Mankai); Acute Test Meal Effects|Recruiting||N/A|36|Anticipated|Ben-Gurion University of the Negev||3|||f||||f||||||||||2017-10-10 21:27:33.262656|2017-10-10 21:27:33.262656
NCT03020212|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-01-11|||February 2016||2016-02-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|June 2017|Anticipated|2017-06-01||Interventional|COPD-LTOT||Long-term Oxygen Therapy in Patients With Chronic Obstructive Pulmonary Disease Who Live at High Altitude|Long-term Oxygen Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Live at High Altitude (2640 Meters Above Sea Level): Evaluation of a Proposal for Adjusting Criteria|Recruiting||N/A|220|Anticipated|Fundación Neumologica Colombiana||2|||f||||f||||||||No||2017-10-10 21:27:33.347667|2017-10-10 21:27:33.347667
NCT03020199|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-05-09|||March 27, 2017|Actual|2017-03-27|May 2017|2017-05-01|April 19, 2022|Anticipated|2022-04-19|April 19, 2022|Anticipated|2022-04-19||Interventional|STEPin||Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis|A Randomized, Multicenter STudy to Evaluate the Effect of Secukinumab 300 mg s.c. Administered During 52 Weeks to Patients Suffering From New-onset Moderate to Severe Plaque Psoriasis as Early Intervention Compared to Standard Treatment With Narrow-band UVB (STEPIn Study)|Recruiting||Phase 4|196|Anticipated|Novartis||5|||f||||f|f|f||||||No||2017-10-10 21:27:33.484064|2017-10-10 21:27:33.484064
NCT03020186|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||November 2016||2016-11-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|DIRECT-PLUS||Effects of Green-MED Diet Via the Gut-fat-brain Axis|Effects of Green-MED Diet Via the Gut-fat-brain Axis; DIRECT-PLUS|Recruiting||N/A|270|Anticipated|Ben-Gurion University of the Negev||3|||f||||t||||||||No||2017-10-10 21:27:33.612273|2017-10-10 21:27:33.612273
NCT03020173|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||The Difference Seen in Granulosa Cells and Immature Oocytes in IVF Treated Patients Sorted by Body Mass Index (BMI)||Not yet recruiting||N/A|100|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||No||2017-10-10 21:27:33.716735|2017-10-10 21:27:33.716735
NCT03020160|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-09-28|||January 30, 2017|Actual|2017-01-30|September 2017|2017-09-01|July 4, 2018|Anticipated|2018-07-04|July 4, 2018|Anticipated|2018-07-04||Interventional|HAVEN 4||A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A|A Multicenter, Open-Label, Phase III Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks (Q4W) in Patients With Hemophilia A|Active, not recruiting||Phase 3|48|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 21:27:33.780389|2017-10-10 21:27:33.780389
NCT03020147|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-11|||February 2017||2017-02-01|January 2017|2017-01-01||||August 2017|Anticipated|2017-08-01||Observational|||Low Birth Weight Follow-up|Follow-up of Low Birth Weight Cohort of 2008-2013|Not yet recruiting||N/A|1258|Anticipated|Bandim Health Project|||2||f||||f||||||||||2017-10-10 21:27:33.920315|2017-10-10 21:27:33.920315
NCT03020134|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-20|||July 2016||2016-07-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China|Phase I Study of Pharmacokinetics and Safety of Ravidasvir in Combination With Ritonavir-boosted Danoprevir in Single and Multiple Doses in Healthy Participants|Active, not recruiting||Phase 1|18|Actual|Ascletis Pharmaceuticals Co., Ltd.||2|||f||||t||||||||||2017-10-10 21:27:33.995111|2017-10-10 21:27:33.995111
NCT03020121|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-31|||November 2016||2016-11-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples|Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples|Terminated||N/A|28|Actual|Becton, Dickinson and Company||1||Lower than anticipated rate of subject enrollment|f||||f||||||||||2017-10-10 21:27:34.082962|2017-10-10 21:27:34.082962
NCT03020108|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-08-24|||August 2016||2016-08-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Observational|||Serum Caspase 3, Annexin a2 and Soluble Fas Levels and Endometriosis|The Relation Between Serum Caspase 3, Annexin a2 and Soluble Fas Levels and Severity of Endometriosis|Completed||N/A|90|Actual|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||3||f||||f||||||Samples Without DNA|"     Serum analysis   "|||2017-10-10 21:27:34.702845|2017-10-10 21:27:34.702845
NCT03019913|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Evaluation of Bedside Methods to Measure Muscularity in Critically Ill Patients|Evaluation of Bedside Methods to Measure Muscularity in Critically Ill Patients: A Prospective Observational Study|Recruiting||N/A|50|Anticipated|La Trobe University|||1||f||||t||||||||Undecided||2017-10-10 21:27:36.913473|2017-10-10 21:27:36.913473
NCT03020095|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-06-29|||August 2015||2015-08-01|January 2017|2017-01-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan|Phase 2 Study To Investigate the Efficacy, Safety And Pharmacokinetics Of Ravidasvir In Combination With Ritonavir-boosted Danoprevir And Ribavirin In Treatment-naive Non-cirrhotic Taiwanese Patients Who Have Chronic Hepatitis C Genotype 1|Completed||Phase 2|38|Actual|Ascletis Pharmaceuticals Co., Ltd.||1|||f||||t||||||||||2017-10-10 21:27:34.885431|2017-10-10 21:27:34.885431
NCT03020082|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-06-29|||June 2016||2016-06-01|January 2017|2017-01-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III|A Multi-centered, Open Label, Phase III Study on Efficacy, Safety of Ritonavir-boosted ASC08 (Danoprevir) in Combination With Peg-IFN and RBV in Treatment-Naive Non-Cirrhotic Patients Who Have Chronic Hepatitis Genotype 1|Completed||Phase 3|127|Actual|Ascletis Pharmaceuticals Co., Ltd.||1|||f||||t||||||||||2017-10-10 21:27:34.987851|2017-10-10 21:27:34.987851
NCT03020069|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||November 2015||2015-11-01|January 2017|2017-01-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes|Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes|Enrolling by invitation||N/A|60|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 21:27:35.112018|2017-10-10 21:27:35.112018
NCT03020056|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2017-01-12|||November 2016||2016-11-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|ICSHE||Impact of Cataract Surgery to Household Economy in Rural Area|Impact of Cataract Surgery to Household Economy in Rural Area of Southern China: A Randomised Controlled Trial|Recruiting||N/A|278|Anticipated|Zhongshan Ophthalmic Center, Sun Yet-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:27:35.205264|2017-10-10 21:27:35.205264
NCT03020043|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||August 2016||2016-08-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01|5 Years|Observational [Patient Registry]|||Evaluation of Longterm Outcome of New York Heart Association Class III Heart Failure Patients Receiving Telemonitoring Using a Pulmonary Artery Pressure Sensor System (CardioMEMS)|CardioMEMS Registry of the Frankfurt Heart Failure Center|Recruiting||N/A|150|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||No||2017-10-10 21:27:35.306388|2017-10-10 21:27:35.306388
NCT03020030|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-07-25|||March 3, 2017|Actual|2017-03-03|July 2017|2017-07-01|December 2026|Anticipated|2026-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents|Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents|Recruiting||Phase 3|400|Anticipated|Dana-Farber Cancer Institute||10|||f||||t|t|f||||||||2017-10-10 21:27:35.39829|2017-10-10 21:27:35.39829
NCT03020017|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-05-16|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|July 2022|Anticipated|2022-07-01|July 2019|Anticipated|2019-07-01||Interventional|||NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery|A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients|Recruiting||Early Phase 1|8|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 21:27:35.646249|2017-10-10 21:27:35.646249
NCT03020004|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-06-29|||January 2016||2016-01-01|January 2017|2017-01-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II|A Phase 2,Multicenter,Open-Label Study to Investigate the Efficacy, Safety and Pharmacokinetics of Ritonavir-boosted Danoprevir in Combination With Peg-IFN and RBV in Treatment-Naive Non-Cirrhotic Patients Who Have Chronic Hepatitis GT1|Completed||Phase 2|70|Actual|Ascletis Pharmaceuticals Co., Ltd.||1|||f||||t||||||||||2017-10-10 21:27:35.758833|2017-10-10 21:27:35.758833
NCT03019991|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-11|||October 2015||2015-10-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Danoprevir/r in Healthy Volunteers China|A Study on Safety, Tolerability and Pharmacokinetics of Ritonavir-boosted Danoprevir in Single and Multiple Doses in Healthy Volunteers|Completed||Phase 1|18|Actual|Ascletis Pharmaceuticals Co., Ltd.||2|||f||||t||||||||No||2017-10-10 21:27:35.84813|2017-10-10 21:27:35.84813
NCT03019978|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||July 2016||2016-07-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|PCAMS||Person-Centered Assessment and Monitoring Systems|Person-Centered Assessment and Monitoring Systems (PCAMS)|Recruiting||N/A|54|Anticipated|Milton S. Hershey Medical Center||1|||f||||f||||||||No||2017-10-10 21:27:35.942265|2017-10-10 21:27:35.942265
NCT03019965|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-05-05|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Betalactam Antibiotics in Prolonged Infusion Compared to Intermittent in Pediatric Patients With Sepsis|Efficacy and Safety of the Administration of Betalactam Antibiotics in Continuous or Extended Infusion Compared to Intermittent Infusion in Patients With Sepsis in Two Pediatric Third-level Care Hospitals|Recruiting||N/A|340|Anticipated|Coordinación de Investigación en Salud, Mexico||6|||f||||t|f|f|||f|||No|Identified individual participant data for all primary and secondary outcome measures will be made available within six months of study completion|2017-10-10 21:27:36.034277|2017-10-10 21:27:36.034277
NCT03019952|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||January 2016||2016-01-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|t-CARE||Effectiveness of the Care Coordination, Assessment, and Responsive Engagement Program for Transition-aged Adolescents (t-CARE) With ASD|Effectiveness of the Care Coordination, Assessment, and Responsive Engagement Program for Transition-aged Adolescents (t-CARE) With ASD|Recruiting||N/A|60|Anticipated|Milton S. Hershey Medical Center||1|||f||||f||||||||||2017-10-10 21:27:36.189144|2017-10-10 21:27:36.189144
NCT03019939|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-06-15|||March 28, 2017|Actual|2017-03-28|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Study of Isavuconazole Prophylaxis in Adults With Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) and Neutropenia|A Phase II Study of Isavuconazole Prophylaxis in Adult Patients With Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) and Neutropenia|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:27:36.29559|2017-10-10 21:27:36.29559
NCT03019900|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-12|||February 2017||2017-02-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Observational|||Survey of Blood Transfusion Practices in Critically Ill Patients at High Altitude|Encuesta Sobre prácticas de transfusión de glóbulos Rojos en el Paciente crítico Atendido en Unidades de Altura|Not yet recruiting||N/A|352|Anticipated|Universidad Tecnológica Equinoccial|||1||f||||t||||||||No||2017-10-10 21:27:37.007663|2017-10-10 21:27:37.007663
NCT03019874|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections|Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections|Recruiting||N/A|24|Anticipated|Charite University, Berlin, Germany|||1||f||||||||||||||2017-10-10 21:27:37.193389|2017-10-10 21:27:37.193389
NCT03019861|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-06-13|||January 2017||2017-01-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|AYURDA||Ayurvedic Nutritional Counseling for Patients With IBS in Comparison to Conventional Nutritional Counseling|Randomized, Controlled Pilot Study on Ayurvedic Nutritional Counseling for Patients With Irritable Bowel Syndrome in Comparison to Conventional Nutritional Counseling|Recruiting||N/A|66|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 21:27:37.292669|2017-10-10 21:27:37.292669
NCT03019848|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-01-11|||May 2016||2016-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Oral Supplementation With Curcumin in Patients With Proteinuric Diabetic Kidney Disease||Recruiting||Phase 2|100|Anticipated|Instituto Nacional de Cardiologia Ignacio Chavez||2|||f||||f||||||||||2017-10-10 21:27:37.414558|2017-10-10 21:27:37.414558
NCT03019835|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-05-17|||December 2016||2016-12-01|May 2017|2017-05-01|April 22, 2017|Actual|2017-04-22|April 22, 2017|Actual|2017-04-22||Interventional|||Can we Antagonize Mivacurium With Neostigmine ?|Can we Antagonize Mivacurium With Neostigmine|Completed||N/A|80|Actual|Université Libre de Bruxelles||5|||f||||f||||||||Yes||2017-10-10 21:27:37.530547|2017-10-10 21:27:37.530547
NCT03019822|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-21|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|LAM||Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing|Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing|Recruiting||Early Phase 1|24|Anticipated|University Hospital, Basel, Switzerland||4|||f||||t|f|f||||||Undecided||2017-10-10 21:27:37.630937|2017-10-10 21:27:37.630937
NCT03019809|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||June 2016||2016-06-01|January 2017|2017-01-01||||June 2018|Anticipated|2018-06-01||Interventional|||A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients|A Trial of Plerixafor With G-CSF as Additional Agents in Conditioning Regimen for Prevention of Graft Failure After Transplantation With TCR Alpha/Beta Grafts Depletion in Patients With Wiskott-Aldrich Syndrome.|Recruiting||Phase 2|30|Anticipated|Federal Research Institute of Pediatric Hematology, Oncology and Immunology||1|||f||||t||||||||||2017-10-10 21:27:37.751868|2017-10-10 21:27:37.751868
NCT03019796|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-05-06|||July 2015||2015-07-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2017|Anticipated|2017-06-01||Interventional|METSYND||Exercise Training Effects on Metabolic Syndrome: Interactions With Medication|Effects of Exercise Training as a Non-pharmacological Treatment for Metabolic Syndrome and Its Interactions With Subjects Habitual Medications.|Recruiting||N/A|160|Anticipated|University of Castilla-La Mancha||2|||f||||t||||||||Undecided||2017-10-10 21:27:37.86125|2017-10-10 21:27:37.86125
NCT03019783|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-04-17|2017-03-07||December 2011||2011-12-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Atazanavir and Endothelial Function in Older HIV Patients|Atazanavir and Endothelial Function in Older HIV Patients|Completed||Phase 2/Phase 3|60|Actual|Brigham and Women's Hospital|There were no limitations.|2|||f||||f||||||||No||2017-10-10 21:27:37.988226|2017-10-10 21:27:37.988226
NCT03019770|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-02-22|||January 2017||2017-01-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Optimizing HIV PrEP Through Shared Decision Making|Optimizing HIV Pre-Exposure Prophylaxis Through Shared Decision Making|Recruiting||N/A|80|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f||||||||No||2017-10-10 21:27:38.363549|2017-10-10 21:27:38.363549
NCT03019757|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-09-18|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease|Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease|Not yet recruiting||N/A|76|Anticipated|Ohio State University|||3||f||||f||||||Samples With DNA|"     Participants will have the option to participate in a lumbar puncture sub-study as well as a     brain donation program. These samples will be retained in the Buckeye Biospecimen Repository     or the Buckeye Brain Bank, respectively.   "|||2017-10-10 21:27:38.478356|2017-10-10 21:27:38.478356
NCT03019744|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-17|||April 2011||2011-04-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|RiSES||Efficacy Study of Functional Electrical Stimulation Controlled by Electromyographic Signal for the Treatment of Upper Limb in Post-stroke Patients|Studio Clinico di Efficacia Della Stimolazione Elettrica Funzionale Controllata da Segnale Elettromiografico Nel Trattamento Dell'Arto Superiore in Pazienti Con Esiti di Ictus Cerebrovascolare (Progetto Rises)|Completed||Phase 2|82|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||||2017-10-10 21:27:38.609717|2017-10-10 21:27:38.609717
NCT03019731|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-10|||September 2016||2016-09-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|BTTS:HBTA||Behavioral Therapy for Tourette Syndrome|Behavioral Therapy for Tourette Syndrome: Home-Based and Therapist-Administered|Recruiting||N/A|80|Anticipated|Johns Hopkins University||1|||f||||f||||||||No||2017-10-10 21:27:38.68102|2017-10-10 21:27:38.68102
NCT03019718|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-08-15|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|July 2017|Actual|2017-07-01||Interventional|||Implementation of the Internet-based Aftercare Program 'GSA-Online Plus'|Implementation of the Online Aftercare Intervention 'GSA-Online Plus' (Healthy and Without Stress at the Workplace)|Active, not recruiting||N/A|88|Actual|Johannes Gutenberg University Mainz||1|||f||||f||||||||||2017-10-10 21:27:38.768136|2017-10-10 21:27:38.768136
NCT03019705|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-10||||||January 2017|2017-01-01||||September 2018|Anticipated|2018-09-01||Observational|||An Examination of the Effects of Health-related Internet Use in Individuals With Pathological Health Anxiety Using Ambulatory Assessment|An Examination of the Effects of Health-related Internet Use in Individuals With Pathological Health Anxiety Using Ambulatory Assessment|Not yet recruiting||N/A|40|Anticipated|Johannes Gutenberg University Mainz|||1||f||||||||||||||2017-10-10 21:27:38.849302|2017-10-10 21:27:38.849302
NCT03019692|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|January 2027|Anticipated|2027-01-01|January 2027|Anticipated|2027-01-01||Observational|NEONATAL ICH||Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage|Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage (IVH, ICH)|Recruiting||N/A|50|Anticipated|Laniado Hospital|||1||f||||f||||||||||2017-10-10 21:27:38.921241|2017-10-10 21:27:38.921241
NCT03019679|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-04-01|||January 2017||2017-01-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Serum Endocan Levels in Polycystic Ovary Syndrome|Serum Endocan Levels in Polycystic Ovary Syndrome: a Possible Marker of Angiogenic Dysfunction|Completed||N/A|175|Actual|Tokat Gaziosmanpasa University|||2||f||||t||||||None Retained|"     serum samples,centrifuged   "|||2017-10-10 21:27:38.993574|2017-10-10 21:27:38.993574
NCT03019666|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-13|||March 2017||2017-03-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|April 2018|Anticipated|2018-04-01||Interventional|||Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL|A Phase I Trial Testing NAM Expanded Haploidentical or Mismatched Related Donor Natural Killer (NK) Cells Followed by a Short Course of IL-2 for the Treatment of Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory CD20+ Non-Hodgkin Lymphoma|Not yet recruiting||Phase 1|24|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-10-10 21:27:39.080173|2017-10-10 21:27:39.080173
NCT03019653|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-08-14|||January 2017||2017-01-01|August 2017|2017-08-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|ANX-042 Aim 1||Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome|A Phase Ib, Double-Blind, Placebo-Controlled, Single-site Trial to Determine the Safety and Efficacy of a Novel Renal-Specific Peptide, ANX-042, in Enhancing GFR Without Significant Hypotension in Human Cardiorenal Syndrome (CRS): ANX-042 Aim #1|Enrolling by invitation||Phase 1|60|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 21:27:39.17785|2017-10-10 21:27:39.17785
NCT03019640|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-25|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Immunotherapy With Ex Vivo-Expanded Cord Blood-Derived NK Cells Combined With Rituximab High-Dose Chemotherapy and Autologous Stem Cell Transplant for B-Cell Non-Hodgkin's Lymphoma|Immunotherapy With Ex Vivo-Expanded Cord Blood-Derived NK Cells Combined With Rituximab High-Dose Chemotherapy and Autologous Stem Cell Transplant for B-Cell Non-Hodgkin's Lymphoma|Not yet recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:27:39.268339|2017-10-10 21:27:39.268339
NCT03019627|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-02-02|||January 2017||2017-01-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||An 8-week Study to Evaluate Safety and Efficacy of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drops Solution Versus Vehicle in Patients With Dry Eye|An 8-week, Phase II, Single-center, Randomized, Double-masked, Vehicle-controlled, Parallel-group Study With 4 Weeks of Follow-up to Evaluate Safety and Efficacy of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drops Solution Versus Vehicle in Patients With Dry Eye|Recruiting||Phase 2|150|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||f||||||||No||2017-10-10 21:27:39.404465|2017-10-10 21:27:39.404465
NCT03019614|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||March 2010||2010-03-01|January 2017|2017-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone|An Open Label, Randomised, Single Dose, 3-period Crossover Study in Healthy Volunteers to: a) Compare the Pharmacokinetics of Chronocort® Formulations Versus Immediate Release Hydrocortisone, and (b) Determine the Dose Proportionality of Chronocort® Formulations|Completed||Phase 1|30|Actual|Diurnal Limited||2|||f||||f||||||||No||2017-10-10 21:27:39.500643|2017-10-10 21:27:39.500643
NCT03019601|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-11|||September 2011||2011-09-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Enhancing Uptake of Family Planning Services by HIV-Infected Women Attending the PMTCT Program|Enhancing Uptake of Family Planning Services by HIV Infected Women Attending the Postpartum Component of the PMTCT Program in Mulago National Referral Hospital, Kampala, Uganda Utilizing HIV-Infected Peers as Family Planning Champions|Completed||N/A|3300|Actual|Johns Hopkins University||1|||f||||f||||||||No||2017-10-10 21:27:39.720949|2017-10-10 21:27:39.720949
NCT03019588|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-28|||February 16, 2017|Actual|2017-02-16|September 2017|2017-09-01|February 19, 2020|Anticipated|2020-02-19|January 21, 2019|Anticipated|2019-01-21||Interventional|||Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063)|A Phase III, Randomized, Open-label Clinical Trial of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine|Recruiting||Phase 3|360|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f|f|f||||||||2017-10-10 21:27:39.827276|2017-10-10 21:27:39.827276
NCT03019562|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Oxycodone vs. Fentanyl in Early Postoperative Pain After Total Hip Replacement|Oxycodone vs. Fentanyl in the Treatment of Early Postoperative Pain After Total Hip Replacement|Recruiting||Phase 4|46|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||No||2017-10-10 21:27:40.323026|2017-10-10 21:27:40.323026
NCT03019549|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-06-19|||January 12, 2017|Actual|2017-01-12|June 2017|2017-06-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Interventional|||A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin|Effect of LY3314814 on the Pharmacokinetics of Rosuvastatin in Caucasian Healthy Subjects|Completed||Phase 1|42|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:27:40.485097|2017-10-10 21:27:40.485097
NCT03019536|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-10-02|||January 31, 2017|Actual|2017-01-31|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease|Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease|Recruiting||Phase 1|132|Anticipated|Eli Lilly and Company||6|||f||||f|t|f||||||||2017-10-10 21:27:40.66707|2017-10-10 21:27:40.66707
NCT03019523|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-24|||August 2016||2016-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of a Caffeine Blend on Reaction Time, Mental Performance and Focus in Athletic Males|Effects Of A Proprietary Supplement On The Acute Responses In Reaction Time, Mental Performance, And Indicators Of Focus In Athletic Populations|Completed||N/A|31|Actual|University of Mary Hardin-Baylor||2|||f||||f||||||||No||2017-10-10 21:27:41.005863|2017-10-10 21:27:41.005863
NCT03019510|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-10|||October 2016||2016-10-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|LIFE||Lowering Impaired Fasting Glucose Levels With Exercise|Dawn Phenomena: Lowering Impaired Fasting Glucose Levels With Exercise (LIFE)|Recruiting||N/A|54|Anticipated|University of Missouri-Columbia||3|||f||||f||||||||No||2017-10-10 21:27:41.107141|2017-10-10 21:27:41.107141
NCT03019497|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|CBT-PTSD-RP||Cognitive-behavioral Therapy for Treatment of Post-traumatic Stress Disorder and Related Problems|Towards Optimization of Traumatic Cognitive-behavioral Therapy for Treatment of Post-traumatic Stress Disorder and Related Problems|Not yet recruiting||N/A|134|Anticipated|Université de Montréal||2|||f||||f||||||||Undecided||2017-10-10 21:27:41.224953|2017-10-10 21:27:41.224953
NCT03019484|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-10|||April 2014||2014-04-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Interventional|SIALAC||Synergy, Self-efficacy, Breastfeeding and Care (SInergia, Autoeficacia, Lactancia y Cuidados)|A Complex Intervention to Promote Breastfeeding Self-efficacy|Completed||N/A|125|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||f||||||||No||2017-10-10 21:27:41.368727|2017-10-10 21:27:41.368727
NCT03019471|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||March 2016||2016-03-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|NICT-NIPT-CA||Non Invasive Cancer Test (NICT): a Proof of Principle Study.|Non Invasive Cancer Test (NICT): a Proof of Principle Study.|Recruiting||N/A|40|Anticipated|Maastricht University Medical Center|||4||f||||t||||||Samples With DNA|"     Blood   "|No||2017-10-10 21:27:41.469296|2017-10-10 21:27:41.469296
NCT03019458|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-06-26|||February 10, 2017|Actual|2017-02-10|June 2017|2017-06-01|June 26, 2017|Actual|2017-06-26|May 8, 2017|Actual|2017-05-08||Interventional|MINGO||MINGO Supplemental Trial in X-linked Dystonia-Parkinsonism Patients|MINGO Supplemental Trial in X-linked Dystonia Parkinsonism Patients: A Prospective Randomized, Open-labeled, Parallel Group Trial|Completed||N/A|50|Actual|Sunshine Care Foundation||2|||f||||f|f|f||||||No||2017-10-10 21:27:41.563653|2017-10-10 21:27:41.563653
NCT03019432|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Perception of Verticality After Stroke|The Effect of Sensory Loss on the E-effect in Post-stroke Patients. A New Insight in Sensory Weighting Strategies|Recruiting||N/A|40|Anticipated|Universiteit Antwerpen|||1||f||||f||||||||Undecided||2017-10-10 21:27:41.653498|2017-10-10 21:27:41.653498
NCT03019419|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-04-27|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)|Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS): A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Trials|Recruiting||Phase 2|60|Anticipated|Tokyo Medical University||3|||f||||t|f|f||||||No||2017-10-10 21:27:41.73739|2017-10-10 21:27:41.73739
NCT03019393|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-11|||May 2016||2016-05-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect of Red Meat Intake on Occurrence of Serum Non-transferrin Bound Iron (NTBI)|Effect of Red Meat Intake on Occurrence of Serum Non-transferrin Bound Iron (NTBI)|Active, not recruiting||N/A|15|Anticipated|National University, Singapore||1|||f||||f||||||||No||2017-10-10 21:27:41.968302|2017-10-10 21:27:41.968302
NCT03019380|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-11|||February 2017||2017-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||"A Clinical Trial to Test the Saftey and Success Rate for a Cerrumen Cleaning Device - Wondertip."|Testing the Effectivness and Safety of the Wondertip|Not yet recruiting||N/A|50|Anticipated|Kaplan Medical Center||1|||f||||t||||||||No|no plan of sharing IPD|2017-10-10 21:27:42.057308|2017-10-10 21:27:42.057308
NCT03019354|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Using High-flow Nasal Oxygen-delivery System in Patients Under Intravenous General Anesthesia|The Effect of Using High-flow Nasal Oxygen-delivery System in Patients Under Intravenous General Anesthesia|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 21:27:42.268535|2017-10-10 21:27:42.268535
NCT03019341|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-04-24|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31|1 Day|Observational [Patient Registry]|||Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media|Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media: Prevalence and Risk Factors|Completed||N/A|1175|Actual|Seoul National University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:27:42.355403|2017-10-10 21:27:42.355403
NCT03019328|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-27|||December 2016||2016-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|EPI||Early Peanut Introduction: Translation to Clinical Practice|Early Peanut Introduction: Translation to Clinical Practice|Recruiting||N/A|400|Anticipated|Johns Hopkins University|||1||f||||t||||||||||2017-10-10 21:27:42.423392|2017-10-10 21:27:42.423392
NCT03019315|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-12|||January 2015||2015-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients|The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients Treated With or Without Paclitaxel Regimens|Recruiting||N/A|5000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 21:27:42.502143|2017-10-10 21:27:42.502143
NCT03019302|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-03-22|||December 2016||2016-12-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study|A Study to Determine the Incidence of Catheter-Related Venous Thrombosis When Using Arrow Peripherally-Inserted Central Catheters With Chlorag+Ard Technology|Recruiting||N/A|100|Anticipated|Teleflex||1|||f||||f||||||||No||2017-10-10 21:27:42.579917|2017-10-10 21:27:42.579917
NCT03019276|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-15|||July 5, 2017|Actual|2017-07-05|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics|Phase I Study of Tolerance and Pharmacokinetics of TQ-B3101 in Patients With Advanced Cancer|Recruiting||Phase 1|20|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f|f|f||||||||2017-10-10 21:27:42.73858|2017-10-10 21:27:42.73858
NCT03019263|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-03-30|||March 31, 2017|Actual|2017-03-31|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Berberine, Chlorogenic Acid and Tocotrienols in Menopause-associated Dyslipidemia|Nutraceutical Intervention With Berberine, Chlorogenic Acid and Tocotrienols for Menopause-associated Dyslipidemia: a Randomized, Controlled Trial|Recruiting||N/A|74|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||f|f|f||||||Undecided||2017-10-10 21:27:42.827292|2017-10-10 21:27:42.827292
NCT03019250|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-06|||January 2017||2017-01-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients|Effects of Colostrum Supplement on Inflammatory and Growth Factors, Immune System Function and Clinical Outcomes in Hospitalized Patients With Enteral Feeding in Intensive Care Unit|Recruiting||N/A|200|Anticipated|National Nutrition and Food Technology Institute||2|||f||||t||||||||Undecided||2017-10-10 21:27:42.910842|2017-10-10 21:27:42.910842
NCT03019237|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||November 2012||2012-11-01|January 2017|2017-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Intranasal Anti-IgE Antibodies on IgE Production|The Effect of Intranasal Application of Anti-IgE Antibodies on IgE Production in Patients Suffering From Seasonal Allergic Rhinitis - a Pilot Study|Completed||N/A|15|Actual|Medical University of Vienna||3|||f||||f||||||||Undecided||2017-10-10 21:27:43.069564|2017-10-10 21:27:43.069564
NCT03019224|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-11|||January 2016||2016-01-01|January 2016|2016-01-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Desensitizing Dentifrices on the Reduction of Pain Sensitivity Caused by In-office Dental Whitening|Effects of Desensitizing Dentifrices on the Reduction of Pain Sensitivity Caused by In-office Dental Whitening: Double Blind Controlled Clinical Study|Completed||Phase 4|4|Actual|University of Campinas, Brazil||4|||f||||f||||||||Undecided||2017-10-10 21:27:43.143476|2017-10-10 21:27:43.143476
NCT03019211|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-05-02|||April 2016||2016-04-01|September 2016|2016-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|PrePhysFalls||Feasibility Aquatic Physical Exercise to Reduce Falls in Institutionalized Elderly|Feasibility of a Physical Exercise Program, Performed Inside or Outside the Aquatic Environment, to Reduce Falls in Institutionalized Elderly: A Pilot Randomised Clinical Study|Completed||N/A|18|Actual|University Ramon Llull||2|||f||||t||||||||No||2017-10-10 21:27:43.229257|2017-10-10 21:27:43.229257
NCT03019198|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-03-07|||December 2013||2013-12-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2014|Actual|2014-03-01||Interventional|||TRANEXAMIC ACID IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY IN A BRAZILIAN REFERENCE ORTHOPEDIC CENTER: A RANDOMIZED CONTROLLED TRIAL|TRANEXAMIC ACID IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY IN A BRAZILIAN REFERENCE ORTHOPEDIC CENTER: A RANDOMIZED CONTROLLED TRIAL|Completed||Phase 4|256|Actual|Instituto Nacional de Traumatologia e Ortopedia||2|||f||||t||||||||No||2017-10-10 21:27:43.305032|2017-10-10 21:27:43.305032
NCT03019185|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-29|||March 2, 2017|Actual|2017-03-02|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|CARDINAL||A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL|A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome|Recruiting||Phase 2/Phase 3|210|Anticipated|Reata Pharmaceuticals, Inc.||3|||f||||t|t|f||||||||2017-10-10 21:27:43.380705|2017-10-10 21:27:43.380705
NCT03019172|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-20|||February 28, 2017|Anticipated|2017-02-28|February 2017|2017-02-01|July 30, 2017|Anticipated|2017-07-30|June 30, 2017|Anticipated|2017-06-30||Interventional|UTIReuteri||Clinical Trial of L. Reuteri in Urinary Tract Infections in Non Pregnant Women|Safety, and Effectiveness of Lactobacillus Reuteri for the Treatment of Urinary Tract Infections in Women: A Pilot Randomized Clinical Trial (RCT)|Not yet recruiting||N/A|40|Anticipated|Innovacion y Desarrollo de Estrategias en Salud||2|||f||||t|f|f||||||No||2017-10-10 21:27:43.547029|2017-10-10 21:27:43.547029
NCT03019159|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||September 2014||2014-09-01|June 2014|2014-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|HSMDP||Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis|Efficacy and Cost-effectiveness Assessment of a Follow-up With Tele-consulting for Patients With Chronic Renal Failure Under Peritoneal Dialysis|Withdrawn||N/A|0|Actual|Assistance Publique - Hôpitaux de Paris|||2|Support funding of the regional health authority stopped|f||||f||||||||||2017-10-10 21:27:43.621217|2017-10-10 21:27:43.621217
NCT03019146|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-10|||November 2016||2016-11-01|January 2017|2017-01-01||||November 2019|Anticipated|2019-11-01||Interventional|eHHH||Exploring Time-efficient Strategies to Improve Fitness for Surgery in Older Adults|Exploring Time-efficient Strategies to Improve Fitness for Surgery in Older Adults|Recruiting||N/A|60|Anticipated|University of Nottingham||4|||f||||f||||||||No||2017-10-10 21:27:45.451761|2017-10-10 21:27:45.451761
NCT03019133|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-10|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|SMART||Trial to Evaluate the Effects of Sound Modulation on Critically Ill Patients|Prospective Randomized Controlled Trial to Compare and Analyze the Effects of Sound Masking and Reduction Techniques on Heart Rate and Blood Pressure Variability in Critically Ill Patients|Recruiting||N/A|120|Anticipated|University of Iowa||3|||f||||f||||||||No|As this is a pilot study, there are no definite plans for sharing individual participant data at this time.|2017-10-10 21:27:45.669443|2017-10-10 21:27:45.669443
NCT03019120|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Dcog||Vitamin D Supplementation and Neurocognition|The Effect of Vitamin D Supplementation on Neurocognitive Function in Older Subjects|Not yet recruiting||Phase 2|30|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||No||2017-10-10 21:27:45.807561|2017-10-10 21:27:45.807561
NCT03019107|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-10|||December 2016||2016-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:27:45.934063|2017-10-10 21:27:45.934063
NCT03019094|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-05-15|||April 2017|Anticipated|2017-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|OPTIMIST-1||Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1|Safety and Performance of the BlueWind RENOVA™ System for the Treatment of Patients Diagnosed With Overactive Bladder (OAB) (OPTIMIST-1 - Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1)|Withdrawn||N/A|0|Actual|Rainbow Medical||1||Sponsor decision|f|||||f|f||||||||2017-10-10 21:27:45.977125|2017-10-10 21:27:45.977125
NCT03019081|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|January 2022|Anticipated|2022-01-01||Interventional|||Augmented Interoceptive Exposure Training in Anorexia Nervosa|Augmented Interoceptive Exposure Training for the Fear of Food in Anorexia Nervosa|Recruiting||N/A|30|Anticipated|Laureate Institute for Brain Research, Inc.||2|||f||||f||||||||No||2017-10-10 21:27:46.05267|2017-10-10 21:27:46.05267
NCT03019068|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-22|||September 2017|Anticipated|2017-09-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|Pred-Inclus||Prediction of Recruitment Potential of Participating Centers in Clinical Trials by Standardized Translation of Selection Criteria and Queries From DRG Database|Prediction of Recruitment Potential of Participating Centers in Clinical Trials by Standardized Translation of Selection Criteria and Queries From the French DRG Database (PMSI)|Not yet recruiting||N/A|3000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 21:27:46.140329|2017-10-10 21:27:46.140329
NCT03019055|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies|Phase 1 Study of Redirected Autologous T Cells Engineered to Contain an Anti CD19 and Anti CD20 scFv Coupled to CD3ζ and 4-1BB Signaling Domains in Patients With Relapsed and/or Refractory CD19 or CD20 Positive B Cell Malignancies|Recruiting||Phase 1|24|Anticipated|Medical College of Wisconsin||1|||f||||t|t|f||||||||2017-10-10 21:27:46.208135|2017-10-10 21:27:46.208135
NCT03019042|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-06-27|||October 11, 2016|Actual|2016-10-11|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Mild Gastrointestinal Disorder|Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Mild Gastrointestinal Disorder: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial|Recruiting||N/A|406|Anticipated|Jiangxi University of Traditional Chinese Medicine||2|||f||||t||||||||No|The individual participant data are not planned to share.|2017-10-10 21:27:46.280741|2017-10-10 21:27:46.280741
NCT03019029|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-07-13|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis|Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis|Enrolling by invitation||Phase 1/Phase 2|10|Anticipated|Mayo Clinic||1|||f||||f|t|f|||f|||||2017-10-10 21:27:46.381653|2017-10-10 21:27:46.381653
NCT03019016|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-01-10|||August 2016||2016-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Observational|||Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy|A Multi-Center Retrospective Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy|Active, not recruiting||N/A|1000|Anticipated|Intuitive Surgical|||4||f||||f||||||||Yes||2017-10-10 21:27:46.543528|2017-10-10 21:27:46.543528
NCT03018808|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-12|||September 18, 2017|Anticipated|2017-09-18|July 2017|2017-07-01|March 17, 2018|Anticipated|2018-03-17|March 17, 2018|Anticipated|2018-03-17||Observational|||Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients|A Cross-sectional Study to Characterize the Prevalence of COPD and Eosinophilia Among Primary Care Patients in Brazil|Not yet recruiting||N/A|2500|Anticipated|GlaxoSmithKline|||3||f||||f|f|f||||||||2017-10-10 21:27:48.246095|2017-10-10 21:27:48.246095
NCT03019003|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-07-20|||March 20, 2017|Actual|2017-03-20|July 2017|2017-07-01|July 2024|Anticipated|2024-07-01|July 2020|Anticipated|2020-07-01||Interventional|||A Phase IB/II Study With Azacitidine, Durvalumab, and Tremelimumab in Recurrent and/or Metastatic Head and Neck Cancer Patients|A Phase IB/II Rescue Study With Azacitidine, Durvalumab (MEDI4736), and Tremelimumab Combination Therapy in Recurrent and/or Metastatic Head and Neck Cancer Patients Who Have Progressed on Anti-PD-1, Anti-PD-L1, or Anti-CTLA-4 Monotherapy|Recruiting||Phase 1/Phase 2|59|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-10 21:27:46.615551|2017-10-10 21:27:46.615551
NCT03018990|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Alcohol Challenge On Liver and Gut Measured by Liver Vein Catheterization. A Pathophysiological Intervention Trial||Recruiting||N/A|40|Anticipated|Odense University Hospital||3|||f||||f||||||||||2017-10-10 21:27:46.717889|2017-10-10 21:27:46.717889
NCT03018977|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Interventional|||Protocolized Sedative Weaning VS. Usual Care in Pediatric Critically Ill, RCT|Protocolized Sedative Weaning Versus Usual Care in Pediatric Critically Ill, Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Ramathibodi Hospital||2|||f||||t||||||||||2017-10-10 21:27:46.803034|2017-10-10 21:27:46.803034
NCT03018951|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-01-13|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Assessing Frailty in Older Adults With Functional Mental Illness|Developing a Tool to Assess Frailty in Older Adults With a Diagnosis of Functional Mental Illness; Tool Development and Pilot Testing.|Recruiting||N/A|65|Anticipated|King's College London|||3||f||||f||||||||No||2017-10-10 21:27:46.988255|2017-10-10 21:27:46.988255
NCT03018938|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-10-02|||February 6, 2017|Actual|2017-02-06|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|CLASSIC||A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus|Comparison Between Basal Insulin Analog and Insulin AnaLog Mid Mixture AS Starter Insulin for Chinese Patients With Type 2 Diabetes Mellitus (CLASSIC Study)|Recruiting||Phase 4|830|Anticipated|Eli Lilly and Company||2|||f||||f|f|f||||||||2017-10-10 21:27:47.096549|2017-10-10 21:27:47.096549
NCT03018925|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-10|||October 2016||2016-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|GOLI2015||Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis|Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis: Pilot Study|Recruiting||N/A|15|Anticipated|Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta|||1||f||||f||||||Samples With DNA|"     STOOL SAMPLE   "|No||2017-10-10 21:27:47.297667|2017-10-10 21:27:47.297667
NCT03018912|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|SSVS||Validating the Use of a Subjectively Reported Sleep Vital Sign|Validating the Use of a Novel Subjectively Reported Sleep Vital Sign for the Identification and Management of Sleep Disorders|Not yet recruiting||N/A|2000|Anticipated|Kaiser Permanente||3|||f||||f||||||||No|This study will be conducted solely within Kaiser Permanente, and it is unnecessary to release IPD to external sources or organizations.|2017-10-10 21:27:47.382205|2017-10-10 21:27:47.382205
NCT03018899|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-01-10|||September 2016||2016-09-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|PVB||Paravertebral Block Versus Epidural Anesthesia for Percutaneous Nephrolithotomy|Comparison of Paravertebral Block Versus Epidural Anesthesia for Surgical Anesthesia of Percutaneous Nephrolithotomy|Recruiting||N/A|50|Anticipated|Huazhong University of Science and Technology||2|||f||||f||||||||No|For patient's privacy|2017-10-10 21:27:47.491041|2017-10-10 21:27:47.491041
NCT03018886|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-11|||May 2001||2001-05-01|January 2017|2017-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Diagnosing Adult Growth Hormone Deficiency|Diagnosis of Adult Growth Hormone Deficiency With Growth Hormone Releasing Hormone Plus Arginine Stimulation Test|Completed||N/A|160|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-10 21:27:47.589386|2017-10-10 21:27:47.589386
NCT03018873|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-01-10|||December 2016||2016-12-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||Long-term Remote Ischemic Preconditioning Improve the Prognosis of Myocardial Infarction Patients With Emergency Reperfusion Therapy||Not yet recruiting||N/A|400|Anticipated|Xuanwu Hospital, Beijing||3|||f||||f||||||||No||2017-10-10 21:27:47.662852|2017-10-10 21:27:47.662852
NCT03018860|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-03-21|||January 25, 2017|Actual|2017-01-25|March 2017|2017-03-01|January 25, 2020|Anticipated|2020-01-25|July 25, 2019|Anticipated|2019-07-25||Interventional|PASST||Alternative to Intensive Management of the Active Phase of the Second Stage of Labor|Alternative to Intensive Management of the Active Phase of the Second Stage of Labor : a Multicenter Randomized Controlled Trial|Recruiting||N/A|3380|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 21:27:47.734501|2017-10-10 21:27:47.734501
NCT03018847|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Evaluation of COPD Co-Pilot|Evaluation of COPD Co-Pilot|Recruiting||N/A|100|Anticipated|HGE Health Care Solutions, LLC|||1||f||||f||||||||No||2017-10-10 21:27:47.824717|2017-10-10 21:27:47.824717
NCT03018834|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-06-13|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|June 15, 2021|Anticipated|2021-06-15|June 15, 2020|Anticipated|2020-06-15||Interventional|ARAMIS||Anakinra Versus Placebo for the Treatment of Acute MyocarditIS|Anakinra Versus Placebo Double Blind Randomized Controlled Trial for the Treatment of Acute MyocarditIS|Recruiting||Phase 2/Phase 3|120|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:27:47.914164|2017-10-10 21:27:47.914164
NCT03018821|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B|Efficacy Comparison Between Two Kind of Chinese Herbal Formulas on Traditional Chinese Medicine Syndromes Among Chronic Hepatitis Patients|Recruiting||N/A|250|Anticipated|Xi'an Traditional Medicine Hospital||3|||f||||||||||||||2017-10-10 21:27:48.026868|2017-10-10 21:27:48.026868
NCT03018795|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||September 2014||2014-09-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|January 2016|Actual|2016-01-01||Interventional|||Ozone Therapy as an Adjunct to the Surgical Treatment of Peri-implantitis|The Effect of Ozone Therapy as an Adjunct to the Surgical Treatment of Peri-implantitis: A Randomized Controlled Clinical Trial|Completed||N/A|21|Actual|Gazi University||2|||f||||f||||||||No||2017-10-10 21:27:48.349985|2017-10-10 21:27:48.349985
NCT03018782|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-01-10|||December 2016||2016-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Pain Screening in Refugee Survivors of Torture|The Implementation of a Novel Pain-screening Tool in the Diagnoses of Pain Symptoms and Syndromes in Refugee Survivors of Torture|Recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||No|There is no plan to make individual participant data available to other researchers|2017-10-10 21:27:48.42326|2017-10-10 21:27:48.42326
NCT03018769|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-01-12|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality||Recruiting||N/A|2000|Anticipated|First Teaching Hospital of Tianjin University of Traditional Chinese Medicine|||1||f||||||||||||||2017-10-10 21:27:48.524328|2017-10-10 21:27:48.524328
NCT03018756|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nebulized Fentanyl in Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis and Chronic Dyspnea|Use of Nebulized Fentanyl in Patients With Mild-to-Moderate Idiopathic Pulmonary Fibrosis and Chronic Dyspnea|Recruiting||Phase 3|20|Anticipated|Queen's University||2|||f||||f||||||||No||2017-10-10 21:27:48.681444|2017-10-10 21:27:48.681444
NCT03018743|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation|Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: a 2-year Prospective Observational Study|Not yet recruiting||N/A|200|Anticipated|Pusan National University Hospital|||1||f||||f||||||||No||2017-10-10 21:27:48.806994|2017-10-10 21:27:48.806994
NCT03018730|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-06-22|||February 23, 2017|Actual|2017-02-23|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and Efficacy of PRX 102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)|An Open Label Study of the Safety and Efficacy of PRX 102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)|Recruiting||Phase 3|22|Anticipated|Protalix||1|||f||||f|t|f||||||No||2017-10-10 21:27:48.908598|2017-10-10 21:27:48.908598
NCT03018717|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-16|||June 2016||2016-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ATLAN_TIC01||Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases|Randomized Multicenter Clinical Trial of a Integral Clinical Care Plan Shared With or Without Telemonitoring of Bio Constants in Patients With Chronic Diseases in Advanced Stages. ATLANTIC Project|Recruiting||Phase 3|510|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||f||||||||No||2017-10-10 21:27:49.050771|2017-10-10 21:27:49.050771
NCT03018704|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-10-03|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|September 29, 2022|Anticipated|2022-09-29|January 31, 2022|Anticipated|2022-01-31||Interventional|||Topiramate Treatment of Alcohol Use Disorders in African Americans|Topiramate Treatment of Alcohol Use Disorder in African Americans|Recruiting||Phase 4|160|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||t|||||2017-10-10 21:27:49.164739|2017-10-10 21:27:49.164739
NCT03018691|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-07-14|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis|A Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Trial to Assess the Safety and Efficacy of 0.3% and 1% OPA-15406 Ointments When Administered for 4 Weeks in Pediatric Patients With Atopic Dermatitis|Completed||Phase 2|73|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-10 21:27:49.262862|2017-10-10 21:27:49.262862
NCT03018678|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-18|||March 2016||2016-03-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia|Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia|Recruiting||N/A|50|Anticipated|University of Pennsylvania|||1||f||||f|f|f||||||Yes|Data will be de-identified prior to sharing with other researchers|2017-10-10 21:27:49.377928|2017-10-10 21:27:49.377928
NCT03018665|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||February 2017||2017-02-01|January 2017|2017-01-01||||December 2021|Anticipated|2021-12-01||Interventional|||A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese|A Randomized,Active-controlled,Open-label Clinical Trial to Evaluate the Effect of GLP-1 Receptor Agonist (Exenatide Injection) in Combination With Metformin Therapy Compared to Premixed Insulin (BIAsp30) in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese|Not yet recruiting||Phase 4|200|Anticipated|First Hospital of Jilin University||2|||f||||||||||||||2017-10-10 21:27:49.494824|2017-10-10 21:27:49.494824
NCT03018652|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-09-18|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1|Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1|Not yet recruiting||Phase 2|16|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:27:49.675908|2017-10-10 21:27:49.675908
NCT03018639|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||December 2012||2012-12-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Impact of Therapist Change on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving DBT|Impact of Therapist Change After Initial Contact and Traumatic Burden on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving Dialectical Behavior Therapy|Completed||N/A|89|Actual|Evangelisches Krankenhaus Bielefeld gGmbH|||1||f||||f||||||||No||2017-10-10 21:27:49.815189|2017-10-10 21:27:49.815189
NCT03018626|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-26|||July 27, 2017|Actual|2017-07-27|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL|Study of R-ACVBP and DA-EPOCH-R in Patients With Newly Diagnosed Non-germinal Center B-cell-like Diffuse Large B-cell Lymphoma|Recruiting||Phase 3|402|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t|f|f|||f|||||2017-10-10 21:27:49.930486|2017-10-10 21:27:49.930486
NCT03018613|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-10|||July 2016||2016-07-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|FMTFCFC||Fecal Microbiota Transplantation for Chronic Functional Constipation|Evaluation of the Effect of Fecal Microbiota Transplantation on Chronic Functional Constipation and Its Mechanism|Recruiting||Phase 1/Phase 2|60|Anticipated|First Affiliated Hospital of Chengdu Medical College||2|||f||||t||||||||No||2017-10-10 21:27:50.08436|2017-10-10 21:27:50.08436
NCT03018600|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-01-10|||January 2016||2016-01-01|April 2016|2016-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|CGM||Continuous Glucose Monitoring on Patients With Active Autoimmune Diseases Following High-dose Predisone Treatment|Glucose Profiles of High-Dose Glucocorticoid Treatment in Young Patients With Diverse Autoimmune Disease With or Without Long-Term Low-Dose Glucocorticoid|Completed||N/A|25|Actual|Peking Union Medical College Hospital|||2||f||||t||||||Samples Without DNA|"     The participants tested the patients' blood sample for insulin, C peptide, HbA1c, GA and     other basic biochemical values (liver and renal function, lipid levels).   "|No||2017-10-10 21:27:50.192992|2017-10-10 21:27:50.192992
NCT03018587|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Feasibility Study of the TruSculpt Radiofrequency Device|Feasibility Study of the TruSculpt Radiofrequency Device|Recruiting||N/A|40|Anticipated|Cutera Inc.||1|||f||||f||||||||No|None. No individual participant data will be shared with other researchers.|2017-10-10 21:27:50.273957|2017-10-10 21:27:50.273957
NCT03018574|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-01-12|||May 2016||2016-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Candidate Gene Screening for Attention Deficit/Hyperactive Disorder (ADHD)|Candidate Gene Screening for 6-14 Year Old Patients With ADHD (Attention Deficit/ Hyperactivity Disorder)|Completed||N/A|100|Actual|Xijing Hospital|||2||f||||t||||||Samples With DNA|"     Whole blood   "|Yes|Publish all data in a paper|2017-10-10 21:27:50.343191|2017-10-10 21:27:50.343191
NCT03018561|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-01-10|||January 2011||2011-01-01|January 2017|2017-01-01|January 2017|Anticipated|2017-01-01|December 2016|Actual|2016-12-01||Interventional|COGNEX||Brain, Cardiac Hemodynamics and Cognition During Exercise in Subjects With Various Cardiovascular Profiles|Cerebral Oxygenation, Cardiac Output, COGnitive Function, and EXercise in Patients With Metabolic Syndrome, Coronary Heart Disease and Chronic Heart Failure|Active, not recruiting||N/A|140|Actual|Montreal Heart Institute||4|||f||||f||||||||No|no IPD plan|2017-10-10 21:27:50.409207|2017-10-10 21:27:50.409207
NCT03018548|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Improvised Explosive Device (IED) Level Blasting of Human Blood With Slosh Prevention|Improvised Explosive Device (IED) Level Blasting of Human Blood With Slosh Prevention|Completed||N/A|40|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||No||2017-10-10 21:27:50.474878|2017-10-10 21:27:50.474878
NCT03018535|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||January 2012||2012-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RI-CYCLO||Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy|A Randomized Controlled Trial of Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy|Recruiting||Phase 3|70|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||f||||||||No||2017-10-10 21:27:50.54937|2017-10-10 21:27:50.54937
NCT03018522|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-23|||September 2015||2015-09-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Observational|||S100B Protein and Postoperative Cognitive Dysfunction|S100B Protein as Predictor of Cognitive Dysfunction After Robot-assisted Radical Prostatectomy: A Prospective Observational Study|Completed||N/A|69|Actual|Antalya Training and Research Hospital|||1||f||||f||||||||No||2017-10-10 21:27:50.671427|2017-10-10 21:27:50.671427
NCT03018509|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-06-29|||December 2016||2016-12-01|June 2017|2017-06-01|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Interventional|||Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects|A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JTE-451 Administered for 4 Weeks in Subjects With Active Plaque Psoriasis|Completed||Phase 1|47|Actual|Akros Pharma Inc.||5|||f||||f||||||||||2017-10-10 21:27:50.759781|2017-10-10 21:27:50.759781
NCT03018496|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Investigating the Effects of Beta-Hydroxy-Beta-Methylbutyrate on Glucose Handling in Older and Younger Men.|Investigating the Effects of Beta-Hydroxy-Beta-Methylbutyrate on Glucose Handling in Older and Younger Men.|Recruiting||N/A|16|Anticipated|University of Nottingham||2|||f||||f||||||||No||2017-10-10 21:27:50.964541|2017-10-10 21:27:50.964541
NCT03018483|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-10|||May 2017||2017-05-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparison Between Three Different Pressure Support Ventilation in Weaning From Mechanical Ventilation|Comparison Between Automated Pressure Support Ventilation, Variable Pressure Support Ventilation and Non-variable Pressure Support Ventilation in Weaning From Mechanical Ventilation|Not yet recruiting||N/A|342|Anticipated|Federico II University||3|||f||||f||||||||No||2017-10-10 21:27:51.06372|2017-10-10 21:27:51.06372
NCT03018470|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Change in Breathing Pattern on Non-invasive Ventilation of COPD Patients Under Home Mechanical Ventilation|Usefulness of built-in Non-invasive Ventilator Software to Detect the Change in the Breathing Pattern of COPD Patients Under Home Mechanical Ventilation Before an Admission for Acute Exacerbation of COPD.|Recruiting||N/A|80|Anticipated|University Hospital, Rouen|||3||f||||f||||||||||2017-10-10 21:27:51.139553|2017-10-10 21:27:51.139553
NCT03018106|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-03-16|||January 2017||2017-01-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction|Ospemifene Versus Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction|Recruiting||Phase 4|104|Anticipated|Emory University||2|||f||||f||||||||No||2017-10-10 21:27:54.265098|2017-10-10 21:27:54.265098
NCT03018457|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Trabecular Microarchitecture of the Alveolar Bone by Micro-computed Tomography and of Osseointegration of Dental Implants by Resonance Frequency Analysis|Evaluation of Trabecular Microarchitecture of the Alveolar Bone by Micro-computed Tomography and of Osseointegration of Dental Implants by Resonance Frequency Analysis: Correlation Study.|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 21:27:51.303997|2017-10-10 21:27:51.303997
NCT03018444|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-03-02|||October 2016||2016-10-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion|The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion|Completed||N/A|15|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||||||||||||2017-10-10 21:27:51.410442|2017-10-10 21:27:51.410442
NCT03018431|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-10|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01|18 Days|Observational [Patient Registry]|ECTOPICUS||CT Scan and Lung Ultrasonography to Improve Diagnostic of Ventilation Acquired Pneumonia in ICU|Impact of CT Scan and Lung Ultrasonogrpahy in Early Diagnostic Accuracy for Ventilation Acquired Lower Respiratory Tract Infections in Intensive Care Units.|Not yet recruiting||N/A|160|Anticipated|Centre Hospitalier Universitaire de Besancon|||2||f||||f||||||||||2017-10-10 21:27:51.513262|2017-10-10 21:27:51.513262
NCT03018418|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-27|||January 2017||2017-01-01|July 2017|2017-07-01|January 2023|Anticipated|2023-01-01|June 2022|Anticipated|2022-06-01||Interventional|||Proton Therapy in Reducing Toxicity in Anal Cancer|A Prospective Pilot Study to Evaluate the Feasibility of Intensity Modulated Proton Therapy in Reducing Toxicity in Anal Cancer|Recruiting||Phase 2|20|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-10 21:27:51.624814|2017-10-10 21:27:51.624814
NCT03018405|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-08-30|||December 2016||2016-12-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|May 2020|Anticipated|2020-05-01||Interventional|THINK||A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications|A Multi-national, Open-label, Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Administrations of NKR-2 in Patients With Different Metastatic Tumor Types (THINK - THerapeutic Immunotherapy With NKR-2)|Recruiting||Phase 1|24|Anticipated|Celyad (formerly named Cardio3 BioSciences)||2|||f||||t||||||||||2017-10-10 21:27:51.730988|2017-10-10 21:27:51.730988
NCT03018392|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium Cage|Fusion Rate and Clinical Outcomes Following 1 or 2 Level Open Transforaminal Lumbar Interbody Fusion for Degenerative Disc Disease With Novel 3-D Printed Titanium Cages With Pedicle Screw Fixation|Enrolling by invitation||N/A|20|Anticipated|Bone and Joint Clinic of Baton Rouge||1|||f||||||||||||||2017-10-10 21:27:51.855228|2017-10-10 21:27:51.855228
NCT03018379|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-11|||June 2013||2013-06-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Body Composition, Dietary Behaviors, Energy Expenditure and Physical Activity Among Moroccan Schoolchildren and Adolescents|Assessment Study of Body Composition, Energy Expenditure and Physical Activity to Inform Design and Improve Interventions for the Prevention and Control of Obesity and Related Health Risks Among Schoolchildren and Adolescent Aged 8 to 14 Years in Morocco|Completed||N/A|432|Actual|Centre National De L'énergie, Des Sciences Et Techniques Nucléaires|||3||f||||f||||||||||2017-10-10 21:27:51.925552|2017-10-10 21:27:51.925552
NCT03018366|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-03-24|||January 2017||2017-01-01|March 2017|2017-03-01|August 2022|Anticipated|2022-08-01|January 2021|Anticipated|2021-01-01||Interventional|||Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women|Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women|Recruiting||Phase 2|30|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:27:51.998242|2017-10-10 21:27:51.998242
NCT03018353|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-30|||March 5, 2017|Actual|2017-03-05|May 2017|2017-05-01|June 4, 2018|Anticipated|2018-06-04|March 4, 2018|Anticipated|2018-03-04||Interventional|CHIP||Curing HCV in Incarcerated Patients|Curing HCV in Incarcerated Patients|Enrolling by invitation||Phase 4|100|Anticipated|San Francisco Department of Public Health||1|||f||||t|t|f|||t|||No|No IPD will be shared with other outside researchers who are not participating in this pilot demonstration project.|2017-10-10 21:27:52.128977|2017-10-10 21:27:52.128977
NCT03018340|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-04-18|||December 2016||2016-12-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder|Recruiting||Phase 2|188|Anticipated|ACADIA Pharmaceuticals Inc.||2|||f||||f||||||||No||2017-10-10 21:27:52.208826|2017-10-10 21:27:52.208826
NCT03018327|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-11|||January 2016||2016-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Ano-genital Human Papillomavirus (HPV) Infection, Precancerous Lesions and Genital Warts Among Danish Renal Transplant Recipients|Ano-genital Human Papillomavirus (HPV) Infection, Genital Warts, Precancerous Lesions and Cancer Among Danish Renal Transplant Recipients|Recruiting||N/A|500|Anticipated|Bispebjerg Hospital|||2||f||||t||||||Samples With DNA|"     HPV samples tested by Inno-lipa   "|||2017-10-10 21:27:52.302442|2017-10-10 21:27:52.302442
NCT03018314|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-08-24|||June 2016||2016-06-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Observational|||Serum Kisspeptin Levels in Infertile Women|Serum Kisspeptin Levels in Infertile Women Due to Anovulatory Cycles, Unexplained Infertility or Male Subfertility: A Prospective Observational Study|Completed||N/A|90|Actual|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||3||f||||f||||||||||2017-10-10 21:27:52.378485|2017-10-10 21:27:52.378485
NCT03018301|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Intravenous Ketamine and Postoperative Pain Following Cesarean Section.|Effect of Single Intravenous Ketamine Dose on Postoperative Pain Following Cesarean Section Under Spinal Anesthesia: A Randomized Control Clinical Trial.|Recruiting||Phase 2|80|Anticipated|Assiut University||2|||f||||f||||||||Yes||2017-10-10 21:27:52.46738|2017-10-10 21:27:52.46738
NCT03018288|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-07-19|||January 3, 2017||2017-01-03|May 19, 2017|2017-05-19|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)|A Randomized, Double Blind Phase II Trial of Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)|Recruiting||Phase 2|108|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 21:27:52.558896|2017-10-10 21:27:52.558896
NCT03018262|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-11|2017-09-02|||December 23, 2016||2016-12-23|April 20, 2017|2017-04-20|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Neurophysiology of Surround Inhibition in the Human Motor Cortex|Detailed Evaluation of the Neurophysiology of Surround Inhibition in the Human Motor Cortex|Recruiting||N/A|65|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:27:52.755138|2017-10-10 21:27:52.755138
NCT03018236|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-20|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.|The Effect of N-acetylcysteine (NAC) on Treatment of Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.|Recruiting||Phase 4|100|Anticipated|Hospital de Clinicas de Porto Alegre||4|||f||||f||||||||Undecided||2017-10-10 21:27:53.281678|2017-10-10 21:27:53.281678
NCT03018223|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-05|||January 10, 2017|Actual|2017-01-10|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT|A Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haploidentical Peripheral Blood Stem Cell Transplantation|Recruiting||Phase 2|32|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 21:27:53.423308|2017-10-10 21:27:53.423308
NCT03018210|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-02-15|||January 2017||2017-01-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|IMPROVE||The Impact of Psychological Well-being on the Outcome of Surgical Repair for Rotator Cuff Tears|The Impact of Psychological Well-being on the Outcome of Surgical Repair for Rotator Cuff Tears: a Prospective Cohort|Recruiting||N/A|223|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||No||2017-10-10 21:27:53.545944|2017-10-10 21:27:53.545944
NCT03018197|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||February 2014||2014-02-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Use of Electronic Personal Health Records to Improve Medication Adherence|The Use of Electronic Personal Health Records to Improve Medication Adherence Among Non-Valvular Atrial Fibrillation Patients: A Pilot Study|Completed||N/A|90|Actual|Parkview Health||2|||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-10 21:27:53.623581|2017-10-10 21:27:53.623581
NCT03018184|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-11|||December 2016||2016-12-01|January 2017|2017-01-01|December 2026|Anticipated|2026-12-01|December 2017|Anticipated|2017-12-01||Observational|||Contractile Cross Sectional Areas and Muscle Strength in Patients With Inherited Muscle Diseases|Contractile Cross Sectional Areas and Muscle Strength in Patients With Inherited Muscle Diseases as Compared to Healthy Individuals|Recruiting||N/A|200|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||||No||2017-10-10 21:27:53.691281|2017-10-10 21:27:53.691281
NCT03018171|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-04-25|||January 2017||2017-01-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|ICA||Intrathecal Clonidine Addiction for Combined Spinal Epidural Analgesia During Labor|Impact on Maternal and Fetal Wellbeing and on Labor Curve of Intrathecal Clonidine Addiction for Labor Analgesia. A Randomized Controlled Trial.|Recruiting||Phase 4|268|Anticipated|San Giovanni Calibita Fatebenefratelli Hospital||2|||f||||||||||||||2017-10-10 21:27:53.76744|2017-10-10 21:27:53.76744
NCT03018158|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||MR Images Variation With or Without Denture Wear|MR Images Variation With or Without Denture Wear. Motion Artifacts Related With Tongue Movements|Recruiting||N/A|20|Anticipated|Nihon University||3|||f||||f||||||||No||2017-10-10 21:27:53.83925|2017-10-10 21:27:53.83925
NCT03018145|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-03-08|||September 20, 2016|Actual|2016-09-20|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Effect of Transportation Method on Preoperative Anxiety in Children|Effect of Transportation Method on Preoperative Anxiety in Children|Completed||N/A|80|Actual|Chonnam National University Hospital||2|||f||||||||||||||2017-10-10 21:27:53.904508|2017-10-10 21:27:53.904508
NCT03018132|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|PROVIDE||Preeclampsia Research on Vitamin D, Inflammation, & Depression|The PROVIDE Study; Preeclampsia Research on Vitamin D, Inflammation, & Depression|Not yet recruiting||N/A|200|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||No||2017-10-10 21:27:54.010751|2017-10-10 21:27:54.010751
NCT03018119|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-10|||November 2015||2015-11-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method|Implementation of the National Partnership for Maternal Safety Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method|Completed||N/A|38|Actual|Brigham and Women's Hospital||4|||f||||t||||||||No||2017-10-10 21:27:54.186496|2017-10-10 21:27:54.186496
NCT03018093|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL|A Phase I Study Evaluating Safety and Efficacy of CBM.CD19-targeted Chimeric Antigen Receptor T Cells (C-CAR011) Treatment in Adult Subjects With Relapsed/Refractory CD19+ B Cells Acute Lymphoblastic Leukemia(CALL-1)|Recruiting||Phase 1|20|Anticipated|Cellular Biomedicine Group Ltd.||1|||f||||t||||||||Undecided||2017-10-10 21:27:54.387376|2017-10-10 21:27:54.387376
NCT03018080|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-06-19|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|PePPy||Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer|LCI-BRE-H2N-PEPP-001: A Pilot Study of Paclitaxel Plus Pembrolizumab in Patients With Metastatic HER2-Negative Breast Cancer (The PePPy Trial)|Recruiting||Phase 2|40|Anticipated|Carolinas Healthcare System||2|||f||||t|t|f||||||Undecided||2017-10-10 21:27:54.473536|2017-10-10 21:27:54.473536
NCT03018067|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01||||May 2017|Anticipated|2017-05-01||Interventional|||A Study Evaluating the Onset-of-Action, Safety, and Efficacy of RDX227675 for the Treatment of Hyperkalemia|A Single-Blind, Placebo-Controlled Study Evaluating the Onset-of-Action, Safety, and Efficacy of RDX227675 for the Treatment of Hyperkalemia|Recruiting||Phase 2|60|Anticipated|Ardelyx||4|||f||||f||||||||No||2017-10-10 21:27:54.576007|2017-10-10 21:27:54.576007
NCT03018054|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-06|||November 28, 2016|Actual|2016-11-28|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis|A Phase 2, Double-Blind, Parallel-Group, Placebo-Controlled Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis|Recruiting||Phase 2|144|Anticipated|Eisai Inc.||3|||f||||t||||||||||2017-10-10 21:27:54.662443|2017-10-10 21:27:54.662443
NCT03018041|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-09-11|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2021|Anticipated|2021-08-31||Interventional|EMiRA||The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation|The Long-term Effect of Marine n-3 Polyunsaturated Fatty Acid Supplementation on Glomerular Filtration Rate and Development of Fibrosis in the Renal Allograft: a Randomized Double Blind Placebo Controlled Intervention Study|Recruiting||Phase 3|174|Anticipated|University Hospital, Akershus||2|||f||||f|f|f||||||||2017-10-10 21:27:54.825485|2017-10-10 21:27:54.825485
NCT03018028|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-06-21|||January 10, 2017|Actual|2017-01-10|June 2017|2017-06-01|September 6, 2018|Anticipated|2018-09-06|August 2, 2018|Anticipated|2018-08-02||Interventional|PIONEER 9||Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes|Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes|Active, not recruiting||Phase 3|240|Anticipated|Novo Nordisk A/S||5|||f||||f|f|f||||||Yes|According to the Novo Nordisk disclosure commitment on novonordisk-trials.com|2017-10-10 21:27:54.978773|2017-10-10 21:27:54.978773
NCT03018015|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||September 2016||2016-09-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Ibuprofen Bioavailability Trial With Oral Single Dose Administration.|Characterisation of Relative Bioavailability of a Newly Developed Ibuprofen Oral Powder Formulation in Comparison With Two Marketed Reference Products in a Single Dose, 3-period-crossover Design Under Fasting Conditions; Controlled, Open-label, Randomised Study With Bioequivalence Assessment|Completed||Phase 1|30|Actual|SocraTec R&D GmbH||3|||f||||f||||||||||2017-10-10 21:27:55.102661|2017-10-10 21:27:55.102661
NCT03018002|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-10|||July 2016||2016-07-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|iSTAR||Intervention for Sustained Testing and Retention Among HIV-infected Patients|Intervention for Sustained Testing and Retention Among HIV-infected Patients|Recruiting||N/A|400|Anticipated|University of Nevada, Las Vegas||2|||f||||t||||||||No||2017-10-10 21:27:55.185372|2017-10-10 21:27:55.185372
NCT03017989|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-04-05|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ICG-Based Fluorescence Imaging for Intra-operative Detection of Endometriosis|The Use of Indocyanine Green-Based Fluorescence Imaging for Intraoperative Detection of Peritoneal Endometriosis|Recruiting||N/A|15|Anticipated|Maastricht University Medical Center||1|||f||||t|f|f||||||Undecided||2017-10-10 21:27:55.283594|2017-10-10 21:27:55.283594
NCT03017976|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-09|||January 2017||2017-01-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|March 2017|Anticipated|2017-03-01||Observational|SWAN||Swimming Pool Environment Impact on the Human Respiratory Health|Swan Study: Swimming Pool Environment Impact on the Human Respiratory Health|Not yet recruiting||N/A|1000|Anticipated|Universidade do Porto|||2||f||||f||||||Samples With DNA|"     Exhaled breath condensate (no DNA) Blood (DNA) Urine (DNA)   "|No||2017-10-10 21:27:55.37137|2017-10-10 21:27:55.37137
NCT03017963|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-01-26|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|SAFE-ACS||Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing PCI Via Radial Approach.|Safety and Tolerability of Sodium Thiosulfate in Patients Presenting With an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Via Radial Approach: a Dose-escalation Study.|Not yet recruiting||Phase 1/Phase 2|21|Anticipated|University Medical Center Groningen||1|||f||||f|t|f|||f|||No||2017-10-10 21:27:55.459634|2017-10-10 21:27:55.459634
NCT03017950|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-19|||December 2016||2016-12-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Pharmacokinetic Drug-drug Interaction of CKD-330 and D086|Phase I Clinical Trial to Evaluate the Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 in Healthy Male Volunteers|Completed||Phase 1|83|Actual|Chong Kun Dang Pharmaceutical||4|||f||||f||||||||||2017-10-10 21:27:55.543786|2017-10-10 21:27:55.543786
NCT03017937|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-31|||November 2016||2016-11-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Sex and Age Ultrasound Response to Differential Jugular Vein Pressure|Sex and Age Ultrasound Response to Differential Jugular Vein Pressure|Completed||N/A|72|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||No||2017-10-10 21:27:55.619781|2017-10-10 21:27:55.619781
NCT03017924|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||December 2016||2016-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|BLAST||Novel Protection Against Potential Brain, Hearing and Vision Injury During Blast Wave Exposure|Novel Protection Against Potential Brain, Hearing and Vision Injury During Blast Wave Exposure|Recruiting||N/A|50|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No||2017-10-10 21:27:55.699545|2017-10-10 21:27:55.699545
NCT03017911|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|COMPLI-PICC||COMPLI-PICC: Study on Picclines' Complications|Prospective Observational Study on Picclines' Complications at Brest Hospital|Recruiting||N/A|120|Anticipated|University Hospital, Brest|||1||f||||f||||||||No||2017-10-10 21:27:55.783764|2017-10-10 21:27:55.783764
NCT03017898|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-03-03|||March 3, 2017|Actual|2017-03-03|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment of Anal Fistula With Lasercoagulation|Treatment of Anal Fistula With Laser Mediated Heat Coagulation Using Fistula Laser Closure (FiLaC)|Recruiting||N/A|52|Anticipated|Region Skane||1|||f||||f|f|f||||||No||2017-10-10 21:27:55.865338|2017-10-10 21:27:55.865338
NCT03017885|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-10-03|||February 28, 2017|Actual|2017-02-28|October 2017|2017-10-01|November 1, 2018|Anticipated|2018-11-01|September 30, 2018|Anticipated|2018-09-30||Observational|||Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy|An Active Surveillance to Monitor the Real World Safety in Indian Patients Prescribed Nintedanib for the Treatment of Locally Advanced, Metastatic or Locally Recurrent Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Tumor Histology After First Line Chemotherapy|Recruiting||N/A|100|Anticipated|Boehringer Ingelheim|||1||f|||||f|f||||||||2017-10-10 21:27:55.960467|2017-10-10 21:27:55.960467
NCT03017872|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-08-30|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|December 30, 2020|Anticipated|2020-12-30|September 30, 2019|Anticipated|2019-09-30||Interventional|D²EFT||Dolutegravir and Darunavir Evaluation in Adults Failing Therapy|A Phase IIIB/IV Randomised Open-label Trial to Compare Dolutegravir + Pharmaco-enhanced Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in Patients With HIV Infection Who Have Failed Recommended First Line Therapy.|Not yet recruiting||Phase 4|610|Anticipated|Kirby Institute||2|||f||||t|f|f|||f|||||2017-10-10 21:27:56.0546|2017-10-10 21:27:56.0546
NCT03017859|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||High Flow Nasal Cannula as a Treatment for Obstructive Sleep Apnea|High Flow Nasal Cannula as a Treatment for Obstructive Sleep Apnea|Not yet recruiting||N/A|30|Anticipated|Rabin Medical Center||1|||f||||t||||||||No||2017-10-10 21:27:56.316183|2017-10-10 21:27:56.316183
NCT03017846|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-09-11|||September 2016||2016-09-01|September 2017|2017-09-01|September 6, 2017|Actual|2017-09-06|September 6, 2017|Actual|2017-09-06||Interventional|||Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2||Completed||Phase 2|30|Actual|Montefiore Medical Center||1|||f||||f||||||||||2017-10-10 21:27:56.400797|2017-10-10 21:27:56.400797
NCT03017833|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-10-04|||March 2018|Anticipated|2018-03-01|October 2017|2017-10-01|March 2023|Anticipated|2023-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Study of TAK-228 (MLN0128) in Combination With Metformin in Patients With Advanced Cancers|Phase I Study of TAK-228 (MLN0128) in Combination With Metformin in Patients With Advanced Cancers|Not yet recruiting||Phase 1|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:27:56.474568|2017-10-10 21:27:56.474568
NCT03017820|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-08-21|||April 4, 2017|Actual|2017-04-04|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, or T-cell Lymphoma|Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, and T-Cell Neoplasms|Recruiting||Phase 1|24|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:27:56.588532|2017-10-10 21:27:56.588532
NCT03017807|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer|A PhaseⅠ,Open-label, Single-center Study to Evaluate Safety and Pharmacokinetics of Recombinant Anti-Epidermal Growth Factor Receptor (EGFr) Antibody in Patients With Metastatic Colorectal Cancer|Recruiting||Phase 1|18|Anticipated|Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.||1|||f||||f||||||||No||2017-10-10 21:27:56.70581|2017-10-10 21:27:56.70581
NCT03017794|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-05-23|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy in Prostate Carcinoma||Recruiting||N/A|125|Anticipated|Mayo Clinic|||3||f||||||||||||||2017-10-10 21:27:56.783119|2017-10-10 21:27:56.783119
NCT03017781|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-09-22|||October 25, 2016|Actual|2016-10-25|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|June 18, 2020|Anticipated|2020-06-18||Observational|||A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder|An Observational Longitudinal Study in Offspring of Parents With Bipolar Disorder to Evaluate the Relationship of Impairment in Psychosocial Functioning With the Manifestation of Mood Symptoms Over 24 Months|Recruiting||N/A|208|Anticipated|Janssen Research & Development, LLC|||2||f||||f||f||||Samples With DNA|"     Blood and Saliva   "|||2017-10-10 21:27:56.865223|2017-10-10 21:27:56.865223
NCT03017768|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-27|||June 2016||2016-06-01|December 2016|2016-12-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|||The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers|The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers: a Randomized, Single-blind, Placebo-controlled Study|Completed||N/A|15|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 21:27:56.979516|2017-10-10 21:27:56.979516
NCT03017755|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-04-19|||April 11, 2017|Actual|2017-04-11|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Scoliosis Survey to Development Treatment Decision Tool|Your Scoliosis Journey: A Survey for Patients Treated for Scoliosis and Their Families|Recruiting||N/A|1000|Anticipated|Mayo Clinic|||1||f||||f||||||||No||2017-10-10 21:27:57.059563|2017-10-10 21:27:57.059563
NCT03017742|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-05-09|||November 2016||2016-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:27:57.14215|2017-10-10 21:27:57.14215
NCT03017547|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-13|||June 2017||2017-06-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Preliminary Efficacy Study of IC14 in Acute Respiratory Distress Syndrome|Not yet recruiting||Phase 2|160|Anticipated|Implicit Bioscience||2|||f||||t||||||||||2017-10-10 21:27:58.681784|2017-10-10 21:27:58.681784
NCT03017729|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-08-28|||February 10, 2017|Actual|2017-02-10|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity|A Phase IV, Prospective, Observational, Multicentre Study Evaluating the Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity.|Recruiting||N/A|210|Anticipated|Ipsen|||1||f||||f|t|f||||||||2017-10-10 21:27:57.192433|2017-10-10 21:27:57.192433
NCT03017716|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Inflammatory Back Pain and Gluten Free Diet|Inflammatory Back Pain and Gluten Free Diet|Not yet recruiting||N/A|50|Anticipated|University of Palermo||2|||f||||f||||||||No||2017-10-10 21:27:57.291561|2017-10-10 21:27:57.291561
NCT03017703|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes|The Role of Aldosterone in Diabetes Related Vascular Disease, a New Therapeutic Target?|Recruiting||N/A|40|Anticipated|University of Southern Denmark||2|||f||||t||||||||No||2017-10-10 21:27:57.377796|2017-10-10 21:27:57.377796
NCT03017690|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-08-28|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)|Lanreotide and Octreotide LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Observational Time and Motion Analysis|Recruiting||N/A|100|Anticipated|Ipsen|||2||f||||f||f||||||||2017-10-10 21:27:57.449842|2017-10-10 21:27:57.449842
NCT03017677|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-11|||June 2017||2017-06-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Mucopolysaccharidosis (MPS) Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia Combined With Pediatric ENT Surgery or Bronchoscopy|Mucopolysaccharidosis (MPS) Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia Combined With Pediatric ENT Surgery or Bronchoscopy|Not yet recruiting||N/A|100|Anticipated|Mackay Memorial Hospital|||1||f||||f||||||||No||2017-10-10 21:27:57.533015|2017-10-10 21:27:57.533015
NCT03017664|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding|An Improvement Project Towards Optimizing Nutrition Intervention With a Higher Protein and Calorie Pediatric Tube Feeding Formula|Not yet recruiting||N/A|100|Anticipated|Nestlé|||2||f||||f||||||||No||2017-10-10 21:27:57.596561|2017-10-10 21:27:57.596561
NCT03017651|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-05-15|||November 2016||2016-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||An Evaluation of Omega-3 Fatty Acid|An Evaluation of a Proprietary Omega-3 Fatty Acid Incorporated Into a MAG on Blood EPA and DHA Levels: a PK Study|Completed||Phase 1|30|Actual|Nestlé||2|||f||||f||||||||No||2017-10-10 21:27:57.668024|2017-10-10 21:27:57.668024
NCT03017638|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||February 2017||2017-02-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Analgesic Efficacy of Quadaratus Lumborum Block (QLB) for Laparoscopic Colectomy Surgery: A Prospective Case Control Trial to Evaluate Clinical Outcomes|Analgesic Efficacy of Quadaratus Lumborum Block (QLB) for Laparoscopic Colectomy Surgery: A Prospective Case Control Trial to Evaluate Clinical Outcomes|Not yet recruiting||Phase 4|15|Anticipated|Rabin Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:27:57.752701|2017-10-10 21:27:57.752701
NCT03017625|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-09|||January 2017||2017-01-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||Platelet Activation and Reactivity in Acute Exacerbations of COPD|Platelet Activation and Responsiveness in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD)|Not yet recruiting||N/A|30|Anticipated|Radboud University|||1||f||||t||||||Samples Without DNA|"     Blood, plasma   "|||2017-10-10 21:27:58.017481|2017-10-10 21:27:58.017481
NCT03017599|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-01-10|||July 2016||2016-07-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||Yield Rate for Procurement the Histologic Core With Endoscopic Ultrasound-guided Fine Needle Biopsy With 20-gauge Ultrasound Biopsy Needles for Solid Pancreatic Masses: Pilot Study||Recruiting||N/A|30|Anticipated|Yonsei University||1|||f||||f||||||||No||2017-10-10 21:27:58.231219|2017-10-10 21:27:58.231219
NCT03017586|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-20|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Efficacy and Safety of DBS in Patients With Primary Dystonia|Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) Deep Brain Stimulation (DBS) in Patients With Primary Dystonia.|Not yet recruiting||N/A|105|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t|f|f||||||Undecided||2017-10-10 21:27:58.343296|2017-10-10 21:27:58.343296
NCT03017573|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2020|Anticipated|2020-12-01||Interventional|SCANDARE||Prospective Biobanking Study in Ovarian, Breast and Head and Neck Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)|Prospective Biobanking Study in Ovarian, Breast and Head and Neck Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response|Recruiting||N/A|500|Anticipated|Institut Curie||1|||f||||f||||||||No||2017-10-10 21:27:58.459173|2017-10-10 21:27:58.459173
NCT03017560|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-09|||December 2015||2015-12-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer|Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer|Suspended||N/A|45|Anticipated|Northwestern University||2||Principal Investigator Medical Leave|f||||f||||||||No||2017-10-10 21:27:58.576589|2017-10-10 21:27:58.576589
NCT03017521|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||K-BASKET, TAS-117, PI3K/AKT Gene Aberration|A Phase II Study of TAS-117 in Advanced Solid Tumors With PI3K/AKT Gene Aberration (Part of K-BASKET Trial; Korea-Biomarker-driven Multi-arm Drug-screening, Knowledge and Evidence-generating Targeted Trial)|Not yet recruiting||Phase 2|30|Anticipated|Yonsei University||1|||f||||f||||||||Undecided||2017-10-10 21:27:58.880828|2017-10-10 21:27:58.880828
NCT03017508|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder|Double-Blind, Placebo-Controlled, Single-Dose Crossover Study Examining the Effects of Sublingual Riluzole (BHV-0223) on Public Speaking in Social Anxiety Disorder|Recruiting||Phase 2/Phase 3|20|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-10 21:27:58.973747|2017-10-10 21:27:58.973747
NCT03017495|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-10|2017-07-26|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||A Clinical Study to Investigate the Potential Interactions Between Food and ACT-541468 and Between ACT-541468 and Midazolam|A Single-center, Open-label Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 and the Effect of Single- and Multiple-dose ACT‑541468 on the Pharmacokinetics of Midazolam and Its Metabolite 1‑Hydroxymidazolam in Healthy Male Subjects|Completed||Phase 1|20|Actual|Actelion||1|||f||||f||||||||||2017-10-10 21:27:59.101154|2017-10-10 21:27:59.101154
NCT03017482|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-01-09|||February 2017||2017-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|670Gstartup||Clinical Startup of the 670G Closed Loop Insulin Delivery System|Clinical Startup of the 670G Closed Loop Insulin Delivery System|Not yet recruiting||N/A|100|Anticipated|Stanford University|||1||f||||f||||||||No|No plan to share|2017-10-10 21:27:59.203924|2017-10-10 21:27:59.203924
NCT03017469|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-09-05|||February 21, 2017|Actual|2017-02-21|September 2017|2017-09-01|October 15, 2017|Anticipated|2017-10-15|May 31, 2017|Actual|2017-05-31||Interventional|||Achieving Resilience in Acute Care Nurses (ARISE).|Achieving Resilience in Acute Care Nurses (ARISE): A Randomized Controlled Trial of a Multi-component Intervention for Nurses in Critical Care and Trauma.|Active, not recruiting||N/A|29|Actual|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 21:27:59.296264|2017-10-10 21:27:59.296264
NCT03017456|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-05-02|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Interventional|||PC 360 Survivorship|Prostate Cancer Survivorship 360°|Recruiting||N/A|180|Anticipated|University Health Network, Toronto||2|||f||||f|f|f||||||No||2017-10-10 21:27:59.460829|2017-10-10 21:27:59.460829
NCT03017443|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-13|||April 2015||2015-04-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Study to Evaluate Effects of a Weight Loss Program in Different Formats on Healthy Adults|Effects of a Commercially-Available Structured Weight Loss Program Provided in Three Different Formats on Anthropometric Measures in Healthy Overweight and Obese Adults|Completed||N/A|181|Actual|Nutrisystem, Inc.||4|||f||||f||||||||No|There is no plan to make individual participant data available to other researchers.|2017-10-10 21:27:59.564171|2017-10-10 21:27:59.564171
NCT03017430|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-10|||January 2014||2014-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Pregabalin for Opiate Withdrawal Syndrome|Randomized Clinical Trial of Pregabalin for Opioid Withdrawal Syndrome|Recruiting||Phase 4|80|Anticipated|St. Petersburg Bekhterev Research Psychoneurological Institute||2|||f||||||||||||||2017-10-10 21:27:59.666608|2017-10-10 21:27:59.666608
NCT03017417|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|COMRADE||A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer|A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer - COMRADE Trial|Not yet recruiting||N/A|50|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||No|no plan to share data|2017-10-10 21:27:59.765411|2017-10-10 21:27:59.765411
NCT03017404|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||May 2015||2015-05-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer|A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection in Neoadjuvant Chemotherapy for Patients With Locally Advanced Breast Cancer|Completed||N/A|18|Actual|Hebei Medical University Fourth Hospital||4|||f||||f||||||||||2017-10-10 21:27:59.850087|2017-10-10 21:27:59.850087
NCT03017391|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-01-09|||January 2017||2017-01-01|December 2016|2016-12-01||||April 2018|Anticipated|2018-04-01||Interventional|||Treatment Algorithm for Nausea and Vomiting in the Palliative Phase|Feasibility Study to Compare 2 Strategies of Treatment Algorithm for Treating Nausea and or Vomiting in the Palliative Phase of Cancer Care|Not yet recruiting||Phase 4|20|Anticipated|Radboud University||2|||f||||f||||||||No||2017-10-10 21:27:59.936066|2017-10-10 21:27:59.936066
NCT03017378|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-10|||October 2013||2013-10-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|April 2014|Actual|2014-04-01||Interventional|||Reactogenicity, Safety and Immunogenicity of a TB/FLU-01L Tuberculosis Vaccine|A Randomized, Open Clinical Trial Phase 1 Vaccine TB/FLU-01L by Intranasal and Sublingual Application for Specific Immunotherapy Pulmonary Tuberculosis|Completed||Phase 1|36|Actual|Research Institute for Biological Safety Problems||2|||f||||t||||||||Undecided||2017-10-10 21:28:00.064673|2017-10-10 21:28:00.064673
NCT03017365|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|KFPS_2||Effects Resistance Training on Motor Control and Cognition|Effects of Different Resistance Training Methods on Strength, Motor Control and Executive Functions in Older Adults|Enrolling by invitation||N/A|80|Anticipated|University of Kassel||3|||f||||f||||||||Yes|Raw results will be published. Age will be described as intervalls (65-69, 70-74, 75-80) and height will be removed, thus no backtracking is possible|2017-10-10 21:28:00.150489|2017-10-10 21:28:00.150489
NCT03017352|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MAG1C||Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases|Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases: A Randomised, Placebo-controlled Trial|Recruiting||Phase 2|100|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-10 21:28:00.239363|2017-10-10 21:28:00.239363
NCT03017339|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-10|||February 2016||2016-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of a Functional Exercise Program Associated With Low Level Laser Therapy on Fibromyalgia|Effect of a Functional Exercise Program Associated With Low Level Laser Therapy on Pain, Functional Capacity and Quality of Life in Individuals With Fibromyalgia: A Double-blind Randomized Clinical Trial|Completed||N/A|22|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||t||||||||||2017-10-10 21:28:00.340158|2017-10-10 21:28:00.340158
NCT03017326|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-05|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|PHITT||Paediatric Hepatic International Tumour Trial|Paediatric Hepatic International Tumour Trial|Not yet recruiting||Phase 3|300|Anticipated|University of Birmingham||6|||f||||t|f|f||||||No||2017-10-10 21:28:00.429157|2017-10-10 21:28:00.429157
NCT03017313|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-09-29|||July 13, 2017|Actual|2017-07-13|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|ANAREN||To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients|A Prospective Post Marketing Non Interventional Study to Evaluate the Criteria on Which Renewal of LHRH Analogue Treatment is Made in Patients With Prostate Cancer Locally Advanced or Metastatic.|Recruiting||N/A|510|Anticipated|Ipsen|||1||f||||f||||||||||2017-10-10 21:28:00.541879|2017-10-10 21:28:00.541879
NCT03017300|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Transdiaphragmatic Pressure and Neural Respiratory Drive Measured During Inspiratory Muscle Training in COPD|Transdiaphragmatic Pressure and Neural Respiratory Drive Measured During Inspiratory Muscle Training in COPD|Completed||N/A|12|Actual|Guangzhou Institute of Respiratory Disease||2|||f||||t||||||||Undecided||2017-10-10 21:28:00.65117|2017-10-10 21:28:00.65117
NCT03017287|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI|Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI|Not yet recruiting||N/A|40|Anticipated|GlucoMe||1|||f||||f||||||||No||2017-10-10 21:28:00.727811|2017-10-10 21:28:00.727811
NCT03017274|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-09|||January 2015||2015-01-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|January 2016|Actual|2016-01-01||Observational|||Abdominal Ultrasound Examination in Non-celiac Wheat Sensitivity|Abdominal Ultrasound Examination in Patients Affected With Non-celiac Wheat Sensitivity|Completed||N/A|100|Actual|University of Palermo|||2||f||||f||||||||No||2017-10-10 21:28:00.811284|2017-10-10 21:28:00.811284
NCT03017261|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-06|||January 2017||2017-01-01|August 2017|2017-08-01||||January 2018|Anticipated|2018-01-01||Interventional|||TSolution One® Total Knee Arthroplasty|TSolution One® Total Knee Arthroplasty Clinical Trial|Recruiting||N/A|115|Anticipated|Think Surgical Inc.||1|||f||||f||||||||||2017-10-10 21:28:00.927643|2017-10-10 21:28:00.927643
NCT03017248|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-29|||January 2016||2016-01-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|June 2016|Actual|2016-06-01||Interventional|||Low-dose Ketamine for Acute Pain in the Emergency Department|Benefit of the Association of Low Doses of Ketamine With Intravenous Morphine in the Treatment of Acute Severe Pain in Emergency Department|Active, not recruiting||Phase 1|125|Actual|Faculty of Medicine, Sousse||3|||f||||t||||||||Undecided||2017-10-10 21:28:01.021526|2017-10-10 21:28:01.021526
NCT03017235|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-06-19|||February 20, 2017|Actual|2017-02-20|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy|A Randomized, Assessor-Blinded, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution Versus Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Powder for Oral Solution (PREPOPIK®) for Colon Cleansing in Preparation for Colonoscopy|Recruiting||Phase 3|900|Anticipated|Ferring Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 21:28:01.11425|2017-10-10 21:28:01.11425
NCT03017222|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-01-10|||July 2015||2015-07-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Therapeutic Efficacy of Ramosetron for Treatment of Established PONV After Laparoscopic Surgery||Completed||N/A|210|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 21:28:01.223735|2017-10-10 21:28:01.223735
NCT03017209|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Locally Prepared Supplement to Support Growth and Brain Health|Study on a Locally Prepared Food Supplement to Support Growth and Brain Health|Recruiting||N/A|1050|Anticipated|Tufts University Jean Mayer USDA Human Nutrition Research Center on Aging||3|||f||||f||||||||No||2017-10-10 21:28:01.291239|2017-10-10 21:28:01.291239
NCT03017183|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-10|||December 2016||2016-12-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy|Detection of Heterogeneity in Central Lung Cancer - Prospective Randomized Controlled Trial to Evaluate the Diagnostic Value of EBUS-TBNA and ctDNA Analysis Compared to Endobronchial Forceps Biopsy|Recruiting||N/A|30|Anticipated|Wissenschaftliches Institut Bethanien e.V||2|||f||||f||||||||||2017-10-10 21:28:01.532128|2017-10-10 21:28:01.532128
NCT03017170|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-09|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB|A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy of Dried Cranberry at 500 mg Daily in Women With Dry Overactive Bladder for 6 Months|Recruiting||Phase 1|76|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||No||2017-10-10 21:28:01.608304|2017-10-10 21:28:01.608304
NCT03017157|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Subclinical Hypothyroidism and Acute Anterior Myocardial Infarction: Is it Cardio-protective or Not?||Not yet recruiting||N/A|50|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||No||2017-10-10 21:28:03.414601|2017-10-10 21:28:03.414601
NCT03017144|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-01-09|||June 2012||2012-06-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|November 2014|Actual|2014-11-01||Observational|||The Evaluation of Technical and Non-technical Skills in Real-life Resuscitation Situations at University Hospital|The Evaluation of Technical and Non-technical Skills in Real-life Resuscitation Situations at University Hospital|Active, not recruiting||N/A|120|Anticipated|Turku University Hospital|||1||f||||f||||||||No|Patients treated by cardiopulmonary resuscitation (CPR) in the videos can be recognized. Video material can not be shared due to patient privacy. Other data is possible to share.|2017-10-10 21:28:03.486393|2017-10-10 21:28:03.486393
NCT03017131|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-10-05|||October 30, 2017|Anticipated|2017-10-30|October 2017|2017-10-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Phase I Open Label Clinical Trial Evaluating the Safety and Efficacy of Adoptive Transfer of NY-ESO-1 TCR Engineered Autologous T Cells in Combination With Decitabine in Patients With Recurrent or Treatment Refractory Ovarian Cancer|Not yet recruiting||Phase 1|12|Anticipated|Roswell Park Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:28:03.556004|2017-10-10 21:28:03.556004
NCT03017118|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Turmeric for Patients With Basal Joint Arthritis|A Randomized Controlled Trial Using Turmeric for Patients With Basal Joint Arthritis|Not yet recruiting||N/A|20|Anticipated|Massachusetts General Hospital||2|||f||||||||||||||2017-10-10 21:28:03.685537|2017-10-10 21:28:03.685537
NCT03017105|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Cross-education for Proximal Humerus Fracture Rehabilitation|A Study Comparing the Use of Cross-education of Strength-training for the Non-injured Limb With Traditional Rehabilitation After Conservatively Managed Proximal Humerus Fractures in Adult Patients|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Royal Liverpool and Broadgreen University Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 21:28:03.747786|2017-10-10 21:28:03.747786
NCT03017092|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-05-01|||January 18, 2017|Actual|2017-01-18|May 2017|2017-05-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|||Tobacco Pilot Study for Low Income Smokers|Tobacco Pilot Study for Low Income Smokers|Completed||N/A|20|Actual|University of Wisconsin, Madison||1|||f||||f|f|f||||||||2017-10-10 21:28:03.814717|2017-10-10 21:28:03.814717
NCT03017079|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-12|||December 2016||2016-12-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A More Physiological Feeding Process in ICU:the Intermittent Infusion With Semi-solidification of Nutrients|A More Physiological Feeding Process in ICU:the Intermittent Infusion With Semi-solidification of Nutrients|Recruiting||N/A|30|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||t||||||||Undecided||2017-10-10 21:28:03.885872|2017-10-10 21:28:03.885872
NCT03017066|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-20|||January 20, 2017|Actual|2017-01-20|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Ultrasound Assessment of Preoperative Gastric Volume in Children|Ultrasound Assessment of Gastric Volume Following Preoperative Fasting Guideline in Pediatric Patients|Recruiting||N/A|117|Anticipated|Seoul National University Hospital||3|||f||||t|f|f||||||||2017-10-10 21:28:03.981798|2017-10-10 21:28:03.981798
NCT03017053|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||July 2016||2016-07-01|January 2017|2017-01-01|July 2025|Anticipated|2025-07-01|July 2025|Anticipated|2025-07-01||Interventional|||The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor|The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor|Recruiting||Phase 4|270|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||2|||f||||f||||||||No||2017-10-10 21:28:04.084025|2017-10-10 21:28:04.084025
NCT03017040|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-02-08|||September 2015||2015-09-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||In Vivo Kinematics of Scapolunate Interosseous Ligament Injuries|In Vivo Kinematics of Scapolunate Interosseous Ligament Injuries|Enrolling by invitation||N/A|10|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 21:28:04.259928|2017-10-10 21:28:04.259928
NCT03017027|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||March 2015||2015-03-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of Animal Assisted Activity on Biobehavioral Stress Responses of Hospitalized Children: A Randomized Control Trial|Effects of Animal Assisted Activity on Biobehavioral Stress Responses of Hospitalized Children: A Randomized Control Trial|Completed||N/A|53|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 21:28:04.337384|2017-10-10 21:28:04.337384
NCT03017014|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-08-02|||September 30, 2017|Anticipated|2017-09-30|August 2017|2017-08-01|March 20, 2028|Anticipated|2028-03-20|March 20, 2028|Anticipated|2028-03-20||Observational|LEA||A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions|Assessing Long-term Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions-LEA|Not yet recruiting||N/A|500|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:28:04.432033|2017-10-10 21:28:04.432033
NCT03017001|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-09|||March 2014||2014-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Preoperative Carbohydrate Load and Intraoperative w3-PUFA in CAGB Surgery|Preoperative Carbohydrate Load and Intraoperative Omega-3 Polyunsaturated Fatty Acids Positively Impacts in Nosocomial Morbidity After CAGB Surgery. A Double-blind Randomized Trial.|Completed||Phase 2/Phase 3|60|Actual|Federal University of Mato Grosso do Sul||4|||f||||f||||||||No||2017-10-10 21:28:04.605465|2017-10-10 21:28:04.605465
NCT03016988|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-01-09|||January 2017||2017-01-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell Lymphoma|Bortezomib Combined With Fludarabine and Cytarabine for Mantle Cell Lymphoma Patients：a Single Arm, Open-labelled, Phase 2 Study|Not yet recruiting||Phase 2|50|Anticipated|Fujian Medical University||1|||f||||t||||||||Yes||2017-10-10 21:28:04.71343|2017-10-10 21:28:04.71343
NCT03016975|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-09-21|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|December 2023|Anticipated|2023-12-01|September 2019|Anticipated|2019-09-01||Interventional|ACTIVE||Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)|Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE) Trial: Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure|Recruiting||N/A|375|Anticipated|Edwards Lifesciences||2|||f||||t|f|t|t|f||||||2017-10-10 21:28:04.804863|2017-10-10 21:28:04.804863
NCT03016962|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||February 2017||2017-02-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Usefulness of Cap-assisted Colonoscopy in Patients With Prior Abdominal Surgery|Usefulness of Cap-assisted Colonoscopy in Patients With Prior Abdominal Surgery: A Randomized, Controlled Trial|Not yet recruiting||N/A|1046|Anticipated|The Catholic University of Korea||2|||f||||t||||||||No||2017-10-10 21:28:04.94294|2017-10-10 21:28:04.94294
NCT03016949|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-06-26|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine|A Phase 3, Open-label, Randomized Trial to Evaluate Humoral Immunogenicity of Various Schedules of Intramuscular Full Dose and Intradermal Fractional Dose of Inactivated Polio Vaccine in Infants|Withdrawn||Phase 3|0|Actual|Fidec Corporation||6||Regulatory timelines for approval expired|f||||f|f|f||||||Undecided||2017-10-10 21:28:05.045634|2017-10-10 21:28:05.045634
NCT03016936|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-09-05|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|MET-REPAIR||MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR)|MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR) Observational Multicentre Study|Recruiting||N/A|15000|Anticipated|European Society of Anaesthesiology|||1||f||||f||||||Samples With DNA|"     For the NTproBNP sub-study, 5 ml of blood is sampled. No storage after measurement.   "|||2017-10-10 21:28:05.155366|2017-10-10 21:28:05.155366
NCT03016923|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-30|||March 2016||2016-03-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Functional Electrical Stimulation (FES) for Upper Extremity Hemiplegia in Children With Cerebral Palsy|An Evaluation of the Effectiveness of Functional Electrical Stimulation Paired With Intensive Therapy to Improve Hand Function in Children With Hemiplegic Cerebral Palsy|Active, not recruiting||N/A|3|Actual|Holland Bloorview Kids Rehabilitation Hospital||1|||f||||f||||||||No||2017-10-10 21:28:05.2617|2017-10-10 21:28:05.2617
NCT03016910|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-08|||March 2016||2016-03-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Observational|CARPEDIEM||Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus.|Coronary Artery Plaque Burden in Type 2 Diabetes Mellitus. Changes Over Time, Relation to Risk Profile, and Comparison to Acute Myocardial Infarction.|Recruiting||N/A|350|Anticipated|Svendborg Hospital|||2||f||||f||||||Samples With DNA|"     Blood samples will be stored at -80 degrees celcius for a biobank. These includes:      5 x 2 ml (serum).      4 x 2 ml (ethylenediaminetetraacetic acid EDTA).      2 x 2 ml (sodium citrate)      1 x 2 ml (buffy coat)   "|No||2017-10-10 21:28:05.375601|2017-10-10 21:28:05.375601
NCT03016897|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-05-10|||February 22, 2017|Actual|2017-02-22|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|ALS AT HOME||ALS Testing Through Home-based Outcome Measures|ALS Testing Through Home-based Outcome Measures (ALS AT HOME)|Recruiting||N/A|250|Anticipated|Barrow Neurological Institute|||3||f||||f||||||||Yes|IPD may be shared with researchers conducting the Answer ALS study. It will be available through the GUID.|2017-10-10 21:28:05.471546|2017-10-10 21:28:05.471546
NCT03016884|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-02-05|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients|Safety and Tolerability of Herpes Zoster Vaccine in Patients With Rheumatoid Arthritis Immunized Prior to Biologics and Tofacitinib Therapy Initiation|Recruiting||Phase 4|250|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||No||2017-10-10 21:28:05.575039|2017-10-10 21:28:05.575039
NCT03016871|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-08-15|||May 8, 2017|Actual|2017-05-08|August 2017|2017-08-01|April 24, 2019|Anticipated|2019-04-24|April 24, 2019|Anticipated|2019-04-24||Interventional|||Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed Hodgkin Lymphoma|A Phase II Trial of Response-Adapted Second-Line Therapy for Hodgkin Lymphoma Using Anti-PD-1 Antibody Nivolumab ± ICE Chemotherapy as a Bridge to Autologous Hematopoietic Cell Transplant (NICE Trial)|Recruiting||Phase 2|43|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:28:05.697311|2017-10-10 21:28:05.697311
NCT03016858|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-07-29|||December 2016||2016-12-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial of Thoracoscopic Bullectomy Surgery Under Spontaneous Ventilating Anesthesia|Multicenter Randomized Controlled Clinical Trial of Thoracoscopic Bullectomy Surgery Under Nonintubated Intravenous Anesthesia With Spontaneous Ventilation|Recruiting||Phase 3|160|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||t||||||||||2017-10-10 21:28:05.847464|2017-10-10 21:28:05.847464
NCT03016845|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-09-26|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|CAPOEIRA||Pharmacokinetics of Ciprofloxacin in Critically Ill Patients|Pharmacokinetics of Ciprofloxacin in Critically Ill Patients - a Screening Study to Assess the Feasibility of Renal Function Markers to Predict Ciprofloxacin Clearance (CAPOEIRA)|Recruiting||N/A|40|Anticipated|Radboud University|||1||f||||f|f|f||||Samples Without DNA|"     plasma samples for determination of ciprofloxacin and cystatin C Urine for measuring 24h     creatinine cleaurance   "|||2017-10-10 21:28:05.93603|2017-10-10 21:28:05.93603
NCT03016832|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-03|||January 2017||2017-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease|A Randomized, Double-blind, Parallel-controlled, Multi-center Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease|Recruiting||Early Phase 1|414|Anticipated|Jiangsu Famous Medical Technology Co., Ltd.||3|||f||||f||||||||||2017-10-10 21:28:06.139535|2017-10-10 21:28:06.139535
NCT03016819|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-27|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|April 2021|Anticipated|2021-04-01||Interventional|APROMISS||A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma|A Phase III Study of AL3818 (Anlotinib) Hydrochloride Monotherapy in Subjects With Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma|Recruiting||Phase 3|219|Anticipated|Advenchen Laboratories, LLC||5|||f||||t|t|f||||||||2017-10-10 21:28:06.241503|2017-10-10 21:28:06.241503
NCT03016806|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-07|||June 2015||2015-06-01|January 2017|2017-01-01|June 2026|Anticipated|2026-06-01|June 2025|Anticipated|2025-06-01||Interventional|Cord Tx||Combined Cord Blood Transplant|Umbilical Cord Blood Transplantation From Unrelated Donors|Recruiting||Phase 1|30|Anticipated|University of Rochester||4|||f||||t||||||||||2017-10-10 21:28:06.366171|2017-10-10 21:28:06.366171
NCT03016793|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Alveolar Cleft Grafting Using Two Different Alloplastic Grafts|Evaluation of Esthetic Satisfaction and Bone Augmentation Quality Using Purabone Added to β-tricalcium Phosphate Versus β-tricalcium Phosphate Alone in Secondry Alveolar Cleft Grafting . Randomized Controlled Clinical Trial|Not yet recruiting||Phase 2|20|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:28:06.496674|2017-10-10 21:28:06.496674
NCT03016780|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-07|||July 2016||2016-07-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|FMTFUC||Fecal Microbiota Transplantation for Ulcerative Colitis|Evaluation of The Effect of Fecal Microbiota Transplantation on Ulcerative Colitis and Its Mechanism|Recruiting||Phase 1/Phase 2|60|Anticipated|First Affiliated Hospital of Chengdu Medical College||2|||f||||t||||||||No||2017-10-10 21:28:06.591658|2017-10-10 21:28:06.591658
NCT03016767|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-09-19|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|July 2017|Actual|2017-07-01||Interventional|||Efficacy of an Oral Stimulation Protocol in Preterm Infants to Shorten the Period Between Enteral and Oral Nutrition|Efficacy of a Manual Oral Stimulation Protocol in Preterm Infants to Shorten the Period Between Enteral and Oral Nutrition|Completed||N/A|44|Actual|Fundacion Para La Investigacion Hospital La Fe||2|||f||||||||||||||2017-10-10 21:28:06.688186|2017-10-10 21:28:06.688186
NCT03016754|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-14|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|HF-Opt||Heart Failure Optimization Study|Heart Failure Optimization Study|Recruiting||N/A|750|Anticipated|Zoll Medical Corporation|||1||f||||f||||||||||2017-10-10 21:28:06.767401|2017-10-10 21:28:06.767401
NCT03016741|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-22|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer|Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer|Recruiting||Phase 4|100|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t|t|f||||||Undecided||2017-10-10 21:28:06.920841|2017-10-10 21:28:06.920841
NCT03016715|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||May 2016||2016-05-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study|A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)|Recruiting||Phase 2|8|Anticipated|Premier Specialists, Australia||2|||f||||f||||||||||2017-10-10 21:28:07.164695|2017-10-10 21:28:07.164695
NCT03016702|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-08-11|||February 27, 2017|Actual|2017-02-27|December 2016|2016-12-01|August 9, 2017|Actual|2017-08-09|August 9, 2017|Actual|2017-08-09||Interventional|CogRes||The Cognitive Resilience Study|The Cognitive Resilience Study: Stress Tests for Alzheimer's Disease|Completed||N/A|29|Actual|Duke University||2|||f||||t|f|f||||||||2017-10-10 21:28:07.289806|2017-10-10 21:28:07.289806
NCT03016689|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-06-21|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|||The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development|The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development|Recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     Oral and oropharyngeal swabs will be collected   "|No||2017-10-10 21:28:07.388684|2017-10-10 21:28:07.388684
NCT03016663|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||September 2015||2015-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|Lipofilling||Volumetric Study of Fat Resorption After Breast Lipofilling|LIPOFILLING IN BREAST SURGERY: VOLUMETRIC EVALUATION OF FAT RESORPTION AFTER WASHING WITH RINGER'S LACTATE|Completed||N/A|10|Actual|University of Malaya|||1||f||||t||||||||No||2017-10-10 21:28:07.552195|2017-10-10 21:28:07.552195
NCT03016650|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Opioid-sparing Effect of Intravenous Ibuprofen||Not yet recruiting||Phase 4|80|Anticipated|Inonu University||2|||f||||f||||||||No||2017-10-10 21:28:07.647455|2017-10-10 21:28:07.647455
NCT03016637|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-10|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PANCOBE||Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy|Pancreatic Core Biopsy Needle Study (PANCOBE)|Completed||Phase 1/Phase 2|40|Actual|Odense University Hospital||1|||f||||f||||||||No||2017-10-10 21:28:07.747831|2017-10-10 21:28:07.747831
NCT03016624|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-05-24|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|HONEST||Coronary Artery Healing and Bioresorbable Scaffold|Coronary Artery Healing Process After BiOresorbable Scaffold iN PatiEnts With Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)|Recruiting||N/A|90|Anticipated|Odense University Hospital||2|||f||||t|f|f||||||||2017-10-10 21:28:07.856045|2017-10-10 21:28:07.856045
NCT03016611|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||February 2017||2017-02-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study||Not yet recruiting||Phase 4|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 21:28:07.938554|2017-10-10 21:28:07.938554
NCT03016598|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-29|||November 27, 2017|Anticipated|2017-11-27|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|SOS||Stimulate Oxytocin Study|6-week Trial of Oxytocin for Co-occurring Cocaine and Opioid Use Disorders|Not yet recruiting||Phase 2|50|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-10 21:28:08.009161|2017-10-10 21:28:08.009161
NCT03016585|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-08|||January 2016||2016-01-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness of Tai Chi on Cardiac Autonomic Function and Symptomatology in Women With Fibromyalgia: a Randomized Controlled Trial|Effectiveness of Tai Chi on Cardiac Autonomic Function and Symptomatology in Women With Fibromyalgia: a Randomized Controlled Trial|Completed||N/A|37|Actual|Pusan National University||2|||f||||||||||||||2017-10-10 21:28:08.111544|2017-10-10 21:28:08.111544
NCT03016572|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-05-17|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PASS||Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for Suicide|PASS (Promote Access to Stop Suicide): A Randomized Controlled Trial Comparing Enhanced Treatment as Usual, Crisis Center Follow up and Wraparound Services for Youth at Risk for Suicide|Recruiting||N/A|135|Anticipated|The Cleveland Clinic||3|||f||||t|f|f||||||No||2017-10-10 21:28:08.175932|2017-10-10 21:28:08.175932
NCT03016559|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-08|||August 2015||2015-08-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Releasing Quadratus Lumborum Muscle on Hip Joint ROM in Asymptomatic Individuals|Effect of Releasing Quadratus Lumborum Muscle on Angles of Hip Joint in Asymptomatic Individuals|Completed||N/A|30|Actual|Mahidol University||1|||f||||t||||||||No||2017-10-10 21:28:08.272574|2017-10-10 21:28:08.272574
NCT03016546|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Integrating HIV and Depression Self-Care to Improve Adherence in Perinatal Women|Integrating HIV and Depression Self-Care to Improve Adherence in Perinatal Women|Recruiting||N/A|40|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 21:28:08.329924|2017-10-10 21:28:08.329924
NCT03016533|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-08-08|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|December 29, 2023|Anticipated|2023-12-29|December 29, 2023|Anticipated|2023-12-29||Interventional|||PH3b, DTG Study in HIV-1 Subjects Completing IMPAACT Study P1093|Open-label Access to Dolutegravir for HIV-1 Infected Children and Adolescents Completing IMPAACT Study P1093|Recruiting||Phase 3|80|Anticipated|ViiV Healthcare||1|||f||||f|t|f||||||||2017-10-10 21:28:08.411762|2017-10-10 21:28:08.411762
NCT03016520|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-02-06|||January 9, 2017|Actual|2017-01-09|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|January 26, 2017|Actual|2017-01-26||Interventional|||Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers|An Open-label, Randomized, Single-dose, 2-way Crossover Study to Compare the Pharmacokinetics and Safety of DWJ1392 and DWC20164 in Healthy Male Volunteers|Recruiting||Phase 1|28|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-10 21:28:08.488342|2017-10-10 21:28:08.488342
NCT03016507|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||July 2015||2015-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|IPOFACO||Intraocular Pressure Variation by Pneumatic Tonometer Before and After Phacoemulsification|Intraocular Pressure Variation by Pneumatic Tonometer Before and After Phacoemulsification|Completed||N/A|100|Actual|VER Excelência em Oftalmologia|||1||f||||t||||||||No||2017-10-10 21:28:08.558926|2017-10-10 21:28:08.558926
NCT03016494|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||February 2016||2016-02-01|January 2017|2017-01-01||||March 2017|Anticipated|2017-03-01||Interventional|||Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects|A Randomized, Open-label, Oral Dose, Crossover Study to Evaluate the Pharmacokinetics and Safety of Fixed-dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects|Recruiting||Phase 1|56|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||No||2017-10-10 21:28:08.745222|2017-10-10 21:28:08.745222
NCT03016481|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|ROSE-SAFE||Healing Through Education, Advocacy and Law (HEAL) in Response to Violence|Healing Through Education, Advocacy and Law (HEAL) in Response to Violence|Not yet recruiting||N/A|300|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 21:28:08.852874|2017-10-10 21:28:08.852874
NCT03016468|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-04-07|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH|A Multicenter, 16-Week, Open-label Study Evaluating the Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Subjects With Pulmonary Arterial Hypertension|Withdrawn||Phase 2|0|Actual|United Therapeutics||1||Business decision|f||||f|t|f||||||||2017-10-10 21:28:08.969604|2017-10-10 21:28:08.969604
NCT03016455|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-05-02|||June 2013||2013-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BHL||B Cell Lymphocyte in Humoral Rejection and Alloimmunisation||Recruiting||N/A|125|Anticipated|University Hospital, Brest|||3||f||||||||||Samples With DNA|"     Whole Blood   "|||2017-10-10 21:28:09.091704|2017-10-10 21:28:09.091704
NCT03016442|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-09|||November 2016||2016-11-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Dinoprostone Vaginal Insert Versus Double Balloon Catheter for Preinduction Cervical Ripening||Recruiting||Phase 2|200|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||f||||||||No||2017-10-10 21:28:09.273556|2017-10-10 21:28:09.273556
NCT03016429|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-02-10|||December 2016||2016-12-01|February 2017|2017-02-01||||May 2019|Anticipated|2019-05-01||Observational|BIDMC-MRI||Safety and Clinical Outcomes of Magnetic Resonance Imaging in Patients With Cardiac Implantable Electrical Devices|Safety and Clinical Outcomes of Magnetic Resonance Imaging in Patients With Cardiac Implantable Electrical Devices|Active, not recruiting||N/A|500|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||||No||2017-10-10 21:28:09.413798|2017-10-10 21:28:09.413798
NCT03016416|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-01-08|||February 2017||2017-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Influence of Rhythm, Cognitive Task and Physical Activity on the Cardiac ANS in Chronic Stroke Patients|The Influence of Rhythm, Cognitive Task and Physical Activity on the Cardiac Autonomic Nerve System in Chronic Stroke Patients and in a Control Group|Not yet recruiting||N/A|32|Anticipated|Clalit Health Services|||2||f||||f||||||||No||2017-10-10 21:28:09.510203|2017-10-10 21:28:09.510203
NCT03016403|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-04-03|||March 24, 2017|Actual|2017-03-24|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||A Stepped Care Intervention to Reduce Disparities in Mental Health Services Among Cancer Patients and Caregivers|A Stepped-Care Intervention to Reduce Disparities in Mental Health Services Among Underserved Lung and Head and Neck Cancer Patients and Their Caregivers|Recruiting||N/A|440|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||Undecided||2017-10-10 21:28:09.571202|2017-10-10 21:28:09.571202
NCT03016377|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2036|Anticipated|2036-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia|Administration of Autologous CAR-T Cells Targeting the CD19 Antigen and Containing the Inducible caspase9 Safety Switch in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia|Not yet recruiting||Phase 1|40|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:28:09.741587|2017-10-10 21:28:09.741587
NCT03016364|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01||||August 2017|Anticipated|2017-08-01||Interventional|||Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain||Recruiting||Phase 1/Phase 2|200|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||1|||f||||||||||||||2017-10-10 21:28:09.866272|2017-10-10 21:28:09.866272
NCT03016351|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||October 2016||2016-10-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|BPVR||Improving Blood Pressure and Cardiovascular Risk With Resistance Exercise in African Americans|Improving Blood Pressure and Cardiovascular Risk With Resistance Exercise in African Americans|Recruiting||N/A|140|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||No||2017-10-10 21:28:09.953224|2017-10-10 21:28:09.953224
NCT03016338|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||March 2017||2017-03-01|January 2017|2017-01-01|September 2022|Anticipated|2022-09-01|March 2022|Anticipated|2022-03-01||Interventional|||Study of Niraparib in Recurrent Endometrial Cancer|A Phase II, Open Label Study of the Poly(ADP-ribose) Polymerase Inhibitor Niraparib (MK 4827) in Recurrent Endometrial Cancer|Not yet recruiting||Phase 2|44|Anticipated|University Health Network, Toronto||1|||f||||t||||||||No||2017-10-10 21:28:10.088806|2017-10-10 21:28:10.088806
NCT03016325|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-09-26|||January 6, 2017|Actual|2017-01-06|September 2017|2017-09-01|April 5, 2019|Anticipated|2019-04-05|November 5, 2018|Anticipated|2018-11-05||Interventional|STANDUP AHF||Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients With Heart Failure and Impaired Systolic Function|Recruiting||Phase 2|310|Anticipated|Bristol-Myers Squibb||5|||f||||t|t|f||||||||2017-10-10 21:28:10.232985|2017-10-10 21:28:10.232985
NCT03016312|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-09-14|||January 11, 2017|Actual|2017-01-11|September 2017|2017-09-01|July 9, 2022|Anticipated|2022-07-09|November 11, 2020|Anticipated|2020-11-11||Interventional|IMbassador250||A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen|A Phase III, Multicenter, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide Versus Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer After Failure of an Androgen Synthesis Inhibitor and Failure of, Ineligibility for, or Refusal of a Taxane Regimen|Recruiting||Phase 3|730|Anticipated|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 21:28:10.817208|2017-10-10 21:28:10.817208
NCT03016299|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-08|||December 2016||2016-12-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|||The Histological Effect of Various Microfracture Techniques on Human Chondral & Sub-chondral Tissue - an Ex-Vivo Study|The Histological Effect of Various Microfracture Techniques on Human Chondral & Sub-chondral Tissue - an Ex-Vivo Study|Not yet recruiting||N/A|40|Anticipated|Meir Medical Center|||2||f||||t||||||||No||2017-10-10 21:28:11.402638|2017-10-10 21:28:11.402638
NCT03016286|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-07-11|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|April 17, 2018|Anticipated|2018-04-17|April 17, 2018|Anticipated|2018-04-17||Interventional|||Bone Myoregulation Reflex & Presynaptic Ia Inhibition|Effects of Cooling of Ankle on Bone Myoregulation Reflex Response and Presynaptic Ia Inhibition Level|Not yet recruiting||N/A|10|Anticipated|Bagcilar Training and Research Hospital||1|||f||||f|f|f||||||||2017-10-10 21:28:11.478416|2017-10-10 21:28:11.478416
NCT03016273|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-09|2017-07-03|||February 20, 2017|Actual|2017-02-20|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Bladder Flap Technique In Elective Cesarean Section|Bladder Flap Versus Non Bladder Flap Technique In Women Undergoing Elective Cesarean Section A Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 21:28:11.55786|2017-10-10 21:28:11.55786
NCT03016260|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-21|||December 2016||2016-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|RABIOPRED||RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα (Anti Tumor Necrosis Factor Alpha) BIologicals in Rheumatoid Arthritis|Proof-of-Performance Study of RABIOPRED Assay as an In Vitro Diagnostic Test to Identify Patients With Rheumatoid Arthritis Who Are Unlikely to Show Response to 1st Treatment With Anti-TNFα and Methotrexate Combination.|Recruiting||N/A|720|Anticipated|TcLand Expression S.A.|||8||f||||t||||||Samples With DNA|"     DNA, RNA, Plasma, Serum, PBMC and Urine   "|||2017-10-10 21:28:11.632026|2017-10-10 21:28:11.632026
NCT03016247|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|TRUST||TRUST Study of Adolescent Weight Self-Managment|Pilot Study Evaluating the Effects of a Trust-Building Intervention on Adolescent Weight Self-Management Behaviors|Not yet recruiting||N/A|30|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||Yes|De-identified data will be shared for further analysis after main results are published.|2017-10-10 21:28:11.800627|2017-10-10 21:28:11.800627
NCT03016234|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-04-24|||September 29, 2016|Actual|2016-09-29|April 2017|2017-04-01|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Interventional|||IOP Changes With Different Anesthetic Agents During Laparoscopic Colorectal Surgery|Intraocular Pressure Changes During Laparoscopic Colorectal Surgery: Propofol Versus Desflurane Anesthesia|Completed||N/A|50|Actual|Saint Vincent's Hospital, Korea||2|||f||||f||||||||No||2017-10-10 21:28:11.907226|2017-10-10 21:28:11.907226
NCT03016221|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SRPT||Local Changes of Skin Characteristics After an Application of a Topical Product With a Warming or Cooling Effect|Local Changes of Skin Characteristics During and After an Application of a Topical Product With a Warming or Cooling Effect - a Randomized, Controlled Clinical Trial|Recruiting||N/A|40|Anticipated|University of Applied Sciences and Arts of Southern Switzerland||16|||f||||t|f|f||||||||2017-10-10 21:28:12.021821|2017-10-10 21:28:12.021821
NCT03016208|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-09|||May 2015||2015-05-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Observational|||The Misoprostol Vaginal Insert for Labour Induction|The Misoprostol Vaginal Insert Used in Standard Compared With Adjusted Criteria for Labour Induction in Term Pregnancies: a Non-interventional Case Control Study|Completed||N/A|138|Actual|Asklepios Kliniken Hamburg GmbH|||2||f||||f||||||||No||2017-10-10 21:28:12.144189|2017-10-10 21:28:12.144189
NCT03016195|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-03|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|USALTI||Evaluation of the Normal Range of Urinary Sodium Levels in Healthy Newborn Babies|Evaluation of the Normal Range of Urinary Sodium Levels in Healthy Newborn Babies|Terminated||N/A|200|Actual|University of Glasgow|||1|Poor return rate/high dropout rate requiring alteration to study methodology|f||||||||||||No||2017-10-10 21:28:12.225512|2017-10-10 21:28:12.225512
NCT03016182|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-02-19|||February 7, 2017|Actual|2017-02-07|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Remote Ischemic Preconditioning on Pulmonary Injury in Cardic Surgery|Effect of Remote Ischemic Preconditioning on Pulmonary Injury in Cardic Surgery|Recruiting||N/A|60|Anticipated|Xuzhou Medical University||2|||f||||t|f|f||||||No|IPD will be available when this trial is finished and the article have been published.|2017-10-10 21:28:12.301857|2017-10-10 21:28:12.301857
NCT03016169|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-14|||March 9, 2017|Actual|2017-03-09|July 2017|2017-07-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Interventional|||Trifecta™ GT Post Market Clinical Follow-up|Trifecta™ GT (Glide Technology) Post Market Clinical Follow-up (PMCF)|Recruiting||N/A|350|Anticipated|St. Jude Medical||1|||f||||f|f|t|f|f|t|||||2017-10-10 21:28:12.430408|2017-10-10 21:28:12.430408
NCT03016156|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-26|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma|Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma|Recruiting||N/A|290|Anticipated|St. Jude Children's Research Hospital||3|||f||||f|f|f||||||||2017-10-10 21:28:12.587093|2017-10-10 21:28:12.587093
NCT03016143|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-08|||October 2016||2016-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)|A Randomized, Blinded, Comparative Study of Phase II Allantoic Split Inactivated Seasonal Influenza Vaccine in Healthy Adults|Completed||Phase 2|300|Actual|Research Institute for Biological Safety Problems||4|||f||||t||||||||Undecided||2017-10-10 21:28:12.71943|2017-10-10 21:28:12.71943
NCT03016130|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-08-25|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|September 1, 2025|Anticipated|2025-09-01|September 1, 2024|Anticipated|2024-09-01||Interventional|||Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101)|A Phase III, Randomized, Clinical Trial Comparing Two Diets in Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT) or Remission Induction Chemotherapy for Acute Leukemia and Myelodysplastic Syndrome (UF-BMT-LDND-101)|Recruiting||Phase 3|518|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 21:28:12.869915|2017-10-10 21:28:12.869915
NCT03016117|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-10-05|||September 2016||2016-09-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Anesthetic Efficacy of PECS II Block and Parasternal Block|Anesthetic Efficacy of PECS II Block and Parasternal Block for Quadrantectomy With or Without Axillary Dissection|Recruiting||N/A|65|Anticipated|San Salvatore Hospital of L'Aquila||1|||f||||t||||||||||2017-10-10 21:28:12.978944|2017-10-10 21:28:12.978944
NCT03016104|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-08|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Mania|Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Mania|Recruiting||N/A|30|Anticipated|Shanghai Mental Health Center||2|||f||||t||||||||No||2017-10-10 21:28:13.076764|2017-10-10 21:28:13.076764
NCT03016091|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-27|||May 2017|Anticipated|2017-05-01|December 2016|2016-12-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma|A Phase II, Open-label, Single Arm Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma|Not yet recruiting||Phase 2|25|Anticipated|Rabin Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:28:13.211637|2017-10-10 21:28:13.211637
NCT03016078|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-15|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|April 7, 2017|Actual|2017-04-07|April 1, 2017|Actual|2017-04-01||Interventional|||Evaluation of a Self-adherent Absorbent Silver Dressing Coated With a Soft Silicone Layer After Elective Primary Total Hip or Knee Arthroplasty|A Single Center, Open, Non-controlled Investigation to Evaluate the Performance of a Flexible, Self-adherent Absorbent Silver Dressing Coated With a Soft Silicone Layer After Elective Primary Total Hip or Knee Arthroplasty|Completed||Phase 4|21|Actual|Molnlycke Health Care AB||1|||f|||||f|f||||||||2017-10-10 21:28:13.314898|2017-10-10 21:28:13.314898
NCT03016065|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-23|||March 29, 2017|Actual|2017-03-29|May 2017|2017-05-01|April 29, 2018|Anticipated|2018-04-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||Efficacy of Pea Hull Fiber - Phase 2|Efficacy of Pea Hull Fiber Supplementation: Phase 2 - Overweight Children|Recruiting||N/A|25|Anticipated|University of Florida||2|||f||||f|f|f||||||Undecided||2017-10-10 21:28:13.40257|2017-10-10 21:28:13.40257
NCT03016052|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-01-09|||May 2016||2016-05-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Anxiety|Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Social and Generalized Anxiety- an ERP Study|Recruiting||N/A|80|Anticipated|Tel Aviv University||1|||f||||f||||||||No||2017-10-10 21:28:13.510726|2017-10-10 21:28:13.510726
NCT03016039|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-01-11|||January 2017||2017-01-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Curcumin Supplementation for Gynecological Diseases|Curcumin Supplementation for Gynecological Diseases Including Pelvic Inflammatory Disease Endometritis, Endometriosis: A Pilot Study|Not yet recruiting||N/A|180|Anticipated|Meir Medical Center||2|||f||||t||||||||No||2017-10-10 21:28:13.631712|2017-10-10 21:28:13.631712
NCT03016026|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-01-09|||November 2016||2016-11-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal Gastrectomy|Effect of Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal Subtotal Gastrectomy: A Single Arm Trial|Recruiting||Phase 2|98|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||No||2017-10-10 21:28:13.704636|2017-10-10 21:28:13.704636
NCT03016013|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-07-31|||September 2016||2016-09-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.|A Phase III Study of RC18,a Recombinant Human B Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein in Subjects With Poor Efficacy of MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.|Recruiting||Phase 3|480|Anticipated|RemeGen||2|||f||||t||||||||||2017-10-10 21:28:13.816413|2017-10-10 21:28:13.816413
NCT03016000|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-26|||July 26, 2017|Actual|2017-07-26|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Thalidomide Maintenance Treatment in DLBCL|A Multicentre, Randomized Phase III Study of Thalidomide Maintenance Treatment in Patients With Diffuse Large B-cell Lymphoma|Recruiting||Phase 3|226|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t|f|f||||||||2017-10-10 21:28:13.921569|2017-10-10 21:28:13.921569
NCT03015987|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-10|||February 2017||2017-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Diode Laser Activated Irrigation Versus Ultrasonic on Post-Operative Pain in Single Visit of Necrotic Teeth|The Effect of Diode Laser Activated Irrigation Versus Ultrasonic Activated Irrigation on Post-Operative Pain in Single Visit Endodontic Treatment of Asymptomatic Necrotic Teeth: A Randomized Controlled Trial|Not yet recruiting||N/A|44|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:28:14.025157|2017-10-10 21:28:14.025157
NCT03015974|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-09|||January 2016||2016-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01|24 Months|Observational [Patient Registry]|RACC||Registry of IgA Nephropathy in Chinese Children|Registry of IgA Nephropathy in Chinese Children|Recruiting||N/A|1200|Anticipated|Peking University First Hospital|||3||f||||t||||||Samples With DNA|"     The urine, serum and DNA of participants are expected to be collected and preserved.   "|Undecided||2017-10-10 21:28:14.105285|2017-10-10 21:28:14.105285
NCT03015961|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-07-17|||November 2016||2016-11-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion Surgery|A Multicenter, Randomized, Double-Blind, Controlled Study of EXPAREL for Postsurgical Pain Management in Subjects Undergoing Open Lumbar Spinal Fusion Surgery|Recruiting||Phase 4|220|Anticipated|Pacira Pharmaceuticals, Inc||2|||f||||t||||||||||2017-10-10 21:28:14.256126|2017-10-10 21:28:14.256126
NCT03015948|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-01-09|||September 2016||2016-09-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Single Dose Study of SHR4640 in Healthy Male Volunteers|A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Dose of SHR4640 in Healthy Male Volunteers|Recruiting||Phase 1|40|Anticipated|Atridia Pty Ltd.||5|||f||||f||||||||No||2017-10-10 21:28:14.39739|2017-10-10 21:28:14.39739
NCT03015935|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-13|||January 2010||2010-01-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|||Safe and Easy Access Technique for the First Trocar in Laparoscopic Obesity Surgery|Safe and Easy Access Technique for the First Trocar in Laparoscopic Obesity Surgery. A Prospective Controlled-cohort Study|Recruiting||N/A|500|Anticipated|Umraniye Education and Research Hospital|||2||f||||t||||||||No||2017-10-10 21:28:14.49445|2017-10-10 21:28:14.49445
NCT03015922|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-06-13|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|October 1, 2020|Anticipated|2020-10-01|July 1, 2019|Anticipated|2019-07-01||Interventional|MUKeleven||Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma|VIRel: Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma - A Phase I Study to Assess the Safety and Tolerability of REOLYSIN® (Pelareorep) in Combination With Lenalidomide or Pomalidomide|Recruiting||Phase 1|44|Anticipated|University of Leeds||1|||f||||t|f|f||||||No||2017-10-10 21:28:14.585038|2017-10-10 21:28:14.585038
NCT03015909|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-01-17|||August 2016||2016-08-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.|A Multi-center, Open, Single-arm, Switch-over, Prospective, Phase IV Study to Assess the Ease of Use, Preference, and Safety After 8 Weeks Subcutaneous Administration of EutropinPen Inj. in Patients Pretreated With Recombinant Human Growth Hormone by Reusable Device|Recruiting||Phase 4|116|Anticipated|LG Life Sciences||1|||f||||f||||||||Undecided||2017-10-10 21:28:14.780551|2017-10-10 21:28:14.780551
NCT03015896|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-12|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma|A Phase I/II Study of the PD-1 Antibody Nivolumab in Combination With Lenalidomide in Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD)|Suspended||Phase 1/Phase 2|102|Anticipated|Ohio State University Comprehensive Cancer Center||1||partial clinical hold per FDA|f||||t|t|f||||||||2017-10-10 21:28:14.863246|2017-10-10 21:28:14.863246
NCT03015883|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-20|||March 1, 2017|Actual|2017-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|DaRT||Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma|A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters on Squamous Cell Carcinoma (First in Man)|Recruiting||Phase 1/Phase 2|35|Anticipated|Alpha Tau Medical LTD.||1|||f||||f|f|f||||||||2017-10-10 21:28:14.967441|2017-10-10 21:28:14.967441
NCT03015870|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-01-06|||September 2014||2014-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Technology-assisted Vocal Exercise for Older Adults|Technology-assisted Vocal Exercise for Older Adults|Completed||N/A|26|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||Yes|Primary data will be made available via https://databank.illinois.edu/ within 6 months of trial completion. Secondary data will be available within 2 years of trial completion.|2017-10-10 21:28:15.07002|2017-10-10 21:28:15.07002
NCT03015857|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-05-01|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Phenylephrine and Noradrenaline for Post Spinal Anesthesia Hypotension|A Comparison Between Phenylephrine and Norepinephrine Boluses in Prevention of Post-spinal Hypotension During Cesarean Delivery|Completed||Phase 2|200|Actual|Kasr El Aini Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:28:15.157721|2017-10-10 21:28:15.157721
NCT03015844|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-09||||||January 2017|2017-01-01||||||||Expanded Access|||A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma|A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma|Temporarily not available||N/A|||Northwell Health|||||f||||||||||||||2017-10-10 21:28:15.245423|2017-10-10 21:28:15.245423
NCT03015831|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-07|||March 2017||2017-03-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Interventional|END-AFLD||Effect of Low Dose ColchiciNe on the InciDence of POAF|Effect of Low Dose ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients|Not yet recruiting||Phase 3|1200|Anticipated|Jordan Collaborating Cardiology Group||2|||f||||t||||||||Yes|Our Group's website will share data. Researchgate will share data. Eventual results will be announced to medical community through local presentations, and international congresses and publications.|2017-10-10 21:28:15.325752|2017-10-10 21:28:15.325752
NCT03015818|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-27|||January 2017||2017-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|TEP-SVD||Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD)|Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD)|Recruiting||Phase 4|30|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 21:28:15.463931|2017-10-10 21:28:15.463931
NCT03015805|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|November 2019|Anticipated|2019-11-01||Interventional|JPO-CM||Teen Success Project|Improving Access to Substance Abuse Evidence-Based Practices for Youth in the Justice System: Strategies Used by JPOs|Not yet recruiting||N/A|540|Anticipated|Oregon Social Learning Center||2|||f||||f|f|f||||||||2017-10-10 21:28:15.549042|2017-10-10 21:28:15.549042
NCT03015792|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-05-23|||March 10, 2017|Actual|2017-03-10|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant|Phase I/II Trial of Ibrutinib, Dexamethasone, and Lenalidomide as Initial Therapy for Transplant Ineligible Multiple Myeloma Patients|Recruiting||Phase 1/Phase 2|63|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:28:15.648044|2017-10-10 21:28:15.648044
NCT03015779|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-08|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency Disease|Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency Disease|Enrolling by invitation||Phase 1/Phase 2|7|Anticipated|He Eye Hospital||1|||f||||f||||||||No||2017-10-10 21:28:15.821633|2017-10-10 21:28:15.821633
NCT03015766|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-05-23|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|June 1, 2019|Anticipated|2019-06-01|October 1, 2018|Anticipated|2018-10-01||Interventional|AAHDIN||Auricular Acupressure for Hemodialysis Patients With Insomnia|Auricular Acupressure for Hemodialysis Patients With Insomnia: Study Protocol for a Multi-centre Double-blind, Randomized Controlled Trial|Recruiting||N/A|112|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||f|f|f||||||Yes|IPD including the demographic information, PSQI scores and drug use at baseline and 8,12,16,20 week from baseline of all participants will be shared. The data will be availbale at ResMan® Clinical Trial Management Public Platform, with the link http://www.medresman.org/uc/index.aspx|2017-10-10 21:28:15.901651|2017-10-10 21:28:15.901651
NCT03015753|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-10|||February 2016||2016-02-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||The Efficacy of Tai Chi Training for the Prophylaxis of Migraine in Chinese Women|A Pilot Randomized Controlled Trial to Test the Complementary Therapeutic Efficacy of Tai Chi for the Prophylaxis of Episodic Migraine in Chinese Women|Recruiting||N/A|60|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||No||2017-10-10 21:28:16.031536|2017-10-10 21:28:16.031536
NCT03015740|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-10-04|||April 23, 2017|Actual|2017-04-23|October 2017|2017-10-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|||MGCD516 Combined With Nivolumab in Renal Cell Cancer (RCC)|Phase I/II Trial of MGCD516 Combined With Nivolumab in Patients With Advanced Clear Cell Renal Cell Cancer That Progressed on Prior VEGF-Targeted Therapy|Recruiting||Phase 1/Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:28:16.160249|2017-10-10 21:28:16.160249
NCT03015727|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-01-09|||December 2016||2016-12-01|December 2016|2016-12-01|December 2024|Anticipated|2024-12-01|December 2022|Anticipated|2022-12-01||Interventional|IRCNPC||Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma|Induction Chemotherapy With Docetaxel and Cisplatin Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 3|440|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:28:16.272327|2017-10-10 21:28:16.272327
NCT03015714|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-07|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|AT-FOG||Aquatic Therapy for Freezing of Gait in Parkinson's Disease Patients|Effectiveness of Aquatic Therapy for Parkinson's Disease Patients in the Context of a Multidisciplinary, Intensive Rehabilitation Treatment|Recruiting||N/A|30|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini||2|||f||||f||||||||No||2017-10-10 21:28:16.393364|2017-10-10 21:28:16.393364
NCT03015701|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-31|||August 1992||1992-08-01|May 2017|2017-05-01|November 2012|Actual|2012-11-01|October 2001|Actual|2001-10-01||Interventional|||S9005 Mifepristone in Meningioma|Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma|Completed||Phase 3|193|Actual|Southwest Oncology Group||2|||f||||t||||||||Yes|https://swog.org/Visitors/Download/Policies/Policy43.pdf|2017-10-10 21:28:16.492006|2017-10-10 21:28:16.492006
NCT03015688|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-09|||June 2012||2012-06-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01|1 Year|Observational [Patient Registry]|||the New Biomarker of the Knee Osteoarthritis Knee Osteoarthritis Occurrence and Progression||Completed||N/A|460|Actual|Shihezi University|||2||f||||||||||||||2017-10-10 21:28:16.573327|2017-10-10 21:28:16.573327
NCT03015675|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-08|2017-05-16|||March 12, 2017|Actual|2017-03-12|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IV Ascorbic Acid in Advanced Gastric Cancer|Phase Ⅲ Study of IV Ascorbic Acid in Combination With XELOX vs Treatment With XELOX Alone as First-line Therapy for Advanced Gastric Cancer|Recruiting||Phase 3|200|Anticipated|Sun Yat-sen University||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:28:16.640773|2017-10-10 21:28:16.640773
NCT03015662|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-06-28|||January 2016||2016-01-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|February 2017|Actual|2017-02-01||Interventional|||Clinical Outcomes After Dry Needling on Cervical Muscles, and Quality of Life, in Patients With Fibromyalgia Syndrome.|Clinical Outcomes After Dry Needling on Cervical Muscles, Quality of Life, Fatigue, Quality of Sleep, Anxiety and Depression in Patients With Fibromyalgia Syndrome.|Active, not recruiting||N/A|64|Actual|Universidad de Almeria||2|||f||||f||||||||No||2017-10-10 21:28:16.731373|2017-10-10 21:28:16.731373
NCT03015649|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-30|||December 2016||2016-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Long Term Use of SAVI SCOUT: Pilot Study|Evaluation of Longer Duration Use of the SAVI SCOUT Surgical Guidance System for Excision of Breast and Axillary Lesions in Neo-adjuvant Therapy Patients: A Pilot Study|Enrolling by invitation||N/A|25|Actual|Sheridan Healthcare, Inc.||1|||f||||f||||||||No||2017-10-10 21:28:16.822811|2017-10-10 21:28:16.822811
NCT03015636|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|BSIP-ADHD||BSIP - Better Sleep in Psychiatric Care - ADHD.|Better Sleep in Psychiatric Care - ADHD. A Randomized Naturalistic Study of a Psychological Group Treatment for Sleep Problems in Psychiatric Patients With Attention Deficit Hyperactivity Disorder.|Enrolling by invitation||N/A|50|Anticipated|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 21:28:16.91807|2017-10-10 21:28:16.91807
NCT03015623|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-10-03|||June 20, 2017|Actual|2017-06-20|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy|A Multi-center, Randomized, Sham-controlled, Double-blind, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 Therapy) in Subjects With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy|Recruiting||Phase 1/Phase 2|24|Anticipated|Sentien Biotechnologies, Inc.||3|||f||||t|t|f||||||||2017-10-10 21:28:17.014279|2017-10-10 21:28:17.014279
NCT03015610|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|GenARA||Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma|Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma|Not yet recruiting||Phase 3|110|Anticipated|Duke University||2|||f||||t|t|f||||||||2017-10-10 21:28:17.100605|2017-10-10 21:28:17.100605
NCT03015597|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-03-01|||October 2016||2016-10-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pilot Study of Contingency Management for Smoking Cessation|Addition of Contingency Management to Stop Smoking Services for Patients Undergoing Treatment for Opiate Addiction: a Randomised Controlled Pilot Study|Active, not recruiting||N/A|40|Actual|King's College London||2|||f||||f||||||||No|Permission is not being sought for this from participants to expedite recruitment|2017-10-10 21:28:17.208146|2017-10-10 21:28:17.208146
NCT03015584|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-08-15|||June 2015||2015-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|CASS||Systems Biology Approach to Cognitive Impairment After SepsiS|Systems Biology Approach to Cognitive Impairment After SepsiS (CASS)|Recruiting||N/A|40|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||Samples With DNA|"     Blood for RNA-seq and whole exome sequencing   "|||2017-10-10 21:28:17.295336|2017-10-10 21:28:17.295336
NCT03015571|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-14|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Influence of Routine Use of Narrow Band Imaging on Heterotopic Gastric Mucosa of the Proximal Esophagus Detection|Influence of Routine Use of Narrow Band Imaging on Heterotopic Gastric Mucosa of the Proximal Esophagus Detection|Recruiting||N/A|1000|Anticipated|H-T. Centrum Medyczne Sp. z o.o. sp. k||4|||f||||f||||||||No||2017-10-10 21:28:17.420199|2017-10-10 21:28:17.420199
NCT03015558|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-18|||November 2016||2016-11-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|STIM-INSULA||Analgesic Effect of Non Invasive Stimulation : Transcranial Direct Current Stimulation of Opercular-insular Cortex|Transcranial Direct Current Stimulation (tDCS) for Neuropathic Chronic Pain : Study of the Opercular-insular Cortex Stimulation|Recruiting||N/A|80|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 21:28:17.526439|2017-10-10 21:28:17.526439
NCT03015545|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-04-24|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of WBV on Muscle Stiffness and Reflex Activity in Stroke.|The Effects of Whole Body Vibration (WBV) on Muscle Stiffness and Reflex Activity in People After Stroke.|Not yet recruiting||N/A|42|Anticipated|The Hong Kong Polytechnic University||2|||f||||t|f|f||||||No||2017-10-10 21:28:17.641247|2017-10-10 21:28:17.641247
NCT03015532|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-29|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia|A Phase 2b, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study of HTX-011 Via Infiltration for Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty|Recruiting||Phase 2|160|Anticipated|Heron Therapeutics||7|||f||||||||||||||2017-10-10 21:28:17.763848|2017-10-10 21:28:17.763848
NCT03015519|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-13|||August 14, 2017|Anticipated|2017-08-14|September 2017|2017-09-01|April 20, 2020|Anticipated|2020-04-20|April 20, 2020|Anticipated|2020-04-20||Interventional|||A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus|A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Albiglutide for the Treatment of Type 2 Diabetes Mellitus in Pediatric Patients|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||6||The study was stopped as the asset will be withdrawn from the market prior to study end.|f||||t|t|f||||||||2017-10-10 21:28:17.883072|2017-10-10 21:28:17.883072
NCT03015506|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-04-26|||January 2017||2017-01-01|January 2017|2017-01-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Measuring the Glycemic Index of Pulse Based Breads|Measuring the Glycemic Index of Pulse Based Breads|Completed||N/A|12|Actual|Glycemic Index Laboratories, Inc||5|||f||||f||||||||No||2017-10-10 21:28:17.995446|2017-10-10 21:28:17.995446
NCT03015493|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-13|||May 2016||2016-05-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effectiveness of Cervical Traction and Neural Mobilization in Patients With Cervical Radiculopathy|Cervical Traction Combined With Neural Mobilization for Patients With Cervical Radiculopathy: A Randomized Controlled Trial.|Active, not recruiting||N/A|50|Anticipated|European University Cyprus||3|||f||||f||||||||Undecided|Undecided|2017-10-10 21:28:18.066491|2017-10-10 21:28:18.066491
NCT03015480|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-03-06|||January 2017||2017-01-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Interventional|FitKidney||Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes|Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes|Enrolling by invitation||N/A|240|Anticipated|Geisinger Clinic||2|||f||||f||||||||No||2017-10-10 21:28:18.136736|2017-10-10 21:28:18.136736
NCT03015467|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-10|||December 2016||2016-12-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP)|Alteration of Intestinal Microflora and Efficacy and Safety of Fecal Microbiota Transplantation for Severe Acute Pancreatitis|Recruiting||Phase 1/Phase 2|80|Anticipated|First Affiliated Hospital of Chengdu Medical College||2|||f||||t||||||||No||2017-10-10 21:28:18.212504|2017-10-10 21:28:18.212504
NCT03015454|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-01-06|||December 2016||2016-12-01|January 2017|2017-01-01||||February 2017|Anticipated|2017-02-01||Interventional|||An Algorithm Driven Sepsis Prediction Biomarker|A Randomized Controlled Clinical Trial of an Algorithm Driven Sepsis Prediction Biomarker|Recruiting||N/A|150|Anticipated|Dascena||2|||f||||||||||||||2017-10-10 21:28:18.302534|2017-10-10 21:28:18.302534
NCT03015441|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-08-21|||February 2, 2017|Actual|2017-02-02|August 2017|2017-08-01|June 21, 2017|Actual|2017-06-21|May 4, 2017|Actual|2017-05-04||Interventional|BREEZE||Evaluation of a 28-day Fermented Milk Product Consumption Twice Daily as Compared to a Non-fermented Milk Product on Intestinal Gas Production in Healthy Subjects High Dihydrogen Producers|Evaluation of a 28-day Fermented Milk Product Consumption Twice Daily as Compared to a Non-fermented Milk Product on Intestinal Gas Production in Healthy Subjects High Dihydrogen Producers A Randomized, Controlled, Double-blind, Parallel Arms, Adaptive Study|Completed||N/A|72|Actual|Danone Research||2|||f||||t|f|f||||||||2017-10-10 21:28:18.387028|2017-10-10 21:28:18.387028
NCT03015428|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-01-07|||October 2015||2015-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||"Living Together With Dementia_Creation and Validation of a Training Program for Family Caregivers of People With Dementia to Live at Home"||Completed||N/A|25|Actual|Centro Hospitalar De São João, E.P.E.||1|||f||||||||||||||2017-10-10 21:28:18.461458|2017-10-10 21:28:18.461458
NCT03015415|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||March 2013||2013-03-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||The Posttraumatic Elbow Stiffness Treatment|A Prospective Randomized Controlled Trial of Open Arthrolysis Versus Non-surgical Treatment for Elbow Stiffness|Recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||t||||||||Undecided||2017-10-10 21:28:18.524346|2017-10-10 21:28:18.524346
NCT03015402|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||June 2017||2017-06-01|January 2017|2017-01-01||||March 2021|Anticipated|2021-03-01||Interventional|PH-HFpEF||Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction|Phase II Clinical Investigation of Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (PH-HFpEF)|Not yet recruiting||Phase 2|26|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 21:28:18.613592|2017-10-10 21:28:18.613592
NCT03015389|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||February 2017||2017-02-01|January 2017|2017-01-01||||February 2019|Anticipated|2019-02-01||Observational|||Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma||Not yet recruiting||N/A|150|Anticipated|CDx Diagnostics|||1||f||||||||||||||2017-10-10 21:28:18.688637|2017-10-10 21:28:18.688637
NCT03015376|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Inherited Susceptible Genes Among Epithelial Ovarian Cancer|Cohort Study on Characters and Distribution of Inherited Susceptible Genes Among Epithelial Ovarian Cancer Patients and Their Relatives in the North of China|Not yet recruiting||N/A|1000|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||Samples With DNA|"     serum from peripheral blood and tumor tissues frome surgical samples   "|Yes|IPD will be shared with authorised researchers via online database.|2017-10-10 21:28:18.756354|2017-10-10 21:28:18.756354
NCT03015363|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-11|||November 2013||2013-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Observational|CCV||Clinical Calibration & Validation of a Next-Generation Blood Pressure Monitor for Patient Management|Comparison, Calibration, and Validation of the Non-invasive Cloud DX Pulsewave Health MonitorTM With Direct Invasive Radial and Central Arterial Measurements During Cardiac Catheterization|Active, not recruiting||N/A|50|Anticipated|Cardiovascular Research New Brunswick|||1||f||||f||||||||Undecided||2017-10-10 21:28:18.91761|2017-10-10 21:28:18.91761
NCT03015350|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-07-19|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Blood Levels of Sevoflurane and Desflurane|Blood Levels of Sevoflurane and Desflurane During One Lung Ventilation|Recruiting||N/A|16|Anticipated|Cukurova University|||4||f||||f||||||||||2017-10-10 21:28:18.991347|2017-10-10 21:28:18.991347
NCT03015337|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-09|||October 2009||2009-10-01|January 2017|2017-01-01||||December 2013|Actual|2013-12-01||Interventional|||Relationship of Motor Skill Competency and Physical Fitness to Physical Activity in Elementary School Students|Relationship of Motor Skill Competency and Physical Fitness to Physical Activity in Elementary School Students|Completed||N/A|1844|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-10 21:28:19.093396|2017-10-10 21:28:19.093396
NCT03015324|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-31|||August 8, 2017|Actual|2017-08-08|March 2017|2017-03-01|September 2028|Anticipated|2028-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors|Biological Effects of Maintenance Usage of Hydroxychloroquine on PAR-4 Levels in Patients With Resected Solid Tumors|Recruiting||Phase 1|43|Anticipated|University of Kentucky||1|||f||||t|t|f|||f|||||2017-10-10 21:28:19.180105|2017-10-10 21:28:19.180105
NCT03015311|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-05-08|||December 2016||2016-12-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|STEP||Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients|Strategy of Systolic Blood Pressure Intervention in the Elderly Hypertensive Patients: A Prospective Randomized Open-Label Blinded-Endpoint Trial|Recruiting||N/A|8000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:28:19.284428|2017-10-10 21:28:19.284428
NCT02977624|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||December 2016||2016-12-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|||Effectiveness of Tele-rehabilitation Intervention to Improve Performance, Participation and Quality of Life for People Post Stroke||Not yet recruiting||N/A|30|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-10-10 21:34:22.027187|2017-10-10 21:34:22.027187
NCT03015298|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer|Comparing the Diagnostic Role of 18F-FDG PET/MRI and of 18F-FDG PET/CT Among Patients With Gastric Cancer：A Randomized Controlled Trial|Not yet recruiting||N/A|100|Anticipated|Chinese PLA General Hospital|||1||f||||t||||||||No||2017-10-10 21:28:19.583195|2017-10-10 21:28:19.583195
NCT03015285|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT|Comparing the Efficacy of CBT for Anxiety Sensitivity to Disorder-specific CBT in Reducing Mental Health Symptoms: A Randomized Controlled Trial|Not yet recruiting||N/A|136|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||No|Data will only be shared between investigators at the two study sites once it has been de-identified and entered into a data analytic program in order to protect participants' privacy and confidentiality.|2017-10-10 21:28:19.683701|2017-10-10 21:28:19.683701
NCT03015272|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-02-23|||November 2014||2014-11-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)|Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)|Recruiting||Phase 2/Phase 3|40|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||Yes||2017-10-10 21:28:19.803703|2017-10-10 21:28:19.803703
NCT03015259|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-05-03|||January 2, 2017|Actual|2017-01-02|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients|Randomized, Single Blind, Parallel Group, Placebo Controlled, Multidose Study Comparing the Therapeutic Equivalence of a 3M Budesonide/Formoterol Fumarate Inhaler and a Symbicort® Reference Inhaler in Adult Subjects With Asthma|Recruiting||Phase 3|1460|Anticipated|3M||3|||f||||f||||||||No|publication of results|2017-10-10 21:28:19.957202|2017-10-10 21:28:19.957202
NCT03015246|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-04-20|||December 2016||2016-12-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|BOS||Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence|Biobehavioral Studies of Opioid Seeking: Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence|Recruiting||Phase 1|40|Anticipated|Wayne State University||2|||f||||t||||||||No||2017-10-10 21:28:20.253371|2017-10-10 21:28:20.253371
NCT03015233|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-06|||June 2016||2016-06-01|January 2017|2017-01-01||||January 2017|Anticipated|2017-01-01||Observational|GALAC||Acute Abdominal Pain: Evaluation of Lactate Value as Predictive Factor of Surgical Issue|Acute Abdominal Pain in Emergency Department: Evaluation of Venous LACtate Value and Strong Ion GAp According to the Stewart Approach as Predictive Factors of Surgical Issue|Recruiting||N/A|660|Anticipated|Association pour la Formation l'Enseignement et la Recherche du Service de l'Accueil des Urgences|||1||f||||||||||||||2017-10-10 21:28:20.387651|2017-10-10 21:28:20.387651
NCT03015220|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-08-25|||January 10, 2017|Actual|2017-01-10|August 2017|2017-08-01|August 2, 2018|Anticipated|2018-08-02|June 28, 2018|Anticipated|2018-06-28||Interventional|PIONEER 10||Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes|Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD in Japanese Subjects With Type 2 Diabetes|Active, not recruiting||Phase 3|455|Anticipated|Novo Nordisk A/S||4|||f||||f|f|f||||||||2017-10-10 21:28:20.50057|2017-10-10 21:28:20.50057
NCT03015207|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-26|||January 6, 2017|Actual|2017-01-06|September 2017|2017-09-01|October 26, 2017|Anticipated|2017-10-26|October 26, 2017|Anticipated|2017-10-26||Interventional|||First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity|A Randomised, Double-blinded, Single-dose, Dose-escalation, First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity|Active, not recruiting||Phase 1|56|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 21:28:20.655918|2017-10-10 21:28:20.655918
NCT03015194|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-20|||January 3, 2017||2017-01-03|September 14, 2017|2017-09-14|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Interventional|||NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation|NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation|Enrolling by invitation||Phase 2|60|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:28:20.76318|2017-10-10 21:28:20.76318
NCT03015181|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-10-03|||December 21, 2016||2016-12-21|October 2, 2017|2017-10-02|December 28, 2018|Anticipated|2018-12-28|December 28, 2018|Anticipated|2018-12-28||Interventional|||VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523lS), Administered Intravenously or Subcutaneously to Healthy Adults|VRC 605: A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults|Active, not recruiting||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 21:28:20.890289|2017-10-10 21:28:20.890289
NCT03015168|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||January 2012||2012-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Prognostic Value of Neutrophil-to-lymphocyte Ratio (NLR) on Rectal Cancer Patients|Prognostic Value of Neutrophil-to-lymphocyte Ratio (NLR) on Rectal Cancer Patients Who Received Capecitabine and Concurrent Intensity Modulated Radiotherapy (IMRT)|Completed||N/A|117|Actual|General Hospital of Ningxia Medical University|||1||f||||f||||||||No||2017-10-10 21:28:20.994845|2017-10-10 21:28:20.994845
NCT03015155|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||March 2017||2017-03-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Therapeutic Effect of Local Hypothermia in Treatment of Acute Myocardial Infarction|Effect of Local Myocardial Hypothermia on Outcomes in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.|Not yet recruiting||N/A|300|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||No||2017-10-10 21:28:21.082921|2017-10-10 21:28:21.082921
NCT03015142|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-03-14|||November 9, 2016|Actual|2016-11-09|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Observational Clinical Study to Plan, Position and Check Instrument Placement for Spine Surgery.|Observational Clinical Study to Plan, Position and Check Instrument Placement for Spine Surgery Interventions.|Recruiting||N/A|25|Anticipated|Philips Healthcare|||1||f||||t||||||||No||2017-10-10 21:28:21.156446|2017-10-10 21:28:21.156446
NCT03015129|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-07|||January 2017||2017-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer|A Phase 2 Trial of Durvalumab [MEDI4736](Anti-PD-L1 Antibody) With or Without Tremelimumab (Anti-CTLA-4 Antibody) in Patients With Persistent or Recurrent Endometrial Carcinoma and Endometrial Carcinosarcoma|Recruiting||Phase 2|80|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||t||||||||||2017-10-10 21:28:21.233344|2017-10-10 21:28:21.233344
NCT03015116|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01||||February 2018|Anticipated|2018-02-01||Interventional|||Photobiomodulation for Plantar Fasciitis|Effectiveness of Photobiomodulation Compared to Usual Care for Plantar Fasciitis|Recruiting||Phase 1|114|Anticipated|Landstuhl Regional Medical Center||3|||f||||f||||||||||2017-10-10 21:28:21.339053|2017-10-10 21:28:21.339053
NCT03015103|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-05|||January 2017||2017-01-01|December 2016|2016-12-01||||February 2017|Anticipated|2017-02-01||Interventional|SAF DER ASSESS||Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity|Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity|Not yet recruiting||N/A|28|Anticipated|Kley Hertz S/A||1|||f||||||||||||||2017-10-10 21:28:21.436889|2017-10-10 21:28:21.436889
NCT03015090|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-05|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylline|Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylline in Han and Uygur Patients With COPD|Recruiting||N/A|100|Anticipated|Kashgar 1st People's Hospital||1|||f||||t||||||||Yes||2017-10-10 21:28:21.498109|2017-10-10 21:28:21.498109
NCT03015077|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-01-08|||July 2014||2014-07-01|February 2015|2015-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy|Impacts of Oral Supplement With L-Glutamine on the Radiation-induced Toxicity and Nutritional Status of Head and Neck Cancer Patients Under Radiotherapy|Completed||N/A|59|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-10 21:28:21.594237|2017-10-10 21:28:21.594237
NCT03015064|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-06|||July 2016||2016-07-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|Catarina||Post-Myocardial Infarction Patients in Santa Catarina, Brazil - Catarina Heart Study|Post-Myocardial Infarction Patients in Santa Catarina, Brazil: a Prospective Cohort Study - Catarina Heart Study|Enrolling by invitation||N/A|1426|Anticipated|Instituto de Cardiologia de Santa Catarina|||1||f||||f||||||||No||2017-10-10 21:28:21.691473|2017-10-10 21:28:21.691473
NCT03015051|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis|Randomized Controlled Trial to Compare the Efficacy of High Flow Nasal Cannula Oxygen Therapy vs Low Flow Oxygen Therapy in Bronchiolitis|Recruiting||Phase 4|130|Anticipated|IRCCS Burlo Garofolo||2|||f||||f||||||||Undecided||2017-10-10 21:28:21.825357|2017-10-10 21:28:21.825357
NCT03015038|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|IMCO||Study of the Immune Response in Colon Adenocarcinoma|Etude de la réponse Immunitaire Dans l'adénocarcinome Colique|Not yet recruiting||N/A|100|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples With DNA|"     Tissu and blood   "|No||2017-10-10 21:28:21.988148|2017-10-10 21:28:21.988148
NCT03015025|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-05|||October 2011||2011-10-01|September 2011|2011-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Pharmacogenetic Dosage Algorithm for Acenocoumarol|Creation and Validation of a Pharmacogenetic Dosage Algorithm for Acenocoumarol in Patients With Venous Thromboembolic Disease, Atrial Fibrillation and/or Mechanical Valvular Heart Prosthesis|Completed||N/A|340|Actual|Instituto de Investigación Hospital Universitario La Paz|||1||f||||f||||||Samples With DNA|"     Patients' consent was requested for the preservation of their DNA sample, in case of new     genes related to the pharmacokinetics or pharmacodynamics of acenocoumarol are discovered in     the future.   "|No||2017-10-10 21:28:22.038466|2017-10-10 21:28:22.038466
NCT03015012|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-18|||April 3, 2017|Actual|2017-04-03|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|NOW||Nutrigenomics, Overweight/Obesity and Weight Management Trial (NOW Trial)|Using Personalized Nutrigenomics Testing to Mitigate Overweight/Obesity Risk in Two Distinct Patient Populations: A Multicentre Randomized Clinical Intervention Trial|Recruiting||N/A|400|Anticipated|Western University, Canada||2|||f||||f|f|f||||||||2017-10-10 21:28:22.111524|2017-10-10 21:28:22.111524
NCT03014999|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2017-01-05|||December 2016||2016-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Corticospinal Excitability After rTMS in Spinal Cord Injury Patients||Recruiting||N/A|12|Anticipated|Universidade Federal de Pernambuco||3|||f||||t||||||||No||2017-10-10 21:28:22.211001|2017-10-10 21:28:22.211001
NCT03014986|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-19|||December 2015||2015-12-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Current Treatment of HCV Infection After HSCT|Current Treatment of HCV Infection After HSCT|Recruiting||N/A|300|Anticipated|European Group for Blood and Marrow Transplantation|||2||f||||f||||||||Undecided||2017-10-10 21:28:22.310306|2017-10-10 21:28:22.310306
NCT03014973|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|HORM||Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status|Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status|Not yet recruiting||N/A|30|Anticipated|Hopital Foch||2|||f||||f||||||||No||2017-10-10 21:28:22.400897|2017-10-10 21:28:22.400897
NCT03014960|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Leader Sleep Improvement on Leadership|The Effects of Leader Sleep Improvement on Leadership|Not yet recruiting||N/A|400|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 21:28:22.507978|2017-10-10 21:28:22.507978
NCT03014947|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-02-21|||May 2014||2014-05-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||MSB11022 in Healthy Subjects|A Phase I, Randomized, Double-Blind, Parallel-Group, Single-Dose Trial to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of MSB11022, US-Reference Product, and EU-Reference Medicinal Product (Humira®) in Healthy Subjects|Completed||Phase 1|237|Actual|Merck KGaA||3|||f||||f||||||||||2017-10-10 21:28:22.583118|2017-10-10 21:28:22.583118
NCT03014934|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-19|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|IPAT||Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation|Impact of Pre-existing Invasive Aspergillosis on Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Acute Leukaemia and Myelodysplastic Syndrome|Recruiting||N/A|2100|Anticipated|European Group for Blood and Marrow Transplantation|||2||f||||f||||||||Undecided||2017-10-10 21:28:22.675263|2017-10-10 21:28:22.675263
NCT03014921|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-06|||December 2016||2016-12-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|FERDOP||Impact of Iron Injection on Blood Donation|Effet de l'Injection de Fer Sur la Donation Sanguine, étude randomisée et contrôlée|Active, not recruiting||N/A|19|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||No||2017-10-10 21:28:24.598975|2017-10-10 21:28:24.598975
NCT03014908|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-06|||January 2014||2014-01-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|T1DM||Metabolic Profiling of Type 1 Diabetes Mellitus in Children and Adolescents|Metabolic Profiling of Type 1 Diabetes Mellitus in Children and Adolescents: a Case-control Study|Completed||N/A|14|Actual|Hasselt University|||2||f||||||||||Samples Without DNA|"     Blood plasma for proton-NMR spectroscopy   "|||2017-10-10 21:28:24.682194|2017-10-10 21:28:24.682194
NCT03014895|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-09-07|||January 25, 2017|Actual|2017-01-25|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects|A Randomized, Double-blind, Placebo-controlled, Single Intravenous Ascending Dose Study of E3112 in Japanese Healthy Adult Male Subjects|Recruiting||Early Phase 1|40|Anticipated|Eisai Inc.||10|||f||||f|f|f||||||||2017-10-10 21:28:24.75891|2017-10-10 21:28:24.75891
NCT03014882|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||February 2015||2015-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?|Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Ain Shams University||1|||f||||t||||||||Undecided||2017-10-10 21:28:24.861716|2017-10-10 21:28:24.861716
NCT03014869|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||High Flow Nasal Cannula vs NPPV in Moderate Chronic Obstructive Pulmonary Disease Exacerbation|Comparison of High Flow Nasal Cannula and Noninvasive Positive Ventilation(NPPV) in Moderate Chronic Obstructive Pulmonary Disease Exacerbation(AECOPD)|Not yet recruiting||N/A|351|Anticipated|China-Japan Friendship Hospital||2|||f||||f||||||||No||2017-10-10 21:28:24.936969|2017-10-10 21:28:24.936969
NCT03014856|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-05|||May 2012||2012-05-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Metabolic Phenotypes in Childhood Obesity|Identification of Metabolic Phenotypes in Childhood Obesity by 1H-NMR Metabolomics of Blood Plasma|Completed||N/A|102|Actual|Hasselt University|||2||f||||||||||Samples Without DNA|"     Blood plasma for proton-NMR spectroscopy   "|||2017-10-10 21:28:25.012713|2017-10-10 21:28:25.012713
NCT03014843|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||October 2013||2013-10-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Naloxone and Methylnaltrexone on Esophageal Sensitivity in Health|The Effect of Naloxone and Mehtylnaltrexone on Esophageal Sensitivity in Healthy Volunteers: a Randomized, Double-blind, Placebo-controlled Study|Completed||N/A|12|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||No||2017-10-10 21:28:25.095608|2017-10-10 21:28:25.095608
NCT03014830|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Alirocumab and Reverse Cholesterol Transport|Effect of Alirocumab on Reverse Cholesterol Transport in Humans|Not yet recruiting||Phase 1|40|Anticipated|Washington University School of Medicine||2|||f||||f||||||||No|No plans to share individual data.|2017-10-10 21:28:25.176791|2017-10-10 21:28:25.176791
NCT03014817|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-03-01|||January 1, 2018|Anticipated|2018-01-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis Trial|Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis. A Randomized, Double Blind, Multicenter Study|Not yet recruiting||N/A|180|Anticipated|Karolinska Institutet||2|||f||||t|f|f||||||No||2017-10-10 21:28:25.262784|2017-10-10 21:28:25.262784
NCT03014791|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-03-03|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Observational|AWE||Influence of Age, Weight and Ethnic Background on Blood Pressure|Influence of Age, Weight and Ethnic Background on Blood Pressure: AWE Study|Recruiting||N/A|1000|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||3||f||||f||||||Samples With DNA|"     During the study, the blood and urine samples will be stored by the research team at the     department of Experimental Medicine and Immunotherapeutics, Division of Cardiovascular     Medicine under the responsibility of the CI who will ensure the security and confidentiality     of the stored material. These samples will not be accessible to any investigator outside the     research team. A small aliquot of the participant's blood and urine sample will be stored at     approximately -80 degrees Celsius for future analyses. All samples taken during this study     will be made anonymous. Samples obtained during this study will be used for future ethically     approved studies. Participants will be made aware of this in the participant information     sheet prior to the process of written informed consent.   "|No||2017-10-10 21:28:25.639259|2017-10-10 21:28:25.639259
NCT03014778|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of Two Vaginal Solutions in Preoperative Use|Efficacy Comparison of Two Vaginal Solutions for Preoperative Use in Candidate Women for Vaginal Surgeries|Not yet recruiting||Phase 4|70|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||No||2017-10-10 21:28:25.79985|2017-10-10 21:28:25.79985
NCT03014765|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|EDOP||Endothelial Dysfunction in Perioperative Period|Endothelial Dysfunction, Indicator of Perioperative Complications and Its Changes in Perioperative Period|Not yet recruiting||N/A|50|Anticipated|University Medical Centre Ljubljana||1|||f||||f||||||||No||2017-10-10 21:28:25.903851|2017-10-10 21:28:25.903851
NCT03014752|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-09-02|||September 2016||2016-09-01|December 2016|2016-12-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy||Completed||Phase 2/Phase 3|50|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 21:28:25.97603|2017-10-10 21:28:25.97603
NCT03014739|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-05|||June 2016||2016-06-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|ME1||Evaluation of Shear Wave Elastography Reproducibility in Achilles Tendons and Plantar Fascia|Evaluation of the Reproducibility of Young's Modulus and Shear Wave Velocity Measurements With SWE™ in Achilles Tendons and Plantar Fascia|Recruiting||N/A|135|Anticipated|SuperSonic Imagine|||1||f||||f||||||||No||2017-10-10 21:28:26.051956|2017-10-10 21:28:26.051956
NCT03014726|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||November 2016||2016-11-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Interventional|ROBUST||ROBUST I Pilot Study|ROBUST I Pilot Study ROBUST I Study Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease|Recruiting||N/A|30|Anticipated|Urotronic Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:28:26.128798|2017-10-10 21:28:26.128798
NCT03014713|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-06|||September 2016||2016-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Dexmedetomidine for Postoperative Intravenous Patient Controlled Analgesia|Effect of Dexmedetomidine Combined With Dezocine and Flubiprofen for Postoperative Intravenous Patient Controlled Analgesia After Colorectal Surgery|Recruiting||Phase 4|50|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-10 21:28:26.210682|2017-10-10 21:28:26.210682
NCT03014700|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-07-14|||June 2016||2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Fibrinogen Concentrate vs Cryoprecipitate|Repurposing of Fibrinogen Concentrate as a Cost-Effective and Safe Hemostatic Agent in Infants Undergoing Cardiac Surgery on Cardiopulmonary Bypass|Recruiting||Phase 4|30|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 21:28:26.322399|2017-10-10 21:28:26.322399
NCT03014687|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|POET||Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study Evaluating the Impact of Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions|Recruiting||Phase 4|116|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||t||||||||Undecided||2017-10-10 21:28:26.404949|2017-10-10 21:28:26.404949
NCT03014674|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-10-04|||January 6, 2017|Actual|2017-01-06|October 2017|2017-10-01|August 11, 2017|Actual|2017-08-11|August 11, 2017|Actual|2017-08-11||Interventional|||A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug|An Open Label, Randomised, Three Arm, Single Dose, Multicentre, Parallel Group Study in Healthy Subjects to Compare the Pharmacokinetics of Subcutaneous Mepolizumab When Delivered as a Liquid Drug Product in a Safety Syringe or an Auto Injector With a Reconstituted Lyophilised Drug Product From a Vial|Completed||Phase 3|246|Actual|GlaxoSmithKline||3|||t||||f|t|f||||||||2017-10-10 21:28:26.519488|2017-10-10 21:28:26.519488
NCT03014661|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-05|||June 2015||2015-06-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen|Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen|Completed||N/A|58|Actual|Saarland University|||1||f||||f||||||||No||2017-10-10 21:28:26.638604|2017-10-10 21:28:26.638604
NCT03014648|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-09-05|||July 18, 2017|Actual|2017-07-18|September 2017|2017-09-01|September 2023|Anticipated|2023-09-01|October 2022|Anticipated|2022-10-01||Interventional|||Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)|A Phase II Clinical Trial Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC) in Patients Previously Treated With PD-1-directed Therapy|Recruiting||Phase 2|111|Anticipated|University of Pittsburgh||1|||f||||t|t|f||||||||2017-10-10 21:28:26.71732|2017-10-10 21:28:26.71732
NCT03014635|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-03-09|||December 2016||2016-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines|A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multi-Center Trial to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines (SAKURA-2)|Active, not recruiting||Phase 3|300|Anticipated|Revance Therapeutics, Inc.||2|||f||||f||||||||No||2017-10-10 21:28:26.80604|2017-10-10 21:28:26.80604
NCT03014622|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-03-09|||December 2016||2016-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines|A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multi-Center Trial to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines (SAKURA-1)|Active, not recruiting||Phase 3|300|Anticipated|Revance Therapeutics, Inc.||2|||f||||f||||||||No||2017-10-10 21:28:26.902867|2017-10-10 21:28:26.902867
NCT03014063|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-18|||November 2016||2016-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock|Vasopressin Plasma Concentrations in Responders and Non-responders to Exogenous Vasopressin Infusion in Patients With Septic Shock|Recruiting||N/A|100|Anticipated|The Cleveland Clinic|||2||f||||f||||||||||2017-10-10 21:28:31.276494|2017-10-10 21:28:31.276494
NCT03014609|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|December 2025|Anticipated|2025-12-01|November 2020|Anticipated|2020-11-01|5 Years|Observational [Patient Registry]|ECO-COPD||Cardiovascular Risk and Chronic Obstructive Pulmonary Disease|Cardiovascular Risk and Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|150|Anticipated|University Hospital, Grenoble|||1||f||||t||||||Samples Without DNA|"     Serum and plasma samples will be collected for each patient at the inclusion visit and     follow-up visits. Parameters of inflammation, cardiovascular risk, oxidative stress and     metabolic function will be measured.   "|||2017-10-10 21:28:27.013196|2017-10-10 21:28:27.013196
NCT03014596|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||February 2017||2017-02-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|Assert||What Matters to You? How to Strengthen Adolescent User Involvement in Primary Mental Health Services With Systematic Idiographic Assessment|What Matters to You? How to Strengthen Adolescent User Involvement in Primary Mental Health Services With Systematic Idiographic Assessment|Not yet recruiting||N/A|250|Anticipated|Regionsenter for barn og unges psykiske helse||2|||f||||f||||||||No||2017-10-10 21:28:27.250686|2017-10-10 21:28:27.250686
NCT03014583|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01||||July 2019|Anticipated|2019-07-01||Interventional|MULTIWAVE||Study Comparing Conventional, Burst and High Frequency (HF) Spinal Cord Stimulation (SCS) in Refractory Failed Back Surgery Syndrome (FBSS) Patients After a 32-contact Surgical Lead Implantation|Prospective, Randomized Study Comparing Conventional, Burst And High Frequency (HF) Spinal Cord Stimulation (SCS) in Refractory Failed Back Surgery Syndrome (FBSS) Patients After a 32-contact Surgical Lead Implantation|Not yet recruiting||N/A|28|Anticipated|Poitiers University Hospital||6|||f||||||||||||||2017-10-10 21:28:27.344189|2017-10-10 21:28:27.344189
NCT03014570|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-06|||April 2016||2016-04-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|EIT-4_BPSD||Testing the Implementation of EIT-4-BPSD|Testing the Implementation of EIT-4-BPSD|Enrolling by invitation||N/A|625|Anticipated|University of Maryland||2|||f||||t||||||||No||2017-10-10 21:28:27.428294|2017-10-10 21:28:27.428294
NCT03014557|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||November 2016||2016-11-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01|5 Years|Observational [Patient Registry]|CREW||China REgistry of WATCHMAN|China REgistry of WATCHMAN Left Atrial Appendage Closure for Non-valvular Atrial Fibrillation|Recruiting||N/A|413|Anticipated|Fu Wai Hospital, Beijing, China|||1||f||||t||||||||No||2017-10-10 21:28:27.512922|2017-10-10 21:28:27.512922
NCT03014544|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-22|||October 26, 2016|Actual|2016-10-26|September 2017|2017-09-01|October 23, 2018|Anticipated|2018-10-23|November 21, 2017|Anticipated|2017-11-21||Observational|||Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)|A Randomized, Multicenter, Crossover Study to Assess the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Subjects With Major Depressive Disorder|Recruiting||N/A|578|Anticipated|Janssen Research & Development, LLC|||2||f||||f||t|t|f||||||2017-10-10 21:28:27.608302|2017-10-10 21:28:27.608302
NCT03014531|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-08-14|||June 2014||2014-06-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Daily Almond Intake as a Preload Before Meals Versus as a Snack Among Korean Adults|Daily Almond Intake as a Preload Before Meals Versus as a Snack Between Meals Has Different Effects on Body Fat Percentages and the Lipid Profile in a Randomized Controlled Trial of Young Adults in South Korea|Completed||N/A|227|Actual|ICAN Nutrition Education and Research||2|||f||||||||||||||2017-10-10 21:28:27.760741|2017-10-10 21:28:27.760741
NCT03014518|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-05|||December 2016||2016-12-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Biomarkers as Predictors of Suicidal Risk in Adolescents|Peripheral Neuroinflammatory Predictors of Suicidal Risk at Time of Inpatient Discharge in Adolescents|Recruiting||N/A|160|Anticipated|The Cleveland Clinic|||2||f||||f||||||Samples Without DNA|"     Plasma and serum   "|No||2017-10-10 21:28:27.839383|2017-10-10 21:28:27.839383
NCT03014505|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-06|||August 2016||2016-08-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|FMTDC||Fecal Microbiota Transplantation for Decompensated Cirrhosis|Fecal Microbiota Transplantation Versus Standard Therapy in Decompensated Cirrhosis: A Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|60|Anticipated|First Affiliated Hospital of Chengdu Medical College||2|||f||||t||||||||No||2017-10-10 21:28:27.968375|2017-10-10 21:28:27.968375
NCT03014492|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||June 2016||2016-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|December 2016|Actual|2016-12-01||Interventional|||Concussion Prevention in Soccer|Novel Protection Against Potential Brain Injury During Competitive Non-helmeted Sport in Females|Active, not recruiting||N/A|68|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 21:28:28.06447|2017-10-10 21:28:28.06447
NCT03014479|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-19|||January 12, 2017|Actual|2017-01-12|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus|Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 4|219|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 21:28:28.146646|2017-10-10 21:28:28.146646
NCT03014466|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Screen-Based Distraction Tool for Preoperative Preparation|Screen-Based Distraction Tool for Preoperative Preparation|Not yet recruiting||N/A|60|Anticipated|Stanford University||2|||f||||t||||||||No||2017-10-10 21:28:28.296554|2017-10-10 21:28:28.296554
NCT03014453|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-06-01|||January 2017||2017-01-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Observational|||Is Gastroesophageal Reflux Really a Potential Risk for the Late Complications of Bronchopulmonary Dysplasia in Extremely Premature Infants?|Is Gastroesophageal Reflux Really a Potential Risk for the Late Complications of Bronchopulmonary Dysplasia in Extremely Premature Infants? A Prospective Cohort Study|Recruiting||N/A|100|Anticipated|Shengjing Hospital|||1||f||||||||||||||2017-10-10 21:28:28.379458|2017-10-10 21:28:28.379458
NCT03014440|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-03-30||||||March 2017|2017-03-01||||||||Expanded Access|||Study of Cannabidiol for Drug-Resistant Epilepsies|A Phase 1/2, Safety, Tolerability, and Dose-Finding Study of Cannabidiol for Drug-Resistant Epilepsies|No longer available||N/A|||Children's Hospital of Philadelphia|||||||||||||||||||2017-10-10 21:28:28.455316|2017-10-10 21:28:28.455316
NCT03014427|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-04-07|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|February 2050|Anticipated|2050-02-01|February 2050|Anticipated|2050-02-01|10 Days|Observational [Patient Registry]|Biobank OIM||Development of a Biological Database in the Field of Operative Intensive Care|Development of a Biological Database in the Field of Operative Intensive Care for the Recording of Clinically Relevant Parameters of Critically Ill Intensive Patients|Recruiting||N/A|99999999|Anticipated|RWTH Aachen University|||1||f||||f||||||Samples With DNA|"     Patients can give consent to the analysis of DNA seperately.   "|Undecided||2017-10-10 21:28:28.517924|2017-10-10 21:28:28.517924
NCT03014414|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-04-24|||March 4, 2017|Actual|2017-03-04|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|||Stanford Healthy Heart Study|Escalating Proportion of Weight-Loss Maintainers Via Modules Prior to Weight Loss|Recruiting||N/A|346|Anticipated|Stanford University||2|||f||||t|f|f||||||Yes|After final quality control and statistical analyses are completed, final project data will be made available to individuals who submit a written data request to the Principal Investigator. This centralized data request process provides a tracking mechanism to inform other external groups about similar analysis activities.|2017-10-10 21:28:28.618979|2017-10-10 21:28:28.618979
NCT03014401|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-05|||May 2016||2016-05-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|May 2020|Anticipated|2020-05-01||Interventional|||The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis|The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis: A Randomized Controlled Trial|Recruiting||N/A|99|Anticipated|Stanford University||2|||f||||f||||||||No||2017-10-10 21:28:28.742893|2017-10-10 21:28:28.742893
NCT03014388|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||January 2017||2017-01-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|MPM||Posterior Maxillary Ridge Augmentation With Sinus Lift Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft|Posterior Maxillary Ridge Augmentation With Sinus Lift Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft (A Randomized Clinical Trial Comparative Study)|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||f||||||||No|Evaluation of the comparative Effectiveness of MPM Augmentation in posterior maxillary ridge defects with Autogenous bone graft.|2017-10-10 21:28:28.844246|2017-10-10 21:28:28.844246
NCT03014375|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||September 2008||2008-09-01|January 2017|2017-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Absorption, Distribution, Metabolism and Excretion of [14C]- Labeled BIA 5-453 and Metabolites|An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 5-453 and Metabolites Following a Single-dose Oral Administration|Completed||Phase 1|4|Actual|Bial - Portela C S.A.||1|||f||||f||||||||Undecided||2017-10-10 21:28:28.919876|2017-10-10 21:28:28.919876
NCT03014362|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TMS4SI||TMS for Suicidal Crisis in Active Duty SMs|Utility of Repetitive Transcranial Magnetic Stimulation (TMS) in Promoting Rapid Psychiatric Stabilization in Acutely Suicidal Military Service Members|Not yet recruiting||N/A|110|Anticipated|Eisenhower Army Medical Center||2|||f||||f||||||||No||2017-10-10 21:28:28.989636|2017-10-10 21:28:28.989636
NCT03014349|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-06|||January 2016||2016-01-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Observational|WDTRGP||Water Drinking Test and Its Reproducibility in Goldmann Applanation Tonometry and Pneumatic Tonometry|Water Drinking Test and Its Reproducibility in Goldmann Applanation Tonometry and Pneumatic Tonometry|Completed||N/A|100|Actual|VER Excelência em Oftalmologia|||1||f||||f||||||||No||2017-10-10 21:28:29.100011|2017-10-10 21:28:29.100011
NCT03014336|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-14|||January 2017||2017-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|memsorb||A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate|A New and Innovative Method for CO2 Removal in Anesthetic Circuits:|Recruiting||N/A|200|Anticipated|DMF Medical Incorporated||2|||f||||f||||||||||2017-10-10 21:28:29.176273|2017-10-10 21:28:29.176273
NCT03014323|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|RDVCGH||Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study|Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study|Active, not recruiting||Phase 1|28|Anticipated|Vanderbilt University Medical Center||4|||f||||f||||||||No|No sharing|2017-10-10 21:28:29.272888|2017-10-10 21:28:29.272888
NCT03014310|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-14|||January 17, 2017|Actual|2017-01-17|July 19, 2017|2017-07-19|June 15, 2018|Anticipated|2018-06-15|June 15, 2018|Anticipated|2018-06-15||Interventional|||H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology|A Phase I Cohort-Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants: Assessment of Immunological Responses and Lymphocyte Interplay|Active, not recruiting||Phase 1|388|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f|||||t|f|||f|||||2017-10-10 21:28:29.361152|2017-10-10 21:28:29.361152
NCT03014297|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-04-21|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression|A Phase 1 Study of Fosbretabulin in Combination With Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After at Least One Prior Regimen for Metastatic Disease|Recruiting||Phase 1|30|Anticipated|University of Kentucky||1|||f||||t|t|f|||f|||No||2017-10-10 21:28:29.477128|2017-10-10 21:28:29.477128
NCT03014284|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|||Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis|Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis|Not yet recruiting||N/A|100|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples Without DNA|"     Obtain human colon tissue for ex vivo studies of B7-H1 expression, signaling pathways and     effects of recombinant Listeria vectors.   "|||2017-10-10 21:28:29.559408|2017-10-10 21:28:29.559408
NCT03014271|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||September 2016||2016-09-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|January 2017|Actual|2017-01-01||Interventional|||Impact of Sources of Strength Youth Suicide Program on Sexual Violence Prevention Among Colorado High School Students|The Impact of Sources of Strength, a Primary Prevention Youth Suicide Program, on Sexual Violence Prevention Among Colorado High School Students|Recruiting||N/A|7200|Anticipated|University of Florida||2|||f||||f||||||||No||2017-10-10 21:28:29.783133|2017-10-10 21:28:29.783133
NCT03014258|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-14|||June 7, 2017|Actual|2017-06-07|July 19, 2017|2017-07-19|November 1, 2020|Anticipated|2020-11-01|November 1, 2020|Anticipated|2020-11-01||Interventional|||A Systems Biology Approach to Malaria Immunity|A Systems Biology Approach to Malaria Immunity Repetitive Controlled Human Malaria Infection (CHMI) Study in Malaria-Naïve Adults Using NF54 Strain Plasmodium Falciparum (Pf)|Recruiting||Phase 1|28|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f|||||t|f|||f|||||2017-10-10 21:28:29.890741|2017-10-10 21:28:29.890741
NCT03014245|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-05-22|||November 2016|Actual|2016-11-01|January 2017|2017-01-01|May 18, 2017|Actual|2017-05-18|April 2017|Actual|2017-04-01||Observational|MEL-P||Melatonin in Pregnancy Compared to Non-pregnant|Circulating Melatonin and 6-hydroxymelatonin Levels During Pregnancy|Completed||N/A|60|Actual|University of Aberdeen|||2||f||||f||||||Samples Without DNA|"     Blood   "|No||2017-10-10 21:28:29.989548|2017-10-10 21:28:29.989548
NCT03014232|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||June 2012||2012-06-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Comparison Cytokine Clearance Between SLED-f Using High Cut-off Dialyzer and High-flux Dialyzer in Septic AKI Patients|Comparison Cytokine Clearance Between Sustained Low-Efficiency Diafiltration (SLED-f) Using High Cut-off Dialyzer and High-flux Dialyzer in Septic AKI Patients|Completed||N/A|16|Actual|Chulalongkorn University||2|||f||||f||||||||No||2017-10-10 21:28:30.100445|2017-10-10 21:28:30.100445
NCT03014219|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-03|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Phase 1 Crohn's Pediatric Sub-study of MSC AFP|A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study|Withdrawn||Phase 1|0|Actual|Mayo Clinic||1||FDA approval was not obtained until adult trial completes accrual|f||||f|t|f||||||||2017-10-10 21:28:30.19719|2017-10-10 21:28:30.19719
NCT03014206|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-02-16|||June 2015||2015-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01|28 Days|Observational [Patient Registry]|||Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-|Prevenar (13v) Adult Special Investigation (Regulatory Post Marketing Commitment Plan)|Completed||N/A|696|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 21:28:30.282389|2017-10-10 21:28:30.282389
NCT03014193|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Simplifying First Trimester Medical Abortion Follow-up|Simplifying First Trimester Medical Abortion Follow-up|Not yet recruiting||N/A|250|Anticipated|Gynuity Health Projects|||1||f||||||||||||||2017-10-10 21:28:30.354532|2017-10-10 21:28:30.354532
NCT03014180|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-07-11|||February 16, 2017|Actual|2017-02-16|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|LEVEA||Clinical Evaluation of LEft VEntricular Auto Threshold Alogrithm (LEVEA)|Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm|Active, not recruiting||Phase 3|60|Actual|LivaNova||1|||f||||f|f|f||||||||2017-10-10 21:28:30.448966|2017-10-10 21:28:30.448966
NCT03014167|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-09-13|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)|Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)|Not yet recruiting||Phase 4|240000|Anticipated|Natural History Museum, United Kingdom||2|||f||||t|f|f||||||||2017-10-10 21:28:30.533081|2017-10-10 21:28:30.533081
NCT03014154|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-01-13|||October 2016||2016-10-01|January 2017|2017-01-01||||January 2017|Actual|2017-01-01||Interventional|||Assessment of the Effects of Physical Activity With Active Video Game Games in Asthmatic Children|Effects of Video Training With Active Gambling Associated With Resistance Exercise Inflammatory and Functional Outcomes in Children Clinical Teaching Blind Randomized|Active, not recruiting||Phase 1/Phase 2|17|Actual|University of Nove de Julho||2|||f||||f||||||||Undecided||2017-10-10 21:28:30.633579|2017-10-10 21:28:30.633579
NCT03014141|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|OATGUT||Effect of Oat Bran on Bowel Function and Appetite|The Effect of Oat Bran on Bowel Function and Appetite. A Randomized, Double-blind, Placebo-controlled, Cross-over Intervention Study in Healthy Humans.|Not yet recruiting||Phase 2|34|Anticipated|DSM Nutritional Products, Inc.||2|||f||||f||||||||No||2017-10-10 21:28:30.708766|2017-10-10 21:28:30.708766
NCT03014128|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-06|||March 2017||2017-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|PEIN||Musculoskeletal Pathologies of the Upper Extremity in Surgical Device Mechanics|Musculoskeletal Pathologies of the Upper Extremity in Surgical Device Mechanics|Not yet recruiting||N/A|90|Anticipated|District Hospital, Tuttlingen|||3||f||||f||||||||||2017-10-10 21:28:30.812153|2017-10-10 21:28:30.812153
NCT03014115|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-05|||November 2016||2016-11-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants|EFFECTS OF DIFFERENT ARA FORMULATIONS OF INFANT FORMULA ON FATTY ACID STATUS, IMMUNE MARKERS AND INFECTION RATES IN INFANTS|Recruiting||N/A|220|Anticipated|DSM Nutritional Products, Inc.||2|||f||||f||||||||No||2017-10-10 21:28:30.904557|2017-10-10 21:28:30.904557
NCT03014102|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-06|||June 2016||2016-06-01|January 2017|2017-01-01||||September 2019|Anticipated|2019-09-01||Interventional|||Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation||Recruiting||Phase 1/Phase 2|50|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||||||||||||2017-10-10 21:28:31.01853|2017-10-10 21:28:31.01853
NCT03014089|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-02-13|||December 2016||2016-12-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects|A Phase 1/2, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of mRNA 1325 Zika Vaccine in Healthy Adults in a Non-endemic Zika Region|Recruiting||Phase 1/Phase 2|90|Anticipated|Moderna Therapeutics||2|||f||||t||||||||No||2017-10-10 21:28:31.110661|2017-10-10 21:28:31.110661
NCT03014076|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-06|||January 2008||2008-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2016|Actual|2016-01-01||Interventional|||Immunotherapy Vaccine and Herceptin in Breast Cancer|Phase Ib Trial of Combination Immunotherapy With HER2/Neu Peptide GP2 + GM-CSF Vaccine and Trastuzumab in Breast Cancer Patients|Completed||Phase 1|30|Actual|Cancer Insight, LLC||2|||f||||t||||||||No||2017-10-10 21:28:31.196826|2017-10-10 21:28:31.196826
NCT03014050|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-24|||September 22, 2017|Actual|2017-09-22|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|BEST||Bio Electro Stimulation Therapy for Parkinson's Disease|Effectiveness of Bio-Electro Stimulation Therapy for the Treatment of Motor and Non-Motor Symptoms in Parkinson's Disease - A Pilot Study|Recruiting||N/A|66|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 21:28:31.39302|2017-10-10 21:28:31.39302
NCT03014037|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-09-14|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration|Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration|Recruiting||N/A|30|Anticipated|Emory University||2|||f||||f|f|f||||||||2017-10-10 21:28:31.488656|2017-10-10 21:28:31.488656
NCT03014024|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-06|2017-01-06|||December 2015||2015-12-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|June 2018|Anticipated|2018-06-01||Interventional|||Low-level Laser Therapy on Distal Radius Fractures|A Double-blind Placebo-controlled Study of Low-level Laser Therapy After Removal of Cast on Distal Radius Fractures|Recruiting||N/A|70|Anticipated|University of Bergen||2|||f||||f||||||||No||2017-10-10 21:28:31.577085|2017-10-10 21:28:31.577085
NCT03014011|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes|Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes|Not yet recruiting||Phase 1|28|Anticipated|Bispebjerg Hospital|||||f||||t||||||||No||2017-10-10 21:28:31.666469|2017-10-10 21:28:31.666469
NCT03013998|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-03-29|||November 2016||2016-11-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Study of Biomarker-Based Treatment of Acute Myeloid Leukemia|A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)|Recruiting||Phase 1/Phase 2|500|Anticipated|Beat AML, LLC||4|||f||||t||||||||No||2017-10-10 21:28:31.736421|2017-10-10 21:28:31.736421
NCT03013985|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-05-23|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Glargine U300 Hospital Trial|A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient and Post-Hospital Discharge Management of Medicine and Surgery Patients With Type 2 Diabetes|Recruiting||Phase 4|180|Anticipated|Emory University||2|||f||||t|t|f||||||||2017-10-10 21:28:31.871266|2017-10-10 21:28:31.871266
NCT03013972|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-06|||November 2015||2015-11-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|||A Longitudinal Study of Cancer-related Fatigue Among Colorectal Cancer Patients During Adjuvant Chemotherapy|A Longitudinal Study of Cancer-related Fatigue Among Colorectal Cancer Patients During Adjuvant Chemotherapy|Recruiting||N/A|60|Anticipated|Mackay Memorial Hospital|||1||f||||f||||||||No||2017-10-10 21:28:31.98964|2017-10-10 21:28:31.98964
NCT03013959|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||November 2016||2016-11-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01|12 Months|Observational [Patient Registry]|OHSV||Observation on the Herpes Simplex Keratitis|Observation on Effect of Anti--inflammatory and Inhibition of Recurrence on the Herpes Simplex Keratitis After Topical NSAIDs Administration|Recruiting||N/A|100|Anticipated|Peking Union Medical College|||4||f||||t||||||||Yes||2017-10-10 21:28:32.081476|2017-10-10 21:28:32.081476
NCT03013946|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-06|||January 2017||2017-01-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|PREPARE||Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib|A Phase III Study Testing the Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic Renal Cell Carcinoma Treated With Sunitinib|Recruiting||Phase 3|430|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||No||2017-10-10 21:28:32.169674|2017-10-10 21:28:32.169674
NCT03013933|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-15|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Brentuximab Vedotin, Cyclosporine, and Verapamil in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma|A Phase I Trial of Brentuximab Vedotin Plus MDR1 Inhibitors in Relapsed/Refractory Hodgkin Lymphoma|Recruiting||Phase 1|34|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:28:32.26184|2017-10-10 21:28:32.26184
NCT03013920|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-05|||August 2016||2016-08-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma|A Prospective In-Vivo Human Pilot Study to Assess Confocal Laser Endomicroscopy Characteristics of Upper Tract Urothelial Carcinoma|Recruiting||N/A|70|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     CLE images and histopathology   "|No||2017-10-10 21:28:32.381277|2017-10-10 21:28:32.381277
NCT03013907|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-04-19|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Emotional Awareness and SElf-regulation for Depression in Patients With Hypertension (EASE) Study|Emotional Awareness and SElf-regulation for Depression in Patients With Hypertension (EASE) Study|Recruiting||N/A|48|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:28:32.450473|2017-10-10 21:28:32.450473
NCT03013894|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-05|||March 2016||2016-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Confocal Laser Endomicroscopy in the Lower Urinary Tract|Feasibility of Confocal Laser Endomicroscopy in Bladder Cancer Diagnosis|Recruiting||N/A|60|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     CLE images (without DNA) and histopathology (with DNA)   "|No||2017-10-10 21:28:32.550221|2017-10-10 21:28:32.550221
NCT03013881|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers|Open-label, Two-part, Dose-escalation and Comparative Pharmacokinetics Study of UB-921 in Healthy Male Volunteers|Recruiting||Phase 1|24|Anticipated|United BioPharma||5|||f||||t|f|f||||||||2017-10-10 21:28:32.62809|2017-10-10 21:28:32.62809
NCT03013309|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|FCU4Health||Raising Healthy Children: A Hybrid Trial of the Family Check-Up 4 Health in Primary Care|An Individually Tailored, Family-Centered Intervention for Childhood Obesity: Connecting Services in Pediatric Primary Healthcare, the Home and the Community|Not yet recruiting||N/A|350|Anticipated|Arizona State University||2|||f||||t||||||||No||2017-10-10 21:28:36.976029|2017-10-10 21:28:36.976029
NCT03013868|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-03-21|||October 2016||2016-10-01|January 2017|2017-01-01|February 2021|Anticipated|2021-02-01|December 2020|Anticipated|2020-12-01||Observational|||CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System|CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System|Recruiting||N/A|200|Anticipated|MiCareo Taiwan Co., Ltd.|||1||f||||f||||||||||2017-10-10 21:28:32.712095|2017-10-10 21:28:32.712095
NCT03013855|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-07-27|||July 2016||2016-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|FIT-DRE||Efficacy of Fecal Immunochemical Test Using Digital Rectal Exam|Efficacy of Fecal Immunochemical Test Using Digital Rectal Exam|Terminated||Phase 1|1|Actual|Boston Medical Center||2||Unable to recruit participants|f||||t|f|t|f|f||||||2017-10-10 21:28:32.762917|2017-10-10 21:28:32.762917
NCT03013842|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-10-04|||December 12, 2016|Actual|2016-12-12|October 2017|2017-10-01|November 13, 2017|Anticipated|2017-11-13|November 13, 2017|Anticipated|2017-11-13||Interventional|||Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects|Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects|Recruiting||N/A|25|Anticipated|University of California, Davis||1|||f||||f||||||||||2017-10-10 21:28:32.83857|2017-10-10 21:28:32.83857
NCT03013829|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-04-19|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Kidney Paired Donation Video-Based Education Trial|Kidney Paired Donation: A Randomized Trial to Increase Knowledge and Informed Decision-Making|Not yet recruiting||N/A|360|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|f|f||||||No||2017-10-10 21:28:32.924026|2017-10-10 21:28:32.924026
NCT03013816|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-03-14|||October 2014||2014-10-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2016|Actual|2016-10-01||Interventional|||Increasing Donor Designation Rates in Teenagers: Effectiveness of a Driver's Education Intervention|Increasing Donor Designation Rates in Teenagers: Effectiveness of a Driver's Education Intervention|Active, not recruiting||N/A|548|Actual|Beth Israel Deaconess Medical Center||3|||f||||f||||||||No||2017-10-10 21:28:32.994875|2017-10-10 21:28:32.994875
NCT03013803|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-10|||December 2016||2016-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Fuchsia||Acceptability Study on Nutricomp® Drink Plus Fibre in Adults|Acceptability Study on Nutricomp® Drink Plus Fibre in Adults|Completed||N/A|19|Actual|B. Braun Melsungen AG||1|||f||||f||||||||||2017-10-10 21:28:33.097926|2017-10-10 21:28:33.097926
NCT03013790|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-07-10|||December 2016||2016-12-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MICE||Melatonin Use in the Intensive Care Elderly Population|Melatonin Use in the Intensive Care Elderly Population|Recruiting||Phase 4|600|Anticipated|MICE Trial Group||3|||f||||t||||||||||2017-10-10 21:28:33.24123|2017-10-10 21:28:33.24123
NCT03013764|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-09-05|||October 2015||2015-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Diet Composition and Physical Inactivity on Insulin Sensitivity and β-cell Function|Interaction Between Diet Composition and Physical Inactivity on Insulin Sensitivity and β-cell Function|Recruiting||N/A|12|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 21:28:33.424182|2017-10-10 21:28:33.424182
NCT03013751|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-24|||January 2017||2017-01-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|FUELExten||A Extension Study of Udenafil in Adolescents|A Phase III Extension Study of Udenafil in Adolescents With Single Ventricle Physiology After Fontan Palliation|Recruiting||Phase 3|300|Anticipated|Mezzion Pharma Co. Ltd||1|||f||||t|t|||||||||2017-10-10 21:28:33.525433|2017-10-10 21:28:33.525433
NCT03013738|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||May 2013||2013-05-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|GPS||The Effects of the GPS Program in Offenders|The Efficacy of the Growing Pro-Social (GPS) Program in Male Prison Inmates: A Randomized Controlled Trial|Completed||N/A|270|Actual|University of Coimbra||2|||f||||f||||||||||2017-10-10 21:28:33.750601|2017-10-10 21:28:33.750601
NCT03013725|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-05|||January 1992||1992-01-01|January 2017|2017-01-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Observational|HUSK||The Hordaland Health Study|The Hordaland Health Studies (HHS)|Completed||N/A|36000|Actual|University of Bergen|||2||f||||||||||Samples Without DNA|"     Blood samples are stored at two biobanks located in Bergen and Levanger. The blood was     divided in full blood, plasma and serum.   "|||2017-10-10 21:28:33.828829|2017-10-10 21:28:33.828829
NCT03013712|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|CARTEPC||A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer|A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer|Recruiting||Phase 1/Phase 2|60|Anticipated|First Affiliated Hospital of Chengdu Medical College||1|||f||||t||||||||No||2017-10-10 21:28:33.894893|2017-10-10 21:28:33.894893
NCT03013699|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||January 2015||2015-01-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Diet Intervention, Head and Neck Cancer, Feasibility|Improving Dietary Patterns in Head and Neck Cancer Survivors to Optimize Disease Outcomes and Supportive Care: A Pilot/Feasibility Intervention Study|Completed||N/A|23|Actual|University of Alabama at Birmingham||2|||f||||f||||||||No||2017-10-10 21:28:33.986143|2017-10-10 21:28:33.986143
NCT03013686|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-07-26|||February 2013||2013-02-01|July 2017|2017-07-01|December 2033|Anticipated|2033-12-01|May 2018|Anticipated|2018-05-01||Interventional|PeriAPPAC||The Treatment of Periappendicular Abscess After the Acute Phase|The Treatment of Periappendicular Abscess After the Acute Phase (PeriAPPAC): a Randomized Clinical Trial Interval Appendectomy Versus Follow-up|Active, not recruiting||N/A|110|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-10 21:28:34.065477|2017-10-10 21:28:34.065477
NCT03010020|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-08-16|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||STI Screening as a Combined HIV Prevention Platform for MSM in Peru|STI Screening as a Combined HIV Prevention Platform for MSM in Peru|Recruiting||N/A|150|Anticipated|University of California, Los Angeles||3|||f||||f|f|f||||||||2017-10-10 21:29:08.850049|2017-10-10 21:29:08.850049
NCT03013673|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|May 2021|Anticipated|2021-05-01||Observational|PreLeisH||Predicting Visceral Leishmaniasis in HIV Infected Patients|Predicting Visceral Leishmaniasis in HIV Infected Patients|Not yet recruiting||N/A|1045|Anticipated|Institute of Tropical Medicine, Belgium|||1||f||||f||||||Samples With DNA|"     All samples and sample left-overs (blood and urine) not used during the course of this study     will be stored for 25 years after the end of the study.   "|||2017-10-10 21:28:34.163741|2017-10-10 21:28:34.163741
NCT03013660|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-08-09|||January 2017||2017-01-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|||Supporting Mothers of Preterm Infants|Supporting Mothers of Preterm Infants: A Randomized Controlled Trial|Recruiting||N/A|68|Anticipated|Tufts Medical Center||2|||f||||f||||||||||2017-10-10 21:28:34.261878|2017-10-10 21:28:34.261878
NCT03013647|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-01-05|||September 2016||2016-09-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization|Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization - Clinical and Histopathological Analysis|Recruiting||N/A|20|Anticipated|University of Sao Paulo General Hospital||1|||f||||t||||||||Yes||2017-10-10 21:28:34.362436|2017-10-10 21:28:34.362436
NCT03013634|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-04|||October 2016||2016-10-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation||Recruiting||N/A|100|Anticipated|Tianjin First Central Hospital||2|||f||||t||||||||No||2017-10-10 21:28:34.461671|2017-10-10 21:28:34.461671
NCT03013621|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-01-05|||January 2017||2017-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|COVD||Venous Congestion and Acute Renal Failure in Cardiac Surgery Postoperative|Venous Congestion and Acute Renal Failure in Cardiac Surgery Postoperative (COVD)|Not yet recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:28:34.553811|2017-10-10 21:28:34.553811
NCT03013608|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-07|||May 22, 2017|Actual|2017-05-22|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|Ongl'HUS||Children's Nail Bed Injuries : Study of the Efficacy of the Simple Relocation of Nail Plate|Children's Nail Bed Injuries : Study of the Efficacy of the Simple Relocation of Nail Plate|Recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France||1|||f||||f|f|f||||||||2017-10-10 21:28:34.642383|2017-10-10 21:28:34.642383
NCT03013595|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-05|||October 2015||2015-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|January 2017|Anticipated|2017-01-01||Interventional|MILESTONE||The MILESTONE Study: Improving Transition From Child to Adult Mental Health Care|The Effectiveness of Managed Transition in Improving the Health and Social Outcomes for Young People Transitioning From Child to Adult Mental Health Care: the MILESTONE Study|Recruiting||N/A|1000|Anticipated|University of Warwick||2|||f||||t||||||||||2017-10-10 21:28:34.73711|2017-10-10 21:28:34.73711
NCT03013582|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01||||July 2018|Anticipated|2018-07-01||Interventional|||Amniotic Membrane Wrapping and Tenolysis Versus Tenolysis Alone for Treatment of Tendon Adhesions of the Hand/Wrist|A Prospective Randomized Trial Comparing Tendon Wrapping With Amniotic Membrane and Tenolysis Versus Tenolysis Alone for Treatment of Tendon Adhesions of the Hand and Wrist|Not yet recruiting||N/A|40|Anticipated|Thomas Jefferson University||2|||f||||||||||||||2017-10-10 21:28:34.880576|2017-10-10 21:28:34.880576
NCT03013569|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-05-15|||January 2017||2017-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||"Spontaneous Fetal EEG Recording During Labor"|"Can Spontaneous Fetal EEG Be Recorded During Labor Using the Established Fetal Scalp Electrode Heart Rate Monitoring System?"|Recruiting||N/A|30|Anticipated|University of Washington|||1||f||||f|f|f||||||Undecided||2017-10-10 21:28:34.969024|2017-10-10 21:28:34.969024
NCT03013556|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-01-16|||November 2016||2016-11-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients|A Prospective, Randomized, Multicenter, Open-label Study of Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients|Recruiting||Phase 4|180|Anticipated|Ruijin Hospital||3|||f||||||||||||||2017-10-10 21:28:35.061875|2017-10-10 21:28:35.061875
NCT03013543|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-10|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity|Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity|Recruiting||Phase 2/Phase 3|25|Anticipated|Rhythm Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 21:28:35.181663|2017-10-10 21:28:35.181663
NCT03013530|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-01|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Assessment of Factors Involved in the Decision-making for ICU Patients' Care|Assessment of Factors Involved in the Decision-making for ICU Patients' Care|Recruiting||N/A|20|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 21:28:35.284061|2017-10-10 21:28:35.284061
NCT03013517|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-09-07|||January 2017||2017-01-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|PEOPLE||Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children|Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut|Active, not recruiting||Phase 3|300|Actual|DBV Technologies||1|||f||||t||||||||||2017-10-10 21:28:35.369656|2017-10-10 21:28:35.369656
NCT03013504|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-08-14|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|TROIKA||A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in Patients With HER2+ Early Breast Cancer|A Randomised, Double-blind, Parallel Group, Equivalence, Multicentre Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in Patients With HER2+ Early Breast Cancer|Not yet recruiting||Phase 3|500|Anticipated|Prestige Biopharma Pte Ltd||2|||f||||t|f|f|||f|||||2017-10-10 21:28:35.512266|2017-10-10 21:28:35.512266
NCT03013296|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-05-24|||October 2016||2016-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)|Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)|Active, not recruiting||N/A|12|Actual|University Hospital, Gentofte, Copenhagen||4|||f||||t||||||||Undecided||2017-10-10 21:28:37.073857|2017-10-10 21:28:37.073857
NCT03013491|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-08-22|||January 2017||2017-01-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas|An Open-Label, Dose-Finding and Proof of Concept Study of the PD-L1 Probody™ Therapeutic , CX-072, as Monotherapy and in Combination With Yervoy (Ipilimumab) or With Zelboraf (Vemurafenib) in Subjects With Advanced or Recurrent Solid Tumors or Lymphomas|Recruiting||Phase 1/Phase 2|150|Anticipated|CytomX Therapeutics||5|||f||||||||||||||2017-10-10 21:28:35.615676|2017-10-10 21:28:35.615676
NCT03013478|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||November 2016||2016-11-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Computer Based Training in CBT in Primary Care|Computer Based Training in CBT in Primary Care|Recruiting||N/A|60|Anticipated|Yale University||2|||f||||t||||||||Yes||2017-10-10 21:28:35.756526|2017-10-10 21:28:35.756526
NCT03013465|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-05-23|||February 27, 2017|Actual|2017-02-27|May 2017|2017-05-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||Daily Consumption of Well-Cooked Broccoli May Affect Glucosinolate Metabolites and Inflammatory Biomarkers|Daily Consumption of Well-Cooked Broccoli May Affect Glucosinolate Metabolites and Inflammatory Biomarkers|Completed||N/A|18|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f|f|f||||||No||2017-10-10 21:28:35.84225|2017-10-10 21:28:35.84225
NCT03013452|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-07-19|||March 9, 2017|Actual|2017-03-09|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|October 30, 2018|Anticipated|2018-10-30||Interventional|oPEP-vs-AD||Oscillating PEP vs Autogenic Drainage in People With Bronchiectasis|A Randomized Controlled Trial of Long Term Airway Clearance With Oscillating Positive End Expiratory Pressure Device Versus Autogenic Drainage in People With Bronchiectasis|Recruiting||N/A|50|Anticipated|Carmel Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 21:28:35.922193|2017-10-10 21:28:35.922193
NCT03013439|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-02-02|||January 6, 2017|Actual|2017-01-06|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)|Phase I Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Administered as Single Bolus Injections or Infusions in Japanese Subjects With Iron Deficiency Anemia|Recruiting||Phase 1|24|Anticipated|Pharmacosmos A/S||4|||f||||f||||||||No||2017-10-10 21:28:36.013129|2017-10-10 21:28:36.013129
NCT03013426|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-10-04|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase Ib Study of NVX-508 in Sickle Cell Disease|A Phase Ib, Dose-finding, Pharmacokinetic, Pharmacodynamic Study of NVX-508 in Sickle Cell Disease Patients|Not yet recruiting||Phase 1|24|Anticipated|University of Pittsburgh||1|||f||||t|t|f||||||||2017-10-10 21:28:36.093494|2017-10-10 21:28:36.093494
NCT03013413|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-04|||September 2011||2011-09-01|January 2017|2017-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy|Evaluation of the Aixplorer Ultrasound System for Evaluation of the Prostate|Completed||N/A|99|Actual|Thomas Jefferson University||1|||f||||f||||||||||2017-10-10 21:28:36.170065|2017-10-10 21:28:36.170065
NCT03013400|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-09-29|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Ebselen as an add-on Treatment in Hypo/Mania|A Randomised, Parallel Group, Double Blind, Placebo Controlled, Add on Clinical Trial to Investigate Whether the Lithium Mimetic, Ebselen, Can Reduce Symptoms of Hypomania and Mania in Bipolar Patients|Recruiting||Phase 2|60|Anticipated|University of Oxford||2|||f||||t|f|f||||||||2017-10-10 21:28:36.23974|2017-10-10 21:28:36.23974
NCT03013387|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-08-23|||January 2017||2017-01-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Dosimetry Guided PRRT With 90Y-DOTATOC|Phase II, Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) in Children and Adults With Neuroendocrine and Other Somatostatin Receptor Expressing Tumors|Withdrawn||Phase 2|0|Actual|University of Iowa||1||"This project has undergone a significant amount of updates and has been resubmitted under IRB#   201708778"|f||||t||||||||||2017-10-10 21:28:36.344266|2017-10-10 21:28:36.344266
NCT03013374|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-09|||January 2015||2015-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Observational|||Protein Balance and Body Composition in Preterm Infants|Protein Balance and Body Composition in Preterm Infants According to Feeding Regimen|Recruiting||N/A|30|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||2||f||||f||||||Samples Without DNA|"     Urine   "|Undecided||2017-10-10 21:28:36.422586|2017-10-10 21:28:36.422586
NCT03013361|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||July 2013||2013-07-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Ropivacaine and Bupivacaine in Sphenopalatine Ganglion Block in Sinus Surgery|Comparison Ropivacaine and Bupivacaine in Sphenopalatine Ganglion Block for Postoperative Analgesia After Functional Endoscopic Sinus Surgery: A Randomized Controlled Trial|Completed||Phase 3|60|Actual|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||No||2017-10-10 21:28:36.501035|2017-10-10 21:28:36.501035
NCT03013348|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-10|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Automated Identification of Psychogenic Nonepileptic Seizures|Automated Identification of Psychogenic Nonepileptic Seizures|Enrolling by invitation||N/A|90|Anticipated|Brain Sentinel|||3||f||||f||||||||||2017-10-10 21:28:36.572068|2017-10-10 21:28:36.572068
NCT03013335|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-01-05|||January 2016||2016-01-01|January 2017|2017-01-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|NIVOREN||Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen|A Phase II Safety Trial of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen|Recruiting||Phase 2|450|Anticipated|UNICANCER||1|||f||||t||||||||||2017-10-10 21:28:36.637011|2017-10-10 21:28:36.637011
NCT03013322|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-01-04|||August 2014||2014-08-01|January 2017|2017-01-01||||April 2017|Anticipated|2017-04-01||Interventional|||Anticholium® Per Se|Anticholium® Per Se a Randomized, Double-blind, Placebo-controlled, Monocentric Trial on the Adjunctive Use of Physostigmine Salicylate (Anticholium®) in Perioperative Sepsis and Septic Shock|Recruiting||N/A|20|Anticipated|University Hospital Heidelberg||2|||f||||f||||||||Undecided||2017-10-10 21:28:36.742994|2017-10-10 21:28:36.742994
NCT03013283|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-04-20|||February 7, 2017|Actual|2017-02-07|March 2017|2017-03-01|February 7, 2018|Anticipated|2018-02-07|February 7, 2018|Anticipated|2018-02-07||Observational|InterfaceVent||CPAP and NIV Interfaces : Side-effects in Home Care Patients|Descriptional Study of the Side Effects Related to the Use of the Interface in Home Care Patients Treated for at Least 3 Months by Continuous Positive Pressure or Non-Invasive Ventilation.|Recruiting||N/A|6000|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||Undecided||2017-10-10 21:28:37.176855|2017-10-10 21:28:37.176855
NCT03013270|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-04|||September 2016||2016-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|ARISTOS-HF||Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure|Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure. The ARISTOS-HF Trial: a Prospective Randomized Multicenter Trial|Recruiting||N/A|60|Anticipated|Onassis Cardiac Surgery Centre||4|||f||||f||||||||Undecided||2017-10-10 21:28:37.293503|2017-10-10 21:28:37.293503
NCT03013257|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-12|||April 25, 2017|Actual|2017-04-25|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||HIFU vs RAI in the Relapsed Graves' Disease|A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease|Recruiting||N/A|266|Anticipated|The University of Hong Kong||2|||f||||t|f|f||||||||2017-10-10 21:28:37.498787|2017-10-10 21:28:37.498787
NCT03013244|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-05|||September 2014||2014-09-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Reducing Eating Disorder Risk Factors Among College-Aged Males|A Randomized Controlled Trial of The Body Project: More Than Muscles for Males With Body Dissatisfaction|Completed||N/A|112|Actual|Florida State University||2|||f||||||||||||No||2017-10-10 21:28:37.673075|2017-10-10 21:28:37.673075
NCT03013231|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-10-03|||January 20, 2017|Actual|2017-01-20|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Effect of Patient Resilience on Return to Sport Post ACL Reconstruction Surgery|Effect of Patient Resilience on Return to Sport Post ACL Reconstruction Surgery|Recruiting||N/A|100|Anticipated|St. Louis University|||1||f||||f||||||||||2017-10-10 21:28:37.801101|2017-10-10 21:28:37.801101
NCT03013218|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-06-28|||February 3, 2017|Actual|2017-02-03|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of ALX148 in Patients With Advanced Solid Tumors and Lymphoma|A Phase 1, Dose Escalation Study of ALX148 in Patients With Advanced Solid Tumors and Lymphoma|Recruiting||Phase 1|110|Anticipated|Alexo Therapeutics, Inc.||3|||f||||f|t|f||||||No||2017-10-10 21:28:37.939153|2017-10-10 21:28:37.939153
NCT03013205|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-05|||February 2017||2017-02-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy of Corticosteroid Injection Into Coracohumeral Ligament in Patients With Adhesive Capsulitis of the Shoulder|Efficacy of Corticosteroid Injection Into Coracohumeral Ligament in Patients With Adhesive Capsulitis of the Shoulder|Not yet recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 21:28:38.100007|2017-10-10 21:28:38.100007
NCT03013179|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-02-27|||September 2014||2014-09-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|InterGEN||Intergenerational Blood Pressure Study|Intergenerational Impact of Genetic and Psychological Factors on Blood Pressure|Recruiting||N/A|500|Anticipated|Yale University|||1||f||||f||||||Samples With DNA|"     Saliva sample for DNA   "|Yes|Genomic Data Sharing Plan in place, in accordance with NIH regulations Only de-identified genomic data will be shared with dbGaP, to which other researchers will be able to apply for access. Data will be submitted within 1 year after analyses are complete.|2017-10-10 21:28:38.294259|2017-10-10 21:28:38.294259
NCT03013166|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-01-05|||September 2016||2016-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or Prednisolone|Resource Use and Clinical Outcomes in Patients With Adrenal Insufficiency Prescribed Either an Immediate Release or Modified Release Hydrocortisone Formulation or Prednisolone: A THIN (The Health Improvement Network) Database Study|Completed||N/A|3500|Actual|Shire|||4||f||||f||||||||No||2017-10-10 21:28:38.396831|2017-10-10 21:28:38.396831
NCT03013153|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-01-11|||December 2016||2016-12-01|December 2016|2016-12-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Low or High Ligation of the IMA With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery|Low or High Ligation of the Inferior Mesenteric Artery With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery: A Prospective, Multi-Center, Randomized, Open-Label, Parallel Group, Non-Inferiority Clinical Trial (LAND)|Recruiting||N/A|748|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||Yes||2017-10-10 21:28:38.504095|2017-10-10 21:28:38.504095
NCT03013140|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Preloading to Prevent Hypotension During Cesarean Section|Pre-optimization of Fluid Status to Prevent Hypotension by Non-invasive Arterial Pressure Monitor During Cesarean Section|Not yet recruiting||N/A|80|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 21:28:38.680492|2017-10-10 21:28:38.680492
NCT03013127|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-05-30|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|November 2019|Anticipated|2019-11-01||Interventional|PROMO||A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery|PROMO: A Phase II Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery|Recruiting||Phase 2|25|Anticipated|Oslo University Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 21:28:38.774557|2017-10-10 21:28:38.774557
NCT03013114|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ITP||A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)|A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) With High Anti-platelet Antibodies Level|Not yet recruiting||Phase 2|20|Anticipated|Shandong University||1|||f||||t||||||||||2017-10-10 21:28:38.881913|2017-10-10 21:28:38.881913
NCT03013101|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-05|||December 2016||2016-12-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma|A Phase II, Open, Multi-center and Single Arm Study Investigating Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Injection in Patients With Locally Advanced or Metastatic Melanoma and Standard Treatment Failure|Recruiting||Phase 2|120|Anticipated|Shanghai Junshi Bioscience Co.,Ltd.||1|||f||||t||||||||||2017-10-10 21:28:38.975417|2017-10-10 21:28:38.975417
NCT03013088|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-04-24|||December 2016||2016-12-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SCSPFIM||Soundbite Crossing System Peripheral First in Man (SCSPFIM)|A First in Man Study to Assess the Soundbite Crossing System When Used to Cross Infrainguinal Chronic Total Occlusions|Recruiting||N/A|50|Anticipated|SoundBite Medical Solutions, Inc.||1|||f||||f||||||||No||2017-10-10 21:28:39.119503|2017-10-10 21:28:39.119503
NCT03013075|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-06-01|||November 2016||2016-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||General Plus Spinal Anesthesia and General Anesthesia Alone on Right Ventricular Function|Comparative Effect of Combined High Spinal and General Anaesthesia With General Anaesthesia Alone On Right Ventricular Function In Patients With Mitral Valvular Disease With Pulmonary Hypertension|Recruiting||Phase 4|50|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 21:28:39.231389|2017-10-10 21:28:39.231389
NCT03013062|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-06-01|||January 2017||2017-01-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Relation Between Mean Pulmonary Artery Pressure and Pulmonary Acceleration Time and Comparison With Previous Formulae|Derivation of New Formula Relating Pulmonary Acceleration Time and Mean Pulmonary Artery Pressure in Indian Population and Comparison With Previous Formulas|Recruiting||N/A|50|Anticipated|Postgraduate Institute of Medical Education and Research|||1||f||||f||||||||||2017-10-10 21:28:39.325044|2017-10-10 21:28:39.325044
NCT03013049|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-05|||January 2016||2016-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Novel Surgical Method in the Treatment of Unstable Vitiligo|A Comparative Study Between Autologous Non Cultured Epidermal Cell Suspension Versus Combination of Autologous Non Cultured Epidermal Cell Suspension and Non Cultured Dermal Cell Suspension in Stable Vitiligo|Recruiting||N/A|40|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||No||2017-10-10 21:28:39.394086|2017-10-10 21:28:39.394086
NCT03013036|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-05|||February 2013||2013-02-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Ultrasonography for Prediction of Difficult Intubation and Prediction of Endotracheal Tube Size|Ultrasonographic Thyrohyoid Distance Measurement for Prediction of Difficult Intubation and Ultrasonographic Prediction of Pediatric Endotracheal Tube Size|Recruiting||N/A|150|Anticipated|Istanbul University||3|||f||||t||||||||Undecided||2017-10-10 21:28:39.475767|2017-10-10 21:28:39.475767
NCT03013023|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-05|||April 2015||2015-04-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||Effects of Early Behavioral and Transaction Interventions on Preterm Infants' and Parents' Biopsychosocial Well-being|Early Behavioral and Transaction Interventions on Preterm Infants' and Parents' Biopsychosocial Well-being|Active, not recruiting||N/A|60|Anticipated|National Defense Medical Center, Taiwan||4|||f||||t||||||||No||2017-10-10 21:28:39.563422|2017-10-10 21:28:39.563422
NCT03013010|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-24|||December 2016||2016-12-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|PREACT||A Randomized, Controlled, Multicenter Study to Compare Preoperative Radiochemotherapy With Preoperative Chemotherapy in Patients With Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma|A Randomized, Controlled, Multicenter Study to Compare Preoperative Radiochemotherapy With Preoperative Chemotherapy in Patients With Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma (PREACT Study)|Recruiting||Phase 3|682|Anticipated|Shanghai Cancer Hospital, China||2|||f||||t||||||||||2017-10-10 21:28:39.653126|2017-10-10 21:28:39.653126
NCT03012997|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-05|||December 2016||2016-12-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effects of Hyperoxia on Open Heart Surgery|Effects of Hyperoxia on Oxidative Stress in Patients Undergoing Open Heart Surgery|Recruiting||N/A|100|Anticipated|Istanbul University||2|||f||||f||||||||||2017-10-10 21:28:39.755525|2017-10-10 21:28:39.755525
NCT03012984|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium|Impact of Dexmedetomidine Supplemented Analgesia on Incidence of Delirium in Elderly Patients After Cancer Surgery: a Multicenter Randomized Controlled Trial|Recruiting||Phase 4|1200|Anticipated|Peking University First Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:28:39.849284|2017-10-10 21:28:39.849284
NCT03012971|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2024|Anticipated|2024-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Dexmedetomidine Supplemented Analgesia and 3-Year Survival After Cancer Surgery|Impact of Dexmedetomidine Supplemented Analgesia on 3-Year Survival in Elderly Patients After Cancer Surgery: a Multicenter Randomized Controlled Trial|Recruiting||Phase 4|1200|Anticipated|Peking University First Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:28:39.991977|2017-10-10 21:28:39.991977
NCT03012958|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||July 2014||2014-07-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|LCI||Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease|Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease|Recruiting||Early Phase 1|400|Anticipated|National Jewish Health||2|||f||||t||||||||Undecided||2017-10-10 21:28:40.145814|2017-10-10 21:28:40.145814
NCT03012945|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-01-05|||November 2014||2014-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Epidural Anesthesia-analgesia and Long-term Outcome|Impact of Epidural Anesthesia-analgesia on Long-term Outcome in Elderly Patients After Surgery: 3-year Follow-up of a Multicenter Randomized Controlled Trial|Active, not recruiting||N/A|1800|Actual|Peking University First Hospital||2|||f||||t||||||||Yes||2017-10-10 21:28:40.250868|2017-10-10 21:28:40.250868
NCT03012737|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Palliation of Dyspnea With Mouth Piece Ventilation|Palliation of Dyspnea With Mouth Piece Ventilation|Recruiting||N/A|60|Anticipated|Tampere University Hospital||1|||f||||f||||||||No||2017-10-10 21:28:44.389109|2017-10-10 21:28:44.389109
NCT03012932|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women|HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women: A Pilot Study|Not yet recruiting||N/A|30|Anticipated|University of Miami||1|||f||||f||||||||No||2017-10-10 21:28:40.343957|2017-10-10 21:28:40.343957
NCT03012919|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-06-17|||February 2015||2015-02-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of an Active Decision Support System for Hemodynamic Optimization During High Risk Vascular Surgery|Evaluation of an Active Decision Support System for Hemodynamic Optimization During High Risk Vascular Surgery|Completed||N/A|31|Actual|Medical University of Vienna||1|||f||||||||||||||2017-10-10 21:28:40.400315|2017-10-10 21:28:40.400315
NCT03012906|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01|2 Years|Observational [Patient Registry]|||Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions|Prospective Multicenter Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions|Recruiting||N/A|500|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||No||2017-10-10 21:28:40.480193|2017-10-10 21:28:40.480193
NCT03012893|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-15|||December 2016||2016-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Identification of C7; Evaluations of 2 Sonographic Methods Using a Transverse and a Sagittal Scan.|Identification of the C7 Vertebral Level; Evaluations of Two Sonographic Methods Using a Transverse Scan of the C7 Transverse Process and a Sagittal Scan of the First Rib.|Completed||N/A|20|Actual|Mahidol University||3|||f||||t||||||||No||2017-10-10 21:28:40.547686|2017-10-10 21:28:40.547686
NCT03012880|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-10-02|||April 12, 2017|Actual|2017-04-12|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma|Phase 2 Trial of Ixazomib, Lenalidomide, Dexamethasone, and Daratumumab in Patients With Newly Diagnosed Multiple Myeloma|Recruiting||Phase 2|40|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:28:40.620068|2017-10-10 21:28:40.620068
NCT03012867|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||June 2010||2010-06-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|July 2014|Actual|2014-07-01||Interventional|||Enteral Nutrition and Glucose Homeostasis|Effect of Different Enteral Nutrition Formulas on Glucose Homeostasis|Completed||Phase 4|60|Actual|Medical University of Vienna||2|||f||||f||||||||No||2017-10-10 21:28:40.764257|2017-10-10 21:28:40.764257
NCT03012854|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-05-11|||December 2016||2016-12-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Different Surgical Procedures of Peroral Endoscopic Myotomy(POEM) for Esophageal Achalasia|Different Surgical Procedures of Peroral Endoscopic Myotomy(POEM) for Esophageal Achalasia: a Multicenter Prospective Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|Nanfang Hospital of Southern Medical University||4|||f||||t||||||||No||2017-10-10 21:28:40.861653|2017-10-10 21:28:40.861653
NCT03012828|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-20|||January 2017||2017-01-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Potential Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers|Completed||Phase 1|60|Actual|Medicines Development Limited||6|||f||||f||||||||||2017-10-10 21:28:42.651942|2017-10-10 21:28:42.651942
NCT03012815|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-02-15|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 1, 2019|Anticipated|2019-12-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Gabapentin for Alcohol Withdrawal Syndrome|A Prospective Randomized Controlled Open Label Trial of Symptom-triggered Benzodiazepine Versus Fixed-dose Gabapentin for Alcohol Withdrawal Syndrome|Recruiting||Phase 4|400|Anticipated|Mayo Clinic||2|||f||||f|t|f||||||No||2017-10-10 21:28:42.730607|2017-10-10 21:28:42.730607
NCT03012802|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-27|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 15, 2018|Anticipated|2018-01-15|60 Days|Observational [Patient Registry]|POWER||Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol|Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Lower Gastrointestinal Surgery|Recruiting||N/A|1068|Anticipated|Grupo Español de Rehabilitación Multimodal|||1||f||||t||||||||||2017-10-10 21:28:42.859862|2017-10-10 21:28:42.859862
NCT03012789|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-05-18|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|NETest_Sx||Surgical Intervention and the NETest|Diagnosis of Neuroendocrine Neoplasms and Assessment of Response to Surgery by Means of Measurement of Gene Transcripts in Blood|Recruiting||N/A|40|Anticipated|Wren Laboratories LLC||1|||f||||f|f|f||||||||2017-10-10 21:28:43.48433|2017-10-10 21:28:43.48433
NCT03012776|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-26|||January 2017||2017-01-01|July 2017|2017-07-01|September 2023|Anticipated|2023-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Pivotal Study of the Premia Spine TOPS™ System|A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS™ System|Recruiting||N/A|266|Anticipated|Premia Spine||2|||f||||t||||||||||2017-10-10 21:28:43.587556|2017-10-10 21:28:43.587556
NCT03012763|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01||||January 2017|Actual|2017-01-01||Interventional|||Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums|Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan After Oral Administration Using 240 ml Non-caloric Water, a Carbohydrate Enriched Drink and Grapefruit Juice in Correlation to the Intestinal Availability of Water as Quantified by MRI-based Volumetry in 9 Healthy Male and Female Subjects|Completed||Phase 1|9|Actual|University Medicine Greifswald||3|||f||||f||||||||No||2017-10-10 21:28:43.714758|2017-10-10 21:28:43.714758
NCT03012750|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||February 2015||2015-02-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Angiosome Perfusion After Tibial Bypass||Completed||Phase 2|40|Actual|University Hospital Erlangen||1|||f||||f||||||||||2017-10-10 21:28:43.816692|2017-10-10 21:28:43.816692
NCT03012724|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-07-31|||March 30, 2017|Actual|2017-03-30|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)|A Prospective Multicenter Double Blind Randomized Controlled Trial to Demonstrate That the Efficacy of the H7-Coil is as Good as the Efficacy of the H1-Coil Deep Transcranial Magnetic Stimulation (DTMS) in Subjects With Major Depression Disorder (MDD)|Recruiting||N/A|106|Anticipated|Brainsway||2|||f||||t|f|t|t|||||||2017-10-10 21:28:44.490969|2017-10-10 21:28:44.490969
NCT03012711|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|NME hip/core||The Effects of Neuromuscular Exercise Training on Core Stability and Hip Strength in Healthy Adolescent Females|The Effectiveness of Neuromuscular Exercise Training on Core Stability and Hip Strength in Healthy Adolescent Females|Not yet recruiting||N/A|40|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-10 21:28:44.594556|2017-10-10 21:28:44.594556
NCT03012698|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-27|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|February 28, 2019|Anticipated|2019-02-28|February 2019|Anticipated|2019-02-01||Interventional|||Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye|Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye|Not yet recruiting||N/A|30|Anticipated|Epitech Mag Ltd.||1|||f|||||f|f||||||||2017-10-10 21:28:44.658682|2017-10-10 21:28:44.658682
NCT03012685|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-01-09|||October 2016||2016-10-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|||Sleep and Wellbeing Study|Relationship Between Sleep the First Night and Week After Trauma and Subsequent Intrusive Memories: a Prospective Study From the Emergency Department|Recruiting||N/A|100|Anticipated|University of Oxford|||1||f||||f||||||||Yes|It is planned to make an anonymised database available via the Open Science Framework|2017-10-10 21:28:44.721732|2017-10-10 21:28:44.721732
NCT03012672|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-06-19|||December 30, 2016|Actual|2016-12-30|June 2017|2017-06-01|July 15, 2020|Anticipated|2020-07-15|July 15, 2020|Anticipated|2020-07-15||Interventional|||Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm|Impact of Treatment Intensity on Survival, Quality of Life, and Resource Utilization in Medically Less Fit Adults With Acute Myeloid Leukemia and Analogous Myeloid Neoplasms: A Randomized Pilot Study|Recruiting||Phase 2|50|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-10 21:28:44.809379|2017-10-10 21:28:44.809379
NCT03012659|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-13|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 29, 2017|Actual|2017-06-29||Interventional|CES||Contraceptive Equity Study 2016|Contraceptive Equity Study|Active, not recruiting||N/A|1015|Actual|Planned Parenthood Federation of America||2|||f||||f||||||||||2017-10-10 21:28:44.986894|2017-10-10 21:28:44.986894
NCT03012646|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-07|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD|A Prospective, Multicenter, Single-arm Study to Evaluate the Safety and Tolerability of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease|Withdrawn||Phase 2|0|Actual|United Therapeutics||1||Business decision|f||||t|t|f||||||||2017-10-10 21:28:45.229511|2017-10-10 21:28:45.229511
NCT03012633|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||January 2017||2017-01-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|FILYTHO||Rapid Diagnostic of Hyperfibrinolysis in Liver Transplantation|Rapid Diagnostic of Hyperfibrinolysis in Liver Transplantation|Not yet recruiting||N/A|30|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||No||2017-10-10 21:28:45.331107|2017-10-10 21:28:45.331107
NCT03012620|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-09-05|||July 5, 2017|Actual|2017-07-05|September 2017|2017-09-01|December 2023|Anticipated|2023-12-01|January 2023|Anticipated|2023-01-01||Interventional|AcSé||Secured Access to Pembrolizumab for Adult Patients With Selected Rare Cancer Types|Secured Access to Pembrolizumab for Adult Patients With Selected Rare Cancer Types|Recruiting||Phase 2|300|Anticipated|UNICANCER||1|||f||||t|f|f|||f|||||2017-10-10 21:28:45.43772|2017-10-10 21:28:45.43772
NCT03012607|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-03-02|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|TARGET||Tenofovir Adherence to Rapidly Guide and Evaluate PrEP and HIV Therapy|Pharmacokinetics of Tenofovir in Blood, Plasma and Urine of Healthy Adults With Perfect, Median and Low Drug Adherence|Enrolling by invitation||N/A|30|Anticipated|University of Washington||3|||f||||f||||||||Undecided|We will make decisions to share IPD on case by case basis|2017-10-10 21:28:45.551838|2017-10-10 21:28:45.551838
NCT03012594|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-13|||November 2016||2016-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Lanreotide in the Treatment of Small Bowel Motility Disorders|A Pilot Study to Evaluate Safety and Effectiveness of Lanreotide in the Treatment of Patients With Small Bowel Motility Disorders (SBMD): a Prospective, Non-randomized, Single-center Study of 20 Participants|Recruiting||Phase 2|20|Anticipated|Northwell Health||1|||f||||f||||||||No||2017-10-10 21:28:45.664729|2017-10-10 21:28:45.664729
NCT03012581|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-07-19|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|January 2023|Anticipated|2023-01-01||Interventional|AcSé||Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types|Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types|Recruiting||Phase 2|250|Anticipated|UNICANCER||1|||f||||t|f|f||||||||2017-10-10 21:28:45.826992|2017-10-10 21:28:45.826992
NCT03012568|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-05|2017-01-05|||November 2016||2016-11-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|ASSUREMRI||Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (SJM) Cardiac Rhythm Management Systems|ASSURE MRI Study - Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (SJM) Cardiac Rhythm Management Systems|Recruiting||N/A|88|Anticipated|St. Jude Medical|||1||f||||f||||||||Undecided||2017-10-10 21:28:45.937123|2017-10-10 21:28:45.937123
NCT03012555|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-04|||October 2014||2014-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Vitamin D3 in Patients With Sickle Cell Disease|Nutritional Vitamin D3 in Patients With Sickle Cell Disease|Active, not recruiting||N/A|50|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||Samples With DNA|"     Whole blood and urine   "|||2017-10-10 21:28:46.039858|2017-10-10 21:28:46.039858
NCT03012165|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-07-06|||December 2016||2016-12-01|March 2017|2017-03-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Study of ADX-102 in Subjects With Allergic Conjunctivitis||Completed||Phase 2|150|Anticipated|Aldeyra Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 21:28:49.357252|2017-10-10 21:28:49.357252
NCT03012542|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-03-07|||January 2017||2017-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease|Randomized Trial of Diet for Crohn's Disease and Impact on Disease Activity and the Microbiome|Recruiting||N/A|32|Anticipated|University of Washington||2|||f||||f||||||||Yes|Requests from investigators will be evaluated on a case by case basis. Data that may be shared include lab values, patient reported outcomes, questionnaires, and microbiome sequences. Specimens may also be shared. Researchers can request data from the study's Principal Investigator in writing.|2017-10-10 21:28:46.120507|2017-10-10 21:28:46.120507
NCT03012516|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-04|||January 2011||2011-01-01|December 2016|2016-12-01|November 2019|Anticipated|2019-11-01|June 2018|Anticipated|2018-06-01||Interventional|||Physical Activity on Prescription in Patients With Metabolic Risk Factors.|Physical Activity on Prescription With Two Different Strategies. One Year Follow-up Regarding Physical Activity Level, Metabolic Health and Health-related Quality of Life. A Randomized Controlled Trial.|Active, not recruiting||N/A|190|Actual|Vastra Gotaland Region||2|||f||||f||||||||No||2017-10-10 21:28:46.483038|2017-10-10 21:28:46.483038
NCT03012503|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||January 2013||2013-01-01|January 2017|2017-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Effect of Biofreeze on Post Manipulation Soreness in Patients With Mechanical Neck Pain|The Effect of Biofreeze on Post Manipulation Soreness in Patients With Mechanical Neck Pain|Completed||N/A|60|Actual|Marquette University||2|||f||||f||||||||No|Through publication and/or requests to the PI|2017-10-10 21:28:46.610004|2017-10-10 21:28:46.610004
NCT03012490|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-22|||February 27, 2017|Actual|2017-02-27|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|ECOST-CRT||Efficacy, Safety and Cost of Remote Monitoring of Patients With Cardiac Resynchronization Therapy|Efficacy, Safety and Cost of Comprehensive Versus Standard Remote Monitoring of Patients With Cardiac Resynchronization Therapy|Recruiting||N/A|652|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||||2017-10-10 21:28:46.710542|2017-10-10 21:28:46.710542
NCT03012477|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-03-24|||January 18, 2017|Actual|2017-01-18|March 2017|2017-03-01|December 2024|Anticipated|2024-12-01|September 2020|Anticipated|2020-09-01||Interventional|||CISPLATIN + AZD-1775 In Breast Cancer|A Phase II Study of Cisplatin + AZD1775 in Metastatic Triple-negative Breast Cancer and Evaluation of pCDC2 as a Biomarker of Target Response|Recruiting||Phase 2|37|Anticipated|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-10 21:28:46.829392|2017-10-10 21:28:46.829392
NCT03012464|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||Pathologic Assessment of Rectal Prolapse in the Young|Pathologic and Functional Assessment of Rectal Prolapse in Young Patients|Recruiting||N/A|10|Anticipated|Mansoura University|||1||f||||t||||||||No|No plan to share IPD|2017-10-10 21:28:46.92815|2017-10-10 21:28:46.92815
NCT03012451|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-04|||April 2015||2015-04-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|September 2016|Actual|2016-09-01||Interventional|||A Psychosocial Program Impact Evaluation in Jordan|Measuring the Health and Wellbeing Impacts of a Scalable Program of Psychosocial Intervention for Refugee Youth|Active, not recruiting||N/A|817|Actual|Yale University||2|||f||||t||||||||No|We are sharing the anonymized dataset with project collaborators, but only with other researchers upon explicit request.|2017-10-10 21:28:47.007224|2017-10-10 21:28:47.007224
NCT03012438|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-15|||March 23, 2017|Actual|2017-03-23|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||NIRF for Parathyroid Visualization: a Pilot Study|The Use of Near-Infrared Fluorescence Imaging in Parathyroid Visualization During Thyroid Surgery: a Pilot Study|Recruiting||N/A|30|Anticipated|Maastricht University Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:28:47.093482|2017-10-10 21:28:47.093482
NCT03012425|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-02|||January 3, 2017|Actual|2017-01-03|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Cognitive Behavioral Therapy for Insomnia (CBT-I) and Acupuncture for Insomnia and Related Distress Among Cancer Caregivers|Pilot Study of Cognitive Behavioral Therapy for Insomnia (CBT-I) and Acupuncture for Insomnia and Related Distress Among Cancer Caregivers|Recruiting||N/A|24|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 21:28:47.182645|2017-10-10 21:28:47.182645
NCT03012412|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-05|||May 2009||2009-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|February 2013|Actual|2013-02-01||Interventional|MBPI||Mindfulness Based Program for Infertility|Mindfulness Based Program for Infertility|Active, not recruiting||N/A|92|Actual|University of Coimbra||2|||f||||f||||||||No||2017-10-10 21:28:47.275228|2017-10-10 21:28:47.275228
NCT03012399|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-19|||March 7, 2017|Actual|2017-03-07|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Biobehavioral Effects of Hypnosis During Breast Cancer Surgery|Biobehavioral Effects of Hypnosis During Breast Cancer Surgery|Recruiting||N/A|50|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 21:28:47.362956|2017-10-10 21:28:47.362956
NCT03012386|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-22|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||CD36 in Nutrient Delivery and Its Dysfunction|Role of CD36 in Nutrient Delivery and Its Dysfunction in African Americans|Recruiting||Phase 1/Phase 2|40|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:28:47.453855|2017-10-10 21:28:47.453855
NCT03012373|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2017-01-05|||June 2016||2016-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|AAMTH||Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts|Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts|Enrolling by invitation||N/A|40|Anticipated|Lu-Tung Christian Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:28:47.678476|2017-10-10 21:28:47.678476
NCT03011970|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-03|||September 2014||2014-09-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin||Completed||Phase 1|116|Actual|University Hospital, Bonn||6|||f||||f||||||||||2017-10-10 21:28:51.302758|2017-10-10 21:28:51.302758
NCT03012360|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-07-03|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|TaVEM||Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis|Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis: a Prospective Randomized Placebo-controlled Double-blind Multicenter Trial|Not yet recruiting||Phase 4|315|Anticipated|University Hospital, Lille||3|||f||||f|f|f||||||||2017-10-10 21:28:47.789213|2017-10-10 21:28:47.789213
NCT03012347|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-15|||January 5, 2017|Actual|2017-01-05|August 2017|2017-08-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|||Evaluation of a Gel Sunscreen in Controlled Use Conditions (208/2016)|Evaluation of a Gel Sunscreen in Controlled Use Conditions|Completed||N/A|72|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 21:28:47.940441|2017-10-10 21:28:47.940441
NCT03012334|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-07-25|||February 7, 2017|Actual|2017-02-07|July 2017|2017-07-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|||The Effects of Lasmiditan on Simulated Driving Performance - Healthy Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, 5-Period, Cross-Over Study Assessing the Effects of Lasmiditan on Simulated Driving Performance in Normal Healthy Volunteers|Completed||Phase 1|90|Actual|CoLucid Pharmaceuticals||5|||f||||f|t|f||||||||2017-10-10 21:28:48.015982|2017-10-10 21:28:48.015982
NCT03012321|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-22|||January 2017||2017-01-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|December 2021|Anticipated|2021-12-01||Interventional|||Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects|BRCAAway: A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects|Recruiting||Phase 2|70|Anticipated|Northwestern University||4|||f||||t||||||||||2017-10-10 21:28:48.111485|2017-10-10 21:28:48.111485
NCT03012308|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-05-11|||December 20, 2016|Actual|2016-12-20|January 2017|2017-01-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20||Observational|ECHOPOG||Trans-thoracic Ultrasound VS Invasive Pressure of the Left Atrium|Evaluation of Left Ventricular Filling Pressures in Post-operative Cardiac Surgery: Trans-thoracic Ultrasound VS Invasive Pressure of the Left Atrium|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 21:28:48.254105|2017-10-10 21:28:48.254105
NCT03012295|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||August 2016||2016-08-01|January 2017|2017-01-01||||March 2017|Anticipated|2017-03-01||Observational|||Genetic Testing of Monogenic Hypertension in Chinese Population||Recruiting||N/A|1000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||||||||||||2017-10-10 21:28:48.332278|2017-10-10 21:28:48.332278
NCT03012282|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-22|||June 22, 2017|Actual|2017-06-22|August 2017|2017-08-01|September 30, 2025|Anticipated|2025-09-30|September 30, 2025|Anticipated|2025-09-30||Interventional|||CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer|Evaluation of CT Perfusion Parameters as a Potential Biomarker for Treatment Response in Pancreatic Cancer|Enrolling by invitation||N/A|75|Anticipated|University of Washington||1|||f||||t|f|t|f|||||||2017-10-10 21:28:48.402743|2017-10-10 21:28:48.402743
NCT03012269|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-01-04|||October 2012||2012-10-01|January 2017|2017-01-01||||October 2018|Anticipated|2018-10-01||Interventional|WMT||The Neural Substrates for Working Memory Training|The Study on the Brain Mechanisms for the Rehabilitation of Working Memory Deficits in Patients With Acquired Brain Injury Using Multimodal Magnetic Resonance Imaging|Recruiting||Phase 2/Phase 3|40|Anticipated|China Rehabilitation Research Center||2|||f||||||||||||||2017-10-10 21:28:48.494681|2017-10-10 21:28:48.494681
NCT03012256|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-08-28|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|DIVERT-CARE||The DIVERT-CARE (Collaboration Action Research & Evaluation) Trial|The DIVERT-CARE (Collaboration Action Research & Evaluation) Trial: A Multi Provincial Pragmatic Cluster Randomized Trial of Cardio-Respiratory Management in Home Care|Not yet recruiting||N/A|1800|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 21:28:48.586694|2017-10-10 21:28:48.586694
NCT03012243|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-15|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|||Bile Aspiration vs Drain in Acute Cholecystitis|Randomized Controlled Trial of Bile Aspiration vs Drain in Acute Cholecystitis|Not yet recruiting||N/A|40|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 21:28:48.716911|2017-10-10 21:28:48.716911
NCT03012230|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-28|||October 31, 2017|Anticipated|2017-10-31|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer|A Phase 1 Study of PD-1 Inhibition With Pembrolizumab Combined With JAK2 Inhibition in Triple Negative Breast Cancer|Not yet recruiting||Phase 1|18|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:28:48.815001|2017-10-10 21:28:48.815001
NCT03012217|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-10|||September 2016||2016-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|RP2||Prospective Clinical Evaluation of the FilmArray Respiratory Panel 2|Prospective Clinical Evaluation of the FilmArray Respiratory Panel 2 (RP2)|Completed||N/A|1612|Actual|BioFire Diagnostics, LLC|||1||f||||f||||||Samples With DNA|"     Nasopharyngeal swabs.   "|No||2017-10-10 21:28:48.939062|2017-10-10 21:28:48.939062
NCT03012204|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-03-14|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparing Effects of Various Combinations of 6 Hertz(Hz) rTMS & LFrTMS on Motor Recovery Due to Cerebrovascular Disease|Series Study About the rTMS Effects on the Recovery of Limb Motor Dysfunction Due to Cerebral Vascular Disease, Part 1: Comparing the Effects of Various Combinations Between 6 Hertz(Hz) rTMS & LFrTMS.|Recruiting||N/A|120|Anticipated|Beijing Hospital||4|||f||||t|f|f||||||Undecided||2017-10-10 21:28:49.039452|2017-10-10 21:28:49.039452
NCT03012191|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa Patients With Nonsense Mutations||Recruiting||Phase 1/Phase 2|7|Anticipated|University of Southern California||1|||f||||||||||||||2017-10-10 21:28:49.15322|2017-10-10 21:28:49.15322
NCT03012178|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|MRI-MVS||MRI as a Predictor of Outcomes in Patients Undergoing Mitral Valve Surgery|Prospective Evaluation of MRI as a Predictor of Outcomes in Patients Undergoing Mitral Valve Surgery: MRI-MVS Study|Not yet recruiting||N/A|100|Anticipated|Atlantic Health System|||1||f||||f||||||||No||2017-10-10 21:28:49.261472|2017-10-10 21:28:49.261472
NCT03012152|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||September 2012||2012-09-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|May 2013|Actual|2013-05-01||Interventional|||A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient Satisfaction|A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient Satisfaction Among Egyptian Females|Completed||N/A|70|Actual|Ain Shams University||2|||f||||t||||||||Undecided||2017-10-10 21:28:49.452031|2017-10-10 21:28:49.452031
NCT03012139|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology|Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology|Recruiting||N/A|120|Anticipated|Mayo Clinic|||3||f||||f||||||Samples With DNA|"     Plasma, serum, and skeletal muscle tissue will be collected.   "|Undecided||2017-10-10 21:28:49.514609|2017-10-10 21:28:49.514609
NCT03012126|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-05|||December 2016||2016-12-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CORD 2||Clinical & Community Approaches to Weight Management|Childhood Obesity Research Demonstration Project 2.0 (CORD 2.0)|Enrolling by invitation||N/A|500|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 21:28:49.602146|2017-10-10 21:28:49.602146
NCT03012113|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-04|||June 2016||2016-06-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|Mirab||Mirabegron and Brown Adipose Tissue|The Effect of Mirabegron on Brown Adipose Tissue in Healthy Young White Caucasian and South Asian Men|Recruiting||Phase 4|20|Anticipated|Leiden University Medical Center||3|||f||||t||||||||||2017-10-10 21:28:49.67304|2017-10-10 21:28:49.67304
NCT03012100|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-04-17|||March 31, 2017|Actual|2017-03-31|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|||Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer|Double Blind, Parallel Groups, Controlled, Randomized Phase II Trial to Evaluate Vaccination With Folate Receptor Alpha Peptide Vaccine With GM-CSF as Vaccine Adjuvant Following Oral Cyclophosphamide Versus GM-CSF/Placebo to Prevent Recurrence in Patients With Triple Negative Breast Cancer|Active, not recruiting||Phase 2|280|Anticipated|Academic and Community Cancer Research United||2|||f||||t|t|f||||||||2017-10-10 21:28:49.756133|2017-10-10 21:28:49.756133
NCT03012087|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-21|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Using m-Health Tools to Reduce the Misuse of Opioid Pain Relievers|Using m-Health Tools to Reduce the Misuse of Opioid Pain Relievers|Completed||N/A|123|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 21:28:49.919713|2017-10-10 21:28:49.919713
NCT03012074|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-06|||March 2, 2017|Actual|2017-03-02|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Episodic to Real-Time Care in Diabetes Self-Management|From Episodic to Real-Time Care in Diabetes Self-Management|Enrolling by invitation||N/A|60|Anticipated|Duke University||1|||f||||t|f|f||||||||2017-10-10 21:28:50.002398|2017-10-10 21:28:50.002398
NCT03012048|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-05|||June 2016||2016-06-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of Point-of-use Water Treatment Technologies to Prevent Stunting Among Children in South Africa|Effectiveness of Low-cost Point-of-use Water Treatment Technologies to Prevent Stunting Among Children in Limpopo, South Africa|Active, not recruiting||N/A|415|Actual|University of Virginia||4|||f||||t||||||||Undecided||2017-10-10 21:28:50.60628|2017-10-10 21:28:50.60628
NCT03012035|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-10-05|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||The Role of Treatment Expectation in Exposure Training With Spider Fearful Participants|The Role of Treatment Expectation in Exposure Training With Spider Fearful Participants|Not yet recruiting||N/A|70|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f||||||||2017-10-10 21:28:50.709219|2017-10-10 21:28:50.709219
NCT03012022|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-04|||November 2010||2010-11-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|CHAMPS||Cleveland Heart and Metabolic Prevention Study|Nitrative Stress in Heart Failure: The Cleveland Heart and Metabolic Prevention Study (CHAMPS)|Recruiting||N/A|2000|Anticipated|The Cleveland Clinic|||1||f||||f||||||Samples With DNA|"     Whole Blood, Serum, Plasma, Red Blood Cells, Buffy Coat, Urine   "|No||2017-10-10 21:28:50.798806|2017-10-10 21:28:50.798806
NCT03012009|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-03|||September 2014||2014-09-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial|A Randomized Controlled Trial of a Full and a Fractional Ablative Carbon Dioxide Laser as Pretreatment for Photodynamic Therapy in the Management of Superficial Non Melanoma Skin Cancer|Recruiting||N/A|20|Anticipated|University Hospital, Ghent||2|||f||||f||||||||Undecided||2017-10-10 21:28:50.925257|2017-10-10 21:28:50.925257
NCT03011996|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-11|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration|An Open-label, Randomized Study to Evaluate Pharmacokinetic Interaction, Pharmacodynamics and Safety After Multiple Oral Dosing of CJ-12420 and Amoxicillin/Clarithromycin in Healthy Subjects|Completed||Phase 1|60|Actual|CJ HealthCare Corporation||6|||f||||f||||||||Undecided||2017-10-10 21:28:51.070091|2017-10-10 21:28:51.070091
NCT03011983|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|August 2022|Anticipated|2022-08-01|January 2018|Anticipated|2018-01-01||Observational|||Neural Injury in Adolescents With Concussion|Neural Injury in Adolescents With Concussion|Not yet recruiting||N/A|280|Anticipated|Children's Hospital of Philadelphia|||2||f||||f||||||||No||2017-10-10 21:28:51.196134|2017-10-10 21:28:51.196134
NCT03011957|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-04|||February 2015||2015-02-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Observational|MATCH||Biomarkers for Muscle Function and Aging in Chronic HIV Infection|Biomarkers for Muscle Function and Aging in Chronic HIV Infection|Active, not recruiting||N/A|160|Actual|Brigham and Women's Hospital|||2||f||||f||||||Samples With DNA|"     Blood, muscle biopsy   "|No|Only aggregate data will be made available through publication|2017-10-10 21:28:51.414921|2017-10-10 21:28:51.414921
NCT03011944|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-06-28|||December 2016||2016-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Impact of a Nutrition Quality Improvement Program on Outcomes of Malnourished Patients|Assessing the Impact of a Comprehensive Nutrition-Focused Quality Improvement Program (QIP) on Health and Economic Outcomes of Malnourished Adult Patients Across the Continuum of Care|Recruiting||N/A|3600|Anticipated|Abbott Nutrition|||2||f||||f||||||||Undecided||2017-10-10 21:28:51.493674|2017-10-10 21:28:51.493674
NCT03011931|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-09-28|||March 2016||2016-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]|Simvastatin Metabolism as a Test for Celiac Disease Activity|Recruiting||N/A|50|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 21:28:51.591508|2017-10-10 21:28:51.591508
NCT03011918|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-01-05|||April 2013||2013-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Observational|||Malnutrition's Role in Fall Risk|Eat Well, Fall Less|Enrolling by invitation||N/A|485|Anticipated|Louis Stokes VA Medical Center|||2||f||||f||||||||Yes|Data collected in this study will be made available to future dietitians and Geriatric researchers obtaining an IRB approved protocol for ad hoc analysis.|2017-10-10 21:28:51.709172|2017-10-10 21:28:51.709172
NCT03011905|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Rebound Pain After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block|Rebound Pain at Block Resolution After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block|Not yet recruiting||Phase 3|50|Anticipated|Oslo University Hospital||2|||f||||f||||||||No||2017-10-10 21:28:51.818213|2017-10-10 21:28:51.818213
NCT03011892|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-07-18|||December 2016||2016-12-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis|A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream-Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis|Recruiting||Phase 2|300|Anticipated|Incyte Corporation||6|||f||||f||||||||||2017-10-10 21:28:51.942476|2017-10-10 21:28:51.942476
NCT03011879|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2017-01-04|||July 2015||2015-07-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Observational|||China STEMI Care Project Phase 2|China STEMI Care Project Phase 2|Recruiting||N/A|18000|Anticipated|Peking University First Hospital|||3||f||||t||||||Samples With DNA|"     patients under thrombolysis   "|No||2017-10-10 21:28:52.23428|2017-10-10 21:28:52.23428
NCT03011866|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-01-04|||February 2017||2017-02-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Interventional|TARGETS||Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries|Intravenous Versus Topical Use of Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries (TARGETS) : A Prospective, Randomized, Double Blind, Head-to-head Comparison Study|Not yet recruiting||N/A|176|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 21:28:52.330742|2017-10-10 21:28:52.330742
NCT03011853|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-01-04|||January 2008||2008-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01|6 Months|Observational [Patient Registry]|||Survival After Failed First-line Non-invasive Ventilation in Acute on Chronic Obstructive Pulmonary Disease|Survival After Failure of First-line Non-invasive Ventilation in Acute on Chronic Obstructive Pulmonary Disease: a Cohort Study of Intensive Care Patients.|Recruiting||N/A|3500|Anticipated|Swedish Intensive Care Registry|||1||f||||f||||||||No||2017-10-10 21:28:52.422171|2017-10-10 21:28:52.422171
NCT03011840|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Patient Information Leaflet on Working Pattern and Patient Satisfaction Level for Day Care Surgeries.|Effect of Patient Information Leaflet on Working Pattern and Patient Satisfaction Level in a Busy Indian Day Care Operative Theatre Complex|Not yet recruiting||N/A|600|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||No||2017-10-10 21:28:52.498466|2017-10-10 21:28:52.498466
NCT03011827|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-09|||September 2017||2017-09-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|September 2020|Anticipated|2020-09-01||Interventional|||Thromboelastometry in Liver Transplantation|Transfusion Prediction Model in Orthotopic Liver Transplantation Based on Thromboelastometry: Prospective Validation Study.|Not yet recruiting||N/A|65|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||Undecided||2017-10-10 21:28:52.579364|2017-10-10 21:28:52.579364
NCT03011814|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-06|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma|A Phase 1/2 Trial of Durvalumab (MEDI4736) When Given as a Single Agent or in Combination With Lenalidomide in Patients With Relapsed/ Refractory Peripheral T-cell Lymphoma, Including Cutaneous T-cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|62|Anticipated|City of Hope Medical Center||2|||f||||t|t|f||||||||2017-10-10 21:28:52.664853|2017-10-10 21:28:52.664853
NCT03011801|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-05-01|||July 1, 2017|Anticipated|2017-07-01|January 2017|2017-01-01|March 28, 2022|Anticipated|2022-03-28|June 30, 2020|Anticipated|2020-06-30||Interventional|||Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms|Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms|Recruiting||N/A|240|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||t|f|f||||||Yes|NIMH Data Archive|2017-10-10 21:28:52.788598|2017-10-10 21:28:52.788598
NCT03011788|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Polyethylene Glycol Cleansing in Patients at High Risk for Poor Bowel Preparation|A Randomized Study of Single vs Two-Day Polyethylene Glycol Cleansing in Patients at High Risk for Poor Bowel Preparation|Recruiting||N/A|270|Anticipated|VA Connecticut Healthcare System||2|||f||||t||||||||Undecided||2017-10-10 21:28:52.89461|2017-10-10 21:28:52.89461
NCT03011775|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-05|||November 2012||2012-11-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|June 2014|Actual|2014-06-01||Interventional|EFFORT||Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease|Effect of Pioglitazone on Insulin Resistance, Progression of Atherosclerosis and Clinical Course of Coronary Heart Disease|Completed||Phase 4|43|Actual|Ukrainian Medical Stomatological Academy||2|||f||||t||||||||No||2017-10-10 21:28:52.984608|2017-10-10 21:28:52.984608
NCT03011762|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||November 2012||2012-11-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Feasibility and Predictive Accuracy of an In-Home Computer Controlled Mandibular Positioner in Identifying Favorable Candidates for Oral Appliance Therapy|Feasibility and Predictive Accuracy of an In-Home Computer Controlled Mandibular Positioner in Identifying Favorable Candidates for Oral Appliance Therapy|Completed||N/A|202|Actual|Zephyr Sleep Technologies||1|||f||||t||||||||No||2017-10-10 21:28:53.097774|2017-10-10 21:28:53.097774
NCT03011749|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-10|||January 2017||2017-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients|Value of FLT PET/CT in Radium-223 Therapy of Patients With Metastatic Castration-resistant Prostate Cancer|Recruiting||N/A|40|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 21:28:53.159636|2017-10-10 21:28:53.159636
NCT03011736|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-24|||May 12, 2016|Actual|2016-05-12|July 2017|2017-07-01|February 4, 2020|Anticipated|2020-02-04|February 4, 2019|Anticipated|2019-02-04||Interventional|||Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism|Single-Arm, Non-inferiority Study of Omission of Intraoperative Intact Parathyroid Hormone (PTH) During Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism|Recruiting||N/A|60|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-10 21:28:53.23417|2017-10-10 21:28:53.23417
NCT03011723|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-02-22|||January 2017||2017-01-01|January 2017|2017-01-01|April 2021|Anticipated|2021-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Tailored Music Therapy for Dementia|Positive Emotions, Communication and Quality of Life in Dementia: A Tailored Music Therapy Intervention|Recruiting||N/A|20|Anticipated|University of Bergen||1|||f||||f||||||||No||2017-10-10 21:28:53.324642|2017-10-10 21:28:53.324642
NCT03011710|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-10-05|||September 2015||2015-09-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Epidemiology and Acute Oral Effects Electronic Cigarette|Epidemiology and Acute Oral Effects of Electronic Cigarette|Enrolling by invitation||N/A|30|Anticipated|Semmelweis University||4|||f||||f||||||||||2017-10-10 21:28:53.403596|2017-10-10 21:28:53.403596
NCT03011697|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-04|||January 2017||2017-01-01|December 2016|2016-12-01|December 2027|Anticipated|2027-12-01|December 2026|Anticipated|2026-12-01||Observational|VHD-ZJU||Valvular Heart Disease Registry Study in Second Affiliated Hospital of ZheJiang University|A Prospective, Single-center,Registry Study of Chinese Hospitalized Adult Patients With Valvular Heart Disease|Not yet recruiting||N/A|10000|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University|||1||f||||t||||||||||2017-10-10 21:28:53.469129|2017-10-10 21:28:53.469129
NCT03011684|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|TALES||Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial|Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial|Recruiting||Phase 3|144|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-10 21:28:53.543883|2017-10-10 21:28:53.543883
NCT03011671|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-15|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|||Phase I Study of Safety and Tolerability of Acetazolamide With Temozolomide|A Phase I Study of Safety and Tolerability of Acetazolamide With Temozolomide in Adults With Newly Diagnosed Malignant Glioma|Not yet recruiting||Phase 1|24|Anticipated|University of Chicago||1|||f||||t|t|f||||||||2017-10-10 21:28:53.622977|2017-10-10 21:28:53.622977
NCT03011658|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-01-04|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Serum Cortisol Levels in Patients With Anxiety and Depression With Symptomatic Oral Lichen Planus|Assessment of Anxiety and Depression in Symptomatic Oral Lichen Planus|Recruiting||Phase 1/Phase 2|60|Anticipated|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||f||||||||No||2017-10-10 21:28:53.694512|2017-10-10 21:28:53.694512
NCT03011645|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-05-08|||January 2018|Anticipated|2018-01-01|January 2017|2017-01-01|November 2022|Anticipated|2022-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Gene-by-Stress Interactions in Intervention Studies Significance|Gene-by-Stress Interactions in Intervention Studies Significance|Not yet recruiting||Phase 1|100|Anticipated|Duke University||3|||f||||f|t|f|||f|||No||2017-10-10 21:28:53.767633|2017-10-10 21:28:53.767633
NCT03011632|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-02-27|||January 2017||2017-01-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|January 2018|Anticipated|2018-01-01||Interventional|RAISe||Response of the Airway in Sinusitis and Asthma|The Role of Nonspecific Immune Response of the Airway Mucosa in Children With Chronic Rhinosinusitis and Asthma|Recruiting||Phase 4|150|Anticipated|Medical Universtity of Lodz||2|||f||||f||||||||Undecided||2017-10-10 21:28:53.979105|2017-10-10 21:28:53.979105
NCT03011619|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-06|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brief CBT for the Treatment of Depression During Inpatient Hospitalization|Brief CBT for the Treatment of Depression During Inpatient Hospitalization|Recruiting||N/A|75|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:28:54.094092|2017-10-10 21:28:54.094092
NCT03011606|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-08-21|||February 2016||2016-02-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|RAFT||Robotic Surgery After Focal Ablation Therapy|Robotic Surgery After Focal Ablation Therapy|Recruiting||N/A|24|Anticipated|Queen Mary University of London||1|||f||||f||||||||||2017-10-10 21:28:54.219753|2017-10-10 21:28:54.219753
NCT03011593|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-03|||November 2015||2015-11-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of UGIR in Adults With Compromised Gut Function and Malabsorption|Effect of UGIR on Quality of Life in Adults With Compromised Gut Function and Malabsorption|Completed||N/A|18|Actual|Metagenics, Inc.||1|||f||||f||||||||No||2017-10-10 21:28:54.316196|2017-10-10 21:28:54.316196
NCT03009448|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-31|||March 2017||2017-03-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Observational|||The Experience of Older Adults Facing Depression for the First Time in Old Age||Not yet recruiting||N/A|15|Anticipated|Shalvata Mental Health Center|||1||f||||t||||||||||2017-10-10 21:29:13.448185|2017-10-10 21:29:13.448185
NCT03011580|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-03-31|||March 14, 2017|Actual|2017-03-14|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|ResolveD-TB||Vitamin D to Resolve Inflammation After Tuberculosis (ResolveD-TB)|Vitamin D3 to Enhance Resolution of Residual Pulmonary Inflammation in Patients Completing Antituberculosis Treatment (ResolveD-TB): a Proof-of-concept Intervention Study|Recruiting||Phase 2|40|Anticipated|Queen Mary University of London||2|||f||||f|||||f|||No|No individual participant data will be available. Non-patient identifiable data will be presented in paper, abstract and presentation to conferences.|2017-10-10 21:28:54.406314|2017-10-10 21:28:54.406314
NCT03011567|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|HIPPS||Hypertension In Postpartum Preeclampsia Study|A Randomized Controlled Trial on the Effects of NSAIDs on Postpartum Blood Pressure in Patients Hypertensive Disorders of Pregnancy|Recruiting||N/A|202|Anticipated|MemorialCare Health System||4|||f||||t||||||||Undecided||2017-10-10 21:28:54.546773|2017-10-10 21:28:54.546773
NCT03011554|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-09-30|||March 22, 2017|Actual|2017-03-22|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 2017|Anticipated|2017-12-01||Interventional|TES||Telescope Exchange Study|A Prospective, Multicenter Clinical Trial of the Implantable Miniature Telescope in Pseudophakic Eyes With Central Vision Impairment Associated With End-Stage Macular Degeneration.|Recruiting||N/A|75|Anticipated|VisionCare, Inc.||1|||f|||||f|t|f|f||||||2017-10-10 21:28:54.666351|2017-10-10 21:28:54.666351
NCT03011541|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-07-17|||January 2016||2016-01-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|SCOTS2||Stem Cell Ophthalmology Treatment Study II|Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II|Recruiting||N/A|500|Anticipated|MD Stem Cells||3|||f||||f||||||||||2017-10-10 21:28:54.855067|2017-10-10 21:28:54.855067
NCT03011528|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-03-23|||December 2016||2016-12-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|May 2020|Anticipated|2020-05-01||Interventional|CombinaiR3||First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years|CombinaiR3 - First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years|Recruiting||Phase 2|45|Anticipated|Institut Curie||4|||f||||t||||||||No||2017-10-10 21:28:55.065949|2017-10-10 21:28:55.065949
NCT03011515|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-06|||March 10, 2017|Actual|2017-03-10|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|OBSERVER||Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)|A Multi-center, Prospective, Validation Study to Assess the Accuracy of a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Adult Patients With Lower Respiratory Tract Infections|Recruiting||N/A|1135|Anticipated|MeMed Diagnostics Ltd.|||3||f||||f||||||Samples Without DNA|"     Venous blood and nasal swab   "|||2017-10-10 21:28:55.285896|2017-10-10 21:28:55.285896
NCT03011502|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-04-21|||December 2016||2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|OSIRIS||InterventiOnal Study of Bone and Joint Infections Related Gut dysbiosIS|InterventiOnal Study of Bone and Joint Infections Related Gut dysbiosIS|Recruiting||N/A|100|Anticipated|MaaT Pharma||1|||f||||f||||||||Yes||2017-10-10 21:28:55.388786|2017-10-10 21:28:55.388786
NCT03011489|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-04-22|||January 2017||2017-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Parent's Satisfaction and Evaluation of Postsurgical Outcomes in Unilateral Cleft Lip / Palate Newly Born Infants With / Without Vacuum Formed Nasoalveolar Molding Aligners : A Controlled Clinical Trial|Parent's Satisfaction and Evaluation of Postsurgical Outcomes in Unilateral Cleft Lip / Palate Newly Born Infants With / Without Vacuum Formed Nasoalveolar Molding Aligners : A Controlled Clinical Trial|Not yet recruiting||N/A|14|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:28:55.498387|2017-10-10 21:28:55.498387
NCT03011476|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|EASE-PIGD||Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease|Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease Characterized by Postural Instability and Gait Disturbance|Not yet recruiting||Phase 4|20|Anticipated|Kyung Hee University Hospital||2|||f||||f||||||||No||2017-10-10 21:28:55.578447|2017-10-10 21:28:55.578447
NCT03011463|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-04-07|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1|Pharmacokinetic Interaction Between Trospium Chloride After Intravenous (2 mg) and Oral Administration (30 mg) With Ranitidine (300 mg p.o.) as an Inhibitor of OCT1 and With Clarithromycin (500 mg p.o.) as an Inhibitor of P-glycoprotein in 24 Healthy Subjects Genotyped for OCT1|Completed||Phase 1|24|Actual|Dr. R. Pfleger Chemische Fabrik GmbH||6|||f||||f||||||||No||2017-10-10 21:28:55.675572|2017-10-10 21:28:55.675572
NCT03011450|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-10-04|||November 2016||2016-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment||Recruiting||Phase 3|420|Anticipated|Kowa Research Institute, Inc.||2|||f||||f||||||||||2017-10-10 21:28:55.789255|2017-10-10 21:28:55.789255
NCT03011437|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light Imaging|Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light Imaging|Recruiting||N/A|50|Anticipated|Kashgar 1st People's Hospital|||1||f||||t||||||Samples Without DNA|"     gastric mucosa   "|No||2017-10-10 21:28:56.243673|2017-10-10 21:28:56.243673
NCT03011424|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-01-04|||October 2013||2013-10-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|||Early Postoperative Extracorporal Liver Support Therapy (ELS) as a Tool to Manage Post Hepatectomy Liver Failure (PLF)|Early Postoperative Extracorporal Liver Support Therapy (ELS) as a Tool to Manage Post Hepatectomy Liver Failure (PLF)|Recruiting||N/A|10|Anticipated|Karolinska University Hospital||1|||f||||f||||||||Yes|Publication in peer reviewed journal|2017-10-10 21:28:56.331679|2017-10-10 21:28:56.331679
NCT03011411|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-03|||January 2008||2008-01-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|COMERE||Comparison of Methods to Collect Healthcare Consumption Data of Patients in Clinical Trials With an Economic Evaluation|Comparison of Methods to Collect Healthcare Consumption Data of Patients in Clinical Trials With an Economic Evaluation|Active, not recruiting||N/A|1000|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||Undecided||2017-10-10 21:28:56.41181|2017-10-10 21:28:56.41181
NCT03011398|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-04|||February 2016||2016-02-01|January 2017|2017-01-01|February 2036|Anticipated|2036-02-01|February 2036|Anticipated|2036-02-01|20 Years|Observational [Patient Registry]|||A Clinical Registry of Orthobiologics Procedures|Interventional Orthopedics Foundation Patient Registry Database-A Clinical Registry of Orthobiologics Procedures|Enrolling by invitation||N/A|50000|Anticipated|Interventional Orthopedics Foundation|||1||f||||f||||||||No||2017-10-10 21:28:56.474773|2017-10-10 21:28:56.474773
NCT03011385|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01||||March 2019|Anticipated|2019-03-01||Interventional|||Effects of Individual, Dyadic, and Collaborative Plans on Physical Activity in Partner-Partner Dyads|Physical Activity and Health-related Quality of Life: Dyadic Research in the Context of Forming Individual, Dyadic, and Collaborative Plans. Trial 3|Recruiting||N/A|400|Anticipated|University of Social Sciences and Humanities, Warsaw||4|||f||||f||||||||Yes|As agreed with the funding institution (the National Science Centre, Poland) the dataset will be publicly available (for research use) not later than in 2023 at the website of the SWPS University of Social Sciences and Humanities, Wroclaw, Poland|2017-10-10 21:28:56.592176|2017-10-10 21:28:56.592176
NCT03011359|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-12|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||The Comparison of Postoperative Pain After Colon Resection in Intravenous Patient-controlled Analgesia Between Conventional Mode and Optimizing B.I Mode With 'PAINSTOP' Equipment|The Comparison of Postoperative Pain After Colon Resection in Intravenous|Recruiting||N/A|76|Anticipated|Yonsei University||2|||f||||f|f|f||||||||2017-10-10 21:28:56.808569|2017-10-10 21:28:56.808569
NCT03011346|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-02-15|||February 8, 2017|Actual|2017-02-08|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|October 2017|Anticipated|2017-10-01||Interventional|SCOPE I||Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis.|Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis for Transcatheter Aortic Valve Implantation by Transfemoral Approach.|Recruiting||N/A|730|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f||||||No||2017-10-10 21:28:58.579091|2017-10-10 21:28:58.579091
NCT03011333|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-26|||January 2017||2017-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 2B Upper Extremity Nerve Block Study|A Phase 2B, Randomized, Controlled Study of HTX-011 Administered Via Pectoral Nerve Block in Subjects Undergoing Upper Extremity Surgery for Augmentation Mammoplasty|Recruiting||Phase 2|120|Anticipated|Heron Therapeutics||5|||f||||f||||||||||2017-10-10 21:28:58.693111|2017-10-10 21:28:58.693111
NCT03011320|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-25|||January 24, 2017|Actual|2017-01-24|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery|An Exploratory, Open-label Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Cytoreductive Surgery|Recruiting||Phase 1|30|Anticipated|Endocyte||4|||f||||f|t|f||||||||2017-10-10 21:28:58.789364|2017-10-10 21:28:58.789364
NCT03011307|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery|Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery|Recruiting||Phase 2|120|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 21:28:58.894908|2017-10-10 21:28:58.894908
NCT03011294|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-03|||December 2016||2016-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|SLEEP-PARTNERS||Cardiovascular Impact, Quality e Quantity of Sleep in Bed Partners of Patients With Obstructive Sleep Apnea|Cardiovascular Impact, Quality e Quantity of Sleep in Bed Partners of Patients With Obstructive Sleep Apnea: a Randomized Study|Recruiting||Phase 4|60|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 21:28:58.972296|2017-10-10 21:28:58.972296
NCT03011281|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-04|||November 2016||2016-11-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis|Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis|Recruiting||N/A|378|Anticipated|Hanyang University|||1||f||||f||||||Samples With DNA|"     Hemoglobin Hematocrit WBC Platelet count ESR CRP ALT AST ALP BUN Creatinine Bilirubin     Urinalysis Total Cholesterol HDL (Calculated) LDL TG Rheumatoid factor(RF) Anti-nuclear     antibodies(ANA) Anti-CCP HbA1c   "|No||2017-10-10 21:28:59.051167|2017-10-10 21:28:59.051167
NCT03011268|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-08-14|||June 9, 2017|Actual|2017-06-09|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|BIOSTOP||Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?|Continuing or Discontinuing Anti-tumor Necrosis Factor Treatment in Patients With Ulcerative Colitis in Clinical Remission: a Prospective Open Randomized Parallel-group Study|Recruiting||N/A|200|Anticipated|Helse Møre og Romsdal HF||2|||f||||t|f|f||||||||2017-10-10 21:28:59.142669|2017-10-10 21:28:59.142669
NCT03011255|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-08-03|||December 2016||2016-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer|Phase II Study of Radiation Therapy With Peptide Specific CTL Therapy in Treating Patients With Unresectable, Advanced or Recurrent Esophageal Cancer|Recruiting||Phase 2|20|Anticipated|Hangzhou Cancer Hospital||1|||f||||t||||||||||2017-10-10 21:28:59.377331|2017-10-10 21:28:59.377331
NCT03011242|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-15|||January 11, 2017|Actual|2017-01-11|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA|DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA|Active, not recruiting||N/A|100|Anticipated|University of Rochester|||2||f||||f||||||Samples With DNA|"     Peripheral blood samples that remain after study assays are completed may be stored for     future non-genetic research.   "|||2017-10-10 21:28:59.457881|2017-10-10 21:28:59.457881
NCT03011229|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-18|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Endoscopic Ultrasound (EUS) Fine Needle Biopsy (FNB) Submucosal Nodule|Endoscopic Ultrasound Fine Needle Biopsy of Submucosal Lesions of the GI Tract; Finding the Right Needle - A Randomized Study|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||f|f|t|f||f|||||2017-10-10 21:28:59.531041|2017-10-10 21:28:59.531041
NCT03011216|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-03|||February 2017||2017-02-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effects of Online Cognitive Control Training on Rumination and Depressive Symptoms|"Ein Training Kognitiver Kontrolle Emotionaler Inhalte im Arbeitsgedächtnis: Effekte Auf Die Häufigkeit Und Auswirkungen Von Grübeln Bei Depressiven Patienten (English: Training Cognitive Control Over Emotional Information in Working Memory: Effects on the Frequency of Rumination and Its Impact on Mood in the Daily Lives of Depressed Patients)"|Not yet recruiting||N/A|52|Anticipated|Freie Universität Berlin||2|||f||||f||||||||Undecided|De-individualized data files are uploaded on Open Science Framework (https://osf.io/) when publications are being prepared|2017-10-10 21:28:59.611855|2017-10-10 21:28:59.611855
NCT03011203|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-02-15|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Acute Nutritional Ketosis in GSD IIIa|Acute Nutritional Ketosis and Exercise in Glycogen Storage Disease Type IIIa|Recruiting||N/A|6|Anticipated|University Medical Center Groningen||2|||f||||t|f|f||||||Undecided||2017-10-10 21:28:59.703681|2017-10-10 21:28:59.703681
NCT03011190|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-03|||September 2015||2015-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effectiveness of the Iconic Therapy for Borderline Personality Disorder Symptoms|Effectiveness of the Iconic Therapy in Youth With Suicidal Ideation/Self-injuring Behavior and Borderline Personality Traits: Study Protocol for a Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|University of Malaga||2|||f||||f||||||||Undecided||2017-10-10 21:28:59.831861|2017-10-10 21:28:59.831861
NCT03011177|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|TELIUS||Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients|A Randomized, Open Label, Parallel-group, Non-inferiority, Active-controlled, Phase Ⅳ Study to Evaluate the Efficacy and Safety of Teneligliptin Versus Linagliptin in Type 2 DM Patients|Not yet recruiting||Phase 4|164|Anticipated|Handok Pharmaceuticals Co., Ltd.||2|||f||||||||||||||2017-10-10 21:28:59.931375|2017-10-10 21:28:59.931375
NCT03011164|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||The Influence of Running and Velocity to Kinematic Parameters|The Influence of Running and Velocity to Kinematic Parameters|Not yet recruiting||N/A|30|Anticipated|Guangzhou General Hospital of Guangzhou Military Command|||4||f||||f||||||||No||2017-10-10 21:29:00.007552|2017-10-10 21:29:00.007552
NCT03011151|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-06-19|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness|Examining the Role of Protease-activated Receptor 2 Agonists in Gastrointestinal Dysfunction in Pediatric Surgical Critical Illness|Recruiting||N/A|80|Anticipated|Boston Children’s Hospital|||1||f||||f||||||Samples Without DNA|"     Blood, Stool   "|No||2017-10-10 21:29:00.099987|2017-10-10 21:29:00.099987
NCT03011138|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-02-09|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|February 6, 2017|Actual|2017-02-06|February 1, 2017|Actual|2017-02-01||Observational|||The Relationship Between Gait Velocity and Gait Parameters|The Relationship Between Gait Velocity and Gait Parameters|Completed||N/A|30|Actual|Guangzhou General Hospital of Guangzhou Military Command|||7||f||||f||||||||No||2017-10-10 21:29:00.189352|2017-10-10 21:29:00.189352
NCT03011125|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-03-15|||January 2017||2017-01-01|January 2017|2017-01-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1)|A Phase 1 Double-blind, Dose-escalation, Placebo-controlled Tolerance Study in Healthy Chinese Adults After Single Intravenous Administration of Dexlansoprazole|Completed||Phase 1|28|Anticipated|First Affiliated Hospital of Zhejiang University||2|||f||||f||||||||No||2017-10-10 21:29:00.305718|2017-10-10 21:29:00.305718
NCT03011112|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-03-01|||January 2, 2017|Actual|2017-01-02|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 20, 2017|Actual|2017-02-20||Observational|||Can 3D Kinematic Parameters Assess the Symptomatic and Functional Severity of KOA?|Can Three Dimensional Kinematic Parameters Assess the Symptomatic and Functional Severity of Medial Knee Osteoarthritis?|Completed||N/A|186|Actual|Guangzhou General Hospital of Guangzhou Military Command|||4||f||||f||||||||No||2017-10-10 21:29:00.373871|2017-10-10 21:29:00.373871
NCT03011086|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-12|||January 2015||2015-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Observational|||Evaluation of Auto Antibodies in Oral Sub Mucous Fibrosis|Evaluation of Auto Antibodies in Oral Sub Mucous Fibrosis - a Clinico-pathological Study|Recruiting||N/A|70|Anticipated|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||2||f||||f||||||||||2017-10-10 21:29:00.561128|2017-10-10 21:29:00.561128
NCT03011073|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-07|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|September 1, 2018|Anticipated|2018-09-01||Observational|EPIC||Evaluation of New Items in Cardiac Echography|Evaluation of New Items in Cardiac Echography|Not yet recruiting||N/A|150|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||t|f|f||||||||2017-10-10 21:29:00.634162|2017-10-10 21:29:00.634162
NCT03011060|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-08|||December 2016||2016-12-01|January 2017|2017-01-01|February 2025|Anticipated|2025-02-01|December 2024|Anticipated|2024-12-01||Interventional|NACVCAC||Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer|A Prospective Randomized Controlled Trail to Evaluate Efficacy and Safety of Sequential Neo-adjuvant Chemotherapy Plus Surgery Followed by Capecitabine Versus Conventional Postoperative Adjuvant Chemotherapy|Recruiting||Phase 3|1588|Anticipated|First Hospital of Jilin University||3|||f||||t||||||||No||2017-10-10 21:29:00.689945|2017-10-10 21:29:00.689945
NCT03011047|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-07-19|||August 18, 2017|Anticipated|2017-08-18|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy of Endoscopic Transantral Surgical Approach in the Repair of Orbital Blow-Out Fractures|Efficacy of Endoscopic Transantral Versus Transorbital Surgical Approaches in the Repair of Orbital Blow-Out Fractures-Randomized Clinical Trial.|Not yet recruiting||N/A|38|Anticipated|Cairo University||2|||f||||t|f|f||||||||2017-10-10 21:29:00.787939|2017-10-10 21:29:00.787939
NCT03011034|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-09-14|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|January 17, 2019|Anticipated|2019-01-17|December 13, 2018|Anticipated|2018-12-13||Interventional|||Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment|A Phase 2 Proof-of-Concept Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment|Recruiting||Phase 2|31|Anticipated|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 21:29:00.903531|2017-10-10 21:29:00.903531
NCT03011021|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes|Phase 1/ Phase 2 Study of the Therapeutic Effect of Ex-vivo Expanded Umbilical Cord Blood Regulatory T Cells With Liraglutide on Autoimmune Diabetes|Recruiting||Phase 1/Phase 2|40|Anticipated|Second Xiangya Hospital of Central South University||4|||f||||||||||||||2017-10-10 21:29:01.117087|2017-10-10 21:29:01.117087
NCT03011008|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Interventional|||Liraglutide as an Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus||Recruiting||Phase 4|20|Anticipated|Second Xiangya Hospital of Central South University||2|||f||||||||||||||2017-10-10 21:29:01.218929|2017-10-10 21:29:01.218929
NCT03010995|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-06-29|||October 15, 2017|Anticipated|2017-10-15|June 2017|2017-06-01|October 15, 2020|Anticipated|2020-10-15|August 15, 2019|Anticipated|2019-08-15||Interventional|ACE||The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study|The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study|Not yet recruiting||Phase 1|40|Anticipated|University of Louisville||3|||f||||f|t|f||||||||2017-10-10 21:29:01.31135|2017-10-10 21:29:01.31135
NCT03010982|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-06-05|||January 2017||2017-01-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors|An Open-Label, Multi-Center, Two-Part, Phase 1 Study to Characterize the Pharmacokinetics of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the Absorption, Distribution, Metabolism and Elimination of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Advanced Solid Tumors|Recruiting||Phase 1|6|Anticipated|Epizyme, Inc.||1|||f||||f||||||||No||2017-10-10 21:29:01.413989|2017-10-10 21:29:01.413989
NCT03010969|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-06-12|||October 2016||2016-10-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|POETRYabd||Perioperative Endothelial Dysfunction in Patients Undergoing Major Acute Abdominal Surgery|Perioperative Endothelial Dysfunction in Patients Undergoing Major Acute Abdominal Surgery. The POETRY Abdominal Study|Recruiting||N/A|175|Anticipated|University Hospital Koge|||1||f||||f||||||Samples With DNA|"     The blood will be collected from a larger vein (e.g. the cubital vein). Cardiac troponin I     Tetrahydrobiopterin: Blood is sampled into 4mL EDTA tubes. Immediately after withdrawal, a     minimum of 1mL blood is mixed with 25μL DTE. The mixture is centrifuged at 2000g for 5     minutes. Plasma is frozen and stored at -80°C.      Arginine and ADMA: Blood is sampled into 4mL EDTA tubes. Blood samples will be centrifuged at     3000g for 10 minutes, plasma frozen and stored at -80°C until analyzed with high performance     liquid chromatography.   "|No|We do not plan to share IPD|2017-10-10 21:29:01.500528|2017-10-10 21:29:01.500528
NCT03010956|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-03|||November 2014||2014-11-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Observational|||Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.|Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.|Recruiting||N/A|60|Anticipated|University of Athens|||2||f||||t||||||||No||2017-10-10 21:29:01.605199|2017-10-10 21:29:01.605199
NCT03010943|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-05-04|||February 17, 2017|Actual|2017-02-17|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CERVO1||Brain Awake Surgery Using Virtual Reality Headset|Chirurgie Eveillee du Cerveau Sous Realite Virtuelle Integree Aux Outils Bloc Operatoire : Etude de Tolerance|Recruiting||N/A|30|Anticipated|University Hospital, Angers||1|||f|||||f|f||||||||2017-10-10 21:29:01.696572|2017-10-10 21:29:01.696572
NCT03010930|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-03|||October 2016||2016-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Repeated Exposure to Umami Taste on Taste Perception, Hedonics, and Satiety|Does Repeated Dietary Exposure to Umami Taste Affect Umami Perception, Hedonics, or Satiety? A Randomized Controlled Study|Completed||N/A|64|Actual|Cornell University||2|||f||||f||||||||No||2017-10-10 21:29:01.777013|2017-10-10 21:29:01.777013
NCT03010917|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Fish Oil vs. Placebo on Subjective Effects of Alcohol|Effect of Fish Oil vs. Placebo on Subjective Effects of Alcohol in Healthy Humans|Not yet recruiting||Phase 1|10|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 21:29:01.847922|2017-10-10 21:29:01.847922
NCT03010904|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-04|2017-08-09|||January 2017||2017-01-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effect of Pasteurized; Pasteurized and Homogenized and UHT Treated Homogenized Cow's Milk on Gastrointestinal Symptoms in Sensitive Adults|The Effect of Pasteurized; Pasteurized and Homogenized and UHT -Treated Homogenized Cow's Milk on Gastrointestinal Symptoms in Sensitive Adults|Recruiting||N/A|20|Anticipated|University of Turku||3|||f||||f||||||||||2017-10-10 21:29:01.957428|2017-10-10 21:29:01.957428
NCT03010891|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-04|||March 2016||2016-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of Bundled Supportive Interventions on Preterm Infants' Stress-Related Outcomes During Invasive Procedures|Effects of Bundled Supportive Interventions on Preterm Infants' Stress-Related Outcomes|Enrolling by invitation||N/A|100|Anticipated|National Defense Medical Center, Taiwan||2|||f||||t||||||||No||2017-10-10 21:29:02.044131|2017-10-10 21:29:02.044131
NCT03010878|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-03|||August 2015||2015-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|YoPain||Yoga and Occupational Therapy to Improve Pain|Yoga and Occupational Therapy to Improve Pain|Completed||Phase 1|83|Actual|Colorado State University||2|||f||||f||||||||No||2017-10-10 21:29:02.120705|2017-10-10 21:29:02.120705
NCT03010865|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-04-28|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|||Sodium Butyrate For Improving Cognitive Function In Schizophrenia|Sodium Butyrate As A Treatment For Improving Cognitive Function In Schizophrenia|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|Shanghai Mental Health Center||2|||f||||f|f|f||||||Undecided|Stanley foundation requests: Based on the terms of your award, Stanley Medical Research Institute (SMRI) now requires submission of the individual patient data from all SMRI funded studies. In order to make the process as efficient as possible and provide a secure location for study data, National Institute of Mental Health (NIMH) is graciously allowing SMRI access to their National Database for Clinical Trials (NDCT) to collect and house data.|2017-10-10 21:29:02.198461|2017-10-10 21:29:02.198461
NCT03010852|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-29|||August 2016||2016-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Focused Incentive Spirometry Monitoring to Reduce Postoperative Oxygen Therapy and Respiratory Complications After Bariatric Surgery|Focused Incentive Spirometry Monitoring to Reduce Postoperative Oxygen Therapy and Respiratory Complications After Bariatric Surgery|Recruiting||N/A|60|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 21:29:02.290401|2017-10-10 21:29:02.290401
NCT03010839|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-02-19|||February 5, 2017|Actual|2017-02-05|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Remote Ischemic Preconditioning for Cardic Surgery|Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Cardic Surgery|Recruiting||N/A|60|Anticipated|Xuzhou Medical University||2|||f||||t|f|f||||||No|IPD will be available when this trial is finished and the article have been published.|2017-10-10 21:29:02.372115|2017-10-10 21:29:02.372115
NCT03010826|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-06-21|||December 2016||2016-12-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Pharmacological Recruitment of Endogenous Neural Precursors to Promote Pediatric White Matter Repair: Establishing Correlations Between Visual Outcomes, Saccadic Function and MEG Oscillations in Children With Demyelinating Disorders in Comparison to Healthy Control Children|Pharmacological Recruitment of Endogenous Neural Precursors to Promote Pediatric White Matter Repair: Establishing Correlations Between Visual Outcomes, Saccadic Function and MEG Oscillations in Children With Demyelinating Disorders in Comparison to Healthy Control Children|Recruiting||N/A|80|Anticipated|The Hospital for Sick Children|||2||f||||||||||||||2017-10-10 21:29:02.469126|2017-10-10 21:29:02.469126
NCT03010813|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-10-05|||December 2016||2016-12-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery|A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery: A Prospective, Single Center, Multispecialty Study|Active, not recruiting||N/A|63|Actual|Chinese University of Hong Kong||1|||f||||t||||||||||2017-10-10 21:29:02.550522|2017-10-10 21:29:02.550522
NCT03010787|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-04|||September 2015||2015-09-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A First Time in Human Study in Healthy Volunteers and Patients|A Four Part, Phase 1, First Time in Human, Single Centre Study in Healthy Male Subjects, Patient Volunteers With Crohn's Disease and in Healthy Patient Volunteers With a Terminal Ileostomy|Completed||Phase 1|47|Actual|VHsquared Ltd.||5|||f||||t||||||||No||2017-10-10 21:29:02.714965|2017-10-10 21:29:02.714965
NCT03010774|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-15|||February 14, 2017|Actual|2017-02-14|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring|Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring|Recruiting||N/A|600|Anticipated|University of Chicago||2|||f||||t|f|f||||||||2017-10-10 21:29:02.797629|2017-10-10 21:29:02.797629
NCT03010761|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-01-04|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer|Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer|Active, not recruiting||Phase 2|90|Anticipated|China Medical University Hospital||3|||f||||t||||||||Yes||2017-10-10 21:29:02.869019|2017-10-10 21:29:02.869019
NCT03010748|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-04-26|||November 2015||2015-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Observational|||Multi-center Clinical Trial on Corneal Morphology Analysis in Chinese Population|Multi-center Clinical Trial on Corneal Morphology Analysis in Chinese Population|Recruiting||N/A|50000|Anticipated|Tianjin Eye Hospital|||1||f||||t||||||||No||2017-10-10 21:29:02.95909|2017-10-10 21:29:02.95909
NCT03010735|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-04|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)|Effects of Bifidobacterium Animalis A6 on Metabolism of Uremic Toxin in Patients With End Stage Renal Disease (ESRD)|Active, not recruiting||Phase 2/Phase 3|150|Actual|China Agricultural University||2|||f||||t||||||||No||2017-10-10 21:29:03.068935|2017-10-10 21:29:03.068935
NCT03010722|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-01-04|||January 2015||2015-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|PROSPECT-R||Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy|A Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy in RAS Mutant Metastatic Colorectal Cancer|Recruiting||Phase 2|49|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||t||||||Samples With DNA|"     Tissue and plasma samples will be retained for a maximum period of 20 years, according to UK     regulatory approval policy and study protocol.   "|||2017-10-10 21:29:03.165782|2017-10-10 21:29:03.165782
NCT03010709|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-03|||February 2017||2017-02-01|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Observational|MMMSAH||Multimodality Monitoring Directed Management of Aneurysmal Subarachnoid Haemorrhage|Multimodality Monitoring Directed Management of Aneurysmal Subarachnoid Haemorrhage|Not yet recruiting||N/A|100|Anticipated|University of Cambridge|||1||f||||f||||||Samples With DNA|"     Microdialysates, cerebrospinal fluid and blood   "|No||2017-10-10 21:29:03.338744|2017-10-10 21:29:03.338744
NCT03010696|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-03|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Observational|||The Correlation Between Gut Microbiome/Metabolite and End Stage Renal Disease (ESRD)|The Correlation Between Gut Microbiome/Metabolite and End Stage Renal Disease (ESRD)|Active, not recruiting||N/A|293|Actual|China Agricultural University|||2||f||||t||||||Samples With DNA|"     whole blood, serum, feces, urine   "|No||2017-10-10 21:29:03.411259|2017-10-10 21:29:03.411259
NCT03010683|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-05|||November 2015||2015-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus|Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus|Recruiting||N/A|90|Anticipated|University of Athens||2|||f||||t||||||||No||2017-10-10 21:29:03.515032|2017-10-10 21:29:03.515032
NCT03010670|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-03|||January 2016||2016-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Oxytocin and Interpersonal Motor Resonance|Oxytocin-based Pharmacotherapy: Investigating the Effect on Interpersonal Motor Resonance Upon Direct Eye Gaze|Completed||Phase 4|27|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||No||2017-10-10 21:29:03.623694|2017-10-10 21:29:03.623694
NCT03010644|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-09-18|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|SWEAT||Summer Weight and Environmental Assessment Trial|Summer Weight and Environmental Assessment Trial (SWEAT)|Active, not recruiting||N/A|192|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-10 21:29:03.850027|2017-10-10 21:29:03.850027
NCT03010631|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-04|||November 2016||2016-11-01|January 2017|2017-01-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers|Comparative Pharmacokinetics and Food-Effect Bioavailability of a Sprinkle Formulation of Lubiprostone After Oral Administration in Healthy Volunteers|Completed||Phase 3|49|Actual|Sucampo Pharma Americas, LLC||4|||f||||f||||||||||2017-10-10 21:29:03.934138|2017-10-10 21:29:03.934138
NCT03010618|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-07-16|||January 24, 2017|Actual|2017-01-24|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effects of Stainless Steel Crowns Applied With Hall Technique on Occlusal Vertical Dimension|Hall Teknik Ile Uygulanan Paslanmaz Celik kronların Okluzal Dikey Boyuta Etkilerinin değerlendirilmesi|Recruiting||N/A|125|Anticipated|Bezmialem Vakif University||1|||f||||f|f|f||||||||2017-10-10 21:29:04.029229|2017-10-10 21:29:04.029229
NCT03010605|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|MED||Measuring Every Day (MED) Study|Evaluation of the Measuring Every Day, Patient Incentive Device, as an Adjunct to Conventional Physical Therapy in the Acceleration of Flexion and Extension Capability in the Post-Operative Total Knee Arthroplasty Patient: A Prospective, Randomized Study|Recruiting||N/A|46|Anticipated|The Christ Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:29:04.141166|2017-10-10 21:29:04.141166
NCT03010592|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|COPD-ENVIRON||Studying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPD|Studying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPD|Not yet recruiting||N/A|80|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 21:29:04.248928|2017-10-10 21:29:04.248928
NCT03010579|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-03|||October 2016||2016-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation|Efficacy and Safety of Erythropoietin in the Treatment of Anemia in Patients With Lymphoma After Autologous Hematopoietic Stem Cell Transplantation|Recruiting||Phase 4|70|Anticipated|Peking University||2|||f||||f||||||||No||2017-10-10 21:29:04.37508|2017-10-10 21:29:04.37508
NCT03010566|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|LVRC-Micro||Lung Volume Reduction Coil Microbiome Study|Studying the Microbiome of the Lung in Patients Treated With Endobronchial Lung Volume Reduction Coils for Emphysema|Not yet recruiting||N/A|30|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Oropharyngeal swab, Broncho-alveolar lavage, Bronchial brushings   "|No||2017-10-10 21:29:04.493214|2017-10-10 21:29:04.493214
NCT03010553|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-02|||February 2008||2008-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GS-OROPHARYNX||Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot|Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot|Recruiting||Phase 2|100|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||No||2017-10-10 21:29:04.612818|2017-10-10 21:29:04.612818
NCT03010540|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-03|||July 2015||2015-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Effect Of Combination of Morphine+Fentanyl on Emergence Delirium in Patients of Cleft Lip and Palate Repair|Emergence Delirium and Recovery Profile in Patients Undergoing Cleft Lip and Palate Repair: Comparison of Combination of Morphine and Fentanyl With Fentanyl Alone|Completed||N/A|70|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||No||2017-10-10 21:29:04.696888|2017-10-10 21:29:04.696888
NCT03010527|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-31|||December 2016||2016-12-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis.|A Multicenter, 48-Week, Double-Blind, Placebo-Controlled, Parallel-Group Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis|Active, not recruiting||Phase 2|217|Actual|UCB Pharma||4|||f||||t||||||||||2017-10-10 21:29:04.783767|2017-10-10 21:29:04.783767
NCT03010514|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-03|||October 2016||2016-10-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Observational|ARSGBTAAD||A Registry Study on Genetics and Biomarkers of Thoracic Aortic Aneurysm/Dissection|A Chinese Registry to Determine the Genetic Risk Factors and Serumal Biomarkers for Thoracic Aortic Aneurysm/Dissection|Recruiting||N/A|600|Anticipated|Beijing Institute of Heart, Lung and Blood Vessel Diseases|||2||f||||t||||||Samples With DNA|"     If a blood specimen is obtained, it will be separated and stored at -80 ℃ as plasma, viable     cells, and extracted DNA. If a saliva specimen is obtained, it is stored for DNA.      If a tissue specimen is obtained, it will be cut into small pieces and stored at liquid     nitrogen.   "|Undecided||2017-10-10 21:29:04.973236|2017-10-10 21:29:04.973236
NCT03010501|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-09-18|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Energy Density Over 5 Days in Preschool Children||Recruiting||N/A|65|Anticipated|Penn State University||3|||f||||f||||||||||2017-10-10 21:29:05.079792|2017-10-10 21:29:05.079792
NCT03010488|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-28|||November 2016||2016-11-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Are Bright Lights and Regulated Sleep Effective Treatment for Depression?|Are Bright Lights and Regulated Sleep Effective Treatment for Depression.|Recruiting||N/A|60|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-10 21:29:05.165688|2017-10-10 21:29:05.165688
NCT03010475|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-15|||January 5, 2017|Actual|2017-01-05|August 2017|2017-08-01|August 9, 2017|Actual|2017-08-09|June 4, 2017|Actual|2017-06-04||Interventional|||A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects|A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects.|Completed||Phase 1|41|Actual|Novo Nordisk A/S||1|||f||||f|f|f||||||||2017-10-10 21:29:05.267534|2017-10-10 21:29:05.267534
NCT03010462|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-05-26|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|E-FIT||Electric Field Navigated 1hz Rtms for Post-stroke Motor Recovery Trial|A Prospective, Multi-center, Randomized, Sham-controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 hz Rtms Administered to the Contralesional Hemisphere as Adjuvant to Task-oriented Rehabilitation in Patients With Ischemic Stroke|Recruiting||N/A|60|Anticipated|Nexstim Ltd||2|||f||||t|f|t|t||f|||Undecided||2017-10-10 21:29:05.36754|2017-10-10 21:29:05.36754
NCT03010449|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-03|||February 2017||2017-02-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|BLOOD-VALVES||LVR in Severe Emphysema Using Bronchoscopic Autologous Blood Instillation in Combination With Intra-bronchial Valves|A Single Arm Pilot Study of Lung Volume Reduction in Severe Emphysema Using Bronchoscopic Autologous Blood Instillation in Combination With Intra-bronchial Valves|Not yet recruiting||Phase 2/Phase 3|20|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||1|||f||||t||||||||No||2017-10-10 21:29:05.474789|2017-10-10 21:29:05.474789
NCT03010436|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-05-08|||April 15, 2017|Actual|2017-04-15|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BITE||Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study|The Efficacy and Safety of Benralizumab In the Treatment of Eosinophilic Grandulomatosis With Polyangiitis (EGPA) Study: BITE|Recruiting||Phase 2|10|Anticipated|National Jewish Health||1|||f||||f|t|f||||||No||2017-10-10 21:29:05.601148|2017-10-10 21:29:05.601148
NCT03010423|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-25|||November 30, 2016|Actual|2016-11-30|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|April 2, 2018|Anticipated|2018-04-02||Interventional|SPET||Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Subjects|An Interventional, Pilot Study to Evaluate the Efficacy of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive CAD Patients (SPET Study)|Recruiting||Phase 4|20|Anticipated|Merck KGaA||2|||f||||f||||||||||2017-10-10 21:29:05.678898|2017-10-10 21:29:05.678898
NCT03010410|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-27|||December 2014||2014-12-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS)|Platelet Immune Responses in Aging and Influenza and Sepsis (INVACS)|Enrolling by invitation||N/A|150|Anticipated|Intermountain Health Care, Inc.|||4||f||||f||||||Samples With DNA|"     The study will bank remaining platelet lysates for future assays.   "|||2017-10-10 21:29:05.790086|2017-10-10 21:29:05.790086
NCT03010397|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-01-04|||November 2016||2016-11-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2016|Actual|2016-11-01|3 Years|Observational [Patient Registry]|PROGRESS||Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes|PROGRESS - Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes|Recruiting||Phase 4|212|Anticipated|Association for Innovation and Biomedical Research on Light and Image|||1||f||||f||||||||Yes||2017-10-10 21:29:05.869945|2017-10-10 21:29:05.869945
NCT03010384|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-01-03|||January 2011||2011-01-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|December 2012|Actual|2012-12-01||Interventional|||Contact to a Physician Specialized in Social Medicine and Return to Work|Contact to a Physician Specialized in Social Medicine and the Impact on Return to Workforce in Patients Suspected of Disc Herniation? - a Randomized Controlled Trial|Completed||N/A|443|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-10-10 21:29:05.945666|2017-10-10 21:29:05.945666
NCT03010371|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-01-04|||January 2016||2016-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|PSONLINE||Presential Vs Online Group-based Psychosocial Treatment for Breast Cancer Survivors.|Presential Vs Online Group-based Psychosocial Treatment for Breast Cancer Survivors.: A Multicentre Randomised Controlled Trial. Efficacy, Medical Cost Offset and Treatment Predictors.|Recruiting||N/A|200|Anticipated|Institut Català d'Oncologia||3|||f||||t||||||||||2017-10-10 21:29:06.009307|2017-10-10 21:29:06.009307
NCT03010358|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-07-24|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|February 28, 2024|Anticipated|2024-02-28|February 28, 2022|Anticipated|2022-02-28||Interventional|||Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma|A Phase I/II Study of Syk Inhibitor Entospletinib (GS-9973) in Combination With Obinutuzumab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and B-Cell Malignancies|Recruiting||Phase 1/Phase 2|29|Anticipated|OHSU Knight Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:29:06.112965|2017-10-10 21:29:06.112965
NCT03010345|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-04|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Use of Self Inflating Tissue Expanders In The Treatment Of Alveolar Cleft|The Use of Self Inflating Tissue Expanders In The Treatment Of Alveolar Cleft|Active, not recruiting||Phase 1|8|Actual|Cairo University||2|||f||||f||||||||No||2017-10-10 21:29:06.228488|2017-10-10 21:29:06.228488
NCT03010332|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-03||||||January 2017|2017-01-01||||||||Expanded Access|||Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease|An Expanded Access Protocol of ATA230 (Third-Party Donor-Derived Cytomegalovirus-Specific T Cells) for the Treatment of CMV Viremia or Disease in Subjects for Whom There Are No Other Comparable Options|Temporarily not available||N/A|||Atara Biotherapeutics|||||||||||||||||||2017-10-10 21:29:06.295964|2017-10-10 21:29:06.295964
NCT03010319|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-21|||January 2017||2017-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||PriMatrix for the Management of Diabetic Foot Ulcers|Prospective, Multi-center, Randomized, Controlled Trial Evaluating the Use of PriMatrix Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers|Recruiting||N/A|204|Anticipated|Integra LifeSciences Corporation||2|||f||||f||||||||||2017-10-10 21:29:06.35667|2017-10-10 21:29:06.35667
NCT03010306|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-12|||September 2013||2013-09-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||CASITA Intervention for Children at Risk of Delay in Carabayllo, Peru|Pilot Community-based Development Intervention (CASITA) for Children With Neurodevelopmental Risk and Delay in Carabayllo, Lima, Peru|Completed||N/A|61|Actual|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 21:29:06.447339|2017-10-10 21:29:06.447339
NCT03010293|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-02|||June 2016||2016-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Pressure Ulcer-associated Osteomyelitis: Evaluation of a Two-stage Surgical Strategy With Prolonged Antimicrobial Therapy|Pressure Ulcer-associated Osteomyelitis: Retrospective Evaluation of a Two-stage Surgical Strategy (Debridement With Vacuum-assisted Closure Therapy and Reconstruction) With Prolonged Antimicrobial Therapy|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:29:06.53938|2017-10-10 21:29:06.53938
NCT03010280|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-03|||April 2016||2016-04-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Immunonutrition on Septic Complications After Roux-en-Y Gastric Bypass|Effect of Immunonutrition on Septic Complications and Analytical Acute Phase Reactants After Roux-en-Y Gastric Bypass|Recruiting||Phase 3|44|Anticipated|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz||2|||f||||t||||||||||2017-10-10 21:29:06.665498|2017-10-10 21:29:06.665498
NCT03010267|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-06-01|||January 3, 2017|Actual|2017-01-03|June 2017|2017-06-01|March 29, 2017|Actual|2017-03-29|March 8, 2017|Actual|2017-03-08||Interventional|||DP-R213 Phase 1 Pharmacokinetics Study|An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetics and Safety of a Fixed Dose Combination of Raloxifen/Cholecalciferol Compared With Coadministration of Raloxifen and Cholecalciferol in Healthy Male Subjects|Completed||Phase 1|46|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-10 21:29:06.818911|2017-10-10 21:29:06.818911
NCT03010254|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-26|||March 21, 2017||2017-03-21||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:29:06.887388|2017-10-10 21:29:06.887388
NCT03010241|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|||The Multi-Centric Clinical Study of Chinese Medicine Intervention on Diabetes Distal Symmetric Polyneuropathy.|A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Traditional Chinese Medicine in the Treatment of Diabetes Distal Symmetric Polyneuropathy|Not yet recruiting||Early Phase 1|188|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:29:06.93156|2017-10-10 21:29:06.93156
NCT03010228|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-12|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis|Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Multivalent Recombinant OspA Vaccine Candidate Against Lyme Borreliosis, In Healthy Adults Aged Below 40 Years|Active, not recruiting||Phase 1|179|Actual|Valneva Austria GmbH||6|||f||||t||||||||||2017-10-10 21:29:07.025457|2017-10-10 21:29:07.025457
NCT03010215|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-02|||January 2010||2010-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|September 2016|Actual|2016-09-01||Interventional|DiabeticMIS1||Treatment of Chronic Diabetic Foot Ulcers by Minimally Invasive Surgery|Treatment of Chronic Diabetic Foot Ulcers by Minimally Invasive Surgery in a Cross-sectional Study|Active, not recruiting||N/A|40|Actual|University of Padua||1|||f||||f||||||||Yes|Age, Gender, Radiological and Clinica parameters and images.|2017-10-10 21:29:07.150482|2017-10-10 21:29:07.150482
NCT03010202|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||The PROLONG Trial - Rituximab Maintenance Therapy in ITP|Prolonging the Response by Low-dose Rituximab Maintenance Therapy in Immune Thrombocytopenia: a Randomized Placebo-controlled Trial - the PROLONG Trial|Recruiting||Phase 3|100|Anticipated|Ostfold Hospital Trust||4|||f||||t||||||||Undecided||2017-10-10 21:29:07.256491|2017-10-10 21:29:07.256491
NCT03010189|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-03-17|||January 2017||2017-01-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Actigraphy and Nocturnal Heartrate Variability in Cluster Headache Patients|Actigraphy and Nocturnal Heartrate Variability in Cluster Headache Patients|Recruiting||N/A|30|Anticipated|Nordlandssykehuset HF||2|||f||||f||||||||No||2017-10-10 21:29:07.384667|2017-10-10 21:29:07.384667
NCT03010176|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-28|||February 3, 2017|Actual|2017-02-03|September 2017|2017-09-01|October 22, 2020|Anticipated|2020-10-22|October 22, 2020|Anticipated|2020-10-22||Interventional|||Study of MK-1454 Alone or in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)|Phase 1 Open Label, Multicenter Study of MK-1454 Administered by Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab for Patients With Advanced/Metastatic Solid Tumors or Lymphomas|Recruiting||Phase 1|80|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f|t|f||||||||2017-10-10 21:29:07.505929|2017-10-10 21:29:07.505929
NCT03010163|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-06-20|||December 2016||2016-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Taxi STEP (Social Networks, Technology, and Exercise Through Pedometers)|Taxi STEP (Social Networks, Technology, and Exercise Through Pedometers)|Recruiting||N/A|184|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-10 21:29:07.631175|2017-10-10 21:29:07.631175
NCT03010150|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-08-14|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Modeling Adherence to Preventive Swallowing Exercises in Head and Neck Cancer|Modeling Adherence to Preventive Swallowing Exercises in Head and Neck Cancer|Recruiting||N/A|230|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||Samples With DNA|"     Blood (about 1-2 teaspoons each time) drawn at two different times to measure the level of     cytokines.   "|||2017-10-10 21:29:07.740751|2017-10-10 21:29:07.740751
NCT03010137|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-03|||December 2015||2015-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial|Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial|Recruiting||N/A|20|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 21:29:07.840308|2017-10-10 21:29:07.840308
NCT03010124|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-15|||September 2016||2016-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|OvBIOMark||Prognostic and Predictive Biomarkers in Ovarian Cancers|Prognostic and Predictive Biomarkers in Ovarian Cancers|Recruiting||N/A|200|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||No||2017-10-10 21:29:07.939131|2017-10-10 21:29:07.939131
NCT03010111|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Latent Tuberculosis Infection in Korean Health Care Workers|Latent Tuberculosis Infection in Korean Health Care Workers Using Interferon Gamma Releasing Assay|Recruiting||N/A|240|Anticipated|Hanyang University||1|||f||||t||||||||No||2017-10-10 21:29:08.018553|2017-10-10 21:29:08.018553
NCT03010098|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|POCD;TCI||The Effect on the Older's Cognition of Dual-loop Target Controlled Infusion Guided by Narcotrend Index||Not yet recruiting||Phase 4|60|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||Undecided||2017-10-10 21:29:08.109207|2017-10-10 21:29:08.109207
NCT03010085|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|OLLEH||Open Versus Laparoscopic Left-sided Hepatectomy Trial|A Multicenter Randomized Controlled Trial of Open Versus Laparoscopic Left-sided Hepatectomy|Not yet recruiting||Phase 3|122|Anticipated|Ewha Womans University Mokdong Hospital||2|||f||||t||||||||No||2017-10-10 21:29:08.206204|2017-10-10 21:29:08.206204
NCT03010072|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-07-25|||June 9, 2017|Actual|2017-06-09|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum|The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum|Recruiting||Phase 2|34|Anticipated|Elisabethinen Hospital||2|||f||||f|f|f||||||||2017-10-10 21:29:08.35381|2017-10-10 21:29:08.35381
NCT03010059|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-06-22|||February 6, 2017|Actual|2017-02-06|June 2017|2017-06-01|May 29, 2017|Actual|2017-05-29|May 29, 2017|Actual|2017-05-29||Interventional|||A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations|An Open-label, Randomized, 3-way Crossover Study in Healthy Adult Subjects to Assess the Relative Bioavailability of a Single Dose of JNJ-64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations|Completed||Phase 1|48|Actual|Janssen Research & Development, LLC||12|||f||||f|f|f||||||||2017-10-10 21:29:08.502472|2017-10-10 21:29:08.502472
NCT03010046|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Single Dose Study of ANX005 in Healthy Volunteers|A Phase 1, Randomized, Placebo-controlled, Double Blind, Single, Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ANX005 Monotherapy and ANX005 in Combination With IVIg in Healthy Volunteers|Recruiting||Phase 1|64|Anticipated|Annexon, Inc.||3|||f||||f||||||||No||2017-10-10 21:29:08.644022|2017-10-10 21:29:08.644022
NCT03010033|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-01|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer|Effects of Pulmonary Rehabilitation and Airway Management on Short-term and Long-term Perioperative Results of Lobectomy in Smoker Patients With Lung Cancer|Recruiting||N/A|200|Anticipated|Ruijin Hospital||2|||f||||f||||||||||2017-10-10 21:29:08.740832|2017-10-10 21:29:08.740832
NCT03010007|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-06-04|||January 2017||2017-01-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|May 2018|Anticipated|2018-05-01||Observational|||Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland|Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland [Prospektive Systemanalyse Der Saisonalen Influenza - Virustransmission Und Evolution in Der Stadt Basel] in German|Active, not recruiting||N/A|800|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples With DNA|"     blood (serum) and nasopharyngeal swabs   "|No||2017-10-10 21:29:08.950071|2017-10-10 21:29:08.950071
NCT03009994|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-01-03|||September 2016||2016-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Exteriorization Versus Non-exteriorization of the Uterus During Repair of Uterine Incision in a Repeated Cesarean Section||Recruiting||Phase 2|1024|Anticipated|Assiut University||2|||f||||f||||||||No||2017-10-10 21:29:09.029074|2017-10-10 21:29:09.029074
NCT03009981|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-03|2017-09-14|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|||A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer|A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer|Recruiting||Phase 3|504|Anticipated|Alliance Foundation Trials, LLC.||3|||f||||t|t|f||||||||2017-10-10 21:29:09.110087|2017-10-10 21:29:09.110087
NCT03009968|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-05-03|||March 17, 2017|Actual|2017-03-17|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Reducing Postoperative Catheterization|Reducing Postoperative Catheterization After Urogynecology Surgery: A Randomized Trial|Recruiting||N/A|140|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||No||2017-10-10 21:29:09.217709|2017-10-10 21:29:09.217709
NCT03009955|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-07-03|||December 2016||2016-12-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Observational|||Comparison of Postoperative Pain Between Patients Received Primary and Repeated Caesarean Section|Comparison of Postoperative Pain Between Patients Received Primary and Repeated Caesarean Section|Completed||N/A|168|Actual|Xinqiao Hospital of Chongqing|||2||f||||t||||||||||2017-10-10 21:29:09.325209|2017-10-10 21:29:09.325209
NCT03009942|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-02|||January 2010||2010-01-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|||Biochemical Mediators After Implant Loading|Nitric Oxide and Arginase Levels in Peri-Implant Tissues After Delayed Loading|Completed||N/A|20|Actual|Gazi University|||1||f||||||||||||||2017-10-10 21:29:09.403031|2017-10-10 21:29:09.403031
NCT03009929|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-10-05|||February 15, 2017|Actual|2017-02-15|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Validation Study of CLASSIC|International Multicentre Cohort Study for the Validation of CLASSIC - Classification of Intraoperative Complications|Recruiting||N/A|2500|Anticipated|University Hospital, Basel, Switzerland|||1||f||||||||||||||2017-10-10 21:29:09.483768|2017-10-10 21:29:09.483768
NCT03009916|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-08-04|||March 2016||2016-03-01|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|August 3, 2017|Actual|2017-08-03||Interventional|||Bileacid Malabsorption and GLP-1 Secretion|Bileacid Malabsorption and GLP-1 Secretion|Completed||Phase 4|24|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||||||||||||2017-10-10 21:29:09.641946|2017-10-10 21:29:09.641946
NCT03009903|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2016-12-30|||January 2017||2017-01-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|||Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage|Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage Using Pore Strips in Humans|Not yet recruiting||N/A|400|Anticipated|MBcure Ltd|||2||f||||f||||||||No|2 sites to be activated. Dr. Shapiro is considered as PI in both sites|2017-10-10 21:29:09.710092|2017-10-10 21:29:09.710092
NCT03009890|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|DART||Surgery vs. Casting for Displaced Articular Radius Fractures in Elderly|The Effectiveness of Surgery Versus Casting for Elderly Patients With Displaced Distal Intra-Articular Radius Fractures: A Randomized Controlled Trial|Not yet recruiting||N/A|154|Anticipated|JointResearch||2|||f||||t||||||||Undecided||2017-10-10 21:29:09.767779|2017-10-10 21:29:09.767779
NCT03009877|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Preoxygenation With Optiflow™ in Morbidly Obese Patients is Superior to Face Mask|Preoxygenation With Optiflow™, a High Flow Nasal Cannula (HFNC), is Superior to Preoxygenation With Facemask in Morbidly Obese Patients Undergoing General Anesthesia|Not yet recruiting||N/A|100|Anticipated|Montefiore Medical Center||2|||f||||f||||||||Yes|This is a collaborative study, so the information will be shared with the researchers in Texas. However, we do not plan to use this information for other studies.|2017-10-10 21:29:09.858026|2017-10-10 21:29:09.858026
NCT03009864|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|September 2019|Anticipated|2019-09-01||Interventional|||The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage|The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage|Not yet recruiting||Early Phase 1|632|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||Undecided||2017-10-10 21:29:09.968967|2017-10-10 21:29:09.968967
NCT03009851|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-02|||September 2014||2014-09-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|OBCHI||Testing the Effectiveness of an Occupation-based Cultural Intervention in Long-term Care|Testing an Occupation-Based Cultural Heritage Intervention in Long-Term Care Facilities|Completed||N/A|21|Actual|Texas Woman's University||2|||f||||f||||||||Yes|"Data will be presented without names and by treatment and/or control group. Information may include: gender, age, ethnicity, education level, and/or scores from the outcome measures. This information will be shared via publications and professional presentations.
The IRB is currently approved and continues to be renewed on a yearly basis. Contact the PI for further information."|2017-10-10 21:29:10.072381|2017-10-10 21:29:10.072381
NCT03009838|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary Syndrome|Letrozole Versus Laparoscopic Ovarian Drilling for Clomiphene-resistant Women With Polycystic Ovary Syndrome|Recruiting||Phase 3|150|Anticipated|Assiut University||2|||f||||t||||||||Yes||2017-10-10 21:29:10.138133|2017-10-10 21:29:10.138133
NCT03009825|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-05-11|||January 2017||2017-01-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|TrOma||Trauma Exposure, Emotion Regulation and Eating Pathology in Obese Patients|TrOma: A Cross-sectional Study Investigating Trauma Exposure, Emotion Regulation and Eating Pathology in Obese Patients|Recruiting||N/A|200|Anticipated|University of Paris 5 - Rene Descartes|||1||f||||f||||||||||2017-10-10 21:29:10.211803|2017-10-10 21:29:10.211803
NCT03009812|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-01|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Transverse vs Longitudinal Incision in Myomectomy|Transverse Versus Longitudinal Uterine Incision in Abdominal Myomectomy|Not yet recruiting||N/A|52|Anticipated|Ain Shams University||2|||f||||f||||||||Undecided||2017-10-10 21:29:10.286842|2017-10-10 21:29:10.286842
NCT03009799|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-05-09|||January 2017||2017-01-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|Goldeneye||Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)|Evaluation of the Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) Versus Placebo in Patients With Adenoviral Conjunctivis|Withdrawn||Phase 2|0|Actual|NicOx||2||Study stopped following management decision|f||||f||||||||Undecided||2017-10-10 21:29:10.361908|2017-10-10 21:29:10.361908
NCT03009786|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-05-31|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|XIvf||Validation of the French Version of the Xerostomia Inventory|Cross-cultural and Psychometric Validation Version of the Xerostomia Inventory Into French Language|Recruiting||N/A|150|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 21:29:10.467718|2017-10-10 21:29:10.467718
NCT03009773|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-07-06|||April 11, 2017|Actual|2017-04-11|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 11, 2017|Anticipated|2017-10-11||Interventional|SYNCOMOT||The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)?|The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)?|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f|f|f||||||||2017-10-10 21:29:10.542336|2017-10-10 21:29:10.542336
NCT03009760|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-19|||January 2015||2015-01-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose Administration|A Phase I , Study to Investigate Pharmacokinetics and Pharmacodynamics of Single and Multiple Dose of CJ-12420 50mg, 100mg in Helicobacter Pylori ?|Completed||Phase 1|16|Actual|CJ HealthCare Corporation||4|||f||||f||||||||No||2017-10-10 21:29:10.634633|2017-10-10 21:29:10.634633
NCT03009747|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|PMCRBDSPS||A Prospective Multi-Center Research on Bowel Dysfunction After Sphincter Preservative Surgery|A Prospective, Randomization and Clinic Cohort Observational Study From Multi Institutions on Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation|Not yet recruiting||N/A|460|Anticipated|Peking University People's Hospital|||1||f||||t||||||||Yes||2017-10-10 21:29:10.709822|2017-10-10 21:29:10.709822
NCT03009734|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-09-25|||December 2016||2016-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of ATx201 as a Topical Antibiotic Agent|A Prospective, Single Center, Randomized, Double-blind, Placebo Controlled Study in Two Phases to Evaluate the Safety and Efficacy of ATx201 as a Topical Antibiotic Agent|Recruiting||Phase 1/Phase 2|76|Anticipated|AntibioTx A/S||3|||f||||t||||||||||2017-10-10 21:29:10.784155|2017-10-10 21:29:10.784155
NCT03009721|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-03|||August 2016||2016-08-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia|A Non-interventional, Multi-center, Retrospective Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia (ROSE Study)|Recruiting||N/A|9707|Anticipated|Daewoong Pharmaceutical Co. LTD.|||1||f||||f||||||||No||2017-10-10 21:29:11.058037|2017-10-10 21:29:11.058037
NCT03009708|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-03-29|||March 21, 2017|Actual|2017-03-21|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|FIPALLOC||Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen|Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen|Recruiting||N/A|15|Anticipated|Institut de Cancérologie de la Loire||1|||f||||f|f|f||||||No||2017-10-10 21:29:11.155359|2017-10-10 21:29:11.155359
NCT03009695|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2017-10-03|||February 2015||2015-02-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transcranial Magnetic Stimulation (TMS) in Obesity|Impact of Deep Transcranial Magnetic Stimulation (dTMS) on Satiety and Weight Control|Recruiting||N/A|50|Anticipated|Ospedale San Donato||5|||f||||t||||||||||2017-10-10 21:29:11.278428|2017-10-10 21:29:11.278428
NCT03009682|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-09-27|||August 2016||2016-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|SUKSES-B||Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations|Phase II, Single-arm Study of Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations(SUKSES-B)|Recruiting||Phase 2|28|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-10 21:29:11.432486|2017-10-10 21:29:11.432486
NCT03009669|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-03|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|||The Application of Pleth Variability Index in Continuous Monitoring the Volume Status of Intraoperative Patients|The Application of Pleth Variability Index in Continuous Monitoring Volume Status in Patients Undergoing Intestinal Tumor Surgery|Active, not recruiting||N/A|50|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||||Undecided||2017-10-10 21:29:11.527812|2017-10-10 21:29:11.527812
NCT03009656|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|HOGAN||Assessing Accuracy of Clinical Diagnosis and Lesion Location in Acute Neurological Deficits - How Good Are Neurologists?|Assessing Accuracy of Clinical Diagnosis and Lesion Location in Acute Neurological Deficits - How Good Are Neurologists?|Not yet recruiting||N/A|800|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||No||2017-10-10 21:29:11.623089|2017-10-10 21:29:11.623089
NCT03009643|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-03|||October 2016||2016-10-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery|Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery|Recruiting||N/A|60|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||No||2017-10-10 21:29:11.708438|2017-10-10 21:29:11.708438
NCT03009630|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-04|||September 2016||2016-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||ENB Guided RFA for Early-stage Peripheral Lung Cancer|The Clinical Study of Electromagnetic Navigation Bronchoscopy (ENB) Guided Radiofrequency Ablation (RFA) for the Treatment of Early-stage Peripheral Lung Cancer|Recruiting||N/A|50|Anticipated|Shanghai Chest Hospital||1|||f||||f||||||||No||2017-10-10 21:29:11.857113|2017-10-10 21:29:11.857113
NCT03009617|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-01-03|||December 2014||2014-12-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effectiveness of Web-Based Health Education and Consultation on Health Promotion Behaviors of Adolescents|Effectiveness of Web-Based Health Education and Consultation on Health Promotion Behaviors of Adolescents: Randomized Controlled Trial|Completed||N/A|252|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||2|||f||||f||||||||No||2017-10-10 21:29:11.983501|2017-10-10 21:29:11.983501
NCT03009604|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Does Simethicone Improve Operative Field in Gynecological Operations||Recruiting||Phase 3|90|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:29:12.084299|2017-10-10 21:29:12.084299
NCT03009591|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-09-26|||February 12, 2017|Actual|2017-02-12|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|HeL-Fascial||Fascial Therapy in Elbow Hemophilic Arthropathy|Prospective and Multicenter Study to Assess the Safety and Effectiveness of a Physiotherapy Treatment Through Fascial Therapy in Hemophilic Elbow Arthropathy. A Pilot Study.|Recruiting||N/A|60|Anticipated|Real Fundación Victoria Eugenia||2|||f||||f|f|f||||||||2017-10-10 21:29:12.201473|2017-10-10 21:29:12.201473
NCT03009578|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-04-25|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia|Intravenous Iron Sucrose Versus Oral Ferrous Bis-glycinate for Treatment of Postpartum Iron Deficiency Anemia: a Randomized Clinical Trial|Recruiting||Phase 3|100|Anticipated|Assiut University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:29:12.312516|2017-10-10 21:29:12.312516
NCT03009565|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-01|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?|Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?|Not yet recruiting||N/A|800|Anticipated|Rabin Medical Center|||2||f||||||||||Samples With DNA|"     blood rectal swab   "|||2017-10-10 21:29:12.403046|2017-10-10 21:29:12.403046
NCT03009552|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-30|||June 2016||2016-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|STRAIN-DHF||Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure|Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure|Recruiting||N/A|176|Anticipated|University of Sao Paulo|||1||f||||t||||||||No||2017-10-10 21:29:12.51261|2017-10-10 21:29:12.51261
NCT03009539|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-30|||January 2017||2017-01-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||eHealth Evidence-based Intervention (EBI) for Latino Youth in Primary Care|Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care|Not yet recruiting||Phase 2/Phase 3|456|Anticipated|University of Miami||2|||f||||t||||||||Undecided||2017-10-10 21:29:12.64316|2017-10-10 21:29:12.64316
NCT03009526|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-07-11|||January 16, 2017|Actual|2017-01-16|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|October 30, 2018|Anticipated|2018-10-30||Interventional|STOPMIP-MW||Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi|A Prospective Randomized Open-Label Study on the Efficacy and Safety of Intermittent Preventive Treatment in Pregnancy (IPTp) With Dihydroartemisinin-Piperaquine (DP) Versus IPTp With Sulfadoxine-Pyrimethamine (SP) in Malawi|Recruiting||Phase 3|602|Anticipated|University of Malawi College of Medicine||2|||f||||t||||||||||2017-10-10 21:29:12.741987|2017-10-10 21:29:12.741987
NCT03009513|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-01|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Teneligliptin-Glimepiride DDI Study||Not yet recruiting||Phase 1|26|Anticipated|Handok Pharmaceuticals Co., Ltd.||1|||f||||||||||||||2017-10-10 21:29:12.883142|2017-10-10 21:29:12.883142
NCT03009500|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-06-19|||January 2017||2017-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|RESPERIST||Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain|A Multi-center Randomized Controlled Trial of Efficacy and Safety of Perineural Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain: The Resperist Study|Recruiting||Phase 3|90|Anticipated|University Health Network, Toronto||3|||f||||f||||||||No||2017-10-10 21:29:12.970472|2017-10-10 21:29:12.970472
NCT03009487|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-01|||November 2016||2016-11-01|January 2017|2017-01-01||||July 2017|Anticipated|2017-07-01||Interventional|||A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia||Recruiting||Phase 3|102|Anticipated|Daewoong Pharmaceutical Co. LTD.||3|||f||||||||||||||2017-10-10 21:29:13.107005|2017-10-10 21:29:13.107005
NCT03009474|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-01-03|||February 2015||2015-02-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers|Clinical Trial to Assess the Pharmacokinetic Characteristics of CJ-30060 in Healthy Male Subjects|Completed||Phase 1|52|Actual|CJ HealthCare Corporation||2|||f||||f||||||||No||2017-10-10 21:29:13.21719|2017-10-10 21:29:13.21719
NCT03009461|ClinicalTrials.gov processed this data on October 10, 2017|2017-01-02|2017-06-27|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis|Randomized Trial of Sorafenib Plus Hepatic Arterial Infusion With Oxaliplatin and Fluorouracil Versus Sorafenib for Hepatocellular Carcinoma With Major Portal Vein Tumor Thrombosis|Recruiting||Phase 2|62|Anticipated|Peking University||2|||f|||||f|f||||||||2017-10-10 21:29:13.3243|2017-10-10 21:29:13.3243
NCT03009435|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-30|||January 2017||2017-01-01|December 2016|2016-12-01||||January 2020|Anticipated|2020-01-01||Interventional|RMOS||RMOS Study : Impact of Manual Rotation of Occiput Posterior Position on Operative Delivery Rate (RMOS)|RMOS Study : Impact of Manual Rotation of Occiput Posterior Position on Operative Delivery Rate|Not yet recruiting||N/A|238|Anticipated|University Hospital, Angers||2|||f||||||||||||||2017-10-10 21:29:13.532063|2017-10-10 21:29:13.532063
NCT03009422|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-30|||November 2014||2014-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.||Active, not recruiting||N/A|20|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 21:29:13.601029|2017-10-10 21:29:13.601029
NCT03009409|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-30|||July 2017||2017-07-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effect of Low Dose Intra-operative Ketamine on Closed-loop Controlled General Anesthesia|The Effect of Low Dose Intra-operative Ketamine on Closed-loop Controlled General Anesthesia|Not yet recruiting||Phase 1|60|Anticipated|NeuroWave Systems Inc.||2|||f||||f||||||||||2017-10-10 21:29:13.686977|2017-10-10 21:29:13.686977
NCT03009396|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-09-20|||March 18, 2017|Actual|2017-03-18|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|MAPUS2||Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease|An Open Label Study to Assess the Efficacy and Safety of Fixed-Dose Combination RHB-104 in Subjects With Active Crohn's Disease Despite 26 Weeks of Participation in the MAP US RHB-104-01 Study|Recruiting||Phase 3|100|Anticipated|RedHill Biopharma Limited||1|||f||||t|t|f||||||||2017-10-10 21:29:13.789463|2017-10-10 21:29:13.789463
NCT03009383|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-31|||October 2016||2016-10-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||A Bedside Portable Endoscopy for the Esophageal Foreign Body|Efficacy of a Bedside Portable Endoscopy on Identifying the Esophageal Foreign Body|Recruiting||N/A|20|Anticipated|Kyungpook National University||1|||f||||t||||||||No||2017-10-10 21:29:13.966997|2017-10-10 21:29:13.966997
NCT03009370|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2016-12-31|||July 2016||2016-07-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||The Effect of the Ovarian Reserve on the Recurrent Pregnancy Loss||Recruiting||N/A|86|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||f||||||||||2017-10-10 21:29:14.043436|2017-10-10 21:29:14.043436
NCT03009357|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-30|||November 2016||2016-11-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|AT-thyro||Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis|Clinical Application of Continuous Monitoring Data for the Pulse Rate, Exercise, and Calorie Intake by Wearable Activity Trackers in the Patients With Thyrotoxicosis|Recruiting||N/A|40|Anticipated|Seoul National University Bundang Hospital|||1||f||||f||||||||No||2017-10-10 21:29:14.123754|2017-10-10 21:29:14.123754
NCT03009344|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-04-18|||January 10, 2017|Actual|2017-01-10|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 1 Study of Tazemetostat in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma|A Phase 1 Study of Tazemetostat in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma|Recruiting||Phase 1|6|Anticipated|Eisai Inc.||1|||f||||f|f|||||||No||2017-10-10 21:29:14.197998|2017-10-10 21:29:14.197998
NCT03009331|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-10-03|||July 25, 2017|Actual|2017-07-25|October 2017|2017-10-01|November 25, 2018|Anticipated|2018-11-25|April 25, 2018|Anticipated|2018-04-25||Interventional|||Descriptive and Comparative Study of Respiratory Function in the Postoperative Cardiac Surgery Patient|Descriptive and Comparative Study of Respiratory Function in the Postoperative Cardiac Surgery Patient|Recruiting||N/A|40|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f|f|f||||||||2017-10-10 21:29:14.328091|2017-10-10 21:29:14.328091
NCT03009318|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-31|||January 2012||2012-01-01|December 2016|2016-12-01||||September 2016|Actual|2016-09-01||Interventional|||Combination of MRS and 11C-methionine PET/CT in the Diagnosis of Glioma|Combination of Magnetic Resonance Spectroscopy and 11C-methionine PET/CT in the Diagnosis of Non-enhancing Supratentorial Glioma.|Completed||N/A|62|Actual|Huashan Hospital||1|||f||||t||||||||||2017-10-10 21:29:14.438258|2017-10-10 21:29:14.438258
NCT03009305|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-03-16|||October 2015||2015-10-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Cerebral Oximetry in Lower Body Negative Pressure|Cerebral Oxygen Saturation, Mean Systemic Filling Pressure and Haemodynamic Effects of PEP and CPAP in Lower Body Negative Pressure|Completed||N/A|20|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-10 21:29:14.527995|2017-10-10 21:29:14.527995
NCT03009292|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2017-04-20|||January 2019|Anticipated|2019-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor|Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor|Not yet recruiting||Phase 1|12|Anticipated|Eisai Inc.||1|||f||||f|f|f||||||||2017-10-10 21:29:14.620906|2017-10-10 21:29:14.620906
NCT03009279|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)|Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)|Not yet recruiting||N/A|10000|Anticipated|Qianfoshan Hospital|||2||f||||t||||||||Yes||2017-10-10 21:29:14.733709|2017-10-10 21:29:14.733709
NCT03009266|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-30|||February 2017||2017-02-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Ischemic Memory Imaging With Myocardial Contrast Echocardiography|Ischemic Memory Imaging With MCE|Not yet recruiting||N/A|40|Anticipated|Oregon Health and Science University||2|||f||||f||||||||No||2017-10-10 21:29:14.803858|2017-10-10 21:29:14.803858
NCT03009253|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-31|||July 2015||2015-07-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRLAPA||Translational Research on Locally Advanced Pancreatic Adenocarcinoma|Translational Research on Locally Advanced Pancreatic Adenocarcinoma|Recruiting||N/A|40|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:29:14.876635|2017-10-10 21:29:14.876635
NCT03009240|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-09-05|||August 21, 2017|Actual|2017-08-21|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia|A Phase I Study of Pevonedistat (TAK-924) and Decitabine Combination Therapy in High Risk Acute Myeloid Leukemia|Recruiting||Phase 1|30|Anticipated|City of Hope Medical Center||1|||||||t|t|f||||||||2017-10-10 21:29:14.96348|2017-10-10 21:29:14.96348
NCT03009214|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2016-12-31|||December 2016||2016-12-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours|A Safety, Tolerability and Pharmacokinetic Dose Escalation and Expansion, Phase I/Ib Study of AMC303 as Monotherapy in Patients With Advanced or Metastatic, Malignant Solid Tumour of Epithelial Origin|Recruiting||Phase 1|50|Anticipated|amcure GmbH||1|||f||||t||||||||No||2017-10-10 21:29:17.048491|2017-10-10 21:29:17.048491
NCT03009201|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-04-10|||January 2017||2017-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery|A Phase 1B Study of Ribociclib in Combination With Doxorubicin in Advanced Soft Tissue Sarcomas|Recruiting||Phase 1|36|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 21:29:17.168825|2017-10-10 21:29:17.168825
NCT03009188|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-31|2016-12-31|||July 2016||2016-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Genetic Findings in a Chinese Family With Axenfeld-Rieger Syndrom|Genetic Findings in a Chinese Family With Axenfeld-Rieger Syndrom|Completed||N/A|9|Actual|Aier Eye Hospital, Changsha|||1||f||||t||||||||No||2017-10-10 21:29:17.285952|2017-10-10 21:29:17.285952
NCT03009175|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-12-30|||June 2013||2013-06-01|February 2016|2016-02-01||||August 2014|Actual|2014-08-01||Observational|PRoMOTE FU||PRoMOTE Follow-up Observational Study|Patient Risk Triage in ICD Remote Follow-up Observational Study (PRoMOTE FU)|Completed||N/A|287|Actual|Medtronic Bakken Research Center|||1||f||||f||||||||Undecided||2017-10-10 21:29:17.342925|2017-10-10 21:29:17.342925
NCT03009162|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-07-25|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|June 4, 2017|Actual|2017-06-04|June 4, 2017|Actual|2017-06-04||Interventional|||Study of Oral Lasmiditan in Subjects With Normal and Impaired Renal Function|A Phase I, Multicenter, Open-Label, Parallel-Group Adaptive Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Renal Function|Completed||Phase 1|16|Actual|CoLucid Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 21:29:17.392728|2017-10-10 21:29:17.392728
NCT03009149|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-30|||November 2016||2016-11-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||Effects of Aerobic Exercise on CD4 Count,Viral Load,Selected Psycho-social Trait|Effects of Aerobic Exercise on CD4 Count,Viral Load,Selected Psycho-social Trait Among People Living With HIV/AIDS in Nekemte, Ethiopia|Enrolling by invitation||Early Phase 1|58|Anticipated|Mekelle University||1|||f||||f||||||||||2017-10-10 21:29:17.464598|2017-10-10 21:29:17.464598
NCT03009136|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-03-12|||December 31, 2016|Actual|2016-12-31|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis|Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis: Study Protocol for a Double-blind, Randomized, Parallel-group, Multi-center Trial|Recruiting||Phase 3|154|Anticipated|Kyung Hee University Hospital at Gangdong||2|||f||||f||||||||Undecided||2017-10-10 21:29:17.535026|2017-10-10 21:29:17.535026
NCT03009123|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-05-08|||January 2016||2016-01-01|May 2017|2017-05-01|May 6, 2017|Actual|2017-05-06|March 15, 2017|Actual|2017-03-15||Observational|EDtoPC||Will Erectile Dysfunction Increase the Risk of Prostate Cancer|Erectile Dysfunction and the Future Risk of Prostate Cancer: a Population-based Longitudinal Follow-up Study With Concurrent Double Comparison Cohorts|Completed||N/A|21558|Actual|Kuang Tien General Hospital|||3||f||||f||||||||No||2017-10-10 21:29:17.622042|2017-10-10 21:29:17.622042
NCT03009110|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-07-18|||February 8, 2017|Actual|2017-02-08|July 2017|2017-07-01|August 2021|Anticipated|2021-08-01|January 2020|Anticipated|2020-01-01||Interventional|Prevena-C||Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial|Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean: a Multicenter Randomized Trial|Recruiting||N/A|2850|Anticipated|Washington University School of Medicine||2|||f||||t|f|f|||f|||||2017-10-10 21:29:17.704326|2017-10-10 21:29:17.704326
NCT03009097|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-03|||April 2013||2013-04-01|December 2016|2016-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Atorvastatin as an Adjunct to DFDBA in Intrabony Defects|"Comparative Evaluation Of The Efficacy Of Atorvastatin Gel As An Adjunct To Allografts In The Treatment Of Intrabony Defects - A Clinico Radiological Study"|Completed||Phase 4|26|Actual|Kamineni Institute of Dental Sciences||2|||f||||||||||||||2017-10-10 21:29:17.82418|2017-10-10 21:29:17.82418
NCT03009084|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2016-12-30|||August 2015||2015-08-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Multidisciplinary Care for Patients With Chronic Kidney Disease to Increase Their Self-management.|Nephrocare: Multidisciplinary Care for Patients With Chronic Kidney Disease: an Increase of Patient Empowerment and Self-management by Using Interactive and Communication Tools and Nursing Interventions.|Recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||Undecided||2017-10-10 21:29:18.023932|2017-10-10 21:29:18.023932
NCT03009071|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-08|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness and Cost-effectiveness of Doin (Conduction Exercise) for Chronic Neck Pain|The Effectiveness and Cost-effectiveness of Doin (Conduction Exercise) for Chronic Neck Pain: a Pilot Multicenter Randomized Controlled Clinical Trial|Recruiting||N/A|30|Anticipated|Jaseng Medical Foundation||2|||f||||f|f|f||||||||2017-10-10 21:29:18.120962|2017-10-10 21:29:18.120962
NCT03009058|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-09-01|||May 24, 2017|Actual|2017-05-24|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Interventional|MODULATE||Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer|A Novel Phase I/IIa Open Label Study of IMM 101 in Combination With Selected Standard of Care (SOC) Regimens in Patients With Metastatic Cancer or Unresectable Cancer at Study Entry|Terminated||Phase 1/Phase 2|300|Anticipated|Immodulon Therapeutics Ltd||17||Commercial reasons|f||||f|f|f||||||||2017-10-10 21:29:18.237197|2017-10-10 21:29:18.237197
NCT03009045|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-03-10|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections|Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections|Recruiting||Phase 2|55|Anticipated|Los Angeles Biomedical Research Institute||1|||f||||t|t|f||||||Yes|After publication of trial results, data will be shared with investigators upon request to the Principal Investigator and after signing a Data Use Agreement.|2017-10-10 21:29:18.521321|2017-10-10 21:29:18.521321
NCT03009032|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-07-30|||February 2014|Actual|2014-02-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|PROMALTIA||Synbiotics in Advanced HIV Infection|Immunological Effects of an Immunomodulatory Synbiotic Intervention at Advanced HIV Disease|Completed||N/A|77|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||f||||||||||2017-10-10 21:29:18.618859|2017-10-10 21:29:18.618859
NCT03009019|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-08-22|||December 2016||2016-12-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy, Tolerability, and Safety of DFN-15||Active, not recruiting||Phase 3|631|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-10 21:29:18.726326|2017-10-10 21:29:18.726326
NCT03009006|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-07-18|||January 3, 2017||2017-01-03|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Post Operative Pain and Level of Endotoxins With Calcium Hydroxide and Calcium Hydroxide Mixed With Chlorhexidine in Treating Necrotic Teeth|Effect Of Combination of Calcium Hydroxide And Chlorhexidine Gel 2% as Intracanal Medication in Comparison to Calcium Hydroxide Paste as Intracanal Medication on Postoperative Pain And Bacterial Endotoxins in Necrotic Teeth:|Not yet recruiting||N/A|45|Anticipated|Cairo University||3|||f||||f||||||||||2017-10-10 21:29:18.898691|2017-10-10 21:29:18.898691
NCT03008993|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-02-14|||October 17, 2016|Actual|2016-10-17|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|HuCare2||A Stepped Wedge Cluster Randomized Controlled Trial to Assess a Strategy Aiming to Optimize Psychosocial Outcomes in Patients With Cancer|Trial Clinico Controllato e Randomizzato, Con Disegno a Cluster Stepped-wedge, Per Valutare Una Strategia Volta ad Ottimizzare Gli Outcomes Psicosociali in Pazienti Affetti da Cancro|Recruiting||N/A|720|Anticipated|Istituti Ospitalieri di Cremona||2|||f||||||||||||||2017-10-10 21:29:19.028418|2017-10-10 21:29:19.028418
NCT03008980|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-30|||March 2002||2002-03-01|December 2016|2016-12-01||||December 2020|Anticipated|2020-12-01||Observational|||The Analysis of WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) Increased Yield of Barrett's Esophagus and Esophageal Dysplasia||Recruiting||N/A|75000|Anticipated|CDx Diagnostics|||7||f||||||||||||||2017-10-10 21:29:19.147831|2017-10-10 21:29:19.147831
NCT03008967|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-12-30|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01|3 Months|Observational [Patient Registry]|||A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark|A Prospective Cohort Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark|Recruiting||N/A|160|Anticipated|Bornholms Regionskommune|||1||f||||f||||||||Yes||2017-10-10 21:29:19.250026|2017-10-10 21:29:19.250026
NCT03007862|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-09|||November 2016||2016-11-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||Bronchial Alpha Amylase as a Marker for Early Aspiration Pneumonia in Therapeutic Hypothermia.|Salivary Alpha Amylase Bronchial Measure for Early Aspiration Pneumonia Diagnosis in Patients Treated With Therapeutic Hypothermia After Out-of-hospital Cardiac Arrest.|Recruiting||N/A|150|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 21:29:19.35335|2017-10-10 21:29:19.35335
NCT03007849|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-30|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Pilot Study of Fecal Microbiome and Neutrophil Cellular Adhesion Molecules in Patients With Sickle Cell Disease (SCD)|A Pilot Study of Fecal Microbiome and Neutrophil Cellular Adhesion Molecules in Patients With Sickle Cell Disease (SCD)|Not yet recruiting||N/A|50|Anticipated|Rhode Island Hospital|||1||f||||f||||||Samples With DNA|"     Stool and blood   "|No||2017-10-10 21:29:19.416992|2017-10-10 21:29:19.416992
NCT03008954|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-30|||July 2012||2012-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:29:19.467893|2017-10-10 21:29:19.467893
NCT03008941|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-14|||January 2017||2017-01-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|REFRESH||Microbiota Restoration Therapy in HIV With Repeated Low-Dose Interventions|A Phase I/II Randomized, Double-Blind, Placebo Controlled Study of Repeated Low-Dose Fecal Microbiota Restoration in HIV-Infected Subjects. The REFRESH Study|Recruiting||Phase 1/Phase 2|30|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||t||||||||||2017-10-10 21:29:19.509205|2017-10-10 21:29:19.509205
NCT03008928|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-08-14|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||The Efficacy of the Alcooquizz App to Reduce Hazardous Alcohol Consumption|The Efficacy of the Alcooquizz App to Reduce Hazardous Alcohol Consumption: Randomized Controlled Trial|Completed||N/A|987|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-10 21:29:19.68925|2017-10-10 21:29:19.68925
NCT03008915|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-08-08|||January 2017||2017-01-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency|Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency|Recruiting||Phase 2|15|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-10 21:29:19.761576|2017-10-10 21:29:19.761576
NCT03008902|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-05-10|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Observational|||A Study of Effects of Age and Hyperkyphosis on Spine Motion and Loading|A Cross-sectional Study Using Motion Analysis to Determine Whether Age and Hyperkyphosis Are Associated With Thoracic Spine Motion and Loading|Recruiting||N/A|60|Anticipated|Beth Israel Deaconess Medical Center|||2||f||||f|f|f||||||No||2017-10-10 21:29:19.85838|2017-10-10 21:29:19.85838
NCT03008525|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-09|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|VITADOSE||Vitamin D and Its Metabolites Quantification in Adipose Tissues of Obese and Non-obese Patients.||Not yet recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 21:29:23.542197|2017-10-10 21:29:23.542197
NCT03008876|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-06-28|||January 2017||2017-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||IV Acetaminophen and Patent Ductus Arteriosus|The Efficacy of IV Acetaminophen on Patent Ductus Arteriosus Closure in Preterm Infants|Recruiting||N/A|40|Anticipated|Albany Medical College||2|||f||||f||||||||No||2017-10-10 21:29:20.087161|2017-10-10 21:29:20.087161
NCT03008863|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-04|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Educating Anesthesia Residents to Improve Perioperative Care for the Elderly|Educating Anesthesia Residents to Improve Perioperative Care for the Elderly|Recruiting||N/A|42|Anticipated|Duke University||2|||f||||||||||||||2017-10-10 21:29:20.196787|2017-10-10 21:29:20.196787
NCT03008850|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-03|||June 2015||2015-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Shivering Prevention During Cesarean Section by Intrathecal Injection of Magnesium Sulfate|Shivering Prevention During Cesarean Section by Intrathecal Injection of Magnesium Sulfate|Completed||Phase 2/Phase 3|84|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:29:20.307377|2017-10-10 21:29:20.307377
NCT03008837|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-06-08|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|May 31, 2019|Anticipated|2019-05-31|December 7, 2018|Anticipated|2018-12-07||Interventional|fMRI||Feasibility Study: fMRI Evaluation of Auricular PENFS for Fibromyalgia|Feasibility Study: fMRI Evaluation of Auricular PENFS for Fibromyalgia|Recruiting||N/A|20|Anticipated|VA Office of Research and Development||2|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:29:20.40276|2017-10-10 21:29:20.40276
NCT03008824|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-29|||September 2012||2012-09-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|PRiDE||Micronutrients in Pregnancy as a Risk Factor for Diabetes and Effects on Mother and Baby|Micronutrients in Pregnancy as a Risk Factor for Diabetes and Effects on Mother and Baby: PRiDE Study|Recruiting||N/A|4500|Anticipated|University of Warwick|||1||f||||f||||||Samples With DNA|"     Plasma, serum and whole blood for isolating DNA   "|Undecided|A core dataset and the metatdata that is funded by MRC will be archived|2017-10-10 21:29:20.552214|2017-10-10 21:29:20.552214
NCT03008811|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-30|||November 2016||2016-11-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|NO PERS-AF||Norwegian Study of Persistent Atrial Fibrillation Treatment: Cryoballoon Versus Radiofrequency Catheter Ablation|Norwegian Randomized Study of Persistent Atrial Fibrillation Treatment: Cryoballoon Versus Radiofrequency Catheter Ablation (NO PERS-AF)|Active, not recruiting||N/A|128|Anticipated|Haukeland University Hospital||2|||f||||f||||||||No||2017-10-10 21:29:20.695158|2017-10-10 21:29:20.695158
NCT03008798|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PRISIT||Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117|Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117--PRISIT Trial|Not yet recruiting||Phase 2|180|Anticipated|Guangzhou University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 21:29:20.834747|2017-10-10 21:29:20.834747
NCT03008785|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-29|||February 2015||2015-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Isoflavone Supplementation Associated With Physical Exercise on Blood Pressure and Climacteric Symptoms|Isoflavone Supplementation Does Not Potentiate Blood Pressure Responses and in Climacteric Symptoms After Training With Combined Exercise|Completed||Phase 4|32|Actual|Federal University of Uberlandia||2|||f||||f||||||||Undecided||2017-10-10 21:29:20.974186|2017-10-10 21:29:20.974186
NCT03008772|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-30|||January 2017||2017-01-01|December 2016|2016-12-01|January 2024|Anticipated|2024-01-01|January 2023|Anticipated|2023-01-01|5 Years|Observational [Patient Registry]|||REWARDS- In-stent Restenosis|REWARDS-In-stent Restenosis|Not yet recruiting||N/A|1000|Anticipated|Medstar Health Research Institute|||2||f||||f||||||||No||2017-10-10 21:29:21.102514|2017-10-10 21:29:21.102514
NCT03008759|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-29|||February 2016||2016-02-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation in Vivo of Dentifrice With Nanoencapsulated Fluoride|Evaluation in Vivo of Experimental Dentifrice With Nanoencapsulated Fluoride|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Federal University of Paraíba||4|||f||||t||||||||Undecided||2017-10-10 21:29:21.194357|2017-10-10 21:29:21.194357
NCT03008746|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-30|||December 2016||2016-12-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|MiPAD||Pulmonary Microbiota in Patients With Chronic Obstructive Pulmonary Disease Colonized With P. Aeruginosa Resistant to Imipenem|Pulmonary Microbiota in COPD Patients Colonized With P. Aeruginosa OprD Mutant Resistant to Imipenem|Recruiting||N/A|100|Anticipated|CHU de Reims||3|||f||||||||||||||2017-10-10 21:29:21.309089|2017-10-10 21:29:21.309089
NCT03008733|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-12-30|||January 2017||2017-01-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2017|Anticipated|2017-03-01||Interventional|EchoNerf||Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG|Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG|Not yet recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Nice||4|||f||||f||||||||No||2017-10-10 21:29:21.450727|2017-10-10 21:29:21.450727
NCT03008720|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-01|||February 2017||2017-02-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of Electrical Activity Tibial Muscle and Postural Control of Individuals With Hemiparesia Post TDCS Associated With FES|EVALUATION OF ELECTRICAL ACTIVITY TIBIAL MUSCLE AND POSTURAL CONTROL OF INDIVIDUALS WITH HEMIPARESIA FROM AVE SUBMITTED TDCS ASSOCIATED WITH FES - CLINICAL STUDY, RANDOMIZED, DOUBLE BLIND.|Not yet recruiting||Phase 2|2|Anticipated|University of Nove de Julho||4|||f||||f||||||||||2017-10-10 21:29:21.552914|2017-10-10 21:29:21.552914
NCT03008707|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-31|||November 2015||2015-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|March 2017|Anticipated|2017-03-01||Observational|STELLA||Laparoscopic Peritoneal Lavage vs Laparoscopic Sigmoidectomy in Perforated Acute Diverticulitis : a Multicenter Prospective Observational Study (STELLA Study)|Laparoscopic Peritoneal Lavage vs Laparoscopic Sigmoidectomy in Perforated Acute Diverticulitis : a Multicenter Prospective Observational Study|Recruiting||N/A|50|Anticipated|Azienda Ospedaliero, Universitaria Pisana|||2||f||||||||||||||2017-10-10 21:29:21.63286|2017-10-10 21:29:21.63286
NCT03008694|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral Cancer Patients|Phrase II Single Arm Study of Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral|Not yet recruiting||Phase 2|100|Anticipated|Zhongnan Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:29:21.716264|2017-10-10 21:29:21.716264
NCT03008681|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-29|||January 2004||2004-01-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||OHRQoL Evaluation After Functional Therapy in JIA Patients|Oral Health-Related Quality of Life in Patients With Juvenile Idiopathic Arthritis and Temporomandibular Joint Disorders Evaluation After Treatment With a Functional Appliance|Completed||N/A|93|Actual|University of Messina||1|||f||||t||||||||No||2017-10-10 21:29:21.79043|2017-10-10 21:29:21.79043
NCT03008668|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2020|Anticipated|2020-12-01||Interventional|||A Trial of Acupuncture for Knee Osteoarthritis With Differential Functional Status of Acupoints||Enrolling by invitation||N/A|664|Anticipated|West China Hospital||2|||f||||||||||||||2017-10-10 21:29:21.859493|2017-10-10 21:29:21.859493
NCT03008655|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||1064-nm Q-switched Nd:YAG Laser and Intradermal Tranexamic Acid for Melasma|A Split-face Comparison of Low Fluence 1064-nm Q-switched Nd:YAG Laser Plus Vitamin C vs Low Fluence 1064-nm Q-switched Nd:YAG Laser Plus Intradermal Tranexamic Acid Injection for Melasma:a Single Blinded, Randomised Study|Not yet recruiting||N/A|20|Anticipated|Taipei Medical University WanFang Hospital||2|||f||||f||||||||No||2017-10-10 21:29:21.923411|2017-10-10 21:29:21.923411
NCT03008642|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-04-25|||May 20, 2017|Anticipated|2017-05-20|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|June 20, 2017|Anticipated|2017-06-20||Interventional|Poly-CO||CO-Rebreathing in Comparison to Isotopic Red Cell Volume Determination in the Diagnosis of Primitive and Secondary Polycythemia|CO-Rebreathing in Comparison to Isotopic Red Cell Volume Determination in the Diagnosis of Primitive and Secondary Polycythemia: a Multicentric Study. Co-Rebreathing for the Measurement of Total Red Cell Mass in Polycythemia.|Not yet recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f|f|f||||||||2017-10-10 21:29:21.996938|2017-10-10 21:29:21.996938
NCT03008629|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Efficacy of Nail Brace for Treatment of Ingrown Toenails|Clinical Efficacy of Nail Brace for Treatment of Ingrown Toenails|Not yet recruiting||N/A|40|Anticipated|Taipei Medical University WanFang Hospital||3|||f||||f||||||||No||2017-10-10 21:29:22.07385|2017-10-10 21:29:22.07385
NCT03008616|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-09-18|||April 12, 2017|Actual|2017-04-12|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of the Efficacy and Safety of DigiFab® in Antepartum Subjects With Severe Preeclampsia|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of DigiFab® in Antepartum Subjects With Severe|Recruiting||Phase 2|200|Anticipated|Velo Bio, LLC||2|||f||||t|t|f||||||||2017-10-10 21:29:22.156521|2017-10-10 21:29:22.156521
NCT03008603|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-01|||March 2017||2017-03-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of the Safety, Effectiveness & Usability of the XACT Robotic System for Image Guided Percutaneous Procedures|Evaluation of the Safety, Effectiveness & Usability of the XACT Robotic System for Image Guided Percutaneous Procedures|Not yet recruiting||Phase 4|100|Anticipated|Xact Robotics Ltd.||1|||f||||f||||||||No||2017-10-10 21:29:22.291281|2017-10-10 21:29:22.291281
NCT03008590|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-08-21|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|March 29, 2019|Anticipated|2019-03-29|March 29, 2019|Anticipated|2019-03-29||Interventional|LDN-VA||Low Dose Naltrexone for Chronic Pain From Arthritis|Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis|Not yet recruiting||Phase 2|60|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-10 21:29:22.384724|2017-10-10 21:29:22.384724
NCT03008577|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-28|||November 2016||2016-11-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|HEAT2||Hypothermia and the Effect of Ambient Temperature 2|The Impact of Ambient Cesarean Room Temperature on Neonatal Morbidity|Recruiting||N/A|4022|Anticipated|University of Texas Southwestern Medical Center||2|||f||||||||||||||2017-10-10 21:29:23.104812|2017-10-10 21:29:23.104812
NCT03008564|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-05-01|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Adductor Canal Block Ultrasound Anatomy in Volunteers|Determining The Location and Ultrasound Anatomy of Two Previously Described Adductor Canal Block Approaches in Volunteers.|Recruiting||N/A|60|Anticipated|University of Iowa|||1||f||||f||||||||No||2017-10-10 21:29:23.229549|2017-10-10 21:29:23.229549
NCT03008551|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-30|||August 18, 2017|Actual|2017-08-18|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Empagliflozin vs Metformin in PCOS|The Effect of Empagliflozin Versus Metformin on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome (PCOS) - a Randomised Open-label Parallel Study.|Recruiting||Phase 2/Phase 3|40|Anticipated|University of Hull||2|||f||||t|f|f||||||||2017-10-10 21:29:23.343132|2017-10-10 21:29:23.343132
NCT03008538|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-30|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Socket Preservation Using Autogenous Bone Graft Versus MPM|Dental Implant Placement in Extraction Socket of Mandibular Anterior and Premolar Areas Treated With Mineralized Plasmatic Matrix Versus Autogenous Bone Graft|Active, not recruiting||Phase 1/Phase 2|20|Actual|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:29:23.461344|2017-10-10 21:29:23.461344
NCT03007368|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-12-29|||March 2012||2012-03-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Digestion of Foods Consumed in Africa|Assessment of Gastric Emptying and Fullness of Different Types of Foods in Mali|Completed||N/A|20|Actual|Purdue University||8|||f||||f||||||||No|Not shared|2017-10-10 21:29:32.671832|2017-10-10 21:29:32.671832
NCT03008512|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-29|||October 2016||2016-10-01|December 2016|2016-12-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib|A Phase II Study of Weekly Genexol-PM in Patients With Advanced Hepatocelluar Carcinoma After Failure of Sorafenib|Recruiting||Phase 2|32|Anticipated|Gachon University Gil Medical Center||1|||f||||t||||||||Undecided||2017-10-10 21:29:23.63579|2017-10-10 21:29:23.63579
NCT03008499|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer||Recruiting||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:29:23.743053|2017-10-10 21:29:23.743053
NCT03008486|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-06-01|||January 2017||2017-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness|Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness|Recruiting||Phase 2|100|Anticipated|University Hospital of Liege||4|||f||||f||||||||No||2017-10-10 21:29:23.83907|2017-10-10 21:29:23.83907
NCT03008473|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-09-23|||January 2017|Actual|2017-01-01|December 2016|2016-12-01|September 24, 2017|Actual|2017-09-24|September 24, 2017|Actual|2017-09-24||Interventional|||Placement of the Univent Tube Without Fiberoptic Bronchoscope Assistance|Placement of the Double-Lumen Tube Without Fiberoptic Bronchoscope Assistance|Completed||N/A|60|Actual|The First Hospital of Qinhuangdao||2|||f||||t||||||||||2017-10-10 21:29:23.967005|2017-10-10 21:29:23.967005
NCT03008460|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-07-25|||September 15, 2017|Anticipated|2017-09-15|July 2017|2017-07-01|October 15, 2018|Anticipated|2018-10-15|September 15, 2018|Anticipated|2018-09-15||Interventional|EASYKID||Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy|Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (Eziclen/Izinova®) in Paediatric Subjects Undergoing Colonoscopy: a Phase III, Multicentre, Randomised, Comparative Study Versus Klean-Prep® (PEG-Electrolytes), Administered on the Day Before Colonoscopy, Investigator-blinded, Non-inferiority in Adolescents of 12 to 17 Years of Age (Inclusive) >40 kg|Not yet recruiting||Phase 3|250|Anticipated|Ipsen||2|||f|||||f|f||||||||2017-10-10 21:29:24.044447|2017-10-10 21:29:24.044447
NCT03008447|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-09-19|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older|A Randomized, Double-Blind, Placebo-Controlled and Active Comparator, 4 Period Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older|Recruiting||Phase 1|60|Anticipated|Eisai Inc.||4|||f||||f|t|||||||||2017-10-10 21:29:24.165931|2017-10-10 21:29:24.165931
NCT03008434|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-03|||October 2015||2015-10-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Traumatic Brain Injury and Yoga|Traumatic Brain Injury and Yoga|Completed||Phase 1|10|Actual|Colorado State University||1|||f||||f||||||||No||2017-10-10 21:29:24.287169|2017-10-10 21:29:24.287169
NCT03008421|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-31|||February 2017||2017-02-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy|Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy: A Randomized Placebo-controlled Double-blinded Trial|Not yet recruiting||Phase 3|1040|Anticipated|Medical University of Vienna||2|||f||||f||||||||Undecided||2017-10-10 21:29:24.381268|2017-10-10 21:29:24.381268
NCT03008408|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-08-21|||August 18, 2017|Actual|2017-08-18|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Study of Ribociclib (LEE011), Everolimus, and Letrozole, in Patients With Advanced or Recurrent Endometrial Carcinoma|A Phase II, Single-Arm Study of Ribociclib (LEE011), Everolimus, and Letrozole, in Patients With Advanced or Recurrent Endometrial Carcinoma|Recruiting||Phase 2|76|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:29:24.48149|2017-10-10 21:29:24.48149
NCT03008395|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-04|||April 2017||2017-04-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|EMMA||Empowerment, Motivation and Medical Adherence (EMMA).|Empowerment, Motivation and Medical Adherence (EMMA). Dialogue Tools for Consultations With Patients With Type 2 Diabetes|Not yet recruiting||N/A|116|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||No||2017-10-10 21:29:24.614895|2017-10-10 21:29:24.614895
NCT03008382|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-08-29|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|ICECAN||Interstitial Cystitis: Examination of the Central Autonomic Network|Interstitial Cystitis: Examination of the Central Autonomic Network|Recruiting||Phase 4|180|Anticipated|Medical College of Wisconsin||2|||f||||t|t|f|||t|||||2017-10-10 21:29:24.74473|2017-10-10 21:29:24.74473
NCT03008369|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-08-28|||September 2017|Anticipated|2017-09-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery|Phase II Trial of Lenvatinib in Metastatic or Advanced Pheochromocytoma and Paraganglioma|Recruiting||Phase 2|25|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:29:24.88293|2017-10-10 21:29:24.88293
NCT03008356|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-28|||January 2017||2017-01-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|LC4COPD||L-carnitine for Fatigue in COPD|L-Carnitine Supplementation With and Without Health Coaching for Fatigue in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Enrolling by invitation||N/A|90|Anticipated|Mayo Clinic||3|||f||||f||||||||No||2017-10-10 21:29:25.007392|2017-10-10 21:29:25.007392
NCT03008343|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-01|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer||Recruiting||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:29:25.112465|2017-10-10 21:29:25.112465
NCT03008330|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-01|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer||Recruiting||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:29:25.21203|2017-10-10 21:29:25.21203
NCT03008317|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-30|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|splitmouth||Microbial Adhesion to Metallic Versus Non Metallic Surfaces of Bounded Removable Partial Denture|Microbial Adhesion to Metallic Versus Non Metallic Surfaces of Bounded Removable Partial Denture|Enrolling by invitation||N/A|2|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:29:25.311583|2017-10-10 21:29:25.311583
NCT03008304|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-01|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer||Recruiting||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:29:25.391725|2017-10-10 21:29:25.391725
NCT03008291|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-04-24|||October 2016||2016-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||His Bundle Pacing in Bradycardia and Heart Failure|His Bundle Pacing in Bradycardia and Heart Failure|Recruiting||N/A|40|Anticipated|Mayo Clinic|||2||f||||f||||||||Undecided||2017-10-10 21:29:25.485143|2017-10-10 21:29:25.485143
NCT03008278|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-09-04|||September 15, 2017|Anticipated|2017-09-15|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery|A Phase 1/2 Study of Olaparib in Combination With Ramucirumab in Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma (10017760)|Not yet recruiting||Phase 1/Phase 2|46|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:29:25.584466|2017-10-10 21:29:25.584466
NCT03008265|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01||||March 2017|Anticipated|2017-03-01||Observational|||Fascial Dehiscence and Mortality|Just a Fascial Dehiscence? Nationwide Cohort Study on the Mortality Associated With Fascial Dehiscence After Colonic Resection|Active, not recruiting||N/A|9000|Anticipated|Bispebjerg Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:29:25.701382|2017-10-10 21:29:25.701382
NCT03008252|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Lactose Intolerance and Cow's Milk Protein Allergy in Non-celiac Wheat Sensitivity Patients|Lactose Intolerance and Cow's Milk Protein Allergy in Non-celiac Wheat Sensitivity Patients|Not yet recruiting||N/A|50|Anticipated|University of Palermo|||1||f||||f||||||||No||2017-10-10 21:29:25.780734|2017-10-10 21:29:25.780734
NCT03008239|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense)|Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense) for Home Use in Diabetic and Prediabetic Individuals|Not yet recruiting||N/A|24|Anticipated|Lee's Pharmaceutical Limited||1|||f||||t|f|f||||||||2017-10-10 21:29:25.87156|2017-10-10 21:29:25.87156
NCT03008226|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-29|||June 2015||2015-06-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Observational|||Spiration Valve System 9 mm European Post Market Evaluation Study|Post Market Evaluation of the 9mm Spiration Valve System in Patients With Severe Heterogeneous Emphysema|Recruiting||N/A|120|Anticipated|Heidelberg University|||1||f||||f||||||||No||2017-10-10 21:29:25.964671|2017-10-10 21:29:25.964671
NCT03008213|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|CINV||Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV|Fixed Dose Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory Chemotherapy-Induced Nausea and Vomiting|Not yet recruiting||Phase 2|50|Anticipated|University of California, San Diego||1|||f||||t||||||||No||2017-10-10 21:29:26.036112|2017-10-10 21:29:26.036112
NCT03008200|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-31|||December 2015||2015-12-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Fetal Pulmonary Artery Acceleration to Ejection Time Ratio (PATET) in the Prediction of Subsequent Development of Respiratory Distress Syndrome (RDS)|Fetal Pulmonary Artery Acceleration to Ejection Time Ratio (PATET) in the Prediction of Subsequent Development of Respiratory Distress Syndrome (RDS)|Completed||N/A|115|Actual|Kayseri Education and Research Hospital|||2||f||||t||||||||Yes|if necessary|2017-10-10 21:29:26.112332|2017-10-10 21:29:26.112332
NCT03008174|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-28|||January 2016||2016-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Early Speech With One-Way Speaking Valve in Tracheostomy Patients|Early Speech With One-Way Speaking Valve in Tracheostomy Patients - Pilot Study|Recruiting||N/A|20|Anticipated|Johns Hopkins University||2|||f||||t||||||||No|Will not be sharing data|2017-10-10 21:29:26.266009|2017-10-10 21:29:26.266009
NCT03008161|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-09-01|||December 2016||2016-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease|A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose Escalation Study of NPT088 in Patients With Probable Alzheimer's Disease|Recruiting||Phase 1|66|Anticipated|Proclara Biosciences, Inc.||4|||f||||t||||||||||2017-10-10 21:29:26.371372|2017-10-10 21:29:26.371372
NCT03008148|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-02|||April 2017||2017-04-01|January 2017|2017-01-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM|Randomized Phase II/III Trial of Radiotherapy Plus Concomitant and Adjuvant Temozolomide With or Without Hydroxychloroquine, Rapamycin for Newly Diagnosed Glioblastoma|Not yet recruiting||Phase 2/Phase 3|264|Anticipated|Johnpro Biotech, Inc.||2|||f||||t||||||||No||2017-10-10 21:29:26.515974|2017-10-10 21:29:26.515974
NCT03008135|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-03-27|||March 21, 2017|Actual|2017-03-21|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Reliability and Validity of the Elderly Mobility Scale, French Version|Reliability and Validity of the Elderly Mobility Scale for Frailty People Living at Home, French Version|Recruiting||N/A|60|Anticipated|Pole Santé Plouasne Saint Pern Becherel|||1||f||||f||||||||Undecided||2017-10-10 21:29:26.724868|2017-10-10 21:29:26.724868
NCT03008122|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-14|||February 24, 2017|Actual|2017-02-24|March 16, 2017|2017-03-16|January 15, 2020|Anticipated|2020-01-15|July 18, 2019|Anticipated|2019-07-18||Interventional|||Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area|Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate the Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) Administered by the Intramuscular Route in Adult Subjects Who Reside in a Flavivirus Endemic Area|Recruiting||Phase 1|90|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-10 21:29:26.835799|2017-10-10 21:29:26.835799
NCT03008109|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-02|||February 2017||2017-02-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor—Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC|Short-term Injection of Recombinant Human Endostatin Plus EGFR-TKI as a Treatment of EGFR Mutation-positive Advanced Non-small Cell Lung Cancer|Not yet recruiting||Phase 3|80|Anticipated|Air Force General Hospital of the PLA||1|||f||||||||||||||2017-10-10 21:29:26.966957|2017-10-10 21:29:26.966957
NCT03008096|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-29|||November 2016||2016-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|LSG-BTC-LVAD||Laparoscopic Sleeve Gastrectomy as Bridge-to-Candidacy for Obese Left-Ventricular Assist Device Patients|Laparoscopic Sleeve Gastrectomy as Bridge-to-Candidacy for Obese Left-Ventricular Assist Device Patients|Recruiting||N/A|10|Anticipated|Medical University of Vienna||1|||f||||f||||||||No||2017-10-10 21:29:27.044003|2017-10-10 21:29:27.044003
NCT03008083|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-30|||July 2017||2017-07-01|December 2016|2016-12-01|October 2022|Anticipated|2022-10-01|December 2020|Anticipated|2020-12-01||Interventional|||Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation|A Prospective Multi-center Open-label Controlled Trial of Comparison 3 vs 12 Months of Dual Anti-Platelet Therapy After Implantation of Firehawk Sirolimus Target- Eluting Stent in Patients With Stable Coronary Artery Disease|Not yet recruiting||Phase 4|2446|Anticipated|Shanghai MicroPort Medical (Group) Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:29:27.134708|2017-10-10 21:29:27.134708
NCT03008070|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-08-03|||December 2016||2016-12-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|NATIVE||Phase 2b Study in NASH to Assess IVA337|A Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-range, Proof-of-concept, 24-week Treatment Study of IVA337 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)|Recruiting||Phase 2|225|Anticipated|Inventiva Pharma||3|||f||||t||||||||||2017-10-10 21:29:27.236931|2017-10-10 21:29:27.236931
NCT03008057|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||The Assessment of the Effect of Vitamin D Supplementation on Inflammatory and Endothelial Factors in the Patients With Type 2 Diabetes .|The Assessment of the Effect of Vitamin D Supplementation on the Serum of AGES and Endothelialy Factors and Gene Expression of Glyoxalase Enzyme and YKL-40 Factor in PBMC Cells in the Patients With Type 2 Diabetes .|Enrolling by invitation||Phase 4|42|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 21:29:27.424606|2017-10-10 21:29:27.424606
NCT03008044|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-08-09|||August 2016||2016-08-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Evaluation of a Percutaneous Optical Fibre Glucose Sensor (FiberSense System)|Evaluation of a Percutaneous Optical Fibre Glucose Sensor (FiberSense) Across the Glycemic Range With Rapid Glucose Excursions Using the Glucose Clamp|Completed||N/A|12|Actual|Lee's Pharmaceutical Limited||2|||f||||t||||||||||2017-10-10 21:29:27.512291|2017-10-10 21:29:27.512291
NCT03008031|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-04-18|||January 2017||2017-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)||Recruiting||N/A|63|Anticipated|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-10 21:29:27.603347|2017-10-10 21:29:27.603347
NCT03008018|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-08-16|||August 7, 2017|Actual|2017-08-07|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|HDAC6i||Safety,Tolerability and MTD KA2507 (HDAC6 Inhibitor) in Patients With Solid Tumours|An Open Label Ascending Dose Study Evaluating the Safety/Tolerability, Pharmacokinetic and Pharmacodynamic Effects of KA2507 in Patients With Solid Tumours|Recruiting||Phase 1|30|Anticipated|Karus Therapeutics Limited||1|||f||||f|t|f||||||||2017-10-10 21:29:27.697022|2017-10-10 21:29:27.697022
NCT03008005|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-05-08|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study|Effects of THC on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study|Not yet recruiting||Phase 4|104|Anticipated|Wayne State University||3|||f||||f|t|f||||||No||2017-10-10 21:29:27.794796|2017-10-10 21:29:27.794796
NCT03007992|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-02-08|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|June 2018|Anticipated|2018-06-01||Interventional|VinoMetro||Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer|Phase II Study of Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer Resistant to Endocrine Therapy|Recruiting||Phase 2|45|Anticipated|Johannes Gutenberg University Mainz||1|||f||||t||||||||||2017-10-10 21:29:27.904572|2017-10-10 21:29:27.904572
NCT03007979|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-06-22|||June 15, 2017|Actual|2017-06-15|June 2017|2017-06-01|June 30, 2021|Anticipated|2021-06-30|July 31, 2019|Anticipated|2019-07-31||Interventional|||Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer|A Phase II Clinical Trial Assessing the Safety of an Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer|Recruiting||Phase 2|35|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||No||2017-10-10 21:29:28.032772|2017-10-10 21:29:28.032772
NCT03007966|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-30|||January 30, 2017|Actual|2017-01-30|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||IINB vs. QLB for Elective Open Inguinal Herniorrhaphy|Ilioinguinal/Iliohypogastric vs. Quadratus Lumborum Nerve Blockade for Elective Open Inguinal Herniorrhaphy|Recruiting||N/A|60|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-10 21:29:28.163679|2017-10-10 21:29:28.163679
NCT03007953|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-05-26|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|PCI2||Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II|Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II|Recruiting||N/A|138|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-10 21:29:28.294885|2017-10-10 21:29:28.294885
NCT03007940|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-28|||September 2015||2015-09-01|December 2016|2016-12-01||||July 2019|Anticipated|2019-07-01||Interventional|||Using NIATx Strategies to Implement Integrated Services in Routine Care|Using NIATx Strategies to Implement Integrated Services in Routine Care|Active, not recruiting||N/A|50|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||Undecided||2017-10-10 21:29:28.406876|2017-10-10 21:29:28.406876
NCT03007927|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-13|||August 2016||2016-08-01|August 2017|2017-08-01|June 29, 2017|Actual|2017-06-29|December 2016|Actual|2016-12-01||Interventional|||Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair Mesh|Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair Mesh|Completed||Phase 4|82|Actual|Hospital Italiano de Buenos Aires||2|||f||||t||||||||||2017-10-10 21:29:28.493429|2017-10-10 21:29:28.493429
NCT03007914|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Effect of Traditional Chinese Medicine on Outcomes in COPD Patients|A Multi-center, Prospective, Cohort Study to Evaluate the Effectiveness of Traditional Chinese Medicine on COPD Patients|Not yet recruiting||N/A|2540|Anticipated|Henan University of Traditional Chinese Medicine|||2||f||||t||||||Samples Without DNA|"     The biological sample bank includes serum samples, plasma samples, sputum samples, urine     samples, stool samples.   "|No||2017-10-10 21:29:28.582719|2017-10-10 21:29:28.582719
NCT03007901|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-04-03|||January 2017||2017-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mindful Climate Action: Improving Health While Reducing Carbon Footprint|Mindful Climate Action: Improving Health While Reducing Carbon Footprint: A Pilot Study|Active, not recruiting||N/A|32|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||No||2017-10-10 21:29:28.660727|2017-10-10 21:29:28.660727
NCT03007888|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-07|||November 14, 2016|Actual|2016-11-14|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease|A Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease|Completed||Phase 2|28|Actual|IMPAX Laboratories, Inc.||2|||f||||t||||||||||2017-10-10 21:29:28.726605|2017-10-10 21:29:28.726605
NCT03007875|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-01-01|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer||Recruiting||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:29:28.825644|2017-10-10 21:29:28.825644
NCT03007836|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-01|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer||Recruiting||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||Yes||2017-10-10 21:29:28.899065|2017-10-10 21:29:28.899065
NCT03007823|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-01|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma||Recruiting||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:29:28.970296|2017-10-10 21:29:28.970296
NCT03007797|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-28|||December 2012||2012-12-01|December 2016|2016-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Realization of the Recommendation for Influenza Vaccination in Pregnant Women|Women - Influencing Factors and Coverage Rate|Completed||N/A|236|Actual|University Hospital, Saarland|||1||f||||||||||||||2017-10-10 21:29:29.125396|2017-10-10 21:29:29.125396
NCT03007784|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-14|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2021|Anticipated|2021-01-01||Interventional|STIMCOM||Two Intensities of Transcranial Direct Current Stimulation to Improve Consciousness in Severely Brain Injured Patients||Recruiting||Phase 3|300|Anticipated|Groupe Hospitalier Pitie-Salpetriere||2|||f||||f||||||||||2017-10-10 21:29:29.183096|2017-10-10 21:29:29.183096
NCT03007771|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-10-04|||September 30, 2017|Anticipated|2017-09-30|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia|A Feasibility Study of Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia in Human Subjects|Withdrawn||Phase 1|0|Actual|Washington University School of Medicine||1||Decision was made to not go forward with the study|f||||t|f|t|t|f|f|||||2017-10-10 21:29:29.281356|2017-10-10 21:29:29.281356
NCT03007758|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-28|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ORREO||Open Versus Robotic Retromuscular Ventral Hernia Repair|Prospective Randomized Control Trial of Open Versus Robotic REtrOmuscular Ventral Hernia Repair (ORREO Trial)|Enrolling by invitation||N/A|100|Anticipated|Greenville Health System||2|||f||||f||||||||Yes|All patients will be entered prospectively into the Americas Hernia Society Quality Collaborative (AHSQC) database.|2017-10-10 21:29:29.354433|2017-10-10 21:29:29.354433
NCT03007745|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2017-07-12|||September 4, 2017|Anticipated|2017-09-04|July 2017|2017-07-01|October 31, 2020|Anticipated|2020-10-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Remote Sleep Apnea Management|Remote Ambulatory Management of Veterans With Sleep Apnea|Not yet recruiting||N/A|356|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:29:29.425776|2017-10-10 21:29:29.425776
NCT02969993|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-01-20|||December 2016||2016-12-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Very Long Term VHI Voice Outcome After MTIS|Very Long Term VHI Voice Outcome After MTIS|Recruiting||N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-10 21:35:37.03606|2017-10-10 21:35:37.03606
NCT03007732|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-07|||April 27, 2017|Actual|2017-04-27|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Pembrolizumab in Combination With Intratumoral SD-101 Therapy|Phase 2 Trial Pembrolizumab or Pembrolizumab in Combination With Intratumoral SD-101 Therapy in Patients With Hormone-Naïve Oligometastatic Prostate Cancer Receiving Definitive Prostatic Radiation and Intermittent Androgen Deprivation Therapy|Recruiting||Phase 2|42|Anticipated|University of California, San Francisco||2|||f||||f|t|f||||||No||2017-10-10 21:29:29.526265|2017-10-10 21:29:29.526265
NCT03007719|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-07-14|||March 7, 2017|Actual|2017-03-07|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||[18F]F-AraG Imaging in Bladder Cancer Patients + Atezolizumab|Functional Imaging of T-cell Activation With [18F]F-AraG in Bladder Cancer Patients Receiving Neoadjuvant or Standard of Care Atezolizumab|Recruiting||Phase 2|31|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||||2017-10-10 21:29:29.629847|2017-10-10 21:29:29.629847
NCT03007706|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-30|||January 2017||2017-01-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01|2 Weeks|Observational [Patient Registry]|||Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery|Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery|Not yet recruiting||N/A|200|Anticipated|Minia Maternity University Hospital|||1||f||||||||||||||2017-10-10 21:29:29.730539|2017-10-10 21:29:29.730539
NCT03007693|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-09-22|||January 6, 2017|Actual|2017-01-06|September 2017|2017-09-01|October 17, 2017|Anticipated|2017-10-17|September 28, 2017|Anticipated|2017-09-28||Interventional|||A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy Participants|A Randomized, Placebo-controlled, Double-blind, Multiple Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy Subjects|Active, not recruiting||Phase 1|71|Actual|Janssen Research & Development, LLC||2|||f||||||f||||||||2017-10-10 21:29:29.779327|2017-10-10 21:29:29.779327
NCT03007680|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-03-12|||January 2017||2017-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effect of Core Muscles Activation for the Increase of Quality in Cardiopulmonary Resuscitation||Completed||N/A|66|Actual|Hallym University Kangnam Sacred Heart Hospital||2|||f||||||||||||||2017-10-10 21:29:29.853344|2017-10-10 21:29:29.853344
NCT03007667|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2016-12-30|||October 2016||2016-10-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||The Impact of Colorectal Cancer Surgery on Localization of Ureters; Prospective Clinical Trail||Recruiting||N/A|30|Anticipated|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital|||1||f||||||||||||||2017-10-10 21:29:29.917977|2017-10-10 21:29:29.917977
NCT03007654|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-30|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|antiadhesion||Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®)|Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) for Intraperitoneal Adhesion in Patient With Gynecological Surgery, a Multicenter Single-blinded, Randomized Study|Recruiting||Phase 3|192|Anticipated|Seoul National University Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:29:29.974811|2017-10-10 21:29:29.974811
NCT03007641|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-03|||August 2016||2016-08-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient|Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient Via a Provider Didactic Intervention|Recruiting||N/A|150|Anticipated|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-10 21:29:30.060194|2017-10-10 21:29:30.060194
NCT03007628|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-02|||October 2016||2016-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Schizophrenia|Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Schizophrenia|Recruiting||N/A|30|Anticipated|Shanghai Mental Health Center||2|||f||||t||||||||No|No plan to share IPD data|2017-10-10 21:29:30.152325|2017-10-10 21:29:30.152325
NCT03007615|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01||||February 2017|Anticipated|2017-02-01||Interventional|DERM GYN ACCEP||Dermal and Gynecological Acceptability (Irritability and Sensitization in the Genital Mucosa) of an Investigational Product and Evaluation of Moisture Efficacy by TEWL and Perceived Efficacy.|Dermal and Gynecological Acceptability (Irritability and Sensitization in the Genital Mucosa) of an Investigational Product and Evaluation of Moisture Efficacy by TEWL and Perceived Efficacy.|Not yet recruiting||N/A|33|Anticipated|Kley Hertz S/A||1|||f||||||||||||||2017-10-10 21:29:30.247013|2017-10-10 21:29:30.247013
NCT03007602|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-05-31|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Upper Extremity Aerobic Exercise Training in Hematopoietic Stem Cell Transplantation Recipients|Effects of Upper Extremity Aerobic Exercise Training in Hematopoietic Stem Cell Transplantation Recipients|Recruiting||N/A|30|Anticipated|Gazi University||2|||f||||f||||||||No|There is not a plan to make individual participant data but when the statistical analyses of all data are made, all results will be shared.|2017-10-10 21:29:30.303779|2017-10-10 21:29:30.303779
NCT03007589|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-28|||April 2014||2014-04-01|December 2016|2016-12-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Interventional|||Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics|Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics|Enrolling by invitation||N/A|200|Anticipated|Sun Protection Foundation||2|||f||||f||||||||No||2017-10-10 21:29:30.498529|2017-10-10 21:29:30.498529
NCT03007563|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-28|||January 2017||2017-01-01|December 2016|2016-12-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice|Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice|Not yet recruiting||N/A|100|Anticipated|St. Olavs Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:29:30.713805|2017-10-10 21:29:30.713805
NCT03007550|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-30|||December 2016||2016-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CLASS02-01||Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric Cancer|Prospective Randomized Controlled Multicenter Clinical Trial For Comparison Of Safety Between Laparoscopic And Open Total Gastrectomy In Patients With Clinical Stage I Gastric Cancer|Active, not recruiting||Phase 2|200|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||No||2017-10-10 21:29:30.817998|2017-10-10 21:29:30.817998
NCT03007537|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2016-12-29|||October 2015||2015-10-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney Injury|The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney Injury|Recruiting||N/A|100|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:29:30.93418|2017-10-10 21:29:30.93418
NCT03007524|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-02-19|||July 2016||2016-07-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|CROWN-1||Early Vascular Healing in Acute Coronary Syndrome Patients With Different Doses of Rosuvastatin|A Randomized Comparison of Low-dose Versus High-dose Rosuvastatin on Optical Coherence Tomography Based Early Vascular Healing for Patients With Acute Coronary Syndrome|Recruiting||Phase 4|80|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:29:31.060538|2017-10-10 21:29:31.060538
NCT03007511|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-12|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|Fidmi||Safety and Usability Evaluation of the Fidmi Low-Profile Enteral Feeding Device|Safety and Usability Evaluation of the Fidmi Low-Profile Enteral Feeding Device|Recruiting||N/A|15|Anticipated|Fidmi Medical||1|||f||||f|f|f||||||No||2017-10-10 21:29:31.236227|2017-10-10 21:29:31.236227
NCT03007498|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-29|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01||||February 2017|Anticipated|2017-02-01||Observational|DERM EV TOPIC||Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation|Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation|Not yet recruiting||N/A|55|Anticipated|Kley Hertz S/A|||1||f||||||||||||||2017-10-10 21:29:31.404195|2017-10-10 21:29:31.404195
NCT03007485|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-20|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|November 15, 2020|Anticipated|2020-11-15|August 15, 2019|Anticipated|2019-08-15||Interventional|||A Comprehensive Disease Management Program to Improve Quality of Life in Disparity Hispanic and African-American Patients Admitted With Exacerbation of Chronic Pulmonary Diseases|A Comprehensive Disease Management Program to Improve Quality of Life in Disparity Hispanic and African-American Patients Admitted With Exacerbation of Chronic Pulmonary Diseases|Recruiting||N/A|276|Anticipated|Northwell Health||2|||f||||f|f|f||||||No||2017-10-10 21:29:31.496357|2017-10-10 21:29:31.496357
NCT03007472|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-09-05|||December 2016||2016-12-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|SME||Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults|Clinical Evaluation of the Cochlear Nucleus(R) CI532 Cochlear Implant in Adults|Recruiting||N/A|100|Anticipated|Cochlear||1|||f||||f||t|f|f||||||2017-10-10 21:29:31.627339|2017-10-10 21:29:31.627339
NCT03007459|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-09-04|||November 2016||2016-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||The Health of Competitive Fitness Athletes|The Health of Competitive Fitness Athletes, a Cohort Study of Female Fitness Athletes and Physical Active Control's During and After Three Months of Fitness Contest Dieting|Active, not recruiting||N/A|47|Actual|Norwegian School of Sport Sciences|||2||f||||f||||||||||2017-10-10 21:29:31.856156|2017-10-10 21:29:31.856156
NCT03007446|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-25|||November 2016||2016-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer|The Exploratory Study of Conversion Surgery for Apatinib in Combination With Oxaliplatin/S-1(SOX) for Patients With Unresectable Gastric Cancer|Recruiting||Phase 2|20|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 21:29:31.996325|2017-10-10 21:29:31.996325
NCT03007433|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-29|||October 2010||2010-10-01|December 2016|2016-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Assessment of GI Function to a Large Test Meal by Non-invasive Imaging|Assessment of Gastric Motor and Sensory Function to a Large Test Meal by Gamma Scintigraphy, Magnetic Resonance Imaging and a Nutrient Drink Test in Health and Patients With Functional Dyspepsia|Completed||N/A|61|Actual|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 21:29:32.114009|2017-10-10 21:29:32.114009
NCT03007407|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-09-11|||July 31, 2017|Actual|2017-07-31|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy|A Phase II Study of the Dual Immune Checkpoint Blockade With Durvalumab (MEDI4736) Plus Tremelimumab Following Palliative Hypofractionated Radiation in Patients With Microsatellite Stable (MSS) Metastatic Colorectal Cancer Progressing on Chemotherapy|Recruiting||Phase 2|21|Anticipated|NSABP Foundation Inc||1|||f||||f|t|f||||||||2017-10-10 21:29:32.324315|2017-10-10 21:29:32.324315
NCT03007394|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-29|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Lorcaserin in the Treatment of Cocaine Use Disorder|Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder|Recruiting||Phase 2|272|Anticipated|National Institute on Drug Abuse (NIDA)||2|||f||||t|t|f||||||||2017-10-10 21:29:32.422975|2017-10-10 21:29:32.422975
NCT03007381|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-08-13|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|KANGAROO||Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn|Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn|Withdrawn||Phase 4|0|Actual|Nova Scotia Health Authority||2||No funding.|f||||f|f|f||||||||2017-10-10 21:29:32.569659|2017-10-10 21:29:32.569659
NCT03007355|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-29|||October 2015||2015-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|PPI||Peripheral Perfusion Index (PPI) as Monitor During Deliberate Hypotensive Anesthesia|The Use of Peripheral Perfusion Index as a Predictor for Patient's Response to Deliberate Hypotension During Functional Endoscopic Sinus Surgery A Prospective Observational Study|Completed||N/A|45|Actual|Cairo University|||1||f||||f||||||||||2017-10-10 21:29:32.770981|2017-10-10 21:29:32.770981
NCT03007342|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Amoxicillin/Clavulanic Acid Combination on Postoperative Endodontic Pain|Effect of Amoxicillin/Clavulanic Acid Combination on Postoperative Endodontic Pain in Patients With Symptomatic Apical Periodontitis: A Randomized Controlled Trial|Not yet recruiting||N/A|78|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:29:32.819898|2017-10-10 21:29:32.819898
NCT03007329|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-13|||March 8, 2017|Actual|2017-03-08|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|March 2018|Anticipated|2018-03-01||Interventional|EXENDA||Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.|A 24 Week Monocentric Prospective Randomized, Placebo-controlled Trial to Evaluate Efficacy of Combination of Exenatide and Dapagliflozin Compared to Dapagliflozin and Placebo and Its Effects on Hepatic, Myocardial and Pancreatic Fat Distribution in Patients With Uncontrolled Type 2 Diabetes Mellitus.|Recruiting||Phase 4|90|Anticipated|Medical University of Vienna||2|||f|||||t|f|||f|||||2017-10-10 21:29:32.917273|2017-10-10 21:29:32.917273
NCT03007316|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01||||February 2018|Anticipated|2018-02-01||Interventional|||Clinical Evaluation of Soft Tissue Esthetics Around Immediate Implants in Vascularized Interpositional Periosteal Connective Tissue Grafted Versus Non-grafted Sites A Randomized Controlled Clinical Trial.||Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f||||||||||||||2017-10-10 21:29:33.074804|2017-10-10 21:29:33.074804
NCT03007303|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-28|||June 2016||2016-06-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01|8 Weeks|Observational [Patient Registry]|||The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients||Recruiting||N/A|30|Anticipated|Dalian Seventh People's Hospital|||2||f||||t||||||Samples With DNA|"     The peripheral blood sample Plasma separated from the peripheral blood   "|Yes||2017-10-10 21:29:33.161571|2017-10-10 21:29:33.161571
NCT03007290|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-29|||January 2016||2016-01-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.||Recruiting||N/A|60|Anticipated|Seoul National University Hospital||1|||f||||f||||||||No||2017-10-10 21:29:33.274415|2017-10-10 21:29:33.274415
NCT03007277|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-29|||October 2016||2016-10-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|PANJO||Evaluation of the French Maternal and Child Protection Services From 11 French Territories That Have Received Common Intervention Guidelines|Evaluation de l'Intervention Des Services de Protection Maternelle et Infantile de 11 départements français Ayant bénéficié d'un référentiel Commun d'Intervention à Domicile (Projet Panjo : Promotion de la Santé et de l'Attachement Des Nouveau-nés et de Leurs Jeunes Parents : un Outil de Renforcement Des Services de PMI)|Recruiting||N/A|447|Anticipated|L'Agence des Nouvelles Interventions Sociales et de Santé||2|||f||||f||||||||No||2017-10-10 21:29:33.365157|2017-10-10 21:29:33.365157
NCT03007264|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-29|||February 2017||2017-02-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Cold Plasma for Wound Treatment, Safety Study|Safety Assessment of Cold Gas Plasma on Intact Skin|Not yet recruiting||Phase 1|25|Anticipated|Association of Dutch Burn Centres||3|||f||||f||||||||No||2017-10-10 21:29:33.458341|2017-10-10 21:29:33.458341
NCT03007251|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-07-17|||June 2016||2016-06-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Immediate Effects of Eurythmy Therapy on Psychophysiological Parameters||Completed||N/A|24|Actual|ARCIM Institute Academic Research in Complementary and Integrative Medicine||4|||f||||f||||||||||2017-10-10 21:29:33.544951|2017-10-10 21:29:33.544951
NCT03007238|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-05-23|||November 17, 2016|Actual|2016-11-17|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease|Phase II Trial of Extracorporeal Photopheresis (ECP) Plus Low Dose IL-2 for Treatment of Steroid Refractory Chronic Graft-versus-Host Disease (cGVHD)|Recruiting||Phase 2|24|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 21:29:33.620942|2017-10-10 21:29:33.620942
NCT03007225|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2016-12-30|||July 2015||2015-07-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients||Completed||Phase 4|50|Actual|Ain Shams University||2|||f||||t||||||||Undecided||2017-10-10 21:29:33.768699|2017-10-10 21:29:33.768699
NCT03007212|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2016-12-29|||September 2014||2014-09-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis||Completed||Phase 4|30|Actual|Ain Shams University||1|||f||||t||||||||Undecided||2017-10-10 21:29:33.827755|2017-10-10 21:29:33.827755
NCT03007199|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-09|||February 2010||2010-02-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01|1 Day|Observational [Patient Registry]|AGNES||Arrhythmia Genetics in the NEtherlandS|Arrhythmia Genetics in the NEtherlandS|Enrolling by invitation||N/A|2000|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f||||||Samples With DNA|"     DNA from blood.   "|||2017-10-10 21:29:33.885026|2017-10-10 21:29:33.885026
NCT03007186|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-28|||October 2016||2016-10-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus|Glucose Monitoring During Threatening Preterm Birth With Particular Focus on Insulin Sensitivity and Glucose Tolerance in Patients With and Without Gestational Diabetes Mellitus|Recruiting||N/A|60|Anticipated|Medical University of Vienna|||2||f||||f||||||||No||2017-10-10 21:29:33.943169|2017-10-10 21:29:33.943169
NCT03007173|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-28|||January 2013||2013-01-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2014|Actual|2014-01-01||Observational|||Umbilical Pilonidal Sinus: a Case Report|Umbilical Pilonidal Sinus: an Underestimated and Little-known Clinical Entity - Report of Two Cases|Completed||N/A|2|Actual|Medical Park Gaziantep Hospital|||1||f||||f||||||Samples Without DNA|"     soft tissue composed of umbilical cyst   "|No||2017-10-10 21:29:34.022428|2017-10-10 21:29:34.022428
NCT03007160|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-29|||July 2016||2016-07-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence|A Randomized, Blank Controlled, Multicenter Clinical Trial of the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence|Recruiting||Phase 4|2001|Anticipated|Dawnrays Pharmaceutical (Holdings) Limited||2|||f||||f||||||||No||2017-10-10 21:29:34.092451|2017-10-10 21:29:34.092451
NCT03007147|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-06|||July 28, 2017|Actual|2017-07-28|September 2017|2017-09-01|June 2026|Anticipated|2026-06-01|June 1, 2026|Anticipated|2026-06-01||Interventional|||Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones|Recruiting||Phase 3|700|Anticipated|Children's Oncology Group||3|||f||||f|t|f||||||||2017-10-10 21:29:34.214448|2017-10-10 21:29:34.214448
NCT03007134|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-29|||July 2007||2007-07-01|December 2016|2016-12-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Observational|||Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial|Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial|Completed||N/A|73|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||No||2017-10-10 21:29:36.552575|2017-10-10 21:29:36.552575
NCT03007121|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|KOLORIT||Intrathecal Morphine Analgesia vs. Continuous Epidural Analgesia vs. Systemic Analgesia in Colorectal Surgery.|Comparison of Intrathecal Morphine, Epidural Bupivacaine With Sufentanil and Systemic Patient Controlled Analgesia With Morphine for Analgesia After Colorectal Surgery: Prospective Randomised Study.|Not yet recruiting||Phase 4|75|Anticipated|Charles University, Czech Republic||3|||f||||f||||||||No||2017-10-10 21:29:36.634492|2017-10-10 21:29:36.634492
NCT03007108|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-30|||February 2017||2017-02-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|TGT||Age-dependency of Thrombin Generation Using a New Standardized Assay|Determination of Normal Range Values of Thrombin Generation Parameters in Pediatrics Population Using a New Standardized Thrombin Generation Assay|Not yet recruiting||N/A|270|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:29:36.717384|2017-10-10 21:29:36.717384
NCT03007095|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|TERM-COG||Preterm Birth and Social Cognition|Preterm Birth and Social Cognition: of the Executive Functions and Parental Anxiety's Stakes|Not yet recruiting||N/A|130|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:29:36.797478|2017-10-10 21:29:36.797478
NCT03007082|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-01-05|||November 2016||2016-11-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|RAPID||Revive AIS Patients ImmeDiately|A Multicenter, Prospective Registry Clinical Study of the Effectiveness and Safety of ReVive SE Thrombectomy for Acute Ischemic Stroke|Recruiting||N/A|100|Anticipated|Changhai Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:29:36.870439|2017-10-10 21:29:36.870439
NCT03007069|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2016-12-30|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Preimplant Site Augmentation Using MPM Versus Autogenous Bone Graft|Implant Insertion in Defective Anterior Maxillary Ridge Augmented Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||f||||||||No|Evaluation of the comparative Effectiveness of MPM Augmentation in Anterior ridge defects with Autogenous bone graft.|2017-10-10 21:29:36.95705|2017-10-10 21:29:36.95705
NCT03007056|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-12-27|||January 2011||2011-01-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|December 2014|Actual|2014-12-01||Observational|HIFLO||High Flow Nasal Cannula in Preterm Infants|Effect of High-flow Nasal Cannula Therapy on Exposure to Nasal Continuous Positive Airway Pressure in Very Preterm Infants|Completed||N/A|207|Actual|Hôpital de la Croix-Rousse|||2||f||||f||||||||No||2017-10-10 21:29:37.039121|2017-10-10 21:29:37.039121
NCT03007043|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-28|||November 2016||2016-11-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Observational|||Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response|Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes as a Causative Factor of Suboptimal Response Following Ovarian Stimulation for IVF/ICSI. A Prospective Cohort Study|Recruiting||N/A|364|Anticipated|Universitair Ziekenhuis Brussel|||2||f||||f||||||||||2017-10-10 21:29:37.127|2017-10-10 21:29:37.127
NCT03007030|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-22|||April 5, 2017|Actual|2017-04-05|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Trial of Adcetris in CD30+ Malignant Mesothelioma|Phase II Trial of Adcetris (Brentuximab Vedotin) in CD30+ Malignant Mesothelioma|Recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:29:37.299391|2017-10-10 21:29:37.299391
NCT03007017|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-28|||January 2017||2017-01-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Novel Strategies for Innovating Deceased Donor Procurement|Novel Strategies for Innovating Deceased Donor Procurement|Not yet recruiting||Early Phase 1|20|Anticipated|University of Maryland||2|||f||||t||||||||No||2017-10-10 21:29:37.402181|2017-10-10 21:29:37.402181
NCT03007004|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-28|||December 2016||2016-12-01|December 2016|2016-12-01||||April 2017|Anticipated|2017-04-01||Interventional|||Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis|Trial to Confirm the Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis|Recruiting||Phase 2|20|Anticipated|Gunma University||2|||f||||||||||||||2017-10-10 21:29:37.468444|2017-10-10 21:29:37.468444
NCT03006991|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-28|||November 2016||2016-11-01|December 2016|2016-12-01|December 2023|Anticipated|2023-12-01|December 2020|Anticipated|2020-12-01||Observational|||Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics|Individual Study of Methotrexate Based on Pharmacogenomics and Pharmacometrics|Recruiting||N/A|100|Anticipated|Guangzhou Women and Children's Medical Center|||2||f||||t||||||Samples With DNA|"     DNA is extracted and stored in freezer with -80°C.   "|No||2017-10-10 21:29:37.555095|2017-10-10 21:29:37.555095
NCT03006978|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-08-07|||December 2016||2016-12-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|March 2017|Actual|2017-03-01||Interventional|||Pilot Study of the TearCare System|Pilot Study of the TearCare System|Active, not recruiting||N/A|24|Actual|Sight Sciences, Inc.||2|||f||||f||||||||||2017-10-10 21:29:37.650581|2017-10-10 21:29:37.650581
NCT03006965|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-02|||March 2017||2017-03-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|||Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®|Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using an Online Medical Application Based on a Published Population Model and a Bayesian Algorithm|Not yet recruiting||N/A|100|Anticipated|Spanish Society of Thrombosis and Haemostasis|||1||f||||f||||||||||2017-10-10 21:29:37.727173|2017-10-10 21:29:37.727173
NCT03006952|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2016-12-29|||April 2015||2015-04-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy|Comparative Effects of add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on Serum NT-PRO BNP and Proteinuria in Type 2 Diabetics With Nephropathy|Completed||Phase 4|59|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 21:29:37.878515|2017-10-10 21:29:37.878515
NCT03006939|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Observational|||Fluid Balance During Surgery for Ovarian Cancer|Intraoperative Fluid Balance During Cytoreductive Surgery for Ovarian Cancer|Recruiting||N/A|60|Anticipated|University Hospital, Bonn|||1||f||||f||||||Samples Without DNA|"     Blood samples are retained to determine the coagulation status as well as the albumine     concentration   "|No||2017-10-10 21:29:37.978983|2017-10-10 21:29:37.978983
NCT03006926|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-09-15|||February 28, 2017|Actual|2017-02-28|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|August 31, 2018|Anticipated|2018-08-31||Interventional|||A Trial of Lenvatinib Plus Pembrolizumab in Subjects With Hepatocellular Carcinoma|An Open-Label Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Subjects With Hepatocellular Carcinoma|Recruiting||Phase 1|30|Anticipated|Eisai Inc.||1|||f||||f|t|f|||f|||||2017-10-10 21:29:38.064094|2017-10-10 21:29:38.064094
NCT03006913|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-29|||April 2017||2017-04-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|GC3Modes||Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients|Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital|Not yet recruiting||N/A|600|Anticipated|University of California, San Francisco||3|||f||||f||||||||No||2017-10-10 21:29:38.173273|2017-10-10 21:29:38.173273
NCT03006900|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-27|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Multiple Sclerosis and Pilates|Determining the Impact of a Pilates Program in Multiple Sclerosis|Recruiting||N/A|30|Anticipated|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 21:29:38.298995|2017-10-10 21:29:38.298995
NCT03006887|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-05-18|||January 19, 2017|Actual|2017-01-19|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|April 26, 2017|Actual|2017-04-26||Interventional|||Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Subjects With Selected Solid Tumors|An Open-Label Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Subjects With Selected Solid Tumors|Active, not recruiting||Phase 1|6|Actual|Eisai Inc.||1|||f||||f|f|f|||f|||No||2017-10-10 21:29:38.413731|2017-10-10 21:29:38.413731
NCT03006874|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-09-11|||May 2, 2016|Actual|2016-05-02|September 2017|2017-09-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|||Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis|A Double Blind, Randomized, Active-controlled, Phase 3 Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis|Completed||Phase 3|302|Actual|CJ HealthCare Corporation||3|||f||||f||||||||||2017-10-10 21:29:38.50059|2017-10-10 21:29:38.50059
NCT03006861|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-06-12|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|May 2017|Actual|2017-05-01||Interventional|||Delivra Topical Creatine Combined With Oral Creatine for Improving Muscular Power|Randomized, Double-blind, Placebo-controlled, Short Term Trial of DelivraTM Livsport Preworkout Cream With or Without Oral Creatine for Improved Power Output and Reduction of Muscle Fatigue During Resistant Training|Active, not recruiting||N/A|132|Anticipated|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 21:29:38.584763|2017-10-10 21:29:38.584763
NCT03006848|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-05-22|||February 16, 2017|Actual|2017-02-16|May 2017|2017-05-01|January 31, 2023|Anticipated|2023-01-31|May 31, 2021|Anticipated|2021-05-31||Interventional|||A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma|A Phase II Trial of Avelumab, A Fully Human Antibody That Targets Cells Expressing PD-L1, in Patients With Recurrent or Progressive Osteosarcoma|Recruiting||Phase 2|40|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-10 21:29:38.67623|2017-10-10 21:29:38.67623
NCT03006835|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-27|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Different Dosage of Domestic and Imported Clopidogrel on the Platelet Inhibition Ratio in Patients Undergoing PCI||Not yet recruiting||Phase 4|120|Anticipated|Xijing Hospital||4|||f||||||||||||||2017-10-10 21:29:38.782442|2017-10-10 21:29:38.782442
NCT03006822|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-10-03|||March 15, 2017|Actual|2017-03-15|October 2017|2017-10-01|July 10, 2017|Actual|2017-07-10|March 20, 2017|Actual|2017-03-20||Interventional|||Time Effect of the Pressure Release Technique Application in the Latent Myofascial Trigger Points|Time Effect of the Pressure Release Technique Application in the Latent Myofascial Trigger Points of the Levator Scapulae|Completed||N/A|60|Actual|University of Alcala||3|||f||||f|f|f||||||||2017-10-10 21:29:38.852191|2017-10-10 21:29:38.852191
NCT03006809|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-05-01|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis|Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis|Not yet recruiting||Phase 1|40|Anticipated|University of California, San Francisco||4|||f||||f|t|f||||||No||2017-10-10 21:29:39.033724|2017-10-10 21:29:39.033724
NCT03006796|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-02-03|||January 2017||2017-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|PUZZLE||Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity.|Observational Prospective stUdy of aZilsartan Medoxomil/ Chlorthalidone Compared With Irbesartan/hydrochlorothiaZide Combination Therapy in Patients With arteriaL Hypertension and obEsity in Routine Clinical Practice (PUZZLE).|Recruiting||N/A|94|Anticipated|Russian Heart Failure Society|||2||f||||t||||||||No||2017-10-10 21:29:39.146206|2017-10-10 21:29:39.146206
NCT03006783|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-28|||March 2016||2016-03-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis|Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis|Completed||N/A|50|Actual|University Medical Center Groningen|||2||f||||||||||||||2017-10-10 21:29:39.233129|2017-10-10 21:29:39.233129
NCT03006770|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-09-13|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization|Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization|Recruiting||Phase 3|246|Anticipated|Pluristem Ltd.||2|||f||||t|t|f||||||||2017-10-10 21:29:39.323719|2017-10-10 21:29:39.323719
NCT03006757|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-29|||May 2016||2016-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|||Measurement of the Biting Force of Rabid Heat Cured Acrylic Resin Versus Modified Conventional Acrylic|Measurement of the Biting Force of Rabid Heat Cured Acrylic Resin Versus Modified Conventional Acrylic Resin With Titanium Dioxide Nanoparticles in Maxillary Single Dentures|Recruiting||N/A|2|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 21:29:39.437331|2017-10-10 21:29:39.437331
NCT03006744|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Sharing Books With Children|How to Promote Children's Language Development Using Family-based Shared Book Reading: Study B; Examining the Effect of Training Shared Reading Practice, With Form-emphasising Books, on Children's Language and Phonological Awareness|Not yet recruiting||N/A|60|Anticipated|University of Manchester||2|||f||||f||||||||No||2017-10-10 21:29:39.526895|2017-10-10 21:29:39.526895
NCT03006731|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-05-03|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|HIIT-Stroke||High Intensity Interval Training for People With Stroke Deficits|High Intensity Interval Training for People With Stroke Deficits: Optimizing the Exercise Intervention (The HIIT-Stroke Study)|Recruiting||N/A|50|Anticipated|University Health Network, Toronto||2|||f||||f|f|f||||||No||2017-10-10 21:29:39.625824|2017-10-10 21:29:39.625824
NCT03006718|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-28|||November 2016||2016-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain|SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain|Recruiting||N/A|150|Anticipated|Children's Research Institute||1|||f||||f||||||||No||2017-10-10 21:29:39.721893|2017-10-10 21:29:39.721893
NCT03006705|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-09-21|||January 2017||2017-01-01|March 2017|2017-03-01||||June 2021|Anticipated|2021-06-01||Interventional|||Study of Adjuvant ONO-4538 With Resected Gastric Cancer|A Multicenter, Double-blind, Randomized Study in Patients With Gastric Cancer Undergoing Postoperative Adjuvant Chemotherapy|Recruiting||Phase 3|700|Anticipated|Ono Pharmaceutical Co. Ltd||2|||f||||t||||||||||2017-10-10 21:29:39.822679|2017-10-10 21:29:39.822679
NCT03006692|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-01|||June 2016||2016-06-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Observational|ABL||Diagnostic Value of Arterial Blood Gas Analysis in Prehospital Patients|Diagnostic Value of Arterial Blood Gas Analysis in Prehospital Patients|Recruiting||N/A|220|Anticipated|Odense University Hospital|||2||f||||f||||||||||2017-10-10 21:29:40.049713|2017-10-10 21:29:40.049713
NCT03006679|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-27|||February 2017||2017-02-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|TANGOIII||A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia|A Phase IIIb, Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia in Hospitalized Adults (TANGO III)|Not yet recruiting||Phase 3|790|Anticipated|The Medicines Company||4|||f||||t||||||||||2017-10-10 21:29:40.12264|2017-10-10 21:29:40.12264
NCT03006653|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Understanding Daily Fluctuations in Self-Regulation|Understanding Daily Fluctuations in Self-Regulation|Not yet recruiting||N/A|120|Anticipated|Northwell Health|||1||f||||f||||||||No|Data will not be shared. No plan in place.|2017-10-10 21:29:40.315903|2017-10-10 21:29:40.315903
NCT03006640|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-27|||January 2016||2016-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|NTG-US-art||Subcutaneous NTG for US Radial Artery Cannulation||Completed||N/A|60|Actual|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 21:29:40.404265|2017-10-10 21:29:40.404265
NCT03006627|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|GenderOpioid||Gender and Opioid Consumption||Not yet recruiting||N/A|100|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 21:29:40.465211|2017-10-10 21:29:40.465211
NCT03006614|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-01-13|||April 2016||2016-04-01|January 2017|2017-01-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|PERS||PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer|Using PERS(PErsonalized Regimen Selection) Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer Multicentric, Prospective, Randomized Controlled Phase III Clinical Study|Recruiting||Phase 3|320|Anticipated|Sun Yat-sen University||2|||f||||f||||||||No||2017-10-10 21:29:40.536536|2017-10-10 21:29:40.536536
NCT03006601|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-12-28|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Vision Therapy in Myopic Children With Poor Accommodative Response|Effect of Vision Therapy on Accommodation in Myopic Chinese Children With Poor Accommodative Response: A Randomized Clinical Trial|Active, not recruiting||N/A|34|Actual|Sun Yat-sen University||2|||f||||f||||||||Undecided||2017-10-10 21:29:40.642382|2017-10-10 21:29:40.642382
NCT03006588|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2016-12-29|||January 2014||2014-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients|Fine Needle Aspiration of Retropharyngeal Lymph Node Guided by Endoscopic Ultrasound for the Diagnosis of Patients With Suspected Recurrent Nasopharyngeal Carcinoma|Recruiting||Phase 2/Phase 3|100|Anticipated|Sun Yat-sen University||1|||f||||t||||||||No||2017-10-10 21:29:40.709648|2017-10-10 21:29:40.709648
NCT03006575|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-04-15|||January 2016||2016-01-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|December 2020|Anticipated|2020-12-01||Interventional|||Study of Consolidation Chemotherapy For Locoregional Recurrence Of Non-small Cell Lung Cancer After Surgical Resection|A Prospective, Randomized, Phase II Study of Consolidation Chemotherapy or Observation After Split-course Chemoradiotherapy For Locoregional Recurrence Of Non-small Cell Lung Cancer After Surgical Resection|Recruiting||Phase 2|260|Anticipated|Sun Yat-sen University||2|||f||||f||||||||Undecided||2017-10-10 21:29:40.801082|2017-10-10 21:29:40.801082
NCT03006562|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-07-24|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|July 2019|Anticipated|2019-07-01||Interventional|PREVENTER||PREvention of VENous ThromboEmbolism Following Radical Prostatectomy|A Randomized Controlled Trial for PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER Trial)|Recruiting||Phase 4|666|Anticipated|Johns Hopkins University||2|||f||||f|t|f|||f|||||2017-10-10 21:29:40.926184|2017-10-10 21:29:40.926184
NCT03006549|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-29|||January 2015||2015-01-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|EM||Using Emergency Manuals During Interprofessional Crisis Management: Are There Unintended Consequences?|Using Emergency Manuals During Interprofessional Crisis Management: Are There Unintended Consequences?|Recruiting||N/A|64|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 21:29:41.017494|2017-10-10 21:29:41.017494
NCT03006536|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-26|||March 2017||2017-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Low-Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: A Randomized, Controlled, Double Blind Trial|Low-Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: A Randomized, Controlled, Double Blind Trial|Not yet recruiting||N/A|100|Anticipated|University Hospital Roskilde||2|||f||||t||||||||||2017-10-10 21:29:41.109469|2017-10-10 21:29:41.109469
NCT03006523|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-02|||March 2013||2013-03-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|April 2016|Actual|2016-04-01||Interventional|||0.2 ml vs. 0.5 Inseminated Volume in Donor Intrauterine Insemination Cycles: A Prospective RCT|Impact of Inseminated Volume and Live Birth Rates After Intrauterine Insemination (IUI) With Donor Sperm (dIUI): A Prospective Randomized COntrolled Trial|Completed||N/A|293|Actual|Institut Universitari Dexeus||2|||f||||f||||||||No||2017-10-10 21:29:41.176374|2017-10-10 21:29:41.176374
NCT03006510|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Hypoglycemia Prediction Model|Leveraging the Power of the EMR: Using a Real Time Prediction Model to Decrease Inpatient Hypoglycemic Events|Not yet recruiting||Early Phase 1|6500|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 21:29:41.253445|2017-10-10 21:29:41.253445
NCT03006497|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-07-20|||January 2017||2017-01-01|July 2017|2017-07-01|July 30, 2017|Anticipated|2017-07-30|May 2017|Actual|2017-05-01||Interventional|||Exercise Program Based on Motor Learning and Forward Head Posture Correction|The Efficacy of Exercise Program Based on Motor Learning Principles in Correction of Forward Head Posture|Enrolling by invitation||N/A|52|Anticipated|Technological Education Institute of Sterea Ellada||2|||f||||f||||||||||2017-10-10 21:29:41.454718|2017-10-10 21:29:41.454718
NCT03006484|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-04-02|||March 21, 2017|Actual|2017-03-21|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|NO-IHCA||Neurological Outcomes After In-Hospital Cardiac Arrest|Neurological Outcomes After In-hospital Cardiac Arrest: a Prospective Observational Study|Recruiting||N/A|1000|Anticipated|Asan Medical Center|||1||f||||f||||||||No||2017-10-10 21:29:41.555426|2017-10-10 21:29:41.555426
NCT03006471|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-03|||March 2016||2016-03-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension|Effect of Dapagliflozin on Blood Pressure Variability in Patients With Prediabetes and Prehypertension Without Pharmacological Treatment|Recruiting||Phase 4|30|Anticipated|University of Guadalajara||2|||f||||f||||||||||2017-10-10 21:29:41.638356|2017-10-10 21:29:41.638356
NCT03006458|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-02-07|||December 2016||2016-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:29:41.757879|2017-10-10 21:29:41.757879
NCT03006445|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-07|||December 2016||2016-12-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of FYU-981 in Hyperuricemia With or Without Gout|Official Title: Safety and Efficacy Evaluation Study of FYU-981 Long-term Administration for Hyperuricemia With or Without Gout (Phase III Study)|Active, not recruiting||Phase 3|330|Anticipated|Fuji Yakuhin Co., Ltd.||1|||f||||f||||||||||2017-10-10 21:29:41.802097|2017-10-10 21:29:41.802097
NCT03006432|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-02-16|||December 2016||2016-12-01|December 2016|2016-12-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|GASTFOX||PHASE III RANDOMISED TRIAL TO EVALUATE FOLFOX WITH OR WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY FOR LOCALLY ADVANCED OR METASTATIC OESOPHAGO-GASTRIC CARCINOMA|ESSAI DE PHASE III RANDOMISE EVALUANT LE FOLFOX AVEC OU SANS DOCETAXEL (TFOX) EN 1ère LIGNE DE CHIMIOTHERAPIE DES ADENOCARCINOMES OESO-GASTRIQUES LOCALEMENT AVANCES OU METASTATIQUES|Recruiting||Phase 3|506|Anticipated|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||No||2017-10-10 21:29:41.875179|2017-10-10 21:29:41.875179
NCT03006419|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-25|||December 2016||2016-12-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients|Basiliximab vs Reduced Dose Rabbit Antithymocyte Globulin (rRTAG): Evaluation of Efficacy and Safety Outcomes in Low Immunological Risk Living Donor Kidney Transplant: 12-month Randomized Controlled Study|Recruiting||Phase 4|100|Anticipated|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||No|No IPD sharing plan|2017-10-10 21:29:42.10309|2017-10-10 21:29:42.10309
NCT03006406|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-29|||January 2016||2016-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis||Recruiting||N/A|50|Anticipated|The First Affiliated Hospital of Zhengzhou University||2|||f||||f||||||||Undecided||2017-10-10 21:29:42.22608|2017-10-10 21:29:42.22608
NCT03006393|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-09-22|||August 2016||2016-08-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression|Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression|Recruiting||Phase 1|80|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 21:29:42.324858|2017-10-10 21:29:42.324858
NCT03006380|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery|Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery|Recruiting||Phase 2|400|Anticipated|Ain Shams Maternity Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:29:42.457763|2017-10-10 21:29:42.457763
NCT03006367|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-03-28|||January 7, 2017|Actual|2017-01-07|March 2017|2017-03-01|March 6, 2017|Actual|2017-03-06|February 26, 2017|Actual|2017-02-26||Interventional|||Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD|An Open-label, Single Ascending Dose, Pharmacokinetic and Tolerability Study of NFC-1 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder|Completed||Phase 1|32|Actual|Aevi Genomic Medicine||4|||f||||f|t|f||||||Undecided||2017-10-10 21:29:42.552514|2017-10-10 21:29:42.552514
NCT03006354|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-03-06|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||nHFOV Versus nCPAP in Transient Tachypnea of the Newborn|Nasal High Frequency Oscillatory Ventilation Versus Nasal Continuous Positive Airway Pressure in Late-Preterm and Term Infants With Transient Tachypnea of the Newborn: a Randomized Controlled Trial|Recruiting||N/A|440|Anticipated|Bursa Yüksek İhtisas Education and Research Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:29:42.660437|2017-10-10 21:29:42.660437
NCT03006341|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-06-13|||February 28, 2017|Actual|2017-02-28|June 2017|2017-06-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Observational|||Validation of Predictors of OAC Initiation Using EMR Data|Validation of Predictors for Oral Anticoagulant Medication Choice Using EMR Data|Completed||N/A|140187|Actual|Boehringer Ingelheim|||2||f|||||t|f|||f|||||2017-10-10 21:29:42.763842|2017-10-10 21:29:42.763842
NCT03006328|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-27|||September 2016||2016-09-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|GEM||The GEM (Goals for Eating and Moving) Study|Technology-Assisted Weight Management Intervention Within Patient-Centered Medical Homes: The GEM (Goals for Eating and Moving) Study|Recruiting||N/A|384|Anticipated|New York University School of Medicine||2|||f||||f||||||||Undecided||2017-10-10 21:29:42.866705|2017-10-10 21:29:42.866705
NCT03006315|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-30|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Mobile Health Device Study for Myeloma Patients|Bio-monitoring of Newly Diagnosed Multiple Myeloma Patients Receiving Induction Chemotherapy Using Mobile Wearable Health Devices|Recruiting||N/A|40|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||||||2017-10-10 21:29:42.958445|2017-10-10 21:29:42.958445
NCT03006302|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-08-28|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|June 2023|Anticipated|2023-06-01|February 2021|Anticipated|2021-02-01||Interventional|||Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer|Phase 2 Study of Epacadostat, Pembrolizumab, and CRS-207, With or Without Cyclophosphamide and GVAX Pancreas Vaccine in Patients With Metastatic Pancreas Cancer|Not yet recruiting||Phase 2|70|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:29:43.063877|2017-10-10 21:29:43.063877
NCT03006289|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-26|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer|Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer|Not yet recruiting||N/A|3000|Anticipated|Qianfoshan Hospital|||2||f||||t||||||||Yes||2017-10-10 21:29:43.175658|2017-10-10 21:29:43.175658
NCT03006276|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-08-22|||December 2016||2016-12-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy, Tolerability, and Safety Study of DFN-15||Active, not recruiting||Phase 3|622|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-10 21:29:43.243157|2017-10-10 21:29:43.243157
NCT03006263|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-26|||November 2016||2016-11-01|December 2016|2016-12-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Randomized Controlled Trials on Clinical Outcomes of Totally Laparoscopic Versus Laparoscopy Assisted Total Gastrectomy for Gastric Cancer|Randomized Controlled Trials on Clinical Outcomes of Totally Laparoscopic Versus Laparoscopy Assisted Total Gastrectomy for Gastric Cancer|Enrolling by invitation||Phase 2|110|Anticipated|Fujian Medical University||2|||f||||t||||||||No||2017-10-10 21:29:43.384286|2017-10-10 21:29:43.384286
NCT03006250|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-12-26|||August 2016||2016-08-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effect of Desflurane vs Sevoflurane on Perioperative Respiratory Complications in Laryngeal Mask Airway Anesthesia|The Effect of Desflurane vs Sevoflurane on Perioperative Respiratory Complications in Laryngeal Mask Airway Anesthesia: A Prospective Randomized Double-blinded Control Study|Recruiting||Phase 4|220|Anticipated|Chiang Mai University||2|||f||||t||||||||No|The investigators don't have a plan to share data. The investigators plan to make an individual participant data available only in site.|2017-10-10 21:29:43.465689|2017-10-10 21:29:43.465689
NCT03006237|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IS-001 Injection Phase-1 Safety, Tolerance and Pharmacokinetics|A Phase 1 Open Label Single Center Safety, Tolerability and Pharmacokinetic Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy Using the da Vinci® Si/Xi Surgical System With Firefly® Fluorescent Imaging|Recruiting||Phase 1|24|Anticipated|Intuitive Surgical||1|||f||||f||||||||Undecided||2017-10-10 21:29:43.57878|2017-10-10 21:29:43.57878
NCT02967744|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-16|||January 2016||2016-01-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||NSAID Treatment of Patients With Osteoarthritis|"BEVAR: Patientspecifik Behandling Ved Artrose - Et Proof-of-concept- Kvalitetssikringsstudie"|Recruiting||N/A|400|Anticipated|Aalborg University||1|||f||||f||||||||||2017-10-10 21:35:57.785152|2017-10-10 21:35:57.785152
NCT03006224|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-04|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|February 2017|Actual|2017-02-01||Interventional|||The Effects of Secondary Smoking During One Lung Ventilation|The Effects of Secondary Smoking to Intraoperative Arterial Oxygen Tension During One Lung Ventilation in Lobectomy|Completed||N/A|60|Actual|Inonu University||2|||f||||f||||||||Undecided||2017-10-10 21:29:43.646099|2017-10-10 21:29:43.646099
NCT03006211|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-04|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|February 2017|Actual|2017-02-01||Interventional|||The Effects of Nitrogen Protoxide and Oxygen on Corneal Endothelial in Pediatric Patients|The Effects of Nitrogen Protoxide + Sevoflurane and Oxygen + Sevoflurane Anesthesia on Corneal Endothelial in Pediatric Patients|Completed||N/A|40|Actual|Inonu University||2|||f||||f||||||||Undecided||2017-10-10 21:29:43.705882|2017-10-10 21:29:43.705882
NCT03006198|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2017-04-20|||February 4, 2016|Actual|2016-02-04|April 2017|2017-04-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Observational|HARIR||Tracking Biologics Along the Silk Road|Tracking Biologics Along the Silk Road|Recruiting||N/A|338|Anticipated|Janssen Pharmaceutica N.V., Belgium|||5||f||||f|f|||||||||2017-10-10 21:29:43.767965|2017-10-10 21:29:43.767965
NCT03006185|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-07-11|||August 2016||2016-08-01|July 2017|2017-07-01|March 1, 2017|Actual|2017-03-01|November 2016|Actual|2016-11-01||Interventional|||Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin|Pretreatment With Ablative Fractional Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin|Completed||Phase 2|18|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-10 21:29:43.871183|2017-10-10 21:29:43.871183
NCT03006172|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-08-02|||November 30, 2016|Actual|2016-11-30|August 2017|2017-08-01|February 29, 2020|Anticipated|2020-02-29|February 29, 2020|Anticipated|2020-02-29||Interventional|||To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer|A Phase I, Open-Label, Dose-Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0077 as a Single Agent in Patients With Locally Advanced or Metastatic PIK3CA-Mutant Solid Tumors and in Combination With Endocrine and Targeted Therapies in Patients With Locally Advanced or Metastatic PIK3CA-Mutant Hormone-Receptor Positive Breast Cancer|Recruiting||Phase 1|156|Anticipated|Genentech, Inc.||6|||f||||||||||||||2017-10-10 21:29:43.955858|2017-10-10 21:29:43.955858
NCT03006159|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-28|||March 2015||2015-03-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients||Completed||Phase 1|36|Actual|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||No||2017-10-10 21:29:44.527822|2017-10-10 21:29:44.527822
NCT03006133|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-02-09|||November 2016||2016-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Prevalence of Bruxism in a Group of Preschool Egyptian Children|Prevalence of Bruxism in a Group of Preschool Egyptian Children|Recruiting||N/A|362|Anticipated|Cairo University|||1||f||||f||||||||||2017-10-10 21:29:44.696017|2017-10-10 21:29:44.696017
NCT03006120|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-28|2016-12-30|||January 2010||2010-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Treatment Management and Factors Affecting Mortality in Retroperitoneal Hemorrhage Due to Cardiac Catheterization; Single Center Experience||Completed||N/A|68|Actual|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital|||3||f||||||||||||||2017-10-10 21:29:44.912506|2017-10-10 21:29:44.912506
NCT03006107|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-27|||December 2016||2016-12-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of a Prophylactic Intraligamentary Injection of Piroxicam Versus Mepecaine of Post-endodontic Pain|Comparison of the Efficacy of Prophylactic Intraligamentary Injection of Piroxicam Versus Mepecaine for Management of Post-endodontic Pain in Posterior Teeth|Not yet recruiting||N/A|26|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:29:44.996113|2017-10-10 21:29:44.996113
NCT03006094|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-07-02|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Greek Version of the Chronic Pain Grade Questionnaire (CPGQ)|Validity, Reliability and Responsiveness of the Greek Version of the Chronic Pain Grade Questionnaire (CPGQ) in Chronic Hip Pain Sufferers|Recruiting||N/A|87|Anticipated|Asklepieion Voulas General Hospital|||1||f||||f||||||||||2017-10-10 21:29:45.119938|2017-10-10 21:29:45.119938
NCT03006081|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-29|||May 2016||2016-05-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy|The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Patients With Diabetic Retinopathy|Recruiting||Phase 2|40|Anticipated|Asan Medical Center||1|||f||||t||||||||Yes||2017-10-10 21:29:45.222775|2017-10-10 21:29:45.222775
NCT03006055|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-29|||April 2016||2016-04-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device||Recruiting||Phase 3|190|Anticipated|Beijing Viroad Biotechnology Co., Ltd.||2|||f||||||||||||||2017-10-10 21:29:46.024361|2017-10-10 21:29:46.024361
NCT03006042|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-26|||November 2014||2014-11-01|December 2016|2016-12-01||||May 2015|Actual|2015-05-01||Observational|||Pharmacokinetics of BPV Following Bilateral US-guided TAP Block for C-section|Pharmacokinetics of Bupivacaine Following Bilateral Ultrasound-guided Transversus Abdominis Plane Block for Cesarean Section|Completed||N/A|17|Actual|University Tunis El Manar|||1||f||||f||||||||No||2017-10-10 21:29:46.10461|2017-10-10 21:29:46.10461
NCT03006029|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-02-14|||February 8, 2017|Actual|2017-02-08|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|TAB08||Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms|A Phase 1b Multiple Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms|Recruiting||Phase 1|38|Anticipated|Theramab LLC||1|||f||||f|f|f||||||Undecided||2017-10-10 21:29:46.173002|2017-10-10 21:29:46.173002
NCT03006016|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-03-21|||January 2017||2017-01-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|Omegobese||Preoperative Omega-3 Polyunsaturated Fatty Acids in Morbidly Obese to Reduce Liver Volume and Steatosis|"Impact of Preoperative 4-week Supplementation With Omega-3 Polyunsaturated Fatty Acids on Liver Volume and Steatosis to Facilitate Bariatric Surgery in Morbdly Obese Patients : the  Omegaobese Study ."|Recruiting||N/A|44|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||No||2017-10-10 21:29:46.26322|2017-10-10 21:29:46.26322
NCT03006003|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-26|||December 2016||2016-12-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Osteoporosis Treatment in Post-menopausal Women|The Assessment of Osteoporosis Treatment in Post-menopausal Women|Not yet recruiting||Phase 4|500|Anticipated|Taichung Veterans General Hospital||3|||f||||f||||||||No|Not available|2017-10-10 21:29:46.365669|2017-10-10 21:29:46.365669
NCT03005990|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The Effects of Exercise Training in Community-dwelling Elderly With Sleep Disturbances With Follow-up|The Effects of Exercise Training in Community-dwelling Elderly With Sleep Disturbances With Follow-up: Body Composition and Energy Metabolism|Active, not recruiting||N/A|260|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:29:46.465157|2017-10-10 21:29:46.465157
NCT03005977|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-04-11|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Identifying Stress Urinary Incontinence in Women With Pelvic Organ Prolapse|What Test is Most Sensitive in Identifying Stress Urinary Incontinence in Women With Pelvic Organ Prolapse; Urodynamics, Standing Cough Stress Test, or Pyridium Pad Test?|Recruiting||N/A|91|Anticipated|The Cleveland Clinic||1|||f||||f|f|f||||||No|Data individual participant data will not be shared with other researches.|2017-10-10 21:29:46.574639|2017-10-10 21:29:46.574639
NCT03005964|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-27|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis|A Multi-Center, Double-Blind, Randomized, Vehicle- Controlled, Parallel-Group Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis|Recruiting||Phase 2|74|Anticipated|AmDerma||2|||f||||f||||||||No||2017-10-10 21:29:46.681447|2017-10-10 21:29:46.681447
NCT03005951|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-12-27|||June 2016||2016-06-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||The Influence of Breakfast on Hormone Responses and Cognitive Performance|The Influence of Breakfast on Hormone Responses and Cognitive Performance, as Assessed by CTET in Lean and Obese Adolescent Males|Recruiting||N/A|24|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||No||2017-10-10 21:29:46.772394|2017-10-10 21:29:46.772394
NCT03005925|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-26|||February 2017||2017-02-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|February 2020|Anticipated|2020-02-01||Interventional|SATIE-PR||Use of Remote Monitoring by Smartphone in the Care Management of Patients With Rheumatoid Arthritis|An Open Prospective Randomized Controlled Study Comparing the Use of Remote Monitoring by Smartphone in the Care Management of Patients With Rheumatoid Arthritis Versus a Standard Outpatient Follow-up by Physical Consultation|Not yet recruiting||N/A|94|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:29:46.953735|2017-10-10 21:29:46.953735
NCT03005912|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2017-04-14|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Telephone vs. Voice Over IP Speech Comprehension in Hearing Aided Subjects.|Clinical Single Centre Cohort Study Comparing Telephone vs. Voice Over Internet Protocol (VoIP) Speech Comprehension for Acoustical and Bluetooth Speech Signal Transmission in Hearing Aided Subjects.|Recruiting||N/A|36|Anticipated|University Hospital Inselspital, Berne||4|||f||||f|f|f||||||No||2017-10-10 21:29:47.03643|2017-10-10 21:29:47.03643
NCT03005899|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-01-10|||November 2016||2016-11-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain|Double-Blind, Placebo-Controlled Comparative Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain|Recruiting||Phase 3|312|Anticipated|SymBio Pharmaceuticals||2|||f||||||||||||||2017-10-10 21:29:47.153246|2017-10-10 21:29:47.153246
NCT03005886|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-02-02|||August 2006||2006-08-01|January 2017|2017-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||The Effect of Periodontal Therapy in Chronic Periodontitis Patients With and Without Acute Myocardial Infarction|The Effect of Periodontal Therapy on Neopterin and Vascular Cell Adhesion Molecule-1 Levels in Chronic Periodontitis Patients With and Without Acute Myocardial Infarction|Completed||N/A|60|Actual|Gazi University||3|||f||||t||||||||Yes|Clinical measurement records of periodontal and medical protocols can be shared with other researches. Researches should send an e-mail to principal investigator.|2017-10-10 21:29:47.292139|2017-10-10 21:29:47.292139
NCT03005873|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-07-11|||March 16, 2017|Actual|2017-03-16|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||A Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for Single Dose Administration of TLC599 in Patients With Osteoarthritis (OA) of Knee|A Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for Single Dose Administration of TLC599 in Patients With Osteoarthritis (OA) of Knee|Recruiting||Phase 2|72|Anticipated|Taiwan Liposome Company||3|||f||||t|f|f||||||||2017-10-10 21:29:47.373272|2017-10-10 21:29:47.373272
NCT03005860|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-12|||February 2017||2017-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery|A Prospective, Randomized, Controlled Trial to Compare the Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serumserum Biomarkers and on PBMCs in Patients Undergoing Breast Cancer Resection Surgery|Not yet recruiting||N/A|40|Anticipated|Tata Memorial Centre||2|||f||||t||||||||No||2017-10-10 21:29:47.486511|2017-10-10 21:29:47.486511
NCT03005847|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-01-18|||March 2017||2017-03-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Fermented Papaya Preparation on Patients With Chronic Kidney Disease Under Dialysis Receiving Intravenous Iron|The Effect of Fermented Papaya Preparation on Patients With Chronic Kidney Disease Under Dialysis Receiving Intravenous Iron|Not yet recruiting||N/A|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||No||2017-10-10 21:29:47.600733|2017-10-10 21:29:47.600733
NCT03005834|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-28|||June 2006||2006-06-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01|1020 Days|Observational [Patient Registry]|SHIP-CS||The Sakakibara Health Integrative Profile Cohort Study|Incidence of Cancers in Patients With Atherosclerotic Cardiovascular Diseases|Completed||N/A|32095|Actual|Sakakibara Heart Institute|||2||f||||f||||||||No||2017-10-10 21:29:47.683057|2017-10-10 21:29:47.683057
NCT03005821|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Chinese Pediatric Massage on Children With Acute Diarrhea: a Randomized Sham Massage Controlled Trial||Recruiting||N/A|128|Anticipated|Guangzhou University of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-10 21:29:47.747371|2017-10-10 21:29:47.747371
NCT03005808|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2016-12-29|||January 2015||2015-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|February 2016|Actual|2016-02-01||Interventional|||Choose the Best Concentration of Ropivacaine on TAP Block for Open Appendectomy in Children|Choose Between Two Different Concentration of Ropivacaine on TAP Block for Children Submitted of Open Appendectomy|Completed||Phase 4|40|Actual|Hospital Infantil Albert Sabin||3|||f||||t||||||||No||2017-10-10 21:29:47.820569|2017-10-10 21:29:47.820569
NCT03005795|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-03-22|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Music and Colposcopy in Women With Cervical Dysplasia.|Does Mozart Reduces Anxiety in Women With Cervical Dysplasia? A Randomized Controlled Trial.|Recruiting||N/A|240|Anticipated|Zydolab - Institute of Cytology and Immune Cytochemistry||2|||f||||f|f|f||||||No||2017-10-10 21:29:47.889995|2017-10-10 21:29:47.889995
NCT03005782|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-02-09|||November 2016||2016-11-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers|A Phase 1, Open-Label, Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety, Tolerability, Activity and Pharmacokinetics of REGN3767 (Anti-LAG-3 mAb) Administered Alone or in Combination With REGN2810 (Anti-PD-1 mAb) in Patients With Advanced Malignancies|Recruiting||Phase 1|283|Anticipated|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-10 21:29:47.963161|2017-10-10 21:29:47.963161
NCT03005769|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-14|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|DOMINO||Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy|Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in the Italian Clinical Practice: a Retrospective Cohort, Observational Study|Completed||N/A|262|Actual|Otsuka Pharmaceutical Europe Ltd|||1||f||||f||||||||||2017-10-10 21:29:48.21413|2017-10-10 21:29:48.21413
NCT03005756|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-26|||January 2017||2017-01-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|NGR||Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma Patients|Single Center and Exploratory Investigator-initiated Trial to Evaluate the Safety and Efficacy of Needle Guiding Robot System for Radiofrequency Ablation in Hepatocellular Carcinoma Patients|Not yet recruiting||N/A|20|Anticipated|Asan Medical Center||1|||f||||f||||||||No||2017-10-10 21:29:48.356186|2017-10-10 21:29:48.356186
NCT03005743|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-25|||December 2016||2016-12-01|December 2016|2016-12-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01||Interventional|COMBAT-Cervix||Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial|COnventional Radiography Based Intracavitary Brachytherapy (Standard Arm) Versus Magnetic Resonance Image Based BrAchyTherapy (Study Arm) in Locally Advanced Cervical Cancers: A Phase III Randomized Controlled Trial (COMBAT - Cervix Trial)|Recruiting||Phase 3|1050|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||||2017-10-10 21:29:48.448767|2017-10-10 21:29:48.448767
NCT03005730|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-28|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|||Effects of Phototherapy in Individuals With Temporomandibular Disorder|Effects of Phototherapy on Muscle Activity and Pain in Individuals With Temporomandibular Disorder: A Study Protocol for a Randomized Controlled Trial|Not yet recruiting||Phase 1/Phase 2|15|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 21:29:48.600113|2017-10-10 21:29:48.600113
NCT03005717|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-04-17|||December 2016||2016-12-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat|Active, not recruiting||Phase 2|162|Actual|Neothetics, Inc||3|||f||||f||||||||No||2017-10-10 21:29:48.697029|2017-10-10 21:29:48.697029
NCT03005704|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-04-05|||January 2017||2017-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|REVSTARTS||Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets|Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets|Recruiting||N/A|10|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f||||||||No||2017-10-10 21:29:48.842419|2017-10-10 21:29:48.842419
NCT03005691|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-28|||January 2017||2017-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|||Central Sensitization in Chronic Whiplash Patients|Central Sensitization in Chronic Whiplash Patients: Metabolite Concentrations in the Anterior Cingulate Cortex and Periacueductal Gray Matter|Not yet recruiting||N/A|30|Anticipated|University of Castilla-La Mancha|||3||f||||f||||||||Yes|To publish in impact journals|2017-10-10 21:29:48.929984|2017-10-10 21:29:48.929984
NCT03005665|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-24|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Acetazolamide on Optic Nerve Sheath Diameter in Laparoscopic Donor Nephrectomies|Effect of Orogastric Acetazolamide on Intraocular Pressure in Laparoscopic Donor Nephrectomies|Completed||N/A|40|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 21:29:49.173576|2017-10-10 21:29:49.173576
NCT03005652|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-28|||March 2017||2017-03-01|December 2016|2016-12-01|February 2020|Anticipated|2020-02-01|August 2018|Anticipated|2018-08-01||Interventional|SCD-WELL||A Superiority Study To Compare The Effects Of An 8-Weeks Mindfulness-based Intervention Versus Health Education Programme On Mental Health And Wellbeing In Individuals With Subjective Cognitive Decline|A Multicenter Randomized Superiority Study To Compare The Effects Of An 8-Weeks Mindfulness-based Intervention Versus Health Education Programme On Mental Health And Wellbeing In Individuals With Subjective Cognitive Decline|Not yet recruiting||N/A|160|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||No||2017-10-10 21:29:49.278859|2017-10-10 21:29:49.278859
NCT03005639|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-11|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma|Neoadjuvant Vemurafenib and Cobimetinib in BRAF V600 Mutant Stage IIIB-C Melanoma|Recruiting||Phase 2|20|Anticipated|Inova Health Care Services||1|||f||||t|t|f|||f|||||2017-10-10 21:29:49.411802|2017-10-10 21:29:49.411802
NCT03005626|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-02-06|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|February 2020|Anticipated|2020-02-01||Interventional|||Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases|Transition From Adolescents to Adulthood for Patients With Congenital Patients With Congenital Heart Diseases: Impact of a Therapeutic Education Program on Quality of Life|Recruiting||N/A|178|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 21:29:49.500691|2017-10-10 21:29:49.500691
NCT03005613|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-28|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Sacrospinous Ligament Fixation vs Ischial Spine Fascia Fixation|A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation|Not yet recruiting||N/A|76|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||No||2017-10-10 21:29:49.620826|2017-10-10 21:29:49.620826
NCT03005600|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-29|||February 2016||2016-02-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Observational|STRiDE||Stratification of Risk of Diabetes in Early Pregnancy|Stratification of Risk of Diabetes in Early Pregnancy|Recruiting||N/A|7400|Anticipated|University of Warwick|||2||f||||f||||||Samples With DNA|"     Both sites have the capacity for all the necessary measurements. All samples will be     temporarily stored in fridge and -20°C freezers after which it will be shifted to -80°C     freezers for long term storage.   "|Yes|Metadata will be archived following the publication of the study findings as per MRC UK's guidelines|2017-10-10 21:29:49.739279|2017-10-10 21:29:49.739279
NCT03005587|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior Decompensation|Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior Decompensation - A Prospective Observational Study.|Not yet recruiting||N/A|80|Anticipated|Institute of Liver and Biliary Sciences, India|||2||f||||f||||||||No||2017-10-10 21:29:49.848902|2017-10-10 21:29:49.848902
NCT03005574|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-08-09|||January 2017||2017-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program|A Randomized Controlled Trial Comparing the Impact of Thinking Skills for Work (TSW)Tablet-based Home Practice Program on Cognitive Functioning and Work With the Traditional TSW Program|Recruiting||N/A|50|Anticipated|Boston University Charles River Campus||2|||f||||f||||||||||2017-10-10 21:29:49.931735|2017-10-10 21:29:49.931735
NCT03005561|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-25|||January 2017||2017-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment|Multi Center, Interventional, Randomized Study Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment|Not yet recruiting||N/A|200|Anticipated|Soroka University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:29:50.029976|2017-10-10 21:29:50.029976
NCT03005548|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-08-29|||June 2016||2016-06-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CMAPTPtDCS||Cortical Modulation of Acute Post-thoracotomy Pain With Transcranial Direct Current Stimulation|Cortical Modulation of Acute Post-thoracotomy Pain With Transcranial Direct Current Stimulation|Recruiting||Phase 2|62|Anticipated|Military Medical Academy, Belgrade, Serbia||2|||f||||t||||||||||2017-10-10 21:29:50.104387|2017-10-10 21:29:50.104387
NCT03005535|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-25|||October 2016||2016-10-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|February 2017|Anticipated|2017-02-01||Interventional|ECLIPSE||Effects of Corn Oil Plus Vitamin E and B6 on LIpids, PcSk9 and Endothelial Function|Randomised Clinical Trial to Assess the Medium-term Effect of 30 g/Day of a Vitaminised Corn Oil or Olive Oil, on Lipid Parameters, Vascular Risk Markers Blood Pressure and Endothelial Function, in Moderately Hypercholesterolemic Subjects|Enrolling by invitation||N/A|65|Actual|University of Bologna||2|||f||||t||||||||Yes||2017-10-10 21:29:50.22366|2017-10-10 21:29:50.22366
NCT03005522|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2016-12-24|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Dexamethasone on the Time to Pain Resolution in Dental Apical Abscess|The Effects of Dexamethasone on the Time to Pain Resolution in Dental Apical Abscess|Not yet recruiting||N/A|100|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-10 21:29:50.30416|2017-10-10 21:29:50.30416
NCT03005509|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-25|||January 2017||2017-01-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|TQI||Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India|Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India: Protocol for a Prospective Observational Study to Assess Effectiveness|Not yet recruiting||N/A|3400|Anticipated|National Trauma Research Institute||2|||f||||f||||||||No||2017-10-10 21:29:50.372068|2017-10-10 21:29:50.372068
NCT03005496|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-20|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β|The Effect of Zinc, Beta-carotene, and Vitamin D3 Supplementation as Pro-inflammation Mediated Regulator in Preterm Delivery Through Placental Protein Adaptor MyD88 and TRIF, Transcription Factor NFkB, and Pro-inflammatory Cytokine IL-1β|Completed||Phase 4|56|Actual|Indonesia University||2|||f||||t||||||||||2017-10-10 21:29:50.463041|2017-10-10 21:29:50.463041
NCT03005483|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-28|||January 2014||2014-01-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|January 2015|Actual|2015-01-01||Interventional|||Gabapentin as Adjuvant for Postoperative Pain in Pediatric Orthopedic Surgery|Placebo Controlled, Randomized,Gabapentin as Adjuvant for Postoperative Pain in Pediatric Orthopedic Surgery|Completed||Phase 4|40|Actual|Hospital Infantil Albert Sabin||2|||f||||t||||||||No||2017-10-10 21:29:50.543856|2017-10-10 21:29:50.543856
NCT03005470|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-23|||January 2017||2017-01-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|TIM||Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT|Technology for Innovative Monitoring of Cardiovascular Prevention: A Precision Randomized Controlled Trial|Not yet recruiting||Phase 3|450|Anticipated|Hospital de Clinicas de Porto Alegre||4|||f||||t||||||||Undecided||2017-10-10 21:29:50.62658|2017-10-10 21:29:50.62658
NCT03005457|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-25|||July 2012||2012-07-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pilot Study to Assess the Feasibility and Initial Efficacy of Therapist-as-consultant, Game-based CI Therapy|A Low-cost Virtual Reality Gaming Platform for Neurorehabilitation of Hemiparesis|Completed||N/A|32|Actual|Ohio State University||2|||f||||f||||||||Yes|Will be shared upon publication acceptance.|2017-10-10 21:29:50.712078|2017-10-10 21:29:50.712078
NCT03005444|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-29|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Anticoagulation for Advanced Cirrhotic Patients After TIPS|Anticoagulation for Development of Further Decompensation and Survival in Advanced Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt: a Multicenter Randomized Controlled Study|Recruiting||N/A|254|Anticipated|Fourth Military Medical University||2|||f||||f|f|f||||||||2017-10-10 21:29:50.786319|2017-10-10 21:29:50.786319
NCT03005431|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-09-29|||January 2017||2017-01-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Parents of Newly Diagnosed Preschool Children With Autism Spectrum Disorder:|Parents of Newly Diagnosed Preschool Children With Autism Spectrum Disorder: The Effectiveness of a Self-Directed On-line Parent Training and Support Program on Parent and Child Outcomes|Enrolling by invitation||N/A|60|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-10 21:29:50.891639|2017-10-10 21:29:50.891639
NCT03005418|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-02-13|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Humacyte Human Acellular Vessel (HAV) in Patients With Limb-threatening Peripheral Arterial Trauma|A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Use as a Vascular Bypass or Interposition Vessel in Patients With Limb-threatening Peripheral Arterial Trauma|Not yet recruiting||Phase 2|20|Anticipated|Humacyte, Inc.||1|||f||||t|t|f||||||No||2017-10-10 21:29:50.974184|2017-10-10 21:29:50.974184
NCT03005405|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-12-23|||February 2015||2015-02-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cost-efficacy of Sealing Moderate Caries Lesions in Occlusal Surfaces of Primary Molars|Cost-efficacy and Applicability of the Treatment of Moderate Caries Using Sealants as an Alternative to the Restorations on Occlusal Surfaces of Deciduous Teeth: a Randomized Controlled Trial|Recruiting||Phase 3|96|Anticipated|University of Sao Paulo||2|||f||||t||||||||Yes|Publication of all results, accessibility to data if necessary|2017-10-10 21:29:51.111976|2017-10-10 21:29:51.111976
NCT03005392|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-23|||June 2015||2015-06-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Home-exercise Program for Children and Adolescent Survivors of Acute Lymphoblastic Leukemia|Effects of a Physical Exercise Program in Patients With Diagnosis of Acute Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|24|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||4|||f||||t||||||||Undecided||2017-10-10 21:29:51.206403|2017-10-10 21:29:51.206403
NCT03005379|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-07-17|||May 1, 2018|Anticipated|2018-05-01|July 2017|2017-07-01|April 28, 2023|Anticipated|2023-04-28|November 30, 2021|Anticipated|2021-11-30||Interventional|MATCH||Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)|CSP #2004 - Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)|Not yet recruiting||Phase 2/Phase 3|390|Anticipated|VA Office of Research and Development||2|||f||||f|t|f|||f|||||2017-10-10 21:29:51.283065|2017-10-10 21:29:51.283065
NCT03005366|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|January 2019|Anticipated|2019-01-01||Interventional|SELECTCARFAP||Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents|Randomized Clinical Trial to Study Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation by Vernakalant and Flecainide|Recruiting||Phase 4|50|Anticipated|Hospital San Carlos, Madrid||2|||f||||t||||||||No||2017-10-10 21:29:51.376527|2017-10-10 21:29:51.376527
NCT03005353|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-06-29|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Cream.|Randomized Clinical Trial for Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Cream.|Not yet recruiting||Phase 2/Phase 3|160|Anticipated|Assiut University||2|||f||||t|f|f|||f|||Yes||2017-10-10 21:29:51.475754|2017-10-10 21:29:51.475754
NCT03005171|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2016-12-28|||January 2017||2017-01-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Perioperative Epidural Versus Intravenous Local Anesthetic Infusion in Open Upper Abdominal Surgery|Perioperative Epidural Versus Intravenous Local Anesthetic Infusion in Open Upper Abdominal Surgery|Not yet recruiting||Phase 2/Phase 3|70|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:29:54.278668|2017-10-10 21:29:54.278668
NCT03005340|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||A Phase 1 Drug Drug Interaction Clinical Trial of C1-R215 and C2-R215 in Healthy Male Volunteers|A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Coadministration of C1-R215 and C2-R215 Compared to the Administration of C1-R215 and C2-R215 Independently in Healthy Male Volunteers|Enrolling by invitation||Phase 1|24|Actual|Alvogen Korea||6|||f||||f||||||||No||2017-10-10 21:29:51.536362|2017-10-10 21:29:51.536362
NCT03005327|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-02-08|||December 2016||2016-12-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|X4P-001-MKKA||A Trial of X4P-001 in Patients With WHIM Syndrome|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of X4P-001 in Patients With WHIM (Warts, Hypogammaglobulinemia, Infections and Myelokathexis) Syndrome|Recruiting||Phase 2/Phase 3|33|Anticipated|X4 Pharmaceuticals||2|||f||||t||||||||||2017-10-10 21:29:51.617669|2017-10-10 21:29:51.617669
NCT03005314|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-24|||August 2016||2016-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Detection of Circulating Tumor Tells as The Guidance of the Neoadjuvant Chemotherapy of Esophageal Cancer|Detection of Circulating Tumor Tells as The Guidance of the Neoadjuvant Chemotherapy of Esophageal Cancer|Recruiting||N/A|120|Anticipated|The Second Hospital of Shandong University||2|||f||||t||||||||No||2017-10-10 21:29:51.694005|2017-10-10 21:29:51.694005
NCT03005301|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2016-12-24|||January 2017||2017-01-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||The CX-DZ-Ⅱ Intelligent Electroacupuncture Instrument for Neck Pain|The CX-DZ-Ⅱ Intelligent Electroacupuncture Instrument for Neck Pain|Not yet recruiting||Phase 1|160|Anticipated|Chengdu University of Traditional Chinese Medicine||2|||f||||f||||||||No||2017-10-10 21:29:51.765554|2017-10-10 21:29:51.765554
NCT03005288|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-24|2017-06-06|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|January 3, 2019|Anticipated|2019-01-03|January 3, 2019|Anticipated|2019-01-03||Interventional|||Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes|A Randomized, Subject- and Investigator-blinded, Placebo Controlled Study to Assess the Safety, Pharmacokinetics and Efficacy of Intravenous Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes|Recruiting||Phase 2|60|Anticipated|Novartis||2|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:29:53.458987|2017-10-10 21:29:53.458987
NCT03005275|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-17|||January 2017||2017-01-01|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||A Comparison of Cost - Effectiveness of Stimulated ICSI and IVM Strategy in PCOS Women|A Comparison of Cost - Effectiveness of Stimulated ICSI and IVM Strategy in PCOS Women|Withdrawn||N/A|0|Actual|Vietnam National University||2|||f||||f||||||||No||2017-10-10 21:29:53.563306|2017-10-10 21:29:53.563306
NCT03005262|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-22||||||December 2016|2016-12-01||||||||Expanded Access|||Single Patient IND, MLN8237|Expanded Access To MLN8237, For An Individual Patient With Adenocarinoma Of The Prostate (CTMS# 16-0122)|No longer available||N/A|||The University of Texas Health Science Center at San Antonio|||||||||||||||||||2017-10-10 21:29:53.65358|2017-10-10 21:29:53.65358
NCT03005249|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2016-12-26|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Neural Stem Cells Therapy for Cerebral Palsy|Neural Stem Cells Therapy for Cerebral Palsy: a Prospective, Randomized, Parallel-controlled Trial|Active, not recruiting||N/A|20|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:29:53.705726|2017-10-10 21:29:53.705726
NCT03005236|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-28|||April 2017||2017-04-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|AGEING||AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation|AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation (AGEING) - a Feasibility Study|Not yet recruiting||Phase 4|40|Anticipated|University Hospital Birmingham NHS Foundation Trust||2|||f||||t||||||||Undecided||2017-10-10 21:29:53.786435|2017-10-10 21:29:53.786435
NCT03005223|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-26|2017-02-14|||January 4, 2017|Actual|2017-01-04|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers||Active, not recruiting||Phase 1|52|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-10 21:29:53.888388|2017-10-10 21:29:53.888388
NCT03005210|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2016-12-28|||November 2016||2016-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)|Open Label Randomized, Single Dose, Three Way Three Sequence Two Treatment Partial Replicate Crossover Bioequivalence Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)|Completed||Phase 1|37|Actual|Genuine Research Center, Egypt||3|||f||||f||||||||Undecided||2017-10-10 21:29:53.96272|2017-10-10 21:29:53.96272
NCT03005197|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-04|||February 2017||2017-02-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Laser Doppler Flowmetry in Assessing the Vitality of Traumatised Teeth|A Prospective Study to Assess the Diagnostic Accuracy of Laser Doppler Flowmetry in Assessing Pulp Vitality of Traumatised Teeth in Paediatric Patients|Not yet recruiting||N/A|30|Anticipated|University of Leeds|||1||f||||f||||||||No||2017-10-10 21:29:54.064945|2017-10-10 21:29:54.064945
NCT03005184|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-09-19|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2|Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2|Recruiting||Phase 2|75|Anticipated|Vanderbilt University Medical Center||12|||f||||t|t|f||||||||2017-10-10 21:29:54.128957|2017-10-10 21:29:54.128957
NCT03005158|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-12-28|||November 2014||2014-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|HiSTORIC||High-Sensitivity Cardiac Troponin On Presentation to Rule Out Myocardial Infarction|High-Sensitivity Cardiac Troponin On Presentation to Rule Out Myocardial Infarction (HiSTORIC): A Stepped Wedge Cluster Randomized Trial|Active, not recruiting||N/A|39000|Anticipated|University of Edinburgh||3|||f||||t||||||||Undecided||2017-10-10 21:29:54.45539|2017-10-10 21:29:54.45539
NCT03005145|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-22|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|BALANCE||Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness|Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: Randomized Controlled Trial|Recruiting||N/A|3598|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t|f|f||||||||2017-10-10 21:29:54.569507|2017-10-10 21:29:54.569507
NCT03005132|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2016-12-23|||January 2016||2016-01-01|December 2016|2016-12-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|||Integrative Analysis of Human Glioblastoma Multiforme|Integrative Analysis of Human Glioblastoma Multiforme|Recruiting||N/A|1000|Anticipated|Shanghai 10th People's Hospital|||3||f||||t||||||||Yes|The investigators are willing to share data.|2017-10-10 21:29:54.801145|2017-10-10 21:29:54.801145
NCT03005119|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-25|2017-09-26|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms|A Phase II, Double-blind, Randomized, Placebocontrolled, Parallel-group, Single-center Study to Evaluate the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in Multiple Sclerosis (MS) Patients With Spasticity-related Symptoms|Not yet recruiting||Phase 2|70|Anticipated|PhytoTech Therapeutics, Ltd.||2|||f|||||f|f||||||||2017-10-10 21:29:54.910656|2017-10-10 21:29:54.910656
NCT03005106|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-10-03|||May 30, 2017|Actual|2017-05-30|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|January 2019|Anticipated|2019-01-01||Interventional|||StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements|A Phase III Open-label, Controlled, Randomized, Multicenter Study Evaluating the Efficacy and Safety of StrataGraft Skin Tissue in Promoting Autologous Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements and for Which Excision and Autografts Are Clinically Indicated|Recruiting||Phase 3|70|Anticipated|Stratatech, a Mallinckrodt Company||1|||f||||t|t|f||||||||2017-10-10 21:29:55.039407|2017-10-10 21:29:55.039407
NCT03005093|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-15|||January 15, 2017|Actual|2017-01-15|August 2017|2017-08-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Observational|||The Turkish Feeding/Swallowing Impact Survey|Reliability and Validity of the Turkish Feeding/Swallowing Impact Survey|Completed||N/A|117|Actual|Hacettepe University|||2||f||||t||||||||||2017-10-10 21:29:55.18755|2017-10-10 21:29:55.18755
NCT03005080|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-02-10|||December 2016||2016-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease|The Utility of Pharmacogenetic Testing in Managing Children With Persistent Gastroesophageal Reflux Disease Despite Therapy|Recruiting||N/A|30|Anticipated|Mayo Clinic|||1||f||||f||||||||Undecided||2017-10-10 21:29:55.26696|2017-10-10 21:29:55.26696
NCT03005067|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-06-14|||December 29, 2016|Actual|2016-12-29|June 2017|2017-06-01|June 7, 2017|Actual|2017-06-07|June 7, 2017|Actual|2017-06-07||Interventional|||To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold|A Randomized, Parallel-Group, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Subjects With Symptoms of Common Cold|Completed||Phase 2|157|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 21:29:55.349106|2017-10-10 21:29:55.349106
NCT03005054|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-10-03|||April 24, 2017|Actual|2017-04-24|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|||StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects|Open-label, Controlled, Randomized, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, and Efficacy of Single or Multiple Applications of StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects|Recruiting||Phase 2|20|Anticipated|Stratatech, a Mallinckrodt Company||1|||f||||t|t|f||||||||2017-10-10 21:29:55.487035|2017-10-10 21:29:55.487035
NCT03005028|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-25|||January 2015||2015-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study|Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study|Recruiting||Phase 3|400|Anticipated|CathWorks Ltd.|||1||f||||f||||||||No||2017-10-10 21:29:55.63582|2017-10-10 21:29:55.63582
NCT03005015|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-12-23|||January 2017||2017-01-01|December 2016|2016-12-01||||July 2020|Anticipated|2020-07-01||Interventional|||Lenvatinib in Second Line Endometrial Carcinoma|A Randomized Phase II Study of Lenvatinib Versus Doxorubicin in Second Line Advanced or Recurrent Endometrial Carcinoma|Withdrawn||Phase 2|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2||supporting company (Eisai) withdrew their interest|f||||t||||||||||2017-10-10 21:29:55.703441|2017-10-10 21:29:55.703441
NCT03005002|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-09-08|||June 28, 2017|Actual|2017-06-28|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver|A Pilot Feasibility Study of Durvalumab (MEDI4736) and Tremelimumab Following Radioembolization in Patients With Metastatic Microsatellite Stable (MSS) Colorectal Cancer to the Liver|Recruiting||Phase 1|18|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:29:55.783712|2017-10-10 21:29:55.783712
NCT03004989|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-30|||May 2012||2012-05-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|November 2013|Actual|2013-11-01||Observational|RTW-GP||Experiences of Participating in Return to Work Group Programmes|Experiences of Participating in Return to Work Group Programmes for People With Musculoskeletal Disorders: A Focus Group Study|Completed||N/A|17|Actual|Revmatismesykehuset AS|||3||f||||f||||||||No||2017-10-10 21:29:55.875231|2017-10-10 21:29:55.875231
NCT03004976|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-14|||March 14, 2017|Actual|2017-03-14|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|CoBIS 2||Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke|Phase 2 Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke - CoBIS 2|Recruiting||Phase 2|100|Anticipated|Duke University||2|||f||||t|t|f||||||||2017-10-10 21:29:55.954949|2017-10-10 21:29:55.954949
NCT03004963|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-28|||October 2016||2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients.|Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients: A Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|RenJi Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:29:56.178561|2017-10-10 21:29:56.178561
NCT03004950|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-01-10|||October 2016||2016-10-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Observational|||Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)|Biomarker Effectiveness Analysis in Contrast Nephropathy|Active, not recruiting||N/A|1100|Anticipated|University of Pittsburgh|||1||f||||f||||||||No||2017-10-10 21:29:56.274956|2017-10-10 21:29:56.274956
NCT03004937|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-04-17|||April 2014||2014-04-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|EAR-PC||Early Auditory Referral in Primary Care|Early Auditory Referral in Primary Care (EAR-PC)|Recruiting||N/A|10000|Anticipated|University of Michigan||1|||f||||t||||||||Yes|In process of data collection. Data will be analyzed, papers written, and results posted in clinicaltrials.gov.|2017-10-10 21:29:56.344243|2017-10-10 21:29:56.344243
NCT03004911|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-05-15|||February 14, 2017|Actual|2017-02-14|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Interventional|||Development of a Mobile Application to Promote Self-care in Patients With Fibromyalgia|Development of a Mobile Application to Promote Self-care in Patients With Fibromyalgia|Recruiting||N/A|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:29:56.748157|2017-10-10 21:29:56.748157
NCT03004898|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-12-23|||February 2013||2013-02-01|December 2016|2016-12-01||||May 2019|Anticipated|2019-05-01||Interventional|||Population-based Chronic Kidney Disease Cohort at Northern Taiwan|Preventing Progression of Renal Disease by Multidisciplinary Education - A Cohort Study at Northern Taiwan.|Recruiting||N/A|10000|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||No||2017-10-10 21:29:56.866054|2017-10-10 21:29:56.866054
NCT03004885|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-22|||January 2017||2017-01-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|PROVAP||Enhanced Lung Protective Ventilation for ARDS Patients With PrismaLung|Enhanced Lung Protective Ventilation for ARDS Patients With PrismaLung|Not yet recruiting||Phase 3|14|Anticipated|Hôpital Européen Marseille||3|||f||||f||||||||No||2017-10-10 21:29:56.963509|2017-10-10 21:29:56.963509
NCT03004872|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-12-23|||September 2016||2016-09-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Relationship Between Postpartum Mood Disorders and Delivery Experience|Relationship Between Postpartum Mood Disorders and Delivery Experience|Recruiting||N/A|1000|Anticipated|University of Michigan|||1||f||||f||||||||No||2017-10-10 21:29:57.06564|2017-10-10 21:29:57.06564
NCT03004859|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-07-21|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01|12 Months|Observational [Patient Registry]|AF-Stroke||Opportunistic Screening in Pharmacies for Atrial Fibrillation in Seniors (>65 Years)|Eine Beobachtungsstudie Zur Erfassung Von (Asymptomatischem)Vorhofflimmern Mittels Eines Gelegenheitsscreenings älteren Menschen ab 65 Jahren|Active, not recruiting||N/A|7606|Actual|RWTH Aachen University|||2||f||||t||||||||||2017-10-10 21:29:57.162586|2017-10-10 21:29:57.162586
NCT03004846|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-07-13|||February 13, 2017|Actual|2017-02-13|July 2017|2017-07-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis|A Two-part Trial to Evaluate the Safety, Tolerability, Clinical Effect and Systemic Exposure Potential of Topically Applied GSK2981278 Ointment in Subjects With Plaque Psoriasis|Completed||Phase 2|8|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 21:29:57.262366|2017-10-10 21:29:57.262366
NCT03004833|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-04-26|||February 21, 2017|Actual|2017-02-21|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|NIVAHL||Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma|Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma|Recruiting||Phase 2|110|Anticipated|University of Cologne||2|||f||||t|f|f||||||||2017-10-10 21:29:57.362849|2017-10-10 21:29:57.362849
NCT03004820|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-07-21|||December 6, 2016|Actual|2016-12-06|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|PICNIC-ONE||Prevention of Ischemic Conditions in Non-disabling Stroke/Transient Ischemic Attack With Remote Ischemic Conditioning|Feasibility of Applying Remote Ischemic Conditioning in Secondary Prevention in Patients With Minor Ischemic Stroke or Transient Ischemic Attack —A Single-arm Futility Study|Recruiting||N/A|165|Anticipated|Capital Medical University||1|||f||||t||f||||||||2017-10-10 21:29:57.481803|2017-10-10 21:29:57.481803
NCT03004807|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-09-18|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Role of Centrum® Silver® in Improving Micronutrient Status in Older Men|Role of Centrum® Silver® in Improving Micronutrient Status in Older Men|Not yet recruiting||N/A|40|Anticipated|Oregon State University||2|||f||||f|f|f||||||||2017-10-10 21:29:57.613361|2017-10-10 21:29:57.613361
NCT03004794|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-23|||June 2015||2015-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Characteristics and Predictors of Progression of an Egyptian Multiple Sclerosis Cohort||Completed||N/A|1581|Actual|Cairo University|||1||f||||||||||||||2017-10-10 21:29:57.73828|2017-10-10 21:29:57.73828
NCT03004781|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-23|||January 2015||2015-01-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|H2M1||Stimulation of Parents' Self-efficacy Beliefs and Emotion Coaching Practices (H2M1)|Stimulation of Parents' Self-efficacy Beliefs and Emotion Coaching Practices to Reduce Externalizing Behavior in Preschoolers|Completed||N/A|45|Actual|Université Catholique de Louvain||3|||f||||f||||||||No||2017-10-10 21:29:57.803412|2017-10-10 21:29:57.803412
NCT03004768|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-23|||January 2017||2017-01-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants|Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants|Not yet recruiting||Phase 1|6|Anticipated|Bristol-Myers Squibb||1|||f||||||||||||||2017-10-10 21:29:57.877681|2017-10-10 21:29:57.877681
NCT03004755|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-23|||March 2014||2014-03-01|December 2016|2016-12-01||||October 2021|Anticipated|2021-10-01||Observational|PEACE||The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study|The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study|Recruiting||N/A|500|Anticipated|University College, London|||1||f||||t||||||||||2017-10-10 21:29:57.962233|2017-10-10 21:29:57.962233
NCT03004742|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-31|||August 2015|Actual|2015-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Flavonoid-rich Supplement Influence on the Human Metabolome|Influence of Ingesting a Flavonoid-rich Supplement on the Human Metabolome and Concentration of Urine Phenolics|Completed||N/A|110|Actual|Appalachian State University||2|||f||||f||||||||Yes|Data will be shared through the Human Metabolome Database (HMDB), other public web sites, and publication in the scientific literature.|2017-10-10 21:29:58.046943|2017-10-10 21:29:58.046943
NCT03004729|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-09-14|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|MOSAIC||Symptoms Based Awareness Confirmation Study - CoMiSS Validation|Symptoms Based Awareness Confirmation Study - CoMiSS Validation|Recruiting||N/A|300|Anticipated|Nestlé||1|||f||||f||||||||||2017-10-10 21:29:58.134956|2017-10-10 21:29:58.134956
NCT03004716|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-03-13|||January 2017||2017-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|TELE-REHAB||Telemonitoring in Pulmonary Rehabilitation: Validity of a Remote Pulse Oxymetry System|Telemonitoring in Pulmonary Rehabilitation: Validity of a Remote Pulse Oxymetry System|Completed||N/A|5|Actual|ADIR Association|||1||f||||||||||||||2017-10-10 21:29:58.249499|2017-10-10 21:29:58.249499
NCT03004703|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-06-28|||December 2016||2016-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|ASSAIL-MI||ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial|ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial|Recruiting||Phase 2|200|Anticipated|Oslo University Hospital||2|||f||||t||||||||Undecided|Undecided|2017-10-10 21:29:58.312039|2017-10-10 21:29:58.312039
NCT03004690|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-01-05|||May 2011||2011-05-01|January 2017|2017-01-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|PPE-Test||Testing of Personal Protective Equipment (PPE)|Limiting Factors for Wearing Personal Protective Equipment (PPE) in a Health Care Environment Evaluated in a Randomised Study: Source of Errors?|Completed||N/A|19|Actual|Medical University of Graz||2|||f||||f||||||||No||2017-10-10 21:29:58.529813|2017-10-10 21:29:58.529813
NCT03004677|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Neo-SIPaS||Effect of Skin-to-skin Contact on Interaction and Parents' Sleep|Effect of Skin-to-skin Contact on Interaction and Parents' Sleep|Recruiting||N/A|50|Anticipated|Linkoeping University||2|||f||||f||||||||No||2017-10-10 21:29:58.623558|2017-10-10 21:29:58.623558
NCT03004664|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-22|||January 2017||2017-01-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Observational|||Comparing Program Options for Latinos With Diabetes|A Patient-Centered Framework to Test the Comparative Effectiveness of Culturally and Contextually Appropriate Program Options for Latinos With Diabetes From Low-Income Households|Not yet recruiting||N/A|240|Anticipated|University of New Mexico|||2||f||||f||||||||No||2017-10-10 21:29:58.733844|2017-10-10 21:29:58.733844
NCT03004651|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-03-30|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|RABODI||BMI and Ultrasound/Clinical Assessments of RA Disease Activity|Impact of Body Mass Index on the Agreement Between Ultrasound- and Clinical Assessments of Disease Activity in RA : Cross-sectionnal Study|Recruiting||N/A|120|Anticipated|University Hospital, Montpellier|||2||f||||f||||||||No||2017-10-10 21:29:58.850271|2017-10-10 21:29:58.850271
NCT03004638|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-08-14|||January 23, 2017|Actual|2017-01-23|August 2017|2017-08-01|November 14, 2017|Anticipated|2017-11-14|November 14, 2017|Anticipated|2017-11-14||Interventional|||Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease|A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease|Recruiting||Phase 2|32|Anticipated|MedImmune LLC||5|||f||||f|t|f||||||||2017-10-10 21:29:58.947979|2017-10-10 21:29:58.947979
NCT03004625|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-02-28|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without NS5A RAV|Treatment Efficacy and Safety of 12 Weeks of Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without Baseline NS5A Resistance-associated Variants (DARING)|Recruiting||Phase 3|70|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||No||2017-10-10 21:29:59.067645|2017-10-10 21:29:59.067645
NCT03004612|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-22|||December 2015||2015-12-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|PRELLIM||Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes|Effect of Linagliptin + Metformin vs Metformin Alone on the Role of Pancreatic Islet Function, Insulin Resistance and Markers of Cardiovascular Risk in Patients With Prediabetes: Randomized Clinical Trial|Recruiting||Phase 4|75|Anticipated|Universidad de Guanajuato||2|||f||||t||||||||No||2017-10-10 21:29:59.165109|2017-10-10 21:29:59.165109
NCT03004599|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-22|||November 2016||2016-11-01|December 2016|2016-12-01|December 2023|Anticipated|2023-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Safety and Efficacy of SYM-SV/DS-002 in Patients With Severe Aortic Stenosis|Safety and Efficacy of SYM-SV/DS-002 in Patients With Severe Aortic Stenosis|Recruiting||Phase 3|136|Anticipated|Medico's Hirata Inc.||1|||f||||||||||||||2017-10-10 21:29:59.28561|2017-10-10 21:29:59.28561
NCT03004586|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-22|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2021|Anticipated|2021-12-01||Interventional|||Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle|Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle; A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 21:29:59.402577|2017-10-10 21:29:59.402577
NCT03004573|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-03-17|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|December 14, 2019|Anticipated|2019-12-14|December 14, 2019|Anticipated|2019-12-14||Interventional|||Role of Deep Brain Stimulation on Social Cognition in Parkinsonian Patients|Functioning of the Mirror Neurons System in Parkinson's Disease and Its Impact on the Social Cognition|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||No||2017-10-10 21:29:59.534941|2017-10-10 21:29:59.534941
NCT03004560|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-24|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Psychology of Minimally Invasive Surgical Scars|Psychology of Minimally Invasive Surgical Scars|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||f||||||||No||2017-10-10 21:29:59.636685|2017-10-10 21:29:59.636685
NCT03004547|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-08-23|||October 2, 2017|Anticipated|2017-10-02|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Observational|||Sodium Deposition in Soft Tissues of Patients With Kidney Disease|Evaluation of Sodium Deposition in Soft Tissues of Patients With Kidney Disease and Its Association With Patient Symptomatology|Not yet recruiting||N/A|70|Anticipated|Lawson Health Research Institute|||4||f||||f||||||Samples With DNA|"     Blood will be taken for storage until the end of the study when endotoxin and uremic toxin     measurement will be performed on all samples.   "|||2017-10-10 21:29:59.731551|2017-10-10 21:29:59.731551
NCT03004534|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-10-04|||September 5, 2017|Actual|2017-09-05|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of ODM-201|A Presurgical Tissue-Acquisition Study to Evaluate Molecular Alterations in Human Breast Cancer Tissue Following Short-Term Exposure to the Androgen Receptor Antagonist ODM-201|Recruiting||Early Phase 1|60|Anticipated|Translational Research in Oncology||1|||f||||f|t|f||||||||2017-10-10 21:29:59.860241|2017-10-10 21:29:59.860241
NCT03004521|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-22|||December 2016||2016-12-01|October 2016|2016-10-01||||June 2020|Anticipated|2020-06-01||Interventional|LQD||Lithium Versus Quetiapine in Treatment Resistant Depression|A Randomised Pragmatic Trial Comparing the Clinical and Cost Effectiveness of Lithium and Quetiapine Augmentation in Treatment Resistant Depression|Recruiting||Phase 4|276|Anticipated|King's College London||2|||f||||t||||||||||2017-10-10 21:30:00.038001|2017-10-10 21:30:00.038001
NCT03004495|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-12-22|||January 2016||2016-01-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001|Open Label, Randomized, Repeated-dose, 3-way Crossover Study to Investigate Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001 Administered in Healthy Subjects Via NEXThaler® Dry Powder Inhaler|Completed||Phase 1|36|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||No||2017-10-10 21:30:00.275383|2017-10-10 21:30:00.275383
NCT03004482|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-06-29|||September 2015||2015-09-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Observational|||Analysis of Video Imaging in Newborns|Noninvasive Monitoring and Diagnosis of Physiologic Disturbances in Term and Preterm Newborns Using Video Analysis Techniques|Recruiting||N/A|80|Anticipated|American University of Beirut Medical Center|||1||f||||f||||||||No||2017-10-10 21:30:00.371945|2017-10-10 21:30:00.371945
NCT03004469|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-09-22|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|March 9, 2018|Anticipated|2018-03-09||Interventional|||Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia|A Multicentre, Randomized, Double-blind, Parallel-group, Controlled Study, to Assess the Efficacy and Safety of P-3074 Cutaneous Spray, Solution, in the Treatment of Male Pattern Baldness|Active, not recruiting||Phase 3|450|Anticipated|Polichem S.A.||3|||f||||f||||||||||2017-10-10 21:30:00.47804|2017-10-10 21:30:00.47804
NCT03004456|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-07-21|||May 10, 2017|Actual|2017-05-10|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Distraction for Reduction of Pain Associated With Venipuncture in the Pediatric Post-Transplant Population|Efficacy of Distraction on Reduction of Procedural Pain Associated With Venipuncture in the Pediatric Post-Transplant Population|Recruiting||N/A|42|Anticipated|Columbia University||2|||f||||f|f|f||||||||2017-10-10 21:30:00.648247|2017-10-10 21:30:00.648247
NCT03004443|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-05-25|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Inflammation-Induced CNS Glutamate Changes in Depression|Inflammation-Induced CNS Glutamate Changes in Depression|Recruiting||Phase 4|200|Anticipated|Emory University||2|||f||||t|t|f||||||||2017-10-10 21:30:00.755054|2017-10-10 21:30:00.755054
NCT03004430|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-19|||January 12, 2017|Actual|2017-01-12|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|MAMED||Mantra Meditation in Major Depression|Mantra Meditation as Adjunctive Therapy in Major Depression: a Randomized Controlled Trial|Recruiting||N/A|130|Anticipated|Diakonie Kliniken Zschadraß||2|||f||||f||||||||Undecided||2017-10-10 21:30:00.871249|2017-10-10 21:30:00.871249
NCT03004417|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-27|||October 2016||2016-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD|A Randomised, Double-blind,Placebo Controlled, Repeated Dose, Three-way Crossover Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD|Recruiting||Phase 2|60|Anticipated|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||No|No plan|2017-10-10 21:30:00.964016|2017-10-10 21:30:00.964016
NCT03004404|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-23|2017-08-22|||January 12, 2017|Actual|2017-01-12|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers|A Partially Randomised, Single-blind, Placebo-controlled Trial to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 730357 Administered as Oral Solution and Tablets to Healthy Subjects, and a Randomized, Open-label, Single-dose, Three-way Cross-over Bioavailability Comparison of BI 730357 as Tablet Versus Oral Solution and Tablet With and Without Food|Completed||Phase 1|85|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:30:01.060091|2017-10-10 21:30:01.060091
NCT03004391|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-05-09|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Observational|||Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125|Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125|Recruiting||N/A|40|Anticipated|Vejle Hospital|||1||f||||f||||||||||2017-10-10 21:30:01.135486|2017-10-10 21:30:01.135486
NCT03004378|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-03|||January 2017||2017-01-01|December 2016|2016-12-01|September 2021|Anticipated|2021-09-01|December 2020|Anticipated|2020-12-01||Interventional|||Interventions for Adolescent Obesity|The Role of Activity Tracking on Weight Loss in Obese Adolescents|Not yet recruiting||N/A|80|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||No||2017-10-10 21:30:01.214351|2017-10-10 21:30:01.214351
NCT03004365|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-06-14|||January 27, 2017|Actual|2017-01-27|December 2016|2016-12-01|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29||Interventional|||A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects|A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Adolescent and Adult Dental Subjects|Completed||Phase 2|33|Actual|C3 Jian, LLC||3|||f||||f|t|f||||||||2017-10-10 21:30:01.299661|2017-10-10 21:30:01.299661
NCT03004352|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-22|||April 2015||2015-04-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Disturbed Blood Flow Induces Endothelial Dysfunction in Severe Chronic Obstructive Pulmonary Disease|Disturbed Blood Flow Induces Endothelial Dysfunction in Severe Chronic Obstructive Pulmonary Disease|Completed||N/A|27|Actual|University of Split, School of Medicine||6|||f||||f||||||||No||2017-10-10 21:30:01.407746|2017-10-10 21:30:01.407746
NCT03004339|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-02-28|||August 2016||2016-08-01|February 2017|2017-02-01|February 13, 2017|Actual|2017-02-13|February 13, 2017|Actual|2017-02-13||Interventional|||Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test|A Phase 1 Randomized, Placebo and Active Comparator-controlled Trial, Double-blind for the IPs, Observer-blind for the Active Comparator, to Assess the Potency of SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment in a Psoriasis Plaque Test|Completed||Phase 1|13|Actual|DFB Soria, LLC||6|||f||||f||||||||No||2017-10-10 21:30:01.487317|2017-10-10 21:30:01.487317
NCT03004326|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-02-21|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|CUTIS||Clinical Transcriptomics in Systemic Vasculitis (CUTIS)|Clinical Transcriptomics in Systemic Vasculitis (CUTIS)|Recruiting||N/A|50|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     Blood samples will be collected solely for research purposes. The reason we are performing     these laboratory-based research studies is to help us better understand whether abnormalities     detected in a subjects skin biopsy can also be detected in their blood.   "|||2017-10-10 21:30:01.626394|2017-10-10 21:30:01.626394
NCT03004313|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-12-22|||January 2011||2011-01-01|December 2016|2016-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Structural and Molecular Neuroplasticity in Migraine|Structural and Molecular Neuroplasticity in Migraine|Completed||N/A|32|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 21:30:01.748951|2017-10-10 21:30:01.748951
NCT03004300|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-07-12|||July 13, 2017|Actual|2017-07-13|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Maxillary Expansion Effects in Children With Upper Airway Obstruction|Maxillary Expansion Effects in the Facial Structures of Children With Upper Airway Obstruction: a Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|Universidade Federal de Goias||3|||f||||f|f|f||||||||2017-10-10 21:30:02.036347|2017-10-10 21:30:02.036347
NCT03004287|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-07|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy|2015-12: A Phase II Study Exploring the Use of Early and Late Consolidation/Maintenance With Anti-CD38 (Protein) Monoclonal Antibody to Improve Progression Free Survival in Patients With Newly Diagnosed Multiple Myeloma|Recruiting||Phase 2|50|Anticipated|University of Arkansas||1|||f||||t|t|f|||f|||||2017-10-10 21:30:02.159036|2017-10-10 21:30:02.159036
NCT03004274|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2016-12-27|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Running Versus Interrupted Deep Plane Sutures in Massive Weight Loss Patients|Running Versus Interrupted Deep Plane Sutures in Massive Weight Loss Patients: a Randomized Double Blind Study|Recruiting||N/A|100|Anticipated|St Joseph University, Beirut, Lebanon||2|||f||||||||||||||2017-10-10 21:30:02.307798|2017-10-10 21:30:02.307798
NCT03004261|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-02-24|||November 2016||2016-11-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||CMV-CTL for the Treatment of CMV Infection After HSCT|Cytomegalovirus Specific Cytotoxic T Lymphocyte for the Treatment of Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 4|30|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||No||2017-10-10 21:30:02.433379|2017-10-10 21:30:02.433379
NCT03004248|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-28|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines|An Open-Label, Multi-Center Trial to Assess the Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines (SAKURA OPEN-LABEL SAFETY)|Recruiting||Phase 3|2100|Anticipated|Revance Therapeutics, Inc.||1|||f||||f||||||||No||2017-10-10 21:30:02.566876|2017-10-10 21:30:02.566876
NCT03004235|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-22|||December 2016||2016-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Suspected Cases of Carbon Monoxide Poisoning in the ED|ED Data Collection of Suspected Carbon Monoxide Poisoning|Recruiting||N/A|25|Anticipated|Nonin Medical, Inc|||1||f||||f||||||||No||2017-10-10 21:30:02.718527|2017-10-10 21:30:02.718527
NCT03004222|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-04|||July 2015||2015-07-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine|A Randomized Double Blinded Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine: Does it Reduce Post-operative Opioid Use Following Laparoscopic Appendectomy?|Recruiting||N/A|150|Anticipated|Metro Health, Michigan||2|||f||||f||||||||No||2017-10-10 21:30:02.804596|2017-10-10 21:30:02.804596
NCT03004209|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-28|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients|Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients|Recruiting||Phase 4|10|Anticipated|Seoul National University Hospital||1|||f||||t||||||||No||2017-10-10 21:30:02.901543|2017-10-10 21:30:02.901543
NCT03004183|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-24|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|November 2023|Anticipated|2023-11-01|May 2022|Anticipated|2022-05-01||Interventional|STOMP||SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC|Phase II Window of Opportunity Trial of Stereotactic Body Radiation Therapy and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer and Metastatic Non-Small Cell Lung Cancer Followed by Pembrolizumab|Recruiting||Phase 2|57|Anticipated|The Methodist Hospital System||1|||f||||f|t|f||||||||2017-10-10 21:30:03.103861|2017-10-10 21:30:03.103861
NCT03004170|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-22|||December 2016||2016-12-01|December 2016|2016-12-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Telephone Counseling to Enhance the Quality and Safety of Romantic and Sexual Relationships in People Living and Aging With HIV||Recruiting||Phase 3|336|Anticipated|Oregon Health and Science University||2|||f||||t||||||||Yes|Raw de-identified data will be made publicly available to the scientific community upon request after the trial is complete and data have been published. Data requests should be directed to the study principal investigator.|2017-10-10 21:30:03.216451|2017-10-10 21:30:03.216451
NCT03004157|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-21|||July 2016||2016-07-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Infant Chest Compression|A Randomized Comparison of Three Chest Compression Techniques and Associated Hemodynamic Effect During Infant CPR: a Randomized Manikin Study|Completed||N/A|42|Actual|Medical University of Warsaw||3|||f||||t||||||||Undecided||2017-10-10 21:30:03.338004|2017-10-10 21:30:03.338004
NCT03004144|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-22|||October 2016||2016-10-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|FLOAT-ADL||Impact of Assistive Forces on Activities of Daily Living|Impact of Robotic Assistive Forces on the Performance of Activities of Daily Living|Recruiting||N/A|140|Anticipated|University of Zurich||1|||f||||||||||||||2017-10-10 21:30:03.451292|2017-10-10 21:30:03.451292
NCT03004131|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-05-29|||January 7, 2017|Actual|2017-01-07|May 2017|2017-05-01|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29||Interventional|||MP-AzeFlu Allergen Chamber - Onset of Action Study|Clinical Trial to Assess Onset of Action of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray Delivered in a Single Spray (MP-AzeFlu) in the Treatment of Allergen-Induced Allergic Rhinitis Symptoms in Comparison to Placebo and Free Combination of Fluticasone Propionate Nasal Spray and Oral Loratadine|Completed||Phase 4|82|Actual|MEDA Pharma GmbH & Co. KG||3|||f||||f|f|f||||||||2017-10-10 21:30:03.54956|2017-10-10 21:30:03.54956
NCT03004118|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-21|||January 2017||2017-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia|Therapeutic Effect of Ursodeoxycholic Acid on Duodenal Permeability and Meal Related Sensory Motor Function in Functional Dyspepsia Patients|Not yet recruiting||Phase 4|16|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 21:30:03.676098|2017-10-10 21:30:03.676098
NCT03004105|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-07-10|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)|Phase II Trial of Immunotherapy With Durvalumab (MEDI4736) With Continuous or Intermittent MEK Inhibitor Selumetinib in KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)|Not yet recruiting||Phase 2|76|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:30:03.827865|2017-10-10 21:30:03.827865
NCT03004092|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-01-24|||January 2017||2017-01-01|December 2016|2016-12-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|||Novel Biomarkers for Invasive Aspergillosis|Novel Biomarkers for Invasive Aspergillosis|Recruiting||N/A|226|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-10 21:30:03.959513|2017-10-10 21:30:03.959513
NCT03004079|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-01-06|||October 2016||2016-10-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Clinical Importance of Glucose Regulation in Relapsing MS|Assessment of the Clinical Importance of Insulin Resistance & Steroid-Associated Hyperglycemia in Relapsing Multiple Sclerosis|Recruiting||N/A|160|Anticipated|University of Virginia|||1||f||||f||||||||No||2017-10-10 21:30:04.094601|2017-10-10 21:30:04.094601
NCT03004066|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-02-28|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|||Daptomycin Concentration in Drainage Fluid and Blood Samples of ICU Patients|Daptomycin Concentration in Drainage Fluid and Blood Samples of ICU Patients|Recruiting||N/A|10|Anticipated|University Hospital Tuebingen|||1||f||||f||||||||No||2017-10-10 21:30:04.23508|2017-10-10 21:30:04.23508
NCT03004053|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-20|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In Vivo|Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In Vivo|Recruiting||N/A|20|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 21:30:04.3249|2017-10-10 21:30:04.3249
NCT03004040|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-04|||December 2016||2016-12-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|1 Year|Observational [Patient Registry]|||Protection From Influenza: Determining the Impact of Prior Infection||Recruiting||N/A|50|Anticipated|Health Sciences North Research Institute|||2||f||||f||||||||No||2017-10-10 21:30:04.418384|2017-10-10 21:30:04.418384
NCT03004027|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2016-12-27|||January 2017||2017-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Enhancing Psychological Self-help With Implementation Intentions|Enhancing Psychological Self-help With Implementation Intentions for Those With Visible Skin Difference and Fear of Negative Evaluation|Not yet recruiting||N/A|144|Anticipated|University of Sheffield||3|||f||||f||||||||Undecided|Possibility that data will be used in future research. Individual participant data includes age, gender, description of visible skin difference and scores on the Brief Fear of Negative Evaluation, General Anxiety Disorder 7, Patient Health Questionnaire 9 questionnaires. Data will be obtained with agreement from the primary investigator Jessica Lane (jlane1@sheffield.ac.uk)|2017-10-10 21:30:04.507195|2017-10-10 21:30:04.507195
NCT03004014|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-21|||January 2015||2015-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Natural Sleep and Drug-induced Sleep Endoscopy|Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy Among Obstructive Sleep Apnea Subjects Referred for Surgical Treatment|Recruiting||N/A|28|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Yes||2017-10-10 21:30:04.59349|2017-10-10 21:30:04.59349
NCT03004001|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-03-10|||January 2017||2017-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome|Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome|Recruiting||N/A|20|Anticipated|Dallas VA Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:30:04.70282|2017-10-10 21:30:04.70282
NCT03003988|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-02|||September 2014||2014-09-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NB4||Physiological Effects of Creatine Supplementation in Active Males|Effects of 28 Days of Different Forms of Creatine Supplementation on Muscle Creatine, Body Composition and Exercise Performance in Recreationally Active Males|Completed||N/A|48|Actual|Texas A&M University||3|||f||||t||||||||No||2017-10-10 21:30:04.871595|2017-10-10 21:30:04.871595
NCT03003975|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-05-07|||November 2014||2014-11-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|SD-CRYO-AF||Single Versus Double Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation|Efficacy of Single Versus Double Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation (SD-Cryo-AF): A Randomized Study|Completed||N/A|140|Actual|Uppsala University Hospital||2|||f||||f||||||||No||2017-10-10 21:30:04.987257|2017-10-10 21:30:04.987257
NCT03003962|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-18|||January 2, 2017|Actual|2017-01-02|September 2017|2017-09-01|June 12, 2020|Anticipated|2020-06-12|October 22, 2018|Anticipated|2018-10-22||Interventional|||A Study of Durvalumab Versus Standard of Care in Advanced Non Small-Cell Lung Cancer|A Phase III Randomized, Open-Label, Multi-Center Study of Durvalumab (MEDI4736) Versus Standard of Care (SoC) Platinum-Based Chemotherapy as First Line Treatment in Patients With PD-L1-High Expression Advanced Non Small-Cell Lung Cancer|Recruiting||Phase 3|440|Anticipated|AstraZeneca||2|||f||||t||||||||||2017-10-10 21:30:05.166086|2017-10-10 21:30:05.166086
NCT03003949|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|January 2022|Anticipated|2022-01-01|December 2021|Anticipated|2021-12-01||Interventional|Changes||The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood|The Menopause Transition: Estrogen Variability, HPA Axis and Affective Symptoms|Not yet recruiting||N/A|250|Anticipated|University of North Carolina, Chapel Hill||4|||f||||f||||||||Yes|The investigators will submit data to the Research Domain Criteria Database (RDoCdb) and/or the National Database for Clinical Trials Related to Mental Illness (NDCT). The investigators will work with RDoCdb and NDCT staff to define data structures for any data being collected as part of the study. Descriptive data will be submitted two times per year and provide supporting documentation as necessary for others to more fully understand the manner in which data were collected. The investigators will submit cumulative data each submission cycle and will review data for any personally identifiable information and ensure that data are loaded correctly. The investigators will share data within 4 months after submission and submit experimental data within 12 months after study completion. Study data for each publication will be created and submit a link to the RDoCdb study along with any publications so readers of articles can link back to the data used in RDoCdb and NDCT.|2017-10-10 21:30:05.480172|2017-10-10 21:30:05.480172
NCT03003936|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-05-03|||December 2014||2014-12-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|ONTIME-DINE||Glucose Tolerance, Meal Timing and MTNR1B|Glucose Tolerance, Meal Timing and MTNR1B in a Mediterranean Population|Recruiting||N/A|280|Anticipated|Universidad de Murcia||2|||f||||t||||||||No||2017-10-10 21:30:05.582939|2017-10-10 21:30:05.582939
NCT03003923|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-21|||September 2016||2016-09-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|December 2016|Actual|2016-12-01||Interventional|||Promoting Vegetable Intake in Preschool Aged Children|A Randomised Control Trial of an Educational and Taste-exposure Intervention to Promote Vegetable Intake in Preschool Aged Children|Active, not recruiting||N/A|160|Anticipated|University of Leeds||4|||f||||f||||||||No||2017-10-10 21:30:05.667152|2017-10-10 21:30:05.667152
NCT03003910|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-27|||February 2013||2013-02-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy of a Positive Psychological Intervention in Patients With Eating Disorders|Efficacy of a Positive Psychological Intervention in Patients With Eating Disorders: a Randomized Control Trial|Completed||N/A|54|Actual|Universitat Jaume I||2|||f||||f||||||||Undecided||2017-10-10 21:30:05.758729|2017-10-10 21:30:05.758729
NCT03003897|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-05-26|||January 2016||2016-01-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.|Effects of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Adults With Overweight and Obesity: a Systematic Review and Meta-analysis of Randomized Controlled Trials.|Active, not recruiting||N/A|1000|Anticipated|University of Illinois at Urbana-Champaign|||2||f||||f||||||||No|Individual participant data has been previously published in the randomized controlled trials we intend to analyze.|2017-10-10 21:30:05.868988|2017-10-10 21:30:05.868988
NCT03003884|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-09-06|||November 2016||2016-11-01|December 2016|2016-12-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy||Completed||Phase 2|153|Actual|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||||||||||||2017-10-10 21:30:05.96951|2017-10-10 21:30:05.96951
NCT03003871|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-04-13|||April 2013||2013-04-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Oral Health Promotion Interventions Amongst Stroke Survivors During Rehabilitation|A Randomized Clinical Trial on the Effect of Powered Toothbrushing and an Antimicrobial Mouth Rinse on Dental Plaque, Pathogenic Microorganisms and Health of Stroke Survivors During Rehabilitation.|Completed||N/A|94|Actual|The University of Hong Kong||2|||f||||f||||||||Yes||2017-10-10 21:30:06.056022|2017-10-10 21:30:06.056022
NCT03003858|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-01-09|||November 2016||2016-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Hyaluronic Acid and Gingivitis in Pediatrics|Retrospective Observational Trial on the Role of a Hyaluronic Acid Medical Device in Pediatric Patients Affected by Gingivitis|Completed||N/A|200|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||1||f||||t||||||||Yes||2017-10-10 21:30:06.146102|2017-10-10 21:30:06.146102
NCT03003845|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-21|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|September 1, 2019|Anticipated|2019-09-01|3 Months|Observational [Patient Registry]|S1P1||S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain|Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain : Identification of Potential Relevant Biomarkers|Not yet recruiting||N/A|50|Anticipated|St. Louis University|||1||f||||f||||||Samples With DNA|"     PERIPHERAL BLOOD LEUKOCYTE (PBLS) ANALYSIS (Research Related):      Using immunoblotting, we will determine if the level of S1PR1 expression in peripheral blood     leukocytes (PBLs) is increased in patients with IC pain. Patients will have blood samples     taken, at the visit they sign the consent form 3 and 6 months later. A total of 4 teaspoons     of blood will be taken for the study.   "|||2017-10-10 21:30:06.205555|2017-10-10 21:30:06.205555
NCT03003832|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-29|||December 2016||2016-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Electronic Defaults to Reduce Opioid Prescribing in Emergency Department and Primary Care Settings|A Cluster-randomized Trial of Modifying Electronic Health Record Defaults to Reduce the Prescribed Quantity of Opioid Analgesics in Primary Care and Emergency Department Settings|Active, not recruiting||N/A|15000|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-10-10 21:30:06.397535|2017-10-10 21:30:06.397535
NCT03003819|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2016-12-22|||October 2016||2016-10-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||A Comparison of Two Socket Sealing Collagen Matrices for Extraction Socket Management|A Prospective, Randomized, Controlled, Multi-center Evaluation of Extraction Socket Management Comparing Two Socket Sealing Collagen Matrices|Recruiting||N/A|64|Anticipated|McGuire Institute||2|||f||||f||||||||No||2017-10-10 21:30:06.494146|2017-10-10 21:30:06.494146
NCT03003806|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-09-27|||September 2017|Anticipated|2017-09-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|Advice4U||Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro Study|Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- Open Label, Parallel , Randomized, Controlled Multicenter Study-The Advice4U Pro Study|Not yet recruiting||N/A|112|Anticipated|Rabin Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:30:06.643947|2017-10-10 21:30:06.643947
NCT03003793|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-04|||November 2015||2015-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Observational|AD-IF||Insulin Sensitivity in Patients With Atopic Dermatitis|Insulin Sensitivity in Patients With Atopic Dermatitis|Active, not recruiting||N/A|32|Actual|University Hospital, Gentofte, Copenhagen|||2||f||||f||||||Samples With DNA|"     Whole blood.   "|||2017-10-10 21:30:06.824841|2017-10-10 21:30:06.824841
NCT03003780|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-04-24|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|January 2020|Anticipated|2020-01-01||Interventional|||Mindful Steps: Promoting Physical Activity|Mindful Steps: Coupling Technology and Mind-Body Exercise to Facilitate Physical Activity in Patients With Cardiopulmonary Disease|Not yet recruiting||N/A|42|Anticipated|Beth Israel Deaconess Medical Center||2|||f|||||f|f||||||||2017-10-10 21:30:06.908785|2017-10-10 21:30:06.908785
NCT03003767|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-27|||December 2016||2016-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:30:06.998351|2017-10-10 21:30:06.998351
NCT03003754|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-22|||June 2015||2015-06-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Supervised Exercise-training in Children With Insulin Resistance or Healthy Metabolic Profile|Supervised Exercise-training in Children With Insulin Resistance or Healthy Metabolic Profile: Cardiometabolic Risk Factors and Muscular Strength Changes in Responders and Non Responders|Recruiting||N/A|60|Anticipated|Universidad Santo Tomas||2|||f||||t||||||||No||2017-10-10 21:30:07.054193|2017-10-10 21:30:07.054193
NCT03003741|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-27|||May 2015||2015-05-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Postoperative Pain Control After Enucleation or Evisceration|Postoperative Pain Control After Enucleation or Evisceration, a Double-Masked Randomized Controlled Trial of Standard Versus Slow-release Bupivacaine|Enrolling by invitation||N/A|88|Anticipated|University of Michigan||2|||f||||f||||||||Undecided||2017-10-10 21:30:07.16758|2017-10-10 21:30:07.16758
NCT03003728|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)|2015-10: A Phase II Pilot Study of Expanded Natural Killer Cells and Elotuzumab to Eradicate High-Risk Myeloma Post Autologous Stem Cell Transplant|Not yet recruiting||Phase 2|10|Anticipated|University of Arkansas||1|||f||||f|t|f||||||||2017-10-10 21:30:07.272041|2017-10-10 21:30:07.272041
NCT03003715|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-27|||September 2011||2011-09-01|December 2016|2016-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain|Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain|Completed||N/A|13|Actual|University of Michigan||2|||f||||t||||||||||2017-10-10 21:30:07.3754|2017-10-10 21:30:07.3754
NCT03003702|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-22|||September 2016||2016-09-01|July 2016|2016-07-01||||March 2018|Anticipated|2018-03-01||Interventional|||Domiciliary Monitoring to Predict Exacerbations of COPD|Domiciliary Monitoring to Predict Exacerbations of COPD|Recruiting||N/A|64|Anticipated|University College, London||2|||f||||||||||||||2017-10-10 21:30:07.474046|2017-10-10 21:30:07.474046
NCT03003689|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-05-08|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Scaling and Root Planing With and Without Er:YAG Laser in Chronic Periodontitis Patients|Randomized Clinical Trial Assessing the Clinical Outcomes and Recolonization Patterns Following Scaling and Root Planing With and Without Using Er.YAG Laser in Chronic Periodontitis Patients|Recruiting||N/A|56|Anticipated|Tufts University School of Dental Medicine||2|||f||||f|f|t|f|f||||No||2017-10-10 21:30:07.557753|2017-10-10 21:30:07.557753
NCT03003676|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-09|||December 2016||2016-12-01|August 2017|2017-08-01||||July 2018|Anticipated|2018-07-01||Interventional|||A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade|A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After PD1 Blockade|Recruiting||Phase 1|12|Anticipated|Targovax ASA||1|||f||||||||||||||2017-10-10 21:30:07.659204|2017-10-10 21:30:07.659204
NCT03003663|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-06-21|||March 2016||2016-03-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Interrupted Time-Series Study for In-hospital Fall Reduction|Interrupted Time-Series Study for In-hospital Fall Reduction|Completed||Phase 2|658|Actual|MedicusTek, Inc||1|||f||||f||||||||||2017-10-10 21:30:07.770503|2017-10-10 21:30:07.770503
NCT03003650|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-21|||September 2011||2011-09-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|July 2013|Actual|2013-07-01||Interventional|||ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2011-03)|ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis|Active, not recruiting||Phase 2|89|Actual|Symetis SA||1|||f||||t||||||||||2017-10-10 21:30:07.84952|2017-10-10 21:30:07.84952
NCT03003637|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-07-17|||February 28, 2017|Actual|2017-02-28|July 2017|2017-07-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|IMCISION||ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma|ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced Or Recurrent Head and Neck Carcinoma. Subtitle: Hypoxia as a Determinant for the Effect of Nivolumab With or Without Ipilimumab on Intra-tumoral T Cell Capacity|Recruiting||Phase 1/Phase 2|32|Anticipated|The Netherlands Cancer Institute||1|||f||||t|f|f||||||||2017-10-10 21:30:07.953348|2017-10-10 21:30:07.953348
NCT03003624|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-21|||March 2015||2015-03-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Comparing the Outcomes of Incisions Made by Colorado® Microdissection Needle|Comparing the Outcomes Of Incisions Made By Colorado® Microdissection Needle, Electrosurgery Tip And Surgical Blade During Periodontal Surgery|Completed||Phase 3|30|Actual|SVS Institute of Dental Sciences||3|||f||||t||||||||No|Publication data will be shared|2017-10-10 21:30:08.053526|2017-10-10 21:30:08.053526
NCT03003611|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-12-21|||April 2014||2014-04-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer|Observational Study on the Impact of Hypnose Used as Sedation in the Oncology Surgery in Breast Cancer|Completed||N/A|150|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||2||f||||t||||||||||2017-10-10 21:30:08.14067|2017-10-10 21:30:08.14067
NCT03003598|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-04|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|January 2017|Actual|2017-01-01||Interventional|||The Effects of Intubation Via McGrath Videolaryngoscope on Intraocular Pressure|The Effects of Endotracheal Intubation Via McGrath Videolaryngoscope on Intraocular Pressure|Completed||N/A|50|Actual|Inonu University||2|||f||||f||||||||Undecided||2017-10-10 21:30:08.217094|2017-10-10 21:30:08.217094
NCT03003585|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-04-04|||December 2016||2016-12-01|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|February 2017|Actual|2017-02-01||Interventional|||Effects of Direct Laryngoscopic and Fiberoptic Intubation on Intraocular Pressure|Comparison of Effects of Direct Laryngoscopic and Fiberoptic Oral Endotracheal Intubation on Intraocular Pressure|Completed||N/A|54|Actual|Inonu University||2|||f||||f||||||||||2017-10-10 21:30:08.303965|2017-10-10 21:30:08.303965
NCT03003572|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-09-08|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Observational|I GET DRY||Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity|Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity|Recruiting||N/A|145|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f|f|f||||Samples Without DNA|"     Blood samples   "|||2017-10-10 21:30:08.386265|2017-10-10 21:30:08.386265
NCT03003559|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-27|||January 2017||2017-01-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||HFNC vs Nasal Cannula in Mild Chronic Obstructive Pulmonary Disease Exacerbation|Comparison of High Flow Nasal Cannula vs Nasal Cannula in Mild Chronic Obstructive Pulmonary Disease Exacerbation(AECOPD)|Not yet recruiting||N/A|328|Anticipated|China-Japan Friendship Hospital||2|||f||||f||||||||No||2017-10-10 21:30:08.514|2017-10-10 21:30:08.514
NCT03003546|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-06-27|||August 2017|Anticipated|2017-08-01|December 2016|2016-12-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma|A Phase I Trial of AR160 (Abraxane/Rituximab 160nm Nanoparticle) in Relapsed/Refractory B Cell Lymphomas Including Transformed Follicular Lymphoma|Not yet recruiting||Phase 1|18|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:30:08.584973|2017-10-10 21:30:08.584973
NCT03003533|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-10-03|||December 2016||2016-12-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||A Gene Transfer Study for Hemophilia A|Gene Transfer, Dose-Finding Safety, Tolerability, and Efficacy Study of SPK-8011 [a Recombinant Adeno-Associated Viral Vector With Human Factor VIII Gene] in Individuals With Hemophilia A|Recruiting||Phase 1/Phase 2|30|Anticipated|Spark Therapeutics||1|||f||||t||f||||||||2017-10-10 21:30:08.676842|2017-10-10 21:30:08.676842
NCT03003338|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-12-21|||May 2016||2016-05-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV|A Monocenter Randomized Double-blind Placebo-controlled Study to Investigate Neuropsychiatric Manifestations of HCV-infection During and After Treatment With Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir|Recruiting||Phase 4|30|Anticipated|Hannover Medical School||2|||f||||f||||||||||2017-10-10 21:30:11.933588|2017-10-10 21:30:11.933588
NCT03003520|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-10-02|||February 28, 2017|Actual|2017-02-28|October 2017|2017-10-01|July 1, 2024|Anticipated|2024-07-01|June 22, 2021|Anticipated|2021-06-22||Interventional|||A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma|A PHASE 2, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE SAFETY AND CLINICAL ACTIVITY OF DURVALUMAB IN COMBINATION WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE (R-CHOP) OR WITH LENALIDOMIDE PLUS R CHOP (R2 CHOP) IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH RISK DIFFUSE LARGE B CELL LYMPHOMA|Recruiting||Phase 2|120|Anticipated|Celgene||2|||f||||t|t|f||||||||2017-10-10 21:30:08.805514|2017-10-10 21:30:08.805514
NCT03003507|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2016-12-27|||October 2009||2009-10-01|December 2016|2016-12-01|April 2013|Actual|2013-04-01|April 2011|Actual|2011-04-01||Interventional|||Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients|Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients: A Cross-over Randomized Clinical Trial|Completed||Phase 4|25|Actual|Hospital Moinhos de Vento||2|||f||||f||||||||No||2017-10-10 21:30:08.994046|2017-10-10 21:30:08.994046
NCT03003494|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-08-08|||June 6, 2017|Actual|2017-06-06|August 2017|2017-08-01|June 18, 2018|Anticipated|2018-06-18|June 18, 2018|Anticipated|2018-06-18||Observational|OTIVACTO||Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy|Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy|Recruiting||N/A|400|Anticipated|Boehringer Ingelheim|||1||f|||||t|f|||f|||||2017-10-10 21:30:09.087271|2017-10-10 21:30:09.087271
NCT03003481|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-12-21|||October 2016||2016-10-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01|6 Months|Observational [Patient Registry]|||Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device||Recruiting||N/A|500|Anticipated|Occlutech International AB|||1||f||||f||||||||||2017-10-10 21:30:09.228201|2017-10-10 21:30:09.228201
NCT03003468|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-08-17|||December 2016||2016-12-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017|A Phase Ib/II Study of Anti-PD-1 Antibody Pembrolizumab and Imprime PGG for Patients With Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017|Recruiting||Phase 1/Phase 2|36|Anticipated|Big Ten Cancer Research Consortium||1|||f||||t||||||||||2017-10-10 21:30:09.314736|2017-10-10 21:30:09.314736
NCT03003455|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-21|||March 2012||2012-03-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Nasotracheal Intubation Over a Bougie|Nasotracheal Intubation Over a Bougie Placed Via a Subsequently Removed Nasal Trumpet|Completed||N/A|257|Actual|University of Iowa||2|||f||||f||||||||No||2017-10-10 21:30:09.435515|2017-10-10 21:30:09.435515
NCT03003442|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-21|||November 2016||2016-11-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Supradyn® Energy 3RDA on Fatigue/Stress, Substrate Metabolism During Exercise and Demanding Cognitive Tasks|Investigation of the Acute and Chronic Effects of Supradyn® Energy 3RDA on Ratings of 'Fatigue/Stress', Substrate Metabolism and Blood Biomarkers of Recovery, as a Consequence of Exercise and Metabolically Demanding Cognitive Tasks|Recruiting||Phase 4|95|Anticipated|Northumbria University||2|||f||||f||||||||No||2017-10-10 21:30:09.526023|2017-10-10 21:30:09.526023
NCT03003429|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-03-07|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|VARIASTRESS||Correlation Study Between Heart Rate Variability and Anxiety in Anorexia Nervosa|Correlation Study Between Heart Rate Variability and Anxiety in Anorexia Nervosa|Recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:30:09.617105|2017-10-10 21:30:09.617105
NCT03003416|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-07-20|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|April 15, 2020|Anticipated|2020-04-15|April 15, 2020|Anticipated|2020-04-15||Observational|Louvre 3||Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)|Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)|Not yet recruiting||N/A|260|Anticipated|Allergan|||1||f||||f||||||||||2017-10-10 21:30:09.695606|2017-10-10 21:30:09.695606
NCT03003403|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-04-13|||January 2017||2017-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care|Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care|Recruiting||N/A|442|Anticipated|Duke University||2|||f||||t||||||||No||2017-10-10 21:30:09.826481|2017-10-10 21:30:09.826481
NCT03003377|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-12-28|||November 2014||2014-11-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Sevoflurane-remifentanil EC50 (The 50% Effective Concentration) Values for LMA-Supreme Versus LMA ProSeal Insertion|Comparison of the Sevoflurane EC50 Values for Laryngeal Mask Airway Supreme Versus Laryngeal Mask Airway ProSeal Insertion During Target-controlled Infusion of Remifentanil. A Randomized Trial|Completed||Phase 4|45|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||t||||||||Undecided||2017-10-10 21:30:11.669265|2017-10-10 21:30:11.669265
NCT03003364|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-04|||December 27, 2016|Actual|2016-12-27|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury|A Phase I/IIa, Randomized, Double-blind, Single-dose, Placebo Controlled, Two-way Crossover Clinical Trial to Assess the Safety and to Obtain Efficacy Data in Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury|Active, not recruiting||Phase 1/Phase 2|10|Anticipated|Banc de Sang i Teixits||2|||f||||f||||||||No||2017-10-10 21:30:11.742677|2017-10-10 21:30:11.742677
NCT03003351|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Zurich Fistula Cohort Study|Assessment of the Natural History and Treatment Outcomes for Patients With Fistula - a Pro- and Retrospective Cohort Study|Not yet recruiting||N/A|100|Anticipated|University of Zurich|||2||f||||||||||||No||2017-10-10 21:30:11.835164|2017-10-10 21:30:11.835164
NCT03003325|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-08-09|||February 2, 2017|Actual|2017-02-02|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Low-PV||The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV|The Benefit/Risk Profile of Pegylated Proline-Interferon Alpha-2b (AOP2014) Added to the Best Available Strategy Based on Phlebotomies in Low-risk Patients With Polycythemia Vera (PV). The Low-PV Randomized Trial|Recruiting||Phase 2|150|Anticipated|Fondazione per la Ricerca Ospedale Maggiore||2|||f||||t|f|f||||||||2017-10-10 21:30:12.062534|2017-10-10 21:30:12.062534
NCT03003312|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-12-21|||July 2016||2016-07-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Prevalence of Pediatric Urolithiasis in Kashgar Area of Xinjiang in China|Prevalence of Pediatric Urolithiasis in Kashgar Area of Xinjiang in China: a Population and Ultrasonography Based Cross-sectional Study|Recruiting||N/A|4751|Anticipated|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||f||||||Samples With DNA|"     A blood sample of each child will be preserved in a -80℃refrigerator for further analysis of     etiology of urolithiasis which include genetics.   "|Undecided||2017-10-10 21:30:12.276032|2017-10-10 21:30:12.276032
NCT03003299|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-24|||January 5, 2017|Actual|2017-01-05|July 2017|2017-07-01|March 5, 2027|Anticipated|2027-03-05|October 5, 2018|Anticipated|2018-10-05||Interventional|P3-AVIV||The PARTNER 3 - AVIV Trial|P3-AVIV is a Prospective, Single-arm, Multicenter Clinical Trial That Will Establish the Safety and Efficacy of SAPIEN 3 THV in Patients With a Failing Aortic Bioprosthetic Valve|Recruiting||Phase 3|125|Anticipated|Edwards Lifesciences||2|||f||||t|f|t|f|f||||||2017-10-10 21:30:12.459554|2017-10-10 21:30:12.459554
NCT03003286|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-21|||November 2013||2013-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Community Based Intervention for Children With ADHD and ASD|Community Based Intervention for Children With ADHD and ASD|Active, not recruiting||N/A|110|Actual|Children's Research Institute||2|||f||||f||||||||No||2017-10-10 21:30:12.741472|2017-10-10 21:30:12.741472
NCT03003273|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-27|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DALFEN||Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study|Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: a Randomized Controlled Study -DALFEN Study|Not yet recruiting||Phase 3|142|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||||||||||||2017-10-10 21:30:12.843142|2017-10-10 21:30:12.843142
NCT03003260|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effect of CanChew® Cannabidiol (CBD) Containing Chewing Gum on Irritable Bowel Syndrome|A Randomized, Double-blind, Cross-over Trial of the Effect of CanChew® Cannabidiol (CBD) Containing Chewing Gum on Patients With Irritable Bowel Syndrome|Enrolling by invitation||N/A|40|Anticipated|Wageningen University||2|||f||||f||||||||No||2017-10-10 21:30:12.92749|2017-10-10 21:30:12.92749
NCT03003247|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-07-24|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|September 30, 2016|Actual|2016-09-30|August 31, 2016|Actual|2016-08-31||Interventional|||Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris|A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris|Completed||Phase 2|364|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-10-10 21:30:13.005721|2017-10-10 21:30:13.005721
NCT03003234|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-23|||March 2015||2015-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Association Between Luminal Bile Salt Content and Duodenal Mucosal Integrity in Functional Dyspepsia|Association Between Luminal Bile Salt Content and Duodenal Mucosal Integrity in Functional Dyspepsia|Completed||N/A|50|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||No||2017-10-10 21:30:13.148238|2017-10-10 21:30:13.148238
NCT03003221|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Improving Dental Care and Oral Health in Children With Autism Spectrum Disorder|Improving Dental Care and Oral Health in Children With Autism Spectrum Disorder|Recruiting||N/A|85|Anticipated|University of California, Irvine||2|||f||||f||||||||No|No plan to share IPD data beyond collaborating sites (MGH and NCH).|2017-10-10 21:30:13.240778|2017-10-10 21:30:13.240778
NCT03003208|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-20|||January 2017||2017-01-01|December 2016|2016-12-01||||May 2019|Anticipated|2019-05-01||Interventional|||Pulmonary Rehabilitation and Cardiovascular Risk in COPD|Pulmonary Rehabilitation and Cardiovascular Risk in COPD|Not yet recruiting||N/A|95|Anticipated|University College, London||1|||f||||||||||||||2017-10-10 21:30:13.342742|2017-10-10 21:30:13.342742
NCT03003195|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-18|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Vaccination of Patients With Metastatic Cancer|The P10s Basket Trial of A Carbohydrate Mimotope-Based Vaccine With MONTANIDE™ ISA 51 VG Combined With Standard Treatment for Metastatic Cancer|Not yet recruiting||Phase 2|80|Anticipated|University of Arkansas||1|||f||||t|t|f||||||||2017-10-10 21:30:13.410427|2017-10-10 21:30:13.410427
NCT03003182|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-06-13|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Observational|||A Study of Nasopharyngeal Carcinoma From Guangdong|A Prospective Cohort Study of Nasopharyngeal Carcinoma to Establish Prognostic Models, to Discover Toxicity Associated Predictors and to Validate Randomized Trials in Clinical Practice|Recruiting||N/A|2000|Anticipated|Sun Yat-sen University|||2||f||||t||||||||No||2017-10-10 21:30:13.476236|2017-10-10 21:30:13.476236
NCT03003169|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-06|||April 8, 2016|Actual|2016-04-08|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|MASTAMBU||Mastectomy in Ambulatory Breast Surgery|Mastectomy in Ambulatory Breast Surgery|Recruiting||N/A|550|Anticipated|Institut de Cancérologie de Lorraine|||1||f||||f||||||||No||2017-10-10 21:30:13.543465|2017-10-10 21:30:13.543465
NCT03003156|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-05-03|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia|50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia|Completed||N/A|18|Actual|Shanghai Mental Health Center||2|||f||||t||||||||No|No plan to share IPD data|2017-10-10 21:30:13.618904|2017-10-10 21:30:13.618904
NCT03003130|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-02|||January 16, 2017|Actual|2017-01-16|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|July 2017|Anticipated|2017-07-01||Interventional|||Restylane Defyne Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds|A Randomized, Multi-center, Evaluator-blinded Study to Evaluate the Efficacy and Safety of Restylane Defyne Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds|Recruiting||N/A|175|Anticipated|Q-Med AB||2|||f||||f||||||||No||2017-10-10 21:30:13.881766|2017-10-10 21:30:13.881766
NCT03003117|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-05-05|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|July 2022|Anticipated|2022-07-01|December 2020|Anticipated|2020-12-01||Interventional|ECAIL||The prEgnanCy and eArly Childhood nutrItion triaL (ECAIL)|Effectiveness of an Early Intervention Aiming at Promoting Healthy Diet and Growth of Children Living in Situation of Social Disadvantage : the prEgnanCy and eArly Childhood nutrItion triaL (ECAIL)|Recruiting||N/A|800|Anticipated|French Red Cross||2|||f||||f|f|f||||||No||2017-10-10 21:30:13.972007|2017-10-10 21:30:13.972007
NCT03003104|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-06-07|||January 2017||2017-01-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||DMT210 Topical Gel in the Treatment of Acne Rosacea|A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of DMT210 Gel In Adult Patients With Moderate To Severe Acne Rosacea|Active, not recruiting||Phase 2|104|Anticipated|Dermata Therapeutics||2|||f||||f||||||||No||2017-10-10 21:30:14.101132|2017-10-10 21:30:14.101132
NCT03003091|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-08|||April 2016||2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Needs-Based Patient Education Versus Traditional Patient Education in Reducing Pre-operative Anxiety in Day Surgery||Completed||N/A|470|Actual|Chulabhorn Hospital||2|||f||||||||||||||2017-10-10 21:30:14.212292|2017-10-10 21:30:14.212292
NCT03003078|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-01|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|PanCO||A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane|An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies|Recruiting||N/A|20|Anticipated|OncoSil Medical Limited||1|||f||||t|f|f||||||||2017-10-10 21:30:14.293939|2017-10-10 21:30:14.293939
NCT03003065|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-04-20|||January 2014||2014-01-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|PDT||Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers|Safety and Tumoricidal Effect of Low Dose Temoporfin Photodynamic Therapy in Patients With Inoperable Bile Duct Cancers (Foscan® Study)|Recruiting||Phase 2|10|Anticipated|Chinese University of Hong Kong||1|||f||||t||||||||No||2017-10-10 21:30:14.503888|2017-10-10 21:30:14.503888
NCT03003052|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-28|||January 2017||2017-01-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01|4 Years|Observational [Patient Registry]|||Assessing Current Clinical Concepts in Dental Practice|Assessing Current Clinical Concepts in Dental Practice|Recruiting||N/A|300|Anticipated|The Campbell Clinic, UK|||1||f||||f||||||||||2017-10-10 21:30:14.615491|2017-10-10 21:30:14.615491
NCT03003039|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-23|||October 2016||2016-10-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|||A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma||Recruiting||Phase 1|80|Anticipated|Nanjing Yoko Biomedical Co., Ltd.||2|||f||||||||||||||2017-10-10 21:30:14.697963|2017-10-10 21:30:14.697963
NCT03003026|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2017-08-07|||December 2016||2016-12-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CPBIKERCT||Bike Skills Training for Children With Cerebral Palsy|Bike Skills Training for Children With Cerebral Palsy: a Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Murdoch Childrens Research Institute||2|||f||||f||||||||||2017-10-10 21:30:14.801571|2017-10-10 21:30:14.801571
NCT03003013|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-14|||November 2016||2016-11-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Biphasic Bone Graft Material With Autologous Platelet-rich Fibrin on Bone Regeneration in a Maxillary Cyst|Effect of Biphasic Bone Graft Material (BGM) in Combination With Autologous Platelet-rich Fibrin (PRF) on Bone Regeneration in an Odontogenic Maxillary Cyst: a Randomized Clinical Trial|Recruiting||Phase 4|28|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:30:14.90404|2017-10-10 21:30:14.90404
NCT03003000|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-09-04|||December 20, 2016|Actual|2016-12-20|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 24, 2017|Anticipated|2017-09-24||Interventional|||Ibuprofen/Caffeine Lower Back or Neck Pain Study|A Randomized, Placebo- and Active-controlled Multi-country, Multi-centre Parallel Group Study to Evaluate the Efficacy and Safety of a Fixed Dose Combination of 400 mg Ibuprofen and 100 mg Caffeine Compared to Ibuprofen 400 mg and Placebo in Patients With Acute Lower Back or Neck Pain.|Recruiting||Phase 3|650|Anticipated|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 21:30:15.000749|2017-10-10 21:30:15.000749
NCT03002987|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-21|||August 2017||2017-08-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|AGp||Active Pregnancy Policy at Work. Greater Wellbeing and Lower Sickness Absence|Active Pregnancy Policy at Work. Greater Wellbeing and Lower Sickness Absence|Not yet recruiting||N/A|600|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:30:15.130391|2017-10-10 21:30:15.130391
NCT03002974|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-07|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2017|Anticipated|2017-08-01||Interventional|anaGO||A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis|A Randomized, Double-blind, Active-control, Multicenter, Efficacy and Safety Study of 2 Dose Levels of Subcutaneous Anakinra Compared to Intramuscular Triamcinolone in the Treatment of Acute Gouty Arthritis, Followed by a One-year Extension|Recruiting||Phase 2|159|Anticipated|Swedish Orphan Biovitrum||3|||f||||f||||||||||2017-10-10 21:30:15.216154|2017-10-10 21:30:15.216154
NCT03002961|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-23|||July 2012||2012-07-01|December 2016|2016-12-01|October 2013|Actual|2013-10-01|February 2013|Actual|2013-02-01||Interventional|SAD||Single Ascending Dose Study of RBP-6000|A Multicenter, Open-Label, Single Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Depot Buprenorphine (RBP-6000) in Opioid-Dependent Subjects|Completed||Phase 1|48|Actual|Indivior Inc.||4|||f||||f||||||||||2017-10-10 21:30:15.443799|2017-10-10 21:30:15.443799
NCT03002948|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-12-21|||April 2016||2016-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|ECTO||Effect of Clitoris Location on Orgasm|Effect of Clitoris Topography on Orgasm|Enrolling by invitation||N/A|42|Anticipated|Bezmialem Vakif University|||1||f||||f||||||||No||2017-10-10 21:30:15.522834|2017-10-10 21:30:15.522834
NCT03002935|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-04-04|||January 2017||2017-01-01|January 2017|2017-01-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||A Safety Study of Orally Administered BPM31510 in Healthy Subjects|A Phase I Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Orally Administered BPM31510 in Healthy Subjects|Completed||Phase 1|25|Actual|Berg, LLC||1|||f||||f||||||||No||2017-10-10 21:30:15.586822|2017-10-10 21:30:15.586822
NCT03002922|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-05-16|||January 18, 2017|Actual|2017-01-18|May 2017|2017-05-01|January 28, 2017|Actual|2017-01-28|January 28, 2017|Actual|2017-01-28||Interventional|||Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)|Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating|Completed||N/A|17|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 21:30:15.670814|2017-10-10 21:30:15.670814
NCT03002909|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-12|||January 2017||2017-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|July 2017|Actual|2017-07-01||Interventional|||Continuous Pre-peritoneal Wound Infiltration Versus Epidural Analgesia in Cancer Surgery|Effect of Continuous Pre-peritoneal Wound Infiltration Versus Epidural Analgesia on Inflammatory Response in Lower Abdominal Cancer Surgery|Active, not recruiting||N/A|40|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 21:30:15.738467|2017-10-10 21:30:15.738467
NCT03002896|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-08-29|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Mobilized Psychoeducation and Skills Based Intervention (Pep-Pal) for Caregivers of Patients With Advanced Illness|A Randomized Controlled Trial of Mobilized Psychoeducation and Skills Based Intervention (Pep-Pal) for Caregivers of Patients With Advanced Illness|Recruiting||N/A|200|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 21:30:15.819971|2017-10-10 21:30:15.819971
NCT03002883|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-03-29|||September 2014||2014-09-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||STAND Community College Tobacco Cessation Trial|Sacramento Taking Action Against Nicotine Dependence (STAND) at Sacramento City College|Completed||N/A|113|Actual|University of California, Davis||3|||f||||f||||||||No||2017-10-10 21:30:15.920189|2017-10-10 21:30:15.920189
NCT03002870|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-08-22|||September 2016||2016-09-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|20900||Characteristics of Patient Population With Endometriosis|Characteristics of Patient Population With Endometriosis - A Prospective Database and BioBank|Enrolling by invitation||N/A|2000|Anticipated|St. Louis University||1|||f||||f||||||||||2017-10-10 21:30:15.992518|2017-10-10 21:30:15.992518
NCT03002857|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-05-06|||September 2015||2015-09-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|BCIM||Comparison of I-gel LMA, Classical LMA With a New Supraglottic Airway the Baska Mask® in Urological Surgery|Comparison of I-gel LMA, Classical LMA With a New Supraglottic Airway the Baska Mask®in Urological Surgery Regarding Their Efficacy and Safety|Completed||N/A|150|Actual|Adiyaman University Research Hospital||3|||f||||f||||||||No||2017-10-10 21:30:16.059806|2017-10-10 21:30:16.059806
NCT03002844|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-25|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|||EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism|EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism|Not yet recruiting||Phase 2|50|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||t||||||||No||2017-10-10 21:30:16.13539|2017-10-10 21:30:16.13539
NCT03002831|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-23|||November 2016||2016-11-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer|Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer: A Prospective, Randomized, Open, Single Center Phase II Study|Recruiting||Phase 2|60|Anticipated|Henan Cancer Hospital||2|||f||||f||||||||No||2017-10-10 21:30:16.349744|2017-10-10 21:30:16.349744
NCT03002818|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-07-07|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|HEMATITE||Quality of Life Measurement in Treatment Naïve Patients With HCV Genotype 1 Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)|Quality of Life Measurement Using Wrist Actigraphy in HCV Genotype 1 Infected, Treatment naïve Patients Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir Tablets and Dasabuvir Tablets (Viekirax®/Exviera®; 3D Regimen): The HEMATITE Study|Recruiting||N/A|100|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:30:16.443003|2017-10-10 21:30:16.443003
NCT03002805|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-07-14|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin|A Phase I Trial of CBT-1® in Combination With Doxorubicin in Patients With Locally Advanced or Metastatic, Unresectable Sarcomas Previously to Have Progressed on 150 mg/m2 or Less of Doxorubicin|Not yet recruiting||Phase 1|46|Anticipated|CBA Research||1|||f|||||t|f||||||||2017-10-10 21:30:16.53595|2017-10-10 21:30:16.53595
NCT03002792|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|||Neurodevelopment Outcomes After Pediatric Dental Caries Treatment Under General Anaesthesia|Neurodevelopment Outcomes After Pediatric Dental Caries Treatment Under General Anaesthesia|Not yet recruiting||N/A|360|Anticipated|Fourth Military Medical University|||2||f||||t||||||||Undecided||2017-10-10 21:30:16.609061|2017-10-10 21:30:16.609061
NCT03002779|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-29|||January 26, 2017|Actual|2017-01-26|May 2017|2017-05-01|March 20, 2017|Actual|2017-03-20|March 10, 2017|Actual|2017-03-10||Interventional|||A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male Participants|A Phase 1, Open Label Study to Characterize the Absorption, Metabolism and Excretion of 14C-JNJ-53718678 After a Single Dose in Healthy Adult Male Subjects|Completed||Phase 1|6|Actual|Janssen Research & Development, LLC||1|||f||||f|f|f|||f|||||2017-10-10 21:30:16.727324|2017-10-10 21:30:16.727324
NCT03002766|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-21|||March 2000||2000-03-01|December 2016|2016-12-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|DCIS||Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast|Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast.|Completed||Phase 2|224|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-10 21:30:16.799578|2017-10-10 21:30:16.799578
NCT03002753|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-27|||December 2016||2016-12-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||Dealing With Intrusive Thoughts in OCD - a Comparison of Detached Mindfulness and Cognitive Restructuring|Zum Umgang Mit Aufdringlichen Gedanken Bei Der Zwangsstörung - Zwei Behandlungsstrategien im Vergleich|Recruiting||N/A|60|Anticipated|Christoph-Dornier-Stiftung für Klinische Psychologie||3|||f||||||||||||||2017-10-10 21:30:16.88604|2017-10-10 21:30:16.88604
NCT03002740|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-06|||January 31, 2016|Actual|2016-01-31|June 2017|2017-06-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation|Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation (Heart-BEAT): A Cohort Study Based on CPRD-HES Data|Active, not recruiting||N/A|21300|Anticipated|Bristol-Myers Squibb|||4||f||||f||||||||||2017-10-10 21:30:16.993042|2017-10-10 21:30:16.993042
NCT03002727|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-03-27|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Role of CD133 & Microsatellite Status in Evaluation of Rectosigmoid Cancer Young Adults Received Neoadjuvant Treatment|Role of CD133 and Microsatellite Status in Evaluation of Young Adults With Rectosigmoid Cancer Received Neoadjuvant Treatment|Recruiting||N/A|30|Anticipated|Assiut University|||1||f||||f||||||Samples With DNA|"     Paraffin blocks of colonoscopic biobsy before neoadjuvant concurrent chemoradiotherapy and     the blocks of surgery at the end of treatment regemin.   "|No||2017-10-10 21:30:17.066963|2017-10-10 21:30:17.066963
NCT03002714|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-21|||October 2014||2014-10-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Blood Pressure Reactivity After Resistance Exercise in Older Women|BLOOD PRESSURE REACTIVITY TO MENTAL STRESS IS ATTENUATED FOLLOWING RESISTANCE EXERCISE IN ELDERLY HYPERTENSIVE WOMEN|Completed||N/A|10|Actual|University of Brasilia||1|||f||||f||||||||No||2017-10-10 21:30:17.150666|2017-10-10 21:30:17.150666
NCT03002701|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-04-13|||December 31, 2016|Actual|2016-12-31|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|UNDERPIN-ICU||The Impact of Nursing Delirium Preventive Interventions in the Intensive Care Unit|The Impact of nUrsiNg DEliRium Preventive INterventions in the Intensive Care Unit (UNDERPIN-ICU): A Multi-centre, Stepped Wedge Randomized Controlled Trial|Recruiting||N/A|1750|Anticipated|Radboud University||2|||f||||f||||||||Undecided||2017-10-10 21:30:17.212291|2017-10-10 21:30:17.212291
NCT03002688|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-05-31|||December 2016||2016-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||OSUWMC EEI Sequential Cataract Patient Experience Project|OSUWMC EEI Sequential Cataract Patient Experience Project|Recruiting||N/A|250|Anticipated|Ohio State University|||1||f||||f||||||||No||2017-10-10 21:30:17.359172|2017-10-10 21:30:17.359172
NCT03002675|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-21|||August 2016||2016-08-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Interventional|exe01||Exenatide and Brown Adipose Tissue|The Effect of Exenatide on Brown Adipose Tissue Activity and Energy Expenditure in Healthy Young Men|Recruiting||Phase 4|24|Anticipated|Leiden University Medical Center||1|||f||||t||||||||||2017-10-10 21:30:17.439847|2017-10-10 21:30:17.439847
NCT03002662|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-08-28|||December 2016||2016-12-01|May 2017|2017-05-01|September 15, 2017|Anticipated|2017-09-15|September 1, 2017|Anticipated|2017-09-01||Observational|||Cecal Intubation Time in Colonoscopy: Prospective Clinical Trial||Recruiting||N/A|1000|Anticipated|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital|||4||f||||||||||||||2017-10-10 21:30:17.552841|2017-10-10 21:30:17.552841
NCT03002649|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-01-25|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|STIR||Study of Tofacitinib in Refractory Dermatomyositis|Study of Tofacitinib in Refractory Dermatomyositis (STIR): Proof of Concept, Open-Label Study of 10 Patients|Recruiting||Phase 1|10|Anticipated|Johns Hopkins University||1|||f||||f||||||||No||2017-10-10 21:30:17.65565|2017-10-10 21:30:17.65565
NCT03002636|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-21|||January 2013||2013-01-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|January 2016|Actual|2016-01-01||Interventional|||Safety and Risk Assessment of Obese Parturient Underwent Cesarean Section(CS) Delivery Under Different Anesthesia Ways|Safety and Risk Assessment of Obese Parturient Underwent Cesarean Section(CS) Delivery Under General Anesthesia or Intraspinal Anesthesia|Completed||N/A|900|Actual|Fudan University||3|||f||||t||||||||No||2017-10-10 21:30:17.777193|2017-10-10 21:30:17.777193
NCT03002623|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-22|2017-06-30|||December 16, 2016||2016-12-16|April 12, 2017|2017-04-12|March 1, 2025|Anticipated|2025-03-01|September 30, 2024|Anticipated|2024-09-30||Interventional|||CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer|A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer|Recruiting||Phase 2|50|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 21:30:17.861152|2017-10-10 21:30:17.861152
NCT03002610|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-03-06|||December 2016||2016-12-01|December 2016|2016-12-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Presenting Summary Information From Cochrane Systematic Reviews to Physicians|Presenting Summary Information From Cochrane Systematic Reviews to Physicians: Protocol for Research of Infographics Presentation vs. Plain Language Summary|Completed||N/A|64|Actual|University Hospital of Split||3|||f||||f||||||||Yes||2017-10-10 21:30:17.969796|2017-10-10 21:30:17.969796
NCT03002597|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||January 2014||2014-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|||Visual Information Restoration and Rehabilitation Via Sensory Substitution Technology in Children|Visual Information Restoration and Rehabilitation Via Sensory Substitution Technology in Children|Recruiting||N/A|26|Anticipated|University of Pittsburgh|||2||f||||t||||||||Undecided||2017-10-10 21:30:18.099783|2017-10-10 21:30:18.099783
NCT03002584|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-04-19|||February 10, 2017|Actual|2017-02-10|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|PRoVING||International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ)|International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ)|Recruiting||N/A|300|Anticipated|University Paris 7 - Denis Diderot|||1||f||||f||||||||No||2017-10-10 21:30:18.224777|2017-10-10 21:30:18.224777
NCT03002571|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects|A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects|Not yet recruiting||Phase 3|348|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||t||||||||Yes||2017-10-10 21:30:18.383519|2017-10-10 21:30:18.383519
NCT03002558|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-20|||June 2016||2016-06-01|December 2016|2016-12-01|June 2023|Anticipated|2023-06-01|June 2023|Anticipated|2023-06-01|5 Years|Observational [Patient Registry]|SARAH||Long-term Cardiovascular Outcomes in Patients With RH and OSA With or Without Treatment With CPAP|Long-term Cardiovascular Outcomes in Patients With Resistant Hypertension and Obstructive Sleep Apnea With or Without Treatment With Continuous Positive Airway Pressure.|Recruiting||N/A|1371|Anticipated|Sociedad Española de Neumología y Cirugía Torácica|||3||f||||t||||||Samples With DNA|"     -  2 tubes EDTA        -  2 tubes with gel for serum        -  1 tube for RNA extraction        -  1 tube for urine   "|Undecided||2017-10-10 21:30:18.479923|2017-10-10 21:30:18.479923
NCT03002545|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Magnesium Supplementation in Type II Diabetes|Effects of a 12-week Supplementation With 400 mg Magnesium From Magnesium Citrate on Blood Sugar, Blood Pressure and Expression of Magnesium-sensitive Genes in Patients With Type II Diabetes|Recruiting||N/A|50|Anticipated|Protina Pharmazeutische GmbH||2|||f||||||||||||||2017-10-10 21:30:18.577848|2017-10-10 21:30:18.577848
NCT03002532|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-21|||August 2015||2015-08-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer|Whole Brain Irradiation With Hippocampal Sparing for Brain Metastases From Breast Cancer: Neurocognitive Function and Prognosis Analysis|Recruiting||N/A|120|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t||||||||No||2017-10-10 21:30:18.688383|2017-10-10 21:30:18.688383
NCT03002519|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-06-28|||February 8, 2017|Actual|2017-02-08|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation|A Phase I Open-label Dose-escalation Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation|Recruiting||Phase 1|30|Anticipated|Pluristem Ltd.||1|||f||||t|t|f||||||||2017-10-10 21:30:18.79278|2017-10-10 21:30:18.79278
NCT03002506|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-08-21|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns|Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns|Recruiting||Phase 4|12|Anticipated|Texas Tech University Health Sciences Center||1|||f||||t|t|f|||t|||||2017-10-10 21:30:18.877888|2017-10-10 21:30:18.877888
NCT03002493|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-03-13|||December 2009||2009-12-01|February 2016|2016-02-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Solid Tumors|An Open-Label Phase I Study to Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate (E7389) in Subjects With Advanced Solid Tumors|Completed||Phase 1|14|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-10 21:30:18.983404|2017-10-10 21:30:18.983404
NCT03002480|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography|Individualizing Bypassing Agent Therapy Utilizing TEG in Hemophilia Patients With Inhibitors|Not yet recruiting||N/A|10|Anticipated|Children's Hospital Los Angeles||1|||f||||f||||||||No||2017-10-10 21:30:19.085348|2017-10-10 21:30:19.085348
NCT03002467|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-20|||September 2016||2016-09-01|December 2016|2016-12-01||||September 2018|Anticipated|2018-09-01||Interventional|iAPP||Impact Analysis of Prognostic Stratification for Pulmonary Embolism|Impact Analysis of Prognostic Stratification for Pulmonary Embolism: A Randomized Controlled Trial|Recruiting||N/A|440|Anticipated|Università degli Studi dell'Insubria||2|||f||||||||||||||2017-10-10 21:30:19.184054|2017-10-10 21:30:19.184054
NCT03002454|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-05-03|2017-01-13||August 2016||2016-08-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo|A Cross-over Comparison of the Diagnostic Accuracy of Technetium (99mTc) Medronate Injection Prepared With 99mTc Derived From Neutron-activation Produced 99Mo Versus the Current Reference Standard of 99mTc Derived From Fission-produced 99Mo|Terminated||Phase 3|4|Actual|University of Manitoba|Early termination. Despite a relatively comprehensive review of the first four subject's bone imaging scans a cause of an observed altered biodistribution is not apparent. As such study recruitment will be terminated.|1||Altered biodistribution in investigational images versus standard images.|f||||f||||||||No||2017-10-10 21:30:19.281187|2017-10-10 21:30:19.281187
NCT03002441|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Same-day Cervical Preparation Before Dilation and Evacuation|Same-day Cervical Preparation With Dilapan-S™ Plus Buccal Misoprostol Compared to Overnight Dilapan-S™ Before Dilation and Evacuation at 16 to 20 Weeks' Gestation: A Randomized Controlled Trial|Recruiting||N/A|92|Anticipated|Planned Parenthood of New York City, Inc.||2|||f||||f||||||||No||2017-10-10 21:30:19.521654|2017-10-10 21:30:19.521654
NCT03002428|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-08-22|||December 2016||2016-12-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Comparison of PF708 and Forteo in Osteoporosis Patients|A Randomized Study Comparing the Effects of PF708 and Forteo in Patients With Osteoporosis|Active, not recruiting||Phase 3|168|Actual|Pfenex, Inc||2|||f||||f||||||||||2017-10-10 21:30:19.627501|2017-10-10 21:30:19.627501
NCT03002415|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-06-12|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Water Intake on the State of Hydration and Renal Function in Elderly Patients|Randomized Clinical Trial to Evaluate the Effect of Water Intake on the State of Hydration and Renal Function in Elderly Patients|Recruiting||N/A|100|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||Undecided||2017-10-10 21:30:19.902028|2017-10-10 21:30:19.902028
NCT03002402|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-19|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Feasibility and Acceptability of an Internet-based Cognitive-behavioral Treatment for Insomnia in Adults With Asthma|Feasibility and Acceptability of an Internet-based Cognitive-behavioral Treatment for Insomnia in Adults With Asthma|Active, not recruiting||N/A|23|Actual|University of Pittsburgh||1|||f||||f|f|f||||||||2017-10-10 21:30:20.040946|2017-10-10 21:30:20.040946
NCT03002389|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-01|||June 5, 2017|Anticipated|2017-06-05|May 2017|2017-05-01|January 31, 2022|Anticipated|2022-01-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics|Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics|Recruiting||Phase 2|95|Anticipated|University of Virginia||1|||f||||t|t|f||||||Undecided|At the conclusion of the study, correlation data between COPD phenotypes and changes in MRI characteristics will be shared. Data from individuals will be complied with unique study-generated subject ID after removing all personal identifiers. Once this is completed, the data may be shared with hyper polarized MR imaging network currently being formed in collaboration with University of WI, U Penn, Duke, U of Cincinnati, and U Missouri. The data will be accessible by these investigators after the data sharing plans are reviewed by the IRB of the record (at the University of Virginia).|2017-10-10 21:30:20.158347|2017-10-10 21:30:20.158347
NCT03002376|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-16|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)|An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Indicators of Clinical Response in Immunomodulatory Treatment-naïve Unresectable Stage III/IV Melanoma Patients Receiving REGN2810 (Anti-PD-1)|Recruiting||Phase 1|30|Anticipated|Regeneron Pharmaceuticals||1|||f||||f|t|f|||t|||||2017-10-10 21:30:20.305654|2017-10-10 21:30:20.305654
NCT03002363|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-09-12|||September 2016||2016-09-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|September 1, 2017|Actual|2017-09-01||Interventional|||The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance|The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance|Active, not recruiting||Phase 1|40|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 21:30:20.43482|2017-10-10 21:30:20.43482
NCT03002350|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-08-09|||August 2016||2016-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01|12 Months|Observational [Patient Registry]|||Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s)|Clinical Relevance of Next-generation Sequencing Analysis for High-purity Circulating Tumor Cells From Cancer Patients With Disruptive Gene Mutation(s)|Recruiting||N/A|40|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||Samples With DNA|"     genomic DNA   "|||2017-10-10 21:30:20.5559|2017-10-10 21:30:20.5559
NCT03002324|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-05-09|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Tailoring of Vaccine-Focused Messages: Disease Salience|Tailoring of Vaccine-Focused Messages: Moral Foundations and Disease Salience - Part 2|Completed||N/A|1320|Actual|Emory University||3|||f||||f||||||||No||2017-10-10 21:30:20.721536|2017-10-10 21:30:20.721536
NCT03002311|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-21|||January 2016||2016-01-01|September 2017|2017-09-01||||December 2020|Anticipated|2020-12-01||Interventional|||Improving Medical Care With Electronic Interventions Based on Automated Text and Phone Messages|Improving Medical Care With Electronic Interventions Based on Automated Text and Phone Messages|Enrolling by invitation||Phase 1/Phase 2|5000|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 21:30:20.854627|2017-10-10 21:30:20.854627
NCT03002298|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-08|||January 2016||2016-01-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Virtual Reality in Individuals With Duchenne Muscular Dystrophy|Motor Learning From Virtual to Natural Environments in Individuals With Duchenne Muscular Dystrophy|Completed||N/A|64|Actual|University of Sao Paulo||4|||f||||f||||||||Undecided||2017-10-10 21:30:21.017264|2017-10-10 21:30:21.017264
NCT03002285|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-20|||January 2016||2016-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Fitts Law in People With Cerebral Palsy|Evaluation of Speed-accuracy Trade-off in a Computer Task in Individuals With Cerebral Palsy|Completed||N/A|96|Actual|University of Sao Paulo||2|||f||||f||||||||Undecided||2017-10-10 21:30:21.138698|2017-10-10 21:30:21.138698
NCT03002272|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|January 2027|Anticipated|2027-01-01|January 2022|Anticipated|2022-01-01||Observational|||Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study||Not yet recruiting||N/A|100|Anticipated|Medstar Health Research Institute|||2||f||||f||||||||No||2017-10-10 21:30:21.2345|2017-10-10 21:30:21.2345
NCT03002259|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-21|||May 2017||2017-05-01|December 2016|2016-12-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|DECS-II||Dexamethasone for Cardiac Surgery-II Trial|Evaluation of Dexamethasone in Cardiac Surgery Using a Novel Trial Design|Not yet recruiting||Phase 4|2800|Anticipated|Bayside Health||2|||f||||t||||||||No||2017-10-10 21:30:21.345662|2017-10-10 21:30:21.345662
NCT03002246|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-07-13|||January 6, 2017|Actual|2017-01-06|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume|Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume|Enrolling by invitation||N/A|120|Anticipated|Baylor College of Medicine|||3||f||||f||||||||||2017-10-10 21:30:21.475238|2017-10-10 21:30:21.475238
NCT03002233|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-07-19|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus|A Phase 1 Study to Observe Safety and Tolerability of Single and Multiple Doses of TRK-820 in Subjects on Hemodialysis and to Observe the Effect on Uremic Pruritus|Completed||Phase 1|23|Actual|Toray Industries, Inc||1|||f||||f||||||||||2017-10-10 21:30:21.56874|2017-10-10 21:30:21.56874
NCT03002220|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-01-10|||November 2016||2016-11-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status|A Phase II Clinical Trial of Radium-223 Activity in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) With Asymptomatic Progression While on Abiraterone Acetate or Enzalutamide Besides AR-V7 Mutational Status|Recruiting||Phase 2|52|Anticipated|MedSIR||1|||f||||f||||||||No||2017-10-10 21:30:21.694105|2017-10-10 21:30:21.694105
NCT03002207|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-01-20|||November 2016||2016-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation|A Prospective, Comparative Study to Evaluate Effectiveness of Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation|Recruiting||N/A|100|Anticipated|Tianjin Hospital||4|||f||||t||||||||No||2017-10-10 21:30:21.871261|2017-10-10 21:30:21.871261
NCT03002194|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-10-03|||November 2016||2016-11-01|October 2017|2017-10-01|September 29, 2017|Actual|2017-09-29|September 29, 2017|Actual|2017-09-29||Interventional|||Change in Skin Elasticity With RF and PEMF|Change in Skin Elasticity After Combined Radiofrequency and Electromagnetic Treatment|Completed||N/A|48|Actual|Venus Concept||1|||f||||f||||||||||2017-10-10 21:30:22.017059|2017-10-10 21:30:22.017059
NCT03002181|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-12-22|||October 2016||2016-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Pain Neurophysiology Education for Sport Therapy Students|The Effect of Pain Neurophysiology Education on Sport Therapy Students Knowledge, Attitudes and Clinical Behaviour Towards Athletes With Chronic Pain: a Randomised Control Trial|Completed||N/A|60|Actual|Teesside University||2|||f||||f||||||||No|No identifiable data was used in the current study|2017-10-10 21:30:22.119207|2017-10-10 21:30:22.119207
NCT03002155|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-17|||January 2017||2017-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of a Exercise Program on Health Outcomes in People With Diabetic Foot Ulcers|Effects of a Community Exercise Program on Physical, Physiological, and Psychosocial Health Outcomes in People With Diabetic Foot Ulcers|Recruiting||N/A|40|Anticipated|University of Washington||2|||f||||||||||||||2017-10-10 21:30:22.355969|2017-10-10 21:30:22.355969
NCT03002142|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-03|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|RACO-MA||Auditory Rehabilitation and Cognition in Alzheimer Patients|Auditory Rehabilitation With Hearing Aids and Cognition in Alzheimer Patients|Recruiting||N/A|184|Anticipated|University Hospital, Tours||2|||f||||t|f|f||||||||2017-10-10 21:30:22.462228|2017-10-10 21:30:22.462228
NCT03002129|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-03-05|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||FLuid Responsiveness Prediction Using EXtra Systoles|FLuid Responsiveness Prediction Using EXtra Systoles|Recruiting||N/A|60|Anticipated|University Medical Center Groningen||1|||f||||f||||||||No||2017-10-10 21:30:22.588703|2017-10-10 21:30:22.588703
NCT03002116|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-22|||January 2016||2016-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Microwave Radiometry Thermometry for the Diagnosis of Critical Limb Ischemia in Diabetic Patients|Microwave Radiometry Thermometry for Non-invasive Diagnosis of Arterial Disease in Diabetic Patients With Suspected Critical Limb Ischemia: A Multi-centre Feasibility Study|Completed||N/A|80|Actual|Attikon Hospital||4|||f||||f||||||||Undecided||2017-10-10 21:30:22.706438|2017-10-10 21:30:22.706438
NCT03002103|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-17|||November 2016||2016-11-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer|An Open-label, Randomized, Controlled Phase III Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer|Recruiting||Phase 3|420|Anticipated|SynCore Biotechnology Co., Ltd.||2|||f||||||||||||||2017-10-10 21:30:22.795963|2017-10-10 21:30:22.795963
NCT03002090|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-20|||August 2014||2014-08-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Defining the Functional Role of Iron in Aerobic Training and Physical Performance|Defining the Functional and Metabolic Role of Iron in Aerobic Training and Physical Performance|Completed||N/A|109|Actual|Cornell University||6|||f||||f||||||||No||2017-10-10 21:30:22.900837|2017-10-10 21:30:22.900837
NCT03002077|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-09-18|||February 3, 2017|Actual|2017-02-03|September 2017|2017-09-01|February 14, 2020|Anticipated|2020-02-14|February 14, 2020|Anticipated|2020-02-14||Interventional|||Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder|An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder|Recruiting||Phase 3|500|Anticipated|Allergan||1|||f||||f|t|f||||||||2017-10-10 21:30:23.027512|2017-10-10 21:30:23.027512
NCT03002064|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients|Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin as First-line Treatment for Metastatic Esophageal Squamous Patients: a Prospective Multicenter, Randomized Controlled Clinical Study|Recruiting||Phase 3|358|Anticipated|Sun Yat-sen University||2|||f||||f||||||||No||2017-10-10 21:30:23.378347|2017-10-10 21:30:23.378347
NCT03002051|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-07-13|||October 2016||2016-10-01|July 2017|2017-07-01||||October 2019|Anticipated|2019-10-01||Interventional|||EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent|EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent for the Management of Pancreato-biliary Diseases: a Multi-national, Multicenter Prospective Study|Recruiting||N/A|80|Anticipated|Chinese University of Hong Kong||1|||f||||t||||||||||2017-10-10 21:30:23.487479|2017-10-10 21:30:23.487479
NCT03002038|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-30|||September 2015||2015-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients|Comparison of Annual Relapse Rate, Expanded Disability Status Scale, and Side Effects Between Azathioprine and Rituximab in Patients With Neuromyelitis Optica Spectrum Disorders|Completed||Phase 2/Phase 3|76|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||Undecided|We may share the individual participant data (anonymously) on request of the journal publishing the study report.|2017-10-10 21:30:23.56472|2017-10-10 21:30:23.56472
NCT03002025|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-09-27|||January 10, 2017|Actual|2017-01-10|September 2017|2017-09-01|September 9, 2017|Actual|2017-09-09|September 9, 2017|Actual|2017-09-09||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants|A Double-blind, Placebo-controlled, Randomized, Single-ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Subjects|Completed||Phase 1|48|Actual|Janssen Pharmaceutical K.K.||4|||f||||f|f|f||||||||2017-10-10 21:30:23.655375|2017-10-10 21:30:23.655375
NCT03002012|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-08-31|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|April 2021|Anticipated|2021-04-01||Interventional|C-ASSERT||Cryptococcal Antigen Screening Plus Sertraline|Cryptococcal Antigen Screening Plus Sertraline|Recruiting||Phase 3|600|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|t|f||||||||2017-10-10 21:30:23.737015|2017-10-10 21:30:23.737015
NCT03001999|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-04-27|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|BEHOLD-16||Boosting Emotions & Happiness in Outpatients Living With Diabetes: Phase I|A Novel Psychological-behavioral Intervention to Improve Activity in Type 2 Diabetes: Proof-of-concept Trial|Recruiting||N/A|12|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:30:23.860316|2017-10-10 21:30:23.860316
NCT03001986|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2017-03-31|||September 2016|Actual|2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children||Active, not recruiting||Phase 4|39189|Actual|Chinese Academy of Medical Sciences||1|||f||||f||||||||No|Participants do not agree to share individual data.|2017-10-10 21:30:23.968279|2017-10-10 21:30:23.968279
NCT03001973|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-22|||November 2013||2013-11-01|December 2016|2016-12-01|December 2026|Anticipated|2026-12-01|December 2016|Anticipated|2016-12-01||Observational|||High Quality Evidence of Chinese Lupus Nephritis (HELP)|High Quality Evidence of Chinese Lupus Nephritis (HELP)|Recruiting||N/A|5000|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     The serum, urine, DNA and renal tissue will be collected.   "|Yes||2017-10-10 21:30:24.221402|2017-10-10 21:30:24.221402
NCT03001960|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2016-12-27|||March 2017||2017-03-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|DAPT-TAVI||Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI|Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in Transcatheter Aortic Valve Implantation (TAVI)|Not yet recruiting||Phase 3|200|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 21:30:24.352051|2017-10-10 21:30:24.352051
NCT03001947|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-22|||November 2012||2012-11-01|December 2016|2016-12-01|December 2026|Anticipated|2026-12-01|December 2016|Anticipated|2016-12-01|10 Years|Observational [Patient Registry]|||IgA Nephropathy Registration Initiative of High Quality (INSIGHT)|IgA Nephropathy Registration Initiative of High Quality (INSIGHT)|Recruiting||N/A|10000|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     The serum, urine, DNA and renal tissue will be collected.   "|Yes||2017-10-10 21:30:24.4842|2017-10-10 21:30:24.4842
NCT03001934|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-22|||April 2016||2016-04-01|December 2016|2016-12-01|December 2028|Anticipated|2028-12-01|December 2018|Anticipated|2018-12-01|10 Years|Observational [Patient Registry]|||Super Chinese Nephrotic Syndrome Registration System (SUCCESS)|Super Chinese Nephrotic Syndrome Registration System (SUCCESS)|Recruiting||N/A|5000|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     The serum, urine, DNA and renal tissue will be collected.   "|Yes||2017-10-10 21:30:24.626552|2017-10-10 21:30:24.626552
NCT03001921|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-23|||December 2013||2013-12-01|December 2016|2016-12-01|December 2027|Anticipated|2027-12-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|||Wise Practice of Chinese Hemodialysis (WISHES)|Wise Practice of Chinese Hemodialysis (WISHES)|Recruiting||N/A|30000|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     he serum, urine, and DNA will be collected.   "|Yes||2017-10-10 21:30:24.781266|2017-10-10 21:30:24.781266
NCT03001908|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||A Comparison of Electromyographic Activity & Glenohumeral Motion|A Comparison of Electromyographic(EMG) Activity & Glenohumeral Motion During Posterior Glide Mobilizations in Healthy & Stiff Shoulders|Recruiting||N/A|88|Anticipated|University of New England||4|||f||||f||||||||No||2017-10-10 21:30:24.921214|2017-10-10 21:30:24.921214
NCT03001895|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-10-03|||July 1, 2017|Actual|2017-07-01|October 2017|2017-10-01|July 2023|Anticipated|2023-07-01|June 2022|Anticipated|2022-06-01||Interventional|||Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer|Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer|Enrolling by invitation||Phase 2|150|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||1|||f||||f|f|f||||||||2017-10-10 21:30:25.118286|2017-10-10 21:30:25.118286
NCT03001882|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-09-13|||March 14, 2017|Actual|2017-03-14|September 2017|2017-09-01|September 29, 2021|Anticipated|2021-09-29|March 18, 2019|Anticipated|2019-03-18||Interventional|CheckMate 592||An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)|An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in Combination With Ipilimumab in Subjects With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|100|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 21:30:25.208483|2017-10-10 21:30:25.208483
NCT03001869|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-10-03|||July 1, 2017|Actual|2017-07-01|October 2017|2017-10-01|July 2023|Anticipated|2023-07-01|July 2022|Anticipated|2022-07-01||Interventional|||PSMA PET/CT in Prostate Cancer|The Safety and Efficacy of 68Ga-HBED-CC-PSMA PET/CT in Prostate Cancer|Enrolling by invitation||Phase 3|1500|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||1|||f||||f|f|f|||f|||||2017-10-10 21:30:25.373902|2017-10-10 21:30:25.373902
NCT03001856|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-08|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Interrupted Oblique Intradermal Suture Versus Conventional Interrupted Intradermal Suture||Completed||N/A|144|Actual|Mae Fah Luang University Hospital||2|||f||||f||||||||||2017-10-10 21:30:25.488756|2017-10-10 21:30:25.488756
NCT03001843|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-02-22|||February 22, 2017|Actual|2017-02-22|February 2017|2017-02-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Observational|||Ketamine vs Hydromorphone|Does a Ketamine Infusion Decrease Post Operative Narcotic Consumption After Gastric Bypass Surgery?|Recruiting||N/A|48|Anticipated|University of Florida|||2||f||||f||||||||No||2017-10-10 21:30:25.600451|2017-10-10 21:30:25.600451
NCT03001830|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-06-14|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|January 2034|Anticipated|2034-01-01|April 2019|Anticipated|2019-04-01||Interventional|GO-8||Gene Therapy for Haemophilia A.|GO-8: Gene Therapy for Haemophilia A Using a Novel Serotype 8 Capsid Pseudotyped Adeno-associated Viral Vector Encoding Factor VIII-V3|Recruiting||Phase 1|18|Anticipated|University College, London||1|||f||||t|t|f||||||No||2017-10-10 21:30:25.731408|2017-10-10 21:30:25.731408
NCT03001817|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-10-04|||November 2016||2016-11-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|July 2018|Anticipated|2018-07-01||Interventional|||Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function||Recruiting||Phase 3|630|Anticipated|Kowa Research Institute, Inc.||2|||f||||f||||||||||2017-10-10 21:30:25.879155|2017-10-10 21:30:25.879155
NCT03001804|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-06|||April 30, 2017|Anticipated|2017-04-30|April 2017|2017-04-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Observational|||Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients|Use of Lenalidomide (Revlimid®) in Combination With Dexamethasone in Untreated Non-transplantable Multiple Myeloma in Practice|Not yet recruiting||N/A|56|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 21:30:26.38567|2017-10-10 21:30:26.38567
NCT03001791|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-12-20|||July 2013||2013-07-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|||Comparison of ER:YAG Laser, CO2 Laser and Scalpel Excision of Fibrous Hyperplasia on the Buccal Mucosa|Clinical and Histopathological Comparison of ER:YAG Laser, CO2 Laser and Scalpel Excision of Fibrous Hyperplasia on the Buccal Mucosa|Recruiting||N/A|75|Anticipated|University of Bern||3|||f||||||||||||||2017-10-10 21:30:26.460526|2017-10-10 21:30:26.460526
NCT03001778|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-07-24|||August 15, 2014|Actual|2014-08-15|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|January 30, 2017|Actual|2017-01-30||Interventional|STEP4Life||Smart Television and Exercise Promotion for Independent Living Facilities|Smart Television and Exercise Promotion for Independent Living Facilities|Completed||N/A|320|Actual|Klein Buendel, Inc.||1|||f||||f||||||||||2017-10-10 21:30:26.547028|2017-10-10 21:30:26.547028
NCT03001765|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-28|||December 2016||2016-12-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|IMPACT||Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia|Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia|Recruiting||N/A|150|Anticipated|St Elizabeth Healthcare||1|||f||||t||||||||No|Individual participant data will not be shared.|2017-10-10 21:30:26.677907|2017-10-10 21:30:26.677907
NCT03001752|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-23|||January 2017||2017-01-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ETPEI-RCT||Immediate Implants Inserted Through Open Flap, Open Flap and Bone Grafting and Flapless Techniques|Evaluation of Morphological and Dimensional Alveolar Bone Changes Around Post-extraction Implants in an Open Flap, Open Flap and Grafting and Flapless Technique. A Clinical Randomized Controlled Study|Not yet recruiting||Early Phase 1|30|Anticipated|University of Bari||3|||f||||t||||||||||2017-10-10 21:30:26.795422|2017-10-10 21:30:26.795422
NCT03001739|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|RAID||Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection|Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection (RAID): Study Protocol for Randomized Controlled Trial|Recruiting||Phase 1|360|Anticipated|Sir Run Run Shaw Hospital||2|||f||||t||||||||No||2017-10-10 21:30:26.920139|2017-10-10 21:30:26.920139
NCT03001726|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2016-12-22|||January 2017||2017-01-01|December 2016|2016-12-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Gastrectomy Plus Chemotherapy Versus Chemotherapy Alone for Advanced Gastric Cancer With a Single Non-curable Factor|Gastrectomy Plus Chemotherapy Versus Chemotherapy Alone for Advanced Gastric Cancer With a Single Non-curable Factor|Enrolling by invitation||Phase 3|188|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||No||2017-10-10 21:30:27.061347|2017-10-10 21:30:27.061347
NCT03001713|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-22|||February 1, 2018|Anticipated|2018-02-01|May 2017|2017-05-01|February 2022|Anticipated|2022-02-01|January 2021|Anticipated|2021-01-01||Interventional|CV_WIZARD||CV Wizard: Does a Clinical Decision Support Tool Improve CVD Risk Factor Control in Safety Net Clinics?|CV Wizard: Does a Prioritized, Point-of-Care Clinical Decision Support Tool Improve Guideline-Based CVD Risk Factor Control in Safety Net Clinics?|Not yet recruiting||N/A|60|Anticipated|Kaiser Permanente||2|||f||||t|f|f||||||||2017-10-10 21:30:27.179726|2017-10-10 21:30:27.179726
NCT03001700|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-06-05|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|May 31, 2017|Actual|2017-05-31||Interventional|PRELUDE||PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE|PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE: PRELUDE Study|Active, not recruiting||N/A|25|Actual|Cagent Vascular LLC||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:30:27.295476|2017-10-10 21:30:27.295476
NCT03001687|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-02-03|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|DEHEPTRA||Impact of Vitamin D Supplementation on Hepcidin Levels and Transfusion Requirements in Surgical and Septic Patients|Impact of Vitamin D Enteral Supplementation on Hepcidin Serum Levels and Transfusion Requirements in Surgical and Critically Ill Patients|Recruiting||N/A|40|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy||2|||f||||f||||||||No|Only on request|2017-10-10 21:30:27.396543|2017-10-10 21:30:27.396543
NCT03001674|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-04-25|2017-04-25||December 2014||2014-12-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure|Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure|Completed||N/A|15|Actual|Tufts Medical Center|Small number of patients studied. Non-randomized study.|2|||f||||f||||||||||2017-10-10 21:30:27.575646|2017-10-10 21:30:27.575646
NCT03001661|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-07-12|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|SOLVE||An RCT of a Synthetic Osmotic Cervical Dilator for Induction of Labour in Comparison to Dinoprostone Vaginal insErt|A Randomised Controlled Trial of a Synthetic Osmotic Cervical Dilator for Induction of Labour in Comparison to Dinoprostone Vaginal insErt: the SOLVE Trial|Not yet recruiting||Phase 3|860|Anticipated|Birmingham Women's NHS Foundation Trust||2|||f||||t|f|f||||||||2017-10-10 21:30:27.785897|2017-10-10 21:30:27.785897
NCT03001648|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-22|||January 2014||2014-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Cumulative Live Birth Rates in Patients With Repeated Implantation Failure (RIF) Undergoing Preimplantation Genetic Screening (PGS )|Cumulative Live Birth Rates in Patients With Repeated Implantation Failure (RIF) Undergoing Preimplantation Genetic Screening (PGS )|Completed||N/A|80|Actual|Institut Universitari Dexeus|||2||f||||f||||||||||2017-10-10 21:30:27.879873|2017-10-10 21:30:27.879873
NCT03001635|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-22|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Role of Oxytocin in Myocardial Infarction|The Impact of Oxytocin Administration on Short and Long Term Prognosis in Patients Undergoing ST Elevation Myocardial Infarction|Not yet recruiting||Phase 2/Phase 3|52|Anticipated|Sheba Medical Center||2|||f||||t||||||||No||2017-10-10 21:30:27.957244|2017-10-10 21:30:27.957244
NCT03001622|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-15|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa|An Open Label Phase II Trial to Evaluate the Safety of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa|Completed||Phase 2|12|Actual|InflaRx GmbH||1|||f||||f||||||||||2017-10-10 21:30:28.058397|2017-10-10 21:30:28.058397
NCT03001609|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-29|||November 2016||2016-11-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Interventional|||Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC|An Open-Label, Non-Randomized, Single-Center Study to Determine the Absorption, Metabolism and Excretion of A Single Dose [14C] AC0010 in Patients With Advanced NSCLC|Completed||Phase 1|7|Actual|Hangzhou ACEA Pharmaceutical Research Co.,Ltd.||1|||f||||f|f|f||||||||2017-10-10 21:30:28.1339|2017-10-10 21:30:28.1339
NCT03001596|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01||Interventional|ESCCNCRTvNCT||Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC|Neoadjuvant Chemoradiotherapy VS. Neoadjuvant Chemotherapy Followed by Minimally Invasive Esophagectomy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma（cT3-4aN0-1M0):A Multi-center Prospective Randomized Clinical Trial|Not yet recruiting||Phase 3|264|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:30:28.219107|2017-10-10 21:30:28.219107
NCT03001583|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-20|||January 2017||2017-01-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Clinical Trial Comparing Two Health Education Programs for Obese Patients (HEPO-TRIAL)|Clinical Trial Comparing Two Health Education Programs for Obese Patients: Groups With Health Education Plus Cooking Program vs. Only Education Without Cooking|Not yet recruiting||N/A|260|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||f||||||||||2017-10-10 21:30:28.385267|2017-10-10 21:30:28.385267
NCT03001570|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-24|||January 2014||2014-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|FAMOSO||Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District|Accelerated Modulated Fractionation (SIB-IMRT) for the Treatment of Locally Advanced Squamous Cell Carcinoma From Head and Neck District|Recruiting||Phase 2|10|Anticipated|European Institute of Oncology||1|||f||||f||||||||No||2017-10-10 21:30:30.218683|2017-10-10 21:30:30.218683
NCT03001557|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-09-27|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Lemborexant in Subjects With Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia|Recruiting||Phase 2|125|Anticipated|Eisai Inc.||5|||f||||f|t|||||||||2017-10-10 21:30:30.311146|2017-10-10 21:30:30.311146
NCT03001544|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-12-20|||July 2015||2015-07-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|TS23Phase1a||Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer|Phase 1 Single-ascending Dose-escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Anti-alpha2-antiplasmin (α2AP) Monoclonal Antibody TS23 in Healthy Human Volunteers|Active, not recruiting||Phase 1|24|Actual|Translational Sciences, Inc.||1|||f||||f||||||||||2017-10-10 21:30:30.471303|2017-10-10 21:30:30.471303
NCT03001531|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-28|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Interventional|DecuHeat||Safety and Tolerance of Local Heat Application in the Paralyzed Area of Patients With Complete Paraplegia|Safety and Tolerance of Local Heat Application in the Paralyzed Area of Patients With Complete Paraplegia|Completed||N/A|15|Actual|Swiss Paraplegic Centre Nottwil||2|||f||||f||||||||||2017-10-10 21:30:30.54355|2017-10-10 21:30:30.54355
NCT03001518|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-05-23|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|April 2027|Anticipated|2027-04-01|May 2020|Anticipated|2020-05-01||Observational|||Immunologic Signatures Following Surgery for Pancreatic Cancer|Immunologic Signatures Following Surgery for Pancreatic Cancer|Recruiting||N/A|30|Anticipated|Duke University|||1||f||||f|f|f||||Samples With DNA|"     Plasma from 4 blood draws   "|No||2017-10-10 21:30:30.621036|2017-10-10 21:30:30.621036
NCT03001505|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-05-08|||May 4, 2017|Actual|2017-05-04|December 2016|2016-12-01|April 2037|Anticipated|2037-04-01|April 2037|Anticipated|2037-04-01|10 Years|Observational [Patient Registry]|||Registry for Pancreatic Cancer|Registry to Evaluate Multi-modality Therapies for Pancreatic Cancer|Recruiting||N/A|750|Anticipated|Duke University|||1||f||||f|f|f||||||No||2017-10-10 21:30:30.713255|2017-10-10 21:30:30.713255
NCT03001492|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Observational|||Does Premature Luteinization Matter?|Does Measurement of Serum Progesterone on the Day of Trigger Matter?|Recruiting||N/A|200|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 21:30:30.806007|2017-10-10 21:30:30.806007
NCT03001479|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-03-21|||March 13, 2017|Actual|2017-03-13|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Noninferiority Trial of Liquid Human Milk Fortifier (HMF) Hydrolyzed Protein Versus Liquid HMF With Supplemental Liquid Protein|Extensively Hydrolyzed Liquid Human Milk Fortifier Versus Liquid Human Milk Fortifier With Supplemental Liquid Protein|Recruiting||N/A|80|Anticipated|St. Louis University||2|||f||||t|f|f||||||||2017-10-10 21:30:30.974877|2017-10-10 21:30:30.974877
NCT03001466|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-12-20|||January 2014||2014-01-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|January 2016|Actual|2016-01-01||Interventional|||A Randomized Controlled Trial Comparing Urea Loaded Nanoparticles to Placebo: a New Concept for Cataract Management|A Randomized Controlled Trial Comparing Urea Loaded Nanoparticles to Placebo: a New Concept for Cataract Management|Completed||Phase 2|50|Actual|Assiut University||2|||f||||t||||||||No||2017-10-10 21:30:31.086568|2017-10-10 21:30:31.086568
NCT03001453|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-12-20|||April 2014||2014-04-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management|Post-surgical Pain Care Pathways During Enhanced Recovery Surgery Using Exparel (Bupivacaine Liposome Injectable Suspension) Plus Bupivacaine With Epinephrine Versus Bupivacaine.|Completed||Phase 2|107|Actual|American Hip Institute||2|||f||||f||||||||No||2017-10-10 21:30:31.19854|2017-10-10 21:30:31.19854
NCT03001440|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||October 2016||2016-10-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||A 7-year Assessment on Subject Understanding of ZYBAN/ WELLBUTRIN Associated Risks|Subject Understanding of the Risks Associated With ZYBAN®, WELLBUTRIN®, WELLBUTRIN SR®, and WELLBUTRIN XL®|Active, not recruiting||N/A|1|Anticipated|GlaxoSmithKline|||1||f||||f||||||||||2017-10-10 21:30:31.319909|2017-10-10 21:30:31.319909
NCT03001427|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||January 2016||2016-01-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Neurocognition, Lifestyle Modification, and Treatment Resistant Hypertension|Neurocognition, Lifestyle Modification, and Treatment Resistant Hypertension|Recruiting||N/A|120|Anticipated|Duke University||2|||f||||t||||||||No||2017-10-10 21:30:31.405685|2017-10-10 21:30:31.405685
NCT03001414|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-19|||April 2017||2017-04-01|December 2016|2016-12-01|April 2021|Anticipated|2021-04-01|October 2020|Anticipated|2020-10-01||Interventional|SAPPHIRE||Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs|A Multicentre, Phase 2 Clinical Trial to Establish the Efficacy and Safety of Repeat Dosing of Autologous Endothelial Progenitor Cells (EPCs) Transfected With Human Endothelial NO-synthase (eNOS) in Patients With Pulmonary Arterial Hypertension (PAH) on Top of Conventional Treatments|Not yet recruiting||Phase 2|45|Anticipated|Northern Therapeutics||3|||f||||t||||||||No||2017-10-10 21:30:31.498458|2017-10-10 21:30:31.498458
NCT03001401|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-19|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Next Generation Laser Techniques of Myopia Correction: iDesign vs. SMILE|Comparison of Next Generation Laser Techniques of Myopia Correction: iDesign vs. SMILE|Recruiting||Phase 4|100|Anticipated|Narayana Nethralaya||2|||f||||t||||||||No||2017-10-10 21:30:31.688069|2017-10-10 21:30:31.688069
NCT03001388|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-30|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Longitudinal Assessment of Transient Elastography in Cystic Fibrosis|Longitudinal Assessment of Transient Elastography in Cystic Fibrosis|Enrolling by invitation||N/A|251|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||||No||2017-10-10 21:30:31.805043|2017-10-10 21:30:31.805043
NCT03001375|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-20|||May 2011||2011-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|||Laparoscopic Splenic Flexure Mobilization|Is it Necessary to do Splenic Flexure Mobilization in Laparoscopic Resection of Upper Rectal Tumors?|Completed||N/A|140|Actual|Ain Shams University||2|||f||||f||||||||Undecided||2017-10-10 21:30:31.907517|2017-10-10 21:30:31.907517
NCT03001362|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-20|||March 2015||2015-03-01|December 2016|2016-12-01|September 2022|Anticipated|2022-09-01|August 2019|Anticipated|2019-08-01||Interventional|||"Patients With Rectal Cancer: a Wait-and-see Approach"|"Radical External Beam Chemoradiation in Patients With Rectal Cancer: a Wait-and-see Approach"|Recruiting||Phase 2|48|Anticipated|McGill University Health Center||1|||f||||f||||||||No||2017-10-10 21:30:31.977027|2017-10-10 21:30:31.977027
NCT03001349|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-09-25||||||September 2017|2017-09-01||||||||Expanded Access|||An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC|An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC|Available||N/A|||M.D. Anderson Cancer Center|||||||||||||||||||2017-10-10 21:30:32.093369|2017-10-10 21:30:32.093369
NCT03001336|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-19|||December 2010||2010-12-01|January 2011|2011-01-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Observational|||Thyroid Function and Diabetes Complications|Association Between Thyroid Function and Diabetes Complications in Elderly Patients With Type 2 Diabetes Mellitus in China|Completed||N/A|260|Actual|Nanjing First Hospital, Nanjing Medical University|||1||f||||f||||||||No||2017-10-10 21:30:32.160592|2017-10-10 21:30:32.160592
NCT03001323|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis|Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis|Not yet recruiting||N/A|42|Anticipated|Minneapolis Medical Research Foundation||2|||f||||f||||||||No||2017-10-10 21:30:32.222303|2017-10-10 21:30:32.222303
NCT03001310|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-07|||January 12, 2016|Actual|2016-01-12|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|CNGB3||Gene Therapy for Achromatopsia (CNGB3)|An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV2/8-hCARp.hCNGB3) for Gene Therapy of Adults and Children With Achromatopsia Owing to Defects in CNGB3|Recruiting||Phase 1/Phase 2|18|Anticipated|MeiraGTx UK II Ltd||3|||f||||t||||||||||2017-10-10 21:30:32.312261|2017-10-10 21:30:32.312261
NCT03001297|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-28|||January 17, 2017|Actual|2017-01-17|September 2017|2017-09-01|February 21, 2018|Anticipated|2018-02-21|February 21, 2018|Anticipated|2018-02-21||Interventional|||Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884|A Phase 1 Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of MEDI5884 in Healthy Volunteers|Recruiting||Phase 1|56|Anticipated|MedImmune LLC||5|||f||||f||||||||||2017-10-10 21:30:32.401001|2017-10-10 21:30:32.401001
NCT03001284|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-20|||October 2012||2012-10-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction||Active, not recruiting||N/A|103|Actual|Carol Davila University of Medicine and Pharmacy|||2||f||||f||||||||No||2017-10-10 21:30:32.504492|2017-10-10 21:30:32.504492
NCT03001271|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-20|||January 2014||2014-01-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|Ang-(1-7)||Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects|Acute Effect of Agiotensin-(1-7) on Bood Pressure and Heart Rate in Healthy and Hypertensive Subjects|Active, not recruiting||Early Phase 1|32|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||||||||||||2017-10-10 21:30:32.578913|2017-10-10 21:30:32.578913
NCT03001258|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-03-11|2017-01-03||February 2015||2015-02-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational||The discrepancy in the sample size (2001 vs 1090) was because we did two separate sample size calculation in this study. Firstly, in the intervention trial for 3 arms, our sample size was 2001. Then, we took sub-sample (1090) from the intervention sample (2001) to capture patients' socio-demographics.|Presbyopia Screening by Community Health Worker in Bangladesh|Presbyopia Screening by Community Health Worker in Bangladesh: Implementation Research|Completed||N/A|2001|Actual|Brac|||3||f||||f||||||||Undecided||2017-10-10 21:30:32.793032|2017-10-10 21:30:32.793032
NCT03001245|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|IPCAS||Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents|Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents: Implementation and Effectiveness Study in School Health Care|Recruiting||N/A|120|Anticipated|Hospital District of Helsinki and Uusimaa||2|||f||||f||||||||Undecided||2017-10-10 21:30:33.139993|2017-10-10 21:30:33.139993
NCT03001232|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-02-02|||March 2014||2014-03-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Solis MDC||The Effect of Movement-oriented Dementia Care on ADL and QoL of Dementia Patients in Nursing Homes|Enriched Environment and Dementia: The Effect of an Individual Daily Calendar on the Activity Level and Mental Functions of Persons With Dementia in a Nursing Home|Completed||N/A|66|Actual|VU University of Amsterdam||2|||f||||f||||||||No||2017-10-10 21:30:33.275768|2017-10-10 21:30:33.275768
NCT03001219|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-09-25|||December 22, 2016|Actual|2016-12-22|September 2017|2017-09-01|September 29, 2018|Anticipated|2018-09-29|September 29, 2018|Anticipated|2018-09-29||Interventional|||A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase II Study to Evaluate The Safety and Efficacy of RO7123520 as Adjunct Treatment in Patients With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to TNF-alpha Inhibitors|Recruiting||Phase 2|204|Anticipated|Hoffmann-La Roche||6|||f||||||||||||||2017-10-10 21:30:33.384145|2017-10-10 21:30:33.384145
NCT03001206|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-01-17|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||The Use of the Master Caution System (MCS) for Continuous Monitoring and Detection of Dysrhythmias and Ischemic Events|The Use of Master Caution System for Continuous Monitoring and Detection of Dysrhythmia and Ischemia|Recruiting||N/A|140|Anticipated|HealthWatch Ltd.|||2||f||||f||||||||No||2017-10-10 21:30:33.671525|2017-10-10 21:30:33.671525
NCT03001193|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-06-16|||December 2016||2016-12-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Effect of Continuous Infusion of Tafoxiparin as an Adjunct Treatment to Oxytocin for up to 36 Hours in Term Pregnant, Nulliparous Women to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest|Recruiting||Phase 2|360|Anticipated|Dilafor AB||4|||f||||f||||||||No||2017-10-10 21:30:33.760083|2017-10-10 21:30:33.760083
NCT03001180|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-04-26|||April 2015||2015-04-01|April 2017|2017-04-01||||January 2050|Anticipated|2050-01-01||Observational|||Identification of Biomarkers for Patients With Vascular Anomalies|Identification of Biomarkers for Patients With Vascular Anomalies|Recruiting||N/A|1000|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     Tissue, Blood, Plasma, and Serum Samples   "|||2017-10-10 21:30:33.896517|2017-10-10 21:30:33.896517
NCT03001167|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-22|||December 2016||2016-12-01|December 2016|2016-12-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Observational|MAGIC||Microbiome, Antibiotics, and Growth Infant Cohort|Early Life Antibiotics, Gut Microbiome Development, and Risk of Childhood Obesity|Recruiting||N/A|420|Anticipated|Children's Hospital of Philadelphia|||1||f||||f||||||Samples With DNA|"     Stool samples Saliva samples   "|No|De-identified individual participant data will be shared with collaborators at the Knights Lab at the University of Minnesota.|2017-10-10 21:30:33.993112|2017-10-10 21:30:33.993112
NCT03001154|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|VRETORIK||Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software|Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software|Not yet recruiting||N/A|50|Anticipated|Stockholm University||2|||f||||f||||||||Undecided||2017-10-10 21:30:34.084305|2017-10-10 21:30:34.084305
NCT03001141|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-27|||February 2017||2017-02-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01|12 Months|Observational [Patient Registry]|||Study Protocol/ Registry of MultiPoint™ Pacing in Brazil|Study Protocol/ Registry of MultiPoint™ Pacing in Brazil|Not yet recruiting||N/A|200|Anticipated|St. Jude Medical|||1||f||||f||||||||Undecided||2017-10-10 21:30:34.161026|2017-10-10 21:30:34.161026
NCT03001128|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-01|||February 23, 2017|Actual|2017-02-23|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Biomarkers to Predict Time to Plasma HIV RNA Rebound|Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control During an Intensively Monitored Antiretroviral Pause (IMAP)|Recruiting||N/A|66|Anticipated|AIDS Clinical Trials Group|||2||f||||t||||||||Undecided||2017-10-10 21:30:34.236666|2017-10-10 21:30:34.236666
NCT03001115|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-02|||March 10, 2017|Actual|2017-03-10|August 2017|2017-08-01|July 26, 2019|Anticipated|2019-07-26|July 26, 2019|Anticipated|2019-07-26||Observational|HS rPMS||Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects|"Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Patients Under the New-Drug Re-examination"|Recruiting||N/A|600|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:30:34.338763|2017-10-10 21:30:34.338763
NCT03001102|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-09|||August 2015||2015-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Preoperative Bath in Patients Submitted to Hip Arthroplasty|Preoperative Bath in Patients Submitted to Hip Arthroplasty: Randomized Clinical Trial|Recruiting||N/A|162|Anticipated|Federal University of Minas Gerais||3|||f||||f||||||||||2017-10-10 21:30:34.441729|2017-10-10 21:30:34.441729
NCT03001089|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-07-24|||June 1, 2017|Actual|2017-06-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|MINIPREM||Impact of the Administration of Fludrocortisone in Very Premature Infants|Impact of the Administration of Fludrocortisone on Fluid and Electrolyte Balance in Very Premature Infants: Pilot Study|Recruiting||Phase 2|66|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:30:34.539248|2017-10-10 21:30:34.539248
NCT03001076|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Bempedoic Acid (ETC 1002) 180 mg/Day as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C|Recruiting||Phase 3|225|Anticipated|Esperion Therapeutics||2|||f||||t||||||||No||2017-10-10 21:30:34.623858|2017-10-10 21:30:34.623858
NCT03001063|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-21|||March 2016||2016-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|MAC-FI||Mental Health in Adults and Children- Frugal Innovations (MAC-FI): Adult Depression Component|Mental Health in Adults and Children: Frugal Innovations|Recruiting||N/A|256|Anticipated|Simon Fraser University||2|||f||||t||||||||||2017-10-10 21:30:34.718313|2017-10-10 21:30:34.718313
NCT03001050|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-05-15|||May 16, 2017|Actual|2017-05-16|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Rotator Cuff: Does the Vascularity Matter and the Role for PINPOINT|Rotator Cuff: Does the Vascularity Matter and the Role for PINPOINT|Recruiting||N/A|10|Anticipated|Loma Linda University||1|||f||||f|f|f||||||No||2017-10-10 21:30:34.796181|2017-10-10 21:30:34.796181
NCT03001037|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-08|||October 2016||2016-10-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|12 Months|Observational [Patient Registry]|BPAM||dorsaVi Back Pain and Movement Registry|dorsaVi Back Pain and Movement Registry|Recruiting||N/A|350|Anticipated|dorsaVi Ltd|||2||f||||t||||||||Undecided||2017-10-10 21:30:34.981454|2017-10-10 21:30:34.981454
NCT03001024|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|WTS-E||WayToServe Español: Online Responsible Beverage Service Training for Spanish-Speaking Servers|WayToServe Español: A Culturally-Appropriate Online Responsible Beverage Service Training for Spanish-Speaking Servers|Not yet recruiting||N/A|80|Anticipated|Klein Buendel, Inc.||2|||f||||f||||||||No||2017-10-10 21:30:35.096693|2017-10-10 21:30:35.096693
NCT03000998|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-06|||January 31, 2017|Actual|2017-01-31|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake|Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake|Recruiting||N/A|900|Anticipated|Klein Buendel, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:30:35.341194|2017-10-10 21:30:35.341194
NCT03000985|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-20|||April 2016||2016-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|PSY EDUC||Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two Arms||Recruiting||N/A|60|Anticipated|Centre Hospitalier Charles Perrens, Bordeaux||2|||f||||f||||||||||2017-10-10 21:30:35.486599|2017-10-10 21:30:35.486599
NCT03000972|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-12-19|||January 2014||2014-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||PFN-A Augmentation for Intertrochanteric Femoral Fractures|PFN-A Intramedullary Nail and Intertrochanteric Hip Fracture. Augmentation of the Femoral Head Assessed by PET-CT (Positron Emission Tomography - Computed Tomography)- a Randomized Trial|Recruiting||N/A|20|Anticipated|Uppsala University||2|||f||||f||||||||No||2017-10-10 21:30:35.614477|2017-10-10 21:30:35.614477
NCT03000959|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-19|||April 2016||2016-04-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||Stroke Unit in the Philippines: Is it Effective|Stroke Unit in the Philippines: Is it Effective?|Recruiting||N/A|922|Anticipated|Jose R. Reyes Memorial Medical Center|||1||f||||t||||||||Undecided|Computerized|2017-10-10 21:30:35.74839|2017-10-10 21:30:35.74839
NCT03000946|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||February 2017||2017-02-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|PREFIPS||Prevention of Postoperative Pancreatic Fistulaby Somatostatin|Prevention of Postoperative Pancreatic Fistula by SOMATOSTATIN Compared to OCTREOTIDE: Prospective, Randomized, Controlled Study|Not yet recruiting||Phase 3|654|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:30:35.832856|2017-10-10 21:30:35.832856
NCT03000933|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-06-27|||January 16, 2017|Actual|2017-01-16|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|HYPER2||Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)|Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men Following Introduction of Universal Male HPV Vaccination Program in Australia|Recruiting||N/A|200|Anticipated|The Alfred|||1||f||||f||||||Samples With DNA|"     1. Oral sampling for HPV        2. Anal sampling for HPV&        3. Penile sampling for HPV        4. Blood for HPV, HIV, Syphilis        5. Anal swabs for rectal gonorrhoea and chlamydia        6. Pharyngeal swabs for gonorrhoea and chlamydia        7. Urine sample for gonorrhoea and chlamydia      Oral, penile, and anal specimens will be collected from each man at two visits 7 days apart.     Routine HIV and STI (chlamydia, gonorrhoea, and syphilis) screening will be performed at     baseline (Day 0).   "|No||2017-10-10 21:30:35.94222|2017-10-10 21:30:35.94222
NCT03000920|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-05-02|||May 2017|Anticipated|2017-05-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|USIMaPI||Evaluation of the Short Message Service Effectiveness in the Screening Invitation Strategy for Breast Cancer (USIMaPI)|Multicenter Randomized Controlled Trial Evaluating the Effectiveness and Cost-effectiveness of the Use of Short Message Service (SMS) in the Screening Invitation Strategy for Breast Cancer.|Not yet recruiting||N/A|12000|Anticipated|University Hospital, Tours||4|||f||||f|f|f||||||No||2017-10-10 21:30:36.029844|2017-10-10 21:30:36.029844
NCT03000907|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-22|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|PRE-FROB||Efficacy of an Intervention to Prevent Frailty in Obese Elderly People (PRE-FROB)|Efficacy of a Multimodal Intervention in the Prevention of Frailty in Obese Elderly People and Study of the Pathophysiological Mechanisms Involved|Not yet recruiting||N/A|360|Anticipated|Consorci Sanitari del Maresme||2|||f||||f||||||||No||2017-10-10 21:30:36.15876|2017-10-10 21:30:36.15876
NCT03000894|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-19|||January 2017||2017-01-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||CBT-I as Early Intervention of Mood Disorders|Cognitive Behavioral Therapy for Insomnia as a Transdiagnostic Early Intervention of Mood Disorders: A Randomized Controlled Trial|Not yet recruiting||N/A|200|Anticipated|The University of Hong Kong||2|||f||||||||||||||2017-10-10 21:30:36.242077|2017-10-10 21:30:36.242077
NCT03000881|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-05-29|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Interventional|||Evaluation of the Influence of Output on Skin Covered by Adhesives||Completed||N/A|15|Actual|Coloplast A/S||1|||f||||f||||||||No||2017-10-10 21:30:36.340764|2017-10-10 21:30:36.340764
NCT03000868|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison of Small Colorectal Polyp Removal Using Cold EMR With Hot EMR|Comparison of Small Colorectal Polyp Removal Using Cold Endoscopic Mucosal Resection With Hot Endoscopic Mucosal Resection: a Pilot Study|Not yet recruiting||N/A|40|Anticipated|Chonnam National University Hospital||2|||f||||f||||||||No|Individual participant data are not planned to be shared to other researchers.|2017-10-10 21:30:36.419946|2017-10-10 21:30:36.419946
NCT03000855|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|DRCBD||EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures|EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures. A Multi-centred Randomised Controlled Trial|Recruiting||Phase 2/Phase 3|77|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 21:30:36.51724|2017-10-10 21:30:36.51724
NCT03000842|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Effects of Transcutaneous Vagal Nerve Stimulation on Hemodynamics Parameters|Effects of Transcutaneous Vagal Nerve Stimulation (tVNS) on Blood Pressure, Heart Rate and Autonomic Control in Hypertensive Subjects|Not yet recruiting||N/A|28|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||t||||||||||2017-10-10 21:30:36.633465|2017-10-10 21:30:36.633465
NCT03000829|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-03|||December 2016||2016-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|COPILOT-Sim||Code Blue Outcomes & Process Improvement Through Leadership Optimization Using Teleintensivists-Simulation|Code Blue Outcomes & Process Improvement Through Leadership Optimization Using Teleintensivists-Simulation|Recruiting||N/A|2000|Anticipated|Intermountain Health Care, Inc.||2|||f||||f||||||||||2017-10-10 21:30:36.704491|2017-10-10 21:30:36.704491
NCT03000816|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-08-20|||December 2016||2016-12-01|December 2016|2016-12-01|December 2021||2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of SBRT for OligoMetastatic ESCC|A Phase 2 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of OligoMetastatic Esophageal Squamous Cell Carcinoma|Recruiting||N/A|34|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-10 21:30:36.823876|2017-10-10 21:30:36.823876
NCT03000803|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-19|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Circadian Control of Human Circulating Endocannabinoid Levels|Circadian Control of Human Circulating Endocannabinoid Levels|Not yet recruiting||N/A|100|Anticipated|University of Chicago||2|||f||||f||||||||Undecided|There is currently no plan to make IPD available to other researchers.|2017-10-10 21:30:36.917258|2017-10-10 21:30:36.917258
NCT03000790|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation Lingual Ring Splint|Clinical Evaluation of Lingual Ring Splint For Management Anterior Disc Displacement With Reduction (Pilot Study Clinical Trial)|Not yet recruiting||N/A|10|Anticipated|Cairo University||1|||f||||f||||||||No||2017-10-10 21:30:36.992094|2017-10-10 21:30:36.992094
NCT03000777|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-26|||February 2016||2016-02-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|MELATOZINC||Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)|An Unicentric, Double-blind, Placebo Controlled, Phase IV Clinical Trial of Oral Melatonin Plus Zinc to Evaluate Relieving Self-reported Fatigue in CFS/ME|Completed||N/A|60|Actual|Laboratorios Viñas, S.A.||2|||f||||f||||||||||2017-10-10 21:30:37.07468|2017-10-10 21:30:37.07468
NCT03000764|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-06-09|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|SPLICI-Rad||RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer|Study of RNA and Heat Shock Protein (HSP) Derived Biomarkers in Radiation-induced Fibrosis in Patients Treated for Breast Cancer.|Recruiting||N/A|20|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f|f|f||||||No||2017-10-10 21:30:37.17773|2017-10-10 21:30:37.17773
NCT03000751|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-08-31|||September 2014||2014-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||CT DOSE Collaboratory|CT Dose Optimization and Standardization Endeavor (DOSE) Collaboratory|Active, not recruiting||N/A|1200000|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-10 21:30:37.289814|2017-10-10 21:30:37.289814
NCT03000569|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-08|||December 2016||2016-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate SAGE-217 in Subjects With Parkinson's Disease|A Phase 2, Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in Subjects With Parkinson's Disease|Recruiting||Phase 2|30|Anticipated|Sage Therapeutics||1|||f||||f||||||||||2017-10-10 21:30:38.99595|2017-10-10 21:30:38.99595
NCT03000738|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-03-30|||December 2016||2016-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||The Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Lymphomas|The Value and Potential Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Non-Hodgkin Lymphomas.|Not yet recruiting||N/A|100|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||Samples Without DNA|"     peripheral blood   "|Undecided||2017-10-10 21:30:37.535358|2017-10-10 21:30:37.535358
NCT03000725|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Adapting Project UPLIFT for Hispanic Patients With Epilepsy II|Adapting Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is for Hispanic Patients With Epilepsy II|Recruiting||N/A|72|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 21:30:37.614166|2017-10-10 21:30:37.614166
NCT03000712|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-05-28|||November 2016||2016-11-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Interventional|||Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.|Single-center, Randomized, Open Label, Negative-controlled Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC(Autologous Adipose Tissue Derived Mesenchymal Stem Cells) After High Tibial Osteotomy Compared to Negative Control in the Osteoarthritis Patients.|Recruiting||N/A|26|Anticipated|Biostar||2|||f||||f||||||||No||2017-10-10 21:30:37.705793|2017-10-10 21:30:37.705793
NCT03000699|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-08-02|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction|Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction|Recruiting||N/A|88|Anticipated|Centre for Addiction and Mental Health||2|||f||||t|f|f||||||||2017-10-10 21:30:37.821867|2017-10-10 21:30:37.821867
NCT03000686|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-06-19|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|December 21, 2017|Anticipated|2017-12-21|December 21, 2017|Anticipated|2017-12-21||Interventional|||Study of GSK2586881 on Acute Hypoxia and Exercise|The Effects of GSK2586881 on the Responses to Acute Hypoxia and Exercise|Recruiting||Phase 1|25|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 21:30:37.919543|2017-10-10 21:30:37.919543
NCT03000673|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2017-10-03|||May 23, 2017|Actual|2017-05-23|October 2017|2017-10-01|October 25, 2017|Anticipated|2017-10-25|October 24, 2017|Anticipated|2017-10-24||Interventional|||A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis|A Study to Assess Safety and Tolerability of Single Oral Doses of BMS-986177 in Patients With ESRD Treated With Chronic Hemodialysis|Recruiting||Phase 1/Phase 2|32|Anticipated|Bristol-Myers Squibb||4|||f||||f|t|f||||||||2017-10-10 21:30:38.025343|2017-10-10 21:30:38.025343
NCT03000660|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis|A Phase I Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis|Recruiting||Phase 1|25|Anticipated|Tufts Medical Center||1|||f||||f||||||||No||2017-10-10 21:30:38.16218|2017-10-10 21:30:38.16218
NCT03000647|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-08-28|||October 2015||2015-10-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Guided Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence in Relapsing-Remitting Multiple Sclerosis|Assessment of the Effectiveness of Guided by a Physiotherapist Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence (UI) in Patients With Relapsing-Remitting (RR) Multiple Sclerosis|Completed||N/A|48|Actual|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz||2|||f||||f||||||||||2017-10-10 21:30:38.406656|2017-10-10 21:30:38.406656
NCT03000634|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-04-12|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|||2015-09: A Phase II Randomized, Open-label Study of Anti-signaling Lymphocytic Activation Molecule Monoclonal Antibody During Maintenance Therapy|2015-09: A Phase II Randomized, Open-label Study of Anti-SLAMF7 mAb During Maintenance Therapy Versus Standard Maintenance Therapy in Gene Expression Profiling (GEP)- Defined Low Risk Multiple Myeloma Patients With High Risk Cytogenetic Abnormalities|Withdrawn||Phase 2|0|Actual|University of Arkansas||2||Study was not and will not be initiated due to lack of funding.|f||||t|t|f||||||No||2017-10-10 21:30:38.505997|2017-10-10 21:30:38.505997
NCT03000621|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-05-24|||December 2016|Actual|2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Comparative Study of Circulating microRNA Changes in Patients With Liver Injury and Healthy Subjects|Comparative Study of Circulating microRNA Changes in Patients With Liver Injury and Healthy Subjects|Recruiting||N/A|200|Anticipated|University of Electronic Science and Technology of China|||2||f||||||||||Samples Without DNA|"     Whole blood extraction from subjects subsequently separated to plasma   "|||2017-10-10 21:30:38.601559|2017-10-10 21:30:38.601559
NCT03000608|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-10-04|||May 17, 2017|Actual|2017-05-17|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Trial for Treatment of Mild-to Moderate Plaque Psoriasis in Adults|A Double-Blind, Multi-Center, Randomized, Placebo Controlled Safety, Tolerability & Efficacy Trial Of A New Botanical Drug Product At One Dose Level For The Treatment Of Mild-To-Moderate Plaque Psoriasis In Adult Subjects|Recruiting||Phase 2|72|Anticipated|Santalis Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:30:38.680422|2017-10-10 21:30:38.680422
NCT03000595|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-07-19|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||A Trial of Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis|A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Botanical Drug Product, Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis|Not yet recruiting||Phase 2|72|Anticipated|Santalis Pharmaceuticals, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:30:38.79831|2017-10-10 21:30:38.79831
NCT03000582|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-19|||June 2014||2014-06-01|December 2016|2016-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|NB3||Assessment of Different Forms of Creatine|Pharmacokinetic Assessment of Acute Ingestion of Different Forms of Creatine|Completed||N/A|13|Actual|Texas A&M University||4|||f||||t||||||||No||2017-10-10 21:30:38.892066|2017-10-10 21:30:38.892066
NCT03000556|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-19|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation|0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation After Corneal Abrasions: a Pilot Study|Recruiting||Phase 3|60|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Yes||2017-10-10 21:30:39.137948|2017-10-10 21:30:39.137948
NCT03000543|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-21|||November 2016||2016-11-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Novel Isotope Dilution Technique to Assess Vitamin A Status and Hypervitaminosis A|Validation of a Novel Isotope Dilution Technique to Assess Vitamin A Status in Infants and Children in Bangladesh and Assessment of Plausible Risk of Hypervitaminosis A Among Preschoolers in Bangladesh|Recruiting||Phase 1/Phase 2|245|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||||||||||||2017-10-10 21:30:39.227875|2017-10-10 21:30:39.227875
NCT03000530|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-08-04|||December 2016||2016-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate SAGE-217 in Subjects With Moderate to Severe Major Depressive Disorder|A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 in the Treatment of Adult Subjects With Moderate to Severe Major Depressive Disorder|Recruiting||Phase 2|98|Anticipated|Sage Therapeutics||2|||f||||f||||||||||2017-10-10 21:30:39.331599|2017-10-10 21:30:39.331599
NCT03000517|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-01|||May 2016||2016-05-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|||PK of Levofloxacin in MDR-TB Patients|Pharmacokinetics of Levofloxacin in MDR-TB Patients|Recruiting||N/A|20|Anticipated|University Medical Center Groningen|||1||f||||f||||||Samples Without DNA|"     Plasma and saliva samples of MDR-TB patients on 0 hr premedication and 1,2,4,8 hrs post     mediation.   "|||2017-10-10 21:30:39.459452|2017-10-10 21:30:39.459452
NCT03000504|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-23|||March 2017||2017-03-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Ballooned Intercostal Drain Trial|A Randomized, Controlled Trial of the Use of a Dedicated Ballooned Intercostal Tube|Not yet recruiting||Phase 3|178|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||No||2017-10-10 21:30:39.555209|2017-10-10 21:30:39.555209
NCT03000491|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-01-20|||December 2016||2016-12-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Learning Health System for Asthma|Developing a National Learning Health System for Asthma to Reduce the Risk of Asthma Attacks and the Risk of Asthma Hospitalisations and Deaths|Not yet recruiting||N/A|750000|Anticipated|University of Edinburgh|||1||f||||f||||||||No||2017-10-10 21:30:39.660219|2017-10-10 21:30:39.660219
NCT03000478|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-20|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|VRET||Virtual Reality Exposure Therapy for Combat|Virtual Reality Treatment for Combat Related PTSD: Is Virtual Azza More Effective Than Traditional Exposure Treatment?|Recruiting||N/A|40|Anticipated|Bar-Ilan University, Israel||2|||f||||f||||||||No||2017-10-10 21:30:39.735535|2017-10-10 21:30:39.735535
NCT03000465|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-19|||May 2015||2015-05-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|IPPCollapseI||Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery|Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse-I)|Completed||N/A|92|Actual|Hospital Universitario La Fe|||1||f||||f||||||||Undecided||2017-10-10 21:30:39.828643|2017-10-10 21:30:39.828643
NCT03000452|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-27|||March 14, 2017|Actual|2017-03-14|September 2017|2017-09-01|July 27, 2020|Anticipated|2020-07-27|July 27, 2020|Anticipated|2020-07-27||Interventional|FUSION-MM-005||A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)|MEDI4736-MM-005 (FUSION MM-005): A Phase 2, Multicenter, Single-Arm, Study to Determine the Efficacy for the Combination of Durvalumab (DURVA) Plus Daratumumab (DARA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) That Have Progressed While on Current Treatment Regimen Containing Daratumumab.|Active, not recruiting||Phase 2|120|Anticipated|Celgene||1|||f||||t|t|f||||||||2017-10-10 21:30:39.930382|2017-10-10 21:30:39.930382
NCT03000426|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-17|||November 2016||2016-11-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Photobiomodulation of Palatal Donor Site After Free Gingival Graft Removal|Comparison of Two Energy Densities for Photobiomodulation of Palatal Donor Site After Free Gingival Graft Removal. Randomized Clinical Trial|Recruiting||N/A|45|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||f||||||||Undecided||2017-10-10 21:30:40.240255|2017-10-10 21:30:40.240255
NCT03000413|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-12-19|||August 2015||2015-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|MACANUDO||Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial|Ketamine Efficacy for Acute Severe Bronchospasm in Mechanically Ventilated-critically Ill Patients: a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|90|Anticipated|Hospital Nossa Senhora da Conceicao||2|||f||||f||||||||||2017-10-10 21:30:40.336063|2017-10-10 21:30:40.336063
NCT03000400|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-05-10|||January 2017||2017-01-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Family Centered Intervention After Traumatic Brain Injury|The Family as a Resource for Improving Patient and Family Functioning After Traumatic Brain Injury. A Randomized Controlled Trial of a Family Centered Intervention|Recruiting||N/A|200|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 21:30:40.427909|2017-10-10 21:30:40.427909
NCT03000387|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|April 2021|Anticipated|2021-04-01|December 2020|Anticipated|2020-12-01||Interventional|||Personalized Dosing of Nicotine Replacement (NRT to Effect)|Personalized Dosing of Nicotine Replacement for Smoking Cessation: An Effectiveness Randomized Placebo-controlled Trial|Not yet recruiting||Phase 3|500|Anticipated|Centre for Addiction and Mental Health||3|||f||||f||||||||No||2017-10-10 21:30:40.525745|2017-10-10 21:30:40.525745
NCT03000374|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-08-01|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|PIER||Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery|Preoperative Induction Therapy With 12 Weeks of Panitumumab in Combination With mFOLFOX-6 in an Enriched Population (Quadruple Wild-Type) of Patients With mrT3 Rectal Cancer of the Middle Third With Clear Mesorectal Fascia|Recruiting||Phase 2|47|Anticipated|Grupo Espanol Multidisciplinario del Cancer Digestivo||1|||f||||f|f|f||||||||2017-10-10 21:30:40.639175|2017-10-10 21:30:40.639175
NCT03000361|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-07-28|||December 2016||2016-12-01|July 2017|2017-07-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|MSCT||Motorized Spiral Colonoscopy Trial: A First Feasibility Trial|Motorized Spiral Colonoscopy Trial (MSCT): A First Feasibility Trial|Completed||N/A|30|Actual|Evangelisches Krankenhaus Düsseldorf||1|||f||||f||||||||||2017-10-10 21:30:40.793486|2017-10-10 21:30:40.793486
NCT03000348|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-08-03|||December 2016||2016-12-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|CARE-CF1||A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease|Recruiting||Phase 2|120|Anticipated|NovaBiotics Ltd.||6|||f||||t||||||||||2017-10-10 21:30:40.883799|2017-10-10 21:30:40.883799
NCT03000335|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-26|||December 2016||2016-12-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|May 2019|Anticipated|2019-05-01||Observational|||Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk|Evaluation of ProALL microRNAs in Blood Specimen for Prediction of Acute Lymphoblastic Leukemia Relapse Risk|Recruiting||N/A|65|Anticipated|Curewize Health Ltd.|||2||f||||f||||||Samples Without DNA|"     Blood samples will be collected and transcribed to RNA. RNA samples will be retained.   "|||2017-10-10 21:30:41.085288|2017-10-10 21:30:41.085288
NCT03000322|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Cooling Vest in Men With Hot Flashes|Investigation of a Cooling Vest in Men With Chemotherapy-Induced Hot Flashes|Recruiting||N/A|10|Anticipated|Englewood Hospital and Medical Center||1|||f||||||||||||||2017-10-10 21:30:41.186553|2017-10-10 21:30:41.186553
NCT03000309|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-03-16|||December 29, 2016|Actual|2016-12-29|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy|Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy|Recruiting||Phase 4|20|Anticipated|Derm Research, PLLC||1|||f||||f||||||||No||2017-10-10 21:30:41.263594|2017-10-10 21:30:41.263594
NCT03000296|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-21|||October 2013||2013-10-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2016|Actual|2016-12-01||Interventional|AutoChron||Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease|Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease|Recruiting||Phase 1/Phase 2|20|Anticipated|Beneficência Portuguesa de São Paulo||1|||f||||t||||||||Yes|The main objective is observe the safety and clinical benefit of autologous HSCT therapy in refractory patients with Crohn's disease. Evaluation during transplant period and 1, 3, 6, 12 and 24 months post-transplant. Safety be evaluated by the amount of related adverse events. Record adverse events in a standardized way. Secondary outcome measures will be disease remission: 1, 3, 6, 12 and 24 months post-transplant both clinical and endoscopic remission. The percentage of patients in sustained disease remission at 1, 3, 6, 12 and 24 months post HSCT will be determined. Sustained disease remission is defined as a CDAI < 150; HBI <4, CCSI< 16, without the use of corticosteroids, immunosuppressant or biologic agents. Mucosal healing will be assessed during ileocolonoscopy at 6, 12, and 24 months following HSCT using SES, CDEIS and Rutgeerts endoscopy index. Heath Quality life, Short Form 36 and IBDQ at 1 3 6 12 and 24 months post-Transplant.|2017-10-10 21:30:41.349956|2017-10-10 21:30:41.349956
NCT03000283|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-04-04|||January 2017||2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study|Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study|Enrolling by invitation||N/A|7|Anticipated|Allina Health System||1|||f||||f||||||||No||2017-10-10 21:30:41.436008|2017-10-10 21:30:41.436008
NCT03000270|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-06-19|||April 11, 2017|Actual|2017-04-11|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|DTU||Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction|Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction to Reduce Infarct Size (DTU): A Prospective Feasibility Study|Recruiting||N/A|50|Anticipated|Abiomed Inc.||2|||f||||f|f|t|f|f||||No||2017-10-10 21:30:41.554356|2017-10-10 21:30:41.554356
NCT03000257|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-07-17|||December 20, 2016||2016-12-20|July 2017|2017-07-01|September 18, 2019|Anticipated|2019-09-18|June 12, 2018|Anticipated|2018-06-12||Interventional|||A Study of ABBV-181 in Participants With Advanced Solid Tumors|A Multicenter, Phase 1, Open-Label, Dose-Escalation Study of ABBV-181, a Monoclonal Antibody, as Monotherapy and in Combination With Another Anti-Cancer Therapy in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|158|Anticipated|AbbVie||2|||f||||f||||||||||2017-10-10 21:30:41.64031|2017-10-10 21:30:41.64031
NCT03000244|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-21|2017-08-22|||December 16, 2016||2016-12-16|August 17, 2017|2017-08-17|August 12, 2021|Anticipated|2021-08-12|August 12, 2021|Anticipated|2021-08-12||Observational|||Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation|Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:30:41.742847|2017-10-10 21:30:41.742847
NCT03000231|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-02-07|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency|Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency: a Case Control Study|Recruiting||N/A|24|Anticipated|University of Chicago|||2||f||||f||||||Samples Without DNA|"     Blood   "|No||2017-10-10 21:30:41.812962|2017-10-10 21:30:41.812962
NCT03000023|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-14|||October 2016||2016-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|||Anticipated and Perceived Benefits Following Hepatitis C Treatment|A Qualitative and Quantitative Evaluation of Patients' Anticipated and Perceived Treatment Benefits Following HCV Viral Eradication|Recruiting||N/A|100|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 21:30:44.955165|2017-10-10 21:30:44.955165
NCT03000218|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-12-22|||August 2016||2016-08-01|December 2016|2016-12-01||||June 2017|Anticipated|2017-06-01||Interventional|||Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems|Clinical Study Evaluating Pharmacokinetics and Biomarkers After Ursodeoxycholic Acid (UDCA) Administration to Subjects Who Are Overweight and Have Liver Problems|Recruiting||Phase 1|30|Anticipated|Seoul National University Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:30:41.886314|2017-10-10 21:30:41.886314
NCT03000205|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-08-30|||June 2016||2016-06-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of Hypertonic Dextrose Water Injection for Supraspinatus Tendinosis Patients|Effects of Hypertonic Dextrose Water Injection for Supraspinatus Tendinosis Patients: Analysis of Clinical and Sonographic Presentation|Recruiting||N/A|60|Anticipated|Taipei Medical University Shuang Ho Hospital||2|||f||||f||||||||||2017-10-10 21:30:41.971298|2017-10-10 21:30:41.971298
NCT03000192|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-02-08|||August 2016||2016-08-01|February 2017|2017-02-01||||December 2020|Anticipated|2020-12-01||Observational|||HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life|HORIZONS: a Cohort Study to Explore Recovery of Health and Well-being in Adults Diagnosed With Cancer|Recruiting||N/A|3000|Anticipated|University Hospital Southampton NHS Foundation Trust|||3||f||||t||||||||Yes|We encourage and facilitate data sharing by researchers from all disciplines. If you would like more information on how to access the HORIZONS data resource please contact the team at HORIZONS@soton.ac.uk.|2017-10-10 21:30:42.224134|2017-10-10 21:30:42.224134
NCT03000179|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-10-04|||March 3, 2017|Actual|2017-03-03|October 2017|2017-10-01|April 15, 2023|Anticipated|2023-04-15|April 15, 2022|Anticipated|2022-04-15||Interventional|||Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma|Pilot Study to Investigate the Safety and Efficacy of Avelumab Monotherapy in Patients With Advanced or Metastatic Adenocarcinoma of the Small Intestine|Recruiting||Phase 1|25|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:30:42.353593|2017-10-10 21:30:42.353593
NCT03000166|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-03-14|||January 31, 2017|Actual|2017-01-31|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Step-Up Intervention for Self-Management of Fatigue in Young Adults Receiving Chemotherapy|Step-Up Intervention for Self-Management of Fatigue in Young Adults Receiving Chemotherapy|Recruiting||N/A|75|Anticipated|University of Wisconsin, Milwaukee||2|||f||||t|f|f||||||No||2017-10-10 21:30:42.463387|2017-10-10 21:30:42.463387
NCT03000153|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-05-03|||May 27, 2017|Anticipated|2017-05-27|May 2017|2017-05-01|June 1, 2017|Anticipated|2017-06-01|May 27, 2017|Anticipated|2017-05-27||Interventional|||Effectiveness of Tracking Goals in Counselling|Goals in Mind: A Randomised Controlled Evaluation of the Effectiveness of Tracking Goals in Counselling|Not yet recruiting||N/A|100|Anticipated|University of Roehampton||2|||f||||f|f|f||||||No||2017-10-10 21:30:42.577098|2017-10-10 21:30:42.577098
NCT03000140|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2016-12-20|||March 2015||2015-03-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||High-Intensity Interval Training on Pre-Hypertensive Subjects|Health Status Factors Predicting Responses to Long-Term Training: Effects of 16-Week High-Intensity Interval Training on Pre-Hypertensive Subjects|Recruiting||N/A|142|Anticipated|Universidad Santo Tomas||2|||f||||t||||||||||2017-10-10 21:30:42.690864|2017-10-10 21:30:42.690864
NCT03000127|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-05-01|||July 1, 2018|Anticipated|2018-07-01|May 2017|2017-05-01|January 1, 2024|Anticipated|2024-01-01|June 30, 2023|Anticipated|2023-06-30||Interventional|||Testosterone for Fatigue in Men With MS|A Pilot Trial of Testosterone Treatment for Fatigue in Men With Multiple Sclerosis|Not yet recruiting||Phase 2|48|Anticipated|University of California, Los Angeles||1|||f||||f|t|f|||t|||No||2017-10-10 21:30:42.821207|2017-10-10 21:30:42.821207
NCT03000114|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2016-12-20|||January 2016||2016-01-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease|Comparison of Collagenase Injection and Percutaneous Needle Aponeurotomy for Treatment of Dupuytren's Disease|Recruiting||Phase 4|334|Anticipated|University of Calgary||2|||f||||f||||||||Undecided||2017-10-10 21:30:42.978146|2017-10-10 21:30:42.978146
NCT03000101|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|POME2016||Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Diseases|New Insight and Knowledge on Anti-inflammatory Effectiveness of Dietary Phenolics (NIKE)|Recruiting||Phase 1|36|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||f||||||||No||2017-10-10 21:30:43.154364|2017-10-10 21:30:43.154364
NCT03000088|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-03-02|2017-01-13||March 2016||2016-03-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Stylet Angle for McGrath Videolaryngoscopy||Completed||N/A|140|Actual|Ajou University School of Medicine|||2||f||||||||||||||2017-10-10 21:30:43.368588|2017-10-10 21:30:43.368588
NCT03000075|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-10-03|||December 2016|Actual|2016-12-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|September 2017|Actual|2017-09-01||Interventional|||BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis|A Phase II/III, Randomized, Double-blind Study to Evaluate Efficacy and Safety of Two Different Dose Regimens of BI 655066 (Risankizumab) and Placebo and Maintenance of Response of BI 655066 (Risankizumab) Administered Subcutaneously in Japanese Patients With Moderate to Severe Chronic Plaque Type Psoriasis.|Active, not recruiting||Phase 2|171|Actual|AbbVie||3|||f||||t||||||||||2017-10-10 21:30:43.808755|2017-10-10 21:30:43.808755
NCT03000062|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-18|||January 2017||2017-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of Overweight in General Practice|Treatment of Overweight in General Practice|Not yet recruiting||N/A|24|Anticipated|University of Oslo||2|||f||||t||||||||Undecided|Data on all outcomes will be available to researchers on request|2017-10-10 21:30:44.003011|2017-10-10 21:30:44.003011
NCT03000049|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-21|||November 2016||2016-11-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|BEMIDIA||Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study|Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study|Recruiting||N/A|500|Anticipated|University Medicine Greifswald|||1||f||||f||||||||No||2017-10-10 21:30:44.724906|2017-10-10 21:30:44.724906
NCT03000036|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-18|||July 2012||2012-07-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|January 2015|Actual|2015-01-01||Interventional|||Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients|Doxorubicin-associated Cardiac Tissue Remodeling Followed by CMR of Myocardial Extracellular Volume and Myocyte Size in Breast Cancer Patients|Completed||N/A|27|Actual|University of Campinas, Brazil||1|||f||||f||||||||No||2017-10-10 21:30:44.812256|2017-10-10 21:30:44.812256
NCT02999997|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-05-01|||January 2017||2017-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|RGM/PD||Evaluation of Ronnie Gardiner Method in Individuals With Parkinson's Disease|Randomized Controlled Trial to Evaluate the Rhythm and Music Based Rehabilitation Method the Ronnie Gardiner Method Regarding Dual-task in Individuals With Parkinson's Disease|Recruiting||N/A|60|Anticipated|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-10 21:30:45.174594|2017-10-10 21:30:45.174594
NCT02999984|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-04|||December 2016||2016-12-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Autologous Cryopreserved CD34+ Hematopoietic Cells Transduced With EFS-ADA Lentivirus for ADA SCID|Efficacy and Safety of a Cryopreserved Formulation of Autologous CD34+ Hematopoietic Stem Cells Transduced Ex Vivo With EFS Lentiviral Vector Encoding for Human ADA Gene in Subjects With ADA Deficiency Severe Combined Immunodeficiency|Recruiting||Phase 1/Phase 2|10|Anticipated|University of California, Los Angeles||1|||f||||t||||||||No||2017-10-10 21:30:45.311326|2017-10-10 21:30:45.311326
NCT02999971|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2016-12-20|||February 2013||2013-02-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Effects of an Aquatic Therapy Program Versus a Land Program in Patients Who Suffered a Stroke|Effects of an Aquatic Circuit Class Therapy Program Versus a Land Circuit Class Therapy Program in Patients Who Suffered a Stroke|Completed||Phase 3|21|Actual|Universidade da Coruña||2|||f||||f||||||||No||2017-10-10 21:30:45.448797|2017-10-10 21:30:45.448797
NCT02999958|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-22|||December 2016||2016-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|Antioxidants||Adding Antioxidants Into Human Sequential Culture Media System|Comparison of G-Series Media System With Antioxidants Versus Standard G-Series Media System|Recruiting||N/A|128|Anticipated|Vitrolife||2|||f||||t||||||||No||2017-10-10 21:30:45.539062|2017-10-10 21:30:45.539062
NCT02999945|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-25|||June 2018|Anticipated|2018-06-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|OPTIGROW||Optimal Growth of Preterm Infants With Growth Restriction|Body Composition, Metabolic Programming and Long Term Outcome of Growth Restricted Preterm Infants Under Different Nutritional Management A Prospective Randomized Controlled Multicenter Trial|Not yet recruiting||N/A|348|Anticipated|Medical University of Vienna||4|||f||||t|f|f||||||||2017-10-10 21:30:45.640196|2017-10-10 21:30:45.640196
NCT02999932|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-05|||February 18, 2017|Actual|2017-02-18|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|POSDOT||Pulse Oxygen Saturation (SpO2) Directed Oxygen Therapy|Effect of Low vs High Pulse Oxygen Saturation (SpO2) Directed Oxygen Therapy on Mortality Among Critically Ill Patients|Recruiting||N/A|1718|Anticipated|Wuhan Union Hospital, China||2|||f||||f||||||||Undecided||2017-10-10 21:30:45.762422|2017-10-10 21:30:45.762422
NCT02999919|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2016-12-20|||April 2015||2015-04-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Body Mass Index and Post-dural Puncture Headache|The Relationship Between Body Mass Index and Post-dural Puncture Headache in Pregnant Women|Completed||N/A|420|Actual|Sakarya University||2|||f||||f||||||||No||2017-10-10 21:30:45.878073|2017-10-10 21:30:45.878073
NCT02999906|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-06-29|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Interventional|||Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Compare the Efficacy and Safety of Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension|Not yet recruiting||Phase 3|600|Anticipated|United Therapeutics||2|||f||||t|t|f||||||||2017-10-10 21:30:45.970476|2017-10-10 21:30:45.970476
NCT02999893|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-05-17|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|April 30, 2023|Anticipated|2023-04-30|June 30, 2019|Anticipated|2019-06-30||Interventional|APROC||A Study of APR-246 in Oesophageal Cancer|A phase1b/2 Study Evaluating the Efficacy of APR-246, a First-in-class Agent Targeting Mutant p53 in the Treatment of Platinum Resistant Advanced and Metastatic Oesophageal or Gastro-oesophageal Junction Cancers|Recruiting||Phase 1/Phase 2|38|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t|f|f||||||||2017-10-10 21:30:46.050484|2017-10-10 21:30:46.050484
NCT02999880|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-18|||July 2017||2017-07-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Layering Technique Selection for Ultimate Aesthetics in Anterior Composites|Clinical Performance of Direct Anterior Composite Restorations Using Innovative Esthetic Dual-Shade Versus Polychromatic Natural Layering Technique Randomized Clinical Trial|Not yet recruiting||N/A|2|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:30:46.192746|2017-10-10 21:30:46.192746
NCT02999867|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-20|||March 2017||2017-03-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Triticale, Mung Bean and Adzuki Bean Intervention on Patients With Type 2 Diabetes|Effect of Triticale, Mung Bean and Adzuki Bean Intervention on Metabolic and Nutritional Status of Patients With Type 2 Diabetes Mellitus|Not yet recruiting||N/A|180|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:30:46.245263|2017-10-10 21:30:46.245263
NCT02999854|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-07-19|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|HATCY||Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer|A Phase III, Multicenter, Randomized Controlled Study to Compare Safety and Efficacy of a Haploidentical HSCT and Adjunctive Treatment With ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted ex Vivo of Host Alloreactive T-cells, Versus a Haploidentical HSCT With Post-transplant Cyclophosphamide in Patients With a Hematologic Malignancy|Not yet recruiting||Phase 3|195|Anticipated|Kiadis Pharma||2|||f||||t|t|f||||||||2017-10-10 21:30:46.33167|2017-10-10 21:30:46.33167
NCT02999841|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-12-18|||March 2016||2016-03-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|VISA-T2DM||Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients|Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Overweight and Obesity Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Randomized Control Study|Recruiting||Phase 4|100|Anticipated|Peking University||2|||f||||f||||||||No|Do not share data.|2017-10-10 21:30:46.430746|2017-10-10 21:30:46.430746
NCT02999828|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-03-31|||September 2016|Actual|2016-09-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||The Phase IVa of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17)|The Safety, Immune Persistence and Consistency of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17)|Active, not recruiting||Phase 4|20770|Actual|Chinese Academy of Medical Sciences||1|||f||||t||||||||No|Participants do not agree to share individual data.|2017-10-10 21:30:46.532392|2017-10-10 21:30:46.532392
NCT02999815|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ITITTT||Intrathecal Tetanus Immunoglobulin to Treat Tetanus|Intrathecal Immunoglobulin for Treatment of Adult Patients With Tetanus: a Randomized Controlled 2x2 Factorial Trial|Active, not recruiting||Phase 1/Phase 2|272|Anticipated|Oxford University Clinical Research Unit, Vietnam||2|||f||||t||||||||Undecided||2017-10-10 21:30:46.614653|2017-10-10 21:30:46.614653
NCT02999802|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-08-01|||October 2015||2015-10-01|August 2017|2017-08-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|||Nutrient Sensing & Signaling in Aging Muscle|Nutrient Sensing & Signaling in Aging Muscle|Completed||N/A|19|Actual|The University of Texas Medical Branch, Galveston||1|||f||||t||||||||||2017-10-10 21:30:46.730829|2017-10-10 21:30:46.730829
NCT02999789|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-16|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|ITHACA||Interventions To Help Asthma Clinical Adherence|Interventions to Help Asthma Clinical Adherence|Not yet recruiting||Phase 4|30|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 21:30:46.797323|2017-10-10 21:30:46.797323
NCT02999776|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis|An Observer Partially-blinded, Lesion-randomized, Intra-patient Controlled, 3-arm, Phase I Study to Assess Safety and Efficacy of Laser-assisted Topical Etanercept Administration in Patients With Mild to Moderate Plaque Psoriasis|Recruiting||Phase 1|30|Anticipated|Pantec Biosolutions AG||3|||f||||t||||||||No||2017-10-10 21:30:46.86754|2017-10-10 21:30:46.86754
NCT02999763|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SlimShape Device for Abdominal Fat and Circumference Reduction|Clinical Study to Evaluate the Safety and Efficacy of the SlimShape Device for Abdominal Fat and Circumference Reduction|Recruiting||N/A|120|Anticipated|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 21:30:48.562421|2017-10-10 21:30:48.562421
NCT02999750|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-16|||October 2013||2013-10-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|December 2016|Actual|2016-12-01||Interventional|||EXtendedAnalysis for Cancer Treatment|EXACT: EXtendedAnalysis for Cancer Treatment A Prospective Investigator-initiated Translational Study Evaluating Individualized Treatment Regiments Based on Respective Biomarker Analyses for Refractory Cancer Patients|Active, not recruiting||N/A|55|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 21:30:48.675277|2017-10-10 21:30:48.675277
NCT02999737|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-10|||November 2016||2016-11-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia|Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial|Active, not recruiting||Phase 4|40|Actual|Skin Care and Laser Physicians of Beverly Hills||2|||f||||f||||||||No||2017-10-10 21:30:48.744786|2017-10-10 21:30:48.744786
NCT02999724|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-17|2017-02-12|||January 2017||2017-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|GROUP||"Gabapentin Reduces Opioid Use Postoperatively (GROUP Study)"|"Gabapentin Reduces Opioid Use Postoperatively (GROUP Study): A Randomized Control Trial in Women Undergoing Reconstructive Pelvic Surgery"|Recruiting||Phase 3|44|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||No||2017-10-10 21:30:48.826083|2017-10-10 21:30:48.826083
NCT02999711|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma|A Randomised, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Effects of Subcutaneously Administered REGN3500 in Adults Patients With Moderate Asthma|Recruiting||Phase 1|24|Anticipated|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 21:30:48.914643|2017-10-10 21:30:48.914643
NCT02999698|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-21|||February 2017||2017-02-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|||Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact|A Comparative Retrospective Study Between Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact|Not yet recruiting||N/A|100|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||f||||||||No||2017-10-10 21:30:48.996119|2017-10-10 21:30:48.996119
NCT02999685|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-12-19|||September 2016||2016-09-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients|Home-based Health Management of COPD Patients|Enrolling by invitation||N/A|115|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:30:49.079677|2017-10-10 21:30:49.079677
NCT02999672|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-21|||December 23, 2016|Actual|2016-12-23|September 2017|2017-09-01|December 20, 2019|Anticipated|2019-12-20|December 20, 2019|Anticipated|2019-12-20||Interventional|||A Study to Evaluate the Efficacy, and Safety of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Urothelial Bladder Cancer (UBC) or Pancreas/Cholangio Cancer (Kameleon Study)|Phase II, Exploratory, Multicenter, Non Randomized, Single Agent Cohort Study to Determine Best Tumor Response With Trastuzumab Emtansine in HER2 Overexpressing Solid Tumors|Recruiting||Phase 2|76|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 21:30:49.14983|2017-10-10 21:30:49.14983
NCT02999659|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|Pupillometry||Impact of Acute Cerebral Diseases on the Autonomous Nervous System: Progression and Correlation to Therapy and Outcome|Impact of Acute Cerebral Diseases on the Autonomous Nervous System: Progression and Correlation to Therapy and Outcome|Recruiting||N/A|300|Anticipated|RWTH Aachen University|||2||f||||f||||||||Undecided||2017-10-10 21:30:49.25063|2017-10-10 21:30:49.25063
NCT02999646|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-06-27|||June 27, 2017|Actual|2017-06-27|June 2017|2017-06-01|December 2024|Anticipated|2024-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC|Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced Head and Neck Squamous Cell Carcinoma. A Single Arm, Open Label, Multicenter Phase II Trial.|Recruiting||N/A|41|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f|f|f||||||No||2017-10-10 21:30:49.434999|2017-10-10 21:30:49.434999
NCT02999620|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-08-09|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|FMAT||FBCx (Alpha-CD) Mechanism of Action Trial|A Single Center, Randomized, Double-blind, Placebo Controlled, Two-way Crossover Study to Determine the Fat Losses in Stool Associated With Alpha-CD Use as Compared to Placebo Using a Radiotracer|Completed||N/A|8|Actual|SFI Research||2|||f||||f||||||||||2017-10-10 21:30:49.694965|2017-10-10 21:30:49.694965
NCT02999607|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2016-12-18|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Brain Glucose Metabolism During Transcranial Direct Current Stimulation|Brain Glucose Metabolism in Healthy Subjects and Depressive Patients During Transcranial Direct Current Stimulation|Recruiting||N/A|40|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 21:30:49.789767|2017-10-10 21:30:49.789767
NCT02999594|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-22|||December 2016||2016-12-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Tramadol for Labor Analgesia: a Placebo Controlled Randomised Control Trial|Tramadol for Labor Analgesia in Low Risk Women: A Placebo Controlled Randomized Trial|Not yet recruiting||Phase 2|86|Anticipated|Maulana Azad Medical College||2|||f||||f||||||||||2017-10-10 21:30:49.868736|2017-10-10 21:30:49.868736
NCT02999581|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-16|||March 2014||2014-03-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NB2||Effects of a Pre-Workout Dietary Supplement on Training Adaptations|Effects of a Pre-Workout Dietary Supplement on Training Adaptations in Resistance Trained Athletes|Completed||N/A|122|Actual|Texas A&M University||3|||f||||t||||||||No||2017-10-10 21:30:49.948358|2017-10-10 21:30:49.948358
NCT02999568|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-18|||February 2017||2017-02-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||The Effect of Exercise on Ovarian Reserve|Open Study to Examine How Different Levels of Physical Activity Impact the Ovarian Reserve During the Pre-menopausal Period|Not yet recruiting||N/A|100|Anticipated|Meir Medical Center|||2||f||||f||||||||||2017-10-10 21:30:50.034983|2017-10-10 21:30:50.034983
NCT02999555|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-18|2017-08-09|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Novel Evaluation of Aspirated Follicular Fluid|Presence and Quantification of Inflammatory Cytokines, Dendritic Cells, Vasorin and Soluble Flt1 in Aspirated Follicular Fluid|Recruiting||N/A|100|Anticipated|Meir Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:30:50.133898|2017-10-10 21:30:50.133898
NCT02999542|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-16|||January 2017||2017-01-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Music on Emergence Delirium|The Effect of Intraoperative Music on the Prevalence and Severity of Emergence Delirium in Paediatric Patients: A Randomised Controlled Trial|Not yet recruiting||N/A|40|Anticipated|University of Pretoria||2|||f||||t||||||||Undecided||2017-10-10 21:30:50.234946|2017-10-10 21:30:50.234946
NCT02999529|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-05-16|||December 2016||2016-12-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Health Literacy Multi-media Study|Improving Patient Understanding of Key Terms Used to Describe Chemotherapy and Its Side Effects|Completed||N/A|100|Actual|Emory University||1|||f||||f||||||||||2017-10-10 21:30:50.303751|2017-10-10 21:30:50.303751
NCT02999516|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Complex Motor Learning With Motor Imaginary|Complex Motor Learning With Motor Imaginary|Recruiting||N/A|60|Anticipated|Centro Universitario La Salle||2|||f||||t||||||||Undecided||2017-10-10 21:30:50.372047|2017-10-10 21:30:50.372047
NCT02999503|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-20|||November 2016||2016-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Attention Deficit Hyperactivity Disorder: Nutrition and Environment|Nutritional and Environmental Conditions in Attention Deficit Hyperactivity Disorder|Recruiting||N/A|70|Anticipated|Hospital El Escorial||2|||f||||f||||||||Undecided||2017-10-10 21:30:50.45068|2017-10-10 21:30:50.45068
NCT02999490|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-12-20|||March 2016||2016-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||18F-FDG PET/CT in Diagnostic Patients of Disorder of Consciousness|18F-FDG PET/CT in Diagnostic Patients of Disorder of Consciousness|Recruiting||Early Phase 1|20|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||Yes||2017-10-10 21:30:50.540978|2017-10-10 21:30:50.540978
NCT02999477|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-03-27|||February 23, 2017|Actual|2017-02-23|March 2017|2017-03-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer|A Pilot Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer|Recruiting||Phase 2|50|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||No||2017-10-10 21:30:50.619378|2017-10-10 21:30:50.619378
NCT02999464|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2017-01-15|||July 2016||2016-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Qigong on Balance, Fall Efficacy, Wellbeing of People With Stroke in Hong Kong|Effect of Qigong on Balance, Fall Efficacy, Physical Functions and Psychological Wellbeing of People With Stroke in Hong Kong: A Randomized Controlled Trial|Recruiting||N/A|58|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||Undecided||2017-10-10 21:30:50.736584|2017-10-10 21:30:50.736584
NCT02999451|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-20|||January 2017||2017-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Snare-assisted POEM for Treatment of Esophageal Achalasia|Safety,Efficacy and Cost-effectiveness of Snare-assisted POEM for Treatment of Esophageal Achalasia|Not yet recruiting||N/A|30|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||No||2017-10-10 21:30:50.832556|2017-10-10 21:30:50.832556
NCT02999438|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-20|||November 2016||2016-11-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Observational|||Frailty in Children With Cardiac Disease|Frailty in Children With Cardiac Disease: A Pilot Study|Recruiting||N/A|100|Anticipated|Children's Mercy Hospital Kansas City|||2||f||||f||||||||||2017-10-10 21:30:50.898416|2017-10-10 21:30:50.898416
NCT02999425|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-20|||October 2016||2016-10-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effectiveness of Targeted Educational Intervention on Healthy Lifestyle Behaviors in Serbian Population|Effectiveness of Targeted Educational Intervention on Healthy Lifestyle Behaviors in Serbian Population: Make Right Choices Fro Lifelong Health|Recruiting||N/A|2000|Anticipated|Center for Health, Exercise and Sport Sciences, Serbia||1|||f||||f||||||||Yes|Assessed outcomes will be shared via open database when study finished, via direct contact with PI|2017-10-10 21:30:50.969857|2017-10-10 21:30:50.969857
NCT02999412|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-12|||February 6, 2017|Actual|2017-02-06|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|November 2019|Anticipated|2019-11-01||Interventional|MedBridge||Medication Reviews Bridging Healthcare: a Cluster-randomised Crossover Trial|Medication Reviews Bridging Healthcare: a Cluster-randomised Crossover Trial to Study the Effects of Hospital-initiated Comprehensive Medication Reviews, Including Active Follow-up, on Elderly Patients' Healthcare Utilisation|Recruiting||N/A|2310|Anticipated|Uppsala County Council, Sweden||3|||f||||f|f|f||||||||2017-10-10 21:30:51.166298|2017-10-10 21:30:51.166298
NCT02999399|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-04-21|||December 2016||2016-12-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism|Assessing the Effect of Glucobrassicin-Rich Brussels Sprouts on the Metabolism of Deuterated Phenanthrene: Developing Food-Based Chemoprevention of Tobacco-Related Lung Cancer|Active, not recruiting||N/A|48|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-10 21:30:51.310842|2017-10-10 21:30:51.310842
NCT02999386|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-20|||October 2016||2016-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|SIHG||Stress Induced Hyperglycemia In Trauma|Role Of Stress Induced Hyperglycemia On The Outcome Of Trauma Patients|Recruiting||N/A|250|Anticipated|Hamad Medical Corporation|||1||f||||f||||||||No|Only the lead PI will have the access to the data which will be coded with subject identifier to ensure data safety and confidentiality. The study will be opened for collaboration with multi-centers. Data from other centers will be shared with the Lead PI.|2017-10-10 21:30:51.395056|2017-10-10 21:30:51.395056
NCT02999373|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-04-07|||April 7, 2017|Anticipated|2017-04-07|April 2017|2017-04-01|July 15, 2019|Anticipated|2019-07-15|July 15, 2018|Anticipated|2018-07-15||Interventional|||Prevention of Preterm Infection by Autologous Umbilical Cord Blood Mononuclear Cells Therapy|Prevention of Preterm Infection by Autologous Umbilical Cord Blood Mononuclear Cells(CBMNC) Therapy|Recruiting||Phase 1|320|Anticipated|Guangdong Women and Children Hospital||4|||f||||f|f|f||||||No||2017-10-10 21:30:51.501356|2017-10-10 21:30:51.501356
NCT02999360|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Aerobic Exercise and Aphasia Treatment|Aerobic Exercise and Aphasia Treatment|Recruiting||N/A|12|Anticipated|New York University School of Medicine||2|||f||||f||||||||Undecided||2017-10-10 21:30:51.622165|2017-10-10 21:30:51.622165
NCT02999347|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-01-19|||August 2014||2014-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Observational|PregnanT||Pregnancy After Tension-free Vaginal Tape and Other Mid-urethral Sling Procedures|The PregnanT-study: Pregnancy Outcomes After TVT and Other Mid-urethral Sling (MUS) Procedures|Recruiting||N/A|80|Anticipated|Oslo University Hospital|||2||f||||f||||||||Undecided||2017-10-10 21:30:51.727515|2017-10-10 21:30:51.727515
NCT02999334|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-16|||September 2013||2013-09-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|May 2015|Actual|2015-05-01||Interventional|||HIV With Innovative Group Antenatal Care in Two African Countries|HIV With Innovative Group Antenatal Care in Two African Countries|Completed||N/A|218|Actual|University of Illinois at Chicago||2|||f||||f||||||||No||2017-10-10 21:30:51.826692|2017-10-10 21:30:51.826692
NCT02999321|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-19|||August 2016||2016-08-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance|The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance|Active, not recruiting||N/A|93|Actual|Purdue University||3|||f||||f||||||||Undecided||2017-10-10 21:30:51.90963|2017-10-10 21:30:51.90963
NCT02999308|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-12-17|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|CHIPS||A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children|Hematology Oncology Center|Recruiting||Phase 4|40|Anticipated|Beijing Children's Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:30:52.017721|2017-10-10 21:30:52.017721
NCT02999295|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-18|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer|A Multicenter, Phase 1/2 Study of Ramucirumab Plus Nivolumab as Second-line Therapy in Participants With Gastric or GEJ Cancer|Recruiting||Phase 1/Phase 2|44|Anticipated|National Cancer Center, Japan||2|||f||||||||||||||2017-10-10 21:30:52.109372|2017-10-10 21:30:52.109372
NCT02999282|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-02-09|||October 31, 2016|Actual|2016-10-31|February 2017|2017-02-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|ReRescuePGR||Rehabilitative Trial for the Rescue of Neurophysiological Parameters in Progranulin Deficient Subjects|Rehabilitative Trial for the Recovery of Neurophysiological Parameters in Progranulin Mutation Carriers Through the Use of Transcranial Direct Current Stimulation (tDCS)|Recruiting||N/A|80|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||4|||f||||t||||||||Undecided||2017-10-10 21:30:52.204648|2017-10-10 21:30:52.204648
NCT02999269|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-12-16|||October 2016||2016-10-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||ECT Pulse Amplitude and Medial Temporal Lobe Engagement|ECT Pulse Amplitude and Medial Temporal Lobe Engagement|Recruiting||Phase 4|90|Anticipated|University of New Mexico||3|||f||||t||||||||Yes|National Database for Clinical Trials Related to Mental Illness|2017-10-10 21:30:52.310116|2017-10-10 21:30:52.310116
NCT02999256|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-16|||June 2016||2016-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Cherry Juice on Fat Oxidation and Cardio-metabolic Markers|The Effect of Tart Cherry Juice Supplementation on Fat Oxidation, Body Composition and Cardio-Metabolic Markers With Cycling Exercise|Completed||N/A|11|Actual|University of Hertfordshire||2|||f||||f||||||||||2017-10-10 21:30:52.410685|2017-10-10 21:30:52.410685
NCT02999243|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-01|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|February 2019|Anticipated|2019-02-01||Interventional|||Development of an HIV Self-testing Intervention|Development of an HIV Self-testing Intervention to Reduce HIV Risks Among MSM: Taking the Guess Out of Seroguessing|Not yet recruiting||Phase 4|400|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||Undecided||2017-10-10 21:30:52.506889|2017-10-10 21:30:52.506889
NCT02999230|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-02-22|||February 22, 2017|Actual|2017-02-22|February 2017|2017-02-01|October 2021|Anticipated|2021-10-01|March 2021|Anticipated|2021-03-01||Interventional|||Probiotics That Moderate pH and Antagonize Pathogens to Promote Oral Health|Probiotics That Moderate pH and Antagonize Pathogens to Promote Oral Health|Recruiting||N/A|260|Anticipated|University of Florida||4|||f||||f|f|f||||||No||2017-10-10 21:30:52.61009|2017-10-10 21:30:52.61009
NCT02999217|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-12-16|||October 2016||2016-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Intravenous Iron for Correction of Anaemia After Colorectal Surgery|The Impact of Treatment of Anaemia With Intravenous Iron on Haematological Values for Patients After Colorectal Surgery|Recruiting||Phase 4|100|Anticipated|Kaunas University of Medicine||2|||f||||t||||||||Yes|De-identified individual participant data for all primary and secondary outcome measures will be made available within 6 months of study completion.|2017-10-10 21:30:52.738481|2017-10-10 21:30:52.738481
NCT02999204|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-12-16|||January 2014||2014-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients|Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients|Recruiting||Phase 4|80|Anticipated|Jewish General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:30:52.873321|2017-10-10 21:30:52.873321
NCT02999191|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-04-18|||January 10, 2017|Actual|2017-01-10|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Interventional|||Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects|Relative Bioavailability of a BI 1467335 Tablet Compared to a BI 1467335 Oral Solution and the Effect of Food on the Bioavailability of the Tablet Following Oral Administration (a Randomised, Open-label, Single Dose, Three-way Crossover Trial in Healthy Male Subjects)|Completed||Phase 1|18|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 21:30:52.987881|2017-10-10 21:30:52.987881
NCT02999178|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-10-03|||January 17, 2017|Actual|2017-01-17|October 2017|2017-10-01|November 15, 2019|Anticipated|2019-11-15|July 12, 2019|Anticipated|2019-07-12||Interventional|PF-ILD||Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)|A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)|Recruiting||Phase 3|600|Anticipated|Boehringer Ingelheim||2|||f||||t||||||||||2017-10-10 21:30:53.09771|2017-10-10 21:30:53.09771
NCT02999165|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Observational|BIRRST||Breastfeeding Infants Receiving Respiratory Support Trial|Breastfeeding Infants Receiving Respiratory Support Trial|Recruiting||N/A|50|Anticipated|Imperial College Healthcare NHS Trust|||2||f||||f||||||||Yes|Anonymised, non-identifiable data available on request|2017-10-10 21:30:53.601445|2017-10-10 21:30:53.601445
NCT02999152|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-08-18|||June 22, 2017|Actual|2017-06-22|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|BIOM-DRI||Validation of Radio-induced Damage Biomarkers|Validation of Radio-induced Damage Biomarkers : BIOM-DRI Study|Recruiting||N/A|20|Anticipated|Institut de Cancérologie de la Loire||2|||f||||f|f|f||||||||2017-10-10 21:30:53.714967|2017-10-10 21:30:53.714967
NCT02999139|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-19|||January 2017||2017-01-01|December 2016|2016-12-01|January 2026|Anticipated|2026-01-01|January 2025|Anticipated|2025-01-01||Observational|||Analytic, Prospective Cohort Study of Athletes Enrolled in an Exercise Training Intervention|Analytic, Prospective Cohort Study of Athletes Enrolled in an Exercise Training Intervention|Not yet recruiting||N/A|3000|Anticipated|Boston Children’s Hospital|||3||f||||||||||||||2017-10-10 21:30:53.81756|2017-10-10 21:30:53.81756
NCT02999126|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-16|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|(TITINDUC)||Slow Stepwise Propofol TCI Induction for Titration Anesthesia Maintenance|Slow Stepwise Propofol TCI Induction for Titration Anesthesia Maintenance|Recruiting||Phase 4|60|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||No||2017-10-10 21:30:53.880395|2017-10-10 21:30:53.880395
NCT02999113|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-06-20|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Shared Mental Models and Technical Assessment in Video Assisted Thoracoscopy Surgery Lobectomies|Shared Mental Models and Technical Assessment in Video Assisted Thoracoscopy Surgery Lobectomies|Recruiting||N/A|60|Anticipated|Copenhagen Academy for Medical Education and Simulation|||1||f||||f||||||||No||2017-10-10 21:30:53.987578|2017-10-10 21:30:53.987578
NCT02999087|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-06|||April 2017||2017-04-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|October 2019|Anticipated|2019-10-01||Interventional|REACH||Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)|A Phase III Randomized Trial of Avelumab-cetuximab-Radiotherapy Versus Standards of Care in Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Not yet recruiting||Phase 3|688|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||4|||f||||t||||||||No||2017-10-10 21:30:54.227915|2017-10-10 21:30:54.227915
NCT02999074|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-12-16|||January 2016||2016-01-01|December 2016|2016-12-01||||January 2020|Anticipated|2020-01-01||Interventional|BENEFIT||Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy|A Randomized 3-arm Exercise Intervention Trial for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy|Recruiting||Phase 3|342|Anticipated|German Cancer Research Center||3|||f||||f||||||||No||2017-10-10 21:30:54.321745|2017-10-10 21:30:54.321745
NCT02999061|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-07-23|||December 2016||2016-12-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Prevalence of Dental Caries in Preterm Birth Children Aged 2-5 Years in Primary Dentition|Prevalence of Dental Caries in Preterm Birth Children Aged 2-5 Years in Primary Dentition: Across Sectional Study|Completed||N/A|383|Actual|Cairo University|||1||f||||f||||||||||2017-10-10 21:30:54.433669|2017-10-10 21:30:54.433669
NCT02999048|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-16|||May 2014||2014-05-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CSTHIHPNS||Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin|Clinical Study on the Treatment of Hypertensive Cerebral Hemorrhage With Panax Notoginseng Saponins|Completed||Phase 4|90|Actual|The First People's Hospital of Jingzhou||2|||f||||t||||||||||2017-10-10 21:30:54.517306|2017-10-10 21:30:54.517306
NCT02999035|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-08-23|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Observational|||Validation of a Newly Developed Liquid Jet Aesthesiometer|Validation of a Newly Developed Liquid Jet Aesthesiometer|Completed||N/A|60|Anticipated|University of Applied Sciences and Arts Northwestern Switzerland|||1||f||||f||||||||||2017-10-10 21:30:54.616058|2017-10-10 21:30:54.616058
NCT02999022|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-04-17|||April 17, 2017|Anticipated|2017-04-17|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|LiFT||Lithium for Fracture Treatment|Lithium for Fracture Treatment: a Double Blind Randomized Control Trial|Recruiting||Phase 2|160|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t|t|f|||f|||No||2017-10-10 21:30:54.68057|2017-10-10 21:30:54.68057
NCT02999009|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-05-26|||January 20, 2017|Actual|2017-01-20|May 2017|2017-05-01|February 2029|Anticipated|2029-02-01|February 2024|Anticipated|2024-02-01||Interventional|||Trident II Tritanium Acetabular Shell Outcomes Study|A Prospective, Post-market, Multi-center Study of the Trident II Tritanium Acetabular Shell|Recruiting||N/A|240|Anticipated|Stryker Orthopaedics||1|||f|||||f|t|f|||||||2017-10-10 21:30:54.807932|2017-10-10 21:30:54.807932
NCT02998996|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-10-05|||September 2016||2016-09-01|October 2017|2017-10-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU|A Phase I/II, Randomised, Placebo-controlled, Partially-blinded, Parallel-group Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU|Completed||Phase 1/Phase 2|162|Actual|Eurocine Vaccines AB||6|||f||||f||||||||||2017-10-10 21:30:54.905893|2017-10-10 21:30:54.905893
NCT02998983|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-11|||November 2016||2016-11-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|November 2019|Anticipated|2019-11-01||Interventional|||Racotumomab in Patients With High-risk Neuroblastoma|Open-label, Multicenter, Phase II Immunotherapy Study With Racotumomab in Patients With High-risk Neuroblastoma|Recruiting||Phase 2|39|Anticipated|Laboratorio Elea S.A.C.I.F. y A.||1|||f||||f||||||||||2017-10-10 21:30:55.009148|2017-10-10 21:30:55.009148
NCT02998970|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-01-31|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|EMPA-HEART||Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes|Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients With Type 2 Diabetes|Recruiting||Phase 4|90|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||No||2017-10-10 21:30:55.116602|2017-10-10 21:30:55.116602
NCT02998957|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-16|||November 2016||2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Acupoint Transcutaneous Electrical Nerve Stimulation in Hospitalized COPD Patients With Severe Dyspnoea|Efficacy of Transcutaneous Electrical Stimulation at Dingchuan (EX-B1) in Hospitalized COPD Patients With Severe Dyspnoea: Patient and Assessor Blinded Randomized Placebo Control Trial|Recruiting||N/A|60|Anticipated|Fundació Sant Joan de Déu||2|||f||||f||||||||||2017-10-10 21:30:55.220506|2017-10-10 21:30:55.220506
NCT02998944|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-16|||January 2011||2011-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|December 2013|Actual|2013-12-01||Observational|||The Study of CCTM and Common Diseases|the Association Study of Constitution of Traditional Chinese Medicine and Common Diseases|Completed||N/A|3748|Actual|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||f||||||||No||2017-10-10 21:30:55.321934|2017-10-10 21:30:55.321934
NCT02998931|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-07-16|||November 2016||2016-11-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients|Effects of Enteral Glutamine on Inflammatory Response, Immune System Function and Clinical Outcomes in Hospitalized Patients With Enteral Feeding in Intensive Care Unit|Recruiting||Phase 3|200|Anticipated|Shahid Beheshti University||2|||f||||t|f|f||||||||2017-10-10 21:30:55.402027|2017-10-10 21:30:55.402027
NCT02998918|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-09-18|||September 2016||2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PSI||Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL||Recruiting||Phase 2|20|Anticipated|University of South Carolina||2|||f||||f||||||||||2017-10-10 21:30:55.531063|2017-10-10 21:30:55.531063
NCT02998905|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-09-18|||April 26, 2017|Actual|2017-04-26|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|NASPAF-ICH||NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH|Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Previous Intracerebral Hemorrhage Study|Recruiting||Phase 2|100|Anticipated|Population Health Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:30:55.656373|2017-10-10 21:30:55.656373
NCT02998892|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-06-06|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Effects of Microbouts of Activity on Metabolic Health|Effects of Microbouts of Activity on Metabolic Health|Not yet recruiting||N/A|30|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||No||2017-10-10 21:30:55.795749|2017-10-10 21:30:55.795749
NCT02996331|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-10-02|||May 16, 2017|Actual|2017-05-16|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors|Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors|Enrolling by invitation||N/A|1386|Anticipated|Duke University||3|||f||||t|f|f||||||||2017-10-10 21:31:20.772699|2017-10-10 21:31:20.772699
NCT02998879|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-01-11|||December 2016||2016-12-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|rhLaman-08||Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis|A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis|Recruiting||Phase 2|3|Anticipated|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||No||2017-10-10 21:30:55.892197|2017-10-10 21:30:55.892197
NCT02998866|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-12-16|||November 2015||2015-11-01|December 2016|2016-12-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Cryoballoon Pulmonary Vein Isolation Including Associated Esophageal Effects|Cryoballoon Pulmonary Vein Isolation and Associated Esophageal Effects|Active, not recruiting||Phase 4|25|Anticipated|Baylor Research Institute||1|||f||||||||||||||2017-10-10 21:30:55.99259|2017-10-10 21:30:55.99259
NCT02998853|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Non Culprit Functional Evaluation With 3D Angio QFR in STEMI PCI Procedure|Reliability of 3D Angio QFR Evaluation of Non Culprit Stenoses in STEMI Patients During First Acute Interventional Procedure: Comparison With Staged Procedure FFR|Recruiting||N/A|120|Anticipated|Azienda Ospedaliera Sant'Anna e San Sebastiano|||1||f||||f||||||||||2017-10-10 21:30:56.053718|2017-10-10 21:30:56.053718
NCT02998840|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-06-27|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|June 26, 2017|Actual|2017-06-26|April 25, 2017|Actual|2017-04-25||Interventional|||A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure|A Prospective, Vehicle Controlled, Double Blinded, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure|Completed||Phase 2|132|Actual|AOBiome LLC||4|||f||||t||||||||No||2017-10-10 21:30:56.146489|2017-10-10 21:30:56.146489
NCT02998827|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-19|||November 2016||2016-11-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Interventional|||Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients||Enrolling by invitation||N/A|90|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||||||||||||2017-10-10 21:30:56.240136|2017-10-10 21:30:56.240136
NCT02998814|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-16|||October 2010||2010-10-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Clinical Follow Up of a Fissure Sealant Placed With Different Adhesive Protocols: 2-Year Randomized Split Mouth Study|Split Mouth Clinical Trial of Fissure Sealant Retention With Self Etching and Total Etch Bonding Agent|Completed||N/A|24|Actual|Hacettepe University||4|||f||||t||||||||||2017-10-10 21:30:56.304129|2017-10-10 21:30:56.304129
NCT02998801|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-04-04|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Interventional|VR-Anxiety||Alleviating Pre-operative Anxiety With Innovative 3D Immersive Virtual Reality|Alleviating Pre-operative Anxiety With Innovative 3D Immersive Virtual Reality|Completed||N/A|100|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||Undecided||2017-10-10 21:30:56.475749|2017-10-10 21:30:56.475749
NCT02998788|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2016-12-19|||June 2016||2016-06-01|December 2016|2016-12-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|REM-HF||Risk Evaluation and Management in Heart Failure|Risk Evaluation and Management in Heart Failure|Recruiting||N/A|1000|Anticipated|Ruijin Hospital|||1||f||||t||||||Samples With DNA|"     Fasting (8-12 hours) venous blood samples were drawn and transfused into vacuum tubes     containing EDTA during the study visits. These samples were stored and further analyzed in     the Central Laboratory of Ruijin Hospital.   "|Undecided||2017-10-10 21:30:56.557779|2017-10-10 21:30:56.557779
NCT02998775|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-07-24|||December 2, 2016|Actual|2016-12-02|June 2017|2017-06-01|August 8, 2018|Anticipated|2018-08-08|February 13, 2018|Anticipated|2018-02-13||Interventional|||Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding|A Multicenter Phase 0 Study In Healthy Subjects and Subjects With Either Hepatic Or Renal Impairment To Obtain Plasma For Assessment In Vitro Lenvatinib Protein Binding|Recruiting||Early Phase 1|52|Anticipated|Eisai Inc.||8|||f||||f||||||||||2017-10-10 21:30:56.669787|2017-10-10 21:30:56.669787
NCT02998762|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-19|||November 2015||2015-11-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|CAN-BIND LTFU||Long-Term Follow Up Study|CAN-BIND (Canadian Biomarker Integration Network for Depression): Long-Term Follow Up Study|Enrolling by invitation||N/A|200|Anticipated|University Health Network, Toronto|||1||f||||t||||||||Yes|"This study is funded in part by the Ontario Brain Institute (OBI). Data collected from this study is entered into a research database called Brain-CODE, deployed at a High Performance Computer Virtual Lab (HPCVL). The HPCVL supports the regulatory-compliant (e.g., 21 CRF Part 11, HIPAA, PIPEDA) processes for securing privacy of healthcare data."|2017-10-10 21:30:56.77133|2017-10-10 21:30:56.77133
NCT02998749|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-19|||July 2013||2013-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|June 2014|Actual|2014-06-01||Observational|||Gasping Improves Long-term Survival After Out-of-hospital Cardiac Arrest|Agonal Breathing is a Positive Predictive Factor of Long Term Survival After Out-of-hospital Cardiac Arrest|Completed||N/A|584|Actual|Charles University, Czech Republic|||1||f||||f||||||||No||2017-10-10 21:30:56.867375|2017-10-10 21:30:56.867375
NCT02998736|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-16|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|PERIOP-04||Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy|PERIOP-04 Phase Ib Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy|Not yet recruiting||Phase 1|24|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||No||2017-10-10 21:30:56.929414|2017-10-10 21:30:56.929414
NCT02998723|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Early or Late Booster for Basic Life Support?|Does an Early Booster Session Improve Performance and Retention of Skills in Basic Life Support Compared to a Later Booster? A Simulation Based Randomized Controlled Trial|Not yet recruiting||N/A|90|Anticipated|Ottawa Hospital Research Institute||3|||f||||f||||||||No||2017-10-10 21:30:57.020821|2017-10-10 21:30:57.020821
NCT02967055|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-08-29|||October 2016||2016-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Observational|||The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant|The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant|Recruiting||N/A|30|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 21:36:06.976737|2017-10-10 21:36:06.976737
NCT02998697|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-19|||January 2016||2016-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|IRON5||Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia|The Effect of Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia|Completed||Phase 2/Phase 3|54|Actual|National Cardiovascular Center Harapan Kita Hospital Indonesia||2|||f||||t||||||||No||2017-10-10 21:30:57.201375|2017-10-10 21:30:57.201375
NCT02998684|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-30|||July 2016||2016-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|LENS||Learning Enhancement Through Neurostimulation in Autism|Learning Enhancement Through Neurostimulation in Autism|Active, not recruiting||N/A|25|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 21:30:57.301821|2017-10-10 21:30:57.301821
NCT02998658|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-19|||February 2017||2017-02-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Barbed Versus Conventional Sutures for Vaginal Cuff Closure During Total Laparoscopic Hysterectomy|Barbed Versus Conventional Sutures for Vaginal Cuff Closure During Total Laparoscopic Hysterectomy. A Randomized Controlled Trial|Not yet recruiting||Phase 2|54|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:30:57.504478|2017-10-10 21:30:57.504478
NCT02998645|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-09-18|||May 11, 2017|Actual|2017-05-11|September 2017|2017-09-01|August 19, 2023|Anticipated|2023-08-19|August 19, 2023|Anticipated|2023-08-19||Interventional|SOAR||Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia|SOAR Trial, A Two-part Study: Interventional Phase II Single-arm Trial to Assess Efficacy and Safety of Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia, and an Extension With up to 60-months Follow-up|Recruiting||Phase 2|50|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 21:30:57.605336|2017-10-10 21:30:57.605336
NCT02998632|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-16|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Posterior Mandibular Ridge Augmentation Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft|The Effect of Posterior Mandibular Ridge Augmentation Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft on Implant Body Stability: A Randomized Clinical Trial Comparative Study|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:30:57.730067|2017-10-10 21:30:57.730067
NCT02998619|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis|Retrospektive Analyse Der Radiotherapie Des Pelvinen Lymphabflusses Beim Lokalisierten Prostatakarzinom Vom Hochrisikotyp Anhand Der Klinikdatenbank 2010-2016|Recruiting||N/A|60|Anticipated|Kantonsspital Graubuenden|||1||f||||f||||||||No||2017-10-10 21:30:57.808233|2017-10-10 21:30:57.808233
NCT02998606|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-04-24|||January 2017||2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Movantik for Opioid-Related Esophageal Disorders|Movantik for Opioid-Related Esophageal Disorders|Recruiting||Phase 2|50|Anticipated|Temple University||2|||f||||f||||||||No||2017-10-10 21:30:57.930176|2017-10-10 21:30:57.930176
NCT02998593|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-04-26|||July 2016||2016-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effect of Combination of Red and White Bahman Retrieved of Iranian Traditional Medicine on Semen Parameters in Idiopathic Oligospermic Men|Effect of Red and White Bahman on Semen Parameters,Testosteron ,LH, FSH and Defragmentation of DNA . A Double Blind Randomised Clinical Trial (Phase 3)|Recruiting||Phase 3|200|Anticipated|Royan Institute||2|||f||||t||||||||No||2017-10-10 21:30:58.045553|2017-10-10 21:30:58.045553
NCT02998580|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Conventional Bilateral rTMS vs. Bilateral Theta Burst Stimulation for Late-Life Depression|Conventional Bilateral rTMS vs. Bilateral Theta Burst Stimulation for Late-Life Depression|Recruiting||N/A|220|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||Undecided||2017-10-10 21:30:58.166173|2017-10-10 21:30:58.166173
NCT02998567|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01||||November 2018|Anticipated|2018-11-01||Interventional|HyPeR||Combination Study of Guadecitabine and Pembrolizumab.|HyPeR: A Phase 1 Dose Escalation Study of Guadecitabine (SGI-110) a Second Generation Hypo-Methylating Agent in Combination With Pembrolizumab (MK3475) in Patients With Refractory Solid Tumours|Not yet recruiting||Phase 1|35|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||||||||||||2017-10-10 21:30:58.30173|2017-10-10 21:30:58.30173
NCT02998528|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-10-02|||January 13, 2017|Actual|2017-01-13|September 2017|2017-09-01|November 8, 2028|Anticipated|2028-11-08|May 8, 2023|Anticipated|2023-05-08||Interventional|CheckMate 816||A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)|Randomized, OpenLabel, Phase 3 Trial of Nivolumab Plus Ipilimumab or Nivolumab Plus Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Early Stage NSCLC|Recruiting||Phase 3|642|Anticipated|Bristol-Myers Squibb||3|||f||||t|t|f||||||||2017-10-10 21:30:58.906066|2017-10-10 21:30:58.906066
NCT02998515|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-08-16|||December 2016||2016-12-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effects of Different Oxygen Devices in Hypoxemic COPD Patients|Effects of Supplemental Oxygen Delivery Via Portable Oxygen Concentrator (Activox™4L) vs. Liquid Oxygen Device in Hypoxemic COPD Patients - a Non-inferiority Study|Completed||N/A|30|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-10 21:30:59.357086|2017-10-10 21:30:59.357086
NCT02998502|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-07-31|||September 2016||2016-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens|Efficacy of a Biofeedback Breathing System for Anxiety and Panic Disorders|Recruiting||N/A|60|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 21:30:59.435953|2017-10-10 21:30:59.435953
NCT02998489|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-19|||April 2014||2014-04-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness and Safety of Fast Enteral Feeding in Preterm Infants Between 1000 and 2000 Grams of Birth Weight|Effectiveness and Safety of Rapid Enteral Feeding in Preterm Infants Between 1000 and 2000 Grams of Birth Weight|Completed||N/A|36|Actual|Hospital Universitario San Ignacio||2|||f||||t||||||||No||2017-10-10 21:30:59.549806|2017-10-10 21:30:59.549806
NCT02998476|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-18|||December 2016||2016-12-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)|A Phase 2, Multicenter, International, Open-Label, Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)|Recruiting||Phase 2|120|Anticipated|Incyte Corporation||2|||f||||f||||||||||2017-10-10 21:30:59.657403|2017-10-10 21:30:59.657403
NCT02998463|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-16|||February 2017||2017-02-01|December 2016|2016-12-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Facilitating Skin-to-Skin Contact In the Postnatal Period|A Skin-to-Skin Contact (SSC) Facilitating Device Used Within a Mother-Infant Dyad: Exploring Its Acceptability, Usage and Effect on Health Outcomes in the Postnatal Period.|Not yet recruiting||N/A|489|Anticipated|Birmingham City University||2|||f||||f||||||||No||2017-10-10 21:30:59.795005|2017-10-10 21:30:59.795005
NCT02998450|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-15|||November 2016||2016-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of IMR-687 in Healthy Adult Volunteers|A Phase 1a Study of IMR-687 in Healthy Adult Volunteers|Recruiting||Phase 1|36|Anticipated|Imara, Inc.||6|||f||||f||||||||No||2017-10-10 21:31:00.041826|2017-10-10 21:31:00.041826
NCT02998437|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-01-24|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|DDI||Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole|A Randomized, Open-label, Parallel-design Study to Evaluate Pharmacokinetic Drug Interactions and Safety After Coadministration of Clarithromycin, Amoxicillin and Ilaprazole|Completed||Phase 1|28|Actual|Il-Yang Pharm. Co., Ltd.||3|||f||||t||||||||Undecided|Undecided|2017-10-10 21:31:00.221985|2017-10-10 21:31:00.221985
NCT02998424|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-16|||May 2016||2016-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Pupillary Diameter Under Different Concentrations of Propofol|Pupillary Diameter Without Stimulation Under Different Concentrations of Propofol Alone|Completed||N/A|40|Actual|Hôpital Armand Trousseau||3|||f||||f||||||||No||2017-10-10 21:31:00.396517|2017-10-10 21:31:00.396517
NCT02998411|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|OptiPOP||Population Pharmacokinetics of Anti-infectives in Hospitalized Patients|Population Pharmacokinetics Approaches for the Optimization of Anti-infective Concentrations Among Hospitalized Patients|Not yet recruiting||N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 21:31:00.565771|2017-10-10 21:31:00.565771
NCT02998398|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-12-15|||October 2015||2015-10-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|October 2016|Actual|2016-10-01||Observational|SIC||Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital|Evaluation of the Switch From the Original Infliximab ( REMICADE®) to Its Biosimilar (INFLECTRA®) in Daily Practice at Cochin Hospital|Active, not recruiting||N/A|262|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     serum   "|No||2017-10-10 21:31:00.734709|2017-10-10 21:31:00.734709
NCT02998385|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|November 2026|Anticipated|2026-11-01|November 2023|Anticipated|2023-11-01||Interventional|SANTAL||Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors|A Phase III Randomized Study of Chemo-radiotherapy Versus Radiotherapy Alone in the Adjuvant Treatment of Salivary Glands and Nasal Tumors|Recruiting||Phase 3|260|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||2|||f||||t||||||||No||2017-10-10 21:31:00.879285|2017-10-10 21:31:00.879285
NCT02998372|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-16|||January 2017||2017-01-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Observational|||Computational Simulation of Patellar Instability|Computational Simulation of Dynamic Motion for Knees With Patellar Instability to Compare MPFL Reconstruction to Tibial Tuberosity Medialization as a Function of Knee Anatomy|Not yet recruiting||N/A|5|Anticipated|Akron General Medical Center|||1||f||||f||||||||No||2017-10-10 21:31:01.030308|2017-10-10 21:31:01.030308
NCT02998359|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-20|||May 2012||2012-05-01|December 2016|2016-12-01||||October 2018|Anticipated|2018-10-01||Interventional|||Hemiarthroplasty Versus Total Hip Replacement for Intracapsular Hip Fractures|Randomised Controlled Trial of Hemiarthroplasty Versus Total Hip Replacement for Intracapsular Hip Fractures|Recruiting||N/A|300|Anticipated|Peterborough and Stamford Hospitals NHS Foundation Trust||2|||f||||f||||||||No|not IPD anticipated|2017-10-10 21:31:01.209821|2017-10-10 21:31:01.209821
NCT02998346|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-19|||April 2014||2014-04-01|December 2016|2016-12-01||||June 2014|Actual|2014-06-01||Observational|||Systemic Metabolic Contribution From Continuous Renal Replacement Therapy (CRRT)|Quantification of Systemic Metabolic Contribution From Continuous Renal Replacement Therapy (CRRT) Utilizing Regional Citrate Anticoagulation|Active, not recruiting||N/A|10|Actual|Mayo Clinic|||1||f||||f||||||||No||2017-10-10 21:31:01.374343|2017-10-10 21:31:01.374343
NCT02998333|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-19|||January 2017||2017-01-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|CAISR||Chronic Ankle Instability, Surgical Repair: Open Versus Closed|Does Arthroscopic Anatomic Repair of the Anterior Talofibular Ligament Provide Better Functional Outcome Compared to Open Anatomic Repair in Patients With Chronic Ankle Instability: a Multicentre Randomized Controlled Trial|Not yet recruiting||N/A|44|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 21:31:01.483262|2017-10-10 21:31:01.483262
NCT02998320|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-19|||January 2017||2017-01-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Compliance With Treatment by Genvoya in HIV Post-exposure Prophylaxis|Evaluation of Compliance With Treatment by Elvitegravir/Cobicistat/FTC/Tenofovir Alafenamide (E/C/F/TAF) in HIV Post-exposure Prophylaxis (to Infected Blood or Sexual Contact)|Not yet recruiting||Phase 3|100|Anticipated|Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux||1|||f||||f||||||||No||2017-10-10 21:31:01.665249|2017-10-10 21:31:01.665249
NCT02998307|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-03|||April 2016||2016-04-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Optimal Training Frequency for Attainment and Maintenance of High-quality CPR on a High-fidelity Manikin|Optimal Serial Training Frequency for Attainment and Maintenance of High Quality CPR Using Real‐Time Automated Performance Feedback Combined With Verbal Feedback From a CPR Instructor|Active, not recruiting||N/A|240|Anticipated|Health Sciences North||4|||f||||f||||||||No||2017-10-10 21:31:01.783373|2017-10-10 21:31:01.783373
NCT02998294|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||March 2016||2016-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Respiratory Volume Measure Using ExSpiron 1Xi||Recruiting||N/A|65|Anticipated|Yonsei University||1|||f||||f||||||||Undecided||2017-10-10 21:31:01.901295|2017-10-10 21:31:01.901295
NCT02998281|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Inspiratory Muscle Training in Children With Cerebral Palsy|Effects of Inspiratory Muscle Training on Respiratory Functions, Trunk Control, Activities of Daily Living, Functional Exercise Capacity and Quality of Life in Children With Cerebral Palsy|Recruiting||N/A|30|Anticipated|Gazi University||2|||f||||t||||||||Undecided|We have no decided yet|2017-10-10 21:31:02.038395|2017-10-10 21:31:02.038395
NCT02998268|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-05-05|||March 7, 2017|Actual|2017-03-07|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma|Randomized, Multicenter Phase II Study of Pembrolizumab in Combination With Chemotherapy and Chemoradiation in Locally Advanced Esophageal Adenocarcinoma|Recruiting||Phase 2|46|Anticipated|Weill Medical College of Cornell University||2|||f||||t|t|f||||||No||2017-10-10 21:31:02.203557|2017-10-10 21:31:02.203557
NCT02998255|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-12|||December 2016||2016-12-01|July 2017|2017-07-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients Undergoing Colonoscopy|Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients|Completed||N/A|940|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-10 21:31:02.393396|2017-10-10 21:31:02.393396
NCT02998242|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-15|||May 2016||2016-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|ARCAP||Apatinib in Combination With Stereotactic Body Radiation Therapy (SBRT) Treatment for Symptomatic Metastatic Prostate Cancer|Apatinib in Combination With SBRT Treatment for Symptomatic Metastatic|Enrolling by invitation||N/A|40|Anticipated|Sichuan Provincial People's Hospital||2|||f||||t||||||||Yes||2017-10-10 21:31:02.515673|2017-10-10 21:31:02.515673
NCT02998229|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-06-21|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|September 2020|Anticipated|2020-09-01||Interventional|ARTISSE||Aneurysm Treatment Using Intrasaccular Flow Diversion With the ARTISSE™ Device|ARTISSE Aneurysm Treatment Using Intrasaccular Flow Diversion With the ARTISSE™ Device|Not yet recruiting||N/A|150|Anticipated|Medtronic Neurovascular Clinical Affairs||1|||f||||t|f|t|f|||||No||2017-10-10 21:31:02.614165|2017-10-10 21:31:02.614165
NCT02998216|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-12-15|||May 2016||2016-05-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Pelvic Floor Symptoms After Bilateral Sacrospinous Fixation|Pelvic Floor Symptoms and Patients´ Satisfaction After Bilateral Sacrospinous Fixation for the Primary Treatment of Pelvic Organ Prolapse ICS-POPQ Stage IV: A Prospective Observational Study|Recruiting||N/A|20|Anticipated|University Hospital Tuebingen|||1||f||||f||||||||No||2017-10-10 21:31:02.694488|2017-10-10 21:31:02.694488
NCT02998203|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-04-18|||January 3, 2017|Actual|2017-01-03|April 2017|2017-04-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|ORGANIKO||Organic Diet Intervention in Primary School Children|Organic Diet and Children's Health - ORGANIKO LIFE+|Completed||N/A|140|Actual|Cyprus University of Technology||2|||f||||t||||||||Undecided||2017-10-10 21:31:02.768145|2017-10-10 21:31:02.768145
NCT02998190|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||First-in-Human Single and Multiple Dose of EB8018|A Randomised, Double-Blind, Placebo-Controlled Study of a Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) of a FimH Antagonist, EB8018, in Healthy Volunteers.|Recruiting||Phase 1|60|Anticipated|Enterome||4|||f||||f||||||||No||2017-10-10 21:31:02.842474|2017-10-10 21:31:02.842474
NCT02998177|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-19|||November 2016||2016-11-01|August 2017|2017-08-01|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Observational|||Characterization of Rebound Pain Following Peripheral Nerve Block and Its Association With Gut Microbiome Diversity|Characterization of Rebound Pain Following Peripheral Nerve Block and Its Association With Gut Microbiome Diversity|Completed||N/A|20|Actual|Cork University Hospital|||1||f||||f||||||Samples Without DNA|"     Pre- and postoperative faecal samples and preoperative salivary samples are going to be     taken.   "|||2017-10-10 21:31:02.927793|2017-10-10 21:31:02.927793
NCT02998164|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-10-04|||October 2016||2016-10-01|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Improving Outcomes Using Technology for Children Who Are DHH|Improving Outcomes Using Augmentative and Alternative Communication for Children Who Are Deaf or Hard of Hearing|Recruiting||N/A|70|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-10 21:31:03.007081|2017-10-10 21:31:03.007081
NCT02998151|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-15|||January 2016||2016-01-01|December 2016|2016-12-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|LAM||Single-Dose Acamprosate, Lovastatin, Minocycline and Placebo in Fragile X Syndrome|Evaluating the Neurophysiologic and Clinical Effects of Single-Dose Acamprosate, Lovastatin, Minocycline and Placebo in Fragile X Syndrome|Enrolling by invitation||Phase 2|36|Actual|Children's Hospital Medical Center, Cincinnati||4|||f||||f||||||||||2017-10-10 21:31:03.085381|2017-10-10 21:31:03.085381
NCT02998138|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-07-05|||December 2016||2016-12-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Postoperative and Chronic Pain Genetic Spine Surgery Study|A Multi-center Study of Genomic and Psychological Factors Affecting Postoperative and Chronic Pain in Children Undergoing Invasive (Spine) Surgery|Enrolling by invitation||N/A|200|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     Blood samples will be analyzed for a defined set of SNPs using PCR (TaqMan, ABI)/and Omni5M     GWAS chip testing. DNA will be isolated from blood samples and also be used for     pyrosequencing studies to obtain DNA methylation information for a specified set of genes or     use of the MethylationEPIC array. The SNP sets were chosen using the adult studies cited in     the Background and Significance section as evidence of potential importance. Given that the     pain response in children and adolescents may involve a novel or different set of SNPs and     additional SNPs of the above genes, the DNA samples gathered will be held for future     analysis.   "|||2017-10-10 21:31:03.178007|2017-10-10 21:31:03.178007
NCT02998125|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-03|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||An Exploration of Outcomes Post-total Knee Arthroplasty in Middle East|A Psychometric Analysis of the Arabic Version of Oxford Knee Score Before and After Total Knee Arthroplasty in a Middle East Population and an Exploration of Outcomes Post-total Knee Arthroplasty in the Middle East|Recruiting||N/A|100|Anticipated|University of Salford|||1||f||||t||||||||||2017-10-10 21:31:03.256552|2017-10-10 21:31:03.256552
NCT02998112|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing||Recruiting||Phase 4|188|Anticipated|The Second Hospital of Nanjing Medical University||2|||f||||f||||||||||2017-10-10 21:31:03.369643|2017-10-10 21:31:03.369643
NCT02998099|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-04-06|||January 26, 2017|Actual|2017-01-26|April 2017|2017-04-01|March 16, 2017|Actual|2017-03-16|February 19, 2017|Actual|2017-02-19||Interventional|||A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.|A Phase 1, Non-randomized, Open-label, Parallel-group Single-dose Study To Estimate The Effect Of Age On The Pharmacokinetics, Safety And Tolerability Of Intravenous Rivipansel (Pf-06460031)|Completed||Phase 1|16|Actual|Pfizer||2|||f||||f|t|f||||||||2017-10-10 21:31:03.46257|2017-10-10 21:31:03.46257
NCT02998086|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||October 2016||2016-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||PRISM for Parents of Children With Cancer Promoting Resilience in Stress Management (PRISM) Intervention for Parents of Children With Cancer|A Pilot Randomized Controlled Trial of the Promoting Resilience in Stress Management (PRISM) Intervention for Parents of Children With Cancer|Recruiting||N/A|75|Anticipated|Seattle Children's Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:31:03.54096|2017-10-10 21:31:03.54096
NCT02998073|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-04-13|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Investigating Psychosocial Intervention Treatment Response in Justice-Involved Youth With Conduct Disorder|A Multiple Biomarker Approach to Investigating Psychosocial Intervention Treatment Response in Justice-Involved Youth With Conduct Disorder|Not yet recruiting||N/A|100|Anticipated|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||Undecided||2017-10-10 21:31:03.67032|2017-10-10 21:31:03.67032
NCT02998060|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-04-08|||March 2017||2017-03-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||Clinical Evidence of Robot Guided vs. Navigated vs. Free Hand Lumbar Spinal Fusion|Clinical Evidence of Robot Guided vs. Navigated vs. Free Hand Lumbar Spinal Fusion|Not yet recruiting||N/A|115|Anticipated|Bergman Clinics||3|||f||||f||||||||No||2017-10-10 21:31:03.745678|2017-10-10 21:31:03.745678
NCT02998047|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-15|||December 2016||2016-12-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|AC-225||Lintuzumab-Ac225 for Refractory Multiple Myeloma|A Phase I Study of 225Ac-Lintuzumab in Patients With Multiple Myeloma Progressing After . 3 Prior Anti-MM Regimens or Refractory to QUAD (Carfilzomib, Lenalidomide, Pomalidomide, and Dexamethasone)|Recruiting||Phase 1|12|Anticipated|Actinium Pharmaceuticals||1|||f||||t||||||||||2017-10-10 21:31:03.84025|2017-10-10 21:31:03.84025
NCT02998034|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-20|||August 2013||2013-08-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||Cemented Hemiarthroplasty Versus Uncemented Furlong Hemiarthroplasty|Randomised Controlled Trial of Cemented Hemiarthroplasty Versus Uncemented Furlong Hemiarthroplasty|Recruiting||N/A|400|Anticipated|Peterborough and Stamford Hospitals NHS Foundation Trust||2|||f||||f||||||||No|no IPD will be generated|2017-10-10 21:31:03.92243|2017-10-10 21:31:03.92243
NCT02998021|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||April 2016||2016-04-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Vibration Exercise on Upper Limb Strength, Function, and Pain|Effect of Vibration Exercise on Upper Limb Strength, Function, and Pain|Recruiting||N/A|24|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 21:31:03.990642|2017-10-10 21:31:03.990642
NCT02998008|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-09-04|||January 2, 2017|Actual|2017-01-02|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Acute High Intensity Exercise Training on Cardiac Function in Type II Diabetes|Effects of Acute High Intensity Exercise Training on Cardiac Function in Type II Diabetes|Recruiting||N/A|20|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 21:31:04.089013|2017-10-10 21:31:04.089013
NCT02997995|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-03-08|||February 15, 2017|Actual|2017-02-15|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|ULTIMATE||Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure|A Phase II Trial Testing Durvalumab Combined With Endocrine Therapy in Patients With ER+/Her2- Breast Cancer Eligible for Neoadjuvant Endocrine Therapy And Who Present CD8+ T Cell Infiltration After 4-6 Weeks Exposure to Immune-Attractant|Recruiting||Phase 2|240|Anticipated|UNICANCER||1|||f||||t|f|f||||||Undecided||2017-10-10 21:31:04.174555|2017-10-10 21:31:04.174555
NCT02997982|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VALZ-Pilot||Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease|Feasibility and Effects on Markers in Spinal Fluid in Persons With Early Alzheimer's Disease When Treated With Valaciclovir - Open Fas II Pilot Study (VALZ-Pilot)|Recruiting||Phase 2|36|Anticipated|Umeå University||1|||f||||t||||||||No||2017-10-10 21:31:04.343825|2017-10-10 21:31:04.343825
NCT02997969|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-28|||May 2016||2016-05-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|HVTN111||Safety and Immune Response to a Clade C DNA HIV Vaccine|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DNA and of MF59-adjuvanted Clade C Env Protein, in Healthy, HIV-uninfected Adult Participants|Recruiting||Phase 1|132|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||No||2017-10-10 21:31:06.006772|2017-10-10 21:31:06.006772
NCT02997956|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-04-21|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)|Phase IB/II Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)|Withdrawn||Phase 1/Phase 2|0|Actual|University of Michigan Cancer Center||1||funding issues|f||||t|t|f||||||||2017-10-10 21:31:06.129323|2017-10-10 21:31:06.129323
NCT02997943|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-12|||June 19, 2017|Actual|2017-06-19|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|SMART||SMART Weight Loss Management|SMART Weight Loss Management|Recruiting||N/A|400|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 21:31:06.207878|2017-10-10 21:31:06.207878
NCT02997930|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-05-16|||January 29, 2017|Actual|2017-01-29|May 2017|2017-05-01|May 29, 2018|Anticipated|2018-05-29|January 29, 2018|Anticipated|2018-01-29||Interventional|||fMRI Connectivity in Fracture Hip Patients|Functional Connectivity (With fMRI) as an Objective Measure of Postoperative Cognitive Function in Elderly Fracture Hip Patients|Recruiting||N/A|16|Anticipated|University of Florida||1|||f||||f|f|f||||||No||2017-10-10 21:31:06.302202|2017-10-10 21:31:06.302202
NCT02997917|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-02-03|||November 2016|Actual|2016-11-01|December 2016|2016-12-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Education on the Responses to Meal Ingestion|Factors That Determine the Response to Meal Ingested: Education|Completed||N/A|28|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||No||2017-10-10 21:31:06.388714|2017-10-10 21:31:06.388714
NCT02997904|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-07-31|2017-06-28||December 2016|Actual|2016-12-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||A Clinical Trial Evaluating the Efficacy of Resultz Lice and Egg Elimination Kit on Pediatric and Adult Subjects|A Randomized Sham Controlled Double Blinded Single Site Clinical Trial Evaluating the Efficacy of Resultz Lice and Egg Elimination Kit for the Removal of Human Head Lice and Eggs on Pediatric and Adult Subjects|Completed||N/A|100|Actual|Piedmont Pharmaceuticals, LLC||2|||f||||f|f|t|f|f||||||2017-10-10 21:31:06.476192|2017-10-10 21:31:06.476192
NCT02997891|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-12-15|||February 2016||2016-02-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|April 2017|Anticipated|2017-04-01||Observational|KogniTEP||Change of Cognitive Performance Through Hip Replacement|Change of Cognitive Performance for Older People Through Artificial Hip Replacement Implantation [German Title: Veränderungen Der Kognitiven Leistungsfähigkeit älterer Menschen Durch Hüft-TEP Implantation]|Recruiting||N/A|260|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f||||||||No||2017-10-10 21:31:06.79244|2017-10-10 21:31:06.79244
NCT02997878|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-04|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|Merlin||A Single-arm,Phase IIa,Safety and Efficacy Trial of Selected MSCs in the Treatment of Patients With PSC & AiH|An Adaptive,Multicentre, Phase IIa, Multi-disease Trial Investigating the Safety & Activity of a Single Infusion of Selected Mesenchymal Stromal Cells in the Treatment of Patients With Primary Sclerosing Cholangitis & Autoimmune Hepatitis|Not yet recruiting||Phase 1/Phase 2|56|Anticipated|University of Birmingham||2|||f||||t|f|f||||||||2017-10-10 21:31:07.037441|2017-10-10 21:31:07.037441
NCT02997865|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-05-08|||January 2017||2017-01-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|January 2021|Anticipated|2021-01-01||Interventional|DASH-2||Stepped Care for Depression in Heart Failure|Stepped Care for Depression in Heart Failure|Recruiting||N/A|180|Anticipated|Washington University School of Medicine||2|||f||||t||||||||Undecided|We may share de-identified data with other researchers after the completion of the study; no specific plans for this have been made yet.|2017-10-10 21:31:07.140928|2017-10-10 21:31:07.140928
NCT02997852|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||July 2016||2016-07-01|December 2016|2016-12-01||||June 2017|Anticipated|2017-06-01||Interventional|||Biobehavioral Effects of Therapy Dog Visitation in Elderly Intensive Care Unit Patients: A Pilot and Feasibility Study|Biobehavioral Effects of Therapy Dog Visitation in Elderly Intensive Care Unit Patients: A Pilot and Feasibility Study|Enrolling by invitation||N/A|20|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 21:31:07.253141|2017-10-10 21:31:07.253141
NCT02997839|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SDPPNCU||Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit|Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit|Recruiting||N/A|20|Anticipated|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 21:31:07.340323|2017-10-10 21:31:07.340323
NCT02997826|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|BABY MILK||Effect of Infant Formula Intake on Infant Growth From 0 to 6 Months.||Recruiting||N/A|100|Anticipated|Institut Pasteur de Lille||1|||f||||||||||||||2017-10-10 21:31:07.453522|2017-10-10 21:31:07.453522
NCT02997813|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-16|||June 2015||2015-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Observational|MOZOBIL||Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies|Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies: High-dose Cyclophosphamide Versus Plerixafor|Completed||N/A|112|Actual|Intergroupe Francophone du Myelome|||2||f||||f||||||||No||2017-10-10 21:31:07.567692|2017-10-10 21:31:07.567692
NCT02997800|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-15|||November 2012||2012-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Intraoperative Labetalol on Time to Discharge|The Effect of Intraoperative Labetalol on Time to Discharge and Hemodynamic Stability in Laparoscopic Cholecystectomy|Recruiting||Phase 2|141|Anticipated|Queen's University||3|||f||||f||||||||||2017-10-10 21:31:07.692488|2017-10-10 21:31:07.692488
NCT02997787|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-23|||January 2016||2016-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|||New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma|Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio Can Be Useful Markers for Distinguishing Uterine Adenomyosis and Leiomyoma|Completed||N/A|60|Actual|Kayseri Education and Research Hospital|||3||f||||||||||||||2017-10-10 21:31:07.798638|2017-10-10 21:31:07.798638
NCT02997774|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-08-14|||February 8, 2017|Actual|2017-02-08|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Cooler Dialysis and Liver Perfusion and Function|Evaluation of the Effects of Cooler Dialysate on Liver Perfusion, Endotoxemia and Uremic Toxin Handling in Hemodialysis Patients|Recruiting||N/A|20|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:31:07.869641|2017-10-10 21:31:07.869641
NCT02997761|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-07-05|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|August 2020|Anticipated|2020-08-01||Interventional|||Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia|A Phase 2 Study of Ibrutinib and Blinatumomab in Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia|Recruiting||Phase 2|20|Anticipated|University of California, Davis||1|||f||||t|t|f||||||||2017-10-10 21:31:07.970906|2017-10-10 21:31:07.970906
NCT02997748|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|RIPCRenal||Remote Ischemic Preconditioning After Cardiac Surgery|Remote Ischemic Preconditioning to Prevent Acute Kidney Injury in High Risk Patients After Cardiac Surgery (RIPCRenal)|Recruiting||N/A|180|Anticipated|University Hospital Muenster||6|||f||||t||||||||No||2017-10-10 21:31:08.090827|2017-10-10 21:31:08.090827
NCT02997735|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-22|||November 2016||2016-11-01|December 2016|2016-12-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Parent eReferral to Tobacco Quitline|Parent eReferral to Tobacco Quitline in Primary Care|Recruiting||N/A|1000|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||No||2017-10-10 21:31:08.196157|2017-10-10 21:31:08.196157
NCT02997722|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-19|||January 2017||2017-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Ketamine: Its Effects on Suicidal Ideations and Inpatient Hospital Length of Stay|Ketamine: Its Effects on Suicidal Ideations and Inpatient Hospital Length of Stay|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|University of Mississippi Medical Center||2|||f||||f||||||||No||2017-10-10 21:31:08.281223|2017-10-10 21:31:08.281223
NCT02997709|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-10-03|||June 24, 2016|Actual|2016-06-24|October 2017|2017-10-01|June 2026|Anticipated|2026-06-01|June 2021|Anticipated|2021-06-01||Interventional|COMBINE||Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients|Collection and Measurement of Blood and Imaging Biomarkers in Patients Undergoing Standard Primary and Postoperative Radiotherapy for Prostatic Neoplasms - The Miami CoMBINe Trial|Recruiting||N/A|300|Anticipated|University of Miami||1|||f||||t||||||||||2017-10-10 21:31:08.371146|2017-10-10 21:31:08.371146
NCT02997696|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-09-20|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|MOTION||A Study to Evaluate ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee|A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee|Recruiting||Phase 2|280|Anticipated|Ono Pharmaceutical Co. Ltd||3|||f||||f||||||||||2017-10-10 21:31:08.509136|2017-10-10 21:31:08.509136
NCT02997683|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2016-12-19|||April 2017||2017-04-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|GALILEOHOME||3-Month Home-based Training With Whole Body Vibration Device in Patients With PAH (GALILEO-PAH-HOME)|Influence of Training With Whole Body Vibration Device on Quality of Life (QoL), Exercise Capacity, as Well as on the Effects of Muscle Power and Muscle Function in Patients With Pulmonal Arterial Hypertension (PAH) in an Extended 3-month Home Based Training. Background and Rationale for the Proposal: Capacity and the Ability to Exercise, in Patients With PAH is Limited. Primary Scientific Question Addressed:Changes in Muscle Power, Changes in 6-Minute Walk Distance (6MWD) and Changes in QoL Are to be Evaluated.|Not yet recruiting||N/A|80|Anticipated|Klinikum der Universität Köln||2|||f||||t||||||||||2017-10-10 21:31:08.840707|2017-10-10 21:31:08.840707
NCT02997670|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-15|||January 2017||2017-01-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|QUARTRMASTER||Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation Therapy Optimisation|Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation Therapy Optimisation|Not yet recruiting||N/A|24|Anticipated|Cardiff and Vale University Health Board||1|||f||||f||||||||No|Individual participant data available on individual written request at the discretion of the investigators.|2017-10-10 21:31:08.917802|2017-10-10 21:31:08.917802
NCT02997657|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-15|||September 2016||2016-09-01|December 2016|2016-12-01|October 2021|Anticipated|2021-10-01|June 2021|Anticipated|2021-06-01||Interventional|||Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial|Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial|Active, not recruiting||Phase 2|340|Anticipated|Brown University||2|||f||||f||||||||No||2017-10-10 21:31:09.038718|2017-10-10 21:31:09.038718
NCT02997462|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-06-02|||November 2011||2011-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Monocyte Phenotypic Changes in Heart Failure|Monocyte Phenotypic Changes in Heart Failure|Recruiting||N/A|32|Anticipated|University of Michigan|||2||f||||f||||||Samples With DNA|"     Blood samples for cytokine measures      Blood samples for monocyte cell surface marker and functional phenotyping   "|||2017-10-10 21:31:10.552607|2017-10-10 21:31:10.552607
NCT02997644|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-19|||June 2016||2016-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|OpiateLEO||Impact of Different Educational Approaches on Post-operative Opiate Utilization After Elective Lower Extremity Surgery|The Effect of an Educational Pain Approach Before Elective Lower-extremity Surgery on 6-month Post-operative Use of Opioid Medication: A Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|Brooke Army Medical Center||2|||f||||f||||||||Yes|Data sharing must go through a Data Sharing Agreement via the Defense Health Agency|2017-10-10 21:31:09.127527|2017-10-10 21:31:09.127527
NCT02997631|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-04-24|||April 20, 2017|Actual|2017-04-20|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|||Robot-Based Distraction to Reduce Pain and Distress in the Pediatric Emergency Department|A Randomized Controlled Trial of Humanoid Robot-Based Distraction for Venipuncture Pain: The MEDi Study|Recruiting||N/A|80|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 21:31:09.246704|2017-10-10 21:31:09.246704
NCT02997618|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-21|||April 2017||2017-04-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The AAA Get Fit Trial: A Pilot Randomised Controlled Trial of Community Based Exercise in Patients With Abdominal Aortic Aneurysms|The AAA Get Fit Trial: A Pilot Randomised Controlled Trial of Community Based Exercise to Improve Fitness and Reduce Morbidity and Mortality of Patients With Abdominal Aortic Aneurysms|Not yet recruiting||N/A|58|Anticipated|University of Manchester||2|||f||||f||||||||Undecided||2017-10-10 21:31:09.336722|2017-10-10 21:31:09.336722
NCT02997605|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|STAR||Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients|Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients in Low Disease Activity or Remission|Not yet recruiting||Phase 4|122|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 21:31:09.423068|2017-10-10 21:31:09.423068
NCT02997592|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-04-13|||March 26, 2017|Actual|2017-03-26|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Interventional|SPINCARE2||Evaluation of the SpinCare™ System in the Treatment of Partial Thickness Burns|Evaluation of the SpinCare™ System in the Treatment of Partial Thickness Burns - A Prospective Single Arm, Safety and Efficacy, Open Labeled Multi-center Study|Recruiting||N/A|20|Anticipated|Nicast Ltd.||1|||f||||f|f|f||||||No||2017-10-10 21:31:09.539568|2017-10-10 21:31:09.539568
NCT02997579|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-05-28|||December 2016||2016-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Vibration Arthrometry Between Patella Resurfacing and Patella Non-resurfacing in Total Knee Replacement Patients|Prospective Randomized Controlled Trial: Comparison of Vibration Arthrometry Between Patella Resurfacing and Patella Non-resurfacing in Total Knee Replacement Patients|Recruiting||N/A|60|Anticipated|Navamindradhiraj University||2|||f||||t||||||||No||2017-10-10 21:31:09.648329|2017-10-10 21:31:09.648329
NCT02997566|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-19|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Autonomic Modulation and Facial Expression in Autism Spectrum Disorder|Autonomic Modulation and Facial Expression in Autism Spectrum Disorder: Cross-sectional Study|Recruiting||N/A|40|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho|||2||f||||t||||||||Undecided||2017-10-10 21:31:09.73539|2017-10-10 21:31:09.73539
NCT02997553|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-06-06|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|GASVERT||Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery|Reliability of Indocyanine Green Use in Sentinel Lymph Node Identification in Cancer Surgery|Not yet recruiting||Phase 3|744|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f|f|f||||||No||2017-10-10 21:31:09.832009|2017-10-10 21:31:09.832009
NCT02997540|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-04-26|||November 2016||2016-11-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Effect of Body Position and Probe Position on the Localization of Breast Mass|Evaluation of the Effect of Body Position and Probe Position on the Localization of Breast Mass in Free-Hand Breast Ultrasound Examination|Recruiting||N/A|35|Anticipated|MetriTrack, Inc.|||1||f||||f||||||||Undecided||2017-10-10 21:31:09.941033|2017-10-10 21:31:09.941033
NCT02997514|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-19|||January 2017||2017-01-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Solution Focused Coaching Strategy Within a Paediatric Multidisciplinary Neuromuscular Clinic|Implementation and Evaluation of Solution Focused Coaching Strategy Within a Paediatric Multidisciplinary Neuromuscular Clinic|Not yet recruiting||N/A|40|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||f||||||||No||2017-10-10 21:31:10.126632|2017-10-10 21:31:10.126632
NCT02997501|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-06-28|||December 23, 2016|Actual|2016-12-23|June 2017|2017-06-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|ADELOS||T790M Plasma Testing Methodology Comparison and Clinical Validation|Detect EGFR T790M Mutation in ctDNA of Chinese Advanced/Metastatic NSCLC Patients by Cobas, Super-ARMS, Digital PCR and NGS and Evaluate Clinical Outcomes of T790M Mutation Positive Patients Who Had AZD9291 Monotherapy|Active, not recruiting||Phase 3|167|Actual|AstraZeneca||1|||f||||f|f|f||||||Undecided||2017-10-10 21:31:10.235385|2017-10-10 21:31:10.235385
NCT02997488|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-06-14|||February 9, 2017|Actual|2017-02-09|June 2017|2017-06-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Observational|||Comparison of Routine Endotracheal Intubation With McGrath Videolaryngoscope and Pentax AirwayScope|Comparison of Routine Endotracheal Intubation With McGrath Videolaryngoscope and Pentax AirwayScope|Completed||N/A|140|Actual|Ajou University School of Medicine|||2||f||||||||||||No||2017-10-10 21:31:10.366378|2017-10-10 21:31:10.366378
NCT02997475|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-12-15|||June 2016||2016-06-01|December 2016|2016-12-01||||May 2019|Anticipated|2019-05-01||Observational|SRBN||Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa|Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa|Recruiting||N/A|90|Anticipated|University of California, San Diego|||2||f||||||||||||||2017-10-10 21:31:10.457411|2017-10-10 21:31:10.457411
NCT02997449|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-12-15|||December 2013||2013-12-01|December 2016|2016-12-01||||June 2017|Anticipated|2017-06-01|6 Months|Observational [Patient Registry]|||Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered|Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom Stereotactic Ablative Radiotherapy (SABR), is Considered|Recruiting||N/A|102|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-10 21:31:10.679032|2017-10-10 21:31:10.679032
NCT02997436|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-19|||January 2017||2017-01-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|FirstAMOS||First Approach for Aspirin Misuse Objective Screening|"Asa Test ; un Nouvel Outil Dans le dépistage du Traitement Par Aspirine ? (This Official Titre is in French and Contains no Spelling Error. English Translation for it Would be : ASA-test. A New Tool for the Screening of Aspirin Treatment)"|Enrolling by invitation||N/A|400|Anticipated|University Hospital, Angers||1|||f||||t||||||||No||2017-10-10 21:31:10.789448|2017-10-10 21:31:10.789448
NCT02997423|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-08-30|||November 2016||2016-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)|Prospective Phase II Study of Cytochrome C Oxidase Activity as a Novel Biomarker In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme|Recruiting||N/A|200|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"     Brain tissue and DNA   "|||2017-10-10 21:31:10.89527|2017-10-10 21:31:10.89527
NCT02997410|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-06-15|||December 2014||2014-12-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|June 2017|Actual|2017-06-01||Interventional|OTMMP||Ozone Therapy for Masticatory Muscle Pain (OTMMP)|Effect of High-frequency Bio-oxidative Ozone Therapy for Masticatory Muscle Pain: a Double-blind Randomized Clinical Trial|Active, not recruiting||N/A|60|Actual|Istanbul University||3|||f||||t||||||||||2017-10-10 21:31:11.054062|2017-10-10 21:31:11.054062
NCT02997397|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2016-12-15|||December 2013||2013-12-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Observational|PPH||A Novel Tourniquet Technic for Massive PPH|A Novel Atraumatic Tourniquet Technique in Cases of Excessive Bleeding During Cesarean Section|Completed||N/A|37|Actual|Irenbe|||2||f||||f||||||||Yes|If needed|2017-10-10 21:31:11.136991|2017-10-10 21:31:11.136991
NCT02997384|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|RIVIERA||Feasibility of Breast Cancer Risk Evaluation in Women From the General Population|Feasibility of Breast Cancer Risk Evaluation in Women From the General Population|Active, not recruiting||N/A|600|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||3||f||||f||||||||No||2017-10-10 21:31:11.221026|2017-10-10 21:31:11.221026
NCT02997371|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-05-03|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|IL1ra||IL-1ra Dose-range Study for Moderate-to-severe TBI Patients|A Randomised Double Blind Placebo Controlled Dose-range Study Using Placebo, 1.5g and 3.0g of Intravenous Recombinant Interleukin-1 Receptor Antagonist (Anakinra) for Patients With Moderate-to-severe TBI|Not yet recruiting||Phase 2|60|Anticipated|University of Cambridge||3|||f||||t|f|f|||f|||||2017-10-10 21:31:11.299633|2017-10-10 21:31:11.299633
NCT02997358|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|LMS04||Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma|Randomised Phase III Multicentric Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin in Non-progressive Patients Versus Doxorubicine Alone as First-line Therapy in Patients With Metastatic or Unresectable Leiomyosarcoma (Uterine or Soft Tissue)|Not yet recruiting||Phase 3|150|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||No||2017-10-10 21:31:11.533343|2017-10-10 21:31:11.533343
NCT02997345|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-12-15|||July 2013||2013-07-01|December 2016|2016-12-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01|1 Year|Observational [Patient Registry]|||PPROM Registry (Preterm Premature Rupture of Membranes)|Patient Registry for Women Diagnosed With Preterm Premature Rupture of Membranes or PPROM During Pregnancy|Recruiting||N/A|3000|Anticipated|American Alliance for pProm Support|||1||f||||t||||||||Undecided||2017-10-10 21:31:11.621165|2017-10-10 21:31:11.621165
NCT02997332|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-10|||March 30, 2017|Actual|2017-03-30|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|MEDINDUCTION||Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma|Phase I Trial Evaluating the Safety of Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU in Induction for Locally Advanced Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1|36|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||t|f|f||||||No||2017-10-10 21:31:11.730119|2017-10-10 21:31:11.730119
NCT02997306|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-15|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|COEBICS||COEBICS: Comparison of Erythema Between Interrupted and Continuous Sutures|COEBICS: Comparison of Erythema Between Interrupted and Continuous Sutures|Not yet recruiting||N/A|100|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 21:31:11.970354|2017-10-10 21:31:11.970354
NCT02997293|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-15|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||An Analysis of the Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery at the University of Arkansas for Medical Sciences|An Analysis of the Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery at the University of Arkansas for Medical Sciences|Recruiting||N/A|120|Anticipated|University of Arkansas|||2||f||||t||||||||||2017-10-10 21:31:12.094814|2017-10-10 21:31:12.094814
NCT02997280|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-08-21|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Ruxolitinib for Steroid-refractory GVHD|Treatment of Steroid-refractory Acute and Chronic Graft-versus-host Disease With Inhibitor of Janus Kinases|Recruiting||Phase 2|50|Anticipated|St. Petersburg State Pavlov Medical University||1|||f||||f||||||||||2017-10-10 21:31:12.184596|2017-10-10 21:31:12.184596
NCT02997267|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-07-30|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Interventional|ECPIS||Early Closure of Protective Ileostomy in Rectal Cancer Patients|The Early Closure of the Protective Ileostomy After Low Anterior Resection Enables Correct Start of Chemotherapy|Completed||N/A|38|Actual|Stanley Dudrick's Memorial Hospital||2|||f||||f||||||||||2017-10-10 21:31:12.279123|2017-10-10 21:31:12.279123
NCT02997254|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-15|||September 2014||2014-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|COMPARE_AF||COMParison of Algorithms for Rotational Evaluation in Atrial Fibrillation|COMParison of Algorithms for Rotational Evaluation in Atrial Fibrillation|Recruiting||N/A|200|Anticipated|Stanford University|||1||f||||f||||||||No||2017-10-10 21:31:12.357159|2017-10-10 21:31:12.357159
NCT02997241|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||January 2017||2017-01-01|December 2016|2016-12-01|September 2022|Anticipated|2022-09-01|December 2017|Anticipated|2017-12-01||Interventional|CCTDRP||Colon Cancer Treatment Decisions and Recurrence Predicting|Circulating Tumor DNA Predict Recurrence and Aid Treatment Decisions in Colon Cancer|Not yet recruiting||N/A|500|Anticipated|MyGenostics Inc., Beijing||4|||f||||f||||||||No||2017-10-10 21:31:12.462846|2017-10-10 21:31:12.462846
NCT02997228|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-19|2017-09-04|||November 7, 2017|Anticipated|2017-11-07|May 2017|2017-05-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2022|Anticipated|2022-04-30||Interventional|||Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Microsatellite Instability-High Metastatic Colorectal Cancer|Colorectal Cancer Metastatic MSI-High Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy With or Without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients With Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer|Not yet recruiting||Phase 3|439|Anticipated|National Cancer Institute (NCI)||3|||f||||f|t|f||||||||2017-10-10 21:31:12.56056|2017-10-10 21:31:12.56056
NCT02997215|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-16|||January 2016||2016-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Intravenous Lidocaine and Postoperative Pain Management|Effect of Intravenous Lidocaine on Postoperative Pain Management After Laparoscopy Cholecystectomy|Recruiting||Phase 4|80|Anticipated|Beijing Tongren Hospital||2|||f||||t||||||||Yes|De-identified individual participants data for primary and secondary outcome measures will be available within 6 months of study completion|2017-10-10 21:31:12.755671|2017-10-10 21:31:12.755671
NCT02997202|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-10-04|||June 7, 2017|Actual|2017-06-07|October 2017|2017-10-01|August 2024|Anticipated|2024-08-01|August 2024|Anticipated|2024-08-01||Interventional|||A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)|A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/ITD AML|Recruiting||Phase 3|346|Anticipated|Astellas Pharma Inc||2|||t||||t|t|f||||||||2017-10-10 21:31:12.843682|2017-10-10 21:31:12.843682
NCT02997189|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-14|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss|A Multicenter, Randomized, Phase 2 Study to Assess the Feasibility, Safety and Efficacy of OTO-104 Given by Intratympanic Administration in Subjects at Risk for Ototoxicity From Cisplatin Chemotherapy Regimens in the Treatment of Cancer|Terminated||Phase 2|12|Actual|Otonomy, Inc.||2||Negative Efficacy Results from the recently completed Phase 3 study 104-201506|f||||t||||||||||2017-10-10 21:31:13.013843|2017-10-10 21:31:13.013843
NCT02997176|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-28|||October 25, 2016|Actual|2016-10-25|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)|A Phase I Open-label Pharmacokinetics And Safety Study Of Talazoparib (mdv3800) In Patients With Advanced Solid Tumors And Normal Or Varying Degrees Of Hepatic Impairment|Recruiting||Phase 1|24|Anticipated|Pfizer||4|||f||||||||||||||2017-10-10 21:31:13.102982|2017-10-10 21:31:13.102982
NCT02997163|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-28|||February 21, 2017|Actual|2017-02-21|September 2017|2017-09-01|December 19, 2017|Anticipated|2017-12-19|December 19, 2017|Anticipated|2017-12-19||Interventional|||An Open-Label Pharmacokinetics and Safety Study of Talazoparib|A Phase I Open-label Pharmacokinetics And Safety Study Of Talazoparib (mdv3800) In Patients With Advanced Solid Tumors And Normal Or Varying Degrees Of Renal Impairment|Recruiting||Phase 1|24|Anticipated|Pfizer||4|||f||||f|t|f||||||||2017-10-10 21:31:13.230874|2017-10-10 21:31:13.230874
NCT02997150|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||February 2017||2017-02-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|NIL-2 pilote||Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot Study|Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot Study|Not yet recruiting||Phase 2|10|Anticipated|University Hospital, Limoges||1|||f||||t||||||||||2017-10-10 21:31:13.333187|2017-10-10 21:31:13.333187
NCT02997137|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||October 2014||2014-10-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|BOT-01||Impact of an Amino Acid Composition With Micronutrients on Wellbeing of Patients With Chronic Exhaustion Conditions|Impact of a Specific Amino Acid Composition With Micronutrients on Wellbeing and Endocrine-cardiometabolic Situation of Patients With Chronic Exhaustion Conditions, Such as Burnout|Completed||Phase 3|74|Actual|Kyberg Vital GmbH||2|||f||||f||||||||No||2017-10-10 21:31:13.443738|2017-10-10 21:31:13.443738
NCT02997124|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-20|||April 2016||2016-04-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Transversus Abdominis Plane Block in Iliac Crest harvest-is it Beneficial?|Transversus Abdominis Plane Block Supplementation During Iliac Crest Bone Graft Harvest - Its Influence on Postoperative Parameters|Completed||N/A|143|Actual|Jubilee Mission Medical College and Research Institute||2|||f||||t||||||||No||2017-10-10 21:31:13.527417|2017-10-10 21:31:13.527417
NCT02997111|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-06-21|||February 14, 2017|Actual|2017-02-14|June 2017|2017-06-01|June 20, 2017|Actual|2017-06-20|June 9, 2017|Actual|2017-06-09||Interventional|||PFA-100 Responsive to Effect of Energy Drinks on Platelet Function|Is the PFA-100 Responsive to the Effect of Energy Drinks on Platelet Function Changes?|Completed||N/A|13|Actual|St. Louis University||1|||f||||f|f|f||||||No|No plan to share individual participant data with other researchers|2017-10-10 21:31:13.613481|2017-10-10 21:31:13.613481
NCT02997072|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||July 2014||2014-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|DPEIT||Lungs Aeration Changes Examined by Impedance Tomography During High Frequency Jet Ventilation.|Assessment of Regional Lungs Aeration Changes Examined by Impedance Tomography, Depending on the Drive Pressure Applied During High Frequency Jet Ventilation.|Completed||N/A|30|Actual|Silesian University of Medicine|||1||f||||f||||||||No||2017-10-10 21:31:13.865175|2017-10-10 21:31:13.865175
NCT02997059|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-14|||July 2008||2008-07-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|AscaMC||Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.|Effect of Fluconazole on the Levels of Anti-Saccharomyces Cerevisiae Antibodies (ASCA) After Surgical Resection for Crohn's Disease. Multicenter, Randomized, and Controlled in Two Parallel Groups Versus Placebo|Terminated||Phase 2|35|Actual|University Hospital, Lille||2||Limited recourse to intestinal resection due to new management of CD|f||||f||||||||No||2017-10-10 21:31:13.92729|2017-10-10 21:31:13.92729
NCT02997046|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|FeMRA in CKD||Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease|Use of Ferumoxytol Enhanced Magnetic Resonance Angiography for Cardiovascular Assessment in Late-stage Chronic Kidney Disease|Recruiting||Phase 4|40|Anticipated|University of Glasgow||3|||f||||f||||||||Undecided|No plans for sharing any data at the moment.|2017-10-10 21:31:14.010926|2017-10-10 21:31:14.010926
NCT02997033|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-14|||May 2014||2014-05-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Observational|||SIBlos EXtension Study (SIBEX)|Longitudinal Extension Phase of Sibling Pair Linkage Analysis of Bone Mineral Density / Geometry and Sex Steroid and Thyroid Status in Healthy Young Men|Enrolling by invitation||N/A|800|Anticipated|University Hospital, Ghent|||1||f||||f||||||Samples With DNA|"     -  Venous blood sampling after overnight fast, with whole blood, serum and plasma samples          to be retained        -  Second void urine samples to be retained   "|||2017-10-10 21:31:14.120737|2017-10-10 21:31:14.120737
NCT02997020|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-15|||November 2016|Actual|2016-11-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Observational|||Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)|Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)|Recruiting||N/A|30|Anticipated|University of Alabama at Birmingham|||2||f||||t||||||||No||2017-10-10 21:31:14.217782|2017-10-10 21:31:14.217782
NCT02997007|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-14|||January 2017||2017-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Neural Correlates of Repeated tDCS|Investigating the Neural Correlates of Repeated tDCS in MCI and Healthy Ageing With fMRI|Not yet recruiting||N/A|80|Anticipated|Maastricht University Medical Center||4|||f||||t||||||||Undecided||2017-10-10 21:31:14.2918|2017-10-10 21:31:14.2918
NCT02996994|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-06-05|||December 2016||2016-12-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Predictors of Postoperative Pain|Predictors of Postoperative Pain in Urogynecologic Surgery|Active, not recruiting||N/A|374|Anticipated|TriHealth Inc.|||1||f||||f||||||||No||2017-10-10 21:31:14.373457|2017-10-10 21:31:14.373457
NCT02996968|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Self-discontinuation of a Transurethral Catheter|Is Self-discontinuation of a Transurethral Catheter Following Pelvic Reconstructive Surgery as Effective as Office-based Discontinuation?; A Randomized Controlled Trial|Recruiting||N/A|168|Anticipated|TriHealth Inc.||2|||f||||f||||||||||2017-10-10 21:31:14.480129|2017-10-10 21:31:14.480129
NCT02996955|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PAPA||Patient Adherence to a Physical Activity Advice|Influence of Social Support and Treatment of Illness Perceptions on Patient's Adherence to a Physical Activity Advice|Recruiting||N/A|240|Anticipated|Maastricht University||2|||f||||f||||||||No||2017-10-10 21:31:14.560201|2017-10-10 21:31:14.560201
NCT02996942|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-12-14|||July 2012||2012-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|3 Years|Observational [Patient Registry]|KAPPA||Key Aspects of Medical Practice in Patients With Haemophilia A|Key Aspects of Medical Practice in Patients With Haemophilia A|Enrolling by invitation||N/A|1000|Anticipated|Lund University|||1||f||||f||||||||Undecided||2017-10-10 21:31:14.659465|2017-10-10 21:31:14.659465
NCT02996929|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-14|||February 2017||2017-02-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Safety and Performance of LeadExx LC System in Lead Extraction|Prospective, Investigational Study to Assess the Safety and Performance of LeadExx LC System in Lead Extraction|Not yet recruiting||N/A|10|Anticipated|LeadExx Cardiac Ltd.||1|||f||||f||||||||No||2017-10-10 21:31:14.8561|2017-10-10 21:31:14.8561
NCT02996916|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-16|||December 2015||2015-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue|Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue|Recruiting||Phase 4|100|Anticipated|Kurume University||2|||f||||t||||||||Undecided||2017-10-10 21:31:14.939207|2017-10-10 21:31:14.939207
NCT02996903|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-09-07|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01|1 Day|Observational [Patient Registry]|PROTECTION-VI||Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017|Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017|Active, not recruiting||N/A|3000|Anticipated|Klinikum der Universitaet Muenchen|||1||f||||t||||||||||2017-10-10 21:31:15.087591|2017-10-10 21:31:15.087591
NCT02996136|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Assessment of the Clinical Performance of the ARROW-FLU System|Assessment of the Clinical Performance of the ARROW-FLU System for the Detection of Influenza A and B in Symptomatic Patients|Not yet recruiting||N/A|3000|Anticipated|Sekisui Diagnostics, LLC||2|||f||||f||||||||No||2017-10-10 21:31:22.265989|2017-10-10 21:31:22.265989
NCT02996877|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|1 Year|Observational [Patient Registry]|OPTIMUM||Outcomes of Percutaneous Revascularization for Management of Surgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease: A Prospective Registry|Outcomes of Percutaneous Revascularization for Management of Surgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease: A Prospective Registry|Recruiting||N/A|800|Anticipated|Saint Luke's Health System|||2||f||||f||||||||||2017-10-10 21:31:15.292294|2017-10-10 21:31:15.292294
NCT02996864|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-07-24|||September 30, 2015||2015-09-30|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|January 31, 2018|Anticipated|2018-01-31||Interventional|||Location-based Smartphone Technology to Guide College Students Healthy Choices|Location-based Smartphone Technology to Guide College Students Healthy Choices Phase II|Recruiting||N/A|300|Anticipated|Klein Buendel, Inc.||2|||f||||f||||||||||2017-10-10 21:31:15.394336|2017-10-10 21:31:15.394336
NCT02996851|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||January 2007||2007-01-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Traumatic Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs|Traumatic Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs: a Nationwide Pharmacoepidemiological Study|Active, not recruiting||N/A|10000|Anticipated|St. Olavs Hospital|||1||f||||f||||||||No||2017-10-10 21:31:15.529891|2017-10-10 21:31:15.529891
NCT02996838|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-15|||May 11, 2017|Actual|2017-05-11|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics|Phase I Study of Tolerance and Pharmacokinetics of TQ-B3234 in Patients With Advanced Cancer|Recruiting||Phase 1|20|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f|f|f||||||||2017-10-10 21:31:15.603415|2017-10-10 21:31:15.603415
NCT02996812|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||April 2015||2015-04-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia|Subcutaneous Injection of Exendin (9-39) in Subjects With Hyperinsulinemic Hypoglycemia Post-Bariatric Surgery|Active, not recruiting||Phase 1|9|Actual|Stanford University||4|||f||||t||||||||No||2017-10-10 21:31:15.825347|2017-10-10 21:31:15.825347
NCT02996799|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-14|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Deferred Cord Clamping Compared to Umbilical Cord Milking in Preterm Infants|Efficacy and Safety of Deferred Umbilical Cord Clamping Compared to Umbilical CordMilking in Preterm Infants: A Randomized Clinical Trial|Not yet recruiting||N/A|180|Anticipated|King Abdulaziz University||2|||f||||t||||||||Undecided|We are planning to publish all the data that we will collect. If other researchers have specific questions about the data, we are willing to answer and share if needed.|2017-10-10 21:31:15.913726|2017-10-10 21:31:15.913726
NCT02996786|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-14|||October 2016||2016-10-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners|Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners|Recruiting||N/A|36|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||No||2017-10-10 21:31:16.01629|2017-10-10 21:31:16.01629
NCT02996773|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine|A Phase I/II Study of Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide and/or Bendamustine|Recruiting||Phase 1/Phase 2|32|Anticipated|University of Arizona||1|||f||||t||||||||||2017-10-10 21:31:16.132702|2017-10-10 21:31:16.132702
NCT02996760|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.|Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity|Not yet recruiting||Phase 3|52|Anticipated|IVI Bilbao||2|||f||||t|f|f||||||||2017-10-10 21:31:16.312306|2017-10-10 21:31:16.312306
NCT02996747|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-21|||August 2016||2016-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|CONDRO1||Low Grade Chondrosarcoma Versus Enchondroma|Low Grade Chondrosarcoma Versus Enchondroma: Challenges in Diagnosis and Management|Completed||N/A|102|Actual|Istituto Ortopedico Rizzoli|||1||f||||f||||||||Yes|publish a paper in international medical journal|2017-10-10 21:31:16.387751|2017-10-10 21:31:16.387751
NCT02996734|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-21|||April 2016||2016-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|GCTLIMBS||Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment|Il Tumore a Cellule Giganti Delle estermità|Completed||N/A|412|Actual|Istituto Ortopedico Rizzoli|||1||f||||f||||||||Yes|publish a manuscript in international medical journal|2017-10-10 21:31:16.456368|2017-10-10 21:31:16.456368
NCT02996721|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-06-02|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|TARGET-D||A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients|A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients (The TARGET-D Study)|Recruiting||Phase 4|890|Anticipated|Intermountain Health Care, Inc.||2|||f|||||t|f||||||No||2017-10-10 21:31:16.528115|2017-10-10 21:31:16.528115
NCT02996695|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-14|||April 6, 2017|Actual|2017-04-06|July 19, 2017|2017-07-19|December 1, 2018|Anticipated|2018-12-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||PfSPZ Challenge With Prophylaxis in Mali|Safety, Tolerability, Immunogenicity and Protective Efficacy Against Naturally-Transmitted Malaria of Infectious, Cryopreserved Plasmodium Falciparum Sporozoites (PfSPZ Challenge) Administered by Direct Venous Inoculation Under Chloroquine Chemoprophylaxis (PfSPZ-CVac), in Malian Adults: A Randomized, Double Blind, Placebo-Controlled Trial|Recruiting||Phase 1|62|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-10 21:31:16.793463|2017-10-10 21:31:16.793463
NCT02996682|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-09-22|||December 26, 2016|Actual|2016-12-26|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis|A Multicenter, Randomized, Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Subjects With Chronic HCV Infection and Decompensated Cirrhosis|Active, not recruiting||Phase 3|102|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-10 21:31:16.959464|2017-10-10 21:31:16.959464
NCT02996669|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-06-08|||October 2016||2016-10-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|November 2019|Anticipated|2019-11-01||Observational|ABC-CT||Autism Biomarker Consortium for Clinical Trials|Autism Biomarker Consortium for Clinical Trials|Recruiting||N/A|275|Anticipated|Yale University|||2||f||||t||||||Samples With DNA|"     Whole blood.   "|||2017-10-10 21:31:17.205678|2017-10-10 21:31:17.205678
NCT02996656|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-02-06|||December 2016||2016-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|PAPA||Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery|Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery: A Double Blinded Randomized Controlled Trial|Recruiting||N/A|88|Anticipated|Université de Montréal||2|||f||||f||||||||Undecided||2017-10-10 21:31:17.357988|2017-10-10 21:31:17.357988
NCT02996643|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-14|||January 2012||2012-01-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Ultrasound-Assisted Brace Casting for AIS|Determine the Optimum Applied Pressure for the Brace Treatment of Scoliosis|Completed||Early Phase 1|34|Actual|University of Alberta||2|||f||||f||||||||No||2017-10-10 21:31:17.49703|2017-10-10 21:31:17.49703
NCT02996630|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-12-14|||May 2013||2013-05-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|NEUROHEART||Assessing Neurodevelopment in Congenital Heart Disease.|Abnormal Neurodevelopment Detection in Congenital Heart Disease: Predictive Methods Based on Prenatal and Postnatal Factors.|Recruiting||N/A|250|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||No||2017-10-10 21:31:17.602935|2017-10-10 21:31:17.602935
NCT02996617|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2016-12-15|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia|PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia|Recruiting||Phase 4|240|Anticipated|Shandong Provincial Hospital||2|||f||||f||||||||No||2017-10-10 21:31:17.77104|2017-10-10 21:31:17.77104
NCT02996604|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-20|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acupuncture for Functional Dyspepsia: a Functional Magnetic Resonance Imaging (fMRI) Study|Acupuncture for Functional Dyspepsia: a Functional Magnetic Resonance Imaging (fMRI) Study|Not yet recruiting||N/A|105|Anticipated|Chengdu University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-10 21:31:17.917848|2017-10-10 21:31:17.917848
NCT02996591|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-07-11|||January 2017||2017-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|LMA vs Spinal||Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery.|Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery: A Double-Blinded Randomized Controlled Trial.|Recruiting||Phase 4|36|Anticipated|Hospital for Special Surgery, New York||2|||f||||||||||||||2017-10-10 21:31:18.048721|2017-10-10 21:31:18.048721
NCT02996578|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-05-12|||April 17, 2017|Actual|2017-04-17|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Effect of Polyphenol-rich Cocoa Products on Cognitive Function|Consumption of Polyphenol Rich Cocoa Products Over 8 Weeks and Its Effect on Cognitive Function in Individuals in Their 5th Decade of Life.|Enrolling by invitation||N/A|128|Anticipated|Queen Margaret University||4|||f||||f|f|f||||||No||2017-10-10 21:31:18.21424|2017-10-10 21:31:18.21424
NCT02996565|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-08-21|||August 2, 2017|Actual|2017-08-02|December 2016|2016-12-01|July 2021|Anticipated|2021-07-01|March 2019|Anticipated|2019-03-01||Interventional|||Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure|Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure|Enrolling by invitation||N/A|2000|Anticipated|HealthPartners Institute||2|||f||||t|f|f||||||||2017-10-10 21:31:18.365991|2017-10-10 21:31:18.365991
NCT02996552|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-04-04|||June 2011||2011-06-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|NOSTRUM||Annuloplasty for Not-Severe TR in Patient Undergoing MV Repair Versus Mitral Repair Only (NOSTRUM)|Annuloplasty for the Treatment of Not-Severe Tricuspid Regurgitation in Patient Undergoing Surgery for Mitral Valve Disease: a Perspective, Spontaneous, Single-centre, Randomized Study|Recruiting||N/A|142|Anticipated|Ospedale San Raffaele||2|||f||||t||||||||No||2017-10-10 21:31:18.498253|2017-10-10 21:31:18.498253
NCT02996539|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-14|||February 2013||2013-02-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients|Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients|Completed||N/A|392|Actual|First People's Hospital of Kunming|||1||f||||t||||||||Yes|The basic records of patients|2017-10-10 21:31:18.600648|2017-10-10 21:31:18.600648
NCT02996526|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-12-20|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01|3 Months|Observational [Patient Registry]|||The Incidence and Impact of Vocal Cord Dysfunction In Patients Undergoing Thoracic Surgery|The Incidence and Impact of Vocal Cord Dysfunction In Patients Undergoing Thoracic Surgery|Recruiting||N/A|141|Anticipated|University of Manitoba|||2||f||||f||||||||Undecided||2017-10-10 21:31:18.6953|2017-10-10 21:31:18.6953
NCT02996513|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-08-24|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|SUPERKID||Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) Method|Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) Method in Preschool Nigerian Children Living in an Area With a High Malaria Burden|Completed||N/A|60|Actual|Wageningen University||1|||f||||f||||||||||2017-10-10 21:31:18.783658|2017-10-10 21:31:18.783658
NCT02996487|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-01-24|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|StoP CDI||Screening to Prophylax Against Clostridium Difficile Infection -|Screening to Prophylax Against Clostridium Difficile Infection|Recruiting||Phase 4|2500|Anticipated|William Beaumont Hospitals||2|||f||||f||||||||||2017-10-10 21:31:19.160215|2017-10-10 21:31:19.160215
NCT02996474|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-09-21|||December 12, 2016||2016-12-12|September 15, 2017|2017-09-15|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia|Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|15|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:31:19.379756|2017-10-10 21:31:19.379756
NCT02996461|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-10-05|||December 8, 2016||2016-12-08|July 27, 2017|2017-07-27|December 28, 2018|Anticipated|2018-12-28|December 28, 2018|Anticipated|2018-12-28||Interventional|||VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults|VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, in Healthy Adults|Active, not recruiting||Phase 1|50|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 21:31:19.500939|2017-10-10 21:31:19.500939
NCT02996448|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-16|2017-08-04|||November 17, 2016||2016-11-17|July 2017|2017-07-01|December 29, 2018|Anticipated|2018-12-29|December 29, 2018|Anticipated|2018-12-29||Interventional|||Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome|A Phase 2a Study to Evaluate the Safety, Tolerability, and Immunogenicity of One Dose of NDV-3A Vaccine in Patients With STAT3-Mutated Hyper-IgE Syndrome|Suspended||Phase 2|40|Anticipated|National Institutes of Health Clinical Center (CC)||1||Study not recruiting at this time due to hold.|f||||||||||||||2017-10-10 21:31:19.614482|2017-10-10 21:31:19.614482
NCT02996435|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-07-28|||December 21, 2016|Actual|2016-12-21|July 2017|2017-07-01|April 3, 2018|Anticipated|2018-04-03|April 3, 2018|Anticipated|2018-04-03||Interventional|||Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation|smartADHERE - Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation|Recruiting||Phase 4|378|Anticipated|Janssen Scientific Affairs, LLC||2|||f||||f||||||||||2017-10-10 21:31:19.749399|2017-10-10 21:31:19.749399
NCT02996422|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-04-17|||November 2016||2016-11-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Appalachians Together Restoring the Eating Environment: Improving Healthy Diet in Rural Appalachian Kentucky|Appalachians Together Restoring the Eating Environment (Appal-TREE): Advancing Sustainable CBPR Interventions to Improve Healthy Diet in Rural Appalachian Children|Enrolling by invitation||N/A|1360|Anticipated|University of Kentucky||3|||f||||f||||||||No||2017-10-10 21:31:19.945922|2017-10-10 21:31:19.945922
NCT02996409|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HAT||High-Volume Image-Guided Injection in Chronic Midportion Achilles Tendinopathy|The Value of a High-Volume Image-Guided Injection in Chronic Midportion Achilles Tendinopathy: a Double-blind, Randomized, Placebo-controlled Clinical Trial|Recruiting||Phase 4|80|Anticipated|Erasmus Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:31:20.040398|2017-10-10 21:31:20.040398
NCT02996396|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01|October 2023|Anticipated|2023-10-01|December 2022|Anticipated|2022-12-01|60 Months|Observational [Patient Registry]|EVAS FORWARD 2||Nellix Registry Study: EVAS-Global|"Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix® System for Endovascular Abdominal Aortic Aneurysm Repair"|Recruiting||N/A|300|Anticipated|Endologix|||1||f||||f||||||||||2017-10-10 21:31:20.180212|2017-10-10 21:31:20.180212
NCT02996383|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-12-16|||May 2016||2016-05-01|December 2016|2016-12-01||||September 2019|Anticipated|2019-09-01||Interventional|||Fixation Versus Arthroplasty for Undisplaced Intracapsular Fractures|Fixation Versus Arthroplasty for Undisplaced Intracapsular Fractures|Recruiting||N/A|50|Anticipated|Peterborough and Stamford Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 21:31:20.285864|2017-10-10 21:31:20.285864
NCT02996370|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-14|||October 2010||2010-10-01|December 2016|2016-12-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Effect of I-Shape Incısıon Technique on Inter-Implant Papilla: A Prospective Randomized Clinical Trial|Effect of I-Shape Incısıon Technique on Inter-Implant Papilla: A Prospective Randomized Clinical Trial|Completed||N/A|12|Actual|Ege University||2|||f||||f||||||||Undecided||2017-10-10 21:31:20.38537|2017-10-10 21:31:20.38537
NCT02996357|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-07-17|||October 4, 2016|Actual|2016-10-04|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|||Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence|Specific Factors Associated With the Development of Incontinence- Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence: Matched Case Control Study|Completed||N/A|206|Actual|University Ghent|||2||f||||f||||||||||2017-10-10 21:31:20.512693|2017-10-10 21:31:20.512693
NCT02996344|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-12-14|||March 2016||2016-03-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Suicide Prevention Training for Primary Care Providers-in-training|Suicide Prevention Training for Primary Care Providers-in-training|Recruiting||N/A|108|Anticipated|University of Rochester||2|||f||||f||||||||No||2017-10-10 21:31:20.665582|2017-10-10 21:31:20.665582
NCT02996318|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-14|||May 2016||2016-05-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|FIMLIMUSDCB||Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon|Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon|Recruiting||Phase 2/Phase 3|50|Anticipated|University Hospital, Saarland||2|||f||||t||||||||No||2017-10-10 21:31:20.874454|2017-10-10 21:31:20.874454
NCT02996305|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-09-19|||January 2016||2016-01-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study in Adults With Angelman Syndrome|A Phase 2 Adult Angelman Syndrome Clinical Trial: A Randomized, Double-Blind, Safety and Efficacy Study of Gaboxadol|Recruiting||Phase 2|75|Anticipated|Ovid Therapeutics Inc.||3|||f||||f||||||||||2017-10-10 21:31:20.997592|2017-10-10 21:31:20.997592
NCT02996292|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-14|||September 2016||2016-09-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Treatment of Crowding Without Extraction Using Self Ligating Brackets|Assessment of Dentoalveolar Changes Resulting From Orthodontic Treatment of Crowding With Self-ligating Brackets Using CBCT Randomized Controlled Trial|Recruiting||Phase 1|60|Anticipated|Damascus University||3|||f||||t||||||||Yes|Individual participant data will be available to the researchers in the department of Orthodontics, Damascus University|2017-10-10 21:31:21.162573|2017-10-10 21:31:21.162573
NCT02996279|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-14|||February 2012||2012-02-01|December 2016|2016-12-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Observational|S100A12||Chorioamnionitis and Proinflammatory S100A12|Impact of Chorioamnionitis on Maternal and Fetal Levels of Proinflammatory S100A12|Completed||N/A|69|Actual|Catholic University of the Sacred Heart|||2||f||||f||||||Samples Without DNA|"     MATERNAL, CORD AND NEONATAL BLOOD   "|No||2017-10-10 21:31:21.270645|2017-10-10 21:31:21.270645
NCT02996266|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-08-02|||January 2017||2017-01-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|INTREPID||Impact of Fever Prevention in Brain Injured Patients|Impact of Fever Prevention in Brain Injured Patients|Recruiting||N/A|1176|Anticipated|C. R. Bard||2|||f||||t||||||||||2017-10-10 21:31:21.340556|2017-10-10 21:31:21.340556
NCT02996253|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-19|||December 2015||2015-12-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Observational|||Endoscopic Transfer of Flexor Hallucis Longus Tendon for Chronic Achilles Tendon Rupture|Endoscopic Assisted Transfer of Flexor Hallucis Longus Tendon for Chronic Achilles Tendon Rupture. A Prospective Multi Center Cohort Study|Recruiting||N/A|40|Anticipated|Oslo University Hospital|||1||f||||f||||||||No||2017-10-10 21:31:21.477392|2017-10-10 21:31:21.477392
NCT02996240|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-06-26|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Breast, Omega 3 Free Fatty Acid, Ph 0|A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Breast Cancer (CTMS# 16-0119)|Recruiting||N/A|220|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||t|f|f|||t|||||2017-10-10 21:31:21.5539|2017-10-10 21:31:21.5539
NCT02996227|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-01-17|||December 2016||2016-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine|Comparison of Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine: A Randomized, Controlled Trial|Recruiting||N/A|640|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-10 21:31:21.634499|2017-10-10 21:31:21.634499
NCT02996214|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|LIPUSU||Lipusu Advanced Squamous Cell Carcinoma of Lung Study Carboplatin in Advanced Squamous Cell Carcinoma of Lung|A Multicenter, Randomized, Open-label, Parallel-group Study of Paclitaxel Liposome Injection and Cisplatin Compared With Gemcitabine and Carboplatin as First-line Therapy in Advanced Squamous Cell Carcinoma of Lung|Not yet recruiting||Phase 4|536|Anticipated|Nanjing Luye Sike Pharmaceutical Co.,Ltd.||2|||f||||t||||||||Undecided||2017-10-10 21:31:21.731681|2017-10-10 21:31:21.731681
NCT02996201|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-12-16|||November 2015||2015-11-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial|Electronic Patient Reporting of Side Effects to Chemotherapy Among Breast Cancer Patients Using the Patient-Reported Outcomes Version of Common Terminology Criteria for Adverse Events (PRO-CTCAE): A Cluster Randomized Controlled Trial|Active, not recruiting||N/A|700|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||No||2017-10-10 21:31:21.821136|2017-10-10 21:31:21.821136
NCT02996188|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-14|||June 2012||2012-06-01|December 2016|2016-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Acute Hemodynamic Changes During Paracentesis||Completed||N/A|36|Actual|Universitätsmedizin Mannheim|||1||f||||t||||||||No||2017-10-10 21:31:21.887379|2017-10-10 21:31:21.887379
NCT02996175|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-10-04|||July 2015||2015-07-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Sleep Disturbances in School-age Children With Down Syndrome|Treatment of Sleep Disturbances in School-age Children With Down Syndrome|Recruiting||N/A|80|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 21:31:21.952307|2017-10-10 21:31:21.952307
NCT02996162|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-02-16|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||The Natural Course of Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease|The Natural Course of Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease|Not yet recruiting||N/A|40|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||Yes|pCO2 values and trends will be provided to families while inpatient in the BIDMC NICU, and in follow-up at CHILD (Center for Healthy Infant Lung Development) visits when applicable.|2017-10-10 21:31:22.062732|2017-10-10 21:31:22.062732
NCT02996149|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Endoscopic Lung Volume Reduction Coil Treatment in Patients With Chronic Hypercapnic Respiratory Failure|Endoscopic Lung Volume Reduction Coil Treatment in Patients With Chronic Hypercapnic Respiratory Failure|Recruiting||N/A|10|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||||||||||||2017-10-10 21:31:22.156404|2017-10-10 21:31:22.156404
NCT02996123|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-14|||October 2016||2016-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Biting Force in Heat Cured Acrylic Resin Versus CAD/CAM Maxillary Single Denture Bases|Biting Force in Heat Cured Acrylic Resin Versus CAD/CAM Maxillary Single Denture Bases: A Randomized Controlled Trial .|Enrolling by invitation||N/A|63|Anticipated|Cairo University||2|||f||||t||||||||Yes|charts with measurements and readings collected will be recorded and available|2017-10-10 21:31:22.373863|2017-10-10 21:31:22.373863
NCT02996110|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-10-04|||January 17, 2017|Actual|2017-01-17|October 2017|2017-10-01|January 18, 2022|Anticipated|2022-01-18|January 17, 2022|Anticipated|2022-01-17||Interventional|FRACTION-RCC||A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma|A Phase 2, Real-time Assessment of Combination Therapies in Immuno-Oncology Study in Participants With Advanced Renal Cell Carcinoma (FRACTION-RCC)|Recruiting||Phase 2|200|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 21:31:22.451948|2017-10-10 21:31:22.451948
NCT02996097|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-16|||April 2016||2016-04-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Interventional|||Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids|Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids|Active, not recruiting||N/A|40|Anticipated|Johns Hopkins University||2|||f||||||||||||||2017-10-10 21:31:22.642001|2017-10-10 21:31:22.642001
NCT02996084|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-10-03|||October 15, 2017|Anticipated|2017-10-15|October 2017|2017-10-01|December 15, 2020|Anticipated|2020-12-15|December 15, 2020|Anticipated|2020-12-15||Observational|||MS PATHS Normative Sub-Study|Longitudinal Brain Volume Change (and Correlates) in Healthy Control Subjects: A Normative Sub-Study of Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)|Not yet recruiting||N/A|200|Anticipated|Biogen|||1||f||||f||||||Samples Without DNA|"     Ribonucleic acid (RNA), serum, and whole blood biomarker samples   "|||2017-10-10 21:31:22.73385|2017-10-10 21:31:22.73385
NCT02996071|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-15|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||May Preoperative Waist to Height Ratio Predict Postoperative Weight Loss in Bariatric Patients?|May Preoperative Waist to Height Ratio Predict Postoperative Weight Loss in Bariatric Patients?|Recruiting||N/A|100|Anticipated|Bezmialem Vakif University||2|||f||||t||||||||Undecided||2017-10-10 21:31:22.790228|2017-10-10 21:31:22.790228
NCT02996058|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2017-06-07|||December 2016||2016-12-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|DEXinPICU||Safety And Efficacy Of Dexmedetomidine Sedation In Intubated Mechanically Ventilated Infants With Respiratory Failure|Dexmedetomidine Sedation in Pediatric Intensive Care Unit|Recruiting||Phase 2/Phase 3|60|Anticipated|Assiut University||2|||f||||t||||||||No||2017-10-10 21:31:22.861048|2017-10-10 21:31:22.861048
NCT02996045|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-15|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|November 2021|Anticipated|2021-11-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Decision Support (CDS) for Radiology Imaging|The Impact of Clinical Decision Support (CDS) for Radiology: A Randomized Control Trial|Enrolling by invitation||N/A|3511|Actual|Abdul Latif Jameel Poverty Action Lab||2|||f||||f||||||||No||2017-10-10 21:31:22.94299|2017-10-10 21:31:22.94299
NCT02996032|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01||||September 2017|Anticipated|2017-09-01||Observational|CRUSH||CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study|CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Study|Recruiting||N/A|160|Anticipated|Boston Medical Center|||1||f||||t||||||||||2017-10-10 21:31:24.81558|2017-10-10 21:31:24.81558
NCT02996019|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-15|||December 31, 2016|Actual|2016-12-31|March 2017|2017-03-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||A Study to Investigate the Comparability of Pharmacokinetics of Etrolizumab Administered Subcutaneously (SC) by a Prefilled Syringe With Needle Safety Device (PFS-NSD) or an Auto-injector (AI)|A Randomized, Open-Label, 2-Part, 2-Arm, Parallel-Group, Single-Dose, Multi-Center Study in Healthy Subjects to Investigate the Comparability of Pharmacokinetics of Etrolizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device or an Auto-Injector|Recruiting||Phase 1|178|Anticipated|Genentech, Inc.||4|||f||||||||||||||2017-10-10 21:31:24.898392|2017-10-10 21:31:24.898392
NCT02996006|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-16|||November 2009||2009-11-01|December 2016|2016-12-01||||July 2016|Actual|2016-07-01|3 Months|Observational [Patient Registry]|||New Techniques to Reduce Intra-operative Bleeding During Complex Liver Resection||Completed||N/A|80|Actual|Tongji Hospital|||1||f||||||||||||||2017-10-10 21:31:25.010265|2017-10-10 21:31:25.010265
NCT02995993|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-07-31|||November 2016||2016-11-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease|An Open-Label, Multi-Center Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGal in Patients With Fabry Disease|Recruiting||Phase 1|6|Anticipated|Greenovation Biotech GmbH||1|||f||||f||||||||||2017-10-10 21:31:25.073476|2017-10-10 21:31:25.073476
NCT02995980|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-07-17|||November 2015||2015-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography|Pilot Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography to Detect Breast Cancer in Patients With Increased Breast Density (BI-RADS Category c or d)|Active, not recruiting||N/A|200|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 21:31:25.16126|2017-10-10 21:31:25.16126
NCT02995967|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|HydrA||Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder|Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder|Recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 21:31:25.258521|2017-10-10 21:31:25.258521
NCT02995954|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-16|||January 2014||2014-01-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|FixFree||Fixed vs Free Dose of ACEi/CCB Combination Therapy|Blood Pressure Reduction by Fixed-dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive Patients|Completed||Phase 4|100|Actual|Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona||2|||f||||f||||||||No||2017-10-10 21:31:25.346353|2017-10-10 21:31:25.346353
NCT02995941|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|SSIS||Shoulder Symptom Irritability Scale: A Single-Blinded Observational Study|Shoulder Symptom Irritability: A Single-Blinded Observational Study of Reliability and Construct Validity|Recruiting||N/A|120|Anticipated|St. Luke's Hospital and Health Network, Pennsylvania|||2||f||||f||||||||No||2017-10-10 21:31:25.428971|2017-10-10 21:31:25.428971
NCT02995928|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2017-05-09|||May 4, 2017|Actual|2017-05-04|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Trial of Prophylactic Decompressive Craniectomy for Poor-grade Aneurysmal Subarachnoid Hemorrhage|Trial of Prophylactic Decompressive Craniectomy for Poor-grade Aneurysmal Subarachnoid Hemorrhage|Recruiting||N/A|60|Anticipated|Tang-Du Hospital||2|||f||||t|f|f||||||No||2017-10-10 21:31:25.673234|2017-10-10 21:31:25.673234
NCT02995915|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-07-06|||November 2016||2016-11-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|November 2020|Anticipated|2020-11-01||Interventional|||Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking|Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking|Recruiting||N/A|10|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 21:31:25.784447|2017-10-10 21:31:25.784447
NCT02995902|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-10-04|||December 11, 2014|Actual|2014-12-11|October 2017|2017-10-01|February 8, 2018|Anticipated|2018-02-08|February 8, 2017|Actual|2017-02-08||Interventional|SIBES II||FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer||Active, not recruiting||N/A|13|Actual|Rigshospitalet, Denmark||1|||f||||||||||||||2017-10-10 21:31:25.910313|2017-10-10 21:31:25.910313
NCT02995889|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-10-04|||November 2014||2014-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer||Recruiting||N/A|70|Anticipated|Rigshospitalet, Denmark||1|||f||||||||||||||2017-10-10 21:31:25.990729|2017-10-10 21:31:25.990729
NCT02995876|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-14|||June 2016||2016-06-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||The Clinical Performance of Inlay Zirconia Bridges|The Clinical Performance of Inlay Zirconia Bridges Using Three Different Designs|Recruiting||N/A|30|Anticipated|Damascus University||3|||f||||t||||||||No||2017-10-10 21:31:26.078549|2017-10-10 21:31:26.078549
NCT02995863|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-25|||December 2016||2016-12-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||This Research Hypothesizes That the Use of a Rigid Rocker Sole Reduces the Recurrence Rate of Diabetic Foot Ulcers in Patients With Peripheral Neuropathy.|Clinical Efficacy of Therapeutic Footwear With a Rigid Rocker Sole in the Prevention of Reulceration in Patients With Diabetes Mellitus and Diabetic Polineuropathy: a Prospective and Randomized Clinical Trial.|Recruiting||N/A|73|Anticipated|Universidad Complutense de Madrid||2|||f||||||||||||||2017-10-10 21:31:26.186548|2017-10-10 21:31:26.186548
NCT02995850|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-06|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|November 2020|Anticipated|2020-11-01||Interventional|||A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis||Recruiting||Phase 1/Phase 2|72|Anticipated|Yonsei University||1|||f||||f||||||||Undecided||2017-10-10 21:31:26.280676|2017-10-10 21:31:26.280676
NCT02995837|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-14|||September 2016||2016-09-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Observational|||CBF and Childhood OSAS|Cerebral Blood Flow and Neurocognition in Children With Obstructive Sleep Apnea|Recruiting||N/A|140|Anticipated|Children's Hospital of Philadelphia|||2||f||||t||||||||No||2017-10-10 21:31:26.389917|2017-10-10 21:31:26.389917
NCT02995824|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-19|||January 2002||2002-01-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Observational|RAL-LT-HIV||Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients|Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients: Retrospective Analysis in a Prospective National Cohort Study (RAL-LT-HIV)|Active, not recruiting||N/A|271|Actual|Hospital Clinic of Barcelona|||1||f||||f||||||||No||2017-10-10 21:31:26.510851|2017-10-10 21:31:26.510851
NCT02995811|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-01-11|||November 2016||2016-11-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|ECMO USS||Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness|Characterising Changes in Muscle Quantity and Quality in Patients Requiring Extracorporeal Membrane Oxygen During Critical Illness: 'ECMO-Ultrasound', An Observational Cohort Study|Recruiting||N/A|40|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||||No|No plan to share individual participant data|2017-10-10 21:31:26.609882|2017-10-10 21:31:26.609882
NCT02995798|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-14|||April 2009||2009-04-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|December 2014|Actual|2014-12-01||Observational|||The Characteristics of Regional Bone Quality in the Cervical Vertebrae Considering BMD|The Characteristics of Regional Bone Quality in the Cervical Vertebrae Considering BMD|Completed||N/A|99|Actual|Gangneung Asan Hospital|||3||f||||f||||||||Undecided||2017-10-10 21:31:26.706657|2017-10-10 21:31:26.706657
NCT02995785|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The First Aid Skill Simulation Training of Nurses of General Wards.|The First Aid Skill Simulation Training of Nurses of General Wards.|Not yet recruiting||N/A|92|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 21:31:26.780465|2017-10-10 21:31:26.780465
NCT02995772|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-19|||August 2011||2011-08-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients|Phase III Open-Label Randomized Clinical Trial: Efficacy of Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients|Recruiting||Phase 3|104|Anticipated|Dharmais National Cancer Center Hospital||2|||f||||f||||||||Undecided|We have not decided on this yet|2017-10-10 21:31:26.854767|2017-10-10 21:31:26.854767
NCT02995759|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-14|||June 2015||2015-06-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Creation, Implementation, and Analysis of a Seizure Action Plan|Creation, Implementation, and Analysis of a Seizure Action Plan|Recruiting||N/A|900|Anticipated|Boston Children’s Hospital|||2||f||||f||||||||No||2017-10-10 21:31:26.974785|2017-10-10 21:31:26.974785
NCT02995746|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-03-23|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 30, 2017|Anticipated|2017-09-30||Interventional|DEMO||Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane|Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane: A Pilot Study|Recruiting||N/A|20|Anticipated|Wills Eye||1|||f||||f||||||||No||2017-10-10 21:31:27.077782|2017-10-10 21:31:27.077782
NCT02995733|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-01-30|||January 30, 2017|Actual|2017-01-30|January 2017|2017-01-01|May 2021|Anticipated|2021-05-01|December 2020|Anticipated|2020-12-01||Interventional|PREPARE||Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief|Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations|Enrolling by invitation||N/A|1200|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||No||2017-10-10 21:31:27.188233|2017-10-10 21:31:27.188233
NCT02995720|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-08-09|||August 26, 2016|Actual|2016-08-26|August 2017|2017-08-01|May 30, 2017|Actual|2017-05-30|November 10, 2016|Actual|2016-11-10||Interventional|||A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin|An Open-label, Randomized, Single-dose, 2X3X3 Partial Replicate, Crossover Study to Compare the Pharmacokinetics and Safety Between a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin and Co-administration of a Fixed Dose Combination of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects|Completed||Phase 1|60|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||||||||||||2017-10-10 21:31:27.254246|2017-10-10 21:31:27.254246
NCT02995694|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-15|||April 2016||2016-04-01|December 2016|2016-12-01||||December 2016|Actual|2016-12-01||Interventional|||A Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%) to Estrace® Cream (0.01%) in Postmenopausal Females With Atrophic Vaginitis|Clinical Endpoint Therapeutic Equivalence Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%; Alvogen Pine Brook LLC.) to Estrace® Cream (0.01%; Warner Chilcott) in Postmenopausal Females With Atrophic Vaginitis|Completed||Phase 3|533|Actual|Alvogen Pine Brook LLC||3|||f||||f||||||||No||2017-10-10 21:31:27.512932|2017-10-10 21:31:27.512932
NCT02995681|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-14|||January 2017||2017-01-01|December 2016|2016-12-01||||May 2020|Anticipated|2020-05-01||Interventional|||Balance Training for Fall Reduction in COPD|Randomized Controlled Trial of Balance Training for Fall Reduction in Individuals With COPD|Not yet recruiting||N/A|380|Anticipated|West Park Healthcare Centre||2|||f||||t||||||||No||2017-10-10 21:31:27.610071|2017-10-10 21:31:27.610071
NCT02995668|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-01-22|||October 2016||2016-10-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|PRE_TKR_BLC||Effects of Specific Balance Training Prior TKR Surgery in the Early Postoperative Outcomes|Influencia de un Entrenamiento Preoperatorio de propiocepción y Equilibrio en Pacientes Con Artrosis Severa de Rodilla en Espera Para la intervención de Artroplastia Total|Recruiting||N/A|63|Anticipated|University of Valencia||3|||f||||t||||||||No||2017-10-10 21:31:27.778366|2017-10-10 21:31:27.778366
NCT02995655|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-24|||April 7, 2017|Actual|2017-04-07|August 2017|2017-08-01|April 30, 2022|Anticipated|2022-04-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia|A Pilot Study of CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia|Recruiting||Phase 1|15|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:31:27.920096|2017-10-10 21:31:27.920096
NCT02995642|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-30|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation|Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation|Not yet recruiting||Phase 2|20|Anticipated|Stanford University||1|||f||||f|t|f||||||No||2017-10-10 21:31:28.081472|2017-10-10 21:31:28.081472
NCT02995629|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-13|||March 2016||2016-03-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation|Patient Comfort Using Green (532 nm) Versus Yellow (577 nm) Laser Indirect Ophthalmoscopy Panretinal Photocoagulation for Proliferative Diabetic Retinopathy|Completed||N/A|40|Actual|Wills Eye||2|||f||||f||||||||Yes|Manuscript is under development.|2017-10-10 21:31:28.204708|2017-10-10 21:31:28.204708
NCT02995616|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-08|||March 16, 2017|Actual|2017-03-16|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Energy Consumption and Cardiorespiratory Load During Robot-Assisted Gait Training in Non-Ambulatory Stroke Patients|Energy Consumption and Cardiorespiratory Load During Robot-Assisted Gait Training in Non-Ambulatory Stroke Patients|Recruiting||N/A|20|Anticipated|Vrije Universiteit Brussel||1|||f||||f|f|f||||||||2017-10-10 21:31:28.328044|2017-10-10 21:31:28.328044
NCT02994667|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-06-19|||January 2015||2015-01-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|PPM in TAVR||Pacemaker Utilization and Ventricular Pacing in Patients Undergoing Trans-catheter Aortic Valve Replacement (TAVR)|Pacemaker Utilization and Ventricular Pacing in Patients Undergoing Trans-catheter Aortic Valve Replacement (TAVR)|Enrolling by invitation||N/A|50|Anticipated|Baylor Research Institute|||1||f||||t||||||||Yes|Data on the clinical and non-clinical risk factors will be summarized using means, standard deviations (SDs) and percentages. The Kaplan-Meier method will be used to construct a ventricular pacing free curve summarizing time-to ventricular pacing incidence in the study cohort -the competing risk of death will be accounted in the analysis.|2017-10-10 21:31:28.444267|2017-10-10 21:31:28.444267
NCT02994654|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-22|||October 2016||2016-10-01|September 2017|2017-09-01||||June 2018|Anticipated|2018-06-01||Interventional|||CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries|CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries|Recruiting||N/A|60|Anticipated|Avita Medical||2|||f||||f||||||||||2017-10-10 21:31:28.557919|2017-10-10 21:31:28.557919
NCT02994641|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-13|||December 2012||2012-12-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|COMA||Critical Care Observation of Motor Activity (COMA) and SICU Outcomes|Critical Care Observation of Motor Activity (COMA) - A Practicable and Valid Predictor of Patients' Outcome in the Surgical Intensive Care Unit: A Observational Study at 2 Surgical Intensive Care Units at Massachusetts General Hospital|Completed||N/A|761|Actual|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-10 21:31:28.714287|2017-10-10 21:31:28.714287
NCT02995603|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-13|||January 2017||2017-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:31:28.801461|2017-10-10 21:31:28.801461
NCT02995590|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||July 2016||2016-07-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Assessing Deformable Image Registration in the Lung Using Hyperpolarized-gas MRI|Assessing Deformable Image Registration in the Lung Using Hyperpolarized-gas|Recruiting||Phase 1|24|Anticipated|University of Virginia||1|||f||||f||||||||No||2017-10-10 21:31:28.848477|2017-10-10 21:31:28.848477
NCT02995577|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01||||May 2018|Anticipated|2018-05-01||Observational|||Biomarkers for Feeding Intolerance in Infants With Complex Congenital Heart Defects Undergoing Single Ventricle Staged Palliation|Biomarkers for Feeding Intolerance in Infants With Complex Congenital Heart Defects Undergoing Single Ventricle Staged Palliation|Recruiting||N/A|30|Anticipated|The University of Texas Health Science Center, Houston|||3||f||||||||||||||2017-10-10 21:31:28.930598|2017-10-10 21:31:28.930598
NCT02995564|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-20|||July 2013||2013-07-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||The Multi-Media Social Skills Project for Adults|The Multi-Media Social Skills Project for Adults: Validation of an Intervention for Adults With Autism Spectrum Disorders|Recruiting||N/A|360|Anticipated|Milton S. Hershey Medical Center||1|||f||||f||||||||No||2017-10-10 21:31:29.02433|2017-10-10 21:31:29.02433
NCT02995551|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-10-05|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|DREAM||Danish Rct on Exercise Versus Arthroscopic Meniscal Surgery for Young Adults|Danish Rct on Exercise Versus Arthroscopic Meniscal Surgery for Young Adults (DREAM) - A Randomized Controlled Trial of Meniscal Tear Treatment in Young Adults|Recruiting||N/A|140|Anticipated|University of Southern Denmark||2|||f||||f||||||||||2017-10-10 21:31:29.156128|2017-10-10 21:31:29.156128
NCT02995538|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-06-28|||January 30, 2017|Actual|2017-01-30|June 2017|2017-06-01|January 2028|Anticipated|2028-01-01|January 2027|Anticipated|2027-01-01|100 Years|Observational [Patient Registry]|||Neurogenetics Patient Registry|Neurogenetics Program Patient Registry: Clinical and Genetic Diagnosis, Natural History Study, Translational Research and Biorepository|Recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"     Blood samples and tissue samples if available after completion of tests ordered on these     patients for clinical purposes will be de-identified and stored to create a biorepository.     DNA sample from genetic testing that is left over after appropriate clinical testing will be     used for storage at the biorepository and for further appropriate research testing.   "|Yes|Results relevant to the participant's clinical condition will be verified in a CLIA-certified laboratory and reported to the participant.|2017-10-10 21:31:29.312744|2017-10-10 21:31:29.312744
NCT02995525|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Observational|PEDIACHROII||Chronic Pain After Scoliosis and Thoracic Surgery in Children|Prevalence of Chronic Pain After Scoliosis and Thoracic Surgery in Children|Recruiting||N/A|100|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||No||2017-10-10 21:31:29.393473|2017-10-10 21:31:29.393473
NCT02995512|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-11|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Mechanistic Effects of Colchicine in Patients With Myocardial Infarction|Mechanistic Effects of Colchicine in Patients With Myocardial Infarction A Single Center Phase 4 Single Arm Open-label Study Evaluating the FDA-approved Drug, Colchicine, at the FDA-approved Gout Dose in Patients With Myocardial Infarction|Recruiting||Phase 4|60|Anticipated|New York University School of Medicine||1|||f||||f|t|f||||||||2017-10-10 21:31:29.462606|2017-10-10 21:31:29.462606
NCT02995499|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-30|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|In-ASK||Inter-rater Reliability of the ASA Classification|Inter-rater Reliability of the ASA Classification|Recruiting||N/A|683|Anticipated|University Clinic Frankfurt|||1||f||||f||||||||No||2017-10-10 21:31:29.560006|2017-10-10 21:31:29.560006
NCT02995486|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-13|||November 2016||2016-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Effects of a Falls Prevention Program Following Hospital Discharge|Effects of a Falls Prevention Program Following Hospital Discharge From a Neuroscience Unit|Recruiting||N/A|60|Anticipated|Florida International University||2|||f||||f||||||||||2017-10-10 21:31:29.663313|2017-10-10 21:31:29.663313
NCT02995473|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-05|||February 8, 2017|Actual|2017-02-08|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis|Multi-center, Randomized, Vehicle-controlled, Investigator-blinded, Parallel Groups Study to Evaluate the Efficacy and Safety of NP000888 in Subjects With Plaque and Nail Psoriasis|Recruiting||Phase 2|60|Anticipated|Galderma R&D||2|||f||||f|f|f||||||||2017-10-10 21:31:29.759306|2017-10-10 21:31:29.759306
NCT02995460|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-16|||January 2013||2013-01-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Interval Training Study in Psoriatic Arthritis|Interval Training Study in Psoriatic Arthritis|Completed||N/A|67|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||No||2017-10-10 21:31:29.85809|2017-10-10 21:31:29.85809
NCT02995447|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-12-13|||November 2012||2012-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|||Differential Effects of Propofol on Scalp and Intracranial EEG|Differential Effects of Propofol on Scalp and Intracranial Electroencephalogram|Recruiting||N/A|15|Anticipated|University Hospital, Bonn|||1||f||||f||||||||No||2017-10-10 21:31:29.940628|2017-10-10 21:31:29.940628
NCT02995018|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-08|||January 2017||2017-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SPF Assay||Sun Protection Factor Assay (317/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|11|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:31:33.51327|2017-10-10 21:31:33.51327
NCT02995434|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-04|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Immersive Multimedia as an Adjunctive Measure for Pain Control in Cancer Patients|Immersive Multimedia as an Adjunctive Measure for Pain Control in Cancer Patients|Recruiting||N/A|100|Anticipated|University of British Columbia||2|||f||||f|f|f||||||Undecided||2017-10-10 21:31:30.046548|2017-10-10 21:31:30.046548
NCT02995421|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-15|||December 2016||2016-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:31:30.290352|2017-10-10 21:31:30.290352
NCT02995408|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-19|||December 2016||2016-12-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ASD||Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder|Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 21:31:30.334542|2017-10-10 21:31:30.334542
NCT02995395|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)|The Role of the Mucosal Impedance Balloon in the Diagnosis and Treatment Eosinophilic Esophagitis|Not yet recruiting||N/A|30|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 21:31:30.434382|2017-10-10 21:31:30.434382
NCT02995382|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-01-18|||February 2017||2017-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Health-Related Quality of Life in Cases of Cubital Tunnel Syndrome|Health-Related Quality of Life in Cases of Anterior Intramuscular Transposition for Cubital Tunnel Syndrome: A Prospective Cohort Study|Not yet recruiting||N/A|78|Anticipated|McMaster University||1|||f||||f||||||||No|Data will not be shared to other researchers|2017-10-10 21:31:30.540021|2017-10-10 21:31:30.540021
NCT02995369|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-15|||January 2017||2017-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||DryShield vs Cotton Roll Isolation During Sealants Placement: Efficiency and Patient Preference|DryShield vs Cotton Roll Isolation During Sealants Placement: Efficiency and Patient|Not yet recruiting||N/A|31|Anticipated|Montefiore Medical Center||4|||f||||f||||||||No||2017-10-10 21:31:30.633922|2017-10-10 21:31:30.633922
NCT02995356|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-13|||September 2016||2016-09-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy||Recruiting||N/A|80|Anticipated|Ege University|||2||f||||||||||||||2017-10-10 21:31:30.775851|2017-10-10 21:31:30.775851
NCT02995343|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-13|||November 2016||2016-11-01|December 2016|2016-12-01||||July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of the Ovarian Reserve in Patients Who Hypogastric Arteries and or Uterine Arteries Had Been Ligated||Recruiting||N/A|40|Anticipated|Ege University||2|||f||||||||||||||2017-10-10 21:31:30.902435|2017-10-10 21:31:30.902435
NCT02995330|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-20|||January 2017||2017-01-01|March 2017|2017-03-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer|A Pilot Study of Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 1|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-10 21:31:31.03477|2017-10-10 21:31:31.03477
NCT02995317|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|NOCfao||Who is Falling? - Fall Risk Prediction Among Community Dwelling Elderly.|The ≥65 Years NOrthern Jutland Cohort of Fall Risk Assessment With Objective Measurements (the NOCfao Study)|Recruiting||N/A|600|Anticipated|University College of Northern Denmark|||1||f||||t||||||||Undecided||2017-10-10 21:31:31.211829|2017-10-10 21:31:31.211829
NCT02995304|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01||||March 2017|Anticipated|2017-03-01||Interventional|||Preemptive Analgesia for Post Tonsillectomy Pain With IV Morphine in Children|Preemptive Analgesia for Post Tonsillectomy Pain With IV Morphine in Children|Not yet recruiting||N/A|60|Anticipated|Dr. Soliman Fakeeh Hospital||2|||f||||t||||||||No||2017-10-10 21:31:31.297924|2017-10-10 21:31:31.297924
NCT02995291|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-16|||February 10, 2017|Actual|2017-02-10|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Reversing the Effects of 0.5% Bupivacaine|Reversing the Effects of 0.5% Bupivacaine: A Randomized Controlled Trial|Recruiting||Phase 4|44|Anticipated|Dalhousie University||2|||f||||f|f|f|||f|||No|Aggregate data to be published in peer reviewed journal|2017-10-10 21:31:31.397558|2017-10-10 21:31:31.397558
NCT02995278|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-13|||October 2016||2016-10-01|December 2016|2016-12-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|||Usage and Plan of Care Changes Due to Drug Screenings|Clinical Researcher Experience Assessment Documenting Usage and Plan of Care Changes Due to Drug Screenings ©|Active, not recruiting||N/A|2000|Anticipated|Data Collection Analysis Business Management|||1||f||||t||||||||Undecided|Plan of care changes by providers after toxicology testing|2017-10-10 21:31:31.519016|2017-10-10 21:31:31.519016
NCT02995265|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-05-08|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|ExStRA||Exoskeleton for Post-Stroke Recovery of Ambulation|Use of a Robotic Exoskeleton to Promote Walking Recovery After Stroke - Phase 2|Recruiting||N/A|40|Anticipated|University of British Columbia||2|||f||||t||||||||No||2017-10-10 21:31:31.621841|2017-10-10 21:31:31.621841
NCT02995252|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-04-30|||December 2014||2014-12-01|April 2017|2017-04-01|November 2025|Anticipated|2025-11-01|January 2020|Anticipated|2020-01-01||Observational|||The HOPE Study: Characterizing Patients With Hepatitis B and C|An Omnibus Protocol to Characterize Patients With Hepatitis B and C (the HOPE Study) With Hepatitis B Treatment Sub-study|Recruiting||N/A|550|Anticipated|University of Maryland|||2||f||||||||||||||2017-10-10 21:31:31.768159|2017-10-10 21:31:31.768159
NCT02995239|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-12-13|||April 2015||2015-04-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Compare the Pharmacokinetic Characteristics of CJ-12420|A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of CJ-12420 in Healthy Male Volunteers|Completed||Phase 1|12|Actual|CJ HealthCare Corporation||2|||f||||f||||||||Undecided||2017-10-10 21:31:31.922995|2017-10-10 21:31:31.922995
NCT02995226|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|April 2020|Anticipated|2020-04-01||Interventional|CAPANOX||Abnormal Regulation, Estimation and Cognitive Impacts of Physical Efforts as an Endophenotype of Anorexia Nervosa|Analysis of the Capacity to Regulate Physical Efforts and to Estimate Its Intensity as an Endophenotype of Anorexia Nervosa, Because of a Specific Impact of the Physical Effort at the Emotional, Cognitive, Pain, Genetic and Biological Level|Not yet recruiting||N/A|180|Anticipated|Centre Hospitalier St Anne||3|||f||||f||||||||No||2017-10-10 21:31:32.044569|2017-10-10 21:31:32.044569
NCT02995213|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-25|||November 2015||2015-11-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|OPTASpr2016||Quantification of UE Use and Effects of Feedback in the Home Setting||Completed||N/A|12|Actual|Cleveland State University||1|||f||||f||||||||||2017-10-10 21:31:32.171288|2017-10-10 21:31:32.171288
NCT02995200|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-25|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|September 2015|Actual|2015-09-01||Interventional|UnSumRes2015||Quantification of Upper Extremity Use and Effects of Feedback in the Home Setting||Completed||N/A|19|Actual|Cleveland State University||2|||f||||f||||||||||2017-10-10 21:31:32.259267|2017-10-10 21:31:32.259267
NCT02995187|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-04|||December 2016||2016-12-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)|A Non-randomized, Open-label, Prospective, Single-center Study of Apatinib Mesylate Tablet as Third-line and Later Therapy in Patients With Small Cell Cancer（SCLC）|Recruiting||Phase 2|25|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 21:31:32.34355|2017-10-10 21:31:32.34355
NCT02995174|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2016-12-20|||August 2015||2015-08-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|March 2017|Anticipated|2017-03-01||Interventional|||Will Perceptual Learning Via Video Game Playing Improve Visual Acuity Stereopsis & Fixation Stability in Mild Amblyopes?|Will Perceptual Learning Via Video Game Playing Improve Visual Acuity, Stereopsis and Fixation Stability in Mild Amblyopes? Part 2 Study|Recruiting||N/A|12|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||No||2017-10-10 21:31:32.467806|2017-10-10 21:31:32.467806
NCT02995161|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-14|||December 30, 2016|Actual|2016-12-30|March 2017|2017-03-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Interventional|||Sun Protection Factor Assay (344/2016)|Sun Protection Factor (SPF) Assay UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment-Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||No||2017-10-10 21:31:32.610521|2017-10-10 21:31:32.610521
NCT02995148|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-03-14|||December 30, 2016|Actual|2016-12-30|March 2017|2017-03-01|January 6, 2017|Actual|2017-01-06|January 6, 2017|Actual|2017-01-06||Interventional|||Sun Protection Factor Assay (343/2016)|Sun Protection Factor (SPF) Assay UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment-Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||No||2017-10-10 21:31:32.688713|2017-10-10 21:31:32.688713
NCT02995135|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-15|||January 2017||2017-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Sun Protection Factor Assay (341/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:31:32.760197|2017-10-10 21:31:32.760197
NCT02995122|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-15|||December 2016||2016-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Sun Protection Factor Assay (339/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:31:32.840046|2017-10-10 21:31:32.840046
NCT02995109|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-15|||January 2017||2017-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Sun Protection Factor Assay (338/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:31:32.909205|2017-10-10 21:31:32.909205
NCT02995096|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-10-03|||January 2016||2016-01-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01|3 Years|Observational [Patient Registry]|||Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma|The Effect of Tumor Characteristics, Pre-transplant Treatments and Immunosuppression on Survival After Liver Transplantation for Hepatocellular Carcinoma - a European Registry Study|Active, not recruiting||N/A|23124|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-10 21:31:32.974367|2017-10-10 21:31:32.974367
NCT02995083|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-05-18|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intra-articular Injections for Knee Osteoarthritis: A Single Blinded Prospective Randomized Trial|Corticosteriods vs. Saline vs. Air Placebo Intra-articular Injections for Knee Osteoarthritis: A Single Blinded Prospective Randomized Trial|Not yet recruiting||Early Phase 1|150|Anticipated|Rush University Medical Center||3|||f||||f|t|f|||f|||No||2017-10-10 21:31:33.075758|2017-10-10 21:31:33.075758
NCT02995070|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-13|||September 2016||2016-09-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Low Intensity Laser Therapy in Connective Tissue Graft for Root Coverage in Smokers|The Influence Low Intensity Laser Therapy (LILT) in Connective Tissue Graft for Root Coverage in Smokers. A Controlled Clinical Trial|Recruiting||N/A|30|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||Undecided||2017-10-10 21:31:33.186171|2017-10-10 21:31:33.186171
NCT02995057|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-12-13|||August 2015||2015-08-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Safety Demonstration of Microneedle Insertion|Safety Demonstration of Microneedle Insertion|Completed||N/A|15|Actual|University of British Columbia|||1||f||||f||||||||No||2017-10-10 21:31:33.275267|2017-10-10 21:31:33.275267
NCT02995044|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-08|||January 2017||2017-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SPF Assay||Sun Protection Factor Assay (319/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Terminated||N/A|5|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:31:33.377474|2017-10-10 21:31:33.377474
NCT02995031|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-08|||January 2017||2017-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SPF Assay||Sun Protection Factor Assay (318/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Terminated||N/A|5|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:31:33.445577|2017-10-10 21:31:33.445577
NCT02995005|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-08-16|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus|Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus|Not yet recruiting||Phase 1/Phase 2|170|Anticipated|Johns Hopkins Bloomberg School of Public Health||1|||f||||f|f|f|||f|||||2017-10-10 21:31:33.600025|2017-10-10 21:31:33.600025
NCT02994992|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-02-04|||December 2016||2016-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SPF Assay||Sun Protection Factor Assay (316/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|12|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:31:33.758189|2017-10-10 21:31:33.758189
NCT02994979|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-13|||November 2016||2016-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Nursing Assistant Intervention to Prevent Delirium in Nursing Homes|Multicomponent Intervention to Prevent Delirium in Nursing Homes|Recruiting||N/A|300|Anticipated|Jewish Home & Hospital Lifecare System||2|||f||||t||||||||||2017-10-10 21:31:33.826899|2017-10-10 21:31:33.826899
NCT02994966|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-13|||November 2016||2016-11-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|DFCCP-Orpyx||Diabetes Foot Care Clinical Pathway - Orpyx Medical Technologies||Recruiting||N/A|120|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-10 21:31:33.914996|2017-10-10 21:31:33.914996
NCT02994953|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-09-26|||January 31, 2017|Actual|2017-01-31|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|COMBO||A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12)|A Phase Ib Open‑Label, Dose‑Finding Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Avelumab in Combination With M9241(NHS-IL12) in Subjects With Locally Advanced, Unresectable, or Metastatic Solid Tumors|Recruiting||Phase 1|170|Anticipated|EMD Serono||1|||f||||f|t|f||||||||2017-10-10 21:31:34.02988|2017-10-10 21:31:34.02988
NCT02994940|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-09-07|||November 11, 2016|Actual|2016-11-11|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MODIV-APAP||Modified Pre-operative Oral Doses Acetaminophen Versus Intravenous Acetaminophen|Modified Pre-operative Oral Doses Acetaminophen Versus Intravenous Acetaminophen|Recruiting||Phase 4|80|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 21:31:34.152081|2017-10-10 21:31:34.152081
NCT02994927|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-09-22|||December 2016||2016-12-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|ADVOCATE||A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis|A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine|Recruiting||Phase 3|300|Anticipated|ChemoCentryx||2|||f||||t||||||||||2017-10-10 21:31:34.343272|2017-10-10 21:31:34.343272
NCT02994914|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|GERABEL||GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance|GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance : GERABEL Study|Recruiting||N/A|210|Anticipated|Institut de Cancérologie de la Loire||3|||f||||f||||||||No||2017-10-10 21:31:34.757607|2017-10-10 21:31:34.757607
NCT02994901|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-13|||November 2016||2016-11-01|December 2016|2016-12-01|November 2019|Anticipated|2019-11-01|December 2017|Anticipated|2017-12-01||Observational|SARCOPENIA||Cause and Importance of the Age-dependent Sarcopenia|Cause and Importance of the Age-dependent Sarcopenia With a Blood Based Bioenergetics & Cytokine Profiling Approach|Recruiting||N/A|150|Anticipated|Charite University, Berlin, Germany|||3||f||||f||||||||No||2017-10-10 21:31:34.879725|2017-10-10 21:31:34.879725
NCT02994888|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-12-16|||November 2012||2012-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PROSPECT-C||PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer|PROSPECT-C: A Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Cetuximab or Panitumumab in Metastatic Colorectal Cancer|Completed||N/A|47|Actual|Royal Marsden NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Both fresh frozen tissue and formalin-fixed paraffin-embedded (FFPE) tissue samples will be     obtained. In addition, the following blood samples will also be taken;        1. Baseline: an initial 20mL research blood sample (EDTA or equivalent (CPT) tube) will be          collected        2. Every 4 weeks until disease progression or patient death: 1 x 10mL research blood sample          (EDTA or equivalent (CPT) tube) will be collected        3. At time of progressive disease: final 10mL research blood sample (EDTA or equivalent          (CPT) tube)   "|||2017-10-10 21:31:34.96756|2017-10-10 21:31:34.96756
NCT02994875|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-12-13|||May 2016||2016-05-01|December 2016|2016-12-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence|Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence|Recruiting||Early Phase 1|40|Anticipated|Yale University||2|||f||||t||||||||Undecided||2017-10-10 21:31:35.048449|2017-10-10 21:31:35.048449
NCT02994862|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||E. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent|One Year Clinical Evaluation of E. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent Before Bonding to Teeth With Amelogenesis Imperfecta|Not yet recruiting||N/A|16|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:31:35.147102|2017-10-10 21:31:35.147102
NCT02994849|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-01|||July 19, 2017|Actual|2017-07-19|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|OPTI-Prem||OPTI-Prem: Optimising Neonatal Service Provision for Preterm Babies Born Between 27 and 31 Weeks of Gestation in England|OPTI-Prem: Optimising Neonatal Service Provision for Preterm Babies Born Between 27 and 31 Weeks of Gestation in England Using National Data, Qualitative Research and Economic Analysis|Recruiting||N/A|24000|Anticipated|The Royal Wolverhampton Hospitals NHS Trust|||1||f||||t||||||||||2017-10-10 21:31:35.225643|2017-10-10 21:31:35.225643
NCT02994836|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )|Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: Multicentre, Prospective, Randomized Clinical Trial and Economic Evaluation|Not yet recruiting||Phase 4|300|Anticipated|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa||2|||f||||f||||||||||2017-10-10 21:31:35.320544|2017-10-10 21:31:35.320544
NCT02994823|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-12-13|||June 2015||2015-06-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|POOL-BM||"The Pooling Expressed Breast Milk: A Method for Improving the Nutritional Intake of Premature Infants"||Recruiting||N/A|20|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:31:35.482908|2017-10-10 21:31:35.482908
NCT02994810|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-12-13|||March 2012||2012-03-01|December 2016|2016-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Orientation Effects of Breastfeeding for Mothers|Orientation Effects of Breastfeeding for Mothers in a Private Hospital: Randomized Controlled Trial|Completed||N/A|217|Actual|Hospital Moinhos de Vento||2|||f||||f||||||||No||2017-10-10 21:31:35.562837|2017-10-10 21:31:35.562837
NCT02994797|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-07-06|||August 2016||2016-08-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|ELSA||Ultrasound Elastography of Salivary Glands|Elastometry of the Salivary Glands in Sicca Syndrome|Recruiting||N/A|30|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:31:35.637596|2017-10-10 21:31:35.637596
NCT02994784|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients|A Phase II Single-Center, Open-Label, Safety and Efficacy Study of Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients Undergoing Autologous Stem Cell Transplantation|Not yet recruiting||Phase 2|43|Anticipated|Boston Medical Center||1|||f||||t||||||||No|There are no plans to share individual participant data.|2017-10-10 21:31:35.712601|2017-10-10 21:31:35.712601
NCT02994771|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-05-30|||June 2016||2016-06-01|May 2017|2017-05-01|March 2024|Anticipated|2024-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema|A Phase I Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of Lymfactin® (AdAptVEGF-C Adenoviral Vector) in Combination With a Surgical Lymph Node Transfer for the Treatment of Patients With Secondary Lymphedema|Recruiting||Phase 1|21|Anticipated|Herantis Pharma Plc.||2|||f||||t||||||||No||2017-10-10 21:31:35.811792|2017-10-10 21:31:35.811792
NCT02994758|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2020|Anticipated|2020-12-01||Interventional|DEDUCER||Development of Diagnostics and Treatment of Urological Cancers|Development of Diagnostics and Treatment of Urological Cancers|Not yet recruiting||N/A|100|Anticipated|Helsinki University Central Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:31:35.921819|2017-10-10 21:31:35.921819
NCT02994745|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-08-09|||December 23, 2016|Actual|2016-12-23|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|February 21, 2017|Actual|2017-02-21||Interventional|||A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.|A Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between a Fixed Dose Combination of Fimasartan 120mg/Atorvastatin 40mg and Co-administration of Fimasartan 120mg and Atorvastatin 40mg in Healthy Male Volunteers.|Recruiting||Phase 1|60|Anticipated|Boryung Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-10 21:31:36.065689|2017-10-10 21:31:36.065689
NCT02994732|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-07-11|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|May 15, 2017|Actual|2017-05-15|February 2017|Actual|2017-02-01||Interventional|||Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled BVD-523 in Volunteers|A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-BVD-523 Following Single Oral Dose Administration in Healthy Male Subjects|Completed||Phase 1|6|Anticipated|BioMed Valley Discoveries, Inc||1|||f||||||||||||||2017-10-10 21:31:36.153965|2017-10-10 21:31:36.153965
NCT02994719|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-03-09|||March 1, 2016|Actual|2016-03-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|||Gait Analysis in Neurological Disease|Gait Pattern Analysis in Neurological Disease|Recruiting||N/A|60|Anticipated|Beth Israel Deaconess Medical Center|||2||f||||f||||||||No||2017-10-10 21:31:36.228054|2017-10-10 21:31:36.228054
NCT02994706|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-12-13|||January 2006||2006-01-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|HOME-CF||A Study of Home Monitoring in Adults With Cystic Fibrosis (HOMECF)|A Prospective Pilot Study of Home Monitoring in Adults With Cystic Fibrosis (HOMECF)|Recruiting||N/A|100|Anticipated|Heart of England NHS Trust||2|||f||||f||||||||No||2017-10-10 21:31:36.315255|2017-10-10 21:31:36.315255
NCT02994693|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-05|||December 2016||2016-12-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy|Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy|Enrolling by invitation||N/A|100|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 21:31:36.410229|2017-10-10 21:31:36.410229
NCT02994680|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-15|||January 18, 2017|Actual|2017-01-18|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|CHAP||Cardiopulmonary Outcomes and Household Air Pollution Trial|Effects of a Liquefied Petroleum Gas Stove and Fuel Distribution Intervention on Adult Cardiopulmonary Health Outcomes in Puno, Peru|Recruiting||N/A|180|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-10 21:31:36.490343|2017-10-10 21:31:36.490343
NCT02994628|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-02-18|||November 2015|Actual|2015-11-01|January 2016|2016-01-01|January 25, 2017|Actual|2017-01-25|December 2016|Actual|2016-12-01||Interventional|||Banana Cultivars and Exercise Performance and Recovery|Influence of Bananas Varying in Carbohydrate and Phenolic Content on Exercise Performance and Recovery|Completed||N/A|23|Actual|Appalachian State University||4|||f||||f||||||||Yes|Data will be shared through the Human Metabolome Database (HMDB) or the Scripps Metabolite and Tandem MS Database (METLIN)], other public web sites, and publication in the scientific literature. We will cooperate in making available cloud-based access to the data and associated informatics components within the general scientific community.|2017-10-10 21:31:36.616875|2017-10-10 21:31:36.616875
NCT02994615|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|PRIMARy||Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy|Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy: The Index of MicrovAscular Resistance (IMR)|Not yet recruiting||N/A|30|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||No||2017-10-10 21:31:36.716449|2017-10-10 21:31:36.716449
NCT02994602|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-22|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|June 2017|Actual|2017-06-01||Interventional|CCN005B||Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males|An Open-Label Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males: Effect of Washing or Clothing Barrier to the Application|Active, not recruiting||Phase 1|12|Actual|Health Decisions||1|||f||||t||||||||||2017-10-10 21:31:36.791396|2017-10-10 21:31:36.791396
NCT02994589|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-12-13|||October 2016||2016-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|OASIS||A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites|A Comparison of OASIS Wound Matrix With Approved Dressings for Split Thickness Skin Graft Donor Sites|Withdrawn||Phase 4|0|Actual|Loma Linda University||3||Study was never started|f||||f||||||||No||2017-10-10 21:31:36.919996|2017-10-10 21:31:36.919996
NCT02994576|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-05-12|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|PRINCEPS||Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer|A Single-arm Phase 2 Study of Atezolizumab as Induction Therapy in Stage IB-IIIA Non N2 Resectable and Untreated Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|60|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||t||||||||No||2017-10-10 21:31:36.99521|2017-10-10 21:31:36.99521
NCT02994563|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-13|||December 2017||2017-12-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study|Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study|Not yet recruiting||N/A|60|Anticipated|Amnis Therapeutics||1|||f||||f||||||||No||2017-10-10 21:31:37.076865|2017-10-10 21:31:37.076865
NCT02994550|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||Influence of FSH/LH Ratio in Controlled Ovarian Stimulation|Influence of FSH/LH Ratio in Controlled Ovarian Stimulation ( 2/1 Ratio vs 4/1 Ratio) in >35 Years Women Undergoing IVF|Not yet recruiting||Early Phase 1|300|Anticipated|Hospital de Cruces||2|||f||||f||||||||Undecided||2017-10-10 21:31:37.147849|2017-10-10 21:31:37.147849
NCT02994537|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-01-16|||October 2013||2013-10-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Study of the Clinical Features of Autoimmune Hepatitis|Study of the Clinical Features of Autoimmune Hepatitis|Recruiting||N/A|500|Anticipated|West China Hospital|||1||f||||f||||||||Undecided|The investigators need to discuss with other participants whether or not to share data of the study.|2017-10-10 21:31:37.218798|2017-10-10 21:31:37.218798
NCT02994524|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-13|||February 2014||2014-02-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|||Intersphincteric Approach to Perianal Fistula With High Risk for Postoperative Fecal Incontinence||Completed||N/A|25|Actual|Ain Shams University||1|||f||||t||||||||Undecided||2017-10-10 21:31:37.302991|2017-10-10 21:31:37.302991
NCT02994511|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-12-13|||December 2014||2014-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Observational|CALIBRATE||Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials|Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials|Recruiting||N/A|100|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Tumour samples Blood Samples ctDNA isolated from bloods samples   "|||2017-10-10 21:31:37.362047|2017-10-10 21:31:37.362047
NCT02994498|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-08-09|||March 2018|Anticipated|2018-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||DCB-BO1301 for Advanced Melanoma|An Open-Label Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and Efficacy of DCB-BO1301 as Add-on Therapy to Dacarbazine in Subjects With Advanced Melanoma|Not yet recruiting||Phase 1/Phase 2|33|Anticipated|A2 Healthcare Taiwan Corporation||3|||f||||t|t|f||||||||2017-10-10 21:31:37.430437|2017-10-10 21:31:37.430437
NCT02994485|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-14|||October 2016||2016-10-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin|Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin|Recruiting||Phase 4|40|Anticipated|Tanta University||2|||f||||t||||||||Undecided||2017-10-10 21:31:37.49356|2017-10-10 21:31:37.49356
NCT02994472|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Gastric Emptying: in Vivo Studies in Healthy Volunteers|Gastric Emptying: in Vivo Studies in Healthy Volunteers (Using Scrambled Egg and Porridge) to Determine Reliable Normal Ranges|Not yet recruiting||N/A|40|Anticipated|Sandwell & West Birmingham Hospitals NHS Trust||1|||f||||f||||||||No|Individual Participant data will not be made available to other researchers.|2017-10-10 21:31:37.569059|2017-10-10 21:31:37.569059
NCT02994459|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-15|||January 2017||2017-01-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|ATGD||Study of Fat Tissue's Ability to Take up Sugar in the Obese Population|Adipose Tissue Glucose Uptake in Obesity (ATGD)|Not yet recruiting||N/A|45|Anticipated|Washington University School of Medicine|||3||f||||t||||||Samples With DNA|"     Blood and adipose/muscle tissue samples   "|Yes|The investigators do not currently anticipate to share IPD, but will do so upon request.|2017-10-10 21:31:37.627045|2017-10-10 21:31:37.627045
NCT02994446|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|SERF-VT||Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia|Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia|Recruiting||N/A|30|Anticipated|Thermedical, Inc.||1|||f||||t||||||||Undecided||2017-10-10 21:31:37.687775|2017-10-10 21:31:37.687775
NCT02994420|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-12-12|||July 2016||2016-07-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Endocrine and Neural Control of Eating in Women|Steroid Hormones in the Peripheral and Central Control of Eating in Women - Physiological Reactions to Eating in Normal- and Overweight Women|Recruiting||N/A|50|Anticipated|University of Zurich|||2||f||||f||||||Samples With DNA|"     Whole blood to determine hormonal parameters (gut hormones and reproductive hormones) and the     presence of the gene TaqIA1.   "|No||2017-10-10 21:31:37.849377|2017-10-10 21:31:37.849377
NCT02994407|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-10-04|||January 30, 2017|Actual|2017-01-30|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|alleviate 1||Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A|Safety, Tolerability, and Pharmacokinetics Study of Single and Multiple Subcutaneous Doses of Turoctocog Alfa Pegol in Patients With Haemophilia A|Recruiting||Phase 1|48|Anticipated|Novo Nordisk A/S||1|||f||||f|t|f||||||||2017-10-10 21:31:38.064317|2017-10-10 21:31:38.064317
NCT02994381|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-01-26|||October 2016||2016-10-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults|A Phase I, Single-Centre, Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults|Completed||Phase 1|6|Actual|Celgene||1|||f||||f||||||||||2017-10-10 21:31:38.378085|2017-10-10 21:31:38.378085
NCT02994368|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-06-16|||December 2016||2016-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||"Natural History Study of Choroideremia"|"A Multicenter Prospective Observational Natural History Study in Patients With Choroideremia"|Recruiting||N/A|50|Anticipated|4D Molecular Therapeutics|||1||f||||f||||||||Yes||2017-10-10 21:31:38.492171|2017-10-10 21:31:38.492171
NCT02994355|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||HIV Testing at Family Planning Clinics in Mombasa County, Kenya|HIV Testing at Family Planning Clinics in Mombasa County, Kenya: A Cluster-Randomized Trial Comparing the Systems Analysis and Improvement Approach (SAIA) to Usual Procedures|Not yet recruiting||N/A|24|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 21:31:38.611271|2017-10-10 21:31:38.611271
NCT02994342|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-27|||October 2012||2012-10-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness|Efficacy, Tolerability and Safety of a New Medical Device, Zp-025 Vaginal Gel, in the Treatment of Vaginal Dryness in Post-menopausal Women With Vaginal Atrophy|Completed||N/A|121|Actual|Zambon SpA||2|||f||||f|f|f||||||Yes|IPD should be requested to sposnor contacts|2017-10-10 21:31:38.73957|2017-10-10 21:31:38.73957
NCT02994329|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-14|||January 2017||2017-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Community-based Distribution of Oral HIV Self-testing Kits|Community-based Distribution of Oral HIV Self-testing Kits-A Pilot Intervention and Rapid Impact Evaluation|Not yet recruiting||Phase 4|12500|Anticipated|Zambart||2|||f||||f||||||||Yes|the de-identified data will be made available via International Initiative for Evaluation's (3ie) public access data repository.|2017-10-10 21:31:38.858251|2017-10-10 21:31:38.858251
NCT02994316|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-12|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|COPACD||Plasma Copeptin Levels in Children With Diabetic Ketoacidosis|Interest of Plasma Copeptin Levels in Management of Children With Diabetic Ketoacidosis|Recruiting||N/A|58|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:31:38.992724|2017-10-10 21:31:38.992724
NCT02994303|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-08-25|||September 2014||2014-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy|Podocyturia, a Non-Invasive Predictor of Renal Dysfunction in Fabry Nephropathy|Recruiting||N/A|58|Anticipated|University of Washington|||1||f||||t|f|f||||Samples Without DNA|"     Urine Sample   "|||2017-10-10 21:31:39.111754|2017-10-10 21:31:39.111754
NCT02994290|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Evaluation of the Implementation and Effectiveness of IPP-HPV|Evaluation of the Implementation and Effectiveness of a Pilot Quality Improvement Program to Increase HPV Vaccine Uptake: Inpatient Postpartum HPV Immunization (IPP-HPV) Program|Not yet recruiting||N/A|35|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 21:31:39.252316|2017-10-10 21:31:39.252316
NCT02994277|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-13|||November 2016||2016-11-01|December 2016|2016-12-01||||May 2017|Anticipated|2017-05-01||Interventional|||Artificial Pancreas in Latin America|Pilot Study of Automatic Glycaemic Correction Systems (Closed-loop) in Patients With Type 1 Diabetes Mellitus With Continuous Subcutaneous Insulin Infusion|Active, not recruiting||N/A|5|Actual|Hospital Italiano de Buenos Aires||1|||f||||f||||||||No||2017-10-10 21:31:39.352285|2017-10-10 21:31:39.352285
NCT02994264|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-14|||August 2015||2015-08-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas|A Retrospective Cohort Study to Assess Adjuvant Concurrent Chemoradiation (CCRT) Compared to Adjuvant Radiation Therapy (RT) in the Treatment of Grade 2 and 3 Extremity Soft Tissue Sarcomas|Completed||N/A|80|Actual|Institut de Cancérologie de Lorraine|||1||f||||||||||||||2017-10-10 21:31:39.438707|2017-10-10 21:31:39.438707
NCT02994251|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma|A Phase II Trial of Systemic Chemotherapy (Gemcitabine and Cisplatin) in Combination With Conventional Transarterial Chemoembolization (cTACE) in Patients With Advanced Intra-Hepatic Cholangiocarcinoma (ICC)|Not yet recruiting||Phase 2|25|Anticipated|Yale University||1|||f||||||||||||||2017-10-10 21:31:39.501635|2017-10-10 21:31:39.501635
NCT02994238|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|iTRACC||iTRACC (Improving Technology-Assisted Recording of Asthma Control in Children)|iTRACC (Improving Technology-Assisted Recording of Asthma Control in Children)|Enrolling by invitation||N/A|250|Anticipated|UnitedHealth Group||2|||f||||f||||||||||2017-10-10 21:31:39.621539|2017-10-10 21:31:39.621539
NCT02994225|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-07-06|||March 10, 2017|Actual|2017-03-10|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ARMONIC||Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity|Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity|Recruiting||N/A|120|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f|f|f||||||||2017-10-10 21:31:39.712344|2017-10-10 21:31:39.712344
NCT02994212|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-15|||July 2014||2014-07-01|December 2016|2016-12-01|November 2014||2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Reduced Visit Frequency in the Treatment of Uncomplicated Severe Acute Malnutrition: Evaluation of Operational Feasibility and Safety|Reduced Frequency of Visits in the Treatment of Uncomplicated Severe Acute Malnutrition: Evaluation of Operational Feasibility and Safety|Completed||N/A|115|Actual|Epicentre||1|||f||||f||||||||No||2017-10-10 21:31:39.790863|2017-10-10 21:31:39.790863
NCT02994199|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-05-31|||January 2016||2016-01-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|||Use of Adapted Controllers for Active Video Gaming in People With Physical Disabilities|Use of Adapted Controllers for Active Video Gaming (Interactive Exercise and Recreation Technologies and Exercise Physiology Benefiting People With Disabilities)|Active, not recruiting||N/A|105|Actual|University of Alabama at Birmingham||1|||f||||f|f|f||||||No||2017-10-10 21:31:39.869743|2017-10-10 21:31:39.869743
NCT02994186|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||Examination of Cognitive Function in Obesity and Following Weight Loss|Longitudinal Assessment of Cognitive Function Following Bariatric Surgery or Medical Weight Loss Treatment|Not yet recruiting||N/A|200|Anticipated|Vanderbilt University Medical Center|||2||f||||f||||||||No||2017-10-10 21:31:39.951217|2017-10-10 21:31:39.951217
NCT02994173|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-09-11|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|DoseRespKeta||Dose-response of Ketamine in Patient Controlled Analgesia in Orthopaedic Surgery Patients|Dose Response Study of Patient Controlled Analgesia (PCA) of S-ketamine in Orthopaedic Spine Surgery Patients|Recruiting||Phase 4|100|Anticipated|Turku University Hospital||4|||f||||f|f|f||||||||2017-10-10 21:31:40.053033|2017-10-10 21:31:40.053033
NCT02994160|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-14|||June 2015||2015-06-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||DExterous Hand Control Through Fascicular Targeting (DEFT) - Phase I (Human Subjects)|DExterous Hand Control Through Fascicular Targeting (DEFT) - Phase I|Recruiting||N/A|8|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:31:40.159544|2017-10-10 21:31:40.159544
NCT02994147|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-13|||August 2016||2016-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy|A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy|Recruiting||Phase 2|24|Anticipated|TWi Biotechnology, Inc.||2|||f||||f||||||||No||2017-10-10 21:31:40.247805|2017-10-10 21:31:40.247805
NCT02994134|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-15|||January 2017||2017-01-01|December 2016|2016-12-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Exercise, Cognitive Function and Neuroplasticity in Healthy Adults|Exercise, Cognitive Function and Neuroplasticity in Healthy Adults|Not yet recruiting||N/A|40|Anticipated|University of Miami||2|||f||||f||||||||No||2017-10-10 21:31:40.325326|2017-10-10 21:31:40.325326
NCT02994121|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|January 2047|Anticipated|2047-01-01|January 2047|Anticipated|2047-01-01||Observational|PROMOTE||Prospective Investigation of Multiple Sclerosis in the Three Rivers Region|Prospective Investigation of Multiple Sclerosis in the Three Rivers Region|Recruiting||N/A|7500|Anticipated|University of Pittsburgh|||2||f||||t||||||Samples With DNA|"     Blood, stool, urine, saliva, and cerebrospinal fluid collection   "|||2017-10-10 21:31:40.392462|2017-10-10 21:31:40.392462
NCT02994108|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-08-02|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|T2P||Txt2Protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men|Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men|Not yet recruiting||N/A|460|Anticipated|Northwestern University||2|||f||||f|f|f||||||||2017-10-10 21:31:40.462685|2017-10-10 21:31:40.462685
NCT02994095|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-14|||March 2014||2014-03-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Pilot Study of a Community Health Agent-led Diabetes Self-Management Program|A Pilot Study of a Community Health Agent-led Diabetes Self-Management Program Using Motivational Interviewing-based Approaches in a Public Primary Care Center in São Paulo, Brazil|Completed||N/A|57|Actual|University of Michigan||1|||f||||f||||||||Yes|De-identified data set available on request.|2017-10-10 21:31:40.550324|2017-10-10 21:31:40.550324
NCT02994082|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-07-06|||December 2016||2016-12-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Treating Smokeless Tobacco Use in Rural Veterans|Treating Smokeless Tobacco Use in Rural Veterans|Not yet recruiting||N/A|50|Anticipated|University of Iowa||2|||f||||f||||||||||2017-10-10 21:31:40.611583|2017-10-10 21:31:40.611583
NCT02994069|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-04-18|||April 11, 2017|Actual|2017-04-11|March 2017|2017-03-01|October 31, 2028|Anticipated|2028-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers|Comparison of Every 3 Week Versus Weekly Cisplatin Concurrent With Radiation in Squamous Cell Carcinoma of the Head and Neck (SCCHN) and Correlation With Oxidative Stress Markers|Recruiting||Phase 2|80|Anticipated|University of Kentucky||2|||f||||t|t|f||||||||2017-10-10 21:31:40.73249|2017-10-10 21:31:40.73249
NCT02993822|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-06-01|||May 10, 2017|Actual|2017-05-10|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough|A Double-Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of Three Doses of Orvepitant in Subjects With Chronic Refractory Cough|Recruiting||Phase 2|244|Anticipated|Nerre Therapeutics Ltd.||4|||f||||f|t|f||||||No||2017-10-10 21:31:44.169591|2017-10-10 21:31:44.169591
NCT02994056|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-09-25|||January 23, 2017|Actual|2017-01-23|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavarin|A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Subjects With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis|Recruiting||Phase 2|50|Anticipated|Gilead Sciences||1|||f||||f|t|f||||||||2017-10-10 21:31:40.836999|2017-10-10 21:31:40.836999
NCT02994043|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||September 2016||2016-09-01|December 2016|2016-12-01||||February 2021|Anticipated|2021-02-01||Interventional|AIM||Mindfulness Based Relapse Prevention||Recruiting||N/A|226|Anticipated|University of Colorado, Boulder||2|||f||||||||||||||2017-10-10 21:31:41.024304|2017-10-10 21:31:41.024304
NCT02994030|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Observational|BioDuchenne||Biomarker for Patients With Duchenne Disease|Biomarker for Duchenne Disease - An International, Multicenter, Epidemiological Protocol|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectrometry 7, 5 ml     EDTA blood and a dry blood spot filter card are taken. To proof the correct diagnosis of     Duchenne disease in those patients where up to the enrollment in the study no genetic testing     has been done, sequencing of Duchenne disease will be done.   "|Undecided||2017-10-10 21:31:41.104127|2017-10-10 21:31:41.104127
NCT02994017|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-12-13|||March 2012||2012-03-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|EFX||Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis|Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis|Recruiting||N/A|300|Anticipated|University Hospital, Lille||1|||f||||f||||||||No||2017-10-10 21:31:41.179235|2017-10-10 21:31:41.179235
NCT02994004|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-12-13|||June 2013||2013-06-01|July 2014|2014-07-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Observational|||Exploring Medical Decisions Using Functional MRI|Medical Decision-making Under Budgetary Constraint: an fMRI Study|Completed||N/A|34|Actual|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 21:31:41.278709|2017-10-10 21:31:41.278709
NCT02993991|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRIMED-001||Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity|Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity|Not yet recruiting||Phase 1|12|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 21:31:41.34791|2017-10-10 21:31:41.34791
NCT02993978|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-14|||August 2012||2012-08-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|DUMBO||Design and Evaluation of Care Environment and Technology at Pediatric Radiotherapy|Design and Evaluation of Care Environment and Technology at Pediatric Radiotherapy|Completed||Phase 2|57|Actual|Umeå University|||2||f||||f||||||||No||2017-10-10 21:31:41.484917|2017-10-10 21:31:41.484917
NCT02993965|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-21|||February 21, 2017|Actual|2017-02-21|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||State Immunization Information Systems to Improve HPV Vaccination Rates|State Immunization Information Systems to Improve HPV Vaccination Rates|Active, not recruiting||N/A|94000|Anticipated|University of Colorado, Denver||7|||f||||f|f|f||||||||2017-10-10 21:31:41.559287|2017-10-10 21:31:41.559287
NCT02993952|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-04-17|||December 12, 2016|Actual|2016-12-12|April 2017|2017-04-01|March 10, 2017|Actual|2017-03-10|February 20, 2017|Actual|2017-02-20||Interventional|||tDCS and Its Therapeutic Effects in CK Fever|Transcranial Direct Current Stimulation (tDCS) and Its Therapeutic Effects in Chikungunya Fever|Completed||N/A|20|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f|f|f||||||No||2017-10-10 21:31:41.64686|2017-10-10 21:31:41.64686
NCT02993939|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 28, 2017|Actual|2017-04-28||Interventional|ISBvsICB-SSB||Interscalene Block Versus Infraclavicular Block Plus Suprascapular Nerve Block|A Randomized Comparison Between Interscalene Brachial Plexus Block and Combined Infraclavicular Brachial Plexus Block-Suprascapular Nerve Block|Completed||N/A|40|Actual|University of Chile||2|||f||||t||||||||No||2017-10-10 21:31:41.726212|2017-10-10 21:31:41.726212
NCT02993926|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-06-30|||June 24, 2017|Actual|2017-06-24|June 2017|2017-06-01|February 27, 2018|Anticipated|2018-02-27|February 27, 2018|Anticipated|2018-02-27||Observational|||A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty Among Chinese Participants|An Observational, Retrospective Study to Evaluate the Long Term Safety and Effectiveness of Leuprorelin in the Treatment of Central Precocious Puberty|Recruiting||N/A|300|Anticipated|Takeda|||2||f||||f|f|f||||||||2017-10-10 21:31:41.804248|2017-10-10 21:31:41.804248
NCT02993913|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-01-03|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Simmiparib in Patients With Malignant Advanced Solid Tumor|A Safety, Tolerability and Pharmacokinetic Study of Single and Repeat Oral Escalating Doses of Simmiparib in Patients With Advanced Malignant Tumors|Recruiting||Phase 1|50|Anticipated|Shanghai Acebright Pharmaceuticals Co., Ltd.||1|||f||||||||||||||2017-10-10 21:31:43.479986|2017-10-10 21:31:43.479986
NCT02993900|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-14|||September 2016||2016-09-01|December 2016|2016-12-01||||September 2021|Anticipated|2021-09-01||Interventional|||Image-Guided Gynecologic Brachytherapy|A Clinical Trial To Evaluate Image-Guided Gynecologic Brachytherapy In The MR Simulator Suite|Recruiting||Phase 2|54|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-10 21:31:43.569232|2017-10-10 21:31:43.569232
NCT02993887|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Resourcefulness Training and Decentering on Self-Management in Caregivers of Technology Dependent Children|The Effects of Resourcefulness Training Intervention and Decentering on Self-Management of Stress in Caregivers of Children With Complex Chronic Conditions Dependent on Lifesaving Medical Technology: A Pilot Study|Not yet recruiting||N/A|30|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:31:43.668495|2017-10-10 21:31:43.668495
NCT02993874|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-08-22|||June 26, 2017|Actual|2017-06-26|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Creatine Supplementation in Patients With Intermittent Claudication.|Effect of Creatine Supplementation Associated to Clinical Treatment of the Functional Capacity of Patients With Intermittent Claudication.|Recruiting||N/A|90|Anticipated|State University of Maringá||2|||f||||t|f|f||||||||2017-10-10 21:31:43.772788|2017-10-10 21:31:43.772788
NCT02993809|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-13|||March 2018||2018-03-01|September 2016|2016-09-01||||December 2019|Anticipated|2019-12-01||Interventional|||Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia||Not yet recruiting||Phase 1|40|Anticipated|South China Research Center for Stem Cell and Regenerative Medicine||2|||f||||t||||||||Yes||2017-10-10 21:31:44.249433|2017-10-10 21:31:44.249433
NCT02993796|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-28|||September 2014||2014-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01|5 Years|Observational [Patient Registry]|||Krabbe Disease Global Patient Registry|The Hunter James Kelly Research Institute's Clinical Database of Patients With Krabbe Disease, A World-Wide Registry|Recruiting||N/A|60|Anticipated|State University of New York at Buffalo|||1||f||||t|f|f||||||||2017-10-10 21:31:45.15846|2017-10-10 21:31:45.15846
NCT02993783|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-09-11|||March 31, 2017|Actual|2017-03-31|September 2017|2017-09-01|June 23, 2019|Anticipated|2019-06-23|March 19, 2019|Anticipated|2019-03-19||Interventional|||A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)|An Open-Label, Dose-Finding Study of Vedolizumab IV for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)|Recruiting||Phase 2|38|Anticipated|Takeda||2|||f||||f|t|f||||||||2017-10-10 21:31:45.296002|2017-10-10 21:31:45.296002
NCT02993770|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-12-13|||March 2016||2016-03-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Endo-nasal Endoscopic DCR and External-DCR in Primary Nasolacrimal Duct Obstruction|Comparison of Endonasal-Endoscopic Dacryocystorhinostomy Versus External Dacryocystorhinostomy|Recruiting||N/A|120|Anticipated|Tehran University of Medical Sciences||2|||f||||||||||||Undecided||2017-10-10 21:31:45.502481|2017-10-10 21:31:45.502481
NCT02993757|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-06-28|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|February 14, 2019|Anticipated|2019-02-14|February 14, 2019|Anticipated|2019-02-14||Interventional|||Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®|Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® in Healthy Subjects Aged 9 to 13 Years in Malaysia|Active, not recruiting||Phase 3|528|Actual|Sanofi||2|||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available at Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:31:45.603132|2017-10-10 21:31:45.603132
NCT02993744|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-05-25|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone|Assessment of Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone Under Threat of Preterm Delivery|Completed||N/A|140|Actual|Medical University of Vienna|||2||f||||f||||||None Retained|"     - blood samples   "|No||2017-10-10 21:31:45.74119|2017-10-10 21:31:45.74119
NCT02993718|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-09-12|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Sedation by Dexmedetomidine and Propofol|Comparison of the Upper Airway Patency by Dexmedetomidine and Propofol Used for Sedation|Completed||N/A|52|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-10-10 21:31:46.051185|2017-10-10 21:31:46.051185
NCT02993705|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|MITO 26||Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26|Phase II Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26|Not yet recruiting||Phase 2|43|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||No||2017-10-10 21:31:46.148786|2017-10-10 21:31:46.148786
NCT02993692|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-04-04|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|January 2017|Actual|2017-01-01||Interventional|||Nasotracheal Intubation in Children for Outpatient Dental Surgery|Nasotracheal Intubation in Children for Outpatient Dental Surgery: Is Fiberoptic Bronchoscopy Useful?|Completed||N/A|80|Actual|Inonu University||2|||f||||f||||||||No||2017-10-10 21:31:46.311503|2017-10-10 21:31:46.311503
NCT02993679|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-14|||July 2014||2014-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|||Stability of the Knee Joint After Anterior Cruciate Ligament and Anterolateral Ligament Reconstruction|Biomechanical Assessment of the Reconstruction of the Anterolateral Ligament During ACL Surgery. The In-vivo Study|Completed||N/A|60|Actual|Hospital Znojmo||2|||f||||f||||||||Undecided||2017-10-10 21:31:46.40375|2017-10-10 21:31:46.40375
NCT02993666|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-09|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Comparison of Upper and Lower Body Air Warming in Patients Undergoing Thoracic Surgery||Completed||N/A|135|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:31:46.468823|2017-10-10 21:31:46.468823
NCT02993653|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-14|||January 2015||2015-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Intensity-modulated Radiotherapy Protocol in Cervix Cancer|Definitive Treatment Protocol for High-dose Intensity-modulated Radiotherapy (IMRT) With Intracavitary Radiotherapy in Locally Advanced Cervical Cancer: A Phase II Trial|Recruiting||Phase 2|80|Anticipated|Seoul St. Mary's Hospital||1|||f||||t||||||||No||2017-10-10 21:31:46.551567|2017-10-10 21:31:46.551567
NCT02993640|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-04-25|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|March 20, 2017|Actual|2017-03-20||Interventional|||Optimization of Hepatic Hemodynamics During Liver Surgery|Effects of Vasopressin and Nitroglycerine in Combination on Splanchnic Blood Flow, and on Hepatic and Portal Venous Pressures in Liver Resection|Enrolling by invitation||N/A|12|Anticipated|Sahlgrenska University Hospital, Sweden||1|||f||||f||||||||No|No plans of sharing IPD|2017-10-10 21:31:46.657223|2017-10-10 21:31:46.657223
NCT02993627|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Effects of Spirulina Supplementation on Overweight or Obese Adults|Effects of Spirulina Supplementation on Anthropometric Measurements, Lipid Profile, Appetite, Liver Enzymes, Inflammatory and Glycemic Markers on Overweight or Obese Adults|Recruiting||Phase 1|40|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:31:46.734407|2017-10-10 21:31:46.734407
NCT02993601|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Feasibility Study of a New Peripheral Oedema Monitor for Heart Failure|Evaluation of the Safety and Feasibility of a New Peripheral Oedema Monitor for Home and Clinical Use for Heart Failure Patients, Using the Heartfelt-1 Device|Recruiting||N/A|80|Anticipated|Heartfelt Technologies|||4||f||||f||||||||No|We are not planning to share individual participant data with other researchers.|2017-10-10 21:31:46.917156|2017-10-10 21:31:46.917156
NCT02993588|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|||Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders|Impact of Melatonin Adjuvant Therapy on IVF/ICSI Outcomes in Prospective Poor Responders: A Double-blind, Randomized, Placebo-controlled Trial|Recruiting||Phase 2/Phase 3|100|Anticipated|Assiut University||2|||f||||f||||||||No|The data will be kept with the study team only and it is not allowed by our institution regulations to share the data.|2017-10-10 21:31:47.028095|2017-10-10 21:31:47.028095
NCT02993575|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-26|||June 1, 2017|Actual|2017-06-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|FANATIC||Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients|Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion as Therapy to Patients With an Infection in the Intensive Care Unit (ICU)|Recruiting||N/A|30|Anticipated|Radboud University|||1||f||||f||||||Samples Without DNA|"     Plasma samples for determination of total flucloxacillin and free flucloxacillin   "|||2017-10-10 21:31:47.243695|2017-10-10 21:31:47.243695
NCT02993562|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-06-13|||August 2015||2015-08-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|Hypomafia||Hypothyroidism, Metabolism and Food Intake|Levothyroxine Substitution Therapy in Hypothyroid Patients - Impact on Appetite and Food Intake|Recruiting||N/A|18|Anticipated|Herlev Hospital|||2||f||||f||||||Samples Without DNA|"     Blood Urine   "|No||2017-10-10 21:31:47.330435|2017-10-10 21:31:47.330435
NCT02993549|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-05-03|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|October 2022|Anticipated|2022-10-01|January 2022|Anticipated|2022-01-01||Observational|monTBI||TBI Multimodal Monitoring Study|Multimodality Monitoring Directed Management of Patients Suffering From Traumatic Brain Injury|Not yet recruiting||N/A|100|Anticipated|University of Cambridge|||1||f||||f||||||Samples With DNA|"     Serum and cerebrospinal fluid if available. Microdialysis samples.   "|||2017-10-10 21:31:47.455974|2017-10-10 21:31:47.455974
NCT02993536|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-13|||November 2015||2015-11-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Observational|||Clonal Evolution of B Cells in High-risk CLL After Idelalisib-rituximab|Clonal Evolution of B Cells in High-risk Chronic Lymphocytic Leukemia Patients After Idelalisib-rituximab Treatment|Recruiting||N/A|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 21:31:47.555718|2017-10-10 21:31:47.555718
NCT02993523|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-09-29|||February 6, 2017|Actual|2017-02-06|September 2017|2017-09-01|January 6, 2021|Anticipated|2021-01-06|February 1, 2020|Anticipated|2020-02-01||Interventional|||A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy|A Randomized, Double-Blind, Placebo Controlled Phase 3 Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy|Recruiting||Phase 3|400|Anticipated|AbbVie||2|||t||||f|t|f||||||||2017-10-10 21:31:47.639994|2017-10-10 21:31:47.639994
NCT02993510|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-02-20|||December 2003||2003-12-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||A Randomized Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects.|Randomised Multi-Center Study: Microfracturing With Chondro-Gide® for the Treatment of Isolated Cartilage Defects in the Knee Project-Nr.: 10830-003|Completed||Phase 3|67|Actual|Geistlich Pharma AG||3|||f||||f||||||||No||2017-10-10 21:31:47.905446|2017-10-10 21:31:47.905446
NCT02993497|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia|Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia|Not yet recruiting||N/A|52|Anticipated|Yonsei University||1|||f||||f||||||||Undecided||2017-10-10 21:31:48.029011|2017-10-10 21:31:48.029011
NCT02993484|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Role of Mitochondrial Respiration in the Cardioprotective Capacity of IPC in Diabetic and Non-diabetic Patients|The Role of Mitochondrial Respiration in the Cardioprotective Capacity of IPC in Diabetic and Non-diabetic Patients|Enrolling by invitation||N/A|40|Anticipated|University of Aarhus||8|||f||||f||||||||No||2017-10-10 21:31:48.117862|2017-10-10 21:31:48.117862
NCT02993471|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-14|||December 2016||2016-12-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of Ixekizumab in Participants With Plaque Psoriasis|Evaluation of the Effect of Ixekizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients With Moderate-to-Severe Plaque Psoriasis|Active, not recruiting||Phase 1|30|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:31:48.217474|2017-10-10 21:31:48.217474
NCT02993445|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||September 2014||2014-09-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension|A Pilot Study on the Effect of Alternate Nostril Breathing and Foot Reflexology on Intraocular Pressure in Ocular Hypertension|Completed||N/A|11|Actual|Temple University||2|||f||||f||||||||No||2017-10-10 21:31:48.480457|2017-10-10 21:31:48.480457
NCT02993432|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||High Volume Foleys Increasing Vaginal Birth Pilot Trial|High Volume Foleys Increasing Vaginal Birth (High FIVe Birth) Pilot Trial|Enrolling by invitation||N/A|130|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||No|There is not currently an IPD sharing plan|2017-10-10 21:31:48.5578|2017-10-10 21:31:48.5578
NCT02993419|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Bacillus Particles Prevent Children Antibiotics Associated Diarrhea|Bacillus Particles Prevent More Children's Antibiotic-associated Diarrhea (AAD), Randomized, Double-blind, Controlled Clinical Trial|Not yet recruiting||Phase 4|480|Anticipated|Jiangsu Famous Medical Technology Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 21:31:48.664773|2017-10-10 21:31:48.664773
NCT02993380|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-03-30|||October 2015||2015-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Olive Oil on Erythrocyte Membrane Fatty Acid Contents in Hemodialysis Patients|Effect of Cooked Olive Oil on Erythrocyte Membrane Fatty Acid Contents in Hemodialysis Patients|Completed||N/A|31|Actual|Dong-A University||2|||f||||f||||||||Undecided||2017-10-10 21:31:48.9494|2017-10-10 21:31:48.9494
NCT02993367|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-03-15|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|EBSCPVCIND||The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND|The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND:A Randomized, Double-blind,and Neuroimaging Study|Recruiting||Phase 2/Phase 3|200|Anticipated|The Second Hospital of Hebei Medical University||2|||f||||t||||||||||2017-10-10 21:31:49.056448|2017-10-10 21:31:49.056448
NCT02993354|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|EUM||Noninvasive Monitoring of Uterine Electrical Activity and Fetal Heart Rate: A New External Monitoring Device|Noninvasive Monitoring of Uterine Electrical Activity and Fetal Heart Rate: A New External Monitoring Device|Not yet recruiting||N/A|55|Anticipated|Montefiore Medical Center|||1||f||||f||||||||||2017-10-10 21:31:49.152896|2017-10-10 21:31:49.152896
NCT02993341|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-12-12|||November 2016||2016-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Topical Tranexamic Acid (TXA) in Hip Fractures|Topical Tranexamic Acid (TXA) in Hip Fractures, A Double-Blind, Randomized Controlled Trial|Recruiting||Phase 3|66|Anticipated|Sault Area Hospital||2|||f||||t||||||||No||2017-10-10 21:31:49.228452|2017-10-10 21:31:49.228452
NCT02993328|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-10-04|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Trial for Treatment of Plaque Psoriasis in Adults|A Double-Blind, Randomized, Placebo Controlled Safety, Tolerability & Efficacy Trial Of A New Botanical Drug Product At One Dose Level For The Treatment Of Mild-To-Moderate Plaque Psoriasis In Adult Subjects|Not yet recruiting||Phase 2|72|Anticipated|Santalis Pharmaceuticals, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:31:49.320401|2017-10-10 21:31:49.320401
NCT02993315|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-12|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2021|Anticipated|2021-10-01||Interventional|MIND-DC||Melanoma Patients Immunized With Natural DenDritic Cells|A Randomized, Double-‐Blind, Placebo‐Controlled Phase III Study to Evaluate Active Immunization in Adjuvant Therapy of Patients With Stage IIIB and IIIC Melanoma With Natural Dendritic Cells Pulsed With Synthetic Peptides.|Recruiting||Phase 3|210|Anticipated|Radboud University||2|||f||||f||||||||Undecided||2017-10-10 21:31:49.406329|2017-10-10 21:31:49.406329
NCT02993289|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-19|||October 2016||2016-10-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|October 2017|Anticipated|2017-10-01||Interventional|DEFINE3||Is Detoxification Needed in Medication-overuse Headache?|Is Detoxification Needed in Medication-overuse Headache?: A Randomized Controlled Trial of 3 Treatment Strategies|Recruiting||N/A|115|Anticipated|Danish Headache Center||5|||f||||f||||||||||2017-10-10 21:31:49.645178|2017-10-10 21:31:49.645178
NCT02993276|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-04-07|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Observational|||Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma|Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma|Enrolling by invitation||N/A|92|Anticipated|Polyganics Innovations BV|||1||f||||t||||||||No||2017-10-10 21:31:49.882709|2017-10-10 21:31:49.882709
NCT02993263|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-10-03|||February 2016||2016-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Postoperative Acute Myocardial Ischemic Injury|Detection and Prediction of Postoperative Acute Myocardial Ischemic Injury/Infarction by the VectraplexECG System With CEB®|Recruiting||N/A|500|Anticipated|The Cleveland Clinic||1|||f||||f||||||||||2017-10-10 21:31:50.007997|2017-10-10 21:31:50.007997
NCT02993237|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2017-08-07|||January 23, 2017|Actual|2017-01-23|August 2017|2017-08-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets|A Study to Assess the Acceptability/Swallowability of DRV-containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets|Completed||Phase 1|27|Actual|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 21:31:50.291555|2017-10-10 21:31:50.291555
NCT02993224|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-08-22|||July 27, 2017|Actual|2017-07-27|August 2017|2017-08-01|May 15, 2020|Anticipated|2020-05-15|May 15, 2020|Anticipated|2020-05-15||Interventional|Jupiter||Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet|Open-label, Multicenter, Single Arm, Phase II Study Assessing Treatment Patient Preference for New Deferasirox Formulation (Film-coated Tablet) Compared to the Reference Deferasirox Dispersible Tablet Formulation|Recruiting||Phase 2|170|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 21:31:50.394372|2017-10-10 21:31:50.394372
NCT02993211|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-07-17|||April 18, 2017|Actual|2017-04-18|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Transurethral En Bloc Versus Standard Resection of Bladder Tumour|Transurethral En Bloc Versus Standard Resection of Bladder Tumour: A Multi-centre Randomised Controlled Trial (EB-StaR Study).|Recruiting||Phase 3|350|Anticipated|Chinese University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 21:31:50.508762|2017-10-10 21:31:50.508762
NCT02993198|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-06-23|||April 2015||2015-04-01|June 2017|2017-06-01||||December 2019|Anticipated|2019-12-01||Interventional|||A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging|A Prospective Study of Early Stage Breast Cancer Patients With Abnormal Myocardial Deformation Treated With Anthracycline and/or Trastuzumab and Pertuzumab-based Cancer Therapy|Recruiting||Phase 2|150|Anticipated|Northwestern University||2|||f||||||||||||||2017-10-10 21:31:50.720874|2017-10-10 21:31:50.720874
NCT02993185|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-07-18|||October 2016||2016-10-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|MHD||Making Healthy Decisions|An Integrated Group-Individual Curriculum to Prevent Teen Pregnancy|Recruiting||N/A|2100|Anticipated|Carnegie Mellon University||2|||f||||f||||||||||2017-10-10 21:31:50.845563|2017-10-10 21:31:50.845563
NCT02993172|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-14|||January 1976||1976-01-01|December 2016|2016-12-01||||January 2014|Actual|2014-01-01||Observational|CCHS||The Copenhagen City Heart Study|The Copenhagen City Heart Study 'Østerbroundersøgelsen'|Completed||N/A|23891|Actual|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-10 21:31:50.985065|2017-10-10 21:31:50.985065
NCT02993159|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-14|2017-08-16|||May 31, 2017|Actual|2017-05-31|August 2017|2017-08-01|July 15, 2019|Anticipated|2019-07-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast|Phase IIB Trial of Neoadjuvant Oral Tamoxifen Versus Transdermal 4-hydroxytamoxifen in Women With DCIS of the Breast|Recruiting||Phase 2|100|Anticipated|Northwestern University||2|||f||||t|t|f||||||||2017-10-10 21:31:51.074681|2017-10-10 21:31:51.074681
NCT02993133|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-06-12|||December 2016|Actual|2016-12-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|PEMPA||Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.|Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.|Recruiting||Phase 3|60|Anticipated|University Hospital, Limoges||1|||f||||f||||||||No||2017-10-10 21:31:51.387988|2017-10-10 21:31:51.387988
NCT02993107|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-09-07|||December 2016||2016-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||PALISADE Follow-on Study (ARC004)|Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) Follow-on Study|Recruiting||Phase 3|500|Anticipated|Aimmune Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 21:31:51.813336|2017-10-10 21:31:51.813336
NCT02993094|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-12|||November 2016||2016-11-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer|Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer|Recruiting||Phase 1/Phase 2|53|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||No||2017-10-10 21:31:52.005127|2017-10-10 21:31:52.005127
NCT02993081|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||May 2016||2016-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Observational|RCYAG||Capsulotomy YAG Laser|REFRACTIVE CHANGES AFTER CAPSULOTOMY WITH YAG LASER|Completed||N/A|67|Actual|Instituto de Olhos de Goiania|||1||f||||||||||||||2017-10-10 21:31:52.133298|2017-10-10 21:31:52.133298
NCT02993055|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-13|||January 2015||2015-01-01|December 2016|2016-12-01||||November 2015|Actual|2015-11-01||Interventional|||A Study to Assess Ulimorelin in Healthy Subjects|A Phase I, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ulimorelin (LP101)|Completed||Phase 1|39|Actual|Lyric Pharmaceuticals||2|||f||||||||||||No||2017-10-10 21:31:52.299514|2017-10-10 21:31:52.299514
NCT02993042|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-10-04|||December 2016||2016-12-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Robot-assisted Gait Training on Gait Automaticity in Patients With Parkinson's Disease|Effect of Robot-assisted Gait Training on Gait Automaticity in Patients With Parkinson's Disease: a Feasibility Study|Recruiting||N/A|12|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 21:31:52.359525|2017-10-10 21:31:52.359525
NCT02993029|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||99Tc-MDP Treatment for Knee Osteoarthritis|99Tc-MDP Versus Celecoxib Treatment in Patients With Knee Osteoarthritis|Not yet recruiting||N/A|40|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||No||2017-10-10 21:31:52.459203|2017-10-10 21:31:52.459203
NCT02993016|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Conventional Versus Patient-specific Instruments in Total Knee Arthroplasty|Comparison of Conventional Versus Patient-specific Instruments in Total Knee Arthroplasty: A Randomized Controlled Trial|Not yet recruiting||N/A|100|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 21:31:52.71868|2017-10-10 21:31:52.71868
NCT02993003|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-10-03|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Optimal Positioning of Nasopharyngeal Temperature Probes|Optimal Positioning of Nasopharyngeal Temperature Probes in Pediatric Patients: A Prospective Cohort Study|Recruiting||N/A|130|Anticipated|The Cleveland Clinic||3|||f||||f||||||||||2017-10-10 21:31:52.811797|2017-10-10 21:31:52.811797
NCT02992990|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade|A Prospective Study To Assess Whether A Preoperative Tumor Biopsy Can Improve Upon The Endoscopic Impression Determination Of Stage And Grade In Non-Muscle-Invasive Urothelial Carcinoma Of The Bladder|Not yet recruiting||N/A|30|Anticipated|Baylor College of Medicine||1|||f||||t||||||||Undecided||2017-10-10 21:31:52.904688|2017-10-10 21:31:52.904688
NCT02992977|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-10-04|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer|A Phase 1 Study of Safety and Tolerability of AutoSynVax™ Vaccine as a Single Agent in Subjects With Advanced Cancer|Active, not recruiting||Phase 1|20|Anticipated|Agenus Inc.||1|||f||||f||||||||||2017-10-10 21:31:52.979196|2017-10-10 21:31:52.979196
NCT02992964|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-04-04|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers|Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers|Recruiting||Phase 1/Phase 2|20|Anticipated|The Hospital for Sick Children||1|||f||||t|f|f||||||Undecided||2017-10-10 21:31:53.078341|2017-10-10 21:31:53.078341
NCT02992951|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-15|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|DRESSINg||DACC in the REduction of Surgical Site INfection|A Randomised Controlled Trial to Assess the Clinical and Cost Effectiveness of Dialkylcarbamoylchloride (DACC) Coated Post-operative Dressings Versus Standard Care in the Prevention of Surgical Site Infection in Clean or Clean-contaminated, Vascular Surgery|Not yet recruiting||Phase 2|712|Anticipated|University of Hull||2|||f||||t||||||||No||2017-10-10 21:31:53.198856|2017-10-10 21:31:53.198856
NCT02992938|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-01-29|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia|Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia: Randomize Double Blind Clinical Trial|Recruiting||Phase 4|50|Anticipated|University of Chile||2|||f||||t||||||||No||2017-10-10 21:31:53.295723|2017-10-10 21:31:53.295723
NCT02992925|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-18|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase 3 Study of BK1310 in Healthy Infants||Recruiting||Phase 3|370|Anticipated|Mitsubishi Tanabe Pharma Corporation||4|||f||||f||||||||||2017-10-10 21:31:53.40765|2017-10-10 21:31:53.40765
NCT02992912|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-05-15|||November 2016||2016-11-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|SABR-PDL1||Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours|A Phase II Study to Assess the Efficacy of the Anti-PD-L1 Antibody Atezolizumab (MPDL3280A) Administered With Stereotactic Ablative Radiotherapy (SABR) in Patients With Metastatic Tumours|Recruiting||Phase 2|180|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 21:31:53.523796|2017-10-10 21:31:53.523796
NCT02992899|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-04-21|||April 19, 2017|Actual|2017-04-19|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder|Closed Loop Vagal Nerve Stimulation in Patients With Posttraumatic Stress Disorder|Recruiting||N/A|75|Anticipated|Emory University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:31:53.621325|2017-10-10 21:31:53.621325
NCT02992886|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-13|||September 2016||2016-09-01|December 2016|2016-12-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly|Multicenter, Phase II Study of Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly|Recruiting||Phase 2|68|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||No||2017-10-10 21:31:53.748301|2017-10-10 21:31:53.748301
NCT02992873|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-08-17|||November 2018|Anticipated|2018-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|SAMBA||The Scandinavian AED and Mobile Bystander Activation Trial|The Scandinavian AED and Mobile Bystander Activation Trial - a Randomized Controlled Trial|Not yet recruiting||N/A|490|Anticipated|Karolinska Institutet||2|||f||||t|f|f||||||||2017-10-10 21:31:53.89405|2017-10-10 21:31:53.89405
NCT02992860|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-04|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|SAMBA||Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY|Single Agent JNJ-56022473 in MDS and AML Patients Failing Hypomethylating Agent Based Therapy|Suspended||Phase 2|43|Anticipated|GWT-TUD GmbH||1||since 27th July 2017|f||||t||||||||||2017-10-10 21:31:54.050466|2017-10-10 21:31:54.050466
NCT02992847|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-12-12|||January 2017||2017-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)|Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)|Not yet recruiting||N/A|160|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 21:31:54.225547|2017-10-10 21:31:54.225547
NCT02992834|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|January 2022|Anticipated|2022-01-01|August 2020|Anticipated|2020-08-01||Interventional|||Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma|Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for Chemotherapy-resistant or Refractory CD19+B Cell Lymphoma:a Double-arm, Single Center, Open-label Clinical Trial|Not yet recruiting||Phase 4|10|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||No||2017-10-10 21:31:54.322141|2017-10-10 21:31:54.322141
NCT02992821|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Pocket Sized Carotid Stenosis Screening by Junior Doctors|Screening Patients Admitted With Stroke or TIA for Carotid Stenosis by Pocked-Sized Ultrasound in Inexperienced Hands and With Novel Doppler Technology|Not yet recruiting||N/A|100|Anticipated|Levanger Hospital||1|||f||||f||||||||Undecided|Depending on university's progress for IPD|2017-10-10 21:31:54.455741|2017-10-10 21:31:54.455741
NCT02992808|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-18|||December 2016||2016-12-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Androgenic Profile Following Controlled Ovarian Stimulation|Follicular Fluid, Serum Endocrine Profile Following Stimulation With Recombinant Gonadotropins or Highly Purified Human Menopausal Gonadotropin During GnRH-antagonist Protocol|Not yet recruiting||Phase 4|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 21:31:54.597733|2017-10-10 21:31:54.597733
NCT02992795|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||November 2016||2016-11-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|||Unblinded Data Collection Study of Concussion Using BrainPulse|A Study to Assess the Effectiveness of the BrainPulse as an Aid to the Diagnosis of Concussion|Recruiting||N/A|450|Anticipated|Jan Medical, Inc.|||4||f||||t||||||||No|All study outcome measures will be made available within 6 months of study completion|2017-10-10 21:31:54.711802|2017-10-10 21:31:54.711802
NCT02992782|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-05-02|||April 15, 2017|Actual|2017-04-15|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|January 1, 2018|Anticipated|2018-01-01||Interventional|DREAM||Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management|Decongestive Progressive Resistance Exercise With Advanced Compression for Breast Cancer Related Lymphedema Management (DREAM): A Pilot Randomized Control Trial|Recruiting||N/A|24|Anticipated|University of Alberta||3|||f||||f|f|f||||||Undecided||2017-10-10 21:31:54.806016|2017-10-10 21:31:54.806016
NCT02992769|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-15|||March 2016||2016-03-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound|A Nomogram to Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound|Recruiting||N/A|120|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|||1||f||||f||||||||No||2017-10-10 21:31:54.924406|2017-10-10 21:31:54.924406
NCT02992756|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-08-21|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Influence of Needling Rich Plasma Growth Factors in Ovaries in Assisted Reproductive Techniques|Prospective Interventional Test on the Activity of PRGF (Rich Plasma in Growth Factors) Administered by Direct Ovarian Puncture in Patients With Low Follicular Reserve Submitted to Assisted Reproduction Treatments.|Not yet recruiting||Phase 3|51|Anticipated|IVI Bilbao||2|||f||||t|f|f||||||||2017-10-10 21:31:55.010502|2017-10-10 21:31:55.010502
NCT02992743|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-05|||November 2016||2016-11-01|September 2017|2017-09-01||||May 2018|Anticipated|2018-05-01||Interventional|||A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma|A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma|Recruiting||Phase 1/Phase 2|15|Anticipated|Adaptimmune||1|||f||||||||||||||2017-10-10 21:31:55.088774|2017-10-10 21:31:55.088774
NCT02992730|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-14|||April 2011||2011-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|WHIP||Predictors of Adjuvant Endocrine Therapy in Women With Breast Cancer|Predictors of Adjuvant Endocrine Therapy in Women With Breast Cancer|Active, not recruiting||N/A|630|Actual|Georgetown University|||1||f||||f||||||Samples With DNA|"     Saliva Sample   "|||2017-10-10 21:31:55.215595|2017-10-10 21:31:55.215595
NCT02992717|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Validation of the 3D-CAM to Detect Postoperative Delirium|Validation of the 3D-CAM in the Recovery Room to Detect Postoperative Delirium Compared to Nu-DESC, CAM and DSM-5 Criteria|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||No||2017-10-10 21:31:55.289445|2017-10-10 21:31:55.289445
NCT02992704|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|INACTIVE||PEG-INTERFERON FOR INACTIVE HBV CARRIERS|RANDOMISED CONTROL STUDY FOR INACTIVE CHRONIC HEPATITIS B PATIENTS WITH LOW VIRAL LOAD, WITH PEG-INTERFERON (INACTIVE)|Recruiting||Phase 2/Phase 3|90|Anticipated|National University Health System, Singapore||3|||f||||f||||||||No||2017-10-10 21:31:55.383334|2017-10-10 21:31:55.383334
NCT02992691|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-05-10|||December 19, 2016|Actual|2016-12-19|May 2017|2017-05-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Interventional|||Efficacy of Three Experimental Toothpastes to Remove Plaque|Dose Response of Three Experimental Dentifrices in Plaque Removal in a Single Brushing Model|Completed||N/A|75|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-10-10 21:31:55.501296|2017-10-10 21:31:55.501296
NCT02992678|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-13|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Pentoxifylline for the Prevention of PEP|Prophylactic Treatment Pentoxifylline for the Prevention of Post-ERCP Pancreatitis|Recruiting||Early Phase 1|110|Anticipated|Anhui Provincial Hospital||2|||f||||t||||||||No||2017-10-10 21:31:55.589096|2017-10-10 21:31:55.589096
NCT02992665|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Can Calcium Ionophore Application Enhance the ICSI Outcomes in Severe Male Factor Infertility?|Can Calcium Ionophore Application Enhance the ICSI Outcomes in Severe Male Factor Infertility?|Recruiting||Phase 2/Phase 3|100|Anticipated|Assiut University||2|||f||||t||||||||Undecided|According to the patient agreement.|2017-10-10 21:31:55.666395|2017-10-10 21:31:55.666395
NCT02992652|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-13|||January 2011||2011-01-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis|Role of Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis|Completed||N/A|100|Actual|Ain Shams University||2|||f||||t||||||||No||2017-10-10 21:31:55.757689|2017-10-10 21:31:55.757689
NCT02992639|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2017-02-14|||June 2015||2015-06-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Weight Loss Effect on Circulating Liver Enzymes|Weight Loss Effect on Circulating Levels of Liver Enzymes in Overweight Subjects With High Visceral Fat Area: 12-week Randomized Controlled Trial|Completed||N/A|80|Actual|Yonsei University||2|||f||||||||||||||2017-10-10 21:31:55.820694|2017-10-10 21:31:55.820694
NCT02992626|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-10-04|||May 2016||2016-05-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Influence of Dogs on Learning in Children|Influence of Interacting With Dogs on Learning in Children|Completed||N/A|30|Actual|Swiss Tropical & Public Health Institute||2|||f||||f||||||||||2017-10-10 21:31:55.900043|2017-10-10 21:31:55.900043
NCT02992613|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultra-Congruent(UC) Versus Posterior-stabilized(PS) Insert in Bilateral Total Knee Arthroplasty|Comparison of Ultra-Congruent(UC) and Posterior-stabilized(PS) Insert in Bilateral Total Knee Arthroplasty|Not yet recruiting||N/A|100|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 21:31:55.967501|2017-10-10 21:31:55.967501
NCT02992600|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-10|||August 2016||2016-08-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|3 Years|Observational [Patient Registry]|||Postoperative Cognitive Dysfunction: Correlations With Olfactory Dysfunction and Related Gene Changes|Postoperative Cognitive Dysfunction: Correlations With Olfactory Dysfunction and Related Gene Changes|Recruiting||N/A|1000|Anticipated|Xuzhou Medical University|||2||f||||||||||Samples With DNA|"     blood   "|Yes|within six months after the trial complete|2017-10-10 21:31:56.026717|2017-10-10 21:31:56.026717
NCT02992587|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-26|||February 2016||2016-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|June 2018|Anticipated|2018-06-01|12 Months|Observational [Patient Registry]|FICS||Frailty In Cardiac Surgery Copenhagen Study|Frailty In Cardiac Surgery Copenhagen Study|Enrolling by invitation||N/A|600|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||No||2017-10-10 21:31:56.102085|2017-10-10 21:31:56.102085
NCT02992574|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-11|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|December 2028|Anticipated|2028-12-01|December 2028|Anticipated|2028-12-01||Interventional|PMRT-NNBC||Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer|Post-Mastectomy Radiation Therapy in High Risk, Node Negative Women With Early Breast Cancer (PMRT-NNBC)|Not yet recruiting||Phase 3|1022|Anticipated|Tata Memorial Centre||2|||f||||t||||||||No||2017-10-10 21:31:56.163971|2017-10-10 21:31:56.163971
NCT02992561|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-10|||September 2016||2016-09-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means|Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means: A Randomized Controlled Trial in Eastern DR Congo|Recruiting||N/A|200|Anticipated|University of Konstanz||2|||f||||f||||||||Undecided||2017-10-10 21:31:56.261882|2017-10-10 21:31:56.261882
NCT02992548|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2016-12-14|||September 2015||2015-09-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease|Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease|Recruiting||Phase 4|62|Anticipated|Dong-A University||1|||f||||f||||||||Undecided||2017-10-10 21:31:56.341563|2017-10-10 21:31:56.341563
NCT02992535|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Intense Pulse Light (IPL) Treatment on Tear Film Osmolarity|Effect of Intense Pulse Light (IPL) Treatment on Tear Film Osmolarity in Dry Eye Disease (DED) With Meibomian Gland Dysfunction (MGD).|Not yet recruiting||Phase 4|60|Anticipated|Carones Ophthalmology Center||1|||f||||f||||||||Undecided||2017-10-10 21:31:56.434858|2017-10-10 21:31:56.434858
NCT02992522|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-03-01|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma|A Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-cell Non-Hodgkin Lymphoma|Recruiting||Phase 1|60|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:31:56.496914|2017-10-10 21:31:56.496914
NCT02992509|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-30|||December 2014||2014-12-01|December 2016|2016-12-01||||November 2015|Actual|2015-11-01||Interventional|||IVES for Treatment of UUI and OAB|EMED Detruset Intravesical Electrical Stimulation Catheter for Treatment of Urge Urinary Incontinence and Overactive Bladder Syndrome in Females|Completed||Early Phase 1|17|Actual|Loma Linda University||1|||f||||t||||||||No|No IPD will be shared|2017-10-10 21:31:56.598924|2017-10-10 21:31:56.598924
NCT02992496|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Investigation of Antidepressant Efficacy of Oral Ketamine Treatment|Investigation of Antidepressant Efficacy of Oral Ketamine Treatment|Not yet recruiting||Phase 2|60|Anticipated|Medical University of Vienna||2|||f||||f||||||||No||2017-10-10 21:31:56.789703|2017-10-10 21:31:56.789703
NCT02992483|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-29|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|July 13, 2019|Anticipated|2019-07-13|April 4, 2019|Anticipated|2019-04-04||Interventional|||Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma|Phase I Open Label, Multi-center Study to Characterize the Safety, Tolerability and Pharmacokinetics of Intravenously Administered MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma|Recruiting||Phase 1|67|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:31:56.874256|2017-10-10 21:31:56.874256
NCT02992470|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Crassostrea Gigas for Liver Health|Hydrolyzed Oyster Extract for Liver Health: a Randomized, Double-blind, Placebo-controlled Trial|Not yet recruiting||N/A|96|Anticipated|Korean Medicine Hospital of Pusan National University||2|||f||||f||||||||||2017-10-10 21:31:56.991327|2017-10-10 21:31:56.991327
NCT02992457|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-10|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Post-hepatitis C Cirrhosis|Retrospective Study of the Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Post-hepatitis C Cirrhosis|Recruiting||Phase 4|1000|Anticipated|Tanta University||4|||f||||t||||||||Undecided||2017-10-10 21:31:57.094442|2017-10-10 21:31:57.094442
NCT02992444|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-31|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Evaluation of the Influence of Output on Skin Covered by Adhesives||Completed||N/A|5|Actual|Coloplast A/S||1|||f||||f||||||||No||2017-10-10 21:31:57.259533|2017-10-10 21:31:57.259533
NCT02992431|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-31|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2017|Anticipated|2017-12-01||Interventional|4PHC||Participatory Patient Care Planning in Primary Care|Participatory Patient Care Planning in Primary Care: Effectiveness and Feasibility in Patients With Hypertension, Ischemic Heart Disease or Diabetes|Recruiting||N/A|700|Anticipated|Kuopio University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:31:57.345735|2017-10-10 21:31:57.345735
NCT02992418|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-06-28|||February 19, 2016|Actual|2016-02-19|June 2017|2017-06-01|January 2, 2019|Anticipated|2019-01-02|January 2, 2019|Anticipated|2019-01-02||Interventional|||Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects|Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects Aged 9 to 60 Years in the Philippines|Active, not recruiting||Phase 3|688|Actual|Sanofi||2|||f||||f|f|f||||||||2017-10-10 21:31:57.473476|2017-10-10 21:31:57.473476
NCT02992405|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||FOCUS:Families OverComing Under Stress|Evaluation of Feasibility and Effect Size of a Resilience Enhancement Program for Couples and Families Contending With Cancer (FOCUS)|Recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-10 21:31:57.613697|2017-10-10 21:31:57.613697
NCT02992392|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome|Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome|Recruiting||N/A|50|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 21:31:57.726773|2017-10-10 21:31:57.726773
NCT02992379|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-10|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Clinical Evaluation of Stabilizing Splint Versus Pivot Splint as Jaw Exercise Together With Stabilizing Splint|Clinical Evaluation of Stabilizing Splint Versus Pivot Splint as Jaw Exercise Together With Stabilizing Splint as Treatment for TMJ Anterior Disc Displacement Without Reduction|Not yet recruiting||N/A|30|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:31:57.831261|2017-10-10 21:31:57.831261
NCT02992366|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2016-12-10|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||: SOCKET SHIELD TECHNIQUE VERSUS EMPTY SOCKET TECHNIQUE|IMMEDIATE IMPLANT PLACEMENT IN THE ESTHETIC ZONE: SOCKET SHIELD TECHNIQUE VERSUS EMPTY SOCKET TECHNIQUE FOR PRESERVATION OF LABIAL ALVEOLAR BONE INTEGRITY|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:31:57.919666|2017-10-10 21:31:57.919666
NCT02992353|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||July 2016||2016-07-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer|Single-port Versus Two-port Versus Three-port Video Assisted Thoracoscopic Pulmonary Resection on Non-small Cell Lung Cancer: a Prospective Randomised Controlled Trial|Recruiting||N/A|231|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:31:58.022955|2017-10-10 21:31:58.022955
NCT02992340|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-10|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC|A Multicentre, Phase 1B/2 Study of Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic Biliary Tract Cancer.|Recruiting||Phase 1/Phase 2|175|Anticipated|Aslan Pharmaceuticals||1|||f||||t||||||||No||2017-10-10 21:31:58.118507|2017-10-10 21:31:58.118507
NCT02992327|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-02-06|||August 2015||2015-08-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|BlacOut||Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)|Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)|Recruiting||N/A|100|Anticipated|HealthPartners Institute|||1||f||||f||||||Samples Without DNA|"     The laboratory has developed and characterized extensively an antibody that reacts with the     SNTF (structural brain protein calpain-cleaved αII-spectrin N-terminal fragment) fragment of     aII-spectrin but does not recognize either the intact aII-spectrin or any other fragment of     it. The laboratory has used this antibody as a foundation for an ultrasensitive, specific,     standardized sandwich immunoassay for measuring trace quantities of SNTF in human serum and     plasma in the acute period after brain injury19,27 The method employs state-of-the-art     electrochemiluminescence chemistry that is widely used in the clinical diagnostics arena for     measuring protein biomarkers in biological fluids.   "|No|There is no plan to share IPD|2017-10-10 21:31:58.243736|2017-10-10 21:31:58.243736
NCT02992314|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-08|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Determination of the Safety and Effectiveness of an Oral Rinse in the Reduction of Medication Associated Metallic Taste|Determination of the Safety and Effectiveness of an Oral Rinse in the Reduction of Medication Associated Metallic Taste|Recruiting||N/A|52|Anticipated|You First Services||2|||f||||t|f|t|t|f|t|||||2017-10-10 21:31:58.329119|2017-10-10 21:31:58.329119
NCT02992301|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-09|||November 2016||2016-11-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab|Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab - a Pilot Study|Recruiting||Phase 4|30|Anticipated|Westside Medical Associates of Los Angeles||1|||f||||t||||||||Undecided||2017-10-10 21:31:58.411157|2017-10-10 21:31:58.411157
NCT02992288|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-27|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|June 7, 2018|Anticipated|2018-06-07|April 20, 2018|Anticipated|2018-04-20||Interventional|PANTHEON||A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction|A Multicenter, Randomized, Placebo-controlled, Parallel Group, Double Blind, Dose-finding Phase II Trial to Study the Efficacy, Safety, Pharmacokinetic and Pharmacodynamic Effects of the Oral Partial Adenosine A1 Receptor Agonist Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction|Recruiting||Phase 2|384|Anticipated|Bayer||6|||f||||t|t|f||||||||2017-10-10 21:31:58.520165|2017-10-10 21:31:58.520165
NCT02992275|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-07-11|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|IMAGINE+NMES||NMES to Improve Hip Abductor Strength and Balance|Neuromuscular Electrical Stimulation as an Adjunct to Improve Hip Abductor Muscle Quality and Reduce Fall Risk|Recruiting||N/A|20|Anticipated|Baltimore VA Medical Center||1|||f||||t|f|f||||||||2017-10-10 21:31:58.793199|2017-10-10 21:31:58.793199
NCT02992262|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Interventional|||Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination|Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination|Not yet recruiting||N/A|300|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||||||||||||2017-10-10 21:31:58.870735|2017-10-10 21:31:58.870735
NCT02992249|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-01-03|||May 2014||2014-05-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Observational|||Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases||Recruiting||N/A|48|Anticipated|Avita Medical|||1||f||||f||||||||No||2017-10-10 21:31:58.928822|2017-10-10 21:31:58.928822
NCT02992236|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-09|||August 2015||2015-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers|Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers|Completed||Phase 1|16|Actual|Vasopharm GmbH||2|||f||||f||||||||Undecided||2017-10-10 21:31:59.035332|2017-10-10 21:31:59.035332
NCT02992223|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-12|||July 2014||2014-07-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT|Retrospective Collection of Data on Patient With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Y90 Ibritumomab Tiuxetan Radioimmunotherapy Plus High-Dose Chemotherapy and Autologous Stem Cell Transplant|Completed||N/A|58|Actual|Azienda Ospedaliera Città della Salute e della Scienza di Torino|||1||f||||f||||||||Yes|paper publication|2017-10-10 21:31:59.112893|2017-10-10 21:31:59.112893
NCT02992210|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-04-29|||May 2016||2016-05-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Study on GD2 Positive Solid Tumors by 4SCAR-GD2|Multicenter Trial of Phase I/II Studies on GD2 Positive Solid Tumors by 4SCAR-GD2|Recruiting||Phase 1/Phase 2|100|Anticipated|Shenzhen Geno-Immune Medical Institute||1|||f||||t||||||||||2017-10-10 21:31:59.171315|2017-10-10 21:31:59.171315
NCT02992197|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-27|||June 12, 2017|Actual|2017-06-12|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity|A Double-blind, Randomized Controlled Trial of the Effect of Vaccine Inoculum on Oral Rotavirus Vaccine (Rotarix, GlaxoSmithKline) Take and Immunogenicity in Dhaka, Bangladesh|Recruiting||Phase 4|220|Anticipated|University of Vermont||2|||f||||t|f|f||||||No||2017-10-10 21:31:59.263405|2017-10-10 21:31:59.263405
NCT02992184|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-13|||September 2016||2016-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||PoC-HCV Genedrive Viral Detection Assay Validation Study||Completed||N/A|417|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||2||f||||f||||||||||2017-10-10 21:31:59.372876|2017-10-10 21:31:59.372876
NCT02992171|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-09-27|||January 2017||2017-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Primary Palliative Care for Patients With Advanced Hematologic Malignancies|Supportive Care Management by Oncology Nurses Study — A Pilot Trial|Recruiting||N/A|80|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 21:31:59.471021|2017-10-10 21:31:59.471021
NCT02992158|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-03-28|||March 2016||2016-03-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Feasibility of a Behavioral Activation Trial|Feasibility of a Behavioral Activation Trial in Community Mental Health|Recruiting||N/A|80|Anticipated|University of Pennsylvania||2|||f||||t||||||||Yes|Data will be shared via the Research Domain Criteria Database (RDoCdb), part of the NIMH Data Archive (NDA). All feasibility and outcome data will be shared.|2017-10-10 21:31:59.540245|2017-10-10 21:31:59.540245
NCT02992145|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2016-12-15|||March 2016||2016-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Androgens Level in the Third Trimester of Pregnancy in Patients With Preeclampsia|Androgens Level in the Third Trimester of Pregnancy in Patients With Preeclampsia|Completed||N/A|80|Actual|Ain Shams Maternity Hospital|||2||f||||t||||||||Undecided||2017-10-10 21:31:59.628464|2017-10-10 21:31:59.628464
NCT02991820|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-09|||June 2016||2016-06-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||VL vs DL in Inexperienced Users: a Pediatric Manikin Study|Comparison of Miller and Macintosh Laryngoscopes, CMAC and Glidescope Videolaryngoscopes in Inexperienced Users: a Pediatric Manikin Study|Enrolling by invitation||N/A|80|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-10 21:32:04.015877|2017-10-10 21:32:04.015877
NCT02992132|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-12|2017-09-25|||November 2016||2016-11-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|||Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)|A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease|Recruiting||Phase 2|432|Anticipated|ACADIA Pharmaceuticals Inc.||3|||f||||t||||||||||2017-10-10 21:31:59.699859|2017-10-10 21:31:59.699859
NCT02992119|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-06-07|||June 4, 2017|Actual|2017-06-04|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RTSS||Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults|Safety and Immunogenicity Evaluation of the Malaria Vaccine, RTS,S/AS01, in Healthy Thai Adults|Recruiting||Phase 2|190|Anticipated|University of Oxford||7|||f||||t|f|f||||||Yes||2017-10-10 21:31:59.84782|2017-10-10 21:31:59.84782
NCT02992106|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-05-10|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|September 2019|Anticipated|2019-09-01||Interventional|EFFECTOR||Evolution of Maternal Weight During Pregnancy and Influence on the Endothelial Function in Her Offspring|Evolution of Maternal Weight During Pregnancy and Influence on the Endothelial Function in Her Offspring|Enrolling by invitation||N/A|270|Anticipated|Universitair Ziekenhuis Brussel||4|||f||||f|f|f||||||No||2017-10-10 21:31:59.950705|2017-10-10 21:31:59.950705
NCT02992093|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|May 2020|Anticipated|2020-05-01||Observational|||A Metabolomic Study of Polycystic Ovary Syndrome With Insulin Resistance and Its Relationship With TCM Syndrome Types|Fujian Maternity and Child Health Hospital|Not yet recruiting||N/A|300|Anticipated|Fujian Maternity and Child Health Hospital|||5||f||||t||||||||No||2017-10-10 21:32:01.717491|2017-10-10 21:32:01.717491
NCT02992080|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-12-09|||July 2016||2016-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Interventional|MIRDIAMUCO||Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis|Determination of Circulating miRNAs as Diagnostic Markers of Lung Disease in Cystic Fibrosis|Recruiting||N/A|80|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:32:01.87573|2017-10-10 21:32:01.87573
NCT02992067|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-09-07|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|April 2017|Actual|2017-04-01||Observational|CK-CEUS||CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer|CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer|Completed||N/A|389|Actual|Zhejiang Cancer Hospital|||1||f||||t||||||Samples With DNA|"     peripheral blood   "|||2017-10-10 21:32:01.963648|2017-10-10 21:32:01.963648
NCT02992054|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-12-09|||December 2010||2010-12-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Observational|KODRO||An Innovative Occupational Program Using New Technologies (KODRO) Life of Nursing|Randomized Controlled Trial for Assessing the Effects Resulting From an Innovative Occupational Program Using New Technologies (KODRO) on Nursing Home Residents' Quality of Life (Pilot Study)|Terminated||N/A|239|Actual|University Hospital, Montpellier|||2|The number of patients were enough for statistic treatment|f||||f||||||||No||2017-10-10 21:32:02.042888|2017-10-10 21:32:02.042888
NCT02992041|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|||Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectomy|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Dose Finding Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectal Surgery|Recruiting||Phase 2|90|Anticipated|Vivozon, Inc.||3|||f||||f||||||||||2017-10-10 21:32:02.138378|2017-10-10 21:32:02.138378
NCT02992028|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-10|||December 2016||2016-12-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|VITCRCR||Postoperative Pain After Intravenous Vitamin C Injection for Arthroscopic Rotator Cuff Repair|Randomized Placebo Controlled Trial of Postoperative Pain After Intravenous Vitamin C Injection for Arthroscopic Rotator Cuff Repair|Recruiting||Phase 4|54|Anticipated|Himchan Hospital||2|||f||||f||||||||||2017-10-10 21:32:02.238392|2017-10-10 21:32:02.238392
NCT02992015|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-15|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma|A Clinical Trial Trial of Gemcitabine in Children With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)|Recruiting||Early Phase 1|10|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-10 21:32:02.32851|2017-10-10 21:32:02.32851
NCT02992002|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-05-18|||December 2016||2016-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Influence of Fluid Challenge on End-Expiratory Lung Impedance in Mechanically Ventilated Patients Monitored With Electrical Impedance Tomography|Influence of Fluid Challenge on End-Expiratory Lung Impedance in Mechanically Ventilated Patients Monitored With Electrical Impedance Tomography|Recruiting||N/A|25|Anticipated|University of Schleswig-Holstein|||1||f||||f||||||||No||2017-10-10 21:32:02.419808|2017-10-10 21:32:02.419808
NCT02991989|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Does Exercise Snacking Improve Muscle Function in Older Adults?|Does Exercise Snacking Improve Muscle Function in Older Adults?|Recruiting||N/A|40|Anticipated|University of Bath||2|||f||||f||||||||No|Individual participant data will not be shared with other researchers|2017-10-10 21:32:02.490938|2017-10-10 21:32:02.490938
NCT02991976|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-21|||November 2016||2016-11-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Oxygen Concentration and Recovery After Carotid Endarterectomy|Effects of High Inspiratory Oxygen on Cerebral Tissue Oxygenation and Patient Recovery After Carotid Endarterectomy|Completed||N/A|80|Actual|Osijek University Hospital||2|||f||||f||||||||||2017-10-10 21:32:02.58226|2017-10-10 21:32:02.58226
NCT02991807|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-07-18|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome (PTEN)|A Randomized Double-Blind Controlled Trial of Everolimus in Children and Adolescents With PTEN Mutations (RAD001XUS257T)|Recruiting||Phase 1/Phase 2|40|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f||||||||2017-10-10 21:32:04.086726|2017-10-10 21:32:04.086726
NCT02991963|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-19|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Epidemiology of Malaria in Ubon Ratchathani, Thailand|Epidemiology of Malaria in Ubon Ratchathani, Thailand: a Case-control Study|Recruiting||N/A|660|Anticipated|University of Oxford|||2||f||||f||||||Samples Without DNA|"     1. Dried Blood Spot             -  To extract information on a broad variety of genetic variations.             -  To analyse for P. falciparum multi-drug resistance gene (MDR) copy number as a               marker of mefloquine resistance, as well as for merozoite surface protein (MSP),               glutamate rich protein (GLURP) and other markers to compare with follow-up samples               to identify relapses and recrudescences.        2. Venous Blood for parasite culture and in vitro drug sensitivity, cryopreservation of          parasites, malaria immunological tests, antimalarial pharmacokinetics, ultrasensitive          Plasmodium PCR and whole genome sequencing   "|Yes|According to Mahidol-Oxford Tropical Medicine Research Unit policy|2017-10-10 21:32:02.769855|2017-10-10 21:32:02.769855
NCT02991950|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-13|||July 2011||2011-07-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial|Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial|Terminated||Phase 3|271|Actual|Istituto Clinico Humanitas||2||Difficulty with patient enrollment|f||||t||||||||No||2017-10-10 21:32:02.87525|2017-10-10 21:32:02.87525
NCT02991937|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|May 2020|Anticipated|2020-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children|Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children|Recruiting||N/A|190|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 21:32:02.955818|2017-10-10 21:32:02.955818
NCT02991924|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-09|||July 2016||2016-07-01|December 2016|2016-12-01|July 2026|Anticipated|2026-07-01|July 2019|Anticipated|2019-07-01|7 Years|Observational [Patient Registry]|||Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer|Risk Factors of Medistinal Metastasis in Endoscopic Medistinal Staging of Non-small Cell Lung Cancer|Recruiting||N/A|600|Anticipated|National Cancer Center, Korea|||1||f||||t||||||||No||2017-10-10 21:32:03.053381|2017-10-10 21:32:03.053381
NCT02991911|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-09-26|||January 6, 2017|Actual|2017-01-06|September 2017|2017-09-01|July 29, 2021|Anticipated|2021-07-29|July 29, 2021|Anticipated|2021-07-29||Interventional|MEDI3726||A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer|A Phase 1/1b Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI3726 in Subjects With Metastatic Castration Resistant Prostate Cancer Who Have Received Prior Treatment With Abiraterone or Enzalutamide|Recruiting||Phase 1|224|Anticipated|MedImmune LLC||3|||f||||f|t|f||||||||2017-10-10 21:32:03.136144|2017-10-10 21:32:03.136144
NCT02991898|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-10-04|||February 16, 2017|Actual|2017-02-16|September 2017|2017-09-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Interventional|||Treg Cell With IL-2 to Suppress aGVHD Umbilical Cord Blood Transplantation|Adoptive Transfer of T Regulatory Cell With IL-2 Support for Suppression of Acute Graft-vs- Host-Disease After a Double Umbilical Cord Blood Transplant for Hematologic Malignancies|Recruiting||Phase 2|10|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f||||||||2017-10-10 21:32:03.264665|2017-10-10 21:32:03.264665
NCT02991885|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-08-31|||December 2016||2016-12-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||HAL-MPE1 Safety and Tolerability Study|A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy|Recruiting||Phase 1|42|Anticipated|HAL Allergy||2|||f||||t||||||||||2017-10-10 21:32:03.39751|2017-10-10 21:32:03.39751
NCT02991872|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-04-10|||December 16, 2016|Actual|2016-12-16|April 2017|2017-04-01|March 12, 2017|Actual|2017-03-12|March 12, 2017|Actual|2017-03-12||Interventional|||A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children|A Phase IV, Open Label, Single-center Extension Study, to Evaluate the Long-term Persistence of Immune Responses After Post-exposure Prophylaxis With Purified Chicken-embryo Cell Rabies Vaccine in Chinese Children|Completed||Phase 4|150|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 21:32:03.524549|2017-10-10 21:32:03.524549
NCT02991859|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-09-18|||February 9, 2017|Actual|2017-02-09|September 2017|2017-09-01|August 27, 2018|Anticipated|2018-08-27|August 27, 2018|Anticipated|2018-08-27||Interventional|||Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects|An Escalating Dose, Randomized, Placebo-controlled, Incomplete-block, 2-period Cross-over Study to Assess the Dose Response for Topical Efficacy Via Airway Responsiveness to Adenosine-5'-Monophosphate (AMP) Challenge and the Dose Response for Systemic Activity Via 24 Hour (h) Plasma Cortisol Suppression and Thereby the Relative Therapeutic Index for Fluticasone Furoate (FF), Fluticasone Propionate (FP) and Budesonide (BUD) in Asthmatic Subjects|Recruiting||Phase 2|48|Anticipated|GlaxoSmithKline||12|||f||||f|f|f||||||||2017-10-10 21:32:03.607742|2017-10-10 21:32:03.607742
NCT02991846|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|GITMO-GVCrOSy||A Prospective Observational Study for Evaluating CGVHD|A Prospective Observational Study for Evaluating Incidence, Severity and Outcomes of Chronic Graft-versus-Host Disease According to 2015 NIH Consensus Criteria|Not yet recruiting||N/A|500|Anticipated|Gruppo Italiano Trapianto di Midollo Osseo|||1||f||||f||||||||||2017-10-10 21:32:03.743457|2017-10-10 21:32:03.743457
NCT02991833|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-13|||November 2014||2014-11-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||Developing Of A New Incontinence Care Product|"Developing Of A New Incontinence Care Product, And Investigation Of The Effect Of Its On Perineal Dermatitis in Woman Patients With Urinary And Fecal Incontinence"|Completed||Early Phase 1|12|Actual|Ege University||2|||f||||f||||||||Yes|Patients were observed and evaluated daily during the morning care between 08:00 AM - 8:30 AM for a maximum 7 daysThe visual scale contrived by (Fader et al.(2003) which is based on International Contact Dermatit Score, was used for graded the severity of IAD. Scoring is is 0-to 4 and when scoring is increased the severity of the IAD increased. Scoring is is 0-to 4 and when scoring is increased the severity of the IAD increased.|2017-10-10 21:32:03.930669|2017-10-10 21:32:03.930669
NCT02991794|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-06-28|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Observational|PROSTEVIS||Prostatectomies Using Einstein Vision® 3D|Prospective, Multi-centre, Non-interventional Trial on Laparoscopic Radical PROSTatectomies Using EinsteinVISion® 3D Visualization System|Recruiting||N/A|180|Anticipated|Aesculap AG|||1||f||||f||||||||No||2017-10-10 21:32:04.224405|2017-10-10 21:32:04.224405
NCT02991781|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-12-09|||January 2017||2017-01-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation|Multidisciplinary Tools for Improving the Efficacy of Public Prevention Measures Against Smoking|Not yet recruiting||N/A|140|Anticipated|Aristotle University Of Thessaloniki||3|||f||||f||||||||Yes|"Individual Patient Data (IPD) will be shared after obtaining the consent of the participants. The consent form will inform the participants for this attribute of the data.
The repository will be based on popular open source software (CKAN) and it'll be accessible through a portal (endpoint) at the following address:
ckan.smokefreebrain.org CKAN is a powerful data management system that makes data accessible - by providing tools to streamline publishing, sharing, finding and using data. CKAN is aimed at data publishers (national and regional governments, companies and organizations) wanting to make their data open and available."|2017-10-10 21:32:04.485255|2017-10-10 21:32:04.485255
NCT02991768|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-03-27|||January 27, 2017|Actual|2017-01-27|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients|Budesonide for Mycophenolic Acid (MPA)-Induced Diarrhea in Renal Transplant Recipients|Recruiting||Phase 2|30|Anticipated|University of Kansas Medical Center||2|||f||||f|t|f|||f|||||2017-10-10 21:32:04.621021|2017-10-10 21:32:04.621021
NCT02991755|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-08-17|||October 2015||2015-10-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|April 2016|Actual|2016-04-01||Interventional|||Use of 5-0 Prolene Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure|Use of 5-0 Prolene Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure|Active, not recruiting||N/A|50|Actual|University of California, Davis||2|||f||||||||||||||2017-10-10 21:32:04.741569|2017-10-10 21:32:04.741569
NCT02991742|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|November 2020|Anticipated|2020-11-01|December 2016|Actual|2016-12-01||Observational|IDPC||Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial)|Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients After Diagnostic and Therapeutic Cardiac Catheterization (IDPC Trial)|Not yet recruiting||N/A|2262|Anticipated|Instituto Dante Pazzanese de Cardiologia|||2||f||||t||||||||Undecided||2017-10-10 21:32:04.819568|2017-10-10 21:32:04.819568
NCT02991729|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-05-07|||January 20, 2017|Actual|2017-01-20|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DAAS||Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening|Use of a Novel Decision Aid for Prenatal Aneuploidy Screening|Recruiting||N/A|184|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||No|Individual participant data will not be shared with other researchers.|2017-10-10 21:32:04.910908|2017-10-10 21:32:04.910908
NCT02991716|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-09-14|||January 2016||2016-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|||Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development|Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development|Enrolling by invitation||N/A|100|Anticipated|NewPace Ltd|||1||f||||f||||||||||2017-10-10 21:32:05.032312|2017-10-10 21:32:05.032312
NCT02991703|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|EPIPOP||Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children||Not yet recruiting||N/A|60|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-10 21:32:05.139187|2017-10-10 21:32:05.139187
NCT02991690|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-03|||May 31, 2017|Actual|2017-05-31|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Systemic Hypothermia in Acute Cervical Spinal Cord Injury|Systemic Hypothermia in Acute Cervical Spinal Cord Injury - A Prospective, Multi-center Case Controlled Study|Recruiting||N/A|120|Anticipated|University of Miami||2|||f||||t|f|f||||||||2017-10-10 21:32:05.250101|2017-10-10 21:32:05.250101
NCT02991677|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-07-13|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Exercise Effect on Chemotherapy-Induced Neuropathic Pain|Exercise Effect on Chemotherapy-Induced Neuropathic Pain, Peripheral Nerve Fibers|Not yet recruiting||N/A|60|Anticipated|Baltimore VA Medical Center||3|||f||||t|f|f||||||||2017-10-10 21:32:05.376638|2017-10-10 21:32:05.376638
NCT02991664|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2016-12-10|||December 2015||2015-12-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Performance of a Glass-ionomer Restorative System in Extended-sized Cavities|Randomized, Controlled Trial of Glass Ionomer System vs Composite Posterior Restorations in Extended Sized Class 2 Cavities|Enrolling by invitation||N/A|50|Actual|Hacettepe University||2|||f||||t||||||||No||2017-10-10 21:32:05.464229|2017-10-10 21:32:05.464229
NCT02991651|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-09|||May 2016||2016-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC|A Phase I Study of IRX4204 in Combination With Erlotinib in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer|Recruiting||Phase 1|12|Anticipated|Io Therapeutics||3|||f||||f||||||||No||2017-10-10 21:32:05.574329|2017-10-10 21:32:05.574329
NCT02991638|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers|Efficacy and Safety of Ibrutinib in Patients With Chronic Lymphocytic Leukemia and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers|Recruiting||Phase 3|62|Anticipated|The University of Hong Kong||1|||f||||f||||||||Undecided||2017-10-10 21:32:05.698915|2017-10-10 21:32:05.698915
NCT02991625|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-09|||January 2017||2017-01-01|December 2016|2016-12-01|January 2035|Anticipated|2035-01-01|January 2027|Anticipated|2027-01-01||Interventional|||Brain Imaging Study on Biomarkers for Chronic Back Pain|Brain Imaging Study on Biomarkers for Chronic Back Pain|Not yet recruiting||N/A|250|Anticipated|Nova Scotia Health Authority||3|||f||||f||||||||Undecided||2017-10-10 21:32:05.826432|2017-10-10 21:32:05.826432
NCT02991612|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2017-08-16|||December 2016||2016-12-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|RFXM||Rifaximin in Patients With Gastroesophageal Variceal Bleeding|Efficacy of Rafiximin in Patients With Cirrhotic Gastroesophageal Variceal Hemorrhage: A Single-center Pilot Study|Recruiting||N/A|60|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 21:32:05.931992|2017-10-10 21:32:05.931992
NCT02991599|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-10|2016-12-10|||October 2014||2014-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients|Immunogenicity and Persistence of Intramuscular High Dose Recombinant Hepatitis B Vaccine in Methadone Maintenance Treatment Patients in China: a Randomized Controlled Trial|Active, not recruiting||Phase 4|196|Actual|Shanxi Medical University||2|||f||||f||||||||||2017-10-10 21:32:06.051068|2017-10-10 21:32:06.051068
NCT02991586|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-12-09|||May 2016||2016-05-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|May 2018|Anticipated|2018-05-01||Interventional|FAL||Effectiveness Study of a Dialectical Behavioral Treatment for Families of Adolescents With Emotional Instability|Effectiveness Study of a Dialectical Behavioral Treatment for Families of Adolescents With Emotional Instability|Recruiting||N/A|40|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||No||2017-10-10 21:32:06.167814|2017-10-10 21:32:06.167814
NCT02991573|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-05-10|||November 2015||2015-11-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Interventional|||Clinical Study Class II on Ceram.x Universal and Prime&Bond|Clinical Post-Market Surveillance Study of Ceram.x Universal and Prime&Bond Universal When Used for Class II Restorations at the University of Sheffield|Active, not recruiting||N/A|81|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||3|||f||||f||||||||No||2017-10-10 21:32:06.266701|2017-10-10 21:32:06.266701
NCT02991560|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-12|||March 2010||2010-03-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Various Taping Techniques in Lateral Epicondylitis on Functional and Ultrasonographic Outcomes|Effects of Various Taping Techniques in Lateral Epicondylitis Administered in Addition to an Intensive Physiotherapy Program on Functional and Ultrasonographic Outcomes: a Double-blind, Randomized Controlled Study|Completed||N/A|25|Actual|Hacettepe University||2|||f||||t||||||||No||2017-10-10 21:32:06.367325|2017-10-10 21:32:06.367325
NCT02991547|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Observational|SAGE||Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus|Study on Outcomes of Active Surveillance Among Invasive Locoregional Adenocarcinoma of Esophagus and Gastroesophageal Junction (GEJ) With Complete Response After Neoadjuvant Combined Chemoradiotherapy|Recruiting||N/A|31|Anticipated|The Guthrie Clinic|||1||f||||f||||||||No||2017-10-10 21:32:06.465328|2017-10-10 21:32:06.465328
NCT02991534|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-07-07|||November 15, 2016|Actual|2016-11-15|July 2017|2017-07-01|September 30, 2020|Anticipated|2020-09-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Cardiovascular Risk Screening and Risk Reduction in Women Vets|Facilitating Cardiovascular Risk Screening and Risk Reduction in Women Veterans (QUE 15-272)|Recruiting||N/A|260|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 21:32:06.600133|2017-10-10 21:32:06.600133
NCT02991521|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study to Improve the FAST Ultrasound Exam|Can we be FASTeR? A Multicenter Study Utilizing Right Sided Roll to Improve Sensitivity of the FAST Examination|Not yet recruiting||N/A|2500|Anticipated|The Guthrie Clinic||1|||f||||f||||||||No||2017-10-10 21:32:06.738414|2017-10-10 21:32:06.738414
NCT02991508|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-03-13|||May 23, 2016|Actual|2016-05-23|March 2017|2017-03-01|September 22, 2016|Actual|2016-09-22|September 22, 2016|Actual|2016-09-22||Interventional|||Adrecizumab Phase 1 Trial|A Randomized Double-blind Placebo-controlled Phase 1 Study on the Safety, Tolerability and Pharmacokinetics/-Dynamics of Escalating Single Intravenous Doses of ADRECIZUMAB (HAM8101) in Healthy Male Subjects|Completed||Phase 1|24|Actual|Radboud University||4|||f||||t||||||||Undecided||2017-10-10 21:32:06.812513|2017-10-10 21:32:06.812513
NCT02991495|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-09-01|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Interventional|YEFE||Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)|A Randomized, Blinded Non-inferiority Trial on the Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines in Kenya and Uganda|Not yet recruiting||Phase 4|960|Anticipated|Epicentre||8|||f||||t|f|f||||||||2017-10-10 21:32:06.89323|2017-10-10 21:32:06.89323
NCT02991482|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-07-28|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PROMISE-meso||PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma|A Multicentre Randomised Phase III Trial Comparing Pembrolizumab Versus Standard Chemotherapy for Advanced Pre-treated Malignant Pleural Mesothelioma|Not yet recruiting||Phase 3|142|Anticipated|European Thoracic Oncology Platform||2|||f||||t|f|f||||||||2017-10-10 21:32:07.010301|2017-10-10 21:32:07.010301
NCT02991443|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|Mindful||Mindfulness Based Stress Reduction for Parents of Children With IBD|The Effect of Mindfulness Based Stress Reduction on Parents of Children With Inflammatory Bowel Disease|Recruiting||N/A|30|Anticipated|Schneider Children's Medical Center, Israel||1|||f||||f||||||||No||2017-10-10 21:32:07.582569|2017-10-10 21:32:07.582569
NCT02991430|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2017-08-08|||June 30, 2017|Actual|2017-06-30|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache|A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache|Recruiting||N/A|120|Anticipated|Scion NeuroStim||2|||f||||f|f|t|t|f||||||2017-10-10 21:32:07.684531|2017-10-10 21:32:07.684531
NCT02991417|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-07-24|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|June 8, 2017|Actual|2017-06-08|March 14, 2017|Actual|2017-03-14||Interventional|CDVAX||Oral Vaccination Against Clostridium Difficile Infection|Safety and Immunogenicity Study of a Clostridium Difficile Vaccine in Healthy Adult Volunteers|Terminated||Phase 1|3|Actual|Royal Holloway University||1|||f||||||||||||||2017-10-10 21:32:07.852957|2017-10-10 21:32:07.852957
NCT02991404|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-03-06|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty|Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty|Recruiting||Early Phase 1|60|Anticipated|Wake Forest University Health Sciences||2|||f||||t|t|f||||||No||2017-10-10 21:32:07.930097|2017-10-10 21:32:07.930097
NCT02991391|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-12-09|||January 2015||2015-01-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys|Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys|Completed||N/A|40690|Actual|Duke University|||1||f||||f||||||||Yes|Through respective state's BRFSS|2017-10-10 21:32:08.058554|2017-10-10 21:32:08.058554
NCT02991378|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-12|||January 2017||2017-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Early Intervention Skills for Preschool Children With Emotional and Stress Related Disorders|Early Intervention Skills for Preschool Children With Emotional and Stress Related Disorders|Not yet recruiting||N/A|1000|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:32:08.162116|2017-10-10 21:32:08.162116
NCT02991365|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Weight Loss on Brain Insulin Sensitivity in Humans|Effekt Von Gewichtsabnahme Auf Die zentralnervöse Insulinresistenz Des Menschen|Recruiting||N/A|40|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||No||2017-10-10 21:32:08.287139|2017-10-10 21:32:08.287139
NCT02991352|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-09-20|||March 21, 2017|Actual|2017-03-21|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SIGVaM||Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study|Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study|Enrolling by invitation||N/A|10|Anticipated|University Hospital Inselspital, Berne||1|||f||||f|f|f||||||||2017-10-10 21:32:08.414074|2017-10-10 21:32:08.414074
NCT02991339|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-12|||June 2016||2016-06-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effects of Dexamethasone Administration on Jaundice Following Liver Resection|The Effects of Dexamethasone Administration on Jaundice Following Liver Resection: a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|76|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||No||2017-10-10 21:32:08.510631|2017-10-10 21:32:08.510631
NCT02991326|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-12|||April 2016||2016-04-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Osteopathic Manipulative Treatment in Individuals With Temporomandibular Disorder Who Make Use of Occlusal Splints|Osteopathic Manipulative Treatment Effect in Individuals With Temporomandibular Disorder Who Make Use of Occlusal Splints|Recruiting||N/A|18|Anticipated|Universidade Federal Fluminense||2|||f||||f||||||||Undecided||2017-10-10 21:32:08.632095|2017-10-10 21:32:08.632095
NCT02991313|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-06-27|||October 1, 2016|Actual|2016-10-01|June 2017|2017-06-01|November 1, 2018|Anticipated|2018-11-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Evaluation of a Multi-electrode Linear Type Catheter (D-1368-01-SI)|Evaluation of a Multi-electrode Linear Type Catheter (D-1368-01-SI) for Endocardial Ablation of Patients With Persistent Atrial Fibrillation (LME-167)|Recruiting||N/A|40|Anticipated|Biosense Webster, Inc.||1|||f|||||f|f||||||||2017-10-10 21:32:08.729867|2017-10-10 21:32:08.729867
NCT02991300|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||September 2016||2016-09-01|December 2016|2016-12-01||||December 2022|Anticipated|2022-12-01|5 Years|Observational [Patient Registry]|||BioPoly® RS Partial Resurfacing Patella Registry Study|Open Label, Prospective, Consecutive Series Registry Database of BioPoly® RS Partial Resurfacing Patella Implant|Recruiting||N/A|35|Anticipated|BioPoly LLC|||1||f||||||||||||No||2017-10-10 21:32:08.838877|2017-10-10 21:32:08.838877
NCT02991287|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-09|||February 2017||2017-02-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Observational|||Validation of Predictive Scale of Chronic Postsurgical Pain|Prospective External Validation of a Predictive Scale of Chronic Postsurgical Pain|Not yet recruiting||N/A|1040|Anticipated|Parc de Salut Mar|||1||f||||f||||||||||2017-10-10 21:32:08.927292|2017-10-10 21:32:08.927292
NCT02991274|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-09-11|||January 16, 2017|Actual|2017-01-16|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central Laboratory|A Study of T790M Mutation Testing in Patient Tissue and Blood With Various Detection Platforms at Hospital Laboratories in Comparison With Central Testing|Recruiting||Phase 4|800|Anticipated|AstraZeneca||1|||f||||f|f|f||||||||2017-10-10 21:32:09.093457|2017-10-10 21:32:09.093457
NCT02991261|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-10-04|||February 6, 2017|Actual|2017-02-06|October 2017|2017-10-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers|"A Randomized, Open-Label, Single-Dose Bioavailability Study of SPARC001in Healthy, Adult Volunteers Under Fed and Fasted Conditions"|Completed||Phase 1|24|Anticipated|Sun Pharma Advanced Research Company Limited||4|||f|||||t|f||||||||2017-10-10 21:32:09.19519|2017-10-10 21:32:09.19519
NCT02991248|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-05-31|||December 30, 2017|Anticipated|2017-12-30|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Improve Dynamic Lateral Balance of Humans With SCI|Improve Dynamic Lateral Balance of Humans With SCI|Not yet recruiting||N/A|54|Anticipated|Shirley Ryan AbilityLab||3|||f||||t|f|f||||||Yes||2017-10-10 21:32:09.28628|2017-10-10 21:32:09.28628
NCT02991235|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease|Evaluation of the Efficacy and Safety of PRJ212 on Improving the Memory of Patients With Mild Severity Alzheimer's Disease: A 6-month Randomized, Double-blind and Placebo-controlled, Followed by a 6-month Open Label Extension Study|Recruiting||N/A|30|Anticipated|Bioiberica||2|||f||||f||||||||No||2017-10-10 21:32:09.369722|2017-10-10 21:32:09.369722
NCT02991222|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-10-04|||January 11, 2017|Actual|2017-01-11|October 2017|2017-10-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers|"A Randomized, Open-Label, Single-Dose Bioavailability Study of SPARC001 in Healthy, Adult Volunteers Under Fed and Fasted Conditions"|Completed||Phase 1|24|Actual|Sun Pharma Advanced Research Company Limited||4|||f||||f||||||||||2017-10-10 21:32:09.455552|2017-10-10 21:32:09.455552
NCT02991209|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-01-10|||November 2016||2016-11-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|Einstein||Study of Testosterone vs Placebo in Testicular Cancer Survivors|A Randomized Double-blind Study of Testosterone Replacement Therapy or Placebo in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency (Einstein-intervention)|Recruiting||Phase 2/Phase 3|70|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||No||2017-10-10 21:32:09.547006|2017-10-10 21:32:09.547006
NCT02991196|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-09-29|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|September 22, 2017|Actual|2017-09-22|September 22, 2017|Actual|2017-09-22||Interventional|||Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer|A Phase 1 Study of TRAIL-R2 (DR5) Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer|Terminated||Phase 1|4|Actual|Daiichi Sankyo, Inc.||1||Business Decision|f||||||||||||||2017-10-10 21:32:09.643168|2017-10-10 21:32:09.643168
NCT02991183|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-08-17|||February 17, 2017|Actual|2017-02-17|December 2016|2016-12-01|August 17, 2017|Actual|2017-08-17|April 21, 2017|Actual|2017-04-21||Interventional|||ACT for Carers of People With Dementia|A Feasibility Study of Acceptance and Commitment Therapy (ACT) to Promote the Wellbeing of Carers of People With Dementia|Completed||N/A|18|Actual|NHS Greater Glasgow and Clyde||1|||f||||f|f|f||||||||2017-10-10 21:32:09.744321|2017-10-10 21:32:09.744321
NCT02991170|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-09|||January 2015||2015-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RACAVA||Effect of Radiofrequency Ablation in Patients With Ventricular Arrhythmia Undergoing CABG|Impact of Radiofrequency Ablation Therapy in Coronary Artery Bypass Grafts Surgery on Outcomes in Patients With Myocardial Infarction Related Ventricular Arrhythmia|Recruiting||N/A|180|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:32:09.820639|2017-10-10 21:32:09.820639
NCT02991157|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-03-27|||December 2016||2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Noninvasive Assessment of Cerebral Oxygenation and Cardiac Function in Patients With Neurovascular Diseases|Noninvasive Assessment of Cerebral Oxygenation and Cardiac Function in Patients With Neurovascular Diseases|Recruiting||N/A|25|Anticipated|National Institute of Mental Health and Neuro Sciences, India|||1||f||||||||||||||2017-10-10 21:32:09.907862|2017-10-10 21:32:09.907862
NCT02991144|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-08-18|||January 2017||2017-01-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|CAPtivate||Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset OTC Deficiency|A Phase 1/2, Open-Label Safety and Dose-Finding Study of Adeno-Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Adults With Late-Onset OTC Deficiency|Recruiting||Phase 1/Phase 2|9|Anticipated|Dimension Therapeutics||3|||f||||t||||||||||2017-10-10 21:32:09.97638|2017-10-10 21:32:09.97638
NCT02991118|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|CLEAR Wisdom||Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk|A Long-term, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk Not Adequately Controlled by Their Lipid-Modifying Therapy|Recruiting||Phase 3|750|Anticipated|Esperion Therapeutics||2|||f||||t||||||||||2017-10-10 21:32:10.213983|2017-10-10 21:32:10.213983
NCT02991105|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-08|||August 2017||2017-08-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|EPCOT||Epidemiology of Cancer After Solid Organ Transplantation - EPCOT Study|Epidemiology of Cancer After Solid Organ Transplantation - EPCOT Study|Not yet recruiting||N/A|38490|Anticipated|University Hospital Birmingham NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 21:32:10.302923|2017-10-10 21:32:10.302923
NCT02991092|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-08|||November 2016||2016-11-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Influence of Different Fluid Therapy Measures on the Postoperative Outcome in Fast Track of Colon Cancer.（FTSlapCC)|The Influence of Different Fluid Therapy Measures on the Postoperative Outcome in Fast Track of Colon Cancer After Laparoscopic Surgery.|Active, not recruiting||N/A|150|Actual|First Hospital of Jilin University||2|||f||||t||||||||Undecided||2017-10-10 21:32:10.35986|2017-10-10 21:32:10.35986
NCT02991079|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-05-30|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Effectiveness of a Multifactorial Intervention to Improve Diet and Physical Activity in Diabetics From Primary Care|Effectiveness of a Multifactorial Intervention to Improve Diet and Physical Activity in Diabetic Patients From Primary Care: A Randomised Controlled Trial|Recruiting||N/A|200|Anticipated|Fundacion para la Investigacion y Formacion en Ciencias de la Salud||2|||f||||f|f|f||||||||2017-10-10 21:32:10.52608|2017-10-10 21:32:10.52608
NCT02991066|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-12-08|||October 2014||2014-10-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia|Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia|Recruiting||N/A|20|Anticipated|First Affiliated Hospital of Harbin Medical University|||2||f||||f||||||Samples Without DNA|"     Venous blood from patients with acute promyelocytic leukemia and from healthy volunteers is     collected into 0.119M sodium citrate Vacuum tubes. platelet-free plasma is prepared within 4h     using 2 serial centrifugations ( 15min at 1,500g, 2 min at 13,000g) and stored at -80℃ until     use. A portion of PFP was filtered through a 0.1-um-pore size filter to collect     microparticle-depleted plasma and stored at -80℃ until use. Experiments concerning     procoagulant activity are detected immediately after blood collection.   "|Yes||2017-10-10 21:32:10.620041|2017-10-10 21:32:10.620041
NCT02991053|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Transversus Abdominis Plane Block and Ilioinguinal / Iliohypogastric Nerve Block|Ultrasonography Guided Ilioinguinal /Iliohypogastric Block Versus Transversus Abdominis Plane Block in Intraoperative Anesthesia in Children - Randomized Controlled Study|Active, not recruiting||N/A|100|Anticipated|Erzincan University||5|||f||||f||||||||No||2017-10-10 21:32:10.713686|2017-10-10 21:32:10.713686
NCT02991040|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-23|||August 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:32:10.797035|2017-10-10 21:32:10.797035
NCT02991027|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||OCT Image Quality Performance Evaluation|OCT Image Quality Performance Evaluation|Enrolling by invitation||N/A|12|Anticipated|Topcon Medical Systems, Inc.||1|||f||||t||||||||No||2017-10-10 21:32:10.844075|2017-10-10 21:32:10.844075
NCT02991014|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|MINTREP||Music-based Intervention for the Reduction of Pain|Music-based Intervention for the Reduction of Pain and Stress in Healthy Adults|Recruiting||N/A|90|Anticipated|Philipps University Marburg Medical Center||3|||f||||f||||||||Undecided||2017-10-10 21:32:10.923894|2017-10-10 21:32:10.923894
NCT02991001|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-01-24|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Hydrodissection for Carpal Tunnel Syndrome|The Effect of Hydrodissection for Patients With Carpal Tunnel Syndrome|Recruiting||N/A|20|Anticipated|Tri-Service General Hospital||2|||f||||t|f|f||||||Yes||2017-10-10 21:32:11.027386|2017-10-10 21:32:11.027386
NCT02990988|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-03-20|||January 2017||2017-01-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Microbiome of Donor Iron Deficient Study|Microbiome of Donor Iron Deficient Study (DIDS)|Enrolling by invitation||N/A|60|Anticipated|Columbia University|||2||f||||f||||||Samples Without DNA|"     Stool collection   "|No||2017-10-10 21:32:11.13414|2017-10-10 21:32:11.13414
NCT02990975|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Transversus Abdominis Plane Block In Children|Effect of Ultrasonography Guided Transversus Abdominis Plane Block to Intraoperative Anesthesia in Children: Randomized Controlled Study|Active, not recruiting||N/A|60|Anticipated|Erzincan University||3|||f||||f||||||||No||2017-10-10 21:32:11.215398|2017-10-10 21:32:11.215398
NCT02990962|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Perineural Injection Therapy Versus Steroid in Patients With Carpal Tunnel Syndrome|The Long-term Effect of Perineural Injection Therapy Versus Steroid in Patients With Carpal Tunnel Syndrome|Recruiting||N/A|30|Anticipated|Tri-Service General Hospital||2|||f||||t||||||||Yes||2017-10-10 21:32:11.315663|2017-10-10 21:32:11.315663
NCT02990949|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-09|||November 2016||2016-11-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||The Impact of the Timing of Trigger on IVF Success|The Impact of the Timing of Trigger on IVF Success: Randomized Control Trial|Recruiting||N/A|100|Anticipated|Colorado Center for Reproductive Medicine||2|||f||||||||||||||2017-10-10 21:32:11.441969|2017-10-10 21:32:11.441969
NCT02990936|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-12-09|||January 2017||2017-01-01|December 2016|2016-12-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|TGV-PI||Prognostic Impact of Tumor Growth Velocity in Oropharyngeal Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy|Prognostic Impact of Tumor Growth Velocity in Oropharyngeal Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy|Not yet recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire Dinant Godinne - UCL Namur|||1||f||||f||||||Samples With DNA|"     Oropharynx biopsy   "|||2017-10-10 21:32:11.540487|2017-10-10 21:32:11.540487
NCT02990923|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||High-Flow Needleless Valve and DualCap Disinfection Devices Associate With Catheter-related Bloodstream Infection|The Effect of High-Flow Needleless Valve and DualCap Disinfection Devices on Incidence of Catheter-related Bloodstream Infection in Hemodialysis Patients: a Single Center Randomized Controlled Trial|Not yet recruiting||Phase 4|102|Anticipated|Peking University First Hospital||3|||f||||f||||||||||2017-10-10 21:32:11.653794|2017-10-10 21:32:11.653794
NCT02990910|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-09|2017-06-01||November 2016|Actual|2016-11-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Individualized Analgesia on Respiratory Adverse Events After Adenotonsillectomy|The Effect of Individualized Analgesia on Respiratory Adverse Events After Adenotonsillectomy in Children —Randomized Double-blind Controlled Trial|Completed||N/A|280|Actual|Children's Hospital of Fudan University|It is difficult to distinguish agitation or pain in children clinically，so this study did not assess the postoperative agitation .|2|||f||||f|f|f||||||||2017-10-10 21:32:11.745826|2017-10-10 21:32:11.745826
NCT02990897|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-07-12|||December 2015||2015-12-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2017|Actual|2017-01-01||Interventional|||Pilot Study of Health Information Technology for Chronic Kidney Disease Management|Pilot Study of Health Information Technology for Chronic Kidney Disease Management|Active, not recruiting||N/A|115|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 21:32:12.241128|2017-10-10 21:32:12.241128
NCT02990884|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Pediatric Ilioinguinal / Iliohyogogastric Nerve Block|Influence of Ultrasonography Guided Ilioinguinal / Iliohipogastric Block in Intraoperative Anesthesia in Children - Randomized Controlled Study|Active, not recruiting||N/A|60|Anticipated|Erzincan University||3|||f||||f||||||||No||2017-10-10 21:32:12.352414|2017-10-10 21:32:12.352414
NCT02990871|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-12-20|||May 2016||2016-05-01|December 2016|2016-12-01||||October 2016|Actual|2016-10-01||Observational|||Efficacy of an Early Rehabilitation on Decannulation Time of Patients With Severe Acquired Brain Injury||Active, not recruiting||N/A|80|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini|||2||f||||f||||||||||2017-10-10 21:32:12.457931|2017-10-10 21:32:12.457931
NCT02990858|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-08|||October 2016||2016-10-01|December 2016|2016-12-01||||December 2020|Anticipated|2020-12-01||Interventional|||An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 Study|An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 Study|Enrolling by invitation||Phase 2/Phase 3|30|Anticipated|CytoDyn, Inc.||1|||f||||t||||||||Undecided|TBD|2017-10-10 21:32:12.568887|2017-10-10 21:32:12.568887
NCT02990845|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PEER||Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer|A Pilot Study of Pembrolizumab and Exemestane/ Leuprolide in Premenopausal Hormone Receptor Positive/ HER2 Negative Locally Advanced or Metastatic Breast Cancer|Not yet recruiting||Phase 1/Phase 2|25|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-10 21:32:12.658923|2017-10-10 21:32:12.658923
NCT02990832|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|DFCCP-Exciton||Diabetes Foot Care Clinical Pathway Project - Exciton Technologies Inc||Not yet recruiting||N/A|70|Anticipated|University of Alberta||1|||f||||f||||||||No||2017-10-10 21:32:12.743602|2017-10-10 21:32:12.743602
NCT02990819|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-05-05|||December 2016||2016-12-01|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies|Phase II Study for Patients With Primary Immunodeficiencies Using and Cd19+ Depleted Unrelated Donor or Partially Matched Related Donor Peripheral Stem Cells|Recruiting||Phase 2|25|Anticipated|Children's Hospital of Philadelphia||2|||f||||t||||||||No||2017-10-10 21:32:12.816437|2017-10-10 21:32:12.816437
NCT02990806|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-03-03|||December 2016||2016-12-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)|A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis|Recruiting||Phase 3|585|Anticipated|Nichi-Iko Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-10 21:32:12.912899|2017-10-10 21:32:12.912899
NCT02990793|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-08-07|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|MeRT-TBI-005||Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Persistent Post-Concussive Symptoms (PPCS)|A Prospective, Double-Blind, Randomized, Sham-Controlled, Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment of Persistent Post-Concussive Symptoms (PPCS) Following Traumatic Brain Injury (TBI)|Recruiting||N/A|150|Anticipated|Newport Brain Research Laboratory||2|||f||||t|f|t|t|f||||||2017-10-10 21:32:13.096588|2017-10-10 21:32:13.096588
NCT02990780|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-09|||December 2015||2015-12-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC|Phase III Randomized Study of Induction Chemotherapy Followed By Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent Chemo-radiotherapy for Limited Stage Small Cell Lung Cancer.|Recruiting||Phase 3|266|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||No||2017-10-10 21:32:13.256821|2017-10-10 21:32:13.256821
NCT02990767|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-09|||June 2016||2016-06-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Observational|||Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester|Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester|Recruiting||N/A|1000|Anticipated|Shanghai First Maternity and Infant Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:32:13.353549|2017-10-10 21:32:13.353549
NCT02990754|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-08|||November 2016||2016-11-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|Fearless||Fearless Physical Activity: Getting and Keeping Ontarians With Congenital Heart Disease Active|Fearless Physical Activity: Getting and Keeping Ontarians With Congenital Heart Disease Active in Community Sport, Recreation and Physical Activity|Recruiting||N/A|760|Anticipated|Children's Hospital of Eastern Ontario||1|||f||||f||||||||No||2017-10-10 21:32:13.423523|2017-10-10 21:32:13.423523
NCT02990741|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|AF-CATCH||A Clinical Trial Screening for Atrial Fibrillation (AF-CATCH)|A Randomized Clinical Trial on Atrial Fibrillation Screening by Using an Automated Electrocardiogram System in an Elderly Chinese Population|Not yet recruiting||N/A|7000|Anticipated|Shanghai Jiao Tong University School of Medicine|||3||f||||t||||||||Undecided||2017-10-10 21:32:13.498222|2017-10-10 21:32:13.498222
NCT02990728|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-08|||March 2016||2016-03-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer|Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer|Enrolling by invitation||Phase 2|120|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-10 21:32:13.565575|2017-10-10 21:32:13.565575
NCT02990715|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-13|||November 2016||2016-11-01|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|September 10, 2017|Actual|2017-09-10||Interventional|||Evaluation of Check-Cap C-Scan System in Providing Structural Information and Detection of Polypoid Lesions|Evaluation of Check-Cap C-Scan System in Providing Structural Information and Detection of Polypoid Lesions|Completed||N/A|66|Actual|Ceck Cap Ltd.||2|||f||||||||||||||2017-10-10 21:32:13.631218|2017-10-10 21:32:13.631218
NCT02990702|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Retroclavicular Approach vs Infraclavicular Approach for Brachial Plexus Block in Obese Patients|Retroclavicular Approach vs Infraclavicular Approach for Brachial Plexus Block in Obese|Not yet recruiting||Phase 4|60|Anticipated|Kahramanmaras Sutcu Imam University||2|||f||||f||||||||No||2017-10-10 21:32:13.706332|2017-10-10 21:32:13.706332
NCT02990689|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-08|||March 2012||2012-03-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Study to Evaluate the Visual Performance of Three Multifocal IOLs||Completed||Phase 4|55|Actual|Carl Zeiss Meditec AG||3|||f||||f||||||||||2017-10-10 21:32:13.788868|2017-10-10 21:32:13.788868
NCT02990676|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-11|||January 25, 2017|Actual|2017-01-25|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|CogTrainHD||Exploring Computerised Cognitive Training for People With Huntington's Disease|Exploring Computerised Cognitive Training for People With Huntington's Disease|Recruiting||N/A|50|Anticipated|Cardiff University||2|||f||||f|f|f||||||||2017-10-10 21:32:13.847963|2017-10-10 21:32:13.847963
NCT02990663|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|February 2021|Anticipated|2021-02-01|May 2020|Anticipated|2020-05-01||Interventional|||The Effect of Antihypertensive Medication Timing on Morbidity and Mortality|"The Effect of Antihypertensive Medication Timing on Morbidity and Mortality: The BedMed RCT"|Enrolling by invitation||Phase 4|8750|Anticipated|University of Alberta||2|||f||||t||||||||Yes|Upon completion of all planned studies related to this project, anonymized patient level data for all outcomes and baseline characteristics will be made available in the form of a downloadable spreadsheet accessed through the Pragmatic Trials Collaborative's website (www.PragmaticTrials.ca)|2017-10-10 21:32:13.93751|2017-10-10 21:32:13.93751
NCT02990650|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2017-01-18|||October 2008||2008-10-01|October 2016|2016-10-01||||September 2013|Actual|2013-09-01||Interventional|||Outcomes Associated With Progressive Balance And Gait Training Using The KineAssist® Robot||Completed||Phase 1|36|Actual|University of Alabama at Birmingham||3|||f||||f||||||||||2017-10-10 21:32:14.02952|2017-10-10 21:32:14.02952
NCT02990637|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-05-09|||June 2016||2016-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||The Effect of Olive Leaf Extract Administration on Cardiovascular Health|The Effect of Olive Leaf Extract Administration on Cardiovascular Health|Completed||N/A|80|Actual|Maastricht University Medical Center||2|||f||||||||||||||2017-10-10 21:32:14.10335|2017-10-10 21:32:14.10335
NCT02990624|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-08|||April 2014||2014-04-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Cardiovascular Risk Evaluation in Psoriasis Treated With Photochemotherapy|Effect of Photochemotherapy on Cardiometabolic Markers in Patients With Psoriasis With and Without Atherosclerosis|Completed||N/A|65|Actual|Cairo University||3|||f||||t||||||||No||2017-10-10 21:32:14.174689|2017-10-10 21:32:14.174689
NCT02990611|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-10-03|||December 5, 2016|Actual|2016-12-05|October 2017|2017-10-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Observational|NICO||Real-Life Efficacy and Safety of Nivolumab Monotherapy or in Combination With Ipilimumab in Patients With Advanced (Unresectable or Metastatic) Melanoma|A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (BMS-936558) Monotherapy or In Combination With Ipilimumab In Patients With Advanced (Unresectable or Metastatic) Melanoma|Recruiting||N/A|700|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 21:32:14.249108|2017-10-10 21:32:14.249108
NCT02990598|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-04-12|||October 2016||2016-10-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Observational|HELPS||Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)|Hydoxyurea Exposure in Lactation: A Pharmacokinetics Study (HELPS)|Recruiting||N/A|20|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples Without DNA|"     1. To obtain blood, urine, and breastmilk samples for pharmacokinetics calculations using a     scheduled collection and analysis strategy. 2. To calculate distribution ratios for     hydroxyurea across compartments, especially plasma to milk; and 3. To create population PK     profiles for hydroxyurea to help calculate potential infant drug exposure   "|No||2017-10-10 21:32:14.360316|2017-10-10 21:32:14.360316
NCT02990585|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-05-09|||October 2016||2016-10-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Back School for Non-specific Low Back Pain (LBP) in an Urban Setting|The Effect of an 8-session Back School Versus a Single, Abbreviated Session When Looking at Non-specific Low Back Pain in an Urban Setting|Recruiting||N/A|50|Anticipated|Wayne State University||2|||f||||f||||||||No||2017-10-10 21:32:14.57243|2017-10-10 21:32:14.57243
NCT02990572|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-13|||October 2016||2016-10-01|December 2016|2016-12-01|December 2030|Anticipated|2030-12-01|December 2026|Anticipated|2026-12-01|100 Years|Observational [Patient Registry]|||Amish/Mennonite Research Contact Registry|Research Contact Registry for Members of the Amish and Mennonite Communities|Recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||f||||||||No||2017-10-10 21:32:14.682552|2017-10-10 21:32:14.682552
NCT02990559|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-09|2017-03-20|||January 2017||2017-01-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Neuroimaging of Donor Iron Deficient Study|Neuroimaging of Donor Iron Deficient Study (DIDS)|Enrolling by invitation||N/A|60|Anticipated|Columbia University|||2||f||||f||||||||No||2017-10-10 21:32:14.786798|2017-10-10 21:32:14.786798
NCT02990546|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-03-01|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01||||November 2018|Anticipated|2018-11-01||Interventional|||Midodrine in the Recovery Phase of Septic Shock|Midodrine Use in the Recovery Phase of Septic Shock|Recruiting||Phase 3|125|Anticipated|University of Virginia||2|||f||||t|t|f|||f|||No||2017-10-10 21:32:14.883259|2017-10-10 21:32:14.883259
NCT02990533|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-12-08|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|GRAMS||Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients|Translating Muscle Anabolic Strategies Into Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients|Recruiting||Phase 1|80|Anticipated|The University of Texas Medical Branch, Galveston||4|||f||||t||||||||Undecided||2017-10-10 21:32:14.994599|2017-10-10 21:32:14.994599
NCT02990520|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-12-08|||January 2015||2015-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|MASS||Prevalence of Malnutrition and/or Sarcopenia at Hospital Admission|Prevalence of Malnutrition and/or Sarcopenia at Hospital Admission|Recruiting||N/A|100|Anticipated|The University of Texas Medical Branch, Galveston|||1||f||||f||||||||No||2017-10-10 21:32:15.141823|2017-10-10 21:32:15.141823
NCT02990494|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|PROSPER||Prevention & Promotion in the Treatment of Obesity|Prevention & Promotion in the Treatment of Obesity|Not yet recruiting||N/A|90|Anticipated|The Miriam Hospital||3|||f||||||||||||||2017-10-10 21:32:15.349443|2017-10-10 21:32:15.349443
NCT02990481|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-06-14|||February 23, 2017|Actual|2017-02-23|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of TRK-950 in Patients With Advanced Solid Tumors|A Phase 1, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of TRK-950 Given Intravenously on a Weekly x3 Followed by One Week Off Schedule in Patients With Advanced Solid Tumors|Recruiting||Phase 1|38|Anticipated|Toray Industries, Inc||1|||f||||f|t|f||||||No||2017-10-10 21:32:15.443512|2017-10-10 21:32:15.443512
NCT02990468|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-05|||April 19, 2017|Actual|2017-04-19|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|BMX-HN||A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer|A Phase 1a-b Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer|Recruiting||Phase 1|66|Anticipated|BioMimetix JV, LLC||1|||f||||f|t|f||||||||2017-10-10 21:32:15.560104|2017-10-10 21:32:15.560104
NCT02990455|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-23|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|RedNic||Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder|Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder|Not yet recruiting||Phase 1|90|Anticipated|Battelle Memorial Institute||2|||f||||f|f|f||||||||2017-10-10 21:32:15.67242|2017-10-10 21:32:15.67242
NCT02990442|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-05-31|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Rapid Transcranial Magnetic Stimulation (rTMS) on Aggression in Forensic Patients|The Effect of Rapid Transcranial Magnetic Stimulation (rTMS) on Aggression in Forensic Patients|Not yet recruiting||Phase 2/Phase 3|10|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f|f|f||||||No||2017-10-10 21:32:15.783172|2017-10-10 21:32:15.783172
NCT02990429|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-06-29|||April 2016||2016-04-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Forced Air and Intravenous Fluid Warmers in Gynecologic Laparoscopic Surgery|Comparison Between Forced Air and Intravenous Fluid Warmers in Gynecologic Laparoscopic Surgery|Enrolling by invitation||N/A|90|Anticipated|Siriraj Hospital||2|||f||||t||||||||||2017-10-10 21:32:15.866984|2017-10-10 21:32:15.866984
NCT02990416|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma|Phase I/II Trial of the A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma|Not yet recruiting||Phase 1/Phase 2|63|Anticipated|Angimmune LLC||1|||f||||t||||||||Undecided||2017-10-10 21:32:15.975251|2017-10-10 21:32:15.975251
NCT02990403|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-03-06|||October 2014||2014-10-01|December 2016|2016-12-01|December 22, 2018|Anticipated|2018-12-22|June 10, 2017|Anticipated|2017-06-10||Interventional|||The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss|The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss|Recruiting||Phase 4|500|Anticipated|Shanghai First Maternity and Infant Hospital||5|||f||||||||||||||2017-10-10 21:32:16.079968|2017-10-10 21:32:16.079968
NCT02990390|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-13|||November 2016||2016-11-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||The Epidemiology of Recurrent Spontaneous Abortion Associated With Thrombophilla|Shanghai First Maternity and Infant Hospital|Recruiting||N/A|45000|Anticipated|Shanghai First Maternity and Infant Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:32:16.18855|2017-10-10 21:32:16.18855
NCT02990377|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|July 2020|Anticipated|2020-07-01||Interventional|||Reducing Non-Medical Opioid Use: An Automatically Adaptive mHealth Intervention|Reducing Non-Medical Opioid Use: An Automatically Adaptive mHealth Intervention|Not yet recruiting||N/A|600|Anticipated|University of Michigan||2|||f||||t||||||||No||2017-10-10 21:32:16.264404|2017-10-10 21:32:16.264404
NCT02990364|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-06-28|||December 2015||2015-12-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Combination Analgesia for Neonatal Circumcision|Analgesia for Neonatal Circumcision: A Randomized Controlled Clinical Trial of EMLA Versus Combination of EMLA, Sucrose and Dorsal Penile Nerve Block or Ring Block|Completed||Phase 3|70|Actual|American University of Beirut Medical Center||4|||f||||t||||||||No|"IPD will not be shared with researchers outside the scope of the approved list by the Institutional Review Board of the American University of Beirut.
Only aggregate and de-identified data will be shared."|2017-10-10 21:32:16.367654|2017-10-10 21:32:16.367654
NCT02990351|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-08|||December 2014||2014-12-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt|Loco-regional Treatment for HCC Patients|Completed||N/A|29|Actual|Ain Shams University|||1||f||||f||||||||Undecided||2017-10-10 21:32:16.455507|2017-10-10 21:32:16.455507
NCT02990325|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-10-04|||March 17, 2017|Actual|2017-03-17|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults|An Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of ABX464 in HIV-1 Seronegative and Seropositive Adults|Recruiting||Phase 1/Phase 2|36|Anticipated|Abivax S.A.||1|||f||||t|f|f||||||||2017-10-10 21:32:16.948104|2017-10-10 21:32:16.948104
NCT02990312|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-05-13|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients|The Effect of Sirolimus Plus Maraviroc on the Expression of Chemokine Receptor 5 (CCR5) and the HIV-1 Viral Reservoir in HIV-Infected Renal Transplant Recipients|Recruiting||Phase 4|15|Anticipated|University of Maryland||1|||f||||f|t|f|||f|||No||2017-10-10 21:32:17.068313|2017-10-10 21:32:17.068313
NCT02990299|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-05-01|||March 24, 2017|Actual|2017-03-24|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|February 2021|Anticipated|2021-02-01||Interventional|mDAS||mHealth for Diabetes Adherence Support|mHealth for Diabetes Adherence Support|Enrolling by invitation||N/A|240|Anticipated|University of Illinois at Chicago||2|||f||||t|f|f||||||No||2017-10-10 21:32:17.190812|2017-10-10 21:32:17.190812
NCT02990286|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-05-05|||January 20, 2017|Actual|2017-01-20|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|June 2020|Anticipated|2020-06-01||Interventional|EvER-ILD||Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases|Evaluation of Efficacy and Safety of Rituximab in Association With Mycophenolate Mofetil Versus Mycophenolate Mofetil Alone in Patients With Interstitial Lung Diseases (ILD) Non-responders to a First-line Immunosuppressive Treatment|Recruiting||Phase 3|122|Anticipated|University Hospital, Tours||2|||f||||t|f|f||||||No||2017-10-10 21:32:17.347888|2017-10-10 21:32:17.347888
NCT02990273|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures|The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures|Not yet recruiting||N/A|70|Anticipated|Li, Zhiping, M.D.||2|||f||||f||||||||Undecided||2017-10-10 21:32:17.529111|2017-10-10 21:32:17.529111
NCT02990260|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|HONEY||Effect of Saccharomyces Cerevisiae in LDL Cholesterol||Recruiting||N/A|201|Anticipated|Lesaffre International||3|||f||||f||||||||Undecided||2017-10-10 21:32:17.61669|2017-10-10 21:32:17.61669
NCT02990247|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-05-16|||November 14, 2016|Actual|2016-11-14|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|AsthmaDom||Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study|Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study|Recruiting||N/A|120|Anticipated|University Hospital, Bordeaux||1|||f||||t||||||||No||2017-10-10 21:32:17.747535|2017-10-10 21:32:17.747535
NCT02990234|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-08|||March 2014||2014-03-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Capsular Repair in FAI Impingement Surgery|The Efficacy of Capsular Repair in Arthroscopic Femoroacetabular|Active, not recruiting||N/A|23|Actual|University of Colorado, Denver||2|||f||||f||||||||No||2017-10-10 21:32:17.898843|2017-10-10 21:32:17.898843
NCT02990221|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-08-07|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy|A Randomized Study to Evaluate the Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization Compared to Cryotherapy|Recruiting||Phase 4|50|Anticipated|"University of Campania Luigi Vanvitelli"||2|||f||||t|f|f|||f|||||2017-10-10 21:32:18.010302|2017-10-10 21:32:18.010302
NCT02990208|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-07|||January 2014||2014-01-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia|Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia: Functional Coping Strategy or Avoidance Behavior? A Pilot Study|Completed||N/A|30|Actual|University of Regensburg||2|||f||||f||||||||No||2017-10-10 21:32:18.144537|2017-10-10 21:32:18.144537
NCT02990195|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|RESCUE||Restoring the Beneficial Effects of Enterohepatic Bile Salt Signalling by Chyme Reinfusion in Patients With a Double Enterostomy|Restoring the Beneficial Effects of Enterohepatic Bile Salt Signalling by Chyme Reinfusion in Patients With a Double Enterostomy|Recruiting||Phase 2|20|Anticipated|Rennes University Hospital||1|||f||||f||||||||No||2017-10-10 21:32:18.2509|2017-10-10 21:32:18.2509
NCT02990182|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-07-12|||April 2015||2015-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Observational|||Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children|Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in Children|Active, not recruiting||N/A|60|Actual|Oswaldo Cruz Foundation|||1||f||||f||||||Samples Without DNA|"     whole blood and plasma   "|||2017-10-10 21:32:19.926652|2017-10-10 21:32:19.926652
NCT02990169|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-15|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Evaluation of CATS Tonometer Prism||Recruiting||N/A|75|Anticipated|Intuor Technologies, Inc.||2|||f||||f||||||||||2017-10-10 21:32:20.041794|2017-10-10 21:32:20.041794
NCT02990156|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-08-28|||August 8, 2017|Actual|2017-08-08|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|CATCH||CATCH [Short Name for: Coil Application Trial in China]|Prospective, Randomized, Controlled, Open Label, All China, Multi-Center, Registration Trial of the MICROPORT NEUROTECH Coil Embolization System for the Traetment of Intracranial Aneurysms|Recruiting||N/A|336|Anticipated|MicroPort NeuroTech Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 21:32:20.125281|2017-10-10 21:32:20.125281
NCT02990143|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-07|||January 2014||2014-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7)|The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7)|Recruiting||Phase 2|40|Anticipated|The New York Eye & Ear Infirmary||2|||f||||f||||||||||2017-10-10 21:32:20.237568|2017-10-10 21:32:20.237568
NCT02990130|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-08|||November 2016||2016-11-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Observational|||Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation|Biochemical and Physiologic Factors That Affect Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation for Hematologic Malignancies|Recruiting||N/A|60|Anticipated|Garcia, Jose M., MD, PhD|||1||f||||f||||||||No||2017-10-10 21:32:20.313874|2017-10-10 21:32:20.313874
NCT02990117|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||ICS Treatment Compliance of Asthma Patients|An In-depth Understanding of Determinants of Inhaled ICS Treatment Compliance of Asthma Patients: Generate Data From Structured Patient Interview & Cross Sectional Survey|Not yet recruiting||N/A|350|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||1||f||||t||||||||Undecided||2017-10-10 21:32:20.394941|2017-10-10 21:32:20.394941
NCT02990104|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-07|||November 2016||2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|PR-GTLA||First Report, Five Years Experience of the Acute Leukemia Work Group|Diagnostic and Treatment in Acute Lymphoblastic Leukemia Adults: A Multicenter Study of Five Years Experience, Retrospective in Acute Lymphoblastic Leukemia Adults Patients, Mexico City: First Report of the Acute Leukemia Work Group (GTLA)|Recruiting||N/A|500|Anticipated|Mexican Agrupation for Hematology Study|||1||f||||t||||||||Undecided||2017-10-10 21:32:20.443763|2017-10-10 21:32:20.443763
NCT02990078|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-08-14|||December 2016||2016-12-01|August 2017|2017-08-01||||January 2025|Anticipated|2025-01-01||Observational|||Non-invasive Measurement of Cerebrovascular Reactivity After Traumatic Brain Injury|Cerebrovascular Reactivity Assessed With Functional Near-infrared Spectroscopy as a Biomarker of Traumatic Microvascular Injury After Moderate-severe Traumatic Brain Injury|Recruiting||N/A|168|Anticipated|University of Pennsylvania|||3||f||||f||||||||||2017-10-10 21:32:20.609783|2017-10-10 21:32:20.609783
NCT02990065|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|OPINiB||Optimizing Protein Intake and Nitrogen Balance in Adult Critically Ill Patients|Optimizing Protein Intake and Nitrogen Balance in Adult Critically Ill Patients: a Randomized Controlled Trial (OPINiB STUDY)|Not yet recruiting||N/A|38|Anticipated|University of Padova||2|||f||||||||||||||2017-10-10 21:32:20.708316|2017-10-10 21:32:20.708316
NCT02990052|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-12-09|||November 2008||2008-11-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2014|Actual|2014-01-01||Interventional|DRF||Conservative Treatment vs. Volar Plating of Distal Radius Fractures|Conservative Treatment vs. Volar Plating of Distal Radius Fractures in Patients Aged Over 50 Years Old: A Prospective Randomized Trial|Completed||N/A|80|Actual|University of Oulu||2|||f||||f||||||||Undecided||2017-10-10 21:32:20.779163|2017-10-10 21:32:20.779163
NCT02990039|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-12-07|||February 2015||2015-02-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Tailored Feasibility Study to Increase Physical Activity and to Reduce Sedentary Time|A Tailored Feasibility Study to Increase Physical Activity and to Reduce Sedentary Time|Completed||N/A|176|Actual|University Medicine Greifswald||2|||f||||f||||||||Undecided||2017-10-10 21:32:20.948457|2017-10-10 21:32:20.948457
NCT02990026|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|SMHP||Specialty Mental Health Probation in North Carolina|Specialty Mental Health Probation in North Carolina|Not yet recruiting||N/A|320|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:32:21.026508|2017-10-10 21:32:21.026508
NCT02990013|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-07|||December 2016||2016-12-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||AvenovaTM as a Sterile Skin Preparation Agent|Comparison of Antimicrobial, Antiviral and Antifungal Activity of AvenovaTM as a Sterile Skin Preparation in Humans|Not yet recruiting||Early Phase 1|30|Anticipated|University of Miami||1|||f||||t||||||||Yes|Requests can be e-mailed to Dr. Wendy Lee: WLee@med.miami.edu|2017-10-10 21:32:21.106909|2017-10-10 21:32:21.106909
NCT02990000|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-01-31|||December 2016||2016-12-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|June 2019|Anticipated|2019-06-01||Interventional|||Enhancing Mental Health Care by Scientifically Matching Patients to Providers' Strengths|Enhancing Mental Health Care by Scientifically Matching Patients to Providers' Strengths|Recruiting||N/A|308|Anticipated|University of Massachusetts, Amherst||2|||f||||t||||||||Yes|Awardees are expected to maintain the Full Data Package at their own institution for a period of at least seven (7) years following acceptance by PCORI of the final research report. During this period, PCORI may notify awardee of PCORI's intent to provide funds for sharing the Full Data Package either through an established repository or directly to a third party requestor. Reasons for such notification may include PCORI's estimation of high importance of and interest in study findings, request(s) from external researchers for data access, or the Awardee's expressed interest in sharing the data.|2017-10-10 21:32:21.217768|2017-10-10 21:32:21.217768
NCT02989987|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-07|||September 2016||2016-09-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|||NET for SGBV Survivors in Eastern DR Congo|Narrative Exposure Therapy for Survivors of Sexual and Gender Based Violence in Eastern DR Congo|Recruiting||N/A|160|Anticipated|University of Konstanz||2|||f||||f||||||||Undecided||2017-10-10 21:32:21.388407|2017-10-10 21:32:21.388407
NCT02989974|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-08-02|||February 10, 2017|Actual|2017-02-10|December 2016|2016-12-01|February 28, 2030|Anticipated|2030-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|KYLEADS-SC||Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program|Kentucky LEADS Lung Cancer Survivorship Care Program - Survivors and Caregivers|Recruiting||N/A|300|Anticipated|University of Kentucky||1|||f||||t|f|f||||||||2017-10-10 21:32:21.546814|2017-10-10 21:32:21.546814
NCT02989961|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-05-03|||November 15, 2013|Actual|2013-11-15|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy of Resticutis Compared to Platelet-Poor Plasma for Treating Diabetic Foot Ulcers|Autologous Intra-lesional Injection of Resticutis Compared to Platelet-Poor Plasma to Improve Healing of Wagner's Grade II/III Diabetic Foot Ulcers (Neuropathic/Neuro-Iscemic)|Active, not recruiting||Phase 1/Phase 2|20|Actual|University of Jordan||2|||f||||t||||||||No||2017-10-10 21:32:21.762063|2017-10-10 21:32:21.762063
NCT02989948|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-07|||January 2017||2017-01-01|December 2016|2016-12-01|September 2024|Anticipated|2024-09-01|June 2024|Anticipated|2024-06-01||Interventional|||Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA|Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal Aortic Aneurysms|Not yet recruiting||N/A|20|Anticipated|University of Colorado, Denver||1|||f||||t||||||||Undecided|No plan to share IPD exists at this time.|2017-10-10 21:32:21.886035|2017-10-10 21:32:21.886035
NCT02989935|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-07|||April 2016||2016-04-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD|RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD|Recruiting||Phase 4|30|Anticipated|University of Calgary||1|||f||||f||||||||Undecided||2017-10-10 21:32:22.06615|2017-10-10 21:32:22.06615
NCT02989922|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-25|||November 2016||2016-11-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study to Evaluate SHR-1210 in Subjects With Advanced HCC|A Randomized Controlled Multicentered Phase 2/3 Study to Evaluate SHR-1210 (PD-1 Antibody) in Subjects With Advanced Hepatocellular Carcinoma (HCC) Who Failed or Intolerable to Prior Systemic Treatment|Recruiting||Phase 2/Phase 3|220|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:32:22.19701|2017-10-10 21:32:22.19701
NCT02989909|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-15|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Evaluation of CATS Tonometer Prism|Clinical Evaluation of CATS Tonometer Prism|Recruiting||N/A|200|Anticipated|Intuor Technologies, Inc.||2|||f||||f||||||||||2017-10-10 21:32:22.371275|2017-10-10 21:32:22.371275
NCT02989896|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Perfusion Index in the Success of Peripheral Nerve Block|Evaluation of Perfusion Index in the Success of Peripheral Nerve Block in Advanced Age Patients|Active, not recruiting||N/A|120|Anticipated|Erzincan University|||1||f||||f||||||||||2017-10-10 21:32:22.455331|2017-10-10 21:32:22.455331
NCT02989883|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-08|||October 2016||2016-10-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Clinical Outcomes of Peroral Endoscopic Myotomy|Clinical Outcomes of Peroral Endoscopic Myotomy for Esophageal Outflow Obstruction|Recruiting||N/A|20|Anticipated|Asan Medical Center||1|||f||||t||||||||No||2017-10-10 21:32:22.521429|2017-10-10 21:32:22.521429
NCT02989870|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-08-18|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma|A Phase I Trial of Sorafenib and Bavituximab Plus Stereotactic Body Radiation Therapy (SBRT) for 1st Line Treatment of Unresectable Hepatocellular Carcinoma|Recruiting||Phase 1|18|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 21:32:22.607578|2017-10-10 21:32:22.607578
NCT02989857|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-27|||December 2016|Actual|2016-12-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|November 2019|Anticipated|2019-11-01||Interventional|ClarIDHy||Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of AG-120 in Previously-treated Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation|Recruiting||Phase 3|186|Anticipated|Agios Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 21:32:22.729406|2017-10-10 21:32:22.729406
NCT02989844|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-10-04|||April 12, 2017|Actual|2017-04-12|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||QUILT-3.035: Relapse Prophylaxis With ALT-803 for AML and MDS Pts Following Allo HSCT|QUILT-3.035: Relapse Prophylaxis With IL-15 Super Agonist ALT-803 in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome Following Allogeneic Stem Cell Transplantation|Recruiting||Phase 2|60|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f||||||||2017-10-10 21:32:22.977011|2017-10-10 21:32:22.977011
NCT02989831|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||April 2014||2014-04-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Random Vibrations on Perception and Balance|The Effects of Random Vibrations on the Vibratory Perception Threshold of the Foot and Standing Balance in People With Diabetic Neuropathy|Completed||N/A|40|Actual|University Medical Center Groningen||2|||f||||f||||||||No||2017-10-10 21:32:23.069911|2017-10-10 21:32:23.069911
NCT02989818|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||March 2016||2016-03-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Observational|||Multi-center Evaluation of the Clinical Utility of ESD in the Western Population|Multi-center Prospective Evaluation of the Clinical Utility of Endoscopic Submucosal Dissection (ESD) in the Western Population|Recruiting||N/A|300|Anticipated|University of Florida|||1||f||||f||||||||Undecided||2017-10-10 21:32:23.154881|2017-10-10 21:32:23.154881
NCT02989805|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-04-24|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|April 2021|Anticipated|2021-04-01||Interventional|EPIC||Engaging Patients With Mental Disorders From the ED in Outpatient Care|Engaging Patients With Mental Disorders From the ED in Outpatient Care: A Comparative Effectiveness Workforce Study of Peer Specialist vs. Professional Care Managers|Recruiting||N/A|1000|Anticipated|Emory University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:32:23.246564|2017-10-10 21:32:23.246564
NCT02989792|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-26|||February 8, 2017|Actual|2017-02-08|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Investigate the Genetic Variation of Dopamine Pathway in Patients With Chronic Pain|A Study to Investigate the Genetic Variation of Dopamine Pathway Associated With the Observed Effects of a New Treatment in Former Studies in Patients With Chronic Pain|Recruiting||N/A|100|Anticipated|Tools4Patient||1|||f||||f|f|f||||||||2017-10-10 21:32:23.353168|2017-10-10 21:32:23.353168
NCT02989779|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|AHIMSA-1||Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressive Behaviour|NK1 Antagonists for Pathological Aggression: A Protocol for Harmful, Impulsive, and Self-/Aggressive Behavior (AHIMSA-1) Trial|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||Yes|De-identified information will be shared with University Health Network, Toronto Western Hospital (UHN-TWH) for analysis, as a collaboration site.|2017-10-10 21:32:23.461209|2017-10-10 21:32:23.461209
NCT02989753|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-07-12|||January 2017||2017-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|Lipiback||Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia|Pilot Study to Assess Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia|Recruiting||Phase 1/Phase 2|40|Anticipated|Valbiotis||3|||f||||t||||||||||2017-10-10 21:32:23.703768|2017-10-10 21:32:23.703768
NCT02989740|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-15|||March 2015||2015-03-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|October 2018|Anticipated|2018-10-01|18 Months|Observational [Patient Registry]|COMBINE||Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients|Combined Optical Coherence Tomography Morphologic and Fractional Flow Reserve Hemodynamic Assessment of Non-Culprit Lesions to Better Predict Adverse Event Outcomes in Diabetes Mellitus Patients. COMBINE (OCT-FFR) Prospective Register|Recruiting||N/A|500|Anticipated|Diagram B.V.|||3||f||||f||||||||No||2017-10-10 21:32:23.89488|2017-10-10 21:32:23.89488
NCT02989727|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-10|||November 2003||2003-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|August 2005|Actual|2005-08-01||Interventional|||Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine|Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine: Results From an 8-week, Multicenter, Double-blind, Placebo-controlled Trial|Active, not recruiting||Phase 4|221|Actual|University of Saskatchewan||4|||f||||f||||||||Yes|Patient-level data for the study (GSK-SCA100223; NCT00274677) is available through www.clinicalstudydatarequest.com.|2017-10-10 21:32:24.072006|2017-10-10 21:32:24.072006
NCT02989714|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-02-22|||February 16, 2017|Actual|2017-02-16|February 2017|2017-02-01|May 16, 2022|Anticipated|2022-05-16|February 16, 2022|Anticipated|2022-02-16||Interventional|||Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer|Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer|Recruiting||Phase 1/Phase 2|23|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f||||||No||2017-10-10 21:32:24.171371|2017-10-10 21:32:24.171371
NCT02989701|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease|Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease|Recruiting||Phase 1|6|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-10 21:32:24.284587|2017-10-10 21:32:24.284587
NCT02989688|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-12-07|||January 2015||2015-01-01|January 2016|2016-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|GRO-HD||Glycaemic Response to Oral Nutrition Support During Haemodialysis|Glycaemic Response to Oral Nutrition Support During Haemodialysis|Completed||N/A|24|Actual|King's College Hospital NHS Trust||3|||f||||f||||||||No||2017-10-10 21:32:24.414509|2017-10-10 21:32:24.414509
NCT02989662|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-05-06|||February 2016||2016-02-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers|INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers|Recruiting||N/A|150|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-10 21:32:24.647302|2017-10-10 21:32:24.647302
NCT02989649|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-02-08|||December 2016||2016-12-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|||Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice|A Prospective, Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice|Recruiting||N/A|1199|Anticipated|Takeda|||1||f||||f||||||||||2017-10-10 21:32:24.774871|2017-10-10 21:32:24.774871
NCT02989623|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-01-20|||September 2015||2015-09-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA|A Pilot Phase I Open Label Study of Cu-64-TP3805 PET Imaging for Detection of Prostate Cancer in Men With Persistently Elevated PSA|Recruiting||N/A|20|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 21:32:25.025172|2017-10-10 21:32:25.025172
NCT02989610|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-04-24|||January 31, 2017|Actual|2017-01-31|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|June 2018|Anticipated|2018-06-01||Observational|PROGRESS||Clinical Evaluation of the Infinity DBS System|Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System|Recruiting||N/A|350|Anticipated|St. Jude Medical|||1||f||||f|f|f||||||No||2017-10-10 21:32:25.115574|2017-10-10 21:32:25.115574
NCT02989597|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-28|||July 29, 2017|Actual|2017-07-29|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|MAPS||Intraoperative Methadone Administration for Improved Pain Control in Spinal Fusion Patients|Single-dose Intraoperative Methadone for Early Ambulation and Sustained Pain Control in Spinal Fusion Surgery Patients|Recruiting||Phase 4|120|Anticipated|Montefiore Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 21:32:25.17969|2017-10-10 21:32:25.17969
NCT02989389|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-08-31|||December 12, 2016|Actual|2016-12-12|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of LY3323795 in Healthy Participants|Single-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3323795 in Healthy Subjects|Recruiting||Phase 1|66|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-10 21:32:26.87957|2017-10-10 21:32:26.87957
NCT02989584|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-04-24|||December 20, 2016||2016-12-20|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Pilot Safety Study of Atezolizumab Combination With Cisplatin + Gemcitabine in Pts With Metastatic Bladder Cancer|A Pilot Safety Study and Single Arm Phase II Study of Gemcitabine and Cisplatin With Atezolizumab (MPDL3280A) in Patients With Metastatic and Muscle Invasive Bladder Cancer, Respectively|Recruiting||Phase 1/Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:32:25.288574|2017-10-10 21:32:25.288574
NCT02989571|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-12-08|||November 2016||2016-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effects of Increased IV Hydration on Nulliparous Women Undergoing an Induction of Labor|A Double-Blinded Randomized Controlled Trial on the Effects of Increased Intravenous Hydration on Nulliparous Women Undergoing an Induction of Labor|Recruiting||Early Phase 1|200|Anticipated|MemorialCare Health System||2|||f||||f||||||||Undecided||2017-10-10 21:32:25.383298|2017-10-10 21:32:25.383298
NCT02989558|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-02-22|||December 2016||2016-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PTOLEMAIOS||A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI|A Prospective, Multicentre, Randomized, Open Label, Blinded Endpoint, Phase 3 Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During Transcatheter Aortic Valve Implantation (TAVI) OperationS - the PTOLEMAIOS Study.|Recruiting||Phase 3|90|Anticipated|University of Athens||2|||f||||f|f|f||||||No||2017-10-10 21:32:25.490365|2017-10-10 21:32:25.490365
NCT02989545|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||"The Use of an Anal-Tape in Patients With Fecal Incontinence"|"The Use of an Anal-Tape in Patients With Fecal Incontinence"|Enrolling by invitation||N/A|20|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-10 21:32:25.594197|2017-10-10 21:32:25.594197
NCT02989493|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-04-13|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Testing Doxazosin to Treat Stress Mechanisms in Alcoholism|Randomized Controlled Trial Targeting Noradrenergic Stress Mechanisms in Alcoholism With Doxazosin|Recruiting||Phase 2|136|Anticipated|University of Wisconsin, Madison||2|||f||||f|t|f|||f|||Yes|Data will be made available online upon study completion at the Open Science Framework: https://osf.io|2017-10-10 21:32:25.760316|2017-10-10 21:32:25.760316
NCT02989480|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-12-07|||August 2015||2015-08-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC|PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC - a Feasibility Study|Recruiting||N/A|20|Anticipated|University of Aberdeen|||2||f||||f||||||None Retained|"     ACE inhibitors and CRP will be measured.   "|No||2017-10-10 21:32:25.970895|2017-10-10 21:32:25.970895
NCT02989467|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying|A Single-Center, Placebo-Controlled, Double-Blind Study to Evaluate the Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying in Healthy Volunteers|Not yet recruiting||Phase 1|24|Anticipated|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-10 21:32:26.102086|2017-10-10 21:32:26.102086
NCT02989454|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-12-07|||August 2015||2015-08-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|HEROIC||Persistent Symptoms and Early Incomplete Recovery After Acute Stress-induced Cardiomyopathy: Is There Ongoing Heart Distress? The HEROIC Study|Persistent Symptoms and Early Incomplete Recovery After Acute Stress-induced Cardiomyopathy: Is There Ongoing Heart Distress? The HEROIC Study|Recruiting||N/A|25|Anticipated|University of Aberdeen|||1||f||||f||||||Samples With DNA|"     Samples for genetic analysis will be stored.   "|No||2017-10-10 21:32:26.239637|2017-10-10 21:32:26.239637
NCT02989441|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-12|||November 2016||2016-11-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Perfusion Index in Anesthesia|Peripheral Perfusion Index as Marker for Systemic Hemodynamics During Anesthesia|Recruiting||N/A|30|Anticipated|Hvidovre University Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:32:26.357684|2017-10-10 21:32:26.357684
NCT02989428|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-05-02|||February 3, 2017|Actual|2017-02-03|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Parathyroidectomy on Cardiovascular Health|Cardiovascular Health in Patients With Primary Hyperparathyroidism: Effect of Parathyroidectomy on Cardiovascular Health: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|University of Aarhus||2|||f||||f|f|f||||||No||2017-10-10 21:32:26.4435|2017-10-10 21:32:26.4435
NCT02989415|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-12|||May 2017||2017-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|AVATaR||Assessment of Ventilatory Management During General Anesthesia for Robotic Surgery|Assessment of Ventilatory Management During General Anesthesia for Robotic Surgery and Its Effects on Postoperative Pulmonary Complications: A Prospective Observational Multicenter Study|Not yet recruiting||N/A|500|Anticipated|Hospital Israelita Albert Einstein|||1||f||||f||||||||Yes|The data will be available for substudies suggested by members of the collaboration.|2017-10-10 21:32:26.576678|2017-10-10 21:32:26.576678
NCT02989402|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-10-04|||December 31, 2017|Anticipated|2017-12-31|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.|A Prospective, 16 Week, Phase IV Study to Evaluate Safety, Tolerability and Effectiveness in Patients With Severe Dementia of the Alzheimer's Type Exposed to Rivastigmine (Exelon)15cm2 Transdermal Patch|Not yet recruiting||Phase 4|102|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 21:32:26.771633|2017-10-10 21:32:26.771633
NCT02989376|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-07-27|||October 2016||2016-10-01|July 2017|2017-07-01||||January 2019|Anticipated|2019-01-01||Interventional|ECHO-SELECT||Carotid Duplex Ultrasound for Selecting Patients for Endovascular Thrombectomy in Acute Stroke Patients|Emergent Carotid Ultrasound in Hyperacute Cerebral Vessel Occlusion for Selecting Patients to be Treated With Endovascular Clot Retrieval Treatment|Recruiting||N/A|60|Anticipated|Kohnan Hospital||1|||f||||||||||||||2017-10-10 21:32:26.998891|2017-10-10 21:32:26.998891
NCT02989363|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-07|||October 2011||2011-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of the Use of Resources and Costs|Evaluation of the Use of Resources and Costs With O-arm in Brain Stimulation Deep Surgeries and Complex Back Surgeries|Recruiting||N/A|80|Anticipated|Instituto de Investigacion Sanitaria La Fe||4|||f||||f||||||||Undecided||2017-10-10 21:32:27.114488|2017-10-10 21:32:27.114488
NCT02989350|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-01-09|||January 2017||2017-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children|Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Randomised Controlled Trial|Recruiting||Phase 2/Phase 3|144|Anticipated|Szpital im. Św. Jadwigi Śląskiej||2|||f||||t||||||||Undecided||2017-10-10 21:32:27.272769|2017-10-10 21:32:27.272769
NCT02989337|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Endothelial Dysfunction in Hyperemesis Gravidarum|Endothelial Dysfunction in Hyperemesis Gravidarum|Recruiting||N/A|50|Anticipated|Kayseri Education and Research Hospital|||2||f||||||||||||||2017-10-10 21:32:27.386333|2017-10-10 21:32:27.386333
NCT02989324|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-28|||January 2016||2016-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Vaginal Misoprostol and Foley Catheter for Late Second Trimester Termination of Pregnancy|Vaginal Misoprostol Versus Combined Low Dose Vaginal Misoprostol Plus Foley Catheter for Late Second Trimester Termination of Pregnancy With Previous Multiple Cesarean Sections|Recruiting||Phase 2|100|Anticipated|Zagazig University||2|||f||||t||||||||||2017-10-10 21:32:27.473734|2017-10-10 21:32:27.473734
NCT02989311|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-10-03|||August 2016||2016-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Timing of Micronutrient Powder Consumption on Iron Absorption in Infants|Testing Iron Absorption From a New Micronutrient Powder Containing Galacto-oligosaccharides (GOS) for Fortification of Infant Foods in Sub-Saharan Africa|Completed||N/A|23|Actual|Swiss Federal Institute of Technology||4|||f||||t||||||||||2017-10-10 21:32:27.583116|2017-10-10 21:32:27.583116
NCT02989298|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-12-07|||December 2013||2013-12-01|December 2016|2016-12-01|December 2026|Anticipated|2026-12-01|December 2016|Anticipated|2016-12-01|10 Years|Observational [Patient Registry]|||Peritoneal Dialysis Registration System (PERSIST)|Peritoneal Dialysis Registration System (PERSIST)|Recruiting||N/A|10000|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     The serum, urine, DNA and peritoneum tissue will be collected.   "|||2017-10-10 21:32:27.684674|2017-10-10 21:32:27.684674
NCT02989285|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-12-07|||July 2016||2016-07-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Identification and Quantification of HIV CNS Latency Biomarkers|The Identification and Quantification of HIV CNS Latency Biomarkers|Recruiting||N/A|70|Anticipated|St Vincent's Hospital, Sydney|||2||f||||t||||||Samples Without DNA|"     Cerebrospinal fluid and bloods   "|||2017-10-10 21:32:27.789279|2017-10-10 21:32:27.789279
NCT02989272|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-09|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Pre-treatment With Magnesium Sulfate on the Duration of Deep Neuromuscular Blockade With Rocuronium|Effect of Pre-treatment With Magnesium Sulfate on the Duration of Deep Neuromuscular Blockade With Rocuronium: Random and Double-blind Clinical Study|Recruiting||Phase 4|60|Anticipated|Hospital Federal de Bonsucesso||2|||f||||t||||||||Yes||2017-10-10 21:32:27.881689|2017-10-10 21:32:27.881689
NCT02989259|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-11|||December 2016||2016-12-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Apatinib for Advanced Non-squamous Head and Neck Cancer|The Clinical Study of Apatinib for Patients With Advanced Non-squamous Head and Neck Cancer|Recruiting||Phase 2|30|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||1|||f||||t||||||||No||2017-10-10 21:32:27.977715|2017-10-10 21:32:27.977715
NCT02989246|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-07|||February 2015||2015-02-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|EOBvent||Effort of Breathing Guided Ventilator Protocol|Effort of Breathing Guided Ventilator Management for Children Using Pressure Rate Product: a Pilot Study|Recruiting||N/A|40|Anticipated|Children's Hospital Los Angeles||1|||f||||f||||||||No||2017-10-10 21:32:28.091036|2017-10-10 21:32:28.091036
NCT02989233|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2016-12-12|||January 2014||2014-01-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Impact of Three Different Education Methods on Oral Hygiene|Impact of Three Different Education Methods on Oral Hygiene and Theoretical Knowledge of Schoolchildren|Completed||Early Phase 1|144|Actual|Bulent Ecevit University||12|||f||||f||||||||No||2017-10-10 21:32:28.177798|2017-10-10 21:32:28.177798
NCT02989220|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-12-07|||January 2014||2014-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Feasibility Study of a Coping Intervention for Recurrent Miscarriage|A Feasibility and Acceptability Study and a Qualitative Process Evaluation of a Coping Intervention for Women With Recurrent Miscarriage|Recruiting||N/A|50|Anticipated|University Hospital Southampton NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 21:32:28.280126|2017-10-10 21:32:28.280126
NCT02989207|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-07|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PEACE||Surgical Approaches in Treating Uncontrolled Glaucoma in Black African and African-Caribbeans|Comparing Surgical Approaches to Treat Black African and Africa-Caribbean Patients With Uncontrolled Primary Open Angle Glaucoma: A Randomised Feasibility Study|Recruiting||N/A|60|Anticipated|Guy's and St Thomas' NHS Foundation Trust||3|||f||||t||||||||No||2017-10-10 21:32:28.365222|2017-10-10 21:32:28.365222
NCT02989194|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-07-26|||December 2016||2016-12-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of VIS410 in Subjects With Uncomplicated Influenza A|A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection|Active, not recruiting||Phase 2|150|Actual|Visterra, Inc.||3|||f||||t||||||||||2017-10-10 21:32:28.497078|2017-10-10 21:32:28.497078
NCT02989181|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-12-07|||November 2014||2014-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RIDA||Continues Positive Airway Pressure Treatment for Patients With Dilated Cardiomyopathy and Obstructive Sleep Apnea|Impact of Continues Positive Airway Pressure Treatment in Patients With Dilated Cardiomyopathy and Obstructive Sleep Apnea (RIDA)|Recruiting||Phase 3|44|Anticipated|Göteborg University||2|||f||||t||||||||Undecided||2017-10-10 21:32:28.75516|2017-10-10 21:32:28.75516
NCT02989168|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01||||July 2017|Anticipated|2017-07-01||Interventional|Zephyr||Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest|A Phase II Open Label Study to Evaluate the Effect of GBT440 on Hypoxemia in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Who Are Using Supplemental Oxygen at Rest (ZEPHYR)|Recruiting||Phase 2|16|Anticipated|Global Blood Therapeutics||1|||f||||||||||||||2017-10-10 21:32:28.881032|2017-10-10 21:32:28.881032
NCT02989155|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-01-18|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty|Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty|Completed||N/A|576|Actual|Ohio State University|||1||f||||f||||||||No||2017-10-10 21:32:28.996181|2017-10-10 21:32:28.996181
NCT02989142|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-06-09|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|inter-act||Inter-pregnAncy Coaching for a Healthy fuTure|Inter-pregnAncy Coaching for a Healthy fuTure|Recruiting||N/A|1100|Anticipated|Katholieke Universiteit Leuven||2|||f||||t|f|f||||||No||2017-10-10 21:32:29.066086|2017-10-10 21:32:29.066086
NCT02989129|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-08-09|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients|Prospective Open Labeled Pilot Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients|Not yet recruiting||Early Phase 1|20|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:32:29.160881|2017-10-10 21:32:29.160881
NCT02989116|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-12-07|||October 2015||2015-10-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|APEX||Executive Training and Brain in Children|Executive Training and Brain in School-Age Children|Recruiting||N/A|150|Anticipated|University Hospital, Caen||5|||f||||t||||||||Undecided||2017-10-10 21:32:29.26869|2017-10-10 21:32:29.26869
NCT02989103|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-10-03|||November 22, 2016||2016-11-22|September 20, 2017|2017-09-20|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Observational|||Hyperthyroid Follow-Up Study|Hyperthyroid Follow-Up Study|Active, not recruiting||N/A|35593|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:32:29.386947|2017-10-10 21:32:29.386947
NCT02989090|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-12-07|||October 2014||2014-10-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ePHR-ICD-SJM||Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagement on Outcomes in the Merlin.Net™|Electronic Patient Notification of Remote Implantable Cardioverter-Defibrillator (ICD) Monitoring Data: Impact of Patient Engagement on Outcomes in the Merlin.Net™ System|Completed||N/A|191|Actual|Parkview Hospital, Indiana||3|||f||||f||||||||No||2017-10-10 21:32:29.490058|2017-10-10 21:32:29.490058
NCT02989077|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-12-07|||January 2017||2017-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01|30 Days|Observational [Patient Registry]|||Risk Profiling for Patients With Isolated or Combined Coronary and Cerebral Ischemia, and Current Management Status|Risk Profiling for Patients With Isolated or Combined Coronary and Cerebral Ischemia, and Their Current Status of Risk Factors Control|Not yet recruiting||N/A|3000|Anticipated|Egyptian Cerebro-Cardio-Vascular Association|||3||f||||t||||||||Yes|after recruiting sites and investigators.|2017-10-10 21:32:29.744405|2017-10-10 21:32:29.744405
NCT02989051|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-07|||September 2016||2016-09-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|LESSER||Fluid Restriction Keeps Children Dry|Fluids in Mechanically Ventilated Children With Acute Infectious Lung Disease: How Dry Should They be?|Recruiting||Phase 2/Phase 3|34|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 21:32:29.943007|2017-10-10 21:32:29.943007
NCT02989038|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-07-25|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|NicRed||Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers|Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers|Recruiting||N/A|90|Anticipated|Duke University||6|||f||||f|f|f|||f|||||2017-10-10 21:32:30.087715|2017-10-10 21:32:30.087715
NCT02989025|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-16|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|PROGRESS||Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia|Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia-The PROGRESS Pilot Study|Recruiting||Phase 3|60|Anticipated|University of Mississippi Medical Center||1|||f||||f|t|f||||||||2017-10-10 21:32:30.274583|2017-10-10 21:32:30.274583
NCT02989012|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-07||||||November 2016|2016-11-01||||July 2019|Anticipated|2019-07-01||Interventional|||Phase IIaTrials of GanMaoKangNing Granules||Not yet recruiting||Phase 2|96|Anticipated|Dalian Zhen-Ao Bio-Tech Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:32:30.420332|2017-10-10 21:32:30.420332
NCT02988999|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-08|||September 2016||2016-09-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy of D-allulose on Weight and Fat Loss and Insulin Resistance in Non-diabetic Obese Subjects|The Efficacy of D-allulose (Psicose) on Weight and Fat Loss and Insulin Resistance by a Randomized Double-blind, Parallel-group Study in Non-diabetic Obese Subjects|Recruiting||N/A|60|Anticipated|Chiang Mai University||2|||f||||t||||||||No||2017-10-10 21:32:30.552746|2017-10-10 21:32:30.552746
NCT02988986|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-04-24|||April 24, 2017|Actual|2017-04-24|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|ANETT||TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer|Open Label, Phase II Trial of Neoadjuvant TAK-228 Plus Tamoxifen in Patients With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer|Recruiting||Phase 2|28|Anticipated|The Methodist Hospital System||1|||f||||f|t|f||||||Yes|Data and materials on human subjects will be shared with other eligible investigators through appropriate means in accordance with the NIH policy on Sharing Research Data (NIH Guide, February 26, 2003). Data will be also shared with the funding agency and regulatory agencies as required. Data will be shared with other investigators within the limits of HIPAA and other patient confidentiality requirements. This will generally require removal of all patient identifiers for all source documents and the use of arbitrarily assigned one-way identifiers. In some cases, requestors will be asked to sign a formal data sharing agreement that will provide for a commitment to use data only for research purposes and not to identify individuals, keep the data secure, and destroy or return data after analyses are complete. Prior approval will be obtained from collaborating investigators, research sponsors, and/or other stake-holders before sharing if proprietary information or products are involved.|2017-10-10 21:32:30.777027|2017-10-10 21:32:30.777027
NCT02988973|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-09-19|||January 12, 2017|Actual|2017-01-12|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia|ASP1517 Phase 3 Clinical Trial; A Multi-center, Randomized, Open-label, Active-comparator (Darbepoetin Alfa) Conversion Study of Intermittent Oral Dosing of ASP1517 in Non-dialysis Chronic Kidney Disease Patients With Anemia|Recruiting||Phase 3|325|Anticipated|Astellas Pharma Inc||3|||f||||f|f|f||||||||2017-10-10 21:32:30.927716|2017-10-10 21:32:30.927716
NCT02988960|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-08|2017-09-29|||February 28, 2017|Actual|2017-02-28|September 2017|2017-09-01|September 11, 2019|Anticipated|2019-09-11|April 16, 2019|Anticipated|2019-04-16||Interventional|||A Study of ABBV-927, an Immunotherapy, in Participants With Advanced Solid Tumors|A Multi-Center, Phase 1, Open-Label, Dose-Escalation Study of ABBV-927, an Immunotherapy, in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|180|Anticipated|AbbVie||6|||f||||f|t|f||||||||2017-10-10 21:32:31.162482|2017-10-10 21:32:31.162482
NCT02988947|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-12-06|||January 2017||2017-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PsInTKA||Effectiveness of a Psychological Intervention in Patients Undergoing Total Knee Arthroplasty|Effectiveness of a Psychological Intervention for the Control and Prevention of Pain and for Surgical Recovery in Patients Undergoing Total Knee Arthroplasty: a Prospective Randomized Controlled Trial|Not yet recruiting||N/A|128|Anticipated|University of Minho||2|||f||||f||||||||No||2017-10-10 21:32:31.306124|2017-10-10 21:32:31.306124
NCT02988934|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-07|||April 2016||2016-04-01|December 2016|2016-12-01||||April 2026|Anticipated|2026-04-01|10 Years|Observational [Patient Registry]|||The WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) U.S. Registry||Recruiting||N/A|10000|Anticipated|CDx Diagnostics|||1||f||||||||||||||2017-10-10 21:32:31.449405|2017-10-10 21:32:31.449405
NCT02988921|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-27|||October 2016||2016-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy||Recruiting||N/A|50|Anticipated|Chinese Academy of Medical Sciences||1|||f||||||||||||||2017-10-10 21:32:31.547771|2017-10-10 21:32:31.547771
NCT02988908|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-11|2017-02-09|||April 2000||2000-04-01|December 2016|2016-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Memory and Mental Health in Aging|Memory and Mental Health in Aging: Psychopharmacological Augmentation of Memory Training in Older Adults|Completed||Phase 4|198|Actual|Stanford University||2|||f||||f||||||||No||2017-10-10 21:32:31.692469|2017-10-10 21:32:31.692469
NCT02988895|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-01|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|NEAMES||Episcleral Brachytherapy for the Treatment of Wet AMD|A Prospective Study of Episcleral Brachytherapy for the Treatment of Neovascular Age-related Macular Degeneration|Recruiting||Phase 2|20|Anticipated|Salutaris Medical Devices, Inc.||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:32:31.830498|2017-10-10 21:32:31.830498
NCT02988882|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-07|||October 2015||2015-10-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Study Evaluating the Efficacy and Safety of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model (CAC®)|A Multi-Center, Randomized, Double-Masked, Vehicle Controlled Phase 3 Study Evaluating the Efficacy and Safety of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model (CAC®)|Completed||Phase 3|86|Actual|Ocular Therapeutix, Inc.||2|||f||||f||||||||No||2017-10-10 21:32:31.987898|2017-10-10 21:32:31.987898
NCT02988869|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-12-08|||July 2016||2016-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment|Comparison of Bronchodilator Efficacy of Tiotropium/Formoterol Combination Treatment Administered (qd) Via Discair® With Tiotropium (qd) Monotherapy or Tiotropium (qd) + Formoterol (Bid) Free Combination Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 4|84|Anticipated|Neutec Ar-Ge San ve Tic A.Ş||3|||f||||f||||||||No||2017-10-10 21:32:32.077038|2017-10-10 21:32:32.077038
NCT02988856|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-08-08|||July 2015||2015-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Magnetic Correction of Eye Lid Paralysis|Non-surgical Correction of Eye Lid Paralysis With External Magnet Systems|Recruiting||N/A|50|Anticipated|Massachusetts Eye and Ear Infirmary||1|||f||||f||||||||||2017-10-10 21:32:32.185189|2017-10-10 21:32:32.185189
NCT02988843|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-10-04|||March 29, 2017|Actual|2017-03-29|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors|Phase II Study of Brentuximab Vedotin and Bevacizumab in Men With Refractory CD-30 Positive Germ Cell Tumors|Recruiting||Phase 2|21|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f||||||||2017-10-10 21:32:32.278105|2017-10-10 21:32:32.278105
NCT02988076|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-08|||November 2016||2016-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:32:42.907472|2017-10-10 21:32:42.907472
NCT02988830|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|IMESCUT||Impact of Subcutaneous Electric Lumbar Stimulation on Treatment of Refractory Chronic and Disabling Lumbago|Impact of Subcutaneous Electric Lumbar Stimulation on Treatment of Refractory Chronic and Disabling Lumbago|Recruiting||N/A|30|Anticipated|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:32:32.393233|2017-10-10 21:32:32.393233
NCT02988817|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-08-14|||December 2016||2016-12-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||HuMax-AXL-ADC Safety Study in Patients With Solid Tumors|First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (HuMax-AXL-ADC) in Patients With Solid Tumors|Recruiting||Phase 1/Phase 2|165|Anticipated|Genmab||1|||f||||t||||||||||2017-10-10 21:32:32.489768|2017-10-10 21:32:32.489768
NCT02988804|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects on the Awakening With Laryngeal Mask vs Endotracheal Tube in Endoscopic Endonasal Transsphenoidal Base Surgery|Effects on the Awakening With Laryngeal Mask vs Endotracheal Tube in Endoscopic Endonasal Transsphenoidal Base Surgery|Not yet recruiting||N/A|42|Anticipated|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||Undecided||2017-10-10 21:32:32.616558|2017-10-10 21:32:32.616558
NCT02988791|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01||||September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of a Probiotic (Bifidobacterium in the Treatment of Infantile Colic (IC)|Randomized Clinical Trial to Evaluate the Efficacy of Bifidobacterium in the Treatment of Infantile Colic (IC)|Active, not recruiting||N/A|80|Anticipated|Federico II University||2|||f||||||||||||||2017-10-10 21:32:32.725294|2017-10-10 21:32:32.725294
NCT02988778|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-14|||February 2018|Anticipated|2018-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|RINEX50||Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis|Phase III, Multicenter, Randomized, Simple-blinded, Parallel Groups to Evaluate Non Inferiority of Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Persistent Rhinitis Moderate to Severe|Not yet recruiting||Phase 3|360|Anticipated|Eurofarma Laboratorios S.A.||2|||f||||f|f|f||||||||2017-10-10 21:32:32.806374|2017-10-10 21:32:32.806374
NCT02988765|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-07|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Morpho-Node||Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status in Women With Invasive Vulvar Carcinoma|Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status in Women With Invasive Vulvar Carcinoma|Recruiting||N/A|120|Anticipated|Catholic University of the Sacred Heart||1|||f||||f||||||||No||2017-10-10 21:32:32.889264|2017-10-10 21:32:32.889264
NCT02988752|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-12-08|||October 2016||2016-10-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|||Comparison Between an Electronic Mobile Device and Optical Coherence Tomography to Determine Cup-to-disc Ratio|Comparison Between an Electronic Mobile Device(DEM) and Optical Coherence Tomography (OCT) to Determine Cup-to-disc Ratio (C/D) Through a Non-inferiority Trial With Masked Data Analysis|Enrolling by invitation||N/A|110|Actual|Clinica Oftamologica Zona Sul||2|||f||||f||||||||No||2017-10-10 21:32:32.998298|2017-10-10 21:32:32.998298
NCT02988739|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-05-29|||February 22, 2017|Actual|2017-02-22|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine|Safety and Immunogenicity of Laser Assisted Epidermally Administered Seasonal Influenza Vaccine in Comparison to Intradermally Administered Seasonal Influenza Vaccine|Active, not recruiting||Phase 1|20|Actual|Pantec Biosolutions AG||2|||f||||f|f|f||||||||2017-10-10 21:32:33.098319|2017-10-10 21:32:33.098319
NCT02988726|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-07-24|||March 1999||1999-03-01|July 2017|2017-07-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma|Phase II Study of Antineoplastons A19 and AS2-1 in Patients With Neurofibroma and Schwannoma|Terminated||Phase 2|3|Actual|Burzynski Research Institute||1||Slow accrual|f||||f||||||||||2017-10-10 21:32:33.20058|2017-10-10 21:32:33.20058
NCT02988713|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-04-06|||December 2016||2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Characterize the Effects of Programming Spinal Cord Stimulation (SCS) in Patients Undergoing a Boston Scientific (BSC) SCS Temporary Trial||Recruiting||N/A|15|Anticipated|Boston Scientific Corporation||1|||f||||||||||||||2017-10-10 21:32:33.298232|2017-10-10 21:32:33.298232
NCT02988700|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ITVSEpidural||Spinal Versus Caudal Analgesia After Pediatric Infra-umbilical Surgery|Safety and Analgesic Efficacy of Spinal Versus Caudal Block in Pediatric Infra-umbilical Surgery|Recruiting||Phase 2/Phase 3|60|Anticipated|Assiut University||2|||f||||t||||||||No||2017-10-10 21:32:33.400305|2017-10-10 21:32:33.400305
NCT02988687|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-08|||November 2016||2016-11-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD|Metabolic and Quality of Life Effects of Growth Hormone Treatment in Patients With Traumatic Brain Injury and AGHD|Recruiting||N/A|16|Anticipated|Garcia, Jose M., MD, PhD|||1||f||||f||||||||No||2017-10-10 21:32:33.527696|2017-10-10 21:32:33.527696
NCT02988674|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-07-07|||December 22, 2016||2016-12-22|July 2017|2017-07-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Observational|||A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation|Prospective, Multi-Center, Observational, Program to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation|Recruiting||N/A|139|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:32:33.631397|2017-10-10 21:32:33.631397
NCT02988661|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-02-21|||January 19, 2017|Actual|2017-01-19|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|WELL||Women Empowered to Live With Lupus Study|Women Empowered to Live With Lupus (WELL) Study|Recruiting||N/A|400|Anticipated|Emory University||2|||f||||f|f|f||||||||2017-10-10 21:32:33.745528|2017-10-10 21:32:33.745528
NCT02988648|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter|A Phase I/II Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter|Recruiting||Phase 1/Phase 2|37|Anticipated|Yale University||1|||f||||t||||||||||2017-10-10 21:32:33.836131|2017-10-10 21:32:33.836131
NCT02988635|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-07|||November 2014||2014-11-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Early Palliative Care on Quality of Life of Advanced Cancer Patients|Evaluation of Effects of Early Palliative Care on Quality of Life of Advanced Cancer Patients. A Multicenter Controlled Randomised Clinical Trial|Completed||Phase 3|281|Actual|Azienda Ospedaliero-Universitaria di Parma||2|||f||||t||||||||No||2017-10-10 21:32:33.919739|2017-10-10 21:32:33.919739
NCT02988609|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-08-21|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|RugbyCom||Concussion in Rugby Players: a Pilote Study of Neural Recovery Using fMRI|Concussion in Rugby Players: a Pilote Study of Neural Recovery Using Functional Magnetic Resonance Imaging (fMRI)|Recruiting||N/A|75|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||||2017-10-10 21:32:34.08876|2017-10-10 21:32:34.08876
NCT02988583|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-08|||October 2016||2016-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Emulsification of Different Viscosity Silicone Oil After Complicated Retinal Detachment Surgery|Emulsification of Different Viscosity Silicone Oil After Complicated Retinal Detachment Surgery: A Randomized Double-masked Clinical Trial|Recruiting||N/A|86|Anticipated|Khon Kaen University||2|||f||||f||||||||No||2017-10-10 21:32:34.583274|2017-10-10 21:32:34.583274
NCT02988570|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|EPILANG2||Study on the Phenotype of Language in Preterm Born Children at 5 Years of Age|Study on the Phenotype of Language in Preterm Born Children at 5 Years of Age|Recruiting||N/A|85|Anticipated|University Hospital, Rouen||1|||f||||f||||||||No||2017-10-10 21:32:35.304363|2017-10-10 21:32:35.304363
NCT02988557|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-02-22|||February 21, 2017|Actual|2017-02-21|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Walking Inclined Plane|Evaluation of the Effect of an Inclined Plane on the Walking of Children With Cerebral Palsy: What Are the Paths for Rehabilitation?|Recruiting||N/A|30|Anticipated|Nantes University Hospital||1|||f|||||f|f||||||||2017-10-10 21:32:35.466656|2017-10-10 21:32:35.466656
NCT02988544|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-06|||February 2017||2017-02-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|BlastoCollapse||Artificial Shrinkage of Fresh Blastocysts|Artificial Shrinkage of Fresh Blastocyst: Impact on Success Rates in Assisted Reproductive Technology|Not yet recruiting||N/A|150|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:32:35.621874|2017-10-10 21:32:35.621874
NCT02988531|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-05-02|||February 9, 2017|Actual|2017-02-09|September 2016|2016-09-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Validation of PET-MRI for Cardiovascular Disease|Validation of PET-MRI for Cardiovascular Disease|Recruiting||N/A|20|Anticipated|University of Edinburgh||1|||f||||f|f|f||||||No|No plans to share patient specific data|2017-10-10 21:32:35.734797|2017-10-10 21:32:35.734797
NCT02988518|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-12-06|||July 2014||2014-07-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|COGMED||Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints|Evaluation of a Cognitive Remediation Program on Patients With Bipolar Disorders, With Memory Complaints|Recruiting||N/A|41|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:32:35.881178|2017-10-10 21:32:35.881178
NCT02988505|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-12-06|||September 2014||2014-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|Lymphorac||Out-of Pocket Payments With Lymphedema in France|Out-of Pocket Payments in Patients With Lymphedema in France and Inequities of Access ti Healthcare|Recruiting||N/A|500|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 21:32:36.013855|2017-10-10 21:32:36.013855
NCT02988492|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-03-31|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Acute Stroke Thrombectomy: Does CT Perfusion Accurately Predict Infarct on MRI After Recanalization|Acute Stroke Thrombectomy: Does CT Perfusion Accurately Predict Infarct on MRI After Recanalization|Not yet recruiting||N/A|40|Anticipated|Ottawa Hospital Research Institute||1|||f||||f|f|f||||||Undecided||2017-10-10 21:32:36.105521|2017-10-10 21:32:36.105521
NCT02988479|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-12-06|||July 2016||2016-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|Lymphorac2||Out-of Pocket Payments in Patients With Lymphedema|Out-of Pocket Payments in Patients With Primary Lymphedema in France and Inequities of Access to Healthcare|Recruiting||N/A|150|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 21:32:36.23714|2017-10-10 21:32:36.23714
NCT02988466|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-10-04|||January 24, 2017|Actual|2017-01-24|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haploidentical Related Hematopoietic|Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haploidentical Related Hematopoietic Cells (Haplo-HCT) For Patients With Hematologic Malignancies|Recruiting||Phase 2|44|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t|t|f||||||||2017-10-10 21:32:36.391576|2017-10-10 21:32:36.391576
NCT02988453|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-01-12|||December 2016||2016-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|MBT-CD||Mentalization-based Training for Adolescents With Conduct Disorder (MBT-CD)|Mentalization-based Training for Adolescents With Conduct Disorder (MBT-CD): A Randomized Controlled Trial|Recruiting||N/A|102|Anticipated|Heidelberg University||2|||f||||f||||||||No||2017-10-10 21:32:37.19825|2017-10-10 21:32:37.19825
NCT02988427|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-03-13|||December 2016||2016-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Measuring Patient Engagement in Diabetes Care|Measuring Patient Engagement in Diabetes Care|Withdrawn||N/A|0|Actual|Northwestern University|||1||f||||f||||||||No||2017-10-10 21:32:37.52592|2017-10-10 21:32:37.52592
NCT02988414|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-04-20|||July 2016||2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Diagnosis of Bacteremia/Septicemia by the Karius Sequencing-Based Infectious Disease Diagnostic Assay|Diagnosis of Bacteremia/Septicemia by the Karius Sequencing-Based Infectious Disease Diagnostic Assay|Completed||N/A|108|Actual|Karius, Inc.|||1||f||||f||||||Samples With DNA|"     Plasma   "|Undecided||2017-10-10 21:32:37.610423|2017-10-10 21:32:37.610423
NCT02988401|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-05-03|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis|Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis|Recruiting||Phase 1/Phase 2|105|Anticipated|Johns Hopkins University||3|||f||||t|t|f||||||No||2017-10-10 21:32:37.691989|2017-10-10 21:32:37.691989
NCT02988388|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-08|||February 23, 2017|Actual|2017-02-23|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|LTRC||Lung Tissue Research Consortium|Lung Tissue Research Consortium|Recruiting||N/A|400|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t|f|f||||Samples With DNA|"     For a subset of LTRC participants who provide applicable consent, a portion of collected     blood will be stored in a Paxgene DNA tube for DNA generation. DNA will be stored in a     central laboratory and available for request by qualified researchers.   "|||2017-10-10 21:32:37.832797|2017-10-10 21:32:37.832797
NCT02988375|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-08|||May 2016||2016-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|SPREAD||Sleep to Prevent Evolving Affecting Disorders||Recruiting||N/A|1500|Anticipated|Henry Ford Health System||2|||f||||f||||||||||2017-10-10 21:32:37.947927|2017-10-10 21:32:37.947927
NCT02988362|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)|An Open-label, Randomized, Cross-over Study to Evaluate Pharmacokinetics and the Safety of HL068 16/10mg Compared to Candesartan 16mg and Amlodipine 10mg Co-administered in Healthy Male Volunteers.|Not yet recruiting||Phase 1|40|Anticipated|HanAll BioPharma Co., Ltd.||2|||f||||||||||||||2017-10-10 21:32:38.043699|2017-10-10 21:32:38.043699
NCT02988336|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-01-29|||September 2016||2016-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||TMHT - New Method of Difficult Intubation Prediction|Thyromental Height Test as a New Method for Prediction of Difficult Intubation With Double Lumen Tube|Completed||N/A|237|Actual|Medical University of Silesia|||1||f||||f||||||||No||2017-10-10 21:32:38.238545|2017-10-10 21:32:38.238545
NCT02988323|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-12-07|||December 2016||2016-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Cervicovestibular Physiotherapy and Aerobic Exercise in Concussion|Cervicovestibular Rehabilitation and Aerobic Exercise in Children and Youth With Persistent Symptoms Following a Sport-related Concussion: A Randomized Controlled Trial.|Not yet recruiting||N/A|96|Anticipated|Sport Injury Prevention Research Centre||3|||f||||t||||||||No||2017-10-10 21:32:38.337468|2017-10-10 21:32:38.337468
NCT02988310|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Comparison of Gait Characteristics in Individuals With Above and Below Knee Limb Loss|Comparison of Gait Characteristics in Individuals With Trans Femaoral and Trans Tibial Limb Loss|Not yet recruiting||N/A|39|Anticipated|Hacettepe University|||3||f||||t||||||||||2017-10-10 21:32:38.514402|2017-10-10 21:32:38.514402
NCT02988297|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-04-10|||January 2019|Anticipated|2019-01-01|April 2017|2017-04-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis|Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis|Not yet recruiting||Phase 2|140|Anticipated|Revalesio Corporation||2|||f|||||t|f||||||||2017-10-10 21:32:38.601361|2017-10-10 21:32:38.601361
NCT02988284|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Gait Variability in Healthy Youngs|Investigating the Gait Variability in Healthy Individuals|Not yet recruiting||N/A|300|Anticipated|Hacettepe University|||1||f||||t||||||||Undecided||2017-10-10 21:32:38.67219|2017-10-10 21:32:38.67219
NCT02988271|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-09|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Self-Administered Meditation Intervention for Cancer Patients With Psychosocial Distress|Self-Administered Meditation Intervention for Cancer Patients With Psychosocial Distress|Not yet recruiting||N/A|30|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 21:32:38.744953|2017-10-10 21:32:38.744953
NCT02987881|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-02-08|||February 1, 2017|Actual|2017-02-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Endometrial Cancer Diet and Exercise|Physical Activity and Nutrition Counseling Intervention in Endometrial Cancer Survivors|Recruiting||N/A|15|Anticipated|Duke University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:32:44.655432|2017-10-10 21:32:44.655432
NCT02988258|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-02-20|||July 2013||2013-07-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|April 2018|Anticipated|2018-04-01||Interventional|CMV_TCR-001||Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT|CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy With CMV TCR-transduced Donor-derived T Cells for Recipients of Allogeneic Haematopoietic Stem Cell Transplantation|Recruiting||Phase 1|10|Anticipated|University College, London||3|||f||||t||||||||Undecided||2017-10-10 21:32:38.853227|2017-10-10 21:32:38.853227
NCT02988245|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-04-20|||January 23, 2017|Actual|2017-01-23|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|January 23, 2018|Anticipated|2018-01-23||Interventional|PGEN for HTN||Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension|Prospective Randomized Controlled Trial Investigating the Use of Genetic Predisposition to Guide Pharmacologic Therapy for Hypertension|Recruiting||Phase 2|800|Anticipated|Geneticure, LLC||2|||f||||t|t|f|||f|||No||2017-10-10 21:32:38.98954|2017-10-10 21:32:38.98954
NCT02988232|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-07|||July 2016||2016-07-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|WRMD||Evaluation of Efficacy and Safety of Herbal Medicine on Work Related Chronic Low Back Pain|Evaluation of Efficacy and Safety of Herbal Medicine on Work Related Chronic Low Back Pain - Multicenter, Randomized, Double Blinded, Parallel Group, Placebo Controlled Pilot Study -|Recruiting||Phase 4|72|Anticipated|Gachon University Gil Oriental Medical Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:32:39.11325|2017-10-10 21:32:39.11325
NCT02988219|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-04-25|2017-01-16||June 2010||2010-06-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method|Evaluation of Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method|Completed||Phase 4|50|Actual|Medical University of Warsaw||2|||f||||f||||||||No||2017-10-10 21:32:39.23605|2017-10-10 21:32:39.23605
NCT02988206|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-12|||March 2015||2015-03-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Personalized Objects Can Improve the Diagnosis of EMCS From MCS||Completed||N/A|21|Actual|Hangzhou Normal University||2|||f||||t||||||||No||2017-10-10 21:32:40.08127|2017-10-10 21:32:40.08127
NCT02988193|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-04-10|||December 2015|Actual|2015-12-01|December 2016|2016-12-01|February 28, 2017|Actual|2017-02-28|January 2017|Actual|2017-01-01||Interventional|PRECISION||Piloting Healthcare Coordination in Hypertension|Piloting Healthcare Coordination in Hypertension|Completed||Phase 2|28|Actual|Optima Integrated Health||3|||f||||t||||||||No||2017-10-10 21:32:40.153277|2017-10-10 21:32:40.153277
NCT02988180|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-07|||October 2015||2015-10-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|RAI||Intervention on Development and Growth at Children in Poverty|Developmental and Growth Status of Children (6-60 Months of Age) in Extreme Poverty in Jimma Town of Ethiopia: Effects of Developmental Stimulation - RAI (Risk Analysis and Intervention)|Completed||N/A|78|Actual|Hasselt University||2|||f||||f||||||||Undecided||2017-10-10 21:32:40.227307|2017-10-10 21:32:40.227307
NCT02988167|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-18|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|EA||Introducing and Evaluating Extubation Advisor|Introducing and Evaluating Extubation AdvisorTM: A Pilot Phase I Observational Study of a Novel Clinical Decision Support Tool to Improve Extubation Decision-making in the Intensive Care Unit|Recruiting||N/A|100|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-10 21:32:40.318521|2017-10-10 21:32:40.318521
NCT02988154|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-01-18|||June 2016||2016-06-01|January 2017|2017-01-01||||January 2017|Anticipated|2017-01-01||Observational|SENSE||Simulation Efficacy in Neurosurgical Education|Investigating the Efficacy of Simulation Curricula in Neurosurgical Education|Recruiting||N/A|20|Anticipated|Johannes Gutenberg University Mainz|||2||f||||f|f|f||||||No||2017-10-10 21:32:40.417308|2017-10-10 21:32:40.417308
NCT02988141|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-01-18|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|February 2021|Anticipated|2021-02-01|December 2020|Anticipated|2020-12-01||Observational|PRECENT||EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC|A Prospective Multi-center Study to Investigate the EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC|Not yet recruiting||N/A|100|Anticipated|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||f||||||Samples With DNA|"     ctDNA in blood and tissues   "|No||2017-10-10 21:32:40.556824|2017-10-10 21:32:40.556824
NCT02988128|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-17|||December 2016||2016-12-01|December 2016|2016-12-01|November 2023|Anticipated|2023-11-01|November 2020|Anticipated|2020-11-01|2 Years|Observational [Patient Registry]|INSPIRE||Neurovascular Product Surveillance Registry|NeuroVascular Product Surveillance Registry (PSR) Platform|Recruiting||N/A|3000|Anticipated|Medtronic Neurovascular Clinical Affairs|||1||f||||f||||||||Undecided||2017-10-10 21:32:40.647137|2017-10-10 21:32:40.647137
NCT02988115|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|CLEAR Serenity||Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant|A Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180 mg Compared to Placebo Added to Background Lipid-Modifying Therapy in Patients With Elevated LDL-C Who Are Statin Intolerant|Recruiting||Phase 3|300|Anticipated|Esperion Therapeutics||2|||f||||t||||||||||2017-10-10 21:32:40.768413|2017-10-10 21:32:40.768413
NCT02988102|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Observational|||Role of Concentration of Biomarkers S100B and NSE in Serum in Mild and Moderate Head Trauma|Role of Concentration of Biomarkers S100B and NSE in Serum in Mild and Moderate Head Trauma Injury in Acute Phase in Relation to Head CT and Post Concusion Syndrome.|Recruiting||N/A|70|Anticipated|University Clinical Centre of Kosova|||1||f||||t||||||Samples Without DNA|"     Biomarkers S100B and NSE in blood sample ( Venous blood)   "|No||2017-10-10 21:32:42.710224|2017-10-10 21:32:42.710224
NCT02988089|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2017-04-23|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment|Efficacy of Two Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment|Recruiting||Phase 4|480|Anticipated|Shandong University||4|||f||||t|f|f||||||No||2017-10-10 21:32:42.797112|2017-10-10 21:32:42.797112
NCT02988063|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-14|||April 10, 2017|Actual|2017-04-10|September 2017|2017-09-01|September 12, 2017|Actual|2017-09-12|September 12, 2017|Actual|2017-09-12||Interventional|||Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs|Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)|Withdrawn||Phase 4|0|Actual|OhioHealth||1||Poor enrollment|f||||f|t|f|||f|||||2017-10-10 21:32:42.948519|2017-10-10 21:32:42.948519
NCT02988050|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-08|||August 2013||2013-08-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Conscious Sedation for Epilepsy Surgery|Propofol-dexmedetomidine Versus Propofol-remifentanil Conscious Sedation for Awake Craniotomy During Epilepsy Surgery|Completed||N/A|60|Actual|Menoufia University||2|||f||||f||||||||No||2017-10-10 21:32:43.034847|2017-10-10 21:32:43.034847
NCT02988037|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-09|||September 2012||2012-09-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study|Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study|Completed||N/A|33|Actual|University of Ottawa||1|||f||||f||||||||No||2017-10-10 21:32:43.134849|2017-10-10 21:32:43.134849
NCT02988024|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-03-17|||December 7, 2016|Actual|2016-12-07|March 2017|2017-03-01|December 28, 2016|Actual|2016-12-28|December 28, 2016|Actual|2016-12-28||Interventional|||Pilot BA Study of New LY03005 vs Pristiq|A Randomized, Open-Label, Single-Dose Study to Assess the Relative Bioavailability of LY03005 Oral Tablets Versus Pristiq Oral Tablets Under Fasting Conditions in Healthy Subjects|Completed||Phase 1|20|Actual|Luye Pharma Group Ltd.||2|||f||||f||||||||||2017-10-10 21:32:43.202967|2017-10-10 21:32:43.202967
NCT02988011|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|CRUDOS||Improving Glucose and Lipid Metabolism Through Caloric Restriction Using Diet or Surgery (CRUDOS)|Influence of Weight Loss by Diet and Surgery on Metabolomic Profile, Body Composition, and Tissue Specific Glucose Uptake: Insights in Type 2 Diabetes Regression (CRUDOS Study)|Not yet recruiting||N/A|50|Anticipated|Uppsala University||2|||f||||f||||||||Undecided|Most of the data is planned to be shared after the study has ended, the date for when this will occur however needs to be decided.|2017-10-10 21:32:43.289944|2017-10-10 21:32:43.289944
NCT02987998|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-06-01|||May 18, 2017|Actual|2017-05-18|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC|A Phase I Safety and Feasibility Study of Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in Resectable Stage 3A Non-Small Cell Lung Cancer|Recruiting||Phase 1|20|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:32:43.384411|2017-10-10 21:32:43.384411
NCT02987985|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy|Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy: a Pilot Study|Not yet recruiting||Phase 3|50|Anticipated|University of Saskatchewan||2|||f||||||||||||No||2017-10-10 21:32:43.48739|2017-10-10 21:32:43.48739
NCT02987972|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-15|||March 21, 2017|Actual|2017-03-21|August 2017|2017-08-01|October 18, 2018|Anticipated|2018-10-18|October 18, 2018|Anticipated|2018-10-18||Interventional|||A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)|A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Infants|Active, not recruiting||Phase 2|1050|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||t|t|f||||||||2017-10-10 21:32:43.722691|2017-10-10 21:32:43.722691
NCT02987959|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-03-02|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas|Phase II Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas With Dysregulation of the mTOR Pathway|Recruiting||Phase 2|33|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:32:43.949241|2017-10-10 21:32:43.949241
NCT02987946|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|TIPOTEE||Leiden Trial In Prevention of Post-Operative ThromboEmbolic Events|Optimizing Anti Coagulant Therapy in Neurosurgical Interventions in Patients With an Increased Risk for Thrombo-embolic Complications|Not yet recruiting||N/A|280|Anticipated|Leiden University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:32:44.046798|2017-10-10 21:32:44.046798
NCT02987933|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-08|||November 2016||2016-11-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Observational|||The Use of Resting State, fMRI and DTI in the Identification of Chronic Pain Conditions|The Use of Resting State, fMRI and DTI in the Identification of Chronic Pain Conditions|Recruiting||N/A|40|Anticipated|Brain Scan Inc.|||2||f||||f||||||||No||2017-10-10 21:32:44.159282|2017-10-10 21:32:44.159282
NCT02987920|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Dextromethorphan Use in Multimodal Analgesia Regimens for Total Knee Arthroplasty|A Randomized Double-blinded Study to Evaluate Preincisional Dextromethorphan in Patients Undergoing Total Knee Arthroplasty and Its Effect on Postoperative Opioid Use|Not yet recruiting||Phase 4|60|Anticipated|University of Southern California||2|||f||||t||||||||No||2017-10-10 21:32:44.257165|2017-10-10 21:32:44.257165
NCT02987907|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-08|||August 2016||2016-08-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Interventional|||The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.||Recruiting||Phase 3|220|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:32:44.390542|2017-10-10 21:32:44.390542
NCT02987894|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-03|||December 2016||2016-12-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01|1 Year|Observational [Patient Registry]|PROGRESS||PRospective Observation of Aortic reGuRgitation aftEr TAVI and progreSS Over Time: PROGRESS PVL Registry|Prospective Observation of Aortic Regurgitation After TAVI and Progress Over Time: PROGRESS PVL Registry|Recruiting||N/A|500|Anticipated|Symetis SA|||1||f||||f|f|f||||||No||2017-10-10 21:32:44.492092|2017-10-10 21:32:44.492092
NCT02987855|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-10|||December 2016||2016-12-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ADcSVF-CRPS||Adipose Stem/Stromal Cells in RSD, CRPS, Fibromyalgia|Use of Autologous Adult Adipose-Derived Stem/Stromal Cells in Reflex Sympathetic Dystrophy (RSD), Complex Regional Pain Syndrome (CRPS), and Fibromyalgia|Recruiting||Phase 1/Phase 2|100|Anticipated|Healeon Medical Inc||3|||f||||t||||||||||2017-10-10 21:32:45.401788|2017-10-10 21:32:45.401788
NCT02987842|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's Disease|Neurofeedback as a Novel Treatment for Mild Cognitive Impairment & Early Alzheimer's|Not yet recruiting||N/A|30|Anticipated|Beersheva Mental Health Center||2|||f||||f||||||||No||2017-10-10 21:32:45.536024|2017-10-10 21:32:45.536024
NCT02987829|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-03-28|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients|An Open-label Phase 1/2A Study To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TRC253, an Androgen Receptor Antagonist, in Patients With Metastatic Castration-resistant Prostate Cancer|Recruiting||Phase 1/Phase 2|80|Anticipated|Tracon Pharmaceuticals Inc.||1|||f||||t|t|f||||||No||2017-10-10 21:32:45.673975|2017-10-10 21:32:45.673975
NCT02987816|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|LETS-LEARN||Neurosurgical Skill Enhancement Using Transcranial Stimulation|Learning Enhancement Using Transcranial Stimulation, Leading Expertise, Acquisition and Retention of Neurosurgical Skills|Not yet recruiting||N/A|24|Anticipated|University of Calgary||2|||f||||f||||||||No||2017-10-10 21:32:45.796891|2017-10-10 21:32:45.796891
NCT02987803|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-07-28|||September 23, 2016|Actual|2016-09-23|July 2017|2017-07-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Interventional|||Helping Mothers Select Better Childbirth Hospitals|Helping Mothers Select Better Childbirth Hospitals|Completed||N/A|18293|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-10 21:32:45.905179|2017-10-10 21:32:45.905179
NCT02987790|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-06-25|||January 2017||2017-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Duration of Antibiotic Therapy in Critically Ill Patients: C-reactive Protein-guided Therapy Versus Best Practice|Duration of Antibiotic Therapy in Critically Ill Patients: C-reactive Protein-guided Therapy Versus Best Practice|Recruiting||N/A|136|Anticipated|Federal University of Minas Gerais||2|||f||||f||||||||Undecided||2017-10-10 21:32:46.011193|2017-10-10 21:32:46.011193
NCT02987777|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-06|||January 2016||2016-01-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer|Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer|Completed||N/A|80|Actual|Institut de Cancérologie de Lorraine|||1||f||||||||||||||2017-10-10 21:32:46.27791|2017-10-10 21:32:46.27791
NCT02987764|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-06|||May 2016||2016-05-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|Cordmilking||Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants|Neurodevelopmental Outcomes of Cord Milking in Preterm Infants: Randomized Controlled Trial|Recruiting||N/A|20|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 21:32:46.349974|2017-10-10 21:32:46.349974
NCT02987751|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-07|||December 2016||2016-12-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients|A Prospective, Multicentric, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog Glargine Plus Glulisine With Premixed Insulin in Adult Patients With Type 2 Diabetes Mellitus|Not yet recruiting||Phase 4|200|Anticipated|India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals||2|||f||||t||||||||Undecided||2017-10-10 21:32:46.471354|2017-10-10 21:32:46.471354
NCT02987738|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-04-20|||February 9, 2017|Actual|2017-02-09|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|DapaDream||Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes|A Randomized, Double-Blind, Placebo-controlled, Single-center, Phase 1 Inpatient Pilot Study to Explore the Safety and Efficacy of DAPAglifozin as Add-on to Day and Night Closed-loop Control in Patients Type 1 Diabetes (T1D)|Enrolling by invitation||Phase 1|30|Anticipated|Kinderkrankenhaus auf der Bult||2|||f||||t|f|f||||||No||2017-10-10 21:32:46.604418|2017-10-10 21:32:46.604418
NCT02987712|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Management of Coagulopathy in Cirrhotic Patients Undergoing Invasive Procedures|Management of Coagulopathy in Cirrhotic Patients Undergoing Invasive Procedures: a Prospective Trial Comparing Standard Management to Thromboelastography Protocol Based Management|Not yet recruiting||N/A|120|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No|we do not plan to share IPD|2017-10-10 21:32:46.861583|2017-10-10 21:32:46.861583
NCT02987699|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2016-12-27|||November 2016||2016-11-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil|Phase II Study of Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin,Leucovorin and 5-Fluorouracil|Recruiting||Phase 2|54|Anticipated|Sun Yat-sen University||3|||f||||t||||||||Undecided||2017-10-10 21:32:46.97922|2017-10-10 21:32:46.97922
NCT02987686|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-07-19|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Topical Infliximab for Sterile Corneal Melt|Topical Infliximab for the Treatment of Sterile Corneal Melt|Recruiting||Phase 1|12|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t|f|f||||||||2017-10-10 21:32:47.10877|2017-10-10 21:32:47.10877
NCT02987673|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-08|||January 2016||2016-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||MGB/OAGB and LSG Effects on Lower Esophageal Sphincter (LES) Function|Effects of Mini/One Anastomosis Gastric Bypass (MGB/OAGB) and Sleeve Gastrectomy (LSG) on Lower Esophageal Sphincter (LES) Function. A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Federico II University||2|||f||||f||||||||Undecided||2017-10-10 21:32:47.219169|2017-10-10 21:32:47.219169
NCT02987660|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-07|2017-08-15|||March 3, 2017|Actual|2017-03-03|August 2017|2017-08-01|July 26, 2017|Actual|2017-07-26|July 26, 2017|Actual|2017-07-26||Interventional|||Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax|Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax|Terminated||N/A|21|Actual|Alcon Research||2||management decision with no risk to patient safety|f||||f|f|f|||f|||||2017-10-10 21:32:47.356894|2017-10-10 21:32:47.356894
NCT02987647|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-12-06|||January 2017||2017-01-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Perception of Efficacy, Safety and Tolerability of Three Non-hormonal Intravaginal Gels and Hormone Cream|Phase IV Pilot, Longitudinal, Prospective, Double-blind, Comparative to Assess the Perception of Efficacy, Safety and Tolerability of Three Non-hormonal Intravaginal Gels and Hormone Cream in Postmenopausal Women|Not yet recruiting||Phase 4|56|Anticipated|Farmoquimica S.A.||4|||f||||t||||||||No||2017-10-10 21:32:47.488875|2017-10-10 21:32:47.488875
NCT02987634|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-11|||December 2016||2016-12-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation and Comparison of Efficacy of PeriActive Mouthwash to Chlorhexidine 0.12% Mouth Rinse|Phase IV Study to Evaluate and Compare the Efficacy of PeriActive Mouthwash to Chlorhexidine 0.12% Rinse With Regards to Managing Post-surgical Inflammation Associated With Dental Implant Surgery|Not yet recruiting||Phase 4|44|Anticipated|Izun Pharma Ltd||2|||f||||t||||||||No|trial results will be published for dentists to see|2017-10-10 21:32:47.614848|2017-10-10 21:32:47.614848
NCT02987621|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS?|Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS?|Recruiting||N/A|30|Anticipated|Colorado State University||2|||f||||f||||||||No||2017-10-10 21:32:47.727438|2017-10-10 21:32:47.727438
NCT02987608|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-12-06|||September 2016||2016-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||A Feasibility Trial of Power Up|A Feasibility Trial of Power Up: A Smartphone App to Support Young People to Make Shared Decisions in Therapy|Recruiting||N/A|120|Anticipated|University College, London||2|||f||||t||||||||No||2017-10-10 21:32:47.819703|2017-10-10 21:32:47.819703
NCT02987595|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-12-06|||June 2015||2015-06-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effects of Lignan-rich Diet on Cardiometabolic Risk Factors|Effects of Lignan-rich Diet on Cardiometabolic Risk Factors|Completed||N/A|41|Actual|Swedish University of Agricultural Sciences||2|||f||||f||||||||||2017-10-10 21:32:47.925084|2017-10-10 21:32:47.925084
NCT02987582|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-12-15|||September 2016||2016-09-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Feasibility Study of an Emotion-Focused Mindfulness Group|A Feasibility Study of an Emotion-Focused Mindfulness Group to Enhance Coping and Resilience in Family Medicine Patients Living With Common Mental Illness|Recruiting||N/A|35|Anticipated|University of Toronto Practice Based Research Network||1|||f||||f||||||||No||2017-10-10 21:32:48.018182|2017-10-10 21:32:48.018182
NCT02987569|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-08|||July 2016||2016-07-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Teen Connections for Support From Multidisciplinary Professionals & Peers|Teen Connections for Support From Multidisciplinary Professionals & Peers|Recruiting||N/A|85|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||No|All data is de-identified and will be reported only in aggregate.|2017-10-10 21:32:48.13836|2017-10-10 21:32:48.13836
NCT02987556|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7)|Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop for Three Months at Home in Comparison With Conventional Treatment by External Insulin Pump in Patients With Type 1 Diabetes.|Not yet recruiting||Phase 3|60|Anticipated|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||No||2017-10-10 21:32:48.254046|2017-10-10 21:32:48.254046
NCT02987543|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-06-30|||February 6, 2017|Actual|2017-02-06|June 2017|2017-06-01|February 5, 2021|Anticipated|2021-02-05|January 20, 2020|Anticipated|2020-01-20||Interventional|||Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)|A Phase III, Open Label, Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have Homologous Recombination Repair Gene Mutations (PROfound)|Recruiting||Phase 3|340|Anticipated|AstraZeneca||2|||f||||t|t|f||||||||2017-10-10 21:32:48.400752|2017-10-10 21:32:48.400752
NCT02987530|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|OPTIPRIM-2||National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection|Phase III Multicenter Randomized Trial Evaluating in Patients at the Time of the Primary HIV-1 Infection, the Impact on the Viral Reservoir of a Combination Including Tenofovir/Emtricitabine and Dolutegravir or Tenofovir/Emtricitabine and Darunavir/Cobicistat|Not yet recruiting||Phase 3|100|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||No||2017-10-10 21:32:49.091602|2017-10-10 21:32:49.091602
NCT02987504|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-08-03|||November 2016||2016-11-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Samalizumab in Patients With Advanced Cancer|A Multicenter, Dose-Escalation, Phase 1 Study of Samalizumab (ALXN6000) to Evaluate the Pharmacokinetics, Safety, and Tolerability in Patients With Advanced Cancer|Suspended||Phase 1|33|Anticipated|Alexion Pharmaceuticals||1|||f||||f||||||||||2017-10-10 21:32:49.301265|2017-10-10 21:32:49.301265
NCT02987491|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-06|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Exercise and Insulin Signaling in Human Skeletal Muscle|Exercise and Insulin Signaling in Human Skeletal Muscle|Recruiting||N/A|100|Anticipated|Oregon State University||2|||f||||f||||||||No||2017-10-10 21:32:49.394937|2017-10-10 21:32:49.394937
NCT02987478|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-06|||March 2016||2016-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|||Effect of Vitamin D Status on Clinical Pregnancy Rates Following Intra Cytoplasmic Sperm Injection|Effect of Vitamin D Status on Clinical Pregnancy Rates Following Intra Cytoplasmic Sperm Injection|Recruiting||Early Phase 1|240|Anticipated|Ain Shams Maternity Hospital|||1||f||||||||||||||2017-10-10 21:32:49.505035|2017-10-10 21:32:49.505035
NCT02987465|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-03-31|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|OPERA-CKD||Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.|An Observational, Open-label Pilot Study to Evaluate the Effect of Standard-of-care Erythropoiesis-stimulating Agents (Darbepoetin Alfa) on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.|Recruiting||N/A|24|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||2||f||||f||||||Samples Without DNA|"     Some serum samples will be collected and stored for future analysis as part of the OPERA-CKD     study.   "|Undecided||2017-10-10 21:32:49.580687|2017-10-10 21:32:49.580687
NCT02987452|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Acute Effects of Different Exercises on Blood Pressure in Hypertensive Subjects|Hemodynamic, Autonomic and Inflammatory Answers to Different Types of Exercises in Resistant Hypertensive Patients: an Metabolomic Approach|Not yet recruiting||N/A|30|Anticipated|University of Campinas, Brazil||3|||f||||f||||||||No||2017-10-10 21:32:49.70315|2017-10-10 21:32:49.70315
NCT02987439|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-08|||November 2013||2013-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD|COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD|Recruiting||N/A|150|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||No||2017-10-10 21:32:49.804808|2017-10-10 21:32:49.804808
NCT02987426|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-06-09|||May 19, 2017|Actual|2017-05-19|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|November 2019|Anticipated|2019-11-01||Interventional|||Can Brief-mindfulness Interventions Improve Psychiatric Symptoms?|Can Brief Mindfulness-oriented Interventions Improve Psychiatric Symptoms and Shorten Psychiatric Hospitalizations? A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|300|Anticipated|Lady Davis Institute||2|||f||||f|f|f||||||No||2017-10-10 21:32:49.918514|2017-10-10 21:32:49.918514
NCT02987413|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-08-04|||April 28, 2015|Actual|2015-04-28|August 2017|2017-08-01|April 5, 2017|Actual|2017-04-05|March 2016|Actual|2016-03-01||Interventional|||Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients|Safety and Efficacy of Mesenchymal Stem Cells Escalated Application in Amyotrophic Lateral Sclerosis Patients: Study Design of a Phase I Trial|Completed||Phase 1|3|Actual|Hospital e Maternidade Dr. Christóvão da Gama||1|||f||||t||||||||||2017-10-10 21:32:50.024936|2017-10-10 21:32:50.024936
NCT02987400|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-05-16|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL|"Phase II Single-arm Window-of-opportunity Study of a Combination of Obinutuzumab (GA-101) and Venetoclax (ABT-199) in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)"|Recruiting||Phase 2|21|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||No||2017-10-10 21:32:50.170931|2017-10-10 21:32:50.170931
NCT02987387|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-25|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 2024|Anticipated|2024-01-01|January 2020|Anticipated|2020-01-01||Interventional|||COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction|New Enrollment SAPIEN XT Post-Approval Study|Not yet recruiting||Phase 4|191|Anticipated|Edwards Lifesciences||1|||f||||f|f|t|f|f|t|||||2017-10-10 21:32:50.314393|2017-10-10 21:32:50.314393
NCT02987374|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-04-03|2016-12-15||May 2012||2012-05-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SLVP023|Participants between the ages of 18-30|Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization|Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization|Completed||Phase 4|10|Actual|Stanford University||1|||f||||f||||||||Yes|The NIH Human Immunology Project Consortium (HIPC) data repositories (ImmPORT) may store the results of the research assays results. Genetic data that is developed in this study may be made available to other researchers through the National Center for Biotechnology Information (NCBI) databases. Results from research assays will be labeled with a unique ID code and the volunteer identity (except for age) will not be disclosed.|2017-10-10 21:32:50.404932|2017-10-10 21:32:50.404932
NCT02987361|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|December 2016|Actual|2016-12-01||Interventional|||Effect of tDCS on Upper Extremity After Strokes|Effects of Transcranial Direct Current Stimulation on Hemiplegic Upper Extremity Function After Strokes|Recruiting||N/A|72|Anticipated|Chonbuk National University Hospital||4|||f||||f||||||||Undecided||2017-10-10 21:32:50.64923|2017-10-10 21:32:50.64923
NCT02987348|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-03-28|||June 30, 2015|Actual|2015-06-30|March 2017|2017-03-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Observational|||Clinical Outcomes of Exenatide Versus Basal Insulin|Evaluation of the Clinical and Economic Outcomes Associated With Exenatide Versus Basal Insulin in People With Type 2 Diabetes|Completed||N/A|18000|Actual|AstraZeneca|||4||f||||t||||||||||2017-10-10 21:32:50.755247|2017-10-10 21:32:50.755247
NCT02987335|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-06-29|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|||Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States|Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States|Not yet recruiting||N/A|80|Anticipated|Albert Einstein College of Medicine, Inc.|||4||f||||t|t|f||||||||2017-10-10 21:32:50.8698|2017-10-10 21:32:50.8698
NCT02987322|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-08|||November 2015||2015-11-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Honey in Idiopathic Dilated Cardiomyopathy|Honey Supplementation in Children With Idiopathic Dilated Cardiomyopathy: A Randomized Controlled Study|Completed||Phase 2/Phase 3|50|Actual|Ain Shams University||1|||f||||t||||||||Undecided|honey as a complementary or alternative treatment in cardiovascular diseases|2017-10-10 21:32:50.954998|2017-10-10 21:32:50.954998
NCT02987309|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-03-30|||March 30, 2017|Actual|2017-03-30|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Indirect Calorimetry: SensorMedics Vmax vs GE Carescape - a Method Comparison Study|Indirect Calorimetry: SensorMedics Vmax vs GE Carescape - a Method Comparison Study|Recruiting||N/A|50|Anticipated|Oslo University Hospital|||1||f||||f||||||||No||2017-10-10 21:32:51.018493|2017-10-10 21:32:51.018493
NCT02987296|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-26|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PERIOP-02||Perioperative Immunonutrition in Colorectal Cancer Patients Undergoing Abdominal Surgery|A Translational Clinical Trial of Perioperative Immunonutrition in Colorectal Cancer Patients Undergoing Abdominal Surgery: PERIOP-02|Recruiting||N/A|24|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:32:51.085398|2017-10-10 21:32:51.085398
NCT02987283|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Evaluating Accuracy of Breath Sound Recordings and STOP-Bang Screening For Obstructive Sleep Apnea While Awake|Safer Sleep: A Diagnostic Accuracy Study Evaluating Breath Sound Recordings and STOP-Bang In Screening For Obstructive Sleep Apnea While Awake|Recruiting||N/A|400|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||Undecided||2017-10-10 21:32:51.193499|2017-10-10 21:32:51.193499
NCT02987270|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-08|||April 2013||2013-04-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MSaT||Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya|Evaluation of Community-based Screening and Treatment for Malaria in the KEMRI/CDC Health and Demographic Surveillance System (HDSS) in Western Kenya|Completed||Phase 3|90000|Actual|Kenya Medical Research Institute||2|||f||||f||||||||No||2017-10-10 21:32:51.283661|2017-10-10 21:32:51.283661
NCT02987257|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-03-28|||August 2018|Anticipated|2018-08-01|March 2017|2017-03-01|August 2022|Anticipated|2022-08-01|May 2022|Anticipated|2022-05-01||Interventional|NATIENS||Cyclosporine and Etanercept in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis|Phase III Randomized Trial of the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Comparing Supportive Care, Cyclosporine, and Biologic Therapy in Adults|Not yet recruiting||Phase 3|267|Anticipated|Ottawa Hospital Research Institute||3|||f||||t|t|f|||f|||No|There are no plans to share individual participant data available to other researchers.|2017-10-10 21:32:51.405415|2017-10-10 21:32:51.405415
NCT02987244|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-06|||March 2016||2016-03-01|December 2016|2016-12-01|March 2023|Anticipated|2023-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma|Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma|Recruiting||Phase 1/Phase 2|100|Anticipated|Peking Union Medical College Hospital||1|||f||||f||||||||No||2017-10-10 21:32:51.544349|2017-10-10 21:32:51.544349
NCT02987231|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-11|||November 2016||2016-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Electrical Stimulation Effect on Coronally Advanced Flap|Electrical Stimulation Effect on Coronally Advanced Flap for the Treatment of Gingival Recession: Randomized Controlled Clinical Trial|Recruiting||N/A|60|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||Undecided||2017-10-10 21:32:51.648235|2017-10-10 21:32:51.648235
NCT02987218|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-12-06|||July 2015||2015-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Comparison of Neuroprotection by Propofol and Desflurane for POCD Following Subarachnoid Hemorrhage Surgery|Comparison Of Pharmacological Neuroprotection Provided By PROPOFOL VERSUS DESFLURANE For Long Term Postoperative Cognitive Dysfunction In Patients Undergoing Surgery For Aneurysmal Subarachnoid Hemorrhage|Completed||Phase 4|100|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||Yes||2017-10-10 21:32:51.772817|2017-10-10 21:32:51.772817
NCT02987192|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-01|||November 2016||2016-11-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Minimally Invasive Lumbar Aneasthesia Used for Cesarean Section|Comparison of the Impact Between Minimally Invasive and Traditional Spinal Anesthesia for Cesarean Section in Maternal Anticoagulation Therapy:Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|RenJi Hospital||2|||f||||f||||||||||2017-10-10 21:32:52.08118|2017-10-10 21:32:52.08118
NCT02987179|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|||Identification of Desaturation Episodes by Means of Continuous Measurement of Oxygen Saturation During Hemodialysis|Identification of Desaturation Episodes by Means of Continuous Measurement of Oxygen Saturation During Hemodialysis|Enrolling by invitation||N/A|30|Anticipated|Renal Research Institute|||1||f||||f||||||||||2017-10-10 21:32:52.203179|2017-10-10 21:32:52.203179
NCT02987166|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-06-12|||March 21, 2017|Actual|2017-03-21|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|UVA-AM-001||HDCRT Plus Pembrolizumab in Advanced Malignancies|A Pilot Study to Assess the Combination of High-Dose Conformal Radiation Therapy (HDCRT) and Pembrolizumab in Modulating Local and Systemic T-cell Responses in Advanced Malignancies|Recruiting||Phase 1|21|Anticipated|University of Virginia||3|||f||||t|t|f||||||No||2017-10-10 21:32:52.307044|2017-10-10 21:32:52.307044
NCT02987153|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|Kypho-IORT||Kypho-Intra Operative Radiation Therapy (IORT) for Localized Spine Metastasis, Phase I/II Study|Kypho-Intra Operative Radiation Therapy (IORT) for Localized Spine Metastasis, Phase I/II Study|Recruiting||N/A|22|Anticipated|Northwell Health||1|||f||||t||||||||No|No plan to share data|2017-10-10 21:32:52.447442|2017-10-10 21:32:52.447442
NCT02987140|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Understand FoG in PD: Behavioral Physiology and Clinical Application|Understand Freezing of Gait in Parkinson's Disease: Behavioral Physiology and Clinical Application|Recruiting||N/A|70|Anticipated|National Taiwan University Hospital||3|||f||||f||||||||||2017-10-10 21:32:52.561211|2017-10-10 21:32:52.561211
NCT02987127|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-06|||February 2016||2016-02-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma|Prospective Study of Frontline Helicobacter Pylori Eradication Therapy in the Treatment of Early-stage Extragastric Mucosa-associated Lymphoid Tissue Lymphoma|Recruiting||Phase 2|21|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 21:32:52.67215|2017-10-10 21:32:52.67215
NCT02987114|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-14|||February 13, 2017|Actual|2017-02-13|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy|A Phase II, Open-label, Single-center Clinical Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy|Recruiting||Phase 2|15|Anticipated|PhytoTech Therapeutics, Ltd.||1|||f||||f|f|f||||||||2017-10-10 21:32:52.758008|2017-10-10 21:32:52.758008
NCT02987101|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction|Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction|Recruiting||N/A|30|Anticipated|Odense University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:32:52.890277|2017-10-10 21:32:52.890277
NCT02987088|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-05-16|||December 2016||2016-12-01|December 2016|2016-12-01|May 2, 2017|Actual|2017-05-02|April 5, 2017|Actual|2017-04-05||Interventional|||Phase 1 Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest|Phase 1 Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest|Completed||Phase 1|120|Actual|University of Washington||1|||f||||t||||||||No||2017-10-10 21:32:53.034592|2017-10-10 21:32:53.034592
NCT02987075|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-07-12|||December 2016||2016-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Comparison of Ongoing Pregnancy Rate Between Cleavage Stage and Early Compacting Embryo Transfer at 66±2 Hours After ICSI Using Single Step Culture Medium|A Comparison of Ongoing Pregnancy Rate Between Cleavage Stage and Early Compacting Embryo Transfer at 66±2 Hours After ICSI Using Single Step Culture Medium|Recruiting||N/A|430|Anticipated|Vietnam National University||2|||f||||f||||||||||2017-10-10 21:32:53.133696|2017-10-10 21:32:53.133696
NCT02987062|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-06-07|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|April 2017|Actual|2017-04-01||Observational|CRAFT||MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT)|CRAFT - Multicenter Experience in Atrial Fibrillation Patients Treated With OAC (CRAFT)|Recruiting||N/A|2000|Anticipated|Medical University of Warsaw|||5||f||||f||||||||||2017-10-10 21:32:53.251285|2017-10-10 21:32:53.251285
NCT02987049|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Intensive Cardiac Rehabilitation (ICR): Tolerability and Effectiveness|Intensive Cardiac Rehabilitation (ICR) With the Pritikin Program: Tolerability and Effectiveness|Not yet recruiting||N/A|500|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples With DNA|"     Blood samples will be obtained and the serum or plasma will be stored for future     quantification of inflammatory cytokines and other factors related to cardiovascular disease     risk.   "|Undecided|The current plan is that individual participant data will be shared with investigators on the research team only.|2017-10-10 21:32:53.370026|2017-10-10 21:32:53.370026
NCT02987036|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-12-05|||January 2015||2015-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|||Delivery of Beta Agonists is Technique Sensitive (DOBATS)Mechanics|Administration of Beta-agonistic Drug Using Two Different Nebulizer Technologies: Effects on Lung Mechanics|Completed||N/A|30|Actual|Southeast University, China||2|||f||||f||||||||No||2017-10-10 21:32:53.46025|2017-10-10 21:32:53.46025
NCT02987023|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-05|||November 2016||2016-11-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01|7 Years|Observational [Patient Registry]|UTX-robot||Uterus Transplantation From Live Donors With Robotic Assisted Surgery - Gothenburg II|Uterus Transplantation From Live Donors With Robotic Assisted Surgery - Gothenburg II|Recruiting||N/A|10|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||t||||||Samples With DNA|"     blood, endometrial tissue, cervical tissue, placental tissue   "|No|Individual data will not be shared.|2017-10-10 21:32:53.584253|2017-10-10 21:32:53.584253
NCT02986997|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-04-27|||December 2016||2016-12-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Over 2000 Epidural Anesthesias for Percutaneous Nephrolithotomy - a Retrospective Analysis|Over 2000 Procedures of Epidural Anesthesia for Percutaneous Nephrolithotomy - a Retrospective Analysis|Recruiting||N/A|2000|Anticipated|Medical University of Warsaw|||1||f||||f||||||||No||2017-10-10 21:32:53.736567|2017-10-10 21:32:53.736567
NCT02986984|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-15|||December 2016||2016-12-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|November 2019|Anticipated|2019-11-01||Observational|TRIDENT||Transformative Research in Diabetic Nephropathy|Transformative Research In DiabEtic NephropaThy|Recruiting||N/A|300|Anticipated|University of Pennsylvania|||2||f||||t||||||Samples With DNA|"     Buffy Coat (Germline DNA) Kidney Biopsy Cores Urine and blood aliquots for RNA   "|||2017-10-10 21:32:53.821262|2017-10-10 21:32:53.821262
NCT02986971|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-08|||January 2017||2017-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Removal of Palpable Subdermal Contraceptive Rod Implants.|A Prospective, Single-centre, Non-comparative Feasibility Investigation to Evaluate Performance and Safety of RemovAid ™ Retrieval Device When Used for Removal of Palpable Subdermal Contraceptive Rod Implants.|Not yet recruiting||N/A|25|Anticipated|RemovAid AS||1|||f||||f||||||||No||2017-10-10 21:32:53.972134|2017-10-10 21:32:53.972134
NCT02986958|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-06|||August 2016||2016-08-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SAMEPage||Involving Family to Improve Communication in Primary Care|Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients|Recruiting||Phase 2/Phase 3|100|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||No||2017-10-10 21:32:54.099392|2017-10-10 21:32:54.099392
NCT02986945|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-16|||December 2016||2016-12-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Community-Partnered Participatory Development of Mobile Interventions|Community-Partnered Participatory Development of Mobile Interventions|Active, not recruiting||N/A|30|Actual|RAND||2|||f||||f||||||||No||2017-10-10 21:32:54.229986|2017-10-10 21:32:54.229986
NCT02986932|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-03-24|||December 2016||2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BBB-Alzheimers||Blood-Brain-Barrier Opening Using Focused Ultrasound With IV Contrast Agents in Patients With Early Alzheimer's Disease|A Study to Evaluate the Safety and Feasibility of Blood-Brain Barrier (BBB) Opening Using Transcranial MR-Guided Focused Ultrasound With Intravenous Ultrasound Contrast Agents in Patients With Early Alzheimer's Disease|Recruiting||N/A|6|Anticipated|InSightec||1|||f||||t||||||||No||2017-10-10 21:32:54.327669|2017-10-10 21:32:54.327669
NCT02986919|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-07-03|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors|A Phase 2 Study of CPI-0610, a Small Molecule Inhibitor of Bromodomain and Extra-Terminal (BET) Proteins, in Patients With Malignant Peripheral Nerve Sheath Tumors|Not yet recruiting||Phase 2|24|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t|t|f|||f|||||2017-10-10 21:32:54.433224|2017-10-10 21:32:54.433224
NCT02986906|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-03-01|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Perineural Injection Therapy for Ulnar Neuropathy at Elbow|The Long-term Effect for Perineural Injection Therapy for Ulnar Neuropathy at Elbow|Recruiting||N/A|40|Anticipated|Tri-Service General Hospital||2|||f||||t|f|f||||||Yes||2017-10-10 21:32:54.519842|2017-10-10 21:32:54.519842
NCT02986893|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Pilot Diet Study for Multiple Sclerosis|Pilot Study of a Dietary Intervention for Multiple Sclerosis (MS)|Recruiting||Phase 1|30|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||No||2017-10-10 21:32:54.633933|2017-10-10 21:32:54.633933
NCT02986880|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-05-24|||June 2011||2011-06-01|May 2017|2017-05-01|January 10, 2014|Actual|2014-01-10|January 10, 2014|Actual|2014-01-10||Interventional|||Effect of Type-A Botulinum Toxin in the Post-radiosurgical Neck Contractures|A Dose-response, Randomized, Double-blind Study to Evaluate the Effect of Type-A Botulinum Toxin in the Post-radiosurgical Neck Contractures|Completed||Phase 2|14|Actual|Hopital Foch||10|||f||||f||||||||No||2017-10-10 21:32:54.748305|2017-10-10 21:32:54.748305
NCT02986867|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||SAbR-induced Innate Immunity|SAbR-Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma|Not yet recruiting||N/A|72|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:32:54.861256|2017-10-10 21:32:54.861256
NCT02986841|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-09-28|||May 10, 2016|Actual|2016-05-10|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|||"A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (CDE-EHR-PC Study), Phase 2"|"A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (CDE-EHR-PC Study), Phase 2"|Recruiting||N/A|50|Anticipated|New York University School of Medicine|||1||f||||f||||||||||2017-10-10 21:32:55.110446|2017-10-10 21:32:55.110446
NCT02986828|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-07|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Platelet Rich Plasma and Hydrodissection for Carpal Tunnel Syndrome|The Long-term Effect of Platelet Rich Plasma and Hydrodissection for Patients With Carpal Tunnel Syndrome|Recruiting||N/A|30|Anticipated|Tri-Service General Hospital||2|||f||||t||||||||Yes||2017-10-10 21:32:55.188032|2017-10-10 21:32:55.188032
NCT02986815|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||[11C]Acetate PET in Patients With Glioma|[11C]Acetate PET in Patients With Glioma|Recruiting||N/A|40|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:32:55.287187|2017-10-10 21:32:55.287187
NCT02986802|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-03-15|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|August 2019|Anticipated|2019-08-01||Observational|PCORIHSV||Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes|Comparative Effectiveness of Treatment Options for Genital Herpes Infection in Pregnant Women to Reduce Adverse Pregnancy Outcomes|Recruiting||N/A|1200|Anticipated|Kaiser Permanente|||4||f||||f||||||||No||2017-10-10 21:32:55.385414|2017-10-10 21:32:55.385414
NCT02986789|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-04-14|||December 2016||2016-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:32:55.463146|2017-10-10 21:32:55.463146
NCT02986776|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-06|||August 2002||2002-08-01|December 2016|2016-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Treatment Settings for Those With an Alcohol Problem|Treatment Settings for Alcoholics: A Field Extension|Completed||N/A|176|Actual|State University of New York at Buffalo||4|||f||||f||||||||||2017-10-10 21:32:55.502291|2017-10-10 21:32:55.502291
NCT02986763|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-06|||June 2015||2015-06-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|SIGEXPOSOME||Evaluation of Pesticide Exposure in the General Population|Evaluation of Pesticide Exposure in the General Population: Use of Spatial, Environmental, Toxicological and Biological Approaches|Active, not recruiting||N/A|166|Actual|Centre Leon Berard|||2||f||||f||||||||||2017-10-10 21:32:55.572312|2017-10-10 21:32:55.572312
NCT02986750|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-19|||June 13, 2016|Actual|2016-06-13|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|February 23, 2017|Actual|2017-02-23||Interventional|||Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome||Recruiting||Phase 4|120|Anticipated|Medical University of Vienna||3|||f||||f||||||||||2017-10-10 21:32:55.647047|2017-10-10 21:32:55.647047
NCT02986737|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-07-20|||December 2014||2014-12-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|March 2015|Actual|2015-03-01||Interventional|TALP-FIM||ACURATE Neo™ Aortic Bioprosthesis for Implantation Using the ACURATE TA™ LP Transapical Delivery System in Patients With Severe Aortic Stenosis|ACURATE Neo™ Aortic Bioprosthesis for Implantation Using the ACURATE TA™ LP Transapical Delivery System in Patients With Severe Aortic Stenosis|Active, not recruiting||N/A|15|Actual|Symetis SA||1|||f||||t||||||||||2017-10-10 21:32:55.742955|2017-10-10 21:32:55.742955
NCT02986724|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|CHRONOS||A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants Wtih Ulcerative Colitis (UC) or Crohn´s Disease (CD)|CHRONOS - A Multicenter, Non - Interventional Study to Observe the Safety and Efficacy of Vedolizumab (Entyvio) in Patients With Ulcerative Colitis or Crohn´s Disease That Are Biologic naïve, Observed in Daily Practice in Austria|Recruiting||N/A|150|Anticipated|Takeda|||1||f||||f||||||||||2017-10-10 21:32:55.827532|2017-10-10 21:32:55.827532
NCT02986711|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-12-05|||December 2013||2013-12-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Penn State TXT2STAYQUIT Study- a Texting Study to Help Hospitalized Smokers Stay Quit|Pilot Randomized Trial of Brief Automated Smoking Cessation Intervention and Evaluation for Smokers Discharged From Hospital|Terminated||N/A|158|Actual|Milton S. Hershey Medical Center||2||Funding exhausted|f||||f||||||||No||2017-10-10 21:32:55.916184|2017-10-10 21:32:55.916184
NCT02986698|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-10-05|||October 5, 2017|Actual|2017-10-05|October 2017|2017-10-01|February 2024|Anticipated|2024-02-01|February 2022|Anticipated|2022-02-01||Interventional|||In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)|A Single-Center, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Alpha Thalassemia Major|Recruiting||Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||f|t|f||||||||2017-10-10 21:32:56.182847|2017-10-10 21:32:56.182847
NCT02986685|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-05|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|rRE||Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole|The Clinical Efficacy and Safety of Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole|Recruiting||Phase 4|500|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||f||||||||No|De-identified individual participant data for all primary and secondary outcome measures will be made available within 6 months of study completion|2017-10-10 21:32:56.351098|2017-10-10 21:32:56.351098
NCT02986672|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-05-02|||September 2017|Anticipated|2017-09-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)|ADHD and Nutrition: The Influence of Omega-3 on ADHD Related Symptoms|Not yet recruiting||N/A|330|Anticipated|University Hospital of North Norway||2|||f||||f|f|f||||||Undecided||2017-10-10 21:32:56.480719|2017-10-10 21:32:56.480719
NCT02986659|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-07-24|||October 2016||2016-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|GOMET||Genomic Outcomes of Metformin|Genomic Outcomes of Metformin|Recruiting||Phase 4|35|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-10 21:32:56.59944|2017-10-10 21:32:56.59944
NCT02986646|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-07|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Comparison of Intra-articular and Intra-tendinous Injections for Treatment of Lateral Epicondylitis|Comparison of Intra-articular and Intra-tendinous Injections for Treatment of Lateral Epicondylitis: A Randomized, Controlled Trial|Not yet recruiting||N/A|114|Anticipated|University of Missouri, Kansas City|||3||f||||f||||||||No||2017-10-10 21:32:56.739079|2017-10-10 21:32:56.739079
NCT02986633|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-06|||December 2014||2014-12-01|December 2016|2016-12-01|December 2025|Anticipated|2025-12-01|September 2025|Anticipated|2025-09-01|10 Years|Observational [Patient Registry]|Echo-CRT||Echocardiography in Cardiac Resynchronization Therapy (Echo-CRT)|Prediction of Response to Cardiac Resynchronization Therapy by New Echocardiographic Methods|Recruiting||N/A|1000|Anticipated|Lille Catholic University|||1||f||||f||||||||||2017-10-10 21:32:56.824245|2017-10-10 21:32:56.824245
NCT02986074|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-05-16|||November 2016||2016-11-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CRISP||CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies|CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies|Enrolling by invitation||N/A|50|Anticipated|St. Jude Medical||2|||f||||f||||||||Yes||2017-10-10 21:33:03.89191|2017-10-10 21:33:03.89191
NCT02986607|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-09|||March 2016||2016-03-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Corticosteroid Rhythms in Hypoparathyroid Patients|Corticosteroid Rhythms in Hypoparathyroid Patients|Recruiting||Early Phase 1|30|Anticipated|University of Bergen||1|||f||||t||||||||No||2017-10-10 21:32:57.049714|2017-10-10 21:32:57.049714
NCT02986594|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-08|||November 2016||2016-11-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla|Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine|Recruiting||Phase 4|600|Anticipated|Shanghai First Maternity and Infant Hospital||3|||f||||||||||||||2017-10-10 21:32:57.16043|2017-10-10 21:32:57.16043
NCT02986581|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-12-06|||November 2016||2016-11-01|October 2016|2016-10-01|November 2021|Anticipated|2021-11-01|November 2017|Anticipated|2017-11-01|3 Months|Observational [Patient Registry]|||Prospective Cohort Study of Rapid Response Team||Recruiting||N/A|79800|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-10 21:32:57.275285|2017-10-10 21:32:57.275285
NCT02986568|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-12-06|||May 2016||2016-05-01|December 2016|2016-12-01||||December 2023|Anticipated|2023-12-01||Interventional|FUSION IV||Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers|Cohort Study for Comparing the Efficacy Between the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers (FUSION Trial IV)|Recruiting||N/A|300|Anticipated|Seoul National University Hospital||6|||f||||t||||||||Undecided||2017-10-10 21:32:57.383516|2017-10-10 21:32:57.383516
NCT02986555|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation|Virtual Reality Stress and Relief Project, Research on Quantification of VR Related Stress, Motion Sickness and Visual Fatigue|Recruiting||N/A|80|Anticipated|Samsung Medical Center||2|||f||||f||||||||No||2017-10-10 21:32:57.548596|2017-10-10 21:32:57.548596
NCT02986542|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-08-12|||December 2016||2016-12-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Success Rates of Femoral Artery Catheterization|Comparison of Success Rates of Femoral Artery Catheterization for Newborns With In-plane and Out-of-plane Ultrasonography Techniques|Recruiting||N/A|80|Anticipated|Kahramanmaras Sutcu Imam University||2|||f||||f||||||||||2017-10-10 21:32:57.711125|2017-10-10 21:32:57.711125
NCT02986529|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects|A Double-blind, Randomized, Three-period, Three-way Crossover Design, Placebo Controlled Single Dose Study to Assess the Bioavailability of Sodium Oligo-mannurarate (GV-971) Capsule 150 mg, 300mg, 450mg in Healthy Chinese Male Subjects|Recruiting||Phase 1|15|Anticipated|Shanghai Greenvalley Pharmaceutical Co., Ltd.||4|||f||||||||||||||2017-10-10 21:32:57.874145|2017-10-10 21:32:57.874145
NCT02986516|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-09-23|||March 16, 2017|Actual|2017-03-16|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|SACRO||Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease|Title of Study: SAcral Chordoma: a Randomized & Observational Study on Surgery Versus Definitive Radiation Therapy in Primary Localized Disease (SACRO)|Recruiting||N/A|100|Anticipated|Italian Sarcoma Group||2|||f||||f|f|f||||||||2017-10-10 21:32:58.025276|2017-10-10 21:32:58.025276
NCT02986503|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-05|||January 2002||2002-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|December 2015|Actual|2015-12-01||Observational|EUROBOSS||European Study in Bone Sarcoma Patients Over 40 Years|A European Treatment Protocol for Bone-sarcoma in Patients Older Than 40 Years|Completed||N/A|100|Actual|Italian Sarcoma Group|||2||f||||f||||||||Yes|Anonymized results will be available upon request at the end of the study and public available into the repository systems like Clinicaltrial.gov|2017-10-10 21:32:58.266316|2017-10-10 21:32:58.266316
NCT02986490|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-12-05|||September 2014||2014-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs|Influence of Magnesium Variations (Serum and Intra-erythrocyte) on Markers of Cardiometabolic Risk in Long-term Prescription of Antipsychotic Drugs: a Prospective Cohort Study|Recruiting||N/A|100|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:32:58.366782|2017-10-10 21:32:58.366782
NCT02986477|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-13|||January 2017||2017-01-01|December 2016|2016-12-01|January 2027|Anticipated|2027-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Clinical Applications of Contrast-Enhanced Ultrasonography in Pediatric Population - Intravesicle Administration|Clinical Applications of Contrast-Enhanced Ultrasonography in Pediatric Population - Intravesicle Administration|Not yet recruiting||N/A|2000|Anticipated|Johns Hopkins University||1|||f||||t||||||||No||2017-10-10 21:32:58.453669|2017-10-10 21:32:58.453669
NCT02986464|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-12|||May 3, 2017|Actual|2017-05-03|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Virtual Reality Distraction for Procedural Pain Management in Children With Burn Injuries: a Randomized Controlled Trial|Virtual Reality Distraction for Procedural Pain Management in Children With Burn Injuries: a Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|St. Justine's Hospital||2|||f||||f|f|f||||||||2017-10-10 21:32:58.516338|2017-10-10 21:32:58.516338
NCT02986451|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma|Efficacy and Safety Study of BiRD (Biaxin [Clarithromycin]/Revlimid [Lenalidomide]/Dexamethasone) Combination Therapy in Relapsed/Refractory Myeloma|Recruiting||Phase 2|60|Anticipated|Sun Yat-sen University||1|||f||||f||||||||No||2017-10-10 21:32:58.630863|2017-10-10 21:32:58.630863
NCT02986061|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01||||January 2017|Anticipated|2017-01-01||Interventional|||To Catheterize or Not? in Total Knee Arthroplasty With Combined Spinal-epidural Analgesia||Recruiting||N/A|200|Anticipated|Southwest Hospital, China||2|||f||||t||||||||No||2017-10-10 21:33:04.008426|2017-10-10 21:33:04.008426
NCT02986438|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-07-20|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TMS_COC_CONN||Treatment With Transcranial Magnetic Stimulation for Cocaine Addiction: Clinical Response and Functional Connectivity.|Effects of Transcranial Magnetic Stimulation on Functional Connectivity and Response to Treatment of Cocaine Dependent Patients|Recruiting||N/A|40|Anticipated|Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente||4|||f||||f|f|f|||f|||||2017-10-10 21:32:58.758358|2017-10-10 21:32:58.758358
NCT02986425|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-07-19|||December 2016||2016-12-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|OPERAM||OPtimising thERapy to Prevent Avoidable Hospital Admissions in the Multimorbid Older People|OPERAM: OPtimising thERapy to Prevent Avoidable Hospital Admissions in the Multimorbid Older People: a Cluster Randomised Controlled Trial|Recruiting||N/A|2000|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 21:32:58.865667|2017-10-10 21:32:58.865667
NCT02986412|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-19|||July 2016||2016-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|VOLUME2||A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2)|Evaluation of the Impact of a Topical Lotion, CG428, on Permanent Chemotherapy Induced Hair and Scalp Disorders in Cancer Survivors: An Open-label 6 Months Extension of VOLUME Study.|Active, not recruiting||N/A|19|Actual|Samsung Medical Center||1|||f||||f||||||||Undecided||2017-10-10 21:32:58.988783|2017-10-10 21:32:58.988783
NCT02986399|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-08-23|||January 2012||2012-01-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Fast Track Hip Fracture - an Optimized Pathway for Hip Fracture Patients|Influence of a Fast Track Pathway for Hip Fracture Patients on Mortality and Quality of Life|Active, not recruiting||N/A|2490|Anticipated|University Hospital, Akershus|||2||f||||f||||||||||2017-10-10 21:32:59.071743|2017-10-10 21:32:59.071743
NCT02986386|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-05|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SOECS||Oral Health for Healthy Cognitive Aging|Oral Health for Healthy Cognitive Aging|Recruiting||N/A|150|Anticipated|Universidad de Granada||4|||f||||f||||||||||2017-10-10 21:32:59.171028|2017-10-10 21:32:59.171028
NCT02986360|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-07-11|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Informed Implementation of Breast Density Reporting|Informed Implementation of Breast Density Reporting|Recruiting||N/A|400|Anticipated|Brigham and Women's Hospital||2|||f||||f|f|f||||||||2017-10-10 21:32:59.427227|2017-10-10 21:32:59.427227
NCT02986347|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-06-27|||May 27, 2017|Actual|2017-05-27|June 2017|2017-06-01|June 1, 2018|Anticipated|2018-06-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Surgical Treatment of Carpal Tunnel Syndrome: Local Anesthesia With Epinephrine x Intravenous Regional Anesthesia.|Surgical Treatment of Carpal Tunnel Syndrome: Local Anesthesia With Epinephrine x Intravenous Regional Anesthesia. Randomized Clinical Trial.|Recruiting||N/A|78|Anticipated|Hospital Alvorada||2|||f||||t|f|f||||||No||2017-10-10 21:32:59.505105|2017-10-10 21:32:59.505105
NCT02986334|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-07|||August 2016||2016-08-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|PICP2||Placebo In Chronic Back Pain (Phase 2)|Brain Mechanisms For Clinical Placebo in Chronic Pain: A Randomized Clinical Trial of Placebo, Active Treatment, and No Treatment in Chronic Back Pain|Recruiting||Phase 4|210|Anticipated|Northwestern University||3|||f||||t||||||||No||2017-10-10 21:32:59.599837|2017-10-10 21:32:59.599837
NCT02986321|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PIONEER||A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD|A 24-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active Controlled, Parallel Group, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF6001 DPI in Patients With COPD on a Background Therapy|Not yet recruiting||Phase 2|1102|Anticipated|Chiesi Farmaceutici S.p.A.||6|||f||||f||||||||Undecided||2017-10-10 21:32:59.710015|2017-10-10 21:32:59.710015
NCT02986308|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-12-05|||June 2016||2016-06-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01|10 Days|Observational [Patient Registry]|||The Metabolomics of Intestinal Polyps of Different Pathological Types and TCM Syndromes and TCM Constitution Types|The Metabolomics of Intestinal Polyps of Different Pathological Types and TCM Syndromes and TCM Constitution Types|Recruiting||N/A|1000|Anticipated|First Affiliated Hospital of Harbin Medical University|||2||f||||||||||Samples With DNA|"     serum   "|No||2017-10-10 21:32:59.811203|2017-10-10 21:32:59.811203
NCT02986295|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-06|||April 2016||2016-04-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|December 2018|Anticipated|2018-12-01|2 Years|Observational [Patient Registry]|SMARTDESK-MX||Real World Drug-Eluting Stent Prospective, Open, Multi-site, Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent By SMart Angioplastry Research Team (SMARTDESK-MX)|Real World Drug-Eluting Stent Prospective, Open, Multi-site, Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent By SMart Angioplastry Research Team (SMARTDESK-MX)|Recruiting||N/A|2000|Anticipated|Samsung Medical Center|||2||f||||f||||||||No||2017-10-10 21:32:59.887588|2017-10-10 21:32:59.887588
NCT02986282|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-06-19|2017-05-09||October 2012||2012-10-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|AFABI||Ankle - Brachial Index Measurement in Atrial Fibrillation|Ankle - Brachial Index Measurement in Patients With Atrial Fibrillation Before and After Electrical Cardioversion|Completed||N/A|115|Actual|Medical University of Warsaw||1|||f||||f||||||||Yes|Raw data will be attached to manuscript.|2017-10-10 21:33:01.785453|2017-10-10 21:33:01.785453
NCT02986269|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-05|||January 2017||2017-01-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|VINHO||PSV on Ventilation Inhomogeneity and Lung Function in Patients Under SB Across LMA|The Value of Pressure Support on Ventilation Inhomogeneity and Lung Function in Patients Under Spontaneous Breathing (SB)Across Laryngeal Mask Airway|Not yet recruiting||N/A|40|Anticipated|University Hospital, Geneva||2|||f||||f||||||||No||2017-10-10 21:33:02.080287|2017-10-10 21:33:02.080287
NCT02986256|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|TELEPIED||Evaluation of the Management of Diabetic Foot Ulcers by Telemedicine on the Number of Hospital Days in Diabetic Patients|Comparative Study, Randomized in Parallel Groups, Evaluating the Consequences of the Management of Diabetic Foot Ulcers by Telemedicine Versus Conventional Monitoring on the Number of Hospital Days in Diabetic Patients|Recruiting||N/A|180|Anticipated|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||No||2017-10-10 21:33:02.227356|2017-10-10 21:33:02.227356
NCT02986243|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-03|||February 2016||2016-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FFC||Preparing for Kidney Transplant by Attaining a Healthy Weight|Preparing for Kidney Transplant by Attaining a Healthy Weight|Enrolling by invitation||N/A|16|Anticipated|University of Chicago||1|||f||||f||||||||No||2017-10-10 21:33:02.341706|2017-10-10 21:33:02.341706
NCT02986230|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-06-09|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|March 2019|Anticipated|2019-03-01||Interventional|CPW||Cancer Prevention Clinical Decision Support|Implementing Cancer Prevention Using Patient-Provider Clinical Decision Support|Not yet recruiting||N/A|150000|Anticipated|HealthPartners Institute||2|||f||||t|f|f||||||No||2017-10-10 21:33:02.415884|2017-10-10 21:33:02.415884
NCT02986217|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2016-12-30|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|CSATS||The Effect of Structured Feedback on Live Surgical Performance|The Effect of Structured Feedback on Live Surgical Performance: A Single-Blind Randomized Control Trial|Enrolling by invitation||N/A|80|Anticipated|George Washington University||2|||f||||f||||||||Undecided||2017-10-10 21:33:02.50481|2017-10-10 21:33:02.50481
NCT02986204|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-09|||January 2017||2017-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ENG||Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant|Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant|Not yet recruiting||N/A|40|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 21:33:02.56561|2017-10-10 21:33:02.56561
NCT02986191|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-05-09|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||The Use of Mucograft® to Treat Gingival Recession|Clinical Applications of 3D Collagen Matrix (Mucograft®) in the Management of Gingival Recession: a Randomized Controlled Trial|Active, not recruiting||N/A|20|Actual|Damascus University||2|||f||||t||||||||No||2017-10-10 21:33:02.667286|2017-10-10 21:33:02.667286
NCT02986178|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-21|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|May 2023|Anticipated|2023-05-01|May 2021|Anticipated|2021-05-01||Interventional|||PVSRIPO With/Without Lomustine|A Randomized Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) Alone or in Combination With Lomustine in Recurrent WHO Grade IV Malignant Glioma Patients|Recruiting||Phase 2|62|Anticipated|Duke University||2|||f||||t|t|f||||||||2017-10-10 21:33:02.88417|2017-10-10 21:33:02.88417
NCT02986165|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-04-26|||September 2016||2016-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|Tomasa||Effect of Ingesting a Tomato Pomace Extract on Platelet Aggregation|Efficacy of a Tomato Pomace Extract for Inhibiting Platelet Aggregation|Enrolling by invitation||N/A|114|Anticipated|Centro de Estudios en Alimentos Procesados||3|||f||||f||||||||No||2017-10-10 21:33:03.011577|2017-10-10 21:33:03.011577
NCT02986152|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-06-29|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Cancer Distress Coach Mobile App Trial|Cancer Distress Coach Mobile App Randomized Controlled Trial|Recruiting||N/A|1000|Anticipated|Duke University||2|||f||||f|f|f||||||No||2017-10-10 21:33:03.10747|2017-10-10 21:33:03.10747
NCT02986139|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-14|||November 29, 2016|Actual|2016-11-29|September 2017|2017-09-01|October 9, 2017|Anticipated|2017-10-09|September 8, 2017|Actual|2017-09-08||Interventional|||Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adult Subjects With RA or PsA|A Multicenter, Randomized, Double-blind, Crossover Study to Assess the Injection Site Pain Associated With a Modified Etanercept Formulation in Adult Subjects With Either Rheumatoid Arthritis or Psoriatic Arthritis|Active, not recruiting||Phase 3|111|Actual|Amgen||2|||f||||f||||||||||2017-10-10 21:33:03.219495|2017-10-10 21:33:03.219495
NCT02986126|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-05-04|||May 4, 2017|Actual|2017-05-04|May 2017|2017-05-01|October 31, 2019|Anticipated|2019-10-31|August 30, 2019|Anticipated|2019-08-30||Interventional|RADD||Resilience Against Depression Disparities (Also Known as Resilience Education to Reduce Depression Disparities)|Resilience Against Depression Disparities (Also Known as Resilience Education to Reduce Depression Disparities)|Recruiting||N/A|320|Anticipated|University of California, Los Angeles||2|||f||||t|f|f||||||Undecided|We will work with the Patient-Centered Outcomes Research Institute (PCORI) staff as the findings emerge to determine the potential value of some or all of the dataset being made publicly available, which would require additional funding from PCORI to complete. In general PCORI works with investigators to make a complete, cleaned, de-identified final data set with detailed descriptions contained within the study protocol available to PCORI for use as a publicly available dataset after study completion.|2017-10-10 21:33:03.383762|2017-10-10 21:33:03.383762
NCT02986113|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|||Men and Providers Preventing Suicide (MAPS)|Men and Providers Preventing Suicide (MAPS): A Randomized Controlled Trial|Recruiting||N/A|380|Anticipated|University of California, Davis||2|||f||||t||||||||No||2017-10-10 21:33:03.529156|2017-10-10 21:33:03.529156
NCT02986100|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-07-20|||November 2016|Actual|2016-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|AME||Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib|An Open-Label, Non-Randomized, Phase I Study to Assess the Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib in Patients With Advanced Solid Tumors|Recruiting||Phase 1|6|Anticipated|Clovis Oncology, Inc.||1|||f||||f||||||||||2017-10-10 21:33:03.666027|2017-10-10 21:33:03.666027
NCT02986087|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-06|2017-09-18|||November 2016||2016-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FETO||Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia|Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia|Recruiting||N/A|5|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-10 21:33:03.789652|2017-10-10 21:33:03.789652
NCT02986022|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-07-13|||November 2016||2016-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||A Psychological Intervention to Enhance Resilience in Mainland New Immigrants to Hong Kong|A Psychological Intervention to Enhance Resilience in Mainland New Immigrants to Hong Kong|Recruiting||N/A|200|Anticipated|City University of Hong Kong||2|||f||||f||||||||||2017-10-10 21:33:04.24585|2017-10-10 21:33:04.24585
NCT02986009|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Be Good Parents (Parent Education)|Be Good Parents (Parent Education)|Not yet recruiting||N/A|300|Anticipated|City University of Hong Kong||2|||f||||f||||||||No||2017-10-10 21:33:04.355935|2017-10-10 21:33:04.355935
NCT02985996|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-04-09|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities|Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities|Recruiting||Phase 1|90|Anticipated|Emory University||3|||f||||f|f|f||||||||2017-10-10 21:33:04.480476|2017-10-10 21:33:04.480476
NCT02985983|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of KHK4827 in Subjects With Axial Spondyloarthritis (axSpA)|A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of KHK4827 in Subjects With Axial Spondyloarthritis|Recruiting||Phase 3|120|Anticipated|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||No||2017-10-10 21:33:04.661946|2017-10-10 21:33:04.661946
NCT02985970|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-04-21|||December 2016||2016-12-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Observational|RSICZ||Rapid Sequence Induction Czech Republic: Survey|Rapid Sequence Induction in Czech Republic: Survey|Completed||N/A|164|Actual|Brno University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:33:04.962451|2017-10-10 21:33:04.962451
NCT02985957|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-10-04|||March 17, 2017|Actual|2017-03-17|October 2017|2017-10-01|March 24, 2022|Anticipated|2022-03-24|December 16, 2018|Anticipated|2018-12-16||Interventional|CheckMate 650||A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer|A Phase 2 Trial of Nivolumab Plus Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 2|90|Anticipated|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 21:33:05.052878|2017-10-10 21:33:05.052878
NCT02985944|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-07|||June 2016||2016-06-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Withdrawal Time and Use of Wide-angle Endoscope to Increase the Adenoma Detection Rate of Screening Colonoscopy|Effect of a Longer Withdrawal Time or of the Use of a Wide-angle Endoscope on the Adenoma Detection Rate of Screening Colonoscopy|Recruiting||N/A|1000|Anticipated|ASST Rhodense|||4||f||||t||||||||No||2017-10-10 21:33:05.211826|2017-10-10 21:33:05.211826
NCT02985931|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-04|||May 2012||2012-05-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Single-scan Rest/Stress Imaging With Cadmium Zinc Telluride-based SPECT for Coronary Flow Quantification|Single-scan Rest/Stress Imaging With Cadmium Zinc Telluride-based SPECT for Coronary Flow Quantification|Completed||N/A|30|Actual|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-10 21:33:05.32123|2017-10-10 21:33:05.32123
NCT02985918|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-12|||January 2017||2017-01-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||High-intensity Versus Conventional-intensity Noninvasive Positive Pressure Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: the HAPPEN Study (HAPPEN)|High-intensity Versus Conventional-intensity Noninvasive Positive Pressure Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: a Multicenter, Randomized, Controlled Trial|Not yet recruiting||N/A|600|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||No||2017-10-10 21:33:05.398826|2017-10-10 21:33:05.398826
NCT02985905|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-06|||July 2011||2011-07-01|December 2016|2016-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Effect of Oral Zinc Supplementation on Thiol Oxido-reductive Index|The Effect of Oral Zinc Supplementation on Thiol Oxido-reductive Index and Thiol Related Enzymes in Spermatozoa of Iraqi Asthenospermic Patients|Completed||Phase 2|120|Actual|Babylon University||2|||f||||f||||||||Yes|I plan to publish the results in a scientific journal|2017-10-10 21:33:05.477861|2017-10-10 21:33:05.477861
NCT02985892|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-05|||October 2016||2016-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Association of Trunk Stretching and Segmental Stabilization Exercises in Chronic Unspecific Low Back Pain|Effects of Association of Trunk Stretching and Segmental Stabilization Exercises in Chronic Unspecific Low Back Pain: a Randomized Clinical Trial|Recruiting||N/A|34|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 21:33:05.55965|2017-10-10 21:33:05.55965
NCT02985866|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-27|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|iDCL||The International Diabetes Closed Loop (iDCL) Trial: Protocol 1|Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial: A Randomized Clinical Trial to Assess the Efficacy of Adjunctive Closed Loop Control Versus Sensor-Augmented Pump Therapy in the Management of Type 1 Diabetes|Not yet recruiting||N/A|126|Anticipated|University of Virginia||2|||f||||t|f|t|t|f||||||2017-10-10 21:33:05.843355|2017-10-10 21:33:05.843355
NCT02985853|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-05|||March 2008||2008-03-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|LABS-3||Longitudinal Assessment of Bariatric Surgery Sub-Study|Longitudinal Assessment of Bariatric Surgery Sub-Study: A Prospective, Longitudinal Cohort Study of the Mechanisms for Improvement of Type 2 Diabetes Following Bariatric Surgery (LABS-3 DIABETES)|Active, not recruiting||N/A|39|Actual|Oregon Health and Science University|||1||f||||t||||||Samples With DNA|"     serum, plasma   "|No||2017-10-10 21:33:06.011838|2017-10-10 21:33:06.011838
NCT02985840|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-01-25|||October 2013||2013-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department|Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department|Recruiting||Phase 4|144|Anticipated|OhioHealth||2|||f||||f||||||||No||2017-10-10 21:33:06.072382|2017-10-10 21:33:06.072382
NCT02985827|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-05|||December 2015||2015-12-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)|An Open-Label, Single-Center Study to Evaluate Symptom Response and Tear Film Cooling Dynamics of Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)|Completed||Phase 4|49|Actual|ORA, Inc.||2|||f||||f||||||||No||2017-10-10 21:33:06.190935|2017-10-10 21:33:06.190935
NCT02985814|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-06|||February 2015||2015-02-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01|2 Months|Observational [Patient Registry]|||Identifying Patients With the COPD-Asthma Overlap Phenotype: Therapeutic Implications|Identifying Patients With the COPD-Asthma Overlap Phenotype: Therapeutic Implications|Recruiting||N/A|250|Anticipated|Clalit Health Services|||1||f||||f||||||||No||2017-10-10 21:33:06.278255|2017-10-10 21:33:06.278255
NCT02985801|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-06-07|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer|Pancreatic Enzyme Replacement Therapy (PERT) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:33:06.363346|2017-10-10 21:33:06.363346
NCT02985788|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-12-05|||September 2016||2016-09-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Self Digital Photography for Assessing Elbow Range of Motion|Validation of Self Digital Photography for Assessing Elbow Range of Motion|Recruiting||N/A|50|Anticipated|Mayo Clinic|||2||f||||f||||||||Undecided||2017-10-10 21:33:06.499259|2017-10-10 21:33:06.499259
NCT02985775|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preemptive Adoptive CMV-CTL Infusion to Prevent Refractory CMV Infection Post Haplo-HSCT|Evaluate the Safety and Efficacy of Preemptive Adoptive CMV-pp65 Specific T Cells Infusion for Prevention of Refractory CMV Infection in Patients After Haploidentical Stem Cell Transplantation|Recruiting||Phase 1/Phase 2|41|Anticipated|Peking University People's Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:33:06.575846|2017-10-10 21:33:06.575846
NCT02985749|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-09-06|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder|A Pilot Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder|Recruiting||Phase 3|60|Anticipated|Massachusetts General Hospital||1|||f||||f|t|f||||||||2017-10-10 21:33:06.776875|2017-10-10 21:33:06.776875
NCT02985736|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-03-02|||September 2016||2016-09-01|March 2017|2017-03-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|||Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray|An Open-Label, Study Evaluating Topicort® Topical Spray 0.25% (Desoximetasone) in Patients With Scalp Psoriasis|Completed||Phase 4|20|Actual|Psoriasis Treatment Center of Central New Jersey||1|||f||||f||||||||No||2017-10-10 21:33:06.915083|2017-10-10 21:33:06.915083
NCT02985723|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-05|||March 2013||2013-03-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|VICTORI||Visual Outcome, Cylinder Correction and Patient Satisfaction After Implantation of AT LISA Tri Toric 939MP Intraocular Lenses|Prospective Study to Evaluate the Visual Outcome, Cylinder Correction and Patient Satisfaction After Implantation of AT LISA Tri Toric 939MP Intraocular Lenses|Completed||Phase 4|||Carl Zeiss Meditec AG||1|||f||||||||||||||2017-10-10 21:33:07.003917|2017-10-10 21:33:07.003917
NCT02985710|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-12-05|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan|Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan|Recruiting||N/A|100|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Yes|Scientific publication at the end of the study|2017-10-10 21:33:07.061384|2017-10-10 21:33:07.061384
NCT02985697|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-06|||January 2017||2017-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety and Efficacy of Intranasal Dexmedetomidine|Safety and Efficacy of Intranasal Dexmedetomidine as a Sedative in Pediatric Dentistry: a Randomized, Double-blind Clinical Study|Not yet recruiting||Phase 4|100|Anticipated|Bon Secours Pediatric Dental Associates||4|||f||||t||||||||No||2017-10-10 21:33:07.167034|2017-10-10 21:33:07.167034
NCT02985684|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-04-05|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|January 2022|Anticipated|2022-01-01|July 2018|Anticipated|2018-07-01||Interventional|ASSURED||Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs|GORE® CARDIOFORM ASD Occluder Clinical Study: A Study to Evaluate Safety and Efficacy in the Treatment of Transcatheter Closure of Ostium Secundum Atrial Septal Defects (ASDs) - The Gore ASSURED Clinical Study|Recruiting||N/A|520|Anticipated|W.L.Gore & Associates||1|||f||||t|f|t|f|||||No||2017-10-10 21:33:07.26509|2017-10-10 21:33:07.26509
NCT02985489|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-02|||January 2017||2017-01-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Pre-Operative Parenteral Nutrition in Malnourished Patients|Preoperative PN Therapy in Malnourished Patients With IBD - A Randomized Controlled Trial|Not yet recruiting||Phase 4|162|Anticipated|University of Calgary||2|||f||||f||||||||No||2017-10-10 21:33:08.991646|2017-10-10 21:33:08.991646
NCT02985671|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-02-14|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|Eiffel||To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.|National Clinical Study, Phase III, Multicenter, Randomized, Open, Controlled, Parallel, to Evaluate the Superiority of the Fixed Association (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to the Drug Comparator Voltaren® (Diclofenac Sodium 50mg), in the Treatment of Acute Episode of Mechanical Postural Low Back Pain.|Not yet recruiting||Phase 3|110|Anticipated|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f|f|f||||||No||2017-10-10 21:33:07.348994|2017-10-10 21:33:07.348994
NCT02985658|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-29||||||December 2016|2016-12-01||||||||Expanded Access|||Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer|Expanded Access Protocol With ABT-888 (Veliparib) in Patients With Metastatic BRCA-Mutation Associated or Triple Negative Breast Cancer|Available||N/A|||University of Washington|||||||||||||||||||2017-10-10 21:33:07.542954|2017-10-10 21:33:07.542954
NCT02985645|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Graftless Maxillary Sinus Augmentation With CGF Utilizing DIVA System|Graftless Maxillary Sinus Augmentation With CGF Utilizing DIVA System|Not yet recruiting||N/A|20|Anticipated|Western Galilee Hospital-Nahariya||1|||f||||f||||||||||2017-10-10 21:33:07.661031|2017-10-10 21:33:07.661031
NCT02985632|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-02-02|||January 11, 2017|Anticipated|2017-01-11|February 2017|2017-02-01|July 7, 2017|Anticipated|2017-07-07|May 18, 2017|Anticipated|2017-05-18||Interventional|||A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants|Single-dose Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||3||Business objectives have changed.|f||||f||||||||||2017-10-10 21:33:07.780861|2017-10-10 21:33:07.780861
NCT02985619|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-03|||August 2015||2015-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|BEVATAAC||Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema|Randomized Trial Evaluating Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema|Completed||Phase 2/Phase 3|74|Actual|University of Sao Paulo||2|||f||||t||||||||Yes||2017-10-10 21:33:07.875539|2017-10-10 21:33:07.875539
NCT02985606|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||How Does Altering the Timing of Pre-exercise Low-dose Caffeine Ingestion Affect Endurance Exercise Performance||Recruiting||N/A|15|Anticipated|University of Exeter||4|||f||||f||||||||||2017-10-10 21:33:07.964738|2017-10-10 21:33:07.964738
NCT02985593|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-14|||December 2016||2016-12-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis|A Phase 1, Single-Blind, Randomized, Placebo-Controlled, Single-Dose or Open-Label Multiple-Dose Study of KHK4083 in Healthy Adults and Subjects With Ulcerative Colitis|Active, not recruiting||Phase 1|52|Anticipated|Kyowa Hakko Kirin Co., Ltd||2|||f||||t||||||||||2017-10-10 21:33:08.100467|2017-10-10 21:33:08.100467
NCT02985580|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-12-02|||October 2013||2013-10-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Blueberry Juice Consumption on Cognitive Function in Healthy Older People|Effects of Blueberry Juice Consumption on Brain Activation and Perfusion in Healthy Older People|Completed||N/A|26|Actual|University of Exeter||2|||f||||f||||||||No||2017-10-10 21:33:08.198674|2017-10-10 21:33:08.198674
NCT02985567|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-05|||September 2013||2013-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children|An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children|Completed||N/A|324|Actual|Johns Hopkins University|||2||f||||t||||||||No||2017-10-10 21:33:08.278264|2017-10-10 21:33:08.278264
NCT02985554|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-04-18|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies|Phase I Study to Assess the Tolerability and Efficacy of Nivolumab as Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Patients With Hematologic Malignancies After Allogeneic Stem Cell Transplantation|Recruiting||Phase 1|29|Anticipated|University of Chicago||1|||f|||||t|f||||||||2017-10-10 21:33:08.369252|2017-10-10 21:33:08.369252
NCT02985541|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-19|||December 22, 2016|Actual|2016-12-22|September 2017|2017-09-01|July 15, 2021|Anticipated|2021-07-15|July 15, 2021|Anticipated|2021-07-15||Interventional|MET||Mirena Extension Trial|Multi-center, Open-label, Uncontrolled Study to Assess Contraceptive Efficacy and Safety of Mirena During Extended Use Beyond 5 Years in Women 18 to 35 Years of Age Including a Subgroup Evaluation of Treatment Effect on Heavy Menstrual Bleeding|Recruiting||Phase 3|360|Anticipated|Bayer||1|||f||||f|t|f||||||||2017-10-10 21:33:08.492127|2017-10-10 21:33:08.492127
NCT02985528|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-06|||February 2016||2016-02-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|CLINRISKETUS||Emergency Thoracic Ultrasound and Clinical Risk Management|Emergency Thoracic Ultrasound and Clinical Risk Management|Completed||N/A|400|Actual|Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele|||2||f||||f||||||||No||2017-10-10 21:33:08.724128|2017-10-10 21:33:08.724128
NCT02985515|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|SNIFFED||Steroid Nasal Irrigation for Flavor Evaluation and Detection Study|Steroid Nasal Irrigation for Flavor Evaluation and Detection (SNIFFED) Study|Recruiting||Phase 4|100|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 21:33:08.797901|2017-10-10 21:33:08.797901
NCT02985502|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||The Comparison of Quality of Life in Patients With Pancreatogenic Diabetes After Pancreatectomy|The Comparison and Association of Fatigue, Self-care Activities and Quality of Life in Patients With Pancreatogenic Diabetes Mellitus After Total Pancreatectomy or Pancreaticoduodenectomy|Recruiting||N/A|120|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-10 21:33:08.902532|2017-10-10 21:33:08.902532
NCT02985476|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-12-03|||May 2010||2010-05-01|December 2016|2016-12-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|ELIJAH||Electronic Linkage for Inflammatory Bowel Disease to Deliver Joint Access to Health Reports|Electronic Linkage for Inflammatory Bowel Disease to Deliver Joint Access to Health Reports|Completed||N/A|61|Actual|Swansea University||2|||f||||t||||||||Undecided|De-identified individual participant data for the primary and secondary outcomes data will be made available upon completion of reporting of the trial.|2017-10-10 21:33:09.075745|2017-10-10 21:33:09.075745
NCT02985463|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-07|||June 2014||2014-06-01|December 2016|2016-12-01||||December 2020|Anticipated|2020-12-01||Observational|LABEL||Left Atrial Appendage Occlusion and Biomarker Evaluation|Left Atrial Appendage Occlusion and Biomarker Evaluation|Recruiting||N/A|200|Anticipated|Universitätsmedizin Mannheim|||1||f||||f||||||Samples With DNA|"     Two peripheral blood withdraws in EDTA, citrate, ammonium heparin, serum tubes 24 hours     before and at mid-term follow up at 6 months after successful LAA occlusion device     implantation.   "|No||2017-10-10 21:33:09.170223|2017-10-10 21:33:09.170223
NCT02985450|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-07|||August 2016||2016-08-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|||A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada|A Prospective Study of Hepatitis B Virus (HBV) Immunity and Hepatitis B Vaccination in Patients With Non Alcoholic Fatty Liver Disease (NAFLD) in Canada|Recruiting||N/A|300|Anticipated|University of Calgary|||1||f||||f||||||Samples With DNA|"     PBMCs will be cryopreserved to assess HBV specific T and B cell responses.   "|No||2017-10-10 21:33:09.254731|2017-10-10 21:33:09.254731
NCT02985437|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-06|||December 8, 2016|Actual|2016-12-08|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Interventional|SATOSU||Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin|Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin and Superficial Subepidermal Lesions in Healthy Volunteers|Completed||Phase 1|24|Actual|University of Bremen||2|||f||||f||||||||||2017-10-10 21:33:09.337767|2017-10-10 21:33:09.337767
NCT02985424|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-04-24|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Observational|||Polymyalgia Rheumatica and Giant Cell Arteritis|Polymyalgia Rheumatica and Giant Cell Arteritis - Three Challenges - Consequences of the Vasculitis Process, Osteoporosis and Malignancy: A Prospective Cohort Study Protocol|Not yet recruiting||N/A|80|Anticipated|Svendborg Hospital|||1||f||||t||||||||No||2017-10-10 21:33:09.431754|2017-10-10 21:33:09.431754
NCT02985411|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-07|||October 2016||2016-10-01|November 2016|2016-11-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Interventional|||Harvest for Health in Older Cancer Survivors|Harvest for Health in Older Cancer Survivors|Recruiting||N/A|426|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||No|Will not share data until study is complete and all data deidentified|2017-10-10 21:33:09.528445|2017-10-10 21:33:09.528445
NCT02985398|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-03-17|||December 2016|Actual|2016-12-01|March 2017|2017-03-01||||June 2018|Anticipated|2018-06-01||Interventional|||An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine|An Open Label Trial to Evaluate the Safety of ALD403 Administered Intravenously in Patients With Chronic Migraines|Active, not recruiting||Phase 3|128|Actual|Alder Biopharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 21:33:09.640632|2017-10-10 21:33:09.640632
NCT02985385|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-07|||June 2001||2001-06-01|December 2016|2016-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|LCM||Lethal Congenital Malformations: Palliative Therapy From An Islamic Point of View|Palliative Therapy For Lethal Congenital Malformations: An Islamic Perspective|Completed||N/A|25958|Actual|Security Forces Hospital|||2||f||||t||||||||Yes|"All the results of lethal malformations are discussed with participants and the management planned approved. The outcome is explained in terms of mortality and length of survival. The feasibility of applying palliative therapy to lethal congenital malformations will enable muslim doctors to take the decision to withhold respiratory support to these cases.
The results of the study have been sent to the Muslim Scholarly Council to review and evaluate them in relation to Islamic guidelines and hence share on the decision of withholding treatment for terminally sick patients. This will add weight to our decision to apply palliative therapy to babies with lethal congenital malformations."|2017-10-10 21:33:09.743869|2017-10-10 21:33:09.743869
NCT02985372|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-03|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia|Efficacy and Safety of Decitabine in Combination With Low-dose Cytarabine as Inductive Treatment in Newly Diagnosed Elderly Patients With Acute Myeloid Leukemia|Enrolling by invitation||Phase 3|30|Anticipated|Shandong University||1|||f||||f||||||||Undecided||2017-10-10 21:33:09.822459|2017-10-10 21:33:09.822459
NCT02985359|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-08-15|||January 2014||2014-01-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Impact Evaluation of the WFP-Implemented Nutrition Program in Malawi|Impact Evaluation of the WFP-Implemented Nutrition Program in Malawi|Completed||N/A|556|Actual|Johns Hopkins Bloomberg School of Public Health|||2||f||||f||||||Samples Without DNA|"     Collection of Dried Blood Spots   "|||2017-10-10 21:33:09.903922|2017-10-10 21:33:09.903922
NCT02985346|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-06|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2020|Anticipated|2020-12-01||Interventional|||Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis|Sun Yat-sen Memorial Hospital|Not yet recruiting||Early Phase 1|100|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-10-10 21:33:09.997693|2017-10-10 21:33:09.997693
NCT02985333|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-08|||January 2014||2014-01-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma|Efficacy and Safety of Paclitaxel/Cyclophosphamide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple MyelomaRefractory|Recruiting||Phase 2|30|Anticipated|Sun Yat-sen University||1|||f||||f||||||||No||2017-10-10 21:33:10.066942|2017-10-10 21:33:10.066942
NCT02985320|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-07-25|||October 2016||2016-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine|A Open-label Phase I Study to Evaluate Safety of a Sabin Inactivated Poliovirus Vaccine (sIPV) in Adults, Children, and Infants, and a Blinded, Randomized and Controlled Phase II to Evaluate Safety and Immunogenicity of it in Infants|Completed||Phase 1/Phase 2|708|Actual|Sinovac Biotech Co., Ltd||12|||f||||f||||||||||2017-10-10 21:33:10.166595|2017-10-10 21:33:10.166595
NCT02985307|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-01-13|||January 2017||2017-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|SMS||Impact of Mobile Phone Texting Service to Support Weight Loss|Efficacy of Mobile Telehealth Short Message Service (SMS) as a Facilitator for Weight Management: A Randomised Controlled Trial|Not yet recruiting||N/A|120|Anticipated|NHS Lothian||2|||f||||t||||||||Yes|De-identified participant data for all primary and secondary outcome measures will be made available within 6months of study completion|2017-10-10 21:33:10.275979|2017-10-10 21:33:10.275979
NCT02985294|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-02|||April 2016||2016-04-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01|3 Years|Observational [Patient Registry]|DOLORiskWP51||Peripheral Physiological Measures as Determinants of Pain Risk|DOLORisk: Understanding Risk Factors and Determinants for Neuropathic Pain - Peripheral Physiological Measures as Determinants of Pain Risk|Recruiting||N/A|200|Anticipated|Neuroscience Technologies SLP, Barcelona|||2||f||||t||||||Samples With DNA|"     blood sample   "|No||2017-10-10 21:33:10.375241|2017-10-10 21:33:10.375241
NCT02985281|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients|Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Daul Therapy in Egyptian Pediatric Patients With Chronic Hepatitis C Infection. A Prospective, Randomized, Multicenter Study|Enrolling by invitation||Phase 2/Phase 3|41|Anticipated|National Liver Institute, Egypt||2|||f||||t||||||||No||2017-10-10 21:33:10.45721|2017-10-10 21:33:10.45721
NCT02985268|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|EVOLVE-HF||Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF|Evaluation of Outcomes of Cardiac Resynchronization Therapy and MitraClip for the Treatment of Low Ejection Fraction and Functional Mitral Valve Regurgitation in Heart Failure|Not yet recruiting||N/A|168|Anticipated|Montreal Heart Institute||4|||f||||t||||||||No||2017-10-10 21:33:10.532134|2017-10-10 21:33:10.532134
NCT02985255|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-12-02|||April 2016||2016-04-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue|Role of Neo-adjuvant Chemotherapy in Organ Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue|Recruiting||Phase 2|30|Anticipated|HealthCare Global Enterprise Ltd.||1|||f||||f||||||||No||2017-10-10 21:33:10.614694|2017-10-10 21:33:10.614694
NCT02985242|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|||Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema|SGLT2-inhibition With Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema (The SUPER-Trial)|Recruiting||Phase 4|80|Anticipated|Hannover Medical School||2|||f||||f||||||||No||2017-10-10 21:33:10.873678|2017-10-10 21:33:10.873678
NCT02985229|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-08-30|||October 2016||2016-10-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Acceptability and Feasibility of Medical Abortion in Singapore|Acceptability and Feasibility of Medical Abortion in Singapore: A Study of 800 μg Buccal Misoprostol Following 200 mg Mifepristone for Abortion Through 70 Days Gestation|Completed||Phase 3|125|Anticipated|Gynuity Health Projects||1|||f||||f||||||||||2017-10-10 21:33:11.004819|2017-10-10 21:33:11.004819
NCT02985216|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-02-14|||January 2017||2017-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain|A Randomized, Double-blind, Active-Controlled, Multi-center, Phase 3 Trial to Compare the Safety and Efficacy Between YHD1119 and Pregabalin in Patients With Peripheral Neuropathic Pain|Recruiting||Phase 3|360|Anticipated|Yuhan Corporation||2|||f||||f||||||||||2017-10-10 21:33:11.086022|2017-10-10 21:33:11.086022
NCT02985203|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-02-23|||November 2016||2016-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|||Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer|A Clinical Study to Investigate the Efficacy and Safety of Combination of Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Patients With Advanced Non-Small Cell Lung Cancer|Recruiting||Phase 2|146|Anticipated|Guangdong Association of Clinical Trials||2|||f||||t||||||||No||2017-10-10 21:33:11.180101|2017-10-10 21:33:11.180101
NCT02985190|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-12|||January 26, 2017|Actual|2017-01-26|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders|A Phase II Study of Efficacy and Tolerance of Azacitidine (AZA) In MDS-associated Steroid Dependent/Refractory Systemic Auto-immune and Inflammatory Disorders (SAID)|Recruiting||Phase 2|30|Anticipated|Groupe Francophone des Myelodysplasies||1|||f||||t|f|f||||||||2017-10-10 21:33:11.292846|2017-10-10 21:33:11.292846
NCT02985177|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-24|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|June 2019|Anticipated|2019-06-01||Interventional|CAST||A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture|A Randomized Controlled Trial of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture at Triage (CAST Trial)|Not yet recruiting||Phase 4|300|Anticipated|St. Justine's Hospital||2|||f||||t|f|f|||f|||No||2017-10-10 21:33:11.682127|2017-10-10 21:33:11.682127
NCT02985164|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-04|||September 2015||2015-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography|Radiation Exposure Affecting Anaesthesia Personnel During Endoscopic Retrograde Cholangiopancreatography|Completed||Phase 3|222|Actual|Siriraj Hospital||2|||f||||t||||||||Yes||2017-10-10 21:33:11.82676|2017-10-10 21:33:11.82676
NCT02985151|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy|A Single Center, Double-blinded Randomized Placebo-controlled Trial to Evaluate Surgical Scars After Treatment With Fractional Carbon Dioxide Rejuvenation Laser Therapy|Recruiting||N/A|50|Anticipated|St. Louis University||2|||f||||f||||||||Yes|De-identified participant data may be accessed after publication of the results in a medical journal.|2017-10-10 21:33:11.951517|2017-10-10 21:33:11.951517
NCT02985138|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Comparison of Unilateral or Bilateral Fixation in the Treatment of LDD|Comparison of Unilateral or Bilateral Fixation Using Pedicle Screws and TLIF in the Treatment of Lumbar Degenerative Disease|Recruiting||N/A|96|Anticipated|Shanghai 9th People's Hospital||2|||f||||||||||||||2017-10-10 21:33:12.069801|2017-10-10 21:33:12.069801
NCT02985125|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-06-07|||May 4, 2017|Actual|2017-05-04|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy|A Phase I/II Study of LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy|Recruiting||Phase 1/Phase 2|44|Anticipated|Georgetown University||5|||f||||t|t|f||||||No||2017-10-10 21:33:12.173272|2017-10-10 21:33:12.173272
NCT02985112|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-09|||March 2015||2015-03-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|INTERFERE||INTegrated Assessment of intERmediate Coronary Stenoses by Fractional Flow rEserve (FFR) and Near-infraREd Spectroscopy (NIRS)|INTegrated Assessment of intERmediate Coronary Stenoses by Fractional Flow rEserve (FFR) and Near-infraREd Spectroscopy (NIRS).|Recruiting||N/A|150|Anticipated|S.M. Misericordia Hospital|||2||f||||||||||||||2017-10-10 21:33:12.303882|2017-10-10 21:33:12.303882
NCT02985099|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-04|||November 2015||2015-11-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus|1.2% Rosuvastatin Subgingivally Delivered In Treatment Of Chronic Periodontitis With Type 2 Diabetes Mellitus: A Placebo Controlled Clinical Trial|Completed||Phase 2/Phase 3|80|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||||||||||||2017-10-10 21:33:12.427953|2017-10-10 21:33:12.427953
NCT02985086|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-10|||July 2013||2013-07-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Immediate Versus Delayed Induction in Term-PROM Using or Not Antibiotic Prophylaxis|The Role of Antibiotic Prophylaxis in Immediate Versus Delayed Induction in Term-PROM - a Randomized Controlled Trial|Recruiting||N/A|568|Anticipated|Hospital de Santa Maria, Portugal||3|||f||||f||||||||||2017-10-10 21:33:12.51729|2017-10-10 21:33:12.51729
NCT02985073|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-02|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparison Between Biological (Veritas®) vs Non Biological Mesh (TIGR®) in Immediate Breast Reconstruction|The Gothenburg TIGR/Veritas® Study - A Comparison Between Biological (Veritas®) vs Non Biological Mesh (TIGR®) in Immediate Breast Reconstruction|Recruiting||N/A|40|Anticipated|Vastra Gotaland Region||2|||f||||f||||||||No||2017-10-10 21:33:12.605575|2017-10-10 21:33:12.605575
NCT02985060|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-12|||November 2016||2016-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|HELMET||Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke|Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke; Prospective, Open, Randomized, Multicenter Phase II Study|Recruiting||Phase 2|40|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 21:33:12.695042|2017-10-10 21:33:12.695042
NCT02985047|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-06-21|||September 2015||2015-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|BAS||Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide|Brief Admission Skane: Can Brief Admission Replace General Admission for Individuals With Self-harm and Acute Risk of Suicide|Active, not recruiting||N/A|125|Anticipated|Region Skane||2|||f||||f||||||||No||2017-10-10 21:33:12.796111|2017-10-10 21:33:12.796111
NCT02985034|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-05|||October 2010||2010-10-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|September 2011|Actual|2011-09-01||Observational|||Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT|Prospective Evaluation of Local Tumor Progression After Radiofrequency Ablation of Hepatocellular Carcinoma: Effectiveness of Immediate Second-Look Evaluation Using Pre-RFA MRI and Post-RFA CT Registration|Completed||N/A|77|Actual|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 21:33:12.889269|2017-10-10 21:33:12.889269
NCT02985021|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-15|||November 2016||2016-11-01|December 2016|2016-12-01||||November 2019|Anticipated|2019-11-01||Interventional|||Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies|A Phase 2 Study of Docetaxel and Carboplatin for Treatment of Patients With Metastatic, Castration Resistant Prostate Cancer and Germline or Somatic DNA Repair Deficiency|Recruiting||Phase 2|35|Anticipated|Seattle Institute for Biomedical and Clinical Research||1|||f||||t||||||||No||2017-10-10 21:33:12.960015|2017-10-10 21:33:12.960015
NCT02985008|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2016-12-05|||April 2016||2016-04-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|1 Year|Observational [Patient Registry]|SMART-RESCUE||Clinical Outcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic Shock|SMart Angioplasty Research Team: A Multi-center, Open, REtrospective and Prospective Observational Study to Investigate Clinical oUtcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic Shock : RESCUE|Recruiting||N/A|1000|Anticipated|Samsung Medical Center|||1||f||||f||||||||Undecided||2017-10-10 21:33:13.079474|2017-10-10 21:33:13.079474
NCT02984982|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-05-15|||November 2016||2016-11-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ODYSSEY J-IVUS||Evaluation of Coronary Artery Plaque Volume Progression/Regression and Safety of Alirocumab in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia|A Randomized, Open-label, Blind-analysis, Parallel Group, Multicenter Study to Evaluate the Efficacy on Coronary Artery Plaque Volume Progression/Regression and Safety of Alirocumab in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia Not Adequately Controlled With Statin|Recruiting||Phase 4|200|Anticipated|Sanofi||2|||f||||f||||||||No|Not available for request.|2017-10-10 21:33:13.269257|2017-10-10 21:33:13.269257
NCT02984969|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-12-04|||July 2016||2016-07-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|November 2016|Actual|2016-11-01||Observational|||Using 16S rRNA Gene Sequencing Analysis Intestinal Microbiota in Constipation Patients|Characterization of Intestinal Microbiota in Constipation Patients: Using 16S rRNA Gene Sequencing Analysis|Recruiting||N/A|20|Anticipated|Jinling Hospital, China|||2||f||||t||||||||Undecided||2017-10-10 21:33:13.448588|2017-10-10 21:33:13.448588
NCT02984956|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Pleth Variability Index and Hypotension|Hypotension Relationship With Pleth Variability Index In Hip Fracture Patients Who Underwent Spinal Anesthesia|Active, not recruiting||N/A|100|Anticipated|Erzincan University|||1||f||||f||||||||No||2017-10-10 21:33:13.527662|2017-10-10 21:33:13.527662
NCT02984943|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-12-09|||November 2016||2016-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effects of Hyperbaric Oxygen on Rheumatoid Arthritis|The Effects of Hyperbaric Oxygen on Rheumatoid Arthritis: A Pilot Study|Enrolling by invitation||N/A|10|Anticipated|David Grant U.S. Air Force Medical Center||1|||f||||t||||||||No||2017-10-10 21:33:13.601332|2017-10-10 21:33:13.601332
NCT02984930|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-12-06|||December 2016||2016-12-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease||Not yet recruiting||N/A|30|Anticipated|Gangnam Severance Hospital||2|||f||||t||||||||No||2017-10-10 21:33:13.683636|2017-10-10 21:33:13.683636
NCT02984917|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-14|||February 6, 2017|Actual|2017-02-06|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Anterior Transversalis Fascia Approach Versus Preperitoneal Space Approach for Inguinal Hernia Repair in Residents|Anterior Transversalis Fascia Approach Versus Preperitoneal Space Approach for Inguinal Hernia Repair in Residents in Northern China: a Prospective, Multi-center, Randomized, Controlled Trial|Recruiting||N/A|2000|Anticipated|The Fourth Affiliated Hospital of China Medical University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:33:13.778578|2017-10-10 21:33:13.778578
NCT02984904|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-02|||April 2015||2015-04-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|November 2015|Actual|2015-11-01|1 Day|Observational [Patient Registry]|||Fusarium Keratitits in Spain 2012 to 2014|Multicenter Study About Fusarium Keratitits in Spain 2012 to 2014|Completed||N/A|23|Actual|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana|||1||f||||t||||||||Undecided||2017-10-10 21:33:13.95|2017-10-10 21:33:13.95
NCT02984891|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-09-25|||October 2016||2016-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging|Dual Imaging Using High-definition Intravascular Ultrasound and Optical Coherence Tomography to Guide Percutaneous Coronary Intervention|Active, not recruiting||N/A|100|Anticipated|Columbia University|||1||f||||f||||||||||2017-10-10 21:33:14.040709|2017-10-10 21:33:14.040709
NCT02984865|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-06-07|||December 20, 2016|Actual|2016-12-20|June 2017|2017-06-01|June 8, 2017|Anticipated|2017-06-08|June 8, 2017|Anticipated|2017-06-08||Interventional|||Multimodal Analgesia Based on Transversus Abdominis Plane Block Combined With κ Receptor Agonist and NSAID(Non-steroidal Anti-inflammatory Drug ) Following Open Gastrointestinal Surgery in Elderly Patients||Recruiting||N/A|160|Anticipated|The First Affiliated Hospital of Anhui Medical University||4|||f||||t||||||||No||2017-10-10 21:33:14.174309|2017-10-10 21:33:14.174309
NCT02984852|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-05|2017-03-31|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants|A Single-dose, Open-label, Randomized, Crossover Study to Assess the Relative Bioavailability of the Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Administered Orally as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Subjects|Completed||Phase 1|30|Actual|Janssen Scientific Affairs, LLC||6|||f||||f|t|||||||||2017-10-10 21:33:14.280268|2017-10-10 21:33:14.280268
NCT02984839|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Observational|||Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observational Study|Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observational Study|Active, not recruiting||N/A|120|Anticipated|OhioHealth|||2||f||||f||||||||No||2017-10-10 21:33:14.379949|2017-10-10 21:33:14.379949
NCT02984826|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-06|||May 2010||2010-05-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Muscle Strength in Shoulder and Neck Muscles in Tension Type Headache Patients. Effect of Specific Strength Training|Muscle Strength in Shoulder and Neck Muscles in Adult Tension Type Headache Patients, and the Effect of Specific Strength Training|Completed||N/A|90|Actual|Danish Headache Center||2|||f||||t||||||||No||2017-10-10 21:33:14.449126|2017-10-10 21:33:14.449126
NCT02984813|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-03|||April 2016||2016-04-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy|Measurement of Oxidative Stress of Retinal Ganglion Cells With and Without Anti-oxidants and Anti-inflammatory Agents in Patients With Glaucoma and Diabetic Retinopathy as Determined by Mitochondrial Flavoprotein Fluorescence|Active, not recruiting||Phase 1|21|Actual|The New York Eye & Ear Infirmary||3|||f||||t||||||||Undecided||2017-10-10 21:33:14.514559|2017-10-10 21:33:14.514559
NCT02984800|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-01-07|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Single Paravertebral Blockade Injection for Herniorrhaphy in Children|The Anesthetic and Analgesic Effectiveness of Single Paravertebral Blockade Injection for Herniorrhaphy in Children|Recruiting||N/A|100|Anticipated|Makassed General Hospital||2|||f||||||||||||||2017-10-10 21:33:14.593827|2017-10-10 21:33:14.593827
NCT02984787|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-04|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||3D Versus 2D Laparoscopic Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection|3D Versus 2D Laparoscopic Total Gastrectomy With Spleen-preserving Splenic Hilum Lymph Nodes Dissection for Advanced Proximal Gastric Cancer: A Randomized Controlled Trial|Not yet recruiting||Phase 3|480|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||No||2017-10-10 21:33:14.759736|2017-10-10 21:33:14.759736
NCT02984774|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-03|||June 2014||2014-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Assessment of Telomerase Activity in Endometrial Tissue and Serum in Endometriosis Patients|Does Telomerase Activity Have an Effect on Infertility in Patients With Endometriosis ? Assessment of Telomerase Activity in Eutopic, Ectopic Endometrial Tissue and Serum|Completed||N/A|47|Actual|Istanbul University||3|||f||||f||||||||Undecided|General results is available for sharing.|2017-10-10 21:33:14.891399|2017-10-10 21:33:14.891399
NCT02984748|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-07|||October 2014||2014-10-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Outcome Prediction in Cochlear Implant Recipients|Prediction of Outcomes in Adult Cochlear Implant Recipients|Recruiting||N/A|320|Anticipated|The Hearing Cooperative Research Centre|||1||f||||f||||||||No||2017-10-10 21:33:15.207433|2017-10-10 21:33:15.207433
NCT02984735|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-08-02|||January 2016||2016-01-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Chewing Performance Level and Gross Motor Function in Children With Cerebral Palsy|Association Between Chewing Performance Level and Gross Motor Function in Children With Cerebral Palsy|Completed||N/A|152|Actual|Hacettepe University|||1||f||||t||||||||||2017-10-10 21:33:15.30579|2017-10-10 21:33:15.30579
NCT02984722|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Extended-release vs Immediate-release Metformin in PCOS Women||Not yet recruiting||N/A|80|Anticipated|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-10 21:33:15.409949|2017-10-10 21:33:15.409949
NCT02984709|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-08-24|||October 2016||2016-10-01|August 2017|2017-08-01|August 10, 2017|Actual|2017-08-10|February 24, 2017|Actual|2017-02-24||Interventional|||Check It! 2.0: Positive Psychology Intervention for Adolescents With T1D|Check It! 2.0: Pilot Test of a Positive Psychology Intervention for Adolescents With Type 1 Diabetes|Completed||N/A|48|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 21:33:15.515647|2017-10-10 21:33:15.515647
NCT02984696|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-12-03|||March 2015||2015-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Interventional|||Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea|Effects of 6 Months of HRT on Total Antioxidant Capacity in Patients Affected by Hypotalamic Amenorrhea|Recruiting||N/A|20|Anticipated|Catholic University of the Sacred Heart||1|||f||||f||||||||Undecided||2017-10-10 21:33:15.616837|2017-10-10 21:33:15.616837
NCT02984670|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-06|||August 2016||2016-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cognitive Behavior Therapy for Insomnia: Analysis of Components, Mediators and Moderators|Cognitive Behavior Therapy for Insomnia: Analysis of Components, Mediators and Moderators|Recruiting||N/A|213|Anticipated|Stockholm University||3|||f||||f||||||||No||2017-10-10 21:33:15.862312|2017-10-10 21:33:15.862312
NCT02984657|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-04|||May 2015||2015-05-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Reverse Trendelenburg Positioning and Its Effect on Outcomes: a Retrospective Study of Consecutive Patients|Evaluation of Operating Room Reverse Trendelenburg Positioning and Its Effect on Postoperative Hypoxemia, Aspiration, and Length of Stay: a Retrospective Study of Consecutive Patients|Completed||N/A|1500|Actual|Mercy Health, Ohio|||2||f||||f||||||||No||2017-10-10 21:33:15.992405|2017-10-10 21:33:15.992405
NCT02984644|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|AZ11040||Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin|Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin (P2)|Not yet recruiting||Phase 3|48|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 21:33:16.118101|2017-10-10 21:33:16.118101
NCT02984631|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2017-07-18|||December 2016|Actual|2016-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Evaluation and Treatment of Elevated Left-Sided Filling Pressures by Balloon Inflation Within the IVC|The Evaluation and Treatment of Elevated Left-Sided Filling Pressures by Balloon Inflation Within the Interior Vena Cava|Recruiting||N/A|10|Anticipated|Cardioflow Technologies, LLC||2|||f||||f||||||||||2017-10-10 21:33:16.21324|2017-10-10 21:33:16.21324
NCT02984618|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-03|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial|Gabriel Guimaraes: Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial|Recruiting||Phase 3|44|Anticipated|Brasilia University Hospital||2|||f||||f||||||||No||2017-10-10 21:33:16.315891|2017-10-10 21:33:16.315891
NCT02984605|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-04|2016-12-04|||December 2016||2016-12-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Nutrition Meal Replacement and Individualized Exercise Prescription on Type 2 Diabetes|Effects of Nutrition Meal Replacement and Individualized Exercise Prescription on Metabolism in Overweight and Obese Type 2 Diabetes|Not yet recruiting||N/A|200|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||No||2017-10-10 21:33:16.414444|2017-10-10 21:33:16.414444
NCT02984592|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-02-02|||November 2016||2016-11-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31|1 Month|Observational [Patient Registry]|||Effect of Exercise on Premature Ejaculation|Regular Physical Activity Improves Ejaculation Time and Patient-reported Outcomes|Completed||N/A|50|Actual|Ankara Training and Research Hospital|||2||f||||t||||||||Yes||2017-10-10 21:33:16.513934|2017-10-10 21:33:16.513934
NCT02984579|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-02-13|||March 2015||2015-03-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|YD||Line Probe Assay Evaluation Study|Multi-center Study to Assess the Non-inferiority of YD REBA MTB-MDR® and Hain GenoType® MTBDRplus V2 Line Probe Assays Compared to Hain GenoType® MTBDRplus V1|Completed||N/A|888|Actual|Foundation for Innovative New Diagnostics, Switzerland|||1||f||||f||||||||||2017-10-10 21:33:16.597733|2017-10-10 21:33:16.597733
NCT02984566|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-02-22|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|LARK||Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)|LARK: Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)|Not yet recruiting||N/A|46|Anticipated|University of Sydney||1|||f||||f|f|f||||||Yes|Anonymised data will be made available to researchers upon request, once evidence of ethical approval has been provided.|2017-10-10 21:33:16.692129|2017-10-10 21:33:16.692129
NCT02984553|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-02|||November 2015||2015-11-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Objective Physical Activity Assesment in Postmenopausal Women|The Use of Lactate Thresholds to Individualize Accelerometer Cut-points and Objectively Assess Physical Activity Levels in Postmenopausal Women|Active, not recruiting||N/A|80|Actual|Centro de Estudios, Investigación y Medicina del Deporte|||1||f||||f||||||||Yes|Codified IPD (personal data not shown, e.g. 321RR) will be shared with the Musculoskeletal Research Unit of the University of Bristol for the deep analysis of the 3th outcome|2017-10-10 21:33:16.788216|2017-10-10 21:33:16.788216
NCT02984540|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-04-18|||February 2015||2015-02-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|BEAM||Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease|Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease|Active, not recruiting||N/A|25|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 21:33:16.876655|2017-10-10 21:33:16.876655
NCT02984527|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-08|||October 2016||2016-10-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Traditional Bed Baths Versus Disposable Wet Wipes|Comparison of Skin Swaps From Traditional Bed Baths Versus Disposable Wet Wipes|Recruiting||Early Phase 1|68|Anticipated|University of Southern Denmark||2|||f||||f||||||||No||2017-10-10 21:33:17.004037|2017-10-10 21:33:17.004037
NCT02984514|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-02|||October 2015||2015-10-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Brown Adipose Tissue in Type 1 Diabetes|Studies of Activity of Brown Adipose Tissue With Positron Emission Tomography Using the Tracer 18F-deoxy Glucose in Patients With Type 1 Diabetes|Recruiting||N/A|12|Anticipated|Uppsala University Hospital||1|||f||||f||||||||||2017-10-10 21:33:17.08836|2017-10-10 21:33:17.08836
NCT02984501|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-02|||March 2013||2013-03-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer|Phase II Study of Induction Chemotherapy Followed by Chemoradiotherapy in Patients With Borderline Resectable and Unresectable Locally Advanced Pancreatic Cancer|Completed||Phase 2|41|Actual|Campus Bio-Medico University||1|||f||||f||||||||No||2017-10-10 21:33:17.165688|2017-10-10 21:33:17.165688
NCT02984488|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-12-06|||December 2016||2016-12-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Pain Following One-visit Versus Two-visit Root Canal of Necrotic Teeth Using Protaper Next|Post-Obturation Pain Following One-visit Versus Two-visit Root Canal Treatment of Necrotic Anterior and Premolar Teeth Using Protaper Next|Not yet recruiting||N/A|50|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:33:17.247508|2017-10-10 21:33:17.247508
NCT02984475|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major|The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalasemia Major|Not yet recruiting||Phase 4|60|Anticipated|Cairo University||2|||f||||||||||||||2017-10-10 21:33:17.331499|2017-10-10 21:33:17.331499
NCT02984462|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-06-02|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|AKIN||Akin Osteotomy With or Without Fixation|Is Fixation of Percutaneous Akin Osteotomy Enhanced First Ray Post-operative Mobility? A Prospective Randomized Study.|Recruiting||N/A|58|Anticipated|University Hospital, Bordeaux||2|||f||||f|f|f||||||No||2017-10-10 21:33:17.406656|2017-10-10 21:33:17.406656
NCT02984449|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-02|||February 2017||2017-02-01|December 2016|2016-12-01|August 2025|Anticipated|2025-08-01|August 2021|Anticipated|2021-08-01||Interventional|Heart-ROCQ||Preventive Heart Rehabilitation to Prevent Complications in Patients Undergoing Elective Open Heart Surgery|Preventive Heart Rehabilitation in Patients Undergoing Elective Open Heart Surgery to Prevent Complications and to Improve Quality of Life (Heart-ROCQ) - A Prospective Randomized Open Controlled Trial, Blinded End-point (PROBE)|Not yet recruiting||N/A|350|Anticipated|University Medical Center Groningen||2|||f||||t||||||||No||2017-10-10 21:33:17.51548|2017-10-10 21:33:17.51548
NCT02984436|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-04-07|||January 25, 2017|Actual|2017-01-25|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Observational|STOP CP||High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification|High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification|Recruiting||N/A|1500|Anticipated|University of Florida|||1||f||||f|f|f||||||No||2017-10-10 21:33:17.614941|2017-10-10 21:33:17.614941
NCT02984423|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-14|||December 27, 2016|Actual|2016-12-27|September 2017|2017-09-01|March 30, 2019|Anticipated|2019-03-30|March 1, 2019|Anticipated|2019-03-01||Observational|FLABRA||FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study|Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study|Recruiting||N/A|480|Anticipated|AstraZeneca|||1||f||||f||||||Samples With DNA|"     Archived tumor blocks or twenty 10-µm sections from eligible patients will be requested from     the local pathology lab and used for BRCA mutations testing.   "|||2017-10-10 21:33:17.72955|2017-10-10 21:33:17.72955
NCT02984410|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-05|||March 2017||2017-03-01|December 2016|2016-12-01||||March 2020|Anticipated|2020-03-01||Interventional|Best Of||"Study Assessing The Best of Radiotherapy vs the Best of Surgery in Patients With Oropharyngeal Carcinoma"|"Phase III Study Assessing The Best of Radiotherapy Compared to the Best of Surgery (Trans-oral Surgery (TOS)) in Patients With T1-T2, N0 Oropharyngeal Carcinoma"|Not yet recruiting||Phase 3|170|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-10 21:33:17.873241|2017-10-10 21:33:17.873241
NCT02984397|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Chronic Widespread Pain and White Blood Cell Activation|Proof of Concept Trial to Test the Efficacy of Treatment With Ketotifen on Pain Sensitivity and Association Between Level of Activity and Reactivity of White Blood Cells and Pain Sensitivity in Teenagers With Chronic Widespread Pain|Recruiting||Phase 1/Phase 2|44|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-10-10 21:33:17.977016|2017-10-10 21:33:17.977016
NCT02984371|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||June 2016||2016-06-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Epicardial Fat Pads Ablation During Coronary Surgery|Ablation of the Epicardial Fat Pads to Treat Paroxysmal Atrial Fibrillation During Coronary Artery Bypass Grafting|Recruiting||Phase 2|264|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||||||||||||2017-10-10 21:33:18.184068|2017-10-10 21:33:18.184068
NCT02984358|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Chronic Mycoprotein Consumption and Nucleotide Content in Metabolic Health|Effect of Chronic Mycoprotein Consumption, and of Its Nucleotide Content, in Uric Acid Concentrations and Other Markers of Metabolic Health in Adults|Not yet recruiting||N/A|30|Anticipated|University of Exeter||3|||f||||f||||||||No||2017-10-10 21:33:18.294548|2017-10-10 21:33:18.294548
NCT02984345|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|ARM||Does the Ingestion of Mycoprotein Elicit an Optimal Anabolic Response in Resting and Exercised Skeletal Muscle?|Does the Ingestion of Mycoprotein Elicit an Optimal Anabolic Response in Resting and Exercised Skeletal Muscle?|Not yet recruiting||N/A|20|Anticipated|University of Exeter||2|||f||||f||||||||No||2017-10-10 21:33:18.366144|2017-10-10 21:33:18.366144
NCT02984332|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-05|||January 2016||2016-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Timecourse of Muscle Atrophy|Timecourse of Muscle Atrophy|Recruiting||N/A|12|Anticipated|University of Exeter||1|||f||||f||||||||No||2017-10-10 21:33:18.428009|2017-10-10 21:33:18.428009
NCT02984319|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-05|||November 2015||2015-11-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect of Cherry Concentrate on Vascular Function|Effect of Cherry Concentrate on Vascular Function|Recruiting||N/A|16|Anticipated|University of Exeter||1|||f||||f||||||||No||2017-10-10 21:33:18.504275|2017-10-10 21:33:18.504275
NCT02984306|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||February 2012||2012-02-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Cherry Powder Supplementation on Vascular Function|Effect of Cherry Powder Supplementation on Vascular Function|Completed||N/A|12|Actual|University of Exeter||1|||f||||f||||||||No||2017-10-10 21:33:18.574557|2017-10-10 21:33:18.574557
NCT02984293|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-04-25|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ImmunoStat||Statin Immune Study|Impact of LILRB5 Genotype on Immune Response to Atorvastatin|Enrolling by invitation||Phase 4|60|Anticipated|University of Dundee||2|||f||||f|f|f||||||Yes|As per GoSHARE tissue bank protocol, the data derived from the existing samples will be returned to the tissue bank for research use.|2017-10-10 21:33:20.189924|2017-10-10 21:33:20.189924
NCT02984280|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-05-03|||September 2016||2016-09-01|November 2016|2016-11-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Specific Respiratory Infections as Triggers of Acute Medical Events|Specific Respiratory Infections as Triggers of Acute Medical Events: Time Series Analysis Using LabBase and Hospital Episode Statistics|Completed||N/A|787000|Actual|University College, London|||1||f||||f||||||||||2017-10-10 21:33:20.310781|2017-10-10 21:33:20.310781
NCT02984267|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|April 15, 2017|Actual|2017-04-15|April 15, 2017|Actual|2017-04-15||Interventional|||Use of Ultrasound Guidance to Assist With Labor Epidural Placement in Patients With a BMI ≥40|Use of Ultrasound Guidance to Assist With Labor Epidural Placement in Patients With a BMI ≥40|Completed||N/A|16|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 21:33:20.408236|2017-10-10 21:33:20.408236
NCT02984254|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bracing for Patellofemoral Osteoarthritis|Bracing for Patellofemoral Osteoarthritis. A Prospective Randomized Study of the Treatment of Patellofemoral Arthritis by an Orthosis|Not yet recruiting||N/A|52|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:33:20.502086|2017-10-10 21:33:20.502086
NCT02984241|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-04-24|||September 2017|Anticipated|2017-09-01|December 2016|2016-12-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||e-Health Coping Skills Training for Women Whose Partner Has a Drinking Problem|eHealth Coping Skills Training for Women Whose Partner Has a Drinking Problem|Not yet recruiting||N/A|450|Anticipated|State University of New York at Buffalo||3|||f||||f|f|f||||||||2017-10-10 21:33:20.629254|2017-10-10 21:33:20.629254
NCT02984228|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-02-22|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis|The Efficacy of Ultrasound Guided Glenohumeral Joint Injections of Platelet Rich Plasma (PRP) Versus Hyaluronic Acid (HA) in the Treatment of Glenohumeral Osteoarthritis: a Randomized, Double-blind Control Trial|Recruiting||Phase 4|70|Anticipated|Hospital for Special Surgery, New York||2|||f||||||||||||||2017-10-10 21:33:20.708808|2017-10-10 21:33:20.708808
NCT02984215|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-12-02|||January 1990||1990-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|January 2012|Actual|2012-01-01||Observational|||aCGH Impacts Survival in Plasma Cell PTLD|Array-CGH in Plasma Cell Post-transplantation Lymphoproliferative Disorders|Completed||N/A|10|Actual|Hospices Civils de Lyon|||1||f||||||||||Samples With DNA|"     the investigators report array-based comparative genomic hybridization (aCGH) of 10 cases of     PCM and PLL-PTLD. aCGH performed on 10 plasma cell PTLD.   "|||2017-10-10 21:33:20.798208|2017-10-10 21:33:20.798208
NCT02984202|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-26|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|March 2020|Anticipated|2020-03-01||Interventional|||Auditory Midbrain Implant Study|Phase I Safety Study for a New Two-Shank Auditory Midbrain Implant (AMI)|Recruiting||N/A|5|Anticipated|Hannover Medical School||1|||f||||t||||||||||2017-10-10 21:33:20.866364|2017-10-10 21:33:20.866364
NCT02984189|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-01|||February 2016||2016-02-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|IMT||Effect of Inspiratory Muscle Training on Recreational Cyclists|Effect of Inspiratory Muscle Training Using the Critical Pressure on Recreational Cyclists: A Randomized Controlled Trial|Recruiting||Phase 2|30|Anticipated|Universidade Federal de Sao Carlos||3|||f||||f||||||||No||2017-10-10 21:33:20.94658|2017-10-10 21:33:20.94658
NCT02984176|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-12-05|||August 2014||2014-08-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Simethicone: Does it Improve Operative Field and Postoperative Pain?|Simethicone and Gynecological Laparoscopies: Does it Improve Operative Field and Postoperative Pain?|Completed||Phase 4|100|Actual|Woman's Health University Hospital, Egypt||2|||f||||f||||||||Yes||2017-10-10 21:33:21.048174|2017-10-10 21:33:21.048174
NCT02984163|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-05|||January 2017||2017-01-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|March 2021|Anticipated|2021-03-01||Interventional|ACE||Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study|"The Alberta Cancer Exercise ACE Program for Cancer Survivors: Supporting Community-based Exercise Participation for Health Promotion and Secondary Cancer Prevention"|Not yet recruiting||N/A|1000|Anticipated|University of Alberta||1|||f||||f||||||||Undecided|No plan in place at this point in time.|2017-10-10 21:33:21.230911|2017-10-10 21:33:21.230911
NCT02984150|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-05-05|||November 2014||2014-11-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Intragastric Administration of Fatty Acids on Generalized Reward Sensitivity|Effect of Intragastric Administration of Fatty Acids on Generalized Reward Sensitivity|Completed||N/A|60|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 21:33:21.334411|2017-10-10 21:33:21.334411
NCT02984137|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-02-21|||September 2013||2013-09-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|||Prospective Neuroimaging Investigation of Idiopathic REM Sleep Behavior Disorder|A Prospective Longitudinal Neuroimaging and Biomarker Cohort Study in Idiopathic Rapid Eye Movement(REM) Sleep Behavior Disorder|Recruiting||N/A|90|Anticipated|Seoul National University Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:33:21.428796|2017-10-10 21:33:21.428796
NCT02984124|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-16|||December 2016||2016-12-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|February 2021|Anticipated|2021-02-01||Interventional|CHART||Communication During Hospitalization About Resuscitation Trial|Communication During Hospitalization About Resuscitation Trial|Recruiting||Phase 2/Phase 3|180|Anticipated|University of Vermont||2|||f||||t||||||||||2017-10-10 21:33:21.569732|2017-10-10 21:33:21.569732
NCT02984111|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-05-24|||January 2016||2016-01-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery|Placebo- Controlled,Randomized,Double Blind Trial of Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery|Enrolling by invitation||N/A|90|Anticipated|Shahid Beheshti University of Medical Sciences||3|||f||||t||||||||No||2017-10-10 21:33:21.697964|2017-10-10 21:33:21.697964
NCT02984098|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-01|||September 2014||2014-09-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|40%D-N-PP||40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose|40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose But Not Sufficiently Reliefs Acute Pain in Term Neonates: A Randomized Controlled Trial|Completed||Phase 4|200|Actual|University of Targu Mures, Romania||2|||f||||t||||||||Yes||2017-10-10 21:33:21.84328|2017-10-10 21:33:21.84328
NCT02984085|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-02-27|||January 30, 2017|Actual|2017-01-30|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HOLOGENE7||Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.|Prospective, Open-label, Uncontrolled Clinical Trial to Assess the Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified With a Gamma-retroviral (rv) Vector Carrying COL7A1 cDNA for Restoration of Epidermis in Patients With Recessive Dystrophic Epidermolysis Bullosa.|Recruiting||Phase 1/Phase 2|12|Anticipated|Holostem Terapie Avanzate s.r.l.||1|||f||||f|f|f||||||No||2017-10-10 21:33:21.961434|2017-10-10 21:33:21.961434
NCT02984072|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-05-01|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|MentholPDT||Menthol for PDT Pain|A Randomised Double Blind, Placebo Controlled Study of the Efficacy of Topical Menthol for Pain Relief During Topical Photodynamic Therapy|Not yet recruiting||Phase 4|30|Anticipated|University of Dundee||2|||f||||f|f|f||||||No|Findings of study will be shared through peer reviewed publications and presentations, although individual participant data not disclosed|2017-10-10 21:33:22.069929|2017-10-10 21:33:22.069929
NCT02984059|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-12-02|||October 2015||2015-10-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease|A Pilot Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease: The ALLAY Study|Recruiting||N/A|80|Anticipated|Connecticut Children's Medical Center|||3||f||||f||||||Samples With DNA|"     pending   "|No||2017-10-10 21:33:22.155789|2017-10-10 21:33:22.155789
NCT02984046|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-02|||November 2015||2015-11-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|CC16||Acute Bronchiolitis and Severity Markers: Interest in Protein CC16|Acute Bronchiolitis and Severity Markers: Interest in Protein CC16|Recruiting||N/A|200|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 21:33:22.246101|2017-10-10 21:33:22.246101
NCT02984033|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||November 2016||2016-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Quality of Life and Psycological Evaluation of Patients Affected by Head and Neck Cancer|Quality of Life and Psychological Evaluation of Patients Affected by Head and Neck Cancer Treated With Curative Intent: Multicentric Prospective Study|Recruiting||N/A|15|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||||No||2017-10-10 21:33:22.337273|2017-10-10 21:33:22.337273
NCT02984020|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-10-01|||May 13, 2016|Actual|2016-05-13|October 2017|2017-10-01|January 2, 2020|Anticipated|2020-01-02|January 2, 2020|Anticipated|2020-01-02||Observational|||Korean Post-marketing Surveillance for Xeljanz|Korean Post-marketing Surveillance For Xeljanz (Registered)|Recruiting||N/A|3000|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 21:33:22.417317|2017-10-10 21:33:22.417317
NCT02984007|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-04|||March 25, 2017|Actual|2017-03-25|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PromovaC||PROMOtion of VAccination in Canada (PromovaC Study)|Addressing Vaccine Hesitancy: Pan-Canadian Validation of an Effective Strategy|Recruiting||N/A|1600|Anticipated|Université de Sherbrooke||2|||f||||t|f|f||||||No||2017-10-10 21:33:22.552504|2017-10-10 21:33:22.552504
NCT02983994|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-20|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Observational|||Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma|Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma|Recruiting||N/A|64|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||2||f||||f||||||||||2017-10-10 21:33:22.652603|2017-10-10 21:33:22.652603
NCT02983981|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-12-02|||March 2016||2016-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Topical Psoriasis Study for Patients Receiving Biologic Therapy|An Open-Label, Observational Study Evaluating Topicort® Topical Spray 0.25% (Desoximetasone) BID in Psoriasis Patients Being Treated With Biologic Agents|Completed||Phase 4|20|Actual|Psoriasis Treatment Center of Central New Jersey||1|||f||||f||||||||No||2017-10-10 21:33:22.734267|2017-10-10 21:33:22.734267
NCT02983968|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-02|||September 2016||2016-09-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|SAMHEPAT||Use of the French Healthcare Insurance Database to Evaluate How Early Diagnosis of Hepatocellular Carcinomas is Implemented in France|Use of the French Healthcare Insurance Database to Evaluate How Early Diagnosis of Hepatocellular Carcinomas is Implemented in France: SAMHEPAT Study|Recruiting||N/A|890|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:33:22.901936|2017-10-10 21:33:22.901936
NCT02983955|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|UPNRIDE_SAFE||UPNRIDE Powered Wheelchair for Individuals With Walking Impairment: Evaluation of Safety and Usability|UPNRIDE Powered Wheelchair for Individuals With Walking Impairment: Evaluation of Safety and Usability|Recruiting||N/A|15|Anticipated|UPnRIDE Robotics Ltd.||1|||f||||t||||||||No||2017-10-10 21:33:22.977717|2017-10-10 21:33:22.977717
NCT02983942|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma|Ketogenic Diet Adjunctive to High Dose Methotrexate Chemotherapy for Primary Central Nervous System Lymphoma|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Beijing Tiantan Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:33:23.055186|2017-10-10 21:33:23.055186
NCT02983929|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-07|||January 2007||2007-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01|2 Months|Observational [Patient Registry]|||Short-Term Follow-up Indicator for Total Knee Arthroplasty and Body Mass Index|Impact of Elevated Body Mass Index on Short-term Follow-up Indicators for Total Knee Arthroplasty : a Retrospective Study|Completed||N/A|244|Actual|Centre Hospitalier Durécu Lavoisier|||2||f||||f||||||||||2017-10-10 21:33:23.153824|2017-10-10 21:33:23.153824
NCT02983916|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-12|||January 2016||2016-01-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Observational|||Laparoscopic Adhesiolysis for Chronic Abdominal Pain Revisited|Laparoscopic Adhesiolysis for Chronic Abdominal Pain Revisited|Active, not recruiting||N/A|100|Anticipated|Radboud University|||3||f||||f||||||||Undecided|Individual patient data will be made available for future research upon reasonable request|2017-10-10 21:33:23.218902|2017-10-10 21:33:23.218902
NCT02983903|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions|An Un-blinded, Intra-patient Comparison of Transbronchial Forceps Biopsy and Cryobiopsy for Peripheral Pulmonary Lesions|Recruiting||N/A|90|Anticipated|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 21:33:23.311801|2017-10-10 21:33:23.311801
NCT02983890|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-05|||September 2016||2016-09-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.|Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolizing Enzymes.|Recruiting||Phase 1|12|Anticipated|Odense University Hospital||2|||f||||t||||||||No||2017-10-10 21:33:23.394746|2017-10-10 21:33:23.394746
NCT02983877|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-16|||March 13, 2017|Actual|2017-03-13|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|iTAB-CV||Medication Adherence in Hypertensive Individuals With Bipolar Disorder|Improving Medication Adherence in Hypertensive Individuals With Bipolar Disorder|Recruiting||N/A|38|Anticipated|Case Western Reserve University||2|||f||||t|f|f||||||||2017-10-10 21:33:23.481244|2017-10-10 21:33:23.481244
NCT02983864|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Group Alcohol Interventions for College Men|Examining an Integrated Bystander and Alcohol Program for Sexual Assault Perpetration: A Preliminary Randomized Controlled Trial|Enrolling by invitation||Phase 2|100|Anticipated|Ohio University||2|||f||||f||||||||No||2017-10-10 21:33:23.572333|2017-10-10 21:33:23.572333
NCT02983851|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Initial Ventilation Strategy for Adult Immunocompromised Patients With Acute Respiratory Failure|Initial Ventilation Strategy for Adult Immunocompromised Patients With Acute Respiratory Failure|Not yet recruiting||N/A|238|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:33:23.652032|2017-10-10 21:33:23.652032
NCT02983838|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-12-05|||April 2016||2016-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Month|Observational [Patient Registry]|||Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging|Development of Biomarker With Neuroimaging : Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor (BDNF) and Amyloid Neuroimaging|Recruiting||N/A|60|Anticipated|Samsung Medical Center|||3||f||||t||||||Samples With DNA|"     blood specimen for pro-inflammatory cytokine and BDNF BDNF genotyping   "|No||2017-10-10 21:33:23.747976|2017-10-10 21:33:23.747976
NCT02983825|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-06-26|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Impact of CPAP Level on V/Q Mismatch in Premature Infants|Impact of Continuous Positive Airway Pressure Level on Ventilation/Perfusion Mismatch in Premature Infants: a Phase II Clinical Trial|Recruiting||N/A|20|Anticipated|University of Pennsylvania||1|||f||||t|f|t|f|f||||No||2017-10-10 21:33:23.836278|2017-10-10 21:33:23.836278
NCT02983812|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-09-12|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Observational|PREDICT||Developing Enhanced Prediction Models|Developing Enhanced Prediction Models to Identify Patients at Risk for Hospital Readmission by Collecting Patient-Generated Health Data|Enrolling by invitation||N/A|500|Anticipated|University of Pennsylvania|||2||f||||f||||||||||2017-10-10 21:33:23.924055|2017-10-10 21:33:23.924055
NCT02983799|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-09-18|||December 22, 2016|Actual|2016-12-22|September 2017|2017-09-01|October 23, 2019|Anticipated|2019-10-23|October 23, 2019|Anticipated|2019-10-23||Interventional|||Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status|Non-Randomized, Open-Label Phase II Study to Assess Olaparib Tablets as a Treatment for Subjects With Different HRD Tumor Status and With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That Have Received at Least 2 Prior Lines of Chemotherapy|Recruiting||Phase 2|120|Anticipated|AstraZeneca||4|||t||||f|t|f||||||||2017-10-10 21:33:23.996762|2017-10-10 21:33:23.996762
NCT02983786|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-08-10|||December 2015||2015-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Observational|NNOM||Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor|Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor|Recruiting||N/A|80|Anticipated|University of Pennsylvania|||1||f||||t||||||||||2017-10-10 21:33:24.145031|2017-10-10 21:33:24.145031
NCT02983773|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-07-11|||January 23, 2017|Actual|2017-01-23|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Marijuana's Impact on Alcohol Motivation and Consumption|Marijuana's Impact on Alcohol Motivation and Consumption|Recruiting||Phase 2|173|Anticipated|Brown University||3|||f||||f|t|f||||||||2017-10-10 21:33:24.235365|2017-10-10 21:33:24.235365
NCT02983760|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-07-31|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|July 10, 2020|Anticipated|2020-07-10|July 10, 2020|Anticipated|2020-07-10||Interventional|SPECTACULAR||Comparison of 3 Diagnostic Strategies of PE: Planar V/Q Scan, CTPA, and V/Q SPECT.|Comparison of 3 Diagnostic Strategies of Pulmonary Embolism : Planar Ventilation-perfusion Scintigraphy (Planar V/Q Scan), Computed Tomography Pulmonary Angiography (CTPA), and V/Q Single Photon Emission Computed Tomography (SPECT)|Recruiting||N/A|3672|Anticipated|University Hospital, Brest||3|||f|||||f|f||||||||2017-10-10 21:33:24.361809|2017-10-10 21:33:24.361809
NCT02983747|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Autologous Platelet Rich Plasma on Low Back Pain|Autologous Platelet Rich Plasma in Ultrasound Guided Intervertebral Disk Injection Therapy for Chronic Low Back Pain|Active, not recruiting||N/A|112|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:33:24.487899|2017-10-10 21:33:24.487899
NCT02983734|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-03-06|||October 2015||2015-10-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|GWDCS||D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)|D-cycloserine: A Novel Treatment for Gulf War Illness|Recruiting||Phase 2|56|Anticipated|Boston University Charles River Campus||2|||f||||f||||||||No||2017-10-10 21:33:24.566934|2017-10-10 21:33:24.566934
NCT02983721|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-02|||August 2011||2011-08-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Trans Radial Versus Transfemoral Route for Coronary Angiography|Comparison Between Transradial and Transfemoral Routes of Coronary Angiography and Interventions|Completed||N/A|400|Actual|Sheri Kashmir Institute of Medical Sciences||2|||f||||t||||||||Yes|can be shared by email|2017-10-10 21:33:24.642583|2017-10-10 21:33:24.642583
NCT02983708|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-05|||August 2011||2011-08-01|December 2016|2016-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells|Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells in Children With Cerebral Palsy: a Randomized, Double-blind Cross-over Study|Completed||Phase 1/Phase 2|57|Actual|Hanyang University Seoul Hospital||2|||f||||t||||||||Undecided|We have to get individual permissions to make IPD available to other researchers.|2017-10-10 21:33:24.737319|2017-10-10 21:33:24.737319
NCT02983695|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-05-30|||February 2, 2017|Actual|2017-02-02|May 2017|2017-05-01|August 30, 2018|Anticipated|2018-08-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Cannabinoid Therapy for Pediatric Epilepsy|Cannabinoid Therapy in Medically Refractory Pediatric Epilepsy - Phase 1: Dosing and Tolerability Study of a Cannabidiol-Rich Whole Plant Extract of Cannabis.|Active, not recruiting||Phase 1|20|Actual|The Hospital for Sick Children||1|||f||||f|f|f||||||No||2017-10-10 21:33:24.806444|2017-10-10 21:33:24.806444
NCT02983682|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lidocaine Infusions for Chronic Pain in Children|A Pilot Study of the Effectiveness of Lidocaine Infusions for the Management of Chronic Pain in Children|Not yet recruiting||Phase 3|20|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||No||2017-10-10 21:33:24.889869|2017-10-10 21:33:24.889869
NCT02983669|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-10-03|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|May 10, 2017|Actual|2017-05-10|April 20, 2017|Actual|2017-04-20||Interventional|ThymeLiv||The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease|The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Biochemical Markers and Imaging Studies of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)|Completed||N/A|86|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 21:33:24.980869|2017-10-10 21:33:24.980869
NCT02983643|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-05-09|||January 2016|Actual|2016-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|||Body Composition Changes During Stem Cell Transplantation: The Case Of Lymphoma Patients|Body Composition Changes During Stem Cell Transplantation: The Case Of Lymphoma Patients|Recruiting||N/A|105|Anticipated|American University of Beirut Medical Center|||1||f||||f||||||||Yes||2017-10-10 21:33:25.157082|2017-10-10 21:33:25.157082
NCT02983630|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-04-12|||July 2016||2016-07-01|April 2017|2017-04-01|July 1, 2017|Anticipated|2017-07-01|June 30, 2017|Anticipated|2017-06-30||Observational|||Allergy Testing of Patients Labeled as Penicillin Allergic|Allergy Testing of Primary Care Patients Labeled as Penicillin Allergic|Active, not recruiting||N/A|50|Anticipated|Albany Medical College|||1||f||||f||||||||||2017-10-10 21:33:25.235512|2017-10-10 21:33:25.235512
NCT02983604|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-09-21|||January 11, 2017|Actual|2017-01-11|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|March 2019|Anticipated|2019-03-01||Interventional|||GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer|A Phase 1b/2 Study of GS-5829 in Combination With Fulvestrant or Exemestane in Subjects With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer|Recruiting||Phase 1/Phase 2|150|Anticipated|Gilead Sciences||4|||f||||f|t|f||||||||2017-10-10 21:33:25.556316|2017-10-10 21:33:25.556316
NCT02983591|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Misoprostol in Reducing Post Partum Hemorrhage After Labor Induction by Oxytocin|Effect of Misoprostol in Reducing Post Partum Hemorrhage After Labor Induction by Oxytocin: a Prospective Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|Makassed General Hospital||2|||f||||||||||||||2017-10-10 21:33:25.710071|2017-10-10 21:33:25.710071
NCT02983578|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-09-08|||March 2, 2017|Actual|2017-03-02|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||AZD9150 With MEDI4736 in Patients With Advanced Pancreatic, Non-Small Lung and Colorectal Cancer|Phase II Clinical Trial Evaluating Intravenous AZD9150 (Antisense STAT3) With MEDI4736 (Anti-PD-L1) in Patients With Advanced Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer|Recruiting||Phase 2|75|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:33:25.808195|2017-10-10 21:33:25.808195
NCT02983565|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-02|||October 2016||2016-10-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Intelligent Oxygen Therapy During Sleep|The Assessment of Intelligent Oxygen Therapy (iO2T) in Patients With Respiratory Failure on Long-term Oxygen Therapy During Sleep|Recruiting||N/A|19|Anticipated|Imperial College London||2|||f||||f||||||||No|No plan to share IPD.|2017-10-10 21:33:25.912875|2017-10-10 21:33:25.912875
NCT02983552|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-04-07|||March 2, 2017|Actual|2017-03-02|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|ATS20||Binocular Dig Rush Game Treatment for Amblyopia|Binocular Dig Rush Game Treatment for Amblyopia|Recruiting||N/A|200|Anticipated|Jaeb Center for Health Research||2|||f||||t|f|f||||||Yes|In accordance with the NIH data sharing policy, a de-identified database is placed in the public domain on the PEDIG public website after the completion of each protocol and publication of the primary manuscript.|2017-10-10 21:33:26.014267|2017-10-10 21:33:26.014267
NCT02983539|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-12-02|||October 2015||2015-10-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|CTCS||Detection of Circulating Tumor Cells in Patients With Sarcomas|Detection of Circulating Tumor Cells in Patients With Metastatic Sarcomas|Recruiting||N/A|20|Anticipated|AC Camargo Cancer Center|||1||f||||t||||||||No||2017-10-10 21:33:26.126429|2017-10-10 21:33:26.126429
NCT02983526|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-04-07|||November 2011||2011-11-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Randomized Controlled Study Comparing a Short Stem Hip Prosthesis With a Stem of Standard Length||Completed||N/A|80|Actual|Sahlgrenska University Hospital, Sweden||1|||f||||f||||||||Undecided||2017-10-10 21:33:26.210462|2017-10-10 21:33:26.210462
NCT02983513|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-09-28|||April 2014||2014-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2017|Actual|2017-04-01||Interventional|||Early Intervention in Preterm Infants: Short and Long Term Developmental Outcome After a Parental Training Program|Early Intervention in Preterm Infants: Effects of a Parental Training Program on Neonatal Brain Development, Visual Functions and Neurobehavioral Outcome|Active, not recruiting||N/A|70|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||||2017-10-10 21:33:26.278199|2017-10-10 21:33:26.278199
NCT02983500|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-12-02|||August 2016||2016-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Observational|PROXie||Patient Reported Outcomes Registry in Patient With Cancer Cachexia|Tablet-based Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced NSCLC or Advanced Pancreatic Cancer With Focus on Cancer Cachexia|Recruiting||N/A|250|Anticipated|iOMEDICO AG|||1||f||||f||||||||No||2017-10-10 21:33:26.373508|2017-10-10 21:33:26.373508
NCT02983487|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-05-30|||January 22, 2017|Actual|2017-01-22|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Observational|PERILIC||Pertussis Immunization Programs in Low Income Countries|Pertussis Immunization Programs in Low Income Countries|Recruiting||N/A|3500|Anticipated|Institut Pasteur|||3||f||||f||||||Samples Without DNA|"     Nasopharyngeal sample; Blood sample   "|No||2017-10-10 21:33:26.455752|2017-10-10 21:33:26.455752
NCT02983474|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-07|||October 2016||2016-10-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|1 Month|Observational [Patient Registry]|KSQIP||Korea Surgical Quality Improvement Program|Development of Cholecystectomy Complication Predictive Model for Developing the Surgical Quality Improvement Program|Enrolling by invitation||N/A|3000|Anticipated|National Evidence-Based Healthcare Collaborating Agency|||1||f||||t||||||||No||2017-10-10 21:33:26.596511|2017-10-10 21:33:26.596511
NCT02983461|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-05-01|||March 10, 2017|Actual|2017-03-10|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Use of Sildenafil for Treatment of Urinary Incontinence|Use of Sildenafil for Treatment of Urinary Incontinence|Recruiting||Phase 1|24|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f|t|f||||||||2017-10-10 21:33:26.671312|2017-10-10 21:33:26.671312
NCT02983448|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-03-27|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NERDD||Noninvasive Neuromodulation to Reserve Diastolic Dysfunction|Noninvasive Neuromodulation to Reserve Diastolic Dysfunction|Recruiting||N/A|26|Anticipated|University of Oklahoma||2|||f||||f||||||||Undecided||2017-10-10 21:33:26.756549|2017-10-10 21:33:26.756549
NCT02983435|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-05-10|||December 2016||2016-12-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|OTCLBP||Osteopathic Treatment for Chronic Low Back Pain|Comparison Between Two Osteopathic Techniques for Chronic Low Back Pain Treatment: a Randomized Crossover Trial.|Completed||N/A|10|Actual|Universidade Norte do Paraná||2|||f||||t||||||||No||2017-10-10 21:33:26.830379|2017-10-10 21:33:26.830379
NCT02983422|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Aminophylline on Renal Function and Urine Volume of AKI Patient|Effects of Aminophylline on Renal Function and Urine Volume Acute Kidney Injury Patient|Not yet recruiting||Early Phase 1|60|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||2|||f||||t||||||||||2017-10-10 21:33:26.929047|2017-10-10 21:33:26.929047
NCT02983409|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-08-17|||January 2011||2011-01-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Analysis the Relationship Between the Abdomen CT and Outcomes in Acute Urinary Stone Patients|A Study of Analysis the Relationship Between the Findings of Abdominal Comptuted Tomography and the Clinical Outcomes in Acute Urinary Stone Patients|Completed||N/A|862|Actual|Konkuk University Medical Center|||1||f||||t||||||||||2017-10-10 21:33:27.013131|2017-10-10 21:33:27.013131
NCT02983396|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|RELF IIa||The Accuracy of the Mini RELF Device for the Diagnosis of an Acute Coronary Artery Occlusion.|The Accuracy of the Mini RELF Device Relative to the 12 Lead ECG for the Diagnosis of an Acute Coronary Artery Occlusion in Patients With Coronary Artery Disease.|Recruiting||N/A|200|Anticipated|University Ghent||1|||f||||t||||||||No||2017-10-10 21:33:27.0931|2017-10-10 21:33:27.0931
NCT02983383|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-08-12|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of TAP Block for Postoperative Pain Control After Varicocele Operations.|Effect of TAP Block for Postoperative Pain Control After Varicocele Operations on Analgesia Quality and Postoperative Analgesic Consumption|Recruiting||N/A|50|Anticipated|Kahramanmaras Sutcu Imam University||2|||f||||t||||||||||2017-10-10 21:33:27.202406|2017-10-10 21:33:27.202406
NCT02983370|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-12-01|||September 2016||2016-09-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CORTIVIS||Development of a Cortical Visual Neuroprosthesis for the Blind|Pilot Study for the Development of a Cortical Visual Neuroprosthesis for the Blind Based on Intracortical Microelectrodes|Recruiting||N/A|5|Anticipated|Universidad Miguel Hernandez de Elche||1|||f||||f||||||||No||2017-10-10 21:33:27.29996|2017-10-10 21:33:27.29996
NCT02983357|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Observational|Glenoid||Long Term Outcomes Follow-up of Glenoid Anchor Peg Component Fixation|Long Term Outcome Follow-up of Glenoid Anchor Peg Component Fixation Utilizing Autologous Bone Graft in Total Shoulder Arthroplasty.|Enrolling by invitation||N/A|30|Anticipated|University of Nebraska|||1||f||||f||||||||No||2017-10-10 21:33:27.399806|2017-10-10 21:33:27.399806
NCT02983344|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-05|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia|Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia : Ultrasound-Guided Fascia Iliaca Compartment Block Versus Intravenous Fentanyl|Completed||N/A|24|Actual|Kuala Lumpur General Hospital||2|||f||||f||||||||||2017-10-10 21:33:27.493604|2017-10-10 21:33:27.493604
NCT02983331|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-01|||April 2016||2016-04-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Mortality After Endoscopic Retrograde Cholangiopancreatography|Patients With Mortality After Endoscopic Retrograde Cholangiopancreatography|Completed||N/A|1471|Actual|Umraniye Education and Research Hospital|||1||f||||f||||||||Yes|The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.|2017-10-10 21:33:27.588136|2017-10-10 21:33:27.588136
NCT02983318|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-29|||August 28, 2017|Actual|2017-08-28|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|February 2018|Anticipated|2018-02-01||Observational|DiME||Molecular Imaging of Brain Inflammation in Depressive Disorders|Molecular Imaging of Brain Inflammation in Depressive Disorders|Recruiting||N/A|24|Anticipated|Lawson Health Research Institute|||1||f||||f||||||None Retained|"     Blood drawn and analyzed   "|||2017-10-10 21:33:27.654785|2017-10-10 21:33:27.654785
NCT02983305|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-06-26|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Optical Head-Mounted Display Technology for Low Vision Rehabilitation|Optical Head-Mounted Display Technology for Low Vision Rehabilitation|Recruiting||N/A|20|Anticipated|University of Michigan||2|||f||||f|f|t|t|f|f|||No||2017-10-10 21:33:27.723119|2017-10-10 21:33:27.723119
NCT02983292|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-01|||October 2016||2016-10-01|December 2016|2016-12-01|November 2020|Anticipated|2020-11-01|October 2020|Anticipated|2020-10-01||Observational|HRA||PyroTITAN Humeral Resurfacing Arthroplasty (HRA)|A Clinical and Radiological Study to Evaluate the Safety and Efficacy of the PyroTITAN Humeral Resurfacing Arthroplasty (HRA) Device in a New Cohort of Patients After Product Re-Release|Recruiting||N/A|137|Anticipated|Integra LifeSciences Corporation|||1||f||||f||||||||||2017-10-10 21:33:27.812305|2017-10-10 21:33:27.812305
NCT02983279|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-01-19|||September 2016||2016-09-01|January 2017|2017-01-01||||October 2021|Anticipated|2021-10-01||Interventional|||Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer|Caloric Restriction for Oncology Research: Pre-operative Caloric Restriction Prior to Definitive Oncologic Surgery|Recruiting||N/A|42|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 21:33:27.894105|2017-10-10 21:33:27.894105
NCT02983266|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-06-08|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Vagal Nerve Stimulation to Reduce Inflammation and Hyperadrenergia|A Study of Safety and Autonomic Responses to Non-Invasive Vagal Stimulation in Persons With Spinal Cord Injury and Non-Disabled Controls Both With and Without Inflammatory Stress|Recruiting||N/A|135|Anticipated|University of Miami||9|||f||||f|f|t|f|f|f|||No||2017-10-10 21:33:27.995863|2017-10-10 21:33:27.995863
NCT02983253|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-07|||June 2016||2016-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Immunmodulation in Patients With HHT|Immunmodulation in Patients With HHT|Recruiting||N/A|200|Anticipated|University Hospital, Essen|||2||f||||f||||||Samples Without DNA|"     blood sample   "|Undecided||2017-10-10 21:33:28.086487|2017-10-10 21:33:28.086487
NCT02983240|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-09-29|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|June 28, 2018|Anticipated|2018-06-28|January 28, 2018|Anticipated|2018-01-28||Interventional|||Electrical Inhibition of Human Preterm Contractions|Electrical Inhibition (EI): A Preliminary Study to Prevent the Uterine Contractions of Human Preterm Labor and Preterm Birth|Recruiting||N/A|10|Anticipated|University of Florida||3|||f||||f|f|t|t|f||||||2017-10-10 21:33:28.160779|2017-10-10 21:33:28.160779
NCT02983227|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-28|||November 30, 2016|Actual|2016-11-30|September 2017|2017-09-01|July 24, 2019|Anticipated|2019-07-24|July 24, 2019|Anticipated|2019-07-24||Interventional|||A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350 (NCT02833350)|A Phase II Open-Label Extension Study of Patients Previously Enrolled in Study GA29350 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Rheumatoid Arthritis|Recruiting||Phase 2|580|Anticipated|Genentech, Inc.||1|||f|||||t|f||||||||2017-10-10 21:33:28.295098|2017-10-10 21:33:28.295098
NCT02983214|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|DORIC||Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?|Study of the Efficacy and Safety of Cilostazol in the Prevention of Ischemic Vascular Events in Diabetic Patients With Symptomatic Peripheral Artery Disease.|Recruiting||Phase 4|1885|Anticipated|University of Ioannina||2|||f||||t||||||||No||2017-10-10 21:33:28.904138|2017-10-10 21:33:28.904138
NCT02983201|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-12-01|||March 2015||2015-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Clinical Study of Acupuncture Comprehensive Therapy on Common Orthopedic Pain Syndromes|A Clinical Study of Acupuncture Comprehensive Therapy on Common Orthopedic Pain Syndromes|Recruiting||N/A|150|Anticipated|The University of Hong Kong||2|||f||||t||||||||Undecided||2017-10-10 21:33:29.032792|2017-10-10 21:33:29.032792
NCT02983188|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-04|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|BER||Berberine as Adjuvant Treatment for Schizophrenia Patients|A Double-blind, Randomized, Placebo-controlled Trial of Berberine as an Adjuvant to Treat Antipsychotic-induced Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|The University of Hong Kong||2|||f||||f|f|f||||||||2017-10-10 21:33:29.129214|2017-10-10 21:33:29.129214
NCT02983175|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|EGASTA||Ultrasound Assessment of Gastric Content Before Anesthesia for Appendectomy|Ultrasound Assessment of Gastric Content and Gastric Volume Before Crash Induction for Appendectomy|Not yet recruiting||N/A|150|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:33:29.245042|2017-10-10 21:33:29.245042
NCT02983162|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-03-10|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Observational|||Is wGRS Associated With DD Recurrence?|Is the Weighted Genetic Risk Score Associated With Dupuytren Disease Recurrence?|Enrolling by invitation||N/A|677|Anticipated|University Medical Center Groningen|||1||f||||f||||||||No||2017-10-10 21:33:29.319731|2017-10-10 21:33:29.319731
NCT02983149|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-12-05|||January 2016||2016-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||A Clinical Comparison of Two New Bronchial Blockers vs. Double Lumen Tubes in One Lung Ventilation|A Clinical Comparison of Two New Bronchial Blockers vs. Double Lumen Tubes in One Lung Ventilation|Recruiting||N/A|90|Anticipated|University Health Network, Toronto||3|||f||||f||||||||No||2017-10-10 21:33:29.396581|2017-10-10 21:33:29.396581
NCT02983136|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-07-03|||May 2015||2015-05-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Safe Hands at the Sharp End- Implementing Aseptic Technique in the Operating Room|Safe Hands at the Sharp End- Implementing Aseptic Technique in the Operating Room, A Prospective Controlled Study With an Embedded Process Evaluation|Active, not recruiting||N/A|2|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 21:33:29.484813|2017-10-10 21:33:29.484813
NCT02983123|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|OUT-ACS||One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome|Introduction of an 1-hour Algorithm for High-sensitivity Cardiac-specific Troponin T for Faster Assessment of NSTEMI in a Low-prevalence Population at Oslo Accident and Emergency Outpatient Clinic|Recruiting||N/A|1480|Anticipated|Oslo University Hospital|||1||f||||f||||||||No||2017-10-10 21:33:29.567024|2017-10-10 21:33:29.567024
NCT02983110|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|SHAMT||Sex Hormone Therapy and Mucosal Tissues|Does Sex Hormone Therapy Decrease Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Active Metabolite Formation in Mucosal Tissues?|Recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill|||5||f||||f||||||||No||2017-10-10 21:33:29.669551|2017-10-10 21:33:29.669551
NCT02983097|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-12-01|||November 2010||2010-11-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|January 2014|Actual|2014-01-01||Interventional|R²-DHAP||Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP|Open-label, Multicenter Phase I/II Study: Salvage Therapy of Progressive and Relapsed Aggressive Non-Hodgkin-Lymphoma by Combination of Lenalidomide (Revlimid®) With Rituximab, Dexamethason, High-dose ARA-C and Cisplatinum (R²-DHAP)|Terminated||Phase 1/Phase 2|34|Actual|Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH||1||Phase II: no scientific interests are given anymore|f||||f||||||||||2017-10-10 21:33:29.79349|2017-10-10 21:33:29.79349
NCT02983071|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-07|||January 2017||2017-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer|Phase 1/2 Safety, Pharmacokinetic, and Antitumor Activity Study of G1T38 in Combination With Fulvestrant in Patients With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer After Endocrine Failure|Recruiting||Phase 1/Phase 2|102|Anticipated|G1 Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 21:33:30.106699|2017-10-10 21:33:30.106699
NCT02983058|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-02-23|||November 2016||2016-11-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations|PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations|Enrolling by invitation||N/A|40|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||Undecided||2017-10-10 21:33:30.37166|2017-10-10 21:33:30.37166
NCT02983045|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-05|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PIVOT-02||A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) in Patients With Select Advanced or Metastatic Solid Tumors|A Phase 1/2, Open-label, Multicenter, Dose Escalation and Dose Expansion Study of NKTR-214 and Nivolumab in Patients With Select Locally Advanced or Metastatic Solid Tumor Malignancies.|Recruiting||Phase 1/Phase 2|140|Anticipated|Nektar Therapeutics||1|||f||||f||||||||||2017-10-10 21:33:30.475413|2017-10-10 21:33:30.475413
NCT02983032|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-09|||January 2017||2017-01-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Brief Behavioural Treatment for Insomnia in Dementia Carers|Brief Behavioural Treatment for Insomnia (BBTI) in Family Carers of People With Dementia: a Feasibility Study|Not yet recruiting||N/A|15|Anticipated|NHS Greater Glasgow and Clyde||1|||f||||f||||||||No||2017-10-10 21:33:30.69153|2017-10-10 21:33:30.69153
NCT02983019|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-02-16|||December 2013||2013-12-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Observational|FLU-EE||Treatment of Influenza in Routine Clinical Practice|Non-interventional Study: Treatment of Influenza in Routine Clinical Practice (FLU-EE)|Completed||N/A|18946|Actual|Nearmedic Plus LLC|||2||f||||f||||||||No||2017-10-10 21:33:30.790121|2017-10-10 21:33:30.790121
NCT02983006|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||October 2016||2016-10-01|December 2016|2016-12-01||||October 2019|Anticipated|2019-10-01||Interventional|||Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma|A Phase 1 Study of TRAIL-DR5 Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Unresectable Stage III or Stage IV Melanoma|Recruiting||Phase 1|36|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 21:33:30.88503|2017-10-10 21:33:30.88503
NCT02982993|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Hepatitis C Infection in World Trade Center Responders|Hepatitis C Infection in World Trade Center Responders|Recruiting||N/A|3900|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||||No||2017-10-10 21:33:30.989932|2017-10-10 21:33:30.989932
NCT02982980|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-13|||August 2011||2011-08-01|December 2016|2016-12-01|October 2013|Actual|2013-10-01|August 2012|Actual|2012-08-01||Interventional|||Upper Limb Muscular Strengthening in the Rehabilitation of Patients Submitted to the Breast Cancer Surgical Treatment|Muscle Strength Exercises After Breast Cancer Surgery: a Randomized Clinical Trial|Completed||N/A|121|Actual|Federal University of São Paulo||4|||f||||t||||||||||2017-10-10 21:33:31.074741|2017-10-10 21:33:31.074741
NCT02982967|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-05|||April 2013||2013-04-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional|||Recreational Physical Activity and Cardiometabolic Profile|The Impact of the Recreational Physical Activity on Irisin Levels, Endothelial Progenitor Cells and Metabolic Profile in Healthy Children|Completed||N/A|100|Actual|Federal University of São Paulo||1|||f||||t||||||||No||2017-10-10 21:33:31.153778|2017-10-10 21:33:31.153778
NCT02982954|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-09-27|||December 7, 2016|Actual|2016-12-07|September 2017|2017-09-01|January 5, 2023|Anticipated|2023-01-05|March 20, 2018|Anticipated|2018-03-20||Interventional|CHECKMATE 920||A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer|Phase 3b/4 Safety Trial of Nivolumab Combined With Ipilimumab in Subjects With Previously Untreated, Advanced or Metastatic RCC (CheckMate 920: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 920)|Recruiting||Phase 4|200|Anticipated|Bristol-Myers Squibb||4|||f||||t|t|f||||||||2017-10-10 21:33:31.240334|2017-10-10 21:33:31.240334
NCT02982941|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-18|||December 2016||2016-12-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors|A Phase 1, Open-label, Dose Escalation Study of MGA271 in Pediatric Patients With B7-H3-Expressing Relapsed or Refractory Solid Tumors|Recruiting||Phase 1|112|Anticipated|MacroGenics||1|||f||||f||||||||||2017-10-10 21:33:31.496865|2017-10-10 21:33:31.496865
NCT02982928|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Observational|||Tylenol Levels in Bariatric Patients|Acetaminophen Pharmacokinetics in Bariatric Patients|Not yet recruiting||N/A|30|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||Samples With DNA|"     Serum Samples   "|No||2017-10-10 21:33:31.595249|2017-10-10 21:33:31.595249
NCT02982915|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-05-23|||November 2016||2016-11-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|HERA||Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty|Effects of Intravenous Delivery of Longeveron Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody Responses in Subjects With Aging Frailty|Recruiting||Phase 1/Phase 2|43|Anticipated|Longeveron LLC||3|||f||||t||||||||No||2017-10-10 21:33:31.662587|2017-10-10 21:33:31.662587
NCT02982902|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-02-02|||December 2016||2016-12-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||T Cell Therapy of Opportunistic Cytomegalovirus Infection|Antigen Specific Adoptive T Cell Therapy for Opportunistic Cytomegalovirus Infection Occurring After Stem Cell Transplant|Recruiting||Early Phase 1|20|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:33:31.759489|2017-10-10 21:33:31.759489
NCT02982889|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-23|||December 5, 2016|Actual|2016-12-05|August 2017|2017-08-01|April 26, 2017|Actual|2017-04-26|March 23, 2017|Actual|2017-03-23||Interventional|||Single Ascending Dose Study of Two Liquidia Bupivacaine Formulations|A Phase 1 Randomized, Controlled, Double-Blind, Single Ascending Dose Safety and Pharmacokinetic/Pharmacodynamic Study in Healthy Adult Males After LIQ865 Injection|Completed||Phase 1|29|Actual|Liquidia Technologies, Inc.||4|||f||||f||||||||||2017-10-10 21:33:31.841674|2017-10-10 21:33:31.841674
NCT02982876|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-02|2017-04-28|||December 2016||2016-12-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Airway Stents for Excessive Dynamic Airway Collapse|Airway Stents for Excessive Dynamic Airway Collapse: A Randomized Controlled Trial|Enrolling by invitation||N/A|60|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||No||2017-10-10 21:33:31.949507|2017-10-10 21:33:31.949507
NCT02982863|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-03-24|||December 2016||2016-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Treatment Pattern of Oral Anticoagulants (OAC) in Japan|Treatment Patterns of Newly Initiated Oral Anticoagulants on Japanese Non-valvular Atrial Fibrillation Patients Using a Japanese Claims Database|Completed||N/A|99999|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 21:33:32.045364|2017-10-10 21:33:32.045364
NCT02982850|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|DECISIVE||Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease|Effectiveness of Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Aortic and Mitral Valvular Atrial Fibrillation Patients|Not yet recruiting||Phase 4|120|Anticipated|Asan Medical Center||2|||f||||t||||||||No||2017-10-10 21:33:32.113174|2017-10-10 21:33:32.113174
NCT02982837|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-12-01|||March 2015||2015-03-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|RC14/055||To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B|Randomized, Multicenter, Open -Label Clinical Trial to Study the Effect of Adding on Pegylated Interferon Therapy for Patients Diagnosed With Chronic Hepatitis B Showing Maintained Response While Receiving Ongoing Nucleotide Analogues|Recruiting||Phase 4|214|Anticipated|King Abdullah International Medical Research Center||2|||f||||f||||||||No||2017-10-10 21:33:32.355475|2017-10-10 21:33:32.355475
NCT02982824|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-07|||September 2016|Actual|2016-09-01|December 2016|2016-12-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy|Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy: A Pilot Study|Completed||N/A|60|Actual|Ain Shams University||3|||f||||t||||||||Yes||2017-10-10 21:33:32.510935|2017-10-10 21:33:32.510935
NCT02982811|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-01|||March 2017||2017-03-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|i-ACT||Intelligent Activity-based Client-centred Training|Intelligent Activity-based Client-centred Training|Not yet recruiting||Phase 3|160|Anticipated|PXL University College||2|||f||||f||||||||No||2017-10-10 21:33:32.622483|2017-10-10 21:33:32.622483
NCT02982798|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-07-27|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers|Recruiting||Phase 1|40|Anticipated|Jeil Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 21:33:32.719129|2017-10-10 21:33:32.719129
NCT02982785|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Knee Replacement Outcome Predicted by Physiotherapists|Knee Replacement Outcome Predicted by Physiotherapists: A Prospective Cohort|Recruiting||N/A|1000|Anticipated|Frederiksberg University Hospital|||1||f||||f||||||||Yes|Upon finalisation of the prespecified analyses we will share the IPD to other researchers based on an email inquiry.|2017-10-10 21:33:32.845906|2017-10-10 21:33:32.845906
NCT02982772|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-12-02|||May 2016||2016-05-01|December 2016|2016-12-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Patch Study - Intervention for HIV Positive Smokers|Biobehavioral Intervention for Smokers Living With HIV (Human Immunodeficiency Virus)|Recruiting||Phase 4|600|Anticipated|Florida International University||2|||f||||t||||||||Undecided||2017-10-10 21:33:32.945669|2017-10-10 21:33:32.945669
NCT02982759|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-02|||April 2016||2016-04-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|May 2020|Anticipated|2020-05-01||Interventional|||Together We STRIDE (Strategizing Together Relevant Interventions for Diet and Exercise)|Together We STRIDE (Strategizing Together Relevant Interventions for Diet and Exercise)|Recruiting||N/A|900|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||Undecided||2017-10-10 21:33:33.054933|2017-10-10 21:33:33.054933
NCT02982746|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-19|||April 2012||2012-04-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Can a Person-centred-care Intervention Improve Health-related Quality of Life in Patients With Head and Neck Cancer||Completed||N/A|96|Actual|Göteborg University||2|||f||||f||||||||No||2017-10-10 21:33:33.152979|2017-10-10 21:33:33.152979
NCT02982733|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Ankaferd Blood Stopper for Hemostasis After Transradial Coronary Angiography|Ankaferd Blood Stopper as a New Strategy to Avoid Early Complication After Transradial Coronary Angiography: A Randomized, Placebo-Controlled Clinical Trial|Recruiting||N/A|600|Anticipated|Acibadem University||3|||f||||f||||||||||2017-10-10 21:33:33.234099|2017-10-10 21:33:33.234099
NCT02982720|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-09-28|||July 5, 2017|Actual|2017-07-05|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron|A Phase II Multi-center Study Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and Sylatron (Peginterferon Alfa-2b) HCRN:GI16-263|Recruiting||Phase 2|44|Anticipated|Hoosier Cancer Research Network||1|||f||||t|t|f||||||||2017-10-10 21:33:33.340936|2017-10-10 21:33:33.340936
NCT02966470|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Hand Grip Strength as a Marker of Frailty in Surgical Patients|Hand Grip Strength as a Marker of Frailty in Surgical Patients|Not yet recruiting||N/A|100|Anticipated|Yale University|||1||f||||f||||||||No||2017-10-10 21:36:11.850473|2017-10-10 21:36:11.850473
NCT02982707|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-01-31|||December 2016||2016-12-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants|Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||3||Business objectives have changed.|f||||f||||||||||2017-10-10 21:33:33.471346|2017-10-10 21:33:33.471346
NCT02982694|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-08|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer|A Phase II Open-label Study With the Anti-PD-L1 Atezolizumab Monoclonal Antibody in Combination With Bevacizumab in Patients With Advanced Chemotherapy Resistant Colorectal Cancer and MSI-like Molecular Signature|Not yet recruiting||Phase 2|58|Anticipated|Vall d'Hebron Institute of Oncology||1|||f||||t|f|f||||||||2017-10-10 21:33:33.576046|2017-10-10 21:33:33.576046
NCT02982681|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-01|||April 2015||2015-04-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Bioactive Glass and Platelet Rich Fibrin in Intrabony Defects|"COMPARATIVE EVALUATION OF BIOACTIVE GLASS PUTTY AND PLATELET RICH FIBRIN IN THE TREATMENT OF HUMAN PERIODONTAL INTRABONY DEFECTS- A CLINICAL AND RADIOGRAPHICAL STUDY"|Completed||Phase 3|10|Actual|Dr. D. Y. Patil Dental College & Hospital||2|||f||||t||||||||||2017-10-10 21:33:33.699546|2017-10-10 21:33:33.699546
NCT02982668|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-13|||January 2017||2017-01-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|OPENS||Optimizing Early Enteral Nutrition in Severe Stroke|A Multi-center Randomised Controlled Trial to Explore the Ideal Initial Enteral Feeding Strategies in Patients With Severe Stroke at Acute Stage|Not yet recruiting||N/A|600|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-10 21:33:33.796491|2017-10-10 21:33:33.796491
NCT02982655|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|CHASE||Controlling Hypertension After Severe Cerebrovascular Event|A Multi-center Randomised Controlled Trial to Explore the Ideal Individualized Anti-hypertension Strategies in Patients With Severe Stroke at Acute Stage|Not yet recruiting||N/A|500|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-10 21:33:33.947975|2017-10-10 21:33:33.947975
NCT02982642|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-06|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment|The Safety and Efficacy of 1612 Capsules in Treatment of aMnestic Mild Cognitive Impairment: a 52-week, Double Blind,Randomized, Parallel,Placebo Controlled Trial.|Not yet recruiting||Phase 4|240|Anticipated|Dongzhimen Hospital, Beijing||2|||f||||t||||||||No||2017-10-10 21:33:34.096103|2017-10-10 21:33:34.096103
NCT02982629|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-30|||March 2013||2013-03-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Improving Access to Eye Care in Glaucoma Patients|Improving Access to Eye Care in Glaucoma Patients a Prospective, Controlled, Randomized Trial|Completed||N/A|250|Actual|Wills Eye||2|||f||||f||||||||Yes|A total of 8 papers have been published. Results will be uploaded by 2016.|2017-10-10 21:33:34.181669|2017-10-10 21:33:34.181669
NCT02982616|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-05|||August 2015||2015-08-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Influence of Intragastric Fatty Acid Infusion on Behavioral Responses to Positive Emotion Induction in Healthy Subjects|Influence of Intragastric Fatty Acid Infusion on Behavioral Responses to Positive Emotion Induction in Normal Weight Subjects|Completed||N/A|12|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||No|Due to ethical rules the individual participant data will be kept confidential.|2017-10-10 21:33:34.273906|2017-10-10 21:33:34.273906
NCT02982603|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-05|||January 2015||2015-01-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment|The Efficacy and Safety of Qinggongshoutao Bolus for aMnestic Mild Cognitive Impairment: A 52- Week Randomized, Double-blind, Controlled,Three Arms, Multi-center Study|Recruiting||Phase 4|360|Anticipated|Dongzhimen Hospital, Beijing||3|||f||||t||||||||No||2017-10-10 21:33:34.407029|2017-10-10 21:33:34.407029
NCT02982590|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-10|||November 2016||2016-11-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus|Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus: A Prospective Randomized Outcome Blinded Study on the Size Reduction or Resolution of Left Ventricular Thrombus|Recruiting||Phase 3|40|Anticipated|University of Science Malaysia||2|||f||||t||||||||Undecided||2017-10-10 21:33:34.529917|2017-10-10 21:33:34.529917
NCT02982577|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-11-30|||April 2016||2016-04-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Pilocarpine in Patients With Xerostomia|Effect of Pilocarpine in Patients With Xerostomia|Recruiting||Phase 4|80|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 21:33:34.636801|2017-10-10 21:33:34.636801
NCT02982564|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-06-05|||March 2016||2016-03-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Effect of Low vs Moderate-intensity Endurance Exercise on Physical Functioning Among Breast Cancer Survivors|Effect of Low-intensity Versus Moderate-intensity Endurance Exercise on Physical Functioning Among Breast Cancer Survivors: a Randomized Controlled Trial|Recruiting||N/A|142|Anticipated|University of Puerto Rico||2|||f||||t||||||||Yes|Data will be presented at the conclusion of the study.|2017-10-10 21:33:34.742885|2017-10-10 21:33:34.742885
NCT02982551|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Insulin Modulation of fMRI Connectivity in Healthy Adults|Insulin Modulation of fMRI Connectivity and Food Reward|Not yet recruiting||Early Phase 1|10|Anticipated|University of Pittsburgh||1|||f||||f||||||||No||2017-10-10 21:33:34.825381|2017-10-10 21:33:34.825381
NCT02982538|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-11-30|||October 2012||2012-10-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Implementation of Prolonged Exposure in the Military|Implementation of Prolonged Exposure in the Army: Is Consultation Necessary for Effective Dissemination?|Recruiting||N/A|120|Anticipated|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 21:33:34.915184|2017-10-10 21:33:34.915184
NCT02965196|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-13|||December 2016||2016-12-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Dexamethasone Therapy for Low Back Pain||Not yet recruiting||N/A|60|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||No||2017-10-10 21:36:27.390588|2017-10-10 21:36:27.390588
NCT02982512|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Dexmedetomidine on Basal Ganglia Neuronal Activity in Parkinson's Disease|Effects of Different Concentrations of Dexmedetomidine on Basal Ganglia Neuronal Activity (Local Field Potentials) in Parkinson's Disease|Not yet recruiting||Phase 4|12|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||t||||||||||2017-10-10 21:33:35.15893|2017-10-10 21:33:35.15893
NCT02982499|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2016-11-30|||September 2016||2016-09-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|March 2018|Anticipated|2018-03-01||Observational|||Biomechanics of Optic Neuropathy|Biomechanics of Optic Neuropathy|Recruiting||N/A|20|Anticipated|University of Miami|||2||f||||f||||||||No||2017-10-10 21:33:35.236151|2017-10-10 21:33:35.236151
NCT02982486|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma|A Phase II Single Arm Study Assessing Efficacy & Safety of Nivolumab Plus Ipilimumab in Nonresectable/Metastatic Sarcoma and Endometrial Carcinoma Patients With Somatic Deficient MMR as a Selection Tool|Not yet recruiting||Phase 2|60|Anticipated|Assaf-Harofeh Medical Center||1|||f||||f||||||||No||2017-10-10 21:33:35.323765|2017-10-10 21:33:35.323765
NCT02982473|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-30|||April 2016||2016-04-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|RACE-IT||Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions|Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions|Recruiting||N/A|3200|Anticipated|Universitätsmedizin Mannheim|||1||f||||f||||||||No||2017-10-10 21:33:35.412185|2017-10-10 21:33:35.412185
NCT02982460|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2017-05-02|||September 2017|Anticipated|2017-09-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Isoinertial Training on Rotator Cuff Tendinopathy|The Effects of Isoinertial Training on Rotator Cuff Tendinopathy. A Randomized Controlled Double-blind Follow-up Trail. A Pilot Study|Not yet recruiting||N/A|24|Anticipated|University of Malaga||2|||f||||t|f|f||||||No||2017-10-10 21:33:35.518332|2017-10-10 21:33:35.518332
NCT02982447|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Comparison of Detection and Miss Rates of Blue Laser Imaging Versus Conventional White Light Colonoscopy|Comparison of Detection and Miss Rates of Colorectal Adenoma by Blue Laser Imaging (BLI) Versus Conventional White Light Colonoscopy.|Recruiting||N/A|420|Anticipated|Yangzhou No.1 People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:33:35.600353|2017-10-10 21:33:35.600353
NCT02982434|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-01|||September 2016||2016-09-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation|Injection of the New Pharmaceutical Composition Containing Botulinum Toxin Into Epicardial Fat Pads to Treat Atrial Fibrillation After Coronary Artery Bypass Grafting|Recruiting||Phase 2|180|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||||||||||||2017-10-10 21:33:35.695977|2017-10-10 21:33:35.695977
NCT02982421|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-12-01|||December 2016||2016-12-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of Art Therapy on Physical and Psychological Symptoms of Breast Cancer Survivors|The Effect of Group Art Therapy on Physical and Psychological Symptoms of Breast Cancer Survivors Receiving Hormonal Therapy|Not yet recruiting||N/A|20|Anticipated|Rabin Medical Center||2|||f||||f||||||||No||2017-10-10 21:33:35.822524|2017-10-10 21:33:35.822524
NCT02982408|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-12-02|||August 2016||2016-08-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes|Can Exercise Training Revert and/or Minimize the Deleterious Cardiometabolic Effects of Carbohydrate Overfeeding in Individuals With and Without Increased Risk of Type 2 Diabetes?|Recruiting||N/A|50|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 21:33:35.919818|2017-10-10 21:33:35.919818
NCT02982395|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-01-19|||December 2016||2016-12-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC|A Phase Ⅲ Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M (Docetaxel-PM) In Bacillius Calmette-Guerin Refractory Non-Muscle Invasive Bladder Cancer|Recruiting||Phase 3|88|Anticipated|Samyang Biopharmaceuticals Corporation||2|||f||||f||||||||No||2017-10-10 21:33:36.005833|2017-10-10 21:33:36.005833
NCT02982382|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Manipulative Therapy and Pain Education in Individuals With CLBP|Neurophysiological and Functional Effects of Manipulative Therapy and Pain Education in Individuals With Chronic Nonspecific Low Back Pain|Recruiting||N/A|128|Anticipated|Santa Catarina Federal University||2|||f||||||||||||||2017-10-10 21:33:36.114787|2017-10-10 21:33:36.114787
NCT02982369|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||The Effects of Vertebral Manipulation and Pain Education in Chronic Neck Pain|The Effects of Vertebral Manipulation and Pain Education in Chronic Neck Pain|Recruiting||N/A|128|Anticipated|Santa Catarina Federal University||2|||f||||||||||||||2017-10-10 21:33:36.273654|2017-10-10 21:33:36.273654
NCT02982356|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy|Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy|Not yet recruiting||N/A|1300|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||f||||||||Undecided|The Individual Participant Data sharing plan will be discussed with the other collaborators|2017-10-10 21:33:36.38254|2017-10-10 21:33:36.38254
NCT02982343|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-08|||December 2016||2016-12-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|BALTiC||BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease|BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease|Recruiting||N/A|16|Anticipated|University College London Hospitals||2|||f||||f||||||||||2017-10-10 21:33:38.107904|2017-10-10 21:33:38.107904
NCT02982317|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-09-05|||January 5, 2017|Actual|2017-01-05|September 2017|2017-09-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Observational|AUSSI||Automated UltraSound Software for Identification of Lumbar Vertebral Levels|Automated UltraSound Software for Identification of Lumbar Vertebral Levels in Obstetric Patients|Completed||N/A|77|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-10 21:33:38.295271|2017-10-10 21:33:38.295271
NCT02982304|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-30|||January 2015||2015-01-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia|Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia|Recruiting||Phase 1|4|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-10-10 21:33:38.37165|2017-10-10 21:33:38.37165
NCT02982291|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-15|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Focused Spinal Stenosis Rehabilitation Program for Lumbar Spinal Stenosis|Focused Spinal Stenosis Rehabilitation Program vs. Generic Williams Flexion Protocol|Recruiting||N/A|40|Anticipated|Hospital for Special Surgery, New York||2|||f|||||f|f||||||||2017-10-10 21:33:38.456482|2017-10-10 21:33:38.456482
NCT02982278|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-30|||September 2015||2015-09-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|CINGS||Wide Spectrum Investigation of Stroke Outcome Disparities on Multiple Levels (WISSDOM)|Wide Spectrum Investigation of Stroke Outcome Disparities on Multiple Levels (WISSDOM): Community-based Intervention Under Nurse Guidance|Recruiting||N/A|90|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 21:33:38.542687|2017-10-10 21:33:38.542687
NCT02982265|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-30|||August 2016||2016-08-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01|3 Months|Observational [Patient Registry]|||Pre-eclampsia/Eclampsia in Italy Over the Years 2010-2016|"Pre-eclampsia/Eclampsia in Italy Over the Years 2010-2016 Retrospective Observational Multicenter Study Carried Out Through an On-line Self-administered Questionnaire"|Recruiting||N/A|400|Anticipated|Papa Giovanni XXIII Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:33:38.640043|2017-10-10 21:33:38.640043
NCT02982252|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-30|||October 2016||2016-10-01|November 2016|2016-11-01||||February 2017|Anticipated|2017-02-01||Interventional|||Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 2)|Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 2)|Recruiting||Phase 2|32|Anticipated|University of British Columbia||4|||f||||f||||||||||2017-10-10 21:33:38.721924|2017-10-10 21:33:38.721924
NCT02982239|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-01|||June 2016|Actual|2016-06-01|November 2016|2016-11-01|January 5, 2017|Actual|2017-01-05|January 4, 2017|Actual|2017-01-04||Interventional|REST||Recovery Enhancement and Sleep Training|Recovery Enhancement and Sleep Training (REST): Sleep and Mental Well-Being in Student Athletes|Completed||N/A|190|Actual|University of Arizona||2|||f||||f||||||||No||2017-10-10 21:33:38.829433|2017-10-10 21:33:38.829433
NCT02982226|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-07|||October 2016||2016-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis|A Comparative Study of Injectable Human Amniotic Allograft (ReNu™) Versus Corticosteroids for Plantar Fasciitis: A Prospective, Randomized, Blinded Study|Recruiting||N/A|150|Anticipated|NuTech Medical, Inc||2|||f||||f||||||||||2017-10-10 21:33:38.959938|2017-10-10 21:33:38.959938
NCT02982213|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-05-18|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|Companion||Presence of a Companion During Performance of Neuraxial Labor Analgesia|Presence of a Companion During Performance of Neuraxial Labor Analgesia|Completed||N/A|150|Actual|Northwestern University||2|||f||||f|f|f||||||No||2017-10-10 21:33:39.153581|2017-10-10 21:33:39.153581
NCT02982200|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-09|||November 2016||2016-11-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|May 2019|Anticipated|2019-05-01||Observational|MEDINA||Medina Embolization Device In Neurovascular Aneurysm Study|The MEDINA Study: Medina Embolization Device In Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study|Recruiting||N/A|280|Anticipated|Medtronic Neurovascular Clinical Affairs|||1||f||||f||||||||||2017-10-10 21:33:39.243666|2017-10-10 21:33:39.243666
NCT02982187|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-08-08|||December 30, 2016|Actual|2016-12-30|August 2017|2017-08-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease|A Randomized, Open-label, Cross-over, Placebo-device Study Investigating Critical and Over All Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Dry Powder Inhaler (DPI) as Compared to HANDIHALER DPI Used in Combination With Either DISKUS DPI or TURBUHALER DPI, in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|160|Actual|GlaxoSmithKline||8|||f||||f||||||||||2017-10-10 21:33:39.389929|2017-10-10 21:33:39.389929
NCT02982174|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of the Signal to Noise Ratio at Various Retinal Layers|Evaluation of the Signal to Noise Ratio at Various Retinal Layers in Spectral Domain Optical Coherence Tomography (SD OCT) Compared to Swept Source Optical Coherence Tomography (SS OCT)|Enrolling by invitation||N/A|30|Anticipated|Topcon Medical Systems, Inc.||1|||f||||t||||||||No||2017-10-10 21:33:39.53239|2017-10-10 21:33:39.53239
NCT02982161|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-05-18|||December 2016||2016-12-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|STARDOM1||Efficacy and Safety in a Randomised Acute Pain Study of MR308 (Tramadol/Celecoxib).|A Randomized, Double-Blind, Multicenter, Placebo- and Active Comparator-Controlled Study to Evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Third Molar Tooth Extraction (STARDOM1).|Recruiting||Phase 3|765|Anticipated|Mundipharma Research GmbH & Co KG||5|||f||||f||||||||No||2017-10-10 21:33:39.609878|2017-10-10 21:33:39.609878
NCT02982148|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-02|||May 2015||2015-05-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients|Comparison Between Intradermal Injection and Subcutaneous Injection With Methylene Blue for Sentinel Lymph Node Biopsy for Breast Cancer Patients|Recruiting||Phase 4|352|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||f||||||||No||2017-10-10 21:33:39.728147|2017-10-10 21:33:39.728147
NCT02982135|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-12-02|||January 2016||2016-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease|Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease:a Prospective Multi-center Cohort Study|Recruiting||N/A|300|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||Yes||2017-10-10 21:33:39.834985|2017-10-10 21:33:39.834985
NCT02982122|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-30|||November 1, 2017|Anticipated|2017-11-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|COGITATE||CPPopt Guided Therapy: Assessment of Target Effectiveness|"A Randomized Clinical Trial Assessing the Effect of Optimal Cerebral Perfusion Pressure Monitoring in the Management of Severe Traumatic Brain Injury"|Not yet recruiting||N/A|60|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:33:39.915632|2017-10-10 21:33:39.915632
NCT02982109|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Pain Evaluation of Venous Cannulation to Predict Postoperative Pain|Prediction of Postoperative Pain From Individually Assessed Pain Intensity Levels Associated With Venous Cannulation|Not yet recruiting||N/A|600|Anticipated|Lund University|||4||f||||f||||||||No||2017-10-10 21:33:40.001192|2017-10-10 21:33:40.001192
NCT02982096|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique|Randomized Controlled Pilot Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique (Membrane or Cream Dressings) in Superficial to Mid-dermal Burn Wounds|Recruiting||N/A|30|Anticipated|Lehigh Valley Hospital||2|||f||||f||||||||No||2017-10-10 21:33:40.090172|2017-10-10 21:33:40.090172
NCT02982083|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis|Clinical Trial on the Efficacy of Raloxifene on Disease Activity and Glucocorticoid-induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis|Not yet recruiting||N/A|40|Anticipated|Mashhad University of Medical Sciences||2|||f||||||||||||||2017-10-10 21:33:40.196885|2017-10-10 21:33:40.196885
NCT02982070|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-02|||September 2016||2016-09-01|November 2016|2016-11-01|June 2022|Anticipated|2022-06-01|May 2022|Anticipated|2022-05-01||Interventional|TUtough||TU Tough: Mental Toughness Training for College Success|TU (University of Tulsa) Tough: Mental Toughness Training for College Success|Enrolling by invitation||N/A|1000|Anticipated|Laureate Institute for Brain Research, Inc.||2|||f||||f||||||||No||2017-10-10 21:33:40.278289|2017-10-10 21:33:40.278289
NCT02982057|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-30|||January 2015||2015-01-01|November 2016|2016-11-01||||July 2017|Anticipated|2017-07-01||Interventional|||Non Culprit Lesion Study|A Randomized Trial of the Treatment of Non- Culprit Lesion After STEMI: Bioresorbable Vascular Scaffold Versus Optimal Medical Therapy (NCLstudy)|Active, not recruiting||Phase 3|20|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||Yes||2017-10-10 21:33:40.35897|2017-10-10 21:33:40.35897
NCT02982044|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-01|||December 2016||2016-12-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|ASPEN||Artery Function Responses to Changes in Blood Flow|Endothelial Function Responses to Manipulations in Blood Flow Pattern|Not yet recruiting||N/A|10|Anticipated|McMaster University||1|||f||||f||||||||No||2017-10-10 21:33:40.480373|2017-10-10 21:33:40.480373
NCT02982031|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-12-01|||June 2016||2016-06-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||A Comparison of Visualization Between Shamrock Technique and Paramedian Transverse Scan in Lumbar Plexus Blockade|A Comparison of Visualization Between Shamrock Technique and Paramedian Transverse Scan in Lumbar Plexus Blockade|Completed||N/A|23|Actual|Mahidol University||2|||f||||t||||||||No||2017-10-10 21:33:40.574062|2017-10-10 21:33:40.574062
NCT02982018|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-03-27|||October 1, 2016||2016-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:33:40.669175|2017-10-10 21:33:40.669175
NCT02982005|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-07|||January 2017||2017-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea|A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of KHK4827 in Subjects With Moderate to Severe Plaque Psoriasis|Active, not recruiting||Phase 3|60|Anticipated|Kyowa Hakko Kirin Korea Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:33:40.83446|2017-10-10 21:33:40.83446
NCT02981992|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2016-12-02|||February 2011||2011-02-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2014|Actual|2014-02-01||Observational|||T Regulatory Cells in Hemodialysis Patients: Observational Study|Observational Study on T Regulatory Cells in Hemodialysis Patients|Completed||N/A|30|Actual|IRCCS Policlinico S. Matteo|||1||f||||f||||||Samples Without DNA|"     Sample used to evaluate T cell subpopulations   "|No||2017-10-10 21:33:40.924807|2017-10-10 21:33:40.924807
NCT02981979|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-09|||December 2016||2016-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|TACTIC||Takayasu Arteritis Clinical Trial in China|Comparison of the Efficacy and Safety of Leflunomide Versus Placebo Combine With the Basic Prednisone Therapy in Patients With Active Phase of Takayasu's Arteritis: a Randomized Controlled Double-blinded Trial|Recruiting||N/A|116|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 21:33:41.005158|2017-10-10 21:33:41.005158
NCT02981966|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects|Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects (11038)|Not yet recruiting||Phase 4|48|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||No||2017-10-10 21:33:41.142125|2017-10-10 21:33:41.142125
NCT02981953|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-12-01|||October 2016||2016-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|TRI-REPAIR||TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System|TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System|Recruiting||N/A|30|Anticipated|Valtech Cardio Ltd||1|||f||||f||||||||Undecided||2017-10-10 21:33:41.235897|2017-10-10 21:33:41.235897
NCT02981940|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-06-27|||February 9, 2017|Actual|2017-02-09|June 2017|2017-06-01|April 2024|Anticipated|2024-04-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study of Abemaciclib in Recurrent Glioblastoma|A Phase 2 Study of Abemaciclib in Recurrent Glioblastoma|Recruiting||Phase 2|47|Anticipated|Dana-Farber Cancer Institute||2|||f||||t|t|f||||||No||2017-10-10 21:33:41.381178|2017-10-10 21:33:41.381178
NCT02981927|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||January 2015||2015-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|BIER||Bed Rest, Inactivity and Early Responses|Bed Rest, Inactivity and Early Responses|Recruiting||N/A|10|Anticipated|University of Exeter||3|||f||||f||||||||No||2017-10-10 21:33:41.508875|2017-10-10 21:33:41.508875
NCT02981914|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-04-18|||March 7, 2017|Actual|2017-03-07|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation|Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation|Recruiting||Early Phase 1|26|Anticipated|University of Chicago||1|||f|||||t|f||||||||2017-10-10 21:33:41.579218|2017-10-10 21:33:41.579218
NCT02981901|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-05|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|Ovaire01||Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France|Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France|Not yet recruiting||N/A|400|Anticipated|Centre Leon Berard|||1||f||||f||||||||||2017-10-10 21:33:41.67116|2017-10-10 21:33:41.67116
NCT02981888|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-30|||July 2016||2016-07-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|Bile Acid||Fecal Bile Acids, Fecal Short Chain Fatty Acids and the Intestinal Microbioita in Patients With IBS and Control Volunteers|Fecal Bile Acids, Fecal Short Chain Fatty Acids and the Intestinal Microbioita in Patients With IBS and Control Volunteers|Recruiting||N/A|90|Anticipated|Indiana University|||3||f||||f||||||||||2017-10-10 21:33:41.762566|2017-10-10 21:33:41.762566
NCT02981875|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-11-30|||January 2015||2015-01-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|September 2015|Actual|2015-09-01||Interventional|||Oculomotor Training Improves Reading Eye Movement|Oculomotor Training Improves Reading Eye Movement|Active, not recruiting||N/A|30|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||No||2017-10-10 21:33:41.86199|2017-10-10 21:33:41.86199
NCT02981862|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CaptHPV||"Validation of the Method CaptHPV for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas"|"Monocentric Study of Validation of the Method CaptHPV for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas From a Biological Specimen."|Recruiting||N/A|100|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 21:33:41.956515|2017-10-10 21:33:41.956515
NCT02981849|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-12-01|||January 2016||2016-01-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Validating Adolescent SBIRT Measures|Validating Adolescent SBIRT Measures|Recruiting||N/A|450|Anticipated|Boston Children’s Hospital|||1||f||||t||||||||No||2017-10-10 21:33:42.034662|2017-10-10 21:33:42.034662
NCT02981836|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-30|||August 2016||2016-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines|A Blind, Randomized and Controlled Clinical Trial to Evaluate the Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccines for Healthy Children|Active, not recruiting||Phase 3|5997|Actual|Sinovac (Dalian) Vaccine Technology Co., Ltd.||2|||f||||t||||||||No||2017-10-10 21:33:42.098713|2017-10-10 21:33:42.098713
NCT02981823|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-01|||January 2015||2015-01-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Periprosthetic Fracture on Hip Function After Femoral Neck-preserving Total Hip Arthroplasty|Effect of Periprosthetic Fracture on Hip Function After Femoral Neck-preserving Total Hip Arthroplasty: a Prospective, Single-center, Self-controlled Trial With 2-year Follow-up|Active, not recruiting||N/A|25|Actual|Hebei Medical University Third Hospital||1|||f||||t||||||||No||2017-10-10 21:33:42.190458|2017-10-10 21:33:42.190458
NCT02981810|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-12-01|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Coblation Channeling Treatment for Chronic Tonsillitis.|Evaluation of Coblation Channeling Treatment for Chronic Tonsillitis.|Not yet recruiting||N/A|120|Anticipated|Hillel Yaffe Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:33:42.255568|2017-10-10 21:33:42.255568
NCT02981797|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-18|||March 5, 2015|Actual|2015-03-05|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223|Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 Treatment|Active, not recruiting||N/A|10|Actual|H. Lee Moffitt Cancer Center and Research Institute|||1||f||||f||||||||||2017-10-10 21:33:42.334195|2017-10-10 21:33:42.334195
NCT02981784|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-01|||January 2000||2000-01-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2011|Actual|2011-12-01||Observational|||Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I|Overall Survival With Ponatinib Versus Allogeneic Stem Cell Transplant in Philadelphia-positive Leukemias With the T315I Mutation|Completed||N/A|184|Actual|Hospices Civils de Lyon|||2||f||||f||||||||No||2017-10-10 21:33:42.41599|2017-10-10 21:33:42.41599
NCT02981771|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-30|||December 2016||2016-12-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Exercise Training Programs On Balance in Older Adults With CVD|The Effect of Exercise Training Programs - Stability and Coordination - On Static Balance, Dynamic Balance and Risk of Falls in Older Adults With Cardiovascular Disease|Not yet recruiting||N/A|50|Anticipated|Hillel Yaffe Medical Center||2|||f||||||||||||||2017-10-10 21:33:42.485508|2017-10-10 21:33:42.485508
NCT02981758|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-30|||July 2016||2016-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|ADOPT||Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT)|Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT) - A Retrospective Blinded Cohort Study|Recruiting||N/A|300|Anticipated|Hackensack University Medical Center|||2||f||||f||||||||No||2017-10-10 21:33:42.561027|2017-10-10 21:33:42.561027
NCT02981745|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-07-18|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia|Study of Safety, Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia|Recruiting||Phase 1/Phase 2|200|Anticipated|Centaurus Biopharma Co., Ltd.||1|||f||||t|f|f||||||||2017-10-10 21:33:42.644989|2017-10-10 21:33:42.644989
NCT02981732|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-03-24|||October 2016||2016-10-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|March 2019|Anticipated|2019-03-01||Interventional|PMOP||CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome|CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome Regulating the Bone Osteoimmunology Mechanism by the OPG/RANKL/RANK Signal System|Recruiting||N/A|60|Anticipated|Fujian Academy of Traditional Chinese Medicine||2|||f||||||||||||||2017-10-10 21:33:42.727696|2017-10-10 21:33:42.727696
NCT02981719|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-12-08|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Clinical Application of IRE Combined With Chemotherapy in the Treatment of Pancreatic Cancer|Clinical Application of IRE Combined With Chemotherapy in the Treatment of Pancreatic Cancer|Recruiting||Phase 1|20|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||Undecided||2017-10-10 21:33:42.798715|2017-10-10 21:33:42.798715
NCT02981706|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis|A Pilot Randomized Trial of Arteriovenous Fistula (AVF) Versus Arteriovenous Graft (AVG) in Elderly Patients With Advanced Chronic Kidney Disease (CKD)|Recruiting||N/A|90|Anticipated|Columbia University||2|||f||||t||||||||Yes|Data will be retained by the Columbia PI for future research use. This applies only to those subjects who consent to allow (a) the storage and use of their data in identifiable form after completion of the study &/or (b) the use of data for future research and/or testing, including for commercial purposes, that may or may not be related to this study. If data is shared, it will only be given in de-identifiable form.|2017-10-10 21:33:42.877125|2017-10-10 21:33:42.877125
NCT02981693|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-11-30|||January 2014||2014-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of iRoot SP as Root Canal Sealer: A Clinical Study|1-year Evaluation of iRoot SP as a Root Canal Sealer Compare to AH Plus Sealer: A Prospective Clinical Study|Completed||N/A|283|Actual|The Dental Hospital of Zhejiang University School of Medicine||2|||f||||||||||||||2017-10-10 21:33:42.965463|2017-10-10 21:33:42.965463
NCT02981680|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-30|||November 2013||2013-11-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect of Remote Ischemic Preconditioning on Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery|Effect of Remote Ischemic Preconditioning on Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial|Active, not recruiting||N/A|170|Anticipated|Shiraz University of Medical Sciences||2|||f||||||||||||||2017-10-10 21:33:43.030557|2017-10-10 21:33:43.030557
NCT02981667|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-02|||September 2015||2015-09-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Higher Enjoyment in Response to High Intensity Interval Training Versus Moderate Intensity Continuous Exercise|Enjoyment Responses to High Intensity Interval Training and Moderate Intensity Continuous Exercise|Completed||N/A|12|Actual|California State University, San Marcos|||1||f||||f||||||||No|Data are accepted for publication in PLoS One, an open-access journal, which makes the aggregate data available to all researchers.|2017-10-10 21:33:43.109486|2017-10-10 21:33:43.109486
NCT02981654|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-12-04|||December 2016||2016-12-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|CO2||Safety and Efficacy of Carbone Dioxide (CO2) Laser System in Treatment of Female Stress Urinary Incontinence.|Prospective, Open-Label, Multi-Center, Non- Comparative Study to Assess the Safety and Efficacy of CO2 Laser System (FemiLiftTM) in the Treatment of Stress Urinary Incontinence (SUI) in Female Subjects.|Not yet recruiting||N/A|60|Anticipated|Sheba Medical Center||1|||f||||f||||||||No||2017-10-10 21:33:43.169428|2017-10-10 21:33:43.169428
NCT02981641|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||December 2015||2015-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|IVCPC||IORT Versus CCRT for Pancreatic Cancer|Intraoperative Radiotherapy (IORT) Versus Concurrent Chemoradiotherapy (CCRT) for Pancreatic Cancer|Recruiting||N/A|100|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||f||||||||No||2017-10-10 21:33:43.360451|2017-10-10 21:33:43.360451
NCT02981628|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-06-07|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia|A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)|Recruiting||Phase 2|56|Anticipated|Children's Oncology Group||1|||f||||f|t|f||||||||2017-10-10 21:33:43.4747|2017-10-10 21:33:43.4747
NCT02981615|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase 3 Multicenter Randomized Double Blind Placebo Controlled Study With Antibacterial Prophylaxis in Azacitidine Treated MDS Patients|A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Safety and Efficacy of Antibacterial Prophylaxis for Prevention of Infections in Azacitidine Treated Myelodysplastic Syndrome Patients.|Not yet recruiting||Phase 3|170|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 21:33:43.584535|2017-10-10 21:33:43.584535
NCT02980198|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-09-08|||November 2016||2016-11-01|September 2017|2017-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Study of IFN-K in Dermatomyositis|A Phase IIa, Single Blind, Randomized, Study to Evaluate the Safety, the Immunogenicity, and the Clinical and Biological Efficacy of IFNα-Kinoid (IFN-K) in Adult Subjects With Dermatomyositis|Recruiting||Phase 2|30|Anticipated|Neovacs||2|||f||||t||||||||||2017-10-10 21:33:58.363046|2017-10-10 21:33:58.363046
NCT02981602|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-06-09|||February 22, 2017|Actual|2017-02-22|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection|A Phase 2, Double-Blinded, Randomized, Placebo-Controlled, Dose-Escalation Study to Examine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ISIS 505358 in Treatment-Naïve Patients With Chronic HBV Infection|Recruiting||Phase 2|24|Anticipated|Ionis Pharmaceuticals, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:33:43.70609|2017-10-10 21:33:43.70609
NCT02981589|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-03|||July 2013||2013-07-01|December 2016|2016-12-01||||December 2016|Anticipated|2016-12-01||Observational|||Weaning Outcome From Invasive Mechanical Ventilation|Weaning Outcome From Invasive Mechanical Ventilation: a Prospective, Observational Cohort Study|Recruiting||N/A|300|Anticipated|Beijing Chao Yang Hospital|||1||f||||t||||||||No||2017-10-10 21:33:43.821858|2017-10-10 21:33:43.821858
NCT02981576|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-01-30|||November 2016||2016-11-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.|Comparative Evaluation of Safety and Effectiveness of Autologous Bone Marrow Derived Mesenchymal Stem Cells (BM-MSC) vs Adipose Tissue Derived Mesenchymal Stem Cells (AT-MSC) in the Treatment of Spinal Cord Injury (SCI) Patient.|Active, not recruiting||Phase 1/Phase 2|14|Actual|University of Jordan||2|||f||||t||||||||Undecided||2017-10-10 21:33:43.916529|2017-10-10 21:33:43.916529
NCT02981563|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-23|||January 2017||2017-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|TT||Time Together: A Multi-site Nursing Intervention Project Using a Single System Experimental Design||Enrolling by invitation||N/A|3|Anticipated|Umeå University||1|||f||||f||||||||||2017-10-10 21:33:44.00647|2017-10-10 21:33:44.00647
NCT02981550|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Infection Detection by Breath Analysis|Infection Detection by Breath Analysis|Enrolling by invitation||N/A|500|Anticipated|BreathTec Biomedical Inc.|||1||f||||t||||||Samples Without DNA|"     Exhaled Breath   "|No||2017-10-10 21:33:44.081946|2017-10-10 21:33:44.081946
NCT02981537|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-07-12|||October 2016||2016-10-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Two-staged Approach in Positioning Endobronchial Blockers Without Fiberoptic Guidance||Completed||N/A|94|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:33:44.149881|2017-10-10 21:33:44.149881
NCT02981524|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-07-06|||May 26, 2017|Actual|2017-05-26|July 2017|2017-07-01|March 2025|Anticipated|2025-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Phase 2 Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer|A Phase 2 Study of GVAX Colon Vaccine (With Cyclophosphamide) and Pembrolizumab in Patients With Mismatch Repair-Proficient (MMR-p) Advanced Colorectal Cancer|Recruiting||Phase 2|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:33:44.223912|2017-10-10 21:33:44.223912
NCT02981498|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-03-12|||June 2015||2015-06-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma|Phase II Trial of Sorafenib Combined With Concurrent Hepatic Arterial Infusion (HAI) of Oxaliplatin, 5-fluorouracil and Leucovorin for Hepatocellular Carcinoma|Recruiting||Phase 2|35|Anticipated|Sun Yat-sen University||1|||f||||t||||||||No||2017-10-10 21:33:44.411891|2017-10-10 21:33:44.411891
NCT02981485|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-03|||December 2016||2016-12-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|FGTBRCL||Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China|Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China|Recruiting||Phase 2|30|Anticipated|Peking Union Medical College||1|||f||||t||||||||No||2017-10-10 21:33:44.506764|2017-10-10 21:33:44.506764
NCT02981472|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-13|||January 4, 2017|Actual|2017-01-04|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|September 29, 2020|Anticipated|2020-09-29||Interventional|||A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation|A Prospective, Randomized, Open Label, Multi-center Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist or LMWH in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention|Recruiting||Phase 2|150|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 21:33:44.610511|2017-10-10 21:33:44.610511
NCT02981459|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-02|||January 2017||2017-01-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women|Pilot Study: Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women, an Open Label Study With Dose Escalation|Not yet recruiting||Phase 4|40|Anticipated|State University of New York at Buffalo||1|||f||||t||||||||No||2017-10-10 21:33:44.889465|2017-10-10 21:33:44.889465
NCT02981446|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT|A Phase III, Randomized, Observer-Masked, Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution 0.002% Compared With Latanoprost Ophthalmic Solution 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension- PEONY Study|Recruiting||Phase 3|360|Anticipated|Santen Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:33:45.019477|2017-10-10 21:33:45.019477
NCT02981264|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CRISPEN||Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During EBUS-TBNA|Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): A Randomised Controlled Trial|Not yet recruiting||N/A|100|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||Undecided||2017-10-10 21:33:48.358476|2017-10-10 21:33:48.358476
NCT02981433|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-26|||October 18, 2017|Anticipated|2017-10-18|September 2017|2017-09-01|August 1, 2019|Anticipated|2019-08-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Vulvodynia: Identification of Potential Relevant Biomarkers|Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Vulvodynia: Identification of Potential Relevant Biomarkers|Not yet recruiting||N/A|150|Anticipated|St. Louis University|||1||f||||f||||||Samples Without DNA|"     Peripheral blood leukocytes (PBLs) may provide a relevant biomarker to predict severity and     pain induction outcomes as well as predict patient responses to anti-S1PR1 approaches.   "|||2017-10-10 21:33:45.111975|2017-10-10 21:33:45.111975
NCT02981420|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-03-02|||December 2016||2016-12-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Implementing a Brief Suicide Intervention for High Risk Youth With Front-Line Juvenile Justice Staff|Implementing a Brief Suicide Intervention for High Risk Youth With Front-Line Juvenile Justice Staff|Recruiting||N/A|300|Anticipated|Rhode Island Hospital||3|||f||||f||||||||No||2017-10-10 21:33:45.172232|2017-10-10 21:33:45.172232
NCT02981407|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-22|||April 25, 2017|Actual|2017-04-25|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|March 2021|Anticipated|2021-03-01||Interventional|MINT||Myocardial Ischemia and Transfusion|Myocardial Ischemia and Transfusion|Recruiting||Phase 3|3500|Anticipated|Rutgers, The State University of New Jersey||2|||f||||t|t|f|||f|||Yes|Limited access data (i.e., records without personal identifiers) will be prepared by the Data Coordinating Center (DCC) and sent to the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) within 3 years after the end of the final patient follow-up or 2 years after the main paper of the trial has been published, whichever comes first. The Trial data set will include baseline patient characteristics, follow-up status, and clinical outcome data. The data will be released to requesting institutions and investigators in accordance with BioLINCC policy.|2017-10-10 21:33:45.257689|2017-10-10 21:33:45.257689
NCT02981394|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01||||December 2021|Anticipated|2021-12-01|5 Years|Observational [Patient Registry]|||Clinical Outcomes of Autologous Bone Marrow Aspirate Concentrate Injections for Musculoskeletal Conditions|Clinical Outcomes of Autologous Bone Marrow Aspirate Concentrate Injections for Musculoskeletal Conditions|Recruiting||N/A|300|Anticipated|Rush University Medical Center|||1||f||||||||||||||2017-10-10 21:33:45.388766|2017-10-10 21:33:45.388766
NCT02981381|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-08-29|||September 2016||2016-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|sTMS||Synchronized Transcranial Magnetic Stimulation for PTSD|Synchronized TMS for Posttraumatic Stress Disorder and Comorbid Depressive Symptoms|Recruiting||Phase 2|20|Anticipated|Providence VA Medical Center||2|||f||||f||||||||||2017-10-10 21:33:46.445238|2017-10-10 21:33:46.445238
NCT02981368|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-26|||November 2016||2016-11-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|OSPREY||Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (OSPREY)|A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients With PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY)|Recruiting||Phase 2/Phase 3|290|Anticipated|Progenics Pharmaceuticals, Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:33:47.061324|2017-10-10 21:33:47.061324
NCT02981355|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-08-11|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|RECORD||Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions|Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions|Recruiting||Phase 4|158|Anticipated|Piramal Healthcare Canada Ltd||2|||f||||t|f|f||||||||2017-10-10 21:33:47.229244|2017-10-10 21:33:47.229244
NCT02981342|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-10-03|||January 2017||2017-01-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma|An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma|Recruiting||Phase 2|231|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 21:33:47.408147|2017-10-10 21:33:47.408147
NCT02981329|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-08-25|||March 2, 2017|Actual|2017-03-02|August 2017|2017-08-01|November 2022|Anticipated|2022-11-01|November 2019|Anticipated|2019-11-01||Interventional|FITMet||Fetal Hemoglobin Induction Treatment Metformin|Use of Metformin as a Fetal Hemoglobin Inducer in Patients With Hemoglobinopathies|Recruiting||Early Phase 1|37|Anticipated|Baylor College of Medicine||2|||f||||t|t|f||||||||2017-10-10 21:33:47.646586|2017-10-10 21:33:47.646586
NCT02981316|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-05-10|||November 2016||2016-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Treatment of Recurrent Clostridium Difficile Infection With RBX7455|Treatment of Recurrent Clostridium Difficile Infection With RBX7455: A Dose-ranging, Prospective, Single Center, Open Label Phase I Trial|Recruiting||Phase 1|40|Anticipated|Mayo Clinic||4|||f||||f|t|f||||||Undecided||2017-10-10 21:33:47.735984|2017-10-10 21:33:47.735984
NCT02981303|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-09|||December 2016||2016-12-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer|A Multicenter, Open-label, Phase 2 Study of Imprime PGG and Pembrolizumab in Subjects With Advanced Melanoma Failing Front-line Treatment With Checkpoint Inhibitors (CPI) or Triple Negative Breast Cancer (TNBC) Failing Front-line Chemotherapy for Metastatic Disease|Recruiting||Phase 2|95|Anticipated|Biothera||2|||f||||f||||||||No||2017-10-10 21:33:47.82749|2017-10-10 21:33:47.82749
NCT02981290|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2016-12-01|||July 2008||2008-07-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study to Compare the Pharmacokinetics of Mycophenolate Mofetil Metabolites From Four Tablet Formulations in Healthy Participants|A Randomized, Open Label, Four-way Crossover Study to Compare the Pharmacokinetics of Mycophenolate Mofetil Metabolites From Four Tablet Formulations in Healthy Subjects|Completed||Phase 1|32|Actual|Hoffmann-La Roche||4|||f||||f||||||||No||2017-10-10 21:33:48.107188|2017-10-10 21:33:48.107188
NCT02981277|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-08-21|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CRISP||Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During Bronchoscopy|Transcricoid Injection Versus Spray as You go Method for Local Anaesthesia During Flexible Bronchoscopy: A Randomised Controlled Trial|Recruiting||N/A|150|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-10 21:33:48.236865|2017-10-10 21:33:48.236865
NCT02981251|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-02|||January 2016||2016-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Community Based Health Education to Manage Uncontrolled Blood Pressure in Surkhet, Nepal|Effectiveness of Community Based Health Education in Reduction of Blood Pressure Among Uncontrolled Hypertensive Patients of Suburban Population of Surkhet District of Nepal|Completed||N/A|142|Actual|Bheri Zonal Ayurveda Hospital||2|||f||||t||||||||||2017-10-10 21:33:48.44252|2017-10-10 21:33:48.44252
NCT02981238|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-02|||September 2016||2016-09-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Descriptive Study of a Phytotherapy Strategy for Sleep Disorders Related to Anxiety With Phytostandard® Eschscholtzia and Valerian, a Dietary Supplement Based on Eschscholtzia and Valerian Extracts||Recruiting||N/A|40|Anticipated|Pileje|||1||f||||f||||||||||2017-10-10 21:33:48.531109|2017-10-10 21:33:48.531109
NCT02981225|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|||Descriptive Study of a Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.||Recruiting||N/A|52|Anticipated|Pileje|||1||f||||f||||||||||2017-10-10 21:33:48.605333|2017-10-10 21:33:48.605333
NCT02981212|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-30|||June 2016||2016-06-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|AIGA||Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy|Multi-center, Randomized, Open Label, Comparative, Phase IV Study to Evaluate the Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid for 48 Weeks in Advanced IgA Nephropathy|Recruiting||Phase 4|100|Anticipated|Yonsei University||2|||f||||t||||||||No||2017-10-10 21:33:48.690983|2017-10-10 21:33:48.690983
NCT02981199|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-15|||January 2016||2016-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients|A Prospective, Multi-center, Randomized Controlled Trial of Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients|Recruiting||N/A|80|Anticipated|Beijing Chao Yang Hospital||2|||f||||||||||||No||2017-10-10 21:33:48.814717|2017-10-10 21:33:48.814717
NCT02981186|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-07-12|||November 2, 2016|Actual|2016-11-02|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)|Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)|Recruiting||N/A|25|Anticipated|Physiol||2|||f||||f|f|f||||||||2017-10-10 21:33:48.926465|2017-10-10 21:33:48.926465
NCT02981173|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-06-22|||November 2016||2016-11-01|June 2017|2017-06-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Psilocybin for the Treatment of Cluster Headache|Safety and Efficacy of Psilocybin for the Treatment of Cluster Headache|Recruiting||Phase 1|24|Anticipated|Yale University||3|||f||||f||||||||No||2017-10-10 21:33:49.022501|2017-10-10 21:33:49.022501
NCT02981160|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-04-12|||December 2016||2016-12-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Breezing||Validation of a Personal Breath Analyzer for Diet and Energy Expenditure Assessment and Management|Validation of a Personal Breath Analyzer for Diet and Energy Expenditure Assessment and Management|Withdrawn||N/A|0|Actual|Banner Health||2||Pending Organization approval|f||||f||||||||Yes|Baseline and demographic characteristics will be summarized by standard descriptive summaries (e.g. means and standard deviations for continuous variables such as age and percentages for categorical variables such as gender). We will measure differences in weight loss in the two groups using the Mann-Whitney U test|2017-10-10 21:33:49.13003|2017-10-10 21:33:49.13003
NCT02981147|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-09|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PEAC||PEAC: Phytus Efficacy in Acute Cough|PEAC: Phytus Efficacy in Acute Cough|Not yet recruiting||Phase 4|1000|Anticipated|PharmEvo Pvt Ltd||1|||f||||t|f|f||||||||2017-10-10 21:33:49.205817|2017-10-10 21:33:49.205817
NCT02981134|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||December 2016||2016-12-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|CT BVS||The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease|The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease; A Single Center, Prospective Observational Study|Not yet recruiting||N/A|300|Anticipated|Asan Medical Center|||1||f||||f||||||||Undecided||2017-10-10 21:33:49.290049|2017-10-10 21:33:49.290049
NCT02981121|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-07-21|||November 2016||2016-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Hospital-based Diabetes Prevention Study in Korea|Hospital-based Diabetes Prevention Study in Korea: A Prospective, Multi-center, Randomized, Open-label Controlled Study|Recruiting||Phase 4|744|Anticipated|Kyunghee University Medical Center||3|||f||||t||||||||||2017-10-10 21:33:49.369375|2017-10-10 21:33:49.369375
NCT02981108|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC|A Phase 1/2, Open-label, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of HS-10296 in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer|Recruiting||Phase 1/Phase 2|300|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||9|||f||||||||||||||2017-10-10 21:33:49.463107|2017-10-10 21:33:49.463107
NCT02981095|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-01|||January 2010||2010-01-01|November 2016|2016-11-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||Effect of Bupivacaine Application on Postthyroidectomy Pain|Bupivacaine Application Reduces Postthyroidectomy Pain: Cerrahpaşa Experience|Completed||N/A|91|Actual|Istanbul University||2|||f||||f||||||||No||2017-10-10 21:33:49.550782|2017-10-10 21:33:49.550782
NCT02981082|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension|A Double-blinded, Placebo-controlled Pilot Study of Dimethyl Fumarate (DMF) in Pulmonary Arterial Hypertension (PAH) Associated With Systemic Sclerosis (SSc-PAH): The Effect of DMF on Clinical Disease and Biomarkers of Oxidative Stress.|Recruiting||Phase 1|34|Anticipated|University of Pittsburgh||2|||f||||t||||||||Undecided||2017-10-10 21:33:49.631963|2017-10-10 21:33:49.631963
NCT02981069|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of GLP-1 Receptor Agonist, Exenatide on Glucosuria Induced Elevation in ENDOGENOUS GLUCOSE PRODUCTION (EGP)|Effect of GLP-1 Receptor Agonist, Exenatide on Glucosuria Induced Elevation in ENDOGENOUS GLUCOSE PRODUCTION (EGP)|Not yet recruiting||Phase 4|80|Anticipated|The University of Texas Health Science Center at San Antonio||4|||f||||t||||||||||2017-10-10 21:33:49.723391|2017-10-10 21:33:49.723391
NCT02981056|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-01|||June 2013||2013-06-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Clinical Assessment of the Efficacy and Effects of Different Skincare Regimens on Infants|A Clinical Assessment of the Efficacy and Effects of Different Skincare Regimens on Infants|Completed||N/A|150|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||No||2017-10-10 21:33:49.817674|2017-10-10 21:33:49.817674
NCT02981043|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-08-22|||September 2016||2016-09-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|Aggressivity||"Does Aggressivity of Endometriosis Correlate to Clinical History or Outcomes?"|"Does Aggressivity of Endometriosis Correlate to Clinical History or Outcomes?"|Enrolling by invitation||N/A|45|Anticipated|St. Louis University|||1||f||||f||||||Samples With DNA|"     1. Blood EDTA (about 10ml) (study related).        2. Peritoneal tissue (about 3-4 samples each the size of 1 tsp) (SOC)        3. Peritoneal fluid, if present (up to 100cc) (SOC) 4 Endometrial biopsy (1/4 to 1/2 inch          long, (1/8 to 1/4 in width) (several SOC biopsies will be taken and one will be sent for          research).      5. Possibly small amount of ovarian tissue (if abnormal) (about size of 1 tsp) (SOC)   "|||2017-10-10 21:33:49.921685|2017-10-10 21:33:49.921685
NCT02981030|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-09|||November 2016||2016-11-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine|Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine: A Demonstration Study of 800 mcg Buccal Misoprostol Following 200 mg Mifepristone for Abortion up to 70 Days Gestation|Recruiting||Phase 4|100|Anticipated|Gynuity Health Projects||1|||f||||f||||||||No||2017-10-10 21:33:49.972848|2017-10-10 21:33:49.972848
NCT02981017|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improvement of Outcomes in Draf III/Endoscopic Modified Lothrop Procedure|Prospective Study for Improvement in Outcomes Following Draf III/Endoscopic Modified Lothrop Procedure Using a Porcine Intestinal Submucosal Graft|Recruiting||Phase 4|50|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 21:33:50.063176|2017-10-10 21:33:50.063176
NCT02981004|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-11-30|||October 2012||2012-10-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|PARI||PAR I - Patient-to-Annulus Relation I|PAR I - Prothesis-to-Annulus Relation (PAR) as Predictor of Hemodynamic Outcome in Aortic Valve Replacement|Recruiting||N/A|300|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-10 21:33:50.161743|2017-10-10 21:33:50.161743
NCT02980991|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-12-01|||December 2015||2015-12-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma|Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma|Recruiting||Phase 2|80|Anticipated|Fudan University||1|||f||||f||||||||Undecided||2017-10-10 21:33:50.257741|2017-10-10 21:33:50.257741
NCT02980978|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-30|||April 2016||2016-04-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|ENHANCED||diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)|diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)|Enrolling by invitation||N/A|144|Anticipated|Minneapolis Heart Institute Foundation||2|||f||||f||||||||No||2017-10-10 21:33:50.337537|2017-10-10 21:33:50.337537
NCT02980965|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2016-11-30|||May 2013||2013-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer|A Randomized Controlled Study to Evaluate the Efficacy and Safety of Endocrine Therapy Plus Chemotherapy Versus Chemotherapy Alone as the Neoadjuvant Therapy in the Treatment of ER-positive, HER2-negative Breast Cancer (IIa-IIIc)|Active, not recruiting||Phase 3|213|Actual|Fudan University||2|||f||||t||||||||||2017-10-10 21:33:50.405259|2017-10-10 21:33:50.405259
NCT02980952|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-01|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Amino Acid Balance During Physical Inactivity|Amino Acid Balance During Physical Inactivity|Not yet recruiting||N/A|40|Anticipated|University of Exeter||4|||f||||f||||||||No||2017-10-10 21:33:50.481974|2017-10-10 21:33:50.481974
NCT02980939|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-27|||November 2016||2016-11-01|May 2017|2017-05-01|March 18, 2017|Actual|2017-03-18|March 18, 2017|Actual|2017-03-18||Interventional|ODIN||The Role of Hydration on Exercise Performance - ODIN|The Role of Hydration on Exercise Performance - ODIN|Completed||N/A|11|Actual|University of Arkansas, Fayetteville||2|||f||||f||||||||No||2017-10-10 21:33:50.566825|2017-10-10 21:33:50.566825
NCT02980926|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-03-23|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty|Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty, a Randomized Controlled Clinical Trial|Completed||Phase 4|32|Actual|Henry Ford Health System||2|||f||||f||||||||No||2017-10-10 21:33:50.654875|2017-10-10 21:33:50.654875
NCT02980913|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-03-22|||February 11, 2016|Actual|2016-02-11|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|May 17, 2016|Actual|2016-05-17||Interventional|||Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome||Active, not recruiting||N/A|45|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 21:33:50.740929|2017-10-10 21:33:50.740929
NCT02980900|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|SPADE||The Effect of Protein Ingestion on the Recovery of Skeletal Muscle Function Following Eccentric Exercise.||Not yet recruiting||N/A|30|Anticipated|University of Exeter||3|||f||||f||||||||No||2017-10-10 21:33:50.826602|2017-10-10 21:33:50.826602
NCT02962193|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-10|||December 2016||2016-12-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Functional and Social Changes After Bariatric Surgery|Evaluation of Functional and Social Changes After Bariatric Surgery|Not yet recruiting||N/A|100|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||||||||||||2017-10-10 21:36:58.293451|2017-10-10 21:36:58.293451
NCT02980887|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-01-27|||November 2016||2016-11-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|PVDOMICS||Pulmonary Vascular Disease Phenomics Program PVDOMICS|Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics (PVDOMICS)|Recruiting||N/A|1500|Anticipated|The Cleveland Clinic|||3||f||||t||||||Samples With DNA|"     Samples for Omics analyses, including DNA   "|Yes||2017-10-10 21:33:50.910129|2017-10-10 21:33:50.910129
NCT02980861|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-05|||January 2017||2017-01-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes Dissection|Laparoscopic Versus Open Total Gastrectomy With Spleen-preserving Splenic Hilum Lymph Nodes Dissection for Advanced Proximal Gastric Cancer: A Randomized Controlled Trial|Not yet recruiting||Phase 3|200|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||No||2017-10-10 21:33:51.191957|2017-10-10 21:33:51.191957
NCT02980848|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2017-07-14|||September 2016||2016-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01|3 Years|Observational [Patient Registry]|BCSC-ADVANCE||Assessing Breast Density's Value in Imaging - A Comparative Effectiveness Study|Comparative Effectiveness of Breast Cancer Screening and Diagnostic Evaluation by Extent of Breast Density|Enrolling by invitation||N/A|1000000|Anticipated|University of California, Davis|||2||f||||f||||||||||2017-10-10 21:33:51.290019|2017-10-10 21:33:51.290019
NCT02980835|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-29|||September 2016||2016-09-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Optimal Timing of Intercostal Nerve Blocks During Video-Assisted Thoracic Surgeries|Optimal Timing of Intercostal Nerve Blocks During Video-Assisted Thoracic Surgeries|Recruiting||N/A|220|Anticipated|University at Buffalo||2|||f||||f||||||||No|The investigators don't plan to make individual participant data (IPD) available to other researchers.|2017-10-10 21:33:51.407202|2017-10-10 21:33:51.407202
NCT02980822|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-02|||January 2011||2011-01-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|1 Year|Observational [Patient Registry]|||Patient Reported Outcome After Surgical Treatment of DDD in Scandinavia|Comparison of Baseline Characteristics and Patient Reported Outcome After Surgical Treatment of Degenerative Lumbar Disc Disease in Scandinavia|Active, not recruiting||N/A|3500|Actual|Sygehus Lillebaelt|||1||f||||f||||||||||2017-10-10 21:33:51.496652|2017-10-10 21:33:51.496652
NCT02980809|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-01|||March 2017||2017-03-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer|Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer|Not yet recruiting||Phase 2|60|Anticipated|First Hospitals affiliated to the China PLA General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:33:51.648115|2017-10-10 21:33:51.648115
NCT02980796|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-11|||November 2016||2016-11-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|EX-ML3||The Influence of Exercise on Neuroplasticity and Motor Learning After Stroke|The Influence of Acute Bouts of Aerobic Exercise on Neuroplasticity and Motor Learning After Stroke|Recruiting||N/A|104|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 21:33:51.735688|2017-10-10 21:33:51.735688
NCT02980783|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-07-20|||October 3, 2016|Actual|2016-10-03|July 2017|2017-07-01|December 14, 2016|Actual|2016-12-14|December 14, 2016|Actual|2016-12-14||Interventional|BEAM||A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Dynamic Radial Cheek Line Skin Depressions|BEAM: Prospective Open Label Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Treatment of Dynamic Radial Cheek Line Skin Depressions|Completed||Phase 4|53|Actual|Allergan||1|||f||||f|f|f||||||||2017-10-10 21:33:51.848585|2017-10-10 21:33:51.848585
NCT02980770|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-04-04|||November 2016||2016-11-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|OHBE||Postoperative Complications in Patients With Obesity Hypoventilation Syndrome|Postoperative Complications in Patients With Obesity Hypoventilation Syndrome Based on Base Excess- OHBE Study: A National, Multicenter, Observational Cohort Study|Recruiting||N/A|999|Anticipated|Marmara University|||3||f||||f||||||Samples Without DNA|"     Biochemistry, blood gases   "|No||2017-10-10 21:33:51.939572|2017-10-10 21:33:51.939572
NCT02980757|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-11-30|||June 2014||2014-06-01|November 2016|2016-11-01||||June 2014|Actual|2014-06-01||Interventional|||Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets|Comparative Randomized, Single Dose, Three-period Crossover Open-label Study to Determine the Bioequivalence of Gliclazide 120 mg Modified Release Tablets Formula A and Gliclazide 120 mg Modified Release Tablets Formula B Manufactured by Indeus Life Sciences PVT. Ltd., Relative to DIAMICRON MR® 60 mg 2 × of Les Laboratories Servier Industrie, France, After an Oral Administration of 120 mg to Healthy Adults Under Fasting Conditions|Withdrawn||Phase 1|0|Actual|Disphar International B.V.||3|||f||||f||||||||||2017-10-10 21:33:52.052269|2017-10-10 21:33:52.052269
NCT02980744|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-11-29|||August 2016||2016-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|STUFFS||A Home-based Intervention to Reduce Sedentary Behaviour and Improve Function After Stroke|The Feasibility of a Home-based Transition Intervention to Reduce Sedentary Behaviour and Improve Function Within the First Six Months After Stroke: STand Up Frequently From Stroke Trial|Recruiting||N/A|35|Anticipated|University of Alberta||1|||f||||f||||||||Yes|Data related to activPAL sedentary and activity monitoring might be shared with supervisors and other researchers|2017-10-10 21:33:52.148039|2017-10-10 21:33:52.148039
NCT02980562|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-01|||May 2015||2015-05-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl|Comparison of a Split Dose Bowel Preparation With 2-L Polyethylene Glycol Plus Ascorbic Acid and 1-L Polyethylene Glycol Plus Ascorbic Acid and Bisacodyl Prior to Colonoscopy|Completed||Phase 3|200|Actual|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-10 21:33:53.627188|2017-10-10 21:33:53.627188
NCT02980731|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-08-02|||December 13, 2016||2016-12-13|August 2017|2017-08-01|January 17, 2023|Anticipated|2023-01-17|November 11, 2020|Anticipated|2020-11-11||Interventional|||A Study Evaluating Venetoclax in Subjects With Chronic Lymphocytic Leukemia Whose Cancer Has Come Back or Who Had No Response to Previous Cancer Treatments Including Subjects Missing Part of Their Chromosome 17, or TP53 Gene Mutation; or Who Received Prior Treatment With a B-Cell Receptor Inhibitor|Open-Label, Single Arm, Phase 3b, Multi-Center Study Evaluating the Impact of Venetoclax on the Quality of Life of Relapsed/Refractory Subjects With Chronic Lymphocytic Leukemia (CLL) Including Those With the 17p Deletion or TP53 Mutation OR Those Who Have Received Prior Treatment With B-Cell Receptor Inhibitor|Recruiting||Phase 3|200|Anticipated|AbbVie||1|||f||||t||||||||||2017-10-10 21:33:52.28497|2017-10-10 21:33:52.28497
NCT02980718|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-28|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Does Olfactory Training Improve Olfaction in a Population With Normal Sense of Smell?|Does Olfactory Training Improve Olfaction in a Population With Normosmia and How is Their Self Assessment of Sense of Smell?|Recruiting||N/A|200|Anticipated|St. Olavs Hospital||3|||f||||f|f|f||||||||2017-10-10 21:33:52.448746|2017-10-10 21:33:52.448746
NCT02980705|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-11|||June 30, 2017|Anticipated|2017-06-30|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Efficacy and Safety Study of SUNPG1622|A Randomized, Double-blind, Placebo-controlled Phase 2a Study to Evaluate the Efficacy and Safety of Tildrakizumab in Subjects With Active Ankylosing Spondylitis or Non-radiographic Axial Spondyloarthritis|Not yet recruiting||Phase 2|180|Anticipated|Sun Pharma Global FZE||2|||f|||||t|f||||||||2017-10-10 21:33:52.547424|2017-10-10 21:33:52.547424
NCT02980692|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-11|||June 30, 2017|Anticipated|2017-06-30|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Efficacy and Safety Study of SUNPG1623|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2b Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Active Psoriatic Arthritis|Not yet recruiting||Phase 2|450|Anticipated|Sun Pharma Global FZE||5|||f||||t|t|f||||||Undecided||2017-10-10 21:33:52.619371|2017-10-10 21:33:52.619371
NCT02980679|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-27|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery|A Pivotal Phase III Study of Cyclotron-produced Tc-99m Pertechnetate (CTC) Compared to Generator-produced Tc-99m Pertechnetate (G-PERT) in Subjects With Thyroid Disorders|Recruiting||Phase 3|30|Anticipated|University of Alberta||1|||f||||f|f|f||||||No||2017-10-10 21:33:52.709143|2017-10-10 21:33:52.709143
NCT02980666|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-20|||January 13, 2017|Actual|2017-01-13|September 2017|2017-09-01|July 3, 2018|Anticipated|2018-07-03|July 3, 2018|Anticipated|2018-07-03||Interventional|||Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support|A 24-week Safety, Efficacy, Pharmacodynamic, and Pharmacokinetic Study of Teduglutide in Japanese Pediatric Subjects, Aged 1 Year Through 15 Years, With Short Bowel Syndrome Who Are Dependent on Parenteral Support|Recruiting||Phase 3|5|Anticipated|Shire||1|||f||||t|t|f|||t|||||2017-10-10 21:33:52.82603|2017-10-10 21:33:52.82603
NCT02980653|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-01-16|||May 2015||2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT|A Phase II Study Assessing the Efficacy of Prophylaxis Use of Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With Head and Neck Cancer Who Receiving Concurrent Chemoradiotherapy|Recruiting||Phase 2|105|Anticipated|TTY Biopharm||1|||f||||f||||||||||2017-10-10 21:33:52.972433|2017-10-10 21:33:52.972433
NCT02980640|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-29|||June 2016||2016-06-01|November 2016|2016-11-01|June 2041|Anticipated|2041-06-01|June 2041|Anticipated|2041-06-01|25 Years|Observational [Patient Registry]|SMSR||Swiss Multiple Sclerosis Registry|Swiss Multiple Sclerosis Registry|Recruiting||N/A|10000|Anticipated|Swiss Multiple Sclerosis Registry|||1||f||||f||||||||Yes|Pseudonimized data are shared with other researchers upon approval of a project proposal. Guidelines describing submission and approval process are in place.|2017-10-10 21:33:53.08792|2017-10-10 21:33:53.08792
NCT02980627|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-05-31|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|iOmit||iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes|iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes|Recruiting||N/A|60|Anticipated|Duke University||1|||f||||t||||||||No||2017-10-10 21:33:53.178034|2017-10-10 21:33:53.178034
NCT02980614|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-30|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|CARDIOFLUX||4D Velocity Mapping of the Heart in rTOF Patients|Cardiac 4D MR Velocity Mapping in Repaired Tetralogy of Fallot Patients: Evaluation of Pulmonary Regurgitant Fraction and Ventricular Volume|Not yet recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||No||2017-10-10 21:33:53.303679|2017-10-10 21:33:53.303679
NCT02980601|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-16|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect|The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect|Recruiting||N/A|100|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|t||||||||2017-10-10 21:33:53.388579|2017-10-10 21:33:53.388579
NCT02980588|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-29|||December 2016||2016-12-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effects of SGC on Glucose Control in Critically Ill Patients With Sepsis|Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Sepsis in ICU|Not yet recruiting||N/A|60|Anticipated|Southeast University, China||1|||f||||||||||||||2017-10-10 21:33:53.471741|2017-10-10 21:33:53.471741
NCT02980575|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Music During Pulmonary Rehabilitation for Patients With COPD|Does Music During Pulmonary Rehabilitation in Individuals With Chronic Obstructive Pulmonary Disease (COPD) Improve Outcome? A Randomized Controlled Trial|Recruiting||N/A|92|Anticipated|West Park Healthcare Centre||2|||f||||f||||||||No||2017-10-10 21:33:53.540033|2017-10-10 21:33:53.540033
NCT02980549|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-11-29|||April 2015||2015-04-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||How Common Are Sleep Disorders and Problems With Emergence From Anesthesia in Surgical Patients|Determining the Incidence of Parasomnias (PS) and Emergence Delirium (ED)in the American Family Children's Hospital Patient Population|Completed||N/A|100|Actual|University of Wisconsin, Madison|||1||f||||f||||||||No||2017-10-10 21:33:53.699712|2017-10-10 21:33:53.699712
NCT02980536|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|||cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China|The Oncogenic Mutation Detection of Advanced NSCLC Patients by cSMART Liquid Biopsy and Dynamic Monitor of Tyrosine Kinase Inhibitor(TKI) Efficiency in Inner-Mongolia China|Recruiting||N/A|1120|Anticipated|Berry Genomics Co., Ltd.|||1||f||||t||||||Samples With DNA|"     There are two types of biospecimen collected in this study. One is the tumor tissue sample     taken by biopsy. The other is the plasma sample from the blood.   "|No||2017-10-10 21:33:53.757753|2017-10-10 21:33:53.757753
NCT02980510|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-05-22|||December 2016||2016-12-01|May 2017|2017-05-01|January 2024|Anticipated|2024-01-01|June 2018|Anticipated|2018-06-01||Interventional|PANIRINOX||Study Comparing FOLFIRINOX + Panitumumab Versus mFOLFOX6 + Panitumumab in Metastatic Colorectal Cancer Patients Selected by RAS and B-RAF Status From Circulating DNA Analysis||Recruiting||Phase 2|209|Anticipated|UNICANCER||2|||f||||||||||||||2017-10-10 21:33:53.940589|2017-10-10 21:33:53.940589
NCT02980497|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||September 2013||2013-09-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study|Determination of the Antiplaque/Antigingivitis Efficacy of Essential Oil Containing Mouthrinses In a Six-Month Study|Completed||N/A|370|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||No||2017-10-10 21:33:54.039478|2017-10-10 21:33:54.039478
NCT02980484|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-11-29|||August 2016||2016-08-01|November 2016|2016-11-01||||August 2019|Anticipated|2019-08-01||Interventional|||fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI|fMRI-neuronavigated Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depression Associated With Traumatic Brain Injury|Recruiting||N/A|50|Anticipated|Washington University School of Medicine||2|||f||||f||||||||Yes|De-identified neuroimaging data will be submitted to FITBIR (Federal Interagency TBI Research)|2017-10-10 21:33:54.124836|2017-10-10 21:33:54.124836
NCT02980471|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-12-01|||March 2014||2014-03-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Comparison of Compensatory Reserve Index to Changes in Stroke Volume and Intravascular Volume|Comparison of Compensatory Reserve Index to Changes in Stroke Volume and Intravascular Volume|Completed||N/A|20|Actual|Flashback Technologies|||1||f||||f||||||||No||2017-10-10 21:33:54.210231|2017-10-10 21:33:54.210231
NCT02980458|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-06|||August 2016||2016-08-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration|Characterisation of Relative Bioavailability of a Generic Deferiprone Formulation in Comparison With a Marketed Reference Product in a Single Dose, 2-period-crossover Design Under Fasting Conditions; Controlled, Open, Randomised, no Blinded Study With Bioequivalence Assessment|Completed||Phase 1|25|Actual|SocraTec R&D GmbH||2|||f||||f||||||||||2017-10-10 21:33:54.260073|2017-10-10 21:33:54.260073
NCT02980445|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Time Outdoors as an Intervention for Myopia in Children|Time Outdoors as an Intervention for Myopia in Children——School-based Randomized Controlled Study|Enrolling by invitation||N/A|7200|Anticipated|Shanghai Eye Disease Prevention and Treatment Center||3|||f||||t||||||||No||2017-10-10 21:33:54.353394|2017-10-10 21:33:54.353394
NCT02980432|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-29|||October 2016||2016-10-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Verticality Perception Assessed by the Haptic Vertical|Verticality Perception - Modulatory Effect of a Rotating Optokinetic Stimulus on the Haptic Vertical in Healthy Human Subjects|Recruiting||N/A|20|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 21:33:54.416243|2017-10-10 21:33:54.416243
NCT02980419|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-29|||June 2016||2016-06-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Effects of Prolonged Roll-tilt in Healthy Human Subjects|Erticality Perception - Effects of Prolonged Roll-tilt in Healthy Human Subjects|Recruiting||N/A|20|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 21:33:54.479337|2017-10-10 21:33:54.479337
NCT02980406|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-29|||September 2015||2015-09-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level|The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level|Completed||N/A|40|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||No||2017-10-10 21:33:54.545999|2017-10-10 21:33:54.545999
NCT02980393|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-20|||May 2012||2012-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SHT||Smart Heart Trial: Structured Lifestyle Intervention for Overweight and Obese Youth With Operated Heart Defects|The Impact of a Structured Lifestyle Intervention on Body Composition and Exercise Capacity in Overweight Children With Operated Heart Defects|Completed||N/A|40|Actual|Western University, Canada||1|||f||||t||||||||||2017-10-10 21:33:54.622322|2017-10-10 21:33:54.622322
NCT02980380|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-29|||June 2014||2014-06-01|November 2016|2016-11-01||||December 2020|Anticipated|2020-12-01||Observational|||Brain Computer Interface Complete locked-in State Communication|Brain Computer Interface Based Communication in the Completely Locked-In State|Recruiting||N/A|15|Anticipated|University Hospital Tuebingen|||1||f||||f||||||||Undecided|Data will be made available to other researcher after publication of the study|2017-10-10 21:33:54.697504|2017-10-10 21:33:54.697504
NCT02980367|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-07|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|July 2020|Anticipated|2020-07-01||Interventional|ACL SNNAP||ACL SNNAP Trial: ACL Surgery Necessity in Non Acute Patients|Comparison of the Clinical and Cost Effectiveness of Two Management Strategies for Non-acute Anterior Cruciate Ligament (ACL) Injury: Rehabilitation Versus Surgical Reconstruction.|Recruiting||N/A|320|Anticipated|University of Oxford||2|||f||||t||||||||Undecided||2017-10-10 21:33:54.783525|2017-10-10 21:33:54.783525
NCT02980354|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-03-08|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|November 2019|Anticipated|2019-11-01||Observational|||Bayraktutan Dunhill Medical Trust EPC Study|Endothelial Progenitor Cells: Potential Biomarkers for Diagnosis and Prognosis of Ischaemic Stroke|Recruiting||N/A|200|Anticipated|University of Nottingham|||4||f||||t||||||Samples Without DNA|"     plasma   "|Yes|De-identified IPD will be made available to other researchers after publication of the research findings. De-identified IPD underlying the results presented in these articles including tables, figures or supplementary material, will be shared as per the regulations of the University of Nottingham indicated on https://www.nottingham.ac.uk/fabs/rgs/research-data-management/data-sharing-and-archiving/sharing-data.aspx.|2017-10-10 21:33:54.875526|2017-10-10 21:33:54.875526
NCT02980341|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer|Phase 1/2, Multicenter, Non-randomized, Open-label, Multiple-Dose First-in-human Study of U3-1402, in Subjects With HER3 Positive Metastatic Breast Cancer|Recruiting||Phase 1/Phase 2|80|Anticipated|Daiichi Sankyo, Inc.||3|||f||||||||||||||2017-10-10 21:33:54.95453|2017-10-10 21:33:54.95453
NCT02980328|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-12-05|||December 2016||2016-12-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Low-level Light Therapy for Overactive Bladder and Urinary Incontinence|Double-blind, Randomized, Shame-controlled Multicenter Clinical Study to Evaluate Efficacy and Safety of Low-level Light Therapy Device(Color DNA-WSF) for the Treatment of Overactive Bladder and Urinary Incontinence in Women|Not yet recruiting||Phase 3|120|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:33:55.027598|2017-10-10 21:33:55.027598
NCT02980315|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application|A New Efficient EBV AssociatedTechnologies of T Cells in Treating Malignant Tumors and Clinical Application|Recruiting||Phase 1/Phase 2|20|Anticipated|The Second Hospital of Nanjing Medical University||2|||f||||||||||||||2017-10-10 21:33:56.685934|2017-10-10 21:33:56.685934
NCT02980302|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Rementips||"Development of the Tool  iPSC  for the Functional Study of Mutations Responsible for Mental Retardation"|"Development of the Tool  iPSC  (Induced Pluripotent Stem Cells) for the Functional Study of Mutations Responsible for Mental Retardation - Application to Familial Study of MYT1L Gene Mutations"|Recruiting||N/A|4|Anticipated|University Hospital, Grenoble||3|||f||||f||||||||||2017-10-10 21:33:56.764128|2017-10-10 21:33:56.764128
NCT02980289|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-11-29|||February 2016||2016-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer.||Recruiting||N/A|1500|Anticipated|Odense University Hospital|||1||f||||f||||||||No||2017-10-10 21:33:56.887833|2017-10-10 21:33:56.887833
NCT02980276|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-09-11|||June 6, 2017|Actual|2017-06-06|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|January 2020|Anticipated|2020-01-01||Interventional|EMERGE||A Clinical Trial of the Effectiveness of Metformin in Addition to Usual Care in the Reduction of Gestational Diabetes Mellitus|A Randomised Placebo Controlled Trial of the Effectiveness of Early MEtformin in Addition to Usual Care in the Reduction of Gestational Diabetes Mellitus Effects (EMERGE)|Recruiting||Phase 3|550|Anticipated|National University of Ireland, Galway, Ireland||2|||f||||t|f|f||||||||2017-10-10 21:33:56.971879|2017-10-10 21:33:56.971879
NCT02980263|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-02-15|||November 15, 2016|Anticipated|2016-11-15|February 2017|2017-02-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease|Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease|Withdrawn||Phase 2|0|Actual|Novartis||1|||f||||t||||||||Undecided||2017-10-10 21:33:57.728831|2017-10-10 21:33:57.728831
NCT02980250|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-09-13|||November 2015||2015-11-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|MCSDDDFI||Multi-Center Study of Different Doses Domperidone in Feeding Intolerance|A Clinical Multi-Center Study of Efficacy Analysis in Different Doses of Domperidone in Feeding Intolerance of Premature Infant|Completed||Phase 4|118|Actual|Nanfang Hospital of Southern Medical University||4|||f||||t||||||||||2017-10-10 21:33:57.808922|2017-10-10 21:33:57.808922
NCT02980237|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-03-04|||April 20, 2017|Anticipated|2017-04-20|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|e-Health||e-Health Education Program at Workplace|Effectiveness of an e-Health Program at Workplace in the Promotion of Quality of Life of Office Workers: Protocol of a Randomized Controlled Trial by Cluster|Not yet recruiting||N/A|384|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t|f|f||||||No||2017-10-10 21:33:57.925183|2017-10-10 21:33:57.925183
NCT02980224|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-03-22|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease|A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease|Completed||Phase 3|180|Actual|OmegaD LLC||2|||f||||f||||||||No||2017-10-10 21:33:58.054563|2017-10-10 21:33:58.054563
NCT02980211|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-03-16|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|August 31, 2018|Anticipated|2018-08-31|March 1, 2018|Anticipated|2018-03-01||Interventional|OSTEO2||Treatment of Post-Extraction Dehisced Socket - A Case Series Study|Clinical, Radiographic and Histologic Evaluation of a Novel Alveolar Ridge Reconstruction Approach in Post-Extraction Dehiscence Defects: A Case Series Study|Recruiting||N/A|20|Anticipated|University of Iowa||1|||f||||f|f|t|f|f|t|||No||2017-10-10 21:33:58.259818|2017-10-10 21:33:58.259818
NCT02980185|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2016-11-29|||June 2007||2007-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2015|Actual|2015-07-01||Observational|||Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer|Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer: a Prospective Validation and Comparison With Open Surgery.|Completed||N/A|66|Actual|Università degli Studi dell'Insubria|||2||f||||f||||||||No||2017-10-10 21:33:58.474958|2017-10-10 21:33:58.474958
NCT02980172|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-07-26|||November 2016||2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Pain Evaluation and Treatment in the Emergency Department|Pain Evaluation and Treatment in the Emergency Department|Completed||N/A|31942|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 21:33:58.581393|2017-10-10 21:33:58.581393
NCT02980159|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-07-26|||November 2016||2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Impact of a Triage Liaison Physician|Impact of a Triage Liaison Physician on the Time to First Medical Evaluation in the Emergency Departement|Completed||N/A|69893|Actual|University Hospital, Geneva|||2||f||||f||||||||||2017-10-10 21:33:58.662669|2017-10-10 21:33:58.662669
NCT02980146|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-29|||June 2016||2016-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|HLA-E CCR||Impact of HLA-E Overexpression by Tumor Cells on the Biology of TIL in Colorectal Cancer|Correlation Between HLA-E Overexpression by Tumor Cells and the Biology of Tumor-infiltrating Lymphocytes Depending on the Microsatellite Status in Colorectal Cancer.|Recruiting||N/A|40|Anticipated|Nantes University Hospital|||1||f||||f||||||Samples Without DNA|"     20 mL of Blood, a tumor fragment and a fragment of colonic mucosa   "|No||2017-10-10 21:33:58.750985|2017-10-10 21:33:58.750985
NCT02980133|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2017-07-14|||December 31, 2016|Actual|2016-12-31|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|August 31, 2018|Anticipated|2018-08-31||Interventional|||Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler|12-Week, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients Aged 4 Through 11 Years With Persistent Asthma|Recruiting||Phase 3|508|Anticipated|Teva Pharmaceutical Industries||4|||f||||f|t|f||||||||2017-10-10 21:33:58.856845|2017-10-10 21:33:58.856845
NCT02980120|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-29|||January 2015||2015-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|EAT_FMRI||Personality Pathology and Cerebral Processing in Eating Disorders|Personality Pathology and Cerebral Processing in Eating Disorders|Recruiting||N/A|110|Anticipated|Medical University Innsbruck|||3||f||||f||||||||Undecided||2017-10-10 21:33:59.227888|2017-10-10 21:33:59.227888
NCT02980107|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-12-18|||November 2016||2016-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Presenting Summary Information From Cochrane Systematic Reviews: Protocol for Research of Infographics Presentation vs. Plain Language Summary||Completed||N/A|100|Actual|University Hospital of Split||2|||f||||f||||||||Yes||2017-10-10 21:33:59.356713|2017-10-10 21:33:59.356713
NCT02980094|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-12-06|||August 2011||2011-08-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Milk Biofortification Promotes Health Benefits in Institutionalized Elderly|Effects of Inclusion of Sunflower Oil, Vitamin E and Selenium in the Diet of Dairy Cows on Milk Composition and Its Influence on Nutrition and Health of Elderly|Completed||N/A|100|Actual|University of Sao Paulo||4|||f||||t||||||||No||2017-10-10 21:33:59.442851|2017-10-10 21:33:59.442851
NCT02980081|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-07-26|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Abdominal Plain X-ray in the Emergency Departement|Abdominal Plain X-ray in the Emergency Departement: Really Usefull?|Completed||N/A|1997|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 21:33:59.551476|2017-10-10 21:33:59.551476
NCT02980055|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||February 2017||2017-02-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of Root Coverage of Gingival Recessions|Comparison of Root Coverage of Gingival Recessions Using Connective Tissue Graft and Collagen Matrix|Not yet recruiting||Phase 2|46|Anticipated|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||No||2017-10-10 21:33:59.853339|2017-10-10 21:33:59.853339
NCT02980042|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Tolerability and Safety of Switching From Rituximab to Ocrelizumab in Patients With Relapsing Forms of Multiple Sclerosis|Evaluating the Tolerability and Safety Profile of Switching From Rituximab to Ocrelizumab: A Real World Evaluation of Patients With Relapsing Forms of Multiple Sclerosis|Not yet recruiting||Phase 3|200|Anticipated|University of Colorado, Denver||2|||f||||||||||||Undecided||2017-10-10 21:33:59.95693|2017-10-10 21:33:59.95693
NCT02980029|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-01-08|||January 2017||2017-01-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pharmacodynamic Effects of Fatty Acid Synthase (FASN) Inhibition With TVB-2640 in Resectable Colon Cancer|Pharmacodynamic Effects of Fatty Acid Synthase (FASN) Inhibition With TVB-2640 in Resectable Colon Cancer|Recruiting||Phase 1|48|Anticipated|University of Kentucky||2|||f||||t||||||||No||2017-10-10 21:34:00.055294|2017-10-10 21:34:00.055294
NCT02980016|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|WHIP3TB||Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals|A Randomised, Pragmatic, Open-Label Trial To Evaluate The Effect Of Three Months Of High Dose Rifapentine Plus Isoniazid Administered As A Single Round Or Given Annually In HIV-Positive Individuals|Recruiting||Phase 3|4000|Anticipated|KNCV Tuberculosis Foundation||3|||f||||t||||||||Undecided||2017-10-10 21:34:00.145961|2017-10-10 21:34:00.145961
NCT02980003|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-29|||March 2015||2015-03-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TEATE||PrevenTion of Contrast-inducEd nephroAThy With urinE Alkalinization|PrevenTion of Contrast-inducEd nephroAThy With urinE Alkalinization: the TEATE Study|Recruiting||Phase 3|240|Anticipated|G. d'Annunzio University||3|||f||||t||||||||No||2017-10-10 21:34:00.268107|2017-10-10 21:34:00.268107
NCT02979990|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-29|||January 2017||2017-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|LOVE||Learning From Online Video Education for Controlled Ovarian Stimulation|Learning From Online Video Education for Controlled Ovarian Stimulation|Not yet recruiting||N/A|250|Anticipated|University of California, San Francisco||2|||f||||t||||||||No||2017-10-10 21:34:00.39487|2017-10-10 21:34:00.39487
NCT02979977|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-05-09|||March 24, 2017|Actual|2017-03-24|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck|Single-Arm Phase II Trial of Dual Inhibition of EGFR With Afatinib and Cetuximab With Correlative Studies in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck|Recruiting||Phase 2|50|Anticipated|Yale University||1|||f||||t|t|f|||f|||No||2017-10-10 21:34:00.50999|2017-10-10 21:34:00.50999
NCT02979964|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Pragmatic Factorial Cluster Trial of Framing and Comparators for Audit and Feedback|Pragmatic Factorial Cluster Trial of Framing and Comparators for Audit and Feedback Aiming to Address High Risk Prescribing in Nursing Homes in Ontario|Active, not recruiting||N/A|285|Actual|Women's College Hospital||4|||f||||f||||||||No|Analyses of outcomes use routine administrative database holdings.|2017-10-10 21:34:00.628901|2017-10-10 21:34:00.628901
NCT02979951|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-07-27|||December 2016||2016-12-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|FORTRESS||Fosfomycin i.v. for Treatment of Severely Infected Patients|A European, Multicentre, Non-comparative, Non-interventional, Prospective Clinical Registry to Evaluate the Clinical Outcome and Safety of the Treatment of Severely Infected Patients With Fosfomycin i.v.|Recruiting||N/A|1000|Anticipated|Infectopharm Arzneimittel GmbH|||1||f||||f||||||||||2017-10-10 21:34:00.740281|2017-10-10 21:34:00.740281
NCT02979938|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-29|||July 2016||2016-07-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection|Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection|Recruiting||N/A|25|Anticipated|Trinidad and Tobago IVF and Fertility Centre|||1||f||||t||||||||No||2017-10-10 21:34:00.897097|2017-10-10 21:34:00.897097
NCT02979912|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-05-03|||February 16, 2017|Actual|2017-02-16|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Autologous Platelet Lysate in Corneal Epithelial Defects|The Use of Autologous Platelet Lysate in Persistent Corneal Epithelial Defects|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Jordan||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:34:01.102373|2017-10-10 21:34:01.102373
NCT02979899|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-07|||February 13, 2017|Actual|2017-02-13|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|TAPPAS||A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA|A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA (TAPPAS)|Recruiting||Phase 3|124|Anticipated|Tracon Pharmaceuticals Inc.||2|||f||||t|t|f||||||||2017-10-10 21:34:01.186298|2017-10-10 21:34:01.186298
NCT02979886|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-01|||January 2017||2017-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Effects of SNP of GnRH Receptor Genes in IVF Patients|Effects of Single Nucleotide Polymorphism of GnRH Receptor Genes on Clinical Response to Pituitary Down Regulation in IVF Patients|Enrolling by invitation||N/A|1500|Anticipated|First Affiliated Hospital of Zhongshan Medical University||1|||f||||f||||||||No||2017-10-10 21:34:01.363393|2017-10-10 21:34:01.363393
NCT02979873|ClinicalTrials.gov processed this data on October 10, 2017|2016-12-01|2017-09-14|||November 21, 2016||2016-11-21|September 13, 2017|2017-09-13|August 31, 2023|Anticipated|2023-08-31|August 31, 2023|Anticipated|2023-08-31||Interventional|||Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy|A Randomized Trial of Sirolimus (Rapamune) for Relapse Prevention in Patients With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy|Recruiting||Phase 2|118|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:34:01.439413|2017-10-10 21:34:01.439413
NCT02979860|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-07-26|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes Risk|Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes Risk|Recruiting||N/A|60|Anticipated|Temple University||4|||f||||f|f|f||||||||2017-10-10 21:34:01.525475|2017-10-10 21:34:01.525475
NCT02979847|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-11-29|||June 2016||2016-06-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Hybrid Catheter Ablation for Persistent Atrial Fibrillation|Epicardial Catheter Ablation in Repeated Procedure for Persistent Atrial Fibrillation: Prospective Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Korea University Anam Hospital||2|||f||||t||||||||Yes||2017-10-10 21:34:01.703679|2017-10-10 21:34:01.703679
NCT02979834|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2016-11-29|||June 2016||2016-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|FFM||When Will I Feel The First Movements of My Baby?|A Frequently Asked Question: When Will I Feel The First Movements of My Baby?|Completed||N/A|423|Actual|Kayseri Education and Research Hospital|||3||f||||f||||||||Yes|The data belonging to participant will be available to any researcher or editorial review board if needed.|2017-10-10 21:34:01.82492|2017-10-10 21:34:01.82492
NCT02979821|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-07|||October 2015||2015-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)|A Phase II Study to Assess Efficacy of Pan-HER Inhibitor (HM781-36B, Poziotinib) in Stage IV Lung Adenocarcinoma With HER2 Mutation|Recruiting||Phase 2|47|Anticipated|Korean Association for the Study of Targeted Therapy||1|||f||||f||||||||Undecided||2017-10-10 21:34:01.926675|2017-10-10 21:34:01.926675
NCT02979808|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-03-20|||October 2016||2016-10-01|March 2017|2017-03-01||||October 2019|Anticipated|2019-10-01||Interventional|||An Open, Qualitative, Prospective, Multicenter Trial of a Novel Transanal Irrigation System in Spinal Cord Injured Patients.|An Open, Qualitative, Prospective, Multicenter Trial of a Novel Transanal Irrigation System in Spinal Cord Injured Patients.|Recruiting||N/A|150|Anticipated|Dentsply International||1|||f||||f||||||||No||2017-10-10 21:34:02.059179|2017-10-10 21:34:02.059179
NCT02979795|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-30|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01|5 Years|Observational [Patient Registry]|||Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis|Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis|Recruiting||N/A|50|Anticipated|China Medical University Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:34:02.21122|2017-10-10 21:34:02.21122
NCT02979782|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-22|||December 2016||2016-12-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Observational|NOMICS||Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft|Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft: a Single-centre Prospective Cohort Study|Recruiting||N/A|150|Anticipated|Jessa Hospital|||3||f||||f||||||||||2017-10-10 21:34:02.439168|2017-10-10 21:34:02.439168
NCT02979769|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-02-10|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France|A Phase 2, Open-Label, Efficacy and Safety Study of an RARγ Specific Agonist (Palovarotene) to Prevent Heterotopic Ossification in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)|Active, not recruiting||Phase 2|17|Anticipated|Clementia Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-10 21:34:02.552169|2017-10-10 21:34:02.552169
NCT02979756|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Improve Detection and Management of Gestational Diabetes Through the Primary Health Care Level in Morocco|Améliorer la Detection et la Prise en Charge du diabète Gestationnel au Niveau Des établissements de Soins de santé Primaires au Maroc|Recruiting||N/A|160|Anticipated|Institute of Tropical Medicine, Belgium||2|||f||||t||||||||Undecided||2017-10-10 21:34:02.668475|2017-10-10 21:34:02.668475
NCT02979743|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-04|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|||MRI-based Neuroimaging Predictors of Clinical Improvements Following Therapy in Children With Cerebral Palsy|MRI-based Neuroimaging Predictors of Clinical Improvements Following Occupational Therapy (OT) or OT Puls Acupuncture and Massage Methods in Children With Cerebral Palsy|Not yet recruiting||N/A|50|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||f||||||||No||2017-10-10 21:34:02.745817|2017-10-10 21:34:02.745817
NCT02979730|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-01|||February 7, 2017|Actual|2017-02-07|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|March 13, 2017|Actual|2017-03-13||Interventional|FluProcess||Impact of Rapid Flu Testing in BMC ED|Proposal to Evaluate the Impact of Point of Care Liat Influenza A/B Testing in the Emergency Department at Boston Medical Center|Active, not recruiting||N/A|233|Actual|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:34:02.82941|2017-10-10 21:34:02.82941
NCT02979717|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-03-28|||November 23, 2016|Actual|2016-11-23|March 2017|2017-03-01|March 14, 2017|Actual|2017-03-14|March 14, 2017|Actual|2017-03-14||Interventional|||The Effect of a High Protein, High Fibre Shake Pre-load on Measures of Satiety and Subsequent Energy Intake|The Effect of a High Protein, High Fibre Shake Pre-load on Measures of Satiety and Subsequent Energy Intake in Healthy Overweight and Obese Subjects: An Acute Randomized, Crossover, Double-blind Placebo-controlled Study|Completed||N/A|50|Actual|Beachbody||2|||f||||||||||||||2017-10-10 21:34:02.898251|2017-10-10 21:34:02.898251
NCT02979704|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-12-01|||September 2016||2016-09-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia|Randomized. Open Label Trial of Comparison Between Rosuvastatin and Atorvastatin on Oxidative Stress, Inflammatory and Thrombogenic Biomarkers in Patients With Hyperlipidemia|Recruiting||Phase 2/Phase 3|90|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||t||||||||No||2017-10-10 21:34:02.973242|2017-10-10 21:34:02.973242
NCT02979678|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-09-05|||June 2015||2015-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|March 2018|Anticipated|2018-03-01||Interventional|||European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update|The Update of the EORTC Quality of Life Questionnaire Breast Cancer Module (EORTC QLQ-Breast 23) Phase 1-3|Recruiting||N/A|260|Anticipated|Medical University of Graz||1|||f||||f||||||||||2017-10-10 21:34:03.162946|2017-10-10 21:34:03.162946
NCT02979665|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-11-29|||September 2014||2014-09-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema|A Clinico-Pathological Study of the Structural and Functional Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema|Active, not recruiting||N/A|40|Anticipated|Lawson Health Research Institute|||2||f||||t||||||||||2017-10-10 21:34:03.275417|2017-10-10 21:34:03.275417
NCT02979652|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-30|||April 2016||2016-04-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01|8 Days|Observational [Patient Registry]|POCUSR||Can Point of Care Chest Ultrasound Predicts Pulmonary Complications After Major Surgery?|Can Point of Care Chest Ultrasound Predicts Pulmonary Complications After Major Surgery?|Recruiting||N/A|325|Anticipated|Hospital Nord|||1||f||||f||||||||No||2017-10-10 21:34:03.361199|2017-10-10 21:34:03.361199
NCT02979483|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-05|||November 2016||2016-11-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Management of Symptomatic Advanced Pancreatic Adenocarcinoma|"Management of Symptomatic Advanced Pancreatic Adenocarcinoma: Urgence Pancreas - A Prospective A.R.CA.D Cohort Study"|Recruiting||N/A|110|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||f||||||||||2017-10-10 21:34:04.741149|2017-10-10 21:34:04.741149
NCT02979639|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-05|||January 16, 2017|Actual|2017-01-16|September 2017|2017-09-01|August 14, 2018|Anticipated|2018-08-14|April 12, 2017|Actual|2017-04-12||Interventional|||Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age|Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GSK Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age|Active, not recruiting||Phase 3|404|Actual|GlaxoSmithKline||1|||f|||||t|f||||||||2017-10-10 21:34:03.424868|2017-10-10 21:34:03.424868
NCT02979626|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-07-17|||February 4, 2017|Actual|2017-02-04|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|M2SFlu||Evaluation of Moderate to Severe Influenza Outcomes in Children|Evaluation of Moderate to Severe Influenza Disease in Children 6 Months to 8 Years in Colorado|Recruiting||N/A|1600|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     Respiratory swab samples   "|||2017-10-10 21:34:03.529433|2017-10-10 21:34:03.529433
NCT02979613|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-15|||December 29, 2016|Actual|2016-12-29|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed|A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching From Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects With Chronic Hepatitis B Who Are Virologically Suppressed|Recruiting||Phase 3|460|Anticipated|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:34:03.648764|2017-10-10 21:34:03.648764
NCT02979600|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Clinical and Biological Efficacy of Peanut Oral Immunotherapy||Completed||N/A|493|Actual|Lille Catholic University|||1||f||||t||||||||No||2017-10-10 21:34:03.862544|2017-10-10 21:34:03.862544
NCT02979587|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-21|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study|The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study|Recruiting||N/A|40|Anticipated|Medtronic Cardiovascular||1|||f||||t|f|t|t|f||||||2017-10-10 21:34:03.926581|2017-10-10 21:34:03.926581
NCT02979574|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-31|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|PEACE||PEACE: Comparing Chronic Pain Treatment Options|Personalize Electro-acupuncture vs. Auricular-acupuncture Comparative Effectiveness|Recruiting||N/A|360|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||f||||||||||2017-10-10 21:34:04.06515|2017-10-10 21:34:04.06515
NCT02979561|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-19|||October 2016||2016-10-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Re-Spire||Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy|A Prospective Randomised Controlled Study to Evaluate Outcomes of the Treatment With Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism Undergoing Endovascular Mechanical Fragmentation and Thrombolytic Therapy|Recruiting||Phase 4|200|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||No||2017-10-10 21:34:04.150786|2017-10-10 21:34:04.150786
NCT02979548|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-01-24|||November 2016||2016-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy|Study to Evaluate the Anti-emetic Effect of Aprepitant as an add-on Therapy in Children and Adolescents Receiving AML Remission Induction Chemotherapy: An Investigator-initiated, Randomized, Open Label Trial|Recruiting||Phase 3|116|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||Undecided|It is undecided but if required the data can be made available.|2017-10-10 21:34:04.235772|2017-10-10 21:34:04.235772
NCT02979535|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-06-28|||November 16, 2016|Actual|2016-11-16|June 2017|2017-06-01|October 11, 2018|Anticipated|2018-10-11|October 11, 2018|Anticipated|2018-10-11||Interventional|||Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®|Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® in Healthy Female Subjects Aged 9 to 14 Years in Mexico|Active, not recruiting||Phase 3|480|Actual|Sanofi||2|||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-10 21:34:04.330951|2017-10-10 21:34:04.330951
NCT02979522|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-09-21|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|October 29, 2021|Anticipated|2021-10-29|June 30, 2020|Anticipated|2020-06-30||Interventional|||A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma|An Open-Label Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients With Advanced Stage Newly Diagnosed Hodgkin Lymphoma|Recruiting||Phase 1/Phase 2|55|Anticipated|Takeda||1|||f||||f|t|f||||||||2017-10-10 21:34:04.432638|2017-10-10 21:34:04.432638
NCT02979509|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-30|||June 2016||2016-06-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|June 2020|Anticipated|2020-06-01||Observational|||Evaluation of Diagnostic Yield of EUS-Guided Tissue Sampling|Multi-center Prospective Evaluation of the Diagnostic Yield of Endoscopic Ultrasound-Guided Tissue Sampling|Recruiting||N/A|300|Anticipated|University of Florida|||1||f||||f||||||||Yes|Computer-based files will only be made available to personnel involved in the study through the use of access privileges, passwords and encryption. The prospectively maintained database will be constructed with the Research Electronic Data Capture software.|2017-10-10 21:34:04.552775|2017-10-10 21:34:04.552775
NCT02979496|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-15|||February 13, 2017|Actual|2017-02-13|August 2017|2017-08-01|April 29, 2017|Actual|2017-04-29|April 29, 2017|Actual|2017-04-29||Interventional|POM||Citrus Beverages and Gastrointestinal Function|The Effect of Citrus Beverages on Gastrointestinal Function in Healthy Adults: a Randomized, Double-blind, Controlled Clinical Trial|Completed||N/A|337|Actual|University of Florida||4|||f||||f|f|f||||||||2017-10-10 21:34:04.655711|2017-10-10 21:34:04.655711
NCT02979470|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-30|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01|12 Months|Observational [Patient Registry]|BMACR||Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers|Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers|Recruiting||N/A|100|Anticipated|AC Camargo Cancer Center|||1||f||||t||||||||No||2017-10-10 21:34:04.875537|2017-10-10 21:34:04.875537
NCT02979457|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-20|||January 24, 2017|Actual|2017-01-24|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Degree of Worry as a Predictor for Utilization of Acute Health Care|Early Patient Involvement in Out-of-hours Health Care|Recruiting||N/A|10000|Anticipated|University of Southern Denmark||2|||f||||f|f|f||||||No||2017-10-10 21:34:04.951593|2017-10-10 21:34:04.951593
NCT02979444|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-01|||August 2016||2016-08-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Comparing the Effectiveness of Clinicians and Paraprofessionals to Reduce Disparities in Perinatal Depression|Comparing the Effectiveness of Clinicians and Paraprofessionals to Reduce Disparities in Perinatal Depression|Recruiting||N/A|1680|Anticipated|Northwestern University||3|||f||||f||||||||No||2017-10-10 21:34:05.064407|2017-10-10 21:34:05.064407
NCT02979418|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-24|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|PEN||Pii Ngima: Consequences of Water Insecurity for Maternal and Child Health|Pii Ngima: Consequences of Water Insecurity for Maternal and Child Health|Completed||N/A|266|Actual|Northwestern University|||1||f||||f|f|f||||||||2017-10-10 21:34:05.551921|2017-10-10 21:34:05.551921
NCT02979405|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-02-22|||January 17, 2017|Actual|2017-01-17|February 2017|2017-02-01|February 21, 2017|Actual|2017-02-21|February 20, 2017|Actual|2017-02-20||Interventional|||Effectiveness of Phenylefrine in Prevention of Hypotension During Spinal Anesthesia for Cesarean Delivery|Effectivenes of Phenylefrine in Prevention of Hypotension During Spinal Anesthesia for Cesarean Delivery: a Randomised Controlled Trial|Completed||Phase 4|140|Actual|Universidad Industrial de Santander||2|||f||||t||||||||No||2017-10-10 21:34:05.617059|2017-10-10 21:34:05.617059
NCT02979392|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-11-29|||December 2016||2016-12-01|November 2016|2016-11-01||||November 2019|Anticipated|2019-11-01||Interventional|||Phase I Study of TENPA in Advanced Solid Cancer|A Prospective, Open-label, Dose Escalation (Part A), Cohort Expansion (Part B) Phase I Study to Investigate the Safety and to Determine Maximum Tolerated Dose and Recommended Phase 2 Dose of TENPA (Targeting-Enhancing Nanoparticles of Paclitaxel) in Patients With Advanced Solid Tumor|Not yet recruiting||Phase 1|50|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 21:34:05.7|2017-10-10 21:34:05.7
NCT02979379|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-09|||April 2016||2016-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Pain in Individuals With COPD During Pulmonary Rehabilitation|Does Pulmonary Rehabilitation Aggravate or Relieve Symptoms of Pain in Individuals With COPD|Recruiting||N/A|86|Anticipated|West Park Healthcare Centre|||2||f||||||||||||||2017-10-10 21:34:05.772855|2017-10-10 21:34:05.772855
NCT02979366|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-18|||March 15, 2017|Actual|2017-03-15|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome|Phase I, International, Multicentre, Open-label, Non-randomised, Non-comparative Study of Intravenously Administered S64315, a Mcl-1 Inhibitor, in Patients With Acute Myeloid Leukaemia (AML) or Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1|80|Anticipated|Servier||1|||f||||f|f|f||||||||2017-10-10 21:34:05.867993|2017-10-10 21:34:05.867993
NCT02979353|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-26|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|Shed-Meds||A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy|A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy Transferred From the Hospital to Skilled Nursing Facilities|Recruiting||N/A|1300|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:34:05.985205|2017-10-10 21:34:05.985205
NCT02979340|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-30|||December 2016||2016-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||MRI to Characterize and Predict CF Liver Disease in PUSH Cohort|Analysis of Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis (PUSH) Cohort Using Advanced MRI to Characterize and Predict CF Liver Disease|Enrolling by invitation||N/A|228|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||||No||2017-10-10 21:34:06.09015|2017-10-10 21:34:06.09015
NCT02979327|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-29|||December 2016||2016-12-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Cardiovascular Effects of Adderall in Healthy Adults.|Cardiovascular Effects of Adderall in Healthy Adults. A Randomized Clinical Trial.|Not yet recruiting||N/A|25|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:34:06.174578|2017-10-10 21:34:06.174578
NCT02979314|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-11-28|||December 2016||2016-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Influence of GVS on Mental Transformation|Overlapping Cortical Networks of Illusory and Mental Body Transformations|Not yet recruiting||N/A|40|Anticipated|University of Zurich||1|||f||||f||||||||Undecided||2017-10-10 21:34:06.266582|2017-10-10 21:34:06.266582
NCT02979301|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||MBI Response toTam|Low-Dose Tamoxifen to Reduce High Background Parenchymal Uptake on Molecular Breast Imaging|Not yet recruiting||N/A|100|Anticipated|Mayo Clinic||1|||f||||||||||||||2017-10-10 21:34:06.34577|2017-10-10 21:34:06.34577
NCT02979106|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-07-13|||January 2015||2015-01-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|January 2016|Actual|2016-01-01||Interventional|||Metabolic Consequences of Heterozygous Hereditary Fructose Intolerance|Are Heterozygous Carriers for Hereditary Fructose Intolerance Predisposed to Metabolic Disturbances When Exposed to Fructose?|Completed||N/A|18|Actual|University of Lausanne||1|||f||||f||||||||||2017-10-10 21:34:07.978547|2017-10-10 21:34:07.978547
NCT02979288|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-06-04|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|LCR35&PTD||Treatment of the Intermediate Vaginal Microbiota With Vaginal Lactobacillus Casei Rhamnosus to Improve Pregnancy Outcome|Treatment of the Intermediate Vaginal Microbiota With Vaginal Probiotics Containing Lactobacillus Casei Rhamnosus (Lcr Regenerans) to Improve Pregnancy Outcomes|Recruiting||Phase 3|120|Anticipated|Medical University of Vienna||4|||f||||f||||||||No||2017-10-10 21:34:06.444801|2017-10-10 21:34:06.444801
NCT02979275|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-28|||October 2015||2015-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Correlation of Brain and Thenar Muscle Oximetry During Cardiac Surgery With Parameters of Acute Kidney Injury|Correlation of Brain and Thenar Muscle Oximetry During Cardiac Surgery With Parameters of Acute Kidney Injury in Adult Cardiac Surgical Patients Operated on Cardiopulmonary Bypass|Recruiting||N/A|100|Anticipated|Medical University of Gdansk|||1||f||||f||||||Samples Without DNA|"     Serum from blood samples obtained at 10 timepoints before, during, and after the cardiac     surgical operation.   "|Undecided|Individual participant data (IPD) may be done available to other researchers upon reasonable request directed to study director.|2017-10-10 21:34:06.599041|2017-10-10 21:34:06.599041
NCT02979262|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-11-28|||May 2016||2016-05-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Intimate Partner Violence and Fatherhood Intervention in Residential Substance Abuse Treatment|IPV and Fatherhood Intervention in Residential Substance Abuse Treatment|Recruiting||N/A|60|Anticipated|University of South Florida||2|||f||||t||||||||Undecided||2017-10-10 21:34:06.730162|2017-10-10 21:34:06.730162
NCT02979249|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-02-24|||December 2016||2016-12-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|EPP||Oral Iron for Erythropoietic Protoporphyrias|Effect of Oral Iron Therapy on Erythrocyte Protoporphyrin Levels in the Erythropoietic Protoporphyrias|Recruiting||N/A|20|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-10 21:34:06.836695|2017-10-10 21:34:06.836695
NCT02979236|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-28|||June 2016||2016-06-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Observational|iPOSITION||Italian Multi-center Registry of Self-apposing Coronary Stent in Patients With STEMI|Prospective, Observational, Italian Multi-center Registry of Self-aPposing cOronary Stent in Patients Presenting With ST-segment Elevation Myocardial InfarcTION: the iPOSITION Registry|Recruiting||N/A|250|Anticipated|UOSD Emodinamica Diagnostica e Interventistica|||1||f||||||||||||||2017-10-10 21:34:06.958306|2017-10-10 21:34:06.958306
NCT02979223|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-04|||November 2016||2016-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation|Comparison the Efficacy Depending on the Order of the Sequential Combination Method Using Sodium Picosulfate and Magnesium Citrate (PMC) and PEG With Ascorbic Acid for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)|Recruiting||Phase 2|134|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||No||2017-10-10 21:34:07.072274|2017-10-10 21:34:07.072274
NCT02979210|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-15|||November 2016||2016-11-01|August 2017|2017-08-01|February 1, 2017|Actual|2017-02-01|January 26, 2017|Actual|2017-01-26||Interventional|||Infant Fecal Insult Study|Fecal Insult Study: An Exploratory Study to Evaluate the Microbial Consortia and Skin Barrier Function After Exposure to Artificial Fecal Irritants|Completed||N/A|24|Actual|Kimberly-Clark Corporation||1|||f||||f|f|f||||||||2017-10-10 21:34:07.152985|2017-10-10 21:34:07.152985
NCT02979197|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-07-31|||November 2016||2016-11-01|July 2017|2017-07-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives|A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine on Renal and Vascular Function in Subjects With Existing Hypertension Requiring Antihypertensive Therapy|Completed||Phase 3|104|Actual|Kitov Pharmaceuticals, Ltd.||3|||f||||f||||||||||2017-10-10 21:34:07.223261|2017-10-10 21:34:07.223261
NCT02979184|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-10-04|||November 2016|Actual|2016-11-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|LYMPHOS||Prevalence of Obstructive Sleep Apnea (OSA) in Patients With Lymphedema, Admitted for Intensive Decongestive Physiotherapy|Prevalence of Obstructive Sleep Apnea Syndrom in Patients With Lymphedema, Admitted for Intensive Decongestive Physiotherapy|Recruiting||N/A|45|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:34:07.328934|2017-10-10 21:34:07.328934
NCT02979171|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-11-28|||March 2016||2016-03-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Comparison in Difficult Airway Scenario Induced in Patients With Laryngeal Mask Airway (LMA)-Classic™, LMA™ - Flexible and LMA - Proseal™||Completed||Phase 4|90|Actual|Marmara University||3|||f||||f||||||||Undecided||2017-10-10 21:34:07.410047|2017-10-10 21:34:07.410047
NCT02979158|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-08|||November 2016||2016-11-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass|Influence of Cardiopulmonary Bypass on Platelet Function in Patients With Preoperative Dual Antiplatelet Therapy:|Recruiting||N/A|60|Anticipated|Umeå University||2|||f||||t||||||||Undecided|Data will be shared after reviewing final results after study completion at this site and through publication in a scientific journal.|2017-10-10 21:34:07.47456|2017-10-10 21:34:07.47456
NCT02979145|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-29|||October 2016||2016-10-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Observational|||Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)|Development of the Charcot-Marie-Tooth Disease Infant Scale (CMTInfS) for Infants With CMT|Recruiting||N/A|200|Anticipated|Sydney Children's Hospitals Network|||2||f||||||||||||||2017-10-10 21:34:07.577578|2017-10-10 21:34:07.577578
NCT02979132|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-10-03|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|March 31, 2019|Anticipated|2019-03-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Iron Long-Term Labelling Study Switzerland|Evaluation of the Validity of a Novel Isotope Dilution Method to Assess the Iron Status and Its Changes in Swiss Women|Recruiting||N/A|90|Anticipated|Swiss Federal Institute of Technology||3|||f||||f|f|f||||||||2017-10-10 21:34:07.684208|2017-10-10 21:34:07.684208
NCT02979119|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-11-28|||June 2014||2014-06-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|20 Years|Observational [Patient Registry]|PedNet||The European Paediatric Network for Haemophilia Management ( PedNet Registry)|The European Paediatric Network for Haemophilia Management and the PedNet Haemophilia Registry|Recruiting||N/A|2200|Anticipated|UMC Utrecht|||1||f||||f||||||||No||2017-10-10 21:34:07.773775|2017-10-10 21:34:07.773775
NCT02979093|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-28|||July 2016||2016-07-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Oxytocin and Brain Responses in Maternal Addiction|Oxytocin and Brain Reward and Stress Responses to Infant Cues in Addicted Mothers|Recruiting||N/A|150|Anticipated|University of Iowa||2|||f||||f||||||||No|The University of Iowa and Yale will compile data from both sites for data analysis purposes only. There is no plan to make individual participant data available.|2017-10-10 21:34:08.047755|2017-10-10 21:34:08.047755
NCT02979080|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-10-03|||June 10, 2017|Actual|2017-06-10|October 2017|2017-10-01|August 31, 2019|Anticipated|2019-08-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Iron Long-Term Labelling Study Benin|The Evaluation of Iron Supplementation and Iron Requirements Using a Novel Isotope Dilution Method in Beninese Women|Active, not recruiting||N/A|63|Anticipated|Swiss Federal Institute of Technology||1|||f||||f|f|f||||||||2017-10-10 21:34:08.149578|2017-10-10 21:34:08.149578
NCT02979067|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-05-11|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|i-Thrive||Improvement of Oxygenation During Apnoea by i-THRIVE|Improvement of Oxygenation During Apnoea by i-THRIVE (Infant Transnasal Humidified Rapid Insufflation Ventilatory Exchange): A Single-centre Prospective Randomized Controlled Trial.|Completed||N/A|60|Actual|University Hospital Inselspital, Berne||3|||f||||f||||||||No||2017-10-10 21:34:08.2108|2017-10-10 21:34:08.2108
NCT02979054|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-03-06|||October 2016||2016-10-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking||Recruiting||N/A|147|Anticipated|Laboratoires Thea||2|||f||||f||||||||||2017-10-10 21:34:08.277761|2017-10-10 21:34:08.277761
NCT02979041|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-11-28|||September 2016||2016-09-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||VR Training for Pilots With Neck Pain|Therapeutic Virtual Reality Training for Neck Pain in Israeli Air Force Pilots - A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|University of Haifa||2|||f||||f||||||||No||2017-10-10 21:34:08.355379|2017-10-10 21:34:08.355379
NCT02979028|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-04-15|||May 1, 2017|Anticipated|2017-05-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|TEAS||Transcutaneous Electrical Acupoint Stimulation (TEAS) on Aged Patients Undergoing Lower Extremity Arthroplasty|The Protective Effect of Transcutaneous Electrical Acupoint Stimulation (TEAS) on Aged Patients Undergoing Lower Extremity Arthroplasty: A Single-Center, Double-Blinded, Randomised Controlled Trial|Not yet recruiting||N/A|300|Anticipated|Second Hospital of Shanxi Medical University||3|||f||||t||||||||||2017-10-10 21:34:08.443078|2017-10-10 21:34:08.443078
NCT02979015|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-09-21|||November 29, 2016|Actual|2016-11-29|September 2017|2017-09-01|November 27, 2017|Anticipated|2017-11-27|November 27, 2017|Anticipated|2017-11-27||Interventional|||A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese Subjects|A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered Alirocumab in Chinese Healthy Subjects|Recruiting||Phase 1|30|Anticipated|Sanofi||2|||f||||f||||||||||2017-10-10 21:34:08.512528|2017-10-10 21:34:08.512528
NCT02979002|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-08-06|||December 2016||2016-12-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco|Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco|Completed||N/A|219|Actual|National School of Public Health, Morocco|||1||f||||f||||||Samples With DNA|"     Suspected Cutaneous leishmaniasis lesions   "|||2017-10-10 21:34:08.588254|2017-10-10 21:34:08.588254
NCT02978989|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-02-20|||December 2016||2016-12-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|SOLOGB||Solo and Non-solo Approach for Laparoscopic Cholecystectomy|A Randomized Controlled Trial Comparing a Solo and Non-solo Approach for Laparoscopic Cholecystectomy|Not yet recruiting||N/A|150|Anticipated|Daejeon St. Mary's hospital||2|||f||||f||||||||No||2017-10-10 21:34:08.748826|2017-10-10 21:34:08.748826
NCT02978976|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-22|2016-12-03|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Antenatal Steroid on Pulmonary Artery Blood Flow|The Effect of Maternal Antenatal Steroid Administration on the Blood Flow Through the Pulmonary Artery in the Term Fetus; a Randomized Control Double Blinded Study|Recruiting||Phase 4|126|Anticipated|Kasr El Aini Hospital||2|||f||||f||||||||Yes|yes|2017-10-10 21:34:08.84809|2017-10-10 21:34:08.84809
NCT02978963|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-09-20|||October 2016||2016-10-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|June 2017|Actual|2017-06-01||Interventional|BiPOro||CBT for Adolescents With Excessive Worry|Cognitive Behavioral Therapy for Adolescents With Excessive Worry - a Case Series|Active, not recruiting||N/A|12|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 21:34:08.956652|2017-10-10 21:34:08.956652
NCT02978950|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-15|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|SToP||SToP: Venous Thromboembolism Screening in the Trauma Population|SToP: Venous Thromboembolism Screening in the Trauma Population|Recruiting||N/A|2000|Anticipated|Intermountain Health Care, Inc.||2|||f||||f|f|f||||||||2017-10-10 21:34:09.068021|2017-10-10 21:34:09.068021
NCT02978937|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-06-06|||April 2015||2015-04-01|June 2017|2017-06-01|January 15, 2017|Actual|2017-01-15|November 2016|Actual|2016-11-01||Observational|||Obstructive Sleep Apnea and Metabolic Health|Obstrutive Sleep Apnea: is it a Biomarker of Metabolically Healthy vs. Unhealthy Obese|Completed||N/A|850|Anticipated|Ohio State University|||1||f||||f||||||||No|Publications|2017-10-10 21:34:09.196379|2017-10-10 21:34:09.196379
NCT02978924|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-28|||December 2016||2016-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|STOP||Trans-spinal Direct Current Stimulation in Primary Orthostatic Tremor|Trans-spinal Direct Current Stimulation in Primary Orthostatic Tremor|Not yet recruiting||N/A|15|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||No||2017-10-10 21:34:09.311137|2017-10-10 21:34:09.311137
NCT02978911|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-29|||July 2016||2016-07-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CN Tracto||Cranial Nerves Tractography|Diffusion Tensor Imaging and Tractography for Cranial Nerves. Interest in Skull Base Surgery and Anatomy|Recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 21:34:09.4017|2017-10-10 21:34:09.4017
NCT02978898|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-11-29|||June 2012||2012-06-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Observational|||CD180 Overexpression in Follicular Lymphoma|CD180 Overexpression in Follicular Lymphoma Is Restricted to the Lymph Node Compartment|Completed||N/A|184|Actual|Hospices Civils de Lyon|||2||f||||||||||Samples Without DNA|"     Using a multiparameter FCM approach, biologists have assessed CD180 mean fluorescence     intensity (MFI) in lymph nodes (LNs) and peripheral blood (PB) samples obtained from patients     with follicular lymphoma (FL; LN/PB, n544/n515), chronic lymphocytic leukemia (CLL,     n526/n521), mantle cell lymphoma (MCL, n513/n517), and marginal zone lymphoma (MZL,     n516/n512). Specimens from non-tumoral PB and LN (n58/n512) were used as controls.   "|||2017-10-10 21:34:09.50002|2017-10-10 21:34:09.50002
NCT02978885|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Imaging of periOP Lung Injury|In Vivo Imaging of Peri-operative (periOP) Destructive Processes in the Lung|Recruiting||Phase 2|40|Anticipated|Columbia University||2|||f||||f|t|f||||||||2017-10-10 21:34:09.570488|2017-10-10 21:34:09.570488
NCT02978872|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-04-18|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Quantra Determination of Coagulation Parameters in Arterial and Venous Blood|Comparison of Coagulation Parameters in Arterial and Venous Blood Measured Using the Quantra System|Completed||N/A|30|Actual|HemoSonics LLC|||1||f||||f||||||||No||2017-10-10 21:34:09.713681|2017-10-10 21:34:09.713681
NCT02978859|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|||MGCD516 in Advanced Liposarcoma and Other Soft Tissue Sarcomas|A Phase II Trial of MGCD516, a Multi-receptor Tyrosine Kinase Inhibitor, in Advanced Liposarcoma and Other Soft Tissue Sarcomas|Recruiting||Phase 2|29|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-10 21:34:09.796527|2017-10-10 21:34:09.796527
NCT02978846|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-09-12|||August 25, 2016|Actual|2016-08-25|September 2017|2017-09-01|August 25, 2019|Anticipated|2019-08-25|August 25, 2018|Anticipated|2018-08-25||Observational|||Perceptions of Side Effects of Cancer Chemoradiotherapy|Patient Perceptions of Side Effects of Cancer Chemoradiotherapy|Recruiting||N/A|100|Anticipated|University of Southern California|||1||f||||t||||||||||2017-10-10 21:34:09.909339|2017-10-10 21:34:09.909339
NCT02978833|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-07-06|||October 1, 2013||2013-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy|Ultrasound-Guided Platelet Rich Plasma Versus Whole Blood Injection for the Treatment of Gluteus Medius Tendinopathy: A Double-Blind Randomized Controlled Study|Terminated||Phase 4|2|Actual|Hospital for Special Surgery, New York||2||slow enrollment, lack of patients|f||||||||||||||2017-10-10 21:34:10.013459|2017-10-10 21:34:10.013459
NCT02978820|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-28|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||The Comparison of Core Stabilization Exercise With Scientific Exercise Approach to Scoliosis in Idiopathic Scoliosis|Core Stabilization Exercise Versus Scientific Exercises Approach to Scoliosis in the Treatment of Adolescent Idiopathic Scoliosis: A Randomized Single Blind Trial|Completed||N/A|30|Actual|Hacettepe University||2|||f||||f||||||||Undecided||2017-10-10 21:34:10.112144|2017-10-10 21:34:10.112144
NCT02978807|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-02|||July 2012||2012-07-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|||Diagnosis of Gestational Diabetes in Eldoret, Kenya|Establishing the Prevalance and Accuracy of Different Diagnostic Techniques for Gestational Diabetes in the Resource-constrained Setting of Eldoret, Kenya|Completed||N/A|935|Actual|Indiana University|||1||f||||f||||||||No|There is no need to send out IPD and only de-identified data was analyzed|2017-10-10 21:34:10.206122|2017-10-10 21:34:10.206122
NCT02978794|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01||||October 2019|Anticipated|2019-10-01||Observational|||Implementation of Clinical Pathway to Improve Quality of Healthcare in Stroke Inpatients||Not yet recruiting||N/A|300|Anticipated|Changhua Christian Hospital|||1||f||||t||||||||||2017-10-10 21:34:10.347156|2017-10-10 21:34:10.347156
NCT02978781|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-08|||December 2016||2016-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate SAGE-217 in Subjects With Essential Tremor|A Phase 2a, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of SAGE-217 in the Treatment of Subjects With Essential Tremor|Recruiting||Phase 2|60|Anticipated|Sage Therapeutics||2|||f||||f||||||||||2017-10-10 21:34:10.432635|2017-10-10 21:34:10.432635
NCT02978768|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-12-08|||August 2011||2011-08-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease|The Effect of the Practice of Tai Chi 6-Form Sports Apparatus and Mental Training on Cognition, Self Care, Mood and General Health in Patients With Mild and Moderate Alzheimer's Disease: a Prospective Study.|Completed||N/A|67|Actual|Chang Gung Memorial Hospital||3|||f||||t||||||||No||2017-10-10 21:34:10.636747|2017-10-10 21:34:10.636747
NCT02978755|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|March 30, 2020|Anticipated|2020-03-30|March 30, 2020|Anticipated|2020-03-30||Interventional|||First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers|Open, Non Controlled, Multicenter, Firs-in-human Study for the Evaluation of the Safety, Pharmacokinetics and Preliminary Antitumor Activity of GM102 in Patients With Advanced Pretreated Gynecological Cancer|Recruiting||Phase 1|84|Anticipated|GamaMabs Pharma||3|||f||||f||||||||||2017-10-10 21:34:10.736035|2017-10-10 21:34:10.736035
NCT02978742|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-01-30|||September 2017|Anticipated|2017-09-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder|Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder|Not yet recruiting||N/A|300|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||No||2017-10-10 21:34:10.86772|2017-10-10 21:34:10.86772
NCT02978729|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-28|||August 2016||2016-08-01|November 2016|2016-11-01||||August 2021|Anticipated|2021-08-01||Interventional|CONNECT4APOE||Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial|A Randomized Study of Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial|Enrolling by invitation||N/A|3000|Anticipated|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 21:34:10.982116|2017-10-10 21:34:10.982116
NCT02978716|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-07|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)|Phase 2 Study of the Safety, Efficacy, and Pharmacokinetics of G1T28 in Patients With Metastatic Triple Negative Breast Cancer Receiving Gemcitabine and Carboplatin Chemotherapy|Recruiting||Phase 2|90|Anticipated|G1 Therapeutics, Inc.||3|||f||||t||||||||||2017-10-10 21:34:11.078755|2017-10-10 21:34:11.078755
NCT02978703|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-24|||January 2017||2017-01-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|AEOLOS||EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece|Non Interventional, Observational, Multi-center Study to Evaluate the Efficacy and Safety of Fluticasone/Salmeterol (Rolenium / Elpenhaler Administration in Greek COPD Pattients|Not yet recruiting||N/A|2000|Anticipated|Elpen Pharmaceutical Co. Inc.|||1||f||||t||||||||No||2017-10-10 21:34:11.437568|2017-10-10 21:34:11.437568
NCT02978690|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-10-02|||December 19, 2016|Actual|2016-12-19|October 2017|2017-10-01|March 19, 2018|Anticipated|2018-03-19|November 27, 2017|Anticipated|2017-11-27||Interventional|||BI655130 Single Dose in Generalized Pustular Psoriasis|Multi-centre, Open-label, Single Arm, Phase I Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacogenomics and Efficacy of a Single Intravenous Dose of BI 655130 in Patients With Active Generalized Pustular Psoriasis.|Recruiting||Phase 1|10|Anticipated|Boehringer Ingelheim||1|||f||||f||||||||||2017-10-10 21:34:11.519048|2017-10-10 21:34:11.519048
NCT02978677|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-06-19|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|December 2028|Anticipated|2028-12-01|December 2027|Anticipated|2027-12-01||Interventional|PANAMA||Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas|Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas|Not yet recruiting||N/A|90|Anticipated|Technische Universität Dresden||3|||f||||t|f|f||||||No||2017-10-10 21:34:11.627499|2017-10-10 21:34:11.627499
NCT02978664|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-11-28|||October 2014||2014-10-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Impact of Distraction on Adenoma Detection Rate|The Impact of Distraction on Adenoma Detection Rate in Patients Undergoing Colonoscopy With Air Insufflation, Water Immersion and Water Exchange|Completed||N/A|500|Actual|Dalin Tzu Chi General Hospital||3|||f||||f||||||||||2017-10-10 21:34:11.701117|2017-10-10 21:34:11.701117
NCT02978651|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2016-11-29|||January 2017||2017-01-01|November 2016|2016-11-01||||January 2019|Anticipated|2019-01-01||Interventional|HAROSA IV||Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness|Efficacy and Safety of Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness|Not yet recruiting||Phase 3|200|Anticipated|Bioprojet||2|||f||||t||||||||No||2017-10-10 21:34:11.771987|2017-10-10 21:34:11.771987
NCT02978638|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-07-19|||September 2014||2014-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Electrical Stimulation for Continence After Spinal Cord Injury|Restoration of Bladder and Bowel Function Using Electrical Stimulation and Block After Spinal Cord Injury|Recruiting||N/A|10|Anticipated|Palo Alto Veterans Institute for Research||1|||f||||t||||||||||2017-10-10 21:34:11.850365|2017-10-10 21:34:11.850365
NCT02978612|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-01-05|||June 2016||2016-06-01|January 2017|2017-01-01|January 2032|Anticipated|2032-01-01|April 2019|Anticipated|2019-04-01||Interventional|ACE||Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III|Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III - Geriatric Assessment and Prognostic Gene Signatures|Recruiting||Phase 2|170|Anticipated|Oslo University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:34:12.068725|2017-10-10 21:34:12.068725
NCT02978599|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-07-17|||November 2016||2016-11-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial of AVL-3288 in Schizophrenia Patients|Double Blind, Two Dose, Cross-over Clinical Trial of the Positive Allosteric Modulator at the alpha7 Nicotinic Cholinergic Receptor AVL-3288 in Schizophrenia Patients|Recruiting||Phase 1|24|Anticipated|New York State Psychiatric Institute||3|||f||||t||||||||||2017-10-10 21:34:12.147727|2017-10-10 21:34:12.147727
NCT02978586|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-04-24|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors|A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors|Not yet recruiting||N/A|20|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f||||||2017-10-10 21:34:12.251713|2017-10-10 21:34:12.251713
NCT02978573|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-30|||October 2016||2016-10-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MOTION||Post Approval Study to Evaluate the Effectiveness and Safety of Cartiva Implant in the Treatment of OA of the Great Toe|A Post Approval Study to Evaluate the Safety and Effectiveness of Cartiva Implant in the Treatment of First Metatarsophalangeal Joint Osteoarthritis as Compared to a Control|Active, not recruiting||Phase 3|135|Anticipated|Cartiva, Inc.||1|||f||||f||||||||No||2017-10-10 21:34:12.328145|2017-10-10 21:34:12.328145
NCT02978560|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-28|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Indocyanine Green Tissue Perfusion Monitoring|Indocyanine Green Tissue Perfusion Monitoring|Not yet recruiting||N/A|30|Anticipated|University of Maryland|||2||f||||t||||||||No||2017-10-10 21:34:12.392547|2017-10-10 21:34:12.392547
NCT02978027|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||July 2014||2014-07-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Mentored Research on Improving Alcohol Brief Interventions in Medical Settings|Mentored Research on Improving Alcohol Brief Interventions in Medical Settings|Recruiting||N/A|300|Anticipated|University of New Mexico||3|||f||||f||||||||No||2017-10-10 21:34:18.36067|2017-10-10 21:34:18.36067
NCT02978547|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-28|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|Metformin 001||The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma|The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma|Not yet recruiting||Phase 2|20|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-10 21:34:14.154907|2017-10-10 21:34:14.154907
NCT02978534|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-28|||March 2016||2016-03-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|Quetiapine||Pharmacokinetics of Quetiapine Across Pregnancy and Postpartum|Pharmacokinetics of Quetiapine Across Pregnancy and Postpartum|Recruiting||N/A|12|Anticipated|Northwestern University|||1||f||||f||||||Samples Without DNA|"     Blood serum specimen will be obtained to measure quetiapine and estradiol levels. Standard of     care labs will be obtained on every participant that is eligible and signs informed consent.     Participants will not have more than 50 ml of blood drawn every 8 weeks. Participants will     also have the option to have blood drawn for DNA banking.      Participants in the study that elect to receive analgesia for pain related to labor and have     a spinal-epidural at Northwestern University will have CSF stored and banked for future     analysis.   "|No||2017-10-10 21:34:14.281677|2017-10-10 21:34:14.281677
NCT02978521|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-28|||August 2016||2016-08-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients|Effect of a Pulmonary Rehabilitation Program on Skeletal Muscle Mass, Pulmonary Function, Inflammatory Response and Overall Survival on Patients Diagnosed With Non-small-cell Advanced Cancer|Recruiting||N/A|94|Anticipated|Instituto Nacional de Cancerologia de Mexico||2|||f||||t||||||||Undecided||2017-10-10 21:34:14.387267|2017-10-10 21:34:14.387267
NCT02978508|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.|A Multi-center, Double-blind, Randomized, Parallel-group Study Comparing Permethrin Cream, 5% With Elimite™ in Patients With Active Scabies.|Recruiting||Phase 3|140|Anticipated|bioRASI, LLC||2|||f||||f||||||||No||2017-10-10 21:34:14.483963|2017-10-10 21:34:14.483963
NCT02978495|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-05-17|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Neoadjuvant Carboplatin in Triple Negative Breast Cancer|Neoadjuvant Carboplatin in Triple Negative Breast Cancer - A Prospective Phase II Study (NACATRINE Trial).|Recruiting||Phase 2|120|Anticipated|Barretos Cancer Hospital||4|||f||||t|f|f|||f|||Undecided||2017-10-10 21:34:14.576023|2017-10-10 21:34:14.576023
NCT02978482|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-08-24|||December 1, 2016|Actual|2016-12-01|August 2017|2017-08-01|August 17, 2018|Anticipated|2018-08-17|March 12, 2018|Anticipated|2018-03-12||Interventional|||A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies|A Phase 1/2 Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Durvalumab (MEDI4736) in Combination With Tremelimumab in Chinese Patients With Advanced Malignancies|Active, not recruiting||Phase 1/Phase 2|26|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 21:34:14.678755|2017-10-10 21:34:14.678755
NCT02978469|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-04|||May 2015||2015-05-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|||Go For It: to Improve Levels of Daily Physical Activity and to Reduce the Sedentary Life Style of Adolescents With CP|Promoting Active Healthy Lifestyle of Adolescents With Brain Damage Due to Traumatic Brain Injury and Cerebral Palsy|Active, not recruiting||N/A|120|Anticipated|Assaf-Harofeh Medical Center||2|||f||||t||||||||No||2017-10-10 21:34:14.802374|2017-10-10 21:34:14.802374
NCT02978456|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-14|||February 23, 2017|Actual|2017-02-23|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|GUIDE DES||Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation|Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation: GUIDE-DES Trial|Recruiting||N/A|1528|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:34:14.888798|2017-10-10 21:34:14.888798
NCT02978443|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-05-25|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab|A Study to Estimate the Anti-Tumor Activity and Identify Potential Predictors of Response in Patients With Advanced Mucosal or Acral Lentiginous Melanoma Receiving Standard Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy|Recruiting||Phase 2|72|Anticipated|Georgetown University||1|||f||||t||||||||No||2017-10-10 21:34:15.149968|2017-10-10 21:34:15.149968
NCT02978430|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-09|||April 2015|Actual|2015-04-01|November 2016|2016-11-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Implementation of Computer-Assisted Intraoperative Goal-Directed Fluid Therapy|Implementation of Computer-Assisted Intraoperative Goal-Directed Fluid Therapy in Major Abdominal Surgery: A Before and After Study|Completed||Phase 2|260|Actual|Erasme University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:34:15.273257|2017-10-10 21:34:15.273257
NCT02978417|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-28|||September 21, 2017|Actual|2017-09-21|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|DC||Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings|A Feasibility Study for Testing the Effects of Extended-release Naltrexone (Vivitrol) on Recidivism and Other Participant Outcomes in Drug Court Settings|Enrolling by invitation||Phase 4|40|Anticipated|Duke University||2|||f||||f|t|f|||f|||||2017-10-10 21:34:15.384166|2017-10-10 21:34:15.384166
NCT02978404|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-07-10|||January 2017||2017-01-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases|A Phase II, Multi-centre Study, of Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases From Non-small Cell Lung Cancer and Renal Cell Cancer|Recruiting||Phase 2|60|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t||||||||||2017-10-10 21:34:15.516766|2017-10-10 21:34:15.516766
NCT02978391|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-21|||May 23, 2016|Actual|2016-05-23|September 2017|2017-09-01|September 18, 2017|Actual|2017-09-18|November 30, 2016|Actual|2016-11-30||Interventional|||UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD||Completed||N/A|76|Actual|Next Biomedical Co., Ltd.||2|||f||||||||||||||2017-10-10 21:34:15.633807|2017-10-10 21:34:15.633807
NCT02978378|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-08-01|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Renal Biomarkers to Predict Recovery Following Venoarterial Extracorporeal Membrane Oxygenation|Renal Biomarkers to Predict Recovery Following Venoarterial Extracorporeal Membrane Oxygenation|Recruiting||N/A|50|Anticipated|Milton S. Hershey Medical Center|||1||f||||f||||||Samples Without DNA|"     urine and blood samples   "|||2017-10-10 21:34:15.719298|2017-10-10 21:34:15.719298
NCT02978365|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-28|||January 2017||2017-01-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Factors Associated With Full Recovery After Surgical Repair of Shoulder Instability|Factors Associated With Full Recovery After Surgical Repair of Shoulder Instability - Cross Sectional Study|Not yet recruiting||N/A|60|Anticipated|Medical Corps, Israel Defense Force||1|||f||||f||||||||No|Data will be published after statistical analysis only.|2017-10-10 21:34:15.796632|2017-10-10 21:34:15.796632
NCT02978352|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-06-22|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||A Comparison of Learning Method (CAM-ICU) Between E-learning and Conventional Face-to-face Lecture and Demonstration|A Comparison of Learning Effectiveness of Confusion Assessment Method (CAM-ICU) Between E-learning and Conventional Face-to-face Lecture and Demonstration|Completed||N/A|180|Actual|Mahidol University||2|||f||||f||||||||No||2017-10-10 21:34:15.895249|2017-10-10 21:34:15.895249
NCT02978339|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-06-22|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis|An Open-Label Pilot Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis|Recruiting||Phase 1/Phase 2|15|Anticipated|Mayo Clinic||1|||f||||f|t|f||||||Undecided||2017-10-10 21:34:15.971862|2017-10-10 21:34:15.971862
NCT02978326|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-08|||December 2016||2016-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression|Recruiting||Phase 2|32|Anticipated|Sage Therapeutics||2|||f||||f||||||||||2017-10-10 21:34:16.065779|2017-10-10 21:34:16.065779
NCT02978313|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Cetuximab Monotherapy Maintenance Treatment in mCRC|Biomarker-Panel Enriched Maintenance Treatment With Cetuximab Monotherapy Versus Continuation After Induction Treatment With Chemotherapy + Cetuximab in Metastatic Colorectal Cancer (mCRC)|Not yet recruiting||Phase 2/Phase 3|500|Anticipated|Ruijin Hospital||2|||f||||f||||||||No||2017-10-10 21:34:16.200301|2017-10-10 21:34:16.200301
NCT02978300|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-03-30|||January 21, 2017|Actual|2017-01-21|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|FLORALI-IM||HFNC Alone or Associated With NIV for Immunocompromised Patients Admitted to ICU for Acute Respiratory Failure|High-Flow Nasal Cannula Oxygen Therapy (HFNC) Alone or Associated With Noninvasive Ventilation (NIV) for Immunocompromised Patients Admitted to Intensive Care Unit for Acute Respiratory Failure : FLORALI-Immunodéprimés|Recruiting||N/A|280|Anticipated|Poitiers University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:34:16.303739|2017-10-10 21:34:16.303739
NCT02978287|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-29|||September 2016||2016-09-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||New Transporting Solution in Parathyroid Allotransplantation|The Effects of Cold Ischemia Time With a New Transporting Solution to Parathyroid Cell Viability and Calcium Sensing Receptor in Parathyroid Allotransplantation|Recruiting||N/A|7|Anticipated|Sisli Etfal Training & Research Hospital||5|||f||||t||||||||No||2017-10-10 21:34:16.415582|2017-10-10 21:34:16.415582
NCT02978274|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||March 2016||2016-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation|Natural Killer Cells Reconstitution Kinetics Post T Cells Repleted Haploidentical Transplantation|Recruiting||N/A|200|Anticipated|Peking University People's Hospital|||2||f||||t||||||Samples With DNA|"     PB of patients post transplantation   "|Undecided||2017-10-10 21:34:16.507635|2017-10-10 21:34:16.507635
NCT02978261|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||September 2016||2016-09-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas|A Phase I, Open-label, Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas|Recruiting||Phase 1|20|Anticipated|Beijing Pearl Biotechnology Limited Liability Company||1|||f||||f||||||||Undecided||2017-10-10 21:34:16.584693|2017-10-10 21:34:16.584693
NCT02978248|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-28|||August 2016||2016-08-01|November 2016|2016-11-01|August 2026|Anticipated|2026-08-01|August 2018|Anticipated|2018-08-01|10 Years|Observational [Patient Registry]|ARENA||ARENA - Project Atrial Fibrilation Rhine-Neckar Region|Af Register RhEin NeckAr - Projekt Vorhofflimmern Rhein Neckar|Recruiting||N/A|10000|Anticipated|Stiftung Institut fuer Herzinfarktforschung|||1||f||||f||||||||No||2017-10-10 21:34:16.67526|2017-10-10 21:34:16.67526
NCT02978235|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-10-02|||March 1, 2017|Actual|2017-03-01|October 2017|2017-10-01|March 2022|Anticipated|2022-03-01|December 2021|Anticipated|2021-12-01||Interventional|||A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma|A Phase 1/2, Open-Label Safety, Pharmacokinetic and Efficacy Study of TAS4464 in Patients With Multiple Myeloma or Lymphoma|Recruiting||Phase 1/Phase 2|243|Anticipated|Taiho Oncology, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:34:16.742755|2017-10-10 21:34:16.742755
NCT02978222|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-09|||January 26, 2017|Actual|2017-01-26|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer|A Randomized Multicenter Phase II Trial to Evaluate the Safety, Efficacy and Immunogenicity of Vaccination With Folate Receptor Alpha Peptides With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer and a Response or Stable Disease to Platinum Therapy|Recruiting||Phase 2|120|Anticipated|Tapimmune Inc.||2|||f||||t|t|f||||||No||2017-10-10 21:34:16.935929|2017-10-10 21:34:16.935929
NCT02978209|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-28|||December 2016||2016-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|UreaIchthyosis||Comparison of Different Concentrations of Carbamide as Moisturizers in Ichthyosis Vulgaris|Double Blinded Randomized Clinical Study of Carbamide as Moisturizer in Ichthyosis Vulgaris|Enrolling by invitation||N/A|75|Anticipated|University of Aarhus||3|||f||||f||||||||||2017-10-10 21:34:17.040745|2017-10-10 21:34:17.040745
NCT02978196|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-30|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||99m-Tc Labeled Anti-PD-L1 VHH for Diagnostic Imaging of Non-Small Cell Lung Cancer|99m-Tc Labeled Anti-PD-L1 VHH for Diagnostic Imaging of Non-Small Cell Lung Cancer|Not yet recruiting||Early Phase 1|50|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-10 21:34:17.130609|2017-10-10 21:34:17.130609
NCT02978183|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-03-28|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis|A Multi-Center, Double-Masked, Randomized, Phase 2 Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo for the Treatment of Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model|Active, not recruiting||Phase 2|70|Actual|Noveome Biotherapeutics, formerly Stemnion||2|||f||||f||||||||Undecided||2017-10-10 21:34:17.216017|2017-10-10 21:34:17.216017
NCT02978170|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Interventional|||A New Guide for Our Guided-Bronchoscopy: The Use of Cone-Beam CT to Enhance Navigation and Diagnostic Yield of RP-EBUS and Hybrid Bronchoscope for Peripheral Lung Nodules Suspicious for Malignancy|A New Guide for Our Guided-Bronchoscopy: The Use of Cone-Beam CT to Enhance Navigation and Diagnostic Yield of RP-EBUS and Hybrid Bronchoscope for Peripheral Lung Nodules Suspicious for Malignancy: A Pilot Study|Recruiting||N/A|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 21:34:17.300546|2017-10-10 21:34:17.300546
NCT02978157|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||February 2015||2015-02-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection|A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment|Recruiting||N/A|120|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||No||2017-10-10 21:34:17.387695|2017-10-10 21:34:17.387695
NCT02978144|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-07-10|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)|In Vivo Imaging of Destructive Processes in Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 2|32|Anticipated|Columbia University||4|||f||||f|t|f||||||||2017-10-10 21:34:17.50819|2017-10-10 21:34:17.50819
NCT02978131|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||May 2015||2015-05-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Observational|||Histopathological Techniques and PCR on Tissues Included in Paraffin for the Diagnosis of Tuberculosis|Evaluation of the Sensitivity of Histopathological Techniques and Molecular Biology (PCR) on Tissues Fixed in Paraformaldehyde and Included in Paraffin for the Diagnosis of Tuberculosis in Current Practice|Active, not recruiting||N/A|20|Actual|Lille Catholic University|||1||f||||f||||||Samples With DNA|"     Pulmonary and extrapulmonary, paraformaldehyde fixed and paraffin embedded tissues   "|No||2017-10-10 21:34:17.620213|2017-10-10 21:34:17.620213
NCT02978118|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-03-27|||March 7, 2017|Actual|2017-03-07|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immune Checkpoint Inhibitors in Genitourinary Malignancies (CTC Immune Based Biomarkers)|Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immune Checkpoint Inhibitors in Genitourinary Malignancies|Recruiting||N/A|10|Anticipated|Duke University|||2||f||||f||||||||||2017-10-10 21:34:17.701504|2017-10-10 21:34:17.701504
NCT02978105|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2016-11-29|||February 2015||2015-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Self-conditioning Techniques in Promoting Weight Loss in Patients With Obesity. A Randomized Controlled Trial|Effects of Self-conditioning Techniques in Promoting Weight Loss in Patients With Severe Obesity. A Randomized Controlled Trial|Recruiting||Phase 3|120|Anticipated|University of Turin, Italy||2|||f||||f||||||||No||2017-10-10 21:34:17.808786|2017-10-10 21:34:17.808786
NCT02978092|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2016-11-30|||April 2016||2016-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Observational|||Monochromatic Digital-Pupillometry With Two Automated Devices in Comparison to Manual Measurements on Digital Photographs||Completed||N/A|15|Actual|University Hospital Tuebingen|||1||f||||||||||||||2017-10-10 21:34:17.903563|2017-10-10 21:34:17.903563
NCT02978079|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-05-02|||February 15, 2017|Actual|2017-02-15|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Pupillometry in Horner's Syndrome|Automated Pupillometry for the Diagnosis of Horner's Syndrome in Acute Stroke Patients Due to Carotid Artery Dissection|Recruiting||N/A|135|Anticipated|University of Zurich||1|||f||||f|f|f||||||No||2017-10-10 21:34:17.958151|2017-10-10 21:34:17.958151
NCT02978066|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-28|||December 2012||2012-12-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Postspinal Hypotension and Cardiac Performance in the Elderly|Is Postspinal Hypotension a Sign of Impaired Cardiac Performance in the Elderly? An Observational Mechanistic Study|Completed||N/A|20|Actual|Karolinska Institutet|||1||f||||f||||||||No||2017-10-10 21:34:18.042886|2017-10-10 21:34:18.042886
NCT02978053|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Light Treatment to Shift-working Nurses|The Effects of Bright Light on Adaptation to Night Work Among Nurses|Recruiting||N/A|40|Anticipated|University of Bergen||2|||f||||f||||||||No||2017-10-10 21:34:18.112098|2017-10-10 21:34:18.112098
NCT02978040|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-09-18|||July 4, 2017|Actual|2017-07-04|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FABOLUS-FASTER||Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.|Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over prasugreL: a mUlticenter Randomized Open-label Trial in patientS With ST-elevation Myocardial inFarction Referred for primAry percutaneouS inTERvention.FABOLUS FASTER Trial|Recruiting||Phase 4|120|Anticipated|University Hospital Inselspital, Berne||3|||f||||t|f|f|||f|||||2017-10-10 21:34:18.21922|2017-10-10 21:34:18.21922
NCT02978014|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-11-30|||October 2016||2016-10-01|November 2016|2016-11-01|October 2023|Anticipated|2023-10-01|October 2020|Anticipated|2020-10-01||Interventional|POPS||A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy|A Randomised Controlled Phase II Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy|Recruiting||Phase 2|245|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||No|We have not made a plan to share IPD at this stage but will finalise this following the first meeting of the Trial Management Group in Spring 2017|2017-10-10 21:34:18.458035|2017-10-10 21:34:18.458035
NCT02978001|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2017-07-06|||August 2016||2016-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Insulin Sensitivity, Glucose - and Fat Metabolism in Patients With Psoriasis|Insulin Sensitivity, Glucose - and Fat Metabolism in Patients With Psoriasis|Recruiting||N/A|32|Anticipated|University Hospital, Gentofte, Copenhagen|||2||f||||t||||||Samples With DNA|"     Muscle and fat biopsies. Blood samples.   "|||2017-10-10 21:34:18.5617|2017-10-10 21:34:18.5617
NCT02977988|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||March 2016||2016-03-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|MBRP-W||Women's Treatment and Early Recovery|Neural Mechanisms in Women's Treatment and Early Recovery|Recruiting||N/A|165|Anticipated|University of Southern California||2|||f||||f||||||||Undecided||2017-10-10 21:34:18.649668|2017-10-10 21:34:18.649668
NCT02977975|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2017-02-17|||September 2016||2016-09-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome|A Randomized Controlled Clinical Trial to Investigate the Efficacy of Traditionally Fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome|Active, not recruiting||N/A|70|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 21:34:18.813895|2017-10-10 21:34:18.813895
NCT02977962|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|December 2020|Anticipated|2020-12-01||Interventional|TALAA||Treatment of Anxiety in Late Adolescents With Autism|Treatment of Anxiety in Late Adolescents With Autism|Not yet recruiting||Phase 2|44|Anticipated|University of South Florida||2|||f||||f||||||||No||2017-10-10 21:34:18.88417|2017-10-10 21:34:18.88417
NCT02977949|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-26|||January 2012||2012-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01|24 Months|Observational [Patient Registry]|||The Effects of Seasonal Changes in Osteoporosis Treatment|The Effects of Seasonal Changes in Osteoporosis Treatment|Recruiting||N/A|200|Anticipated|Tomidahama Hospital|||1||f||||||||||||||2017-10-10 21:34:18.964448|2017-10-10 21:34:18.964448
NCT02977936|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Descriptive Study for the Management of Joint Pain Associated With Osteoarthritis of the Knee: Association of Extracts of Curcuma Longa, Boswellia Serrata and Porphyra Umbilicalis.||Not yet recruiting||N/A|126|Anticipated|Pileje|||1||f||||f||||||||||2017-10-10 21:34:19.040124|2017-10-10 21:34:19.040124
NCT02977923|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2017-09-12|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|DREAM-P||Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: a Pilot Study|Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: a Pilot Study|Recruiting||N/A|20|Anticipated|St. Justine's Hospital||2|||f||||f|f|f||||||||2017-10-10 21:34:19.100872|2017-10-10 21:34:19.100872
NCT02977910|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-26|||January 2017||2017-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment Strategy of Ankle Fracture Combined With Deltoid Ligament Rupture|Comparative Study for Ankle Fracture Combined With Deltoid Ligament Rupture|Not yet recruiting||N/A|200|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine||2|||f||||f||||||||Undecided||2017-10-10 21:34:19.216919|2017-10-10 21:34:19.216919
NCT02977897|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-28|||January 2017||2017-01-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Observational|||Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide|Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide|Not yet recruiting||N/A|10|Anticipated|University Health Network, Toronto|||1||f||||f||||||||No||2017-10-10 21:34:19.290211|2017-10-10 21:34:19.290211
NCT02977884|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-26|||August 2012||2012-08-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Complete Health Improvement Program (CHIP) Risk Reduction/Claims Evaluation Project|Complete Health Improvement Program (CHIP) Risk Reduction/Claims Evaluation Project|Recruiting||N/A|200|Anticipated|Ohio University||1|||f||||f||||||||No||2017-10-10 21:34:19.395048|2017-10-10 21:34:19.395048
NCT02977871|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-30|||July 2016||2016-07-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Bladder Flap Versus Omission of Flap During Cesarean Section of Primiparous Women|A Randomized Trial Comparing Bladder Flap Versus Omission of Flap During Cesarean Section of Primiparous Women|Completed||N/A|201|Actual|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||f||||||||No||2017-10-10 21:34:19.640903|2017-10-10 21:34:19.640903
NCT02977858|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-28|||August 2016||2016-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Observational|||ISE to Support Constipation Management|Interactive Spaced Education Game to Support Constipation Management in Pediatric Primary Care|Recruiting||N/A|160|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||||No||2017-10-10 21:34:19.750883|2017-10-10 21:34:19.750883
NCT02977845|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-26|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.|Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.|Recruiting||N/A|162|Anticipated|Nam Dinh University of Nursing||2|||f||||f||||||||Undecided|Later|2017-10-10 21:34:19.879999|2017-10-10 21:34:19.879999
NCT02977832|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-02-26|||January 2015||2015-01-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|Odyliresin||Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia|A Pilot Study of Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia|Completed||N/A|30|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||Undecided||2017-10-10 21:34:20.001052|2017-10-10 21:34:20.001052
NCT02977819|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-25|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|January 2019|Anticipated|2019-01-01||Interventional|Age-Well||Interventional Study in Cognitively Intact Seniors Aiming to Assess the Effects of Meditation Training and Foreign Language Learning on Behavioral, Biological and Neuroimaging Measures|Interventional Study in Cognitively Intact Seniors Aiming to Assess the Effects of Meditation Training and Foreign Language Learning on Behavioral, Biological and Neuroimaging Measures|Not yet recruiting||N/A|156|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||t||||||||||2017-10-10 21:34:20.178393|2017-10-10 21:34:20.178393
NCT02977806|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-06-02|||March 27, 2017|Actual|2017-03-27|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|March 22, 2019|Anticipated|2019-03-22||Observational|||Iron Long-Term Labelling Study Malawi|The Evaluation of Iron Metabolism Using a Novel Isotope Dilution Method in Malawian Children, Who Have Previously Participated in a Stable Isotope Study|Recruiting||N/A|48|Anticipated|Swiss Federal Institute of Technology|||1||f||||f||||||||No||2017-10-10 21:34:20.378227|2017-10-10 21:34:20.378227
NCT02977793|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Comparative Study of the TOMEY Specular Microscope EM-4000 and the Konan CellChek XL|Comparative Study of the TOMEY Specular Microscope EM-4000 and the Konan CellChek XL for the Measurements of Endothelial Cell Density, Coefficient of Variation of Endothelial Cell Area, % Hexagonality, Central Corneal Thickness|Active, not recruiting||N/A|81|Actual|Tomey Corporation|||3||f||||f||||||||No||2017-10-10 21:34:20.463848|2017-10-10 21:34:20.463848
NCT02977780|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-08-02|||February 9, 2017|Actual|2017-02-09|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|||INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)|INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)|Recruiting||Phase 2|280|Anticipated|Dana-Farber Cancer Institute||4|||f||||t|t|f||||||||2017-10-10 21:34:20.562132|2017-10-10 21:34:20.562132
NCT02977767|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-31|||January 2018|Anticipated|2018-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|HYPNO-TRACH||Evaluation of the Effect of Conversational Hypnosis When Changing Tracheal Cannula in Adult Patients|Evaluation of the Effect of Conversational Hypnosis When Changing Tracheal Cannula in Adult Patients: a Pilot Study|Not yet recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de la Réunion||1|||f||||f|f|f||||||||2017-10-10 21:34:20.778942|2017-10-10 21:34:20.778942
NCT02977754|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-26|||January 2016||2016-01-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib|Exploring the Prognostic Role of 18F-FDG PET/CT Imaging in Patients Affected by Hepatocellular Carcinoma (HCC) and Candidate to Treatment With Sorafenib|Recruiting||N/A|10|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||||No||2017-10-10 21:34:20.867488|2017-10-10 21:34:20.867488
NCT02977741|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-01-18|||November 2016||2016-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting||Recruiting||N/A|20|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-10-10 21:34:20.968863|2017-10-10 21:34:20.968863
NCT02977728|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-02-22|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01|1 Year|Observational [Patient Registry]|||Olfactory Function in Patients With Acute Mild Traumatic Brain Injury|Olfactory Function in Patients With Acute Mild Traumatic Brain Injury|Not yet recruiting||N/A|60|Anticipated|Hôpital de Viege|||2||f||||t||||||||No||2017-10-10 21:34:21.063916|2017-10-10 21:34:21.063916
NCT02977715|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-02-27|||February 23, 2017|Actual|2017-02-23|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||IMVAMUNE® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo|An Open-Label Prospective Cohort Study of IMVAMUNE® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo|Recruiting||Phase 3|1000|Anticipated|Centers for Disease Control and Prevention||1|||f||||f|t|f||||||No||2017-10-10 21:34:21.156268|2017-10-10 21:34:21.156268
NCT02977702|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-28|||December 2015||2015-12-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma|Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma|Completed||N/A|114|Actual|Institut de Cancérologie de Lorraine|||1||f||||||||||||||2017-10-10 21:34:21.290642|2017-10-10 21:34:21.290642
NCT02977689|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-20|||April 2018|Anticipated|2018-04-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Trial of IDH305 in IDH1 Mutant Grade II or III Glioma|Phase 2 Study of IDH305 in Subjects With IDH1 Mutant Grade II or III Glioma That Has Progressed After Observation or Radiation Therapy|Not yet recruiting||Phase 2|28|Anticipated|New York University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 21:34:21.389838|2017-10-10 21:34:21.389838
NCT02977676|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-25|||February 2013||2013-02-01|November 2016|2016-11-01||||January 2016|Actual|2016-01-01||Observational|||Ventilator-Associated Events: Prevalence, Outcome and Preventability|Ventilator-Associated Events: Prevalence, Outcome and Preventability|Completed||N/A|400|Actual|Hospital Sao Domingos|||1||f||||t||||||||||2017-10-10 21:34:21.549539|2017-10-10 21:34:21.549539
NCT02977650|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2016|Actual|2016-11-01|3 Years|Observational [Patient Registry]|||EUS-FNA for Patients Taking Anticoagulants Without Heparin Bridge|EUS-FNA for Patients Taking Anticoagulants Without Heparin Bridge|Recruiting||N/A|150|Anticipated|Hokkaido Pancreatobiliary Endoscopic Intervention Study Group|||1||f||||f||||||||Undecided||2017-10-10 21:34:21.766685|2017-10-10 21:34:21.766685
NCT02977637|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-03-28|||November 2016||2016-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||MRA With Feraheme in HHT|The Use of Ferumoxytol (Feraheme) for Whole Body Magnetic Resonance Angiography in Hereditary Hemorrhagic Telangiectasia|Recruiting||Phase 1|10|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-10 21:34:21.882069|2017-10-10 21:34:21.882069
NCT02977611|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-05-02|||January 2017|Anticipated|2017-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Safety of a High-Dose, Rapid Infusion of Iron Sucrose|The Safety of a High-Dose, Rapid Infusion of Iron Sucrose in a Non-Dialysis Dependent Population|Withdrawn||Phase 2|0|Actual|The Guthrie Clinic||1||FDA Clinical Hold|f||||t||||||||No||2017-10-10 21:34:22.117916|2017-10-10 21:34:22.117916
NCT02977598|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-26|||February 2014||2014-02-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||Relations Between Atherogenic Index of Plasma-Glucose Metabolism|Association Between Atherogenic Index of Plasma, Blood Pressure and Impaired Glucose Metabolism|Completed||N/A|448|Actual|Erzincan University|||3||f||||f||||||||No||2017-10-10 21:34:22.226974|2017-10-10 21:34:22.226974
NCT02977585|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Helmet Continuous Positive Airway Pressure Support for Severe Bronchiolitis in PICUs|Helmet Continous Positive Airway Pressure (CPAP) Management and Positive End Expiratory Pressure (PEEP) Level Impact on Severe Bronchiolitis Admitted in Pediatric Intensive Care Units (PICUs)|Recruiting||N/A|488|Anticipated|Bambino Gesù Hospital and Research Institute||2|||f||||f||||||||Undecided||2017-10-10 21:34:22.333948|2017-10-10 21:34:22.333948
NCT02977572|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-06-22|2016-12-09||July 2007||2007-07-01|June 2017|2017-06-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Non-invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema|Non-Invasive Mechanical Ventilation Versus Continuous Positive Airway Pressure Relating to Cardiogenic Pulmonary Edema in an Intensive Care Unit|Completed||N/A|114|Actual|Hospital General Universitario de Castellón||2|||f||||f||||||||No||2017-10-10 21:34:22.484134|2017-10-10 21:34:22.484134
NCT02977559|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-30|||March 2017||2017-03-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study Between the Laryngeal Tube Suction-Disposable and the Ambu AuraGain in Pediatric Patients|A Comparative Randomized Prospective Study Between the New Laryngeal Tube Suction-Disposable and the Ambu AuraGain in Pediatric Patients|Not yet recruiting||N/A|60|Anticipated|Bnai Zion Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:34:23.42876|2017-10-10 21:34:23.42876
NCT02977546|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-03-14|||November 2016||2016-11-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01|1 Day|Observational [Patient Registry]|||Noninvasive Pulse Contour Analysis for Hemodynamic Assessment in Patients With Chronic Heart Failure|Noninvasive Pulse Contour Analysis for Hemodynamic Assessment in Patients With Chronic Heart Failure|Completed||N/A|107|Actual|Heart and Diabetes Center North-Rhine Westfalia|||1||f||||f||||||||No||2017-10-10 21:34:23.497823|2017-10-10 21:34:23.497823
NCT02977533|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-13|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|March 20, 2018|Anticipated|2018-03-20|March 20, 2018|Anticipated|2018-03-20||Interventional|||A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis|A Randomized, Double-blind, Placebo-controlled Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Dose of GZ402668 in Men and Women With Progressive Multiple Sclerosis|Active, not recruiting||Phase 1|24|Anticipated|Sanofi||2|||f||||f||||||||||2017-10-10 21:34:23.576258|2017-10-10 21:34:23.576258
NCT02977520|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01||||May 2017|Anticipated|2017-05-01||Interventional|PAOCA||Preoperative Assessment and Individualized Operation Optimization of Acute Ruptured Cerebral Aneurysms|Preoperative Assessment and Individualized Operation Optimization of Acute Ruptured Cerebral Aneurysms|Recruiting||N/A|40|Anticipated|Beijing Luhe Hospital||2|||f||||||||||||||2017-10-10 21:34:23.667441|2017-10-10 21:34:23.667441
NCT02977507|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-07-16|||December 13, 2016|Actual|2016-12-13|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Subjects With Moderate Facial Melasma|Randomized, Double-blinded, Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Subjects With Moderate Facial Melasma|Recruiting||Phase 1|20|Anticipated|Allergan||2|||f|||||t|f|||f|||||2017-10-10 21:34:23.759058|2017-10-10 21:34:23.759058
NCT02977494|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-03-24|||December 2016||2016-12-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|GMMG-DANTE||Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment|Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment Including Subjects Undergoing Hemodialysis: A Phase 2, Open-label, Multicenter Trial|Recruiting||Phase 2|36|Anticipated|University Hospital Tuebingen||1|||f||||t||||||||Undecided||2017-10-10 21:34:23.85399|2017-10-10 21:34:23.85399
NCT02977481|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-17|||November 2016||2016-11-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Ear Temperature as Predictor of Rectal Temperature Measured With Modern Devices in the Emergency Department.|Ear Temperature, Measured With 3. Generation Tympanic Thermometers as Predictor of Rectal Temperature in the Emergency Department Population|Completed||N/A|600|Actual|University of Southern Denmark|||1||f||||f||||||||No||2017-10-10 21:34:23.964553|2017-10-10 21:34:23.964553
NCT02977468|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-05-22|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Pembro/IORT||Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer|Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer With and Without Intra-operative RT: a Window of Opportunity Study|Recruiting||Phase 1|15|Anticipated|Columbia University||1|||f||||t|t|f||||||Undecided||2017-10-10 21:34:24.040156|2017-10-10 21:34:24.040156
NCT02977455|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-27|||October 2016||2016-10-01|October 2016|2016-10-01||||March 2017|Anticipated|2017-03-01||Observational|||Study on the Neurovascular Coupling Function in Patients Undergoing Cardiac Surgery||Enrolling by invitation||N/A|30|Anticipated|Xiangya Hospital of Central South University|||1||f||||||||||||||2017-10-10 21:34:24.135987|2017-10-10 21:34:24.135987
NCT02977442|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-08-25|||November 2016||2016-11-01|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|DYNAMMO-T2DEX||Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise|Dynamics of Muscle Mitochondria in Type 2 Diabetes|Recruiting||N/A|60|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 21:34:24.181741|2017-10-10 21:34:24.181741
NCT02977429|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-11-27|||October 2016||2016-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After Surgery|Clinical Study of Central Venous-to-Arterial Carbon Dioxide Difference(Pcv-aCO2) in the Evaluation of Fluid Therapy for Postoperative Patients With Abdominal Cancer|Recruiting||N/A|150|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||Yes||2017-10-10 21:34:24.26697|2017-10-10 21:34:24.26697
NCT02977416|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|May 2020|Anticipated|2020-05-01||Interventional|OSE-JIA||Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα|Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα|Recruiting||N/A|66|Anticipated|University Hospital, Clermont-Ferrand||3|||f||||||||||||||2017-10-10 21:34:24.54703|2017-10-10 21:34:24.54703
NCT02977403|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-29|2017-07-20|||November 15, 2016||2016-11-15|July 13, 2017|2017-07-13|December 31, 2020|Anticipated|2020-12-31|March 1, 2020|Anticipated|2020-03-01||Interventional|||Mobile Attention Retraining in Overweight Female Adolescents|Pilot Study of Mobile Attention Training in Overweight Female Adolescents|Recruiting||Phase 2|120|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 21:34:24.66899|2017-10-10 21:34:24.66899
NCT02977390|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-30|||October 2013||2013-10-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Passive Leg Raise Induced Stroke Volume Changes in Elderly Prior to Elective Surgery Measured by LiDCOplusTM|Passive Leg Raise Induced Stroke Volume Changes in Elderly Prior to Elective Surgery Measured by LiDCOplusTM to Guide Fluid Therapy|Completed||N/A|10|Actual|Karolinska Institutet||1|||f||||f||||||||No||2017-10-10 21:34:24.788992|2017-10-10 21:34:24.788992
NCT02977377|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-25|||January 2015||2015-01-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effects Of Whole Body Vibration On Postural Control In Patients With Ataxia|Ataksili Hastalarda Tüm Vücut Vibrasyonunun Postüral Kontrol Üzerine Etkileri|Recruiting||N/A|25|Anticipated|Hacettepe University||2|||f||||f||||||||||2017-10-10 21:34:24.878943|2017-10-10 21:34:24.878943
NCT02977364|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-27|||November 2016||2016-11-01|November 2016|2016-11-01|November 2021|Anticipated|2021-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours|Phase I Trial to Investigate Safety and Tolerability Profile and Pharmacokinetics of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours|Recruiting||Phase 1|50|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||6|||f||||f||||||||No||2017-10-10 21:34:25.023699|2017-10-10 21:34:25.023699
NCT02977351|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-29|||January 2014||2014-01-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01||Interventional|||Determining the Relationship Between the Atherosclerosis and Periodontopathogenic Microorganisms|Determining the Relationship Between the Atherosclerosis and Periodontopathogenic Microorganisms in Chronic Periodontitis Patients|Completed||N/A|40|Actual|Izmir Katip Celebi University||2|||f||||f||||||||No||2017-10-10 21:34:25.132999|2017-10-10 21:34:25.132999
NCT02977338|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-12-01|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation in Patients With Obstructive Sleep Apnea That Had Undergone Diagnosis and Surgical Treatment|Evaluation in Patients With Obstructive Sleep Apnea That Had Undergone Diagnosis and Surgical Treatment|Not yet recruiting||N/A|200|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||Undecided||2017-10-10 21:34:25.21464|2017-10-10 21:34:25.21464
NCT02977325|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2016-12-02|||July 2015||2015-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Observational|ASES||Validation of the Questionnaire ASES|Translation and Cultural Adaptation of the Arthritis Self-Efficacy Scale|Completed||N/A|50|Actual|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-10 21:34:25.285848|2017-10-10 21:34:25.285848
NCT02977312|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-29|||August 2012||2012-08-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|CCMLJ||Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan|Observational Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan|Completed||N/A|91|Actual|Hikma Pharmaceuticals LLC|||1||f||||f||||||||No||2017-10-10 21:34:25.387814|2017-10-10 21:34:25.387814
NCT02977299|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-28|2017-09-25|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|October 2021|Anticipated|2021-10-01||Interventional|ASCERTAINTRD||Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD|Augmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With Treatment Resistant Depression (ASCERTAIN-TRD)|Recruiting||Phase 4|639|Anticipated|Massachusetts General Hospital||3|||f||||t|t|t|f|f||||||2017-10-10 21:34:25.512943|2017-10-10 21:34:25.512943
NCT02977286|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids|Impact of Naloxegol on Prevention of Lower GI Tract Paralysis in Critically Ill Adults Initiated on Scheduled Intravenous Opioid Therapy: A Randomized, Double-Blind, Placebo-Controlled, Phase II, Single-Center, Proof of Concept Study|Recruiting||Phase 4|36|Anticipated|Tufts Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:34:25.654519|2017-10-10 21:34:25.654519
NCT02977273|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Lunch Study: the Combined Effects of Food Texture and Portion Size on Intake|The Lunch Study: the Combined Effects of Food Texture and Portion Size on Intake|Completed||N/A|53|Actual|Clinical Nutrition Research Centre, Singapore||4|||f||||t||||||||No||2017-10-10 21:34:25.816076|2017-10-10 21:34:25.816076
NCT02977260|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Lunch Study: the Combined Effects of Food Texture and Energy Density on Intake|The Lunch Study: the Combined Effects of Food Texture and Energy Density on Intake|Completed||N/A|63|Actual|Clinical Nutrition Research Centre, Singapore||4|||f||||t||||||||No||2017-10-10 21:34:25.912957|2017-10-10 21:34:25.912957
NCT02977247|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-02-13|||November 2016||2016-11-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|SV PCC ARM2||Delphinus SoftVue Prospective Case Collection - ARM 2|ARM 2: A Prospective, Multicenter, Multi-arm, Clinical Case Collection Program to Acquire Breast Image Data and Establish an Image Library of Exams for Use in Future Research Studies, Training, and Product Development Efforts.|Enrolling by invitation||N/A|1000|Anticipated|Delphinus Medical Technologies, Inc.|||1||f||||f||||||||No||2017-10-10 21:34:26.023165|2017-10-10 21:34:26.023165
NCT02977234|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-29|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx|Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate in Patients With Hydrosalpinx|Recruiting||Phase 1/Phase 2|25|Anticipated|Ain Shams University||1|||f||||t||||||||Undecided||2017-10-10 21:34:26.2302|2017-10-10 21:34:26.2302
NCT02977221|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-07-26|||March 2016||2016-03-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy of Piezosurgey Corticotomy (a Minimally Invasive Surgical Technique) in Accelerating Orthodontic Alignment|Evaluation of the Efficacy of Flapless Corticotomy Accomplished by Piezosurgery in Accelerating Orthodontic Treatment of Crowding in Adults: a Randomized Controlled Trial|Completed||N/A|36|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 21:34:26.339639|2017-10-10 21:34:26.339639
NCT02977208|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-25|||September 2016||2016-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use|Impact of Genetic Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use of the Drug|Recruiting||Phase 4|55|Anticipated|São Paulo State University||2|||f||||f||||||||No||2017-10-10 21:34:26.469518|2017-10-10 21:34:26.469518
NCT02977195|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-09-13|||January 9, 2017|Actual|2017-01-09|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|July 2018|Anticipated|2018-07-01||Interventional|NP137||First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors|NP137 - An Open-label, First in Human, Phase I Trial Aiming to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of a Humanized Monoclonal Antibody Targeting Netrin 1 (NP137) in Patients With Advanced/Metastatic Solid Tumors.|Recruiting||Phase 1|44|Anticipated|Centre Leon Berard||1|||f||||t||||||||||2017-10-10 21:34:26.578506|2017-10-10 21:34:26.578506
NCT02977182|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Lymphedema Treatment for Blunt Facial Trauma|The Effect of Lymphedema Treatment for the Management of Blunt Facial Trauma|Recruiting||N/A|50|Anticipated|Our Lady of the Lake Regional Medical Center||2|||f||||f||||||||No||2017-10-10 21:34:26.684915|2017-10-10 21:34:26.684915
NCT02977169|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-12-25|||November 2016||2016-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer|Phase II Study to Evaluate the Role of Postoperative Radiotherapy for Low Risk of Locoregional Recurrence Patients With Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer|Recruiting||Phase 2|300|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||No||2017-10-10 21:34:26.772931|2017-10-10 21:34:26.772931
NCT02977156|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-09-13|||January 3, 2017|Actual|2017-01-03|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|ISI-JX||Immunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors.|A Phase I Dose Escalation Trial Evaluating the Impact of an in Situ Immunization Strategy With Intra-Tumoral Injections of Pexa-Vec in Combination With Ipilimumab in Metastatic / Advanced Solid Tumors With Injectable Lesions.|Recruiting||Phase 1|60|Anticipated|Centre Leon Berard||1|||f||||t||||||||||2017-10-10 21:34:26.885729|2017-10-10 21:34:26.885729
NCT02977143|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-11-27|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery|Comparison of Positive End-expiratory Pressure-induced Increase in Central Venous Pressure and Stroke Volume Variation to Predict Fluid Responsiveness in Robot-assisted Laparoscopic Surgery: A Prospective Clinical Trial|Recruiting||N/A|49|Anticipated|Seoul National University Hospital||1|||f||||t||||||||No||2017-10-10 21:34:26.98118|2017-10-10 21:34:26.98118
NCT02977130|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-29|||May 2014||2014-05-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Influence of Conversation Map on the Health Behaviors of Diabetes Patients|The Influence of Conversation Map on the Health Behaviors of Diabetes Patients|Completed||N/A|615|Actual|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 21:34:27.084895|2017-10-10 21:34:27.084895
NCT02977117|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2017-06-13|||December 2016||2016-12-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis|The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects With End-Stage Renal Disease Treated With Haemodialysis - A Randomised Clinical Trial|Completed||Phase 2|59|Actual|Nordsjaellands Hospital||2|||f||||f||||||||||2017-10-10 21:34:27.155154|2017-10-10 21:34:27.155154
NCT02977104|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-27|||July 2013||2013-07-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Maestro Handheld Cardiac Monitor Validation|Maestro Handheld Cardiac Monitor Validation|Recruiting||N/A|150|Anticipated|University of Michigan||2|||f||||f||||||||No||2017-10-10 21:34:27.232901|2017-10-10 21:34:27.232901
NCT02977091|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-27|||December 2016||2016-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Fitness Level in Short Stature Children and After Growth Hormone Treatment|Fitness Level in Short Stature Children and After Growth Hormone Treatment|Not yet recruiting||N/A|50|Anticipated|Meir Medical Center|||2||f||||f||||||||No||2017-10-10 21:34:27.303823|2017-10-10 21:34:27.303823
NCT02977078|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Improving Asthma Treatment Using Inhaler Technology|Improving Asthma Treatment Using Inhaler Technology|Recruiting||N/A|50|Anticipated|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||No|No plan to share IPD|2017-10-10 21:34:27.385195|2017-10-10 21:34:27.385195
NCT02977065|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2016-11-29|||January 2017||2017-01-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors|Multicenter, Parallel-group, Double-blind, Randomized, Active-controlled, Dose-ranging Study to Assess the Safety, Efficacy, and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors, in Subjects With Dyslipidemia|Not yet recruiting||Phase 2|60|Anticipated|Chong Kun Dang Pharmaceutical||6|||f||||f||||||||No||2017-10-10 21:34:27.470736|2017-10-10 21:34:27.470736
NCT02977039|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-27|||January 2017||2017-01-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Effect of a Nutrient Dense Plant Rich Diet on Glycemic Control in People With Type 2 Diabetes and Obesity||Not yet recruiting||N/A|80|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No|We will not share individual participant data with other researchers|2017-10-10 21:34:27.704128|2017-10-10 21:34:27.704128
NCT02977026|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2017-08-10|||December 2016||2016-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Comparing the Efficacy of the Alcohol Help Centre and Check Your Drinking to a no Intervention Control Condition|Comparing the Efficacy of the Alcohol Help Centre and Check Your Drinking to a no Intervention Control Condition: Randomized Controlled Trial|Completed||N/A|511|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-10-10 21:34:27.79348|2017-10-10 21:34:27.79348
NCT02977013|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-27|2017-03-31|||August 2013||2013-08-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism|Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism|Completed||N/A|42|Actual|Al Mouwasat Hospital|||1||f||||f||||||||||2017-10-10 21:34:27.868782|2017-10-10 21:34:27.868782
NCT02977000|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-29|||May 2016||2016-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants|Department of Neonatology, Children's Hospital of Zhengzhou|Recruiting||N/A|100|Anticipated|Zhengzhou Children's Hospital, China||1|||f||||t||||||||No||2017-10-10 21:34:27.93601|2017-10-10 21:34:27.93601
NCT02976987|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-25|||February 2013||2013-02-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.|A Prolongation of Phase II Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions|Completed||Phase 2|36|Actual|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 21:34:28.014484|2017-10-10 21:34:28.014484
NCT02976974|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-02|||July 2017|Anticipated|2017-07-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|MTEAC||Efficacy of Manual Therapy and Exercise in Patients With Shoulder Adhesive Capsulitis. A Randomized Clinical Trial.|Efficacy of Manual Therapy and Therapeutic Exercise in Patients With Shoulder Adhesive Capsulitis. Which Factors Are More Correlated With?|Not yet recruiting||N/A|30|Anticipated|University of Malaga||2|||f||||f|f|f||||||Yes|The results obtained in this project will be disseminated to the research community through different vias such as publications and oral/poster presentations|2017-10-10 21:34:28.104268|2017-10-10 21:34:28.104268
NCT02976961|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-17|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|June 2018|Anticipated|2018-06-01||Interventional|ACQUIRE-ICD||A Personalized and Interactive Web-based Health Care Innovation to Advance the Quality of Care|A Personalized and Interactive Web-based Health Care Innovation to AdvanCe the QualIty of Life and caRE of Patients With an Implantable Cardioverter Defibrillator|Recruiting||N/A|478|Anticipated|University of Southern Denmark||2|||f||||f|f|f||||||No||2017-10-10 21:34:28.196401|2017-10-10 21:34:28.196401
NCT02976948|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-11-26|||July 2015||2015-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|BIOSAID||Evaluation of a New Sequencing Strategy in Autoinflammatory Siseases (BIOSAID)|Evaluation of a New Sequencing Strategy in Autoinflammatory Diseases Diagnostic Value and Therapeutic Orientation|Recruiting||N/A|300|Anticipated|University Hospital, Montpellier|||1||f||||f||||||Samples Without DNA|"     Patients with prerequisites established jointly by the reference centers . At least 3     unexplained inflammatory access elevated CRP (C reactive protein)   "|||2017-10-10 21:34:28.28917|2017-10-10 21:34:28.28917
NCT02976935|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-11-24|||February 2014||2014-02-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Functional MR Lung Imaging Using Hyperpolarised 129Xe|FUNCTIONAL MAGNETIC RESONANCE LUNG IMAGING USING INHALED HYPERPOLARISED 129Xe|Recruiting||N/A|150|Anticipated|University of Nottingham|||3||f||||f||||||||||2017-10-10 21:34:28.372955|2017-10-10 21:34:28.372955
NCT02976922|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2017-03-11|||January 2016||2016-01-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||The Salivary and Faecal Microbiome of Recurrent Aphthous Stomatitis Patients Before and After Treatment With Probiotics|Characterisation of the Salivary and Faecal Microbiome in Patients With Recurrent Aphthous Stomatitis Before and After Treatment With Probiotics|Recruiting||N/A|20|Anticipated|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 21:34:28.442409|2017-10-10 21:34:28.442409
NCT02976909|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of TPFinduction Chemotherapy Boundary Resectable Local Advanced Esophageal Squamous Cell Carcinoma|Paclitaxel In Combination With DDP and 5-FU(TPF) as Neoadjuvant Chemotherapy in Treating Boundary Resectable Advanced Esophageal Squamous Carcinoma: A Phase II Clinical Trial|Recruiting||Phase 2|46|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 21:34:28.529396|2017-10-10 21:34:28.529396
NCT02976896|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-30|||August 2016||2016-08-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|Poetry-1||Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment|Efficacy and Safety of Apatinib Mesylate in Recurrent/Metastatic Esophageal Squamous Cell Carcinoma After the Failure of Conventional Treatment: a Phase II Clinical Trial|Recruiting||Phase 2|43|Anticipated|Sun Yat-sen University||1|||f||||t||||||||Yes||2017-10-10 21:34:28.616984|2017-10-10 21:34:28.616984
NCT02976883|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-11-25|||November 2015||2015-11-01|November 2016|2016-11-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|OXYPET||[18F]HX4 PET/CT Imaging for Detection of Hypoxia|A Phase II, Single Centre Exploratory Study of [18F]HX4 PET/CT Imaging to Detect Hypoxia in Patients With Head and Neck and Lung Cancer, Receiving Radiotherapy With Curative Intent|Recruiting||Phase 2|50|Anticipated|Nottingham University Hospitals NHS Trust||1|||f||||f||||||||Undecided||2017-10-10 21:34:28.693605|2017-10-10 21:34:28.693605
NCT02976870|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-11-28|||November 2012||2012-11-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|HAALIF||Hydronephrosis After Anterior Lumbar Interbody Fusion (ALIF)|Hydronephrosis After Anterior Lumbar Interbody Fusion (ALIF)|Completed||N/A|39|Actual|Nottingham University Hospitals NHS Trust||1|||f||||f||||||||||2017-10-10 21:34:28.766998|2017-10-10 21:34:28.766998
NCT02976857|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-03-11|||December 2016||2016-12-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|C-CAR011||A Phase 1 Study Evaluating Safety and Efficacy of C-CAR011 Treatment in DLBCL Subjects|A Phase 1 Single Center, Non-randomized Study Evaluating Safety and Efficacy of Anti-CD19 Chimeric Antigen Receptor T-cell (C-CAR011) Treatment in Subjects With Refractory Diffuse Large B-cell Lymphoma|Recruiting||Phase 1|15|Anticipated|Cellular Biomedicine Group Ltd.||1|||f||||t||||||||Undecided||2017-10-10 21:34:28.940192|2017-10-10 21:34:28.940192
NCT02976844|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-03|||August 2016||2016-08-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Effect of Positive End-expiratory Pressure on Optimal Balloon Volume During Esophageal Pressure Monitoring|Effect of Positive End-expiratory Pressure on Optimal Balloon Volume During Esophageal Pressure Monitoring in Mechanical Ventilated Patients: A Clinical Feasibility Study|Completed||N/A|12|Actual|Capital Medical University|||2||f||||t||||||||||2017-10-10 21:34:29.037051|2017-10-10 21:34:29.037051
NCT02976831|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-06-13|||December 9, 2016|Actual|2016-12-09|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|||Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects|A Phase I Randomized Single-blind Placebo-controlled 2-part Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 Following Single and Multiple Ascending Dose Administration to Healthy Subjects|Completed||Phase 1|83|Actual|AstraZeneca||2|||f||||t|f|f||||||||2017-10-10 21:34:29.12698|2017-10-10 21:34:29.12698
NCT02976818|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-05-03|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|FHLPA||Lp(a) and Aortic Valve Calcification|Relationships Between Lipoprotein(a) Levels and Aortic Valve Calcification in Patients With Heterozygous Familial Hypercholesterolemia|Recruiting||N/A|200|Anticipated|Laval University|||1||f||||f||||||||No||2017-10-10 21:34:29.26538|2017-10-10 21:34:29.26538
NCT02976805|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-02-17|||February 13, 2017|Actual|2017-02-13|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|B-CLEANR||Multi-centre Failed Bowel Prep RCT|A Multi-centre Endoscopist Blinded Randomized Clinical Trial to Compare Two Bowel Preparations After a Colonoscopy With Inadequate Bowel Preparation|Recruiting||Phase 3|196|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||No||2017-10-10 21:34:29.37836|2017-10-10 21:34:29.37836
NCT02976792|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-11-28|||September 2016||2016-09-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|AKI-TAVI||Effectiveness of the NephroCheck™ After TAVI|Effectiveness of the NephroCheck™ to Predict Postoperative Acute Kidney Injury in Patients Undergoing a Transcatheter Aortic Valve Implantation|Recruiting||N/A|125|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||No||2017-10-10 21:34:29.531458|2017-10-10 21:34:29.531458
NCT02976779|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-11-28|||February 2017||2017-02-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers|A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers|Not yet recruiting||Phase 1|26|Anticipated|One World Cannabis Ltd.||2|||f||||t||||||||No||2017-10-10 21:34:29.638279|2017-10-10 21:34:29.638279
NCT02976766|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-03-22|||February 4, 2017|Actual|2017-02-04|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Gypenosides Treatment for Optic Neuritis|Gypenosides Treatment for Optic Neuritis: a Randomised, Double-blind, Placebo-controlled Trial|Recruiting||Phase 2|28|Anticipated|First Affiliated Hospital of Guangxi Medical University||2|||f|||||f|f||||||||2017-10-10 21:34:29.735981|2017-10-10 21:34:29.735981
NCT02976753|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-09-18|||October 2016||2016-10-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products|24-month Prospective, Multicentre, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products in the Prophylactic Treatment of Patients With Haemophilia A (A-SURE)|Recruiting||N/A|350|Anticipated|Swedish Orphan Biovitrum|||2||f||||f||||||||||2017-10-10 21:34:29.858062|2017-10-10 21:34:29.858062
NCT02976740|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy|A Prospective Multi-center Phase II Study: Assessment of the Safety and Abscopal Effects of SBRT Combination With rhGM-CSF and Thymosin Alpha 1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy|Recruiting||Phase 2|48|Anticipated|The First Affiliated Hospital of Xiamen University||1|||f||||f||||||||No||2017-10-10 21:34:30.055035|2017-10-10 21:34:30.055035
NCT02976727|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-28|||May 2014||2014-05-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis|Efficacy of Topical Calcipotriol-assisted Ablative Fractional Laser Photodynamic Therapy for the Treatment of Actinic Keratosis: 12-month Follow-up Results of a Prospective, Randomised, Comparative Trial|Completed||Phase 1|48|Actual|Dong-A University||2|||f||||f||||||||No||2017-10-10 21:34:30.251581|2017-10-10 21:34:30.251581
NCT02976714|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-05-11|||December 12, 2016|Actual|2016-12-12|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|MethylBiomark||Identification of Epigenetic Biomarkers Allowing to Predict the Evolution of Lung Disease Severity in Cystic Fibrosis, in Order to Improve Patient Follow-up and to Move Toward Personalized Medicine|Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic Fibrosis|Recruiting||N/A|50|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:34:30.396966|2017-10-10 21:34:30.396966
NCT02976701|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-10-03|||November 2016||2016-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of DLBS1033 After Primary PCI in Patients With STE-ACS|The Effect of DLBS1033 in Patients With ST Elevation Acute Coronary Syndrome (STE-ACS) After Primary Percutaneous Coronary Intervention|Recruiting||Phase 2/Phase 3|40|Anticipated|Dexa Medica Group||2|||f||||t||||||||||2017-10-10 21:34:30.500964|2017-10-10 21:34:30.500964
NCT02976688|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-28|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|PLAN||Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis|Effects of Short-chain Fatty Acids, Here Sodium Propionate, a Metabolism Product of the Human Gut-microbiome, on Inflammatory and Metabolic Parameters in Patients on Maintenance Hemodialysis - a Pilot Study|Not yet recruiting||Phase 2/Phase 3|15|Anticipated|Azienda Sanitaria ASL Avellino 2||1|||f||||f||||||||No||2017-10-10 21:34:30.629928|2017-10-10 21:34:30.629928
NCT02976675|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-06-14|||January 2015||2015-01-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency|Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency: A Multicenter, Randomized, Open-label, Parallel Phase IV Clinical Trial With Different Administration Frequency of PEG Somatropin|Recruiting||Phase 4|600|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||3|||f||||f||||||||||2017-10-10 21:34:30.749304|2017-10-10 21:34:30.749304
NCT02976662|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2016-11-28|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AS||Artificial Shrinkage for Human Blastocyst Prior Vitrification|Removal of Blastocoel Fluid Before Blastocyst Vitrification by Laser Pulse and Its Effect on Clinical Outcomes|Recruiting||N/A|100|Anticipated|Dar AlMaraa Center||2|||f||||||||||||||2017-10-10 21:34:30.901336|2017-10-10 21:34:30.901336
NCT02976649|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-25|||January 2016||2016-01-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Proposal of a Score to Detect the Need for Postoperative Intensive Care Unit Admission After Bariatric Surgery|Proposal of a Score to Detect the Need for Postoperative Intensive Care Unit Admission After Bariatric Surgery|Completed||N/A|111|Actual|Ain Shams University|||1||f||||f||||||||Undecided||2017-10-10 21:34:30.979774|2017-10-10 21:34:30.979774
NCT02976636|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-04-25|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|August 2022|Anticipated|2022-08-01|June 2021|Anticipated|2021-06-01||Interventional|Re-FRESH||Reinforced Enhanced - Families Responsibility Education Support and Health|Parent Training Program to Improve Outcomes in Childhood Obesity Treatment|Recruiting||N/A|160|Anticipated|University of California, San Diego||2|||f||||t|f|f||||||No||2017-10-10 21:34:31.049495|2017-10-10 21:34:31.049495
NCT02976623|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-05-04|||June 2016||2016-06-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Metric-based Feedback Training for the Acquisition of Sonographic Skills|Effects of Metric-based Feedback Training on Acquisition of Sonographic Skills Relevant to Performance of Ultrasound Guided Axillary Brachial Plexus Block|Completed||N/A|13|Actual|University College Cork||2|||f||||f||||||||No||2017-10-10 21:34:31.166031|2017-10-10 21:34:31.166031
NCT02976610|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-06-09|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department.|Open Label, Single Center Clinical Trial of a Novel Hemolysis Point of Care Test at an Emergency Department.|Completed||N/A|1671|Actual|Hemcheck Sweden AB||2|||f||||f||||||||No||2017-10-10 21:34:31.276597|2017-10-10 21:34:31.276597
NCT02976597|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-06-27|||November 2016||2016-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TAB||Ultrasound Guided TAP Block for Postoperative Analgesia After Major Abdominal Surgery.|Morphine as an Adjunct in Sonar Guided Transversus Abdominis Plane Block for Postoperative Analgesia in Patients Undergoing Major Abdominal Surgery.|Recruiting||Phase 2/Phase 3|75|Anticipated|Assiut University||3|||f||||t||||||||No||2017-10-10 21:34:31.384697|2017-10-10 21:34:31.384697
NCT02976584|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-11-23|||July 2016||2016-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|EPOCAS||Epileptic Potentials During Cardiac Surgery and Association With Postoperative Neurological Outcome|Incidence of Epileptic Potentials During Cardiac Surgery and Postoperative Neurological Outcome: A Prospective Observational Study|Recruiting||N/A|1000|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||No||2017-10-10 21:34:31.58679|2017-10-10 21:34:31.58679
NCT02976571|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-06|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Local and Intraperitoneal Analgetics in Gynecologic Laparoscopy for Post Operative Pain Relief|Local and Intraperitoneal Analgetics in Gynecologic Laparoscopy for Post Operative Pain Relief|Active, not recruiting||N/A|120|Anticipated|Wolfson Medical Center||4|||f||||f||||||||No||2017-10-10 21:34:31.679558|2017-10-10 21:34:31.679558
NCT02976558|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-03|||December 2016||2016-12-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|November 2019|Anticipated|2019-11-01||Interventional|TriCAM||The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation|Prospective Open Randomized Monocentric Two-armed Controlled Clinical Trial in Parallel Groups to Investigate the Influence of Complementary Medicine (CAM) Interventions on Quality of Life and The Treatment Process of Patients Undergoing Allogenic Stem Cell Transplantation|Recruiting||N/A|80|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-10 21:34:31.773032|2017-10-10 21:34:31.773032
NCT02976532|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-28|||July 2013||2013-07-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Controlling Femoral Derotation Osteotomy With Electromagnetic Tracking|Controlling Femoral Derotation Osteotomy With Electromagnetic Tracking - an in Vivo Study|Recruiting||N/A|20|Anticipated|Heidelberg University||1|||f||||f||||||||No||2017-10-10 21:34:31.983202|2017-10-10 21:34:31.983202
NCT02976519|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-10-02|||February 15, 2017|Actual|2017-02-15|October 2017|2017-10-01|February 28, 2018|Anticipated|2018-02-28|December 30, 2017|Anticipated|2017-12-30||Interventional|||BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects|A Phase Ib, Multicentre, Double Blind, Randomized, Two-part Study, First Part Multiple Rising Dose and Second Part Two-way Cross-over, to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of BI 443651 Compared to Placebo Via Respimat® in Healthy Volunteers and CF Subjects.|Recruiting||Phase 1|64|Anticipated|Boehringer Ingelheim||2|||f|||||f|f||||||||2017-10-10 21:34:32.07054|2017-10-10 21:34:32.07054
NCT02976506|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-23|||March 2014||2014-03-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Unsupervised Physical Activity in Elderly|Safety of an Unsupervised Physical Activity Program and Effects Over Blood Pressure, Physical Fitness and Quality of Life of Elderly Hypertensive Patients|Completed||N/A|60|Actual|Universidade Federal de Goias||2|||f||||t||||||||Undecided|OPEN ACCESS|2017-10-10 21:34:32.190832|2017-10-10 21:34:32.190832
NCT02976493|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-25|2017-10-03|||September 28, 2016|Actual|2016-09-28|October 2017|2017-10-01|August 19, 2019|Anticipated|2019-08-19|August 19, 2019|Anticipated|2019-08-19||Observational|||Elotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple Myeloma|Elotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple Myeloma|Recruiting||N/A|330|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:34:32.264837|2017-10-10 21:34:32.264837
NCT02976480|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-01-25|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|ION-SiLac||The Irrigation Or No Irrigation In Simple Lacerations Trials|The Irrigation Or No Irrigation In Simple Lacerations Trials|Recruiting||N/A|1000|Anticipated|Université de Sherbrooke||2|||f||||f||||||||Undecided||2017-10-10 21:34:32.397301|2017-10-10 21:34:32.397301
NCT02976454|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-04-25|||December 12, 2016|Actual|2016-12-12|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|GOTDoc||Guided Self-Help Obesity Treatment in the Doctor's Office - GOT Doc|Using a Guided Self-Help Treatment Model for Childhood Obesity Management in the Primary Care Setting|Recruiting||N/A|200|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 21:34:32.650447|2017-10-10 21:34:32.650447
NCT02976441|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-02-16|||January 2017||2017-01-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas|Feasibility of Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas|Withdrawn||Early Phase 1|0|Actual|Washington University School of Medicine||1||Physician decided not to go through with study|f||||f||||||||||2017-10-10 21:34:32.767763|2017-10-10 21:34:32.767763
NCT02976428|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-23|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Conventional vs. Sensor Guided Soft Tissue Balancing in TKA RCT|Randomized Controlled Trial of Sensor Guided Knee Balancing Compared to Standard Balancing Technique in Total Knee Arthroplasty|Not yet recruiting||Phase 4|154|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f||||||||No||2017-10-10 21:34:32.867526|2017-10-10 21:34:32.867526
NCT02976415|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CardiO Cycle||In-Bed Cycling in ICU Patients Post Cardiac Surgery|CardiO Cycle: A Pilot Safety and Feasibility Study of In-Bed Cycling in Patients Post Cardiac Surgery|Not yet recruiting||N/A|30|Anticipated|Hamilton Health Sciences Corporation||1|||f||||f||||||||No||2017-10-10 21:34:32.965103|2017-10-10 21:34:32.965103
NCT02976402|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|SHARP||Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy|Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy: a Phase I Feasibility Study|Recruiting||Phase 1|30|Anticipated|Fundacao Champalimaud||1|||f||||f||||||||||2017-10-10 21:34:33.072259|2017-10-10 21:34:33.072259
NCT02976389|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-24|||January 2017||2017-01-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|July 2019|Anticipated|2019-07-01||Interventional|SCNIP||Southern California Nutrition Incentive Program|Southern California Nutrition Incentive Program|Not yet recruiting||N/A|3780|Anticipated|University of California, San Diego||3|||f||||f||||||||Undecided|Data will be shared with USDA on a quarterly basis. Data will include number of participants recruited, amount of incentive dollars used. USDA will determine when this data will be released|2017-10-10 21:34:33.170003|2017-10-10 21:34:33.170003
NCT02976376|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-19|||May 12, 2016||2016-05-12|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|TheBox||The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients|The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients|Recruiting||N/A|200|Anticipated|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 21:34:35.00883|2017-10-10 21:34:35.00883
NCT02976363|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-23|||December 2015||2015-12-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Maximal Respiratory Pressures After Radiotherapy|Study of Maximal Respiratory Pressures After Exposure to Breast Radiotherapy in Women|Completed||N/A|16|Actual|Federal University of Mato Grosso do Sul|||2||f||||f||||||||No||2017-10-10 21:34:35.096883|2017-10-10 21:34:35.096883
NCT02976350|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2016-11-23|||January 2015||2015-01-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01|6 Months|Observational [Patient Registry]|MHDS in HFpEF||Hormone Deficiency in Heart Failure With Preserved Ejection Fraction|Multiple Hormone Deficiency Syndrome in Heart Failure With Preserved Ejection Fraction|Completed||N/A|35|Actual|Federico II University|||1||f||||t||||||Samples Without DNA|"     serum for determination of hormonal levels   "|Yes||2017-10-10 21:34:35.178835|2017-10-10 21:34:35.178835
NCT02976337|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-29|||January 2017||2017-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|TME||Effect of High-dose Naloxone Following Third Molar Extraction|Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperal-gesia in Patients Following Recovery From Impacted Mandibular Third Molar Extraction. A Randomized, Placebo-controlled, Double-blind Crossover Study.|Not yet recruiting||Phase 2|14|Anticipated|University of Copenhagen||2|||f||||f||||||||Yes|Data will be made available as a supplementum to the published scientific article. Anticipated available in Spring 2018.|2017-10-10 21:34:35.248599|2017-10-10 21:34:35.248599
NCT02976324|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-24|||November 2016||2016-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of External Diaphragmatic Pacemaker on the Patients With Chronic Cor Pulmonale|The Effect of External Diaphragmatic Pacemaker on the Patients With Chronic Cor Pulmonale|Not yet recruiting||N/A|69|Anticipated|Tongji University||2|||f||||t||||||||Undecided||2017-10-10 21:34:35.371966|2017-10-10 21:34:35.371966
NCT02976311|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-24|||April 2016||2016-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|C/S||Comparison of Inflammatory Responses Subsequent to Different Cesarean Section Techniques|Comparison of Inflammatory Reactions Following Two Different Cesarean Surgery Techniques; The Modified Misgav-Ladach Versus the Pfannenstiel-Kerr Technique|Completed||N/A|88|Actual|Kayseri Education and Research Hospital||2|||f||||t||||||||Yes|If needed|2017-10-10 21:34:35.463131|2017-10-10 21:34:35.463131
NCT02976298|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-12-06|||February 2013||2013-02-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|CERESMARCHE||Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control|Rôle du Cervelet et de l'Aire Motrice supplémentaire Dans le contrôle Postural au Cours de la Marche Chez l'Homme|Completed||Phase 1/Phase 2|20|Actual|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||f||||||||||2017-10-10 21:34:35.543208|2017-10-10 21:34:35.543208
NCT02976285|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-23|||June 2012||2012-06-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Polyester Patch in Massive Rotator Cuff Repair Improves Healing|Application of a New Polyester Patch in Arthroscopic Massive Rotator Cuff Repair Significantly Improves Clinical Outcome and Tendon Integrity|Completed||N/A|54|Actual|Etzel Clinic|||1||f||||t||||||||No||2017-10-10 21:34:35.631001|2017-10-10 21:34:35.631001
NCT02976272|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-28|||September 2016||2016-09-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|SENSIB||Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple|Assessment of Sensory Disorders Associated With Peripheral Neuropathy Induced by Bortezomib: Prospective Comparative Study|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 21:34:35.6949|2017-10-10 21:34:35.6949
NCT02976259|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-24|||December 2016||2016-12-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|DOLUPRIM||Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection|Kinetics of HIV-RNA Decay in Seminal Plasma of Men Receiving a Dolutegravir-based Regimen at the Time of Primary HIV Infection (IMEA 051-DOLUPRIM Study)|Not yet recruiting||Phase 3|20|Anticipated|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba||1|||f||||f||||||||No||2017-10-10 21:34:35.786557|2017-10-10 21:34:35.786557
NCT02976246|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|June 2019|Anticipated|2019-06-01||Interventional|RenaKvit||Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients|Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients: A Prospective, Randomized Placebo-controlled Double Blind Trial|Recruiting||Phase 2/Phase 3|140|Anticipated|Zealand University Hospital||4|||f||||f||||||||Undecided||2017-10-10 21:34:35.96988|2017-10-10 21:34:35.96988
NCT02976233|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-11-24|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01|1 Year|Observational [Patient Registry]|||Diaphragmatic Ultrasound to Predict NIV Outcome in Patients With De-novo ARF|Measuring Diaphragm Thickening Using Ultrasonography to Predict NIV Outcome in Patients With De-novo ARF Admitted to the Emergency Department|Recruiting||N/A|100|Anticipated|Policlinico Universitario Agostino Gemelli|||1||f||||f||||||||No||2017-10-10 21:34:36.108685|2017-10-10 21:34:36.108685
NCT02976220|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-10-05|||November 2016|Actual|2016-11-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|October 2017|Actual|2017-10-01||Interventional|HOPE||Health Outcomes Patient Education|Health Outcomes Patient Education|Recruiting||N/A|26|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 21:34:36.226064|2017-10-10 21:34:36.226064
NCT02976207|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-29|||January 2017||2017-01-01|November 2016|2016-11-01||||January 2020|Anticipated|2020-01-01|3 Years|Observational [Patient Registry]|OSA||Long Follow up on Patients With Obstructive Sleep Apnea That Undergo Diagnosis and Surgical Treatment||Not yet recruiting||N/A|200|Anticipated|Hillel Yaffe Medical Center|||1||f||||||||||||||2017-10-10 21:34:36.351192|2017-10-10 21:34:36.351192
NCT02976194|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|CyPov||Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy|Intraocular Cytokine Changes in Recurrence of Polypoidal Choroidal Vasculopathy|Not yet recruiting||Phase 4|28|Anticipated|Pusan National University Hospital||1|||f||||f||||||||No||2017-10-10 21:34:36.426899|2017-10-10 21:34:36.426899
NCT02976181|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-11-24|||December 2016||2016-12-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|6 Months|Observational [Patient Registry]|||Brady MX a Quality Improvement Study||Not yet recruiting||N/A|500|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-10-10 21:34:36.552269|2017-10-10 21:34:36.552269
NCT02975427|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-28|||December 2011||2011-12-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|June 2013|Actual|2013-06-01||Observational|BIA||Bioimpedance Analysis for Follow-up of Dieters|Abdominal Bioelectric Impedance for Follow-up of Dieters: A Prospective Study|Completed||N/A|103|Actual|Baskent Univesity Ankara Hospital|||1||f||||f||||||||No||2017-10-10 21:34:42.937453|2017-10-10 21:34:42.937453
NCT02976168|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-03-01|||March 2016||2016-03-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|IPCog||Intracranial Pressure and Brain Function: Effects of Head Down Tilt Upon Brain Perfusion and Cognitive Performance|Intracranial Pressure and Brain Function: Effects of Head Down Tilt Upon Brain Perfusion and Cognitive Performance|Completed||N/A|13|Actual|DLR German Aerospace Center||2|||f||||f||||||||Undecided||2017-10-10 21:34:36.62085|2017-10-10 21:34:36.62085
NCT02976155|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-29|||October 2016||2016-10-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Standardized Enteral Nutrition on Critically Ill Patients|The Effect of a Standard Enteral Nutrition Protocol on Critically Ill Patients: a Multiple-center, Prospective, Before-after Study|Recruiting||N/A|400|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||t||||||||Undecided||2017-10-10 21:34:36.726302|2017-10-10 21:34:36.726302
NCT02976142|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|November 2018|Anticipated|2018-11-01||Interventional|||The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer|Prospective Randomized Phase II Clinical Trial: the Efficacy of Surgical Treatment in Combinations With Intraperitoneal Immunotherapy and Systemic Chemotherapy in Patients With Gastric Cancer and Verified Free Cancer Cells|Not yet recruiting||Phase 2|150|Anticipated|Moscow Clinical Scientific Center||2|||f||||||||||||||2017-10-10 21:34:36.812875|2017-10-10 21:34:36.812875
NCT02976129|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-07-14|||December 2016||2016-12-01|July 2017|2017-07-01||||November 2017|Anticipated|2017-11-01||Interventional|HarbOR||A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease|Phase 2 Study to Investigate the Efficacy, Safety, and Tolerability of Six Weeks Treatment With V565 in Subjects With Active Crohn's Disease|Recruiting||Phase 2|126|Anticipated|VHsquared Ltd.||2|||f||||f||||||||||2017-10-10 21:34:36.90591|2017-10-10 21:34:36.90591
NCT02976116|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer|Fruquintinib in Combination With Gefitinib as First-line Therapy in Patients With Advanced Non-squamous Non-small-cell Lung Cancer Harboring Activating EGFR Mutations : a Single-arm, Multicenter, Phase II Study|Recruiting||Phase 2|20|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||No||2017-10-10 21:34:37.098723|2017-10-10 21:34:37.098723
NCT02976103|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-10-02|||March 7, 2017|Actual|2017-03-07|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket|Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket: Randomized Trial|Recruiting||Phase 3|130|Anticipated|Dana-Farber Cancer Institute||2|||||||f|f|t|f|||||||2017-10-10 21:34:37.192847|2017-10-10 21:34:37.192847
NCT02976090|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-02|||January 2017|Actual|2017-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|BIONADEGE||Phenotyping of Small Bowel Adenocarcinoma|Phenotyping of Small Bowel Adenocarcinoma|Active, not recruiting||N/A|187|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Tumour block   "|No||2017-10-10 21:34:37.297491|2017-10-10 21:34:37.297491
NCT02976077|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-17|||December 2016||2016-12-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|RC2S+||RC2S+: Remediation of Social Cognitive Impairments|Preliminary Validation of the RC2S+ Therapy in Schizophrenia|Active, not recruiting||N/A|58|Actual|Hôpital le Vinatier||2|||f||||||||||||||2017-10-10 21:34:37.35693|2017-10-10 21:34:37.35693
NCT02976064|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-24|||January 2017||2017-01-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|January 2019|Anticipated|2019-01-01||Interventional|NEXTCARE-PA||Implementation of Collaborative Self-management Services to Promote Physical Activity|Protocol for Implementation of Collaborative Self-management Services to Promote Physical Activity|Not yet recruiting||N/A|2300|Anticipated|Hospital Clinic of Barcelona||6|||f||||f||||||||Undecided||2017-10-10 21:34:37.44109|2017-10-10 21:34:37.44109
NCT02976051|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-07-26|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC|DAHANCA 33: Functional Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 2|60|Anticipated|Danish Head and Neck Cancer Group||1|||f||||f||||||||||2017-10-10 21:34:37.525905|2017-10-10 21:34:37.525905
NCT02976038|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-03-01|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Disease (PMD)|A Multicenter, Open-Label Phase 2 Extension Trial to Characterize the Long-term Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Disease (PMD)|Enrolling by invitation||Phase 2|36|Anticipated|Stealth BioTherapeutics Inc.||1|||f||||f||||||||No||2017-10-10 21:34:37.725411|2017-10-10 21:34:37.725411
NCT02976025|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||January 2017||2017-01-01|November 2016|2016-11-01|March 2021|Anticipated|2021-03-01|June 2020|Anticipated|2020-06-01||Interventional|MInD-I||Remote Supervision for Implementing Collaborative Care for Perinatal Depression|Remote Supervision for Implementing Collaborative Care for Perinatal Depression|Not yet recruiting||N/A|20|Anticipated|University of Washington||2|||f||||t||||||||Yes|We intend to share de-identified data once study is complete.|2017-10-10 21:34:37.818935|2017-10-10 21:34:37.818935
NCT02976012|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-11-23|||June 2016||2016-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|LASERLESS||Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH|Endolaserless Vitrectomy With Intravitreal Aflibercept Injection for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage (LASER LESS TRIAL)|Recruiting||Phase 1/Phase 2|24|Anticipated|Southeast Retina Center, Georgia||2|||f||||f||||||||Undecided||2017-10-10 21:34:37.905414|2017-10-10 21:34:37.905414
NCT02975999|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-04-02|||December 2016||2016-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of Vasopressin Following the Fontan Operation|Use of Vasopressin Following the Fontan Operation: Both Pilot and Multicenter Studies|Recruiting||Phase 2/Phase 3|84|Anticipated|Advocate Health Care||2|||f||||t||||||||No||2017-10-10 21:34:38.023071|2017-10-10 21:34:38.023071
NCT02975986|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||January 2017||2017-01-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|September 2020|Anticipated|2020-09-01||Interventional|IUAN||Renal Uptake of Fatty Acids (FFA) in Patients With Idiopathic Uric Acid Nephrolithiasis (IUAN)|Renal Uptake of Fatty Acids (FFA) in Patients With Idiopathic Uric Acid Nephrolithiasis (IUAN)|Not yet recruiting||N/A|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||No||2017-10-10 21:34:38.141281|2017-10-10 21:34:38.141281
NCT02975973|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia|Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center, Houston||4|||f||||t||||||||Yes|Data will be open to sharing after primary findings of study have been published|2017-10-10 21:34:38.245255|2017-10-10 21:34:38.245255
NCT02975960|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-23|||October 2016||2016-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|||ADMSCs for the Treatment of Systemic Sclerosis|Adipose Tissue-derived Mesenchymal Stem Cells for Cell-based Therapy in the Treatment of Systemic Sclerosis|Recruiting||N/A|12|Anticipated|The Catholic University of Korea||1|||f||||t||||||||No||2017-10-10 21:34:38.364056|2017-10-10 21:34:38.364056
NCT02975947|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-23|||August 2013||2013-08-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Warmed Humidified CO2 on Peritoneum During Laparotomy|Effect of Intraoperative Humidified CO2 Insufflation in Open Laparotomy Colorectal Surgery Patients: a Randomized Controlled Trial|Completed||N/A|40|Actual|Concord Repatriation General Hospital||2|||f||||f||||||||No||2017-10-10 21:34:38.498649|2017-10-10 21:34:38.498649
NCT02975934|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2017-09-12|||January 2017||2017-01-01|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|February 2022|Anticipated|2022-02-01||Interventional|TRITON3||A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency|TRITON3: A Multicenter, Randomized, Open Label Phase 3 Study of Rucaparib Versus Physician's Choice of Therapy for Patients With Metastatic Castration Resistant Prostate Cancer Associated With Homologous Recombination Deficiency|Recruiting||Phase 3|400|Anticipated|Clovis Oncology, Inc.||2|||f||||t||||||||||2017-10-10 21:34:38.636381|2017-10-10 21:34:38.636381
NCT02975921|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-06-27|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Betadine Pleurodesis Via Tunneled Pleural Catheters|Efficacy of Povidone-Iodine Instillation Via Tunneled Pleural Catheters in Achieving Pleurodesis: A Randomized Controlled Trial|Not yet recruiting||Phase 4|150|Anticipated|Yale University||4|||f||||f|t|f||||||No||2017-10-10 21:34:38.820175|2017-10-10 21:34:38.820175
NCT02975908|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-11-23|||August 2015||2015-08-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Observational|CHARDSnet||A Realworld Study of Acute Respiratory Distress Syndrome in China|A Realworld Study of Acute Respiratory Distress Syndrome in China|Recruiting||N/A|400|Anticipated|China-Japan Friendship Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:34:38.951246|2017-10-10 21:34:38.951246
NCT02975895|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-05-23|||December 2016||2016-12-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Outcome of Different IOLs in Patients With and Without Uveitis|Outcome With Hydrophobic and Hydrophilic Intraocular Lens in Patients With and Without Uveitis|Recruiting||N/A|300|Anticipated|Vastra Gotaland Region||2|||f||||f||||||||Undecided||2017-10-10 21:34:39.072805|2017-10-10 21:34:39.072805
NCT02975882|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-10-02|||July 24, 2017|Actual|2017-07-24|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors|A Phase 1 Study of ABI-009 (NAB-RAPAMYCIN) in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors as a Single Agent and in Combination With Temozolomide and Irinotecan|Recruiting||Phase 1|51|Anticipated|Children's Oncology Group||1|||f||||f|t|f||||||||2017-10-10 21:34:39.206241|2017-10-10 21:34:39.206241
NCT02975869|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-08-12|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia|Randomized Trial of a Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia|Recruiting||N/A|160|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 21:34:39.346715|2017-10-10 21:34:39.346715
NCT02975856|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||December 2015||2015-12-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|||Bioavailability of Red Wine Anthocyanins|Bioavailability of Table Red Wine and Young Port Red Wine Anthocyanins|Completed||Phase 1|6|Actual|Universidade do Porto||2|||f||||||||||||||2017-10-10 21:34:39.466726|2017-10-10 21:34:39.466726
NCT02975843|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-06-22|||November 21, 2016|Actual|2016-11-21|June 2017|2017-06-01|April 11, 2017|Actual|2017-04-11|March 21, 2017|Actual|2017-03-21||Interventional|||Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients|Open Label, Uncontrolled, Non-randomized, Single Dose, Scintigraphic Study to Investigate Lung Deposition of Inhaled 99mTc Radiolabelled CHF5993 pMDI in Healthy Volunteers, Asthmatic and COPD Patients|Completed||Phase 1|28|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-10 21:34:39.540336|2017-10-10 21:34:39.540336
NCT02975830|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-01-01|||March 2016||2016-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Tracheobronchial Angle in Children - Three-dimensional Computed Tomography Based Measurements|Tracheobronchial Angle in Children - Three-dimensional Computed Tomography Based Measurements|Completed||N/A|270|Actual|King Fahad Medical City|||4||f||||f||||||||No||2017-10-10 21:34:39.605522|2017-10-10 21:34:39.605522
NCT02975817|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-05-15|||June 2016||2016-06-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Preventing Inadvertent Hypothermia in Paediatric Neurosurgery in Malawi|Preventing Inadvertent Hypothermia in Children Undergoing Elective Neurosurgery in Malawi - a Prospective Randomized Clinical Trial|Recruiting||N/A|80|Anticipated|Oslo University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:34:39.667821|2017-10-10 21:34:39.667821
NCT02974452|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-22|||January 2014||2014-01-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Observational|SEMG||Age-related Changes of Shoulder Muscles|Age-related Changes in Activation Patterns of Shoulder Muscles|Completed||N/A|60|Actual|University of Alcala|||3||f||||t||||||||No||2017-10-10 21:34:55.061531|2017-10-10 21:34:55.061531
NCT02975791|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Ultrasonography Versus Palpation for Identification of the Cricothyroid Membrane|Ultrasonography Versus Palpation for Identification of the Cricothyroid Membrane|Not yet recruiting||N/A|40|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||No||2017-10-10 21:34:39.876305|2017-10-10 21:34:39.876305
NCT02975778|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|DOLOAGE||Prediction of Pain During Old People Care Measured by Skin Conductance|Prediction of Pain During Old People Care Measured by Skin Conductance|Not yet recruiting||N/A|120|Anticipated|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:34:39.958864|2017-10-10 21:34:39.958864
NCT02975765|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-07-26|||March 2016||2016-03-01|July 2017|2017-07-01|April 23, 2017|Actual|2017-04-23|December 12, 2016|Actual|2016-12-12||Interventional|||Evaluation of the Levels of Pain and Discomfort Between Two Methods of Correcting Misaligned Teeth|Evaluation of the Levels of Pain and Discomfort Between Piezosurgery-assisted Corticotomy Versus Traditional Method of Aligning Crowded Lower Anterior Teeth: a Randomized Controlled Trial|Completed||N/A|36|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 21:34:40.047133|2017-10-10 21:34:40.047133
NCT02975752|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||March 2015||2015-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Observational|EGFRdelEx19||EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA|Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lymph Node Metastases From Patients With Lung Adenocarcinoma|Completed||N/A|48|Actual|University Hospital, Essen|||1||f||||f||||||Samples With DNA|"     EBUS-TBNA specimen of lymph nodes and primary tumor   "|No||2017-10-10 21:34:40.128702|2017-10-10 21:34:40.128702
NCT02975739|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-23|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HIT||Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors|Feasibility of Holmium-166 Microspheres for Selective Intra-tumoural Treatment in Head and Neck Cancer: Biodistribution and Safety in Patients With Malignancy of the Tongue|Recruiting||Early Phase 1|10|Anticipated|UMC Utrecht||1|||f||||t||||||||Undecided||2017-10-10 21:34:40.192903|2017-10-10 21:34:40.192903
NCT02975726|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-26|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites|Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites Management: A Randomized Un-Blinded Pilot Study|Recruiting||N/A|50|Anticipated|University of Manitoba||2|||f||||t||||||||Undecided||2017-10-10 21:34:40.446646|2017-10-10 21:34:40.446646
NCT02975713|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-07-17|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Observational|||Progesterone Diurnal Rhythm During Ovarian Stimulation for IVF|Progesterone Diurnal Rhythm During Ovarian Stimulation for IVF|Not yet recruiting||N/A|12|Anticipated|IVI Middle East Fertility Clinic|||1||f||||f||||||Samples Without DNA|"     blood samples extracted from the vein   "|||2017-10-10 21:34:40.623395|2017-10-10 21:34:40.623395
NCT02975687|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Interventional|||CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia|CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia|Recruiting||Phase 1|20|Anticipated|Institute of Hematology & Blood Diseases Hospital||1|||f||||||||||||||2017-10-10 21:34:40.926175|2017-10-10 21:34:40.926175
NCT02975674|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|213CEIH2016||Evaluation of MT-12 Implant Survival and Marginal Bone Loss|Evaluation of MT-12 Implant Survival and Marginal Bone Loss|Recruiting||N/A|30|Anticipated|Universidad de Granada||2|||f||||f||||||||||2017-10-10 21:34:41.030183|2017-10-10 21:34:41.030183
NCT02975661|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-24|||November 2016||2016-11-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|November 2019|Anticipated|2019-11-01|2 Years|Observational [Patient Registry]|||Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery|Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery|Not yet recruiting||N/A|840|Anticipated|Qidong Gaitianli Medicines Co., Ltd|||4||f||||t||||||||||2017-10-10 21:34:41.123723|2017-10-10 21:34:41.123723
NCT02975648|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-28|||January 2017||2017-01-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Education Model for Cardiac Patients|Effect of an Educational Model With Telephone Booster in the Performance of Physical Activity in Individuals Submitted to Percutaneous Coronary Intervention: Randomized Controlled Trial|Not yet recruiting||N/A|156|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 21:34:41.189167|2017-10-10 21:34:41.189167
NCT02975635|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-03-31|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Patients' Preferences for Repair Versus Replacement Restorations|Patients' Preferences for Repair Versus Replacement Restorations|Enrolling by invitation||N/A|100|Anticipated|University of Göttingen|||2||f||||f|f|f||||||No||2017-10-10 21:34:41.285446|2017-10-10 21:34:41.285446
NCT02975622|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||August 2016||2016-08-01|November 2016|2016-11-01||||December 2020|Anticipated|2020-12-01||Interventional|USCATH||Immediate Complications According to Ultrasound-guided Central Venous Catheters Insertion Site: a Non-inferiority Randomized Clinical Trial|Immediate Complications According to Ultrasound-guided Central Venous Catheters Insertion Site: a Non-inferiority Randomized Clinical Trial Comparing Jugular and Subclavian Approaches|Recruiting||N/A|1600|Anticipated|Hospital Nossa Senhora da Conceicao||2|||f||||||||||||||2017-10-10 21:34:41.378173|2017-10-10 21:34:41.378173
NCT02975609|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-11-24|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer|Phase II Trial of Stereotactic Body Radiation Therapy Compared With Conventional Fractionated Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer|Not yet recruiting||Phase 2|100|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||No||2017-10-10 21:34:41.455694|2017-10-10 21:34:41.455694
NCT02975596|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-22|||December 2016||2016-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|MenBVaccine||MenB Vaccine: Implementation Via Information, Empowerment and Accessibility|Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal (MenB) Disease Recommendations in Older Adolescents and Young Adults.|Recruiting||N/A|84|Anticipated|University of Florida|||3||f||||f|f|f||||||||2017-10-10 21:34:41.554661|2017-10-10 21:34:41.554661
NCT02975583|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Vorapaxar and Lower Extremity Bypass Grafts|A Double-blind, Randomized, Parallel Design Two Center Study to Compare the Effect of Vorapaxar vs. Placebo on Lower Extremity Vein Graft Maturation, Remodeling, and Function|Not yet recruiting||Phase 4|100|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f|||f|||||2017-10-10 21:34:41.738896|2017-10-10 21:34:41.738896
NCT02975570|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-07|||August 2017|Anticipated|2017-08-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|DAZZLE||Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin|Prospective, Randomized, Open Label Phase 3 Study of the Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin for Treatment of Patients With Fluoroquinolone-susceptible Multidrugresistant-‐Tuberculosis (MDR-TB)|Withdrawn||Phase 3|0|Actual|Boston University||6||The study could not be conducted since funding was not obtained.|f||||t|t|f|||t|||||2017-10-10 21:34:41.834772|2017-10-10 21:34:41.834772
NCT02975557|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-08-31|||May 2016||2016-05-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)|A Phase I/II Randomized, Placebo-Controlled, Double-Blind, Single-Center, Tolerability And Preliminary Efficacy Study Of Use of Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)|Terminated||Phase 1/Phase 2|15|Actual|University of Illinois at Chicago||3||Slow accrual of subjects. May take longer than expected to complete the trial.|f||||f||||||||||2017-10-10 21:34:41.957405|2017-10-10 21:34:41.957405
NCT02975544|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-28|||March 2015||2015-03-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|April 2015|Actual|2015-04-01||Interventional|CRECES||An Exploratory Trial of a Health Education Programme Based on the Social and Emotional Competence in Children|Pilot Study of CRECES Programme: Promoting Healthy Life Styles in Children Through the Social and Emotional Competence|Completed||N/A|37|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||f||||||||No||2017-10-10 21:34:42.077985|2017-10-10 21:34:42.077985
NCT02975531|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-11-28|||February 2008||2008-02-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|April 2008|Actual|2008-04-01||Interventional|||Simulator of Pompage Technique for Physiotherapists|Simulator of Pompage Technique for Education and Training of Physiotherapists|Completed||N/A|72|Actual|University of Mogi das Cruzes||5|||f||||t||||||||Yes||2017-10-10 21:34:42.163943|2017-10-10 21:34:42.163943
NCT02975518|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||December 2015||2015-12-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Tracking Endothelial Cells in Arterial Injury||Recruiting||N/A|36|Anticipated|University of Edinburgh||4|||f||||f||||||||||2017-10-10 21:34:42.261483|2017-10-10 21:34:42.261483
NCT02975505|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-16|||February 10, 2017|Actual|2017-02-10|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|PERFORMANCE||Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD|Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD|Recruiting||Phase 2|60|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||No||2017-10-10 21:34:42.358491|2017-10-10 21:34:42.358491
NCT02975492|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-28|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|DonneDVit||Assessing the Impact of a Mode of Vitamin D Supplementation (Sequential Dose vs Daily Dose) on the Incidence of Hypercalciuria in Children Aged From 2 to 6 Years||Not yet recruiting||N/A|280|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:34:42.443735|2017-10-10 21:34:42.443735
NCT02975479|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2016-12-12|||May 2016||2016-05-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Intralymphatic Immunotherapy in Increasing Doses, Substudy|Intralymphatic Immunotherapy in Increasing Doses up to 10 000 SQ-U - a Human Randomized Clinical Trial. Substudy.|Active, not recruiting||Phase 2/Phase 3|40|Anticipated|Karolinska Institutet||2|||f||||t||||||||Undecided||2017-10-10 21:34:42.542893|2017-10-10 21:34:42.542893
NCT02975466|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-01|||January 2017||2017-01-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparing the Efficiency of Three Third-generation Supraglottic Airways as an Intubation Route|Randomized Controlled Trial Comparing the Efficiency of Three Third Generation Supraglottic Airways as an Intubation Route|Not yet recruiting||N/A|135|Anticipated|Université de Sherbrooke||3|||f||||f||||||||No||2017-10-10 21:34:42.645452|2017-10-10 21:34:42.645452
NCT02975453|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-26|||December 5, 2016|Actual|2016-12-05|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|December 15, 2019|Anticipated|2019-12-15||Observational|EMIR||Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban|Study of Risk Factors of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With a Direct Oral Anticoagulant (Rivaroxaban)|Active, not recruiting||N/A|1503|Actual|Bayer|||1||f||||f||||||||||2017-10-10 21:34:42.738563|2017-10-10 21:34:42.738563
NCT02975440|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-06-30|||November 10, 2016|Actual|2016-11-10|June 2017|2017-06-01|April 11, 2017|Actual|2017-04-11|January 27, 2017|Actual|2017-01-27||Interventional|||Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan|Non-randomized, Non-blinded, Non-placebo-controlled Study to Investigate the Influence of Repeated Daily Administration of 600 mg Rifampicin Given Once Daily Over 11 Days on the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of 4 mg Vilaprisan in Healthy Postmenopausal Women.|Completed||Phase 1|12|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 21:34:42.834493|2017-10-10 21:34:42.834493
NCT02975414|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-23|||September 2016||2016-09-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|Robust_2||Robotic Utility for Surgical Treatment of Umbilical Hernias|Prospective Observational Cohort Study of Robot-assisted Laparoscopic Hernia Umbilical Hernia Repair (rTARUP)|Recruiting||N/A|40|Anticipated|Algemeen Ziekenhuis Maria Middelares|||1||f||||f||||||||No||2017-10-10 21:34:43.021017|2017-10-10 21:34:43.021017
NCT02975401|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-24|||September 2016||2016-09-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|Robust _1||Robotic Utility for Surgical Treatment of Groin Hernias|Prospective Observational Cohort Study on Robot-assisted Laparoscopic Hernia Repair (rTAPP)|Completed||N/A|50|Actual|Algemeen Ziekenhuis Maria Middelares|||1||f||||f||||||||||2017-10-10 21:34:43.114826|2017-10-10 21:34:43.114826
NCT02975388|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-24|2017-09-25|||December 13, 2016|Actual|2016-12-13|September 2017|2017-09-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Interventional|||A Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics (PK) of RO7079901|A Multi-Center, Open-Label, Two-Part Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics of RO7079901|Completed||Phase 1|15|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-10-10 21:34:43.189071|2017-10-10 21:34:43.189071
NCT02975375|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-06|||April 2002||2002-04-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|March 2014|Actual|2014-03-01||Observational|||The Impact of Perioperative Geriatric Care on Outcomes After Elective Noncardiac Surgery|The Impact of Perioperative Geriatric Care on Outcomes After Elective Noncardiac Surgery|Completed||N/A|200000|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||||No||2017-10-10 21:34:43.300465|2017-10-10 21:34:43.300465
NCT02975362|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-06-21|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Acupuncture Treatment on Motor Dysfunction in Stroke Patients|Standardized Treatment of Acupuncture on Motor Dysfunction in Stroke Patients: a Multi-center Randomized Controlled Trial|Recruiting||N/A|240|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:34:43.392006|2017-10-10 21:34:43.392006
NCT02975349|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-25|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|February 27, 2019|Anticipated|2019-02-27|February 27, 2019|Anticipated|2019-02-27||Interventional|||A Study of Efficacy and Safety of M2951 in Subjects With Relapsing Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled Phase II Study of M2951 With a Parallel, Open-Label, Active Control Group (Tecfidera), in Patients With Relapsing Multiple Sclerosis to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Biological Activity.|Active, not recruiting||Phase 2|267|Actual|EMD Serono||5|||f||||t|t|f||||||||2017-10-10 21:34:43.510353|2017-10-10 21:34:43.510353
NCT02975336|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-10-05|||January 4, 2017|Actual|2017-01-04|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)|A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With Systemic Lupus Erythematosus (SLE)|Recruiting||Phase 2|451|Anticipated|EMD Serono||4|||f||||t||||||||||2017-10-10 21:34:43.72082|2017-10-10 21:34:43.72082
NCT02975323|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-02|||December 2014||2014-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|DPH||Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension|Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension (DPH Trial)|Recruiting||Phase 3|50|Anticipated|Aga Khan University||1|||f||||t||||||||No||2017-10-10 21:34:44.222548|2017-10-10 21:34:44.222548
NCT02975310|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-09-20|||April 11, 2017|Actual|2017-04-11|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|||In-clinic Endoscopic Polypectomy for Chronic Sinusitis With Nasal Polyps|Endoscopic Polypectomy Performed In Clinic for Chronic Rhinosinusitis With Polyps: The EPIC Randomised Controlled Trial|Recruiting||N/A|140|Anticipated|Ottawa Hospital Research Institute||2|||f||||t|f|f||||||||2017-10-10 21:34:44.32227|2017-10-10 21:34:44.32227
NCT02975297|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-23|||July 2016||2016-07-01|November 2016|2016-11-01||||June 2019|Anticipated|2019-06-01||Interventional|||Exenatide Once Weekly for Smoking Cessation|Exenatide Once Weekly for Smoking Cessation: A Randomized Clinical Trial|Recruiting||Phase 1/Phase 2|90|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 21:34:44.456134|2017-10-10 21:34:44.456134
NCT02975284|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-23|||August 2015||2015-08-01|November 2016|2016-11-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01||Observational|||Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study|TASMA Extension Study: Long Term Efficacy and Safety of Bronchial Thermoplasty in Severe|Recruiting||N/A|40|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     Two years after BT blood DNA/RNA will be retained   "|Undecided||2017-10-10 21:34:44.611518|2017-10-10 21:34:44.611518
NCT02975271|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-06-07|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|AUBURN||Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury|Terminated||Phase 2|1|Actual|Menlo Therapeutics Inc.||2||Business Reasons|f||||||||||||||2017-10-10 21:34:44.714073|2017-10-10 21:34:44.714073
NCT02975245|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-19|||February 2013||2013-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Short Term Genetic Effects of Chemotherapy on Male Germ Cells|Short Term Genetic Effects of Chemotherapy on Male Germ Cells|Recruiting||N/A|200|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Semen sample   "|||2017-10-10 21:34:45.083|2017-10-10 21:34:45.083
NCT02968342|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-06|||July 2016||2016-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women|Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women|Recruiting||Phase 4|30|Anticipated|Bezmialem Vakif University||2|||f||||t||||||||Undecided||2017-10-10 21:35:53.264268|2017-10-10 21:35:53.264268
NCT02975232|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-28|||April 2016||2016-04-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Supermarket Science: Multipronged Approaches to Increasing Fresh, Frozen and Canned Fruit and Vegetable Purchases|Supermarket Science: Multipronged Approaches to Increasing Fresh, Frozen and Canned Fruit and Vegetable Purchases|Active, not recruiting||N/A|605|Actual|University of New England||2|||f||||f||||||||No||2017-10-10 21:34:45.183342|2017-10-10 21:34:45.183342
NCT02975219|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-06-26|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|Endo-light||Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis|Determine the Feasibility of Detecting Endometriosis During Surgery Using a Molecular Targeted Fluorescent Imaging Tracer|Recruiting||Phase 1|10|Anticipated|University Medical Center Groningen||1|||f||||f|f|f||||||||2017-10-10 21:34:45.263444|2017-10-10 21:34:45.263444
NCT02975206|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-22|||November 2016|Actual|2016-11-01|May 2017|2017-05-01||||June 2018|Anticipated|2018-06-01||Interventional|ATOMIK||Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis|A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis|Recruiting||Phase 2|450|Anticipated|Menlo Therapeutics Inc.||3|||f||||t||||||||||2017-10-10 21:34:45.362638|2017-10-10 21:34:45.362638
NCT02975193|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-02-01|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Neural Correlates of Cognition in Parkinson's Disease|Neural Correlates of Cognition in Parkinson's Disease|Recruiting||N/A|200|Anticipated|University of Florida||2|||f||||f|f|f||||||Yes|IPD will be shared only to investigators. It will be deidentified and only accessible through secure, password-protected, encrypted hard drives.|2017-10-10 21:34:45.768129|2017-10-10 21:34:45.768129
NCT02975180|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-22|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||FES in Young Children With Perinatal Stroke|Functional Electrical Stimulation to Improve Upper Extremity Function in Young Children With Perinatal Stroke: A Proof of Concept Study|Not yet recruiting||N/A|24|Anticipated|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 21:34:45.936376|2017-10-10 21:34:45.936376
NCT02975167|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor|Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor|Recruiting||N/A|160|Anticipated|MemorialCare Health System||2|||f||||f||||||||No||2017-10-10 21:34:46.053275|2017-10-10 21:34:46.053275
NCT02975141|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-29|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AFFECT||Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer|Gemcitabine and Nab-Paclitaxel Combined With the Oral Irreversible ErbB Family Blocker Afatinib in Patients With Metastatic Pancreatic Cancer: A Phase Ib Trial|Recruiting||Phase 1|18|Anticipated|Ludwig-Maximilians - University of Munich||4|||f||||t||||||||No||2017-10-10 21:34:46.330134|2017-10-10 21:34:46.330134
NCT02975128|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-12-02|||January 2017||2017-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|BLES||Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance|Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance|Not yet recruiting||N/A|125|Anticipated|Radboud University||1|||f||||f||||||||||2017-10-10 21:34:46.48466|2017-10-10 21:34:46.48466
NCT02975115|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-23|||November 2013||2013-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|November 2016|Actual|2016-11-01||Observational|||Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization|The Catholic University of Korea Cancer Research Institute|Active, not recruiting||N/A|102|Actual|Seoul St. Mary's Hospital|||1||f||||t||||||Samples Without DNA|"     Rest of RNA samples after Q-RT-PCR analysis   "|No||2017-10-10 21:34:46.593742|2017-10-10 21:34:46.593742
NCT02975102|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-06-20|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye|A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye|Recruiting||N/A|84|Anticipated|Laboratoire Chauvin||2|||f||||f|f|f||||||No||2017-10-10 21:34:47.173438|2017-10-10 21:34:47.173438
NCT02975076|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-22|||December 2016||2016-12-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study|Radix/Rhizoma Notoginseng Extract (Sanchitongtshu) Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Placebo-controlled Study|Not yet recruiting||N/A|120|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||Yes||2017-10-10 21:34:47.37976|2017-10-10 21:34:47.37976
NCT02975063|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-12-07|||January 2017||2017-01-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|November 2018|Anticipated|2018-11-01||Interventional|||Alive & Thrive Nigeria Impact Evaluation|Alive & Thrive Nigeria Impact Evaluation|Not yet recruiting||N/A|11742|Anticipated|RTI International||3|||f||||f||||||||||2017-10-10 21:34:47.489375|2017-10-10 21:34:47.489375
NCT02975050|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-23|||November 2016||2016-11-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Observational|ViVUS||Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)|Vital Signs Validation Study of the μ-Cor System (ViVUS Validation)|Not yet recruiting||N/A|30|Anticipated|Kyma Medical Technologies|||2||f||||f||||||||No||2017-10-10 21:34:47.57343|2017-10-10 21:34:47.57343
NCT02975037|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-22|||December 2016||2016-12-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Evaluation of Metabolic Markers for the Prediction of DDI of Various CYP3A Substrates and Inhibitors|Evaluation and Validation of Metabolic Markers for the Prediction of Drug-drug Interaction of Various CYP3A4 Substrates and Inhibitors in Healthy Male Subjects|Not yet recruiting||Phase 4|32|Anticipated|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:34:47.67443|2017-10-10 21:34:47.67443
NCT02975011|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-11|||March 4, 2017|Actual|2017-03-04|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Effectiveness and Safety of Korean Medicine for Lumbar Stenosis Patients With Sciatica|Observational Study on the Effectiveness and Safety of Integrative Korean Medicine Treatment for Patients With Sciatica Due to Lumbar Stenosis: Multicenter, Prospective, Single Group Observational Study|Recruiting||N/A|120|Anticipated|Jaseng Medical Foundation|||1||f||||f||||||||||2017-10-10 21:34:47.893499|2017-10-10 21:34:47.893499
NCT02974998|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Expanding HIV Testing and Prevention to Reach Vulnerable Young Women|Expanding HIV Testing and Prevention to Reach Vulnerable Young Women|Recruiting||Phase 2|500|Anticipated|RTI International||2|||f||||t||||||||||2017-10-10 21:34:48.039312|2017-10-10 21:34:48.039312
NCT02974985|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-12-13|||April 2016||2016-04-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study of the Lifting Capacity of Fillers|A Study of the Lifting Capacity of Fillers|Recruiting||N/A|20|Anticipated|Abington Memorial Hospital||2|||f||||t||||||||||2017-10-10 21:34:48.129431|2017-10-10 21:34:48.129431
NCT02974972|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-08-23|||August 2014||2014-08-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|PM2||Pith Moromo 2: Cohort to Study Health Consequences of Food and Nutrition Insecurity During Pregnancy and Lactation||Completed||N/A|371|Actual|Northwestern University|||1||f||||f|f|f||||||||2017-10-10 21:34:48.224313|2017-10-10 21:34:48.224313
NCT02974959|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-07-20|||October 2016||2016-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Vagus Nerve Stimulation to Treat Moderate Traumatic Brain Injury|Vagus Nerve Stimulation to Treat Mild To Moderate Traumatic Brain Injury|Recruiting||Phase 1|30|Anticipated|Minneapolis Medical Research Foundation||2|||f||||t||||||||||2017-10-10 21:34:48.28965|2017-10-10 21:34:48.28965
NCT02974946|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||January 2017||2017-01-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|KIDNEY||Kidney Protection Using the RenalGuard® System in Cardiac Surgery|Kidney Protection Using the RenalGuard® System in Cardiac Surgery|Not yet recruiting||N/A|220|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||2|||f||||t||||||||||2017-10-10 21:34:48.377689|2017-10-10 21:34:48.377689
NCT02974933|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-02-15|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer|Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer ：Single Arm Exploratory Study|Recruiting||Phase 2|48|Anticipated|Hubei Cancer Hospital||1|||f||||t|f|f||||||No||2017-10-10 21:34:48.449199|2017-10-10 21:34:48.449199
NCT02974920|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-01-19|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|November 2022|Anticipated|2022-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Rivaroxaban or Aspirin for Biological Aortic Prosthesis|Randomized Trial of Aspirin Versus Rivaroxaban After Replacement of the Aortic Valve With a Biological Valve Prosthesis|Recruiting||Phase 4|1000|Anticipated|Aalborg Universitetshospital||2|||f||||t||||||||Undecided||2017-10-10 21:34:48.545157|2017-10-10 21:34:48.545157
NCT02974907|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-22|||November 2016||2016-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2|A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of RGN-259 Ophthalmic Solutions for the Treatment of Dry Eye : ARISE-2|Active, not recruiting||Phase 3|500|Anticipated|ReGenTree, LLC||2|||f||||f||||||||||2017-10-10 21:34:48.642179|2017-10-10 21:34:48.642179
NCT02974894|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-30|||February 2013||2013-02-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||The Effects of Lactobacillus Plantarum on Cortisol, IgA and Alpha-amylase Levels in Human Saliva During Stress|The Effects of Lactobacillus Plantarum on Cortisol, IgA and Alpha-amylase Levels in Human Saliva During Stress|Completed||N/A|42|Actual|Lund University||2|||f||||f||||||||No||2017-10-10 21:34:48.938559|2017-10-10 21:34:48.938559
NCT02974881|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-08-28|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|July 2018|Anticipated|2018-07-01||Interventional|||HighLife™ Transcatheter Mitral Valve Replacement System Study|HighLife™ Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk|Recruiting||N/A|20|Anticipated|HighLife SAS||1|||f||||t|f|f||||||||2017-10-10 21:34:49.062543|2017-10-10 21:34:49.062543
NCT02974868|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-10-04|||December 15, 2016|Actual|2016-12-15|October 2017|2017-10-01|May 12, 2019|Anticipated|2019-05-12|May 12, 2019|Anticipated|2019-05-12||Interventional|||Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata|A Phase 2a Randomized, Double-blind, Placebo-controlled, Multicenter Study With An Extension Period To Evaluate The Efficacy And Safety Profile Of Pf-06651600 And Pf-06700841 In Subjects With Moderate To Severe Alopecia Areata|Recruiting||Phase 2|132|Anticipated|Pfizer||3|||f||||t|t|f||||||||2017-10-10 21:34:49.270334|2017-10-10 21:34:49.270334
NCT02974855|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-27|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|November 25, 2018|Anticipated|2018-11-25|November 25, 2018|Anticipated|2018-11-25||Interventional|||PF-06741086 Multiple Dose Study in Severe Hemophilia|A Multicenter, Open-label, Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of Subcutaneous And/or Intravenous Pf-06741086 In Subjects With Severe Hemophilia|Recruiting||Phase 2|24|Anticipated|Pfizer||4|||f||||f|t|f||||||||2017-10-10 21:34:49.609331|2017-10-10 21:34:49.609331
NCT02974842|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-13|||November 2, 2016|Actual|2016-11-02|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|||Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device Performance|Cytological Evaluation of Specimens Collected With the MAKO 7 Device in Pre Salpingo-Oophorectomy Subjects for Determination and/or Differentiation of Normal Versus Atypical Versus Malignant Cells|Active, not recruiting||N/A|50|Anticipated|nVision Medical|||1||f||||f||||||Samples Without DNA|"     Cell samples   "|||2017-10-10 21:34:49.782264|2017-10-10 21:34:49.782264
NCT02974829|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||May 2016||2016-05-01|November 2016|2016-11-01||||January 2022|Anticipated|2022-01-01||Observational|||REALM China Extension Study|A 5-Year Follow-up Study of Subjects Who Completed REALM-China Study|Recruiting||N/A|4000|Anticipated|Nanfang Hospital of Southern Medical University|||1||f||||t||||||||Undecided||2017-10-10 21:34:49.890304|2017-10-10 21:34:49.890304
NCT02974816|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-06-21|||May 15, 2017|Actual|2017-05-15|June 2017|2017-06-01|November 15, 2018|Anticipated|2018-11-15|November 15, 2018|Anticipated|2018-11-15||Interventional|||Glooko mHealth Advantage Study|The Glooko Diabetes Mobile Monitoring and Management Advantage Study|Recruiting||N/A|260|Anticipated|Glooko||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:34:50.191537|2017-10-10 21:34:50.191537
NCT02974790|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Observational|ECHOBEDSIDE||Diagnostic Performance of Echocardiography Performed by Emergency Physicians After a Basic Training|Diagnostic Performance of Echocardiography Performed by Emergency Physicians After a Basic Training|Recruiting||N/A|240|Anticipated|University Hospital, Limoges|||1||f||||f||||||||No||2017-10-10 21:34:50.421401|2017-10-10 21:34:50.421401
NCT02974777|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-25|||July 2012||2012-07-01|November 2016|2016-11-01||||December 2020|Anticipated|2020-12-01||Interventional|IDEAL-PCI ext||The IDEAL-PCI Extended Registry|Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Extended Registry|Recruiting||Phase 4|5000|Anticipated|Kaiser Franz Josef Hospital||2|||f||||||||||||||2017-10-10 21:34:50.526296|2017-10-10 21:34:50.526296
NCT02974764|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||March 2016||2016-03-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|||Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma|Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma|Recruiting||N/A|200|Anticipated|Johns Hopkins University|||3||f||||f||||||Samples With DNA|"     Blood sample draw (50 ml or 3-4 tablespoons)   "|No||2017-10-10 21:34:50.616819|2017-10-10 21:34:50.616819
NCT02974751|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-30|||August 31, 2017|Anticipated|2017-08-31|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|September 30, 2019|Anticipated|2019-09-30|12 Months|Observational [Patient Registry]|OPEN WATER||Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue|Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue|Recruiting||N/A|200|Anticipated|PROCEPT BioRobotics|||1||f||||f|f|f||||||||2017-10-10 21:34:50.723811|2017-10-10 21:34:50.723811
NCT02974738|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-20|||December 2016||2016-12-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors|A Phase 1, Multiple-Dose, Dose-Escalation and Expansion Trial of PT2977, a HIF-2α Inhibitor, in Patients With Advanced Solid Tumors|Recruiting||Phase 1|125|Anticipated|Peloton Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 21:34:50.808094|2017-10-10 21:34:50.808094
NCT02974725|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-22|||February 24, 2017|Actual|2017-02-24|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Study of LXH254 and LTT462 in NSCLC|A Phase Ib, Open-label, Multicenter Study of Oral LXH254 in Combination With Oral LTT462 in Adult Patients With Advanced or Metastatic KRAS or BRAF Mutant Non-Small Cell Lung Cancer|Recruiting||Phase 1|75|Anticipated|Novartis||1|||f||||t|t|f||||||||2017-10-10 21:34:50.926427|2017-10-10 21:34:50.926427
NCT02974712|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-25|||December 2016||2016-12-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effects of Two Induction Means on Emergence After General Anesthesia|The Effects of Two Induction Means on Emergence After General Anesthesia for Elderly Patients Undergoing Transurethral Endoscopic Operation|Not yet recruiting||N/A|60|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-10 21:34:51.060682|2017-10-10 21:34:51.060682
NCT02974699|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-05-01|||January 2017||2017-01-01|May 2017|2017-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Role of Gastrointestinal Microbes on Digestion of Resistant Starch and Tryptophan Availability to Humans||Recruiting||Early Phase 1|20|Anticipated|Wayne State University||2|||f||||||||||||||2017-10-10 21:34:51.123344|2017-10-10 21:34:51.123344
NCT02974686|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation|Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation|Not yet recruiting||Phase 4|30|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 21:34:51.1969|2017-10-10 21:34:51.1969
NCT02974673|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-04-24|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|EDGE||Pilot Study of Ejaculatory Dyssynergia by Electronic Microsensors of Sphincters|Ejaculation of Spinal Cord Patient: Pilot Study of Ejaculatory Dyssynergia by Electronic Microsensors of Sphincters|Recruiting||N/A|50|Anticipated|Lille Catholic University||1|||f||||f|f|f||||||No||2017-10-10 21:34:51.267606|2017-10-10 21:34:51.267606
NCT02974660|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-06-12|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|PS TAVI||Protamine Sulfate During Transcatheter Aortic Valve Implantation|Use of Protamine Sulfate During Transcatheter Aortic Valve Implantation - Impact on Bleeding and Thromboembolic Complications|Recruiting||Phase 4|200|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-10 21:34:51.366236|2017-10-10 21:34:51.366236
NCT02974634|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|PCORI||Ostomy Telehealth For Cancer Survivors||Recruiting||N/A|174|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 21:34:51.590248|2017-10-10 21:34:51.590248
NCT02974582|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-06-30|||November 15, 2016||2016-11-15|June 14, 2017|2017-06-14|October 6, 2021|Anticipated|2021-10-06|October 6, 2019|Anticipated|2019-10-06||Interventional|||Understanding How Cigarette Direct Mail Marketing Influences Smoking Behaviors Among High and Low Socioeconomic Status Young Adult Smokers|Understanding How Cigarette Direct Mail Marketing Influences Smoking Behaviors Among High and Low Socioeconomic Status Young Adult Smokers|Recruiting||N/A|530|Anticipated|National Institutes of Health Clinical Center (CC)||5|||f||||||||||||||2017-10-10 21:34:52.041891|2017-10-10 21:34:52.041891
NCT02974569|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-09-06|||November 1, 2016||2016-11-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|CSCAT2||Improving Symptom Self-management in Adolescents & Young Adults With Cancer|Improving Symptom Self-management in Adolescents & Young Adults With Cancer|Recruiting||N/A|90|Anticipated|Virginia Commonwealth University|||1||f||||f|f|f||||||||2017-10-10 21:34:52.129766|2017-10-10 21:34:52.129766
NCT02974556|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-05-02|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|March 2024|Anticipated|2024-03-01|March 2022|Anticipated|2022-03-01||Interventional|PROMENADE||Proactive Management of Endoperitoneal Spread in Colonic Cancer|Proactive Management of Endoperitoneal Spread in Colonic Cancer|Not yet recruiting||Phase 3|140|Anticipated|University of Roma La Sapienza||2|||f||||f|f|f||||||No||2017-10-10 21:34:52.219977|2017-10-10 21:34:52.219977
NCT02974543|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-04-07|2017-04-07||September 2014||2014-09-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional||Baseline data are included only for those participants for whom outcome measure data was completed (N=20). One subject was consented and began the study, but withdrew after week one.|Auditory-somatosensory Stimulation to Alleviate Tinnitus|Combined Auditory-Somatosensory Stimulation to Alleviate Tinnitus|Completed||N/A|35|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 21:34:52.367169|2017-10-10 21:34:52.367169
NCT02974530|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-07-12|||August 2016||2016-08-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Observational|AVC-MODE||Description and Modeling of Swallowing Disorders After a Stroke||Recruiting||N/A|150|Anticipated|University Hospital, Grenoble|||2||f||||f||||||||||2017-10-10 21:34:52.725652|2017-10-10 21:34:52.725652
NCT02974517|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Observational|||The Application of Time-lapse System in IVF/ICSI|The Application of Time-lapse System in IVF/ICSI: Can it be Beneficial to Final Pregnancy Outcome?|Recruiting||N/A|300|Anticipated|The First Affiliated Hospital of Zhengzhou University|||3||f||||f||||||||No||2017-10-10 21:34:52.814039|2017-10-10 21:34:52.814039
NCT02974504|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-20|||September 2016||2016-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes|A Multicenter, Randomized, Double-blind, Active-contrelled, Parallel-group, Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin After Oral Administration in Patiend With Type 2 Diabetes|Recruiting||Phase 4|200|Anticipated|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:34:52.887775|2017-10-10 21:34:52.887775
NCT02974491|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-22|||August 2015||2015-08-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Consumption of Apple Juice in Hemodialysis Patients|Acute Consumption of Fuji Apple Juice Does Not Affect Oxidative Stress Biomarkers in Hemodialysis Patients: A Pilot Intervention Study|Completed||N/A|6|Actual|Universidade Federal de Santa Catarina||1|||f||||t||||||||||2017-10-10 21:34:54.779817|2017-10-10 21:34:54.779817
NCT02974478|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-04-22|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Orange Juice Consumption and Glucose Metabolism and Antioxidative Status|Impact of Orange Juice Consumption on Glucose Homeostasis and Antioxidative Status in Healthy Subjects|Completed||N/A|26|Actual|University of Hohenheim||3|||f||||f||||||||No||2017-10-10 21:34:54.877515|2017-10-10 21:34:54.877515
NCT02974465|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-22|||July 2014||2014-07-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|EMG-BFB||Electromyographic Biofeedback and Physical Therapy in Upper Limb Hemiparesis|Electromyographic Biofeedback and Physical Therapy in Upper Limb Hemiparesis: A Randomized Controlled Clinical Trial|Completed||N/A|40|Actual|University of Alcala||2|||f||||t||||||||No||2017-10-10 21:34:54.964014|2017-10-10 21:34:54.964014
NCT02974426|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-12-25|||November 2016||2016-11-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer|Phase III Study to Evaluate the Optimal Timing of Postoperative Radiotherapy for High Risk of Locoregional Recurrence Patients With Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer|Recruiting||Phase 3|1094|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||No||2017-10-10 21:34:55.232995|2017-10-10 21:34:55.232995
NCT02974413|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-11-22|||March 2016||2016-03-01|November 2016|2016-11-01||||November 2016|Actual|2016-11-01||Interventional|||Effectiveness of Self-care Rests on Knowledge, Self-care and Cardiometabolic Control of Adult Men With Diabetes Mellitus|Effectiveness of Self-care Rests on Knowledge, Self-care and Cardiometabolic Control of Adult Men With Diabetes Mellitus|Recruiting||N/A|140|Anticipated|Universidade Estadual de Maringá||2|||f||||||||||||||2017-10-10 21:34:55.355077|2017-10-10 21:34:55.355077
NCT02974400|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-13|||December 6, 2016|Actual|2016-12-06|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|EviBaS||Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis|Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for Persecutory Ideation and Auditory Verbal Hallucinations|Recruiting||N/A|140|Anticipated|University of Bern||2|||f||||f||||||||||2017-10-10 21:34:55.43918|2017-10-10 21:34:55.43918
NCT02974387|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-22|||April 2017||2017-04-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study|Randomized, Single Blinded Controlled Trial for Evaluation of the Safety and Efficacy of Loteprednol Versus Fluorometholone After Photorefractive Keratectomy for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study|Not yet recruiting||Phase 4|200|Anticipated|Dr Salouti Eye Research Center||2|||f||||t||||||||No||2017-10-10 21:34:55.553999|2017-10-10 21:34:55.553999
NCT02974374|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-02-16|||October 2016||2016-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess Safety, Tolerability And Pharmacokinetics Of Single, Escalating, Oral Doses Of Pf-06835919 In Healthy Adult Subjects|Completed||Phase 1|16|Actual|Pfizer||2|||f||||||||||||||2017-10-10 21:34:55.744186|2017-10-10 21:34:55.744186
NCT02974361|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|May 3, 2017|Actual|2017-05-03|April 28, 2017|Actual|2017-04-28||Interventional|||Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen|An Open-label, Single-dose, Randomised, Crossover Study to Evaluate Changes in the Pharmacokinetics of Ibuprofen From Ibuprofen-LDH Dosed With and Without Release Modifying Excipients in Normal, Healthy, Adult Subjects|Completed||Phase 1|30|Actual|Oxford Pharmascience Ltd||17|||f||||||||||||||2017-10-10 21:34:55.831376|2017-10-10 21:34:55.831376
NCT02974348|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-25|||January 2013||2013-01-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|May 2013|Actual|2013-05-01||Interventional|||Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa|Assessment of Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa|Completed||Phase 3|300|Actual|University of Bamenda||6|||f||||t||||||||No||2017-10-10 21:34:55.933825|2017-10-10 21:34:55.933825
NCT02974335|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-10-04|||July 25, 2017|Actual|2017-07-25|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|||"A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (CDE-EHR-PC Study), Phase 1"|"A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (CDE-EHR-PC Study), Phase 1"|Recruiting||N/A|102|Anticipated|New York University School of Medicine|||1||f||||f|f|f||||||||2017-10-10 21:34:56.068885|2017-10-10 21:34:56.068885
NCT02974322|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-28|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 24, 2018|Anticipated|2018-12-24|November 17, 2018|Anticipated|2018-11-17||Interventional|||A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease|A Phase 3, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease|Not yet recruiting||Phase 3|798|Anticipated|Celgene||3|||f||||t|t|f||||||||2017-10-10 21:34:56.221692|2017-10-10 21:34:56.221692
NCT02974309|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-06|||June 1, 2017|Actual|2017-06-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|FREADOM||Family Routines Enhancing Adolescent Diabetes by Optimizing Management|Extending Sleep to Improve Glycemic Control in Pediatric Type 1 Diabetes|Recruiting||N/A|175|Anticipated|University of Arizona||2|||f||||t|f|f|||f|||||2017-10-10 21:34:57.156498|2017-10-10 21:34:57.156498
NCT02974296|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-15|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|NIPUTFD||Neuroimaging in Patients Undergoing TMS for Depression|Neuroimaging in Patients Undergoing TMS for Depression|Recruiting||N/A|60|Anticipated|New York State Psychiatric Institute||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:34:57.271704|2017-10-10 21:34:57.271704
NCT02974283|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2016-11-23|||December 2016||2016-12-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Protective Effects of Normobaric Hyperoxia on Blood Brain Barrier in Patients With Acute Ischemic Stroke|The Effect of Normobaric Hyperoxia on Blood Brain Barrier in AIS Patients Based on a Blood Marker for the Evaluation of Blood Brain Barrier Damage From Animal Experiments|Not yet recruiting||N/A|40|Anticipated|Capital Medical University||2|||f||||f||||||||||2017-10-10 21:34:57.373405|2017-10-10 21:34:57.373405
NCT02974270|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-11-22|||June 2016||2016-06-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate|Analysis of Body Mass Index in Central Precocious Puberty(CPP) Patients Treated With Leuprolide Acetate|Recruiting||Phase 4|100|Anticipated|Kyungpook National University||1|||f||||||||||||||2017-10-10 21:34:57.464862|2017-10-10 21:34:57.464862
NCT02974257|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-07|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Thiamine vs. Placebo to Increase Oxygen Consumption After Cardiac Arrest|Randomized, Double-blind, Placebo-controlled Trial of the Effect of Thiamine on Oxygen Consumption After In-hospital Cardiac Arrest.|Recruiting||Phase 2|100|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|t|f|||f|||||2017-10-10 21:34:57.540015|2017-10-10 21:34:57.540015
NCT02974244|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-03-28|||October 28, 2014|Actual|2014-10-28|March 2017|2017-03-01|October 28, 2014|Actual|2014-10-28|October 28, 2014|Actual|2014-10-28||Observational|||Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins|A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States|Completed||N/A|7000|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-10 21:34:57.640753|2017-10-10 21:34:57.640753
NCT02974231|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-11-25|||December 2014||2014-12-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer|Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer|Completed||N/A|240|Actual|Institut de Cancérologie de Lorraine|||1||f||||||||||||||2017-10-10 21:34:57.722911|2017-10-10 21:34:57.722911
NCT02974218|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-22|||January 2000||2000-01-01|November 2016|2016-11-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01|10 Years|Observational [Patient Registry]|SaLVaRe||Saint Luc Valve Registry|Saint Luc Valve Registry|Recruiting||N/A|5000|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||No||2017-10-10 21:34:57.778349|2017-10-10 21:34:57.778349
NCT02974205|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-22|||January 2016||2016-01-01|November 2016|2016-11-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Interventional|||Rehabilitation of Patient With Acute Isolated PCL Rupture|Kneelaxity and Self-reported Knee Function After Rehabilitation With the Use of Dynamic Kneeorthosis for Patients With Acute Isolated Posterior Cruciate Ligament Injury: A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Oslo University Hospital||3|||f||||t||||||||No||2017-10-10 21:34:57.860365|2017-10-10 21:34:57.860365
NCT02974192|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-01-14|||November 2016||2016-11-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Neopterin Effects on Ischemic Stroke|Neoptrin, Soluble CD40-ligand and Ischemic Stroke: a Clinical Perspective|Recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t||||||||Undecided||2017-10-10 21:34:57.957837|2017-10-10 21:34:57.957837
NCT02974179|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-09-14|||February 20, 2017|Actual|2017-02-20|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia|A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia|Enrolling by invitation||N/A|7|Anticipated|AnGes USA, Inc.|||1||f||||f|t|||||||||2017-10-10 21:34:58.030089|2017-10-10 21:34:58.030089
NCT02974166|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-22|||March 2012||2012-03-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|November 2015|Actual|2015-11-01||Interventional|||Analysis of the Effects of the Osteopathic Manipulative Treatment in Carriers of Temporomandibular Disorders|Analysis of the Effects of the Osteopathic Manipulative Treatment in Carriers of Temporomandibular Disorders: Randomized Clinical Trial|Completed||N/A|32|Actual|Instituto Brasileiro de Osteopatia||2|||f||||t||||||||No||2017-10-10 21:34:58.0934|2017-10-10 21:34:58.0934
NCT02974153|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-08-11|||November 2016||2016-11-01|July 2017|2017-07-01||||June 2018|Anticipated|2018-06-01||Interventional|PROMISE 2||Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine|A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Chronic Migraine|Recruiting||Phase 3|1050|Anticipated|Alder Biopharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-10 21:34:58.196918|2017-10-10 21:34:58.196918
NCT02974140|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-07-27|||March 2, 2017|Actual|2017-03-02|July 2017|2017-07-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|||Cataract Refractive Suite Study|A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques|Terminated||N/A|39|Actual|Alcon Research||2||Management Decision|f||||f|f|t|f|||||||2017-10-10 21:34:58.682441|2017-10-10 21:34:58.682441
NCT02974127|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-11-22|||April 2011||2011-04-01|November 2016|2016-11-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|MuRaLM||Multisession Radiosurgery in Large Meningiomas|Multisession Radiosurgery in Large Meningiomas|Active, not recruiting||N/A|170|Anticipated|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta|||1||f||||f||||||||Undecided||2017-10-10 21:34:58.76243|2017-10-10 21:34:58.76243
NCT02974101|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-07-12|||November 2016||2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|EMINENT||AdaptiveStim Objectifying Subjective Pain Questionnaires|AdaptiveStim Objectifying Subjective Pain Questionnaires|Completed||N/A|39|Actual|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-10 21:34:58.945744|2017-10-10 21:34:58.945744
NCT02974088|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-22|||May 2006||2006-05-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Neem Lotion With Combing for Lice|"A Randomised, Assessor Blinded Proof of Concept (Phase IIa) Clinical Study to Assess the Efficacy and Safety of Nice 'n Clear Head Lice Lotion in the Treatment of Head Lice"|Completed||Phase 2/Phase 3|47|Actual|Medical Entomology Centre||2|||f||||f||||||||Undecided|Contact Principal Investigator|2017-10-10 21:34:59.028632|2017-10-10 21:34:59.028632
NCT02973568|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-09-07|||April 1, 2016||2016-04-01|November 2016|2016-11-01|July 15, 2017|Actual|2017-07-15|December 31, 2016|Actual|2016-12-31||Observational|DASAU||Comparative Study on Acute Pain Evaluation Between Spanish and French Hospital Emergency Unit|Comparative Study on Acute Pain Evaluation Between Spanish and French Hospital Emergency Unit|Completed||N/A|641|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:35:03.313153|2017-10-10 21:35:03.313153
NCT02974075|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-22|||August 2016||2016-08-01|November 2016|2016-11-01||||November 2016|Actual|2016-11-01||Interventional|||Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical Prostatectomy|Safety and Efficacy of Salvage Lymph Node Dissection in Prostate Cancer Patients With Nodal Recurrence After Radical Prostatectomy With Curative Intent - a Prospective Single Center Phase I/II Study|Recruiting||N/A|70|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-10-10 21:34:59.118475|2017-10-10 21:34:59.118475
NCT02974062|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-03-28|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Immediate Effect of Core Stabilization Exercise on Trunk Proprioception in Healthy Individuals|Immediate Effect of Core Stabilization Exercise on Trunk Proprioception in Healthy Individuals: A Feasibility Study|Completed||N/A|60|Actual|Mahidol University||2|||f||||f||||||||Yes|All data will be made available for other researchers after the end of the study.|2017-10-10 21:34:59.19971|2017-10-10 21:34:59.19971
NCT02974049|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||January 2015||2015-01-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2015|Actual|2015-08-01||Interventional|||Lymphatic Filariasis (LF) in Ivory Coast|Alternative Chemotherapies for Lymphatic Filariasis (LF) Treatment and Elimination in Africa [Cote d'Ivoire]|Active, not recruiting||N/A|189|Actual|University Hospitals Cleveland Medical Center||4|||f||||t||||||||Yes|Not personal identifying data but infection levels will be shared.|2017-10-10 21:34:59.282714|2017-10-10 21:34:59.282714
NCT02974023|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-09|||August 2017|Anticipated|2017-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||"Efficacy of Pain Gear in Patients With Chronic Musculoskeletal Pain"|"Efficacy of Pain Gear in Patients With Chronic Musculoskeletal Pain"|Not yet recruiting||N/A|200|Anticipated|PharmEvo Pvt Ltd|||1||f||||t||||||||||2017-10-10 21:34:59.481203|2017-10-10 21:34:59.481203
NCT02974010|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-23|||June 15, 2017|Anticipated|2017-06-15|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|STABIL-B||STABIL-B Trial of NRX-101 for Acute Suicidal Ideation and Behavior|Placebo Controlled Trial of NRX-101 for the Maintenance of Stabilization From Acute Suicidal Ideation and Behavior in Bipolar Depression (STABIL-B)|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|NeuroRx, Inc.||3|||f||||t|t|f||||||No||2017-10-10 21:34:59.551254|2017-10-10 21:34:59.551254
NCT02973997|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-23|2017-01-24|||April 2017|Anticipated|2017-04-01|November 2016|2016-11-01||||September 2018|Anticipated|2018-09-01||Interventional|||Pembrolizumab and Lenvatinib in Treating Metastatic or Recurrent Differentiated Thyroid Cancer That Cannot Be Removed by Surgery|Combination Targeted Therapy With Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers|Not yet recruiting||Phase 2|60|Anticipated|Academic and Community Cancer Research United||1|||f||||t|t|f||||||||2017-10-10 21:34:59.642075|2017-10-10 21:34:59.642075
NCT02973984|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-08-11|||November 18, 2016||2016-11-18|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|EUROSAF||The European Registry of Older Subjects With Atrial Fibrillation (EUROSAF)|Evaluating the Efficacy and Risks of Anticoagulant Treatments in Multimorbid Frail Older Subjects With Atrial Fibrillation. The European Registry of Older Subjects With Atrial Fibrillation (EUROSAF)|Recruiting||N/A|3000|Anticipated|Ente Ospedaliero Ospedali Galliera|||1||f||||t||||||||||2017-10-10 21:34:59.783069|2017-10-10 21:34:59.783069
NCT02973971|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-01-23|||November 2016||2016-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||ADDIA Chronobiological Study|Pilot Study on Patients With Mild to Moderate Form of Alzheimer's Disease and Healthy Volunteers: Characterization of Intra-subject Variability and Chronobiological Variations of ADDIA Biomarkers.|Recruiting||N/A|24|Anticipated|Amoneta Diagnostics SAS|||2||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-10 21:34:59.889513|2017-10-10 21:34:59.889513
NCT02973958|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-06-27|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision|A Pilot Study Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision|Recruiting||Phase 1|30|Anticipated|Alberta Children's Hospital||2|||f||||t|t|f|||t|||Undecided||2017-10-10 21:34:59.982437|2017-10-10 21:34:59.982437
NCT02973945|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-05-30|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||High Flow Nasal Cannula and Aerobic Capacity Training|High Flow Nasal Cannula Versus The Venturi Mask During Exercise Training in Chronic Obstructive Pulmonary Disease Patients, a Randomized, Simple Blind, Controlled Trial.|Not yet recruiting||N/A|60|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t|f|f||||||Yes||2017-10-10 21:35:00.169951|2017-10-10 21:35:00.169951
NCT02973932|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-25|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Interventional|||iCBT for Children and Adolescents With Obsessive-compulsive Disorder|Internet-based Cognitive Behavioral Psychotherapy for Children and Adolescents With Obsessive-compulsive Disorder|Not yet recruiting||N/A|20|Anticipated|University Hospital Tuebingen||1|||f||||||||||||||2017-10-10 21:35:00.27113|2017-10-10 21:35:00.27113
NCT02973919|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-21|||July 2015||2015-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||EMDR in Spider Phobia: Work Mechanisms and Treatment Outcome|EMDR in Spider Phobia: Work Mechanisms and Treatment Outcome|Completed||N/A|53|Actual|University of Regensburg||2|||f||||f||||||||No||2017-10-10 21:35:00.341442|2017-10-10 21:35:00.341442
NCT02973906|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-11-25|||July 2015||2015-07-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Comparing Web, Group, and Telehealth Formats of a Military Parenting Program|Comparing Web, Group, and Telehealth Formats of a Military Parenting Program|Recruiting||N/A|360|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||Undecided||2017-10-10 21:35:00.414452|2017-10-10 21:35:00.414452
NCT02973373|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||MRI of the Chest Under High Frequency Ventilation|MRI of the Chest Under High Frequency Ventilation|Recruiting||N/A|10|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||No||2017-10-10 21:35:04.831186|2017-10-10 21:35:04.831186
NCT02973893|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-10-02|||November 2016||2016-11-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of VF001-DP in Patients With Chronic Venous Leg Ulcers|A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial Comparing Two Doses of VF001-DP to Placebo as an Adjunct to Standard Care in Patients With Chronic Venous Leg Ulcers|Recruiting||Phase 2|168|Anticipated|Factor Therapeutics Ltd.||3|||f||||f||||||||||2017-10-10 21:35:00.509578|2017-10-10 21:35:00.509578
NCT02973880|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-02-13|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction|A Prospective, Multi-center, Controlled, Double-blind Study to Evaluate the Efficacy and Tolerability of a Steroid/Antibiotic Associated Treatment Following Cataract Extraction by Means of Phaco-emulsification|Not yet recruiting||Phase 3|180|Anticipated|SIFI SpA||2|||f||||t|f|f||||||No||2017-10-10 21:35:00.791115|2017-10-10 21:35:00.791115
NCT02973867|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-24|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Bonamy||Myokines Role During Obesity|Myokines Role in Bone Mineral Density Increase During Obesity|Not yet recruiting||N/A|150|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||Undecided||2017-10-10 21:35:00.975894|2017-10-10 21:35:00.975894
NCT02973854|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-08-22|||September 2016||2016-09-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|February 2018|Anticipated|2018-02-01||Observational|S1P1||Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat|Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat|Enrolling by invitation||N/A|200|Anticipated|St. Louis University|||1||f||||f||||||Samples With DNA|"     Per the PI's standard surgical approach to endometriosis, all areas of abnormal peritoneum     will be excised (removed).      After surgical excision has been performed, in order to provide standardized specimens for     our research, a 3mm punch biopsy will be obtained from the excised peritoneum tissue. The 3     mm biopsy will be sent for research analysis, and the rest of the excised peritoneum tissue     will be sent to histology (SSM) for evaluation and classification as having endometriosis or     not. For each patient in the study, blood will also be collected to look for markers for     endometriosis.   "|||2017-10-10 21:35:01.0415|2017-10-10 21:35:01.0415
NCT02973841|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-23|||February 2017||2017-02-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|Sono-ease||Sono-ease Device for Internal Jaguar Vein Cannulation||Not yet recruiting||N/A|40|Anticipated|Mansoura University||1|||f||||t||||||||Yes||2017-10-10 21:35:01.090318|2017-10-10 21:35:01.090318
NCT02973828|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-06-22|||September 1, 2017|Anticipated|2017-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy|Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy (MRIgRT)|Not yet recruiting||N/A|173|Anticipated|Institute of Cancer Research, United Kingdom|||3||f||||f||||||||||2017-10-10 21:35:01.155037|2017-10-10 21:35:01.155037
NCT02973815|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-21|||September 2016||2016-09-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|January 2020|Anticipated|2020-01-01||Interventional|NU-HOME||New Ulm at HOME (Healthy Offerings Via the Mealtime Environment), NU-HOME|New Ulm at HOME (Healthy Offerings Via the Mealtime Environment), NU-HOME|Enrolling by invitation||N/A|255|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||Undecided||2017-10-10 21:35:01.255773|2017-10-10 21:35:01.255773
NCT02973802|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-09-05|||September 2016||2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy|Safety and Proof of Principle Study of ATX-GD-59 in Male and Female Subjects With Graves' Disease Not Currently Treated With Anti-thyroid Therapy: An Open Label Study, With an Upward Titration Over Five Dose Levels Administered by Intradermal Injection|Active, not recruiting||Phase 1|12|Actual|Apitope International NV||1|||f||||t||||||||||2017-10-10 21:35:01.370515|2017-10-10 21:35:01.370515
NCT02973789|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-23|||December 2016||2016-12-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Effect of Tumor Treating Fields (TTFields) (150 kHz) as Second Line Treatment of Non-small Cell Lung Cancer (NSCLC) in Combination With PD-1 Inhibitors or Docetaxel (LUNAR)|LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) (150 kHz) in Combination With PD-1 Inhibitors or Docetaxel, for Second Line Treatment of Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 3|512|Anticipated|NovoCure Ltd.||2|||f||||t|f|f||||||Undecided||2017-10-10 21:35:01.469946|2017-10-10 21:35:01.469946
NCT02973776|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-08|||December 2016||2016-12-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Vasoconstriction Trial With LEO 90100 Aerosol Foam|Vasoconstriction Trial Comparing LEO 90100 With Dermovate Cream, Diprosone Ointment, Elocon Cream, Locoid Ointment and LEO 90100 Vehicle|Completed||Phase 1|36|Actual|LEO Pharma||6|||f||||f||||||||No||2017-10-10 21:35:01.606477|2017-10-10 21:35:01.606477
NCT02973763|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-23|||December 2016||2016-12-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer|Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Patients With Advanced Non Small Cell Lung Cancer Who Progressed on Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Agent|Not yet recruiting||Phase 1|30|Anticipated|Allist Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-10 21:35:01.727881|2017-10-10 21:35:01.727881
NCT02973750|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-28|||August 31, 2016|Actual|2016-08-31|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer|Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer: Prospective Study of Pharmacokinetics Patterns and Underlying Biology|Recruiting||N/A|55|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||1||f||||f||||||Samples With DNA|"     Whole blood samples, Pharmacokinetic (PK) samples, Tumor tissue, Ascites.   "|||2017-10-10 21:35:01.831891|2017-10-10 21:35:01.831891
NCT02973737|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||July 2016||2016-07-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer|Pyrotinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer:a Randomised, Double-blind, Multicentre, Phase 3 Trial|Recruiting||Phase 3|350|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||Yes||2017-10-10 21:35:01.987763|2017-10-10 21:35:01.987763
NCT02973724|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-06-08|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||EC95 of Remifentanil for Preventing Cough|Predicted EC95 of Effect-site Concentration of Remifentanil for Preventing Cough After Laryngomicrosurgery From Propofol Anesthesia|Completed||N/A|40|Actual|Ajou University School of Medicine||1|||f||||t||||||||No||2017-10-10 21:35:02.086371|2017-10-10 21:35:02.086371
NCT02973711|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-06-15|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML|A Phase I/II Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML Who Have Achieved a Complete Hematologic Remission, Complete Cytogenetic Remission, and Major Molecular Remission, But Not a Complete Molecular Remission on a Tyrosine Kinase Inhibitor Alone.|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Michigan Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:35:02.181716|2017-10-10 21:35:02.181716
NCT02973698|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-25|||June 2014||2014-06-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease Patients|Effects of a Speech-Language Pathology Intervention on Individuals With Parkinson's Disease|Completed||N/A|26|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||Undecided||2017-10-10 21:35:02.277995|2017-10-10 21:35:02.277995
NCT02973685|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-12-27|||October 2016||2016-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.|The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Compared With Transarterial Chemoembolization in Patients With Large Hepatocellular Carcinoma Staged BCLC A/B.|Recruiting||Phase 3|304|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:35:02.356486|2017-10-10 21:35:02.356486
NCT02973672|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-05-12|||January 2016||2016-01-01|November 2016|2016-11-01|January 31, 2018|Anticipated|2018-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas|A Phase I Study Assessing the Safety and Performance of SGM-101, a Fluorochrome-labeled Anti-carcino-embryonic Antigen Monoclonal Antibody for the Detection of Neoplastic Lesions in Patients With Colorectal Cancer or Pancreatic Cancer|Recruiting||Phase 1/Phase 2|60|Anticipated|Surgimab||1|||f||||t||||||||No||2017-10-10 21:35:02.459756|2017-10-10 21:35:02.459756
NCT02973659|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-23|||May 2015||2015-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.|The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.|Completed||N/A|61|Actual|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||Undecided||2017-10-10 21:35:02.582365|2017-10-10 21:35:02.582365
NCT02973646|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-23|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection|Investigation on Antiviral Therapy of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B Patients Based on Detection of Interferon Gene Mutation and Interferon Receptor|Recruiting||Phase 4|100|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 21:35:02.678111|2017-10-10 21:35:02.678111
NCT02973633|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2016-11-23|||January 2017||2017-01-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Diffusion MRI in Heart Failure|Diffusion MRI in Heart Failure|Not yet recruiting||Phase 1/Phase 2|160|Anticipated|Massachusetts General Hospital||3|||f||||f||||||||No|IPD will not be shared|2017-10-10 21:35:02.795885|2017-10-10 21:35:02.795885
NCT02973620|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-23||||||November 2016|2016-11-01||||||||Expanded Access|||Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure|Expanded Access Protocol; Intermediate Size Protocol: Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure Who Are Refractory to Standard Therapy|Available||N/A|||Tenax Therapeutics, Inc.|||||||||||||||||||2017-10-10 21:35:02.897829|2017-10-10 21:35:02.897829
NCT02973607|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-06-29|||May 23, 2017|Actual|2017-05-23|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|CRIB-DONOR II||Effects of a Reduction in Renal Function on Cardiovascular Structure and Function|Effects of a Reduction in Renal Function on Cardiovascular Structure and Function: A 5 Year Study of Kidney Donors.|Recruiting||N/A|124|Anticipated|University Hospital Birmingham NHS Foundation Trust|||2||f||||f||||||Samples With DNA|"     Serum, plasma, acellular urine and DNA (for telomere length).   "|||2017-10-10 21:35:02.968233|2017-10-10 21:35:02.968233
NCT02973594|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-16|||November 2016||2016-11-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|PROBE-IT||Pulse Reduction On Beta-blocker and Ivabradine Therapy|Pulse Reduction On Beta-blocker and Ivabradine Therapy|Recruiting||Phase 4|36|Anticipated|University of Colorado, Denver||2|||f||||t||||||||Yes|Upon completion of primary data analysis, all gene expression data will be submitted to the Gene Expression Omnibus (GEO). In addition to the standard descriptive and protocol information, the Metadata Spreadsheet will contain subject information required to reproduce primary analyses. Once released by GEO these data will be available for public download. We anticipate this to be complete approximately 2 years after the completion of final subject follow-up.|2017-10-10 21:35:03.060447|2017-10-10 21:35:03.060447
NCT02973581|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-07-03|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|SPI VS||SPI-directed Analgesia for Vitreoretinal Surgeries|Influence of Surgical Pleth Index-guided Analgesia With Different Techniques on the Presence of Postoperative Pain, Nausea and Vomiting and of Oculocardiac Reflex in Patients Undergoing Vitreoretinal Surgery Under General Anaesthesia: Randomised, Controlled Trial|Completed||N/A|176|Actual|Medical University of Silesia||5|||f||||t||||||||||2017-10-10 21:35:03.195866|2017-10-10 21:35:03.195866
NCT02973555|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Platelet-Rich Protein and the Endometrium|Can Platelet-rich Plasma (PRP) Promote Endometrial Growth and Improve Pregnancy Outcome of Patients With Thin Endometrium Undergoing Assisted Reproductive Technology (ART) Treatments?|Not yet recruiting||N/A|50|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||No||2017-10-10 21:35:03.377272|2017-10-10 21:35:03.377272
NCT02973542|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-24|||February 2017||2017-02-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|IBSET||Ethosuximide to Treat IBS|Evaluation of the Efficacy and Tolerance of Ethosuximide in the Treatment of Abdominal Pain Associated With Irritable Bowel Syndrome|Not yet recruiting||Phase 2|286|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 21:35:03.445124|2017-10-10 21:35:03.445124
NCT02973529|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-14|||January 2016||2016-01-01|March 2017|2017-03-01|September 2028|Anticipated|2028-09-01|May 2018|Anticipated|2018-05-01||Interventional|BIFSORB||The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study|Bioresorbable Vascular Stents for Treatment of Coronary Bifurcation Lesions Assessed by Optical Coherence Tomography - The BIFSORB Study|Active, not recruiting||N/A|120|Anticipated|Aarhus University Hospital Skejby||2|||f||||t||||||||Undecided||2017-10-10 21:35:03.555071|2017-10-10 21:35:03.555071
NCT02973516|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-03-22|||December 2016||2016-12-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis|Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis, Phase IIa Clinical Study|Recruiting||Phase 2|30|Anticipated|Guerbet||1|||f||||f||||||||No||2017-10-10 21:35:03.69505|2017-10-10 21:35:03.69505
NCT02973503|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|STREAGER||Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis|A Phase 3, Global, Multicenter, Open-Label Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis|Not yet recruiting||Phase 3|70|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 21:35:03.774078|2017-10-10 21:35:03.774078
NCT02973490|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||January 2017||2017-01-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor|Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor: A Prospective, Multi-Center, Randomized, Open-Label, Parallel Group, Superiority Clinical Trial|Not yet recruiting||N/A|1200|Anticipated|Fudan University||2|||f||||t||||||||No||2017-10-10 21:35:03.862894|2017-10-10 21:35:03.862894
NCT02973477|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-02-14|||January 12, 2017|Actual|2017-01-12|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|||Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)|Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)|Recruiting||Phase 4|45|Anticipated|University of Michigan||2|||f||||t|t|f|||f|||No||2017-10-10 21:35:03.924974|2017-10-10 21:35:03.924974
NCT02973464|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-12-01|||June 2016||2016-06-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|||The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population|The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population|Recruiting||Phase 3|450|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||3||f||||t||||||||No||2017-10-10 21:35:04.019783|2017-10-10 21:35:04.019783
NCT02973451|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-27|||April 2016||2016-04-01|November 2016|2016-11-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Laparoscopic Guided Transversus Abdominis Plane Block Versus Trocar Site Infiltration in Gynecologic Laparoscopy.|Laparoscopic Guided Transversus Abdominis Plane Block Versus Trocar Site Local Anesthetic Infiltration in Gynecologic Laparoscopy.|Completed||Phase 2|80|Anticipated|Zagazig University||2|||f||||t||||||||||2017-10-10 21:35:04.25229|2017-10-10 21:35:04.25229
NCT02973438|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-08-03|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of Intermittent Hypoxia (IH) on Metabolism and Dysglycemia, in Overweight/Obese Persons SCI|Effects of Acute Intermittent Hypoxia (AIH) on Metabolism and Dysglycemia, in Overweight/Obese Persons With Spinal Cord Injuries (SCI)|Recruiting||N/A|12|Anticipated|University of Miami||4|||f||||f||||||||||2017-10-10 21:35:04.343383|2017-10-10 21:35:04.343383
NCT02973425|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01||||July 2020|Anticipated|2020-07-01||Interventional|||Take a Break (TAB): mHealth-assisted Skills Building Challenge for Unmotivated Smokers|Take a Break (TAB): mHealth-assisted Skills Building Challenge for Unmotivated Smokers|Not yet recruiting||N/A|600|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||No||2017-10-10 21:35:04.443698|2017-10-10 21:35:04.443698
NCT02973412|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-05-02|||December 2016||2016-12-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|CODEC||Chronotype of Patients With Type 2 Diabetes and Effect on Glycaemic Control|Chronotype of Patients With Type 2 Diabetes and Effect on Glycaemic Control: The CODEC Study|Recruiting||N/A|2247|Anticipated|University of Leicester|||1||f||||f||||||Samples With DNA|"     Collection of whole blood for genetic analysis   "|Undecided||2017-10-10 21:35:04.535417|2017-10-10 21:35:04.535417
NCT02973399|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-07-25|||February 7, 2017|Actual|2017-02-07|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL|A Phase 1, Open-label Study of SNX‑5422 Added to Ibrutinib in Chronic Lymphocytic Leukemia Subjects With Residual Disease|Recruiting||Phase 1|20|Anticipated|Esanex Inc.||1|||f||||f|t|f||||||||2017-10-10 21:35:04.642928|2017-10-10 21:35:04.642928
NCT02973386|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-01-19|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients|Randomized Trial of Concurrent Cisplatin Chemoradiotherapy Plus Capecitabine Adjuvant Chemotherapy vs Concurrent Cisplatin Chemoradiotherapy Alone for Patients With Local Advanced Nasopharyngeal Carcinoma at High Risk of Distant Metastasis|Recruiting||Phase 2/Phase 3|278|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 21:35:04.73911|2017-10-10 21:35:04.73911
NCT02973360|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-10-03|||March 2, 2017|Actual|2017-03-02|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|September 21, 2017|Actual|2017-09-21||Interventional|||Dose-Finding Study of SC411 in Children With Sickle Cell Disease|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study of SC411 in Children With Sickle Cell Disease|Active, not recruiting||Phase 2|68|Actual|Sancilio and Company, Inc.||4|||f||||t|t|f||||||||2017-10-10 21:35:04.932005|2017-10-10 21:35:04.932005
NCT02973347|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||January 2017||2017-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Intermittent and Continuous Enteral Feeding on Ventilator-associated Pneumonia in Pediatric ICUs|Impact of Intermittent and Continuous Enteral Feeding on Ventilator-associated Pneumonia in Pediatric ICUs|Not yet recruiting||N/A|400|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:35:05.053631|2017-10-10 21:35:05.053631
NCT02973334|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-03-23|||October 2015||2015-10-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|EduStress||Acute Effects of Artificial Sweeteners or Sugar on Hemodynamic and Metabolic Stress Responses|Acute Effects of Artificial Sweeteners' or Sugar's Ingestion on Hemodynamic and Metabolic Stress Response: An Exploratory, Randomized, Cross-over Trial in Healthy Young Women.|Recruiting||N/A|12|Anticipated|University of Lausanne||3|||f||||f||||||||No||2017-10-10 21:35:05.163714|2017-10-10 21:35:05.163714
NCT02973321|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-09-04|||December 2016||2016-12-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus|A 26-Week Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 2|270|Anticipated|Sanofi||7|||f||||t||||||||||2017-10-10 21:35:05.28689|2017-10-10 21:35:05.28689
NCT02973308|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-11-21|||September 2016||2016-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|CPEX||The Inter and Intra Reliability of Cardiopulmonary Exercise Testing in Abdominal Aortic Aneurysm Patients|The Inter and Intra Reliability of Cardiopulmonary Exercise Testing in Abdominal Aortic Aneurysm Patients|Recruiting||N/A|40|Anticipated|University of Hull||4|||f||||f||||||||No|No plan to share participant data|2017-10-10 21:35:05.558413|2017-10-10 21:35:05.558413
NCT02973295|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-21|||January 2017||2017-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|SINF||Silymarin in NAFLD|Silymarin® - Efficacy in Treatment of Non-alcoholic Fatty Liver Disease (NAFLD) Controlled by Laboratory and and Elastographic Parameters|Not yet recruiting||Phase 4|400|Anticipated|University Hospital Rijeka||2|||f||||t||||||||Yes|All patient data will be available to other researchers after interim analysis|2017-10-10 21:35:05.671971|2017-10-10 21:35:05.671971
NCT02973282|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|SMARTCOUGH-C||Diagnosing Respiratory Disease in Children Using Cough Sounds|Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds|Active, not recruiting||N/A|1245|Actual|ResApp Health Limited|||1||f||||t||||||||||2017-10-10 21:35:05.783568|2017-10-10 21:35:05.783568
NCT02973269|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-09|||November 14, 2016|Actual|2016-11-14|August 2017|2017-08-01||||May 31, 2017|Actual|2017-05-31||Interventional|||DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis|A Phase 2, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis|Suspended||Phase 2|7|Actual|Revance Therapeutics, Inc.||2||New trial with same indication initiated|f||||f||||||||||2017-10-10 21:35:05.866672|2017-10-10 21:35:05.866672
NCT02973256|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-11-21|||November 2016||2016-11-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|November 2019|Anticipated|2019-11-01||Observational|ATYPICMENING||Oncological Care for Patients With Meningioma|Postoperative Oncological Care for Patients With Meningioma With Malignant Components|Not yet recruiting||N/A|1204|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||Undecided||2017-10-10 21:35:05.946864|2017-10-10 21:35:05.946864
NCT02973243|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-04-11|||October 5, 2016|Actual|2016-10-05|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|||The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III|The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III|Completed||N/A|446|Actual|Philips Healthcare|||2||f||||t||||||||No||2017-10-10 21:35:06.023585|2017-10-10 21:35:06.023585
NCT02973230|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-23|||October 2006||2006-10-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Serum VEGF as a Tubal Pregnancy Marker|Serum Vascular Endothelial Growth Factor (VEGF) As a Marker for Tubal Pregnancy|Completed||N/A|90|Actual|University of Sao Paulo General Hospital|||||f||||||||||||||2017-10-10 21:35:06.119455|2017-10-10 21:35:06.119455
NCT02973217|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||October 2016||2016-10-01|November 2016|2016-11-01||||October 2019|Anticipated|2019-10-01||Interventional|||Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer|Prospective, Open, Non Comparative Trial to Evaluate Safety and Feasibility of Immunostimulating Interstitial Laser Thermotherapy (imILT) in Stage III Pancreatic Carcinoma|Recruiting||N/A|5|Anticipated|Clinical Laserthermia Systems AB||1|||f||||t||||||||No||2017-10-10 21:35:06.190812|2017-10-10 21:35:06.190812
NCT02973204|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01|5 Years|Observational [Patient Registry]|||Circulating Tumor Cells and Tumor DNA in HCC and NET|Circulating Tumor Cells and Tumor DNA in HCC and NET - Patient-specific Biomarkers for Clinical Decision Support and Tailored Relapse Diagnostics|Recruiting||N/A|130|Anticipated|University of Aarhus|||4||f||||f||||||Samples With DNA|"     Blood samples and biopsies when available.   "|No||2017-10-10 21:35:06.276558|2017-10-10 21:35:06.276558
NCT02973191|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-04-07|||December 20, 2016|Anticipated|2016-12-20|April 2017|2017-04-01|January 24, 2021|Anticipated|2021-01-24|June 25, 2019|Anticipated|2019-06-25||Interventional|ORBIT||A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia|A Phase 2, Open-label, Multiple Cohort, Single-arm, Multi-center Trial to Determine the Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-cell Acute Lymphoblastic Leukemia.|Withdrawn||Phase 1/Phase 2|0|Actual|Celgene||1||"Development of JCAR015 has been discontinued. No subjects were enrolled/treated under protocol   JCAR015-ALL-001"|f||||t||||||||||2017-10-10 21:35:06.417314|2017-10-10 21:35:06.417314
NCT02973152|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-09-26|||May 2016||2016-05-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|VOCALIST||Laryngeal Reinnervation Versus Thyroplasty in Patients With Vocal Fold Weakness.|Does Laryngeal Reinnervation or Type I Thyroplasty Give Better Voice Results for Patients With Unilateral Vocal Fold Paralysis (VOCALIST): a Feasibility Study.|Recruiting||Phase 2|30|Anticipated|Royal National Throat, Nose and Ear Hospital||2|||f||||f||||||||||2017-10-10 21:35:06.605957|2017-10-10 21:35:06.605957
NCT02973139|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-11|||July 14, 2017|Actual|2017-07-14|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Fibrinolysis Compared to Thoracoscopy for Pleural Infection|Fibrinolytic Therapy Versus Medical Thoracoscopy for Treatment of Pleural Infection: A Randomized Clinical Trial|Recruiting||N/A|80|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:35:06.725766|2017-10-10 21:35:06.725766
NCT02973126|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-28|||September 2016||2016-09-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|AFFECTS||Heartflow (AFFECTS)|Assessment of Fractional Flow reservE Computed Tomography Versus Single Photon Emission Computed Tomography in the Diagnosis of Hemodynamically Significant Coronary Artery Disease. (AFFECTS)|Recruiting||Phase 3|270|Anticipated|Baylor Research Institute||1|||f||||t||||||||No||2017-10-10 21:35:06.803498|2017-10-10 21:35:06.803498
NCT02973113|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-05-05|||February 16, 2016|Actual|2016-02-16|May 2017|2017-05-01|February 16, 2020|Anticipated|2020-02-16|April 16, 2019|Anticipated|2019-04-16||Interventional|PREVALE||Nivolumab With Epstein Barr Virus Specific T Cells (EB-VSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)|Phase I Study Combining Nivolumab With Epstein Barr Virus Specific T Cells (EB-VSTS) in Relapsed/Refractory EBV Positive Lymphoma Patients (PREVALE)|Recruiting||Phase 1|36|Anticipated|Baylor College of Medicine||1|||f||||t|t|f||||||No||2017-10-10 21:35:06.877437|2017-10-10 21:35:06.877437
NCT02973100|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-08-16|||December 2016||2016-12-01|August 2017|2017-08-01|August 14, 2017|Actual|2017-08-14|July 15, 2017|Actual|2017-07-15||Interventional|||A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy|A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy|Completed||Phase 2|318|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 21:35:06.977137|2017-10-10 21:35:06.977137
NCT02973087|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||rVWF IN PROPHYLAXIS|A Prospective, Phase 3, Open Label, International Multicenter Study on Efficacy and Safety of Prophylaxis With rVWF in Severe Von Willebrand Disease|Not yet recruiting||Phase 3|18|Anticipated|Baxalta US Inc.||1|||f||||t||||||||||2017-10-10 21:35:07.202771|2017-10-10 21:35:07.202771
NCT02973074|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-25|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Oral Iron Substitution for Orthopedic Surgery|Pilot Study for Investigation of the Feasibility and for Optimization of Oral Iron Substitution in the Course of Patient Blood Management for Orthopedic Surgery|Recruiting||N/A|20|Anticipated|Kepler University Hospital||1|||f||||f||||||||No||2017-10-10 21:35:07.302403|2017-10-10 21:35:07.302403
NCT02973061|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||January 2015||2015-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents|The Impact of the Use of Recombinant Human Growth Hormone on Attention Hyperactivity Deficit Characteristics in Children and Adolescents|Recruiting||N/A|100|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||||No||2017-10-10 21:35:07.383114|2017-10-10 21:35:07.383114
NCT02973048|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-01-12|||June 2016||2016-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hyperbaric Bupivacaine Versus Hyperbaric Prilocaine 2% for Cesarean Section Under Spinal Anesthesia|Hyperbaric Bupivacaine Versus Hyperbaric Prilocaine 2% for Cesarean Section Under Spinal Anesthesia: a Randomised Clinical Trial|Recruiting||Phase 3|100|Anticipated|Centre Hospitalier Universitaire Saint Pierre||2|||f||||t||||||||No||2017-10-10 21:35:07.453559|2017-10-10 21:35:07.453559
NCT02973035|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2017-01-11|||December 2016||2016-12-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension|Effect of Add-on of Amlodipine Versus Valsartan on Diastolic Dysfunction Associated With Hypertension|Recruiting||Phase 4|130|Anticipated|Asan Medical Center||2|||f||||f||||||||No||2017-10-10 21:35:07.547359|2017-10-10 21:35:07.547359
NCT02973022|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-28|||October 2016||2016-10-01|November 2016|2016-11-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|||A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2|A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2|Recruiting||N/A|60|Anticipated|University of Wisconsin, Madison|||4||f||||t||||||||||2017-10-10 21:35:07.630236|2017-10-10 21:35:07.630236
NCT02973009|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-22|||January 2017||2017-01-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|TROCSLEEVE||Impact of the Systematic Closure of the Epigastric Trocar on Postoperative Incisional Hernia After Sleeve Gastrectomy Rate of First Intention. Monocentric Study, Before / After Prospective.|Impact of the Systematic Closure of the Epigastric Trocar on Postoperative Incisional Hernia After Sleeve Gastrectomy Rate of First Intention. Monocentric Study, Before / After Prospective.|Not yet recruiting||N/A|124|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:35:07.702395|2017-10-10 21:35:07.702395
NCT02972996|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-22|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Blueberry Consumption and Type 2 Diabetes|Effects of Blueberry Consumption on Cardiometabolic Parameters in Men With Type 2 Diabetes.|Recruiting||N/A|48|Anticipated|Albany Research Institute, Inc.||2|||f||||t||||||||No||2017-10-10 21:35:07.872641|2017-10-10 21:35:07.872641
NCT02972983|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-06-26|||November 2016||2016-11-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|DASH||Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia|Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia|Recruiting||Phase 4|102|Anticipated|McGill University Health Center||2|||f||||t||||||||Undecided|We will make this available under the right conditions including the appropriate data sharing agreements and ethics applications under Quebec law.|2017-10-10 21:35:07.957849|2017-10-10 21:35:07.957849
NCT02972970|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-06-08|||October 2016||2016-10-01|June 2017|2017-06-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|||"Feasibility Study to Assess the Scan, Fit and Print Process for the Aveera Patient Matched CPAP Mask"|"Feasibility Study to Assess the Scan, Fit and Print Process for the Aveera Patient Matched CPAP Mask"|Completed||N/A|13|Actual|Metamason||1|||f||||f||||||||No|there is no plan to share individual data|2017-10-10 21:35:08.084497|2017-10-10 21:35:08.084497
NCT02972957|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-23|||January 2017||2017-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|NASIMMUNE||A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia|A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia - The NASIMMUNE Study|Not yet recruiting||Phase 4|365|Anticipated|Medical Research Council Unit, The Gambia||4|||f||||t||||||||No||2017-10-10 21:35:08.178255|2017-10-10 21:35:08.178255
NCT02972944|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-28|||October 2016||2016-10-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients|A Prospective Randomized Multi-center Study of Acute Cholecystitis in the Elderly: Comparison of Laparoscopic Cholecystectomy vs. Conservative Treatment With Antibiotics|Recruiting||N/A|200|Anticipated|Kuopio University Hospital||2|||f||||t||||||||No||2017-10-10 21:35:08.287522|2017-10-10 21:35:08.287522
NCT02972931|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-09-06|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|LoViReT||LoViReT (Low Viral Reservoir Treated Patients)|Impact of Antiretroviral Treatment and Predictors in Subjects With Extremely Low HIV-1 Reservoir: Optimization of New Cure Strategies|Not yet recruiting||N/A|80|Anticipated|IrsiCaixa|||2||f||||f||||||||||2017-10-10 21:35:08.412524|2017-10-10 21:35:08.412524
NCT02972918|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-09-20|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2017|Actual|2017-09-01||Interventional|OPL||Preoperative levosimendán and Hip Fracture|Preoperative Optimization Levosimendan in Heart Failure Patients Undergoing Hip Fracture|Recruiting||N/A|30|Anticipated|Hospital Universitario de Canarias||1|||f||||f||||||||||2017-10-10 21:35:08.51786|2017-10-10 21:35:08.51786
NCT02972905|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-01-16|||October 2016||2016-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects|A Single Center, Double-blind, Randomized, Placebo-controlled, Parallel, Single and Repeat, Dose-ascending Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA™ Dry Powder Inhaler to Healthy Japanese Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline||8|||f||||f||||||||||2017-10-10 21:35:08.637115|2017-10-10 21:35:08.637115
NCT02971800|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-03-21|||August 2016||2016-08-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy|Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy|Active, not recruiting||N/A|30|Actual|CHU de Quebec-Universite Laval||1|||f||||t||||||||No||2017-10-10 21:35:08.766999|2017-10-10 21:35:08.766999
NCT02971787|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-06-06|||November 2016||2016-11-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Salt Intake and Lactobacillus Abundance|Influence of Increased Salt Intake on Lactobacillus Abundance in Healthy Men|Completed||N/A|8|Actual|Charite University, Berlin, Germany||1|||f||||f||||||||No||2017-10-10 21:35:08.84887|2017-10-10 21:35:08.84887
NCT02971774|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-02-28|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Observational|||Development of a Multimodal Approach to Assess Stroke Patients Daily Life Activities|Development of a Multimodal Approach to Assess Stroke Patients Daily Life Activities and Development of a New Tool to Evaluate the Impact of Botulinum Toxin Injection on Patients Social Integration|Recruiting||N/A|190|Anticipated|Centre d'Investigation Clinique et Technologique 805|||2||f||||f||||||||No||2017-10-10 21:35:08.938245|2017-10-10 21:35:08.938245
NCT02972892|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-06-27|||June 9, 2017||2017-06-09||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:35:09.025044|2017-10-10 21:35:09.025044
NCT02972879|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-05|||March 1, 2018|Anticipated|2018-03-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Effectiveness of Non-surgical Interventions for the Trigger Finger: a Randomized Clinical Trial|Effectiveness of Non-surgical Interventions for the Trigger Finger: a Randomized Clinical Trial|Not yet recruiting||N/A|132|Anticipated|Federal University of São Paulo||2|||f||||t|f|f||||||||2017-10-10 21:35:09.080085|2017-10-10 21:35:09.080085
NCT02972866|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-09-14|||March 1, 2018|Anticipated|2018-03-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|RINEX32||Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis|Phase III, Multicenter, Randomized, Simple-blinded, Paralel Groups to Evaluate Non Inferiority of Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Persistent Rhinitis Moderate to Severe|Not yet recruiting||Phase 3|456|Anticipated|Eurofarma Laboratorios S.A.||2|||f||||f|f|f||||||||2017-10-10 21:35:09.1936|2017-10-10 21:35:09.1936
NCT02972853|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-04-19|||September 2016||2016-09-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|MindfulPCMRI||Mindful Self-Regulation fMRI Pilot Study|Mindfulness Influences on Self-Regulation: Mental and Physical Health Implications: Mindful Self-Regulation fMRI Pilot Study|Enrolling by invitation||N/A|26|Anticipated|Cambridge Health Alliance||1|||f||||f||||||||No||2017-10-10 21:35:09.292222|2017-10-10 21:35:09.292222
NCT02972840|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-10-03|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|April 2023|Anticipated|2023-04-01|October 2022|Anticipated|2022-10-01||Interventional|||A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma|A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination With Acalabrutinib (ACP-196) in Subjects With Previously Untreated Mantle Cell Lymphoma|Recruiting||Phase 3|546|Anticipated|Acerta Pharma BV||2|||f||||t|t|f||||||||2017-10-10 21:35:09.381671|2017-10-10 21:35:09.381671
NCT02972827|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-22|||October 2015||2015-10-01|November 2016|2016-11-01||||March 2017|Anticipated|2017-03-01||Interventional|||Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic Shock|Comparison of the Accuracy of Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic Shock|Recruiting||Phase 1|50|Anticipated|Santa Barbara Cottage Hospital||1|||f||||f||||||||No||2017-10-10 21:35:09.616004|2017-10-10 21:35:09.616004
NCT02972814|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-06-28|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|T-POCT||Time Gain in the Diagnosis Myocardial Infarction by Troponin Point of Care Testing in the Emergency Room|Time Gain in the Diagnosis of Non-ST Elevation Myocardial Infarction by Troponin Point of Care Testing in the Emergency Room|Recruiting||N/A|50|Anticipated|Ziekenhuis Oost-Limburg|||1||f||||f||||||||No||2017-10-10 21:35:09.722487|2017-10-10 21:35:09.722487
NCT02972801|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-11-29|||January 2010||2010-01-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Testicular Tissue Cryopreservation for Fertility Preservation|Testicular Tissue Cryopreservation for Fertility Preservation in Patients Facing Infertility-causing Diseases or Treatment Regimens|Recruiting||N/A|250|Anticipated|University of Pittsburgh||1|||f||||t||||||||Yes|The investigators will publish individual participant data. The investigators will also report each individual participants data back to them. Participants will be identified with unique ID numbers. No identifiable information will be shared.|2017-10-10 21:35:09.837783|2017-10-10 21:35:09.837783
NCT02972788|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-22|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of Enamel Matrix Proteins on Clinical Attachment Level and Alveolar Bone in Periodontal Maintenance Patients||Not yet recruiting||N/A|50|Anticipated|University of Nebraska||2|||f||||f||||||||No||2017-10-10 21:35:09.943476|2017-10-10 21:35:09.943476
NCT02972775|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-01-30|||January 2005||2005-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|MORTCOP||15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease|Principal Investigator, Pulmonologist, Martijn de Kruif, MD, PhD|Recruiting||N/A|800|Anticipated|Zuyderland Medisch Centrum|||1||f||||f||||||||No||2017-10-10 21:35:10.027972|2017-10-10 21:35:10.027972
NCT02972762|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-13|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Anesthesia Depth's Influence on Postoperative Delirium|The Clinical Investigation of Anesthesia Depth's Influence in Total Intravenous Anesthesia on Postoperative Delirium of Elderly Patients|Recruiting||Early Phase 1|80|Anticipated|Xiangya Hospital of Central South University||2|||f||||||||||||||2017-10-10 21:35:10.117093|2017-10-10 21:35:10.117093
NCT02972749|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||MLS and Glaucoma - RCT|Modifiable Factors in the Management of Glaucoma - a Randomized Controlled Trial|Recruiting||N/A|25|Anticipated|Wolfson Medical Center||2|||f||||||||||||||2017-10-10 21:35:10.195181|2017-10-10 21:35:10.195181
NCT02972736|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-04-04|||January 2016||2016-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|RODEO||RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study|RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study|Completed||N/A|17711|Actual|Ospedale Sandro Pertini, Roma|||3||f||||f||||||||||2017-10-10 21:35:10.265538|2017-10-10 21:35:10.265538
NCT02972723|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-22|||March 2011||2011-03-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Metformin Therapy in HCV Infection|A Study of the Antiviral Activity of Metformin as an Anti-Hepatitis C Virus Agent in Patients With Chronic Hepatitis C Virus Infection|Completed||Phase 4|16|Actual|Nottingham University Hospitals NHS Trust||1|||f||||t||||||||||2017-10-10 21:35:10.33421|2017-10-10 21:35:10.33421
NCT02972710|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain|A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain: A Randomized Control Trial|Recruiting||N/A|76|Anticipated|Northern Arizona University||2|||f||||f||||||||No||2017-10-10 21:35:10.411265|2017-10-10 21:35:10.411265
NCT02972697|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-04-12|||November 2016||2016-11-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB|Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB|Recruiting||Phase 1|5|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-10 21:35:10.490267|2017-10-10 21:35:10.490267
NCT02972684|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-18|||January 3, 2017|Actual|2017-01-03|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|IMOTEC||Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass|Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery Using Conventional Blood Coagulation Tests or Thrombo-elastographic Point of Care Test - IMOTEC|Recruiting||N/A|1000|Anticipated|Nantes University Hospital||2|||f||||f||||||||No||2017-10-10 21:35:10.574752|2017-10-10 21:35:10.574752
NCT02972671|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-04-01|||November 2016||2016-11-01|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2018|Anticipated|2018-03-01||Interventional|DESSOLVEJ||Trial of MiStent Compared to Xience in Japan|Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MT005) for Revascularization of Coronary Arteries|Active, not recruiting||N/A|120|Actual|Micell Technologies||2|||f||||t||||||||No||2017-10-10 21:35:10.74009|2017-10-10 21:35:10.74009
NCT02972658|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-10-03|||March 15, 2017|Actual|2017-03-15|October 2017|2017-10-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia|A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)|Enrolling by invitation||Phase 3|1400|Anticipated|Eli Lilly and Company||4|||f||||t|t|f||||||||2017-10-10 21:35:10.843883|2017-10-10 21:35:10.843883
NCT02972645|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-07-21|||December 5, 2016|Actual|2016-12-05|July 2017|2017-07-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Interventional|||A Study of LY3305677 in Healthy Participants|A First-in-Human, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3305677 in Healthy Subjects|Completed||Phase 1|66|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:35:13.053126|2017-10-10 21:35:13.053126
NCT02972632|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-22|||December 22, 2016|Actual|2016-12-22|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder|An Open-Label, Single-Arm, Multicenter, Prospective, Phase 4, Interventional, Flexible Dose Study to Evaluate the Effectiveness of Vortioxetine on Goal Achievement After a Change in Antidepressant Medication for the Treatment of Subjects With Major Depressive Disorder|Recruiting||Phase 4|120|Anticipated|Takeda||1|||f||||f||||||||||2017-10-10 21:35:13.153078|2017-10-10 21:35:13.153078
NCT02972619|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health|Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health - A Cluster Randomized Trial in Singapore Polyclinics|Not yet recruiting||N/A|1000|Anticipated|Duke-NUS Graduate Medical School||2|||f||||t||||||||No||2017-10-10 21:35:13.309727|2017-10-10 21:35:13.309727
NCT02972606|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-05|||November 2016||2016-11-01|September 2016|2016-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|||OPEN Study: Pain Management Treatment Needs Interviews|Online Psychological Treatment for People With Painful HIV-related Peripheral Neuropathy (OPEN Study): Qualitative Investigation of Treatment Needs|Completed||N/A|26|Actual|King's College London|||1||f||||f||||||||||2017-10-10 21:35:13.396508|2017-10-10 21:35:13.396508
NCT02972593|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-01-03|||March 2014||2014-03-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|ORACL||ORthopaedic Trauma Anemia With Conservative Versus Liberal Transfusion|ORthopaedic Trauma Anemia With Conservative Versus Liberal Transfusion|Enrolling by invitation||Phase 4|300|Anticipated|Indiana University||2|||f||||t||||||||No||2017-10-10 21:35:13.574208|2017-10-10 21:35:13.574208
NCT02972580|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-10|||June 2016||2016-06-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD|Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD)|Recruiting||N/A|250|Anticipated|Nationwide Children's Hospital|||3||f||||f||||||Samples With DNA|"     The blood sample for genetic testing will be delivered to the Molecular Genetics lab at     Nationwide Children's Hospital, where genomic DNA will be isolated from peripheral white     blood cells. DNA will be banked frozen while a portion of the sample will be delivered to the     Emory Molecular Genetics Laboratories for testing of the DMD gene.   "|||2017-10-10 21:35:13.657737|2017-10-10 21:35:13.657737
NCT02972567|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-21|||May 2016||2016-05-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|PROSIR||Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver Disease|Evaluation of the Effect of a Lactobacillus Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver Disease in Obese Subjects With Insulin Resistance|Recruiting||Phase 2|60|Anticipated|Biosearch S.A.||2|||f||||f||||||||No||2017-10-10 21:35:13.773767|2017-10-10 21:35:13.773767
NCT02972554|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-01-13|||January 2016||2016-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Does Propranolol Attenuate Inflammatory Responses to a Psychological Stressor?|Beta-Blockers and Stress|Recruiting||Phase 4|80|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:35:13.884455|2017-10-10 21:35:13.884455
NCT02972541|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-12-06|||September 2016||2016-09-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|NACSOC||Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer|NeoAdjuvant Chemotherapy Versus Surgery Alone After Stent Placement for Left-sided Obstructive Colonic Cancer: a Multicenter Randomized Controlled Trial (NACSOC Trial)|Recruiting||N/A|248|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||No||2017-10-10 21:35:14.046531|2017-10-10 21:35:14.046531
NCT02972528|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-02-23|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer|Allogeneic Defibrinated Platelet Rich Plasma Lysate for the Healing of Chronic Diabetic Foot Ulcer|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Jordan||2|||f||||t|f|f||||||Undecided||2017-10-10 21:35:14.282698|2017-10-10 21:35:14.282698
NCT02972515|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-05-01|||January 2013||2013-01-01|November 2016|2016-11-01|December 30, 2016|Actual|2016-12-30|December 2015|Actual|2015-12-01||Interventional|Imagery||Mobile Application for Guided Imagery to Address Smoking, Diet and Physical Activity|Mobile Application for Guided Imagery to Address Smoking, Diet and Physical Activ|Completed||N/A|166|Actual|University of Arizona||1|||f||||f||||||||No||2017-10-10 21:35:14.375913|2017-10-10 21:35:14.375913
NCT02972502|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-22|||February 2014||2014-02-01|May 2017|2017-05-01|January 1, 2027|Anticipated|2027-01-01|April 24, 2017|Actual|2017-04-24||Interventional|||Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department|Investigating the Efficacy of Using Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department: A Prospective Randomized Clinical Trial|Suspended||Phase 4|104|Anticipated|OhioHealth||2||PI lapsed institutional training|f||||f||||||||No||2017-10-10 21:35:14.458394|2017-10-10 21:35:14.458394
NCT02972489|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-21|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Using 3D Imaging to Optimize Bifurcation Stenting|On-line 3-dimensional Optical Frequency Domain Imaging to Optimize Bifurcation Stenting Using UltiMaster Stent: OPTIMUM Study|Not yet recruiting||Phase 4|106|Anticipated|Increase Co., Ltd.||2|||f||||t||||||||No||2017-10-10 21:35:14.550089|2017-10-10 21:35:14.550089
NCT02972476|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-05-01|||December 2016||2016-12-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MUSIC||Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial|Investigating the Mechanism of Inhaled Corticosteroids Associated Pneumonia by Longitudinal Characterisation of the Airway Microbiome in Patients With Severe COPD|Recruiting||Phase 4|200|Anticipated|University of Dundee||4|||f||||f||||||||Undecided||2017-10-10 21:35:14.655644|2017-10-10 21:35:14.655644
NCT02972463|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-12|||January 2017||2017-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||The Influence of IgY Max on Inflammatory Markers and the Gut Microbiome|A Randomized, Double-blind, Placebo-controlled, Parallel Dose Ranging Study on the Influence of IgY Max on Inflammatory Markers and the Gut Microbiome|Recruiting||Phase 1/Phase 2|100|Anticipated|Igy Nutrition, LLC||4|||f||||f||||||||||2017-10-10 21:35:14.800092|2017-10-10 21:35:14.800092
NCT02972450|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-21|||February 2017||2017-02-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|EHVAT01||An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection|A Phase IIb Randomised Therapeutic HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection|Not yet recruiting||Phase 2|170|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||4|||f||||t||||||||No||2017-10-10 21:35:14.897731|2017-10-10 21:35:14.897731
NCT02972437|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-27|||December 2016||2016-12-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Detection of Group A Streptococcus (GAS) in Oral Cavity|Detection of Group A Streptococcus (GAS) in Oral Cavity Using Molecular Techniques|Not yet recruiting||N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||No||2017-10-10 21:35:14.986131|2017-10-10 21:35:14.986131
NCT02972424|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-08-08|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|December 2020|Anticipated|2020-12-01||Interventional|||PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial|PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial|Recruiting||Phase 2|100|Anticipated|Helen Hayes Hospital||2|||f||||t|t|f||||||||2017-10-10 21:35:15.084271|2017-10-10 21:35:15.084271
NCT02972411|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-11-21|||October 2016||2016-10-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness|Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness: A Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|Hospital del Trabajador de Santiago||2|||f||||f||||||||No||2017-10-10 21:35:15.253503|2017-10-10 21:35:15.253503
NCT02972398|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2016-11-20|||September 2015||2015-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders|N-Acetyl Cysteine add-on to Antidepressant Medication in Therapy Refractory Major Depressive Disorder Patients With Increased Inflammatory Activity|Recruiting||N/A|200|Anticipated|Tianjin Anding Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:35:15.366484|2017-10-10 21:35:15.366484
NCT02972385|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-07-31|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Pharmacogenomics of Warfarin in Hispanics and Latinos|Pharmacogenomics of Warfarin in Hispanics and Latinos|Recruiting||N/A|400|Anticipated|University of Arizona|||1||f||||f||||||Samples With DNA|"     Retention: Samples with DNA Description: Isolated DNA will be stored in freezers at minus 80     degrees.   "|||2017-10-10 21:35:15.478975|2017-10-10 21:35:15.478975
NCT02972372|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-04-18|||November 2016||2016-11-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|CELAEC||Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer|A Randomized, Open-label, Multicenter Trial of the Chemoradiation Versus Standard Esophagectomy for Locally Advanced Resectable Esophageal Squamous Cell Cancer in Chinese Patients|Recruiting||N/A|196|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology||2|||f||||t||||||||No||2017-10-10 21:35:15.558167|2017-10-10 21:35:15.558167
NCT02972359|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-07|||December 20, 2016|Actual|2016-12-20|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Safety of Intravenous Neridronic Acid in CRPS|Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)|Recruiting||Phase 3|220|Anticipated|Grünenthal GmbH||1|||f||||t|t|f||||||||2017-10-10 21:35:15.693726|2017-10-10 21:35:15.693726
NCT02972346|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-20|||November 2016||2016-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Availability Study of ACTH to Treat Children SRNS/SDNS|Availability and Safety Study of ACTH to Treat Children SRNS/SDNS|Recruiting||N/A|42|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||Yes||2017-10-10 21:35:15.888695|2017-10-10 21:35:15.888695
NCT02972333|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-20|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M|Open Label, Multi-center, Prospective Study to Investigate the Efficacy and Safety of AZD9291 in Brain Metastases From Patients With EGFR T790M Positive NSCLC Who Have Received Prior Therapy With an EGFR-TKI|Not yet recruiting||Phase 3|150|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||t||||||||No||2017-10-10 21:35:16.005019|2017-10-10 21:35:16.005019
NCT02972320|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-11-22|||June 2016||2016-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic|Lobaplatin Combined With Etoposide for First-line Treatment in Extensive Stage Sclc Then Benefit Patients Follow up Temozolomide Maintain Therapeutic|Recruiting||Phase 2|60|Anticipated|China Medical University, China||1|||f||||t||||||||No||2017-10-10 21:35:16.114732|2017-10-10 21:35:16.114732
NCT02972307|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-21|||July 2016||2016-07-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Observational|||Caregiver-aided Powered Wheelchair Skills|The Extent to Which Caregivers Enhance the Wheelchair Skills of Powered Wheelchair Users: a Descriptive Cross-sectional Study|Recruiting||N/A|125|Anticipated|Nova Scotia Health Authority|||1||f||||f||||||||Undecided||2017-10-10 21:35:16.204234|2017-10-10 21:35:16.204234
NCT02972294|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-03-31|||March 31, 2017|Actual|2017-03-31|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|HiFIT||HiFIT Study : Hip Fracture: Iron and Tranexamic Acid|HiFIT Study: Interest of Intravenous Iron and Tranexamic Acid to Reduce Transfusion in Hip Fracture Patients|Recruiting||Phase 3|780|Anticipated|University Hospital, Angers||4|||f||||f|f|f||||||No||2017-10-10 21:35:16.291192|2017-10-10 21:35:16.291192
NCT02972281|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-23|||March 2015||2015-03-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|SPIDAC||Systematic Search for Primary Immunodeficiency in Adults With Infections|Systematic Search for Primary Immunodeficiency in Adults With Unexplained Recurrent and/or Severe Infections With Encapsulated Bacteria|Recruiting||N/A|240|Anticipated|University Hospital, Lille||1|||f||||f||||||||Undecided||2017-10-10 21:35:16.49652|2017-10-10 21:35:16.49652
NCT02968329|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-08-09|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Left Atrial Function in Recurrent Stroke of Unknown Cause|Left Atrial Function as Predictor of Recurrent Stroke or Paroxysmal Atrial Fibrillation in Patients With Cryptogenic Stroke|Completed||N/A|500|Actual|Hasselt University|||4||f||||f||||||||||2017-10-10 21:35:53.361884|2017-10-10 21:35:53.361884
NCT02972268|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-22|||January 2016||2016-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH|Clinical Trial to Compare the Efficacy and Safety of Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia|Recruiting||Phase 3|734|Anticipated|Jeil Pharmaceutical Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:35:16.603757|2017-10-10 21:35:16.603757
NCT02972255|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-05-18|||October 31, 2016|Actual|2016-10-31|May 2017|2017-05-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of RO7079901 Administered Intravenously Both Alone and in Combination With Meropenem in Adult Healthy Volunteers|Completed||Phase 1|46|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-10 21:35:16.725653|2017-10-10 21:35:16.725653
NCT02972242|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-21|||November 2014||2014-11-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|FOCUS-CCTA||Focused Field of View Calcium Scoring Prior to Coronary CT Angiography|Focused Field of View Calcium Scoring Prior to Coronary CT Angiography|Enrolling by invitation||N/A|175|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||||2017-10-10 21:35:16.961104|2017-10-10 21:35:16.961104
NCT02972229|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Whole Versus Partial Vertebral Body IMRT for Spinal Metastases|Whole Versus Partial Vertebral Body IMRT for Spinal Metastases|Not yet recruiting||N/A|60|Anticipated|Wuhan Union Hospital, China||2|||f||||t||||||||No||2017-10-10 21:35:17.032281|2017-10-10 21:35:17.032281
NCT02972216|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-21|||November 2014||2014-11-01|November 2016|2016-11-01||||October 2016|Actual|2016-10-01||Observational|||Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy|A Post-marketing Surveillance Study to Evaluate the Effectiveness and Safety of Docetaxel-Based Chemotherapy|Completed||Phase 4|40|Actual|Yung Shin Pharm. Ind. Co., Ltd.|||2||f||||||||||||||2017-10-10 21:35:17.093269|2017-10-10 21:35:17.093269
NCT02972203|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-22|||October 2015||2015-10-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|MINDFUL-PC||MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home|MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study|Active, not recruiting||N/A|87|Actual|Cambridge Health Alliance||2|||f||||f||||||||||2017-10-10 21:35:17.181189|2017-10-10 21:35:17.181189
NCT02972190|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-24|||November 2016||2016-11-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Clinical Study of Bilateral Decompression With Interbody Fusion for Spondylolisthesis|Clinical Study of Bilateral Decompression With Interbody Fusion for Spondylolisthesis|Recruiting||N/A|90|Anticipated|Shanghai 9th People's Hospital||2|||f||||||||||||||2017-10-10 21:35:17.329698|2017-10-10 21:35:17.329698
NCT02972177|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2016-11-21|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Transbronchial Ablation for Peripheral Lung Cancer|The Clinical Study of Navigation Bronchoscopy Guided Ablation for the Treatment of Early-stage Peripheral Lung Cancer|Not yet recruiting||N/A|80|Anticipated|Shanghai Chest Hospital||3|||f||||f||||||||No||2017-10-10 21:35:17.48217|2017-10-10 21:35:17.48217
NCT02972164|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-22|||August 2013||2013-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Adapted Cognitive Behavioral Approach to Addressing Overweight and Obesity Among Qatari Youth|Adapted Cognitive Behavioural Approach to Addressing Overweight and Obesity Among Qatari Youth|Recruiting||N/A|1000|Anticipated|Qatar University||2|||f||||t||||||||No||2017-10-10 21:35:17.584478|2017-10-10 21:35:17.584478
NCT02972151|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-21|||November 2016||2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae|Clinical Promotion Research of Complex Treatment With TCM to Diagnosis and Treatment on Different Syndrome Types of Pelvic Inflammatory Disease Sequelae|Not yet recruiting||Phase 2|175|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||No||2017-10-10 21:35:17.690778|2017-10-10 21:35:17.690778
NCT02972138|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-10-05|||January 2010||2010-01-01|December 2015|2015-12-01|September 2017|Actual|2017-09-01|December 2015|Actual|2015-12-01||Observational|||Vitamin D and Bisphosphonates in the Treatment of Sickle Cell Disease|Vitamin D Supplementation and Anti-resorptive Therapy (Bisphosphonates) Treatment of Young Adult Patients With Sickle Cell Disease|Completed||N/A|80|Actual|Società Italiana Talassemie ed Emoglobinopatie|||1||f||||f||||||||||2017-10-10 21:35:17.786356|2017-10-10 21:35:17.786356
NCT02972125|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-03-09|||November 2016||2016-11-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subjects|A Single-Center, Open-Label, Randomized, Single-Oral Dose, 2-Way Cross-Over Study to Investigate the Bioequivalence Between Lacosamide Tablet and Dry Syrup in Healthy Male Japanese Subjects|Completed||Phase 1|24|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-10 21:35:17.883584|2017-10-10 21:35:17.883584
NCT02972112|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Ultrashort Cognitive Behavioral Intervention for Tokophobia- A Prospective Randomized Single Blinded Controlled Trial|Ultrashort Cognitive Behavioral Intervention for Tokophobia- A Prospective Randomized Single Blinded Controlled Trial|Not yet recruiting||N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-10 21:35:17.970432|2017-10-10 21:35:17.970432
NCT02972099|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-12|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|TcPRF||Pulsed Radiofrequency for Emotional Stress|The Psychological Effects of Transcutaneous Pulsed Radiofrequency (TcPRF) in Patients With Emotional Stress|Recruiting||N/A|50|Anticipated|Swiss Paraplegic Centre Nottwil||2|||f||||t||||||||||2017-10-10 21:35:18.051894|2017-10-10 21:35:18.051894
NCT02972086|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-07|||January 7, 2017|Actual|2017-01-07|September 2017|2017-09-01|August 7, 2017|Actual|2017-08-07|August 7, 2017|Actual|2017-08-07||Interventional|||Improving Behavioral Health Care for Children With ADHD|Improving Behavioral Health Care for Children With ADHD: Integration of Family Peer Advocates to Deliver Behavioral Parent Training in Pediatric Care Settings|Completed||N/A|7|Actual|New York University School of Medicine||1|||f||||f|f|f||||||||2017-10-10 21:35:18.135579|2017-10-10 21:35:18.135579
NCT02972073|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-08-28|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigation of Trunk Neuromuscular Control in Patients With Non-specific Low Back Pain|Investigation of Trunk Neuromuscular Control in Patients With Non-specific Low Back Pain|Recruiting||N/A|272|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-10 21:35:18.209532|2017-10-10 21:35:18.209532
NCT02972060|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-28|||March 2017||2017-03-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|March 2020|Anticipated|2020-03-01||Interventional|||ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer|A Phase 2 Randomized Open-Label Study of Oral ODM-201 vs. Androgen Deprivation Therapy (ADT) With LHRH Agonists or Antagonist in Men With Hormone Naive Prostate Cancer|Not yet recruiting||Phase 2|250|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||No||2017-10-10 21:35:18.322132|2017-10-10 21:35:18.322132
NCT02972047|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-23|||December 2016||2016-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux|Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux|Not yet recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:35:18.427688|2017-10-10 21:35:18.427688
NCT02972034|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-12|||January 13, 2017|Actual|2017-01-13|September 2017|2017-09-01|December 20, 2020|Anticipated|2020-12-20|December 20, 2020|Anticipated|2020-12-20||Interventional|||Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)|A Phase Ib Study to Evaluate the Safety and Tolerability of MK-8353 in Combination With Pembrolizumab in Patients With Advanced Malignancies|Recruiting||Phase 1|96|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||f|t|f||||||||2017-10-10 21:35:18.519229|2017-10-10 21:35:18.519229
NCT02972021|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||High Flow Nasal Cannulae Oxygen Therapy in Respiratory Insufficiency Patients|High Flow Nasal Cannulae Oxygen Therapy in Respiratory Insufficiency Patients|Not yet recruiting||N/A|300|Anticipated|Shanghai 10th People's Hospital||2|||f||||t||||||||||2017-10-10 21:35:18.624311|2017-10-10 21:35:18.624311
NCT02972008|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-05-18|||March 9, 2017|Actual|2017-03-09|May 2017|2017-05-01|February 2022|Anticipated|2022-02-01|February 2019|Anticipated|2019-02-01||Observational|METHYSTROKE||Identification of Epigenetic Risk Factors for Ischemic Complication During the TAVR Procedure in the Elderly|Identification of Epigenetic Risk Factors for Ischemic Complication During the TAVR Procedure in the Elderly|Recruiting||N/A|542|Anticipated|University Hospital, Lille|||2||f||||t|f|f||||Samples With DNA|"     We compare the pre-operative leukocyte DNA methylation rate measured by the Luminometric     Methylation Assay (LUMA) method in patients treated with TAVI according to the presence or     absence of at least one new cerebral ischemic lesion detected on postoperative cerebral MRI.   "|No||2017-10-10 21:35:18.711547|2017-10-10 21:35:18.711547
NCT02971995|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-21|||December 2014||2014-12-01|June 2015|2015-06-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|PROSTEPIRM||Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies|Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies in Prostate Cancer Patients|Completed||N/A|31|Actual|Lille Catholic University||2|||f||||f||||||||No||2017-10-10 21:35:18.796845|2017-10-10 21:35:18.796845
NCT02971982|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-11-20|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia|Velcade/Dexamethasone/Cyclophosphamide(PCD) Versus Rituximab /Dexamethasone/Cyclophosphamide(RCD) for the Treatment of Patients With Waldenstrom's Macroglobulinemia|Recruiting||Phase 1/Phase 2|40|Anticipated|The First Affiliated Hospital of Soochow University||2|||f||||f||||||||No||2017-10-10 21:35:18.865396|2017-10-10 21:35:18.865396
NCT02971969|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Observational|||Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B|A Long-Term Follow-up Study to Evaluate the Safety, Tolerability, and Efficacy of Adeno-Associated Virus (AAV) rh10-Mediated Gene Transfer of Human Factor IX in Adults With Moderate/Severe to Severe Hemophilia B|Recruiting||Phase 1/Phase 2|12|Anticipated|Dimension Therapeutics|||1||f||||f||||||Samples With DNA|"     Blood   "|Undecided||2017-10-10 21:35:18.95551|2017-10-10 21:35:18.95551
NCT02971956|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-12-07|||December 2016||2016-12-01|December 2016|2016-12-01|June 2024|Anticipated|2024-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Pembrolizumab in Refractory Advanced Esophageal Cancer|A Phase II Study of Pembrolizumab in Refractory Advanced Esophageal Cancer|Not yet recruiting||Phase 2|50|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:35:19.034471|2017-10-10 21:35:19.034471
NCT02971943|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-20|||May 2015||2015-05-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||Classification of Ankle Injury Observed With X-ray Combined With Magnetic Resonance Imaging|Classification of Ankle Injury Observed With X-ray Combined With Magnetic Resonance Imaging: a Retrospective, Self-controlled, Clinical Trial With 3-month Follow-up|Completed||N/A|68|Actual|The First Hospital of Hebei Medical University||1|||f||||t||||||||Undecided||2017-10-10 21:35:19.143258|2017-10-10 21:35:19.143258
NCT02971917|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|ART||A Clinical Study of TRUVIEW ART™(Advanced Reconstruction Tech)to Improve Image Quality on Chest Radiograph|A Clinical Study of TRUVIEW ART(Advanced Reconstruction Tech)to Improve Image Quality on Chest Radiograph|Recruiting||N/A|50|Anticipated|Seoul National University Hospital||1|||f||||f||||||||Yes||2017-10-10 21:35:19.292578|2017-10-10 21:35:19.292578
NCT02971904|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-07-25|||August 2015||2015-08-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|August 2016|Actual|2016-08-01|10 Days|Observational [Patient Registry]|MISTU||Analyzer of Human Milk: Applicability in Clinical Practice in Order to Achieve the Best Nutrition for Infants|Analyzer of Human Milk: Applicability in Clinical Practice in Order to Achieve the Best Nutrition for Infants: Observational Study.|Completed||N/A|30|Actual|Danone Early Life Nutrition Brazil|||1||f||||t||||||||||2017-10-10 21:35:19.376269|2017-10-10 21:35:19.376269
NCT02971891|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-11|||January 2017||2017-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts|A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts|Recruiting||Phase 3|480|Anticipated|Cutanea Life Sciences, Inc.||2|||f||||||||||||||2017-10-10 21:35:19.459278|2017-10-10 21:35:19.459278
NCT02971878|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-23|||November 2016||2016-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparisons of Human Embryonic Development Using Single Medium With and Without the Addition of Antioxidants|Adding Antioxidants Into Human Embryo Culture Media|Recruiting||N/A|128|Anticipated|Fertilitetscentrum AB||2|||f||||t||||||||||2017-10-10 21:35:19.607433|2017-10-10 21:35:19.607433
NCT02971865|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-20|||June 2015||2015-06-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Manual Medicine or Cognitive Behavioral Therapy With Chronic Uncontrolled Diabetes|Effect of Manual Medicine or Cognitive Behavioral Therapy With Chronic Uncontrolled Diabetes Within a Shared Primary Care Visit (A Randomized Clinical Trial)|Completed||N/A|72|Actual|Community Wellness Center, West Linn, OR||2|||f||||t||||||||Yes|Plan to share individual participant data with other researchers via Journal of Manipulative and Physiological Therapeutics (JMPT). Also, annual collaborative of primary care providers in Oregon.|2017-10-10 21:35:19.688445|2017-10-10 21:35:19.688445
NCT02971852|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-07-18|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Effects of Hypnosis on Skin Temperature|Hypnotic Glove Anesthesia: Effects of Hypnosis on Skin Temperature Measured by Infrared Thermography|Completed||N/A|30|Actual|Claude Bernard University|||1||f||||f||||||||||2017-10-10 21:35:19.766218|2017-10-10 21:35:19.766218
NCT02971839|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-09-06|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations|A Phase 2, Randomized, Parallel-Group, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of CTP-656 With an Open-Label Active Comparator in Patients With Cystic Fibrosis With CFTR Gating Mutations.|Terminated||Phase 2|11|Actual|Vertex Pharmaceuticals Incorporated||5||Decision by Sponsor.|f||||t||||||||||2017-10-10 21:35:19.842199|2017-10-10 21:35:19.842199
NCT02971826|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-10-05|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|REVIVE SE||Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke|Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke|Not yet recruiting||N/A|15|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:35:19.939839|2017-10-10 21:35:19.939839
NCT02971813|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-07-13|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|April 27, 2018|Anticipated|2018-04-27|February 27, 2018|Anticipated|2018-02-27||Interventional|||A Social Media Intervention for Exercise Motivation and Cardiac Rehabilitation Adherence|Feasibility of a Social Media Intervention for Exercise Motivation and Cardiac Rehabilitation Adherence|Recruiting||N/A|60|Anticipated|The Cleveland Clinic||2|||f||||f|f|f||||||||2017-10-10 21:35:20.047556|2017-10-10 21:35:20.047556
NCT02971748|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-05-30|||January 26, 2017|Actual|2017-01-26|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A Study of Anti-PD-1 (Pembrolizumab) + Hormonal Therapy in HR-positive Localized IBC Patients With Non-pCR to Neoadjuvant Chemotherapy|A Phase II Study of Anti-PD-1 (Pembrolizumab) in Combination With Hormonal Therapy in Patients With Hormone Receptor (HR)-Positive Localized Inflammatory Breast Cancer (IBC) Who Did Not Achieve a Pathological Complete Response (pCR) to Neoadjuvant Chemotherapy|Recruiting||Phase 2|37|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:35:20.427063|2017-10-10 21:35:20.427063
NCT02971735|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-20|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cognitive Style and Mobile Technology in E-learning in Undergraduate Medical Education|Cognitive Style and Mobile Technology in E-learning in Undergraduate Medical Education- A Randomized Controlled Trial of Otolaryngology-head and Neck Surgery|Not yet recruiting||N/A|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||No|The individua participant data of UME students may be not suitable to be available to other researchers|2017-10-10 21:35:20.571311|2017-10-10 21:35:20.571311
NCT02971722|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-12-05|||December 2016||2016-12-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|May 2017|Anticipated|2017-05-01||Interventional|||a Study of JY09 in Chinese Healthy Subjects|Randomized,Double-blind,Placebo-controlled,Dose-escalating Phase I,Healthy Subjects Study of JY09,a Recombinant GLP-1 Receptor Agonist|Not yet recruiting||Phase 1|26|Anticipated|Beijing Dongfang Biotech Co., Ltd.||8|||f||||f||||||||No||2017-10-10 21:35:20.697369|2017-10-10 21:35:20.697369
NCT02971709|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-07-24|||July 2010||2010-07-01|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|Shade||Use of Shade in U.S. and Australian City Parks|Norms and Built Environment: Use of Shade in U.S. and Australian City Parks|Completed||N/A|144|Actual|Klein Buendel, Inc.||2|||f||||f||||||||||2017-10-10 21:35:20.79095|2017-10-10 21:35:20.79095
NCT02971696|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-03-15|||December 2016||2016-12-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients.|Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. Prospective Phase III Study|Recruiting||Phase 3|20|Anticipated|Ain Shams University||2|||f||||t||||||||Yes||2017-10-10 21:35:20.874686|2017-10-10 21:35:20.874686
NCT02971124|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-22|||February 2017||2017-02-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Observational|||Dr Solitaire: Assessing Cognitive Performance Through Meaningful Play|Observational Study to Assess Cognitive Performance in Elderly Life Via Meaning Play|Not yet recruiting||N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||Undecided||2017-10-10 21:35:26.073943|2017-10-10 21:35:26.073943
NCT02971670|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-05-12|2017-03-28||October 2015||2015-10-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial|Amendment of Phase 1 Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults|Completed||Phase 1|23|Actual|Biomedizinische Forschungs gmbH||4|||f||||t||||||||Yes||2017-10-10 21:35:21.37095|2017-10-10 21:35:21.37095
NCT02971657|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2016-11-23|||November 2011||2011-11-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|StaphType||Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients` Clinical Outcome in Orthopedic Device Related Bone Infections|Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients` Clinical Outcome in Orthopedic Device Related Bone Infections|Completed||N/A|126|Actual|BG Unfallklinik|||1||f||||f||||||Samples Without DNA|"     Bacterial samples from orthopaedic device related infections   "|||2017-10-10 21:35:21.815331|2017-10-10 21:35:21.815331
NCT02971644|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-20|||December 2014||2014-12-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||Cobalt Alloy Pedicle Screw Implantation for Severe Kyphosis Deformity in Spinal Tuberculosis|Cobalt Alloy Pedicle Screw Implantation for Severe Kyphosis Deformity in Spinal Tuberculosis: a Selfcontrolled Trial|Active, not recruiting||N/A|84|Anticipated|Affiliated Hospital of Hebei University||1|||f||||t||||||||Undecided||2017-10-10 21:35:21.914323|2017-10-10 21:35:21.914323
NCT02971631|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-20|||January 2017||2017-01-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Gastrectomy, Eating Behaviour and GLP-1|The Effect of Glucagon Like Peptide-1 (GLP-1) on Glycaemic Profile and Eating Behaviour Following Gastrectomy|Not yet recruiting||N/A|16|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:35:21.997517|2017-10-10 21:35:21.997517
NCT02971605|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-21|2017-07-17|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Persisting Effects of Psilocybin|Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin|Recruiting||Phase 1/Phase 2|12|Anticipated|Johns Hopkins University||1|||f||||f|t|f||||||||2017-10-10 21:35:22.171198|2017-10-10 21:35:22.171198
NCT02971592|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|E_MDcure_LBP||Estimation of Therapeutic Effect of MDcure on Patients With Chronic Lower Back Pain|Estimation of Therapeutic Effect of MDcure on Patients With Chronic Back Pain|Not yet recruiting||Phase 4|40|Anticipated|Assuta Medical Center||2|||f||||f||||||||No||2017-10-10 21:35:22.250506|2017-10-10 21:35:22.250506
NCT02971579|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-28|||September 2016||2016-09-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|November 2016|Actual|2016-11-01||Observational|REQUEST||A Register on the Quality of ERCP and Training of Endoscopists in Italy|A Network on the Quality of ERCP, on the Organization of the Endoscopic Units and on the Training of the Endoscopists in Italy|Recruiting||N/A|1800|Anticipated|ASST Rhodense|||1||f||||f||||||||No||2017-10-10 21:35:22.316113|2017-10-10 21:35:22.316113
NCT02971566|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2016-11-22|||February 2013||2013-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|AREDF-SO||Splanchnic Oxygenation Response to Enteral Feeds in Preterm Infants With Abnormal Antenatal Doppler.|Splanchnic Oxygenation and Perfusion Response to Enteral Feeds in Preterm Infants With Abnormal Antenatal Doppler: Pattern Assessment and Correlation With Feeding Intolerance|Completed||N/A|20|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||2||f||||f||||||||No||2017-10-10 21:35:22.396705|2017-10-10 21:35:22.396705
NCT02971553|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-05-18|||September 2016||2016-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PEEPrest||PEEP Resuscitation Trial|A Randomised Controlled Trial on Positive End-expiratory Pressure (PEEP) During Resuscitation of Non-breathing Neonates|Recruiting||N/A|330|Anticipated|Helse Stavanger HF||2|||f||||t||||||||No||2017-10-10 21:35:22.475359|2017-10-10 21:35:22.475359
NCT02971540|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-03|||February 2016||2016-02-01|July 2017|2017-07-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Interventional|SPI||SPI-directed Analgesia for Lumbar Discectomy|Comparative, Randomized Trial of SPI-directed Intravenous Analgesia Using Metamizole With Tramadol Versus Preemptive Wound Infiltration Using 0,2 % Ropivacaine With Fentanyl or 0,2 % Bupivacaine With Fentanyl for Lumbar Discectomy|Recruiting||N/A|120|Anticipated|Medical University of Silesia||5|||f||||t||||||||||2017-10-10 21:35:22.555823|2017-10-10 21:35:22.555823
NCT02971527|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-12|||February 28, 2017|Actual|2017-02-28|April 2017|2017-04-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||Efficacy and Safety Study of Ultrasound Bone Strength Device to Measure Calcaneal Bone Strength Index of Human Subjects|A Multicenter, Open-Labeled, Self-Paired Study to Examine the Effectiveness and Safety of Ultrasound Bone Strength Device Used for Measuring Calcaneal Bone Strength Index of Human Subjects|Completed||N/A|150|Actual|The Second Hospital of Nanjing Medical University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:35:22.683833|2017-10-10 21:35:22.683833
NCT02971514|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-19|||May 2014||2014-05-01|November 2016|2016-11-01||||April 2015|Actual|2015-04-01||Interventional|||Comparative Efficacy of Dental Flossing Before or After Tooth Brushing on Interproximal Plaque Reduction and Fluoride Retention in That Area||Completed||N/A|25|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-10 21:35:22.766251|2017-10-10 21:35:22.766251
NCT02971488|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-11-19|||January 2017||2017-01-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01|2 Years|Observational [Patient Registry]|||The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID|The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID|Not yet recruiting||N/A|930|Anticipated|Hospital Universitario Infanta Leonor|||1||f||||f||||||||||2017-10-10 21:35:22.973946|2017-10-10 21:35:22.973946
NCT02971475|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-11-19|||November 2016||2016-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||ESWL Versus ESWL and Endoscopic Treatment|Extracorporeal Shock Wave Lithotripsy Versus Extracorporeal Shock Wave Lithotripsy Combined With Endoscopic Treatment for Painful Calcified Chronic Pancreatitis|Not yet recruiting||N/A|62|Anticipated|Changhai Hospital||2|||f||||t||||||||No||2017-10-10 21:35:23.042038|2017-10-10 21:35:23.042038
NCT02971462|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-19|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Remote Ischemic Conditioning for Reducing Stroke Risk of Symptomatic Vertebrobasilar Lesion of Atherosclerosis||Not yet recruiting||N/A|80|Anticipated|Capital Medical University||2|||f||||f||||||||||2017-10-10 21:35:23.131782|2017-10-10 21:35:23.131782
NCT02971449|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Using mHealth Tools to Deliver Integrated Community Case Management (ICCM) to Village Health Team (VHT) Volunteers.|Using mHealth Tools to Deliver Integrated Community Case Management (ICCM) to Village Health Team (VHT) Volunteers in Uganda.|Recruiting||N/A|200|Anticipated|Omni Med||2|||f||||t||||||||No||2017-10-10 21:35:23.199531|2017-10-10 21:35:23.199531
NCT02971436|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-06-26|||December 2016||2016-12-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of Treatment Efficacy of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea||Recruiting||N/A|100|Anticipated|Fisher and Paykel Healthcare||6|||f||||t||||||||||2017-10-10 21:35:23.297065|2017-10-10 21:35:23.297065
NCT02971423|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-06-01|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Subjects|A Phase I, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Subjects|Completed||Phase 1|124|Actual|Entasis Therapeutics||15|||f||||t||||||||||2017-10-10 21:35:23.405108|2017-10-10 21:35:23.405108
NCT02971410|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-05-08|||April 2017|Anticipated|2017-04-01|May 2017|2017-05-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma|Overcoming Chemotherapy Resistance in Refractory Multiple Myeloma With Simvastatin, A Pilot Study|Withdrawn||Early Phase 1|0|Actual|Wake Forest University Health Sciences||1||PI no longer interested in pursuing study.|f|||||t|f|||f|||||2017-10-10 21:35:23.573408|2017-10-10 21:35:23.573408
NCT02971397|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-07-31|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|Cytarabine Plus Continuous Infusion Daunorubicin Induction Therapy for Adults With Acute Myeloid Leukemia: A Feasibility Study With Cardiac MRI Monitoring|Recruiting||Phase 2|40|Anticipated|Wake Forest University Health Sciences||1|||f||||t|t|f||||||||2017-10-10 21:35:23.660519|2017-10-10 21:35:23.660519
NCT02971384|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01||||May 2017|Anticipated|2017-05-01||Interventional|||Echinacea Junior vs Vitamin C in Children 4-12 Years Old|Controlled, Randomized, Multicentre Study on Safety and Efficacy of Echinaforce Junior Tablets in Comparison With Vitamin C for the Prevention of Viral Respiratory Tract Infections in Children (4-12 Years)|Not yet recruiting||Phase 3|200|Anticipated|Bioforce AG||2|||f||||f||||||||No||2017-10-10 21:35:23.784214|2017-10-10 21:35:23.784214
NCT02971371|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-19|||October 2015||2015-10-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Role of MNS in Improving Motor Performance|The Role of Mirror Neuron System in Improving Motor Performance by Using Virtual Reality, as Revealed by EEG: a Randomized Clinical Trial|Completed||N/A|24|Actual|"IRCCS Centro Neurolesi Bonino-Pulejo"||2|||f||||f||||||||||2017-10-10 21:35:23.858646|2017-10-10 21:35:23.858646
NCT02971358|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-03-21|||August 2016||2016-08-01|March 2017|2017-03-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer|Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer - a Prospective Single Center Phase I/II Study|Recruiting||Phase 1/Phase 2|50|Anticipated|Medical University of Vienna||1|||f||||f||||||||Undecided||2017-10-10 21:35:24.045586|2017-10-10 21:35:24.045586
NCT02971345|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2017-01-08|||January 2017||2017-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus|Endovascular Brachytherapy Combined With Stent Placement and Transcatheter Arterial Chemoembolization (TACE) for Treatment of HCC With Main Portal Vein Tumor Thrombus Versus TACE Alone: a Prospective Randomized Controlled Multicentre Trial|Recruiting||Phase 3|253|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 21:35:24.152438|2017-10-10 21:35:24.152438
NCT02971332|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-20|2016-11-21|||June 2007||2007-06-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2010|Actual|2010-01-01||Observational|LTSTARR||Long Term Results of STARR With Contour Transtar|STARR With Contour Transtar for Obstructed Defecation Syndrome: Long Term Results|Completed||N/A|113|Actual|University of Roma La Sapienza|||1||f||||f||||||||No||2017-10-10 21:35:24.321002|2017-10-10 21:35:24.321002
NCT02970383|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||October 2015||2015-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Narcotic Use After Minor Hand Surgery||Completed||N/A|200|Actual|Carilion Clinic||2|||f||||f||||||||No|none currently|2017-10-10 21:35:34.19163|2017-10-10 21:35:34.19163
NCT02971319|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-08-30|||September 2016||2016-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma|Exploratory Phase II Study in Patients After Treatment of High Grade Brain Tumors to Assess the Technical Performance of Tc-99m Tetrofosmin for Differentiation of Recurrence Versus Radiation Necrosis|Active, not recruiting||Phase 2|24|Anticipated|Proactina S.A.||1|||f||||||||||||||2017-10-10 21:35:24.408346|2017-10-10 21:35:24.408346
NCT02971306|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-09-18|||July 2014||2014-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||G-CSF Plus NAC In Severe Alcoholic Hepatitis|Granulocyte Colony Stimulating Factor Plus N-Acetyl Cysteine In Severe Alcoholic Hepatitis|Recruiting||Phase 4|60|Anticipated|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||||2017-10-10 21:35:24.518986|2017-10-10 21:35:24.518986
NCT02971293|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-08-25|||December 15, 2016|Actual|2016-12-15|August 2017|2017-08-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Interventional|||Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871|A Phase IIa, Randomised, Multi-Centre, Double-Blind, Placebo-Controlled, 3 Periods, Crossover Study to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of Inhaled AZD8871 Administered Once Daily for 2 Weeks in Patients With Moderate to Severe COPD.|Completed||Phase 2|42|Actual|AstraZeneca||3|||f||||f|f|f||||||||2017-10-10 21:35:24.646575|2017-10-10 21:35:24.646575
NCT02971280|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Observational|||Influence of Heavy Metals Exposure on in Vitro Fertilization (IVF) Outcome||Not yet recruiting||N/A|100|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||No|Data will be published in scientific journal. Individual researchers will have access to source data anonymously.|2017-10-10 21:35:24.76104|2017-10-10 21:35:24.76104
NCT02971267|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-19|||June 2015||2015-06-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Observational|SFB/TR19plus||Follow-up of the Cardiomyopathy Cohort SFB/TR19|Follow-up of the Inflammatory Cardiomyopathy Cohort of SFB/TR19|Recruiting||N/A|150|Anticipated|University Medicine Greifswald|||1||f||||f||||||Samples With DNA|"     blood   "|No||2017-10-10 21:35:24.836577|2017-10-10 21:35:24.836577
NCT02971254|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-07-17|||April 2013||2013-04-01|July 2017|2017-07-01||||November 2017|Anticipated|2017-11-01||Interventional|||The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients||Recruiting||Phase 2|39|Anticipated|Asklepieion Voulas General Hospital||2|||f||||f||||||||||2017-10-10 21:35:24.9379|2017-10-10 21:35:24.9379
NCT02971241|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2016-11-19|||August 2015||2015-08-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|IMTOP||INTERGENERATIONAL MOBILE TECHNOLOGY OPPORTUNITIES PROGRAM IN TAIWAN|Intergenerational Mobile Technology Opportunities Program (IMTOP) in Taiwan|Recruiting||N/A|630|Anticipated|University of Southern California||2|||f||||t||||||||Yes||2017-10-10 21:35:25.075681|2017-10-10 21:35:25.075681
NCT02971228|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-06-20|||November 2016||2016-11-01|June 2017|2017-06-01|June 7, 2017|Actual|2017-06-07|May 24, 2017|Actual|2017-05-24||Interventional|dasiglucagon||Feasibility Trial Testing the Bionic Pancreas With ZP4207|The Bionic Pancreas Feasibility Trial Testing the Bionic Pancreas With ZP4207|Completed||Phase 2|10|Actual|Zealand Pharma||4|||f||||t||||||||No||2017-10-10 21:35:25.215239|2017-10-10 21:35:25.215239
NCT02971215|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-03-21|||November 2016||2016-11-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Subacromial Impingement Syndrome Approach Using High Intensity Laser Therapy|Effectiveness of High Intensity Laser Therapy in the Treatment of Subacromial Impingement Syndrome|Active, not recruiting||N/A|46|Actual|University of Castilla-La Mancha||2|||f||||f||||||||||2017-10-10 21:35:25.372114|2017-10-10 21:35:25.372114
NCT02971202|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)|A Novel Cross-sectional Analysis of Insulin Sensitivity Among Adolescents and Young Adults With Type 1 Diabetes, MODY2, and Normal Controls: the Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance|Recruiting||Phase 1|30|Anticipated|Vanderbilt University Medical Center||3|||f||||t||||||||Undecided||2017-10-10 21:35:25.48559|2017-10-10 21:35:25.48559
NCT02971189|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Interventional|LEADERUK||Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom|Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss in Sites Across the United Kingdom|Not yet recruiting||N/A|40|Anticipated|Birmingham Women's NHS Foundation Trust||1|||f||||t||||||||No||2017-10-10 21:35:25.597073|2017-10-10 21:35:25.597073
NCT02971176|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-06-24|||November 2016||2016-11-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Low-dose Protocol for Computed Tomography-guided Lung Biopsy|Low-dose Protocol for Computed Tomography-guided Lung Biopsy|Enrolling by invitation||N/A|280|Actual|Xuzhou Central Hospital||2|||f||||t||||||||Yes|We wil share all data of this study. We aim to show our data by publishing article. The data may be available on March 2020.|2017-10-10 21:35:25.678039|2017-10-10 21:35:25.678039
NCT02971163|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|SynDA||Syncope Decision Aid for Emergency Care|SynDA: Syncope Decision Aid for Emergency Care|Recruiting||N/A|50|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-10 21:35:25.786758|2017-10-10 21:35:25.786758
NCT02971150|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-05-30|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Treatment Resistant Depression and Insomnia in Older Veterans|Treatment Resistant Depression and Insomnia in Older Veterans: A Pilot Study|Completed||N/A|12|Actual|VA Pittsburgh Healthcare System||2|||f||||f||||||||Undecided||2017-10-10 21:35:25.885139|2017-10-10 21:35:25.885139
NCT02971137|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-05-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|PASS||Pain and Smoking Study|Pain-related Anxiety Invervention for Smokers With Chronic Pain: A Comparative Effectiveness Trial of Smoking Cessation Counseling for Veterans|Not yet recruiting||N/A|370|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 21:35:25.965507|2017-10-10 21:35:25.965507
NCT02971111|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-19|2017-02-16|||January 2013||2013-01-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||No Bleeding During Invasive Procedures in Sepsis With Normal ROTEM and Prolonged INR|Invasive Procedures in Septic Patients With Normal Thromboelastometry Performed Without Bleeding Complications Despite Prolonged Prothrombin Time|Completed||N/A|76|Actual|University Hospital, Motol|||1||f||||||||||||||2017-10-10 21:35:26.139517|2017-10-10 21:35:26.139517
NCT02971098|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-01-16|||September 2016||2016-09-01|January 2017|2017-01-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Mechanisms of Skeletal Muscle Insulin Resistance in Older Adults|Novel Molecular Mechanisms of Skeletal Muscle Insulin, Resistance if Physically Inactive Older Adults|Recruiting||Phase 1|15|Anticipated|University of Utah||1|||f||||t||||||||No||2017-10-10 21:35:26.184983|2017-10-10 21:35:26.184983
NCT02971085|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-04-21|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|January 2027|Anticipated|2027-01-01|January 2022|Anticipated|2022-01-01|3 Months|Observational [Patient Registry]|SUPER-PC-AS||Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance|Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance|Recruiting||N/A|410|Anticipated|Seoul National University Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:35:26.263641|2017-10-10 21:35:26.263641
NCT02971072|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-11-21|||July 2014||2014-07-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Neurophysiology of Weakness and Exercise in Rotator Cuff Tendinopathy|Neurophysiology of Weakness and Exercise in Rotator Cuff Tendinopathy|Recruiting||N/A|180|Anticipated|University of Oregon||1|||f||||f||||||||No||2017-10-10 21:35:26.380121|2017-10-10 21:35:26.380121
NCT02971059|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-04-07|||August 2016||2016-08-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phenylalanine Requirement of Adults >65 Years.|Phenylalanine Requirement of Healthy Older Adult Males and Females > 65 Years Determined by Direct Amino Acid Oxidation (DAAO) Method.|Recruiting||Phase 1|20|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||No||2017-10-10 21:35:26.556458|2017-10-10 21:35:26.556458
NCT02971046|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Glutathione (GSH) Synthesis in Healthy School-aged Children|Glutathione (GSH) Synthesis in Response to Graded Protein Intakes: a Functional Measure of Protein Requirement in Healthy School-aged Children|Recruiting||Early Phase 1|5|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||No||2017-10-10 21:35:26.711057|2017-10-10 21:35:26.711057
NCT02971033|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-07-28|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C|Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C|Not yet recruiting||Phase 2|95|Anticipated|VA Office of Research and Development||3|||f||||f|t|f||||||||2017-10-10 21:35:26.875026|2017-10-10 21:35:26.875026
NCT02971020|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-11-21|||May 2016||2016-05-01|November 2016|2016-11-01||||May 2018|Anticipated|2018-05-01||Interventional|CAVIAR||Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement|Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.|Recruiting||N/A|60|Anticipated|Minnesota Veterans Medical Research and Education Foundation||2|||f||||t||||||||No||2017-10-10 21:35:27.043989|2017-10-10 21:35:27.043989
NCT02971007|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-08-09|||November 2016||2016-11-01|May 2017|2017-05-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)|A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)|Completed||Phase 2|137|Actual|Matinas BioPharma Nanotechnologies, Inc.||3|||f||||f||||||||||2017-10-10 21:35:27.141766|2017-10-10 21:35:27.141766
NCT02970994|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2017-03-16|||January 2015||2015-01-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Linear Growth and Neurobehavioural Outcome in PT Neonates (<34 Wks) at 37 and 40 Wks of CGA|Linear Growth and Neurobehavioural Outcome in Preterm Neonates (<34 Weeks) at 37 Weeks and 40 Weeks of Corrected Gestational Age : a Prospective Observational Study|Completed||N/A|70|Actual|Lady Hardinge Medical College|||1||f||||t||||||||Undecided||2017-10-10 21:35:27.346389|2017-10-10 21:35:27.346389
NCT02970981|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Interventional|||Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma|A Pilot Trial of Ipilimumab With Nivolumab for Participants With Resected Stages IIIB/IIIC/ IV Melanoma|Not yet recruiting||Phase 2|25|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 21:35:27.410258|2017-10-10 21:35:27.410258
NCT02970968|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-22|||November 2016||2016-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy of VLY-686 (Tradipitant) in Relieving Symptoms of Gastroparesis|Recruiting||Phase 2|150|Anticipated|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-10 21:35:27.506809|2017-10-10 21:35:27.506809
NCT02970955|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Observational|||Prospecitve Observational Study on a Risk Adaptive Scheme for SBRT for Thoracic Nodes Metastases|Prospective Observational Study on a Risk Adaptive Scheme for Stereotactic Body Radiation Therapy (SBRT) for Medically Inoperable Thoracic Nodes Metastases|Recruiting||N/A|32|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||||No||2017-10-10 21:35:27.659706|2017-10-10 21:35:27.659706
NCT02970929|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-20|||January 31, 2017|Actual|2017-01-31|April 2017|2017-04-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia|A 26-Week Open-label Safety and Tolerability Extension Study of SEP-363856 in Adult Subjects With Schizophrenia|Recruiting||Phase 2|180|Anticipated|Sunovion||1|||f||||f|t|f||||||||2017-10-10 21:35:29.657609|2017-10-10 21:35:29.657609
NCT02970916|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-31|||November 2016||2016-11-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|POLAF||Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms|A Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms|Recruiting||Phase 2|100|Anticipated|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1|||f||||f||||||||||2017-10-10 21:35:29.774824|2017-10-10 21:35:29.774824
NCT02970903|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-03-09|||October 2016||2016-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU|VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU; Project Phases 1 (System Development) and 2 (Prototype Evaluation)|Enrolling by invitation||N/A|25|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 21:35:29.888566|2017-10-10 21:35:29.888566
NCT02970890|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-04-18|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Effects of Photobiomodulation Therapy (PBMT) in Total Hip Arthroplasty|Effects of Photobiomodulation Therapy (PBMT) on Acute Pain and Inflammation in Patients Who Underwent Total Hip Arthroplasty|Completed||N/A|18|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 21:35:29.971356|2017-10-10 21:35:29.971356
NCT02970877|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-08-30|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients|Fecal Microbiota Transplant From Healthy Lean Donors to Morbidly Obese Individuals: Effect on Insulin Resistance and Other Obesity-related Parameters. A Randomized Controlled Trial.|Recruiting||Phase 2|48|Anticipated|University Health Network, Toronto||2|||f||||t|f|f||||||||2017-10-10 21:35:30.092361|2017-10-10 21:35:30.092361
NCT02970864|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-05-02|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|UMANC||A Phase I Trial of a Novel Synthetic Polymer Nerve Conduit 'Polynerve' in Participants With Sensory Digital Nerve Injury|A Phase I Trial of a Novel Synthetic Polymer Nerve Conduit 'Polynerve' in Participants With Sensory Digital Nerve Injury|Not yet recruiting||N/A|16|Anticipated|University of Manchester||1|||f||||t|f|f||||||||2017-10-10 21:35:30.388944|2017-10-10 21:35:30.388944
NCT02970851|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-11-17|||April 2013||2013-04-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) and Rubidium-82 (82Rb) Positron Emission Tomography/Computed Tomography (PET/CTs) on Pulmonary Arterial Hypertension (PAH) or Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|Effect of Endothelin Receptor Antagonist Bosentan in Glucose Metabolism of the Myocardium and Coronary Dependant Endothelial Vasoreactivity Measured by 18F-FDG PET / CT and 82Rb PET / CT in Patients With PAH or CTEPH|Recruiting||Phase 1/Phase 2|40|Anticipated|University of Lausanne Hospitals|||1||f||||f||||||||No||2017-10-10 21:35:30.53222|2017-10-10 21:35:30.53222
NCT02970838|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-18|||November 2012||2012-11-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|TADIA||Therapy of Obesity and Diabetes Mellitus Type 2|Evaluation of a Structured Weight-loss Program for Therapy of Obesity and Diabetes Mellitus Type 2|Completed||N/A|36|Actual|University Medicine Greifswald||1|||f||||f||||||||No||2017-10-10 21:35:30.661021|2017-10-10 21:35:30.661021
NCT02970825|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2017-05-01|||September 2016||2016-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|November 2017|Anticipated|2017-11-01||Interventional|Move&FG||Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being.|"Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being. Effets de l'entraînement Physique Intensif Sur la plasticité cérébrale, la Cognition et le Bien être Psychologique."|Recruiting||N/A|100|Anticipated|Université Catholique de Louvain||2|||f||||f||||||||No|This is a monocentric study. All individual participant data that allow subject identification will be kept confidential.|2017-10-10 21:35:30.795889|2017-10-10 21:35:30.795889
NCT02970812|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-18|||January 2004||2004-01-01|November 2016|2016-11-01|September 2004|Actual|2004-09-01|May 2004|Actual|2004-05-01||Interventional|||Effects of Electrical Muscle Stimulation on Waist Circumference in Adults|Effects of Electrical Muscle Stimulation on Waist Circumference in Adults: A Randomized Controlled Trial|Completed||N/A|60|Actual|Pusan National University Yangsan Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:35:30.902876|2017-10-10 21:35:30.902876
NCT02970799|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-03-27|||August 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:35:30.966878|2017-10-10 21:35:30.966878
NCT02970786|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans||Recruiting||Phase 1|10|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||No||2017-10-10 21:35:31.016345|2017-10-10 21:35:31.016345
NCT02970773|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|rivaroxaban||Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injury|Prospective, Non-randomized, Open-label, Mono-centric, Cohort Study on the Absorption of Oral Rivaroxaban in Patients With a Cervical Spinal Cord Injury|Not yet recruiting||N/A|24|Anticipated|Swiss Paraplegic Centre Nottwil||1|||f||||f||||||||No||2017-10-10 21:35:31.10952|2017-10-10 21:35:31.10952
NCT02970760|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||December 2016||2016-12-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Computer Assisted Measurement of Colorectal Polyps||Not yet recruiting||N/A|500|Anticipated|Technische Universität München|||1||f||||f||||||Samples Without DNA|"     Colonic polyps   "|No||2017-10-10 21:35:31.182533|2017-10-10 21:35:31.182533
NCT02970747|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-06-29|||October 25, 2016|Actual|2016-10-25|June 2017|2017-06-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Observational|CARO||Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone in Multiple Myeloma Patients|A Non-interventional Study of Carfilzomib (Kyprolis®) in Combination With Lenalidomide (Revlimid®) and Dexamethasone or Carfilzomib in Combination With Dexamethasone Alone in Patients With Multiple Myeloma Who Have Received at Least One Prior Therapy (CARO)|Recruiting||N/A|300|Anticipated|iOMEDICO AG|||2||f||||f||||||||No||2017-10-10 21:35:31.248771|2017-10-10 21:35:31.248771
NCT02970734|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-02-01|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluating an Internet-based Program for Anxious Adolescents|Evaluating an Internet-based Program for Anxious Adolescents: A Randomized Controlled Trial|Recruiting||N/A|708|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-10 21:35:31.348271|2017-10-10 21:35:31.348271
NCT02970721|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-09|||September 2016||2016-09-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|||Risk of Adverse Birth Outcomes in Women Treated for Bipolar Disorder During Pregnancy||Active, not recruiting||N/A|1300|Anticipated|Western University, Canada|||3||f||||f||||||||||2017-10-10 21:35:31.448895|2017-10-10 21:35:31.448895
NCT02970708|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-17|||January 2017||2017-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of Eyetronix Flicker Glasses to the Treatment of Anisometropic Amblyopia|Efficacy and Safety of Eyetronix Flicker Glasses to the Treatment of Anisometropic Amblyopia in Chinese Children|Not yet recruiting||N/A|176|Anticipated|Shanghai Eye Disease Prevention and Treatment Center||2|||f||||f||||||||Undecided||2017-10-10 21:35:31.534196|2017-10-10 21:35:31.534196
NCT02970695|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-11-18|||May 2016||2016-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Auriculotherapy on Older People With Insomnia|Effectiveness of Auriculotherapy on Older People With Insomnia|Active, not recruiting||N/A|150|Anticipated|The Hong Kong Polytechnic University||3|||f||||f||||||||No||2017-10-10 21:35:31.6149|2017-10-10 21:35:31.6149
NCT02970682|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-21|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Interventional|STEM||SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer|STEM: A Multicentre Phase 2 Study of SFX-01 Treatment and Evaluation in Patients With Estrogen Receptor (ER) Positive and Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer Progressing on Either an Aromatase Inhibitor (AI) or Tamoxifen or Fulvestrant|Recruiting||Phase 1/Phase 2|60|Anticipated|Evgen Pharma||3|||f||||f||||||||No||2017-10-10 21:35:31.70307|2017-10-10 21:35:31.70307
NCT02970669|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-01-17|||December 2016||2016-12-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|AWAKE-HF||Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.|Multicenter, Randomized, Double-blind, Double Dummy, Parallel Group, Active-controlled 8-week Study and 8-week Open Label Extension to Evaluate the Effect of Initiation of Sacubitril/Valsartan on Objective Measures of Waking Activity and Sleep, as Health-related Quality of Life Functions in Subjects With Heart Failure and Reduced Ejection Fraction (AWAKE-HF).|Recruiting||Phase 4|136|Anticipated|Novartis||2|||t||||||||||||||2017-10-10 21:35:31.835916|2017-10-10 21:35:31.835916
NCT02970656|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-03-01|||January 15, 2017|Actual|2017-01-15|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect|A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect|Recruiting||N/A|60|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 21:35:31.929142|2017-10-10 21:35:31.929142
NCT02970643|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-22|||July 2016||2016-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN|Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting|Enrolling by invitation||N/A|48|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||1|||f||||t||||||||No||2017-10-10 21:35:32.145982|2017-10-10 21:35:32.145982
NCT02970630|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-07-26|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study|Envarsus® Tablets Administered Once Daily in Combination With Everolimus in Elderly De-novo Kidney Transplant Recipients: Open-label, Multicentre, Single-arm, Pharmacokinetic and Clinical Study|Recruiting||Phase 2|25|Anticipated|Chiesi Farmaceutici S.p.A.||1|||f||||f||f||||||||2017-10-10 21:35:32.249856|2017-10-10 21:35:32.249856
NCT02970617|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-01|||August 15, 2016|Actual|2016-08-15|August 2017|2017-08-01|August 15, 2020|Anticipated|2020-08-15|August 15, 2019|Anticipated|2019-08-15||Interventional|||Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients|Are Last Impressions Lasting Impressions? Intervention of Ringing a Bell at the End of Cancer Treatment|Recruiting||N/A|240|Anticipated|University of Southern California||2|||f||||t||||||||||2017-10-10 21:35:32.391336|2017-10-10 21:35:32.391336
NCT02970604|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||May 2016||2016-05-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||PPARGC1β and CNTN4 Genotype Aspirin Study|PPARGC1β And CNTN4 Genotype as a Pharmacogenetic Assay of Thrombosis and Bleeding Risks - a Cross-Over Controlled Trial of Aspirin in Individuals at Increased Cardiovascular Risk.|Recruiting||Phase 4|160|Anticipated|Royal College of Surgeons, Ireland||2|||f||||f||||||||No||2017-10-10 21:35:32.486414|2017-10-10 21:35:32.486414
NCT02970591|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-10-04|||January 2017||2017-01-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|Car-IBS||A Comparison of Three Different Treatment Options for Irritable Bowel Syndrome|A Comparison of Three Different Treatment Options for Irritable Bowel Syndrome; Traditional Dietary Advice Including Low FODMAP Content, vs a Low Carbohydrate Diet vs Optimized Medical Treatment for Adult Patients With IBS.|Recruiting||N/A|300|Anticipated|Sahlgrenska University Hospital, Sweden||3|||f||||||||||||||2017-10-10 21:35:32.578939|2017-10-10 21:35:32.578939
NCT02970370|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-21|||December 2015||2015-12-01|November 2016|2016-11-01||||July 2016|Actual|2016-07-01|15 Years|Observational [Patient Registry]|||Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in Egypt||Completed||N/A|2752|Actual|Cairo University|||1||f||||||||||||||2017-10-10 21:35:34.257311|2017-10-10 21:35:34.257311
NCT02970578|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-18|||November 2012||2012-11-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|||3D-printed Module-assisted Minimally Invasive Lumbar Pedicle Screw Placement|3D-printed Module-assisted Minimally Invasive Lumbar Pedicle Screw Placement: a Retrospective, Self-controlled, Open-label Clinical Trial|Completed||N/A|36|Actual|The Affiliated Hospital of Putian University||1|||f||||t||||||||Undecided||2017-10-10 21:35:32.678964|2017-10-10 21:35:32.678964
NCT02970565|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-21|||October 2016||2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Family Nurture Intervention, A Group Model in Connecticut|Family Nurture Intervention, A Group Model: Short and Long Term Effects on Behavior and Development of Preschool Aged Children|Recruiting||N/A|96|Anticipated|Columbia University||2|||f||||t||||||||No||2017-10-10 21:35:32.756194|2017-10-10 21:35:32.756194
NCT02970552|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-08-22|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth|Z 31606 - A Pilot Study of Vaginal Progesterone to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy|Recruiting||Phase 4|140|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|t|f|||t|||||2017-10-10 21:35:32.876177|2017-10-10 21:35:32.876177
NCT02970539|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-08-15|||December 8, 2016|Actual|2016-12-08|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers|A Phase 1b Study of Oraxol in Combination With Ramucirumab in Patients With Gastric, Gastro-esophageal, or Esophageal Cancers|Recruiting||Phase 1|18|Anticipated|Kinex Pharmaceuticals Inc||1|||f||||f||||||||||2017-10-10 21:35:32.978281|2017-10-10 21:35:32.978281
NCT02970526|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-11|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|PREVOX||Long Term Effect of Oxaliplatin Treatment in Cancer Survivors|Evaluation of Intensity and Consequences of Neuropathic Disorders Induced by Oxaliplatin in Patients After Chemotherapy: Observational and Cross-sectional Study|Recruiting||N/A|700|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 21:35:33.112486|2017-10-10 21:35:33.112486
NCT02970513|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-22|||January 2017||2017-01-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|MicrobioPSY||Psychological Evaluation According Colonic Colonization by Escherichia Coli of Patients After Colorectal Surgery|Psychological Evaluation According Colonic Colonization by Escherichia Coli of Patients After Colorectal Surgery|Not yet recruiting||N/A|66|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 21:35:33.229683|2017-10-10 21:35:33.229683
NCT02970500|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-01-30|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CogMet||Effect of Methylphenidate on Cancer-related Cognitive Impairment|Étude Pilote de Phase II Sur l'Effet du méthylphénidate Sur la Fonction Cognitive Des Patientes en rémission d'un Cancer du Sein|Not yet recruiting||Phase 2|40|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f||||||||No||2017-10-10 21:35:33.344839|2017-10-10 21:35:33.344839
NCT02970487|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-03-02|||June 2016||2016-06-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|PEACE||Precisight® Intraocular Lens Implantation for Cataract Treatment|Refractive Outcome and Optimization of IOL-Constants After Implantation of the Precisight® Intraocular Lens.|Recruiting||N/A|125|Anticipated|InfiniteVision Optics||1|||f||||f||||||||No||2017-10-10 21:35:33.452078|2017-10-10 21:35:33.452078
NCT02970474|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-28|||August 2016||2016-08-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study Utilizing 3D Printing in Patients Undergoing External Beam Radiation Therapy|A Study Utilizing 3D Printing in Patients Undergoing External Beam Radiation Therapy|Recruiting||Phase 1/Phase 2|20|Anticipated|Tulane University||1|||f||||f||||||||No|Currently there is no plan to share IPD.|2017-10-10 21:35:33.539829|2017-10-10 21:35:33.539829
NCT02970461|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-17|||July 2016||2016-07-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Gamifying Patient's Personal Data Validation and Completion in a Personal Health Record|Gamifying Patient's Personal Data Validation and Completion in a Personal Health Record|Active, not recruiting||N/A|40000|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||Undecided||2017-10-10 21:35:33.629288|2017-10-10 21:35:33.629288
NCT02970448|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-08-23|||May 18, 2017|Actual|2017-05-18|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas|Expedited Laser Interstitial Thermal Therapy and Chemoradiation for Patients With Newly Diagnosed High Grade Gliomas|Recruiting||Early Phase 1|45|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f||||||2017-10-10 21:35:33.748706|2017-10-10 21:35:33.748706
NCT02970435|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||December 2016||2016-12-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluating the Impact of Video Discharge Instructions for Mohs Surgery Post-Operative Care|Evaluating the Impact of Video Discharge Instructions for Mohs Surgery Post-Operative Care|Not yet recruiting||N/A|628|Anticipated|Case Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 21:35:33.847827|2017-10-10 21:35:33.847827
NCT02970422|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Chronic Obstructive Pulmonary Disease Patient Preferences Survey|COPD Patient Preferences, Activities, and Participation Survey|Recruiting||N/A|200|Anticipated|McGill University|||1||f||||f||||||||No||2017-10-10 21:35:33.946996|2017-10-10 21:35:33.946996
NCT02970409|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-11-21|||October 2015||2015-10-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Heparin Versus Saline in Peripheral Venous Catheter|A Randomized Study to Test Peripheral Venous Catheter Lock Therapy With Either Heparin or Saline in Patients Admitted to the Internal Medicine Department|Recruiting||N/A|950|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-10 21:35:34.039031|2017-10-10 21:35:34.039031
NCT02970396|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-04-13|||September 2014||2014-09-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|SMART||Self-management for People With Epilepsy and a History of Negative Health Events|Self-management for People With Epilepsy and a History of Negative Health Events (SMART)|Active, not recruiting||N/A|120|Anticipated|Case Western Reserve University||2|||f||||f||||||||||2017-10-10 21:35:34.124025|2017-10-10 21:35:34.124025
NCT02970357|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-07-31|||January 2016||2016-01-01|July 2017|2017-07-01|February 6, 2017|Actual|2017-02-06|November 29, 2016|Actual|2016-11-29||Interventional|PROGETE||Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes|Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes. A French Monocentric Prospective Study. Pilot Study|Completed||N/A|68|Actual|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace||1|||f||||f||||||||||2017-10-10 21:35:34.310979|2017-10-10 21:35:34.310979
NCT02970344|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-06-23|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|I HEAL||I HEAL for Breast Cancer Survivors With Diabetes|Improving Health Engagement and Lifestyle Management for Breast Cancer Survivors With Diabetes|Recruiting||N/A|230|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 21:35:34.401528|2017-10-10 21:35:34.401528
NCT02970331|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis|A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis|Not yet recruiting||Phase 2|50|Anticipated|Cutanea Life Sciences, Inc.||1|||f||||f||||||||||2017-10-10 21:35:34.490142|2017-10-10 21:35:34.490142
NCT02970318|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-23|||September 2016||2016-09-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL|A Randomized, Multicenter, Open-Label, Phase 3 Study of Acalabrutinib (ACP-196) Versus Investigator's Choice of Either Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Subjects With R/R Chronic Lymphocytic Leukemia|Recruiting||Phase 3|306|Anticipated|Acerta Pharma BV||2|||f||||t||||||||||2017-10-10 21:35:34.556696|2017-10-10 21:35:34.556696
NCT02970305|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-04-18|||November 2016||2016-11-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia|Recruiting||Phase 2|380|Anticipated|ACADIA Pharmaceuticals Inc.||2|||f||||t||||||||No||2017-10-10 21:35:34.762686|2017-10-10 21:35:34.762686
NCT02970292|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-04-18|||October 2016||2016-10-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia|Recruiting||Phase 3|380|Anticipated|ACADIA Pharmaceuticals Inc.||2|||f||||t||||||||No||2017-10-10 21:35:34.878966|2017-10-10 21:35:34.878966
NCT02970279|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-17|||December 2016||2016-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reducing Stasis Outcomes for Depression in Group Behavioural Activation Therapy|Effect of Treatment Augmentations Embedded in Behavioural Activation Group Therapy on Reducing Drop-out and Stasis Rates in Depression|Not yet recruiting||N/A|34|Anticipated|University of Sheffield||1|||f||||f||||||||No|The data will be anonymised and analysed collectively so individual participant data will not be identifiable within any reports or publications.|2017-10-10 21:35:34.989895|2017-10-10 21:35:34.989895
NCT02970266|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-18|||September 2010||2010-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2015|Actual|2015-09-01||Observational|GENPHENACL||Genetic Decryption of Leber Congenital Amaurosis (LCA) in a Large Cohort of Independent Families.|Genetic Decryption of Leber Congenital Amaurosis (LCA) in a Large Cohort of Independent Families: Establishment of Genotype-phenotype Correlations and Updating the Clinical Definition of This Retinal Dystrophy|Completed||N/A|659|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 21:35:35.107987|2017-10-10 21:35:35.107987
NCT02970253|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Interventional|||Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention|Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention|Not yet recruiting||Early Phase 1|100|Anticipated|ZOL||2|||f||||||||||||||2017-10-10 21:35:35.180591|2017-10-10 21:35:35.180591
NCT02970240|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-20|||June 2014||2014-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Cardiopulmonary Testing in ME/CFS to Improve Diagnostic Accuracy|Cardiopulmonary Exercise Testing as a Diagnostic Tool and a Quantitative Measure of Post-exertional Malaise in Myalgic Encephalopathy/Chronic Fatigue Syndrome|Active, not recruiting||N/A|90|Anticipated|University of Oslo|||3||f||||f||||||Samples With DNA|"     Whole blood   "|No||2017-10-10 21:35:35.247107|2017-10-10 21:35:35.247107
NCT02970227|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-21|||January 2004||2004-01-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01|12 Years|Observational [Patient Registry]|SFB/TR19||Inflammatory Cardiomyopathy Baseline Cohort (SFB/TR19)|"Inflammatory Cardiomyopathy Cohort of the SFB/TR19 [Kohorte Entzündliche Kardiomyopathien Des Sonderforschungsbereichs/Transregio 19 (SFB/TR19)]"|Completed||N/A|920|Actual|University Medicine Greifswald|||1||f||||f||||||||No||2017-10-10 21:35:35.357259|2017-10-10 21:35:35.357259
NCT02970214|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-19|||November 2016||2016-11-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01|3 Years|Observational [Patient Registry]|GANIFU-Card||Follow-up of GANI_MED Cardio Cohorts|Greifswald Approach to Individualized Medicine (GANI_MED) - Follow-up of Cardiovascular Cohorts|Recruiting||N/A|1200|Anticipated|University Medicine Greifswald|||2||f||||f||||||Samples With DNA|"     blood, urine   "|No||2017-10-10 21:35:35.428764|2017-10-10 21:35:35.428764
NCT02970201|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-28|||February 2015||2015-02-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2015|Actual|2015-06-01||Interventional|||Improving Adherence in Renal Dialysis Patients Through Electronic Interventions|Improving Adherence in Renal Dialysis Patients; a Randomized Crossover Trial for an Electronic Intervention|Active, not recruiting||N/A|26|Actual|Washington University School of Medicine||2|||f||||f||||||||No||2017-10-10 21:35:35.526985|2017-10-10 21:35:35.526985
NCT02970188|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||April 2016||2016-04-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults|The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults|Recruiting||Phase 1/Phase 2|12|Anticipated|University of Colorado, Boulder||2|||f||||f||||||||No||2017-10-10 21:35:35.618646|2017-10-10 21:35:35.618646
NCT02970175|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||January 2017||2017-01-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|TERLAB||Interest of in Situ Terlipressin Administration Before the Realisation of Bronchial Biopsy|Interest of in Situ Terlipressin Administration Before the Realisation of Bronchial Biopsy|Not yet recruiting||Phase 3|130|Anticipated|University Hospital, Rouen||2|||f||||t||||||||No||2017-10-10 21:35:35.705039|2017-10-10 21:35:35.705039
NCT02970162|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-10-03|||November 2016||2016-11-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)|A Phase 3, Double-Blind, Placebo-controlled, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Amifampridine Phosphate in Patients With Lambert-Eaton Myasthenic Syndrome|Recruiting||Phase 3|28|Anticipated|Catalyst Pharmaceuticals, Inc.||2|||t||||f||||||||||2017-10-10 21:35:35.795549|2017-10-10 21:35:35.795549
NCT02970149|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-05|||November 2016||2016-11-01|February 2017|2017-02-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease|Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease|Recruiting||N/A|90|Anticipated|University of Manitoba|||1||f||||f||||||||No||2017-10-10 21:35:35.888111|2017-10-10 21:35:35.888111
NCT02970136|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-05-16|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|February 28, 2022|Anticipated|2022-02-28|August 30, 2020|Anticipated|2020-08-30||Interventional|||Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention|Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention: South Florida Center for Reducing Health Disparities|Recruiting||N/A|900|Anticipated|University of Miami||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:35:35.979651|2017-10-10 21:35:35.979651
NCT02970123|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-01-19|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|SLIMM||Sit Less, Interact, Move More (SLIMM) Intervention for Sedentary Behavior in Chronic Kidney Disease (CKD)|Sit Less, Interact, Move More (SLIMM) Intervention for Sedentary Behavior in Chronic Kidney Disease (CKD)|Recruiting||N/A|100|Anticipated|University of Utah||2|||f||||f||||||||No||2017-10-10 21:35:36.088412|2017-10-10 21:35:36.088412
NCT02970110|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-07-11|||February 27, 2017|Actual|2017-02-27|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Specimen Collection Study for H. Pylori Testing|Specimen Collection Study for H. Pylori Testing in Patients With Dyspepsia|Recruiting||N/A|200|Anticipated|Biomerica|||1||f||||f|f|f||||Samples Without DNA|"     Biospecimen   "|||2017-10-10 21:35:36.227737|2017-10-10 21:35:36.227737
NCT02970097|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-25|||September 2016||2016-09-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Single Shot Infraclavicular Brachial Plexus Block vs Local Infiltration After Wrist Arthroscopy Surgery|Comparison Between Infraclavicular Brachial Plexus Block Versus Local Infiltration for Postoperative Analgesia After Wrist Arthroscopy, a Prospective Randomized Open Label Study|Recruiting||N/A|50|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 21:35:36.304974|2017-10-10 21:35:36.304974
NCT02970084|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-10-04|||November 2016||2016-11-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Vitamin K2 for Reduction the Calcium at Carotid Bifurcation in Patients With Subcritical Lesions|Role of Vitamin K2 in the Reduction of the Calcium Content at the Level of the Carotid Bifurcation in Patients With Subcritical Lesions|Recruiting||N/A|60|Anticipated|Scientific Institute San Raffaele||2|||f||||||||||||||2017-10-10 21:35:36.404258|2017-10-10 21:35:36.404258
NCT02970071|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||November 2016||2016-11-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Application Value of STIC in the Diagnosis of Fetal Complex Congenital Heart Disease|The Application Value of STIC in the Diagnosis of Fetal Complex Congenital Heart|Not yet recruiting||N/A|265|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||t||||||||Undecided||2017-10-10 21:35:36.476504|2017-10-10 21:35:36.476504
NCT02970058|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-06-26|||December 2016||2016-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Platelet-rich Plasma Use as Prophylactic of Low Back Pain Post-spinal Following Gynecological Surgery|Platelet-rich Plasma Use as Prophylactic of Low Back Pain Post-spinal Following Gynecological Surgery|Recruiting||N/A|60|Anticipated|Assiut University||2|||f|||||f|f||||||||2017-10-10 21:35:36.559985|2017-10-10 21:35:36.559985
NCT02970045|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-31|||May 2, 2016|Actual|2016-05-02|July 2017|2017-07-01|May 2, 2037|Anticipated|2037-05-02|May 2, 2036|Anticipated|2036-05-02||Observational|||Norris ORIEN Total Cancer Care|Norris ORIEN Total Cancer Care Protocol: A Lifetime Partnership With Patients|Recruiting||N/A|10000|Anticipated|University of Southern California|||1||f||||t|f|f||||Samples With DNA|"     Tumor tissue, bone marrow, blood, saliva, sputum, urine, feces, hair, surface skin   "|||2017-10-10 21:35:36.647188|2017-10-10 21:35:36.647188
NCT02970032|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01||||October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin|Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin|Recruiting||Early Phase 1|50|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-10 21:35:36.767148|2017-10-10 21:35:36.767148
NCT02970019|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-19|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease||Not yet recruiting||Phase 2|360|Anticipated|Sun Pharma Advanced Research Company Limited||2|||f||||f||||||||||2017-10-10 21:35:36.852032|2017-10-10 21:35:36.852032
NCT02970006|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||October 2016||2016-10-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Investigating Mechanisms Underlying Spinal Cord Stimulation Efficacy Using Virtual Reality and Full Body Illusion|Investigating Mechanisms Underlying Spinal Cord Stimulation Efficacy Using Virtual Reality and Full Body Illusion|Recruiting||Phase 1|25|Anticipated|Ohio State University||1|||f||||f||||||||No||2017-10-10 21:35:36.932284|2017-10-10 21:35:36.932284
NCT02969980|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS|Allogeneic Hematopoietic Cell Transplantation Using Post-transplantation Cyclophosphamide in Myelodysplastic Syndrome Patients|Recruiting||Phase 2|40|Anticipated|Asan Medical Center||1|||f||||||||||||||2017-10-10 21:35:37.125509|2017-10-10 21:35:37.125509
NCT02969967|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effectiveness of a Dynamic Wrist-hand Orthosis in Early Outpatient Rehabilitation of the Upper Extremity Post Stroke|Effectiveness of a Dynamic Wrist-hand Orthosis in Early Outpatient Rehabilitation of the Upper Extremity Post Stroke: a Multiple Single Subject Design Evaluation|Recruiting||N/A|3|Anticipated|University of Manitoba||1|||f||||f||||||||No||2017-10-10 21:35:37.208743|2017-10-10 21:35:37.208743
NCT02969954|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Stories for Change: Digital Storytelling as a Tool for Engagement in Facilitated Discussion for Diabetes|Stories for Change: Digital Storytelling as a Tool for Engagement in Facilitated Discussion for Reduction of Diabetes-Related Health Disparities|Recruiting||N/A|30|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 21:35:37.328369|2017-10-10 21:35:37.328369
NCT02969941|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-09-07|||June 2016||2016-06-01|September 2017|2017-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Parkinson Disease||Recruiting||N/A|40|Anticipated|Anhui Medical University||2|||f||||f||||||||||2017-10-10 21:35:37.428158|2017-10-10 21:35:37.428158
NCT02969928|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-04-23|||March 2015||2015-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis|Full-mouth Periodontal Debridement Associated With Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis: Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|44|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||Undecided||2017-10-10 21:35:37.534095|2017-10-10 21:35:37.534095
NCT02969915|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-07-28|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Strategies to Improve the HIV Care Continuum Among Key Populations in India|Strategies to Improve the HIV Care Continuum Among Key Populations in India|Not yet recruiting||Phase 3|18400|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-10 21:35:37.655186|2017-10-10 21:35:37.655186
NCT02969902|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-08-16|||November 2014||2014-11-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Buzzy Distraction During Venipuncture|Randomized Controlled Trial to Compare Buzzy and Hand-held Computer Distraction for Pain Control in Children Underwent Venipuncture.|Completed||N/A|200|Actual|IRCCS Burlo Garofolo||2|||f||||f|f|f||||||||2017-10-10 21:35:37.75418|2017-10-10 21:35:37.75418
NCT02969889|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-02-02|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA|Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA|Completed||N/A|80|Actual|Kocaeli University||2|||f||||f||||||||||2017-10-10 21:35:37.853477|2017-10-10 21:35:37.853477
NCT02969876|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|VOR-IISR||Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine|Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine|Recruiting||Phase 4|20|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 21:35:37.950419|2017-10-10 21:35:37.950419
NCT02969863|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-06-21|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|December 2, 2017|Anticipated|2017-12-02||Interventional|||The Monitoring Study|The Monitoring Study: Evaluating the Effect of Remote Monitoring For Hypoglycemia on Bionic Pancreas Safety and Efficacy|Active, not recruiting||N/A|48|Anticipated|Massachusetts General Hospital||6|||f||||t|f|t|t|f||||Undecided||2017-10-10 21:35:38.214823|2017-10-10 21:35:38.214823
NCT02969850|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-12-20|||February 2016||2016-02-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A New Paradigm for Vitamin D Sufficiency|A New Paradigm for Vitamin D Sufficiency: A 6-month, Randomized, Double-blind, Placebo-controlled Study to Investigate Vitamin D Status in Elderly Caucasian Women|Recruiting||N/A|260|Anticipated|Winthrop University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:35:38.313841|2017-10-10 21:35:38.313841
NCT02969837|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-09-29|||July 10, 2017|Actual|2017-07-10|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma|Open-label, Single-arm, Phase 2 Study of Initial Treatment With Elotuzumab, Carfilzomib (Kyprolis), Lenalidomide (Revlimid) and Low Dose Dexamethasone (E-KRd) in Newly Diagnosed, Multiple Myeloma Requiring Systemic Chemotherapy|Recruiting||Phase 2|55|Anticipated|University of Chicago||1|||f||||t|t|f||||||||2017-10-10 21:35:38.423134|2017-10-10 21:35:38.423134
NCT02969824|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-02-16|||February 16, 2017|Actual|2017-02-16|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|November 2017|Anticipated|2017-11-01||Interventional|||Post-acute Structured Exercise Following Sport Concussion|Post-acute Structured Exercise Following Sport Concussion: a Randomized Controlled Study|Recruiting||N/A|150|Anticipated|University of Toronto||2|||f||||t|f|f||||||No|Individual participant data will not be made available to other researchers. Study data will be retained for 10 years by the principal investigator, allowing adequate time for preparation and dissemination of research findings. All electronic files will be permanently deleted at the end of the retention period. De-identified data in the collective form may be made available to other researchers within our institution before this happens in order to generate more publications from this dataset. It may obtained by the principal investigator, who will maintain this data within a password-protected network.|2017-10-10 21:35:38.546574|2017-10-10 21:35:38.546574
NCT02969811|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2016-11-18|||December 2016||2016-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Cardiac Injury and Anaemia Following Surgery for Fractured Neck of Femur: An Observational Study Study Protocol: Cardiac Injury and Anaemia Following Surgery for Fractured Neck of Femur|Cardiac Injury and Anaemia Following Surgery for Fractured Neck of Femur: An Observational Study Study Protocol: Cardiac Injury and Anaemia Following Surgery for Fractured Neck of Femur: An Observational Study|Not yet recruiting||N/A|200|Anticipated|NHS Lothian|||1||f||||f||||||Samples Without DNA|"     Blood, Urine   "|||2017-10-10 21:35:38.664731|2017-10-10 21:35:38.664731
NCT02969798|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-11|||January 2014||2014-01-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)|Preservation of Beta Cell Function in Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)|Recruiting||N/A|700|Anticipated|The University of Texas Health Science Center at San Antonio||4|||f||||t||||||||||2017-10-10 21:35:38.727209|2017-10-10 21:35:38.727209
NCT02969785|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|PCMALBP||Postural Control and Trunk Neuromuscular Activation in Athletes With Chronic Low Back Pain|An Intervention Program for the Trunk Neuromuscular Pattern and Postural Control in Athletes Chronic With Low Back Pain: A Feasibility and Clinical Trial Study|Recruiting||N/A|40|Anticipated|Universidade Norte do Paraná||2|||f||||t||||||||No||2017-10-10 21:35:38.864516|2017-10-10 21:35:38.864516
NCT02969772|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-16|||December 2005||2005-12-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2006|Actual|2006-12-01||Interventional|||Reach and Palmar Grasp in Tetraplegics With Neuromuscular Electrical Stimulation: Assessment and Training.|Reach and Palmar Grasp in Tetraplegics With Neuromuscular Electrical Stimulation: Assessment and Training.|Completed||N/A|23|Actual|University of Campinas, Brazil||2|||f||||t||||||||No||2017-10-10 21:35:38.986111|2017-10-10 21:35:38.986111
NCT02969759|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|Fibro-ALS||Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis|Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis|Not yet recruiting||Early Phase 1|30|Anticipated|University Hospital, Angers||2|||f||||||||||||||2017-10-10 21:35:39.070039|2017-10-10 21:35:39.070039
NCT02969746|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-06-08|||September 2017|Anticipated|2017-09-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CACAOD||Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants|Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants|Not yet recruiting||Phase 4|140|Anticipated|University Hospital, Angers||2|||f||||t|f|f|||f|||No||2017-10-10 21:35:39.160759|2017-10-10 21:35:39.160759
NCT02969733|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-09-11|||January 2011||2011-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|KETALIDO||The Interest of the Xylocaine® and Ketamine on the Management of Acute and Chronic Ain After Colectomy by Laparoscopy|The Interest of the Xylocaine® and Ketamine on the Per and Postoperative Management of Acute and Chronic Postoperative Pain After Colectomy by Laparoscopy|Completed||Phase 2/Phase 3|135|Actual|University Hospital, Lille||3|||f||||f||||||||||2017-10-10 21:35:39.286355|2017-10-10 21:35:39.286355
NCT02969720|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-17|||March 2017||2017-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|FESIME||Therapeutic Efficacy of Phytosterols on Metabolic Syndrome|Double Blind, Randomized, Phase III, Parallel, Placebo-controled Study to Evaluate Therapeutic Efficacy of 2 Grams Phytosterols Daily Supplemention on Patients With Metabolic Syndrome|Not yet recruiting||Phase 3|200|Anticipated|Universidad Los Andes, Chile||2|||f||||f||||||||Undecided|PI will share IPD after doing all possible publications.|2017-10-10 21:35:39.391208|2017-10-10 21:35:39.391208
NCT02969707|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-23|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Use of Repetitive Transcranial Magnetic Stimulation to Augment Hypnotic Analgesia|Use of Repetitive Transcranial Magnetic Stimulation to Augment Hypnotic Analgesia|Not yet recruiting||N/A|100|Anticipated|Stanford University||2|||f||||t|f|t|f|f||||Undecided|Undecided.|2017-10-10 21:35:39.470373|2017-10-10 21:35:39.470373
NCT02969694|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-21|||September 2016||2016-09-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|HYPERCHEM||Evaluation of Relationship Between Hypersexuality and Psychostimulant Among Men Who Have Sex With Men|Evaluation of Relationship Between Hypersexuality and Psychostimulant Among Men Who Have Sex With Men|Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:35:39.581605|2017-10-10 21:35:39.581605
NCT02969681|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-01-08|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IV Ascorbic Acid in Advanced Colorectal Cancer|Phase ⅢStudy of IV Ascorbic Acid in Combination With FOLFOX/FOLFIRI +/- Bevacizumab vs Treatment With FOLFOX/FOLFIRI +/- Bevacizumab Alone as First-line Therapy for Advanced Colorectal Cancer|Not yet recruiting||Phase 3|512|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:35:39.668755|2017-10-10 21:35:39.668755
NCT02969668|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2017-05-29|||March 2016||2016-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01|24 Weeks|Observational [Patient Registry]|INFO||Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients|Effectiveness and Safety of Interferon-free Antiviral Regimens for the Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients|Recruiting||N/A|325|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||||||||||Undecided||2017-10-10 21:35:39.771526|2017-10-10 21:35:39.771526
NCT02969655|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-08-25|||November 21, 2016|Actual|2016-11-21|August 2017|2017-08-01|July 2, 2018|Anticipated|2018-07-02|July 2, 2018|Anticipated|2018-07-02||Interventional|||A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)|A 52-week, Phase III, Double-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Currently ESA Users|Active, not recruiting||Phase 3|270|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 21:35:39.93589|2017-10-10 21:35:39.93589
NCT02969642|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-12-01|||March 2016||2016-03-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Study of Low-level Laser Therapy in the Acute Treatment of Migraine|A Single-center, Sham-controlled, Single Attack Study of Laser Therapy to the Sphenopalatine Ganglion (SPG) in the Acute Treatment of Migraine|Recruiting||Phase 2|60|Anticipated|The San Francisco Clinical Research Center||2|||f||||f||||||||No||2017-10-10 21:35:40.134502|2017-10-10 21:35:40.134502
NCT02968316|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-16|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Bioelectric Impedance Analysis and Pregnancy Outcomes|Bioelectric Impedance Analysis and Pregnancy Outcomes|Not yet recruiting||N/A|1000|Anticipated|Maternal Fetal Medicine Associates|||1||f||||f||||||||No||2017-10-10 21:35:53.442588|2017-10-10 21:35:53.442588
NCT02969629|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-11-20|||December 2012||2012-12-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effects of Apomorphine on Experimental and Clinical Pain in Patients With Chronic Radicular Pain|The Effects of the Dopamine Agonist (Apomorphine) on Experimental and Clinical Pain in Patients With Chronic Radicular Pain: a Randomized, Double-blind, Placebo-controlled, Cross-over Study|Completed||Phase 4|59|Actual|Rambam Health Care Campus||2|||f||||f||||||||No|Individual participant data will not be shared.|2017-10-10 21:35:40.216276|2017-10-10 21:35:40.216276
NCT02969616|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-06-05|||September 2016||2016-09-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||Trinity Elite in Lumbar Fusion|A Prospective, Post Market, Multi-center, Open Label, Non-Randomized Clinical Study of the Efficacy of Using Trinity ELITE in Lumbar Fusion Surgery|Enrolling by invitation||N/A|120|Anticipated|Orthofix Inc.|||1||f||||f||||||||Undecided||2017-10-10 21:35:40.297049|2017-10-10 21:35:40.297049
NCT02969603|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-11-16|||September 2013||2013-09-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of Leg Muscular Activity Using MRI and 11C-acetate PET/MRI. Pilot Study|Evaluation of Leg Muscular Activity Using Magnetic Resonance Imaging and 11C-acetate Positron Tomography (PET/MRI). Pilot Study|Active, not recruiting||Phase 1/Phase 2|10|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 21:35:40.364881|2017-10-10 21:35:40.364881
NCT02969590|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-11-17|||March 2015||2015-03-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Regulation of Cervical Mucus Secretion|Regulation of Cervical Mucus Secretion|Recruiting||Phase 4|10|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 21:35:40.457283|2017-10-10 21:35:40.457283
NCT02969577|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-17|||January 2017||2017-01-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men|Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men|Not yet recruiting||N/A|150|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-10 21:35:40.563893|2017-10-10 21:35:40.563893
NCT02969564|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-11-16|||May 2016||2016-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.|18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.|Recruiting||N/A|10|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 21:35:40.665157|2017-10-10 21:35:40.665157
NCT02969551|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-03-16|||January 2014||2014-01-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Detection of Airway Obstruction by Manometry in Different Sleep Stages and Comparing it to DISE|Detection of Airway Obstruction by Manometry in Different Sleep Stages and Comparing it to DISE|Recruiting||N/A|30|Anticipated|Technische Universität München|||1||f||||f||||||||No||2017-10-10 21:35:40.748025|2017-10-10 21:35:40.748025
NCT02969538|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Shortening the Etching Time on the Clinical Performance of Resin Composite Restorations in Primary Teeth|Effect of Shortening the Etching Time on the Clinical Performance of Resin Composite Restorations in Primary Teeth|Not yet recruiting||N/A|70|Anticipated|Universidade Federal de Santa Maria||2|||f||||t||||||||Undecided||2017-10-10 21:35:40.826071|2017-10-10 21:35:40.826071
NCT02969525|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-08-31|||October 2016||2016-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|November 2017|Anticipated|2017-11-01||Interventional|||A Multicenter Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis.|A Multicenter, Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy and Safety of Bimekizumab in Active Psoriatic Arthritis|Active, not recruiting||Phase 2|206|Actual|UCB Pharma||5|||f||||t||||||||||2017-10-10 21:35:40.90739|2017-10-10 21:35:40.90739
NCT02969512|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-16|||December 2016||2016-12-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|HIPPER||Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER)|Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER) Intervention Protocol: An eHealth Approach for Pre-surgical Hip Replacement Education|Not yet recruiting||N/A|40|Anticipated|University of British Columbia||2|||f||||t||||||||No||2017-10-10 21:35:41.058778|2017-10-10 21:35:41.058778
NCT02969499|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01|14 Weeks|Observational [Patient Registry]|ECTBPSD||Safety and Efficacy of ECT for BPSD|Electroconvulsive Therapy for Behavioural and Psychological Symptoms of Dementia: A Prospective, Open-Label, Observational Study|Not yet recruiting||N/A|30|Anticipated|University of British Columbia|||1||f||||f||||||||No|Data will be collected and analyzed collectively and there is no plan of making the individual data available|2017-10-10 21:35:41.150963|2017-10-10 21:35:41.150963
NCT02969486|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-02-01|||September 2016||2016-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PAP-EIT||Non-invasive Estimation of Pulmonary Artery Pressure in Healthy Subjects by Electrical Impedance Tomography|Prospective Proof-of-concept Study Non-invasive Estimation of Pulmonary Artery Pressure in Healthy Subjects by Electrical Impedance Tomography|Completed||N/A|30|Actual|University Hospital Inselspital, Berne|||1||f||||t||||||||No||2017-10-10 21:35:41.234653|2017-10-10 21:35:41.234653
NCT02969473|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-16|||October 2010||2010-10-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma|Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma: a Phase II Randomized Controlled Trial|Active, not recruiting||Phase 2|120|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 21:35:41.292203|2017-10-10 21:35:41.292203
NCT02969460|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-03-20|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Neurotrack Virtual Cognitive Health Study||Active, not recruiting||N/A|85|Actual|Evidation Health||1|||f||||||||||||||2017-10-10 21:35:41.387067|2017-10-10 21:35:41.387067
NCT02969447|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-10-03|||October 20, 2016|Actual|2016-10-20|October 2017|2017-10-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|ANDDROID||Management of Third-stage of Labor After Second Trimester Medical Pregnancy Termination|Effect of Intra-venous Oxytocin Injection After Fetal Expulsion in Management of Third-stage of Labor After Second Trimester Medical Pregnancy Termination|Completed||Phase 4|27|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 21:35:41.444516|2017-10-10 21:35:41.444516
NCT02969434|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-20|||November 2016|Actual|2016-11-01|January 2017|2017-01-01|April 20, 2017|Actual|2017-04-20|April 2017|Actual|2017-04-01||Interventional|||Chronic Pain and Assessment of Sleep|Accuracy of the Brief Pain Inventory in Identifying Sleep Disturbances in Chronic Pain Patients|Completed||N/A|51|Actual|University of Aberdeen||1|||f||||f||||||||No||2017-10-10 21:35:41.515449|2017-10-10 21:35:41.515449
NCT02969421|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-04-17|||January 10, 2016|Actual|2016-01-10|November 2016|2016-11-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||Pain Perception With Tenaculum Placement|A Randomized Controlled Study of Patient Pain Perception With Tenaculum Placement During In-office Procedures|Completed||N/A|66|Actual|Duke University||2|||f||||f||||||||||2017-10-10 21:35:41.577744|2017-10-10 21:35:41.577744
NCT02969395|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-04-12|||April 2016||2016-04-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01|4 Years|Observational [Patient Registry]|||3T MRI CIED Post-Approval Study|Pacing Capture Threshold Change Following 3T MRI Scan of MR Conditional Cardiac Implantable Electronic Devices|Recruiting||N/A|2382|Anticipated|Medtronic|||1||f||||f||||||||||2017-10-10 21:35:41.998746|2017-10-10 21:35:41.998746
NCT02969369|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis|A Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of SEP 363856 in Subjects With Parkinson's Disease Psychosis|Recruiting||Phase 2|36|Anticipated|Sunovion||2|||f||||f||||||||||2017-10-10 21:35:42.566972|2017-10-10 21:35:42.566972
NCT02969356|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-07-28|||December 2016||2016-12-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ENGAGE||Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)|An International, Multicentre, Prospective, Single-Arm Study to Assess the Effect on Voluntary Movements of AbobotulinumtoxinA 1500 U Administered in Both Upper and Lower Limbs in Conjunction With a Guided Self-Rehabilitation Contract in Adult Subjects With Spastic Hemiparesis|Recruiting||Phase 4|155|Anticipated|Ipsen||1|||f||||f||||||||||2017-10-10 21:35:42.805982|2017-10-10 21:35:42.805982
NCT02969343|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-03-22|||April 2015|Actual|2015-04-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|PSLL||Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered|Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered|Recruiting||N/A|21000|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 21:35:42.964974|2017-10-10 21:35:42.964974
NCT02969330|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-17|||December 2016||2016-12-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||Effect of Peripheral Electrical Stimulation (PES) on Brain Response to Glucose Stimuli|Effect of Short Peripheral Electrical Stimulation (PES) on Brain Response to Glucose Stimuli Evaluated by BOLD and Functional Diffusion MRI: a Crossover Pilot Study|Not yet recruiting||N/A|20|Anticipated|Tel Aviv University||2|||f||||f||||||||No||2017-10-10 21:35:43.127125|2017-10-10 21:35:43.127125
NCT02969317|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-08-17|||February 24, 2017|Actual|2017-02-24|August 2017|2017-08-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients|An Open-label Trial to Assess Pharmacokinetics and Safety of Tiotropium + Olodaterol Fixed-dose Combination (5 µg/ 5 µg) Delivered by the RESPIMAT Inhaler After Single and Multiple Dose Treatment in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|12|Actual|Boehringer Ingelheim||1|||f|||||f|f||||||||2017-10-10 21:35:43.20831|2017-10-10 21:35:43.20831
NCT02969304|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-07-18|||December 30, 2016|Actual|2016-12-30|July 2017|2017-07-01|March 2, 2017|Actual|2017-03-02|March 2, 2017|Actual|2017-03-02||Observational|||Study of Utilization Patterns of Dimethyl Fumarate in Germany|Claims Database Study of Utilization Patterns of Dimethyl Fumarate in Germany|Completed||N/A|930|Actual|Biogen|||2||f||||f||||||||||2017-10-10 21:35:43.317762|2017-10-10 21:35:43.317762
NCT02969291|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-17|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Home-Based Study to Enhance Activity in Breast Cancer Survivors|A Home-Based Study to Enhance Activity in Breast Cancer Survivors|Recruiting||N/A|25|Anticipated|Baystate Medical Center||1|||f||||f||||||||Undecided||2017-10-10 21:35:43.416492|2017-10-10 21:35:43.416492
NCT02969278|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-17|||July 2013||2013-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|GroSNaPET||Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy|Study on the Prediction of Groin Lymphonodal Status Through 18FDG-PET/CT Combined With Sentinel Lymph Node Biopsy in Bulky a/o Multifocal a/o Pretreated Vulvar Cancer, N0 at Conventional Imaging (GRO-SNaPET Study)|Recruiting||N/A|50|Anticipated|Catholic University of the Sacred Heart||1|||f||||f||||||||No||2017-10-10 21:35:43.519115|2017-10-10 21:35:43.519115
NCT02969265|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-06-08|||May 9, 2017|Anticipated|2017-05-09|June 2017|2017-06-01|July 26, 2018|Anticipated|2018-07-26|July 12, 2018|Anticipated|2018-07-12||Interventional|||An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension|A Phase-3 Randomized, Double-Blind, Parallel-Group Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine (8/5 mg) in Chinese Subjects With Mild/Moderate Essential Hypertension, Who Do Not Achieve Target Blood Pressure Following Treatment With Amlodipine 5 mg Monotherapy|Withdrawn||Phase 3|0|Actual|Takeda||2||Business reasons unrelated to product safety|f||||f|f|f||||||||2017-10-10 21:35:43.623015|2017-10-10 21:35:43.623015
NCT02969252|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-17|||July 2015||2015-07-01|November 2016|2016-11-01||||August 2015|Actual|2015-08-01||Interventional|||Pharmacokinetics and Safety Study of Rifamycin SV-MMX® 600 mg Tablets After Single and Multiple t.i.d. Doses in Healthy Male and Female Volunteers|Pharmacokinetics and Safety Study of Rifamycin SV-MMX® 600 mg Tablets After Single and Multiple t.i.d. Doses in Healthy Male and Female Volunteers. Single and Multiple Dose, Open Label, Pharmacokinetics and Safety Study|Completed||Phase 1|18|Actual|Cosmo Technologies Ltd||1|||f||||||||||||||2017-10-10 21:35:43.758116|2017-10-10 21:35:43.758116
NCT02969239|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-03-08|||January 2016||2016-01-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Norepinephrine and Phenylephrine for Maternal Cardiac Output During Spinal Anesthesia for Elective Cesarean Delivery|Norepinephrine and Phenylephrine for Cesarean Section|Recruiting||Phase 4|50|Anticipated|Jeju National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:35:43.835383|2017-10-10 21:35:43.835383
NCT02969226|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-05-29|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Frequency of Screening and SBT Technique Trial: The FAST Trial|The Frequency of Screening and SBT Technique Trial: The FAST Trial, A North American Weaning Collaboration|Not yet recruiting||N/A|760|Anticipated|St. Michael's Hospital, Toronto||4|||f||||f|f|f||||||No||2017-10-10 21:35:43.941123|2017-10-10 21:35:43.941123
NCT02969213|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Big Data Construction and Biological Etiological Epidemiology Study of Children Epilepsy in China|Big Data Construction and Biological Etiological Epidemiology Study of Children Epilepsy in China|Not yet recruiting||N/A|10000|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||6||f||||f||||||||Undecided||2017-10-10 21:35:44.077747|2017-10-10 21:35:44.077747
NCT02969200|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-02-21|||April 2015||2015-04-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|January 2017|Actual|2017-01-01||Observational|||Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance|Fabry Disease: Renal Function During Long-term Enzyme Replacement Therapy Evaluated by Gold Standard GFR 51Cr-EDTA Clearance|Enrolling by invitation||N/A|52|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||No||2017-10-10 21:35:44.176345|2017-10-10 21:35:44.176345
NCT02969187|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|||Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patients Undergoing Laparoscopic Gastric Bypass|Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patients Undergoing Laparoscopic Gastric Bypass: A Randomized, Double-blind, Controlled Trial|Recruiting||Phase 4|100|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 21:35:44.249603|2017-10-10 21:35:44.249603
NCT02969174|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-17||||||November 2016|2016-11-01||||||||Expanded Access|||Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.|Clinical Professor of Shanghai Tongji Hospital|Approved for marketing||N/A|||Shanghai Tongji Hospital, Tongji University School of Medicine|||||f||||||||||||||2017-10-10 21:35:44.330042|2017-10-10 21:35:44.330042
NCT02969161|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-19|||March 2016||2016-03-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SG+||Safe Generations Plus: Swaziland PMTCT LTF Study|Safe Generations Plus: Mother Infant Retention Across the Option B-plus Cascade|Enrolling by invitation||N/A|944|Anticipated|Columbia University|||1||f||||f||||||||No||2017-10-10 21:35:44.377322|2017-10-10 21:35:44.377322
NCT02969148|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|November 2024|Anticipated|2024-11-01|November 2022|Anticipated|2022-11-01||Interventional|LBDL||Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer|Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in II,III Stage Gastric Carcinoma: A Prospective, Randomized, Single Blind, Parallel Group Clinical Trial|Recruiting||N/A|100|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-10 21:35:44.494253|2017-10-10 21:35:44.494253
NCT02969135|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Progressive Active Exercise After Surgical Rotator Cuff Repair|Physiotherapy With Progressive Active Exercise Training After Surgical Rotator Cuff Repair -A Randomized Controlled Trial With 3 and 12 Months Follow-up|Recruiting||N/A|100|Anticipated|Frederiksberg University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:35:44.609817|2017-10-10 21:35:44.609817
NCT02969122|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2016-11-23|||November 2016||2016-11-01|November 2016|2016-11-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|Cy-plus||Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor|Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor (Cy-plus): a Phase 2, Randomized Controlled Trial|Recruiting||N/A|59|Anticipated|Peking University||2|||f||||f||||||||No||2017-10-10 21:35:44.686634|2017-10-10 21:35:44.686634
NCT02969109|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-17|||November 2015||2015-11-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer|Clinical Validation of a Urine-based Assay With Genomic and Epigenomic Markers for Predicting Recurrence During Surveillance for Non-muscle Invasive Bladder Cancer|Recruiting||N/A|380|Anticipated|Genomic Health®, Inc.|||1||f||||f||||||Samples Without DNA|"     Urine and tissue   "|No||2017-10-10 21:35:44.78602|2017-10-10 21:35:44.78602
NCT02969096|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-17|||October 2016||2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma|Evaluating the Safety and Efficacy of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma|Active, not recruiting||Phase 2|30|Anticipated|Shanghai University of Traditional Chinese Medicine||1|||f||||f||||||||Undecided||2017-10-10 21:35:44.84367|2017-10-10 21:35:44.84367
NCT02969083|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-09-07|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|URANUS||Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma|"Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma: A Feasibility Phase II Randomized Clinical Trial (URANUS)"|Not yet recruiting||Phase 2|210|Anticipated|The European Uro-Oncology Group||5|||f||||t|f|f||||||||2017-10-10 21:35:44.915039|2017-10-10 21:35:44.915039
NCT02969070|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|NUTRENDO||Effects of Nutraceutical Therapies on Endothelial Function, Platelet Aggregation, and Coronary Flow Reserve|Randomized Trial to Evaluate the Effects of Two Different Nutraceutical Therapies on Endothelial Function, Platelet Aggregation, and Coronary Flow Reserve in Hypercholesterolemic Patients at Moderate Cardiovascular Risk|Recruiting||Phase 3|30|Anticipated|Federico II University||2|||f||||f||||||||Undecided||2017-10-10 21:35:45.002|2017-10-10 21:35:45.002
NCT02969057|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-05-23|||October 2016||2016-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PARBO||Palm And Rice Bran Oil Study|Effects of Liquid Oil vs Oleogel Co-ingested With a Carbohydrate-rich Meal on Human Blood Triglycerides, Glucose, Insulin and Appetite.|Active, not recruiting||N/A|18|Actual|Clinical Nutrition Research Centre, Singapore||5|||f||||f||||||||||2017-10-10 21:35:45.103092|2017-10-10 21:35:45.103092
NCT02969044|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-10-03|||December 2016|Actual|2016-12-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate|A Phase 2a, Randomized, Double-blind, Parallel Group, Placebo-controlled, Multi-center Study To Assess The Efficacy And Safety Profile Of Pf-06651600 In Subjects With Moderate To Severe Active Rheumatoid Arthritis With An Inadequate Response To Methotrexate|Recruiting||Phase 2|60|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-10 21:35:45.183808|2017-10-10 21:35:45.183808
NCT02969031|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||January 2017||2017-01-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Improving Communication Between Cancer Patients & Oncologists|Improving Communication Between Cancer Patients and Oncologists Using Patient Feedback on Actual Conversations and the ABIM Maintenance of Certification Program|Not yet recruiting||N/A|6490|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-10 21:35:47.029863|2017-10-10 21:35:47.029863
NCT02969018|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-09-22|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis|A Phase 2a, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-06700841 In Subjects With Moderate To Severe Plaque Psoriasis|Recruiting||Phase 2|200|Anticipated|Pfizer||8|||f||||f||||||||||2017-10-10 21:35:47.137463|2017-10-10 21:35:47.137463
NCT02969005|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-23|||January 2010||2010-01-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Use of a Radiopaque Localizer Grid and Methylene Blue Staining as an Aid to Reduce Radiation Exposure|Use of a Radiopaque Localizer Grid and Methylene Blue Staining as an Aid to Reduce Radiation Exposure in Resection Small Femur Lesions|Completed||N/A|40|Actual|Children's Hospital of Chongqing Medical University||1|||f||||f||||||||No||2017-10-10 21:35:47.326813|2017-10-10 21:35:47.326813
NCT02968992|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-16|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|ELCIE||Effects of rhLactoferrin on Chronic Inflammation in the Elderly|Effects of Lactoferrin on Chronic Inflammation in the Elderly|Recruiting||Phase 2|60|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||||2017-10-10 21:35:47.888669|2017-10-10 21:35:47.888669
NCT02968979|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2016-11-18|||July 2016||2016-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|CacheMire||Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.|Cross-sectional, Multicentric, Non-interventional Study to Assess the Frequency and the Management of Cachexia and Associated Symptoms in Patients With Non-small Cell Lung Cancer.|Completed||N/A|539|Actual|Chugai Pharma France|||1||f||||f||||||||No||2017-10-10 21:35:48.17245|2017-10-10 21:35:48.17245
NCT02968966|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-03-29|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|EE||Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies|Pathophysiologie Basierte Therapie Von früh Beginnenden Epileptischen Enzephalopathien|Not yet recruiting||Phase 2|25|Anticipated|University Hospital Tuebingen||1|||f||||t||||||||No||2017-10-10 21:35:48.290708|2017-10-10 21:35:48.290708
NCT02968953|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-06-28|||November 2016||2016-11-01|June 2017|2017-06-01||||November 2018|Anticipated|2018-11-01||Expanded Access|||Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome|Treatment With UX007 (Triheptanoin) for a Single Patient (ERS) With Glucose Transporter 1 (GLUT1) Deficiency Syndrome|Available||N/A|||University of Pittsburgh||||||t|||||||||||||2017-10-10 21:35:48.403195|2017-10-10 21:35:48.403195
NCT02968940|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-17|2017-03-13|||February 10, 2017|Actual|2017-02-10|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma|A Phase II, Open-label, Single Arm, Multicenter Study of Avelumab With Hypofractionated Radiation in Adult Subjects With Transformed IDH Mutant Glioblastoma|Recruiting||Phase 2|43|Anticipated|New York University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 21:35:48.503179|2017-10-10 21:35:48.503179
NCT02968927|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-05-11|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TBHDT||TB Host Directed Therapy|A Ph2 Randomized Trial to Evaluate the Safety Preliminary Efficacy and Biomarker Response of Host Directed Therapies Added to Rifabutin-modified Standard Therapy in Adults With Drug-Sensitive Smear-Positive Pulmonary TB|Recruiting||Phase 2|200|Anticipated|The Aurum Institute NPC||5|||f||||t||||||||Undecided||2017-10-10 21:35:48.612969|2017-10-10 21:35:48.612969
NCT02968914|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-07-24|||January 4, 2017|Actual|2017-01-04|July 2017|2017-07-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Interventional|||Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers|A Multicenter, Randomized, Open-Label, Parallel Group Phase 1 Pharmacokinetic Comparability Study of Benralizumab Administrated Using Accessorized Pre-Filled Syringe (APFS) or Autoinjector (AI) in Healthy Volunteers.|Completed||Phase 1|180|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 21:35:48.749478|2017-10-10 21:35:48.749478
NCT02968901|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-17|||September 2015||2015-09-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|OPTIMA||Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)|Prospective, Multicenter, Open-label Study Evaluating the Effects of First-line Oral Combination Therapy of Macitentan and Tadalafil in Patients With Newly Diagnosed Pulmonary Arterial Hypertension (OPTIMA).|Recruiting||Phase 4|60|Anticipated|Actelion||1|||f||||f||||||||Undecided||2017-10-10 21:35:48.888855|2017-10-10 21:35:48.888855
NCT02968888|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-16|||August 2014||2014-08-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|April 2015|Actual|2015-04-01||Interventional|||Anabolic Effects of Whey and Casein After Strength Training in Young and Elderly|Effects of Whey and Casein Supplementation on Acute Anabolic Responses in Muscle After Strength Training in Young and Elderly|Active, not recruiting||N/A|43|Actual|Norwegian School of Sport Sciences||3|||f||||f||||||||Undecided||2017-10-10 21:35:49.048377|2017-10-10 21:35:49.048377
NCT02968875|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-04-19|||July 2015||2015-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|MARAE||Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training|Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training|Recruiting||N/A|60|Anticipated|University Hospital Center of Martinique||2|||f||||f||||||||No||2017-10-10 21:35:49.23194|2017-10-10 21:35:49.23194
NCT02968862|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-18|||January 2009||2009-01-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Comparing Analgesia for Postoperative Pain Relief in Spine Surgery|Preemptive Analgesia for Postoperative Pain Relief in Thoraco-lumbo-sacral Spine Surgery: a Double-blinded Randomized Controlled Trial|Completed||N/A|99|Actual|Brigham and Women's Hospital|||1||f||||t||||||||No||2017-10-10 21:35:49.347772|2017-10-10 21:35:49.347772
NCT02968849|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-12-28|||October 2016||2016-10-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|HVTN702||Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa|A Pivotal Phase 2b/3 Multisite, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120/MF59 in Preventing HIV-1 Infection in Adults in South Africa|Recruiting||Phase 2/Phase 3|5400|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||No||2017-10-10 21:35:49.415761|2017-10-10 21:35:49.415761
NCT02968836|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||Safety and Efficacy of an Amino Acid Blend on Muscle and Gut Functionality in ICU Patients|Safety and Efficacy of an Amino Acid Blend on Muscle and Gut Functionality in ICU Patients|Not yet recruiting||N/A|50|Anticipated|Nestlé||2|||f||||f||||||||No||2017-10-10 21:35:49.566372|2017-10-10 21:35:49.566372
NCT02968823|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Licorice Versus Sugar-water Gargling for Pain in Patients Recovering From Ear-Nose-Throat and Maxilla-Facial Surgery|Licorice Versus Sugar-water Gargling for Pain in Patients Recovering From Ear-Nose-Throat (ENT) and Maxilla-Facial Surgery - A Randomized, Double-blind Study|Not yet recruiting||N/A|252|Anticipated|Medical University of Vienna||2|||f||||f||||||||No||2017-10-10 21:35:49.754778|2017-10-10 21:35:49.754778
NCT02968810|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-18|2017-09-04|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis|Statin Therapy to Reduce Disease Progression From Liver Cirrhosis to Cancer|Recruiting||Phase 2|80|Anticipated|National Cancer Institute (NCI)||2|||f||||t|t|f||||||||2017-10-10 21:35:49.836218|2017-10-10 21:35:49.836218
NCT02968797|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-11-16|||September 2016||2016-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|SafeSed||Clinical Comparative Study to Validate Performance of SafeSed Prototype Monitoring Endoscopy Under Sedation|SafeSed Validation Study, Compairing Performance to Capnography, as a Monitoring Technology of Respiratory Parameters|Not yet recruiting||N/A|100|Anticipated|Meir Medical Center|||1||f||||f||||||||No||2017-10-10 21:35:49.939681|2017-10-10 21:35:49.939681
NCT02968784|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-08-15|||June 2016||2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer|Focal ExAblate™ MR-Guided Focused Ultrasound (MRgFUS) Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer (OC-IRPC): Evaluation of Safety and Effectiveness|Recruiting||N/A|68|Anticipated|InSightec||1|||f||||f||||||||||2017-10-10 21:35:50.006704|2017-10-10 21:35:50.006704
NCT02968771|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-17|||November 2016||2016-11-01|March 2017|2017-03-01|June 2022|Anticipated|2022-06-01|October 2017|Anticipated|2017-10-01||Observational|METS||Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT|Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT|Recruiting||N/A|500|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||3||f||||f||||||Samples Without DNA|"     Samples without DNA   "|||2017-10-10 21:35:50.127483|2017-10-10 21:35:50.127483
NCT02968758|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-11|||February 6, 2017|Actual|2017-02-06|August 2017|2017-08-01|August 10, 2017|Actual|2017-08-10|August 2, 2017|Actual|2017-08-02||Interventional|||Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains|Prospective Multi-Center Study for Clinical Validation of the Molecular-Based GenePOC CDiff System for the Detection of Toxin B Gene From Toxigenic Clostridium Difficile Strains in Unformed (Soft or Liquid) Human Stool Specimens|Completed||N/A|2581|Actual|GenePOC||1|||f||||f|f|t|f|||||||2017-10-10 21:35:50.238941|2017-10-10 21:35:50.238941
NCT02968745|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-18|||June 2009||2009-06-01|November 2016|2016-11-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Observational|||Occupational Performance Problems in Individuals With Rheumatoid Arthritis|Occupational Performance Problems Frequently Reported by Individuals With Rheumatoid Arthritis|Completed||N/A|81|Actual|Federal University of Minas Gerais|||1||f||||f||||||||No|Not plan to Share IPD|2017-10-10 21:35:50.325271|2017-10-10 21:35:50.325271
NCT02968732|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-03-23|||November 11, 2016|Actual|2016-11-11|March 2017|2017-03-01|April 1, 2027|Anticipated|2027-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder|Assessment of Reliability of Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder at the Time of Radical Cystectomy|Recruiting||N/A|80|Anticipated|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-10 21:35:50.384548|2017-10-10 21:35:50.384548
NCT02968719|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-07-28|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|July 2017|Actual|2017-07-01||Interventional|||A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®|Phase 1 Pharmacokinetic (PK) Study to Evaluate Once-weekly Corplex™ Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept® in Healthy Adult Subjects|Active, not recruiting||Phase 1|107|Actual|Corium International Inc.||5|||f||||f||||||||||2017-10-10 21:35:50.488123|2017-10-10 21:35:50.488123
NCT02968706|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-02-17|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|HFNC||HFNC Versus Conventional Nasal Cannula in Oxygen Performance in Patients Receiving Colonoscopy Under IV Sedation|High Flow Nasal Cannula Versus Conventional Nasal Cannula in Oxygen Performance in Patients Receiving Colonoscopy Under Intravenous Sedation|Recruiting||N/A|300|Anticipated|Aventura Hospital and Medical Center||2|||f||||f||||||||No||2017-10-10 21:35:50.588275|2017-10-10 21:35:50.588275
NCT02968693|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-16|||April 2011||2011-04-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Drug Delivery Devices for Osteomyelitis||Completed||N/A|51|Actual|Yulin Orthopedics Hospital of Chinese and Western Medicine|||2||f||||f||||||||No||2017-10-10 21:35:50.686271|2017-10-10 21:35:50.686271
NCT02968680|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-11-16|||December 2016||2016-12-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma|Pilot Translational Study of Sonazoid-Enhanced Ultrasonography for Sentinel Lymph Node Mapping in Cutaneous Melanoma|Not yet recruiting||Phase 1|20|Anticipated|University of Southern California||1|||f||||t||||||||||2017-10-10 21:35:50.755063|2017-10-10 21:35:50.755063
NCT02968667|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-17|||November 2015||2015-11-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial|The Effectiveness of Hopelessness and Helplessness on Recovery Rate Among People Diagnosed With Schizophrenia|Completed||Phase 2|102|Actual|Fakeeh College for Medical Sciences||2|||f||||f||||||||||2017-10-10 21:35:50.845557|2017-10-10 21:35:50.845557
NCT02968654|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-16|||September 2016||2016-09-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|June 2021|Anticipated|2021-06-01||Interventional|TRAIN||TRansfusion Strategies in Acute Brain INjured Patients|Transfusion Strategies in Acute Brain Injured Patients. A Prospective Multicenter Randomized Study.|Recruiting||Phase 3|4610|Anticipated|Erasme University Hospital||2|||f||||t||||||||No||2017-10-10 21:35:50.91807|2017-10-10 21:35:50.91807
NCT02968641|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-16|||March 2017||2017-03-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|LOWR-5||A Study of Lonafarnib With or Without Ritonavir in Patients With HDV|A Phase 2b, Open-Label, Randomized Study of the Safety, Tolerability, and Pharmacodynamic Activity of Lonafarnib With or Without Ritonavir in Patients Chronically Infected With Hepatitis Delta Virus (LOWR-5)|Not yet recruiting||Phase 2|60|Anticipated|Eiger BioPharmaceuticals||3|||f||||||||||||||2017-10-10 21:35:51.022068|2017-10-10 21:35:51.022068
NCT02968628|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-11-16|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)|Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)|Recruiting||N/A|70|Anticipated|University of Rochester|||2||f||||f||||||||No||2017-10-10 21:35:51.116938|2017-10-10 21:35:51.116938
NCT02968615|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-16|||May 2015||2015-05-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Interventional|||Simple Changes Weight Loss Intervention|Simple Changes Weight Loss Intervention|Completed||N/A|15|Actual|University of Massachusetts, Worcester||1|||f||||t||||||||Undecided|Please contact with PI|2017-10-10 21:35:51.202134|2017-10-10 21:35:51.202134
NCT02968602|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-05-01|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Minocycline and Tobacco Craving in Smokers With Schizophrenia|Minocycline and Tobacco Craving in Smokers With Schizophrenia|Recruiting||Phase 4|30|Anticipated|University of Maryland||2|||f||||t|t|f|||f|||No|This study was funded prior to the NIH requirements for sharing of IPD, therefore is not within our budget.|2017-10-10 21:35:51.277864|2017-10-10 21:35:51.277864
NCT02968589|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-15|||September 2015||2015-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|@ctiveHip||@ctiveHip Tele-rehabilitation System|@ctiveHip: Tele-rehabilitation System for Hip Fracture Patients|Active, not recruiting||N/A|70|Anticipated|Universidad de Granada||2|||f||||t||||||||||2017-10-10 21:35:51.349872|2017-10-10 21:35:51.349872
NCT02968576|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-07-24|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|A-TEAM||Bioequivalence of Tenofovir and Emtricitabine Following Overencapsulation|Bioequivalence of Tenofovir and Emtricitabine Following Overencapsulation|Completed||N/A|24|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 21:35:51.423191|2017-10-10 21:35:51.423191
NCT02968563|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-09-27|||December 13, 2016|Actual|2016-12-13|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)|A Prospective, Randomized, Open-Label, Multicenter, Phase 2 Trial to Evaluate the Safety and Efficacy of the Combination of GS-4059 and Idelalisib With and Without Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia|Recruiting||Phase 2|36|Anticipated|Gilead Sciences||2|||f||||f||f||||||||2017-10-10 21:35:51.498506|2017-10-10 21:35:51.498506
NCT02968550|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-03-29|||January 2016||2016-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Shunt Evaluation With ALPE System in Thoracic Surgery||Completed||N/A|41|Actual|Università degli Studi di Ferrara|||2||f||||t||||||||||2017-10-10 21:35:51.61304|2017-10-10 21:35:51.61304
NCT02968537|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-06-15|||December 2016||2016-12-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|May 2018|Anticipated|2018-05-01||Interventional|INTRA||Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders|Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders. A Randomized Controlled Trial|Recruiting||N/A|246|Anticipated|University of Bern||6|||f||||f||||||||Undecided||2017-10-10 21:35:51.672713|2017-10-10 21:35:51.672713
NCT02968524|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-03-03|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|Thermospot||Evaluation of Thermospot Accuracy in Nigerian Infants Exposed to Ambient Temperature and Validation of Maternal Readings and Responses|Evaluation of Thermospot Accuracy in Nigerian Infants Exposed to Ambient Temperature and Validation of Maternal Readings and Responses|Recruiting||N/A|500|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||No||2017-10-10 21:35:51.770731|2017-10-10 21:35:51.770731
NCT02968511|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|EGESTA||EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant|EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota|Recruiting||N/A|5|Anticipated|Milton S. Hershey Medical Center||1|||f||||t||||||||No||2017-10-10 21:35:51.923539|2017-10-10 21:35:51.923539
NCT02968498|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-03-02|||November 2016||2016-11-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers|Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers|Completed||N/A|24|Actual|Fresenius Kabi||2|||f||||f||||||||No||2017-10-10 21:35:52.012535|2017-10-10 21:35:52.012535
NCT02968485|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-24|||November 2016||2016-11-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase I Study of SHR7390 in Patients With Advanced Solid Tumors|A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR7390 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|60|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||No||2017-10-10 21:35:52.115966|2017-10-10 21:35:52.115966
NCT02968472|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||March 2015||2015-03-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia|Single Center, Open, Phase I Clinical Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia|Recruiting||Phase 1|30|Anticipated|The First People's Hospital of Yunnan||1|||f||||t||||||||Undecided||2017-10-10 21:35:52.232061|2017-10-10 21:35:52.232061
NCT02968459|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety and Efficacy of Umbilical Cord Mesenchyme Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Umbilical Cord Mesenchyme Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars|Recruiting||Phase 2|120|Anticipated|Maternal and Child Health Hospital of Foshan||2|||f||||t||||||||Undecided||2017-10-10 21:35:52.326117|2017-10-10 21:35:52.326117
NCT02968446|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-04-04|||November 17, 2016|Actual|2016-11-17|April 2017|2017-04-01|August 15, 2017|Anticipated|2017-08-15|July 15, 2017|Anticipated|2017-07-15||Interventional|||Effect of Vitamin D After Application With Valchlor|The Effect of Oral Vitamin D (Cholecalciferol) Supplementation After Topical Application With Valchlor|Recruiting||Early Phase 1|28|Anticipated|Case Comprehensive Cancer Center||2|||f||||f|t|f|||f|||||2017-10-10 21:35:52.431032|2017-10-10 21:35:52.431032
NCT02968433|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-02-21|||November 2016||2016-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SPDP||The Stanford Parkinson's Disease Plasma Study|The Stanford Parkinson's Disease Plasma (SPDP) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Moderate Parkinson's Disease|Active, not recruiting||Phase 1|5|Actual|Stanford University||1|||f||||t||||||||No||2017-10-10 21:35:52.539526|2017-10-10 21:35:52.539526
NCT02968420|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-19|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|Merck08||Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine|Long Term Immune Memory Responses to Human Papillomavirus (HPV) Vaccination Following 2 Verses 3 Doses of Quadrivalent HPV Vaccine|Recruiting||Phase 4|18|Anticipated|University of British Columbia||3|||f||||f|f|f||||||||2017-10-10 21:35:52.630084|2017-10-10 21:35:52.630084
NCT02968407|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-24|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|self-rate||Peer- and Self-rating of Open Surgery Skills|Peer- and Self-rating of Open Surgery Skills Using Objective Structured Assessment of Technical Skills|Completed||N/A|22|Actual|Copenhagen Academy for Medical Education and Simulation|||1||f||||f||||||||||2017-10-10 21:35:52.736073|2017-10-10 21:35:52.736073
NCT02968394|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-18|||March 2014||2014-03-01|November 2016|2016-11-01||||March 2017|Anticipated|2017-03-01||Interventional|||Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions|Influence of Omalizumab Co-treatment on Honey-bee Venom Immunotherapy Failure Due to Systemic Reactions|Recruiting||N/A|11|Anticipated|The University Clinic of Pulmonary and Allergic Diseases Golnik||1|||f||||f||||||||||2017-10-10 21:35:52.803588|2017-10-10 21:35:52.803588
NCT02968381|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-01-31|||February 2018|Anticipated|2018-02-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|QLImagery||A Guided Imagery Tobacco Cessation Intervention Delivered by a Quit Line and Website|A Guided Imagery Tobacco Cessation Intervention Delivered by a Quit Line and Website|Not yet recruiting||N/A|145|Anticipated|University of Arizona||2|||f||||t|f|f||||||No||2017-10-10 21:35:52.906478|2017-10-10 21:35:52.906478
NCT02968355|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-16|||March 2017||2017-03-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Observational|||Clinical Evaluation of the FilmArray® Global Fever (GF) Panel|Clinical Evaluation of the FilmArray® Global Fever (GF) Panel|Not yet recruiting||N/A|1500|Anticipated|BioFire Defense LLC|||1||f||||f||||||Samples With DNA|"     Whole blood specimen may be retained at the participating clinical sites for future use.     Specimen nucleic acid may be retained at BioFire and participating clinical sites for future     performance evaluations of the FilmArray.   "|No|IPD will not be shared with other researchers.|2017-10-10 21:35:53.159961|2017-10-10 21:35:53.159961
NCT02968303|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-05-12|||January 27, 2017|Actual|2017-01-27|May 2017|2017-05-01|October 2023|Anticipated|2023-10-01|October 2022|Anticipated|2022-10-01||Interventional|COWBOY||Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy|Phase 2 Study With COmbination of Vemurafenib With Cobimetinib in B-RAF V600E/K Mutated Melanoma Patients to Normalize LDH and Optimize Nivolumab and Ipilimumab therapY|Recruiting||Phase 2|200|Anticipated|Radboud University||2|||f||||t|f|f||||||Undecided||2017-10-10 21:35:53.536536|2017-10-10 21:35:53.536536
NCT02968290|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-20|||August 2016||2016-08-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|Cataract||Quantification of Posterior Capsule Opacification in Cataract Pediatric.|Quantification of Posterior Capsule Opacity With Software Analysis Comparing Intraocular Lenses Hydrophilic x Hydrophobic in Pediatric Cataracts.|Recruiting||Phase 4|40|Anticipated|University of Sao Paulo||2|||f||||t||||||||Undecided||2017-10-10 21:35:53.645921|2017-10-10 21:35:53.645921
NCT02968277|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-21|||June 2016||2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||LifeWalker Upright Walker vs. Conventional Rollator Walker and Predicate Device|LifeWalker Upright Walker Versus Conventional Rollator Walker and Predicate Device|Active, not recruiting||N/A|30|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-10 21:35:53.741476|2017-10-10 21:35:53.741476
NCT02968264|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-09-20|||June 2015||2015-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|20 Years|Observational [Patient Registry]|TOF-LIFE||Tetralogy of Fallot for Life|Tetralogy of Fallot for Life|Recruiting||N/A|3000|Anticipated|Population Health Research Institute|||1||f||||f||||||||||2017-10-10 21:35:53.82721|2017-10-10 21:35:53.82721
NCT02968251|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-08|||October 2016||2016-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Designing and Evaluating a School-based Hand Washing Program in Malawi|Designing and Evaluating a School-based Hand Washing Program in Malawi|Recruiting||N/A|360|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-10 21:35:54.000392|2017-10-10 21:35:54.000392
NCT02968238|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-14|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|||Tranquil Moments II-CBT vs. Yoga for Worry|Cognitive-behavioral Therapy Versus Yoga for the Treatment of Worry in Anxious Older Adults: A Randomized Preference Trial|Recruiting||N/A|500|Anticipated|Wake Forest University Health Sciences||4|||f||||t|f|f||||||||2017-10-10 21:35:54.077654|2017-10-10 21:35:54.077654
NCT02968225|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-04-03|||August 2016||2016-08-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|SAGA||Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism|Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism|Recruiting||N/A|28|Anticipated|Penn State University||2|||f||||t||||||||No||2017-10-10 21:35:54.182048|2017-10-10 21:35:54.182048
NCT02968212|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-09-19|||April 11, 2017|Actual|2017-04-11|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)|Phase 2 Study of Clofazimine for the Treatment of Pulmonary Mycobacterium Avium Disease|Recruiting||Phase 2|102|Anticipated|Oregon Health and Science University||2|||f||||t|t|f||||||||2017-10-10 21:35:54.267067|2017-10-10 21:35:54.267067
NCT02968199|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-03-28|||January 2006|Actual|2006-01-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|December 2012|Actual|2012-12-01||Interventional|||Building a Community-based Network to Promote Smoking Cessation|Development of a Community-based Network to Promote Smoking Cessation Among Female Smokers in Hong Kong|Completed||N/A|457|Actual|The University of Hong Kong||1|||f||||t||||||||No||2017-10-10 21:35:54.376397|2017-10-10 21:35:54.376397
NCT02968186|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-06-27|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Implementing Screening and Brief Interventions for Excessive Drinkers in Primary Health Care|Implementing Screening and Brief Interventions for Excessive Drinkers in Primary Health Care|Active, not recruiting||N/A|250|Anticipated|Agrupamento de Centros de Saúde de Dão Lafões||2|||f||||f||||||||No||2017-10-10 21:35:54.452067|2017-10-10 21:35:54.452067
NCT02968173|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-07-28|||November 9, 2016||2016-11-09|July 2017|2017-07-01|July 13, 2017|Actual|2017-07-13|July 10, 2017|Actual|2017-07-10||Interventional|Synagis Russia||A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus|A Prospective, International, Multicenter, Open-Label, Non-Controlled Study of Safety and Effectiveness of Palivizumab, in Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus|Completed||Phase 3|50|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 21:35:54.53774|2017-10-10 21:35:54.53774
NCT02968160|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-05-30|||October 2016||2016-10-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome||Recruiting||Phase 4|204|Anticipated|Yuhan Corporation||2|||f||||f||||||||No||2017-10-10 21:35:54.633444|2017-10-10 21:35:54.633444
NCT02968147|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-15|||December 2016||2016-12-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||High Frequency Jet Ventilation in AF Ablation|High Frequency Jet Ventilation in AF Ablation|Not yet recruiting||N/A|30|Anticipated|Oxford University Hospitals NHS Trust||2|||f||||f||||||||No||2017-10-10 21:35:54.724811|2017-10-10 21:35:54.724811
NCT02968134|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|POSA||Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients|Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients|Not yet recruiting||Phase 4|8|Anticipated|Royal Brisbane and Women's Hospital||1|||f||||f||||||||No|De-identified data for all primary and secondary endpoints will be reported as a collective data set. Individual results will not be reported.|2017-10-10 21:35:54.815377|2017-10-10 21:35:54.815377
NCT02968121|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-02-14|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia|A Phase 1, Two-part, Open-label, Randomized, Exploratory and Single Ascending Dose, Parallel Arm Trial to Determine the Pharmacokinetics, Safety, and Tolerability of Brexpiprazole Long-acting Injectable Administered Subcutaneously or Intramuscularly in Adult Subjects With Schizophrenia|Recruiting||Phase 1|110|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||5|||f||||f||||||||||2017-10-10 21:35:55.082818|2017-10-10 21:35:55.082818
NCT02968108|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-10-03|||January 18, 2017|Actual|2017-01-18|October 2017|2017-10-01|March 21, 2023|Anticipated|2023-03-21|January 2, 2019|Anticipated|2019-01-02||Interventional|STELARA||A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease|A Randomized Double-blind Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease|Recruiting||Phase 1|40|Anticipated|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 21:35:55.203183|2017-10-10 21:35:55.203183
NCT02968095|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-17|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|August 2019|Anticipated|2019-08-01||Interventional|||Text Message Support to Prevent Smoking Relapse|Text Message Support to Prevent Smoking Relapse in Community Treatment Settings|Not yet recruiting||N/A|40|Anticipated|Miami University||2|||f||||f|f|f||||||||2017-10-10 21:35:55.379566|2017-10-10 21:35:55.379566
NCT02968082|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effects of Preoperative Scopolamine Patch Application on the Postoperative Nausea and Vomiting in MVD Surgery|The Effects of Preoperative Scopolamine Patch Application on the Postoperative Nausea and Vomiting in Microvascular Decompression Surgery|Not yet recruiting||Phase 4|60|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 21:35:55.450629|2017-10-10 21:35:55.450629
NCT02968069|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-16|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions|Development and Validation of a Predictive Model for Early Gastric Cancerous Lesions Under Endoscopic Observation|Not yet recruiting||N/A|300|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||No||2017-10-10 21:35:55.540449|2017-10-10 21:35:55.540449
NCT02968056|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||One Staged Hybrid Approach of Surgical/Catheter Ablation for Persistent Atrial Fibrillation|One Staged Hybrid Approach of Minimally Invasively Surgical/Catheter Ablation for Persistent Atrial Fibrillation: A Non-Randomized Controlled Trial|Not yet recruiting||N/A|160|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:35:55.619627|2017-10-10 21:35:55.619627
NCT02968043|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-16|||January 2017||2017-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Physiotherapeutic Scoliosis Specific Exercises in Adolescent Idiopathic Scoliosis|Application Research of Physiotherapeutic Scoliosis Specific Exercises in Adolescent Idiopathic Scoliosis|Not yet recruiting||N/A|42|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||No||2017-10-10 21:35:55.72756|2017-10-10 21:35:55.72756
NCT02968030|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-27|||January 2008||2008-01-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|July 2008|Actual|2008-07-01||Interventional|||Strengthening in Functional Mobility of Active Elderly|Influence of a Strengthening Exercise Program for Lower Limbs in Functional Mobility From Irregularly Active Elderly|Completed||N/A|7|Actual|Universidade Federal do Triangulo Mineiro||1|||f||||t||||||||||2017-10-10 21:35:55.839768|2017-10-10 21:35:55.839768
NCT02968017|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Observational|||Middle Cerebral Artery Doppler in Uncomplicated Term Pregnancy|Variability in Middle Cerebral Artery Doppler Measurements in Uncomplicated Term Pregnancies.|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||||Undecided||2017-10-10 21:35:55.913883|2017-10-10 21:35:55.913883
NCT02968004|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-09-06|||December 2016||2016-12-01|October 2016|2016-10-01||||February 2019|Anticipated|2019-02-01||Interventional|||Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children|A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency|Recruiting||Phase 3|220|Anticipated|Opko Biologics||2|||f||||||||||||||2017-10-10 21:35:55.984568|2017-10-10 21:35:55.984568
NCT02967991|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-07-31|||August 2016||2016-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|EUSLB1922||19 Versus 22-Gauge Needle for EUS-LB|19 Versus 22-Gauge Fine Needle Biopsy (FNB) Needles for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB): A Prospective Pilot Study|Completed||N/A|20|Actual|Geisinger Clinic||4|||f||||t||||||||||2017-10-10 21:35:56.092163|2017-10-10 21:35:56.092163
NCT02967978|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|||Study on the Predictive Value of the Natural Calcium Isotope Ratio in Urine and Serum for the Diagnosis of Osteoporosis|Study on the Predictive Value of the Natural Calcium Isotope Ratio in Urine and Serum for the Diagnosis of Osteoporosis|Not yet recruiting||N/A|100|Anticipated|Clinical Research Center Kiel GmbH|||1||f||||t||||||Samples Without DNA|"     serum sample, plasma sample, urine sample, stool sample   "|No||2017-10-10 21:35:56.213771|2017-10-10 21:35:56.213771
NCT02967965|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-16|||December 2013||2013-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CARIM||CARdioprotection in Myocardial Infarction|CARIM Cohort (CARdioprotection in Myocardial Infarction)|Recruiting||Phase 4|2000|Anticipated|EZUS-LYON 1|||1||f||||f||||||Samples With DNA|"     J2-4: 63 mL (3 dry tubes ; 2 citrate tubes and 4 tubes with EDTA, with 2 for DNA isolation)     M6: 28 mL (2 dry tube, 1 citrate tube and 1 tube with EDTA) M12: 21 mL (1 dry tube, 1 citrate     tube and 1 tube with EDTA) Optional: In centers adequately equipped for management of blood     samples in the catheterization laboratory, blood samples will be also taken at JO, before and     4 hours after reperfusion (14 ml each: 1 dry tube and 1 tube with EDTA) after obtention of     the agreement of the patient to be included in the cohort CARIM.   "|No||2017-10-10 21:35:56.297356|2017-10-10 21:35:56.297356
NCT02967952|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|SAVE||A RCT on Supraglottic Airway Versus Endotracheal Intubation in OHCA|A RCT on Supraglottic Airway Versus Endotracheal Intubation in OHCA (SAVE)|Not yet recruiting||N/A|852|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-10 21:35:56.390809|2017-10-10 21:35:56.390809
NCT02967939|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-09-12|||April 17, 2017|Actual|2017-04-17|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients|Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802(Tenofovir Disoproxil Orotate) and Viread®(Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients|Recruiting||Phase 3|120|Anticipated|Dong-A ST Co., Ltd.||2|||f||||t|f|f||||||||2017-10-10 21:35:56.481998|2017-10-10 21:35:56.481998
NCT02967926|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-16|||December 2015||2015-12-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy|Digital SpyGlass Cholangioscopy Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy|Completed||Phase 3|51|Actual|Chulalongkorn University||1|||f||||f||||||||No||2017-10-10 21:35:56.573432|2017-10-10 21:35:56.573432
NCT02967913|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-17|||May 2007||2007-05-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Urinary Symptoms and the Omission of the Bladder Flap at the Time of Primary Cesarean Delivery|Urinary Symptoms and the Omission of the Bladder Flap at the Time of Primary Cesarean Delivery|Completed||N/A|70|Actual|National Naval Medical Center||2|||f||||f||||||||No||2017-10-10 21:35:56.655633|2017-10-10 21:35:56.655633
NCT02967900|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-08-29|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Observational|||Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies|Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies|Not yet recruiting||N/A|15|Anticipated|Michelson Diagnostics Ltd.|||1||f||||f||||||Samples Without DNA|"     2 mm punch biopsy   "|||2017-10-10 21:35:56.745151|2017-10-10 21:35:56.745151
NCT02967887|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-07-13|||November 2016||2016-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SHINE||Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC|Single-arm, Prospective, Multicenter Clinical Trial to Assess the Efficacy and the Safety of Combination Therapy of Hepatic Arterial Infusion of Cisplatin and 5-FU in Advanced Hepatocellular Carcinoma With Low Expression of HMGB2 Biomarker|Recruiting||Phase 2|96|Anticipated|CbsBioscience||1|||f||||t||||||||||2017-10-10 21:35:56.807275|2017-10-10 21:35:56.807275
NCT02967874|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||March 2016||2016-03-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment|Safety/Efficacy of Intra-articularly Administrated Autologous Adipose -Derived Stromal Vascular Fraction Cells in Treatment of Knee Osteoarthritis|Recruiting||Phase 1/Phase 2|40|Anticipated|Russian Academy of Medical Sciences||2|||f||||||||||||||2017-10-10 21:35:56.929207|2017-10-10 21:35:56.929207
NCT02967861|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-15|||January 2016||2016-01-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Pranayama on Periodontal Health|Effect of Pranayama on Peroxisome Proliferator-activated Receptor Gamma, Nuclear Factor Kappa B and Red Complex Microorganisms in Patients With Chronic Periodontitis|Completed||Early Phase 1|60|Actual|Meenakshi Ammal Dental College and Hospital||2|||f||||t||||||||No||2017-10-10 21:35:57.03377|2017-10-10 21:35:57.03377
NCT02967848|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|LiverINSPECT||Liver Function Investigation With SPECT|Liver Function Investigation With Single Photon Emission Computed Tomography After Radiotherapy|Not yet recruiting||N/A|20|Anticipated|Royal North Shore Hospital|||1||f||||f||||||||Yes|Data will be processed remotely at Peter MacCallum Cancer Centre, by the AI, Nicholas Hardcastle.|2017-10-10 21:35:57.111041|2017-10-10 21:35:57.111041
NCT02967835|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-11-16|||August 2016||2016-08-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||Effectiveness and Satisfaction With Brief Synchronous Tele-psychiatry Consult|Pilot to Assess Effectiveness of and Satisfaction With Brief Synchronous Tele-psychiatry Consult|Recruiting||N/A|50|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 21:35:57.194787|2017-10-10 21:35:57.194787
NCT02967822|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-08-24|||May 2016||2016-05-01|August 2017|2017-08-01|May 2031|Anticipated|2031-05-01|May 2031|Anticipated|2031-05-01||Observational|MRKH||Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome|Etude de Génétique moléculaire du Syndrome de Mayer-Rokitansky-Kuster-Hauser|Recruiting||N/A|410|Anticipated|Imagine Institute|||2||f||||f||||||Samples With DNA|"     -  Blood samples (for patients and healthy relatives)        -  Uterine tissue (for patients who have a surgical intervention during their routine          follow-up, and only if samples remain available after routine care analyses).   "|||2017-10-10 21:35:57.261801|2017-10-10 21:35:57.261801
NCT02967809|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-16|||October 2016||2016-10-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01|1 Month|Observational [Patient Registry]|||Usefulness of an Ultraportative Ultrasound Device in the Management of Intra Hospital Emergencies|Usefulness of an Ultraportative Ultrasound Device in the Management of Intra Hospital Emergencies|Recruiting||N/A|172|Anticipated|Hospital Nord|||2||f||||f||||||||No||2017-10-10 21:35:57.338806|2017-10-10 21:35:57.338806
NCT02967796|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-16|||September 2015||2015-09-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|PiL-Obs-ProtSC||Descriptive Study About a Strategy of Micronutrient Management in Parturient and Layered Women With Proteochoc®, a Dietary Supplement Rich in Porphyra HSP®|Descriptive Study About a Strategy of Micronutrient Management in Parturient and Layered Women With Proteochoc®, a Dietary Supplement Rich in Porphyra HSP®|Active, not recruiting||N/A|60|Actual|Pileje|||2||f||||f||||||||||2017-10-10 21:35:57.413955|2017-10-10 21:35:57.413955
NCT02967783|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-06-09|||February 7, 2017|Actual|2017-02-07|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|March 23, 2017|Actual|2017-03-23||Interventional|||A Campaign-based ID fIPV Administration Trial|A Pragmatic Trial to Quantitatively and Qualitatively Assess Different Techniques for the ID Administration of Fractional Dose IPV in a Campaign Setting in The Gambia|Active, not recruiting||N/A|2721|Actual|Medical Research Council Unit, The Gambia||3|||f||||f|f|f||||||No||2017-10-10 21:35:57.495015|2017-10-10 21:35:57.495015
NCT02967770|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-03-30|||November 2016||2016-11-01|March 2017|2017-03-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|PanCAN||Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic Cancer|A Randomized Phase II Trial Comparing Molecularly Tailored Therapy to Physician's Discretion Standard of Care as Second-Line Therapy for Patients With Metastatic Pancreatic Cancer|Recruiting||Phase 2|58|Anticipated|Georgetown University||2|||f||||t||||||||No||2017-10-10 21:35:57.585282|2017-10-10 21:35:57.585282
NCT02967731|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-06-08|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||480 Biomedical Sinus Drug Depot|An Exploratory Safety Study of 480 Biomedical Sinus Drug Depot in Adult Subjects With Chronic Sinusitis|Recruiting||Phase 1|20|Anticipated|480 Biomedical, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:35:57.853809|2017-10-10 21:35:57.853809
NCT02967718|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-20|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|||Innovation Research of Differentiation and Treatment Methods Based on CHD Phlegm and Blood Stasis Syndrome|Clinical Observation of CHD Phlegm and Blood-stasis Syndrome Patients|Recruiting||N/A|13000|Anticipated|China Academy of Chinese Medical Sciences|||6||f||||t||||||Samples Without DNA|"     serum sample   "|Undecided||2017-10-10 21:35:57.921675|2017-10-10 21:35:57.921675
NCT02967705|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-16|||February 2016||2016-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Pain Management Groups in Occupational Health Settings|Pilot Study on Pain Management Groups in Occupational Health Settings|Active, not recruiting||N/A|60|Actual|Finnish Institute of Occupational Health||2|||f||||f||||||||No||2017-10-10 21:35:57.99684|2017-10-10 21:35:57.99684
NCT02967679|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-15|||September 2016||2016-09-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study||Recruiting||Phase 1/Phase 2|15|Anticipated|MedDay Pharmaceuticals SA||1|||f||||t||||||||||2017-10-10 21:35:58.218505|2017-10-10 21:35:58.218505
NCT02967666|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01||||May 2017|Anticipated|2017-05-01||Interventional|||Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts|Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts|Recruiting||Phase 1|30|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-10 21:35:58.30587|2017-10-10 21:35:58.30587
NCT02967640|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-21|||January 2017||2017-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Does Subacromial Injection With Glutamate Receptor Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?|Does Subacromial Injection With Glutamate Receptor (NMDAR) Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?|Not yet recruiting||Phase 2/Phase 3|20|Anticipated|Helse Møre og Romsdal HF||2|||f||||t||||||||No||2017-10-10 21:35:58.489471|2017-10-10 21:35:58.489471
NCT02967627|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|VACCRR||VAC Dressings for Colorectal Resections|Incisional Negative Pressure Wound Therapy Following Colorectal Resection: a Single Site, Prospective, Randomized Control Trial|Not yet recruiting||N/A|400|Anticipated|University of British Columbia||2|||f||||t||||||||Undecided|To be decided|2017-10-10 21:35:58.70564|2017-10-10 21:35:58.70564
NCT02967614|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2016-12-19|||December 2016||2016-12-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||KJ-TFC-004 Drug-drug Interaction Study|A Randomized, Open-label, 2-period, Parallel Group, Multiple-dose Study to Evaluate the Drug-drugs Interaction Between Dorzolamide and Brimonidine in Healthy Korean Male Volunteers|Recruiting||Phase 1|32|Anticipated|Kukje Pharma||2|||f||||f||||||||No||2017-10-10 21:35:58.82801|2017-10-10 21:35:58.82801
NCT02967601|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Observational|||Influence of Preoperative Anxiety on Shivering During Elective Caesarean Section Under Spinal Anaesthesia||Recruiting||N/A|200|Anticipated|Centre of Postgraduate Medical Education|||1||f||||f||||||||No||2017-10-10 21:35:58.956927|2017-10-10 21:35:58.956927
NCT02967588|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-06-30|||March 6, 2017|Actual|2017-03-06|September 2016|2016-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||An Intervention to Support Medication Adherence Following Acute Coronary Syndrome|Development and Feasibility of a Brief Hospital-Based Intervention to Support Medication Adherence Following Acute Coronary Syndrome|Completed||N/A|15|Actual|King's College London||1|||f||||f|f|f||||||||2017-10-10 21:35:59.056279|2017-10-10 21:35:59.056279
NCT02967575|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-14|||November 2016||2016-11-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Observational|||Triadyme-C, a Polycrystalline Diamond Compact Cervical Disc Replacement (cTDR)|Triadyme-C, a Polycrystalline Diamond Compact Cervical Disc Replacement (cTDR): Evaluation of Clinical and Radiographic Outcome|Recruiting||N/A|100|Anticipated|Dymicron EU GmbH|||1||f||||f||||||||||2017-10-10 21:35:59.153043|2017-10-10 21:35:59.153043
NCT02967562|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Neonatal Resuscitation - Sustained Inflations|Comparison of a Sustained Inflation to Shorter Inflation Breaths During Resuscitation at Delivery of Prematurely Born Infants|Recruiting||N/A|40|Anticipated|King's College London||2|||f||||f||||||||||2017-10-10 21:35:59.291853|2017-10-10 21:35:59.291853
NCT02967549|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Neurally Adjusted Ventilatory Assist vs Proportional Assist Ventilation|Optimisation of Neonatal Ventilation - NAVA vs PAV|Recruiting||N/A|18|Anticipated|King's College London||2|||f||||f||||||||||2017-10-10 21:35:59.394934|2017-10-10 21:35:59.394934
NCT02957721|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-05-09|||March 2018|Anticipated|2018-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|DEAP||Diabetes Engagement and Activation Platform|DEAP: Diabetes Engagement and Activation Platform|Not yet recruiting||N/A|320|Anticipated|Virginia Commonwealth University||2|||f||||t|f|f||||||No||2017-10-10 21:37:44.097166|2017-10-10 21:37:44.097166
NCT02967536|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-11-15|||November 2016||2016-11-01|July 2016|2016-07-01||||October 2020|Anticipated|2020-10-01||Observational|INcOSA||Investigating the Effect of Continuous Positive Airway Pressure on the Neuropathology of Obstructive Sleep Apnoea|Investigating the Effect of Continuous Positive Airway Pressure on the Neuropathology of Obstructive Sleep Apnoea|Not yet recruiting||N/A|14|Anticipated|King's College London|||2||f||||f||||||Samples With DNA|"     Participants will be invited to donate samples (blood or saliva) to the BRC Bioresource. In     order to have statistical power for genetic analysis, samples from INcOSA participants will     need to be combined with those from the OSA BioResource (Research Tissue Bank) volunteers who     have provided consented biological samples for future research.      These samples may be used for genetic, epigenetic, metabolomic or proteomic analysis.   "|||2017-10-10 21:35:59.500091|2017-10-10 21:35:59.500091
NCT02967523|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||May 2016||2016-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01|6 Months|Observational [Patient Registry]|||Surefire Precision Infusion System Registry|Surefire Precision Infusion System Registry|Enrolling by invitation||N/A|150|Anticipated|Surefire Medical, Inc.|||1||f||||f||||||||No||2017-10-10 21:35:59.58754|2017-10-10 21:35:59.58754
NCT02967497|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-12-30|||October 2016||2016-10-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild Type|An Open Label Study of UanQiHuoLi Tang Plus Cisplatin-based Chemotherapy in Advanced Epidermal Growth Factor Receptor Wild Type Non-small Cell Lung Cancer|Enrolling by invitation||Phase 2|56|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||No||2017-10-10 21:35:59.901575|2017-10-10 21:35:59.901575
NCT02967484|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-23|2017-07-24|||November 20, 2016|Actual|2016-11-20|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke|Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke: Study Protocol for a Multicenter, Pragmatic,Randomized Controlled, Assessor-blinded Clinical Trial|Recruiting||N/A|480|Anticipated|First Teaching Hospital of Tianjin University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 21:35:59.998338|2017-10-10 21:35:59.998338
NCT02967471|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-18|||October 2017||2017-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Discovery of New Early Detection Biomarkers From Peripheral Blood of Acute Respiratory Distress Syndrome(ARDS)|Discovery of New Early Detection Biomarkers From Peripheral Blood of Acute Respiratory Distress Syndrome(ARDS)|Not yet recruiting||N/A|120|Anticipated|The Third Affiliated Hospital of Southern Medical University|||2||f||||t||||||||No||2017-10-10 21:36:00.149218|2017-10-10 21:36:00.149218
NCT02967458|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-10-03|||February 21, 2017|Actual|2017-02-21|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study|Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study|Recruiting||Phase 2|50|Anticipated|Thomas Jefferson University||1|||f||||t|t|f||||||||2017-10-10 21:36:00.242748|2017-10-10 21:36:00.242748
NCT02967445|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Physical Examination-Indicated Pessary||Recruiting||Phase 3|50|Anticipated|Federico II University||2|||f||||f||||||||||2017-10-10 21:36:00.36507|2017-10-10 21:36:00.36507
NCT02967432|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-17|||October 2016||2016-10-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|||Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU|Randomized Controlled Trial of Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a Neonatal Intensive Care Unit|Recruiting||Phase 2|200|Anticipated|Crouse Hospital||2|||f||||t||||||||No||2017-10-10 21:36:00.461628|2017-10-10 21:36:00.461628
NCT02967419|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-16|||January 2017||2017-01-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||The Study of the Relationship Between TWEAK/Fn14, JAK/STAT3 and IDO in the Immune Microenvironment of Endometrium in Repeated Implantation Failure|The Study of the Relationship Between TWEAK/Fn14, JAK/STAT3 and IDO in the Immune Microenvironment of Endometrium in Repeated Implantation Failure|Not yet recruiting||N/A|60|Anticipated|Tongji Hospital|||2||f||||||||||Samples With DNA|"     whole blood, serum, white cells, urine, endometrium   "|||2017-10-10 21:36:00.577067|2017-10-10 21:36:00.577067
NCT02967406|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-05-30|||March 2016||2016-03-01|May 2017|2017-05-01|August 2027|Anticipated|2027-08-01|March 2027|Anticipated|2027-03-01||Interventional|||Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population|Impact of Lifestyle Modification on Prevention of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population: Cluster Randomized Controlled Trial|Active, not recruiting||N/A|3600|Anticipated|Sanpasitthiprasong Hospital||2|||f||||t||||||||||2017-10-10 21:36:00.687587|2017-10-10 21:36:00.687587
NCT02967393|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-05-08|||October 10, 2016|Actual|2016-10-10|May 2017|2017-05-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Influenza Vaccine Feasibility Study in Children With Persistent Asthma|Feasibility Study to Assess the Safety of Quadrivalent, Live Attenuated Influenza Vaccine (LAIV4) Versus Quadrivalent Inactivated Influenza Vaccine (IIV4) in Children Aged 5-11 Years With Persistent Asthma of Varied Severity (Cell Culture Quadrivalent IIV Used as Surrogate for LAIV4)|Completed||Phase 4|50|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 21:36:00.805|2017-10-10 21:36:00.805
NCT02967380|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-03-22|||December 14, 2011|Actual|2011-12-14|March 2017|2017-03-01|October 14, 2015|Actual|2015-10-14|October 14, 2014|Actual|2014-10-14||Interventional|||Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases|Dynamic Contrast Enhanced Steady State T1-Weighted Perfusion MRI (DCE MRI): Characterization of Intracranial Lesions|Terminated||N/A|14|Actual|University of Southern California||1||Insufficient Accrual|f||||t|f|f||||||||2017-10-10 21:36:00.888492|2017-10-10 21:36:00.888492
NCT02967367|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-04-25|||September 2016||2016-09-01|December 2016|2016-12-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Reliability of Consumer Sleep Trackers in Patients Suffering From Obstructive Sleep Apnea Syndrome|Reliability of Consumer Sleep Trackers in Patients Suffering From Obstructive Sleep Apnea Syndrome|Completed||N/A|20|Actual|Centre Hospitalier Universitaire Saint Pierre||1|||f||||f||||||||No||2017-10-10 21:36:00.986767|2017-10-10 21:36:00.986767
NCT02967354|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-05-02|||January 2013||2013-01-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||[11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes|[11C]5-Hydroxy-tryptophan Positron Emission Tomography for Assessment of Islet Mass During Progression of Type 2 Diabetes|Completed||N/A|39|Actual|Uppsala University Hospital||5|||f||||f||||||||||2017-10-10 21:36:01.074225|2017-10-10 21:36:01.074225
NCT02967341|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-11-15|||March 2016||2016-03-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients|Validation of Central Venous (Port A Cath®) Blood Draws for Ciprofloxacin Pharmacokinetic Research in Patients Under Treatment for Childhood Cancer|Recruiting||Phase 4|15|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||t||||||||Yes||2017-10-10 21:36:01.154885|2017-10-10 21:36:01.154885
NCT02967328|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||RP% Measurement by FCM as a Diagnostic Test for ITP|A Multi-Center Prospective Blind Study of RP% Measurement by Flow Cytometry in the Diagnosis of Primary Immune Thrombocytopenia|Recruiting||N/A|500|Anticipated|Shandong University|||1||f||||t||||||||||2017-10-10 21:36:01.272433|2017-10-10 21:36:01.272433
NCT02967315|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-15|||August 2013||2013-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Changes in Fluid Status on Right Ventricular Volumes and Function|Effects of Changes in Fluid Status on Right Ventricular Volumes and Function|Recruiting||N/A|6|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||No||2017-10-10 21:36:01.382556|2017-10-10 21:36:01.382556
NCT02967302|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-15|||August 2015||2015-08-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||NEUROIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the Knee Joint|"NEUROIMPA Intraarticular Application of Opioids in Chronic Arthritis"|Recruiting||Phase 2/Phase 3|112|Anticipated|Charite University, Berlin, Germany||3|||f||||t||||||||No|no plan|2017-10-10 21:36:01.499422|2017-10-10 21:36:01.499422
NCT02967289|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-10-04|||March 27, 2017|Actual|2017-03-27|October 2017|2017-10-01|June 2026|Anticipated|2026-06-01|June 2024|Anticipated|2024-06-01||Interventional|IROCAS||IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting|A Phase III, Randomised, International Trial Comparing mFOLFIRINOX Triplet Chemotherapy to mFOLFOX for High-risk Stage III Colon Cancer in Adjuvant Setting|Recruiting||Phase 3|640|Anticipated|UNICANCER||2|||f||||t|f|f||||||||2017-10-10 21:36:01.64925|2017-10-10 21:36:01.64925
NCT02967276|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-05-01|||January 2017||2017-01-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|METDEXA-MM||Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma|Phase II Trial, Open Label, Clinical Activity of Metformin in Combination With High-dose of Dexamethasone (HDdexa) in Patients With Relapsed/Refractory Multiple Myeloma|Recruiting||Phase 2|28|Anticipated|University of Campinas, Brazil||1|||f||||f||||||||No||2017-10-10 21:36:01.828734|2017-10-10 21:36:01.828734
NCT02967263|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-08-30|||January 2015||2015-01-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Observational|||Etiology, Epidemiology and Prognostics of AKI|The Study of Etiology, Epidemiology and Prognostic Factors of Acute Kidney Injury|Recruiting||N/A|600|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University|||1||f||||t||||||Samples Without DNA|"     blood or urine samples   "|||2017-10-10 21:36:01.977848|2017-10-10 21:36:01.977848
NCT02967250|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment|7T Magnetic Resonance Spectroscopy Monitoring Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment|Not yet recruiting||Phase 1|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||Undecided||2017-10-10 21:36:02.074417|2017-10-10 21:36:02.074417
NCT02967237|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-08-30|||January 4, 2016||2016-01-04|August 2017|2017-08-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|Transition II||Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin Treatment|An Interventional, Open-label, Single-arm, Multicenter, 24 Weeks Phase 4 Study Assessing the Efficacy and Safety of Toujeo in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin|Completed||Phase 4|136|Actual|Sanofi||1|||f||||f||||||||||2017-10-10 21:36:02.15727|2017-10-10 21:36:02.15727
NCT02967224|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-16|||November 2015||2015-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|Reach-Control||"A Real World Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to Standard of Care Basal Insulins in Insulin Naïve Patients Initiating Insulin"|"A Twenty-six Week, Randomized, Open-label, 2-Arm Parallel Group Real World Pragmatic Trial to Assess the Clinical and Health Outcomes Benefit of Toujeo® Compared to Standard of Care Insulin for Initiating Basal Insulin in Insulin Naïve Patients With Uncontrolled Type 2 Diabetes Mellitus, With 6-Month Extension"|Active, not recruiting||Phase 4|680|Actual|Sanofi||2|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:36:04.182727|2017-10-10 21:36:04.182727
NCT02967211|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-19|||December 2015||2015-12-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|REGAIN CONTROL||"A Real World Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to Standard of Care Basal Insulin in Patients Already Using Basal Insulin"|"A Twenty-six Week, Randomized, Open-label, 2-arm Parallel Group Real World Pragmatic Trial to Assess the Clinical and Health Outcomes Benefit of Transition to Toujeo Compared to Standard of Care Insulin in Basal Insulin Treated Patients With Uncontrolled Type 2 Diabetes Mellitus, With Six-Month Extension"|Active, not recruiting||Phase 4|580|Anticipated|Sanofi||2|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:36:04.730472|2017-10-10 21:36:04.730472
NCT02967198|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2016-11-16|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Pre-procedure Planning for Liver Biopsy or Radiofrequency Ablation Using CT or MR/US Fusing Imaging|Pre-procedure Planning for Liver Biopsy or Radiofrequency Ablation Using the Automatic Fusion Images of the Registrated 3D CT or MR-US Scans|Completed||N/A|185|Actual|Seoul National University Hospital||1|||f||||t||||||||No||2017-10-10 21:36:05.484102|2017-10-10 21:36:05.484102
NCT02967185|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-15|||May 2005||2005-05-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|REST||Intraindividual Variability in Sleep and Cognitive Performance in Older Adults|Intraindividual Variability in Sleep and Cognitive Performance in Older Adults|Completed||Phase 2|62|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-10-10 21:36:05.611729|2017-10-10 21:36:05.611729
NCT02967172|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01||||May 2018|Anticipated|2018-05-01||Interventional|||Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures|Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures: A Randomized Controlled Trial|Recruiting||Phase 4|200|Anticipated|University of Iowa||2|||f||||f||||||||No||2017-10-10 21:36:05.726992|2017-10-10 21:36:05.726992
NCT02967159|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-04-11|||November 24, 2016|Actual|2016-11-24|April 2017|2017-04-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|||A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male Participants|A RANDOMIZED OPEN LABEL CROSS-OVER STUDY TO EVALUATE PHARMACOKINETICS AND SAFETY OF SINGLE INHALED DOSES OF ABEDITEROL AND AZD7594 GIVEN ALONE, IN FIXED DOSE COMBINATION (FDC) AND IN FREE COMBINATION, USING DPI, IN MALE HEALTHY VOLUNTEERS.|Completed||Phase 1|14|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-10 21:36:05.876582|2017-10-10 21:36:05.876582
NCT02967146|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-01-03|||November 2016||2016-11-01|January 2017|2017-01-01||||November 2017|Anticipated|2017-11-01||Interventional|||Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer|Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer A Multicenter Double-blinded, Randomized Study|Recruiting||Phase 3|170|Anticipated|Samsung Medical Center||2|||f||||||||||||||2017-10-10 21:36:06.024308|2017-10-10 21:36:06.024308
NCT02967133|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-15|||December 2016||2016-12-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer|Nivolumab With or Without Nab-Paclitaxel in Previously Treated, Advanced Stage, Non-small Cell Lung Cancer: A Randomized Phase II Study|Not yet recruiting||Phase 2|200|Anticipated|Alliance Foundation Trials, LLC.||2|||f||||t||||||||Undecided|Anonymized (de-identified) data generated from biospecimens used for future correlative research, including somatic and constitutional (germline) genomic data, may be shared with other researchers or deposited in a publicly accessible or controlled-access data repositories. Correlative study results and data will never be returned to individual patients.|2017-10-10 21:36:06.144981|2017-10-10 21:36:06.144981
NCT02967120|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-09-20|||January 2014||2014-01-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Early Diagnosis of Oral Cancer by Detecting p16 Hydroxymethylation|A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Hydroxymethylation|Recruiting||N/A|265|Anticipated|Beijing Municipal Administration of Hospitals|||1||f||||t||||||Samples With DNA|"     Oral mucosal biopsy tissues were formalin fixed , paraffin embedded , sliced；or frozen     tissues;   "|||2017-10-10 21:36:06.283056|2017-10-10 21:36:06.283056
NCT02967107|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-13|2016-11-15|||August 2016||2016-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|CSP-EMR||Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Colonic Sessile Serrated Polyps|Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Colonic Sessile Serrated Polyps - A Randomised Controlled Trial|Recruiting||N/A|400|Anticipated|Western Sydney Local Health District||2|||f||||t||||||||Undecided||2017-10-10 21:36:06.414052|2017-10-10 21:36:06.414052
NCT02967094|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-27|||November 2016||2016-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Mucolytic Solution Before Upper Endoscopy|The Use of Mucolytic Solution Before Upper Endoscopy: A Randomized, Double-blinded Trial|Recruiting||N/A|150|Anticipated|Vitkovice Hospital||3|||f||||f||||||||No||2017-10-10 21:36:06.546981|2017-10-10 21:36:06.546981
NCT02967081|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01|10 Days|Observational [Patient Registry]|||Evaluation of Dentinal Fluid for the Presence of Matrix Metalloproteinase 9 (MMP-9) in Pulpal Inflammation||Recruiting||N/A|60|Anticipated|University of Zurich|||4||f||||f||||||||No||2017-10-10 21:36:06.678553|2017-10-10 21:36:06.678553
NCT02967068|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-02-21|||November 2016||2016-11-01|February 2017|2017-02-01||||December 2019|Anticipated|2019-12-01||Observational|||VCRC Tissue Repository|VCRC Tissue Biorepository Collection Protocol|Recruiting||N/A|1000|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     Biopsy specimens collected as standard of care for these diseases will be retrieved and used     in research. The most common biopsies performed are kidney, lung, skin, nerves, and vessels.   "|No||2017-10-10 21:36:06.772265|2017-10-10 21:36:06.772265
NCT02967042|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-11-16|||August 2016||2016-08-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|CKD-Bone||Chronic Kidney Disease and Bone - Correlation Between 18F-PET-TT Imaging and Histomorphometry of Bone in CKD Patients|Chronic Kidney Disease and Bone - Correlation Between 18F-PET-TT Imaging and Histomorphometry of Bone in Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism|Recruiting||N/A|90|Anticipated|Turku University Hospital||1|||f||||t||||||||No||2017-10-10 21:36:07.059515|2017-10-10 21:36:07.059515
NCT02967029|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Controlled Hypotension on Cerebral Oxygen Saturation|Effect of Controlled Hypotension on Cerebral Oxygen Saturation in Patients Undergoing Functional Endoscopic Sinus Surgery: a Prospective Randomized Single Blind Clinical Trial|Not yet recruiting||Phase 4|150|Anticipated|Istanbul University||2|||f||||f||||||||No||2017-10-10 21:36:07.162296|2017-10-10 21:36:07.162296
NCT02967016|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-07-24|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Physical Activity After a Normal Spontaneous or Cesarean Delivery|A Pilot Study: To Compare Physical Activity After a Normal Spontaneous or Cesarean Delivery by Use of a Actigraph GT3X|Recruiting||N/A|60|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|f|f||||||||2017-10-10 21:36:07.270597|2017-10-10 21:36:07.270597
NCT02966990|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-15|||December 2016||2016-12-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Biomechanical Analysis of the Effects of Upper Limb Orthosis During the Execution of a Functional Task|Biomechanical Analysis of the Effects of Upper Limb Orthosis During the Execution of a Functional Task|Not yet recruiting||N/A|25|Anticipated|University of Sao Paulo||1|||f||||f||||||||No||2017-10-10 21:36:07.371351|2017-10-10 21:36:07.371351
NCT02966977|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-04-10|||October 2016||2016-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|March 31, 2017|Actual|2017-03-31||Interventional|||Extending Urine Analysis By Direct Mass Spectrometry|Clinical Study To Analyse The Influence Of An Extended Urine Analysis By Mass Spectrometry On Internal Medicine Wards At The University Hospital Of Basel|Active, not recruiting||N/A|192|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||No||2017-10-10 21:36:07.437603|2017-10-10 21:36:07.437603
NCT02966964|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-09-21|||April 2015||2015-04-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|||A Clinical Trials to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With HBV|An Exploratory, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With Hepatitis B Virus(HBV)|Recruiting||Phase 2|90|Anticipated|Uijeongbu St. Mary Hospital||3|||f||||||||||||||2017-10-10 21:36:07.529355|2017-10-10 21:36:07.529355
NCT02966951|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-05-03|||January 17, 2017|Actual|2017-01-17|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis|Knee Osteoarthrosis (KOA) in Jordanian Patients: a Phase I Dose-finding Study Using Adipose Tissue Derived Mesenchymal Stem Cells (ATMSC) for Advanced Stage III and IV KOA|Recruiting||Phase 1|10|Anticipated|University of Jordan||1|||f||||f|f|f|||f|||Undecided||2017-10-10 21:36:07.626726|2017-10-10 21:36:07.626726
NCT02966938|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-17|||December 2015||2015-12-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|REVIALL||Visual Recognition of Allergens by Allergic Patients and/or Their Parents|Visual Recognition of Allergens by Allergic Patients and/or Their Parents|Completed||N/A|440|Actual|Lille Catholic University|||1||f||||t||||||||No||2017-10-10 21:36:07.720336|2017-10-10 21:36:07.720336
NCT02966925|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-17|||May 2016||2016-05-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness|Evaluation of the Benefit of the Use of Platelet-Rich Plasma (PRP) Combined to Hyaluronic Acid (HA) for Vulvovaginal Dryness|Recruiting||N/A|20|Anticipated|Regen Lab SA||1|||f||||f||||||||No||2017-10-10 21:36:07.783326|2017-10-10 21:36:07.783326
NCT02966912|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity|Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity|Recruiting||N/A|40|Anticipated|Providence VA Medical Center||2|||f||||f||||||||||2017-10-10 21:36:07.881425|2017-10-10 21:36:07.881425
NCT02966899|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Reversal of Right Ventricular Steatosis in Pulmonary Hypertension|Reversal of Right Ventricular Steatosis in Pulmonary Hypertension|Recruiting||N/A|30|Anticipated|Providence VA Medical Center||1|||f||||f||||||||Undecided||2017-10-10 21:36:07.989307|2017-10-10 21:36:07.989307
NCT02966886|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-07-20|||January 2017||2017-01-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Approach to Glenoid Management in Shoulder Osteoarthritis (OA)|Comparison of Techniques in the Management of Glenoid Deficiencies in Shoulder Arthroplasty: A Protocol for Two Parallel Randomized Controlled Trials|Recruiting||N/A|160|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 21:36:08.07636|2017-10-10 21:36:08.07636
NCT02966873|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-09-29|||October 2016||2016-10-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)|A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid Post Traumatic Stress Disorder|Recruiting||Phase 2|200|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 21:36:08.18083|2017-10-10 21:36:08.18083
NCT02966860|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-04-04|||August 2016||2016-08-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects|A Single-Dose Study Evaluating the Oral Pharmacokinetics of an Oxycodone/Acetaminophen Solution in Healthy Subjects Under Fasted Conditions|Completed||Phase 1|18|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-10 21:36:08.31304|2017-10-10 21:36:08.31304
NCT02966847|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|CAVIT||Assessment of Cone-beam Computed Tomography (CBCT) Assistance to Video-assisted Thoracoscopic Surgery|Assessment of Cone-beam Computed Tomography (CBCT) Assistance to Video-assisted Thoracoscopic Surgery|Recruiting||N/A|30|Anticipated|Rennes University Hospital||1|||f||||f||||||||No||2017-10-10 21:36:08.390817|2017-10-10 21:36:08.390817
NCT02966821|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Sulfatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma|A Phase II, Single-arm, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sulfatinib as a Second-line Treatment in Patients With Surgically Unresectable or Metastatic Biliary Tract Carcinoma|Recruiting||Phase 2|32|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||No||2017-10-10 21:36:08.79831|2017-10-10 21:36:08.79831
NCT02966808|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-18|||December 2016||2016-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|RETROFAM||Retrospective Observational Study About Long-term Effect of Fampridine in Patients With Multiple Sclerosis|Retrospective Study About Long-term Effect of Fampridine in Patients With Multiple Sclerosis|Recruiting||N/A|50|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||f||||||||||2017-10-10 21:36:08.905564|2017-10-10 21:36:08.905564
NCT02966795|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-09-29|||January 25, 2017|Actual|2017-01-25|September 2017|2017-09-01|October 10, 2018|Anticipated|2018-10-10|July 18, 2018|Anticipated|2018-07-18||Interventional|||A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection|M16-126 A Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection|Recruiting||Phase 3|80|Anticipated|AbbVie||2|||t||||f|t|f||||||||2017-10-10 21:36:08.993077|2017-10-10 21:36:08.993077
NCT02966769|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-16|||June 2016||2016-06-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|||N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation|Multicentric Retrospective Observation Study: Neoadjuvant Treatment and Surgery Versus Definitive Chemoradiation in the Non-Small Cell Lung Cancer (NSCLC) IIIA-N2|Recruiting||N/A|220|Anticipated|Grupo de Investigación Clínica en Oncología Radioterapia|||2||f||||f||||||||No||2017-10-10 21:36:09.425395|2017-10-10 21:36:09.425395
NCT02966756|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-09-05|||October 5, 2017|Anticipated|2017-10-05|September 2017|2017-09-01|August 28, 2024|Anticipated|2024-08-28|June 18, 2021|Anticipated|2021-06-18||Interventional|||A Study Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia in the Presence of 17p Deletion|A Phase 2 Open-Label Study of the Efficacy of Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia in the Presence of 17p Deletion|Not yet recruiting||Phase 2|70|Anticipated|AbbVie||1|||f||||t|f|f||||||||2017-10-10 21:36:09.520331|2017-10-10 21:36:09.520331
NCT02966743|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-12-05|||November 2016||2016-11-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|2||Effect of Sedatives on Regional Cerebral Oxygen Saturation|Effect of Medazolam or Dexmedetomidine on Regional Cerebral Oxygen Saturation During Spinal Anesthesia in the Elderly Patients|Recruiting||N/A|60|Anticipated|Gachon University Gil Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:36:09.672809|2017-10-10 21:36:09.672809
NCT02966730|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-03-02|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy|Protocol 20060 (PCYC): A Multicenter, Open-Label Pilot Study of Follicular Lymphoma Ibrutinib Consolidation for FDG-PET Positivity After Frontline Chemoimmunotherapy (FLIPP)|Recruiting||N/A|21|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:36:09.793682|2017-10-10 21:36:09.793682
NCT02966717|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-18|||August 2016||2016-08-01|November 2016|2016-11-01|October 2021|Anticipated|2021-10-01|October 2016|Actual|2016-10-01||Interventional|CKD||Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)|The Clinical Study of Rituximab Combined With Mesenchymal Stem Cells in the Treatment of Primary Nephrotic Syndrome (3-4 Stage of Chronic Kidney Disease)|Active, not recruiting||Phase 2|116|Anticipated|Zhujiang Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:36:09.944974|2017-10-10 21:36:09.944974
NCT02966704|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-11-14|||April 2016||2016-04-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Stable Isotope Method to Assess Dietary Protein Quality|A Dual Stable Isotope Method to Assess Dietary Protein Quality in Humans: Characterization of Intrinsically Labelled 15N Milk Protein as a Reference Protein|Active, not recruiting||N/A|10|Anticipated|Wageningen University||2|||f||||f||||||||||2017-10-10 21:36:10.063592|2017-10-10 21:36:10.063592
NCT02966691|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-07-26|||January 2017||2017-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|VISIOCYT 1||Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors|Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors|Recruiting||N/A|1300|Anticipated|Vitadx||3|||f||||f||||||||||2017-10-10 21:36:10.132275|2017-10-10 21:36:10.132275
NCT02966678|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-06-19|||November 8, 2016|Actual|2016-11-08|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Observational|||Incidence of Dyschromatopsia in Glaucoma|Incidence of Dyschromatopsia in Glaucoma|Completed||N/A|100|Actual|University of Zurich|||1||f||||f||||||||No||2017-10-10 21:36:10.276033|2017-10-10 21:36:10.276033
NCT02966665|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-01-19|||September 2008||2008-09-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||: Vascular Function in Health and Disease|Vascular Function in Health & Disease: Rehabilitation for Hypertension; Exercise and Skeletal Muscle Afferent Feedback|Recruiting||Phase 1|420|Anticipated|University of Utah||7|||f||||f||||||||No||2017-10-10 21:36:10.361846|2017-10-10 21:36:10.361846
NCT02966652|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-04-13|||September 2016||2016-09-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism|A Phase 1, Randomised, Open-label, 2-cohort, Cross-over Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Native Oral Testosterone Formulation (DITEST) in the Fed and Fasted State and Compared to Testosterone Undecanoate in Adult Men With Primary or Secondary Hypogonadism|Recruiting||Phase 1|24|Anticipated|Diurnal Limited||2|||f||||t||||||||No||2017-10-10 21:36:10.539334|2017-10-10 21:36:10.539334
NCT02966639|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis|Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis|Recruiting||N/A|400|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||f||||||||Yes||2017-10-10 21:36:10.66224|2017-10-10 21:36:10.66224
NCT02966626|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-21|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Real World Experience of Dapaglifozin in Type 2 Diabetes|Dapaglifozin in Type 2 Diabetes Mellitus Patients: A Single-centre Retrospective Cohort Study|Not yet recruiting||N/A|200|Anticipated|University of Malaya|||1||f||||f||||||||No||2017-10-10 21:36:10.75676|2017-10-10 21:36:10.75676
NCT02966613|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-11-15|||September 2013||2013-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|MyKnee||Fully Disposable Patient-Specific Instrumentation|Primary TKA Using a Fully Disposable Patient-Specific Instrumentation: A Multicenter Controlled Study|Completed||N/A|210|Actual|Cochin Hospital||3|||f||||f||||||||||2017-10-10 21:36:10.822596|2017-10-10 21:36:10.822596
NCT02966600|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-14|||February 2016||2016-02-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Strength Training and Different Subtypes of Parkinson´s Disease|Effects of Progressive Resistance Exercise in Akinetic-rigid Parkinson's Disease Patients|Completed||N/A|28|Actual|University of Oviedo||2|||f||||t||||||||Undecided||2017-10-10 21:36:10.904925|2017-10-10 21:36:10.904925
NCT02966587|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-09-05|||November 15, 2017|Anticipated|2017-11-15|September 2017|2017-09-01|November 15, 2022|Anticipated|2022-11-15|November 15, 2022|Anticipated|2022-11-15||Interventional|||Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer|Durvalumab (MEDI4736) in Hypermutated Metastatic Castration-Resistant Prostate Cancer|Not yet recruiting||Phase 2|28|Anticipated|University of Washington||1|||f||||t|t|f||||||||2017-10-10 21:36:10.98133|2017-10-10 21:36:10.98133
NCT02966574|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-16|||December 2016||2016-12-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers|Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers|Not yet recruiting||N/A|50|Anticipated|Brugmann University Hospital||1|||f||||f||||||||No||2017-10-10 21:36:11.08288|2017-10-10 21:36:11.08288
NCT02966561|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-11-22|||June 2016||2016-06-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|STAR||Pedometer-based Behavioural Intervention for Individuals With COPD to Stay Active After Rehabilitation|Effects of a Brief Pedometer-based Behavioural Intervention for Individuals With COPD During In-patient Pulmonary Rehabilitation on 6-weeks and 6-months Objectively Measured Physical Activity - A Randomised Controlled Trial|Recruiting||N/A|502|Anticipated|University of Erlangen-Nürnberg||2|||f||||f||||||||No||2017-10-10 21:36:11.168218|2017-10-10 21:36:11.168218
NCT02966548|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-10-04|||November 28, 2016|Actual|2016-11-28|October 2017|2017-10-01|July 1, 2020|Anticipated|2020-07-01|September 30, 2018|Anticipated|2018-09-30||Interventional|||Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors|A Phase 1 Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Advanced Solid Tumors|Recruiting||Phase 1|45|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 21:36:11.281163|2017-10-10 21:36:11.281163
NCT02966535|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-09-03|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial|The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial|Completed||N/A|32|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 21:36:11.382972|2017-10-10 21:36:11.382972
NCT02966522|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-16|||October 2016||2016-10-01|November 2016|2016-11-01||||September 2019|Anticipated|2019-09-01||Interventional|TaPiOCA||Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis|Frontline Thalidomide for Amyloidosis Involving Myocardium: Investigation of Organ Reversing Capacity of Lenalidomide|Recruiting||Phase 2|30|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 21:36:11.503409|2017-10-10 21:36:11.503409
NCT02966496|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-14|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy of Implantation of Two Multifocal Intraocular Lenses in the Treatment of Senile Cataract|Safety and Efficacy of Implantation of Two Multifocal Intraocular Lenses in the Treatment of Senile Cataract: a Randomized Controlled Clinical Trial|Active, not recruiting||N/A|40|Anticipated|Qinghai University||2|||f||||t||||||||Undecided||2017-10-10 21:36:11.69251|2017-10-10 21:36:11.69251
NCT02966483|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-12-01|||January 2017||2017-01-01|December 2016|2016-12-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer|Transanal Versus Laparoscopic Total Mesorectal Excision For Mid And Low Rectal Cancer (TaLaR): A Multicentre Randomised Clinical Trial|Not yet recruiting||Phase 2/Phase 3|1114|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:36:11.757942|2017-10-10 21:36:11.757942
NCT02966457|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-06-27|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|DEHAM||A Study of DEcolonization in Patients With HAematological Malignancies (DEHAM)|A Randomized Clinical Study of the Decolonization of MDR Gram-negative Bacteria in Patients With Haematological Malignancies|Recruiting||Phase 4|60|Anticipated|Minsk State Clinical Hospital No 9||2|||f||||t||||||||No||2017-10-10 21:36:11.910492|2017-10-10 21:36:11.910492
NCT02966444|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition|Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition|Recruiting||N/A|16|Anticipated|Texas Christian University||3|||f||||f||||||||No||2017-10-10 21:36:11.996172|2017-10-10 21:36:11.996172
NCT02966431|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-15|||January 2017||2017-01-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Effects of a Weight Loss Intervention in College-age Women|Effects of a Weight Loss Intervention in College-age Women|Not yet recruiting||N/A|20|Anticipated|Texas Christian University||2|||f||||f||||||||No||2017-10-10 21:36:12.08639|2017-10-10 21:36:12.08639
NCT02966418|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-09-01|||January 2017||2017-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Trial of Mild Hypoxia Preconditioning in Patients Undergoing Interventional Treatment|The Effects of Mild Hypoxia Preconditioning on Neurological Recovery in Patients Undergoing Interventional Treatment for Ischemic Cerebrovascular Disease|Recruiting||N/A|50|Anticipated|Tianjin Huanhu Hospital||2|||f||||t||||||||||2017-10-10 21:36:12.311378|2017-10-10 21:36:12.311378
NCT02966405|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-21|||October 2016||2016-10-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|2 Years|Observational [Patient Registry]|||The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women|The Establish of Trimester-specific Reference Ranges for Thyroid Tests in Pregnant Women and the Influence of Thyroid Disorders on Pregnancy and Its Outcomes.|Recruiting||N/A|1000|Anticipated|Peking University International Hospital|||2||f||||t||||||||Undecided||2017-10-10 21:36:12.425277|2017-10-10 21:36:12.425277
NCT02966392|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-09-18|||November 2016||2016-11-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|VARI-prevent||Continuous Endotracheal Cuff Pressure Control to Prevent Ventilator Associated Respiratory Infections|A Randomised Controlled Trial of Continuous Endotracheal Cuff Pressure Control for the Prevention of Ventilator Associated Respiratory Infections|Recruiting||N/A|600|Anticipated|Oxford University Clinical Research Unit, Vietnam||2|||f||||t||||||||||2017-10-10 21:36:12.510583|2017-10-10 21:36:12.510583
NCT02966379|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-23|||June 2016||2016-06-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor|Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor|Recruiting||N/A|18|Anticipated|Oticon Medical||1|||f||||f||||||||No||2017-10-10 21:36:12.629922|2017-10-10 21:36:12.629922
NCT02966366|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-23|||August 2013||2013-08-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|October 2014|Actual|2014-10-01||Interventional|||Tinnitus Treatment With Cochlear Implant in Single Sided Deafness|Tinnitus Treatment With Cochlear Implant in Single Sided Deafness|Active, not recruiting||N/A|27|Actual|Oticon Medical||1|||f||||f||||||||No||2017-10-10 21:36:12.758661|2017-10-10 21:36:12.758661
NCT02966353|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-10-03|||April 2, 2017|Actual|2017-04-02|October 2017|2017-10-01|December 23, 2018|Anticipated|2018-12-23|December 23, 2018|Anticipated|2018-12-23||Interventional|REALISE||Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients.|A Multicenter Phase II, Open Label, Single Arm Study to Evaluate the Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients.|Recruiting||Phase 2|50|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 21:36:12.868141|2017-10-10 21:36:12.868141
NCT02966340|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment|Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment|Recruiting||Phase 1/Phase 2|128|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||Yes|The investigators will share on Open Science Framework de-identified and anonymous physiology (e.g., EMG startle response) and self-report survey/questionnaire data collected from participants during the study.|2017-10-10 21:36:13.01786|2017-10-10 21:36:13.01786
NCT02966327|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-14|||June 2015||2015-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Early Compression and Exercise on Lymphedema Incidence in Patients With Gynecological Cancer|Effect of Early Compression Therapy and Individualized Exercise on Incidence of Lymphedema in Patients Treated for Gynecological Cancer: a Pilot Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|McGill University Health Center||2|||f||||f||||||||No||2017-10-10 21:36:13.12031|2017-10-10 21:36:13.12031
NCT02966314|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-06-28|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy|A Phase IV, Randomized, Double-Blind, Placebo-Controlled Exploratory Study of Xolair (Omalizumab) for Treatment of Idiopathic Angioedema in Patients Who Remain Symptomatic Despite Current Therapy|Recruiting||Phase 4|40|Anticipated|University of Wisconsin, Madison||2|||f||||t|f|f||||||No||2017-10-10 21:36:13.224953|2017-10-10 21:36:13.224953
NCT02966301|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-07-03|||December 2016||2016-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|GvHD-ATO||Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide|Phase II Study of First Line Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide|Recruiting||Phase 2|24|Anticipated|Medsenic||1|||f||||t||||||||||2017-10-10 21:36:13.336091|2017-10-10 21:36:13.336091
NCT02966288|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-16|||January 2017||2017-01-01|November 2016|2016-11-01||||January 2019|Anticipated|2019-01-01||Interventional|||A Trial to Assess the Pain-control Efficacy of Intra-articular Toradol Compared to Oral NSAIDs|A Randomized Controlled Trial to Assess the Pain-control Efficacy of Intra-articular Toradol Compared to Oral NSAIDs: A Pilot Study|Not yet recruiting||Phase 4|28|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 21:36:13.481|2017-10-10 21:36:13.481
NCT02966275|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-07-06|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Post Bariatric Closed Loop Glucagon Trial|Closed-Loop Glucagon Administration For The Automated Treatment Of Post-Bariatric Hypoglycemia|Active, not recruiting||N/A|12|Actual|Massachusetts General Hospital||2|||f||||t|f|t|t|f||||||2017-10-10 21:36:13.576428|2017-10-10 21:36:13.576428
NCT02966262|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-11-14|||April 2016||2016-04-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01|10 Years|Observational [Patient Registry]|||Korea University Anam Hospital Optical Coherence Tomography Registry|Optical Coherence Tomography Registry of Korea University Anam Hospital|Recruiting||N/A|2000|Anticipated|Korea University Anam Hospital|||1||f||||f||||||||No||2017-10-10 21:36:13.68302|2017-10-10 21:36:13.68302
NCT02966249|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2016-11-14|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Dexmetomidine Intrathecally and Intravenously Additionally to Spinal Anaesthesia, in Total Knee Arthroplasty|Comparison of Dexmetomidine's Efficacy as an Adjuvant to Intrathecal Levobupivacaine and Intravenous Administration Additionally to Spinal Anaesthesia, In Total Knee Arthroplasty|Recruiting||Phase 4|90|Anticipated|KAT General Hospital||6|||f||||f||||||||No||2017-10-10 21:36:13.765012|2017-10-10 21:36:13.765012
NCT02966236|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-16|||April 2016||2016-04-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Impact of Tranexamic Acid Use in Percutaneous Nephrolithotomy|Impact of Tranexamic Acid Use in Transfusion Rate in Patients With Complex Kidney Stone Undergoing Percutaneous Nephrolithotomy: Randomised, Double-blind, Placebo Controlled Trial|Recruiting||Phase 4|184|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 21:36:13.897257|2017-10-10 21:36:13.897257
NCT02966210|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-11-14|||August 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:36:14.086452|2017-10-10 21:36:14.086452
NCT02966197|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-16|||June 2015||2015-06-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta|the Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta|Completed||N/A|114|Actual|Tongji Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:36:14.129258|2017-10-10 21:36:14.129258
NCT02966184|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-06-28|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Albuterol for Status Asthmaticus|Comparison of Benzalkonium Chloride Containing Albuterol Versus Preservative Free Albuterol for the Treatment of Status Asthmaticus|Not yet recruiting||Phase 4|350|Anticipated|University of Louisville||2|||f||||t|f|f||||||No|IPD will not be made sharable.|2017-10-10 21:36:14.1987|2017-10-10 21:36:14.1987
NCT02966171|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-15|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies|A Phase I, Open-label, Multi-center, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of HMPL-453 in Patients With Advanced Solid Malignancies|Recruiting||Phase 1|24|Anticipated|Hutchison Medipharma Limited||1|||f||||t||||||||||2017-10-10 21:36:14.271467|2017-10-10 21:36:14.271467
NCT02966158|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|May 2018|Anticipated|2018-05-01||Interventional|CAT vs MICE||A Randomized Controlled Trial in Women With Coronary Artery Disease Investigating the Effects of Aerobic Interval Training Versus Moderate Intensity Continuous Exercise|A Randomized Controlled Trial in Women With Coronary Artery Disease Investigating the Effects of Aerobic Interval Training Versus Moderate Intensity Continuous Exercise in the Standard Cardiac Rehabilitation Setting: Aerobic Exercise Capacity and Cognitive Function|Not yet recruiting||N/A|80|Anticipated|University Health Network, Toronto||2|||f||||f||||||||Yes|Individual participant data IPD will be shared with other researchers upon request (i.e. contacting researchers via email, phone, etc,.) once the study is complete and the data is shared and presented through publication. IPD may be used for secondary purposes, such as in meta-analyses, or in re-analyses including different comparator groups, and for the replication of results.|2017-10-10 21:36:14.382341|2017-10-10 21:36:14.382341
NCT02966145|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-15|||January 2016||2016-01-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|4RTNI-2||4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2|The Four-Repeat Tauopathy Neuroimaging Initiative|Recruiting||N/A|232|Anticipated|University of California, San Francisco|||3||f||||f||||||Samples With DNA|"     Plasma, serum, cell lines and cerebrospinal fluid (CSF) will be retained by study     investigators and stored at NIH-funded repositories.   "|No||2017-10-10 21:36:14.491697|2017-10-10 21:36:14.491697
NCT02966132|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|iMD||Interactive Mobile Doctor (iMD) for Asian Smokers|Interactive Mobile Doctor (iMD) for Asian Smokers|Enrolling by invitation||Phase 3|150|Anticipated|University of California, San Francisco||2|||f||||t||||||||No|No plan to make individual participant data available at this time.|2017-10-10 21:36:14.62814|2017-10-10 21:36:14.62814
NCT02966119|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-05-18|||December 7, 2016|Actual|2016-12-07|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|RESTART-Fr||REstart or STop Antithrombotic Randomised Trial in France|Evaluation of the Benefit/Risk Ratio of Restarting or Avoiding Antiplatelet Drugs in Patients Who Had a Spontaneous Intracerebral Hemorrhage While Treated With Antithrombotic Drugs : RESTART-FR Study|Recruiting||Phase 3|292|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||Yes|we plan to make IPD analysis with sister trial: RESTART UK|2017-10-10 21:36:14.705343|2017-10-10 21:36:14.705343
NCT02952859|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|IRE Marg||Impact of Margin-accentuation IRE in Pancreatic Cancer|Impact of Margin-accentuation IRE in Pancreatic Cancer|Recruiting||N/A|36|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-10 21:38:34.211957|2017-10-10 21:38:34.211957
NCT02966106|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-18|||December 2016||2016-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||The Antidepressant Efficacy of Low Frequency rTMS as add-on|The Antidepressive Effect of Low Frequency Right Prefrontal Repetitive Transcranial Magnetic Stimulation as add-on to Antidepressant Drug Treatment. A Blinded, Placebo Controlled Randomised Study.|Not yet recruiting||Phase 4|56|Anticipated|University of Aarhus||2|||f||||f||||||||No||2017-10-10 21:36:14.790104|2017-10-10 21:36:14.790104
NCT02966093|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-04-19|||February 7, 2017|Actual|2017-02-07|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|||A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Lenvatinib (E7080) in 131 I-Refractory Differentiated Thyroid Cancer in China|Recruiting||Phase 3|150|Anticipated|Eisai Inc.||2|||f||||t|f|f||||||||2017-10-10 21:36:14.868422|2017-10-10 21:36:14.868422
NCT02966080|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-16|||December 2016||2016-12-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|December 2020|Anticipated|2020-12-01||Interventional|||Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous ECMO With a Heparin Bonded Circuit.|Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous Extracorporeal Membrane Oxygenation (ECMO) With a Heparin Bonded Circuit.|Withdrawn||N/A|0|Actual|University of Arizona||2||No participants enrolled, study will not be conducted.|f||||t||||||||||2017-10-10 21:36:14.978096|2017-10-10 21:36:14.978096
NCT02966067|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-05-30|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Split Mouth Trial to Compare Microneedles vs. Standard Needles in Dental Anaesthetic Delivery|A Split Mouth, Randomised Controlled Trial to Compare the Efficacy of an Array of 2x3 Pyramidal Microneedles of 280µm Height Versus a Standard 30-gauge Dental Needle in the Delivery of Local Anaesthetic Solution for Dental Procedures|Not yet recruiting||N/A|25|Anticipated|University of Dublin, Trinity College||2|||f||||f|f|f||||||No||2017-10-10 21:36:15.070447|2017-10-10 21:36:15.070447
NCT02966054|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-04-10|||August 2014||2014-08-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|Smart Pace||Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial|Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial|Active, not recruiting||Phase 2|42|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 21:36:15.151852|2017-10-10 21:36:15.151852
NCT02966041|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Prophylactic Ondansetron in Post-op Cardiac Surgery Patients to Prevent Post-operative Nausea and Vomiting|A Double-blinded, Randomized Control Trial of Prophylactic Ondansetron in a Post-operative Cardiac Surgery Population for Post-operative Nausea and Vomiting|Not yet recruiting||N/A|180|Anticipated|University of British Columbia||2|||f||||t||||||||Undecided||2017-10-10 21:36:15.24105|2017-10-10 21:36:15.24105
NCT02966028|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-08-29|||November 2016||2016-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of SNF472 on Progression of Cardiovascular Calicification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)|A Double-blind, Randomised, Placebo-controlled Study to Assess the Effect of SNF472 on Progression of Cardiovascular Calcification on Top of Standard of Care in End-stage-renal-disease (ESRD) Patients on Hemodialysis (HD)|Recruiting||Phase 2|450|Anticipated|Laboratoris Sanifit||3|||f||||t||||||||||2017-10-10 21:36:15.382948|2017-10-10 21:36:15.382948
NCT02966002|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-15|||April 2016||2016-04-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Interventional|||Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients|Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients|Recruiting||Phase 4|20|Anticipated|University of Michigan||1|||f||||||||||||||2017-10-10 21:36:15.693117|2017-10-10 21:36:15.693117
NCT02965976|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-04-06|||December 30, 2016|Actual|2016-12-30|April 2017|2017-04-01|October 5, 2019|Anticipated|2019-10-05|October 5, 2018|Anticipated|2018-10-05||Interventional|||Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer|Double-Arm, Randomized Study of Botulinum Toxin Injection as a Pyloric Drainage Procedure for Minimally Invasive Esophagectomy (Phase II)|Recruiting||Phase 2|50|Anticipated|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-10 21:36:16.094205|2017-10-10 21:36:16.094205
NCT02965963|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-09-05|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||The Effect of Dopamine on Pulmonary Diffusion and Capillary Blood Volume During Exercise|The Effect of Dopamine on Pulmonary Diffusion and Capillary Blood Volume During Exercise|Recruiting||N/A|35|Anticipated|University of Alberta||3|||f||||||||||||||2017-10-10 21:36:16.253743|2017-10-10 21:36:16.253743
NCT02965950|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-14|||October 2016||2016-10-01|November 2016|2016-11-01|May 2030|Anticipated|2030-05-01|May 2020|Anticipated|2020-05-01||Interventional|p53b||The p53 Breast Cancer Trial|Treatment of Patients With Advanced Breast Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Breast Cancer Trial|Recruiting||Phase 2|140|Anticipated|Haukeland University Hospital||4|||f||||t||||||||Yes|Plan to share with collaborators|2017-10-10 21:36:16.416197|2017-10-10 21:36:16.416197
NCT02965937|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-14|||January 2013||2013-01-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Effectiveness of Story-Centred Care Intervention Program in Older Persons Living in Long-term Care Facilities|Effectiveness of Story-Centred Care Intervention Program in Older Persons Living in Long-term Care Facilities：A Randomised Clinical Study|Completed||N/A|70|Actual|Tri-Service General Hospital||2|||f||||f||||||||No||2017-10-10 21:36:16.612302|2017-10-10 21:36:16.612302
NCT02965924|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes|Effect of Topical Phenylephrine 2.5% on Episcleral Venous Pressure in Normal Human Eyes|Recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 21:36:16.744836|2017-10-10 21:36:16.744836
NCT02965911|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2016-11-15|||January 2016||2016-01-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA|A Randomized Controlled Clinical Trial on the Efficacy and Safety of Fenofibrate Combined With Ursodeoxycholic Acid in PBC Patients With an Incomplete Biochemical Response to UDCA|Recruiting||Phase 1/Phase 2|72|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||No||2017-10-10 21:36:16.857114|2017-10-10 21:36:16.857114
NCT02965898|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-14|||September 2016||2016-09-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|September 2020|Anticipated|2020-09-01||Interventional|||The Effect of Vitamin D Substitution on the Development of Chronic Pancreatitis|The Effect of Vitamin D Substitution on Pancreatic Parenchyma and Development of Fibrosis After First Acute Alcoholic Pancreatitis: A Randomized Prospective Trial|Recruiting||N/A|260|Anticipated|Tampere University Hospital||2|||f||||f||||||||Yes|The data will be written into an article, which shall be displayed in a national and international forum.|2017-10-10 21:36:16.994919|2017-10-10 21:36:16.994919
NCT02965885|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-08-15|||May 1, 2017|Actual|2017-05-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of TAS-116 in Patients With Solid Tumors|A Phase IA/IB Study Evaluating TAS-116 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|250|Anticipated|Taiho Oncology, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:36:17.161524|2017-10-10 21:36:17.161524
NCT02965872|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Learning Effect of Computerized Balance Evaluation System|Investigating the Learning Effect of Computerized Balance Evaluation System|Not yet recruiting||N/A|30|Anticipated|Hacettepe University|||1||f||||t||||||||Undecided||2017-10-10 21:36:17.339135|2017-10-10 21:36:17.339135
NCT02965859|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-11-21|||December 2012||2012-12-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B|A Randomized,Double-blind,Double-dummy,Multiple-dose Parallel Control,Multiple Centers Study to Assess the Safety and Dose-range of Metacavir Enteric-coated Capsules for Patients With Chronic Hepatitis B|Recruiting||Phase 2|180|Anticipated|Guangzhou Yipinhong Pharmaceutical CO.,LTD||5|||f||||f||||||||||2017-10-10 21:36:17.450639|2017-10-10 21:36:17.450639
NCT02965846|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-06-28|||December 13, 2016|Actual|2016-12-13|June 2017|2017-06-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Interventional|||Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye|Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye|Terminated||Phase 3|10|Actual|Allergan||2|||f||||f||||||||||2017-10-10 21:36:17.615843|2017-10-10 21:36:17.615843
NCT02965833|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-03-31|||December 13, 2016|Actual|2016-12-13|March 2017|2017-03-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|||CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers|Clinical Study of CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers|Completed||N/A|126|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 21:36:17.813705|2017-10-10 21:36:17.813705
NCT02965820|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-15|2017-04-13|||December 16, 2016|Actual|2016-12-16|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers|Clinical Study of OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers|Completed||N/A|122|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 21:36:17.928835|2017-10-10 21:36:17.928835
NCT02965807|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-14|||February 2015||2015-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China|Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China|Recruiting||Phase 1/Phase 2|50|Anticipated|Guangzhou Institute of Respiratory Disease||1|||f||||f||||||||Undecided||2017-10-10 21:36:18.017366|2017-10-10 21:36:18.017366
NCT02965794|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-12-04|||October 2014||2014-10-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|CP4GICAN||Care Pathways for Colorectal Cancer Surgery|Descriptive Study to Evaluate the Care Process and the Quality of Care for Adult Cancer Patients Who Are Admitted for Colorectal Cancer Surgery.|Active, not recruiting||N/A|480|Anticipated|European Pathway Association|||2||f||||t||||||||No||2017-10-10 21:36:18.11454|2017-10-10 21:36:18.11454
NCT02965781|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-18|||December 2016||2016-12-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|P2a||Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis|A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application|Recruiting||Phase 1/Phase 2|94|Anticipated|Squarex, LLC||3|||f||||t||||||||||2017-10-10 21:36:18.197388|2017-10-10 21:36:18.197388
NCT02965768|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-03-20|||January 2016||2016-01-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Immune Effects of Low-dose Naltrexone in ME/CFS|The Immune Effects of Low-dose Naltrexone in People With Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS)|Suspended||N/A|30|Anticipated|University of Alabama at Birmingham||2||"Temporarily suspended to focus on other projects. At suspension, no participants were   determined eligible and none started the protocol."|f||||f||||||||No||2017-10-10 21:36:18.301986|2017-10-10 21:36:18.301986
NCT02965755|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-08-15|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|IMAGE-II||Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins|Individualized Molecular Analyses Guide Efforts in Breast Cancer - Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins|Not yet recruiting||N/A|200|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-10 21:36:18.382476|2017-10-10 21:36:18.382476
NCT02965742|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-14|||February 2016||2016-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Evaluation Of An X-Ray Bone Densitometer:Use Of DXA Technology For Precise Assessment Of Human Body Composition|Clinical Evaluation Of An X-Ray Bone Densitometer: Use Of DXA Technology For Precise Assessment Of Body Composition In Humans|Recruiting||N/A|50|Anticipated|Diagnostic Medical Systems||2|||f||||f||||||||Undecided||2017-10-10 21:36:18.454438|2017-10-10 21:36:18.454438
NCT02965729|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-09-26|||July 2014||2014-07-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|OLOL||Our Lifestyles Our Lives|Our Lifestyles, Our Lives: Obesity Treatment and Physical Activity Promotion for Underserved Children and Adolescents|Completed||N/A|105|Actual|Pennington Biomedical Research Center||3|||f||||f||||||||||2017-10-10 21:36:18.549278|2017-10-10 21:36:18.549278
NCT02965716|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-10-04|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|July 15, 2019|Anticipated|2019-07-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma|A Phase II Study of Combining T-VEC (NSC-785349) and Pembrolizumab (NSC-776864) in Patients With Advanced Melanoma Who Have Progressed on Anti-PD1/L1 Based Therapy|Recruiting||Phase 2|64|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:36:18.643529|2017-10-10 21:36:18.643529
NCT02965703|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-16|2017-05-01|||May 25, 2017|Anticipated|2017-05-25|May 2017|2017-05-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma|Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention|Not yet recruiting||Phase 2|222|Anticipated|National Cancer Institute (NCI)||3|||f||||t|t|f||||||||2017-10-10 21:36:18.763083|2017-10-10 21:36:18.763083
NCT02965690|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Kinematics of Contemporary Knee Arthroplasty|Comparison of in Vivo Kinematics of Different Implants in ACL-sacrificing vs. Medially Stabilized Arthroplasty (Implant Design Study)|Not yet recruiting||N/A|26|Anticipated|Oslo University Hospital||2|||f||||t||||||||No||2017-10-10 21:36:18.915006|2017-10-10 21:36:18.915006
NCT02965677|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-03|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of The Femoral Popliteal Artery Treated With LEGFLOW OTW|Evaluation of the Safety and Efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation Catheter （LEGFLOW）in Treatment of Stenosis or Occlusion in Femoral-popliteal Arteries：A Prospective, Multicenter, Randomized, Controlled Clinical Study|Recruiting||N/A|172|Anticipated|ZhuHai Cardionovum Medical Device Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 21:36:19.058587|2017-10-10 21:36:19.058587
NCT02965664|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-07-31|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects|A Phase 2a, Double-Masked, Randomized, Placebo-Controlled, Single-Administration Study to Establish Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects|Completed||Phase 2|36|Actual|Orasis Pharmaceuticals Ltd.||2|||f||||t||||||||||2017-10-10 21:36:19.256491|2017-10-10 21:36:19.256491
NCT02965651|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-03-15|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Engaging Women With the Gabby System to Deliver Multiple Health-Related Behavioral Changes: A Feasibility Study|"A Randomized Controlled Trial of A Virtual Patient Advocate System: Go to Gabby for Health and Wellness Information"|Completed||N/A|61|Actual|Boston Medical Center||2|||f||||f||||||||No||2017-10-10 21:36:19.346902|2017-10-10 21:36:19.346902
NCT02965638|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-14|||September 2015||2015-09-01|November 2016|2016-11-01||||July 2017|Anticipated|2017-07-01||Interventional|P-RCT-MHO||Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia|A Pilot Randomized Controlled Trial of Maternal Oxygen Therapy for Fetal Left Heart Hypoplasia|Recruiting||N/A|12|Anticipated|Baylor College of Medicine||2|||f||||f||||||||No|No.|2017-10-10 21:36:19.448947|2017-10-10 21:36:19.448947
NCT02965625|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-11-14|||October 2016||2016-10-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Observational|||Characterization of Epicardial and Pericardial Adipose Tissue in Coronary Artery Disease|Characterization of Epicardial and Pericardial Adipose Tissue in Coronary Artery Disease|Recruiting||N/A|48|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     Plasma Whole blood Serum Cardiac adipose tissue Cardiac adipose tissue cell culture   "|No||2017-10-10 21:36:19.548359|2017-10-10 21:36:19.548359
NCT02965612|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-14|||May 2015||2015-05-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Specific Immunotherapy for Allergic Child|Tolerability and Side Effects for a New Device in Specific Immunotherapy for Allergic Child|Recruiting||N/A|36|Anticipated|Bambino Gesù Hospital and Research Institute||2|||f||||f||||||||No||2017-10-10 21:36:19.640199|2017-10-10 21:36:19.640199
NCT02965599|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-09-25|||December 27, 2016||2016-12-27|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis|A Randomised, Multi-center, Double Blind (Sponsor Open), Placebo-controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Severe, Active Rheumatoid Arthritis|Recruiting||Phase 2|40|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 21:36:19.750923|2017-10-10 21:36:19.750923
NCT02965586|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-01-03|||November 2016||2016-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy of Intrathecal Versus Intravenous Dexmedetomidine for Prevention of Post Spinal Anesthesia Shivering|Efficacy of Intrathecal Versus Intravenous Dexmedetomidine for Prevention of Post Spinal Anesthesia Shivering in Patients Undergoing TURP|Recruiting||Phase 1/Phase 2|90|Anticipated|Assiut University||3|||f||||f||||||||No||2017-10-10 21:36:19.900957|2017-10-10 21:36:19.900957
NCT02965573|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-09-07|||December 2016||2016-12-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness|A Randomized, Double-blind, Placebo-Controlled Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness|Recruiting||Phase 2|24|Anticipated|arGEN-X BVBA||2|||f||||t||||||||||2017-10-10 21:36:21.586394|2017-10-10 21:36:21.586394
NCT02965560|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|PGE2||Prostaglandin E2 Predicts the Outcome of Acute-on-chronic Liver Failure|A Study on Prostaglandin E2 Predicting the Outcome of Acute-on-chronic Liver Failure|Not yet recruiting||N/A|200|Anticipated|First Affiliated Hospital of Zhejiang University|||1||f||||||||||||||2017-10-10 21:36:21.78913|2017-10-10 21:36:21.78913
NCT02965547|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-12-28|||December 2016||2016-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|RIPCA||Remote Ischemic Preconditioning of Dynamic Cerebral Autoregulation in Healthy Adults|Remote Ischemic Preconditioning of Dynamic Cerebral Autoregulation in Healthy Adults|Not yet recruiting||Phase 2/Phase 3|50|Anticipated|First Hospital of Jilin University||1|||f||||t||||||||||2017-10-10 21:36:21.854382|2017-10-10 21:36:21.854382
NCT02965521|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-05-09|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|SUCCEED||Survivor Choices for Eating and Drinking - Colorectal Cancer|Survivor Choices for Eating and Drinking - Colorectal Cancer|Recruiting||N/A|50|Anticipated|University of California, San Francisco||2|||f||||f|f|f||||||||2017-10-10 21:36:22.044005|2017-10-10 21:36:22.044005
NCT02965508|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Home-based Primary Care for Homebound Seniors|Home-based Primary Care for Homebound Seniors: a Randomized Controlled Trial|Recruiting||N/A|350|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-10 21:36:22.149041|2017-10-10 21:36:22.149041
NCT02965495|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee|A Multicenter, Randomized, Double-blinded, Parallel, Placebo-controlled, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular YYD302 Once in the Treatment of Patients With Osteoarthritis of the Knee|Recruiting||Phase 1/Phase 2|30|Anticipated|Yooyoung Pharmaceutical Co.,Ltd.||3|||f||||t||||||||Undecided||2017-10-10 21:36:22.268452|2017-10-10 21:36:22.268452
NCT02965482|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-06-12|||November 2016||2016-11-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Investigation of Novel Procedure for Methacholine Challenge Testing|Volumetric Versus Standard Two Minute Tidal Breathing Methodology for Methacholine Challenge Testing|Completed||N/A|15|Actual|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 21:36:22.406895|2017-10-10 21:36:22.406895
NCT02965469|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-08-16|||May 2016||2016-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Psychosocial Stress and Aging in HIV|The Syndemic of Stress and Aging in an HIV-infected Population|Active, not recruiting||N/A|100|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-10 21:36:22.516126|2017-10-10 21:36:22.516126
NCT02965456|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-04-26|||October 30, 2015|Actual|2015-10-30|April 2017|2017-04-01|April 12, 2017|Actual|2017-04-12|February 23, 2017|Actual|2017-02-23||Interventional|||Efficacy and Safety of IDP-121 Lotion and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris|A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 Lotion and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris|Completed||Phase 3|820|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 21:36:22.711831|2017-10-10 21:36:22.711831
NCT02965443|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-11|||December 2016||2016-12-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|DapaSaxaBBIT||Dapagliflozin + Saxagliptin in a Basal-bolus Insulin Treatment|Effectiveness of Dapagliflozin + Saxagliptin to Revert From a Basal-bolus Insulin Treatment (BBIT) Regimen to a Basal Supported Oral Therapy (BOT) in Patients With Type 2 Diabetes|Not yet recruiting||Phase 4|40|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||No||2017-10-10 21:36:22.88228|2017-10-10 21:36:22.88228
NCT02965430|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||PERFORMANCE STUDY OF THE AL-SENSE|PERFORMANCE STUDY OF THE AL-SENSE|Not yet recruiting||Phase 3|323|Anticipated|Common Sense||1|||f||||f||||||||No||2017-10-10 21:36:22.999992|2017-10-10 21:36:22.999992
NCT02965417|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-01-31|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients|An Open-label, Multicenter, Phase 2 Trial Investigating Sym004 in Patients With Metastatic Colorectal Cancer and Acquired Resistance to Anti-EGFR Monoclonal Antibodies and Documented Mutation of Extra Cellular Domain of EGFR (ECD-EGFR)|Withdrawn||Phase 2|0|Actual|Symphogen A/S||1||Symphogen made a business decision to no longer perform the clinical study.|f||||t||||||||Undecided||2017-10-10 21:36:23.09458|2017-10-10 21:36:23.09458
NCT02965404|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-19|||April 2016||2016-04-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children|A Blind, Randomized and Controlled Clinical Trial to Evaluate the Safety of Live Attenuated Varicella Vaccines for Healthy Adults, Adolescents and Children|Active, not recruiting||Phase 1|270|Anticipated|Sinovac (Dalian) Vaccine Technology Co., Ltd.||3|||f||||t||||||||No||2017-10-10 21:36:23.19022|2017-10-10 21:36:23.19022
NCT02965391|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-09-18|||November 2016||2016-11-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|September 2017|Anticipated|2017-09-01|3 Years|Observational [Patient Registry]|||Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients|Dynamic Changes and Surveillance of Circulating Tumor DNA in Surgical Non-small Cell Lung Cancer Patients|Recruiting||N/A|20|Anticipated|Peking University People's Hospital|||1||f||||t||||||Samples With DNA|"     A series of lung cancer patients plasma before or after surgery.   "|||2017-10-10 21:36:23.333228|2017-10-10 21:36:23.333228
NCT02965378|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-10-03|||June 2014||2014-06-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2017|Actual|2017-06-01||Interventional|||S1400D Lung-MAP: AZD4547 as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches|A Phase II Study of AZD4547 for Previously Treated FGFR-Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)|Active, not recruiting||Phase 2/Phase 3|42|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-10 21:36:23.709607|2017-10-10 21:36:23.709607
NCT02965365|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-16|||January 2016||2016-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|PATET||PATET Ratio to Rule Out Transient Tachypnea of the Newborn|A Non-invasive Method To Rule Out Transient Tachypnea of the Newborn (TTN) : Pulmonary Artery Acceleration to Ejection Time Ratio|Completed||N/A|105|Actual|Kayseri Education and Research Hospital|||2||f||||f||||||||Yes|The data belonging to participants, will be available to any researcher or editorial review board if needed.|2017-10-10 21:36:26.193932|2017-10-10 21:36:26.193932
NCT02965352|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-18|||June 2015||2015-06-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Peripheral for Quantify Strength of Children Functional During the Pinch Movement|Peripheral for Quantify Strength of Children Functional During the Pinch Movement|Completed||N/A|30|Actual|University of Mogi das Cruzes||1|||f||||t||||||||Undecided||2017-10-10 21:36:26.292281|2017-10-10 21:36:26.292281
NCT02965339|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Observational|DYVA||Evaluation of the Association Between Pre-existing Endothelial Dysfunction and the Onset of Vasoplegia During Cardiac Surgery With Cardiopulmonary Bypass|Evaluation of the Association Between Pre-existing Endothelial Dysfunction and the Onset of Vasoplegia During Cardiac Surgery With Cardiopulmonary Bypass|Not yet recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||||||2017-10-10 21:36:26.360197|2017-10-10 21:36:26.360197
NCT02965326|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-11|||May 2016||2016-05-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|March 2020|Anticipated|2020-03-01||Interventional|BIO-CFTR||Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients|Personalized Therapy of Cystic Fibrosis: Set-up of Response Markers|Recruiting||N/A|75|Anticipated|Hôpital Necker-Enfants Malades||3|||f||||f||||||||No||2017-10-10 21:36:26.428288|2017-10-10 21:36:26.428288
NCT02965313|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|COMET||Composite Outcomes of Mesh vs Suture Techniques for Prolapse Repair: A Randomized Controlled Multicentre Trial|Vaginal Surgery for the Pelvic Floor: A Randomized Trial of Synthetic Mesh Versus Synthetic Sutures|Recruiting||N/A|358|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 21:36:26.509133|2017-10-10 21:36:26.509133
NCT02965300|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-14|||October 2016||2016-10-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|VOCs||The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis|The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis|Recruiting||N/A|230|Anticipated|Chinese PLA General Hospital|||3||f||||t||||||Samples Without DNA|"     Exhaled breath   "|No|considering of personal privacy, the research-related individual participant data do not intend for public sharing.|2017-10-10 21:36:26.715107|2017-10-10 21:36:26.715107
NCT02965274|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-14|||November 2013||2013-11-01|November 2016|2016-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE of Fluoxetine Tablets 20 mg [Torrent,India] Versus Sarafem 20 mg Tablet [ Warner Chilcott LLC, USA] in Healthy Subjects-Fed Condition.|Completed||Phase 1|26|Actual|Torrent Pharmaceuticals Limited||2|||f||||f||||||||No||2017-10-10 21:36:26.868677|2017-10-10 21:36:26.868677
NCT02965261|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-14|||November 2013||2013-11-01|November 2016|2016-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE Study of Fluoxetine Tablets 20 mg [Torrent,India] Versus Sarafem 20 mg Tablet [ Warner Chilcott LLC, USA] in Healthy Subjects-Fasted Condition.|Completed||Phase 1|26|Actual|Torrent Pharmaceuticals Limited||2|||f||||f||||||||No||2017-10-10 21:36:26.940677|2017-10-10 21:36:26.940677
NCT02965248|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01|November 2023|Anticipated|2023-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)|Multicenter, Randomized Controlled Trial Designed to Evaluate the Efficacy and Safety of Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Raltitrexed or Oxaliplatin Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)|Recruiting||Phase 2|147|Anticipated|Fudan University||3|||f||||t||||||||||2017-10-10 21:36:27.016001|2017-10-10 21:36:27.016001
NCT02965235|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-14|||September 2016||2016-09-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Correlations of Epigenetic Changes With POCD in Surgical Patients|Correlations of Epigenetic Changes With POCD in Surgical Patients|Active, not recruiting||N/A|100|Anticipated|Central South University|||2||f||||t||||||Samples With DNA|"     For analysis of epigenetic changes   "|No||2017-10-10 21:36:27.127845|2017-10-10 21:36:27.127845
NCT02965222|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-11|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study Select Top-grade Embryo by Time-lapse Imaging|A Study Select Top-grade Embryo by Time-lapse Imaging|Not yet recruiting||N/A|150|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||t||||||||||2017-10-10 21:36:27.195097|2017-10-10 21:36:27.195097
NCT02965209|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-16|||November 2015||2015-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ENMSET||European Novel Motorized Spiral Endoscopy Trial|European Novel Motorized Spiral Endoscopy Trial|Recruiting||N/A|132|Anticipated|Evangelisches Krankenhaus Düsseldorf||1|||f||||f||||||||Undecided||2017-10-10 21:36:27.28715|2017-10-10 21:36:27.28715
NCT02965183|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Correlation Between Adenoid Hypertrophy and Body Temperature in Children Before and After Adenoidectomy|The Correlation Between Adenoid Hypertrophy and Body Temperature in Children Before and After Adenoidectomy|Not yet recruiting||N/A|60|Anticipated|Hillel Yaffe Medical Center||1|||f||||f||||||||||2017-10-10 21:36:27.482344|2017-10-10 21:36:27.482344
NCT02965170|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-07-05|||October 2016||2016-10-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|IIT12||Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS|Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in a Multiple Sclerosis Patient Cohort|Recruiting||N/A|500|Anticipated|Rocky Mountain MS Research Group, LLC|||1||f||||f||||||||||2017-10-10 21:36:27.557427|2017-10-10 21:36:27.557427
NCT02965157|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-11-14|||August 2016||2016-08-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Interventional|||Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma||Recruiting||Phase 1/Phase 2|15|Anticipated|Beijing Biohealthcare Biotechnology Co.,Ltd||1|||f||||t||||||||||2017-10-10 21:36:27.651697|2017-10-10 21:36:27.651697
NCT02965144|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-11|||December 2016||2016-12-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Long Term Survivors of High-grade Glioma and Their Caregivers|Long-term Survivors of High-grade Glioma|Not yet recruiting||N/A|22|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||No|The results from the thematic analysis of the interviews will be discussed with other researchers|2017-10-10 21:36:27.736871|2017-10-10 21:36:27.736871
NCT02965131|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-15|||February 2014||2014-02-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Effects of the Anhepatic Phase Extended by Temporary Portocaval Shunt on Anesthetic Sensitivity and Cognitive Function|The Effects of the Anhepatic Phase Extended by Temporary Portocaval Shunt on Anesthetic Sensitivity to Desflurane Administered at Constant Minimum Alveolar Concentration and Its Associative Postoperative Cognitive Function|Completed||N/A|67|Actual|Daegu Catholic University Medical Center||2|||f||||t||||||||No||2017-10-10 21:36:27.828387|2017-10-10 21:36:27.828387
NCT02965118|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-27|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis|Multi Center, Randomized, Double-blind, Placebo-controlled Parallel-group, Phase III Clinical Trial to Evaluate the Safety and Efficacy of PAC-14028 Cream in Mild to Moderate Atopic Dermatitis Patients|Recruiting||Phase 3|240|Anticipated|Amorepacific Corporation||2|||f||||t||||||||No||2017-10-10 21:36:27.898353|2017-10-10 21:36:27.898353
NCT02965105|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-02-28|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers|Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers|Completed||N/A|28|Actual|Coloplast A/S||2|||f||||f||||||||No||2017-10-10 21:36:27.984332|2017-10-10 21:36:27.984332
NCT02965092|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-13|||April 2016||2016-04-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|January 2021|Anticipated|2021-01-01||Interventional|||CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphocytic Leukemia|Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia by CD19 Chimeric Antigen Receptor (CAR)-Modified T Cells|Recruiting||Phase 1|20|Anticipated|Wuhan Sian Medical Technology Co., Ltd||1|||f||||t||||||||Undecided||2017-10-10 21:36:28.077432|2017-10-10 21:36:28.077432
NCT02965079|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-11|||January 2016||2016-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|REXECOR||Registry on the EXperience of Extracorporeal CO2 Removal in Intensice Care Units|Registry on the EXperience of Extracorporeal CO2 Removal in Intensice Care Units|Active, not recruiting||N/A|200|Anticipated|Rexecor|||1||f||||f||||||||||2017-10-10 21:36:28.15531|2017-10-10 21:36:28.15531
NCT02965066|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-11|||September 2016||2016-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers|Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers|Completed||N/A|28|Actual|Coloplast A/S||2|||f||||f||||||||No||2017-10-10 21:36:28.228739|2017-10-10 21:36:28.228739
NCT02965053|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-01-30|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis|A Single-center, Randomized, 2-Period, Crossover, Study to Explore The Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis|Recruiting||Phase 1|24|Anticipated|Chugai Pharmaceutical||4|||f||||||||||||||2017-10-10 21:36:28.326205|2017-10-10 21:36:28.326205
NCT02965040|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-06-19|||December 12, 2016|Actual|2016-12-12|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function|A Phase 1 Study to Evaluate the Pharmacokinetics of Roxadustat in Subjects With Different Degrees of Renal Function|Recruiting||Phase 1|48|Anticipated|Astellas Pharma Inc||4|||f||||f||||||||Undecided||2017-10-10 21:36:28.430025|2017-10-10 21:36:28.430025
NCT02965027|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Prazosin for Post-Concussive Headaches|Prazosin for the Prophylaxis of Chronic Post-Traumatic Headaches in OEF/OIF/OND Service Members and Veterans With Mild TBI|Recruiting||Phase 4|228|Anticipated|Seattle Institute for Biomedical and Clinical Research||2|||f||||t||||||||No||2017-10-10 21:36:28.587208|2017-10-10 21:36:28.587208
NCT02964845|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-10|||July 2016||2016-07-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|WISH||Women's Initiative Supporting Health Increasing Healthcare Access|Availability is Not Access:Recently Incarcerated Women, HIV Risk, and Substance Use Disorders|Recruiting||N/A|100|Anticipated|University of Rochester||2|||f||||t||||||||No||2017-10-10 21:36:30.997629|2017-10-10 21:36:30.997629
NCT02959216|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Aerobic Exercise Intervention After Concussion|Aerobic Exercise Intervention in Acute Recovery Phase After Concussion: A Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||No||2017-10-10 21:37:27.106026|2017-10-10 21:37:27.106026
NCT02965014|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-02-02|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||NC Young Women's CoOperative (CoOp)|Young Women-Focused HIV Prevention: Seek & Test in North Carolina (NC) Clinics|Recruiting||N/A|700|Anticipated|RTI International||3|||f||||f||||||||Yes|"Analytic data sets will be prepared in accordance with the Privacy Rule of the Health Insurance Portability and Accountability Act (HIPAA; http://www.hhs.gov/ocr/) as limited data sets in which names and other personal health identifiers are removed, birthdays have been converted to age at intake, and other dates have been changed to be days before or after the date of intake. Because there are fewer than 20,000 people in the data set, HIPAA says we cannot ensure that it is completely de-identified; consequently, HIPAA requires that we treat it as a limited data set and that we have a data sharing agreement (DSA) in place before giving anyone access to the client-level data. After the main findings are published, we will welcome other researchers who want to analyze the data in other ways. Requesting access to data will involve drafting an abstract, checking the feasibility relative to the available data, and seeking the permission of the PI and her team."|2017-10-10 21:36:28.741715|2017-10-10 21:36:28.741715
NCT02965001|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer|Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer|Recruiting||Phase 2|104|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-10 21:36:28.857458|2017-10-10 21:36:28.857458
NCT02964988|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer|uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer|Recruiting||Phase 2|43|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-10 21:36:28.941226|2017-10-10 21:36:28.941226
NCT02964975|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2016-11-16|||September 2015||2015-09-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized Comparison of Optimal Medical Therapy and Percutaneous Recanalization for Chronic Total Occlusion|Quality of Life Assessment in Patients With Coronary Artery Chronic Total Occlusion: Randomized Comparison of Optimal Medical Therapy and Percutaneous Coronary Intervention|Recruiting||Phase 4|100|Anticipated|Clinical Centre of Serbia||2|||f||||f||||||||Undecided||2017-10-10 21:36:29.031866|2017-10-10 21:36:29.031866
NCT02964962|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-07-28|||April 1, 2018|Anticipated|2018-04-01|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||REPRISE EDGE 29 mm EU Study|REPRISE EDGE 29 mm EU Study: REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE 29 mm Valve - Evaluation of Safety and Performance|Not yet recruiting||N/A|60|Anticipated|Boston Scientific Corporation||1|||f||||f|f|f||||||||2017-10-10 21:36:29.123026|2017-10-10 21:36:29.123026
NCT02964936|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-09-19|||January 11, 2017|Actual|2017-01-11|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia|ASP1517 Phase 3 Clinical Trial -A Multi-center, Randomized, 2-arm, Open-label Study of Intermittent Oral Dosing of ASP1517 for the Treatment of Anemia in ESA-untreated Chronic Kidney Disease Patients Not on Dialysis-|Recruiting||Phase 3|100|Anticipated|Astellas Pharma Inc||2|||f||||f|f|f||||||||2017-10-10 21:36:29.985846|2017-10-10 21:36:29.985846
NCT02964923|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-10|||April 2016||2016-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia|Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia|Active, not recruiting||N/A|300|Anticipated|Xijing Hospital|||3||f||||f||||||Samples With DNA|"     whole blood   "|Yes||2017-10-10 21:36:30.249579|2017-10-10 21:36:30.249579
NCT02964910|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-12|||September 2016||2016-09-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )|An Open, Pared Trial of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® in the Chronic Hepatitis B Patients on the Clinical Stability .( Aged 30 Years or Over)|Active, not recruiting||Phase 4|464|Anticipated|Xiamen Innovax Biotech Co., Ltd||2|||f||||t||||||||Yes||2017-10-10 21:36:30.338977|2017-10-10 21:36:30.338977
NCT02964897|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-05-25|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|PIE||Improving Linkage to Health and Other Services for Veterans Leaving Incarceration|Veterans Justice Reentry (Post-Incarceration) (QUE 15-284)|Not yet recruiting||N/A|180|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 21:36:30.46259|2017-10-10 21:36:30.46259
NCT02964884|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-07-26|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||NF1 Health Sciences Protocol|Neurobiology and Treatment of Reading Disability in NF1|Recruiting||Phase 2|99|Anticipated|Vanderbilt University||3|||f||||t||||||||||2017-10-10 21:36:30.599634|2017-10-10 21:36:30.599634
NCT02964871|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-04-03|||November 2016||2016-11-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|May 2019|Anticipated|2019-05-01||Interventional|Rapid-LTCF||Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care Facilities|Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care Facilities|Active, not recruiting||N/A|20|Actual|University of Wisconsin, Madison||2|||f||||t||||||||Undecided||2017-10-10 21:36:30.748955|2017-10-10 21:36:30.748955
NCT02964858|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2017-02-20|||November 2016||2016-11-01|February 2017|2017-02-01|June 2023|Anticipated|2023-06-01|November 2022|Anticipated|2022-11-01||Interventional|DOBL||Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.|Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma (DOBL) - A Randomised Phase III Non- Inferiority Trial.|Recruiting||Phase 3|840|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||Yes||2017-10-10 21:36:30.875507|2017-10-10 21:36:30.875507
NCT02964832|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-12|||January 2017||2017-01-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Assessment of Chest Compression Depth Obtained Using the Smartphone Application as an Educational Tool With New Attachment Device|Assessment of Chest Compression Depth Obtained Using the Smartphone Application as an Educational Tool With New Attachment Device|Not yet recruiting||N/A|50|Anticipated|Soonchunhyang University Hospital||3|||f||||||||||||||2017-10-10 21:36:31.107457|2017-10-10 21:36:31.107457
NCT02964819|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-01-15|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|January 2016|Actual|2016-01-01||Interventional|||Influence of Interferential Current Therapy in the Treatment of Individuals With Shoulder Impact Syndrome: A Randomized, Placebo Controlled Clinical Trial.|Influence of Interferential Current Therapy in the Treatment of Individuals With Shoulder Impact Syndrome: A Randomized, Placebo Controlled Clinical Trial.|Completed||N/A|45|Actual|University of Nove de Julho||3|||f||||t||||||||||2017-10-10 21:36:31.202559|2017-10-10 21:36:31.202559
NCT02964806|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-02-15|||November 2016||2016-11-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients||Recruiting||N/A|30|Anticipated|Yonsei University||3|||f||||f||||||||No||2017-10-10 21:36:31.301901|2017-10-10 21:36:31.301901
NCT02964793|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-10-03|||January 1, 2018|Anticipated|2018-01-01|October 2017|2017-10-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|HPAG||Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age Infants|Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age Infants|Not yet recruiting||N/A|10000|Anticipated|University Hospital, Grenoble||2|||f||||f|f|f||||||||2017-10-10 21:36:31.400702|2017-10-10 21:36:31.400702
NCT02964780|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-10|||June 2016||2016-06-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Observational|SMELSS||Study on Mechanisms of Changes in Liver Disease and Sex Steroid Metabolism During Weight Loss|Study on Mechanisms of Changes in Liver Disease and Sex Steroid Metabolism During Weight Loss|Recruiting||N/A|90|Anticipated|University Ghent|||2||f||||||||||||||2017-10-10 21:36:31.606672|2017-10-10 21:36:31.606672
NCT02964767|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2017-09-06|2017-01-23||June 2015||2015-06-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Observational|||HIV-Tb Confections Among HIV Patients|Prevalence of HIV-Tb co Infections Among HIV Patients and Their CD4+ T Cell Status-A Single Centre Study in India|Completed||N/A|219|Actual|Singh, Ranjan Kumar, M.D.|this is a cross sectional study; findings are limited to the patients attending ART centre.||2||f||||f||||||||||2017-10-10 21:36:31.710778|2017-10-10 21:36:31.710778
NCT02964754|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2016-11-12|||December 2014||2014-12-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|April 2016|Actual|2016-04-01||Interventional|||Digital Three-dimensional Imaging Models for Repair of Complex Long Bone Fractures|Digital Three-dimensional Imaging Models for Repair of Complex Long Bone Fractures: a Randomized Controlled Trial With 6-month Follow-up|Active, not recruiting||N/A|63|Anticipated|Qinghai University||2|||f||||t||||||||Undecided||2017-10-10 21:36:32.008813|2017-10-10 21:36:32.008813
NCT02964741|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-03-28|||February 22, 2017|Actual|2017-02-22|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|April 2020|Anticipated|2020-04-01||Interventional|||Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)|Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)|Recruiting||N/A|90|Anticipated|University of Michigan||3|||f||||f|f|t|t|||||No||2017-10-10 21:36:32.107894|2017-10-10 21:36:32.107894
NCT02964728|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2016-12-05|||November 2015||2015-11-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Botulinum Toxin in Burning Mouth Syndrome|Botulinum Toxin in Burning Mouth Syndrome|Completed||Phase 2|6|Actual|Presidio Ospedaliero Garibaldi-Centro||2|||f||||f||||||||No||2017-10-10 21:36:32.237865|2017-10-10 21:36:32.237865
NCT02964715|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-05-27|||November 2016||2016-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes|The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes|Recruiting||Phase 4|25|Anticipated|University of Malaya||1|||f||||t||||||||No||2017-10-10 21:36:32.361567|2017-10-10 21:36:32.361567
NCT02964702|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-11|||October 2016||2016-10-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|TRON1-Japan||Thrombectomy Revascularization of Intracranial Vessel OcclusioN by Originating From Japan (TRON1-Japan)|A Multicenter, Single-arm Study of the Efficacy and Safety of a Thrombectomy Device (T-01) for the Treatment of Acute Cerebral Infarction|Recruiting||N/A|50|Anticipated|JIMRO Co., Ltd.||1|||f||||||||||||||2017-10-10 21:36:32.498226|2017-10-10 21:36:32.498226
NCT02964689|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2017-05-01|||April 12, 2017|Actual|2017-04-12|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.|Binimetinib, Pemetrexed and Cisplatin, Followed by Maintenance With Binimetinib and Pemetrexed, in Patients With Advanced Non-small Cell Lung Cancer NSCLC With KRAS Mutations. A Multicenter Phase IB Trial.|Recruiting||Phase 1|18|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f|f|f||||||No||2017-10-10 21:36:32.59612|2017-10-10 21:36:32.59612
NCT02964676|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-14|2016-11-23|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure Glaucoma|Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Chinese Primary Angle Closure Glaucoma|Not yet recruiting||N/A|246|Anticipated|Shanghai Eye Disease Prevention and Treatment Center||2|||f||||f||||||||Undecided||2017-10-10 21:36:32.792116|2017-10-10 21:36:32.792116
NCT02964663|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-10|||November 2013||2013-11-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Comparison of the Ability of the esCCO and the Volume View to Measure Trends in Cardiac Output During Cardiac Surgery|Comparison of the Ability of the esCCO and the Volume View to Measure Trends in Cardiac Output During Cardiac Surgery|Completed||N/A|19|Actual|Université Libre de Bruxelles|||1||f||||t||||||||||2017-10-10 21:36:32.884168|2017-10-10 21:36:32.884168
NCT02964650|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-06-23|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|January 31, 2019|Anticipated|2019-01-31|July 31, 2018|Anticipated|2018-07-31||Interventional|OPT-C||Optimising Pacemaker Therapy for Contractility|The Safety and Efficacy of Optimising Pacemaker Heart Rate for Contractility: Effects on Walk Time, Cardiac Remodelling and Quality of Life.|Recruiting||Phase 2|60|Anticipated|University of Leeds||2|||f||||f|f|f||||||Undecided||2017-10-10 21:36:33.051897|2017-10-10 21:36:33.051897
NCT02964637|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-10|||August 2015||2015-08-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Diagnosing Frontotemporal Lobar Degeneration|Multimodal Assessment For Predicting Specific Pathological Substrate in Frontotemporal Lobar Degeneration|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||7||f||||f||||||Samples With DNA|"     Blood for biomarkers will be collected from participants for genetic testing. In addition,     cerebrospinal fluid (CSF) will be collected to measure levels of different proteins, such as     tau.   "|No||2017-10-10 21:36:33.196345|2017-10-10 21:36:33.196345
NCT02964624|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-03-09|||July 2017|Anticipated|2017-07-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|Knee||Ostearthritis Biomarkers and Rehabilitation|Response of Osteoarthritis Biomarkers After a Rehabilitation Program|Not yet recruiting||N/A|65|Anticipated|Hospital Israelita Albert Einstein||1|||f||||f|f|f||||||Undecided||2017-10-10 21:36:33.35669|2017-10-10 21:36:33.35669
NCT02964611|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-10|||January 2013||2013-01-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Observational|||Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration|Assessing Changes in Social Cognition and Personality in Patients With Frontotemporal Lobar Degeneration, Alzheimer's Disease and Parkinson's Disease and Their Effect on the Patient-caregiver Relationship|Recruiting||N/A|120|Anticipated|University Health Network, Toronto|||4||f||||f||||||||No||2017-10-10 21:36:33.481771|2017-10-10 21:36:33.481771
NCT02964598|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SleepHel||SleepHelsinki! CIRCADIAN SLEEP REGULATION IN ADOLESCENCE|Sleep Helsinki! CIRCADIAN SLEEP REGULATION IN ADOLESCENCE|Enrolling by invitation||N/A|270|Anticipated|Helsinki University||7|||f||||f||||||||No||2017-10-10 21:36:33.603404|2017-10-10 21:36:33.603404
NCT02964585|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-08-28|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes|Role of Canagliflozin on Gene Expression and Function of CD34+ Endothelial Progenitor Cells and Renal Function in Patients With Type 2 Diabetes|Recruiting||Phase 4|40|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-10 21:36:33.732844|2017-10-10 21:36:33.732844
NCT02964572|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-02-17|||November 2016||2016-11-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes||Recruiting||N/A|87|Anticipated|Yonsei University||2|||f||||f||||||||Undecided||2017-10-10 21:36:33.862362|2017-10-10 21:36:33.862362
NCT02964559|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-02-08|||January 27, 2017|Actual|2017-01-27|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer|A Phase II Trial of Pembrolizumab (MK-3475) in Metastatic Cutaneous Squamous Cell Carcinoma|Recruiting||Phase 2|29|Anticipated|Emory University||1|||f||||t|t|f||||||Undecided||2017-10-10 21:36:33.963269|2017-10-10 21:36:33.963269
NCT02964546|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-11-10|||June 2015||2015-06-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|REINACO||Glomerular Filtration Rate-Estimating Equations During Use of Direct Oral Anticoagulants in Elderly Patients|Impact of the Choice of Glomerular Filtration Rate-Estimating Equations on Plasmatic Concentrations of Direct Oral Anticoagulants in Elderly Patients With Atrial Fibrillation|Recruiting||N/A|300|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 21:36:34.075216|2017-10-10 21:36:34.075216
NCT02964533|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-12|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01||||February 2017|Anticipated|2017-02-01||Interventional|||Thunder-Fire Moxibustion Therapy for Chronic Fatigue Syndrome on Shenque Acupoint: a Randomized Controlled Trial|Thunder-Fire Moxibustion Therapy for Chronic Fatigue Syndrome on Shenque Acupoint: a Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|Guangzhou University of Chinese Medicine||2|||f||||||||||||||2017-10-10 21:36:34.174116|2017-10-10 21:36:34.174116
NCT02964520|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-01-04|||July 2015||2015-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety|Alpha/Theta Neurofeedback Training as Treatment Method for Individuals With Moderate to Severe Trait Anxiety|Completed||N/A|28|Actual|University of Hartford||2|||f||||f||||||||No||2017-10-10 21:36:34.286153|2017-10-10 21:36:34.286153
NCT02964494|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-11-15|||July 2016||2016-07-01|November 2016|2016-11-01|January 2031|Anticipated|2031-01-01|July 2026|Anticipated|2026-07-01|15 Years|Observational [Patient Registry]|||The Congenital Dyserythropoietic Anemia Registry (CDAR)|The Congenital Dyserythropoietic Anemia Registry (CDAR)|Recruiting||N/A|1000|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     Subject DNA isolated from subject's oral cells or blood or other biological samples donated     to be used for gene sequencing diagnostic studies (evaluate for known or novel genes that may     be causative of CDA)      Bone marrow will be collected ONLY when bone marrow samples are being collected for standard     diagnostic or treatment related reasons. No interventional procedure other than a voluntary     blood draw, if patient consents, is required as part of the CDAR Registry   "|Yes|"Data regarding subjects that meet inclusion will be collected confidentially at initial presentation or diagnosis and periodically thereafter over a long period of time (>15 years). In addition, blood, bone marrow and/or DNA samples of enrolled subjects will be stored for research studies with the aim to improve diagnosis, treatment and care of CDA.
The samples and medical information (that is not associated with a patient's name) may be used by other researchers studying CDA, at Cincinnati Children's Hospital Medical Center or at other institutions. The researchers must get Institutional Review Board (a board that is in charge of regulating research done on people) approval prior to requesting data and/or samples from this repository if applicable. No identifying information (that associates the medical information with the subject or sample) will be available to them."|2017-10-10 21:36:34.740554|2017-10-10 21:36:34.740554
NCT02964481|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-29|||August 2015||2015-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2017|Anticipated|2017-08-01||Observational|||Malignant Hyperthermia Registry and Genetic Testing|Donation of Blood for Genetic Testing With Clinical Data From the North American Malignant Hyperthermia Registry|Recruiting||N/A|130|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples With DNA|"     Blood samples will be used to extract DNA for genotyping, pyrosequencing and pluripotent stem     cells.   "|||2017-10-10 21:36:34.845753|2017-10-10 21:36:34.845753
NCT02964468|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-12|||September 2016||2016-09-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2016|Actual|2016-11-01||Interventional|||Dose-escalation Trial of Preoperative Radiotherapy and Concurrent Chemotherapy in Locally Advanced Rectal Cancer|Multicenter Dose-escalation Trial of Radiotherapy in Patients With Locally Advanced Rectal Cancer|Recruiting||Phase 3|525|Anticipated|Grupo de Investigación Clínica en Oncología Radioterapia||2|||f||||t||||||||Undecided||2017-10-10 21:36:34.955585|2017-10-10 21:36:34.955585
NCT02964455|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-13|2017-10-03|||November 2016||2016-11-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma|A Prospective, Open-label, Phase I Study of Docetaxel and Nedaplatin Twice Weekly in Combination With Chest Radiotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma|Recruiting||Phase 1|18|Anticipated|Sun Yat-sen University||1|||f||||f||||||||||2017-10-10 21:36:35.100684|2017-10-10 21:36:35.100684
NCT02964442|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-12|||October 2015||2015-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TACTICAL-II||Brown Adipose Tissue Activation and Energy Expenditure by Capsinoids Stimulation With Trimodality Imaging Using 18-FDG-PET, Fat Fraction MRI and Infrared Thermography|Brown Adipose Tissue Activation and Energy Expenditure by Capsinoids Stimulation With Trimodality Imaging Using 18-FDG-PET, Fat Fraction MRI and Infrared Thermography|Recruiting||N/A|30|Anticipated|Clinical Nutrition Research Centre, Singapore||2|||f||||f||||||||No||2017-10-10 21:36:35.21006|2017-10-10 21:36:35.21006
NCT02964429|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-02-06|||November 14, 2016|Actual|2016-11-14|February 2017|2017-02-01|December 23, 2016|Actual|2016-12-23|December 23, 2016|Actual|2016-12-23||Interventional|||Determination In-vivo KUF for Diacap Pro Hemodialyser|Determination of the In-vivo Ultrafiltration Coefficient and Evaluation of Performance, Hemo- and Biocompatibility- and Safety-data of High Flux Hemodialyser Diacap Pro in Patients With End Stage Renal Disease on Chronic Hemodialysis|Completed||N/A|12|Actual|B.Braun Avitum AG||1|||f||||f||||||||No||2017-10-10 21:36:35.319534|2017-10-10 21:36:35.319534
NCT02964416|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-11-11|||March 2016||2016-03-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Single Dose Tramadol Effect on Extubation Response and Quality of Emergence Post-supratentorial Intracranial Surgery|Effect of Single Dose of Tramadol on Extubation Response and Quality of Emergence(Cough and Nausea Vomiting) Following Supratentorial Intracranial Surgery|Recruiting||Phase 4|78|Anticipated|Aga Khan University||2|||f||||t||||||||No||2017-10-10 21:36:35.396597|2017-10-10 21:36:35.396597
NCT02964403|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-13|||December 2016||2016-12-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||COX-2 Inhibitor to Prevent Post-ERCP Pancreatitis|Effect Observation Study of COX-2 Inhibitor to Prevent Post-ERCP Pancreatitis|Not yet recruiting||Phase 4|2700|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||Yes||2017-10-10 21:36:35.512026|2017-10-10 21:36:35.512026
NCT02964390|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-11-13|||July 2013||2013-07-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Balloon Pulmonary Angioplasty in Non-operable CTEPH Patients|Assessment of Safety and Efficacy of Balloon Pulmonary Angioplasty in Non-operable CTEPH Patients|Recruiting||N/A|50|Anticipated|Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Med||1|||f||||f||||||||No||2017-10-10 21:36:35.587211|2017-10-10 21:36:35.587211
NCT02964377|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents|A Single Center Dose Ranging Pilot Study of (+)-Epicatechin in Non-ambulatory Adolescents With Duchenne Muscular Dystrophy and Pre-symptomatic Cardiac Dysfunction|Recruiting||Phase 1/Phase 2|15|Anticipated|University of California, Davis||1|||f||||f||||||||No||2017-10-10 21:36:35.742376|2017-10-10 21:36:35.742376
NCT02964364|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-11-13|||August 2016||2016-08-01|September 2016|2016-09-01|July 2026|Anticipated|2026-07-01|July 2026|Anticipated|2026-07-01|10 Years|Observational [Patient Registry]|||China Takayasu Arteritis Registry (CTA Registry)|China Takayasu Arteritis Registry (CTA Registry)|Recruiting||N/A|1000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t||||||||Undecided|Medical clinical data base|2017-10-10 21:36:35.83343|2017-10-10 21:36:35.83343
NCT02964351|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-15|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer||Not yet recruiting||N/A|120|Anticipated|Assuta Medical Center|||1||f||||f||||||Samples Without DNA|"     MicroRNA   "|No||2017-10-10 21:36:35.901342|2017-10-10 21:36:35.901342
NCT02964338|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-07-17|||December 7, 2016|Actual|2016-12-07|July 2017|2017-07-01|October 30, 2018|Anticipated|2018-10-30|September 26, 2018|Anticipated|2018-09-26||Interventional|||A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)||Recruiting||Phase 3|300|Anticipated|Teva Pharmaceutical Industries||3|||f||||f|t|f||||||||2017-10-10 21:36:35.980934|2017-10-10 21:36:35.980934
NCT02964325|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-08-29|||May 5, 2017|Actual|2017-05-05|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|MIPLATE||Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia|Clinical Effectiveness of Conventional Versus Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia|Recruiting||N/A|556|Anticipated|Terumo BCTbio||2|||f||||t|f|t|t|f||||||2017-10-10 21:36:36.183493|2017-10-10 21:36:36.183493
NCT02964312|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-02-13|||November 2016||2016-11-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OFFICE) Study||Recruiting||N/A|250|Anticipated|Spirox, Inc.||1|||f||||f||||||||No||2017-10-10 21:36:36.294289|2017-10-10 21:36:36.294289
NCT02964299|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-10|||July 2016||2016-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Mandibular Advancement Bite Block Efficacy Observational Study|Mandibular Advancement Bite Block Efficacy Observational Study|Completed||N/A|120|Actual|Taipei Veterans General Hospital, Taiwan|||2||f||||t||||||||Undecided||2017-10-10 21:36:36.399241|2017-10-10 21:36:36.399241
NCT02964286|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-28|||July 2015||2015-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced Myelosupression|The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced Myelosupression Among Patients With Cancer|Recruiting||N/A|200|Anticipated|Taipei Medical University||2|||f||||t||||||||No||2017-10-10 21:36:38.022102|2017-10-10 21:36:38.022102
NCT02964273|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-09-06|||September 2016||2016-09-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)|A Phase 3b, Two-part, Multicenter, One Year Randomized, Double-blind, Placebo-controlled Trial of the Safety, Pharmacokinetics, Tolerability, and Efficacy of Tolvaptan Followed by a Two Year Open-label Extension in Children and Adolescent Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Recruiting||Phase 3|100|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-10-10 21:36:38.129528|2017-10-10 21:36:38.129528
NCT02964260|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-15|||May 2016||2016-05-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|October 2019|Anticipated|2019-10-01||Interventional|||RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma|Randomized Controlled Trial of Transarterial Embolization Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma|Recruiting||N/A|410|Anticipated|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 21:36:38.277192|2017-10-10 21:36:38.277192
NCT02964234|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2016-11-11|||January 2017||2017-01-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Empowering Latinas to Obtain Breast Cancer Screenings|Empowering Latinas to Obtain Breast Cancer Screenings|Not yet recruiting||Phase 1|150|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||Yes|After major study findings have been accepted for publication, Dr. Molina will develop an anonymized data set (i.e., no personally identifiable information) available to qualified scientists upon request. Data will only be made available to scientists who complete a data-sharing agreement that indicates: 1) commitment to using the data only for research purposes and not to identify any individual participant; 2) commitment to securing data using appropriate computer technology; and 3) commitment to destroying or returning the data after analyses are completed.|2017-10-10 21:36:38.81926|2017-10-10 21:36:38.81926
NCT02964221|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-05-08|||June 15, 2016|Actual|2016-06-15|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Observational|Cognigram||Cognitive Changes After Major Joint Replacement|Assessing Postoperative Cognitive Changes After Major Joint Arthroplasty: A Feasibility Study Using the CogState Brief Battery|Completed||N/A|90|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||Undecided||2017-10-10 21:36:38.956185|2017-10-10 21:36:38.956185
NCT02964208|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-11-10|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2023|Anticipated|2023-10-01||Observational|||AMPLATZER™ LAA Occluder Post Approval Study (PAS)|AMPLATZER™ LAA Occluder Post Approval Study (PAS)|Recruiting||N/A|1000|Anticipated|St. Jude Medical|||1||f||||f||||||||No||2017-10-10 21:36:39.047026|2017-10-10 21:36:39.047026
NCT02964195|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|EoR-GEVB||Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding|Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Hemorrhage: A Multi-center Randomized Controlled Clinical Trial|Recruiting||N/A|308|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||No||2017-10-10 21:36:39.139792|2017-10-10 21:36:39.139792
NCT02964182|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-09-29|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Concomitant Use of Very Low Nicotine Content Cigarettes and e-Cigarettes|Evaluating Concomitant Use of Very Low Nicotine Content Cigarettes and e-Cigarettes Among Daily and Non-Daily Smokers|Not yet recruiting||N/A|480|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|f|f||||||||2017-10-10 21:36:39.2712|2017-10-10 21:36:39.2712
NCT02964169|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-03-15|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Family Planning and HIV in Postpartum Women in Mbarara|Family Planning Support and Its Impact on Pregnancy Desires and Contraceptive Use Among Recently Postpartum HIV Positive Women Delivering at Mbarara Regional Referral Hospital|Recruiting||N/A|480|Anticipated|Mbarara University of Science and Technology||2|||f||||t||||||||Undecided||2017-10-10 21:36:39.414275|2017-10-10 21:36:39.414275
NCT02964156|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-11-10|||May 2011||2011-05-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|December 2012|Actual|2012-12-01||Interventional|||Effect of a Thin Customized Insole in RA|Effect of a Thin Customized Insole on Pain and Walking Ability in Rheumatoid Arthritis: A Randomised Study|Completed||N/A|21|Actual|Revmatismesykehuset AS||2|||f||||t||||||||No||2017-10-10 21:36:39.510116|2017-10-10 21:36:39.510116
NCT02964143|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-07-17|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Clinical Investigation to Compare the Safety and Efficacy of Cellular Matrix to Those of Ostenil® Plus and to Those of PRP Only|Prospective, Randomized, Controlled Clinical Investigation to Compare the Safety and Performance of a Combination of Autologous Platelet-rich Plasma (PRP) and Hyaluronic Acid Prepared With Cellular MatrixTM to Those of Ostenil® Plus and to Those of PRP Alone in the Treatment of Mild to Moderate Osteoarthritis of the Knee|Not yet recruiting||N/A|306|Anticipated|Regen Lab SA||3|||f||||f|f|f||||||||2017-10-10 21:36:39.605347|2017-10-10 21:36:39.605347
NCT02964130|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|PREDIBACK||Study on Failed Back Surgery Syndrome Pathway Optimization: A Focus on Patient Identification, Chronicization Factors and Outcome Predictors|A Multicenter Prospective Study on Failed Back Surgery Syndrome Pathway Optimization: A Focus on Patient Identification, Chronicization Factors and Outcome Predictors|Not yet recruiting||N/A|200|Anticipated|Poitiers University Hospital||1|||f||||f||||||||||2017-10-10 21:36:39.708479|2017-10-10 21:36:39.708479
NCT02964117|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-10|||November 2014||2014-11-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Associations Between Air Pollutants Exposures and Respiratory System Study|Associations Between Air Pollutants Exposures and Respiratory System Study|Completed||N/A|106|Actual|Peking University Third Hospital|||1||f||||t||||||Samples Without DNA|"     Urine,Blood,Sputum and Exhaled breath condensate   "|||2017-10-10 21:36:39.773089|2017-10-10 21:36:39.773089
NCT02964104|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-06-06|||November 2016||2016-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes|A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0287 C (Insulin 287) for Subcutaneous Administration in Subjects With Type 2 Diabetes|Recruiting||Phase 1|48|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 21:36:39.833441|2017-10-10 21:36:39.833441
NCT02964091|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-10|||October 2016||2016-10-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|SHARED||Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World|Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World|Recruiting||Phase 4|300|Anticipated|Partners in Health||1|||f||||t||||||||Undecided||2017-10-10 21:36:39.930101|2017-10-10 21:36:39.930101
NCT02964078|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-09-22|||April 11, 2017|Actual|2017-04-11|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer|Coordinated High Dose Interleukin-2 (Aldesleukin, Proleukin™) and Pembrolizumab (Anti-PD1, Keytruda™) for Therapy of Metastatic Kidney Cancer|Recruiting||Phase 2|26|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 21:36:40.076156|2017-10-10 21:36:40.076156
NCT02964065|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-09-13|||November 2016||2016-11-01|September 2017|2017-09-01||||August 2017|Actual|2017-08-01||Interventional|||A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅲ Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)|Completed||Phase 3|9000|Actual|Changchun BCHT Biotechnology Co.||2|||f||||f||||||||||2017-10-10 21:36:40.18122|2017-10-10 21:36:40.18122
NCT02964052|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-23|||November 2016||2016-11-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01|6 Months|Observational [Patient Registry]|||Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy (SECRET) Study: Development of Patient Selection Criteria Using CT Images and Accompanying Diseases for Efficient Intravenous Thrombolytic and Intra-arterial Recanalization Therapy in Acute Ischemic Stroke||Recruiting||N/A|546|Anticipated|Yonsei University|||1||f||||f||||||||No||2017-10-10 21:36:40.268666|2017-10-10 21:36:40.268666
NCT02964026|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-02-15|||September 2016||2016-09-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients|Retrospective Analysis of Clinical Outcomes Associated With Use of the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients Within the Cerner HealthFacts Database|Completed||N/A|6844|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||No||2017-10-10 21:36:40.57229|2017-10-10 21:36:40.57229
NCT02964013|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-11|2017-10-05|||December 13, 2016|Actual|2016-12-13|October 2017|2017-10-01|March 23, 2020|Anticipated|2020-03-23|March 23, 2020|Anticipated|2020-03-23||Interventional|||Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001)|A Phase 1 Trial of MK-7684 as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|240|Anticipated|Merck Sharp & Dohme Corp.||5|||f||||f|t|f||||||||2017-10-10 21:36:40.668733|2017-10-10 21:36:40.668733
NCT02964000|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-02-17|||November 2016||2016-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis|Adjunct Use of the Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid-containing Medication on a PRN Basis|Recruiting||N/A|75|Anticipated|Phoenix Thera-lase Systems, LLC||3|||f||||f||||||||Yes||2017-10-10 21:36:40.771789|2017-10-10 21:36:40.771789
NCT02963987|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-16|||June 2015||2015-06-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Portion Size Over 5 Days in Preschool Children||Completed||N/A|50|Actual|Penn State University||2|||f||||f||||||||||2017-10-10 21:36:40.877859|2017-10-10 21:36:40.877859
NCT02963974|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-12|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|CIPUHL||Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss|Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss|Recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f|f|t|f|f||||||2017-10-10 21:36:40.954796|2017-10-10 21:36:40.954796
NCT02963961|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-04-21|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cognitive Training for the Prevention of Postoperative Delirium|Cognitive Training for the Prevention of Postoperative Delirium: a Pilot Study|Recruiting||N/A|60|Anticipated|University of Michigan||2|||f||||f|f|f||||||Undecided||2017-10-10 21:36:41.060685|2017-10-10 21:36:41.060685
NCT02963948|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-03-15|||February 13, 2017|Actual|2017-02-13|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|||"A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (CDE-EHR-PC Study), Phase 3"|"A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (CDE-EHR-PC Study), Phase 3"|Active, not recruiting||N/A|340|Anticipated|New York University School of Medicine|||3||f||||f||||||||||2017-10-10 21:36:41.161276|2017-10-10 21:36:41.161276
NCT02963935|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-09-20|||February 5, 2017|Actual|2017-02-05|September 2017|2017-09-01|June 21, 2018|Anticipated|2018-06-21|May 22, 2018|Anticipated|2018-05-22||Interventional|SCALE™ IBT||Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting|Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting|Active, not recruiting||Phase 3|282|Anticipated|Novo Nordisk A/S||2|||f|||||t|f||||||||2017-10-10 21:36:41.250297|2017-10-10 21:36:41.250297
NCT02963922|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-10-02|||February 6, 2017|Actual|2017-02-06|October 2017|2017-10-01|September 25, 2018|Anticipated|2018-09-25|August 3, 2018|Anticipated|2018-08-03||Interventional|SCALE™ Insulin||Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin|Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin|Active, not recruiting||Phase 3|400|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 21:36:41.378503|2017-10-10 21:36:41.378503
NCT02963909|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-09-14|||November 1, 2016|Actual|2016-11-01|August 1, 2017|2017-08-01||||February 1, 2019|Anticipated|2019-02-01||Interventional|||A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.|A Phase 1, First-in-Human, Double-blinded, Randomized, Placebo-controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of an Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Healthy Flavivirus-Naïve and Flavivirus-Primed Subjects|Active, not recruiting||Phase 1|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f|||||t|f|||f|||||2017-10-10 21:36:41.585817|2017-10-10 21:36:41.585817
NCT02963896|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-14|||January 2014||2014-01-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ITG||Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma|Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma With Pretreatment Prehabituation by Chemical Vestibular Ablation|Completed||N/A|20|Actual|University Hospital, Motol||1|||f||||f||||||||No||2017-10-10 21:36:41.703005|2017-10-10 21:36:41.703005
NCT02963883|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-29|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|PITT||Erythrocyte Transfusion Based on the Measurement of Central Venous Oxygen Saturation in Postoperative Cardiac Surgery|Erythrocyte Transfusion Based on the Measurement of Central Venous Oxygen Saturation in Postoperative Cardiac Surgery: a Bicentric, Prospective Randomized Study|Not yet recruiting||N/A|146|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 21:36:41.782101|2017-10-10 21:36:41.782101
NCT02963870|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-29|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|SECURIPLAN||The Cognitive-behavioral Approach, Standard Plan Security on Relapse Suicidal Adolescents|Randomized Controlled Trial of the Effectiveness of the Cognitive-behavioral Approach, Standard Plan Security on Relapse Suicidal Adolescents|Not yet recruiting||N/A|338|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 21:36:41.882976|2017-10-10 21:36:41.882976
NCT02963857|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-16|||March 2016||2016-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Evaluation of a Breast Biblock Analgesia for the Mastectomy With Radical Axillary Lymphadenectomy Surgery|Evaluation of a Breast Biblock Analgesia for the Mastectomy With Radical Axillary Lymphadenectomy Surgery|Completed||N/A|9|Actual|Maison de Santé Prostestante de Bordeaux Bagatelle|||1||f||||f||||||||No||2017-10-10 21:36:41.951662|2017-10-10 21:36:41.951662
NCT02963844|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-05-04|||November 2016||2016-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||The Inspiratory Muscle Training Improves the Severity of Obstructive Sleep Apnea and Sleep Quality?|The Inspiratory Muscle Training Improves the Severity of Obstructive Sleep Apnea and Sleep Quality?|Recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||No||2017-10-10 21:36:42.004189|2017-10-10 21:36:42.004189
NCT02963831|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-09-07|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|July 2020|Anticipated|2020-07-01||Interventional|||A Phase 1/2 Study to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies|A Phase 1/2 Dose Escalation Study With Expansion Cohorts to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies|Recruiting||Phase 1/Phase 2|78|Anticipated|Ludwig Institute for Cancer Research||3|||f||||f|t|f||||||||2017-10-10 21:36:42.092698|2017-10-10 21:36:42.092698
NCT02963818|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|STEADY||Smartphone Technology: Young Adult Drinking|Smartphone Technology Effects on Alcohol Drinking Among Young (STEADY) Adults Study|Recruiting||Phase 1/Phase 2|99|Anticipated|University of Florida||3|||f||||f||||||||No||2017-10-10 21:36:42.17641|2017-10-10 21:36:42.17641
NCT02963805|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-12-07|||September 2006||2006-09-01|December 2016|2016-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|A-CLASS||Active City of Liverpool Active Schools and SportsLinx Project: a Clustered Randomised Controlled Trial|Active City of Liverpool Active Schools and SportsLinx Project: a Clustered Randomised Controlled Trial (The A-CLASS Project)|Completed||N/A|152|Actual|Liverpool John Moores University||4|||f||||f||||||||No||2017-10-10 21:36:42.266371|2017-10-10 21:36:42.266371
NCT02963792|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|BUPHER||Burnout Preventions, Professionalism Heightening, and Enhancing Resiliency (BUPHER)|Values and Virtues in Medical Practice: Quasi-Experimental Intervention for Burnout Preventions, Professionalism Heightening, and Enhancing Resiliency (BUPHER) in a Hospital Surgical Division|Not yet recruiting||N/A|1000|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||Yes|The participants data will be shared with the research team from the Department of Medical Education, Sackler Faculty of Medicine, Tel Aviv University and Cohen-Harris Resilience Center|2017-10-10 21:36:42.469397|2017-10-10 21:36:42.469397
NCT02963779|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-10-05|||December 2016||2016-12-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of LY2775240 in Healthy Participants|A 2-Part, Safety, Tolerability, and Pharmacokinetic Study of LY2775240 in Healthy Subjects|Active, not recruiting||Phase 1|35|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 21:36:42.559991|2017-10-10 21:36:42.559991
NCT02963766|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Interventional|AWARD-PEDS||A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes|A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)|Recruiting||Phase 3|150|Anticipated|Eli Lilly and Company||3|||f||||t||||||||||2017-10-10 21:36:42.654746|2017-10-10 21:36:42.654746
NCT02963753|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-04-12|||January 2016||2016-01-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Hyperemesis Gravidarum and 75 Gram Oral Glucose Tolerance Test|Effect of Hyperemesis Gravidarum on 75 Gram Oral Glucose Tolerance Test Screening and Gestational Diabetes Mellitus|Completed||N/A|560|Actual|Kayseri Education and Research Hospital|||2||f||||||||||||||2017-10-10 21:36:43.00621|2017-10-10 21:36:43.00621
NCT02963740|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-04-19|||November 2016||2016-11-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors|Feasibility of High Levels of Energy Expenditure From Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors|Completed||N/A|11|Actual|University of Kansas Medical Center||1|||f||||f||||||||No||2017-10-10 21:36:43.071894|2017-10-10 21:36:43.071894
NCT02963727|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-05-03|||January 27, 2017|Actual|2017-01-27|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis|Knee Osteoarthrosis (KOA) in Jordanian Patients: a Phase I Dose-finding Study Using Wharton Jelly Derived Mesenchymal Stem Cells (WJMSC) for Advanced Stage III and IV KOA|Recruiting||Phase 1|10|Anticipated|University of Jordan||1|||f||||t|f|f|||f|||Undecided||2017-10-10 21:36:43.154745|2017-10-10 21:36:43.154745
NCT02963714|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-10|||April 2014||2014-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients|Immunogenicity and Persistence of Intramuscular High Dose Recombinant Hepatitis B Vaccine in Hemodialysis Patients in China: a Multicenter Randomized Controlled Trial|Active, not recruiting||Phase 4|352|Actual|Shanxi Medical University||2|||f||||f||||||||No||2017-10-10 21:36:43.23925|2017-10-10 21:36:43.23925
NCT02963701|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-07-05|||December 20, 2016|Actual|2016-12-20|July 2017|2017-07-01|February 8, 2017|Actual|2017-02-08|January 31, 2017|Actual|2017-01-31||Interventional|||Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects|Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil® (200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in at Least 48 Healthy Male and Female Subjects (Open-label, Randomized, Laboratory Blind, Single Dose, Two-way Crossover, Phase I Trial).|Completed||Phase 1|56|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:36:43.330829|2017-10-10 21:36:43.330829
NCT02963688|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-14|||January 2010||2010-01-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer|Prevalence Study of Germline and/or Somatic BRCA1/2 Mutation in Korean Patients With High-Grade Serous and/or Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Completed||N/A|298|Actual|Samsung Medical Center|||1||f||||f||||||||No||2017-10-10 21:36:43.424483|2017-10-10 21:36:43.424483
NCT02963675|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-07-12|||November 15, 2016|Actual|2016-11-15|July 2017|2017-07-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|SMARCOS||Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden|Incidence of Second Primary MAlignancies in pRostate Cancer Patients With bOne Metastases - an Observational Retrospective Cohort Study in Sweden (SMARCOS)|Completed||N/A|15953|Actual|Bayer|||2||f||||f||||||||||2017-10-10 21:36:43.483983|2017-10-10 21:36:43.483983
NCT02963662|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-11-10|||October 2015||2015-10-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Impact of Gut Hormones and Inflammatory Adipokines in Obese Patients Underwent Bariatric Surgery|Impact of Gut Hormone and Inflammatory Adipokines in Obese Patients Underwent Bariatric Surgery|Completed||N/A|100|Actual|First Affiliated Hospital of Jinan University||3|||f||||t||||||||Undecided||2017-10-10 21:36:43.568382|2017-10-10 21:36:43.568382
NCT02963649|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-07-11|||March 2, 2017|Actual|2017-03-02|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA|Randomized Study of IN.PACT 014 Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter vs. Standard Percutaneous Transluminal Angioplasty for the Treatment of Chronic Total Occlusions in the Infrapopliteal Arteries|Recruiting||N/A|60|Anticipated|Medtronic Endovascular||2|||f||||f|f|f||||||||2017-10-10 21:36:43.659856|2017-10-10 21:36:43.659856
NCT02963636|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-11-14|||August 2015||2015-08-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|FMG||Proximity Work in Family Medicine Groups : the Impact of Pharmacists|Proximity Work in Family Medicine Groups : the Impact of Pharmacists|Completed||N/A|62|Actual|Laval University||1|||f||||f||||||||No||2017-10-10 21:36:43.768559|2017-10-10 21:36:43.768559
NCT02963623|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-04-10|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Fibtem Predicts Postoperative Bleeding|The Prediction of Postoperative Hemorrahge Amount in Total Knee Replacement Using Fibtem|Recruiting||N/A|44|Anticipated|Konkuk University Medical Center|||1||f||||t|f|f||||||Yes||2017-10-10 21:36:43.85015|2017-10-10 21:36:43.85015
NCT02963610|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-04-05|||March 29, 2017|Actual|2017-03-29|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer|A Phase I Study of Lenalidomide Plus Pembrolizumab in Patients With Relapsed and/or Refractory Solid Tumors With Phase II Expansion in Non-small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|44|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:36:43.915906|2017-10-10 21:36:43.915906
NCT02958683|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-11-04|||July 2011||2011-07-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|CWM||Chest Wall Motion Analysis in Disease|An Observational Study of Chest Wall Motion Analysis in Disease|Recruiting||N/A|400|Anticipated|Heart of England NHS Trust|||10||f||||f||||||||No||2017-10-10 21:37:35.234335|2017-10-10 21:37:35.234335
NCT02963597|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-16|||October 2016||2016-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ASAP-HF||Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea.|Auto-PAP for Pulmonary Hypertension Treatment in Decompensated Heart Failure Patients With Obstructive Sleep Apnea: A Two Center Pilot Study|Recruiting||Phase 4|20|Anticipated|Albert Einstein Healthcare Network||2|||f||||t||||||||No||2017-10-10 21:36:44.012777|2017-10-10 21:36:44.012777
NCT02963584|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-14|||November 2016||2016-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Decision Aid in Chronic Total Occlusion (CTO) Patients|A Pilot Randomized Trial of a Decision Aid in CTO Patients|Not yet recruiting||N/A|160|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||f||||||||||2017-10-10 21:36:44.11082|2017-10-10 21:36:44.11082
NCT02963571|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-10|||August 2010||2010-08-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|December 2011|Actual|2011-12-01||Interventional|||Posterior Percutaneous Pedicle Screw Fixation for Acute Thoracolumbar Vertebral Fractures|Posterior Percutaneous Pedicle Screw Fixation for Acute Thoracolumbar Vertebral Fractures With Simple Anterior Spinal Column Injury: a Retrospective, Self-controlled Trial|Completed||N/A|32|Actual|153rd Hospital of Chinese People's Liberation Army||1|||f||||t||||||||Undecided||2017-10-10 21:36:44.182715|2017-10-10 21:36:44.182715
NCT02963558|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-06-05|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ASPIRE||A Study Promoting Critical Illness Recovery in the Elderly-- Pilot|ASPIRE: A Study Promoting Critical Illness Recovery in the Elderly-- Pilot Study|Recruiting||N/A|30|Anticipated|Wake Forest University Health Sciences||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:36:44.248582|2017-10-10 21:36:44.248582
NCT02963545|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-11-16|||October 2012||2012-10-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|November 2014|Actual|2014-11-01||Interventional|||TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke|Simultaneous Assessments of Serotonin and Kynurenine Pathways Parameters in Patients Shortly (Less Than 4 Hours and a Half) After the Onset of a Cerebral Infarction|Completed||N/A|28|Actual|Versailles Hospital||2|||f||||f||||||||||2017-10-10 21:36:44.359039|2017-10-10 21:36:44.359039
NCT02963532|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-01-12|||December 2016||2016-12-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Observational|||Extubation in Pediatric Patients: An Observational Study|A Direct Comparison of Predictors for Extubation in Children Less Than 7 Years Old Undergoing Anesthesia: A Prospective Observational Study|Recruiting||N/A|300|Anticipated|Wake Forest University Health Sciences|||1||f||||f||||||||No||2017-10-10 21:36:44.445096|2017-10-10 21:36:44.445096
NCT02963519|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|VISTACARE01||Evaluation of Improved Preparation Time to a Coverage in Patients With Acute Wounds by Use of VistaCare® Versus Dressings|Evaluation of Improved Preparation Time to a Coverage in Patients With Acute Wounds by Use of the Medical Device VistaCare® Versus Dressings|Not yet recruiting||N/A|40|Anticipated|Qualissima||2|||f||||f||||||||||2017-10-10 21:36:44.526758|2017-10-10 21:36:44.526758
NCT02963506|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-08-31|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2017|Anticipated|2017-10-01||Interventional|||A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis|A Multicenter, Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis|Active, not recruiting||Phase 2|303|Actual|UCB Pharma||5|||f||||t||||||||||2017-10-10 21:36:44.61614|2017-10-10 21:36:44.61614
NCT02963493|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-07-21|||November 2016||2016-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|HORIZON||A Study of Melflufen in Combination With Dexamethasone in Relapsed Refractory Multiple Myeloma Patients|A Single Arm, Open-Label, Phase 2 Study of Melflufen in Combination With Dexamethasone in Patients With Relapsed Refractory Multiple Myeloma Who Are Refractory to Pomalidomide and/or Daratumumab|Recruiting||Phase 2|78|Anticipated|Oncopeptides AB||1|||f||||t||||||||||2017-10-10 21:36:44.806014|2017-10-10 21:36:44.806014
NCT02963480|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-11-14|||September 2016||2016-09-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Investigation of Inflammatory Parameters in a Perioperative Closed-meshed Standard Progress in CPB Patients|Investigation of Inflammatory Parameters in a Perioperative Closed-meshed Standard Progress in CPB Patients|Recruiting||N/A|100|Anticipated|Medical University of Vienna|||2||f||||t||||||||Undecided||2017-10-10 21:36:45.118696|2017-10-10 21:36:45.118696
NCT02963467|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Smoking on Ventilation-Perfusion Ratio|Acute Effect of Smoking Cigarettes on Ventilation-Perfusion Ratio: A Pilot Study in Healthy Volunteers|Not yet recruiting||N/A|20|Anticipated|Medical University of Vienna||3|||f||||f||||||||No||2017-10-10 21:36:45.247175|2017-10-10 21:36:45.247175
NCT02963454|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-10|||January 2011||2011-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic Shock|Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic Shock: A Randomised Controlled Study|Recruiting||N/A|50|Anticipated|Military Hospital of Tunis||2|||f||||f||||||||No|via emails|2017-10-10 21:36:45.381947|2017-10-10 21:36:45.381947
NCT02963441|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-12-21|||November 2016||2016-11-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|||A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy|A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy|Enrolling by invitation||N/A|834|Anticipated|IDx LLC|||1||f||||f||||||||No||2017-10-10 21:36:45.495327|2017-10-10 21:36:45.495327
NCT02963428|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-12-13|||November 2016||2016-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|TAGG||Teaching Appropriate Gestational Weight Gain|Teaching Appropriate Gestational Weight Gain|Recruiting||N/A|200|Anticipated|Geisinger Clinic||2|||f||||f||||||||Undecided||2017-10-10 21:36:45.56905|2017-10-10 21:36:45.56905
NCT02958670|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-06-20|||November 2016||2016-11-01|June 2017|2017-06-01|November 2023|Anticipated|2023-11-01|November 2020|Anticipated|2020-11-01||Interventional|Add-Tau||Imaging Tau Deposition in the Brain of Elderly Subjects|Imaging Tau Deposition in the Brain of Elderly Subjects|Enrolling by invitation||N/A|200|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 21:37:35.34942|2017-10-10 21:37:35.34942
NCT02963415|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-09-21|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VRCT||Concurrent Aerobic Exercise and Virtual Reality Cognitive Training|Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in At-risk Older Adults|Not yet recruiting||N/A|12|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f|f|f||||||||2017-10-10 21:36:45.683468|2017-10-10 21:36:45.683468
NCT02963402|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Observational|||Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab|Analysis of Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab|Recruiting||N/A|40|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 21:36:45.76257|2017-10-10 21:36:45.76257
NCT02963389|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-05-26|||October 4, 2016|Actual|2016-10-04|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients|A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim After Single Administration in Pediatric Solid Tumor/Lymphoma Patients|Recruiting||Phase 1|32|Anticipated|Dong-A ST Co., Ltd.||4|||f||||||||||||||2017-10-10 21:36:45.851644|2017-10-10 21:36:45.851644
NCT02963376|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-11-14|||December 2016||2016-12-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 1b in Patients With Acute Ischemic Stroke|A Phase 1b Dose-finding Study of DDFPe in Patients With Acute Ischemic Stro|Not yet recruiting||Phase 1|24|Anticipated|University of Arkansas||6|||f||||f||||||||||2017-10-10 21:36:45.947876|2017-10-10 21:36:45.947876
NCT02963363|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-14|||January 2017||2017-01-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|APACAN2||Adapted Physical Activity for Breast Cancer HER2 Positive Patient|Feasibility Study of an Adapted Physical Activity (APA) for Breast Cancer Patients Treated by Neoadjuvant Chemotherapy and Targeted Therapy Against HER2|Not yet recruiting||N/A|70|Anticipated|Centre Jean Perrin||1|||f||||f||||||||||2017-10-10 21:36:46.033522|2017-10-10 21:36:46.033522
NCT02963350|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-07-21||||||July 2017|2017-07-01||||||||Expanded Access|||A Multicenter, Multi-national Open-label Program to Provide BMN 190 to Patients Diagnosed With CLN2 Disease|A Multicenter, Multi-national Open-label Program to Provide BMN 190 to Patients Diagnosed With CLN2 Disease|Approved for marketing||N/A|||BioMarin Pharmaceutical|||||||||||||||||||2017-10-10 21:36:46.129126|2017-10-10 21:36:46.129126
NCT02963337|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-01-28|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Remifentanil vs. Combined Spinal-epidural Analgesia for Labor Analgesia and Progress of Labor in Multiparous|Pain Relief and Progress of Labour With Remifentanil Patient-controlled Analgesia Versus Combined Spinal-epidural Analgesia in Multiparous Women: a Prospective Observational Study|Recruiting||N/A|180|Anticipated|University Medical Centre Ljubljana|||2||f||||f||||||||Undecided||2017-10-10 21:36:46.201494|2017-10-10 21:36:46.201494
NCT02963324|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-01-31|||November 2016||2016-11-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|IVMPBPK||Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers|Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers - a Single-center, Open-label Pharmacokinetics Study|Completed||Phase 1|12|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||Undecided||2017-10-10 21:36:46.303439|2017-10-10 21:36:46.303439
NCT02963311|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-05-16|||December 13, 2016|Actual|2016-12-13|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|November 2018|Anticipated|2018-11-01||Interventional|ORION-2||A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia|An Open-Label, Single-Arm, Multicenter Pilot Study to Evaluate Safety, Tolerability, and Efficacy of ALN-PCSSC in Subjects With Homozygous Familial Hypercholesterolemia|Recruiting||Phase 2|10|Anticipated|The Medicines Company||1|||f||||t|t|f||||||No||2017-10-10 21:36:46.388939|2017-10-10 21:36:46.388939
NCT02963298|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-11-10|||October 2016||2016-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|GCRRT||CRRT for Glutamate Elimination After Cardiac Arrest|Pilot Trial Concerning Glutamate Elimination With CRRT for Neurological Outcome After Cardiac Arrest|Recruiting||N/A|40|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 21:36:46.499944|2017-10-10 21:36:46.499944
NCT02963285|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||December 2016||2016-12-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Observational|||Optimal Positioning of Nasopharyngeal Temp Probe|Optimal Positioning of Nasopharyngeal Temperature Probes in Pediatric Patients: A Prospective Cohort Study|Not yet recruiting||N/A|180|Anticipated|University of Texas Southwestern Medical Center|||5||f||||f||||||||||2017-10-10 21:36:46.583119|2017-10-10 21:36:46.583119
NCT02963272|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-03-30|||January 19, 2017|Actual|2017-01-19|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|STADE-HF||ST2 for the Management of Heart Failure - STADE-HF|Interest of ST2 to Diagnosis and Management of Patients With Heart Failure (HF)|Recruiting||N/A|300|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f||||||No||2017-10-10 21:36:46.688421|2017-10-10 21:36:46.688421
NCT02963259|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-04-24|||March 30, 2017|Actual|2017-03-30|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|March 2019|Anticipated|2019-03-01||Observational|PREFERENCE-H||IPG Replacement Study (PREFERENCE-H)|Prospective Evaluation Comparing the Effects of Constant Current Versus Constant Voltage in Deep Brain Stimulation Using Hybrid Systems|Recruiting||N/A|170|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-10 21:36:46.792582|2017-10-10 21:36:46.792582
NCT02963246|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-07-27|||May 5, 2017|Actual|2017-05-05|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|Mindfulness||Mindfulness Therapy in Inflammatory Bowel Disease|Effects of a Mindfulness Therapy Intervention for Individuals With Inflammatory Bowel Disease: A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Cardenal Herrera University||2|||f||||f|f|f||||||||2017-10-10 21:36:46.8676|2017-10-10 21:36:46.8676
NCT02963233|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-10|||July 2015||2015-07-01|November 2016|2016-11-01||||July 2018|Anticipated|2018-07-01||Observational|||Type II Pediatric Supracondylar Humerus Fracture Management and Outcomes: A Prospective Multi-centre Cohort Study||Recruiting||N/A|60|Anticipated|British Columbia Children's Hospital|||2||f||||f||||||||No||2017-10-10 21:36:46.955977|2017-10-10 21:36:46.955977
NCT02963220|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-07-19|||October 2016||2016-10-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CBT-AR Pilot||Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: A Treatment Development and Pilot Study|Cognitive-Behavioral Therapy for Avoidant/Restrictive Eating Disorder: A Treatment Development and Pilot Study|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 21:36:47.116017|2017-10-10 21:36:47.116017
NCT02963207|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-09|||June 2013||2013-06-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||MS Versus NICE for Colorectal Lesions|Prospective Randomised Study Comparing Modified Sano's (MS) Classification and NBI International Colorectal Endoscopic (NICE) for Differentiating Colorectal Lesions|Completed||N/A|348|Actual|Lyell McEwin Hospital||2|||f||||t||||||||No||2017-10-10 21:36:47.225603|2017-10-10 21:36:47.225603
NCT02963194|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-11-09|||November 2015||2015-11-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Oxytocin Effects on Self and Other Processing||Completed||N/A|44|Actual|University of Electronic Science and Technology of China||2|||f||||||||||||||2017-10-10 21:36:47.322352|2017-10-10 21:36:47.322352
NCT02963181|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-23|||September 2017|Anticipated|2017-09-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension|Identifying the Pathophysiology of Neurogenic Orthostatic Hypotension and the Effects of Melatonin on Reducing Supine Hypertension in Peripherally Intact Versus Denervated Post-ganglionic Sympathetic Nerves|Not yet recruiting||Early Phase 1|60|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||No||2017-10-10 21:36:47.430749|2017-10-10 21:36:47.430749
NCT02963168|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-12|||April 20, 2017|Actual|2017-04-20|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies|A Dose Regimen-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of Oradoxel Monotherapy in Subjects With Advanced Malignancies|Recruiting||Phase 1|24|Anticipated|Kinex Pharmaceuticals Inc||1|||f||||f|t|f||||||No||2017-10-10 21:36:47.562317|2017-10-10 21:36:47.562317
NCT02963155|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-02-03|||November 2016||2016-11-01|February 2017|2017-02-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|NKPROSTATE||Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration|Prospective Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration|Recruiting||N/A|30|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 21:36:48.297207|2017-10-10 21:36:48.297207
NCT02963142|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-09|||November 2016||2016-11-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|S-CAP||A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia|A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia (S-CAP Study)|Not yet recruiting||N/A|60|Anticipated|Imperial College London|||3||f||||f||||||Samples With DNA|"     whole blood, serum, bronchoalveolar lavage,nose and throat swab and oropharyngeal swabs.   "|Undecided||2017-10-10 21:36:48.435272|2017-10-10 21:36:48.435272
NCT02963129|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-11-09|||June 2017||2017-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT|Treatment of Nasal Staphylococcus Aureus Colonization in Patients With Hereditary Hemorrhagic Telangiectasia With Recurrent Epistaxis.|Not yet recruiting||Phase 3|40|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||No||2017-10-10 21:36:48.517276|2017-10-10 21:36:48.517276
NCT02963116|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-03-08|||December 20, 2016|Actual|2016-12-20|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet|A Randomized, 5-Period, 5-Treatment, Single-Dose, Open-Label, Single-Center, Crossover Study to Estimate the Effect of AZD5718 on the Pharmacokinetics of Rosuvastatin, and to Assess the Relative Bioavailability of AZD5718 Oral Suspension vs AZD5718 IR Tablet Formulation and the Food Effect of AZD5718.|Completed||Phase 1|12|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-10 21:36:48.626767|2017-10-10 21:36:48.626767
NCT02963103|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-11-22|||May 2010||2010-05-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen|A Single-center Pilot Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen|Terminated||Phase 4|13|Actual|Astellas Pharma Inc||1||Sponsor decision to terminate the study because subject enrollment was difficult.|f||||f||||||||Undecided||2017-10-10 21:36:48.755759|2017-10-10 21:36:48.755759
NCT02963090|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-03-27|||December 20, 2017|Anticipated|2017-12-20|March 2017|2017-03-01|May 20, 2019|Anticipated|2019-05-20|May 20, 2019|Anticipated|2019-05-20||Interventional|||Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer|A Randomized Phase II Study Evaluating Pembrolizumab vs Topotecan in the Second-Line Treatment of Patients With Small Cell Lung Cancer|Recruiting||Phase 2|98|Anticipated|Alliance Foundation Trials, LLC.||2|||f||||t|t|f||||||No||2017-10-10 21:36:48.879441|2017-10-10 21:36:48.879441
NCT02963077|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-15|||July 2013||2013-07-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384|A Phase I, Double-Blind Single and Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of A4250 as Monotherapy, and in Combination With Colonic Release Cholestyramine (A3384) or Commercially Available Cholestyramine (Questran™) in Healthy Subjects|Completed||Phase 1|94|Actual|Albireo||24|||f||||f||||||||||2017-10-10 21:36:49.015123|2017-10-10 21:36:49.015123
NCT02963064|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-09|||August 2016||2016-08-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||AMG191 Conditioning/CD34+CD90 Stem Cell Transplant Study for SCID Patients|A Phase 1 Study to Evaluate the Safety and Tolerability of Tandemly-purified Allogenic CD34+CD90+ HSC Administered Following Conditioning With AMG 191 to Achieve Engraftment and Immune Reconstitution in Patients With SCID|Recruiting||Phase 1|90|Anticipated|Stanford University||1|||f||||t||||||||Undecided||2017-10-10 21:36:49.128225|2017-10-10 21:36:49.128225
NCT02963051|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-08-07|||July 11, 2017|Actual|2017-07-11|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer|A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer|Recruiting||Phase 1|36|Anticipated|Duke University||3|||f||||f|t|f||||||||2017-10-10 21:36:49.239741|2017-10-10 21:36:49.239741
NCT02963038|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-04-27|||June 2016||2016-06-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|June 2017|Anticipated|2017-06-01||Interventional|||CAR T Cells for Refractory B Cell Malignancy|Autologous CD19-targeting CAR T Cells for Refractory B Cell Malignancy|Recruiting||Phase 1/Phase 2|10|Anticipated|Hebei Senlang Biotechnology Inc., Ltd.||1|||f||||f||||||||No||2017-10-10 21:36:49.374751|2017-10-10 21:36:49.374751
NCT02963025|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01||||November 2020|Anticipated|2020-11-01||Interventional|||Protective Ventilation With High Versus Low PEEP During One-lung Ventilation for Thoracic Surgery|PROtective Ventilation With High Versus Low PEEP During One-lung Ventilation for THORacic Surgery PROTHOR: A Randomized Controlled Trial|Recruiting||N/A|2378|Anticipated|Technische Universität Dresden||2|||f||||t||||||||No||2017-10-10 21:36:49.471841|2017-10-10 21:36:49.471841
NCT02963012|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-11-14|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||The Correlation Between Uterine Endometrial Pattern and Ectopic Pregnancy|The Correlation Between Uterine Endometrial Pattern and Ectopic Pregnancy|Not yet recruiting||N/A|242|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||Undecided||2017-10-10 21:36:49.731545|2017-10-10 21:36:49.731545
NCT02962999|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-07-24|||January 2017||2017-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation|Effect Of Ketamine Infusion On Oxygenation And Ventilation Mechanics In Patients With Chronic Obstructive Pulmonary Disease Applied One Lung Ventilation|Recruiting||Phase 4|50|Anticipated|Cukurova University||2|||f||||f||||||||||2017-10-10 21:36:49.806328|2017-10-10 21:36:49.806328
NCT02962986|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-23|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||A Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent Spinal-induced Hypotension in Cesarean Deliveries|A Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent Spinal-induced Hypotension in Cesarean Deliveries: a Randomized Controlled Study|Completed||N/A|112|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||No||2017-10-10 21:36:49.960652|2017-10-10 21:36:49.960652
NCT02962973|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-23|||August 2016||2016-08-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|ADVANCE HF||European Clinical Evaluation of the Carmat Total Artificial Heart|Clinical Evaluation of the Carmat Total Artificial Heart for Patients With Advanced Heart Failure|Recruiting||N/A|10|Anticipated|Carmat SA||1|||f||||t||||||||||2017-10-10 21:36:50.089443|2017-10-10 21:36:50.089443
NCT02962960|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-09-01|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|January 2, 2019|Anticipated|2019-01-02|February 1, 2018|Anticipated|2018-02-01||Interventional|||A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Characterizing the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab Following Subcutaneous Administration in Adult Systemic Lupus Erythematosus Subjects With Type I Interferon Test High Result and Active Skin Manifestations.|Recruiting||Phase 2|32|Anticipated|AstraZeneca||4|||f||||f|t|f||||||||2017-10-10 21:36:50.210237|2017-10-10 21:36:50.210237
NCT02962947|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-11-09|||June 2017||2017-06-01|November 2016|2016-11-01|June 2022|Anticipated|2022-06-01|June 2019|Anticipated|2019-06-01||Interventional|||MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients|Melablock: A Multicentre Randomized, Double---blinded and Placebo---controlled Clinical Trial on the Efficacy and Safety of Once Daily Propranolol 80 mg Retard for the Prevention of Cutaneous Malignant Melanoma Recurrence|Not yet recruiting||Phase 2/Phase 3|546|Anticipated|Azienda Sanitaria di Firenze||2|||f||||f||||||||No||2017-10-10 21:36:50.37614|2017-10-10 21:36:50.37614
NCT02962934|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-09|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|CT-PK||An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT|An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without Continuous Renal Replacement Therapy.|Not yet recruiting||N/A|18|Anticipated|Royal Brisbane and Women's Hospital|||2||f||||f||||||Samples Without DNA|"     Urine, blood and ultrafiltrate   "|No|All data will be reported and analysed in a de-identified format.|2017-10-10 21:36:50.49677|2017-10-10 21:36:50.49677
NCT02962921|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-11-09|||February 2003||2003-02-01|November 2016|2016-11-01|November 2004|Actual|2004-11-01|May 2003|Actual|2003-05-01||Interventional|||Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus|Acute Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus|Completed||Phase 4|6|Actual|Rambam Health Care Campus||1|||f||||f||||||||Undecided|First we need to learn how to share data|2017-10-10 21:36:50.5916|2017-10-10 21:36:50.5916
NCT02962908|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-09-01|||August 2016||2016-08-01|September 2017|2017-09-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine|A Randomised, Double-blind, Placebo-controlled, Single-centre Phase IIb Trial as Part of the EU-funded UNISEC Project to Assess the Immunogenicity and Safety of Different Formulations and Dosing Regimens of FLU-v Vaccine in Healthy Adults|Completed||Phase 2|170|Actual|PepTcell Limited||4|||f||||f||||||||||2017-10-10 21:36:50.715016|2017-10-10 21:36:50.715016
NCT02962895|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-07-13|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|November 13, 2019|Anticipated|2019-11-13|November 12, 2019|Anticipated|2019-11-12||Interventional|||Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)|Study of Safety and Efficacy of Multiple VAY736 Doses in Patients With Moderate to Severe Primary Sjogren's Syndrome (pSS)|Recruiting||Phase 2|180|Anticipated|Novartis||4|||f|||||t|f||||||||2017-10-10 21:36:50.855047|2017-10-10 21:36:50.855047
NCT02962206|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-03-23|||January 10, 2017|Actual|2017-01-10|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Point-of-care Ultrasound Guidance for Distal Radius Fracture Reduction|The Effect of Point-of-care Ultrasound Guidance for Distal Radius Fracture Reduction|Recruiting||N/A|100|Anticipated|Western University, Canada||2|||f||||||||||||||2017-10-10 21:36:58.197956|2017-10-10 21:36:58.197956
NCT02962882|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-11-09|||September 2016||2016-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PUP16_01||Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings|A Multi-Centre, Open, Non-controlled, Clinical Investigation to Evaluate the User Friendliness and Wear Time of Multi-layer Foam Dressings With Safetac® for Pressure Injury Prevention in the Intensive Care Unit|Recruiting||Phase 4|50|Anticipated|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-10 21:36:50.975308|2017-10-10 21:36:50.975308
NCT02962856|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2016-12-09|||November 2016||2016-11-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Human Phototoxicity Test (823/2016)|Human Phototoxicity Test|Completed||N/A|38|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:36:51.140255|2017-10-10 21:36:51.140255
NCT02962843|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-09|||August 2009||2009-08-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|IYTCMNOR||Evaluation of the IY TCM Program in Norwegian School and Day-care Settings|Evaluation of the Incredible Years Teacher Classroom Management Program in Norwegian School and Day-care Settings: Changes in Students' (6-8 Year) and Children's Behavior (3-6 Year)|Completed||N/A|5807|Actual|University of Tromso||2|||f||||f||||||||Undecided|The data for the current study is protected by Norwegian law and cannot be made publicly available at the present moment. The UiT -Arctic University of Norway is in the process of making the metadata available for sharing through the Eutro program.|2017-10-10 21:36:51.229241|2017-10-10 21:36:51.229241
NCT02962830|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-05-30|||April 19, 2017|Actual|2017-04-19|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|2IAS||Sufentanil Pharmacokinetics After Intra Amniotic Injection|Assessment of Fetal and Maternal Sufentanil Pharmacokinetics After Intra-amniotic Injection|Recruiting||Phase 2|35|Anticipated|University Hospital, Lille||1|||f||||t|f|f||||||No||2017-10-10 21:36:51.335026|2017-10-10 21:36:51.335026
NCT02962817|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-10|||October 2016||2016-10-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||The Influence of an Educational Intervention in the Beliefs and Attitudes of Primary Care Professionals|The Influence of a Biopsychosocial Educational Intervention Through Information and Communications Technology in the Beliefs and Attitudes of Primary Care Professionals on Chronic Nonspecific Low Back Pain: Mixed Method Study|Recruiting||N/A|60|Anticipated|Universitat de Lleida||2|||f||||t||||||||No||2017-10-10 21:36:51.431015|2017-10-10 21:36:51.431015
NCT02962804|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||December 2016||2016-12-01|November 2016|2016-11-01||||January 2019|Anticipated|2019-01-01||Interventional|||Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)|Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent RCC|Not yet recruiting||Phase 2|30|Anticipated|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-10 21:36:51.533492|2017-10-10 21:36:51.533492
NCT02962791|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||January 2017||2017-01-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|TRIPLEAD||Prospective Randomized Trial Comparing TRIPLE Site ventriculAr Stimulation Versus Conventional Pacing in CRT canDidates|Prospective Randomized Trial Comparing TRIPLE Site ventriculAr Stimulation Versus Conventional Pacing in CRT canDidates: TRIPLEAD Trial|Not yet recruiting||N/A|166|Anticipated|University Hospital, Rouen||2|||f||||t||||||||No||2017-10-10 21:36:51.631141|2017-10-10 21:36:51.631141
NCT02962778|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-03-27|||October 2016||2016-10-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||RAS Peptide Profiles in Patients With Treatment-resistant Arterial Hypertension|Renin-angiotensin-system (RAS) Peptide Profiles in Patients With Treatment-resistant Arterial Hypertension (TRHT-01 Study). An Observational Single Centre Study|Recruiting||N/A|20|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     Plasma samples for concentration measurement of RAS peptides and quantification of     antihypertensive drug concentrations   "|No|The results of this research project will be published in an appropriate scientific journal.|2017-10-10 21:36:51.726881|2017-10-10 21:36:51.726881
NCT02962765|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-07-21|||January 2015||2015-01-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|June 2019|Anticipated|2019-06-01||Observational|||Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ|Prospective, Multinational, Non-interventional Post-authorisation Study to Document the Long-term Immunogenicity, Safety, and Efficacy of Human-cl rhFVIII (Simoctocog Alfa) in Patients With Haemophilia A Treated in Routine Clinical Practice|Recruiting||N/A|200|Anticipated|Octapharma|||1||f||||f||||||Samples Without DNA|"     Citrate Plasma for measuring FVIII inhibitors is recommended throughout the study.   "|||2017-10-10 21:36:51.822504|2017-10-10 21:36:51.822504
NCT02962752|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-09|||January 2012||2012-01-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Pharmacodynamic Profile of 'Blackadder' Blackcurrant Juice Effects Upon the Monoamine Axis in Humans|Pharmacodynamic Profile of 'Blackadder' Blackcurrant Juice Effects Upon the Monoamine Axis in Humans|Completed||N/A|8|Actual|Northumbria University||2|||f||||f||||||||No||2017-10-10 21:36:51.926373|2017-10-10 21:36:51.926373
NCT02962739|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-04-25|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TAF-DBS||The Cellular Pharmacology of F-TAF in Dried Blood Spots|The Cellular Pharmacology of F-TAF in Dried Blood Spots|Recruiting||Phase 1|72|Anticipated|University of Colorado, Denver||6|||f||||f||||||||No||2017-10-10 21:36:52.000257|2017-10-10 21:36:52.000257
NCT02962726|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-11|||September 2016||2016-09-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Observational|MaAN||Microbiome Shifts in Adolescent Anorexia Nervosa|Microbiome Shifts in Adolescent Anorexia Nervosa|Recruiting||N/A|200|Anticipated|RWTH Aachen University|||2||f||||f||||||||No||2017-10-10 21:36:52.092832|2017-10-10 21:36:52.092832
NCT02962713|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|November 2017|Anticipated|2017-11-01||Interventional|||Effectiveness Of Art Restorations Using Three Different Materials|Effectiveness of ART Restorations Using 3 Different Materials: a Randomized Clinical Trial|Not yet recruiting||Phase 4|264|Anticipated|University of Sao Paulo||3|||f||||f|f|f||||||||2017-10-10 21:36:52.18556|2017-10-10 21:36:52.18556
NCT02962700|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-10|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Continuous Haemofiltration vs Intermittent Haemodialysis on Microcirculatory Parameters in Septic Shock|Effects of Continuous Haemofiltration vs Intermittent Haemodialysis on Microcirculatory Parameters in Septic Shock|Recruiting||N/A|100|Anticipated|Military Hospital of Tunis||2|||f||||t||||||||||2017-10-10 21:36:52.302147|2017-10-10 21:36:52.302147
NCT02962687|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-24|||May 25, 2017|Anticipated|2017-05-25|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|December 29, 2017|Anticipated|2017-12-29||Interventional|||Video-Enhanced Care Management for Medically Complex Veterans|Video-Enhanced Care Management for Medically Complex Veterans|Not yet recruiting||N/A|80|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Yes|"A de-identified, anonymized dataset will be available upon request. Prior to distribution, a local privacy officer and study statistician will certify that the dataset contains no protected health information (PHI). Data will be provided to requestor in electronic format.
Sufficient data and descriptors will be made available to duplicate statistical analysis and confirm conclusions in publication.
No data or statistical code that could lead to re-identification of individuals will be released.
Data will be stored & maintained in an approved, secured location as described in the VA Research Data Inventory Form.
The study statistician will create de-identified, publication-specific datasets that includes all variables presented in the study publication.
Data will only be released per appropriate authorizations or agreements. Written agreements will specify that recipients are prohibited from taking steps to re-identify any individual whose data are included in the dataset."|2017-10-10 21:36:52.395033|2017-10-10 21:36:52.395033
NCT02962674|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-06-03|||September 2016||2016-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||ProstaCare Study for BPH|ProstaCare Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia|Recruiting||N/A|50|Anticipated|ProstaCare Singapore Pte. Ltd.||1|||f||||f||||||||No||2017-10-10 21:36:52.496775|2017-10-10 21:36:52.496775
NCT02962661|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-10-04|||April 2018|Anticipated|2018-04-01|October 2017|2017-10-01|April 2026|Anticipated|2026-04-01|April 2025|Anticipated|2025-04-01||Interventional|||Trial With Mesenchymal Stromal Cells (MSCs) vs Standard of Care in Cardiomyopathy|Randomized 3-Arm Trial With Standard of Care Alone vs Either Intravenous Infusion or Transendocardial Injection of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) Plus Standard of Care in Patients With Anthracycline-Associated Cardiomyopathy|Not yet recruiting||Phase 1|72|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-10 21:36:52.625684|2017-10-10 21:36:52.625684
NCT02962648|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-02-24|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|FerWonExt||An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside (Monofer®)|An Open-label, Multicentre, Extension Trial to Assess the Safety of Re-dosing of Intravenous Iron Isomaltoside (Monofer®)|Recruiting||Phase 3|100|Anticipated|Pharmacosmos A/S||1|||f||||t||||||||||2017-10-10 21:36:52.723473|2017-10-10 21:36:52.723473
NCT02962635|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-02|||October 2016||2016-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|DRYWEIGHT||Role of Biomarkers in Patients Undergoing Dialysis Treatment|A Pilot stuDy to Investigate the Role of Biomarkers and Bioimpedance technologY to Assess VolumE Status In Patients underGoing Hemodialysis Treatment|Active, not recruiting||N/A|45|Actual|University of Zurich|||2||f||||f||||||Samples Without DNA|"     Blood samples   "|Undecided||2017-10-10 21:36:52.798194|2017-10-10 21:36:52.798194
NCT02962622|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-11-09|||November 2014||2014-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|CMEx||Cognition Metabolism and Exercise Among Women Living With HIV in Puerto Rico|Soluble Insulin Receptor Dysfunction Correlates With HAND in HIV+ Women on CART|Recruiting||N/A|45|Anticipated|University of Puerto Rico||2|||f||||f||||||||Undecided||2017-10-10 21:36:52.869281|2017-10-10 21:36:52.869281
NCT02962609|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-08|||January 2015||2015-01-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Feeding Positions of Preterm Infants on Some Physiological Characteristics|Comparing the Effect of Feeding Preterm Infants in Two Different Positions on Some Physiological Characteristics: A Randomized-Controlled Trial|Completed||N/A|80|Actual|Istanbul University||2|||f||||t||||||||No||2017-10-10 21:36:52.961561|2017-10-10 21:36:52.961561
NCT02962596|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-15|||February 2014||2014-02-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Observational|||EURAD MRI Classification of US Indeterminate Adnexa Lesions|European Multicenter Validation of an ADNEXMR SCORING System for Characterizing Adnexal Masses: EURAD-MR Classification|Recruiting||N/A|1340|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||||Yes|Images and associated data will be labeled with a unique study number that identifies the research site and the patient number (e.g. UWisc001). The link to identifiable information will remain at the University of Wisconsin|2017-10-10 21:36:53.023672|2017-10-10 21:36:53.023672
NCT02962583|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-04-06|||January 2017||2017-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Addition of Probiotic Consumption to a Nutritional Intervention and Caloric Restriction on Body Weight and Composition in Overweight Participants|The Addition of Probiotic Consumption to a Nutritional Intervention and Caloric Restriction on Body Weight and Composition in Overweight Participants: A Randomized, Double-blind, Placebo Controlled Study|Recruiting||Phase 2|152|Anticipated|Laval University||2|||f||||t||||||||No||2017-10-10 21:36:53.093701|2017-10-10 21:36:53.093701
NCT02962570|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-06-28|||November 2016||2016-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||On-Demand Oxygen Delivery System Study|Comparison of an On-Demand Oxygen Delivery System to Continuous Flow Supplemental Oxygen in the Operating/Procedure Room|Active, not recruiting||N/A|100|Anticipated|University of Utah||1|||f||||f||||||||No|There is no plan to share individual participant data.|2017-10-10 21:36:53.19354|2017-10-10 21:36:53.19354
NCT02962557|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-11-08|||September 2016||2016-09-01|November 2016|2016-11-01||||March 2017|Anticipated|2017-03-01||Interventional|||Detecting Post-surgical Respiratory Compromise and Prompting Patients to Self-rescue: An Early Feasibility Study|Detecting Post-surgical Respiratory Compromise and Prompting Patients to Self-rescue: An Early Feasibility Study|Not yet recruiting||N/A|40|Anticipated|University of Utah||2|||f||||f||||||||No||2017-10-10 21:36:53.270656|2017-10-10 21:36:53.270656
NCT02962544|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-09|||March 2015||2015-03-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison Between FS- LASIK and FS-SMILE for Correction of Myopia and Myopic Astigmatism|Comparison Between Femtosecond Assisted LASIK and Small Incision Lenticule Extraction (SMILE) for Correction of Myopia and Myopic Astigmatism|Recruiting||N/A|60|Anticipated|Kasr El Aini Hospital||2|||f||||t||||||||No||2017-10-10 21:36:53.356951|2017-10-10 21:36:53.356951
NCT02962531|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-01-12|||November 2016||2016-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|IX-0106 RBA||Relative Bioavailability Study of IX-01 Caplet Versus Aqueous Dispersion and Food Effect of the Caplet in Healthy Males|A Randomized, Single-Dose, 3-Way Crossover Study to Evaluate the Relative Bioavailability of the IX-01 Caplet Formulation Compared With the IX 01 Aqueous Dispersion Formulation, and the Effect of Food on the IX-01 Caplet Formulation, in Healthy Male Subjects|Completed||Phase 1|12|Actual|Ixchelsis Limited||3|||f||||f||||||||No||2017-10-10 21:36:55.650545|2017-10-10 21:36:55.650545
NCT02962518|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-08|||July 2014||2014-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|PRESSURE||Pressure Device in the Treatment of Ear Keloids|PRESSURE: Prospektive, Randomisierte Und Kontrollierte Untersuchung Von Lokaler Druckapplikation im Rahmen Der Keloid-Therapie Der Ohrmuschel|Completed||N/A|18|Actual|University of Ulm||2|||f||||f||||||||No||2017-10-10 21:36:55.771238|2017-10-10 21:36:55.771238
NCT02962505|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-09-15|||November 2016||2016-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|CRADL||Continuous Regional Analysis Device for Neonate Lung|Continuous Regional Analysis Device for Neonate Lung|Recruiting||N/A|200|Anticipated|University of Schleswig-Holstein|||1||f||||f||||||||||2017-10-10 21:36:55.900039|2017-10-10 21:36:55.900039
NCT02962492|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes|An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes|Not yet recruiting||Phase 4|80|Anticipated|University at Buffalo||4|||f||||t||||||||No||2017-10-10 21:36:56.01461|2017-10-10 21:36:56.01461
NCT02962479|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-09|||October 2016||2016-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis?||Enrolling by invitation||N/A|50|Anticipated|St. Lawrence Health System|||5||f||||f||||||Samples Without DNA|"     Subjects will have the option to provide additional consent for specimens to be retained by     the research team indefinitely for research purposes. These samples will be identified only     by the numeric study ID; no personally identifying information will be associated with the     retained samples. The samples could be used to make new products, tests or findings, which     may have value and may be developed and owned by the research team and/or others.     Investigators will not be able to provide subjects with results from any future research that     is done using their samples.   "|||2017-10-10 21:36:56.107821|2017-10-10 21:36:56.107821
NCT02962466|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-15|||November 2016||2016-11-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|MC_CC-Test||Multicenter Prospective Cumulus Cell Test Study|Cumulus Cell Messenger Ribonucleic Acid (mRNA) Analysis as Oocyte Quality Marker in the Fertility Lab in a Prospective Multicenter Study|Recruiting||N/A|100|Anticipated|Universitair Ziekenhuis Brussel||3|||f||||f||||||||No||2017-10-10 21:36:56.172326|2017-10-10 21:36:56.172326
NCT02962453|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-06-30|||November 2016||2016-11-01|June 2017|2017-06-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||Evaluation of Gait Rehabilitation Robot of an End-Effector on Neuro-Muscular Pathway in Patients After Knee Arthroplasty|Multi-Modalities Evaluation of Gait Rehabilitation Robot of an End-Effector on Neuro-Muscular Pathway of the Proximal Muscles in Patients After Total Knee Arthroplasty|Completed||N/A|20|Actual|Ulsan University Hospital||2|||f||||t||||||||||2017-10-10 21:36:56.256174|2017-10-10 21:36:56.256174
NCT02962440|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-06-06|||November 2016||2016-11-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Dosing in Healthy Male Subjects|A Single Centre, Open Label Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Subcutaneous Dosing in Healthy Male Subjects|Completed||Phase 1|7|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-10 21:36:56.330573|2017-10-10 21:36:56.330573
NCT02962427|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Treatment of Post-dural Puncture Headache in Postpartum Patients: Sphenopalatine Ganglion Block to Epidural Blood Patch.|Treatment of Post-dural Puncture Headache in Postpartum Parturients: Comparing Sphenopalatine Ganglion Block to Epidural Blood Patch.|Recruiting||Phase 4|100|Anticipated|University of Colorado, Denver||2|||f||||f||||||||No|Not sharing IPD with other researchers|2017-10-10 21:36:56.396012|2017-10-10 21:36:56.396012
NCT02962414|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-08-24|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|January 5, 2028|Anticipated|2028-01-05|April 2, 2027|Anticipated|2027-04-02||Interventional|||Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment|An Open-label, Multi-center Long-term Safety Roll-over Study in Patients With Tuberous Sclerosis Complex (TSC) and Refractory Seizures Who Are Judged by the Investigator to Benefit From Continued Treatment With Everolimus After Completion of Study CRAD001M2304.|Recruiting||Phase 3|218|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:36:56.579715|2017-10-10 21:36:56.579715
NCT02962401|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-09-12|||March 7, 2017|Actual|2017-03-07|September 2017|2017-09-01|March 2025|Anticipated|2025-03-01|March 2019|Anticipated|2019-03-01||Interventional|RemodelWM3||Efficacity of Idelalisib and Obinutuzumab in Patient With Relapsed Refractory Waldenstrom's Macroglobulinemia|"An Open Label Non-randomized Phase II Study Exploring Chemo-free  Treatment Association With Idelalisib + Obinutuzumab in Patient With Relapsed/Refractory Waldenstrom's Macroglobulinemia"|Recruiting||Phase 2|50|Anticipated|French Innovative Leukemia Organisation||1|||f||||t|f|f|||f|||||2017-10-10 21:36:56.77536|2017-10-10 21:36:56.77536
NCT02962219|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-08|||September 2016||2016-09-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|ExPO||Exercise Prior to Oesophagectomy|A Pre-operative Personalised Exercise Programme to Improve Physical Fitness and Reduce Post-operative Cardiopulmonary Complications After Oesophagectomy in Patients With Oesophageal Adenocarcinoma: A Feasibility Randomised Controlled Trial|Recruiting||N/A|32|Anticipated|University of East Anglia||2|||f||||t||||||||No||2017-10-10 21:36:57.965696|2017-10-10 21:36:57.965696
NCT02962388|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-01-16|||January 2017||2017-01-01|October 2016|2016-10-01|November 2022|Anticipated|2022-11-01|October 2018|Anticipated|2018-10-01||Interventional|||The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line|A Randomized, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Ruxolitinib Versus Best Available Therapy in Patients With High Risk Essential Thrombocythemia, Who Are Resistant or Intolerant to Hydroxyurea: A FIM Study|Recruiting||Phase 2/Phase 3|280|Anticipated|French Innovative Leukemia Organisation||2|||f||||t||||||||Yes|e crf|2017-10-10 21:36:56.8764|2017-10-10 21:36:56.8764
NCT02962375|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-05-19|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|PEP||Effect of Orange Pomace Fiber on Glycemic Response|Pilot Study to Assess the Effect of Orange Pomace Fiber on Glycemic Response in Healthy Adults|Active, not recruiting||N/A|12|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f|f|f||||||Undecided||2017-10-10 21:36:56.985332|2017-10-10 21:36:56.985332
NCT02962362|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-09|||August 2016||2016-08-01|November 2016|2016-11-01||||September 2019|Anticipated|2019-09-01||Observational|||eGPS® in Total Knee Arthroplasty|A Prospective Multi-center Data Collection to Assess the Exactech Guided Personalized Surgery eGPS® in Total Knee Arthroplasty|Recruiting||N/A|100|Anticipated|Exactech|||1||f||||f||||||||No||2017-10-10 21:36:57.065409|2017-10-10 21:36:57.065409
NCT02962336|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||May 2011||2011-05-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE of FDC of Olmesaartan Medoxomil, Amlopdipine and Hydrochlorothiazide (40+10+25) mg Tab [Torrent,India] Vs Tribenzor(40+10+25) mg Tab [ Daichi Sankyo, Inc USA] in Healthy Subjects-Fasted Condition.|Completed||Phase 1|34|Actual|Torrent Pharmaceuticals Limited||2|||f||||f||||||||No||2017-10-10 21:36:57.145528|2017-10-10 21:36:57.145528
NCT02962323|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||November 2009||2009-11-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE of Rosuvastatin Ca Tab 40 mg [Torrent,India] Versus Crestor 40 mg Tab [ AstraZeneca Pharmaceuticals LP, USA] in Healthy Subjects-Fed Condition.|Completed||Phase 1|48|Actual|Torrent Pharmaceuticals Limited||2|||f||||f||||||||No||2017-10-10 21:36:57.219803|2017-10-10 21:36:57.219803
NCT02962310|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||October 2009||2009-10-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE of Rosuvastatin Ca Tab 40 mg [Torrent,India] Versus Crestor 40 mg Tab [ AstraZeneca Pharmaceuticals LP, USA] in Healthy Subjects-Fasted Condition.|Completed||Phase 1|48|Actual|Torrent Pharmaceuticals Limited||2|||f||||t||||||||No||2017-10-10 21:36:57.295083|2017-10-10 21:36:57.295083
NCT02962297|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-15|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|January 2021|Anticipated|2021-01-01||Interventional|||Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis|VENS is a Multicenter, Randomized, Double-masked, Placebo Parallel Controlled Trial to Evaluate the Efficacy and Safety of Treatment With Vitamin E Softgel in Non Diabetic Adults With NASH Compared to Treatment With Placebo in China|Recruiting||N/A|120|Anticipated|Zhejiang Medicine Co., Ltd.||2|||f||||||||||||||2017-10-10 21:36:57.366923|2017-10-10 21:36:57.366923
NCT02962284|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-09|||November 2016||2016-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™|An Open-Label, Single-Arm, Multiple Center Extension Study to Evaluate One Year of Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With YONSA™ 500 mg (4 x 125 mg qd) With Methylprednisolone (4 mg Bid)|Enrolling by invitation||Phase 2|25|Anticipated|Churchill Pharmaceutical LLC||1|||f||||f||||||||No|We do not plan to make individual participant data available|2017-10-10 21:36:57.499404|2017-10-10 21:36:57.499404
NCT02962271|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-09|||January 2016||2016-01-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Comparation of Ultrasonic Imaging of Enthesopathy in Patients With Psoriatic Arthritis and Psoriasis|Comparation of Ultrasonic Imaging of Enthesopathy in Patients With Psoriatic Arthritis and Psoriasis|Recruiting||N/A|187|Anticipated|Chinese PLA General Hospital|||2||f||||t||||||||Yes|All individual participant data (IPD) are to be shared with other researchers, whenever it will be available, and it may be obtained by requesting from the principal investigator|2017-10-10 21:36:57.580959|2017-10-10 21:36:57.580959
NCT02962258|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||May 2011||2011-05-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE of FDC of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab 40+10+25 mg [Torrent,India] Vs Tribenzor 40+10+25 mg Tablets [ Daichi,USA] in Healthy Subjects-Fed Condition.|Completed||Phase 1|34|Actual|Torrent Pharmaceuticals Limited||2|||f||||f||||||||No||2017-10-10 21:36:57.657889|2017-10-10 21:36:57.657889
NCT02962245|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis|Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis: An Open-label,Randomized,Phase IV Clinical Trial|Not yet recruiting||Phase 4|238|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||||||||||||2017-10-10 21:36:57.71979|2017-10-10 21:36:57.71979
NCT02962232|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-03|||November 2016||2016-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of Below The Knee Arteries' Stenosis or Occlusion Treated With LEGFLOW OTW|Evaluation the Safety and Efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation Catheter （LEGFLOW）in Treatment of Stenosis or Occlusion in Below The Knee Arteries: A Prospective, Multicenter, Randomized, Controlled Clinical Study|Recruiting||N/A|172|Anticipated|ZhuHai Cardionovum Medical Device Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 21:36:57.792727|2017-10-10 21:36:57.792727
NCT02962180|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-10|||March 2016||2016-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|||Transplantation of Basal Cell Layer Suspension Using Derma-rolling System in Vitiligo|Transplantation With Dermarolling System of Basal Cell Layer Suspension Obtained by Soft Trypsinisation in Vitiligo Lesion|Recruiting||N/A|10|Anticipated|Mohammed V Souissi University||1|||f||||f||||||||No||2017-10-10 21:36:58.370238|2017-10-10 21:36:58.370238
NCT02962167|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-05|||November 2016||2016-11-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|||Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT|A Phase 1 Study of Modified Measles Virus (MV-NIS) for the Treatment of Children and Young Adults With Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT)|Recruiting||Phase 1|24|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||||2017-10-10 21:36:58.478932|2017-10-10 21:36:58.478932
NCT02962154|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-11-08|||February 2016||2016-02-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|NIRVANA||Neurocardiac Interactions Evaluated by Anatomic and Physiologic MRI Assessment|Neurocardiac Interactions Evaluated by Anatomic and Physiologic MRI Assessment|Active, not recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||Samples With DNA|"     2mL of blood will be drawn for sample banking for future research studies ONLY from subjects     who provide permission for storing their sample for use in future research   "|Undecided||2017-10-10 21:36:58.639465|2017-10-10 21:36:58.639465
NCT02962141|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-05-03|||October 2016||2016-10-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With APERTO|Evaluation of the Safety and Efficacy of the Paclitaxel Eluting Hemodialysis Shunt Balloon Dilatation Catheter (APERTO) in Treatment of Hemodialysis Arteriovenous Fistulae Stenosis: A Prospective, Multicenter, Randomized, Controlled Clinical Study|Recruiting||N/A|160|Anticipated|ZhuHai Cardionovum Medical Device Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 21:36:58.762545|2017-10-10 21:36:58.762545
NCT02962128|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-18|||November 29, 2016|Actual|2016-11-29|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Role of Polyunsaturated Fatty Acids (PUFA)-Gene Interactions in Heath Disparities|Role of PUFA-Gene Interactions in Health Disparities|Recruiting||N/A|150|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 21:36:58.929064|2017-10-10 21:36:58.929064
NCT02962115|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-08-17|||November 2016||2016-11-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention|Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention|Completed||N/A|1000|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-10-10 21:36:59.05297|2017-10-10 21:36:59.05297
NCT02962102|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-06-06|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|ACTIVATE-AKI||Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury|Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury (ACTIVATE-AKI)|Recruiting||Phase 2|150|Anticipated|Brigham and Women's Hospital||3|||f||||t|t|f||||||No||2017-10-10 21:36:59.141854|2017-10-10 21:36:59.141854
NCT02962089|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-01-20|||August 2016||2016-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|MIDIWA||Microbiota and Protein-energy Wasting (MIDIWA)|Do Branched Chain Amino Acids Counteract Protein Energy Wasting Through Gut Microbiota Changes in Hemodialysis Patients ?|Recruiting||N/A|36|Anticipated|University Hospital, Geneva||2|||f||||f||||||||No||2017-10-10 21:36:59.272172|2017-10-10 21:36:59.272172
NCT02962076|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||December 2016||2016-12-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia|Cardiac Positron Emission Tomography for Detection of Cardiac Sympathetic Dysinnervation to Guide Ablation of Ventricular Tachycardia|Not yet recruiting||N/A|15|Anticipated|Mercy Research||1|||f||||f||||||||Undecided||2017-10-10 21:36:59.401971|2017-10-10 21:36:59.401971
NCT02962063|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01||||November 2018|Anticipated|2018-11-01||Interventional|||Durvalumab, an Anti-PD-L1 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer|Pilot Phase Ib/II Study of Durvalumab (MEDI4736) and Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma|Recruiting||Phase 1/Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:36:59.470016|2017-10-10 21:36:59.470016
NCT02962050|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-07-18|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|June 30, 2024|Anticipated|2024-06-30|June 30, 2022|Anticipated|2022-06-30||Observational|||Delineating Swallowing Impairment and Decline in ALS|Delineating Physiologic Mechanisms of Swallowing Impairment and Decline in ALS|Recruiting||N/A|100|Anticipated|University of Florida|||2||f||||t|t|f||||||||2017-10-10 21:36:59.605727|2017-10-10 21:36:59.605727
NCT02962037|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-09|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Are Patients Suffering From DSPS Show Compromising in Everyday Functions and Abilities Before Handling the Disorder?|Are Patients Suffering From DSPS Show Compromising in Everyday Functions and Abilities (Attention and Concentration, Mood and Fatigue) Before Handling the Disorder? And Whether the Treatment Fixes the Disorder?|Not yet recruiting||Phase 4|20|Anticipated|Assuta Medical Center||2|||f||||t||||||||No||2017-10-10 21:36:59.78481|2017-10-10 21:36:59.78481
NCT02962024|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-21|||November 2016||2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Does Local Morphine Add to Local Anesthetics in Serratus Anterior Plane Block Has a System Analgesic Effect?|Does Local Morphine Add to Local Anesthetics in Serratus Anterior Plane Block for Post Mastectomy Pain Has a System Analgesic Effect? A Clinical and Pharmacokinetics Study|Active, not recruiting||N/A|60|Anticipated|Assiut University||2|||f||||t||||||||Yes||2017-10-10 21:36:59.886907|2017-10-10 21:36:59.886907
NCT02962011|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-04-13|||August 1, 2016|Actual|2016-08-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|March 31, 2017|Actual|2017-03-31||Interventional|barbed||Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section|Randomized Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section|Active, not recruiting||Phase 3|102|Actual|Ziv Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:36:59.982769|2017-10-10 21:36:59.982769
NCT02961998|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-08|||July 2015||2015-07-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail|Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome|Completed||Phase 4|130|Actual|Sun Yat-sen University||2|||f||||f||||||||No||2017-10-10 21:37:00.071476|2017-10-10 21:37:00.071476
NCT02961985|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-05-16|||October 2016||2016-10-01|May 2017|2017-05-01|March 2023|Anticipated|2023-03-01|April 2018|Anticipated|2018-04-01|5 Years|Observational [Patient Registry]|MIR-SL||Myocardial Infarction Register of the Saarland|Myokardinfarkt-Register Des Saarlandes (MIR-SL)|Recruiting||N/A|600|Anticipated|Stiftung Institut fuer Herzinfarktforschung|||1||f||||f||||||||No||2017-10-10 21:37:00.155067|2017-10-10 21:37:00.155067
NCT02961972|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-27|||January 2015||2015-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Effects of Oral Supplementation With Creatine on Systemic Microvascular Endothelial Function in Vegetarian Individuals|Effects of Oral Supplementation With Creatine on Plasma Homocysteine Levels and Systemic Microvascular Endothelial Function in Vegetarian Individuals|Completed||N/A|49|Actual|National Institute of Cardiology, Laranjeiras, Brazil||2|||f||||f||||||||||2017-10-10 21:37:00.253378|2017-10-10 21:37:00.253378
NCT02961959|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-08|||October 2008||2008-10-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|November 2012|Actual|2012-11-01||Interventional|||Sacro-iliac Joint Arthrodesis or Non-operative Care for Treatment of Chronic Pelvic Pain. A Randomized Study.|Sacro-iliac Joint Arthrodesis or Non-operative Care for Treatment of Chronic Pelvic Pain. A Randomized Study.|Active, not recruiting||N/A|19|Actual|Spinal Surgery Clinic, Strängnäs||2|||f||||f||||||||No||2017-10-10 21:37:00.357956|2017-10-10 21:37:00.357956
NCT02961946|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-09|||December 2016||2016-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality|Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality|Not yet recruiting||N/A|210|Anticipated|Massachusetts General Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:37:00.430146|2017-10-10 21:37:00.430146
NCT02961933|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-06-26|||December 2016||2016-12-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|USE AP OX||Utah Study Evaluating Apneic Oxygenation for Emergency Department Intubation|Utah Study Evaluating Apneic Oxygenation for Emergency Department Intubation|Recruiting||N/A|500|Anticipated|Intermountain Health Care, Inc.||2|||f||||t||||||||No||2017-10-10 21:37:00.502903|2017-10-10 21:37:00.502903
NCT02961920|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-07-17|||November 2016||2016-11-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|September 2017|Anticipated|2017-09-01||Observational|||The Effect of Prolonged Inspiratory Time on Pulmonary Mechanics in Obese Patients|The Influence of Prolonged Inspiratory Time on Respiratory Mechanics and Oxygenation in Obese Patients Undergoing Spine Surgery in the Prone Position|Recruiting||N/A|50|Anticipated|Gachon University Gil Medical Center|||2||f||||t||||||||||2017-10-10 21:37:00.584723|2017-10-10 21:37:00.584723
NCT02961894|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-09-21|||June 7, 2017|Actual|2017-06-07|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|REVEAL||Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization|Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization|Recruiting||N/A|121|Anticipated|Rex Medical||1|||f||||t|f|t|t|f||||||2017-10-10 21:37:00.737391|2017-10-10 21:37:00.737391
NCT02961881|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-09-22|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|January 21, 2020|Anticipated|2020-01-21|January 21, 2020|Anticipated|2020-01-21||Interventional|||A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma|A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma|Recruiting||Phase 1|33|Anticipated|Amgen||1|||f||||t|t|f||||||||2017-10-10 21:37:00.997063|2017-10-10 21:37:00.997063
NCT02961868|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-16|||November 2009||2009-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PROFILE||Cohort Follow-up of Patients With Renal or Craniocervical Fibromuscular Dysplasia|PROgression of FIbromuscular LEsions|Active, not recruiting||N/A|340|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 21:37:01.104368|2017-10-10 21:37:01.104368
NCT02961855|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-14|||January 2011||2011-01-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy and Safety of CLIFE1 Gel in Benign Anorectal Surgery|Double-blinded Multicenter Randomized Clinical Trial to Evaluate the Efficacy and Safety of CLIFE1 and CLIFE2 Gels in Benign Anorectal Surgery|Completed||Phase 4|120|Actual|Hospital de Viladecans||2|||f||||t||||||||No||2017-10-10 21:37:01.231791|2017-10-10 21:37:01.231791
NCT02961842|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-03-20|||November 20, 2016|Actual|2016-11-20|March 2017|2017-03-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||Combined Colloid Preload And Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery|Combined Colloid Preload And Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery|Completed||N/A|200|Actual|Mansoura University||2|||f||||f||||||||No||2017-10-10 21:37:01.315956|2017-10-10 21:37:01.315956
NCT02961829|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-01-27|||July 2015||2015-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure|Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure|Active, not recruiting||N/A|30|Actual|Federal University of São Paulo||6|||f||||t||||||||Undecided||2017-10-10 21:37:01.43989|2017-10-10 21:37:01.43989
NCT02961621|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-10|||September 2014||2014-09-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|NG911||Multi-tasking to Hyper-tasking: Investigating the Impact of Next Generation 911|Multi-tasking to Hyper-tasking: Investigating the Impact of Next Generation 911|Enrolling by invitation||N/A|180|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 21:37:03.077575|2017-10-10 21:37:03.077575
NCT02961816|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-04-20|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma|Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||3||Lack of funding|f||||f|t|f||||||||2017-10-10 21:37:01.576784|2017-10-10 21:37:01.576784
NCT02961790|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-10-03|||December 9, 2016|Actual|2016-12-09|October 2017|2017-10-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Oxybutynin Chloride in Managing Hot Flashes|A Phase III, Double-Blind, Controlled Trial of Oxybutynin in the Management of Hot Flashes|Recruiting||Phase 3|150|Anticipated|Academic and Community Cancer Research United||4|||f||||t||||||||||2017-10-10 21:37:01.852492|2017-10-10 21:37:01.852492
NCT02961777|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-09|||January 2014||2014-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Month|Observational [Patient Registry]|CP4ACS||Study to Evaluate the Care Process and the Quality of STEMI Care|Study to Evaluate the Care Process and the Quality of Care for Adult Patients With ST Elevated Myocardial Infarction|Active, not recruiting||N/A|640|Anticipated|European Pathway Association|||3||f||||t||||||||No||2017-10-10 21:37:02.035137|2017-10-10 21:37:02.035137
NCT02961764|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-13|||November 29, 2016|Actual|2016-11-29|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)|A Pragmatic Trial Designed to Evaluate a New Critical Pathway for Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections|Recruiting||Phase 4|322|Anticipated|Allergan||2|||f||||f|t|f||||||||2017-10-10 21:37:02.113193|2017-10-10 21:37:02.113193
NCT02961751|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-09-14|||October 19, 2016|Actual|2016-10-19|April 11, 2017|2017-04-11|September 15, 2018|Anticipated|2018-09-15|January 15, 2018|Anticipated|2018-01-15||Interventional|||Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrheaoe|Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrheaoe|Recruiting||N/A|257|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f|||||f|f|||f|||||2017-10-10 21:37:02.22813|2017-10-10 21:37:02.22813
NCT02961738|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-10|||January 2011||2011-01-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Is Narrative Reformulation During Cognitive Analytic Therapy Helpful?|Efficacy of Narrative Reformulation During Cognitive Analytic Therapy: A Randomized Dismantling Trial|Completed||Phase 2/Phase 3|95|Actual|University of Sheffield||2|||f||||f||||||||||2017-10-10 21:37:02.31848|2017-10-10 21:37:02.31848
NCT02961725|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-09|||April 2016||2016-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Stem Cells for Treatment of Bronchopleural Fistula|Umbilical Cord Mesenchymal Stem Cells for Treatment of Bronchopleural Fistula|Recruiting||Phase 1|10|Anticipated|The Second Affiliated Hospital of Fujian Medical University||1|||f||||t||||||||Undecided||2017-10-10 21:37:02.403256|2017-10-10 21:37:02.403256
NCT02961712|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-04-24|||July 2016||2016-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)|Immunotherapy of Natural Killer in HTLV-1 Associated Myelopathy|Recruiting||Phase 1|15|Anticipated|The Second Affiliated Hospital of Fujian Medical University||1|||f||||f||||||||Undecided||2017-10-10 21:37:02.49067|2017-10-10 21:37:02.49067
NCT02961699|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-08-15|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|||Healing Chronic Venous Stasis Wounds With Autologous Cell Therapy|Healing Chronic Venous Stasis Wounds With Autologous Cell Therapy|Recruiting||N/A|36|Anticipated|InGeneron, Inc.||2|||f||||t|f|t|t|f||||||2017-10-10 21:37:02.573369|2017-10-10 21:37:02.573369
NCT02961686|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||November 2016||2016-11-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Quality of Life and Sexuality in Patients With Prostate Cancer|Quality of Life and Sexuality in Patients Treated With Radical Radiotherapy for Prostate Cancer|Recruiting||N/A|50|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||||No||2017-10-10 21:37:02.660758|2017-10-10 21:37:02.660758
NCT02961673|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-11-08|||September 2016||2016-09-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines|A Phase I/Ⅱ Clinical Trial to Compare the Safety and Efficacy of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines|Recruiting||Phase 1/Phase 2|60|Anticipated|Huons Co.,Ltd.||2|||f||||f||||||||No||2017-10-10 21:37:02.742096|2017-10-10 21:37:02.742096
NCT02961660|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-10-05|||November 9, 2016|Actual|2016-11-09|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir|An Open-label Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir|Recruiting||Phase 1|16|Anticipated|Janssen Research & Development, LLC||2|||f||||f||f||||||||2017-10-10 21:37:02.822459|2017-10-10 21:37:02.822459
NCT02961647|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-05-16|||October 2014||2014-10-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|HEMI||Hemodynamic Stress Test in Severe Mitral Regurgitation (HEMI)|Invasive Hemodynamic Stress Test in Symptomatic and Asymptomatic Mitral Regurgitation|Recruiting||N/A|80|Anticipated|Odense University Hospital|||2||f||||t||||||Samples Without DNA|"     Blood and tissue samples   "|No||2017-10-10 21:37:02.91135|2017-10-10 21:37:02.91135
NCT02961634|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-03-30|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis|Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis|Not yet recruiting||Phase 3|46|Anticipated|MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA||2|||f||||f|f|f||||||No||2017-10-10 21:37:03.00446|2017-10-10 21:37:03.00446
NCT02961608|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-11-08|||May 2016||2016-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|TACPKPD||Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day.|Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day.|Recruiting||Phase 4|25|Anticipated|Hospital Universitari de Bellvitge||1|||f||||||||||||||2017-10-10 21:37:03.131016|2017-10-10 21:37:03.131016
NCT02961595|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-10|||October 1999||1999-10-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Live Enterovirus Vaccine and Type 1 Diabetes|Live Enterovirus Vaccine and Type 1 Diabetes|Completed||Phase 1|315|Actual|University of Tampere||2|||f||||f||||||||No||2017-10-10 21:37:03.203633|2017-10-10 21:37:03.203633
NCT02961582|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Effectiveness and Cost-effectiveness of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation|Effectiveness and Cost-effectiveness of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation Refractory to Conservative Treatments|Recruiting||Phase 4|64|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||No||2017-10-10 21:37:03.274055|2017-10-10 21:37:03.274055
NCT02961569|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-04-26|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Comparison Between Two Strategies for the Diagnosis of TB|Comparative Study Between the Classical Strategy and a Faster, Daily Collection for the Diagnosis of Contagious Pulmonary Tuberculosis|Completed||N/A|34|Actual|Hopital Lariboisière||1|||f||||f||||||||No||2017-10-10 21:37:03.392346|2017-10-10 21:37:03.392346
NCT02961556|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-05-19|||November 15, 2016|Actual|2016-11-15|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation|General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation|Active, not recruiting||Phase 3|39|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-10 21:37:03.453947|2017-10-10 21:37:03.453947
NCT02961543|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-16|||July 2016||2016-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Rehabilitation Programs Based on Eccentric Exercise of Knee Extensor Muscles in Isotonic and Isokinetic Conditions After Anterior Cruciate Ligament Reconstruction|Effect of Rehabilitation Programs Based on Eccentric Exercise of Knee Extensor Muscles in Isotonic and Isokinetic Conditions After Anterior Cruciate Ligament Reconstruction|Recruiting||N/A|30|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||||||||||||2017-10-10 21:37:03.557515|2017-10-10 21:37:03.557515
NCT02961530|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-16|||July 2016||2016-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Rehabilitation Programs Based on Eccentric Exercise of Knee Extensor Muscles in Isotonic and Isokinetic Conditions After Partial Menisectomy|Effect of Rehabilitation Programs Based on Eccentric Exercise of Knee Extensor Muscles in Isotonic and Isokinetic Conditions After Partial Menisectomy|Recruiting||N/A|32|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||f||||||||||2017-10-10 21:37:03.643411|2017-10-10 21:37:03.643411
NCT02961517|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-08|||December 2016||2016-12-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Format of Patient Education for Different Sociodemographic Groups|The Influence of Socio-demographic Characteristics on the Preferred Format of Patient Education Delivery in Individuals With Type 2 Diabetes Mellitus or Cardiovascular Disease: a Questionnaire Study|Not yet recruiting||N/A|200|Anticipated|University of Leicester|||1||f||||f||||||||No||2017-10-10 21:37:03.712232|2017-10-10 21:37:03.712232
NCT02961504|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-10|||January 2017||2017-01-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|TREASURE||Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements|Placebo-Controlled, Double-Blind, Phase 2/3 Efficacy and Safety Trial of HLCM051 (MultiStem®) in Patients With Ischemic Stroke|Not yet recruiting||Phase 2/Phase 3|220|Anticipated|Healios K.K.||2|||f||||||||||||||2017-10-10 21:37:03.777452|2017-10-10 21:37:03.777452
NCT02961491|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-10-04||||||October 2017|2017-10-01||||||||Expanded Access|||Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma|Expanded Access Program of AZEDRA (Ultratrace Iobenguane I131) in Subjects With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma: A Sub-study of Protocol MIP-IB12B|Available||N/A|||Molecular Insight Pharmaceuticals, Inc.|||||||||||||||||||2017-10-10 21:37:03.847188|2017-10-10 21:37:03.847188
NCT02961478|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-06-26|||February 10, 2017|Actual|2017-02-10|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|IOXSOR||Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure|Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure|Recruiting||Phase 3|150|Anticipated|University Hospital, Angers||1|||f||||f|f|f||||||||2017-10-10 21:37:03.923211|2017-10-10 21:37:03.923211
NCT02961465|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-08-28|||December 2017|Anticipated|2017-12-01|December 2016|2016-12-01|August 2021|Anticipated|2021-08-01|March 2021|Anticipated|2021-03-01||Observational|||Effectiveness and Safety of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation|Effectiveness and Safety of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation Refractory to Conservative Treatments|Not yet recruiting||N/A|61|Anticipated|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-10 21:37:04.145879|2017-10-10 21:37:04.145879
NCT02961452|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-10|||January 2016||2016-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Phenotypical Characterization of Peanut Allergic Children|Phenotypical Characterization of Peanut Allergic Children With Differences in Cross-allergy to Tree Nuts and Other Legumes|Completed||N/A|317|Actual|Lille Catholic University|||1||f||||f||||||||No||2017-10-10 21:37:04.243695|2017-10-10 21:37:04.243695
NCT02961439|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-08-09|||November 2016||2016-11-01|August 2017|2017-08-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Observational|VEREEFY||Validation of Epworth Richmond's Echocardiography Education Focused Year|Validation of Epworth Richmond's Echocardiography Education Focused Year|Completed||N/A|252|Actual|Epworth Healthcare|||2||f||||f||||||||||2017-10-10 21:37:04.318334|2017-10-10 21:37:04.318334
NCT02961426|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-05-10|||September 2016||2016-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection|Open Label Phase II/III, Multicenter, Trial to Assess the Efficacy, Safety, Tolerance, and Pharmacokinetics of Sofosbuvir Plus Ravidasvir in HCV (+/- HIV) Chronically Infected Adults With no or Compensated Cirrhosis in Thailand and Malaysia|Recruiting||Phase 2/Phase 3|750|Anticipated|Drugs for Neglected Diseases||2|||f||||f||||||||Undecided||2017-10-10 21:37:04.403858|2017-10-10 21:37:04.403858
NCT02961413|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-08-30|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|DILI-P||A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）|A Multi-center, Prospective, Non-interventional Cohort Study on Drug Induced Liver Injury in Mainland China|Recruiting||N/A|10000|Anticipated|Drug Induced Liver Disease Study Group|||6||f||||f||||||Samples Without DNA|"     serum, plasma, histology, urine   "|||2017-10-10 21:37:04.537084|2017-10-10 21:37:04.537084
NCT02961400|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-11-08|||October 2013||2013-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Memory for Sleep Treatment Content With Text Messages|Improving Memory for Sleep Treatment Content With Text Messages|Active, not recruiting||Phase 1/Phase 2|176|Actual|University of California, Berkeley||3|||f||||t||||||||||2017-10-10 21:37:04.724021|2017-10-10 21:37:04.724021
NCT02961387|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Clinical Trial on Effectiveness and Safety of Hydrogen Generator to Treat Dyspnea for the Patients With Tracheal Stenosis: A Randomized, Double-blind and Single-center Clinical Study|A Clinical Trial on Effectiveness and Safety of Inhaling Hydrogen-oxygen to Decreases Inspiratory Effort for the Patients With Tracheal Stenosis: A Randomized, Double-blind and Single-center Clinical Study|Recruiting||N/A|50|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||f||||||||||2017-10-10 21:37:04.842345|2017-10-10 21:37:04.842345
NCT02961374|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-10|2017-09-26|||October 13, 2017|Anticipated|2017-10-13|September 2017|2017-09-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer|Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis|Not yet recruiting||Phase 2|70|Anticipated|National Cancer Institute (NCI)||1|||f||||t|t|f||||||||2017-10-10 21:37:04.949544|2017-10-10 21:37:04.949544
NCT02961361|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-22|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block|the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block|Enrolling by invitation||Phase 4|60|Anticipated|The First Hospital of Qinhuangdao||2|||f||||t||||||||Undecided||2017-10-10 21:37:05.110921|2017-10-10 21:37:05.110921
NCT02961348|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-02-20|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|May 2019|Anticipated|2019-05-01||Interventional|||TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation|Timing of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation: a Prospective Multicenter Registry-based Non-inferiority Randomized Controlled Clinical Trial|Recruiting||N/A|3000|Anticipated|Uppsala University||2|||f||||t|f|f||||||No||2017-10-10 21:37:05.213949|2017-10-10 21:37:05.213949
NCT02961335|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-08|||January 2017||2017-01-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|Microsemio-PI||Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases|Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases : A Multicentric Prospective Study|Not yet recruiting||N/A|240|Anticipated|University Hospital, Rouen||1|||f||||f||||||||No||2017-10-10 21:37:05.319068|2017-10-10 21:37:05.319068
NCT02961322|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-08|||January 2017||2017-01-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|LIRA||Medico-economic Study of the Lobo-isthmectomy Assisted Robot|Medico-economic Study of the Lobo-isthmectomy Assisted Robot|Not yet recruiting||N/A|25|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:37:05.411715|2017-10-10 21:37:05.411715
NCT02961309|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-08-23|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MJCIG||A Laboratory Model of Increasing Delta-9-tetrahydrocannabinol (THC) Potency on Cigarette Smoking|A Laboratory Model of Increasing THC Potency on Cigarette Smoking|Not yet recruiting||Phase 1|7|Anticipated|Battelle Memorial Institute||2|||f||||f|t|f||||||||2017-10-10 21:37:05.471101|2017-10-10 21:37:05.471101
NCT02961296|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-08|||October 2016||2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|||Helicobacter Pylori Antibiotic Susceptibility Testing of Korea|Helicobacter Pylori Antibiotic Susceptibility Testing of Korea|Not yet recruiting||N/A|400|Anticipated|Asan Medical Center|||1||f||||f||||||Samples Without DNA|"     Mucosa on the antrum and body of the stomach.   "|No||2017-10-10 21:37:05.550573|2017-10-10 21:37:05.550573
NCT02961283|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-13|||October 2016||2016-10-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of ASN003 in Subjects With Advanced Solid Tumors|A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|100|Anticipated|Asana BioSciences||4|||f||||f||||||||No||2017-10-10 21:37:05.636318|2017-10-10 21:37:05.636318
NCT02961270|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation|Clinical Activity of Icotinib in Patients With Advanced Non-small-cell Lung Cancer Harbouring Uncommon EGFR Mutations: a Single-arm, Prospective, Phase 2 Study|Recruiting||Phase 2|30|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 21:37:05.754156|2017-10-10 21:37:05.754156
NCT02961257|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-05-30|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|CABASTY||Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel|Randomized Multicenter, Phase III Trial Evaluating the Safety of 2 Schedules of Cabazitaxel (Bi-weekly Versus Tri-weekly) Plus Prednisone in Elderly Men (≥ 70 Years) With mCRPC Previously Treated With a Docetaxel-containing Regimen|Recruiting||Phase 3|170|Anticipated|Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie||2|||f||||f|f|f||||||No||2017-10-10 21:37:05.836605|2017-10-10 21:37:05.836605
NCT02961244|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-05-14|2017-01-06||June 2013||2013-06-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Standard Normothermia Protocol On Surgical Site Infections|Effect of Standard Normothermia Protocol On Surgical Site Infections: Randomized Controlled Trial|Completed||N/A|118|Actual|Dokuz Eylul University|Surgical etiologies were various.It was a single-centered trial whose power was 80%.The room temperatures could not be kept constant.The number of samples were not enough to make variate analysis of SSI and hypothermia risk factors.|2|||f||||t||||||||Yes||2017-10-10 21:37:06.020273|2017-10-10 21:37:06.020273
NCT02961231|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||Evaluation of PCV Schedules in a Naive Population in Vietnam|Evaluation of PCV Schedules in a Naive Population in Vietnam|Not yet recruiting||Phase 4|32400|Anticipated|Nagasaki University||4|||f||||t||||||||Undecided||2017-10-10 21:37:07.390433|2017-10-10 21:37:07.390433
NCT02961205|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NutriSuP CVS||Nutrition Supplementation in Cardiovascular Surgery Patients|Nutrition Supplementation in Cardiovascular Surgery Patients-A Randomized Controlled Pilot Trial|Not yet recruiting||Phase 2|60|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 21:37:07.594033|2017-10-10 21:37:07.594033
NCT02961179|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-02-27|||January 2017|Actual|2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRODIGE||Dairy Products, Diabetes and Genetics|Nutrigenomics Approach to Investigate the Benefits of Dairy Product Consumption on Glucose Homeostasis|Recruiting||N/A|33|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f||||||||No||2017-10-10 21:37:07.783021|2017-10-10 21:37:07.783021
NCT02961166|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-11-08|||January 2012||2012-01-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Observational|IVIG||IgM Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Syndrom (ARDS) Patients|Intravenous Immunoglobulin Therapy in ARDS Patients With Extracorporeal Membrane Oxygenation (ECMO) Therapy|Completed||N/A|57|Actual|University Hospital Tuebingen|||2||f||||f||||||||Undecided||2017-10-10 21:37:07.886585|2017-10-10 21:37:07.886585
NCT02961153|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-09|||August 2016||2016-08-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Mortality in Pediatric Intensive Care Unit|Epidemiology of Death in the PICU of Southeast China|Enrolling by invitation||N/A|10000|Anticipated|Children's Hospital of Fudan University|||1||f||||t||||||||No||2017-10-10 21:37:07.972072|2017-10-10 21:37:07.972072
NCT02961140|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Different Anesthetic Managements of Esophageal Resection and Reconstruction|The Effects of Different Anesthetic Managements on Inflammation, Oxidative Injuries, and Major Organ Complications: a Prospective Investigations on Esophageal Reconstruction and Intraoperative Shock|Not yet recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 21:37:08.030856|2017-10-10 21:37:08.030856
NCT02961127|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|||Association Study to Evaluate TFPI Gene in CAD in Han Chinese|Association Study to Evaluate TFPI Gene in CAD in Han Chinese|Not yet recruiting||N/A|2000|Anticipated|Chinese PLA General Hospital|||2||f||||t||||||Samples With DNA|"     Venous blood was collected by standard vein puncture in fasting condition. Four     single-nucleotide polymorphisms (SNPs) (rs7586970, rs6434222, rs10153820 and rs8176528) were     detected with polymerase chain reaction-direct sequencing method. And the genotypes of these     SNPs were determined in both CAD patients and non-CAD controls.   "|No||2017-10-10 21:37:08.228071|2017-10-10 21:37:08.228071
NCT02961114|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-08-23|||November 2016||2016-11-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|SVF-BPN||Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy|Use of Autologous Adipose-Derived Stem/Stromal Cells In Symptomatic Benign Prostate Hypertrophy|Recruiting||Phase 1/Phase 2|200|Anticipated|Healeon Medical Inc||3|||f||||t||||||||||2017-10-10 21:37:08.308199|2017-10-10 21:37:08.308199
NCT02961101|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-10|||May 2016||2016-05-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Anti-PD-1 Antibody in Combination With Low-dose Decitabine in Relapsed or Refractory Malignancies|Anti-PD-1 Antibody in Combination With Low-dose Decitabine in Relapsed or Refractory Malignancies: an Open-label Phase I/II Trial|Recruiting||Phase 1/Phase 2|100|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 21:37:08.428753|2017-10-10 21:37:08.428753
NCT02961088|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-16|||August 2016||2016-08-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|||Meta-analyses of Pasta as Part of Low Glycemic Index Diets and Adiposity|Effect of Pasta as Part of Low Glycemic Index Diets on Body Weight and Markers of Adiposity in Humans: A Series of Systematic Reviews and Meta-analyses to Provide Evidence-based Guidance for Nutrition Guidelines Development|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||No|All data will be included in the meta-analyses and available online as supplemental material|2017-10-10 21:37:08.55172|2017-10-10 21:37:08.55172
NCT02961075|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-01-23|||May 2016||2016-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Impact of Local Anesthesia on Postbronchoscopy Fever: a Randomised Controlled Study|Impact of Local Anesthesia on Postbronchoscopy Fever: a Randomised Controlled Study|Completed||N/A|160|Actual|The Second Affiliated Hospital of Dalian Medical University||2|||f||||t||||||||||2017-10-10 21:37:08.648301|2017-10-10 21:37:08.648301
NCT02961049|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Influences of Gingival Cord Retractor in Retention Rate of Non-carious Cervical Lesions Restorations.|Influences of Gingival Cord Retractor in Retention Rate of Non-carious Cervical Lesions Restorations With Different Adhesive Systems. Randomized Clinical Trials.|Recruiting||N/A|55|Anticipated|Federal University of Uberlandia||4|||f||||f||||||||No||2017-10-10 21:37:08.849443|2017-10-10 21:37:08.849443
NCT02961036|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2017-03-23|||November 2016||2016-11-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Interventional|SupMatQT||The Role of Supplementary Material in Journal Articles QT|The Role of Supplementary Material in Journal Articles Surveys of Authors, Reviewers and Readers Questionnaire Trial|Enrolling by invitation||N/A|20000|Anticipated|ThinkWell||7|||f||||f||||||||No|Data will be shared in aggregated form upon request in order to comply with data protection policies|2017-10-10 21:37:08.972142|2017-10-10 21:37:08.972142
NCT02961023|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-22|||February 2016||2016-02-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Adding Exercise Training to Optimal Therapy in PAH|The Effect of Adding Exercise Training to Optimal Therapy in Pulmonary Arterial Hypertension|Recruiting||N/A|30|Anticipated|National Health Service, United Kingdom||2|||f||||t||||||||No||2017-10-10 21:37:09.113525|2017-10-10 21:37:09.113525
NCT02961010|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-08-04|||June 2015||2015-06-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluating the Effectiveness of Keeping Safe - a School Based Intervention Aimed at Preventing Abuse|A Cluster Randomised Controlled Trial of Keeping Safe: Investigating the Effectiveness of a Whole School Preventative Education Programme in Improving Children's Knowledge and Understanding to Keep Safe in Situations of Abuse|Active, not recruiting||N/A|6300|Actual|National Society for the Prevention of Cruelty to Children||2|||f||||f||||||||||2017-10-10 21:37:09.227907|2017-10-10 21:37:09.227907
NCT02960997|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-08-29|||May 2016||2016-05-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study|A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)|Recruiting||Phase 2|8|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 21:37:09.36543|2017-10-10 21:37:09.36543
NCT02960984|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis|Effects of Neurorehabilitation on Upper Limb Performance and on Fatigue in People With Multiple Sclerosis|Not yet recruiting||N/A|20|Anticipated|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||Undecided||2017-10-10 21:37:09.487565|2017-10-10 21:37:09.487565
NCT02960971|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-05-30|||January 2, 2017|Actual|2017-01-02|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Neuropathic Pain After Lung Surgery|DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Lung Surgery|Recruiting||N/A|275|Anticipated|Danish Pain Research Center|||1||f||||t||||||Samples With DNA|"     Blood   "|Undecided||2017-10-10 21:37:09.572921|2017-10-10 21:37:09.572921
NCT02960958|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-01-16|||December 2016||2016-12-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01|1 Year|Observational [Patient Registry]|||Metabolome Analysis in Patients With Rheumatoid Arthritis|Metabolome Analysis in Patients With Rheumatoid Arthritis|Enrolling by invitation||N/A|200|Anticipated|The Catholic University of Korea|||1||f||||t||||||Samples Without DNA|"     Urine   "|No||2017-10-10 21:37:09.69141|2017-10-10 21:37:09.69141
NCT02960945|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-03-27|||November 2016||2016-11-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Open-Label Crossover Study Comparing CTP-543 to Jakafi®|An Open-Label Single-Dose Crossover Pharmacokinetic Study to Compare CTP-543 to Jakafi® in Healthy Volunteers|Completed||Phase 1|12|Actual|Concert Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 21:37:09.764786|2017-10-10 21:37:09.764786
NCT02960932|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-09-13|||February 21, 2017|Actual|2017-02-21|March 2017|2017-03-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Interventional|ELASTOREPRO||Reproducibility Inter-session of the Measurement Elastography of the Passive Stiffness of Medial Beams of Gastrocnemius Muscle of the Hemiplegic Cerebral Child.|Reproducibility Inter-session of the Measurement Elastography of the Passive Stiffness of Medial Beams of Gastrocnemius Muscle of the Hemiplegic Cerebral Child.|Completed||N/A|13|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 21:37:09.857205|2017-10-10 21:37:09.857205
NCT02960919|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-08|||October 2016||2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Innovative Treatments in Pneumonia (ITIP) 3|Prospective, Observational Study of Clinical Outcomes Among Children 2 to 59 Months of Age With Childhood Pneumonia and Other Co-morbidities in Lilongwe, Malawi Who Have Been Excluded From Pneumonia Clinical Trials|Recruiting||N/A|1000|Anticipated|Save the Children|||1||f||||f||||||||||2017-10-10 21:37:09.951406|2017-10-10 21:37:09.951406
NCT02960906|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-07-25|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|BIONIKK||A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer|A Phase 2 BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer|Recruiting||Phase 2|150|Anticipated|Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie||8|||f||||t|f|f||||||||2017-10-10 21:37:10.069345|2017-10-10 21:37:10.069345
NCT02960893|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-08-22|||December 2016||2016-12-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 18, 2017|Actual|2017-08-18||Interventional|||Trial in Adult Subjects With Spinocerebellar Ataxia|A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects With Spinocerebellar Ataxia|Active, not recruiting||Phase 2/Phase 3|120|Anticipated|Biohaven Pharmaceutical Holding Company Ltd.||2|||f||||f||||||||||2017-10-10 21:37:10.263412|2017-10-10 21:37:10.263412
NCT02960880|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-03-06|||October 2016||2016-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists|Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists|Completed||N/A|99999|Actual|Bayer|||2||f||||f||||||||||2017-10-10 21:37:10.393858|2017-10-10 21:37:10.393858
NCT02960867|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-08|||April 2016||2016-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01|3 Years|Observational [Patient Registry]|EurAKID||European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI)|European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI)|Recruiting||N/A|1892|Anticipated|Bambino Gesù Hospital and Research Institute|||1||f||||f||||||||No||2017-10-10 21:37:10.485074|2017-10-10 21:37:10.485074
NCT02960854|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-09-26|||December 7, 2016|Actual|2016-12-07|September 2017|2017-09-01|January 12, 2018|Anticipated|2018-01-12|January 11, 2018|Anticipated|2018-01-11||Interventional|||A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.|Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-936558 (Nivolumab) in Participants With Severe Sepsis or Septic Shock.|Recruiting||Phase 1|30|Anticipated|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 21:37:10.581748|2017-10-10 21:37:10.581748
NCT02960841|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2016-11-09|||January 2012||2012-01-01|November 2016|2016-11-01||||January 2016|Actual|2016-01-01||Interventional|IMLD||Effectiveness of Intracavitary Manual Lymphatic Drainage|Effectiveness of Intracavitary Manual Lymphatic Drainage Versus Conventional Treatment in the Prevention of Perineal Trauma During Labor.|Completed||Phase 4|49|Actual|Universidad Europea de Madrid||2|||f||||||||||||||2017-10-10 21:37:10.738507|2017-10-10 21:37:10.738507
NCT02960828|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-11-09|||January 2016||2016-01-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|SAVE||"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally Study"|Focal Subthreshold Laser Treatment for Macular Drusen|Recruiting||N/A|21|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||Undecided|undecided|2017-10-10 21:37:10.802607|2017-10-10 21:37:10.802607
NCT02960802|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-14|||January 2017||2017-01-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|Transkidney||Kidney Transplantation and Renal and Myocardial Perfusion|Kidney Transplantation and Renal and Myocardial Perfusion|Not yet recruiting||N/A|60|Anticipated|Turku University Hospital||2|||f||||t||||||||Yes|Data is obtained via imaging (PET). The data includes perfusion values of kidneys and heart. The data will be available in the end of study period, 12/2022.|2017-10-10 21:37:10.985867|2017-10-10 21:37:10.985867
NCT02960789|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-01-30|||November 2016||2016-11-01|January 2017|2017-01-01||||September 2017|Anticipated|2017-09-01||Interventional|||Hydration Status Evaluation of Dehydrated Children With Experimental Devices|Hydration Status Evaluation on Admittance and During Rehydration of Dehydrated Children at Boston Children's Hospital, With Exploratory Hydration Assessment Devices|Enrolling by invitation||N/A|120|Anticipated|Massachusetts Institute of Technology||1|||f||||||||||||||2017-10-10 21:37:11.07678|2017-10-10 21:37:11.07678
NCT02960776|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Impact of Sleep Restriction on Performance in Adults|Effect of Long Term Sleep Restriction on Energy Balance|Recruiting||N/A|66|Anticipated|Columbia University||2|||f||||f||||||||Yes|De-identified data will be provided on request after discussion among parties.|2017-10-10 21:37:11.173729|2017-10-10 21:37:11.173729
NCT02960763|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-08-04|||February 24, 2017|Actual|2017-02-24|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|OPTIMUM||Optimizing Outcomes of Treatment-Resistant Depression in Older Adults|Optimizing Outcomes of Treatment-Resistant Depression in Older Adults|Recruiting||Phase 4|1500|Anticipated|Washington University School of Medicine||5|||f||||t|t|f|||f|||||2017-10-10 21:37:11.272553|2017-10-10 21:37:11.272553
NCT02960750|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-07|||September 2010||2010-09-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|W@WS||"Effectiveness of a Workplace Sit Less and Move More Web-based Program in Spanish Office Employees (Walk@WorkSpain)"|"Effectiveness of a Workplace Sit Less and Move More Web-based Program (Walk@WorkSpain) on Occupational Sedentary Behavior, Habitual Physical Activity, Physical Risk Factors for Chronic Disease and Efficiency-related Outcomes in Spanish Office Employees"|Completed||N/A|264|Actual|University of Vic - Central University of Catalonia||2|||f||||f||||||||||2017-10-10 21:37:11.417696|2017-10-10 21:37:11.417696
NCT02960737|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-05-23|||October 2017|Anticipated|2017-10-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|DESIRE||Dysphagia Evaluation After Stroke- Incidence and Effect of Oral Screen Intervention on Swallowing Dysfunction|Dysphagia Evaluation After Stroke - an Incidence and Randomized Controlled Study of Oral Screen Intervention on Swallowing Dysfunction|Not yet recruiting||N/A|60|Anticipated|Umeå University||2|||f||||f|f|f||||||No||2017-10-10 21:37:11.627004|2017-10-10 21:37:11.627004
NCT02960724|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer|Phase II Trial: uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer|Recruiting||Phase 2|90|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||No||2017-10-10 21:37:11.70999|2017-10-10 21:37:11.70999
NCT02960711|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-11-07|||February 2014||2014-02-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MeMeMe||Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome|Randomized Controlled Trial of Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome|Recruiting||Phase 3|2000|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||4|||f||||f||||||||No||2017-10-10 21:37:11.799691|2017-10-10 21:37:11.799691
NCT02960698|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-09|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|COGIT||Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging Study|"Identifying the Neural Correlates of Cognitive Impulsivity in Patients With Tourette Syndrome. COGIT."|Recruiting||N/A|120|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||f||||||||No||2017-10-10 21:37:11.883371|2017-10-10 21:37:11.883371
NCT02960685|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-09|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2016|Actual|2016-11-01|1 Month|Observational [Patient Registry]|||Telesonography for Visually Estimating Ejection Fraction|Can Offsite Expert Accurately Estimate the Ejection Fraction by Watching and Instructing the Onsite Novice Sonographer's Practice Via the Social Network System?|Recruiting||N/A|60|Anticipated|Hanyang University|||1||f||||||||||||||2017-10-10 21:37:11.972109|2017-10-10 21:37:11.972109
NCT02960672|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-07|||March 2013||2013-03-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2016|Actual|2016-10-01||Observational|||Sequential Changes of Serum KL-6 Predict Progression in Interstitial Lung Disease|Sequential Changes of Serum KL-6 Predict Progression in Interstitial Lung Disease|Active, not recruiting||N/A|70|Actual|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||f||||||Samples Without DNA|"     blood biomarkers   "|No||2017-10-10 21:37:12.052547|2017-10-10 21:37:12.052547
NCT02960659|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-09|2017-10-05|||November 7, 2016||2016-11-07|June 23, 2017|2017-06-23|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes|Therapeutic Targets in African-American Youth With Type 2 Diabetes|Recruiting||Phase 1|32|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f|||||t|f||||||||2017-10-10 21:37:12.122902|2017-10-10 21:37:12.122902
NCT02960646|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-09-19|||January 18, 2017|Actual|2017-01-18|September 2017|2017-09-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Clinical Trial Using an Engineered Peripheral Blood Graft for Haploidentical Transplantation|Phase I Clinical Trial Using an Engineered Peripheral Blood Graft for Haploidentical Transplantation|Recruiting||Phase 1|12|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:37:12.199761|2017-10-10 21:37:12.199761
NCT02960633|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2021|Anticipated|2021-11-01||Interventional|||Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Corail Prosthesis With or Without Collar Design|Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Corail Prosthesis With or Without Collar Design|Not yet recruiting||N/A|150|Anticipated|ZOL||2|||f||||||||||||||2017-10-10 21:37:12.313426|2017-10-10 21:37:12.313426
NCT02960620|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-09-22||||||September 2017|2017-09-01||||||||Expanded Access|||Therasphere for Unresectable Primary or Secondary Liver Neoplasia|A Humanitarian Device Exemption (HDE) Treatment Protocol of TheraSphere® For Treatment of Unresectable Primary or Secondary Liver Neoplasia - HDE #980006|Available||N/A|||H. Lee Moffitt Cancer Center and Research Institute|||||f||||||||||||||2017-10-10 21:37:12.366382|2017-10-10 21:37:12.366382
NCT02960607|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC|A Phase II Study of High-dose Icotinib in Previously Treated Non-small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutation|Recruiting||Phase 2|25|Anticipated|Chinese Academy of Medical Sciences||1|||f||||||||||||||2017-10-10 21:37:12.519994|2017-10-10 21:37:12.519994
NCT02960594|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-09-11|||December 2014||2014-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRT-001||hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse|A Study of hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Post Definitive Surgery and Standard Therapy|Recruiting||Phase 1|54|Anticipated|Inovio Pharmaceuticals||6|||f||||f||||||||||2017-10-10 21:37:12.605121|2017-10-10 21:37:12.605121
NCT02960581|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-03-06|||November 2016||2016-11-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Clinical Trial of the Safety, Pharmacokinetics and Antiviral Activity of PGT121 Monoclonal Antibody (mAb) in HIV-uninfected and HIV-infected Adults|A Phase 1 Randomized Placebo-controlled Clinical Trial of the Safety, Pharmacokinetics and Antiviral Activity of PGT121 Monoclonal Antibody (mAb) in HIV-uninfected and HIV-infected Adults|Enrolling by invitation||Phase 1|63|Anticipated|International AIDS Vaccine Initiative||12|||f||||||||||||||2017-10-10 21:37:12.801562|2017-10-10 21:37:12.801562
NCT02960568|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-08|||January 2016||2016-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Genetic Variability in CYP2D6 in U.S Active Duty Population|Genetic Variability in the Cytochrome P-450 Isoenzyme 2D6 (CYP2D6) in an Active Duty U.S. Military Population and the Impact of CYP2D6 Phenotype on Primaquine Metabolism.|Recruiting||Phase 1|550|Anticipated|Walter Reed Army Institute of Research (WRAIR)||2|||f||||f||||||||||2017-10-10 21:37:12.944999|2017-10-10 21:37:12.944999
NCT02960555|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-10-02|||February 8, 2017|Actual|2017-02-08|October 2017|2017-10-01|February 1, 2022|Anticipated|2022-02-01|February 1, 2022|Anticipated|2022-02-01||Interventional|||Trial of Isatuximab (SAR650984) in Patients With High Risk Smoldering Multiple Myeloma|Phase II Single Arm Trial of Isatuximab (SAR650984) in Patients With High Risk Smoldering Multiple Myeloma|Recruiting||Phase 2|61|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:37:13.063593|2017-10-10 21:37:13.063593
NCT02960542|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-07-31|||June 26, 2017|Actual|2017-06-26|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|HELP PC||HELP Prevent Cancer Pilot Study|Healthy Living Partnerships to Prevent Cancer (HELP PC) Pilot Study|Active, not recruiting||N/A|20|Anticipated|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-10 21:37:13.19935|2017-10-10 21:37:13.19935
NCT02960529|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-07|||August 2016||2016-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||A Comparative Study on Trans-umbilical Single-port Laparoscopic Extra-peritoneal Approach Versus Conventional Repair for Inguinal Hernia in Children||Recruiting||Phase 2|300|Anticipated|Zunyi Medical College|||2||f||||t||||||||||2017-10-10 21:37:13.300373|2017-10-10 21:37:13.300373
NCT02959762|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-28|||October 2016||2016-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)|Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk|Recruiting||Phase 1/Phase 2|60|Anticipated|Augusta University||3|||f||||t||||||||||2017-10-10 21:37:22.661824|2017-10-10 21:37:22.661824
NCT02960516|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-05-16|||October 2016||2016-10-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|October 2020|Anticipated|2020-10-01||Observational|||MRI Diffusion Tensor Tractography to Track and Monitor Peripheral Nerve Recovery After Severe Crush or Cut/Repair Nerve Injury|MRI Diffusion Tensor Tractography to Track and Monitor Peripheral Nerve Recovery After Severe Crush or Cut/Repair Nerve Injury|Recruiting||N/A|24|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||||Undecided||2017-10-10 21:37:13.404583|2017-10-10 21:37:13.404583
NCT02960503|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-07|||September 2016||2016-09-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease|Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease: a Feasibility Trial|Recruiting||Phase 1/Phase 2|40|Anticipated|Vanderbilt University||2|||f||||t||||||||Yes||2017-10-10 21:37:13.511857|2017-10-10 21:37:13.511857
NCT02960490|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-08-01|||November 26, 2016|Actual|2016-11-26|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics|A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics|Recruiting||Phase 2|60|Anticipated|Eisai Inc.||4|||f||||f||||||||||2017-10-10 21:37:13.650866|2017-10-10 21:37:13.650866
NCT02960477|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-11|||January 2018|Anticipated|2018-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Effectiveness of Pain Neuroscience Education vs Biomedical Education for Patients Undergoing Surgery for Shoulder Pain|Effectiveness of Pain Neuroscience Education vs Biomedical Education for Patients Undergoing Surgery for Shoulder Pain: Protocol for a Randomized Controlled Trial|Not yet recruiting||N/A|84|Anticipated|University of Malaga||2|||f||||t|f|f||||||||2017-10-10 21:37:13.876281|2017-10-10 21:37:13.876281
NCT02960464|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-11-09|||October 2016||2016-10-01|November 2016|2016-11-01||||June 2018|Anticipated|2018-06-01||Interventional|||tDCS for Treatment of Depression in Parkinson's Disease|Transcranial Direct Current Stimulation for Treatment of Depression in Parkinson's Disease, a Randomized Placebo-controlled Clinical Trial|Recruiting||N/A|50|Anticipated|Hospital Santa Marcelina||2|||f||||f||||||||No||2017-10-10 21:37:13.97087|2017-10-10 21:37:13.97087
NCT02960451|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||January 2015||2015-01-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||PRIME vs Usual Care for Clinical High Risk|Randomized Trial of Usual Care vs. Specialized, Phase-specific Care for Youth at Risk for Psychosis|Recruiting||N/A|128|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-10 21:37:14.097263|2017-10-10 21:37:14.097263
NCT02960438|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-08-01|||November 2, 2016|Actual|2016-11-02|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|March 2018|Anticipated|2018-03-01||Interventional|||A Dose Response Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Methotrexate|A Dose Response Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Methotrexate|Recruiting||Phase 2|175|Anticipated|Eisai Inc.||4|||f||||||||||||||2017-10-10 21:37:14.212469|2017-10-10 21:37:14.212469
NCT02960425|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-12-27|||October 2016||2016-10-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Delivra Topical Creatine for Improving Muscular Power|Randomized, Double-blind, Placebo-controlled, Short Term Trial of DelivraTM Livsport Preworkout Cream for Improved Power Output and Reduction of Muscle Fatigue During Resistant Training|Recruiting||Phase 3|132|Anticipated|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 21:37:14.498412|2017-10-10 21:37:14.498412
NCT02960412|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Interventional|||Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy|Randomized Controlled Trial Evaluating Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy|Not yet recruiting||Phase 4|144|Anticipated|University of South Florida||2|||f||||t|t|f|||t|||No||2017-10-10 21:37:14.593636|2017-10-10 21:37:14.593636
NCT02960399|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-11-07|||December 2015||2015-12-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older|Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older|Recruiting||N/A|50|Anticipated|University of South Florida||2|||f||||f||||||||Undecided||2017-10-10 21:37:14.685958|2017-10-10 21:37:14.685958
NCT02960386|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-02-27|||January 2016||2016-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|iTrackFitnes||An Engagement Engine for Fitness Trackers|Evaluating an Engagement Engine to Support Long Term Use of Fitness Trackers and Sustain Physical Activity|Recruiting||N/A|138|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:37:14.891396|2017-10-10 21:37:14.891396
NCT02960373|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Dried Fruit and Postprandial Glycemia Trial|Dried Fruit as a Means for Lowering the Glycemic Response to High Glycemic Index-carbohydrate Foods|Not yet recruiting||N/A|10|Anticipated|University of Toronto||4|||f||||f||||||||Undecided||2017-10-10 21:37:14.984101|2017-10-10 21:37:14.984101
NCT02960347|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-07|||February 2016||2016-02-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures|Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures|Completed||Phase 2/Phase 3|1|Actual|Herzog Hospital||1|||f||||f||||||||No||2017-10-10 21:37:15.127908|2017-10-10 21:37:15.127908
NCT02960334|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-08-30|||November 2016||2016-11-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Observational|||Screening for Actionable Atrial Fibrillation During Preoperative Consultation With the MyDiagnostick|Screening for Actionable Atrial Fibrillation During Preoperative Consultation With the MyDiagnostick|Completed||N/A|505|Actual|Martini Hospital Groningen|||1||f||||f||||||||||2017-10-10 21:37:15.195578|2017-10-10 21:37:15.195578
NCT02960321|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-01-04|||June 2016||2016-06-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|TRIP-CZ||Troponin Release Induced by Procedure - Czech|Myocardial Injury Related to Coronary Angiography in the Era of High-sensitivity Cardiac Troponin I|Completed||N/A|220|Actual|Tomas Bata Hospital, Czech Republic|||2||f||||f||||||||No||2017-10-10 21:37:15.251675|2017-10-10 21:37:15.251675
NCT02960308|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-07|||October 2016||2016-10-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors|A Pilot Study of Whole-Neck CT Perfusion With the Toshiba Aquilion ONE ViSION-320 Detector Row CT Scanner for Use in Head &Amp; Neck Tumor Patients|Recruiting||N/A|50|Anticipated|University of Southern California||1|||f||||t||||||||No||2017-10-10 21:37:15.307042|2017-10-10 21:37:15.307042
NCT02960295|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-11-07|||September 2014||2014-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Virtual Visit for Women With Gestational Diabetes|The Virtual Visit for Women With Gestational Diabetes|Completed||N/A|10|Actual|Kaiser Permanente||1|||f||||f||||||||No||2017-10-10 21:37:15.377749|2017-10-10 21:37:15.377749
NCT02960282|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-07|||October 2016||2016-10-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy|The Role of Microbiome in Cancer Therapy|Recruiting||N/A|80|Anticipated|University of Southern California|||1||f||||t||||||Samples With DNA|"     Feces   "|||2017-10-10 21:37:15.467402|2017-10-10 21:37:15.467402
NCT02960269|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-01|||November 2016||2016-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||Interprofessional Management of Chronic Back Pain in Rural and Remote Setting: Use of Telehealth vs. Secure Laptop-based Videoconferencing||Active, not recruiting||N/A|12|Anticipated|University of Saskatchewan||1|||f||||||||||||||2017-10-10 21:37:15.553045|2017-10-10 21:37:15.553045
NCT02960256|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-09|||December 2016||2016-12-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Observational|||The Impact of Infectious Disease on QT Segment|The Impact of Infectious Disease on QT Segment|Not yet recruiting||N/A|200|Anticipated|HaEmek Medical Center, Israel|||1||f||||t||||||||No||2017-10-10 21:37:15.632914|2017-10-10 21:37:15.632914
NCT02960243|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-07|||August 2016||2016-08-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|EVT||Deep Brain Stimulation for Voice Tremor: Left, Right, or Both Hemispheres?|Left, Right, or Bilateral Thalamic Deep Brain Stimulation for Voice Tremor: A Prospective, Randomized, Double-Blinded Trial|Recruiting||Phase 1/Phase 2|10|Anticipated|University of British Columbia||4|||f||||f||||||||||2017-10-10 21:37:15.695506|2017-10-10 21:37:15.695506
NCT02960230|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-29|||November 2016||2016-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||H3.3K27M Peptide Vaccine for Children With Newly Diagnosed DIPG and Other Gliomas|H3.3K27M Specific Peptide Vaccine Combined With Poly-ICLC for the Treatment of Newly Diagnosed HLA-A2+ H3.3K27M Positive Diffuse Intrinsic Pontine Glioma (DIPG) as Well as Other Newly Diagnosed HLA-A2+ H3.3K27M Positive Gliomas|Recruiting||Phase 1|29|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||||2017-10-10 21:37:15.804635|2017-10-10 21:37:15.804635
NCT02960204|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-05-17|||October 17, 2016|Actual|2016-10-17|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|ENCORE-PH||Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension|Recruiting||Phase 2|240|Anticipated|Conatus Pharmaceuticals Inc.||4|||f||||t||||||||No|There is no plan to share this data with outside researchers|2017-10-10 21:37:16.077983|2017-10-10 21:37:16.077983
NCT02960191|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-11-07|||December 2008||2008-12-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Functional Neuroimaging and Genetic Vulnerability to Suicidal Behavior||Terminated||N/A|95|Actual|University Hospital, Montpellier||3||recruitment difficult|f||||f||||||||||2017-10-10 21:37:16.235888|2017-10-10 21:37:16.235888
NCT02960178|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-05-09|||January 2017||2017-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Reactive Stepping Training in Individuals With Spinal Cord Injury|Assessment and Training of Reactive Stepping in Individuals With Spinal Cord Injury|Recruiting||N/A|24|Anticipated|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 21:37:16.314664|2017-10-10 21:37:16.314664
NCT02960165|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-10|||March 2016||2016-03-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Real and Virtual Tasks in Older Adults|Functional Performance Comparison Between Real and Virtual Tasks in Older Adults|Completed||N/A|65|Actual|University of Sao Paulo||4|||f||||f||||||||No||2017-10-10 21:37:16.405344|2017-10-10 21:37:16.405344
NCT02960152|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-05-01|||October 2014||2014-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Observational|PERIOED||Periodontal Impact of Eating Disorders (the PERIOED Study)|Periodontal Impact of Eating Disorders (the PERIOED Study)|Recruiting||N/A|90|Anticipated|University Paris 7 - Denis Diderot|||3||f||||f||||||||Yes|IPD will be available on request.|2017-10-10 21:37:18.188831|2017-10-10 21:37:18.188831
NCT02960139|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-23|||January 2017||2017-01-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys® Surgical Sealant|A Pivotal, Prospective, Randomized, Controlled, Multicenter Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys® Surgical Sealant|Not yet recruiting||N/A|754|Anticipated|Cohera Medical, Inc.||2|||f||||||||||||||2017-10-10 21:37:18.282951|2017-10-10 21:37:18.282951
NCT02960126|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|CESAC-AF||Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk|Comparison of Efficacy and Safety Between Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk|Not yet recruiting||Phase 3|1500|Anticipated|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||No||2017-10-10 21:37:18.352722|2017-10-10 21:37:18.352722
NCT02960113|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-08-28|||May 2016||2016-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section|Is the Application of Scopolamine Patch With or Without Intra-operative Acupressure Point P6 Stimulation More Effective Than Intra-operative Acupressure Point P6 Stimulation Alone?|Recruiting||Phase 4|240|Anticipated|Rutgers, The State University of New Jersey||3|||f||||f||||||||||2017-10-10 21:37:18.434108|2017-10-10 21:37:18.434108
NCT02960100|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-07|||October 2016||2016-10-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||mHealth Intervention in Increasing HPV Vaccinations in College Students|S.M.A.R.T. (Students Motivating and Acting in Real-Time) eStudy|Recruiting||N/A|100|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-10 21:37:18.55684|2017-10-10 21:37:18.55684
NCT02960087|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-08-14|||November 4, 2016||2016-11-04|March 2017|2017-03-01|May 2024|Anticipated|2024-05-01|November 2023|Anticipated|2023-11-01||Interventional|||Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer|A Randomized Phase II Trial Evaluating Hight Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer|Recruiting||Phase 2|232|Anticipated|Canadian Cancer Trials Group||2|||f||||t|f|f||||||||2017-10-10 21:37:18.653862|2017-10-10 21:37:18.653862
NCT02960074|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-03-08|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluating the Safety and Efficacy of Fecal Microbiota Transplant in Peanut Allergic Patients|A Phase I Open Label Trial to Evaluate the Safety and Efficacy of Fecal Microbiota Transplantation in Peanut Allergic Patients|Recruiting||Phase 1|10|Anticipated|Boston Children’s Hospital||1|||f||||t|t|f||||||Undecided||2017-10-10 21:37:18.750283|2017-10-10 21:37:18.750283
NCT02960061|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-08|||November 2016||2016-11-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|HIPEC||Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer|D2 Radical Resection After Neoadjuvant Chemotherapy Combined With HIPEC for Advanced Gastric Cancer: a Prospective Randomized Controlled Trial|Not yet recruiting||Phase 3|640|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:37:18.845351|2017-10-10 21:37:18.845351
NCT02960048|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Clinical Evaluation of Stabilizing Splint (Michigan-type Occlusal Splint) Versus Anterior Repositioning Splint .|Clinical Evaluation of Stabilizing Splint (Michigan-type Occlusal Splint) Versus Anterior Repositioning Splint in Patients With Temporomandibular Joint Anterior Disc Displacement With Reduction . ( Randomized Controlled Clinical Study)|Not yet recruiting||N/A|60|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:37:18.957242|2017-10-10 21:37:18.957242
NCT02960035|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-11-07|||April 2014||2014-04-01|November 2016|2016-11-01||||September 2016|Actual|2016-09-01||Interventional|||A Study of the Use of the Madrid Ultrasound Scoring System in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis|A Prospective Study of the Use of the Madrid Ultrasound Scoring System in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis|Completed||Phase 4|96|Actual|Sun Yat-sen University||3|||f||||t||||||||Yes|The data will be published on the Journals.|2017-10-10 21:37:19.177434|2017-10-10 21:37:19.177434
NCT02960009|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-15|||June 20, 2016|Actual|2016-06-20|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Motor Excitability Study of High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Chronic Stroke|Motor Excitability Study of High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Chronic Stroke|Recruiting||N/A|30|Anticipated|Chinese University of Hong Kong||3|||f||||f|f|f||||||||2017-10-10 21:37:19.516635|2017-10-10 21:37:19.516635
NCT02959996|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-09-27|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|September 25, 2017|Actual|2017-09-25||Interventional|||Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain|Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain|Active, not recruiting||Phase 2/Phase 3|80|Actual|Massachusetts General Hospital||2|||f||||f|t|f||||||||2017-10-10 21:37:19.61035|2017-10-10 21:37:19.61035
NCT02959983|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-13|||October 25, 2016|Actual|2016-10-25|July 2017|2017-07-01|May 18, 2018|Anticipated|2018-05-18|May 18, 2018|Anticipated|2018-05-18||Interventional|||Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use|A Phase 4 Multicenter, Multinational, Prospective, Randomized, Placebo-Controlled, Double-Blinded Parallel Group Study to Assess Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) in Patients Who Report Inadequate Control of IBS-D Symptoms With Prior Loperamide Use (RELIEF)|Recruiting||Phase 4|340|Anticipated|Allergan||2|||f||||f|t|f||||||||2017-10-10 21:37:19.712634|2017-10-10 21:37:19.712634
NCT02959970|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-06|||October 31, 2016|Actual|2016-10-31|July 2017|2017-07-01|March 24, 2019|Anticipated|2019-03-24|March 24, 2019|Anticipated|2019-03-24||Interventional|||Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris|An Open-Label Phase 4 Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris|Recruiting||Phase 4|100|Anticipated|Allergan||1|||f||||f|t|f||||||||2017-10-10 21:37:19.981375|2017-10-10 21:37:19.981375
NCT02959957|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-11-07|||May 2016||2016-05-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections|A Randomized, Controlled, Multicentre Trial of Collateral Damage on the Intestinal Microbiota Inferred by Temocillin Versus Cefotaxime in Patients Receiving Empirical Treatment for Febrile Urinary Tract Infections|Recruiting||Phase 4|332|Anticipated|Public Health Agency of Sweden||2|||f||||f||||||||No||2017-10-10 21:37:20.177565|2017-10-10 21:37:20.177565
NCT02959944|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-01|||December 2016||2016-12-01|August 2017|2017-08-01||||March 2020|Anticipated|2020-03-01||Interventional|iNTEGRATE||Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD)|Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD) (iNTEGRATE)|Recruiting||Phase 3|186|Anticipated|Pharmacyclics LLC.||2|||f||||||||||||||2017-10-10 21:37:20.308833|2017-10-10 21:37:20.308833
NCT02959931|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-05-23|||June 2013|Actual|2013-06-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Postprandial Effects of a High Potassium Meal|Postprandial Physiological Effects of a High Potassium Meal in Patients With Hypertension|Completed||N/A|33|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||No||2017-10-10 21:37:20.576702|2017-10-10 21:37:20.576702
NCT02959918|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-10-03|||October 2016||2016-10-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid|An Open Label Phase II Multiple Dose Safety, Pharmacokinetic and Pharmacodynamics Study of SEL-212 Followed by Open Label Administration of SEL-037 in Subjects With Symptomatic Gout and Elevated Blood Uric Acid|Recruiting||Phase 2|36|Anticipated|Selecta Biosciences, Inc.||6|||f||||f||||||||||2017-10-10 21:37:20.655846|2017-10-10 21:37:20.655846
NCT02959905|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-01-08|||December 2016||2016-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment of Metastatic Melanoma With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)|Phase I Clinical Trial of TSA-CTL (Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes) In the Treatment of Metastatic Melanoma|Recruiting||Phase 1|24|Anticipated|BGI, China||3|||f||||t||||||||Undecided||2017-10-10 21:37:20.785643|2017-10-10 21:37:20.785643
NCT02959892|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-06-29|||January 18, 2017|Actual|2017-01-18|June 2017|2017-06-01|August 23, 2017|Anticipated|2017-08-23|August 23, 2017|Anticipated|2017-08-23||Interventional|||A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)|A Phase 1, Open-Label, Positron Emission Tomography Study in Healthy Subjects to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the CNS After Single-Dose Oral Administration|Active, not recruiting||Phase 1|12|Anticipated|Takeda||1|||f||||f|f|f||||||||2017-10-10 21:37:20.885605|2017-10-10 21:37:20.885605
NCT02959879|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-07|||December 2016||2016-12-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|PANACHE01||Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma|Resectable Pancreatic Adenocarcinoma Neo-Adjuvant FOLF(IRIN)OX-based CHEmotherapy - A Multicenter, Randomised Phase II Trial (PANACHE01-PRODIGE48 Study)|Not yet recruiting||Phase 2|160|Anticipated|University Hospital, Rouen||3|||f||||t||||||||No||2017-10-10 21:37:20.968152|2017-10-10 21:37:20.968152
NCT02959866|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-20|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Implementation and Impact of an Online Tool Used in Primary Care to Improve Income Security|Evaluating the Implementation and Impact of an Online Tool Used Within Primary Care to Improve the Income Security of Patients With Complex Health and Social Needs in Ontario and Manitoba|Completed||N/A|380|Actual|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-10 21:37:21.085418|2017-10-10 21:37:21.085418
NCT02959853|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-12-06|||June 2016||2016-06-01|November 2016|2016-11-01||||July 2017|Anticipated|2017-07-01||Interventional|||Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)|Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)|Recruiting||Phase 4|20|Anticipated|Baylor College of Medicine||2|||f||||||||||||||2017-10-10 21:37:21.183889|2017-10-10 21:37:21.183889
NCT02959840|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-08-27|2017-04-20||July 2015|Actual|2015-07-01|August 2017|2017-08-01|August 23, 2017|Actual|2017-08-23|March 2016|Actual|2016-03-01||Interventional|||Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean|Is Intra-operative Acupuncture Point P6 Stimulation as Effective as Traditional Pharmacotherapy in Reducing Nausea and Vomiting During Cesarean Section With Regional Anesthesia?|Completed||Phase 4|180|Actual|Rutgers, The State University of New Jersey||3|||f||||f||||||||||2017-10-10 21:37:21.321307|2017-10-10 21:37:21.321307
NCT02959827|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-17|||October 15, 2016|Actual|2016-10-15|September 2017|2017-09-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Observational|||Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States|Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States|Completed||N/A|2320|Actual|Bayer|||1||f||||f|t|f||||||||2017-10-10 21:37:22.121704|2017-10-10 21:37:22.121704
NCT02959814|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-06-08|||October 2016||2016-10-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|October 2017|Anticipated|2017-10-01||Observational|FAVOR II EJ||Diagnostic Accuracy of On-line Quantitative Flow Ratio (QFR). FAVOR II Europe-Japan|Diagnostic Accuracy of On-line Quantitative Flow Ratio. Functional Assessment by Virtual Online Reconstruction (The FAVOR II Europe-Japan Study)|Recruiting||N/A|310|Anticipated|Aarhus University Hospital Skejby|||1||f||||t||||||||Undecided||2017-10-10 21:37:22.193159|2017-10-10 21:37:22.193159
NCT02959801|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-11-06|||January 2016||2016-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis|Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis|Recruiting||Phase 4|50|Anticipated|Beijing Tsinghua Chang Gung Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:37:22.335301|2017-10-10 21:37:22.335301
NCT02959788|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-02-10|||April 2016|Actual|2016-04-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Heart Rate Variability as a Predictor of Ischemic Heart Disease|Heart Rate Variability as a Predictor of Ischemic Heart Disease|Completed||N/A|62|Actual|University of Iowa|||1||f||||f|f|f||||||No||2017-10-10 21:37:22.426063|2017-10-10 21:37:22.426063
NCT02959775|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-07|||August 2014||2014-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immunogenicity of Hepatitis B Vaccination Among Drug Users|Immunogenicity and Safety of High-dose Hepatitis B Vaccine Among Drug Users: a Randomized, Controlled Trial|Active, not recruiting||Phase 4|480|Actual|Shanxi Medical University||3|||f||||f||||||||No||2017-10-10 21:37:22.545815|2017-10-10 21:37:22.545815
NCT02959749|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-07|||August 2015||2015-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer|Phase III Study of Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer|Recruiting||Phase 2/Phase 3|300|Anticipated|Qingdao Central Hospital||2|||f||||f||||||||No||2017-10-10 21:37:22.882528|2017-10-10 21:37:22.882528
NCT02959736|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-09|||November 2016||2016-11-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|November 2019|Anticipated|2019-11-01|1 Month|Observational [Patient Registry]|MATADOC||Validating the MATADOC Against Best Practice Standard External Reference Standard|Validating the Music Therapy Assessment Tool for Awareness in Disorders of Consciousness (MATADOC) Against the Best Practice External Reference Standard|Not yet recruiting||N/A|80|Anticipated|Temple University|||3||f||||f||||||||No||2017-10-10 21:37:22.984846|2017-10-10 21:37:22.984846
NCT02959723|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-11-08|||January 2015||2015-01-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies|Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies|Recruiting||N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     Blood, Lung tissue   "|Undecided||2017-10-10 21:37:23.108854|2017-10-10 21:37:23.108854
NCT02959710|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-04-10|||November 2016||2016-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production|A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production|Completed||Phase 1|16|Anticipated|Accera, Inc.||3|||f||||f||||||||||2017-10-10 21:37:23.240371|2017-10-10 21:37:23.240371
NCT02959697|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-06|||December 2016||2016-12-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair|Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair|Not yet recruiting||N/A|100|Anticipated|University of Manitoba||1|||f||||t||||||||||2017-10-10 21:37:23.425939|2017-10-10 21:37:23.425939
NCT02959684|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-07-06|||April 14, 2017|Actual|2017-04-14|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|STRADA||Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France|Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France|Recruiting||N/A|70000|Anticipated|University Paris 7 - Denis Diderot|||1||f||||f||||||||||2017-10-10 21:37:23.503963|2017-10-10 21:37:23.503963
NCT02959658|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|FUMAPMS||Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis|Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis|Recruiting||Phase 2|90|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||No||2017-10-10 21:37:23.735777|2017-10-10 21:37:23.735777
NCT02959632|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Animal Assisted Therapy Intervention for Hospitalized Patients in a Tertiary Care Center|Animal Assisted Therapy Intervention for Hospitalized Patients in a Tertiary Care Center: A Pilot Study|Recruiting||N/A|70|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 21:37:23.940636|2017-10-10 21:37:23.940636
NCT02959619|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-04-25|||November 2016||2016-11-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK|Phase 1, Dose-escalating, Open-label Study of Ensartinib, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer|Recruiting||Phase 1|24|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||No||2017-10-10 21:37:24.010608|2017-10-10 21:37:24.010608
NCT02959606|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-08|2017-07-26|||December 2016||2016-12-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study|SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study : a Randomized Controlled Trial|Recruiting||Phase 4|272|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:37:24.10588|2017-10-10 21:37:24.10588
NCT02959593|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-07|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Visior on Ocular Hemodynamics|The Effects of Visior on Ocular Hemodynamics|Recruiting||N/A|35|Anticipated|Visior Technologies Ltd.||2|||f||||t||||||||No||2017-10-10 21:37:24.197033|2017-10-10 21:37:24.197033
NCT02959580|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-01-18|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01||||September 2020|Anticipated|2020-09-01||Interventional|MSTIGM||Medical and Surgical Treatment for Idiopathic Granulomatous Mastitis|Evaluation of Topical Steroids and Surgical Treatment for Idiopathic Granulomatous Mastitis|Recruiting||Phase 4|100|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||No||2017-10-10 21:37:24.28924|2017-10-10 21:37:24.28924
NCT02959567|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness and Safety Evaluation of Aqueduct 100-device|Effectiveness and Safety Evaluation of Aqueduct 100-device|Not yet recruiting||N/A|100|Anticipated|Aqueduct Medical Ltd||1|||f||||f||||||||Undecided||2017-10-10 21:37:24.400022|2017-10-10 21:37:24.400022
NCT02959554|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-06-12|||November 2016||2016-11-01|June 2017|2017-06-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|NIVOSWITCH||Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control|A Randomized Phase II Study With NIVOlumab or Continuation of Therapy as an Early SWITCH Approach in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) and Disease Control After 3 Months of Treatment With a Tyrosine Kinase Inhibitor|Recruiting||Phase 2|244|Anticipated|AIO-Studien-gGmbH||2|||f||||f||||||||No||2017-10-10 21:37:24.494648|2017-10-10 21:37:24.494648
NCT02959541|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-08|||September 2016||2016-09-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer|An Open Randomized Single Site Pharmacokinetic and Pharmacodynamic Study, of Calciumfolinat 60 mg/m², 200 mg/m² or 500 mg/ m² in Blood, Tumor and Adjacent Mucosa From Patients With Colon Cancer|Enrolling by invitation||N/A|30|Actual|Vastra Gotaland Region||3|||f||||t||||||||||2017-10-10 21:37:24.6086|2017-10-10 21:37:24.6086
NCT02959528|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-03-06|||October 2015||2015-10-01|March 2017|2017-03-01|January 19, 2017|Actual|2017-01-19|November 25, 2016|Actual|2016-11-25||Interventional|||The Effects of Working Memory Training in Children With Attention-Deficit/Hyperactivity Disorder|The Effects of Working Memory Training in Children With Attention-Deficit/Hyperactivity Disorder|Completed||N/A|40|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||No||2017-10-10 21:37:24.700468|2017-10-10 21:37:24.700468
NCT02959515|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-08|||October 2016||2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|OLVinFACHIR||The Effects of Different Types of Non-ventilated Lung Management on DO2 During OLV in the Supine Position|The Effects of Different Methods of Non-ventilated Lung Management on Oxygen Delivery (DO2) During One Lung Ventilation (OLV) in the Supine Position for Video Assisted Thoracoscopic (VATS) Atrial Fibrillation Ablation|Recruiting||N/A|40|Anticipated|Centro Cardiologico Monzino||2|||f||||f||||||||||2017-10-10 21:37:24.777912|2017-10-10 21:37:24.777912
NCT02959502|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-03-30|||October 2016||2016-10-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression|Home-Based Cognitive Remediation and Transcranial Direct Current Stimulation to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression|Recruiting||N/A|40|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 21:37:24.864085|2017-10-10 21:37:24.864085
NCT02959489|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-12-19|||November 2016||2016-11-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|REVEAL-SCAN||Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)|Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)|Recruiting||N/A|270|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||No||2017-10-10 21:37:24.964001|2017-10-10 21:37:24.964001
NCT02959476|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-06-15|||March 13, 2017|Actual|2017-03-13|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery|A Double Blind, Multi-center, Randomized, Placebo-Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery|Recruiting||Phase 3|130|Anticipated|BioQ Pharma, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:37:25.093596|2017-10-10 21:37:25.093596
NCT02959463|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-09-28|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Adjuvant Pembrolizumab After Radiation Therapy for Lung-Intact Malignant Pleural Mesothelioma|Phase I Trial of Adjuvant Pembrolizumab After Radiation Therapy for Lung-Intact Malignant Pleural Mesothelioma|Recruiting||Phase 1|24|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:37:25.211218|2017-10-10 21:37:25.211218
NCT02959450|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||May 2015||2015-05-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia|Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia. Compared With Traditional Practice: Randomized Clinical Trial, Simple Blind|Recruiting||N/A|80|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||No||2017-10-10 21:37:25.337101|2017-10-10 21:37:25.337101
NCT02959437|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-04-20|||January 24, 2017|Actual|2017-01-24|April 2017|2017-04-01|October 2021|Anticipated|2021-10-01|September 2021|Anticipated|2021-09-01||Interventional|||Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)|A Phase 1/2 Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of Azacitidine in Combination With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors and Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Stage IV Microsatellite-Stable Colorectal Cancer (ECHO-206)|Recruiting||Phase 1/Phase 2|142|Anticipated|Incyte Corporation||1|||f||||f|t|f||||||Undecided||2017-10-10 21:37:25.446315|2017-10-10 21:37:25.446315
NCT02959424|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||October 2016||2016-10-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Observational|||NEQOL Survey Spanish Validation in a Hispanic Clinic Based Population|"Quality of Life Among Patients With Chronic Esophageal Disorders : Spanish Translation and Validation of the Survey Northwestern Esophageal Quality of Life Scale in Hispanics"|Recruiting||N/A|100|Anticipated|Instituto Ecuatoriano de Enfermedades Digestivas|||1||f||||t||||||||No||2017-10-10 21:37:25.526803|2017-10-10 21:37:25.526803
NCT02959411|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-04-28|||October 2016||2016-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Tolvaptan for Advanced or Refractory Heart Failure|Tolvaptan for the Management of Acute Decompensated Heart Failure in Patients With Advanced or Refractory Heart Failure|Recruiting||Phase 4|30|Anticipated|University of Calgary||2|||f||||f||||||||Undecided||2017-10-10 21:37:25.604763|2017-10-10 21:37:25.604763
NCT02959398|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-07|||November 2016||2016-11-01|October 2016|2016-10-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|ETOLE||Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions|"EVALUATION DE LA TOMOSYNTHESE DANS LA CARACTERISATION ET LA PRISE EN CHARGE DES LESIONS MAMMAIRES : ETOLE"|Not yet recruiting||N/A|2000|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 21:37:25.690569|2017-10-10 21:37:25.690569
NCT02959385|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2017-07-13|||September 2016||2016-09-01|October 2016|2016-10-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer|A Phase II Trial to Compare Efficacy and Safety of Definitive Radiochemotherapy VS Neoadjuvant Radiochemotherapy Plus Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Treatment for Stage II-III Esophageal Cancer|Recruiting||Phase 2|40|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-10 21:37:25.771503|2017-10-10 21:37:25.771503
NCT02959372|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|LUS-HF||Lung Ultrasoung Guided Treatment in Chronic Heart Failure Patients: a Randomized Controlled Trial|Lung Ultrasoung Guided Treatment in Chronic Heart Failure Patients: a Randomized Controlled Trial|Recruiting||N/A|102|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||||||||||||2017-10-10 21:37:25.862143|2017-10-10 21:37:25.862143
NCT02959359|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-08-04|||November 2016||2016-11-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|June 2022|Anticipated|2022-06-01||Interventional|||DAA in the Risk of Recurrence After Curative Treatment of HCC|The Role of DAA in Reducing the Risk of Recurrence After Curative Treatment of HCC in Patients With Chronic Hepatitis C and Early Stage HCC|Withdrawn||Phase 4|0|Actual|Taipei Veterans General Hospital, Taiwan||1||The supplies of study drug were halted by Gilead Sciences Ltd.|f||||f||||||||||2017-10-10 21:37:25.929098|2017-10-10 21:37:25.929098
NCT02959346|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Acupuncture in Postoperative Pain Control for Minimal Invasive Thoracoscopic Surgery Patients|Investigate the Efficacy of Acupuncture in Postoperative Pain Control for Minimal Invasive Thoracoscopic Surgery Patients|Recruiting||N/A|100|Anticipated|China Medical University Hospital||2|||f||||t||||||||No||2017-10-10 21:37:26.132784|2017-10-10 21:37:26.132784
NCT02959333|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-07|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Human Amniotic Epithelial Cells for Treatment of Bronchial Fistula|Human Amniotic Epithelial Cells for Treatment of Bronchial Fistula|Recruiting||Phase 1|10|Anticipated|The Second Affiliated Hospital of Fujian Medical University||1|||f||||t||||||||Undecided||2017-10-10 21:37:26.228768|2017-10-10 21:37:26.228768
NCT02959320|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|||Direct Anterior vs. Anterolateral Approach for Hip Arthroplasty After Femoral Neck Fracture in the Senior Population|A Randomized Clinical Trial of Direct Anterior vs. Anterolateral Approach for Hip Arthroplasty After Femoral Neck Fracture in the Senior Population|Recruiting||N/A|142|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:37:26.3103|2017-10-10 21:37:26.3103
NCT02959307|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-07-14|||November 2016||2016-11-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|ELATED-3||Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3)|Transcranial Continuous and Pulse Near-Infrared Light in Depression: a Placebo-Controlled Study (ELATED-3).|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 21:37:26.40255|2017-10-10 21:37:26.40255
NCT02959294|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-09-10|||November 2016||2016-11-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|C-TBI||Use of Adipose-Derived Stem/Stromal Cells in Concussion and Traumatic Brain Injuries|Use of Adipose-Derived Cellular Stromal Vascular Fraction (AD-cSVF) Parenterally in Post-Concussion Injuries and Traumatic Brain Injuries (TBI)|Recruiting||Phase 1/Phase 2|200|Anticipated|Healeon Medical Inc||3|||f||||t||||||||||2017-10-10 21:37:26.516433|2017-10-10 21:37:26.516433
NCT02959281|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bioimpedance and Hand-held Echocardiographay for Clinical Decision-making in Treatment of Cardio-renal Syndrome Type I|The Application of Bio-impedance System NICAS and Hand-held Echocardiographic System (VSCAN) as Tools for Clinical Decision-making in the Treatment of In-patients With Cardio-renal Syndrome Type I|Not yet recruiting||N/A|200|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||No|Investigators do not plan to share the IPD with any body. After completion of study we plan to publish results.|2017-10-10 21:37:26.654438|2017-10-10 21:37:26.654438
NCT02959268|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-02-05|||November 2016||2016-11-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|PRALS||Pivotal Study of the Rx Al-Sense Liner for Amniotic Fluid Leakage Screening|Pivotal Study of the Rx Al-Sense Liner for Amniotic Fluid Leakage Screening in the Second and Third Trimesters of Pregnancy|Recruiting||N/A|400|Anticipated|Common Sense||1|||f||||f||||||||No||2017-10-10 21:37:26.730928|2017-10-10 21:37:26.730928
NCT02959255|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection|A Greek, Single Center, Randomized, Double Blind Controlled Clinical Study Comparing the 10-day Versus the 14-day Concomitant Proton Pump Inhibitor [PPI] + Amoxicillin + Metronidazole + Clarithromycin (PAMC) Therapeutic Scheme as First-line Treatment Strategy for the Eradication of H. Pylori Infection|Not yet recruiting||Phase 4|364|Anticipated|Elpen Pharmaceutical Co. Inc.||2|||f||||f||||||||No||2017-10-10 21:37:26.843121|2017-10-10 21:37:26.843121
NCT02959242|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2016-11-08|||January 2006||2006-01-01|November 2016|2016-11-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|||Dresden Glaucoma and Treatment Study (DGTS)|Dresden Glaucoma and Treatment Study: Analysis to Assure the Quality of Follow-up and Therapy of Glaucoma Patients in a Tertiary University Hospital Glaucoma Service.|Recruiting||N/A|10000|Anticipated|Technische Universität Dresden|||1||f||||f||||||||No|Individual participant data are only shared between researchers of our Institute.|2017-10-10 21:37:26.936522|2017-10-10 21:37:26.936522
NCT02959229|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-05|||August 2014||2014-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Interventional|||Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis|Systematic Randomized , Single Blinded, Placebo-Controlled Trial of Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis|Completed||Phase 4|180|Actual|Ain Shams University||3|||f||||t||||||||Undecided||2017-10-10 21:37:27.018921|2017-10-10 21:37:27.018921
NCT02959203|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-04|||June 2016||2016-06-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|COMBUX||Comparison of Bedside Ultrasound With Chest X-ray for Confirmation of Central Venous Catheter Position|Comparison of Bedside Ultrasound With Chest X-ray for Confirmation of Central Venous Catheter Position and Detection of Potential Complications|Recruiting||N/A|730|Anticipated|VU University Medical Center|||1||f||||f||||||||Undecided||2017-10-10 21:37:27.192261|2017-10-10 21:37:27.192261
NCT02959190|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-10-03|||February 7, 2017|Actual|2017-02-07|October 2017|2017-10-01|December 23, 2019|Anticipated|2019-12-23|February 24, 2019|Anticipated|2019-02-24||Interventional|||A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine|A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 (Galcanezumab) in Japanese Patients With Migraine|Recruiting||Phase 3|300|Anticipated|Eli Lilly and Company||2|||f||||f|t|f|||t|||||2017-10-10 21:37:27.280249|2017-10-10 21:37:27.280249
NCT02959177|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-09-21|||November 2016||2016-11-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine|A Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 (Galcanezumab) in Japanese Patients With Episodic Migraine|Recruiting||Phase 2|451|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 21:37:27.535097|2017-10-10 21:37:27.535097
NCT02959164|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2017-06-23|||December 2016||2016-12-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma|A Phase 1b Study: Treatment of Refractory Pancreatic Adenocarcinoma and Advanced Soft Tissue or Bone Sarcomas Using Decitabine Combined With Gemcitabine|Recruiting||Phase 1|42|Anticipated|University of Iowa||1|||f||||t||||||||||2017-10-10 21:37:27.768249|2017-10-10 21:37:27.768249
NCT02959151|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-07|||July 2016||2016-07-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy|A Single-arm Pilot Clinical Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy|Recruiting||Phase 1/Phase 2|20|Anticipated|Shanghai GeneChem Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:37:27.866368|2017-10-10 21:37:27.866368
NCT02959138|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-09-14|||November 21, 2016|Actual|2016-11-21|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics of GS-9876 in Adults With Impaired Renal Function|A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of GS-9876 in Subjects With Impaired Renal Function|Recruiting||Phase 1|60|Anticipated|Gilead Sciences||3|||f||||f|t|f||||||||2017-10-10 21:37:27.955667|2017-10-10 21:37:27.955667
NCT02959125|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||NutFish and Nutrient Supplementation in Pregnancy Class to Improve Maternal and Birth Outcomes|NutFish and Nutrient Supplementation in Pregnancy Class to Improve Maternal and Birth Outcomes|Not yet recruiting||Phase 2|72|Anticipated|Semarang Health Polytechnic||2|||f||||t||||||||Undecided||2017-10-10 21:37:28.044608|2017-10-10 21:37:28.044608
NCT02959112|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-05|||May 2016||2016-05-01|November 2016|2016-11-01||||May 2019|Anticipated|2019-05-01||Interventional|||Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography|Epinephrine Sprayed on the Papilla and Rectal Indomethacin Versus Sterile Water Sprayed on the Papilla and Rectal Indomethacin for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Prospective, Randomized, Controlled Trial|Recruiting||N/A|948|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||No||2017-10-10 21:37:28.150251|2017-10-10 21:37:28.150251
NCT02959099|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-04|||February 2014||2014-02-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|ICONIC||Incident COronary EveNts Identified by Computed Tomography|Incident COronary EveNts Identified by Computed Tomography|Active, not recruiting||N/A|1998|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||||Undecided||2017-10-10 21:37:28.256525|2017-10-10 21:37:28.256525
NCT02959086|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-08-31|||January 2002|Actual|2002-01-01|August 2017|2017-08-01|January 2030|Anticipated|2030-01-01|April 2017|Actual|2017-04-01|10 Years|Observational [Patient Registry]|||Shanghai Epidemiology Study for Adolescents and Children With Cancer|Shanghai Epidemiology Study for Adolescents and Children With Cancer|Recruiting||N/A|2000|Anticipated|Children's Cancer Group, China|||1||f||||t||||||||||2017-10-10 21:37:28.365363|2017-10-10 21:37:28.365363
NCT02959073|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-05-02|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|HypoScore-2||Evaluation of a New Self-assessed, Home-based Symptom Score in Cat Allergic Patients|Evaluation of a New Self-assessed, Home-based Symptom Score in Cat Allergic Patients|Terminated||N/A|10|Actual|University of Zurich|||1|Company's strategic reasons|f||||f||||||||No||2017-10-10 21:37:28.448745|2017-10-10 21:37:28.448745
NCT02959060|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-07|2017-01-05|||November 2016||2016-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects|An Open-Label, Single-Sequence Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects|Completed||Phase 1|16|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 21:37:28.512127|2017-10-10 21:37:28.512127
NCT02959047|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-07-20|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|July 17, 2020|Anticipated|2020-07-17|July 17, 2019|Anticipated|2019-07-17||Interventional|||A Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease|A Double Blind, Randomized Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease|Recruiting||Phase 4|54|Anticipated|University of Virginia||2|||f||||t|t|f||||||||2017-10-10 21:37:28.587593|2017-10-10 21:37:28.587593
NCT02959034|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-12-13|||September 2016||2016-09-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Observational|PMMR||Pediatric Metabolism and Microbiome Repository|Pediatric Metabolism and Microbiome Repository|Recruiting||N/A|350|Anticipated|Duke University|||3||f||||f||||||Samples With DNA|"     Human microbial cell lines, stool and/or DNA and RNA will be collected from participants     10-18 years with a BMI greater than 95th percentile and their healthy siblings.      Specimens will be collected at 3 time points over a seven month period. Healthy siblings will     provide just one blood and stool sample. Samples will be maintained at the Duke Medical     Science Research Laboratory.   "|Yes|Anonymized data may be shared as investigators discretion following submission of request, receipt of a data transfer agreement and local IRB approval|2017-10-10 21:37:28.681977|2017-10-10 21:37:28.681977
NCT02959021|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-03-22|||January 2017||2017-01-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|PROMISE||Partnership Optimizes Weight Management in Primary Care|Primary Care Obesity Management in the Southeast_PROMISE|Recruiting||N/A|375|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||Yes|With the documented permission of the IRB, the PI may develop a transportable de-identified database, codebook, and mechanism by which data can be shared with qualified investigators. Interested investigators will be asked to complete a standardized request form stating the specific aims of the analyses, the analytic plan, available resources for completing the proposed project, proposed timeline, and goals (i.e., manuscripts, presentations, and/or grant applications). The PI and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed. If any of these issues are problematic, the PI and research team will attempt to negotiate a fair resolution with the interested investigators and NIH program staff.|2017-10-10 21:37:28.768655|2017-10-10 21:37:28.768655
NCT02959008|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-15|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Continous Assessment of Cerebral Autoregulation With Near-infrared Spectroscopy|Continous Assessment of Cerebral Autoregulation With Near-infrared Spectroscopy|Not yet recruiting||N/A|40|Anticipated|Beijing Electric Power Hospital|||2||f||||f||||||||No||2017-10-10 21:37:28.853297|2017-10-10 21:37:28.853297
NCT02958995|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-01-20|2016-11-14||January 1997||1997-01-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational||The observational study population consisted of T2DM participants who were identified from KPNC registry (with or without diabetes) and had completed the KPNC survey and MHS in the analysis.|Epidemiologic Study Of Diabetes And Cancer Risk|Epidemiologic Study Of Diabetes And Cancer Risk|Completed||N/A|2738161|Actual|Takeda|||2||f||||f||||||||||2017-10-10 21:37:28.924223|2017-10-10 21:37:28.924223
NCT02958982|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-07-24|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals|A Phase I/IIa, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, and Pharmacokinetics of Single and Multiple Ascending Dose of RP3128 in HV and Effect on LAR to Allergen Challenge in Mild Asthmatics|Recruiting||Phase 1/Phase 2|68|Anticipated|Rhizen Pharmaceuticals SA||2|||f||||t||||||||||2017-10-10 21:37:29.334996|2017-10-10 21:37:29.334996
NCT02958969|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-05|||January 2017||2017-01-01|November 2016|2016-11-01||||December 2019|Anticipated|2019-12-01||Interventional|||Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma|Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy|Not yet recruiting||Phase 4|50|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 21:37:29.42667|2017-10-10 21:37:29.42667
NCT02958956|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-12|2016-11-12||January 1997||1997-01-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational||Population consisted of Type 2 diabetes mellitus (T2DM) participants who were identified from the Kaiser Diabetes Registry, were included in the membership database, medication benefit database, hospitalization and surgery procedures databases, cancer registry database merged along with data in the diabetes registry were evaluable for analysis.|Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.|Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes Mellitus|Completed||N/A|252467|Actual|Takeda|||2||f||||f||||||||||2017-10-10 21:37:29.664069|2017-10-10 21:37:29.664069
NCT02958943|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-05|||January 2017||2017-01-01|November 2016|2016-11-01||||December 2019|Anticipated|2019-12-01||Interventional|||Electronic Alerts for Stroke Prevention in Atrial Fibrillation|Electronic Alert-Based Computerized Decision Support to Increase Prescription of Anticoagulation in High-Risk Atrial Fibrillation Patients in the Outpatient Setting|Not yet recruiting||N/A|400|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 21:37:31.164584|2017-10-10 21:37:31.164584
NCT02958930|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-15|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease|A Phase 1 Study to Evaluate the Safety and Efficacy of Transcranial Electromagnetic Treatment (TEMT) for the Treatment of Alzheimer's Disease|Enrolling by invitation||Phase 1|12|Actual|NeuroEM Therapeutics, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:37:31.260819|2017-10-10 21:37:31.260819
NCT02958917|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-05-01|||March 4, 2017|Actual|2017-03-04|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis|A Randomized, Double-Blind, Placebo-Controlled, Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis|Recruiting||N/A|40|Anticipated|National Jewish Health||2|||f||||f|f|f||||||No||2017-10-10 21:37:31.380178|2017-10-10 21:37:31.380178
NCT02958904|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-07|||March 2015||2015-03-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Observational|||Depressive Symptoms and Sexual Dysfunction in Traumatic Spinal Cord Injury|Association Between Depressive Symptoms and Sexual Dysfunction in Men With Traumatic Spinal Cord Injury|Completed||N/A|44|Actual|Universidade Federal de Pernambuco|||1||f||||t||||||||No||2017-10-10 21:37:31.486242|2017-10-10 21:37:31.486242
NCT02958891|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-13|||March 2016||2016-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Observational|||Dental Health Epidemiology Among Israel Defense Forces (IDF) Recruits|Caries, Gingivitis, Dental Trauma and Fluorosis Prevalence Among IDF Recruits - an Epidemiological Survey|Active, not recruiting||N/A|700|Actual|Medical Corps, Israel Defense Force|||1||f||||f||||||||No|Data will be published after statistical analysis only.|2017-10-10 21:37:31.557967|2017-10-10 21:37:31.557967
NCT02958878|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2017-05-18|||January 3, 2017|Actual|2017-01-03|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair|Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair|Enrolling by invitation||Phase 4|160|Anticipated|Genesys Regional Medical Center||2|||f||||f||||||||No||2017-10-10 21:37:31.635671|2017-10-10 21:37:31.635671
NCT02958865|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-10-03|||February 3, 2017|Actual|2017-02-03|October 2017|2017-10-01|January 28, 2020|Anticipated|2020-01-28|July 12, 2019|Anticipated|2019-07-12||Interventional|||Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis|A Phase 2b, Double-blind, Randomized, Placebo-controlled, Parallel Group, Dose Ranging Study Of Oral Pf-06651600 And Pf-06700841 As Induction And Chronic Therapy In Subjects With Moderate To Severe Ulcerative Colitis|Recruiting||Phase 2|360|Anticipated|Pfizer||12|||f||||t|t|f||||||||2017-10-10 21:37:31.721461|2017-10-10 21:37:31.721461
NCT02958852|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|ABC-SE||A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer|A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer|Recruiting||Phase 2|126|Anticipated|Lund University Hospital||3|||f||||f||||||||No||2017-10-10 21:37:32.070429|2017-10-10 21:37:32.070429
NCT02958839|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|REBECCA||Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Catheter Ablation|The Relationship Between Fibroblast Growth Factor 23 and the Recurrence of Atrial Fibrillation After Catheter Ablation: a Nested Case-Control Study|Enrolling by invitation||N/A|200|Anticipated|Peking University Third Hospital|||2||f||||f||||||Samples With DNA|"     Blood samples will be obtained by a peripheral venipuncture and will be centrifuged at 3,200     *g for 10 minutes at approximately 4℃ within an hour of collection. The serum will be     separated into aliquots and stored at -80℃ until personnel blinded to the patients' clinical     information performed the analysis.   "|||2017-10-10 21:37:32.169029|2017-10-10 21:37:32.169029
NCT02958826|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-10-02|||October 2016|Actual|2016-10-01|October 2017|2017-10-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|||Impact of Sensory Stimuli on Patient Preferences During Outpatient Surgery|Determining the Impact of External Sensory Stimuli on Patient Preferences During Outpatient Surgery|Completed||N/A|160|Actual|University of Missouri-Columbia|||1||f||||f||||||||||2017-10-10 21:37:32.2405|2017-10-10 21:37:32.2405
NCT02958813|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-05-09|||November 1, 2012|Actual|2012-11-01|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|IMARA||An Integrated HIV Prevention Model for African American Mothers and Daughters||Active, not recruiting||N/A|514|Actual|University of Illinois at Chicago||2|||f||||t||||||||Undecided||2017-10-10 21:37:32.314216|2017-10-10 21:37:32.314216
NCT02958800|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-04|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Deprescribing Antipsychotics in Long-Term Care|Developing a Single Patient Open-label Trial Tapering Algorithm for Antipsychotics in Long-Term Care - A Pilot Study|Not yet recruiting||N/A|20|Anticipated|McMaster University||1|||f||||f||||||||Undecided||2017-10-10 21:37:32.394024|2017-10-10 21:37:32.394024
NCT02958787|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-04|||November 2004||2004-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|October 2009|Actual|2009-10-01||Interventional|||Vessel Sparing Prostate Radiation Therapy|Vessel Sparing Prostate Radiation Therapy: Dose Limitation to Critical Erectile Structures (Corpus Cavernosum and Internal Pudendal Artery) by MRI Based Treatment Planning|Active, not recruiting||Phase 2|135|Actual|University of Michigan Cancer Center||1|||f||||f||||||||No|No sharing|2017-10-10 21:37:32.482708|2017-10-10 21:37:32.482708
NCT02958774|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01||||March 2020|Anticipated|2020-03-01||Interventional|||Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation|Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation|Not yet recruiting||Phase 2|296|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-10 21:37:32.551409|2017-10-10 21:37:32.551409
NCT02958748|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-06|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Observational|||Change of Immune Cell of ARDS Patients：an Observational Study||Not yet recruiting||N/A|60|Anticipated|Southeast University, China|||2||f||||t||||||||||2017-10-10 21:37:34.749|2017-10-10 21:37:34.749
NCT02958735|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-08-15|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|EXACT||Exercise and Cognition Trials|Human Performance: Role of Acute Exercise in Enhancing Cognitive Function|Completed||N/A|60|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-10-10 21:37:34.808932|2017-10-10 21:37:34.808932
NCT02958722|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-10-05|||November 2016||2016-11-01|November 2016|2016-11-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Comparison Between Two Different Distention Medium in Diagnostic Hysteroscopy|CO2 or Physiological Solution as Distension Medium: Which One is Better in Diagnostic Hysteroscopy?|Completed||N/A|2000|Actual|Policlinico Universitario Agostino Gemelli||2|||f||||f||||||||||2017-10-10 21:37:34.928913|2017-10-10 21:37:34.928913
NCT02958709|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-02-24|||February 22, 2017|Actual|2017-02-22|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|TBM-KIDS||Optimizing Treatment to Improve TBM Outcomes in Children|Phase I/II Randomized, Open-label Trial to Evaluate the PK, Safety, and Outcomes of Treatment Including High Dose Rifampicin +/- Levofloxacin vs Standard Treatment for Pediatric Tuberculous Meningitis (TBM)|Recruiting||Phase 1/Phase 2|120|Anticipated|Johns Hopkins University||3|||f||||t|f|f||||||No||2017-10-10 21:37:34.999007|2017-10-10 21:37:34.999007
NCT02958696|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-02-02|||October 2016||2016-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules|A Phase 1, Randomised, Open Label, 2-period Crossover, Single Centre, 3-arm, Single Dose Study to Investigate the Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsule Formation in Healthy Volunteers|Completed||Phase 1|37|Actual|Heptares Therapeutics Limited||3|||f||||f||||||||No||2017-10-10 21:37:35.144665|2017-10-10 21:37:35.144665
NCT02958657|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-05-01|||October 2016||2016-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Influence of Exercise Training on Platelet Aggregability in a Post-myocardial Infarction Population|Influence of Exercise Training on the Autonomic Nervous System and Its Correlation With Platelet Aggregability in a Post-myocardial Infarction Population|Recruiting||N/A|90|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 21:37:35.446541|2017-10-10 21:37:35.446541
NCT02958644|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-09-15|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|Synbiotic||Effect of Synbiotic Supplement on the Body Mass Index of Participants With Severe Obesity|Effect of Synbiotic Supplement on the Body Mass Index of Participants With Severe Obesity|Not yet recruiting||N/A|180|Anticipated|Hospital Dona Helena||2|||f||||f|f|f||||||||2017-10-10 21:37:35.67135|2017-10-10 21:37:35.67135
NCT02958631|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-05|||November 2014||2014-11-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Blood Pressure Lowering Effect Between Fimasartan and Losartan|Comparison of Blood Pressure Lowering Effect Between Fimasartan and Losartan in the Hypertensive Patient During Night and Early Morning Time|Active, not recruiting||Phase 4|40|Anticipated|Chuncheon Sacred Heart Hospital||2|||f||||f||||||||No||2017-10-10 21:37:35.788508|2017-10-10 21:37:35.788508
NCT02958618|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-05|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Different Duration of Bolloon Dilation During ESBD|The Effect of Three Different Duration of Bolloon Dilation During ESBD in the Treatment of Common Bile Duct Stones|Not yet recruiting||N/A|120|Anticipated|RenJi Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:37:35.878281|2017-10-10 21:37:35.878281
NCT02958605|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-10-04|||November 2016|Actual|2016-11-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Interventional|SMARTER||Smartphone Apps for Pediatric Resuscitation|Smartphone Medical Applications to Reduce Treatment Dosage Errors in Pediatric Resuscitation; a Randomized Simulation Trial|Completed||N/A|40|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-10 21:37:36.000143|2017-10-10 21:37:36.000143
NCT02958592|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-05|||June 2015||2015-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Observational|||Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study|Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study|Completed||N/A|121|Actual|Sun Yat-sen University|||1||f||||f||||||||No||2017-10-10 21:37:36.099961|2017-10-10 21:37:36.099961
NCT02958579|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-05|2016-11-05|||January 2005||2005-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Observational|MetSCoM||a Population Based Study on Metabolic Syndrome Complications, and Mortality|A Population Based Cohort Study on Metabolic Syndrome Complications, and Mortality; (MetSCoM) Study|Recruiting||N/A|10000|Anticipated|Tehran University of Medical Sciences|||5||f||||||||||||||2017-10-10 21:37:36.175709|2017-10-10 21:37:36.175709
NCT02958566|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-03-16|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery|Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery as Part of an Enhanced Recovery After Surgery Protocol: A Randomized Prospective Single- Center Trial.|Recruiting||Phase 4|80|Anticipated|University of Illinois College of Medicine at Peoria||2|||f||||t||||||||No||2017-10-10 21:37:36.31085|2017-10-10 21:37:36.31085
NCT02958553|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-04-11|||November 2016||2016-11-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|EASE||EmPOWERing Active Seniors With Energy|EmPOWERing Active Seniors With Energy|Suspended||N/A|35|Anticipated|Otto Bock Healthcare Products GmbH||2||Enrollment is on hold to review study design|f||||f||||||||No||2017-10-10 21:37:37.015707|2017-10-10 21:37:37.015707
NCT02958540|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-09-07|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|SynGEM||Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine|Randomized, Doubleblind, Placebo-controlled Trial in Healthy Adults of Safety and Immunogenicity of 2 Intranasal Doses of SynGEM®, an RSV Candidate Vaccine Containing F Glycoprotein Linked to a Bacterium-like-Particle (BLP) Carrier|Active, not recruiting||Phase 1|48|Actual|Mucosis BV||3|||f||||t||||||||||2017-10-10 21:37:37.122819|2017-10-10 21:37:37.122819
NCT02958527|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-09-29|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)|Drug Use Investigation Of Effexor|Active, not recruiting||N/A|1|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 21:37:37.196838|2017-10-10 21:37:37.196838
NCT02958514|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction|Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction|Not yet recruiting||N/A|20|Anticipated|Peking University Third Hospital||2|||f||||f||||||||Yes||2017-10-10 21:37:37.275023|2017-10-10 21:37:37.275023
NCT02958501|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Vitamin D Substitution During Winter Time|Optimal Substitution Dose of the Vitamin D During Winter Time in Patient With Inflammatory Bowel Diseases (IBD)|Not yet recruiting||Phase 4|176|Anticipated|Faculty Hospital Kralovske Vinohrady||2|||f||||f||||||||No||2017-10-10 21:37:37.359473|2017-10-10 21:37:37.359473
NCT02958488|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-11-04|||March 2016||2016-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PRIMAIR||Efficacy and Tolerance of High Flow Nasal Cannula for Respiratory Distress Syndrom in Late Preterms (34-36 Weeks)|Prospective Efficacy and Tolerance Data Collection in 34 to 36 Weeks Preterm Neonates Treated by High Flow Nasal Cannula for Respiratory Distress Syndrom|Recruiting||N/A|50|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 21:37:37.440902|2017-10-10 21:37:37.440902
NCT02958293|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-06-13|||November 2016||2016-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Perioperative Morbidity in Elective Surgery Based on the Time of the Year|Does Procedural Timing Impact Perioperative Morbidity in Elective Surgery?|Active, not recruiting||N/A|24000|Anticipated|TriHealth Inc.|||2||f||||f||||||||No||2017-10-10 21:37:39.39759|2017-10-10 21:37:39.39759
NCT02958475|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-26|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MMM||Mother's Milk Messaging: Evaluation of a Bilingual APP to Support Initiation and Exclusive Breastfeeding in New Mothers|Mother's Milk Messaging: Evaluation of a Bilingual APP to Support Initiation and Exclusive Breastfeeding in New Mothers|Recruiting||N/A|500|Anticipated|University of Colorado, Denver||3|||f||||f|f|f||||||||2017-10-10 21:37:37.524869|2017-10-10 21:37:37.524869
NCT02958462|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|January 2023|Anticipated|2023-01-01|June 2022|Anticipated|2022-06-01||Interventional|||Pre-myeloid Cancer and Bone Marrow Failure Clinic Study|Pre-myeloid Cancer and Bone Marrow Failure Clinic Study|Recruiting||N/A|100|Anticipated|Mayo Clinic||1|||f||||f||||||||Undecided||2017-10-10 21:37:37.629922|2017-10-10 21:37:37.629922
NCT02958449|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-03-06|||December 2016||2016-12-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Prospective Clinical Investigation Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu® and No Drains (Test) in Mastectomy|Prospective Clinical Investigation for a Randomized, Controlled, Multicenter Non-inferiority Study Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu® and No Drains (Test) in Mastectomy|Recruiting||N/A|84|Anticipated|Cohera Medical, Inc.||2|||f||||||||||||||2017-10-10 21:37:37.713022|2017-10-10 21:37:37.713022
NCT02958436|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-19|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects|Active, not recruiting||Phase 1|40|Actual|Regeneron Pharmaceuticals||5|||f||||f||||||||||2017-10-10 21:37:37.827406|2017-10-10 21:37:37.827406
NCT02958423|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|DCSErCPP||tDCS Versus tsDCS for Endometriosis-related Chronic Pelvic Pain Treatment|Transcranial Direct Current Stimulation (tDCS) vs Trans-spinal Direct Current Stimulation (tsDCS) for Endometriosis-related Chronic Pelvic Pain Treatment: A Single Center, Prospective, Randomized, Controlled, Parallel Group Pilot Study|Recruiting||Phase 1/Phase 2|20|Anticipated|University Hospital of Liege||4|||f||||f||||||||Yes|anonymized data will be made available on request via e-mail|2017-10-10 21:37:37.916282|2017-10-10 21:37:37.916282
NCT02958410|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-06|||October 2016||2016-10-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies|A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies|Recruiting||Phase 1/Phase 2|45|Anticipated|Southwest Hospital, China||1|||f||||f||||||||Undecided||2017-10-10 21:37:38.158378|2017-10-10 21:37:38.158378
NCT02958397|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-06|||October 2016||2016-10-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies|A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies|Recruiting||Phase 1/Phase 2|45|Anticipated|Southwest Hospital, China||1|||f||||f||||||||Undecided||2017-10-10 21:37:38.278924|2017-10-10 21:37:38.278924
NCT02958384|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-06|2016-11-06|||October 2016||2016-10-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Clinical Research of LeY-Targeted CAR-T in Myeloid Malignancies|A Clinical Research of LeY-Targeted CAR-T in Myeloid Malignancies|Recruiting||Phase 1/Phase 2|45|Anticipated|Southwest Hospital, China||1|||f||||f||||||||Undecided||2017-10-10 21:37:38.397052|2017-10-10 21:37:38.397052
NCT02958371|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|PLEASIN||Effect of Choice on Food Pleasure Using fMRI|Effect of Choice on Food Pleasure Using fMRI|Not yet recruiting||N/A|55|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 21:37:38.504118|2017-10-10 21:37:38.504118
NCT02958358|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-11-10|||September 2014||2014-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan|Evaluation of FDG Uptake and Pulmonary Perfusion by Positron Emission Tomography in Patients With Pulmonary Arterial Hypertension Before and After Treatment With Ambrisentan|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||1||inability to recruit subjects|f||||f||||||||No|None obtained|2017-10-10 21:37:38.607654|2017-10-10 21:37:38.607654
NCT02958345|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-20|2017-04-26||June 2013||2013-06-01|June 2017|2017-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™|Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™|Completed||Phase 4|28|Actual|Tulane University||2|||f||||f||||||||No||2017-10-10 21:37:38.70853|2017-10-10 21:37:38.70853
NCT02958332|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-05-03|||November 2016||2016-11-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast Cancer|Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast Cancer|Completed||N/A|11|Actual|Universidad de Burgos||1|||f||||f||||||||||2017-10-10 21:37:39.140606|2017-10-10 21:37:39.140606
NCT02958319|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-05|||June 2016||2016-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid Arthritis|Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid Arthritis Patients at 6, 12 and 18 Months|Recruiting||N/A|262|Anticipated|Universidad Autonoma de Nuevo Leon|||2||f||||t||||||||Undecided|via email request|2017-10-10 21:37:39.21885|2017-10-10 21:37:39.21885
NCT02958306|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-04|||December 2016||2016-12-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of Platelet Rich Plasma (PRP) on the Esthetic Outcome and Scar Formation of Unilateral Cleft Lip Repair|Evaluation of the Effect of Platelet Rich Plasma (PRP) on the Esthetic Outcome and Scar Formation of Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty: A Randomized Clinical Trial|Not yet recruiting||Phase 2|24|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:37:39.308166|2017-10-10 21:37:39.308166
NCT02958280|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Tailored Physical Activity Smartphone App for Patients With Alcohol Dependence|A Tailored Physical Activity Smartphone App for Patients With Alcohol Dependence|Recruiting||N/A|30|Anticipated|Butler Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:37:39.455094|2017-10-10 21:37:39.455094
NCT02958267|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-07-31|||December 2016||2016-12-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee|Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee: Effect on Pain and Quality of Life|Active, not recruiting||Phase 2|30|Actual|OhioHealth||2|||f||||||||||||||2017-10-10 21:37:39.551641|2017-10-10 21:37:39.551641
NCT02958254|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-04|||December 2016||2016-12-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||Ultrasound Measurements Hamstring Muscles Thickness|Ultrasound Measurements of Hamstring Muscles Thickness Are a Valid Tool|Not yet recruiting||N/A|15|Anticipated|University of Valencia|||1||f||||t||||||||Undecided||2017-10-10 21:37:39.649178|2017-10-10 21:37:39.649178
NCT02958241|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Supine vs. Upright Weight Bearing MRI in the Evaluation of Patients With Lumbar Spondylolisthesis|Supine vs. Upright Weight Bearing MRI in the Evaluation of Patients With Lumbar Spondylolisthesis|Enrolling by invitation||N/A|25|Anticipated|Texas Back Institute||1|||f||||f||||||||No||2017-10-10 21:37:39.730363|2017-10-10 21:37:39.730363
NCT02958228|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-04-18|||November 2016||2016-11-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Computerized Cognitive Training on Mood and Thinking Style Amongst Patients in Inpatient Settings|The Effect of Computerized Cognitive Training on Mood and Thinking Style Amongst Patients in Inpatient Settings|Recruiting||N/A|90|Anticipated|Ruhr University of Bochum||3|||f||||f||||||||Yes|It is planned to make individual participant data available on publication of the associated study results, via a publicly-available data repository such as Open Science Framework. Data made available will be the research data reported in the publication, with the exception of any data that could compromise participant anonymity.|2017-10-10 21:37:39.822717|2017-10-10 21:37:39.822717
NCT02958215|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-05-16|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Phenylephrine and Hypotension During Spinal Anesthesia for Cesarean Section|A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction During Spinal Anesthesia for Cesarean Section and Its Relation to the Effect of Prophylaxis Phenylephrine|Completed||Phase 2|980|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:37:39.935499|2017-10-10 21:37:39.935499
NCT02958202|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-09|||April 2016||2016-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD)|A Multi Center, Multi National, Open Label, Extension Study to Evaluate the Long-term Efficacy and Safety of BMN 044 (PRO044) in Subjects With Duchenne Muscular Dystrophy|Terminated||Phase 2|7|Actual|BioMarin Pharmaceutical||3||"Regulatory approval was not obtained for drisapersen, hence BioMarin is stopping the   development of all exon skipping oligonucleotides in DMD."|f||||t||||||||No||2017-10-10 21:37:40.081764|2017-10-10 21:37:40.081764
NCT02958189|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-02-08|||November 2016||2016-11-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Tweet4Wellness: An Online Virtual Support Group for Promoting Increased Physical Activity|Tweet4Wellness: An Online Virtual Support Group for Promoting Increased Physical Activity|Recruiting||N/A|75|Anticipated|Stanford University||3|||f||||f||||||||||2017-10-10 21:37:40.175358|2017-10-10 21:37:40.175358
NCT02958176|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-04|||October 2016||2016-10-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder|Autonomic Imbalance and Female Sexual Arousal Disorder: The Identification of Heart Rate Variability Level as a Risk Factor and Treatment Target|Recruiting||N/A|65|Anticipated|University of Texas at Austin||3|||f||||f||||||||Undecided||2017-10-10 21:37:40.255298|2017-10-10 21:37:40.255298
NCT02958163|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-03-13|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Interventional|HepSTAR||Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)|Randomized Controlled Phase II Trial Comparing Trans-Arterial Chemo-Embolization (TACE) With TACE Plus Stereotactic Ablative Radiotherapy (SABR) in Stage BCLC B Hepatocarcinoma (HepSTAR)|Recruiting||Phase 2|102|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f|f|f||||||No|Every participant data will be anonymized for the trial purpose.|2017-10-10 21:37:40.34428|2017-10-10 21:37:40.34428
NCT02958150|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-04|||October 2016||2016-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|DEX-PCH-VMNI||Dexmedetomidine Versus Standard Clinical Practice During Non Invasive Mechanical Ventilation|Randomised Clinical Trial: Dexmedetomidine Versus Standard Clinical Practice During Non Invasive Mechanical Ventilation|Recruiting||Phase 4|180|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-10 21:37:40.492345|2017-10-10 21:37:40.492345
NCT02958137|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-04|||January 2004||2004-01-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|ARA:BJA-OA||Arthroscopic Resection Arthroplasty of Carpometacarpal and/or Pantrapezial Osteoarthritis|Arthroscopic Resection Arthroplasty of Basal Joint Arthritis: Comparing Outcomes of Isolated Carpometacarpal to Pantrapezial Disease|Completed||N/A|125|Actual|Orthopaedic Specialist, PC, Davenport, IA|||2||f||||f||||||||No|All patient health information was protected and complied with data privacy legal requirements. Personally identifiable patient information was removed from the data set prior to data analysis.|2017-10-10 21:37:40.585336|2017-10-10 21:37:40.585336
NCT02958124|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-11-07|||September 2016||2016-09-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Observational|||Early Mobilization: Evaluation of Feasibility and Security in Pediatric Intensive Care Unit||Recruiting||N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||||||||||||2017-10-10 21:37:40.647001|2017-10-10 21:37:40.647001
NCT02957747|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-03|||August 2016||2016-08-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|January 2020|Anticipated|2020-01-01||Interventional|SHE||Addressing the Health Concerns of VA Women With Sexual Trauma|Addressing the Health Concerns of VA Women With Sexual Trauma|Recruiting||Phase 1|150|Anticipated|VISN 17 Center of Excellence||2|||f||||t||||||||No|No IPD will be made available for sharing|2017-10-10 21:37:43.925763|2017-10-10 21:37:43.925763
NCT02958111|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-04-17|||January 2017||2017-01-01|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01||Interventional|CAN||Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma|Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multicentre, Randomised Controlled Trial (CAN)|Recruiting||Phase 3|402|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:37:40.706062|2017-10-10 21:37:40.706062
NCT02958098|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||My Research Legacy Pilot Study|My Research Legacy Pilot Study|Not yet recruiting||N/A|2000|Anticipated|American Heart Association|||5||f||||t||||||||No|Individual participant data will not be made available to other researchers.|2017-10-10 21:37:40.941845|2017-10-10 21:37:40.941845
NCT02958072|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-12|||November 2016||2016-11-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|LiDMUS||LeucoPatch in Malleoli Ulcer Study|LeucoPatch in Malleoli Ulcer Study|Recruiting||N/A|36|Anticipated|Nordsjaellands Hospital||2|||f||||f||||||||||2017-10-10 21:37:41.141485|2017-10-10 21:37:41.141485
NCT02958059|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient||Not yet recruiting||N/A|400|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 21:37:41.266081|2017-10-10 21:37:41.266081
NCT02958046|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-11-04|||January 2014||2014-01-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity|Phase 4 Study, Assessing the Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity|Completed||Phase 4|12|Actual|Neutec Ar-Ge San ve Tic A.Ş||1|||f||||f||||||||Undecided||2017-10-10 21:37:41.367689|2017-10-10 21:37:41.367689
NCT02958033|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|November 2024|Anticipated|2024-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Shandong Cancer Hospital Affiliated to Shandong University|Shandong Cancer Hospital Affiliated to Shandong University|Recruiting||Phase 3|100|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||t||||||||Undecided||2017-10-10 21:37:41.485228|2017-10-10 21:37:41.485228
NCT02958020|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|October 2028|Anticipated|2028-10-01|October 2026|Anticipated|2026-10-01||Observational|||Multicenter Cohort Study on Osteoporosis|Multicenter Cohort Study on Osteoporosis in the Middle-aged and Elderly People in Shanghai, China|Not yet recruiting||N/A|18000|Anticipated|Shanghai University of Traditional Chinese Medicine|||1||f||||t||||||Samples With DNA|"     DNA from blood cells will be preserved for specific study.   "|No||2017-10-10 21:37:41.562868|2017-10-10 21:37:41.562868
NCT02958007|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-10-04|||June 1, 2018|Anticipated|2018-06-01|October 2017|2017-10-01|May 31, 2022|Anticipated|2022-05-31|November 30, 2021|Anticipated|2021-11-30||Interventional|||Peer Support for Exercise in Older Veterans With Psychotic Disorders|Peer Support for Exercise in Older Veterans With Psychotic Disorders|Not yet recruiting||N/A|56|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:37:41.684499|2017-10-10 21:37:41.684499
NCT02957994|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-28|||December 22, 2016|Actual|2016-12-22|June 2017|2017-06-01|November 1, 2017|Anticipated|2017-11-01|June 21, 2017|Actual|2017-06-21||Interventional|||TAF Switch Study in Hepatitis B Monoinfection|"Analysis of Proximal Renal Tubular Function of Real World Chronic Hepatitis B (CHB) Patients Who Are Suppressed on TDF and Switched to TAF"|Active, not recruiting||Phase 4|82|Actual|Asian Pacific Liver Center at St. Vincent Medical Center||1|||f||||f|t|f|||t|||No||2017-10-10 21:37:41.791381|2017-10-10 21:37:41.791381
NCT02957981|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-04|||October 2016||2016-10-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|GEM||The Genetic Education for Men Trial: Web-Based Education vs. Standard Care|The Genetic Education for Men (GEM) Trial: Web-Based Genetic Education vs. Standard Care in Men From Hereditary Cancer Families|Enrolling by invitation||Phase 2|375|Anticipated|Georgetown University||2|||f||||f||||||||No|Individual patient data will not be shared with other researchers.|2017-10-10 21:37:41.86197|2017-10-10 21:37:41.86197
NCT02957968|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-09-14|||January 24, 2017|Actual|2017-01-24|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Neoadj Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca|T-Cell Immune Checkpoint Inhibition Plus Hypomethylation for Locally Advanced HER2-Negative Breast Cancer - A Phase 2 Neoadjuvant Window Trial of Pembrolizumab and Decitabine Followed by Standard Neoadjuvant Chemotherapy|Recruiting||Phase 2|50|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f||||||||2017-10-10 21:37:41.958293|2017-10-10 21:37:41.958293
NCT02957955|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|PREHAB||Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation (PREHAB HTx Study)|Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation - Addressing Clinical Needs (PREHAB HTx Study)|Not yet recruiting||N/A|30|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||Undecided||2017-10-10 21:37:42.107472|2017-10-10 21:37:42.107472
NCT02957942|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-08-30|||January 2017||2017-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||rTMS in Spasmodic Dysphonia|Repetitive Transcranial Magnetic Stimulation in Spasmodic Dysphonia|Recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 21:37:42.221744|2017-10-10 21:37:42.221744
NCT02957734|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-11-03|||January 2016||2016-01-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Interventional|NTWP||Full Occlusal Rehabilitation for Patients With Severe Tooth Wear Using Indirect Composite Restorations|The Use of LAVA Ultimate Restorations in a Full Occlusal Rehabilitation for Patients With Severe Tooth Wear|Recruiting||N/A|22|Anticipated|Radboud University||1|||f||||f||||||||No||2017-10-10 21:37:44.020297|2017-10-10 21:37:44.020297
NCT02957929|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-31|||October 2016||2016-10-01|March 2017|2017-03-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|||Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally|A Phase 1, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of APX001, to Investigate the Effect of Food on APX001 and to Investigate the Drug-Drug Interaction Potential of APX001|Completed||Phase 1|46|Anticipated|Amplyx Pharmaceuticals||9|||f||||f||||||||||2017-10-10 21:37:42.334383|2017-10-10 21:37:42.334383
NCT02957916|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-01-17|||November 2012||2012-11-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|November 2020|Anticipated|2020-11-01|1 Year|Observational [Patient Registry]|VCOR||Vanderbilt Childhood Obesity Registry|Vanderbilt Childhood Obesity Registry|Recruiting||N/A|3000|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||Samples With DNA|"     DNA sample collected once in the form of either saliva or 5 mL of blood   "|No|Data will be shared with collaborators and on a case by case basis. Please contact Dr. Shoemaker for information.|2017-10-10 21:37:42.474347|2017-10-10 21:37:42.474347
NCT02957903|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-01-25|||November 2016||2016-11-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Sensory Distribution of Lateral Femoral Cutaneous Nerve Block|Sensory Distribution of Lateral Femoral Cutaneous Nerve Block - A Randomized, Blinded, Paired Trial in Healthy Volunteers|Completed||Phase 4|20|Actual|Zealand University Hospital||2|||f||||f||||||||Yes|If data is requested by an editor it will be allowed|2017-10-10 21:37:42.565129|2017-10-10 21:37:42.565129
NCT02957890|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-08-02|||November 18, 2016|Actual|2016-11-18|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|RETAIN||Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong|Immunogenicity of Twice-annual Vaccination Against Seasonal Influenza for Two Hemispheres in Older Adults in Hong Kong - a Randomised Controlled Trial|Active, not recruiting||Phase 4|400|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 21:37:42.676358|2017-10-10 21:37:42.676358
NCT02957877|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-04|||March 2016||2016-03-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||LMWH Infusion as Anticoagulation for Home HD|Low-molecular Heparin Infusion as Anticoagulation for Nocturnal Home Hemodialysis|Recruiting||Phase 4|12|Anticipated|Alice Ho Miu Ling Nethersole Hospital||2|||f||||f||||||||No||2017-10-10 21:37:42.782384|2017-10-10 21:37:42.782384
NCT02957864|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-07|||October 2016||2016-10-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|BACTAF||Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide|Switching to Tenofovir Alafenamide Fumarate or Abacavir in Patients With Tenofovir Disoproxil Fumarate Associated eGFR Decline. A Randomized Trial.|Recruiting||Phase 4|80|Anticipated|Erasmus Medical Center||2|||f||||f||||||||No||2017-10-10 21:37:42.902697|2017-10-10 21:37:42.902697
NCT02957851|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-05-29|||November 2016||2016-11-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|ProtoTOP||EMONO for the Treatment of Peripheral Neuropathic Pain|Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) for the Treatment of Peripheral Neuropathic Pain: A Randomises, International, Multicentre, Placebo-Controlled, Phenotype-stratified Phase IIa Study|Recruiting||Phase 2|250|Anticipated|Air Liquide Santé International||2|||f||||f||||||||No||2017-10-10 21:37:43.048877|2017-10-10 21:37:43.048877
NCT02957838|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Mitochondrial Effects of C18:0 Supplementation in Humans|Mitochondrial Effects of C18:0 Supplementation in Type 2 Diabetics Versus Healthy Controls|Recruiting||N/A|40|Anticipated|University Hospital Heidelberg||2|||f||||f||||||||Yes|All relevant, collected data will be published.|2017-10-10 21:37:43.231483|2017-10-10 21:37:43.231483
NCT02957825|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-01-13|||December 2016||2016-12-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|SHEPHERD||Surveillance of High-risk Early Postsurgical Patients for Real-time Detection of Complications|Surveillance of High-risk Early Postsurgical Patients for Real-time Detection of Complications Using Continuing Wireless Monitoring|Not yet recruiting||N/A|1892|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||No||2017-10-10 21:37:43.334085|2017-10-10 21:37:43.334085
NCT02957812|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-01-16|||November 2016||2016-11-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effects of 12-week Custom-made Orthotic Intervention on the Structure and Function of the Foot of Healthy Young Adults During Gait Termination||Recruiting||N/A|30|Anticipated|Wilfrid Laurier University||2|||f||||f||||||||Undecided||2017-10-10 21:37:43.416476|2017-10-10 21:37:43.416476
NCT02957799|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-05-12|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Improving South African Government Workers' Capacities to Deliver HIV Interventions|A Randomized Controlled Trial to Improve the South African Government's Community Health Workers' Capacities to Deliver Evidence-based Interventions for Optimizing HIV Outcomes and Reducing Its Comorbidities|Not yet recruiting||Phase 3|1080|Anticipated|University of California, Los Angeles||2|||f||||t|f|f||||||Yes|At the conclusion of this study we have a plan to de-identify the data and to make it available to other researchers.|2017-10-10 21:37:43.502991|2017-10-10 21:37:43.502991
NCT02957786|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-19|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|RAUORA||Cytisine Versus Varenicline for Smoking Cessation|RAUORA: Cytisine Versus Varenicline for Smoking Cessation|Recruiting||Phase 3|2140|Anticipated|University of Auckland, New Zealand||2|||f||||t|f|f|||f|||||2017-10-10 21:37:43.599436|2017-10-10 21:37:43.599436
NCT02957773|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-13|||January 2017||2017-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Integration of Social Art Activities and Qigong for Older People in Nursing Home in Indonesia|Integration of Social Art Activities and Qigong Exercises to Increase the Well-Being of Older People in Nursing Homes in Indonesia|Recruiting||N/A|265|Anticipated|Radboud University||4|||f||||t||||||||||2017-10-10 21:37:43.714803|2017-10-10 21:37:43.714803
NCT02957760|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-25|||December 2015||2015-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|PNPRO_HC||Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.|Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.|Recruiting||Phase 2|30|Anticipated|Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts||1|||f||||f||||||||||2017-10-10 21:37:43.843786|2017-10-10 21:37:43.843786
NCT02957708|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-11-03|||December 2007||2007-12-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Constraint-induced Movement Therapy and Self-regulation for Children With Cerebral Palsy|Effectiveness of Modified Constraint-induced Movement Therapy and Self-regulation Learning for Children With Hemiplegic Cerebral Palsy|Completed||N/A|10|Actual|University of Western Sydney||2|||f||||t||||||||||2017-10-10 21:37:44.169387|2017-10-10 21:37:44.169387
NCT02957695|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-02-08|||April 2015||2015-04-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Neurofeedback in Patients With Frontal Brain Lesions|Neurofeedback in Patients With Frontal Brain Lesions: Randomised Controlled Double-blind Trial|Completed||N/A|20|Actual|Rehab Basel||2|||f||||f||||||||No||2017-10-10 21:37:44.380119|2017-10-10 21:37:44.380119
NCT02957682|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-08-16|||November 18, 2016|Actual|2016-11-18|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Praluent on Neurocognitive Function in Patients With Heterozygous Familial Hypercholesterolemia or With Non-Familial Hypercholesterolemia at High and Very High Cardiovascular Risk|Recruiting||Phase 4|2170|Anticipated|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 21:37:44.474032|2017-10-10 21:37:44.474032
NCT02957669|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-03|||July 2016||2016-07-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|PS-R||Evaluation of Practice Self-Regulation|Evaluation of Practice Self-Regulation (PS-R)|Enrolling by invitation||N/A|600|Anticipated|The Policy & Research Group||2|||f||||f||||||||Undecided|If we shared IPD with other researchers, the dataset would need to be de-identified and approved by an Institutional Review Board before sharing.|2017-10-10 21:37:44.796065|2017-10-10 21:37:44.796065
NCT02957656|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-10|||December 2016||2016-12-01|May 2017|2017-05-01||||September 2017|Anticipated|2017-09-01||Interventional|||Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant|A Phase I Study In Healthy Adults To Assess The Safety And Immunogenicity Of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant|Recruiting||Phase 1|72|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-10-10 21:37:44.873389|2017-10-10 21:37:44.873389
NCT02957643|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement||Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Hippocration General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:37:44.992707|2017-10-10 21:37:44.992707
NCT02957630|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-03-21|||September 2016||2016-09-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"|A Single Center, Randomized,Open-label,Controlled, Three-arm Study to Evaluate the Effect of a New Combined Oral Contraceptive (COC) Containing 15 mg Estetrol (E4) and 3 mg Drospirenone (DRSP) and of Two Reference COCs Containing Either 30 mcg Ethinylestradiol (EE) and 150 mcg Levonorgestrel (LNG) or 20 mcg EE and 3 mg DRSP on Endocrine Function, Metabolic Control and Hemostasis During 6 Treatment Cycles|Active, not recruiting||Phase 1/Phase 2|101|Actual|Estetra||3|||f||||f||||||||Undecided||2017-10-10 21:37:45.069877|2017-10-10 21:37:45.069877
NCT02957617|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-10-05|||February 10, 2017|Actual|2017-02-10|October 2017|2017-10-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|RELAY-1 Extend||Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074|An Uncontrolled, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy|Recruiting||Phase 2|320|Anticipated|Biogen||1|||f||||t|f|f||||||||2017-10-10 21:37:45.204488|2017-10-10 21:37:45.204488
NCT02957604|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-07-10|||December 22, 2016|Actual|2016-12-22|June 2017|2017-06-01|April 29, 2032|Anticipated|2032-04-29|April 29, 2032|Anticipated|2032-04-29|5 Years|Observational [Patient Registry]|||Evolocumab Pregnancy Exposure Registry|Evolocumab Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study|Recruiting||N/A|375|Anticipated|Amgen|||4||f||||f||||||||||2017-10-10 21:37:45.386234|2017-10-10 21:37:45.386234
NCT02957591|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-04|||January 2017||2017-01-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Probiotic Supplementation in Severe Depression|The Effect of Probiotic Supplementation on the Efficacy of Antidepressant Treatment in Depression|Recruiting||N/A|60|Anticipated|Psychiatric Hospital of the University of Basel||2|||f||||f|f|f||||||||2017-10-10 21:37:45.503206|2017-10-10 21:37:45.503206
NCT02957578|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-12-02|||December 2016||2016-12-01|December 2016|2016-12-01|November 2019|Anticipated|2019-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Study of Solo Tympanostomy Tube Device (TTD)|Post-Market Approval Study of the Solo Tympanostomy Tube Device|Recruiting||N/A|20|Anticipated|Nottingham University Hospitals NHS Trust||1|||f||||f||||||||No|No Plan to Share Individual Participant Data|2017-10-10 21:37:45.623329|2017-10-10 21:37:45.623329
NCT02957565|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-09-21|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit|Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-10-10 21:37:45.717289|2017-10-10 21:37:45.717289
NCT02957552|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-06-18|||March 10, 2017|Actual|2017-03-10|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|MYSTEP1||Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation|Safety and Tolerance of Immunomodulating Therapy With Donor-specific Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation, a 24-month, Non-randomized, Open-label, Prospective, Single-center Pilot Trial|Recruiting||Phase 1|7|Anticipated|University Hospital Tuebingen||1|||f||||t|f|f||||||No||2017-10-10 21:37:45.823041|2017-10-10 21:37:45.823041
NCT02947724|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-01-30|||January 2013||2013-01-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Surgicel Reduces Ovarian Endometriomas Recurrence|The Use of Surgicel in Preventing Recurrence of Ovarian Endometriomas During Laparoscopic Surgery|Recruiting||Phase 2|200|Anticipated|Cairo University||4|||f||||t||||||||||2017-10-10 21:39:26.762987|2017-10-10 21:39:26.762987
NCT02957539|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-04-26|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|July 2019|Anticipated|2019-07-01||Interventional|||Financial vs. Non-Financial Rewards for Weight Loss and Weight Maintenance|Financial vs. Non-Financial Rewards for Weight Loss and Weight Maintenance: A Randomized Controlled Trial|Not yet recruiting||N/A|280|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||Yes|A corresponding data repository has been created for this project. Participants must consent to both the main project and the data repository to be included in both.|2017-10-10 21:37:45.912278|2017-10-10 21:37:45.912278
NCT02957526|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-03|||December 2015||2015-12-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|AETAPP||Web-Base App To Improve Aromatase Inhibitor Adherence|Use of an Innovative Mobile Health Application to Improve Health Outcomes for Breast Cancer Patients|Completed||N/A|44|Actual|University of Tennessee||2|||f||||f||||||||Undecided||2017-10-10 21:37:46.011|2017-10-10 21:37:46.011
NCT02957513|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-17|||November 2016||2016-11-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|MODEL||The Management of Diabetes in Everyday Life Program|Improving Self-Care Decisions of Medically Underserved African-Americans With Uncontrolled Diabetes: Effectiveness of Patient-Driven Text Messaging Versus Health Coaching|Recruiting||N/A|1000|Anticipated|University of Tennessee||3|||f||||t||||||||Yes|Data may be exported from the database system that houses study data in a variety of formats for sharing and/or analysis. At study completion, the investigators anticipate extracting all data from the system for sharing with other sources once appropriate governance and sharing restrictions have been addressed. Data dictionaries and associated metadata will be provided as needed upon request. Data can be shipped or mailed in approved, encrypted format or collected via SFTP (secure file transfer protocol) from our servers. The cost of allowing prospective investigators access to the de-identified data from this project will include IRB costs to review the application, salary support to cover staff time to review the concept proposal, submit documents to the IRB, and to establish password-protected and secured transfer application of the data. This cost is per application per investigator who wishes access granted to the de-identified data.|2017-10-10 21:37:46.104981|2017-10-10 21:37:46.104981
NCT02957500|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-03-26|||November 22, 2016|Actual|2016-11-22|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|antiadhesion||To Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®)|To Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Intrauterine Surgery in Patient With Gynecological Disease, a Multicenter, Randomized, Double- Blinded Study|Recruiting||N/A|198|Anticipated|CGBio Inc.||2|||f||||f||||||||Undecided|undecided|2017-10-10 21:37:46.233608|2017-10-10 21:37:46.233608
NCT02957487|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-11-03|||September 2013||2013-09-01|November 2016|2016-11-01||||October 2017|Anticipated|2017-10-01||Observational|||Maxillary 3-implant Removable Prostheses Without Palatal Coverage on Locator Abutments|Maxillary 3-implant Removable Prostheses Without Palatal Coverage on Locator Abutments - a Prospective Cohort Study|Recruiting||N/A|30|Anticipated|University of Tromso|||1||f||||f||||||||||2017-10-10 21:37:46.317395|2017-10-10 21:37:46.317395
NCT02957474|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-01-11|||November 2016||2016-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects|A Phase 1, Open Label, Single Center, Randomized, Six-Sequence, Crossover Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects|Completed||Phase 1|18|Actual|Celgene||4|||f||||||||||||||2017-10-10 21:37:46.403039|2017-10-10 21:37:46.403039
NCT02957461|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-09-28|||February 9, 2017|Actual|2017-02-09|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|CASVAL||Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes|Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes|Recruiting||N/A|220|Anticipated|BrainScope Company, Inc.|||1||f||||f||||||||||2017-10-10 21:37:46.494969|2017-10-10 21:37:46.494969
NCT02957448|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-02-21|||November 2016||2016-11-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects|An Open-Label, Single-Sequence Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986141 in Healthy Subjects|Completed||Phase 1|16|Actual|Bristol-Myers Squibb||1|||f||||f||||||||Undecided||2017-10-10 21:37:46.608165|2017-10-10 21:37:46.608165
NCT02957435|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-07-13|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Pharmacokinetics Study of Eplerenone Coated Tablets|Phase I, Open-label, Three Periods Study in Health Male and Female Subjects, Under Fasting Condition for Evaluation of Pharmacokinetics Profile of Single Dose of Eplerenone in Coated Tablets Formulation on Concentrations of 25mg, 50mg and 100mg, Produced by Biolab Sanus Farmacêutica Ltda|Not yet recruiting||Phase 1|12|Anticipated|Biolab Sanus Farmaceutica||1|||f||||f|f|f||||||||2017-10-10 21:37:46.68212|2017-10-10 21:37:46.68212
NCT02957422|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-02-10|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Dairy Intake and Cerebral Antioxidant Defense in Aging: a Dietary Intervention Study|Dairy Intake and Cerebral Antioxidant Defense in Aging: a Dietary Intervention Study|Recruiting||N/A|60|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||No||2017-10-10 21:37:46.761932|2017-10-10 21:37:46.761932
NCT02957409|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-03-07|||May 2016||2016-05-01|March 2017|2017-03-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01|3 Years|Observational [Patient Registry]|PARTHENON||PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada|PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada|Recruiting||N/A|1000|Anticipated|Novartis|||1||f||||f||||||||Undecided||2017-10-10 21:37:46.830823|2017-10-10 21:37:46.830823
NCT02957214|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-02|||June 2016||2016-06-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Interventional|||Effects of an Intervention Program Based on Pain Education in Patients With Chronic Pelvic Pain|Prospective Controlled Study of the Effects of an Intervention Program Based on Pain Education in Pain Activity Patterns and Brain Connectivity in Patients With Chronic Pelvic Pain by Magnetic Resonance Images|Recruiting||N/A|15|Anticipated|University of Valencia||1|||f||||||||||||||2017-10-10 21:37:49.267154|2017-10-10 21:37:49.267154
NCT02957396|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-04-21|||November 17, 2016|Actual|2016-11-17|April 2017|2017-04-01|March 1, 2017|Actual|2017-03-01|January 13, 2017|Actual|2017-01-13||Interventional|||Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects|Relative Bioavailability Study to Investigate the Pharmacokinetics, Safety and Tolerability of a Single Oral Dose of Finerenone 20 mg as Suspension (Pediatric Formulation), Intact Tablet and Crushed Tablet (Adult Formulation) in the Fasting Condition, and to Investigate the Effect of a High Fat, High Calorie Meal on the Suspension in Healthy Male Subjects in a Randomized, Open-label, Four-fold Crossover Design.|Completed||Phase 1|16|Actual|Bayer||4|||f||||f|f|f||||||||2017-10-10 21:37:46.93709|2017-10-10 21:37:46.93709
NCT02957383|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-05|||July 2015||2015-07-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Evning Exposure to Computer Screen Disrupts Sleep, Attention and Biological Rhythms|Evning Exposure to Computer Screen Disrupts Sleep, Attention and Biological Rhythms|Completed||N/A|19|Actual|Assuta Medical Center||2|||f||||t||||||||No||2017-10-10 21:37:47.043876|2017-10-10 21:37:47.043876
NCT02957370|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-11-03|||June 2015||2015-06-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|||Molecular Biosensors for Detection of Bladder Cancer|Electro-Phage and Colorimetric Aptamer Sensors for Clinical Staging and Monitoring of Bladder Cancer|Recruiting||N/A|230|Anticipated|University of California, Irvine|||2||f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-10 21:37:47.142229|2017-10-10 21:37:47.142229
NCT02957357|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-08|||February 2016||2016-02-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Observational|||Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors|Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors|Active, not recruiting||N/A|14000|Anticipated|Alliance Foundation Trials, LLC.|||1||f||||f||||||||No|The investigators do not plan to share data or to make individual participant data available.|2017-10-10 21:37:47.24518|2017-10-10 21:37:47.24518
NCT02957344|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-01-17|||August 2016||2016-08-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers|Randomized Trial to Assess Parental Response to Different Presentations of Vaccination Data for Schools and Child Care Centers|Completed||N/A|679|Actual|University of Colorado, Denver|||4||f||||f||||||||No||2017-10-10 21:37:47.294709|2017-10-10 21:37:47.294709
NCT02957331|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-03|||January 2016||2016-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Beta Blockade in in Traumatic Brain Injury|Beta-Adrenergic Blockade for Suppression of Catecholamine Surge Following Traumatic Brain Injury: A Randomized Trial|Recruiting||Phase 4|60|Anticipated|University of Tennessee||2|||f||||f||||||||No||2017-10-10 21:37:47.35716|2017-10-10 21:37:47.35716
NCT02957318|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-12|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|POFIBA||Effect of Potato Fiber on Appetite and Fecal Fat Excretion|Effect of Potato Fiber on Appetite and Fecal Fat Excretion|Completed||N/A|18|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-10 21:37:47.455496|2017-10-10 21:37:47.455496
NCT02957305|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2017-04-11|||December 21, 2016|Actual|2016-12-21|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MISO200||Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage|Comparison Between 400 µg or 200 µg of Misoprostol for Cervical Dilatation in 1st Trimester Miscarriage - A Clinical Trial|Recruiting||Phase 4|190|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||No||2017-10-10 21:37:47.533059|2017-10-10 21:37:47.533059
NCT02957292|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-04|||June 2016||2016-06-01|November 2016|2016-11-01||||March 2020|Anticipated|2020-03-01||Interventional|COLIBRI||A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).|A Randomized Controlled Trial to Compare the Menstrual Bleeding Profile Among Copper and 13,5mg Levonorgestrel-releasing IUD Users.|Recruiting||Phase 4|106|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 21:37:47.629538|2017-10-10 21:37:47.629538
NCT02957279|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-04|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Dendritic Cells-Derived Exosomes in Human Sepsis|A Cohort Study to Investigate the Impacts of Peripheral Blood Dendritic Cells-Derived Exosomes at Early Phase on the Prognosis in Human Sepsis|Recruiting||N/A|50|Anticipated|Jinling Hospital, China|||2||f||||t||||||Samples With DNA|"     peripheral venous blood   "|||2017-10-10 21:37:47.718719|2017-10-10 21:37:47.718719
NCT02957266|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-14|||March 2015||2015-03-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|CERVIPIB||Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy|Improvement of Locally Advanced Cervical Cancer Radiotherapy Efficacy by Use of Volumetric Arc Therapy, Individualized Polyradiosensitization and Interstitial Brachytherapy|Recruiting||Phase 3|400|Anticipated|The National Center of Oncology, Azerbaijan||2|||f||||f||||||||No||2017-10-10 21:37:47.804819|2017-10-10 21:37:47.804819
NCT02957253|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-04-13|||October 2016||2016-10-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|September 2020|Anticipated|2020-09-01||Interventional|||Effects on Liver Cirrhotic Patients' by a Nurse-led Clinic|Effects on Liver Cirrhotic Patient's Health Related Quality of Life by a Nurse-led Clinic: A Multicenter Randomized Controlled Trial|Recruiting||N/A|570|Anticipated|Uppsala University||4|||f||||f||||||||Undecided||2017-10-10 21:37:48.76328|2017-10-10 21:37:48.76328
NCT02957240|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-19|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Graded Motor Imagery for Women at Risk for Developing Type I CRPS Following Closed Treatment of Distal Radius Fractures|Graded Motor Imagery for Women at Risk for Developing Type I CRPS Following Closed Treatment of Distal Radius Fractures: A Pilot Randomized Comparative Effectiveness Trial|Not yet recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|f||||||No||2017-10-10 21:37:49.015679|2017-10-10 21:37:49.015679
NCT02957227|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-11-02|||July 2016||2016-07-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Diagnosis of Alzheimer's Disease Using Event Related Potentials|Diagnosis of Alzheimer's Disease Using Event Related Potentials|Recruiting||N/A|130|Anticipated|VA Boston Healthcare System|||1||f||||t||||||||Yes|De-identified data will be shared with other investigators upon written request.|2017-10-10 21:37:49.161545|2017-10-10 21:37:49.161545
NCT02957201|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-04|||July 2016||2016-07-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|EPIC||The Effect on EPCs by Successful Cardiac Occlusion Device Implantation|The Effect on Endothelial Progenitor Cells (EPCs) by Successful Cardiac Occlusion Device Implantation|Recruiting||N/A|20|Anticipated|University Hospitals of North Midlands NHS Trust||1|||f||||f||||||||No||2017-10-10 21:37:49.409736|2017-10-10 21:37:49.409736
NCT02957188|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-02|||August 2015||2015-08-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Metabolism of Omega-3 and Omega-6 During Healthy Aging|Metabolism of Uniformly Labelled 13C Eicosapentaenoic Acid and 13C Arachidonic Acid During Healthy Aging|Completed||N/A|13|Actual|Université de Sherbrooke|||2||f||||f||||||Samples With DNA|"     Fasted blood samples were collected before breakfast (baseline) and thereafter at 2 h, 4 h, 6     h, 24 h, 7 d, 14 d, after the tracer intake.   "|||2017-10-10 21:37:49.517039|2017-10-10 21:37:49.517039
NCT02957175|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-11-02|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Immunophenotyping of Patients With Postoperative SIRS|Immunophenotyping of Patients Undergoing Open Heart Surgery to Assess Their Susceptibility of Developing a Systemic Inflammatory Response Syndrome (SIRS)|Not yet recruiting||N/A|50|Anticipated|University of Bonn|||2||f||||f||||||Samples With DNA|"     Serum and Leukocytes   "|No||2017-10-10 21:37:49.600987|2017-10-10 21:37:49.600987
NCT02957162|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-11-03|||March 2016||2016-03-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ALL COMERS||"The Effect on EPCs by Statin Loading in All Comers With an ACS"|"The Effect on Endothelial Progenitor Cells (EPCs) by Statin Loading in All Comers With an Acute Coronary Syndrome (ACS)"|Recruiting||Phase 4|40|Anticipated|University Hospitals of North Midlands NHS Trust||1|||f||||f||||||||No||2017-10-10 21:37:49.702902|2017-10-10 21:37:49.702902
NCT02957149|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-08-29|||December 2016||2016-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Platelet Rich Plasma During Radical Prostatectomy|A Study Evaluating Intraoperative Application of Platelet-Rich Plasma to the Neurovascular Bundles During Nerve-Sparing Radical Prostatectomy: Initial Technical Description and Prospective Early Postoperative Outcomes Analysis|Recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|||||||2017-10-10 21:37:49.82883|2017-10-10 21:37:49.82883
NCT02957136|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|URI DxED||Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department|Randomized Clinical Trial of Multi-respiratory Pathogen Testing Versus Usual Care in Emergency Department (ED) Patients With Upper Respiratory Symptoms|Recruiting||N/A|304|Anticipated|University of California, Davis||2|||f||||f||||||||No||2017-10-10 21:37:49.936478|2017-10-10 21:37:49.936478
NCT02957123|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-04|||March 2016||2016-03-01|November 2016|2016-11-01|May 2021|Anticipated|2021-05-01|November 2020|Anticipated|2020-11-01||Interventional|||Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome|Safety/Efficacy of Intranasally-Administered Bioactive Factors Produced by Autologous M2 Macrophages in Patients With Organic Brain Syndrome|Recruiting||Phase 1/Phase 2|60|Anticipated|Russian Academy of Medical Sciences||1|||f||||||||||||||2017-10-10 21:37:50.076568|2017-10-10 21:37:50.076568
NCT02957110|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|LAF||Laughter Frequency and Fibromyalgia Symptoms|The Relationships Between Laughter Frequency, Pain Perception, and Affect in Fibromyalgia Patients|Recruiting||N/A|62|Anticipated|Walden University|||1||f||||f||||||||No||2017-10-10 21:37:50.190189|2017-10-10 21:37:50.190189
NCT02957097|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-03-23|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures|Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures|Not yet recruiting||Phase 4|30|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||Undecided||2017-10-10 21:37:50.277169|2017-10-10 21:37:50.277169
NCT02957084|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2016-11-03|||March 2013||2013-03-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Anatomic Features of the Neck and Preoperative Tests as Predictive Markers of Difficult Laryngoscopy|Anatomic Features of the Neck and Preoperative Tests as Predictive Markers of Difficult Direct Laryngoscopy|Completed||N/A|1142|Actual|National and Kapodistrian University of Athens|||1||f||||f||||||||No||2017-10-10 21:37:50.390467|2017-10-10 21:37:50.390467
NCT02957071|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-12-14|||November 2016||2016-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:37:50.489832|2017-10-10 21:37:50.489832
NCT02957058|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-05-26|||January 2017||2017-01-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|January 2019|Anticipated|2019-01-01||Interventional|PROSPER||PROSpective Assessment of Post EmR Recurrence|A Prospective Study Stratifying Patients to Follow up Intervals Based on Risk of Recurrence Post Wide Field Colonic EMR|Recruiting||N/A|700|Anticipated|Western Sydney Local Health District||2|||f||||t||||||||||2017-10-10 21:37:50.529908|2017-10-10 21:37:50.529908
NCT02957045|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-11-04|||August 2005||2005-08-01|November 2016|2016-11-01|June 2009|Actual|2009-06-01|May 2008|Actual|2008-05-01||Interventional|ESPIRATOS||Alternative Measurements of Cough Pressure and Effects of Epidural Anaesthesia on Cough Pressure|Alternative Measurements of Cough Pressure and Effects of Epidural Anaesthesia on Cough Pressure|Completed||N/A|8|Actual|Parc de Salut Mar||1|||f||||f||||||||||2017-10-10 21:37:50.623113|2017-10-10 21:37:50.623113
NCT02957032|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-11-03|||January 2016||2016-01-01|October 2016|2016-10-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation|A Dose-finding Phase I Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 1|30|Anticipated|Philogen S.p.A.||1|||f||||||||||||||2017-10-10 21:37:50.695272|2017-10-10 21:37:50.695272
NCT02956668|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-01-20|||September 2016||2016-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TABRTHH||tDCS Associated to Blindsight Rehabilitation for the Treatment of Homonymous Hemianopsia|tDCS Associated to Blindsight Rehabilitation for the Treatment of Homonymous Hemianopsia|Withdrawn||N/A|0|Actual|University of Milano Bicocca||2|||f||||t||||||||Undecided||2017-10-10 21:37:54.943543|2017-10-10 21:37:54.943543
NCT02957019|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-03|||January 2015||2015-01-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Phase I/II Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)|A Phase I/II Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)|Recruiting||Phase 1/Phase 2|38|Anticipated|Philogen S.p.A.||1|||f||||t||||||||||2017-10-10 21:37:50.790664|2017-10-10 21:37:50.790664
NCT02956993|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-05-05|||November 2016||2016-11-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)|A Phase 1, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Vonapanitase Administered Following Angioplasty of a Distal Popliteal, Tibial or Peroneal Artery in Patients With Peripheral Artery Disease|Recruiting||Phase 1|40|Anticipated|Proteon Therapeutics||2|||f||||t||||||||||2017-10-10 21:37:50.962497|2017-10-10 21:37:50.962497
NCT02956980|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-04-24|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Impact of Gender and Pubertal Status on Human Plasmacytoid Dendritic Cells|Impact of Gender and Pubertal Status on Human Plasmacytoid Dendritic Cells - PLASMACYTOKID Study|Not yet recruiting||N/A|120|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-10 21:37:51.05112|2017-10-10 21:37:51.05112
NCT02956967|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-03-14|||September 23, 2015|Actual|2015-09-23|March 2017|2017-03-01|December 12, 2016|Actual|2016-12-12|December 12, 2016|Actual|2016-12-12||Observational|||Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia|Home Administration Of Nivestimtm In The Primary Prophylaxis Of Chemotherapy-induced Febrile Neutropenia Non-interventional, Observational, Prospective Study Short Name: Home|Completed||N/A|171|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 21:37:51.137734|2017-10-10 21:37:51.137734
NCT02956954|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-04|||December 2016||2016-12-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|MyFABT1||Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease|Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease (AFD): Impact of Treatment by Agalsidase Alpha (Replagal®)|Not yet recruiting||N/A|25|Anticipated|University Hospital, Rouen||2|||f||||f||||||||No||2017-10-10 21:37:51.269337|2017-10-10 21:37:51.269337
NCT02956941|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-10|||October 2016||2016-10-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|BCC||Effect of Behavior Change Communication About Improved Micronutrient Intake on Nutritional Status and Academic Performance of School Age Children in Meskan District, Gurage Zone, South Ethiopia||Recruiting||Early Phase 1|376|Anticipated|Jimma University||2|||f||||t||||||||Undecided|It depends on the data quality and quantity.|2017-10-10 21:37:51.35808|2017-10-10 21:37:51.35808
NCT02956928|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-22|||November 2016||2016-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:37:51.43721|2017-10-10 21:37:51.43721
NCT02956915|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-08-21|||May 22, 2017|Actual|2017-05-22|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FAST-TAVI||Evaluation of Length of Stay After TF-TAVI|Evaluation of Length of Stay and Predisposing Factors of Late Discharge After Transfemoral Transcatheter Aortic Valve Implantation Using the SAPIEN-3 Prosthesis: A French Multicenter Prospective Observational Trial|Recruiting||N/A|300|Anticipated|University Hospital, Rouen|||1||f||||f|f|f||||||||2017-10-10 21:37:51.479534|2017-10-10 21:37:51.479534
NCT02956902|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-07|||December 2016||2016-12-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||A Smartphone Intervention With Telemedicine Support for Management of Post-traumatic Stress Disorder: A Randomized Trial|A Smartphone Intervention With Telemedicine Support for Management of Post-traumatic Stress Disorder: A Randomized Trial|Not yet recruiting||N/A|80|Anticipated|Ontario Shores Centre for Mental Health Sciences||2|||f||||f||||||||||2017-10-10 21:37:51.595113|2017-10-10 21:37:51.595113
NCT02956889|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-11-03|||October 2016||2016-10-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|virgilio||To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma|A Single Arm, Phase II, Multicenter Study To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Patients With High Risk Or Locally Advanced Basal Cell Carcinoma Not Amenable To Radical Surgery|Recruiting||Phase 2|42|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||No|not planned|2017-10-10 21:37:51.656797|2017-10-10 21:37:51.656797
NCT02956876|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|INCISIVE||Equivalence of Monitoring by a Nurse Practitioner for Patients With Digestive Cancer|Equivalence of Monitoring by a Nurse Practitioner for Patients With Digestive Cancer, Requiring Intravenous Chemotherapy Versus a Medical Monitoring|Not yet recruiting||Phase 3|754|Anticipated|University Hospital, Rouen||2|||f||||t||||||||Undecided||2017-10-10 21:37:51.743796|2017-10-10 21:37:51.743796
NCT02956863|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-03-21|||December 2016||2016-12-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Osteopathic Treatment in Pain and Functionality Individuals With Chronic Neck Pain|The Effect of Osteopathic Manipulative Treatment in Pain and Functionality Individuals With Nonspecific Chronic Neck Pain: Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Instituto Brasileiro de Osteopatia||2|||f||||f||||||||No||2017-10-10 21:37:51.826136|2017-10-10 21:37:51.826136
NCT02956850|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-10-05|||December 12, 2016|Actual|2016-12-12|October 2017|2017-10-01|April 24, 2019|Anticipated|2019-04-24|April 24, 2019|Anticipated|2019-04-24||Interventional|||A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531||Recruiting||Phase 1|110|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 21:37:51.915235|2017-10-10 21:37:51.915235
NCT02956824|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-11-02|||November 2015||2015-11-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|MISIA||Incidence of MRI Sacro-Iliac Joint Anomalies in Young Women|Incidence of Sacro-Iliac Joint Anomalies on MRI in Women Aged From 18 to 50 Years Old|Recruiting||N/A|500|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 21:37:52.161131|2017-10-10 21:37:52.161131
NCT02956811|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-08-04|||February 14, 2017|Actual|2017-02-14|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|DAPA-LVH||Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?|DAPA-LVH - Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?|Recruiting||Phase 4|64|Anticipated|University of Dundee||2|||f||||f|f|f||||||||2017-10-10 21:37:53.840903|2017-10-10 21:37:53.840903
NCT02956785|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2017-04-25|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRODUCT||What After the First Propess|What After the First Propess. A Randomised Comparative Prospective Study|Recruiting||Phase 2|330|Anticipated|South Warwickshire NHS Foundation Trust||3|||f||||f||||||||||2017-10-10 21:37:54.024646|2017-10-10 21:37:54.024646
NCT02956772|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-02-21|||November 2016||2016-11-01|February 2017|2017-02-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients|A Prospective Multicenter Randomized Controlled Open-label Trial of Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients|Not yet recruiting||Phase 2|190|Anticipated|Hunan Provincial People's Hospital||2|||f||||f||||||||No||2017-10-10 21:37:54.121184|2017-10-10 21:37:54.121184
NCT02956759|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-11-03|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Early Laser Treatment for Diabetic Eye Disease in China : A Pilot Randomized Trial|Early Laser Treatment for Diabetic Eye Disease in China: The PEARL Pilot Randomized Trial|Recruiting||N/A|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:37:54.218652|2017-10-10 21:37:54.218652
NCT02956746|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-08-14|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|RabiesMab||A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines|A Phase 2 Randomized Blinded Placebo Controlled Comparison of the Safety Pharmacokinetics and Pharmacodynamics of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines in Healthy Adult Subjects|Recruiting||Phase 1/Phase 2|160|Anticipated|Synermore Biologics Co., Ltd.||4|||f||||f||||||||||2017-10-10 21:37:54.322218|2017-10-10 21:37:54.322218
NCT02956733|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-03|||October 2015||2015-10-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Dermotaxis v/s Loop Suture Technique for Closure of Fasciotomy Wounds : a Study of 50 Cases|Dermotaxis v/s Loop Suture Technique for Closure of Fasciotomy Wounds : a Study of 50 Cases|Completed||N/A|50|Actual|Government Medical College, Patiala||2|||f||||f||||||||Undecided||2017-10-10 21:37:54.42773|2017-10-10 21:37:54.42773
NCT02956720|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-07-30|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||UltraShape Power in Combination With U-sculpt-n Transducer|Clinical Evaluation of UltraShape Power System in Conjunction With the U-Sculpt-N Transducer for Non-invasive Circumference Reduction|Recruiting||N/A|24|Anticipated|Syneron Candela||1|||f||||||||||||||2017-10-10 21:37:54.493993|2017-10-10 21:37:54.493993
NCT02956707|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-11-03|||July 2016||2016-07-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Impact of Pre-operative Steroids on Adrenal Insufficiency|Impact of Pre-operative Steroids on Adrenal Insufficiency and Clinical Outcomes After Neonatal Cardiac Surgery With Cardiopulmonary Bypass|Recruiting||N/A|40|Anticipated|University of Alabama at Birmingham|||2||f||||t||||||Samples With DNA|"     As a separate portion to this study consenting subject's legally authorized representative     can provide consent to allow specimens to be stored for future research related to heart     disease. These specimens include: blood (cell pellet and plasma), urine, and peritoneal     dialysis fluid (if applicable).   "|No|On de-identified study data will be published|2017-10-10 21:37:54.662164|2017-10-10 21:37:54.662164
NCT02956694|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-03|||October 2016||2016-10-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Intervention to Improve Shared Decision Making Among Seniors With Dementia, Their Caregivers and Healthcare Providers|Design, Implementation and Evaluation of a Tailored Intervention to Improve Shared Decision Making Among Seniors With Dementia, Their Caregivers and Healthcare Providers|Recruiting||N/A|162|Anticipated|Laval University||2|||f||||f||||||||Undecided||2017-10-10 21:37:54.775051|2017-10-10 21:37:54.775051
NCT02956681|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-11-02|||October 2007||2007-10-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|September 2012|Actual|2012-09-01||Interventional|||Statewide Communication to Reach Diverse Low Income Women|Statewide Communication to Reach Diverse Low Income Women|Completed||N/A|88|Actual|University of California, San Francisco||2|||f||||t||||||||No||2017-10-10 21:37:54.87393|2017-10-10 21:37:54.87393
NCT02954341|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-11-01|||October 2016||2016-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||CardioMEMS HF System OUS Post Approval Study|CardioMEMS HF System OUS Post Approval Study|Recruiting||N/A|250|Anticipated|St. Jude Medical|||1||f||||f||||||||No||2017-10-10 21:38:19.367659|2017-10-10 21:38:19.367659
NCT02956655|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-04|||July 2016||2016-07-01|November 2016|2016-11-01||||July 2017|Anticipated|2017-07-01||Interventional|||Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients|Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients|Recruiting||N/A|60|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||No||2017-10-10 21:37:55.047661|2017-10-10 21:37:55.047661
NCT02956642|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-02|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SUGAR||Study of Unprecedented Glucose Analysis and Results|Study of Unprecedented Glucose Analysis and Results: A Randomized Controlled Trial of the Effect of the Livongo Health Diabetes Management Program vs. Standard Care on Glycemic Control|Not yet recruiting||Phase 2|200|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 21:37:55.156098|2017-10-10 21:37:55.156098
NCT02956616|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-07|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|ERAC||Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay|Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay|Recruiting||N/A|118|Anticipated|Montefiore Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:37:55.385272|2017-10-10 21:37:55.385272
NCT02956603|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-03|||November 2014||2014-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Studying Electromyographic Activity in Patients With Upper Limb Amputations|Studying Electromyographic Activity in Patients With Upper Limb Amputations|Enrolling by invitation||N/A|20|Anticipated|University of Michigan||3|||f||||f||||||||No|Individual participant data will not be shared|2017-10-10 21:37:55.491126|2017-10-10 21:37:55.491126
NCT02956590|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-03-23|||January 2017||2017-01-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|DO-IT||Dyslipidemia of Obesity Intervention in Teens|Dyslipidemia of Obesity Intervention in Teens Trial|Not yet recruiting||Phase 4|354|Anticipated|New England Research Institutes||2|||f||||t||||||||||2017-10-10 21:37:55.557856|2017-10-10 21:37:55.557856
NCT02956577|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-04-24|||March 2016||2016-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Observational|DIABECHO||Cardiac Function and Microcirculation: Type 2 DIABetes and ECHOcardiographic Changes Over Time|Systolic and Diastolic Left Ventricular Function in Patients With Type 2 DIABetes Mellitus: Changes Over Time and Comparison With Cardiac Microcirculation. An ECHOcardiographic Study|Recruiting||N/A|300|Anticipated|Svendborg Hospital|||3||f||||f||||||Samples With DNA|"     Storage in biobank (-80° C):      5 x 2 ml (serum).      4 x 2 ml (ethylenediaminetetraacetic acid).      2 x 2 ml (sodium citrate)      1 x 2 ml (erythrocyte sedimentation rate)   "|No||2017-10-10 21:37:55.637699|2017-10-10 21:37:55.637699
NCT02956564|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-12-09|||December 2016||2016-12-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment|Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment|Not yet recruiting||N/A|144|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:37:55.717848|2017-10-10 21:37:55.717848
NCT02956551|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|SKLB1608||Neoantigen-primed Dendritic Cells (DC)- Pre-activated T (PreT) Cell Therapy for Refractory Non-small Cell Lung Cancer|Neoantigen-primed DC-PreT Cell Therapy for Refractory Non-small Cell Lung Cancer|Not yet recruiting||Phase 1|20|Anticipated|Sichuan University||1|||f||||f||||||||Undecided||2017-10-10 21:37:55.788151|2017-10-10 21:37:55.788151
NCT02956538|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-11-03|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide|Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide: A Randomized, Double-blind, Placebo-controlled Multicenter Clinical Study|Recruiting||Early Phase 1|72|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||Yes||2017-10-10 21:37:55.871994|2017-10-10 21:37:55.871994
NCT02956525|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-04|||June 2017||2017-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 200 mg.|Open-label, Randomized, Single Dose, Crossover 2x2 to Assess the Interaction of Food on the Pharmacokinetics of Dexibuprofen 200 mg (Apsen Pharmaceuticals A / S.) After Oral Administration in Healthy Subjects of Both Sexes Under Conditions of Fasting and Fed|Not yet recruiting||Phase 1|24|Anticipated|Apsen Farmaceutica S.A.||2|||f||||||||||||||2017-10-10 21:37:55.980787|2017-10-10 21:37:55.980787
NCT02956512|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-04|||June 2017||2017-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 300 mg.|Open-label, Randomized, Single Dose, Crossover 2x2 to Assess the Interaction of Food on the Pharmacokinetics of Dexibuprofen 300 mg (Apsen Pharmaceuticals A / S.) After Oral Administration in Healthy Subjects of Both Sexes Under Conditions of Fasting and Fed|Not yet recruiting||Phase 1|24|Anticipated|Apsen Farmaceutica S.A.||2|||f||||f||||||||||2017-10-10 21:37:56.099059|2017-10-10 21:37:56.099059
NCT02956499|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-31|||May 2016|Actual|2016-05-01|November 2016|2016-11-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Safety, Tolerability and Pharmacokinetics of APX001 Administered Intravenously|A First-in-Human, Randomized, Dose-Escalation, Double-Blind, Placebo Controlled Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects|Completed||Phase 1|120|Actual|Amplyx Pharmaceuticals||10|||f||||f||||||||||2017-10-10 21:37:56.199859|2017-10-10 21:37:56.199859
NCT02956486|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-03-15|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|MissionAD1||A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease|A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease|Recruiting||Phase 3|1330|Anticipated|Eisai Inc.||2|||f||||t||||||||Undecided||2017-10-10 21:37:56.338118|2017-10-10 21:37:56.338118
NCT02956473|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-03|||December 2016||2016-12-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Supine MRI in Breast Cancer Patients Receiving Neoadjuvant Therapy|Supine MRI in Breast Cancer Patients Receiving Neoadjuvant Therapy|Not yet recruiting||N/A|74|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:37:56.921511|2017-10-10 21:37:56.921511
NCT02956460|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-05-17|||October 27, 2016|Actual|2016-10-27|May 2017|2017-05-01|April 17, 2017|Actual|2017-04-17|January 27, 2017|Actual|2017-01-27||Interventional|||Performance Comparison Between Fanfilcon A and Senofilcon C Sphere Lenses|Performance Comparison Between Fanfilcon A and Senofilcon C Sphere Lenses|Completed||N/A|64|Actual|Coopervision, Inc.||2|||f||||f||||||||No||2017-10-10 21:37:57.049762|2017-10-10 21:37:57.049762
NCT02956447|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-06-16|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|February 2021|Anticipated|2021-02-01|January 2021|Anticipated|2021-01-01||Interventional|||Administration of Kisspeptin in Patients With Hyperprolactinemia|Administration of Kisspeptin in Patients With Hyperprolactinemia|Not yet recruiting||Phase 2|45|Anticipated|Massachusetts General Hospital||3|||f||||t|t|f||||||Yes|After primary results are published, the authors will provide individual participant data upon request as long as it does not conflict with state or institutional regulations|2017-10-10 21:37:57.144859|2017-10-10 21:37:57.144859
NCT02956434|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-25|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2021|Anticipated|2021-08-31||Interventional|||An Adjunctive Family Intervention for Individual Posttraumatic Stress Disorder Treatment|An Adjunctive Family Intervention for Individual PTSD Treatment|Not yet recruiting||N/A|58|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 21:37:57.257218|2017-10-10 21:37:57.257218
NCT02956421|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-06|||February 2016||2016-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen|Phase II Study to Determine the Efficacy and Safety of PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen|Completed||Phase 2|126|Actual|Yisheng Biopharma (Singapore) Pte. Ltd.||2|||f||||t||||||||No||2017-10-10 21:37:57.344006|2017-10-10 21:37:57.344006
NCT02956408|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Efficacy of Vitamin D Supplementation in Obese Children|Efficacy of Vitamin D Supplementation in Obese Children|Enrolling by invitation||Phase 4|400|Anticipated|Columbia University||2|||f||||f||||||||No||2017-10-10 21:37:57.440265|2017-10-10 21:37:57.440265
NCT02956395|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-04-22|||September 1, 2017|Anticipated|2017-09-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|September 1, 2019|Anticipated|2019-09-01||Interventional|Nextcare_CCP||Implementation of Community-based Collaborative Management of Complex Chronic Patients|Protocol for Regional Implementation of Community-based Collaborative Management of Complex Chronic Patients (CCP)|Not yet recruiting||N/A|3000|Anticipated|Hospital Clinic of Barcelona||2|||f||||f|f|f||||||Undecided||2017-10-10 21:37:57.531337|2017-10-10 21:37:57.531337
NCT02956382|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-08-30|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma|Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma|Recruiting||Phase 1/Phase 2|41|Anticipated|Georgetown University||5|||f||||t|t|f||||||||2017-10-10 21:37:57.630378|2017-10-10 21:37:57.630378
NCT02956369|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-04|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effect of Daily Intake of SATIOSTAT Over 6 Weeks on Weight Loss, Glucose Tolerance, Gastrointestinal Tolerance and Gut Microbiota.|Chronic Effect of Daily Intake of SATIOSTAT Over 6 Weeks on Weight Loss, Glucose Tolerance, Gastrointestinal Tolerance and Gut Microbiota.|Recruiting||N/A|30|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||Undecided||2017-10-10 21:37:57.74828|2017-10-10 21:37:57.74828
NCT02956356|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Acute Effects of SATIOSTAT Ingestion on Satiation Hormones, Gastric Emptying, Subjective Feelings of Appetite and Energy Intake|Acute Effects of SATIOSTAT Ingestion on Satiation Hormones, Gastric Emptying, Subjective Feelings of Appetite and Energy Intake|Recruiting||N/A|15|Anticipated|University Hospital, Basel, Switzerland||4|||f||||f||||||||Undecided||2017-10-10 21:37:57.854755|2017-10-10 21:37:57.854755
NCT02956343|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-19|||December 2016||2016-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|WATCHAF||SmartWATCHes for Detection of Atrial Fibrillation|SmartWATCHes for Detection of Atrial Fibrillation|Recruiting||N/A|600|Anticipated|University Hospital, Basel, Switzerland|||2||f||||t||||||||||2017-10-10 21:37:57.958305|2017-10-10 21:37:57.958305
NCT02956330|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-06-22|||November 2016||2016-11-01|June 2017|2017-06-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Observational|||Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201|Retrospective Study of the Safety and Efficacy of Suprachoroidal CLS-TA in Combination With Intravitreal Aflibercept for the Treatment of Macular Edema Associated With RVO in Subjects Who Completed Parent Study CLS1003-201|Completed||N/A|20|Actual|Clearside Biomedical, Inc.|||1||f||||||||||||||2017-10-10 21:37:58.062328|2017-10-10 21:37:58.062328
NCT02956317|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||A Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophic Scar|A Randomized, Double-Blind, Within-Subject Placebo Controlled Study to Evaluate the Safety and Efficacy of Various Doses of STP705 Administered as Intradermal Injection in Subjects With Hypertrophic Scar|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Sirnaomics||2|||f||||||||||||Undecided||2017-10-10 21:37:58.146308|2017-10-10 21:37:58.146308
NCT02956304|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-04-26|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|SIMULANG-TMS||" Effect of Affordance of Objects on the Memory: Study in Transcranial Magnetic Stimulation "|" Effect of Affordance of Objects on the Memory: Study in Transcranial Magnetic Stimulation  (SIMULANG-TMS)"|Recruiting||N/A|30|Anticipated|Centre Hospitalier St Anne||6|||f||||f|f|f||||||Undecided||2017-10-10 21:37:58.21856|2017-10-10 21:37:58.21856
NCT02956291|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-04-24|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors|Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors|Not yet recruiting||N/A|84|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:37:58.317521|2017-10-10 21:37:58.317521
NCT02956278|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-02|||November 2016||2016-11-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics||Recruiting||Phase 4|15|Anticipated|University of California, San Francisco||2|||f||||||||||||||2017-10-10 21:37:58.396887|2017-10-10 21:37:58.396887
NCT02956265|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-03|||October 2016||2016-10-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|SPETROLIVE||Optical Spectroscopy for Skin Carcinomas' Surgical Management|Assessment of Optical Spectroscopy's (Combining Autofluorescence and Diffuse Reflectance) Diagnosis Accuracy (Sensitivity and Specificity) When Non-invasively and Automatically Classifying Skin Lesions in One of the Following Histological Classes: Healthy, Actinic Keratosis, in Situ Carcinoma and Invasive Carcinoma.|Recruiting||N/A|140|Anticipated|Centre Hospitalier Régional Metz-Thionville||1|||f||||t||||||||No||2017-10-10 21:37:58.468261|2017-10-10 21:37:58.468261
NCT02956252|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-04|||June 2008||2008-06-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Observational|||Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy|Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy: a Cohort Study With Unselected Consecutive Patients|Completed||N/A|1500|Actual|Medical Park Gaziantep Hospital|||2||f||||t||||||||No||2017-10-10 21:37:58.52989|2017-10-10 21:37:58.52989
NCT02956239|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-11-04|||February 2017||2017-02-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|DELTA||Development, Field Testing and Evaluation of the Efficacy of a Hand-held, Portable and Affordable Thermo-coagulator to Prevent Cervical Cancer in Low- and Middle-income Countries|Development, Field Testing and Evaluation of the Efficacy of a Hand-held, Portable and Affordable Thermo-coagulator to Prevent Cervical Cancer in Low- and Middle-income Countries|Not yet recruiting||N/A|450|Anticipated|International Agency for Research on Cancer||3|||f||||f||||||||Yes||2017-10-10 21:37:58.59723|2017-10-10 21:37:58.59723
NCT02956226|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-06-26|||January 2017||2017-01-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|CBA||Cannabinoids for Behavioral Problems in Children With ASD|Cannabinoids for Behavioral Problems in Autism Spectrum Disorder: A Double Blind, Randomized, Placebo-controlled Trial With Crossover.|Recruiting||Phase 2|120|Anticipated|Shaare Zedek Medical Center||3|||f||||t||||||||Undecided||2017-10-10 21:37:58.674653|2017-10-10 21:37:58.674653
NCT02956213|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-08-28|||November 2016||2016-11-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Indoor Air Quality and Respiratory Symptoms in Former Smokers|Assessing the Effect of Different Efficiency Indoor Air Filters on Respiratory Symptoms in Former Smokers|Recruiting||N/A|80|Anticipated|Intermountain Health Care, Inc.||2|||f||||f||||||||||2017-10-10 21:37:58.874022|2017-10-10 21:37:58.874022
NCT02956200|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-11-06|||November 2016||2016-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|FAMTAIS||Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke|A Randomised Controlled Trial of Combinating an Immune Modulator Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke|Not yet recruiting||Phase 2|96|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||f||||||||Undecided||2017-10-10 21:37:59.000461|2017-10-10 21:37:59.000461
NCT02956187|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-06-13|||June 2016||2016-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Treatment of Constipation in Functional Dyspepsia|Effect of Treatment of Constipation on Dyspeptic Symptoms in Patients With Constipation and Functional Dyspepsia|Recruiting||N/A|40|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||No||2017-10-10 21:37:59.109939|2017-10-10 21:37:59.109939
NCT02956174|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-05|||May 2012||2012-05-01|November 2016|2016-11-01||||July 2016|Actual|2016-07-01||Interventional|||Posterior CAD/CAM Cobalt-chromium Alloy Single Crowns: 4-year Prospective Clinical Study|Posterior CAD/CAM Cobalt-chromium Alloy Single Crowns: 4-year Prospective Clinical Study|Completed||N/A|89|Actual|Federico II University||2|||f||||||||||||||2017-10-10 21:37:59.193507|2017-10-10 21:37:59.193507
NCT02956161|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-02|||September 2016||2016-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|STIMENPHASE||Effects of Synchronised Auditory Stimulations of the Sleep Slow Oscillation on Deep Sleep Quality|Effects of Synchronised Auditory Stimulations of the Sleep Slow Oscillation on Deep Sleep|Completed||N/A|24|Actual|Rythm||3|||f||||f||||||||Yes||2017-10-10 21:37:59.260245|2017-10-10 21:37:59.260245
NCT02956148|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-11-02|||June 2015||2015-06-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|LONGPDE10||Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers|Follow-up Measurement of Brain Phosphodiesterase 10 A (PDE10A) Enzyme Levels in Huntington´s Disease Gene Expansion Carriers, 18 to 28 Months After Initial Positron Emission Tomography (PET) Measurement in CHDIKI1201/PET-HD-PDE10A (NCT02061722)|Recruiting||Early Phase 1|45|Anticipated|CHDI Foundation, Inc.||1|||f||||f||||||||No||2017-10-10 21:37:59.360339|2017-10-10 21:37:59.360339
NCT02956135|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-12-20|||September 2013||2013-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|July 2015|Actual|2015-07-01||Observational|||Relationship Between Dysfunctions of Movement in the Lower Back and Pelvis With Overuse Injuries in Handball Players|Relationship Between Dysfunctions of Movement in the Lower Back and Pelvis With Overuse Injuries in Handball Players|Completed||N/A|22|Actual|Cardenal Herrera University|||1||f||||f||||||||Undecided||2017-10-10 21:37:59.471735|2017-10-10 21:37:59.471735
NCT02946645|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|BENEFIT||Efficiency of Neuromuscular Bite vs Physiotherapy in TMD Patients||Active, not recruiting||N/A|150|Anticipated|University of L'Aquila||3|||f||||f||||||||No||2017-10-10 21:39:37.473934|2017-10-10 21:39:37.473934
NCT02956122|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-07|||April 26, 2017|Actual|2017-04-26|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD|A Two-Part, Multi-Center, Prospective, Phase 2/3 Clinical Study to Evaluate the Safety and Efficacy of GLASSIA as an Add-On Biopharmacotherapy to Conventional Steroid Treatment in Subjects With Acute Graft-Versus-Host Disease With Lower Gastrointestinal Involvement|Suspended||Phase 2/Phase 3|168|Anticipated|Baxalta US Inc.||3||The decision to discontinue the study was based on business reasons.|f||||t|t|f||||||||2017-10-10 21:37:59.544224|2017-10-10 21:37:59.544224
NCT02956109|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-07-06|||November 16, 2016|Actual|2016-11-16|July 2017|2017-07-01|March 17, 2017|Actual|2017-03-17|December 22, 2016|Actual|2016-12-22||Interventional|||Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers|Relative Bioavailability Study to Investigate the Pharmacokinetics, Safety and Tolerability of Single Oral Doses of Finerenone 1.25 mg and 5 x 0.25 mg Orodispersible Tablet (Pediatric Formulation) in Comparison to 10 mg Tablet (Adult Formulation) in the Fasting Condition and to Investigate the Effect of a High Fat, High Calorie Meal on 1.25 mg Oro-dispersible Tablet in Healthy Male Subjects in a Randomized, Open-label, Four-fold Crossover Design|Completed||Phase 1|16|Actual|Bayer||4|||f||||f|f|f||||||||2017-10-10 21:37:59.684872|2017-10-10 21:37:59.684872
NCT02956096|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-11-22|||December 2016||2016-12-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluation of Autonomic Modulation in Stroke After Transcranial Direct Current Stimulation and Treadmill Training|Evaluation of Autonomic Modulation in the Hemiparetic Patients After Transcranial Direct Current Stimulation (tDCS) and Treadmill Training: Clinical Trial, Controlled, a Randomized, Double-blind|Not yet recruiting||N/A|30|Anticipated|University of Nove de Julho||2|||f||||t||||||||Undecided||2017-10-10 21:37:59.777092|2017-10-10 21:37:59.777092
NCT02956083|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-02|||July 2014||2014-07-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Tear Supplements on Contact Lens Comfort|The Effect of Tear Supplements on Contact Lens Comfort|Completed||N/A|30|Actual|University of the Incarnate Word||3|||f||||f||||||||No||2017-10-10 21:37:59.887868|2017-10-10 21:37:59.887868
NCT02956070|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-11-02|||October 2015||2015-10-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Anti-inflammatory Steroids in the Prevention of Tooth Sensitivity|Evaluation of Anti-inflammatory Steroids of Use in the Prevention of Tooth Sensitivity in Teeth Whitening Technique Office|Completed||N/A|70|Actual|Universidade Federal Fluminense||2|||f||||f||||||||No||2017-10-10 21:37:59.960432|2017-10-10 21:37:59.960432
NCT02956044|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-18|||November 2016||2016-11-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin|A Phase 1, Open-label, Randomized, Three-period, Crossover Study to Evaluate Pharmacokinetic Interaction Between Bexagliflozin Tablets and Metformin, Glimepiride, or Sitagliptin in Healthy Subjects|Completed||Phase 1|54|Actual|Theracos||9|||f||||t|t|f||||||||2017-10-10 21:38:00.187792|2017-10-10 21:38:00.187792
NCT02956031|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01||||November 2019|Anticipated|2019-11-01|3 Months|Observational [Patient Registry]|DiaVACCS||Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.|Primary HPV Screening as an Indicator of Cervical Pre-invasive and Invasive Neoplasia in HIV-positive and -Negative Southern African Women|Recruiting||N/A|1000|Anticipated|University of Pretoria|||3||f||||||||||||||2017-10-10 21:38:00.306608|2017-10-10 21:38:00.306608
NCT02956018|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-02|||November 2016||2016-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Kidney Transplant Monitoring Using Near Infra-red Spectroscopy|Continuous Monitoring of Kidney Transplant Perfusion Using Near Infra-red Spectroscopy|Recruiting||N/A|50|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 21:38:00.43148|2017-10-10 21:38:00.43148
NCT02956005|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-02|||September 2016||2016-09-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|EXR||Envarsus XR in African American Renal Transplant Recipients|Envarsus XR in African American Renal Transplant Recipients|Recruiting||N/A|100|Anticipated|Georgetown University||1|||f||||f||||||||||2017-10-10 21:38:00.500136|2017-10-10 21:38:00.500136
NCT02955992|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2016-11-03|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|April 2019|Anticipated|2019-04-01||Interventional|COSMIC||Guiding ICU Physicians' Communication and Behavior Towards Bereaved Relatives: a Randomized Controlled Trial|Guiding ICU Physicians' Communication and Behavior Towards Bereaved Relatives: a Randomized Controlled Trial (COSMIC - EOL)|Not yet recruiting||N/A|900|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-10 21:38:00.584389|2017-10-10 21:38:00.584389
NCT02955979|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-12-12|||December 2016||2016-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CANOPY||Incidence of Acute Renal Failure Associated With Iodinated Contrast Agents in Pediatrics|Incidence of Acute Renal Failure Associated With Iodinated Contrast Agents in Pediatrics. Study CANOPY. Prospective Multicenter Study|Recruiting||N/A|500|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 21:38:00.701697|2017-10-10 21:38:00.701697
NCT02955966|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-07-31|||June 2, 2017|Actual|2017-06-02|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|August 2019|Anticipated|2019-08-01||Interventional|OPTIFIL||PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis|PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||||2017-10-10 21:38:00.809227|2017-10-10 21:38:00.809227
NCT02955953|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-03-20|||November 14, 2016|Actual|2016-11-14|March 2017|2017-03-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Interventional|||A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants|Bioequivalence Study Comparing the Pharmacokinetics and Glucodynamics of LY2963016 U-200 Formulation With LY2963016 U-100 Formulation in Healthy Subjects|Completed||Phase 1|127|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:38:00.933438|2017-10-10 21:38:00.933438
NCT02955940|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-06-02|||November 2016||2016-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib|An Open-Label, Multicenter, Rollover Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib|Enrolling by invitation||Phase 2|150|Anticipated|Incyte Corporation||3|||t||||f||||||||Undecided||2017-10-10 21:38:01.005109|2017-10-10 21:38:01.005109
NCT02955927|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-06-13|||November 2016||2016-11-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial|Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-10 21:38:01.104071|2017-10-10 21:38:01.104071
NCT02955914|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-05-04|||September 2016||2016-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||The Effect of Patient Optimism & Pessimism on Recovery From Elective Cardiac Surgery|The Effect of Patient Optimism & Pessimism on Recovery From Elective Cardiac Surgery|Recruiting||N/A|419|Anticipated|Papworth Hospital NHS Foundation Trust|||2||f||||f||||||||Yes|The data will be disseminated among the research team. Patients can see a copy of the final report upon request.|2017-10-10 21:38:01.203281|2017-10-10 21:38:01.203281
NCT02955901|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-01-21|||January 1, 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||3-day vs. 1-day Low Residue Diet Influence in Colonoscopy Preparation and Patient Tolerability|A 3-day Versus 1-day Low Residue Diet to Improve Colonoscopy Preparation Result and Patient Tolerability: A Prospective, Randomized, Single-blinded, Controlled Trial|Enrolling by invitation||N/A|412|Anticipated|Portuguese Oncology Institute, Coimbra||2|||f||||f||||||||No||2017-10-10 21:38:01.28757|2017-10-10 21:38:01.28757
NCT02955888|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-27|||January 3, 2017|Actual|2017-01-03|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance|A Phase 2, Double-Blind, Placebo Controlled Study to Evaluate the Safety & Tolerability of PBI-4050 and Its Effects on Pancreatic and Pulmonary Function in Cystic Fibrosis Patients With Abnormal Glucose Tolerance|Recruiting||Phase 2|90|Anticipated|ProMetic Pharma SMT Limited||2|||f||||t|f|f||||||||2017-10-10 21:38:01.386012|2017-10-10 21:38:01.386012
NCT02955875|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-02|||January 2015||2015-01-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|IMPACT4-DM||Pharmaceutical Care Service in Diabetes|Impact of Pharmaceutical Care Service for Type 2 Diabetes Mellitus Patients in Korea|Completed||N/A|257|Actual|Pusan National University||2|||f||||||||||||||2017-10-10 21:38:01.484308|2017-10-10 21:38:01.484308
NCT02955862|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-03|||June 2015||2015-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report|Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report From June 2015 to June 2016|Recruiting||Phase 1|1500|Anticipated|National Hospital for Tropical Diseases, Hanoi, Vietnam||1|||f||||f||||||||No||2017-10-10 21:38:01.586283|2017-10-10 21:38:01.586283
NCT02955849|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-11-02|||September 2016||2016-09-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|||A Trial of China Laser and Surgery Study Glaucoma in Rural China|The China Laser and Surgery Study : A Mixed Methods Study With an Random Control Trial Comparing Outcomes From Selective Laser Trabeculoplasty Versus Surgical Treatment (Trabeculectomy) for Glaucoma in Rural China .|Active, not recruiting||Early Phase 1|200|Anticipated|Sun Yat-sen University||3|||f||||t||||||||Yes||2017-10-10 21:38:01.721957|2017-10-10 21:38:01.721957
NCT02955836|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-05-02|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Effectiveness of Monitoring Information System of Nursing Related Patient Safety and Quality Indicators|Establishing and Exploring the Need and Effectiveness of Monitoring Information System of Nursing-related Patient Safety and Quality Indicators|Recruiting||N/A|2000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 21:38:01.834706|2017-10-10 21:38:01.834706
NCT02955810|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-11-25|||November 2016||2016-11-01|November 2016|2016-11-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|CyBorD-Dara||Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)|"Phase Ib Study of Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) in Transplant Eligible Patients With Newly Diagnosed Multiple Myeloma (MM): The CyBorD-DARA Study"|Recruiting||Phase 1|18|Anticipated|National University of Ireland, Galway, Ireland||1|||f||||t||||||||||2017-10-10 21:38:02.23943|2017-10-10 21:38:02.23943
NCT02955797|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-09-29|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers|Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers 12 to 23 Months of Age.|Active, not recruiting||Phase 3|918|Actual|Sanofi||4|||f||||f|f|f||||||||2017-10-10 21:38:02.358003|2017-10-10 21:38:02.358003
NCT02955784|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-05-04|||January 22, 2015|Actual|2015-01-22|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Sinasprite: A Pilot Feasibility Study for Patients With Anxiety or Stress|Sinasprite: A Pilot Feasibility Study of a Casual Game for Primary Care Patients With Mild Stress, Anxiety or Depression|Recruiting||N/A|50|Anticipated|Madigan Army Medical Center||1|||f||||f||||||||Undecided|Study still in data collection process|2017-10-10 21:38:02.55197|2017-10-10 21:38:02.55197
NCT02955771|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-09|||October 2016||2016-10-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma|Multi-center, Randomized, Controlled, Open-label Study of Deuteporfin Photodynamic Therapy Plus Stenting Versus Stenting Alone as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma|Recruiting||Phase 2|50|Anticipated|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||3|||f||||f||||||||Undecided||2017-10-10 21:38:02.647211|2017-10-10 21:38:02.647211
NCT02955758|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-02-21|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer|A Phase II Trial of Pembrolizumab in Metastatic Non-squamous NSCLC Examining Circulating Tumor DNA Levels as a Surrogate Biomarker of Response|Recruiting||Phase 2|25|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 21:38:02.767867|2017-10-10 21:38:02.767867
NCT02955745|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-06-09|||November 2016||2016-11-01|June 2017|2017-06-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Observational|||Iodine-129 Tracer Method for Investigating Human Iodine Metabolism|Plasma, Urine and Stools Appearance of an Orally Administered 129I-tracer for the Assessment of Dietary Iodine Absorption, Retention and Excretion in Humans: an Observational Study|Completed||N/A|8|Actual|Swiss Federal Institute of Technology|||1||f||||||||||||||2017-10-10 21:38:02.86493|2017-10-10 21:38:02.86493
NCT02955732|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-03|2017-09-11|||January 1, 2017||2017-01-01|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|April 30, 2017|Actual|2017-04-30||Interventional|PINDEX||Pharmacological Characteristics of Intranasally Given Dexmedetomidine in Paediatric Patients|Bioavailability and Pharmacokinetics of Intranasal Dexmedetomidine in Children|Active, not recruiting||Phase 4|50|Actual|Turku University Hospital||1|||f||||f||||||||||2017-10-10 21:38:02.942829|2017-10-10 21:38:02.942829
NCT02955719|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-03-30|||April 2016||2016-04-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|CCI||CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia|CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia: Depression, Anxiety, and Mild Cognitive Impairment|Recruiting||N/A|150|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 21:38:03.024388|2017-10-10 21:38:03.024388
NCT02955706|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-06|||April 2016||2016-04-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease|Recruiting||Phase 4|328|Anticipated|Dong-A ST Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:38:03.144185|2017-10-10 21:38:03.144185
NCT02955693|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-12-21|||September 2016||2016-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|LAS41008||Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008|Randomized, Open-label, Single-center, Four-way Crossover, Single Dose Study to Investigate the Pharmacokinetics of LAS41008 120 mg Gastro-resistant Tablet and Fumaderm® 120 mg Gastro-resistant Tablet Under Fasting and Fed Conditions in Healthy Subjects|Completed||Phase 1|32|Actual|Almirall, S.A.||4|||f||||f||||||||No||2017-10-10 21:38:03.230823|2017-10-10 21:38:03.230823
NCT02955680|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-02-07|||November 2016||2016-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|Maternal voice||Recorded Maternal Voice on the Emergence of General Anesthesia on Pediatric Patients|Comparison Between Recorded Mother's and Stranger's Voice on the Emergence of General Anesthesia on Pediatric Patients|Recruiting||N/A|66|Anticipated|Daegu Catholic University Medical Center||2|||f||||||||||||||2017-10-10 21:38:03.340491|2017-10-10 21:38:03.340491
NCT02955667|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2016-11-03|||December 2016||2016-12-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||The Application of Invivo Microscopy Imaging in the Early Diagnosis of Cervical Cancer|The Application of Invivo Microscopy Imaging in the Early Diagnosis of Cervical Cancer|Not yet recruiting||N/A|600|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||f||||||||No||2017-10-10 21:38:03.429918|2017-10-10 21:38:03.429918
NCT02955654|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-04-27|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder|Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder|Not yet recruiting||N/A|135|Anticipated|Shanghai Mental Health Center||3|||f||||t|f|f||||||Undecided||2017-10-10 21:38:03.503329|2017-10-10 21:38:03.503329
NCT02955641|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-11-02|||November 2016||2016-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy|Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center||4|||f||||f||||||||Undecided||2017-10-10 21:38:03.600117|2017-10-10 21:38:03.600117
NCT02955628|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-02-13|||December 13, 2016|Actual|2016-12-13|November 2016|2016-11-01|August 2023|Anticipated|2023-08-01|August 2023|Anticipated|2023-08-01||Interventional|||RICE-ibrutinib in Relapsed DLBCL|A Phase II Study of Ibrutinib With R-ICE Chemotherapy for Transplant-eligible Relapsed/Refractory Diffuse Large B-cell Lymphoma Followed by Ibrutinib Maintenance in Patients Not Achieving a Complete Response at Pre-transplant Interim Assessment|Recruiting||Phase 2|34|Anticipated|Singapore General Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:38:03.716249|2017-10-10 21:38:03.716249
NCT02955615|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-05-31|||November 2016|Actual|2016-11-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|LUPIL-2||ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)|A Phase II, Multi-centre, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)|Recruiting||Phase 2|100|Anticipated|Iltoo Pharma||2|||f||||t||||||||Undecided||2017-10-10 21:38:03.825718|2017-10-10 21:38:03.825718
NCT02955602|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-08-28|||November 28, 2016|Actual|2016-11-28|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)|An 8-week, Dose Ranging, Open Label, Randomized, Phase 2 Study With a 44-week Extension, to Evaluate the Safety and Efficacy of MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or Intolerance to Ursodeoxycholic Acid (UDCA)|Recruiting||Phase 2|116|Anticipated|CymaBay Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 21:38:04.036867|2017-10-10 21:38:04.036867
NCT02955589|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-10-04|||November 2016||2016-11-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)|A Phase 2b Open-Label Single-Arm Study to Evaluate the Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)|Recruiting||Phase 2|30|Anticipated|HUYA Bioscience International||1|||f||||t||||||||||2017-10-10 21:38:04.271812|2017-10-10 21:38:04.271812
NCT02955576|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-14|||September 2016||2016-09-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|February 2017|Anticipated|2017-02-01||Interventional|||Microneedle Patch for Psoriatic Plaques|Efficacy of Microneedle Patch on Topical Ointment Treatment of Psoriasis|Recruiting||N/A|20|Anticipated|The Catholic University of Korea||3|||f||||t||||||||Undecided||2017-10-10 21:38:04.391993|2017-10-10 21:38:04.391993
NCT02955563|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-03|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|CSDM Pilot||CSDM: A Trial to Improve Communication and Shared Decision Making Using a Web-Based Tool|CSDM: A Trial to Improve Communication and Shared Decision Making Using a Web-Based Tool|Recruiting||N/A|200|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||No|Individual participant data will not be made available.|2017-10-10 21:38:04.486414|2017-10-10 21:38:04.486414
NCT02955550|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-21|||January 19, 2017|Actual|2017-01-19|July 2017|2017-07-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)|A Phase 1, Multicenter, Open-label, Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion Following Autologous Stem Cell Transplant for Multiple Myeloma|Recruiting||Phase 1|40|Anticipated|Celgene||1|||f||||t|t|f||||||||2017-10-10 21:38:04.591213|2017-10-10 21:38:04.591213
NCT02955537|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-19|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|MI-BP||MI-BP: mHealth to Improve Blood Pressure Control in Hypertensive African Americans|MI-BP: mHealth to Improve Blood Pressure Control in Hypertensive African Americans|Not yet recruiting||N/A|396|Anticipated|University of Michigan||2|||f||||t|f|f||||||||2017-10-10 21:38:04.696033|2017-10-10 21:38:04.696033
NCT02955524|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-06|||March 2018|Anticipated|2018-03-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|TOPIAC||Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma|Topical Anesthesia to Decrease the Trigeminal-Cardiac Reflex During Intra-arterial Injection of Chemotherapy for Retinoblastoma in Children.|Not yet recruiting||Early Phase 1|10|Anticipated|University of Miami||1|||f||||t|t|f|||t|||||2017-10-10 21:38:04.791812|2017-10-10 21:38:04.791812
NCT02955511|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-05|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparison of 3 Direct Laryngoscopes for Tracheal Intubation in Patients Undergoing Lumbar Spine Surgery|Comparison of 3 Direct Laryngoscopes: Inscope DL Blade Size 3.5 and DL Blade 3.5 Sun-Med GreenLine®/D™ to DL Blade 3 Sun-Med GreenLine®/D™ for Tracheal Intubation in Patients Undergoing Lumbar Spine Surgery, a Prospective Randomized Study|Not yet recruiting||N/A|120|Anticipated|Cedars-Sinai Medical Center||3|||f||||f|f|f||||||||2017-10-10 21:38:04.887109|2017-10-10 21:38:04.887109
NCT02955498|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-02|||April 2014||2014-04-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects|A Randomized, Open-label, Single-Dose, 2-Treatment, 2-Way, 2-Period Crossover Study to Assess the Safety and the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects|Completed||Phase 1|32|Actual|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:38:04.956187|2017-10-10 21:38:04.956187
NCT02955485|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-03-21|||October 2016||2016-10-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|Predict||A Prediction Model for Chronic Ankle Instability|A Prediction Model for Chronic Ankle Instability: Indications for Early Surgical Treatment? An Observational Prospective Cohort|Recruiting||N/A|1500|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f||||||||||2017-10-10 21:38:05.058273|2017-10-10 21:38:05.058273
NCT02955472|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-04-11|||November 2016||2016-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|November 2016|Actual|2016-11-01||Interventional|||Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg|A Randomized, Open-label, Single Dose, Crossover Phase 1 Study to Compare the Pharmacokinetic Characteristics of GLA5PR GLARS-NF1 Tablet 150 mg and GLA5PR GLARS-NF3 Tablet 150 mg in Healthy Volunteers|Completed||Phase 1|24|Actual|GL Pharm Tech Corporation||2|||f||||f||||||||No||2017-10-10 21:38:05.175149|2017-10-10 21:38:05.175149
NCT02955459|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-20|||November 2016||2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers|VNRX-5133-101/102: A Randomized, Double Blind, Placebo-Controlled, Sequential Group, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of VNRX-5133 in Healthy Adult Volunteers|Completed||Phase 1|84|Actual|VenatoRx Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-10 21:38:05.259012|2017-10-10 21:38:05.259012
NCT02955446|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-06-16||||||June 2017|2017-06-01||||||||Expanded Access|||Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies|Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies: Continuing Study Drug Administration in Desmoid Patients Receiving Clinical Benefit|No longer available||N/A|||University of Colorado, Denver||||||||t|||||||||||2017-10-10 21:38:05.324289|2017-10-10 21:38:05.324289
NCT02955433|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-05-18|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|April 2017|Actual|2017-04-01||Interventional|||The Impact of Rideshare Transportation Services on Appointment Adherence||Enrolling by invitation||N/A|390|Anticipated|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 21:38:05.504587|2017-10-10 21:38:05.504587
NCT02955420|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-06-14|||August 2016||2016-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects|A Three-part, Randomized Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy, Young Subjects and Elderly Subjects|Recruiting||Phase 1|74|Anticipated|Berlin Cures GmbH||1|||f||||||||||||||2017-10-10 21:38:05.593569|2017-10-10 21:38:05.593569
NCT02955407|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-11-03|||September 2016||2016-09-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|Backgene||Genetic Predisposition for Chronic Non-specific Low Back Pain|Genetic Predisposition for Reduced Back Muscle Strength and Back Muscle Endurance in Patients With Chronic Non-specific Low Back Pain|Recruiting||N/A|100|Anticipated|Balgrist University Hospital|||2||f||||f||||||||No||2017-10-10 21:38:05.713049|2017-10-10 21:38:05.713049
NCT02955381|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-04-24|||March 28, 2017|Actual|2017-03-28|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Restylane Silk Acne Scar Efficacy Evaluation Study|6 Month Double-Blind Randomized Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Small Particle Hyaluronic Acid to Treat Acne Scars Located on the Cheeks and Forehead|Recruiting||N/A|30|Anticipated|Schweiger Dermatology, PLLC||2|||f||||f|f|t|f|f||||No|This is an investigator initiated study and will use the primary data to create a final data report. Individual patient data will not be available to other researchers.|2017-10-10 21:38:05.949094|2017-10-10 21:38:05.949094
NCT02955368|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-06-01|||February 2017|Anticipated|2017-02-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of DP-R212|A Multi-center, Randomized, Double-blind, Parallel-group Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R212 Fixed Dose Combination in Patients With Dyslipidemia and Hypertension|Withdrawn||Phase 3|0|Actual|Alvogen Korea||3||Canceled|f||||f|f|f||||||No||2017-10-10 21:38:06.086697|2017-10-10 21:38:06.086697
NCT02955355|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP|Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)|Recruiting||Phase 3|149|Anticipated|Baxalta US Inc.||1|||f||||f||||||||||2017-10-10 21:38:06.194214|2017-10-10 21:38:06.194214
NCT02955342|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-11-03|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|Youngback||Back and Neck Pain in Adolescence|Back and Neck Pain in Adolescence: A Prospective Cohort Study Using a German Version of the Young Spine Questionnaire|Recruiting||N/A|400|Anticipated|Balgrist University Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:38:06.307222|2017-10-10 21:38:06.307222
NCT02955329|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-04|||January 2017||2017-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||E-cigarette THC Study|Intake and Pharmacokinetics of THC Vaped From Electronic Cigarettes|Not yet recruiting||N/A|14|Anticipated|University of California, San Francisco||2|||f||||t||||||||No||2017-10-10 21:38:06.402699|2017-10-10 21:38:06.402699
NCT02955316|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-04|||February 10, 2017|Actual|2017-02-10|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|IRONS||Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China|Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China|Recruiting||N/A|3000|Anticipated|AstraZeneca|||1||f||||t|f|f||||||||2017-10-10 21:38:06.514382|2017-10-10 21:38:06.514382
NCT02955303|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-08-06|||November 2016||2016-11-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Feasibility of TECH: Tablet Enhancement of Cognition and Health for Healthy Adults|The Feasibility of TECH: Tablet Enhancement of Cognition and Health, Cognitive Training Using Touchscreen Tablet Gaming Applications, for Healthy Older Adults - a Pilot Randomized Control Trial|Recruiting||N/A|30|Anticipated|Assuta Hospital Systems||1|||f||||f||||||||||2017-10-10 21:38:06.59802|2017-10-10 21:38:06.59802
NCT02955290|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-08|||December 9, 2016||2016-12-09|July 2017|2017-07-01|June 9, 2021|Anticipated|2021-06-09|June 9, 2020|Anticipated|2020-06-09||Interventional|||CIMAvax Vaccine and Nivolumab in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer|A Phase I/II Study of the EGF Vaccine CIMAvax in Combination With the Anti-PD1 Nivolumab in Patients With Previously Treated Advanced NSCLC|Recruiting||Phase 1/Phase 2|136|Anticipated|Roswell Park Cancer Institute||3|||f||||t||||||||||2017-10-10 21:38:06.692197|2017-10-10 21:38:06.692197
NCT02955277|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-08-06|||November 2016||2016-11-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|TECH||The Effectiveness of TECH: Tablet Enhancement of Cognition and Health|The Effectiveness of TECH: Tablet Enhancement of Cognition and Health, Cognitive Training Using Touchscreen Tablet Gaming Applications, for Older Adults With Mild Cognitive Impairment|Recruiting||N/A|90|Anticipated|Assuta Hospital Systems||2|||f||||f||||||||||2017-10-10 21:38:06.822099|2017-10-10 21:38:06.822099
NCT02955264|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-11-02|||July 2014||2014-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation|Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation|Recruiting||Phase 2|10|Anticipated|Tulane University||1|||f||||f||||||||||2017-10-10 21:38:06.923605|2017-10-10 21:38:06.923605
NCT02955238|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-11-02|||August 2009||2009-08-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|LUNA||Latinos Understanding the Need for Adherence|San Diego Partnership to Reduce Diabetes & Cardiovascular Disease in Latinos|Completed||N/A|587|Actual|San Diego State University||2|||f||||t||||||||No||2017-10-10 21:38:07.133678|2017-10-10 21:38:07.133678
NCT02954146|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-08|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Mobile Health Application for Family and Behavioral Health Provider Communication|Mobile Health Application for Family and Behavioral Health Provider Communication|Recruiting||N/A|120|Anticipated|InferLink Corporation||2|||f||||f||||||||No||2017-10-10 21:38:20.954445|2017-10-10 21:38:20.954445
NCT02955225|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Using Pressure Detecting Insoles to Reduce Knee Loading|Using Pressure Detecting Insoles to Reduce Knee Loading and Improve Function|Recruiting||Phase 1|40|Anticipated|Rush University Medical Center||2|||f||||f||||||||Yes|Data will be published through peer reviewed journals.|2017-10-10 21:38:07.212773|2017-10-10 21:38:07.212773
NCT02955212|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-18|||October 15, 2017|Anticipated|2017-10-15|July 2017|2017-07-01|March 8, 2020|Anticipated|2020-03-08|February 10, 2019|Anticipated|2019-02-10||Interventional|||A Study With ABT-494 in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With ABT-494 in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)|Not yet recruiting||Phase 3|450|Anticipated|AbbVie||4|||f||||t|f|f||||||||2017-10-10 21:38:07.311889|2017-10-10 21:38:07.311889
NCT02955199|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-01|||April 2015||2015-04-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Stage III Community-based Efficacy Trial for Mothering From the Inside Out|Fostering Mothers' Emotionally-Responsive Parenting: A Stage III Community-Based Efficacy Trial|Recruiting||Phase 2|120|Anticipated|Yale University||2|||f||||t||||||||||2017-10-10 21:38:07.421019|2017-10-10 21:38:07.421019
NCT02955186|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-05-24|||May 9, 2017|Actual|2017-05-09|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||Saracatinib and Alcohol Drinking|Fyn Kinase Inhibitors and Alcohol Drinking|Recruiting||Phase 2|60|Anticipated|Yale University||2|||f||||t|t|f||||||||2017-10-10 21:38:07.510969|2017-10-10 21:38:07.510969
NCT02955173|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-02-08|||December 2016||2016-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer|Significance of Circulating Tumor Cells (CTC) Detected by the CTCBIOPSY System as Potential Blood-based Biomarkers in Providing Prognostic and Predictive Information for Surgical Treatment of Gastric and Rectal Cancer|Recruiting||N/A|600|Anticipated|Qilu Hospital of Shandong University||4|||f||||f||||||||No||2017-10-10 21:38:07.589778|2017-10-10 21:38:07.589778
NCT02955160|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-21|||November 3, 2016|Actual|2016-11-03|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years|A Phase 1, Randomized, Controlled, Observer-blinded Trial To Evaluate The Safety And Immunogenicity Of A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults Aged 18 To 49 Years|Completed||Phase 1|66|Actual|Pfizer||2|||f||||t||||||||||2017-10-10 21:38:07.67952|2017-10-10 21:38:07.67952
NCT02955147|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-02-16|||December 1, 2016|Actual|2016-12-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|UGCA||Ustekinumab for the Treatment of Giant Cell Arteritis|Open Label Study to Test the Safety and Efficacy of Ustekinumab in Patients With Giant Cell Arteritis|Recruiting||Phase 1/Phase 2|20|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 21:38:07.758264|2017-10-10 21:38:07.758264
NCT02955134|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-15|||December 2016||2016-12-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|January 2020|Anticipated|2020-01-01||Interventional|||The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis|Follow-up Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis Based on Histological Evaluation|Not yet recruiting||N/A|468|Anticipated|Wangjing Hospital, China Academy of Chinese Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:38:07.846677|2017-10-10 21:38:07.846677
NCT02955121|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-12-28|||November 2016||2016-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||IU Health Krannert Personalized Medicine Study|IU Health Krannert Personalized Medicine Study - Influencing Prescriber Behavior for the Use of Clopidogrel|Recruiting||Phase 4|270|Anticipated|Indiana University||2|||f||||f||||||||Yes|De-identified Data Sharing only|2017-10-10 21:38:07.987072|2017-10-10 21:38:07.987072
NCT02955108|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-02|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Diseases|The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Disease|Not yet recruiting||N/A|50|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 21:38:08.071394|2017-10-10 21:38:08.071394
NCT02955095|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-10-05|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Usability and Pilot Testing - Intervention for Smoking Cessation|Usability and Pilot Testing - Intervention for Smoking Cessation|Not yet recruiting||N/A|40|Anticipated|New York University School of Medicine||1|||f|||||f|f||||||||2017-10-10 21:38:08.151015|2017-10-10 21:38:08.151015
NCT02955082|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-05-25|||May 25, 2017|Actual|2017-05-25|May 2017|2017-05-01|April 25, 2022|Anticipated|2022-04-25|May 25, 2019|Anticipated|2019-05-25||Interventional|BARCODE2||The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment|The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment|Recruiting||Phase 2|450|Anticipated|Institute of Cancer Research, United Kingdom||1|||f||||t|f|f||||||Yes|Anonymised data can be applied for via the Data Access Committee.|2017-10-10 21:38:08.251468|2017-10-10 21:38:08.251468
NCT02955069|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-10-05|||February 14, 2017|Actual|2017-02-14|October 2017|2017-10-01|December 19, 2019|Anticipated|2019-12-19|December 19, 2019|Anticipated|2019-12-19||Interventional|||Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)|An Open Label Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC), That Have Progressed on Prior Treatment EUDRACT 2016-002522-36|Recruiting||Phase 2|110|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:38:08.341916|2017-10-10 21:38:08.341916
NCT02955056|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-03|||October 2016||2016-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Ankle Fractures Treated With Teriparatide|A Feasibility Study to Explore the Difference in Healing Time Between Teriparatide Treatment and Standard Care on Weber B Ankle Fractures in Older People|Recruiting||Phase 4|10|Anticipated|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||No|No plan to share IPD|2017-10-10 21:38:08.523427|2017-10-10 21:38:08.523427
NCT02955043|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-23|||October 2016||2016-10-01|November 2016|2016-11-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery|A Pilot Trial of a Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery|Recruiting||N/A|48|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||No||2017-10-10 21:38:08.606032|2017-10-10 21:38:08.606032
NCT02955030|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-14|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|March 2017|Actual|2017-03-01||Interventional|||Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers|Phase 1 Study to Determine the Safety and Immunogenicity of a Sublingual Administration of NSV0001 in Healthy Male Volunteers|Completed||Phase 1|90|Anticipated|Nitto Denko Corporation||5|||f||||f||||||||||2017-10-10 21:38:08.704931|2017-10-10 21:38:08.704931
NCT02955017|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|MHI||Mobile Health Intervention|Use of New Technologies for the Follow-up in Adolescent Obesity|Recruiting||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:38:10.391295|2017-10-10 21:38:10.391295
NCT02955004|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-05-07|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ECAF-STAR||Electrical Cardioversion of Recent Onset Atrial Fibrillation - Silent Thromboembolic Events, Reverse Atrial Remodeling|Electrical Cardioversion of Recent Onset Atrial Fibrillation - a Study of Silent Thromboembolic Events, Reverse Atrial Electrical and Functional Remodeling Including Inflammatory, Neurohormonal and Thromboembolic Biomarkers|Recruiting||N/A|40|Anticipated|Uppsala University Hospital|||1||f||||f||||||Samples Without DNA|"     CRP P- von Willebrandfaktor- antigen P- Interleukin-6 [IL-6] P- Fibrin, D-dimer S-     N-terminalt pBNP P- Troponin I Pt(Lkc)- Faktor V, genotyp S- Heparin/PF4-antikroppar     P-Protrombinfragment 1+2 P-selectin factor VIII:C Brain marker S100   "|||2017-10-10 21:38:10.506322|2017-10-10 21:38:10.506322
NCT02954991|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-25|||November 2016||2016-11-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer|A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer|Recruiting||Phase 2|209|Anticipated|Mirati Therapeutics Inc.||3|||f||||f||||||||||2017-10-10 21:38:10.626204|2017-10-10 21:38:10.626204
NCT02954978|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-03-15|||January 2017||2017-01-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|May 2020|Anticipated|2020-05-01||Interventional|PD Nilotinib||Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease|A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Low Doses of Nilotinib Treatment on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease|Recruiting||Phase 2|75|Anticipated|Georgetown University||3|||f||||t||||||||No||2017-10-10 21:38:10.749444|2017-10-10 21:38:10.749444
NCT02954965|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-05-23|||November 2016||2016-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brief Mood Enhancement Intervention|Enhancing Mood Among Graduate Students: Evaluation of a Brief, Phone-Administered Behavioral Intervention|Recruiting||N/A|102|Anticipated|Duke University||3|||f||||||||||||||2017-10-10 21:38:10.856743|2017-10-10 21:38:10.856743
NCT02954952|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-09|||November 2016||2016-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:38:10.955193|2017-10-10 21:38:10.955193
NCT02954939|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-07-03|||March 2012||2012-03-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis||Recruiting||N/A|50|Anticipated|The University of Hong Kong||2|||f||||||||||||||2017-10-10 21:38:10.995158|2017-10-10 21:38:10.995158
NCT02954926|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-02|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis|Effect of Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis|Completed||Phase 3|92|Actual|Hormozgan University of Medical Sciences||2|||f||||t||||||||No||2017-10-10 21:38:11.080156|2017-10-10 21:38:11.080156
NCT02954913|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-03|||December 2016||2016-12-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|RESECT||Simultaneous Resection of Colorectal Cancer With Synchronous Liver Metastases|Simultaneous RESEction of Colorectal Cancer With Synchronous Liver MeTastases (RESECT): A Feasibility Study|Not yet recruiting||N/A|30|Anticipated|Hamilton Health Sciences Corporation||1|||f||||t||||||||No||2017-10-10 21:38:11.147889|2017-10-10 21:38:11.147889
NCT02954900|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-05-09|||March 15, 2016||2016-03-15|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|KYRAS||Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study|Study of Web-based Decision Aids for Breast Cancer Risk Assessment and Increasing Breast Cancer Chemoprevention in the Primary Care Setting: Pilot|Active, not recruiting||N/A|100|Anticipated|Columbia University||1|||f||||f||||||||Undecided||2017-10-10 21:38:11.37359|2017-10-10 21:38:11.37359
NCT02954887|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-03-17|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)|A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study|Recruiting||Phase 3|202|Anticipated|GW Research Ltd||1|||f||||f|t|f||||||||2017-10-10 21:38:11.481934|2017-10-10 21:38:11.481934
NCT02953587|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-05-01|||September 2016||2016-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery|Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery|Recruiting||Phase 1|70|Anticipated|Vanderbilt University Medical Center||4|||f||||t|t|f||||||Undecided||2017-10-10 21:38:27.933454|2017-10-10 21:38:27.933454
NCT02954861|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-11-01|||May 2016||2016-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||A Study to Identify the Incidence of Post Traumatic Stress Symptoms in Patients With Delirium Following Cardiac Surgery|A Study to Identify the Incidence of Post Traumatic Stress Symptoms in Patients With Delirium Following Cardiac Surgery|Active, not recruiting||N/A|400|Anticipated|University of Edinburgh|||1||f||||f||||||||No||2017-10-10 21:38:14.205952|2017-10-10 21:38:14.205952
NCT02954848|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-28|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|June 9, 2018|Anticipated|2018-06-09|June 9, 2018|Anticipated|2018-06-09||Interventional|TBD||Phase 3 Study of TAK-438 (10 mg) in the Treatment of Non-Erosive Gastroesophageal Reflux Disease|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 10 mg Once-daily in the Treatment of Non-Erosive Gastroesophageal Reflux Disease|Recruiting||Phase 3|474|Anticipated|Takeda||2|||f||||f|f|f||||||||2017-10-10 21:38:14.276449|2017-10-10 21:38:14.276449
NCT02954835|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Negative Pressure Therapy for Groin Wounds|Negative Pressure Therapy for Closed Groin Wounds in Patients Undergoing Vascular Surgery|Recruiting||Phase 4|100|Anticipated|Englewood Hospital and Medical Center||2|||f||||f||||||||No||2017-10-10 21:38:14.534664|2017-10-10 21:38:14.534664
NCT02954822|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-15|||November 14, 2016|Actual|2016-11-14|September 2017|2017-09-01|August 9, 2017|Actual|2017-08-09|January 25, 2017|Actual|2017-01-25||Interventional|||Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg|A Randomized, Open-label, Multiple Dosing, Cross-over Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg After Oral Administration in Healthy Male Subjects|Completed||Phase 1|36|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:38:14.62879|2017-10-10 21:38:14.62879
NCT02954809|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-03|||October 2016||2016-10-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors|Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors|Recruiting||N/A|14|Anticipated|State University of New York at Buffalo||2|||f||||t||||||||No||2017-10-10 21:38:14.716356|2017-10-10 21:38:14.716356
NCT02954796|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-09-28|||December 2016||2016-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma|Phase 1 Study of SGN-CD352A in Patients With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1|75|Anticipated|Seattle Genetics, Inc.||1|||f||||t||||||||||2017-10-10 21:38:14.83021|2017-10-10 21:38:14.83021
NCT02954783|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-04-30|||November 2016||2016-11-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|PRO-TEST||PROstaTe Cancer - Exercise-STudy (PRO-TEST)|Effect of Different Exercise Regimens on Intratumoral Natural Killer (NK) Cell Variability in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy - a Randomized Controlled Pilot Study|Recruiting||N/A|30|Anticipated|Rigshospitalet, Denmark||3|||f||||f||||||||Undecided||2017-10-10 21:38:15.015892|2017-10-10 21:38:15.015892
NCT02954770|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-02-02|||October 2016||2016-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Long-term Usage of the Fitbit® Among Medical Residents|Fitbit® Challenge: Can we Motivate Residents to Improve Their Physical Well Being?|Completed||N/A|38|Actual|TriHealth Inc.|||1||f||||f||||||||No||2017-10-10 21:38:15.158813|2017-10-10 21:38:15.158813
NCT02954757|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-01-27|||August 2016||2016-08-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis|Therapeutic Efficacy of High-intensity Focused Ultrasound in the Treatment of Uterine Adenomyosis|Enrolling by invitation||N/A|10|Anticipated|Queen Mary Hospital, Hong Kong||1|||f||||t||||||||||2017-10-10 21:38:15.237806|2017-10-10 21:38:15.237806
NCT02954744|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-07-31|||March 2012||2012-03-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Actual|2017-08-01||Interventional|||High-intensity Focused Ultrasound in Treatment of Uterine Fibroid|Therapeutic Efficacy of High-intensity Focused Ultrasound in the Treatment of Uterine Fibroid|Active, not recruiting||N/A|20|Actual|Queen Mary Hospital, Hong Kong||1|||f||||t||||||||||2017-10-10 21:38:15.318955|2017-10-10 21:38:15.318955
NCT02954731|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-06|||December 2016||2016-12-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|TRACT-RCT||Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder|Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder: A Pragmatic, Multicenter Non-inferiority Randomized Controlled Trial|Enrolling by invitation||N/A|248|Anticipated|Psychiatric Research Unit, Region Zealand, Denmark||2|||f||||f||||||||||2017-10-10 21:38:15.400469|2017-10-10 21:38:15.400469
NCT02954718|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-03|||February 2015||2015-02-01|February 2015|2015-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Video-Based Task Oriented Activity Training in Patients With Juvenile Idiopathic Arthritis|Effects of Video-Based Task Oriented Activity Training on Activity Performance and Participation in Patients With Juvenile Idiopathic Arthritis|Completed||N/A|50|Actual|Istanbul University||2|||f||||t||||||||||2017-10-10 21:38:15.550798|2017-10-10 21:38:15.550798
NCT02954705|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-04|||January 2016||2016-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|MINERVA||MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITIS|MICRO-RNAs OF NEUTROPHILS IN RENAL ANCA-ASSOCIATED VASCULITIS|Recruiting||N/A|70|Anticipated|Nantes University Hospital|||2||f||||f||||||Samples Without DNA|"     50 mL of blood and 10 mL of urine by patient   "|No||2017-10-10 21:38:15.621985|2017-10-10 21:38:15.621985
NCT02954692|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-04|||November 30, 2016|Actual|2016-11-30|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EASE||A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey|A National, Multicenter, Prospective, Interventional, Open-label, Single-arm, 24-Week Phase IV Study to Evaluate the Effectiveness and Safety of Initiation and Titration of Insulin Glargine U300 in Insulin-naïve Patients With T2DM Inadequately Controlled on OAD Treatment in Turkey|Active, not recruiting||Phase 4|110|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-10 21:38:15.706386|2017-10-10 21:38:15.706386
NCT02954679|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-02|||January 23, 2017|Actual|2017-01-23|April 2017|2017-04-01|July 23, 2019|Anticipated|2019-07-23|July 23, 2019|Anticipated|2019-07-23||Observational|ENQUETE-COSYS||French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students|French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students (Enquête Nationale Sur le Dopage Intellectuel et Les Consommations de Substances Psychoactives Chez Les Jeunes étudiants)|Recruiting||N/A|30000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 21:38:15.823506|2017-10-10 21:38:15.823506
NCT02954666|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-12-31|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|CardNMH2||Second Study on Cardio-neuromodulation in Humans|Second Study on Cardio-neuromodulation in Humans|Recruiting||Phase 2|50|Anticipated|Imelda Hospital, Bonheiden||2|||f||||t||||||||No||2017-10-10 21:38:15.936209|2017-10-10 21:38:15.936209
NCT02954653|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-09-28|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia|A Phase 1 Dose Escalation Study To Evaluate The Safety, Pharmacokinetics And Pharmacodynamics Of Intravenous Pf-06747143, Administered As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia|Recruiting||Phase 1|152|Anticipated|Pfizer||4|||f||||f||||||||||2017-10-10 21:38:16.052525|2017-10-10 21:38:16.052525
NCT02954640|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-08-24|||February 2016||2016-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Génétique-DIH||Evaluation of the Efficacy of the Sequencing Method by Gene-panel|Evaluation of the Efficacy of the Sequencing Method by Gene-panel, Compared to the Reference Sanger Method, on Patients With Primary Immuno-deficiencies, and Who Need a Genetic Diagnosis.|Recruiting||N/A|115|Anticipated|Imagine Institute||1|||f||||f||||||||||2017-10-10 21:38:16.191432|2017-10-10 21:38:16.191432
NCT02954627|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-04-25|||November 2016||2016-11-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|CIMT-LOSEIT-I||Ultrasound Assessment of the Carotid Intimal Medial Thickness in Obese Subjects; Weight Loss|Ultrasound Assessment of the Carotid Intimal Medial Thickness in Obese Subjects Following a Significant Weight Loss|Recruiting||N/A|200|Anticipated|Parker Research Institute|||1||f||||t||||||||||2017-10-10 21:38:16.287474|2017-10-10 21:38:16.287474
NCT02954614|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-03-03|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Active Play in After School Programs|Active Play -an After-school-program Intervention to Promote Physical Activity and Health-related Quality of Life in Young Children|Active, not recruiting||N/A|400|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||No||2017-10-10 21:38:16.372096|2017-10-10 21:38:16.372096
NCT02954601|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-11-05|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of Single and Multiple Doses of ORMD-0801 (Study Drug) or Placebo in Subjects With T2 (Type 2) DM (Diabetes Mellitus)|A Phase 2a, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Way Crossover Study to Compare Safety, Efficacy, and Pharmacodynamics of Single and Multiple Doses of ORMD-0801 in Adult Subjects With Type 2 Diabetes Mellitus|Recruiting||Phase 2|30|Anticipated|Oramed, Ltd.||3|||f||||t||||||||No||2017-10-10 21:38:16.445817|2017-10-10 21:38:16.445817
NCT02954588|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|||Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity|The Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity; a Double-blind Randomized Placebo Controlled Trial in Abdominally Obese Subjects.|Recruiting||N/A|120|Anticipated|Maastricht University Medical Center||3|||f||||||||||||||2017-10-10 21:38:16.540148|2017-10-10 21:38:16.540148
NCT02954562|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-09-07|||November 7, 2015||2015-11-07|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|July 1, 2017|Actual|2017-07-01||Observational|||Correlates of Anxiety Associated With a Life-threatening Illness|Physiological Correlates of Anxiety Associated With a Life-threatening Illness.|Active, not recruiting||N/A|12|Anticipated|Multidisciplinary Association for Psychedelic Studies|||1||f||||f||||||||||2017-10-10 21:38:16.7671|2017-10-10 21:38:16.7671
NCT02954549|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-05-04|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Vitamin D Supplementation in Warfighters|Genomics of Vitamin D Supplementation and Warfighter Nutritional Resilience|Active, not recruiting||N/A|133|Actual|Madigan Army Medical Center||3|||f||||t||||||||No||2017-10-10 21:38:16.85239|2017-10-10 21:38:16.85239
NCT02954536|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-08-09|||November 3, 2016|Actual|2016-11-03|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer|Phase II Trial of Pembrolizumab in Combination With Trastuzumab, Capecitabine/Cisplatin in First Line Stage IV HER2-positive Metastatic Esophagogastric (EG) Cancer|Recruiting||Phase 2|37|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:38:16.948558|2017-10-10 21:38:16.948558
NCT02954523|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-23|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|November 2021|Anticipated|2021-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations|Phase I/II Study of Dasatinib and Osimertinib (AZD9291) in Patients With Advanced Non-small Cell Lung Cancer With EGFR Mutations|Recruiting||Phase 1/Phase 2|38|Anticipated|Georgetown University||1|||f||||t||||||||Undecided||2017-10-10 21:38:17.075312|2017-10-10 21:38:17.075312
NCT02954510|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Ferumoxytol for Magnetic Resonance Imaging in Patients With Severe Kidney Disease|Ferumoxytol for Magnetic Resonance Imaging for the Interpretation of Coronary Artery Defects in Patients With Severe Kidney Disease|Recruiting||Phase 3|30|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 21:38:17.293443|2017-10-10 21:38:17.293443
NCT02954497|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-06-20|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|November 2022|Anticipated|2022-11-01|April 2021|Anticipated|2021-04-01||Interventional|PumpKIN||Pumps for Kids, Infants, and Neonates|Pumps for Kids, Infants, and Neonates|Recruiting||N/A|88|Anticipated|New England Research Institutes||2|||f||||t|f|t|t|f||||Yes|Limited use data set will be made available through NHLBI after the conclusion of the trial.|2017-10-10 21:38:17.382923|2017-10-10 21:38:17.382923
NCT02954484|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-09-12|||April 2015||2015-04-01|October 2016|2016-10-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty|Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty: A Randomized Controlled Trial|Completed||Phase 3|116|Actual|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-10 21:38:17.527192|2017-10-10 21:38:17.527192
NCT02954471|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-10-02|||October 21, 2016|Actual|2016-10-21|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia|A Retrospective, Observational Molecular Epidemiology Study of HER2 Expression in Patients With Early / Metastatic Breast Cancer in Saudi Arabia|Recruiting||N/A|351|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 21:38:17.660599|2017-10-10 21:38:17.660599
NCT02954458|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-08-01|||January 1, 2017||2017-01-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome (SBS) Who Completed TED-C14-006|A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006|Recruiting||Phase 3|34|Anticipated|Shire||1|||f||||t||||||||||2017-10-10 21:38:17.74151|2017-10-10 21:38:17.74151
NCT02954445|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-11-06|||October 2016||2016-10-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies|A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies|Recruiting||Phase 1/Phase 2|45|Anticipated|Southwest Hospital, China||1|||f||||f||||||||Undecided||2017-10-10 21:38:17.910793|2017-10-10 21:38:17.910793
NCT02954432|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-10-04|||November 2016|Actual|2016-11-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Effects of tDCS and TUS on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain|Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS) on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain (NSCLBP).|Recruiting||N/A|20|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||f|f|f||||||||2017-10-10 21:38:18.012069|2017-10-10 21:38:18.012069
NCT02954419|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2016-12-03|||November 2016||2016-11-01|December 2016|2016-12-01|January 2027|Anticipated|2027-01-01|November 2026|Anticipated|2026-11-01||Observational|INTEREST||IgA Nephropathy Biomarkers Evaluation Study (INTEREST)|IgA Nephropathy Biomarkers Evaluation Study (INTEREST)|Recruiting||N/A|2000|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     Blood and urine samples of the patients are collected.   "|Undecided||2017-10-10 21:38:18.13873|2017-10-10 21:38:18.13873
NCT02954406|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-02|2017-07-28|||April 10, 2017|Actual|2017-04-10|July 2017|2017-07-01|April 26, 2019|Anticipated|2019-04-26|April 26, 2019|Anticipated|2019-04-26||Interventional|||A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma|A Phase 1b, Dose Escalation Study to Determine the Recommended Phase 2 Dose of TAK-659 in Combination With Bendamustine (±Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Patients With Advanced Non-Hodgkin Lymphoma After At Least 1 Prior Line of Therapy|Recruiting||Phase 1|100|Anticipated|Takeda||5|||f||||f|t|f||||||||2017-10-10 21:38:18.23298|2017-10-10 21:38:18.23298
NCT02954393|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-01|||May 2015||2015-05-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|MOMENT||Amoxicillin and Metronidazole During Periodontal Treatment|Influence of Moment of Systemic Metronidazole and Amoxicillin Administration in the Treatment of Chronic Periodontitis: a Randomized Clinical Trial.|Recruiting||N/A|180|Anticipated|University of Guarulhos||3|||f||||f||||||||No||2017-10-10 21:38:18.373807|2017-10-10 21:38:18.373807
NCT02954380|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-03-22|||November 2016||2016-11-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|ALERT-AF||The Comparative Efficacy of the Zio Patch vs Implantable Loop Recorder in Atrial Fibrillation|The Comparative Efficacy of the Zio Patch vs Implantable Loop Recorder in Atrial Fibrillation|Withdrawn||N/A|0|Actual|University of Florida||1||Funding|f||||f||||||||No||2017-10-10 21:38:18.544052|2017-10-10 21:38:18.544052
NCT02954367|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-11-01|||April 2016||2016-04-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||Meat and Whey Protein Supplementation in Endurance Athletes|Effects of Meat Protein Administration on Body Composition, Strength, Immunological, Microbiota and Haematological Markers in Endurance Athletes|Active, not recruiting||N/A|44|Anticipated|Universidad Europea de Madrid||2|||f||||f||||||||No||2017-10-10 21:38:18.6416|2017-10-10 21:38:18.6416
NCT02954354|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-08|||November 1, 2016||2016-11-01|May 2017|2017-05-01|April 22, 2017|Actual|2017-04-22|April 14, 2017|Actual|2017-04-14||Interventional|CAPSTONE 1||A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza|A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza|Completed||Phase 3|1494|Actual|Shionogi Inc.||5|||f||||f||||||||||2017-10-10 21:38:18.759103|2017-10-10 21:38:18.759103
NCT02954328|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-04-20|||November 2016||2016-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Transcranial Direct Current Stimulation (tDCS) on Motor and Cognitive Functions in Idiopathic Fallers|The Effect of Transcranial Direct Current Stimulation (tDCS) on Motor and Cognitive Functions in Idiopathic Fallers|Recruiting||N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||No||2017-10-10 21:38:19.437833|2017-10-10 21:38:19.437833
NCT02954315|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-04-17|||October 25, 2016|Actual|2016-10-25|November 2016|2016-11-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||The Effect of Almonds on Skin Lipids and Wrinkles|The Effect of Almonds on Skin Lipids and Wrinkles|Recruiting||N/A|30|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 21:38:19.51928|2017-10-10 21:38:19.51928
NCT02954302|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-11-01|||September 2016||2016-09-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy|Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy: A Randomized Controlled Trial|Recruiting||N/A|140|Anticipated|The First Affiliated Hospital of Xiamen University||2|||f||||t||||||||No|There is no plan to make individual participant data.|2017-10-10 21:38:19.591813|2017-10-10 21:38:19.591813
NCT02954289|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-03|||February 2014||2014-02-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Cooking Class Intervention Project for Men With Prostate Cancer and Their Partners|Increasing Healthy Outcomes for Prostate Cancer Survivors: An Innovative Cooking Class Intervention Pilot Study|Completed||N/A|44|Actual|University of British Columbia||1|||f||||f||||||||No||2017-10-10 21:38:19.78741|2017-10-10 21:38:19.78741
NCT02954276|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-02|||March 2016||2016-03-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers|A Randomized, Open Label, Crossover, Bioavailability Study to Compare Omexa Sumatriptan Transmucosal Sublingual Tablet Versus Commercial Imitrex® Sumatriptan Oral Tablet in Healthy Volunteers|Active, not recruiting||Phase 1|13|Actual|Targia Pharmaceuticals Ltd.||2|||f||||f||||||||No||2017-10-10 21:38:19.893446|2017-10-10 21:38:19.893446
NCT02954263|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-08-25|||November 2016||2016-11-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects|A Phase 1, Double-blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−1439 in Healthy Subjects|Completed||Phase 1|40|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||||2017-10-10 21:38:19.977044|2017-10-10 21:38:19.977044
NCT02954250|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-11-01|||September 2016||2016-09-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide|Modified Mindfulness Based Cognitive Therapy for the Treatment of Depressive Symptoms and Cognitive Inhibition in Patients at Risk for Suicide: A Pilot Randomized Controlled Trial|Recruiting||Early Phase 1|30|Anticipated|Lady Davis Institute||2|||f||||f||||||||||2017-10-10 21:38:20.086534|2017-10-10 21:38:20.086534
NCT02954237|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-11-01|||November 2016||2016-11-01|November 2016|2016-11-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Observational|ACP PAS China||AMPLATZER™ Cardiac Plug Observational Post-Approval Study (ACP PAS China)|AMPLATZER™ Cardiac Plug Observational Post-Approval Study|Not yet recruiting||N/A|343|Anticipated|St. Jude Medical|||1||f||||||||||||||2017-10-10 21:38:20.172797|2017-10-10 21:38:20.172797
NCT02954224|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-01|||March 2016||2016-03-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PODESA||Prevention Of Delirium in Elderly With Obstructive Sleep Apnea (PODESA)|Prevention Of Delirium in Elderly With Obstructive Sleep Apnea (PODESA)|Recruiting||N/A|304|Anticipated|University Health Network, Toronto||2|||f||||t||||||||No||2017-10-10 21:38:20.248106|2017-10-10 21:38:20.248106
NCT02954211|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-03|||December 2016||2016-12-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||rTMS and Physical Therapy as a Clinical Service for People With Stroke|rTMS and Physical Therapy as a Clinical Service for People With Stroke|Not yet recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||No||2017-10-10 21:38:20.369301|2017-10-10 21:38:20.369301
NCT02954198|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-02-28|||December 2016||2016-12-01|December 2016|2016-12-01||||September 2018|Anticipated|2018-09-01||Interventional|||Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients|Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients|Recruiting||N/A|40|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 21:38:20.453273|2017-10-10 21:38:20.453273
NCT02954185|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-10-04|||November 2016||2016-11-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Wellclub Shoulder Therapy Outcome Validation|Wellclub Shoulder Therapy Outcome Validation|Recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 21:38:20.575456|2017-10-10 21:38:20.575456
NCT02954172|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-03-13|||November 2016|Actual|2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC|Study to Evaluate the Efficacy and Safety of IBI305 in Combination With Paclitaxel/Carboplatin Versus Bevacizumab in Combination With Paclitaxel/Carboplatin in Treatment-naïve Patients With Advanced or Recurrent Non-squamous NSCLC|Recruiting||Phase 3|436|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||2|||f||||f||||||||Undecided||2017-10-10 21:38:20.720302|2017-10-10 21:38:20.720302
NCT02954159|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-07-07|||May 18, 2017|Actual|2017-05-18|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|COVET||Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC|Induction of Response and Remission of Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in Patients With Moderately to Severely Active Ulcerative Colitis|Recruiting||Phase 3|46|Anticipated|Medical College of Wisconsin||2|||f||||t|t|f||||||||2017-10-10 21:38:20.83656|2017-10-10 21:38:20.83656
NCT02954133|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-01|||July 2016||2016-07-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effect of OrthoPulse™ Photobiomodulation on Tooth Movement and Treatment Time When Used With Invisalign Treatment|The Effect of OrthoPulse™ Photobiomodulation on Tooth Movement and Treatment Time When Used With Invisalign Treatment|Recruiting||N/A|120|Anticipated|Biolux Research Ltd.||3|||f||||f||||||||||2017-10-10 21:38:21.058887|2017-10-10 21:38:21.058887
NCT02954120|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-01|||May 2013||2013-05-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01|1 Day|Observational [Patient Registry]|||Chronic Periodontitis and Polycystic Ovary Syndrome|Evaluation Of Lipid Peroxidation, Oxidative DNA Damage And Total Antioxidant Status In Patients With Periodontitis And Polycystic Ovary Syndrome: A Cross Sectional Study|Completed||N/A|88|Actual|Bezmialem Vakif University|||4||f||||t||||||Samples With DNA|"     Serum and saliva samples were obtained and stored until biochemical analyses   "|||2017-10-10 21:38:21.186198|2017-10-10 21:38:21.186198
NCT02954107|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-11-02|||September 2016||2016-09-01|July 2016|2016-07-01||||September 2019|Anticipated|2019-09-01|2 Years|Observational [Patient Registry]|LEES||Longitudinal Early Epilepsy Study|Longitudinal Early Epilepsy Study|Recruiting||N/A|60|Anticipated|Maastricht University Medical Center|||2||f||||t||||||||No||2017-10-10 21:38:21.275417|2017-10-10 21:38:21.275417
NCT02954094|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-10-04|||December 2016||2016-12-01|October 2017|2017-10-01|October 2024|Anticipated|2024-10-01|October 2024|Anticipated|2024-10-01|5 Years|Observational [Patient Registry]|||A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC|A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma (HCC)|Recruiting||N/A|5000|Anticipated|Target PharmaSolutions, Inc.|||1||f||||f||||||Samples With DNA|"     Patients enrolled in TARGET-HCC may be invited to participate in the Biorepository Specimen     Bank (BSB). Blood samples and tissue samples for biomarker and DNA assays will be collected     on a voluntary basis and participation in this project will not affect participation in the     main study. These samples will be shipped to a central repository for storage to use in     future studies. Samples stored at the biorepository will be identified only with the     participant's unique study ID number and the date that the sample was obtained. This link     between the participant's study ID number and their name will be available only at the site     where the samples were obtained.   "|||2017-10-10 21:38:21.391564|2017-10-10 21:38:21.391564
NCT02954081|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-04-26|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|APART||APremilast After FumaRic Acid Ester Treatment|Real-world Benefit of Apremilast Treatment of Patients With Moderate-to-severe Psoriasis After Transition From Fumaric Acid Esters|Recruiting||N/A|1600|Anticipated|Sciderm GmbH|||1||f||||f|f|f||||||No||2017-10-10 21:38:21.545676|2017-10-10 21:38:21.545676
NCT02954068|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||IV Versus IM Administration of Oxytocin for Postpartum Bleeding|Intravenous Versus Intramuscular Administration of Oxytocin and Its Relationship With Postpartum Bleeding and Other Clinical Signs: a Randomized Placebo-controlled Study|Recruiting||Phase 4|486|Anticipated|Gynuity Health Projects||2|||f||||||||||||||2017-10-10 21:38:21.62359|2017-10-10 21:38:21.62359
NCT02954055|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-07-31|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|METEORA-II||MEtronomic TrEatment Option in Advanced bReast cAncer|A Randomized Phase II Trial of Metronomic Oral Vinorelbine Plus Cyclophosphamide and Capecitabine (VEX) Versus Weekly Paclitaxel as First-line or Second-line Treatment in Patients With ER-positive/HER2-negative Advanced or Metastatic Breast Cancer|Recruiting||Phase 2|160|Anticipated|International Breast Cancer Study Group||2|||f||||t|f|f||||||||2017-10-10 21:38:21.718827|2017-10-10 21:38:21.718827
NCT02954042|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-03-14|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pelvital Stress Urinary Incontinence Training Device: P-SUIT|Pelvital Stress Urinary Incontinence Training Device: P-SUIT|Recruiting||Phase 2|120|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|t|t|f|f|||Undecided||2017-10-10 21:38:21.880874|2017-10-10 21:38:21.880874
NCT02954029|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-11-02|||April 2016||2016-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures|Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures|Recruiting||Phase 4|315|Anticipated|Seoul National University Bundang Hospital||4|||f||||t||||||||No||2017-10-10 21:38:22.00074|2017-10-10 21:38:22.00074
NCT02954016|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-01|||March 2016||2016-03-01|November 2016|2016-11-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Interventional|ePass||The ePass Clinical Trial for the Treatment of Obese Subjects|Safety and Efficacy of the ValenTx EndoPass™ System for the Treatment of Obese Subjects: The ePass Clinical Trial|Active, not recruiting||N/A|10|Actual|ValenTx, Inc.||1|||f||||t||||||||No||2017-10-10 21:38:22.096419|2017-10-10 21:38:22.096419
NCT02954003|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2015|Actual|2015-10-01||Interventional|||The ValenTx Endo Bypass System in Obese Subjects|An Open Label Trial of the Safety and Effectiveness of the ValenTx Endo Bypass System and Use of the Endoscopic Anchor Placement Device in Obese Subjects|Active, not recruiting||N/A|40|Actual|ValenTx, Inc.||1|||f||||t||||||||No||2017-10-10 21:38:22.175638|2017-10-10 21:38:22.175638
NCT02953990|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-01|||September 2016||2016-09-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Self-Management of Chronic Depressive Symptoms in Pregnancy|Self-Management of Chronic Depressive Symptoms in Pregnancy|Recruiting||N/A|120|Anticipated|Virginia Commonwealth University||1|||f||||t||||||||No||2017-10-10 21:38:22.250027|2017-10-10 21:38:22.250027
NCT02953977|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-05-08|||September 1, 2017|Anticipated|2017-09-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|May 2020|Anticipated|2020-05-01||Interventional|SMSC||Strong Men, Strong Communities|Strong Men, Strong Communities: Cultural Tradition to Improve Native Men's Health|Not yet recruiting||N/A|240|Anticipated|Washington State University||2|||f||||f|f|f||||||||2017-10-10 21:38:22.358325|2017-10-10 21:38:22.358325
NCT02953964|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-01|||May 2010||2010-05-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Memory Encoding Strategies for People With Mild Cognitive Impairments|Perceptual and Semantic Memory Encoding Strategies for People With Mild Cognitive Impairment|Completed||N/A|60|Actual|University of Western Sydney||3|||f||||f||||||||No||2017-10-10 21:38:22.428977|2017-10-10 21:38:22.428977
NCT02953951|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-11-01|||January 2014||2014-01-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|May 2014|Actual|2014-05-01||Observational|||Blood Transfusions in Coronary Artery Bypass Surgery|Blood Transfusions May Impair Endothelium-dependent Vasodilatation in Isolated Left Mammary Arterial Artery Rings and Peripheral Artery Tonometry During Coronary Artery Bypass Surgery|Completed||N/A|95|Actual|Universita di Verona|||3||f||||f||||||Samples With DNA|"     blood, left internal mammary artery (discared rings)   "|No||2017-10-10 21:38:22.504208|2017-10-10 21:38:22.504208
NCT02953925|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-05-16|||November 2016||2016-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|China-PHC||National-wide Survey on Primary Health Care in China|National-wide Survey on Primary Health Care in China|Completed||N/A|50000|Actual|China National Center for Cardiovascular Diseases|||1||f||||f||||||||Undecided||2017-10-10 21:38:22.66969|2017-10-10 21:38:22.66969
NCT02953912|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-02|||November 2016||2016-11-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Assessment of Postoperative Pain Using Reciproc Versus One Shape Files in Patients With Irreversible Pulpitis|Assessment of Postoperative Pain After Using Reciproc Versus One Shape NiTi Systems in Patients With Symptomatic Irreversible Pulpitis.|Not yet recruiting||N/A|54|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:38:22.731762|2017-10-10 21:38:22.731762
NCT02953899|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Contingency Management as an Adjunct Treatment for Rural and Remote Disordered Gamblers|Piloting the Addition of Contingency Management to Best Practice Counselling as an Adjunct Treatment for Rural and Remote Disordered Gamblers|Recruiting||N/A|54|Anticipated|University of Lethbridge||2|||f||||f||||||||No|Only the research team will have access to the individual participant data|2017-10-10 21:38:24.348844|2017-10-10 21:38:24.348844
NCT02953886|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-01|||November 2016||2016-11-01|May 2017|2017-05-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|||The Effect of Silver Diamine Fluoride (SDF) on Bacteria Involved in Root or Cervical Carious Lesions|The Effect of Silver Diamine Fluoride (SDF) on Bacteria Involved in Root or Cervical Carious Lesions Using HOMINGS Technology. A Clinical Study|Completed||Phase 4|21|Actual|University of Michigan||1|||f||||f||||||||No||2017-10-10 21:38:24.450437|2017-10-10 21:38:24.450437
NCT02953873|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-05-22|||May 5, 2017|Actual|2017-05-05|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients|Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus|Recruiting||Phase 4|25|Anticipated|Medical University of South Carolina||1|||f||||t|t|f||||||No|The data will not be shared.|2017-10-10 21:38:24.533249|2017-10-10 21:38:24.533249
NCT02953860|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-08-18|||July 6, 2017|Actual|2017-07-06|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer|Phase II Trial of Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer|Recruiting||Phase 2|24|Anticipated|University of Colorado, Denver||1|||f||||t|t|f||||||||2017-10-10 21:38:24.624359|2017-10-10 21:38:24.624359
NCT02953847|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-05-09|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|BIO3FDC||The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB)|The Bioavailability of Rifampicin in Fixed Dose Combinations (FDCs) Widely Used in South Africa to Treat Drug-susceptible Tuberculosis (TB)|Completed||Phase 1|21|Actual|University of Cape Town||6|||f||||f||||||||Yes||2017-10-10 21:38:24.70809|2017-10-10 21:38:24.70809
NCT02953834|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-06-06|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Kisspeptin Influence on Glucose Homeostasis|Kisspeptin Influence on Glucose Homeostasis|Recruiting||Phase 1|413|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||Yes|After primary results are published, the authors will provide individuals participant data upon request as long as it does not conflict with state or Institutional regulations.|2017-10-10 21:38:24.819193|2017-10-10 21:38:24.819193
NCT02953821|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-22|||October 2016||2016-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Active Systemic Lupus Erythematosus (SLE)|A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Persistently Active Systemic Lupus Erythematosus Despite Moderate Dose Corticosteroids|Recruiting||Phase 4|162|Anticipated|Mallinckrodt||2|||f||||||||||||||2017-10-10 21:38:24.932506|2017-10-10 21:38:24.932506
NCT02953808|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-01-18|||November 2016||2016-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase 1 Study of GSK2315698 in Healthy Japanese Subjects|A Single Centre, Double-blind, Randomised, Placebo-controlled, and Single Dose-ascending Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics, of Single Intravenous Doses of GSK2315698 in Healthy Japanese Subjects|Completed||Phase 1|18|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-10 21:38:25.272178|2017-10-10 21:38:25.272178
NCT02953782|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-22|||November 2016||2016-11-01|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|May 2018|Anticipated|2018-05-01||Interventional|||Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer|A Phase 1b/2 Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer|Recruiting||Phase 1/Phase 2|112|Anticipated|Forty Seven, Inc.||3|||f||||f||||||||||2017-10-10 21:38:25.415251|2017-10-10 21:38:25.415251
NCT02953769|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-20|||March 29, 2017|Actual|2017-03-29|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Observational|||Prevena Incision Management System Wound Care|Use of Prevena Incision Management System in Wound Morbidity in Complex Ventral Hernia Patients. A Prospective Randomized Control Trial|Recruiting||N/A|198|Anticipated|Florida Hospital|||2||f||||f||||||||||2017-10-10 21:38:25.615513|2017-10-10 21:38:25.615513
NCT02953756|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-01|||October 2015||2015-10-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)|Cognitive Outcome After Gamma Knife Radiosurgery in Patients With 1-10 Brain Metastases|Recruiting||N/A|100|Anticipated|Elisabeth-TweeSteden Ziekenhuis|||1||f||||f||||||||Undecided||2017-10-10 21:38:25.731564|2017-10-10 21:38:25.731564
NCT02953743|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-21|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 28, 2017|Actual|2017-06-28||Interventional|||Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)|Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)|Active, not recruiting||Phase 1|25|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-10 21:38:25.87536|2017-10-10 21:38:25.87536
NCT02953730|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-01|||September 2015||2015-09-01|November 2016|2016-11-01||||June 2016|Actual|2016-06-01||Interventional|||The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents|The Study on the Pharmacokinetics of Pegylated Recombinant Human Granulocyte Stimulating Factor（PEG-rhG-CSF） in Children and Adolescents|Completed||Phase 4|9|Actual|Chinese Academy of Medical Sciences||1|||f||||||||||||||2017-10-10 21:38:25.997783|2017-10-10 21:38:25.997783
NCT02953717|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-01|||February 2016||2016-02-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)|A Prospective Randomized Study to Compare Cognitive Outcome After Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Patients With 11-20 Brain Metastases|Recruiting||N/A|80|Anticipated|Elisabeth-TweeSteden Ziekenhuis||2|||f||||f||||||||Undecided||2017-10-10 21:38:26.115513|2017-10-10 21:38:26.115513
NCT02953704|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-20|||December 2016||2016-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Observational|||Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)|Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients With Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy|Recruiting||N/A|1500|Anticipated|Incyte Corporation|||2||f||||f||||||||||2017-10-10 21:38:26.293835|2017-10-10 21:38:26.293835
NCT02953691|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-23|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Exploring the Impact of Perioperative Galacto-Oligosaccharides (GOS) on Stress, Anxiety and Cognition|Exploring the Impact of Perioperative Galacto-Oligosaccharides (GOS) on Stress, Anxiety and Cognition|Recruiting||Phase 2|8|Anticipated|Duke University||2|||f||||f|t|f||||||No||2017-10-10 21:38:26.679095|2017-10-10 21:38:26.679095
NCT02953678|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-18|||November 2016||2016-11-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|||A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH1)|A Single-Cohort, Phase 2 Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH1)|Recruiting||Phase 2|70|Anticipated|Incyte Corporation||1|||t||||f||||||||||2017-10-10 21:38:26.831462|2017-10-10 21:38:26.831462
NCT02953665|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-11|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Safety and Efficacy of Liraglutide in Parkinson's Disease|A Phase II, Randomized, Double-blinded, Placebo-controlled Trial of Liraglutide in Parkinson's Disease|Recruiting||Phase 2|57|Anticipated|Cedars-Sinai Medical Center||2|||f||||t|t|f||||||No||2017-10-10 21:38:27.078319|2017-10-10 21:38:27.078319
NCT02953652|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-10-04|||November 2016||2016-11-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)|A Phase 2b Open-Label Single Arm Study to Evaluate the Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)|Recruiting||Phase 2|40|Anticipated|HUYA Bioscience International||1|||f||||t||||||||||2017-10-10 21:38:27.322966|2017-10-10 21:38:27.322966
NCT02953639|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-09-25|||November 30, 2016|Actual|2016-11-30|September 2017|2017-09-01|August 23, 2018|Anticipated|2018-08-23|August 23, 2018|Anticipated|2018-08-23||Interventional|||A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics|A Phase IIb, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Basmisanil (RO5186582) as Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia Treated With Antipsychotics|Recruiting||Phase 2|180|Anticipated|Hoffmann-La Roche||3|||f|||||t|f||||||||2017-10-10 21:38:27.481566|2017-10-10 21:38:27.481566
NCT02953626|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-05-11|||May 2016||2016-05-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Mother Matters Online Postpartum Support|Mother Matters: Pilot Randomized Waitlist Controlled Trial of an Online Postpartum Mental Health Support Group|Completed||N/A|96|Actual|Women's College Hospital||2|||f||||f||||||||No||2017-10-10 21:38:27.639301|2017-10-10 21:38:27.639301
NCT02953613|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-06-17|||April 28, 2016||2016-04-28|June 2017|2017-06-01|August 2022|Anticipated|2022-08-01|December 2017|Anticipated|2017-12-01||Interventional|LUNAR-CCTA||LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:|LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries: Correlations With Non-invasive Coronary Computer Tomographic Angiography. (LUNAR-CCTA Study)|Recruiting||N/A|200|Anticipated|William Beaumont Hospitals||1|||f||||t||||||||Undecided||2017-10-10 21:38:27.743754|2017-10-10 21:38:27.743754
NCT02953600|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-10|||November 2016||2016-11-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration|Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration|Recruiting||N/A|72|Anticipated|Taipei Medical University WanFang Hospital||3|||f||||f||||||||No||2017-10-10 21:38:27.835244|2017-10-10 21:38:27.835244
NCT02953574|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-08-07|||September 2016||2016-09-01|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|August 3, 2017|Actual|2017-08-03||Interventional|||Daily Sleep Enhancement for Hospitalized People With Dementia Following a Nursing Protocol|Daily Sleep Enhancement for Hospitalized People With Dementia Following a 7 Step Nursing Protocol: a Quasi-experimental Pilot Study|Completed||N/A|40|Actual|University of Zurich||2|||f||||f||||||||||2017-10-10 21:38:28.059042|2017-10-10 21:38:28.059042
NCT02953561|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-05-30|||February 20, 2017|Actual|2017-02-20|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Avelumab (antiPDL1) and Azacytidine in Acute Myeloid Leukemia (AML)|An Open-label Phase Ib/II Study of Avelumab in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/Relapsed Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|58|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:38:28.139832|2017-10-10 21:38:28.139832
NCT02953548|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-03-17|||March 16, 2017|Actual|2017-03-16|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)|A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study|Recruiting||Phase 3|10|Anticipated|GW Research Ltd||1|||f||||t|t|f||||||||2017-10-10 21:38:28.268087|2017-10-10 21:38:28.268087
NCT02953535|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-01|||May 2016||2016-05-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)|Comparative Open-label,Randomized, Fasting, Three Way Three Sequence Two Treatment Partial Replicate Crossover Bioequivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)|Completed||Phase 1|36|Actual|Genuine Research Center, Egypt||3|||f||||f||||||||Undecided||2017-10-10 21:38:28.360422|2017-10-10 21:38:28.360422
NCT02953522|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-03|||November 2015||2015-11-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Polymorphism C677T MTHFR and Effects of Folate Intake|Polymorphism C677T MTHFR and Diet With Folate in Oxidative Stress, Lipid Profile and Homocysteine|Completed||N/A|48|Actual|Federal University of Paraíba||2|||f||||t||||||||Yes|The data of the participants are in the excel database|2017-10-10 21:38:28.501895|2017-10-10 21:38:28.501895
NCT02953509|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-28|||November 2016||2016-11-01|July 2017|2017-07-01|January 2023|Anticipated|2023-01-01|March 2018|Anticipated|2018-03-01||Interventional|||Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma|A Phase 1b/2 Trial of Hu5F9-G4 in Combination With Rituximab in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|72|Anticipated|Forty Seven, Inc.||3|||f||||f||||||||||2017-10-10 21:38:28.590532|2017-10-10 21:38:28.590532
NCT02953496|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-03-30||||||March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety/Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries|A Phase 1 Multi-Center, Dose-Escalation Study of Vonapanitase Administered Percutaneously to the Superficial Femoral or Popliteal Artery in Patients With Peripheral Artery Disease|Not yet recruiting||Phase 1|30|Anticipated|Proteon Therapeutics||1|||f||||t||||||||||2017-10-10 21:38:28.720243|2017-10-10 21:38:28.720243
NCT02953483|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Ex Vivo Lung Perfusion : Effect of Cellular Perfusate on Mechanical Properties and Gas Exchange Function of Donor Lungs|Ex Vivo Lung Perfusion : Evaluating the Effect of Cellular Perfusate on Mechanical Properties and Gas Exchange Function of the Donor Lungs : A Randomised Cross Over Study|Recruiting||N/A|6|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||No||2017-10-10 21:38:28.804859|2017-10-10 21:38:28.804859
NCT02953470|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect Study of on Intervention on Pain, Function, Health and Behaviour for Older Adults Living With Chronic Pain|Community-dwelling Older Adults Living With Chronic Musculoskeletal Pain: The Effect of an Evidence-based Intervention on Pain, Function, Health and Behaviour|Recruiting||N/A|150|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||t||||||||No||2017-10-10 21:38:28.895953|2017-10-10 21:38:28.895953
NCT02953457|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-07-10|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|August 15, 2020|Anticipated|2020-08-15|August 15, 2019|Anticipated|2019-08-15||Interventional|||Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation|A Phase I/II Evaluation of Olaparib in Combination With Durvalumab (Medi4736) and Tremelimumab in the Treatment of Recurrent Platinum Sensitive or Resistant or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Patients Who Carry a BRCA1 or BRCA2 Mutation|Recruiting||Phase 1/Phase 2|39|Anticipated|Roswell Park Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:38:29.012738|2017-10-10 21:38:29.012738
NCT02953444|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-12-13|||November 2016||2016-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice|The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice|Recruiting||N/A|120|Anticipated|Duke University||3|||f||||f||||||||No||2017-10-10 21:38:29.121338|2017-10-10 21:38:29.121338
NCT02953431|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-11-01|||December 2016||2016-12-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01||Interventional|||Increased Lung Volume as Controller Therapy for Asthma|Increased Lung Volume as Controller Therapy for Asthma|Not yet recruiting||Phase 1/Phase 2|29|Anticipated|University of Vermont||2|||f||||t||||||||Yes|Results will be published in the archival literature, and this will include a complete description of experimental and analytical methods used. All original data will be stored and available to interested investigators with appropriate regulatory approvals in place|2017-10-10 21:38:29.221151|2017-10-10 21:38:29.221151
NCT02953418|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-05-11|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|REACH||RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous Neoplasia|A Multicenter Trial of Endoscopic Radiofrequency Ablation for High-grade and Low-grade Intraepithelial Squamous Neoplasia Using the Barrx™ Flex Radiofrequency Ablation System|Recruiting||N/A|150|Anticipated|Medtronic - MITG||1|||f||||t|f|f||||||Undecided||2017-10-10 21:38:29.297741|2017-10-10 21:38:29.297741
NCT02953405|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-11-01|||December 2015||2015-12-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease||Recruiting||N/A|1000|Anticipated|Daewoong Pharmaceutical Co. LTD.|||1||f||||||||||||||2017-10-10 21:38:29.373774|2017-10-10 21:38:29.373774
NCT02953392|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-31|||May 2016||2016-05-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Implant-Abutment Interface Design on Bone and Soft Tissue Levels Around Implants Placed Using Different Transcrestal Sinus Floor Elevation|Evaluation of Implant-Abutment Interface Design on Bone and Soft Tissue Levels Around Implants Placed Using Two Different Transcrestal Sinus Floor Elevation Approaches: A Multi-Center, Double Blind, Randomized Trial|Recruiting||N/A|60|Anticipated|The Bluestone Center for Clinical Research||4|||f||||t||||||||No||2017-10-10 21:38:29.437154|2017-10-10 21:38:29.437154
NCT02953379|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-01-20|||September 2017|Anticipated|2017-09-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis|Phase III, National, Multicenter, Randomized, Single-blind, Non-inferiority to Compare the Efficacy of Mometasone Nasal Gel Compared to Mometasone Nasal Spray in the Treatment of Persistent or Intermittent Allergic Rhinitis in Adults|Not yet recruiting||Phase 3|278|Anticipated|EMS||2|||f||||t|f|f||||||||2017-10-10 21:38:29.644229|2017-10-10 21:38:29.644229
NCT02953366|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-01-20|||September 2017|Anticipated|2017-09-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis|Phase III, National, Multicenter, Randomized, Single-blind, Non-inferiority to Compare the Efficacy of Mometasone Nasal Gel Compared to Mometasone Nasal Spray in the Treatment of Persistent or Intermittent Allergic Rhinitis in Childrens|Not yet recruiting||Phase 3|418|Anticipated|EMS||2|||f||||t|f|f||||||||2017-10-10 21:38:29.730155|2017-10-10 21:38:29.730155
NCT02953353|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-11-09|||February 2017||2017-02-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity|Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity: a Proof-of-concept Study|Not yet recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 21:38:29.826503|2017-10-10 21:38:29.826503
NCT02953340|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-07-12|||April 13, 2017|Actual|2017-04-13|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Early- Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (RECOVER)|Randomized, OpEn-Label, Active-ContrOl Trial of SPI-2012 (Eflapegrastim) Versus Pegfilgrastim in the Management of Chemotherapy-Induced Neutropenia in Early-Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) (RECOVER)|Recruiting||Phase 3|218|Anticipated|Spectrum Pharmaceuticals, Inc||2|||f||||f|t|f||||||||2017-10-10 21:38:29.942479|2017-10-10 21:38:29.942479
NCT02953327|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-01-31|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau|Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau|Recruiting||Phase 4|40|Anticipated|Bandim Health Project||2|||f||||f||||||||||2017-10-10 21:38:30.086831|2017-10-10 21:38:30.086831
NCT02953314|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-02-07|||October 2016||2016-10-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of VX-661/Ivacaftor in Pediatric Subjects With Cystic Fibrosis|A Phase 3, Open Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of VX-661 in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous or Heterozygous for the F508del CFTR Mutation|Recruiting||Phase 3|72|Anticipated|Vertex Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-10-10 21:38:30.187023|2017-10-10 21:38:30.187023
NCT02953288|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-01|||October 2016||2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Observational|||Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.|Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.|Active, not recruiting||N/A|3000|Anticipated|Shanghai 10th People's Hospital|||2||f||||t||||||Samples With DNA|"     Thyroid tissue   "|Undecided||2017-10-10 21:38:30.536994|2017-10-10 21:38:30.536994
NCT02953275|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-05-12|||April 13, 2017|Actual|2017-04-13|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Synergistic Effect of Vedolizumab and Pentoxifylline|Synergistic Effect of Vedolizumab and Pentoxifylline in the Management of Patients With Inflammatory Bowel Disease|Recruiting||Early Phase 1|30|Anticipated|University of Miami||2|||f||||f|t|f||||||No||2017-10-10 21:38:30.624957|2017-10-10 21:38:30.624957
NCT02953262|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-09-21|||February 1, 2019|Anticipated|2019-02-01|September 2017|2017-09-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Improving Diabetes Care Through Effective Personalized Patient Portal Interactions|Improving Diabetes Care Through Effective Personalized Patient Portal Interactions|Not yet recruiting||N/A|200|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:38:30.733242|2017-10-10 21:38:30.733242
NCT02953249|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-10-31|||September 2016||2016-09-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|June 2017|Anticipated|2017-06-01|60 Days|Observational [Patient Registry]|||Wound Healing After Tooth Extraction in Individuals With Type 1 Diabetes Mellitus|Wound Healing After Tooth Extraction in Individuals With Type 1 Diabetes Mellitus|Recruiting||N/A|60|Anticipated|University of Sao Paulo|||2||f||||f||||||None Retained|"     stimulated saliva   "|No||2017-10-10 21:38:30.844989|2017-10-10 21:38:30.844989
NCT02953236|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-03-30|||January 2016||2016-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|January 2016|Actual|2016-01-01||Interventional|ECA_TMI||INSTRUMENTED-MANUAL PHYSIOTHERAPY VERSUS NONINSTRUMENTED|THE INMEDIATE EFFECTS OF RICHELLI'S PAINRELIEVER ON UPPER TRAPEZIUS MYOFASCIAL TRIGGER POINT IN PATIENTS SUFFERING FROM NECK PAIN: A RANDOMIZED CONTROLLED TRIAL|Completed||N/A|30|Actual|University of Malaga||2|||f||||f||||||||Yes||2017-10-10 21:38:30.945239|2017-10-10 21:38:30.945239
NCT02953197|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-31|||February 2013||2013-02-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|FiGaRO||18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal Tumours|18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal Tumours (FiGaRO), A Phase 1 Pilot Study|Recruiting||Phase 1|25|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 21:38:31.301223|2017-10-10 21:38:31.301223
NCT02953184|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy|Marched Pair Study of the Standard Chemotherapy 4doxorubicin Plus Cyclophosphamide(AC) 60 + 4 Docetaxel Protocol Versus 4 PLD C35+4 Docetaxel in Neoadjuvant Chemotherapy of Breast Cancer|Recruiting||Phase 2|160|Anticipated|Jilin University||2|||f||||t||||||||Yes||2017-10-10 21:38:31.375373|2017-10-10 21:38:31.375373
NCT02953171|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-31|||September 2016||2016-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Probiotics in the Treatment of Irritable Bowel Syndrome|A Randomized Controlled Clinical Trial to Investigate the Efficacy of Lacto-fermented Sauerkraut and the Probiotic E. Coli Nissle 1917 in the Treatment of Irritable Bowel Syndrome|Recruiting||N/A|140|Anticipated|University of Copenhagen||4|||f||||f||||||||Undecided||2017-10-10 21:38:31.499927|2017-10-10 21:38:31.499927
NCT02953158|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-02-03|||January 3, 2017|Actual|2017-01-03|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|HAWLS||Effectiveness of Changing Dietary Fat on Weight Loss|A Comparison of A Hypocaloric Diet Plus One Hass Avocado Per Day Versus An Equally Hypocaloric Diet for Weight Loss, Satiety, Changes in Body Composition, and Risk Factors for Chronic Disease (HAWLS)|Recruiting||N/A|60|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 21:38:31.592177|2017-10-10 21:38:31.592177
NCT02953145|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||The Use of Fibrin Sealant to Reduce Post Operative Pain in Cleft Palate Surgery|The Use of Fibrin Sealant to Reduce Post Operative Pain in Cleft Palate Surgery|Recruiting||Phase 4|40|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-10 21:38:31.669716|2017-10-10 21:38:31.669716
NCT02953132|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-05-16|||November 2016||2016-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers|A Randomised, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of MT-4129 in Healthy Subjects; Including the Effect of Gender and Age on the Pharmacokinetics of a Single Dose of MT-4129 in Healthy Subjects|Completed||Phase 1|116|Anticipated|Mitsubishi Tanabe Pharma Corporation||2|||f||||||||||||||2017-10-10 21:38:31.778578|2017-10-10 21:38:31.778578
NCT02953119|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|PISO||Prehabilitation for Elective Major Abdominal Surgery||Recruiting||N/A|150|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||No||2017-10-10 21:38:31.865607|2017-10-10 21:38:31.865607
NCT02953106|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-01|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MAN06||Assessing the Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma and Allergic Rhinitis|Proof of Concept Study to Assess Downstream Effects of Using Combined Intranasal Fluticasone Propionate Plus Azelastine Nasal Spray on Asthmatic Inflammation in Patients With Persistent Asthma and Allergic Rhinitis|Not yet recruiting||Phase 4|20|Anticipated|University of Dundee||2|||f||||f||||||||No||2017-10-10 21:38:31.943735|2017-10-10 21:38:31.943735
NCT02953093|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-31|||November 2016||2016-11-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SAIL||Study of Acarbose in Longevity|Study of Changes in Muscle and Fat Gene Transcription With Acarbose Treatment: a Crossover Study|Not yet recruiting||Phase 2|30|Anticipated|Montefiore Medical Center||2|||f||||f||||||||No|There is no plan to share individual participant data to researchers who are not part of the study|2017-10-10 21:38:32.036717|2017-10-10 21:38:32.036717
NCT02953080|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-10-31|||November 2016||2016-11-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software Support|Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software Support|Not yet recruiting||N/A|600|Anticipated|Makerere University||2|||f||||f||||||||Undecided||2017-10-10 21:38:32.116489|2017-10-10 21:38:32.116489
NCT02953067|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-01|||March 2012||2012-03-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Treatment of Lisfranc Injuries|A Multi-center, Prospective, Randomised Study of Treatment of Lisfranc Injuries|Recruiting||N/A|130|Anticipated|Tampere University Hospital||3|||f||||f||||||||No||2017-10-10 21:38:32.184294|2017-10-10 21:38:32.184294
NCT02953041|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-12|||October 2016||2016-10-01|June 2017|2017-06-01|January 9, 2017|Actual|2017-01-09|January 2017|Actual|2017-01-01||Interventional|||Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve|The Effect of Glycopyrronium and Indacaterol, as Monotherapy and in Combination, on the Methacholine Dose-response Curve|Completed||Phase 4|31|Actual|University of Saskatchewan||3|||f||||f||||||||Yes|Journal Publication|2017-10-10 21:38:32.389149|2017-10-10 21:38:32.389149
NCT02953028|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-10-31|||October 2014||2014-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Obstructive Sleep Apnea - Patient Specific Factors, Success Rate and Compliance|Treatment of Mild and Moderate Obstructive Sleep Apnea (OSA) by Continuous Positive Airway Pressure (CPAP) or Mandibular Advancing Splint (MAS) - a Randomized Controlled Trial on Patient Specific Factors, Success Rate and Compliance|Recruiting||N/A|140|Anticipated|University of Tromso||2|||f||||f||||||||No||2017-10-10 21:38:32.64127|2017-10-10 21:38:32.64127
NCT02953015|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-11-01|||January 2016||2016-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|MIGRANE||Non-pharmacological Management of Chronic Migraine|Effects of Cervical and Thoracic Manipulative Techniques Combined With OnabotulinumtoxinA Prophylaxis in the Management of Chronic Migraine: a Pilot Single-blind Randomized Controlled Trial|Active, not recruiting||N/A|16|Actual|Universita di Verona||2|||f||||t||||||||No||2017-10-10 21:38:32.799995|2017-10-10 21:38:32.799995
NCT02953002|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-02|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Correlation Between The New Sepsis Scores - SOFA, Quick SOFA and Calibrated Automated Thrombogram Values|The Correlation Between The New Sepsis Scores - SOFA, Quick SOFA and Calibrated Automated Thrombogram Values|Not yet recruiting||N/A|200|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-10 21:38:32.914161|2017-10-10 21:38:32.914161
NCT02952989|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-28|||February 23, 2017|Actual|2017-02-23|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|July 2019|Anticipated|2019-07-01||Interventional|||A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors|A Phase 1, Multicenter, Open-label, Dose-escalation Study of SGN-2FF in Patients With Advanced Solid Tumors|Recruiting||Phase 1|158|Anticipated|Seattle Genetics, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:38:32.993155|2017-10-10 21:38:32.993155
NCT02952976|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-04-24|||July 1, 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique|Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique|Not yet recruiting||Phase 3|94|Anticipated|Sociedade Brasileira de Atendimento Integrado ao Trauma||2|||f||||f|f|t|f|f|t|||No||2017-10-10 21:38:33.150376|2017-10-10 21:38:33.150376
NCT02952963|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-07|||October 2016||2016-10-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass|Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass|Recruiting||Phase 4|8|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||Yes||2017-10-10 21:38:33.242696|2017-10-10 21:38:33.242696
NCT02952950|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2016-11-02|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Is it Possible to Extend the Duration of Breastfeeding to the Premature Infant? - a Prospectivt Study|Is it Possible to Extend the Duration of Breastfeeding to the Premature Infant? - a Prospectivt Study|Recruiting||N/A|200|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||No||2017-10-10 21:38:33.3509|2017-10-10 21:38:33.3509
NCT02952937|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-04-11|||November 2016||2016-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|November 2016|Actual|2016-11-01||Interventional|||Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg|A Randomized, Open-label, Single Dose, Crossover Phase 1 Study to Compare the Pharmacokinetic Characteristics of GLA5PR GLARS-NF1 Tablet 300 mg and GLA5PR GLARS-NF3 Tablet 300 mg in Healthy Volunteers|Completed||Phase 1|24|Actual|GL Pharm Tech Corporation||2|||f||||f||||||||No||2017-10-10 21:38:33.482362|2017-10-10 21:38:33.482362
NCT02952924|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-08-07|||December 14, 2016|Actual|2016-12-14|August 2017|2017-08-01|January 25, 2019|Anticipated|2019-01-25|January 25, 2019|Anticipated|2019-01-25||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants||Recruiting||Phase 1|128|Anticipated|Hoffmann-La Roche||6|||f||||||||||||||2017-10-10 21:38:33.587674|2017-10-10 21:38:33.587674
NCT02952911|ClinicalTrials.gov processed this data on October 10, 2017|2016-11-01|2017-05-08|||November 28, 2016|Actual|2016-11-28|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility Study||Recruiting||N/A|120|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 21:38:33.772684|2017-10-10 21:38:33.772684
NCT02952898|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-08-01|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|April 2017|Actual|2017-04-01||Interventional|||Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses|Active, not recruiting||Phase 3|600|Anticipated|Gage Development Company, LLC||3|||f||||f||||||||||2017-10-10 21:38:33.860653|2017-10-10 21:38:33.860653
NCT02952872|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-10-05|||December 2016||2016-12-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Brief Alcohol E-Interventions Study|Optimizing E-interventions for Alcohol Use: Do Common Factors Apply?|Active, not recruiting||N/A|352|Actual|Wayne State University||16|||f||||f||||||||||2017-10-10 21:38:34.113414|2017-10-10 21:38:34.113414
NCT02952846|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-11-02|||May 2016||2016-05-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ASWISPIC||Tapering of Analgosedation and Occurrence of Withdrawal Syndrome in Paediatric Intensive Care Treatment|Tapering of Analgosedation and Occurrence of Withdrawal Syndrome in Paediatric Intensive Care Treatment|Recruiting||N/A|80|Anticipated|Oslo University Hospital||2|||f||||f||||||||No||2017-10-10 21:38:34.28922|2017-10-10 21:38:34.28922
NCT02952833|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-09-14|||October 14, 2016|Actual|2016-10-14|June 27, 2017|2017-06-27|October 2, 2018|Anticipated|2018-10-02|January 15, 2018|Anticipated|2018-01-15||Interventional|||ZIKA Vaccine in Naive Subjects|Phase 1, Double-blinded, Placebo-Controlled Study of the Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) Administered by the Intramuscular Route in Flavivirus Naïve Adult Subjects|Recruiting||Phase 1|90|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f|||||t|f|||f|||||2017-10-10 21:38:34.37723|2017-10-10 21:38:34.37723
NCT02952820|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-08-14|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Long-term Study of Lemborexant in Insomnia Disorder|A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder|Recruiting||Phase 3|900|Anticipated|Eisai Inc.||3|||f||||t||||||||||2017-10-10 21:38:34.505096|2017-10-10 21:38:34.505096
NCT02952807|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-06-14|||January 2016||2016-01-01|November 2016|2016-11-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Vaginal Misoprostol and Foley Catheter for Induction of Labor|Sequential Versus Concurrent Use of Vaginal Misoprostol Plus Foley Catheter for Induction of Labor|Completed||Phase 2|160|Actual|Zagazig University||2|||f||||t||||||||||2017-10-10 21:38:34.817412|2017-10-10 21:38:34.817412
NCT02952794|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Endoscopic Submucosal Dissection (ESD) and Endoscopic Mucosal Band Ligation (EMBL) for Early Cancer||Not yet recruiting||N/A|50|Anticipated|Fudan University|||2||f||||||||||||||2017-10-10 21:38:34.897433|2017-10-10 21:38:34.897433
NCT02952781|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-03-03|||October 2016||2016-10-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial|Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial|Completed||N/A|30|Actual|EvergreenHealth|||1||f||||f||||||||No||2017-10-10 21:38:34.966886|2017-10-10 21:38:34.966886
NCT02952768|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-02-21|||August 2014||2014-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Novel US-C-A-B Protocol: Curriculum Implementation and Evaluation of Proficiency|The Novel US-C-A-B Protocol: Curriculum Implementation and Evaluation of Proficiency|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||No||2017-10-10 21:38:35.044464|2017-10-10 21:38:35.044464
NCT02952755|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-02-14|||November 28, 2016|Actual|2016-11-28|February 2017|2017-02-01|December 20, 2016|Actual|2016-12-20|December 12, 2016|Actual|2016-12-12||Interventional|||Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers|A Randomized, Open-label, Crossover Study to Explore Drug-drug Interactions Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers|Completed||Phase 1|45|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-10 21:38:35.114419|2017-10-10 21:38:35.114419
NCT02952742|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-11-01|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Black Cohosh for Host Flashes Due to Androgen Deprivation Therapy|Black Cohosh (Actaea Racemosa) for Hot Flashes in Prostate Cancer Patients on Androgen Deprivation Therapy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial|Not yet recruiting||Phase 2|34|Anticipated|Midwestern Regional Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:38:35.187468|2017-10-10 21:38:35.187468
NCT02952729|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-05|||November 2016||2016-11-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2|A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1522 in Patients With Advanced Breast Cancer and Other Advanced Tumors Expressing HER2|Recruiting||Phase 1|120|Anticipated|Mersana Therapeutics||1|||f||||f||||||||Undecided||2017-10-10 21:38:35.266304|2017-10-10 21:38:35.266304
NCT02952716|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2017-04-17|||October 2016||2016-10-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning|Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning|Recruiting||Phase 1/Phase 2|60|Anticipated|Liaocheng People's Hospital||2|||f||||f||||||||No||2017-10-10 21:38:35.356571|2017-10-10 21:38:35.356571
NCT02952703|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Disseminating and Implementing a Smoking Cessation Program for Pregnant and Postpartum Women|Disseminating and Implementing a Smoking Cessation Program Fro Pregnant and Postpartum Women|Not yet recruiting||N/A|250|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||No||2017-10-10 21:38:35.434187|2017-10-10 21:38:35.434187
NCT02952690|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Comparison of Different Stylet Angles for Orotracheal Intubation Using Glidescope® Video Laryngoscope in Children|Clinical Comparison of Different Stylet Angles for Orotracheal Intubation Using Glidescope® Video Laryngoscope in Children|Not yet recruiting||N/A|120|Anticipated|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:38:35.510011|2017-10-10 21:38:35.510011
NCT02952677|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-10-31|||November 2013||2013-11-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||"Remind-to-move for Promoting Upper Extremity Recovery in Patients With Stroke After Subacute Discharge"|"Remind-to-move Using Wearable Devices in Home-based Treatment for Promoting Upper Extremity Recovery in Patients With Stroke After Subacute Discharge"|Completed||N/A|84|Actual|The Hong Kong Polytechnic University||3|||f||||f||||||||No||2017-10-10 21:38:35.583229|2017-10-10 21:38:35.583229
NCT02952664|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-07-13|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Interventional|PUMP||Pressure Ulcer Monitoring Platform (PUMP)|Pressure Ulcer Monitoring Platform (PUMP): A Device to Monitor Patient Positioning|Completed||N/A|12|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 21:38:35.704848|2017-10-10 21:38:35.704848
NCT02952651|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-09-24|||May 10, 2017|Actual|2017-05-10|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prediction of Fluid Responsiveness in Children Undergoing Major Surgery|Prediction of Fluid Responsiveness Using Respiratory Variation in Pulse Oximeter Plethysmography in Children Undergoing Major Surgery|Recruiting||N/A|55|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||||2017-10-10 21:38:35.773153|2017-10-10 21:38:35.773153
NCT02952638|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-11-01|||January 2015||2015-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Dietary Sources of Lysophospholipids|Dietary Sources of Lysophospholipids|Recruiting||N/A|60|Anticipated|University of Kentucky|||3||f||||t||||||Samples Without DNA|"     Plasma samples to measure lysophosphilipid levels   "|No|We do not plan to share individual participant data.|2017-10-10 21:38:36.023171|2017-10-10 21:38:36.023171
NCT02952625|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-31|||February 2015||2015-02-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||PET/MR in Radiotherapy for Head and Neck Cancer Pilot|An Exploratory Study to Assess the Feasibility of Incorporating PET/MR in the Radiotherapy Pathway of Patients With Head and Neck Cancer and Guide Adaptive Dose Escalation|Recruiting||N/A|10|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 21:38:36.122639|2017-10-10 21:38:36.122639
NCT02952612|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-05|||October 2016||2016-10-01|November 2016|2016-11-01|October 2021|Anticipated|2021-10-01|October 2017|Anticipated|2017-10-01||Observational|||Active Surveillance of Papillary Thyroid Microcarcinoma|Active Surveillance of Papillary Thyroid Microcarcinoma (PTMC) in Catholic Medical Center|Recruiting||N/A|300|Anticipated|Seoul St. Mary's Hospital|||1||f||||f||||||||Yes||2017-10-10 21:38:36.216704|2017-10-10 21:38:36.216704
NCT02952599|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-10-03|||March 27, 2017|Actual|2017-03-27|October 2017|2017-10-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Observational|||Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)|Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism (VTE) in Korea and Taiwan|Recruiting||N/A|350|Anticipated|Daiichi Sankyo, Inc.|||1||f||||f||||||||||2017-10-10 21:38:36.320426|2017-10-10 21:38:36.320426
NCT02952586|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-10-03|||November 28, 2016|Actual|2016-11-28|October 2017|2017-10-01|May 18, 2022|Anticipated|2022-05-18|April 8, 2021|Anticipated|2021-04-08||Interventional|||Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)|A Randomized Double-blind Phase 3 Study Of Avelumab In Combination With Standard Of Care Chemoradiotherapy (Cisplatin Plus Definitive Radiation Therapy) Versus Standard Of Care Chemoradiotherapy In The Front-line Treatment Of Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck|Recruiting||Phase 3|640|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 21:38:36.555808|2017-10-10 21:38:36.555808
NCT02952573|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-07-25|||June 13, 2017|Actual|2017-06-13|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|January 2023|Anticipated|2023-01-01||Interventional|||Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement|A Phase II Open Label, Multicenter, Trial of JNJ-42756493 In Combination With Dexamethasone For The Treatment Of FGFR3 Wild-type Or Mutation Positive Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 2|20|Anticipated|University Health Network, Toronto||2|||f||||t|f|f||||||||2017-10-10 21:38:37.162637|2017-10-10 21:38:37.162637
NCT02952560|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-10-31|||March 2012||2012-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||A Comparative Study of Ultrasound Versus CT Measurement of Tongue and Oral Cavity Size|A Comparative Study of Ultrasound Versus CT Measurement of Tongue and Oral Cavity Size: Validation of Sonographic Technique|Recruiting||N/A|24|Anticipated|University Health Network, Toronto|||1||f||||||||||||||2017-10-10 21:38:37.260686|2017-10-10 21:38:37.260686
NCT02952547|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-02-14|||October 30, 2016|Actual|2016-10-30|February 2017|2017-02-01|January 10, 2017|Actual|2017-01-10|November 26, 2016|Actual|2016-11-26||Interventional|||Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects|A Randomized, Open-label, Oral Dose, Crossover Study to Compare the Safety and Pharmacokinetics Between Co-administration and Fixed Dose Combination of DWC20155 and DWC20156 in Healthy Subjects|Completed||Phase 1|52|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||No||2017-10-10 21:38:37.349826|2017-10-10 21:38:37.349826
NCT02952534|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-12|||November 2016||2016-11-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|TRITON2||A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency|TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer Associated With Homologous Recombination Deficiency|Recruiting||Phase 2|160|Anticipated|Clovis Oncology, Inc.||1|||f||||t||||||||||2017-10-10 21:38:37.435641|2017-10-10 21:38:37.435641
NCT02952521|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-10-31|||May 2015||2015-05-01|October 2016|2016-10-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Observational|||Ovarian Tumor Biopsies to Study Response to Treatments|Paired Biopsies to Develop a Cellular Signature|Active, not recruiting||N/A|60|Anticipated|University Health Network, Toronto|||1||f||||t||||||Samples With DNA|"     -  Whole blood samples        -  Tumor tissue samples   "|No||2017-10-10 21:38:37.61272|2017-10-10 21:38:37.61272
NCT02952508|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-08-29|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of CLR 131 in Relapsed or Refractory Select B-Cell Malignancies|An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients With Relapsed or Refractory (R/R) Select B-Cell Malignancies|Recruiting||Phase 2|80|Anticipated|Cellectar Biosciences, Inc.||1|||f|||||t|f||||||||2017-10-10 21:38:37.691923|2017-10-10 21:38:37.691923
NCT02952495|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-01|||September 2013||2013-09-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Online Education to Inform the Elderly About Age-related Alcohol Risks|Online Education to Inform the Elderly About Age-related Alcohol Risks: A Randomized Trial of Effectiveness and Costs|Enrolling by invitation||Phase 2|600|Anticipated|Arlene Fink Associates||2|||f||||t||||||||Yes||2017-10-10 21:38:37.776125|2017-10-10 21:38:37.776125
NCT02952482|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-01-05|||November 2016||2016-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Observational|||Newborn Screening for Adrenoleukodystrophy|Newborn Screening for Adrenoleukodystrophy|Recruiting||N/A|60000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 21:38:37.857274|2017-10-10 21:38:37.857274
NCT02952469|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-01|||July 2016||2016-07-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC|Biodistribution and Reproducibility of Ga-68 PSMA-HBED-CC Positron Emission Tomography in Patients With Biopsy Proven Metastatic Prostate Cancer|Enrolling by invitation||N/A|20|Anticipated|University of Iowa||1|||f||||t||||||||No||2017-10-10 21:38:37.9306|2017-10-10 21:38:37.9306
NCT02952456|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-03-03|||September 2016||2016-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Phenomenological Approach of Epilepsy in Patients With Epilepsy|Phenomenological Approach of Epilepsy in Patients With Epilepsy and Their Relatives for Risk Prevention|Recruiting||N/A|30|Anticipated|University Hospital, Montpellier|||3||f||||t||||||||Undecided||2017-10-10 21:38:37.997474|2017-10-10 21:38:37.997474
NCT02952443|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|ERF||Exercise Intervention to Reverse Frailty|A Multi-Component Exercise Intervention for Pre-Frail Older Females.|Recruiting||N/A|50|Anticipated|University of British Columbia|||2||f||||f||||||||No||2017-10-10 21:38:38.086769|2017-10-10 21:38:38.086769
NCT02952430|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-01|||December 2016||2016-12-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|ELF||Emergency Laparotomy and Frailty Study|Emergency Laparotomy and Frailty; a National Multicentre Prospective Cohort Study of Older Surgical Patients (ELF Study)|Not yet recruiting||N/A|500|Anticipated|North Western Research Collaborative|||2||f||||t||||||||No||2017-10-10 21:38:38.192999|2017-10-10 21:38:38.192999
NCT02952417|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-01|||December 2003||2003-12-01|October 2016|2016-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01|10 Years|Observational [Patient Registry]|||Sex Differences in Relative Survival and Excess Mortality Following Acute Myocardial Infarction|Sex Differences in Relative Survival and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry|Completed||N/A|180000|Actual|University of Leeds|||2||f||||t||||||||No||2017-10-10 21:38:38.275889|2017-10-10 21:38:38.275889
NCT02952404|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-09-05|||November 2015||2015-11-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|May 2017|Actual|2017-05-01||Observational|||Incidence of Obstetric Anal Sphincter Injuries After a Protection Training|Incidence of Obstetric Anal Sphincter Injuries After Training to Protect the Perineum|Active, not recruiting||N/A|400|Actual|TriHealth Inc.|||2||f||||f||||||||||2017-10-10 21:38:38.340659|2017-10-10 21:38:38.340659
NCT02952391|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-28|||September 2016||2016-09-01|November 2016|2016-11-01||||February 2017|Anticipated|2017-02-01||Observational|||Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol|Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol|Recruiting||N/A|20|Anticipated|University Medical Center Groningen|||2||f||||||||||||Undecided||2017-10-10 21:38:38.443364|2017-10-10 21:38:38.443364
NCT02952378|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-01|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|VAB||Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects|Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects|Recruiting||Phase 4|30|Anticipated|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-10 21:38:38.529226|2017-10-10 21:38:38.529226
NCT02952365|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Tissue Sealant Use in LASIK Enhancement Surgery|A Prospective Evaluation of Tissue Sealant to Prevent Epithelial Ingrowth in Repeat LASIK Surgery|Recruiting||Phase 4|25|Anticipated|Stanford University||1|||f||||f||||||||No||2017-10-10 21:38:38.607443|2017-10-10 21:38:38.607443
NCT02952352|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-05-08|||May 8, 2017|Actual|2017-05-08|October 2016|2016-10-01|September 15, 2019|Anticipated|2019-09-15|June 2019|Anticipated|2019-06-01||Interventional|NARCH||Nxstan: A Culturally Tailored Intervention to Prevent Diabetes in American Indian Men|A Culturally Tailored Intervention to Prevent Diabetes in American Indian Men|Recruiting||N/A|150|Anticipated|Washington State University||2|||f||||f|f|f||||||||2017-10-10 21:38:38.679419|2017-10-10 21:38:38.679419
NCT02952339|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-03-17|||August 2016||2016-08-01|March 2017|2017-03-01||||May 2017|Anticipated|2017-05-01||Interventional|||Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age|Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, LID ΔM2-2 1030s, Lot RSV#010A, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age|Active, not recruiting||Phase 1|33|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 21:38:38.754532|2017-10-10 21:38:38.754532
NCT02952326|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-14|||December 2016||2016-12-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparing Between XP Endo Finisher and Conventional Irrigation Method On Post-Operative Flare Ups In Necrotic Teeth|Comparison Of The Effect of Adding XP Endo Finisher To The Irrigation Protocol Versus Conventional Irrigation Method On Post-Operative Flare Ups In Necrotic Teeth|Not yet recruiting||N/A|34|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:38:38.830387|2017-10-10 21:38:38.830387
NCT02952313|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-09-25|||September 2016||2016-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study|Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study|Active, not recruiting||N/A|126|Actual|Spirox, Inc.||1|||f||||f||||||||||2017-10-10 21:38:38.894065|2017-10-10 21:38:38.894065
NCT02952300|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-01|||January 2017||2017-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Post Operative Pain of Root Canal Preparation With Wave One and Neolix in Acute Irreversible Pulpitis|Comparative Evaluation of Postoperative Pain After Root Canal Preparation With Wave One and Neolix in Acute Irreversible Pulpitis of Mandibular Premolar Teeth|Not yet recruiting||N/A|44|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:38:38.974031|2017-10-10 21:38:38.974031
NCT02952287|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-10-31|||November 2016||2016-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|4D Flow||Assessment of Flow With the New Four-dimensional Velocity-encoded Magnetic Resonance Imaging Technique|Assessment of Flow With the New Four-dimensional Velocity-encoded Magnetic Resonance Imaging Technique|Not yet recruiting||N/A|100|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||No||2017-10-10 21:38:39.064246|2017-10-10 21:38:39.064246
NCT02952274|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-01|||December 2016||2016-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ball Vs Locator Attachment in Overdenture Retained by Single Mandibular Implant|Comparison Between Ball and Locator Attachments in Patients Receiving Complete Mandibular Overdenture Retained by Single Midline Implant|Not yet recruiting||N/A|22|Anticipated|Cairo University||2|||f||||t||||||||Yes||2017-10-10 21:38:39.156236|2017-10-10 21:38:39.156236
NCT02952261|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-01|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Application of 3D Printing Technique in Small Pulmonary Nodule Localization|Phase 1 Study of Application of 3D Printing Technique in Small Pulmonary Nodule Localization|Recruiting||Phase 2|200|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||t||||||||Yes||2017-10-10 21:38:40.802937|2017-10-10 21:38:40.802937
NCT02952248|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-10-02|||November 21, 2016|Actual|2016-11-21|October 2017|2017-10-01|May 29, 2019|Anticipated|2019-05-29|May 29, 2019|Anticipated|2019-05-29||Interventional|||A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours|An Open-label, Phase I Trial to Determine the Maximum-tolerated Dose and Investigate Safety, Pharmacokinetics, and Efficacy of BI 754091 in Patients With Advanced Solid Tumours|Recruiting||Phase 1|45|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 21:38:40.882388|2017-10-10 21:38:40.882388
NCT02952235|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-06-07|||March 31, 2016|Actual|2016-03-31|June 2017|2017-06-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Interventional|||Evaluation of Sunscreens Under Actual Use Conditions|A Single Center, Randomized, Split-Face, Double-Blinded, Single Sun Exposure Evaluation of Sunscreens of SPF 50+ and Above Under Actual Use Conditions|Completed||N/A|199|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f|f|f||||||No||2017-10-10 21:38:40.972255|2017-10-10 21:38:40.972255
NCT02952222|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-06-08|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Synergistic Effect of Dexmedetomidine on Propofol for Sedation for Pediatric Endoscopy|The Synergistic Effect of Dexmedetomidine on Propofol for Sedation for Pediatric Endoscopy|Not yet recruiting||Phase 4|70|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f||||||No||2017-10-10 21:38:41.041208|2017-10-10 21:38:41.041208
NCT02952209|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-07-13|||October 2016||2016-10-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Effect of Alveolar Ridge Preservation After Tooth Extraction in the Posterior Maxilla|The Effect of Alveolar Ridge Preservation After Tooth Extraction in the Posterior Maxilla: A Randomized, Split-Mouth, Controlled Trial.|Recruiting||N/A|15|Anticipated|The Bluestone Center for Clinical Research||2|||f||||t||||||||||2017-10-10 21:38:41.126931|2017-10-10 21:38:41.126931
NCT02952183|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-30|||July 2015||2015-07-01|October 2016|2016-10-01||||August 2018|Anticipated|2018-08-01||Interventional|FUSION V||Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors|Exploratory Study for Evaluating the Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors (FUSION Trial V)|Recruiting||N/A|30|Anticipated|Seoul National University Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:38:41.287087|2017-10-10 21:38:41.287087
NCT02952170|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-01|||September 2014||2014-09-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Interventional|AWLS||Impact of Weight Loss Surgery in Adolescents With NAFLD|The Impact of Weight Loss Surgery in Adolescents on Fatty Liver Disease|Recruiting||N/A|15|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||Yes|Anticipate to share overall results through publication|2017-10-10 21:38:41.397594|2017-10-10 21:38:41.397594
NCT02952157|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-30|||November 2016||2016-11-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect on Postoperative Sore Throat of Lidocaine Jelly Application Over the Endotracheal Tube of Tapered-shaped Cuff|Effect on Postoperative Sore Throat of Lidocaine Jelly Application Over the Endotracheal Tube of Tapered-shaped Cuff|Not yet recruiting||Phase 4|210|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||t||||||||No||2017-10-10 21:38:41.484214|2017-10-10 21:38:41.484214
NCT02952144|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-10-30|||October 2015||2015-10-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|||Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis|Treatment of Dialysis-Related Amyloidosis Using Lixelle® β2-microglobulin Apheresis Column|Recruiting||N/A|40|Anticipated|Kaneka Pharma America LLC||2|||f||||f||||||||No||2017-10-10 21:38:41.560977|2017-10-10 21:38:41.560977
NCT02952131|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-08-23|||November 2016||2016-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|ADcSVF-IBD||Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease|Use of Autologous Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease|Recruiting||Phase 1/Phase 2|100|Anticipated|Healeon Medical Inc||3|||f||||t|f|f||||||||2017-10-10 21:38:41.777511|2017-10-10 21:38:41.777511
NCT02952118|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-30|||November 2016||2016-11-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Interventional|||Nasal Appliance for the Treatment of Snoring in Adult Subjects - A Pilot Study|Nasal Appliance for the Treatment of Snoring in Adult Subjects - A Pilot Study|Not yet recruiting||N/A|20|Anticipated|GE Sleeping||1|||f||||f||||||||||2017-10-10 21:38:41.929381|2017-10-10 21:38:41.929381
NCT02952105|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-01|||April 2016||2016-04-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Observational|IVFOD||Identification of Ventricular Fibrillation and Optimization of Defibrillation During CPR|Identification of Ventricular Fibrillation and Optimization of Defibrillation During Chest Compression of CPR: A Multiple Study of Cardiac Arrest Patients in China.|Enrolling by invitation||N/A|90|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology|||2||f||||t||||||||Undecided||2017-10-10 21:38:42.008429|2017-10-10 21:38:42.008429
NCT02950857|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-31|||December 2016||2016-12-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||A Study of EPEG in Beta Thalassemia Patients|A Phase Ib, Open-label, Repeat Dose, Study of EPEG in Beta Thalassemia Patients With Non-transfusion Dependent Thalassemia (β NTDT)|Not yet recruiting||Phase 1|6|Anticipated|Prolong Pharmaceuticals||3|||f||||f||||||||No||2017-10-10 21:38:57.06992|2017-10-10 21:38:57.06992
NCT02952079|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2016-11-01|||May 2015||2015-05-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis|Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis|Recruiting||N/A|60|Anticipated|University of the Incarnate Word||2|||f||||f||||||||No|No plan to share IPD to other researchers|2017-10-10 21:38:42.340631|2017-10-10 21:38:42.340631
NCT02952066|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2017-08-07|||December 2016||2016-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TRPV1||Expressions of TRPV1 in Airway of Asthmatics|Expressions of TRPV1 in Airway of Asthmatics|Not yet recruiting||N/A|12|Anticipated|University of Kentucky||1|||f||||f||||||||||2017-10-10 21:38:42.425275|2017-10-10 21:38:42.425275
NCT02952053|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2016-11-01|||December 2016||2016-12-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Can Myotonometry Quantify Dry Needling Effectiveness on Myofascial Trigger Points?|Can Myotonometry Quantify Dry Needling Effectiveness on Myofascial Trigger Points?|Not yet recruiting||N/A|40|Anticipated|University of Castilla-La Mancha||2|||f||||f||||||||No||2017-10-10 21:38:42.526821|2017-10-10 21:38:42.526821
NCT02952040|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-01-23|||November 2016||2016-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate|Pharmacokinetic Study of ASP1517 - Evaluation of the Effect of Lanthanum Carbonate Hydrate on the Pharmacokinetics of ASP1517 in Non-elderly Healthy Adult Male Subjects -|Completed||Phase 1|18|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 21:38:42.611484|2017-10-10 21:38:42.611484
NCT02952027|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-09-04|||August 2016||2016-08-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluating the Effectiveness of Incentive Spirometry|Evaluating the Effectiveness of Incentive Spirometry|Enrolling by invitation||N/A|250|Anticipated|Lifespan||2|||f||||||||||||||2017-10-10 21:38:42.707937|2017-10-10 21:38:42.707937
NCT02952014|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-30|||February 2014||2014-02-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|NB1||Assessment of a Pre-Workout Dietary Supplement|Pharmacokinetic, Thermogenic, Hemodynamic, Ergogenic Assessment of a Pre-Workout Dietary Supplement|Completed||N/A|31|Actual|Texas A&M University||3|||f||||t||||||||No||2017-10-10 21:38:42.808728|2017-10-10 21:38:42.808728
NCT02951988|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-08-06|||November 13, 2016|Actual|2016-11-13|August 2017|2017-08-01|September 27, 2019|Anticipated|2019-09-27|September 27, 2019|Anticipated|2019-09-27||Interventional|||A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder|A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder|Recruiting||Phase 3|600|Anticipated|Allergan||3|||f||||t|t|f||||||||2017-10-10 21:38:43.022674|2017-10-10 21:38:43.022674
NCT02951975|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-07-24|||January 2017||2017-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Observational|Louvre 2||Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye|Multicentre Longitudinal Study of the Prescription of Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye|Recruiting||N/A|400|Anticipated|Allergan|||1||f||||f||||||||||2017-10-10 21:38:43.493237|2017-10-10 21:38:43.493237
NCT02951962|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-01-31|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin|A Phase 1, Open Label, Two-cohort, Single-Sequence, Crossover Study to Investigate the Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers|Completed||Phase 1|60|Anticipated|Yuhan Corporation||2|||f||||f||||||||No||2017-10-10 21:38:43.605345|2017-10-10 21:38:43.605345
NCT02951949|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-30|||November 2014||2014-11-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Observational|||Estrogen Exposure and Atherosclerosis in Postmenopausal Women|Exposure to Endogenous Estrogens and Imaging Parameters of Atherosclerosis Burden in Postmenopausal Women|Completed||N/A|92|Actual|University of Valencia|||1||f||||t||||||||No|There is no plan to make individual participant data (IPD) available to other researchers.|2017-10-10 21:38:43.691958|2017-10-10 21:38:43.691958
NCT02951936|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-11-01|||December 2016||2016-12-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Utility of Regional Bioimpedance in Chronically Ventilated Patients|The Utility of Regional Bioimpedance in Chronically Ventilated Patients|Not yet recruiting||Phase 2|100|Anticipated|Rabin Medical Center||2|||f||||f||||||||Yes||2017-10-10 21:38:43.769631|2017-10-10 21:38:43.769631
NCT02951923|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-10-30|||December 2014||2014-12-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of 8-weeks of Bovine Colostrum and Soy Protein Supplementation in Rugby Players|The Effect of 8-weeks of Bovine Colostrum and Soy Protein Supplementation on Fitness, Muscle Mass, Inflammation and Immune Function During Intense Training in Rugby Players|Completed||N/A|24|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-10 21:38:43.843895|2017-10-10 21:38:43.843895
NCT02951910|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||July 2016||2016-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||A Study of the Effect of Zinc-Hyaluronate on Ocular Surface Sensations in Patients With Dry Eye|A Study of the Effect of Zinc-Hyaluronate on Ocular Surface Sensations in Patients With Dry Eye|Completed||Phase 4|20|Actual|Semmelweis University||1|||f||||f||||||||No||2017-10-10 21:38:43.927688|2017-10-10 21:38:43.927688
NCT02951897|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-31|||April 2016||2016-04-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|CTCs detection||Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma|Application of Detecting Circulating Tumor Cells in the Accurate Diagnosis and Treatment of Early Stage Lung Adenocarcinoma|Recruiting||N/A|120|Anticipated|Third Military Medical University||6|||f||||t||||||||No||2017-10-10 21:38:43.993865|2017-10-10 21:38:43.993865
NCT02951884|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-29|||November 2016||2016-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Local Anesthetic Injection and Hemarthrosis Aspiration on Pain and Narcotic/Opioid Analgesia Use-Tibial Plateau Fractures||Not yet recruiting||N/A|60|Anticipated|Loyola University||3|||f||||f||||||||No||2017-10-10 21:38:44.100657|2017-10-10 21:38:44.100657
NCT02951871|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-11-08|||January 2000||2000-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Observational|||Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis|Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis|Completed||N/A|237|Actual|Hospices Civils de Lyon|||4||f||||||||||||||2017-10-10 21:38:44.208168|2017-10-10 21:38:44.208168
NCT02951858|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Substance Use Screening Among Drug User|Screening and Brief Interventions for Substance Use in Primary Medical Institution|Not yet recruiting||N/A|218|Anticipated|Shanghai Mental Health Center||2|||f||||f||||||||No||2017-10-10 21:38:44.279673|2017-10-10 21:38:44.279673
NCT02951845|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-12-29|||November 2016||2016-11-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076 in Healthy Participants|An Exploratory Open-Label, Single Dose, Randomized, Three-Way Crossover Study In Healthy Subjects to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076|Terminated||Phase 1|42|Anticipated|Janssen Research & Development, LLC||12||JNJ-54416076 program has been stopped for strategic business reasons.|f||||f||||||||||2017-10-10 21:38:44.371355|2017-10-10 21:38:44.371355
NCT02951806|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-29|||October 2016||2016-10-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect of Slow Injection of Fentanyl on the Incidence of Spinal Anesthesia Induced Itching in Cesarean Section|Effect of Slow Injection of Fentanyl on the Incidence of Spinal Anesthesia Induced Itching in Cesarean Section|Not yet recruiting||N/A|200|Anticipated|Dr. Soliman Fakeeh Hospital||2|||f||||t||||||||Yes|I hope to publish the data in a respected journal.|2017-10-10 21:38:44.732382|2017-10-10 21:38:44.732382
NCT02951793|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-17|||March 2016||2016-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Observational|||Abuse and Addiction in ICU|Effect of Recent Alcohol, Smoking and Psychotropic Drug Use on Delirium in ICU|Recruiting||N/A|200|Anticipated|Seoul National University Hospital|||6||f||||t||||||||No||2017-10-10 21:38:44.800266|2017-10-10 21:38:44.800266
NCT02951780|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-03-08|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|January 24, 2017|Actual|2017-01-24||Interventional|||A Study of LY3185643 and rGlucagon in Healthy Participants|A Randomized, 9-Way, Single-Dose, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of LY3185643 and rGlucagon in Healthy Subjects|Completed||Phase 1|18|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:38:44.891568|2017-10-10 21:38:44.891568
NCT02951767|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2017-08-02|2017-02-14||July 3, 2014|Actual|2014-07-03|August 2017|2017-08-01|May 25, 2018|Anticipated|2018-05-25|October 3, 2015|Actual|2015-10-03||Interventional||Cohort 1 Safety Evaluable Population included all participants who received any amount of study drug.|A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)|A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer|Active, not recruiting||Phase 2|119|Actual|Hoffmann-La Roche||1|||t|||||t|f||||||||2017-10-10 21:38:44.991457|2017-10-10 21:38:44.991457
NCT02951754|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-10-31|||February 2002||2002-02-01|October 2016|2016-10-01|December 2032|Anticipated|2032-12-01|December 2032|Anticipated|2032-12-01||Interventional|||Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder|Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder|Recruiting||Phase 4|600|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||f||||||||Undecided||2017-10-10 21:38:45.788549|2017-10-10 21:38:45.788549
NCT02951728|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-30|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|DR-CHOP||Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma|Phase I/II Trial of Decitabine + R-CHOP in Diffuse Large B-Cell Lymphoma|Recruiting||Phase 1/Phase 2|58|Anticipated|Ruijin Hospital||1|||f||||t||||||||No||2017-10-10 21:38:46.012041|2017-10-10 21:38:46.012041
NCT02951715|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-31|2016-10-31|||December 2013||2013-12-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss|Evaluation of the Effects of Zinc in the Management on Tinnitus Patients With Noise Induced Hearing Loss|Completed||N/A|20|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||No||2017-10-10 21:38:46.113946|2017-10-10 21:38:46.113946
NCT02951689|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-30|||September 2016||2016-09-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Probiotics in Occupational Shift Workers|Influence of Probiotics on Body Composition and Health in Occupational Shift Workers|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:38:46.285604|2017-10-10 21:38:46.285604
NCT02951676|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2017-01-15|||December 2015||2015-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Impact of Antibiotic Treatment and Extraction on the Oral Micro Biome|The Impact of Amoxicillin Use on the Stability of the Oral Microbiome in Systemically Healthy Cohorts Undergoing Tooth Extractions - A Prospective Clinical Study|Recruiting||N/A|67|Anticipated|The University of Hong Kong|||3||f||||t||||||Samples With DNA|"     Saliva      Supragingival plaque   "|Undecided||2017-10-10 21:38:46.375077|2017-10-10 21:38:46.375077
NCT02951663|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-30|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Protein Supplementation Post Bariatric Surgery|Evaluation of Body Composition and Metabolism Following Bariatric Surgery, Effects of a Protein Supplement: A Feasibility Study|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:38:46.475458|2017-10-10 21:38:46.475458
NCT02951650|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2017-08-02|||January 2015||2015-01-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Long Term Observational Study of a Vagal Nerve Stimulation Device in Crohn's Disease|Long Term Observational Study of the Safety and Efficacy of an Active Implantable Vagal Nerve Stimulation Device in Patients With Crohn's Disease|Active, not recruiting||Phase 1/Phase 2|15|Anticipated|SetPoint Medical Corporation||1|||f||||f||||||||||2017-10-10 21:38:46.556865|2017-10-10 21:38:46.556865
NCT02951637|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-29|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial|Chemotherapy Plus Gefitinib Versus Gefitinib Alone as First-line Treatment for Patients With Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial|Not yet recruiting||Phase 2|300|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:38:46.646762|2017-10-10 21:38:46.646762
NCT02951624|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-30|2016-11-24|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BPS2||The Effect of Frequency and Duration of Breaks in Sitting Time on Metabolic Cardiovascular Risk Factors|The Effect of Frequency and Duration of Breaks in Sitting Time on Metabolic Cardiovascular Risk Factors|Recruiting||N/A|15|Anticipated|Rigshospitalet, Denmark||4|||f||||f||||||||Undecided|Data may be available after publication (fully anonymized) by contact the PI|2017-10-10 21:38:46.743123|2017-10-10 21:38:46.743123
NCT02951611|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2017-03-16|||November 2016||2016-11-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Acupuncture Stimulation on Systemic Inflammation|Effects of Acupuncture Stimulation on Systemic Inflammation in Patients Undergoing Video-assisted Thoracoscopic Lobectomy Surgery|Recruiting||N/A|60|Anticipated|RenJi Hospital||2|||f||||||||||||Undecided||2017-10-10 21:38:46.850585|2017-10-10 21:38:46.850585
NCT02951585|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-28|||May 2013||2013-05-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|EPIKART||Pilot, Prospective, Comparative Multicentric Study Evaluating the Effects on the Arthrosis Biomarkers, the Clinical Effectiveness, the Tolerance of an Intra-articular Injection of Hyaluronic Acid KARTILAGE CROSS Versus Placebo in Patients Suffering From Knee Osteoarthritis|Pilot, Prospective, Comparative Multicentric Study Evaluating the Effects on the Arthrosis Biomarkers, the Clinical Effectiveness, the Tolerance of an Intra-articular Injection of Hyaluronic Acid KARTILAGE CROSS Versus Placebo in Patients Suffering From Knee Osteoarthritis.|Completed||N/A|81|Actual|Laboratoires Vivacy||2|||f||||f||||||||No||2017-10-10 21:38:47.405364|2017-10-10 21:38:47.405364
NCT02951572|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-10-28|||February 2013||2013-02-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Non-invasive Ventilation and Physical Activity|Non-invasive Ventilation and Physical Activity in Patients With Neuromuscular Disorders and Thoracic Wall Disorders|Recruiting||N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-10 21:38:47.495335|2017-10-10 21:38:47.495335
NCT02951559|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-28|||March 2016||2016-03-01|October 2016|2016-10-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies|Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies|Recruiting||Phase 4|250|Anticipated|University of Turin, Italy||1|||f||||f||||||||No||2017-10-10 21:38:47.588462|2017-10-10 21:38:47.588462
NCT02951546|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Study on Metabolic Flexibility and Gut Microbiota Composition in Obese Subjects With NAFLD, Taking Into Account PNPLA3 and TM6SF2 Polymorphisms. Effects of Nutritional Intervention Combined to Exercise|Body Composition, Adiposity Phenotype, Metabolic Flexibility, and Gut Microbiota in PNPLA3 and TM6SF2 Gene Variant Carriers and Non-carriers With Nonalcoholic Fatty Liver Disease and Obesity. Effects of a Nutritional Intervention Combined to Exercise|Recruiting||N/A|120|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||Undecided||2017-10-10 21:38:47.664372|2017-10-10 21:38:47.664372
NCT02951533|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-09-05|||December 12, 2016|Actual|2016-12-12|September 2017|2017-09-01|June 7, 2018|Anticipated|2018-06-07|December 19, 2017|Anticipated|2017-12-19||Interventional|POLARIS||A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis|Multicenter, Randomized, Open-Label, Efficacy Assessor-Blinded, Active Comparator-Controlled Phase 3b Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters (Fumaderm Initial/ Fumaderm) for Adult Patients With Moderate to Severe Plaque Psoriasis Who Are Candidates for and Naive to Systemic Treatment|Active, not recruiting||Phase 3|119|Actual|Janssen-Cilag G.m.b.H||2|||f||||f||f||||||||2017-10-10 21:38:47.953518|2017-10-10 21:38:47.953518
NCT02951520|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2016-11-01|||October 2016||2016-10-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||A Novel Single-puncture Triple Nerve Block; Sciatic, Obturator, Femoral Technique (SOFT), as a Sole Anesthesia for Knee Surgeries||Recruiting||Phase 4|50|Anticipated|Healthpoint Hospital||1|||f||||||||||||||2017-10-10 21:38:48.120195|2017-10-10 21:38:48.120195
NCT02951507|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Patient Satisfaction and Biting Force of New Design of Extracoronal Attachment (O T Cap Unilateral Attachment) Versus Conventional Partial Denture for Treatment of Unilateral Mandibular Distal Extension Area||Not yet recruiting||N/A|42|Anticipated|Cairo University||2|||f||||||||||||||2017-10-10 21:38:48.225065|2017-10-10 21:38:48.225065
NCT02951494|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-28|||August 2016||2016-08-01|October 2016|2016-10-01||||August 2017|Anticipated|2017-08-01||Interventional|||Impact of Lower Body Weight Support Using an AlterG Anti-Gravity Treadmill on Cardiopulmonary Exercise Capacity and Trainability|Einfluss Der Körpergewichtsunterstützung Auf Einem AlterG®-Antigravitationslaufband Auf Die Kardiopulmonale Leistungsfähigkeit Und Trainierbarkeit|Recruiting||N/A|32|Anticipated|University Medicine Greifswald||2|||f||||f||||||||||2017-10-10 21:38:48.320809|2017-10-10 21:38:48.320809
NCT02951481|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-03-02|||February 8, 2017|Actual|2017-02-08|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|PACTA-ICD||Antimicrobial Stewardship Program for Clostridium Difficile Infection.|Antimicrobial Stewardship Program Based on the Detection and Monitoring of Patients With Clostridium Difficile Infection (PACTA-ICD)|Recruiting||N/A|100|Anticipated|Hospital Universitario 12 de Octubre|||2||f||||f||||||Samples Without DNA|"     As patients with CDI are going to be prospectively followed, apart from the routine     hematology and biochemistry analysis, serum immunoglobulin levels, serum complement levels     (C3 and C4) and peripheral blood lymphocyte subpopulations will be measured at the end of CDI     treatment.      The levels of these immunological parameters will be tested as markers for relapse by     retrospectively comparing them between patients with and without recurrence.      A stool sample will be collected at the end of treatment to evaluate predictors of bad     outcome or recurrence: Inflammatory markers (lactoferrin, calprotectin, IL-10) We will     retrospectively compare these parameters between patients with and without recurrence.   "|No||2017-10-10 21:38:49.018459|2017-10-10 21:38:49.018459
NCT02951468|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-11-03|||January 2010||2010-01-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|December 2014|Actual|2014-12-01||Observational|Nonunion||Mid-term Outcome Following Revision Surgery of Clavicular Non- and Malunion|Mid-term Outcome Following Revision Surgery of Clavicular Non- and Malunion Using Anatomic Locking Compression Plate and Iliac Crest Bone Graft|Completed||N/A|14|Actual|Technische Universität München|||1||f||||t||||||||No|No Plan|2017-10-10 21:38:49.125338|2017-10-10 21:38:49.125338
NCT02951455|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-02-22|||January 2017||2017-01-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Community Wise Optimization Trial|Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use|Recruiting||N/A|548|Anticipated|University of Illinois at Urbana-Champaign||16|||f||||t||||||||Yes|"Investigators will require a data- sharing agreement that provides for the following conditions at minimum: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate tools and computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.
All data will be stripped of personal identifiers so as to be suitable for use by other investigators. Even though the database will be stripped of identifiers prior to any sharing, however, we will make the data and associated documentation available to users only under a data-sharing agreement that provides for the above-stated commitments."|2017-10-10 21:38:49.211387|2017-10-10 21:38:49.211387
NCT02951442|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-01-27|||January 2011||2011-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|January 2014|Actual|2014-01-01||Interventional|KLOTHO||Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the First Year of Renal Transplant|Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the First Year of Renal Transplant|Active, not recruiting||N/A|117|Actual|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:38:49.361296|2017-10-10 21:38:49.361296
NCT02951429|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-10-02|||January 13, 2017|Actual|2017-01-13|October 2017|2017-10-01|March 28, 2020|Anticipated|2020-03-28|April 1, 2019|Anticipated|2019-04-01||Interventional|||Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension|A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Sildenafil Added to Pirfenidone in Patients With Advanced Idiopathic Pulmonary Fibrosis and Intermediate or High Probability of Group 3 Pulmonary Hypertension|Recruiting||Phase 2|176|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 21:38:49.459559|2017-10-10 21:38:49.459559
NCT02951416|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-10-28|||September 2009||2009-09-01|October 2016|2016-10-01|January 2040|Anticipated|2040-01-01|January 2025|Anticipated|2025-01-01|60 Months|Observational [Patient Registry]|eurIPFreg||Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank|The European IPF Registry - an Internet-based, Pan-European Registry Linked to the European IPF Biobank (eurIPFbank)|Recruiting||N/A|2000|Anticipated|University of Giessen|||15||f||||f||||||Samples With DNA|"     EDTA blood, Plasma, Serum, GenePAX blood, BALF, BALCP, lung tissue   "|Undecided||2017-10-10 21:38:49.703433|2017-10-10 21:38:49.703433
NCT02951403|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-10-31|||January 2016||2016-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Results of the Treatment of Patients With Elbow Osteoarthritis|Results of the Treatment of Patients With Elbow Osteoarthritis|Recruiting||N/A|100|Anticipated|Tampere University Hospital||2|||f||||f||||||||No||2017-10-10 21:38:49.856841|2017-10-10 21:38:49.856841
NCT02951390|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-17|||July 2016||2016-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|EndoLynch||High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome.|High Definition White-Light Colonoscopy Versus Chromoendoscopy for Surveillance of Lynch Syndrome. A Prospective, Multicenter and Randomized Study|Recruiting||N/A|244|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||No||2017-10-10 21:38:49.977409|2017-10-10 21:38:49.977409
NCT02951377|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-16|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Mechanical Diagnosis and Treatment and/or Steroid Injections for Lumbar Radiculopathy|Mechanical Diagnosis and Treatment and/or Transforaminal Epidural Steroid Injections Versus Usual Care for Chronic Lumbar Radiculopathy: A Pilot Study.|Not yet recruiting||Phase 1|30|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 21:38:50.141806|2017-10-10 21:38:50.141806
NCT02951351|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-29|2017-08-28|||October 2016||2016-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections|Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections|Recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 21:38:50.458668|2017-10-10 21:38:50.458668
NCT02951338|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-24|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||PROPEL Randomized Trial|Promoting Optimal Physical Exercise for Life (PROPEL) - Aerobic Exercise and Self-management Early After Stroke to Increase Daily Physical Activity: a Randomized Trial|Enrolling by invitation||N/A|280|Anticipated|Toronto Rehabilitation Institute||2|||f||||f|f|f||||||No||2017-10-10 21:38:50.55959|2017-10-10 21:38:50.55959
NCT02951325|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-28|||October 2016||2016-10-01|October 2016|2016-10-01||||March 2023|Anticipated|2023-03-01||Interventional|BART||Bladder Cancer Adjuvant Radiotherapy Trial|Prospective Randomized Trial of Adjuvant Radiotherapy Following Surgery and Chemotherapy in Muscle Invasive Transitional Cell Carcinoma of Urinary Bladder|Recruiting||Phase 3|153|Anticipated|Tata Memorial Centre||2|||f||||t||||||||||2017-10-10 21:38:50.662318|2017-10-10 21:38:50.662318
NCT02951312|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-28|||May 2009||2009-05-01|October 2016|2016-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Single-dose, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Bronchodilatory Effects of Glycopyrrolate Inhalation Solution (GIS) Using a High Efficiency Nebulizer in Patients With COPD|Completed||Phase 2|12|Actual|Sunovion Respiratory Development Inc.||7|||f||||f||||||||||2017-10-10 21:38:50.749278|2017-10-10 21:38:50.749278
NCT02951299|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-24|||May 1, 2017|Anticipated|2017-05-01|November 2016|2016-11-01|August 31, 2017|Anticipated|2017-08-31|June 1, 2017|Anticipated|2017-06-01||Interventional|||The Protective Effect of Pentoxifylline on Acute Kidney Injury|Branch Director, Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital.|Not yet recruiting||Phase 2/Phase 3|140|Anticipated|Taipei Medical University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:38:50.874154|2017-10-10 21:38:50.874154
NCT02951286|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-02-17|||February 2016||2016-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Molar Intrusion Using High Pull Headgear|Skeletal and Dentoalveolar Changes Following Posterior Teeth Intrusion With High Pull Headgear in The Treatment of Patients With Anterior Open Bite|Recruiting||N/A|24|Anticipated|Damascus University||2|||f||||t||||||||No|The IPD will be available to all researchers in Damascus University|2017-10-10 21:38:50.950117|2017-10-10 21:38:50.950117
NCT02951260|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-26|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|April 2017|Actual|2017-04-01||Interventional|||The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation|The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation|Completed||N/A|15|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 21:38:51.159578|2017-10-10 21:38:51.159578
NCT02951247|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-02-28|||November 8, 2016|Actual|2016-11-08|February 2017|2017-02-01|February 20, 2017|Actual|2017-02-20|February 20, 2017|Actual|2017-02-20||Interventional|||Quality Control of CE-Certified Phonak Hearing Aids - 2016_05|Quality Control of CE-Certified Phonak Hearing Aids|Completed||N/A|30|Actual|Sonova AG||1|||f||||||||||||||2017-10-10 21:38:51.243954|2017-10-10 21:38:51.243954
NCT02951234|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-03|||September 2016||2016-09-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease|Kawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan|Recruiting||Phase 4|278|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:38:51.303318|2017-10-10 21:38:51.303318
NCT02951221|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-02-23|||December 2016||2016-12-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||New Formulation and Food Effect Study of BIIB074|A Phase 1, Open-label Study to Evaluate the Relative Bioavailability of Two Formulations of BIIB074 and to Assess the Effect of Food on BIIB074 Pharmacokinetics in Healthy Subjects|Completed||Phase 1|28|Actual|Biogen||2|||f||||f||||||||||2017-10-10 21:38:51.389537|2017-10-10 21:38:51.389537
NCT02951208|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-28|||October 2016||2016-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth|Transcranial Direct Current Stimulation Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth|Recruiting||N/A|22|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 21:38:51.473187|2017-10-10 21:38:51.473187
NCT02951195|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-04-12|||November 2016||2016-11-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study Evaluating the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis|A Phase 2, Randomized, Double Blind, Controlled Study to Evaluate the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis|Recruiting||Phase 2|60|Anticipated|Vertex Pharmaceuticals Incorporated||10|||f||||t||||||||||2017-10-10 21:38:51.577117|2017-10-10 21:38:51.577117
NCT02951182|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-09-28|||October 2016||2016-10-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis|A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of VX-440 Combination Therapy in Subjects Aged 12 Years and Older With Cystic Fibrosis|Completed||Phase 2|74|Actual|Vertex Pharmaceuticals Incorporated||12|||f||||t||||||||||2017-10-10 21:38:51.719074|2017-10-10 21:38:51.719074
NCT02951169|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-28|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Exploration of Standard Surgical Indication in Gallbladder Benign Disease|Multicenter Cohort Study: To Explore the Standard Surgical Indication in Gallbladder Benign Disease|Not yet recruiting||N/A|20000|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||t||||||||Yes|Database including 20000 patients diagnosed with gallbladder benign disease will be available in the website and investigators' article.|2017-10-10 21:38:52.257023|2017-10-10 21:38:52.257023
NCT02951156|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-09-28|||December 16, 2016|Actual|2016-12-16|September 2017|2017-09-01|May 29, 2021|Anticipated|2021-05-29|February 2, 2021|Anticipated|2021-02-02||Interventional|Javelin DLBCL||Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)|Phase 1b/Phase 3 Multicenter Study Of Avelumab (msb0010718c) In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, Cd20 Antagonist And/or Conventional Chemotherapy In Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma (Dlbcl) Javelin Dlbcl|Recruiting||Phase 3|304|Anticipated|Pfizer||5|||f||||t||||||||||2017-10-10 21:38:52.42771|2017-10-10 21:38:52.42771
NCT02951143|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-03-29|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace||Recruiting||N/A|232|Anticipated|Virginia Polytechnic Institute and State University||6|||f||||f||||||||||2017-10-10 21:38:52.772169|2017-10-10 21:38:52.772169
NCT02951130|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-09-22|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Milrinone in Congenital Diaphragmatic Hernia|Milrinone in Congenital Diaphragmatic Hernia|Recruiting||Phase 2|66|Anticipated|NICHD Neonatal Research Network||2|||f||||t|t|f||||||||2017-10-10 21:38:52.889661|2017-10-10 21:38:52.889661
NCT02951117|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-06-01|||August 31, 2017|Anticipated|2017-08-31|June 2017|2017-06-01|April 28, 2021|Anticipated|2021-04-28|July 28, 2020|Anticipated|2020-07-28||Interventional|||A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment|A Phase 1b, Open Label, Multicenter, Dose Escalation Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma|Withdrawn||Phase 1|0|Actual|AbbVie||2||No participants enrolled|f||||f|t|f||||||||2017-10-10 21:38:53.111277|2017-10-10 21:38:53.111277
NCT02951104|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-28|||December 2016||2016-12-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension|Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension|Not yet recruiting||Phase 1|30|Anticipated|Santa Barbara Cottage Hospital||1|||f||||||||||||||2017-10-10 21:38:53.23436|2017-10-10 21:38:53.23436
NCT02951091|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||January 2016||2016-01-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|||Biomarker-Integrated Umbrella, Advanced Gastric Cancer|The Master Protocol for Biomarker-Integrated Umbrella Trial in Advanced Gastric Cancer|Recruiting||N/A|400|Anticipated|Yonsei University|||2||f||||||||||||||2017-10-10 21:38:53.302173|2017-10-10 21:38:53.302173
NCT02951078|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer||Not yet recruiting||Phase 3|172|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-10 21:38:53.38344|2017-10-10 21:38:53.38344
NCT02951065|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-08|||March 2015||2015-03-01|May 2017|2017-05-01|April 10, 2017|Actual|2017-04-10|February 15, 2017|Actual|2017-02-15||Interventional|||Effect of Bristle-less Toothbrush (PeriClean) on Gum Recession|A Pilot Randomized Clinical Trial of a Manual Bristle-less Tooth Brush Demonstrates Slight Improvement in Gingival Recession Compared to a Conventional Soft Manual Brush|Completed||N/A|23|Actual|Western University of Health Sciences||2|||f||||f||||||||No||2017-10-10 21:38:53.462154|2017-10-10 21:38:53.462154
NCT02951052|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-09-14|||October 28, 2016|Actual|2016-10-28|September 2017|2017-09-01|February 3, 2022|Anticipated|2022-02-03|May 23, 2018|Anticipated|2018-05-23||Interventional|||Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults|A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current INI- NNRTI-, or PI-based Antiretroviral Regimen in HIV-1-infected Adults Who Are Virologically Suppressed|Active, not recruiting||Phase 3|570|Anticipated|ViiV Healthcare||2|||f||||t||||||||||2017-10-10 21:38:53.561815|2017-10-10 21:38:53.561815
NCT02949960|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-06-07|||October 2016||2016-10-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||DMT210 Topical Gel in the Treatment of Atopic Dermatitis|DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis|Active, not recruiting||Phase 2|25|Anticipated|Dermata Therapeutics||2|||f||||f||||||||No||2017-10-10 21:39:04.937393|2017-10-10 21:39:04.937393
NCT02951039|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-10-03|||February 21, 2017|Actual|2017-02-21|October 2017|2017-10-01|September 2021|Anticipated|2021-09-01|March 2021|Anticipated|2021-03-01||Observational|||Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN)|Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation (NVAF)|Recruiting||N/A|2500|Anticipated|Daiichi Sankyo, Inc.|||1||f||||f||||||||||2017-10-10 21:38:53.936089|2017-10-10 21:38:53.936089
NCT02951026|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-04-18|||September 2016||2016-09-01|April 2017|2017-04-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Observational|||An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis|A Phase 3, Multicenter, Observational Long-term Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis|Active, not recruiting||N/A|2000|Anticipated|Samumed LLC|||4||f||||f||||||||||2017-10-10 21:38:54.157252|2017-10-10 21:38:54.157252
NCT02951013|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-28|||January 2017||2017-01-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|||Transfusion Strategies for Pediatric Liver Transplantation|The Perioperative Liberal or Restrictive Transfusion in Pediatric Liver Transplantation: A Prospective Randomized Controlled Trial|Not yet recruiting||N/A|110|Anticipated|RenJi Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:38:54.341975|2017-10-10 21:38:54.341975
NCT02951000|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-10-04|||February 2016|Actual|2016-02-01|October 2016|2016-10-01|June 2017|Actual|2017-06-01|November 2016|Actual|2016-11-01||Interventional|Platysma||Platysma Trial - Platysma Suturing Versus no Sutures for Wound Closure After Primary Thyroid Surgery|Platysma Trial - a Randomized Controlled Trial of Platysma Suturing Versus no Sutures for Wound Closure After Primary Thyroid Surgery|Completed||N/A|80|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 21:38:54.4258|2017-10-10 21:38:54.4258
NCT02950987|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-31|||March 2012||2012-03-01|October 2016|2016-10-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes|Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes|Recruiting||Early Phase 1|150|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:38:54.497606|2017-10-10 21:38:54.497606
NCT02950974|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-28|||November 2014||2014-11-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Change in Serum Chloride Level After Loading Dose of Sterofundin Solution Compared With Normal Saline Solution|Change in Serum Chloride Level After Loading Dose of Sterofundin Solution Compared With Normal Saline Solution|Completed||N/A|20|Actual|Ramathibodi Hospital||2|||f||||f||||||||No||2017-10-10 21:38:54.577309|2017-10-10 21:38:54.577309
NCT02950961|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-10|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|CCWV||Collaborative Care for Women Veterans|Implementation of Tailored Collaborative Care For Women Veterans (CCWV) (QUE 15-272)|Not yet recruiting||Phase 1|240|Anticipated|VA Office of Research and Development||1|||f||||f||||||||No||2017-10-10 21:38:54.654896|2017-10-10 21:38:54.654896
NCT02950948|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-07-07|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Progesterone in Luteal Phase Deficiency|Prospective, Randomised, Double-blind, Placebo Controlled, Phase III Clinical Study Assessing the Efficacy of 25 mg Natural Progesterone Administered Subcutaneously in Restoring the Normal Luteal Phase in Women With Previous Diagnosis of Luteal Phase Deficiency|Not yet recruiting||Phase 3|60|Anticipated|IBSA Institut Biochimique SA||2|||f||||f|f|f||||||||2017-10-10 21:38:54.759476|2017-10-10 21:38:54.759476
NCT02950935|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-07-07|||April 4, 2017|Actual|2017-04-04|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|||Progesterone in Threatened Abortion|Prospective, Double-blind, Randomised, Placebo Controlled, Phase III Clinical Study Assessing the Efficacy of Natural Progesterone 25 mg/Bid Administered Subcutaneously in the Maintenance of Early Pregnancy in Women With Symptoms of Threatened Abortion|Recruiting||Phase 3|268|Anticipated|IBSA Institut Biochimique SA||2|||f||||f|f|f||||||||2017-10-10 21:38:54.819043|2017-10-10 21:38:54.819043
NCT02950922|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-07-25|||November 2016||2016-11-01|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Interventional|||Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis|Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis|Completed||Phase 2|157|Actual|Dermavant Sciences, Inc.||3|||f||||f||||||||||2017-10-10 21:38:54.889396|2017-10-10 21:38:54.889396
NCT02950909|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-28|||October 2016||2016-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 28, 2017|Actual|2017-06-28||Interventional|||Effect of Therapeutic Exercise on the Activation of the Neck Extensors in People With Chronic Neck Pain|Effect of Therapeutic Exercise on the Activation of the Neck Extensors in People With Chronic Neck Pain|Recruiting||N/A|46|Anticipated|University of Valencia||2|||f||||f||||||||No||2017-10-10 21:38:54.997731|2017-10-10 21:38:54.997731
NCT02950896|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-01|||October 2016||2016-10-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study|Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study|Recruiting||N/A|55|Anticipated|Washington University School of Medicine|||1||f||||f||||||||No||2017-10-10 21:38:56.750072|2017-10-10 21:38:56.750072
NCT02950870|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.|An Open-Label Study to Evaluate Long-Term Outcomes With Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Fertile Women With Genotype 1 and 4 Chronic Hepatitis C Virus (HCV) Infection|Not yet recruiting||Phase 4|75|Anticipated|University of Modena and Reggio Emilia||2|||f||||f||||||||No||2017-10-10 21:38:56.961434|2017-10-10 21:38:56.961434
NCT02950844|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-03-16|||October 2016||2016-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Identification, Electro-mechanical Characterisation and Ablation of Driver Regions in Persistent Atrial Fibrillation|Identification, Electro-mechanical Characterisation and Ablation of Driver Regions in Persistent Atrial Fibrillation (STAR MAPPING)|Recruiting||Phase 4|60|Anticipated|Barts & The London NHS Trust|||||f||||||||||||||2017-10-10 21:38:57.149293|2017-10-10 21:38:57.149293
NCT02950818|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-01-24|||December 2016||2016-12-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||A Partnership to Translate an Evidence-based Intervention (Take Heart) for Vulnerable Older Adults With Heart Disease|A Partnership to Translate an Evidence-based Intervention for Vulnerable Older Adults With Heart Disease|Recruiting||N/A|376|Anticipated|University of Michigan||2|||f||||f|f|f||||||Yes|Data sharing: We will have self-reported data (baseline and 12-month) on health, demographics, and psychosocial functioning from both intervention and control participants. An anonymized dataset will be created, which will be made available to other researchers who have appropriate approvals from all relevant Institutional Review Boards (IRBs) through a secure file transfer protocol (FTP) site, M+Box, whose encryption protocols allow secure uploading of files, with sharing limited to specified users (see: http://www.itcs.umich.edu/storage/box/faq.php#storage). Data dictionaries and data collection forms will also be made available. Researchers using the data will be instructed to delete their copy of the dataset once analyses are complete. An email address to reach University of Michigan investigators will be available for questions about the datasets.|2017-10-10 21:38:58.040419|2017-10-10 21:38:58.040419
NCT02950805|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-10-03|||May 30, 2017|Actual|2017-05-30|October 2017|2017-10-01|January 12, 2018|Anticipated|2018-01-12|January 12, 2018|Anticipated|2018-01-12||Interventional|||A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis|A Phase 1b Randomized Blinded Placebo-Controlled, Cross-Over Study to Assess the Effect of AZD5634 on Mucociliary Clearance as Well as Safety, Tolerability, and Pharmacokinetic Parameters Following Single Inhaled Dose Administration to Patients With Cystic Fibrosis.|Recruiting||Phase 1|12|Anticipated|AstraZeneca||2|||f||||t|t|f||||||||2017-10-10 21:38:58.143951|2017-10-10 21:38:58.143951
NCT02950792|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-08-24|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Interventional|||MRI Adaptive Replanning Using ViewRay|A Study of Adaptive Radiotherapy Using ViewRay MRI Based Imaging in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||N/A|0|Actual|University of Miami||1||Investigator Decision|f||||t|f|t|f|f||||||2017-10-10 21:38:58.426535|2017-10-10 21:38:58.426535
NCT02950779|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Assessment of Handgrip Strength in Adults With Inflammatory Bowel Disease|An Investigation Into Handgrip Strength as a Dietetic Assessment Tool to Detect Changes in the Nutritional and Health Status of Adults With Inflammatory Bowel Disease: A Longitudinal Observational Pilot Study|Not yet recruiting||N/A|25|Anticipated|University of Southampton|||1||f||||t||||||||No||2017-10-10 21:38:58.537192|2017-10-10 21:38:58.537192
NCT02950766|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-28|||October 2016||2016-10-01|October 2016|2016-10-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study Combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, With Ipilimumab to Treat High-risk Renal Cell Carcinoma|A Phase I Study Combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, With Ipilimumab to Treat High-risk Renal Cell Carcinoma|Not yet recruiting||Phase 1|20|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:38:58.620917|2017-10-10 21:38:58.620917
NCT02950753|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-06-10|||January 4, 2017|Actual|2017-01-04|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|May 5, 2017|Actual|2017-05-05||Interventional|||Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?|Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?|Completed||Early Phase 1|30|Actual|University Medical Center of Southern Nevada||2|||f||||f||||||||No|Identifiable Patient Data (IPD) will not be shared|2017-10-10 21:38:58.728466|2017-10-10 21:38:58.728466
NCT02950740|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-10-28|||October 2015||2015-10-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|Nutrilife||Nutritional Status, Food Intake and Fecal Microbiota of Brazilians Toddlers|Evaluation of Nutritional Status, Food Intake and Fecal Microbiota of 1-3 Year-old Children From Four Regions of Brazil|Completed||N/A|228|Actual|Danone Early Life Nutrition Brazil|||4||f||||t||||||Samples Without DNA|"     Blood sample (plasma, serum and erythrocytes Fecal sample   "|No||2017-10-10 21:38:58.831437|2017-10-10 21:38:58.831437
NCT02950727|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-21|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|March 7, 2017|Actual|2017-03-07|March 7, 2017|Actual|2017-03-07||Interventional|||Comparing Stability and Cost-Effectiveness of 3 Bicortical Screws Vs Adjustable Plate and 2 Bicortical Screws in Fixation of BSSRO|Stability of Bilateral Sagittal Split Ramus Osteotomy (BSSRO) Using Adjustable Mandibular Plates in Adjunction With Bicortical Screws Versus Traditional Positional Screws for Antero-posterior Mandibular Deficient Patients|Completed||N/A|12|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-10 21:38:58.9109|2017-10-10 21:38:58.9109
NCT02950714|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-01-31|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Dissemination of the Lupus Interactive Navigator|Dissemination of the Lupus Interactive Navigator: Measuring Its Uptake and Impact on Global Health and Self-care|Not yet recruiting||N/A|2000|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f||||||||No||2017-10-10 21:38:58.989873|2017-10-10 21:38:58.989873
NCT02950701|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-12-21|||November 2016||2016-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Suspected Cases of Carbon Monoxide Poisoning|Data During Emergency Medical Transport in Suspected Carbon Monoxide Poisoning|Recruiting||N/A|25|Anticipated|Nonin Medical, Inc|||1||f||||f||||||||No||2017-10-10 21:38:59.088935|2017-10-10 21:38:59.088935
NCT02948660|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-11-25|||October 2016||2016-10-01|October 2016|2016-10-01||||December 2024|Anticipated|2024-12-01||Interventional|||The Role of Sleep-modulating Drugs in the Recovery of Patients With Disorders of Consciousness||Recruiting||Phase 4|200|Anticipated|Xijing Hospital||2|||f||||||||||||||2017-10-10 21:39:17.429455|2017-10-10 21:39:17.429455
NCT02950688|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-04-18||||||April 2017|2017-04-01||||December 2020|Anticipated|2020-12-01||Interventional|||Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus|Evaluation of Correlates of Protective Efficacy of Seasonal Live Attenuated Influenza Vaccine (LAIV) by Utilization of a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus|Not yet recruiting||Phase 1|24|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 21:38:59.168826|2017-10-10 21:38:59.168826
NCT02950675|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-11-03|||July 2016||2016-07-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|||The Relationship of Body Function, Participation and Quality of Life in Patients With Burn: A Longitudinal Study|The Relationship of Body Function, Participation and Quality of Life in Patients With Burn: A Longitudinal Study|Recruiting||N/A|130|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||||No||2017-10-10 21:38:59.269053|2017-10-10 21:38:59.269053
NCT02950662|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||(PEEK) Housing Verses Metallic Housing of Ball and Socket Attachment on Retention of Mandibular Overdenture|Effect of Polyether Ether Ketone (PEEK) Housing Verses Metallic Housing of Ball and Socket Attachment on Retention of Mandibular Implant Retained Overdentures: Randomized Clinical Trial|Not yet recruiting||N/A|30|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:38:59.35535|2017-10-10 21:38:59.35535
NCT02950649|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-11-01|||November 2016||2016-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care|Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care in Moderate to High Risk Patients With Poor Functional Status|Not yet recruiting||Phase 1|190|Anticipated|Loma Linda University||2|||f||||f||||||||No||2017-10-10 21:38:59.426589|2017-10-10 21:38:59.426589
NCT02950636|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Yoga on Mood and Quality of Life in Patients With Refractory Epilepsy|Effect of Yoga on Mood and Quality of Life in Patients With Refractory Epilepsy|Recruiting||N/A|20|Anticipated|University of Kansas Medical Center||1|||f||||||||||||||2017-10-10 21:38:59.513844|2017-10-10 21:38:59.513844
NCT02950623|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-28|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Microbiological Study on Maxillary Complete Dentures of Two Different Materials|Microbiological Comparative Study Between Single Maxillary Denture Fabricated From Rapid Heat Cured Resin and Conventional Acrylic Resin Modified by Titanium Dioxide Nanoparticles|Not yet recruiting||N/A|2|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:38:59.586606|2017-10-10 21:38:59.586606
NCT02950610|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-10-27|||January 2016||2016-01-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|BEN||Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease|Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease (BEN) Study|Recruiting||N/A|90|Anticipated|University of Edinburgh|||3||f||||t||||||Samples Without DNA|"     Stool, urine and blood sample for predetermined Non-DNA analysis. Intestinal microbial     identification with 16s RNA sequencing   "|No|Individual participant data will not shared. Participants will be identified as a part of pre-defined cohort as categorised clinically.|2017-10-10 21:38:59.657077|2017-10-10 21:38:59.657077
NCT02950597|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-06-16|||November 2016||2016-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Clinical Impact of Non-invasive Hemodynamic Monitoring|Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Preventative Care of Heart Failure Patients|Recruiting||N/A|60|Anticipated|Loma Linda University|||1||f||||f|f|t|f|||||No||2017-10-10 21:38:59.74203|2017-10-10 21:38:59.74203
NCT02950584|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Surface Roughness of Heat Cured Acrylic Resin Versus Acrylic Resin With Titanium Dioxide|The Surface Roughness of Rapid Heat Cured Acrylic Resin Versus Modified Conventional Acrylic Resin With Titanium Dioxide Nanoparticles in Maxillary Single Dentures: A Randomized Clinical Trials|Not yet recruiting||Phase 1|20|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:38:59.817579|2017-10-10 21:38:59.817579
NCT02950571|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-09-27|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient Setting|A Randomized Controlled Trial Examining the Effectiveness of Digital Picture Frame Use on the Long Term Inpatient Experience|Completed||N/A|40|Anticipated|Centre for Addiction and Mental Health||2|||f||||f|f|f||||||||2017-10-10 21:38:59.881691|2017-10-10 21:38:59.881691
NCT02950558|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-27|||January 2017||2017-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Anesthesia for Pain After Ankle Fracture Surgery|Pilot Study: Extended Regional Anesthesia to Prevent Chronic Pain After Ankle Fracture Surgery|Not yet recruiting||Phase 2|60|Anticipated|University of Cincinnati||2|||f||||f||||||||No||2017-10-10 21:38:59.964298|2017-10-10 21:38:59.964298
NCT02950545|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-28|||April 2016||2016-04-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Interventional|||Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3|Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3|Recruiting||N/A|43|Anticipated|University of Virginia||1|||f||||f||||||||Undecided||2017-10-10 21:39:00.163291|2017-10-10 21:39:00.163291
NCT02950532|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-09-07|||November 2016||2016-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PAM||Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures|Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures (T11-L2): A Diagnostic Test Study to Analyze Sensitivity and Specificity|Recruiting||N/A|205|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f|f|f||||||||2017-10-10 21:39:00.249579|2017-10-10 21:39:00.249579
NCT02950519|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Endotracheal Tube Cuff Pressures in Ventilated Patients|Assessing Endotracheal Tube Cuff Pressures in Mechanically Ventilated Patients|Recruiting||N/A|300|Anticipated|Barnes-Jewish Hospital||2|||f||||f||||||||Undecided|We are undecided on this point.|2017-10-10 21:39:00.372848|2017-10-10 21:39:00.372848
NCT02950506|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-10-28|||November 2016||2016-11-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Interictal Dysfunction in Epilepsy|Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Interictal Dysfunction in Epilepsy|Not yet recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||No|There is currently no plan to make individual participant data available.|2017-10-10 21:39:00.472653|2017-10-10 21:39:00.472653
NCT02950493|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-03|||December 2016||2016-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Use of Reactivated DEFINITY in Patients Undergoing Stress Echo|Use of Reactivated DEFINITY in Patients Undergoing Stress Echo|Recruiting||Phase 2|50|Anticipated|University of Nebraska||1|||f||||f||||||||No|There is no plan to share data.|2017-10-10 21:39:00.630085|2017-10-10 21:39:00.630085
NCT02950480|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-07-25|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial|Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial|Recruiting||Phase 2|90|Anticipated|University of California, San Francisco||2|||f|||||t|f|||t|||||2017-10-10 21:39:00.727789|2017-10-10 21:39:00.727789
NCT02950467|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-07-05|||July 6, 2017|Anticipated|2017-07-06|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|July 30, 2019|Anticipated|2019-07-30||Interventional|||Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors|Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors|Recruiting||Phase 1|36|Anticipated|University of California, San Francisco||1|||f||||t|t|f||||||||2017-10-10 21:39:00.819294|2017-10-10 21:39:00.819294
NCT02950454|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Interventional|||The Effect of High Intensity Interval Training on Cardiovascular Fitness in People With Progressive Multiple Sclerosis.|The Effect of High Intensity Interval Training on Cardiovascular Fitness in People With Progressive Multiple Sclerosis.|Not yet recruiting||N/A|20|Anticipated|University of Glasgow||2|||f||||f||||||||No||2017-10-10 21:39:00.929438|2017-10-10 21:39:00.929438
NCT02950441|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-05|||June 2016||2016-06-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|NADMet||Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype|Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype (NADMet)|Recruiting||Phase 2|12|Anticipated|University of Birmingham||2|||f||||f||||||||No||2017-10-10 21:39:01.032392|2017-10-10 21:39:01.032392
NCT02950428|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-07-20|||November 18, 2015|Actual|2015-11-18|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|March 28, 2017|Actual|2017-03-28||Interventional|||ACURATE Neo™ TA Delivery System in Patient With Severe Aortic Stenosis|ACURATE Neo™ Aortic Bioprosthesis for Implantation Using the ACURATE Neo™ TA Transapical Delivery System in Patients With Severe Aortic Stenosis|Active, not recruiting||N/A|60|Anticipated|Symetis SA||1|||f||||t||||||||||2017-10-10 21:39:01.147312|2017-10-10 21:39:01.147312
NCT02950415|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-09-19|||May 16, 2017|Actual|2017-05-16|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Does Virtual Parental Presence Reduce Preoperative Anxiety in Children|Does Virtual Parental Presence Reduce Preoperative Anxiety in Children: A Randomized Controlled Trial|Recruiting||N/A|320|Anticipated|The Hospital for Sick Children||4|||f||||f|f|f||||||||2017-10-10 21:39:01.24457|2017-10-10 21:39:01.24457
NCT02950402|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-07-07|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dried Plums and Chronic Disease Markers|Impact of California Dried Plums on Markers of Bone, Cardiovascular and Digestive Health|Active, not recruiting||N/A|25|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 21:39:01.352321|2017-10-10 21:39:01.352321
NCT02950389|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||January 2016||2016-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|RECORDER||REmoval of Free Light Chains. A COmpaRison of Three Different dialyzERs|REmoval of Free Light Chains in Hemodialysis Patients Without Multiple Myeloma. A Crossover COmpaRison of Three Different dialyzERs|Completed||Phase 4|20|Actual|St. Orsola Hospital||2|||f||||f||||||||No||2017-10-10 21:39:01.425093|2017-10-10 21:39:01.425093
NCT02950376|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-04-28|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Novel Addiction Assessment Study in Synthetic Drugs Addiction|Development of Virtual Reality-Based Addiction Assessment System for Synthetic Drugs Addiction|Not yet recruiting||N/A|1500|Anticipated|Shanghai Mental Health Center|||3||f||||f||||||||No||2017-10-10 21:39:01.532873|2017-10-10 21:39:01.532873
NCT02950363|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-08-24|||July 2016||2016-07-01|March 2017|2017-03-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Observational|||Physician Mental Health Study for Medical Trainees|Assessment of Physician Mental Health Using Voice Analysis, Physiological Metrics and Smartphone Enabled Behavioral Modification|Completed||N/A|40|Actual|Scripps Translational Science Institute|||1||f||||f||||||||||2017-10-10 21:39:01.617422|2017-10-10 21:39:01.617422
NCT02950350|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||December 2016||2016-12-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2016|Anticipated|2016-12-01||Observational|||Clinical Trial of Laparoscopic Pelvic and Para-aortic Lymphadenectomy and Uterine Blood Vessel Blocking for Precision Diagnosis and Treatment in Advanced Cervical Cancer|Clinical Trial of Laparoscopic Pelvic and Para-aortic Lymphadenectomy and Uterine Blood Vessel Blocking for Precision Diagnosis and Treatment in Advanced Cervical Cancer|Not yet recruiting||N/A|50|Anticipated|Shanghai First Maternity and Infant Hospital|||2||f||||f||||||||Undecided|we need get the patients' agreement to share data.|2017-10-10 21:39:01.679335|2017-10-10 21:39:01.679335
NCT02950337|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-31|||December 2015||2015-12-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer|Phase II Study of Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer|Recruiting||Phase 2|41|Anticipated|Loyola University||3|||f||||t||||||||Undecided||2017-10-10 21:39:01.749641|2017-10-10 21:39:01.749641
NCT02946437|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-03-14|||August 2015||2015-08-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|Sevoflurane||Sevoflurane in Subarachnoidal Haemorrhage|Short Term Application of Sevoflurane in Patients With Subarachnoid Haemorrhage: a Feasibility and Safety Study|Recruiting||Phase 2|10|Anticipated|University of Zurich||3|||f||||f||||||||No||2017-10-10 21:39:39.496828|2017-10-10 21:39:39.496828
NCT02950324|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-27|||November 2016||2016-11-01|October 2016|2016-10-01|November 2022|Anticipated|2022-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Does Prehabilitation Improve Exercise Performance and Insulin Resistance After Surgery for Oesophago-gastric Cancer?|Does Prehabilitation Improve Performance in Cardiopulmonary Exercise Testing and Reduce Insulin Resistance in Patients Undergoing Neo-adjuvant Treatment and Surgery for Oesophago-gastric Cancer?|Not yet recruiting||N/A|50|Anticipated|Royal Surrey County Hospital NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:39:01.853028|2017-10-10 21:39:01.853028
NCT02950311|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-12-05|||February 2017||2017-02-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Xylitol for Otitis Media|A Prospective, Randomized, Double-blinded, Placebo-controlled Pilot Study for Evaluating the Effectiveness of Intranasal Xylitol in Treating Otitis Media With Effusion (OME) in Children|Not yet recruiting||N/A|30|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 21:39:02.012935|2017-10-10 21:39:02.012935
NCT02950298|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-10-28|||December 2015||2015-12-01|October 2016|2016-10-01||||July 2019|Anticipated|2019-07-01||Observational|||Pompe Telemedicine Developmental Study|Developmental Outcomes of School-aged Children With Infantile-onset Pompe Disease: A Telemedicine Approach to Assessment and Cognitive Training|Recruiting||N/A|20|Anticipated|Duke University|||1||f||||||||||||||2017-10-10 21:39:02.099817|2017-10-10 21:39:02.099817
NCT02950285|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-12|||February 7, 2017|Actual|2017-02-07|June 2017|2017-06-01|May 7, 2017|Actual|2017-05-07|May 7, 2017|Actual|2017-05-07||Interventional|||Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation|Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation|Completed||N/A|2336|Actual|Massachusetts General Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:39:02.179389|2017-10-10 21:39:02.179389
NCT02950272|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||September 2016||2016-09-01|October 2016|2016-10-01||||September 2022|Anticipated|2022-09-01|6 Years|Observational [Patient Registry]|||Chinese Adolescent Registry for Diabetes (CARD) Study||Recruiting||N/A|1500|Anticipated|Qilu Hospital of Shandong University|||1||f||||||||||||||2017-10-10 21:39:02.254277|2017-10-10 21:39:02.254277
NCT02950259|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-03-01|||February 9, 2017|Actual|2017-02-09|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|||Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)|A Phase Ib Study to Assess the Safety, Tolerability and Immunologic Activity of Preoperative IRX 2 In Early Stage Breast Cancer|Recruiting||Phase 1|20|Anticipated|Providence Health & Services||1|||f||||f|t|f||||||Yes|Providence Health & Services has agreed to allow IRX Therapeutics to have access PHI for auditing purposes. Any non-Providence Health & Services employee who will access PHI will be required to sign a confidentiality agreement and will not be permitted to remove PHI from Providence Health & Services.|2017-10-10 21:39:02.311258|2017-10-10 21:39:02.311258
NCT02950246|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-10-31|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|CHLOVEPI||Alcoholic Chlorhexidine Compared to Povidone Iodine to Limit Perineural Catheter Colonisation|Effect of 2% Alcoholic Chlorhexidine Compared to Povidone Iodine Solution to Limit Colonisation After Perineural Catheterization in Orthopaedic Surgery|Not yet recruiting||N/A|92|Anticipated|Hôpital Raymond Poincaré||2|||f||||t||||||||||2017-10-10 21:39:02.430067|2017-10-10 21:39:02.430067
NCT02950233|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-09-18|||May 4, 2017|Actual|2017-05-04|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|PAIN-STOP||Preventing pAIn With NMDA Antagonists - Steroids in Thoracoscopic lObectomy Procedures (PAIN-STOP) Pilot Trial|NMDA Antagonists and Steroids for the Prevention of Persisting Post-Surgical Pain After Thoracoscopic Surgeries: A Randomized Controlled, Factorial Design, International, Multicentre Pilot Study|Recruiting||Phase 3|48|Anticipated|Population Health Research Institute||4|||f||||f|t|f||||||||2017-10-10 21:39:02.501248|2017-10-10 21:39:02.501248
NCT02950220|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01||||December 2019|Anticipated|2019-12-01||Interventional|||Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma|A Phase I/Ib Study of the PD-1 Antibody Pembrolizumab in Combination With Ibrutinib in Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL)|Recruiting||Phase 1|58|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 21:39:02.614503|2017-10-10 21:39:02.614503
NCT02950207|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-02|||January 2014||2014-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|BC-P1-2013||Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100|Prospective Observational Study to Evaluate the Correlation Between Antitumor Activity of Hormone Therapy and the Expression of Micro-RNA (miRNA) 100|Recruiting||N/A|180|Anticipated|Fondazione del Piemonte per l'Oncologia|||1||f||||f||||||||No||2017-10-10 21:39:02.828559|2017-10-10 21:39:02.828559
NCT02950194|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-24|||August 2016||2016-08-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|May 2019|Anticipated|2019-05-01||Observational|PPAWI||Mesh Augmentation and Panniculectomy for the Treatment of Post-partum Abdominal Wall Insufficiency|Navel Sparing Retro-muscular Mesh Augmentation and Panniculectomy for the Treatment of Post-partum Abdominal Wall Insufficiency (PPAWI)|Active, not recruiting||N/A|20|Anticipated|Algemeen Ziekenhuis Maria Middelares|||1||f||||f||||||||||2017-10-10 21:39:02.914712|2017-10-10 21:39:02.914712
NCT02950181|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-27|||January 2014||2014-01-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|NIRSCI||Descriptive Analysis of Near Infrared Spectroscopy in Critically Ill and Injured Pediatric and Neonatal Patients|Descriptive Analysis of Near Infrared Spectroscopy in Critically Ill and Injured Pediatric and Neonatal Patients|Recruiting||N/A|400|Anticipated|Arkansas Children's Hospital Research Institute||1|||f||||f||||||||No||2017-10-10 21:39:03.013944|2017-10-10 21:39:03.013944
NCT02950168|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-28|||November 2016||2016-11-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01|30 Days|Observational [Patient Registry]|EMIT-AF/VTE||Edoxaban Management in Diagnostic and Therapeutic Procedures|Edoxaban Management in Diagnostic and Therapeutic Procedures|Not yet recruiting||N/A|2000|Anticipated|Daiichi Sankyo, Inc.|||1||f||||f||||||||||2017-10-10 21:39:03.143504|2017-10-10 21:39:03.143504
NCT02950155|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-10-31|||August 2016||2016-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|Rinomax||A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis|A Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating the Safety and Efficacy of Rituximab (Mabthera®) in Patients With New Onset Generalized Myasthenia Gravis (MG)|Recruiting||Phase 3|60|Anticipated|Karolinska Institutet||2|||f||||t||||||||No||2017-10-10 21:39:03.271249|2017-10-10 21:39:03.271249
NCT02950142|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-27|||November 1, 2017|Anticipated|2017-11-01|October 2016|2016-10-01|October 1, 2020|Anticipated|2020-10-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Evidence-based Laboratory Test Order Sets in Primary Care|The Effect of Evidence-based Order Sets Within a CPOE System on the Quantity and Quality of Laboratory Test Ordering in Family Practice: a Cluster Randomised Trial|Not yet recruiting||N/A|300|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t|f|f||||||||2017-10-10 21:39:03.378138|2017-10-10 21:39:03.378138
NCT02950129|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-10-27|||February 2009||2009-02-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||IRB-HSR # 14073 Investigation of Pelvic Girdle Dysfunction in the Low Back Pain Population|IRB-HSR # 14073 Investigation of Pelvic Girdle Dysfunction in the Low Back Pain Population|Completed||Phase 2|55|Actual|University of Virginia||1|||f||||f||||||||No||2017-10-10 21:39:03.485561|2017-10-10 21:39:03.485561
NCT02950116|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-06-19|||March 9, 2017|Actual|2017-03-09|May 2017|2017-05-01|April 7, 2017|Actual|2017-04-07|March 31, 2017|Actual|2017-03-31||Interventional|||Lung Clearance Index (LCI) in Pediatric Patients With Obstructive Lung Disease|Lung Clearance Index in Pediatric Patients With Obstructive Lung Disease|Terminated||N/A|27|Actual|Universitair Ziekenhuis Brussel||3||Availabe time for inclusion ended (master thesis)|f||||f|f|f||||||No||2017-10-10 21:39:03.589296|2017-10-10 21:39:03.589296
NCT02950103|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-04-12|||August 2016||2016-08-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients|Efficacy and Safety Evaluation of Synthetic Phosphoethanolamine in Solid Tumor Patients|Suspended||Phase 2|1000|Anticipated|Secretaria de Estado da Saúde||1|||f||||t||||||||No||2017-10-10 21:39:03.68024|2017-10-10 21:39:03.68024
NCT02950090|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-27|||September 2015||2015-09-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||MobilWise: Mobile Phone Remote Coaching After Worksite Joint ADventure Exposure|MobilWise: Mobile Phone Remote Coaching After Worksite Joint ADventure Exposure|Recruiting||N/A|61|Anticipated|Rush University Medical Center||3|||f||||f||||||||Undecided||2017-10-10 21:39:03.756804|2017-10-10 21:39:03.756804
NCT02950077|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-04-25|||February 14, 2017|Actual|2017-02-14|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Mindfulness - Based Stress Reduction and the Relationship on Inflammation in Autoimmune Hepatitis|Mindfulness - Based Stress Reduction and the Relationship on Inflammation in Autoimmune Hepatitis - A Human Pilot Study Protocol|Recruiting||N/A|25|Anticipated|Yale University||1|||f||||f|f|f||||||No||2017-10-10 21:39:03.857258|2017-10-10 21:39:03.857258
NCT02950064|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-23|||September 2016||2016-09-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations|Escalation Study of BTP-114 in Patients With Advanced Solid Tumors and BRCA or DNA Repair Mutation|Recruiting||Phase 1|95|Anticipated|Placon Therapeutics||1|||f||||f||||||||Undecided||2017-10-10 21:39:03.951563|2017-10-10 21:39:03.951563
NCT02950051|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-02|||October 2016||2016-10-01|October 2016|2016-10-01|January 2024|Anticipated|2024-01-01|January 2023|Anticipated|2023-01-01||Interventional|GAIA||Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation|A Phase 3 Multicenter, Randomized, Prospective, Open-label Trial of Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab Plus Venetoclax (RVe) Versus Obinutuzumab (GA101) Plus Venetoclax (GVe) Versus Obinutuzumab Plus Ibrutinib Plus Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation|Recruiting||Phase 3|920|Anticipated|German CLL Study Group||4|||f||||t||||||||||2017-10-10 21:39:04.072099|2017-10-10 21:39:04.072099
NCT02950038|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-02-10|||December 2016||2016-12-01|February 2017|2017-02-01||||December 2019|Anticipated|2019-12-01||Interventional|||Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)|A Phase II Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Advanced Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 21:39:04.302776|2017-10-10 21:39:04.302776
NCT02950025|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-01-23|||January 19, 2017|Actual|2017-01-19|January 2017|2017-01-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies|A Randomized Controlled Phase II Study of Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies|Recruiting||Phase 2|100|Anticipated|Washington University School of Medicine||2|||f||||t|f|t|f|f|f|||No||2017-10-10 21:39:04.39086|2017-10-10 21:39:04.39086
NCT02950012|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-12-22|||October 2016||2016-10-01|December 2016|2016-12-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population|A Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population|Recruiting||Phase 2|100|Anticipated|BIO-CAT Microbials, LLC||2|||f||||f||||||||No||2017-10-10 21:39:04.498106|2017-10-10 21:39:04.498106
NCT02949999|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-01-03|||October 2016||2016-10-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Voclosporin in Healthy Japanese Volunteers|A Single-center, Double-blind, Placebo-controlled, Randomized, Ascending Multiple-dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Voclosporin in Healthy Japanese Volunteers|Recruiting||Phase 1|40|Anticipated|Aurinia Pharmaceuticals Inc.||5|||f||||f||||||||No||2017-10-10 21:39:04.609572|2017-10-10 21:39:04.609572
NCT02949986|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-27|||August 2016||2016-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility of a Tablet-based Fall Prevention Program for Older Adults|Feasibility of a Tablet-based Fall Prevention Program for Older Adults|Recruiting||N/A|20|Anticipated|East Tennessee State University||1|||f||||f||||||||No||2017-10-10 21:39:04.726218|2017-10-10 21:39:04.726218
NCT02949973|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-09-18|||June 2015||2015-06-01|September 2017|2017-09-01|February 17, 2017|Actual|2017-02-17|December 2016|Actual|2016-12-01||Interventional|AURION||Aurinia Early Urinary Protein Reduction Predicts Response|An Exploratory Study Assessing the Short Term Predictors of Remission of Voclosporin 23.7mg BID in Combination With Standard of Care in Patients With Active Lupus Nephritis|Completed||Phase 2|10|Actual|Aurinia Pharmaceuticals Inc.||1|||f||||f||||||||||2017-10-10 21:39:04.837536|2017-10-10 21:39:04.837536
NCT02949947|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-18|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Efficacy of Ferric Carboxymaltose in Patients With Gastrointestinal Stromal Tumor (GIST) Receiving Systemic Therapy|Efficacy of Ferric Carboxymaltose in Patients With Gastrointestinal Stromal Tumor (GIST) Receiving Systemic Therapy|Not yet recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:39:05.029527|2017-10-10 21:39:05.029527
NCT02949934|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||May 2016||2016-05-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control||Recruiting||Phase 2|90|Anticipated|Medical University of South Carolina||2|||f||||t||||||||No||2017-10-10 21:39:05.136277|2017-10-10 21:39:05.136277
NCT02949921|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-21|||December 2015||2015-12-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Radiological Evaluation of Radiesse Implantation in the Hands|Radiesse® Post Approval Safety Study - Radiological Evaluation of Implantation in the Hands|Active, not recruiting||N/A|20|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 21:39:05.217566|2017-10-10 21:39:05.217566
NCT02949908|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-27|||February 9, 2017|Actual|2017-02-09|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Observational|MESTRE-MS||MEasuring Satisfaction of Treatment With REbif After Initial Treatment of MS (MESTRE-MS)|A Phase IV, Prospective, Multicenter, Open Label, Uncontrolled, Non-interventional, Single Arm Study to Measure Treatment Satisfaction of Multiple Sclerosis (MS) Patients on Rebif® After Discontinuing Initial First-line Treatment|Recruiting||N/A|133|Anticipated|Merck KGaA|||1||f||||t||||||||||2017-10-10 21:39:05.294808|2017-10-10 21:39:05.294808
NCT02949895|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-09-15|||November 29, 2016|Actual|2016-11-29|September 2017|2017-09-01|August 29, 2017|Actual|2017-08-29|August 29, 2017|Actual|2017-08-29||Interventional|||Study of BMS-986012 in Subjects With Small Cell Lung Caner|A Phase 1 Study of the Safety and Tolerability of BMS-986012 in Subjects With Small Cell Lung Cancer|Completed||Phase 1|7|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-10 21:39:05.389386|2017-10-10 21:39:05.389386
NCT02949882|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2016-11-16|||April 2017||2017-04-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Improving Bowel Habits of Elderly With Probiotics and Non-probiotics|Comparing a Probiotic and Non-probiotic Intervention in Their Ability to Improve Bowel Habits of Residents in Nursing Homes|Not yet recruiting||Phase 4|260|Anticipated|Athena Institute, Netherlands||2|||f||||f||||||||Undecided||2017-10-10 21:39:05.486399|2017-10-10 21:39:05.486399
NCT02949869|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||November 2016||2016-11-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Variability of Infant LP Insertion Site Based On Procedural Experience|Variability of Infant LP Insertion Site Based On Procedural Experience|Not yet recruiting||N/A|110|Anticipated|Boston Children’s Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:39:05.558891|2017-10-10 21:39:05.558891
NCT02949856|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||E-T Tube Cuff Pressure Change After Changing Position From Neutral to Hyperextension of Neck|Endotracheal Tube Intracuff Pressure Change After Changing Position From Neutral to Hyperextension of Neck - Comparison of a Tapered Shaped- and Cylindrical Shaped Cuff|Not yet recruiting||N/A|50|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||t||||||||No||2017-10-10 21:39:05.634995|2017-10-10 21:39:05.634995
NCT02949843|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-04-18|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations|Phase II Pilot Study Evaluating Strategies to Overcome Resistance at the Time of Progression for Patients With Non-small Cell Lung Cancers Harboring Major Oncogenic Drivers|Recruiting||Phase 2|75|Anticipated|Wake Forest University Health Sciences||3|||f|||||t|f|||f|||||2017-10-10 21:39:05.69671|2017-10-10 21:39:05.69671
NCT02949830|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-28|2017-06-02|||October 2016||2016-10-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|May 2020|Anticipated|2020-05-01||Interventional|||A Study to Evaluate Long-term Safety and Clinical Activity of ALN-AS1 in Patient With Acute Intermittent Porphyria (AIP)|A Multicenter, Open-label Extension Study to Evaluate the Long-term Safety and Clinical Activity of Subcutaneously Administered ALN-AS1 in Patients With Acute Intermittent Porphyria Who Have Completed a Previous Clinical Study With ALN-AS1|Enrolling by invitation||Phase 1/Phase 2|17|Anticipated|Alnylam Pharmaceuticals||1|||f||||f||||||||Undecided||2017-10-10 21:39:05.807751|2017-10-10 21:39:05.807751
NCT02949817|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-10-28|||November 2016||2016-11-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effect of Digital Rehabilitation System With Wearable Multi-IMU (Inertial Measurement Unit) Sensors on Upper Limb Functions in Children With Cerebral Palsy||Not yet recruiting||N/A|40|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 21:39:05.885496|2017-10-10 21:39:05.885496
NCT02949804|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-01-09|||December 2016||2016-12-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Relation Between Vasovagal Tendency and Smoking Among University Students|Relation Between Vasovagal Tendency and Smoking Among University Students|Recruiting||N/A|200|Anticipated|Jordan Collaborating Cardiology Group|||2||f||||f||||||||Undecided|Once data is collected it will be shared with researchers after making individuals anonymous|2017-10-10 21:39:05.953874|2017-10-10 21:39:05.953874
NCT02949791|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-27|||December 2014||2014-12-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|HIPEC-IAP||HIPEC Using High Intra-abdominal Pressure|Effects of High Intra-abdominal Pressure on Tissue Diffusion and Pharmacokinetics of Cisplatin During HIPEC|Recruiting||Phase 2|38|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||t||||||||No||2017-10-10 21:39:06.031303|2017-10-10 21:39:06.031303
NCT02949778|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Quadratus Lumborum Block for Abdominoplasty|Quadratus Lumborum Block for Perioperative Analgesia in Patients Treated With Abdominoplasty: A Randomised Controlled Trial|Not yet recruiting||Phase 4|50|Anticipated|Vestre Viken Hospital Trust||2|||f||||t||||||||No|Requires approval by ethics committee and second consent form.|2017-10-10 21:39:06.250398|2017-10-10 21:39:06.250398
NCT02949765|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-03-11|||December 2015||2015-12-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease|Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease|Recruiting||N/A|35|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||No||2017-10-10 21:39:06.342097|2017-10-10 21:39:06.342097
NCT02949752|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-03-05|||August 2016||2016-08-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile|Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile|Recruiting||Phase 4|60|Anticipated|Institute of Mental Health, Singapore||1|||f||||t||||||||No||2017-10-10 21:39:06.435954|2017-10-10 21:39:06.435954
NCT02949739|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-15|||January 2015||2015-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|November 2018|Anticipated|2018-11-01||Interventional|iHealth-T2D||Prevention of Type 2 Diabetes Amongst South Asians With Central Obesity and Prediabetes|Lifestyle Intervention to Prevent Type 2 Diabetes Amongst South Asians With Central Obesity and Prediabetes|Recruiting||Phase 2/Phase 3|3600|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-10 21:39:06.534486|2017-10-10 21:39:06.534486
NCT02949726|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-05-03|||April 24, 2017|Actual|2017-04-24|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development|Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development|Recruiting||Phase 1|100|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f|t|t|t|||||||2017-10-10 21:39:06.622261|2017-10-10 21:39:06.622261
NCT02949713|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||June 2017||2017-06-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Text Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected Women|Feasibility and Effects of Mobile Phone Text Messaging Plus Motivational Interviewing Versus Usual Care in Promotion of Breastfeeding Among HIV-infected Women in South Africa: A Randomized, Parallel Group, Controlled Pilot Trial|Not yet recruiting||N/A|84|Anticipated|University of Stellenbosch||2|||f||||f||||||||Yes|The IPD will be available from the corresponding author on reasonable request|2017-10-10 21:39:06.734064|2017-10-10 21:39:06.734064
NCT02949700|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-03-28|||January 26, 2017|Actual|2017-01-26|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma|A Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|32|Anticipated|Baylor College of Medicine||1|||f||||t|t|f|||f|||No||2017-10-10 21:39:06.841656|2017-10-10 21:39:06.841656
NCT02949687|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-04|||September 2016||2016-09-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Surgical Treatment in Diabetic Patients With Grade 1 Obesity|Duodenal Ileal Interposition With Sleeve Gastrectomy and Selective Intra-Abdominal Denervation for Type 2 Diabetes Mellitus|Enrolling by invitation||N/A|40|Actual|Universidade Positivo||1|||f||||t||||||||||2017-10-10 21:39:06.929449|2017-10-10 21:39:06.929449
NCT02949661|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-31|||September 2016||2016-09-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Local Wound Infiltration for Tracheal Reconstruction|Local Wound Infiltration Versus Bilateral Superficial Cervical Plexus Block With Levobupivacaine for Upper Tracheal Resection and Reconstruction Surgery Under General Anesthesia.|Enrolling by invitation||N/A|60|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 21:39:07.09892|2017-10-10 21:39:07.09892
NCT02949648|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-10-27|||September 2015||2015-09-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Observational|||Electronic Cigarette Use and Quitting in Youth|A Pilot Study on Electronic Cigarette Use and Their Impact on Smoking and Quitting in Youth|Completed||N/A|189|Actual|The University of Hong Kong|||2||f||||f||||||||No||2017-10-10 21:39:07.184321|2017-10-10 21:39:07.184321
NCT02949635|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-05-30|||September 2016||2016-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|DAMAGE||Patient Outcomes After Hospitalization in Acute Geriatric Unit|Risks of Death, Hospital Readmission, and Institutionalization After Hospitalization in Acute Geriatric Unit|Recruiting||N/A|3500|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||No||2017-10-10 21:39:07.268094|2017-10-10 21:39:07.268094
NCT02949622|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-06-20|||February 2013||2013-02-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|PROMETS||Multimodal Intervention Program for Patients With Metabolic Syndrome|Development and Validation of a Multimodal Intervention Program for Patients With Metabolic Syndrome|Completed||N/A|136|Actual|Universidad de Granada||2|||f||||f||||||||No||2017-10-10 21:39:07.355158|2017-10-10 21:39:07.355158
NCT02949609|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-27|||April 2016||2016-04-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|MT||Mirror Therapy: Effects on Functional Recuperation of Severe Upper Limb Paresis After Stroke|Mirror Therapy: Effects on Functional Recuperation of Severe Upper Limb Paresis After Stroke|Recruiting||N/A|30|Anticipated|University Hospital, Geneva||2|||f||||t||||||||No||2017-10-10 21:39:07.475208|2017-10-10 21:39:07.475208
NCT02949596|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-28|||October 2015||2015-10-01|October 2016|2016-10-01|May 2021|Anticipated|2021-05-01|October 2020|Anticipated|2020-10-01||Observational|||Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy|Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy|Recruiting||N/A|50|Anticipated|Instituto do Cancer do Estado de São Paulo|||1||f||||t||||||||No||2017-10-10 21:39:07.566351|2017-10-10 21:39:07.566351
NCT02949583|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-10-27|||March 2012||2012-03-01|October 2016|2016-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Mouthwash of Pomegranate Against Biofilm and Gingival Inflammation in School Children|Clinical Effectiveness and Microbiological Evaluation of a Mouthwash of Pomegranate (Punica Granatum Linn.) in School Children|Completed||N/A|35|Actual|Universidade Estadual da Paraiba||2|||f||||t||||||||No||2017-10-10 21:39:07.656769|2017-10-10 21:39:07.656769
NCT02949570|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-27|||February 2014||2014-02-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|ICT10||Study to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM Study|Phase 2 Study to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM Study|Recruiting||Phase 2|54|Anticipated|Hybrigenics Corporation||1|||f||||t||||||||No||2017-10-10 21:39:07.747658|2017-10-10 21:39:07.747658
NCT02949544|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-09|||November 22, 2016|Actual|2016-11-22|October 2016|2016-10-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Interventional|IMMERSE-HF||Water Immersion in Chronic Stable Heart Failure|Water Immersion and Water-based Exercise in Patients With Chronic Stable Heart Failure: A Pilot Study|Completed||N/A|27|Actual|Hull and East Yorkshire Hospitals NHS Trust||1|||f||||f|f|f||||||||2017-10-10 21:39:07.91008|2017-10-10 21:39:07.91008
NCT02949531|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-09|||November 3, 2016|Actual|2016-11-03|September 2016|2016-09-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|STOP-EF||Use of Oxygen in Heart Failure With Preserved Ejection Fraction|Randomised, Cross Over, Single Blind, Control Trial of Short Term Oxygen Use During Cycle Ergometry in Patients With Chronic Heart Failure With Preserved Ejection Fraction|Completed||Phase 2|50|Actual|Hull and East Yorkshire Hospitals NHS Trust||3|||f||||t||||||||||2017-10-10 21:39:08.002529|2017-10-10 21:39:08.002529
NCT02949518|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ERAS for Spine||Enhanced Recovery After Spine Surgery|Enhanced Recovery After Spine Surgery: A Prospective Randomized Controlled Trial to Assess Quality of Recovery and the Biochemical Stress Response to Lumbar Fusion|Not yet recruiting||N/A|56|Anticipated|Hospital for Special Surgery, New York||2|||f||||||||||||||2017-10-10 21:39:08.078772|2017-10-10 21:39:08.078772
NCT02949505|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-07-15|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation|Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation|Active, not recruiting||N/A|20|Anticipated|University of Birmingham||1|||f||||f|f|f||||||||2017-10-10 21:39:08.175035|2017-10-10 21:39:08.175035
NCT02949492|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-18|||September 15, 2017|Anticipated|2017-09-15|October 2016|2016-10-01|September 15, 2021|Anticipated|2021-09-15|September 15, 2019|Anticipated|2019-09-15||Interventional|LITE||Low-dose IL-2 for Treg Expansion and Tolerance (LITE)|Low Dose IL-2 to Expand Endogenous Regulatory T-cells and Achieve Tolerance in Liver Transplantation|Not yet recruiting||Phase 4|25|Anticipated|King's College London||1|||f||||t|f|f|||f|||||2017-10-10 21:39:08.257863|2017-10-10 21:39:08.257863
NCT02949479|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-27|||November 2016||2016-11-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|DISSO||Dissociation Investigation Study in Sex Offenders|Dissociative Experience During the Offence in Sex Offenders : Clinical and Prognosis Correlates|Not yet recruiting||N/A|120|Anticipated|Hôpital le Vinatier||1|||f||||f||||||||No||2017-10-10 21:39:08.363403|2017-10-10 21:39:08.363403
NCT02949466|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-29|||October 2016||2016-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Additional Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis|Additional Therapeutic Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis: A Double Blind, Randomized-controlled Clinical Trial|Not yet recruiting||Phase 4|56|Anticipated|Taipei Medical University||2|||f||||t||||||||No||2017-10-10 21:39:08.443716|2017-10-10 21:39:08.443716
NCT02949453|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-04-03|||March 3, 2017|Actual|2017-03-03|April 2017|2017-04-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|ACCEPT-S||ACCeptation and Qualitative Evaluation of Phone-delivered Intervention|ACCeptation and Qualitative Evaluation of Phone-delivered Intervention To Prevent Suicide Reattempt|Recruiting||N/A|20|Anticipated|Hôpital le Vinatier||1|||f||||f|f|f||||||No||2017-10-10 21:39:08.53155|2017-10-10 21:39:08.53155
NCT02949440|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-28|||October 2016||2016-10-01|October 2016|2016-10-01|December 2024|Anticipated|2024-12-01|February 2020|Anticipated|2020-02-01||Interventional|LRHCTC-1||A Study of Laparoscopic Right Hemicolectomy Using the Caudal-to-cranial Approach|A Prospective Randomized Controlled Clinical Study of Laparoscopic Right Hemicolectomy Using the Caudal-to-cranial Approach|Recruiting||N/A|150|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-10 21:39:08.617909|2017-10-10 21:39:08.617909
NCT02949427|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-06-28|||March 6, 2017|Actual|2017-03-06|June 2017|2017-06-01|November 30, 2021|Anticipated|2021-11-30|November 30, 2021|Anticipated|2021-11-30||Observational|||The Oronasal Microbiota in Pediatric Oncology Patients|The Oronasal Microbiota in Pediatric Oncology Patients|Recruiting||N/A|60|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-10 21:39:08.711769|2017-10-10 21:39:08.711769
NCT02949414|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-07-11|||September 2016||2016-09-01|July 2017|2017-07-01|June 2024|Anticipated|2024-06-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells|A Phase I Open-label Study to Assess the Safety, Tolerability and Potential Efficacy of a Novel Tracheal Replacement Consisting of a Tissue-engineered Decellularised Tracheal Scaffold With Seeded Autologous Mesenchymal Cells in Subjects With Severe Tracheal Stenosis or Malacia|Active, not recruiting||Phase 1|4|Anticipated|Cell Therapy Catapult||1|||f||||t||||||||||2017-10-10 21:39:08.804655|2017-10-10 21:39:08.804655
NCT02948647|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-01|||November 2016||2016-11-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Interventional|HEROES||Healthy Eating Through Reduction Of Excess Sugar|Diets Based on PNPLA3 Genotype for Reducing Liver Fat in Hispanics With Pediatric Non-alcoholic Fatty Liver Disease|Recruiting||N/A|120|Anticipated|University of Southern California||2|||f||||t|f|f||||||No||2017-10-10 21:39:17.517698|2017-10-10 21:39:17.517698
NCT02949388|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-08-30|||October 2016||2016-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis|A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis|Active, not recruiting||Phase 2|189|Anticipated|Cellceutix Corporation||3|||f||||f||||||||||2017-10-10 21:39:08.969288|2017-10-10 21:39:08.969288
NCT02949375|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||September 2015||2015-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|GRI-201||Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease|A Double-blind, Randomized, Placebo-Controlled Phase 2a Trial of GRI-0621 in Patients With Chronic Liver Disease|Recruiting||Phase 2|60|Anticipated|GRI Bio, Inc.||3|||f||||t||||||||No||2017-10-10 21:39:09.134128|2017-10-10 21:39:09.134128
NCT02949362|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-08-01|||November 1, 2016||2016-11-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study|A Retrospective and Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed TED-C13-003|Recruiting||Phase 3|40|Anticipated|Shire||1|||f||||t||||||||||2017-10-10 21:39:09.235983|2017-10-10 21:39:09.235983
NCT02949349|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-03-01|||July 2015||2015-07-01|March 2017|2017-03-01|January 25, 2017|Actual|2017-01-25|December 30, 2016|Actual|2016-12-30||Interventional|||Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis|Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis|Completed||Phase 2|32|Actual|Genovate Biotechnology Co., Ltd.,||3|||f||||f||||||||No||2017-10-10 21:39:09.410115|2017-10-10 21:39:09.410115
NCT02949336|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|UKA||Kinematics Analysis of SIGMA® Partial Knee System|Kinematics Analysis: Traditional (ACL Retaining) and ACL Deficient (Reduced Tibial Slope) Medial, Fixed Bearing Primary Unicondylar Knee Arthroplasty With the SIGMA® High Performance Partial Knee System|Recruiting||N/A|20|Anticipated|Institute for Biomechanics, ETH Zürich|||2||f||||f||||||||Undecided||2017-10-10 21:39:09.500156|2017-10-10 21:39:09.500156
NCT02949323|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-28|||November 2016||2016-11-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Etiological Diagnosis of Urinary Stone in Chinese Children|Etiological Diagnosis of Urinary Stone in Chinese Children|Not yet recruiting||N/A|200|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||2||f||||f||||||||No|no plan|2017-10-10 21:39:09.57519|2017-10-10 21:39:09.57519
NCT02949310|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-28|||September 2016||2016-09-01|October 2016|2016-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Effectiveness of Nefopam in Breast Cancer Surgery||Recruiting||N/A|88|Anticipated|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-10 21:39:09.667257|2017-10-10 21:39:09.667257
NCT02949297|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-07-18|||March 30, 2017|Actual|2017-03-30|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|ELEVATE||Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study|Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study|Recruiting||N/A|75|Anticipated|Endologix||1|||f||||t|f|t|f|f||||||2017-10-10 21:39:09.73257|2017-10-10 21:39:09.73257
NCT02949284|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-06-21|||June 20, 2017|Actual|2017-06-20|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery|Randomized Three-Arm Trial to Evaluate the Effect of Neoadjuvant Apalutamide Alone or in Combination With Abiraterone Acetate and GnRH Agonist on Enhancing Surgical Outcome of Nerve-Sparing Radical Prostatectomy in Men With High-Risk Prostate Cancer|Recruiting||Phase 2|90|Anticipated|Rutgers, The State University of New Jersey||3|||f||||t|t|f||||||||2017-10-10 21:39:09.845304|2017-10-10 21:39:09.845304
NCT02949271|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-06|||November 8, 2016|Actual|2016-11-08|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of PIEB vs CEI for Labor Analgesia|Comparison of Programmed Intermittent Epidural Boluses With Continuous Epidural Infusion for Maintenance of Labor Analgesia|Recruiting||Phase 4|120|Anticipated|Duke University||2|||f||||f||||||||Undecided||2017-10-10 21:39:09.994297|2017-10-10 21:39:09.994297
NCT02949258|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-27|||January 2017||2017-01-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|NCT-B4||Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer|A Phase II Study of Neoadjuvant Chemotherapy With SEEOX Regimen Via Intra-arterial and Intravenous Administration Followed by Surgery for Borrmann Type 4 Gastric Cancer|Not yet recruiting||Phase 2|40|Anticipated|Jinling Hospital, China||1|||f||||f||||||||||2017-10-10 21:39:10.204492|2017-10-10 21:39:10.204492
NCT02949245|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-02-03|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Observational|||Neurologic Complications in Spinal Deformity Surgery - Extension|Evaluation of Neurologic Complications Associated With Surgical Correction of Adult Spinal Deformity (Scoli-RISK-1): A Prospective, Observational, Multi-center Study 5 Year Follow-up Extension|Not yet recruiting||N/A|272|Anticipated|AOSpine International|||1||f||||t||||||||Undecided||2017-10-10 21:39:10.324996|2017-10-10 21:39:10.324996
NCT02949232|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-31|||July 2014||2014-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Prednisolone Addition for Patients With Recent-onset Psychotic Disorder|Prednisolone Addition for Patients With Recent-onset Psychotic Disorder: the Role of Immune-modulating Strategies in the Treatment of Psychosis|Recruiting||Phase 4|90|Anticipated|UMC Utrecht||2|||f||||t||||||||No||2017-10-10 21:39:10.476934|2017-10-10 21:39:10.476934
NCT02949219|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-07-10|||March 24, 2017|Actual|2017-03-24|July 2017|2017-07-01|March 24, 2022|Anticipated|2022-03-24|November 1, 2018|Anticipated|2018-11-01||Interventional|||Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery|A Multicenter Phase II Study of Pembrolizumab (MK-3475) in Patients With Advanced Small Bowel Adenocarcinomas|Recruiting||Phase 2|40|Anticipated|Academic and Community Cancer Research United||1|||f||||t|t|f||||||||2017-10-10 21:39:10.601841|2017-10-10 21:39:10.601841
NCT02949206|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-22|||November 14, 2016|Actual|2016-11-14|September 2017|2017-09-01|August 9, 2017|Actual|2017-08-09|August 9, 2017|Actual|2017-08-09||Interventional|||A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male Subjects|A 3-Part First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male Subjects|Completed||Phase 1|80|Actual|Janssen Research & Development, LLC||10|||f||||f|f|f||||||||2017-10-10 21:39:10.78474|2017-10-10 21:39:10.78474
NCT02949193|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2016-10-27|||May 2013||2013-05-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes|A Phase III Clinical Trial to Investigate the Efficacy and Safety of Evogliptin When Added to Ongoing Metformin Monotherapy in Patients With Type 2 Diabetes|Completed||Phase 3|222|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:39:10.929434|2017-10-10 21:39:10.929434
NCT02949180|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-19|||October 2016||2016-10-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|DETECTAF-pro||Enhanced Diagnostics for Early Detection of Atrial Fibrillation - Prospective Validation|Enhanced Diagnostics for Early Detection of Atrial Fibrillation - Prospective Validation|Recruiting||N/A|660|Anticipated|University Hospital, Basel, Switzerland|||2||f||||t||||||||||2017-10-10 21:39:11.035843|2017-10-10 21:39:11.035843
NCT02949167|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-10-03|||November 2016||2016-11-01|November 2016|2016-11-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|MyHealth||MyHealth: Follow-up After Breast Cancer Treatment|MyHealth: Nurse-led Compared to Physician-led Breast Cancer Follow-up: A Randomized Controlled Trial|Recruiting||N/A|494|Anticipated|Danish Cancer Society||2|||f||||f||||||||||2017-10-10 21:39:11.133683|2017-10-10 21:39:11.133683
NCT02949154|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-05-04|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients|Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients|Completed||N/A|65|Actual|University Medical Center Groningen|||1||f||||f||||||||No||2017-10-10 21:39:11.236006|2017-10-10 21:39:11.236006
NCT02949141|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-19|2017-05-18||November 2016||2016-11-01|August 2017|2017-08-01|May 1, 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Diagnostic Use of Lung Ultrasound for Suspected Pneumonia in Nepal|Diagnostic Use of Lung Ultrasound Compared to Chest X-Ray for Suspected Pneumonia in Nepal|Completed||N/A|62|Actual|Patan Academy of Health Sciences||1|||f||||f||||||||||2017-10-10 21:39:11.311375|2017-10-10 21:39:11.311375
NCT02949128|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-21|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)||Recruiting||Phase 3|55|Anticipated|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-10-10 21:39:11.543415|2017-10-10 21:39:11.543415
NCT02949115|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-01-06|||November 2016||2016-11-01|January 2017|2017-01-01||||July 2018|Anticipated|2018-07-01||Interventional|||Effects of Red Beetroot Juice on High-Fat Meal-Induced Endothelial Dysfunction and Cardiometabolic Disturbances|Acute and Chronic Effects of Red Beetroot Juice on High-Fat Meal-Induced Endothelial Dysfunction and Cardiometabolic Disturbances|Recruiting||Phase 2|15|Anticipated|Colorado State University||4|||f||||f||||||||No||2017-10-10 21:39:11.689418|2017-10-10 21:39:11.689418
NCT02949102|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||December 2015||2015-12-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Crave Crush Neuroimaging Study|Effects of Gymnemic Acids Lozenge on Reward Region Response to Receipt and Anticipated Receipt of High-Sugar Food, High-Sugar Food Pictures, and Ad Lib Candy Intake|Completed||N/A|40|Actual|Oregon Research Institute||2|||f||||f||||||||No||2017-10-10 21:39:11.795153|2017-10-10 21:39:11.795153
NCT02949089|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2016-10-27|||January 2013||2013-01-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects|An Open Label, Dose Escalation Study of ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects|Completed||Phase 1|60|Actual|Ache Laboratorios Farmaceuticos S.A.||1|||f||||f||||||||||2017-10-10 21:39:11.858264|2017-10-10 21:39:11.858264
NCT02949076|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-26|||July 2016||2016-07-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Skeletal Muscle Atrophy and Dysfunction in Human Cancer|Skeletal Muscle Atrophy and Dysfunction in Human Cancer|Recruiting||N/A|20|Anticipated|University of Vermont||1|||f||||t||||||||Yes|Research data (deidentified) which documents, supports and validates research findings will be stored on the University of Vermont College of Medicine computer system and will be made available upon final acceptance for publication of the major findings from the proposed studies. This includes raw data generated from all clinical and laboratory-based assessments under a data-sharing agreement.|2017-10-10 21:39:11.950154|2017-10-10 21:39:11.950154
NCT02949063|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-28|||March 2013||2013-03-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|CCProgram||Creating a Comfortable Cafeteria: Staff and Student Feedback - Outcome Study (Cafeteria Prog)|The Comfortable Cafeteria Program for Promoting Student Participation and Enjoyment: An Outcome Study|Completed||N/A|366|Actual|Cleveland State University|||1||f||||f||||||||No||2017-10-10 21:39:12.038303|2017-10-10 21:39:12.038303
NCT02949050|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-10-26|||August 2016||2016-08-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Corn Occupational Rhinitis SCIT Efficacy Study|Corn Based Occupational Rhinitis; SCIT Efficacy Study|Enrolling by invitation||N/A|40|Anticipated|United Allergy Services||2|||f||||t||||||||No||2017-10-10 21:39:12.100641|2017-10-10 21:39:12.100641
NCT02949037|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-04-20|||September 2016||2016-09-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Enhancing mHealth Technology to Activate Chronic Care Patients|Enhancing mHealth Technology in the PCMH Environment to Activate Chronic Care Patients|Recruiting||N/A|240|Anticipated|Clemson University||2|||f||||f||||||||Undecided||2017-10-10 21:39:12.18496|2017-10-10 21:39:12.18496
NCT02949024|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-07-27|||November 2016||2016-11-01|November 2016|2016-11-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|HULK||Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema|Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema|Completed||Phase 1/Phase 2|20|Actual|Clearside Biomedical, Inc.||2|||f||||f||||||||||2017-10-10 21:39:12.273168|2017-10-10 21:39:12.273168
NCT02949011|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-02-23|||December 2016||2016-12-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|July 2018|Anticipated|2018-07-01||Interventional|CAPSTONE 2||Study of S-033188 Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications|A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Patients With Influenza at High Risk of Influenza Complications|Recruiting||Phase 3|2157|Anticipated|Shionogi Inc.||3|||f||||t||||||||||2017-10-10 21:39:12.410313|2017-10-10 21:39:12.410313
NCT02948998|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-11-07|||November 2016||2016-11-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy|Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy-- a Multicenter Randomized Control Trial|Not yet recruiting||Phase 4|260|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||No||2017-10-10 21:39:14.739728|2017-10-10 21:39:14.739728
NCT02948985|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01|3 Years|Observational [Patient Registry]|||Evaluation of CTCs Combined With Tumor Marker Detection of Efficacy of Chemotherapy in mCRC|Evaluation of Individual Peripheral Blood Circulating Tumor Cells Combined With Tumor Marker Detection of Efficacy of Chemotherapy in Patients With Advanced Colorectal Cancer: A Observational Clinical Trial|Not yet recruiting||N/A|100|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||||||||Samples With DNA|"     Peripheral blood samples of 10 mL were collected from the patients for ctDNA and CTCs     analysis   "|||2017-10-10 21:39:14.855206|2017-10-10 21:39:14.855206
NCT02948972|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-05-18|||November 17, 2016|Actual|2016-11-17|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|ENDOFERT||Impact of Complete Surgery of Colorectal Deep Infiltrating Endometriosis on Fertility|Impact of Complete Surgery of Colorectal Deep Infiltrating Endometriosis on Fertility: Complete Surgery + IVF Versus IVF (ENDOFERT)|Recruiting||N/A|120|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:39:14.929097|2017-10-10 21:39:14.929097
NCT02948946|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-07-05|||January 9, 2017|Actual|2017-01-09|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|||Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors|The Clinical Utility of a Blood-Based Multitranscriptome Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors|Recruiting||N/A|200|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||2||f||||f|f|f||||||||2017-10-10 21:39:15.318056|2017-10-10 21:39:15.318056
NCT02948933|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-06-28|||December 14, 2016|Actual|2016-12-14|June 2017|2017-06-01|July 27, 2021|Anticipated|2021-07-27|July 27, 2021|Anticipated|2021-07-27||Observational|||Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine|Post-Authorization Safety Study: Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine|Active, not recruiting||N/A|30000|Actual|Sanofi|||1||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-10 21:39:15.423724|2017-10-10 21:39:15.423724
NCT02948920|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-28|||September 2016||2016-09-01|August 2017|2017-08-01|August 12, 2017|Actual|2017-08-12|August 12, 2017|Actual|2017-08-12||Interventional|||Effects of Intravenous Ephedrine in Preventing Intraoperative Hypothermia in Patients Undergoing Spinal Anesthesia for Arthroscopic Knee Surgery|Effects of Intravenous Ephedrine in Preventing Intraoperative Hypothermia in Patients Undergoing Spinal Anesthesia for Arthroscopic Knee Surgery|Completed||N/A|40|Actual|Ramathibodi Hospital||2|||f||||f||||||||||2017-10-10 21:39:15.530519|2017-10-10 21:39:15.530519
NCT02948907|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-10-28|||September 2015||2015-09-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||"Elastography and Tissue Harmonic Imaging for Characterisation of Hilar and Mediastinal Lymph Nodes"|"Endobronchial Ultrasound Elastography and Tissue Harmonic Imaging for Characterisation of Hilar and Mediastinal Lymph Nodes"|Recruiting||N/A|100|Anticipated|Heidelberg University||1|||f||||||||||||||2017-10-10 21:39:15.619602|2017-10-10 21:39:15.619602
NCT02948894|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-12|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|May 2020|Anticipated|2020-05-01||Interventional|MOSAIC||Mandibular Advancement Device for Treatment of Obstructive Sleep Apnea and Its Impact on Cardiac Remodeling|Mandibular Advancement Device for Treatment of Obstructive Sleep Apnea and Its Impact on Cardiac Remodeling|Not yet recruiting||Phase 2|100|Anticipated|National University, Singapore||2|||f||||t|f|f||||||||2017-10-10 21:39:15.704129|2017-10-10 21:39:15.704129
NCT02948881|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-27|||August 2005||2005-08-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo|A One Year, Parallel, Placebo-controlled, Double-blind, Randomized Study to Assess the Effect of Monthly 150mg Oral Ibandronate Dosing Versus Placebo on Bone Quality and Strength at the Proximal Femur in Women With Osteoporosis|Completed||Phase 4|100|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 21:39:15.786256|2017-10-10 21:39:15.786256
NCT02948868|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-11-03|||January 2016||2016-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CM||Combating Craving With Contingency Management: Neuroplasticity and Methamphetamine Abuse in South Africa|Combating Craving With Contingency Management: Neuroplasticity and Methamphetamine Abuse in South Africa|Recruiting||N/A|30|Anticipated|University of Cape Town||1|||f||||f||||||||No||2017-10-10 21:39:15.886732|2017-10-10 21:39:15.886732
NCT02948855|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Observational|||Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases|Study on Regulation of LncRNA to Regulatory B Cells(Bregs) Through Notch Pathway in Patients With Thymoma and Autoimmune Diseases|Recruiting||N/A|100|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||3||f||||t||||||Samples With DNA|"     The patients of Thymoma complicated with autoimmune diseases:      Thymoma tissues Lymph glands Peripheral blood Thymoma tissues and Lymph glands will be     retained formalin and -80℃ refrigerator.      Peripheral blood will be detected by flow cytometry.   "|Yes||2017-10-10 21:39:15.980426|2017-10-10 21:39:15.980426
NCT02948842|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-28|||December 2016||2016-12-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Clostridium Histolyticum Collagenase Injection for Urethral Disease|Clostridium Histolyticum Collagenase Injection Treatment for Urethral Disease: a Prospective, Single-center, Open-label Study|Not yet recruiting||Phase 2|20|Anticipated|University of South Florida||1|||f||||t||||||||No||2017-10-10 21:39:16.076391|2017-10-10 21:39:16.076391
NCT02948829|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-05-17|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|August 12, 2020|Anticipated|2020-08-12|July 1, 2017|Anticipated|2017-07-01||Interventional|||Safety and Immunogenicity of Takeda's TDV in Healthy Children|An Open Label, Phase 2 Study to Investigate Cell-mediated Immunity and Safety of a Tetravalent Dengue Vaccine Candidate (TDV) Administered Subcutaneously in Healthy Children Aged 4 to 16 Years|Recruiting||Phase 2|200|Anticipated|Takeda||1|||f||||t|f|f||||||||2017-10-10 21:39:16.154685|2017-10-10 21:39:16.154685
NCT02948816|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effects of Social Media on Food Intake and Behaviour|The Effects of Social Media on Food Intake and Behaviour|Recruiting||N/A|25|Anticipated|University of Prince Edward Island||3|||f||||f||||||||No||2017-10-10 21:39:16.249068|2017-10-10 21:39:16.249068
NCT02948803|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-08-16|||September 12, 2016|Actual|2016-09-12|August 2017|2017-08-01|February 17, 2017|Actual|2017-02-17|February 17, 2017|Actual|2017-02-17||Interventional|||A Smartphone-based Intervention to Promote an Active Lifestyle in Low Educated Working Young Adults|A Smartphone-based Intervention to Promote an Active Lifestyle in Low Educated Working Young Adults|Completed||N/A|130|Actual|University Ghent||2|||f||||||||||||||2017-10-10 21:39:16.32111|2017-10-10 21:39:16.32111
NCT02948790|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-02-24|||March 2017||2017-03-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|NeuriStim||Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma|Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma : Feasibility Study|Not yet recruiting||N/A|34|Anticipated|Oticon Medical||2|||f||||f|f|f||||||No||2017-10-10 21:39:16.399607|2017-10-10 21:39:16.399607
NCT02948777|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Effects of PCSK9 Inhibition by Evolocumab on Postprandial Lipid Metabolism in Type 2 Diabetes|Effects of PCSK9 Inhibition by Evolocumab on Postprandial Lipid Metabolism in Type 2 Diabetes|Recruiting||Phase 4|12|Anticipated|Clinical Research Institute HUCH Ltd||1|||f||||||||||||||2017-10-10 21:39:16.479395|2017-10-10 21:39:16.479395
NCT02948764|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2017-03-30|||January 2017||2017-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|RESPONDER||Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer|RESPONDER Trial - Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer|Recruiting||N/A|600|Anticipated|Heidelberg University||1|||f||||t||||||||Yes||2017-10-10 21:39:16.567115|2017-10-10 21:39:16.567115
NCT02948751|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-28|||October 2016||2016-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:39:16.652041|2017-10-10 21:39:16.652041
NCT02948738|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-11|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|June 2017|Actual|2017-06-01||Interventional|AIREd||Asthma Inpatient Research on Education|Asthma Inpatient Research on Education: A Randomized Clinical Trial|Active, not recruiting||N/A|140|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-10 21:39:16.732886|2017-10-10 21:39:16.732886
NCT02948725|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-06-15|||November 2016||2016-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|X-Ed-Stroke01||Clinical Application of Cross-education During Stroke Rehabilitation|Clinical Application of Cross-education During Stroke Rehabilitation|Enrolling by invitation||N/A|24|Anticipated|University of Saskatchewan||2|||f||||f||||||||Undecided|Co-Investigators will have access to the data. Plans beyond that|2017-10-10 21:39:16.892575|2017-10-10 21:39:16.892575
NCT02948712|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-08-23|||February 7, 2017|Actual|2017-02-07|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|AYAST||Adolescent and Young Adult Survivor Transition|Adolescent and Young Adult Survivor Transition (AYAST)|Recruiting||N/A|50|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-10 21:39:17.003392|2017-10-10 21:39:17.003392
NCT02948699|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-12|||November 2016||2016-11-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients|A Prospective, Randomized Controlled Open Research About the Impact of Nutritional Support on the Radiation Tolerance and Clinical Outcomes for Local Advanced Nasopharyngeal Carcinoma Patients|Recruiting||Phase 4|100|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||No||2017-10-10 21:39:17.122725|2017-10-10 21:39:17.122725
NCT02948686|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-08-04|||August 2016||2016-08-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|April 2017|Actual|2017-04-01||Interventional|AUC||Different Application Strategies When Using Ambar Universal in Class V Cavities|Clinical Evaluation of Different Application Strategies When Using a Universal Adhesive System in Class V Cavities|Active, not recruiting||N/A|38|Actual|Universidade Federal Fluminense||4|||f||||f||||||||||2017-10-10 21:39:17.228392|2017-10-10 21:39:17.228392
NCT02948673|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-26|||May 2016||2016-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DIMITOS||The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise|The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise in Patients With Type 2 Diabetes|Recruiting||N/A|40|Anticipated|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 21:39:17.325188|2017-10-10 21:39:17.325188
NCT02948634|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-03-08|||October 2016||2016-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Low-level Laser Therapy in Patients With Chronic Fibromyalgia|A Prospective, Randomized, Double-blind, Sham-controlled Study of the Low-level Phoenix Thera-lase 42 Watt Laser in Patients With Chronic Fibromyalgia|Recruiting||N/A|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 21:39:17.606994|2017-10-10 21:39:17.606994
NCT02948621|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|Endosleeve||Endoscopic Sleeve Gastroplasty|Endoscopic Sleeve Gastroplasty|Recruiting||N/A|20|Anticipated|IHU Strasbourg|||1||f||||f||||||||No||2017-10-10 21:39:17.704083|2017-10-10 21:39:17.704083
NCT02948608|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-04-06|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Clinical Characteristics of Importance to Outcome in Patients With Spondyloarthritis|Effectiveness and Patient-reported Outcomes in Patients With Spondyloarthropathies Treated With Biological Agents|Recruiting||N/A|60|Anticipated|Svendborg Hospital|||1||f||||t||||||Samples With DNA|"     A Biobank will be established in connection with the routine blood samples taken at baseline     (~ 90 ml). The blood samples will be handled and registered by research laboratory     technicians at the laboratory department, and stored at Odense University Hospital, Denmark     (in the cold store)   "|No||2017-10-10 21:39:17.801218|2017-10-10 21:39:17.801218
NCT02948595|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-10-26|||November 2016||2016-11-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Video Feedback Versus Verbal Feedback|Video Feedback Versus Verbal Feedback in Simulated Laparoscopic Vaginal Cuff Closure|Not yet recruiting||N/A|24|Anticipated|University of New Mexico||2|||f||||f||||||||No||2017-10-10 21:39:17.908913|2017-10-10 21:39:17.908913
NCT02948582|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||July 2010||2010-07-01|October 2016|2016-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Randomized, Placebo-Controlled, Double-Blind, Dose Ranging, Single-Dose, 6-Way Crossover Study to Assess Safety, Efficacy and Pharmacokinetics of EP-101 Using eFlow Nebuliser in Patients With COPD|Completed||Phase 2|42|Actual|Sunovion Respiratory Development Inc.||6|||f||||f||||||||||2017-10-10 21:39:17.976673|2017-10-10 21:39:17.976673
NCT02948569|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-05-09|||February 1, 2017|Actual|2017-02-01|October 2016|2016-10-01|January 31, 2018|Anticipated|2018-01-31|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome|Evaluation of 3-V Bioscience-2640, a FASN Inhibitor, to Reduce de Novo Lipogenesis in Subjects With Characteristics of the Metabolic Syndrome|Recruiting||Phase 1/Phase 2|12|Anticipated|University of Missouri-Columbia||1|||f||||t|t|f||||||No||2017-10-10 21:39:18.090109|2017-10-10 21:39:18.090109
NCT02948556|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-01|||June 2016||2016-06-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Observational|||ME/CFS: Activity Patterns and Autonomic Dysfunction|ME/CFS: Activity Patterns and Autonomic Dysfunction|Recruiting||N/A|150|Anticipated|Stony Brook University|||1||f||||f||||||||Yes||2017-10-10 21:39:18.190111|2017-10-10 21:39:18.190111
NCT02948543|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-10-26|||July 2013||2013-07-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|BCG+MMC||Adding Mitomycin C to Bacillus of Calmette-Guerin (BCG) as Adjuvant Intravesical Therapy for High-risk, Non-Muscle-invasive Bladder Cancer|Adding Mitomycin C to Bacillus of Calmette-Guerin (BCG) as Adjuvant Intravesical Therapy for High-risk, Non-Muscle-invasive Bladder Cancer: a Randomised Phase 3 Trial|Recruiting||Phase 3|500|Anticipated|University of Sydney||2|||f||||t||||||||||2017-10-10 21:39:18.269743|2017-10-10 21:39:18.269743
NCT02948530|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|||Measurement of Lung Elastance and Transpulmonary Pressure Using Two Different Methods (Lungbarometry)|Measurement of Lung Elastance and Transpulmonary Pressure Using Two Different Methods (Lungbarometry)|Recruiting||N/A|30|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||Undecided||2017-10-10 21:39:18.429655|2017-10-10 21:39:18.429655
NCT02948517|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-11-04|||September 2016||2016-09-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Time Restricted Feeding for Weight Loss and Cardio-protection|Time Restricted Feeding for Weight Loss and Cardio-protection|Active, not recruiting||N/A|31|Actual|University of Illinois at Chicago||2|||f||||f||||||||No||2017-10-10 21:39:18.503336|2017-10-10 21:39:18.503336
NCT02948504|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-14|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Chinese Small Intracranial Aneurysm Study (CSIAS)|Treatment of Small Unruptured Intracranial Aneurysms Based on Clinical Characteristics, Morphology and Hemodynamic Features|Not yet recruiting||N/A|500|Anticipated|RenJi Hospital|||2||f||||f||||||||No||2017-10-10 21:39:18.572447|2017-10-10 21:39:18.572447
NCT02948491|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-26|||June 2017||2017-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|EMT-DRNP||Effectiveness of Music Therapy on the Development of Preterm Neonates|Effectiveness of Music Therapy on the Intra-hospital Evolution and Neurodevelopment of Preterm Neonates Treated in Neonatal Intensive Care Units in the Bucaramanga Metropolitan Area|Not yet recruiting||N/A|90|Anticipated|Universidad Manuela Beltrán||2|||f||||t||||||||Undecided||2017-10-10 21:39:18.652845|2017-10-10 21:39:18.652845
NCT02948478|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-01-13|||December 2016||2016-12-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|DESSEIN||Economic and Social Disparities and Breast Cancer|Breast Cancer and Precariousness: Influence of Socio-demographic Inequalities in Cancer Stage at Diagnosis, Treatment Management and Rehabilitation in the Ile de France Area|Recruiting||N/A|1040|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||Undecided||2017-10-10 21:39:18.744102|2017-10-10 21:39:18.744102
NCT02948465|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-11-03|||July 2016||2016-07-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Observational|THINK||Impact of Neutrophil Extracellular Traps (NET) on Thrombolysis in Acute Phase of Cerebral Ischemia|Impact of Neutrophil Extracellular Traps (NET) on Thrombolysis in Acute Phase of Cerebral Ischemia|Recruiting||N/A|120|Anticipated|Hopital Foch|||1||f||||f||||||||No||2017-10-10 21:39:18.864431|2017-10-10 21:39:18.864431
NCT02948452|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-26|||November 2015||2015-11-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Observational|||Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa|Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa|Recruiting||N/A|96|Anticipated|University of California, Los Angeles|||2||f||||t||||||||Yes|"Investigators will share deidentified subject-level data loaded to the new database for the National Institute of Mental Health Research Domain Criteria project (RDoC-db).
The work involves defining data dictionaries for each data structure, cleaning and formatting data, and uploading the data to the appropriate National Institute of Mental Health server. The data so shared will contribute to the building of a large information commons for RDoC that will permit analyses of large data sets that have more power to uncover new relationships among highly multivariate and dimensional data sets."|2017-10-10 21:39:18.928232|2017-10-10 21:39:18.928232
NCT02948439|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-10-27|||July 2016||2016-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|PEACH||Prenatal Exercise and Cardiovascular Health (PEACH)|Exercise and Neurovascular Function During Pregnancy|Recruiting||N/A|100|Anticipated|University of Alberta, Physical Education||2|||f||||f||||||||No||2017-10-10 21:39:19.008117|2017-10-10 21:39:19.008117
NCT02948426|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-09-12|||October 20, 2016||2016-10-20|September 5, 2017|2017-09-05|July 1, 2019|Anticipated|2019-07-01|July 31, 2018|Anticipated|2018-07-31||Interventional|||Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer|Phase 1 Study of Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer|Recruiting||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:39:19.10313|2017-10-10 21:39:19.10313
NCT02948413|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-27|2017-10-03|||October 18, 2016||2016-10-18|September 27, 2017|2017-09-27|August 19, 2019|Anticipated|2019-08-19|August 19, 2019|Anticipated|2019-08-19||Observational|||Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials|Exploring the Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials|Suspended||N/A|35|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:39:19.284021|2017-10-10 21:39:19.284021
NCT02948400|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-01-04|||December 2016||2016-12-01|January 2017|2017-01-01|April 2021|Anticipated|2021-04-01|November 2020|Anticipated|2020-11-01||Interventional|||Virtual Reality by Mobile Phone: Improving Child Pedestrian Safety|Virtual Reality by Mobile Phone: Improving Child Pedestrian Safety|Recruiting||Phase 3|498|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||Undecided|will share with qualified investigators upon their individual request|2017-10-10 21:39:19.364449|2017-10-10 21:39:19.364449
NCT02948387|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-26|||November 2016||2016-11-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Observational|||Preventing Infections in Orthopaedic Patients|Antibiotic Prophylaxis for Type II and III Open Fractures: a Retrospective Chart Review|Not yet recruiting||N/A|50|Anticipated|Triple O Research Institute PA|||1||f||||f||||||||Yes||2017-10-10 21:39:19.45585|2017-10-10 21:39:19.45585
NCT02948374|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|BIO-ICU||Biomarkers in Cerebrospinal Fluid in Critical Care Patients With Delirium|Biomarkers in Cerebrospinal Fluid in Critical Care Patients With Delirium|Recruiting||N/A|80|Anticipated|Sahlgrenska University Hospital, Sweden|||2||f||||f||||||Samples Without DNA|"     Cerebrospinal fluid Blood   "|No||2017-10-10 21:39:19.554494|2017-10-10 21:39:19.554494
NCT02948361|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-22|||August 2016||2016-08-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PROGRESS||Clinical PRoduct DevelOpment StudyinG the QT Ultrasound® BReast ScannEr With Volunteer SubjectS|Clinical PRoduct DevelOpment StudyinG the QT Ultrasound® BReast ScannEr With Volunteer SubjectS|Enrolling by invitation||N/A|1500|Anticipated|QT Ultrasound LLC||1|||f||||f||||||||No||2017-10-10 21:39:19.657199|2017-10-10 21:39:19.657199
NCT02948348|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-02-15|||October 2016||2016-10-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Nivolumab Following Preoperative Chemoradiotherapy|A Phase 1b/2 Multicenter Study to Investigate the Safety, Efficacy and Proof of Concept (POC) of Nivolumab Monotherapy as a Sequential Therapy Following Preoperative Chemoradiotherapy Patients With Locally Advanced Resectable Rectal Cancer|Recruiting||Phase 1/Phase 2|50|Anticipated|National Cancer Center Hospital East||1|||f||||t||||||||Undecided||2017-10-10 21:39:19.729725|2017-10-10 21:39:19.729725
NCT02948335|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-03-31|||October 23, 2016|Actual|2016-10-23|October 2016|2016-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Interactions of Environmental and Human Microbial Communities in a Pediatric Oncology Hospital|Interactions of Environmental and Human Microbial Communities in a Pediatric Oncology Hospital|Recruiting||N/A|40|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-10 21:39:19.826535|2017-10-10 21:39:19.826535
NCT02948322|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-10-26|||December 2014||2014-12-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|ACROCOEUR||Cardiac (CMRI) Assessment of Acromegaly|Cardiac Structure and Function in Acromegalic Patients: A Cardiac Magnetic Resonance Imaging Study|Recruiting||N/A|40|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:39:19.912398|2017-10-10 21:39:19.912398
NCT02948309|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-28|||June 2016||2016-06-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|MISTRAL||Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer|Mistletoe Therapy in Primary & Recurrent Inoperable Pancreatic Cancer. A Phase III Prospective Randomized Double Blinded Multicenter Parallel Group Placebo Controlled Clinical Trial on Overall Survival and Quality of Life|Recruiting||Phase 3|290|Anticipated|Karolinska University Hospital||2|||f||||f||||||||Yes|The trial results will be submitted for publication in relevant medical journals|2017-10-10 21:39:20.021407|2017-10-10 21:39:20.021407
NCT02948296|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-26|||January 2016||2016-01-01|October 2016|2016-10-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|ARC4||Charleston ARC Clinical Project 4- Cortical rTMS as a Tool to Change Craving and Brain Reactivity to Alcohol Cues|Charleston ARC Clinical Project 4- Cortical rTMS as a Tool to Change Craving and Brain Reactivity to Alcohol Cues|Recruiting||N/A|66|Anticipated|Medical University of South Carolina||3|||f||||t||||||||Yes|Neuroimaging data will be uploaded to the NIH neuroimaging biorepository|2017-10-10 21:39:20.134752|2017-10-10 21:39:20.134752
NCT02948283|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-09-13|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia|A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia|Recruiting||Phase 1|24|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:39:20.226083|2017-10-10 21:39:20.226083
NCT02948270|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-10-26|||September 2012||2012-09-01|October 2016|2016-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Communication in Adolescents With ADHD|Communication in Adolescents With ADHD|Completed||N/A|9|Actual|The Hospital for Sick Children|||2||f||||f||||||||No||2017-10-10 21:39:20.374992|2017-10-10 21:39:20.374992
NCT02948257|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-08-30|||January 19, 2017|Actual|2017-01-19|August 2017|2017-08-01|October 10, 2017|Anticipated|2017-10-10|September 28, 2017|Anticipated|2017-09-28|30 Days|Observational [Patient Registry]|ANTEGRADE-PVD||VASCADE ANTEGRADE-PVD Post-Market Registry|A Multi-center, Prospective, Post-market Registry to Evaluate Procedural Outcomes Data Using the Cardiva VASCADE Vascular Closure System (VCS) for the Management of the Femoral Arteriotomy After Percutaneous Endovascular Procedures Via Antegrade Access.|Active, not recruiting||N/A|53|Actual|Cardiva Medical, Inc.|||1||f||||t||||||||||2017-10-10 21:39:20.454027|2017-10-10 21:39:20.454027
NCT02948244|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-08-31|||September 2017|Anticipated|2017-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD|Effect of Creatine Monohydrate on Functional Muscle Strength and Muscle Mass in Children With FSHD: a Multi-centre, Randomised, Double-blind Placebo-controlled Crossover Trial|Not yet recruiting||Phase 2|20|Anticipated|Murdoch Childrens Research Institute||2|||f||||f|f|f|||f|||||2017-10-10 21:39:20.558282|2017-10-10 21:39:20.558282
NCT02948231|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-10-26|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MERIT||MERIT Study - Mistral Percutaneous Mitral Valve Repair FIM Study|MERIT Study - Mistral Percutaneous Mitral Valve Repair FIM Study|Recruiting||Phase 1|10|Anticipated|Mitralix||1|||f||||f||||||||||2017-10-10 21:39:20.719403|2017-10-10 21:39:20.719403
NCT02948218|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-26|||January 2017||2017-01-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Multi-center Clinical Research of Acupuncture Treatment of Knee Osteoarthritis|Multi-center Clinical Research of Acupuncture Treatment of Knee Osteoarthritis|Not yet recruiting||Phase 3|400|Anticipated|Shanghai University of Traditional Chinese Medicine||4|||f||||t||||||||Yes|individual participant data (IPD) available|2017-10-10 21:39:20.896129|2017-10-10 21:39:20.896129
NCT02948205|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-26|||December 2016||2016-12-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Analysis of TU-LESS by 3D Laparoscopy in the Treatment of Infertility|Analysis of Trans-umbilical Laparoendoscopic Single-site Surgery by 3D Laparoscopy in the Treatment of Infertility|Not yet recruiting||N/A|500|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||f||||||||No||2017-10-10 21:39:21.054843|2017-10-10 21:39:21.054843
NCT02948192|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-26|||November 2016||2016-11-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|August 2019|Anticipated|2019-08-01||Observational|||The Reproductive Microbiome & Perinatal Health Outcomes|The Reproductive Microbiome & Perinatal Health Outcome|Not yet recruiting||N/A|200|Anticipated|Baylor Research Institute|||2||f||||f||||||Samples Without DNA|"     Sample collection for bacterial microbiome identification and metabolic products   "|No||2017-10-10 21:39:21.176234|2017-10-10 21:39:21.176234
NCT02948179|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-04-24|||September 2016||2016-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|ESPERANCE||Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial|Efficacy and Safety of Preimplantation Genetic Diagnosis in Blocking Pathogenic Gene Inheritance for Autosomal Dominant Polycystic Kidney Disease: a Multicenter Clinical Trial|Recruiting||N/A|100|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||No||2017-10-10 21:39:21.291784|2017-10-10 21:39:21.291784
NCT02948166|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2017-05-03|||January 2016||2016-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Remote Endarterectomy and Endovascular Treatments in Patients With the Femoral Artery Occlusive Disease|Prospective Randomized Clinical Trial of the Remote Endarterectomy and the Femoral Arteries Endovascular Treatments in Patients With the Femoral Artery Occlusive Disease (TASC C, D)|Recruiting||N/A|174|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 21:39:21.469448|2017-10-10 21:39:21.469448
NCT02948153|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-26|||January 2014||2014-01-01|September 2015|2015-09-01|April 2016|Actual|2016-04-01|September 2015|Actual|2015-09-01||Observational|MUCITOLL||Mucins and Toll-like Receptors in Asthma|Asthma With Bronchial Hypersecretion: Expression of Mucins and Toll-like Receptors in Sputum and Blood|Completed||N/A|43|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||f||||||||No||2017-10-10 21:39:21.615973|2017-10-10 21:39:21.615973
NCT02948140|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-26|||November 2016||2016-11-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|IRMA2||Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction||Not yet recruiting||N/A|64|Anticipated|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:39:21.701906|2017-10-10 21:39:21.701906
NCT02948127|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-12|||September 2016||2016-09-01|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age|Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age|Active, not recruiting||Phase 1|8|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 21:39:21.842493|2017-10-10 21:39:21.842493
NCT02948114|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-07-03|||October 2016||2016-10-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Feeding Infant Formula Containing Prebiotics and/or Probiotics|The Effect of Feeding Infant Formula Containing Prebiotics and/or Probiotics|Recruiting||N/A|154|Anticipated|Mead Johnson Nutrition||5|||f||||f||||||||||2017-10-10 21:39:21.952141|2017-10-10 21:39:21.952141
NCT02948101|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Pre-Conditioning Effects of Anti-Macrophage Therapy Using PD 0360324 in Recurrent Platinum-Resistant Epithelial Ovarian Cancer|Pilot Study of the Pre-Conditioning Effects of Anti-Macrophage Therapy Using PD 0360324 in Recurrent Platinum-Resistant Epithelial Ovarian Cancer|Not yet recruiting||Phase 2|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 21:39:22.088177|2017-10-10 21:39:22.088177
NCT02948075|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-03-28|||September 2015||2015-09-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy|Multicenter, Open-label Study of Safety and Efficacy of Quisinostat in Combination With Paclitaxel + Carboplatin Chemotherapy in Patients With Metastatic or Locally Advanced Epithelial Ovarian Cancer, Primarily Peritoneal or Fallopian Tube Carcinoma, Resistant to First Line Platinum and Paclitaxel Based Chemotherapy|Active, not recruiting||Phase 2|31|Actual|NewVac LLC||1|||f||||t||||||||No||2017-10-10 21:39:22.321824|2017-10-10 21:39:22.321824
NCT02948062|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-07-27|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|||Early Diagnosis Of Childhood Cerebral ALD|Early Diagnosis Of Childhood Cerebral Adrenoleukodystrophy|Not yet recruiting||N/A|100|Anticipated|Masonic Cancer Center, University of Minnesota|||1||f||||||||||Samples Without DNA|"     Blood and cerebral spinal fluid.   "|||2017-10-10 21:39:22.454678|2017-10-10 21:39:22.454678
NCT02948049|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-04-20|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Observational|||Accelerometer Based Objective Clinical Outcomes of Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS)|Accelerometer Based Objective Clinical Outcomes of Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS)|Terminated||N/A|2|Actual|Holy Cross Hospital, Florida|||1|Principal Investigator resigned from institution|f||||f||||||||No||2017-10-10 21:39:22.55377|2017-10-10 21:39:22.55377
NCT02948036|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-06-26|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Closed-loop Assessment and Treatment Platform for Mood Disorders|A Closed-loop Assessment and Treatment Platform for Mood Disorders|Not yet recruiting||N/A|25|Anticipated|Posit Science Corporation||1|||f||||f|f|f||||||||2017-10-10 21:39:23.209574|2017-10-10 21:39:23.209574
NCT02948023|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-08-19|||January 2014||2014-01-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ExCell||Stem Cells Therapy for Corneal Blindness|Ex-vivo Cultivated Limbal Stem Cell Transplantation for Treatment of Superficial Corneal Pathologies|Recruiting||Phase 1|20|Anticipated|L.V. Prasad Eye Institute||2|||f||||t||||||||||2017-10-10 21:39:23.344142|2017-10-10 21:39:23.344142
NCT02948010|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-06-26|||November 2016||2016-11-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||CPAP Device In-lab Assessment NZ|CPAP Device In-lab Assessment NZ|Completed||N/A|104|Actual|Fisher and Paykel Healthcare||9|||f||||t||||||||No||2017-10-10 21:39:23.451583|2017-10-10 21:39:23.451583
NCT02947997|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-07-11|||September 2015||2015-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Pilot Study for Imaging of the Esophagus Using Tethered Capsule OCT Endomicroscopy With Distal Scanning|Pilot Study for Imaging of the Esophagus Using Tethered Capsule OCT Endomicroscopy With Distal Scanning|Active, not recruiting||N/A|10|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 21:39:23.567677|2017-10-10 21:39:23.567677
NCT02947984|ClinicalTrials.gov processed this data on October 10, 2017|2007-12-28|2017-05-15|2017-04-12||March 1999||1999-03-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Proton/Photon Rt - Benign Meningiomas(P92-13)|Prospective Study Of Patients With Recurrent Or Incomplete Excised Benign Intercranial Meningiomas For The Evaluation Of Treatment Result With Combined Proton And Photon Irradiation To Doses 55.8 Or 63.0 CGE|Completed||Phase 3|44|Actual|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 21:39:23.697581|2017-10-10 21:39:23.697581
NCT02947971|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-10-26|||September 2015||2015-09-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System|Pilot Study for TCE (Tethered Capsule Endomicroscopy) Imaging of the Esophagus Using an OFDI (Optical Frequency Domain Imaging) Capsule With a Compact Imaging System|Recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 21:39:24.914423|2017-10-10 21:39:24.914423
NCT02947958|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia|Evaluation of the Effectiveness of the Use of Teleconsultation in Qualifying Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia: Randomized Clinical Trial of Noninferiority|Recruiting||N/A|284|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:39:24.995331|2017-10-10 21:39:24.995331
NCT02947945|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-12|||September 12, 2017|Actual|2017-09-12|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|RITE||Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study|Open-Label, to Evaluate the Efficacy and Safety of Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study: RITE Study|Recruiting||Phase 2|10|Anticipated|National Jewish Health||1|||f||||f|t|f||||||||2017-10-10 21:39:25.126918|2017-10-10 21:39:25.126918
NCT02947932|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-26|||December 2016||2016-12-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Oral Resveratrol to Prevent Post-ERCP Pancreatitis|Oral Resveratrol Before ERCP Redused Overall Pancreatitis in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP): A Multi-center, Single-blinded, Randomized Controlled Trial|Not yet recruiting||Phase 4|2700|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||||||||||||2017-10-10 21:39:25.228336|2017-10-10 21:39:25.228336
NCT02947919|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-26|||July 2016||2016-07-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Impact of Music in the Preoperative Stress of Children Undergoing General Surgery|Impacto de la música en el estrés Preoperatorio en niños Sometidos a cirugía General|Recruiting||N/A|60|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||Undecided||2017-10-10 21:39:25.324638|2017-10-10 21:39:25.324638
NCT02947906|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Plantar Pressure Distribution in Patient With Multiple Sclerosis|Investigating the Plantar Pressure Distribution in Patient With Multiple Sclerosis|Not yet recruiting||N/A|70|Anticipated|Hacettepe University|||2||f||||t||||||||Undecided||2017-10-10 21:39:25.425914|2017-10-10 21:39:25.425914
NCT02947893|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|AD||Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease|A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of Low Doses of Nilotinib (Tasigna®) on Safety, Biomarkers and Clinical Outcomes in Subjects With Mild to Moderate Alzheimer's Disease|Recruiting||Phase 2|42|Anticipated|Georgetown University||2|||f||||t||||||||No||2017-10-10 21:39:25.500597|2017-10-10 21:39:25.500597
NCT02947880|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-27|||December 2016||2016-12-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|BUMAUTEP||Evaluation of the Efficiency of Treatment by BUMETANIDE on Autistic Children With a Known Ethiology|Evaluation of the Efficiency of Treatment by BUMETANIDE on Autistic Children With a Known Ethiology : Multicenter and Double Blind-study With Randomized Parallel Group, Against Placebo.|Not yet recruiting||Phase 2|88|Anticipated|University Hospital, Limoges||2|||f||||t||||||||||2017-10-10 21:39:25.604977|2017-10-10 21:39:25.604977
NCT02947867|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-28|||January 2017||2017-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|STRONG||Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG|Prospective, Randomised, Placebo-controlled, Double-masked, Three-armed Multi-centre Trial of Aganirsen Versus Vehicle in Patients After Ischaemic Central Retinal Vein Occlusion With a High Risk to Develop Neovascular Glaucoma|Not yet recruiting||Phase 2/Phase 3|333|Anticipated|Gene Signal SAS||3|||f||||t||||||||No||2017-10-10 21:39:25.695398|2017-10-10 21:39:25.695398
NCT02947854|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-24|||September 2016|Actual|2016-09-01|August 2017|2017-08-01||||March 2018|Anticipated|2018-03-01||Interventional|||Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant|An Open-label, Phase I/Proof of Principle, Dose Escalation Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation (PCI) of Antigen/Adjuvant in Healthy Male/Female Subjects|Recruiting||Phase 1|110|Anticipated|PCI Biotech AS||3|||f||||t||||||||||2017-10-10 21:39:25.787506|2017-10-10 21:39:25.787506
NCT02947841|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|AltStim DBS||The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients|The Effectiveness of Alternating Ventral Intermediate Nucleus Deep Brain Stimulation Parameters in Preventing Tolerance in Essential Tremor Patients|Recruiting||N/A|26|Anticipated|Oregon Health and Science University||2|||f||||t||||||||No||2017-10-10 21:39:25.899605|2017-10-10 21:39:25.899605
NCT02947828|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|May 2018|Anticipated|2018-05-01||Observational|||Polyneuropathy in Diabetes Mellitus Type 2|Polyneuropathy in Diabetes Mellitus Type 2|Recruiting||N/A|700|Anticipated|Danish Pain Research Center|||2||f||||f||||||Samples With DNA|"     Skin punch biopsies and blood   "|Yes|Data is shared among collaborators.|2017-10-10 21:39:26.002347|2017-10-10 21:39:26.002347
NCT02947815|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm|A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase II/III Clinical Trial to Compare the Safety and Efficacy of NABOTA Versus BOTOX in Treatment of Essential Blepharospasm|Recruiting||Phase 2/Phase 3|234|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||No||2017-10-10 21:39:26.089415|2017-10-10 21:39:26.089415
NCT02947802|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-02-22|||October 2016||2016-10-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Sugar Sweetened Beverage Labeling Support|Sugar Sweetened Beverage Labeling Support|Completed||N/A|400|Actual|Harvard University||2|||f||||||||||||||2017-10-10 21:39:26.182699|2017-10-10 21:39:26.182699
NCT02947789|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-05-10|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Predictive Model for Postoperative Mortality|Predictive Model for Postoperative Mortality in Adult Emergency Surgical Patients Under General Anesthesia|Completed||N/A|740|Actual|Khon Kaen University|||1||f||||f||||||||No||2017-10-10 21:39:26.258085|2017-10-10 21:39:26.258085
NCT02947776|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-07-31|||May 25, 2017|Actual|2017-05-25|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|May 25, 2019|Anticipated|2019-05-25||Interventional|SUPERB||Adjustment With Aphasia After Stroke: SUPERB|Adjustment Post Stroke and Aphasia: Supporting Psychological Wellbeing Through Peer Befriending|Recruiting||N/A|60|Anticipated|City, University of London||2|||f||||t|f|f||||||||2017-10-10 21:39:26.333236|2017-10-10 21:39:26.333236
NCT02947763|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-31|||November 2016||2016-11-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Single Versus Multiple Visits Endodontic Treatment|Healing Rates After Single Versus Multiple Visits Endodontic Treatment of Necrotic Teeth With Apical Periodontitis: A Randomized Clinical Trial|Not yet recruiting||Phase 1|40|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:39:26.456942|2017-10-10 21:39:26.456942
NCT02947750|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|NeurovEx||Neurovascular Transduction During Exercise in Chronic Kidney Disease|Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease|Recruiting||Phase 2|150|Anticipated|Emory University||4|||f||||f||||||||||2017-10-10 21:39:26.535456|2017-10-10 21:39:26.535456
NCT02947737|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-09-11|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Amniotic Membrane for Donor Site Healing|Investigating the Effects of Amniotic Membrane on Donor Site Healing and Postoperative Pain|Completed||N/A|10|Anticipated|Emory University||2|||f||||f|f|f||||||||2017-10-10 21:39:26.684711|2017-10-10 21:39:26.684711
NCT02947711|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-03-06|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects|An Open-label, Single-Sequence, Drug-Drug Interaction Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects|Completed||Phase 1|16|Actual|Eisai Inc.||1|||f||||f||||||||Yes||2017-10-10 21:39:26.869421|2017-10-10 21:39:26.869421
NCT02947698|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||January 2016||2016-01-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Effect of Weekend Admission on Mortality Associated With Severe Acute Kidney Injury in England: a Propensity Score Matched, Population-based Study|Effect of Weekend Admission on Mortality Associated With Severe Acute Kidney Injury in England: a Propensity Score Matched, Population-based Study|Completed||N/A|53878|Actual|Derby Hospitals NHS Foundation Trust|||2||f||||f||||||||No|The data is anonymised and freely available from HSCIC|2017-10-10 21:39:26.972011|2017-10-10 21:39:26.972011
NCT02947685|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-07-14|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|August 31, 2024|Anticipated|2024-08-31|October 31, 2020|Anticipated|2020-10-31||Interventional|PATINA||Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer|A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer|Recruiting||Phase 3|496|Anticipated|Alliance Foundation Trials, LLC.||2|||f||||t|t|f||||||||2017-10-10 21:39:27.05117|2017-10-10 21:39:27.05117
NCT02947672|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-26|||November 2016||2016-11-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Intravenous Versus Intra-peritoneal Dexamethasone on the Incidence of Postoperative Nausea and Vomiting|Effect of Intravenous Versus Intra-peritoneal Dexamethasone on the Incidence of Postoperative Nausea and Vomiting Following Laparoscopic Gynecological Surgeries|Recruiting||N/A|100|Anticipated|Assiut University||2|||f||||||||||||||2017-10-10 21:39:27.219572|2017-10-10 21:39:27.219572
NCT02947659|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-27|||October 2015||2015-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Observational|||Body Mass Index, Academic Stress and Musculoskeletal Disorders Relationships|The Relationship Between the Development of Musculoskeletal Disorders and Body Mass Index and Academic Stress in Bahraini University Students|Completed||N/A|94|Actual|Ahlia University|||1||f||||t||||||||||2017-10-10 21:39:27.285995|2017-10-10 21:39:27.285995
NCT02947646|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-02-17|||November 2016||2016-11-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Feasibility of BabyGentleStick- Adult Pilot Study||Completed||N/A|20|Actual|Actuated Medical, Inc.||2|||f||||t||||||||No||2017-10-10 21:39:27.337673|2017-10-10 21:39:27.337673
NCT02947633|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-10-26|||March 2015||2015-03-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Sciatic Technique Comparison of Nerve Blockade for Pain Control Following Hamstring Autograft Harvest in Adolescents|Sciatic Peripheral Nerve Blockade for Pain Control Following Hamstring Autograft Harvest in Adolescents: A Comparison of Two Techniques|Enrolling by invitation||N/A|140|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||Undecided||2017-10-10 21:39:27.400061|2017-10-10 21:39:27.400061
NCT02947620|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-28|||August 2015||2015-08-01|October 2016|2016-10-01||||February 2017|Anticipated|2017-02-01||Interventional|||A Multi-center, Randomized, Double-blind, Active-controlled, Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia||Recruiting||Phase 3|180|Anticipated|Daewoong Pharmaceutical Co. LTD.||3|||f||||||||||||||2017-10-10 21:39:27.475728|2017-10-10 21:39:27.475728
NCT02947607|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-12-12|||July 2016||2016-07-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Observational|||Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma|Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and Carcinoma|Recruiting||Early Phase 1|1126|Anticipated|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||Samples With DNA|"     Saliva Stool Tissue   "|No||2017-10-10 21:39:27.545155|2017-10-10 21:39:27.545155
NCT02947594|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-02-13|||January 2011||2011-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Observational|||Half-life of Plasma Phytosterols in Very Low Birth Weight Preterm Infants With Parenteral Nutrition-associated Cholestasis||Completed||N/A|37|Actual|Università Politecnica delle Marche|||1||f||||||||||||||2017-10-10 21:39:27.647546|2017-10-10 21:39:27.647546
NCT02947581|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-25|||November 2016||2016-11-01|October 2016|2016-10-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|SANTO||Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)|A Randomized Trial of Combined Albendazole Plus Praziquantel for Subarachnoid Cysticercosis of the Sylvian Fissure or the Basal Cisterns|Not yet recruiting||Phase 3|164|Anticipated|Universidad Peruana Cayetano Heredia||2|||f||||t||||||||Yes|Anonymized patient data will be shared upon request and review by the project leaders.|2017-10-10 21:39:27.701346|2017-10-10 21:39:27.701346
NCT02947568|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|NAFLDDMCKD||Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease|Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease|Recruiting||N/A|600|Anticipated|University of Pecs|||3||f||||f||||||||No||2017-10-10 21:39:27.791296|2017-10-10 21:39:27.791296
NCT02947555|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|CRADILA||Cardiovascular Risk Assesment in Diabetic Patients Via Lens Autofluorecscence Detection|Cardiovascular Risk Assesment in Diabetic Patients Via Lens Autofluorecscence Detection|Recruiting||N/A|420|Anticipated|University of Pecs|||4||f||||f||||||||||2017-10-10 21:39:28.041376|2017-10-10 21:39:28.041376
NCT02947542|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-05-14|||April 2016||2016-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|UDDC||Use of Different Diagnostic Coronary Catheters Over the Radial Access - the UDDC - Radial Trial|Use of Different Diagnostic Coronary Catheters Over the Radial Access - the UDDC - Radial Trial|Completed||N/A|300|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||Undecided||2017-10-10 21:39:28.15128|2017-10-10 21:39:28.15128
NCT02947529|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-09-20|||August 2015||2015-08-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 1, 2017|Actual|2017-08-01||Interventional|||Tranexamic Acid Use in Acute Hip Fractures|The Use of Tranexamic Acid to Reduce the Need for Transfusion 1 Week Post-operatively for Hemiarthroplasty or Intramedullary Nailing Needed to Correct Acute Hip Fractures|Completed||N/A|400|Actual|Carilion Clinic||2|||f||||f||||||||||2017-10-10 21:39:28.291697|2017-10-10 21:39:28.291697
NCT02947516|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-26|||January 2017||2017-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of EUS-Guided Liver Biopsy With Percutaneous Liver Biopsy|Comparison of Pain Scores Between Endoscopic Ultrasound (EUS)-Guided Liver Biopsy and Percutaneous Liver Biopsy|Not yet recruiting||N/A|90|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||No||2017-10-10 21:39:28.395364|2017-10-10 21:39:28.395364
NCT02947503|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01|December 2040|Anticipated|2040-12-01|June 2019|Anticipated|2019-06-01||Interventional|POEM||Pregnancy Outcomes: Effects of Metformin Study (POEM Study)|Pregnancy Outcomes: Effects of Metformin Study (POEM Study), a Long Term Randomized Controlled Study in Gestational Diabetes|Not yet recruiting||Phase 3|500|Anticipated|Bethesda Diabetes Research Center||2|||f||||t||||||||Yes||2017-10-10 21:39:28.497328|2017-10-10 21:39:28.497328
NCT02947490|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-10-25|||September 2013||2013-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|TEST-BP||Effectiveness of Self-monitoring and Treatment of Blood Pressure Following Stroke or Transient Ischaemic Attack|Trial of the Effectiveness and Cost Effectiveness of Self-monitoring and Treatment of Blood Pressure in Secondary Prevention Following Stroke or Transient Ischaemic Attack (TIA)|Completed||Phase 3|165|Actual|University of East Anglia||3|||f||||t||||||||Undecided||2017-10-10 21:39:28.613645|2017-10-10 21:39:28.613645
NCT02947477|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01||||January 2017|Anticipated|2017-01-01||Interventional|ETSR||Emotion Tracking Study for Residents|EmoTrak, Ecological Momentary Assessment of Emotion, Stress and Satisfaction Among Residents|Recruiting||N/A|80|Anticipated|University of California, San Francisco||2|||f||||||||||||No||2017-10-10 21:39:28.736774|2017-10-10 21:39:28.736774
NCT02947464|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-07|||November 2015||2015-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|ERMES||Rapid Maxillary Expansión for Residual Pediatric Obstructive Sleep Apnea After Adenotonsillectomy|Rapid Maxillary Expansion for Residual Pediatric Obstructive Sleep Apnea After Adenotonsillectomy: a Randomized Controlled Trial|Recruiting||N/A|54|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-10 21:39:28.845871|2017-10-10 21:39:28.845871
NCT02947451|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Immediate Effects of Manual Therapy Versus TENS in Patients With Knee Osteoarthritis|Immediate Effects of Manual Therapy Versus TENS in Patients With Knee Osteoarthritis|Active, not recruiting||N/A|62|Anticipated|Universidade Federal do Ceara||2|||f||||f||||||||No||2017-10-10 21:39:28.957456|2017-10-10 21:39:28.957456
NCT02947438|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-26|||December 2015||2015-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|BEAT_002||Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)|A Prospective, Randomized, Double Blind, Parallel Group Study to Evaluate a 1:1 Dose Conversion From EPREX to EPIAO in Term of Clinical Efficacy and Safety in Subjects With End-Stage Renal Disease on Haemodialysis|Recruiting||Phase 4|264|Anticipated|Shenyang Sunshine Pharmaceutical Co., LTD.||2|||f||||t||||||||No||2017-10-10 21:39:29.090994|2017-10-10 21:39:29.090994
NCT02947425|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-25|||July 2013||2013-07-01|August 2016|2016-08-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01|10 Years|Observational [Patient Registry]|TARGIT R||TARGeted Intraoperative radioTherapy (TARGIT) Registry Database|TARGIT R: TARGeted Intraoperative radioTherapy (TARGIT) Registry Database|Recruiting||N/A|2000|Anticipated|University College, London|||1||f||||f||||||||Yes|All requests for data sharing will adhere to the UCL Surgical & Interventional Trials Unit (SITU) data sharing agreement policy. UCL Medical School is supportive of data sharing and will endeavour to assist in requests for data sharing. These data will be held at UCL on secure servers and will not be released to any third parties until the final study report has been published. All requests for access to the data will be formally requested through the use of a SITU data request form which will state the purpose, analysis and publication plans together with the named collaborators. All requests are dealt with on a case by case basis. All requests will be logged and those successful will have a data transfer agreement which will specify appropriate acknowledgement of the Royal Free Hospital, the sponsor, and funders.|2017-10-10 21:39:29.233425|2017-10-10 21:39:29.233425
NCT02947412|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-29|||January 2007||2007-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Observational|||Long Term Results After Sleeve Gastrectomy|Long Term Results After Sleeve Gastrectomy as a Primary Procedure in Obesity Surgery|Completed||N/A|40|Actual|Sana Klinikum Offenbach|||1||f||||f||||||||No||2017-10-10 21:39:29.362927|2017-10-10 21:39:29.362927
NCT02947399|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-03-03|||November 2008||2008-11-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal|Comparison of I-124 and I-131 Radiopharmacokinetics In Patient With Well Differentiated Thyroid Cancer After Thyroid Hormone Withdrawal|Recruiting||N/A|30|Anticipated|Washington Hospital Center||1|||f||||t||||||||No||2017-10-10 21:39:29.472332|2017-10-10 21:39:29.472332
NCT02947386|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-07-08|||June 29, 2017|Actual|2017-06-29|July 2017|2017-07-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer|A Phase I/II Open-Label Study of Nimotuzumab in Combination With Nivolumab in Patients With Advanced Non-small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|54|Anticipated|Roswell Park Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 21:39:29.601343|2017-10-10 21:39:29.601343
NCT02947373|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-10|||January 25, 2017|Actual|2017-01-25|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors|PNOC 011: Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors|Recruiting||Phase 1|9|Anticipated|University of California, San Francisco||1|||f||||t|t|f||||||||2017-10-10 21:39:29.737543|2017-10-10 21:39:29.737543
NCT02947360|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-10-27|||November 2016||2016-11-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|FOVUS-ER||The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER|The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Suspected Ischemic Chest Pain in the Emergency Department|Not yet recruiting||N/A|500|Anticipated|Queen's University||1|||f||||f||||||||No||2017-10-10 21:39:29.858025|2017-10-10 21:39:29.858025
NCT02947334|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2016-12-09|||October 2016||2016-10-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|SPIRE-ASIA||Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects|A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Bococizumab (Pf-04950615) In Asian Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events|Withdrawn||Phase 3|0|Actual|Pfizer||2|||f||||t||||||||||2017-10-10 21:39:30.155915|2017-10-10 21:39:30.155915
NCT02947321|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-26|||November 2016||2016-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial|GREAT Knee Pain Reduction Trial, Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial|Not yet recruiting||N/A|60|Anticipated|Vanderbilt University||2|||f||||f||||||||No||2017-10-10 21:39:30.246946|2017-10-10 21:39:30.246946
NCT02947308|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-26|||August 2016||2016-08-01|October 2016|2016-10-01||||January 2025|Anticipated|2025-01-01||Observational|RDoC||A Study Examining Adolescents With Non-Suicidal Self-Injury|A Longitudinal Study Examining Three RDoC Constructs in Adolescents With Non-Suicidal Self-Injury|Recruiting||N/A|152|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||Samples Without DNA|"     De-identified saliva samples will be retained until the completion of the study. At the time     of the completion, samples will be destroyed.   "|||2017-10-10 21:39:30.384138|2017-10-10 21:39:30.384138
NCT02947295|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-09-26|||September 2012||2012-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Global Genomic and Proteomic Profiling of African Children With Typhoid Fever|Global Genomic and Proteomic Profiling of African Children With Typhoid Fever|Recruiting||N/A|192|Anticipated|University of Nebraska|||1||f||||f||||||Samples With DNA|"     Blood, urine, stool, nasopharyngeal swab/aspirate as well as cerebrospinal fluid (CSF),     pleural fluid, induced sputum, gastric aspirates or synovial fluid with clinical indication.   "|||2017-10-10 21:39:30.49061|2017-10-10 21:39:30.49061
NCT02947282|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-31|||June 2013||2013-06-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PREPARED||PREgnancy-associated Pelvic Floor Health Knowledge And REDuction of Symptoms: The PREPARED Trial|PREgnancy-associated Pelvic Floor Health Knowledge And REDuction of Symptoms: The PREPARED Trial|Completed||N/A|100|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 21:39:30.562785|2017-10-10 21:39:30.562785
NCT02947269|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-25|||January 2017||2017-01-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Prucalopride in Postoperative Ileus|A Randomized Double-blind Placebo Controlled Trial of Prucalopride to Reduce the Duration of Postoperative Ileus in Patients Undergoing Elective Colorectal Surgery|Not yet recruiting||Phase 3|140|Anticipated|University of Auckland, New Zealand||2|||f||||t||||||||||2017-10-10 21:39:30.647778|2017-10-10 21:39:30.647778
NCT02947256|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-22|2016-10-29|||July 2013||2013-07-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Laparoscopic Cholecystectomy With Retro-infundibular Approach|Laparoscopic Cholecystectomy With Retro-infundibular Approach Versus Standard Laparoscopic Cholecystectomy in Difficult Cases, Where Calot's Triangle is Unsafe to be Dissected|Completed||Phase 2|125|Actual|Minia University||2|||f||||t||||||||No||2017-10-10 21:39:30.724843|2017-10-10 21:39:30.724843
NCT02947243|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-24|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|DREAM-T||Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: Trial|Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: Trial|Not yet recruiting||N/A|40|Anticipated|St. Justine's Hospital||2|||f||||f|f|f||||||||2017-10-10 21:39:30.805355|2017-10-10 21:39:30.805355
NCT02947230|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-28|||March 7, 2017|Actual|2017-03-07|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|November 1, 2017|Anticipated|2017-11-01||Interventional|||Evaluating the Impact of the McMaster Optimal Aging Portal on Physical Mobility Outcomes|Evaluating the Impact of the McMaster Optimal Aging Portal on Knowledge, Behavioural Intentions and Health Behaviours Related to Physical Mobility|Active, not recruiting||N/A|535|Actual|McMaster University||2|||f||||f|f|f||||||||2017-10-10 21:39:30.903076|2017-10-10 21:39:30.903076
NCT02947217|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-01-18|||January 19, 2017|Actual|2017-01-19|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|IVF-FluVac||Effect of Influenza Vaccination on IVF Outcomes - IVF|A Randomized Controlled Trial of the Effect of Influenza Vaccination on Implantation and Pregnancy Rates After In-Vitro Fertilization|Enrolling by invitation||Phase 4|238|Anticipated|Center for Human Reproduction||2|||f||||f|t|f||||||No|The investigators do not plan to share individual participant data (IPD)|2017-10-10 21:39:30.980316|2017-10-10 21:39:30.980316
NCT02947204|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-03-10|||November 2016||2016-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Oxygen Saturation Monitoring in Bronchiolitis|Intermittent vs. Continuous Oxygen Saturation Monitoring in Infants Hospitalized for Bronchiolitis: A Randomized Controlled Trial|Recruiting||N/A|210|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||Undecided||2017-10-10 21:39:31.055449|2017-10-10 21:39:31.055449
NCT02946424|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-07-03|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|September 30, 2021|Anticipated|2021-09-30|September 2021|Anticipated|2021-09-01||Interventional|||Simvastatin to Prevent SCI-Induced Bone Loss|Simvastatin to Improve Bone Health in SCI: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial|Recruiting||Phase 2|76|Anticipated|Craig Hospital||2|||f||||f|t|f||||||||2017-10-10 21:39:39.598282|2017-10-10 21:39:39.598282
NCT02947191|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-11-19|||November 2016||2016-11-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation|The Safety and Efficacy Assessment of Collagen Membrane Combined With Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Nasal Septum Perforation|Recruiting||Phase 1/Phase 2|12|Anticipated|Chinese Academy of Sciences||1|||f||||||||||||||2017-10-10 21:39:31.193739|2017-10-10 21:39:31.193739
NCT02947178|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Hip Arthroscopy Pain Control Randomized Control Trial (RCT)|Liposomal Bupivacaine Versus Bupivacaine With Fascia Iliaca Blockade for Perioperative Pain Management During Hip Arthroscopy: A Double-Blinded Prospective Randomized Control Trial|Recruiting||Phase 4|106|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||No|Individual participant data will be combined together for data analysis.|2017-10-10 21:39:31.27157|2017-10-10 21:39:31.27157
NCT02947165|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-06-05|||April 25, 2017|Actual|2017-04-25|June 2017|2017-06-01|January 12, 2020|Anticipated|2020-01-12|January 12, 2020|Anticipated|2020-01-12||Interventional|||Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.|A Phase I/Ib, Open-label, Multi-center Dose Escalation Study of NIS793 in Combination With PDR001 in Adult Patients With Advanced Malignancies|Recruiting||Phase 1|154|Anticipated|Novartis||2|||f||||f|t|f||||||No||2017-10-10 21:39:31.361267|2017-10-10 21:39:31.361267
NCT02947152|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-13|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 30, 2019|Anticipated|2019-08-30||Interventional|||HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma|A Phase I, Multicenter, Open-label Dose Escalation and Expansion Study of HKT288, Administered Intravenously in Adult Patients With Advanced Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma|Suspended||Phase 1|120|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 21:39:31.458908|2017-10-10 21:39:31.458908
NCT02947139|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-02-14|||September 29, 2016|Actual|2016-09-29|February 2017|2017-02-01|November 2, 2016|Actual|2016-11-02|October 24, 2016|Actual|2016-10-24||Interventional|||Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers|A Randomized, Open Label, Crossover Study to Explore Drug-drug Interaction Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers|Completed||Phase 1|53|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-10 21:39:31.555655|2017-10-10 21:39:31.555655
NCT02947126|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-07-24|||November 2016||2016-11-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Multilevel Models of Therapeutic Response in the Lungs|Multilevel Models of Therapeutic Response in the Lungs|Recruiting||N/A|62|Anticipated|University of Pittsburgh||4|||f||||t||||||||||2017-10-10 21:39:31.621851|2017-10-10 21:39:31.621851
NCT02947113|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|HYPOLAN||Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC|Feasibility Trial on Combination of Platinum Doublets and Hypofractionated Radiotherapy for Locally-advanced Stage and / or Inoperable Non-small Cell Lung Carcinoma|Not yet recruiting||Phase 2|50|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 21:39:31.715197|2017-10-10 21:39:31.715197
NCT02947100|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-09-26|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Omega-3 Fatty Acids in Sickle Cell Disease|Phase I/II Safety and Dose Escalation Trial of the Omega-3 Fatty Acids Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) in Children and Young Adults With Sickle Cell Disease (SCD)|Not yet recruiting||Phase 1/Phase 2|42|Anticipated|Nemours Children's Clinic||1|||f||||f|t|f||||||||2017-10-10 21:39:31.804806|2017-10-10 21:39:31.804806
NCT02947087|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis|Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival|Recruiting||Phase 1/Phase 2|48|Anticipated|Medical University of South Carolina||2|||f||||t||||||||Yes||2017-10-10 21:39:33.513463|2017-10-10 21:39:33.513463
NCT02947074|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-26|||July 2016||2016-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Meditation Practice in Pediatric Healthcare Professionals|Meditation Practice in Pediatric Healthcare Professionals: a Randomized Controlled Clinical Trial|Recruiting||N/A|60|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 21:39:33.665737|2017-10-10 21:39:33.665737
NCT02947061|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-27|||April 2015||2015-04-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|||S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer|S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer: a Phase 2, Prospective,Multicenter, Randomised Study|Recruiting||Phase 2|300|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||No||2017-10-10 21:39:33.75589|2017-10-10 21:39:33.75589
NCT02947048|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Safety of L1-79 in Young Adults With Autism|A Phase 2 Safety Study of L1-79 for the Treatment of Autism|Recruiting||Phase 2|40|Anticipated|Yamo Pharmaceuticals LLC||5|||f||||f||||||||No||2017-10-10 21:39:33.848672|2017-10-10 21:39:33.848672
NCT02947035|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Molecular Testing to Direct Extent of Initial Thyroid Surgery|Molecular Testing to Direct Extent of Initial Thyroid Surgery|Recruiting||Phase 2|90|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-10 21:39:33.93581|2017-10-10 21:39:33.93581
NCT02947022|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-01-19|||October 2016||2016-10-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease|Investigator Initiated Investigational New Drug Application to Study the Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease|Suspended||Phase 1/Phase 2|20|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t||||||||No||2017-10-10 21:39:34.029519|2017-10-10 21:39:34.029519
NCT02947009|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-08-10|||November 2016||2016-11-01|October 2016|2016-10-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Interventional|||Exercise-induced Paradoxical Vocal Fold Motion Disorder: Clinical Features and Potential Mechanisms|Exercise-induced Paradoxical Vocal Fold Motion Disorder: Clinical Feature Characteristics and Potential Mechanisms|Completed||N/A|27|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 21:39:34.135903|2017-10-10 21:39:34.135903
NCT02946996|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-06-13|||December 28, 2016|Actual|2016-12-28|June 2017|2017-06-01|March 1, 2020|Anticipated|2020-03-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy|Randomized Phase II Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy|Recruiting||Phase 2|60|Anticipated|Medical University of South Carolina||3|||f||||t||||||||No||2017-10-10 21:39:34.248272|2017-10-10 21:39:34.248272
NCT02946983|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-10-26|||September 2015||2015-09-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Influence of Intragastric Fructose Infusion on Behavioural and Neural Responses to Negative Emotion Induction||Completed||N/A|15|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||No||2017-10-10 21:39:34.347197|2017-10-10 21:39:34.347197
NCT02946970|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-10-26|||September 2015||2015-09-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Brain Responses to Intragastric Administration of a Bitter Agonist in Homeostatic and Hedonic Brain Regions|Brain Responses to Intragastric Administration of a Bitter Agonist in Homeostatic and Hedonic Brain Regions|Completed||N/A|15|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 21:39:34.538079|2017-10-10 21:39:34.538079
NCT02946957|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|OATS||OsteoArthritis and Therapy for Sleep|Efficacy of Scalable CBT for Insomnia in Older Adults With Osteoarthritis Pain|Recruiting||N/A|270|Anticipated|University of Washington||2|||f||||t||||||||No||2017-10-10 21:39:34.616432|2017-10-10 21:39:34.616432
NCT02946944|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-29|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|PSCAT||Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism|Pilot Randomized Study of the Sidlenafil Efficacy in Combination With Oral Anticoagulants in the Treatment of Patients With Intermediate-high Risk of Pulmonary Embolism|Recruiting||Phase 1|100|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||||||||||||2017-10-10 21:39:34.723693|2017-10-10 21:39:34.723693
NCT02946931|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-22|||November 2, 2016|Actual|2016-11-02|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Observational|||PMS for Idarucizumab in Japan|The Drug Use-results Survey (All-Case Surveillance) on Prizbind® for Intravenous Solution 2.5 g in Japan|Recruiting||N/A|300|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 21:39:34.815853|2017-10-10 21:39:34.815853
NCT02946918|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-12|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy|Levothyroxine Replacement With Liquid Gel Capsules or Tablets in Post-thyroidectomy Stage in Low Risk Differentiated Thyroid Cancer Patients|Recruiting||Phase 4|20|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|t|f||||||No||2017-10-10 21:39:34.886319|2017-10-10 21:39:34.886319
NCT02946905|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-25|||April 2016||2016-04-01|October 2016|2016-10-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Observational|||Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease|Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease|Enrolling by invitation||N/A|200|Anticipated|University of Pittsburgh|||2||f||||f||||||Samples Without DNA|"     blood biomarkers of inflammation and oxidative damage   "|No||2017-10-10 21:39:34.99361|2017-10-10 21:39:34.99361
NCT02946892|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-06-21|||November 2016||2016-11-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of Carvedilol on Exercise Performance in Fontan Patients|Effect of Carvedilol on Exercise Performance in Fontan Patients|Recruiting||Phase 4|30|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-10 21:39:35.074206|2017-10-10 21:39:35.074206
NCT02946879|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-07|||November 2016||2016-11-01|September 2017|2017-09-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Observational|||Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)|Long-term Follow-up Study of Participants Following an Open Label, Multi-centre, Phase I/II Dose Escalation Trial of an Adeno-associated Virus Vector (AAV2/5-OPTIRPE65) for Gene Therapy of Adults and Children With Retinal Dystrophy Owing to Defects in RPE65 (LCA2)|Recruiting||N/A|27|Anticipated|MeiraGTx UK II Ltd|||3||f||||t||||||||||2017-10-10 21:39:35.177104|2017-10-10 21:39:35.177104
NCT02946866|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-26|2017-01-14|||June 2016||2016-06-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|CHOCOOATE||CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study|A Prospective Study for the Natural History and the Risk Factors of Prospective Symptomatic Hemorrhage in Adult Patients With Cerebral Cavernous Malformation|Recruiting||N/A|228|Anticipated|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 21:39:35.290073|2017-10-10 21:39:35.290073
NCT02946853|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-03-22|||October 2016||2016-10-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Junctional AV Ablation in CRT-D: JAVA-CRT|Junctional AV Ablation in CRT-D Patients With Atrial Fibrillation (JAVA-CRT Trial)|Recruiting||N/A|80|Anticipated|University of Rochester||2|||f||||t||||||||No||2017-10-10 21:39:35.447835|2017-10-10 21:39:35.447835
NCT02946840|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-10-26|||August 2016||2016-08-01|October 2016|2016-10-01||||March 2017|Anticipated|2017-03-01||Observational|||The Use of a New Core Needle in the Endoscopic Ultrasound Assisted Tissue Sampling for Pancreatic Solid Masses|The Use of a New Core Needle in the Endoscopic Ultrasound Assisted Tissue Sampling for Pancreatic Solid Masses|Recruiting||N/A|100|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||||No||2017-10-10 21:39:35.549511|2017-10-10 21:39:35.549511
NCT02946411|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Correlation of Hospital Stay Length With the Glucose Levels After Cardiac Surgery|Correlation of Hospital Stay Length With the Glucose Measured Continuously Levels After Cardiac Surgery|Not yet recruiting||N/A|48|Anticipated|Coordinación de Investigación en Salud, Mexico|||1||f||||t||||||||Undecided||2017-10-10 21:39:39.709823|2017-10-10 21:39:39.709823
NCT02946827|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-26|||January 2016||2016-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||A Low FODMAPs Diet in Celiac Patients With Persistent Gastrointestinal Symptoms|The Efficacy of a Low FODMAPs (Fermentable Oligo- di- and Monosaccharides and Polyols) Diet in Celiac Patients With Persistent Gastrointestinal Symptoms|Recruiting||N/A|68|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||No||2017-10-10 21:39:35.663333|2017-10-10 21:39:35.663333
NCT02946814|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01||||November 2016|Anticipated|2016-11-01||Interventional|||Immediate Effect and Substantivity of the Essential Oils Without Alcohol on the Oral Biofilm in Situ|Immediate Effect and Substantivity of the Essential Oils Without Alcohol on the Oral Biofilm in Situ. A Randomized Clinical Trial|Not yet recruiting||Phase 4|20|Anticipated|University of Santiago de Compostela||3|||f||||f||||||||No||2017-10-10 21:39:35.795737|2017-10-10 21:39:35.795737
NCT02946801|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-26|||November 2016||2016-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Antiplaque Effect of Essential Oils With and Without Alcochol on an in Situ Model of Oral Biofilm Growth|Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an in Situ Model of Oral Biofilm Growth. A Randomized Clinical Trial|Not yet recruiting||Phase 4|20|Anticipated|University of Santiago de Compostela||3|||f||||f||||||||No||2017-10-10 21:39:35.902685|2017-10-10 21:39:35.902685
NCT02946788|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-07-18|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel|An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)|Recruiting||Phase 2|20|Anticipated|BioPharmX, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:39:36.032151|2017-10-10 21:39:36.032151
NCT02946775|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-10-26|||September 2008||2008-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|CABSYNC||Community Acquired Bacteremic Syndromes in Young Nigerian Children|Community Acquired Bacteremic Syndromes in Young Nigerian Children|Recruiting||N/A|15000|Anticipated|University of Nebraska|||1||f||||f||||||Samples With DNA|"     Blood, urine, stool, nasopharyngeal swab/aspirate as well as cerebrospinal fluid (CSF),     pleural fluid, induced sputum, gastric aspirates or synovial fluid with clinical indication.   "|||2017-10-10 21:39:36.148204|2017-10-10 21:39:36.148204
NCT02946762|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-22|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||TasP in Correctional Facilities|Z 31501 - Treatment as Prevention (TasP) in Correctional Facilities in Zambia and South Africa|Recruiting||N/A|6000|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-10 21:39:36.25013|2017-10-10 21:39:36.25013
NCT02946749|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-22|2017-07-30|||December 2016||2016-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research|Abnormal Placenta Plant Disease Early Diagnosis and Individualized Treatment Research|Not yet recruiting||N/A|3000|Anticipated|Shanghai First Maternity and Infant Hospital|||4||f||||t||||||||||2017-10-10 21:39:36.368539|2017-10-10 21:39:36.368539
NCT02946736|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-09-18|||July 21, 2017|Actual|2017-07-21|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|MESH||Oregon Military Employee Sleep and Health Study|Evaluation of a Work-Family and Sleep Leadership Intervention in the Oregon National Guard: A Behavioral Health Leadership Approach|Recruiting||N/A|960|Anticipated|Oregon Health and Science University||2|||f||||f|f|f||||||||2017-10-10 21:39:36.457378|2017-10-10 21:39:36.457378
NCT02946723|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||February 2017||2017-02-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB) With X-Ray Guided Technique|A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB)With X-Ray Guided Technique|Not yet recruiting||Phase 1|30|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 21:39:36.754401|2017-10-10 21:39:36.754401
NCT02946710|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-02-21|||December 2014||2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|P75NTR-MND||P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid|P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid|Recruiting||N/A|120|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||No||2017-10-10 21:39:36.835017|2017-10-10 21:39:36.835017
NCT02946697|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-11-03|||January 2015||2015-01-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|JLA||A Culturally Sensitive Social Support Intervention|A Culturally Sensitive Social Support Intervention|Recruiting||N/A|190|Anticipated|University of Houston||2|||f||||t||||||||Undecided||2017-10-10 21:39:36.928203|2017-10-10 21:39:36.928203
NCT02946684|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-10-25|||August 2016||2016-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|RIOT-A||Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment|Reducing the Impact of Ovarian Stimulation - The RIOT Project. Study RIOT-A: The Role of Aromatase Inhibitor in Reducing the Detrimental Effects of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles|Recruiting||Phase 2/Phase 3|128|Anticipated|Herlev Hospital||2|||f||||t||||||||No||2017-10-10 21:39:37.031719|2017-10-10 21:39:37.031719
NCT02946671|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients|Phase I Study of Pre-operative Combination Therapy With Mogamulizumab (Anti-CCR4) and Nivolumab (Anti-PD-1) Against Solid Cancer Patients|Recruiting||Phase 1|18|Anticipated|Osaka University||3|||f||||||||||||||2017-10-10 21:39:37.173396|2017-10-10 21:39:37.173396
NCT02946658|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-23|||October 2016||2016-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ADcSVF-COPD||Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders|Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Chronic Lung Disorders|Recruiting||Phase 1/Phase 2|100|Anticipated|Healeon Medical Inc||3|||f||||t|f|f||||||||2017-10-10 21:39:37.297853|2017-10-10 21:39:37.297853
NCT02946632|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-26|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes|Effectiveness and Tolerability of Novel, Initial Triple Combination Therapy With Xigduo (Dapagliflozin Plus Metformin) and Saxagliptin vs. Conventional Stepwise add-on Therapy in Drug-naïve Patients With Type 2 Diabetes|Not yet recruiting||Phase 3|104|Anticipated|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-10 21:39:37.591969|2017-10-10 21:39:37.591969
NCT02946619|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-20|||June 2012||2012-06-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors|Reducing Psychological Burdens Among Chinese Breast Cancer Survivors|Completed||N/A|136|Actual|University of Houston||3|||f||||f||||||||No||2017-10-10 21:39:37.731101|2017-10-10 21:39:37.731101
NCT02946606|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-09-04|||January 2015||2015-01-01|September 2017|2017-09-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Interventional|||A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9|A Randomized, Active-controlled, Multiple-dose, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of the Long-acting Antibody-fused Recombinant Human Growth Hormone (GX-H9) in Adult Growth Hormone Deficiency (AGHD)|Completed||Phase 2|45|Actual|Genexine, Inc.||3|||f||||t||||||||||2017-10-10 21:39:37.858125|2017-10-10 21:39:37.858125
NCT02946593|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-12|||January 2017||2017-01-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Stroll Safe Outdoor Fall Prevention Program|Stroll Safe Outdoor Fall Prevention Program|Completed||N/A|24|Actual|New York University||2|||f||||f||||||||||2017-10-10 21:39:37.973903|2017-10-10 21:39:37.973903
NCT02946580|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-02-07|||January 2017||2017-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients|A Double-blind, Randomized, Placebo-controlled Trial of Naloxegol for Prevention of Post-operative Constipation in Spinal Surgery Patients|Recruiting||Phase 4|186|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:39:38.057869|2017-10-10 21:39:38.057869
NCT02946567|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-10-03|||September 2016||2016-09-01|October 2017|2017-10-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|NoisyCity||Game to Improve Hearing Health Care Outcomes|Game to Improve Hearing Health Care Outcomes|Completed||N/A|159|Actual|Photozig, Inc.||2|||f||||||||||||||2017-10-10 21:39:38.185329|2017-10-10 21:39:38.185329
NCT02946554|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-09-22|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|HEP101||Phase II Safety Study of 2 Dose Regimens of HepaStem in Patients With ACLF|Multicenter Phase II Safety and Preliminary Efficacy Study of 2 Dose Regimens of HepaStem in Patients With Acute on Chronic Liver Failure|Recruiting||Phase 2|12|Anticipated|Promethera Biosciences||2|||f||||f||||||||||2017-10-10 21:39:38.269795|2017-10-10 21:39:38.269795
NCT02946541|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2017-03-26|||July 2013||2013-07-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin|A Randomized, Double-blind, Placebo-controlled, Phase III Clinical Trial to Investigate the Efficacy and Safety of Evogliptin After Oral Administration in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Diet and Exercise|Completed||Phase 3|160|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:39:38.408661|2017-10-10 21:39:38.408661
NCT02946528|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Urgent-start Peritoneal Dialysis in ESRD Patients：Safety and Efficacy|A Multi-center Clinical Tial of Safety and Efficacy of Urgent-start Peritoneal Dialysis in ESRD Patients|Not yet recruiting||N/A|200|Anticipated|RenJi Hospital||2|||f||||t||||||||No||2017-10-10 21:39:38.514335|2017-10-10 21:39:38.514335
NCT02946515|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-15|||July 27, 2017|Actual|2017-07-27|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SIM-PLICITY||The SIM-PLICITY Study: The SIMulation Project - LIstening & Intervention in Pediatric obeSITY|Virtual Role-Plays to Reduce the Occurrence of Childhood Obesity|Recruiting||N/A|100|Anticipated|HealthPartners Institute||2|||f||||f|f|f||||||||2017-10-10 21:39:38.618752|2017-10-10 21:39:38.618752
NCT02946502|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-05-02|||January 17, 2017||2017-01-17|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|GRIPWEAN||Handgrip Strength Value in Predicting Mechanical Ventilation Weaning|Prognostic Value of Dominant Hand Held Dynamometry in Mechanical Ventilation Weaning: a Prospective, Multicenter Study|Recruiting||N/A|240|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 21:39:38.723521|2017-10-10 21:39:38.723521
NCT02946489|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-08-07|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Facilitating the Behavioral Treatment of Cannabis Use Disorder|Facilitating the Behavioral Treatment of Cannabis Use Disorder|Recruiting||Phase 2/Phase 3|15|Anticipated|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-10 21:39:38.801415|2017-10-10 21:39:38.801415
NCT02946476|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||November 2009||2009-11-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|NCC-HF||Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients|Prevalence and Prognostic Impact of Noncardiac Comorbidities in Heart Failure Outpatients With Preserved and Reduced Ejection Fraction: A Community-Based Study|Completed||N/A|2314|Actual|Ospedale Maggiore Di Trieste|||2||f||||f||||||||||2017-10-10 21:39:38.877289|2017-10-10 21:39:38.877289
NCT02946463|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-07-28|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ALXN1210 Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)|A Phase 3, Randomized, Open-Label, Active-Controlled Study of ALXN1210 Versus Eculizumab in Complement Inhibitor-Naïve Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)|Active, not recruiting||Phase 3|246|Actual|Alexion Pharmaceuticals||2|||f||||||||||||||2017-10-10 21:39:38.9567|2017-10-10 21:39:38.9567
NCT02946450|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||March 2014||2014-03-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01|14 Days|Observational [Patient Registry]|||Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients|Multi-center, Prospective, Non-interventional, Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients|Recruiting||N/A|3000|Anticipated|Daewoong Pharmaceutical Co. LTD.|||1||f||||f||||||||No||2017-10-10 21:39:39.425708|2017-10-10 21:39:39.425708
NCT02946398|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-06-23|||July 14, 2016|Actual|2016-07-14|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|May 2, 2017|Actual|2017-05-02||Observational|RiSEuP||Risk Stratification in the Emergency Department in Acutely Ill Older Patients|Risk Stratification in Elderly Patients in the Emergency Department|Active, not recruiting||N/A|600|Actual|Zuyderland Medisch Centrum|||1||f||||f||||||Samples Without DNA|"     Venous serum samples: 2. These samples will only be taken in patients who are enrolled in the     study in Zuyderland MC (450 patients - anticipated).   "|No||2017-10-10 21:39:39.782873|2017-10-10 21:39:39.782873
NCT02946385|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-10-02|||November 15, 2016|Actual|2016-11-15|October 2017|2017-10-01|March 12, 2018|Anticipated|2018-03-12|March 12, 2018|Anticipated|2018-03-12||Interventional|||Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents|A Phase 2b Open-Label Multi-Center Study Assessing the Immunological Persistence of Antibodies at Approximately 2 Years After the Last Meningococcal Vaccination in Study V102_15 (NCT02212457) and the Response to a Booster Dose of GSK MenABCWY or Meningococcal Serogroup B Vaccines, in Healthy Adolescents|Active, not recruiting||Phase 2|750|Anticipated|GlaxoSmithKline||6|||f|||||f|f||||||||2017-10-10 21:39:39.863751|2017-10-10 21:39:39.863751
NCT02946372|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-01|||November 2016||2016-11-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|February 2017|Actual|2017-02-01||Interventional|ILMT||Evaluation of a New Surgical Technique for Macular Hole Which Was Not Closed After a Previous Surgery|Transposition of Internal Limiting Membrane in the Treatment of Macular Holes. A Descriptive Pilot Study|Completed||N/A|16|Actual|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace||1|||f||||f||||||||||2017-10-10 21:39:40.009585|2017-10-10 21:39:40.009585
NCT02946359|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-01|||July 2016||2016-07-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||A+C in Metastatic Lung Adenocarcinoma Cancer|Crizotinib Combined With Bevacizumab as First-line Therapy in Metastatic Lung Adenocarcinoma Cancer With ALK Translocation or MET Amplification or ROS1 Translocation (CAMAR)|Recruiting||Phase 2|60|Anticipated|Chinese PLA General Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:39:40.089073|2017-10-10 21:39:40.089073
NCT02946346|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-12-06|||November 2016||2016-11-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|PAPCLEAR||Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women|KINETICS AND ECOLOGY OF HUMAN PAPILLOMAVIRUS (HPV) GENITAL INFECTIONS IN YOUNG WOMEN|Recruiting||N/A|225|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:39:40.181198|2017-10-10 21:39:40.181198
NCT02946333|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-07-20|||November 25, 2016|Actual|2016-11-25|July 2017|2017-07-01|October 30, 2025|Anticipated|2025-10-30|October 10, 2020|Anticipated|2020-10-10||Observational|QoLMMBuS||A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain|Observational Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain|Recruiting||N/A|450|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 21:39:40.277006|2017-10-10 21:39:40.277006
NCT02946320|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-25|||November 2016||2016-11-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|OPTI-BVS||Optimal Predilatation Technique for BVS Implantation|Optimal Predilatation Technique for BVS Implantation|Not yet recruiting||Phase 3|45|Anticipated|Cardiology Center Agel||3|||f||||f||||||||Yes||2017-10-10 21:39:40.485929|2017-10-10 21:39:40.485929
NCT02946307|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-26|||August 2016||2016-08-01|October 2016|2016-10-01|June 2022|Anticipated|2022-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Assess the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease|A Prospective, Multi-center, Randomized, Controlled Clinical Trial, Assessing the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease in Chinese Population With Coronary Heart Disease|Active, not recruiting||N/A|260|Anticipated|ZhuHai Cardionovum Medical Device Co., Ltd.||3|||f||||||||||||||2017-10-10 21:39:40.571021|2017-10-10 21:39:40.571021
NCT02946294|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-02-20|||October 2016||2016-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Modified Pectoral Nerves Block Versus Serratus Plane Block in Major Breast Cancer Surgery|A Comparative Study for Evaluation of the Analgesic Profile of Ultrasound-Guided Modified Pectoral Nerves Block Versus Serratus Plane Block in Major Breast Cancer Surgery|Recruiting||Phase 2|75|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:39:40.679993|2017-10-10 21:39:40.679993
NCT02946281|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-02-06|||December 2016||2016-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Do CHANGE||Do Cardiac Health: Advanced New Generation Ecosystem|Do Cardiac Health: Advanced New Generation Ecosystem|Recruiting||N/A|200|Anticipated|Elisabeth-TweeSteden Ziekenhuis||2|||f||||t||||||||||2017-10-10 21:39:40.788358|2017-10-10 21:39:40.788358
NCT02946268|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-25|||November 2016||2016-11-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Optimal Volume, Rate, and Interval of Bolus Nerve Catheters for Shoulder Surgery|Up-down Sequential Allocation Study to Determine the Optimal Volume, Rate, and Interval of Bolus of Ropivacaine 0.2% in Interscalene Continuous Nerve Catheters for Shoulder Surgery|Not yet recruiting||Phase 4|99|Anticipated|Duke University||3|||f||||f||||||||No||2017-10-10 21:39:40.884|2017-10-10 21:39:40.884
NCT02946255|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-14|||May 16, 2017|Actual|2017-05-16|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Testing the Effectiveness of The Welcome Basket Intervention|Testing the Effectiveness of a Brief, Peer Support Intervention to Facilitate Transition Form Psychiatric Hospitalization|Recruiting||N/A|125|Anticipated|Centre for Addiction and Mental Health||3|||f||||f|f|f||||||||2017-10-10 21:39:40.957733|2017-10-10 21:39:40.957733
NCT02946242|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-20|||October 2016||2016-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Development Of Medical Ultrasound Systems, Accessories, And Components - GE Bangalore|Development Of Medical Ultrasound Systems, Accessories, And Components - GE Bangalore|Recruiting||N/A|150|Anticipated|GE Healthcare||1|||f||||f|f|f|||f|||No||2017-10-10 21:39:41.047411|2017-10-10 21:39:41.047411
NCT02946216|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC|Frequency and Abundance of ALK/ROS1/MET Mutations on Circulating Tumor DNA in Patients With Non-small Cell Lung Cancer Using Single Molecule Amplifcation and Re-sequencing Technology: a Perspective Observational Study|Not yet recruiting||N/A|200|Anticipated|First People's Hospital of Hangzhou|||1||f||||t||||||||||2017-10-10 21:39:41.19474|2017-10-10 21:39:41.19474
NCT02946203|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients|Prospective Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients Undergoing CT and MR Enterography|Recruiting||Phase 4|80|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||No||2017-10-10 21:39:41.259384|2017-10-10 21:39:41.259384
NCT02946190|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-05-05|||October 27, 2016|Actual|2016-10-27|May 2017|2017-05-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||The PertADO Geneva Trial|A Phase II Randomized, Observer-blind Controlled Pilot Study to Compare the Safety and Immunogenicity of Acellular Pertussis Vaccines Including Chemically or Genetically-detoxified Pertussis Toxin in Adolescents Aged 11-15 Years Previously Immunized With Acellular Pertussis Vaccines|Completed||Phase 2|60|Anticipated|University Hospital, Geneva||2|||f||||t||||||||||2017-10-10 21:39:41.343741|2017-10-10 21:39:41.343741
NCT02946177|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-01-18|||January 19, 2017|Actual|2017-01-19|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|DE-FluVac||Effect of Influenza Vaccination on Donor Egg Recipient Outcomes|A Randomized Controlled Trial of the Effect of Influenza Vaccination on Implantation and Pregnancy Rates After Donor Egg Recipient In-Vitro Fertilization|Enrolling by invitation||Phase 4|126|Anticipated|Center for Human Reproduction||2|||f||||f|t|f|||f|||No|We do not plan to share individual participant data (IPD)|2017-10-10 21:39:41.424099|2017-10-10 21:39:41.424099
NCT02946164|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Advancing HIV Prevention and Linkage to Care Among MSM With Gamification|Advancing HIV Prevention and Linkage to Care Among MSM With Gamification|Recruiting||N/A|120|Anticipated|University of California, Berkeley||2|||f||||f||||||||No||2017-10-10 21:39:41.507647|2017-10-10 21:39:41.507647
NCT02946151|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-04|||November 2016||2016-11-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Subcutaneous EEG in Epilepsy|Subcutaneous EEG in Epilepsy - Proof of Concept and Clinical Applications|Recruiting||N/A|40|Anticipated|Zealand University Hospital||1|||f||||f||||||||||2017-10-10 21:39:41.597068|2017-10-10 21:39:41.597068
NCT02946138|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma|A Prospective Phase II Single-institution Trial of Carbon-ion Radiotherapy Combined With Granulocyte-macrophage Colony-stimulating Factor for the Treatment of Hepatocellular Carcinoma|Recruiting||Phase 2|44|Anticipated|Shanghai Proton and Heavy Ion Center||1|||f||||t||||||||No||2017-10-10 21:39:41.677609|2017-10-10 21:39:41.677609
NCT02946125|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-12-06|||October 2016||2016-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil|A Single-Center, Open-Label, Observer-Masked, Active-Controlled, Phase 2 Study of the Safety, Efficacy and Pharmacokinetics of EYN-1601 in Dilation of the Pupil|Completed||Phase 2|12|Actual|Eyenovia Inc.||3|||f||||f||||||||No||2017-10-10 21:39:41.757007|2017-10-10 21:39:41.757007
NCT02946112|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-01-09|||November 2016||2016-11-01|October 2016|2016-10-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01|1 Day|Observational [Patient Registry]|||Shoulder Position in Volleyball Players With Shoulder Pain|Relationship Between Shoulder Position and Neuromuscular Mechanosensitivity in Volleyball Players With Shoulder Pain|Completed||N/A|39|Actual|Cardenal Herrera University|||2||f||||f||||||||Undecided||2017-10-10 21:39:41.835552|2017-10-10 21:39:41.835552
NCT02946099|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-03-26|||November 2016||2016-11-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison Between Reciproc and Protaper Next|Comparison of Postoperative Pain After Root Canal Instrumentation Using Reciproc and ProTaper Next in Asymptomatic Necrotic Molars: A Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:39:41.907774|2017-10-10 21:39:41.907774
NCT02946086|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-10-24|||April 2013||2013-04-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HABIT-ILE_CP||Effect of HABIT-ILE on Visuo-spatial Attention of Children With Unilateral CP|Effect of Rehabilitation in Deficiencies, Activities Limitations and Restrictions of the Participation of the Children Presenting Neurological Lesions. Impact of Contextual Factors on the Functioning of These Patients. Part II|Completed||N/A|35|Actual|Université Catholique de Louvain||2|||f||||f||||||||Undecided||2017-10-10 21:39:41.997419|2017-10-10 21:39:41.997419
NCT02946073|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-01-11|||October 2016||2016-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CAM2038||Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain Currently Treated With Opioids|Recruiting||Phase 3|340|Anticipated|Braeburn Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 21:39:42.201706|2017-10-10 21:39:42.201706
NCT02946060|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|February 2017|Actual|2017-02-01||Interventional|MAINTAIN-II||The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment - II|The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment - II|Active, not recruiting||N/A|169|Anticipated|Toronto Rehabilitation Institute||3|||f||||f||||||||No||2017-10-10 21:39:42.344134|2017-10-10 21:39:42.344134
NCT02946047|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-13|||March 20, 2017|Actual|2017-03-20|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of Ixazomib on the Latent HIV Reservoir|Pilot Study of Ixazomib to Reduce the Number of HIV DNA Positive Lymphoid Cells|Recruiting||Phase 1/Phase 2|17|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 21:39:42.447568|2017-10-10 21:39:42.447568
NCT02946034|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-10-04|||February 1, 2017|Actual|2017-02-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Viekira Pak Treatment for Patient With Chronic Kidney Disease and Hepatitis C|Safety, Efficacy, and Changes in Traditional and Novel Biomarkers of Kidney Function in Patients With Hepatitis C and Advanced Chronic Kidney Disease Treated With Abbvie Viekira Pak Regimen|Recruiting||Phase 4|24|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f|||f|||||2017-10-10 21:39:42.531474|2017-10-10 21:39:42.531474
NCT02946021|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-04-26|||October 2016||2016-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-related Lymphedema|Assessment of Lymphatic Structure and Function Pre- and Post- Treatment and During Recovery in Head and Neck Cancer Patients Using NIR Fluorescence Lymphatic Imaging|Recruiting||Phase 1/Phase 2|5|Anticipated|Tactile Medical||2|||f||||f||||||||No||2017-10-10 21:39:42.640077|2017-10-10 21:39:42.640077
NCT02946008|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-28|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|January 2024|Anticipated|2024-01-01|January 2023|Anticipated|2023-01-01||Interventional|||Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer|A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer|Recruiting||Phase 1|38|Anticipated|University of Michigan Cancer Center||1|||f||||t|f|t|f|f||||||2017-10-10 21:39:42.742589|2017-10-10 21:39:42.742589
NCT02945995|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-02-21|||January 2015||2015-01-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|||Outcome After Arthroscopic Surgery in Patients Treated With PAO|Outcome After Arthroscopic Labrum Surgery in Patients Treated With Periacetabular Osteotomy|Completed||N/A|45|Anticipated|Aarhus University Hospital|||1||f||||t||||||||||2017-10-10 21:39:42.834364|2017-10-10 21:39:42.834364
NCT02945982|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-24|||December 2016||2016-12-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|November 2019|Anticipated|2019-11-01||Interventional|||Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Traditional Chinese Medicine and Entecavir|A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Assess the Efficacy and Safety of Traditional Chinese Medicine Combined With Entecavir and Carvedilol in Moderate and Severe Cirrhotic Portal Hypertension Due to Hepatitis B Virus|Not yet recruiting||Phase 4|240|Anticipated|ShuGuang Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:39:42.896725|2017-10-10 21:39:42.896725
NCT02945969|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-16|||November 2016||2016-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|SUPER||Sodium Lowering and Urinary Protein Reduction Trial|Effect of Dietary Sodium Reduction in Kidney Disease Patients With Albuminuria|Recruiting||Phase 3|150|Anticipated|Tulane University||2|||f||||t||||||||No||2017-10-10 21:39:42.987157|2017-10-10 21:39:42.987157
NCT02945956|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|November 2019|Anticipated|2019-11-01||Interventional|||Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir|A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Assess the Efficacy and Safety of Fuzheng Huayu Combined With Entecavir in Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus|Not yet recruiting||Phase 4|200|Anticipated|ShuGuang Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:39:43.075089|2017-10-10 21:39:43.075089
NCT02945943|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||February 2012||2012-02-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effects of Mobilization in Conjunction With Therapeutic Exercise in Participants With a History of Ankle Sprain|Effects of a Six-week Rehabilitation Program in Conjunction With Thrust Mobilization on Lower Extremity Function in Subjects Reporting Chronic Ankle Instability|Completed||N/A|19|Actual|Shenandoah University||2|||f||||||||||||Yes|Data from subjective and objective outcome measures from all participants obtained prior to and after intervention have been analyzed.|2017-10-10 21:39:43.162694|2017-10-10 21:39:43.162694
NCT02945930|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Observational|||"Study the Safety and Efficacy of Compont Medical Glue in the Treatment of Esophagogastric Varices"|"A Prospective Multicenter, Open Study on the Safety and Efficacy of Compont Medical Glue in the Treatment of Esophagogastric Varices"|Recruiting||N/A|2200|Anticipated|Shanghai Zhongshan Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:39:43.269131|2017-10-10 21:39:43.269131
NCT02945917|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-25|||April 2015||2015-04-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Positive End-expiratory Pressure and Esophageal Catheter Optimal Calibration Volume in ARDS Patients|Positive End-expiratory Pressure and Esophageal Catheter Optimal Calibration Volume in ARDS Patients|Recruiting||N/A|16|Anticipated|San Gerardo Hospital|||1||f||||f||||||||||2017-10-10 21:39:43.371934|2017-10-10 21:39:43.371934
NCT02945904|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-10-25|||October 2016||2016-10-01|August 2016|2016-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|MATCH||IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism||Not yet recruiting||N/A|140|Anticipated|Queen Mary University of London|||1||f||||t||||||Samples With DNA|"     Following adrenalectomy tissue will be genotyped for somatic mutations in KCNJ5, ATP1A1,     ATP2B3, CACNA1D, CTNNB1 and phenotyping by histological grading, gene expression and     immunohistochemistry.   "|Undecided||2017-10-10 21:39:43.432847|2017-10-10 21:39:43.432847
NCT02945891|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-05|||April 2014||2014-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SESAM||SElf-SAMpling in Cervical Cancer Screening; SESAM Study|SElf-SAMpling in Cervical Cancer Screening. SESAM Study; a Key to Better Health. Clinical Validation of a Self-sampling Device in Patients With Cervical Cancer and Cervical Pre-invasive Neoplasia|Active, not recruiting||N/A|310|Actual|Oslo University Hospital||1|||f||||f||||||||No|We can`t make individual participant data available due to restrictions set by the ethical approval and the informed consent. Our data contains several variables with personal health information, including age, dates, test results and diagnoses. Even without direct identifiers, it would be possible for a person to recognize herself from the dataset and that is strictly forbidden.|2017-10-10 21:39:43.49839|2017-10-10 21:39:43.49839
NCT02945683|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-26|||February 2015||2015-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effects of Lactobacillus Reuteri Plus Vitamin D3 in Children With Atopic Dermatitis|Randomized Controlled Trial to Evaluate the Beneficial Effects of a Probiotic Food Supplement in Children With Atopic Dermatitis|Recruiting||N/A|88|Anticipated|Noos S.r.l.||2|||f||||t||||||||No||2017-10-10 21:39:45.042686|2017-10-10 21:39:45.042686
NCT02945878|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-27|||October 2016||2016-10-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|||Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma|Predictive Factors of Acute Oral Mucositis Induced by Intensity-Modulated Radiation Therapy With Concurrent Chemotherapy for Local Advanced Nasopharyngeal Carcinoma|Recruiting||N/A|90|Anticipated|Zhejiang Cancer Hospital|||1||f||||t||||||||No||2017-10-10 21:39:43.596853|2017-10-10 21:39:43.596853
NCT02945865|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|April 2016|Actual|2016-04-01||Interventional|||Systematic Pain Assessment in Nursing Home Residents With Advanced Dementia|Systematic Pain Assessment in Nursing Home Residents With Advanced Dementia; Effect on Pain Management and Patient Outcomes|Active, not recruiting||N/A|112|Actual|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||No||2017-10-10 21:39:43.672399|2017-10-10 21:39:43.672399
NCT02945852|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.|Phase II Study of Apatinib as Third- or Further-line Treatment for Patients With Extensive Stage Small Cell Lung Cancer|Recruiting||Phase 2|30|Anticipated|Zhejiang Cancer Hospital||1|||f||||||||||||||2017-10-10 21:39:43.755749|2017-10-10 21:39:43.755749
NCT02945839|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-08-09|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department|Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department|Not yet recruiting||Phase 4|90|Anticipated|New York University School of Medicine||2|||f||||f|t|f|||f|||||2017-10-10 21:39:43.836396|2017-10-10 21:39:43.836396
NCT02945826|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-04|||January 2017|Actual|2017-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||uPAR-PET/MRI in Glioblastoma Multiforme|uPAR-PET/MRI in Glioblastoma Multiforme|Recruiting||Phase 2|35|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||No||2017-10-10 21:39:43.930798|2017-10-10 21:39:43.930798
NCT02945813|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-10-02|||September 6, 2017|Actual|2017-09-06|October 2017|2017-10-01|December 2029|Anticipated|2029-12-01|December 2018|Anticipated|2018-12-01||Interventional|||SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy|SAKK 08/15 - PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy|Recruiting||Phase 2|170|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||t|f|f||||||||2017-10-10 21:39:44.035673|2017-10-10 21:39:44.035673
NCT02945800|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-02|||October 21, 2016||2016-10-21|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma|Phase II Study of Nab-Paclitaxel in Combination With Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults|Recruiting||Phase 2|72|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 21:39:44.202174|2017-10-10 21:39:44.202174
NCT02945787|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-18|||October 24, 2016|Actual|2016-10-24|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Spanish-Language Smoking Cessation Trial|Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-Language Trial|Recruiting||N/A|1240|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:39:44.357673|2017-10-10 21:39:44.357673
NCT02945774|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||August 2016||2016-08-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|||Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias|Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias|Recruiting||N/A|40|Anticipated|Lawson Health Research Institute||1|||f||||t||||||||||2017-10-10 21:39:44.437953|2017-10-10 21:39:44.437953
NCT02945761|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||High Concentration of Sugar Solution Irrigation Promotes the Healing of Infected Wound|Ningbo NO.4 Hospital,CHINA.|Enrolling by invitation||N/A|3|Anticipated|Ningbo Municipal No.4 Hospital||2|||f||||||||||||||2017-10-10 21:39:44.511025|2017-10-10 21:39:44.511025
NCT02945748|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||July 2016||2016-07-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Observational|||Uninvasive Cardiac Output Monitoring (USCOM) in Critically Ill Children: Validation and Prediction of Hemodynamic Instability|Uninvasive Cardiac Output Monitoring (USCOM) in Critically Ill Children: Validation and Prediction of Hemodynamic Instability|Recruiting||N/A|200|Anticipated|Rabin Medical Center|||1||f||||f||||||||No||2017-10-10 21:39:44.584289|2017-10-10 21:39:44.584289
NCT02945735|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-01-08|||October 2016||2016-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Gaze Contingent Feedback in Major Depressive Disorder (MDD)|Gaze Contingent Feedback in Major Depressive Disorder|Recruiting||N/A|60|Anticipated|Tel Aviv University||2|||f||||f||||||||No||2017-10-10 21:39:44.64416|2017-10-10 21:39:44.64416
NCT02945722|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|CIBERSTAPH||Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers|Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers on the Occurrence of S. Aureus Infections in Hemodialysis Patients|Not yet recruiting||Phase 4|850|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 21:39:44.733308|2017-10-10 21:39:44.733308
NCT02945709|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-02-19|||October 2016||2016-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Attention Control Treatment for Post Traumatic Stress Disorder ׂ(PTSD)|Attention Control Treatment for Post Traumatic Stress Disorder|Recruiting||N/A|60|Anticipated|Tel Aviv University||3|||f||||f||||||||No||2017-10-10 21:39:44.859654|2017-10-10 21:39:44.859654
NCT02945696|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Abdominal Wall Nerve Blockade: A Comparison With Local Port Site Injection as Well as Between the Use of Ultrasound and Laparoscopy to Guide Placement|Abdominal Wall Nerve Blockade: A Comparison With Local Port Site Injection as Well as Between the Use of Ultrasound and Laparoscopy to Guide Placement|Active, not recruiting||N/A|150|Anticipated|University of Pittsburgh||3|||f||||f||||||||No||2017-10-10 21:39:44.940277|2017-10-10 21:39:44.940277
NCT02945670|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-25|||November 2016||2016-11-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Observational|||Using Focus Group to Explore Cultural Acceptability of Contraception|Using Focus Group to Explore Cultural Acceptability of Long Acting Contraception in a Diverse, Urban Population.|Not yet recruiting||N/A|84|Anticipated|University of Pittsburgh|||1||f||||f||||||||No||2017-10-10 21:39:45.148752|2017-10-10 21:39:45.148752
NCT02945657|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-29|||October 2016||2016-10-01|August 2017|2017-08-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|||Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis|Protocol MEDI-MM36-206: A Phase 2 Multi-center, Open-label Study to Assess Pharmacokinetic Parameters and Safety of Topical MM36 (1%) in Pediatric Subjects 2 to < 18 Years of Age With Atopic Dermatitis Under Maximal Use Conditions|Completed||Phase 2|32|Actual|Medimetriks Pharmaceuticals, Inc||1|||f||||t||||||||||2017-10-10 21:39:45.216787|2017-10-10 21:39:45.216787
NCT02945644|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-30|||February 13, 2017|Actual|2017-02-13|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|TrazoDose||Trazodone Dose Tolerance and APAP Adherence|Randomized Controlled Trial of Trazodone Dose Tolerance and APAP Adherence|Recruiting||Phase 1|45|Anticipated|Louis Stokes VA Medical Center||3|||f||||t|t|f|||f|||No||2017-10-10 21:39:45.330878|2017-10-10 21:39:45.330878
NCT02945631|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||April 2016||2016-04-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Quarterback 2 - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer|Quarterback 2: A Phase II Clinical Trial of Sequential Therapy and De-Intensified Chemoradiotherapy for Locally Advanced HPV Positive Oropharynx Cancer|Recruiting||Phase 2|65|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||No||2017-10-10 21:39:45.461204|2017-10-10 21:39:45.461204
NCT02945618|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-08-29|||June 2015||2015-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Neurocryostimulation for Acute Lateral Ankle Sprain|Neurocryostimulation for the Treatment of Acute Lateral Ankle Sprain : a Single Blind Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 21:39:45.571041|2017-10-10 21:39:45.571041
NCT02945605|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-03-13|||March 9, 2017|Actual|2017-03-09|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of Early Vestibular Rehabilitation in Patients With Dizziness and Balance Disorders After Sport Concussion|Effects of Early Vestibular Rehabilitation Compared to Standard Care in Patients With Dizziness and Balance Disorders After Sport and Recreation Concussion|Recruiting||N/A|72|Anticipated|University of Michigan||2|||f||||f|f|f||||||No||2017-10-10 21:39:45.675126|2017-10-10 21:39:45.675126
NCT02945592|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Active Cue-Training in Neglect|Active Cue-Training in Neglect|Recruiting||N/A|24|Anticipated|Klinikum Bremen Ost||2|||f||||f||||||||Undecided||2017-10-10 21:39:45.764333|2017-10-10 21:39:45.764333
NCT02945579|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-14|||January 20, 2017|Actual|2017-01-20|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Eliminating Breast Cancer Surgery in Exceptional Responders With Neoadjuvant Systemic Therapy|Eliminating Breast Cancer Surgery in Exceptional Responders With Neoadjuvant Systemic Therapy|Recruiting||N/A|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|f|f||||||||2017-10-10 21:39:45.835917|2017-10-10 21:39:45.835917
NCT02945566|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-06-26|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|STAR-TREC||Can the Rectum be Saved by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?|STAR-TREC:Can the Rectum be Saved by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer|Not yet recruiting||Phase 2|120|Anticipated|University of Birmingham||3|||f||||t|f|f||||||No||2017-10-10 21:39:45.921637|2017-10-10 21:39:45.921637
NCT02945553|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Prevention of Skeletal Muscle Adaptations to Traumatic Knee Injury and Surgery||Recruiting||Phase 1/Phase 2|20|Anticipated|University of Vermont||2|||f||||t||||||||Yes|Research data (deidentified) which documents, supports and validates research findings will be stored on the University of Vermont College of Medicine computer system and will be made available upon final acceptance for publication of the major findings from the proposed studies. This includes raw data generated from all clinical and laboratory-based assessments under a data-sharing agreement.|2017-10-10 21:39:46.1429|2017-10-10 21:39:46.1429
NCT02945540|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-10-24|||April 2016||2016-04-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|SATISFYDG||"Assessment of Patient Satisfaction Program Gestational Diabetes"|"Assessment of Patient Satisfaction Supported in the Patient Education Program Gestational Diabetes at the University Hospital of Caen"|Recruiting||N/A|350|Anticipated|University Hospital, Caen|||1||f||||f||||||||No||2017-10-10 21:39:46.249172|2017-10-10 21:39:46.249172
NCT02945527|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-10-24|||December 2015||2015-12-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)|Open Controled Randomized Pilot Study on the Use of Acetazolamide and Dexamethasone for the Acute Phase of Perilesional Edema in Calcified Neurocysticercosis|Recruiting||Phase 2/Phase 3|24|Anticipated|Universidad Peruana Cayetano Heredia||3|||f||||f||||||||Yes|As a concrete product, the clinical trial should provide base data to implement an affordable therapy for edema-related seizures. The data produced will be published in a peer reviewed journal.|2017-10-10 21:39:46.336862|2017-10-10 21:39:46.336862
NCT02945514|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-04-18|||September 2016||2016-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Providing Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response.|Validation of the Measurement and Prediction of the Postprandial Glycemic Response to Food and Providing Personally Tailored Dietary Recommendations|Recruiting||N/A|500|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Whole blood and Stool   "|Undecided||2017-10-10 21:39:46.450269|2017-10-10 21:39:46.450269
NCT02945124|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01||||December 2019|Anticipated|2019-12-01||Interventional|||Taping for Children With and Without Movement Clumsiness|The Effects of K-Tape on Walking Pattern, Muscle Activity, and Motor Performance in Children With and Without Developmental Coordination Disorder: a Randomized Controlled Trial|Active, not recruiting||N/A|200|Anticipated|The University of Hong Kong||4|||f||||t||||||||No||2017-10-10 21:39:51.909441|2017-10-10 21:39:51.909441
NCT02945488|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-24|||August 2016||2016-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|IBDPreconcep||Exercise and Nutrition in IBD & Preconception|Exercise and Nutrition as Treatment Alternatives in Women With Inflammatory Bowel Disease During Preconception: Saskatchewan Multidisciplinary Inflammatory Bowel Diseases Clinic (MDIBDC)|Recruiting||N/A|20|Anticipated|University of Saskatchewan||4|||f||||f||||||||No||2017-10-10 21:39:46.680388|2017-10-10 21:39:46.680388
NCT02945475|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-03-15|||February 2016||2016-02-01|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Neural Mechanisms for Appetitive Responses to High Reward Foods|Neural Mechanisms for Appetitive Responses to High Reward Foods|Recruiting||N/A|120|Anticipated|University of Southern California|||3||f||||t||||||Samples With DNA|"     Blood Samples   "|||2017-10-10 21:39:46.813091|2017-10-10 21:39:46.813091
NCT02945462|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-11-15|||September 2013||2013-09-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|November 2015|Actual|2015-11-01||Interventional|||Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED)|The Safety and Efficacy of Using Bone Marrow-derived Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction in Diabetic Patients|Completed||Phase 1|4|Actual|University of Jordan||1|||f||||f||||||||Undecided||2017-10-10 21:39:46.914633|2017-10-10 21:39:46.914633
NCT02945449|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-05-03|||January 4, 2017|Actual|2017-01-04|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Use of Wharton Jelly in Erectile Dysfunction|Phase Ib: Comparative Evaluation of the Safety and as a Secondary End Point the Effectiveness for Three Different Dosage of Wharton Jelly Stem Cells for the Treatment of Erectile Dysfunction in Diabetic Patients.|Recruiting||Phase 1/Phase 2|15|Anticipated|University of Jordan||3|||f||||t|f|f|||f|||Undecided||2017-10-10 21:39:46.988695|2017-10-10 21:39:46.988695
NCT02945436|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-04-14|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|June 2020|Anticipated|2020-06-01||Interventional|Swerve||Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention|Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use|Recruiting||N/A|600|Anticipated|University of Michigan||4|||f||||t|f|f||||||No||2017-10-10 21:39:47.096356|2017-10-10 21:39:47.096356
NCT02945423|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-03|||December 2016||2016-12-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|A-CAT||Improving the Understanding of Catatonia in Autism|Improving the Understanding of Catatonia in Autism|Not yet recruiting||N/A|30|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"     DNA: one 8ml vial of blood will be drawn and stored for future DNA analysis. DNA will be     stored as part of the Heinz C. Prechter Genetics Repository.Once the DNA is extracted and     genotyped, researchers will sequence the genetic information for specific variants. All     samples and data will be de-identified.   "|Undecided||2017-10-10 21:39:47.213514|2017-10-10 21:39:47.213514
NCT02945410|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Effect of Caloric Restriction and Protein Intake on Metabolism and Anabolic Sensitivity|Can Increased Dietary Protein Prevent the Suppression of Metabolism and Maintain Anabolic Sensitivity of Bone and Skeletal Muscle During Caloric Restriction?|Recruiting||N/A|24|Anticipated|University of Nebraska Lincoln||3|||f||||f||||||||No||2017-10-10 21:39:47.286953|2017-10-10 21:39:47.286953
NCT02945397|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-01-24|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||"Effect Evaluation of the Work Rehabilitation Effort Best iLag"|"Effect Evaluation of the Work Rehabilitation Effort Best iLag"|Active, not recruiting||N/A|168|Actual|Uni Research||2|||f||||f||||||||No||2017-10-10 21:39:47.441984|2017-10-10 21:39:47.441984
NCT02945384|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-10-24|||September 2013||2013-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Broader Implementation of a Successful Dual-Generation Intervention in Partnership With Head Start of Lane County|Broader Implementation of a Successful Dual-Generation Intervention in Partnership With Head Start of Lane County|Recruiting||N/A|2800|Anticipated|University of Oregon||2|||f||||f||||||||||2017-10-10 21:39:47.572049|2017-10-10 21:39:47.572049
NCT02945371|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|REV||Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life|Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life|Completed||N/A|103|Actual|University of Oregon||2|||f||||f||||||||No||2017-10-10 21:39:47.712868|2017-10-10 21:39:47.712868
NCT02945358|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-02-28|||September 2016||2016-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Assessment of OHIR Score to Predict a Prolonged Intensive Care Unit Stay|Assessment of OHIR Score to Predict a Prolonged Intensive Care Unit Stay for Adult Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Completed||N/A|120|Actual|Khon Kaen University|||1||f||||f||||||||No||2017-10-10 21:39:47.829864|2017-10-10 21:39:47.829864
NCT02945345|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-10-24|||June 2008||2008-06-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|CDASI||Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)|Evaluation of Clinical Responsiveness Using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)|Recruiting||N/A|300|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Blood, skin tissue biopsies   "|||2017-10-10 21:39:47.917484|2017-10-10 21:39:47.917484
NCT02945332|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-08-25|||October 2016||2016-10-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Incentivizing Lifestyle Modification to Reduce Disease Burden||Completed||N/A|8|Actual|Texas Tech University||2|||f||||f||||||||||2017-10-10 21:39:47.988835|2017-10-10 21:39:47.988835
NCT02945319|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-25|||January 2017||2017-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma||Not yet recruiting||N/A|300|Anticipated|International Extranodal Lymphoma Study Group (IELSG)|||1||f||||f||||||||||2017-10-10 21:39:48.078027|2017-10-10 21:39:48.078027
NCT02945306|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-03-10|||December 2016||2016-12-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Sleep Disordered Breathing, Adenotonsillectomy, Cognition and Pre-school Age Children|Does Sleep Disordered Breathing in Pre School Age Children Cause Cognitive Weakness Reversible by Adenotonsillectomy? A Feasibility Study|Recruiting||N/A|40|Anticipated|South Tees Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:39:48.140312|2017-10-10 21:39:48.140312
NCT02945293|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-03-08|||November 2015||2015-11-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|CAAP||Cognitive, Behavioral and Aging Effects of Pain Medication in Alcohol Users|Cognitive, Behavioral and Aging Effects of Pain Medication in Alcohol Users|Recruiting||Phase 4|120|Anticipated|Seattle Institute for Biomedical and Clinical Research||1|||f||||t||||||||No|VAPSHCS IRB ISO, and PO do not allow the sharing of data, even de-identified data with other investigators- if VA regulations allow data sharing, then the investigators will be allowed to share data|2017-10-10 21:39:48.22334|2017-10-10 21:39:48.22334
NCT02945280|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-02-27|||February 22, 2017|Actual|2017-02-22|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|ARM-DVT||Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis|Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis|Recruiting||Phase 4|375|Anticipated|Intermountain Health Care, Inc.||1|||f||||t|t|f|||f|||No||2017-10-10 21:39:48.327276|2017-10-10 21:39:48.327276
NCT02945267|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||September 2016||2016-09-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer|A Randomized, Controlled, Double Blind, Multicenter Study of Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Advanced or Metastatic Pancreatic Cancer After First-line Treatment|Not yet recruiting||Phase 4|60|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||Yes||2017-10-10 21:39:48.446354|2017-10-10 21:39:48.446354
NCT02945254|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-16|||August 2016||2016-08-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|Noise||Effect of Background Noise on Sleep Quality|Effect of Continuous Background Noise at Specific Frequencies on Objective and Subjective Sleep Quality|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 21:39:49.163035|2017-10-10 21:39:49.163035
NCT02945241|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-01-03|||April 2014||2014-04-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Interventional|||Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project|Impact of Cystatin-C C-guided Vancomycin Dosing Recommendation on Target Trough Achievement and Clinical Outcomes in Critically Ill Adults|Completed||Phase 1|399|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:39:49.270912|2017-10-10 21:39:49.270912
NCT02945228|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-08-02|||October 26, 2016||2016-10-26|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2|Drug Use-Results Survey in Patients Infected With Hepatitis C Virus Genotype 2|Recruiting||N/A|480|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:39:49.404469|2017-10-10 21:39:49.404469
NCT02945215|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-04-10|||November 2016||2016-11-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study to Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma Patients|A Multicenter, Randomized, Double-blinded, Parallel Controlled Study to Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma Patients|Recruiting||Phase 1|140|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||2|||f||||f||||||||No||2017-10-10 21:39:49.711205|2017-10-10 21:39:49.711205
NCT02945202|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-26|||January 2017||2017-01-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Influence of Trabeculectomy and Phaco-trabeculectomy on Corneal Astigmatism|Einfluss Der Trabekulektomie Und Der Kombinierten Phako-Trabekulektomie Auf Den Kornealen Astigmatismus|Not yet recruiting||N/A|150|Anticipated|University of Zurich||1|||f||||t||||||||No||2017-10-10 21:39:49.813499|2017-10-10 21:39:49.813499
NCT02945189|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-18|||October 2016|Actual|2016-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Observational|||Urine Sample Collection From Non Pregnant Peri and Post-menopausal Women|Collection of Urine Samples From Non-pregnant Peri and Post-menopausal Women|Active, not recruiting||N/A|300|Anticipated|SPD Development Company Limited|||2||f||||f||||||Samples With DNA|"     Urine samples collected and stored   "|No|This is a sample collection study only, no research IPD available|2017-10-10 21:39:49.878386|2017-10-10 21:39:49.878386
NCT02945176|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-08-15|||March 2015||2015-03-01|August 2017|2017-08-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|||Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation|A Prospective Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of ARGOS-IO System in Patients Undergoing Implantation of a Boston Keratoprosthesis (BKPro)|Completed||N/A|12|Actual|Implandata Ophthalmic Products GmbH||1|||f||||t||||||||||2017-10-10 21:39:49.931786|2017-10-10 21:39:49.931786
NCT02945163|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2016-10-25|||January 2017||2017-01-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy||Not yet recruiting||Phase 4|184|Anticipated|Shanghai Public Health Clinical Center||2|||f||||||||||||||2017-10-10 21:39:50.016854|2017-10-10 21:39:50.016854
NCT02945150|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-28|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant|A Proof of Concept Study of Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant|Recruiting||Phase 4|11|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f|||f|||||2017-10-10 21:39:51.73937|2017-10-10 21:39:51.73937
NCT02945137|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-04-25|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||Optimal Site for Rapid Urease Test in the Stomach|Comparison of Rapid Urease Test Between the Gastric Body and Antrum in Helicobacter Pylori-Infected Stomach|Recruiting||N/A|300|Anticipated|Soonchunhyang University Hospital|||1||f||||t||||||Samples Without DNA|"     Biospecimen would be obtained for urease test (commercial name: CLOtest).   "|No||2017-10-10 21:39:51.838606|2017-10-10 21:39:51.838606
NCT02945111|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Watching Live VIA/VILI Examinations on a Digital Screen May Reduce Patients' Anxiety|Watching Live VIA/VILI Examinations on a Digital Screen May Reduce Patients' Anxiety: a Randomized Trial of an Educational Intervention|Completed||N/A|122|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 21:39:51.983519|2017-10-10 21:39:51.983519
NCT02945098|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Kinesio Taping in Muscle Damage Response Induced by Eccentric Exercise|Kinesio Taping® Does Not Interfere in Muscle Damage Response Induced by Eccentric Exercise: a Randomized Controlled Trial|Completed||N/A|60|Actual|Universidade Federal do Rio Grande do Norte||3|||f||||f||||||||No||2017-10-10 21:39:52.050798|2017-10-10 21:39:52.050798
NCT02945085|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||3D Team Care for Cognitively Vulnerable Older Adults|3D Team Care for Cognitively Vulnerable Older Adults|Not yet recruiting||N/A|1140|Anticipated|UConn Health||2|||f||||t||||||||No||2017-10-10 21:39:52.119908|2017-10-10 21:39:52.119908
NCT02945072|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-28|||January 2017||2017-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|PST||Clinical Study of Behavior Problems in Children After Different Anesthesia Methods|Postoperative Behavior in Children: A Comparison of Inhalation Anesthesia (Sevoflurane) Versus Total Intravenous Anesthesia (TIVA)|Not yet recruiting||Phase 4|500|Anticipated|University Children's Hospital, Zurich||2|||f||||t||||||||No||2017-10-10 21:39:52.203885|2017-10-10 21:39:52.203885
NCT02945059|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|EMBORES||Reversible Portal Vein Embolization Before Major Hepatectomy|Multicentric Prospective Study Assessing the Efficiency of Preoperative Reversible Selective Portal Vein Embolization in Patients Requiring Major Hepatic Resection|Not yet recruiting||Phase 1|50|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 21:39:52.301359|2017-10-10 21:39:52.301359
NCT02945046|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-09-29|||November 30, 2016|Actual|2016-11-30|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)||Recruiting||Phase 3|300|Anticipated|Teva Pharmaceutical Industries||3|||f||||f|t|f||||||||2017-10-10 21:39:52.401375|2017-10-10 21:39:52.401375
NCT02945033|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-24|||December 2016||2016-12-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|ASPIK French||Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk|French Prospective Randomised Double Blind Study, on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation|Not yet recruiting||Phase 3|264|Anticipated|University Hospital, Rouen||2|||f||||f||||||||Undecided||2017-10-10 21:39:52.771405|2017-10-10 21:39:52.771405
NCT02945020|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-06-07|||November 10, 2016|Actual|2016-11-10|June 2017|2017-06-01|January 20, 2017|Actual|2017-01-20|January 9, 2017|Actual|2017-01-09||Interventional|||A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants|A Phase 1, Open-label, Sequential Study to Investigate the Pharmacokinetic Interaction Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Subjects|Completed||Phase 1|15|Actual|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-10 21:39:52.88028|2017-10-10 21:39:52.88028
NCT02945007|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-07-18|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-53718678 Administered as Oral Concept Formulation Compared to the Current Oral Solution and to Assess the Effect of Food on the Pharmacokinetics of Oral Concept Formulation|A Phase 1, Open-label, Randomized Crossover Study, in Healthy Adult Subjects to Assess the Relative Oral Bioavailability of a Single 500-mg Dose of JNJ-53718678 Administered as (an) Oral Concept Formulation(s) Compared to the Current Oral Solution and to Assess the Effect of Food on the Pharmacokinetics of (an) Oral Concept Formulation(s)|Recruiting||Phase 1|48|Anticipated|Janssen Research & Development, LLC||4|||f||||f|f|f||||||||2017-10-10 21:39:52.959378|2017-10-10 21:39:52.959378
NCT02944994|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-10-02|||December 2014||2014-12-01|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Effectiveness of a Unified Transdiagnostic Treatment in Routine Care|Effectiveness of a Unified Transdiagnostic Treatment in Routine Clinical Care|Recruiting||N/A|50|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 21:39:53.063786|2017-10-10 21:39:53.063786
NCT02944981|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-05-10|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Gabapentin to Reduce Postoperative Nausea and Vomiting|Gabapentin Premedication to Reduce Postoperative Nausea and Vomiting in Surgical Patient Receiving Spinal Morphine|Completed||Phase 4|80|Actual|Khon Kaen University||2|||f||||f||||||||No||2017-10-10 21:39:53.15247|2017-10-10 21:39:53.15247
NCT02944968|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-07-25|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|June 29, 2018|Anticipated|2018-06-29|March 30, 2018|Anticipated|2018-03-30||Interventional|||Clinical Study for Workflow and Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System for Treating Symptomatic Paroxysmal AF (QDOT-Micro)|Clinical Study for Workflow and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System (the THERMOCOOL SMARTTOUCH® SF-5D Catheter With Temperature Sensing Capabilities and Micro Electrodes and CARTO 3 V 6.0 Technology) in Treatment of Patients With Paroxysmal Atrial Fibrillation (QDOT-Micro)|Recruiting||Phase 1|50|Anticipated|Biosense Webster, Inc.||1|||f||||t|f|f||||||||2017-10-10 21:39:53.243243|2017-10-10 21:39:53.243243
NCT02944955|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-24|||February 2017||2017-02-01|October 2016|2016-10-01||||December 2019|Anticipated|2019-12-01||Interventional|||A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)||Not yet recruiting||Phase 2|52|Anticipated|BioLite, Inc.||1|||f||||t||||||||||2017-10-10 21:39:53.33912|2017-10-10 21:39:53.33912
NCT02944942|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-25|2017-02-28|||September 2016||2016-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Risk Factors for Postoperative Nausea/Vomiting|Risk Factors for Postoperative Nausea/Vomiting After Implementation of Prophylaxis Guideline for High Risk Patients|Completed||N/A|400|Actual|Khon Kaen University|||1||f||||f||||||||No||2017-10-10 21:39:53.419756|2017-10-10 21:39:53.419756
NCT02944929|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-25|||October 2016||2016-10-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|ADJU-TOX||The Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke|Randomised Controlled Trial to Evaluate the Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity (Repeated Botulinum Toxin Injections and Physiotherapy) on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke|Not yet recruiting||Phase 4|220|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 21:39:53.497374|2017-10-10 21:39:53.497374
NCT02944916|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Pilot Study Evaluating the Use of a New Device for Transanal Irrigation in Patient With Bowel Disorders|Pilot Study Evaluating the Use of a New Device for Transanal Irrigation in Patient With Bowel Disorders|Not yet recruiting||N/A|15|Anticipated|BBraun Medical SAS||1|||f||||f||||||||||2017-10-10 21:39:53.593658|2017-10-10 21:39:53.593658
NCT02944903|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-06-10|||October 2016||2016-10-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Observational|||Audit of Lung Cancer Screening Practice in Chest Physicians: An Update|Lung Cancer Screening Practice in Chest Physicians|Completed||N/A|75|Actual|Assiut University|||1||f||||f||||||||Undecided||2017-10-10 21:39:53.668059|2017-10-10 21:39:53.668059
NCT02944890|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-07-26|||May 2016||2016-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis|A Multicenter, Randomized, Controlled Study to Compare the Efficacy and Safety of 2 Types of Drug Eluting Balloon Catheters (RESTORE DEB and SeQuent® Please) in Chinese Patient With Coronary In-stent Restenosis (ISR)|Active, not recruiting||N/A|240|Anticipated|ZhuHai Cardionovum Medical Device Co., Ltd.||2|||f||||||||||||||2017-10-10 21:39:53.739965|2017-10-10 21:39:53.739965
NCT02944877|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-01|||May 2015||2015-05-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||HOPE Social Media Intervention for HIV Testing and Studying Social Networks|HOPE Social Media Intervention for HIV Testing and Studying Social Networks|Recruiting||N/A|600|Anticipated|University of California, Los Angeles||2|||f||||||||||||||2017-10-10 21:39:53.850924|2017-10-10 21:39:53.850924
NCT02944864|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-15|||August 13, 2017|Actual|2017-08-13|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics|Phase I Study of Tolerance and Pharmacokinetics of TQ-B3395 in Patients With Advanced Cancer|Recruiting||Phase 1|35|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f|f|f||||||||2017-10-10 21:39:53.921673|2017-10-10 21:39:53.921673
NCT02944851|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Comparison of the Accuracy of Non-invasive Hemoglobin Measurement (SpHb) and Vena Cava Inferior Ultrasound|Comparison of Noninvasive Two Methods to Monitoring Blood Loss; Inferior Vena Cava (IVC) Ultrasound - Non-invasive Hemoglobin Measurement (SpHb)|Completed||N/A|128|Actual|Haseki Training and Research Hospital|||1||f||||f||||||||||2017-10-10 21:39:53.993016|2017-10-10 21:39:53.993016
NCT02944838|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-31|||July 2016||2016-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Senior Change Makers Study: Improving Physical Activity Environments|Senior Change Makers Study: Improving Physical Activity Environments|Active, not recruiting||N/A|80|Actual|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 21:39:54.073974|2017-10-10 21:39:54.073974
NCT02944825|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|STENTABX||Antibiotic Prophylaxis With Routine Ureteral Stent Removal|A Randomized, Prospective, Single-Blinded Control Trial to Assess the Need for Antibiotic Prophylaxis With Routine Ureteral Stent Removal After Kidney Stone Procedure|Recruiting||N/A|80|Anticipated|University of California, San Diego||2|||f||||f||||||||Yes|Secure Server Data Sharing System|2017-10-10 21:39:54.354475|2017-10-10 21:39:54.354475
NCT02944812|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma|Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma, a Single-Center, Nonrandomized Phase II Clinical Trial|Recruiting||Phase 2|12|Anticipated|Guangdong General Hospital||1|||f||||t||||||||Yes|Data of the trial would be available on the corresponding website after the trial has been finished.|2017-10-10 21:39:54.485358|2017-10-10 21:39:54.485358
NCT02944799|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-06-01|||December 2015||2015-12-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|ALOSTRA||Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis|Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis - Indication and Duration: A Randomized, Double-blind, Placebocontrolled Study to Evaluate the Effects of Discontinuation of Alendronate in Patients With Both Rheumatoid Arthritis and Osteoporosis|Recruiting||Phase 2|160|Anticipated|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-10 21:39:54.617283|2017-10-10 21:39:54.617283
NCT02944786|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-25|||September 2016||2016-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HOPE||Help Overcoming Pain Early - an Adolescent-centered School Health Prevention Program|Help Overcoming Pain Early - an Adolescent-centered School Health Prevention Program When Adolescents Have Chronic Pain|Recruiting||N/A|90|Anticipated|Göteborg University||2|||f||||f||||||||No||2017-10-10 21:39:54.771584|2017-10-10 21:39:54.771584
NCT02944773|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-02-09|||October 2016||2016-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of Facilitated Tucking During the Procedure of Daily Weight on the Level of Stress in Preterm Infants|Assessment of the Effect of Facilitated Tucking During the Procedure of Daily Weight on the Level of Stress in Preterm Infants|Recruiting||N/A|20|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||Yes|september 2018|2017-10-10 21:39:54.886663|2017-10-10 21:39:54.886663
NCT02944760|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Low-level Laser Therapy in Chronic Kidney Disease|Acute Effects of Low-level Laser Therapy in Functional Capacity of Patients With Chronic Kidney Disease: Randomized Clinical Trial|Active, not recruiting||N/A|16|Actual|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||Yes||2017-10-10 21:39:54.989073|2017-10-10 21:39:54.989073
NCT02944747|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-26|||November 2016||2016-11-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Saving Lives With Better Gestational Age Estimation|Saving Lives With Better Gestational Age Estimation: Improving the Accuracy of Recall and Reporting of the Date of Last Menstrual Period (LMP) in Rural Bangladesh|Not yet recruiting||N/A|3200|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||f||||||||Undecided||2017-10-10 21:39:55.089033|2017-10-10 21:39:55.089033
NCT02944734|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-21|||September 2014||2014-09-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension|A Multi-center, Randomized, Double-blind, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy vs. Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension|Completed||Phase 2|392|Actual|Shin Poong Pharmaceutical Co. Ltd.||8|||f||||||||||||||2017-10-10 21:39:55.191394|2017-10-10 21:39:55.191394
NCT02944721|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|November 2020|Anticipated|2020-11-01||Interventional|DOLORISKSEIN||Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer|Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer|Not yet recruiting||N/A|600|Anticipated|Hopital Foch||2|||f||||f||||||||No||2017-10-10 21:39:55.385735|2017-10-10 21:39:55.385735
NCT02944708|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma|A Randomized Phase III Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma|Recruiting||Phase 3|384|Anticipated|Shanghai Proton and Heavy Ion Center||3|||f||||t||||||||||2017-10-10 21:39:55.504724|2017-10-10 21:39:55.504724
NCT02944695|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-22|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|||Audit of Bronchoscopy Practice in Egypt: Adherence to Safety and Infection Control Guidelines|Adherence to Safety and Infection Control Guideline in Bronchoscopy Units|Recruiting||N/A|80|Anticipated|Assiut University|||1||f||||f||||||||No||2017-10-10 21:39:55.683305|2017-10-10 21:39:55.683305
NCT02944669|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-02-01|||June 2016||2016-06-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||ReWalk Personal Device Postmarket Study|Long-Term, Prospective, Non-Interventional Study Monitoring Safety and Training in Patients With Spinal Cord Injuries and Their Trained Companions Recently Initiated With the ReWalk™ Personal Device|Recruiting||N/A|60|Anticipated|ReWalk Robotics, Inc.|||1||f||||f||t|f|f||||Yes|De-identified IPD will be made available after the 3-, 6-, and 12-month intervals.|2017-10-10 21:39:55.930972|2017-10-10 21:39:55.930972
NCT02944656|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-05-16|||December 8, 2016|Actual|2016-12-08|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Gaba||Gabapentin as an Adjunct to Paracervical Block for Perioperative Pain Management|Gabapentin as an Adjunct to Paracervical Block for Perioperative Pain Management for Surgical Abortion: a Randomized Controlled Trial|Recruiting||Phase 4|134|Anticipated|Emory University||2|||f||||t|t|f||||||No||2017-10-10 21:39:56.03004|2017-10-10 21:39:56.03004
NCT02944643|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-01-11|||June 2016||2016-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis|Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis|Completed||N/A|20|Actual|Hunter Holmes Mcguire Veteran Affairs Medical Center||1|||f||||f||||||||No||2017-10-10 21:39:56.130385|2017-10-10 21:39:56.130385
NCT02944630|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Psychotherapy for Patients With Psoriasis: Effects in Quality of Life|Psychotherapy for Patients With Psoriasis: Effects in Quality of Life|Recruiting||N/A|120|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||No||2017-10-10 21:39:56.205116|2017-10-10 21:39:56.205116
NCT02944604|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-26|||June 2016||2016-06-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy||Recruiting||Phase 4|240|Anticipated|Peking University||1|||f||||||||||||||2017-10-10 21:39:56.395003|2017-10-10 21:39:56.395003
NCT02944591|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Observational|||Evaluation of COPD Co-Pilot|Evaluation of COPD Co-Pilot|Recruiting||N/A|100|Anticipated|HGE Health Care Solutions, LLC|||1||f||||f||||||||No||2017-10-10 21:39:56.465257|2017-10-10 21:39:56.465257
NCT02944578|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Topical Curcumin for Precancer Cervical Lesions|Biomolecular Effects of Topical Curcumin in HSIL Cervical Neoplasia|Recruiting||Phase 2|40|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 21:39:56.551493|2017-10-10 21:39:56.551493
NCT02944565|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-23|||February 22, 2017|Actual|2017-02-22|June 2017|2017-06-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Daratumumab in Treating Patients With Multiple Myeloma|Daratumumab Infusion Acceleration|Active, not recruiting||Phase 2|28|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:39:56.66051|2017-10-10 21:39:56.66051
NCT02944552|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-04|||August 18, 2017|Actual|2017-08-18|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Multicenter, Randomized, Double-blind Clinical Trial Was Conducted to Evaluate the Efficacy and Safety of Bicyclol in the Treatment of Acute Drug-induced Liver Injury and to Screen Biomarkers for Prognosis|The Multi Center, Randomized, Double-blind, Positive Controlled Phase II Clinical Trial of Bicyclol Tablets in the Treatment of Acute Drug-induced Liver Injury|Recruiting||Phase 2|240|Anticipated|Drug Induced Liver Disease Study Group||3|||f|||||f|f||||||||2017-10-10 21:39:56.733238|2017-10-10 21:39:56.733238
NCT02944539|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Association Between Mitochondrial DNA Content and Risk of Gastric Cancer|Association Between Mitochondrial DNA Content and Risk of Gastric Cancer|Completed||N/A|600|Actual|Fourth Military Medical University|||2||f||||t||||||Samples With DNA|"     Mitochondria are responsible for multiple cellular functions including regulation of energy     production, modulation of oxidation-reduction status, generation of reactive oxygen species     and apoptosis. Each mitochondrion possesses multiple copies of a mitochondrial genome     comprised of independently replicating double stranded DNA (mtDNA).   "|No||2017-10-10 21:39:56.934781|2017-10-10 21:39:56.934781
NCT02944526|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-11-24|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of 3 Ropivacaine Suprascapular Nerve Blocks in Subacute Adhesive Capsulitis: a Randomized Controlled Trial|The Effect of 3 Ropivacaine Suprascapular Nerve Blocks in Subacute Adhesive Capsulitis: a Randomized Controlled Trial|Recruiting||Phase 4|60|Anticipated|Clinique Saint-Jean, Bruxelles||2|||f||||f||||||||No||2017-10-10 21:39:57.001657|2017-10-10 21:39:57.001657
NCT02944513|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of the Quell Wearable Device for Chronic Low Back Pain||Not yet recruiting||Phase 4|69|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 21:39:57.09937|2017-10-10 21:39:57.09937
NCT02944500|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-01-25|||November 2016||2016-11-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Saxenda: Underlying Mechanisms and Clinical Outcomes|Saxenda: Underlying Mechanisms and Clinical Outcomes|Recruiting||Phase 4|28|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No|Patient data is protected by HIPAA. Results will be published in a peer-reviewed journal.|2017-10-10 21:39:57.156906|2017-10-10 21:39:57.156906
NCT02944487|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||October 2002||2002-10-01|October 2016|2016-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects|A Randomised, Double-blind, Placebo-controlled Ascending Dose Tolerance Study of OGT 923 in Healthy Male Volunteers|Completed||Phase 1|39|Actual|Actelion||4|||f||||f||||||||No||2017-10-10 21:39:57.24624|2017-10-10 21:39:57.24624
NCT02944474|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-25|||December 2003||2003-12-01|October 2016|2016-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects|A Randomised Double-blind, Placebo-controlled, Ascending Multiple Dose Phase 1 Study of CDP923 in Healthy Volunteers to Assess Safety, Tolerability, Pharmacokinetics and Food Effect|Completed||Phase 1|37|Actual|Actelion||5|||f||||f||||||||No||2017-10-10 21:39:57.337432|2017-10-10 21:39:57.337432
NCT02944461|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris|Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris|Recruiting||Phase 4|30|Anticipated|Derm Research, PLLC||1|||f||||f||||||||No||2017-10-10 21:39:57.445218|2017-10-10 21:39:57.445218
NCT02944448|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-07-18|||September 2016||2016-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee|A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee|Completed||Phase 2|480|Actual|Cara Therapeutics, Inc.||4|||f||||f||||||||||2017-10-10 21:39:57.562934|2017-10-10 21:39:57.562934
NCT02944435|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-01-03|||October 2016||2016-10-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Comparative, Pharmacokinetic Study of CB-839 Capsule and Tablet Formulations in Healthy Adults|A Comparative, Randomized, Single-Dose, 2-Way Crossover Pharmacokinetic Comparability Study of CB-839 Administered as Capsule and Tablet Formulations in Healthy Adult Subjects|Completed||Phase 1|14|Actual|Calithera Biosciences, Inc||2|||f||||f||||||||No||2017-10-10 21:39:57.726587|2017-10-10 21:39:57.726587
NCT02944422|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01||||February 2017|Anticipated|2017-02-01||Observational|||The Prevalence of Oral Habits in a Group of Primary School Children in Cairo Governorate|The Prevalence of Oral Habits in a Group of Primary School Children in Cairo Governorate: A Cross-Sectional Study|Not yet recruiting||N/A|624|Anticipated|Cairo University|||2||f||||f||||||||No||2017-10-10 21:39:57.811926|2017-10-10 21:39:57.811926
NCT02944409|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-24|||July 2016||2016-07-01|October 2016|2016-10-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Observational|||VEGA System® Study in the Total Knee Arthroplasty|Prospective Non-interventional, Prospective Multicenter Study of VEGA System® Prosthesis in the Total Knee Arthroplasty|Recruiting||N/A|125|Anticipated|BBraun Medical SAS|||1||f||||f||||||||No||2017-10-10 21:39:57.893371|2017-10-10 21:39:57.893371
NCT02944396|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-17|||December 28, 2016||2016-12-28|July 2017|2017-07-01|June 23, 2018|Anticipated|2018-06-23|September 13, 2017|Anticipated|2017-09-13||Interventional|||Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase 1 Dose-Escalation and Phase 2 Randomized, Open-Label Study of Nivolumab and Veliparib in Combination With Platinum Doublet Chemotherapy in Subjects With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|192|Anticipated|AbbVie||2|||f||||f||||||||||2017-10-10 21:39:57.964869|2017-10-10 21:39:57.964869
NCT02944383|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-08-24|||December 2016||2016-12-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|INDIGO-1||A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia|A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)|Recruiting||Phase 2|104|Anticipated|Gemphire Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 21:39:58.101145|2017-10-10 21:39:58.101145
NCT02944370|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-12-06|||August 2016||2016-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||PlayFit Pilot: Encouraging Social Physical Play in the Community|PlayFit Pilot: Encouraging Social Physical Play in the Community|Completed||N/A|8|Actual|Milton S. Hershey Medical Center||1|||f||||f||||||||||2017-10-10 21:39:58.383183|2017-10-10 21:39:58.383183
NCT02944357|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01||||November 2021|Anticipated|2021-11-01||Interventional|||Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery|Pilot Study of Gemcitabine and Cisplatin Plus AGS-003-BLD in Patients With Muscle-Invasive Bladder Cancer Undergoing Neoadjuvant Cisplatin-Based Chemotherapy|Not yet recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 21:39:58.493309|2017-10-10 21:39:58.493309
NCT02944344|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-29|||December 15, 2016|Actual|2016-12-15|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Four Conversations RCT|Four Conversations Randomized Controlled Trial|Recruiting||N/A|250|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 21:39:58.63508|2017-10-10 21:39:58.63508
NCT02944331|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-08-15|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||3-4 Year Outcomes Following Endovenous Steam Ablation for Venous Insufficiency|3-4 Year Outcomes Following Endovenous Steam Ablation of the Saphenous Veins for the Treatment of Venous Insufficiency|Enrolling by invitation||N/A|200|Anticipated|Lovisenberg Diakonale Hospital|||1||f||||f||||||||||2017-10-10 21:39:58.728044|2017-10-10 21:39:58.728044
NCT02944318|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-24|||March 2014||2014-03-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||The Movement Program for an Active and Healthy Lifestyle in Adolescents|The Movement Program for an Active and Healthy Lifestyle in Adolescents and Its Relationship With School Performance|Recruiting||Early Phase 1|1400|Anticipated|Universidade Federal de Santa Catarina||2|||f||||t||||||||No||2017-10-10 21:39:58.798933|2017-10-10 21:39:58.798933
NCT02944305|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-02-28|||September 2016||2016-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||A Predictive Model for Difficult Intubation|A New Prognostic Model Developed by Using Multi-predictive Tests for Prediction of Difficult Intubation in Adult Anesthetic Patients|Completed||N/A|7500|Actual|Khon Kaen University|||1||f||||f||||||||No||2017-10-10 21:39:58.914889|2017-10-10 21:39:58.914889
NCT02944292|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Effect of Sedation on Intra-abdominal Pressure|Prospective, Interventional Multicentre Study on the Effect of Deepening of Sedation on Intra-abdominal Pressure|Not yet recruiting||Phase 4|40|Anticipated|Tartu University Hospital||1|||f||||f||||||||No||2017-10-10 21:39:58.982527|2017-10-10 21:39:58.982527
NCT02944279|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-23|||January 2011||2011-01-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Neutrophil Elastase and Elafin as Prognostic Biomarker for Acute Respiratory Distress Syndrome||Completed||N/A|500|Actual|Peking University Third Hospital|||5||f||||||||||||No||2017-10-10 21:39:59.069279|2017-10-10 21:39:59.069279
NCT02944266|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-23|||January 2016||2016-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Focussed Echocardiography to Detect Preoperative Hypovolemia and Left Ventricular Dysfunction as a Predictor of Post-Induction Hypotension|Focussed Echocardiography to Detect Preoperative Hypovolemia and Left Ventricular Dysfunction as a Predictor of Post-Induction Hypotension|Recruiting||N/A|150|Anticipated|Postgraduate Institute of Medical Education and Research|||2||f||||f||||||||||2017-10-10 21:39:59.125958|2017-10-10 21:39:59.125958
NCT02944253|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-12|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||What is the Maximum Amount of Carbohydrates That is Still Able to Induce Ketosis and Suppress Appetite?|Ketosis and Appetite Suppression - What is the Maximum Carbohydrate Intake That is Still Associated With Appetite Suppression in a Low Energy Diet?|Recruiting||N/A|100|Anticipated|Norwegian University of Science and Technology||3|||f||||f|f|f||||||||2017-10-10 21:39:59.21432|2017-10-10 21:39:59.21432
NCT02944227|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-10-23|||February 2016||2016-02-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration|Efficacy of Fixed Monthly Dosing of Lucentis® (Ranibizumab) on Subretinal Fluid (SRF) Associated With Persistent Pigment Epithelial Detachment (PED) in Neovascular Age-related Macular Degeneration (AMD): A Pilot Study|Recruiting||Phase 4|20|Anticipated|Seoul National University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:39:59.293182|2017-10-10 21:39:59.293182
NCT02944214|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients|Compare the Renal Protective Effects of Febuxostat and Benzbromarone in Middle-to-late Stages of Chronic Kidney Disease Patients: a Multi-center Randomized Controlled Study|Not yet recruiting||N/A|800|Anticipated|Shanghai 10th People's Hospital||2|||f||||f||||||||No||2017-10-10 21:39:59.37359|2017-10-10 21:39:59.37359
NCT02944201|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-07|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate|Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate|Recruiting||Phase 2|22|Anticipated|Montefiore Medical Center||1|||f||||t||||||||No||2017-10-10 21:39:59.449242|2017-10-10 21:39:59.449242
NCT02944188|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-10-23|||December 2014||2014-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Laparoscopic Versus Open Right Hemicolectomy Within ERAS in Right-sided Colon Cancer|Laparoscopic Versus Open Right Hemicolectomy Within Enhanced Recovery After Surgery(ERAS) Programs in the Treatment of Right-sided Colon Cancer|Recruiting||N/A|500|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 21:39:59.523982|2017-10-10 21:39:59.523982
NCT02944175|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||July 2016||2016-07-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine|Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium Neuromuscular Blockade In Cases Of Supratentorial Tumors: A Comparative Study Between Sugammadex Versus Neostigmine|Enrolling by invitation||N/A|40|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 21:39:59.604766|2017-10-10 21:39:59.604766
NCT02944162|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2016-12-04|||October 2016||2016-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML|Clinical Investigation of Chimeric CD(Cluster of Differentiation)33 Antigen Receptor-modified NK92 Cells in Relapsed and/or Refractory Acute Myeloid Leukemias|Recruiting||Phase 1/Phase 2|10|Anticipated|PersonGen BioTherapeutics (Suzhou) Co., Ltd.||1|||f||||t||||||||Yes|(1) The use of a controlled access approach, using a transparent and robust system to review requests and provide secure data access; (2) Seeking consent for sharing IPD from trial participants in all future clinical trials with adequate assurance that patient privacy and confidentiality can be maintained; and (3) Establishing an approach to resource the sharing of IPD which would include support from trial funders, sponsor organisations and users of IPD.|2017-10-10 21:39:59.677172|2017-10-10 21:39:59.677172
NCT02944149|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-08-01|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Safety of Minilaparotomy Provided by Trained Clinical Officers and Assistant Medical Officers: a Non-inferiority Trial|Safety of Minilaparotomy Provided by Trained Clinical Officers and Assistant Medical Officers: a Non-inferiority Trial|Completed||N/A|1970|Actual|EngenderHealth||2|||f||||t||||||||||2017-10-10 21:39:59.875141|2017-10-10 21:39:59.875141
NCT02944136|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Collaborative Care Intervention for Cancer Caregivers|Collaborative Care Intervention for Cancer Caregivers|Not yet recruiting||N/A|40|Anticipated|University of Pittsburgh||2|||f||||f||||||||No||2017-10-10 21:39:59.978184|2017-10-10 21:39:59.978184
NCT02944123|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-06-08|||September 2016||2016-09-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)|An Open-label, Randomized, Prospective Study Exploring Half Dose of Prasugrel and Ticagrelor in Platelet Response After Acute Coronary Syndromes|Recruiting||Phase 3|100|Anticipated|Dong-A University||3|||f||||t||||||||Undecided||2017-10-10 21:40:00.09209|2017-10-10 21:40:00.09209
NCT02944110|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-09-04|||May 2016||2016-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PX-GRA||Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism|Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism|Enrolling by invitation||N/A|20|Anticipated|University Hospital, Gentofte, Copenhagen||4|||f||||f||||||||||2017-10-10 21:40:00.193493|2017-10-10 21:40:00.193493
NCT02944097|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-05-02|||March 2015||2015-03-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|May 2015|Actual|2015-05-01||Interventional|||Bioavailability of Resveratrol From Vineatrol30 Extract Incorporated Into Micelles|Study of the Oral Bioavailability of Trans-epsilon-viniferin and Trans-resveratrol From Native and Micellar Solubilized vineatrol30 Vine Extract|Completed||Early Phase 1|12|Actual|University of Hohenheim||2|||f||||f||||||||||2017-10-10 21:40:00.28092|2017-10-10 21:40:00.28092
NCT02944084|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|June 2016|Actual|2016-06-01||Interventional|||Absorption and Excretion Kinetics of the Bioactive Ingredients of Rice Bran Extract|Absorption and Excretion Kinetics of the Bioactive Ingredients of Rice Bran Extract|Completed||Early Phase 1|12|Actual|University of Hohenheim||3|||f||||f||||||||||2017-10-10 21:40:00.38701|2017-10-10 21:40:00.38701
NCT02944071|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-03-06|||October 2016||2016-10-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Study of the Boston Scientific Paclitaxel-Coated PTA（Percutaneous Transluminal Angioplasty） Balloon Catheter (Ranger™ and Ranger™ SL (OTW) DCB) in China||Recruiting||N/A|123|Anticipated|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-10 21:40:00.502005|2017-10-10 21:40:00.502005
NCT02944058|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-23|||October 2016||2016-10-01|October 2016|2016-10-01|October 2024|Anticipated|2024-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures|Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures. A RCT|Recruiting||N/A|90|Anticipated|University Hospital, Akershus||2|||f||||t||||||||Yes|De-identified individual participant data for all primary and secondary outcome measures will be made available within 6 months of study completion|2017-10-10 21:40:00.610722|2017-10-10 21:40:00.610722
NCT02944045|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-02-27|||February 15, 2017|Actual|2017-02-15|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|PIC||Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients|Intérêt de la corticothérapie Dans la Pneumocystose Grave du Patient immunodéprimé Non VIH. Essai Prospectif Multicentrique Randomisé Contrôlé : PIC|Recruiting||Phase 3|222|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:40:00.711533|2017-10-10 21:40:00.711533
NCT02944032|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-03-13|||May 2016||2016-05-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|COGTRAIN||Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1|Multimodal Intervention Trial for Cognitive Deficits in Neurofibromatosis Type 1: Efficacy of Computerized Cognitive Training and Stimulant Medication|Recruiting||N/A|130|Anticipated|Children's Research Institute||2|||f||||f||||||||No||2017-10-10 21:40:00.82066|2017-10-10 21:40:00.82066
NCT02944006|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2017-05-30|||December 2016||2016-12-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersampling|Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Including DCE-MRI Based on Incoherent Undersampling|Recruiting||N/A|25|Anticipated|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 21:40:01.011256|2017-10-10 21:40:01.011256
NCT02942095|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-06-22|||March 6, 2017|Actual|2017-03-06|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Study of Ixazomib and Erlotinib in Solid Tumors|A Phase I Study of Ixazomib and Erlotinib in Advanced Solid Tumor Patients|Recruiting||Phase 1|36|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:40:17.853904|2017-10-10 21:40:17.853904
NCT02943993|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-24|2016-10-26|||August 2015||2015-08-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|December 2020|Anticipated|2020-12-01||Observational|ETNA-VTE||Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe|Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe|Recruiting||N/A|2700|Anticipated|Daiichi Sankyo, Inc.|||1||f||||t||||||||Yes||2017-10-10 21:40:01.108578|2017-10-10 21:40:01.108578
NCT02943980|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-06-28|||January 3, 2017|Actual|2017-01-03|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|January 15, 2017|Actual|2017-01-15||Interventional|LiON||Influenced the Type of Laryngoscopy the Intraoperative Nerve Monitoring During Thyroid Surgery|Influenced the Type of Laryngoscopy the Intraoperative Nerve Monitoring During Thyroid Surgery; a Controlled, Randomized Study (LiON-Study)|Enrolling by invitation||N/A|260|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f||||||||No||2017-10-10 21:40:01.231257|2017-10-10 21:40:01.231257
NCT02943967|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-24|||January 2010||2010-01-01|October 2016|2016-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Corneal Cross-linking and Refractive Surface Ablation in Patients With Asymmetric Corneas|Two Years Follow up of Corneal Cor Cross-linking and Refractive Surface Ablation in Patients With Asymmetric Corneal Topography|Completed||N/A|44|Actual|Federal University of São Paulo||2|||f||||f||||||||Yes||2017-10-10 21:40:01.329197|2017-10-10 21:40:01.329197
NCT02943954|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-08-28|||December 2016||2016-12-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|FLOWER-MI||FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction|FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction|Recruiting||N/A|1170|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 21:40:01.48321|2017-10-10 21:40:01.48321
NCT02943928|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-23|2017-02-17|||October 2016||2016-10-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Placement of the Double-Lumen Tube Without Fiberoptic Bronchoscope Assistance|Placement of the Double-Lumen Tube Without Fiberoptic Bronchoscope Assistance|Recruiting||N/A|60|Anticipated|The First Hospital of Qinhuangdao||2|||f||||t||||||||Yes||2017-10-10 21:40:01.746065|2017-10-10 21:40:01.746065
NCT02943915|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-04-07|||September 2016||2016-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|WISE||The WISE Trial - Walking Improvement for SCI With Exoskeleton|The WISE Trial - Walking Improvement for SCI With Exoskeleton|Recruiting||N/A|164|Anticipated|Ekso Bionics||3|||f||||f||||||||Undecided|Undecided|2017-10-10 21:40:01.839338|2017-10-10 21:40:01.839338
NCT02943902|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-05-02|||January 9, 2017|Actual|2017-01-09|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|PCV1+1||Reduced PCV Dosing Schedules in South African Infants|An Open-labeled, Randomized Controlled Trial Evaluating for Non-inferiority of 1+1 Compared to 2+1 Dosing Schedules of 10-valent and 13-valent Pneumococcal Conjugate Vaccine (PCV) in South African Children|Recruiting||Phase 3|600|Anticipated|University of Witwatersrand, South Africa||6|||f||||t||||||||Yes|The data will be made publically available, within one year of completion of the study to any investigators or BMGF nominated partners, who wish to use the data to address any specific questions not directly addressed under the study objectives and which the data would lend itself to|2017-10-10 21:40:02.001457|2017-10-10 21:40:02.001457
NCT02943889|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Stem Cell Transplantation in Cirrhotic Patients|The Role of Bone-marrow Derived Stem Cell Transplantation in Patients With Decompensated Liver Cirrhosis: Clinical Trial|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:40:02.128465|2017-10-10 21:40:02.128465
NCT02943876|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-05-01|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|||The Impact of Disclosing Personalized Depression Risk Information on High-risk Individuals' Outcomes|The Impact of Disclosing Personalized Depression Risk Information on High-risk Individuals' Outcomes|Not yet recruiting||N/A|700|Anticipated|University of Calgary||2|||f||||t|f|f||||||Undecided||2017-10-10 21:40:02.205881|2017-10-10 21:40:02.205881
NCT02943863|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-23|||September 2014||2014-09-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia|Comparison of Regional Ventilation Pattern During High Flow Nasal Cannula Between Conventional Low Flow System Nasal Cannula in Patients With Mild to Moderate Hypoxia|Completed||N/A|24|Actual|Asan Medical Center||2|||f||||||||||||||2017-10-10 21:40:02.296928|2017-10-10 21:40:02.296928
NCT02943850|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-08-01|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||CNS10-NPC-GDNF for the Treatment of ALS|Human Neural Progenitor Cells Secreting Glial Cell Line-Derived Neurotrophic Factor (CNS10-NPC-GDNF) for the Treatment of Amyotrophic Lateral Sclerosis|Recruiting||Phase 1|18|Anticipated|Cedars-Sinai Medical Center||1|||f||||f|t|t|f|||||||2017-10-10 21:40:02.367552|2017-10-10 21:40:02.367552
NCT02943837|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-23|||October 2016||2016-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||EUS-guided Fine Needle Aspiration (EUS-FNA) Versus EUS-guided Fine Needle Biopsy (EUS-FNB) for Diagnosis of Subepithelial Tumors||Not yet recruiting||N/A|61|Anticipated|Asan Medical Center||2|||f||||||||||||||2017-10-10 21:40:02.460324|2017-10-10 21:40:02.460324
NCT02943824|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-25|||August 24, 2017|Actual|2017-08-24|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MOPP||Machine-learning Optimization for Prostate Brachytherapy Planning|Machine-learning Optimization for Prostate Brachytherapy Planning (MOPP): a Randomized-controlled Trial Evaluating Dosimetric Outcomes|Recruiting||N/A|42|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t|f|f||||||||2017-10-10 21:40:02.533579|2017-10-10 21:40:02.533579
NCT02943811|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-22|2016-11-14|||October 2016||2016-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer|Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer: a Multi-centric Study|Completed||N/A|951|Actual|Università degli Studi dell'Insubria|||2||f||||f||||||||No||2017-10-10 21:40:02.6471|2017-10-10 21:40:02.6471
NCT02943798|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-22|2016-10-22|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma|Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma: a Prospective, Randomized, Open-label, Phase 2 Study|Not yet recruiting||Phase 2|118|Anticipated|Shanghai Chest Hospital||2|||f||||f||||||||No||2017-10-10 21:40:02.724094|2017-10-10 21:40:02.724094
NCT02943785|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-24|||March 21, 2017|Actual|2017-03-21|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01||Interventional|||Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)|Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation (TAVI) - in Atrial Fibrillation|Recruiting||Phase 3|1400|Anticipated|Daiichi Sankyo, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:40:02.801522|2017-10-10 21:40:02.801522
NCT02943772|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-22|||September 2016||2016-09-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|||Does Local Cooling of Testis in Patients With Epididymitis Relieve Pain and Reduce Quantity of Analgetics Intake?|Effect of Local Cooling of Testis in Patient With Epididymitis on Analgetics Consumption and Pain Level|Recruiting||N/A|60|Anticipated|Kaplan Medical Center||2|||f||||f||||||||No||2017-10-10 21:40:02.898563|2017-10-10 21:40:02.898563
NCT02943759|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Resolution of Pain and Swelling After the Use of Neem Leaf Extract Compared to Chlorhexidine Gluconate as an Intracanal Irrigant During Pulpectomy|Resolution of Pain and Swelling After the Use of Neem Leaf Extract (Azadirachta Indica) Compared to Chlorhexidine Gluconate as an Intracanal Irrigant in Necrotic Primary Molar Teeth in Children Undergoing Pulpectomy Treatment: A Randomised Controlled Trial|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:40:02.977228|2017-10-10 21:40:02.977228
NCT02943746|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-06-26|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|||Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants|Utilizing Targeted Fortification to Evaluate the Effects of a High Versus Standard Protein Diet on Linear Growth and Body Composition in Infants < 1000 g Birth Weight.|Recruiting||N/A|120|Anticipated|Baylor College of Medicine||2|||f||||t||||||||Yes|Pertinent safety data will be shared with the DSMB.|2017-10-10 21:40:03.055543|2017-10-10 21:40:03.055543
NCT02943733|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-13|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs|Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic Neuroendocrine Tumors|Recruiting||Phase 1|33|Anticipated|University of Wisconsin, Madison||1|||f||||t|t|f||||||||2017-10-10 21:40:03.139232|2017-10-10 21:40:03.139232
NCT02943720|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-11-24|||September 2016||2016-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|ATIBAR||ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen|A Multicentre, Double-blind, Placebo-Controlled, Randomized Trial to Assess the Efficacy and Tolerability of Two Dosing Regimens of AllerT in Adults With Birch Pollen Allergic Rhinitis|Recruiting||Phase 2|400|Anticipated|Anergis||3|||f||||f||||||||Undecided||2017-10-10 21:40:03.268868|2017-10-10 21:40:03.268868
NCT02943707|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|ABMSCIFTLD||Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases.|Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases.|Recruiting||Phase 2|40|Anticipated|Wenzhou Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:40:03.445333|2017-10-10 21:40:03.445333
NCT02943694|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|FSI-TaTME||The Feasibility and Safety of Instruments in Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer|The Feasibility and Safety of Instruments in Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer|Not yet recruiting||Phase 1/Phase 2|32|Anticipated|Ruijin Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:40:03.575246|2017-10-10 21:40:03.575246
NCT02943681|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||A Second Dose of Measles Vaccine (MV) in the Second Year of Life|Boosting the Beneficial Non-specific Effects of Live Attenuated Vaccines: A Randomized Controlled Trial (RCT) of a Second Dose of Measles Vaccine (MV) in the Second Year of Life|Recruiting||N/A|8500|Anticipated|Bandim Health Project||2|||f||||t||||||||No||2017-10-10 21:40:03.659021|2017-10-10 21:40:03.659021
NCT02943668|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-03-31|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|September 2, 2020|Anticipated|2020-09-02|March 2, 2020|Anticipated|2020-03-02||Interventional|||Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome|A Phase II Study of Deferasirox in Patients With Red Blood Cell Transfusion Dependent Myelodysplastic Syndromes|Recruiting||Phase 2|25|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f||||||||2017-10-10 21:40:03.725466|2017-10-10 21:40:03.725466
NCT02943655|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause|Combined Oral Contraceptives, Progestogens, and Non-steroidal Anti-inflammatory Drugs for Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause|Not yet recruiting||Phase 3|240|Anticipated|Assiut University||3|||f||||t||||||||Undecided||2017-10-10 21:40:03.925131|2017-10-10 21:40:03.925131
NCT02943642|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-21|||January 2017||2017-01-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|December 2018|Anticipated|2018-12-01||Interventional|Resimmune®||Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides|Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein (Resimmune®) in Subjects With Mycosis Fungoides: A Phase II Multi-center Randomized Clinical Trial|Not yet recruiting||Phase 2|162|Anticipated|Angimmune LLC||3|||f||||t||||||||Undecided||2017-10-10 21:40:04.045688|2017-10-10 21:40:04.045688
NCT02935270|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Examining Measurement of Behavioral Neglect Post Stroke|Examining Measurement of Behavioral Neglect Post Stroke|Recruiting||N/A|100|Anticipated|Medical University of South Carolina|||1||f||||f||||||||No||2017-10-10 21:41:22.111851|2017-10-10 21:41:22.111851
NCT02943629|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||"A Less-rapid Sequence Anesthetic Induction/Intubation Sequence? Does Apneic Oxygenation by Means of an Oxygenating Laryngoscope Blade Prolong the Duration of Apnea Without Desaturation in Paralyzed Non-obese and Morbidly Obese Patients?"|"A Less-rapid Sequence Anesthetic Induction/Intubation Sequence? Does Apneic Oxygenation by Means of an Oxygenating Laryngoscope Blade Prolong the Duration of Apnea Without Desaturation in Paralyzed Non-obese and Morbidly Obese Patients?"|Recruiting||N/A|50|Anticipated|Vanderbilt University||4|||f||||f||||||||No||2017-10-10 21:40:04.173132|2017-10-10 21:40:04.173132
NCT02943616|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-08-02|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|December 2018|Anticipated|2018-12-01||Interventional|||ABSORB Post-Approval Clinical Study|ABSORB Post-Approval Clinical Study|Not yet recruiting||N/A|2000|Anticipated|Abbott Vascular||1|||f||||t|f|t|f|f||||||2017-10-10 21:40:04.313196|2017-10-10 21:40:04.313196
NCT02943603|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-25|||January 2017||2017-01-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach|A Phase II Study of Perioperative mFOLFOX6 Chemotherapy Plus Pembrolizumab(MK-3475) Combination in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach|Withdrawn||Phase 2|0|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 21:40:04.521283|2017-10-10 21:40:04.521283
NCT02943590|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-02-24|||January 13, 2017|Actual|2017-01-13|February 2017|2017-02-01|May 2022|Anticipated|2022-05-01|June 2021|Anticipated|2021-06-01||Interventional|||STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)|STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)|Recruiting||Phase 2|300|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 21:40:04.620136|2017-10-10 21:40:04.620136
NCT02943577|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-06|||November 2, 2016|Actual|2016-11-02|August 2017|2017-08-01|December 14, 2018|Anticipated|2018-12-14|December 14, 2018|Anticipated|2018-12-14||Interventional|||A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)|A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder|Recruiting||Phase 3|700|Anticipated|Allergan||2|||f||||t|t|f||||||||2017-10-10 21:40:04.747371|2017-10-10 21:40:04.747371
NCT02943564|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-06|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|December 13, 2018|Anticipated|2018-12-13|December 13, 2018|Anticipated|2018-12-13||Interventional|||A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)|A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder|Recruiting||Phase 3|1050|Anticipated|Allergan||3|||f||||t|t|f||||||||2017-10-10 21:40:04.952706|2017-10-10 21:40:04.952706
NCT02943551|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-03-09|||July 18, 2016|Actual|2016-07-18|March 2017|2017-03-01|June 30, 2019|Anticipated|2019-06-30|May 30, 2018|Anticipated|2018-05-30||Interventional|DART||Dialogue Around Respiratory Illness Treatment|Dialogue Around Respiratory Illness Treatment|Recruiting||N/A|7200|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||Yes||2017-10-10 21:40:05.194091|2017-10-10 21:40:05.194091
NCT02943538|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-01-16|||May 2014||2014-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TECCU||Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU)|Clinical Impact of Telemedicine in Crohn's Disease and Ulcerative Colitis: Study Teccu|Completed||N/A|60|Actual|Instituto de Investigacion Sanitaria La Fe||3|||f||||f||||||||No||2017-10-10 21:40:05.397757|2017-10-10 21:40:05.397757
NCT02943525|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-12-19|||November 2016||2016-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Vaginal Packing After Laparoscopic Sacrocolpopexy|Vaginal Packing After Laparoscopic Sacrocolpopexy; Patient Pain and Satisfaction in Short Follow-up and Surgery Outcome and Complications in One Year Follow-up|Recruiting||N/A|100|Anticipated|Charles University, Czech Republic||2|||f||||f||||||||No||2017-10-10 21:40:05.480867|2017-10-10 21:40:05.480867
NCT02943512|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-05-01|||November 2016||2016-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Same Day Discharge|Same Day Discharge|Recruiting||N/A|40|Anticipated|University of Cincinnati||2|||f||||f||||||||Undecided||2017-10-10 21:40:05.570234|2017-10-10 21:40:05.570234
NCT02943499|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-12-15|||October 2016||2016-10-01|December 2016|2016-12-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Mechanisms of Mindfulness for Smoking Cessation|Mechanisms of Mindfulness for Smoking Cessation: Optimizing Quantity and Quality.|Recruiting||N/A|260|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-10 21:40:05.653212|2017-10-10 21:40:05.653212
NCT02943486|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-21|||January 2017||2017-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|MSCDTDFU||Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2|Mesenchymal Stromal Cell Derivatives: a New Alternative and Potential Product for the Treatment of Diabetic Foot Ulcers 1 and 2|Not yet recruiting||Phase 1/Phase 2|51|Anticipated|Universidad Autónoma de Bucaramanga||3|||f||||t||||||||No||2017-10-10 21:40:05.72777|2017-10-10 21:40:05.72777
NCT02943473|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-06-26|||November 2016||2016-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients|A Phase 2 Study of the Effect of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib on Disease Response in Patients With High Risk Smoldering Multiple Myeloma|Recruiting||Phase 2|36|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-10 21:40:05.810927|2017-10-10 21:40:05.810927
NCT02943460|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-10-05|||November 29, 2016|Actual|2016-11-29|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|March 2018|Anticipated|2018-03-01||Interventional|PSC-Phase 2||Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis|A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Primary Sclerosing Cholangitis Without Cirrhosis|Recruiting||Phase 2|50|Anticipated|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 21:40:05.907239|2017-10-10 21:40:05.907239
NCT02943265|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-08-09|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System|Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System (Project Connect)|Not yet recruiting||N/A|1500|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:40:08.969143|2017-10-10 21:40:08.969143
NCT02943447|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-10-05|||December 1, 2016|Actual|2016-12-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|November 2017|Anticipated|2017-11-01||Interventional|PBC-Phase 2||Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis|A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Primary Biliary Cholangitis Without Cirrhosis|Recruiting||Phase 2|75|Anticipated|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 21:40:06.046575|2017-10-10 21:40:06.046575
NCT02943434|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||June 2016||2016-06-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Diet-Induced Thermogenesis: A Comparison of Whole and Processed Foods|Diet-Induced Thermogenesis: A Comparison of Whole and Processed Foods|Completed||Phase 1|12|Actual|Central Washington University||2|||f||||f||||||||No||2017-10-10 21:40:06.179438|2017-10-10 21:40:06.179438
NCT02943421|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||December 2016||2016-12-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|||Transverse B-Lynch in Management of Placenta Accreta|Evaluation of the Efficacy of Transverse B-Lynch in Management of Placenta Accreta|Not yet recruiting||N/A|50|Anticipated|Assiut University|||1||f||||t||||||||No||2017-10-10 21:40:06.235632|2017-10-10 21:40:06.235632
NCT02943408|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-05-24|||July 31, 2017|Anticipated|2017-07-31|May 2017|2017-05-01|June 1, 2022|Anticipated|2022-06-01|January 1, 2022|Anticipated|2022-01-01||Interventional|PCC MH||Development of a Patient Centered Mental Health Intervention for Recent Veterans|Development of a Patient Centered Mental Health Intervention for Recent Veterans|Not yet recruiting||N/A|88|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Yes|Final datasets will be maintained locally until enterprise-level resources become available. Final data sets will be made available to the public upon request as outlined in Question 5 above. Specifically, complete person-level data will be provided as either a Limited Dataset or as a de-identified, anonymized dataset depending on the needs of the requester.|2017-10-10 21:40:06.310171|2017-10-10 21:40:06.310171
NCT02943395|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-21|||January 2017||2017-01-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Color Stability of E.Max CAD Laminate Veneers Cemented With Light Cure Versus Dual Cure Amine Free Adhesive Resin Cement||Not yet recruiting||N/A|16|Anticipated|Cairo University||2|||f||||||||||||||2017-10-10 21:40:06.399749|2017-10-10 21:40:06.399749
NCT02943382|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-10-21|||November 2016||2016-11-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Fingerprick Autologous Blood (FAB) in Mebomian Gland Dysfunction (MGD)|The Use of Fingerprick Autologous Blood (FAB) in the Treatment of Mebomian Gland Dysfunction (MGD)|Not yet recruiting||N/A|20|Anticipated|Bedford Hospital NHS Trust||1|||f||||||||||||Undecided||2017-10-10 21:40:06.458779|2017-10-10 21:40:06.458779
NCT02943369|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-17|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI|Cangrelor Administration Following Ticagrelor Loading vs Ticagrelor Loading Alone in ST Segment Elevation Myocardial Infarction Patients: A Randomized, Pharmacodynamic Study|Recruiting||Phase 4|30|Anticipated|Attikon Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:40:06.519015|2017-10-10 21:40:06.519015
NCT02943356|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||July 2016||2016-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction|Observational Study to Evaluate the Effect of Tadalafil 5mg Once Daily on Erectile Dysfunction and QOL in Andropause Patients With Erectile Dysfunction|Recruiting||Phase 4|40|Anticipated|The Catholic University of Korea||1|||f||||f||||||||Undecided||2017-10-10 21:40:06.609305|2017-10-10 21:40:06.609305
NCT02943343|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||January 2008||2008-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01|3 Years|Observational [Patient Registry]|CURES||The China Pulmonary Thromboembolism Registry Study|The China Pulmonary Thromboembolism Registry Study (CURES)|Recruiting||N/A|11000|Anticipated|China-Japan Friendship Hospital|||1||f||||||||||||Undecided||2017-10-10 21:40:06.686875|2017-10-10 21:40:06.686875
NCT02943330|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-23|||August 2007||2007-08-01|October 2016|2016-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life|Relation Between Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life|Completed||N/A|170|Actual|Chang Gung Memorial Hospital|||2||f||||f||||||Samples With DNA|"     IL-1β, IL-6 and TNF-α, as well as genotype the 5-HTTLPR triallelic polymorphism on all     subjects.   "|No||2017-10-10 21:40:06.759246|2017-10-10 21:40:06.759246
NCT02943317|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-05-15|||October 2016||2016-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer|A Phase 1/1b Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer|Recruiting||Phase 1|98|Anticipated|Verastem, Inc.||2|||f||||f||||||||Undecided||2017-10-10 21:40:06.851112|2017-10-10 21:40:06.851112
NCT02943304|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||May 2016||2016-05-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|ZEN Iniciative||Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero|Risk Evaluation of Fetal Nervous System and Neurodevelopment Disorders in Infants of Women Exposed to Zika Virus Infection During Pregnancy|Recruiting||N/A|440|Anticipated|Universidad Industrial de Santander|||2||f||||f||||||Samples Without DNA|"     Maternal serum Amniotic Fluid Urine CSF   "|No||2017-10-10 21:40:06.950339|2017-10-10 21:40:06.950339
NCT02943291|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-07-27|||October 24, 2016|Actual|2016-10-24|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|HIT-FAT||Adipose Tissue Function and Response to Exercise Training in Women With and Without Polycystic Ovary Syndrome|Adipose Tissue Function and Response to Exercise Training in Women With and Without Polycystic Ovary Syndrome|Recruiting||N/A|30|Anticipated|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 21:40:08.774313|2017-10-10 21:40:08.774313
NCT02943278|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-28|||August 2016||2016-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Sleep Therapy for Insomnia and Depression|Sleep Therapy for Insomnia and Depression|Recruiting||N/A|20|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 21:40:08.883336|2017-10-10 21:40:08.883336
NCT02943252|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|||The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer|PhaseⅡSingle-center, Open-label, Exploratory Clinical Study of Apatinib in Combination With S1 for the Patients With Advanced Non-squamous Head and Neck Cancer|Recruiting||Phase 2|30|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||1|||f||||t||||||||No||2017-10-10 21:40:09.060513|2017-10-10 21:40:09.060513
NCT02943239|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-02-09|||December 2016||2016-12-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women|A Randomised, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacodynamics Effects of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women|Recruiting||Phase 1|48|Anticipated|Regeneron Pharmaceuticals||4|||f||||f||||||||||2017-10-10 21:40:09.167741|2017-10-10 21:40:09.167741
NCT02943226|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Effect of Three Side Hole Infusion Catheter on CT Image Quality Compared to a Standard Infusion Catheter|IV Contrast Administration: Effect of Three Side Hole Infusion Catheter on CT Image Quality, Infusion Pressure, and Infusion Rates, Compared to a Standard Infusion Catheter|Not yet recruiting||N/A|200|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 21:40:09.263879|2017-10-10 21:40:09.263879
NCT02943200|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|||The Prevalence of Malocclusion Development in a Group of Egyptian Children With Digit Sucking Aged 3 to 6 Years|The Prevalence of Malocclusion Development in a Group of Egyptian Children With Digit Sucking Aged 3 to 6 Years: A Cross Sectional Study|Not yet recruiting||N/A|185|Anticipated|Cairo University|||1||f||||f||||||||No||2017-10-10 21:40:09.442713|2017-10-10 21:40:09.442713
NCT02943187|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-07-28|||October 2016||2016-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|(MCI)||Multidisciplinary Intervention for Mild Cognitive Impairment|Novel Functional Medicine Intervention With Cognitive Training for Mild Cognitive Impairment (MCI): A Multiple Baseline Study Across Cases|Enrolling by invitation||N/A|5|Anticipated|Gibson Institute of Cognitive Research||1|||f||||f||||||||||2017-10-10 21:40:09.516443|2017-10-10 21:40:09.516443
NCT02943174|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||MIND Programme for Cancer Patients|MIND Programme for Cancer Patients: A Group Intervention Programme Based on Third Wave Psychotherapies|Enrolling by invitation||N/A|80|Anticipated|University of Coimbra||2|||f||||f||||||||||2017-10-10 21:40:09.696452|2017-10-10 21:40:09.696452
NCT02943161|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-01|||April 5, 2017|Actual|2017-04-05|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|ALPS||Asthma L-Citrulline Pilot Study|Asthma L-Citrulline Pilot Study|Recruiting||N/A|20|Anticipated|University of Colorado, Denver||1|||f||||f|f|f||||||||2017-10-10 21:40:09.773345|2017-10-10 21:40:09.773345
NCT02943148|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Prediction of Pelvic Adhesions at Repeat Cesarean Delivery|Predictive Value of Striae Gravidarum Severity and Cesarean Scar Characteristics for Pelvic Adhesions at Repeat Cesarean Delivery|Recruiting||N/A|300|Anticipated|Assiut University|||1||f||||f||||||||Yes||2017-10-10 21:40:09.881021|2017-10-10 21:40:09.881021
NCT02943135|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-04-07|||October 2016||2016-10-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Lidocaine In-situ Gel Before Intrauterine Device Insertion|Effect of Self-administered Lidocaine In-situ Gel on Intrauterine Device Insertion Pain: A Randomized Controlled Trial|Recruiting||Phase 3|120|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:40:09.951015|2017-10-10 21:40:09.951015
NCT02943122|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||December 2016||2016-12-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Ambulatory Blood Pressure Monitoring in Post-Partum Pre-Eclamptic Patients|Prognostic Value of Ambulatory Blood Pressure Monitoring Pattern in Post-Partum Pre-Eclamptic Patients|Not yet recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t||||||||No||2017-10-10 21:40:10.088482|2017-10-10 21:40:10.088482
NCT02943109|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-04-20|||November 2016||2016-11-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside|High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside|Recruiting||N/A|6000|Anticipated|Ohio State University||4|||f||||f||||||||No||2017-10-10 21:40:10.158735|2017-10-10 21:40:10.158735
NCT02943096|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|Flavanol||Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression|Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression|Not yet recruiting||N/A|50|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-10-10 21:40:10.264608|2017-10-10 21:40:10.264608
NCT02943083|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Promoting Mother-Baby Bonding Through a Relaxation Routine During Pregnancy|Promoting Mother-Baby Bonding Through a Relaxation Routine During Pregnancy|Not yet recruiting||N/A|106|Anticipated|New York State Psychiatric Institute||4|||f||||f||||||||No||2017-10-10 21:40:10.359647|2017-10-10 21:40:10.359647
NCT02943070|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-10-23|||March 2012||2012-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|February 2013|Actual|2013-02-01||Interventional|Rezum Pilot||Rezum I Pilot Study for BPH|NxThera Benign Prostatic Hyperplasia Rezum System Pilot Study|Active, not recruiting||N/A|50|Actual|NxThera Inc||1|||f||||f||||||||No||2017-10-10 21:40:10.451851|2017-10-10 21:40:10.451851
NCT02943057|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-21|||August 2016||2016-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis|Intra-cameral Penetration and Efficacy of Ganciclovir Following Topical Administration of 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis|Recruiting||Phase 4|25|Anticipated|Singapore National Eye Centre||1|||f||||t||||||||Yes||2017-10-10 21:40:10.555751|2017-10-10 21:40:10.555751
NCT02943044|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-03-01|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma|Characterization of Physiological and Morphological Features of Clinical Head & Neck Squamous Cell Carcinomas (HNSCCs) Using a Quantitative Optical Sensor|Recruiting||N/A|50|Anticipated|Zenalux Biomedical, Inc.|||1||f||||f|f|f||||||No|Data will be de-identified prior to being shared outside of Duke.|2017-10-10 21:40:10.645082|2017-10-10 21:40:10.645082
NCT02943031|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of Individualized Precision Therapy Programs in Patients With BTC|The Effect of Individualized Precision Therapy Programs in Patients With Biliary Tract Cancer|Not yet recruiting||Phase 4|60|Anticipated|RenJi Hospital||1|||f||||t||||||||No||2017-10-10 21:40:10.718926|2017-10-10 21:40:10.718926
NCT02943018|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-21|||May 2013||2013-05-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2014|Actual|2014-06-01||Observational|||Anovaginal Distance, Interobserver Agreement|Interobserver Agreement in Perineal Ultrasound of the Anovaginal Distance- a Methodology-study|Completed||N/A|40|Actual|Ostergotland County Council, Sweden|||1||f||||f||||||||No||2017-10-10 21:40:10.783839|2017-10-10 21:40:10.783839
NCT02943005|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-12-15|||September 2016||2016-09-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Post-operative Mobilisation After Rotator Cuff Repair|Post-operative Mobilisation After Rotator Cuff Repair: Sling Versus Nothing. A Randomized Prospective Study.|Recruiting||N/A|80|Anticipated|La Tour Hospital||2|||f||||t||||||||No||2017-10-10 21:40:10.869516|2017-10-10 21:40:10.869516
NCT02942992|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-21|||January 2017||2017-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Implementing Resistance Exercise to Reduce Frailty for Older Adult|Implementing Resistance Exercise to Reduce Frailty for Older Adult Medicaid Waiver Recipients|Not yet recruiting||N/A|126|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 21:40:10.958629|2017-10-10 21:40:10.958629
NCT02942979|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-08-23|||February 12, 2016|Actual|2016-02-12|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|March 31, 2018|Anticipated|2018-03-31|12 Months|Observational [Patient Registry]|MISSION-HPACT||Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking|Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking (MISSION) (QUE 15-284)|Recruiting||N/A|200|Anticipated|VA Office of Research and Development|||2||f||||f|f|f|||f|||||2017-10-10 21:40:11.019904|2017-10-10 21:40:11.019904
NCT02942966|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-09-19|||February 8, 2017|Actual|2017-02-08|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|December 2019|Anticipated|2019-12-01||Interventional|TOBA II BTK||Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries|Tack Optimized Balloon Angioplasty Study for the Below The Knee Arteries Using the Tack Endovascular System®|Recruiting||N/A|232|Anticipated|Intact Vascular||1|||f||||t|f|t|t|f||||||2017-10-10 21:40:11.121533|2017-10-10 21:40:11.121533
NCT02942953|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-10-21|||June 2015||2015-06-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|6 Months|Observational [Patient Registry]|DP||Diaphragmatic Pacer Placement: Anesthetic Management (DP)|Diaphragmatic Pacer Placement: Anesthetic Management (DP)|Completed||N/A|16|Actual|Institut Guttmann|||1||f||||f||||||||Undecided||2017-10-10 21:40:11.313396|2017-10-10 21:40:11.313396
NCT02942940|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Conventional Follow-up Versus Mobile App For Post-Operative ACL Reconstruction Patients|Conventional Follow-up Versus Mobile App Home Monitoring For Post-Operative Anterior Cruciate Ligament (ACL) Reconstruction Patients: A Randomized Controlled Trial|Recruiting||N/A|32|Anticipated|University of Toronto Orthopaedic Sports Medicine||2|||f||||f||||||||Undecided||2017-10-10 21:40:11.506209|2017-10-10 21:40:11.506209
NCT02942927|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-28|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|TAPER-RCT||Team Approach to Polypharmacy Evaluation and Reduction|Team Approach to Polypharmacy Evaluation and Reduction Randomized Controlled Trial|Not yet recruiting||N/A|360|Anticipated|McMaster University||2|||f||||t|f|f||||||||2017-10-10 21:40:11.594881|2017-10-10 21:40:11.594881
NCT02942914|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-07-21|||December 20, 2016|Actual|2016-12-20|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes|A First-in-Human, Ascending-Dose Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single, Subcutaneous Dose of LY3209590|Recruiting||Phase 1|80|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 21:40:11.698844|2017-10-10 21:40:11.698844
NCT02942901|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||January 2015||2015-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|||Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases|Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases - a Prospective Monocentric Feasibility Study|Recruiting||N/A|40|Anticipated|Lung Clinic Heckeshorn|||1||f||||f||||||||Undecided||2017-10-10 21:40:11.805382|2017-10-10 21:40:11.805382
NCT02942888|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|NAD||The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition|The Effects of NAD on Brain Function and Cognition|Not yet recruiting||N/A|26|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||No||2017-10-10 21:40:11.885925|2017-10-10 21:40:11.885925
NCT02942875|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||September 2014||2014-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Motor Recovery of the Severely Impaired Paretic Upper Limb After Mirror Therapy in Sub-acute Stroke|Motor Recovery of the Severely Impaired Paretic Upper Limb After Mirror Therapy in Sub-acute Stroke|Completed||N/A|35|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||No||2017-10-10 21:40:12.004816|2017-10-10 21:40:12.004816
NCT02942862|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||February 2015||2015-02-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Evaluation of New Histoprognostic Criteria in a Retrospective Study of Colon Cancers Operated at Amiens University Hospital|Evaluation of New Histoprognostic Criteria in a Retrospective Study of Colon Cancers Operated at Amiens University Hospital|Completed||N/A|231|Actual|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:40:12.103802|2017-10-10 21:40:12.103802
NCT02942849|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Technology|Prospective Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Technology|Recruiting||N/A|1800|Anticipated|Finox AG|||1||f||||f||||||||Undecided||2017-10-10 21:40:12.169242|2017-10-10 21:40:12.169242
NCT02942836|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||March 2016||2016-03-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|RSP||CareTaker Respiratory Rate Detection Study|CareTaker Respiratory Rate Detection Study|Completed||N/A|21|Actual|CareTaker Medical LLC|||1||f||||f||||||||Undecided||2017-10-10 21:40:12.267628|2017-10-10 21:40:12.267628
NCT02942823|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|KOP-2||Kids Obesity Prevention Program Part 2|Kids Obesity Prevention Program Part 2 (KOP-2)|Not yet recruiting||N/A|34|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 21:40:12.344595|2017-10-10 21:40:12.344595
NCT02942810|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment|A Phase 1, Open-label, Single-dose Study to Investigate the Pharmacokinetics of Intravenous WCK 5222 (FEP-ZID) in Patients With Renal Impairment|Recruiting||Phase 1|48|Anticipated|Wockhardt||1|||f||||||||||||||2017-10-10 21:40:12.463131|2017-10-10 21:40:12.463131
NCT02942797|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-04-06|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||NRS 2002 as a Predictor of Prognosis in COPD With Respiratory Failure|Nutritional Risk Screening 2002 Should be Used to Predict Prognostic Outcomes in Chronic Obstructive Pulmonary Disease With Respiratory Failure|Recruiting||N/A|500|Anticipated|West China Hospital|||2||f|||||f|f||||||||2017-10-10 21:40:12.568568|2017-10-10 21:40:12.568568
NCT02942784|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-04-06|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||A Comparison of Three Nutritional Assessment Methods Predicting Prognosis in COPD With Respiratory Failure|Prediction of Prognosis in Patients With Chronic Obstructive Pulmonary Disease With Respiratory Failure: A Comparison of Three Nutritional Assessment Methods|Recruiting||N/A|750|Anticipated|West China Hospital|||1||f|||||f|f||||||||2017-10-10 21:40:12.666798|2017-10-10 21:40:12.666798
NCT02942771|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-26|||January 2017||2017-01-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A MAD Study of TT301/MW189 in Healthy Volunteers|A Phase 1b, Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TT301/MW189 Administered Intravenously to Healthy Volunteers|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|University of Kentucky||3|||f||||t||||||||No||2017-10-10 21:40:12.782288|2017-10-10 21:40:12.782288
NCT02942758|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-05-01|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|AML-ViVA||Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML|Randomized Phase II Trial With Safety run-in Phase Evaluating Low-dose AZA, ATRA and Pioglitazone Versus Standard Dose Azacitidine in Patients >=60 Years With AML Who Are Refractory to Standard Induction Chemotherapy|Recruiting||Phase 2|94|Anticipated|University Hospital Regensburg||2|||f||||t|f|f||||||Undecided||2017-10-10 21:40:12.926489|2017-10-10 21:40:12.926489
NCT02942745|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-10-03|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|BENIT||Testing the Effectiveness of a Betel Nut Cessation Program|NIH-NCI U54 University of Guam/Cancer Center of Hawaii Partnership Full Project II: The Betel Nut Intervention Trial|Recruiting||N/A|324|Anticipated|University of Guam||2|||f||||t||||||||||2017-10-10 21:40:13.066456|2017-10-10 21:40:13.066456
NCT02942732|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-21|||February 2013||2013-02-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Vitamin D Supplementation and Glycemic Outcomes|Effect of Treating Vitamin D Deficiency on Glucose Homeostasis and Metabolic Markers in Apparently Healthy, Young or Aged, Normal-weight or Obese Lebanese People|Completed||N/A|180|Actual|Université d'Auvergne||4|||f||||t||||||||Undecided||2017-10-10 21:40:13.291122|2017-10-10 21:40:13.291122
NCT02942719|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-21|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Establishment and Application of the New Labor Progress Centered System of Reducing Cesarean Section Rates in China|The Establishment and Application of the New Labor Progress Centered System of Reducing Cesarean Section Rates in China|Recruiting||N/A|15000|Anticipated|Shanghai First Maternity and Infant Hospital|||20||f||||t||||||||Undecided|There are 20 hospitals participated this study, we need get their agreement to share data.|2017-10-10 21:40:13.396006|2017-10-10 21:40:13.396006
NCT02942706|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2016-10-20|||November 2016||2016-11-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC|Biomarker-Panel Guided Maintenance Treatment With Cetuximab Monotherapy Versus Continuation After First Line Induction Therapy of Metastatic Colorectal Cancer (mCRC) : a Multicenter, Prospective, Randomized Controlled Trial|Not yet recruiting||Phase 2/Phase 3|200|Anticipated|Ruijin Hospital||2|||f||||t||||||||No||2017-10-10 21:40:13.488218|2017-10-10 21:40:13.488218
NCT02942693|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||November 2016||2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma|A Phase II Randomized Trial of Efficacy and Safety of Particle Therapy With or Without Apatinib as Induction Therapy for Treatment of Head and Neck Adenoid Cystic Carcinoma|Not yet recruiting||Phase 2|50|Anticipated|Shanghai Proton and Heavy Ion Center||2|||f||||t||||||||Undecided||2017-10-10 21:40:13.56852|2017-10-10 21:40:13.56852
NCT02942680|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-10-21|||January 2016||2016-01-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy and Safety of Aspirin Therapy With CABG|A Prospective Randomized Study of the Efficacy and Safety of Aspirin Therapy With CABG|Recruiting||Phase 3|350|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||No||2017-10-10 21:40:13.64019|2017-10-10 21:40:13.64019
NCT02942654|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-01-06|||November 2016||2016-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study of LY900014 Formulation in Healthy Participants|Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro Following Single-Dose Administration in Healthy Subjects|Completed||Phase 1|32|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:40:13.780983|2017-10-10 21:40:13.780983
NCT02942641|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-21|||June 2014||2014-06-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Indwelling Urinary Catheterization Versus Clean Intermittent Catheterization for the Short-term Management of Hospitalized Patients With Transient Acute Urinary Retention|Indwelling Urinary Catheterization Versus Clean Intermittent Catheterization for the Short-term Management of Hospitalized Patients With Transient Acute Urinary Retention: A Prospective Randomized Trial|Completed||N/A|100|Actual|Ramathibodi Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:40:13.848632|2017-10-10 21:40:13.848632
NCT02942628|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-04-25|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|VERDI||Vegetarian Diet in Patients With Ischemic Heart Disease|Vegetarian Diet in Patients With Ischemic Heart Disease: An Open-label, Randomized, Prospective Crossover Study|Not yet recruiting||N/A|30|Anticipated|Region Örebro County||2|||f||||f|f|f||||||||2017-10-10 21:40:13.917331|2017-10-10 21:40:13.917331
NCT02942615|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-21|||November 2016||2016-11-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.||Not yet recruiting||Phase 3|220|Anticipated|Ruijin Hospital||2|||f||||||||||||||2017-10-10 21:40:13.989354|2017-10-10 21:40:13.989354
NCT02942602|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-21|||June 2013||2013-06-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia||Recruiting||N/A|150|Anticipated|Yonsei University||5|||f||||f||||||||No||2017-10-10 21:40:14.080762|2017-10-10 21:40:14.080762
NCT02942589|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-20|||February 2014||2014-02-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Portion-control Training on Food Intake||Completed||N/A|105|Actual|Penn State University||4|||f||||f||||||||No||2017-10-10 21:40:14.164474|2017-10-10 21:40:14.164474
NCT02942563|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer|A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer|Active, not recruiting||Phase 2|100|Anticipated|RenJi Hospital||1|||f||||||||||||||2017-10-10 21:40:14.463263|2017-10-10 21:40:14.463263
NCT02942550|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|MOVEMENT||Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients|Methylnaltrexone as a Method to imprOVE Platelet Inhibition of Ticagrelor in Morphine-treated Patients With ST-segMENT Elevation Myocardial Infarction: a Prospective, Single Blinded Randomized, Placebo-controlled Trial|Recruiting||Phase 4|80|Anticipated|Karolinska University Hospital||2|||f||||f||||||||No|Data will only be published on a group level.|2017-10-10 21:40:14.545329|2017-10-10 21:40:14.545329
NCT02942537|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-20|||November 2016||2016-11-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|MYOMIC1||Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment|Single Blinded Randomized Study of Volume Reduction of Uterine Fibroids After Uterine Artery Embolization Versus Computer Tomography or Ultrasound Guided Percutaneous Microwave Ablation Evaluated by Magnetic Resonance Imaging|Not yet recruiting||Phase 2/Phase 3|36|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 21:40:14.660554|2017-10-10 21:40:14.660554
NCT02942524|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-14|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|TEPID||Checklist Tool in Engaging Patients in the Discharge Planning Process|Tool to Engage Patients in Discharge (TEPID)|Completed||N/A|450|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 21:40:14.771467|2017-10-10 21:40:14.771467
NCT02942511|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||January 2014||2014-01-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Observational|||Predictors Favoring the Role of Exclusive Enteral Nutrition in Active Crohn's Disease||Recruiting||Phase 1|60|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University|||1||f||||||||||||||2017-10-10 21:40:14.859305|2017-10-10 21:40:14.859305
NCT02942498|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-21|||July 2016||2016-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|SXF2-8||Clinical Trial for Asses the Safety and Efficacy of Vitamin C and Vitamin E in Combination Versus Placebo for Treating Cognitive and Behavior Disorder in Children With Fragile X Syndrome|Clinical Trials Phase III, Double Blind, Crossover to Asses the Safety and Efficacy of Vitamin C and Vitamin E in Combination Versus Placebo for Treating Cognitive and Behavior Disorder in Children With Fragile X Syndrome|Recruiting||Phase 3|40|Anticipated|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||2|||f||||f||||||||||2017-10-10 21:40:14.933268|2017-10-10 21:40:14.933268
NCT02942485|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-08-10|||December 1, 2016|Actual|2016-12-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Treatment of Giardia Lamblia Infections in Children|Treatment of Giardia Lamblia Infections in Children: Randomized Open-labeled Trial Comparing Rectal Metronidazole With Oral Tinidazole|Recruiting||Phase 4|180|Anticipated|Helsinki University Central Hospital||2|||f||||t||||||||||2017-10-10 21:40:15.046564|2017-10-10 21:40:15.046564
NCT02942472|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Position Of The Tip Of The Inner Catheter And Air Bubbles As Predictors Of Pregnancy During ICSI Cycles|Position Of The Tip Of The Inner Catheter And Air Bubbles As Predictors Of Pregnancy During ICSI Cycles:Prospective Observational Study|Not yet recruiting||N/A|94|Anticipated|Ain Shams Maternity Hospital|||1||f||||t||||||||Yes||2017-10-10 21:40:15.130574|2017-10-10 21:40:15.130574
NCT02942459|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-03-15|||September 2015||2015-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Music Therapy Towards Schizophrenia, Negative Symptoms|Music Therapy for Treatment of Patients Suffering From Schizophrenia With Negative Symptoms - A Double-blinded Study|Recruiting||N/A|120|Anticipated|Aalborg Universitetshospital||2|||f||||f||||||||No||2017-10-10 21:40:15.189546|2017-10-10 21:40:15.189546
NCT02942446|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Investigative Headgear With Nasal Pillows Continuous Positive Airway Pressure (CPAP) Mask|Investigative Headgear With Nasal Pillows CPAP Mask|Recruiting||N/A|20|Anticipated|Fisher and Paykel Healthcare||1|||f||||t||||||||||2017-10-10 21:40:15.283564|2017-10-10 21:40:15.283564
NCT02942433|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-04-11|||March 2016||2016-03-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2017|Actual|2017-04-01||Interventional|||Intimate Partner Violence Prevention in Nepal|Change Starts at Home: A Cluster Randomized Controlled Trial of a Media and Community Engagement Behavior Change Strategy to Prevent Intimate Partner Violence in Nepal|Active, not recruiting||N/A|4910|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 21:40:15.367087|2017-10-10 21:40:15.367087
NCT02942420|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-05-16|||May 1, 2017|Actual|2017-05-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Bucillamine Phase 2 Trial in Patients With Cystinuria|Phase 2 Multi-Center, Dose Escalation Trial To Assess The Safety And Effectiveness Of Bucillamine On Urinary Cystine Excretion And Cystine Capacity In Patients With Cystinuria|Recruiting||Phase 2|30|Anticipated|Revive Therapeutics, Ltd.||2|||f||||f|t|f||||||No||2017-10-10 21:40:15.450573|2017-10-10 21:40:15.450573
NCT02942407|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-07-25|||December 2016||2016-12-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|RENAL-AF||Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation|RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial|Recruiting||Phase 4|762|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 21:40:15.558302|2017-10-10 21:40:15.558302
NCT02942394|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-02-28|||December 2016||2016-12-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Treatment of the Postthrombotic Syndrome With the Oblique Stent - TOPOS Study|Non-interventional, Multicenter, Multinational Venous Stent Study for the Treatment of the Post-thrombotic Syndrome With Common Iliac Vein Compression|Recruiting||N/A|60|Anticipated|Optimed Medizinische Instrumente GmbH|||1||f||||f||||||||||2017-10-10 21:40:15.719864|2017-10-10 21:40:15.719864
NCT02942381|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-21|||August 2016||2016-08-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy||Recruiting||Phase 2|60|Anticipated|Peking University First Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:40:15.808005|2017-10-10 21:40:15.808005
NCT02942368|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-08-16|||April 14, 2017|Actual|2017-04-14|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Adaptive tDCS for Treatment-Resistant MDD|Adaptive Transcranial Direct Current Stimulation as an Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder|Recruiting||N/A|25|Anticipated|Washington University School of Medicine||1|||f||||f|f|t|t|f|f|||||2017-10-10 21:40:15.889825|2017-10-10 21:40:15.889825
NCT02942355|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-04-29|||November 2016||2016-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer|Pilot Trial of Anastrozole and Palbociclib as First-Line Therapy and as Maintenance Therapy After First Line Chemotherapy in Hormone Receptor Positive, HER2-Negative Postmenopausal Metastatic Breast Cancer|Recruiting||Phase 2|40|Anticipated|Carolinas Healthcare System||2|||f||||t||||||||Undecided||2017-10-10 21:40:15.978441|2017-10-10 21:40:15.978441
NCT02942342|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-10-21|||March 2016||2016-03-01|October 2016|2016-10-01||||March 2019|Anticipated|2019-03-01||Interventional|ESCAPE MI||Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo, MI|Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo County and Neighboring Areas in Michigan, Who Have Risk Factors of Coronary Artery Disease|Recruiting||N/A|500|Anticipated|Borgess Research Institute||1|||f||||||||||||||2017-10-10 21:40:16.07965|2017-10-10 21:40:16.07965
NCT02942329|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|||Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer|Exploratory Clinical Study of the Combination of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||1|||f||||f||||||||Undecided||2017-10-10 21:40:16.161802|2017-10-10 21:40:16.161802
NCT02942316|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-05-05|||October 2016||2016-10-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Pupillary Dilation Reflex (PDR) Evaluation During General Anesthesia|Pupillary Dilation Reflex (PDR) Evaluation During General Anesthesia: a Pilot Study|Completed||N/A|41|Actual|University Hospital, Antwerp||1|||f||||f||||||||No||2017-10-10 21:40:16.253354|2017-10-10 21:40:16.253354
NCT02942303|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-05-11|||October 2016||2016-10-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Impact of Botulinum Toxin on Brow Height and Morphology: A Randomized Controlled Trial||Recruiting||Phase 4|30|Anticipated|St Joseph University, Beirut, Lebanon||2|||f||||||||||||||2017-10-10 21:40:16.334693|2017-10-10 21:40:16.334693
NCT02942290|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-09-26|||March 13, 2017|Actual|2017-03-13|September 2017|2017-09-01|December 12, 2020|Anticipated|2020-12-12|September 15, 2019|Anticipated|2019-09-15||Interventional|||A Study Evaluating Venetoclax in Combination With Azacitidine in Subjects With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)|A Phase 1b Dose Escalation Study Evaluating the Safety and Pharmacokinetics of Venetoclax in Combination With Azacitidine in Subjects With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)|Recruiting||Phase 1|44|Anticipated|AbbVie||1|||f||||f|t|f||||||||2017-10-10 21:40:16.42676|2017-10-10 21:40:16.42676
NCT02942277|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-09-12|||October 6, 2016||2016-10-06|September 1, 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali|Phase 1 Dose Escalating, Double-Blind, Randomized Comparator Controlled Trial of the Safety andImmunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum at Full and Fractional Dosing in Adults in Mali|Active, not recruiting||Phase 1|900|Anticipated|National Institutes of Health Clinical Center (CC)||11|||f||||||||||||||2017-10-10 21:40:16.597211|2017-10-10 21:40:16.597211
NCT02942264|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-21|2017-10-04|||October 17, 2016||2016-10-17|September 27, 2017|2017-09-27|August 2, 2022|Anticipated|2022-08-02|August 2, 2021|Anticipated|2021-08-02||Interventional|||TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma|Phase I Trial of TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma|Recruiting||Phase 1/Phase 2|152|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 21:40:16.729347|2017-10-10 21:40:16.729347
NCT02942251|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-25|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RPM-FED||Relapse Predicting Model for First Episode Depression|The Study of Relapse Predicting Model for First Episode Depression: Big Data Analysis Based on Clinical Features and Immunochemistry|Not yet recruiting||N/A|300|Anticipated|Shanghai Mental Health Center||6|||f||||t||||||||Undecided||2017-10-10 21:40:16.815943|2017-10-10 21:40:16.815943
NCT02942238|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-12-20|||January 2017||2017-01-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|January 2020|Anticipated|2020-01-01||Interventional|||Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC)|Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC)|Not yet recruiting||N/A|582|Anticipated|Ruijin Hospital||2|||f||||f||||||||No||2017-10-10 21:40:16.897774|2017-10-10 21:40:16.897774
NCT02942225|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-10-02|||August 2016||2016-08-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||The Metabolome Profiling and Pathway Analysis of ADHD|The Metabolome Profiling and Pathway Analysis of ADHD|Recruiting||N/A|70|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples With DNA|"     The investigators will collect blood samples from each participant after 8-hour fasting.     Blood samples will be transferred into evacuated tubes that contain anticoagulant sodium     dihydrogen phosphate (EDTA), centrifuged at 2000g for 10 minutes at 4°C. Serum will be     extracted and stored at −80°C for sample analysis. The collection of blood sample will be     conducted at the NTUH.   "|||2017-10-10 21:40:16.96882|2017-10-10 21:40:16.96882
NCT02942212|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-20|||December 2016||2016-12-01|October 2016|2016-10-01||||December 2019|Anticipated|2019-12-01||Interventional|||Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II|Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II|Not yet recruiting||N/A|80|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 21:40:17.046412|2017-10-10 21:40:17.046412
NCT02942199|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-01-26|||November 2016|Actual|2016-11-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)|MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)|Recruiting||N/A|12|Anticipated|Cambridge Health Alliance||1|||f||||t||||||||Yes||2017-10-10 21:40:17.139001|2017-10-10 21:40:17.139001
NCT02942173|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT|A Phase II Prospective Randomized Trial of Donor T-memory Cells (CD45RA Depleted) Infusion for Prevention of Infections After Allogeneic TcRαβ/CD19-depleted Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2/Phase 3|100|Anticipated|Federal Research Institute of Pediatric Hematology, Oncology and Immunology||2|||f||||||||||||||2017-10-10 21:40:17.213654|2017-10-10 21:40:17.213654
NCT02942160|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-06-15|||October 2016||2016-10-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)|A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy|Enrolling by invitation||Phase 2|350|Anticipated|Endo Pharmaceuticals||1|||f||||f||||||||||2017-10-10 21:40:17.296294|2017-10-10 21:40:17.296294
NCT02942147|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2015|Actual|2015-09-01||Interventional|||Conventional Radiofrequency, Pulse Radiofrequency, and TENS for Lumbar Facet Joint Pain|Comparison of the Efficacy of Conventional Radiofrequency, Pulse Radiofrequency, and TENS Therapies for Lumbar Facet Joint Pain: A Single-blind Randomized Controlled Trial|Completed||Phase 4|60|Actual|Ege University||3|||f||||f||||||||Undecided||2017-10-10 21:40:17.530967|2017-10-10 21:40:17.530967
NCT02942134|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-20|||November 2016||2016-11-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Observational|||Acute Dyspnea After Use of Non-invasive Ventilation in COPD and Emphysema (Deventilation Syndrome)|Acquisition and Evaluation of Augemented Dyspnea After Use of Non-invasive Ventilation in Patients With COPD and Empysema (Deventilation Syndrome)|Not yet recruiting||N/A|70|Anticipated|Heidelberg University|||1||f||||f||||||||No||2017-10-10 21:40:17.602179|2017-10-10 21:40:17.602179
NCT02942121|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||September 2016||2016-09-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Application-based Perioperative Management of the Radical Cystectomy Patient|Application-based Perioperative Management of the Radical Cystectomy Patient|Recruiting||N/A|20|Anticipated|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-10 21:40:17.668599|2017-10-10 21:40:17.668599
NCT02942082|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-20|||November 2017||2017-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Evaluation for Post Bleaching Hypersensitivity Using Desensitizing Agent During In-office Bleaching|Clinical Evaluation for Post Bleaching Hypersensitivity Using Desensitizing Agent Before and /or After In-office Bleaching|Not yet recruiting||N/A|36|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:40:17.952445|2017-10-10 21:40:17.952445
NCT02942069|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-08-04|||December 2016||2016-12-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Reproducibility of Glucose Fluctuations by Standardized Exercise for Patients With Type 1 Diabetes - a Method Study Based on Continuous Glucose Monitoring|Reproducibility of Glucose Fluctuations by Standardized Exercise for Patients With Type 1 Diabetes - a Method Study Based on Continuous Glucose Monitoring|Active, not recruiting||N/A|12|Actual|Nordsjaellands Hospital|||1||f||||t||||||||||2017-10-10 21:40:18.018654|2017-10-10 21:40:18.018654
NCT02942056|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-20|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus|The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus|Not yet recruiting||Phase 2|250|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-10 21:40:18.082545|2017-10-10 21:40:18.082545
NCT02942043|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|May 2019|Anticipated|2019-05-01||Interventional|||Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer|A Prospective, Multicenter, Randomized Controlled Clinical Trial of Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer|Recruiting||Phase 2|87|Anticipated|Beijing Cancer Hospital||3|||f||||f||||||||Yes||2017-10-10 21:40:18.154853|2017-10-10 21:40:18.154853
NCT02942030|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-27|||November 2016||2016-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Differences in Attentional Profile of Children Diagnosed With ADHD Versus Children Diagnosed With Other Mental Conditions|Differences in Attentional Profile of Children Diagnosed With ADHD Versus Children Diagnosed With Other Mental Conditions|Not yet recruiting||N/A|70|Anticipated|Clalit Health Services|||2||f||||f||||||||No||2017-10-10 21:40:18.261131|2017-10-10 21:40:18.261131
NCT02942017|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-09-08|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate SAGE-547 in Patients With Moderate Postpartum Depression|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression|Recruiting||Phase 3|100|Anticipated|Sage Therapeutics||2|||f||||f||||||||||2017-10-10 21:40:18.345081|2017-10-10 21:40:18.345081
NCT02942004|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-09-08|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression|Recruiting||Phase 3|120|Anticipated|Sage Therapeutics||3|||f||||f||||||||||2017-10-10 21:40:18.614628|2017-10-10 21:40:18.614628
NCT02941991|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-09-07|||January 16, 2013|Actual|2013-01-16|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)|Follow-up to 5 Years of a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)|Active, not recruiting||N/A|11|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 21:40:18.888123|2017-10-10 21:40:18.888123
NCT02941978|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||December 2015||2015-12-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|MISOAC-AF||Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF)|Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF): A Prospective Randomized Clinical Study|Recruiting||N/A|1000|Anticipated|AHEPA University Hospital||2|||f||||f||||||||||2017-10-10 21:40:18.983317|2017-10-10 21:40:18.983317
NCT02941965|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-03-13|||May 1, 2017|Anticipated|2017-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Preimplantation Genetic Screening in Patients With Male Factor Infertility|Preimplantation Genetic Screening in Patients With Male Factor Infertility|Not yet recruiting||N/A|480|Anticipated|International Peace Maternity and Child Health Hospital||2|||f||||t|f|f||||||Undecided|Undecided|2017-10-10 21:40:19.109745|2017-10-10 21:40:19.109745
NCT02941952|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-06-09|||October 28, 2016|Actual|2016-10-28|June 2017|2017-06-01|July 28, 2018|Anticipated|2018-07-28|July 27, 2018|Anticipated|2018-07-27||Interventional|CLEARPICCO||Comparative Noninvasive Continuous Cardiac Output by the Clearsight® With Invasive Monitoring by PICCO® in Abdominal Major Surgery||Recruiting||N/A|||Poitiers University Hospital|||||f||||||||||||||2017-10-10 21:40:19.240581|2017-10-10 21:40:19.240581
NCT02941939|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-03-20|||April 2016||2016-04-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|HITOP||Effects of High-Intensity Interval Training (HIT) While in a Hyperoxic-Hyperbaric Environment on Exercise Performance|Effects of High-Intensity Interval Training (HIT) While in a Hyperoxic-Hyperbaric Environment on Exercise Performance (HITOP Study)|Active, not recruiting||N/A|50|Anticipated|Intermountain Health Care, Inc.||2|||f||||f||||||||No||2017-10-10 21:40:19.336721|2017-10-10 21:40:19.336721
NCT02941744|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-23|||March 2016||2016-03-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|ipniv||A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases|A Phase IB Clinical Trial on Adjuvant Low-dose Ipilimumab Plus Nivolumab Following the Resection of Melanoma Macrometastases|Recruiting||Phase 1/Phase 2|6|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f||||||||Yes|data wil be published in total and anonymous|2017-10-10 21:40:22.306301|2017-10-10 21:40:22.306301
NCT02941926|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-09-14|||July 20, 2015|Actual|2015-07-20|September 2017|2017-09-01|May 14, 2021|Anticipated|2021-05-14|November 30, 2019|Anticipated|2019-11-30||Interventional|||Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC|COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease|Recruiting||Phase 3|3775|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 21:40:19.486487|2017-10-10 21:40:19.486487
NCT02941913|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-08-25|||October 2016||2016-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Interventional|||Compare Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients|Comparative Study Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients Undergoing Breast Surgery|Recruiting||Phase 4|80|Anticipated|Instituto Nacional de Cancer, Brazil||2|||f||||t||||||||||2017-10-10 21:40:20.76644|2017-10-10 21:40:20.76644
NCT02941900|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-07-19|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Interest and Impact of Skin Cancer Genetic Testing|PERSONALIZED GENOMIC TESTING FOR MELANOMA: MAXIMIZING COMPREHENSION AND HEALTH OUTCOMES IN SKIN CANCER PATIENTS|Enrolling by invitation||N/A|75|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     saliva sample   "|||2017-10-10 21:40:20.921793|2017-10-10 21:40:20.921793
NCT02941887|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-21|||October 2013||2013-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Global Behavior and Periodontal Disease in Down's Syndrome Patients|Down's Syndrome Patients Behavior Correlations to Periodontal Disease Status|Completed||N/A|33|Actual|University of Sao Paulo|||1||f||||t||||||||No||2017-10-10 21:40:21.046216|2017-10-10 21:40:21.046216
NCT02941874|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-04-12|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|IRAP||Determining of Normal Values and Conformity Assessment of the Dosage of a Plasmatic Marker of the Cellular Captation of Glucose: the IRAP Protein|Determining of Normal Values and Conformity Assessment of the Dosage of a Plasmatic Specific Marker of the Cellular Captation of Glucose: the IRAP Protein (Insulin Regulated AminoPeptidase)|Recruiting||N/A|100|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 21:40:21.156457|2017-10-10 21:40:21.156457
NCT02941861|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-20|||August 2016||2016-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|||Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery|Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery|Completed||N/A|67|Actual|Chulabhorn Hospital|||2||f||||t||||||||Yes||2017-10-10 21:40:21.273911|2017-10-10 21:40:21.273911
NCT02941848|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-19|||November 2014||2014-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers|A Randomized, Open-Label, Two-way Crossover, Single-Dose Study to Compare Pharmacokinetic Properties and Safety After Administration of HCP1306 Tablet and Co-administration of HGP0816 Tablet, HGP1404 Tablet in the Healthy Adults|Completed||Phase 1|60|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 21:40:21.397597|2017-10-10 21:40:21.397597
NCT02941835|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|April 2017|2017-04-01|June 2027|Anticipated|2027-06-01|June 2021|Anticipated|2021-06-01||Interventional|PROBI||Preoperative Breast Irradiation|Preoperative Breast Irradiation, the PROBI Trial. A Phase I/II Feasibility Trial|Recruiting||N/A|94|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 21:40:21.536383|2017-10-10 21:40:21.536383
NCT02941822|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-10-19|||December 2016||2016-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AiM-PD||Ambroxol in Disease Modification in Parkinson Disease|A Phase IIA Prospective, Single-Centre, Open Label Clinical Trial to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of Ambroxol in Patients With Parkinson Disease: Ambroxol in Disease Modification in Parkinson Disease|Not yet recruiting||Phase 2|20|Anticipated|University College, London||1|||f||||f||||||||Undecided|No, all subject's data will be anonymised.|2017-10-10 21:40:21.654871|2017-10-10 21:40:21.654871
NCT02941809|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-14|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Harnessing Placebo Effects in Methadone Treatment|Open-labeled Dose-extending Placebos as an Adjunct to Methadone Treatment: A Pilot Study|Enrolling by invitation||N/A|120|Anticipated|University of Maryland||2|||f||||t|f|f||||||||2017-10-10 21:40:21.793124|2017-10-10 21:40:21.793124
NCT02941796|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-19|||June 2016||2016-06-01|August 2016|2016-08-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers|An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics and Safety After Administration of HCP1105 Alone and Co-administration of HGP0918 and HGP0816 in Healthy Adult Subjects|Completed||Phase 1|68|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-10 21:40:21.906656|2017-10-10 21:40:21.906656
NCT02941770|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|PAC-MAnO||Physical Activity Consultation in the Management of Adolescent Overweight|The Effect of a Physical Activity Consultation in the Management of Adolescent Overweight, Including Anthropometry, Physical Activity Levels, Cardiorespiratory Fitness, and Endothelial Health|Recruiting||N/A|129|Anticipated|University of Lisbon||3|||f||||f||||||||No||2017-10-10 21:40:22.09485|2017-10-10 21:40:22.09485
NCT02941757|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Feeding America's Bravest: Mediterranean Diet-Based Interventions to Change Firefighters' Eating Habits|Feeding America's Bravest: Mediterranean Diet-Based Interventions to Change Firefighters' Eating Habits and Improve Cardiovascular Risk Profiles|Recruiting||N/A|1000|Anticipated|Harvard School of Public Health||2|||f||||t||||||||||2017-10-10 21:40:22.205089|2017-10-10 21:40:22.205089
NCT02941731|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-19|||April 2015||2015-04-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions|An Open-label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetics of HIP1403 in Healthy Male Subjects|Completed||Phase 1|32|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 21:40:22.410905|2017-10-10 21:40:22.410905
NCT02941718|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-05-10|||November 2016||2016-11-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|||Examination of Sleep, Smoking Cessation, and Cardiovascular Health|Examination of Sleep, Smoking Cessation, and Cardiovascular Health|Recruiting||Phase 3|90|Anticipated|University of Delaware||2|||f||||f|||||t|||No||2017-10-10 21:40:22.491288|2017-10-10 21:40:22.491288
NCT02941705|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-08-15|||July 12, 2017|Actual|2017-07-12|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|Regress-HFpEF||Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFPEF Patients Treated With Allogeneic CDCs|Regress-HFPEF: Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFPEF Patients Treated With Allogeneic CDCs|Recruiting||Phase 2|40|Anticipated|Cedars-Sinai Medical Center||2|||f||||t|t|f||||||||2017-10-10 21:40:22.595371|2017-10-10 21:40:22.595371
NCT02941692|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-03-22|||June 2014|Actual|2014-06-01|October 2016|2016-10-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Oxytocin for Couples Conflict Resolution|The Effects of Oxytocin on Couples Conflict Resolution Interactions|Completed||Phase 2|72|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 21:40:22.722886|2017-10-10 21:40:22.722886
NCT02941679|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients|A 24-week, Randomized, Double-Blind, Active-controlled, Parallel Study of HCP1202 Combination Product, HGP1011, and HCP0910 in Treatment of Subjects With COPD|Not yet recruiting||Phase 3|252|Anticipated|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||No||2017-10-10 21:40:22.792506|2017-10-10 21:40:22.792506
NCT02941666|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-20|||September 2016||2016-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip|Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip in Patients With Osteonecrosis of the Femoral Head|Recruiting||N/A|60|Anticipated|Mayo Clinic|||3||f||||t||||||||Undecided||2017-10-10 21:40:22.866022|2017-10-10 21:40:22.866022
NCT02941653|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-05-01|||November 2016||2016-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Potassium Oxalate and Potassium Nitrate and Post-bleaching Sensitivity|Effect of Potassium Oxalate and Potassium Nitrate on Tooth Sensitivity Related to in Office Bleaching: Randomized Clinical Trial|Recruiting||Phase 3|47|Anticipated|Universidade Federal de Sergipe||2|||f||||f||||||||No||2017-10-10 21:40:22.938425|2017-10-10 21:40:22.938425
NCT02941640|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-06-10|2017-03-06||October 2, 2016|Actual|2016-10-02|June 2017|2017-06-01|January 30, 2017|Actual|2017-01-30|December 30, 2016|Actual|2016-12-30||Interventional||Sex baseline measure|Influence of the Different Ways of Appendix Stump Closure on Patient Outcome in Laparoscopic Appendectomy|Influence of the Different Ways of Appendix Stump Closure on Patient Outcome in Laparoscopic Appendectomy|Completed||N/A|120|Actual|University Clinical Center Tuzla||4|||f||||t||||||||No|We have no plan to share IPD.|2017-10-10 21:40:23.018765|2017-10-10 21:40:23.018765
NCT02941627|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-02-23|||January 2017||2017-01-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults|The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults|Recruiting||N/A|55|Anticipated|Oticon Medical||1|||f||||t||||||||Undecided||2017-10-10 21:40:23.506977|2017-10-10 21:40:23.506977
NCT02941601|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)|A Multicenter, Phase 2 Study of Gemcitabine-Carboplatin Plus Necitumumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 2|0|Actual|Eli Lilly and Company||2||"This was a strategic decision for business planning purposes and not out of concern for patient   safety."|f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 21:40:23.705032|2017-10-10 21:40:23.705032
NCT02941588|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-08-18|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||The Impact of Early Surgery and Maintenance of Antiplatelet Therapy on Intraoperative Bleeding and Major Adverse Cardiovascular Event After Percutaneous Coronary Intervention|The Impact of Early Surgery and Maintenance of Antiplatelet Therapy on Intraoperative Bleeding and Major Adverse Cardiovascular Event After Percutaneous Coronary Intervention|Completed||N/A|962|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-10 21:40:23.818865|2017-10-10 21:40:23.818865
NCT02941575|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-19|||December 2016||2016-12-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Patient Satisfaction and Peri-Implant Tissue Success of Hybrid Ceramic Versus E-Max Superstructures|Esthetic Patient Satisfaction and Peri-Implant Tissue Success of Crystal Ultra Hybrid Ceramic Compared to E-Max Superstructures in Esthetic Zone|Not yet recruiting||N/A|22|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:40:23.881191|2017-10-10 21:40:23.881191
NCT02941211|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-10-20|||January 2015||2015-01-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effectiveness and Safety Evaluation of Aqueduct -100 Device|Effectiveness and Safety Evaluation of Aqueduct -100 Device|Completed||N/A|50|Actual|Aqueduct Medical Ltd||1|||f||||f||||||||Yes|"An article has been published in the digital edition of Hysteroscopy Newsletter"|2017-10-10 21:40:28.877961|2017-10-10 21:40:28.877961
NCT02941562|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-21|||December 2016||2016-12-01|October 2016|2016-10-01||||December 2019|Anticipated|2019-12-01||Interventional|||A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT||Not yet recruiting||Phase 2|150|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-10 21:40:23.953845|2017-10-10 21:40:23.953845
NCT02941549|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD|A Randomised, Double-Blind, Placebo-Controlled, Exploratory Phase IIa Study To Assess The Safety And Efficacy Of Orally Administered DS102 In Patients With NAFLD|Not yet recruiting||Phase 2|69|Anticipated|Afimmune||3|||f||||f||||||||||2017-10-10 21:40:26.074144|2017-10-10 21:40:26.074144
NCT02941536|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-03-12|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer|Prospective Evaluation of Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Stereotactic Radiotherapy for Encephalic Metastases of Breast Cancer|Recruiting||N/A|40|Anticipated|AC Camargo Cancer Center||1|||f||||f||||||||Undecided||2017-10-10 21:40:26.138834|2017-10-10 21:40:26.138834
NCT02941523|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-03-04|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid Tumours|Phase Ia/Ib and Potential Phase IIa Study of the Safety and Pharmacokinetics of NOX66 Both as a Monotherapy and in Combination With Carboplatin in Patients With Refractory Solid Tumours|Recruiting||Phase 1/Phase 2|36|Anticipated|Noxopharm Limited||3|||f||||f|f|f||||||Yes|De-identified individual participant data for primary and secondary outcome measure will be made available within 12 months after study completion|2017-10-10 21:40:26.226049|2017-10-10 21:40:26.226049
NCT02941510|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-03-09|||March 6, 2017|Actual|2017-03-06|March 2017|2017-03-01|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|||Inhaled Budesonide for Altitude Illness Prevention|Inhaled Budesonide for Altitude Illness Prevention|Withdrawn||Phase 3|0|Actual|University of Colorado, Denver||2||Stopped prior to enrollment per PI and DSMB decision.|f||||t|f|f||||||No||2017-10-10 21:40:26.333208|2017-10-10 21:40:26.333208
NCT02941497|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||August 2014||2014-08-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Get Fruved: Obesity Prevention for Older Adolescents|"Get Fruved: A Peer-led, Train-the-trainer Social Marketing Intervention to Increase Fruit and Vegetable Intake and Prevent Childhood Obesity."|Recruiting||N/A|5800|Anticipated|The University of Tennessee, Knoxville||2|||f||||f||||||||No|There is no plan at this time.|2017-10-10 21:40:26.408762|2017-10-10 21:40:26.408762
NCT02941484|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-20|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Early Oral Intake After Pancreaticoduodenectomy in the Age of ERAS|A Prospective, Randomized Trial of Early Oral Intake After Pancreaticoduodenectomy in the Age of ERAS|Not yet recruiting||N/A|100|Anticipated|Xuzhou Medical University||2|||f||||t||||||||Yes||2017-10-10 21:40:26.551451|2017-10-10 21:40:26.551451
NCT02941458|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-04-25|||July 2016||2016-07-01|April 2017|2017-04-01|December 2030|Anticipated|2030-12-01|December 2025|Anticipated|2025-12-01|10 Years|Observational [Patient Registry]|RTT||Thoracic Tumours Register|Thoracic Tumours Register|Recruiting||N/A|10000|Anticipated|Spanish Lung Cancer Group|||5||f||||t||||||||No||2017-10-10 21:40:26.732174|2017-10-10 21:40:26.732174
NCT02941445|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||October 2015||2015-10-01|October 2015|2015-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss||Completed||Phase 4|24|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||No||2017-10-10 21:40:26.814667|2017-10-10 21:40:26.814667
NCT02941432|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-20|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Black Tea Compresses for Facial Eczema and Perioral Dermatitis|Pilot Study of Effects and Tolerance of Black Tea Compress Treatment in Facial Eczema and Perioral Dermatitis|Recruiting||N/A|25|Anticipated|University of Luebeck||1|||f||||f||||||||Yes|It is planned to publish the study results, including anonymized clinical patient data and photographs in a scientific journal.|2017-10-10 21:40:27.00568|2017-10-10 21:40:27.00568
NCT02941419|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-05-03|||March 5, 2013|Actual|2013-03-05|May 2017|2017-05-01|February 9, 2017|Actual|2017-02-09|September 15, 2016|Actual|2016-09-15||Interventional|||Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis|Safety and Efficacy of Platelet Lysate for Therapeutic Angiogenesis in Patients With Peripheral Arterial Disease|Completed||Phase 1/Phase 2|10|Actual|University of Jordan||1|||f||||f||||||||No||2017-10-10 21:40:27.097944|2017-10-10 21:40:27.097944
NCT02941406|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-20|||July 2015||2015-07-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Observational|||MP3 (Microperimeter 3) Reproducibility in Healthy Subjects and Macular Patients|Reproducibility of Microperimetry Using Nidek MP3 (Microperimeter 3) in Healthy Subjects and Patients With Macular Disease - Pilot Study|Active, not recruiting||N/A|22|Actual|Vienna Institute for Research in Ocular Surgery|||2||f||||f||||||||||2017-10-10 21:40:27.200712|2017-10-10 21:40:27.200712
NCT02941393|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-10-20|||November 2012||2012-11-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Internal Versus External Tocodynamometry and Labor Outcome|Influence of Measurement Method of Labor Contractions on Labor Outcome and Newborn|Recruiting||N/A|2500|Anticipated|Tampere University Hospital||2|||f||||f||||||||No||2017-10-10 21:40:27.303256|2017-10-10 21:40:27.303256
NCT02939963|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-08-29|||August 23, 2017|Actual|2017-08-23|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Ventilation Strategies During Spontaneous Breathing Trial|Comparison of Two Ventilatory Modes During Spontaneous Breathing Trial in Intubated Patients|Recruiting||N/A|20|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:40:38.746771|2017-10-10 21:40:38.746771
NCT02941380|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-10-20|||July 2011||2011-07-01|October 2016|2016-10-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Observational|||Exploration of Cerebral Pathophysiology During and After CABG Using CPB|Cerebral Oxidative and Inflammatory Stress and Cerebral Hemodynamics During and After Coronary Artery Bypass Grafting With Use of Cardiopulmonary Bypass|Completed||N/A|24|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     Whole blood Serum   "|No||2017-10-10 21:40:27.457332|2017-10-10 21:40:27.457332
NCT02941367|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-09-20|||February 23, 2017|Actual|2017-02-23|September 2017|2017-09-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|LixiRam||Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan|International, Randomized, Open Label Study to Compare the Safety and Efficacy of Lixisenatide vs. Sulfonylurea on Top of Basal Insulin Treatment in Type 2 Diabetes Mellitus Subjects Who Elect to Fast During Ramadan|Completed||Phase 4|184|Actual|Sanofi||2|||f||||f|f|f||||||||2017-10-10 21:40:27.558851|2017-10-10 21:40:27.558851
NCT02941354|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-08-02|||October 10, 2016|Actual|2016-10-10|August 2017|2017-08-01|June 20, 2017|Actual|2017-06-20|June 1, 2017|Actual|2017-06-01||Interventional|guardian ™9||Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A.|A Multicentre, Open-label Trial Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A|Completed||Phase 1|35|Actual|Novo Nordisk A/S||1|||f||||f|t|f||||||||2017-10-10 21:40:27.747569|2017-10-10 21:40:27.747569
NCT02941341|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|BIRTH||Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Techniques in Spain.|Ambispective Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Techniques in Spain.|Recruiting||N/A|1800|Anticipated|Finox AG|||1||f||||f||||||||Undecided||2017-10-10 21:40:27.875683|2017-10-10 21:40:27.875683
NCT02941328|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-19|||December 2015||2015-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|SPACE||SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4|A Phase II, Mono-center, Placebo-controlled, Double-blind, Crossover Trial to Investigate Effect and Efficacy of Pyridostigmine in Dutch Patients With Spinal Muscular Atrophy Types 2, 3 and 4|Recruiting||Phase 2|50|Anticipated|UMC Utrecht||2|||f||||f||||||||No||2017-10-10 21:40:28.012346|2017-10-10 21:40:28.012346
NCT02941315|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-19|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Risk Stratification of Heart Failure in Cardiomyopathies.|Risk Stratification of Heart Failure in Cardiomyopathies With Unknown Etiology.|Not yet recruiting||Phase 1|150|Anticipated|RenJi Hospital||4|||f||||t||||||||Undecided||2017-10-10 21:40:28.135267|2017-10-10 21:40:28.135267
NCT02941302|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|||Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study|Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study|Recruiting||N/A|50|Anticipated|General Hospital of Ningxia Medical University||1|||f||||t||||||||No||2017-10-10 21:40:28.24141|2017-10-10 21:40:28.24141
NCT02941289|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-22|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2017|Actual|2017-05-01||Interventional|ARVA-MA||Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's Disease|Visuospatial Attention and Eye Movement Behaviour in Patients With Alzheimer's Disease When Searching in Realistic Scenes and a Natural Setting: Exploring Perceptual and Cognitive Mechanisms and Their Relationships With IADLs|Recruiting||N/A|64|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 21:40:28.331101|2017-10-10 21:40:28.331101
NCT02941276|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-16|||November 2011||2011-11-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|LEONIDAS-2||A Trial Looking at Treating Dry Mouth After Radiotherapy for Head and Neck Cancer|Long-term Evaluation of the Effectiveness Of a Novel Intra-oral Electro-stimulator for the Treatment of raDiotherapy-ASsociated Dry Mouth|Completed||Phase 3|84|Actual|University College, London||2|||f||||f||||||||Yes|Research manuscript in preparation.|2017-10-10 21:40:28.41584|2017-10-10 21:40:28.41584
NCT02941263|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-20|2017-10-05|||October 11, 2016||2016-10-11|September 28, 2017|2017-09-28|June 21, 2020|Anticipated|2020-06-21|June 21, 2020|Anticipated|2020-06-21||Observational|||Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration|The Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration|Recruiting||N/A|25|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:40:28.505688|2017-10-10 21:40:28.505688
NCT02941250|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2017-09-14|||September 2016||2016-09-01|October 2016|2016-10-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|NPC01PRG||Acute Defibrillation Performance of a Novel Can-less Shock Pathway|Acute Defibrillation Performance of a Novel Can-less Shock Pathway|Completed||N/A|22|Actual|NewPace Ltd||1|||f||||f||||||||||2017-10-10 21:40:28.599382|2017-10-10 21:40:28.599382
NCT02941237|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-21|||December 2016||2016-12-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Development of a Robust and Reliable Pulse Oximeter for Children With Pneumonia in Low-income Countries|Development of a Robust and Reliable Pulse Oximeter for Use by Frontline Healthcare Providers Caring for Children With Pneumonia in Low-income Countries|Not yet recruiting||N/A|180|Anticipated|The Lifebox Foundation||2|||f||||f||||||||Yes|Yes. De-identified individual participant data for all primary and secondary outcomes will be made available for all study participants within 6 months of study completion|2017-10-10 21:40:28.678149|2017-10-10 21:40:28.678149
NCT02941224|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-05-31|||October 2016||2016-10-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|||First-in-human Evaluation of the SELUTION DCB, a Novel Sirolimus Coated Balloon in Peripheral Arteries|SELUTION™ Sirolimus Coated PTA Balloon Catheter Prospective, Controlled, Multi-Center, Open, Single-Arm Clinical Investigation for the Treatment of Patients With Femoropopliteal Artery Lesions With a Novel Drug Coated Balloon|Active, not recruiting||Phase 1|50|Actual|M.A. Med Alliance S.A.||1|||f||||||||||||||2017-10-10 21:40:28.783742|2017-10-10 21:40:28.783742
NCT02941198|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-20|||August 2016||2016-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||Postpartum Immediate Contraception in Cesarean Deliveries-Comparison of Two Intrauterine Systems|Comparative of Two Devices (Conventional Intrauterine Devices (Cu T380 A)/Frameless Intrauterine Devices (GyneFix)) for Postpartum Immediate Contraception in Cesarean Deliveries|Recruiting||Phase 2|200|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t||||||||Yes||2017-10-10 21:40:29.140373|2017-10-10 21:40:29.140373
NCT02941185|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-02-03|||January 2014||2014-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Multi-dose Vitamin D Supplementation in Preterm Infants||Completed||Phase 4|121|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||3|||f||||||||||||||2017-10-10 21:40:29.237843|2017-10-10 21:40:29.237843
NCT02941172|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-09-21|||January 2015||2015-01-01|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|July 30, 2017|Actual|2017-07-30||Interventional|CANBAT||CB1 Receptors in Human Brown Adipose Tissue|Cannabinoid CB1 Receptors in Human Brown Adipose Tissue|Active, not recruiting||N/A|20|Anticipated|Turku University Hospital||3|||f||||f||||||||||2017-10-10 21:40:29.318267|2017-10-10 21:40:29.318267
NCT02941159|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-20|||September 2016||2016-09-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|SF2000SD||SF2000SD Clinical Trial in Zambia|A Phase I Single Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Safety and Tolerability of SF2000SD in Healthy Male Volunteers|Active, not recruiting||Phase 1|43|Actual|Tropical Diseases Research Centre, Zambia||2|||f||||t||||||||No||2017-10-10 21:40:29.415061|2017-10-10 21:40:29.415061
NCT02941146|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-06-20|||October 2016|Actual|2016-10-01|October 2016|2016-10-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|DSA||DualSculpting the Abdomen|DualSculpting the Abdomen Using Cryolipolysis|Completed||N/A|15|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-10 21:40:29.529871|2017-10-10 21:40:29.529871
NCT02941133|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-05-02|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Comparison of Neural Mobilization Techniques to Standard Care Treatment in Patients With Lumbar Radiculitis|Effectiveness of Neural Mobilization Techniques Compared to Standard Care Treatment in Patients With Lumbar Radiculitis: A Randomized Clinical Trial|Not yet recruiting||N/A|130|Anticipated|University of Nicosia||2|||f||||f|f|f||||||Undecided||2017-10-10 21:40:29.624857|2017-10-10 21:40:29.624857
NCT02941120|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-06-23|||December 2015||2015-12-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|RENOVO||Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects|Retrospective Observational Study for Reconstruction of Localized, Full-thickness Cartilage Defects in the Knee Joint With In-situ Polymerizable and Chondrocyte Populated Biomaterial (NOVOCART® Inject)|Recruiting||N/A|125|Anticipated|Tetec AG|||1||f||||f||||||||Undecided||2017-10-10 21:40:29.733493|2017-10-10 21:40:29.733493
NCT02941094|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-11-21|||October 2016||2016-10-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|US_angle||Insertion Angle and Needle Visualization During Ultrasound Guided Internal Jugular Vein Cannulation||Recruiting||N/A|150|Anticipated|Mansoura University||3|||f||||t||||||||Undecided||2017-10-10 21:40:29.931702|2017-10-10 21:40:29.931702
NCT02941081|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-06-20|||October 2017|Anticipated|2017-10-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|IHAT-Gut||A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial|A Novel Nano-iron Supplement (IHAT) to Safely Combat Iron Deficiency and Anaemia (IDA) in Young Children: a Doubleblind Randomised Controlled Trial|Not yet recruiting||Phase 2|705|Anticipated|Medical Research Council Unit, The Gambia||3|||f||||t|f|f||||||||2017-10-10 21:40:30.146313|2017-10-10 21:40:30.146313
NCT02941068|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-19|||March 2012||2012-03-01|October 2016|2016-10-01||||June 2016|Actual|2016-06-01||Interventional|||the Influence of Prophylactic and Empirical Anti-fungal Treatment in Severe Sepsis Patients With Perforations|Prophylactic Annti-fungal Treatment in Severe Sepsis Patients With Perforations in SICU|Completed||Phase 2|223|Actual|Nanjing PLA General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:40:30.271273|2017-10-10 21:40:30.271273
NCT02941055|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-08-11|||January 2017||2017-01-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ADIRA||ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis)|ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis)|Recruiting||N/A|80|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 21:40:30.371492|2017-10-10 21:40:30.371492
NCT02941029|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-09-22|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2017|Actual|2017-03-01||Observational|RADTOX||RADTOX: Measuring Radiation Toxicity Using Circulating DNA|RADTOX: Measuring Radiation Toxicity Using Circulating DNA|Active, not recruiting||N/A|70|Actual|University of Florida|||1||f||||t|f|f||||Samples With DNA|"     collection of plasma   "|||2017-10-10 21:40:30.613107|2017-10-10 21:40:30.613107
NCT02941016|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2020|Anticipated|2020-10-01||Interventional|||Vascular Inflammation and Cholesterol Lowering Therapy|Vascular Inflammation and Cholesterol Lowering Therapy|Recruiting||Phase 4|10|Anticipated|Rigshospitalet, Denmark||1|||f||||||||||||||2017-10-10 21:40:30.717569|2017-10-10 21:40:30.717569
NCT02941003|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-25|||February 2016||2016-02-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer|Establishment and Evaluation for Pathological Diagnostic Criteria of Intraoperative Frozen Section of Early Stage Lung Cancer|Recruiting||N/A|540|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:40:30.8323|2017-10-10 21:40:30.8323
NCT02940990|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01||||December 2019|Anticipated|2019-12-01||Interventional|||SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations||Not yet recruiting||Phase 2|50|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||No||2017-10-10 21:40:30.9794|2017-10-10 21:40:30.9794
NCT02940977|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique|Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique|Not yet recruiting||N/A|120|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples With DNA|"     Fresh blood 5 ml *2   "|Yes||2017-10-10 21:40:31.092639|2017-10-10 21:40:31.092639
NCT02940964|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-02-12|||October 17, 2016|Actual|2016-10-17|February 2017|2017-02-01|November 23, 2016|Actual|2016-11-23|October 20, 2016|Actual|2016-10-20||Interventional|COMSCPR||Evaluation of Culture-specific Popular Music as a Mental Metronome for Cardiopulmonary Resuscitation|Evaluation of Culture-specific Popular Music as a Mental Metronome for Cardiopulmonary Resuscitation: A Randomized Crossover Trial|Completed||N/A|90|Actual|Singapore General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:40:31.193027|2017-10-10 21:40:31.193027
NCT02940951|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-10-19|||July 2016||2016-07-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Quality of Life Assessment and Practice Support System in Home Care Services for Older Adults|Integrating a Quality of Life Assessment and Practice Support System in Home Care Services for Older Adults With Chronic Life-limiting Illness and Their Families|Recruiting||N/A|540|Anticipated|Trinity Western University||2|||f||||f||||||||Yes|As part of the project, the investigators will explore the possibility of using the tablets (intervention) as part of routine care. The tablet would be used to administer the questionnaires to patients and families as part of their care and to obtain a report of the assessment data that will drive the clinical team to service/care improvement, for clinical purposes. This generation of the report will happen in real time, will contain the patient's name and personal health identifier, and can be placed in the patient's chart as part of care services delivered to that patient. No other individual participant data collected for research is shared.|2017-10-10 21:40:31.262091|2017-10-10 21:40:31.262091
NCT02940938|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-06-23|||January 2017|Actual|2017-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study on Changes of Pulse Oximeter Plethysmographic Amplitude Induced by Respiration in Pediatric Patients|Study on Changes of Pulse Oximeter Plethysmographic Amplitude Induced by Respiration in Pediatric Patients: the Effect of Contacting Force|Recruiting||N/A|35|Anticipated|Seoul National University Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:40:31.359354|2017-10-10 21:40:31.359354
NCT02940925|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-10-20|||September 2016||2016-09-01|October 2016|2016-10-01|August 2024|Anticipated|2024-08-01|August 2019|Anticipated|2019-08-01||Interventional|||TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma|TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma, a Prospective,Parallel, Randomized, Open Labeled, Multicenter Phase III Clinical Trial|Recruiting||Phase 3|220|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Yes|The diagnosis, treatment regimen, toxicity and followup data will be shared once every year through email, phone or meeting.|2017-10-10 21:40:31.438277|2017-10-10 21:40:31.438277
NCT02940912|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-02-27|||October 2016||2016-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|APOMORPHEE||Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease|Double Bind Randomized Placebo-controlled Cross-over Study to Evaluate Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease|Recruiting||Phase 4|45|Anticipated|Clinique Beau Soleil||2|||f||||||||||||||2017-10-10 21:40:31.537379|2017-10-10 21:40:31.537379
NCT02940899|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-10-19|||January 2015||2015-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|February 2016|Actual|2016-02-01||Interventional|SUFFP||Syracuse University Fit Families Program: Autism|Fit Families Program for Children With Autism|Active, not recruiting||N/A|90|Actual|Syracuse University||2|||f||||f||||||||No||2017-10-10 21:40:31.706041|2017-10-10 21:40:31.706041
NCT02940886|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-11|||November 2016||2016-11-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|||Iron Isomaltoside and Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)|A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside (Monofer®) and Iron Sucrose in Subjects With Iron Deficiency Anemia (Ferwon IDA)|Recruiting||Phase 3|1500|Anticipated|Pharmacosmos A/S||2|||f||||t||||||||||2017-10-10 21:40:31.778586|2017-10-10 21:40:31.778586
NCT02940873|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-04-19|||March 9, 2017|Actual|2017-03-09|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|HARPdoc||Hypoglycaemia Awareness Restoration Programme|Beyond Education: A Hypoglycaemia Awareness Restoration Programme for People With Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc)|Recruiting||N/A|96|Anticipated|King's College London||2|||f||||t|f|f||||||No||2017-10-10 21:40:31.853423|2017-10-10 21:40:31.853423
NCT02940860|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|||Iron Isomaltoside and Iron Sucrose for the Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease|A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside (Monofer®) and Iron Sucrose in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (FerWonNephro)|Recruiting||Phase 3|1500|Anticipated|Pharmacosmos A/S||2|||f||||t||||||||||2017-10-10 21:40:32.081647|2017-10-10 21:40:32.081647
NCT02939573|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-06-19|||January 2017||2017-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ARAMIS||A Randomized Multicenter Study for Isolated Skin Vasculitis|A Randomized Multicenter Study for Isolated Skin Vasculitis|Recruiting||Phase 2|90|Anticipated|University of Pennsylvania||2|||f||||t||||||||No||2017-10-10 21:40:42.458305|2017-10-10 21:40:42.458305
NCT02940847|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2017-07-27|||November 13, 2016|Actual|2016-11-13|July 2017|2017-07-01|March 2017|Actual|2017-03-01|January 26, 2017|Actual|2017-01-26||Interventional|ECHO_NCMB||Ultrasound-guided Versus Blind Technique in Medial Brachial Cutaneous Nerve and Intercostobrachial Nerve Blocks|The Effectiveness of Ultrasound-guided Technique Compared to Blind Technique in Medial Brachial Cutaneous Nerve Block and Intercostobrachial Nerve Block, in the Axilla|Completed||N/A|84|Actual|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-10-10 21:40:32.188158|2017-10-10 21:40:32.188158
NCT02940834|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||December 2015||2015-12-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Sodium Imbalance in Traumatic Brain Injury Patients: Prevalence, Predictors and Prognostic Significance in a Tertiary Care Centre|Sodium Imbalance in Traumatic Brain Injury Patients: Prevalence,Predictors and Prognostic Significance in a Tertiary Care Centre|Recruiting||N/A|55|Anticipated|Postgraduate Institute of Medical Education and Research|||2||f||||f||||||||||2017-10-10 21:40:32.29169|2017-10-10 21:40:32.29169
NCT02940821|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-06-13|||June 2016||2016-06-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Assessing the Effects of Three Oral Care Regimens|Assessing Three Oral Care Regimen on Plaque, Gingivitis, and Tooth Whitening|Active, not recruiting||N/A|141|Anticipated|Pearl Network||3|||f||||f||||||||||2017-10-10 21:40:32.367317|2017-10-10 21:40:32.367317
NCT02940808|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-03-07|||May 2016||2016-05-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effects of Caffeine on EEG Theta/Beta Ratio and Cognitive Control|The Effects of a Single Administration of a Moderate Dose of Caffeine on Cognitive Control and Spontaneous EEG Theta/Beta Ratio|Completed||N/A|41|Actual|Leiden University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:40:32.472681|2017-10-10 21:40:32.472681
NCT02940795|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-01-23|||April 2016|Actual|2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Dietary Sugars Found In Breast Milk|Maternal Transmission of Dietary Sugars in Breast Milk|Completed||N/A|41|Actual|University of Oklahoma||2|||f||||t||||||||No|No there is not a plan to share data.|2017-10-10 21:40:32.5858|2017-10-10 21:40:32.5858
NCT02940782|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||January 2017||2017-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison Between Reciproc and Oneshape Systems|Assessment of Postoperative Pain After Using Reciroc Versus One Shape NiTi Systems in Patients With Symptomatic Irreversible Pulpitis (A Randomized Clinical Trial): Part Two|Not yet recruiting||N/A|54|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:40:32.67408|2017-10-10 21:40:32.67408
NCT02940769|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-10-19|||June 2014||2014-06-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Neurobiological Effects of Light on MDD|Neurobiological Effects of Light on MDD|Recruiting||Early Phase 1|110|Anticipated|University of Michigan||2|||f||||f||||||||Undecided||2017-10-10 21:40:32.766539|2017-10-10 21:40:32.766539
NCT02940743|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-04-27|||April 27, 2017|Actual|2017-04-27|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Behavioral Management of Phosphorus in Hemodialysis Patients|Behavioral Management of Phosphorus in Hemodialysis|Recruiting||N/A|42|Anticipated|New York University School of Medicine||3|||f||||f|f|f||||||||2017-10-10 21:40:33.027876|2017-10-10 21:40:33.027876
NCT02940730|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-07-17|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients|Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients|Not yet recruiting||Phase 4|10|Anticipated|University of Colorado, Denver||2|||f|||||t|f||||||||2017-10-10 21:40:33.143087|2017-10-10 21:40:33.143087
NCT02940717|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-18|||January 2017||2017-01-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Evaluation of the Fracture Resistance for E-max Cad and Vita Suprinity Laminate Veneers|Clinical Evaluation of the Fracture Resistance for E-max Cad and Vita Suprinity Laminate Veneers|Active, not recruiting||N/A|16|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-10 21:40:33.23006|2017-10-10 21:40:33.23006
NCT02940704|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-07-19|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Assessment of Postoperative Pain After Using Reciproc Versus One Shape NiTi Systems|Assessment of Postoperative Pain After Using Reciproc Versus One Shape NiTi Systems in Patients With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial (Part I)|Active, not recruiting||N/A|54|Actual|Cairo University||2|||f||||f||||||||||2017-10-10 21:40:33.322562|2017-10-10 21:40:33.322562
NCT02940691|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-20|||December 2016||2016-12-01|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|April 2021|Anticipated|2021-04-01||Interventional|DARLO-C||Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs|A Phase IV, Open-label, Single Arm, Multicentre Trial of Grazoprevir/Elbasvir for Genotype 1 or 4 in People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use|Recruiting||Phase 4|150|Anticipated|Kirby Institute||1|||f||||f||||||||||2017-10-10 21:40:33.425988|2017-10-10 21:40:33.425988
NCT02940678|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-25|||October 2016||2016-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Transferability of Clinical Prediction Models for Early Trauma Care in a Swedish Setting|Transferability of Clinical Prediction Models for Early Trauma Care in a Swedish Setting|Active, not recruiting||N/A|30000|Anticipated|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 21:40:33.539336|2017-10-10 21:40:33.539336
NCT02940665|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-05-01|||March 2014||2014-03-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|April 2015|Actual|2015-04-01||Observational|||A Comparison of Protein Intake Between ERAS and Conventional Care After Elective Colorectal Surgery|Higher Protein Intakes Are Associated With Reduced Length of Stay: A Comparison Between ERAS and Conventional Care After Elective Colorectal Surgery|Completed||N/A|115|Actual|University of Calgary|||2||f||||f||||||||No||2017-10-10 21:40:33.617802|2017-10-10 21:40:33.617802
NCT02940652|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-06-21|||October 2016||2016-10-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|LPIMRICH||Laryngeal Mask Position in Magnetic Resonance Imaging in Children|Position of Laryngeal Mask in Paediatric Patients During Magnetic Resonance Imaging: Prospective Observational Cohort Study|Completed||N/A|205|Actual|Brno University Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:40:33.685656|2017-10-10 21:40:33.685656
NCT02940639|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-10-03|||September 18, 2016|Actual|2016-09-18|October 2017|2017-10-01|October 31, 2024|Anticipated|2024-10-31|October 31, 2024|Anticipated|2024-10-31||Observational|||Real-Life Efficacy and Safety of Nivolumab in Patients With Advanced Renal Cell Carcinoma After Prior Therapy|A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (BMS-936558) in Patients With Advanced Renal Cell Carcinoma After Prior Therapy|Recruiting||N/A|323|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:40:33.775125|2017-10-10 21:40:33.775125
NCT02940626|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-27|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of ASN100 for the Prevention of Staphylococcus Aureus Pneumonia in Heavily Colonized, Mechanically Ventilated Subjects|Recruiting||Phase 2|354|Anticipated|Arsanis, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:40:33.88025|2017-10-10 21:40:33.88025
NCT02940613|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-11-15|||December 2016||2016-12-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Using Visual Feedback to Influence Rapid Response in the Treatment of Eating Disorders|Do Visuals of Symptom Change Increase Rates of Rapid Response in First Weeks of CBT for Eating Disorders?|Not yet recruiting||N/A|40|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||No|For reasons of confidentiality, only aggregated data will be made available.|2017-10-10 21:40:34.084237|2017-10-10 21:40:34.084237
NCT02940600|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|CEFEMA||Efficacy Evaluation of Normothermic Perfusion Machine Preservation in Liver Transplant Using Very Old Donors|Pilot, Open, Monocentric, Randomized, Prospective Trial for the Evaluation of the Efficacy of Normothermic Perfusion Machine for Organ Preservation in Liver Transplantation Using Brain Death Donors Older or Equal Than 70 Years|Recruiting||N/A|30|Anticipated|Azienda Ospedaliero, Universitaria Pisana||2|||f||||f||||||||No||2017-10-10 21:40:34.191105|2017-10-10 21:40:34.191105
NCT02940587|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||February 2015||2015-02-01|January 2015|2015-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effectiveness of Aurix Therapy in Venous Leg Ulcers|A Multi-Center, Prospective, Randomized Trial Comparing the Effectiveness of Aurix Therapy to Usual and Customary Care in Venous Leg Ulcers|Withdrawn||Phase 4|0|Actual|Cytomedix||2||"New record created in clinical trials due to company re-branding, and inability to list new   name as the sponsor."|f||||f||||||||||2017-10-10 21:40:34.28356|2017-10-10 21:40:34.28356
NCT02940574|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neural and Behavioral Effects of Oxytocin in Autism Spectrum Disorders|Oxytocin-based Pharmacotherapy for Autism Spectrum Disorders: Investigating the Neural and Behavioral Effects of a Promising Intervention Approach|Enrolling by invitation||Phase 4|42|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||Undecided||2017-10-10 21:40:34.355609|2017-10-10 21:40:34.355609
NCT02940561|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-10-19|||August 2016||2016-08-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||BE Study in Patients - Methotrexate Tablets|A Multicenter, Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single-dose, Two-way, Crossover, Bioequivalence Study of Methotrexate Tablets USP, 2.5 mg Manufactured by Amneal Pharmaceuticals, With Methotrexate Tablets USP 2.5 mg Manufactured for DAVA Pharmaceuticals, Inc., Fort Lee, NJ 07024 USA in Patients With Mild to Severe Psoriasis or Rheumatoid Arthritis, Who Are Already on Established Regimens of 2.5 mg Every 12 Hours Under Fasting Condition.|Recruiting||Phase 1|48|Anticipated|Amneal Pharmaceuticals, LLC||2|||f||||t||||||||No||2017-10-10 21:40:34.450992|2017-10-10 21:40:34.450992
NCT02940548|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|NARRAS||Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness|A Comparative Study for the Effects of Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness in the Young and Middle-aged Subjects With Non-dipper Hypertension|Recruiting||Phase 4|120|Anticipated|Peking University People's Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:40:34.558517|2017-10-10 21:40:34.558517
NCT02940535|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-10-19|||December 2016||2016-12-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response|Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response: a Randomized Control Trial|Not yet recruiting||N/A|200|Anticipated|Navy General Hospital, Beijing||2|||f||||t||||||||Yes||2017-10-10 21:40:34.6596|2017-10-10 21:40:34.6596
NCT02940522|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-06-26|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women|A Multi-Center, Randomized, Open-Label Study Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women|Completed||Phase 1|122|Actual|AMAG Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 21:40:34.749158|2017-10-10 21:40:34.749158
NCT02940509|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-03-24|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|||Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids|The Role of Ketamine and Magnesium in Post-operative Pain Control After Laparoscopic Surgery in Patients With Chronic Pelvic Pain Treated With Opioids: A Double-Blinded Randomized Control Trial.|Not yet recruiting||Phase 1|128|Anticipated|Milton S. Hershey Medical Center||2|||f||||f|t|f|||f|||No||2017-10-10 21:40:34.832866|2017-10-10 21:40:34.832866
NCT02940496|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-09-26|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Pembrolizumab (MK-3475) in Hepatocellular Carcinoma|A Phase I/II Study of Pembrolizumab (MK-3475) in Subjects With Advanced Hepatocellular Carcinoma Who Progressed on or Were Intolerant to First-Line Systemic Therapy|Recruiting||Phase 1/Phase 2|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:40:34.924003|2017-10-10 21:40:34.924003
NCT02940483|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-08-17|||December 2016||2016-12-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|5-AZA||Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Ependymoma|Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle or Resection Cavity in Children With Recurrent Posterior Fossa Ependymoma: A Pilot Study|Recruiting||Early Phase 1|10|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 21:40:35.015803|2017-10-10 21:40:35.015803
NCT02940470|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||January 2009||2009-01-01|October 2016|2016-10-01|August 2010|Actual|2010-08-01|January 2010|Actual|2010-01-01||Interventional|||Weight Loss Pilot Study in Postmenopausal Breast Cancer Survivors|Weight Loss Pilot Study in Postmenopausal Breast Cancer Survivors|Completed||N/A|22|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||No||2017-10-10 21:40:35.098694|2017-10-10 21:40:35.098694
NCT02940457|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-25|||November 2016||2016-11-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|MICE||Cognitive Ability Training for Seniors With Mild Cognitive Impairment|Verbesserung Kognitiver Fähigkeiten Bei Personen Mit Verdacht Auf Eine Leichte Kognitive Beeinträchtigung|Not yet recruiting||N/A|50|Anticipated|Wuerzburg University Hospital||2|||f||||f||||||||No||2017-10-10 21:40:35.175392|2017-10-10 21:40:35.175392
NCT02940444|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-21|||June 2016||2016-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery|Safety and Efficacy of Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery|Recruiting||Phase 1/Phase 2|2000|Anticipated|West China Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:40:35.240544|2017-10-10 21:40:35.240544
NCT02940431|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-09-21|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Active Games: Increasing the Attractiveness of Active Video Game Play for Youth|Active Games: Increasing the Attractiveness of Active Video Game Play for Youth|Recruiting||N/A|50|Anticipated|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 21:40:35.469069|2017-10-10 21:40:35.469069
NCT02940418|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-05-03|||February 19, 2017|Actual|2017-02-19|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Use of Stem Cells in Diabetes Mellitus Type 1|The Use of Mesenchymal Stromal Cells (MSC) in Type 1 Diabetes Mellitus in Adult Humans: Phase I Clinical Trial|Recruiting||Phase 1|20|Anticipated|University of Jordan||2|||f||||t|f|f|||f|||Undecided||2017-10-10 21:40:35.546775|2017-10-10 21:40:35.546775
NCT02940405|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-20|||January 2017||2017-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Ketorolac Premedication for Anesthetic Efficiency of IANB & Postendodontic Pain in Teeth With Irreversible Pulpitis|Effect of Ketorolac Premedication on Anesthetic Efficiency of Inferior Alveolar Nerve Block, Pre-Treatment and Post-Endodontic Pain in Teeth With Irreversible Pulpitis: A Randomized Controlled Double Blinded Trial|Not yet recruiting||N/A|38|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:40:35.625534|2017-10-10 21:40:35.625534
NCT02940392|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||February 2012||2012-02-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2012|Actual|2012-12-01||Interventional|Rezum FIM||Rezum FIM Optimization|Rezum First in Man Feasibility Study for the Treatment of BPH With the Rezum System|Active, not recruiting||N/A|15|Actual|NxThera Inc||1|||f||||f||||||||No||2017-10-10 21:40:35.711312|2017-10-10 21:40:35.711312
NCT02940379|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-01-17|||October 2016||2016-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol|A Two-cohort, Open-label, Fixed-sequence, Two-period, Two-treatment Pharmacokinetic Interaction Study of Repeated Oral Doses of Sotagliflozin on a Single Dose Cocktail of Metoprolol and Midazolam Used as Probe Substrates for CYP2D6 and CYP3A Activities, Respectively, in Healthy Subjects|Completed||Phase 1|24|Actual|Sanofi||2|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:40:35.788134|2017-10-10 21:40:35.788134
NCT02940366|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-02-08|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome|the Long-term Effects of High-doSe pitavaStatin on Diabetogenicity in Comparison With Atorvastatin in Patients With Metabolic Syndrome (LESS-DM) Randomized Clinical Trial|Recruiting||Phase 4|500|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:40:35.878002|2017-10-10 21:40:35.878002
NCT02940353|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-03-29|||April 2016||2016-04-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|April 2022|Anticipated|2022-04-01||Interventional|||The TREFOIL Concept 5 Year Clinical Investigation|The TREFOIL Concept: A Clinical Investigation in the Mandible on 3 Implants With a Fixed Prefabricated Framework|Active, not recruiting||N/A|90|Anticipated|Nobel Biocare||1|||f||||f||||||||||2017-10-10 21:40:35.948174|2017-10-10 21:40:35.948174
NCT02940340|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||January 2016||2016-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Evaluation of Systemic Microvascular Endothelial Dysfunction in Patients Presenting With Infective Endocarditis|Evaluation of Systemic Microvascular Endothelial Dysfunction in Patients Presenting With Infective Endocarditis Using the Imaging Method of Cutaneous Laser Speckle Flowmetry|Recruiting||N/A|50|Anticipated|National Institute of Cardiology, Laranjeiras, Brazil|||1||f||||t||||||||No||2017-10-10 21:40:36.023434|2017-10-10 21:40:36.023434
NCT02940158|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-12-22|||October 2016||2016-10-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Various Serving Sizes of Lentils on Blood Glucose and Insulin|The Effect of Various Serving Sizes of Lentils and Other Starchy Meals on Post Prandial Blood Glucose Response and Insulin|Recruiting||N/A|42|Anticipated|University of Guelph||2|||f||||f||||||||No||2017-10-10 21:40:37.435704|2017-10-10 21:40:37.435704
NCT02940327|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-05-23|||February 2016||2016-02-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|Mi-ECMO||Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN|A Feasibility Study to Consider the Relationship Between Markers of Red Cell Damage, Inflammation and the Recovery Process of Newborns Requiring Extracorporeal Membrane Oxygenation (ECMO) for Persistent Pulmonary Hypertension of the Newborn (PPHN): Mi-ECMO|Recruiting||N/A|24|Anticipated|University of Leicester|||1||f||||f||||||Samples With DNA|"     Blood samples, Urine samples, Respiratory samples   "|Yes|statistical analysis|2017-10-10 21:40:36.099949|2017-10-10 21:40:36.099949
NCT02940314|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||March 2016||2016-03-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, 2-way Crossover Study to Compare the Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 21:40:36.223348|2017-10-10 21:40:36.223348
NCT02940301|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-03-17|||December 20, 2016|Actual|2016-12-20|March 2017|2017-03-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma|A Phase 2 Trial of Ibrutinib and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma|Recruiting||Phase 2|17|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-10 21:40:36.29493|2017-10-10 21:40:36.29493
NCT02940288|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||September 2016||2016-09-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Acu-Pilot||Acupuncture for Postoperative Analgesia in Laparoscopic Surgery|Acupuncture for Postoperative Analgesia in Laparoscopic Surgery|Recruiting||N/A|40|Anticipated|Emory University||2|||f||||f||||||||No||2017-10-10 21:40:36.397864|2017-10-10 21:40:36.397864
NCT02940275|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Population Research of Sublingual Microcirculation Data of Patients With Systemic Diseases|Population Research of Sublingual Microcirculation Data of Patients With Systemic Diseases|Recruiting||N/A|420|Anticipated|National Taiwan University Hospital|||7||f||||f||||||||||2017-10-10 21:40:36.489375|2017-10-10 21:40:36.489375
NCT02940262|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-25|||September 2016||2016-09-01|October 2016|2016-10-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|||68Ga-PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy|68Ga-PSMA PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy|Recruiting||N/A|200|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 21:40:36.566999|2017-10-10 21:40:36.566999
NCT02940249|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-09-27|||January 2017||2017-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|GLU-Pomme||Effects of an Apple Extract on Glycaemia: The GLU-Pomme Study|Dose-response Effect of an Apple Extract on Postprandial Glycaemia: a Randomised Controlled Trial. The GLU-POMME Study.|Active, not recruiting||N/A|33|Anticipated|King's College London||4|||f||||f||||||||||2017-10-10 21:40:36.680991|2017-10-10 21:40:36.680991
NCT02940236|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-08-01|||October 2016||2016-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Gastric Volumes After Oral Multimodal Analgesia in the Pre-operative Setting: A Prospective Case Series||Enrolling by invitation||N/A|100|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 21:40:36.791401|2017-10-10 21:40:36.791401
NCT02940223|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-20|||March 16, 2017|Actual|2017-03-16|July 2017|2017-07-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Effects of Fish Oil and Physical Activity on Fatigue in Patients With Advanced Cancer Receiving Regorafenib|Effects of Fish Oil and Physical Activity on Fatigue in Patients With Advanced Cancer Receiving Regorafenib|Recruiting||Phase 2|96|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 21:40:36.859418|2017-10-10 21:40:36.859418
NCT02940210|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2016-10-19|||August 2016||2016-08-01|October 2016|2016-10-01||||March 2017|Anticipated|2017-03-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy|A Randomized, Single-blind, Multi-center, Phase III Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy|Recruiting||Phase 3|172|Anticipated|CGBio Inc.||2|||f||||f||||||||No||2017-10-10 21:40:37.003821|2017-10-10 21:40:37.003821
NCT02940197|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-09-17|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|May 2017|Actual|2017-05-01||Interventional|||Comparison of Two Calorie Restricted MediterrAsian Diet on Weight Loss in FTO rs9939609 Overweight Carriers|Comparison of the Effect of MediterrAsian Diet With Two Different Calorie Restriction on Anthropometric Indices in Carriers of FTO rs9939609 Polymorphism With Overweigh: Toward Personalized Nutrition|Recruiting||N/A|80|Anticipated|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 21:40:37.086985|2017-10-10 21:40:37.086985
NCT02940184|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-10-19|||June 2016||2016-06-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||GLP-1 Signaling in Truncally Vagotomized Subjects|Vagal Mechanisms Mediating the Effects of Glucagon-Like Peptide 1 (GLP-1) on the Endocrine Pancreas - the Entero-endocrine Axis.|Recruiting||N/A|24|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-10 21:40:37.19519|2017-10-10 21:40:37.19519
NCT02940171|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-19|||December 25, 2016|Actual|2016-12-25|September 2017|2017-09-01|December 25, 2021|Anticipated|2021-12-25|March 25, 2021|Anticipated|2021-03-25||Observational|EARLYBURN||Surgery Timing In Outcome Burn Patients|Impact of Timing of Surgery on Outcome of Severely Ill Burn Patients|Recruiting||N/A|800|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     Serum and urine bank 1 / day of inclusion (D0): 1 sample (3 x 5 ml of blood). 1 sample (10 ml     sample of urine) 2 / The seventh day of inclusion (D7): 1 sample (3 x 5 ml of blood) 1 sample     (10 ml sample of urine) 3 / The twenty eighth day of inclusion (D28): 1 sample (3 x 5 ml of     blood) 1 sample (10 ml sample of urine) 4 / The sixtieth day of inclusion (J60) or the day of     the release from hospital: 1 sample (3 x 5 ml of blood) 1 sample (10 ml sample of urine) The     aliquots will be stored locally at -20 °C or 80°C Every 6 months, they will be transported to     the Centre de Ressources Biologiques (CRB) of the Lariboisière Hospital. The samples will     be preserved for 10 years   "|||2017-10-10 21:40:37.314915|2017-10-10 21:40:37.314915
NCT02940145|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-06-19|||March 2014||2014-03-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|||Phase Angle and Body Composition, Inflammatory and Oxidative Stress Biomarkers.|Modifications to Phase Angle After Resistance Training Are Associated With Changes in Body Composition, Inflammatory and Oxidative Stress Biomarkers in Older Women|Completed||N/A|51|Actual|Universidade Estadual de Londrina||2|||f||||f||||||||No||2017-10-10 21:40:37.548317|2017-10-10 21:40:37.548317
NCT02940132|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-20|||October 2016||2016-10-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of SC10914 in Patients With Advanced Solid Tumors|Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics/ Pharmacodynamics and Preliminary Efficacy of SC10914 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|72|Anticipated|Jiangxi Qingfeng Pharmaceutical Co. Ltd.||1|||f||||f||||||||Yes||2017-10-10 21:40:37.624695|2017-10-10 21:40:37.624695
NCT02940119|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-27|||November 2015||2015-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Neck and Shoulder Pain Research Study|Effects of Phototherapy With Different Sources of Light in Muscle Skeletal Chronic Pain Relief From Neck and Shoulders|Completed||N/A|72|Actual|University of Nove de Julho||2|||f||||||||||||||2017-10-10 21:40:37.711216|2017-10-10 21:40:37.711216
NCT02940106|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Clinical Pregnancies After Cryopreservation of Donor Oocytes With an Open or Closed Device|Investigation of the Clinical Pregnancies Obtained After Cryopreservation of Donor Oocytes With an Open or Closed Device|Not yet recruiting||N/A|40|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||Undecided||2017-10-10 21:40:37.791192|2017-10-10 21:40:37.791192
NCT02940093|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-18|||November 2016||2016-11-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|ImMiGeNe||Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers|Implementation of a Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers for Stratified Clinical Management|Not yet recruiting||N/A|60|Anticipated|University Hospital Tuebingen|||2||f||||t||||||Samples With DNA|"     Urine Feces Blood   "|||2017-10-10 21:40:37.880981|2017-10-10 21:40:37.880981
NCT02940080|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-05-04|||October 2016||2016-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Anthocyanins Extracted From Purple Potatoes on Healthy Study Subjects' Postprandial Glycemia and Insulinemia|Effect of Anthocyanins Extracted From Purple Potatoes on Healthy Study Subjects' Postprandial Glycemia and Insulinemia|Recruiting||N/A|20|Anticipated|University of Turku||2|||f||||f||||||||||2017-10-10 21:40:37.943182|2017-10-10 21:40:37.943182
NCT02940067|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2017-05-01|||March 28, 2017|Actual|2017-03-28|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|MedEx||Enhancing Fitness Before Pancreatic Surgery|A Multimodal Approach to Improve Fitness and Surgical Outcomes for Patients Undergoing Pancreatic Resection|Recruiting||N/A|40|Anticipated|Royal Surrey County Hospital NHS Foundation Trust||2|||f||||t|f|f||||||No||2017-10-10 21:40:38.032649|2017-10-10 21:40:38.032649
NCT02940054|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-21|||February 2015||2015-02-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|RED-FLAGS2||RED-FLAGS Index Validation in Crohn's Disease Patients|Validation of the RED-FLAGS Index for Early Diagnosis of Crohn's Disease: Prospective Observational Study|Recruiting||N/A|600|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||||||2017-10-10 21:40:38.13535|2017-10-10 21:40:38.13535
NCT02940041|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|CERTUM||Concordance Between Gynaecologic Sonography Amd Pelvic MRI for the Pre-surgical Diagnosis of Uterine Mesenchimal Malignant Tumors|Concordance Between Gynaecologic Sonography Amd Pelvic MRI for the Pre-surgical Diagnosis of Uterine Mesenchimal Malignant Tumors|Not yet recruiting||N/A|50|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||Yes||2017-10-10 21:40:38.205366|2017-10-10 21:40:38.205366
NCT02940028|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-19|||April 29, 2017|Actual|2017-04-29|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||ICU Experience Among Family Members of ICU Patients|ICU Experience Among Family Members of ICU Patients|Recruiting||N/A|120|Anticipated|Intermountain Health Care, Inc.||2|||f||||f|f|f||||||No||2017-10-10 21:40:38.260463|2017-10-10 21:40:38.260463
NCT02940002|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-03-20|||October 12, 2016|Actual|2016-10-12|March 2017|2017-03-01|March 17, 2017|Actual|2017-03-17|January 27, 2017|Actual|2017-01-27||Interventional|||BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test|A 28-day, Double-blind, Randomized, Reference-controlled Psoriasis Plaque Test to Evaluate the Efficacy and Safety of Two Different BAY1003803 Formulation Types in 2 Concentrations Each in Treatment of Symptomatic Volunteers With Plaque-type Psoriasis|Completed||Phase 1|23|Actual|Bayer||6|||f||||f||||||||||2017-10-10 21:40:38.407924|2017-10-10 21:40:38.407924
NCT02939989|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-17|||November 21, 2016||2016-11-21|July 2017|2017-07-01|September 6, 2019|Anticipated|2019-09-06|June 14, 2019|Anticipated|2019-06-14||Interventional|MAGELLAN-3||A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study|An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Chronic Hepatitis C (HCV) Infected Subjects Who Have Experienced Virologic Failure in AbbVie HCV Clinical Studies (MAGELLAN-3)|Enrolling by invitation||Phase 3|40|Anticipated|AbbVie||2|||f||||f||||||||||2017-10-10 21:40:38.502986|2017-10-10 21:40:38.502986
NCT02939976|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-09-22|||August 30, 2017|Actual|2017-08-30|September 2017|2017-09-01|March 30, 2021|Anticipated|2021-03-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)|Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)|Enrolling by invitation||N/A|875|Anticipated|Duke University||3|||f||||t|f|t|f|f||||||2017-10-10 21:40:38.62437|2017-10-10 21:40:38.62437
NCT02939950|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-10-18|||April 2015||2015-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Silicone Hydrogel Soft Contact Lens 7-Day Extended Wear Basis|A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Soft Contact Lens When Worn on a 7-Day Extended Wear Basis|Completed||N/A|816|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 21:40:38.836304|2017-10-10 21:40:38.836304
NCT02939937|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-10-18|||July 2016||2016-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Phenytoin on the Ganglion Cell Inner Plexiform Layer and Visual Field in Patients With an Acute Optic Neuritis|a Phase II Double Blind, Randomized, Placebo Controlled Trial of Effect of Phenytoin on the Ganglion Cell Inner Plexiform Layer (GCIPL) and Visual Field in Patients With a First Episode of Acute Optic Neuritis|Recruiting||Phase 2|108|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:40:38.909887|2017-10-10 21:40:38.909887
NCT02939924|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-05-04|||April 7, 2017|Actual|2017-04-07|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|June 2018|Anticipated|2018-06-01||Interventional|KANSHAS1||Treatment of Patients With Lesions in the Superficial Femoral or Popliteal Arteries Using Kanshas Drug Coated Balloon|Prospective, Multi-Center, Open, Single Arm Study for the Treatment of Patients Presenting De Novo Lesions in the Superficial Femoral or Popliteal Arteries Using a Kanshas Drug Coated Balloon Catheter|Recruiting||N/A|50|Anticipated|Terumo Europe N.V.||1|||f||||t|f|f||||||Undecided||2017-10-10 21:40:38.993513|2017-10-10 21:40:38.993513
NCT02939911|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|REPEB||Residual Neuromuscular Blockade in Pediatric Anesthesia|Residual Neuromuscular Blockade in Paediatric Patients Before Extubation and in Postanesthetic Care Unit:Prospective Observational Cohort Study|Recruiting||N/A|200|Anticipated|Brno University Hospital|||1||f||||t||||||||Yes||2017-10-10 21:40:39.086756|2017-10-10 21:40:39.086756
NCT02939898|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-19|||August 2016||2016-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|RIOT-B||Mapping of Specific Factors That Determine Stimulation of the Ovaries Under Fertility Treatment|Reducing the Impact of Ovarian Stimulation - The RIOT Project Study RIOT-B: Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles|Recruiting||Phase 2/Phase 3|32|Anticipated|Herlev Hospital||2|||f||||t||||||||Yes|The study will share data with Study RIOT-A|2017-10-10 21:40:39.170312|2017-10-10 21:40:39.170312
NCT02939885|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-10-19|||January 2006||2006-01-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ICF||fMRI Study of Brain Mechanisms Related to Emotions|Imagerie Fonctionnelle cérébrale: Aspects Normaux et Pathologiques|Completed||N/A|22|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||||||||||||2017-10-10 21:40:39.459782|2017-10-10 21:40:39.459782
NCT02939872|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-06-15|||March 10, 2017|Actual|2017-03-10|June 2017|2017-06-01|June 30, 2024|Anticipated|2024-06-30|December 31, 2019|Anticipated|2019-12-31||Interventional|BVS LATE||Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events|Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events: BVS-LATE Trial|Recruiting||Phase 4|2000|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||Undecided||2017-10-10 21:40:39.533849|2017-10-10 21:40:39.533849
NCT02939859|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-09-10|||September 2016||2016-09-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|cSVF||Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions|Use of Cellular Stromal Vascular Fraction (cSVF) for Select Multiple Sclerosis, Autoimmune, Inflammatory, and Neurologic Conditions: Clinical Interventional Study of Adverse Events and Clinical Outcomes Using Autologous Stem-Stromal Cells.|Recruiting||N/A|100|Anticipated|Healeon Medical Inc||3|||f||||t||||||||||2017-10-10 21:40:39.742421|2017-10-10 21:40:39.742421
NCT02939846|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-01-25|||May 2017||2017-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Pharmacokinetics of Single and Repeat Oral Doses of Trametinib in Chinese Subjects With Solid Tumours|A Phase I Study to Evaluate the Pharmacokinetics and Safety of Single and Repeat Oral Doses of Trametinib in Chinese Subjects With Solid Tumours|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||1||Change in strategy|f||||f||||||||||2017-10-10 21:40:39.913763|2017-10-10 21:40:39.913763
NCT02939833|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-18|||January 2017||2017-01-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|||Effects of Scalp Nerve Blocks on Systemic Inflammation|Effects of Scalp Nerve Blocks on Systemic Inflammation After Meningeoma Resection Surgery：a Prospective Randomized Controlled Trial|Not yet recruiting||N/A|160|Anticipated|RenJi Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:40:40.034548|2017-10-10 21:40:40.034548
NCT02939820|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-08-21||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)|Expanded Access Protocol of Patisiran for Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR Amyloidosis) With Polyneuropathy|Available||N/A|||Alnylam Pharmaceuticals|||||||||||||||||||2017-10-10 21:40:40.146345|2017-10-10 21:40:40.146345
NCT02939807|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-02-24|||December 14, 2016|Actual|2016-12-14|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|January 2021|Anticipated|2021-01-01||Interventional|||A Phase II Study of ABC294640 as Second-Line Monotherapy in Patients With Advanced Hepatocellular Carcinoma|A Phase II Study of ABC294640 in Patients With Advanced Hepatocellular Carcinoma Who Have Progressed on Sorafenib|Recruiting||Phase 2|39|Anticipated|RedHill Biopharma Limited||1|||f||||t||||||||||2017-10-10 21:40:40.317129|2017-10-10 21:40:40.317129
NCT02939794|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-10-27|||November 2016||2016-11-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac Surgery|The Effect of Intra Venus Ferric Carboxymaltose Preoperative on Hemoglobin and Blood Transfusion Post Cardiac Surgery|Not yet recruiting||Phase 4|200|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||Yes||2017-10-10 21:40:40.465528|2017-10-10 21:40:40.465528
NCT02939781|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Observational|IGUANA||Measuring the Metabolic Cost of Fever|Measuring Energy Expenditure Before and After Fever in Critically Ill Children|Not yet recruiting||N/A|15|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 21:40:40.583318|2017-10-10 21:40:40.583318
NCT02939768|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-20|||August 2016||2016-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Impact of Different Types of Exercise Training on Biochemical Markers of Insulin-dependent Patients|Effects of High-intensity Interval Training and/or Strength Training on Inflammatory, Oxidative Stress and Glycemic Metabolism Parameters in Type 1 Diabetes Mellitus Patients|Recruiting||N/A|27|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||No||2017-10-10 21:40:40.677129|2017-10-10 21:40:40.677129
NCT02939755|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-06-05|||December 2016||2016-12-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|WBCCI||Web-based Collaborative Care Intervention Study|Collaborative Care Intervention for Cancer Patients and Their Family Caregivers|Recruiting||Phase 2|450|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-10 21:40:40.823462|2017-10-10 21:40:40.823462
NCT02939742|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-17|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?|Does a Repeat Course of Antenatal Corticosteroids in Pregnant Women With Preterm Premature Rupture of Membranes Decrease Neonatal Morbidity?|Not yet recruiting||Phase 2/Phase 3|98|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||No||2017-10-10 21:40:40.9919|2017-10-10 21:40:40.9919
NCT02939729|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-10-18|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Physiotherapy Prehabilitation in Patients Undergoing Cardiac or Thoracic Surgery|The Effect of a Physiotherapy Prehabilitation Programme on Postoperative Outcomes in Patients Undergoing Cardiac or Thoracic Surgery|Recruiting||N/A|40|Anticipated|Golden Jubilee National Hospital||2|||f||||f||||||||No||2017-10-10 21:40:41.158218|2017-10-10 21:40:41.158218
NCT02939716|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-05-03|||October 2016||2016-10-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|LETIS||Assessing the Effect of Lettuce on Intestinal Water Content Through Magnetic Resonance Imaging of the Small Bowel|A Pilot Study to Assess the Effect of Lettuce on Intestinal Water Content Through Magnetic Resonance Imaging of the Small Bowel: LETIS|Completed||N/A|18|Actual|University of Nottingham||3|||f||||f||||||||No||2017-10-10 21:40:41.325369|2017-10-10 21:40:41.325369
NCT02939703|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01||||June 2021|Anticipated|2021-06-01||Interventional|||Integrating Quantitative Energetics Determines the Microbiome's Contribution to Energy Balance|Integrating Quantitative Energetics Determines the Microbiome's Contribution to Energy Balance|Recruiting||Phase 1|18|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida||2|||f||||t||||||||No||2017-10-10 21:40:41.421699|2017-10-10 21:40:41.421699
NCT02939690|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Umbilical Venous Catheter Insertion Depth in Neonates|Estimation of Umbilical Venous Catheter Insertion Depth in Newborns Using Weight or Body Measurement: A Randomized Trial|Recruiting||N/A|200|Anticipated|University of Calgary||2|||f||||t||||||||Undecided||2017-10-10 21:40:41.530778|2017-10-10 21:40:41.530778
NCT02939677|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-01-13|||January 2017||2017-01-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|RATE||Can Targeted Exercise Improve Knee Strength Following ACLR (RATE)|Can Targeted Exercise Improve Knee Strength in Patients With Persisting Hamstring Deficiency Following ACL-reconstruction? - A Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|University of Southern Denmark||2|||f||||t||||||||No||2017-10-10 21:40:41.653735|2017-10-10 21:40:41.653735
NCT02939664|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-22|||April 2016||2016-04-01|September 2017|2017-09-01|January 2034|Anticipated|2034-01-01|January 2034|Anticipated|2034-01-01||Interventional|LGB-vs-LbGB||Laparoscopic Gastric Bypass Versus Laparoscopic Banded Gastric Bypass Randomized Prospective Clinical Trial|Laparoscopic Gastric Bypass Versus Laparoscopic Banded Gastric Bypass, a Randomized Prospective Clinical Trial|Recruiting||N/A|80|Anticipated|Puerta de Hierro University Hospital||2|||f||||t||||||||||2017-10-10 21:40:41.767446|2017-10-10 21:40:41.767446
NCT02939651|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of Pembrolizumab in Patients With Neuroendocrine Tumors|A Phase 2, Open-label Study of Pembrolizumab Monotherapy in Patients With Metastatic High Grade Neuroendocrine Tumors|Recruiting||Phase 2|21|Anticipated|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-10 21:40:41.910129|2017-10-10 21:40:41.910129
NCT02939638|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-07-05|||October 2016||2016-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TEF||Diet, Insulin Sensitivity, and Postprandial Metabolism|A Randomized, Controlled Trial on Diet, Insulin Sensitivity, and Postprandial Metabolism|Recruiting||N/A|60|Anticipated|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-10-10 21:40:42.006344|2017-10-10 21:40:42.006344
NCT02939625|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||CPAP Application in the Treatment of Asthmatic Children|Effects of Continuous and Bilevel Positive Airway Pressure During Exercise-induced Bronchoconstriction in Asthmatic Children: Controlled Clinical Trial, Randomized|Recruiting||N/A|45|Anticipated|University of Nove de Julho||3|||f||||t||||||||No||2017-10-10 21:40:42.1155|2017-10-10 21:40:42.1155
NCT02939612|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial|Testing a Computerized Interactive Stress Management Intervention in Early Stage Cancer: A Randomized Controlled Trial|Recruiting||N/A|280|Anticipated|Oslo University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:40:42.200753|2017-10-10 21:40:42.200753
NCT02939599|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-07-11|||October 2, 2017|Anticipated|2017-10-02|July 2017|2017-07-01|October 2, 2019|Anticipated|2019-10-02|October 2, 2019|Anticipated|2019-10-02||Interventional|||Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients|Long-term, Open Label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of QCC374 in Patients With Pulmonary Arterial Hypertension (PAH)|Not yet recruiting||Phase 2|38|Anticipated|Novartis||1|||f||||t|t|f||||||||2017-10-10 21:40:42.296256|2017-10-10 21:40:42.296256
NCT02939586|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-02-22|||October 2016||2016-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sleep Apnoea in Haemodialysis|A Cross-sectional, Randomised-controlled Study to Investigate the Effect of HDF in Sleep Apnoea|Recruiting||N/A|200|Anticipated|John Hunter Hospital||2|||f||||t||||||||No||2017-10-10 21:40:42.370938|2017-10-10 21:40:42.370938
NCT02939560|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-20|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|TAD||TMS for Adults With Autism and Depression|Transcranial Magnetic Stimulation for Adults With Autism Spectrum Disorder and Depression|Recruiting||N/A|15|Anticipated|Medical University of South Carolina||1|||f||||t||||||||No|Individual participant data will not be shared.|2017-10-10 21:40:42.551013|2017-10-10 21:40:42.551013
NCT02939547|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-07-18|||September 28, 2017|Anticipated|2017-09-28|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)|A Phase I Study to Evaluate the Single and Multiple-dose Pharmacokinetics of Intravenous Trappsol Cyclo (HP-Beta-CD) in Patients With Niemann-Pick Disease Type C (NPC-1) and the Effects of Dosing Upon Biomarkers of NPC Disease|Recruiting||Phase 1|12|Anticipated|CTD Holdings, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:40:42.636361|2017-10-10 21:40:42.636361
NCT02939534|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-06-12|||February 2015||2015-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Antigen Presentation and Lymphocyte Response in Parkinson's Disease|Antigen Presentation and Lymphocyte Response in Parkinson's Disease|Active, not recruiting||N/A|180|Anticipated|Columbia University|||1||f||||f|f|f||||Samples With DNA|"     Blood   "|No||2017-10-10 21:40:42.801237|2017-10-10 21:40:42.801237
NCT02939521|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-19|||September 2014||2014-09-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Reconstructive Surgical Approach for Pincer Nail|Reconstructive Surgical Approach for Pincer Nail|Completed||N/A|10|Actual|Clínica María del Mar Ruiz||1|||f||||f||||||||No||2017-10-10 21:40:42.872573|2017-10-10 21:40:42.872573
NCT02939508|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-18|||July 2015||2015-07-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Should Colon or Non-colon Originated Lesions be Distinguished?|Acute Lower Gastrointestinal Dysfunction in Critical Care Patients: Should Colon or Non-colon Originated Lesions be Distinguished?|Recruiting||Phase 1/Phase 2|158|Anticipated|Chinese Medical Association||2|||f||||t||||||||Undecided||2017-10-10 21:40:42.932452|2017-10-10 21:40:42.932452
NCT02939495|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2017-08-23|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Interventional|DAP-SPEED||The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy|The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy in the Treatment of Men With Premature Ejaculation and Erectile Dysfunction (DAP-SPEED Study)|Completed||Phase 4|75|Anticipated|Neutec Ar-Ge San ve Tic A.Ş||1|||f||||f||||||||||2017-10-10 21:40:43.007665|2017-10-10 21:40:43.007665
NCT02939482|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2017-10-02|||October 2016||2016-10-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study Comparison of Clinical Outcome After Different Rate of Infusion in Caudal Epidural Steroid Injection|A Prospective Study Comparison of Clinical Outcome After Different Rate Infusion in Caudal Epidural Steroid Injection|Enrolling by invitation||N/A|88|Anticipated|Navamindradhiraj University||2|||f||||f||||||||||2017-10-10 21:40:43.078209|2017-10-10 21:40:43.078209
NCT02939469|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Skin Sympathetic Nerve Activity and Cardiac Arrhythmias|STTR Phase II : Skin Sympathetic Nerve Activity and Cardiac Arrhythmias|Not yet recruiting||Phase 2|42|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-10 21:40:43.151139|2017-10-10 21:40:43.151139
NCT02939456|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||June 2016||2016-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|DIRMP||Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study|Comparison Of Double Inversion Recovery Magnetic Resonance Imaging (Dir-Mri) And Dynamic Contrast Enhanced Magnetic Imaging (Dce-Mri) In Detection Of Prostate Cancer: A Pilot Study|Recruiting||N/A|150|Anticipated|University Hospitals of North Midlands NHS Trust||1|||f||||f||||||||No||2017-10-10 21:40:43.217413|2017-10-10 21:40:43.217413
NCT02939443|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-18|||April 2014||2014-04-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Prone-position CT for Diagnosing Inguinal Hernia|Diagnosis of Inguinal Hernia by Prone- vs. Supine-position Computed Tomography|Completed||N/A|68|Actual|Nagareyama Central Hospital||1|||f||||||||||||||2017-10-10 21:40:43.289835|2017-10-10 21:40:43.289835
NCT02939430|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-02-05|||November 2016||2016-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|Suga_bleeding||Sugammadex Reversal of Neuromuscular Blockade and Postoperative Bleeding||Recruiting||N/A|40|Anticipated|Mansoura University||2|||f||||t||||||||Yes||2017-10-10 21:40:43.342262|2017-10-10 21:40:43.342262
NCT02939417|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||One Year Clinical Evaluation of E.Max Laminate Veneers With and Without Using Grape Seed Extract as a Natural Collagen Cross-linking Agent Before Bonding|One Year Clinical Evaluation of E.Max Laminate Veneers With and Without Using Grape Seed Extract as a Natural Collagen Cross-linking Agent Before Bonding|Not yet recruiting||N/A|16|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:40:43.412569|2017-10-10 21:40:43.412569
NCT02939404|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-19|2017-07-20|||October 6, 2016||2016-10-06|June 26, 2017|2017-06-26|December 30, 2022|Anticipated|2022-12-30|December 30, 2022|Anticipated|2022-12-30||Observational|||Food Intake Response to Short-Term Modifications of Metabolism in Humans|Energy Intake Response to Short-Term Alterations of Energy Expenditure in Humans|Not yet recruiting||N/A|160|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:40:45.362555|2017-10-10 21:40:45.362555
NCT02939391|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-04|||September 2016||2016-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of KW-6356 in Subjects With Early Parkinson's Disease|An Early Phase 2 Study of KW-6356 in Subject With Early Parkinson's Disease|Active, not recruiting||Phase 2|150|Anticipated|Kyowa Hakko Kirin Co., Ltd||3|||f||||f||||||||||2017-10-10 21:40:45.457584|2017-10-10 21:40:45.457584
NCT02939378|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|KGDinrGBM||Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study|Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study|Recruiting||Phase 1/Phase 2|60|Anticipated|Beijing Tiantan Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:40:45.545909|2017-10-10 21:40:45.545909
NCT02939365|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-19|||December 2016||2016-12-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|PROBE||Precision Medicine Offers Belatacept Monotherapy|Precision Medicine Offers Belatacept Monotherapy (PROBE)|Not yet recruiting||Phase 4|40|Anticipated|University of California, San Francisco||1|||f||||t||||||||No||2017-10-10 21:40:45.640687|2017-10-10 21:40:45.640687
NCT02939352|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-10-18|||September 2014||2014-09-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|addictionTBS||The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues|The Effects of a Single Session of Real Versus Sham Theta Burst Stimulation on the Brain Response to Drug-cues|Completed||Phase 1|49|Actual|Medical University of South Carolina||2|||f||||f||||||||No||2017-10-10 21:40:45.720951|2017-10-10 21:40:45.720951
NCT02939339|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-06-07|||October 2015||2015-10-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Theta Burst TMS as a Tool to Change Smoking Behavior|Theta Burst TMS as a Tool to Change Smoking Behavior|Recruiting||Phase 2|30|Anticipated|Medical University of South Carolina||2|||f||||t||||||||No||2017-10-10 21:40:45.827673|2017-10-10 21:40:45.827673
NCT02939326|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-08-16|||December 2016||2016-12-01|August 2017|2017-08-01|July 12, 2017|Actual|2017-07-12|July 12, 2017|Actual|2017-07-12||Interventional|||Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines||Completed||Phase 2|42|Anticipated|Bonti, Inc.||2|||f||||||||||||||2017-10-10 21:40:45.951245|2017-10-10 21:40:45.951245
NCT02939313|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-10-26|||January 2016||2016-01-01|August 2016|2016-08-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|ARC4||Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues|Charleston ARC Clinical Project 4 Cortical rTMS as a Tool to Change Craving and Brain Reactivity to Alcohol Cues|Recruiting||N/A|66|Anticipated|Medical University of South Carolina||3|||f||||t||||||||Yes|Data will be shared with the National Institute of Health Neuroimaging Biorepository at the completion of the study|2017-10-10 21:40:46.03551|2017-10-10 21:40:46.03551
NCT02939300|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-28|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|January 2024|Anticipated|2024-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma|Phase II Trial of Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma|Recruiting||Phase 2|18|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 21:40:46.162456|2017-10-10 21:40:46.162456
NCT02939287|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Aprepitant Versus Olanzapine With High Dose Melphalan|Aprepitant Versus Olanzapine for Prevention of Acute and Delayed Nausea and Vomiting Associated With High Dose Melphalan and BEAM in Autologous Stem Cell Transplant Patients|Not yet recruiting||Phase 3|370|Anticipated|Rush University Medical Center||2|||f||||f||||||||No||2017-10-10 21:40:46.422855|2017-10-10 21:40:46.422855
NCT02939274|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-02-08|||October 2016||2016-10-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer||Recruiting||Phase 2|15|Anticipated|Rogers Sciences Inc.||1|||f||||t||||||||||2017-10-10 21:40:46.544417|2017-10-10 21:40:46.544417
NCT02939261|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-20|||January 2016||2016-01-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|GFHS||Guelph Family Health Study: Full Study|Guelph Family Health Study: Full Study|Recruiting||N/A|900|Anticipated|University of Guelph||2|||f||||f||||||||No||2017-10-10 21:40:46.655387|2017-10-10 21:40:46.655387
NCT02939248|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-08-08|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine|Differences in the Pharmacokinetic and Pharmacodynamic Profile of Ticagrelor and Its Active Metabolite AR-C124900XX Between Patients With Unstable Angina Pectoris Treated With Crushed Ticagrelor and a Combination of Morphine and Naloxone or Morphine Alone - a Randomized Study|Recruiting||Phase 4|30|Anticipated|Collegium Medicum w Bydgoszczy||2|||f||||f||||||||||2017-10-10 21:40:46.776401|2017-10-10 21:40:46.776401
NCT02939235|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-08-08|||July 2016||2016-07-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine|Differences in the Pharmacokinetic and Pharmacodynamic Profile of Ticagrelor and Its Active Metabolite AR-C124900XX Between Patients With Unstable Angina Pectoris Treated With Crushed Ticagrelor and a Combination of Morphine and Metoclopramide or Morphine Alone - a Randomized Study|Recruiting||Phase 4|30|Anticipated|Collegium Medicum w Bydgoszczy||2|||f||||f||||||||||2017-10-10 21:40:46.879699|2017-10-10 21:40:46.879699
NCT02939222|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Impact of Buccal Bone Thickness on Pathological Peri-implant Bone Loss: A 3-year Prospective Cohort Study|Impact of Buccal Bone Thickness on Pathological Peri-implant Bone Loss: A 3-year Prospective Cohort Study|Recruiting||N/A|100|Anticipated|Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain||1|||f||||t||||||||||2017-10-10 21:40:46.980405|2017-10-10 21:40:46.980405
NCT02939209|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-05-28|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pre-emptive Opioid Treatment to Prevent Rebound Pain After Arthroscopic Rotator Cuff Repair Under General Anesthesia and Interscalene Block|Preventing Rebound Pain After Arthroscopic Rotator Cuff Repair Under General Anesthesia and Interscalene Block: A Randomized Controlled Trial of Pre-emptive Opioid Treatment Compared to Placebo|Recruiting||Phase 4|70|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||||2017-10-10 21:40:47.06075|2017-10-10 21:40:47.06075
NCT02939196|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-07-19|||November 2016||2016-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Pain in Different Office Hysteroscopy Diameter|Comparison of Pain Accompanying the Use of 3.7 mm and 4 mm Office Hysteroscopy in Nullipara: A Randomized Clinical Trial|Recruiting||N/A|140|Anticipated|Assiut University|||2||f||||f||||||||||2017-10-10 21:40:47.173262|2017-10-10 21:40:47.173262
NCT02937662|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-05-22|||October 2016||2016-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML||Recruiting||Phase 2|60|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:40:59.978263|2017-10-10 21:40:59.978263
NCT02939170|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-12-13|||November 2016||2016-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks|Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks|Completed||N/A|87|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 21:40:47.415957|2017-10-10 21:40:47.415957
NCT02939157|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-02-26|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|POCUS||Pocket-sized Ultrasound for Point-of-care Diagnosis of Heart Failure|Pocket-sized Ultrasound for Point-of-care Diagnosis of Heart Failure|Enrolling by invitation||N/A|250|Anticipated|Umeå University|||1||f||||f||||||||No||2017-10-10 21:40:47.506934|2017-10-10 21:40:47.506934
NCT02939144|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-07-18|||November 2016|Actual|2016-11-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||An Investigation Into the Effect of Liquorice Ingestion on the Salivary Cortisol to Cortisone Molar Ratio|An Investigation Into the Effect of Liquorice Ingestion on the Salivary Cortisol to Cortisone Molar Ratio|Recruiting||N/A|12|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||1|||f||||f||||||||||2017-10-10 21:40:47.59645|2017-10-10 21:40:47.59645
NCT02939131|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-07-14|||March 6, 2017|Actual|2017-03-06|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||IMPAACT 2002: Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among US Youth With HIV|IMPAACT 2002: Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States|Enrolling by invitation||N/A|156|Anticipated|International Maternal Pediatric Adolescent AIDS Clinical Trials Group||2|||f||||t|f|f||||||||2017-10-10 21:40:47.699275|2017-10-10 21:40:47.699275
NCT02939118|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Observational|||Three Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™|A Three-Year, Multicenter, Observational, Follow-up Safety Study in Subjects Previously Implanted With VC-01™ Combination Product|Enrolling by invitation||N/A|200|Anticipated|ViaCyte|||1||f||||||||||||||2017-10-10 21:40:47.841032|2017-10-10 21:40:47.841032
NCT02939105|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-06-20|||December 2, 2016|Actual|2016-12-02|October 2016|2016-10-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|ARM||DualSculpting the Upper Arms|DualSculpting the Upper Arms Using Vacuum Applicators and a Customized Treatment Approach|Completed||N/A|15|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-10 21:40:47.892059|2017-10-10 21:40:47.892059
NCT02939092|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-07-18|||November 2016||2016-11-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Mouthwash Containing Pomegranate Peel Extract and Chlorhexidine Mouthwash on Bleeding on Brushing|The Effect of Mouthwash Containing Pomegranate Peel Extract and Chlorhexidine Mouthwash on Bleeding on Brushing Among a Group of Egyptian Children With Full Permanent Dentition, Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-10 21:40:47.955867|2017-10-10 21:40:47.955867
NCT02939079|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-17|||April 2015||2015-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients|Evaluating the Effect of Fingolimod With Fish Oil Compared to Fingolimod With Placebo on Tumor Necrosis Factor-α , Interleukin1b , Interleukin6, and Interferon-gamma in Patients With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2/Phase 3|50|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||Undecided|The investigators may make individual participant data available regarding drug side effects or other factors that need to be described individually however the primary outcome will be published as group result and not individual results.|2017-10-10 21:40:48.041931|2017-10-10 21:40:48.041931
NCT02939066|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-02-14|||May 2016||2016-05-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Observational|||Endoscopic Ultrasound-guided Needle-based Confocal Laser Endomicroscopy for Evaluation of Malignant Lymph Nodes - a Pilot Study||Recruiting||N/A|30|Anticipated|Shandong University|||1||f||||t||||||||||2017-10-10 21:40:48.155863|2017-10-10 21:40:48.155863
NCT02939053|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Correlation of SOZO BIS Measures With CardioMEMS PA Pressure|Correlation of Bioimpedance Measurements From the SOZO Device With Pulmonary Arterial Pressure Measurements From the CardioMEMS HF System|Not yet recruiting||N/A|20|Anticipated|ImpediMed Limited|||1||f||||f||||||||||2017-10-10 21:40:48.251509|2017-10-10 21:40:48.251509
NCT02939040|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-10-03|||June 2016||2016-06-01|October 2017|2017-10-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Pilot Study of a Brief Pre-Operative Intervention for Patients Undergoing Breast Surgery|A Pilot Study of a Brief Pre-Operative Intervention for Patients Undergoing Breast Surgery|Completed||N/A|22|Actual|University of Michigan||2|||f||||t||||||||||2017-10-10 21:40:48.402887|2017-10-10 21:40:48.402887
NCT02939027|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-17|||July 2013||2013-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma|Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma|Completed||N/A|40|Actual|Instituto de Investigacion Sanitaria La Fe||2|||f||||f||||||||Undecided||2017-10-10 21:40:48.495512|2017-10-10 21:40:48.495512
NCT02939014|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-08-15|||November 30, 2016|Actual|2016-11-30|August 2017|2017-08-01|April 30, 2020|Anticipated|2020-04-30|November 1, 2018|Anticipated|2018-11-01||Interventional|||Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)|A Phase 2, Single-Arm, Open-label Study of Brentuximab Vedotin in Chinese Patients With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)|Active, not recruiting||Phase 2|39|Actual|Takeda||1|||f||||f|f|f||||||||2017-10-10 21:40:48.581046|2017-10-10 21:40:48.581046
NCT02939001|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||September 2016||2016-09-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluating the Effect of Laser Vision Surgery, Phakic Intraocular Lens Implantation, Cataract Surgery, and Pupil Dilation on the Iris Recognition Scanner Function of Smartphone||Recruiting||N/A|80|Anticipated|Yonsei University||1|||f||||f||||||||No||2017-10-10 21:40:48.689959|2017-10-10 21:40:48.689959
NCT02938988|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||October 2013||2013-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Antimicrobial Photodynamic Therapy as an Adjunct Treatment for Periodontal Disease in Down's Syndrome Patients|Full-mouth Antimicrobial Photodynamic Therapy as an Adjunct to Non-surgical Periodontal Disease Treatment in Down's Syndrome Patients|Completed||N/A|33|Actual|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 21:40:48.782168|2017-10-10 21:40:48.782168
NCT02938975|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-03|||November 2017|Anticipated|2017-11-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|URCT||Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents for Malaria Prevention|Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents To Reduce Malaria Incidence In Military Personnel On Active Duty In Regions Of Hyperendemicity|Not yet recruiting||Phase 3|1500|Anticipated|Ifakara Health Institute||4|||f||||t|t|f|||t|||||2017-10-10 21:40:48.889766|2017-10-10 21:40:48.889766
NCT02938962|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01||||November 2018|Anticipated|2018-11-01||Interventional|VITALITY-X||Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)|Revision Total Hip Arthroplasty: Comparison of the Effects of Intravenous and Topically Administered Tranexamic Acid in a Prospective Randomized Trial (VITALITY-X)|Recruiting||Phase 4|160|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-10 21:40:49.60639|2017-10-10 21:40:49.60639
NCT02938949|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-02-07|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Alirocumab in Patients With Acute Myocardial Infarction|Alirocumab in Patients With Acute Myocardial Infarction: A Randomized Controlled Double-Blinded Study|Recruiting||Phase 4|20|Anticipated|Virginia Commonwealth University||2|||f||||f|t|f||||||Yes|The investigators plan to present the data promptly upon analysis as an abstract to a national meeting and/or a manuscript.|2017-10-10 21:40:49.726704|2017-10-10 21:40:49.726704
NCT02938936|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Waiting Time. Wasting Time: A Randomized Control Trial to Investigate the Health Impacts of Improving the Quality of Antenatal Care in Mozambique||Not yet recruiting||N/A|240|Anticipated|Harvard School of Public Health||2|||f||||f||||||||||2017-10-10 21:40:49.842988|2017-10-10 21:40:49.842988
NCT02938923|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-17|||July 2017||2017-07-01|October 2016|2016-10-01|January 2023|Anticipated|2023-01-01|June 2022|Anticipated|2022-06-01||Interventional|||Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture|Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture|Not yet recruiting||Phase 3|300|Anticipated|Washington University School of Medicine||3|||f||||t||||||||Undecided||2017-10-10 21:40:49.918045|2017-10-10 21:40:49.918045
NCT02938910|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-10-17|||November 2012||2012-11-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|COEURALDO||Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism|Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism Noninvasive Comparative Study in Humans of the Respective Cardiovascular Effects of Hyperaldosteronism and Hypertension by Magnetic Resonance Imaging|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||Samples Without DNA|"     Urines and plasma   "|||2017-10-10 21:40:50.04951|2017-10-10 21:40:50.04951
NCT02938897|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-10-17|||January 2016||2016-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Telenutrition Weight Loss Study for Men|A Pilot Randomized Controlled Trial of a Home Telenutrition Weight Loss Program in Men|Completed||N/A|60|Actual|West Virginia University||2|||f||||f||||||||No|Data will only be reported in aggregate.|2017-10-10 21:40:50.157807|2017-10-10 21:40:50.157807
NCT02938884|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-12-07|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|HidrateMe||Hidrate Me Smart Water Bottle Use in Patient With Nephrolithiasis|Investigation of Non-Invasive Hydration Monitoring With Smart Water Bottle to Increase Fluid Intake in Patients With Nephrolithiasis and Low Urine Volume|Not yet recruiting||N/A|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 21:40:50.268242|2017-10-10 21:40:50.268242
NCT02938871|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-17|||March 2016||2016-03-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Synbiotic on Postoperative Complications After Liver Transplantation|Effect of Synbiotic on Postoperative Complications After Liver Transplantation - A Randomized Double-blind Clinical Trial|Recruiting||N/A|76|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:40:50.367987|2017-10-10 21:40:50.367987
NCT02938858|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-10-17|||October 2015||2015-10-01|October 2016|2016-10-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01|5 Years|Observational [Patient Registry]|||French Registry of First-line Treatment of Acute Promyelocytic Leukemia|The French Registry on the First-line Treatment of Non High-risk Acute Promyelocytic Leukemia (APL) in Patients Aged ≤ 70 Years|Recruiting||N/A|400|Anticipated|Groupe Francophone des Myelodysplasies|||2||f||||f||||||||No||2017-10-10 21:40:50.472462|2017-10-10 21:40:50.472462
NCT02938845|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-12-06|||January 2013||2013-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Does Minimally Invasive Surgery Reduce Anxiety?|Factors Related to Patients' Anxiety Before and After Hysterectomy|Completed||N/A|74|Actual|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||f||||||||Yes||2017-10-10 21:40:50.651606|2017-10-10 21:40:50.651606
NCT02938832|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|October 2023|Anticipated|2023-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Does the Advice to Eat a Mediterranean Diet With Low Carbohydrate Intake, Compared With a Low-fat Diet, Reduce Diabetes and Cardiovascular Disease?|The CardioDiet Trial|Recruiting||Phase 4|1200|Anticipated|University Hospital, Linkoeping||2|||f||||f||||||||Yes||2017-10-10 21:40:50.732311|2017-10-10 21:40:50.732311
NCT02938819|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-12-13|||August 2016||2016-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Goal-oriented Intervention in Parkinson's Disease|Effects of a Goal-oriented Upper-limb Intervention in Patients With Parkinson's Disease|Completed||N/A|54|Actual|Universidad de Granada||2|||f||||f||||||||Undecided||2017-10-10 21:40:50.810249|2017-10-10 21:40:50.810249
NCT02938806|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-18|||June 2016||2016-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in Children|The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in Children|Recruiting||N/A|120|Anticipated|University of California, San Diego|||4||f||||f||||||Samples Without DNA|"     Stool Urine   "|No||2017-10-10 21:40:50.881765|2017-10-10 21:40:50.881765
NCT02938793|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-01-24|||December 1, 2016|Actual|2016-12-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors|A Phase II Study of Durvalumab (MEDI4736) (Anti-PD-L1 Antibody) in Combination With Tremelimumab (Anti-CTLA-4 Antibody) in Subjects With Advanced Rare Solid Tumors|Recruiting||Phase 2|50|Anticipated|Greenville Health System||1|||f||||f||||||||No|aggregate data only|2017-10-10 21:40:50.964869|2017-10-10 21:40:50.964869
NCT02938780|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-10-18|||June 2015||2015-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Using Behavioral Economics to Achieve Improved Healthy Behavior Outcomes in Breast Cancer Survivors|Using Behavioral Economics to Achieve Improved Healthy Behavior Outcomes in Breast Cancer Survivors|Recruiting||N/A|310|Anticipated|Texas Tech University Health Sciences Center||2|||f||||f||||||||No||2017-10-10 21:40:51.063306|2017-10-10 21:40:51.063306
NCT02938767|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-19|||January 2012||2012-01-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Carotid Intima-media Thickness as Cardiovascular Mortality Predictor in Peritoneal Dialysis Patients|Carotid Intima-media Thickness and Coronary Flow Reserve as Cardiovascular Event and Mortality Predictors in Peritoneal Dialysis Patients: Results of Seven-year Follow-up From a Single Center|Completed||N/A|57|Actual|Istanbul University|||2||f||||f||||||Samples Without DNA|"     hemogram, serum creatinine, uric asid, calcium, phosphorus and albumin   "|No||2017-10-10 21:40:51.142897|2017-10-10 21:40:51.142897
NCT02938754|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||Rehabilitation Gaming System for Cerebral Palsy|Motor and Cognitive Training With the Rehabilitation Gaming System for Patients Affected by Cerebral Palsy|Not yet recruiting||N/A|20|Anticipated|Universitat Pompeu Fabra||2|||f||||f||||||||Undecided||2017-10-10 21:40:51.21197|2017-10-10 21:40:51.21197
NCT02938741|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-23|||October 2016||2016-10-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors|Hematology , Shanghai Jiaotong University Affiliated Shanghai First People's Hospital, Shanghai, China|Recruiting||Phase 4|130|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Yes||2017-10-10 21:40:51.297933|2017-10-10 21:40:51.297933
NCT02938728|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Observational|PREDIMEL||Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma|Definition and Validation of an Immune Signature Predictive of Anti-PD1 Antibody Used Alone or an Association With antiCTLA4 in the Treatment of Advanced Melanoma : PREDIMEL|Not yet recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 21:40:51.396369|2017-10-10 21:40:51.396369
NCT02938715|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-04-17|||October 2016|Actual|2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracil|Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracil|Recruiting||N/A|50|Anticipated|University of California, Davis||2|||f||||||||||||||2017-10-10 21:40:51.612454|2017-10-10 21:40:51.612454
NCT02938702|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-10-18|||May 2016||2016-05-01|October 2016|2016-10-01||||January 2021|Anticipated|2021-01-01||Observational|||Active Surveillance on Papillary Thyroid Microcarcinoma||Recruiting||N/A|400|Anticipated|Seoul National University Hospital|||2||f||||f||||||||Undecided||2017-10-10 21:40:51.717854|2017-10-10 21:40:51.717854
NCT02938689|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy Comparison of the Exercises Based on the Lumbar Extension and Flexion in Chronic Low Back Pain|Efficacy Comparison of the Exercises Based on the Lumbar Extension and Flexion in Chronic Low Back Pain|Not yet recruiting||N/A|66|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:40:51.797203|2017-10-10 21:40:51.797203
NCT02938676|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||Satisfaction Degree in a Nurse Educational Program to Heart Transplant Patient|Satisfaction Degree With the Education Received in an Educational Program to Heart Transplant Patient During Hospitalization|Not yet recruiting||N/A|20|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||Undecided||2017-10-10 21:40:51.891953|2017-10-10 21:40:51.891953
NCT02938663|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-10-18|||January 2014||2014-01-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|HCP||Health & Culture Project: Cultural Factors Underlying Obesity in African-American Adolescents|Cultural Factors Underlying Obesity in African-American Adolescents|Completed||N/A|273|Actual|University of Michigan|||1||f||||f||||||||No||2017-10-10 21:40:51.955188|2017-10-10 21:40:51.955188
NCT02938637|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-18|||October 2016||2016-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:40:52.164506|2017-10-10 21:40:52.164506
NCT02938624|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-17|||January 7, 2017|Actual|2017-01-07|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|MK3475-223||Anti PD-1 Neo-adjuvant Treatment for NSCLC|Anti PD-1 Neo-adjuvant Treatment for Early Stage NSCLC - Phase I Study|Recruiting||Phase 1|28|Anticipated|Sheba Medical Center||4|||f||||t||||||||No||2017-10-10 21:40:52.207133|2017-10-10 21:40:52.207133
NCT02938611|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2017-06-16|||November 2017|Anticipated|2017-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|MRC-Gard||Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France|Feasibility Study on Estimating the Prevalence and Management of Stage 4 Chronic Kidney Disease in Adults Via Laboratories and Nephrologists in the Gard, France|Not yet recruiting||N/A|3375|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:40:52.329442|2017-10-10 21:40:52.329442
NCT02938598|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-05-24|||October 2016||2016-10-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MOM2||Motivating Our Mothers 2|Optimizing a Pediatric Intervention to Increase Maternal Depression Care-Seeking|Recruiting||N/A|312|Anticipated|University of California, Davis||8|||f||||f||||||||No||2017-10-10 21:40:52.433358|2017-10-10 21:40:52.433358
NCT02938585|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-08-31|||December 12, 2016|Actual|2016-12-12|August 2017|2017-08-01|December 14, 2018|Anticipated|2018-12-14|December 14, 2018|Anticipated|2018-12-14||Interventional|guardian TM 7||Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A|Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A|Recruiting||Phase 3|65|Anticipated|Novo Nordisk A/S||2|||f||||f|f|f||||||||2017-10-10 21:40:52.546016|2017-10-10 21:40:52.546016
NCT02938572|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-26|||October 19, 2016|Actual|2016-10-19|September 2017|2017-09-01|July 4, 2017|Actual|2017-07-04|June 17, 2017|Actual|2017-06-17||Interventional|||A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus|This Trial is Conducted in Europe. The Aim of This Trial is to Investigate Pharmacodynamics (the Effect of the Investigated Drug on the Body) , Pharmacokinetics (the Exposure of the Trial Drug in the Body), and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus.|Completed||Phase 1|47|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 21:40:52.659472|2017-10-10 21:40:52.659472
NCT02938559|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-08-17|||December 2016||2016-12-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy?|Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy?|Recruiting||N/A|178|Anticipated|University of California, Berkeley||2|||f||||t||||||||||2017-10-10 21:40:52.753227|2017-10-10 21:40:52.753227
NCT02938546|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-19|||November 2016||2016-11-01|October 2016|2016-10-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|||18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study|18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study|Not yet recruiting||Phase 3|200|Anticipated|Shanghai Chest Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:40:52.868916|2017-10-10 21:40:52.868916
NCT02938533|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-17|||August 2015||2015-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in Care|Pilot Study of a Multi-Pronged Intervention Using Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in Care Among Adults Living With HIV in Tanzania|Completed||N/A|438|Actual|University of California, Berkeley||2|||f||||f||||||||||2017-10-10 21:40:52.971248|2017-10-10 21:40:52.971248
NCT02938507|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects|A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Immediate and Modified Release Formulations of Orally Administered Solabegron in Healthy Male Subjects|Enrolling by invitation||Phase 1|24|Anticipated|Velicept Therapeutics, Inc.||2|||f||||f||||||||No||2017-10-10 21:40:53.446003|2017-10-10 21:40:53.446003
NCT02938494|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-17|||November 2015||2015-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris|A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac® (Tazarotene) Cream, in the Treatment of Acne Vulgaris|Completed||Phase 2|210|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||Yes||2017-10-10 21:40:53.520164|2017-10-10 21:40:53.520164
NCT02938481|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-20|||January 2015||2015-01-01|October 2016|2016-10-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Observational|T-REX||International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer|International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer|Recruiting||N/A|4000|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||f||||||Samples With DNA|"     -  Resected surgical specimens to take photographs        -  Lymph nodes retrieved from Resected surgical specimens to categorise   "|Undecided||2017-10-10 21:40:53.663677|2017-10-10 21:40:53.663677
NCT02938468|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-10-18|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Mgt of Chronic Subdural Hematoma Using Dexamethasone|Efficacy and Safety of Dexamethasone in Management of Chronic Subdural Hematoma: A Single Center Randomized Control Trial|Recruiting||Phase 2/Phase 3|326|Anticipated|University of Calgary||2|||f||||t||||||||Undecided||2017-10-10 21:40:53.821943|2017-10-10 21:40:53.821943
NCT02934165|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-10-12|||September 2009||2009-09-01|October 2016|2016-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|Preschool_2||Safety Skills Training For Parents of Preschool Children|Safety Skills Training For Parents of Preschool Children|Completed||N/A|151|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||No||2017-10-10 21:41:31.334501|2017-10-10 21:41:31.334501
NCT02938455|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-01-19|||October 2016||2016-10-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|2 Days|Observational [Patient Registry]|MEDAPO||DNA Methylation and Perioperative Pain Treatment|Explorative Study About the Degree of DNA Methylation Related to Acute Perioperative Pain Treatment|Recruiting||N/A|20|Anticipated|University of Bologna|||1||f||||f||||||||No||2017-10-10 21:40:53.908291|2017-10-10 21:40:53.908291
NCT02938442|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-06-12|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Vaccination of Triple Negative Breast Cancer Patients|A Combined Phase II Efficacy Study of a Carbohydrate Mimotope-based Vaccine With MONTANIDE™ ISA 51 VG Combined With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer|Not yet recruiting||Phase 2|102|Anticipated|University of Arkansas||2|||f||||t|t|f||||||No||2017-10-10 21:40:53.978251|2017-10-10 21:40:53.978251
NCT02938429|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-06-01|||October 2016||2016-10-01|June 2017|2017-06-01||||October 2019|Anticipated|2019-10-01||Interventional|||Physical Activity Measured Through Accelerometers and Its Association With Endothelial Function in Young Patients With Fontan Physiology||Not yet recruiting||N/A|73|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 21:40:54.070328|2017-10-10 21:40:54.070328
NCT02938416|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||January 2013||2013-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Isokinetic Strengthening Training|Comparison of the Functional Recovery and Cytokines Changes Between Isokinetic and Isotonic Training in Patients With Acute Stroke, After Total Hip Replacement or After Total Knee Replacement|Recruiting||N/A|120|Anticipated|Taichung Veterans General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:40:54.129418|2017-10-10 21:40:54.129418
NCT02938403|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-04-17|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|||In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence|In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence|Recruiting||N/A|500|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 21:40:54.208985|2017-10-10 21:40:54.208985
NCT02938390|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-18|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Localization of Intercostal Perforating Vessels Reduces Wound Complications From Nipple Sparing Mastectomy|Ultrasound Localization of Intercostal Perforating Vessels Reduces Post-Operative Wound Complications From Nipple Sparing Mastectomy|Recruiting||N/A|100|Anticipated|Amita Health|||1||f||||f||||||||Yes||2017-10-10 21:40:54.283605|2017-10-10 21:40:54.283605
NCT02938364|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-04-10|||October 25, 2016|Actual|2016-10-25|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Ear Plugs Versus Acupressure for Management of Severe Gag Reflex|Ear Plugs Versus Acupressure for Management of Severe Gag Reflex: A Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|Riyadh Colleges of Dentistry and Pharmacy||3|||f||||f||||||||Undecided||2017-10-10 21:40:54.608044|2017-10-10 21:40:54.608044
NCT02938338|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-10-17|||June 2015||2015-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Physical Activity, Sedentary and Energy Consumption After Bariatric Surgery|Physical Activity, Sedentary and Energy Consumption After Bariatric Surgery|Recruiting||N/A|150|Anticipated|Region Örebro County|||1||f||||f||||||||Undecided||2017-10-10 21:40:54.776664|2017-10-10 21:40:54.776664
NCT02938325|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-17|||January 2017||2017-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Monitoring Awareness and Pain Under Anesthesia Using a New EEG Based System|Monitoring Awareness and Pain Under Anesthesia Using a New EEG Based System|Not yet recruiting||N/A|60|Anticipated|Rambam Health Care Campus|||2||f||||f||||||||No||2017-10-10 21:40:54.864391|2017-10-10 21:40:54.864391
NCT02938312|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-21|||August 2010||2010-08-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|JTBH||Journey to Better Health|Deep South Network for Cancer Control - Healthier Weight Among African American Women|Completed||N/A|409|Actual|University of Alabama at Birmingham||2|||f||||f||||||||No||2017-10-10 21:40:54.958403|2017-10-10 21:40:54.958403
NCT02938299|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-30|||July 2016||2016-07-01|May 2017|2017-05-01||||December 2018|Anticipated|2018-12-01||Interventional|Pivotal||Neoadjuvant L19IL2/L19TNF- Pivotal Study|A Pivotal Phase III, Open-label, Randomized, Controlled Multi-center Study of the Efficacy of L19IL2/L19TNF Neoadjuvant Intratumoral Treatment Followed by Surgery Versus Surgery Alone in Clinical Stage III B/C Melanoma Patients|Recruiting||Phase 3|214|Anticipated|Philogen S.p.A.||2|||f||||t||||||||||2017-10-10 21:40:55.070736|2017-10-10 21:40:55.070736
NCT02938286|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2017-03-28|||March 2016||2016-03-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Fractional Laser Assisted Delivery of Anesthetics III|Parameters in Fractional Laser Assisted Delivery of Topical Anesthetics: Role of Laser Type and Laser Settings|Completed||Phase 4|15|Actual|Netherlands Institute for Pigment Disorders||4|||f||||f||||||||||2017-10-10 21:40:55.210932|2017-10-10 21:40:55.210932
NCT02938273|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-03-07|||December 2, 2016|Actual|2016-12-02|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)|Bioimmunoradiotherapy (BIR) With Concurrent Avelumab, Cetuximab and Radiotherapy as First Line Treatment in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. A Feasibility Study in Patients Unfit for Cisplatin|Recruiting||Phase 1|10|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||No||2017-10-10 21:40:55.334|2017-10-10 21:40:55.334
NCT02938260|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-20|||January 2010||2010-01-01|October 2016|2016-10-01||||September 2016|Actual|2016-09-01||Observational|||Diltiazem vs. Metoprolol in the Acute Management of AF in Patients With HFrEF|Diltiazem vs. Metoprolol in the Acute Management of Atrial Fibrillation in Patients With Heart Failure With Reduced Ejection Fraction|Active, not recruiting||N/A|200|Anticipated|Rush University Medical Center|||2||f||||||||||||||2017-10-10 21:40:55.432008|2017-10-10 21:40:55.432008
NCT02938247|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-10-19|||September 2016||2016-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled Intake|Prospective Tolerance and Compliance Study With a High Caloric, High Protein Oral Nutritional Supplement in Nursing Home Residents - Scheduled Intake|Completed||N/A|20|Actual|Fresenius Kabi||1|||f||||f||||||||No||2017-10-10 21:40:55.512409|2017-10-10 21:40:55.512409
NCT02938234|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-10-17|||September 2016||2016-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Free Intake|Prospective Tolerance and Compliance Study With a High Caloric, High Protein Oral Nutritional Supplement in Nursing Home Residents - ad Libitum Intake|Completed||N/A|20|Actual|Fresenius Kabi||1|||f||||f||||||||No||2017-10-10 21:40:55.614363|2017-10-10 21:40:55.614363
NCT02938221|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-01-11|||October 2016||2016-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Telemedical Examination of a Three-Component Oculomotor Testing Battery|Feasibility and Safety of a Telemedically Performed Three-Component Oculomotor Testing Battery (HINTS) in Healthy Adults|Completed||N/A|30|Actual|Munich Municipal Hospital||1|||f||||f||||||||No||2017-10-10 21:40:55.706875|2017-10-10 21:40:55.706875
NCT02938208|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2017-07-24|||November 3, 2016|Actual|2016-11-03|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|November 21, 2016|Actual|2016-11-21||Interventional|||An Investigation to Test a Prototype Full-face Mask in the Home Setting|An Investigation to Test a Prototype Full-face Mask in the Home Setting|Completed||N/A|14|Actual|Fisher and Paykel Healthcare||1|||f||||t||||||||||2017-10-10 21:40:55.79144|2017-10-10 21:40:55.79144
NCT02938195|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-18|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer|Phase II Study of Optimum Design of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer|Recruiting||Phase 2|50|Anticipated|Shanghai Chest Hospital||1|||f||||t||||||||No||2017-10-10 21:40:55.882488|2017-10-10 21:40:55.882488
NCT02938182|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Migraine Prophylaxis With Clopidogrel Trial|A Prospective Trial to Evaluate the Effectiveness of Clopidogrel to Relieve Migraine With Right-to-left Shunt|Not yet recruiting||Phase 4|50|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||1|||f||||f||||||||No|The information of the patients need to keep confidential.|2017-10-10 21:40:55.985882|2017-10-10 21:40:55.985882
NCT02938169|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-17|||May 2016||2016-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|EMG||The Effect of Lumbar Stabilization Exercise and Gait Training on Lower Back Muscles- Electromyographic(EMG) Analysis|The Effect of Lumbar Stabilization Exercise and Gait Training on Lower Back Muscles- Electromyographic(EMG) Analysis|Recruiting||N/A|60|Anticipated|Seoul National University Hospital||4|||f||||t||||||||Yes||2017-10-10 21:40:56.100129|2017-10-10 21:40:56.100129
NCT02938156|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-09-13|||December 17, 2016|Actual|2016-12-17|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||UK - EHL Outcomes Registry|Evaluation of Real World Outcomes With Extended Half-Life Concentrates for Routine Clinical Use in Haemophilia A and B: UK - EHL Outcomes Registry|Recruiting||N/A|500|Anticipated|Royal Free Hospital NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 21:40:56.213927|2017-10-10 21:40:56.213927
NCT02938143|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-02-13|||January 2017||2017-01-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Exercise Therapy for Patellar Tendinopathy Evaluated With Advanced UTE-MRI|Progressive Tendon-loading Exercise Therapy for Patellar Tendinopathy in Jumping Athletes: A Randomized Controlled Clinical Trial Evaluated With Advanced 3D UTE MR|Recruiting||N/A|76|Anticipated|Erasmus Medical Center||2|||f||||f||||||||No||2017-10-10 21:40:56.346699|2017-10-10 21:40:56.346699
NCT02938130|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||The Impact of Community-based Wellness Programs on The Triple Aim|The Impact of Community-based Wellness Programs on The Triple Aim|Recruiting||Phase 1|350|Anticipated|University of Pittsburgh||1|||f||||f||||||||No||2017-10-10 21:40:56.452354|2017-10-10 21:40:56.452354
NCT02938117|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-17|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|OPEX||Impact of a Training Program on the Body Composition of Overweight and Obese Young Adults : Concentric Versus Eccentric Exercise|Impact of a Training Program on the Body Composition of Overweight and Obese Young Adults : Concentric Versus Eccentric Exercise|Not yet recruiting||N/A|30|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 21:40:56.555255|2017-10-10 21:40:56.555255
NCT02938104|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-17|||August 2014||2014-08-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery|Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery|Recruiting||N/A|60|Anticipated|McGill University Health Center||2|||f||||f||||||||Undecided||2017-10-10 21:40:56.670967|2017-10-10 21:40:56.670967
NCT02938091|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-17|||January 2008||2008-01-01|October 2016|2016-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Dietary Modulation of Hepatic Lipase (LIPC) -514 C/T Variant Associations With Lipids and Glucose|Hepatic Lipase Variant -514 C/T in a High Fat vs. Low Fat Diet for Cardio-metabolic Outcomes: A Crossover Randomized Dietary Intervention Trial|Completed||N/A|42|Actual|Tufts University||2|||f||||f||||||||No||2017-10-10 21:40:56.76778|2017-10-10 21:40:56.76778
NCT02938078|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||Ocular Comfort and Inflammation in Lid Hygiene Therapy|Ocular Comfort and Markers of Inflammation in Subjects Undergoing Lid Hygiene Therapy|Recruiting||N/A|30|Anticipated|Minnesota Eye Consultants, P.A.||2|||f||||f||||||||||2017-10-10 21:40:56.840637|2017-10-10 21:40:56.840637
NCT02938065|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-21|||June 2016||2016-06-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|GERS||Gastric Emptying Ultrasound Research Study|Gastric Emptying of Novel Protein and Carbohydrate Rich Clear Liquids|Completed||N/A|48|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||||||||||||2017-10-10 21:40:56.919672|2017-10-10 21:40:56.919672
NCT02938052|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-03-22|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|REACH II||Researching Emotions And Cardiac Health (REACH): Phase II|Developing a Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: proof-of Concept Trial|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-10 21:40:57.008414|2017-10-10 21:40:57.008414
NCT02938039|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-17|||May 2015||2015-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||I-Gel vs Ambu Laryngeal Mask Airways in Infants and Children Undergoing Surgical Procedures|I-Gel vs Ambu Laryngeal Mask Airways in Infants and Children Undergoing Surgical Procedures: A Randomized Clinical Trial|Completed||N/A|112|Actual|King Saud University||2|||f||||t||||||||Undecided||2017-10-10 21:40:57.10127|2017-10-10 21:40:57.10127
NCT02938026|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-17|||May 2016||2016-05-01|October 2016|2016-10-01||||May 2018|Anticipated|2018-05-01||Interventional|||Changes of Diet, Physical Activity and Sleep Pattern and Their Effects on Glycemic and Weight Control in Hong Kong Chinese Obese Patients With Type 2 Diabetes After Bariatric Surgery Compared to Telephone Intensive Lifestyle Counselling||Enrolling by invitation||N/A|200|Anticipated|Chinese University of Hong Kong||3|||f||||||||||||No||2017-10-10 21:40:57.170657|2017-10-10 21:40:57.170657
NCT02938013|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-06-21|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|deLIVER||deLIVER: Direct Acting Antiviral Effects on the Liver|deLIVER: Direct Acting Antiviral Effects on the Liver|Recruiting||Phase 4|15|Anticipated|Johns Hopkins University||3|||f||||t|t|f||||||Undecided||2017-10-10 21:40:57.247089|2017-10-10 21:40:57.247089
NCT02938000|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-11-09|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||E-Rehabilitation: Aerobic Resistance Training for Stroke Survivors|E-Rehabilitation: Aerobic Resistance Training for Stroke Survivors|Recruiting||Phase 1/Phase 2|50|Anticipated|Kaiser Permanente||2|||f||||f||||||||Undecided||2017-10-10 21:40:57.330656|2017-10-10 21:40:57.330656
NCT02937987|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-01-30|||April 2016||2016-04-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic Patients||Enrolling by invitation||N/A|200|Anticipated|Chinese University of Hong Kong|||1||f||||||||||||||2017-10-10 21:40:57.435706|2017-10-10 21:40:57.435706
NCT02937974|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD|Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD：a Multicentre Randomised Controlled Trial|Active, not recruiting||Phase 4|254|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:40:57.478915|2017-10-10 21:40:57.478915
NCT02937961|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-11-26|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Early Versus Late Sustained Low Efficiency Dialysis in Critically Ill Cirrhotics With Septic Shock and Acute Kidney Injury|Early Versus Late Sustained Low Efficiency Dialysis in Critically Ill Cirrhotics With Septic Shock and Acute Kidney Injury -A Prospective Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||No||2017-10-10 21:40:57.552668|2017-10-10 21:40:57.552668
NCT02937948|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-02-28|||March 30, 2017|Anticipated|2017-03-30|February 2017|2017-02-01|January 2021|Anticipated|2021-01-01|June 2020|Anticipated|2020-06-01||Interventional|ARCOL||Adaptative Radiotherapy for Locally Advanced Cervical Cancer|Phase II Study of Adaptative Radiotherapy for Locally Advanced Cervical Cancer|Not yet recruiting||N/A|79|Anticipated|Center Eugene Marquis||1|||f||||t|f|f||||||No|Not authorized in France|2017-10-10 21:40:57.627825|2017-10-10 21:40:57.627825
NCT02937935|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-22|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||On Demand Versus Protocol-guided Renal Replacement Therapy for Management of Stage 3 Acute Kidney Injury in Patients With Cirrhosis|On Demand Versus Protocol-guided Renal Replacement Therapy for Management of Stage 3 Acute Kidney Injury in Patients With Cirrhosis -A Prospective Randomized Controlled Trial|Active, not recruiting||N/A|2|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 21:40:57.728898|2017-10-10 21:40:57.728898
NCT02937922|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-17|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Exercise on Endothelial Injury in Hypertensive Patients|Effect of Aerobic Exercise, Resistance or Combined in Endothelial Injury in Hypertensive Patients|Active, not recruiting||N/A|51|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||3|||f||||t||||||||Yes|Data will be presented to participants from lectures.|2017-10-10 21:40:57.807313|2017-10-10 21:40:57.807313
NCT02937909|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-10-17|||October 2016||2016-10-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study to Evaluate the Benefits of Using a Range of Wound Care Products From a Single Manufacturer|A Prospective Study With Historical Data Comparison to Evaluate the Benefits of Using a Range of Products From a Single Manufacturer for Training, Competencies in Wound Care and the Appropriate Use of Product|Not yet recruiting||N/A|74|Anticipated|BSN Medical Ltd. UK||2|||f||||f||||||||No||2017-10-10 21:40:57.884509|2017-10-10 21:40:57.884509
NCT02937896|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-18|||January 2015||2015-01-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control|Comparison of Intranasal Desmopressin vs IV Ketorolac in Renal Colic Patients|Completed||N/A|40|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:40:57.963366|2017-10-10 21:40:57.963366
NCT02937883|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-10-17|||September 2016||2016-09-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Empowerment Intervention for Persons With Young Onset Dementia|Effects of an Empowerment Intervention for Community-dwelling Persons With Young Onset Dementia and Their Informal Caregivers|Recruiting||N/A|100|Anticipated|Radboud University||2|||f||||f||||||||Undecided||2017-10-10 21:40:58.033396|2017-10-10 21:40:58.033396
NCT02937870|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-01-16|||March 2017||2017-03-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive|A Proof of Principle Bite Force Study Using Two New Test Adhesives and a Currently Marketed Denture Adhesive.|Not yet recruiting||N/A|25|Anticipated|GlaxoSmithKline||4|||f||||||||||||||2017-10-10 21:40:58.236168|2017-10-10 21:40:58.236168
NCT02937857|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-18|||August 2016||2016-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.|A Multicenter, Randomized, Open Label, Add-on Study to Assess Efficacy and Safety of Xiyanping Injection in Subjects With Pediatric Bronchitis|Recruiting||Phase 4|240|Anticipated|Jiangxi Qingfeng Pharmaceutical Co. Ltd.||2|||f||||f||||||||Undecided||2017-10-10 21:40:58.332635|2017-10-10 21:40:58.332635
NCT02937844|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-10-17|||July 2016||2016-07-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme|A Safety and Efficacy Study of Autologous Chimeric Switch Receptor Engineered T Cells Redirected to PD-L1 in Patients With Recurrent Glioblastoma Multiforme|Recruiting||Phase 1|20|Anticipated|Beijing Sanbo Brain Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:40:58.455336|2017-10-10 21:40:58.455336
NCT02937831|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-08-17|||November 16, 2016|Actual|2016-11-16|August 2017|2017-08-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2021|Anticipated|2021-04-30||Observational|||RIXUBIS Drug Use-Result Survey (Japan)|RIXUBIS Drug Use-Result Survey (Japan)|Recruiting||N/A|30|Anticipated|Baxalta US Inc.|||1||f||||f||||||||||2017-10-10 21:40:58.568783|2017-10-10 21:40:58.568783
NCT02937818|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-08-17|||November 28, 2016|Actual|2016-11-28|August 2017|2017-08-01|January 22, 2021|Anticipated|2021-01-22|January 22, 2021|Anticipated|2021-01-22||Interventional|||A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer|A Phase II, Open-Label, Multi-Arm Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer|Recruiting||Phase 2|80|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-10-10 21:40:58.676057|2017-10-10 21:40:58.676057
NCT02937805|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-06-19|||October 2016||2016-10-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes||Active, not recruiting||N/A|225|Actual|Aromtech Ltd.||3|||f||||f||||||||No||2017-10-10 21:40:58.822058|2017-10-10 21:40:58.822058
NCT02937792|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section|Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section|Recruiting||N/A|30|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:40:58.917013|2017-10-10 21:40:58.917013
NCT02937766|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-06-26|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women|A Phase III, Single-Center, Open-labeled, Randomized Controlled Study Assessing Injection Pain of Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women|Completed||Phase 3|60|Actual|AMAG Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 21:40:59.118976|2017-10-10 21:40:59.118976
NCT02937727|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-06-22|||November 2016||2016-11-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||MRI Compatible and Long-term LFP Recordable Deep Brain Stimulation on PD Patients|Evaluate the Safety and Effectiveness of 3T MRI Compatible and Long-term LFP Recordable Deep Brain Stimulation on PD Patients|Recruiting||Phase 1|10|Anticipated|Beijing Pins Medical Co., Ltd||1|||f||||t||||||||Yes||2017-10-10 21:40:59.308014|2017-10-10 21:40:59.308014
NCT02937714|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Effectiveness of School Based Intervention for Promoting Mental Health Literacy Among Teachers|Effectiveness of School Based Intervention for Promoting Mental Health Literacy Among Teachers: A Randomized Controlled Trial|Not yet recruiting||N/A|220|Anticipated|King Edward Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:40:59.40119|2017-10-10 21:40:59.40119
NCT02937701|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-22|||October 10, 2016|Actual|2016-10-10|August 2017|2017-08-01|August 2, 2018|Anticipated|2018-08-02|April 12, 2018|Anticipated|2018-04-12||Interventional|||Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab|A Randomized, Double-Blind Phase 3 Study to Assess the Efficacy and Safety of ABP 710 Compared to Infliximab in Subjects With Moderate to Severe Rheumatoid Arthritis|Active, not recruiting||Phase 3|558|Actual|Amgen||2|||f||||t||||||||||2017-10-10 21:40:59.501342|2017-10-10 21:40:59.501342
NCT02937688|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-08-29|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|REACH-PD||Deep Brain Stimulation (DBS) for Parkinson's Disease International Study|Deep Brain Stimulation (DBS) for Parkinson's Disease International Study (REACH-PD)|Recruiting||N/A|264|Anticipated|MedtronicNeuro|||1||f||||f||||||||||2017-10-10 21:40:59.789884|2017-10-10 21:40:59.789884
NCT02937675|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-03-24|||October 2016||2016-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies|A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies|Recruiting||Phase 1/Phase 2|96|Anticipated|Effector Therapeutics||2|||f||||||||||||||2017-10-10 21:40:59.862384|2017-10-10 21:40:59.862384
NCT02937649|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-17|||January 2017||2017-01-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|BOUST||Bougie Sleeve Trial|Multicentric Randomized Prospective Study Assessing the Impact of the Bougie Calibration Size During Laparoscopic Sleeve Gastrectomy on the Rate of Postoperative Staple-line Leak Rate|Not yet recruiting||Phase 3|1658|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:41:00.069573|2017-10-10 21:41:00.069573
NCT02937623|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-05-10|||November 21, 2016|Actual|2016-11-21|May 2017|2017-05-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Interventional|||To Evaluate the Efficacy of an Experimental Dissolvable Strip in Rapidly Relieving Dentinal Hypersensitivity (DH)|A Proof-of-principle Clinical Study Investigating the Efficacy of a Dissolvable Strip in Providing Rapid Relief From Dentinal Hypersensitivity.|Completed||N/A|118|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 21:41:00.208549|2017-10-10 21:41:00.208549
NCT02937610|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-17|||October 2011||2011-10-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Observational|||Percutaneous Endoscopic Gastrostomy in Hands of ORL-HN Surgeon|Prospective Experience of Percutaneous Endoscopic Gastrostomy Tubes in an Otolaryngologist Service - Safety and Benefits|Completed||N/A|127|Actual|Helsinki University|||1||f||||t||||||||No||2017-10-10 21:41:00.287423|2017-10-10 21:41:00.287423
NCT02937597|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2017-01-10|||October 2016||2016-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|eISBAR||E-learning Proficiency Based Progression Training Programme for Clinical Communication on ISBAR Performance (eISBAR)|The Effect of an E-learning Proficiency Based Progression Training Programme for Clinical Communication on ISBAR Performance|Recruiting||N/A|120|Anticipated|University College Cork||3|||f||||f||||||||No||2017-10-10 21:41:00.344015|2017-10-10 21:41:00.344015
NCT02937584|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-15|||December 29, 2016|Actual|2016-12-29|September 2017|2017-09-01|March 5, 2018|Anticipated|2018-03-05|March 5, 2018|Anticipated|2018-03-05||Interventional|||A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPD|A Randomized, Double-Blind, Two Treatment, Two Period, Chronic Dosing (2 Weeks), Cross-Over, Multi-Center Study to Evaluate the Effects of PT001 and PT005 on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD.|Recruiting||Phase 3|20|Anticipated|Pearl Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:41:00.448448|2017-10-10 21:41:00.448448
NCT02937571|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-06-30|||October 2016||2016-10-01|June 2017|2017-06-01||||October 2018|Anticipated|2018-10-01||Interventional|||High Dose Carfilzomib for Newly Diagnosed Myeloma|Carfilzomib, Lenalidomide, and Dexamethasone in Newly-Diagnosed Multiple Myeloma: A Clinical and Correlative Phase I/II Dose Escalation Study|Recruiting||Phase 1/Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:41:00.525775|2017-10-10 21:41:00.525775
NCT02937558|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-11-29|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism|A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism|Recruiting||Phase 2|12|Anticipated|Xeris Pharmaceuticals||2|||f||||t||||||||No||2017-10-10 21:41:00.626768|2017-10-10 21:41:00.626768
NCT02937545|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-05-23|||February 22, 2017|Actual|2017-02-22|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting|Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting|Enrolling by invitation||N/A|150|Anticipated|Duke University||2|||f||||f|f|f||||||No||2017-10-10 21:41:00.738901|2017-10-10 21:41:00.738901
NCT02937532|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-04-13|||February 2015||2015-02-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Fear of Falling in Patients With Chronic Stroke|Effects of Combining Cognitive Behavioural Therapy With Task-oriented Balance Training for Reducing Fear of Falling in People With Chronic Stroke: A Randomized Controlled Trial|Recruiting||N/A|88|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||Undecided||2017-10-10 21:41:00.841695|2017-10-10 21:41:00.841695
NCT02937519|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-10-16|||June 2015||2015-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer|Multi-center Phase II Clinical Randomized Study of Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer|Recruiting||Phase 2|160|Anticipated|Guiyang Medical University||2|||f||||f||||||||Yes||2017-10-10 21:41:00.922251|2017-10-10 21:41:00.922251
NCT02937506|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-08-30|2017-08-30||November 2013||2013-11-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional||Patients scheduled for an outpatient colonoscopy at a single ambulatory surgery center.|Patient Satisfaction With Propofol for Out Patient Colonoscopy|Patient Satisfaction With Propofol for Out Patient Colonoscopy: A Prospective, Randomized, Double-Blind Study|Completed||Phase 4|600|Actual|Mount Carmel Health System||2|||f||||t||||||||||2017-10-10 21:41:01.03093|2017-10-10 21:41:01.03093
NCT02937493|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-18|||January 2008||2008-01-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|1 Day|Observational [Patient Registry]|||Intimate Partner Violence and a New Screening Score - a Prospective Observational Study Over Eight Years|Intimate Partner Violence and a New Screening Score - a Prospective Observational Study Over Eight Years|Completed||N/A|351000|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-10-10 21:41:01.244739|2017-10-10 21:41:01.244739
NCT02937480|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-10-17|||August 2016||2016-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Task-specific Training in Physical Activity Level Post-stroke|Efficacy of Task-specific Training in Physical Activity Level of Subjects With Stroke: a Randomized Controlled Trial|Recruiting||N/A|38|Anticipated|Federal University of Minas Gerais||2|||f||||f||||||||Undecided||2017-10-10 21:41:01.30905|2017-10-10 21:41:01.30905
NCT02937467|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-15|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Expanded Access|||The Multi-Center Study of Shear Wave Elastography on Thyroid Nodules|Evaluation of Shear Wave Elastography in the Diagnosis and Management of Thyroid Nodules in Chinese Population: A Prospective, Multicenter Study|Available||N/A|||Beijing Cancer Hospital|||||f||||||||||||||2017-10-10 21:41:01.439311|2017-10-10 21:41:01.439311
NCT02937454|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-09-08|||April 3, 2017|Actual|2017-04-03|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|Affirm-AHF||Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency|A Randomised, Double-Blind Placebo Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron Deficient Patients Admitted for Acute Heart Failure (Affirm-AHF)|Recruiting||Phase 4|1100|Anticipated|Vifor Inc.||2|||f||||t|f|f||||||||2017-10-10 21:41:01.498642|2017-10-10 21:41:01.498642
NCT02937441|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-18|||August 2016||2016-08-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||Evaluation of the Cerebral Edema in Children Having Diabetic Ketoacidosis|Evaluation of the Cerebral Edema With Measurement of Optic Nerve Sheath in Children Having Diabetic Ketoacidosis|Recruiting||N/A|20|Anticipated|Cukurova University|||1||f||||t||||||||Undecided||2017-10-10 21:41:01.594213|2017-10-10 21:41:01.594213
NCT02937428|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-23|||October 2016||2016-10-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||To Look or Not to Look at the Needle During Vaccination|To Look or Not to Look? Pilot Study of the Effectiveness of a Simple Psychological Intervention in Reducing Vaccination Pain and Fear in Adult|Recruiting||Phase 3|160|Anticipated|University of Toronto||4|||f||||f||||||||No||2017-10-10 21:41:03.566967|2017-10-10 21:41:03.566967
NCT02937415|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2016-10-16|||July 2012||2012-07-01|October 2016|2016-10-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Carbon Monoxide and Oxidative Stress in Waterpipe Smokers|Breath Carbon Monoxide Measurement Predicts Oxidative Stress Which Cause of Deteriorations of Lung Functions in Waterpipe Smokers|Completed||N/A|100|Actual|Ataturk Training and Research Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:41:03.674301|2017-10-10 21:41:03.674301
NCT02937402|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-08-04|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer|Predictors of Response to Immune Checkpoint Inhibitors in Non-small Cell and Small Cell Lung Cancer|Not yet recruiting||N/A|30|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t|f|f||||||||2017-10-10 21:41:03.768036|2017-10-10 21:41:03.768036
NCT02937389|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-03|||May 2015||2015-05-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Observational|||Endoscopic Evaluation for Predicting the Complications Related to Gastric Conduit After Esophagectomy|Endoscopic Evaluation for Predicting the Complications Related to Gastric Conduit After Esophagectomy|Recruiting||N/A|60|Anticipated|Nagasaki University|||1||f||||f||||||Samples With DNA|"     dmpDNA   "|||2017-10-10 21:41:03.847745|2017-10-10 21:41:03.847745
NCT02937376|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||November 2016||2016-11-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise|Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise|Not yet recruiting||Early Phase 1|12|Anticipated|University of Thessaly||2|||f||||||||||||||2017-10-10 21:41:03.919818|2017-10-10 21:41:03.919818
NCT02937363|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||November 2016||2016-11-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise|Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise|Not yet recruiting||N/A|12|Anticipated|University of Thessaly||2|||f||||||||||||||2017-10-10 21:41:04.01318|2017-10-10 21:41:04.01318
NCT02937350|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-05-17|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|CLEAR||Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease|Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease|Recruiting||Phase 1|120|Anticipated|University of Washington||1|||f||||f|t|f||||||Yes||2017-10-10 21:41:04.112501|2017-10-10 21:41:04.112501
NCT02937337|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Laryngeal Mask Airway With Video-stylet|Video Stylet Guided Laryngeal Mask Airway Insertion in Pediatrics: a Randomized Controlled Trial|Not yet recruiting||N/A|108|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:41:04.203847|2017-10-10 21:41:04.203847
NCT02937324|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-18|||September 2016||2016-09-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|CUSSP||The CloudUPDRS Smartphone Software in Parkinson's Study.|The CloudUPDRS Smartphone Software in Parkinson's Study - a Pilot Single-site, Open Label Study Comparing the Validity and Usability of Smartphone Software for Home Monitoring of Symptoms and Signs in Parkinson's Disease.|Recruiting||N/A|60|Anticipated|University College, London||2|||f||||f||||||||No||2017-10-10 21:41:04.269993|2017-10-10 21:41:04.269993
NCT02937311|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-17|||February 2015||2015-02-01|October 2015|2015-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Kinesio Tape vs Neuromuscular Stimulation For Conserative of Treatment Hemiplegic Shoulder|Kinesio Tape vs Neuromuscular Stimulation For Conserative of Treatment Hemiplegic Shoulder: Which One Improves Function More?|Completed||N/A|60|Actual|Hacettepe University||3|||f||||t||||||||Undecided||2017-10-10 21:41:04.352521|2017-10-10 21:41:04.352521
NCT02937298|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-18|||May 2016||2016-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|ThermicFoods||Thermic Effects of Some Scottish Plant Foods|The Thermic Effect of Some Plant Foods Native to Scotland: A Pilot Study.|Recruiting||N/A|7|Anticipated|University of Aberdeen||4|||f||||f||||||||No||2017-10-10 21:41:04.572193|2017-10-10 21:41:04.572193
NCT02937116|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-11-30|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors|An Open-Label, Multicenter Study of IBI308 in Subjects With Selected Advanced Solid Tumors|Not yet recruiting||Phase 1|104|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||5|||f||||f||||||||Undecided||2017-10-10 21:41:05.9288|2017-10-10 21:41:05.9288
NCT02937285|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-14|||November 2010||2010-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|MITOX-REBIF||National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis|National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Beta-1a (REBIF 44mg 3 Times / Week) Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis|Recruiting||Phase 3|266|Anticipated|Rennes University Hospital||2|||f||||f||||||||No||2017-10-10 21:41:04.677698|2017-10-10 21:41:04.677698
NCT02937272|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-10-05|||November 21, 2016|Actual|2016-11-21|October 2017|2017-10-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|||A Study of LY3200882 in Participants With Solid Tumors|A Phase 1 Study of LY3200882 in Patients With Solid Tumors|Recruiting||Phase 1|149|Anticipated|Eli Lilly and Company||7|||f||||f||||||||||2017-10-10 21:41:04.791006|2017-10-10 21:41:04.791006
NCT02937259|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-17|||August 2014||2014-08-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Self-admission: A New Treatment Approach for Patients With Severe Eating Disorders|Self-admission: A New Treatment Approach for Patients With Severe Eating Disorders|Enrolling by invitation||N/A|40|Anticipated|Karolinska Institutet||1|||f||||f||||||||No||2017-10-10 21:41:04.986658|2017-10-10 21:41:04.986658
NCT02937246|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-17|||June 2016||2016-06-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction|Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction: A Multicenter Prospective Randomized Trial|Recruiting||N/A|156|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 21:41:05.09212|2017-10-10 21:41:05.09212
NCT02937233|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-09-27|||December 8, 2016|Actual|2016-12-08|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|Z001||Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study|A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults|Active, not recruiting||Phase 1|36|Actual|Beth Israel Deaconess Medical Center||3|||f||||t||||||||||2017-10-10 21:41:05.172947|2017-10-10 21:41:05.172947
NCT02937220|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-17|||December 2016||2016-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Influence of Superstructure Material on Crestal Bone Resorption and Esthetic Outcome of Dental Implants|Influence of Superstructure Material on Crestal Bone Resorption and Esthetic Outcome of Dental Implants|Not yet recruiting||N/A|34|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:41:05.254805|2017-10-10 21:41:05.254805
NCT02937194|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-16|||January 2014||2014-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Family-centered Oral Health Promotion for New Parents|Family-centered Oral Health Promotion for New Parents and Their Infants: a Randomized Controlled Trial|Recruiting||N/A|584|Anticipated|The University of Hong Kong||2|||f||||f||||||||Undecided||2017-10-10 21:41:05.47251|2017-10-10 21:41:05.47251
NCT02937181|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-26|||December 2016||2016-12-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|||Antibiotic Prophylaxis in Open Fractures|Antibiotic Prophylaxis With Ceftaroline for Type II and II Open Fractures: a Phase 4, Open-label, Prospective Clinical Trial|Not yet recruiting||Phase 4|50|Anticipated|Triple O Research Institute PA||1|||f||||t||||||||Yes|no personal data, identifier and the data are made available|2017-10-10 21:41:05.552628|2017-10-10 21:41:05.552628
NCT02937168|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-07-13|||February 17, 2017|Actual|2017-02-17|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|February 28, 2019|Anticipated|2019-02-28||Interventional|||An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation|Distribution of Eosinophils in Asthma After Reslizumab (DEAR). A 7-week, Placebo- Controlled, Double-Blinded, Parallel-Group, Imaging Study Using Positron Emission Tomography/Computed Tomography (PET/CT) to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation in Patients With Eosinophilic Asthma|Recruiting||Phase 4|15|Anticipated|Teva Pharmaceutical Industries||2|||f||||f|t|f|||f|||||2017-10-10 21:41:05.632648|2017-10-10 21:41:05.632648
NCT02937155|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-11-09|||November 2016||2016-11-01|November 2016|2016-11-01||||October 2017|Anticipated|2017-10-01||Observational|||In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer?|HSIL/ACIS/Early Cervical Cancer: What Are The Current Causative HPV Subtypes in the Era of HPV Vaccination?|Recruiting||N/A|100|Anticipated|Sunnybrook Health Sciences Centre|||2||f||||f||||||||||2017-10-10 21:41:05.717004|2017-10-10 21:41:05.717004
NCT02937142|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-01-05|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder|Cognitive Behavior Group Therapy in Adolescents (14-18 Years) With Attention Deficit Hyperactivity Disorder (ADHD)|Recruiting||N/A|96|Anticipated|St. Olavs Hospital||2|||f||||f||||||||No||2017-10-10 21:41:05.784277|2017-10-10 21:41:05.784277
NCT02937129|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-15|||August 2015||2015-08-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Clinical Accuracy and Reliability of Infrared Tympanic Thermometer in an Adult Emergency Department|Clinical Accuracy and Reliability of Infrared Tympanic Thermometer in an Adult Emergency Department|Completed||N/A|68|Actual|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||f||||||||||2017-10-10 21:41:05.879016|2017-10-10 21:41:05.879016
NCT02933619|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-25|||August 2016||2016-08-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|May 2021|Anticipated|2021-05-01||Observational|||ProMRI ICD/CRT-D Post Approval Study|ProMRI ICD/CRT-D Post Approval Study|Active, not recruiting||N/A|8437|Anticipated|Biotronik, Inc.|||1||f||||t||||||||||2017-10-10 21:41:35.682516|2017-10-10 21:41:35.682516
NCT02937103|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-11-02|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies|A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies|Recruiting||Phase 1/Phase 2|45|Anticipated|Southwest Hospital, China||1|||f||||f||||||||Undecided||2017-10-10 21:41:06.006035|2017-10-10 21:41:06.006035
NCT02937090|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-15|||May 2016||2016-05-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Intestinal Microbiota Survey of Polycystic Ovary Syndrome|The Cross-sectional Study of Intestinal Microbiota in Women With Polycystic Ovary Syndrome and Its Association With Clinical and Biological Parameters|Recruiting||N/A|100|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|||2||f||||f||||||||No||2017-10-10 21:41:06.088128|2017-10-10 21:41:06.088128
NCT02937077|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-02-05|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|NOR-FIB||Atrial Fibrillation in Cryptogenic Stroke and TIA|The Nordic Atrial Fibrillation and Stroke Study|Recruiting||N/A|500|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     blood samples   "|Yes|Plan to share IPD|2017-10-10 21:41:06.293928|2017-10-10 21:41:06.293928
NCT02937064|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-03|||November 2016||2016-11-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|MAKnee||Multimodal Assessment of Knee Conditions|Multimodal Assessment of Knee Conditions|Completed||N/A|109|Actual|University of Oulu|||6||f||||||||||||||2017-10-10 21:41:06.394587|2017-10-10 21:41:06.394587
NCT02937051|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-07-20|||October 2016||2016-10-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Cigar Flavors on Measures of Abuse Liability Among Young Adults|Effects of Cigar Flavors on Measures of Abuse Liability Among Young Adults|Recruiting||N/A|25|Anticipated|Virginia Commonwealth University||5|||f||||f||||||||||2017-10-10 21:41:06.466386|2017-10-10 21:41:06.466386
NCT02937038|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-19|||June 2016||2016-06-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Observational|HYBISKUS||Reference Values and Determinants of Hydration in Children 3-13 y|Reference Values and Determinants of Hydration in Children 3-13 y|Recruiting||N/A|2000|Anticipated|University of Arkansas, Fayetteville|||2||f||||f||||||Samples Without DNA|"     Urine samples   "|Yes|Individual report for nutrition and hydration information will be provided to the volunteers|2017-10-10 21:41:06.569306|2017-10-10 21:41:06.569306
NCT02937025|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Safety and Efficacy of a Left Atrial Appendage Occulder||Not yet recruiting||Phase 1/Phase 2|154|Anticipated|Shanghai 10th People's Hospital||1|||f||||||||||||||2017-10-10 21:41:06.660669|2017-10-10 21:41:06.660669
NCT02937012|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders|Efficacy and Security of Bezafibrate in Patients With Primary Biliary Cirrhosis Without Biochemical Response to Ursodeoxycholic Acid: A Randomized, Double-blind, Placebo-controlled Trial|Recruiting||Phase 3|34|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||Undecided||2017-10-10 21:41:06.756675|2017-10-10 21:41:06.756675
NCT02936999|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-14|||August 2016||2016-08-01|October 2016|2016-10-01||||August 2018|Anticipated|2018-08-01||Interventional|||Vitamin D Supplementation in Women With DCIS and/or LCIS|An Exploratory Pilot Study of Vitamin D Supplementation in Women With DCIS and/or LCIS|Recruiting||N/A|15|Anticipated|Inova Health Care Services||1|||f||||t||||||||||2017-10-10 21:41:06.898978|2017-10-10 21:41:06.898978
NCT02936986|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-02-14|||May 2016||2016-05-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Observational|||Endoscopic Ultrasound-guided Needle-based Confocal Laser Endomicroscopy for the Diagnosis of Gastric Submucosal Tumors||Recruiting||N/A|30|Anticipated|Shandong University|||1||f||||t||||||||||2017-10-10 21:41:07.026221|2017-10-10 21:41:07.026221
NCT02936973|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2017-04-20|||November 2016||2016-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Catgut Implantation at Acupoints for the Treatment of Simple Obesity|Clinical Effect of Catgut Implantation at Acupoints for the Treatment of Simple Obesity: a Multicentre Randomized Controlled Trial|Recruiting||N/A|216|Anticipated|Hubei Hospital of Traditional Chinese Medicine||2|||f||||t||||||||Undecided|the data will be published in the form of public papers before May 2019 for public inquiries|2017-10-10 21:41:07.096328|2017-10-10 21:41:07.096328
NCT02936960|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-02-21|||May 2016||2016-05-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Observational|||Endoscopic Ultrasound-guided Needle-based Confocal Laser Endomicroscopy in Solid Pancreatic Masses||Recruiting||N/A|30|Anticipated|Shandong University|||1||f||||t||||||||||2017-10-10 21:41:07.202255|2017-10-10 21:41:07.202255
NCT02936947|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-05-30|||July 2016||2016-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy Treatment|Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy Treatment|Recruiting||Phase 2|51|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||No||2017-10-10 21:41:07.267978|2017-10-10 21:41:07.267978
NCT02936934|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Adverse Drug Reactions Associated for Oxycodone and Morphine in Postoperative Pain After Abdominal Hysterectomy||Not yet recruiting||Phase 4|64|Anticipated|Hospital Civil de Guadalajara||2|||f||||f||||||||No||2017-10-10 21:41:07.360315|2017-10-10 21:41:07.360315
NCT02936921|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-10-14|||January 1988||1988-01-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2016|Anticipated|2016-12-01||Observational|||Lyon Cohort of Maternal and Congenital Toxoplasma Infections|Lyon Clinical Research Program on Maternal and Congenital Toxoplasmosis Based on the Toxo-Ly Cohort: Risks and Clinical Consequences, Prevention, Diagnosis and Treatment|Recruiting||N/A|4030|Anticipated|Hospices Civils de Lyon|||3||f||||f||||||Samples With DNA|"     samples with and without DNA are analyzed. blood samples taken during pregnancy to confirm     maternal infection amniotic fluid analysed with PCR and inoculation to mice blood samples     taken after birth for children born from a mother included in the cohort   "|||2017-10-10 21:41:07.442193|2017-10-10 21:41:07.442193
NCT02936908|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-28|||August 2016||2016-08-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Respiratory Care in Intensive Care Unit for Neuromuscular Patients|Modalities of Respiratory Care, Vital and Respiratory Prognosis in Neuromuscular Patients Admitted to an Intensive Care Unit for Respiratory Failure|Recruiting||N/A|300|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:41:07.522437|2017-10-10 21:41:07.522437
NCT02936895|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||January 2015||2015-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|January 2016|Actual|2016-01-01||Interventional|||Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia|The Effects of Vitamin D Supplementation in Respiratory Index of Severity in Children (RISC) of Hospitalized Patients With Community-acquired Pneumonia|Completed||Phase 4|100|Actual|Hormozgan University of Medical Sciences||2|||f||||t||||||||No||2017-10-10 21:41:07.60472|2017-10-10 21:41:07.60472
NCT02936882|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-14|||March 2016||2016-03-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of Antral Ultrasonography for Full Stomach Diagnosis Before Pediatric Surgical Emergencies||Recruiting||N/A|50|Anticipated|Hôpital Necker-Enfants Malades||1|||f||||f||||||||Undecided||2017-10-10 21:41:07.678978|2017-10-10 21:41:07.678978
NCT02936869|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-02-22|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Incentives for Postnatal Care Demand|Incentives for Postnatal Care Demand|Completed||N/A|208|Actual|Harvard School of Public Health||2|||f||||||||||||||2017-10-10 21:41:07.752391|2017-10-10 21:41:07.752391
NCT02936856|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-02-23|||November 2015||2015-11-01|February 2017|2017-02-01||||November 2017|Anticipated|2017-11-01||Interventional|RDSA||Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications||Recruiting||N/A|200|Anticipated|Guangxi Medical University||2|||f||||||||||||||2017-10-10 21:41:07.827527|2017-10-10 21:41:07.827527
NCT02936843|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-01-12|||October 2016||2016-10-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|TINSAL-T1DN||Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy|Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy-TINSAL -T1DN|Recruiting||Phase 2/Phase 3|60|Anticipated|University of Michigan||2|||f||||t||||||||No||2017-10-10 21:41:07.900684|2017-10-10 21:41:07.900684
NCT02936830|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-16|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Effectiveness of Nanohydroxyapetite Paste on Reducing Dentin Hypersensitivity|Effectiveness of Nano-hydroxyapetite Care Paste in Reducing Dentinhypersenstitivity: A Double Blind Randomized Control Trial|Recruiting||Phase 4|60|Anticipated|Riyadh Colleges of Dentistry and Pharmacy||3|||f||||t||||||||No||2017-10-10 21:41:07.989957|2017-10-10 21:41:07.989957
NCT02936817|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI|A Study to Assess the Effect of the Aerobika® Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using Functional Respiratory Imaging (FRI)|Completed||Phase 4|10|Anticipated|FLUIDDA nv||1|||f||||f||||||||||2017-10-10 21:41:08.081669|2017-10-10 21:41:08.081669
NCT02936804|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-17|||December 2016||2016-12-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Precision Diagnosis and Therapy for Early Stage Lung Cancer|Key Technology in Precision Diagnosis and Therapy for Early Stage Lung Cancer: a Single Arm Clinical Trial|Not yet recruiting||N/A|60000|Anticipated|Shanghai Chest Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:41:08.166699|2017-10-10 21:41:08.166699
NCT02936791|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-17|||April 2016||2016-04-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|5 Years|Observational [Patient Registry]|||Early-Stage Polycystic Kidney Disease Biomarkers Repository Study|Polycystic Kidney Disease (PKD) Biomarkers Repository Study|Recruiting||N/A|250|Anticipated|University of Kansas Medical Center|||3||f||||f||||||Samples With DNA|"     Blood and urine samples are being collected from study participants. Researchers will only     receive de-identified samples. No identifies will be given to investigators.   "|No||2017-10-10 21:41:08.2348|2017-10-10 21:41:08.2348
NCT02936778|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||August 2016||2016-08-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Observational|||Status Asthmaticus on the Intensive Care Prospective - STATIC PRO|Risk Factors for Intensive Care Admission of Children With Severe Acute Wheeze or Asthma (SAA)|Recruiting||N/A|220|Anticipated|Erasmus Medical Center|||2||f||||f||||||||||2017-10-10 21:41:08.321536|2017-10-10 21:41:08.321536
NCT02936765|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||June 2016||2016-06-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Software-assisted Implantation of Elastic Spine Pad (TM) With Respect to Postoperative Change in Neck Disability Index (NDI) With the Conventional Disc Spacer Squale (TM) After Anterior Cervical Discectomy for Cervical Disc Prolapse||Recruiting||N/A|52|Anticipated|Technische Universität Dresden||2|||f||||||||||||||2017-10-10 21:41:08.40112|2017-10-10 21:41:08.40112
NCT02936752|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-04|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Entinostat and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome After DNMTi Therapy Failure|A Phase 1b Study of the Anti-PD1 Antibody Pembrolizumab in Combination With the Histone Deacetylase Inhibitor, Entinostat for Treatment of Patients With Myelodysplastic Syndromes After DNA Methyltransferase Inhibitor Therapy Failure|Recruiting||Phase 1|27|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:41:08.480491|2017-10-10 21:41:08.480491
NCT02936739|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||June 2016||2016-06-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Software-assisted Implantation of Elastic Spine Pad (TM) With Respect to Postoperative Change in Neck Disability Index (NDI) With the Conventional Disc Prosthesis Rotaio (TM) After Anterior Cervical Discectomy for Cervical Disc Prolapse||Recruiting||N/A|52|Anticipated|Technische Universität Dresden||2|||f||||||||||||||2017-10-10 21:41:08.589337|2017-10-10 21:41:08.589337
NCT02936726|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-17|||September 2016||2016-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Examining Exercise, Health Coaching and Meditation for University Employees|The Healthy Staff Initiative Study: Examining Exercise, Health Coaching and Meditation for University Employees: a Randomized Trial|Recruiting||Phase 1/Phase 2|60|Anticipated|York University||2|||f||||f||||||||No|Data is analyzed as group data|2017-10-10 21:41:08.786702|2017-10-10 21:41:08.786702
NCT02936713|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-02-08|||October 22, 2014|Actual|2014-10-22|February 2017|2017-02-01|December 23, 2016|Actual|2016-12-23|December 23, 2016|Actual|2016-12-23||Interventional|FLATBACK||Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms|Exploratory Study Aiming at Assessing the Impact of Specific and Controlled Diets Combined With a Fermented Milk Product on Gas-related Symptoms and Associated Measurements in FGID and Non-FGID Subjects|Completed||N/A|126|Actual|Danone Research||2|||f||||f||||||||||2017-10-10 21:41:08.876897|2017-10-10 21:41:08.876897
NCT02936700|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-10-14|||May 2015||2015-05-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|IMPACT||Biomarkers of Efficiency of Acceptance and Commitment Therapy in Suicidal Behavior|Identification of Prognostic Biomarkers by fMRI of Acceptance and Commitment Therapy in Suicidal Behavior Disorder|Active, not recruiting||N/A|42|Actual|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:41:08.968267|2017-10-10 21:41:08.968267
NCT02936687|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-08-15|||January 31, 2017|Actual|2017-01-31|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Mechanisms of Cerebrovascular Control|Mechanisms of Cerebrovascular Control: Acute Insulin Surges Lead to Brain Hypoperfusion in Human Metabolic Syndrome|Recruiting||Phase 1|60|Anticipated|University of Wisconsin, Madison||4|||f||||t|t|f||||||||2017-10-10 21:41:09.06399|2017-10-10 21:41:09.06399
NCT02936674|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-08|||October 2016||2016-10-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Color-dependent Melatonin Suppression||Recruiting||N/A|10|Anticipated|VA Palo Alto Health Care System||2|||f||||f||||||||Yes|All relevant individual data will be published.|2017-10-10 21:41:09.180231|2017-10-10 21:41:09.180231
NCT02936661|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-10-17|||April 2017||2017-04-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Tranexamic Acid for Preventing Postpartum Hemorrhage After Cesarean Section||Not yet recruiting||Phase 4|6700|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:41:09.266853|2017-10-10 21:41:09.266853
NCT02936635|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-09-11|||October 2016||2016-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|VIGOR-ALS||A Study for Patients Who Completed VITALITY-ALS (CY 4031)|A Phase 3, Open-Label Extension Study of Tirasemtiv for Patients With Amyotrophic Lateral Sclerosis (ALS) Who Completed VITALITY-ALS (CY 4031)|Enrolling by invitation||Phase 3|350|Anticipated|Cytokinetics||1|||f||||f||||||||||2017-10-10 21:41:09.418577|2017-10-10 21:41:09.418577
NCT02936622|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-15|||February 21, 2017|Actual|2017-02-21|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|April 2018|Anticipated|2018-04-01||Interventional|XPEDITE||Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses|Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses|Recruiting||N/A|150|Anticipated|Cook Group Incorporated||3|||f|||||f|t|t|f|t|||||2017-10-10 21:41:09.634278|2017-10-10 21:41:09.634278
NCT02936609|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-01-09|||April 2016||2016-04-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01|9 Years|Observational [Patient Registry]|ACCESS||Assessing Community Cancer Care After Insurance ExpanSionS|Assessing Community Cancer Care After Insurance ExpanSionS|Active, not recruiting||N/A|938132|Anticipated|OHSU Knight Cancer Institute|||2||f||||f||||||||No||2017-10-10 21:41:09.76064|2017-10-10 21:41:09.76064
NCT02936596|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|||Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome|Biochemical Response of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Induced by Ursodeoxycholic Acid Only or Combination Therapy of Immunosuppressive Agents|Recruiting||N/A|53|Anticipated|West China Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:41:09.833159|2017-10-10 21:41:09.833159
NCT02936583|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-29|||October 26, 2016|Actual|2016-10-26|September 2017|2017-09-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional|||Sun Protection Factor Assay (SPF Assay 207/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|6|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:41:09.923035|2017-10-10 21:41:09.923035
NCT02936570|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-29|||October 26, 2016|Actual|2016-10-26|September 2017|2017-09-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional|||Sun Protection Factor Assay (SPF Assay 206/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|5|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:41:09.98781|2017-10-10 21:41:09.98781
NCT02936557|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2016-12-19|||October 2016||2016-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Sun Protection Factor Assay (SPF Assay 205/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|11|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:41:10.067446|2017-10-10 21:41:10.067446
NCT02936531|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2017-08-07|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|October 2018|Anticipated|2018-10-01||Observational|FXTAS-BNA||Brain Network Activation and Gait and Posture in FXTAS|Mapping Functional Networks of Brain Activity (Brain Network Activation) Based on Analysis of Evoked Response Potential (ERP) Signals and Registration of Posture and Gait-related Data in FMR1 Premutation Carriers and Patients With FXTAS.|Recruiting||N/A|150|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-10 21:41:10.211551|2017-10-10 21:41:10.211551
NCT02936518|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-09-19|||June 2014||2014-06-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|April 2015|Actual|2015-04-01||Interventional|||Anterior Lingual Frenectomy is Inadequate in Improving Breastfeeding Outcomes: a Prospective Cohort Study|Anterior Lingual Frenectomy is Inadequate in Improving Breastfeeding Outcomes: a Prospective Cohort Study|Completed||N/A|55|Anticipated|The Oregon Clinic||1|||f||||||||||||||2017-10-10 21:41:10.31904|2017-10-10 21:41:10.31904
NCT02936505|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-15|2017-08-12|||October 2016||2016-10-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|October 2021|Anticipated|2021-10-01||Interventional|ScanCLAD||Clinical Study Evaluating Two Treatment Protocols for Immunosuppresive Drugs. Looking at 3-year Incidence of CLAD.|A Scandinavian Controlled, Randomized, Open-label, and Multi-centre Study Evaluating if Once-daily Tacrolimus or Twice-daily Cyclosporin, Reduces the 3-year Incidence of Chronic Lung Allograft Dysfunction After Lung Transplantation|Recruiting||N/A|242|Anticipated|Vastra Gotaland Region||2|||f||||t||||||||||2017-10-10 21:41:10.394052|2017-10-10 21:41:10.394052
NCT02936492|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-17|2017-09-28|||October 24, 2016|Actual|2016-10-24|September 2017|2017-09-01|October 5, 2017|Anticipated|2017-10-05|April 18, 2017|Actual|2017-04-18||Interventional|||BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study|Escalating Dose Study for Safety, Tolerability and Pharmacokinetics After Single and Multiple Dermal Administration of Two BAY1003803 Formulation Types With Two Concentrations Each in Healthy Male Volunteers, Applying a Double-blind, Vehicle-controlled Design and Including a Positive Control Group|Terminated||Phase 1|32|Actual|Bayer||3|||f||||f|f|f||||||||2017-10-10 21:41:10.57909|2017-10-10 21:41:10.57909
NCT02936479|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||C1-INH for Refractory Antibody Mediated Renal Allograft Rejection|Use of C1-INH (Berinert) for Renal Allograft Salvage in Refractory Antibody Mediated Rejection|Enrolling by invitation||Phase 2|5|Anticipated|New York University Langone Medical Center||1|||f||||f||||||||||2017-10-10 21:41:10.69041|2017-10-10 21:41:10.69041
NCT02936466|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-10-14|||December 2014||2014-12-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Bipolife||Evaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group|Evaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group|Recruiting||N/A|210|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 21:41:10.753798|2017-10-10 21:41:10.753798
NCT02936453|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-01-20|||July 2016||2016-07-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|STIMO||STIMO: Epidural Electrical Simulation (EES) With Robot-assisted Rehabilitation in Patients With Spinal Cord Injury.|Efficacy of Spinal Epidural Electrical Stimulation (EES) in Combination With Robot-assisted Neurorehabilitation in Patients With Spinal Cord Injury (STIMO)|Recruiting||N/A|8|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||t||||||||Yes||2017-10-10 21:41:10.838445|2017-10-10 21:41:10.838445
NCT02936440|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||May 2011||2011-05-01|October 2016|2016-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Assessment of Hydration Status Using Bioelectrical Impedance Vector Analysis|Assessment of Hydration Status Using Bioelectrical Impedance Vector Analysis in Critical Patients With Acute Kidney Injury|Completed||N/A|224|Actual|Catholic University of Pelotas|||1||f||||f||||||||No||2017-10-10 21:41:10.950181|2017-10-10 21:41:10.950181
NCT02936427|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-21|2017-05-15|||July 2016||2016-07-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects and Dose Response of Dexamethasone on Intercostal Blocks With Bupivicaine in Post Thoracic Surgery Patients|The Effects and Dose Response of Dexamethasone on Intercostal Nerve Blocks With Bupivicaine in Post Thoracic Surgery Patients|Recruiting||Phase 3|60|Anticipated|University College Dublin||3|||f||||f||||||||Undecided||2017-10-10 21:41:11.018609|2017-10-10 21:41:11.018609
NCT02936414|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-17|||July 2014||2014-07-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients||Completed||N/A|100|Actual|Tianjin Anding Hospital||2|||f||||t||||||||No||2017-10-10 21:41:11.111103|2017-10-10 21:41:11.111103
NCT02936401|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-10-14|||March 2015||2015-03-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders|Interventions for Symptom Management in Older Patients With HAND|Recruiting||N/A|180|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 21:41:11.192768|2017-10-10 21:41:11.192768
NCT02936388|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-14|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|SirTac||Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis|A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma|Recruiting||Phase 2|108|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||Yes||2017-10-10 21:41:11.295954|2017-10-10 21:41:11.295954
NCT02936375|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-26|||March 2017||2017-03-01|October 2016|2016-10-01||||January 2019|Anticipated|2019-01-01||Interventional|||Iguratimod as Treatment for Active Lupus Nephritis||Not yet recruiting||Phase 2|120|Anticipated|RenJi Hospital||2|||f||||||||||||||2017-10-10 21:41:11.387901|2017-10-10 21:41:11.387901
NCT02936362|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||February 2016||2016-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals|Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals: Randomized Trial|Completed||N/A|20|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-10 21:41:11.467863|2017-10-10 21:41:11.467863
NCT02936349|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-08-01|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|||Graded TTCE for Post-Embolization PAVM Monitoring|Correlation of Graded Transthoracic Contrast Echocardiography With Chest CT Findings After Pulmonary Arteriovenous Malformation Embolization in Patients With Hereditary Hemorrhagic Telangiectasia, 2016|Recruiting||N/A|100|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 21:41:11.559035|2017-10-10 21:41:11.559035
NCT02936336|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||November 2009||2009-11-01|November 2009|2009-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Exercise Intervention on the Community's Older Adults|The Effect of Exercise Intervention on the Physical Fitness, Bone Mineral Density and Health-related Quality of Life in the Community's Older Adults|Completed||N/A|411|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:41:11.631375|2017-10-10 21:41:11.631375
NCT02913820|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-01-30|||January 2007||2007-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Association of Snowfall and Myocardial Infarction|Association of Snowfall and Myocardial Infarction|Active, not recruiting||N/A|12000|Anticipated|Medical University of Graz|||1||f||||f||||||||||2017-10-10 21:46:48.42277|2017-10-10 21:46:48.42277
NCT02936323|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-06-28|||December 8, 2016|Actual|2016-12-08|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers|A Phase 1/2a, Open-label Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of PEN-221 in Patients With Somatostatin Receptor 2 Expressing Advanced Cancers, Including Gastroenteropancreatic or Lung or Thymus or Other Neuroendocrine Tumors or Small Cell Lung Cancer or Large Cell Neuroendocrine Carcinoma of the Lung|Recruiting||Phase 1/Phase 2|120|Anticipated|Tarveda Therapeutics||1|||f||||f||||||||||2017-10-10 21:41:11.704964|2017-10-10 21:41:11.704964
NCT02936310|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-27|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|MLWS||Mindful Living With Stress for Nurses Caring for HIV/AIDS Patients in China|Effect of Mindful Living With Stress (MLWS) Intervention for Nurses Caring for HIV/AIDS Patients in China|Recruiting||N/A|18|Anticipated|Central South University||1|||f||||f||||||||||2017-10-10 21:41:11.918297|2017-10-10 21:41:11.918297
NCT02936297|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-10-17|||June 2016||2016-06-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|NCGS||Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study|Quantitative Measurement of Stool and Urine Gluten Immunogenic Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study Study|Recruiting||N/A|90|Anticipated|Thomas Jefferson University||3|||f||||t||||||||||2017-10-10 21:41:12.005846|2017-10-10 21:41:12.005846
NCT02936284|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-11-28|||November 2016||2016-11-01|August 2016|2016-08-01|July 2021|Anticipated|2021-07-01|January 2021|Anticipated|2021-01-01||Interventional|||Infant Environment Study|Enhancing Alternatives to Eating in Infancy|Recruiting||N/A|92|Anticipated|State University of New York at Buffalo||2|||f||||t||||||||Yes||2017-10-10 21:41:12.09614|2017-10-10 21:41:12.09614
NCT02936271|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-04-27|||October 2016||2016-10-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting|Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting.|Withdrawn||N/A|0|Actual|Spectrum Health Hospitals||2|||f||||f||||||||No||2017-10-10 21:41:12.193753|2017-10-10 21:41:12.193753
NCT02936258|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|PRECISE||PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures|A Phase III Multi-centre Open-label Randomized Controlled Trial of Multi-parametric Magnetic Resonance Imaging (MRI)-Targeted Biopsy Compared to Systematic Trans-rectal Ultrasound (TRUS) Guided Biopsy|Not yet recruiting||Phase 3|450|Anticipated|Canadian Urology Research Consortium||2|||f||||t||||||||Yes|Plan to share publication|2017-10-10 21:41:12.293528|2017-10-10 21:41:12.293528
NCT02936245|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||October 2013||2013-10-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Observational|||Predictors of Outcome and Natural History in Patients With Cervical Spondylotic Myelopathy|Predictors of Outcome and Natural History in Patients With Cervical Spondylotic Myelopathy|Recruiting||N/A|350|Anticipated|Shanghai University of Traditional Chinese Medicine|||1||f||||t||||||||Yes|individual participant data (IPD) available|2017-10-10 21:41:12.382811|2017-10-10 21:41:12.382811
NCT02936232|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-14|||August 2014||2014-08-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|3 Months|Observational [Patient Registry]|||Severe Sepsis and Septic Shock Registry of SNUH, SNUBH, and SNUBoH|Severe Sepsis and Septic Shock Registry of SNUH, SNUBH, and SNUBoH|Recruiting||N/A|500|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-10 21:41:12.478989|2017-10-10 21:41:12.478989
NCT02936219|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-09-25|||April 2016||2016-04-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2018|Anticipated|2018-06-01||Observational|PREWEAN||The PREWEAN Study. Weaning of Preterm Infants During the First Year of Life.|Weaning of Preterm Infants During the First Year of Life: Impact on Anthropometry, Body Composition, Atopy and Neurodevelopmental Outcome|Recruiting||N/A|198|Anticipated|Medical University of Vienna|||6||f||||f||||||||||2017-10-10 21:41:12.56814|2017-10-10 21:41:12.56814
NCT02936206|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Examination of Breast Cancer Cells of Pre-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.|Comparison in the Change of Proliferation Index Between Fulvestrant and Tamoxifen in Cyclin D1 +, Estrogen Receptor + Breast Cancer|Recruiting||Phase 1|64|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-10 21:41:12.668077|2017-10-10 21:41:12.668077
NCT02936193|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|LAPPG||Laparoscopy-assisted Pylorus-vagus Nerve Preserving Gastrectomy in the Treatment of Early Gastric Cancer|Laparoscopy-assisted Pylorus-vagus Nerve Preserving Gastrectomy in the Treatment of Early Gastric Cancer: Clinical Outcomes of a Randomised Controlled Trial|Recruiting||N/A|100|Anticipated|RenJi Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:41:12.776783|2017-10-10 21:41:12.776783
NCT02936180|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|IV-RA||Standard Versus High Dose Inactivated Influenza Vaccine in RA|Improving Influenza Immunization Responses in Rheumatoid Arthritis: A Strategy To Enhance Protection Against A Preventable Cause Of Death In An At Risk Population?|Enrolling by invitation||Phase 4|407|Anticipated|McGill University Health Center||2|||f||||t||||||||Undecided||2017-10-10 21:41:12.867038|2017-10-10 21:41:12.867038
NCT02936167|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||September 2016||2016-09-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Comparison of Ringer Lactate and Isotonic Acetate Solution as Perioperative Maintenance Fluid for Children|Comparison of Ringer Lactate and Isotonic Acetate Solution as Maintenance Fluids in Children Undergoing Elective Laparoscopic Surgery|Recruiting||N/A|50|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||Undecided||2017-10-10 21:41:12.951878|2017-10-10 21:41:12.951878
NCT02933606|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-07|||June 30, 2016|Actual|2016-06-30|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|RESTORE||Phase II Study of BNC210 in PTSD|A Randomized, Double-blind, Placebo-controlled Phase II Study of BNC210 in Adults With Post-Traumatic Stress Disorder (PTSD).|Recruiting||Phase 2|192|Anticipated|Bionomics Limited||4|||f|||||t|||||||||2017-10-10 21:41:35.751008|2017-10-10 21:41:35.751008
NCT02936154|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-11-11|||August 2016||2016-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects|A Phase 1, Double Blind (Sponsor Open), Placebo-controlled, Multiple-dose Study To Evaluate The Tolerability, Safety And Pharmacokinetics Of A Modified Release Formulation Of Pf-06650833 Under Fed Condition In Healthy Adult Japanese Subjects|Completed||Phase 1|10|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 21:41:13.05936|2017-10-10 21:41:13.05936
NCT02936141|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-14|||August 2008||2008-08-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|July 2009|Actual|2009-07-01||Interventional|||Psychosocial Intervention Designed to Familial Reintegration of Homeless With Mental Disorder in Maputo and Matola City|Psychosocial Intervention Targeting Homeless With Mental Disorders in the City of Maputo and Matola: a Study Protocol|Completed||N/A|71|Actual|Ministry of Health, Mozambique||1|||f||||f||||||||Yes|There is a need of reformulating database so as to better protect participant`s confidentiality|2017-10-10 21:41:13.150156|2017-10-10 21:41:13.150156
NCT02936128|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-04-04|||July 2016||2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers|A Multicenter, Randomized, Single-Blind Study Comparing the Clinical Outcomes of TruSkin® and an Active Comparator for the Treatment of Chronic Venous Leg Ulcers|Terminated||Phase 4|7|Actual|Osiris Therapeutics||2||Osiris decision|f||||f||||||||No||2017-10-10 21:41:13.235735|2017-10-10 21:41:13.235735
NCT02936115|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-04-04|||July 2016||2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers|A Multicenter, Randomized, Single-Blind Study Comparing the Clinical Outcomes of TruSkin® and an Active Comparator for the Treatment of Chronic Diabetic Foot Ulcers|Terminated||Phase 4|14|Actual|Osiris Therapeutics||2||Osiris decision|f||||f||||||||No||2017-10-10 21:41:13.34038|2017-10-10 21:41:13.34038
NCT02936102|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-09-14|||October 21, 2016|Actual|2016-10-21|September 2017|2017-09-01|October 6, 2019|Anticipated|2019-10-06|October 6, 2019|Anticipated|2019-10-06||Interventional|||A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.|A Phase I, Open-label, Multi-center Dose Escalation Study of FAZ053 as Single Agent and in Combination With PDR001 in Adult Patients With Advanced Malignancies|Recruiting||Phase 1|315|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:41:13.43278|2017-10-10 21:41:13.43278
NCT02936089|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+|Risk Stratification-directed Therapy for Acute Myeloid Leukemia With t(8;21) /AML1-ETO-positive|Not yet recruiting||N/A|80|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||Yes||2017-10-10 21:41:13.555867|2017-10-10 21:41:13.555867
NCT02936076|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-01-13|||January 2017||2017-01-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Exercise as a Buffer Against Stress-induced Overeating|Exercise as a Buffer Against Stress-induced Overeating|Recruiting||N/A|60|Anticipated|The Miriam Hospital||2|||f||||f||||||||No||2017-10-10 21:41:13.632588|2017-10-10 21:41:13.632588
NCT02936063|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-10-05|||March 2018|Anticipated|2018-03-01|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Outcomes Comparing Different Methods of Skin Closure in Patients Undergoing Head and Neck Surgery.|Outcomes Comparing Different Methods of Skin Closure in Patients Undergoing Head and Neck Surgery.|Withdrawn||N/A|0|Actual|Boston Medical Center||2||PI left the institution before any participants were enrolled.|f||||t|f|f||||||||2017-10-10 21:41:13.709442|2017-10-10 21:41:13.709442
NCT02936050|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-01-31|||October 2016|Actual|2016-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Telemedicine for Ultrasound Support in Nurse-based Outpatient Heart Failure Clinic|The Use of Ultrasound Diagnostics for Clinical Decision Making at Remote Locations - Data From an Outpatient Heart Failure Clinic|Completed||N/A|50|Actual|Levanger Hospital||1|||f||||f||||||||||2017-10-10 21:41:13.783469|2017-10-10 21:41:13.783469
NCT02936024|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-08-28|||April 11, 2017|Actual|2017-04-11|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|GSLO||One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy (GSLO)|One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy: A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|McMaster University||2|||f||||t|f|f||||||||2017-10-10 21:41:14.182941|2017-10-10 21:41:14.182941
NCT02936011|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|DISCRETE-CTO||DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in CTO.|DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in Chronic Total Occlusion. The DISCRETE CTO Study.|Recruiting||N/A|50|Anticipated|Belfast Health and Social Care Trust||1|||f||||t||||||||No||2017-10-10 21:41:14.253555|2017-10-10 21:41:14.253555
NCT02935998|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation|A Multi-Center,Open-Labeled,Intervention Study:The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation|Not yet recruiting||Phase 4|1000|Anticipated|Beijing HuiLongGuan Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:41:14.320628|2017-10-10 21:41:14.320628
NCT02935816|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-13|||January 2015||2015-01-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|LOCATE||Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques|Whole Body Multi--‐Parametric MRI: Accuracy in Staging of Biochemically Relapsed Prostate Cancer|Recruiting||N/A|130|Anticipated|University College, London|||1||f||||f||||||Samples With DNA|"     100 ml of blood sample for exosome analysis   "|Yes||2017-10-10 21:41:15.807869|2017-10-10 21:41:15.807869
NCT02935985|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-07-07|||December 2016||2016-12-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Observational|EsICH||Tranexamic Acid and Biomarkers in Emergency Management of Spontaneous Intracerebral Hemorrhage - Biomarkers Substudy|Tranexamic Acid and Biomarkers in Emergency Management of Spontaneous Intracerebral Hemorrhage - Biomarkers Substudy|Recruiting||N/A|99|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy|||1||f||||f||||||Samples Without DNA|"     Venous blood samples will be collected from patients who have suffered a spontaneous     intracerebral hemorrhage less than 8h ago.      Point-of-care bio-markers will be assessed by using an immunoanalyzer in the Emergency     Department.      From the blood samples used for determining the other biological parameters (CBC,     biochemistry, coagulogram), serum samples will be stored at -80 C degrees for further studies     on this topic.      The participant will be explicitly asked for consent for storing the serum sample.   "|||2017-10-10 21:41:14.408536|2017-10-10 21:41:14.408536
NCT02935972|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-01-20|||November 2013|Actual|2013-11-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy|Pain Reduction During Transrectal Ultrasound-guided Biopsy of the Prostate: Intravenous Diazepam, Local Periprostatic Nerve Block or Combination|Completed||Phase 2/Phase 3|336|Actual|Assiut University||3|||f||||t||||||||Undecided||2017-10-10 21:41:14.5073|2017-10-10 21:41:14.5073
NCT02935959|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-07|||October 2016||2016-10-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Premedication With Nebulized Ketamine,Dexmedetomidine Versus Midazolam in Oncologic Preschool Children|Premedication With Different Nebulized Ketamine,Dexmedetomidine Versus Midazolam in Oncologic Preschool Children|Recruiting||Phase 1/Phase 2|60|Anticipated|Assiut University||3|||f||||f||||||||||2017-10-10 21:41:14.601127|2017-10-10 21:41:14.601127
NCT02935946|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Cold Liquids Fed to Preterm Infants: Efficacy and Safety After 10 Minutes of Exposure|Cold Liquids Fed to Preterm Infants: Efficacy and Safety After 10 Minutes of Exposure|Enrolling by invitation||N/A|40|Anticipated|Winthrop University Hospital||3|||f||||t||||||||Yes|in publication|2017-10-10 21:41:14.704569|2017-10-10 21:41:14.704569
NCT02935933|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-04-15|||October 2016||2016-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Paravertebral Morphine Versus Dexmedetomidine on Acute and Chronic Postmastectomy Pain|Safety and Efficacy of Paravertebral Morphine Versus Dexmedetomidine on Acute and Chronic Pain|Recruiting||Phase 1/Phase 2|90|Anticipated|Assiut University||3|||f||||f||||||||No||2017-10-10 21:41:14.801655|2017-10-10 21:41:14.801655
NCT02935920|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-05-26|||April 2016||2016-04-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy|A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy|Recruiting||N/A|200|Anticipated|Vejle Hospital||2|||f||||f||||||||No||2017-10-10 21:41:14.885117|2017-10-10 21:41:14.885117
NCT02935907|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-06-21|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|APG-115||APG-115 in Patients With Advanced Solid Tumors or Lymphomas|A Phase I Study of the Safety, Pharmacokinetic and Pharmacodynamic Properties of Orally Administered APG-115 in Patients With Advanced Solid Tumors or Lymphomas|Recruiting||Phase 1|50|Anticipated|Ascentage Pharma Group Inc.||1|||f||||t||||||||No||2017-10-10 21:41:14.961888|2017-10-10 21:41:14.961888
NCT02935881|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-14|||January 2015||2015-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|STRETTAGERD||STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD|A Prospective Randomized Trial Comparing Endoscopic Radio Frequency Ablation (RFA) - STRETTA vs Sham Therapy for the Treatment of Refractory Gastroesophageal Reflux Disease|Recruiting||Phase 3|20|Anticipated|Asian Institute of Gastroenterology, India||2|||f||||t||||||||No||2017-10-10 21:41:15.176947|2017-10-10 21:41:15.176947
NCT02935868|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-13|||November 2013||2013-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Periodontal and Salivary Evaluation of Type 1 Diabetes Mellitus Patients|Periodontal and Salivary Evaluation of a Sample of Type 1 Diabetes Mellitus Patients in Brazil|Completed||N/A|30|Actual|University of Sao Paulo|||2||f||||t||||||||No||2017-10-10 21:41:15.251636|2017-10-10 21:41:15.251636
NCT02935855|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-10-17|||September 2015||2015-09-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|ORGANON||ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)|Efficacy and Safety of Non-vitamin K Oral Anticoagulants and Vitamin K Oral Anticoagulants on Some Metabolic and Coagulation Parameters in Diabetic and Nondiabetic Patients With First Diagnosis of Non-valvular Atrial Fibrillation|Recruiting||Phase 4|320|Anticipated|University of Pavia||4|||f||||f||||||||No||2017-10-10 21:41:15.321854|2017-10-10 21:41:15.321854
NCT02935842|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|EILT||Evaluation of Intensive Language Therapy|Effectiveness of High-frequency Specific Speech Therapy on Verbal Fluency Decline and/ or Verbal Apraxia in Patients With Parkinson's Disease With and Without Deep Brain Stimulation (DBS) - a Randomized Controlled Single-blinded Trial|Recruiting||N/A|70|Anticipated|University Hospital, Basel, Switzerland||6|||f||||t||||||||Undecided|Possible only on an individual basis, i.e. if participant himself wishes to see score sheet for further therapy (after completion of the study and only for further therapeutic interventions independent of this study)|2017-10-10 21:41:15.458977|2017-10-10 21:41:15.458977
NCT02935829|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-01-19|||March 2014||2014-03-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||Short-term Effects of a Carob Snack on Postprandial Glycemic Responses and Energy Intake and Satiety|Short-term Effects of a Low Glycemic Index Snack Including Carob on Postprandial Glycemic Responses, Energy Intake and Satiety in Normal-weight, Healthy Adults|Completed||N/A|140|Actual|Agricultural University of Athens||6|||f||||f||||||||No||2017-10-10 21:41:15.686944|2017-10-10 21:41:15.686944
NCT02935803|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-10-13|||July 2016||2016-07-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Interventional|TVMvsmTVM||A Study on the Anti-incontinent Effectiveness of the mTVM Method in POPQ Stage II-III Patients|A Prospective and Randomised Single Centre Study on the Anti-incontinent Effectiveness of the Modified Trans Vaginal Mesh Method in POPQ Stage II-III Patients|Recruiting||N/A|76|Anticipated|Szeged University||2|||f||||t||||||||Yes||2017-10-10 21:41:15.903759|2017-10-10 21:41:15.903759
NCT02935790|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-08-22|||September 30, 2016|Actual|2016-09-30|August 2017|2017-08-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|||Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab|A Phase 1b Study of the Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma|Completed||Phase 1|1|Actual|Celgene||1|||f||||f||||||||||2017-10-10 21:41:16.02748|2017-10-10 21:41:16.02748
NCT02935777|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-13|||April 2014||2014-04-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|POM-03||Acute Effect of Pomegranate Extract on Cognitive Function|Investigation of the Acute Effect of Pomegranate Extract on Cognitive Function in Human Volunteers: A Double-blind, Placebo-controlled, Crossover Trial|Completed||Phase 1|20|Actual|Queen Margaret University||2|||f||||f||||||||No||2017-10-10 21:41:16.142781|2017-10-10 21:41:16.142781
NCT02935764|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2019|Anticipated|2019-10-01||Interventional|||FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients|Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Regimen (FOLFIRI) Versus Irinotecan Monodrug as Second-line Treatment in Metastatic Colorectal Cancer Patients|Not yet recruiting||Phase 3|164|Anticipated|Fudan University||2|||f||||||||||||||2017-10-10 21:41:16.254099|2017-10-10 21:41:16.254099
NCT02935751|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|ADIOS||Apixaban Discontinuation Prior to Major Surgery|Apixaban Discontinuation Prior to Major Surgery|Recruiting||N/A|130|Anticipated|Thomas Jefferson University|||1||f||||t||||||||No||2017-10-10 21:41:16.376388|2017-10-10 21:41:16.376388
NCT02935738|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-14|||October 2014||2014-10-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies|Improvement in Pregnancy Outcomes in Immunologically Infertile Male Patients Undergoing Prednisolone Treatment and Conventional IVF Preceded by Sperm Penetration Assay: A Randomized Controlled Trial|Completed||N/A|241|Actual|Barz IVF Center for Infertility Treatment and Embryo Research||4|||f||||t||||||||Undecided||2017-10-10 21:41:16.466413|2017-10-10 21:41:16.466413
NCT02935725|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-08-21|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males|A Phase 1, Single-centre, Double-blind, Placebocontrolled Crossover Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Male Participants|Recruiting||Phase 1|16|Anticipated|Autifony Therapeutics Limited||4|||f||||f||||||||||2017-10-10 21:41:16.598464|2017-10-10 21:41:16.598464
NCT02935712|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-07|||December 16, 2016|Actual|2016-12-16|August 2017|2017-08-01|January 2, 2018|Anticipated|2018-01-02|August 4, 2017|Actual|2017-08-04||Interventional|||Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)|A Phase I, Randomized, Single-Blind, Placebo Controlled Study to Assess the Safety, Tolerability and Pharmacodynamics Of AZD8601 After Single Dose Administration to Male Patients With Type II Diabetes Mellitus (T2DM)|Active, not recruiting||Phase 1|44|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 21:41:16.720025|2017-10-10 21:41:16.720025
NCT02935699|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-03-31|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria|A Phase III, Multi-center, Double Blind, Randomized, Active Controlled Clinical Trial to Evaluate the Non-Inferiority Comparing Cetirizine Injection 10 mg (Aka JDP-205) to Diphenhydramine Injection, 50 mg, for the Treatment of Acute Urticaria|Recruiting||Phase 3|256|Anticipated|JDP Therapeutics, Inc.||2|||f||||t|t|f||||||No||2017-10-10 21:41:16.838856|2017-10-10 21:41:16.838856
NCT02935660|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Multi-Wavelength Laser Tattoo Removal Pivotal Study|A Prospective, Multi-Center Pivotal Clinical Evaluation of a Novel Multi-Wavelength Laser for Tattoo Removal|Recruiting||N/A|30|Anticipated|Cutera Inc.||1|||f||||f||||||||No||2017-10-10 21:41:17.510198|2017-10-10 21:41:17.510198
NCT02935647|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Burst Suppression Anesthesia for Treatment of Severe Depression|Burst Suppression Anesthesia for Treatment of Severe Depression|Enrolling by invitation||Phase 1|10|Anticipated|University of Utah||1|||f||||t||||||||No||2017-10-10 21:41:17.59794|2017-10-10 21:41:17.59794
NCT02935634|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-10-04|||November 23, 2016|Actual|2016-11-23|October 2017|2017-10-01|November 18, 2021|Anticipated|2021-11-18|November 17, 2021|Anticipated|2021-11-17||Interventional|FRACTION-GC||A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer|A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants With Advanced Gastric Cancer (FRACTION-Gastric Cancer)|Recruiting||Phase 2|300|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 21:41:17.672405|2017-10-10 21:41:17.672405
NCT02935621|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-02|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain|Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain Conditions and Opioid Related Problems|Recruiting||N/A|260|Anticipated|University of Utah||2|||f||||t|f|f||||||||2017-10-10 21:41:17.872068|2017-10-10 21:41:17.872068
NCT02935595|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||September 2016||2016-09-01|October 2016|2016-10-01||||September 2018|Anticipated|2018-09-01||Interventional|ketamine||Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients|A Systematic Investigation of Neurophysiological Correlates of Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients|Enrolling by invitation||Phase 2|20|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 21:41:18.189992|2017-10-10 21:41:18.189992
NCT02935582|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-06-28|||January 2017||2017-01-01|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Observational|PSOREAL||PSOREAL - Managing PSOriasis in the REAL World|One-year Prospective, Observational Study of the Journey of Patients With Plaque Psoriasis Prescribed Calcipotriol/Betamethasone Aerosol Foam or Other Topical Therapy|Recruiting||N/A|5000|Anticipated|LEO Pharma|||2||f||||f||||||||No||2017-10-10 21:41:18.263755|2017-10-10 21:41:18.263755
NCT02935569|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-02-27|||May 2012||2012-05-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy|Feasibility Clinical Study of Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy|Terminated||N/A|4|Actual|University of Rochester||1||Results with 4 subjects suggest a redesign of Compression system is required.|f||||f|f|f||||||Yes|Researchers can contact the PI to obtain IPD with collaboration.|2017-10-10 21:41:18.350505|2017-10-10 21:41:18.350505
NCT02935556|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||January 2017||2017-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Characterization and Epigenetics of Post-Partum Preeclampsia|Characterization and Epigenetics of Post-Partum Preeclampsia|Not yet recruiting||N/A|22|Anticipated|Columbia University|||2||f||||f||||||Samples With DNA|"     DNA will be isolated from the whole blood.   "|No||2017-10-10 21:41:18.411927|2017-10-10 21:41:18.411927
NCT02935543|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01||||April 2018|Anticipated|2018-04-01||Interventional|||CART19 in Patient With ALL|Phase 2 Study of CD19-directed Chimeric Antigen Receptor-modified T Cells (CART19) for Adult Patients With Minimal Residual Disease During Upfront Treatment for Acute Lymphoblastic Leukemia|Recruiting||Phase 2|24|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 21:41:18.475001|2017-10-10 21:41:18.475001
NCT02935530|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||January 2016||2016-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Thromboprophylaxis After Surgery for Gynecologic Malignancy in China|Effectiveness and Safety of Thromboprophylaxis After Surgery for Gynecologic Malignancy in China|Recruiting||Phase 3|300|Anticipated|Huazhong University of Science and Technology||3|||f||||t||||||||No||2017-10-10 21:41:18.550645|2017-10-10 21:41:18.550645
NCT02935504|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-17|||March 2014||2014-03-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PRISM-Pilot||PRogram In Support of Moms (PRISM): A Pilot Study|PRogram In Support of Moms (PRISM): A Pilot Group Randomized Controlled Trial|Completed||N/A|33|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||Undecided||2017-10-10 21:41:18.730633|2017-10-10 21:41:18.730633
NCT02935491|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-03-10|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|C4CAPRI||4 Cities for Assessing CAlcification PRognostic Impact After TAVI|4 Cities for Assessing CAlcification PRognostic Impact After TAVI|Completed||N/A|1600|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:41:20.386587|2017-10-10 21:41:20.386587
NCT02935478|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-20|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation|A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization in Obese Patients With Hepatocellular Carcinoma to Achieve Appropriate Weight Loss That May Allow Them to be Transplanted|Not yet recruiting||N/A|8|Anticipated|St. Louis University||1|||f||||t|f|t|f|f||||||2017-10-10 21:41:20.471457|2017-10-10 21:41:20.471457
NCT02935465|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-13|||September 2016||2016-09-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation|Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation in Opioid-Treated Chronic Pain Patients|Recruiting||N/A|140|Anticipated|University of Utah||2|||f||||t||||||||Undecided||2017-10-10 21:41:20.577012|2017-10-10 21:41:20.577012
NCT02935452|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-10-13|||November 2016||2016-11-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|GeCop||Implementing and Evaluating the Genie Tool in COPD|Implementing and Evaluating the GENIE Tool in Southampton Integrated COPD Service: A Clinical Trial to Ascertain Cost Effectiveness and Patient Benefit|Not yet recruiting||N/A|60|Anticipated|University of Southampton||2|||f||||f||||||||No||2017-10-10 21:41:20.669731|2017-10-10 21:41:20.669731
NCT02935439|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||February 2011||2011-02-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Novel Fully Integrated Mobile Management Solution Using Cell Phone Technology for Heart Failure|A Novel Fully Integrated Mobile Management Solution Using Cell Phone Technology for Heart Failure|Completed||N/A|61|Actual|University of Miami||2|||f||||f||||||||No||2017-10-10 21:41:20.763967|2017-10-10 21:41:20.763967
NCT02935426|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||November 2016||2016-11-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparison of Cyanoacrylate Adhesives to Sutures in the Palate After Connective Tissue Graft|Comparison of Cyanoacrylate Tissue Adhesives to Polytetrafluoroethylene (PTFE) Sutures in the Donor Site of Connective Tissue Grafts- A Randomized Clinical Trial|Not yet recruiting||Phase 4|32|Anticipated|University of Manitoba||2|||f||||t||||||||Undecided||2017-10-10 21:41:20.849963|2017-10-10 21:41:20.849963
NCT02935413|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||January 2013||2013-01-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Combined tDCS and Vision Restoration Training in Subacute Stroke Rehabilitation: A Pilot Study|Combined tDCS and Vision Restoration Training in Subacute Stroke Rehabilitation: A Pilot Study|Completed||Phase 1/Phase 2|14|Actual|University of Magdeburg||2|||f||||f||||||||No||2017-10-10 21:41:20.938093|2017-10-10 21:41:20.938093
NCT02935400|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-17|||January 2014||2014-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Acute Porphyria Biomarkers|Acute Porphyrias: Biomarkers for Disease Activity and Response to Treatment|Enrolling by invitation||N/A|50|Anticipated|The University of Texas Medical Branch, Galveston|||2||f||||f||||||Samples Without DNA|"     1. Blood specimens collected in Paxgene tubes for isolation of RNA for expression studies.        2. Blood samples for metabolomic studies        3. Urine samples for metabolomic studies        4. Stool samples for metabolomic studies   "|Undecided|Data not entered|2017-10-10 21:41:21.011921|2017-10-10 21:41:21.011921
NCT02935387|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-03-20|||November 2016||2016-11-01|March 2017|2017-03-01|November 2023|Anticipated|2023-11-01|November 2022|Anticipated|2022-11-01||Interventional|REMINDRA||REMission INDuction in Very Early Rheumatoid Arthritis|REMission INDuction in Very Early Rheumatoid Arthritis|Recruiting||Phase 4|267|Anticipated|UMC Utrecht||2|||f||||f||||||||Undecided||2017-10-10 21:41:21.081126|2017-10-10 21:41:21.081126
NCT02935374|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|AOMMi||Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children|Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children: A Randomized Controlled Trial|Recruiting||Phase 4|150|Anticipated|University of Oulu||4|||f||||f||||||||No||2017-10-10 21:41:21.161763|2017-10-10 21:41:21.161763
NCT02935361|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-04|||November 2, 2016|Actual|2016-11-02|August 2017|2017-08-01|November 2, 2021|Anticipated|2021-11-02|November 2, 2020|Anticipated|2020-11-02||Interventional|||Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed|A Phase I/II Multicenter Study Combining Guadecitabine, a DNA Methyltransferase Inhibitor, With Atezolizumab, an Immune Checkpoint Inhibitor, in Patients With Intermediate or High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia|Recruiting||Phase 1/Phase 2|72|Anticipated|University of Southern California||1|||f||||t|t|f|||f|||||2017-10-10 21:41:21.382694|2017-10-10 21:41:21.382694
NCT02935348|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-10-13|||February 2014||2014-02-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|PET/MRI||Whole Body PET-MRI in Paediatric and Adolescent Lymphoma|Feasibility of Using Whole Body PET-MRI to Stage and Restage Paediatric and Adolescent Hodgkin Lymphoma - a Pilot Study|Recruiting||N/A|25|Anticipated|University College, London|||1||f||||t||||||||Yes||2017-10-10 21:41:21.50591|2017-10-10 21:41:21.50591
NCT02935322|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-12|||September 2009||2009-09-01|October 2016|2016-10-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Interaction Between Chlorhexidine and Fluoride|Interaction Chlorhexidine-fluoride - a 4-day and 6-week Randomised Clinical Mouthrinse Study|Completed||Phase 4|32|Actual|University of Oslo||4|||f||||f||||||||Undecided||2017-10-10 21:41:21.657358|2017-10-10 21:41:21.657358
NCT02935309|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-23|||October 11, 2016|Actual|2016-10-11|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma|Phase I Study of Pre-operative Capecitabine and Lenvatinib With External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma|Recruiting||Phase 1|28|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 21:41:21.768653|2017-10-10 21:41:21.768653
NCT02935296|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-06-20|||February 2015||2015-02-01|October 2016|2016-10-01|June 16, 2018|Anticipated|2018-06-16|June 16, 2017|Actual|2017-06-16||Interventional|||Integrated Treatment and Prevention for People Who Inject Drugs|Integrated Treatment and Prevention for People Who Inject Drugs: A Vanguard Study for a Network-based Randomized HIV Prevention Trial Comparing an Integrated Intervention Including Supported Antiretroviral Therapy to the Standard of Care|Active, not recruiting||Phase 3|1281|Actual|HIV Prevention Trials Network||2|||f||||t||||||||No|no individual data will be shared|2017-10-10 21:41:21.89133|2017-10-10 21:41:21.89133
NCT02935283|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-10-13|||August 2016||2016-08-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Observational|UCD||Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders|Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders|Recruiting||N/A|56|Anticipated|Children's Research Institute|||4||f||||t||||||||Yes|Data will be kept on UCD website and released after study completion|2017-10-10 21:41:21.988247|2017-10-10 21:41:21.988247
NCT02935257|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-10-03|||September 29, 2017|Actual|2017-09-29|October 2017|2017-10-01|November 2024|Anticipated|2024-11-01|April 2020|Anticipated|2020-04-01||Interventional|ALLCAR19||Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia Using CAR T-cells to Target CD19|Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia|Recruiting||Phase 1|20|Anticipated|University College, London||1|||f||||t|f|f|||f|||||2017-10-10 21:41:22.197079|2017-10-10 21:41:22.197079
NCT02935244|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-29|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Observational|ASPIRE-SSI||Advanced Understanding of Staphylococcus Aureus Infections in Europe - Surgical Site Infections|Advanced Understanding of Staphylococcus Aureus Infections in Europe - Surgical Site Infections|Recruiting||N/A|5000|Anticipated|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     -  A preoperative blood sample        -  An additional blood sample after an SSI episode   "|Undecided||2017-10-10 21:41:22.281171|2017-10-10 21:41:22.281171
NCT02935231|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-03-20|||September 2016||2016-09-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||PMCAN for Smokers at Smoking Hotspots|Proactive Minimal Cessation Advice Plus Nicotine Replacement Therapy (PMCAN) for Smoking Cessation in Smokers at Smoking Hotspots: a Pilot Randomized Controlled Trial|Active, not recruiting||N/A|32|Actual|The University of Hong Kong||4|||f||||t||||||||Undecided||2017-10-10 21:41:22.380419|2017-10-10 21:41:22.380419
NCT02935218|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-10-13|||January 2015||2015-01-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program|Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program|Completed||N/A|15|Actual|Freie Universität Berlin||1|||f||||f||||||||No|qualitative data not suitable for sharing|2017-10-10 21:41:22.474165|2017-10-10 21:41:22.474165
NCT02935205|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||January 2017||2017-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer|A Phase I/II Study of Enzalutamide in Combination With Indomethacin in Castration-Resistant Prostate Cancer (CRPC)|Not yet recruiting||Phase 1/Phase 2|38|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 21:41:22.540526|2017-10-10 21:41:22.540526
NCT02935192|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-04-07|||November 28, 2016|Actual|2016-11-28|September 2016|2016-09-01|March 25, 2017|Actual|2017-03-25|January 8, 2017|Actual|2017-01-08||Interventional|Torlak-300||Phase 3 Trial of Serbian Seasonal Influenza Vaccine|A Phase 3 Double Blinded, Randomized, Placebo- Controlled Study to Examine the Safety and Immunogenicity of a Seasonal Trivalent Split Inactivated Influenza Vaccine Produced by Institute Torlak in 18-65 Year Old Volunteers in Serbia|Completed||Phase 3|476|Actual|Institute of Virology, Vaccines and Sera, Torlak||2|||f||||f||||||||Yes|We will return overall results of clinical trial to participants via letter|2017-10-10 21:41:22.645582|2017-10-10 21:41:22.645582
NCT02935179|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||September 2016||2016-09-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of White Sweet Potato Meal Replacement on Weight Control of the Obesity||Enrolling by invitation||N/A|60|Anticipated|Taipei Medical University||2|||f||||t||||||||No||2017-10-10 21:41:22.734557|2017-10-10 21:41:22.734557
NCT02935166|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||February 2015||2015-02-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|INNOTORIO||Innovations in Respiratory Muscles Training in Patients With Chronic Obstructive Pulmonary Disease. (INNOTORIO)|INNOTORIO: Innovations in the Training of the Inspiratory Muscles on Patients With Chronic Obstructive Pulmonary Disease: Design of a Digital Dual Valve and Evaluation of a New High-intensity Training Scheme of Short Duration.|Completed||N/A|30|Actual|Fundación Cardiovascular de Colombia||3|||f||||f||||||||Yes||2017-10-10 21:41:22.81737|2017-10-10 21:41:22.81737
NCT02935153|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-11-02|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies|A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies|Recruiting||Phase 1/Phase 2|45|Anticipated|Southwest Hospital, China||1|||f||||f||||||||Undecided||2017-10-10 21:41:22.892343|2017-10-10 21:41:22.892343
NCT02935140|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-11-18|||December 2015||2015-12-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Safe Use of Speaking Valve in Children During Sleep Using Trans-tracheal Pressure Measurement|Safe Use of Speaking Valve in Children During Sleep Using Trans-tracheal Pressure Measurement|Completed||N/A|8|Actual|St Mary's Hospital for Children|||1||f||||f||||||||Yes||2017-10-10 21:41:22.978372|2017-10-10 21:41:22.978372
NCT02935127|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||November 2016||2016-11-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|April 2017|Anticipated|2017-04-01||Interventional|ASPeVaS||Absorbable Sutures in Vascular Surgery|Absorbable Sutures in Peripheral Vascular Surgery|Not yet recruiting||N/A|100|Anticipated|University of Cantanzaro||2|||f||||t||||||||No||2017-10-10 21:41:23.181757|2017-10-10 21:41:23.181757
NCT02935114|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-11-12|||May 2016||2016-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||IN-OFFICE TOOTH BLEACHING WITH 37% CARBAMIDE PEROXIDE|EVALUATION OF CLINICAL EFFICACY AND SENSIBILITY OF BLEACHING AGENT 37% CARBAMIDE PEROXIDE IN-OFFICE TOOTH BLEACHING: CLINICAL TRIAL RANDOMIZED CONTROLLED|Completed||Phase 3|50|Actual|Universidade Federal de Sergipe||2|||f||||f||||||||No||2017-10-10 21:41:23.275973|2017-10-10 21:41:23.275973
NCT02935101|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-29|||October 2016||2016-10-01|May 2017|2017-05-01||||September 2018|Anticipated|2018-09-01||Interventional|Goliath||Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants|Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants|Terminated||Phase 2|120|Anticipated|University of Basel||2||difficulties in recruiting study participants|f||||f||||||||Undecided||2017-10-10 21:41:23.368735|2017-10-10 21:41:23.368735
NCT02935088|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-09-06|||October 12, 2016|Actual|2016-10-12|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||PRESSUREwire Study|Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures|Recruiting||N/A|2000|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-10 21:41:23.494689|2017-10-10 21:41:23.494689
NCT02935075|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-25|||January 2017||2017-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|OAT||Optimization of Antiretroviral Therapy|Optimization of Antiretroviral Therapy|Not yet recruiting||Phase 4|184|Anticipated|Shanghai Public Health Clinical Center||2|||f||||||||||||||2017-10-10 21:41:23.814565|2017-10-10 21:41:23.814565
NCT02935062|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-05-11|||July 2016||2016-07-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||New Therapeutical Perspectives in Cases of Phonological Disorders|New Therapeutical Perspectives in Cases of Phonological Disorders|Recruiting||N/A|24|Anticipated|Universidade Federal de Santa Maria||3|||f||||t||||||||Undecided|It is not yet decided whether the data sharing will be individual for each participant or the general set of results from all participants. If so, the initial datas will be in october 2016.|2017-10-10 21:41:23.925568|2017-10-10 21:41:23.925568
NCT02935049|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|HYBRID ESD||Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique|Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique|Recruiting||N/A|120|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:41:24.040146|2017-10-10 21:41:24.040146
NCT02935036|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-03|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|||Efficacy Study in Patients With Acne Vulgaris.|A Multi-center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Adps in the Treatment of Acne Vulgaris|Completed||Phase 2|300|Actual|Taro Pharmaceuticals USA||2|||f||||f||||||||No||2017-10-10 21:41:24.122594|2017-10-10 21:41:24.122594
NCT02935023|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-13|||September 2016||2016-09-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer|Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer|Recruiting||Phase 2|47|Anticipated|Shanghai Proton and Heavy Ion Center||1|||f||||t||||||||No||2017-10-10 21:41:24.218198|2017-10-10 21:41:24.218198
NCT02935010|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-02-16|||February 5, 2017|Actual|2017-02-05|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment|Efficacy of Antibiotic Susceptibility-based Tailored Versus Empiric Therapy for Helicobacter Pylori First-line Treatment：a Randomized Clinical Trial|Recruiting||Phase 4|500|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t|f|f||||||No||2017-10-10 21:41:24.307202|2017-10-10 21:41:24.307202
NCT02934997|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-06-16|||November 1, 2016|Actual|2016-11-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||The Role of Dysfunctional HDL in Sepsis|The Role of Dysfunctional HDL in Community and Hospital Acquired Sepsis|Enrolling by invitation||N/A|160|Anticipated|University of Florida|||2||f||||f||||||Samples With DNA|"     Samples of Serum and Plasma will be drawn and retained for several clinically relevant     biomarkers as well as future testing.   "|||2017-10-10 21:41:24.456628|2017-10-10 21:41:24.456628
NCT02934984|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||July 2016||2016-07-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Observational|||Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer|Analysis of Factors Related to Pancreatic Cancer Recurrence Using Circulating Cell-free Tumor DNA(ctDNA)|Recruiting||N/A|100|Anticipated|Samsung Medical Center|||1||f||||t||||||Samples With DNA|"     we will collect peripheral blood cell-free tumor DNA(ctDNA) in pancreatic cancer patients.   "|Undecided||2017-10-10 21:41:24.538657|2017-10-10 21:41:24.538657
NCT02934971|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-10-13|||January 2017||2017-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|MERMAID||Optimized Multi-modality Machine Learning Approach During Cardio-toxic Chemotherapy to Predict Arising Heart Failure|Optimized Multi-modality Machine Learning Approach During Cardio-toxic Chemotherapy to Predict Arising Heart Failure|Not yet recruiting||N/A|470|Anticipated|RWTH Aachen University|||4||f||||f||||||||||2017-10-10 21:41:24.60813|2017-10-10 21:41:24.60813
NCT02934958|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||October 2015||2015-10-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||FIT Mailing Protocol-For Cancer Screening Navigation|FIT Mailing Protocol-For Cancer Screening Navigation|Active, not recruiting||N/A|13392|Anticipated|Renown Regional Medical Center||2|||f||||f||||||||||2017-10-10 21:41:24.69186|2017-10-10 21:41:24.69186
NCT02934945|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-13|||September 2015||2015-09-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients||Recruiting||Phase 4|30|Anticipated|Zhujiang Hospital||2|||f||||f||||||||||2017-10-10 21:41:24.784362|2017-10-10 21:41:24.784362
NCT02934932|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-04-25|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|October 31, 2019|Anticipated|2019-10-31|April 30, 2019|Anticipated|2019-04-30||Interventional|||A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD|A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD|Recruiting||Phase 2|35|Anticipated|Duke University||3|||f||||f|t|f|||f|||No||2017-10-10 21:41:24.889239|2017-10-10 21:41:24.889239
NCT02934919|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||December 2016||2016-12-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|Nalmefene TCI||Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study|Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study|Not yet recruiting||Phase 2|30|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 21:41:24.968346|2017-10-10 21:41:24.968346
NCT02934906|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-13|||January 2017||2017-01-01|October 2016|2016-10-01||||December 2019|Anticipated|2019-12-01||Observational|||Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women|A Multi-center Prospective Cohort Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women|Not yet recruiting||N/A|55497|Anticipated|Xinqiao Hospital of Chongqing|||2||f||||t||||||||||2017-10-10 21:41:25.053803|2017-10-10 21:41:25.053803
NCT02934893|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-10-13|||April 2015||2015-04-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||A Study to Evaluate the Effect and Benefit of Diabetes Management Decision Support Software for Blood Glucose Control|A Randomized, Controlled, Open-label, Multi-center Study to Evaluate the Effect and Benefit of Diabetes Management Decision Support Software for Blood Glucose Control|Enrolling by invitation||N/A|129|Anticipated|Rimidi Diabetes, Inc.||3|||f||||f||||||||Undecided||2017-10-10 21:41:25.13105|2017-10-10 21:41:25.13105
NCT02934880|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|COG-SPORTIF||Impact of Adapted Physical Activity on Cognitive Functions in Breast Cancer|Study of Impact of Adapted Physical Activity on Cognitive Functions and Quality of Life in Patients Treated for Locally Advanced Breast Cancer|Recruiting||N/A|152|Anticipated|Centre Henri Becquerel||2|||f||||f||||||||No||2017-10-10 21:41:25.196812|2017-10-10 21:41:25.196812
NCT02934867|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-10-13|||September 2016||2016-09-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|CONTAC||Out of Hospital Cardiac Arrest: Trial Assessing the Survival Impact of Phone Advice|Out of Hospital Cardiac Arrest: Cluster Randomized Trial Assessing the Survival Impact of Phone Advice Delivered by Medical Call Center|Not yet recruiting||N/A|2600|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-10 21:41:25.281363|2017-10-10 21:41:25.281363
NCT02934854|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-11-23|||October 2016||2016-10-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|BioCDS||Biomarker for Creatine Deficiency Syndromes|Biomarker for Creatine Deficiency Syndromes: An International, Multicenter, Epidemiological Protocol|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectrometry 7, 5 ml     EDTA blood and a dry blood spot filter card are taken. To proof the correct diagnosis of     creatine deficiency syndromes in those patients where up to the enrollment in the study no     genetic testing has been done, sequencing of creatine deficiency syndromes will be done.      The analyses are done in the Centogene AG Schillingallee 68 D-18057 Rostock Germany   "|Undecided||2017-10-10 21:41:25.430484|2017-10-10 21:41:25.430484
NCT02934841|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||Conbercept in Choroidal Neovascularization Secondary to Uveitis||Not yet recruiting||Phase 2|40|Anticipated|Chongqing Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:41:25.511296|2017-10-10 21:41:25.511296
NCT02934828|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2016-10-15|||October 2014||2014-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer|A Randomized Study of Preoperative Chemotherapy or Postoperative Chemotherapy for Early Triple Negative or Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Operable Breast Cancer|Recruiting||Phase 2|230|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||Undecided||2017-10-10 21:41:25.74902|2017-10-10 21:41:25.74902
NCT02934815|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||January 2015||2015-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|BC-SEGT||Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast Cancer|Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention (SEGT) for Women With Breast Cancer|Recruiting||N/A|50|Anticipated|Universidade do Porto||2|||f||||f||||||||No||2017-10-10 21:41:25.835201|2017-10-10 21:41:25.835201
NCT02934802|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2016-10-14|||May 2016||2016-05-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|||Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty|Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty|Recruiting||N/A|140|Anticipated|BBraun Medical SAS|||1||f||||f||||||||No||2017-10-10 21:41:25.919856|2017-10-10 21:41:25.919856
NCT02934789|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-14|2017-06-27|||September 2014||2014-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|HSCMyomecty||Effectiveness of Truclear on Patient Quality of Life|Randomized Prospective Study of the Effectiveness of the Truclear Device for Hysteroscopic Myomectomy on Patient Quality of Life|Recruiting||N/A|62|Anticipated|All For Women Healthcare, Illinois||2|||f||||t||||||||Yes||2017-10-10 21:41:25.99474|2017-10-10 21:41:25.99474
NCT02934763|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol|Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol, in Laparoscopic Abdominal Surgery|Not yet recruiting||Phase 4|80|Anticipated|Pontificia Universidad Catolica de Chile||3|||f||||f||||||||Undecided||2017-10-10 21:41:26.199752|2017-10-10 21:41:26.199752
NCT02934750|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-01-31|||October 2016||2016-10-01|October 2016|2016-10-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||Pursed Lip Breathing in Interstitial Lung Disease|Effects of Pursed Lip Breathing on Exercise Capacity and Dyspnea in Patients With Interstitial Lung Disease: a Randomized Crossover Study|Completed||N/A|35|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||No||2017-10-10 21:41:26.282538|2017-10-10 21:41:26.282538
NCT02934737|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|RESISTIN||Role of markErs in the progreSsion of dIabeteS in Obese paTIeNts|Role of Some Markers in the Progression of Diabetes in Obese Patients: a 8-year Observational Study|Active, not recruiting||N/A|1000|Anticipated|University of Pavia|||1||f||||f||||||||No||2017-10-10 21:41:26.383146|2017-10-10 21:41:26.383146
NCT02934724|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-05-03|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2017|Actual|2017-04-01||Observational|||Impact of HPV Vaccine On The Prevalence Of HPV In Norway|Impact of HPV Vaccine On The Prevalence Of Human Papillomavirus In Mouth And Vagina In Norway|Active, not recruiting||N/A|317|Actual|Oslo University Hospital|||2||f||||f||||||Samples With DNA|"     Self samples from vagina and the oral cavity   "|Undecided||2017-10-10 21:41:26.453025|2017-10-10 21:41:26.453025
NCT02934711|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-06-16|||March 20, 2017|Actual|2017-03-20|June 2017|2017-06-01|September 20, 2018|Anticipated|2018-09-20|September 20, 2018|Anticipated|2018-09-20||Observational|QualSoPrim||A Quality Rating Scale for Patients in Complex Situations and Their Caregivers|Establish a Quality Rating Scale for Primary Care Centers and Nursing Homes Pluri Professionals Integrating the Perspective of Patients in Complex Situations and Their Caregivers|Recruiting||N/A|80|Anticipated|University Hospital, Brest|||1||f||||f||||||||No||2017-10-10 21:41:26.558334|2017-10-10 21:41:26.558334
NCT02934698|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-09-07|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations|An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations|Active, not recruiting||Phase 3|2|Actual|Medical University of South Carolina||1|||f||||f||||||||||2017-10-10 21:41:26.624824|2017-10-10 21:41:26.624824
NCT02934685|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-11-16|||June 2016||2016-06-01|November 2016|2016-11-01|May 2021|Anticipated|2021-05-01|February 2017|Anticipated|2017-02-01||Interventional|||IG-VMAT for Localized Prostate Cancer|A Phase III Randomized Study of Hypofractionated Image-guided Volumetric Modulated Arc Radiotherapy (IG-VMAT) Versus Conventionally Fractionated IG-VMAT in Patients With Localized Prostate Cancer|Recruiting||Phase 3|60|Anticipated|Beijing Hospital||2|||f||||t||||||||No||2017-10-10 21:41:26.702548|2017-10-10 21:41:26.702548
NCT02934672|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-28|||June 2016||2016-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||KineSpring® System Patient Preference Study|KineSpring® System Patient Preference Study|Completed||N/A|323|Actual|Moximed|||1||f||||f||||||||||2017-10-10 21:41:26.797106|2017-10-10 21:41:26.797106
NCT02934659|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-05-09|||November 2016||2016-11-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|Atlas-USA||Atlas Knee System Clinical System Clinical Study (USA)|Prospective, Multi-Center, Single Arm, Pilot Study to Evaluate Symptom Relief in Subjects With Medial Knee Osteoarthritis Treated With the AtlasTM Knee System for Load Reduction|Recruiting||N/A|50|Anticipated|Moximed||1|||f||||t||||||||No||2017-10-10 21:41:26.853948|2017-10-10 21:41:26.853948
NCT02934646|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-19|||July 2014||2014-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Powered Exoskeleton for the Treatment of Elbow Spasticity|Clinical Validation of a Powered Exoskeleton for the Treatment of Elbow Spasticity: Phase II Study|Completed||Phase 2|20|Actual|Auxilium Vitae Volterra||1|||f||||f||||||||No||2017-10-10 21:41:26.964931|2017-10-10 21:41:26.964931
NCT02934633|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2016-10-13|||August 2006||2006-08-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|BabySafety_2||Parent Training in Child Safety Practices|Parent Training in Child Safety Practices|Completed||Phase 2|414|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||No||2017-10-10 21:41:27.032978|2017-10-10 21:41:27.032978
NCT02934620|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-06-09|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Promoting CSD500 Use Among Women in Established Relationships|Promoting CSD500 Use Among Women in Established Relationships|Recruiting||N/A|500|Anticipated|Ohio State University||2|||f||||t|f|f||||||No||2017-10-10 21:41:27.106711|2017-10-10 21:41:27.106711
NCT02934607|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-03-31|||November 4, 2016|Actual|2016-11-04|March 2017|2017-03-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|||A Study to Assess How Much Drug Reaches the Blood When Given From Symbicort pMDI With Spacer Compared to That of Symbicort pMDI Without Spacer in Healthy Volunteers|A Randomised, Open-Label, Single-Dose, Single-Centre, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of Symbicort pMDI 160/4.5µg Administered With a Spacer (With and Without Charcoal) and Symbicort pMDI 160/4.5µg Administered Without a Spacer (With and Without Charcoal)|Completed||Phase 1|135|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-10 21:41:27.215723|2017-10-10 21:41:27.215723
NCT02934594|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01|2 Years|Observational [Patient Registry]|||Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival Rate|Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival Rate|Not yet recruiting||N/A|500|Anticipated|National Taiwan University Hospital|||3||f||||t||||||||No||2017-10-10 21:41:27.322094|2017-10-10 21:41:27.322094
NCT02934581|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-13|||September 2015||2015-09-01|October 2016|2016-10-01||||August 2017|Anticipated|2017-08-01||Observational|||Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units|Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units|Recruiting||N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:41:27.395023|2017-10-10 21:41:27.395023
NCT02934568|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-14|||December 15, 2016|Actual|2016-12-15|September 2017|2017-09-01|April 27, 2022|Anticipated|2022-04-27|April 27, 2022|Anticipated|2022-04-27||Interventional|||Ribociclib (LEE011) Rollover Study for Continued Access|An Open-label, Multi-center Rollover Protocol for Patients Who Have Participated in a Novartis-sponsored Ribociclib (LEE011) Study and Are Continuing to Benefit From Ribociclib as Single Agent or in Combination With Other Investigational Treatments|Recruiting||Phase 2|40|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:41:27.461902|2017-10-10 21:41:27.461902
NCT02934555|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-03-03|||March 2016||2016-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest|Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest|Recruiting||Phase 2|48|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-10 21:41:27.562069|2017-10-10 21:41:27.562069
NCT02934542|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-09-03|||September 2016||2016-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of Laparoscopic Procedures With and Without the Aid of the AutoLap System- a Robotic Camera Holder|Comparison of Laparoscopic Procedures With and Without the Aid of the AutoLap System- a Robotic Camera Holder|Recruiting||N/A|100|Anticipated|M.S.T. Medical Surgery Technology LTD.||2|||f||||f||||||||||2017-10-10 21:41:27.652406|2017-10-10 21:41:27.652406
NCT02934529|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-10-13|||March 2015||2015-03-01|October 2016|2016-10-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|AIO-KRK-0114||Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab|A Randomised Study to Assess the Efficacy of Cetuximab Rechallenge in Patients With Metastatic Colorectal Cancer (RAS Wild-type) Responding to First-line Treatment With FOLFIRI Plus Cetuximab|Recruiting||Phase 3|550|Anticipated|Ludwig-Maximilians - University of Munich||5|||f||||f||||||||||2017-10-10 21:41:27.735393|2017-10-10 21:41:27.735393
NCT02934516|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||December 2016||2016-12-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PLUS||Push With Lower Uterine Segment Support|Delivery of Impacted Fetal Head During Cesarean Section for Obstructed Labor: Push Method Versus Abdominal Disimpaction With Lower Uterine Segment Support|Not yet recruiting||N/A|66|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:41:27.874794|2017-10-10 21:41:27.874794
NCT02934503|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-31|||December 12, 2016|Actual|2016-12-12|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)|A Phase II Study of Pembrolizumab and Dynamic PD-L1 Expression in Extensive Stage Small Cell Lung Cancer (SCLC)|Recruiting||Phase 2|60|Anticipated|New York University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 21:41:27.970079|2017-10-10 21:41:27.970079
NCT02934490|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-01-11|||January 2009||2009-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||The Effect of New-style Vaginal Repair Mesh in the Treatment of Female Stress Urinary Incontinence||Recruiting||N/A|316|Anticipated|Jinan Military General Hospital||1|||f||||||||||||||2017-10-10 21:41:28.069984|2017-10-10 21:41:28.069984
NCT02934477|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-07-27|||November 2016||2016-11-01|July 2017|2017-07-01|October 2027|Anticipated|2027-10-01|November 2026|Anticipated|2026-11-01||Observational|||Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis|Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis|Recruiting||N/A|650|Anticipated|Center for International Blood and Marrow Transplant Research|||2||f||||f||||||||||2017-10-10 21:41:28.1387|2017-10-10 21:41:28.1387
NCT02934464|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-12-28|||December 2016||2016-12-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|ARMANI||Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers: the ARMANI Phase III Trial|Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers: the ARMANI Phase III Trial|Recruiting||Phase 3|280|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||No||2017-10-10 21:41:28.258443|2017-10-10 21:41:28.258443
NCT02934451|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||August 2016||2016-08-01|October 2016|2016-10-01|July 2025|Anticipated|2025-07-01|July 2020|Anticipated|2020-07-01||Observational|||Dental Malocclusion and Craniofacial Development in OI|Dental Malocclusion and Craniofacial Development in OI|Recruiting||N/A|50|Anticipated|Baylor College of Medicine|||1||f||||t||||||||No|The clinical information collected for this study will be stored in a computer database at the Data Management and Coordinating Center at the University of South Florida in Tampa, FL and also sent to a Federal data repository. A data repository provides a way for researchers to store the information collected during the research study for future research studies. The data management center uses several layers of protection for the clinical data stored in its computer database. It meets all of the local and federal security requirements for research datacenters. Information is stored only using a study identification number. Only the investigators and the study staff who collect and enter study data will have access to the key which links the identification number to the participant.|2017-10-10 21:41:28.369429|2017-10-10 21:41:28.369429
NCT02934438|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Neo40 on PAD|The Effects of an Oral Nitric Oxide Lozenge on Peripheral Artery Disease|Not yet recruiting||N/A|30|Anticipated|HumanN||2|||f||||f||||||||Undecided||2017-10-10 21:41:28.48946|2017-10-10 21:41:28.48946
NCT02934425|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-03-22|||August 2016||2016-08-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effects of Lean Pork, High Protein Breakfast on Satiety and Metabolic Health in Pre-diabetes|A Randomized, Controlled, Crossover Trial to Assess the Effects of a Lean Pork-containing, High-protein Breakfast on Indices of Satiety and Metabolic Health in Men and Women With Pre-diabetes|Completed||N/A|22|Actual|Midwest Center for Metabolic and Cardiovascular Research||2|||f||||f||||||||No||2017-10-10 21:41:28.566687|2017-10-10 21:41:28.566687
NCT02934412|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-01-04|||August 2016||2016-08-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||A Study of SHR-1314 in Healthy Subjects|A Phase I, Randomized, Double-blind, Placebo-controlled, Single Dose Escalation Study to Investigate Safety and Pharmacokinetics of SHR-1314 in Healthy Subjects|Recruiting||Phase 1|40|Anticipated|Atridia Pty Ltd.||5|||f||||f||||||||No||2017-10-10 21:41:28.646781|2017-10-10 21:41:28.646781
NCT02934399|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|ultradian||Dynamic Hormone Diagnostics in Endocrine Disease|Dynamic Hormone Diagnostics (Ultradian)|Not yet recruiting||Phase 2/Phase 3|350|Anticipated|Haukeland University Hospital|||7||f||||f||||||Samples Without DNA|"     Subcutaneous fluid/dialysate, saliva samples, urine samples and blood samples   "|No||2017-10-10 21:41:28.747511|2017-10-10 21:41:28.747511
NCT02934386|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-02-06|||October 2016||2016-10-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|WBPS||WBPS A Prospective, Method Comparison, Proof of Concept Study|Validation of the WBPS - Wrist Blood Pressure System A Prospective, Method Comparison, Proof of Concept Study|Recruiting||N/A|50|Anticipated|Centre Suisse d'Electronique et Microtechnique SA||1|||f||||t||||||||No||2017-10-10 21:41:28.920602|2017-10-10 21:41:28.920602
NCT02934373|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-11-15||||||November 2016|2016-11-01||||November 2016|Actual|2016-11-01||Interventional|||Evaluation of Subjective Ratings on a New Sound Processor and Compatible Products|Evaluation of Subjective Ratings on a New Sound Processor and Compatible Products|Withdrawn||N/A|0|Actual|Cochlear||2|||f||||f||||||||No||2017-10-10 21:41:29.098472|2017-10-10 21:41:29.098472
NCT02934360|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-09|||September 2016||2016-09-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||TR(ACE) Assay Clinical Specimen Study|Evaluation of the TR(ACE) Assay for the Ability to Aid in Monitoring Disease Progress, Response to Therapy or for Recurrent or Residual Disease for Patients With Previously Diagnosed Cancers (Stage III and IV Lung and Stage IV Breast)|Recruiting||N/A|450|Anticipated|Biological Dynamics|||2||f||||f||||||Samples With DNA|"     Plasma specimens will be collected prospective and tested retrospectively   "|||2017-10-10 21:41:29.184093|2017-10-10 21:41:29.184093
NCT02934347|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-04-05|2016-10-17||February 2012||2012-02-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Observational|||Comparison of Glottic Views and Intubation Times in the Supine and 25 Degree Back-up Positions|Comparison of Glottic Views and Intubation Times in the Supine and 25 Degree Back-up Positions|Completed||N/A|781|Actual|Betsi Cadwaladr University Health Board|"The present study was under-powered to detect small differences in glottic views.
There would be additional variation as the results were reported by the whole Anaesthetic Dept rather than a few investigators"||2||f||||f||||||||Yes|Publish anonymised raw data as supplementary file|2017-10-10 21:41:29.374963|2017-10-10 21:41:29.374963
NCT02934334|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-12-16|||June 2016||2016-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CBN-Well||Wellness Monitoring for Major Depressive Disorder|A Collaborative Investigation of Predictors of Relapse in Major Depressive Disorder: CAN-BIND-1 Extension Study|Enrolling by invitation||N/A|100|Anticipated|University Health Network, Toronto|||1||f||||t||||||Samples With DNA|"     At each 8 week visit, blood samples for biochemical, genomic, and proteomic analysis will be     collected and stored at -80'C freezer.      Plasma: Venous blood will be collected in 6mL and 10ml EDTA blood tubes, followed by     centrifugation in a refrigerated centrifuge to obtain the plasma. Two milliliters of plasma     from each tube will be divided into 8 cryovials (500µL).      DNA for methylation analysis: Venous blood will be collected in 8.5 mL PAXgene DNA tubes.      DNA for studying histone modifications: Venous blood will be collected in 6mL EDTA blood     tubes and the mixed contents will be divided evenly into three 2 mL screw-cap tubes.      RNA for mRNA and miRNA sequencing: Venous blood will be collected in 6mL EDTA blood tubes and     the mixed contents will be passed through LeukoLOCK filters according to the manufacturer's     instructions.   "|Yes|"This study is funded in part by the Ontario Brain Institute (OBI). Data collected from this study is entered into a research database called Brain-CODE, deployed at a High Performance Computer Virtual Lab (HPCVL). The HPCVL supports the regulatory-compliant (e.g., 21 CRF Part 11, HIPAA, PIPEDA) processes for securing privacy of healthcare data."|2017-10-10 21:41:29.948486|2017-10-10 21:41:29.948486
NCT02934321|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-09-18|||September 18, 2017|Actual|2017-09-18|September 2017|2017-09-01|August 29, 2019|Anticipated|2019-08-29|August 29, 2018|Anticipated|2018-08-29||Interventional|||Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage|Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage|Recruiting||N/A|25|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 21:41:30.074442|2017-10-10 21:41:30.074442
NCT02934308|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||September 2015||2015-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ICUPAIN||Comparison of the Skin Conductance Values and Patient Pain Scores During Minor Procedures in the ICU|Comparison of the Skin Conductance Values and Patient Pain Scores During Minor Procedures in the ICU|Recruiting||N/A|60|Anticipated|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:41:30.178249|2017-10-10 21:41:30.178249
NCT02934295|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-01-31|||February 2012||2012-02-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|ImmRubVac||Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies|Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies|Completed||N/A|192|Actual|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:41:30.273387|2017-10-10 21:41:30.273387
NCT02934282|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-05-22||||||May 2017|2017-05-01||||||||Expanded Access|||HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option|Expanded Access Protocol Using HBOC-201|Available||N/A|||University of Miami|||||f||||||||||||||2017-10-10 21:41:30.359935|2017-10-10 21:41:30.359935
NCT02934269|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-01-11|||November 2016||2016-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 in Healthy Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 in Healthy Subjects|Recruiting||Phase 1|40|Anticipated|Celgene||6|||f||||f||||||||||2017-10-10 21:41:30.437105|2017-10-10 21:41:30.437105
NCT02934256|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-02-07|||July 2016||2016-07-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|Icotinib||Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors|Icotinib Hydrochloride Tablets Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors|Recruiting||Phase 2|20|Anticipated|Beijing Tiantan Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:41:30.537165|2017-10-10 21:41:30.537165
NCT02934243|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-06-29|||July 1, 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|July 1, 2017|Anticipated|2017-07-01||Observational|||Identification of Risk Factors Causing Difficulty in Laryngeal Mask Insertion|Identification of Risk Factors Causing Difficulty in Laryngeal Mask Insertion|Not yet recruiting||N/A|1664|Anticipated|Azienda Ospedaliero-Universitaria Careggi|||2||f||||t||||||||Yes||2017-10-10 21:41:30.659164|2017-10-10 21:41:30.659164
NCT02934230|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-03-13|||January 5, 2017|Actual|2017-01-05|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|||The Prehabilitation Study: Exercise Before Surgery to Improve Patient Function in People|The Prehabilitation Study: Exercise Before Surgery to Improve Patient Function in People|Recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||No||2017-10-10 21:41:30.786802|2017-10-10 21:41:30.786802
NCT02934217|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||March 2014||2014-03-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|CIRCUS II||Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study|Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study|Recruiting||Phase 3|868|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 21:41:30.902747|2017-10-10 21:41:30.902747
NCT02934204|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||February 2016||2016-02-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma|Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma|Recruiting||Phase 2|51|Anticipated|Guangdong General Hospital||1|||f||||t||||||||No||2017-10-10 21:41:31.036064|2017-10-10 21:41:31.036064
NCT02934178|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-10|||November 2016||2016-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Shigella WRSS1 Vaccine Trial in Bangladesh|A Phase 1 Randomized, Double-Blinded, Placebo-controlled, Dose-Escalation Study to Assess the Safety, Tolerability and Immunogenicity of Live Attenuated, Oral Shigella WRSS1 Vaccine in Bangladeshi Toddlers (12 to 24 Months Old)|Recruiting||Phase 1|64|Anticipated|PATH||4|||f||||t||||||||||2017-10-10 21:41:31.24655|2017-10-10 21:41:31.24655
NCT02934152|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication|Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication|Not yet recruiting||Phase 4|400|Anticipated|National Taiwan University Hospital||3|||f||||f||||||||No||2017-10-10 21:41:31.432442|2017-10-10 21:41:31.432442
NCT02934139|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-01-27|||October 2016||2016-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|(SNO-9)||MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9)|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of N91115 in Healthy Subjects|Completed||Phase 1|32|Actual|Nivalis Therapeutics, Inc.||5|||f||||f||||||||No||2017-10-10 21:41:31.529723|2017-10-10 21:41:31.529723
NCT02934126|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|December 28, 2016|Actual|2016-12-28|December 28, 2016|Actual|2016-12-28||Observational|M16SDM||The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer|The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer|Completed||N/A|15|Actual|The Netherlands Cancer Institute|||1||f||||f||||||||||2017-10-10 21:41:31.624146|2017-10-10 21:41:31.624146
NCT02934113|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||September 2016||2016-09-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||"Working for You Workplace Obesity Intervention"|Worksite Interventions to Reduce Obesity and Diabetes Risk in Low SES Populations|Recruiting||N/A|1200|Anticipated|Washington University School of Medicine||3|||f||||t||||||||Yes|Investigators will add data to the NIDDK data repository and share it in accordance with the NIDDK data sharing policy upon conclusion of the study.|2017-10-10 21:41:31.696366|2017-10-10 21:41:31.696366
NCT02934100|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-12|||August 2016||2016-08-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur|Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur|Recruiting||N/A|120|Anticipated|Medical Universtity of Lodz||4|||f||||f||||||||||2017-10-10 21:41:31.779022|2017-10-10 21:41:31.779022
NCT02934087|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2016-10-12|||August 2011||2011-08-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|EVAR||Endovascular Aneurysm Repair (EVAR) Gate Study|Evaluation of a Randomized Comparison of Direct Versus Snare Techniques for Cannulation of Contralateral Gate During an Endovascular Aneurysm Repair (EVAR) Procedure|Completed||N/A|102|Actual|Minneapolis Heart Institute Foundation||2|||f||||t||||||||Undecided||2017-10-10 21:41:31.882893|2017-10-10 21:41:31.882893
NCT02934074|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01|20 Days|Observational [Patient Registry]|||Relationship Between Gait Variability and Sensation|Investigating the Relationship Between Gait Variability and Related Factors in Individuals With Lower Limb Loss|Not yet recruiting||N/A|20|Anticipated|Hacettepe University|||1||f||||||||||||||2017-10-10 21:41:31.957135|2017-10-10 21:41:31.957135
NCT02934061|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-15|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Study to Assess the Efficacy and Safety of Tizaspray® Versus Sirdalud®, in Patients With Acute Low Back Pain|A Phase III, Multicenter, Randomized Study to Assess the Efficacy and Safety of 0,5 mg Tizaspray® Administered Intranasally Versus Sirdalud® 2 mg Tablets, in Patients With Acute Low Back Pain|Completed||Phase 3|117|Actual|MDM S.p.A.||2|||f||||f|f|f||||||Yes||2017-10-10 21:41:32.021717|2017-10-10 21:41:32.021717
NCT02934048|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection||Not yet recruiting||Phase 4|700|Anticipated|Shandong University||3|||f||||t||||||||||2017-10-10 21:41:32.107827|2017-10-10 21:41:32.107827
NCT02934035|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-14|||September 2016||2016-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder||Active, not recruiting||N/A|10000|Anticipated|University Medical Center Groningen|||2||f||||f||||||||No||2017-10-10 21:41:32.186162|2017-10-10 21:41:32.186162
NCT02934022|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-10-13|||June 2012||2012-06-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients|Adding Maraviroc to the HAART Regimen of HIV-infected Patients Who Are Well Controlled, and the Effect on CD4 Lymphocyte Counts|Completed||N/A|25|Actual|Southern California Institute for Research and Education||1|||f||||f||||||||||2017-10-10 21:41:32.263607|2017-10-10 21:41:32.263607
NCT02934009|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-07-03|||October 2016|Actual|2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SHN||Dermal Profile Analysis Using the NMR-MOUSE|Dermal Profile Analysis Using NMR-MOUSE (Nuclear Magnetic Resonance - Mobile Universal Surface Explorer)|Recruiting||Phase 2|85|Anticipated|RWTH Aachen University||2|||f||||f|f|f||||||||2017-10-10 21:41:32.341265|2017-10-10 21:41:32.341265
NCT02933996|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Perioperative TEAS to Improve Post Cardiac Surgery Immunosuppression: A Randomized Controlled Clinical Trial|Perioperative TEAS to Improve Post Cardiac Surgery Immunosuppression: A Randomized Controlled Clinical Trial|Recruiting||N/A|90|Anticipated|ShuGuang Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:41:32.426934|2017-10-10 21:41:32.426934
NCT02933983|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-10-13|||May 2015||2015-05-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|ProCure||Microbiota Upper Respiratory Tract|Study of the Microbiota and the Potential of Probiotics for Chronic Rhinosinusitis|Recruiting||N/A|200|Anticipated|University Hospital, Antwerp|||2||f||||f||||||||No||2017-10-10 21:41:32.510359|2017-10-10 21:41:32.510359
NCT02933047|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-10-11|||October 2013||2013-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|LH||Laparoscopic Hysterectomy - Outpatient Versus Inpatient Regimen|Laparoscopic Hysterectomy - A Randomized Controlled Trial on Outpatient Versus Inpatient Regimen|Completed||N/A|204|Actual|University of Aarhus||2|||f||||t||||||||No||2017-10-10 21:41:41.783962|2017-10-10 21:41:41.783962
NCT02933970|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2017-04-25|||February 28, 2017|Actual|2017-02-28|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Comparison of Telemedicine to Usual Care for HCV Management for Methadone-maintained Individuals|Stepped-Wedge Randomized Control Trial to Compare Integrated, Co-located, Telemedicine-based HCV Management for Individuals on Opiate Agonist Treatment Versus Usual Care Treatment of HCV of Individuals on Opiate Agonist Treatment|Recruiting||N/A|624|Anticipated|State University of New York at Buffalo||2|||f||||t|f|f||||||Yes|At the completion of the study, the data will be filed with the Patient-Centered Outcomes Research Institute and will be publicly availability.|2017-10-10 21:41:32.581862|2017-10-10 21:41:32.581862
NCT02933957|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-13|||January 2015||2015-01-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Observational|CASE-SMS||Chinese Arteriosclerosis Series Evaluation-She Minority Study||Recruiting||N/A|300|Anticipated|Peking University Shougang Hospital|||1||f||||||||||||||2017-10-10 21:41:32.675868|2017-10-10 21:41:32.675868
NCT02933944|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-03-16|||September 2016||2016-09-01|March 2017|2017-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Recurrent Oncogenic RAS Exon 2 Mutant Rectal Cancer|A Non-Randomised Open-Label Phase Ib Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Recurrent Oncogenic RAS Exon 2 Mutant Rectal Cancer|Recruiting||Phase 1|20|Anticipated|Targovax ASA||1|||f||||||||||||||2017-10-10 21:41:32.749664|2017-10-10 21:41:32.749664
NCT02933931|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-06-08|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Observational|||Immune Durability After VSV-EBOV Vaccination|Long-term Immune Durability After Vaccination With the Vesicular Stomatitis Virus-vectored Zaire Ebola Candidate Vaccine (VSV-EBOV): a Prospective Observational Cohort Study|Enrolling by invitation||N/A|100|Anticipated|University Hospital, Geneva|||3||f||||f||||||Samples Without DNA|"     whole blood (RNA preservation)   "|No||2017-10-10 21:41:32.866387|2017-10-10 21:41:32.866387
NCT02933918|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-12|||November 2016||2016-11-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety of Intranasal Irrigation Probiotics in Healthy Volunteers|Safety of Intranasal Irrigation Probiotics in Healthy Volunteers|Not yet recruiting||Phase 1|40|Anticipated|Probionase Therapies Inc.||1|||f||||f||||||||No||2017-10-10 21:41:32.930999|2017-10-10 21:41:32.930999
NCT02933905|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-14|||January 2014||2014-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|January 2015|Actual|2015-01-01||Observational|||Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection||Completed||N/A|38|Actual|Fundació Institut Germans Trias i Pujol|||2||f||||t||||||||||2017-10-10 21:41:33.02617|2017-10-10 21:41:33.02617
NCT02933892|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|RADIAL-CKD||Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization|Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization, A Single Center Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Texas Tech University Health Sciences Center||2|||f||||t||||||||Yes|Yes, the research group may be potentially interested in sending data for further analyses.|2017-10-10 21:41:33.08753|2017-10-10 21:41:33.08753
NCT02933879|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-17|||March 21, 2016|Actual|2016-03-21|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|February 15, 2018|Anticipated|2018-02-15||Interventional|||Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study|A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical Study to Assess the Efficacy, Safety and Tolerability Patients With Mild to Moderate Onychomycosis|Recruiting||Phase 2|180|Anticipated|Taro Pharmaceuticals USA||2|||f||||f||||||||||2017-10-10 21:41:33.326429|2017-10-10 21:41:33.326429
NCT02933866|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-03|||March 11, 2016|Actual|2016-03-11|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis|A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS Topical Product in Patients With Mild to Severe Scalp Psoriasis|Active, not recruiting||Phase 3|370|Actual|Taro Pharmaceuticals USA||2|||f||||f||||||||No||2017-10-10 21:41:33.457497|2017-10-10 21:41:33.457497
NCT02933853|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-07-26|||December 22, 1956|Actual|1956-12-22|July 2017|2017-07-01|October 14, 2017|Anticipated|2017-10-14|October 14, 2017|Anticipated|2017-10-14||Interventional|||A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus|This Trial is Conducted in Europe. The Aim of This Trial is to Investigate Pharmacokinetic (the Exposure of the Trial Drug in the Body) and Pharmacodynamic (the Effect of the Investigated Drug on the Body) Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus|Recruiting||Phase 1|60|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 21:41:33.571082|2017-10-10 21:41:33.571082
NCT02933840|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||January 2017||2017-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Using a Remote Patient Monitoring Alert System to Improve Care|Using a Remote Patient Monitoring Alert System to Improve Care in Geriatric Orthopedic Trauma Patients|Not yet recruiting||N/A|1200|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 21:41:33.674922|2017-10-10 21:41:33.674922
NCT02933827|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||December 2016||2016-12-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease|A Phase I/II Study to Evaluate the Safety and Efficacy of Allogeneic Infusion of Adipose-Derived Stem Cells in Moderate to Severe Chronic Kidney Disease|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|UnicoCell Biomed CO. LTD||3|||f||||t||||||||Undecided||2017-10-10 21:41:33.796326|2017-10-10 21:41:33.796326
NCT02933814|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Liposomal Bupivacaine in Ambulatory Hand Surgery|Liposomal Bupivacaine in Ambulatory Hand Surgery|Not yet recruiting||Phase 4|40|Anticipated|Loma Linda University||2|||f||||f||||||||No||2017-10-10 21:41:33.921644|2017-10-10 21:41:33.921644
NCT02933034|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-12-12|||April 2015||2015-04-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury||Recruiting||Phase 1/Phase 2|70|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 21:41:41.873497|2017-10-10 21:41:41.873497
NCT02933801|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-08-11|||March 10, 2017|Actual|2017-03-10|August 2017|2017-08-01|December 2024|Anticipated|2024-12-01|December 2018|Anticipated|2018-12-01||Interventional|||ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.|ODM-201 Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Previously Treated With One Novel Hormonal Agent First Line and Non-progressive Disease After Second Line Treatment With a Taxane: A Multicenter Randomized Double-blind Placebo-controlled Phase II Trial.|Recruiting||Phase 2|88|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||f|f|f||||||||2017-10-10 21:41:34.012947|2017-10-10 21:41:34.012947
NCT02933788|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients|Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients|Not yet recruiting||Phase 4|116|Anticipated|Kangbuk Samsung Hospital||2|||f||||t||||||||No||2017-10-10 21:41:34.20535|2017-10-10 21:41:34.20535
NCT02933775|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|April 2018|Anticipated|2018-04-01||Interventional|||CD19-redirected Autologous Cells (CAR-CD19 T Cells)|Autologous T Cells With a Chimeric Antigen Receptor in Patients With CD19-positive Malignant B Cell Leukemia and Lymphoma|Not yet recruiting||Phase 1|45|Anticipated|RenJi Hospital||1|||f||||t||||||||||2017-10-10 21:41:34.340257|2017-10-10 21:41:34.340257
NCT02933762|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-01-13|||September 2016||2016-09-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma|An Exploratory, Single-Blind, Placebo-Controlled, Randomized, Single- and Multiple-Dose Pharmacodynamics Study in Healthy Subjects to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma|Completed||Phase 1|25|Actual|Janssen Research & Development, LLC||13|||f||||f||||||||||2017-10-10 21:41:34.472961|2017-10-10 21:41:34.472961
NCT02933749|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-13|||November 2016||2016-11-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effects of the Prone and the Sitting Positions on the Brain Oxygenation in Posterior Fossa Surgery|Effects of the Prone and the Sitting Positions on the Brain Oxygenation in Posterior Fossa Surgery|Not yet recruiting||N/A|62|Anticipated|Istanbul University||2|||f||||f||||||||Yes||2017-10-10 21:41:34.604215|2017-10-10 21:41:34.604215
NCT02933736|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-01-04|||October 2016||2016-10-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients|A Phase 0/II Study of Ribociclib (LEE011) in Preoperative Rb-Positive Recurrent High-Grade Glioma and Meningioma Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration|Recruiting||Early Phase 1|48|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||1|||f||||t||||||||No||2017-10-10 21:41:34.695647|2017-10-10 21:41:34.695647
NCT02933723|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Immunogenicity of Influenza Vaccine in Long Term Care|Comparison of Immunogenicity of Adjuvanted and Non-Adjuvanted Influenza Vaccination in a Long-Term Care Population|Recruiting||Phase 4|200|Anticipated|Insight Therapeutics, LLC||2|||f||||f||||||||No||2017-10-10 21:41:34.794686|2017-10-10 21:41:34.794686
NCT02933710|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-07-27|||October 7, 2016|Actual|2016-10-07|July 2017|2017-07-01|November 29, 2018|Anticipated|2018-11-29|November 29, 2018|Anticipated|2018-11-29||Observational|||Postmarketing Surveillance Study for IMOJEV® in Republic of Korea|Postmarketing Surveillance Study for a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Republic of Korea|Recruiting||N/A|632|Anticipated|Sanofi|||1||f||||f|f|f|||t|||||2017-10-10 21:41:34.906572|2017-10-10 21:41:34.906572
NCT02933697|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-07-20|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|AXADIA||Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)|A Safety Study Assessing Oral Anticoagulation With Apixaban Versus Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment|Recruiting||Phase 3|222|Anticipated|German Atrial Fibrillation Network||2|||f||||t|f|f||||||||2017-10-10 21:41:34.994242|2017-10-10 21:41:34.994242
NCT02933684|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-02-27|||January 2018|Anticipated|2018-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|||D-Cycloserine and Virtual Reality Exposure Therapy|D-Cycloserine and Virtual Reality Exposure Therapy Delivered on an iPad: Increasing Access to Treatment for Social Anxiety Disorder|Not yet recruiting||Phase 2|34|Anticipated|Georgia State University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:41:35.12684|2017-10-10 21:41:35.12684
NCT02933671|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-02|||August 1, 2017|Actual|2017-08-01|July 2017|2017-07-01|January 2, 2018|Anticipated|2018-01-02|January 1, 2018|Anticipated|2018-01-01||Interventional|||Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty|Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty|Recruiting||Phase 4|40|Anticipated|Duke University||2|||f||||f|t|f|||f|||||2017-10-10 21:41:35.254272|2017-10-10 21:41:35.254272
NCT02933658|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-12|||November 2015||2015-11-01|October 2016|2016-10-01||||November 2015|Actual|2015-11-01||Interventional|||Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers||Completed||Phase 1|71|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 21:41:35.374011|2017-10-10 21:41:35.374011
NCT02933645|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-10-12|||April 2016||2016-04-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NASO-PET||Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity|Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity|Recruiting||N/A|10|Anticipated|Turku University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:41:35.455114|2017-10-10 21:41:35.455114
NCT02933632|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-09-10|||August 2013||2013-08-01|September 2017|2017-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|ARTHA||Accelerated Rehabilitation in Hip Arthroplasty|Accelerated Rehabilitation Versus Conventional Rehabilitation in Total Hip Arthroplasty: A Randomized Double Blinded Clinical Trial|Completed||N/A|48|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 21:41:35.598581|2017-10-10 21:41:35.598581
NCT02933593|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-03-03|||August 2016||2016-08-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols|Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols|Withdrawn||N/A|0|Actual|St. Louis University||3||PI withdrew the protocol|f||||f||||||||No||2017-10-10 21:41:35.886137|2017-10-10 21:41:35.886137
NCT02933580|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-03-10|||October 12, 2016|Actual|2016-10-12|March 2017|2017-03-01|February 4, 2017|Actual|2017-02-04|February 4, 2017|Actual|2017-02-04||Interventional|||A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-56136379 in Healthy Japanese Adult Participants|A Double-blind, Placebo-controlled, Randomized, Phase 1, Single Ascending Dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-56136379 in Healthy Japanese Adult Subjects|Completed||Phase 1|39|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-10 21:41:35.961417|2017-10-10 21:41:35.961417
NCT02933554|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-07-02|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis|A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization, to Promote Short-term Weight Loss in Obese Patients With Nonalcoholic Steatohepatitis (NASH) and Thereby Improve NASH|Not yet recruiting||N/A|8|Anticipated|St. Louis University||1|||f||||t|f|t|f|f||||||2017-10-10 21:41:36.100431|2017-10-10 21:41:36.100431
NCT02933541|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-07|||September 2016||2016-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|||Central Arterial Pressure Changes With Use of Regional Anesthesia in Obstetric Patients|Central Arterial Pressure Changes With Use of Regional Anesthesia in Obstetric Patients|Enrolling by invitation||N/A|1000|Anticipated|St. Louis University|||1||f||||f|f|f||||||||2017-10-10 21:41:36.198464|2017-10-10 21:41:36.198464
NCT02933528|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-03|||July 11, 2016|Actual|2016-07-11|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS|An Open-Label, Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS in Patients With Moderate to Severe Scalp Psoriasis|Recruiting||Phase 2|20|Anticipated|Taro Pharmaceuticals USA||1|||f||||f||||||||No||2017-10-10 21:41:36.247821|2017-10-10 21:41:36.247821
NCT02933515|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-12|||July 2014||2014-07-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MY-OT||Merging Yoga and Group OT (MY-OT) to Improve Balance and Decrease Fall Risk After Stroke|Merging Yoga and Group OT (MY-OT)|Completed||Phase 1|14|Actual|Colorado State University||1|||f||||f||||||||No||2017-10-10 21:41:36.342344|2017-10-10 21:41:36.342344
NCT02933502|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-03|||July 11, 2016|Actual|2016-07-11|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product|An Open-label, Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS 1538b Topical Product Applied Once-daily in Patients With Moderate to Severe Scalp Psoriasis|Recruiting||Phase 2|10|Anticipated|Taro Pharmaceuticals USA||1|||f||||f||||||||No||2017-10-10 21:41:36.417132|2017-10-10 21:41:36.417132
NCT02933476|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-01-09|||May 2016||2016-05-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Vibrotactile Stimulation in Parkinson's Disease|Vibrotactile Stimulation in Parkinson's Disease|Completed||N/A|5|Actual|Stanford University||1|||f||||f||||||||No||2017-10-10 21:41:36.604311|2017-10-10 21:41:36.604311
NCT02933463|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01||||August 2017|Anticipated|2017-08-01||Interventional|||Clinical Effectiveness of Embrace Wetbond and Clinpro as Pits and Fissure Sealants in Young Permanent Molars|Clinical Effectiveness of Embrace Wetbond and Clinpro as Pits and Fissure Sealants in Young Permanent Molars, Randomized Clinical Trial|Not yet recruiting||N/A|32|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:41:36.680964|2017-10-10 21:41:36.680964
NCT02933450|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-05-05|||August 2016||2016-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)|Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)|Recruiting||Phase 4|30|Anticipated|Baylor College of Medicine||2|||f||||f||||||||Yes|Data will be coded and shared with the sponsor|2017-10-10 21:41:36.760899|2017-10-10 21:41:36.760899
NCT02933437|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-08|||September 26, 2017|Anticipated|2017-09-26|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||The Response To Ajmaline Provocation in Healthy Subjects|An Observational Study Into the Variety of Electrocardiographic Responses to an Ajmaline Provocation in a Healthy Subjects. What Are the Genetic and Structural Variations Dictating This Response ?|Not yet recruiting||Phase 2|100|Anticipated|St George's, University of London||1|||f||||f|f|f||||||||2017-10-10 21:41:36.83715|2017-10-10 21:41:36.83715
NCT02933424|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-23|||September 2016||2016-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|||Project Plant Protein: the P3 Study in Humans|The Effects of Plant Proteins on Blood Glucose & Amino Acid Levels and Satiety in Humans|Active, not recruiting||N/A|20|Actual|Clinical Nutrition Research Centre, Singapore||4|||f||||f||||||||||2017-10-10 21:41:36.944892|2017-10-10 21:41:36.944892
NCT02931578|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-12-05|||October 2016||2016-10-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Glycemic Index of Commonly Consumed Sweeteners|Glycemic Index of Commonly Consumed Sweeteners|Recruiting||N/A|20|Anticipated|Yale University||3|||f||||f||||||||Undecided||2017-10-10 21:41:57.070495|2017-10-10 21:41:57.070495
NCT02933411|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-07-20|||January 5, 2017||2017-01-05|July 2017|2017-07-01|November 2025|Anticipated|2025-11-01|November 2019|Anticipated|2019-11-01||Observational|Low VWF||Low VW Activity in Adolescent HMB|Genotypic and Phenotypic Analysis of Adolescents With Heavy Menstrual Bleeding and Low Von Willebrand Activity|Recruiting||N/A|125|Anticipated|Baylor College of Medicine|||1||f||||f||||||Samples With DNA|"     Blood sample will be drawn to assess the number of participants enrolled that have heavy     menstrual bleeding and low von willebrand activity disease causing sequence variation in the     von willebrand factor gene and other genes affecting bleeding, clotting and blood vessel     biology.   "|||2017-10-10 21:41:37.022247|2017-10-10 21:41:37.022247
NCT02933398|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-10-14|||January 2017||2017-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|RALPLPNNX||A Trial Comparing - Robotic Assisted Versus Laparoscopic Partial Nephrectomy For Small Renal Masses|A Prospective Randomized Controlled Trial Comparing Two Minimally Invasive Surgical Modalities - Robotic Assisted Vs. Pure Laparoscopic Partial Nephrectomy For Small Renal Masses.|Not yet recruiting||Phase 3|104|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-10 21:41:37.153966|2017-10-10 21:41:37.153966
NCT02933385|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-12|||November 2016||2016-11-01|October 2016|2016-10-01||||October 2019|Anticipated|2019-10-01||Interventional|||Evaluation of the Défi Santé + Program||Not yet recruiting||N/A|500|Anticipated|Université de Montréal||5|||f||||||||||||||2017-10-10 21:41:39.021535|2017-10-10 21:41:39.021535
NCT02933372|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-08-22|||February 2015||2015-02-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|UdallP3||Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease - Proj#3|Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease - Proj#3|Enrolling by invitation||Phase 2|45|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-10 21:41:39.116587|2017-10-10 21:41:39.116587
NCT02933359|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-10-13|||October 2010||2010-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Osteogenic Profiling of Normal Calvarial Bone|Osteogenic Profiling of Normal Calvarial Bone|Recruiting||N/A|50|Anticipated|Children's Hospital of Pittsburgh|||1||f||||f||||||Samples With DNA|"     Bone samples will be collected from bone tissue that would normally be discarded during the     reconstructive surgery, so no additional procedures are needed to collect the bone samples.     Bone marrow tissues will be collected from patients at the time of surgery without any     additional dissection or incisions. Bone will be finely minced and then plated in tissue     culture flasks as previously reported by other groups.      The procedure will not involve any extra incisions or dissection, as these tissues will be     exposed during the reconstructive procedure. At the time of surgery one sample of tissue will     be taken from otherwise discarded bone   "|No|No plan to share data|2017-10-10 21:41:39.200929|2017-10-10 21:41:39.200929
NCT02933346|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-09-28|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Observational|CLINIVO||Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program|Assessment and Follow-up of Patients With Non-small Cell Lung Cancer (NSCLC) Treated With Nivolumab Under the French Temporary Authorization for Use (ATU) Program|Active, not recruiting||N/A|907|Actual|Intergroupe Francophone de Cancerologie Thoracique|||1||f||||f||||||||||2017-10-10 21:41:39.28645|2017-10-10 21:41:39.28645
NCT02933333|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-12|||September 2016||2016-09-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor|G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor: a Prospective, Multicentre, Randomised Controlled Trial|Not yet recruiting||Phase 4|405|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||No||2017-10-10 21:41:39.485221|2017-10-10 21:41:39.485221
NCT02933320|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia|A Cancer Research UK Phase I/IIa Clinical Trial of BI-1206; an Antibody to FcƔRIIB (CD32b), as a Single Agent and in Combination With an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Malignancy|Recruiting||Phase 1/Phase 2|81|Anticipated|Cancer Research UK||3|||f||||f||||||||||2017-10-10 21:41:39.696|2017-10-10 21:41:39.696
NCT02933307|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-04-24|||April 2015|Actual|2015-04-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Continuous Monitoring on the General Ward|Continuous Monitoring of Vital Signs in Hospitalized Patients|Completed||N/A|90|Actual|Radboud University||3|||f||||f||||||||No||2017-10-10 21:41:39.820464|2017-10-10 21:41:39.820464
NCT02933294|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-12|||May 2015||2015-05-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer|Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer: a Multicenter Randomized Controlled Trial|Recruiting||N/A|356|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:41:39.917871|2017-10-10 21:41:39.917871
NCT02933281|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-07|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|A-050||MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa|MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled,Safety, Immunogenicity, and Dose-escalation Study in Adults With and Without Latent Tuberculosis Infection in South Africa|Not yet recruiting||Phase 1/Phase 2|120|Anticipated|Aeras||9|||f||||f|t|f||||||||2017-10-10 21:41:40.047933|2017-10-10 21:41:40.047933
NCT02933268|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-10-12|||September 2016||2016-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|DRINK||A Randomised Feasibility Trial of High Water Intake in Polycystic Kidney Disease|Determining Feasibility of Randomisation to High vs ad Libitum Water Intake in Polycystic Kidney Disease: The DRINK Randomised Feasibility Trial|Not yet recruiting||N/A|50|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||Yes||2017-10-10 21:41:40.177451|2017-10-10 21:41:40.177451
NCT02933255|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-13|2017-10-03|||October 7, 2016||2016-10-07|September 27, 2017|2017-09-27|August 1, 2021|Anticipated|2021-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer|Phase I/II Study of PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer|Recruiting||Phase 1/Phase 2|29|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 21:41:40.289515|2017-10-10 21:41:40.289515
NCT02933242|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-05-30|||November 2016||2016-11-01|May 2017|2017-05-01|October 2023|Anticipated|2023-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases|Phase II Non-randomized Trial of Stereotactic Ablative Radiotherapy (SABR) for Oligometastases|Recruiting||Phase 2|200|Anticipated|British Columbia Cancer Agency||1|||f||||t||||||||No||2017-10-10 21:41:40.407487|2017-10-10 21:41:40.407487
NCT02933229|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|October 2031|Anticipated|2031-10-01|October 2031|Anticipated|2031-10-01||Interventional|||The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study||Not yet recruiting||Phase 4|300|Anticipated|Shandong University||1|||f||||t||||||||No||2017-10-10 21:41:40.516675|2017-10-10 21:41:40.516675
NCT02933216|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-12|||November 2016||2016-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Comparison of the Therapeutic Effects of VR and Hysteroscope + Laparoscope in the Treatment of Cesarean Scar Diverticula|Comparison of the Therapeutic Effects of Vaginal Repair and Hysteroscopic Combined With Laparoscopic Excision in the Treatment of Cesarean Scar Diverticula|Not yet recruiting||N/A|100|Anticipated|Shanghai First Maternity and Infant Hospital|||2||f||||||||||||||2017-10-10 21:41:40.594712|2017-10-10 21:41:40.594712
NCT02933203|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-07-18|||October 2015||2015-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Genetic Biomarkers of Executive Stress|Genetic Biomarkers of Executive Stress|Completed||N/A|51|Actual|Stanford University|||1||f||||t||||||Samples With DNA|"     Saliva or blood samples   "|||2017-10-10 21:41:40.666433|2017-10-10 21:41:40.666433
NCT02933190|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-10-12|||November 2016||2016-11-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy|Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy|Not yet recruiting||N/A|50|Anticipated|Shanghai First Maternity and Infant Hospital||1|||f||||||||||||Undecided||2017-10-10 21:41:40.736467|2017-10-10 21:41:40.736467
NCT02933177|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-22|||May 2016||2016-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effectiveness of Flash Mediation Therapy|Study on Effectiveness of Flash Mediation Therapy in the Context of Acute Psychological and Behavioral Symptoms of Dementia in Nursing Homes|Recruiting||N/A|400|Anticipated|Hospices Civils de Lyon||2|||f||||||||||||||2017-10-10 21:41:40.819525|2017-10-10 21:41:40.819525
NCT02933164|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-19|||October 2016||2016-10-01|May 2017|2017-05-01||||August 2017|Anticipated|2017-08-01||Interventional|||A Feasibility Trial to Evaluate the Senseonics Continuous Glucose Monitoring System in Canada|A Feasibility Trial to Evaluate the Senseonics Continuous Glucose Monitoring System in Canada|Active, not recruiting||N/A|36|Actual|Senseonics, Inc.||1|||f||||||||||||||2017-10-10 21:41:40.911199|2017-10-10 21:41:40.911199
NCT02933151|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|HELPS-HD||Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial)|Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial) An Open-Label Cluster Randomized Pragmatic Trial Evaluating the Effectiveness of Oral Intradialytic Nutritional Supplements on Mortality in Hemodialysis Patients|Enrolling by invitation||N/A|5500|Anticipated|Dialysis Clinic, Inc.||2|||f||||f||||||||No||2017-10-10 21:41:40.980399|2017-10-10 21:41:40.980399
NCT02933138|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||July 2010||2010-07-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|July 2012|Actual|2012-07-01||Observational|||Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia|Systematic Study of Post Herapin Lipoprotein Lipase Activity and Lipoprotein Remodelling in Multifactorial Chylomicronemia|Completed||N/A|62|Actual|Hospices Civils de Lyon|||1||f||||||||||Samples With DNA|"     post-heparin EDTA plasma ADN   "|||2017-10-10 21:41:41.045167|2017-10-10 21:41:41.045167
NCT02933125|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-28|||July 2013||2013-07-01|June 2013|2013-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Group Psychotherapy for Adolescents With Substance Use|Effectiveness of Family-based Group Psychotherapy for Adolescents With Illicit Drug Use|Unknown status|Recruiting|N/A|200|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-10 21:41:41.104558|2017-10-10 21:41:41.104558
NCT02933112|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-06-28|||October 2016||2016-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Workflow Validation of an In-home Auto-titrating Mandibular Positioner|Workflow Validation of an In-home Auto-titrating Mandibular Positioner|Recruiting||N/A|250|Anticipated|Zephyr Sleep Technologies||1|||f||||t||||||||No||2017-10-10 21:41:41.189091|2017-10-10 21:41:41.189091
NCT02933099|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|CINV||Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting|Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting Following High-dose Cisplatin in Nasopharyngeal Carcinoma Patients：a Randomized Phase 3 Trial|Not yet recruiting||Phase 3|300|Anticipated|Wuhan Union Hospital, China||2|||f||||t||||||||Undecided||2017-10-10 21:41:41.400902|2017-10-10 21:41:41.400902
NCT02933073|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-07-18|||November 2016||2016-11-01|July 2017|2017-07-01|October 2026|Anticipated|2026-10-01|October 2026|Anticipated|2026-10-01||Interventional|||Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma|A Phase I Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma|Recruiting||Phase 1|15|Anticipated|UConn Health||1|||f||||t||||||||||2017-10-10 21:41:41.588465|2017-10-10 21:41:41.588465
NCT02933021|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-09-22|||July 2016||2016-07-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)|Understanding Monoclonal Gammopathy of Unknown Significance (MGUS): A Research Study to Investigate the Functional Consequences of Paraprotein Production in MGUS|Recruiting||N/A|1000|Anticipated|Human Antibody Factory Limited|||1||f||||f||||||Samples With DNA|"     Plasma and serum   "|||2017-10-10 21:41:41.969222|2017-10-10 21:41:41.969222
NCT02933008|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-05-09|||December 2016||2016-12-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|August 2021|Anticipated|2021-08-01||Interventional|||Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality|Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality|Recruiting||N/A|324|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No|While study results will be released, individual subject data will remain de-identified.|2017-10-10 21:41:42.112407|2017-10-10 21:41:42.112407
NCT02932995|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|October 2017|Anticipated|2017-10-01||Observational|||DXR Stent for Vascular Healing and Thrombus Formation: OCT Study|Evaluation of DUAL Drug-eluting Stent ( DXR Stent) for Vascular Healing and Thrombus Formation : an Optical Coherence Tomography Study|Not yet recruiting||Phase 4|60|Anticipated|Chung-Ang University|||1||f||||t||||||||No||2017-10-10 21:41:42.212069|2017-10-10 21:41:42.212069
NCT02932982|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-17|||October 2016||2016-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|RaisDiag||Diagnostic Reasoning and Sense of Alarm at Dyspnoea and / or Chest Pain|Diagnostic Reasoning and Sense of Alarm at Dyspnoea and / or Chest Pain|Recruiting||N/A|440|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:41:42.317199|2017-10-10 21:41:42.317199
NCT02932969|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-30|||October 4, 2016|Actual|2016-10-04|May 2017|2017-05-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||Study With Healthy Japanese and Non-Asian Participants With BMS-986231|A Randomized, Double-Blind, Placebo-controlled, Single Continuous Intravenous Infusion Study of BMS-986231 to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy Japanese and Non- Asian Participants|Completed||Phase 1|56|Actual|Bristol-Myers Squibb||3|||f||||f||||||||No||2017-10-10 21:41:42.413936|2017-10-10 21:41:42.413936
NCT02932956|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-01-05|||March 2018||2018-03-01|January 2017|2017-01-01|May 2036|Anticipated|2036-05-01|April 2021|Anticipated|2021-04-01||Interventional|GAP||Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)|Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells as Immunotherapy for Patients With Pediatric Solid Tumors|Not yet recruiting||Phase 1|14|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 21:41:42.50134|2017-10-10 21:41:42.50134
NCT02932943|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-03|||October 15, 2016|Actual|2016-10-15|May 2017|2017-05-01|November 23, 2018|Anticipated|2018-11-23|November 23, 2018|Anticipated|2018-11-23||Interventional|||A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)|A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder|Recruiting||Phase 3|700|Anticipated|Allergan||2|||f||||t|t|f||||||||2017-10-10 21:41:42.607815|2017-10-10 21:41:42.607815
NCT02932930|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Ultrasound Guided Quadratus Lumborum Block for Postoperative Pain in Abdominoplasty|Ultrasound Guided Quadratus Lumborum Block for Postoperative Pain in Abdominoplasty: A Randomized Controlled Study|Recruiting||N/A|30|Anticipated|St Joseph University, Beirut, Lebanon||2|||f||||||||||||||2017-10-10 21:41:42.764134|2017-10-10 21:41:42.764134
NCT02932917|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-19|||June 2016||2016-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||MapMySmoke: Smoking Cessation App With Geospatial Capture|MapMySmoke: Feasibility of a New Quit Cigarette Smoking Mobile Phone Application Using Integrated Geo-positioning Technology, and Motivational Messaging Within Primary Care Setting|Enrolling by invitation||Phase 1|110|Anticipated|University of St Andrews||1|||f||||t||||||||No||2017-10-10 21:41:42.868873|2017-10-10 21:41:42.868873
NCT02932904|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-06-22|||November 21, 2016|Actual|2016-11-21|June 2017|2017-06-01|June 9, 2017|Actual|2017-06-09|June 9, 2017|Actual|2017-06-09||Interventional|||Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers|A Randomized, Double-Blind, Parallel Group, Placebo- and Active-Controlled, Phase 4 Study Evaluating the Effect of Vortioxetine 10 and 20 mg/Day vs Paroxetine 20 mg/Day on Sexual Functioning in Healthy Subjects|Completed||Phase 4|352|Actual|Takeda||4|||f||||f|t|f||||||||2017-10-10 21:41:42.934263|2017-10-10 21:41:42.934263
NCT02932891|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-03|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.|An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS Topical Product in Patients With Atopic Dermatitis|Recruiting||Phase 2|50|Anticipated|Taro Pharmaceuticals USA||1|||f||||f||||||||No||2017-10-10 21:41:43.042294|2017-10-10 21:41:43.042294
NCT02932878|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-05-03|||September 2, 2016|Actual|2016-09-02|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Open Label, Safety Study to Assess the Potential for Adrenal Suppression|An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS Topical Product in Patients With Plaque Psoriasis|Recruiting||Phase 2|50|Anticipated|Taro Pharmaceuticals USA||1|||f||||f||||||||No||2017-10-10 21:41:43.119846|2017-10-10 21:41:43.119846
NCT02932865|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|SemiFluid||Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility|Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility|Recruiting||N/A|60|Anticipated|Turku University Hospital|||3||f||||t||||||Samples With DNA|"     Semen sample Serum sample   "|No||2017-10-10 21:41:43.204239|2017-10-10 21:41:43.204239
NCT02932852|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2016-10-11|||November 2015||2015-11-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|A-ADAS-CT-CD||Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases|Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases|Recruiting||Early Phase 1|12|Anticipated|Vissum, Instituto Oftalmológico de Alicante||3|||f||||t||||||||||2017-10-10 21:41:43.287596|2017-10-10 21:41:43.287596
NCT02932839|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-11|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|IN-MAP||Investigating the Neuronal Bases of Epilepsy With Micro-electrode Arrays in Candidates for Epilepsy Surgery|Investigating the Neuronal Bases of Epilepsy With Micro-electrode Arrays in Patients Who Are Candidates for Epilepsy Surgery|Not yet recruiting||N/A|6|Anticipated|Wyss Center for Bio and Neuroengineering||1|||f||||t||||||||Undecided||2017-10-10 21:41:43.395864|2017-10-10 21:41:43.395864
NCT02932826|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes|Phase 1/ Phase 2 Study of the Therapeutic Effect of Ex-vivo Expanded Umbilical Cord Blood Regulatory T Cells on Autoimmune Diabetes|Recruiting||Phase 1/Phase 2|40|Anticipated|Second Xiangya Hospital of Central South University||2|||f||||||||||||||2017-10-10 21:41:43.477973|2017-10-10 21:41:43.477973
NCT02932813|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|THINK||Translational Health After School Program on Health-Related Knowledge/Behaviors and Exercise Perception|The Effects of a Translational Health After School Program on Health-Related Knowledge/Behaviors and Exercise Perception in Minority Children|Not yet recruiting||N/A|200|Anticipated|University of Miami||2|||f||||f||||||||Yes||2017-10-10 21:41:43.562059|2017-10-10 21:41:43.562059
NCT02932800|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-10-12|||November 2015||2015-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Fixing the Short Stay Central Venous Catheter: Comparison of Two Techniques|Fixing the Short Stay Central Venous Catheter: Comparison of Two Techniques|Recruiting||N/A|62|Anticipated|Universidade do Vale do Sapucai||2|||f||||t||||||||Undecided||2017-10-10 21:41:43.783143|2017-10-10 21:41:43.783143
NCT02932787|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-12|||December 2013||2013-12-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Installing Height-adjustable Workstations on Office Workers Workplace Sitting Time and Productivity|Effects of Installing Height-adjustable Workstations on Occupational Sitting Time and Workplace Productivity in Desk-based Workers|Completed||N/A|32|Actual|Sheffield Hallam University||2|||f||||f||||||||||2017-10-10 21:41:43.874088|2017-10-10 21:41:43.874088
NCT02932774|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-04-19|||March 2001||2001-03-01|April 2017|2017-04-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)|Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Zyrtec® (Cetirizine HCl) Syrup vs. Claritin® (Loratadine) Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 4|683|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||t||||||||Yes||2017-10-10 21:41:43.95346|2017-10-10 21:41:43.95346
NCT02932761|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-11|||November 2016||2016-11-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparison of the Therapeutic Effects of VR and VR + GnRHa in the Treatment of Cesarean Scar Diverticula|Comparison of the Therapeutic Effects of Vaginal Repair and Vaginal Repair Combined With GnRHa in the Treatment of Cesarean Scar Diverticula: a Randomized Clinical Trial|Not yet recruiting||N/A|220|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||t||||||||No||2017-10-10 21:41:44.057521|2017-10-10 21:41:44.057521
NCT02932748|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-07-31|||January 2017||2017-01-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|January 2021|Anticipated|2021-01-01||Interventional|M-DEx||Midwest Diet and Exercise Trial|Weight Management in Rural Communities|Recruiting||N/A|200|Anticipated|University of Kansas||3|||f||||t||||||||||2017-10-10 21:41:44.165673|2017-10-10 21:41:44.165673
NCT02932735|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Efficacy of Probe-based Confocal Laser Endomicroscopy in Staging OLGIM||Not yet recruiting||N/A|30|Anticipated|Shandong University|||1||f||||t||||||||No||2017-10-10 21:41:44.26873|2017-10-10 21:41:44.26873
NCT02932722|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-09-18|||September 2016||2016-09-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Propofol on Cardioprotective Role of Remote Ischemic Preconditioning (RIPC)|Effect of Propofol on Cardioprotective Role of Remote Ischemic Preconditioning (RIPC)|Recruiting||N/A|51|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-10 21:41:44.32939|2017-10-10 21:41:44.32939
NCT02932709|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||January 2010||2010-01-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|EXBRAYAT||Effect of Telephone Follow-up on Repeated Suicide Attempt in Patients|Effect of Telephone Follow-up on Repeated Suicide Attempt in Patients Discharged From an Emergency Psychiatry Department: a Controlled Study|Completed||N/A|876|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-10 21:41:44.42869|2017-10-10 21:41:44.42869
NCT02932696|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-06-16|||May 5, 2017|Actual|2017-05-05|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|TrainStrain||Post Infarction Exercise Effects on Myocardial Function Assessed by 2D Strain Ultrasound|Post Infarction Exercise Training Effects on Systolic and Diastolic Myocardial Function Assessed by 2D Strain Ultrasound|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f|||||f|f||||||||2017-10-10 21:41:44.523439|2017-10-10 21:41:44.523439
NCT02932683|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-13|||October 2015||2015-10-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||MedNav: Improving Neonatal Life Support (NLS)|Mednav: A Randomised Control Trial of Novice Users of Mednav a Neonatal Resuscitation Device at 0 and 7 Weeks Follow up.|Completed||N/A|41|Actual|Chelsea and Westminster NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:41:44.668176|2017-10-10 21:41:44.668176
NCT02932670|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-03-21|||October 2016||2016-10-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Minimum Effective Volume of Lidocaine Costoclavicular Brachial Plexus Block|Minimum Effective Volume of Lidocaine for Ultrasound-Guided Costoclavicular Infraclavicular Brachial Plexus Block|Completed||N/A|60|Actual|McGill University Health Center||2|||f||||f||||||||No||2017-10-10 21:41:44.746057|2017-10-10 21:41:44.746057
NCT02931019|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-05-11|||October 13, 2016|Actual|2016-10-13|May 2017|2017-05-01|January 2, 2017|Actual|2017-01-02|January 2, 2017|Actual|2017-01-02||Interventional|||The Effect of Head Position on the Intubating Condition Using Fiberoptic Bronchoscopy||Completed||N/A|54|Actual|Chonnam National University Hospital||2|||f||||||||||||||2017-10-10 21:42:01.850839|2017-10-10 21:42:01.850839
NCT02932657|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-09|||June 29, 2017|Actual|2017-06-29|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|June 30, 2018|Anticipated|2018-06-30||Observational|MUCO-ART-PLUS||Perceived Impact of Art Therapy in Patients With Cystic Fibrosis and in Professional Interdisciplinary Teams Taking Care of Them.|Perceived Impact of Art Therapy in Patients With Cystic Fibrosis (Adolescents, Adults and Transplanted Not Transplanted) and in Professional Interdisciplinary Teams Taking Care of Them.|Recruiting||N/A|68|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:41:44.824952|2017-10-10 21:41:44.824952
NCT02932644|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-12|||October 1999||1999-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Vitamin D and Cardiovascular Events in Rheumatoid Arthritis|Association Between Baseline Vitamin D Metabolite Levels and Risk of Cardiovascular Events in Rheumatoid Arthritis Patients. A Cohort Study With Patient-record Evaluated Outcomes.|Completed||N/A|160|Actual|Odense University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:41:44.909036|2017-10-10 21:41:44.909036
NCT02932631|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-10-10|||August 2015||2015-08-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Different Methods of Physical Therapy for Stroke|EFFECTS OF CONSTRAINT-INDUCED MOVEMENT THERAPY OR MENTAL SIMULATION OF MOVEMENTS Versus CONVENTIONAL PHYSICAL THERAPY ON FUNCTIONAL RECOVERY AND QUALITY OF LIFE AFTER STROKE|Recruiting||N/A|60|Anticipated|Universidade Metodista de Piracicaba||4|||f||||f||||||||No||2017-10-10 21:41:45.040207|2017-10-10 21:41:45.040207
NCT02932618|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-10-31|||November 2016||2016-11-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||BAX 111 rVWF in Pediatrics|A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease|Not yet recruiting||Phase 3|39|Anticipated|Baxalta US Inc.||3|||f||||t||||||||||2017-10-10 21:41:45.178345|2017-10-10 21:41:45.178345
NCT02932605|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-10-10|||January 2017||2017-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|CANGLIA||Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia|Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia|Not yet recruiting||N/A|50|Anticipated|UMC Utrecht||2|||f||||t||||||||No||2017-10-10 21:41:45.28202|2017-10-10 21:41:45.28202
NCT02932592|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-11|||March 2016||2016-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|AGREEMENT||evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients (AGREEMENT)|evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients|Recruiting||Phase 4|60|Anticipated|University of Pavia||1|||f||||f||||||||No||2017-10-10 21:41:45.376079|2017-10-10 21:41:45.376079
NCT02932579|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-21|||November 2016||2016-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes||Not yet recruiting||N/A|238|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 21:41:45.479585|2017-10-10 21:41:45.479585
NCT02932566|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-16|||March 7, 2017|Actual|2017-03-07|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|PIROUETTE||The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction|A Randomised, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction (PIROUETTE)|Recruiting||Phase 2|200|Anticipated|University Hospital of South Manchester NHS Foundation Trust||2|||f||||t|f|f||||||Undecided||2017-10-10 21:41:45.567936|2017-10-10 21:41:45.567936
NCT02932553|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-06-07|||April 19, 2017|Actual|2017-04-19|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|October 31, 2019|Anticipated|2019-10-31||Interventional|BIVA-pilot||BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease|BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease: Pilot Study|Enrolling by invitation||Phase 4|30|Anticipated|Asan Medical Center||1|||f||||t|f|f||||||Undecided||2017-10-10 21:41:45.679006|2017-10-10 21:41:45.679006
NCT02932540|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-05-19|||November 2015||2015-11-01|May 2016|2016-05-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||Head Position on Cerebral Haemodynamics in Acute Ischemic Stroke and Controls|The Effects of Head Positioning on Beat to Beat Cerebral Haemodynamics: a Comparison Between Acute Stroke Patients and Healthy Control Subjects|Completed||N/A|51|Actual|University of Leicester|||4||f||||f||||||||No||2017-10-10 21:41:45.759708|2017-10-10 21:41:45.759708
NCT02932527|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-11|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|CANNASPERM||Effect of Cannabis Consumption on Sperm Nuclear Quality in Infertile Men|Effect of Cannabis Consumption on Sperm Nuclear Quality in Infertile Men : a Prospective Exposed / Unexposed Study|Not yet recruiting||N/A|200|Anticipated|University Hospital, Rouen||2|||f||||f||||||||No||2017-10-10 21:41:45.848138|2017-10-10 21:41:45.848138
NCT02932514|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-05-19|||October 2016||2016-10-01|May 2017|2017-05-01||||July 2017|Anticipated|2017-07-01||Interventional|HOUSE||Home Use Sensor Study|Home Use Sensor (HOUSE) Study|Active, not recruiting||N/A|17|Actual|Senseonics, Inc.||1|||f||||f||||||||||2017-10-10 21:41:45.950165|2017-10-10 21:41:45.950165
NCT02932501|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-08-14|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|June 2021|Anticipated|2021-06-01|1 Year|Observational [Patient Registry]|MRONJ||Medication-related Osteonecrosis of the Jaw (MRONJ) Registry|International, Multicenter, Prospective Registry to Collect Data of Treatment Patterns of Patients With Medication-related Osteonecrosis of the Jaw (MRONJ) and Their Outcome|Recruiting||N/A|500|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-10 21:41:46.014424|2017-10-10 21:41:46.014424
NCT02932488|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-12|||September 2016||2016-09-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation|Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation|Recruiting||Phase 1|42|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||Yes|Via database of Center for Integrated Molecular Brain Imaging (Knudsen et al 2016, NeuroImage) data will be available for neuroscience research community contingent on approval by scientific board.|2017-10-10 21:41:46.108037|2017-10-10 21:41:46.108037
NCT02932475|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-30|||May 25, 2017|Actual|2017-05-25|May 2017|2017-05-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|MOMPOD||Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)|Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy|Recruiting||Phase 3|1200|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|t|f||||||Yes||2017-10-10 21:41:46.199|2017-10-10 21:41:46.199
NCT02932462|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2017-05-04|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|December 15, 2016|Actual|2016-12-15|November 15, 2016|Actual|2016-11-15||Interventional|||Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis|A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS 1535 in Patients With Mild to Severe Scalp Psoriasis|Completed||Phase 3|370|Actual|Taro Pharmaceuticals USA||2|||f||||f|t|f||||||No||2017-10-10 21:41:46.306305|2017-10-10 21:41:46.306305
NCT02932449|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-09-18|||October 2016||2016-10-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis|A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis|Recruiting||N/A|1500|Anticipated|Target PharmaSolutions, Inc.|||1||f||||f||||||Samples With DNA|"     Participants enrolled in TARGET-PBC will be invited to participate in the optional     Biorepository Specimen Bank (BSB). Blood samples for biomarker and DNA/RNA assays will be     collected on a voluntary basis and participation in this project will not affect     participation in the main study.      Blood samples for exploratory genetic and biomarker studies can be used for research purposes     to identify potential biomarkers predictive of PBC diagnosis, assess correlates of response     to PBC treatment (in terms of mode of action, efficacy, dose, safety and tolerability),     understand factors influencing disease progression, determine how best to monitor and treat     PBC, aid in the development of a new medical products, or explore complications of PBC and     treatment.   "|||2017-10-10 21:41:46.385112|2017-10-10 21:41:46.385112
NCT02932436|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2016-11-08|||October 2016||2016-10-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|EmDia||Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics|A Phase IV, Single-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study on the Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Individuals With Type 2 Diabetes|Recruiting||Phase 4|264|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f||||||||Undecided||2017-10-10 21:41:46.555839|2017-10-10 21:41:46.555839
NCT02932423|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-08-21|||October 18, 2016|Actual|2016-10-18|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|May 17, 2017|Actual|2017-05-17||Interventional|AQUAGLU-1||Metabolic Response to Beverages With Various Sweetening Systems Consumed During Meal in Overweight and Obese Subjects|Impact of Beverage Consumption With Varying Sweetening Systems During Meal on Post-prandial Glucose and Insulin Concentrations, and Lipid Metabolism in Overweight and Obese Subjects|Completed||N/A|48|Actual|Danone Research||2|||f||||f||||||||||2017-10-10 21:41:46.789677|2017-10-10 21:41:46.789677
NCT02932410|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-10-02|||November 5, 2017|Anticipated|2017-11-05|October 2017|2017-10-01|July 14, 2022|Anticipated|2022-07-14|July 14, 2022|Anticipated|2022-07-14||Interventional|TOMORROW||A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)|A Multicenter, Open-label, Randomized, Event-driven Study to Assess Efficacy, Safety and Pharmacokinetics of Macitentan Versus Standard of Care in Children With Pulmonary Arterial Hypertension|Recruiting||Phase 3|300|Anticipated|Actelion||2|||f||||t|t|f||||||||2017-10-10 21:41:46.887887|2017-10-10 21:41:46.887887
NCT02932397|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-07-18|||October 2016||2016-10-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|PROPOREV||Efficacy of Propofol vs Placebo in the Prevention of Coughing During Emergence of General Anesthesia Under Desflurane|Efficacy of an Intravenous Dose of Propofol Versus Placebo in the Prevention of Coughing During Emergence of General Anesthesia Under Desflurane|Recruiting||N/A|154|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-10 21:41:47.2708|2017-10-10 21:41:47.2708
NCT02932384|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-10-11|||August 2015||2015-08-01|October 2016|2016-10-01|February 2020|Anticipated|2020-02-01|August 2017|Anticipated|2017-08-01||Interventional|PtW||Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness|Passport to Wellness-Full Intervention Phase|Recruiting||N/A|130|Anticipated|Charles Drew University of Medicine and Science||2|||f||||f||||||||No||2017-10-10 21:41:47.395996|2017-10-10 21:41:47.395996
NCT02932371|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-13|||January 2013||2013-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|April 2013|Actual|2013-04-01||Interventional|EVALECOM2||Evaluation of the ECOM™ Monitor for Continuous and Non-invasive Measure of the Cardiac Output in Cardiac Surgery Patients||Terminated||N/A|5|Actual|Hopital Foch||1||Recruitment difficulties|f||||f||||||||No||2017-10-10 21:41:47.519104|2017-10-10 21:41:47.519104
NCT02932358|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-04-27|||January 15, 2017|Actual|2017-01-15|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness and Safety of a Flexible Family Visitation Model for Delirium Prevention in the ICU|Effectiveness and Safety of a Flexible Family Visitation Model for Delirium Prevention in Intensive Care Units: A Cluster-Randomized, Crossover Trial|Recruiting||N/A|1750|Anticipated|Hospital Moinhos de Vento||2|||f||||f||||||||||2017-10-10 21:41:47.607946|2017-10-10 21:41:47.607946
NCT02932345|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-07-21|||October 31, 2016|Actual|2016-10-31|July 2017|2017-07-01|July 4, 2017|Actual|2017-07-04|July 4, 2017|Actual|2017-07-04||Observational|||Gefitinib Long-term Survivor Study|A Study of Clinical and Genomic Analysis on Long-term Survivors of EGFR Mutation Positive Advanced Non-small-cell Lung Cancer Patients With Gefitinib Treatment in China|Completed||N/A|59|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-10 21:41:47.734535|2017-10-10 21:41:47.734535
NCT02932332|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-04-18|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients|High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients|Recruiting||Phase 2|36|Anticipated|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-10-10 21:41:47.853572|2017-10-10 21:41:47.853572
NCT02932319|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-05-18|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|FOLOUT||Outpatient Foley Catheter for Induction of Labor in Nulliparous for Prolonged Pregnancy|Outpatient Foley Catheter for Induction of Labor in Nulliparous for Prolonged Pregnancy|Recruiting||N/A|138|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:41:47.981196|2017-10-10 21:41:47.981196
NCT02932306|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-04-26|||October 29, 2015|Actual|2015-10-29|April 2017|2017-04-01|March 20, 2017|Actual|2017-03-20|February 14, 2017|Actual|2017-02-14||Interventional|||Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris|A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle- Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris|Completed||Phase 1|820|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 21:41:48.08701|2017-10-10 21:41:48.08701
NCT02932293|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-05-11|||December 2016|Anticipated|2016-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Triple Combination DAAs for Treating HCV GT1b Subjects|Triple Combination DAAs for Ultra Short Duration Therapy for HCV Genotype 1b in Chinese (SODAPI II Study)|Withdrawn||Phase 2|0|Actual|Humanity and Health Research Centre||2||"The collaborating pharmaceutical company will not wish to continue with the trial due to the   internal issues in the company."|f||||t||||||||Undecided||2017-10-10 21:41:48.255544|2017-10-10 21:41:48.255544
NCT02932280|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-07-21|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment|A Phase I/II Study of Neratinib in Pediatric Patients With Relapsed or Refractory Solid Tumors or Hematologic Malignancies (POE16-01)|Recruiting||Phase 1/Phase 2|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:41:48.346016|2017-10-10 21:41:48.346016
NCT02932267|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-25|||December 2016||2016-12-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|EDeN||Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne|Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide 2.5% in Moderate to Severe Acne in Dark Skin Phototype Subjects|Not yet recruiting||Phase 3|60|Anticipated|Galderma||1|||f||||f||||||||||2017-10-10 21:41:48.465188|2017-10-10 21:41:48.465188
NCT02932254|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-11-27|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex|Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex|Recruiting||Phase 4|60|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||No||2017-10-10 21:41:48.568608|2017-10-10 21:41:48.568608
NCT02932241|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-05-30|||June 2016||2016-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Computerized DBT Skills Training for Suicidal and Heavy Episodic Drinkers|Computerized DBT Skills Training for Suicidal and Heavy Episodic Drinkers|Active, not recruiting||Phase 1|60|Actual|University of Washington||2|||f||||f||||||||Undecided|The investigators have yet to determine whether or not to share data; if so, all data would be de-identified.|2017-10-10 21:41:48.682948|2017-10-10 21:41:48.682948
NCT02932228|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-10-04|||January 1, 2013|Actual|2013-01-01|October 2017|2017-10-01|May 1, 2015|Actual|2015-05-01|June 1, 2014|Actual|2014-06-01||Interventional|ImPACT||Evaluation of Intensive Management Patient Aligned Care Team|Evaluating Innovative Care Models for High-Utilizing Patients|Completed||N/A|583|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-10 21:41:48.76489|2017-10-10 21:41:48.76489
NCT02932215|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-01-03|||October 2016||2016-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder|Pilot Study: Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder|Recruiting||Phase 1|15|Anticipated|New York State Psychiatric Institute||1|||f||||t||||||||Undecided||2017-10-10 21:41:48.853659|2017-10-10 21:41:48.853659
NCT02932202|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-05-31|||July 8, 2016|Actual|2016-07-08|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|WEIGHT||Women Eating With Interactive Tracking to Gain Healthily Through Term Pregnancy Trial|Women Eating With Interactive Tracking to Gain Healthily Through Term Pregnancy (WEIGHT) Trial|Withdrawn||N/A|0|Actual|Loyola University||2||The trial was stopped due to no recruitment|f||||f|f|f||||||No|There is no individual participant data.|2017-10-10 21:41:48.938406|2017-10-10 21:41:48.938406
NCT02932189|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-24|||January 2016||2016-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Use of a New Isokinetic Device for Inspiratory Muscle Training|Use of a New Isokinetic Device Oriented by Software for Inspiratory Muscle Training in Prolonged Weaning|Recruiting||N/A|70|Anticipated|Universidade Federal Fluminense||2|||f||||f||||||||No||2017-10-10 21:41:49.024184|2017-10-10 21:41:49.024184
NCT02932176|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-02-17|||September 7, 2016|Actual|2016-09-07|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|DopplerZAM||Machine Learning for Handheld Vascular Studies|Development and Validation of a Novel Machine-learning Algorithm to Assist in Handheld Vascular Diagnostics|Recruiting||N/A|100|Anticipated|Duke University|||1||f||||f|f|f||||||No||2017-10-10 21:41:49.122377|2017-10-10 21:41:49.122377
NCT02932163|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-11|||February 2016||2016-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Observational|||Predictors of Chronic Non-specific Low Back Pain|Relationships Between Muscular Impairments, Pain, and Disability in Patients With Chronic Non-specific Low Back Pain: a Cross Sectional Study|Completed||N/A|90|Actual|Fondazione Don Carlo Gnocchi Onlus|||1||f||||f||||||||No||2017-10-10 21:41:49.662733|2017-10-10 21:41:49.662733
NCT02932150|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-10-02|||November 2016|Actual|2016-11-01|October 2017|2017-10-01|November 2023|Anticipated|2023-11-01|June 2019|Anticipated|2019-06-01||Interventional|||Tenofovir Alafenamide (TAF) in Adolescents With Chronic Hepatitis B Virus Infection|A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents With Chronic Hepatitis B Virus Infection|Recruiting||Phase 2|75|Anticipated|Gilead Sciences||3|||f||||t||||||||||2017-10-10 21:41:49.72687|2017-10-10 21:41:49.72687
NCT02932137|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-12|||May 2016||2016-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Anti-infection of Low-does IL-2 in SLE|Potential Effect of Anti-infection by Low-dose IL-2 in Treatment of SLE|Recruiting||N/A|30|Anticipated|Peking University People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:41:49.917944|2017-10-10 21:41:49.917944
NCT02932124|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-11|||January 2007||2007-01-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|1 Day|Observational [Patient Registry]|||Application of Mechanical Cardiopulmonary Resuscitation Devices and Their Value in Out-of-hospital Cardiac Arrest: A Retrospective Analysis of the German Resuscitation Registry|Application of Mechanical Cardiopulmonary Resuscitation Devices and Their Value in Out-of-hospital Cardiac Arrest: A Retrospective Analysis of the German Resuscitation Registry|Completed||N/A|19609|Actual|German Resuscitation Registry|||2||f||||f||||||||No||2017-10-10 21:41:50.086402|2017-10-10 21:41:50.086402
NCT02932111|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-12-07|||December 2016||2016-12-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|IBSOMT||Irritable Bowel Syndrome and Osteopathic Manipulative Therapy|Effectiveness of Osteopathic Manipulative Therapy for Managing Symptoms of Irritable Bowel Syndrome. A Prospective Randomized Study -IBSOMT|Not yet recruiting||N/A|210|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 21:41:50.178463|2017-10-10 21:41:50.178463
NCT02932098|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-12|||August 2016|Actual|2016-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|POGO||Post-Operative Gynecological Oncology App Study|Post-Op Gynecological Oncology Web-Based App Study|Recruiting||N/A|30|Anticipated|University of Tennessee||2|||f||||f||||||||Undecided||2017-10-10 21:41:50.275783|2017-10-10 21:41:50.275783
NCT02932085|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-07-27|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pilot Study for the Effects of Transcranial Magnetic Stimulation on the Brain Using an Electronic Medical Device|Pilot Study for the Effects of Transcranial Magnetic Stimulation on the Brain Using an Electronic Medical Device: A Single Institution, Randomized, Double-blind, Sham-controlled Study Using Multimodal Neuroimaging in Healthy Young Adults|Recruiting||N/A|40|Anticipated|Ewha Womans University Mokdong Hospital||2|||f||||t||||||||||2017-10-10 21:41:50.364488|2017-10-10 21:41:50.364488
NCT02932072|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|Autoscope||Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)|Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)|Not yet recruiting||N/A|160|Anticipated|University of Oxford|||1||f||||f||||||Samples Without DNA|"     Blood collection from finger-prick (maximum 150-200 µL), which will be used to prepare     slides.   "|No||2017-10-10 21:41:50.437327|2017-10-10 21:41:50.437327
NCT02932059|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-07-25|||June 19, 2017|Actual|2017-06-19|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|February 2020|Anticipated|2020-02-01||Interventional|Metamemory 2||Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With Schizophrenia|Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With Schizophrenia|Recruiting||N/A|120|Anticipated|University Hospital, Clermont-Ferrand||4|||f|||||f|f||||||||2017-10-10 21:41:50.515989|2017-10-10 21:41:50.515989
NCT02932046|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-10-12|||February 2014||2014-02-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|HUSAAN||Hunger and Satiety in Anorexia Nervosa|Hunger and Satiety Perception in Patients With Anorexia Nervosa|Completed||N/A|47|Actual|Odense University Hospital|||1||f||||f||||||||No||2017-10-10 21:41:50.613564|2017-10-10 21:41:50.613564
NCT02932033|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-11-02|||November 2016||2016-11-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|TEP||Trial Comparing Tack Versus Histoacryl Mesh Fixation After Endoscopic TEP(Total Extraperitoneal) Repair for Bilateral Inguinal Hernia|Randomized Control Trial Comparing Tack Versus Histoacryl Mesh Fixation After Endoscopic TEP (Total Extraperitoneal) Repair for Groin Hernias|Not yet recruiting||N/A|100|Anticipated|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation||2|||f||||t||||||||No||2017-10-10 21:41:50.689526|2017-10-10 21:41:50.689526
NCT02932020|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||AlloGen-LI Treatment of Spinal Stenosis|Pilot Study Investigating the Utility of Epidural AlloGen-LI Injection for Treatment of Spinal Stenosis Symptoms|Enrolling by invitation||N/A|20|Anticipated|University of Southern California||2|||f||||f||||||||Undecided||2017-10-10 21:41:50.758102|2017-10-10 21:41:50.758102
NCT02932007|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Chloroquine for Symptomatic Persistent and Longstanding Persistent AF|Chloroquine for Patients With Symptomatic Persistent and Longstanding Persistent Atrial Fibrillation: A Prospective Pilot Study|Recruiting||Phase 2|40|Anticipated|University of South Florida||1|||f||||t||||||||No||2017-10-10 21:41:50.987999|2017-10-10 21:41:50.987999
NCT02931994|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-12|||April 2015||2015-04-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|Knotfloss-1||Evaluation of Plaque Removal Efficacy and Patient Acceptability of Knotted Floss Technique in Type I Gingival Embrasures|Comparative Evaluation of the Plaque Removal Efficacy and Patient Acceptability of the Knotted Floss Technique With Conventional Flossing Technique in Type I Gingival Embrasures|Completed||N/A|30|Actual|Uttaranchal Dental & Medical Research Institute||4|||f||||t||||||||Undecided||2017-10-10 21:41:51.131501|2017-10-10 21:41:51.131501
NCT02931981|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2016|Anticipated|2016-10-01||Observational|||Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor|Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor|Recruiting||N/A|50|Anticipated|RenJi Hospital|||1||f||||t||||||||||2017-10-10 21:41:51.271667|2017-10-10 21:41:51.271667
NCT02931968|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-13|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Full-arch Monolithic Zirconia ISFDP Follow up|A Retrospective Clinical Study Evaluating Full-Arch Monolithic Zirconia Implant Supported Fixed Dental Prosthesis|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f|f|f||||||||2017-10-10 21:41:51.371538|2017-10-10 21:41:51.371538
NCT02931955|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-11|||August 2016||2016-08-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|SYS-T-ACT||Applying Systems Immunology to the Search for Personalized Biomarkers of Clinical Efficacy|Applying Systems Immunology to the Search for Personalized Biomarkers of Clinical Efficacy: Predicting the T Cell Activation Potential in Vivo From Resting T Cells of Patients|Recruiting||N/A|30|Anticipated|Luxembourg Institute of Health|||2||f||||t||||||Samples With DNA|"     Both lymphocytes and stool samples of the patients will be retained.   "|No||2017-10-10 21:41:51.524164|2017-10-10 21:41:51.524164
NCT02931942|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-10-11|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Changing Over Time of Ascorbic Acid After Chemotherapy|The Changing Over Time of Ascorbic Acid After Chemotherapy|Recruiting||N/A|150|Anticipated|Maastricht University Medical Center|||6||f||||f||||||Samples Without DNA|"     peripheral blood on AA level and blood count   "|No||2017-10-10 21:41:51.631984|2017-10-10 21:41:51.631984
NCT02931929|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT|MITIGATE-NeoBOMB1: A Phase I/IIa Study to Evaluate Safety, Biodistribution, Dosimetry+Preliminary Diagnostic Performance of 68Ga-NeoBOMB1 in Pat. With Advanced TKI-treated GIST Using Positron-emission Tomography/Computer Tomography (PET/CT)|Not yet recruiting||Phase 1/Phase 2|12|Anticipated|Medical University Innsbruck||1|||f||||f||||||||No||2017-10-10 21:41:51.744194|2017-10-10 21:41:51.744194
NCT02931916|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-14|||November 2016||2016-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Evaluation of Reliability and Validity of a Smart-phone Postural Control Assessment Application|Evaluation of Reliability and Validity of a Smart-phone Application Designed for Chronic Ankle Instability Subjects' Postural Control Assessment|Recruiting||N/A|200|Anticipated|National Yang Ming University|||2||f||||f||||||||||2017-10-10 21:41:51.836396|2017-10-10 21:41:51.836396
NCT02931903|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-12|||January 2017||2017-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|RCT||Lithium Disilicate Glass-ceramic Versus Hybrid Ceramic Superstructure Materials on Implant Stability|The Effect of Lithium Disilicate Glass-ceramic (IPS Emax) Versus Hybrid Ceramic (Vita Enamic) Superstructure Materials on Implant Stability in Implant Supported Restorations|Not yet recruiting||N/A|20|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:41:51.919685|2017-10-10 21:41:51.919685
NCT02931890|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Interventional|CRITICS-II||Multicentric Randomised Trial for Resectable Gastric Cancer|A Multicentre Randomised Phase II Trial of Neo-adjuvant Chemotherapy Followed by Surgery vs. Neo-adjuvant Chemotherapy and Subsequent Chemoradiotherapy Followed by Surgery vs. Neo-adjuvant Chemoradiotherapy Followed by Surgery in Resectable Gastric Cancer|Recruiting||Phase 2|207|Anticipated|The Netherlands Cancer Institute||3|||f||||f|f|f||||||||2017-10-10 21:41:52.022023|2017-10-10 21:41:52.022023
NCT02931877|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Postoperative Outcome After Sevoflurane and Propofol Anaesthesia|Comparison of Postoperative Outcome and Cognitive Function After Sevoflurane and Propofol Anaesthesia for Cardiac Valvular Surgery With Cardiopulmonary Bypass|Recruiting||Phase 4|508|Anticipated|Xinqiao Hospital of Chongqing||3|||f||||t||||||||Undecided||2017-10-10 21:41:52.16894|2017-10-10 21:41:52.16894
NCT02931864|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||November 2016||2016-11-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors|Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on Quality of Life in Breast Cancer Survivors|Not yet recruiting||Phase 3|188|Anticipated|National University, Singapore||4|||f||||f||||||||No||2017-10-10 21:41:52.280806|2017-10-10 21:41:52.280806
NCT02931851|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-06-13|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|ICU-Families||Family Information Management in the Intensive Care Unit|Family Information Management in the Intensive Care Unit: A Randomized Controlled Trial|Not yet recruiting||N/A|110|Anticipated|Medical University of Graz||2|||f||||f|f|f||||||Undecided||2017-10-10 21:41:52.405207|2017-10-10 21:41:52.405207
NCT02931838|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-09-27|||November 15, 2016|Actual|2016-11-15|September 2017|2017-09-01|November 21, 2017|Anticipated|2017-11-21|November 20, 2017|Anticipated|2017-11-20||Interventional|||Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Study to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects With Moderate to Severe Psoriasis|Recruiting||Phase 2|250|Anticipated|Bristol-Myers Squibb||6|||f||||t|t|f||||||||2017-10-10 21:41:52.557004|2017-10-10 21:41:52.557004
NCT02931825|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|ISIRECC||Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System|Identification of High Risk People for Colorectal Cancer in Indre-et-Loire (France) and Evaluation of a Specific Surveillance System : a Randomized Trial Assessing the Efficacy of a Letter Encouraging People to Perform Colonoscopy Screening|Enrolling by invitation||N/A|7500|Anticipated|University Hospital, Tours||2|||f||||f||||||||No||2017-10-10 21:41:53.091831|2017-10-10 21:41:53.091831
NCT02931812|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-10|||May 2014||2014-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|GREFFE||Feeding Behavior and Taste Sensitivity Before and After Liver or Renal Transplantation|Feeding Behavior and Taste Sensitivity Before and After Liver or Renal Transplantation|Recruiting||N/A|60|Anticipated|University of Burgundy|||3||f||||t||||||Samples Without DNA|"     Blood samples for hormones measurments (leptine, ghrelin, insulin) and plasmatic amino-acids   "|No||2017-10-10 21:41:53.190976|2017-10-10 21:41:53.190976
NCT02931799|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-08-14|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|PRICE||Prevention of Readmissions at IBD Centres of Excellence|Prevention of Readmissions at Inflammatory Bowel Disease Centres of Excellence|Not yet recruiting||N/A|400|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f|f|f||||||||2017-10-10 21:41:53.286218|2017-10-10 21:41:53.286218
NCT02931786|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-10-12|||August 2014||2014-08-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|||Effects of Propofol and Ketofol on Core Body Temperature in MRI|Does Magnetic Resonance Imaging Increase Core Body Temperature in Anesthetized Children? Evaluating the Effects of Propofol and Ketofol|Completed||N/A|90|Actual|Istanbul University||2|||f||||t||||||||No||2017-10-10 21:41:53.40705|2017-10-10 21:41:53.40705
NCT02912182|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-20|||December 2015||2015-12-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Acute Unilateral Vestibulopathy and Corticosteroid Treatment|Acute Unilateral Vestibulopathy and Corticosteroid Treatment|Recruiting||Phase 4|180|Anticipated|Lund University||3|||f||||t||||||||No||2017-10-10 21:47:11.746501|2017-10-10 21:47:11.746501
NCT02931773|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-12|||August 2016||2016-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|ACNDM2||Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients (ACNDM2)|Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients and in Pre-Diabetes Patients|Recruiting||N/A|60|Anticipated|Instituto Nacional de Cardiologia Ignacio Chavez|||3||f||||t||||||||Yes|By publishing results as on as a paper on a Medical Journal|2017-10-10 21:41:53.498135|2017-10-10 21:41:53.498135
NCT02931760|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|POCKET-RCT||Placement Of Cardiac PacemaKer Trial (POCKET)-RCT|Placement Of Cardiac PacemaKer Trial (POCKET)-RCT|Recruiting||N/A|200|Anticipated|Region Gävleborg||2|||f||||f||||||||Yes|IPD will be available (without identification of each individual) upon request by the journal (i.e Supplement file)|2017-10-10 21:41:53.618519|2017-10-10 21:41:53.618519
NCT02931747|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2017-08-15|||July 2016||2016-07-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effect of Bacopa Monnieri on Working Memory and Cognitive Processing in Student||Completed||Phase 1|75|Actual|Khon Kaen University||3|||f||||f||||||||||2017-10-10 21:41:53.732039|2017-10-10 21:41:53.732039
NCT02931734|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-13|||October 2014||2014-10-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Interventional|CDH||Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment|Analysis of the Association of Products for the Treatment of Cervical Dentin Hypersensitivity|Completed||N/A|140|Actual|Federal University of Uberlandia||7|||f||||f||||||||No||2017-10-10 21:41:53.826571|2017-10-10 21:41:53.826571
NCT02931721|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-10|||August 2016||2016-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|TESE-MRI||Treatment of Severe Male Infertility - Predictive Factors (Imaging)|Treatment of Severe Male Infertility - Predictive Factors (Imaging)|Recruiting||N/A|20|Anticipated|Turku University Hospital|||2||f||||f||||||||Undecided||2017-10-10 21:41:53.956858|2017-10-10 21:41:53.956858
NCT02931708|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-10-11|||November 2015||2015-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Diaphragmatic Functional Electrical Stimulation in Heart Failure|Diaphragmatic Functional Electrical Stimulation in Heart Failure Patients: Uncontrolled Clinical Trial|Recruiting||N/A|20|Anticipated|Federal University of Health Science of Porto Alegre||1|||f||||t||||||||Yes||2017-10-10 21:41:54.042076|2017-10-10 21:41:54.042076
NCT02931695|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-07-10|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|QuTe||Influence of Sex Hormones Variation During Third Trimester of Pregnancy and Post-partum on QT Interval Duration|Influence of Sex Hormones Variation During Third Trimester of Pregnancy and Post-partum on QT Interval Duration|Recruiting||N/A|60|Anticipated|French Cardiology Society||2|||f||||f|f|f||||||||2017-10-10 21:41:54.149324|2017-10-10 21:41:54.149324
NCT02931682|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-09-01|||October 2016||2016-10-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Observational|Vigilan||Observational Study of Males With Creatine Transporter Deficiency|Observational Study of Males With Creatine Transporter Deficiency|Recruiting||N/A|50|Anticipated|Lumos Pharma|||1||f||||f||||||Samples With DNA|"     Whole blood, cerebrospinal fluid, urine and fibroblasts   "|||2017-10-10 21:41:54.243964|2017-10-10 21:41:54.243964
NCT02931669|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-09-17|||October 2016||2016-10-01|September 2017|2017-09-01|September 17, 2017|Anticipated|2017-09-17|September 17, 2017|Anticipated|2017-09-17||Observational|AAC||Meaning, Value and Purpose of Augmentative and Alternative Communication (AAC)|What Does AAC Mean to You?: An Exploration of the Meaning and Value of AAC to Users and Stakeholders.(AAC: Augmentative and Alternative Communication)|Recruiting||N/A|200|Anticipated|University of Dublin, Trinity College|||5||f||||f||||||||||2017-10-10 21:41:54.339107|2017-10-10 21:41:54.339107
NCT02931656|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-06-23|||March 2016||2016-03-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Acute Effects of an Aquatic Physical Exercise on Glycemic Control of Gestational Diabetes|Acute Effects of an Aquatic Physical Exercise on Glycemic Control of Gestational Diabetes|Completed||N/A|70|Actual|Professor Fernando Figueira Integral Medicine Institute||2|||f||||t||||||||No||2017-10-10 21:41:54.448152|2017-10-10 21:41:54.448152
NCT02931643|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Postprandial Effects of Mixed Herbs and Spices on Pathways Associated With Glucose Homeostasis and Inflammation on PBMCs of Healthy Subjects|Postprandial Effects of Mixed Herbs and Spices on Pathways Associated With Glucose Homeostasis and Inflammation on PBMCs of Healthy Subjects - Molecular Insights Through Integration of Transcriptomics of Peripheral Blood Mononuclear Cells (PBMC) and Circulating miRNA|Recruiting||Phase 1/Phase 2|20|Anticipated|Lund University||2|||f||||f||||||||Undecided||2017-10-10 21:41:54.540053|2017-10-10 21:41:54.540053
NCT02931630|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-07-13|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|MERITS||The Effect of Whey Protein and Dietary Fibers on Risk Markers of the Metabolic Syndrome and Bone Health|The Effect of Whey Protein and Dietary Fibers on Risk Markers of the Metabolic Syndrome and Bone Health|Completed||N/A|72|Actual|Aarhus University Hospital||4|||f||||f||||||||||2017-10-10 21:41:54.656955|2017-10-10 21:41:54.656955
NCT02931617|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-10-10|||September 2013||2013-09-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of Two Modes of Respiratory Physiotherapy in Cardio-thoracic Surgical Patients|Comparison of Two Modes of Respiratory Physiotherapy in Cardio-thoracic Surgical Patients|Completed||N/A|120|Actual|Tampere University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:41:56.766988|2017-10-10 21:41:56.766988
NCT02931604|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-10|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|November 2019|Anticipated|2019-11-01||Interventional|||Study Designed to Clinically Evaluate Sinus Wash Device Prototypes|Pilot Study Designed to Clinically Evaluate Sinus Wash Device Prototypes in Patients With Sinusitis During Endoscopic Sinus Surgery (ESS) and in the Hospital Outpatient|Not yet recruiting||N/A|50|Anticipated|SinuSafe Medical LTD||1|||f||||||||||||||2017-10-10 21:41:56.861002|2017-10-10 21:41:56.861002
NCT02931591|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-12|||November 2016||2016-11-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|November 2019|Anticipated|2019-11-01||Interventional|||Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children|Effect of Insulin Sensitization on Insulin Like Growth Factor-1 Responses to Growth Hormone Treatment in Children Born Small for Gestational Age|Not yet recruiting||N/A|24|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t||||||||No||2017-10-10 21:41:56.957797|2017-10-10 21:41:56.957797
NCT02931565|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2017-05-25|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type II Achalasia|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-dose, Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IW-1701 in Patients With Achalasia|Recruiting||Phase 2|20|Anticipated|Ironwood Pharmaceuticals, Inc.||2|||f||||f||||||||Yes||2017-10-10 21:41:57.188931|2017-10-10 21:41:57.188931
NCT02931552|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-11|||September 2015||2015-09-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Nuevo Amanecer II: Translating a Stress Management Program for Latinas|Translating a Stress Management Program for Latinas|Recruiting||N/A|150|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 21:41:57.325067|2017-10-10 21:41:57.325067
NCT02931539|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-10-04|||December 1, 2016|Actual|2016-12-01|October 2017|2017-10-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment|A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir|Recruiting||Phase 3|351|Anticipated|Shire||2|||f|||||t|f||||||||2017-10-10 21:41:57.458641|2017-10-10 21:41:57.458641
NCT02931526|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-10-10|||August 2016||2016-08-01|July 2016|2016-07-01||||August 2017|Anticipated|2017-08-01||Observational|||Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)|Pharmacokinetics of Tigecycline in Critical Ill Patients Undergoing Continuous Renal Replacement Therapy|Recruiting||N/A|20|Anticipated|Zhujiang Hospital|||2||f||||t||||||None Retained|"     Whole blood, serum, urine, effluent fluid from dialysis machine   "|||2017-10-10 21:41:58.031151|2017-10-10 21:41:58.031151
NCT02931513|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-11|2016-10-31|||September 2016||2016-09-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||sCD163 in PBC Patients - Assessment of Treatment Response|Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Treatment Response to UDCA|Recruiting||N/A|40|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Liverbiopsies if obtained during prognostication Blood samples for measuring sCD163 and sMR   "|Undecided||2017-10-10 21:41:58.128635|2017-10-10 21:41:58.128635
NCT02931500|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-06-26|||July 2016||2016-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Machine Learning for Identification of Future Disease Development: A Nationwide Cohort Study (MILESTONE)|MachIne LEarning for Identification of Future Development of cardiovaScular and meTabOlic Disease: a NationwidE Time-series Cohort Study (MILESTONE)|Recruiting||N/A|510000|Anticipated|Yonsei University|||1||f||||f||||||||Undecided||2017-10-10 21:41:58.218638|2017-10-10 21:41:58.218638
NCT02931487|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-10-13|||May 2015||2015-05-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Restoring Emotion Regulation Networks in Depression Vulnerability|Restoring Emotion Regulation Networks in Depression Vulnerability: An Experimental Study Applying an Attention Bias Modification Procedure|Recruiting||N/A|200|Anticipated|University of Oslo||2|||f||||f||||||||No||2017-10-10 21:41:58.315283|2017-10-10 21:41:58.315283
NCT02931474|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-12|2017-06-30|||October 6, 2016||2016-10-06|March 8, 2017|2017-03-08|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Interventional|||Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia|The Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 21:41:58.429269|2017-10-10 21:41:58.429269
NCT02931461|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-10-10||||||July 2016|2016-07-01||||October 2017|Anticipated|2017-10-01||Interventional|||Interest of Procore Needle® for Diagnosis of Lung Cancer||Not yet recruiting||N/A|50|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 21:41:58.517248|2017-10-10 21:41:58.517248
NCT02931448|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-10-12||||||October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Observational|MAS-CO||Occult Carbon Monoxide Poisoning Detection by Pulsated Carboxymetry in an Emergency Department||Not yet recruiting||N/A|150|Anticipated|Poitiers University Hospital|||1||f||||||||||||||2017-10-10 21:41:58.587222|2017-10-10 21:41:58.587222
NCT02931435|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-03-08|||December 2016||2016-12-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|DEFIANT||Radiofrequency For Chronic Knee Pain Post-Arthroplasty|Radiofrequency For The Treatment Of Chronic Knee Pain Following Total Knee Arthroplasty: A Double-Blind Randomized Controlled Pilot Study|Recruiting||N/A|40|Anticipated|Willis-Knighton River Cities Clinical Research Center||2|||f||||f||||||||Undecided||2017-10-10 21:41:58.663887|2017-10-10 21:41:58.663887
NCT02931422|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-02-02|||September 2016||2016-09-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|FIT-Pilot||Financial Incentives to Increase Pediatric HIV Testing Pilot Study (FIT-Pilot)|Financial Incentives to Increase Pediatric HIV Testing Pilot Study|Completed||N/A|60|Anticipated|University of Washington||3|||f||||f||||||||||2017-10-10 21:41:58.759013|2017-10-10 21:41:58.759013
NCT02931409|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-01-05|||October 2016||2016-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Intraoperative PEEP Optimization: Effects on Postoperative Pulmonary Complications and Inflammatory Response|Intraoperative PEEP Optimization: Effects on Postoperative Pulmonary Complications and Inflammatory Response. A Double-center, Prospective, Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Péterfy Sándor Hospital||2|||f||||t||||||||No|IPD are not relevant in terms of results.|2017-10-10 21:41:58.846518|2017-10-10 21:41:58.846518
NCT02931396|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-02|||September 2015||2015-09-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Functional Electrical Stimulation Use in Trans-tibial Amputations|Functional Electrical Stimulation Use in Trans-tibial Amputations|Recruiting||N/A|20|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 21:41:58.971293|2017-10-10 21:41:58.971293
NCT02931006|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-10-10|||January 2017||2017-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Influence of Bovine Milk Consumption on Hormonal Profile in Males|Influence of Bovine Milk Consumption on Hormonal Profile in Males|Not yet recruiting||N/A|50|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||Undecided||2017-10-10 21:42:02.050743|2017-10-10 21:42:02.050743
NCT02931383|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-02-07|||November 2016||2016-11-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|US-LOSEIT-II||Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance|Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis Following Liraglutide Treatment, Investigating the Impact on Inflammation|Recruiting||Phase 4|150|Anticipated|Parker Research Institute||2|||f||||t||||||||||2017-10-10 21:41:59.04978|2017-10-10 21:41:59.04978
NCT02931370|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-02-07|||November 2016||2016-11-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|US-LOSEIT-I||Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss|Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis Following a Significant Weight Loss, Investigating the Impact on Inflammation|Recruiting||N/A|200|Anticipated|Parker Research Institute|||1||f||||t||||||||No||2017-10-10 21:41:59.129398|2017-10-10 21:41:59.129398
NCT02931357|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-05-15|||September 2013||2013-09-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants|A Randomized, Open, Parallel-group Multicenter Study of Efficacy and Tolerability of a New Medical Device in Gel Formulation (Hyaluronic Acid 0.54%) Versus Calgel® for the Topical Treatment of Teething in Infants|Completed||Phase 3|54|Actual|Ricerfarma S.r.l||2|||f||||t|f|f||||||Yes||2017-10-10 21:41:59.207558|2017-10-10 21:41:59.207558
NCT02931344|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-02-07|||November 2016||2016-11-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|BIO-LOSEIT-I||Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss|Biomarkers in Obese Patients With Knee Osteoarthritis Following a Significant Weight Loss|Recruiting||N/A|200|Anticipated|Parker Research Institute||1|||f||||t||||||||No||2017-10-10 21:41:59.405864|2017-10-10 21:41:59.405864
NCT02931318|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2016-10-10|||February 2016||2016-02-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Knowledge Levels and Attitudes of the People Living in Nevşehir on Organ Donation and Transplantation|The Knowledge Levels and Attitudes of the People Living in the City Center of Nevşehir on Organ Donation and Transplantation|Completed||N/A|414|Actual|Nevsehir Public Hospital||1|||f||||f||||||||No||2017-10-10 21:41:59.593719|2017-10-10 21:41:59.593719
NCT02931305|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|||Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease|Randomized, Double-blind, Placebo-controlled, Phase 1A Clinical Trial to Assess the Safety, Pharmacokinetic and Pharmacodynamic Effects of Single Escalating Doses of a Standardized Epimedium Prenylflavonoids (EP) Extract (HSA Chinese Proprietary Medicine No: 123317) in Healthy Men.|Recruiting||Phase 1|30|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||Undecided||2017-10-10 21:41:59.659641|2017-10-10 21:41:59.659641
NCT02931292|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-12|||June 2005||2005-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Observational|SG||A Decade of Sleeve Gastrectomy: Analysis of Short and Long-term Outcome of 562 Patients|A Decade of Sleeve Gastrectomy as a Single Bariatric/Metabolic Procedure: Analysis of Short and Long-term Outcome of 562 Patients|Completed||N/A|562|Actual|Medical Park Gaziantep Hospital|||1||f||||f||||||||No||2017-10-10 21:41:59.76034|2017-10-10 21:41:59.76034
NCT02931279|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-10-10|||September 2016||2016-09-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||PASS OCT® Post-market Clinical Follow-up|Evaluation of the Efficacy and Safety of the Cervical Posterior Fixation System PASS OCT®|Recruiting||N/A|40|Anticipated|Medicrea International|||1||f||||f||||||||No||2017-10-10 21:41:59.840721|2017-10-10 21:41:59.840721
NCT02931266|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-10-10|||September 2016||2016-09-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||PASS MIS® Post-market Clinical Follow-up|Evaluation of the Efficacy and Safety of the PASS MIS® System in the Treatment of Spinal Thoracolumbar Fractures|Recruiting||N/A|55|Anticipated|Medicrea International|||1||f||||f||||||||No||2017-10-10 21:41:59.933861|2017-10-10 21:41:59.933861
NCT02931253|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-02|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Metformin as an Upstream Therapy in Atrial Fibrillation|Metformin as an Upstream Therapy in Atrial Fibrillation|Recruiting||Phase 2|800|Anticipated|The Guthrie Clinic||2|||f||||t|t|f||||||No||2017-10-10 21:42:00.028475|2017-10-10 21:42:00.028475
NCT02931240|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-07-13|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||BioVentrix Revivent TC™ System Clinical Study|Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms|Recruiting||Phase 2/Phase 3|126|Anticipated|BioVentrix||2|||f||||t|f|t|f|||||||2017-10-10 21:42:00.127653|2017-10-10 21:42:00.127653
NCT02931227|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-04-14|||August 2014|Actual|2014-08-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TempCore||Accuracy of Zero Heat Flux Cutaneous Temperature in Intensive Care Adults||Recruiting||N/A|120|Anticipated|Poitiers University Hospital||4|||f||||||||||||||2017-10-10 21:42:00.23909|2017-10-10 21:42:00.23909
NCT02931214|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-07-11|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GMI-1359 in Healthy Adult Subjects|Recruiting||Phase 1|60|Anticipated|GlycoMimetics Incorporated||2|||f||||f||||||||||2017-10-10 21:42:00.355637|2017-10-10 21:42:00.355637
NCT02931201|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma|Evaluating Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography /Computed Tomography With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma|Recruiting||N/A|100|Anticipated|Beijing Cancer Hospital||1|||f||||f||||||||No||2017-10-10 21:42:00.46614|2017-10-10 21:42:00.46614
NCT02931188|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-06-23|||January 2017||2017-01-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|REVEAL-Vasc||The Effect of Anacetrapib on Vascular Function and Arterial Stiffness|A Cross-sectional REVEAL Sub-study Evaluating the Effect of Anacetrapib on Vascular Function and Arterial Stiffness [An Investigator Led Sub-study of HPS3/TIMI 55: REVEAL]|Recruiting||N/A|130|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||2||f||||f||||||Samples Without DNA|"     15ml blood samples will be collected from each participant at visit 1.   "|||2017-10-10 21:42:00.575918|2017-10-10 21:42:00.575918
NCT02931175|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-10|||January 2017||2017-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Interventional|ACTHAR||ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)|An Open-label, Multi-center, Randomized, Phase II Study of the Safety, and Bioactivity of Two Dose Regimens of Subcutaneous Injections of ACTH Gel in Patients With Non-infectious Uveitis|Not yet recruiting||Phase 2|36|Anticipated|Ocular Imaging Research and Reading Center||2|||f||||t||||||||No||2017-10-10 21:42:00.689874|2017-10-10 21:42:00.689874
NCT02931162|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-10-18|||October 2016||2016-10-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effects of Moxibustion on Ulcerative Colitis|Efficacy of Moxibustion Treatment on Patients With Ulcerative Colitis|Not yet recruiting||N/A|60|Anticipated|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||Undecided||2017-10-10 21:42:00.830321|2017-10-10 21:42:00.830321
NCT02931149|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-13|||August 2016||2016-08-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluation of the Efficacy of Platelet-rich Plasma (PRP) on Advanced Endoscopic Resection Techniques|Evaluation of the Efficacy of Platelet-rich Plasma (PRP) on Advanced Endoscopic Resection Techniques|Recruiting||Phase 3|12|Anticipated|Germans Trias i Pujol Hospital||1|||f||||f||||||||||2017-10-10 21:42:00.932552|2017-10-10 21:42:00.932552
NCT02931136|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-11|||November 2016||2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging|Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging|Not yet recruiting||Phase 4|300|Anticipated|Shanghai Mental Health Center||2|||f||||t||||||||Yes||2017-10-10 21:42:01.022067|2017-10-10 21:42:01.022067
NCT02931123|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-10|||November 2015||2015-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY||Recruiting||Phase 1/Phase 2|58|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||Undecided||2017-10-10 21:42:01.118871|2017-10-10 21:42:01.118871
NCT02931110|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-03-17|||January 2017||2017-01-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of IV CBL0137 in Previously Treated Hematological Subjects|A Phase 1 Dose-Escalation and Cohort-Expansion Study of Intravenous CBL0137 in Subjects With Previously Treated Hematological Cancers|Recruiting||Phase 1|110|Anticipated|Incuron||1|||f||||f||||||||Undecided||2017-10-10 21:42:01.190983|2017-10-10 21:42:01.190983
NCT02931097|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-11|||October 2016||2016-10-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|GAITPARK||DBS of the MLR for Gait and Balance Disorders in PD Patients|Effects of Deep Brain Stimulation of the Mesencephalic Locomotor Region on Gait and Balance Disorders in Parkinson's Disease Patients : a Randomized, Double-blind, Cross-over Study|Recruiting||Phase 1/Phase 2|12|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||f||||||||No||2017-10-10 21:42:01.273984|2017-10-10 21:42:01.273984
NCT02931084|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|December 2025|Anticipated|2025-12-01|October 2020|Anticipated|2020-10-01|4 Years|Observational [Patient Registry]|NACOX||Natural Course and Recovery After ACL-injury|Natural Course and Recovery After ACL-injury|Recruiting||N/A|800|Anticipated|Linkoeping University|||2||f||||f||||||Samples With DNA|"     Blood, urine and joint fluid will be collected from approximately 120 patientes rom one site     of the study   "|No||2017-10-10 21:42:01.366724|2017-10-10 21:42:01.366724
NCT02931071|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-10-10|||September 2013||2013-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1|Clinical Phase II Trial to Evaluate Efficacy and Safety of CD34+ Cells Mobilization and Collection After Treatment With Plerixafor and Filgrastim in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene and Reinfusion in the Patient|Recruiting||Phase 2|10|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||||||||||||2017-10-10 21:42:01.467165|2017-10-10 21:42:01.467165
NCT02931058|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-09-06|||October 2016||2016-10-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|QUADX-1||Quadriceps Exercise Before Total Knee Arthroplasty (The QUADX-1 Trial)|Efficacy of Pre-operative Quadriceps Strength Training on Knee-extension Strength Before and Shortly Following Total Knee Arthroplasty: A Randomized Dose-response Trial (The QUADX-1 Trial)|Recruiting||N/A|140|Anticipated|Hvidovre University Hospital||3|||f||||t||||||||||2017-10-10 21:42:01.554112|2017-10-10 21:42:01.554112
NCT02931045|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|AFFECT EV||Antiplatelet Therapy Effect on Platelet Extracellular Vesicles in Acute Myocardial Infarction|Antiplatelet Therapy Effect on Platelet Extracellular Vesicles in Acute Myocardial Infarction|Recruiting||Phase 4|60|Anticipated|Medical University of Warsaw||2|||f||||f||||||||No|The data will be presented in a collective form. If a particular study participant presents with an especially high or low concentration of the studied biomarker , the participant's characteristics may be described separately in a way which does not allow to identify the participant's personal data.|2017-10-10 21:42:01.673638|2017-10-10 21:42:01.673638
NCT02931032|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-10|||November 2016||2016-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Diagnosis of Common Oral Diseases by Signature Volatile Profiles|Diagnosis of Common Oral Diseases by Signature Volatile Profiles|Enrolling by invitation||N/A|100|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||No||2017-10-10 21:42:01.778543|2017-10-10 21:42:01.778543
NCT02930993|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||August 2016||2016-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors|A Safety and Efficacy Study of Autologous T Cells Engineered to Express Chimeric Antigen Receptor Targeting Mesothelin in Patients With Recurred or Metastatic Malignant Tumors|Recruiting||Phase 1|20|Anticipated|China Meitan General Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:42:02.131697|2017-10-10 21:42:02.131697
NCT02930980|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-05-26|||October 14, 2016|Actual|2016-10-14|May 2017|2017-05-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|MASS2||Micra Accelerometer Sensor Study 2||Completed||N/A|45|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f|f|f||||||Undecided||2017-10-10 21:42:02.214064|2017-10-10 21:42:02.214064
NCT02930967|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||August 2016||2016-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant Tumors|A Safety and Efficacy Study of Chimeric Switch Receptor Modified T Cells in Patients With Recurrent or Metastatic Malignant Tumors|Recruiting||Phase 1|20|Anticipated|China Meitan General Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:42:02.287541|2017-10-10 21:42:02.287541
NCT02930954|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||November 2016||2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance|Combination of Gefitinib With Chemotherapy or Anti-angiogenesis as 1st Line Treatment in Advanced NSCLC Patients Detected With Bim Deletion or Low EGFR Activating Mutation Abundance|Not yet recruiting||Phase 2|180|Anticipated|Tongji University||3|||f||||t||||||||Yes|Share the patient characteristics, results of test, treatment and outcome.|2017-10-10 21:42:02.381145|2017-10-10 21:42:02.381145
NCT02930941|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-08-10|||February 2016||2016-02-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department|Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department|Recruiting||N/A|70|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-10-10 21:42:02.498257|2017-10-10 21:42:02.498257
NCT02930928|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-28|||October 2016|Actual|2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|Including MUC||Can Habitus Adapted Length Based Body Weight Estimation be Improved by Adding Further Parameters?|Evaluation of an Algorithm for Gender Specific and Habitus Adapted Length Based Body Weight Estimation in Children - Improvement by Adding Another Parameter?|Recruiting||N/A|500|Anticipated|University Children's Hospital, Zurich|||1||f||||t||||||||||2017-10-10 21:42:02.636819|2017-10-10 21:42:02.636819
NCT02930915|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-10|||June 2016||2016-06-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||Acquisition of 3D Facial Geometry of Patients' Scheduled for Radiotherapy Treatment|Feasibility Study: Acquisition of Three Dimensional Facial Geometry of Patients' Scheduled for Head and Neck Radiotherapy Treatment.|Enrolling by invitation||N/A|12|Anticipated|University of East Anglia|||1||f||||f||||||||Undecided||2017-10-10 21:42:02.728054|2017-10-10 21:42:02.728054
NCT02930889|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)|Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)|Recruiting||Phase 1/Phase 2|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-10 21:42:02.976021|2017-10-10 21:42:02.976021
NCT02930876|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-03-06|||July 2016||2016-07-01|August 2016|2016-08-01|February 8, 2017|Actual|2017-02-08|February 8, 2017|Actual|2017-02-08||Interventional|||Feasibility of Home vs. Hospital Based Resistance Training for Advanced Cancer Patients|Feasibility of Home vs. Hospital Based Resistance Training for Advanced Cancer Patients: a Phase II Trial|Completed||Phase 2|15|Actual|King's College London||3|||f||||f||||||||Yes|Presentation in conferences and publication in peer reviewed journals|2017-10-10 21:42:03.093246|2017-10-10 21:42:03.093246
NCT02930863|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Pulse Oximetry With Automated Verbal Prompts|Prevention of Post Operative Hypoxia in the Post Anesthesia Care Unit Using Pulse Oximetry With Automated Verbal Prompts|Recruiting||N/A|500|Anticipated|University of Florida||2|||f||||f||||||||No||2017-10-10 21:42:03.215243|2017-10-10 21:42:03.215243
NCT02930850|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-05-09|||September 2016||2016-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:42:03.307828|2017-10-10 21:42:03.307828
NCT02930824|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-19|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing|Implementing Genomics in Practice (IGNITE) Proof of Concept Study: CYP2C19 Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing|Recruiting||N/A|180|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-10 21:42:03.450557|2017-10-10 21:42:03.450557
NCT02930811|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-04-12|||June 2017|Anticipated|2017-06-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|VALSTAR||Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claudication|Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claudication. A National, Multicentre, Prospective, Randomised, Double-Blind, Placebo-Controlled Trial.|Not yet recruiting||Phase 3|500|Anticipated|University Hospital, Angers||2|||f||||t|f|f||||||No||2017-10-10 21:42:03.540241|2017-10-10 21:42:03.540241
NCT02930798|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-28|||October 18, 2016|Actual|2016-10-18|September 2017|2017-09-01|October 19, 2016|Actual|2016-10-19|October 19, 2016|Actual|2016-10-19||Interventional|||Sun Protection Factor Assay (SPF Assay 203/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|3|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:42:03.615883|2017-10-10 21:42:03.615883
NCT02930785|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-28|||October 12, 2016|Actual|2016-10-12|September 2017|2017-09-01|October 27, 2016|Actual|2016-10-27|October 27, 2016|Actual|2016-10-27||Interventional|||Sun Protection Factor Assay (SPF Assay 202/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|5|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:42:03.691385|2017-10-10 21:42:03.691385
NCT02930759|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-27|||October 12, 2016|Actual|2016-10-12|September 2017|2017-09-01|October 13, 2016|Actual|2016-10-13|October 13, 2016|Actual|2016-10-13||Interventional|||Sun Protection Factor Assay (SPF Assay 200/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|3|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:42:03.825249|2017-10-10 21:42:03.825249
NCT02930746|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-09-27|||October 12, 2016|Actual|2016-10-12|September 2017|2017-09-01|October 13, 2016|Actual|2016-10-13|October 13, 2016|Actual|2016-10-13||Interventional|||Sun Protection Factor Assay (SPF Assay 199/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|3|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:42:03.894481|2017-10-10 21:42:03.894481
NCT02930733|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-01-21|||July 2016||2016-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SPB||Serratus Plane Block For Breast Reduction Surgery|The Effects of Bilateral Serratus Plane Block on Postoperative Opioid Consumption After Breast Reduction Surgery|Completed||Phase 4|40|Actual|Ataturk University||2|||f||||f||||||||||2017-10-10 21:42:03.963518|2017-10-10 21:42:03.963518
NCT02930720|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|SUI||Pelvic Floor Displacement in Women With SUI and Healthy Women: An Ultrasound Study (Stress Urinary Incontinence)|The Influence of Various Breathing Protocols and Cough on the Amount of Pelvic Floor Displacement in Women With Stress Urinary Incontinence and Healthy Women: An Ultrasound Study|Not yet recruiting||N/A|50|Anticipated|Assuta Hospital Systems|||1||f||||f||||||||No||2017-10-10 21:42:04.05227|2017-10-10 21:42:04.05227
NCT02930707|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||January 2016||2016-01-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||TAP Block With Magnesium Sulfate Added to Local Anesthetic in Abdominal Hysterectomy|Efficacy and Safety of Magnesium Sulfate Added to Local Anesthetic in TAP Block for Postoperative Analgesia Following Total Abdominal Hysterectomy.|Active, not recruiting||Phase 2/Phase 3|60|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 21:42:04.112865|2017-10-10 21:42:04.112865
NCT02930694|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-02-15|||October 2016||2016-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female Participants|A Randomized, Open-label, 2-Way Crossover, Parallel-group Study in Healthy Male and Female Subjects to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446|Completed||Phase 1|32|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-10 21:42:04.179798|2017-10-10 21:42:04.179798
NCT02930681|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-02-07|||August 2016||2016-08-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects|Double-blind, Randomised, Placebo-controlled, 3-way Cross-over Study to Evaluate the Benefit of Two Glucosanol™ Dosages to Reduce Post-prandial Glucose Levels in Overweight Subjects|Completed||N/A|24|Actual|InQpharm Group||3|||f||||f||||||||No||2017-10-10 21:42:04.258317|2017-10-10 21:42:04.258317
NCT02930668|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-02-07|||May 2016||2016-05-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy and Safety of Glucosanol™ in Body Weight Reduction|Double-blind, Randomised, Placebo-controlled Study to Evaluate Benefit of Glucosanol™ in Reducing Body Weight in Overweight and Moderately Obese Subjects|Completed||N/A|89|Actual|InQpharm Group||3|||f||||f||||||||No||2017-10-10 21:42:04.326091|2017-10-10 21:42:04.326091
NCT02930655|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-07-25|||February 1, 2015|Actual|2015-02-01|July 2017|2017-07-01|February 1, 2016|Actual|2016-02-01|February 1, 2016|Actual|2016-02-01||Interventional|||A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease|A Single-center, Open-label, Randomized, Versus a Control Group, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Oral Lucerastat in Adult Subjects With Fabry Disease Receiving Enzyme Replacement Therapy|Completed||Phase 1|14|Actual|Actelion||2|||f||||f||||||||||2017-10-10 21:42:04.392227|2017-10-10 21:42:04.392227
NCT02930642|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-10|||June 2016||2016-06-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|FIOI||Food Insecurity, Obesity, and Impulsive Food Choice|Food Insecurity, Obesity, and Impulsive Food Choice|Active, not recruiting||Phase 1|120|Actual|Idaho State University||3|||f||||t||||||||Yes||2017-10-10 21:42:04.468631|2017-10-10 21:42:04.468631
NCT02930629|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-04-27|||October 2016||2016-10-01|April 2017|2017-04-01|August 18, 2017|Anticipated|2017-08-18|August 18, 2017|Anticipated|2017-08-18||Observational|||Residual Block in Postoperative Anaesthetic Care Unit|Assessment of Residual Paralysis in Patients in the Postoperative Anaesthetic Care Unit (PACU)|Recruiting||N/A|400|Anticipated|Singapore General Hospital|||1||f||||f||||||||No||2017-10-10 21:42:04.537407|2017-10-10 21:42:04.537407
NCT02930616|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Comparison of pCLE Based Targeted Biopsy and WLE Based Standard Biopsy in Staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM): A Randomized，Cross-over Study||Not yet recruiting||Phase 4|40|Anticipated|Shandong University||2|||f||||t||||||||No||2017-10-10 21:42:04.604324|2017-10-10 21:42:04.604324
NCT02930603|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-10|||April 2014||2014-04-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|||A Longitudinal Study of Function and Participation in Life Activities of Patients With Developmental Disabilities|A Longitudinal Study of Function and Participation in Life Activities of Patients With Developmental Disabilities|Recruiting||N/A|700|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||||No||2017-10-10 21:42:04.678342|2017-10-10 21:42:04.678342
NCT02930577|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-10-10|||October 2015||2015-10-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Observational|TASU||Treatment Adherence in Substance Users|Factors Associated With Treatment Adherence in Substance Users|Completed||N/A|216|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||t||||||Samples Without DNA|"     Patients who completed addiction treatment between November 2013 and January 2016   "|Undecided||2017-10-10 21:42:04.815609|2017-10-10 21:42:04.815609
NCT02930564|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2017-01-31|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep Remission|The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep Remission|Not yet recruiting||N/A|10|Anticipated|Wolfson Medical Center||1|||f||||t|f|f||||||Undecided||2017-10-10 21:42:04.880833|2017-10-10 21:42:04.880833
NCT02930551|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-10|||September 2016||2016-09-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Neuromas as the Cause of Pain|Infiltration of Neuromas With Local Anesthetics to Eliminate Pain: A Double-blinded Crossover Study|Recruiting||N/A|24|Anticipated|Danish Pain Research Center||2|||f||||t||||||||No||2017-10-10 21:42:04.94107|2017-10-10 21:42:04.94107
NCT02930538|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-04-20|||November 22, 2016|Actual|2016-11-22|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Can Postoperative Outcomes be Predicted From Asking OSA Screening Questions Pre-operatively?||Enrolling by invitation||N/A|1000|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:42:05.010727|2017-10-10 21:42:05.010727
NCT02930525|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-11|||September 2016||2016-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|HiFiPPS||Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation|Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation: A Randomized Controlled Pilot Trial|Recruiting||N/A|50|Anticipated|University of Freiburg||2|||f||||f||||||||No||2017-10-10 21:42:05.212751|2017-10-10 21:42:05.212751
NCT02930512|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-18|||June 2016||2016-06-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Observational|PAFOS||Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease|Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease|Recruiting||N/A|200|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 21:42:05.319236|2017-10-10 21:42:05.319236
NCT02930499|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-03-28|||January 2016||2016-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Hyaluronic Acid ECM on Venous Ulcers|A Prospective, Randomized, Controlled, Longitudinal Study Using Repeated Measures Design to Evaluate a Hyaluronic Acid Extracellular Matrix (Hyalomatrix®) in the Management of Chronic Venous Ulcers|Suspended||N/A|20|Actual|Calvary Hospital, Bronx, NY||2||Investigator relocation|f||||f||||||||Undecided||2017-10-10 21:42:05.413059|2017-10-10 21:42:05.413059
NCT02930486|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-10-09|||January 2016||2016-01-01|October 2016|2016-10-01|October 2022|Anticipated|2022-10-01|October 2017|Anticipated|2017-10-01||Interventional|S16||Ziptight or Tricortical Screw Fixation of Acute Tibiofibular Syndesmotic Injury|Ziptight or Tricortical Screw Fixation of Acute Tibiofibular Syndesmotic Injury|Recruiting||N/A|120|Anticipated|Vestre Viken Hospital Trust||2|||f||||f||||||||No||2017-10-10 21:42:05.512638|2017-10-10 21:42:05.512638
NCT02930473|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-12|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Evaluation of a Psychotherapeutic Intervention Model in Nursing|"Short-term Efficacy Evaluation of a Psychotherapeutic Intervention Model in Nursing on Nursing Diagnosis Anxiety: A Randomised Controlled Trial"|Completed||N/A|133|Actual|Universidade do Porto||2|||f||||f||||||||No||2017-10-10 21:42:05.611176|2017-10-10 21:42:05.611176
NCT02930460|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-04-11|||November 2016||2016-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|PoP IN VAuto||Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy.|Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure, Treated With Bilevel Positive Airway Pressure (AirCurve 10 VAutoTM) as Second-line Therapy: PoP IN VAuto|Recruiting||N/A|40|Anticipated|ResMed|||1||f||||f||||||||No||2017-10-10 21:42:05.696113|2017-10-10 21:42:05.696113
NCT02930447|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-10|||January 2017||2017-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty|Prospective, Randomized, Controlled Study to Evaluate the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty|Not yet recruiting||N/A|56|Anticipated|Regen Lab SA||2|||f||||f||||||||Undecided||2017-10-10 21:42:05.789054|2017-10-10 21:42:05.789054
NCT02929706|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-10|||July 2016||2016-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effectiveness of Thiopurine Dose Optimization by NUDT 15 R139C on Reducing Thiopurine-induced Leucopenia in Inflammatory Bowel Disease||Recruiting||N/A|400|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||||||||||||2017-10-10 21:42:11.9194|2017-10-10 21:42:11.9194
NCT02930434|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|AntarD||Effects of Antarctic Environment on Vitamin D Status and Health Risk Biomarkers of Its Inhabitants|Effects of Antarctic Environment on Vitamin D Status and Health Risk Biomarkers of Its Inhabitants|Enrolling by invitation||N/A|150|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||Undecided||2017-10-10 21:42:05.861566|2017-10-10 21:42:05.861566
NCT02930421|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2017-03-30|||March 2015||2015-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Exercise Training in Patients With Mild COPD|Clinical and Physiological Effects of Exercise Training in Symptomatic Patients With Mild COPD|Recruiting||N/A|60|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||Yes||2017-10-10 21:42:05.956031|2017-10-10 21:42:05.956031
NCT02930408|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||January 2014||2014-01-01|August 2016|2016-08-01||||July 2015|Actual|2015-07-01||Interventional|||Compare Train and 3D-4D Left Ventricular Systolic Function in Subjects Suffering From Dystrophy and Healthy Subjects||Terminated||N/A|70|Anticipated|Poitiers University Hospital|||||f||||||||||||||2017-10-10 21:42:06.057841|2017-10-10 21:42:06.057841
NCT02930395|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|RUGBYPROS100B||Blood Biomarkers for the Management of Concussion in Professional Rugby Players|Blood Biomarkers for the Management of Concussion in Professional Rugby Players|Not yet recruiting||N/A|560|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 21:42:06.115771|2017-10-10 21:42:06.115771
NCT02930382|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-12|||February 2015||2015-02-01|August 2016|2016-08-01||||September 2017|Anticipated|2017-09-01||Interventional|BARODEF||Assessment of Spontaneous Baroreflex Sensitivity in Carriers of Implantable Cardioverter Defibrillators: Association With Disorders of the Ventricular Heart Rate. Case-control Study||Recruiting||N/A|32|Anticipated|Poitiers University Hospital||1|||f||||||||||||||2017-10-10 21:42:06.205686|2017-10-10 21:42:06.205686
NCT02930369|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-11|||June 2015||2015-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effects of Different Area of Internal Limiting Membrane Peeling (ILM) Peeling on Anatomical Outcomes in Macular Hole Surgery|A Randomized, Comparative, Prospective Study of Anatomical Outcomes With Different Internal Limiting Membrane Peeling Area in Surgery for Idiopathic Macular Hole|Completed||Phase 4|128|Actual|Peking University People's Hospital||2|||f||||||||||||||2017-10-10 21:42:06.280027|2017-10-10 21:42:06.280027
NCT02930356|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-10|2016-10-10|||January 2016||2016-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|ETCSNSGD||Effect of Tooth Cleaning in Smokers and Non Smokers With Gum Disease.|Effects of Nonsurgical Periodontal Therapy on Plasma Hepatocyte Growth Factor Levels in Smokers and Non Smokers With Chronic Periodontitis|Completed||N/A|40|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||f||||||||No||2017-10-10 21:42:06.373865|2017-10-10 21:42:06.373865
NCT02930343|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-09|||September 2016||2016-09-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy|Comparison of Sulfasalazine Versus Leflunomide Based Combination Disease Modifying Anti-rheumatic Drug Therapy (DMARD) in Patients With Rheumatoid Arthritis Failing Methotrexate Monotherapy : A Randomized Control Trial|Recruiting||Phase 4|150|Anticipated|Jawaharlal Institute of Postgraduate Medical Education & Research||2|||f||||f||||||||No||2017-10-10 21:42:06.499423|2017-10-10 21:42:06.499423
NCT02930330|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-08-30|||October 2015||2015-10-01|August 2017|2017-08-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|||Interval Training in Cardiac Rehabilitation|Interval Training in Cardiac Rehabilitation: Effects on Cardiorespiratory Fitness and Platelet Function - A Randomized Controlled Trial|Completed||N/A|82|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 21:42:06.654345|2017-10-10 21:42:06.654345
NCT02930317|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-11|||August 2016||2016-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A|An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of rFVIII in the Prevention and Treatment of Bleeding Episodes in Chinese With Hemophilia A|Recruiting||Phase 3|60|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||f||||||||Undecided||2017-10-10 21:42:06.756297|2017-10-10 21:42:06.756297
NCT02930304|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2017-02-11|||August 2016||2016-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Non-Surgical Treatment Approaches in Patients With Newly Diagnosed Lateral Epicondylitis: A Randomized Clinical Trial|Non-Surgical Treatment Approaches in Patients With Newly Diagnosed Lateral Epicondylitis: A Randomized Clinical Trial|Completed||N/A|45|Actual|Hacettepe University||3|||f||||t||||||||No||2017-10-10 21:42:06.867155|2017-10-10 21:42:06.867155
NCT02930291|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-10-12|||September 2016||2016-09-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Observational|||The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic Gastrectomy|The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic Gastrectomy— A Prospective Cohort Study|Recruiting||N/A|310|Anticipated|Fujian Medical University|||1||f||||t||||||||No||2017-10-10 21:42:06.968125|2017-10-10 21:42:06.968125
NCT02930278|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-10-12|||September 2016||2016-09-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic Gastrectomy|The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic Gastrectomy— A Prospective Cohort Study|Recruiting||N/A|400|Anticipated|Fujian Medical University|||1||f||||t||||||||No||2017-10-10 21:42:07.068874|2017-10-10 21:42:07.068874
NCT02930265|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-08|||September 2016||2016-09-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy|Chinese People's Liberation Army General Hospital|Enrolling by invitation||N/A|400|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||No||2017-10-10 21:42:07.172796|2017-10-10 21:42:07.172796
NCT02928055|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-02-10|||October 2016||2016-10-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Peripheral Nerve Stimulation for Shoulder Pain: Dose Response|Implanted PNS for Shoulder Pain in Stroke|Recruiting||N/A|30|Anticipated|MetroHealth Medical Center||3|||f||||f|f|t|f|f||||No||2017-10-10 21:42:30.073421|2017-10-10 21:42:30.073421
NCT02930252|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-11|||December 2014||2014-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|SEMS||Covered Versus Uncovered SEMS for Palliation of Malignant Biliary Strictures.|Covered Versus Uncovered Self-conformable Metal Stent for Palliation of Primary Malignant Extra-hepatic Biliary Strictures: a Randomized Multicenter Study|Completed||N/A|170|Actual|Azienda USL 1 Imperiese||2|||f||||f||||||||No||2017-10-10 21:42:07.27059|2017-10-10 21:42:07.27059
NCT02930239|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-10-11|||March 2016||2016-03-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|July 2017|Anticipated|2017-07-01||Interventional|||Gait Rehabilitation Following an Anterior Cruciate Ligament Reconstruction|Early Initiated Gait Rehabilitation Using the Anti-gravity Treadmill Following an Anterior Cruciate Ligament Reconstruction|Recruiting||Phase 2|30|Anticipated|Linkoeping University||2|||f||||f||||||||No||2017-10-10 21:42:07.40152|2017-10-10 21:42:07.40152
NCT02930226|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-06-16|||May 1, 2016|Actual|2016-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|FDP||Ascending Doses of Autologous FDP vs FFP|A Phase 1, Single-Center, Partial Double-Blind, Randomized, Controlled (Versus Fresh Frozen Plasma [FFP] in Cohort 3 Only) Clinical Study of the Safety of Ascending Doses of Autologous Freeze Dried Plasma (FDP) in Healthy Volunteers|Recruiting||Phase 1|24|Anticipated|U.S. Army Medical Research and Materiel Command||6|||f||||t||||||||Undecided||2017-10-10 21:42:07.508965|2017-10-10 21:42:07.508965
NCT02930213|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-11|||January 2015||2015-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01|8 Days|Observational [Patient Registry]|||The Core Body Temperature Rhythms: Distinguishing MCS From UWS|The Core Body Temperature Rhythms:A Promising Indicator of Distinguishing MCS From UWS|Completed||Phase 2|7|Actual|Hangzhou Normal University|||1||f||||t||||||||||2017-10-10 21:42:07.601253|2017-10-10 21:42:07.601253
NCT02930200|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-31|||May 30, 2017|Actual|2017-05-30|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Smart-T2||Clinical Trial of an Automated Smartphone Based Smoking Cessation Treatment|Pilot Randomized Clinical Trial of an Automated Smartphone Based Smoking Cessation Treatment|Recruiting||N/A|90|Anticipated|University of Oklahoma||3|||f||||f|f|f||||||No||2017-10-10 21:42:07.66613|2017-10-10 21:42:07.66613
NCT02930187|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-07|||March 2015||2015-03-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|EVER-1||Ultrasound Evaluation of Remission in Rheumatoid Arthritis|Agreement Between Disease Activity and Ultrasound Scoring (Naredo-12) in Patients With Rheumatoid Arthritis With Clinical Remission in Daily Practice.|Completed||N/A|225|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 21:42:07.753699|2017-10-10 21:42:07.753699
NCT02930174|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-07-20|||November 2016||2016-11-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||EIT Assessment of Lung Volume and Tidal Distribution: A Comparison of Non-Invasive Ventilation Devices|EIT Assessment of Lung Volume and Tidal Distribution: A Comparison of Non-Invasive Ventilation Devices|Enrolling by invitation||N/A|20|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-10 21:42:07.815352|2017-10-10 21:42:07.815352
NCT02930161|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-07|||June 2016||2016-06-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome|Многоцентровое двойное слепое плацебо-контролируемое рандомизированное исследование препарата Рунихол® у пациентов с неалкогольной жировой болезнью печени на фоне метаболического синдрома|Recruiting||Phase 2|204|Anticipated|Scientific Technological Pharmaceutical Firm Polysan, Ltd.||3|||f||||f||||||||Undecided||2017-10-10 21:42:07.894497|2017-10-10 21:42:07.894497
NCT02930148|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-11|||October 2016||2016-10-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|PEGASO||Personalised Guidance Service for Lifestyle Management and Obesity Prevention in Teen-agers Pilot Study|Personalised Guidance Service for Lifestyle Management and Obesity Prevention in Teen-agers: A Multicenter Quasi-experimental Pilot Study|Not yet recruiting||N/A|525|Anticipated|Agència de Qualitat i Avaluació Sanitàries||2|||f||||f||||||||||2017-10-10 21:42:08.001385|2017-10-10 21:42:08.001385
NCT02930135|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-11-18|||August 2015||2015-08-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of Post Operative Pain Following Indirect Pulp Capping Using Antibacterial Bonding System|Evaluation of Post Operative Pain Following Indirect Pulp Treatment in Young Permanent Teeth Using Antibacterial Versus Conventional Two-Step Bonding System: A Randomized Clinical Trial|Active, not recruiting||Phase 2/Phase 3|36|Actual|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:42:08.085235|2017-10-10 21:42:08.085235
NCT02930122|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-08-07|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions|A Prospective, Single-Center, Randomized, Triple-Blinded, Placebo-Controlled Study of IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions|Not yet recruiting||Phase 2|60|Anticipated|University of Kentucky||3|||f||||t|t|f||||||||2017-10-10 21:42:08.166792|2017-10-10 21:42:08.166792
NCT02930109|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-05-17|||September 2016||2016-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia|A Phase I-II Study of Triciribine Phosphate Monohydrate (PTX-200) Plus Cytarabine in Refractory or Relapsed Acute Leukemia|Recruiting||Phase 1/Phase 2|40|Anticipated|Prescient Therapeutics, Ltd.||1|||f||||f||||||||No||2017-10-10 21:42:08.262942|2017-10-10 21:42:08.262942
NCT02930096|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-07-03|||March 2016||2016-03-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Observational|D-Velocity||Study of the Effect of the Supine Position at Brain Velocities in Noncerebro - Injured Patient||Recruiting||N/A|40|Anticipated|Poitiers University Hospital|||1||f||||||||||||||2017-10-10 21:42:08.372053|2017-10-10 21:42:08.372053
NCT02927847|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-05-24|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation|Targeting Reward Dysfunction as a Mechanism to Improve Smoking Cessation|Recruiting||Phase 1/Phase 2|100|Anticipated|Duke University||2|||f||||f|t|f||||||No||2017-10-10 21:42:32.073293|2017-10-10 21:42:32.073293
NCT02930070|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-11|||September 2016||2016-09-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|qSOFAGAUGE||qSOFA in General Wards: the Accuracy in Diagnosis of Sepsis|Diagnostic Accuracy of qSOFA Score for the Diagnosis of Sepsis in General Wards: a Single Center Cohort Study|Recruiting||N/A|4000|Anticipated|Peking Union Medical College Hospital|||4||f||||f||||||||Undecided||2017-10-10 21:42:08.491839|2017-10-10 21:42:08.491839
NCT02930057|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Transforaminal Epidural Steroid Injection With Pulsed Radiofrequency for Chronic Lumbosacral Radicular Pain Management|Transforaminal Epidural Steroid Injection in Conjunction With Pulsed Radiofrequency Treatment of the Lumbar Dorsal Root Ganglion for the Management of Chronic Lumbosacral Radicular Pain: a Randomized, Double-blind Trial|Not yet recruiting||Phase 4|120|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 21:42:08.579383|2017-10-10 21:42:08.579383
NCT02930044|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-30|||October 2016||2016-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis|Prospective Comparison of Early Subcutaneous Insulin Glargine Plus Standard of Care Versus Standard of Care for Treatment of Diabetic Ketoacidosis in the Emergency Department|Recruiting||N/A|18|Anticipated|University of Maryland||2|||f||||f||||||||No|Individual subject results will not be shared with those involved in the prospective arm.|2017-10-10 21:42:08.698955|2017-10-10 21:42:08.698955
NCT02930031|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-07|||January 2015||2015-01-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Redox Status and Immune Function|Evidence of a Redox-dependent Regulation of Immune Responses to Exercise-Induced Inflammation|Completed||N/A|10|Actual|National and Kapodistrian University of Athens||2|||f||||t||||||||||2017-10-10 21:42:08.814098|2017-10-10 21:42:08.814098
NCT02930018|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-03-02|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|ESCAPE-NA1||Safety and Efficacy of NA-1 in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1)|A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy|Recruiting||Phase 3|1120|Anticipated|NoNO Inc.||2|||f||||t|t|f||||||Undecided||2017-10-10 21:42:08.940146|2017-10-10 21:42:08.940146
NCT02930005|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-07|||August 2015||2015-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders|A Pilot Open-label Trial of Pentosan Polysulfate Sodium and Meclofenamic Acid As Adjunctive Treatments in Patients With Psychotic Disorders|Enrolling by invitation||Phase 2|20|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||No||2017-10-10 21:42:09.111948|2017-10-10 21:42:09.111948
NCT02929992|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|DO ART||Delivery Optimization for Antiretroviral Therapy (The DO ART Study)|Delivery Optimization for Antiretrovial Therapy (The DO ART Study): A Prospective, Interventional, Randomized Study of Community-based ART Initiation, Delivery, and Monitoring in South Africa and Uganda|Recruiting||N/A|1200|Anticipated|University of Washington||3|||f||||t||||||||||2017-10-10 21:42:09.192268|2017-10-10 21:42:09.192268
NCT02929979|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-08-15|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|August 15, 2019|Anticipated|2019-08-15|August 15, 2019|Anticipated|2019-08-15||Interventional|||Cognitive Remediation for Alcohol Use Disorder and Posttraumatic Stress Disorder|Cognitive Remediation for Alcohol Use Disorder and Posttraumatic Stress Disorder|Recruiting||N/A|148|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:42:09.48736|2017-10-10 21:42:09.48736
NCT02929966|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PULFIP||Palliative Care in Pulmonary Fibrosis|Effect of Palliative Care in Patients With End Stage Pulmonary Fibrosis: a Randomized Control Study|Not yet recruiting||N/A|50|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||No||2017-10-10 21:42:09.638882|2017-10-10 21:42:09.638882
NCT02929953|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-08|||January 2014||2014-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|T1Dpremies||Prematurity Prevalence Among T1D Patients and Its Characteristics Compared With Premature-born Non-diabetic Patients|Prevalence of Premature Birth History Among Type 1 Diabetes Mellitus (T1D) Patients and Characteristics of Premature Born Children Who Develop T1D Compared With Those Who do Not|Active, not recruiting||N/A|3600|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||||No|IPD data will not be available for anyone other than the PI and co-investigators.|2017-10-10 21:42:09.758338|2017-10-10 21:42:09.758338
NCT02929940|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-05-29|||April 2015||2015-04-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01|5 Years|Observational [Patient Registry]|||Liver Disease in Patients With alpha1-antitrypsin Deficiency|Multi-center Study of the Liver Disease in European Patients With alpha1-antitrypsin Deficiency|Recruiting||N/A|500|Anticipated|RWTH Aachen University|||4||f||||t||||||Samples With DNA|"     Blood specimen for serologic and genetic analyses   "|No||2017-10-10 21:42:09.918319|2017-10-10 21:42:09.918319
NCT02929927|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-10|||March 2016||2016-03-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Estimate the Effect of the Photo-activated Disinfection on the Root Canal Therapy|Acess the Clinical Effect of Photodynamic Therapy(PDT) in the Root Canal Disinfection.|Recruiting||N/A|40|Anticipated|Fujian Medical University||3|||f||||f||||||||No||2017-10-10 21:42:10.085574|2017-10-10 21:42:10.085574
NCT02929914|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-17|||June 2016||2016-06-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Effect of Photodynamic Therapy on Deep Caries in Permanent Tooth,A Controlled Clinical Trial|Effect of Photodynamic Therapy on Deep Caries in Permanent Tooth,A Controlled Clinical Trial|Recruiting||Phase 1|40|Anticipated|Fujian Medical University||2|||f||||f||||||||No||2017-10-10 21:42:10.276483|2017-10-10 21:42:10.276483
NCT02929901|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-14|||December 2016||2016-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes||Not yet recruiting||Phase 2/Phase 3|200|Anticipated|National Nutrition and Food Technology Institute||4|||f||||||||||||||2017-10-10 21:42:10.425763|2017-10-10 21:42:10.425763
NCT02929888|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Interventional|ECCLIPSE-STEMI||Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients|Effects of Intravenous Lysine Acetylsalicylate Versus Oral Aspirin on Platelet Responsiveness in Patients With ST-segment Elevation Myocardial Infarction: a Pharmacodynamic Study (ECCLIPSE-STEMI Trial)|Recruiting||Phase 2/Phase 3|60|Anticipated|Fundacion Investigacion Interhospitalaria Cardiovascular||2|||f||||||||||||||2017-10-10 21:42:10.530317|2017-10-10 21:42:10.530317
NCT02929875|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-30|||December 2015||2015-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||The Effect of Educational Intervention on Delivery Type Selection in Pregnant Women at Kermanshah, Iran|Assessing the Effect of Education Based on Theory of Planned Behavior (TPB) on Delivery Type Selection in Pregnant Women Referring to Kermanshah Health Centers at 1393|Completed||N/A|100|Actual|Ilam University of Medical Sciences||2|||f||||f||||||||No||2017-10-10 21:42:10.648385|2017-10-10 21:42:10.648385
NCT02929862|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-02-20|||December 2016||2016-12-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer|A Phase 1/2a Multicenter, Open-Label Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer|Recruiting||Phase 1/Phase 2|90|Anticipated|Lycera Corp.||1|||f||||||||||||||2017-10-10 21:42:10.730933|2017-10-10 21:42:10.730933
NCT02929849|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-02-04|||August 2015||2015-08-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|June 2016|Actual|2016-06-01||Interventional|||Satiety and Glucose Indices in Adults|Influence of Herb With Alpha-glucosidase Properties (Salacia Chinensis) on Appetite, Glucose and Hormonal Factors: A Double Blind Randomized Placebo Controlled-crossover Trial|Active, not recruiting||Phase 1|51|Actual|Rutgers University||3|||f||||t||||||||Undecided|rules/regulations would need to be confirmed|2017-10-10 21:42:10.841007|2017-10-10 21:42:10.841007
NCT02929836|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-19|||May 2016||2016-05-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Catheter Ablation of Longstanding Persistent Atrial Fibrillation|Optimal Ablation Endpoint for Longstanding Persistent Atrial Fibrillation: a Randomized Prospective Study|Recruiting||N/A|450|Anticipated|Shanghai Chest Hospital||3|||f||||t||||||||No||2017-10-10 21:42:10.955987|2017-10-10 21:42:10.955987
NCT02929823|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-13|||September 2016||2016-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Safety and Efficacy of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders|A Double-Masked, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study of SJP-0035 Ophthalmic Solution Compared With Placebo to Assess Safety and Efficacy of Two Dose Concentrations of SJP-0035 Ophthalmic Solution for Corneal Epithelial Wound Healing in Patients With Moderate to Severe Corneal Epithelial Disorders|Recruiting||Phase 2|105|Anticipated|Senju Pharmaceutical Co., Ltd.||3|||f||||t||||||||Yes||2017-10-10 21:42:11.075205|2017-10-10 21:42:11.075205
NCT02929810|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2017-08-08|||October 2016||2016-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Sleep Extension and Blood Pressure|Lowering Blood Pressure by Sleep Extension: a Randomized, Controlled Trial|Recruiting||N/A|54|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 21:42:11.181589|2017-10-10 21:42:11.181589
NCT02929797|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-10|||August 2016||2016-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|AKT||Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer|A Randomized, Double Blinding, Placebo-Controlled Clinical Trials of CD8+NKG2D+ AKT Cell Immunotherapy to the Pancreatic Cancer Patients Treated With Adjuvant Chemotherapy|Recruiting||Early Phase 1|72|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:42:11.267413|2017-10-10 21:42:11.267413
NCT02929784|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-09|2016-10-10|||November 2016||2016-11-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||tDCS to Treat Hemiplegic Shoulder Pain|Assesing Hemiplegic Shoulder Pain and the Use of tDCS to Treat This Pain|Not yet recruiting||N/A|100|Anticipated|Loewenstein Hospital||3|||f||||t||||||||||2017-10-10 21:42:11.377075|2017-10-10 21:42:11.377075
NCT02929771|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-10-03|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Using Virtual Reality to Reduce Procedural Pain in Children With Cancer|Using Virtual Reality to Reduce Procedural Pain in Children With Cancer: A Pilot Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|The Hospital for Sick Children||2|||f||||t|f|f||||||||2017-10-10 21:42:11.463407|2017-10-10 21:42:11.463407
NCT02929758|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-04-05|||February 2015||2015-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Speed of Processing Training in Patients With Parkinson's Disease and Healthy Older Adults|The Effect of Speed of Processing Training on Pedestrian Behavior in Patients With Parkinson's Disease and Healthy Older Adults|Recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||4|||f||||f||||||||||2017-10-10 21:42:11.567458|2017-10-10 21:42:11.567458
NCT02929745|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-09-05|||July 2016||2016-07-01|September 2017|2017-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||Single Cell Genomics of Psoriatic Skin|Elucidating the Fundamental Differences Between HLA-Cw6 Positive and HLA-Cw6 Negative Psoriasis Skin Lesions, With a Comparison to Healthy Skin, at the Single Cell Level of the Infiltrated Immune Cell Types|Recruiting||N/A|30|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 21:42:11.676473|2017-10-10 21:42:11.676473
NCT02929732|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-19|||November 2016||2016-11-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Interventional|MIBG-RLS||Analysis of Sympathetic Activity in Willis-Ekbom Disease||Not yet recruiting||N/A|40|Anticipated|University Hospital, Montpellier||2|||f||||||||||||||2017-10-10 21:42:11.770833|2017-10-10 21:42:11.770833
NCT02929719|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2017-05-03|||April 2014||2014-04-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris|A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Test Gel, 5% to ACZONE Gel, 5% and Both Active Treatment to a Placebo Control in the Treatment of Acne Vulgaris|Completed||Phase 1|1134|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||No||2017-10-10 21:42:11.84193|2017-10-10 21:42:11.84193
NCT02910336|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-09-19|||December 2010||2010-12-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01|1 Day|Observational [Patient Registry]|QST||Somatosensory Investigation of Orofacial Pain Patients|Somatosensory Investigation of Orofacial Pain Patients|Completed||N/A|336|Actual|University of Sao Paulo|||2||f||||f||||||||No||2017-10-10 21:47:27.828084|2017-10-10 21:47:27.828084
NCT02929693|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-08|||October 2016||2016-10-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma|Clinical Study of Yiqi-yangyin-jiedu Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma Patients With Activating EGFR Mutation|Enrolling by invitation||Phase 3|198|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-10 21:42:11.998317|2017-10-10 21:42:11.998317
NCT02929680|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-09-21|||October 2016||2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical Evaluation of FilmArray LRTI Panel|Prospective Clinical Evaluation of the FilmArray Lower Respiratory Tract Infection (LRTI) Panel BioFire Study #DX-SDY-024947|Recruiting||N/A|500|Anticipated|University of Nebraska|||1||f||||||||||||||2017-10-10 21:42:12.084578|2017-10-10 21:42:12.084578
NCT02929667|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-05|||February 16, 2017|Actual|2017-02-16|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI|Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI|Recruiting||Phase 2|100|Anticipated|University of Iowa||2|||f||||f|t|f||||||||2017-10-10 21:42:12.151496|2017-10-10 21:42:12.151496
NCT02929654|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-08-14|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||Assessment of Blood Glucose Monitoring Devices With New Insight Features||Completed||N/A|267|Anticipated|LifeScan||3|||f||||f||||||||||2017-10-10 21:42:12.252351|2017-10-10 21:42:12.252351
NCT02929641|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-11|||August 2016||2016-08-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Evalution of Optical Enhancement With Magnification for Polyop Histology|Evaluation of a New Image-enhanced Endoscopic Technology With Magnification Using I-scan Optical Enhancement for Prediction Colorectal Polyp Histology|Recruiting||N/A|100|Anticipated|Shandong University|||1||f||||||||||||No||2017-10-10 21:42:12.330572|2017-10-10 21:42:12.330572
NCT02929628|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-08|2016-10-12|||December 2016||2016-12-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's Disease|Evaluate the Safety and Effectiveness Between Various Frequency Stimulation and Traditional High Frequency Stimulation for the Treatment of Patients With Parkinson's Disease|Not yet recruiting||Phase 2|106|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||Yes||2017-10-10 21:42:12.401065|2017-10-10 21:42:12.401065
NCT02929615|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-10|||June 2015||2015-06-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors||Recruiting||Phase 4|50|Anticipated|Peking University||1|||f||||||||||||||2017-10-10 21:42:12.455877|2017-10-10 21:42:12.455877
NCT02929602|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-10-07|||June 2007||2007-06-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|November 2011|Actual|2011-11-01||Observational|||Analgesic Use and Effectiveness for Dental Procedures|PRL0706: Analgesic Use and Effectiveness|Completed||N/A|2773|Actual|Pearl Network|||1||f||||t||||||||Yes|Will send to the NIDCR.|2017-10-10 21:42:12.516139|2017-10-10 21:42:12.516139
NCT02929589|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-08-09|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy|Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy: A Prospective, Placebo-Controlled, Double-Blind, Randomized Controlled Trial|Not yet recruiting||Phase 3|185|Anticipated|Mike O'Callaghan Federal Hospital||4|||f||||f|t|f|||f|||||2017-10-10 21:42:12.631855|2017-10-10 21:42:12.631855
NCT02929576|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-06-01|||September 2016||2016-09-01|June 2017|2017-06-01||||April 2019|Anticipated|2019-04-01||Interventional|ENDEAR||Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer|A Phase 3, Randomized, International Study Comparing the Efficacy and Safety of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer|Withdrawn||Phase 3|0|Actual|Medivation, Inc.||3||Further understanding about the role of androgen signaling in TNBC was required|f||||t||||||||No||2017-10-10 21:42:12.712911|2017-10-10 21:42:12.712911
NCT02929563|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-05-15|||January 9, 2017|Actual|2017-01-09|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PIC-UP||Pediatric Intensive Care Ulcer Prophylaxis Pilot Trial|Pediatric Intensive Care Ulcer Prophylaxis Pilot Trial|Recruiting||Phase 3|120|Anticipated|McMaster University||2|||f||||t||||||||Undecided||2017-10-10 21:42:12.82265|2017-10-10 21:42:12.82265
NCT02929550|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-11|||January 2015||2015-01-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01|1 Year|Observational [Patient Registry]|GuLLD||Impact of Guidelines on Cardiovascular and Economic Outcomes With Focus on Lipid Lowering Drugs|Predicted Impact on Cardiovascular and Economic Outcomes of Swedish Atherosclerotic Cardiovascular Disease Guideline 2014 With Focus on Lipid Lowering Treatment|Completed||N/A|5904|Actual|Karolinska Institutet|||1||f||||f||||||||No||2017-10-10 21:42:12.919655|2017-10-10 21:42:12.919655
NCT02929537|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-10-07|||May 2015||2015-05-01|April 2015|2015-04-01||||December 2018|Anticipated|2018-12-01|3 Months|Observational [Patient Registry]|||China Chronic Obstructive Pulmonary Disease Registration Research|Transformation and Application of Diagnosis and Treatment Programs for COPD Based on Chronic Obstructive Pulmonary Disease Registration Research in China|Enrolling by invitation||N/A|3012|Anticipated|Henan University of Traditional Chinese Medicine|||3||f||||t||||||||||2017-10-10 21:42:12.986089|2017-10-10 21:42:12.986089
NCT02929524|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-07|||April 2015||2015-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Intranasal Ketamine as a Sedative for Venipuncture|Intranasal Ketamine for Peripheral Venous Puncture in Pediatric Patients: A Randomized Double Blind and Placebo Controlled Study|Completed||Phase 2/Phase 3|39|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:42:13.04954|2017-10-10 21:42:13.04954
NCT02907450|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-14|||October 2012||2012-10-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|TolTwiCare||TolTwiCare : Qualitative Evaluation Routine Care From Primary Tolerance of a Prefabricated and Removable Orthosis||Completed||N/A|20|Actual|Nantes University Hospital||1|||f||||f||||||||No||2017-10-10 21:47:54.656761|2017-10-10 21:47:54.656761
NCT02929511|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-08-07|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reciprocation vs Rotational Single-file Systems in Postoperative Pain|Influence of Reciprocating and Rotational Single-file Systems on the Postoperative Pain: A Randomized Clinical Trial.|Recruiting||N/A|70|Anticipated|Isparta Military Hospital||2|||f||||t|f|f||||||||2017-10-10 21:42:13.118451|2017-10-10 21:42:13.118451
NCT02929498|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-28|||July 31, 2017|Actual|2017-07-31|September 2017|2017-09-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2019|Anticipated|2019-05-15||Interventional|||Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)|A Phase I/II, Open-label, 2 Arm Study to Investigate the Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of GSK2879552 Administered Alone or in Combination With Azacitidine, in Adult Subjects With IPSS-R High and Very High Risk Myelodysplastic Syndromes (MDS) Previously Treated With Hypomethylating Agents (HMA)|Recruiting||Phase 2|74|Anticipated|GlaxoSmithKline||2|||f||||f|t|f||||||||2017-10-10 21:42:13.204872|2017-10-10 21:42:13.204872
NCT02929485|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-10|||July 2013||2013-07-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor|Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor|Active, not recruiting||N/A|38|Actual|University of California, San Francisco||3|||f||||f||||||||No||2017-10-10 21:42:13.30798|2017-10-10 21:42:13.30798
NCT02929472|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-07|||May 2015||2015-05-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|||Effect of a Multicomponent Intervention in Children and Adolescents|Effect of a Multicomponent Intervention on Physical Fitness and Metabolic Risk Markers in Children and Adolescents: A Pilot Study|Completed||N/A|35|Actual|Federal University of Paraíba||2|||f||||f||||||||No||2017-10-10 21:42:15.31371|2017-10-10 21:42:15.31371
NCT02929459|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-07|||November 2016||2016-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota|Effects of Oral Riboflavin Supplementation on the Growth of Faecalibacterium Prausnitzii and the Impact on the Gut Microbiota: A Randomized, Double-blind, Placebo-controlled Human Intervention Trial|Not yet recruiting||Phase 2|105|Anticipated|DSM Nutritional Products, Inc.||3|||f||||f||||||||No||2017-10-10 21:42:15.420489|2017-10-10 21:42:15.420489
NCT02929446|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-02-28|||December 2016||2016-12-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Mobilization Immediate After Abdominal Surgery|Postoperative Mobilization Immediate After Open Abdominal Surgery|Recruiting||N/A|200|Anticipated|Karolinska Institutet||3|||f||||f||||||||No||2017-10-10 21:42:15.515878|2017-10-10 21:42:15.515878
NCT02929433|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-07|||January 2013||2013-01-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Cycloergometer and Rotator Cuff Tear|Conservative Treatment of Rotator Cuff Tear: The Role of Cycloergometer|Completed||N/A|38|Actual|Fondazione Salvatore Maugeri||2|||f||||f||||||||Yes|Scientific manuscript|2017-10-10 21:42:15.605651|2017-10-10 21:42:15.605651
NCT02929420|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-10-07|||October 2016||2016-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule|A Multicenter, Randomized, Open, Parallel Controlled Clinical Study on the Efficacy and Safety of the Treatment of Cyclomastopathy With Xiaoru Sanjie Capsule|Recruiting||Phase 4|600|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||t||||||||Yes||2017-10-10 21:42:15.680026|2017-10-10 21:42:15.680026
NCT02929394|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Trabectedin Maintenance Post 1st-line in STS|Maintenance Therapy With Trabectedin Versus Observation After First Line Treatment With Doxorubicin of Patients With Advanced or Metastatic Soft Tissue Sarcoma.|Recruiting||Phase 3|90|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t|f|f||||||||2017-10-10 21:42:15.890796|2017-10-10 21:42:15.890796
NCT02929381|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-07|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|AEI||Advanced Endoscopic Imaging in Colonoscopy|A Prospective Randomized Clinical Trial to Assess the Utility of Advanced Endoscopic Imaging and the Impact of New Technologies on Quality in Colonic Examinations|Recruiting||N/A|400|Anticipated|Jagiellonian University||2|||f||||f||||||||||2017-10-10 21:42:16.003633|2017-10-10 21:42:16.003633
NCT02929368|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-07-12|||June 2016||2016-06-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|3CG||SHERLOCK 3CG vs. Fluoroscopy in Implantation of PICC-Line|Randomized Controlled Noninferiority Study to Evaluate Safety and Efficacy of the Integrated Magnetic Tracking and ECG-guided Tip Location System (SHERLOCK 3CG) vs. Fluoroscopy in Implantation of Peripherally Inserted Central Catheter|Recruiting||N/A|210|Anticipated|Jena University Hospital||2|||f||||f||||||||||2017-10-10 21:42:16.126684|2017-10-10 21:42:16.126684
NCT02929355|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-07|||January 2012||2012-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|PROCAVE-D||Carotid Atherosclerosis and Vascular Events in People With Diabetes|Progression of Carotid Atherosclerosis and Vascular Events in People With Diabetes: A Prospective Cohort Study|Completed||N/A|731|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:42:16.382496|2017-10-10 21:42:16.382496
NCT02929342|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-07|||July 2016||2016-07-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers|An Open Label, Single-Period Repeated Dose Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Pitolisant, at Steady-State Conditions, in Healthy CYP2D6 Genotyped Male Subjects|Completed||Phase 1|8|Actual|Bioprojet||2|||f||||f||||||||||2017-10-10 21:42:16.479801|2017-10-10 21:42:16.479801
NCT02929329|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-16|||January 6, 2017|Actual|2017-01-06|August 2017|2017-08-01|January 27, 2021|Anticipated|2021-01-27|January 27, 2021|Anticipated|2021-01-27||Interventional|GALACTIC-HF||Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)|Recruiting||Phase 3|8000|Anticipated|Amgen||2|||f||||t||||||||||2017-10-10 21:42:16.803328|2017-10-10 21:42:16.803328
NCT02929316|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Vedolizumab Induction May Prevent Celiac Enteritis|Vedolizumab Induction May Prevent Celiac Enteritis After Gluten Challenge in Established Celiac Patients in Histological Remission|Not yet recruiting||Phase 2|10|Anticipated|AGA Clinical Research Associates, LLC||1|||f||||f||||||||No||2017-10-10 21:42:18.3363|2017-10-10 21:42:18.3363
NCT02929303|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-07||||||October 2016|2016-10-01||||||||Expanded Access|||Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD|Expanded Access of Omegaven IV Fat Emulsion (Fish Oil Infusion) to Infants and Children With Parenteral Nutrition-associated Liver Disease|Available||N/A|||Advocate Health Care|||||||||||||||||||2017-10-10 21:42:18.439547|2017-10-10 21:42:18.439547
NCT02929290|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC|Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC: A Phase Ib Study,Open-label,Dose-expansion Study|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||f||||||||No||2017-10-10 21:42:18.51971|2017-10-10 21:42:18.51971
NCT02929277|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-07|||October 2013||2013-10-01|October 2016|2016-10-01||||June 2015|Actual|2015-06-01||Interventional|PATUREIV||Protection Against Allergy: Study in Rural Environnement - Part IV (PATURE IV)||Completed||N/A|113|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:42:18.590638|2017-10-10 21:42:18.590638
NCT02929264|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-12-16|||December 2016||2016-12-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates|An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates|Recruiting||Phase 1|16|Anticipated|Abide Therapeutics||3|||f||||f||||||||||2017-10-10 21:42:18.670824|2017-10-10 21:42:18.670824
NCT02929251|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-07-04|||June 28, 2017|Actual|2017-06-28|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|RUBI||Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis|Multicentre, Randomized, Multi-arm Trial Comparing the Efficacy and Safety of Adalimumab, Anakinra and Tocilizumab in Subjects With Non-infectious Refractory Uveitis RUBI: Refractory Uveitis BIotherapies|Recruiting||Phase 2|120|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t|f|f||||||||2017-10-10 21:42:18.774982|2017-10-10 21:42:18.774982
NCT02929238|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-01-18|||June 2016||2016-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Wound Vac Polypropylene Suture Pilot Study|Polypropylene Suture Interfaced Between Wound and Negative Pressure Wound Therapy to Reduce Pain: a Pilot Study|Recruiting||N/A|10|Anticipated|Greenville Health System||2|||f||||f||||||||||2017-10-10 21:42:18.889992|2017-10-10 21:42:18.889992
NCT02929225|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-09-28|||November 2016||2016-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effectiveness of Probiotics to Treat End Stage Renal Disease|Effect of Probiotics on Modulating the Bacterial Translocation and Improving Micro-inflammation in Hemodialysis Patients|Active, not recruiting||Early Phase 1|47|Actual|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||||2017-10-10 21:42:18.983143|2017-10-10 21:42:18.983143
NCT02929212|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-01-30|||September 2009||2009-09-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|LAF 28||Effect of Number of Meals on Metabolism After Weight Loss Surgery|Effect of Number of Meals on Metabolism After Weight Loss Surgery|Completed||N/A|33|Actual|Columbia University||4|||f||||t|f|f||||||No||2017-10-10 21:42:19.088336|2017-10-10 21:42:19.088336
NCT02929199|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-11|||January 2017||2017-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Different Types Crowns on Bio Compatibility and Biological Tissue Response|Evaluation of Bio Compatibility of Bio-HPP Crown Veneered With Visio.Lign Compared to Lithium Disilicate (E-max) Crown Veneered With E-max Veneering System in Anterior Esthetic Zone (Randomized Clinical Trial)|Not yet recruiting||Phase 2|42|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:42:19.35109|2017-10-10 21:42:19.35109
NCT02929173|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-10|||January 2017||2017-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Different Types of Crowns on Patient Satisfaction and Clinical Assesment|Patient Satisfaction and Clinical Assessment of Biocompatible High Performance Polymers Crown Veneered With Visio.Lign Versus E-max Crown Veneered With E-max Veneering System in Anterior Aesthetic Zone.(Randomized Controlled Clinical Trial)|Not yet recruiting||Phase 2|24|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:42:19.536839|2017-10-10 21:42:19.536839
NCT02929160|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-09|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|PERSIST||Percutaneous Nephrostomy Versus Stent In Sepsis Trial|Optimal Method of Decompression of the Renal Collecting System in Acute Obstruction: a Prospective Randomised Trial|Recruiting||N/A|70|Anticipated|The Adelaide and Meath Hospital, incorporating The National Children's Hospital||2|||f||||f||||||||No||2017-10-10 21:42:19.653284|2017-10-10 21:42:19.653284
NCT02927834|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-25|||August 2015||2015-08-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps|The Role of Oral Steroids in the Management of Chronic Rhinosinusitis Without Nasal Polyps|Recruiting||N/A|40|Anticipated|Loma Linda University||3|||f||||f||||||||||2017-10-10 21:42:32.181988|2017-10-10 21:42:32.181988
NCT02929147|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-10|||November 2016||2016-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of Efficacy and Safety of the Postoperative Analgesia Methods|Comparison of Efficacy and Safety of the Postoperative Analgesia Methods for Supratentorial Craniotomy by Integrated Pulmonary Index (IPI)|Not yet recruiting||Phase 4|90|Anticipated|Istanbul University||3|||f||||f||||||||Undecided||2017-10-10 21:42:19.777508|2017-10-10 21:42:19.777508
NCT02929134|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-07-19|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|LeDoxy-SL||A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka|A Multi-center, Double-blind, Randomized, 24-month Study, to Compare the Efficacy of Doxycycline Once Daily for 6 Weeks Versus Placebo in Improving Filarial Lymphedema Independent of Active Filarial Infection|Not yet recruiting||Phase 3|250|Anticipated|The Task Force for Global Health||2|||f||||t|f|f||||||||2017-10-10 21:42:19.902126|2017-10-10 21:42:19.902126
NCT02929121|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-07-19|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|LeDoxy-India||A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India|A Multi-center, Double-blind, Randomized, 24-month Study, to Compare the Efficacy of Doxycycline Once Daily for 6 Weeks Versus Placebo in Improving Filarial Lymphedema Independent of Active Filarial Infection|Not yet recruiting||Phase 3|250|Anticipated|The Task Force for Global Health||2|||f||||t|f|f||||||||2017-10-10 21:42:20.049712|2017-10-10 21:42:20.049712
NCT02929108|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-10-02|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|February 2022|Anticipated|2022-02-01|January 2022|Anticipated|2022-01-01||Interventional|ACCESS||ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making|ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision|Recruiting||N/A|420|Anticipated|University of Missouri-Columbia||3|||f||||f|f|f||||||||2017-10-10 21:42:20.166087|2017-10-10 21:42:20.166087
NCT02929095|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam on Patient's Satisfaction||Not yet recruiting||N/A|70|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 21:42:20.258995|2017-10-10 21:42:20.258995
NCT02929082|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-07|||October 2016||2016-10-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|FORCE||Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer|Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer|Not yet recruiting||N/A|130|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||Undecided||2017-10-10 21:42:20.335037|2017-10-10 21:42:20.335037
NCT02929069|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-06-05|||September 2016||2016-09-01|October 2016|2016-10-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|||A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk|A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk|Recruiting||N/A|250|Anticipated|Yale University||3|||f||||t||||||||Undecided||2017-10-10 21:42:20.431144|2017-10-10 21:42:20.431144
NCT02929056|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-06-18|||January 2017||2017-01-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|AmnioExCel||Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations|A Prospective Randomized Comparative Parallel Study of Amniotic Membrane in the Management of Venous Leg Ulcerations|Enrolling by invitation||N/A|40|Anticipated|Greenville Health System||2|||f||||f||||||||Yes|Data collected from participants who sign consent will be sent in a de-identified fashion to Clemson University for data analysis. Clemson University will submit safety information to BioDLogics, LLC, in a de-identified fashion as appropriate.|2017-10-10 21:42:20.580597|2017-10-10 21:42:20.580597
NCT02929043|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-07|||July 2015||2015-07-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Observational|||Psychophysical Characterization and Brain Correlates of Dentine Hypersensitivity|Psychophysical Characterization and Brain Correlates of Dentine Hypersensitivity|Recruiting||Early Phase 1|30|Anticipated|University of Zurich|||1||f||||f||||||||Yes||2017-10-10 21:42:20.65297|2017-10-10 21:42:20.65297
NCT02929030|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-12-29|||August 2016||2016-08-01|December 2016|2016-12-01|January 2022|Anticipated|2022-01-01|January 2018|Anticipated|2018-01-01|5 Years|Observational [Patient Registry]|||Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease|Safety and Efficacy of Polymer-free Sirolimus-eluting Coronary Stents in Patients With Coronary Artery Disease.|Recruiting||N/A|2500|Anticipated|Xijing Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:42:20.727943|2017-10-10 21:42:20.727943
NCT02929017|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-03-28|||March 23, 2017|Actual|2017-03-23|March 2017|2017-03-01|July 31, 2019|Anticipated|2019-07-31|April 2019|Anticipated|2019-04-01||Interventional|||Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers|Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers|Recruiting||N/A|80|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||No||2017-10-10 21:42:20.834746|2017-10-10 21:42:20.834746
NCT02929004|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-12-05|||December 2016||2016-12-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|VIB_LCA||Chronic Effects of Local Vibration on Neuromuscular Reconditioning After Anterior Cruciate Ligament Reconstruction|Chronic Effects of Local Vibration on Neuromuscular Reconditioning After Anterior Cruciate Ligament Reconstruction|Recruiting||N/A|38|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 21:42:20.960911|2017-10-10 21:42:20.960911
NCT02928991|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-27|||April 2015||2015-04-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Fludarabine Based RIC for Bone Marrow Failure Syndromes|Fludarabine-Based Conditioning for Matched Related Donor Bone Marrow Transplantation in Patients With Bone Marrow Failure Syndromes|Recruiting||Early Phase 1|25|Anticipated|Children's Hospital of Philadelphia||3|||f||||f||||||||No||2017-10-10 21:42:21.061061|2017-10-10 21:42:21.061061
NCT02928978|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-02-07|||January 2017||2017-01-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|TBCRC 042||Ruxolitinib for Premalignant Breast Disease|TBCRC 042 - A Randomized Phase II Window-of-Opportunity Trial of Ruxolitinib in Patients With High Risk and Premalignant Breast Conditions|Not yet recruiting||Phase 2|100|Anticipated|Baylor Breast Care Center||2|||f||||t||||||||No||2017-10-10 21:42:21.168337|2017-10-10 21:42:21.168337
NCT02928965|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-06|||February 2013||2013-02-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|BeneMin||The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms|The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms|Completed||Phase 2|207|Actual|University of Manchester||2|||f||||t||||||||Yes|Fully anonymised database will be made available in 2018|2017-10-10 21:42:21.272664|2017-10-10 21:42:21.272664
NCT02928952|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-06|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|Mind-STRIDE||Mindful Stress Reduction in Diabetes Self-management Education for Veterans|Effects of a Mindfulness Intervention Delivered Within Diabetes Education on Diabetes-related Outcomes in Military Veterans|Recruiting||N/A|120|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:42:21.39004|2017-10-10 21:42:21.39004
NCT02928939|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||Therapeutic Conflicts and Multimorbidity|Therapeutic Conflicts in Hospitalized Patients: Retrospective Analyses of Patients With GI Bleeding or Exacerbated Diabetes and Impact of Multimorbidity.|Recruiting||N/A|1600|Anticipated|University of Zurich|||1||f||||t||||||||Undecided||2017-10-10 21:42:21.489847|2017-10-10 21:42:21.489847
NCT02928926|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||April 2016||2016-04-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|CHIST||Cerebral Haemodynamics in Stroke Thrombolysis Study (CHIST)|Cerebral Haemodynamics in Stroke Thrombolysis (CHIST) Study|Recruiting||N/A|22|Anticipated|University of Leicester|||2||f||||f||||||||No||2017-10-10 21:42:21.566562|2017-10-10 21:42:21.566562
NCT02928913|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-05-02|||May 2016||2016-05-01|May 2017|2017-05-01||||May 2017|Anticipated|2017-05-01||Observational|||The Associations Between Sedentary Behaviour and Impact Characteristics on Bone Health|The Associations Between Sedentary Behaviour and Impact Characteristics on Bone Health|Active, not recruiting||N/A|56|Actual|University of Wolverhampton|||2||f||||f||||||||||2017-10-10 21:42:21.649882|2017-10-10 21:42:21.649882
NCT02928900|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-17|||September 26, 2016||2016-09-26|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|SPEED||Patient Actor Training to Improve HIV Services for Adolescents in Kenya|Simulated Patient Encounters to Promote Early Detection and Engagement in HIV Care for Adolescents|Enrolling by invitation||N/A|7450|Anticipated|University of Washington||2|||f||||t||||||||Yes|The study investigators are prepared to share data with other researchers in accordance with NIH policies and other local regulations.|2017-10-10 21:42:21.719419|2017-10-10 21:42:21.719419
NCT02928887|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-08-22|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Light Therapy in Cardiopulmonary Bypass Surgery|Light Therapy in Cardiopulmonary Bypass Surgery|Not yet recruiting||N/A|30|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||||2017-10-10 21:42:21.813855|2017-10-10 21:42:21.813855
NCT02928874|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-06|||September 2014||2014-09-01|October 2016|2016-10-01||||August 2018|Anticipated|2018-08-01||Interventional|||Eating Phenotypes for Childhood Obesity in the Context of Familial Obesity Risk|Eating Phenotypes for Childhood Obesity in the Context of Familial Obesity Risk|Recruiting||N/A|225|Anticipated|University of Pennsylvania||2|||f||||||||||||||2017-10-10 21:42:21.882636|2017-10-10 21:42:21.882636
NCT02928861|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma|18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma|Recruiting||N/A|100|Anticipated|Beijing Cancer Hospital||1|||f||||f||||||||No||2017-10-10 21:42:22.202683|2017-10-10 21:42:22.202683
NCT02928848|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-06|||September 2014||2014-09-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Baseline Severity and tDCS in PPA|Baseline Performance Predicts tDCS-mediated Improvements in Language Symptoms in Primary Progressive Aphasia|Enrolling by invitation||N/A|17|Actual|University of Pennsylvania||2|||f||||||||||||||2017-10-10 21:42:22.301174|2017-10-10 21:42:22.301174
NCT02928835|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||June 2011||2011-06-01|October 2016|2016-10-01|November 2013|Actual|2013-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Dynamic Splinting on Knee Flexion Angle After Total Knee Arthroplasty: A Randomized Controlled Trial|Effects of Dynamic Splinting on Knee Flexion Angle After Total Knee Arthroplasty: A Randomized Controlled Trial|Completed||N/A|60|Actual|Universidade Norte do Paraná||2|||f||||f||||||||No||2017-10-10 21:42:22.389231|2017-10-10 21:42:22.389231
NCT02928822|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-10-06|||July 2016||2016-07-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Virtual Reality Based Sensorimotor Speech Therapy|Terapia de Lenguaje, Sensorial y Motora, Basada en Realidad Virtual|Recruiting||N/A|18|Anticipated|Universitat Pompeu Fabra||2|||f||||t||||||||Undecided||2017-10-10 21:42:22.485898|2017-10-10 21:42:22.485898
NCT02928809|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Low-level Laser Prior to the Induction of Fatigue|Effect of Low-level Laser Administered to the Masseter and Anteriortemporal Muscles Prior to the Induction of Fatigue|Recruiting||N/A|90|Anticipated|University of Nove de Julho||6|||f||||t||||||||No||2017-10-10 21:42:22.597518|2017-10-10 21:42:22.597518
NCT02928796|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-06|||September 2016||2016-09-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Observational|ACCP||Attentional Capacity and Clinician Performance|Attentional Capacity and Clinician Performance: Eye-Tracking Participants When Using a High-Fidelity Surgical Simulator That Emulates Cardiology Procedures|Recruiting||N/A|14|Anticipated|University College Cork|||2||f||||f||||||||||2017-10-10 21:42:22.708504|2017-10-10 21:42:22.708504
NCT02928783|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-10-06|||June 2013||2013-06-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of Exercise Tolerance and Cardiac Output in Patients With Heart Failure After Intervention of Rehabilitation Program||Completed||N/A|37|Actual|Taichung Veterans General Hospital||2|||f||||||||||||||2017-10-10 21:42:22.798857|2017-10-10 21:42:22.798857
NCT02928770|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-04-24|||February 2015||2015-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Disposable Device NAS to Treat Obstructive Sleep Apnea and Snoring|A Disposable Device NAS to Treat Obstructive Sleep Apnea and Snoring|Active, not recruiting||N/A|30|Anticipated|Stanford University||1|||f||||f||f||||||No||2017-10-10 21:42:22.901454|2017-10-10 21:42:22.901454
NCT02928757|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-15|||December 2016||2016-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Complex Care for Kids Ontario (CCKO)|Complex Care for Kids Ontario (CCKO): A Patient- and Family-centred Implementation and Evaluation of Care Coordination for Children With Medical Complexity|Recruiting||N/A|140|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||Undecided||2017-10-10 21:42:22.989608|2017-10-10 21:42:22.989608
NCT02928744|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-10|||December 2011||2011-12-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|March 2013|Actual|2013-03-01||Interventional|OSCILLOREVERS||Evaluation of the Reversibility of the Bronchial Obstruction by Impulse Oscillometry Technique in Chronic Obstructive Pulmonary Disease (COPD): Correlation With Functional Features Measured by Plethysmography and Dyspnoea||Terminated||N/A|23|Actual|Hopital Foch||1||Recruitment difficulties|f||||f||||||||No||2017-10-10 21:42:23.153254|2017-10-10 21:42:23.153254
NCT02928731|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-25|||June 2014||2014-06-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Impact of Cancer on the Physical and Psychological Well-being of Children in Mainland China|The Impact of Cancer and Therapy-related Symptoms on Mainland Chinese Children's Physical and Psychological Well-being: An Exploratory Study|Completed||N/A|425|Actual|The University of Hong Kong|||2||f||||t||||||||No||2017-10-10 21:42:23.239573|2017-10-10 21:42:23.239573
NCT02928718|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-10-06|||August 2015||2015-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations|The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations|Recruiting||N/A|120|Anticipated|Seoul National University Hospital|||1||f||||t||||||Samples With DNA|"     Blood sample   "|Undecided||2017-10-10 21:42:23.326206|2017-10-10 21:42:23.326206
NCT02928705|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-10-06|||January 2014||2014-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Observational|||Quality of Telemedically Guided Prehospital Analgesia|Comparison of Analgesic Treatment Quality Between Prehospital Emergency Care of Telemedically Guided Paramedics and On-scene Physicians - a Retrospective Longitudinal Study|Completed||N/A|381|Actual|RWTH Aachen University|||2||f||||f||||||||No|No additional research benefits.|2017-10-10 21:42:23.428028|2017-10-10 21:42:23.428028
NCT02928692|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-06|||July 2015||2015-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MAPOCD||Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium|Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium: A Multicenter, Randomized, Double-Blind Clinical Trail|Recruiting||Phase 3|750|Anticipated|RenJi Hospital||3|||f||||||||||||||2017-10-10 21:42:23.541642|2017-10-10 21:42:23.541642
NCT02928679|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|IM-LOSEIT-II||Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance|Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis Following Liraglutide Treatment, Investigating the Impact on Inflammation|Recruiting||Phase 4|150|Anticipated|Parker Research Institute||2|||f||||t||||||||No||2017-10-10 21:42:23.678573|2017-10-10 21:42:23.678573
NCT02928666|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-04-27|||October 2018|Anticipated|2018-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Integration of Guidelines for Comorbidities|Goal-oriented Ontology-supported Methodology for Integrating Computer-interpretable Clinical Guidelines and Medical Knowledge to Support Comorbidity Management|Not yet recruiting||N/A|30|Anticipated|Rambam Health Care Campus||2|||f||||f|f|f||||||Undecided||2017-10-10 21:42:23.77352|2017-10-10 21:42:23.77352
NCT02928653|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-04-04|||December 2015||2015-12-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|LCS||Beverage Consumption and Fine Motor Control|The Effect of Low Calorie Sweetener Consumption on Body Weight, Body Composition, Appetite, and Energy Intake|Recruiting||N/A|200|Anticipated|Purdue University||5|||f||||f||||||||Undecided||2017-10-10 21:42:23.878497|2017-10-10 21:42:23.878497
NCT02928640|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-18|||September 2016||2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate Biopsy|Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing TRUS-Guided Prostrate Biopsy With or Without MR Fusion For Prostrate Tissue Classification Algorithm Development|Active, not recruiting||N/A|200|Anticipated|Precision Biopsy, Inc.||1|||f||||f||||||||||2017-10-10 21:42:23.98582|2017-10-10 21:42:23.98582
NCT02928627|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-05-03|||June 1, 2017|Anticipated|2017-06-01|October 2016|2016-10-01|December 10, 2018|Anticipated|2018-12-10|December 10, 2018|Anticipated|2018-12-10||Observational|||Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma|Hepatic and Circulating microRNAs miR-221 and miR-222 Expression and Its Clinical Significance in Hepatocellular Carcinoma (HCC)|Not yet recruiting||N/A|10|Anticipated|University of Aberdeen|||2||f||||f||||||Samples Without DNA|"     -  hepatic tissue (matched tumoral/non tumoral) from patients with HCC        -  blood sample from patients with HCC and from healthy controls   "|No||2017-10-10 21:42:24.092674|2017-10-10 21:42:24.092674
NCT02928614|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|BIO-LOSEIT-II||Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance|Biomarkers in Obese Patients With Knee Osteoarthritis Following Long-term Weight Maintenance|Recruiting||Phase 4|150|Anticipated|Parker Research Institute||2|||f||||t||||||||||2017-10-10 21:42:24.190486|2017-10-10 21:42:24.190486
NCT02928601|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-08-21|||November 2016||2016-11-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Norepinephrine Consumption After Prophylactic Ondansetron|Does Prophylactic Ondansetron Reduce Norepinephrine Consumption in Patients Undergoing Caesarean Section With Spinal Anesthesia?|Completed||Phase 4|108|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 21:42:24.278652|2017-10-10 21:42:24.278652
NCT02928575|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-06|||August 2012||2012-08-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma|A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients With an Unmethylated MGMT Gene Promoter|Recruiting||Phase 2|45|Anticipated|McGill University Health Center||1|||f||||f||||||||||2017-10-10 21:42:24.365245|2017-10-10 21:42:24.365245
NCT02928562|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2017-06-05|||October 1, 2013|Actual|2013-10-01|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|August 30, 2017|Anticipated|2017-08-30||Interventional|||The Impaction of Exercise Training on Bone Mineral Density in Patients After Total Knee Arthroplasty|The Impaction of Exercise Training on Bone Mineral Density in Patients After Total Knee Arthroplasty|Recruiting||N/A|180|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:42:24.477914|2017-10-10 21:42:24.477914
NCT02928549|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-10-03|||September 2016||2016-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study|Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study|Recruiting||N/A|25|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 21:42:24.55887|2017-10-10 21:42:24.55887
NCT02928536|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-12-01|||December 2016||2016-12-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||The TackSHS Survey: a Pan-European Study on SHS|The TackSHS Survey: a Cross-sectional Study on Secondhand Smoke in 12 European Countries|Recruiting||N/A|12000|Anticipated|Mario Negri Institute for Pharmacological Research|||1||f||||f||||||||No|No plan is made to share IPD. Main results (aggregated data) will be published in peer-reviewed open-access journals|2017-10-10 21:42:24.646434|2017-10-10 21:42:24.646434
NCT02928523|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-10-06|||June 2016||2016-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|ODYSSEE||PreventiOn of DYSbioSis Complications With Autologous Fecal Microbiota Transplantation in acutE myEloid Leukemia Patients Undergoing Intensive Treatment|PreventiOn of DYSbioSis Complications With Autologous Fecal Microbiota Transplantation in acutE myEloid Leukemia Patients Undergoing Intensive Treatment: A Feasibility and Safety Study ODYSSEE STUDY|Recruiting||Phase 1/Phase 2|35|Anticipated|MaaT Pharma||1|||f||||t||||||||Yes||2017-10-10 21:42:24.713818|2017-10-10 21:42:24.713818
NCT02928497|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-12|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|ASAP-TOO||Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation|Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)|Recruiting||N/A|888|Anticipated|Boston Scientific Corporation||2|||f||||t|f|t|f|f||||No||2017-10-10 21:42:24.901997|2017-10-10 21:42:24.901997
NCT02928484|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-10-07|||June 2016||2016-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function|"Evaluación Del Efecto Del Suplemento Nutricional probiótico Biopolis Sobre la función Gastrointestinal"|Recruiting||Phase 1/Phase 2|60|Anticipated|Biopolis S.L.||2|||f||||f||||||||Undecided||2017-10-10 21:42:25.068723|2017-10-10 21:42:25.068723
NCT02928471|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|IM-LOSEIT-I||Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss|"Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis Following a Significant Weight Loss, Investigating the Impact on Inflammation (A Substudy to Effect of Liraglutide on Body Weight and Pain in Overweight or Obese Patients With Knee Osteoarthritis: A Randomised, Double Blind, Placebo-controlled, Parallel Group, Single-centre Trial (NCT02905864)"|Recruiting||Phase 4|200|Anticipated|Parker Research Institute|||1||f||||t||||||||||2017-10-10 21:42:25.152984|2017-10-10 21:42:25.152984
NCT02928458|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-10-06|||October 2016||2016-10-01|October 2016|2016-10-01||||May 2020|Anticipated|2020-05-01||Interventional|||Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol|Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol|Not yet recruiting||N/A|350|Anticipated|The Guthrie Clinic||2|||f||||f||||||||No||2017-10-10 21:42:25.226405|2017-10-10 21:42:25.226405
NCT02928445|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-09-20|||October 2016||2016-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension|A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)|Enrolling by invitation||Phase 2/Phase 3|240|Anticipated|Axovant Sciences Ltd.||2|||f||||t||||||||||2017-10-10 21:42:25.303981|2017-10-10 21:42:25.303981
NCT02928432|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-01-26|||June 2013||2013-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone|Phase II Pilot Study of the Prednisone to Dexamethasone Switch in Metastatic Castration Resistant Prostate Cancer (CRPC) Patients With Asymptomatic Biochemical and/or Limited Radiological Progression on Abiraterone and Prednisone|Completed||Phase 2|26|Actual|Centro Nacional de Investigaciones Oncologicas CARLOS III||1|||f||||t||||||||No||2017-10-10 21:42:25.588204|2017-10-10 21:42:25.588204
NCT02928419|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-05-29|||May 2015||2015-05-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q|Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q: a Multicenter, Randomized, Double-blind, Placebo Controlled Study - QOL-ONE Rev2MDS|Recruiting||Phase 2|144|Anticipated|Associazione Qol-one||2|||f||||t||||||||Undecided||2017-10-10 21:42:25.678498|2017-10-10 21:42:25.678498
NCT02928406|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-08-01|||November 30, 2016|Actual|2016-11-30|August 2017|2017-08-01|May 31, 2022|Anticipated|2022-05-31|May 31, 2022|Anticipated|2022-05-31||Interventional|||A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract||Recruiting||Phase 3|1000|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 21:42:25.932317|2017-10-10 21:42:25.932317
NCT02928367|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|ELDER-BIOME||The Effect of Leukocyte Dna mEthylation and micRoBIOME Diversity on Host Defense Mechanisms During Community-acquired Pneumonia (ELDER-BIOME)|The Effect of Leukocyte Dna mEthylation and micRoBIOME Diversity on Host Defense Mechanisms During Community-acquired Pneumonia|Recruiting||N/A|231|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f||||||Samples With DNA|"     feces, nasofaryngeal swabs, blood   "|||2017-10-10 21:42:26.605728|2017-10-10 21:42:26.605728
NCT02928354|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-03-24|||November 25, 2016|Actual|2016-11-25|March 2017|2017-03-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|||A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.|A Randomized Open Label Three-Way Crossover Study in Healthy Male Volunteers to Investigate the Effect of Particle Size on Pharmacokinetics Following a Single Inhaled Dose of AZD7594 Via a Dry Powder Inhaler|Completed||Phase 1|12|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 21:42:26.71486|2017-10-10 21:42:26.71486
NCT02928341|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01||||April 2019|Anticipated|2019-04-01||Interventional|||Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of Congo|Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal in Uvira, Democratic Republic of Congo|Recruiting||N/A|5000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||No||2017-10-10 21:42:26.840871|2017-10-10 21:42:26.840871
NCT02928328|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessment of Peripheral GABA Receptors for Local Pain Relief|Vurdering af Perifere GABAA-receptorer Med Henblik på Lokal Smertelindring|Recruiting||N/A|90|Anticipated|Aalborg University||3|||f||||t||||||||No||2017-10-10 21:42:26.934093|2017-10-10 21:42:26.934093
NCT02928315|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-07|||August 2015||2015-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||The Effect of Magnesium Therapy to Prevent Post-operative Atrial Fibrillation After Cardiac Surgery in Adults|The Effect of Magnesium Therapy to Prevent Post-operative Atrial Fibrillation After Cardiac Surgery in Adults, Concerning the Perioperative Changes in Serum Electrolytes|Completed||N/A|40|Actual|Assiut University||2|||f||||t||||||||Yes||2017-10-10 21:42:27.042052|2017-10-10 21:42:27.042052
NCT02928302|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-07-01|||October 2016||2016-10-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy Without Prior Spontaneous Preterm Birth|Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy Without Prior Spontaneous Preterm Birth|Recruiting||Phase 3|6044|Anticipated|Federico II University||2|||f||||f||||||||||2017-10-10 21:42:27.128259|2017-10-10 21:42:27.128259
NCT02928289|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-07-25|||November 2016||2016-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study)|Multi-Center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma|Recruiting||N/A|497|Anticipated|Sight Sciences, Inc.||2|||f||||||||||||||2017-10-10 21:42:27.208698|2017-10-10 21:42:27.208698
NCT02928263|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2017-07-13|||February 28, 2017|Actual|2017-02-28|July 2017|2017-07-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Observational|||Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents|A Healthcare Cost and Resource Utilization Analysis of Intravenous and Oral Agents in the Treatment of Metastatic Renal Cell Carcinoma|Withdrawn||N/A|0|Actual|Bristol-Myers Squibb|||2|Business objectives have changed|f||||f||||||||||2017-10-10 21:42:27.404546|2017-10-10 21:42:27.404546
NCT02928250|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-07|2016-10-07|||August 2015||2015-08-01|October 2016|2016-10-01||||May 2016|Actual|2016-05-01||Interventional|||Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes||Completed||N/A|90|Actual|Ain Shams University||2|||f||||||||||||||2017-10-10 21:42:27.480699|2017-10-10 21:42:27.480699
NCT02928237|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2016-10-06|||April 2015||2015-04-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Effect of tDCS on Chronic Abdominal Visceral Pain in HCC Patients|Effect of the Transcranial Direct Current Stimulation (tDCS) of the Motor Cortex on Chronic Abdominal Pain in Patients With Hepatocellular Carcinoma|Completed||N/A|40|Actual|Assiut University||2|||f||||t||||||||Yes||2017-10-10 21:42:27.550628|2017-10-10 21:42:27.550628
NCT02928042|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-07-24|||November 2016||2016-11-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01|7 Months|Observational [Patient Registry]|||Inhibition Effects of Probiotics on Pathogens Associated With VAP|Inhibition Effects of Probiotics on Pathogens Associated With Ventilator Associated Pneumonia|Recruiting||N/A|60|Anticipated|Cukurova University|||2||f||||f||||||||||2017-10-10 21:42:30.22184|2017-10-10 21:42:30.22184
NCT02928224|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-10-02|||August 2016||2016-08-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|BEACON CRC||Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer|A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5- Fluorouracil (5-FU)/Folinic Acid (FA) /Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer|Recruiting||Phase 3|645|Anticipated|Array BioPharma||3|||f||||t||||||||||2017-10-10 21:42:27.637258|2017-10-10 21:42:27.637258
NCT02928211|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-07-26|||July 2016||2016-07-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations|An Evaluation of Aftobetin-HCl and Fluorescence Detection as Measured by Sapphire II to Determine the Number and Timing of Administrations in Subjects With Normal Cognition, Mild Cognitive Impairment, and Mild Alzheimer's Disease|Recruiting||Phase 1|105|Anticipated|Cognoptix, Inc.||1|||f||||f||||||||||2017-10-10 21:42:28.235675|2017-10-10 21:42:28.235675
NCT02928198|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-01-04|||June 2016||2016-06-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|BISORB OCT||Bifurcation ABSORB OCT Trial|Bifurcation ABSORB OCT Trial|Active, not recruiting||N/A|3|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||||||||||||2017-10-10 21:42:28.383417|2017-10-10 21:42:28.383417
NCT02928185|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-10-03|||September 2016||2016-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers|Adaptation of Coping Together, Self-directed Coping Skills Training Manuals for Patients and Caregivers in the Context of Hematopoietic Stem Cell Transplantation|Recruiting||N/A|27|Anticipated|Memorial Sloan Kettering Cancer Center|||4||f||||||||||||||2017-10-10 21:42:28.61014|2017-10-10 21:42:28.61014
NCT02928159|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-06|||April 2013||2013-04-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Low Pulse Amplitude Seizure Therapy (LAP-ST Study)|Low Pulse Amplitude Seizure Therapy (LAP-ST Study)|Completed||Phase 1|22|Actual|Behman Hospital||1|||f||||f||||||||No||2017-10-10 21:42:28.960667|2017-10-10 21:42:28.960667
NCT02928146|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||January 2017||2017-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|TAPP&TEP||Lichtenstein Versus TAPP and TEP in Groin Hernioplasty|Comparison of Lichtenstein Versus TAPP and TEP Techniques for Inguinal Hernia Repair|Not yet recruiting||N/A|150|Anticipated|Jagiellonian University||3|||f||||f||||||||Undecided||2017-10-10 21:42:29.096645|2017-10-10 21:42:29.096645
NCT02928133|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-10-06|||April 2014||2014-04-01|October 2016|2016-10-01||||May 2018|Anticipated|2018-05-01|2 Years|Observational [Patient Registry]|NOTE||NOACs for Atrial Tachyarrhythmias in Congenital Heart Disease|Prospective Registry of Non-vitamin K Antagonist Oral Anticoagulants for ThromboEmbolic Prevention in Adult Patients With Atrial Tachyarrhythmias and Congenital Heart Disease (NOTE)|Recruiting||N/A|300|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||t||||||||||2017-10-10 21:42:29.212235|2017-10-10 21:42:29.212235
NCT02928120|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-06|||February 2015||2015-02-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer|Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer|Recruiting||N/A|658|Anticipated|Aalborg Universitetshospital|||5||f||||t||||||Samples With DNA|"     EDTA plasma   "|Undecided||2017-10-10 21:42:29.351703|2017-10-10 21:42:29.351703
NCT02928107|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-12-05|||October 2016||2016-10-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Addressing Barriers to Adult Hearing Healthcare|Addressing Barriers to Adult Hearing Healthcare|Recruiting||N/A|665|Anticipated|Duke University||3|||f||||f||||||||Yes|A process will be developed to facilitate providing other investigators with access to de-identified data in the format that is most helpful to them. Trial description information, data collection forms, and data structure will be posted on a website after the primary manuscript is published, whichever comes last. Data will be posted to the Data Share Site after publication of the primary manuscript. Until that time, a message will also appear stating that the trial data will be available within two weeks of publication of the primary manuscript.|2017-10-10 21:42:29.48093|2017-10-10 21:42:29.48093
NCT02928094|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-03-20|||September 1, 2017|Anticipated|2017-09-01|March 2017|2017-03-01|March 1, 2020|Anticipated|2020-03-01|September 1, 2019|Anticipated|2019-09-01||Interventional|AFFIRM||Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Ad5FGF-4 in Patients With Refractory Angina Due to Myocardial Ischemia|Not yet recruiting||Phase 3|320|Anticipated|Angionetics Inc.||2|||f||||t|t|f||||||Undecided||2017-10-10 21:42:29.630378|2017-10-10 21:42:29.630378
NCT02928081|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||January 2016||2016-01-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|February 2021|Anticipated|2021-02-01||Interventional|||Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma|Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy|Recruiting||N/A|320|Anticipated|West China Hospital||2|||f||||t||||||||No||2017-10-10 21:42:29.781921|2017-10-10 21:42:29.781921
NCT02928068|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||April 2015||2015-04-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Telehealth Coaching for Families of Children With Autism|Telehealth Coaching for Families of Children With Autism|Recruiting||N/A|30|Anticipated|University of Kansas Medical Center||1|||f||||f||||||||No||2017-10-10 21:42:29.947933|2017-10-10 21:42:29.947933
NCT02928016|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-08|||September 2014||2014-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|April 2015|Actual|2015-04-01||Interventional|||Effectiveness of Carbohydrate Counting Method With Mixed Meals|Effectiveness of the Carbohydrate Counting Method on Postprandial Glucose Concentrations After Consumption of Mixed Meals in Adults With Type 1 Diabetes|Completed||N/A|120|Actual|Agricultural University of Athens||6|||f||||t||||||||No||2017-10-10 21:42:30.486317|2017-10-10 21:42:30.486317
NCT02928003|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-11-22|||November 2016||2016-11-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|DOLORPOUMON||Chronic Neuropathic Pain After Lung Surgery: Prevalence and Predictive Factors|Chronic Neuropathic Pain After Lung Surgery: Prevalence and Predictive Factors|Not yet recruiting||N/A|250|Anticipated|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:42:30.602716|2017-10-10 21:42:30.602716
NCT02927990|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-04-20|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Observational|||Contrast Volume Reduction During PCI With the Use of a New Assisting Software Package|Contrast Volume Reduction During Percutaneous Coronary Interventions With the Use of a New Assisting Software Package|Not yet recruiting||N/A|70|Anticipated|Philips Healthcare|||2||f||||f||||||||||2017-10-10 21:42:30.68979|2017-10-10 21:42:30.68979
NCT02927977|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-08|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Effectiveness of Dry Needling Adding to Physical Therapy in Patients With Chronic Non-Specific Neck Pain|Dry-needling Added to Physical Therapy for Treating Patients With Chronic Non-specific Neck Pain: a Randomized Controlled Trial|Not yet recruiting||N/A|116|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||Undecided||2017-10-10 21:42:30.783533|2017-10-10 21:42:30.783533
NCT02927964|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-04-06|||November 2016||2016-11-01|April 2017|2017-04-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma|Intratumoral Injection of SD-101, an Immunostimulatory CpG, in Combination With Ibrutinib and Local Radiation in Relapsed or Refractory Low-Grade Follicular Lymphoma|Recruiting||Phase 1/Phase 2|30|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 21:42:30.889093|2017-10-10 21:42:30.889093
NCT02927938|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-10-04|||September 2016||2016-09-01|October 2017|2017-10-01||||September 2022|Anticipated|2022-09-01||Interventional|||Leukemia Stem Cell Detection in Acute Myeloid Leukemia|Leukemia Stem Cell Detection in Acute Myeloid Leukemia|Recruiting||Phase 3|400|Anticipated|Carolinas Healthcare System||8|||f||||t||||||||||2017-10-10 21:42:31.16929|2017-10-10 21:42:31.16929
NCT02927925|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-09-14|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|August 22, 2019|Anticipated|2019-08-22|August 22, 2019|Anticipated|2019-08-22||Interventional|||A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type|An Open Label, Phase 2 Study to Assess the Clinical Efficacy and Safety of Daratumumab in Patients With Relapsed or Refractory Natural Killer/T-Cell Lymphoma, Nasal Type|Recruiting||Phase 2|32|Anticipated|Janssen Research & Development, LLC||1|||f||||f|t|f||||||||2017-10-10 21:42:31.298004|2017-10-10 21:42:31.298004
NCT02927912|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-07-21|||March 23, 2017|Actual|2017-03-23|July 2017|2017-07-01|November 1, 2022|Anticipated|2022-11-01|November 1, 2020|Anticipated|2020-11-01||Interventional|||Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction|Multi-institution Phase II Trial of Intraoperative Electron Beam Radiotherapy Boost at the Time of Breast Conserving Surgery With Oncoplastic Reconstruction in Women With Early-Stage Breast Cancer|Recruiting||Phase 2|176|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 21:42:31.46643|2017-10-10 21:42:31.46643
NCT02927899|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||April 2015||2015-04-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|||Taste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate Cancer|Acceptability in the Taste of Tomato-Soy-Arugula Seed Beverages in Men With Prostate Cancer|Active, not recruiting||N/A|27|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 21:42:31.590275|2017-10-10 21:42:31.590275
NCT02927886|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-17|||November 2016||2016-11-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|G-POEM||Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy|Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy|Not yet recruiting||Phase 3|40|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:42:31.687396|2017-10-10 21:42:31.687396
NCT02927860|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Sleep and Activity Monitoring After Thoracic Surgery|Sleep and Activity Monitoring After Thoracic Surgery|Recruiting||N/A|100|Anticipated|Mayo Clinic|||1||f||||f||||||||No||2017-10-10 21:42:31.993379|2017-10-10 21:42:31.993379
NCT02927808|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-08|||June 2016||2016-06-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|IDEAL-LDL||Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study|Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study|Recruiting||N/A|300|Anticipated|AHEPA University Hospital||2|||f||||f||||||||No||2017-10-10 21:42:32.444081|2017-10-10 21:42:32.444081
NCT02927795|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-10-03|||April 26, 2017|Actual|2017-04-26|October 2017|2017-10-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||OTIVACTO Spain Non Interventional Study|Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice|Recruiting||N/A|1000|Anticipated|Boehringer Ingelheim|||1||f||||f|f|f||||||||2017-10-10 21:42:32.546494|2017-10-10 21:42:32.546494
NCT02927782|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||October 2015||2015-10-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Mobilisation Algorithm After Incidental Durotomy|Flat Bed Rest vs. Immediate Mobilisation After Incidental Durotomy During Lumbar Spinal Surgery: A Prospective Randomised Trial|Recruiting||N/A|60|Anticipated|Balgrist University Hospital||2|||f||||t||||||||No||2017-10-10 21:42:34.919382|2017-10-10 21:42:34.919382
NCT02927769|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-09-26|||March 27, 2017|Actual|2017-03-27|September 2017|2017-09-01|March 27, 2022|Anticipated|2022-03-27|March 28, 2021|Anticipated|2021-03-28||Interventional|CheckMate 744||A Study of Nivolumab + Brentuximab Vedotin in Children, Adolescents, and Young Adults With Classic Hodgkin Lymphoma (cHL) After Failure of First Line Therapy, Followed by Brentuximab Vedotin + Bendamustine for Participants With a Suboptimal Response|Risk-based, Response-adapted, Phase II Open-label Trial of Nivolumab + Brentuximab Vedotin (N + Bv) for Children, Adolescents, and Young Adults With Relapsed/Refractory (R/R) CD30 + Classic Hodgkin Lymphoma (cHL) After Failure of First-line Therapy, Followed by Brentuximab + Bendamustine (Bv + B) for Participants With a Suboptimal Response (CheckMate 744: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation)|Recruiting||Phase 2|80|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 21:42:35.068853|2017-10-10 21:42:35.068853
NCT02927756|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-06|||October 2016||2016-10-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|FLT-Oss-2015||Italian Multicenter Retrospective Observational Study on Transformed Lymphomas|Italian Multicenter Retrospective Observational Study on Transformed Lymphomas|Not yet recruiting||N/A|180|Anticipated|Azienda Ospedaliera Città della Salute e della Scienza di Torino|||1||f||||f||||||||Yes|paper publication|2017-10-10 21:42:35.677241|2017-10-10 21:42:35.677241
NCT02927743|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-06|||June 2015||2015-06-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Evidence-based Reminders on Use of Antibiotics|Effect of Continuous Evidence-based Feed Back to Increase Appropriate Use of Antibiotics|Completed||N/A|8053|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 21:42:35.758628|2017-10-10 21:42:35.758628
NCT02927730|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||September 2016||2016-09-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|October 2016|Actual|2016-10-01||Observational|WHI||The Correlation Between Clinical Diagnosis of Retained Placenta And Histology|The Correlation Between Clinical Diagnosis of Retained Placenta And Histology|Active, not recruiting||N/A|240|Actual|Bait Balev Hospital|||2||f||||f||||||||||2017-10-10 21:42:35.849598|2017-10-10 21:42:35.849598
NCT02927717|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-06|||October 2016||2016-10-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|FL3b-Oss-2015||An Italian Experience on Grade 3b Follicular Lymphoma|An Italian Experience on Grade 3b Follicular Lymphoma|Not yet recruiting||N/A|60|Anticipated|Azienda Ospedaliera Città della Salute e della Scienza di Torino|||1||f||||f||||||||Yes|paper publication|2017-10-10 21:42:35.935462|2017-10-10 21:42:35.935462
NCT02927704|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||March 2011||2011-03-01|October 2016|2016-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|MCP-1||Gingival Crevicular Fluid Levels Of Monocyte Chemoattractant Protein-1|Gingival Crevicular Fluid Levels Of Monocyte Chemoattractant Protein-1 in Patients With Aggressive Periodontitis|Completed||N/A|160|Actual|Abant Izzet Baysal University|||2||f||||f||||||||No||2017-10-10 21:42:36.016015|2017-10-10 21:42:36.016015
NCT02927678|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||January 2014||2014-01-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||White Blood Cell SPECT/CT and Diabetic Foot Osteomyelitis|Assessment of White Blood Cell SPECT/CT in Monitoring Antibiotic Treatment in Patients With Diabetic Foot Osteomyelitis|Recruiting||N/A|56|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:42:36.200976|2017-10-10 21:42:36.200976
NCT02927665|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-26|||September 2016||2016-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|ReShapePAS||A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects|A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects|Recruiting||N/A|250|Anticipated|ReShape Medical, Inc.|||1||f||||f||||||||No||2017-10-10 21:42:36.305264|2017-10-10 21:42:36.305264
NCT02927652|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-07-27|||January 23, 2017|Actual|2017-01-23|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Psychiatric Comorbidity|Evaluating Psychiatric Comorbidity in Otolaryngology|Recruiting||N/A|1000|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 21:42:36.896082|2017-10-10 21:42:36.896082
NCT02927626|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||August 2016||2016-08-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|YYFZTIHBVHCC||Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma|Clinical Research of Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma Basing on Immune Microenviroment|Recruiting||Early Phase 1|132|Anticipated|Beijing Ditan Hospital||2|||f||||||||||||||2017-10-10 21:42:37.057688|2017-10-10 21:42:37.057688
NCT02927613|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-05|||November 2014||2014-11-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Patient Characteristics, Feasibility, and Outcomes of a Home Mechanical Ventilation Program in a Developing Country|Patient Characteristics, Feasibility, and Outcomes of a Home Mechanical Ventilation Program in a Developing Country|Completed||N/A|12|Actual|Thammasat University|||1||f||||t||||||||Yes||2017-10-10 21:42:37.14935|2017-10-10 21:42:37.14935
NCT02927600|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-11|||September 2016||2016-09-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Bed and Breakfast (B&B) Study|Impact of Low Glycemic Responses Breakfast or Dinner on Postprandial Glycemia of the Subsequent Meals|Recruiting||N/A|44|Anticipated|Nestlé||4|||f||||f||||||||No||2017-10-10 21:42:37.234462|2017-10-10 21:42:37.234462
NCT02927587|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-06|||November 2015||2015-11-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Optimal TCI Regimen for Sedation of Elderly Undergoing Fiberoptic Bronchoscopy|Optimal TCI Regimen for Sedation of Elderly Undergoing Fiberoptic Bronchoscopy: A Prospective Randomized Controlled Trial.|Completed||N/A|70|Actual|The Second Affiliated Hospital of Dalian Medical University||2|||f||||t||||||||||2017-10-10 21:42:37.477609|2017-10-10 21:42:37.477609
NCT02927574|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-17|||July 2016||2016-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|2 Years|Observational [Patient Registry]|DOND||Systematic Review and Meta-Analysis on DCB vs. POBA in De-novo Femoropopliteal Disease|Drug Or No Drug (DOND): Systematic Review and Meta-Analysis on Drug-Coated Balloon Angioplasty (DCB) vs. Plain Old Balloon Angioplasty (POBA) in De-novo Femoropopliteal Disease|Active, not recruiting||N/A|1400|Anticipated|Jena University Hospital|||2||f||||f||||||||||2017-10-10 21:42:37.555152|2017-10-10 21:42:37.555152
NCT02927561|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-05|||June 2015||2015-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|||Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening|Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening|Completed||N/A|220|Actual|Retina Clinic, Sao Paulo, Brazil|||1||f||||t||||||||No||2017-10-10 21:42:37.64317|2017-10-10 21:42:37.64317
NCT02927548|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-06|||January 2005||2005-01-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|June 2012|Actual|2012-06-01||Observational|||Evaluation of the Efficacy and Safety of Advantage® Strips in Women Stress Urinary Incontinence (SUI )||Completed||N/A|500|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:42:37.722438|2017-10-10 21:42:37.722438
NCT02927535|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-10-06|||January 2015||2015-01-01|September 2016|2016-09-01||||September 2016|Actual|2016-09-01||Observational|||Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France||Completed||N/A|813|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:42:37.777851|2017-10-10 21:42:37.777851
NCT02927522|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|DAPOCD||Donepezil Attenuate Postoperative Cognitive Dysfunction|Donepezil Attenuate Postoperative Cognitive Dysfunction in Aged Patients- A Multi-center, Case Control, Randomized Clinical Trail|Not yet recruiting||Phase 3|550|Anticipated|RenJi Hospital||2|||f||||||||||||||2017-10-10 21:42:37.85883|2017-10-10 21:42:37.85883
NCT02927509|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-10-06|||May 2014||2014-05-01|September 2016|2016-09-01||||September 2016|Actual|2016-09-01||Observational|||Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France||Completed||N/A|813|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:42:37.962136|2017-10-10 21:42:37.962136
NCT02927496|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-07-19|||August 15, 2017|Anticipated|2017-08-15|July 2017|2017-07-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|LeDoxy-Mali||A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali|A Multi-center, Double-blind, Randomized, 24-month Study, to Compare the Efficacy of Doxycycline Once Daily for 6 Weeks Versus Placebo in Improving Filarial Lymphedema Independent of Active Filarial Infection|Not yet recruiting||Phase 3|250|Anticipated|The Task Force for Global Health||2|||f||||t|f|f||||||||2017-10-10 21:42:38.047771|2017-10-10 21:42:38.047771
NCT02927483|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-27|||November 2016||2016-11-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|EVELINE||Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency|A Comparative Study to Assess the Efficacy and Safety of Endolex Forte vs Diosmin and Hesperidin in Reducing the symptomatoLogy of Patients With ChronIc VeNous Insufficiency Between Functional Classes CEAP 1-4, During a Period of 6 Months|Not yet recruiting||Phase 3|120|Anticipated|SunWave Pharma||2|||f||||t||||||||Yes||2017-10-10 21:42:38.146137|2017-10-10 21:42:38.146137
NCT02927470|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-08|||November 2016||2016-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TMS of Visual Working Memory|Transcranial Magnetic Stimulation of Visual Working Memory|Recruiting||N/A|80|Anticipated|New York University School of Medicine||1|||f||||f|f|t|f|f||||||2017-10-10 21:42:38.247216|2017-10-10 21:42:38.247216
NCT02927444|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2016-10-06|||October 2015||2015-10-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Immunogenicity and Safety Study of NBP606 in Healthy Toddlers|Multi-Center, Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of Booster Vaccination With NBP606 in Healthy Toddlers (The Extension Study of NBP606_PCVI_III_2013)|Recruiting||Phase 3|534|Anticipated|SK Chemicals Co.,Ltd.||2|||f||||||||||||||2017-10-10 21:42:38.505081|2017-10-10 21:42:38.505081
NCT02927431|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-19|||January 19, 2017|Actual|2017-01-19|September 2017|2017-09-01|May 24, 2017|Actual|2017-05-24|May 24, 2017|Actual|2017-05-24||Interventional|||Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza|A Phase II, Global, Randomized Study to Evaluate the Efficacy and Safety of Danirixin (GSK1325756) Co-administered With a Standard-of-care Antiviral (Oseltamivir), in the Treatment of Adults Hospitalized With Influenza|Terminated||Phase 2|11|Actual|GlaxoSmithKline||3||The study was stopped early due to lack of enrollment.|f||||t|t|f||||||||2017-10-10 21:42:38.598235|2017-10-10 21:42:38.598235
NCT02927418|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-05-05|||November 2016|Actual|2016-11-01|October 2016|2016-10-01|May 2017|Actual|2017-05-01|April 9, 2017|Actual|2017-04-09||Interventional|||Strength Training for Injury Prevention|Strength Training for Injury Prevention|Completed||N/A|43|Actual|University of Manitoba||2|||f||||f||||||||No||2017-10-10 21:42:38.845962|2017-10-10 21:42:38.845962
NCT02927405|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-04-11|||May 1, 2017|Anticipated|2017-05-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain|Combination of Preoperative Gabapentin and TAP Blocks in Decreasing Postoperative Pain|Not yet recruiting||Phase 4|130|Anticipated|State University of New York - Downstate Medical Center||2|||f||||t|t|f||||||No||2017-10-10 21:42:38.912512|2017-10-10 21:42:38.912512
NCT02927392|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-07-11|||January 2017||2017-01-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Brown Adipose Tissue Activity in Pre- and Postmenopausal Women|The Impact of Estrogen Status on the Biological Function of Brown Adipose Tissue in Women Measured Using Quantitative PET/CT|Recruiting||N/A|72|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 21:42:38.986251|2017-10-10 21:42:38.986251
NCT02927379|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-27|||June 2016||2016-06-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Wound Infiltration by Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical Stress|Effects of Local Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical Stress Response and Postoperative Pain in Major Abdominal Cancer Surgery|Active, not recruiting||Phase 3|90|Actual|Assiut University||3|||f||||t||||||||Undecided||2017-10-10 21:42:39.070081|2017-10-10 21:42:39.070081
NCT02927366|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-04-04|||May 15, 2017|Anticipated|2017-05-15|April 2017|2017-04-01|April 25, 2019|Anticipated|2019-04-25|March 26, 2019|Anticipated|2019-03-26||Interventional|||Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients|A Randomized, Parallel-group, Placebo-controlled Subject and Investigator Blinded Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of QCC374 in the Treatment of Pulmonary Arterial Hypertension|Not yet recruiting||Phase 2|38|Anticipated|Novartis||2|||f||||t|t|f||||||Yes||2017-10-10 21:42:39.160393|2017-10-10 21:42:39.160393
NCT02927353|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-08-17|||August 2016||2016-08-01|June 2016|2016-06-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|DMB-3113-1||A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects|A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects|Completed||Phase 1|180|Actual|Meiji Seika Pharma Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:42:39.239352|2017-10-10 21:42:39.239352
NCT02927340|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-15|||October 2016||2016-10-01|May 2017|2017-05-01|March 2023|Anticipated|2023-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions|A Phase II Study of Lorlatinib (PF-06463922) in Advanced Anaplastic Lymphoma Kinase (ALK) and ROS Proto-Oncogene 1 (ROS1) Rearranged Non-Small Cell Lung Cancer (NSCLC) With Central Nervous System (CNS) Metastasis in the Absence of Measurable Extracranial Lesions|Recruiting||Phase 2|30|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 21:42:39.319906|2017-10-10 21:42:39.319906
NCT02927327|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-06|||November 2016||2016-11-01|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Clinical Evaluation Of MP26 Features in Adults|Clinical Evaluation Of MP26 Features in Adults|Recruiting||N/A|75|Anticipated|GE Healthcare||2|||f||||f||||||||||2017-10-10 21:42:39.500085|2017-10-10 21:42:39.500085
NCT02927314|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-10-06|||February 2017||2017-02-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|||A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)|Not yet recruiting||Phase 2|60|Anticipated|Can-Fite BioPharma||3|||f||||||||||||||2017-10-10 21:42:39.588301|2017-10-10 21:42:39.588301
NCT02927301|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-08-01|||January 31, 2017|Actual|2017-01-31|August 2017|2017-08-01|July 31, 2023|Anticipated|2023-07-31|July 31, 2023|Anticipated|2023-07-31||Interventional|||A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Stage IB, II, or IIIA Resectable and Untreated Non-Small Cell Lung Cancer (NSCLC)|A Phase II, Open-Label, Multicenter, Single-Arm Study to Investigate the Efficacy and Safety of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients With Stage IB, II, or IIIA Resectable and Untreated Non-Small Cell Lung Cancer|Recruiting||Phase 2|180|Anticipated|Genentech, Inc.||1|||f|||||t|f||||||||2017-10-10 21:42:39.68392|2017-10-10 21:42:39.68392
NCT02927288|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-05|||January 2012||2012-01-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy|Identifying Biomarkers That Distinguish Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury Using Advanced Magnetic Resonance Spectroscopy|Recruiting||N/A|330|Anticipated|Brigham and Women's Hospital|||5||f||||f||||||||No|Data may be uploaded to FITBIR in the future.|2017-10-10 21:42:39.848997|2017-10-10 21:42:39.848997
NCT02927275|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-10-05|||April 2012||2012-04-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|CIM||Cognition in Motion|Cognition in Motion: Attitudes, Utilization, and Cognitive Impact of Low Intensity Exercise Among Medical Students|Completed||N/A|88|Actual|Baylor College of Medicine||4|||f||||f||||||||No|Individual performance on testing rounds was incorporated into cumulative statistical analysis and will not be made public.|2017-10-10 21:42:39.944559|2017-10-10 21:42:39.944559
NCT02927262|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-09-25|||January 10, 2017|Actual|2017-01-10|September 2017|2017-09-01|March 2024|Anticipated|2024-03-01|March 2024|Anticipated|2024-03-01||Interventional|||A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the FLT3 Inhibitor Gilteritinib (ASP2215) Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FLT3/ITD AML in First Complete Remission|Recruiting||Phase 3|354|Anticipated|Astellas Pharma Inc||2|||t||||t||||||||||2017-10-10 21:42:40.110168|2017-10-10 21:42:40.110168
NCT02927249|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-09-29|||December 2016||2016-12-01|September 2017|2017-09-01||||April 2021|Anticipated|2021-04-01||Interventional|||Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy|A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial|Recruiting||Phase 3|2936|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 21:42:40.914724|2017-10-10 21:42:40.914724
NCT02927236|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-06|2017-08-22|||October 3, 2016||2016-10-03|August 15, 2017|2017-08-15|December 31, 2021|Anticipated|2021-12-31|December 21, 2020|Anticipated|2020-12-21||Interventional|||Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use|Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use|Recruiting||Phase 1/Phase 2|170|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 21:42:47.797791|2017-10-10 21:42:47.797791
NCT02927223|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)|Pretreatment With Atropine to Reduce Exercise-triggered Ventricular Ectopy in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)|Not yet recruiting||N/A|15|Anticipated|Vanderbilt University||2|||f||||f||||||||No||2017-10-10 21:42:47.883281|2017-10-10 21:42:47.883281
NCT02927210|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-08|||December 2016||2016-12-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|DMAU||Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)|Injectable DMAU for Male Contraception: Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of Single IM or SC DMAU Injection Dose Escalation Study in Healthy Male Volunteers|Recruiting||Phase 1|72|Anticipated|Health Decisions||2|||f||||t||||||||||2017-10-10 21:42:47.954097|2017-10-10 21:42:47.954097
NCT02927197|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-12-14|||June 2015||2015-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2016|Actual|2016-03-01||Interventional|||LearningRx Brain Training for Children 8-14|A Randomized, Controlled Study on the Effects of LearningRx Brain Training for Improving Cognitive Skills in Students Ages 8-14|Active, not recruiting||N/A|39|Actual|Gibson Institute of Cognitive Research||2|||f||||f||||||||Yes|Harvard Dataverse|2017-10-10 21:42:48.090049|2017-10-10 21:42:48.090049
NCT02927184|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-07-17|||August 2016||2016-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess The Efficacy, Safety, and Tolerability of VK2809 Administered for 12 Weeks Followed by a 4-Week Off-Drug Phase in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease|Recruiting||Phase 2|80|Anticipated|Viking Therapeutics, Inc.||4|||f||||t||||||||||2017-10-10 21:42:48.304265|2017-10-10 21:42:48.304265
NCT02927171|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-08-30|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Shifting Rehabilitation Paradigms in Skilled Nursing Facilities|Shifting Rehabilitation Paradigms in Skilled Nursing Facilities|Recruiting||N/A|86|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:42:48.484724|2017-10-10 21:42:48.484724
NCT02927158|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-08-28|||August 2016||2016-08-01|October 2016|2016-10-01|August 2030|Anticipated|2030-08-01|August 2026|Anticipated|2026-08-01||Observational|||Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community|Use of Whole Exome Sequencing/Whole Genome Sequencing in the Plain Communities|Recruiting||N/A|300|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"     Whole blood will be collected and DNA will be isolated and stored. Samples may also be     collected on newborn screening filter papers.   "|||2017-10-10 21:42:48.598111|2017-10-10 21:42:48.598111
NCT02927145|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-07-11|||October 17, 2016|Actual|2016-10-17|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate|A Phase I/IIa Clinical Trial to Assess the Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Falciparum Malaria Vaccine Candidate RH5.1/AS01|Recruiting||Phase 1/Phase 2|78|Anticipated|University of Oxford||6|||f||||t||||||||||2017-10-10 21:42:48.718586|2017-10-10 21:42:48.718586
NCT02927132|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Guilt and Expressive Writing for Reducing Alcohol Use in College Students||Enrolling by invitation||N/A|600|Anticipated|University of Houston||6|||f||||||||||||No||2017-10-10 21:42:48.827104|2017-10-10 21:42:48.827104
NCT02927119|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||August 2014||2014-08-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Serum Thyroglobulin as a Marker of Iodine Status During Pregnancy|Serum Thyroglobulin as a Marker of Iodine Nutrition Status During Pregnancy in Hungarian Population|Completed||N/A|189|Actual|University of Debrecen|||2||f||||t||||||Samples Without DNA|"     serum urine   "|Undecided||2017-10-10 21:42:48.957879|2017-10-10 21:42:48.957879
NCT02927106|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-07-25|||February 15, 2017|Actual|2017-02-15|July 2017|2017-07-01|February 15, 2025|Anticipated|2025-02-15|February 15, 2024|Anticipated|2024-02-15||Interventional|||Beat AML Core Study|Beat AML: Personalized Medicine for Acute Myeloid Leukemia Based on Functional Genomics|Recruiting||N/A|50|Anticipated|University of Florida||1|||f||||t|f|f||||||||2017-10-10 21:42:49.049085|2017-10-10 21:42:49.049085
NCT02927093|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-07|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life|Neonatal, Clinical and Neurodevelopmental Outcome of Neonates Hospitalized for Neonatal Hyperbilirubinemia Reaching Exchange Transfusion Threshold in a Remote Setting Along the Thai-Myanmar Border|Completed||N/A|78|Actual|University of Oxford|||2||f||||f||||||||Yes|The data will be stored in the database and may be shared with other researchers in the future, however, data will be anonymous and the researchers will not know the participant identity.|2017-10-10 21:42:49.169738|2017-10-10 21:42:49.169738
NCT02927080|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-09-06|||November 2016||2016-11-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy|Recruiting||Phase 2|76|Anticipated|Acceleron Pharma, Inc.||5|||f||||t||||||||||2017-10-10 21:42:49.260019|2017-10-10 21:42:49.260019
NCT02927067|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-20|||April 6, 2017|Actual|2017-04-06|September 2017|2017-09-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients|A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients|Recruiting||Phase 3|550|Anticipated|Shire||2|||f||||t|t|f||||||||2017-10-10 21:42:49.551477|2017-10-10 21:42:49.551477
NCT02927054|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||July 2014||2014-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Education on Resident Physician Knowledge of Sepsis|Effect of Education on Resident Physician Knowledge of Sepsis|Completed||N/A|239|Actual|University of Utah||5|||f||||f||||||||Yes|If requested, will share with other authors or institutions|2017-10-10 21:42:50.146581|2017-10-10 21:42:50.146581
NCT02927041|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-05-02|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|OPTEMUS||Observational Prospective Transesophageal Myocardial Ultrasound Survey|Observational Prospective Transesophageal Myocardial Ultrasound Survey|Not yet recruiting||N/A|60|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||f|f|t|f|f|f|||Undecided||2017-10-10 21:42:50.232823|2017-10-10 21:42:50.232823
NCT02927028|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-10-05|||August 2015||2015-08-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||The Effects of Mastication on Energy Release From Walnuts|The Effects of Mastication and Digestion on the Bio Accessibility of Energy From Walnuts|Active, not recruiting||N/A|50|Actual|Purdue University||1|||f||||f||||||||Undecided||2017-10-10 21:42:50.32473|2017-10-10 21:42:50.32473
NCT02927015|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-05|||January 2016||2016-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Glucose Response From Antioxidant Rich Potato Chips|Glucose Response From Antioxidant Rich Potato Chips|Completed||N/A|11|Actual|Purdue University||4|||f||||t||||||||No||2017-10-10 21:42:50.406443|2017-10-10 21:42:50.406443
NCT02926989|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intravenous Fluids in Hospitalised Children|Isotonic Versus Hypotonic Intravenous Fluids in Hospitalised Children - a Randomised Controlled Trial|Not yet recruiting||Phase 4|610|Anticipated|University of Oulu||2|||f||||f||||||||No||2017-10-10 21:42:50.695982|2017-10-10 21:42:50.695982
NCT02926976|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||November 2016||2016-11-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Optimal Treatment for Treatment-resistant Schizophrenia|The Optimal Treatment for Treatment-resistant Schizophrenia|Not yet recruiting||N/A|150|Anticipated|Shanghai Mental Health Center||5|||f||||t||||||||No||2017-10-10 21:42:50.850278|2017-10-10 21:42:50.850278
NCT02926963|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-27|||October 2010||2010-10-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|FIBRO CGD||Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.|Generation of Powerful Biological Tools - Fibroblast or Inducible Pluripotent Bone Marrow Cells - for Understanding the Pathophysiology of Chronic Granulomatous Disease.|Terminated||N/A|3|Actual|University Hospital, Grenoble||1||insufficient recruitment|f||||f||||||||||2017-10-10 21:42:50.985051|2017-10-10 21:42:50.985051
NCT02926950|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-27|||November 2016||2016-11-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin|Recruiting||Phase 3|500|Anticipated|Sanofi||2|||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:42:51.09792|2017-10-10 21:42:51.09792
NCT02926911|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-14|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|June 2021|Anticipated|2021-06-01||Interventional|COMET||Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS|Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS: A Phase III Prospective Randomized Trial|Recruiting||N/A|1200|Anticipated|Alliance Foundation Trials, LLC.||2|||f||||t|f|f||||||||2017-10-10 21:42:51.715656|2017-10-10 21:42:51.715656
NCT02926898|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-09|||September 2016||2016-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome|A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome|Recruiting||Phase 3|100|Anticipated|Zogenix, Inc.||4|||f||||t||||||||||2017-10-10 21:42:51.953317|2017-10-10 21:42:51.953317
NCT02926885|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-06|||August 2015||2015-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy Evaluation of the Esophagogastric Junction Exposure Obtained by the Flexible Liver Retractor in Gastroplasty|Efficacy Evaluation of the Esophagogastric Junction Exposure Obtained by the Flexible Liver Retractor in Gastroplasty for Obesity|Completed||N/A|100|Actual|Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara||2|||f||||t||||||||No||2017-10-10 21:42:52.274567|2017-10-10 21:42:52.274567
NCT02926872|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-06-14|||November 2016||2016-11-01|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Observational|||Screening for Lysosomal Acid Lipase Deficiency|SCREENING FOR LYSOSOMAL ACID LIPASE DEFICIENCY AS THE UNDERLYING SOURCE OF HEPATIC INJURY IN PEDIATRIC PATIENTS WITH EVIDENCE OF ABNORMAL CLINICAL OR BIOCHEMICAL TESTS (DETECT)|Terminated||N/A|22|Actual|Alexion Pharmaceuticals|||1|Study scope re-assessed.|f||||f||||||Samples Without DNA|"     A stored (Dried Blood Spot) DBS card is collected for future assay development may be used     irrespective of a patient's DBS LAL enzyme activity result.   "|No||2017-10-10 21:42:52.37017|2017-10-10 21:42:52.37017
NCT02926859|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-14|||April 8, 2017|Actual|2017-04-08|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Enhancing Recovery in Early Schizophrenia|Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol vs. Placebo as an add-on to an Individualized Antipsychotic Treatment|Recruiting||Phase 2|180|Anticipated|Central Institute of Mental Health, Mannheim||2|||f||||t|f|f||||||||2017-10-10 21:42:52.455888|2017-10-10 21:42:52.455888
NCT02926846|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-10-06|||March 2014||2014-03-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|||IV Antibiotics With Lavage for Severe PD Peritonitis|Randomized Trial on Intravenous Antibiotics With Adjunctive Lavage for Severe Peritoneal-dialysis Related Peritonitis|Recruiting||Phase 4|40|Anticipated|Alice Ho Miu Ling Nethersole Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:42:52.577113|2017-10-10 21:42:52.577113
NCT02926833|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-07-25|||September 2016||2016-09-01|July 2017|2017-07-01|June 2023|Anticipated|2023-06-01|June 2018|Anticipated|2018-06-01||Interventional|ZUMA-6||A Study Evaluating KTE-C19 in Combination With Atezolizumab in Subjects With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Subjects With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Recruiting||Phase 1/Phase 2|31|Anticipated|Kite Pharma, Inc.||1|||f||||t||||||||||2017-10-10 21:42:52.697517|2017-10-10 21:42:52.697517
NCT02926820|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-07|||February 2015||2015-02-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Working Memory Training in Huntington's Disease|Working Memory Training in Individuals With Huntington's Disease: A Pilot Project|Completed||N/A|9|Actual|York University||1|||f||||f||||||||No||2017-10-10 21:42:52.924169|2017-10-10 21:42:52.924169
NCT02926807|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-02-06|||January 2017||2017-01-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Trial on Vascular Inflammation in Atopic Dermatitis|Vascular Inflammation and Coronary Atherosclerosis Risks in Subjects With Atopic Dermatitis|Recruiting||N/A|60|Anticipated|Innovaderm Research Inc.|||2||f||||f||||||||No||2017-10-10 21:42:53.025392|2017-10-10 21:42:53.025392
NCT02926794|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-11-02|||March 2014||2014-03-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Reducing College Student Drinking by Integrating Self-Affirmation and Implementation Intentions||Completed||N/A|293|Actual|University of California, Santa Barbara||4|||f||||f||||||||No||2017-10-10 21:42:53.144886|2017-10-10 21:42:53.144886
NCT02926781|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||November 2016||2016-11-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Interventional|||A Comparative Study to Evaluate Bone Height Gain Following Transcrestal Sinus Floor Elevation Using Specially Designed Drills Versus the Conventional Osteotome Technique.|A Comparative Study to Evaluate Bone Height Gain Following Transcrestal Sinus Floor Elevation Using Specially Designed Drills Versus the Conventional Osteotome Technique: a Randomized Controlled Clinical Trial.|Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 21:42:53.215722|2017-10-10 21:42:53.215722
NCT02926768|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-08-14|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors|A Phase I/II, Open-Label, Safety, Pharmacokinetic and Efficacy Study of Ascending Doses of Oral CK-101 in Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|122|Anticipated|Checkpoint Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 21:42:53.301104|2017-10-10 21:42:53.301104
NCT02926755|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-06-05|||January 20, 2016|Actual|2016-01-20|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MIAMI||Multi-modality Imaging in Acute Myocardial Infarction|Multi-modality Imaging in Acute Myocardial Infarction|Recruiting||N/A|100|Anticipated|William Beaumont Hospitals||1|||f||||t||||||||Undecided||2017-10-10 21:42:53.417203|2017-10-10 21:42:53.417203
NCT02926742|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||February 2014||2014-02-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|SPEEK||Submassive Pulmonary Embolism Experience With EKOS|Submassive Pulmonary Embolism Experience With EKOS|Recruiting||N/A|50|Anticipated|Fairfield Medical Center|||1||f||||f||||||||Undecided|De-identified individual study participant data will be made available 6 months after study completion. This data to include all primary and secondary outcome measures.|2017-10-10 21:42:53.54799|2017-10-10 21:42:53.54799
NCT02926729|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy|Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy|Not yet recruiting||N/A|98|Anticipated|Dana-Farber Cancer Institute||2|||f||||f||||||||No||2017-10-10 21:42:53.643752|2017-10-10 21:42:53.643752
NCT02926716|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-02-16|||December 14, 2015|Actual|2015-12-14|February 2017|2017-02-01|December 29, 2016|Actual|2016-12-29|December 29, 2016|Actual|2016-12-29||Observational|||NBI for Identifying Resection Margin Status in Gastric Cancer|Efficacy of Narrow Band Imaging Technique for Identifying Resection Margin Status After Gastrectomy for Gastric Cancer|Completed||N/A|100|Actual|Ajou University School of Medicine|||1||f||||||||||||||2017-10-10 21:42:53.72974|2017-10-10 21:42:53.72974
NCT02926703|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-06|||November 2015||2015-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure|Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure|Completed||N/A|85|Actual|RWTH Aachen University|||2||f||||f||||||Samples Without DNA|"     2-5 ml blood sample for the measurements of serum lactate and creatine kinase concentrations   "|No||2017-10-10 21:42:53.843546|2017-10-10 21:42:53.843546
NCT02926690|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-29|||May 29, 2017|Actual|2017-05-29|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|||Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer|A Phase I Study of OTS167PO, a MELK Inhibitor, to Evaluate Safety, Tolerability and Pharmacokinetics in Patients With Advanced Breast Cancer and Dose-Expansion Study in Patients With Triple Negative Breast Cancer|Recruiting||Phase 1|70|Anticipated|OncoTherapy Science, Inc.||1|||f|||||t|f||||||No||2017-10-10 21:42:53.949166|2017-10-10 21:42:53.949166
NCT02926677|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Child Characteristics, Neuromarkers, and Intervention Components Impacting Treatment Outcome: CCT, TF-CBT, TAU|Child Characteristics, Neuromarkers, and Intervention Components Impacting Treatment Outcome: A Randomized Controlled Trial of Cue-Centered Treatment (CCT), Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT), and Treatment as Usual (TAU)|Not yet recruiting||N/A|144|Anticipated|Stanford University||3|||f||||f||||||||No||2017-10-10 21:42:54.027276|2017-10-10 21:42:54.027276
NCT02926664|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-04-24|||October 2016||2016-10-01|April 2017|2017-04-01|May 1, 2017|Anticipated|2017-05-01|May 1, 2017|Anticipated|2017-05-01||Observational|DELTASCREEN||Delta qSOFA for Risk Stratification in Emergency Infected Patients|Prognostic Value of Quick Sequential Organ Failure Assessment Kinetics After Fluids Challenge in the Emergency Department|Active, not recruiting||N/A|322|Anticipated|Societe Française de Medecine d'urgence|||1||f||||f||||||||Yes|data will be available upon request to the principal investigator|2017-10-10 21:42:54.113398|2017-10-10 21:42:54.113398
NCT02926651|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty|Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty|Not yet recruiting||Phase 4|302|Anticipated|Rush University Medical Center||4|||f||||f||||||||No||2017-10-10 21:42:54.196685|2017-10-10 21:42:54.196685
NCT02926638|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-10-03|||June 2014||2014-06-01|October 2017|2017-10-01|May 2022|Anticipated|2022-05-01|April 2022|Anticipated|2022-04-01||Interventional|||S1400E Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches|A Phase II/III Randomized Study of Rilotumumab Plus Erlotinib Versus Erlotinib as Second Line Therapy for C-Met Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung- Map Sub-Study)|Active, not recruiting||Phase 2/Phase 3|310|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-10 21:42:54.329597|2017-10-10 21:42:54.329597
NCT02926625|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-07-27|||November 2015||2015-11-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|TRAction||Universal Versus Conditional Three-day Follow-up Visit for Children With Unclassified Fever|Universal Versus Conditional Three-day Follow-up Visit for Children With Unclassified Fever at the Community Level: A Study to be Conducted in Ethiopia|Completed||Phase 4|4179|Actual|Malaria Consortium||2|||f||||f||||||||||2017-10-10 21:42:55.86385|2017-10-10 21:42:55.86385
NCT02926612|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-04-12|||June 2016||2016-06-01|April 2017|2017-04-01||||December 2019|Anticipated|2019-12-01||Observational|||Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients With Suspected Lower Respiratory Tract Infection|Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients With Suspected Lower Respiratory Tract Infection|Recruiting||N/A|250|Anticipated|Pediatric Blood and Marrow Transplant Foundation, Inc.|||1||f||||t||||||||Undecided|Individual patient results will be available to the patient site, but it is undecided whether or not to make these results available to everyone.|2017-10-10 21:42:55.965788|2017-10-10 21:42:55.965788
NCT02926599|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|TOP||Potential Optimization Training in Simulation.|High Fidelity Simulation Performance After a Potential Optimization Training for Anesthesiologist Resident: a Randomized Controlled Trial.|Recruiting||N/A|120|Anticipated|Claude Bernard University||2|||f||||f||||||||Undecided||2017-10-10 21:42:56.047367|2017-10-10 21:42:56.047367
NCT02926586|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||July 2016||2016-07-01|October 2016|2016-10-01||||July 2019|Anticipated|2019-07-01||Interventional|||Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML|Fludarabine and Cytarabine Versus High-dose Cytarabine in Consolidation Treatment of Core-bing Factor Acute Myeloid Leukemia: A Prospective, Multicenter, Randomized Study|Recruiting||Phase 4|200|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-10 21:42:56.133119|2017-10-10 21:42:56.133119
NCT02926573|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-04|||July 2016||2016-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|GABA||Effect of Gabapentin on Postoperative Pain Control Among Head and Neck Cancer Patients|A Prospective Randomized Controlled Trial on the Effect of Gabapentin on Postoperative Pain Control Among Head and Neck Cancer Patients|Recruiting||Phase 4|120|Anticipated|Washington University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:42:56.224156|2017-10-10 21:42:56.224156
NCT02926560|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-10-06|||June 2016||2016-06-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Observational|||Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism||Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:42:56.312049|2017-10-10 21:42:56.312049
NCT02926547|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-01-31|||March 2014||2014-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement||Active, not recruiting||N/A|108|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||||||||Samples Without DNA|"     This proteomic study is performed on biological samples originally as part of a diagnostic     approach reclassified in the absence of opposition from patients, from the Biobank of Nîmes     University hospital (Ministry of Higher Education and Research No. AC-2008-107; South     Mediterranean CPP III No. COL2008.04.02).      For validation part, the investigators will work on sections of TMA already made from samples     drawn between 2000 and 2003.   "|||2017-10-10 21:42:56.448118|2017-10-10 21:42:56.448118
NCT02926534|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|||Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan|A Cross-sectional Study of the Socio-demographic and Other Determinants of Chronic Obstructive Pulmonary Disease (COPD) Among Those Who Smoke, Quit Smoking and Never-smoking Cigarettes|Recruiting||N/A|900|Anticipated|Kazakhstan Academy of Preventive Medicine|||3||f||||f||||||Samples Without DNA|"     Serum   "|Yes|The investigators will share all participant data except personally identifiable information. Data will be available to open-access after the completion of the study (after July 31, 2017). Access to study data, which is going to be located in our web site, will be granted by request.|2017-10-10 21:42:56.511524|2017-10-10 21:42:56.511524
NCT02926521|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-05|||January 2017||2017-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Assessing Current Peripheral Nerve Block Catheter Fixation and Dressing Strategies: An Equivalence Study|Assessing Current Peripheral Nerve Block Catheter Fixation and Dressing Strategies: An Equivalence Study|Not yet recruiting||N/A|800|Anticipated|Boston Children’s Hospital||4|||f||||f||||||||No||2017-10-10 21:42:56.611322|2017-10-10 21:42:56.611322
NCT02926508|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-10-04|||July 2016||2016-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OxPiC||Oxford Study of Prebiotics in Children|Investigating the Effects of a Prebiotic Supplement on Learning and Behaviour in Children From Academic Year Groups 3, 4 and 5, Whose Reading Scores Suggest There is Room for Improvement: a Randomised Placebo-controlled Study|Enrolling by invitation||N/A|60|Anticipated|University of Oxford||2|||f||||t||||||||Undecided||2017-10-10 21:42:56.704442|2017-10-10 21:42:56.704442
NCT02926495|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-02-17|||November 2016|Anticipated|2016-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension.||Withdrawn||N/A|0|Actual|Valencia Technologies Corporation||2||The study was stopped before start because the project was not fully-funded.|f||||||||||||||2017-10-10 21:42:56.799393|2017-10-10 21:42:56.799393
NCT02926482|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-04|||April 2016||2016-04-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Intervention to Expand Buprenorphine Prescribers|Test of a Workforce Development Intervention to Expand Buprenorphine Prescribers|Recruiting||N/A|70|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||No||2017-10-10 21:42:56.872815|2017-10-10 21:42:56.872815
NCT02926469|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-26|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|VRAIL||Virtual Reality Analgesia in Labor: The VRAIL Pilot Study|Virtual Reality Analgesia in Labor: The VRAIL Pilot Study|Completed||N/A|28|Actual|University of Michigan||2|||f||||f||||||||No||2017-10-10 21:42:57.033879|2017-10-10 21:42:57.033879
NCT02926443|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-01-05|||January 2016||2016-01-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Effectiveness of Supervised Motor Control Exercises on Rotator Cuff Tendinopathies|Effectiveness of the Upper Extremity Neuromuscular Training Program (UpEx-NTP) on Shoulder Function of People With Rotator Cuff Tendinopathies: A Randomized Control Trial|Recruiting||N/A|44|Anticipated|Laval University||2|||f||||t||||||||No||2017-10-10 21:42:57.244845|2017-10-10 21:42:57.244845
NCT02926209|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-07-30|||February 21, 2017|Actual|2017-02-21|July 2017|2017-07-01|March 20, 2018|Anticipated|2018-03-20|February 20, 2018|Anticipated|2018-02-20||Interventional|||Post Market Evaluation of Aer-O-Scope Visualization|Post Market Evaluation of Aer-O-Scope Visualization|Recruiting||N/A|300|Anticipated|GI View Ltd.||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:42:58.977151|2017-10-10 21:42:58.977151
NCT02926417|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-10-04|||June 2016||2016-06-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|IPOD-B2||Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2)|Interventions for Postoperative Delirium: Biomarker-2 (IPOD-B2) Pilot Study|Recruiting||N/A|38|Anticipated|University of Wisconsin, Madison|||1||f||||t||||||Samples Without DNA|"     Participant blood and cerebral spinal fluid samples will be collected and stored for future     analysis.   "|||2017-10-10 21:42:57.453564|2017-10-10 21:42:57.453564
NCT02926404|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-10-05|||July 2014||2014-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01|24 Months|Observational [Patient Registry]|||UNiD Rods Register|Evaluation of Patients Treated With Patient Specific Rods: UNiD Rods Register|Recruiting||N/A|300|Anticipated|Medicrea International|||1||f||||f||||||||No||2017-10-10 21:42:57.529711|2017-10-10 21:42:57.529711
NCT02926391|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-10-05|||June 2016||2016-06-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01|24 Months|Observational [Patient Registry]|||UNiD 3D VBR Register|Evaluation of Safety and Efficency of Custom-made Corpectomy Implants: UNiD 3D VBR|Recruiting||N/A|60|Anticipated|Medicrea International|||2||f||||f||||||||No||2017-10-10 21:42:57.630943|2017-10-10 21:42:57.630943
NCT02926365|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|April 2019|Anticipated|2019-04-01||Interventional|BIPBJÖRN||BIP in Jämtland Härjedalen: Increased Access to CBT Within Regular Health Care in Northern Sweden|Increased Access to Psychological Treatment for Children and Adolescents Through Internet-delivered CBT - a Pragmatic Evaluation Within Regular Health Care in a Rural Area of Sweden|Recruiting||N/A|160|Anticipated|Karolinska Institutet||1|||f||||f||||||||Undecided||2017-10-10 21:42:57.787752|2017-10-10 21:42:57.787752
NCT02926352|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-10-04|||August 2015||2015-08-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training|Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training in the Modification of Pathological Fear|Recruiting||Phase 1/Phase 2|120|Anticipated|University of Texas at Austin||4|||f||||f||||||||||2017-10-10 21:42:57.861804|2017-10-10 21:42:57.861804
NCT02926339|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Teens Against Tobacco Use: A Tobacco Prevention Curriculum and Advocacy Initiative|Teens Against Tobacco Use: A Tobacco Prevention Curriculum and Advocacy Initiative|Not yet recruiting||N/A|2500|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||Undecided||2017-10-10 21:42:57.966788|2017-10-10 21:42:57.966788
NCT02926326|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-21|||September 2016||2016-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers|An Open-label, Single-sequence Study to Evaluate the Effect of Azithromycin on BCT197 Exposure in Healthy Male Subjects|Completed||Phase 1|16|Actual|Mereo BioPharma||1|||f||||f||||||||No||2017-10-10 21:42:58.041944|2017-10-10 21:42:58.041944
NCT02926313|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||October 2012||2012-10-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||The Effectiveness of Specialist Seating Provision for Nursing Home Residents|The Effectiveness of Specialist Seating Provision for Nursing Home Residents|Completed||N/A|40|Actual|University of Ulster||2|||f||||t||||||||No||2017-10-10 21:42:58.301177|2017-10-10 21:42:58.301177
NCT02926300|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-09-05|||November 2015||2015-11-01|September 2016|2016-09-01|November 2021|Anticipated|2021-11-01|October 2021|Anticipated|2021-10-01||Observational|||Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)|Extension Study, An Open-labelled, Multi Center, Comparative Phase I/IIa Clinical Trials to Evaluate the Efficacy and Safety of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease|Recruiting||N/A|24|Anticipated|Kang Stem Biotech Co., Ltd.|||1||f||||t||||||||||2017-10-10 21:42:58.359351|2017-10-10 21:42:58.359351
NCT02926287|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||August 2015||2015-08-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|August 2016|Actual|2016-08-01||Interventional|PCAP||Ambulatory Surgery for Urogenital Prolapse : a Pilot Study|Ambulatory Surgery for Urogenital Prolapse : a Pilot Study|Active, not recruiting||N/A|157|Actual|Clinique Beau Soleil||1|||f||||f||||||||No||2017-10-10 21:42:58.449896|2017-10-10 21:42:58.449896
NCT02926274|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-04-19|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Transfusion Using Stored Fresh Whole Blood|Transfusion of Stored Fresh Whole Blood in a Civilian Trauma Center: A Prospective Evaluation of Feasibility and Outcomes|Not yet recruiting||N/A|98|Anticipated|University of California, Los Angeles|||2||f||||f||||||Samples With DNA|"     Blood samples   "|Yes|Fully deidentified data will be available to other researchers upon request|2017-10-10 21:42:58.51045|2017-10-10 21:42:58.51045
NCT02926261|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-10-05|||December 2016||2016-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Methods for Nutritional Assessment in Cirrhosis|Evaluation of Three Methods for Nutritional Assessment in Patients With Cirrhosis|Not yet recruiting||N/A|180|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||f||||||Samples Without DNA|"     Serum and plasma samples collected at time of evaluation and stored at -80°.   "|No||2017-10-10 21:42:58.608131|2017-10-10 21:42:58.608131
NCT02926248|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-29|||May 2016||2016-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Colchine MUA||Effect of Colchicine on Range of Motion After Manipulation Under Anesthesia for the Stiff Total Knee Replacement|Effect of Colchicine on Range of Motion After Manipulation Under Anesthesia for the Stiff Total Knee Replacement: A Prospective Randomized Controlled Trial|Recruiting||Phase 4|112|Anticipated|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-10 21:42:58.680951|2017-10-10 21:42:58.680951
NCT02926235|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-05-22|||April 2016||2016-04-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|Amino Acid||Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty|Randomized Control Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty|Recruiting||Phase 4|60|Anticipated|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-10 21:42:58.77872|2017-10-10 21:42:58.77872
NCT02926196|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-06-19|||June 2016||2016-06-01|June 2017|2017-06-01|June 2023|Anticipated|2023-06-01|June 2021|Anticipated|2021-06-01||Interventional|A-Brave||Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab|Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab: A Phase III Randomized Trial. Sponsor: Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova|Recruiting||Phase 3|335|Anticipated|Istituto Oncologico Veneto IRCCS||2|||f||||||||||||||2017-10-10 21:42:59.170661|2017-10-10 21:42:59.170661
NCT02926183|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-06|||October 2016||2016-10-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Study of NAC of GA Therapy for Patients With BRPC|Phase II Study of Neoadjuvant Chemotherapy of Gemcitabine+Nab-paclitaxel Therapy for Patients With Borderline Resectable Pancreatic Cancer|Recruiting||Phase 2|60|Anticipated|Wakayama Medical University||1|||f||||t||||||||No||2017-10-10 21:42:59.40023|2017-10-10 21:42:59.40023
NCT02926170|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||March 2013||2013-03-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|October 2016|Actual|2016-10-01||Interventional|||Rivaroxaban for Patients With Antiphospholipid Syndrome|Rivaroxaban Versus Acenocumarol for Secondary Thromboprophylaxis in Patients With Antiphospholipid Syndrome: a Randomized, Prospective, Phase III Study. Analysis of Stratification Prognostic Factors|Active, not recruiting||Phase 3|190|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||Undecided||2017-10-10 21:42:59.55304|2017-10-10 21:42:59.55304
NCT02926157|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-10-01|||October 2016||2016-10-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Buying Time: Improving Sleep to Promote Cognitive Function in Older Adults|Buying Time: Improving Sleep to Promote Cognitive Function in Older Adults|Recruiting||N/A|96|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 21:42:59.633499|2017-10-10 21:42:59.633499
NCT02926144|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-12-14|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|MGM3||Does McGRATH® MAC Videolaryngoscope Decrease the Number of People Required to Perform Intubation During Anesthesia ?|Can the Use of the McGRATH® MAC Videolaryngoscope Decrease the Number of People Required for Tracheal Intubation in a Population of Patients Without Predicted Difficult Intubation?|Recruiting||N/A|300|Anticipated|Hopital Foch||2|||f||||f||||||||No||2017-10-10 21:42:59.736254|2017-10-10 21:42:59.736254
NCT02926131|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-10-04|||November 2016||2016-11-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|Bilistick||A Study to Evaluate a New Jaundice Stick Test|Field Evaluation of a Point-Of-Care Test for Serum Bilirubin Levels in Infants Born in a Tropical Limited-resource Setting.|Not yet recruiting||N/A|180|Anticipated|University of Oxford|||1||f||||f||||||Samples Without DNA|"     Blood   "|No||2017-10-10 21:42:59.849489|2017-10-10 21:42:59.849489
NCT02926118|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-05-01|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 15, 2017|Anticipated|2017-07-15||Interventional|GLOW||Continuous Glucose Monitoring During Diets That Differ in Glycemic Load|Continuous Glucose Monitoring During Diets That Differ in Glycemic Load|Recruiting||N/A|20|Anticipated|Unilever R&D||2|||f||||f|f|f||||||No||2017-10-10 21:42:59.929828|2017-10-10 21:42:59.929828
NCT02926105|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-11-10|||October 2016||2016-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|SwissCHEF||Comparison of Home-based Exercise Programmes for Falls Prevention and Quality of Life in Older Adults|Comparison of the Effects of Three Home-based Exercise Programmes Regarding Falls, Quality of Life and Exercise-adherence in Older Adults at Risk of Falling: Protocol for a Randomised Controlled Trial|Recruiting||Phase 3|405|Anticipated|HES-SO Valais-Wallis||3|||f||||t||||||||Yes||2017-10-10 21:43:00.036154|2017-10-10 21:43:00.036154
NCT02926092|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-04-21|||October 31, 2016|Actual|2016-10-31|April 2017|2017-04-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Observational|||Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)|A Prospective, Multicenter, Longitudinal, Observational Natural History Study to Evaluate Disease Progression in Subjects With Autosomal Dominant Retinitis Pigmentosa (adRP) With Misfolded Rod Opsin Mutations|Terminated||N/A|1|Actual|Shire|||1|Development of SHP630 was discontinued based on lack of preclinical efficacy.|f||||f||||||Samples With DNA|"     Whole blood will be obtained during the pre-screening period   "|No||2017-10-10 21:43:00.145606|2017-10-10 21:43:00.145606
NCT02926079|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-08-16|||December 2016||2016-12-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|IMAGINE||Investigation of Mechanisms for Transmission of Impaired Glucose Metabolism in Infants Exposed to Diabetes in Utero|Investigation of Mechanisms for Transmission of Impaired Glucose Metabolism in Infants Exposed to Diabetes in Utero|Recruiting||N/A|20|Anticipated|Pennington Biomedical Research Center|||2||f||||f||||||Samples Without DNA|"     Maternal Blood Collection: Approximately 33mL of blood will be collected during the visit.      Infant Blood Collection: Approximately 2mL of blood will be collected during the visit.   "|||2017-10-10 21:43:00.211554|2017-10-10 21:43:00.211554
NCT02926066|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|NTUH-AADC-011||A Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion|A Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion|Recruiting||Phase 2|5|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:43:00.281555|2017-10-10 21:43:00.281555
NCT02926053|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TIL Therapy for Metastatic Renal Cell Carcinoma|T Cell Therapy for Patients With Metastatic Renal Cell Carcinoma|Recruiting||Phase 1|6|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-10-10 21:43:00.412994|2017-10-10 21:43:00.412994
NCT02926040|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|September 2023|Anticipated|2023-09-01|September 2018|Anticipated|2018-09-01||Observational|IRE Qol||Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer|Impact of Irreversible Electroporation on Quality of Life for Patients With Locally Advanced Pancreatic Cancer|Recruiting||N/A|20|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 21:43:00.49949|2017-10-10 21:43:00.49949
NCT02925091|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04|||February 2015||2015-02-01|October 2016|2016-10-01||||July 2016|Actual|2016-07-01||Observational|||Primary Antimicrobial Resistance Patterns of Austrian Helicobacter Pylori Clinical Isolates||Completed||N/A|2000|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 21:43:10.290185|2017-10-10 21:43:10.290185
NCT02926027|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-06-23|||September 2016||2016-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|EVAPORATE||Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy|Effect of Vascepa on Progression of Coronary Atherosclerosis in Persons With Elevated Triglycerides (200-499) on Statin Therapy|Recruiting||N/A|80|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||t||||||||Yes|Data will be tabulated and analysed. Study site will not share any of the subject identifiers.|2017-10-10 21:43:00.576207|2017-10-10 21:43:00.576207
NCT02926014|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-10-04|||October 2014||2014-10-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Lingual Tonsil Hypertrophy Grading and Its Relation to Sociodemographic Factors and Clinical Symptoms|Lingual Tonsil Hypertrophy Grading and Its Relation to Sociodemographic Factors and Clinical Symptoms|Completed||N/A|100|Actual|Lithuanian University of Health Sciences||2|||f||||t||||||||||2017-10-10 21:43:00.661907|2017-10-10 21:43:00.661907
NCT02926001|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-05|||October 2011||2011-10-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Evaluation of the Impact of a Sugar-Sweetened Beverage Tax in Chile|Empirical Evaluation of the Short Term Impact of a Sugar-Sweetened Beverage Tax in Chile|Completed||N/A|2836|Actual|University of York|||1||f||||f||||||||Undecided||2017-10-10 21:43:00.746787|2017-10-10 21:43:00.746787
NCT02925988|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Combined Amplitude-integrated and Conventional EEG Monitoring in High-risk Critically Ill Neonates|Combined Amplitude-integrated and Conventional EEG Monitoring in High-risk Critically Ill Neonates: A Pilot Study|Not yet recruiting||N/A|20|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||No||2017-10-10 21:43:00.809192|2017-10-10 21:43:00.809192
NCT02925975|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-06|||January 2015||2015-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS|Early Precise Diagnosis and Intervention of Cirrhotic Portal Hypertension (CPT) Based on a Noninvasive 3D-virtual-model of Hepatic Portal System (3D-vHPS)|Recruiting||Phase 4|500|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine||4|||f||||t||||||||Undecided||2017-10-10 21:43:00.870575|2017-10-10 21:43:00.870575
NCT02925962|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-07-20|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CDSSR18||Evaluation of an Electronic CKD Clinical Decision Support System (CDSS) in Clinical Care|A Randomized Trial to Evaluate an Electronic CKD Clinical Decision Support System (CDSS) in Clinical Care|Not yet recruiting||N/A|540|Anticipated|University of California, San Francisco||3|||f||||f|f|f||||||||2017-10-10 21:43:00.959353|2017-10-10 21:43:00.959353
NCT02925949|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-08-14|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|June 2020|Anticipated|2020-06-01||Interventional|DuoPACT||Duo Partnership Adherence Commitment Therapy|A Couples-based Approach to Improving Engagement in HIV Care|Recruiting||N/A|300|Anticipated|University of California, San Francisco||2|||f||||t|f|f||||||||2017-10-10 21:43:01.030997|2017-10-10 21:43:01.030997
NCT02925936|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-10-04|||June 2014||2014-06-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Choice of Tube Extremity in Emission of Lowest Radiation Dose in Pediatric Patients|Choice of Tube Extremity in Emission of Lowest Radiation Dose in Pediatric Patients|Completed||N/A|48|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||f||||||||No||2017-10-10 21:43:01.103204|2017-10-10 21:43:01.103204
NCT02925923|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-04|||September 2016||2016-09-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Ticagrelor Versus Clopidogrel and Eptifibatide Bolus|Ticagrelor Versus Clopidogrel and Eptifibatide Bolus in Patients With Stable or Unstable Angina Undergoing Coronary Intervention: A Randomized Pharmacodynamic Study|Recruiting||Phase 2|100|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||Undecided||2017-10-10 21:43:01.168602|2017-10-10 21:43:01.168602
NCT02925910|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-09|||October 2016||2016-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Comparison of User Experience With Wheelsoft Wheels Intalled on a Wheelchair Compared With Normal Wheels.|Assesment of Patient Experience Using a Wheelchair Equipped With Suspension Wheels|Not yet recruiting||N/A|52|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||No||2017-10-10 21:43:01.406956|2017-10-10 21:43:01.406956
NCT02925897|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-03-01|||May 2016||2016-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Enhancing Self-care in the Housebound|Enhancing Self-care Through Opportunistic Motivational Techniques, Used by Community Nurses, While Caring for Housebound Patients With Long-term Conditions: a Mixed Methods Feasibility Study|Active, not recruiting||N/A|62|Actual|King's College London||2|||f||||t||||||||No|no individual participant data will be made available|2017-10-10 21:43:01.503142|2017-10-10 21:43:01.503142
NCT02925884|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-10-04|||June 2013||2013-06-01|October 2016|2016-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Gunnar Computer Glasses on Viewing Comfort and Performance|The Effect of Computer Eyewear on Viewing Comfort and Performance in Office Work|Terminated||N/A|34|Actual|Pacific University||2||The sponsor failed to provide financial support as promised.|f||||f||||||||No|All 34 subjects were recruited but data collection was early terminated. Data entry was not completed.|2017-10-10 21:43:01.604792|2017-10-10 21:43:01.604792
NCT02925871|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-10-07|||April 2016||2016-04-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|MissingLink||The Missing Link- Development and Evaluation of Person-centred Transitions From the Stroke Unit to the Home|The Missing Link- Development and Evaluation of Person-centred Transitions From the Stroke Unit to the Home - a Co-design Project|Recruiting||N/A|300|Anticipated|Karolinska Institutet|||1||f||||t||||||||Undecided|The investigators would be happy to share the data but there are some limitations due to the Swedish legislation that may hamper the possibilities to share the data|2017-10-10 21:43:01.697105|2017-10-10 21:43:01.697105
NCT02925858|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-05|||August 28, 2017|Actual|2017-08-28|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Effect of Ketamine on Analgesia Post-Cardiac Surgery|Pilot Study: The Effect of Intraoperative Ketamine on Analgesia Post-Cardiac Surgery and Prevention of Chronic Pain|Recruiting||Phase 4|80|Anticipated|Jewish General Hospital||2|||f||||f|f|f|||f|||||2017-10-10 21:43:01.765929|2017-10-10 21:43:01.765929
NCT02925845|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-04|||January 2015||2015-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|NMS||Neuromuscular Electrostimulation in Radiocephalic Fistula|Neuromuscular Electrostimulation Effect on the Maturation of Native Vascular Access (VA) Patients With Kidney Disease 5- Chronic Stages 5d Estimated by Doppler Ultrasound|Recruiting||N/A|34|Anticipated|Hospital de Terrassa||2|||f||||f||||||||No||2017-10-10 21:43:01.865307|2017-10-10 21:43:01.865307
NCT02925832|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-01-24|||October 2016||2016-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|DTFNB||Comparing Ropivacaine and Bupivacaine in DTFNB Anesthesia in Patients Undergoing Phacoemulsification|Comparison Between Ropivacaine and Bupivacaine in Deep Topical Fornix Nerve Block Anesthesia in Patients Undergoing Cataract Surgery by Phacoemulsification.|Completed||N/A|100|Actual|Government Medical College, Haldwani||2|||f||||t||||||||Undecided||2017-10-10 21:43:01.973372|2017-10-10 21:43:01.973372
NCT02925819|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01|2 Years|Observational [Patient Registry]|MITRAGISTER||Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery|Management And Clinical Outcomes Of Patients With Severe Mitral Disease Not Suitable For Surgery: A Prospective, Multicentric, Observational Study|Recruiting||N/A|500|Anticipated|French Cardiology Society|||1||f||||f||||||||No||2017-10-10 21:43:02.087174|2017-10-10 21:43:02.087174
NCT02925806|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-04||||||October 2016|2016-10-01||||July 2019|Anticipated|2019-07-01||Observational|||Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products|Drug Utilization Study of Trends in Prescriptions for Class REMS ER/LA Opioids and Comparator Products; Evaluation of Drug Utilization Patterns|Enrolling by invitation||N/A|5575834|Anticipated|ER/LA Opioid REMS Program Companies (RPC)|||4||f||||||||||||||2017-10-10 21:43:02.181903|2017-10-10 21:43:02.181903
NCT02925793|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-05|2017-04-07|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients|A Randomised, Double-blind, Vehicle-Controlled, Phase IIb Study to Assess the Efficacy and Safety of Topically Applied DS107 Cream to Adults With Mild to Moderate Atopic Dermatitis|Recruiting||Phase 2|300|Anticipated|DS Biopharma||3|||f||||f||||||||||2017-10-10 21:43:02.250201|2017-10-10 21:43:02.250201
NCT02925780|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-04|||December 2016||2016-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Action of Infiltration Resin Icon in Fluorosis, Clinical Trial, Monitoring for 12 Month||Not yet recruiting||N/A|31|Anticipated|DMG Dental Material Gesellschaft mbH||2|||f||||f||||||||No||2017-10-10 21:43:02.427185|2017-10-10 21:43:02.427185
NCT02925767|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||August 2016||2016-08-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo|Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo|Recruiting||N/A|16|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-10-10 21:43:02.533599|2017-10-10 21:43:02.533599
NCT02925754|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-10-05|||August 2015||2015-08-01|September 2016|2016-09-01||||April 2016|Actual|2016-04-01||Observational|||Catastrophism Among Chronic Pain Patients in Rheumatology||Completed||N/A|72|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:43:02.627565|2017-10-10 21:43:02.627565
NCT02925728|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-03-10|||February 7, 2017|Actual|2017-02-07|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FIFO||"Nutritional Intake of Finger-food on Elderly People in Seniors's Resident"|"Nutritional Intake of Finger-food on Elderly People in Seniors's Resident"|Recruiting||N/A|60|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||f|f|f||||||||2017-10-10 21:43:02.788258|2017-10-10 21:43:02.788258
NCT02925715|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-06|||September 2015||2015-09-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Comparative Evaluation of Ultrasound Guided Supraclavicular and Infraclavicular Subclavian Venous Catheterizations in Adult Patients Undergoing Major Surgeries|Comparative Evaluation of Ultrasound Guided Supraclavicular and Infraclavicular Subclavian Venous Catheterizations in Adult Patients Undergoing Major Surgeries|Completed||Phase 4|96|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 21:43:02.875912|2017-10-10 21:43:02.875912
NCT02925702|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-03-26|||February 2016||2016-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|PRORADIUM||PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Radium-223|Prospective Multi-centre Studies of Prognostic Factors in Castration Resistant PROState Cancer Treated With Radium-223|Recruiting||N/A|161|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III|||1||f||||f||||||Samples With DNA|"     Paxgene and tempus tubes on baseline, pre-cycle 3 and progression Tumor paraffine sample at     baseline   "|||2017-10-10 21:43:02.967417|2017-10-10 21:43:02.967417
NCT02925676|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-10-04|||September 2016||2016-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluation of the Hypoglycaemia Alarm Device Hyposafe H02|Evaluation of the Hypoglycaemia Alarm Device Hyposafe H02 - the Pilot 2 Study - in Subjects With Type 1 Diabetes|Recruiting||Early Phase 1|20|Anticipated|Hypo-Safe A/S||1|||f||||t||||||||Yes|The main findings of study will be submitted for publication in a peer reviewed journal or made publically available at www.clinicaltrials.gov|2017-10-10 21:43:03.323386|2017-10-10 21:43:03.323386
NCT02925663|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-07-28|||October 2016||2016-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01||Interventional|EFI-E||Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy|Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy|Active, not recruiting||Phase 2|32|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 21:43:03.424288|2017-10-10 21:43:03.424288
NCT02924545|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-04|||January 2015||2015-01-01|September 2016|2016-09-01||||December 2015|Actual|2015-12-01||Observational|||Evaluation of Osteoporosis Support After a Severe Osteoporotic Fracture in Women Over 50 Years in University Hospital||Completed||N/A|500|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||No||2017-10-10 21:43:17.907232|2017-10-10 21:43:17.907232
NCT02925650|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-05-29|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|DISCOVER||Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamic (PD) Effects of Posiphen® in Subjects With Early Alzheimer's Disease (AD)|Recruiting||Phase 1/Phase 2|24|Anticipated|QR Pharma Inc.||4|||f||||t|t|f||||||Yes|"Data from this research will be shared with other researchers pursuant to the 02/26/2003 NIH Final Statement on Sharing Research Data."|2017-10-10 21:43:03.499303|2017-10-10 21:43:03.499303
NCT02925637|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-08-17|||April 2016||2016-04-01|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Effectiveness of FACoT for Individuals Post Stroke|Effectiveness of a Novel Meta-cognitive-functional Intervention (FACoT) for Individuals Post Mild-moderate Stroke|Recruiting||N/A|46|Anticipated|Bait Balev Hospital||2|||f||||t||||||||||2017-10-10 21:43:03.586869|2017-10-10 21:43:03.586869
NCT02925624|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-08-18|||December 2015||2015-12-01|August 2017|2017-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||CLOSE to CURE Study|'CLOSE'-Guided Pulmonary Vein Isolation as Cure for Paroxysmal Atrial Fibrillation?|Active, not recruiting||N/A|100|Anticipated|AZ Sint-Jan AV||1|||f||||f||||||||||2017-10-10 21:43:03.664065|2017-10-10 21:43:03.664065
NCT02925611|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-10-04|||January 2016||2016-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison of Postoperative Delirium in Patients Anaesthetised With Isoflurane and Desflurane During Spinal Surgery|Comparison of Postoperative Delirium in Patients Anaesthetised With Isoflurane and Desflurane During Spinal Surgery|Recruiting||Phase 4|60|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 21:43:03.741813|2017-10-10 21:43:03.741813
NCT02925598|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-05-06|||January 2015||2015-01-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|AILMALC||AuraGainTM and I-Gel® Laryngeal Masks in General Anesthesia for Laparoscopic Cholecystectomy|AuraGainTM and I-Gel® Laryngeal Masks in General Anesthesia for Laparoscopic Cholecystectomy - Performance Characteristics and Effects on Hemodynamics|Completed||N/A|114|Actual|Adiyaman University Research Hospital||3|||f||||t||||||||No||2017-10-10 21:43:03.82608|2017-10-10 21:43:03.82608
NCT02925585|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-06-26|||September 2016||2016-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Vaginal Tactile Imaging|Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions|Enrolling by invitation||N/A|150|Anticipated|Artann Laboratories|||1||f||||f||||||||Yes|Scientific Publications of the study results|2017-10-10 21:43:03.904099|2017-10-10 21:43:03.904099
NCT02925572|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-03-06|||January 1, 2017|Actual|2017-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|TEXTOO||Teenagers: Impact of Eccentric eXercise Training on Overweight and Obesity|Impact of Muscular Training Program on Body Composition of Overweight and Obese Teenagers: classi201c Cycling Exercise in Concentric Versus Eccentric|Recruiting||N/A|40|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 21:43:03.974647|2017-10-10 21:43:03.974647
NCT02925559|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-04|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EFFORT||Effect of Anti-diabetic Drugs on Glycemic Variability|Effect of Anti-diabetic Drugs on Glycemic Variability. A Comparison Between Gliclazide MR (Modified Release) and Dapagliflozin on Glycemic Variability Measured by Continuous Glucose Monitoring (CGM) in Patients With Uncontrolled Type 2 Diabetes|Not yet recruiting||Phase 4|120|Anticipated|Centro de Diabetes Curitiba Ltda||2|||f||||f||||||||Undecided||2017-10-10 21:43:04.071433|2017-10-10 21:43:04.071433
NCT02925546|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-01-24|||October 2016||2016-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets|An Open Label, Randomized, Single Dose, Crossover Study to Determine the Pharmacokinetics of Three Tablet Formulations of GSK2798745 in Healthy Subjects|Completed||Phase 1|18|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-10 21:43:04.185099|2017-10-10 21:43:04.185099
NCT02925533|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-06-26|||December 14, 2016|Actual|2016-12-14|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract|A Phase 1B Study of B-701 in Combination With Pembrolizumab in Relapsed or Refractory Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract|Terminated||Phase 1|1|Actual|Dana-Farber Cancer Institute||1||Terminated due to safety concerns.|f||||t||||||||No||2017-10-10 21:43:04.435294|2017-10-10 21:43:04.435294
NCT02925520|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04||||||October 2016|2016-10-01||||||||Expanded Access|||Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children|Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children|Available||N/A|||Cook Children's Health Care System|||||||||||||||||||2017-10-10 21:43:04.511565|2017-10-10 21:43:04.511565
NCT02925507|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-07-21|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Observational|CASE||Computerized Acoustic Swallowing Evaluation|Computerized Acoustic Swallowing Evaluation in Patients With Stroke|Withdrawn||N/A|0|Actual|Cedars-Sinai Medical Center|||2|Problems with biosensor not working properly and not functional for study|f||||f||||||||||2017-10-10 21:43:04.597829|2017-10-10 21:43:04.597829
NCT02925494|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2017-07-17|||September 14, 2016||2016-09-14|July 2017|2017-07-01|July 16, 2019|Anticipated|2019-07-16|January 28, 2019|Anticipated|2019-01-28||Interventional|||An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids|Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids|Enrolling by invitation||Phase 3|400|Anticipated|AbbVie||2|||f||||t||||||||||2017-10-10 21:43:04.682544|2017-10-10 21:43:04.682544
NCT02925481|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04|||April 2016||2016-04-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Yoga Online Feasibility to Reduce PTSD|Yoga Online: Interconception Care to Prevent PTSD Symptoms After Stillbirth|Recruiting||N/A|90|Anticipated|Arizona State University||3|||f||||||||||||||2017-10-10 21:43:04.957082|2017-10-10 21:43:04.957082
NCT02904512|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-06-13|||October 2016||2016-10-01|June 2017|2017-06-01||||December 2021|Anticipated|2021-12-01||Interventional|||Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices||Recruiting||Phase 2/Phase 3|200|Anticipated|University of Maryland||2|||f|||||f|t|f|f|f|||No|Only de-identified data are going to be shared.|2017-10-10 21:48:23.179285|2017-10-10 21:48:23.179285
NCT02925468|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-10-04|||October 2016||2016-10-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|||Orthodontic Reduction of an Increased Overbite in Adolescents - the Mechanism and Rate of Occlusal Adaptation|Orthodontic Reduction of an Increased Overbite in Adolescents - the Mechanism and Rate of Occlusal Adaptation|Not yet recruiting||N/A|38|Anticipated|NHS Tayside||2|||f||||t||||||||Undecided||2017-10-10 21:43:05.033824|2017-10-10 21:43:05.033824
NCT02925455|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Contralaterally Controlled FES for Hand Opening in Hemiplegic Cerebral Palsy|Contralaterally Controlled Functional Electrical Stimulation for Hand Opening in Hemiplegic Cerebral Palsy: Pilot Randomized Controlled Trial|Recruiting||N/A|20|Anticipated|MetroHealth Medical Center||2|||f||||f||||||||||2017-10-10 21:43:05.109474|2017-10-10 21:43:05.109474
NCT02925429|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-11-28|||May 2013||2013-05-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|PostNAPS||PostNAPS: FI, Nutrition, and Psychosocial Health Among Women of Mixed HIV Status and Their Infants in Gulu, Uganda|The PostNAPS Study: Food Insecurity As A Major Determinant of Poor Nutritional and Psychosocial Health Outcomes Among HIV-Infected and -Uninfected Lactating Women and Their Infants in Gulu, Northern Uganda.|Completed||N/A|246|Actual|Northwestern University|||1||f||||f||||||||No||2017-10-10 21:43:05.273575|2017-10-10 21:43:05.273575
NCT02925416|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-06-28|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|June 20, 2017|Actual|2017-06-20|June 2017|Actual|2017-06-01||Interventional|||Safety of Either a Single or Two IV Doses of Orbactiv in Subjects With ABSSSI|A Double-Blind, Randomized Study to Evaluate the Safety of Either a Single 1200-mg Intravenous (IV) Dose of Orbactiv™ (Oritavancin) and Placebo or Two IV Doses of Orbactiv™ in Subjects Being Treated for Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|Completed||Phase 4|22|Actual|The Medicines Company||2|||f||||f||||||||No||2017-10-10 21:43:05.326992|2017-10-10 21:43:05.326992
NCT02925403|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-06-19|||August 2016||2016-08-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant|A Phase Ib Randomised, Controlled, Single-blind Study to Assess the Safety, Immunogenicity of the Malaria Vaccine Candidate R21 With Matrix-M1 Adjuvant in West African Adult Volunteers|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|University of Oxford||3|||f||||||||||||||2017-10-10 21:43:05.407594|2017-10-10 21:43:05.407594
NCT02925390|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-08-22|||September 2016||2016-09-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|Fertility||Natural Procreative Technology Evaluation and Surveillance of Treatment for Infertility and Miscarriage|Natural Procreative Technology Evaluation and Surveillance of Treatment for Infertility and Miscarriage|Enrolling by invitation||N/A|100|Anticipated|St. Louis University|||1||f||||f||||||||||2017-10-10 21:43:05.487603|2017-10-10 21:43:05.487603
NCT02925377|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04|||September 2010||2010-09-01|October 2016|2016-10-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|||Neuromuscular Warm-up Intervention to Improve Postural Control in Female Handball Players|Efficacy of a Specific Warm-up Program to Improve Static and Dynamic Postural Control in Adult Female Handball Players|Completed||N/A|41|Actual|University of Erlangen-Nürnberg||2|||f||||f||||||||Undecided||2017-10-10 21:43:05.532035|2017-10-10 21:43:05.532035
NCT02925364|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-18|||September 2016||2016-09-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Functional and Anatomical MRI of the Spinal Cord and Peri-spinal Tissues|Functional and Anatomical MRI of the Spinal Cord and Perispinal Tissues 6 Months After Cardiac Surgery With Standard vs. Gradual Sternal Retraction: Implications for Chronic Post-surgical Pain|Recruiting||N/A|30|Anticipated|Queen's University|||2||f||||f||||||||||2017-10-10 21:43:07.682379|2017-10-10 21:43:07.682379
NCT02925338|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-10-03|||October 2016|Actual|2016-10-01|October 2017|2017-10-01|September 23, 2020|Anticipated|2020-09-23|September 23, 2020|Anticipated|2020-09-23||Observational|ReFLECT||National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life|Observatoire National D'Utilisation D'Inflectra™ En Vie Réelle.|Recruiting||N/A|1200|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 21:43:07.87845|2017-10-10 21:43:07.87845
NCT02925325|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-10-04|||October 2016||2016-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|MTMDDRS||Music Therapy for Major Depressive Disorder Residual Symptoms|Music Therapy for Major Depressive Disorder Residual Symptoms|Recruiting||N/A|48|Anticipated|Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente||2|||f||||f||||||||||2017-10-10 21:43:08.011805|2017-10-10 21:43:08.011805
NCT02925312|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04|||November 2014||2014-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|DM Pathway||MedStar Pathway to Diabetes Control|MedStar Pathway to Diabetes Control Demonstration Project|Active, not recruiting||N/A|450|Anticipated|Medstar Health Research Institute||2|||f||||t||||||||||2017-10-10 21:43:08.098088|2017-10-10 21:43:08.098088
NCT02925299|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-08-15|||May 12, 2017|Actual|2017-05-12|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|DAN05||Day and Night Closed-loop in Young People With Type 1 Diabetes|An Open-label, Multi-centre, Randomized, Single-period, Parallel Study to Assess the Efficacy, Safety and Utility of 12 Month Day-and-night Automated Closed-loop Insulin Delivery Under Free Living Conditions Compared to Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes|Recruiting||N/A|150|Anticipated|Jaeb Center for Health Research||2|||f||||t|f|t|t|||||||2017-10-10 21:43:08.18303|2017-10-10 21:43:08.18303
NCT02925286|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-04|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|Alna||Effects of a Workplace Prevention Program for Problematic Gambling|Effects of a Workplace Prevention Program for Problematic Gambling|Active, not recruiting||N/A|550|Anticipated|Stockholm University||2|||f||||f||||||||No||2017-10-10 21:43:08.335533|2017-10-10 21:43:08.335533
NCT02925273|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-10-04|||July 2016||2016-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|GRASP||Hand Grasping Techniques on Eliciting the Grasp Reflex in Patients With Dementia|The Effect of Hand Grasping Techniques on Eliciting the Grasp Reflex in Patients With Dementia or Suspected Frontal Lobe Dysfunction|Recruiting||N/A|30|Anticipated|Rowan University||1|||f||||f||||||||No||2017-10-10 21:43:08.453528|2017-10-10 21:43:08.453528
NCT02925260|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-14|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||MRI in Normal Ileal Pouches, and a Feasibility Study of Dynamic MRI Enema and Defaecating MRI Pouchography|Pelvic Collections on MRI in Patients With Ileal Pouches, and a Feasibility Study of Dynamic MRI Enema and Defaecating MRI Pouchography|Recruiting||N/A|20|Anticipated|London North West Healthcare NHS Trust|||1||f||||f||||||||||2017-10-10 21:43:08.61927|2017-10-10 21:43:08.61927
NCT02925247|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04|||November 2016||2016-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients|Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients|Not yet recruiting||N/A|150|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:43:08.739113|2017-10-10 21:43:08.739113
NCT02925234|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-10-04|||August 2016||2016-08-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|DRUP||The Drug Rediscovery Protocol (DRUP Trial)|A Dutch National Study on Behalf of the CPCT to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to Determine the Potential Efficacy in Treatment of Advanced Cancers With a Known Molecular Profile|Recruiting||Phase 2|400|Anticipated|The Netherlands Cancer Institute||11|||f||||t||||||||No||2017-10-10 21:43:08.835355|2017-10-10 21:43:08.835355
NCT02925221|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-09-29|||January 2016||2016-01-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Observational|C-MAJOR||Canadian Medical Assessment of JINARC™ Outcomes Registry|Canadian Observational Cohort Study of the Real-life Assessment of Tolvaptan (JINARC™) in Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Recruiting||N/A|2000|Anticipated|Otsuka Canada Pharmaceutical Inc.|||1||f||||t||||||||||2017-10-10 21:43:09.074014|2017-10-10 21:43:09.074014
NCT02925208|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-05|||January 2010||2010-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|||Radiological Classification of the Facial Nerve|Radiological Classification of the Vertical Segment of Facial Nerve in Cochlear Implant Surgery|Completed||N/A|140|Actual|Dammam University|||1||f||||t||||||||Undecided||2017-10-10 21:43:09.201109|2017-10-10 21:43:09.201109
NCT02925195|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-05-17|||January 11, 2017|Actual|2017-01-11|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|INVITE||Individualized Response to Vitamin D Treatment Study|Multi Ethnic Study of Atherosclerosis Individualized Response to Vitamin D Treatment Study|Enrolling by invitation||N/A|1600|Anticipated|University of Washington||2|||f||||t||f||||||Yes||2017-10-10 21:43:09.287523|2017-10-10 21:43:09.287523
NCT02925182|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-04|||January 2015||2015-01-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|May 2015|Actual|2015-05-01||Interventional|||Treatment of Recurrent Aphthous Stomatitis With Er,Cr:YSGG Laser Irradiation|Treatment of Recurrent Aphthous Stomatitis With Er,Cr:YSGG Laser Irradiation: A Randomized Controlled Clinical Study|Completed||N/A|40|Actual|Near East University, Turkey||2|||f||||f||||||||No||2017-10-10 21:43:09.390117|2017-10-10 21:43:09.390117
NCT02925169|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2016-10-04|||April 2016||2016-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Shape and Dimensions of the Upper Airway in Infants Using Computed Tomography Imaging|Shape and Dimensions of the Upper Airway in Infants Using Computed Tomography Imaging|Completed||N/A|40|Actual|King Fahad Medical City|||1||f||||f||||||||No||2017-10-10 21:43:09.466732|2017-10-10 21:43:09.466732
NCT02925156|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-07-20|||July 2008||2008-07-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|METS||Modeling the Epidemiologic Transition Study|Modeling the Epidemiologic Transition Study|Active, not recruiting||N/A|2506|Actual|Loyola University|||5||f||||f||||||||||2017-10-10 21:43:09.535829|2017-10-10 21:43:09.535829
NCT02925143|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-10-02|||November 21, 2016|Actual|2016-11-21|October 2017|2017-10-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|INVERT||Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning|Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning - a Multicenter Interrupted Time Series Study (INVERT Study)|Completed||N/A|2351|Actual|Herlev Hospital||1|||f||||t||||||||||2017-10-10 21:43:09.625458|2017-10-10 21:43:09.625458
NCT02925130|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-09-29|||October 2016||2016-10-01|March 2017|2017-03-01|September 28, 2017|Actual|2017-09-28|September 28, 2017|Actual|2017-09-28||Interventional|BETACTIV||Beta2-mimetic and Central Nervous System|Beta2-mimetic and Central Nervous System: Effects of Salbutamol on Cortical Excitability and Cerebral Activation|Completed||N/A|15|Actual|University Hospital, Grenoble||3|||f||||f||||||||||2017-10-10 21:43:09.714264|2017-10-10 21:43:09.714264
NCT02925117|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-29|||January 30, 2017|Actual|2017-01-30|September 2017|2017-09-01|January 25, 2019|Anticipated|2019-01-25|March 31, 2018|Anticipated|2018-03-31||Interventional|||A Study to Evaluate ABT-494 (Upadacitinib) in Adult Subjects With Moderate to Severe Atopic Dermatitis|A Phase 2b Multicenter, Randomized, Placebo-Controlled, Double-Blind Dose-Ranging Study to Evaluate ABT-494 (Upadacitinib) in Adult Subjects With Moderate to Severe Atopic Dermatitis|Active, not recruiting||Phase 2|167|Anticipated|AbbVie||4|||f||||t|t|f||||||||2017-10-10 21:43:09.802818|2017-10-10 21:43:09.802818
NCT02925104|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-12|||December 14, 2016|Actual|2016-12-14|September 2017|2017-09-01|December 18, 2017|Anticipated|2017-12-18|November 6, 2017|Anticipated|2017-11-06||Interventional|||A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.|A Multicenter, Open Label, Phase 1 Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INC280 Tablet Formulation With Food in Patients With cMET Dysregulated Advanced Solid Tumors.|Recruiting||Phase 1|35|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:43:10.02192|2017-10-10 21:43:10.02192
NCT02925078|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-04-26|||October 2016||2016-10-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Influence of Mucosa Tissue Thickness on Marginal Bone Loss of Implants With Smooth Collars|The Influence of Mucosa Tissue Thickness on Marginal Bone Loss of Implants With Smooth Collars: A Prospective Controlled Trial|Recruiting||N/A|28|Anticipated|University of Michigan||2|||f||||f||||||||Undecided||2017-10-10 21:43:10.346816|2017-10-10 21:43:10.346816
NCT02925065|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-01-30|||November 2016||2016-11-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|PD/Guitar||Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease Patients|Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease Patients|Recruiting||N/A|30|Anticipated|Johns Hopkins University||2|||f||||f||||||||Undecided||2017-10-10 21:43:10.453817|2017-10-10 21:43:10.453817
NCT02925052|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2017-06-08|||September 2016||2016-09-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|GTG||Evaluation of the Gastric Tube Guide to Place Orogastric Tubes|Evaluation of the Gastric Tube Guide to Place Orogastric Tubes: : A Prospective, Randomized Trial|Recruiting||N/A|150|Anticipated|Johannes Gutenberg University Mainz||2|||f||||||||||||||2017-10-10 21:43:10.609926|2017-10-10 21:43:10.609926
NCT02925039|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-05-10|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|FIRST||Sit-to-stand Exercise Training With Performance Feedback|"The Feedback Integrated Rehabilitation for Sit-to-stand Training: a Pilot Randomised Controlled Trial Testing Clinical Acceptability and Effectiveness"|Recruiting||N/A|40|Anticipated|University of Strathclyde||2|||f||||f|f|f||||||No||2017-10-10 21:43:10.711707|2017-10-10 21:43:10.711707
NCT02925026|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-01-10|||October 2016||2016-10-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction||Recruiting||N/A|250|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 21:43:10.835809|2017-10-10 21:43:10.835809
NCT02925013|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-04|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|OM3||Maternal Dietary Lipids and Omega 3 Essential Fatty Acids Profile in Pregnant Women at Term and Their Fetuses|Maternal Dietary Lipids and Omega 3 Essential Fatty Acids Profile in Pregnant Women at Term and Their Fetuses|Not yet recruiting||N/A|50|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 21:43:10.967959|2017-10-10 21:43:10.967959
NCT02925000|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-10|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy|A Phase I/IIa, Open Label, Dose-escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy|Recruiting||Phase 1/Phase 2|51|Anticipated|Taiwan Liposome Company||1|||f||||t|t|f||||||||2017-10-10 21:43:11.069434|2017-10-10 21:43:11.069434
NCT02924987|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-03-23|||November 2016||2016-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|Eylea||Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema|Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema|Recruiting||Phase 4|40|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||No||2017-10-10 21:43:11.193513|2017-10-10 21:43:11.193513
NCT02924974|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|SALMON-RARP||Spinal Morphine in Robotic Assisted Radical Prostatectomy|Spinal Morphine in Robotic Assisted Radical Prostatectomy|Recruiting||Phase 4|160|Anticipated|Maasstad Hospital||2|||f||||f||||||||||2017-10-10 21:43:11.290365|2017-10-10 21:43:11.290365
NCT02924961|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-10-03|||April 2008||2008-04-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|July 2011|Actual|2011-07-01||Interventional|||Fluoroscopic and RSA Evaluation of the Triathlon Total Knee Prosthetic Design|Fluoroscopic and RSA Evaluation of the Triathlon Total Knee Prosthetic Design|Terminated||N/A|48|Actual|Leiden University Medical Center||2||Mobile-bearing insert dislocation|f||||f||||||||Undecided|IPD analysis is scheduled|2017-10-10 21:43:11.384304|2017-10-10 21:43:11.384304
NCT02924948|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Comparison of Endoscopic Ultrasound Insertion Methods|A Comparison of Endoscopic Ultrasound Insertion Methods: Conventional vs Inflated Balloon Method|Not yet recruiting||N/A|482|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 21:43:11.479953|2017-10-10 21:43:11.479953
NCT02924935|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-10-03|||January 2017||2017-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Histidine Therapy: A Project to Treat HARS Deficiency|Histidine Therapy: A Project to Treat HARS Deficiency|Not yet recruiting||Early Phase 1|11|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||No||2017-10-10 21:43:11.553847|2017-10-10 21:43:11.553847
NCT02924922|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-03|||May 2016||2016-05-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy|Robot Assisted Partial Nephrectomy (RAPN) in Selective Ischemia Versus Laparoscopic Partial Nephrectomy (LPN) in Total Ischemia: Prospective Randomized Study to Assess Oncological and Functional Outcomes|Recruiting||N/A|82|Anticipated|Luzerner Kantonsspital||2|||f||||t||||||||||2017-10-10 21:43:11.640883|2017-10-10 21:43:11.640883
NCT02924909|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-10-03|||November 2016||2016-11-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|QUIMERA||Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer|Phase II Trial of Induction Chemotherapy Followed by Chemoradiotherapy With Paclitaxel and Carboplatin Before Minimal Invasive Surgery in Patients With Localized Esophageal and Gastro-esophageal Junction Cancer|Not yet recruiting||Phase 2|50|Anticipated|Instituto Nacional de Cancer, Brazil||1|||f||||t||||||||Yes||2017-10-10 21:43:11.809942|2017-10-10 21:43:11.809942
NCT02924896|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-03|||September 2016||2016-09-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Interventional|APO||Effect of Palm Olein Intake on Lipid Profile and Appetite Regulation|The Chemical Structure of a Lipid Determines Its Effect on Blood Lipid Profile and Appetite Regulation|Recruiting||N/A|12|Anticipated|Imperial College London||6|||f||||f||||||||No||2017-10-10 21:43:11.900264|2017-10-10 21:43:11.900264
NCT02924883|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-09-27|||September 26, 2016|Actual|2016-09-26|September 2017|2017-09-01|August 29, 2019|Anticipated|2019-08-29|May 1, 2018|Anticipated|2018-05-01||Interventional|KATE2||A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy|A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trastuzumab and Taxane Based Therapy|Active, not recruiting||Phase 2|200|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 21:43:12.025273|2017-10-10 21:43:12.025273
NCT02924870|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2017-03-13|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|EA-EPOC||Long-term Effect of an Health Education Program on Daily Physical Activity in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease||Recruiting||Phase 4|128|Anticipated|Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-10 21:43:12.321832|2017-10-10 21:43:12.321832
NCT02924857|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-05-08|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Chocolate Touch Study|A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions|Not yet recruiting||N/A|585|Anticipated|TriReme Medical, LLC||2|||f||||t|f|t|t|f||||No||2017-10-10 21:43:12.446476|2017-10-10 21:43:12.446476
NCT02924844|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04|||January 2013||2013-01-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures|Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures|Completed||N/A|2787|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||||||||||||2017-10-10 21:43:12.767629|2017-10-10 21:43:12.767629
NCT02924831|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-03|||November 2016||2016-11-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||High-tech Acupuncture for Treatment of Chronic Fatigue Syndrome|High-tech Acupuncture for Treatment of Chronic Fatigue Syndrome - A Sino-Austrian Cooperation Randomized Controlled Trial(RCT) on Heart Rate Variability|Not yet recruiting||Phase 2|210|Anticipated|Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust||5|||f||||t||||||||Undecided||2017-10-10 21:43:12.832647|2017-10-10 21:43:12.832647
NCT02924818|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-04|||September 2015||2015-09-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|RINNOPARI||Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases|Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases: The RINNOPARI Project|Recruiting||N/A|225|Anticipated|CHU de Reims||5|||f||||||||||||||2017-10-10 21:43:12.948513|2017-10-10 21:43:12.948513
NCT02924805|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||November 2013||2013-11-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|March 2015|Actual|2015-03-01||Observational|||Telemedical Versus Conventional Emergency Care of Hypertensive Emergencies|Telemedical Versus Conventional Emergency Care of Hypertensive Emergencies and Urgencies|Completed||N/A|331|Actual|RWTH Aachen University|||2||f||||f||||||||No||2017-10-10 21:43:13.095288|2017-10-10 21:43:13.095288
NCT02924792|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-10-05|||November 2016||2016-11-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis|Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis|Recruiting||N/A|30|Anticipated|Haukeland University Hospital|||3||f||||f||||||||||2017-10-10 21:43:13.198897|2017-10-10 21:43:13.198897
NCT02924779|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||June 2016||2016-06-01|October 2016|2016-10-01||||October 2016|Anticipated|2016-10-01||Observational|||An Observational Study Investigating the Positioning of Epidural Catheters and Their Function During Labour Analgesia|An Observational Study Investigating the Influence of Physical Position of Epidural Catheters and Their Function During Labour Analgesia|Recruiting||N/A|40|Anticipated|Rotkreuzklinikum München gGmbH|||1||f||||f||||||||No||2017-10-10 21:43:13.315645|2017-10-10 21:43:13.315645
NCT02924766|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-08-17|||October 3, 2016|Actual|2016-10-03|August 2017|2017-08-01|May 8, 2018|Anticipated|2018-05-08|May 7, 2018|Anticipated|2018-05-07||Interventional|||A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)|A Safety and Pharmacokinetics Study of Niraparib Plus Androgen Receptor-Targeted Therapy (Apalutamide or Abiraterone Acetate Plus Prednisone) in Men With Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 1|60|Anticipated|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-10 21:43:13.407664|2017-10-10 21:43:13.407664
NCT02924753|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-04|||September 2016||2016-09-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|September 2017|Anticipated|2017-09-01||Interventional|||The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).|The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Acute Lymphoblastic Leukemia.|Recruiting||Phase 1|20|Anticipated|Henan Cancer Hospital||1|||f||||f||||||||||2017-10-10 21:43:13.549508|2017-10-10 21:43:13.549508
NCT02924740|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-03|||October 2016||2016-10-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effects of Vaginal Tampon Training Added to Pelvic Floor Muscle Training in Stress Urinary Incontinence|The Effects of Vaginal Tampon Training Added to Pelvic Floor Muscle Training in Stress Urinary Incontinence|Not yet recruiting||N/A|50|Anticipated|Hacettepe University||2|||f||||t||||||||No||2017-10-10 21:43:13.656943|2017-10-10 21:43:13.656943
NCT02924532|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-04|||February 2012||2012-02-01|September 2016|2016-09-01||||December 2013|Actual|2013-12-01||Observational|||Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy|Diagnostic Value of Immediate Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy: A Retrospective Observational Study|Completed||N/A|300|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:43:17.972984|2017-10-10 21:43:17.972984
NCT02924519|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-10-03|||May 2014||2014-05-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Observational|||Postoperative Pain After Ambulatory Arthroscopic Shoulder Surgery|Postoperative Pain After Ambulatory Arthroscopic Shoulder Surgery|Active, not recruiting||N/A|150|Anticipated|University of Aarhus|||1||f||||f||||||||No||2017-10-10 21:43:18.04505|2017-10-10 21:43:18.04505
NCT02924727|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-06-06|||April 23, 2016|Actual|2016-04-23|June 2017|2017-06-01|July 17, 2019|Anticipated|2019-07-17|July 17, 2019|Anticipated|2019-07-17||Interventional|PARADISE-MI||Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI|A Multi-center, Randomized, Double-blind, Active-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Ramipril on Morbidity and Mortality in High Risk Patients Following an AMI|Recruiting||Phase 3|4650|Anticipated|Novartis||2|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:43:13.806063|2017-10-10 21:43:13.806063
NCT02924714|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-03-15|||January 2017||2017-01-01|March 2017|2017-03-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|||SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST|Discontinuation of Imatinib in Patients With Oligo-metastatic Gastrointestinal Stromal Tumor That Has Become Radiologically Undetectable With Treatment|Recruiting||Phase 2|31|Anticipated|Oslo University Hospital||1|||f||||t||||||||||2017-10-10 21:43:14.385357|2017-10-10 21:43:14.385357
NCT02924701|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2016-10-31|||September 2016||2016-09-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis|Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis|Recruiting||N/A|140|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Blood samples for sCD163 and sMR measurement   "|Undecided||2017-10-10 21:43:14.517524|2017-10-10 21:43:14.517524
NCT02924675|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-05-17|||June 5, 2015|Actual|2015-06-05|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|LYRORL||Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.|Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.|Recruiting||Phase 2|80|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:43:16.981542|2017-10-10 21:43:16.981542
NCT02924649|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-04-25|||January 2017||2017-01-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|||Early Mobilisation After Severe Traumatic Brain Injury|Early and Intensive Mobilisation of Patients With Severe Traumatic Brain Injury|Recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-10 21:43:17.165073|2017-10-10 21:43:17.165073
NCT02924636|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-05-18|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|ePPOP-ID||Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery|Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery - ePPOP Study|Not yet recruiting||N/A|860|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:43:17.268482|2017-10-10 21:43:17.268482
NCT02924623|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-10-06|||February 2016||2016-02-01|September 2016|2016-09-01||||February 2017|Anticipated|2017-02-01||Observational|DIAPO||Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity||Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:43:17.349658|2017-10-10 21:43:17.349658
NCT02924597|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||January 2016||2016-01-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage|Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage : Clinical Outcomes of a Randomised Controlled Trial|Recruiting||N/A|100|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-10 21:43:17.428419|2017-10-10 21:43:17.428419
NCT02924584|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-09-08|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|February 28, 2017|Actual|2017-02-28||Observational|||Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan|The Treatment For Recurrent Female Breast Cancer After Initial Endocrine Therapy Among Taiwanese Population|Active, not recruiting||N/A|1|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 21:43:17.642807|2017-10-10 21:43:17.642807
NCT02924571|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-09|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||BMAC & Allograft vs BMP-2|Prospective, Blinded, Non-randomized Study of Thoracolumbar Spinal Fusion Graft Efficacy: Bone Marrow Aspirate Concentrate and Allograft Versus Recombinant Bone Morphogenetic Protein-2 (BMP)|Not yet recruiting||N/A|30|Anticipated|New York University School of Medicine||2|||f||||f|f|f|||f|||||2017-10-10 21:43:17.715783|2017-10-10 21:43:17.715783
NCT02924558|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||February 2015||2015-02-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Metabolic Effects of Egg Protein and Unsaturated Fat Intakes in Subjects With Hypertriglyceridemia|Metabolic Effects of Replacing Dietary Refined Carbohydrate With a Combination of Egg Protein and Unsaturated Fats in Men and Women With Elevated Triglycerides|Completed||N/A|28|Actual|Midwest Center for Metabolic and Cardiovascular Research||2|||f||||f||||||||No||2017-10-10 21:43:17.804151|2017-10-10 21:43:17.804151
NCT02924506|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-04|||February 2015||2015-02-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|DISC-C||"Cervical Arthroplasty Fixed Core Versus Movable Core: Clinical and Radiological Impact in the Medium Term"|"Cervical Arthroplasty Fixed Core Versus Movable Core: A Controlled Prospective Study, Clinical and Radiological Impact in the Medium Term"|Recruiting||N/A|190|Anticipated|Centre Hospitalier Régional d'Orléans||2|||f||||f||||||||No||2017-10-10 21:43:18.120504|2017-10-10 21:43:18.120504
NCT02924493|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-10-03|||November 2016||2016-11-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Dietary Treatment of Endometriosis-related Irritable Bowel Syndrome|Dietary Treatment of Endometriosis-related Irritable Bowel Syndrome: A Pilot Study|Not yet recruiting||N/A|24|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 21:43:18.235326|2017-10-10 21:43:18.235326
NCT02924480|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-03|||October 12, 2016|Actual|2016-10-12|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Lidocaine||Intravenous Lidocaine for Cystectomy Procedures|Intravenous Lidocaine in the Perioperative Setting and the Effects on Postoperative Pain and Bowel Function Following Cystectomy: A Pilot Study|Recruiting||N/A|50|Anticipated|CAMC Health System||2|||f||||f||||||||||2017-10-10 21:43:18.327911|2017-10-10 21:43:18.327911
NCT02924467|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-04-28|||November 1, 2016|Actual|2016-11-01|April 2017|2017-04-01|May 1, 2017|Anticipated|2017-05-01|May 1, 2017|Anticipated|2017-05-01||Interventional|||Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates in New York State|Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates in New York State|Active, not recruiting||N/A|100000|Anticipated|University of California, Los Angeles||4|||f||||f||||||||Undecided||2017-10-10 21:43:18.45206|2017-10-10 21:43:18.45206
NCT02924454|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-04-11|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Interventional|||Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.|An Investigation Into the Effects of Intravenous Lipid Emulsion (ILE) on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.|Completed||Phase 4|10|Actual|University Hospital Bispebjerg and Frederiksberg||4|||f||||f||||||||No||2017-10-10 21:43:18.564322|2017-10-10 21:43:18.564322
NCT02924441|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Women's Mammography Study to Improve Comfort During Mammography|A Study Attempting to Improve the Comfort During Screening Mammography|Not yet recruiting||N/A|1250|Anticipated|The University of Texas Health Science Center at San Antonio||4|||f||||t||||||||No||2017-10-10 21:43:18.721596|2017-10-10 21:43:18.721596
NCT02924428|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-01|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Venus Versa Diamondpolar Applicator Treatment Followed by AC Dual Applicator Treatment for Facial Acne Vulgaris|Clinical Evaluation of Venus Versa Diamonpolar Applicator Treatment Followed by AC Dual Applicator Treatment Using 2 Intense Pulsed Light Wavelength Bands for Facial Acne Vulgaris|Recruiting||N/A|20|Anticipated|Venus Concept||2|||f||||f||||||||||2017-10-10 21:43:18.82224|2017-10-10 21:43:18.82224
NCT02924415|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-04|||April 2013||2013-04-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|FISTAR||Future Internet Social and Technological Alignment Research|Future Internet Social and Technological Alignment Research (FISTAR)|Completed||N/A|50|Actual|Basque Health Service||2|||f||||f||||||||No||2017-10-10 21:43:18.900306|2017-10-10 21:43:18.900306
NCT02924402|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-10|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|August 2020|Anticipated|2020-08-01||Interventional|||Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies|A Phase 1 Multidose Study to Evaluate the Safety and Tolerability of XmAb13676 in Patients With CD20-Expressing Hematologic Malignancies|Recruiting||Phase 1|66|Anticipated|Xencor, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:43:18.968551|2017-10-10 21:43:18.968551
NCT02924376|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-13|||October 2016||2016-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy|A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy|Recruiting||Phase 2|100|Anticipated|Incyte Corporation||3|||f||||f||||||||||2017-10-10 21:43:19.157855|2017-10-10 21:43:19.157855
NCT02924363|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-01-19|||January 2017||2017-01-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|MITRA-REV||Effect of MitraClip on Acute and Chronic Reverse Cardiac Remodeling Assessed by CMR: The MITRA-REVERSE Study|Effect of MitraClip on Reverse Cardiac Remodeling Assessed by CMR and Echocardiography: The MITRA-REVERSE Study A Prospective Multicenter Study|Recruiting||N/A|60|Anticipated|The Methodist Hospital System||1|||f||||f|f|f|||f|||No||2017-10-10 21:43:19.57137|2017-10-10 21:43:19.57137
NCT02924350|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-07-07|||November 7, 2016|Actual|2016-11-07|July 2017|2017-07-01|March 17, 2017|Actual|2017-03-17|March 17, 2017|Actual|2017-03-17||Interventional|||The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity (DH)|A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|Completed||N/A|246|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 21:43:19.675882|2017-10-10 21:43:19.675882
NCT02924337|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-02-09|||September 2016||2016-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects|A Randomised, Double-blind, Placebo and Active Controlled Crossover Study to Assess the Effect of Single Dose Administration of 2 Doses of Imeglimin on QT/QTc Intervals in Healthy Subjects|Completed||Phase 1|55|Actual|Poxel SA||4|||f||||||||||||||2017-10-10 21:43:19.754017|2017-10-10 21:43:19.754017
NCT02923960|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-04-14|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Nutritional Products in Subjects With Type 2 Diabetes|Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetes|Completed||N/A|43|Actual|Abbott Nutrition||3|||f||||f||||||||Undecided||2017-10-10 21:43:22.55343|2017-10-10 21:43:22.55343
NCT02924324|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-21|||October 2016||2016-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients|Local Analgesia Use for Bone Marrow Procedures for Pediatric Neuroblastoma Patients: a Prospective Randomized Cross-over Clinical Trial|Recruiting||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 21:43:19.842408|2017-10-10 21:43:19.842408
NCT02924311|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-08-03|||September 21, 2016|Actual|2016-09-21|August 2017|2017-08-01|November 15, 2019|Anticipated|2019-11-15|September 15, 2019|Anticipated|2019-09-15||Observational|APOLLON||Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema|A Prospective Observational Study Conducted in France to Describe Routine Clinical Practice for Treatment naïve or Previously Treated Patients With Diabetic Macular Edema (DME) Who Are Starting IVT Aflibercept|Active, not recruiting||N/A|401|Actual|Bayer|||3||f||||f||||||||||2017-10-10 21:43:19.948264|2017-10-10 21:43:19.948264
NCT02924298|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-10-03|||September 2013||2013-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|SLIMM||Effect of Sit Less, Interact, Move More (SLIMM) Regimen on Patients With Chronic Kidney Disease (CKD)|Sit Less, Interact, Move More (SLIMM) Intervention Pilot Study|Terminated||N/A|32|Actual|University of Utah||2||Lack of funding|f||||f||||||||||2017-10-10 21:43:20.052326|2017-10-10 21:43:20.052326
NCT02924272|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-06-05|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2021|Anticipated|2021-10-01||Interventional|||Ixazomib Rollover Study|An Open-Label, Rollover Protocol for Patients Previously Enrolled in Millennium-Sponsored Ixazomib Studies|Recruiting||Phase 2|250|Anticipated|Takeda||1|||f||||f|t|f||||||||2017-10-10 21:43:20.216284|2017-10-10 21:43:20.216284
NCT02924259|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-11-30|||September 2016||2016-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Does Self-myofascial Release With a Foam Roll Change Pressure Pain Thresholds in Lower Extremity Muscles|Does Self-myofascial Release With a Foam Roll Change Pressure Pain Threshold of the Ipsilateral Lower Extremity Agonist, Antagonist, and Contralateral Muscle Groups? an Exploratory Study|Completed||N/A|45|Actual|California State University, Dominguez Hills||1|||f||||f||||||||No||2017-10-10 21:43:20.299312|2017-10-10 21:43:20.299312
NCT02924246|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-01-12|||August 2016||2016-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|MOSAIC-2||Effect of Milk on the Vaccination Response|MOSAIC-2: Effect of Raw Milk on the Immune Response Upon Cholera Vaccination|Active, not recruiting||N/A|108|Actual|NIZO Food Research||4|||f||||f||||||||No||2017-10-10 21:43:20.366502|2017-10-10 21:43:20.366502
NCT02924233|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-08-25|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer|An Open-label, Randomized, Multicenter, Phase 1b/2b Trial Investigating the Safety and Preliminary Antitumor Effects of Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|Symphogen A/S||3||Symphogen made a business decision to no longer perform the clinical study|f||||f||||||||||2017-10-10 21:43:20.547686|2017-10-10 21:43:20.547686
NCT02924220|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-01|||February 16, 2017|Actual|2017-02-16|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|MONALISAGENBIO||Genetic Susceptibility and Biomarkers in Listeriosis|Genetic Susceptibility and Biomarkers in Listeriosis (MONALISA-GENBIO)|Enrolling by invitation||N/A|1274|Anticipated|Institut Pasteur|||2||f||||f||||||Samples With DNA|"     Biological samples (serum, plasma, mononuclear cells and DNA) previously collected from cases     patients and control patients included in the MONALISA cohort.   "|||2017-10-10 21:43:20.63399|2017-10-10 21:43:20.63399
NCT02924207|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-01-12|||September 2016||2016-09-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PATH||Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes|Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes|Recruiting||N/A|200|Anticipated|St Elizabeth Healthcare||1|||f||||t||||||||Yes||2017-10-10 21:43:20.710733|2017-10-10 21:43:20.710733
NCT02924194|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|December 2020|Anticipated|2020-12-01||Interventional|||Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease|Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (nbM) to Treat Parkinson's Patients With Mild Cognitive Impairment, Amnestic Subtype|Recruiting||N/A|6|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||t||||||||Undecided||2017-10-10 21:43:20.807235|2017-10-10 21:43:20.807235
NCT02924181|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-10-03|||June 2015||2015-06-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison Between Contact Force Guided and Blinded Strategy on PV Isolation in AF Patients|Comparison of Acute Pulmonary Vein (PV) Reconnection Between Contact Force Guided and Blinded PV Isolation in Patients With Symptomatic Atrial Fibrillation|Recruiting||Phase 4|60|Anticipated|Seoul National University Hospital||4|||f||||f||||||||Yes||2017-10-10 21:43:20.916874|2017-10-10 21:43:20.916874
NCT02924168|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-02-08|||September 2013||2013-09-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Radial Shock Waves for Functional Disability in Stroke|Effect of Radial Shock Waves for the Treatment of Upper Limb Functional Disability in Stroke Sequelae|Recruiting||N/A|20|Anticipated|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 21:43:21.021536|2017-10-10 21:43:21.021536
NCT02924155|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01||||November 2016|Anticipated|2016-11-01||Interventional|||Clinical Study to Investigate the Systemic Exposure, Safety, and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Male Volunteers|A Randomized, Double-blind, Placebo-controlled, Single Day/Multiple Day Dosing, Phase I Clinical Trial to Investigate the Systemic Exposure, Safety and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Korean Male Subjects|Recruiting||Phase 1|12|Anticipated|Samjin Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 21:43:21.125903|2017-10-10 21:43:21.125903
NCT02924142|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|OTCap||Treatment Outcomes After Receiving Conventional Clasp or Precision Attachment Removable Partial Dentures.|Treatment Outcomes Based on Patient's Oral Health Related Quality of Life (OHRQoL) After Receiving Conventional Clasp or Precision Attachment Removable Partial Dentures in Distal Extension Cases: A Randomized Controlled Clinical Trial|Not yet recruiting||N/A|32|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:43:21.232092|2017-10-10 21:43:21.232092
NCT02924129|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-09-18|||January 16, 2017|Actual|2017-01-16|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|EVOKE||Safety and Efficacy Study of the Evoke™ SCS System With Feedback vs. Conventional Stimulation|A Prospective, Multicenter, Randomized Double-blind Study Examining the Safety and Efficacy of Using the Evoke™ Spinal Cord Stimulator (SCS) System With Feedback to Treat Patients With Chronic Pain of the Trunk and/or Limbs.|Recruiting||N/A|134|Anticipated|Saluda Medical Pty Ltd||2|||f||||||||||||||2017-10-10 21:43:21.323314|2017-10-10 21:43:21.323314
NCT02924116|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-20|||August 2016||2016-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Bioboosti Device for Insomnia Treatment|Use of Bioboosti Non-pharmacologic Device for Insomnia Treatment: A Pilot Study|Enrolling by invitation||Phase 4|20|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||No||2017-10-10 21:43:21.431296|2017-10-10 21:43:21.431296
NCT02924103|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-26|||December 2016||2016-12-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|March 1, 2018|Anticipated|2018-03-01||Interventional|||Contamination Free Bacterial Swap|Danish Title: Afprøvning af indføringsrør Til Forureningsfri Podning af næsens Bihuler (Den Forureningsfri Podepind)|Recruiting||N/A|70|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 21:43:21.521992|2017-10-10 21:43:21.521992
NCT02924090|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-20|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression|Hyperventilation and ECT Seizure Duration: Effects on Cerebral Oxygen Saturation, and Therapeutic Outcome With Comparisons Between Etomidate and Ketamine in Patients With Major Depressive Disorder|Recruiting||Phase 4|48|Anticipated|University of Manitoba||4|||f||||f||||||||No||2017-10-10 21:43:21.613241|2017-10-10 21:43:21.613241
NCT02924077|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-03|||October 2012||2012-10-01|October 2016|2016-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||PROTECT Pregnancy Study: An Exploratory Study of Self-reported Medication Use in Pregnant Women|IMI PROTECT - Work Package 4 - Pregnancy Study: An Exploratory Study of Self-reported Medication Use in Pregnant Women|Completed||N/A|2521|Actual|Quintiles, Inc.|||1||f||||f||||||||No||2017-10-10 21:43:21.73454|2017-10-10 21:43:21.73454
NCT02924064|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-10-05|||September 2016||2016-09-01|October 2017|2017-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus||Recruiting||Phase 3|240|Anticipated|Mitsubishi Tanabe Pharma Corporation||2|||f||||||||||||||2017-10-10 21:43:21.784516|2017-10-10 21:43:21.784516
NCT02924038|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-20|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)|Pilot Randomized Neo-adjuvant Evaluation of Agonist Anti-CD27 Monoclonal Antibody Varlilumab on Immunologic Activities of IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)|Recruiting||Phase 1|30|Anticipated|University of California, San Francisco||2|||f||||t||||||||Undecided||2017-10-10 21:43:21.919492|2017-10-10 21:43:21.919492
NCT02924025|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-10-03|||September 2014||2014-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Motivational Interviewing as an Intervention for PCOS|Motivational Interviewing as an Intervention for Women With Polycystic Ovary Syndrome and BMI Above 30 kg/m2|Completed||N/A|28|Actual|Odense University Hospital||2|||f||||t||||||||Yes|The plan is to publish the results by the end of 2016. Individual participant data will be available by request|2017-10-10 21:43:22.03219|2017-10-10 21:43:22.03219
NCT02924012|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||May 2015||2015-05-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Active Video Game and Potential to Cause Post-exercise Hypotension|Energy Demand in a Video Game Active Session and Potencial to Promove Post Exercise Hypotension in Hypertensive Women|Completed||N/A|14|Actual|Federal University of Paraíba||3|||f||||f||||||||No||2017-10-10 21:43:22.102087|2017-10-10 21:43:22.102087
NCT02923999|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-08|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|FuturePharma||Study of Single IV Administration of P2G12|Phase I Dose Escalation Trial to Evaluate Safety and Reactogenicity of Single IV Administration of P2G12|Not yet recruiting||Phase 1|18|Anticipated|St George's, University of London||3|||f||||t|f|f||||||||2017-10-10 21:43:22.191555|2017-10-10 21:43:22.191555
NCT02923986|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-10-03|||November 2016||2016-11-01|October 2016|2016-10-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML|A Phase Ib/IIa Single-arm, Open-label Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of BP1001 (a Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib (Das) in Patients With Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) in Accelerated or Blast Phase|Not yet recruiting||Phase 1/Phase 2|46|Anticipated|Bio-Path Holdings, Inc.||2|||f||||t||||||||Undecided||2017-10-10 21:43:22.294505|2017-10-10 21:43:22.294505
NCT02923973|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-06-29|||October 2016||2016-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy With Prior Spontaneous Preterm Birth||Recruiting||Phase 3|500|Anticipated|Federico II University||2|||f||||f||||||||||2017-10-10 21:43:22.457221|2017-10-10 21:43:22.457221
NCT02904122|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-13|||July 2013||2013-07-01|June 2013|2013-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|EDENT1||Oral Teleconsultation|Validation Study of Oral Teleconsultation|Completed||N/A|200|Actual|University Hospital, Montpellier|||1||f||||t||||||||Undecided||2017-10-10 21:48:25.537393|2017-10-10 21:48:25.537393
NCT02923947|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-01|||May 4, 2017|Actual|2017-05-04|September 2017|2017-09-01|August 28, 2018|Anticipated|2018-08-28|August 28, 2018|Anticipated|2018-08-28||Interventional|||Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment|Open-label,Non-randomised,Multicentre,Phase I Study to Assess the Pharmacokinetics, Safety & Tolerability of Osimertinib Following a Single Oral 80mg Dose to Patients w/ Adv Solid Tumours & Normal Renal Function or Severe Renal Impairment|Recruiting||Phase 1|16|Anticipated|AstraZeneca||2|||f||||f|f|f||||||||2017-10-10 21:43:22.631754|2017-10-10 21:43:22.631754
NCT02923934|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2017-09-20|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|December 2023|Anticipated|2023-12-01|August 2023|Anticipated|2023-08-01||Interventional|||A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers|A Phase II Clinical Trial Evaluating Ipilimumab and Nivolumab in Combination for the Treatment of Rare Gastrointestinal, Neuro-Endocrine and Gynaecological Cancers|Recruiting||Phase 2|60|Anticipated|Olivia Newton-John Cancer Research Institute||1|||f||||t|f|f||||||||2017-10-10 21:43:22.747576|2017-10-10 21:43:22.747576
NCT02923882|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2016-10-06|||April 2013||2013-04-01|March 2013|2013-03-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||$100Kitchen and Low-birth-weight Study in Rural Bangladesh|"Simple and Safe 100-dollar-kitchen to Prevent Low-birth-weight in a Rural Area in Bangladesh: A Cluster Randomized Controlled Trial"|Completed||Phase 2|1300|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||||||||||||2017-10-10 21:43:23.719468|2017-10-10 21:43:23.719468
NCT02923869|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-09-05|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate Surgery|Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate Surgery|Completed||Phase 2/Phase 3|60|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 21:43:23.824141|2017-10-10 21:43:23.824141
NCT02923856|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-03-27|||January 2017||2017-01-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin|A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Based on Accurate Susceptibility Testing of Clarithromycin|Recruiting||N/A|672|Anticipated|Sanmen People's Hospital||7|||f||||||||||||||2017-10-10 21:43:23.947177|2017-10-10 21:43:23.947177
NCT02923843|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-19|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Are Geriatric Out-patient Care Better Than Usual Care?|Are Care Given by a Geriatric Hospital-Based Out Patient-Care Team Better Than Usual Care? - a Randomised Controlled Trial (The GerOP-Ca-trial)|Recruiting||N/A|450|Anticipated|Region Skane||2|||f||||f||||||||Yes||2017-10-10 21:43:24.102887|2017-10-10 21:43:24.102887
NCT02923830|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-07-14|||April 2016||2016-04-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes|Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes|Recruiting||Phase 4|396|Anticipated|TriHealth Inc.||2|||f||||f||||||||||2017-10-10 21:43:24.244496|2017-10-10 21:43:24.244496
NCT02923817|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-01-09|||September 2016||2016-09-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|DNH||Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury|Phase I-II Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury|Recruiting||Phase 2|30|Anticipated|Da Nang Hospital||1|||f||||||||||||||2017-10-10 21:43:24.392434|2017-10-10 21:43:24.392434
NCT02923804|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-04-03|||October 2015||2015-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients|A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care|Active, not recruiting||N/A|128|Anticipated|Pronova BioPharma||2|||f||||f||||||||No||2017-10-10 21:43:24.505737|2017-10-10 21:43:24.505737
NCT02923791|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-02-20|||October 2016||2016-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.|"A Phase I, Randomized Open-label, 2-period, Parallel Arm Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of Filgrastim Hospira (US) Or US-approved Neupogen(Registered) Reference Product In Healthy Volunteers"|Completed||Phase 1|256|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 21:43:24.616278|2017-10-10 21:43:24.616278
NCT02923778|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-04|2017-09-12|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery|A Phase 2 Study of Talimogene Laherparepvec (T-VEC) and Radiation in Localized Soft Tissue Sarcoma|Suspended||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1||Other - Additional pre-registration requirements needed.|f||||f|t|f||||||||2017-10-10 21:43:24.711158|2017-10-10 21:43:24.711158
NCT02923765|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-28|||November 2016||2016-11-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|November 2017|Anticipated|2017-11-01||Interventional|||Stepper Aerobic Training on Fitness, Disability, Inflammation and Thrombosis in Stroke Patients|Efficacy of Stepper Aerobic Training on Cardiopulmonary Fitness, Disability, Systemic Inflammation and Thrombosis in Stroke Patients With Hemiplegia|Not yet recruiting||N/A|170|Anticipated|Chang Gung Memorial Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:43:24.828648|2017-10-10 21:43:24.828648
NCT02923752|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-10-03|||February 1, 2017|Actual|2017-02-01|October 2017|2017-10-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Observational|WISP||Whole Brain Vessel Wall Imaging in Stroke Patients (WISP): An International Multi-Center Registry|Whole Brain Vessel Wall Imaging in Stroke Patients (WISP): An International Multi-Center Registry|Recruiting||N/A|1000|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||t|f|||||||2017-10-10 21:43:24.918309|2017-10-10 21:43:24.918309
NCT02923739|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-10-05|||May 5, 2017|Actual|2017-05-05|October 2017|2017-10-01|May 2025|Anticipated|2025-05-01|May 2025|Anticipated|2025-05-01||Interventional|||Induction Discontinuation Trial of Emactuzumab Following Paclitaxel and Bevacizumab in Patients With Platinum-Resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer - REDIRECT|A Randomized Phase II Induction Discontinuation Trial of Emactuzumab Following Paclitaxel and Bevacizumab in Patients With Platinum-Resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer - REDIRECT|Recruiting||Phase 2|121|Anticipated|M.D. Anderson Cancer Center||4|||f||||t|t|f||||||||2017-10-10 21:43:25.080751|2017-10-10 21:43:25.080751
NCT02923700|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-09-12|||September 2016||2016-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|PRP014||Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial|Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial|Recruiting||Phase 4|192|Anticipated|Istituto Ortopedico Rizzoli||2|||f||||t||||||||||2017-10-10 21:43:25.817551|2017-10-10 21:43:25.817551
NCT02923687|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-04|||September 2016||2016-09-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain|Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain|Enrolling by invitation||Phase 2|60|Anticipated|Azad University of Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 21:43:25.913141|2017-10-10 21:43:25.913141
NCT02923674|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-04-03|||November 2016||2016-11-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|EMPOWER||Empowered With Movement to Prevent Obesity and Weight Regain|Empowered With Movement to Prevent Obesity and Weight Regain|Recruiting||N/A|180|Anticipated|Wake Forest University Health Sciences||3|||f||||t||||||||No||2017-10-10 21:43:25.999772|2017-10-10 21:43:25.999772
NCT02923661|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2016-10-03|||February 2016||2016-02-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Patient Satisfaction in Single Implant Mandibular Complete Overdentures Retained by CM LOC Versus Ball Attachment|Patient Satisfaction in Single Implant Mandibular Complete Overdentures Retained by CM LOC Versus Ball Attachment|Recruiting||N/A|40|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:43:26.092882|2017-10-10 21:43:26.092882
NCT02923648|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-05|||March 2013||2013-03-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Observational|LUNAPRE||Lung Obstruction in Adulthood of Prematurely Born (LUNAPRE)|Lung Obstruction in Adulthood of Prematurely Born (LUNAPRE)|Recruiting||N/A|102|Anticipated|Karolinska Institutet|||4||f||||t||||||Samples With DNA|"     Bronchoalveolar lavage (BAL) cells, BAL fluid, bronchial biopsies, airway epithelial     brushings, serum, plasma, blood cells, and urine are collected and stored.   "|No||2017-10-10 21:43:26.171443|2017-10-10 21:43:26.171443
NCT02923635|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2016-10-03|||September 2012||2012-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|August 2013|Actual|2013-08-01||Interventional|||A Prospective Comparative Study Between Oncoplastic Breast Surgery and Standard Wide Local Excision|A Prospective Comparative Study Between Oncoplastic Breast Surgery and Standard Wide Local Excision:Margin Length and Patient Satisfaction|Completed||N/A|70|Actual|Ain Shams University||2|||f||||t||||||||Undecided||2017-10-10 21:43:26.283408|2017-10-10 21:43:26.283408
NCT02923622|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-10-01|||September 2016||2016-09-01|September 2016|2016-09-01||||March 2020|Anticipated|2020-03-01||Observational|||Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer||Not yet recruiting||N/A|384|Anticipated|Xiyuan Hospital of China Academy of Chinese Medical Sciences|||3||f||||t||||||||No||2017-10-10 21:43:26.348527|2017-10-10 21:43:26.348527
NCT02923609|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-04|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CELLpEF||Cell Therapy in HFpEF|A PILOT TRIAL OF CELL THERAPY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION|Recruiting||Phase 2|30|Anticipated|University Medical Centre Ljubljana||2|||f||||f||||||||No||2017-10-10 21:43:26.428934|2017-10-10 21:43:26.428934
NCT02923596|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-10-01|||September 2016||2016-09-01|October 2016|2016-10-01|September 2023|Anticipated|2023-09-01|September 2022|Anticipated|2022-09-01||Observational|||Retrospective Study of Keloid Disorder|Retrospective Study of Keloid Disorder|Recruiting||N/A|5000|Anticipated|Tirgan, Michael H., M.D.|||3||f||||f||||||||Yes||2017-10-10 21:43:26.500512|2017-10-10 21:43:26.500512
NCT02923037|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-06|||October 2016||2016-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Hatha Yoga in Breast Cancer Survivors|Feasibility and Preliminary Efficacy of Hatha Yoga in Breast Cancer Survivors: Pilot Study|Active, not recruiting||N/A|15|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 21:43:33.190093|2017-10-10 21:43:33.190093
NCT02923583|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-05-19|||October 2016||2016-10-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects|A Randomized, Double-blind, Three-arm, Parallel Group, Single-dose Study to Compare the Pharmacokinetics, Safety, and Immunogenicity of M834 (Abatacept Biosimilar Candidate), US-Sourced Orencia®, and European Union (EU)-Sourced Orencia® in Normal Healthy Volunteers|Active, not recruiting||Phase 1|243|Actual|Momenta Pharmaceuticals, Inc.||3|||f||||f||||||||Undecided||2017-10-10 21:43:26.592124|2017-10-10 21:43:26.592124
NCT02923557|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2021|Anticipated|2021-11-01||Interventional|||Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients||Recruiting||Phase 2|200|Anticipated|Peking University First Hospital||2|||f||||||||||||||2017-10-10 21:43:26.765816|2017-10-10 21:43:26.765816
NCT02923544|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-10-03|||September 2016||2016-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Trial of YUMI Uterine Manipulator|Pilot Trial of YUMI Uterine Manipulator|Recruiting||N/A|40|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:43:26.854777|2017-10-10 21:43:26.854777
NCT02923531|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-07-24|||September 2016||2016-09-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Addition of X4P-001 to Nivolumab Treatment in Patients With Renal Cell Carcinoma|A Phase 1b/2a Trial Adding X4P-001 in Patients Receiving Nivolumab for Treatment of Advanced Clear Cell Renal Cell Carcinoma|Recruiting||Phase 1/Phase 2|20|Anticipated|X4 Pharmaceuticals||1|||f||||||||||||||2017-10-10 21:43:26.935157|2017-10-10 21:43:26.935157
NCT02923518|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-01|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Observational|MASTERSCREEN||Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes)|Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes) Who Participate in Long Distance Endurance Training and Competitions.|Recruiting||N/A|80|Anticipated|LHL Helse|||2||f||||f||||||||No||2017-10-10 21:43:27.013488|2017-10-10 21:43:27.013488
NCT02923505|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-03|||May 2016||2016-05-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Observational|||Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF)|Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF)|Recruiting||N/A|500|Anticipated|Wissenschaftliches Institut Bethanien e.V|||3||f||||||||||||No||2017-10-10 21:43:27.096067|2017-10-10 21:43:27.096067
NCT02923492|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-30|||February 22, 2017|Actual|2017-02-22|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Translation of an Intervention for Violence Among Adolescents in Emergency Departments|Translation of an Intervention for Violence Among Adolescents in Emergency Departments|Recruiting||N/A|400|Anticipated|University of Michigan||3|||f||||f|f|f||||||||2017-10-10 21:43:27.185342|2017-10-10 21:43:27.185342
NCT02923479|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-01|||March 2013||2013-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Robot-assisted Rehabilitation of Ankle Fractures: Efficacy and Comparison With Traditional Methods|Robot-assisted Ankle Rehabilitation Using the High-performance Robotic Device IIT-ARBOT: A Pilot Randomised Controlled Study|Completed||N/A|32|Actual|Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro||2|||f||||f||||||||No||2017-10-10 21:43:29.042448|2017-10-10 21:43:29.042448
NCT02923466|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-07|||April 17, 2017|Actual|2017-04-17|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Trial of Intratumoral Administration of Recombinant Vesicular Stomatitis Virus in Patients With Refractory Solid Tumors|Phase I Trial of Intratumoral Administration of Vesicular Stomatitis Virus (VSV) Genetically Engineered to Express Sodium Iodine Symporter (NIS) and Human Interferon Beta (IFNβ), in Patients With Refractory Solid Tumors|Recruiting||Phase 1|42|Anticipated|Vyriad, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:43:29.140476|2017-10-10 21:43:29.140476
NCT02923453|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||March 1998||1998-03-01|October 2016|2016-10-01|August 2002|Actual|2002-08-01|December 2001|Actual|2001-12-01||Interventional|||Effect of Ginseng in Type 2 Diabetes|Efficacy and Safety of American Ginseng (Penax Quinquefolius) Extract on Glycemic Control in Individuals With Type 2 Diabetes: A Double-blind, Randomized, Crossover Clinical Trial|Completed||Phase 2|23|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 21:43:29.217708|2017-10-10 21:43:29.217708
NCT02923440|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-03|||October 2016||2016-10-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|October 2019|Anticipated|2019-10-01||Interventional|SEA-HD||Creation of a French South-Eastern Database and DNA-bank of Congenital Heart Disease to Explore the Genetic Pathways|Creation of a French South-Eastern Database and DNA-bank of Congenital Heart Disease to Explore the Genetic Pathways|Not yet recruiting||N/A|300|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:43:29.310326|2017-10-10 21:43:29.310326
NCT02923427|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-02-08|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||I-gel vs LMA Supreme in Laparoscopic Gynecological Surgery|Comparison of I-gel and LMA Supreme Without Neuromuscular Blocker in Laparoscopic Gynecological Surgery|Recruiting||N/A|100|Anticipated|Dokuz Eylul University||2|||f||||f||||||||Yes||2017-10-10 21:43:29.381368|2017-10-10 21:43:29.381368
NCT02923414|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-04|||September 2016||2016-09-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||Comparison of High Versus Escalating Shocks in Cardioverting Atrial Fibrillation|The Efficiency and Safety of a High Energy Shock Protocol (360-360-360 J) Versus a Standard Escalating Energy Shock Protocol (125-150-200 J) in Cardioverting Atrial Fibrillation|Recruiting||N/A|276|Anticipated|University of Aarhus||2|||f||||t||||||||No||2017-10-10 21:43:29.475887|2017-10-10 21:43:29.475887
NCT02923401|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-03-24|||September 30, 2016|Actual|2016-09-30|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer|High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer|Recruiting||N/A|36|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 21:43:29.575461|2017-10-10 21:43:29.575461
NCT02923388|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-07-31|||October 2016||2016-10-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Neuroprotective Effect of Vitamin B12 and Vitamin B6 Against Vincristine Induced Peripheral Neuropathy|Neuroprotective Effect of Vitamin B12 and Vitamin B6 Against Vincristine Induced Peripheral Neuropathy: A Randomized, Double Blind, Placebo Controlled, Multi Center Trial|Recruiting||Phase 2|78|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||f||||||||||2017-10-10 21:43:29.676087|2017-10-10 21:43:29.676087
NCT02923375|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-06-07|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease|An Open-Label Phase 1 Study to Investigate the Safety and Efficacy of CYP-001 for the Treatment of Adults With Steroid-Resistant Acute Graft Versus Host Disease|Recruiting||Phase 1|16|Anticipated|Cynata Therapeutics Limited||2|||f||||t|t|f|||t|||||2017-10-10 21:43:29.773858|2017-10-10 21:43:29.773858
NCT02923362|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-08-08|||May 2016||2016-05-01|August 2017|2017-08-01|May 2023|Anticipated|2023-05-01|May 2018|Anticipated|2018-05-01|5 Years|Observational [Patient Registry]|ROARS||Registry of Outcomes From AntiReflux Surgery|Registry of Outcomes From AntiReflux Surgery (ROARS)|Recruiting||N/A|1000|Anticipated|The Heartburn Foundation|||2||f||||f||||||||||2017-10-10 21:43:29.976513|2017-10-10 21:43:29.976513
NCT02923349|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-07-27|||October 2016||2016-10-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors|A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|157|Anticipated|Incyte Corporation||1|||f||||f||||||||||2017-10-10 21:43:30.240341|2017-10-10 21:43:30.240341
NCT02923336|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2016-10-03|||May 2015||2015-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|October 2016|Actual|2016-10-01||Interventional|||Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics|Evaluation of Gastrointestinal Transite in Cirrhotic Patient Pre and Post Treatment With Non Selective Betablockers (Propanolol)|Recruiting||N/A|10|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||1|||f||||f||||||||||2017-10-10 21:43:30.377202|2017-10-10 21:43:30.377202
NCT02923323|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-10-03|||March 2016||2016-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|T1DM||Cross-sectional, Case Control Study of Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy|Cross-sectional, Case Control Study of Electrical Activity and Neurocognitive Performance During Hyperglycemia and Near Normoglycemia, and Brain Tissue Integrity in Children and Youth With Type 1 Diabetes and in Healthy Population|Recruiting||N/A|90|Anticipated|Assaf-Harofeh Medical Center||2|||f||||t||||||||No||2017-10-10 21:43:30.476929|2017-10-10 21:43:30.476929
NCT02923310|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-09-30|||November 2013||2013-11-01|September 2016|2016-09-01||||September 2016|Actual|2016-09-01||Interventional|||Evaluation of Two Types of PRP in Knee Osteoarthritis||Recruiting||Phase 1/Phase 2|120|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||No||2017-10-10 21:43:30.569437|2017-10-10 21:43:30.569437
NCT02923297|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2017-03-24|||April 2015|Actual|2015-04-01|March 2017|2017-03-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Interventional|GALIGPARK||GALIG Gene Expression in Parkinson's Disease|GALIG Gene Expression in Parkinson's Disease|Completed||N/A|37|Actual|Centre Hospitalier Régional d'Orléans||1|||f||||f||||||||No||2017-10-10 21:43:30.648304|2017-10-10 21:43:30.648304
NCT02923284|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-10-03|||August 2016||2016-08-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|March 2019|Anticipated|2019-03-01||Observational|||NANOTECH RCC Biomarkers|Nanotech Biomarkers For Renal Cancer Intervention: Clinical Validation & Utility|Recruiting||N/A|1200|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples Without DNA|"     Urine samples will be retained with a study-specific code that links the samples to data     collected from the electronic medical record.   "|No||2017-10-10 21:43:30.73551|2017-10-10 21:43:30.73551
NCT02923271|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-26|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Promoting Intrafamily Accountability for Reducing Cellphone Use While Driving in Adults and Their Teen Children|Promoting Intrafamily Accountability for Reducing Cellphone Use While Driving in Adults and Their Teen Children|Recruiting||N/A|250|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||No||2017-10-10 21:43:30.812541|2017-10-10 21:43:30.812541
NCT02923258|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Postoperative CCRT With Docetaxel vs Cisplatin in High Risk HNSCC|Postoperative Radiation and Concurrent Chemotherapy With Weekly Docetaxel Versus Cisplatin in Patients With High Risk Squamous Cell Carcinoma of Head & Neck: a Randomized Multi-center Phase III Clinical Trial|Not yet recruiting||Phase 2/Phase 3|387|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||2|||f||||t||||||||No||2017-10-10 21:43:30.905092|2017-10-10 21:43:30.905092
NCT02923245|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2017-04-04|||September 2015||2015-09-01|April 2017|2017-04-01|November 5, 2016|Actual|2016-11-05|November 5, 2016|Actual|2016-11-05||Interventional|PEEFREI||Point-of-care-ultrasound Expedited Evaluation for Reproductive Emergency Imaging|Emergency Department Point-of-Care Ultrasound (POCUS) to Determine Adequate Bladder Fullness for Transabdominal Pelvic Ultrasound|Completed||N/A|118|Actual|Brown University||2|||f||||f||||||||No||2017-10-10 21:43:30.986883|2017-10-10 21:43:30.986883
NCT02923232|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-02|||November 2014||2014-11-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|ACL||Ocular Adaptation and Visual Performance for Accommodative Contact Lens|Ocular Adaptation and Visual Performance for Accommodative Contact Lens|Recruiting||Early Phase 1|64|Anticipated|Pacific University||1|||f||||f||||||||||2017-10-10 21:43:31.055226|2017-10-10 21:43:31.055226
NCT02901470|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-07-27|||December 2015||2015-12-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Observational Study of the Incidence of Pressure Ulcers on the Help Support of Prevention of Bedsores POLYAIR®||Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:48:47.862113|2017-10-10 21:48:47.862113
NCT02923219|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-10-02|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|ADSCs||The Clinical Application of Adipose-Derived Stem Cells on Facial Rejuvenation|The Clinical Application of Adipose-Derived Stem Cells on Facial Rejuvenation|Not yet recruiting||N/A|50|Anticipated|Xuzhou Medical University||1|||f||||t||||||||Undecided||2017-10-10 21:43:31.128315|2017-10-10 21:43:31.128315
NCT02923206|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-04-10|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|April 2019|Anticipated|2019-04-01||Interventional|SAVE||Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis|Proof-of-Concept Trial on Selective Removal of the Antiangiogenic Factor Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) in Pregnant Women With Preeclampsia Via Apheresis Utilizing the Flt-1 Adsorption Column|Recruiting||N/A|23|Anticipated|Miltenyi Biotec GmbH||3|||f||||t||||||||No||2017-10-10 21:43:31.198361|2017-10-10 21:43:31.198361
NCT02923180|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-06-22|||October 2016||2016-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer|Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer - a Pilot and Biomarker Study|Recruiting||Early Phase 1|16|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-10 21:43:31.688644|2017-10-10 21:43:31.688644
NCT02923167|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-31|||May 2, 2017|Actual|2017-05-02|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy|Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy: a Pilot Study on Clinical Outcomes and Muscle Synergies as a Possible Predictor of Response|Recruiting||N/A|10|Anticipated|Spaulding Rehabilitation Hospital||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:43:31.782322|2017-10-10 21:43:31.782322
NCT02923154|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-02|2017-09-08|||September 2016||2016-09-01|September 2017|2017-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)|An Exploratory Study of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) (Placebo-Controlled Double-Blind Study)|Active, not recruiting||Phase 2|40|Anticipated|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-10 21:43:31.877037|2017-10-10 21:43:31.877037
NCT02923141|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-01-28|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TIARAS||Trauma Intervention for Affect Regulation, AIDS, and Substances|Trauma Intervention for Affect Regulation, AIDS, and Substances|Recruiting||N/A|30|Anticipated|University of Miami||2|||f||||f||||||||No||2017-10-10 21:43:31.960513|2017-10-10 21:43:31.960513
NCT02923128|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-10-08|||November 2016||2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction|Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction|Not yet recruiting||Phase 4|150|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||No||2017-10-10 21:43:32.06048|2017-10-10 21:43:32.06048
NCT02923115|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-09-18|||September 2016||2016-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b When Added to Standard of Care Anticoagulation Therapy in Subjects With Acute Submassive Pulmonary Embolism|Recruiting||Phase 1/Phase 2|132|Anticipated|Daiichi Sankyo, Inc.||2|||f||||t||||||||||2017-10-10 21:43:32.158091|2017-10-10 21:43:32.158091
NCT02923102|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-04-25|||October 2016||2016-10-01|October 2016|2016-10-01|March 15, 2017|Actual|2017-03-15|January 15, 2017|Actual|2017-01-15||Interventional|||Effects of Recoverben® on Recovery After Exhaustive Exercise|Effects of Recoverben® on Recovery After Exhaustive Exercise in Healthy People - a Randomized, Double-blind, Placebo-controlled Study With Parallel Design|Completed||N/A|40|Actual|Vital Solutions GmbH||2|||f||||f||||||||||2017-10-10 21:43:32.472047|2017-10-10 21:43:32.472047
NCT02923089|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-10-18|||January 2017||2017-01-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Postprandial Blood Glucose and Insulin Levels Following Consumption of Lentil-containing Food Products|The Love of Lentils (LoL) Study - Phase 2: The Effect of Acute Consumption of Lentil-containing Food Products on Post-prandial Blood Glucose and Insulin in Healthy Adults|Not yet recruiting||N/A|20|Anticipated|University of Guelph||9|||f||||f||||||||No||2017-10-10 21:43:32.628738|2017-10-10 21:43:32.628738
NCT02923076|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-30|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HIVECT||HIV Eradication Through Cord-blood Transplantation|A Prospective Clinical Research Protocol of Allogeneic CCR5 delta32/delta32 Cord Blood Cell Transplantation to Cure HIV Infection|Recruiting||N/A|5|Anticipated|Puerta de Hierro University Hospital||1|||f||||||||||||||2017-10-10 21:43:32.829296|2017-10-10 21:43:32.829296
NCT02923063|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-04|||September 2016||2016-09-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|ESTEEM-CKD||Exercise Study Testing Enhanced Energetics of Muscle Mitochondria in CKD|A Randomized, Controlled Trial of Combined Aerobic and Resistance Exercise on Muscle Mitochondrial Function and Metabolism|Recruiting||Phase 2|30|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 21:43:32.975903|2017-10-10 21:43:32.975903
NCT02923050|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-01|||January 2015||2015-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Simple Suppers Scale-up (S3)|Simple Suppers Scale-up (S3): an Expanded Pilot Study to Determine the Effectiveness of a Family Meals Intervention Aimed at Eliciting Positive Changes in Child Diet and Weight Status|Completed||N/A|223|Actual|Ohio State University||2|||f||||f||||||||No||2017-10-10 21:43:33.104346|2017-10-10 21:43:33.104346
NCT02923024|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-07-10|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Oscar Health Patient Pings|Utilizing Existing Technology Using Patient Pings to Increase Physician Engagement at Oscar Health|Not yet recruiting||N/A|100|Anticipated|University of Pennsylvania||3|||f||||f|f|f||||||||2017-10-10 21:43:33.301149|2017-10-10 21:43:33.301149
NCT02923011|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-09|||November 2016||2016-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas|Phase III Study to Compare the Effectiveness of Magnetic Resonance Guided Focused Ultrasound With Computed Tomography Guided Radiofrequency Ablation for Treatment of Osteoid Osteomas|Recruiting||Phase 3|56|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 21:43:33.396125|2017-10-10 21:43:33.396125
NCT02922998|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-30|||September 2016||2016-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|CD64SEPLDX||CD64 and Antibiotics in Human Sepsis|Monitoring CD64 on Neutrophils Regarding Effects of Antibiotics in Patients With SIRS Developing Sepsis|Recruiting||N/A|100|Anticipated|University of Ulm|||1||f||||f||||||Samples With DNA|"     blood, plasma   "|No||2017-10-10 21:43:33.520904|2017-10-10 21:43:33.520904
NCT02922985|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-11-21|||October 2016||2016-10-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Multimodal Pain Management for Cesarean Delivery|Multimodal Pain Management for Cesarean Delivery: A Randomized Control Trial|Recruiting||Phase 4|120|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-10 21:43:33.625015|2017-10-10 21:43:33.625015
NCT02922972|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-03|||May 2014||2014-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Treatment of Keloid Scar by Autologous Platelet Rich Plasma Obtained With RgenKit-BCT|Efficay of Autologous Platelet Rich Plasma Obtained With RgenKit-BCT in the Prevention and the Treatment of Keloid Scars|Completed||N/A|15|Actual|Regen Lab SA||1|||f||||f||||||||No||2017-10-10 21:43:33.715949|2017-10-10 21:43:33.715949
NCT02922959|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-05-01|||February 7, 2017|Actual|2017-02-07|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|TTIP-PRO||A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses|A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses|Enrolling by invitation||N/A|80|Anticipated|University of Cincinnati||2|||f||||t|f|f||||||Yes|Data will be shared in a timely manner, i.e., no later than the acceptance for publication of the main findings from the final dataset. The dataset will include information about illegal activities (e.g., illicit opioid use, etc.). Thus, in addition to only a de-identified database being shared, we will also require a data sharing agreement. The data sharing agreement will require commitment to: 1) not re-disclose the data; 2) secure the data; 3) use the data for research purposes only; 4) make no attempt to identify individual participants; 5) destroy the data once the planned research activities have been completed; 6) follow all relevant NIH policies.|2017-10-10 21:43:33.77802|2017-10-10 21:43:33.77802
NCT02922946|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-10-02|||October 2016||2016-10-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat|A 2-Stage, Open-Label, Randomized, Single-Dose, Crossover Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat in Healthy Adult Subjects|Not yet recruiting||Phase 1|48|Anticipated|Syndax Pharmaceuticals||2|||f||||f||||||||No|Data will be reviewed throughout the study by the sponsor, clinical research organization assisting with serious adverse event management, and routine monitoring to safeguard the interests of the trial subjects and to assess the safety of the interventions administered during the trial.|2017-10-10 21:43:33.872939|2017-10-10 21:43:33.872939
NCT02922933|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-01-30|||November 2016||2016-11-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects|An Open-Label, 3-Part, 2-Period Study to Examine the Effect of Omeprazole (Part 1), Famotidine (Part 2), and of an Acidic Beverage (Part 3) on the Single-Dose Pharmacokinetics of Entinostat in Healthy Adult Subjects|Recruiting||Phase 1|204|Anticipated|Syndax Pharmaceuticals||3|||f||||f||||||||No|Data will be reviewed throughout the study by the sponsor, clinical research organization assisting with serious adverse event management, and routine monitoring to safeguard the interests of the trial subjects and to assess the safety of the interventions administered during the trial.|2017-10-10 21:43:33.976722|2017-10-10 21:43:33.976722
NCT02922920|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-03|||November 2014||2014-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Tart Cherry Juice on the Body|Effects of Tart Cherry Juice on the Body|Completed||N/A|37|Actual|University of Delaware||2|||f||||f||||||||No||2017-10-10 21:43:34.085351|2017-10-10 21:43:34.085351
NCT02922907|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-03-24|||March 24, 2017|Actual|2017-03-24|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|BRM4||Rice Bran Supplementation in Treated HIV Infection|Anti-Inflammatory Effects of Arabinoxylan Rice Bran Supplementation in Participants With Treated, Suppressed HIV Infection and Inadequate Immune Reconstitution|Recruiting||N/A|24|Anticipated|University of Southern California||2|||f||||f|f|f||||||||2017-10-10 21:43:34.166856|2017-10-10 21:43:34.166856
NCT02922894|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-06-12|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|February 2021|Anticipated|2021-02-01|September 2020|Anticipated|2020-09-01||Interventional|||Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury|Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury|Recruiting||Phase 4|100|Anticipated|John D. Dingell VA Medical Center||3|||f||||t|t|f||||||No||2017-10-10 21:43:34.421055|2017-10-10 21:43:34.421055
NCT02922881|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|UCD||Microbiota-targeted Diet for Pediatric UC|Use of a Novel Diet (UC Diet) Targeting the Microbiota for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis: An Open Label Pilot Study|Recruiting||N/A|15|Anticipated|Children's Hospital of Philadelphia||1|||f||||f||||||||No||2017-10-10 21:43:34.52485|2017-10-10 21:43:34.52485
NCT02922868|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-04-17|||March 2016||2016-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy|Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Flexible Cystoscopy|Completed||N/A|94|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||Undecided||2017-10-10 21:43:34.62514|2017-10-10 21:43:34.62514
NCT02922855|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-06-09|||January 2014||2014-01-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Incentives for Primary Care Use in a Safety Net Setting|Incentives for Primary Care Use: A Randomized Controlled Trial in a Safety Net Setting|Active, not recruiting||N/A|1643|Actual|Virginia Commonwealth University||4|||f||||f||||||||No||2017-10-10 21:43:34.72088|2017-10-10 21:43:34.72088
NCT02922842|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-14|||July 2016||2016-07-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder|A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder|Recruiting||N/A|135|Anticipated|University of Rochester||3|||f||||||||||||||2017-10-10 21:43:34.794119|2017-10-10 21:43:34.794119
NCT02922829|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-11-28|||October 2013||2013-10-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||The PreNAPS Study: FI, Nutrition, and Psychosocial Health Outcomes at Gulu Regional Referral Hospital|The PreNAPS Study: Food Insecurity, Prenatal Nutrition, and Psychosocial Health Outcomes Among HIV Infected and Uninfected Pregnant Women Attending ANC Services at Gulu Regional Referral Hospital|Completed||N/A|403|Actual|Northwestern University|||1||f||||f||||||||No||2017-10-10 21:43:34.886541|2017-10-10 21:43:34.886541
NCT02922816|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-10-04|||December 1, 2016|Actual|2016-12-01|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PREMIX||FMT for MDRO Colonization After Infection in Renal Transplant Recipients|A Pilot Study Using Fecal Microbiota Transplant in Renal Transplant Recipients to Eliminate Multidrug-Resistant Organism Colonization After Infection and Compare Gastrointestinal Carriage in a Randomized, Controlled, Crossover Design|Recruiting||Phase 1|20|Anticipated|Emory University||2|||f||||t|t|f||||||||2017-10-10 21:43:34.962476|2017-10-10 21:43:34.962476
NCT02922803|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-30|||May 2010||2010-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Vitamin D and Physical Performance Before and After Intervention and Birth Outcome in Pregnant Somali and Swedish Women|Vitamin D and Physical Performance Before and After Intervention and Birth Outcome in Pregnant Somali and Swedish Women|Completed||N/A|123|Actual|Uppsala University||2|||f||||f||||||||No||2017-10-10 21:43:35.08718|2017-10-10 21:43:35.08718
NCT02922790|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-03|||November 2016||2016-11-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|||Feasibility and Smokers' Reactions to DNA Feedback|Feasibility and Smokers' Reactions to DNA Feedback|Not yet recruiting||N/A|100|Anticipated|Duke University||3|||f||||f||||||||No||2017-10-10 21:43:35.195209|2017-10-10 21:43:35.195209
NCT02922777|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.|Phase 1 Trial of Dose Escalated BGB324 in Combination With Docetaxel for Previously Treated Advanced Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|30|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:43:35.318138|2017-10-10 21:43:35.318138
NCT02922764|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-10-03|||November 2016||2016-11-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of RGX-104 in Patients With Advanced Solid Malignancies and Lymphoma|A Phase 1 Study of RGX-104, a Small Molecule LXR Agonist, in Patients With Advanced Solid Malignancies and Lymphoma With an Expansion in Select Malignancies|Recruiting||Phase 1|80|Anticipated|Rgenix, Inc.||1|||f||||t||||||||||2017-10-10 21:43:35.414828|2017-10-10 21:43:35.414828
NCT02922751|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-27|||November 16, 2016|Actual|2016-11-16|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|January 2019|Anticipated|2019-01-01||Observational|FORCE||FibroScan™ in Pediatric Cholestatic Liver Disease Study Protocol|Childhood Liver Disease Research Network (ChiLDReN): FibroScan™ in Pediatric Cholestatic Liver Disease Study Protocol|Enrolling by invitation||N/A|450|Anticipated|Arbor Research Collaborative for Health|||1||f||||t||||||Samples Without DNA|"     Plasma and serum   "|||2017-10-10 21:43:35.565859|2017-10-10 21:43:35.565859
NCT02922738|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-06-09|||June 2015||2015-06-01|June 2017|2017-06-01|November 15, 2016|Actual|2016-11-15|November 2016|Actual|2016-11-01||Interventional|||The Impact of a Dermatology Information Source on Skin Problem Outcomes in Primary Care|The Impact of a Dermatology Information Source on Skin Problem Outcomes in Primary Care|Completed||N/A|499|Actual|University of Vermont||2|||f||||f||||||||Undecided||2017-10-10 21:43:35.71614|2017-10-10 21:43:35.71614
NCT02922725|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females|A Randomized, Double-blind, Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression Associated With Hypobaric Hypoxia in Females|Recruiting||Phase 4|54|Anticipated|University of Utah||3|||f||||t||||||||Undecided||2017-10-10 21:43:35.798157|2017-10-10 21:43:35.798157
NCT02922712|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||March 2011||2011-03-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|NISE-2013||Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteoarthrosis (Gonarthrosis)|Evaluation of Clinical Efficacy and Safety of the Drug Nise (Nimesulide) in Complex Treatment of Patients With Osteoarthritis of the Knee and Hip Joints|Completed||Phase 4|202|Actual|Dr. Reddy's Laboratories Limited||1|||f||||f||||||||Undecided||2017-10-10 21:43:35.883513|2017-10-10 21:43:35.883513
NCT02922699|ClinicalTrials.gov processed this data on October 10, 2017|2016-10-03|2016-10-03|||January 2013||2013-01-01|October 2016|2016-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Omez-RU2013||Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases|A Prospective, Randomized, Open-label Comparative Study to Evaluate the Efficacy and Safety of Two First-line H.Pylori Eradication Regimens Including the Omeprazole 40 or 80 mg, Clarithromycin and Amoxicillin.|Completed||Phase 4|120|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||Undecided||2017-10-10 21:43:35.954787|2017-10-10 21:43:35.954787
NCT02922686|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-09-30|||December 2016||2016-12-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PEDOCELL||Penicillin for the Emergency Department Outpatient Treatment of CELLulitis|Oral Flucloxacillin Alone Versus Flucloxacillin and Phenoxymethylpenicillin for the Emergency Department Outpatient Treatment of Cellulitis: a Non-inferiority Randomised Controlled Trial.|Not yet recruiting||Phase 4|414|Anticipated|Royal College of Surgeons, Ireland||2|||f||||t||||||||Undecided||2017-10-10 21:43:36.033563|2017-10-10 21:43:36.033563
NCT02922673|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-04-24|||September 2016||2016-09-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|SALYCENDO||The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia|The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia|Active, not recruiting||N/A|30|Anticipated|Radboud University||3|||f||||t||||||||Undecided||2017-10-10 21:43:36.189266|2017-10-10 21:43:36.189266
NCT02922660|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-07-24|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of Desflurane Anesthesia Versus TIVA-TCI in Patients Undergoing Ophthalmic Ambulatory Surgery|Comparison of Desflurane Balanced Anesthesia Versus TIVA-TCI (Total IntraVenous Anesthesia-Target Controlled Infusion) in Patients Undergoing Ophthalmic Ambulatory Surgery: A Single Center, Prospective, Randomized, Controlled Study|Enrolling by invitation||N/A|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 21:43:36.306162|2017-10-10 21:43:36.306162
NCT02922647|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-01-17|||October 2016||2016-10-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|GRECCAR10||Suprapubic Versus Transurethral Catheterization After Rectal Resection With Low Anastomosis for Cancer in Males|Suprapubic Versus Transurethral Catheterization After Rectal Resection With Low Anastomosis for Cancer in Males|Recruiting||N/A|220|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 21:43:36.415478|2017-10-10 21:43:36.415478
NCT02922634|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-10-03|||February 2016||2016-02-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Observational|||Preoperative Cognitive Screening in Older Thoracic and Spinal Surgical Patients|Preoperative Cognitive Screening in Older Thoracic and Spinal Surgical Patients: Feasibility and Utility for Predicting Morbidity|Active, not recruiting||N/A|500|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:43:36.513096|2017-10-10 21:43:36.513096
NCT02922621|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-09-30|||January 2017||2017-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:43:36.606026|2017-10-10 21:43:36.606026
NCT02922608|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-07-20|||October 2016||2016-10-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|Simsleep||French Survey About Student's Sleep Perturbations Before Simulation Session.|French National Investigation About Student's Sleep Perturbations Before Simulation Session.|Recruiting||N/A|500|Anticipated|Claude Bernard University|||1||f||||f||||||||||2017-10-10 21:43:36.65525|2017-10-10 21:43:36.65525
NCT02922595|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-30|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of iLTS-D® and ILMA® for Intubation With Fiberoptic Control|Comparison of iLTS-D® and ILMA® for Intubation With Fiberoptic Control. Multicentric Randomised Patient-blind Study of Non-inferiority|Not yet recruiting||N/A|198|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||No||2017-10-10 21:43:36.724534|2017-10-10 21:43:36.724534
NCT02922569|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-05-30|||March 31, 2017|Actual|2017-03-31|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|CogMind||Home-Based, Online, Mindfulness and Cognitive Training for Soldiers and Veterans With TBI|Home-Based, Online, Mindfulness and Cognitive Training for Soldiers and Veterans With TBI|Recruiting||N/A|60|Anticipated|Posit Science Corporation||2|||f|||||f|f||||||||2017-10-10 21:43:36.893952|2017-10-10 21:43:36.893952
NCT02922556|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-18|||September 2015||2015-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MDD||Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)|Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)|Recruiting||N/A|30|Anticipated|Posit Science Corporation||2|||f||||f||||||||||2017-10-10 21:43:36.980059|2017-10-10 21:43:36.980059
NCT02922543|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-05-26|||February 18, 2011|Actual|2011-02-18|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use|Revlimid 5 mg Capsules Special Use-results Surveillance of Long Term Use|Active, not recruiting||N/A|361|Actual|Celgene|||1||f||||f||||||||||2017-10-10 21:43:37.058792|2017-10-10 21:43:37.058792
NCT02922530|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-02-21|||November 2016||2016-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)|Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)|Withdrawn||N/A|0|Actual|Posit Science Corporation||2||Principal Investigator departed for another position.|f||||||||||||||2017-10-10 21:43:37.117489|2017-10-10 21:43:37.117489
NCT02922517|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-10-03|||June 2014||2014-06-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|HCM||Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy|Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy|Recruiting||N/A|115|Anticipated|Nantes University Hospital|||3||f||||f||||||Samples With DNA|"     Blood sample for biomarkers assessment   "|||2017-10-10 21:43:37.181006|2017-10-10 21:43:37.181006
NCT02922504|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-30|||October 2016||2016-10-01|September 2016|2016-09-01||||October 2016|Anticipated|2016-10-01||Interventional|AlgoMusic||Impact of Music Intervention on Pain Control In First Trimester Surgical Abortion Under Local Anesthesia|Impact of Music Intervention on Pain Control In First Trimester Surgical Abortion Under Local Anesthesia|Not yet recruiting||N/A|75|Anticipated|University Hospital, Angers||2|||f||||||||||||||2017-10-10 21:43:37.263398|2017-10-10 21:43:37.263398
NCT02922491|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2017-02-19|||June 1, 2016|Actual|2016-06-01|February 2017|2017-02-01|December 10, 2016|Actual|2016-12-10|November 1, 2016|Actual|2016-11-01||Interventional|||Effect of Vitamin E Supplementation in Methylation and microRNAs Profile|EFFECT OF VITAMIN E SUPPLEMENTATION IN METHYLATION AND MICRORNAS PROFILE IN ADULT WOMEN WITH OVERWEIGHT|Completed||N/A|45|Actual|Federal University of Paraíba||3|||f||||t||||||||No||2017-10-10 21:43:37.321416|2017-10-10 21:43:37.321416
NCT02922478|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-30|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2018|Anticipated|2018-09-01|1 Week|Observational [Patient Registry]|RoC-HF||Role of Comorbidities in Chronic Heart Failure Study|Role of Comorbidities in Chronic Heart Failure (RoC-HF) Study|Active, not recruiting||N/A|205|Anticipated|Medical University of Graz|||1||f||||f||||||Samples With DNA|"     EDTA plasma, serum and buffy coat will be stored at -80 °C for later determination of     biomarkers and DNA sequencing.   "|Undecided||2017-10-10 21:43:37.379131|2017-10-10 21:43:37.379131
NCT02922465|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-12-20|||September 2016||2016-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers||Completed||Phase 1|20|Actual|Kowa Research Institute, Inc.||1|||f||||f||||||||||2017-10-10 21:43:37.432835|2017-10-10 21:43:37.432835
NCT02922452|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-12-19|||September 2016||2016-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects|An Open-Label, Single-Sequence Study to Evaluate the Effect of Diltiazem on the Single-Dose Pharmacokinetics of BMS-986141 in Healthy Subjects|Completed||Phase 1|16|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 21:43:37.492048|2017-10-10 21:43:37.492048
NCT02922439|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-30|||January 2017||2017-01-01|September 2016|2016-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|FV2||Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II|Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II|Not yet recruiting||N/A|520|Anticipated|Nova Southeastern University||2|||f||||f||||||||Yes|At study conclusion a cleaned data set will be made available to interested researchers.|2017-10-10 21:43:37.678871|2017-10-10 21:43:37.678871
NCT02922426|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-18|||September 2016||2016-09-01|August 2017|2017-08-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||An Insulin Sensitivity Study in Healthy Subjects|A Randomized, Double-Blind, Parallel-Group Study in Healthy Subjects to Characterize Insulin Sensitivity and Lipid Metabolism in Response to Treatment With ALKS 3831 and Olanzapine|Completed||Phase 1|60|Actual|Alkermes, Inc.||3|||f||||f||||||||||2017-10-10 21:43:37.764725|2017-10-10 21:43:37.764725
NCT02922413|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2016-09-29|||August 2015||2015-08-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Panhematin for Prevention of Acute Attacks of Porphyria Panhematin for Prevention of Acute Attacks of Porphyria|Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria|Recruiting||Phase 2|20|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-10 21:43:37.844756|2017-10-10 21:43:37.844756
NCT02922400|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-29|||November 2006||2006-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2016|Actual|2016-09-01||Interventional|||Social Cognition Assessment in Young Adults|Social Cognition Assessment in Young Adults|Enrolling by invitation||Phase 1/Phase 2|200|Anticipated|The University of Texas at Dallas||1|||f||||f||||||||No||2017-10-10 21:43:37.930388|2017-10-10 21:43:37.930388
NCT02922387|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-30|||May 2012||2012-05-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Smoking Cessation Intervention in Respiratory Inpatients|Varenicline and Advanced Behavioral Support on Smoking Cessation and Quality of Life in Inpatients With Acute Exacerbation of COPD, Bronchial Asthma Attack, or Community-acquired Pneumonia: a Prospective Open-label 52-week Follow-up Trial|Completed||Phase 4|101|Actual|General Hospital of Kavala||2|||f||||f||||||||No||2017-10-10 21:43:38.022073|2017-10-10 21:43:38.022073
NCT02922374|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-20|||January 2013||2013-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis|Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis: A Prospective Observational Study|Active, not recruiting||Phase 1/Phase 2|117|Actual|Jinling Hospital, China||1|||f||||t||||||||||2017-10-10 21:43:38.106965|2017-10-10 21:43:38.106965
NCT02922361|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Spending and Outcomes for Complex Medicare Advantage Patients|Characterizing High-Cost, High-Need Patient Populations and Response to Care Management Programs at a NetworkModel Medicare Advantage Health Maintenance Organization|Active, not recruiting||N/A|400|Anticipated|University of Pennsylvania|||1||f||||f||||||||No||2017-10-10 21:43:38.176764|2017-10-10 21:43:38.176764
NCT02922348|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-07-12|||March 2016||2016-03-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|HOPE||Hormone Replacement for Premature Ovarian Insufficiency|Optimal Hormone Replacement for Women With Premature Ovarian Insufficiency|Recruiting||Phase 3|40|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 21:43:38.232354|2017-10-10 21:43:38.232354
NCT02922335|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-12-07|||September 2016||2016-09-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|MST-EA||Multisystemic Therapy-Emerging Adults Trial|Effectiveness Trial of Treatment to Reduce Serious Antisocial Behavior in Emerging Adults With Mental Illness|Recruiting||N/A|240|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||Yes||2017-10-10 21:43:38.359893|2017-10-10 21:43:38.359893
NCT02922322|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-09-30|||February 2016||2016-02-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness of Mat Pilates Exercises in Individuals With Chronic Nonspecific Low Back Pain|Effectiveness of Mat Pilates Exercises in Individuals With Chronic Nonspecific Low Back Pain: A Randomized Controlled Trial|Completed||N/A|30|Actual|Federal University of Paraíba||2|||f||||t||||||||No||2017-10-10 21:43:38.472271|2017-10-10 21:43:38.472271
NCT02922309|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-30|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effectiveness of Delivering Vocal Training Via Telepractice for Elderly Using Integrated Communication Technology||Enrolling by invitation||N/A|80|Anticipated|Far Eastern Memorial Hospital||2|||f||||f||||||||No||2017-10-10 21:43:38.554873|2017-10-10 21:43:38.554873
NCT02922296|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-09-29|||May 2015||2015-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||Glucose Metabolism in Sickle Cell Disease|Glucose Metabolism in Sickle Cell Disease|Recruiting||N/A|75|Anticipated|University of Illinois at Chicago|||1||f||||f||||||Samples With DNA|"     Blood samples will be stored temporarily in the laboratory of the Principal Investigator at     the University of Illinois at Chicago, long term storage of specimens will be at the UIC     Biobank. The research data will be stored in a locked file cabinet in the PI's research     office. The patient's name or other identifying data will not be revealed, except to those     directly involved in this study.   "|No||2017-10-10 21:43:38.619804|2017-10-10 21:43:38.619804
NCT02922283|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-04-20|||October 2016||2016-10-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||IL2 Imaging in Metastatic Melanoma|[18F]FB-IL2 Imaging of T Cell Response as Biomarker to Guide Treatment Decisions in Metastatic Melanoma Patients|Recruiting||Phase 1|30|Anticipated|University Medical Center Groningen||1|||f||||f||||||||No||2017-10-10 21:43:38.684665|2017-10-10 21:43:38.684665
NCT02922270|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-10-21|||October 1995||1995-10-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Outcome and Risk Factors For Mortality in Peritoneal Dialysis Patients: 20 Years Experience in a Single Turkish Center|Outcome and Risk Factors For Mortality in Peritoneal Dialysis Patients: 20 Years Experience in a Single Turkish Center|Completed||N/A|277|Actual|Istanbul University|||1||f||||f||||||||No||2017-10-10 21:43:38.783215|2017-10-10 21:43:38.783215
NCT02922257|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-22|||November 2016||2016-11-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery|Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery|Recruiting||N/A|20|Anticipated|Corcept Therapeutics|||1||f||||f||||||||||2017-10-10 21:43:38.862279|2017-10-10 21:43:38.862279
NCT02922244|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-01-22|||May 2016||2016-05-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients|Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients|Recruiting||N/A|150|Anticipated|Chulabhorn Cancer Center||5|||f||||t||||||||Yes||2017-10-10 21:43:38.935123|2017-10-10 21:43:38.935123
NCT02922231|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-08-22|||January 6, 2017|Actual|2017-01-06|August 2017|2017-08-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Observational|||Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea|Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea|Recruiting||N/A|600|Anticipated|Baxalta US Inc.|||1||f||||||||||||||2017-10-10 21:43:39.05042|2017-10-10 21:43:39.05042
NCT02922218|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-03-26|||June 2016||2016-06-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|PROSENZA||PROSENZA: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Enzalutamide|Prospective Multi-centre Study of Prognostic Factors in Castration Resistant PROState Cancer Treated With Enzalutamide|Recruiting||N/A|187|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III|||1||f||||f||||||Samples With DNA|"     Paxgene and tempus tubes on baeline, pre-cycle 3 and progression Tumor paraffine sample at     baseline   "|No||2017-10-10 21:43:39.146799|2017-10-10 21:43:39.146799
NCT02922205|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-30|||November 2016||2016-11-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01|6 Months|Observational [Patient Registry]|||Stapler Post-market Observational Study|Assessing the Safety and Performance of the Endoscopic Linear Cutter Stapler in Laparoscopic Gastric Bypass Surgery.|Not yet recruiting||N/A|100|Anticipated|be Medical|||1||f||||f||||||||No||2017-10-10 21:43:39.343403|2017-10-10 21:43:39.343403
NCT02922192|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-05|||January 2006||2006-01-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|September 2015|Actual|2015-09-01||Observational|||Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis|Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis|Active, not recruiting||N/A|100000|Anticipated|Biologics & Biosimilars Collective Intelligence Consortium|||3||f||||t||||||||Yes|BBCIC Charter requires transparency and publication|2017-10-10 21:43:39.411218|2017-10-10 21:43:39.411218
NCT02922179|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-05|||January 2011||2011-01-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|September 2015|Actual|2015-09-01||Observational|||Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics|Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics|Active, not recruiting||N/A|100000|Anticipated|Biologics & Biosimilars Collective Intelligence Consortium|||2||f||||t||||||||Yes|BBCIC Charter requires transparency and publication|2017-10-10 21:43:39.499964|2017-10-10 21:43:39.499964
NCT02922166|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-02-07|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans|Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Fear and Anxiety in Humans|Recruiting||Phase 1|47|Anticipated|Azevan Pharmaceuticals||2|||f||||t|t|f||||||Yes|Data and samples will be shared with Azevan Pharmaceuticals Inc., its affiliates and research partners working with Azevan Pharmaceuticals Inc.|2017-10-10 21:43:39.571872|2017-10-10 21:43:39.571872
NCT02922153|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-09-14|||June 2016||2016-06-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|FROST||The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)|The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)|Recruiting||N/A|100|Anticipated|AtriCure, Inc.||2|||f||||f||||||||||2017-10-10 21:43:39.648841|2017-10-10 21:43:39.648841
NCT02922140|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-12-12|||September 2015||2015-09-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit|The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit|Active, not recruiting||N/A|40|Anticipated|Ain Shams University||2|||f||||f||||||||Undecided||2017-10-10 21:43:39.754151|2017-10-10 21:43:39.754151
NCT02922127|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-02-06|||December 16, 2016|Actual|2016-12-16|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation|A Prospective, Randomized, Single-blind Study to Compare the Effects of Daily Ulipristal Acetate (UPA) 10mg With a Combined Oral Contraceptive (COC) Pill on Breast Epithelial Cell Proliferation in Reproductive Age Women|Recruiting||Phase 1|45|Anticipated|Columbia University||2|||f||||f|t|f||||||Undecided||2017-10-10 21:43:39.833149|2017-10-10 21:43:39.833149
NCT02922114|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-03|||September 2013||2013-09-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|LUPUS||Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients|Comparison of the Clinical Examination and the Joint Ultrasonography in the Evaluation of Disease Activity in Systemic Lupus Patients|Completed||N/A|152|Actual|Centre Hospitalier Régional d'Orléans||1|||f||||f||||||||No||2017-10-10 21:43:39.925207|2017-10-10 21:43:39.925207
NCT02922101|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|||Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care|Increasing the Effectiveness and Understanding of Audit and Feedback Interventions in Intensive Care: Protocol for a Mixed-methods Study|Recruiting||N/A|30|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||||||||||Yes|The National Intensive Care Evaluation (NICE) foundation has a policy for sharing data among its participating ICUs.|2017-10-10 21:43:40.005769|2017-10-10 21:43:40.005769
NCT02922088|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-07-05|||September 2016||2016-09-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|October 2021|Anticipated|2021-10-01|5 Years|Observational [Patient Registry]|VASC||EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC]|European (EU) Multi-Center Registry to Assess Outcomes in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery: Treatment of Vascular Conduits With DuraGraft®, a Novel Endothelial Damage Inhibitor [VASC]|Recruiting||N/A|3000|Anticipated|Somahlution LLC|||1||f||||f||f||||||||2017-10-10 21:43:40.127995|2017-10-10 21:43:40.127995
NCT02922075|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-29|||February 2013||2013-02-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01||Interventional|||Impact of Soft Tissue Grafts on Tissue Alterations After Immediate Tooth Replacement|Soft and Hard Tissue Stability After Immediate Tooth Replacement With Implant in Fresh Sockets Grafted With Different Soft Tissue Grafts|Completed||Phase 4|24|Actual|São Paulo State University||3|||f||||f||||||||Undecided||2017-10-10 21:43:40.260095|2017-10-10 21:43:40.260095
NCT02922062|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-09-29|||December 2016||2016-12-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effects of Consuming Palm Oil With Different Macronutrient Intakes on Blood Lipids|The Effects of Palm Oil Consumed Under Different Macronutrient Distributions on Circulating Lipoprotein and Fatty Acid Profiles|Not yet recruiting||N/A|24|Anticipated|Ohio State University||2|||f||||f||||||||No|There is no plan to share data with other scientists but participants will be provided with their own individual data when the study is complete.|2017-10-10 21:43:40.388415|2017-10-10 21:43:40.388415
NCT02922049|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-07|||April 2016||2016-04-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||pCLE in the Detection of Esophageal and Gastric Lesions and Intestinal Metaplasia or Dysplasia in Patients After Endoscopic Treatment of BORN|Probe-based Confocal Laser Endomicroscopy in Accurate Histopathologic Diagnosis of Neoplastic Gastrointestinal Lesion|Recruiting||N/A|80|Anticipated|Institute for Clinical and Experimental Medicine||1|||f||||f||||||||Yes||2017-10-10 21:43:40.533938|2017-10-10 21:43:40.533938
NCT02922036|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|SOLVE CRT||Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders and Previously Untreatable Patients|Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders and Previously Untreatable Patients, SOLVE CRT|Not yet recruiting||Phase 3|350|Anticipated|EBR Systems, Inc.||2|||f||||t|f|t|f|f||||||2017-10-10 21:43:40.616874|2017-10-10 21:43:40.616874
NCT02922023|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-09-21|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Management of Uncontrolled Hypertension (HTN)|Management of Uncontrolled Hypertension: Ambulatory Blood Pressure Monitoring and Subsequent Modification of Therapy or Shifting Anti-hypertensive Medication to Night-time Dosing|Recruiting||N/A|25|Anticipated|University of Florida||2|||f||||f|f|t|f|f||||||2017-10-10 21:43:40.686989|2017-10-10 21:43:40.686989
NCT02922010|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-18|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|OHBABY||"A Follow-Up Survey of Oral Hygiene and Health Outcomes for Women Previously Enrolled in OHMOM"|"A Follow-Up Survey of Oral Hygiene and Health Outcomes of Women Enrolled in the OHMOM Clinical Trial at the University of Alabama Birmingham"|Completed||N/A|35|Actual|Procter and Gamble|||1||f||||||||||||||2017-10-10 21:43:40.765983|2017-10-10 21:43:40.765983
NCT02921997|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-14|||November 7, 2016|Actual|2016-11-07|April 5, 2017|2017-04-05|March 17, 2018|Anticipated|2018-03-17|March 28, 2017|Actual|2017-03-28||Interventional|||H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses|A Phase II Study to Evaluate and Compare the Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine Administered With and Without AS03 Adjuvant and Monovalent Inactivated Influenza A/H3N2v Virus Vaccine Administered Without Adjuvant in Healthy Adults Through Standard and Systems Biology Analyses|Active, not recruiting||Phase 2|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f|||||t|f|||f|||||2017-10-10 21:43:40.821085|2017-10-10 21:43:40.821085
NCT02921984|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2016-09-30|||September 2013||2013-09-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors|Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors|Recruiting||Phase 1|20|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||3|||f||||t||||||||No||2017-10-10 21:43:40.911574|2017-10-10 21:43:40.911574
NCT02921958|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-30|||November 2014||2014-11-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Life Participation for Parents as an Outcome Measure|The Life Participation for Parents as an Outcome Measure|Completed||N/A|32|Actual|The University of Texas Medical Branch, Galveston|||1||f||||f||||||||No||2017-10-10 21:43:41.290803|2017-10-10 21:43:41.290803
NCT02921945|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-29|||October 2016||2016-10-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A|A Multi-center, Phase III, Non-controlled, Open-label Trial to Evaluate the Safety and Efficacy of SCT800 for On-demand Treatment in Previously Treated Patients With Hemophilia A|Not yet recruiting||Phase 3|50|Anticipated|Sinocelltech Ltd.||1|||f||||f||||||||No||2017-10-10 21:43:41.386746|2017-10-10 21:43:41.386746
NCT02921932|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-10-05|||March 1, 2017|Actual|2017-03-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||The Impact of Prehabilitation Bundle on Perioperative Outcome for Frail Elderly Patients Undergoing Major Abdominal Surgery|A Randomized Control Trial on the Impact of Prehabilitation Bundle on Perioperative Outcome for Frail Elderly Patients Undergoing Major Abdominal Surgery|Recruiting||N/A|62|Anticipated|Singapore General Hospital||2|||f||||t|f|f||||||||2017-10-10 21:43:41.485635|2017-10-10 21:43:41.485635
NCT02921919|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-09-28|||November 8, 2016|Actual|2016-11-08|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Open-Label Extension and Safety Study of Talazoparib|A Single-arm, Open-label, Multicenter, Extended Treatment, Safety Study In Patients Treated With Talazoparib|Recruiting||Phase 2|150|Anticipated|Pfizer||1|||f||||||||||||||2017-10-10 21:43:41.618322|2017-10-10 21:43:41.618322
NCT02921906|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-07-04|||June 2016||2016-06-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|FoND||Effect of Food Composition on Postprandial Insulin Secretion in Neonatal Diabetes|Assessing the Effect of Food Composition on Postprandial Insulin Secretion in KCNJ11 Neonatal Diabetes (FoND Study)|Recruiting||N/A|30|Anticipated|Royal Devon and Exeter NHS Foundation Trust||3|||f||||f||||||||||2017-10-10 21:43:41.835901|2017-10-10 21:43:41.835901
NCT02921893|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-09|||October 2016||2016-10-01|January 2017|2017-01-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome|Ixazomib, Lenalidomide, and Dexamethasone for Patients With POEMS Syndrome|Recruiting||Phase 2|34|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 21:43:41.995794|2017-10-10 21:43:41.995794
NCT02921880|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-13|||May 2016||2016-05-01|September 2017|2017-09-01|September 13, 2017||2017-09-13|September 1, 2017|Actual|2017-09-01||Interventional|RECOVER-TAVR||Does Cardiac REhabilitation Improve Functional, Independence, Frailty and Emotional outCOmes Following Trans Catheter Aortic ValvE Replacement?|Does Cardiac REhabilitation Improve Functional, Independence, Frailty and Emotional outCOmes Following Trans Catheter Aortic ValvE Replacement?|Completed||N/A|30|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 21:43:42.226822|2017-10-10 21:43:42.226822
NCT02921867|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-09-26|||November 2016||2016-11-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||A Trial on the Effect of Simulation-based Diagnostic Abdominal Ultrasound Training|A Randomized Trial on the Effect of Simulation-based Diagnostic Abdominal Ultrasound Training|Recruiting||N/A|22|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 21:43:42.316979|2017-10-10 21:43:42.316979
NCT02921854|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-10-03|||April 4, 2017|Actual|2017-04-04|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ICD||Detection of Circulating Biomarkers of Immunogenic Cell Death|Detection of Circulating Biomarkers of Immunogenic Cell Death After Radiotherapy and Chemotherapy: An Exploratory Study|Recruiting||N/A|40|Anticipated|Maastricht Radiation Oncology||1|||f||||f|f|f||||||||2017-10-10 21:43:42.435388|2017-10-10 21:43:42.435388
NCT02921841|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-14|||November 2016||2016-11-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|DSTAR||Digital Star: HIV Prevention for Youth in Mental Health Treatment|Digital Star: HIV Prevention for Youth in Mental Health Treatment|Enrolling by invitation||N/A|120|Anticipated|Rhode Island Hospital||2|||f||||t||||||||||2017-10-10 21:43:42.560188|2017-10-10 21:43:42.560188
NCT02921828|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-05-25|||May 21, 2015|Actual|2015-05-21|May 2017|2017-05-01|May 20, 2025|Anticipated|2025-05-20|May 20, 2025|Anticipated|2025-05-20||Observational|||A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg|Pomalyst®Capsules Special Use-results Surveillance (All-case Surveillance)|Active, not recruiting||N/A|1149|Actual|Celgene|||1||f||||f||||||||||2017-10-10 21:43:42.747263|2017-10-10 21:43:42.747263
NCT02921815|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-06-06|||March 3, 2011|Actual|2011-03-03|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment|Revlimid 5 mg Capsules Special Use-results Surveillance of Transformation to Acute Myeloid Leukemia|Active, not recruiting||N/A|84|Actual|Celgene|||1||f||||f||||||||||2017-10-10 21:43:42.827017|2017-10-10 21:43:42.827017
NCT02921802|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-05-26|||July 20, 2010|Actual|2010-07-20|May 2017|2017-05-01|June 19, 2020|Anticipated|2020-06-19|June 19, 2020|Anticipated|2020-06-19||Observational|||A Study of Special Use Results Surveillance of Revlimid 5mg Capsules|Revlimid 5 mg Capsules Special Use-results Surveillance (All-case Surveillance)|Active, not recruiting||N/A|4626|Actual|Celgene|||1||f||||f||||||||||2017-10-10 21:43:42.923644|2017-10-10 21:43:42.923644
NCT02921789|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-09-21|||May 22, 2017|Actual|2017-05-22|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|September 2019|Anticipated|2019-09-01||Interventional|||Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients|A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients|Recruiting||Phase 2|60|Anticipated|Astellas Pharma Inc||2|||f||||t|t|f||||||||2017-10-10 21:43:43.060234|2017-10-10 21:43:43.060234
NCT02921776|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vidatalk Communication Application: Usability, Acceptability and Efficacy Study|Improving Outcomes for Mechanically Ventilated Patients With the Digital EZ Board|Not yet recruiting||N/A|124|Anticipated|Ohio State University||4|||f||||t||||||||No||2017-10-10 21:43:43.24933|2017-10-10 21:43:43.24933
NCT02901275|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-27|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Enhancing Medication-based Analgesia in Humans|Enhancing Medication-based Analgesia in Humans|Recruiting||Phase 2|60|Anticipated|Johns Hopkins University||1|||f||||t||||||||No||2017-10-10 21:48:51.743734|2017-10-10 21:48:51.743734
NCT02921763|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-05-24|||August 2016||2016-08-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|7 Months|Observational [Patient Registry]|||A Survey on Efficacy and Safety in Patients With Endometriosis|Duphaston® Tablets 5 mg - A Survey on Efficacy and Safety in Patients With Endometriosis|Active, not recruiting||N/A|60|Actual|Mylan Inc.|||1||f||||f||||||||Yes||2017-10-10 21:43:43.369547|2017-10-10 21:43:43.369547
NCT02921750|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-08-30|||October 2016|Actual|2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PD-497314||Investigation to Evaluate the Efficacy and Safety of Exufiber Versus Aquacel Extra in Moderately or Strongly Exuding Venous and Mixed Ulcers of Predominantly Venous Origin|A Randomised Multi-centre Non-inferiority Investigation to Evaluate the Efficacy and Safety of Exufiber Versus Aquacel Extra in Moderately or Strongly Exuding Venous and Mixed Ulcers of Predominantly Venous Origin|Recruiting||N/A|212|Anticipated|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-10 21:43:43.503464|2017-10-10 21:43:43.503464
NCT02921737|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)|A Phase II Trial of TAS-102 (Lonsurf) in Patients With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma After Progression Through First Line Chemotherapy|Recruiting||Phase 2|33|Anticipated|University of Florida||1|||f||||t|t|f||||||||2017-10-10 21:43:43.644215|2017-10-10 21:43:43.644215
NCT02921724|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-03|||May 2015||2015-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Participatory Research for Fine-tuning of a 2.0 System to Optimise Home Management of Oral Cancer Therapies.|Participatory Research for Fine-tuning of a 2.0 System to Optimise Home Management of Oral Cancer Therapies.|Recruiting||N/A|80|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||Undecided||2017-10-10 21:43:43.734525|2017-10-10 21:43:43.734525
NCT02921711|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-29|||June 2012||2012-06-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|18 Months|Observational [Patient Registry]|TRAIL||TRAIL: Treatment of Intracranial Aneurysms With LVIS® System|TRAIL: Treatment of Intracranial Aneurysms With LVIS® System|Completed||Phase 4|90|Actual|Microvention-Terumo, Inc.|||1||f||||t||||||||Undecided||2017-10-10 21:43:43.824224|2017-10-10 21:43:43.824224
NCT02921698|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-30|||July 2014||2014-07-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01|12 Months|Observational [Patient Registry]|SAFE||Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment|Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment|Active, not recruiting||N/A|100|Actual|Microvention-Terumo, Inc.|||1||f||||t||||||||||2017-10-10 21:43:43.897676|2017-10-10 21:43:43.897676
NCT02921685|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-16|||October 2016||2016-10-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|May 2018|Anticipated|2018-05-01||Interventional|PIRAT||Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell Transplantation|A Phase 1 Study of MONALIZUMAB (IPH2201), a Humanized Anti CD94/NKG2A Monoclonal Antibody (Mab) Initiated 2 Months After an HLA Matched Allogenic Stem Cell Transplantation (SCT) Prepared With a Reduced Intensity Conditioning|Recruiting||Phase 1|18|Anticipated|Institut Paoli-Calmettes||1|||f||||t||||||||||2017-10-10 21:43:43.956166|2017-10-10 21:43:43.956166
NCT02921672|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-08-11|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline|Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline|Recruiting||N/A|30|Anticipated|University of Kansas Medical Center||3|||f||||f||||||||||2017-10-10 21:43:44.065592|2017-10-10 21:43:44.065592
NCT02921659|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-11-29|||April 2015||2015-04-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults|Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults|Completed||Phase 1/Phase 2|30|Actual|University of Colorado, Boulder||2|||f||||t||||||||No||2017-10-10 21:43:44.171988|2017-10-10 21:43:44.171988
NCT02921646|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-12-01|||January 2017||2017-01-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|EnergiePancrea||Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas Cancer|Monocentric, Prospective Study Assessing the Feasibility to Use Resting Energy Expenditure by Indirect Calorimetry as Prognostic Marker of Tumoral Response to 1st Line Chemotherapy in Patients Suffering From Metastatic Pancreatic Cancer|Not yet recruiting||N/A|20|Anticipated|Center Eugene Marquis||1|||f||||f||||||||No||2017-10-10 21:43:44.254001|2017-10-10 21:43:44.254001
NCT02921633|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-29|||October 2016||2016-10-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Childhood Influenza Immunisation in General Practice Invitation Trial|Can Uptake of Childhood Influenza Immunisation in GP Practices be Increased Through Behavioural-insight Informed Changes to the Invitation Process?|Not yet recruiting||N/A|45134|Anticipated|Public Health England||2|||f||||f||||||||No||2017-10-10 21:43:44.329761|2017-10-10 21:43:44.329761
NCT02921620|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-19|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease|A Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease Patients|Not yet recruiting||Phase 3|38|Anticipated|Protalix||2|||f||||f|t|f||||||Undecided||2017-10-10 21:43:44.431558|2017-10-10 21:43:44.431558
NCT02921607|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-03-14|||September 2016||2016-09-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Development of Scalable New Model(s) Focused on Care Co-ordination and Care Provision for Medically Complex, Co-morbid Chronic Disease Patient Segments Focusing on Heart Failure|Development of Scalable New Model(s) Focused on Care Co-ordination and Care Provision for Medically Complex, Co-morbid Chronic Disease Patient Segments Focusing on Heart Failure|Recruiting||N/A|50|Anticipated|Portsmouth Hospitals NHS Trust|||1||f||||f||||||||Yes|Participant data will be shared in an anonymized form as part of a larger database and in a collaborative fashion.|2017-10-10 21:43:44.510425|2017-10-10 21:43:44.510425
NCT02921594|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties|Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties: A Cross Sectional Pilot Study Evaluating Intraarticular Kinematics and Standing Balance by Dynamic Fluoroscopy and Force Plate Examination|Recruiting||N/A|10|Anticipated|Hvidovre University Hospital||2|||f||||||||||||||2017-10-10 21:43:44.586586|2017-10-10 21:43:44.586586
NCT02921581|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-07|||June 2015||2015-06-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|RIDPAINT||ReIrradiation With FDG-PET Guided Dose Painting|ReIrradiation With FDG-PET Guided Dose Painting for Recurrent and Second Primary Head and Neck Cancer|Recruiting||Phase 1|20|Anticipated|Oslo University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:43:44.667022|2017-10-10 21:43:44.667022
NCT02921568|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-03-13|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes|Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes|Recruiting||N/A|20|Anticipated|Optos, PLC.||1|||f||||||||||||||2017-10-10 21:43:44.747284|2017-10-10 21:43:44.747284
NCT02921555|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-07-21|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|November 15, 2020|Anticipated|2020-11-15|November 2019|Anticipated|2019-11-01||Interventional|CECUM||Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis|Efficacy of High-dose Corticosteroid Pulses Added to Conventional Oral Corticosteroid Course for Moderate Flares of Ulcerative Colitis.|Not yet recruiting||Phase 4|148|Anticipated|Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa||2|||f||||t|f|f|||f|||||2017-10-10 21:43:44.827017|2017-10-10 21:43:44.827017
NCT02921542|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-10-03|||August 2016||2016-08-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|REX||An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies|REX - A Pilot Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies|Recruiting||N/A|60|Anticipated|Spectranetics Corporation|||4||f||||f||||||||||2017-10-10 21:43:44.918118|2017-10-10 21:43:44.918118
NCT02921529|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-07-06|||September 2016||2016-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Enhanced Effect of Acupuncture on Postoperative Recovery After Colon Surgery|Enhanced Effect of Acupuncture on Postoperative Recovery After Colon Surgery: A Multi-center, Randomized, Double-blinded, Controlled Clinical Trial|Recruiting||N/A|100|Anticipated|Fourth Military Medical University||2|||f||||||||||||||2017-10-10 21:43:47.409679|2017-10-10 21:43:47.409679
NCT02921516|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-29|||September 2016||2016-09-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings|Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings|Recruiting||N/A|240|Anticipated|Florida International University||3|||f||||f||||||||No||2017-10-10 21:43:47.519157|2017-10-10 21:43:47.519157
NCT02921503|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-08-29|||June 5, 2017|Actual|2017-06-05|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Topical Corticosteroid App|Impact of a Mobile App on Topical Corticosteroid Prescribing by Family Practitioners|Active, not recruiting||N/A|15|Anticipated|Milton S. Hershey Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:43:47.615452|2017-10-10 21:43:47.615452
NCT02921490|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||FDG PET/MRI Evaluation of Facet Joint Pain|Molecular and Magnetic Resonance Imaging Biomarkers of Facet Joint Pain of the Lumbar Spine With PET/MRI|Recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||f||||||||Undecided||2017-10-10 21:43:47.694213|2017-10-10 21:43:47.694213
NCT02921477|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-30|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias|Open Label Study for the Use of Tyrosine Kinase Inhibitors for Treatment of Cognitive Decline Due to Degenerative Dementias|Enrolling by invitation||Phase 1|20|Anticipated|Neurological Associates of West Los Angeles||1|||f||||f||||||||No||2017-10-10 21:43:47.785328|2017-10-10 21:43:47.785328
NCT02921464|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-09-29|||June 2016||2016-06-01|August 2016|2016-08-01||||May 2018|Anticipated|2018-05-01|1 Year|Observational [Patient Registry]|FCQN||Florida Cardiovascular Quality Network||Recruiting||N/A|4000|Anticipated|Florida Cardiovascular Quality Network|||2||f||||f||||||||No||2017-10-10 21:43:47.883107|2017-10-10 21:43:47.883107
NCT02921451|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-03-24|||August 2016||2016-08-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse|Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse|Recruiting||N/A|40|Anticipated|Michigan Institution of Women's Health PC||1|||f||||f||||||||No||2017-10-10 21:43:47.997817|2017-10-10 21:43:47.997817
NCT02921438|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-08-01|||February 6, 2017|Actual|2017-02-06|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Observational|MAGNET-ACS||VitalScan MCG Rule-out Multi-centre Pivotal Study - UK|A Prospective Multi-centre Observational Study to Evaluate the Diagnostic Accuracy of a Portable Magnetocardiograph Device for Acute Coronary Syndrome (ACS), Focusing on Rule-out Capability, in Patients Who Present to the Emergency Department With Chest Pain Symptoms Consistent With ACS.|Recruiting||N/A|756|Anticipated|Creavo Medical Technologies Ltd|||1||f||||t|f|f||||||||2017-10-10 21:43:48.105374|2017-10-10 21:43:48.105374
NCT02921425|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-01|||January 31, 2015|Actual|2015-01-31|September 2017|2017-09-01|August 31, 2016|Actual|2016-08-31|April 30, 2016|Actual|2016-04-30||Interventional|||Use of Track Health Function of the MyHealthevet Personal Health Record|Use of the Track Health Function of the MyHealtheVet Personal Health Record|Completed||N/A|38|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-10-10 21:43:48.238594|2017-10-10 21:43:48.238594
NCT02921412|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-05-17|||October 1, 2016|Actual|2016-10-01|May 2017|2017-05-01|March 21, 2017|Actual|2017-03-21|February 1, 2017|Actual|2017-02-01||Interventional|||Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses|Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses|Completed||N/A|44|Actual|Coopervision, Inc.||2|||f||||f||||||||No||2017-10-10 21:43:48.337132|2017-10-10 21:43:48.337132
NCT02921048|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2019|Anticipated|2019-09-01||Observational|PISCES||Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults|Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults|Recruiting||N/A|60|Anticipated|U.S. EPA Human Studies Facility|||2||f||||||||||||||2017-10-10 21:43:55.027733|2017-10-10 21:43:55.027733
NCT02921399|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-30|||October 2016||2016-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection for Gastric Neoplasm|Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection|Not yet recruiting||N/A|148|Anticipated|Gangnam Severance Hospital|||2||f||||t||||||||||2017-10-10 21:43:48.615982|2017-10-10 21:43:48.615982
NCT02921386|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-01-30|||October 2016||2016-10-01|January 2017|2017-01-01|January 21, 2017|Actual|2017-01-21|January 21, 2017|Actual|2017-01-21||Interventional|||The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate|A Phase 2 Study of the Effect of Meals With Various Amounts of Fat Given Immediately After Dosing on the Pharmacokinetics of an Oral Testosterone Undecanoate|Completed||Phase 2|18|Actual|Clarus Therapeutics, Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:43:48.681416|2017-10-10 21:43:48.681416
NCT02921373|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-29|||January 2017||2017-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRACK||Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI|A Phase I Study Evaluating the Feasibility of Using Fluorine-19 Cell Sense to Image Human Peripheral Blood Mononuclear Cells In Vivo|Not yet recruiting||Phase 1|12|Anticipated|Western University, Canada||2|||f||||f||||||||No|Only group data will be presented|2017-10-10 21:43:48.789496|2017-10-10 21:43:48.789496
NCT02921360|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-10-03|||August 2016||2016-08-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Early Administration of Aspirin in Patients With Acute Ischemic Stroke Treated With Systemic Thrombolysis|Randomised Controlled Prospective Trial of Early Administration of Aspirin After Systemic Thrombolysis in Acute Ischemic Stroke|Active, not recruiting||N/A|120|Anticipated|City Clinical Hospital No. 67, Moscow, Russia||2|||f||||||||||||||2017-10-10 21:43:48.906873|2017-10-10 21:43:48.906873
NCT02921347|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Switching Between Invasive and Noninvasive Ventilation to Facilitate Weaning in Difficult-weaning Patients|Efficacy and Safety of Switching Between Invasive and Noninvasive Ventilation to Facilitate Weaning in Difficult-weaning Patients: a Randomized Control Trial|Recruiting||N/A|160|Anticipated|Chongqing Medical University||2|||f||||f||||||||Undecided||2017-10-10 21:43:49.00082|2017-10-10 21:43:49.00082
NCT02921334|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Early Tracheotomy for Switching Between Invasive and Noninvasive Ventilation to Facilitate Weaning|Efficacy and Safety of Early Tracheotomy for Switching Between Invasive and Noninvasive Ventilation to Facilitate Weaning: a Randomized Control Trial|Recruiting||N/A|200|Anticipated|Chongqing Medical University||2|||f||||f||||||||Undecided||2017-10-10 21:43:49.098469|2017-10-10 21:43:49.098469
NCT02921321|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-29|||January 2014||2014-01-01|September 2016|2016-09-01|January 2025|Anticipated|2025-01-01|January 2024|Anticipated|2024-01-01||Observational|||Pilot Study of Cardiac MR in Patients With Muscular Dystrophy|Pilot Study of Cardiac Magnetic Resonance in Patients With Muscular Dystrophy|Recruiting||N/A|100|Anticipated|Children's Research Institute|||1||f||||f||||||Samples Without DNA|"     An additional 5cc of blood work will be drawn at the time that the intravascular catheter is     inserted for contrast agent administration for the cardiac MRI scans. This blood will be used     to identify serum biomarkers in myocardial fibrosis, and to validate the potential use for     diagnostic purposes. No genetic testing will be done on these samples. The blood samples will     be identified with the study ID number only, and will be stored in a secure freezer.   "|Yes|The participant will be given the findings of the MRI scan.|2017-10-10 21:43:49.192147|2017-10-10 21:43:49.192147
NCT02921308|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|PICTURE||Pulmonary MRI of Ex-preterm Children With and Without BPD To Understand Risk of Emphysematous Changes|Pulmonary Magnetic Resonance Imaging of Ex-preterm Children With and Without Bronchopulmonary Dysplasia To Understand Risk of Emphysematous Changes (PICTURE)|Not yet recruiting||N/A|40|Anticipated|Children's Hospital of Eastern Ontario|||2||f||||f||||||||||2017-10-10 21:43:49.318577|2017-10-10 21:43:49.318577
NCT02921295|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-06-05|||September 2016||2016-09-01|June 2017|2017-06-01|April 28, 2017|Actual|2017-04-28|April 2017|Actual|2017-04-01||Interventional|||A Comparative Analysis Between College Park Sidekick Feet and Conventional Stubby Prosthesis||Completed||N/A|1|Actual|University of Pittsburgh||2|||f||||||||||||||2017-10-10 21:43:49.457803|2017-10-10 21:43:49.457803
NCT02921282|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-06-16|||August 2016||2016-08-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms|Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms|Recruiting||N/A|30|Anticipated|Centre for Addiction and Mental Health|||2||f||||f||||||Samples With DNA|"     Blood samples will be collected   "|Yes|Data will be shared with collaborators at NIDA-IRP|2017-10-10 21:43:49.530343|2017-10-10 21:43:49.530343
NCT02921269|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-30|2017-09-28|||March 10, 2017|Actual|2017-03-10|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer|A Phase 2 Study of Atezolizumab (MPDL3280A) in Combination With Bevacizumab in Patients With Recurrent, Persistent, or Metastatic Cervical Cancer|Suspended||Phase 2|22|Anticipated|National Cancer Institute (NCI)||1||Scheduled Interim Monitoring|f||||f|t|f||||||||2017-10-10 21:43:49.635207|2017-10-10 21:43:49.635207
NCT02921243|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Schizophrenia and the Gut Microbiome|Schizophrenia and the Gut Microbiome|Not yet recruiting||N/A|20|Anticipated|University of Maryland|||2||f||||f||||||Samples With DNA|"     Metatranscriptomics: Metatranscriptomics analyses provide a snapshot of the expressed genes     in a sample, which allows for mechanistic insights into the microbiome not possible with 16S     rRNA profiling only.   "|No||2017-10-10 21:43:53.247914|2017-10-10 21:43:53.247914
NCT02921230|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-10-02|||October 2016||2016-10-01|October 2017|2017-10-01|May 2021|Anticipated|2021-05-01|June 2019|Anticipated|2019-06-01||Interventional|EMINENT||Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery|A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries|Recruiting||N/A|750|Anticipated|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-10 21:43:53.31485|2017-10-10 21:43:53.31485
NCT02921217|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-09-30|||July 2016||2016-07-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|BIFFAT||Effect of a Probiotic on Visceral Fat Accumulation|Randomized, Parallel, Double Blinded, Placebo-controlled Study for the Evaluation of the Effectiveness on Visceral Fat Accumulation in Individuals With Abdominal Obesity of a Specific Probiotic Compound|Recruiting||Phase 3|129|Anticipated|Biopolis S.L.||3|||f||||f||||||||Undecided||2017-10-10 21:43:53.559322|2017-10-10 21:43:53.559322
NCT02921204|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-30|||August 2015||2015-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|VDAW||Dietary Intake and Vitamin D Level in Adult Women|Study is to Assess the Effect of Dietary Intake of Nutrients and Level of Vitamin D in Women|Completed||N/A|168|Actual|Princess Nourah Bint Abdulrahman University|||1||f||||t||||||||Undecided||2017-10-10 21:43:53.664444|2017-10-10 21:43:53.664444
NCT02921191|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-10-05|||January 2008||2008-01-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|September 2015|Actual|2015-09-01||Observational|||Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated|Descriptive Analysis of First-Cycle Prophylactic Use of G-CSF in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated With High Neutropenia Risk Chemotherapy|Active, not recruiting||N/A|100000|Anticipated|Biologics & Biosimilars Collective Intelligence Consortium|||2||f||||t||||||||Yes|BBCIC Charter requires transparency and publication|2017-10-10 21:43:53.732998|2017-10-10 21:43:53.732998
NCT02921178|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma Patients|Effects of Omalizumab Compared to Non-Omalizumab Treatment in the Propensity- Matched Group on Asthma Exacerbation in Asthma Patients in Korea: a Retrospective Cohort in a Real World|Active, not recruiting||N/A|124|Anticipated|Ajou University School of Medicine|||1||f||||f||||||||Undecided||2017-10-10 21:43:53.954749|2017-10-10 21:43:53.954749
NCT02921165|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-29|||May 2016||2016-05-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of Topical Analgesic With Saline Rinses in Post Extraction Healing|Comparison of Topical Analgesic With Saline Rinses in Post Extraction Healing Among Hypertensive and Non-hypertensive Subjects|Completed||Phase 4|66|Actual|Aga Khan University||3|||f||||f||||||||No||2017-10-10 21:43:54.047108|2017-10-10 21:43:54.047108
NCT02921152|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-09-29|||April 2016||2016-04-01|August 2016|2016-08-01|April 2021|Anticipated|2021-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Bone Marrow Micrometastases in Patients With Early Stage Breast Cancer|Bone Marrow Micrometastases in Patients With Early Stage Breast Cancer|Recruiting||N/A|1000|Anticipated|Acibadem University||1|||f||||f||||||||Undecided||2017-10-10 21:43:54.14194|2017-10-10 21:43:54.14194
NCT02921139|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|TASABR||Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)|Comparing Re-trans-catheter Arterial Chemoembolization Versus Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma Patients Who Had Incomplete Response After Prior TACE (TASABR Trial): a Randomized Controlled Trial|Recruiting||Phase 3|120|Anticipated|Dalin Tzu Chi General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:43:54.233537|2017-10-10 21:43:54.233537
NCT02921126|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-07-13|||April 30, 2017|Actual|2017-04-30|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|RE-FIT||Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy|Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy|Active, not recruiting||N/A|40900|Anticipated|Bristol-Myers Squibb|||3||f||||f||||||||||2017-10-10 21:43:54.364734|2017-10-10 21:43:54.364734
NCT02921113|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-05|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Observational|||suPAR in the Early Diagnosis of Acute Kidney Injury(AKI) After On-Pump Cardiac Surgery|Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Early Diagnosis of Acute Kidney Injury After On-Pump Cardiac Surgery|Completed||N/A|105|Actual|Marmara University|||1||f||||f||||||Samples With DNA|"     plasma(suPAR) plasma(NGAL) urine NGAL serum creatinine plasma Cystatine C   "|||2017-10-10 21:43:54.461811|2017-10-10 21:43:54.461811
NCT02921100|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-29|||January 2015||2015-01-01|September 2016|2016-09-01||||October 2016|Anticipated|2016-10-01||Interventional|||Comparison of DNA Ploidy and Conventional Cytology|A Prospective Comparison of Digital Image Analysis and Routine Cytology for the Identification of Pancreatic Neoplasia in Patient Undergoing EUS-FNA|Active, not recruiting||N/A|150|Anticipated|Changhai Hospital||2|||f||||t||||||||No||2017-10-10 21:43:54.558163|2017-10-10 21:43:54.558163
NCT02921074|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-18|||March 2016||2016-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|STATE||STATE Trial: SusTained Attention Training to Enhance Sleep|STATE Trial: SusTained Attention Training to Enhance Sleep|Recruiting||N/A|24|Anticipated|Posit Science Corporation||2|||f||||||||||||||2017-10-10 21:43:54.777579|2017-10-10 21:43:54.777579
NCT02921061|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-07-10|||November 17, 2016|Actual|2016-11-17|July 2017|2017-07-01||||June 15, 2018|Anticipated|2018-06-15||Interventional|||Decitabine, Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome|"Randomized Phase 1 Study of Sequential (Primed) vs. Concurrent Decitabine in Combination With G-CSF, Cladribine, Cytarabine, and Mitoxantrone (G-CLAM) in Adults With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)"|Recruiting||Phase 1|48|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-10 21:43:54.869877|2017-10-10 21:43:54.869877
NCT02921035|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-05|||June 30, 2016|Actual|2016-06-30|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|June 30, 2018|Anticipated|2018-06-30||Observational|MAIN-MS||Non-interventional Study to Assess Adherence to Treatment for Patients With Relapsing Multiple Sclerosis|A Multicenter, Prospective, Non-interventional Study to Assess Adherence to Treatment for patIeNts With Relapsing Multiple Sclerosis (RMS) Who Are Prescribed Subcutaneous (sc) Interferon Beta-1a|Recruiting||N/A|824|Anticipated|Merck KGaA|||1||f||||f||||||||||2017-10-10 21:43:55.107815|2017-10-10 21:43:55.107815
NCT02921022|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-07-13|||October 2016||2016-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma|Pilot Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma|Recruiting||N/A|56|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 21:43:55.230799|2017-10-10 21:43:55.230799
NCT02921009|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-11-17|||September 2016||2016-09-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||McNeel Eye Center Corneal Crosslinking Study|Study of Effectiveness and Safety of Transepithelial Collagen Cross-linking at Varying Fluence Levels.|Recruiting||N/A|100|Anticipated|McNeel Eye Center||1|||f||||f||||||||Yes|Data will be shared with ophthalmic community|2017-10-10 21:43:55.364173|2017-10-10 21:43:55.364173
NCT02920996|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-08-01|||November 2016||2016-11-01|August 2017|2017-08-01|March 2024|Anticipated|2024-03-01|October 2020|Anticipated|2020-10-01||Interventional|||Merestinib In Non-Small Cell Lung Cancer And Solid Tumors|A Phase II Study of Merestinib in Non-Small Cell Lung Cancers Harboring MET Exon 14 Mutations and Solid Tumors With NTRK Rearrangements|Recruiting||Phase 2|25|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 21:43:55.448092|2017-10-10 21:43:55.448092
NCT02920983|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-03-01|||September 2016||2016-09-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|||A Clinical Comparison of Three Soft Daily Disposable Contact Lenses|A Clinical Comparison of Three Soft Daily Disposable Contact Lenses|Completed||N/A|50|Actual|Coopervision, Inc.||3|||f||||f||||||||No||2017-10-10 21:43:55.545105|2017-10-10 21:43:55.545105
NCT02920944|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-10-02|||July 2016||2016-07-01|October 2017|2017-10-01|October 2017|Actual|2017-10-01|October 2017|Actual|2017-10-01||Interventional|||Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions|Technical Feasibility and Diagnostic Yield of New 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions; Comparison With 22-gauge Procore Needle|Completed||N/A|35|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-10 21:43:55.945529|2017-10-10 21:43:55.945529
NCT02920931|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-01-25|||February 2016||2016-02-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers||Completed||Phase 1|50|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||f||||||||No||2017-10-10 21:43:56.016307|2017-10-10 21:43:56.016307
NCT02920918|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-11-10|||October 2016||2016-10-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Treatment of Diabetes in Patients With Systolic Heart Failure|A Randomized Active-Control Double-Blinded Study to Evaluate the Treatment of Diabetes in Patients With Systolic Heart Failure|Recruiting||Phase 4|88|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||Yes|The investigators plan to present the data promptly upon analysis as an abstract to a national meeting and/or a manuscript.|2017-10-10 21:43:56.093007|2017-10-10 21:43:56.093007
NCT02920905|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-29|||November 2015||2015-11-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Atracurium Mixed With Magnesium Sulfate Versus Atracurium Alone as Adjuvant to Lidocaine in IVRA|Atracurium Mixed With Magnesium Sulfate Versus Atracurium Alone as Adjuvant to Lidocaine in Intravenous Regional Anesthesia|Recruiting||Phase 3|75|Anticipated|Assiut University||3|||f||||f||||||||Undecided||2017-10-10 21:43:56.212184|2017-10-10 21:43:56.212184
NCT02920892|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-11|||August 17, 2017|Actual|2017-08-17|September 2017|2017-09-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||AFQ056 for Language Learning in Children With FXS|Effects of AFQ056 on Language Learning in Young Children With Fragile X Syndrome (FXS)|Recruiting||Phase 2|100|Anticipated|Rush University Medical Center||2|||f||||t|t|f||||||||2017-10-10 21:43:56.324402|2017-10-10 21:43:56.324402
NCT02920879|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-30|||October 2016||2016-10-01|September 2016|2016-09-01||||February 2017|Anticipated|2017-02-01||Interventional|||Airway Effects of PEEP During Anesthesia Induction.|Airway Effects of PEEP During Anesthesia Induction.|Not yet recruiting||N/A|120|Anticipated|Region Örebro County||4|||f||||f||||||||||2017-10-10 21:43:56.434004|2017-10-10 21:43:56.434004
NCT02920866|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-07|||November 1, 2016|Actual|2016-11-01|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||Improving Rehabilitation Outcomes After Total Hip Arthroplasty|Improving Rehabilitation Outcomes After Total Hip Arthroplasty|Recruiting||N/A|100|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:43:56.511924|2017-10-10 21:43:56.511924
NCT02920853|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|August 2020|Anticipated|2020-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Enhanced Biofeedback for Musculoskeletal Pain|Testing the Efficacy of Enhanced Biofeedback on Chronic Musculoskeletal Pain|Recruiting||N/A|60|Anticipated|University of Tulsa||2|||f||||f||||||||No||2017-10-10 21:43:56.639704|2017-10-10 21:43:56.639704
NCT02919930|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-09-27|||February 2015||2015-02-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Interface Selection for Adaptive Servo Ventilation|Interface Selection for Adaptive Servo Ventilation: A Randomized Controlled Study|Recruiting||N/A|15|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 21:44:05.770834|2017-10-10 21:44:05.770834
NCT02920840|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|BOSSFRONT||Brain-oscillation Synchronised Stimulation of the Prefrontal Cortex|Brain-oscillation Synchronised Stimulation of the Prefrontal Cortex: Development and Validation of a Personalized Closed-loop TMS Protocol for the Treatment of Major Depression|Recruiting||N/A|18|Anticipated|University Hospital Tuebingen||3|||f||||f||||||||Undecided||2017-10-10 21:43:56.815165|2017-10-10 21:43:56.815165
NCT02920827|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-05|||August 2009||2009-08-01|September 2017|2017-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring|A Double-Blind, Randomised, Placebo-Controlled Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess Delivery of Dapivirine From the Matrix Vaginal Ring Containing 25 MG of Dapivirine|Completed||Phase 1|16|Actual|International Partnership for Microbicides, Inc.||2|||f||||t||||||||||2017-10-10 21:43:56.941339|2017-10-10 21:43:56.941339
NCT02920814|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-29|||April 2016||2016-04-01|April 2016|2016-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Time Intensive CBT for a Specific Phobia of Vomiting|Time Intensive Cognitive Behavioural Therapy for a Specific Phobia of Vomiting Using a Single Case Experimental Design|Recruiting||Phase 1|8|Anticipated|King's College London||1|||f||||f||||||||No||2017-10-10 21:43:57.04629|2017-10-10 21:43:57.04629
NCT02920801|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-30|||December 2014||2014-12-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients||Completed||Phase 4|31|Actual|Shanghai Zhongshan Hospital||2|||f||||||||||||||2017-10-10 21:43:57.165783|2017-10-10 21:43:57.165783
NCT02920788|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-13|||March 9, 2017|Actual|2017-03-09|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|June 30, 2021|Anticipated|2021-06-30||Interventional|MTAR||Mild TBI Assessment & Rehabilitation|Multi-Level Assessment and Rehabilitation of Combat Mild TBI|Recruiting||N/A|36|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:43:57.274822|2017-10-10 21:43:57.274822
NCT02920775|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28||||||September 2016|2016-09-01||||July 2019|Anticipated|2019-07-01||Observational|||Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics||Enrolling by invitation||N/A|360000|Anticipated|ER/LA Opioid REMS Program Companies (RPC)|||15||f||||||||||||||2017-10-10 21:43:57.397482|2017-10-10 21:43:57.397482
NCT02920762|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28||||||September 2016|2016-09-01||||July 2019|Anticipated|2019-07-01||Observational|||Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers||Enrolling by invitation||N/A|5575834|Anticipated|ER/LA Opioid REMS Program Companies (RPC)|||8||f||||||||||||||2017-10-10 21:43:57.51998|2017-10-10 21:43:57.51998
NCT02920749|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2017-04-08|2016-10-11||September 2014||2014-09-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|SACRP||Study of Anaesthesia Costs and Recovery Profiles|Recovery Profiles and Costs in Sevoflurane and Propofol Based Anaesthesia|Completed||N/A|120|Actual|University of Pecs|This study is restricted to anaesthesia of otorhinolaryngological surgery with controlled hypotension. Therefore, we cannot draw any conclusions related to other surgeries.|4|||f||||t||||||||Yes|Data of primary outcome measures will be made available within one month of study completion|2017-10-10 21:43:57.672745|2017-10-10 21:43:57.672745
NCT02920736|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-29|||January 2016||2016-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Value of Urine sTREM-1 on Early Predicting AKI in Sepsis|Value of Urine sTREM-1 on Early Predicting Secondary Acute Kidney Injury in Sepsis: a Mutilcenter and Prospective Clinical Study|Active, not recruiting||N/A|500|Anticipated|Chinese PLA General Hospital|||3||f||||t||||||Samples With DNA|"     Whole blood and urine   "|No||2017-10-10 21:43:58.797895|2017-10-10 21:43:58.797895
NCT02920723|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-07-25|||July 2016|Actual|2016-07-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|FOLLOW_EXESAS||Follow-up of the Patients Included in the EXESAS Study|Follow-up of the Patients Included in the EXESAS Study : Analysis of the Profit of the Physical Activity for the Control Group and of the Preservation of a Regular Physical Activity for the Group Initially Trained|Enrolling by invitation||N/A|96|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 21:43:58.884513|2017-10-10 21:43:58.884513
NCT02920710|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-29|||October 2016||2016-10-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||ACTHAR Therapy for Central Nervous System Sarcoidosis|ACTHAR Therapy for Central Nervous System Sarcoidosis|Not yet recruiting||N/A|20|Anticipated|The Cleveland Clinic||1|||f||||f||||||||Undecided||2017-10-10 21:43:59.008154|2017-10-10 21:43:59.008154
NCT02920697|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-03-17|||March 2014||2014-03-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|February 2018|Anticipated|2018-02-01||Interventional|||Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma|Phase I Dose-escalation Study of Oral Administration of the Selective Bcl2 Inhibitor S 55746 in Patients With Refractory or Relapsed Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma|Recruiting||Phase 1|120|Anticipated|Servier||2|||f||||f||||||||||2017-10-10 21:43:59.115749|2017-10-10 21:43:59.115749
NCT02920684|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2017-08-01|||December 2016||2016-12-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Haemodynamic and Metabolism Response During Early Rehabilitation in Sedated Patients||Completed||Phase 3|20|Actual|University Hospital, Rouen||4|||f||||f||||||||||2017-10-10 21:43:59.242354|2017-10-10 21:43:59.242354
NCT02920671|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-27|||October 2016||2016-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Muscle OXPHOS and Nutrient Homeostasis|Skeletal Muscle Oxidative Phosphorylation Capacity and Nutrient Homeostasis in Individuals With Primary (Genetic) and Secondary (Obesity-related) Mitochondrial Impairment as Compared to Healthy, Normal-weight Individuals|Recruiting||N/A|45|Anticipated|University of Pennsylvania|||3||f||||f||||||Samples With DNA|"     Blood will be collected as part of this protocol. Results from screening laboratory studies     will be entered into the secure database, and copies will be sent to the participant, as well     as his/her physician if s/he wishes.      De-identified, specimens coded with the participant's ID number will be stored in     anticipation of future studies.      DNA/RNA will be extracted and stored pending future analyses to be specified (e.g., whole     exome or mitochondrial DNA sequencing, gene expression studies). No results of genetic     analyses will be included in the electronic medical record. Participants will not be informed     of results.   "|||2017-10-10 21:43:59.327866|2017-10-10 21:43:59.327866
NCT02920658|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-09-29|||December 2010||2010-12-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||"Topical Non-Aromatic Very Rich in Steranes (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases"|Nonaromatic Naphthalan - Composition Study and Biological Effects on Epithelial Tissues|Completed||Phase 2|57|Actual|University of Zagreb||2|||f||||t||||||||Yes|Yes, de-identified data are available upon request.|2017-10-10 21:43:59.441171|2017-10-10 21:43:59.441171
NCT02920645|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|AVICH||Multicenter Validation of the AVICH Score|Multicenter Validation of the AVICH Score|Enrolling by invitation||N/A|500|Anticipated|University of Zurich|||1||f||||f||||||||No||2017-10-10 21:43:59.541955|2017-10-10 21:43:59.541955
NCT02920632|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-29|||January 2017||2017-01-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|March 2019|Anticipated|2019-03-01||Interventional|cogtips||Cognitive Training in Parkinson Study|COGTIPS (COGnitive Training In Parkinson Study): The Effect of Online Cognitive Training on Cognition and Brain Networks in Parkinson's Disease|Not yet recruiting||N/A|120|Anticipated|VU University Medical Center||2|||f||||f||||||||No||2017-10-10 21:43:59.620532|2017-10-10 21:43:59.620532
NCT02920619|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|ULTRA||The ULTRA Study: Cross-Comparison of Ultrasound Systems|The ULTRA Study: Cross-Comparison of Muscle Composition Measures in Multiple Ultrasound Systems|Recruiting||N/A|30|Anticipated|Washington D.C. Veterans Affairs Medical Center|||1||f||||f||||||||No||2017-10-10 21:43:59.759943|2017-10-10 21:43:59.759943
NCT02920606|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-10-06|||April 2016||2016-04-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pulpotomy as a Treatment of Irreversible Pulpitis|Pulpotomy as a Permanent Treatment of Irreversible Pulpitis on Mature Molar Teeth - a Pilot Study|Enrolling by invitation||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||No||2017-10-10 21:43:59.847812|2017-10-10 21:43:59.847812
NCT02920593|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-10-04|||October 2016||2016-10-01|October 2017|2017-10-01|March 31, 2019|Anticipated|2019-03-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy|A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy|Recruiting||Phase 4|412|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-10-10 21:43:59.911295|2017-10-10 21:43:59.911295
NCT02920580|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-02-03|||February 1, 2017|Actual|2017-02-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|March 2021|Anticipated|2021-03-01||Interventional|NEURO-ETT||The NEUROlogically-impaired Extubation Timing Trial|The NEUROlogically-impaired Extubation Timing Trial|Recruiting||Phase 3|756|Anticipated|Sunnybrook Health Sciences Centre||3|||f||||t||||||||Undecided||2017-10-10 21:44:00.02334|2017-10-10 21:44:00.02334
NCT02920567|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||January 2014||2014-01-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion|Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion and Pancreatic Fistula After Pancreatoduodenectomy|Recruiting||N/A|282|Anticipated|Saint Vincent's Hospital, Korea||2|||f||||f||||||||||2017-10-10 21:44:00.301917|2017-10-10 21:44:00.301917
NCT02920554|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||July 2014||2014-07-01|September 2016|2016-09-01||||June 2023|Anticipated|2023-06-01||Interventional|||The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer|The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer Operation: Prospective Randomized Controlled Trial|Recruiting||N/A|88|Anticipated|Saint Vincent's Hospital, Korea||2|||f||||f||||||||Undecided||2017-10-10 21:44:00.389662|2017-10-10 21:44:00.389662
NCT02920541|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-03-17|||January 2015||2015-01-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome|Phase I Dose-escalation Study of the Orally Administered Selective Bcl-2 Inhibitor S 055746 as Monotherapy for the Treatment of Patients With Acute Myeloid Leukaemia (AML) or High or Very High Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1|80|Anticipated|Servier||1|||f||||f||||||||||2017-10-10 21:44:00.467483|2017-10-10 21:44:00.467483
NCT02920528|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-07-24|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain|Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain: A Randomized Controlled Trial|Recruiting||Phase 3|96|Anticipated|Los Angeles Biomedical Research Institute||3|||f||||t|t|f|||f|||||2017-10-10 21:44:00.555661|2017-10-10 21:44:00.555661
NCT02920515|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-28|||September 2012||2012-09-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty|Multi-site Study of Comprehensive Treatment for Children Precocious Puberty|Completed||Phase 4|740|Actual|Ruijin Hospital||3|||f||||f||||||||Yes||2017-10-10 21:44:00.650912|2017-10-10 21:44:00.650912
NCT02920502|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-07|||June 2013||2013-06-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of a One Time Dose of Cholecalciferol on Serum Concentration of 25-Hydroxyvitamin D and Macrophages|Effect of a One Time Dose of Cholecalciferol on Serum Concentration of 25-Hydroxyvitamin D and Macrophages|Completed||Phase 3|24|Actual|University Hospitals Cleveland Medical Center||4|||f||||f||||||||No||2017-10-10 21:44:00.743007|2017-10-10 21:44:00.743007
NCT02920489|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-15|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Individualized Timing of Analgesia and Effectiveness of Labor Analgesia|Impact of Individualized Timing of Analgesia on the Effectiveness of Labor Analgesia: a Randomized Controlled Trial|Completed||N/A|200|Actual|Peking University First Hospital||2|||f||||t||||||||||2017-10-10 21:44:00.837065|2017-10-10 21:44:00.837065
NCT02920476|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-10-04|||July 19, 2017|Actual|2017-07-19|October 2017|2017-10-01|July 30, 2021|Anticipated|2021-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|||TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003)|A Phase II Trial of TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Carcinoma of the Lung|Recruiting||Phase 2|30|Anticipated|University of Florida||1|||f||||t|t|f|||f|||||2017-10-10 21:44:00.947184|2017-10-10 21:44:00.947184
NCT02920463|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|DIANA||DetermInants of Antimicrobial Use aNd De-escalAtion in Critical Care (DIANA)|DetermInants of Antimicrobial Use aNd De-escalAtion in Critical Care (DIANA Study)|Recruiting||N/A|2500|Anticipated|University Hospital, Ghent|||1||f||||f||||||||Yes|Data will be shared with participating centers only. Data provided by the local investigators are primarily the property of the ICU that collected the data. Local investigators shall have access to their data after they have been entered in the central database.|2017-10-10 21:44:01.136286|2017-10-10 21:44:01.136286
NCT02920450|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-10-04|||September 25, 2017|Actual|2017-09-25|October 2017|2017-10-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)|A Non-Randomized Phase Ib-II Protocol of Paclitaxel, Carboplatin and the Dual PI3K/mTOR Kinase Inhibitor, PF-05212384, for Patients With Advanced, or Metastatic Non-Small Cell Carcinoma of the Lung|Recruiting||Phase 1/Phase 2|41|Anticipated|University of Florida||1|||f||||t|t|f||||||||2017-10-10 21:44:01.26521|2017-10-10 21:44:01.26521
NCT02920437|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-07-11|||October 2016||2016-10-01|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong|A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong|Recruiting||N/A|200|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 21:44:01.380703|2017-10-10 21:44:01.380703
NCT02920424|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-28|||October 2016||2016-10-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus|Not yet recruiting||Phase 1|49|Anticipated|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 21:44:01.474053|2017-10-10 21:44:01.474053
NCT02920411|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-28|||October 2016||2016-10-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|KAOS||Effectiveness of a Combined Dermatological Treatment in Children With Atopic Dermatitis|Estudio Piloto Sobre la Efectividad de la acción Conjunta de Una Crema Corporal y un bálsamo Corporal en niños Con Dermatitis atópica|Not yet recruiting||Phase 4|35|Anticipated|Laboratorios Ordesa||1|||f||||f||||||||No||2017-10-10 21:44:01.57477|2017-10-10 21:44:01.57477
NCT02920398|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-14|||October 4, 2016|Actual|2016-10-04|September 2017|2017-09-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|pathfinder™7||A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A.|This Trial is Conducted in Europe and the United States of America. The Aim of This Trial is to Investigate Single Dose Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A.|Completed||Phase 1|21|Actual|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 21:44:01.698655|2017-10-10 21:44:01.698655
NCT02920385|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-06-26|||October 10, 2016|Actual|2016-10-10|June 2017|2017-06-01|June 16, 2017|Actual|2017-06-16|April 26, 2017|Actual|2017-04-26||Interventional|||A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.|A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects|Completed||Phase 1|45|Anticipated|Novo Nordisk A/S||1|||f||||f|f|f||||||Yes|According to Novo Nordisk disclosure commitment on novonordisk-trials.com|2017-10-10 21:44:01.821279|2017-10-10 21:44:01.821279
NCT02920372|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-10-04|||November 30, 2016|Actual|2016-11-30|October 2017|2017-10-01|September 30, 2017|Actual|2017-09-30|January 17, 2017|Actual|2017-01-17||Interventional|||Generation of Positive Biological Samples to Epoetin for Doping Control.|Generation of Positive Biological Samples to Epoetin for Doping Control.|Completed||Phase 1|2|Actual|Parc de Salut Mar||1|||f|||||f|f||||||||2017-10-10 21:44:01.92087|2017-10-10 21:44:01.92087
NCT02920359|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-10-05|||November 17, 2016|Actual|2016-11-17|October 2017|2017-10-01|September 30, 2017|Actual|2017-09-30|December 13, 2016|Actual|2016-12-13||Interventional|||Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control|Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control|Completed||Phase 1|5|Actual|Parc de Salut Mar||1|||f|||||f|f||||||||2017-10-10 21:44:01.987485|2017-10-10 21:44:01.987485
NCT02920346|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-09-28|||April 2014||2014-04-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor|Heart Sounds at Home: Prospective Maternal Surveillance of SSA Positive Pregnancies Using a Hand-Held Fetal Heart Rate Monitor|Recruiting||N/A|500|Anticipated|University of Colorado, Denver|||1||f||||f||||||||No||2017-10-10 21:44:02.048542|2017-10-10 21:44:02.048542
NCT02920333|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2016-09-28|||September 2015||2015-09-01|July 2015|2015-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy of the Non-invasive Brain Stimulation Techniques for Lower Limb Recovery in Stroke Patients|Efficacy of the Non-invasive Brain Stimulation Techniques for Lower Limb Recovery in Stroke Patients|Unknown status|Not yet recruiting|N/A|45|Anticipated|National University Hospital, Singapore||3|||f||||t||||||||||2017-10-10 21:44:02.14098|2017-10-10 21:44:02.14098
NCT02920320|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-28|||July 2016||2016-07-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|iCompassion||iCompassion: Internet-based Self-help for More Self-compassion|iCompassion: Internet-based Self-help for More Self-compassion|Recruiting||N/A|180|Anticipated|University of Bern||2|||f||||f||||||||No||2017-10-10 21:44:02.254483|2017-10-10 21:44:02.254483
NCT02920307|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-29|||May 2010||2010-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of Laparoscopic Inguinal Hernia Repair|Prospective, Randomized and Controlled Study Comparing Fixation Versus no Fixation of Mesh in Laparoscopic Inguinal Hernia Repair|Completed||N/A|400|Actual|Medical Park Gaziantep Hospital||4|||f||||t||||||||Yes||2017-10-10 21:44:02.358104|2017-10-10 21:44:02.358104
NCT02920294|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|INSIDE||Modulation of Microbial Composition in Ileostomy Patients|Modulation of Small Intestinal Microbial Composition and Activity,Systemic Immune Adaptation and Blood Transcriptional Changes Induced by 2-wks Consumption With 2 Fermented Milk Products;a Randomized,Exploratory,Cross-over,Double Blind,Controlled Study in Ileostomy Patients|Recruiting||N/A|20|Anticipated|Maastricht University Medical Center||3|||f||||f||||||||Yes||2017-10-10 21:44:02.526872|2017-10-10 21:44:02.526872
NCT02920281|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-10-10|||November 2014||2014-11-01|September 2016|2016-09-01||||November 2016|Anticipated|2016-11-01||Interventional|WEAN SLEEP 1||Impact of Sleep Quality on Respiratory Function and Weaning of Mechanical Ventilation||Recruiting||N/A|50|Anticipated|Poitiers University Hospital|||||f||||||||||||||2017-10-10 21:44:02.636137|2017-10-10 21:44:02.636137
NCT02920268|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2016-09-29|||April 2016||2016-04-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|Just in TIME||Just in TIME - Intervention With Dance and Yoga for Girls With Recurrent Abdominal Pain|Just in TIME - Intervention With Dance and Yoga for Girls With Recurrent Abdominal Pain|Recruiting||N/A|160|Anticipated|Region Örebro County||2|||f||||f||||||||No||2017-10-10 21:44:02.724075|2017-10-10 21:44:02.724075
NCT02920255|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-10-03|||October 2016||2016-10-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Comparison of Electronic Calipers to Conventional Calipers and X-ray Measurement of Spinal Tilt|Comparison of Electronic Caliper Measurements of Spinal Tilt to Conventional Caliper and X-ray Measurements of Spinal Tilt|Not yet recruiting||N/A|100|Anticipated|KKT Orthopedic Spine Center|||3||f||||f||||||||No||2017-10-10 21:44:02.816722|2017-10-10 21:44:02.816722
NCT02920242|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-29|2017-09-12|||December 15, 2016|Actual|2016-12-15|September 2017|2017-09-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|||A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.|A Randomized, Double-blind, Parallel Group, Placebo-controlled, Multi-center, Therapeutic Equivalence Study to Compare Rifaximin 200 mg Tablets (Sandoz GmbH) to Xifaxan® 200 mg Tablets (Salix Pharmaceuticals, Inc.) and Placebo in Patients With Travelers' Diarrhea|Terminated||Phase 3|28|Actual|Sandoz||3||Terminated due to low enrollment|f||||f||||||||||2017-10-10 21:44:02.951741|2017-10-10 21:44:02.951741
NCT02920229|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-09-29|||November 2015||2015-11-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|GaPSMA||68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated|68Ga-PSMA, N,N'-Bis(2-hydroxybenzyl)Ethylenediamine-N,N'-Diacetic Acid (HBED)-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated|Recruiting||N/A|67|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||Undecided|undecided|2017-10-10 21:44:03.049208|2017-10-10 21:44:03.049208
NCT02920216|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-12-13|||December 2016||2016-12-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|SALVADS-Fluo||Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area|Pilot Study of Evaluation of the Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area|Recruiting||N/A|10|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 21:44:03.145763|2017-10-10 21:44:03.145763
NCT02920203|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-10-07|||September 2016||2016-09-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|AGEMOS||Genetic Autopsy and Sudden Death|Genetic Autopsy and Sudden Death of Young Subject|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     Heart and spleen tissue (from autopsy)   "|No||2017-10-10 21:44:03.277881|2017-10-10 21:44:03.277881
NCT02920190|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-03|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat|Reduction of Antigen-Lipid-Driven Monoclonal Gammopathies by Targeting Epicardial Fat and Its Lipids Content With Liraglutide: A Glucagon Like Peptide-1 Receptor Analogue (GLP-1RA)|Not yet recruiting||Phase 4|20|Anticipated|University of Miami||1|||f||||f|f|f||||||||2017-10-10 21:44:03.377778|2017-10-10 21:44:03.377778
NCT02920177|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-31|||August 2016||2016-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement|Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement|Recruiting||Phase 4|40|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-10 21:44:03.457011|2017-10-10 21:44:03.457011
NCT02920164|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-29|||April 2012||2012-04-01|September 2016|2016-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|AAAnx||Auricular Acupuncture for Exam Anxiety in Medical Students|Auricular Acupuncture for Exam Anxiety in Medical Students: A Randomized Crossover Investigation|Completed||Phase 2|44|Actual|University Medicine Greifswald||3|||f||||f||||||||Undecided||2017-10-10 21:44:03.543464|2017-10-10 21:44:03.543464
NCT02920151|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-28|||February 2015||2015-02-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|BECA||Effects of Balance Exercises Circuit in Patients With Hip or Knee Arthroplasty|Effects of Balance Exercises Circuit in Patients With Total Hip or Knee Arthroplasty (BECA): A Randomized Clinical Trial|Completed||N/A|65|Actual|Grupo de Estudos e Pesquisas Sobre Atividade Física Para Idosos||2|||f||||f||||||||No||2017-10-10 21:44:03.615753|2017-10-10 21:44:03.615753
NCT02920138|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-28|||January 2014||2014-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||The Effect of PEEP and Intraabdominal Pressure Levels on Cerebral Oxygenation Morbidly Obese.|the Effect of PEEP, ZEEP and Intraabdominal Pressure Levels on Cerebral Oxygenation (rso2) in the Morbidly Obese Undergoing Sleeve Gastrectomy|Completed||N/A|58|Actual|Duzce University|||2||f||||f||||||||No||2017-10-10 21:44:03.68402|2017-10-10 21:44:03.68402
NCT02920125|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-25|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Interventional|SHARP||Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.|A Study to Evaluate the Results of Integrative Treatment (by Including Ayurvedic Capsules Suved & Reimmugen) for Vascular Disease: Namely: Cerebro Vascular Accident - Embolic and Atherosclerotic, CVA, CAD, IHD,DVT,|Completed||Phase 3|96|Actual|Health Solutions, India||2|||f||||t||||||||||2017-10-10 21:44:03.766266|2017-10-10 21:44:03.766266
NCT02920112|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-28|||May 2014||2014-05-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Tele-CBT One Year Following Bariatric Surgery: A Pilot Study|Telephone-Based Cognitive Behavioural Therapy for Bariatric Surgery Patients One Year Following Bariatric Surgery: A Pilot Study|Recruiting||N/A|51|Anticipated|University Health Network, Toronto||1|||f||||f||||||||No|Individual participant data (IPD) will not be shared publicly in order to protect patient confidentiality. Aggregate and anonymous data will be shared in peer-reviewed journal articles and scientific presentations.|2017-10-10 21:44:03.852364|2017-10-10 21:44:03.852364
NCT02920099|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-28|||June 2013||2013-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Adaptation and Validation of a Nutrition Literacy Assessment Instrument|Adaptation and Validation of a Nutrition Literacy Assessment Instrument|Completed||N/A|450|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-10 21:44:03.964074|2017-10-10 21:44:03.964074
NCT02920086|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|IMPACT||Improving Partnerships With Family Members of ICU Patients|Improving Partnerships With Family Members of ICU Patients: The IMPACT Trial|Not yet recruiting||N/A|150|Anticipated|Clinical Evaluation Research Unit at Kingston General Hospital||3|||f||||t||||||||No||2017-10-10 21:44:04.063673|2017-10-10 21:44:04.063673
NCT02920073|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-12-12|||October 2016||2016-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|INT-METAVOSA||Intestinal Metagenome of Undernourished in Patients|Intestinal Metagenome of Undernourished in Patients|Recruiting||N/A|250|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     Stool Samples   "|||2017-10-10 21:44:04.170594|2017-10-10 21:44:04.170594
NCT02920060|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-28|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus|Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus : An Open Randomized Study|Completed||Phase 2|80|Actual|Banaras Hindu University||2|||f||||f||||||||No||2017-10-10 21:44:04.250874|2017-10-10 21:44:04.250874
NCT02920047|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-02-03|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subjects|A Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between a Fixed Dose Combination of Fimasartan/Amlodipine and Co-administration of Fimasartan and Amlodipine in Healthy Male Volunteers|Completed||Phase 1|60|Actual|Boryung Pharmaceutical Co., Ltd||3|||f||||f||||||||No||2017-10-10 21:44:04.330901|2017-10-10 21:44:04.330901
NCT02920034|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-28|||August 2015||2015-08-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|RADIOSOUND||Randomized Comparison of Ultrasound Versus Radiofrequency Denervation in Patients With Therapy Resistant Hypertension|A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients With Therapy Resistant Arterial Hypertension With Large Renal Arteries|Recruiting||N/A|120|Anticipated|University of Leipzig||3|||f||||f||||||||Undecided||2017-10-10 21:44:04.398191|2017-10-10 21:44:04.398191
NCT02920008|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-19|||March 16, 2017|Actual|2017-03-16|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia|A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) Versus Treatment Choice in Adults With Previously Treated Acute Myeloid Leukemia|Recruiting||Phase 3|404|Anticipated|Astex Pharmaceuticals||2|||f||||t|t|f||||||||2017-10-10 21:44:04.772524|2017-10-10 21:44:04.772524
NCT02919995|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-07-27|||February 8, 2017|Actual|2017-02-08|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of RPL554 in Patients With Cystic Fibrosis|A Phase IIa, Randomised, Double Blind, Placebo Controlled, Three Way Crossover Study to Assess the Pharmacokinetics of RPL554 Administered to Adult Patients With Cystic Fibrosis.|Recruiting||Phase 2|10|Anticipated|Verona Pharma plc||3|||f||||f|f|f||||||||2017-10-10 21:44:05.068944|2017-10-10 21:44:05.068944
NCT02919982|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-09|||October 2016||2016-10-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01|1 Day|Observational [Patient Registry]|BOAT-AF||Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation|Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation: A Study of Clinical Characteristics With Insight From Patient and Physician Perspectives|Enrolling by invitation||N/A|1250|Anticipated|Baim Institute for Clinical Research|||1||f||||f||||||||||2017-10-10 21:44:05.169372|2017-10-10 21:44:05.169372
NCT02919969|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-11-23|||September 2016||2016-09-01|November 2016|2016-11-01|March 2024|Anticipated|2024-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Pembrolizumab in Refractory Metastatic Anal Cancer|A Multicenter Phase 2 Clinical Trial of Pembrolizumab in Refractory Metastatic Anal Cancer|Recruiting||Phase 2|32|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:44:05.272115|2017-10-10 21:44:05.272115
NCT02919956|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-29|||April 2016||2016-04-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Cerebral Anatomy, Hemodynamics and Metabolism|Cerebral Anatomy, Hemodynamics and Metabolism In Single Ventricles: Relationship to Neurodevelopment|Recruiting||N/A|150|Anticipated|Children's Hospital of Philadelphia|||5||f||||t||||||||||2017-10-10 21:44:05.505201|2017-10-10 21:44:05.505201
NCT02919943|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-14|||July 2016||2016-07-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Observational Study of Angiographic Coregistered Optical Coherence Tomography in Patients Undergoing PCI|"Impact of Angiographic Coregistered Optical Coherence Tomography-diagnostics on Physicians Decision-making During Percutaneous Coronary Intervention in Patients With Advanced Coronary Artery Disease - the OPTICO-Integration-Trial"|Completed||N/A|50|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||Undecided||2017-10-10 21:44:05.676313|2017-10-10 21:44:05.676313
NCT02919917|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-01-13|||January 2017||2017-01-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Treatment of Post-SCI Hypotension|Treatment of Post-SCI Hypotension: A Randomized Controlled Study of Usual Care Versus Anti Hypotension Therapy|Not yet recruiting||N/A|60|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f||||||||Yes||2017-10-10 21:44:05.878465|2017-10-10 21:44:05.878465
NCT02919904|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-05-11|||July 2015||2015-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT|Feasibility of Using the ARESTM Device to Measure Sleep Parameters in Men With Asymptomatic Prostate Cancer Before as Well as at 3 and 6 Months After Starting Androgen Deprivation Therapy|Recruiting||N/A|25|Anticipated|Vancouver Prostate Centre|||1||f||||f||||||||No||2017-10-10 21:44:06.002818|2017-10-10 21:44:06.002818
NCT02919891|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-04-24|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Relationship of Intra-Epidermal Nerve Fibre Density (IENFD) and Structure to Chronic Post-Mastectomy Pain Syndrome (PMPS)|The Relationship of Intra-epidermal Nerve Fibre Density (IENFD) and Structure to Chronic Post-Mastectomy Pain Syndrome (PMPS)|Recruiting||N/A|100|Anticipated|Royal Infirmary of Edinburgh|||2||f||||f||||||||No||2017-10-10 21:44:06.10663|2017-10-10 21:44:06.10663
NCT02919878|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-09-27|||December 2014||2014-12-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer|Phase II Study of Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced (T3 and T4 or Node Positive) Rectal Adenocarcinoma|Recruiting||Phase 2|25|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||Undecided||2017-10-10 21:44:06.200803|2017-10-10 21:44:06.200803
NCT02919865|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-02-01|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas|Accuracy of MR Perfusion Without and With Gadolinium at 3T in the Diagnosis of Patients With Suspected Recurrent High Grade Gliomas|Not yet recruiting||N/A|50|Anticipated|Ottawa Hospital Research Institute||1|||f||||f|f|t|f|||||Undecided||2017-10-10 21:44:06.318426|2017-10-10 21:44:06.318426
NCT02919852|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|prolapse||Laparoscopic Retrovesical Colpopectinopexia|Laparoscopic Retrovesical Colpopectinopexia in Treatment Pelvic Organ Prolapse|Recruiting||N/A|70|Anticipated|Orel Regional Hospital, Russia||1|||f||||f||||||||Undecided||2017-10-10 21:44:06.403107|2017-10-10 21:44:06.403107
NCT02919839|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Observational|||Measuring and Predicting Glycemic Response to Food in Patients With Type 1 Diabetes|Measuring and Predicting Glycemic Response to Food in Patients With Type 1 Diabetes|Not yet recruiting||N/A|200|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples Without DNA|"     Blood glucose, microbiome   "|Undecided||2017-10-10 21:44:06.493425|2017-10-10 21:44:06.493425
NCT02919826|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-28|||August 2016||2016-08-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Dialectical Behaviour Group Therapy for Adults With Intellectual Disabilities|Adapting and Evaluating Dialectical Behaviour Group Therapy for Adults With Dual Diagnosis (Intellectual Disabilities With Psychiatric Disorder)|Recruiting||N/A|18|Anticipated|Queen's University||2|||f||||f||||||||No||2017-10-10 21:44:06.563193|2017-10-10 21:44:06.563193
NCT02919813|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-28|||January 2016||2016-01-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||M-gCBT for Women With Provoked Localized Vulvodynia|Mindfulness-Based Group Cognitive Behavior Therapy for Women With Provoked Localized Vulvodynia: A Randomized Pilot Study|Recruiting||N/A|48|Anticipated|Oregon Health and Science University||2|||f||||f||||||||No||2017-10-10 21:44:06.656878|2017-10-10 21:44:06.656878
NCT02919800|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-27|||November 2016||2016-11-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male|A Phase 1,Randomized, Single-blind, Placebo-controlled, Single Dose, Dose-escalated Study to Assess the Safety, Pharmacokinetic and Pharmacodynamic Profile of Subcutaneous Administration of a Long-acting Recombinant Factor VIIa in Healthy Adult Males|Not yet recruiting||Phase 1|64|Anticipated|Opko Biologics||2|||f||||t||||||||Undecided||2017-10-10 21:44:06.756105|2017-10-10 21:44:06.756105
NCT02919787|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|October 2022|Anticipated|2022-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Norwegian Pancreatic Cancer Trial (NorPACT) - 1|Norwegian Pancreatic Cancer Trial (NorPACT) - 1: Norwegian Multicentre Un-blinded Phase III Randomized Controlled Trial (RCT) Evaluating the Additional Efficacy of Adding Chemotherapy Prior to Resection of a Pancreatic Head Malignancy to Avoid Early Mortality in Those Ultimately Resected|Recruiting||Phase 2/Phase 3|90|Anticipated|Oslo University Hospital||2|||f||||f||||||||No||2017-10-10 21:44:06.840426|2017-10-10 21:44:06.840426
NCT02919774|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-07-13|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Pomaglumetad Effects on Glutamate Biomarkers|Biomarker Assessment of Pomaglumetad on Glutamate Targets: Proof of Clinical Mechanism of Action (POCM)|Recruiting||Phase 1|100|Anticipated|New York State Psychiatric Institute||3|||f||||t||||||||||2017-10-10 21:44:06.94014|2017-10-10 21:44:06.94014
NCT02919761|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-09-27|||November 2016||2016-11-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis|A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis With Persistently Active Disease|Recruiting||Phase 4|232|Anticipated|Mallinckrodt||3|||f||||f||||||||||2017-10-10 21:44:07.043868|2017-10-10 21:44:07.043868
NCT02919748|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-30|||July 2015||2015-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Choral Singing For the Prevention of Dementia|Choral Singing For the Prevention of Dementia: A Randomized Controlled Trial|Recruiting||N/A|360|Anticipated|National University, Singapore||2|||f||||f||||||||No||2017-10-10 21:44:07.217644|2017-10-10 21:44:07.217644
NCT02919735|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2017-08-30|||October 2016||2016-10-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|ELAN||Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)|A Randomized, Double Blind, Single Center, Controlled Study to Compare the Efficacy, Safety and Tolerability of CG 428 Cutaneous Solution With Placebo on Alopecia in Cancer Female Patients Under Chemotherapy|Recruiting||Phase 2|36|Anticipated|Legacy Healthcare SA||2|||f||||t||||||||||2017-10-10 21:44:07.318457|2017-10-10 21:44:07.318457
NCT02919709|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||November 2013||2013-11-01|September 2016|2016-09-01||||November 2018|Anticipated|2018-11-01||Interventional|ANOPEC 3||Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells|Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:44:07.47566|2017-10-10 21:44:07.47566
NCT02919696|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-01|||August 7, 2017|Actual|2017-08-07|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers|A Phase 1 Study of Abemaciclib in Native Chinese Patients With Advanced and/or Metastatic Cancers|Recruiting||Phase 1|20|Anticipated|Eli Lilly and Company||2|||f||||f|f|f||||||||2017-10-10 21:44:07.54986|2017-10-10 21:44:07.54986
NCT02919683|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-11-12|||November 2016||2016-11-01|November 2016|2016-11-01|April 2024|Anticipated|2024-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity|Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity|Recruiting||Phase 2|40|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-10 21:44:07.641437|2017-10-10 21:44:07.641437
NCT02919670|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-07-18|||October 2016||2016-10-01|July 2017|2017-07-01|April 2024|Anticipated|2024-04-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma|A Randomized Double-Blinded Phase 2 Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma|Recruiting||Phase 2|114|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 21:44:07.848041|2017-10-10 21:44:07.848041
NCT02919657|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-03-23|2016-10-04||June 2016||2016-06-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional||20 Post Op Gastric Bypass patients. 10 men, 10 women. All participants were between the ages of 30-46 years of age. All participants have been post operation from their weight loss surgery for a minimum of 3 months prior to the start of the study and no longer than 12 months at the start of the study.|Absorption Comparison on Equivalency Value of Genepro Gen2|Genepro Gen2 Equivalency Study as Compared to Whey Isolate (1 Tablespoon of Genepro Gen2 and 30g Whey Isolate.|Completed||Phase 4|20|Actual|Musclegen Research, Inc.||2|||f||||t||||||||Yes|10 subjects will be administered genepro for the first 6 weeks of the study and whey protein the last 6 week. The other 10 subjects will be administered whey protein for the first 6 weeks of the study and Genepro Gen2 for the last 6 weeks. Weekly blood draws will be taken from each subject to analyze blood protein levels.|2017-10-10 21:44:07.947605|2017-10-10 21:44:07.947605
NCT02919644|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-07-20|||April 2016||2016-04-01|July 2017|2017-07-01|April 2023|Anticipated|2023-04-01|April 2019|Anticipated|2019-04-01||Interventional|COREVAX-1||Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.|Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer: a Phase II Study|Active, not recruiting||Phase 2|19|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||t||||||||||2017-10-10 21:44:08.197972|2017-10-10 21:44:08.197972
NCT02919631|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||October 2016||2016-10-01|July 2016|2016-07-01||||September 2017|Anticipated|2017-09-01||Interventional|||Triheptanoin in Mc Ardle|The Effect of Triheptanoin in Adults With Mc Ardle Disease (Glycogen Storage Disease Type V)|Not yet recruiting||Phase 2|12|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||||||||||||2017-10-10 21:44:08.275292|2017-10-10 21:44:08.275292
NCT02919618|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-06-09|||July 2016||2016-07-01|June 2017|2017-06-01||||July 2018|Anticipated|2018-07-01||Interventional|ENCORE-VT||Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia|Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia|Recruiting||Phase 1/Phase 2|20|Anticipated|Washington University School of Medicine||1|||f||||t||||||||Yes|Open sharing at the time of publication of results|2017-10-10 21:44:08.345853|2017-10-10 21:44:08.345853
NCT02919605|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-09-28|||January 2014||2014-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis|Efficacy and Safety of Single, Double and Triple Dose Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis: a Pilot Study|Completed||Phase 2|159|Actual|Fundação de Medicina Tropical Dr. Heitor Vieira Dourado||3|||f||||t||||||||No||2017-10-10 21:44:08.433876|2017-10-10 21:44:08.433876
NCT02919592|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-09-19|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|September 1, 2028|Anticipated|2028-09-01|September 1, 2028|Anticipated|2028-09-01||Interventional|Glow||Memory Gel and Shape Combined Cohort|"MemoryShape® and MemoryGel® Breast Implants Post Approval New Enrollment Study (Glow Study)"|Recruiting||N/A|2818|Anticipated|Mentor Worldwide, LLC||5|||f||||f||||||||||2017-10-10 21:44:08.513911|2017-10-10 21:44:08.513911
NCT02919228|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-25|||August 18, 2017|Actual|2017-08-18|September 2017|2017-09-01|July 18, 2021|Anticipated|2021-07-18|July 18, 2021|Anticipated|2021-07-18||Interventional|||Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 4 of 7)|Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach|Recruiting||N/A|50|Anticipated|University of Bern||8|||f||||f|f|f||||||||2017-10-10 21:44:13.486768|2017-10-10 21:44:13.486768
NCT02919579|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-06-22|||October 7, 2016|Actual|2016-10-07|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|DriveSaFe2||A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder|A Placebo- and Active-Controlled Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Subjects With Major Depressive Disorder (DriveSaFe2)|Recruiting||Phase 1|24|Anticipated|Janssen Research & Development, LLC||7|||f||||f||f||||||||2017-10-10 21:44:08.671024|2017-10-10 21:44:08.671024
NCT02919566|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2017-06-21|||October 2016||2016-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:44:08.777104|2017-10-10 21:44:08.777104
NCT02919553|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2017-09-26|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions|Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions|Not yet recruiting||N/A|288|Anticipated|Loma Linda University||2|||f||||f|f|f||||||||2017-10-10 21:44:08.812206|2017-10-10 21:44:08.812206
NCT02919540|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-09|||September 2016||2016-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||"Effect of Kangaroo Mother Care on Premature Infants Physiological Outcomes"|"Effect of Kangaroo Mother Care Approach on Premature Infants' Physiological Outcomes in Jordan"|Active, not recruiting||Early Phase 1|35|Actual|Jordan University of Science and Technology||2|||f||||t||||||||Undecided||2017-10-10 21:44:08.90254|2017-10-10 21:44:08.90254
NCT02919527|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-23|||September 2016||2016-09-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Acute Effects of Foam Rolling on Viscoelastic Tissue Properties and Fascial Sliding|Acute Effects of Foam Rolling on Viscoelastic Tissue Properties and Fascial Sliding: A Randomized, Controlled Crossover Trial|Recruiting||N/A|16|Anticipated|Goethe University||3|||f||||||||||||||2017-10-10 21:44:08.967643|2017-10-10 21:44:08.967643
NCT02919514|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-28|||January 2017||2017-01-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Surfaces on Fall in Elderly|Effects of Physical Training on Hard, Sand and Soft Surfaces on Functional Ability and Incidence of Falls in Elderly With or Without History of Falls|Not yet recruiting||N/A|130|Anticipated|Khon Kaen University||3|||f||||f||||||||No||2017-10-10 21:44:09.039056|2017-10-10 21:44:09.039056
NCT02919501|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-07-05|||September 27, 2016|Actual|2016-09-27|July 2017|2017-07-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|||Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder|Interventional, Randomised, Double-blind, Parallel-group Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder|Completed||Phase 2|55|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-10 21:44:09.097754|2017-10-10 21:44:09.097754
NCT02919488|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-01|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of an Acute Bout of Exercise on High-sugar Meal Induced Endothelial Dysfunction|The Effect of an Acute Bout of Exercise on High-sugar Meal Induced Endothelial Dysfunction|Recruiting||N/A|20|Anticipated|Texas Christian University||2|||f||||f||||||||||2017-10-10 21:44:09.191513|2017-10-10 21:44:09.191513
NCT02919475|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01||||July 2018|Anticipated|2018-07-01||Interventional|MOVE-RA||Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis|A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Efficacy and Safety of JTE-051 Administered for 12 Weeks to Subjects With Active Rheumatoid Arthritis (MOVE-RA)|Recruiting||Phase 2|250|Anticipated|Akros Pharma Inc.||5|||f||||f||||||||||2017-10-10 21:44:11.424322|2017-10-10 21:44:11.424322
NCT02919462|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||March 2016||2016-03-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|HighTySy||Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression|Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression|Recruiting||Phase 2|130|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||Undecided||2017-10-10 21:44:11.536092|2017-10-10 21:44:11.536092
NCT02919449|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-08-03|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Trial of Measles Virotherapy in Combination With Atezolizumab in Patients With Metastatic Non-Small Cell Lung Cancer|Phase 1 Dose Escalation Trial of Intra-Tumoral Injection of Sodium Iodide Simporter (NIS) Measles Virus (Edmonston Strain) in Combination With Atezolizumab in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|42|Anticipated|Vyriad, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:44:11.690911|2017-10-10 21:44:11.690911
NCT02919436|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||March 2016||2016-03-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|DRIPS||Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery|Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery|Recruiting||Phase 4|500|Anticipated|Maine Medical Center||2|||f||||t||||||||Yes|Final results will be submitted to peer-reviewed journal for potential publication.|2017-10-10 21:44:11.773018|2017-10-10 21:44:11.773018
NCT02919423|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||December 2016||2016-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TMSINS02||TMS Modulation of Insula-related Brain Networks.02|TMS Modulation of Insula-related Brain Networks.02|Not yet recruiting||N/A|60|Anticipated|Duke University||4|||f||||f||||||||No||2017-10-10 21:44:11.865094|2017-10-10 21:44:11.865094
NCT02919410|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-28|||October 2014||2014-10-01|September 2016|2016-09-01||||May 2016|Actual|2016-05-01||Interventional|||Bacterial Colonization With and Without Iodophor-impregnated Adhesive Drapes in Hip Surgery: a Prospective, Randomized Trial||Completed||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-10 21:44:11.940586|2017-10-10 21:44:11.940586
NCT02919397|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-27|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes|Effectiveness of Integrating Motivational Instant Messaging Into an E-diabetes Prevention Programme in People at High Risk of Type 2 Diabetes: a Prospective, Parallel-group, Randomised Controlled Trial (Diabetes Stopwatch)|Not yet recruiting||N/A|200|Anticipated|King's College London||2|||f||||f||||||||Undecided||2017-10-10 21:44:12.026359|2017-10-10 21:44:12.026359
NCT02919384|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-03-16|||September 2016||2016-09-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|February 2017|Actual|2017-02-01||Interventional|LO2||Evaluation of the Impact of Reduced Oxygen Concentration on Embryonic Development|Evaluation of the Impact of Reduced Oxygen Concentration on Embryonic Development|Active, not recruiting||N/A|60|Actual|Reproductive Medicine Associates of New Jersey||2|||f||||f||||||||No||2017-10-10 21:44:12.110908|2017-10-10 21:44:12.110908
NCT02919371|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-09-27|||December 2014||2014-12-01|February 2016|2016-02-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)|Phase I/II Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)|Recruiting||Phase 1/Phase 2|77|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||f||||||||No|No- unless the data are so encouraging then this can be done|2017-10-10 21:44:12.202052|2017-10-10 21:44:12.202052
NCT02919358|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-07-26|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Music and Feeding in NICU|The Mozart Effect and the Assessment of Weight Gain and Development of Feeding Skills in the NICU.|Recruiting||N/A|40|Anticipated|Christiana Care Health Services||2|||f||||f||||||||||2017-10-10 21:44:12.410745|2017-10-10 21:44:12.410745
NCT02919345|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-28|||January 2017||2017-01-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|ADDENDA||Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery|Comparative Study of Dapagliflozin Versus Glibenclamide Effect on Endothelial Function of Coronary Artery Disease Patients|Not yet recruiting||Phase 4|98|Anticipated|University of Campinas, Brazil||2|||f||||f||||||||Yes||2017-10-10 21:44:12.504536|2017-10-10 21:44:12.504536
NCT02919319|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-08-24|||February 1, 2015|Actual|2015-02-01|August 2017|2017-08-01|May 1, 2015|Actual|2015-05-01|May 1, 2015|Actual|2015-05-01||Interventional|||A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects|Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, Pharmacodynamics, Absolute Bioavailability, Mass Balance, and Metabolism of ACT-541468 in Healthy Male Subjects|Completed||Phase 1|40|Actual|Actelion||5|||f||||||||||||||2017-10-10 21:44:12.72809|2017-10-10 21:44:12.72809
NCT02919306|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-11|||September 16, 2016|Actual|2016-09-16|September 2017|2017-09-01|September 18, 2018|Anticipated|2018-09-18|September 7, 2018|Anticipated|2018-09-07||Interventional|||Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults|A Combined Phase 1/2a, Exploratory Study of a Therapeutic Vaccine Using an Adenovirus Type 26 Vector Prime and Modified Vaccinia Ankara Boost Combination With Mosaic Inserts in HIV-1 Infected Adults Who Initiated Antiretroviral Treatment During Acute HIV Infection|Recruiting||Phase 1/Phase 2|27|Anticipated|Janssen Vaccines & Prevention B.V.||2|||f||||t||f||||||||2017-10-10 21:44:12.846508|2017-10-10 21:44:12.846508
NCT02919293|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||August 2016||2016-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age|Immunogenicity and Safety of Adjuvant and Adjuvant-Free Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age|Recruiting||Phase 1/Phase 2|360|Anticipated|Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-10 21:44:12.95035|2017-10-10 21:44:12.95035
NCT02919280|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-04-20|||September 2016||2016-09-01|April 2017|2017-04-01|September 2026|Anticipated|2026-09-01|September 2026|Anticipated|2026-09-01||Observational|D2K||Dallas 2K: A Natural History Study of Depression|Dallas 2K: A Natural History Study of Depression|Recruiting||N/A|2000|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples With DNA|"     One of the aims of this study is to establish a Dallas 2K biospecimen resource consisting of     blood, plasma, serum, PBMCs, DNA, RNA, saliva and urine samples collected from subjects at     baseline and at follow-up visits, as a platform for translational research into biochemical     and molecular characterization of depression.   "|Yes||2017-10-10 21:44:13.047133|2017-10-10 21:44:13.047133
NCT02919267|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01||||January 2017|Anticipated|2017-01-01||Interventional|PLC-OLV||Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms|Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms|Not yet recruiting||N/A|40|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 21:44:13.148751|2017-10-10 21:44:13.148751
NCT02919254|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-05-03|||August 2016||2016-08-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Beetroot Juice Doses and Anaerobic Performance|Evaluation of Various Doses of Beetroot Juice on Anaerobic Performance|Active, not recruiting||N/A|13|Actual|University of Manitoba||3|||f||||f||||||||No||2017-10-10 21:44:13.266673|2017-10-10 21:44:13.266673
NCT02919241|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-28|||August 2016||2016-08-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Diagnostic Interview and One-session Cognitive Therapy in Treatment of Dental Fear|An Application of Treatment Regarding a Diagnostic Interview and One-session Cognitive Behavioural Therapy - Effectiveness in Treatment of Dental Fear|Recruiting||N/A|30|Anticipated|University of Eastern Finland||2|||f||||f||||||||Undecided|It has been planned to use same data later in a follow-up study|2017-10-10 21:44:13.377209|2017-10-10 21:44:13.377209
NCT02918851|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-01-25|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?|VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?|Recruiting||Phase 4|30|Anticipated|Stony Brook University||3|||f||||f|t|f|||f|||No||2017-10-10 21:44:16.434515|2017-10-10 21:44:16.434515
NCT02919215|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-27|||January 2017||2017-01-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|June 2017|Anticipated|2017-06-01||Interventional|TeacherHelp||Teacher Help for Children and Youth With Mental Health Disorders|Teacher Help: Novel Technologies for Meeting the Immediate Needs of Youth With Mental Health Disorders in Canada|Not yet recruiting||N/A|550|Anticipated|IWK Health Centre||2|||f||||t||||||||No|There is no plan to make individual participant data available. The team will engage in usual end-of-study knowledge translation, such as presenting at local, national and international conferences, as well as preparing manuscripts for high-impact open journals. We will also prepare a number of social media products (e.g., webinars) that share the results of the study. We will include the voices of our end-users in these materials; however, they will not be identified.|2017-10-10 21:44:13.612268|2017-10-10 21:44:13.612268
NCT02919202|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-02|||October 26, 2016|Actual|2016-10-26|May 2017|2017-05-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Interventional|||Clinical Trial to Compare the Efficacy of a Fluoride Gel and a Dental Bonding Agent in Treatment of Tooth Sensitivity|A Randomised Controlled Trial Investigating a Comparison of Fluoride Varnish vs Self-Etching Dentine Bonding Agent in the Reduction of Cervical Dentine Sensitivity in Patients Attending a General Dental Practice in West Sussex, UK.|Completed||N/A|26|Actual|University of Kent||2|||f||||f||||||||No||2017-10-10 21:44:13.698782|2017-10-10 21:44:13.698782
NCT02919189|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-28|||September 1, 2018|Anticipated|2018-09-01|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 5 of 7)|Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach|Not yet recruiting||N/A|50|Anticipated|University of Bern||8|||f||||f|f|f||||||||2017-10-10 21:44:13.778712|2017-10-10 21:44:13.778712
NCT02919176|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-05-24|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Brown Fat Activation Study|The Activation of Brown and Beige Fat and Role in Insulin Sensitivity|Recruiting||Early Phase 1|75|Anticipated|University of Kentucky||3|||f||||f||||||||No||2017-10-10 21:44:13.88889|2017-10-10 21:44:13.88889
NCT02919163|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-28|||September 1, 2018|Anticipated|2018-09-01|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 6 of 7)|Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach|Not yet recruiting||N/A|50|Anticipated|University of Bern||8|||f||||f|f|f||||||||2017-10-10 21:44:13.992558|2017-10-10 21:44:13.992558
NCT02919150|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-02|||October 2016||2016-10-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Myotonometric Measurement of Myofascial Trigger Points: Reliability, Validity and Sensitivity|Myotonometric Measurement of Myofascial Trigger Points: Reliability, Validity and Sensitivity|Not yet recruiting||N/A|40|Anticipated|University of Castilla-La Mancha|||1||f||||t||||||||Yes||2017-10-10 21:44:14.103729|2017-10-10 21:44:14.103729
NCT02919137|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-28|||September 1, 2018|Anticipated|2018-09-01|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|July 31, 2021|Anticipated|2021-07-31||Interventional|||Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 7 of 7)|Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach|Not yet recruiting||N/A|50|Anticipated|University of Bern||8|||f||||f|f|f||||||||2017-10-10 21:44:14.166184|2017-10-10 21:44:14.166184
NCT02919124|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Epicardial Echocardiography of Coronary Anastomoses Using the Echoclip Device|During Coronary Artery Bypass Surgery. A Feasibility Study.|Not yet recruiting||N/A|100|Anticipated|Aalborg Universitetshospital||1|||f||||t||||||||Yes|Individual participant data are available for Monitor|2017-10-10 21:44:14.383568|2017-10-10 21:44:14.383568
NCT02919111|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|PSMA PreRP||Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients|Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients|Recruiting||Phase 2/Phase 3|150|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 21:44:14.472669|2017-10-10 21:44:14.472669
NCT02919098|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-12|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||In-School Evaluation of Bystander: A Game-Based Intervention for Sexual Violence Prevention|In-School Evaluation of Bystander: A Game-Based Intervention for Sexual Violence Prevention|Recruiting||N/A|1200|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 21:44:14.572556|2017-10-10 21:44:14.572556
NCT02919085|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-06-02|||December 2016||2016-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Critical Patients Mobilization on Respiratory and Peripheral Muscle Strength and Functional Capacity.|Effect of Spontaneously Breathing Critical Patients Mobilization on Respiratory and Peripheral Muscle Strength and Functional Capacity.|Recruiting||N/A|40|Anticipated|Universidade Federal de Pernambuco||1|||f||||||||||||||2017-10-10 21:44:14.675416|2017-10-10 21:44:14.675416
NCT02919072|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-27|||October 2016||2016-10-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Chloroprocaine 3% - Epidural|Comparison of Epidural Chloroprocaine 3% and Ropivacaine 0.75% for Unplanned Caesarean Section in Labouring Women Who Have an Epidural Catheter in Situ|Not yet recruiting||Phase 3|60|Anticipated|Sintetica SA||2|||f||||f||||||||Yes||2017-10-10 21:44:14.768406|2017-10-10 21:44:14.768406
NCT02919059|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-03-28|||December 13, 2016|Actual|2016-12-13|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.|A Randomized, Unicenter, Parallel Study of the Effect of Dapagliflozin on Central Blood Pressure Reduction Compared to Glimepiride in Adult Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control.|Recruiting||Phase 4|159|Anticipated|IInstituto Gallego de Medicina Vascular||2|||f||||f||||||||No||2017-10-10 21:44:14.880251|2017-10-10 21:44:14.880251
NCT02919046|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-03-13|||September 2016||2016-09-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children|Single Arm and Multicenter Clinical Trial to Evaluating the Efficacy and Safety of the Chimeric Antigen Receptor T Cell Immunotherapy (CAR-T) for Relapsed or Refractory Neuroblastoma in Children|Recruiting||N/A|22|Anticipated|Sinobioway Cell Therapy Co., Ltd.||1|||f||||f||||||||No||2017-10-10 21:44:14.977755|2017-10-10 21:44:14.977755
NCT02919033|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Compare the Effects of Telemedicine Approach With Usual Care in Hypertension Management in China|A Coordinated PCP-Cardiologist Telemedicine Model (PCTM) in China's Community Hypertension Care: Study Protocol for a Randomized Controlled Trial|Recruiting||N/A|330|Anticipated|Shanghai Chest Hospital||3|||f||||f||||||||No||2017-10-10 21:44:15.088965|2017-10-10 21:44:15.088965
NCT02919020|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|PNF||Efficacy of Proprioceptive Neuromuscular Facilitation in Older Women With Gonarthrosis|Efficacy of Proprioceptive Neuromuscular Facilitation About Functional Performance, Pain and Quality of Life in Older Women With Gonarthrosis: Randomized Controlled Trial|Not yet recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||No||2017-10-10 21:44:15.224169|2017-10-10 21:44:15.224169
NCT02919007|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-27|||December 2015||2015-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Silk'n HST Device Usability and Self Selection Study|Clinical Evaluation of Silk'n HST Self-selection, Labeling Comprehension, and Device Use|Completed||N/A|25|Actual|Home Skinovations Ltd.||1|||f||||f||||||||No||2017-10-10 21:44:15.312436|2017-10-10 21:44:15.312436
NCT02918994|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-07-28|||September 2016||2016-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||LearningRx Cognitive Training for TBI|LearningRx Cognitive Training for Traumatic Brain Injury (TBI): A Multiple Baseline Study Across Cases|Active, not recruiting||N/A|3|Actual|Gibson Institute of Cognitive Research||1|||f||||f||||||||||2017-10-10 21:44:15.374432|2017-10-10 21:44:15.374432
NCT02918981|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-05-01|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Nutritional Strategies to Augment the Postprandial Muscle Protein Synthetic Response to the Ingestion of a Low Dose of Protein in Middle-aged Women||Recruiting||N/A|60|Anticipated|University of Illinois at Urbana-Champaign||5|||f||||t||||||||No||2017-10-10 21:44:15.461174|2017-10-10 21:44:15.461174
NCT02918968|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-25|||November 2, 2016|Actual|2016-11-02|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer|A Randomized Phase IV Study Comparing Enzalutamide Versus Flutamide in CRPC Patients Who Have Failed Combined Androgen Blockade Therapy With Bicalutamide Plus ADT|Recruiting||Phase 4|200|Anticipated|Astellas Pharma Inc||2|||f||||f|t|f|||t|||||2017-10-10 21:44:15.559478|2017-10-10 21:44:15.559478
NCT02918955|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01|June 2022|Anticipated|2022-06-01|March 2020|Anticipated|2020-03-01||Interventional|UPFRONT-NECK||Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection|Definitive Chemo-Radiotherapy With or Without Up-front Neck Dissection for Regionally Advanced Head and Neck Squamous Cell Carcinoma: A Phase III Multi-center Prospective Randomized Controlled Trial With Two Additional Observational Cohorts|Recruiting||Phase 3|182|Anticipated|University Hospital Inselspital, Berne||4|||f||||t||||||||No||2017-10-10 21:44:15.747256|2017-10-10 21:44:15.747256
NCT02918942|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||September 2016||2016-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:44:15.859296|2017-10-10 21:44:15.859296
NCT02918929|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-16|||September 2016||2016-09-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD|A Randomized, Double-Blind, Placebo-Controlled, First-In-Human Study of Orally Administered EDP-305 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses (SAD), Multiple Ascending Doses (MAD) and the Effect of Food on EDP-305 Pharmacokinetics in Healthy Subjects, and of Multiple Ascending Doses (MAD) in Subjects With Presumptive NAFLD|Completed||Phase 1|146|Actual|Enanta Pharmaceuticals||4|||f||||f||||||||||2017-10-10 21:44:15.91172|2017-10-10 21:44:15.91172
NCT02918916|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||January 2017||2017-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phototherapy Applied During Combined Training|Effect of Phototherapy Applied During Combined Training on Performance and Post-exercise Recovery: Study Protocol of a Randomized Controlled Trial by Stratified Sample, Double-blind, Placebo-controlled|Not yet recruiting||N/A|45|Anticipated|São Paulo State University||3|||f||||t||||||||No||2017-10-10 21:44:16.013491|2017-10-10 21:44:16.013491
NCT02918903|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||December 2016||2016-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Pulp Symptoms After Minimal Caries Removal in Treatment of Deep Caries|Evaluation of Pulpal Symptoms Following Minimal Caries Removal Technique in Comparison to Complete Caries Removal in Molars With Deep Caries|Not yet recruiting||N/A|52|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:44:16.093251|2017-10-10 21:44:16.093251
NCT02918890|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-04|||September 2014||2014-09-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|August 2020|Anticipated|2020-08-01||Interventional|||Intensive Unimanual (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegia|Intensive Unimanual (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegia|Recruiting||N/A|82|Anticipated|Teachers College, Columbia University||2|||f||||f||||||||||2017-10-10 21:44:16.163753|2017-10-10 21:44:16.163753
NCT02918877|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-06-09|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|APLICS||Anesthetics to Prevent Lung Injury in Cardiac Surgery|Anesthetics to Prevent Lung Injury in Cardiac Surgery|Recruiting||Phase 1/Phase 2|45|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|t|f|||f|||No||2017-10-10 21:44:16.249606|2017-10-10 21:44:16.249606
NCT02918864|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-01-20|||August 2016||2016-08-01|November 2016|2016-11-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|ION-ASD||Oxytocin and Social Cognitive Skills Groups|Integrated Oxytocin and Nonverbal, Emotion Recognition, and Theory of Mind Training for Children With Autism Spectrum Disorder|Recruiting||Phase 2|60|Anticipated|Rush University Medical Center||2|||f||||t||||||||Yes|Data from this study may be submitted to the National Database for Autism Research (NDAR), a computer system run by the National Institutes of Health that allows researchers studying autism to collect and share information. Data will be shared with study collaborators as well.|2017-10-10 21:44:16.344971|2017-10-10 21:44:16.344971
NCT02918838|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-04-12|||August 2016||2016-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|SATA||Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing|Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing|Active, not recruiting||N/A|216|Actual|RAND||3|||f||||f||||||||Undecided||2017-10-10 21:44:16.510838|2017-10-10 21:44:16.510838
NCT02918825|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia|A Randomized Trial to Compare the Efficiency and Side Effect Between Olanzapine and Long-acting Paliperidone Palmitate Injection in Schizophrenia|Recruiting||N/A|100|Anticipated|Beijing HuiLongGuan Hospital||2|||f||||t||||||||Yes||2017-10-10 21:44:16.592569|2017-10-10 21:44:16.592569
NCT02918812|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Intracervical Lidocaine Versus Intramuscular Diclofenac for Pain Relief in HSG in a Tertiary Hospital in Kano|The Effect of Intracervical Lidocaine Versus Intramuscular Diclofenac for Pain Relief During Hysterosalpingography Among Infertile Women In A Tertiary Hospital In Kano: A Randomized Controlled Trial|Recruiting||Phase 4|140|Anticipated|Bayer University Kano, Nigeria||2|||f||||f||||||||Undecided||2017-10-10 21:44:16.80633|2017-10-10 21:44:16.80633
NCT02918799|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-27|||October 2016||2016-10-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pilot of Mpowerment for Young Men Who Have Sex With Men (YMSM) in Beirut|Pilot of Culturally Tailored Mpowerment for HIV Prevention Among YMSM in Beirut|Not yet recruiting||N/A|400|Anticipated|RAND||2|||f||||f||||||||No||2017-10-10 21:44:16.912671|2017-10-10 21:44:16.912671
NCT02918786|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-27|||February 2016||2016-02-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||The Efficacy of the Whisperflow CPAP System Versus Nasal High Flow in Patients at High Risk for Postextubation Failure|The Efficacy of the Whisperflow CPAP System Versus High Flow Nasal Cannula Oxygen Therapy in Patients at High Risk for Postextubation Failure|Recruiting||N/A|140|Anticipated|Ramathibodi Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:44:16.985561|2017-10-10 21:44:16.985561
NCT02918773|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-28|2017-09-08|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|April 15, 2017|Actual|2017-04-15|April 15, 2017|Actual|2017-04-15||Interventional|||Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto)|Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto)|Completed||N/A|22|Actual|Emory University||2|||f||||f||||||||||2017-10-10 21:44:17.091349|2017-10-10 21:44:17.091349
NCT02918760|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||March 2016||2016-03-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Interventional|||Oral Gabapentin in Management of Chronic Pelvic Pain in Females: A Randomised Placebo-controlled Study.|Oral Gabapentin in Management of Chronic Pelvic Pain in Females: A Randomised Placebo-controlled Study.|Recruiting||Phase 3|64|Anticipated|Ain Shams University||2|||f||||t||||||||Undecided||2017-10-10 21:44:17.204634|2017-10-10 21:44:17.204634
NCT02918747|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|||PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage|P-Gemoxd Regimen Followed by Radiotherapy Versus P-CHOP Regimen Followed by Radiotherapy in ENKTL With Early Stage: a Randomized, Multicenter, Open-label, Phase 3 Study|Recruiting||Phase 3|186|Anticipated|Hunan Cancer Hospital||2|||f||||f||||||||No||2017-10-10 21:44:17.304795|2017-10-10 21:44:17.304795
NCT02918734|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-09-27|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|October 2027|Anticipated|2027-10-01|October 2027|Anticipated|2027-10-01||Interventional|||Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction. Endobutton vs Metal Interference Screws|A Prospective Randomized Controlled Trial Comparing the Endobutton CL BTB Fixation System With Metal Interference Screws in the Femoral Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction.|Recruiting||N/A|220|Anticipated|St. Olavs Hospital||2|||f||||f||||||||||2017-10-10 21:44:17.438155|2017-10-10 21:44:17.438155
NCT02918721|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-06-07|||February 8, 2017|Actual|2017-02-08|June 2017|2017-06-01|May 11, 2017|Actual|2017-05-11|April 27, 2017|Actual|2017-04-27||Interventional|||Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds|A Randomised, Multi-center, Subject and Evaluator-blinded Study Comparing Pain and Safety Profile Associated With Correction of Moderate to Severe Nasolabial Folds Using Restylane With and Without Addition of 0.3% Lidocaine Hydrochloride|Completed||N/A|70|Actual|Q-Med AB||2|||f||||f|f|f||||||No||2017-10-10 21:44:17.559132|2017-10-10 21:44:17.559132
NCT02918708|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-30|||July 2017|Anticipated|2017-07-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|PINC||Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants|Assessment of Antibody Responses in UK Infants Given Two Doses of 10 or 13 Valent Pneumococcal Conjugate Vaccine (PCV) in Infancy and PCV13 in the Second Year of Life (Study Code: Pneumococcal in New Combinations (PINC))|Withdrawn||Phase 4|0|Actual|Public Health England||2||funding channel amended by UK department of health|f||||f|f|f||||||No||2017-10-10 21:44:17.639672|2017-10-10 21:44:17.639672
NCT02918682|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-28|||December 2016||2016-12-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|MIF||A Multi-component Intervention in Frail Community-dwelling Older People|The Effects of a Multi-component Intervention on the Functional Capacity, Upper and Lower-body Muscle Strength, Balance and Gait in Frail Community-dwelling Older People: a Randomized Clinical Trial|Not yet recruiting||Early Phase 1|102|Anticipated|University of Sao Paulo||2|||f||||f||||||||Yes|After the end of the protocol and the data evaluation, the results will be send to each participant.|2017-10-10 21:44:17.935218|2017-10-10 21:44:17.935218
NCT02918474|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-01|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Decision Making Tool for Contralateral Prophylactic Mastectomy|Decision Making Tool for Contralateral Prophylactic Mastectomy|Recruiting||N/A|10|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|f||||||||2017-10-10 21:44:19.806304|2017-10-10 21:44:19.806304
NCT02918669|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-02-02|||April 2016||2016-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Investigate the Long Term Survivorship of Coflex|Study to Investigate the Long Term Survivorship of Coflex CT Study: Sub-Analysis of 24 Month Spinous Process Fractures Via Post-60 Month CT Scan|Active, not recruiting||N/A|12|Actual|Paradigm Spine||1|||f||||f||||||||No||2017-10-10 21:44:18.038813|2017-10-10 21:44:18.038813
NCT02918656|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-12-18|||October 2016||2016-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Presenting Summary Information From Cochrane Systematic Reviews|Presenting Summary Information From Cochrane Systematic Reviews: Randomized Controlled Trial of Infographics Presentation vs. Standard Word Summaries|Completed||N/A|171|Actual|University Hospital of Split||3|||f||||f||||||||No|Data will be collected electronically, using the SurveyMonkey platform. The data will be fully anonymous and will be kept on a secure server of the School of Medicine.|2017-10-10 21:44:18.124172|2017-10-10 21:44:18.124172
NCT02918643|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-28|||August 2016||2016-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Using a Mobile Application as a Support at the Prescription of Appropriate Medications for Elderly|Development and Evaluation of the Use of a Mobile Application as a Support at the Prescription of Appropriate Medications for Elderly|Active, not recruiting||N/A|30|Anticipated|Federal University of Bahia||2|||f||||f||||||||No||2017-10-10 21:44:18.212823|2017-10-10 21:44:18.212823
NCT02918630|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-27|||October 2016||2016-10-01|September 2016|2016-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia|E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia|Not yet recruiting||N/A|20|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 21:44:18.285807|2017-10-10 21:44:18.285807
NCT02918617|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-03-28|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream|Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream|Completed||Phase 2|225|Actual|The University of Texas Health Science Center at San Antonio||9|||f||||f||||||||No||2017-10-10 21:44:18.383729|2017-10-10 21:44:18.383729
NCT02918604|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-27|||January 2015||2015-01-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||Pediatric Veins Cannulation Technique|Peripheral Veins Cannulation in Children Using Veinsite: a Randomized Clinical Trial|Completed||N/A|80|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||f||||||||Undecided||2017-10-10 21:44:18.498258|2017-10-10 21:44:18.498258
NCT02918578|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-28|||August 2016||2016-08-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Tailored Multicomponent Intervention for Remote Physical Activity Promotion in Inactive Adults|Tailored Multicomponent Intervention for Remote Physical Activity Promotion in Inactive Adults|Recruiting||N/A|300|Anticipated|University of Basel||3|||f||||t||||||||No||2017-10-10 21:44:18.645311|2017-10-10 21:44:18.645311
NCT02918565|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|MATCH||Mechanisms for Alcohol Treatment Change [MATCH] Study|Mechanisms for Alcohol Treatment Change [MATCH] Study|Recruiting||N/A|1875|Anticipated|University of Pittsburgh||5|||f||||t||||||||Yes|De-identified dataset provided upon request|2017-10-10 21:44:18.745839|2017-10-10 21:44:18.745839
NCT02918552|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-07-24|||April 3, 2017|Actual|2017-04-03|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|ONOH||Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction|Nitrite Benefits to Mediate Fatigability in Older HFpEF Patients|Recruiting||Phase 2|18|Anticipated|University of Pittsburgh||2|||f||||f|t|f||||||||2017-10-10 21:44:18.838889|2017-10-10 21:44:18.838889
NCT02918539|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-08-21|||October 2016||2016-10-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|2 Years|Observational [Patient Registry]|RAmP||Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials|Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials|Recruiting||N/A|2000|Anticipated|Avid Radiopharmaceuticals|||1||f||||f||||||||||2017-10-10 21:44:18.983791|2017-10-10 21:44:18.983791
NCT02918526|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-28|||October 2016||2016-10-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Hemodynamic Study With PRAM of the Cardiovascular Response to the Positioning of the Extraglottic Device|Hemodynamic Study With Pressure Recording Analytical Method (PRAM) of the Cardiovascular Response to the Positioning of the Extraglottic Device in Gynecological Surgery|Not yet recruiting||N/A|94|Anticipated|Azienda Ospedaliero-Universitaria Careggi||2|||f||||t||||||||Yes||2017-10-10 21:44:19.323342|2017-10-10 21:44:19.323342
NCT02918513|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-09-12|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)|WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)|Enrolling by invitation||N/A|150|Anticipated|University of Texas at Austin||1|||f||||f||||||||||2017-10-10 21:44:19.411075|2017-10-10 21:44:19.411075
NCT02918500|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Effect of Pre-op NRT on Peri-operative Complications and Long-term Abstinence: A Pilot Trial in Patients Undergoing CABG Surgery|Effect of Pre-operative Nicotine Replacement Therapy on Peri-operative Complications and Long-term Abstinence: A Pilot Placebo-controlled Trial in Patients Undergoing Coronary Artery Bypass Surgery (CABG)|Not yet recruiting||Phase 4|60|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f|f|f||||||||2017-10-10 21:44:19.514507|2017-10-10 21:44:19.514507
NCT02918487|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-06-11|||December 2016||2016-12-01|June 2017|2017-06-01|December 30, 2017|Anticipated|2017-12-30|December 5, 2017|Anticipated|2017-12-05||Interventional|||Role of Herbs in the Management of Asthma|Role of Breathe Free® in the Management of Bronchial Asthma- A Randomized Placebo Controlled Trial|Recruiting||N/A|120|Anticipated|Organic India||2|||f||||t||||||||Undecided||2017-10-10 21:44:19.602526|2017-10-10 21:44:19.602526
NCT02918461|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-08-23|||January 10, 2017|Actual|2017-01-10|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Emerging From the Haze for Gynecologic Cancer Survivors|A Pilot Study of Emerging From the Haze Evaluating a Trainee-taught Psycho-educational Program to Improve Cancer-related Cognitive Complaints in Gynecologic Cancer Survivors|Active, not recruiting||N/A|11|Actual|Cedars-Sinai Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:44:19.89601|2017-10-10 21:44:19.89601
NCT02918448|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-26|||March 2015||2015-03-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|||Resistance Training and Metabolic Syndrome|A Resistance Training Program Decreases the Risk of Metabolic Syndrome and Inflammatory Biomarkers in Older Adult Women: A Randomized Controlled Trial|Completed||Phase 2|53|Actual|Universidade Estadual de Londrina||2|||f||||f||||||||No||2017-10-10 21:44:19.970431|2017-10-10 21:44:19.970431
NCT02918422|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-09-26|||September 2015||2015-09-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption|Controlled Feeding Study to Show Effects of Manipulating Carbohydrate and Cheese on Health Markers In Individuals With Metabolic Syndrome|Recruiting||N/A|30|Anticipated|Ohio State University||4|||f||||f||||||||Yes|Final results will be published via peer-review process.|2017-10-10 21:44:20.174433|2017-10-10 21:44:20.174433
NCT02918409|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-09-26|||August 2016||2016-08-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|May 2019|Anticipated|2019-05-01||Interventional|||IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy|IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy|Recruiting||Phase 4|270|Anticipated|National Jewish Health||3|||f||||t||||||||Undecided||2017-10-10 21:44:20.273718|2017-10-10 21:44:20.273718
NCT02918396|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-01-03|||April 2016||2016-04-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SIMPle-AF||The Substrate and Intervention Mechanisms for Persistent Atrial Fibrillation Trial|The Substrate and Intervention Mechanisms for Persistent Atrial Fibrillation (SIMPle AF) Trial|Terminated||N/A|5|Actual|Johns Hopkins University||3||Due to low enrollment of participants meeting eligibility criteria|f||||f||||||||No||2017-10-10 21:44:20.380122|2017-10-10 21:44:20.380122
NCT02918383|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-22|||June 2016||2016-06-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ICG||Subchondral Perfusion Mapping Using Indocyanin Green Laser|Differential Subchondral Perfusion Mapping Using Indocyanin Green Laser Angiography|Recruiting||N/A|30|Anticipated|Loma Linda University||1|||f||||t|f|f|||f|||||2017-10-10 21:44:20.499319|2017-10-10 21:44:20.499319
NCT02918370|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-03-23|||November 2016||2016-11-01|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Aripiprazole for Bipolar Disorder and Alcohol Use Disorder|Aripiprazole for Bipolar Disorder and Alcohol Use Disorder|Recruiting||Phase 3|132|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-10 21:44:20.578465|2017-10-10 21:44:20.578465
NCT02918357|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|PSMA BCR||Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence|Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence|Recruiting||Phase 2/Phase 3|375|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 21:44:20.690802|2017-10-10 21:44:20.690802
NCT02918344|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies|Prospective Study: Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies|Not yet recruiting||N/A|192|Anticipated|Universitair Ziekenhuis Brussel|||2||f||||f||||||Samples Without DNA|"     microbiological smear in case of infection   "|No||2017-10-10 21:44:20.798987|2017-10-10 21:44:20.798987
NCT02918331|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-17|||September 27, 2016|Actual|2016-09-27|August 2017|2017-08-01|April 15, 2020|Anticipated|2020-04-15|April 15, 2020|Anticipated|2020-04-15||Interventional|||A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation|A Phase 1b Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone (DRd) in Japanese Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation|Recruiting||Phase 1|6|Anticipated|Janssen Pharmaceutical K.K.||1|||f||||f||f||||||||2017-10-10 21:44:20.910722|2017-10-10 21:44:20.910722
NCT02918318|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-22|||December 13, 2016|Actual|2016-12-13|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression|A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Subjects With Treatment Resistant Depression|Recruiting||Phase 2|183|Anticipated|Janssen Pharmaceutical K.K.||4|||f||||f||f||||||||2017-10-10 21:44:21.039738|2017-10-10 21:44:21.039738
NCT02918305|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-29|||June 2016||2016-06-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|REQUIRE||Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension|A Clinical Study of the Ultrasound Renal Denervation System in Patients With Resistant Hypertension|Recruiting||Phase 3|140|Anticipated|JIMRO Co., Ltd.||2|||f||||||||||||||2017-10-10 21:44:21.281144|2017-10-10 21:44:21.281144
NCT02918292|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-29|||May 19, 2017|Actual|2017-05-19|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|CHAMP||Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)|Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (CHAMP) (BMT CTN #1502)|Recruiting||Phase 2|60|Anticipated|Medical College of Wisconsin||2|||f||||t|t|f|||f|||||2017-10-10 21:44:21.464245|2017-10-10 21:44:21.464245
NCT02918279|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-18|||September 29, 2016|Actual|2016-09-29|August 2017|2017-08-01|August 8, 2019|Anticipated|2019-08-08|February 7, 2019|Anticipated|2019-02-07||Interventional|||Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity|Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity. 56-week, Double-blind, Randomised, Parallel-group, Placebo-controlled Multi-national Trial Followed by a 26-week Period Off Study-drug|Recruiting||Phase 3|228|Anticipated|Novo Nordisk A/S||2|||f||||t||||||||||2017-10-10 21:44:21.740672|2017-10-10 21:44:21.740672
NCT02918266|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-02|||December 5, 2016||2016-12-05|May 2017|2017-05-01|October 13, 2017|Anticipated|2017-10-13|October 13, 2017|Anticipated|2017-10-13||Interventional|||TAK-071 Scopolamine-Induced Cognitive Impairment Study|A Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, 5-Period Crossover, Phase 1b Study To Evaluate The Effects Of Single Oral Administration of TAK-071 On Scopolamine-Induced Cognitive Impairment In Healthy Subjects|Recruiting||Phase 1|46|Anticipated|Takeda||11|||f||||f||||||||||2017-10-10 21:44:21.919936|2017-10-10 21:44:21.919936
NCT02918253|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-03-23|||October 2016||2016-10-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||HDR Focal: Feasibility Study|HDR Monotherapy for Prostate Cancer: A Feasibility Study of Focal Radiotherapy Yields|Recruiting||N/A|30|Anticipated|University Health Network, Toronto||2|||f||||t||||||||No||2017-10-10 21:44:22.103634|2017-10-10 21:44:22.103634
NCT02918240|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||How Often Should We See Our Orthodontic Patients|The Effect of Different Appointment Intervals on Treatment Time in Patients Receiving Orthodontic Treatment With Fixed Appliances|Recruiting||N/A|100|Anticipated|King's College London||4|||f||||||||||||||2017-10-10 21:44:22.197302|2017-10-10 21:44:22.197302
NCT02918227|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|EMMECH||Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia|Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia|Recruiting||N/A|30|Anticipated|University Hospital, Limoges||1|||f||||f||||||||No||2017-10-10 21:44:22.311856|2017-10-10 21:44:22.311856
NCT02918214|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-03-16|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|PRODIASYS2||Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock|Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock|Recruiting||N/A|440|Anticipated|University Hospital, Limoges|||1||f||||f||||||||No||2017-10-10 21:44:22.43971|2017-10-10 21:44:22.43971
NCT02918201|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-13|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||The Effect of Topical Tranexamic Acid on Postoperative Bleeding and Effusions From Superficial Wounds|The Effect of Topical Application of Tranexamic Acid on Postoperative Bleeding and Wound Effusions in Patients Undergoing Tangential Skin Excision|Not yet recruiting||Phase 4|17|Anticipated|St. Olavs Hospital||2|||f||||t|f|f||||||||2017-10-10 21:44:23.311481|2017-10-10 21:44:23.311481
NCT02918188|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-03-27|||January 2016||2016-01-01|March 2017|2017-03-01|January 2031|Anticipated|2031-01-01|January 2026|Anticipated|2026-01-01||Interventional|||Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD|Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent Chronic Graft-versus-host-disease|Recruiting||Phase 2|100|Anticipated|Navy General Hospital, Beijing||1|||f||||f||||||||Undecided||2017-10-10 21:44:23.423339|2017-10-10 21:44:23.423339
NCT02918175|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-25|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Interventional|TARGET-HFDM||Mobile Health Behavioral Intervention in Patients With Heart Failure and Diabetes Mellitus|Technology to Improve Drug Adherence and Reinforce Guideline Based Exercise Targets in Patients With Heart Failure and Diabetes Mellitus (TARGET-HFDM)|Recruiting||N/A|200|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 21:44:23.562478|2017-10-10 21:44:23.562478
NCT02918162|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-04-18|||January 25, 2017|Actual|2017-01-25|April 2017|2017-04-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Perioperative Chemo and Pembrolizumab in Gastric Cancer|A Phase II Study of Chemotherapy and Immune Checkpoint Blockade With Pembrolizumab in the Perioperative and Maintenance Treatment of Locoregional Gastric or GE Junction Adenocarcinoma.|Recruiting||Phase 2|40|Anticipated|Columbia University||1|||f||||t|t|f||||||Undecided||2017-10-10 21:44:23.681324|2017-10-10 21:44:23.681324
NCT02918149|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-29|||September 2016||2016-09-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Ultrasound Assisted Lumbar Puncture in the Neonate|A Randomized Controlled Trial of Ultrasound-Assisted Versus Traditional Landmark Lumbar Puncture in the Neonatal and Infant Population|Recruiting||N/A|190|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 21:44:23.793701|2017-10-10 21:44:23.793701
NCT02918136|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-06-14|||December 2016||2016-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy Adipose-Derived Stem Cell Injection Partial Thickness Rotator Cuff Tears|Safety and Efficacy of Adult Adipose-Derived Stem Cell Injections Into Partial Thickness Rotator Cuff Tears|Active, not recruiting||Phase 1|18|Anticipated|InGeneron, Inc.||2|||f||||t||||||||No||2017-10-10 21:44:23.917588|2017-10-10 21:44:23.917588
NCT02918123|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-01|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|||Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis|Phase 1 Clinical Trial to Evaluate the Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis.|Not yet recruiting||Phase 1|9|Anticipated|Kang Stem Biotech Co., Ltd.||1|||f|||||f|f||||||||2017-10-10 21:44:24.02432|2017-10-10 21:44:24.02432
NCT02918110|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Vaginal Misodel® in Comparison With Orally Administrated Misoprostol (Cytotec®) at Induction of Labour|Vaginal Misodel® in Comparison With Orally Administrated Misoprostol (Cytotec®) at Induction of Labour|Recruiting||Phase 4|320|Anticipated|Karolinska Institutet||2|||f||||f||||||||No||2017-10-10 21:44:24.113516|2017-10-10 21:44:24.113516
NCT02918097|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-26|||May 2010||2010-05-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional|||Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode|Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode|Completed||Phase 4|78|Actual|Federal University of Rio Grande do Sul||1|||f||||t||||||||No||2017-10-10 21:44:24.198048|2017-10-10 21:44:24.198048
NCT02918084|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-27|||June 2013||2013-06-01|September 2016|2016-09-01|June 2028|Anticipated|2028-06-01|June 2028|Anticipated|2028-06-01||Interventional|GIM10-CONSENT||CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer|A Phase III Study Comparing the Concurrent Versus the Sequential Administration of Chemotherapy and Aromatase Inhibitors, as Adjuvant Treatment of Post-menopausal Patients With Endocrine-responsive Early Breast Cancer.|Recruiting||Phase 3|1000|Anticipated|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||2|||f||||f||||||||No||2017-10-10 21:44:24.315692|2017-10-10 21:44:24.315692
NCT02918071|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-19|||November 10, 2016|Actual|2016-11-10|September 2017|2017-09-01|August 21, 2017|Actual|2017-08-21|August 21, 2017|Actual|2017-08-21||Interventional|GRECO||Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home|A Multicenter, Open-Label, Functionality, Reliability and Performance Study of a Single-Use Auto-Injector With Home-administered Subcutaneous Benralizumab in Adult Patients With Severe Asthma (GRECO)|Completed||Phase 3|121|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 21:44:24.905895|2017-10-10 21:44:24.905895
NCT02918058|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-02-10|||September 2016||2016-09-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Reducing Post-discharge Potentially Inappropriate Medications Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention|Reducing Post-discharge Potentially Inappropriate Medications Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention|Recruiting||N/A|480|Anticipated|McGill University Health Center||3|||f||||t||||||||No||2017-10-10 21:44:25.120107|2017-10-10 21:44:25.120107
NCT02918045|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-05-03|||April 11, 2017|Actual|2017-04-11|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|DUALex||Dental Extractions in Patients Under Dual Antiplatelet Therapy|Dental Extractions in Patients Under Dual Antiplatelet Therapy: Comparison of Two Local Hemostatic Techniques|Recruiting||N/A|60|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|t|f|f|t|||Undecided||2017-10-10 21:44:25.274364|2017-10-10 21:44:25.274364
NCT02918032|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-10-04|||January 2014||2014-01-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|December 2018|Anticipated|2018-12-01||Observational|||International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases|International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases|Recruiting||N/A|100|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||f||||||||||2017-10-10 21:44:25.422124|2017-10-10 21:44:25.422124
NCT02918019|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-19|||September 20, 2016|Actual|2016-09-20|September 2017|2017-09-01|September 19, 2019|Anticipated|2019-09-19|September 19, 2019|Anticipated|2019-09-19||Interventional|||A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma|A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma|Recruiting||Phase 2|500|Anticipated|Hoffmann-La Roche||4|||f||||t||||||||||2017-10-10 21:44:25.691019|2017-10-10 21:44:25.691019
NCT02918006|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-26|||August 2016||2016-08-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine|Phase 2 Randomized, Controlled, Human Influenza A (H1N1) Challenge Study Following Administration of an Oral H1N1 HA Adenoviral-Vector Based Seasonal Influenza Vaccine and dsRNA Adjuvant to Healthy Adult Volunteers|Recruiting||Phase 2|180|Anticipated|Vaxart||3|||f||||f||||||||Undecided||2017-10-10 21:44:26.213821|2017-10-10 21:44:26.213821
NCT02917993|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-07-14|||November 2016||2016-11-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|January 2019|Anticipated|2019-01-01||Interventional|||An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer|An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|57|Anticipated|Incyte Corporation||1|||f||||f||||||||||2017-10-10 21:44:26.339391|2017-10-10 21:44:26.339391
NCT02917980|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||January 2016||2016-01-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|1 Year|Observational [Patient Registry]|||Surgery and Transcatheter Intervention for Structural Heart Diseases|Multicenter Registry Study of Surgery and Transcatheter Intervention for Structural Heart Diseases|Recruiting||N/A|10000|Anticipated|Xijing Hospital|||3||f||||f||||||||Yes||2017-10-10 21:44:26.567057|2017-10-10 21:44:26.567057
NCT02917967|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||A Pilot Study of the Effect of Botulinum Toxin Type a (Dysport®, Abobotulinum Toxin A) Injection on Changes in Musculotendinous Length and Dynamics of Hamstring Muscles During Gait in Children With Spastic Cerebral Palsy Walking With Excessive Knee Flexion||Not yet recruiting||N/A|32|Anticipated|Yonsei University||1|||f||||f||||||||No||2017-10-10 21:44:26.656542|2017-10-10 21:44:26.656542
NCT02917954|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-08-29|||May 4, 2017|Actual|2017-05-04|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Electronic Patient Reported Outcome (ePRO) Mobile Application Pragmatic Trial|Full Evaluation, Scale and Spread: Pragmatic Trial of the HSPRN-Bridgepoint Electronic Patient Reported Outcome (ePRO) Mobile Application to Support the Needs of Persons With Complex Chronic Disease and Disability|Recruiting||N/A|480|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f|f|f||||||||2017-10-10 21:44:26.75504|2017-10-10 21:44:26.75504
NCT02917941|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-09-28|||September 23, 2016|Actual|2016-09-23|September 2017|2017-09-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||A Phase 2, Open-Label, Multicenter Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Patients With Relapsed and/or Refractory Multiple Myeloma|A Phase 2, Open-Label, Multicenter Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Patients With Relapsed and/or Refractory Multiple Myeloma|Active, not recruiting||Phase 2|34|Actual|Takeda||1|||f||||f|f|f||||||||2017-10-10 21:44:26.869537|2017-10-10 21:44:26.869537
NCT02917928|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-04-28|||October 2016||2016-10-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health|The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health in Patients With Prediabetes and Type 2 Diabetes: a Randomsied, Double-blinded, Placebo-controlled Trial|Recruiting||Phase 2|50|Anticipated|Monash University||2|||f||||t||||||||No||2017-10-10 21:44:26.97325|2017-10-10 21:44:26.97325
NCT02917915|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-09-07|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|CoNSPiRE||The CaNadian Standardized Pulmonary Rehabilitation Efficacy Trial|The CaNadian Standardized Pulmonary Rehabilitation Efficacy Trial|Recruiting||N/A|200|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 21:44:27.114134|2017-10-10 21:44:27.114134
NCT02917902|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-26|||January 2015||2015-01-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Assessing Health Outcomes in Low-income Diabetics Who Receive Monthly Boxes of Healthy Food at Clinic|Impact of Food Distribution at Low-income Clinics on Health Outcomes of Patients With Diabetes|Completed||N/A|201|Actual|University of California, San Diego||2|||f||||f||||||||Undecided||2017-10-10 21:44:27.210749|2017-10-10 21:44:27.210749
NCT02917889|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-28|||February 2015||2015-02-01|September 2016|2016-09-01||||August 2016|Actual|2016-08-01||Interventional|||Acute Caffeine Effects on Cardiac Autonomic and Cardiorespiratory Parameters Responses After Aerobic Exercise|Acute Caffeine Effects on Cardiac Autonomic and Cardiorespiratory Parameters Responses After Aerobic Exercise|Active, not recruiting||N/A|35|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||||||||||||2017-10-10 21:44:27.290372|2017-10-10 21:44:27.290372
NCT02917876|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Observational|DE-SAP||Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy|Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy|Recruiting||N/A|450|Anticipated|The Miriam Hospital|||1||f||||f||||||Samples With DNA|"     Blood samples will be stored for future testing   "|Yes|Presentations at national and international scientific meetings, and publications in scientific journals.|2017-10-10 21:44:27.373566|2017-10-10 21:44:27.373566
NCT02917863|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-26|||May 2016||2016-05-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism|Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism|Recruiting||Phase 4|70|Anticipated|Meyer Children's Hospital||2|||f||||f||||||||No||2017-10-10 21:44:27.442337|2017-10-10 21:44:27.442337
NCT02917850|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-08-22|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|ISOKINETIC||Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients|Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients|Recruiting||N/A|40|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 21:44:27.530759|2017-10-10 21:44:27.530759
NCT02917837|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-27|||January 2017||2017-01-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Effect of Diagnostic Imaging Utilization Reports|Effect of a Diagnostic Imaging Utilization Report on Family Physician Ordering Practices in the Eastern Health Regional Health Authority, Newfoundland and Labrador|Not yet recruiting||N/A|100|Anticipated|Memorial University of Newfoundland||2|||f||||f||||||||||2017-10-10 21:44:27.608709|2017-10-10 21:44:27.608709
NCT02917824|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-26|||May 2016||2016-05-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Intensity, Specificity and Reversibility of Inspiratory Muscle Training in Asthmatics|Intensity, Specificity and Reversibility of Inspiratory Muscle Training in Asthmatics: a Randomized Clinical Trial|Recruiting||N/A|36|Anticipated|Universidade Federal do Rio Grande do Norte||2|||f||||||||||||||2017-10-10 21:44:27.666885|2017-10-10 21:44:27.666885
NCT02917811|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-03-29|||January 2016||2016-01-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|||Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU||Completed||N/A|250|Actual|Università degli Studi di Ferrara|||1||f||||||||||||||2017-10-10 21:44:27.72513|2017-10-10 21:44:27.72513
NCT02917798|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-09-26|||July 12, 2016|Actual|2016-07-12|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes|Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes|Recruiting||N/A|200|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     Blood   "|||2017-10-10 21:44:27.776072|2017-10-10 21:44:27.776072
NCT02917785|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-11-23|||October 2016||2016-10-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Testing the Efficiency of Karman Curette in the Treatment of Misoprostol Failure in Women With Missed Abortion||Recruiting||N/A|60|Anticipated|Meir Medical Center||2|||f||||||||||||||2017-10-10 21:44:29.888225|2017-10-10 21:44:29.888225
NCT02917772|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-05-31|||October 2016||2016-10-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|April 2018|Anticipated|2018-04-01||Interventional|TITAN-RCC||Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma|A Phase II Single Arm Clinical Trial of a Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma|Recruiting||Phase 2|200|Anticipated|AIO-Studien-gGmbH||1|||f||||f||||||||No||2017-10-10 21:44:29.982768|2017-10-10 21:44:29.982768
NCT02917746|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-11-07|||November 2016||2016-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|TOPIC-3||Imiquimod Treatment of High-grade CIN|TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia, a Multicenter, Open-label, Non-randomized, Controlled Study (TOPIC-3 Study)|Recruiting||N/A|120|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||No||2017-10-10 21:44:30.214608|2017-10-10 21:44:30.214608
NCT02917733|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-01-06|||September 2016||2016-09-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy Participants|Disposition of [¹⁴C₂]-Labeled LY3039478 Following Oral Administration in Healthy Subjects|Completed||Phase 1|8|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 21:44:30.373216|2017-10-10 21:44:30.373216
NCT02917720|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-08-23|||December 2016||2016-12-01|September 2016|2016-09-01|May 2023|Anticipated|2023-05-01|May 2018|Anticipated|2018-05-01||Interventional|NAUT||2nd TKI-stop After 2 Years Nilotinib Pre-treatment in Patients With First Unsuccessful Treatment Discontinuation in CML|Multicenter Prospective Trial After First Unsuccessful Treatment Discontinuation in Chronic Myeloid Leukemia ( CML) Estimating the Efficacy of Nilotinib in Inducing the Persistence of Molecular Remission After Stopping TKI a 2nd Time|Recruiting||Phase 2|200|Anticipated|European LeukemiaNet||1|||f||||t||||||||||2017-10-10 21:44:30.483185|2017-10-10 21:44:30.483185
NCT02917707|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||January 2016||2016-01-01|September 2016|2016-09-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|CRC-LM||Integrative Analysis of CRC Liver Metastasis|Integrative Analysis of CRC Liver Metastasis|Recruiting||N/A|1000|Anticipated|Shanghai 10th People's Hospital|||3||f||||f||||||||Yes|The investigators are willing to share data.|2017-10-10 21:44:30.608013|2017-10-10 21:44:30.608013
NCT02917694|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-08-11|||November 2016||2016-11-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|||A Feasibility Study to Assess Pre Admission Status and Six Month Outcomes After Major Trauma|A Feasibility Study to Assess Pre Admission Status and Six Month Outcomes of Major Trauma Patients Admitted to an Intensive Care Unit, Using the WHO DAS 2.0.|Recruiting||N/A|100|Anticipated|Oxford University Hospitals NHS Trust|||1||f||||f||||||||||2017-10-10 21:44:30.723066|2017-10-10 21:44:30.723066
NCT02917681|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis||Recruiting||Phase 1/Phase 2|28|Anticipated|University of Sao Paulo General Hospital||1|||f||||t||||||||No||2017-10-10 21:44:30.920696|2017-10-10 21:44:30.920696
NCT02917668|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2017-08-24|||September 2016||2016-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Cardiac Surgery Patients|Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Patients in a Cardiac Surgery Postoperative Setting|Recruiting||N/A|15|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 21:44:31.018264|2017-10-10 21:44:31.018264
NCT02917655|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-01-13|||November 2016||2016-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|PARQVE3||P.A.R.Q.V.E III - Comparison of the Educational Program With and Without Multidisciplinary Care|PARQVE - Project Arthritis Recovering Quality of Life by Means of Education - A Prospective Randomized Study Comparing the Educational Program With and Without Multidisciplinary Care|Active, not recruiting||N/A|90|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:44:31.137905|2017-10-10 21:44:31.137905
NCT02917642|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-26|||January 2014||2014-01-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Passive Ultrasonic Irrigation on the Reduction of Bacteria and Endotoxins in Root Canals|Clinical Evaluation of the Effect of Passive Ultrasonic Irrigation on the Reduction of Bacteria and Endotoxins in Root Canals|Active, not recruiting||N/A|40|Actual|University of Sao Paulo||2|||f||||t||||||||Undecided||2017-10-10 21:44:31.308844|2017-10-10 21:44:31.308844
NCT02917629|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-08-22|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|June 10, 2019|Anticipated|2019-06-10|June 10, 2019|Anticipated|2019-06-10||Interventional|||ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment|Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus Met® XR in Subjects With Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment|Recruiting||Phase 2|39|Anticipated|National Cancer Institute (NCI)||2|||f||||t|t|f||||||||2017-10-10 21:44:31.402029|2017-10-10 21:44:31.402029
NCT02917616|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||November 2015||2015-11-01|September 2016|2016-09-01||||April 2016|Actual|2016-04-01||Interventional|||The Effect of Drinking-Water pH on the Human Gut Microbiota||Completed||N/A|30|Actual|The Novo Nordisk Foundation Center for Basic Metabolic Research||2|||f||||t||||||||Yes|Anonymised datasets generated during the current study are available from the corresponding author on reasonable request|2017-10-10 21:44:31.55305|2017-10-10 21:44:31.55305
NCT02917603|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-10-02|||September 2016||2016-09-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Shared Decision Making to Improve Palliative Care in the Nursing Home|Shared Decision Making to Improve Palliative Care in the Nursing Home|Active, not recruiting||N/A|47|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 21:44:31.649046|2017-10-10 21:44:31.649046
NCT02917590|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-26|||October 2015||2015-10-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|||Dual-task Obstacle Crossing Training in Ambulatory Subjects With Spinal Cord Injury|Dual Task Obstacle Crossing: Effects on Walking and Balance Ability, and Relationship With Falls in Independent Ambulatory Patients With Spinal Cord Injury|Active, not recruiting||N/A|7|Actual|Khon Kaen University||2|||f||||f||||||||No||2017-10-10 21:44:31.742368|2017-10-10 21:44:31.742368
NCT02917577|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Hepatitis A Vaccine Dosing Regimens Among Pediatric Rheumatology Patients on Immunosuppressive Therapy|Comparison of Responses to Two Hepatitis A Vaccine Dosing Regimens Among Pediatric Rheumatology Patients on Immunosuppressive Therapy: A Pilot Study|Recruiting||N/A|60|Anticipated|University of Calgary||2|||f||||f||||||||Undecided||2017-10-10 21:44:31.8324|2017-10-10 21:44:31.8324
NCT02917564|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|TRICEPS||Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery|Subtenons Triamcinolone Acetonide Injections for Treatment of Persistent Choroidal Effusions Post Glaucoma Surgery|Recruiting||Phase 4|20|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||Undecided|Summary data will be reported, individual participant data will not|2017-10-10 21:44:31.936799|2017-10-10 21:44:31.936799
NCT02917551|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-09-08|||October 10, 2016|Actual|2016-10-10|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|BALANCE-Wards||BALANCE on the Wards: A Pilot RCT|Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness- BALANCE on the Wards: A Pilot RCT|Recruiting||N/A|50|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 21:44:32.06597|2017-10-10 21:44:32.06597
NCT02917538|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-10-03|||September 1, 2016|Actual|2016-09-01|October 2017|2017-10-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|CF-CTIA||A Randomized Study of Contact Force in Atrial Flutter Ablation|A Randomized Study of Contact Force in Atrial Flutter Ablation|Recruiting||N/A|150|Anticipated|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-10 21:44:32.193134|2017-10-10 21:44:32.193134
NCT02917525|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-28|||August 2016||2016-08-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|BASIK2||Bicuspid Aortic Valve Stenosis and the Effect of vItamin K2 on Calciummetabolism on 18F-NaF PET/MRI|Bicuspid Aortic Valve Stenosis and the Effect of vItamin K2 on Calciummetabolism on 18F-NaF PET/MRI (BASIK2): a Pilot Study|Recruiting||Phase 2|44|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 21:44:32.283354|2017-10-10 21:44:32.283354
NCT02917512|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-26|||March 2016||2016-03-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Interventional|||Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome|A Multicenter, Placebo Controlled, Restasis® Referenced, Randomized, Double Blind, Phase II Study to Evaluate the Efficacy and Safety of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome|Recruiting||Phase 2|105|Anticipated|Huons Co.,Ltd.||4|||f||||f||||||||No||2017-10-10 21:44:32.371658|2017-10-10 21:44:32.371658
NCT02917486|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-12-06|||January 2016||2016-01-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Observational|EC-MOTION||EC-MOTION : ExtraCorporeal Membrane Oxygenation and Therapeutic Drug Monitoring of Drugs of infectION||Recruiting||N/A|60|Anticipated|Rennes University Hospital|||2||f||||||||||||||2017-10-10 21:44:32.555328|2017-10-10 21:44:32.555328
NCT02917473|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-09-26|||October 2016||2016-10-01|September 2016|2016-09-01||||June 2018|Anticipated|2018-06-01||Interventional|FADEMELA||Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma|Written Advice to Improve Compliance With Early Detection of Melanoma in First-degree Relatives: a Multicenter, Cluster-randomized Intervention Trial to Evaluate the Impact of Specific Incentives and Study Psychological Determinants of Early Melanoma Detection Behavior in First-degree Relatives|Not yet recruiting||N/A|1125|Anticipated|University Hospital, Tours||2|||f||||f||||||||Undecided||2017-10-10 21:44:32.633631|2017-10-10 21:44:32.633631
NCT02917460|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-09-26|||July 2016||2016-07-01|September 2016|2016-09-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Interventional|||Rady Children's Institute Genomic Biorepository|Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data|Recruiting||N/A|102000|Anticipated|Rady Pediatric Genomics & Systems Medicine Institute||1|||f||||f||||||||Yes|We may share samples and data confidentially with collaborators, such as commercial laboratories or technology companies. All data and sample sharing will be strictly confidential. No identifying information will be shared.|2017-10-10 21:44:32.894466|2017-10-10 21:44:32.894466
NCT02917447|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-07-31|||July 5, 2016|Actual|2016-07-05|July 2017|2017-07-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Evaluation of Web-Based CBT for Women Veterans With PTSD|Evaluation of Web-Based CBT for Women Veterans With PTSD|Enrolling by invitation||N/A|100|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 21:44:33.010646|2017-10-10 21:44:33.010646
NCT02917434|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-26|||April 2016||2016-04-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|VIPsA||Effects of Weight-loss Treatment in Obese Patients With Psoriatic Arthritis|Effects of Weight-loss Treatment in Obese Patients With Psoriatic Arthritis|Enrolling by invitation||N/A|100|Anticipated|Vastra Gotaland Region||2|||f||||f||||||||Undecided||2017-10-10 21:44:33.137444|2017-10-10 21:44:33.137444
NCT02917421|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-08-18|||August 2016||2016-08-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|ART||Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations|Accelarated Radiation Therapy (ART) to the Breast and Nodal Stations After Neo-adjuvant Chemotherapy and Surgery : A Feasibility Study.|Recruiting||Phase 1/Phase 2|74|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-10 21:44:33.244937|2017-10-10 21:44:33.244937
NCT02917408|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-06-12|||September 2016||2016-09-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital|Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital|Completed||N/A|769|Actual|West China Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:44:33.345421|2017-10-10 21:44:33.345421
NCT02917395|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-10-03|||November 2016||2016-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients|Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients; Comparison of Two Echocardiography Based Methods: Global Longitudinal Strain vs. Left Ventricle Ejection Fraction|Not yet recruiting||N/A|50|Anticipated|Rabin Medical Center||1|||f||||f||||||||Undecided||2017-10-10 21:44:33.424272|2017-10-10 21:44:33.424272
NCT02917382|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-04-09|||July 2013|Actual|2013-07-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Evolution and Clinical Outcomes in Patients Undergoing Liver Transplantation|Evolution of Nutritional Status, Metabolic, Functional and Clinical Outcomes in Patients Undergoing Liver Transplantation|Recruiting||N/A|70|Anticipated|Federal University of Minas Gerais|||2||f||||t||||||||No||2017-10-10 21:44:33.515019|2017-10-10 21:44:33.515019
NCT02917369|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2016-09-27|||January 2016||2016-01-01|September 2016|2016-09-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|LCLC||Integrative Analysis of Large-cell Lung Cancer|Integrative Analysis of Large-cell Lung Carcinoma|Recruiting||N/A|1000|Anticipated|Shanghai 10th People's Hospital|||3||f||||t||||||||Yes|The investigators are willing to share data.|2017-10-10 21:44:33.603317|2017-10-10 21:44:33.603317
NCT02917226|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-28||||||September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Mobile and Web-Based Clinical Decision Support and Monitoring System for Diabetes Mellitus Patients in Primary Care||Not yet recruiting||N/A|||Dokuz Eylul University||2|||f||||f||||||||Undecided||2017-10-10 21:44:35.224953|2017-10-10 21:44:35.224953
NCT02917356|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-26|||August 2016||2016-08-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|April 2018|Anticipated|2018-04-01||Interventional|||"The Effect of Laying on of Hands in Older Women With Knee Osteoarthritis"|The Effect of Laying on of Hands on the Pain, Joint Stiffness and Functional Capacity of Older Women With Knee Osteoarthritis: A Randomized Controlled Trial|Recruiting||N/A|105|Anticipated|Federal University of Juiz de Fora||3|||f||||t||||||||Yes||2017-10-10 21:44:33.737415|2017-10-10 21:44:33.737415
NCT02917343|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-26|||October 2014||2014-10-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Mirror Therapy and Task Oriented Training for Persons With Paretic Upper Extremity|Effect of Mirror Therapy and Repetitive Task Training on Upper Extremity Function for Persons With Subacute Stroke|Completed||N/A|4|Actual|Quinnipiac University||1|||f||||f||||||||Yes||2017-10-10 21:44:33.844802|2017-10-10 21:44:33.844802
NCT02917330|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-12-15|||January 2015||2015-01-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Stretching and Strength Training for Improved Gait Function in Children With Spastic Cerebral Palsy|Stretching and Strength Training for Children With Cerebral Palsy -an Intervention Study|Completed||N/A|34|Actual|Oslo University Hospital||2|||f||||f||||||||No||2017-10-10 21:44:33.91782|2017-10-10 21:44:33.91782
NCT02917317|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-09-12|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|September 1, 2020|Anticipated|2020-09-01||Observational|||South China Prospective Cohort Study of Chronic Disease|South China Prospective Cohort Study of Chronic Disease|Recruiting||N/A|110000|Anticipated|Sun Yat-sen University|||1||f||||f|f|f||||Samples With DNA|"     Retention Blood ,Urine and Stool samples for biochemical tests, biomarkers, DNA and so on   "|||2017-10-10 21:44:34.042026|2017-10-10 21:44:34.042026
NCT02917304|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-24|||October 10, 2016|Actual|2016-10-10|May 2017|2017-05-01|May 8, 2017|Actual|2017-05-08|December 2, 2016|Actual|2016-12-02||Interventional|||A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older|A Multicenter, Open-label, Single Arm Study to Evaluate the Immunological Efficacy and Safety of GC3110A. Administered Intramuscularly in Healthy Subjects Aged 65 Years and Older|Completed||Phase 3|274|Actual|Green Cross Corporation||1|||f||||f||||||||No||2017-10-10 21:44:34.142026|2017-10-10 21:44:34.142026
NCT02917291|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-02-23|||December 2016||2016-12-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|April 2019|Anticipated|2019-04-01||Interventional|SPINE||Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury|Clinical Trial of Phase 1/2 to Evaluate the Feasibility, Safety, Tolerability and Preliminary Efficacy of the Administration of FAB117-HC, a Drug Whose Active Ingredient is HC016, Allogeneic Adipose Derived Adult Mesenchymal Stem Cells Expanded and Pulsed With H2O2, in Acute Traumatic SCI Patients.|Recruiting||Phase 1/Phase 2|46|Anticipated|Ferrer Internacional S.A.||3|||f||||t||||||||||2017-10-10 21:44:34.252097|2017-10-10 21:44:34.252097
NCT02917278|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-04-05|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Pilot Study of Nutrition in Maintenance Hemodialysis Patients||Completed||N/A|19|Actual|Purdue University||2|||f||||t||||||||Undecided||2017-10-10 21:44:34.374987|2017-10-10 21:44:34.374987
NCT02915471|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-23|||August 2016||2016-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Virtual Peer-to-Peer (VP2P) Support Mentoring for Adolescents With Cancer|Virtual Peer-to-peer (VP2P) Support Mentoring for Adolescents With Cancer: A Pilot Pragmatic Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|The Hospital for Sick Children||2|||f||||||||||||||2017-10-10 21:44:34.472294|2017-10-10 21:44:34.472294
NCT02915458|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-23|||January 2016||2016-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Predictive Analysis Software for Successful Weaning From Ventilator of Patients|Predictive Analysis Software for Successful Weaning From Ventilator of Patients in Critical Condition|Recruiting||N/A|188|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:44:34.573433|2017-10-10 21:44:34.573433
NCT02915445|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-23|||July 2016||2016-07-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||EpCAM CAR-T for Treatment of Nasopharyngeal Carcinoma and Breast Cancer|T Cells Armed With Chimeric Antigen Receptor Recognizing EpCAM for Patients With Nasopharyngeal Carcinoma and Breast Cancer|Recruiting||Phase 1|30|Anticipated|Sichuan University||1|||f||||t||||||||No||2017-10-10 21:44:34.677137|2017-10-10 21:44:34.677137
NCT02915432|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-04-23|||December 2016||2016-12-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|||The Study to Evaluate JS001 in Patients With Advanced GC, ESCC, NPC, HNSCC|A Multi-Center, Open Label Phase Ib/II Clinical Study to Evaluate JS001 in Patients With Advanced Gastric Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Nasopharyngeal Carcinoma and Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|448|Anticipated|Shanghai Junshi Bioscience Co.,Ltd.||2|||f||||t||||||||No||2017-10-10 21:44:34.79205|2017-10-10 21:44:34.79205
NCT02915419|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-23|||October 2016||2016-10-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Survival of Mature Second Premolar Treated With Regenerative Techniques|Evaluation of Survival of Mature Second Premolar With Periapical Lesion Following Different Regenerative Treatment Protocols|Not yet recruiting||N/A|30|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:44:35.000494|2017-10-10 21:44:35.000494
NCT02917265|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-09-15|||September 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:44:35.080829|2017-10-10 21:44:35.080829
NCT02917252|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-27|2017-04-07|||February 1, 2017|Actual|2017-02-01|September 2016|2016-09-01|April 3, 2017|Actual|2017-04-03|April 3, 2017|Actual|2017-04-03||Interventional|||How Orally Consumed 3-hydroxybuturate Alters Metabolism|Ketone Bodies Ingested Orally Alter Metabolism for Glucose, Lipid, and Protein|Completed||N/A|6|Actual|University of Aarhus||2|||f||||f|f|f||||||No||2017-10-10 21:44:35.116545|2017-10-10 21:44:35.116545
NCT02917239|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-03|||July 2014||2014-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)|Prevalence Analysis of Ocular Disorders in Patients on Treatment for Symptomatic Multiple Myeloma|Completed||N/A|100|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||1||f||||f||||||||No||2017-10-10 21:44:35.177633|2017-10-10 21:44:35.177633
NCT02917213|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|ISBITAMI||Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction|A Prospective, Observational Study to Assess the Efficacy of New Quantitative Imaging Methods to Assess the Risk of Acute and Subacute Thromboembolic Complications of Myocardial Infarction|Recruiting||N/A|92|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||f||||||||Undecided||2017-10-10 21:44:35.28095|2017-10-10 21:44:35.28095
NCT02917200|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-11|||May 11, 2016|Actual|2016-05-11|September 2017|2017-09-01|December 2, 2016|Actual|2016-12-02|December 2, 2016|Actual|2016-12-02||Interventional|||Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers|Impact of Different DAV132 Dose Regimens (From 2 to 22.5 g/Day During 7 Days, Bid and Tid) on the Fecal Moxifloxacin Concentrations and the Intestinal Microbiota of Healthy Volunteers Treated With Moxifloxacin 400 mg/Day During 5 Days|Completed||Phase 1|150|Actual|Da Volterra||12|||f||||f||||||||||2017-10-10 21:44:35.390982|2017-10-10 21:44:35.390982
NCT02917174|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-05-15|||March 25, 2017|Actual|2017-03-25|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||National Mobile Asthma Management System-E Project|National Mobile Asthma Management System-E Project|Recruiting||N/A|960|Anticipated|China-Japan Friendship Hospital||2|||f|||||f|f||||||||2017-10-10 21:44:35.742665|2017-10-10 21:44:35.742665
NCT02917161|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2017-08-08|||September 2016||2016-09-01|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|June 2017|Actual|2017-06-01||Interventional|||Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study|Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study|Completed||N/A|12|Actual|Cantonal Hospital of St. Gallen||1|||f||||f||||||||||2017-10-10 21:44:35.822819|2017-10-10 21:44:35.822819
NCT02917135|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-12-12|||July 2016||2016-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|33 Days|Observational [Patient Registry]|||Angel® Catheter Post Market Registry|European Angel® Catheter Post Market Registry|Recruiting||N/A|2000|Anticipated|BiO2 Medical|||1||f||||f||||||||No||2017-10-10 21:44:35.983302|2017-10-10 21:44:35.983302
NCT02917122|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-09-27|||August 2015||2015-08-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|Parkinson's||The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease|The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|National Cheng-Kung University Hospital||2|||f||||t||||||||No||2017-10-10 21:44:36.101238|2017-10-10 21:44:36.101238
NCT02917109|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-07-28|||September 2016||2016-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||LearningRx Cognitive Training for ADHD|LearningRx Cognitive Training for ADHD: A Multiple Baseline Study Across Cases|Active, not recruiting||N/A|3|Actual|Gibson Institute of Cognitive Research||1|||f||||f||||||||||2017-10-10 21:44:36.194556|2017-10-10 21:44:36.194556
NCT02917096|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-09-14|||October 5, 2016|Actual|2016-10-05|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis|Pilot Open-Label Study of Safety and Efficacy of Ruxolitinib Given Peri-transplant During Reduced Intensity Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients With Myelofibrosis|Recruiting||N/A|18|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 21:44:36.280354|2017-10-10 21:44:36.280354
NCT02917083|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-06-13|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|February 2035|Anticipated|2035-02-01|April 2020|Anticipated|2020-04-01||Interventional|RELY-30||CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)|Phase I Study of Relapsed CD30 Expressing Lymphoma Treated With CD30 CAR T Cells (RELY-30)|Recruiting||Phase 1|18|Anticipated|Baylor College of Medicine||1|||f||||t|t|f||||||||2017-10-10 21:44:36.419758|2017-10-10 21:44:36.419758
NCT02917070|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-26|||February 2016||2016-02-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01|6 Months|Observational [Patient Registry]|CAKD||Parental Consanguinity and Family History of Kidney Disease in Turkish Kidney Disease Population|The Importance of Parental Consanguinity and Family History of Kidney Disease in Turkish Adult Chronic Kidney Disease Population|Completed||N/A|2576|Actual|Istanbul University|||2||f||||f||||||||No||2017-10-10 21:44:36.532188|2017-10-10 21:44:36.532188
NCT02917057|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-03-28|||August 1, 2015|Actual|2015-08-01|March 2017|2017-03-01|August 1, 2015|Actual|2015-08-01|August 1, 2015|Actual|2015-08-01||Observational|||Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment|A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States - Additional Analyses|Completed||N/A|7000|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-10 21:44:36.617815|2017-10-10 21:44:36.617815
NCT02917044|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-09-27|||March 2016||2016-03-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|HD-WACA||Use of a High Density Mapping System to Complete Wide Area Circumferential Ablation of the Pulmonary Veins and Avoid Ostial Segmental Ablation|Use of a High Density Mapping System to Complete Wide Area Circumferential Ablation of the Pulmonary Veins and Avoid Ostial Segmental Ablation|Recruiting||N/A|48|Anticipated|Imperial College Healthcare NHS Trust||2|||f||||f||||||||||2017-10-10 21:44:36.703512|2017-10-10 21:44:36.703512
NCT02917031|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-10-04|||January 10, 2017|Actual|2017-01-10|October 2017|2017-10-01|March 7, 2019|Anticipated|2019-03-07|March 7, 2019|Anticipated|2019-03-07||Interventional|MEASURE-HF||Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure|A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure|Recruiting||Phase 4|330|Anticipated|AstraZeneca||3|||f||||t|t|f||||||||2017-10-10 21:44:36.817848|2017-10-10 21:44:36.817848
NCT02917018|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-01-03|||May 2016||2016-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Dexmedetomidine on Stress Response and Emergence Agitation During Laparoscopic Surgery|Effect of Different Doses of Dexmedetomidine on Stress Response and Emergence Agitation After Laparoscopic Cholecystectomy in Adults|Completed||Phase 2/Phase 3|90|Actual|Assiut University||3|||f||||t||||||||Undecided||2017-10-10 21:44:37.126737|2017-10-10 21:44:37.126737
NCT02917005|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-26|||November 2016||2016-11-01|September 2016|2016-09-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|FATIMA||PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer|A Phase II Study of Ovarian Function Suppression And ExemesTane With or Without PalbocIclib in PreMenopausal Women With ER Positive / HER-2 Negative MetAstatic Breast Cancer|Not yet recruiting||Phase 2|160|Anticipated|Africa Middle East Cancer Intergroup||2|||f||||||||||||Yes|Presentation in a conference proceedings in mid 2019 Full publication in January 2020|2017-10-10 21:44:37.205777|2017-10-10 21:44:37.205777
NCT02916992|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Prevalence of Spontaneous Pneumothorax in BHD|Prevalence of Birt-Hogg-Dubé Syndrome Among Patients With (Hereditary) Spontaneous Pneumothorax|Recruiting||Phase 1|200|Anticipated|Free University Medical Center||2|||f||||f||||||||No||2017-10-10 21:44:37.292739|2017-10-10 21:44:37.292739
NCT02916979|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-09-26|||August 2016||2016-08-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|FluBuATG||Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG|A Pilot Trial Examining Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic Stem Cell Transplant Recipients Using Myeloablative Busulfan and Fludarabine|Recruiting||Phase 1|20|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||No||2017-10-10 21:44:37.412742|2017-10-10 21:44:37.412742
NCT02916966|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-02-03|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01|1 Year|Observational [Patient Registry]|||Population-Based Ohio ALS Repository and ALS Risk Factors|A Population-Based Ohio ALS Repository and a Case-Controlled Study of ALS Risk Factors|Recruiting||N/A|1000|Anticipated|Dartmouth-Hitchcock Medical Center|||4||f||||||||||||||2017-10-10 21:44:37.512852|2017-10-10 21:44:37.512852
NCT02916953|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-07-19|||December 17, 2016||2016-12-17||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:44:37.593847|2017-10-10 21:44:37.593847
NCT02916940|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-02-01|||November 2016||2016-11-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.|Randomized Controlled Prospective Study on the Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers (Thumb Excluded).|Recruiting||Phase 2|60|Anticipated|Brugmann University Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:44:37.635017|2017-10-10 21:44:37.635017
NCT02916927|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-03|||September 2016||2016-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department|Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department: A Prospective, Randomized, Double-blind Placebo Controlled Trial|Completed||Phase 4|56|Actual|Alameda Health System||2|||f||||f||||||||Undecided||2017-10-10 21:44:37.746355|2017-10-10 21:44:37.746355
NCT02916914|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-13|||September 30, 2016|Actual|2016-09-30|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|May 31, 2017|Actual|2017-05-31||Interventional|||Impact of Feeding Interval of Preterms on the Time of Transition From Tube Feeding to Oral Feeding|Impact of Feeding Interval of Preterms on the Time of Transition From Tube Feeding to Oral Feeding|Completed||N/A|80|Actual|Etlik Zubeyde Hanim Womens' Health and Teaching Hospital||2|||f||||f||||||||||2017-10-10 21:44:37.821869|2017-10-10 21:44:37.821869
NCT02916901|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-02-20|||August 2016|Actual|2016-08-01|September 2016|2016-09-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|||Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers|A Randomized, Double-blind, Placebo-controlled, Multiple Dosing, Cross-over Phase I Clinical Trial to Investigate the Effect of CKD-519 on 24-h Ambulatory Blood Pressure After Oral Administration in Healthy Adult Volunteers|Completed||Phase 1|32|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||No||2017-10-10 21:44:37.896889|2017-10-10 21:44:37.896889
NCT02916888|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists|Patient and Caregiver Quality of Life in the Treatment of Atopic Dermatitis in Pediatric Patients: a Comparison Between a General Pediatric Practice and a Pediatric Dermatology Practice|Recruiting||N/A|70|Anticipated|Yale University|||2||f||||f||||||Samples With DNA|"     Saliva samples for salivary cortisol detection   "|Undecided||2017-10-10 21:44:37.980116|2017-10-10 21:44:37.980116
NCT02916875|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01|March 2021|Anticipated|2021-03-01|October 2017|Anticipated|2017-10-01||Observational|||Individual Survivorship Program for Ovarian Cancer Patients Based on PROM's and Shared Decision Making|Individual Survivorship Program for Ovarian Cancer Patients Based on PROM's and Shared Decision Making|Recruiting||N/A|300|Anticipated|Vejle Hospital|||1||f||||f||||||||||2017-10-10 21:44:38.073706|2017-10-10 21:44:38.073706
NCT02916680|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-10|||March 2016||2016-03-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study|Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study|Recruiting||Phase 1|4|Anticipated|University Hospital, Basel, Switzerland||1|||f||||t||||||||No||2017-10-10 21:44:39.736474|2017-10-10 21:44:39.736474
NCT02916862|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-05-11|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in Adolescents|Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in Adolescents|Not yet recruiting||Phase 2/Phase 3|168|Anticipated|University of Puerto Rico||3|||f||||t|f|f||||||Yes|Data will be obtained on self-reported demographics, lifestyles (nutrition, use of supplements, physical activity), health-related variables (sexual maturity, medical conditions, use of medications), adherence to the treatment, anthropometrics, blood pressure measurements, laboratory data regarding fasting blood samples (blood lipids, serum 25(OH)D levels, bone biomarkers, glucose, calcium and phosphate) and urinary samples (calcium, phosphate and bone biomarkers), bone scan (bone mineral content and density). The final dataset will be stripped of identifiers prior to release for sharing.|2017-10-10 21:44:38.141472|2017-10-10 21:44:38.141472
NCT02916849|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Feasibility Study of a Mobile Application Intervention to Promote Strength and Balance Exercises in Older People|A Feasibility Study of an Intervention Using a Mobile Application to Promote Strength and Balance and Reduce Risk of Falls in Older People|Recruiting||N/A|90|Anticipated|Umeå University||5|||f||||f||||||||Yes|Contact the author. Data will be kept for 10 years after trial finishes.|2017-10-10 21:44:38.226697|2017-10-10 21:44:38.226697
NCT02916836|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-26|||January 2017||2017-01-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|IATROMED||Effect of the Use of a Therapeutic Conciliation Document at the Outlet of Hospital, on the Emergency Use of Hospital Care in Patient Aged Over 75 Years Old.|Effect of the Use of a Therapeutic Conciliation Document at the Outlet of Hospital, on the Emergency Use of Hospital Care in Patient Aged Over 75 Years Old.|Not yet recruiting||N/A|750|Anticipated|Centre Hospitalier Universitaire de Nice|||2||f||||f||||||||||2017-10-10 21:44:38.313084|2017-10-10 21:44:38.313084
NCT02916823|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-10-12|||October 2016||2016-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:44:38.378818|2017-10-10 21:44:38.378818
NCT02916810|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-13|||October 2016||2016-10-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||TMS for Symptom Reduction in Schizophrenia|TMS for Symptom Reduction in Schizophrenia|Recruiting||N/A|130|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-10 21:44:38.573536|2017-10-10 21:44:38.573536
NCT02916797|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-08-15|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Stepping Training Using Feedback in Stroke|Effects of Stepping Training With and Without the Use of Visually Weight-taking Machine (VWTM) on Walking and Balance Ability in Patients With Stroke|Active, not recruiting||N/A|22|Actual|Khon Kaen University||2|||f||||f||||||||||2017-10-10 21:44:38.689706|2017-10-10 21:44:38.689706
NCT02916784|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-23|||July 2015||2015-07-01|November 2015|2015-11-01|July 2016|Actual|2016-07-01|October 2015|Actual|2015-10-01||Observational|||Sit-to-stand in Spinal Cord Injury Patient|Relationship Between Ability of Sit-to-stand and Types of Walking Device Used in Ambulatory Patients With Spinal Cord Injury|Completed||N/A|69|Actual|Khon Kaen University|||2||f||||t||||||||No||2017-10-10 21:44:38.77412|2017-10-10 21:44:38.77412
NCT02916758|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-23|||June 2015||2015-06-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Promoting Community Mobility for Wellness in Older Adults in Urban Environments|Let's Go: Promoting Community Mobility for Wellness in Older Adults in Urban Environments|Completed||N/A|52|Actual|Kean University||1|||f||||f||||||||Yes|Data files will be uploaded for review|2017-10-10 21:44:38.954375|2017-10-10 21:44:38.954375
NCT02916745|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-10-05|||January 26, 2017|Actual|2017-01-26|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer|A Multicenter, Prospective, Open-label, Single-arm Clinical Study of the Safety and Feasibility of Using Navigational Bronchoscopy to Perform Interstitial Photodynamic Therapy Using Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung|Recruiting||Phase 4|20|Anticipated|Concordia Laboratories Inc.||1|||f||||t|t|t|f|f|f|||||2017-10-10 21:44:39.047696|2017-10-10 21:44:39.047696
NCT02916732|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-26|||April 2016||2016-04-01|April 2016|2016-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01|9 Months|Observational [Patient Registry]|ZIKA-DFA-FE||Zika Virus Infection's Pregnancy Consequences in French Department of America|Études Observationnelles Des conséquences de l'Infection à Virus Zika au Cours de la Grossesse Pendant l'épidémie Des départements français d'Amérique de l'année 2016|Recruiting||N/A|26980|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||5||f||||f||||||Samples With DNA|"     -  bio-bank of serum from all pregnant women.        -  bio-bank of maternal blood and infant cord blood        -  bio-bank of maternal blood and fetal tissues   "|No||2017-10-10 21:44:39.243212|2017-10-10 21:44:39.243212
NCT02916719|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging|Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging|Not yet recruiting||N/A|24|Anticipated|Brugmann University Hospital||1|||f||||f||||||||No||2017-10-10 21:44:39.371935|2017-10-10 21:44:39.371935
NCT02916706|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-10-05|||September 2016||2016-09-01|October 2017|2017-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus||Recruiting||Phase 3|240|Anticipated|Mitsubishi Tanabe Pharma Corporation||2|||f||||||||||||||2017-10-10 21:44:39.483438|2017-10-10 21:44:39.483438
NCT02916693|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-09-29|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Mirabegron For Erectile Dysfunction|Mirabegron For Erectile Dysfunction|Recruiting||Phase 1/Phase 2|20|Anticipated|Johns Hopkins University||1|||f||||f|t|f||||||||2017-10-10 21:44:39.5942|2017-10-10 21:44:39.5942
NCT02916667|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-10-09|||November 2016||2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|CN||Chrono Nutrition (CN) Intervention Program in Gestational Diabetes Mellitus|Chrono Nutrition Intervention Program in Gestational Diabetes Mellitus|Not yet recruiting||N/A|280|Anticipated|Rabin Medical Center||2|||f||||f||||||||No||2017-10-10 21:44:39.859188|2017-10-10 21:44:39.859188
NCT02916654|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-03-23|||April 2015||2015-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|||Sucrosomial Iron in Patients With Celiac Disease and IDA|Sucrosomial Iron Supplementation in Anaemic Patients With Celiac Disease Not Tolerating Oral Ferrous Sulfate|Recruiting||N/A|20|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||t||||||||||2017-10-10 21:44:39.992382|2017-10-10 21:44:39.992382
NCT02916641|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-09-26|||January 2016||2016-01-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid||Recruiting||Phase 3|200|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||||||||||||2017-10-10 21:44:40.119241|2017-10-10 21:44:40.119241
NCT02916628|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-09-05|||July 2013|Actual|2013-07-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Auricular Acupressure and Group Counseling on Smoking Cessation Tobacco Withdrawal Symptoms|Effects of Auricular Acupressure and Group Therapy on Smoking Cessation Tobacco Withdrawal Symptoms, Depressive Symptoms, Resilience, and Serum Serotonin Level|Active, not recruiting||N/A|225|Actual|Inha University Hospital||4|||f||||t||||||||||2017-10-10 21:44:40.261712|2017-10-10 21:44:40.261712
NCT02916615|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-09-27|||January 2016||2016-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|DINO||Effects of Nitrate in Vegetables on Blood Pressure in Subjects With Prehypertension|Diet and Nitric Oxide (DINO): A Study on the Effects of Dietary Nitrate on Blood Pressure in Subjects With Prehypertension|Recruiting||N/A|300|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-10 21:44:40.418417|2017-10-10 21:44:40.418417
NCT02916602|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-10-19|||April 2015||2015-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605|A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605|Completed||Phase 3|340|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 21:44:40.580167|2017-10-10 21:44:40.580167
NCT02916589|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Nutrition, Oral Health and Type 2 Diabetes|The Impact of Diet on Oral Health in Overweight Individuals With Type 2 Diabetes|Recruiting||Phase 1/Phase 2|30|Anticipated|Kristianstad University||2|||f||||f||||||||||2017-10-10 21:44:40.680526|2017-10-10 21:44:40.680526
NCT02916576|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-02-13|||September 2016||2016-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015|User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015|Completed||N/A|140|Anticipated|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm||1|||f||||||||||||||2017-10-10 21:44:40.758857|2017-10-10 21:44:40.758857
NCT02915406|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-08-12||||||August 2017|2017-08-01||||||||Expanded Access|||cliniMACs HUD for T Cell Depletion|cliniMACs HUD for T Cell Depletion|No longer available||N/A|||University of Miami|||||f||||||||||||||2017-10-10 21:44:40.819839|2017-10-10 21:44:40.819839
NCT02915393|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|September 2017|Anticipated|2017-09-01||Observational|SBSDS||System Biology of Spleen Deficiency Syndrome|"System Biology Research of Spleen Qi Deficiency Associated Qi Deficiency Constitution-Disease"|Not yet recruiting||N/A|90|Anticipated|Beijing University of Chinese Medicine|||9||f||||f||||||Samples With DNA|"     frozen tissue, whole blood   "|Undecided||2017-10-10 21:44:40.879378|2017-10-10 21:44:40.879378
NCT02915380|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-23|||January 2017||2017-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|TIRASH||Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage|Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage|Not yet recruiting||N/A|50|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||||Undecided||2017-10-10 21:44:40.954126|2017-10-10 21:44:40.954126
NCT02915367|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-03-23|||December 21, 2016|Actual|2016-12-21|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|January 2020|Anticipated|2020-01-01||Interventional|MPYA||Monitoring Pre-exposure Prophylaxis for Young Adult Women|Next Generation Real-time Monitoring for PrEP Adherence in Young Kenyan Women|Recruiting||N/A|350|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Yes|De-identified data will be made available at the end of the study upon request.|2017-10-10 21:44:41.033442|2017-10-10 21:44:41.033442
NCT02915354|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-11-15|||July 2007||2007-07-01|November 2016|2016-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study|Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Three Years' Following-up Study|Completed||Phase 4|35|Actual|Sun Yat-sen University||1|||f||||t||||||||Yes|The data will be published on the Journals.|2017-10-10 21:44:41.122384|2017-10-10 21:44:41.122384
NCT02916563|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-26|||July 2016||2016-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:44:41.195445|2017-10-10 21:44:41.195445
NCT02916550|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Breathing Intervention for Cardiac Anxiety|Anatomical and Psychophysiological Substrates of Interoception|Recruiting||N/A|50|Anticipated|Laureate Institute for Brain Research, Inc.||1|||f||||f||||||||Yes|Not IPD, just de-identified data.|2017-10-10 21:44:41.242639|2017-10-10 21:44:41.242639
NCT02916355|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-23|||August 2016||2016-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|Chäs2||Role of Interleukin (IL)-1 in Postprandial Fatigue - The Chäschüechli 2 Study|Role of IL-1 in Postprandial Fatigue - The Chäschüechli 2 Study|Active, not recruiting||N/A|16|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||No||2017-10-10 21:44:42.452115|2017-10-10 21:44:42.452115
NCT02916537|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Phase 1 Trial for Safety and Imaging Evaluation of CTT1057, a Small Molecule Inhibitor of Prostate Specific Membrane Antigen (PSMA)|A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057, a Small Molecule Inhibitor of Prostate Specific Membrane Antigen (PSMA)|Recruiting||Phase 1|20|Anticipated|Cancer Targeted Technology||2|||f||||f||||||||Undecided||2017-10-10 21:44:41.325111|2017-10-10 21:44:41.325111
NCT02916524|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-04-25|||October 2016||2016-10-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|September 2020|Anticipated|2020-09-01||Interventional|PROCoM||Predicting Rehabilitation Outcomes in Bilingual Aphasia Using Computational Modeling|Double-blind Randomized Trial Investigating the Use of Computational Modeling to Predict Rehabilitation Outcomes in Bilingual Aphasia|Recruiting||N/A|48|Anticipated|Boston University Charles River Campus||2|||f||||t||||||||No||2017-10-10 21:44:41.417942|2017-10-10 21:44:41.417942
NCT02916511|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-08-20|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|March 1, 2021|Anticipated|2021-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|ESO-Shanghai9||Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma||Recruiting||Phase 2|74|Anticipated|Fudan University||1|||f||||||||||||||2017-10-10 21:44:41.50573|2017-10-10 21:44:41.50573
NCT02916498|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-09-18|||February 7, 2017|Actual|2017-02-07|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Field Shape and Amplitude Sensitivity Exploratory Study (CONTOUR Study)|Field Shape and Amplitude Sensitivity Exploratory Study (CONTOUR Study)|Recruiting||N/A|10|Anticipated|Boston Scientific Corporation||2|||f||||f|f|f||||||||2017-10-10 21:44:41.584685|2017-10-10 21:44:41.584685
NCT02916485|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-06-13|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|BIOSOLVE-India||Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold|BIOTRONIK - Safety and Clinical Performance Of the Magmaris Drug Eluting Absorbable Metal Scaffold in a Cohort of Patients in India With de Novo Lesions in NatiVE Coronary Arteries|Suspended||N/A|100|Anticipated|Biotronik AG||1||"Awaiting National Pharmaceutical Pricing Authority (NPPA) review of ceiling prices for   innovative products in India."|f||||f|f|f||||||No||2017-10-10 21:44:41.662053|2017-10-10 21:44:41.662053
NCT02916472|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-01-05|||August 2016||2016-08-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||CyberCycling to Reduce Therapeutic Side Effects and Improve Quality of Life in AYA Cancers|'Rainbow Riders': A Pilot Trial of CyberCycling to Reduce Therapeutic Side Effects and Improve Quality of Life in Adolescent and Young Adults (AYA) Diagnosed With Cancer|Recruiting||Early Phase 1|20|Anticipated|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 21:44:41.748743|2017-10-10 21:44:41.748743
NCT02916459|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-02-06|||October 2016||2016-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||EBUS-TBNA vs Flex 19G EBUS-TBNA|Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) Versus Flexible 19G Endobronchial Ultrasound Transbronchial Needle (Flex 19G EBUS-TBNA) in the Assessment of Mediastinal and Hilar Lymph-adenopathy: a Randomised Trial|Recruiting||N/A|250|Anticipated|Heidelberg University||2|||f||||||||||||||2017-10-10 21:44:41.834776|2017-10-10 21:44:41.834776
NCT02916446|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-04-13|||October 2016||2016-10-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|REALISE||Safety Study of Viaskin Peanut to Treat Peanut Allergy||Active, not recruiting||Phase 3|393|Actual|DBV Technologies||2|||f||||t||||||||||2017-10-10 21:44:41.919384|2017-10-10 21:44:41.919384
NCT02916433|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients|Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients: A Randomized Controlled Trial|Enrolling by invitation||Phase 2|30|Anticipated|Danbury Hospital||2|||f||||f||||||||||2017-10-10 21:44:42.036778|2017-10-10 21:44:42.036778
NCT02916420|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-10-31|||September 2016||2016-09-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma|A Multicenter, Single-arm, Open-label Study to Evaluate the Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma|Recruiting||Phase 3|73|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:44:42.103779|2017-10-10 21:44:42.103779
NCT02916407|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-24|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Preoperative Ketamine on the Emergence Characteristics in Children Undergoing Entropion Surgery|The Effect of Preoperative Ketamine on the Emergence Characteristics After Desflurane or Sevoflurane Anesthesia in Children Undergoing Entropion Surgery|Recruiting||N/A|56|Anticipated|Inje University||2|||f||||f||||||||No||2017-10-10 21:44:42.171375|2017-10-10 21:44:42.171375
NCT02916394|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||In Vivo IGF-1R Molecular Imaging Using [68Ga]- Labelling Anti-IGF-1R Affibody Molecule|Targeted Molecular Imaging of [68Ga]- Labelling Anti-IGF-1R Affibody Molecule in IGF-1R Overexpression Cancer Patients （Such as Colon Cancer、NSCLC and Gliomas）and Healthy Volunteers|Not yet recruiting||N/A|100|Anticipated|Harbin Medical University||4|||f||||t||||||||Undecided||2017-10-10 21:44:42.258767|2017-10-10 21:44:42.258767
NCT02916381|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2017-05-04|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||The Analgesic Efficacy of the Pectoral Block After Mastectomy|The Analgesic Efficacy of the Pectoral Block After Mastectomy|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||||2017-10-10 21:44:42.325132|2017-10-10 21:44:42.325132
NCT02916368|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||January 2017||2017-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma|The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell|Not yet recruiting||Phase 1|100|Anticipated|Beijing Tongren Hospital|||2||f||||t||||||||Yes||2017-10-10 21:44:42.40289|2017-10-10 21:44:42.40289
NCT02916342|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-26|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks|Interscalene Brachial Block Versus Combined Supraprascapular: Axillary Nerve Blocks - Respiratory and Acute Pain-related Outcomes|Recruiting||Phase 4|30|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||Yes||2017-10-10 21:44:42.530145|2017-10-10 21:44:42.530145
NCT02916329|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-24|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|October 2016|Anticipated|2016-10-01||Interventional|||In Vivo EGFR-ECD Molecular Imaging Using [68Ga]- Labelling Anti-EGFR Affibody Molecule|Targeted Molecular Imaging of [68Ga]- Labelling Anti-EGFR Affibody Molecule in EGFR ECD in Lung Cancer Patients and Healthy Volunteers|Recruiting||N/A|100|Anticipated|Harbin Medical University||6|||f||||t||||||||Undecided||2017-10-10 21:44:42.605642|2017-10-10 21:44:42.605642
NCT02916316|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-09-06|||January 2014||2014-01-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell|Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell|Recruiting||N/A|150|Anticipated|Fondazione Italiana Linfomi ONLUS|||1||f||||f||||||||||2017-10-10 21:44:42.801278|2017-10-10 21:44:42.801278
NCT02916303|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-03-13|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|PAFIPEC||Cost-effectiveness of Interventions in First-episode Psychosis|Cost-effectiveness of Early Intervention in First-episode Psychosis: Economic Evaluation of the PAFIP Program at Medium and Long-term|Enrolling by invitation||N/A|490|Anticipated|Fundación Marques de Valdecilla|||1||f||||f|f|f||||||No||2017-10-10 21:44:43.046397|2017-10-10 21:44:43.046397
NCT02916290|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-09-26|||January 2016||2016-01-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis||Recruiting||Phase 3|200|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||||||||||||2017-10-10 21:44:43.152658|2017-10-10 21:44:43.152658
NCT02916277|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-24|||August 2016||2016-08-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01|5 Days|Observational [Patient Registry]|||Endocan in Ventilator-associated Pneumonia|Endocan; Can be a New Biomarker in Ventilator-associated Pneumonia?|Recruiting||N/A|60|Anticipated|Erzincan University|||1||f||||f||||||||No||2017-10-10 21:44:43.258902|2017-10-10 21:44:43.258902
NCT02916264|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-26|||July 2016||2016-07-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||The Effect of Scalp Block on Surgical Pleth Index(SPI) During a Mayfield Head-holder Insertion|The Effect of Scalp Block on Surgical Pleth Index(SPI) During a Mayfield Head-holder Insertion in Neurosurgery : a Randomized Control Trial|Recruiting||Phase 4|30|Anticipated|Chiang Mai University||2|||f||||t||||||||Undecided||2017-10-10 21:44:43.346898|2017-10-10 21:44:43.346898
NCT02916251|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-04-20|||December 1, 2016|Actual|2016-12-01|April 2017|2017-04-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|||ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon|Randomised, Sequential, Cross-over Trial Assessing PK and PD Responses After Micro-doses of ZP4207 Administered s.c. to Patients With T1D Under eu- and Hypoglycemic Conditions and With Reference to Freshly Reconstituted Lyophilized Glucagon|Completed||Phase 2|38|Actual|Zealand Pharma||2|||f||||f||||||||Undecided||2017-10-10 21:44:43.449143|2017-10-10 21:44:43.449143
NCT02916238|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-11-29|||February 2014||2014-02-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|MBC||Measurement-based Care for Depression in Resource-Poor Settings|Measurement-based Care for Depression in Resource-Poor Settings|Completed||Phase 4|140|Actual|Florida International University||2|||f||||t||||||||Yes||2017-10-10 21:44:43.581635|2017-10-10 21:44:43.581635
NCT02916225|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-25|||June 2014||2014-06-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||High Intensity Interval Training Versus Moderate Continuous Training in Heart Failure With Preserved Ejection Fraction|High Intensity Interval Training Versus Moderate Continuous Training in Heart Failure With Preserved Ejection Fraction Patients: a Randomized Study.|Active, not recruiting||N/A|20|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||No||2017-10-10 21:44:43.691628|2017-10-10 21:44:43.691628
NCT02916212|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-01-19|||December 2015||2015-12-01|September 2016|2016-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|QI-MAOS||Quality Improvement - Monitoring Alarm Optimization Study|Quality Improvement - Monitoring Alarm Optimization Study|Completed||N/A|||Duke University||2|||f||||f||||||||||2017-10-10 21:44:43.789099|2017-10-10 21:44:43.789099
NCT02916199|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-24|2016-09-25|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method|Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method in Patients With High Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Multicenter Randomized Controlled Trial|Recruiting||Phase 3|202|Anticipated|Hallym University Kangnam Sacred Heart Hospital||2|||f||||t||||||||No||2017-10-10 21:44:43.856093|2017-10-10 21:44:43.856093
NCT02916186|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-26|||October 2016||2016-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of Subepithelial Connective Tissue Graft Versus Acellular Dermal Matrix With Tunnel Technique in Treatment of Multiple Gingival Recessions|Evaluation of Subepithelial Connective Tissue Graft Versus Acellular Dermal Matrix With Tunnel Technique in Treatment of Multiple Gingival Recessions (Randomized Clinical Trial, Parallel Design)|Not yet recruiting||N/A|68|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:44:43.980027|2017-10-10 21:44:43.980027
NCT02916173|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-25|||November 2016||2016-11-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Triggering of Follicular Maturation|Triggering of Follicular Maturation Using Human Chorionic Gonadotrophin With Gonadotrophin Releasing Hormone Agonist Versus Human Chorionic Gonadotrophin Alone in Antagonist Protocol in Assisted Reproductive Technology : a Randomized Controlled Trial|Not yet recruiting||Phase 3|148|Anticipated|Assiut University||2|||f||||f||||||||No||2017-10-10 21:44:44.06759|2017-10-10 21:44:44.06759
NCT02916160|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-04-10|||September 22, 2016|Actual|2016-09-22|March 2017|2017-03-01|June 22, 2019|Anticipated|2019-06-22|March 22, 2019|Anticipated|2019-03-22||Interventional|ENTRESTO696||Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study|Evaluation in Real Life Conditions of Sacubitril-valsartan Combination in Patients With Chronic Heart Failure and Sleep Apnea Syndrome|Recruiting||N/A|100|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:44:44.165695|2017-10-10 21:44:44.165695
NCT02916147|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-26|||October 2016||2016-10-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy|Comparison of Volatile and IV Anesthesia on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy|Not yet recruiting||N/A|40|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-10 21:44:44.294066|2017-10-10 21:44:44.294066
NCT02916134|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-11-23|||August 2016||2016-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|COMMA||Conservative Versus Operative ManageMent of Acute Uncomplicated Appendicitis|Conservative Versus Operative ManageMent of Acute Uncomplicated Appendicitis|Recruiting||Phase 2|400|Anticipated|Beaumont Hospital||2|||f||||f||||||||No||2017-10-10 21:44:44.389264|2017-10-10 21:44:44.389264
NCT02916121|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-22|||October 2016||2016-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia|Relationships of One-carbon Cycle Pathway With Psychopathology and Metabolic Abnormalities in Patients With Schizophrenia and Potential Intervention Strategy With Folic Acid and Vitamin B12|Not yet recruiting||N/A|88|Anticipated|Taipei Medical University WanFang Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:44:44.485819|2017-10-10 21:44:44.485819
NCT02916108|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-26|||October 2016||2016-10-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Interhemispheric Anterior Delta Desynchronization in Children Who Present to the Emergency Department With Acute Concussion: A Proof of Concept Study|Interhemispheric Anterior Delta Desynchronization in Children Who Present to the Emergency Department With Acute Concussion: A Proof of Concept Study|Not yet recruiting||N/A|60|Anticipated|Rambam Health Care Campus|||2||f||||f||||||||||2017-10-10 21:44:44.580763|2017-10-10 21:44:44.580763
NCT02916095|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-26|||November 2016||2016-11-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Kanitinib in Treating Patients With Advanced Solid Tumors|Evaluation Kanitinib Treatment of Recurrent or Metastatic Malignant Solid Tumors Safety, Tolerability and Pharmacokinetic Open, Dose Escalation Phase I Clinical Study|Not yet recruiting||Phase 1|45|Anticipated|Beijing Konruns Pharmaceutical Co., Ltd.||1|||f||||f||||||||No||2017-10-10 21:44:44.665593|2017-10-10 21:44:44.665593
NCT02916082|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-25|||November 2015||2015-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Observational|||Cervical Length Pre-induction as a Tool to Predict Vaginal Birth|Use of Cervical Length Previous to the Use of Prostaglandins as a Tool to Predict Vaginal Birth in Pregnancies With > 41 Weeks Gestation.|Completed||N/A|200|Actual|Saint Thomas Hospital, Panama|||1||f||||f||||||||||2017-10-10 21:44:44.736845|2017-10-10 21:44:44.736845
NCT02916069|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-07-05|||September 2016||2016-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Multi Modal Brain Monitoring and Cardiac Surgery|The Impact Multi Modal Brain Monitoring on Patient Out Come After Adult Cardiac Surgery|Recruiting||N/A|1200|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 21:44:44.801081|2017-10-10 21:44:44.801081
NCT02916043|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-11-13|||April 2016||2016-04-01|September 2016|2016-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Neutrophil, Lymphocyte and Platelet as a Predictor for AKI and Mortality|Risk Factor of Acute Kidney Injury After Open Heart Surgery With Cardiopulmonary Bypass|Completed||N/A|1099|Actual|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 21:44:45.094304|2017-10-10 21:44:45.094304
NCT02916030|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2016-09-25|||September 2016||2016-09-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Vitamin D and Stroke|Vitamin D and Stroke: A Comparative Study to Risk Factors and Stroke Type|Recruiting||N/A|50|Anticipated|Assiut University|||2||f||||t||||||||Undecided||2017-10-10 21:44:45.16095|2017-10-10 21:44:45.16095
NCT02916017|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-02|||November 18, 2016||2016-11-18|August 2017|2017-08-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Observational|||HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis|HUMIRA® Special Investigation (Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis)|Recruiting||N/A|250|Anticipated|AbbVie|||1||f||||||||||||||2017-10-10 21:44:45.242452|2017-10-10 21:44:45.242452
NCT02916004|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-06-07|||October 2016||2016-10-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients.|Responsiveness to Noxious Stimuli in Ventilated Intensive Care Unit (ICU) Patients With Propofol / Remifentanil Sedation Protocol by Using the Nociception Flexion Reflex (RIII Reflex) and the Pupillary Dilatation Reflex.|Recruiting||N/A|50|Anticipated|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-10 21:44:45.387653|2017-10-10 21:44:45.387653
NCT02915991|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-12-15|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|Prepare II||User Evaluation Study of SyncVision System With Software v4.X|Prospective, Single Arm, Open Label, User Evaluation Sudy of SyncVision System With Software v4.X|Recruiting||N/A|200|Anticipated|Volcano Corporation|||1||f||||f||||||||No||2017-10-10 21:44:45.485089|2017-10-10 21:44:45.485089
NCT02915978|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-02-23|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|February 10, 2017|Actual|2017-02-10|February 10, 2017|Actual|2017-02-10||Interventional|||Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain|A Phase 2 Multicenter, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain|Completed||Phase 2|45|Actual|INSYS Therapeutics Inc||3|||f||||f||||||||||2017-10-10 21:44:45.569296|2017-10-10 21:44:45.569296
NCT02915965|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-09-24|||October 2016||2016-10-01|September 2016|2016-09-01||||October 2018|Anticipated|2018-10-01||Interventional|||A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma|A Phase II Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma|Not yet recruiting||Phase 2|80|Anticipated|Sun Yat-sen University||1|||f||||||||||||||2017-10-10 21:44:45.650597|2017-10-10 21:44:45.650597
NCT02915952|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-08-02|||August 2016||2016-08-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|ZIPS-C||Zip Incision Approximation vs. Suture for C-Section|A Prospective, Non-blinded, Randomized Controlled Post-market Study Designed to Compare the Use of the Zip Surgical Skin Closure Device Versus Sutures for Skin Closure in Subjects Who Undergo a Cesarean Section Procedure.|Recruiting||N/A|60|Anticipated|ZipLine Medical Inc.||2|||f||||f||||||||||2017-10-10 21:44:45.716413|2017-10-10 21:44:45.716413
NCT02915939|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-03-13|||December 2016||2016-12-01|September 2016|2016-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|RCTM||The Residential Care Transition Module|The Residential Care Transition Module|Recruiting||N/A|240|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||Yes|Public access to the research data generated from this study will be offered via de-identified data files maintained by the Principal Investigator, Dr. Gaugler. All personal identifiers of family caregivers of persons with Alzheimer's disease or a related dementia (ADRD) participating in the study will be removed and replaced with random identification numbers prior to distributing WinZip data files. Dr. Gaugler plans to keep all data from the proposed 5-year project on the secure School of Nursing shared server folder for at least 7 years following study completion. Potential external investigators will be asked to complete a data user agreement. Dr. Gaugler will oversee the distribution of public data during the course of the funding period and for an indefinite time thereafter.|2017-10-10 21:44:45.796968|2017-10-10 21:44:45.796968
NCT02915926|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-05-02|||July 26, 2016|Actual|2016-07-26|May 2017|2017-05-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|||Occupational Performance Coaching in Mothers of Children With Cerebral Palsy||Completed||N/A|30|Actual|University of Social Welfare and Rehabilitation Science||2|||f|||||f|f||||||||2017-10-10 21:44:45.886258|2017-10-10 21:44:45.886258
NCT02915913|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|BrainFit||Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults|Effects of High Intensity Interval- vs Resistance or Combined- Training for Improving Cognitive Function and Neurotrophic Factors in Overweight Adults (BrainFit Study): Factorial Randomised Controlled Trial|Active, not recruiting||N/A|60|Anticipated|Universidad Santo Tomas||4|||f||||t||||||||No||2017-10-10 21:44:45.956086|2017-10-10 21:44:45.956086
NCT02915900|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-09-18|||October 2014||2014-10-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|December 2016|Actual|2016-12-01||Interventional|||Optimising FSH Dosage During in Vitro Fertilization Fertilization (IVF)|Method for Determining Optimal FSH Dosage During in Vitro Fertilization (IVF)|Completed||N/A|196|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 21:44:47.631687|2017-10-10 21:44:47.631687
NCT02915887|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-26|||January 2015||2015-01-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of Cervical Taping on Neck Pain and Kinematics in Patients With Chronic Neck Pain|The Short-term Effect of Cervical Taping on Neck Pain, Disability and Kinematics in Patients With Chronic Neck Pain: A Non-randomised Clinical Trial|Completed||N/A|27|Actual|University of Haifa||1|||f||||f||||||||No||2017-10-10 21:44:47.735557|2017-10-10 21:44:47.735557
NCT02915874|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-08-29|||October 2014||2014-10-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|January 2018|Anticipated|2018-01-01||Interventional|ACT on Anxiety||Does Treating Anxiety Symptoms With ACT Improve Vascular Inflammation and Function?||Recruiting||N/A|150|Anticipated|University of Iowa||2|||f||||f||||||||||2017-10-10 21:44:47.84288|2017-10-10 21:44:47.84288
NCT02915861|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||November 2016||2016-11-01|September 2016|2016-09-01||||November 2018|Anticipated|2018-11-01||Observational|EXIST||Eschar Investigations in Scrub Typhus|Eschar Investigations to Improve Diagnostics, Understand Early Immune Responses and Characterize Strains for Vaccines in Scrub Typhus|Not yet recruiting||N/A|36|Anticipated|University of Oxford|||4||f||||f||||||Samples With DNA|"     1. Non-invasive eschar samples        2. Eschar biopsy        3. Lymph node fine-needle aspiration biopsy (LN FNA)        4. Blood   "|No||2017-10-10 21:44:47.929933|2017-10-10 21:44:47.929933
NCT02915848|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-26|||July 2016||2016-07-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Long-term Stability of LFP Recorded From the STN and the Effects of DBS|Long-term Stability of Local Field Potentials Recorded From the Subthalamic Nucleus and the Effects of Deep Brain Stimulation|Recruiting||Phase 2|10|Anticipated|University Health Network, Toronto||1|||f||||t||||||||No||2017-10-10 21:44:48.031911|2017-10-10 21:44:48.031911
NCT02915835|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-05-09|||September 2016||2016-09-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|RESCUE||Riociguat in Scleroderma Associated Digital Ulcers|A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers|Recruiting||Phase 2|20|Anticipated|University of Michigan||2|||f||||t||||||||No||2017-10-10 21:44:48.140233|2017-10-10 21:44:48.140233
NCT02915822|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-23|||January 2017||2017-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||COSMIC Study - Comparing Open Scarf/Akin Osteotomy and Minimally Invasive Chevron/Akin. A Feasibility Study|COSMIC Study - Comparing Open Scarf/Akin Osteotomy and Minimally Invasive Chevron/Akin. A Feasibility Study|Not yet recruiting||Phase 2|100|Anticipated|Northumbria Healthcare NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:44:48.264698|2017-10-10 21:44:48.264698
NCT02915809|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-25|2016-09-27|||October 2016||2016-10-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults|A Randomized, Double-Blind, Multicenter Study to Compare the Immunological Efficacy and Safety of GC3110B With GCFLU Quadrivalent Inj. Administered Intramuscularly in Healthy Adults|Not yet recruiting||Phase 3|414|Anticipated|Green Cross Corporation||2|||f||||f||||||||No||2017-10-10 21:44:48.343208|2017-10-10 21:44:48.343208
NCT02914964|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-22|||August 2016||2016-08-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|||Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study|Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study|Recruiting||N/A|100|Anticipated|University of Iowa||2|||f||||t||||||||No||2017-10-10 21:46:33.694478|2017-10-10 21:46:33.694478
NCT02915796|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty|Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty: A Randomized Controlled Clinical Trial in Diabetic Patients With Below the Knee Critical Limb Ischemia|Recruiting||Phase 1|345|Anticipated|Shanghai 10th People's Hospital||3|||f||||f||||||||No||2017-10-10 21:44:48.443435|2017-10-10 21:44:48.443435
NCT02915783|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-10-05|||February 20, 2017|Actual|2017-02-20|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase 2 Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease|A Single-arm, Multicenter, Phase 2 Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease|Recruiting||Phase 2|31|Anticipated|Eisai Inc.||1|||f||||f|t|f||||||||2017-10-10 21:44:48.721443|2017-10-10 21:44:48.721443
NCT02915770|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-09-26|||December 2015||2015-12-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Clinical Application of Cholangiojejunostomy in the Surgical Treatment of Cholelithiasis With Moderate Dilatation of Common Bile Duct||Recruiting||N/A|1|Anticipated|Southwest Hospital, China||2|||f||||t||||||||Undecided||2017-10-10 21:46:27.284492|2017-10-10 21:46:27.284492
NCT02915757|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-09-26|||March 2015||2015-03-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|EUDOR-A||Electrodermal Hyporeactivity And Depression|Naturalistic Clinical Studies in Several Centres of Electrodermal Hyporeactivity in Adult Patients With Primary Depression|Active, not recruiting||N/A|112|Actual|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:46:27.40023|2017-10-10 21:46:27.40023
NCT02915744|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-07-26|||November 2016||2016-11-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|ATTAIN||A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine|A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine|Recruiting||Phase 3|350|Anticipated|Nektar Therapeutics||2|||f||||t||||||||||2017-10-10 21:46:27.495749|2017-10-10 21:46:27.495749
NCT02915731|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-23|||April 2016||2016-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Total Body Vitamin A Before and After Vitamin A Supplementation in a Community Where Liver is Frequently Eaten|Total Body Vitamin A Pool Size in Preschool Children Before and After Vitamin A Supplementation in an Impoverished South African Community Where Liver is Frequently Eaten and Children Exposed to Vitamin A Fortified Staple Foods|Completed||N/A|95|Actual|Medical Research Council, South Africa|||1||f||||f||||||Samples Without DNA|"     Serum   "|Undecided||2017-10-10 21:46:27.732751|2017-10-10 21:46:27.732751
NCT02915718|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-08|||October 2016||2016-10-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy|A Randomized, Open, Controlled Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy|Recruiting||N/A|40|Anticipated|Wuhan Union Hospital, China||2|||f||||t||||||||Yes||2017-10-10 21:46:27.814005|2017-10-10 21:46:27.814005
NCT02915705|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-05-02|||September 2016||2016-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|PIXLES||Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)|A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)|Recruiting||Phase 3|60|Anticipated|Ultragenyx Pharmaceutical Inc||2|||f||||t||||||||||2017-10-10 21:46:27.924042|2017-10-10 21:46:27.924042
NCT02915692|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-09-23|||October 2012||2012-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters|A Clinical Study to Compare the CAUTI Rates Following ERASE CAUTI Tray Silver Coated Foley Catheters Verse Silver Coated Foley Catheters|Terminated||N/A|753|Actual|Medline Industries|||2|Withdrawn funding|f||||f||||||||No||2017-10-10 21:46:28.116092|2017-10-10 21:46:28.116092
NCT02915679|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-09-23|||June 2015||2015-06-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|DOCS||Pain Perception in Suicidal Behavior Vulnerability|Pain Perception in Suicidal Behavior Vulnerability|Recruiting||N/A|424|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:46:28.191341|2017-10-10 21:46:28.191341
NCT02915666|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-11-22|||October 2016||2016-10-01|November 2016|2016-11-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Clinical Trial of Patients With Melanoma|A Phase 1B Clinical Trial of Dabrafenib, Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma|Recruiting||Phase 1|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:46:28.28847|2017-10-10 21:46:28.28847
NCT02915653|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|APPP||Adult Primary and Preventive Practice (APPP) Study|Adult Primary and Preventive Practice (APPP) Study|Recruiting||N/A|210|Anticipated|Qure Healthcare, LLC||3|||f||||t||||||||No||2017-10-10 21:46:28.40357|2017-10-10 21:46:28.40357
NCT02915640|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-26|||March 2015||2015-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Use of a Mobile Remote Device to Optimize Pediatric Inter-facility Transportation: A Feasibility Study|Remote Technology for Paediatric Patient Assessment, Stabilization and Triaging Prior to Paediatric Inter-facility Transportation: A Feasibility Study|Completed||N/A|69|Actual|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 21:46:28.588609|2017-10-10 21:46:28.588609
NCT02914574|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||June 2016||2016-06-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|PFP-FP||The Patellofemoral Pain Functional Performance Study|The Patellofemoral Pain Functional Performance and Arthrogenic Muscle Inhibition Study|Recruiting||N/A|40|Anticipated|University of Salford||1|||f||||f||||||||||2017-10-10 21:46:37.740157|2017-10-10 21:46:37.740157
NCT02915627|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-14|||November 2016||2016-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hemodynamic Responses in Hemodialysis Patients to Blood Flow Restriction Using Non-pneumatic Anti-shock Garments|Study to Examine the Hemodynamic Responses in Hemodialysis Patients to Blood Flow Restriction Using Non-pneumatic Anti-shock Garments|Recruiting||N/A|30|Anticipated|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-10 21:46:28.700221|2017-10-10 21:46:28.700221
NCT02915614|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-22|||December 2016||2016-12-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Effects of Pulmonary Rehabilitation on Skeletal Muscle in COPD Patients|Effects of Pulmonary Rehabilitation on Skeletal Muscle Morphology and Metabolism in PiMM vs. PiZZ COPD Patients|Not yet recruiting||N/A|40|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||Undecided||2017-10-10 21:46:28.790929|2017-10-10 21:46:28.790929
NCT02915601|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-07-14|||January 15, 2017|Actual|2017-01-15|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Bicarbonate Administration in CKD|Bicarbonate Administration in CKD|Recruiting||N/A|108|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 21:46:28.875246|2017-10-10 21:46:28.875246
NCT02915588|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-23|||January 2012||2012-01-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Early Active Rehabilitation After Arthroscopic Rotator Cuff Repair|Early Active Rehabilitation After Arthroscopic Rotator Cuff Repair: A Prospective Randomized Pilot Study|Completed||N/A|30|Actual|Johannes Kepler University of Linz||2|||f||||f||||||||No||2017-10-10 21:46:28.972741|2017-10-10 21:46:28.972741
NCT02915575|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-26|||October 2016||2016-10-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Improving Post Discharge Care After Acute Kidney Injury|Improving Post Discharge Care After Acute Kidney Injury|Not yet recruiting||N/A|166|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-10 21:46:29.064836|2017-10-10 21:46:29.064836
NCT02915562|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-09-23|||April 2016||2016-04-01|September 2016|2016-09-01||||October 2016|Anticipated|2016-10-01||Interventional|||Influence of Depressive Mood on Rehab Outcome|Influence of Depressive Mood on Short Term Rehab Outcome at an Acute Geriatrics Unit|Recruiting||N/A|100|Anticipated|Johannes Kepler University of Linz||2|||f||||f||||||||No||2017-10-10 21:46:29.189772|2017-10-10 21:46:29.189772
NCT02915549|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-08-03|||September 2016||2016-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Early Progressive Feeding in Human-Milk Fed Extremely Preterm Infants: A Randomized Trial|Early Progressive Feeding in Human-Milk Fed Extremely Preterm Infants: A Randomized Trial|Active, not recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 21:46:29.287363|2017-10-10 21:46:29.287363
NCT02915536|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-27|||January 2013||2013-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Observational|||Exploration of Effects of Excessive Iodine on Children and Tolerable Upper Intake Level of Iodine for Children|Exploration of Effects of Excessive Iodine on Children and Tolerable Upper Intake Level of Iodine for Children|Completed||N/A|2229|Actual|Tianjin Medical University|||1||f||||f||||||Samples With DNA|"     -  whole blood        -  24-h urine samples        -  spot urine samples   "|Undecided||2017-10-10 21:46:29.391788|2017-10-10 21:46:29.391788
NCT02915523|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-04-04|||January 10, 2017|Actual|2017-01-10|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer|A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer Which Has Progressed or Recurred After First-line Platinum-based Chemotherapy and at Least Two Subsequent Lines of Treatment With a Safety Lead-in|Recruiting||Phase 1/Phase 2|138|Anticipated|Syndax Pharmaceuticals||2|||f||||t||||||||No|An independent data safety monitoring board (DSMB) will be established for the Phase 2 portion of this study to act in an advisory capacity to the Sponsor with respect to safeguarding the interests of trial patients and assessing the safety of the interventions administered during the trial.|2017-10-10 21:46:29.495364|2017-10-10 21:46:29.495364
NCT02915510|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-09-22|||July 2016||2016-07-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||GMP Drink for PKU Study|Evaluating the Tolerance, Safety and Acceptability of PKU GMPro, a Whey Protein Derived Feed for the Dietary Management of Phenylketonuria in Children and Adults - a Pilot Trial|Recruiting||N/A|80|Anticipated|Nutricia UK Ltd||1|||f||||f||||||||No||2017-10-10 21:46:29.629468|2017-10-10 21:46:29.629468
NCT02915497|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-25|||February 2016|Actual|2016-02-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Early Prevention of PTSD in Patients Within One Week of Acute Physical Trauma|A Pilot Randomized Controlled Trial in Patients Within One Week of Acute Physical Trauma to Test the Feasibility and Effectiveness of Abbreviated Early Prolonged Exposure Therapy (AEPET) Plus Resilience Based Therapy (RBT) Versus RBT Alone for the Prevention of PTSD and Depression|Enrolling by invitation||N/A|20|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-10 21:46:29.723634|2017-10-10 21:46:29.723634
NCT02915484|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-09-29|||June 2016||2016-06-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|TDCS-PSA||Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy|Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy|Terminated||N/A|12|Anticipated|Stony Brook University||2||Difficulty with recruitment.|f||||f||||||||||2017-10-10 21:46:29.798449|2017-10-10 21:46:29.798449
NCT02915341|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-26|||December 2016||2016-12-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|AutoSense||Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network|Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network|Not yet recruiting||N/A|25|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||Yes|De-identified data will be reviewed by IRB and shared with DSMB every 6 months, as per the monitoring protocol set forth by the CTN and this study.|2017-10-10 21:46:29.890285|2017-10-10 21:46:29.890285
NCT02915328|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-23|||April 2016||2016-04-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection.||Recruiting||N/A|100|Anticipated|Centro Cardiologico Monzino||4|||f||||f||||||||No||2017-10-10 21:46:29.951886|2017-10-10 21:46:29.951886
NCT02915315|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-02-23|||February 28, 2017|Anticipated|2017-02-28|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|SHSL||Salt-sensitive Hypertension Study in Lantian County|Genetics Study of Salt-Sensitive Hypertension in a Chinese Population|Not yet recruiting||N/A|70|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||3||f||||f|f|f||||Samples With DNA|"     Lantian county adult salt-sensitive hypertension study is a family-based dietary     interventional study. Whole blood specimen was collected from each participant who underwent     a chronic salt load and potassium supplementation trial.Genomic DNA was extracted from whole     blood specimen using the GOLDMAG Whole Blood Genomic DNA Purification Kit.   "|No||2017-10-10 21:46:30.044915|2017-10-10 21:46:30.044915
NCT02915289|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery|Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery: A Randomized Comparator Controlled Trial|Recruiting||Phase 3|1500|Anticipated|Richmond University Medical Center||2|||f||||f||||||||||2017-10-10 21:46:30.290739|2017-10-10 21:46:30.290739
NCT02915276|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-23|||October 2016||2016-10-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effectiveness of Blastocentesis Versus Trophectoderm Biopsy|Comparison of Genomic DNA Analysis Between Blastocoele Fluid and Trophectoderm Biopsy in Human Embryos|Not yet recruiting||Early Phase 1|250|Anticipated|Center for Reproductive an Genetic Health||2|||f||||f||||||||No||2017-10-10 21:46:30.372465|2017-10-10 21:46:30.372465
NCT02915263|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-22|||September 11, 2017|Actual|2017-09-11|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes|A Double-Blind, Randomized, Placebo-Controlled Trial To Evaluate The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes|Recruiting||Phase 2|20|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|t|f||||||||2017-10-10 21:46:30.559896|2017-10-10 21:46:30.559896
NCT02915250|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-06-28|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes|A Randomised, Double-blind, Double-dummy, Three-period Cross-over Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes|Completed||Phase 1|36|Actual|Adocia||3|||f||||f||||||||No||2017-10-10 21:46:30.691893|2017-10-10 21:46:30.691893
NCT02915237|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-09-26|||August 2016||2016-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness|Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness|Recruiting||Phase 1/Phase 2|60|Anticipated|Icahn School of Medicine at Mount Sinai||6|||f||||t||||||||||2017-10-10 21:46:30.822227|2017-10-10 21:46:30.822227
NCT02915211|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-23|||April 2016||2016-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|Keyo||Evaluation of Keyo in Children With Epilepsy|A Feasibility Study to Evaluate the Acceptability of Keyo, a Food for Special Medical Purposes (FSMP) for Use in the Ketogenic Diet (KD) With Regard to Product Tolerance, Compliance and Acceptability|Completed||N/A|17|Actual|Vitaflo International, Ltd||1|||f||||f||||||||Undecided||2017-10-10 21:46:31.128211|2017-10-10 21:46:31.128211
NCT02915185|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-06-06|||April 28, 2017|Actual|2017-04-28|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Brain Stimulation and Tailored Interventions to Promote Recovery in Stroke Survivors|Combining Neurostimulation Technique With Tailored Interventions for the Affected Upper Extremity: Can it Promote Better Recovery in Stroke Survivors?|Recruiting||N/A|84|Anticipated|Université de Sherbrooke||2|||f||||t|f|f||||||No|The investigators are not planning on sharing individual data to the participants|2017-10-10 21:46:31.463499|2017-10-10 21:46:31.463499
NCT02915172|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-06-23|||December 2016||2016-12-01|June 2017|2017-06-01||||December 2022|Anticipated|2022-12-01||Interventional|||Lenvatinib and Capecitabine in Patients With Advanced Malignancies|A Phase I Trial of Lenvatinib (Multi-kinase Inhibitor) and Capecitabine (Anti-metabolite) in Patients With Advanced Malignancies|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:46:31.617168|2017-10-10 21:46:31.617168
NCT02915159|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-09-26|||December 6, 2016|Actual|2016-12-06|September 2017|2017-09-01|August 7, 2021|Anticipated|2021-08-07|September 18, 2019|Anticipated|2019-09-18||Interventional|||A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Primary Sjögrens Syndrome|Recruiting||Phase 3|172|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 21:46:31.775991|2017-10-10 21:46:31.775991
NCT02915146|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-05-01|||August 2016||2016-08-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|||Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema|A Randomised Assessor-blinded Study to Compare Narrowband Ultraviolet B With Combined Narrowband Ultraviolet B and Ultraviolet A1 for Atopic Eczema|Recruiting||N/A|40|Anticipated|University of Dundee||2|||f||||f||||||||Yes||2017-10-10 21:46:32.239777|2017-10-10 21:46:32.239777
NCT02915133|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-10-06|||October 2016||2016-10-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Observational|||The Relationship Between Structure and Visual Function in Myopia Foveoschisis|Correlation of Structural and Visual Function Changes in Myopia Foveoschisis Patients Undergoing Macular Buckle Surgery|Recruiting||N/A|20|Anticipated|Sun Yat-sen University|||1||f||||||||||||Undecided||2017-10-10 21:46:32.345345|2017-10-10 21:46:32.345345
NCT02915120|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-08-11|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|USPRFGENOAK||Ultrasound-Guided Pulsed Radiofrequency In The Treatment Of Patients With Osteoarthritis Knee (USPRFGENOAK)|Ultrasound-Guided Pulsed Radiofrequency Of The Genicular Nerves In The Treatment Of Patients With Osteoarthritis Knee Pain: Randomized, Double-Blind, Placebo Controled Trial|Recruiting||N/A|142|Anticipated|Hospital Son Llatzer||2|||f||||t|f|f||||||||2017-10-10 21:46:32.426443|2017-10-10 21:46:32.426443
NCT02915107|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-01-16|||September 2016||2016-09-01|January 2017|2017-01-01|September 2022|Anticipated|2022-09-01|September 2017|Anticipated|2017-09-01||Interventional|OCT STEMI SOIX||The SORT OUT IX STEMI OCT Trial|Randomized Comparison of Vascular Healing of a Polymer-Free Biolimus-eluting BIOFREEDOM Stent With a Biodegradable-Polymer Sirolimus-eluting ORSIRO Stent in Patients With ST-segment Elevation Myocardial Infarction|Recruiting||Phase 4|80|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-10 21:46:32.551251|2017-10-10 21:46:32.551251
NCT02915094|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-08-10|||October 2012||2012-10-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Kineret in the Treatment of Rheumatoid Arthritis|Kineret in the Treatment of Rheumatoid Arthritis|Completed||N/A|30|Actual|Swedish Orphan Biovitrum|||1||f||||f||||||||||2017-10-10 21:46:32.640774|2017-10-10 21:46:32.640774
NCT02915081|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2017-08-01|||October 1, 2018|Anticipated|2018-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Blue Light Therapy for Liver Surgery|Blue Light Therapy for Liver Surgery|Not yet recruiting||N/A|30|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||||2017-10-10 21:46:32.705921|2017-10-10 21:46:32.705921
NCT02915068|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-09-13|||June 2015||2015-06-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room|Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room|Completed||N/A|126|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 21:46:32.784081|2017-10-10 21:46:32.784081
NCT02915055|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-05-04|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|||NSAID vs. Narcotics|Multimodal Analgesia With NSAID vs. Narcotics Alone for Post-operative Meniscectomy: A Prospective Observational Study|Completed||N/A|77|Actual|New York University School of Medicine|||1||f||||f|t|f||||||||2017-10-10 21:46:32.858604|2017-10-10 21:46:32.858604
NCT02915042|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-23|2017-01-30|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Dexmedetomidine vs Placebo for Pediatric Cleft Palate Repair|A Randomized, Double-Blinded, Placebo Controlled Trial Using Single Dose Dexmedetomidine In The Treatment Of Pain In Patients Undergoing Cleft Palate Repair|Not yet recruiting||Phase 4|114|Anticipated|Baylor College of Medicine||2|||f||||f||||||||No||2017-10-10 21:46:32.946316|2017-10-10 21:46:32.946316
NCT02915029|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-23|||October 2013||2013-10-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|HBKC||Home-base Kidney Care in Zuni Indians|Reducing Health Disparity in Chronic Kidney Disease in Zuni Indians|Completed||N/A|125|Actual|University of New Mexico||2|||f||||f||||||||Undecided|Anonymized data will be available to share once the Zuni tribal leadership approves it.|2017-10-10 21:46:33.049805|2017-10-10 21:46:33.049805
NCT02915016|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-04-17|||December 2016||2016-12-01|April 2017|2017-04-01||||January 2018|Anticipated|2018-01-01||Interventional|||Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults|A Phase 1/2a Clinical Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DNA, and of MF59®- or AS01B-Adjuvanted Clade C Env Protein in Various Combinations, in Healthy, HIV-Uninfected Adult Participants|Recruiting||Phase 1/Phase 2|334|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||t||||||||||2017-10-10 21:46:33.132441|2017-10-10 21:46:33.132441
NCT02915003|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-09-14|||September 20, 2016|Actual|2016-09-20|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Partnership Approach to Enhance Health Care Literacy|A Partnership Approach to Enhance Health Care Literacy|Active, not recruiting||N/A|248|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 21:46:33.386213|2017-10-10 21:46:33.386213
NCT02914990|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-04-14|||October 2016||2016-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients|A Phase 1 Study of BPI-15086 in Patients With Epidermal Growth Factor Receptor T790M Mutation-positive Non-Small Cell Lung Cancer Who Have Progressed on Previous EGFR Tyrosine Kinase Inhibitor Therapy|Recruiting||Phase 1|80|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||No||2017-10-10 21:46:33.461526|2017-10-10 21:46:33.461526
NCT02914977|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Interventional|||Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia|A Pilot Study of Low-Dose Daunorubicin in Patients With Relapsed/Refractory Acute Leukemia|Recruiting||Phase 1|12|Anticipated|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-10 21:46:33.565761|2017-10-10 21:46:33.565761
NCT02914951|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability|Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents (An Open Pilot Study in Autism Spectrum Disorder)|Recruiting||N/A|6|Anticipated|Yale University||1|||f||||f||||||||||2017-10-10 21:46:33.93592|2017-10-10 21:46:33.93592
NCT02914938|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-29|||October 2016||2016-10-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|March 2020|Anticipated|2020-03-01||Interventional|||Study of ME-401 in Subjects With Relapsed/Refractory CLL/SLL or FL|A Phase 1b, Open-Label, Dose Escalation Study of ME-401 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Follicular Lymphoma (FL)|Recruiting||Phase 1|84|Anticipated|MEI Pharma, Inc.||1|||f||||f||||||||||2017-10-10 21:46:34.067204|2017-10-10 21:46:34.067204
NCT02914925|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-23|||February 2016||2016-02-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Combined Armeospring and CIT on Neuro-motor and Functional Recovery in Children With Unilateral CP|The Effect of Combined Armeospring Pediatric and Constraint Induced Therapy on Neuro-motor and Functional Recovery in Children With Unilateral Cerebral Palsy|Recruiting||N/A|10|Anticipated|St Mary's Hospital for Children||1|||f||||f||||||||Yes||2017-10-10 21:46:34.189382|2017-10-10 21:46:34.189382
NCT02914912|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01|12 Months|Observational [Patient Registry]|||Investigation of Chronic Intestinal Ischemia|Investigation of Chronic Intestinal Ischemia|Recruiting||Phase 1/Phase 2|50|Anticipated|Oslo University Hospital|||1||f||||t||||||||No||2017-10-10 21:46:34.309504|2017-10-10 21:46:34.309504
NCT02914899|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-06-13|||August 2016||2016-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for Chinese Taxi Drivers|Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for Chinese Taxi Drivers|Enrolling by invitation||N/A|112|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 21:46:34.389115|2017-10-10 21:46:34.389115
NCT02914886|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-04-20|||September 2016||2016-09-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|LAS||Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)|Lipoatrophy in Children, Adolescents and Adults With Modern Treatment Modalities: is There a Beneficial Effect of Insulin Glulisine?|Enrolling by invitation||Phase 4|24|Anticipated|Kinderkrankenhaus auf der Bult||2|||f||||t||||||||No||2017-10-10 21:46:34.492515|2017-10-10 21:46:34.492515
NCT02914873|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Interventional|PCASTT||SPCG17: Prostate Cancer Active Surveillance Trigger Trial|SPCG17: Prostate Cancer Active Surveillance Trigger Trial (PCASTT)|Recruiting||N/A|2000|Anticipated|Uppsala University||2|||f||||t||||||||Undecided||2017-10-10 21:46:34.623839|2017-10-10 21:46:34.623839
NCT02914860|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology||Recruiting||Phase 1/Phase 2|60|Anticipated|Meshalkin Research Institute of Pathology of Circulation||4|||f||||f||||||||||2017-10-10 21:46:34.74944|2017-10-10 21:46:34.74944
NCT02914847|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-04|||September 2016||2016-09-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|Imaginator||Imaginator: a Pilot of Brief Functional Imagery Training for Self-harm|Imaginator: a Pilot of a Brief Functional Imagery Training Intervention for Self-harm in Young People, Supported by a Smart-phone 'App'|Not yet recruiting||N/A|40|Anticipated|Medical Research Council||2|||f||||f||||||||Undecided||2017-10-10 21:46:34.865575|2017-10-10 21:46:34.865575
NCT02914834|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-13|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|AIMS-A||Acupuncture for Women With Stable Angina|Feasibility Testing of a Randomized Controlled Trial of Acupuncture to Improve Symptoms for Women With Stable Angina (AIMS-A)|Not yet recruiting||N/A|26|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||Yes|One year after study completion deidentified data will be completed.|2017-10-10 21:46:34.979048|2017-10-10 21:46:34.979048
NCT02914821|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2017-04-17|||September 1, 2016|Actual|2016-09-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Do Taxes Reduce the Purchasing of Soda?|Do Taxes Reduce the Purchasing of Soda?|Terminated||N/A|50|Actual|Harvard University||4||Harvard University dining workers went on strike, we hope to relaunch in Fall 2017.|f||||||||||||No||2017-10-10 21:46:35.11884|2017-10-10 21:46:35.11884
NCT02914808|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-12-22|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|CHROEDEM||Oedema Study : Chroedem|Assessment of Tissue and Biomolecular Complements of Lower Limb Chronic Oedema|Not yet recruiting||N/A|48|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 21:46:35.20688|2017-10-10 21:46:35.20688
NCT02914795|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-09-22|||June 2015||2015-06-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Platelet Function in Resuscitated Patients|Platelet Function in Resuscitated Patients|Completed||N/A|23|Actual|Medical University of Graz|||2||f||||f||||||||No||2017-10-10 21:46:35.301054|2017-10-10 21:46:35.301054
NCT02914782|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01|2 Weeks|Observational [Patient Registry]|Clinibil||Investigation of Fluid- and Electrolyte Balance in Post Cardiac-surgery Patients|An Open Monocentric Observational Study to Investigate Fluid- and Electrolyte Balance in Post Cardiac-surgery Patients in the ICU|Recruiting||N/A|50|Anticipated|Medical University of Graz|||1||f||||f||||||Samples Without DNA|"     In the course of the stay at the ICU we will collect serum and urine samples during routine     patient care to analyze for electrolytes, oxygen and kidney biomarkers.   "|||2017-10-10 21:46:35.431788|2017-10-10 21:46:35.431788
NCT02914769|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-02-15|||February 2014||2014-02-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression|Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression|Completed||Phase 1/Phase 2|35|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||t||||||||No||2017-10-10 21:46:35.547545|2017-10-10 21:46:35.547545
NCT02914756|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||September 2014||2014-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||HMGB1 in ICU-survivors|Cognitive Impairment After Critical Illness, Links Between Sepsis, Cognitive Function and Non-resolving Inlflammation.|Recruiting||N/A|140|Anticipated|Karolinska University Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 21:46:35.674508|2017-10-10 21:46:35.674508
NCT02914743|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-03|||November 2016||2016-11-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Providing Preventive Periodontal Treatment to Hospitalized Patients With Diabetes|Providing Preventive Periodontal Treatment to Hospitalized Patients With Diabetes|Enrolling by invitation||N/A|90|Actual|Massachusetts General Hospital||3|||f||||f||||||||||2017-10-10 21:46:35.774356|2017-10-10 21:46:35.774356
NCT02914730|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-02-28|||September 2016||2016-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Observational|||Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections||Recruiting||N/A|125|Anticipated|Joslin Diabetes Center|||1||f||||||||||||||2017-10-10 21:46:35.885547|2017-10-10 21:46:35.885547
NCT02914717|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Observational|BE SMART||The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis|One Year Outcome of Golimumab for Patients With Moderate-to-severe Ulcerative Colitis: a Retrospective Multi-centre Belgian Cohort Study|Not yet recruiting||N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||Undecided||2017-10-10 21:46:35.952152|2017-10-10 21:46:35.952152
NCT02914704|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-09-22|||January 2016||2016-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU)|Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU)|Recruiting||N/A|100|Anticipated|Turku University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:46:36.037905|2017-10-10 21:46:36.037905
NCT02914691|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-26|||August 2015||2015-08-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Interventional|DapKid||Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes|Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes|Recruiting||Phase 4|40|Anticipated|Steno Diabetes Center||2|||f||||t||||||||No||2017-10-10 21:46:36.107112|2017-10-10 21:46:36.107112
NCT02914678|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-22|||October 2016||2016-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Is There an Ideal Dose of Intravenous Fentanyl in the Prehospital Setting|Is There an Ideal Dose of Intravenous Fentanyl in the Prehospital Setting: A Prospective Cluster-randomized Comparison of 2 vs. 3 μg/kg/Transport|Not yet recruiting||N/A|7093|Anticipated|University of Aarhus||2|||f||||f||||||||No||2017-10-10 21:46:36.19398|2017-10-10 21:46:36.19398
NCT02914665|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-12|||September 2016||2016-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure|Recruiting||Phase 2|300|Anticipated|Stealth BioTherapeutics Inc.||2|||f||||t||||||||||2017-10-10 21:46:36.283192|2017-10-10 21:46:36.283192
NCT02914652|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-23|||October 2016||2016-10-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.|The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Ventrucular Septal Defect Patients With Persistant or Surgically Corrected Conditions - The VENTI Trial|Not yet recruiting||Phase 4|90|Anticipated|University of Aarhus||3|||f||||t||||||||Yes||2017-10-10 21:46:36.464266|2017-10-10 21:46:36.464266
NCT02914639|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-07-19|||October 5, 2016|Actual|2016-10-05|July 2017|2017-07-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)|A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Neovascular Age-related Macular Degeneration (AMD)|Completed||Phase 1/Phase 2|44|Actual|SciFluor Life Sciences, Inc.||2|||f||||f||||||||||2017-10-10 21:46:36.574236|2017-10-10 21:46:36.574236
NCT02914626|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-24|||October 2016||2016-10-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study|Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study|Not yet recruiting||Phase 3|28|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 21:46:36.674158|2017-10-10 21:46:36.674158
NCT02914613|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-30|||August 24, 2016|Actual|2016-08-24|May 2017|2017-05-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|||Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)|A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)|Completed||Phase 1/Phase 2|44|Actual|SciFluor Life Sciences, Inc.||2|||f||||f||||||||||2017-10-10 21:46:36.741582|2017-10-10 21:46:36.741582
NCT02914587|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-02-09|||August 2016||2016-08-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study|Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study|Active, not recruiting||N/A|32|Actual|Restoration Robotics, Inc.||2|||f||||f||||||||||2017-10-10 21:46:37.653502|2017-10-10 21:46:37.653502
NCT02914561|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-10-03|||October 2016|Actual|2016-10-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease|Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Crohn's Disease|Recruiting||Phase 3|1320|Anticipated|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 21:46:37.873042|2017-10-10 21:46:37.873042
NCT02914548|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-07-14|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Study of OPA-15406 Ointment in Patients With Atopic Dermatitis|A Multi-center, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Assess the Efficacy and Safety of OPA-15406 Ointment in Patients With Atopic Dermatitis|Completed||Phase 2|200|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-10 21:46:38.465945|2017-10-10 21:46:38.465945
NCT02914522|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-09-18|||November 14, 2016|Actual|2016-11-14|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis|Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis|Recruiting||Phase 3|1300|Anticipated|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 21:46:40.508294|2017-10-10 21:46:40.508294
NCT02914509|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-09-13|||September 2016|Actual|2016-09-01|September 2017|2017-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||OTX-16-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-TP in Subjects With Open-Angle Glaucoma and Ocular Hypertension|A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3A Study Evaluating the Safety and Efficacy of OTX-TP in the Treatment of Subjects With Open-Angle Glaucoma or Ocular Hypertension|Recruiting||Phase 3|550|Anticipated|Ocular Therapeutix, Inc.||2|||f||||||||||||||2017-10-10 21:46:42.595461|2017-10-10 21:46:42.595461
NCT02914496|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-22|||October 2016||2016-10-01|September 2016|2016-09-01|October 2021|Anticipated|2021-10-01|October 2017|Anticipated|2017-10-01||Interventional|||ACT Stress Management in Type 1 Diabetes|"Diabetes in Balance - a Randomized Controlled Trial to Evaluate the Effects on Glucose Control, Self-care and Psychosocial Factors?"|Enrolling by invitation||N/A|70|Anticipated|Karolinska Institutet||2|||f||||f||||||||No|Data will primarily be presented at the group level. Individual data will where appropriate be anonymised|2017-10-10 21:46:42.692989|2017-10-10 21:46:42.692989
NCT02914483|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-01-04|||August 2016||2016-08-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|HARP||Women's Heart Attack Research Program: Stress Ancillary Study|Women's Heart Attack Research Program: Stress Ancillary Study; Telephone-Based Stress Management for Women With Myocardial Infarction|Recruiting||N/A|200|Anticipated|New York University School of Medicine||2|||f||||t||||||||Yes|De-identified data will be shared after the end of the study.|2017-10-10 21:46:42.776693|2017-10-10 21:46:42.776693
NCT02914470|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-09-12|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|August 2017|Actual|2017-08-01||Interventional|PROLOG||Carboplatin-cyclophosphamide Combined With Atezolizumab|A Phase 1b to Assess the Safety and Tolerability of Carboplatin-cyclophosphamide Combined With Atezolizumab, an Antibody That Targets Programmed Death Ligand 1 (PD-L1), in Patients With Advanced Breast Cancer and Gynaecologic Cancer|Active, not recruiting||Phase 1|12|Anticipated|The Netherlands Cancer Institute||1|||f||||t|f|f||||||||2017-10-10 21:46:42.876015|2017-10-10 21:46:42.876015
NCT02914457|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-03-07|||November 7, 2016|Actual|2016-11-07|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|SYNSEQ||Left Ventricular Synchronous Versus Sequential MultiSpot Pacing for Cardiac Resynchronization Therapy (CRT)|Left Ventricular Synchronous Versus Sequential MultiSpot Pacing for CRT|Recruiting||N/A|40|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||3|||f||||f||||||||Undecided||2017-10-10 21:46:42.949739|2017-10-10 21:46:42.949739
NCT02914444|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-23|||June 2015||2015-06-01|September 2016|2016-09-01|June 2025|Anticipated|2025-06-01|June 2025|Anticipated|2025-06-01|1 Day|Observational [Patient Registry]|||Registry Construction of Intraoperative Vital Signs and Clinical Information in Surgical Patients|Registry Construction of Intraoperative Vital Signs and Clinical Information for Retrospective Cohort Study in Surgical Patients|Recruiting||N/A|200000|Anticipated|Seoul National University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:46:43.045945|2017-10-10 21:46:43.045945
NCT02914431|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-10-01|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Personalized Titanium Plates vs CAD/CAM Surgical Splints in Maxillary Repositioning of Orthognathic Surgery|A Randomized Controlled Trial of the Accuracy of Maxillary Repositioning Using Personalized Titanium Plates vs CAD/CAM Surgical Splints in Orthognathic Surgery|Not yet recruiting||Phase 4|72|Anticipated|Shanghai 9th People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:46:43.108531|2017-10-10 21:46:43.108531
NCT02914418|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-05-04|||January 2016||2016-01-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|TUSI||Transcranial Magnetic Stimulation (TMS) for Upper Limb Dysfunction in Spinal Cord Injury: a Feasibility Study|Feasibility Study to Investigate the Effects of Transcranial Magnetic Stimulation (TMS) Using Theta Burst Stimulation (TBS) to Treat Upper Limb Dysfunction and Spasticity in Patients With Spinal Cord Injury|Completed||N/A|12|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||Undecided||2017-10-10 21:46:43.186489|2017-10-10 21:46:43.186489
NCT02914405|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|Inbraced||Phase I Study of Investigational Medicinal Products in Children With Relapsed/Refractory Neuroblastoma|A Phase I Study of 131-1 Meta-iodobenzylguanidine (mIBG) Followed by Nivolumab and Chimeric 14.18 Anti-GD2 Monoclonal Antibody Produced in Chinese Hamster Ovary Cells (ch14.18/CHO) in Children With Relapsed/Refractory Neuroblastoma|Not yet recruiting||Phase 1|36|Anticipated|University Hospital Southampton NHS Foundation Trust||1|||f||||t|f|f||||||||2017-10-10 21:46:43.283354|2017-10-10 21:46:43.283354
NCT02914392|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01||Observational|||Study on the Relationship Between Maternal Exposure to Environmental Factors and Fetal Congenital Heart Disease|Multi-center Clinical Study on the Relationship Between Maternal Exposure to Important Environmental Factors and Fetal Congenital Heart Disease|Not yet recruiting||N/A|600|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||Samples Without DNA|"     The content of folic acid in serum of cases and controls is determined.   "|Undecided||2017-10-10 21:46:43.536221|2017-10-10 21:46:43.536221
NCT02914379|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-12-09|||September 2016||2016-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of LY3337641 in Healthy Male Participants|Disposition of [¹⁴C]-LY3337641 Following Oral Administration in Healthy Male Subjects|Completed||Phase 1|6|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 21:46:43.607701|2017-10-10 21:46:43.607701
NCT02914366|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-03-06|||November 2015||2015-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Ambroxol as a Treatment for Parkinson's Disease Dementia|Ambroxol as a Novel Disease Modifying Treatment for Parkinson's Disease Dementia|Recruiting||Phase 2|75|Anticipated|Lawson Health Research Institute||3|||f||||t||||||||Yes|"Peer reviewed publication | Presentation"|2017-10-10 21:46:43.695501|2017-10-10 21:46:43.695501
NCT02914353|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-30|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate The Safety Tolerability, Pharmacokinetics, and Pharmacodynamcs of Single and Multiple Ascending Doses of EP-7041 in Hea;Thy Subjects|Completed||Phase 1|80|Actual|eXIthera Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 21:46:43.834963|2017-10-10 21:46:43.834963
NCT02914340|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-03-21|||September 2016||2016-09-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||REACH SVS Control Patient Cross-Over Study|REACH (Research to Assess SVS Safety and Effectiveness for the Treatment of Severe EmphysemA in China) SVS Control Patient Cross-Over Study|Active, not recruiting||N/A|20|Anticipated|Spiration, Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:46:43.938768|2017-10-10 21:46:43.938768
NCT02914327|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-04-25|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Activity of SNX-5422 Plus Ibrutinib in CLL|A Phase 1, Open-label Study of SNX‑5422 and Ibrutinib in Chronic Lymphocytic Leukemia Subjects With a Mutation in Bruton's Tyrosine Kinase|Recruiting||Phase 1|10|Anticipated|Esanex Inc.||1|||f||||f|t|f||||||No||2017-10-10 21:46:44.007874|2017-10-10 21:46:44.007874
NCT02914314|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-11|||February 20, 2017|Actual|2017-02-20|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy|An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 24 Months (<2 Years) of Age With Epilepsy|Recruiting||Phase 2|16|Anticipated|Eisai Inc.||1|||f||||t|t|f||||||||2017-10-10 21:46:44.11342|2017-10-10 21:46:44.11342
NCT02914301|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-01|||July 2015||2015-07-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|SPROUT||Mobile App for Prenatal Care to Reduce Visits and Improve Satisfaction Study|Effectiveness of a Mobile App for Prenatal Care to Safely Reduce In-Person Visits and Improve Patient Satisfaction: Study Protocol for a Multicenter Prospective Quasi-Randomized Trial|Completed||N/A|181|Actual|George Washington University||2|||f||||f||||||||||2017-10-10 21:46:44.260043|2017-10-10 21:46:44.260043
NCT02914288|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-22|||April 2016||2016-04-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI|Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI|Recruiting||N/A|20|Anticipated|Asan Medical Center|||1||f||||t||||||||||2017-10-10 21:46:44.337169|2017-10-10 21:46:44.337169
NCT02914275|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-08-21|||September 2016||2016-09-01|August 2017|2017-08-01|August 17, 2017|Actual|2017-08-17|March 9, 2017|Actual|2017-03-09||Interventional|||A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.|A Phase 3, Randomized, Multicenter, Observer-blinded, Noninferiority Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Inactivated Influenza Virus Vaccine (Seqirus QIV) With a US-licensed Quadrivalent Inactivated Comparator Influenza Virus Vaccine (Comparator QIV) in a Pediatric Population 6 Months Through 59 Months of Age|Completed||Phase 3|2251|Actual|Seqirus||4|||f||||t||||||||||2017-10-10 21:46:44.422032|2017-10-10 21:46:44.422032
NCT02914262|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-03-15|||August 2016||2016-08-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers|Phase 1a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of AKB 4924 in Healthy Male Volunteers|Completed||Phase 1|40|Actual|Aerpio Therapeutics||2|||f||||f||||||||No||2017-10-10 21:46:44.575485|2017-10-10 21:46:44.575485
NCT02914249|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-26|||September 2015||2015-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|LCD-OJ-OBESE||Effect of Low-calorie Diet and Orange Juice on Body Weight and Metabolic Parameters of Obese Subjects|Low-calorie Diet Combined With Orange Juice Results in Weight Loss: Randomized Controlled Trial|Completed||N/A|78|Actual|São Paulo State University||2|||f||||f||||||||||2017-10-10 21:46:44.657142|2017-10-10 21:46:44.657142
NCT02914236|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-06-04|||September 2016||2016-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Nasal Airway Obstruction Using the Aerin Medical Device|A Prospective, Multi-Center Non-Randomized Study to Evaluate Treatment of Nasal Airway Obstruction Using the Aerin Medical Device|Active, not recruiting||N/A|50|Actual|Aerin Medical||1|||f||||f||||||||No||2017-10-10 21:46:44.742787|2017-10-10 21:46:44.742787
NCT02914223|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-07-25|||September 1, 2016||2016-09-01|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||A Study to Evaluate Cenerimod in Healthy Male Subjects|Single-center, Open-label Study With 14C-radiolabeled Cenerimod to Investigate the Mass Balance, Pharmacokinetics, and Metabolism Following Single Oral Administration to Healthy Male Subjects|Completed||Phase 1|6|Actual|Actelion||2|||f||||f|f|||||||||2017-10-10 21:46:44.842314|2017-10-10 21:46:44.842314
NCT02914210|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-08-02|||October 2016|Actual|2016-10-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Virtual vs. Traditional Physical Therapy Following Total Knee Replacement|Virtual Exercise Rehabilitation In-home Therapy: A Randomized Study (VERITAS)|Recruiting||N/A|300|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 21:46:44.915117|2017-10-10 21:46:44.915117
NCT02914197|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-08-28|||November 2016||2016-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Implementation of Provision of Balanced Information on Mammography in Family Practice|Implementation of Provision of Balanced Information on Mammography in Family Practice: a Randomized Controlled Trial|Not yet recruiting||N/A|608|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 21:46:45.037826|2017-10-10 21:46:45.037826
NCT02914171|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|September 2020|Anticipated|2020-09-01||Interventional|Ebstein||Study of Autologous Bone Marrow Derived Mononuclear Cells for Treatment of Ebstein Anomaly|Phase I Safety and Feasibility Study of Intramyocardial Delivery of Autologous Bone Marrow Derived Mononuclear Cells to Right Ventricle of Patients With Ebstein Anomaly During Cardiac Surgery|Recruiting||Phase 1|20|Anticipated|Mayo Clinic||2|||f||||t||||||||No||2017-10-10 21:46:45.666328|2017-10-10 21:46:45.666328
NCT02914158|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2017-08-01|||April 2016||2016-04-01|August 2017|2017-08-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|ASPAIT||Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women|Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen for Hormone Receptor-Positive Breast Cancer in Women Younger Than 35: A Multicenter Randomized Clinical Trial|Recruiting||Phase 3|680|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 21:46:45.787344|2017-10-10 21:46:45.787344
NCT02914145|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-22|||November 2015||2015-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MDAM||Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique|Mass Drug Administration of Monthly DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique|Active, not recruiting||N/A|50000|Anticipated|Centro de Investigacao em Saude de Manhica||1|||f||||t||||||||Undecided||2017-10-10 21:46:45.972271|2017-10-10 21:46:45.972271
NCT02914132|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-06-16|||February 2016||2016-02-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis|Safety and Performance Evaluation of the Seraph® 100 Microbind® Affinity Blood Filter for Reducing Bacteremia in Patients on Hemodialysis|Recruiting||N/A|15|Anticipated|ExThera Medical Corporation||1|||f||||t||||||||Undecided||2017-10-10 21:46:46.054908|2017-10-10 21:46:46.054908
NCT02914119|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-10-02|||October 1, 2016|Actual|2016-10-01|October 2017|2017-10-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01|1 Day|Observational [Patient Registry]|||Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals|Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals - a Cross-sectional Study|Completed||N/A|30126|Actual|Herlev Hospital|||1||f||||t||||||||||2017-10-10 21:46:46.151736|2017-10-10 21:46:46.151736
NCT02914106|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-22|||June 2014||2014-06-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Neuroactive Steroids in Acute Ischemic Stroke|Neuroactive Steroids in Acute Ischemic Stroke: Association With Cognitive, Functional and Neurological Outcomes.|Completed||N/A|60|Actual|Hospital Militar Central, Argentina|||2||f||||t||||||||Yes||2017-10-10 21:46:46.250278|2017-10-10 21:46:46.250278
NCT02914093|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|THYPISK-f||IMT in Hypercapnic Patients With COPD|Feasibility of Inspiratory Muscle Training in Patients With Chronic Hypercapnia and Severe Chronic Obstructive Pulmonary Disease|Not yet recruiting||N/A|10|Anticipated|Hvidovre University Hospital||1|||f||||t||||||||No||2017-10-10 21:46:46.344634|2017-10-10 21:46:46.344634
NCT02914080|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-22|||November 2014||2014-11-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|MUTAC||Validation of a Psychological Fragility Questionnary in the Elderly in Isolation||Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 21:46:46.440819|2017-10-10 21:46:46.440819
NCT02914067|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-03-03|||October 26, 2016|Actual|2016-10-26|March 2017|2017-03-01|January 30, 2022|Anticipated|2022-01-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Cognitive Biomarkers in Pediatric Brain Tumor Patients|Cognitive Biomarkers in Pediatric Brain Tumor Patients|Recruiting||Phase 1|60|Anticipated|Washington University School of Medicine||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:46:46.504511|2017-10-10 21:46:46.504511
NCT02914054|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-15|||October 1, 2016|Actual|2016-10-01|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|September 15, 2017|Actual|2017-09-15||Interventional|||Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone|Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With 3 Cycles Pulses of High-dose Dexamethasone (HD-DXM)|Completed||Phase 2/Phase 3|36|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-10 21:46:46.62087|2017-10-10 21:46:46.62087
NCT02914041|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-08-18|||February 2016||2016-02-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|December 2016|Actual|2016-12-01||Observational|||Kyphotic Measure Using Distance From the Wall|Kyphotic Measure Using Distance From the Wall: Reliability, Validity and Distance From the Wall to Indicate Risk for Spinal Fracture|Enrolling by invitation||N/A|96|Anticipated|Khon Kaen University|||1||f||||f||||||||||2017-10-10 21:46:46.709276|2017-10-10 21:46:46.709276
NCT02914028|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-23|||April 2016||2016-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||TAP Block and Subacute Pain in Inguinal Herniography|Evaluation of the Effects of Subcostal Transversus Abdominis Plane Block on Subacute Pain Development Following Inguinal Herniography: a Randomized Clinical Study|Completed||N/A|2|Actual|Istanbul University||2|||f||||f||||||||No||2017-10-10 21:46:46.771103|2017-10-10 21:46:46.771103
NCT02914015|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Ultrasound-guided Continous Quadratus Lumborum Block: Effect on Acute Pain and Quality of Recovery After Hepatic Surgery With Right Subcostal Incision||Recruiting||N/A|62|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-10 21:46:46.841558|2017-10-10 21:46:46.841558
NCT02914002|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-23|||June 2016||2016-06-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Psychoeducational Intervention Model to Improve Nutritional Status in Low Resource Settings|A Psychoeducational Intervention Model in Nutrition to Improve Nutritional Status in 15 Low Resource Populations Through a Network of Food Banks in Mexico.|Recruiting||N/A|14400|Anticipated|Universidad de Monterrey||3|||f||||t||||||||No||2017-10-10 21:46:46.939963|2017-10-10 21:46:46.939963
NCT02913989|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-22|||March 2014||2014-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|June 2014|Actual|2014-06-01||Observational|||Characterization of Smoking Habits Patterns in Medical Doctors of a Central Hospital in Portugal - What Has Changed After 15 Years? A Comparative Cross-sectional Study||Completed||N/A|423|Actual|Centro Hospitalar Lisboa Ocidental|||2||f||||||||||||||2017-10-10 21:46:47.043162|2017-10-10 21:46:47.043162
NCT02913976|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-12-21|||October 2016||2016-10-01|September 2016|2016-09-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Changes on Pain and Range of Motion by the Use of Kinesio Taping in Patients Diagnosed With Cervical Pain|Changes on Pain and Range of Motion by the Use of Kinesio Taping in With Its Corrective of Space Variant on Upper Trapezius Muscle in Patients Diagnosed With Cervical Pain|Completed||N/A|30|Actual|Cardenal Herrera University||2|||f||||f||||||||No||2017-10-10 21:46:47.101748|2017-10-10 21:46:47.101748
NCT02913963|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-12-21|||October 2016||2016-10-01|September 2016|2016-09-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Changes on Pain and Range of Motion by the Use of Kinesio Taping in Subjects With Myofascial Trigger Point|Changes on Pain and Range of Motion by the Use of Kinesio Taping With Its Corrective of Space Variant on Upper Trapezius Muscle in Subjects With Myofascial Trigger Point|Completed||N/A|102|Actual|Cardenal Herrera University||2|||f||||f||||||||No||2017-10-10 21:46:47.194606|2017-10-10 21:46:47.194606
NCT02913950|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-27|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Pediatric Bristol Stool Scale|Pediatric Bristol Stool Scale|Not yet recruiting||N/A|100|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||f||||||||Yes||2017-10-10 21:46:47.276445|2017-10-10 21:46:47.276445
NCT02913937|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-02-07|||February 2017|Anticipated|2017-02-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Passive Ultrasonic Irrigation Versus Needle Irrigation on Postoperative Pain and Periapical Healing|Comparison of Postoperative Pain and Healing After Passive Ultrasonic Irrigation and Needle Irrigation in Patients With Apical Periodontitis: A Randomized Clinical Trial|Not yet recruiting||N/A|66|Anticipated|Cairo University||2|||f||||f|f|f||||||Undecided||2017-10-10 21:46:47.351606|2017-10-10 21:46:47.351606
NCT02913924|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-05-15|||September 2016||2016-09-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|||Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients|Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients: Combined Inpatient/Outpatient Study|Recruiting||Phase 2|80|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-10 21:46:47.437399|2017-10-10 21:46:47.437399
NCT02913911|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-28|||November 2015||2015-11-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Sit-to-stand With Feedback in SCI Patients|The Provision of External Feedback During Sit-to-stand in Ambulatory Patients With Spinal Cord Injury|Active, not recruiting||N/A|15|Actual|Khon Kaen University||2|||f||||f||||||||No||2017-10-10 21:46:47.534504|2017-10-10 21:46:47.534504
NCT02913898|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Dynamic Learning in Depression|Dynamic Learning in Depression|Recruiting||N/A|120|Anticipated|University of Oxford||2|||f||||f||||||||Yes|Anonymised data will be shared with researchers who contact the PI after study completion.|2017-10-10 21:46:47.604022|2017-10-10 21:46:47.604022
NCT02913885|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-23|||January 2017||2017-01-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Curodont Repair on Color Change of White Spot Lesions|Comparative Study Using Biomimetic Remineralization Versus Fluoride Varnish In Management Of White Spot Lesion In Post Orthodontic Treated Patient: (Split Mouth Technique ) A Randomized Clinical Trial|Not yet recruiting||Phase 2|64|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:46:47.871851|2017-10-10 21:46:47.871851
NCT02913872|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-21|||June 2016||2016-06-01|September 2016|2016-09-01||||February 2018|Anticipated|2018-02-01||Observational|CHAMPIONS||Childhood Asthma Management in Primary Care: Implementation Of Exhaled Nitric Oxide and Spirometry Testing|Childhood Asthma Management in Primary Care: Implementation Of Exhaled Nitric Oxide and Spirometry Testing|Recruiting||N/A|500|Anticipated|University of Leicester|||1||f||||||||||||||2017-10-10 21:46:47.974058|2017-10-10 21:46:47.974058
NCT02913859|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-21|||December 2016||2016-12-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer|Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer|Not yet recruiting||Phase 2|60|Anticipated|"University Hospital Sestre Milosrdnice"||2|||f||||f||||||||Yes||2017-10-10 21:46:48.077501|2017-10-10 21:46:48.077501
NCT02913846|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Impact of Denutrition on the Hospital Length of Stay for Patients Undergoing Rehabilitation|The Impact of Denutrition on the Hospital Length of Stay for Patients Undergoing Rehabilitation|Recruiting||N/A|180|Anticipated|Brugmann University Hospital|||1||f||||f||||||||No||2017-10-10 21:46:48.220336|2017-10-10 21:46:48.220336
NCT02913833|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Impact of Pain Assessment on the Hospital Length of Stay of Patients in a Rehabilitation Unit|The Impact of Pain Assessment on the Hospital Length of Stay of Patients in a Rehabilitation Unit|Recruiting||N/A|180|Anticipated|Brugmann University Hospital||2|||f||||f||||||||No||2017-10-10 21:46:48.330524|2017-10-10 21:46:48.330524
NCT02913807|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-08-09|||December 2016||2016-12-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Traditional Versus Computerized Mandibular Reconstruction|The Utility and Effectiveness of Computer-Assisted, Customized Reconstruction of the Mandible|Enrolling by invitation||N/A|20|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:46:48.506196|2017-10-10 21:46:48.506196
NCT02913794|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-07-25|||October 11, 2016|Actual|2016-10-11|September 2016|2016-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|FIMARO||Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control|A Single-center Cross-sectional Study to Evaluate the Effectiveness of Antihypertensive Treatment Including Fimasartan and the Dyslipidemia Treatment Including Rosuvastatin and to Assess the Association Between the Two Treatments|Recruiting||N/A|1056|Anticipated|Boryung Pharmaceutical Co., Ltd|||1||f||||f||||||||||2017-10-10 21:46:48.581688|2017-10-10 21:46:48.581688
NCT02913781|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2017-02-05|||February 2016||2016-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|PBRBICSI||Polar Body Removal Before ICSI for Oocyte Activation in Previous Fertilization Failure Cases|Polar Body Removal Before ICSI as a Method of Oocyte Activation in Previous Fertilization Failure Cases|Recruiting||N/A|50|Anticipated|Benha University||1|||f||||f||||||||Undecided||2017-10-10 21:46:48.666812|2017-10-10 21:46:48.666812
NCT02913768|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-06-06|||October 2016||2016-10-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Reduction in Spinal-induced Hypotension With Ondansetron in Parturients Undergoing Caesarean Section|Reduction in Spinal-induced Hypotension With Ondansetron in Parturients Undergoing Caesarean Section: A Double-blind Randomised, Placebo-controlled Study|Recruiting||Phase 4|80|Anticipated|Assiut University||2|||f||||||||||||||2017-10-10 21:46:48.754652|2017-10-10 21:46:48.754652
NCT02913755|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-05-03|||April 7, 2017|Actual|2017-04-07|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Motivation and Self-awareness in Acquired Brain Injury (ABI)|Improving Treatment Motivation and Self-awareness in People With Moderate to Severe Acquired Brain Injury (ABI)|Recruiting||N/A|20|Anticipated|University of Glasgow||2|||f||||f|f|f||||||No||2017-10-10 21:46:48.850902|2017-10-10 21:46:48.850902
NCT02913742|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-04-27|||March 2017|Anticipated|2017-03-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||The Utility of NIOM During LITT for Refractory MTLE|A Prospective Study of the Utility of Neurophysiologic Intraoperative Monitoring by Stereotactic Depth Electrodes During MRI-guided Laser-interstitial Thermal Therapy for Refractory Mesial Temporal Lobe Epilepsy|Withdrawn||N/A|0|Actual|Duke University||1||IRB determined need for an IDE, which was not approved|f||||f|f|f||||||Undecided||2017-10-10 21:46:48.942317|2017-10-10 21:46:48.942317
NCT02913729|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-09-26|||September 2016||2016-09-01|October 2016|2016-10-01|October 2026|Anticipated|2026-10-01|September 2021|Anticipated|2021-09-01||Interventional|PAPBI-2||Pre- Versus Postoperative Accelerated Partial Breast Irradiation|Pre- Versus Postoperative Accelerated Partial Breast Irradiation in Early Stage Breast Cancer Patients|Recruiting||N/A|500|Anticipated|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-10-10 21:46:49.039043|2017-10-10 21:46:49.039043
NCT02913716|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-01-26|||August 2015||2015-08-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Phase I, Open-label Study of Absorption, Metabolism, and Excretion of Defactinib (VS-6063) in Healthy Male Subjects|A Phase I, Open-label Study of the Absorption, Metabolism and Excretion of Defactinib (VS-6063-106) in Healthy Male Subjects|Completed||Phase 1|5|Actual|Verastem, Inc.||1|||f||||f||||||||No||2017-10-10 21:46:49.159984|2017-10-10 21:46:49.159984
NCT02913703|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-10-02|||January 11, 2017|Actual|2017-01-11|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Preprandial Ghrelin Effect|Effect of Preprandial Ghrelin on Postprandial Glucose Tolerance|Recruiting||Phase 1|80|Anticipated|Duke University||6|||f|||||t|f||||||||2017-10-10 21:46:49.254407|2017-10-10 21:46:49.254407
NCT02913690|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-09-21|||May 2015||2015-05-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|PATCH||Palm Tocotrienols in Chronic Hemodialysis (Malaysia) (PATCH)|Effects of Dietary Supplementation Using Palm Tocotrienols in Chronic Hemodialysis (PATCH) Patients - A Multicenter Study Evaluating Markers of Inflammation, Oxidative Stress and Blood Lipids|Active, not recruiting||N/A|400|Anticipated|Wayne State University||2|||f||||f||||||||Undecided||2017-10-10 21:46:49.352401|2017-10-10 21:46:49.352401
NCT02913677|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-02-14|||September 2016|Actual|2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Prolonged Minimal Enteral Nutrition Versus Slowly Advancing Enteral Nutrition in Very Low Birth Weight Infants:||Recruiting||N/A|200|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-10 21:46:49.469603|2017-10-10 21:46:49.469603
NCT02913664|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-04-17|||September 2016||2016-09-01|April 2017|2017-04-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|rrAD||Risk Reduction for Alzheimer's Disease|Exercise and Intensive Vascular Risk Reduction in Preventing Dementia|Recruiting||Phase 2/Phase 3|640|Anticipated|University of Texas Southwestern Medical Center||4|||f||||t||||||||Yes|Data from the study will be shared approximately 18-24 months after the primary study publication.|2017-10-10 21:46:49.58846|2017-10-10 21:46:49.58846
NCT02913651|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-01-24|||January 2016||2016-01-01|September 2016|2016-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia|Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia|Completed||N/A|33|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f|f|f||||||No||2017-10-10 21:46:49.762366|2017-10-10 21:46:49.762366
NCT02913638|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-02-10|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||A Post Breastfeeding Follow-Up Study|A Post-Breastfeeding Intervention Observational Follow-Up Study|Completed||N/A|196|Actual|Abbott Nutrition|||1||f||||f||||||||No||2017-10-10 21:46:49.851697|2017-10-10 21:46:49.851697
NCT02913625|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-07-03|||September 2016||2016-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Retroclavicular Approach vs Infraclavicular Approach for Plexic Bloc Anesthesia of the Upper Limb|Retroclavicular Approach vs Infraclavicular Approach for Plexic Bloc Anesthesia of the Upper Limb: a Multi-centric Non-inferiority Randomised Controlled Trial|Completed||N/A|110|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-10 21:46:49.938799|2017-10-10 21:46:49.938799
NCT02913612|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-10-02|||May 5, 2017|Actual|2017-05-05|October 2017|2017-10-01|September 28, 2018|Anticipated|2018-09-28|September 28, 2018|Anticipated|2018-09-28||Interventional|TIM01||Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)|Efficacy, Safety, and Pharmacokinetics of Timolol in Infants With Infantile Hemangioma (IH)|Recruiting||Phase 2|110|Anticipated|Duke University||2|||f||||t|t|f||||||||2017-10-10 21:46:50.062145|2017-10-10 21:46:50.062145
NCT02913573|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction|Pectoral Nerve Block vs. Standard Anesthesia in Patients Undergoing Mastectomy and Immediate Breast Reconstruction: Impact on Post-operative Pain and Nausea/Vomiting|Recruiting||Phase 2|60|Anticipated|Huntington Memorial Hospital||2|||f||||t||||||||No||2017-10-10 21:46:50.231017|2017-10-10 21:46:50.231017
NCT02913560|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||August 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:46:50.804283|2017-10-10 21:46:50.804283
NCT02913547|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-21|||November 2015||2015-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Silk'n HST for Wrinkle Reduction - Clinical Study Protocol|Safety, Efficacy and Usage Compliance of the Silk'n HST Home Use Device for Treating Periorbital Wrinkles and Improving Skin Appearance|Completed||N/A|30|Actual|Home Skinovations Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:46:50.858651|2017-10-10 21:46:50.858651
NCT02913534|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||March 2014||2014-03-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy|Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy|Completed||N/A|100|Actual|Institut de Cancérologie de Lorraine|||1||f||||||||||||||2017-10-10 21:46:50.944946|2017-10-10 21:46:50.944946
NCT02913521|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||June 2015||2015-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%|A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Three-Arm, Multi-Site Study to Evaluate the Clinical Equivalence of Diclofenac Sodium Topical Gel 1% (Hi-Tech Pharmacal Co., Inc.) With Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis) in Patients With Osteoarthritis of the Knee|Completed||Phase 3|796|Actual|Akorn, Inc.||3|||f||||f||||||||No||2017-10-10 21:46:51.051408|2017-10-10 21:46:51.051408
NCT02913508|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2016-09-22|||April 2014||2014-04-01|September 2016|2016-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease|A Randomized, Open Label Phase 2 Study to Assess Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety and Exploratory Efficacy of Vedolizumab Subcutaneous Compared to Vedolizumab Intravenous in Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease|Withdrawn||Phase 2|0|Actual|Takeda||5|||f||||t||||||||||2017-10-10 21:46:51.244037|2017-10-10 21:46:51.244037
NCT02913495|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-22|2017-05-24|||September 2016||2016-09-01|May 2017|2017-05-01||||August 2018|Anticipated|2018-08-01||Interventional|VIP||Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth|Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth|Recruiting||Phase 4|224|Anticipated|Thomas Jefferson University||2|||f||||t||||||||Undecided|Results will be available, individual participant data may not be|2017-10-10 21:46:51.369541|2017-10-10 21:46:51.369541
NCT02913482|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-10-02|||December 23, 2016|Actual|2016-12-23|October 2017|2017-10-01|July 7, 2020|Anticipated|2020-07-07|April 30, 2019|Anticipated|2019-04-30||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Infants With Type1 Spinal Muscular Atrophy (Firefish)|A Two Part Seamless, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Infants With Type 1 Spinal Muscular Atrophy|Recruiting||Phase 2|48|Anticipated|Hoffmann-La Roche||2|||f|||||f|f||||||||2017-10-10 21:46:51.505535|2017-10-10 21:46:51.505535
NCT02913469|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-22|||December 2014||2014-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction|The Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Interven Tion|Recruiting||Phase 4|128|Anticipated|General Hospital of Chinese Armed Police Forces||4|||f||||t||||||||Yes||2017-10-10 21:46:51.630801|2017-10-10 21:46:51.630801
NCT02913443|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-09-21|||December 20, 2016|Actual|2016-12-20|September 2017|2017-09-01|September 20, 2019|Anticipated|2019-09-20|September 20, 2019|Anticipated|2019-09-20||Interventional|||A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)|A Multi-Center, Open Label, Phase I, Dose Finding and Expansion Study of RO7051790 Administered Orally in Patients With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)|Recruiting||Phase 1|70|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 21:46:52.122355|2017-10-10 21:46:52.122355
NCT02913430|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-07-19|||October 2016||2016-10-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase II Treatment of Metastatic Breast Cancer With Fulvestrant or Tamoxifen|Treatment of Metastatic Breast Cancer With Fulvestrant or Tamoxifen: A Randomized Phase II Trial With ESR1 Mutation Tested in Circulating Tumor DNA.|Recruiting||Phase 2|150|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 21:46:52.290767|2017-10-10 21:46:52.290767
NCT02913417|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-12-08|||October 2016||2016-10-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases|A Feasibility Study of Sequential Hepatic Internal Radiation and Systemic Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastatic to Liver.|Recruiting||Phase 1/Phase 2|18|Anticipated|California Pacific Medical Center Research Institute||1|||f||||t||||||||No||2017-10-10 21:46:52.418484|2017-10-10 21:46:52.418484
NCT02913404|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||ACL-reconstruction vs ACL-reconstruction With EAT|Functional Biomechanical Outcome of ACL-reconstruction vs. ACL-reconstruction and Extra-articular-tenodesis in Patients|Not yet recruiting||N/A|20|Anticipated|University of Pittsburgh||2|||f||||f||||||||No||2017-10-10 21:46:52.580543|2017-10-10 21:46:52.580543
NCT02913391|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-22|||April 2016||2016-04-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy and Safety of Using Noninvasive Ventilation in Cardiac Postoperative With Alveolar Recruitment Maneuver|Efficacy and Safety of Using Non-Invasive Ventilation in Postoperative Revascularization of the Myocardium With Alveolar Recruitment Maneuver: Randomized Clinical Trial|Recruiting||N/A|28|Anticipated|University of Sao Paulo||2|||f||||f||||||||Undecided|"Improvement of oxygenation (increase of 10% of PaO2 related to the control group);
Improvement in X-ray (score);
Extubation failure rate.
Hospitalization length in Intensive care unit;
Mechanical ventilation duration;
Intra-hospital mortality rate.
Occurrence of barotrauma;
Occurrence of arrhythmia;
Occurrence of hemodynamic instability;
Data will be available on August 2017 Contact us by email"|2017-10-10 21:46:52.685115|2017-10-10 21:46:52.685115
NCT02913378|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-21|||January 2016||2016-01-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Conservative vs Surgical Treatment for Proximal Humerus Fractures in the Elderly|Conservative Treatment vs Locked Plate Osteosynthesis for Proximal Humerus Fractures in the Elderly: a Randomized Controlled Trial|Recruiting||Phase 4|58|Anticipated|University of Sao Paulo||2|||f||||f||||||||Undecided||2017-10-10 21:46:52.802972|2017-10-10 21:46:52.802972
NCT02913365|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-22|||October 2012||2012-10-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis|Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis in a North-American Tertiary Center at the Beginning of the 21st Century|Recruiting||N/A|1000|Anticipated|Université de Sherbrooke|||1||f||||f||||||||Undecided||2017-10-10 21:46:52.923648|2017-10-10 21:46:52.923648
NCT02913352|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|January 2022|Anticipated|2022-01-01|September 2021|Anticipated|2021-09-01||Interventional|||Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation|Randomized Trial for the Treatment of Recurrent Anterior Dislocation of the Shoulder: Latarjet Versus Modified Eden-Hybinette|Recruiting||Phase 4|60|Anticipated|University of Sao Paulo||2|||f||||f||||||||Undecided||2017-10-10 21:46:53.09119|2017-10-10 21:46:53.09119
NCT02913339|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-21|||January 2016||2016-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|mHealth||mHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina.|MHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina.|Recruiting||N/A|740|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 21:46:53.224567|2017-10-10 21:46:53.224567
NCT02913326|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-10-03|||December 13, 2016|Actual|2016-12-13|October 2017|2017-10-01|June 27, 2018|Anticipated|2018-06-27|June 27, 2018|Anticipated|2018-06-27||Interventional|||A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)|RE-SPECT CVT: a Randomised, Open-label, Exploratory Trial With Blinded Endpoint Adjudication (PROBE), Comparing Efficacy and Safety of Oral Dabigatran Etexilate Versus Oral Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis Over a 24-week Period|Recruiting||Phase 3|120|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:46:53.350943|2017-10-10 21:46:53.350943
NCT02913313|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-09-15|||November 29, 2016|Actual|2016-11-29|September 2017|2017-09-01|July 2, 2021|Anticipated|2021-07-02|July 1, 2021|Anticipated|2021-07-01||Interventional|||An Investigational Immuno-therapy Study to Evaluate the Safety and Effectiveness of Experimental Medication BMS-986207 by Itself and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread|Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination With Nivolumab in Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|170|Anticipated|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-10 21:46:53.591529|2017-10-10 21:46:53.591529
NCT02913300|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-08-21|||May 2016||2016-05-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||1% vs. 2 % Lignocaine for Endobronchial Ultrasound Guided Transbronchial Needle Aspiration|Comparison of 1% Versus 2% Lignocaine for Topical Anaesthesia in Endobronchial Ultrasound Guided Transbronchial Needle Aspiration|Completed||N/A|100|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-10 21:46:53.822818|2017-10-10 21:46:53.822818
NCT02913287|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-21|||November 2015||2015-11-01|September 2016|2016-09-01||||November 2016|Anticipated|2016-11-01||Interventional|||Seaweed-Derived Mineral-Rich Nutraceuticals in Cognition|A Randomised, Double-blind, Placebo-controlled Study of the Cognitive-Enhancing Potential of Seaweed-Derived Mineral-Rich Nutraceuticals (a Combination of Aquamin F and Aquamin MG)|Active, not recruiting||N/A|60|Anticipated|University College Cork||2|||f||||f||||||||Undecided||2017-10-10 21:46:53.926481|2017-10-10 21:46:53.926481
NCT02913274|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-07-19|||March 20, 2017|Actual|2017-03-20|July 2017|2017-07-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|FAVABED||Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty|Fistules Artério-Veineuses: Angioplastie Par Ballon à Elution de Drogue (FAVABED) - Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty|Recruiting||N/A|262|Anticipated|Rennes University Hospital||2|||f|||||f|f||||||||2017-10-10 21:46:54.025763|2017-10-10 21:46:54.025763
NCT02913248|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-02-02|||October 2016||2016-10-01|February 2017|2017-02-01|January 2, 2017|Actual|2017-01-02|January 2, 2017|Actual|2017-01-02||Interventional|||Salivary Bacterial Profiles in Relation to Periodontal Treatment|Short and Long Term Alterations of Subgingival and Salivary Microbiota in Relation to Periodontal Treatment|Completed||N/A|30|Actual|University of Copenhagen||1|||f||||t||||||||Yes|All individual participant data will be handled anonymously|2017-10-10 21:46:54.448935|2017-10-10 21:46:54.448935
NCT02913235|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-02-02|||September 2016||2016-09-01|February 2017|2017-02-01|January 2, 2017|Actual|2017-01-02|January 2, 2017|Actual|2017-01-02||Interventional|||Salivary Bacterial Associations to Short Term Discontinuation of Self-performed Oral Hygiene|Does Short Term Discontinuation of Self-performed Oral Hygiene Procedures Influence the Composition of the Salivary Microbiota?|Completed||N/A|30|Actual|University of Copenhagen||1|||f||||t||||||||Yes||2017-10-10 21:46:54.543521|2017-10-10 21:46:54.543521
NCT02913222|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-07-17|||February 4, 2017|Actual|2017-02-04|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Movement Pattern Training in People With Intra-articular, Prearthritic Hip Disorders|Movement Pattern Training in People With Intra-articular, Prearthritic Hip Disorders|Recruiting||N/A|46|Anticipated|Washington University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:46:54.625402|2017-10-10 21:46:54.625402
NCT02913209|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-11-27|||April 2016||2016-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Quantitative Fatigue and Muscle Performance in Multiple Sclerosis|Quantitative Fatigue and Muscle Performance in Multiple Sclerosis|Enrolling by invitation||N/A|30|Actual|Washington D.C. Veterans Affairs Medical Center|||1||f||||f||||||||||2017-10-10 21:46:54.770516|2017-10-10 21:46:54.770516
NCT02913196|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-03-01|||December 2016||2016-12-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC|A Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)|Recruiting||Phase 1|24|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-10 21:46:54.892631|2017-10-10 21:46:54.892631
NCT02913183|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-21|||October 2016||2016-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Young Health Plasma on Acute Stroke|Efficacy and Safety of Young Health Plasma on Acute Stroke|Not yet recruiting||Phase 2|78|Anticipated|Xinqiao Hospital of Chongqing||2|||f||||t||||||||Yes|Neurofunctional assessment including NIHSS, modified Barthel Index, modified Rankin Scale,and Glasgow coma scale, hematoma volume,and peripheral edema volume are to be shared.|2017-10-10 21:46:55.011701|2017-10-10 21:46:55.011701
NCT02913170|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-22|||May 2015||2015-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Nattokinase Supplementation and Hemostatic Factors|Nattokinase Supplementation and Hemostatic Factors|Completed||Phase 4|100|Actual|Yonsei University||2|||f||||t||||||||No||2017-10-10 21:46:55.117318|2017-10-10 21:46:55.117318
NCT02913157|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-01-27|||November 2016||2016-11-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Hydroxychloroquine in Primary Progressive Multiple Sclerosis|Open-label, Single-center, Single-arm Futility Trial Evaluating Oral Hydroxychloroquine 200mg BID for Reducing Progression of Disability in Patients With Primary Progressive Multiple Sclerosis (PPMS)|Recruiting||Phase 2|35|Anticipated|University of Calgary||1|||f||||t||||||||Yes||2017-10-10 21:46:55.210797|2017-10-10 21:46:55.210797
NCT02913144|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-22|||May 2014||2014-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01|7 Years|Observational [Patient Registry]|||7 Year Follow-up Study of the DanRisk Population|Implication of a Coronary Calcium Screening Examination, Incidence of Cardiovascular Events and Progression of Coronary Artery Calcium Over up to 7 Year of Follow-up in a Danish Middle-aged General Population|Completed||N/A|1257|Actual|Odense University Hospital|||1||f||||f||||||Samples Without DNA|"     a biobank consisting of plasma and serum was established in 2009 and also in 2014-15.   "|Undecided||2017-10-10 21:46:55.312405|2017-10-10 21:46:55.312405
NCT02913131|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-29|||December 2015||2015-12-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies|Hyperpolarized C-13 Pyruvate as a Biomarker of PI3K/mTOR Pathway Inhibition in Patients With Advanced Solid Tumor Malignancies|Active, not recruiting||Phase 2|40|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 21:46:55.393898|2017-10-10 21:46:55.393898
NCT02913118|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-21|||July 2016||2016-07-01|September 2016|2016-09-01||||January 2018|Anticipated|2018-01-01||Interventional|||Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia|Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia: A Multicenter Randomized Controlled Clinical Trial|Recruiting||Phase 4|462|Anticipated|Qingfeng Pharmaceutical Group||2|||f||||t||||||||||2017-10-10 21:46:55.490739|2017-10-10 21:46:55.490739
NCT02913092|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients|Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma|Not yet recruiting||N/A|80|Anticipated|Montefiore Medical Center||2|||f||||f||||||||No||2017-10-10 21:46:55.823573|2017-10-10 21:46:55.823573
NCT02913079|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-03-14|||September 2016||2016-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels|The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels|Recruiting||N/A|25|Anticipated|University of Prince Edward Island||2|||f||||f||||||||No|No.|2017-10-10 21:46:55.93212|2017-10-10 21:46:55.93212
NCT02913066|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-06-14|||September 2016||2016-09-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma|Prospective, Randomized, Multicenter, Phase II Noninferiority Study of S-1 Concurrent Intensity-modulated Radiation Therapy (IMRT) Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma|Recruiting||Phase 2|88|Anticipated|Mianyang Central Hospital||2|||f||||t||||||||Yes||2017-10-10 21:46:56.012808|2017-10-10 21:46:56.012808
NCT02913053|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-09-21|||June 2015||2015-06-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|NeuroExercise||The Effects of an Extensive Exercise Program on the Progression of Mild Cognitive Impairment|The Effects of an Extensive Exercise Program on the Progression of Mild Cognitive Impairment (MCI)|Recruiting||Phase 2|225|Anticipated|Radboud University||3|||f||||f||||||||Undecided||2017-10-10 21:46:56.090158|2017-10-10 21:46:56.090158
NCT02913040|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2016-10-15|||December 2016||2016-12-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||High Flow in Infants With Bronchiolitis|High Flow Nasal Cannula Therapy for Infants With Bronchiolitis|Not yet recruiting||N/A|118|Anticipated|Princess Amalia Children's Clinic||2|||f||||f||||||||Yes||2017-10-10 21:46:56.346038|2017-10-10 21:46:56.346038
NCT02913027|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-04-03|||September 5, 2016|Actual|2016-09-05|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|March 15, 2017|Actual|2017-03-15||Interventional|||Can We Improve the Comfort of Pelvic Exams?|Can We Improve the Comfort of Pelvic Exams?|Completed||N/A|200|Actual|Philadelphia Urosurgical Associates||2|||f||||f||||||||Undecided||2017-10-10 21:46:56.491578|2017-10-10 21:46:56.491578
NCT02913014|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-08-16|||October 2016||2016-10-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|||Comparison of Recurrence of Atrial Fibrillation 90 Days Post Cryoballoon Ablation With and Without Anti-Arrhythmic Drugs|Monitoring Safety and Recurrence of Paroxysmal Atrial Fibrillation After 1st Cryo-Ablation With And Without Anti-Arrhythmic Drug Therapy During the 90-day Blanking Period; Examined With Adverse Event Monitoring and Implantable Loop Recorder|Recruiting||N/A|50|Anticipated|Palmetto Health||2|||f||||f||||||||||2017-10-10 21:46:56.591815|2017-10-10 21:46:56.591815
NCT02913001|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2016-09-21|||September 2014||2014-09-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Effect of a Low Glycemic Load Diet on Hormonal Markers Associated With Acne|The Effect of a Low Glycemic Load Diet on Hormonal Markers Associated With Acne|Completed||N/A|97|Actual|New York University||2|||f||||f||||||||No||2017-10-10 21:46:56.713297|2017-10-10 21:46:56.713297
NCT02912988|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-23|||November 2016||2016-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Letrozole in Stimulated IVF Cycles|A Randomized Trial of Letrozole as an Adjunct to Follicle Stimulating Hormone in Stimulated in Vitro Fertilization Cycles|Not yet recruiting||Phase 3|900|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 21:46:56.815759|2017-10-10 21:46:56.815759
NCT02912975|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-04-24|||March 2016||2016-03-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||A Clinical Trial of Mirror Treatment for Phantom Pain|A Randomized Controlled Clinical Trial of Mirror Treatment in the Management of Phantom and Residual Limb Pain in Patients With Trans-tibial Land Mine Amputations in Cambodia|Recruiting||N/A|45|Anticipated|Trauma Care Foundation, Norway||2|||f||||t||||||||||2017-10-10 21:46:56.935158|2017-10-10 21:46:56.935158
NCT02912962|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01||||May 2018|Anticipated|2018-05-01||Interventional|||Self-Regulation in Adolescents With FASD: The Efficacy of a Targeted Intervention|Self-Regulation in Adolescents With FASD: The Efficacy of a Targeted Intervention|Not yet recruiting||N/A|60|Anticipated|University of Alberta||2|||f||||||||||||||2017-10-10 21:46:57.04632|2017-10-10 21:46:57.04632
NCT02912949|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-03-24|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of MCLA-128 in Patients With Solid Tumors|A Phase I/II Study of MCLA-128, a Full Length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients With Solid Tumors|Recruiting||Phase 1/Phase 2|130|Anticipated|Merus N.V.||6|||f||||t||||||||Yes|Individual participant data are made available only to the individual patient upon specific request of that individual patient or its treating physician|2017-10-10 21:46:57.159681|2017-10-10 21:46:57.159681
NCT02912936|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|MINT-01||A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease|A Medium Chain Triglyceride INTervention for Alzheimer Disease (A MINT for AD)|Recruiting||Phase 1|40|Anticipated|University of British Columbia||2|||f||||||||||||||2017-10-10 21:46:57.353434|2017-10-10 21:46:57.353434
NCT02912923|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-03-30|||September 14, 2016|Actual|2016-09-14|March 2017|2017-03-01|December 8, 2016|Actual|2016-12-08|December 8, 2016|Actual|2016-12-08||Interventional|RISP3||Reaching in Stroke 3rd Phase|Reducing Compensatory Movements in Stroke Therapy Through the Use of Robotic Devices and Augmented Feedback, 3rd Phase|Completed||N/A|23|Actual|University of British Columbia||2|||f||||f||||||||No||2017-10-10 21:46:57.482367|2017-10-10 21:46:57.482367
NCT02912910|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-03-03|||September 2016|Anticipated|2016-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Changes in Central Arterial Pressure When Comparing Nifedipine/Labetalol for Routine Hypertension Control in Pregnancy|Changes in Central Arterial Pressure When Comparing Nifedipine and Labetalol for Routine Hypertension Control in Pregnancy|Withdrawn||N/A|0|Actual|St. Louis University|||2|PI withdrew protocol|f||||f||||||||No||2017-10-10 21:46:57.591313|2017-10-10 21:46:57.591313
NCT02912897|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-21|||January 2017||2017-01-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|MS and EBV-CTL||Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy With Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients With a First Clinical Episode Highly Suggestive of Multiple Sclerosis|An Open Single-center, Phase I Proof of Concept Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy With Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients With a First Clinical Episode Highly Suggestive of Multiple Sclerosis|Not yet recruiting||Phase 1|8|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 21:46:57.681547|2017-10-10 21:46:57.681547
NCT02912884|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Observational|MPNClot||Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure|Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure|Recruiting||N/A|80|Anticipated|University Hospital, Geneva|||2||f||||f||||||Samples Without DNA|"     Plasma samples   "|No||2017-10-10 21:46:57.756178|2017-10-10 21:46:57.756178
NCT02912871|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-01-30|||April 2016||2016-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease|A Pilot Clinical Trial of the Feasibility, Safety and Efficacy of Subthalamotomy Using the ExAblate Transcranial System to Treat the Cardinal Motor Features of Parkinson's Disease|Completed||N/A|10|Actual|Fundación de investigación HM||1|||f||||||||||||No||2017-10-10 21:46:57.851408|2017-10-10 21:46:57.851408
NCT02912858|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-04-12|||August 2017|Anticipated|2017-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer Patients|Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer Patients: Comparison of Effects on Lower Limb Circulation|Not yet recruiting||N/A|12|Anticipated|Firstkind Ltd||1|||f||||f|f|f||||||Yes||2017-10-10 21:46:57.934386|2017-10-10 21:46:57.934386
NCT02912845|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-25|||January 2017||2017-01-01|September 2016|2016-09-01||||April 2018|Anticipated|2018-04-01||Interventional|||Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies||Not yet recruiting||Phase 3|30|Anticipated|Kamada, Ltd.||1|||f||||f||||||||||2017-10-10 21:46:57.999069|2017-10-10 21:46:57.999069
NCT02912832|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-21|||October 2014||2014-10-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Prospective Assessment of TBDx Feasibility|TBDx Feasibility Study: Prospective Study to Determine the Feasibility of Automated Smear Microscopy|Completed||N/A|572|Actual|Foundation for Innovative New Diagnostics, Switzerland||1|||f||||f||||||||Yes|De-identified patient and results dataset will be made available upon publication of study findings|2017-10-10 21:46:58.074646|2017-10-10 21:46:58.074646
NCT02912819|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-21|||January 2016||2016-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Individualized Lung Recruitment Maneuver Guide by Pulse-oximetry in Anesthetized Patients|Individualized Lung Recruitment Maneuver Guide by Pulse-oximetry in Anesthetized Patients|Completed||N/A|30|Actual|Fundación para la Investigación del Hospital Clínico de Valencia|||1||f||||f||||||||Yes|Shared data will be anonymous|2017-10-10 21:46:58.172257|2017-10-10 21:46:58.172257
NCT02912806|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-22|||January 2013||2013-01-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01|1 Year|Observational [Patient Registry]|GreenCare||Dartmouth-Hitchcock GreenCare Registry for Total Knee Replacement|The Dartmouth GreenCare Program: Implementation of Shared Decision Making and Patient-reported Outcomes in a Standardized Care Path for Knee Replacement|Completed||N/A|545|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||f||||||||Yes|The consented data that has been collected will be stripped of all identifiers and kept as a dataset appropriate for sharing with future researchers for secondary analyses. A Project Proposal form and Data Use Agreement will be required.|2017-10-10 21:46:58.247005|2017-10-10 21:46:58.247005
NCT02912793|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-09-29|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1|A Phase I/II Study to Evaluate the Safety and PK of iv Trappsol Cyclo (HP-β-CD) in Patients With Niemann-Pick Disease Type C NPC-1 and the Pharmacodynamic Effects of Treatment Upon Markers of Cholesterol Metabolism and Clinical Outcomes|Recruiting||Phase 1/Phase 2|12|Anticipated|CTD Holdings, Inc.||3|||f||||f|f|f||||||||2017-10-10 21:46:58.346846|2017-10-10 21:46:58.346846
NCT02912780|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-21|||January 2013||2013-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Introduction of Microsystems in a Level 3 Neonatal Intensive Care Unit|Introduction of Microsystems in a Level 3 Neonatal Intensive Care Unit - an Interprofessional Approach|Recruiting||N/A|200|Anticipated|McMaster Children's Hospital|||1||f||||f||||||||No||2017-10-10 21:46:58.475709|2017-10-10 21:46:58.475709
NCT02912767|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-07-11|||July 20, 2016||2016-07-20|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer|Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer|Active, not recruiting||N/A|625|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-10 21:46:58.563535|2017-10-10 21:46:58.563535
NCT02912754|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-03-08|||March 2017|Anticipated|2017-03-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients|A Phase I/II Trial of Ruxolitinib in Chronic Lymphocytic Leukemia Patients at Risk for Progression on Ibrutinib|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t|f|f||||||Yes|the results from the study will be published in peer-review journals|2017-10-10 21:46:58.628194|2017-10-10 21:46:58.628194
NCT02912741|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-21|||January 2017||2017-01-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||One Year Clinical Evaluation of White Spot Lesions Treated With Newly Introduced Resin Modified Glass Ionomer in Comparison to Resin Infiltration in Anterior Teeth Split Mouth Technique|Double Blinded Randomized Clinical Trial for Evaluation of Resin Modified Glass Ionomer Cement Versus Resin Infiltration in Treating White Spot Lesions|Not yet recruiting||Phase 2|35|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:46:58.711141|2017-10-10 21:46:58.711141
NCT02912728|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-02|||January 30, 2017|Actual|2017-01-30|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|SENCE||Strategies to Enhance New CGM Use in Early Childhood (SENCE)|Strategies to Enhance New CGM Use in Early Childhood: A Randomized Clinical Trial to Assess the Efficacy and Safety of Continuous Glucose Monitoring in Youth < 8 With Type 1 Diabetes|Recruiting||N/A|200|Anticipated|Jaeb Center for Health Research||3|||f||||t|f|t|f|f|f|||||2017-10-10 21:46:58.787368|2017-10-10 21:46:58.787368
NCT02908555|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-20|||January 2016||2016-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SleepT1D||Sleep, Coping and Executive Functioning in Youth With Type 1 Diabetes|Sleep, Coping, and Executive Functioning in Youth With Type 1 Diabetes|Enrolling by invitation||N/A|40|Anticipated|Yale University|||1||f||||f||||||||Yes||2017-10-10 21:47:44.960629|2017-10-10 21:47:44.960629
NCT02912715|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-22|||November 2016||2016-11-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Study of Passeo-18 Lux Balloon Catheter for the Treatment of Atherosclerotic Lesions(BIOLUX-P IV CHINA)|Prospective, Multi-center, Non-randomized Clinical Trial of Passeo-18 Lux DCB in New and Non-stented Re-stenotic Lesions in the Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA) in a Chinese Patient Population|Not yet recruiting||Phase 3|158|Anticipated|Biotronik (Beijing) Medical Device Ltd.||1|||f||||t||||||||Yes||2017-10-10 21:46:58.877896|2017-10-10 21:46:58.877896
NCT02912702|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||L-DEP as an Initial Treatment for EBV-HLH|A Randomized Controlled Trial of L-DEP as an Initial Treatment for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis|Recruiting||Phase 3|120|Anticipated|Beijing Friendship Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:46:58.963797|2017-10-10 21:46:58.963797
NCT02912689|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NAVA-NICE||NIV - NAVA vs NIV - PS for COPD Exacerbation|Non-invasive Ventilation (NIV) - Neurally Adjusted Ventilatory Assist (NAVA) vs NIV for Acute Hypercapneic Respiratory Failure in COPD: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||Yes|Will share, if required|2017-10-10 21:46:59.062432|2017-10-10 21:46:59.062432
NCT02912676|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-04-24|||October 2016||2016-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TEAM||Thiopurine EnhAnced Maintenance Therapy|A Phase 1-2 Study of 6-Thioguanine in Combination With Methotrexate and 6-Mercaptopurine During Maintenance Therapy of Childhood, Adolescent, and Adult Lymphoblastic Non-Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia|Recruiting||Phase 1/Phase 2|30|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||Yes|Individual participant data will be entered into the Leukemia Registry of the Nordic Society of Pediatric Hematology/Oncology|2017-10-10 21:46:59.185755|2017-10-10 21:46:59.185755
NCT02912663|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-06-15|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|MAVARIC||Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study.|Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum (MAVARIC) in the Kentucky Regional Population: a Clinical and Translational Study.|Not yet recruiting||Phase 1|30|Anticipated|University of Kentucky||2|||f||||t|t|f||||||No||2017-10-10 21:46:59.308286|2017-10-10 21:46:59.308286
NCT02912650|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-07-28|2017-06-28||September 2015|Actual|2015-09-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SDDP|Full analysis set (FAS) included all randomized participants who were dosed with the study medication and provided a baseline assessment.|A Safety And Efficacy Study of Ibuprofen 250 mg / Acetaminophen 500 mg In The Treatment Of Post-Surgical Dental Pain|A Phase 3, Double-Blind, Randomized, Safety And Efficacy Study Comparing A Single Oral Dose Of Ibuprofen (IBU) 250 Mg/Acetaminophen (APAP) 500 Mg (Administered As Two Tablets Of IBU/APAP 125 Mg/250 Mg) To Each Active Drug Monocomponent Alone And To Placebo In The Treatment Of Post-Surgical Dental Pain|Completed||Phase 3|568|Actual|Pfizer||4|||f||||f||||||||||2017-10-10 21:46:59.611543|2017-10-10 21:46:59.611543
NCT02912637|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-05-25|||October 2016||2016-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Hyperpolarized Xenon Imaging in Patients With Cystic Fibrosis|Hyperpolarised 129Xe MRI for Non-invasive Assessment of Ventilation, Perfusion and the Alveolar Membrane - a Physiological Study in Healthy Volunteers & Cystic Fibrosis Patients|Recruiting||N/A|30|Anticipated|Papworth Hospital NHS Foundation Trust|||2||f||||f||||||||No||2017-10-10 21:47:07.13493|2017-10-10 21:47:07.13493
NCT02912624|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-23|||March 2015||2015-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01|90 Days|Observational [Patient Registry]|SICS-I||Simple Intensive Care Studies I (SICS-I)|Combining Conventional With Advanced Hemodynamic Parameters for Predicting the Outcome of Critically Ill Patients: a Pilot for a Registry|Recruiting||N/A|1500|Anticipated|University Medical Center Groningen|||1||f||||t||||||||Undecided||2017-10-10 21:47:07.221141|2017-10-10 21:47:07.221141
NCT02912611|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-11-23|||October 2016||2016-10-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Detection and Management of Acute Kidney Injury (AKI) in Low and Low Middle Income Countries: A Pilot Feasibility Project||Recruiting||N/A|3600|Anticipated|University of California, San Diego||1|||f||||f||||||||Undecided||2017-10-10 21:47:07.312466|2017-10-10 21:47:07.312466
NCT02912598|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-22|||January 2015||2015-01-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Lung Isolation in Thoracic Surgery - a Randomized Trial Comparing the VivaSight™ EB Endobronchial Blocker With Established Devices|Lung Isolation in Thoracic Surgery - a Comparison of the VivaSight™ EB Endobronchial Blocker With Established Devices|Completed||Phase 4|104|Actual|Otto-von-Guericke University Magdeburg||4|||f||||f||||||||||2017-10-10 21:47:07.403017|2017-10-10 21:47:07.403017
NCT02912585|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-09-22|||July 2013||2013-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Oropharyngeal Administration of Colostrum|Oropharyngeal Administration of Colostrum and Prevention of Infections in Very Low Birthweight Infants|Completed||N/A|145|Actual|Federal University of Uberlandia||3|||f||||t||||||||No||2017-10-10 21:47:07.479795|2017-10-10 21:47:07.479795
NCT02912572|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-06-05|||November 14, 2016|Actual|2016-11-14|June 2017|2017-06-01|April 2024|Anticipated|2024-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer|A Phase 2, Two-Group, Two-Stage, Open-Label Study of Avelumab (MSB0010718C) in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer|Recruiting||Phase 2|70|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-10 21:47:07.559254|2017-10-10 21:47:07.559254
NCT02912546|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-04-19|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PerfIRMAVC||Cerebral Perfusion Associated With Postural Changes: an ASL MR Perfusion Study|Évaluation en IRM (séquence ASL) de la Variation de Perfusion cérébrale liée à la Position Corporelle.|Recruiting||N/A|54|Anticipated|University Hospital Center of Martinique||2|||f||||f|f|f||||||No||2017-10-10 21:47:08.457312|2017-10-10 21:47:08.457312
NCT02912533|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-21||||||September 2016|2016-09-01||||September 2018|Anticipated|2018-09-01||Interventional|||A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)||Recruiting||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-10 21:47:08.538269|2017-10-10 21:47:08.538269
NCT02912520|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-04-23|||June 2016||2016-06-01|April 2017|2017-04-01|April 23, 2017|Actual|2017-04-23|April 23, 2017|Actual|2017-04-23||Observational|||Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy|Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy|Completed||N/A|20|Actual|Medical University of Vienna|||2||f||||f||||||Samples Without DNA|"     bronchoalveolar lavage fluid of patients with and without antibiotic therapy.   "|No||2017-10-10 21:47:08.60381|2017-10-10 21:47:08.60381
NCT02912507|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-09-20|||September 9, 2016|Actual|2016-09-09|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal|An Open Label, Split-tattoo Study Comparing the Safety and Efficacy of the 670nm Picosecond Laser Versus the 755 nm Picosecond Laser for Tattoo Removal|Active, not recruiting||N/A|11|Actual|Cutera Inc.||2|||f||||f||||||||||2017-10-10 21:47:08.785323|2017-10-10 21:47:08.785323
NCT02912494|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-21||||||September 2016|2016-09-01||||February 2018|Anticipated|2018-02-01||Interventional|||A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)||Recruiting||Phase 3|||Kissei Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 21:47:08.880161|2017-10-10 21:47:08.880161
NCT02912481|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-09-04|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Posterior Tibial Artery Catheterization|Real-time Ultrasound-guided Arterial Catheterization in Pediatric Patients: Comparison of Success Rate Among the Arteries|Completed||N/A|275|Actual|Seoul National University Hospital||3|||f||||||||||||||2017-10-10 21:47:08.982119|2017-10-10 21:47:08.982119
NCT02912455|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-06-29|||January 5, 2017|Actual|2017-01-05|June 2017|2017-06-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes|Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes|Recruiting||Phase 4|36|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 21:47:09.331111|2017-10-10 21:47:09.331111
NCT02912442|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-21|||December 2016||2016-12-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Thyroid Autoimmunity and Reproductive Failure in Danish Women|Thyroid Autoimmunity and Reproductive Failure - a Study of Autoimmunity in Association With Treatment Outcome in Infertile Danish Women With Infertility or Recurrent Miscarriages.|Not yet recruiting||N/A|1200|Anticipated|Rigshospitalet, Denmark|||3||f||||t||||||||Undecided|Undecided|2017-10-10 21:47:09.478081|2017-10-10 21:47:09.478081
NCT02912429|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01||||January 2020|Anticipated|2020-01-01||Interventional|||Onlay vs. Inlay Patellofemoral Arthroplasty|Onlay- vs. Inlay-Type Patellofemoral Arthroplasty: a Prospective, Comparative Study|Recruiting||N/A|110|Anticipated|Medical University Innsbruck||2|||f||||||||||||||2017-10-10 21:47:09.549038|2017-10-10 21:47:09.549038
NCT02912416|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01||||June 2018|Anticipated|2018-06-01||Interventional|||Efficacy of Probiotics on Iron Status During Pregnancy||Recruiting||N/A|254|Anticipated|Probi AB||2|||f||||f||||||||No||2017-10-10 21:47:09.630442|2017-10-10 21:47:09.630442
NCT02912403|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-03-03|||August 2016|Anticipated|2016-08-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|||Ambulatory Blood Pressure and the Normal Increase in Maternal Blood Pressure Postpartum|Ambulatory Blood Pressure and the Normal Increase in Maternal Blood Pressure Postpartum|Withdrawn||N/A|0|Actual|St. Louis University|||1|Unable to enroll|f||||f||||||||No||2017-10-10 21:47:09.709631|2017-10-10 21:47:09.709631
NCT02912390|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-05|||August 2016||2016-08-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|||Cerclage for Short Cervix in Twins|Cerclage for Ultrasound-Diagnosed Short Cervix in Twins: A Randomized Controlled Trial|Enrolling by invitation||N/A|178|Anticipated|St. Louis University||2|||f||||f||||||||||2017-10-10 21:47:09.784332|2017-10-10 21:47:09.784332
NCT02912377|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-17|||September 2016||2016-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects|Multiple-doses, Randomised, Double-blind, Three-periods, Two-sequences Crossover Study to Assess the Immunogenicity and Pharmacodynamic Comparability of a Biosimilar Pegfilgrastim (B12019) and the Reference Product Neulasta® in Healthy Subjects|Completed||Phase 1|96|Actual|Cinfa Biotech||2|||f||||f||||||||||2017-10-10 21:47:09.863025|2017-10-10 21:47:09.863025
NCT02912364|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-21|||July 2016||2016-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults|Double-Blind, Randomized, Two Period Crossover Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults|Recruiting||Phase 4|46|Anticipated|Stanford University||2|||f||||f||||||||No||2017-10-10 21:47:09.951102|2017-10-10 21:47:09.951102
NCT02911974|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-02|||August 2016||2016-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|Expect||Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic Masses|Randomized Trial Comparing Fine Needle Biopsy and Fine Needle Aspiration Needles for Endoscopic Ultrasound -Guided Sampling of Solid Pancreatic Masses|Active, not recruiting||N/A|48|Actual|Florida Hospital||2|||f||||t||||||||||2017-10-10 21:47:13.220451|2017-10-10 21:47:13.220451
NCT02912351|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-05-23|||January 2017||2017-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Post-Market Retrospective Study on Revision Total Knee Arthroplasty Using Medacta GMK® Revision Prosthesis|A Post-Market, Single-Center, Retrospective Study to Collect Clinical Outcomes and Safety Data From Patients Who Have Undergone Revision Total Knee Arthroplasty Using Medacta GMK® Revision Prosthesis and Are at Least 2 Years Past Surgery|Recruiting||N/A|50|Anticipated|Medacta USA|||1||f||||t||||||||||2017-10-10 21:47:10.090418|2017-10-10 21:47:10.090418
NCT02912338|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-21|||September 2015||2015-09-01|September 2016|2016-09-01||||March 2016|Actual|2016-03-01||Interventional|||The Effectiveness of Lifestyle Intervention on Body Composition, Physical Performances and Quality of Life Among Elderly People in Long-term Care Facilities||Completed||N/A|123|Actual|Central Taiwan University of Science and Technology||2|||f||||||||||||||2017-10-10 21:47:10.173124|2017-10-10 21:47:10.173124
NCT02912325|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-21|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS|A Pilot, Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS in Metabolic Syndrome|Recruiting||N/A|20|Anticipated|MDM S.p.A.||1|||f||||t|f|f||||||||2017-10-10 21:47:10.263459|2017-10-10 21:47:10.263459
NCT02912312|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-06-27|||February 23, 2017|Actual|2017-02-23|June 2017|2017-06-01|February 2030|Anticipated|2030-02-01|February 2030|Anticipated|2030-02-01||Interventional|||Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer|Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized Trial of Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer|Recruiting||Phase 2|290|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|f|f||||||||2017-10-10 21:47:10.355431|2017-10-10 21:47:10.355431
NCT02912299|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-05|||November 3, 2016|Actual|2016-11-03|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|September 5, 2017|Actual|2017-09-05||Observational|InCa||Investigation on Differences in Skin Sodium Content Between Normal Subjects and ICU-patients|Onderzoek Naar Intracutane Natriumopslag Bij Intensive Care patiënten (InCa-studie)|Completed||N/A|45|Actual|Medical Centre Leeuwarden|||3||f||||f||||||Samples With DNA|"     Slides for microscopic investigations, containing slices of the skin biopsies. These biopsies     are only diagnostic and these are specific and only for study properties. Study involvement     will not influence diagnostic or therapeutic interventions that are due to common treatment.   "|||2017-10-10 21:47:10.451222|2017-10-10 21:47:10.451222
NCT02912286|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-22|||January 2017||2017-01-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Postoperative Pain Following Irrigation With Endodontic Needle, Sonic and Passive Ultrasonic Techniques|Postoperative Pain Following Irrigation With Endodontic Needle, Sonic and Passive Ultrasonic Techniques: A Randomized Controlled Trial|Not yet recruiting||N/A|57|Anticipated|Cairo University||3|||f||||f||||||||No||2017-10-10 21:47:10.551159|2017-10-10 21:47:10.551159
NCT02912273|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-03-02|||October 12, 2016|Actual|2016-10-12|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Optimizing Fall-risk Prediction in Older Adults With Cancer|Optimizing Fall-risk Prediction in Older Adults With Cancer|Recruiting||N/A|200|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 21:47:10.634122|2017-10-10 21:47:10.634122
NCT02912260|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-08-01|||September 2016||2016-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)|A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis|Active, not recruiting||Phase 2|125|Actual|Madrigal Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 21:47:10.763704|2017-10-10 21:47:10.763704
NCT02912247|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-10-12|||September 2016||2016-09-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Interventional|||Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers|A Open, Randomized, Single-dose, Comparative Bioequivalency and Safety Study of Human Recombinant Anti-tumor Necrosis Factor Alpha Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers|Not yet recruiting||Phase 1|180|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||2|||f||||f||||||||No||2017-10-10 21:47:10.9226|2017-10-10 21:47:10.9226
NCT02912234|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-11-18|||September 2016||2016-09-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants|Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants|Completed||Phase 1|20|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 21:47:11.000843|2017-10-10 21:47:11.000843
NCT02912221|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-06-05|||April 24, 2017|Actual|2017-04-24|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|SUFIA||Stepping Up For Inflammatory Arthritis|Influence of Increased Physical Activity on Patient Reported Measures of Disease Activity in Inflammatory Arthritis|Recruiting||N/A|70|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||Yes|The investigators will share the results of the study after completion of the study through publication in a peer-reviewed journal. Investigators wishing to use the de-identified dataset for additional analyses can contact the PI after publication.|2017-10-10 21:47:11.081203|2017-10-10 21:47:11.081203
NCT02912208|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-21|||June 2011||2011-06-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes|Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes (EQol-MDS)|Recruiting||Phase 2|174|Anticipated|Associazione Qol-one||2|||f||||t||||||||Undecided||2017-10-10 21:47:11.168405|2017-10-10 21:47:11.168405
NCT02912195|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-26|||March 2016||2016-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Intravenous Lidocaine Versus Morphine for Severe Pain in the ED|Intravenous Lidocaine Versus Provider Chosen Dose of Morphine for the Treatment of Severe Pain in the Emergency Department: An Open-label Randomized Controlled Pilot Study|Completed||Phase 4|32|Actual|Alameda Health System||2|||f||||f||||||||Undecided||2017-10-10 21:47:11.642346|2017-10-10 21:47:11.642346
NCT02912169|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-07-19|||November 2015||2015-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Vascular Fraction (AD-SVF) Cells Delivered Intravenous (IV) and Intranasal in Patients With Alzheimer's Disease|Recruiting||Phase 1/Phase 2|100|Anticipated|Ageless Regenerative Institute||1|||f||||f||||||||||2017-10-10 21:47:11.871427|2017-10-10 21:47:11.871427
NCT02912156|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-22|||June 2016||2016-06-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Pharmacokinetics of Two Different Formulation of Voriconazole|A Randomized, Parallel, Single-Dose Study to Evaluate the Pharmacokinetics of Two Different Formulation of Voriconazole 200mg Tablets in Healthy Adult Subjects|Completed||Phase 4|29|Actual|Yung Shin Pharm. Ind. Co., Ltd.||2|||f||||||||||||||2017-10-10 21:47:11.952281|2017-10-10 21:47:11.952281
NCT02912143|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2017-01-26|||January 1, 2017||2017-01-01|January 2017|2017-01-01|January 1, 2022|Anticipated|2022-01-01|January 1, 2022|Anticipated|2022-01-01|5 Years|Observational [Patient Registry]|GEPHARD||German Pediatric Hemophilia Research Database|German Pediatric Hemophilia Research Database|Recruiting||N/A|200|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||t||||||||No|Individual Patient data will not be shared outside specified collaborating studies (none yet)|2017-10-10 21:47:12.024472|2017-10-10 21:47:12.024472
NCT02912130|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Exercise and Nutrition Interventions in Age-related Sarcopenia|The Multidimensional Effects of Exercise and Nutritional Interventions on Musculoskeletal Functioning, Nutritional Status and Quality of Life in Age-related Sarcopenia|Recruiting||Phase 1|160|Anticipated|Liverpool Hope University||4|||f||||t||||||||Undecided||2017-10-10 21:47:12.107941|2017-10-10 21:47:12.107941
NCT02912117|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-20|||August 2016||2016-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay|Determining the Etiologic Diagnosis in Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay|Recruiting||N/A|100|Anticipated|Karius, Inc.|||1||f||||f||||||Samples With DNA|"     Plasma   "|Undecided||2017-10-10 21:47:12.245728|2017-10-10 21:47:12.245728
NCT02912104|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|June 2017|Anticipated|2017-06-01||Interventional|POI||A Therapeutic Trial of Human Amniotic Epithelial Cells Transplantation for Primary Ovarian Insufficiency Patients|International Peace Maternity and Child Health Hospital (IPMCH) Affiliated to School of Medicine, Shanghai Jiaotong University, Shanghai, China|Recruiting||Phase 1|2|Anticipated|International Peace Maternity and Child Health Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:47:12.315308|2017-10-10 21:47:12.315308
NCT02912078|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-12-09|||September 2016||2016-09-01|December 2016|2016-12-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Pocket Warming of Epidural Medication|Pocket Warming of Epidural Medication to Shorten Onset of Labor Analgesia|Recruiting||Phase 4|150|Anticipated|Ohio State University||2|||f||||f||||||||No||2017-10-10 21:47:12.412378|2017-10-10 21:47:12.412378
NCT02912065|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-10-04|||January 2015||2015-01-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay|Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay: A Retrospective Assessment|Completed||N/A|13|Actual|Nestlé|||1||f||||f||||||||No|All data will be presented in manuscript|2017-10-10 21:47:12.513211|2017-10-10 21:47:12.513211
NCT02912052|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-22|||October 2016||2016-10-01|September 2016|2016-09-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|PEPCORLI||Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis|Peri-operative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis: a Prospective Randomized Clinical Trial|Not yet recruiting||Phase 3|240|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:47:12.587897|2017-10-10 21:47:12.587897
NCT02912039|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-08-28|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Electromyographic Assessment of the TetraGraph in Normal Volunteers|Electromyographic Assessment of the TetraGraph in Normal Volunteers|Enrolling by invitation||N/A|10|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-10 21:47:12.732654|2017-10-10 21:47:12.732654
NCT02912026|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-03-06|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ADME||Radiolabelled IV and Oral Metabolism Study of F901318|An Open-Label, Single-Dose, Single-Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-F901318 Administered Via the Intravenous and Oral Routes to Healthy Male Subjects|Not yet recruiting||Phase 1|10|Anticipated|F2G Ltd.||2|||f||||f|f|f||||||No||2017-10-10 21:47:12.798753|2017-10-10 21:47:12.798753
NCT02912013|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2017-02-28|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|OHR2-MeMini||The Efficacy of the Me Mini Device for Hair Removal|The Efficacy of the Me Mini Device for Hair Removal: A Prospective, Open Label Study With Before-After Design|Recruiting||N/A|15|Anticipated|Iluminage Ltd.||1|||f||||t|f|t|f||f|||No||2017-10-10 21:47:12.882129|2017-10-10 21:47:12.882129
NCT02912000|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|TEACH||TEACH: Technology Evaluation to Address Child Health|TEACH: Technology Evaluation to Address Child Health|Recruiting||N/A|800|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:47:12.975847|2017-10-10 21:47:12.975847
NCT02911987|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-08-08|||August 2016||2016-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|LBP-HIT-RCT||Structural and Functional Effects of High Intensity Training (HIT) Program in Patients With Non-specific Chronic Low Back Pain|Structural and Functional Effects of High Intensity Training (HIT) Program in Patients With Non-specific Chronic Low Back Pain. A Randomized Clinical Trial|Recruiting||N/A|125|Anticipated|Hasselt University||5|||f||||f||||||||||2017-10-10 21:47:13.08185|2017-10-10 21:47:13.08185
NCT02911961|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|||APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors|Serum Acetaminophen-Cysteine (APAP-CYS) Adduct Concentrations in Subjects Expected to Develop Aminotransferase Elevations With Liver-Directed Therapy Intended to Treat Hepatic Tumors|Not yet recruiting||Phase 4|30|Anticipated|Denver Health and Hospital Authority||2|||f||||t|t|f||||||||2017-10-10 21:47:13.315948|2017-10-10 21:47:13.315948
NCT02911948|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-09-26|||September 20, 2016|Actual|2016-09-20|September 2017|2017-09-01|November 21, 2017|Anticipated|2017-11-21|October 3, 2017|Anticipated|2017-10-03||Interventional|DUAL™ II Japan||A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs|This Trial is Conducted in Asia. The Aim of This Trial is to Compare the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs.|Active, not recruiting||Phase 3|247|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 21:47:13.431918|2017-10-10 21:47:13.431918
NCT02911935|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2017-05-15|||November 2016||2016-11-01|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|April 2021|Anticipated|2021-04-01||Interventional|APW-RSV-II||Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II|Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II|Recruiting||Phase 2/Phase 3|188|Anticipated|Washington University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:47:13.617006|2017-10-10 21:47:13.617006
NCT02911922|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-08-18|||September 2016||2016-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer|Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer|Recruiting||N/A|40|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-10 21:47:13.71622|2017-10-10 21:47:13.71622
NCT02911896|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-09-21|||August 2015||2015-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Observational|PaciFIC||Physical Function in Critical Care (PaciFIC)|Physical Function in Critical Care (PaciFIC): An Multi-centre Observational Study|Recruiting||N/A|130|Anticipated|University of Melbourne|||1||f||||f||||||||Undecided||2017-10-10 21:47:13.915306|2017-10-10 21:47:13.915306
NCT02911883|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-06-16|||August 29, 2016|Actual|2016-08-29|June 2017|2017-06-01|February 2, 2017|Actual|2017-02-02|February 1, 2017|Actual|2017-02-01||Observational|||Evaluation of the Repeatability and Reproducibility of AngioVue||Completed||N/A|70|Actual|Optovue|||3||f||||f||||||||||2017-10-10 21:47:13.993017|2017-10-10 21:47:13.993017
NCT02911870|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-05-29|||September 22, 2016|Actual|2016-09-22|May 2017|2017-05-01|May 10, 2017|Actual|2017-05-10|May 4, 2017|Actual|2017-05-04||Interventional|||A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects|A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects|Completed||Phase 1|84|Actual|Novo Nordisk A/S||3|||f||||f|f|f||||||Yes|According to the Novo Nordisk disclosure commitment on novonordisk-trials.com|2017-10-10 21:47:14.065389|2017-10-10 21:47:14.065389
NCT02911844|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-01|||April 10, 2017|Actual|2017-04-10|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|ERA-PAH||Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension|Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension|Recruiting||Phase 2|5|Anticipated|University of Pennsylvania||1|||f||||f|t|f|||t|||||2017-10-10 21:47:14.212253|2017-10-10 21:47:14.212253
NCT02911831|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-26|||November 2016||2016-11-01|September 2016|2016-09-01||||November 2017|Anticipated|2017-11-01||Interventional|||IV Tranexamic Acid Prior to Hysterectomy|IV Tranexamic Acid Prior to Hysterectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial|Not yet recruiting||Early Phase 1|248|Anticipated|Northwestern University||6|||f||||||||||||||2017-10-10 21:47:14.308344|2017-10-10 21:47:14.308344
NCT02911818|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-05-24|||August 2016||2016-08-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MODEL||Lifestyle Modification and Liraglutide|Combining Lifestyle Modification and Liraglutide to Improve Weight Loss and Health Outcomes|Active, not recruiting||Phase 4|150|Actual|University of Pennsylvania||3|||f||||||||||||No||2017-10-10 21:47:14.40844|2017-10-10 21:47:14.40844
NCT02911805|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-01|||June 10, 2015|Actual|2015-06-10|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation|Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation|Enrolling by invitation||N/A|20|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:47:14.504586|2017-10-10 21:47:14.504586
NCT02911402|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-20|||October 2014||2014-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|SICKVEST||Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe||Recruiting||N/A|360|Anticipated|University Hospital, Caen|||1||f||||f||||||||No||2017-10-10 21:47:17.593865|2017-10-10 21:47:17.593865
NCT02911792|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-09-28|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|Hyper||Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration|Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration|Not yet recruiting||Phase 4|80|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t|t|f||||||||2017-10-10 21:47:14.647304|2017-10-10 21:47:14.647304
NCT02911779|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-21|||February 2012||2012-02-01|September 2016|2016-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||The Optimal Angle of Mediolateral Episiotomy at Crowning of the Head During Labor|The Optimal Angle of Mediolateral Episiotomy at Crowning of the Head During Labor|Completed||N/A|102|Actual|Wolfson Medical Center||1|||f||||f||||||||No||2017-10-10 21:47:14.770721|2017-10-10 21:47:14.770721
NCT02911766|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-04|||November 2016||2016-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Efficacy of Different Chlorhexidine Concentrations|Comparing the Effect of 0,06 % -, 0,12 % and 0,2 % Chlorhexidine on Plaque, Bleeding and Side Effects in an Experimental Gingivitis Model. A Parallel, Double Masked, Randomized, Placebo-controlled Clinical Trial|Not yet recruiting||Phase 4|59|Anticipated|University of Oslo||3|||f||||f||||||||Yes|Via Scientific Journals|2017-10-10 21:47:14.841279|2017-10-10 21:47:14.841279
NCT02911753|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-21|||June 2016||2016-06-01|July 2016|2016-07-01||||June 2017|Anticipated|2017-06-01||Interventional|||Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults|Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults|Recruiting||Phase 1|50|Anticipated|University of Arizona||3|||f||||f||||||||No||2017-10-10 21:47:15.041086|2017-10-10 21:47:15.041086
NCT02911740|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Additive Benefit of the Urine LAM Test to Current TB Diagnostics in HIV Positive Adults in Panama City, Panama|Investigating the Additive Benefit of the Urine Lipoarabinomannan Test to Current TB Diagnostics Among HIV+ Adults in Panama City, Panama|Not yet recruiting||N/A|292|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 21:47:15.182868|2017-10-10 21:47:15.182868
NCT02911727|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-20|||October 2016||2016-10-01|September 2016|2016-09-01||||September 2018|Anticipated|2018-09-01||Interventional|||Fast-track Discharge After Elective Cesarean Section|Fast-track Discharge After Elective Cesarean Section|Not yet recruiting||N/A|142|Anticipated|Herning Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:47:15.273058|2017-10-10 21:47:15.273058
NCT02911714|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Contrast-Enhanced Ultrasound for Kidney Transplant|A Pilot Study to Develop Contrast-Enhanced Ultrasound for Kidney Transplant|Not yet recruiting||Phase 1|55|Anticipated|University of Utah||2|||f||||t|t|f||||||||2017-10-10 21:47:15.348185|2017-10-10 21:47:15.348185
NCT02911701|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-11-14|||September 2016||2016-09-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features|Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features|Recruiting||Phase 4|100|Anticipated|University of New Mexico||2|||f||||t||||||||No||2017-10-10 21:47:15.452972|2017-10-10 21:47:15.452972
NCT02911688|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-01-11|||September 2016||2016-09-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|Gammoz||Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure|Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure|Recruiting||Phase 2|32|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:47:15.613577|2017-10-10 21:47:15.613577
NCT02911675|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-19|||October 2016||2016-10-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01|6 Months|Observational [Patient Registry]|Dual ICP||Assessing the Accuracy and the Impact of Standard-practice Ventricular Drainage on Intracranial Pressure Measurements Following Traumatic Brain Injury|Assessing the Accuracy and the Impact of Standard-practice Ventricular Drainage on Intracranial Pressure Measurements Following Traumatic Brain Injury|Not yet recruiting||N/A|50|Anticipated|University of Maryland|||2||f||||t||||||||No||2017-10-10 21:47:15.743046|2017-10-10 21:47:15.743046
NCT02911662|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Asymptomatic Bacteriuria in Pregnancy||Recruiting||N/A|101|Anticipated|Saint Joseph Mercy Health System||2|||f||||f||||||||||2017-10-10 21:47:15.837029|2017-10-10 21:47:15.837029
NCT02911649|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Reducing Sedentary Behaviour With Technology|Reducing Sedentary Behaviour Through Wearable Technology and Education|Not yet recruiting||N/A|136|Anticipated|University Health Network, Toronto||4|||f||||f||||||||No||2017-10-10 21:47:15.969659|2017-10-10 21:47:15.969659
NCT02911636|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-04-24|||October 2016||2016-10-01|April 2017|2017-04-01|October 2022|Anticipated|2022-10-01|October 2017|Anticipated|2017-10-01||Interventional|5Star||5 Fractions of Pelvic SABR With Intra Prostatic SABR|5 Fractions of Pelvic SABR With Intra Prostatic SABR|Active, not recruiting||Phase 2|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||No||2017-10-10 21:47:16.105086|2017-10-10 21:47:16.105086
NCT02911610|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-09-20|||January 2017||2017-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|WRIST||Assessment of Arthroscopy in Patients Undergoing Wrist Fracture|Open and Controlled Trial to Assess the Arthroscopy Use in Patients Undergoing Wrist Fracture Surgery by Volar Plate|Not yet recruiting||N/A|186|Anticipated|Hospital San Carlos, Madrid||2|||f||||f||||||||Undecided||2017-10-10 21:47:16.288573|2017-10-10 21:47:16.288573
NCT02911597|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2017-10-04|||September 2016||2016-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|Ket_Nal||Double-Blind, Cross-Over Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)|Double-Blind, Cross-Over Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)|Recruiting||Phase 1|30|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 21:47:16.375793|2017-10-10 21:47:16.375793
NCT02911584|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-22|||December 2014||2014-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Laparoscopic Sacrocolpopexy Versus POPS in the Management of Pelvic Prolapse|Laparoscopic Sacrocolpopexy Versus POPS in the Surgical Management of Pelvic Organ Prolapse: A Prospective Randomized Trial|Completed||N/A|30|Actual|Policlinico Universitario Agostino Gemelli||2|||f||||||||||||||2017-10-10 21:47:16.486606|2017-10-10 21:47:16.486606
NCT02911571|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-10-03|||November 15, 2017|Anticipated|2017-11-15|October 2017|2017-10-01|December 2024|Anticipated|2024-12-01|November 15, 2019|Anticipated|2019-11-15||Interventional|PROMMIS||PRospective Multiple Myeloma Impact Study|Prospective Multicenter Study to Measure the Impact of MMprofiler on Treatment Intention in Active Multiple Myeloma Patients|Not yet recruiting||N/A|250|Anticipated|SkylineDx||1|||f||||f|f|f||||||||2017-10-10 21:47:16.576673|2017-10-10 21:47:16.576673
NCT02911558|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-01-17|||January 2015||2015-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|August 2015|Actual|2015-08-01||Observational|EVE||Implication of a Mobile Team of Palliative Care and Reality of the Palliative Approach in the Units|Implication of a Mobile Team of Palliative Care and Reality of the Palliative Approach in the Units|Active, not recruiting||N/A|430|Actual|Hopital Foch|||1||f||||f||||||||||2017-10-10 21:47:16.665699|2017-10-10 21:47:16.665699
NCT02911545|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-21|||October 2011||2011-10-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Observational|FinCV3||Non-vitamin K Oral Anticoagulants in Cardioversion|Non-vitamin K Oral Anticoagulants in Cardioversion of Atrial Fibrillation. FinCV3|Completed||N/A|1000|Actual|Helsinki University Central Hospital|||1||f||||f||||||||No||2017-10-10 21:47:16.73625|2017-10-10 21:47:16.73625
NCT02911532|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-08-12|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|October 1, 2017|Anticipated|2017-10-01||Interventional|TECTPA||Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia|Tissue Engineering Conjunctiva Transplantation and Conjunctival Sac Formation for the Treatment of Pterygium and Atretoblepharia|Recruiting||N/A|60|Anticipated|Shandong Eye Hospital||1|||f||||f||||||||||2017-10-10 21:47:16.805374|2017-10-10 21:47:16.805374
NCT02911519|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-19|||August 2013||2013-08-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Brief Grupal Psychoeducation for Schizophrenia|Efficacy of a Brief Group Psychoeducation Program Aimed at Patients With Schizophrenia and Their Families: A Clinical Controlled Trial|Active, not recruiting||N/A|192|Anticipated|Salud Mental Integral S.A.S.||2|||f||||f||||||||Yes|The information will be available at the sponsor webpage.|2017-10-10 21:47:16.901128|2017-10-10 21:47:16.901128
NCT02911506|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-26|||November 2015||2015-11-01|September 2016|2016-09-01||||November 2017|Anticipated|2017-11-01||Observational|WEAN SLEEP 2||Sleep Quality in Intensive Care Unit Patients at High Risk of Extubation Failure||Recruiting||N/A|72|Anticipated|Poitiers University Hospital|||1||f||||||||||||||2017-10-10 21:47:16.980291|2017-10-10 21:47:16.980291
NCT02911493|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-11-03|||September 2016||2016-09-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|Rest-HF||Reducing Sedentary Time in Patients With Heart Failure|Reducing Sedentary Time in Patients With Heart Failure|Recruiting||N/A|72|Anticipated|University of Colorado, Denver||3|||f||||t||||||||||2017-10-10 21:47:17.047946|2017-10-10 21:47:17.047946
NCT02911480|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-04-06|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin||Not yet recruiting||Phase 1|12|Anticipated|Oxytone Bioscience BV||5|||f||||||||||||||2017-10-10 21:47:17.132787|2017-10-10 21:47:17.132787
NCT02911467|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-06-09|||July 2016||2016-07-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|MR||Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer|Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (13C) as a Predictive Biomarker of Response to Androgen Signaling Inhibitors in Castration-Resistant Prostate Cancer|Recruiting||Phase 1|75|Anticipated|University of California, San Francisco||1|||f||||t||||||||Yes||2017-10-10 21:47:17.201562|2017-10-10 21:47:17.201562
NCT02911454|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-09-13|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Assess the Effects of Infant Formula on Infant Stool Characteristics, Behaviour and Parental Experience in Everyday Situations||Completed||N/A|252|Actual|Nutricia Research||1|||f||||||||||||||2017-10-10 21:47:17.289836|2017-10-10 21:47:17.289836
NCT02911441|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-20|||December 2015||2015-12-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Evaluating CBT Delivered by Community Health Workers on Maternal Mental Health and Infant Cognitive Development in Insecure Environments||Active, not recruiting||N/A|262|Actual|Heartland Alliance||2|||f||||f||||||||No||2017-10-10 21:47:17.373719|2017-10-10 21:47:17.373719
NCT02911428|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-19|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Open Study of the Duration of Immunity After Vaccination With GamEvac|Open Study of the Duration of Immunity After Vaccination With Medicinal Product GamEvac-Vector-Based Vaccine Against Ebola Virus Disease|Recruiting||Phase 4|60|Anticipated|Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|||2||f||||f||||||Samples With DNA|"     The duration of immunity persistence following product administration will be assessed in     healthy volunteers based on the measurements of specific antibody titers.        -  by ELISA method 12, 18 and 24 months after the vaccination vs. baseline values;        -  in virus neutralization reaction 12 months after the vaccination vs. baseline values   "|Undecided||2017-10-10 21:47:17.435277|2017-10-10 21:47:17.435277
NCT02911415|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-19|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi|Open Study of the Duration of Immunity After Vaccination With Medicinal Product GamEvac-Combi - Combined Vector-Based Vaccine Against Ebola Virus Disease, 0.5 ml+0.5 ml/Dose|Recruiting||Phase 4|60|Anticipated|Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|||2||f||||f||||||Samples With DNA|"     The duration of immunity persistence following product administration will be assessed in     healthy volunteers based on the measurements of specific antibody titers.        -  by ELISA method 12, 18 and 24 months after the vaccination vs. baseline values;        -  in virus neutralization reaction 12 months after the vaccination vs. baseline values.   "|Undecided||2017-10-10 21:47:17.510967|2017-10-10 21:47:17.510967
NCT02911389|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-19|||March 2016||2016-03-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||Home PT vs FORCE PT|Unsupervised Home Exercise With and Without a Web-based Recovery Platform as Compared to Traditional Outpatient Physiotherapy After Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial|Recruiting||N/A|||Rothman Institute Orthopaedics||3|||f||||||||||||||2017-10-10 21:47:17.736444|2017-10-10 21:47:17.736444
NCT02911376|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-09-21|||January 2014||2014-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:47:17.820757|2017-10-10 21:47:17.820757
NCT02911363|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-08|||January 2016||2016-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma|Randomized Trial Comparing Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma|Recruiting||N/A|30|Anticipated|Florida Hospital||2|||f||||f||||||||||2017-10-10 21:47:17.863499|2017-10-10 21:47:17.863499
NCT02911350|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-28|||May 2000||2000-05-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer|Phase I Study of Bi-weekly Taxol and Definitive Radiation in Androgen Ablated Locally Advanced Prostate Cancer|Completed||Phase 1|23|Actual|New York University School of Medicine||1|||f||||||||||||||2017-10-10 21:47:17.952315|2017-10-10 21:47:17.952315
NCT02911337|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-09-20|||August 2015||2015-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|WTLSSCHF||Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction|Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction|Recruiting||N/A|50|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-10-10 21:47:18.024479|2017-10-10 21:47:18.024479
NCT02911324|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-12|||September 2016||2016-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cannabinoid Medication for Adults With OCD|Cannabinoid Medication for Adults With Obsessive-Compulsive Disorder (OCD)|Recruiting||Phase 1/Phase 2|25|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-10 21:47:18.097854|2017-10-10 21:47:18.097854
NCT02911298|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-04-03|||November 25, 2016|Actual|2016-11-25|April 2017|2017-04-01|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|||Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules|An Open Label, Single-site Pharmaco-Scintigraphic Phase I - Study in Healthy Subjects to Evaluate the Gastrointestinal Transit and Release Profile of Radio-labelled Metronidazole Benzoate Capsules|Completed||Phase 1|18|Actual|Tillotts Pharma AG||2|||f||||f||||||||No||2017-10-10 21:47:18.241868|2017-10-10 21:47:18.241868
NCT02911285|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-29|||October 2016||2016-10-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|DoD-NAC||NAC for Treating Comorbid PTSD and SUD|Glial Regulators for Treating Comorbid Posttraumatic Stress Disorder and Substance Use Disorders|Recruiting||Phase 2|90|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 21:47:18.319448|2017-10-10 21:47:18.319448
NCT02911272|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-20|||April 2008||2008-04-01|September 2016|2016-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|Partograph||Best Partograph Action Line to Prevent Prolonged Labour|Labour Outcomes With Partograph Action Line Placement at 2 Hour Versus 4 Hours: A Randomised Controlled Trail|Completed||N/A|640|Actual|University of Benin||2|||f||||f||||||||No||2017-10-10 21:47:18.43328|2017-10-10 21:47:18.43328
NCT02911259|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-04-24|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|SPOCT||Suction on Post-Operative Chest Tubes|Suction on Post-Operative Chest Tubes After Video-Assisted Thoracoscopic Surgery Lobectomy for Presumed or Confirmed Primary Lung Cancer - At Which Level?|Recruiting||N/A|230|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||No||2017-10-10 21:47:18.505198|2017-10-10 21:47:18.505198
NCT02911246|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-22|||December 2014||2014-12-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Observational|UREA||Evaluation Report of the Urea / Urine Creatinine as a Marker of Nutritional Status Predictive of ICU Care Associated Infections|Evaluation Report of the Urea / Urine Creatinine as a Marker of Nutritional Status Predictive of ICU Care Associated Infections|Completed||N/A|309|Actual|Nantes University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:47:18.599779|2017-10-10 21:47:18.599779
NCT02911233|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-20|||March 2014||2014-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|SOLUCLOT||Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation Capacity||Completed||N/A|10|Actual|University Hospital, Caen|||1||f||||||||||||||2017-10-10 21:47:18.664815|2017-10-10 21:47:18.664815
NCT02911220|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|GANA||Genetic Study of Familial Forms of Non-atopic Asthma|Genetic Study of Familial Forms of Non-atopic Asthma|Not yet recruiting||N/A|63|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 21:47:18.72508|2017-10-10 21:47:18.72508
NCT02911207|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|August 2019|Anticipated|2019-08-01||Interventional|EvAd||Evaluation of Emotion Management Skill Strengthening in Chronically Ill Patients, Benefiting From Creative and Physical Activities|Evaluation of Emotion Management Skill Strengthening in Chronically Ill Patients, Benefiting From Creative and Physical Activities|Not yet recruiting||N/A|160|Anticipated|Nantes University Hospital||2|||f||||f||||||||No||2017-10-10 21:47:20.446704|2017-10-10 21:47:20.446704
NCT02911194|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-14|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|A2MT||a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)|A1 Beta Casein Free Milk (a2 Milk) for Autism and Attention-deficit Hyperactivity Disorder|Recruiting||N/A|40|Anticipated|Northumbria University||2|||f||||f||||||||||2017-10-10 21:47:20.521458|2017-10-10 21:47:20.521458
NCT02911168|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of US-Guided Paravertebral and Proximal Intercostal Nerve Blocks|A Prospective, Randomized Comparison Between the Ultrasound Guided Paravertebral Block and the Ultrasound Guided Proximal Intercostal Nerve Block|Recruiting||N/A|48|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||No||2017-10-10 21:47:20.685458|2017-10-10 21:47:20.685458
NCT02911155|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-06-30|||June 30, 2016||2016-06-30|May 16, 2017|2017-05-16|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists|Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:47:20.787922|2017-10-10 21:47:20.787922
NCT02911142|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-06-30|||September 15, 2016||2016-09-15|May 12, 2017|2017-05-12|October 1, 2025|Anticipated|2025-10-01|October 1, 2022|Anticipated|2022-10-01||Interventional|||Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma|Phase I/II Study of Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R(2)) In Primary Effusion Lymphoma or KSHV-Associated Large Cell Lymphoma|Recruiting||Phase 1/Phase 2|36|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:47:20.859397|2017-10-10 21:47:20.859397
NCT02911129|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-10-03|||September 14, 2016||2016-09-14|September 28, 2017|2017-09-28|May 31, 2018|Anticipated|2018-05-31|February 28, 2018|Anticipated|2018-02-28||Observational|||Effects of Prism Adaption and rTMS on Brain Connectivity and Visual Representation|Effects of Prism Adaption and rTMS on Brain Connectivity and Visual Representation|Recruiting||N/A|194|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:47:20.960922|2017-10-10 21:47:20.960922
NCT02911116|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-08-08|||August 29, 2016||2016-08-29|August 3, 2017|2017-08-03|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ustekinumab (STELARA ) for the Treatment of Active Sight-Threatening Uveitis|A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis|Recruiting||Phase 2|7|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:47:21.029115|2017-10-10 21:47:21.029115
NCT02911103|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-21|2017-07-28|||August 21, 2016||2016-08-21|July 6, 2017|2017-07-06|September 30, 2020|Anticipated|2020-09-30|September 1, 2020|Anticipated|2020-09-01||Interventional|||Deep Brain Stimulation Surgery for Focal Hand Dystonia|Deep Brain Stimulation Surgery for Treatment of Focal Hand Dystonia|Not yet recruiting||Phase 1/Phase 2|15|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:47:21.1199|2017-10-10 21:47:21.1199
NCT02911090|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-03-10|||June 2016||2016-06-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01|5 Years|Observational [Patient Registry]|EPPIC||Endometriosis Pelvic Pain Interdisciplinary Cohort Data Registry|Endometriosis Pelvic Pain Interdisciplinary Cohort (EPPIC) Data Registry|Enrolling by invitation||N/A|5000|Anticipated|BC Women's Hospital & Health Centre|||1||f||||f||||||||No||2017-10-10 21:47:21.285566|2017-10-10 21:47:21.285566
NCT02911064|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-06-26|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Expectations Regarding Mobility and Self-Care|Assessment of Expectations Regarding Mobility and Self-Care Between Physiatrists and Oncology Patients|Recruiting||N/A|111|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-10 21:47:21.449739|2017-10-10 21:47:21.449739
NCT02911051|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Clinical Study Evaluating the Safety of a New Catheter for Urinary Intermittent Catheterization in Self Catheterized Patients|Clinical Study Evaluating the Safety of a New Catheter for Urinary Intermittent Catheterization in Self Catheterized Patients|Recruiting||N/A|38|Anticipated|BBraun Medical SAS||1|||f||||f||||||||No||2017-10-10 21:47:21.540484|2017-10-10 21:47:21.540484
NCT02911038|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2017-06-22|||November 2016||2016-11-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|September 2017|Anticipated|2017-09-01||Observational|PRIDENTPRO||Stereolithographic Technique for Dentures|Stereolithographic Technique for Complete Denture Fabrication|Recruiting||N/A|35|Anticipated|Concordia Dent Srl|||1||f||||t||||||||Undecided||2017-10-10 21:47:21.626517|2017-10-10 21:47:21.626517
NCT02911025|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-20|||January 2015||2015-01-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy|Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy|Enrolling by invitation||N/A|30|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||No||2017-10-10 21:47:21.716847|2017-10-10 21:47:21.716847
NCT02911012|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-11-25|||October 2016||2016-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Observational|MOSE||Multiple Algorithms System Of All Scores in Embolism (MOSE)|Multiple Algorithms System Of All Scores in Embolism - MOSE|Recruiting||N/A|15208|Anticipated|University Magna Graecia|||1||f||||f||||||||No||2017-10-10 21:47:21.790901|2017-10-10 21:47:21.790901
NCT02910999|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-10-05|||July 11, 2016|Actual|2016-07-11|October 2017|2017-10-01|August 15, 2023|Anticipated|2023-08-15|August 15, 2023|Anticipated|2023-08-15||Observational|ENLARGE-Lung||Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy|A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (BMS-936558) In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology (Stage IIIB/IV) After Prior Chemotherapy|Recruiting||N/A|660|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 21:47:21.88837|2017-10-10 21:47:21.88837
NCT02910986|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-27|||September 2016||2016-09-01|October 2016|2016-10-01|November 2020|Anticipated|2020-11-01|March 2019|Anticipated|2019-03-01||Interventional|||Latinas Learning About Density|Latinas LEarning About Density (LLEAD Study)|Enrolling by invitation||N/A|2000|Anticipated|Mayo Clinic||3|||f||||f||||||||Undecided||2017-10-10 21:47:21.980587|2017-10-10 21:47:21.980587
NCT02910973|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-08|||September 2016||2016-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TEACAP||Using a Transcutaneous Electrical Auricular Stimulator to Harness the Cholinergic Anti-Inflammatory Pathway|Using a Transcutaneous Electrical Auricular Stimulator to Harness the Cholinergic Anti-Inflammatory Pathway|Recruiting||N/A|56|Anticipated|Northwell Health||2|||f||||f||||||||||2017-10-10 21:47:22.076985|2017-10-10 21:47:22.076985
NCT02910960|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-07-17|||December 2016||2016-12-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|Expect||Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses|Randomized Trial Comparing Two Fine Needle Biopsy Needles for Endoscopic Ultrasound-guided Sampling of Solid Pancreatic Masses.|Active, not recruiting||N/A|50|Actual|Florida Hospital||2|||f||||t||||||||||2017-10-10 21:47:22.165314|2017-10-10 21:47:22.165314
NCT02910947|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-19|||October 2016||2016-10-01|September 2016|2016-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Comparative Evaluation of Quadratus Lumborum and Transverses Abdominis Plane Block for Postoperative Pain Relief in Lower Abdominal Surgeries|Comparative Evaluation of Quadratus Lumborum and Transverses Abdominis Plane Block for Postoperative Pain Relief in Lower Abdominal Surgeries|Not yet recruiting||Phase 4|120|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||||||||||||2017-10-10 21:47:22.240086|2017-10-10 21:47:22.240086
NCT02910934|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-06-07|||January 10, 2017|Actual|2017-01-10|June 2017|2017-06-01|March 10, 2019|Anticipated|2019-03-10|January 10, 2019|Anticipated|2019-01-10||Interventional|COST||Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique|Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique|Recruiting||N/A|4636|Anticipated|PATH||2|||f||||f||||||||No||2017-10-10 21:47:22.306484|2017-10-10 21:47:22.306484
NCT02910921|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-07-31|||November 2016||2016-11-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|Migraine Alert||Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit|Individualized Prediction of Migraine Attacks Using a Mobile Phone App|Recruiting||N/A|30|Anticipated|Second Opinion Health|||1||f||||f||||||||||2017-10-10 21:47:22.401826|2017-10-10 21:47:22.401826
NCT02910908|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-26|||November 2009||2009-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2010|Actual|2010-11-01||Observational|PSPA||Characteristics,Treatment Course and Prognosis of Patients Older Than 75 Yrs Old Reaching End Stage Renal Disease (PSPA)|Characteristics and Treatment Course of Patients Older Than 75 Years Old Reaching ESRD. Development of a Prognosis Tools for Early Mortality|Completed||N/A|581|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||No||2017-10-10 21:47:22.488457|2017-10-10 21:47:22.488457
NCT02910895|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-09-26|||September 9, 2017|Actual|2017-09-09|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|SarcomaPDX||Sarcoma Patient Derived Xenografts|Development of a Platform of Patient Derived Xenografts (PDX) of Soft Tissue Sarcomas (STS): Protocol to Obtain Biopsies From Patients With (Non)-Metastatic STS|Recruiting||N/A|25|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 21:47:22.554789|2017-10-10 21:47:22.554789
NCT02910882|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-07-14|||January 3, 2017|Actual|2017-01-03|July 2017|2017-07-01|December 1, 2018|Anticipated|2018-12-01|June 1, 2018|Anticipated|2018-06-01||Interventional|HALO-IST||PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer|A Phase II Study Combining PEGPH20 With Concurrent Gemcitabine and Radiotherapy in Patients With Localized, Unresectable Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|10|Anticipated|Scripps Health||1|||f||||f||||||||||2017-10-10 21:47:22.642692|2017-10-10 21:47:22.642692
NCT02910869|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Observational|PREDICT||PREDICT: Nutrigenetic Profile of Patients With Weight Loss Success|PREDICT: Nutrigenetic Profile of Patients With Weight Loss Success in MOVE! and TeleMOVE! Programs|Enrolling by invitation||N/A|200|Anticipated|San Diego Veterans Healthcare System|||2||f||||t||||||Samples With DNA|"     Saliva Blood   "|||2017-10-10 21:47:22.735818|2017-10-10 21:47:22.735818
NCT02910856|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-21|||July 2014||2014-07-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|ELDERL-IE||Infective Endocarditis in the Elderly|Infective Endocarditis in the Elderly: Description of the Geriatric Characteristics and Their Influence on Therapeutic Care and the Morbidity and Mortality at 3 Months (ELDERL-IE)|Recruiting||N/A|120|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||Undecided||2017-10-10 21:47:22.810842|2017-10-10 21:47:22.810842
NCT02910843|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-01|||February 22, 2017|Actual|2017-02-22|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|October 2019|Anticipated|2019-10-01||Interventional|RECAP||Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer|Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer. A Multicenter Phase Ib Trial (RECAP)|Recruiting||Phase 1|37|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f|f|f||||||No||2017-10-10 21:47:22.884044|2017-10-10 21:47:22.884044
NCT02910830|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-20|||September 2014||2014-09-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|September 2014|Actual|2014-09-01|5 Years|Observational [Patient Registry]|||"Osteoarthritis Relationships and Tobacco  Ancillary Study Khoala "|"Osteoarthritis Relationships and Tobacco  Ancillary Study Khoala "|Completed||N/A|848|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 21:47:23.118523|2017-10-10 21:47:23.118523
NCT02910817|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-20|||January 2014||2014-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Impact of Metformin on In Vitro Fertilization Outcomes in Overweight and Obese PCOS Women|Impact of Metformin on In Vitro Fertilization Outcomes in Overweight and Obese Polycystic Ovary Syndrome Women; A Quasi Experimental Study|Completed||N/A|102|Actual|Assiut University||2|||f||||t||||||||No||2017-10-10 21:47:23.173169|2017-10-10 21:47:23.173169
NCT02910804|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-23|||November 2015||2015-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma|PET-NIRF Dual Modality Imaging Guiding Surgery in Patients With Glioblastoma|Recruiting||Early Phase 1|30|Anticipated|Beijing Tiantan Hospital||1|||f||||t||||||||||2017-10-10 21:47:23.262978|2017-10-10 21:47:23.262978
NCT02910791|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Observational|||The Role of Bacterial Toxins in Human Skin Disease|The Role of Bacterial Toxins in Human Skin Disease|Recruiting||N/A|100|Anticipated|National Jewish Health|||3||f||||f||||||||Undecided||2017-10-10 21:47:23.373786|2017-10-10 21:47:23.373786
NCT02910778|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-03-21|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Effect of Atorvastatin Treatment for 14 Days in Combination With an Acute Dose of Ticagrelor on Ischemia Reperfusion Induced Endothelial Dysfunction of the Forearm Vasculature in Healthy Male Subjects|Completed||Phase 4|32|Actual|Medical University of Vienna||2|||f||||t||||||||Undecided||2017-10-10 21:47:23.45849|2017-10-10 21:47:23.45849
NCT02910765|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-20|||October 2016||2016-10-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Methylene Blue and Ozone in Early Sepsis|Methylene Blue and Ozone in Early Sepsis , a Randomized Double Blind Trial|Not yet recruiting||Phase 4|40|Anticipated|Assiut University||2|||f||||t||||||||No||2017-10-10 21:47:23.546583|2017-10-10 21:47:23.546583
NCT02910752|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation|Salavge Chemotherapy With Cladribine, Cytarabine and Mitoxantrone Followed by Mobilized Peripheral Stem Cell Infusion From the Original Donor for Relapsed Patients After Allogeneic Stem Cell Transplantation: Phase I/II Study|Recruiting||Phase 1/Phase 2|20|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||Undecided||2017-10-10 21:47:23.631673|2017-10-10 21:47:23.631673
NCT02910739|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-07-27|||October 11, 2016|Actual|2016-10-11|July 2017|2017-07-01|April 12, 2017|Actual|2017-04-12|April 3, 2017|Actual|2017-04-03||Interventional|||An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)|A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-10 21:47:23.734755|2017-10-10 21:47:23.734755
NCT02910726|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-04-19|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers|Non-inferiority Study of Intra-operative Indocyanine Green Fluorescent Dye Versus Technetium Lymphoscintigraphy for Sentinel Lymph Node Biopsy in Pediatric Malignancies|Recruiting||Phase 2/Phase 3|60|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:47:23.838126|2017-10-10 21:47:23.838126
NCT02909946|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-01|||September 2016||2016-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents|Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents|Recruiting||N/A|478|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 21:47:23.931893|2017-10-10 21:47:23.931893
NCT02909933|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-16|||July 2015||2015-07-01|June 2015|2015-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity||Completed||Phase 4|30|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||No||2017-10-10 21:47:24.032686|2017-10-10 21:47:24.032686
NCT02909920|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-10|||September 2016||2016-09-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|telerehab||Effectiveness of Telerehabilitation Program in Subacromial Syndrome (Telerehab Sis)|Effectiveness of Telerehabilitation Program Following Surgery Procedures in Subacromial Syndrome Compared With Traditional Therapy. A Randomized Clinical Trial (Telerehab)|Recruiting||N/A|138|Anticipated|University of Malaga||2|||f||||f||||||||No||2017-10-10 21:47:24.136523|2017-10-10 21:47:24.136523
NCT02909907|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-09-26|||August 2016||2016-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|FLEX-D ET||Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles Versus Flexor Muscles Alone for the Treatment of Essential Hand Tremor (FLEX-D ET)|Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles Versus Flexor Muscles Alone for the Treatment of Essential Hand Tremor (FLEX-D ET)|Recruiting||N/A|20|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 21:47:24.283571|2017-10-10 21:47:24.283571
NCT02909894|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-02-16|||May 26, 2016|Actual|2016-05-26|August 2016|2016-08-01|August 30, 2016|Actual|2016-08-30|August 30, 2016|Actual|2016-08-30||Interventional|AYH||Arming Health: Can Breaking up Restful Sitting Time With Upper Body Contractile Activity Regulate Metabolic Health.|Investigating Whether Breaking up Sedentary Behaviour With Seated Upper Body Contractile Activity Can Regulate an Individual's Metabolic Health.|Completed||N/A|13|Actual|University of Leicester||2|||f||||f||||||||No||2017-10-10 21:47:24.385438|2017-10-10 21:47:24.385438
NCT02909881|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athletes|Dose Response Oxidation of a Sweet-corn Derived Polysaccharide (PhytoSpherix) During Exercise in Endurance Trained Athletes|Not yet recruiting||N/A|8|Anticipated|University of Western Ontario, Canada||1|||f||||t||||||||No||2017-10-10 21:47:24.474755|2017-10-10 21:47:24.474755
NCT02909868|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||CS-03 Pressure-Volume Loop Sub-study With RV Lead Positioning|Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial - PV Loops Sub-study|Recruiting||N/A|15|Anticipated|BackBeat Medical Inc||1|||f||||t||||||||Undecided||2017-10-10 21:47:24.589727|2017-10-10 21:47:24.589727
NCT02909855|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-05-02|||October 2016||2016-10-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Observational|||Factors Associated With Parental Observation of Side Effects Following the Child Flu Vaccine|Factors Associated With Parental Observation of Side Effects Following the Child Flu Vaccine|Active, not recruiting||N/A|300|Anticipated|King's College London|||1||f||||f||||||||Undecided||2017-10-10 21:47:24.708589|2017-10-10 21:47:24.708589
NCT02909842|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-28|||January 1, 2016||2016-01-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|September 1, 2016|Actual|2016-09-01||Interventional|||Effect of Drinking Fermented Milk on Immune Response|Immunomodulating Effects of Drinking Fermented Milk Containing Lactobacillus Paracasei (IMULUSTM): a Randomized Controlled Trial Using an Influenza Vaccination Model|Completed||N/A|60|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 21:47:24.830471|2017-10-10 21:47:24.830471
NCT02910700|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-09-20|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib in Patients With BRAF or NRAS-Mutated Metastatic Melanoma|A Phase II Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib in Patients With BRAF or NRAS-Mutated Metastatic Melanoma|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:47:24.970521|2017-10-10 21:47:24.970521
NCT02910687|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-09|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Observational|FINE75+5||FINE75+: 5 Year Follow up|Frailty as an INstrument for Evaluation of Elderly Patients With Non ST ElevationMyocardial Infarction (NSTEMI) - 5 Year Follow up (FINE75+5)|Completed||N/A|307|Actual|Linkoeping University|||1||f||||t||||||||||2017-10-10 21:47:25.093155|2017-10-10 21:47:25.093155
NCT02910674|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-20|||July 2016||2016-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:47:25.172607|2017-10-10 21:47:25.172607
NCT02910661|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-26|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|August 6, 2017|Actual|2017-08-06|August 6, 2017|Actual|2017-08-06||Observational|TAKE-IT TOO||Teen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1)|TAKE-IT TOO: Teen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1)|Completed||N/A|95|Actual|McGill University Health Center|||3||f||||f||||||||||2017-10-10 21:47:25.209355|2017-10-10 21:47:25.209355
NCT02910648|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-15|||July 2016||2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|NAP||Healthy Behaviors Learning Task and Sleep|Sleep Conditioning and Healthy Food Choices|Recruiting||N/A|110|Anticipated|Johns Hopkins University||3|||f||||f||||||||||2017-10-10 21:47:25.301442|2017-10-10 21:47:25.301442
NCT02910635|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-07-26|||September 19, 2016|Actual|2016-09-19|March 2017|2017-03-01|December 20, 2016|Actual|2016-12-20|December 20, 2016|Actual|2016-12-20||Interventional|||A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers|A Randomized, Placebo-Controlled, Four-Period Crossover, Study to Evaluate the Effect of Volanesorsen on the QTc Interval Using a Therapeutic and Supra-Therapeutic Dose Compared With Placebo in Healthy Volunteers: a Thorough QT Study|Completed||Phase 1|52|Actual|Ionis Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-10-10 21:47:25.384238|2017-10-10 21:47:25.384238
NCT02910622|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-22|||June 2012||2012-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|ONCO S-O||Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer.|Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer.|Completed||N/A|30|Actual|University Hospital, Limoges|||2||f||||f||||||Samples With DNA|"     tumor fragment   "|No||2017-10-10 21:47:25.464752|2017-10-10 21:47:25.464752
NCT02910609|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-20|||January 2017||2017-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01|3 Months|Observational [Patient Registry]|||International Experience in Timing And Choices for Ductal Closure in Patent Ductus Arteriosus:INTERPDA Trial|International Experience in Timing And Choices of Treatment For Ductal Closure in Patent Ductus Arteriosus: INTERPDA Trial|Not yet recruiting||N/A|1000|Anticipated|Ankara University|||2||f||||t||||||||No|No data individual data will be shared|2017-10-10 21:47:25.534573|2017-10-10 21:47:25.534573
NCT02910596|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2016-09-30|||October 2016||2016-10-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA||Not yet recruiting||Phase 4|56|Anticipated|Rajavithi Hospital||4|||f||||f||||||||No||2017-10-10 21:47:25.600822|2017-10-10 21:47:25.600822
NCT02910583|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-08-17|||October 2016||2016-10-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|February 2021|Anticipated|2021-02-01||Interventional|||Ibrutinib Plus Venetoclax in Patients With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma|Phase 2 Study of the Combination of Ibrutinib Plus Venetoclax in Subjects With Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Active, not recruiting||Phase 2|150|Actual|Pharmacyclics LLC.||5|||f||||t||||||||||2017-10-10 21:47:25.793317|2017-10-10 21:47:25.793317
NCT02910570|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-02-07|||November 2016||2016-11-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis|"The Association Between Weight Loss With Subsequent Maintenance Using Liraglutide and Changes in Skin Autoflouresence in Overweight or Obese Patients With Knee Osteoarthritis - a Substudy to Effect of Liraglutide on Body Weight and Pain in Overweight or Obese Patients With Knee Osteoarthritis: A Randomised, Double Blind, Placebo-controlled, Parallel Group, Single-centre Trial (NCT02905864)"|Recruiting||Phase 4|150|Anticipated|Parker Research Institute||2|||f||||t||||||||||2017-10-10 21:47:25.96428|2017-10-10 21:47:25.96428
NCT02910557|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-10-04|||August 10, 2017|Actual|2017-08-10|October 2017|2017-10-01|August 28, 2024|Anticipated|2024-08-28|August 28, 2024|Anticipated|2024-08-28||Observational|||Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection|A Postmarketing Prospective Cohort Study of Melanoma Patients Treated With IMLYGIC® in Clinical Practice to Characterize Risk of Herpetic Infection Among Patients, Close Contacts, Health Care Providers & Long-term Safety in Treated Patients|Recruiting||N/A|920|Anticipated|Amgen|||1||f||||f|f|f||||||||2017-10-10 21:47:26.066609|2017-10-10 21:47:26.066609
NCT02910544|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-02-07|||November 2016||2016-11-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|November 2017|Anticipated|2017-11-01||Observational|||Weight Loss and Physical Activity in Overweight/Obese Individuals With Knee Osteoarthritis|The Association Between Weight Loss and Changes in Physical Activity in Overweight/Obese Individuals With Knee Osteoarthritis: An Observational Cohort Study|Recruiting||N/A|150|Anticipated|Parker Research Institute|||1||f||||t||||||||Undecided||2017-10-10 21:47:26.173651|2017-10-10 21:47:26.173651
NCT02910531|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-07-18|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|May 2022|Anticipated|2022-05-01|May 2020|Anticipated|2020-05-01||Interventional|ALA||Lipoic Acid Supplement for Cystine Stone|The Effect of Lipoic Acid Natural Supplement on Cystine Stone Formation|Recruiting||Phase 2|50|Anticipated|University of California, San Francisco||2|||f||||f|t|f||||||||2017-10-10 21:47:26.27308|2017-10-10 21:47:26.27308
NCT02910518|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-06-09|||February 17, 2017|Actual|2017-02-17|June 2017|2017-06-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Interventional|||A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus|A Randomized, Double-blind, Single-dose, 2-Treatment, 2-Period, 2-Sequence Crossover Bioequivalence Study Comparing Two Formulations of Insulin Glulisine (Insulin Glulisine 300 Units/mL Versus Insulin Glulisine 100 Units/mL Marketed as Apidra® 100 Units/mL) Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus|Completed||Phase 1|44|Actual|Sanofi||2|||f||||f|f|f||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:47:26.368|2017-10-10 21:47:26.368
NCT02910505|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of a Novel Multi-Wavelength Laser for Tattoo Removal||Not yet recruiting||N/A|10|Anticipated|Cutera Inc.||1|||f||||f||||||||No||2017-10-10 21:47:26.492773|2017-10-10 21:47:26.492773
NCT02910492|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of a Novel Laser for Skin Rejuvenation||Recruiting||N/A|20|Anticipated|Cutera Inc.||1|||f||||f||||||||No||2017-10-10 21:47:26.573051|2017-10-10 21:47:26.573051
NCT02910479|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-09-21|||November 2015||2015-11-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|e-TEMP||Study Evaluating the Relevance and Reliability of Gastrointestinal Temperature Measurements From a New Device (E-celsius)|Phase 1 Study Evaluating the Relevance and Reliability of Gastrointestinal Temperature Measurements From a New Device (E-celsius)|Completed||Phase 1|22|Actual|University Hospital, Caen||1|||f||||t||||||||||2017-10-10 21:47:26.673109|2017-10-10 21:47:26.673109
NCT02910466|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-07-11|||October 1, 2016||2016-10-01|July 2017|2017-07-01|September 18, 2019|Anticipated|2019-09-18|September 18, 2019|Anticipated|2019-09-18||Interventional|||Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism|A Phase 4, Open-Label, Single-Center Clinical Study of Extended Use of rhPTH(1-84) in Hypoparathyroidism|Active, not recruiting||Phase 4|36|Anticipated|Shire||1|||f||||f|t|f||||||||2017-10-10 21:47:26.754838|2017-10-10 21:47:26.754838
NCT02910453|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-21|||January 2015||2015-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|VOLO||VATS Versus Open Pulmonary Lobectomy in the Limelight of OEP|VATS Versus Open Pulmonary Lobectomy for Lung Cancer: a Prospective Analysis of Different Impacts on Ribcage Kinematics With Optoelectronic Plethysmography|Completed||N/A|78|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||2||f||||||||||||||2017-10-10 21:47:26.841077|2017-10-10 21:47:26.841077
NCT02910440|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-20|2017-03-24||||||March 2017|2017-03-01||||August 2017|Anticipated|2017-08-01||Interventional|||A Safety and Efficacy Study of DCL-101 Compared to GoLyTELY|A Randomized, Investigator-blinded, Non-inferiority, Multicenter Study Evaluating the Safety and Efficacy of DCL-101 Compared to GoLYTELY in Adult Outpatients Undergoing Routine Colonoscopy|Recruiting||Phase 2|357|Anticipated|Dark Canyon Laboratories, LLC||2|||f||||||||||||||2017-10-10 21:47:26.916174|2017-10-10 21:47:26.916174
NCT02910427|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-20|||January 2009||2009-01-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Intervention With Potassium and/ or Magnesium-enriched Salt on Neurological Performance of Stroke Patients|The Effect of Intervention With Potassium and/ or Magnesium-enriched Salt on Neurological Performance of Stroke Patients|Completed||N/A|291|Actual|Academia Sinica, Taiwan||3|||f||||t||||||||||2017-10-10 21:47:27.00571|2017-10-10 21:47:27.00571
NCT02910414|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||October 2016||2016-10-01|September 2016|2016-09-01|October 2020|Anticipated|2020-10-01|December 2017|Anticipated|2017-12-01||Interventional|TARGET BP I||TARGET BP I Clinical Trial|TARGET BP I Trial: A Phase 2, Multicenter, Double-Blinded, Sham-Procedure Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects With Hypertension|Not yet recruiting||Phase 2|100|Anticipated|Ablative Solutions, Inc.||2|||f||||t||||||||No||2017-10-10 21:47:27.085989|2017-10-10 21:47:27.085989
NCT02910401|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-16|||September 2016||2016-09-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Clinical Response to Rhinovirus Challenge|Clinical Response to Rhinovirus Challenge in Human Asthmatics|Recruiting||Phase 2|60|Anticipated|University of Virginia||3|||f||||t||||||||||2017-10-10 21:47:27.179001|2017-10-10 21:47:27.179001
NCT02910388|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||LLETZ Under Direct Colposcopic Vision|Direct Colposcopic Vision and Large Loop Excision of the Transformation Zone in Women With Cervical Dysplasia: a Randomized Controlled Trial.|Recruiting||N/A|150|Anticipated|Zydolab - Institute of Cytology and Immune Cytochemistry||2|||f||||f||||||||No||2017-10-10 21:47:27.275504|2017-10-10 21:47:27.275504
NCT02910375|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-01-02|||December 2016||2016-12-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|GOUDA||Golimumab Dried Blood Spot Analysis|A Prospective Multi-centric Belgian Trial to Validate the Use of Golimumab Serum Level Analysis Using the Dried Blood Spot (DBS) Methodology|Recruiting||Phase 4|10|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 21:47:27.367955|2017-10-10 21:47:27.367955
NCT02910362|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-06-30|2017-04-25||September 2016|Actual|2016-09-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines|Intra-surgical Evaluation of CATS Tonometer Prism and AMO Versus Alcon Phacoemulsification Machines|Completed||N/A|15|Actual|Intuor Technologies, Inc.|small population size|2|||f||||f||||||||||2017-10-10 21:47:27.490797|2017-10-10 21:47:27.490797
NCT02910349|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-09-19|||September 2015||2015-09-01|September 2016|2016-09-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Observational|MOLLI-GLS-Hx||Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation|Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation - Echocardiography and Magnetic Resonance|Recruiting||N/A|150|Anticipated|Institute for Clinical and Experimental Medicine|||1||f||||t||||||Samples With DNA|"     Myocardial biopsy specimen   "|Yes||2017-10-10 21:47:27.714186|2017-10-10 21:47:27.714186
NCT02910323|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-19|||May 2016||2016-05-01|September 2016|2016-09-01|December 2035|Anticipated|2035-12-01|December 2035|Anticipated|2035-12-01||Observational|WEC1||The Will Erwin Headache Research Center - Cluster Headache Study|The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia|Recruiting||N/A|1500|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||f||||||Samples With DNA|"     Blood, urine, saliva, skin cells, other   "|Yes||2017-10-10 21:47:27.893013|2017-10-10 21:47:27.893013
NCT02910310|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-12-02|||October 2016||2016-10-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|UBT||Introduction of UBT for PPH Management in Three Countries|Introduction of a Uterine Balloon Tamponade for Postpartum Hemorrhage in Three Low Income Countries: a Stepped Wedge Cluster Randomized Trial|Recruiting||N/A|43200|Anticipated|Gynuity Health Projects||2|||f||||t||||||||||2017-10-10 21:47:27.983343|2017-10-10 21:47:27.983343
NCT02910297|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-19|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy||Not yet recruiting||N/A|40|Anticipated|Gillette Children's Specialty Healthcare|||1||f||||f||||||Samples Without DNA|"     Blood samples collected to measure cannabidiol concentrations   "|||2017-10-10 21:47:28.158193|2017-10-10 21:47:28.158193
NCT02910284|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-12-19|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity|A Long-term Follow-up Study of Efficacy and Immunogenicity of GEN-003 in Subjects With Genital Herpes Simplex Virus Type 2 (HSV-2) Infection|Active, not recruiting||N/A|225|Anticipated|Genocea Biosciences, Inc.|||1||f||||f||||||||Undecided||2017-10-10 21:47:28.217847|2017-10-10 21:47:28.217847
NCT02910271|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-04-25|||May 2016||2016-05-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Clinical Features and Prevalence of Asymptomatic Peripheral Artery Disease in Patients With Type 1 Diabetes Mellitus|Clinical Features and Prevalence of Asymptomatic Peripheral Artery Disease in Patients With Type 1 Diabetes Mellitus|Recruiting||N/A|299|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal|||1||f||||t||||||||Undecided||2017-10-10 21:47:28.311389|2017-10-10 21:47:28.311389
NCT02910258|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-19|||September 2012||2012-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|PEG-MF||Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis|Etude de l'efficacité et de la tolérance de l'interféron-pégylé Dans Les myélofibroses|Recruiting||N/A|100|Anticipated|University Hospital, Brest|||1||f||||f||||||||No||2017-10-10 21:47:28.423873|2017-10-10 21:47:28.423873
NCT02910245|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|OPTIC||Mercaptopurine Therapy in Ulcerative Colitis|Efficacy of Optimized Thiopurine Therapy in Ulcerative Colitis (OPTIC)|Not yet recruiting||Phase 3|136|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||No||2017-10-10 21:47:28.549775|2017-10-10 21:47:28.549775
NCT02910232|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-18|||February 2014||2014-02-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Observational|||In Vivo Clinical Trial of Porous Starch - Hydroxyapatite Composite Biomaterials for Bone Regeneration|In Vivo Clinical Trial of Porous Starch - Hydroxyapatite Composite Biomaterials for Bone Regeneration|Completed||Phase 3|44|Actual|Chiang Mai University|||1||f||||t||||||||Yes|yes, we plan|2017-10-10 21:47:28.721936|2017-10-10 21:47:28.721936
NCT02910219|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-04-19|||January 31, 2017|Actual|2017-01-31|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|HALT-D||Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients|Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Receiving Trastuzumab, Pertuzumab, and Docetaxel or Paclitaxel With or Without Carboplatin: HALT-D|Recruiting||Phase 2|46|Anticipated|Georgetown University||2|||f||||t|t|f||||||No|No plan to make individual participant data available|2017-10-10 21:47:28.815801|2017-10-10 21:47:28.815801
NCT02910206|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|EPO||Etomidate to Improve Outcome in Elderly Patients|Comparative Efficacy and Safety of Etomidate or Propofol in Elderly Patients|Not yet recruiting||N/A|3428|Anticipated|Fourth Military Medical University||2|||f||||t||||||||No||2017-10-10 21:47:29.047296|2017-10-10 21:47:29.047296
NCT02910193|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-09-19|||January 2014||2014-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Day|Observational [Patient Registry]|eMedAlcohol||Alcohol Addiction: A Systems-oriented Approach|Alcohol Addiction: A Systems-oriented Approach; Functional Validation II: Neuroimaging x Genetics|Recruiting||N/A|168|Anticipated|Charite University, Berlin, Germany|||3||f||||f||||||Samples With DNA|"     EDTA and PAX blood samples   "|Yes|"Data will be shared within the study consortium SysMedAlcoholism."|2017-10-10 21:47:29.155931|2017-10-10 21:47:29.155931
NCT02910180|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01|6 Months|Observational [Patient Registry]|||Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders|Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders|Recruiting||N/A|900|Anticipated|Cedars-Sinai Medical Center|||1||f||||t||||||Samples With DNA|"     Blood samples, microdialysis samples, cerebral spinal fluid, and tissue.   "|Yes||2017-10-10 21:47:29.259076|2017-10-10 21:47:29.259076
NCT02910167|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-02-23|||September 2016||2016-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima|Observational Prospective Cohort Study to Evaluate the Incidence of Adverse Events (AE), Risk Factors, and Drug Utilization Patterns Related to Treatment With BUSCAPINA COMPOSITUM N From March to December 2016 in Patients From Metropolitan Lima|Completed||N/A|360|Anticipated|Boehringer Ingelheim|||2||f||||||||||||||2017-10-10 21:47:29.37199|2017-10-10 21:47:29.37199
NCT02910154|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-02-13|||December 2016||2016-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|CORA||Comprehensive Treatment of Angina in Women With Microvascular Dysfunction|Comprehensive Treatment of Angina in Women With Microvascular Dysfunction - a Proof of Concept Study of the iPower Cohort|Recruiting||N/A|60|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:47:29.466456|2017-10-10 21:47:29.466456
NCT02910141|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-03-01|||January 2014||2014-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|January 2016|Actual|2016-01-01||Observational|||Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 Diabetes|Individual Patient Data Meta-analysis of Randomised Controlled Trials Comparing Glycaemic Control During Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injections in Type 2 Diabetes Mellitus|Completed||N/A|590|Actual|King's College London|||2||f||||f||||||||Yes||2017-10-10 21:47:29.647041|2017-10-10 21:47:29.647041
NCT02910128|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-20|||October 2016||2016-10-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Childhood Obesity Prevention Trough Education Innovation in Primary School: A Quasi-experimental Trial|"Childhood Obesity Prevention Trough the CHIQUICHEFS Program of Education Innovation and Cooking in a Primary School: A Quasi Experimental Study"|Not yet recruiting||N/A|150|Anticipated|Hospital El Escorial||2|||f||||f||||||||No||2017-10-10 21:47:29.734528|2017-10-10 21:47:29.734528
NCT02910115|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-06-09|||September 2016||2016-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Cooling the Uterus in C-section After Dysfunctional Labor|Can Cooling the Uterus During Cesarean Delivery Reduce Blood Loss, Reduce Drug Use, and Decrease the Risk for Hysterectomy in Women With Dysfunctional Labor?|Enrolling by invitation||N/A|100|Anticipated|Baylor Research Institute||2|||f||||f||||||||No||2017-10-10 21:47:29.806846|2017-10-10 21:47:29.806846
NCT02910102|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-09-27|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia|A Phase 2, Double-blind, Randomized, Placebo-controlled Crossover Study Evaluating the Effect of RVT-101 on Gait and Balance in Subjects With Alzheimer's Disease, Dementia With Lewy Bodies, or Parkinson's Disease Dementia|Active, not recruiting||Phase 2|40|Anticipated|Axovant Sciences Ltd.||2|||f||||t||||||||||2017-10-10 21:47:29.895792|2017-10-10 21:47:29.895792
NCT02910089|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-05|||October 27, 2016|Actual|2016-10-27|September 2017|2017-09-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20||Interventional|ENGAGE-DM||ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus|ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM): A 12-month Study of the Impact of Combined Shared-decision Making and Brief Negotiated Interviewing on Disease Control and Medication Adherence in Patients With Diabetes|Active, not recruiting||Phase 4|1400|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 21:47:30.013387|2017-10-10 21:47:30.013387
NCT02910076|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-20|||October 2016||2016-10-01|August 2016|2016-08-01||||August 2018|Anticipated|2018-08-01||Interventional|||The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin Secretion||Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 21:47:30.130095|2017-10-10 21:47:30.130095
NCT02910050|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-20|||January 2016||2016-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|BETTER||Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer|A Phase II Study of the Efficacy and Tolerability of Bicalutamide Plus Aromatase Inhibitors in Estrogen Receptor(+)/Androgen Receptor(+)/HER2(-) Metastatic Breast Cancer|Recruiting||Phase 2|58|Anticipated|Sun Yat-sen University||1|||f||||t||||||||No||2017-10-10 21:47:30.41152|2017-10-10 21:47:30.41152
NCT02910037|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-19|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:47:30.530021|2017-10-10 21:47:30.530021
NCT02910024|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-07-07|||April 2016||2016-04-01|July 2017|2017-07-01||||February 2018|Anticipated|2018-02-01||Interventional|TheSiReS||Theta-Burst-Stimulation in Early Rehabilitation of Stroke|Theta-Burst-Stimulation in Der frühen Rehabilitation Von Schlaganfallpatienten|Recruiting||Phase 2/Phase 3|150|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-10 21:47:30.578602|2017-10-10 21:47:30.578602
NCT02910011|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-07|||May 18, 2017|Actual|2017-05-18|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Topical NanoDox® for Atopic Dermatitis|A Phase 2, Exploratory Study to Investigate Safety and Efficacy of Doxycycline Monohydrate Hydrogel (NANODOX® HYDROGEL 1%) In Atopic Dermatitis|Recruiting||Phase 2|20|Anticipated|University of Florida||1|||f||||f|t|f||||||||2017-10-10 21:47:30.675303|2017-10-10 21:47:30.675303
NCT02909998|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-19|||October 2008||2008-10-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Biomarkers in Chronic Arthritis|Evaluation of Predictive Genetic Markers of Response to Biologic Therapies in Chronic Arthritis|Completed||N/A|379|Actual|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 21:47:30.773404|2017-10-10 21:47:30.773404
NCT02909985|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-09-16|||September 2015||2015-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Visual Activity Evoked by Infrared in Humans After Dark Adaptation|Visual Activity Evoked by Infrared in Humans After Dark Adaptation|Completed||N/A|29|Actual|University of New Mexico||3|||f||||f||||||||No||2017-10-10 21:47:30.841482|2017-10-10 21:47:30.841482
NCT02909972|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-06-26|||September 2016||2016-09-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome|A Phase 1/1b Open-Label Study to Determine the Safety and Tolerability of ALRN-6924 Alone and in Combination With Cytarabine (Ara-C) in Patients With Relapsed/Refractory Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome With Wild-Type TP53|Recruiting||Phase 1|60|Anticipated|Aileron Therapeutics||2|||f||||f|t|f||||||No||2017-10-10 21:47:30.943056|2017-10-10 21:47:30.943056
NCT02909660|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder|What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder|Recruiting||N/A|42|Anticipated|Concordia University||2|||f||||f||||||||No||2017-10-10 21:47:32.335891|2017-10-10 21:47:32.335891
NCT02909959|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-04-26|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder|A Phase II, Randomized, Double-blind, Placebo-controlled Study of Myrosinase-enriched Glucoraphanin, a Sulforaphane Precursor System, in Autism Spectrum Disorder|Recruiting||Phase 2|54|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|t|f||||||Yes|The investigators plan to publish the results of this trial in a peer-reviewed journal and on ClinicalTrials.gov upon completion of the study. No personal identifiable participant data will be included in the reporting of results.|2017-10-10 21:47:31.047667|2017-10-10 21:47:31.047667
NCT02909829|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-20|||October 2016||2016-10-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy of Artificial Pancreas With and Without a Meal Detection Module on Glycemic Control in Adolescents With Type 1 Diabetes After a Missed Bolus|An Open-label, Randomized, Three-way, Crossover Study to Assess the Safety and Efficacy of Closed-loop Delivery With and Without Meal Detection Module and Conventional Pump Therapy in Regulating Glucose Levels After a Missed Bolus in Adolescents With Type 1 Diabetes in Inpatient Settings|Not yet recruiting||Phase 2|12|Anticipated|McGill University||3|||f||||f||||||||No||2017-10-10 21:47:31.159338|2017-10-10 21:47:31.159338
NCT02909816|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-02-22|||April 2015||2015-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Observational|||Adverse Event Risk Assessment in the Use of Nitrous Oxide for Pediatric Dental Patients|Adverse Event Risk Assessment in the Use of Nitrous Oxide for Pediatric Dental Patients|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 21:47:31.263495|2017-10-10 21:47:31.263495
NCT02909803|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-20|||January 2013||2013-01-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|March 2013|Actual|2013-03-01||Interventional|||Measuring the Glycemic Index and Tracking Metabolites of New and Emerging Lentil Varieties|Measuring the Glycemic Index and Tracking Metabolites of New and Emerging Lentil Varieties|Completed||N/A|10|Actual|Guelph Food Research Centre||2|||f||||f||||||||No||2017-10-10 21:47:31.329898|2017-10-10 21:47:31.329898
NCT02909790|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-22|||May 2016||2016-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study Safety and Effectiveness of CURVE Laser Therapy for Circumference Reduction of the Waistline.|A RandomizEd DoUble Blinded ControllEd Study to Evaluate the Safety and Effectiveness of the CURVE Low Level Laser Therapy (LLLT) for Circumference Reduction of the Waistline.|Completed||N/A|40|Actual|Yolo Medical Inc.||2|||f||||f||||||||Undecided||2017-10-10 21:47:31.418062|2017-10-10 21:47:31.418062
NCT02909777|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-06-24|||October 2016||2016-10-01|June 2017|2017-06-01|October 2022|Anticipated|2022-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma|Phase 1 Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma|Recruiting||Phase 1|44|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:47:31.490283|2017-10-10 21:47:31.490283
NCT02909764|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-02-17|||January 2016||2016-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Shifting Salty Taste Preferences in Children|Salty Taste: Assessing a Strategy to Reduce Children's Preference|Completed||N/A|64|Actual|Monell Chemical Senses Center||2|||f||||f||||||||No||2017-10-10 21:47:31.603229|2017-10-10 21:47:31.603229
NCT02909751|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-09-21|||September 2016||2016-09-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|NeoToc||Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer|Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer|Recruiting||Phase 2|78|Anticipated|Vejle Hospital||2|||f||||f||||||||||2017-10-10 21:47:31.678709|2017-10-10 21:47:31.678709
NCT02909738|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-04-26|||August 2016||2016-08-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Measuring Ability of Healthy Volunteers to Power a Bicycle-powered Oxygen Concentrator|Measuring Ability of Healthy Volunteers to Power a Bicycle-powered Oxygen Concentrator|Completed||N/A|30|Actual|University of Utah|||1||f||||f||||||||No||2017-10-10 21:47:31.781218|2017-10-10 21:47:31.781218
NCT02909725|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||February 2016||2016-02-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|BUP||"The Blossom Project: BlossomUP Methods to Decrease Sedentary Time in Pregnancy"|"The Blossom Project: BlossomUP Evaluating Methods to Decrease Sedentary Time in Pregnancy"|Recruiting||N/A|36|Anticipated|Iowa State University||3|||f||||f||||||||No||2017-10-10 21:47:31.851539|2017-10-10 21:47:31.851539
NCT02909712|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-19|||September 2016||2016-09-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Cardio‑Safety of Dihydroartemisinin‑Piperaquine and Pharmacokinetics of Piperaquine Amongst Pregnant Women in Tanzania|Cardio‑Safety of Dihydroartemisinin‑Piperaquine and Pharmacokinetics of Piperaquine Amongst Pregnant Women in Tanzania|Recruiting||Phase 2|200|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||No|Results will be published in a peer-reviewed journal|2017-10-10 21:47:31.943883|2017-10-10 21:47:31.943883
NCT02909699|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|CORE||Cardiovascular Health of Older Adults and Resveratrol (CORE)|Cardiovascular Health of Older Adults and Resveratrol|Recruiting||N/A|36|Anticipated|University of Florida|||3||f||||t||||||||No||2017-10-10 21:47:32.066198|2017-10-10 21:47:32.066198
NCT02909686|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-08-11|||July 2016||2016-07-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Effects of Botanical Microglia Modulators in Gulf War Illness|Effects of Botanical Microglia Modulators in Gulf War Illness|Recruiting||N/A|40|Anticipated|University of Alabama at Birmingham||10|||f||||f||||||||||2017-10-10 21:47:32.151178|2017-10-10 21:47:32.151178
NCT02909673|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|May 2021|Anticipated|2021-05-01||Interventional|CRT||School Based Program to Prevent Teen Dating Violence|Cluster Randomized Trial of School Based Program to Prevent Teen Dating Violence|Not yet recruiting||N/A|3500|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||Undecided|Will comply with NIH|2017-10-10 21:47:32.264725|2017-10-10 21:47:32.264725
NCT02898428|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||April 2016||2016-04-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Observational|||Continuous Glucose Monitoring in New Mothers With Type 1 Diabetes|Continuous Glucose Monitoring During Breastfeeding or Formula Feeding in New Mothers With Type 1 Diabetes|Recruiting||N/A|60|Anticipated|Steno Diabetes Center|||2||f||||||||||||||2017-10-10 21:49:17.98726|2017-10-10 21:49:17.98726
NCT02909647|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-21|||January 2014||2014-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Three Dimensional Digital Preoperative Planning for the Osteosynthesis of Distal Radius Fractures|Three Dimensional Digital Preoperative Planning for the Osteosynthesis of Distal Radius Fractures|Completed||N/A|30|Actual|Tokyo Medical University||2|||f||||f||||||||No||2017-10-10 21:47:32.423818|2017-10-10 21:47:32.423818
NCT02909634|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-07-19|||April 1, 2018|Anticipated|2018-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Combining Ostom-I With Abstats Sensors to Improve Prediction of Ostomy Output|Combining Ostom-I With Abstats Sensors to Improve Prediction of Ostomy Output|Not yet recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center|||1||f||||f|f|||||||||2017-10-10 21:47:32.488989|2017-10-10 21:47:32.488989
NCT02909621|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-04-26|||May 2014||2014-05-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|COPRA||Evaluation of FLEXOFYTOL® Versus PLACEBO|Evaluation of Efficacy, Tolerance, and Dose Effects of a Curcuma Extract (FLEXOFYTOL®) Versus PLACEBO in Patients With Knee osteoARthritis (COPRA)|Recruiting||N/A|150|Anticipated|Tilman S.A.||3|||f||||f||||||||No||2017-10-10 21:47:32.568876|2017-10-10 21:47:32.568876
NCT02909608|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-07-15|||October 7, 2016|Actual|2016-10-07|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Actigraphy in Pediatric Pulmonary Hypertension|Investigation of Actigraphy, an Exercise Measurement Device, as a Novel, Well-defined, Reliable, Feasible, Easy to Use, and Non-Invasive Study Endpoint to Facilitate Pediatric Pulmonary Arterial Hypertension Trials and Drug Development|Recruiting||N/A|200|Anticipated|University of Colorado, Denver|||2||f||||f||||||||||2017-10-10 21:47:32.668995|2017-10-10 21:47:32.668995
NCT02909595|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-12-13|||November 2014||2014-11-01|September 2016|2016-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Balloon Catheter vs. Basket Catheter for Endoscopic Bile Duct Stone Extraction|Balloon Catheter Versus Basket Catheter for Endoscopic Bile Duct Stone Extraction in Patients With Periampullary Diverticulum:a Multicenter Randomized Trial|Completed||Phase 4|80|Actual|Anhui Provincial Hospital||2|||f||||t||||||||No||2017-10-10 21:47:32.754157|2017-10-10 21:47:32.754157
NCT02909582|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|O-CHIP||Obesity: Cesarean Health by Incision Placement|Obesity: Cesarean Health by Incision Placement|Recruiting||N/A|284|Anticipated|Thomas Jefferson University||2|||f||||t||||||||No||2017-10-10 21:47:32.825475|2017-10-10 21:47:32.825475
NCT02909569|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-07-28|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|CIPS||Relieving Chronic Itch: Oral Medication|Relieving Chronic Itch : Oral Medication|Not yet recruiting||Phase 2|20|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 21:47:32.902816|2017-10-10 21:47:32.902816
NCT02909556|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-05-03|||December 16, 2016|Actual|2016-12-16|May 2017|2017-05-01|October 2022|Anticipated|2022-10-01|October 2017|Anticipated|2017-10-01||Interventional|||ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis|ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis|Recruiting||N/A|120|Anticipated|Symetis SA||1|||f||||t||||||||Undecided||2017-10-10 21:47:33.108094|2017-10-10 21:47:33.108094
NCT02909543|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-18|||September 2016||2016-09-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||The Life Experience of Young Women (Age 18-38) Who Live With Congenital Heart Disease|The Life Experience of Young Women (Age 18-38) Who Live With Congenital Heart Disease|Recruiting||N/A|15|Anticipated|Hillel Yaffe Medical Center|||1||f||||||||||||||2017-10-10 21:47:33.249298|2017-10-10 21:47:33.249298
NCT02909530|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-11-24|||September 2016||2016-09-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Comparison Between Olympus EZ Shot 3Plus 19G and EZ Shot 2 19G in EUS-guided FNB of Solid Pancreatic Masses|Comparison Between the Olympus EZ Shot 3Plus 19G and EZ Shot 2 19G in Endoscopic Ultrasound-guided Fine Needle Biopsy of Solid Pancreatic Masses|Recruiting||N/A|40|Anticipated|University of Ulm||2|||f||||f||||||||No||2017-10-10 21:47:33.342098|2017-10-10 21:47:33.342098
NCT02909517|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-16|||March 2016||2016-03-01|September 2016|2016-09-01||||February 2017|Anticipated|2017-02-01||Observational|||The Role of Inflammation in Ocular Tumours|The Role of Inflammation in Ocular Tumours|Recruiting||N/A|30|Anticipated|St. Michael's Hospital, Toronto|||5||f||||||||||||||2017-10-10 21:47:33.480999|2017-10-10 21:47:33.480999
NCT02909504|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Gao NARASD Lithium Study|Biomarkers in Mononuclear Blood Cells for Lithium Treatment Response of Bipolar Disorder|Recruiting||Phase 4|50|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||t||||||||No||2017-10-10 21:47:33.583182|2017-10-10 21:47:33.583182
NCT02909491|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-04-28|||June 2016||2016-06-01|September 2016|2016-09-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Observational|||Ionized Calcium and Behavioural Disorders in Older Adults (CALICO Study)|Ionized Calcium and Behavioural Disorders in Older Adults (CALICO Study)|Completed||N/A|90|Actual|University Hospital, Angers|||2||f||||t||||||||No||2017-10-10 21:47:33.676414|2017-10-10 21:47:33.676414
NCT02909478|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-19|||December 2016||2016-12-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer|Steroid-free Regimen With Aprepitant in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer Receiving FOLFOX Chemotherapy: a Randomized Phase 3 Trial|Not yet recruiting||Phase 3|298|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 21:47:33.770462|2017-10-10 21:47:33.770462
NCT02909465|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-03-03|||July 2016||2016-07-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation|A Comparison of Midazolam or Haloperidol Premedication Versus Placebo for Reducing Ketamine Induced Agitation After Adult Procedural Sedation in the Emergency Department|Active, not recruiting||Phase 4|180|Anticipated|Tehran University of Medical Sciences||3|||f||||t||||||||Undecided||2017-10-10 21:47:33.876796|2017-10-10 21:47:33.876796
NCT02909452|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-02-24|||September 2016||2016-09-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors|A Phase 1, Randomized, Open-Label, Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (SNDX-275-0141, MK3475-460/KEYNOTE-460)|Recruiting||Phase 1|30|Anticipated|Syndax Pharmaceuticals||3|||f||||f||||||||No|Data will be reviewed throughout the study by the sponsor, clinical research organization assisting with SAE management, and routine monitoring to safeguard the interests of the trial patients and to assess the safety of the interventions administered during the trial.|2017-10-10 21:47:34.001338|2017-10-10 21:47:34.001338
NCT02909439|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-05-31|||November 2016||2016-11-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Quality of Recovery After Reversal With Neostigmine or Sugammadex.|Pulmonary Function, Muscle Strength, Time to Extubation and Quality of Recovery in the Post Anesthesia Care Unit After Reversal of Neuromuscular Blockade With Neostigmine or Sugammadex.|Recruiting||Phase 4|80|Anticipated|Stony Brook University||2|||f||||t||||||||No||2017-10-10 21:47:34.175288|2017-10-10 21:47:34.175288
NCT02909413|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-09-16|||October 2016||2016-10-01|September 2016|2016-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Comparison of Desflurane With Sevoflurane for School-age Children in Postoperative Cognitive Function||Not yet recruiting||N/A|600|Anticipated|Shengjing Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:47:34.389138|2017-10-10 21:47:34.389138
NCT02909400|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|KHENERGY||The KHENERGY Study|An Exploratory, Double-blind, Randomized, Placebo-controlled, Single-center, Two-way Cross-over Study With KH176 in Patients With the Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation and Clinical Signs of Mitochondrial Disease|Recruiting||Phase 2|20|Anticipated|Khondrion BV||2|||f||||f||||||||No||2017-10-10 21:47:34.49523|2017-10-10 21:47:34.49523
NCT02909387|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-11|||August 2016||2016-08-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Adapting Project UPLIFT for Blacks in Georgia|Adapting Evidence-Based Epilepsy Self-Management Programs for Blacks in Georgia|Recruiting||N/A|60|Anticipated|Morehouse School of Medicine||2|||f||||t||||||||||2017-10-10 21:47:34.653392|2017-10-10 21:47:34.653392
NCT02909374|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-09-16|||February 2016||2016-02-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||"Stay Balanced - Prevention of Falls in Older Adults - From Clinical Research to Clinical Practice"|"Stay Balanced - Prevention of Falls in Older Adults Through Implementation of Evidence Based Balance Training - From Clinical Research to Clinical Practice"|Recruiting||N/A|400|Anticipated|Karolinska Institutet||1|||f||||f||||||||Undecided||2017-10-10 21:47:35.301026|2017-10-10 21:47:35.301026
NCT02909348|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|March 2019|Anticipated|2019-03-01||Observational|PASIP||Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab|Phenotyping of Blood Samples to Detect Autoimmune Signature Following Immunotherapy With Pembrolizumab|Recruiting||N/A|50|Anticipated|Royal Free Hospital NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     White cells, Serum   "|No||2017-10-10 21:47:35.504255|2017-10-10 21:47:35.504255
NCT02909335|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-16|||November 2016||2016-11-01|September 2016|2016-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|FOREVER||De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study|De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study|Not yet recruiting||Phase 3|180|Anticipated|Rennes University Hospital||2|||f||||f||||||||No||2017-10-10 21:47:35.597652|2017-10-10 21:47:35.597652
NCT02909322|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-18|||April 2016||2016-04-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||Epidural Versus Paravertebral Block Analgesia After Hepatectomy|Analgesic and Hemodynamic Effects of Continuous Epidural Analgesia Compared to Paravertebral Block in Liver Resection Patients|Recruiting||Phase 4|50|Anticipated|Queen's University||2|||f||||f||||||||||2017-10-10 21:47:35.735493|2017-10-10 21:47:35.735493
NCT02909309|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-11-06|||October 2016||2016-10-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|JAWAC||Pilot Study : New Sensors to Monitor Apnea During Sedation|Pilot Study : Evaluation of a Mandibular and Abdominal Motion Detection Sensors (JAWAC) to Prevent Apnea During Sedation With Propofol in TCI Mode|Recruiting||N/A|40|Anticipated|Erasme University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:47:35.934842|2017-10-10 21:47:35.934842
NCT02909296|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-16|||April 2007||2007-04-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|COLLECTOR||Endoscopic Drainage of Collections After Pancreatic Surgery|Endoscopic Drainage of Collections After Pancreatic Surgery|Completed||N/A|40|Actual|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:47:36.039789|2017-10-10 21:47:36.039789
NCT02909283|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-08-24|||March 2015||2015-03-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|DREAM²||Sickle Cell Anemia and Cerebral Microcirculation : Multimodal Exploration|Determinants of Cerebral Oxygenation and Perfusion in SCA Children Based on Combined ASL MRI, NIRS and Hemorheological Investigation|Completed||N/A|64|Actual|Imagine Institute|||1||f||||f||||||Samples With DNA|"     Blood samples are taken, in order to create Biobank (DNA, serum and plasma)   "|||2017-10-10 21:47:36.114757|2017-10-10 21:47:36.114757
NCT02909270|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-18|||August 2016||2016-08-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy|A Randomized, Single-blind, Multi-center, Phase III Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy|Recruiting||Phase 3|172|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||||2017-10-10 21:47:36.206603|2017-10-10 21:47:36.206603
NCT02909257|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-01|||September 2016||2016-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Motor-Sparing Femoral Nerve Block Dose|Minimum Effective Concentration of Bupivacaine for Motor-Sparing Femoral Nerve Block|Recruiting||Phase 4|60|Anticipated|University of Chile||2|||f||||t||||||||||2017-10-10 21:47:36.286338|2017-10-10 21:47:36.286338
NCT02909244|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-08-24|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|DIPobiota||Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease|Study of Gut Microbiota in Primary Immune Deficiencies, Possibly Associated With Inflammatory Bowel Disease (Chronic Granulomatous Disease, XIAP Gene Deficiency, or TTC7A Gene Deficiency)|Completed||N/A|51|Actual|Imagine Institute|||2||f||||f||||||Samples Without DNA|"     Feces samples collected on all patients for study of gut microbiota   "|||2017-10-10 21:47:36.83772|2017-10-10 21:47:36.83772
NCT02909231|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||One-year Patient Reported Outcomes Following Hospitalization for Trauma|One-year Patient Reported Outcomes Following Hospitalization for Trauma|Recruiting||N/A|500|Anticipated|University of Calgary|||2||f||||f||||||||No||2017-10-10 21:47:36.968965|2017-10-10 21:47:36.968965
NCT02909218|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2017-02-03|||September 2014||2014-09-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|MaxART||MaxART: Early Access to ART for All in Swaziland|MaxART: Early Access to ART for All in Swaziland|Recruiting||N/A|4501|Anticipated|Clinton Health Access Initiative Inc.||2|||f||||t||||||||No||2017-10-10 21:47:37.066755|2017-10-10 21:47:37.066755
NCT02909205|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-16|||November 2012||2012-11-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|Gastrostomy||a Care Protocol for Caregivers and Parents of Children Recently Gastrostomised|Development and Evaluation of a Care Protocol for Caregivers and Parents of Children Recently Gastrostomised|Recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 21:47:37.167259|2017-10-10 21:47:37.167259
NCT02909192|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-20|||December 2016||2016-12-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease|Bright Light Modulation of Non-motor Symptoms in Parkinson's Disease|Not yet recruiting||N/A|65|Anticipated|Massachusetts General Hospital||2|||f||||||||||||Undecided||2017-10-10 21:47:37.246447|2017-10-10 21:47:37.246447
NCT02909179|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-20|||June 2016||2016-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|mCARE-II||Measuring the Impact of a Mobile Health System to Support Healthy Pregnancies and Improve Newborn Survival|mCARE II: Enhancing, Integrating and Scaling mCARE and Measuring the Impact of a Mobile Health System to Support Healthy Pregnancies and Improve Newborn Survival|Recruiting||N/A|23474|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||No||2017-10-10 21:47:37.335939|2017-10-10 21:47:37.335939
NCT02909166|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||January 2012||2012-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|RALF||Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF.|Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF. A Double-blind, Randomized, Parallel-group, Single Centre Study|Recruiting||Phase 3|70|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||No||2017-10-10 21:47:37.437711|2017-10-10 21:47:37.437711
NCT02909153|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-08-04|||January 2017||2017-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis|Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis|Completed||Phase 1|30|Actual|Rockwell Medical Technologies, Inc.||2|||f||||f||||||||||2017-10-10 21:47:37.585534|2017-10-10 21:47:37.585534
NCT02909140|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Optimal Method for Mydriasis in Cataract Surgery|Optimal Method for Mydriasis in Cataract Surgery|Recruiting||N/A|210|Anticipated|Johns Hopkins University||3|||f||||f||||||||No||2017-10-10 21:47:37.666113|2017-10-10 21:47:37.666113
NCT02909127|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-12-25|||January 2016||2016-01-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||The Pediatric Eating Assessment Tool|The Development of the Pediatric Eating Assessment Tool (PEDI-EAT-10)|Completed||N/A|138|Actual|Hacettepe University|||2||f||||t||||||||Undecided||2017-10-10 21:47:37.763312|2017-10-10 21:47:37.763312
NCT02909114|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-20|||January 2016||2016-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer|Phase II Study of Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer|Recruiting||Phase 2|50|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||Yes||2017-10-10 21:47:37.840974|2017-10-10 21:47:37.840974
NCT02909101|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-04-27|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Project IMPACT: Improving Memory Performance by Applying Cognitive Training|Cognitive Training to Reduce Impulsivity in HIV-infected Cocaine Users|Recruiting||N/A|50|Anticipated|Duke University||2|||f||||f|f|t|f|||||||2017-10-10 21:47:37.911933|2017-10-10 21:47:37.911933
NCT02909088|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).|An Open-label Study to Evaluate the Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).|Recruiting||Phase 2/Phase 3|10|Anticipated|CITrials||2|||f||||||||||||||2017-10-10 21:47:38.006077|2017-10-10 21:47:38.006077
NCT02909075|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-10-03|||August 2016||2016-08-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||A Study to Assess Thymic Function Using PET/CT and MRI|An Initial Study of FDG-PET/CT and MRI to Assess Thymic Function|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 21:47:38.11349|2017-10-10 21:47:38.11349
NCT02909062|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-18|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.|Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy|Recruiting||N/A|200|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 21:47:38.205936|2017-10-10 21:47:38.205936
NCT02909049|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-09-25|||April 2016||2016-04-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy|Open Randomized Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy|Recruiting||Phase 4|100|Anticipated|Complexo Hospitalario Universitario de A Coruña||2|||f||||f||||||||No||2017-10-10 21:47:38.310201|2017-10-10 21:47:38.310201
NCT02909036|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-05-03|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.|Pharmacokinetic (PK)-Directed Dosing of Captisol Enabled Melphalan for Patients With Multiple Myeloma or Light Chain (AL) Amyloidosis Undergoing High Dose Therapy and Autologous Hematopoietic Progenitor Cell Transplant|Active, not recruiting||Phase 1|11|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:47:40.208779|2017-10-10 21:47:40.208779
NCT02909023|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-12-28|||July 2016||2016-07-01|September 2016|2016-09-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Observational|||Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured|Performance of the Hepatitis B Virus (HBV) ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured|Completed||N/A|34|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:47:40.288119|2017-10-10 21:47:40.288119
NCT02909010|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2016-09-19|||May 2015||2015-05-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|BIS65||Bispectral Index Monitoring To Guide Sedation In The Critical Care Setting|Bispectral Index Monitoring To Guide Sedation In Patients With Non-Neurological Pathology Over 65 Years, Admitted To Intensive Care Unit: Randomized Control Trial|Active, not recruiting||N/A|150|Anticipated|Hospital Universitari de Bellvitge||2|||f||||f||||||||Undecided||2017-10-10 21:47:40.369425|2017-10-10 21:47:40.369425
NCT02908997|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-01|||January 17, 2017|Actual|2017-01-17|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||MindMate: A Study of a Reminder System for People With Dementia|MindMate: A Single Case Experimental Design Study of a Reminder System for People With Mild Dementia|Recruiting||N/A|3|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f||||||||||2017-10-10 21:47:40.447659|2017-10-10 21:47:40.447659
NCT02908984|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-28|||October 2016||2016-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Specific Neck Rehabilitation for Unilateral Neck Related Headache and Structural Changes in the Brain|Efficacy of Specific Neck Rehabilitation on Unilateral Neck Related Headache, and Structural Changes of Cerebral Gray and White Matter|Recruiting||N/A|42|Anticipated|University of Tromso||2|||f||||f||||||||No||2017-10-10 21:47:40.529224|2017-10-10 21:47:40.529224
NCT02908971|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-10-05|||May 2013||2013-05-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Association Between Soy Based Formula in Infancy and Puberty|Association Between Soy Based Formula Consumption During Infancy and the Timing of Pubertal Signs and BMI-SDS|Recruiting||N/A|100|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||||No||2017-10-10 21:47:40.635079|2017-10-10 21:47:40.635079
NCT02908958|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-06-13|||November 2014||2014-11-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|||Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency|Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Children Growth Hormone Deficiency: A Multicenter, Randomized, Parallel, Dose-control Clinical Trial II|Recruiting||Phase 4|900|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-10-10 21:47:40.751911|2017-10-10 21:47:40.751911
NCT02908945|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-06-21|||September 2016||2016-09-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||The Effect of Ketamine on the WAVCNS Index During General Anesthesia: A Feasibility Study|The Effect of Ketamine on the WAVCNS Index During General Anesthesia: A Feasibility Study|Completed||N/A|30|Actual|Fraser Health||3|||f||||f||||||||Yes|Once data collection is complete, a de-identified version of the data may be made available to other researchers. This will be specifically stated in the consent form, and participants will be asked to provide their consent for releasing their anonymized data as well as for participating in the study. Participants may still participate in the study if they do not consent to make their data available.|2017-10-10 21:47:40.957632|2017-10-10 21:47:40.957632
NCT02908932|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-16|||August 2016||2016-08-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RRIPP-3||Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's|Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's|Enrolling by invitation||N/A|450|Anticipated|Medical University of South Carolina||2|||f||||t||||||||No||2017-10-10 21:47:41.155471|2017-10-10 21:47:41.155471
NCT02908919|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-11-01|||August 2016||2016-08-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Impact of Time Intervals of Preparation on Quality and Tolerance of the Bowel Preparation|Impact of Time Intervals on Quality and Tolerance of the Bowel Preparation|Recruiting||Phase 4|480|Anticipated|Faculty Hospital Kralovske Vinohrady||3|||f||||f||||||||No||2017-10-10 21:47:41.293029|2017-10-10 21:47:41.293029
NCT02908906|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-14|||November 21, 2016|Actual|2016-11-21|September 2017|2017-09-01|July 18, 2019|Anticipated|2019-07-18|April 30, 2019|Anticipated|2019-04-30||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers|A First-in-Human, Open-label, Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects With Advanced Cancers|Recruiting||Phase 1|169|Anticipated|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-10 21:47:41.423388|2017-10-10 21:47:41.423388
NCT02908893|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-20|||September 2016||2016-09-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Promoting Flu Vaccination Through a Mobile Wellness Program|Promoting Flu Vaccination Through a Mobile Wellness Program|Enrolling by invitation||N/A|77983|Anticipated|Evidation Health||3|||f||||f||||||||Undecided|Aggregated outcome data may be shared.|2017-10-10 21:47:41.582856|2017-10-10 21:47:41.582856
NCT02908880|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|September 2017|Actual|2017-09-01||Interventional|MANTA||MANTA Vascular Closure Device Clinical Study|Pivotal Clinical Study to Evaluate the Safety and Effectiveness of MANTA Vascular Closure Device|Active, not recruiting||N/A|263|Actual|Essential Medical, Inc.||1|||f||||t||||||||||2017-10-10 21:47:41.669522|2017-10-10 21:47:41.669522
NCT02908867|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-20|||March 2015||2015-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Observational|||Therapeutic Strategies in Sexual Function|Therapeutic Strategies in Sexual Function of Men With Spinal Cord Injury|Completed||N/A|24|Actual|Universidade Federal de Pernambuco|||1||f||||t||||||||No||2017-10-10 21:47:41.804179|2017-10-10 21:47:41.804179
NCT02908841|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-16|||July 2016||2016-07-01|September 2016|2016-09-01||||September 2019|Anticipated|2019-09-01||Interventional|||Surgicel Snow in Gynecological Surgery|Surgicel Snow in Gynecological Surgery|Recruiting||N/A|60|Anticipated|Danbury Hospital||2|||f||||f||||||||||2017-10-10 21:47:41.96636|2017-10-10 21:47:41.96636
NCT02908828|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-19|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|September 19, 2017|Actual|2017-09-19|September 19, 2017|Actual|2017-09-19||Interventional|||Calanus Oil Supplementation and Maximal Oxygen Uptake|Effect of Copepod Oil Supplementation (Calanus Finmarchicus) on Endurance and VO2max in Healthy Obese Subjects|Completed||N/A|71|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 21:47:42.122383|2017-10-10 21:47:42.122383
NCT02908815|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-08-30|||November 2016||2016-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease|Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease|Recruiting||N/A|200|Anticipated|University of Manitoba||3|||f||||t||||||||||2017-10-10 21:47:42.237397|2017-10-10 21:47:42.237397
NCT02908802|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-20|||November 2016||2016-11-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Probiotic Supplement as Treatment for Students With ADHD|A Double-Blind Placebo Controlled Study of Probiotic Supplement as Treatment for Students With Attention Deficit Hyperactivity Disorder (ADHD)|Not yet recruiting||N/A|80|Anticipated|Tel Hai College||2|||f||||f||||||||No||2017-10-10 21:47:42.354799|2017-10-10 21:47:42.354799
NCT02908789|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-18|||March 2016||2016-03-01|September 2016|2016-09-01||||November 2016|Anticipated|2016-11-01||Interventional|||Evaluation of Antimicrobial Photodynamic Therapy for the Treatment of Deep Carious Lesions in Children: an in Vivo Study|Evaluation of Antimicrobial Photodynamic Therapy for the Treatment of Deep Carious Lesions in Children: an in Vivo Study|Active, not recruiting||N/A|30|Anticipated|Universidade Federal Fluminense||1|||f||||||||||||||2017-10-10 21:47:42.457282|2017-10-10 21:47:42.457282
NCT02908776|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|MYDA-MI||MYocardial DAmage AND MIcrobiota STUDY|Gut Flora Modulation for The Prevention of Pci-Related Myocardial Injury - A Randomized, Placebo Controlled, Double Blind, Investigator-Initiated, Single Centre, Preliminary Study|Recruiting||Phase 4|250|Anticipated|San Filippo Neri General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:47:42.543287|2017-10-10 21:47:42.543287
NCT02908763|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-09-18|||August 2016||2016-08-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients|HBsAg Loss/Seroconversion in Low Replicative Chronic HBV Infection Patients With Low Level HBsAg Treated With Peginterferon Alpha|Recruiting||Phase 4|200|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||Undecided||2017-10-10 21:47:42.64631|2017-10-10 21:47:42.64631
NCT02908750|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-25|||March 2, 2017|Actual|2017-03-02|July 2017|2017-07-01|August 3, 2017|Anticipated|2017-08-03|August 3, 2017|Anticipated|2017-08-03||Interventional|||Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC|An Open-label, Non-randomised, Phase I Study to Assess the Effect of Single and Multiple Oral Doses of Osimertinib (TAGRISSO™) on the Pharmacokinetics of a P-glycoprotein Probe Drug (Fexofenadine) in Patients With Advanced EGFRm NSCLC That Have Progressed on a Prior EGFR-TKI Regimen|Active, not recruiting||Phase 1|24|Actual|AstraZeneca||1|||f||||f|f|f||||||||2017-10-10 21:47:42.770857|2017-10-10 21:47:42.770857
NCT02908581|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2017-07-11|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|April 2017|Actual|2017-04-01||Interventional|||Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis|Randomized, Open Label Trial of Iron and Folic Acid on Change of Fungal Pattern|Completed||Phase 2|42|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||f||||||||||2017-10-10 21:47:44.812531|2017-10-10 21:47:44.812531
NCT02908568|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|PTCRSTIM||Stimulation of the Proprioceptive Trigeminocardiac Reflex|Effect of Stimulation of the Proprioceptive Trigeminocardiac Reflex Through Medical Device for the Pain of Patients With Temporomandibular Disorders|Not yet recruiting||Phase 2/Phase 3|36|Anticipated|Azienda USL 12 Versilia||2|||f||||t||||||||Yes||2017-10-10 21:47:44.888277|2017-10-10 21:47:44.888277
NCT02908737|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-16|||July 2016||2016-07-01|September 2016|2016-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|CLASS||Clinical Evaluation of Bass and Treble Controls for CI Subjects|Clinical Evaluation of Bass and Treble Controls for CI Subjects|Recruiting||N/A|34|Anticipated|Cochlear||1|||f||||f||||||||No|"Identifiable data will not be made available to the public. Data will be kept in a secure, locked environment and only the researchers working on the study, relevant authorities and authorised representatives will have access to it.
Subject health records and any information obtained during the research project are subject to inspection (for the purpose of verifying the procedures and the data) by the Food and Drug Administration (FDA) of the United States of America, other national drug regulatory authorities and such as the Australian Government's Therapeutic Goods Administration (TGA), local Ethics Committees, and other duly authorised representatives of the Sponsor, or as required by law.
Study subjects have consented to this."|2017-10-10 21:47:43.047985|2017-10-10 21:47:43.047985
NCT02908724|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-09-17|||November 2014||2014-11-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|November 2014|Actual|2014-11-01||Observational|||Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy|Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy - A Nationwide Danish Clinical Cohort Study|Enrolling by invitation||N/A|66|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||No||2017-10-10 21:47:43.193882|2017-10-10 21:47:43.193882
NCT02908711|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-12-01|||October 2016||2016-10-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Interventional|||Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA)|Analgesic Efficacy of Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA): A Prospective Randomized Trial to Compare Postoperative Clinical Outcomes|Recruiting||Phase 4|100|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-10 21:47:43.300039|2017-10-10 21:47:43.300039
NCT02908698|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-16|||October 2016||2016-10-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|OSAD||Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis|A Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral Steroids on Skin of Patients With Moderate to Severe Atopic Dermatitis Patients|Not yet recruiting||N/A|20|Anticipated|McMaster University||2|||f||||f||||||||Yes|We plan to tabulate and include IPD in publication in medical journal.|2017-10-10 21:47:43.4515|2017-10-10 21:47:43.4515
NCT02908685|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-19|2017-09-05|||October 20, 2016|Actual|2016-10-20|September 2017|2017-09-01|May 7, 2020|Anticipated|2020-05-07|April 30, 2019|Anticipated|2019-04-30||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Type 2 and 3 Spinal Muscular Atrophy Participants (Sunfish)|A Two-Part Seamless, Multi-Center Randomized, Placebo-Controlled, Double-blind Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Type 2 and 3 Spinal Muscular Atrophy Patients|Recruiting||Phase 2|186|Anticipated|Hoffmann-La Roche||6|||f||||||||||||||2017-10-10 21:47:43.572567|2017-10-10 21:47:43.572567
NCT02908659|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-07-18|||September 21, 2016|Actual|2016-09-21|July 2017|2017-07-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|FR-REA||Relevance and Nuisances of Respiratory Rate Alarm Generated by Multi-parametric Monitors in Non Ventilated ICU Patients|Relevance and Possible Nuisances of Respiratory Rate Alarm Generated by Multi-parametric Monitors in Non Ventilated ICU Patients.A Prospective, Monocentric, Observational Study|Completed||N/A|123|Actual|Centre Hospitalier Departemental Vendee|||1||f||||f||||||||||2017-10-10 21:47:44.310909|2017-10-10 21:47:44.310909
NCT02908646|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2016-09-17|||June 2016||2016-06-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparing of Microcoil Localization and Hook Wire Localization for Resectable Pulmonary Small Nodules|Comparing of Computed Tomography Guided Microcoil Localization and Hook Wire Localization for Pulmonary Small Nodules and Ground-glass Opacity Prior to Thoracoscopic Resection|Recruiting||Phase 3|72|Anticipated|Peking University People's Hospital||2|||f||||f||||||||No|no plan to make individual participant data (IPD) available|2017-10-10 21:47:44.376849|2017-10-10 21:47:44.376849
NCT02908633|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-17|2016-09-17|||February 2016||2016-02-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy of Three Variants of Canaloplasty With Phacoemulsification to Treat Glaucoma and Cataract|Comparison of Safety and Efficacy of Three Variants of Canaloplasty: Ab-externo, Ab-interno and Minicanaloplasty Combined With Phacoemulsification to Treat Glaucoma and Cataract. A Randomised, Prospective Study.|Recruiting||N/A|90|Anticipated|Military Institute of Medicine, Poland||3|||f||||f||||||||||2017-10-10 21:47:44.460413|2017-10-10 21:47:44.460413
NCT02908620|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-07-18|||December 7, 2016|Actual|2016-12-07|July 2017|2017-07-01|June 7, 2017|Actual|2017-06-07|April 2, 2017|Actual|2017-04-02||Interventional|||Experimental Pain Study to Assess Local Anesthetic Efficacy and Safety of CTY-5339 Anesthetic Spray in Normal Volunteers|A Double-blind, Partial Cross-over, Incomplete Factorial Study to Assess the Local Anesthetic Efficacy and Safety of CTY-5339 Anesthetic Spray (CTY-5339-A) When Applied to the Cheek Mucosal Tissue in Normal Volunteers|Completed||Phase 2|40|Actual|Cetylite Industries||3|||f||||f||||||||||2017-10-10 21:47:44.574119|2017-10-10 21:47:44.574119
NCT02908607|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-18|2016-09-20|||November 2016||2016-11-01|September 2016|2016-09-01||||March 2019|Anticipated|2019-03-01||Interventional|||Thermal Imaging for Evaluation of the Cervix|Thermal Imaging for Cervical Cancer Screening and Early Detection|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Meir Medical Center||1|||f||||||||||||||2017-10-10 21:47:44.66834|2017-10-10 21:47:44.66834
NCT02908542|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-16|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|HyCaGene||Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel|Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel|Recruiting||N/A|75|Anticipated|University Hospital, Caen|||1||f||||f||||||Samples With DNA|"     blood or DNA samples   "|Yes|The data will be communicated to the referent physician of the patient.|2017-10-10 21:47:45.052555|2017-10-10 21:47:45.052555
NCT02908529|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-02-21|||September 2016||2016-09-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ATOSA||Atomoxetine and Oxybutynin in Obstructive Sleep Apnea|Effect of Atomoxetine and Oxybutynin on Phenotype Traits and OSA Severity|Recruiting||Phase 1/Phase 2|20|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||Yes||2017-10-10 21:47:45.12716|2017-10-10 21:47:45.12716
NCT02908516|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-09-29|||September 18, 2017|Actual|2017-09-18|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures|Safety and Efficacy of Oral Tranexamic Acid in Reducing Blood Loss and Transfusion in Femoral Neck, Intertrochanteric and Subtrochanteric Femur Fractures|Recruiting||Phase 4|100|Anticipated|Yale University||2|||f||||f|t|f||||||||2017-10-10 21:47:45.197389|2017-10-10 21:47:45.197389
NCT02908503|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-05-10|||July 2016||2016-07-01|May 2017|2017-05-01|February 14, 2017|Actual|2017-02-14|February 14, 2017|Actual|2017-02-14||Interventional|FLAG||Vaginal Film Administration and Placement Study: FLAG|Vaginal Film Administration and Placement Study: FLAG|Completed||N/A|32|Actual|University of Pittsburgh||4|||f||||f||||||||No||2017-10-10 21:47:45.298741|2017-10-10 21:47:45.298741
NCT02908490|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-06-25|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?|Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?|Recruiting||Phase 2|60|Anticipated|University of Pittsburgh||2|||f||||f|t|f|||f|||Yes||2017-10-10 21:47:45.516461|2017-10-10 21:47:45.516461
NCT02908477|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-07-19|||August 2016||2016-08-01|July 2017|2017-07-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01||Interventional|||Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer|DART-HPV: A Phase III Evaluation of De-escalated Adjuvant Radiation Therapy for HPV-Associated Oropharynx Cancer|Recruiting||Phase 3|214|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 21:47:45.640311|2017-10-10 21:47:45.640311
NCT02908464|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-04-07|||November 2016||2016-11-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|PEaPoD||Prevention of Early Postoperative Decline|Prevention of Early Postoperative Decline|Recruiting||N/A|45|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:47:45.773456|2017-10-10 21:47:45.773456
NCT02908451|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-08-30|||April 24, 2017|Actual|2017-04-24|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer|A Phase I Dose Escalation Study, With Cohort Expansion, to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of AbGn-107 Therapy in Patients With Chemo-refractory Locally Advanced, Recurrent, or Metastatic Gastric, Colorectal, or Pancreatic Cancer|Recruiting||Phase 1|54|Anticipated|AbGenomics B.V Taiwan Branch||1|||f||||f|t|f||||||||2017-10-10 21:47:45.874404|2017-10-10 21:47:45.874404
NCT02908438|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles|Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles|Not yet recruiting||Phase 1|400|Anticipated|Northwest Women's and Children's Hospital, Xi'an, Shaanxi||2|||f||||||||||||||2017-10-10 21:47:46.000423|2017-10-10 21:47:46.000423
NCT02908425|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-09-07|||July 2016||2016-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|February 2017|Actual|2017-02-01||Interventional|||Cholesterol and Statin in Healthy Adults|Human Metabolism of HMB|Active, not recruiting||N/A|13|Actual|Texas A&M University||1|||f||||f||||||||||2017-10-10 21:47:46.082382|2017-10-10 21:47:46.082382
NCT02908412|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-15|||October 2016||2016-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Non-invasive Perioperative Hb Monitoring in Spinal Surgery|Evaluating and Comparing the Accuracy of Non-invasive Hemoglobin Monitoring by Spectrophotometry With and Without Digital Nerve Block in Patients Undergoing Spinal Surgery in Sina Hospital During 2016-2017|Not yet recruiting||Phase 4|30|Anticipated|Tehran University of Medical Sciences||2|||f||||||||||||||2017-10-10 21:47:46.216205|2017-10-10 21:47:46.216205
NCT02908399|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-28|||October 2016||2016-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Interventional|||Thermal Images on Smartphones to Diagnose Bacterial Pneumonia in Children in Pakistan|Thermal Images on Smartphones to Diagnose Bacterial Pneumonia in Children in Pakistan|Enrolling by invitation||N/A|250|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 21:47:46.345683|2017-10-10 21:47:46.345683
NCT02908386|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-09-16|||November 2015||2015-11-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|June 2016|Anticipated|2016-06-01||Observational|ROCOCO||ROCOCO - Adaptive IMRT Versus IMPT in Head and Neck Cancer|In Silico Clinical Trial on Adaptive Radiotherapy in Oropharynx Cancer, Comparing Photon & Proton Therapy: A Multicentric ROCOCO Planning Study Based on a Reference Dataset.|Withdrawn||N/A|0|Actual|Maastricht Radiation Oncology|||1|At the moment no participants are enrolled untill a new agreement is made|f||||t||||||||Yes||2017-10-10 21:47:46.454214|2017-10-10 21:47:46.454214
NCT02908373|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-15|||September 2015||2015-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|EHPAGE||Risk Management in Nursing Homes|Measuring Impact on Safety Culture in Nursing Homes, a Multifaceted Device for the Analysis of Care Associated Adverse Events|Recruiting||N/A|61|Anticipated|Nantes University Hospital|||2||f||||f||||||||Undecided||2017-10-10 21:47:46.560114|2017-10-10 21:47:46.560114
NCT02908191|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-07-05|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study in Healthy Volunteers and Patients With Chronic Hepatitis B|A Phase 1a/1b, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of ABI-H0731 in Healthy Volunteers and Patients With Chronic Hepatitis B|Recruiting||Phase 1|114|Anticipated|Assembly Biosciences||3|||f||||t|f|f||||||||2017-10-10 21:47:47.907302|2017-10-10 21:47:47.907302
NCT02908360|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-15|||July 2015||2015-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Prévall-DP||Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis|Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis|Recruiting||N/A|90|Anticipated|Nantes University Hospital|||3||f||||f||||||Samples With DNA|"     PBMC   "|Undecided||2017-10-10 21:47:46.696157|2017-10-10 21:47:46.696157
NCT02908347|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-03-20|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients|A Randomized (1:1), Double-blind, Parallel, Placebo-controlled Exploratory Pilot Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Systemic (po) Application of MP1032 in Patients With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|44|Anticipated|MetrioPharm AG||2|||f||||f||||||||No||2017-10-10 21:47:46.786935|2017-10-10 21:47:46.786935
NCT02908334|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-16|||November 2016||2016-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis|Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis|Not yet recruiting||Phase 2|120|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 21:47:46.882561|2017-10-10 21:47:46.882561
NCT02908321|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-16|||August 2016||2016-08-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||CBT for Anxiety Disorder in Children With Co-morbid ASD|Cognitive Behavioural Therapy for Anxiety Disorder in Children With Co-morbid Autism Spectrum Disorder|Recruiting||N/A|50|Anticipated|University of Aarhus||2|||f||||f||||||||No|Data will be on group basis only|2017-10-10 21:47:46.959583|2017-10-10 21:47:46.959583
NCT02908308|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-10-05|||November 15, 2017|Anticipated|2017-11-15|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|TTM-2||Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest|Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest (TTM2) - A Randomised Clinical Trial|Not yet recruiting||N/A|1200|Anticipated|Helsingborgs Hospital||2|||f||||t|f|f||||||||2017-10-10 21:47:47.066849|2017-10-10 21:47:47.066849
NCT02908295|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Rectal Misoprostol in Women Undergoing Myomectomy for Intraoperative Blood Loss: A Randomized Placebo-controlled Study||Not yet recruiting||Phase 4|20|Anticipated|Rajavithi Hospital||2|||f||||f||||||||No||2017-10-10 21:47:47.199164|2017-10-10 21:47:47.199164
NCT02908282|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-11-18|||October 2016||2016-10-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|REMOTOP||Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye||Recruiting||N/A|100|Anticipated|TRB Chemedica AG||2|||f||||f||||||||No||2017-10-10 21:47:47.277178|2017-10-10 21:47:47.277178
NCT02908269|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-06-28|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|December 9, 2016|Actual|2016-12-09|December 9, 2016|Actual|2016-12-09||Interventional|||Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations|Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations|Completed||Phase 4|180|Actual|Sanofi||3|||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 21:47:47.373057|2017-10-10 21:47:47.373057
NCT02908256|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-20|||April 2011||2011-04-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of Intraoperative Volume Replacement Determined by the Plethysmograph Variability Index (PVI) With That Determined by the Delta PP in the Digestive, Gynecological, Urological, and Abdominal Surgery and Their Impact on the Length of Stay|Randomized Double-blind Comparison of Intraoperative Volume Replacement Determined by the Plethysmograph Variability Index (PVI) With That Determined by the Delta PP in the Digestive, Gynecological, Urological, and Abdominal Surgery and Their Impact on the Length of Stay|Completed||N/A|80|Actual|Brugmann University Hospital||2|||f||||f||||||||No||2017-10-10 21:47:47.471944|2017-10-10 21:47:47.471944
NCT02908243|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-16|||February 2015||2015-02-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|||Outcomes of Prophylaxis and On-demand Treatment for Severe Hemophiliacs and Collection of Baseline Data in Hemophiliacs in Taiwan||Enrolling by invitation||N/A|350|Anticipated|Taiwan Society of Thrombosis and Hemostasis|||3||f||||t||||||||Yes|Plan to share whole data|2017-10-10 21:47:47.547631|2017-10-10 21:47:47.547631
NCT02908230|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-19|||May 2015||2015-05-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Camp NERF: Methods of a Summer Nutrition Ed Rec & Fitness Program to Prevent Unhealthy Weight Gain in Children|Camp NERF: Methods of a Theory-Based Nutrition Education Recreation and Fitness Program Aimed at Preventing Unhealthy Weight Gain in Underserved Elementary Children During Summer Months|Completed||N/A|87|Actual|Ohio State University||3|||f||||f||||||||No||2017-10-10 21:47:47.62249|2017-10-10 21:47:47.62249
NCT02908204|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-19|||October 2016||2016-10-01|September 2016|2016-09-01||||October 2017|Anticipated|2017-10-01||Observational|||Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma|Long-term Outcomes After Treatment for Superficial Esophageal Squamous Cell Carcinoma|Recruiting||N/A|1800|Anticipated|Shanghai Zhongshan Hospital|||2||f||||f||||||||No||2017-10-10 21:47:47.838971|2017-10-10 21:47:47.838971
NCT02908178|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ|Comparative Effectiveness of Sentinel Lymph Node Biopsy (SLNB) for Ductal Carcinoma In Situ (DCIS)|Not yet recruiting||N/A|20000|Anticipated|Yale University|||2||f||||f||||||||No||2017-10-10 21:47:47.985923|2017-10-10 21:47:47.985923
NCT02908165|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-15|||June 2016||2016-06-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Randomized Phase II Trial of Chemoembolization and Sorafenib|Randomized Phase II Trial of Chemoembolization and Sorafenib: Comparison Between Continuous and Sequential Treatment Regimens|Recruiting||Phase 2|64|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-10 21:47:48.074731|2017-10-10 21:47:48.074731
NCT02908152|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-19|||February 2017||2017-02-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Curcumin Supplement in Nonalcoholic Fatty Liver Patients With Type 2 Diabetes|The Effect of Curcumin Supplement on Metabolic Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Patients With Type 2 Diabetes|Not yet recruiting||Phase 2/Phase 3|50|Anticipated|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-10 21:47:48.163134|2017-10-10 21:47:48.163134
NCT02908139|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-06-13|||September 2016||2016-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients|Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients|Recruiting||N/A|40|Anticipated|Medical University of Warsaw|||1||f||||t||||||||No||2017-10-10 21:47:48.240373|2017-10-10 21:47:48.240373
NCT02908126|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-09-18|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility|Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility|Not yet recruiting||Phase 1|24|Anticipated|Oxytone Bioscience BV||2|||f|||||f|f||||||||2017-10-10 21:47:48.329099|2017-10-10 21:47:48.329099
NCT02908113|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-10-04|||September 2015||2015-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PREMAVISION||Visual Perception in Preterm Infants|Sensory Maturation of Preterm Infants: From Visual Sensitivity to Multisensory Perception|Recruiting||N/A|150|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||No||2017-10-10 21:47:48.38715|2017-10-10 21:47:48.38715
NCT02908100|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-11|||January 19, 2017|Actual|2017-01-19|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus|A Phase II, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus|Recruiting||Phase 2|240|Anticipated|Genentech, Inc.||3|||f|||||t|f||||||||2017-10-10 21:47:48.574414|2017-10-10 21:47:48.574414
NCT02908087|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-15|||March 2016||2016-03-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Incretin-based Therapy in Early Diagnosed Type 1 Diabetes|Incretin-based Therapy in Early Diagnosed Type 1 Diabetes|Enrolling by invitation||Phase 2|10|Anticipated|University of Oulu||2|||f||||t||||||||||2017-10-10 21:47:48.891781|2017-10-10 21:47:48.891781
NCT02908074|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-08-02|||November 2016||2016-11-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||A 6 Month Safety Extension Study of MBGS205 Evaluating the Long Term Effects of BGS649 on Bone Mineral Density|A 6 Month, Double-blind Safety Extension Study of MBGS205 Evaluating the Effects of Long Term Treatment With BGS649 on Bone Mineral Density|Enrolling by invitation||Phase 2|120|Anticipated|Mereo BioPharma||3|||f||||t||||||||||2017-10-10 21:47:48.993165|2017-10-10 21:47:48.993165
NCT02908061|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-10-04|||August 2016||2016-08-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia|A Prospective, Randomized Trial of Preventive Mesh Placement at the Time of Radical Cystectomy to Reduce the Chances of Developing a Parastomal Hernia|Recruiting||Phase 3|160|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 21:47:49.134025|2017-10-10 21:47:49.134025
NCT02908022|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-03-27|||September 2016||2016-09-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Brain Mechanisms of Psychosocial Aspects of Acupuncture Therapy|Optimization of Brain-based Mechanisms Supporting Psychosocial Aspects of Acupuncture Therapy - a Hyperscanning fMRI Study|Recruiting||N/A|180|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 21:47:49.458348|2017-10-10 21:47:49.458348
NCT02908009|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-02-03|||September 2016||2016-09-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|Ob-Card||A Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery|An Observational Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery|Recruiting||N/A|80|Anticipated|University of Leicester|||1||f||||f||||||Samples With DNA|"     Atrial Biopsy: A 0.5cm x 0.5cm section of the right atrial wall is routinely excised to allow     cannulation of the left atrium for connection to the cardiopulmonary bypass machine. This     segment is routinely discarded. We propose to collect this specimen immediately after it has     been discarded.   "|Undecided||2017-10-10 21:47:49.549804|2017-10-10 21:47:49.549804
NCT02907996|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-09-26|||September 9, 2016|Actual|2016-09-09|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Evaluate the Safety and Effectiveness of Sovaldi Treatment Regimens in Patients With Chronic Hepatitis C Virus (HCV) Infection in a Korean Real-World Setting|Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Sovaldi Treatment Regimens in Patients With Chronic Hepatitis C Virus (HCV) Infection in a Korean Real-World Setting|Recruiting||N/A|3000|Anticipated|Gilead Sciences|||1||f||||f|t|f||||||||2017-10-10 21:47:49.639438|2017-10-10 21:47:49.639438
NCT02907983|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-06-07|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|R01||Stellate Ganglion Blockade in Post-Menopausal Women|Stellate Ganglion Blockade for the Management of Vasomotor Symptoms|Not yet recruiting||Phase 2|220|Anticipated|Northwestern University||2|||f||||t|t|f|||f|||||2017-10-10 21:47:49.856466|2017-10-10 21:47:49.856466
NCT02907970|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-16|||October 2016||2016-10-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|FOSFORE||Perceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment|Identification Des barrières au dépistage du Cancer du Col utérin à la Réunion et Des Leviers d'amélioration|Not yet recruiting||N/A|1000|Anticipated|Centre Hospitalier Universitaire de la Réunion|||1||f||||t||||||||||2017-10-10 21:47:49.954163|2017-10-10 21:47:49.954163
NCT02907957|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Interventional|||Infrared Thermography for Assessment of Caudal Block in Children|A Clinical Evaluation Of Infrared Thermography To Assess Successful Caudal Block In Children|Recruiting||N/A|100|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||No||2017-10-10 21:47:50.03627|2017-10-10 21:47:50.03627
NCT02907944|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-07-18|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|WHAT IF?||Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation|Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (WHAT IF?)|Recruiting||N/A|375|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 21:47:50.123551|2017-10-10 21:47:50.123551
NCT02907931|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-02-02|||September 2016||2016-09-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Carotid VTI as a Measure of Intravascular Volume Status During Lower Body Negative Pressure Simulation||Not yet recruiting||N/A|30|Anticipated|Yale University||1|||f||||f||||||||||2017-10-10 21:47:50.238851|2017-10-10 21:47:50.238851
NCT02907918|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-27|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|November 30, 2024|Anticipated|2024-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|PALTAN||Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer|A Phase II Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN)|Recruiting||Phase 2|48|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:47:50.322525|2017-10-10 21:47:50.322525
NCT02907905|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-19|||March 2016||2016-03-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Epidemiology of Viral Hepatitis Among Subjects in Precarious|Epidemiology of Hepatitis A,B and C Virus by Dried Blood Spot in Homeless Population|Recruiting||N/A|200|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:47:50.970906|2017-10-10 21:47:50.970906
NCT02907892|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Effect of Intra-operative Glove-changing During Cesarean Section on Post-op Complications: A Randomized Controlled Trial|Effect of Intra-operative Glove-changing During Cesarean Section on Post-op Complications:|Completed||N/A|554|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 21:47:51.046772|2017-10-10 21:47:51.046772
NCT02907879|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2017-09-21|||July 2013||2013-07-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|June 2018|Anticipated|2018-06-01||Observational|||Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAH|Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After Subarachnoid Hemorrhage|Recruiting||N/A|100|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 21:47:51.122903|2017-10-10 21:47:51.122903
NCT02907866|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-04-18|||September 2016||2016-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Use of Endobronchial Ultrasound Scope (EBUS) Transducer to Identify Pneumothorax-A Feasibility Study|Use of Endobronchial Ultrasound Scope (EBUS) Transducer to Identify Pneumothorax-A Feasibility Study|Recruiting||N/A|20|Anticipated|University of Oklahoma|||3||f||||t||||||||No||2017-10-10 21:47:51.210304|2017-10-10 21:47:51.210304
NCT02907853|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||September 2015||2015-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Contingency Management for Meth in South Africa Methamphetamine Abuse in South Africa|Combating Craving With Contingency Management: Neuroplasticity and Methamphetamine Abuse in South Africa|Recruiting||Phase 1/Phase 2|30|Anticipated|University of California, Los Angeles||1|||f||||f||||||||Yes|"Data will be shared with other investigators following publication of the main paper or 2 years after the last subject completes participation, whichever comes first. Shared data will be stripped of all PHI and potentially personally identifying variables.
Requests should briefly state the concept of interest, provide a brief timeline for analyzing the data and preparing a manuscript, and include a copy of the CV of the investigator making the request and documentation of proof of training in the ethical treatment of human subjects in research.
The concept proposal will be evaluated based on three criteria, including the potential impact or contribution to the research in advancing knowledge; the feasibility of the proposed research; and that the aim of the proposed research will not overlap with any of the aims or planned analyses."|2017-10-10 21:47:51.308113|2017-10-10 21:47:51.308113
NCT02907840|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-05-05|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|January 2017|Actual|2017-01-01||Interventional|||Prediction of Response to Recruitment Maneuvers in Patients With Acute Respiratory Failure|Prediction of Response to Recruitment Maneuvers in Patients With Acute Respiratory Failure|Completed||N/A|14|Actual|Università degli Studi di Ferrara||1|||f||||f||||||||No||2017-10-10 21:47:51.387926|2017-10-10 21:47:51.387926
NCT02907645|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-07-26|||October 6, 2016|Actual|2016-10-06|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|May 31, 2017|Actual|2017-05-31||Interventional|||Influenza Vaccine Randomized Educational Trial: Adult||Completed||N/A|222|Actual|Columbia University||3|||f||||f||||||||||2017-10-10 21:47:53.078935|2017-10-10 21:47:53.078935
NCT02907827|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-23|||November 2014||2014-11-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|DW-MRi||Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.|Whole-body Diffusion-weighted Magnetic Resonance Imaging and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence Following Surgery or Systemic Therapy|Recruiting||N/A|100|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||Yes|anonymous|2017-10-10 21:47:51.471012|2017-10-10 21:47:51.471012
NCT02907814|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-03-20|||September 2016||2016-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography|Objective, Prospective Measurement of Anterior Chamber Cell Grading Using Anterior Chamber Ocular Coherence Tomography|Recruiting||N/A|50|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||No||2017-10-10 21:47:51.569239|2017-10-10 21:47:51.569239
NCT02907801|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-05-07|||November 2016||2016-11-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|P-AA||Perception-Action Approach Intervention for Infants With Congenital Muscular Torticollis|Effects of Perception-Action Approach Intervention in Infants With Congenital Muscular Torticollis: A Randomized Nonconcurrent Multiple Baseline Study|Recruiting||N/A|3|Anticipated|Rosalind Franklin University of Medicine and Science||1|||f||||f||||||||Undecided||2017-10-10 21:47:51.655509|2017-10-10 21:47:51.655509
NCT02907788|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-20|||September 2014||2014-09-01|September 2016|2016-09-01||||September 2019|Anticipated|2019-09-01|5 Years|Observational [Patient Registry]|I-BALL||Inflammatory Markers in Broncho-alveolar Lavage Fluid as Risk Factors for Lung Disease in Infants With Cystic Fibrosis: the I-BALL Study|Inflammatory Markers in Broncho-alveolar Lavage Fluid as Risk Factors for Lung Disease in Infants With Cystic Fibrosis: the I-BALL Study|Recruiting||N/A|60|Anticipated|Erasmus Medical Center|||2||f||||t||||||Samples With DNA|"     -  Whole Blood        -  Bronchoscopies and bronchoalveolar lavage fluid (BALF)   "|No||2017-10-10 21:47:51.746661|2017-10-10 21:47:51.746661
NCT02907775|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-22|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MUSTS||Multi-channel Stimulation for Post Stroke Spasticity (MUSTS)|Multi-channel Stimulation for Post Stroke Spasticity (MUSTS): A Randomised Controlled Cross Over Feasibility Trial|Not yet recruiting||N/A|20|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:47:51.820514|2017-10-10 21:47:51.820514
NCT02907762|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-15|||November 2015||2015-11-01|September 2016|2016-09-01|November 2021|Anticipated|2021-11-01|November 2017|Anticipated|2017-11-01|5 Years|Observational [Patient Registry]|FIH-NZ||Aorfix Intelliflex First in Human Study|"Aorfix™ Generation IV Delivery System IntelliFlex™ Study"|Active, not recruiting||N/A|10|Anticipated|Lombard Medical|||1||f||||t||||||||||2017-10-10 21:47:51.889735|2017-10-10 21:47:51.889735
NCT02907736|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-02-08|||November 12, 2015|Actual|2015-11-12|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|THROMBONETS||Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients||Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:47:52.16837|2017-10-10 21:47:52.16837
NCT02907723|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-29|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BRACELET||Feasibility of Continuous Sleep Recording in Patients Undergoing Deep Brain Stimulation for Parkinson's Disease|Assessment of a Wrist Device Recording Sleep Parameters, Before and After Deep Brain Stimulation for Parkinson's Disease|Completed||N/A|5|Actual|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 21:47:52.291896|2017-10-10 21:47:52.291896
NCT02907710|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||October 2016||2016-10-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma|A Multicenter, Prospective, Randomized Controlled Clinical Trial Comparing Endostar With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)|Not yet recruiting||Phase 3|300|Anticipated|First Affiliated Hospital of Guangxi Medical University||2|||f||||||||||||||2017-10-10 21:47:52.400201|2017-10-10 21:47:52.400201
NCT02907697|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-14|||July 2015||2015-07-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|September 2019|Anticipated|2019-09-01||Interventional|||Adherence Intervention for HIV-infected Drug Users|Adherence Intervention for HIV-infected Drug Users|Active, not recruiting||Phase 1|132|Anticipated|Rhode Island Hospital||2|||f||||f||||||||No||2017-10-10 21:47:52.534582|2017-10-10 21:47:52.534582
NCT02907684|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-03-30|||March 29, 2017|Actual|2017-03-29|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|Almonds||The Impact of Almond Nut Consumption on Markers of CVD & Metabolic Health|A Randomised, Controlled Parallel Dietary Intervention to Investigate the Effect of Almond Snack Consumption on Cardio-metabolic Disease Risk Markers Compared With Isocaloric Snacks, in Adults at Moderate Risk of Cardiovascular Disease|Recruiting||N/A|100|Anticipated|King's College London||2|||f||||f|f|f||||||No||2017-10-10 21:47:52.653649|2017-10-10 21:47:52.653649
NCT02907671|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-09-14|||October 2016||2016-10-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Effectiveness of Ultrasound Guided Corticoanesthetic Injection in Carpal Tunnel Syndrome|Effectiveness of Ultrasound Guided Corticoanesthetic Injection in Carpal Tunnel Syndrome Comparing Two Different Injection Sites|Not yet recruiting||N/A|40|Anticipated|Rehabilitace MUDr. Hasan Mezian s.r.o.||2|||f||||t||||||||Yes|Publication in the relevant journal|2017-10-10 21:47:52.847303|2017-10-10 21:47:52.847303
NCT02907658|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-09-19|||September 2015||2015-09-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|PROTECT||Efficacy of Internet Use Disorder Prevention|A Randomized Efficacy Trial of a Cognitive-Behavioral Intervention to Prevent Internet Use Disorder Onset in Adolescents: the PROTECT Study|Active, not recruiting||N/A|480|Actual|Pädagogische Hochschule Heidelberg||2|||f||||f||||||||||2017-10-10 21:47:52.964844|2017-10-10 21:47:52.964844
NCT02907632|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||January 2017||2017-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Methoclopramide for Gastroesophageal Reflux in Premature Infants|Use of Metoclopramide for the Prevention of Gastroesophageal Reflux in Premature Infants Followed in an Outpatient Kangaroo Mother Care Clinic Before 40 Weeks of Gestational Age: A Randomized Controlled Trial|Not yet recruiting||Phase 4|520|Anticipated|Kangaroo Foundation||2|||f||||t||||||||Yes|We could break the masking if there´s a serious adverse effect attributable to Metoclopramide|2017-10-10 21:47:53.175137|2017-10-10 21:47:53.175137
NCT02907619|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-10-03|||October 13, 2016|Actual|2016-10-13|October 2017|2017-10-01|March 13, 2023|Anticipated|2023-03-13|March 13, 2023|Anticipated|2023-03-13||Interventional|||An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy|A Multicenter, Open-label Extension Study To Evaluate The Long Term Safety Of Pf-06252616 In Boys With Duchenne Muscular Dystrophy|Recruiting||Phase 2|105|Anticipated|Pfizer||1|||f||||t|t|f||||||||2017-10-10 21:47:53.300854|2017-10-10 21:47:53.300854
NCT02907606|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-14|||September 2016||2016-09-01|September 2016|2016-09-01|August 2020|Anticipated|2020-08-01|June 2017|Anticipated|2017-06-01|3 Years|Observational [Patient Registry]|||Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study|Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study|Not yet recruiting||N/A|45|Anticipated|Peking University People's Hospital|||1||f||||f||||||Samples With DNA|"     Fresh tumor tissue, peripheral blood samples and urinary samples will be collected from each     patient.      Time:Preoperative, intraoperative, 3 days and 1、6、12 months after surgery.   "|No|We will not make individual participant data (IPD) available|2017-10-10 21:47:53.454683|2017-10-10 21:47:53.454683
NCT02907593|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-07|||September 2016||2016-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|SASSIE||Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial|Steroids and Surfactant in Extremely Low Gestation Age Infants Pilot Dose Escalation Trial|Recruiting||Phase 1/Phase 2|32|Anticipated|Oregon Health and Science University||4|||f||||t||||||||||2017-10-10 21:47:53.561193|2017-10-10 21:47:53.561193
NCT02907580|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-07-26|||September 13, 2016|Actual|2016-09-13|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|May 31, 2017|Actual|2017-05-31||Interventional|||Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric|Influenza Vaccine Attitudes, Intent, and Receipt|Completed||N/A|400|Actual|Columbia University||3|||f||||f||||||||||2017-10-10 21:47:53.719306|2017-10-10 21:47:53.719306
NCT02907567|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-12-10|||September 2016||2016-09-01|December 2016|2016-12-01||||May 2017|Anticipated|2017-05-01||Interventional|||Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Phase I Study of the Safety & Pharmacokinetics of Two Doses of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease|Recruiting||Phase 1/Phase 2|16|Anticipated|Cognition Therapeutics||3|||f||||t||||||||||2017-10-10 21:47:53.805477|2017-10-10 21:47:53.805477
NCT02907554|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|Cys-A-Rein||Cyclosporine A Pretreatment and Kidney Graft Function|Effects of Cyclosporine A Pretreatment of Deceased Donor on Kidney Graft Function: A Randomized Controlled Trial|Not yet recruiting||Phase 4|648|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 21:47:53.916293|2017-10-10 21:47:53.916293
NCT02907541|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-19|||January 2017||2017-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Protocol for Evaluation of eLearning of Quality Improvement Methods|Evaluation of eLearning of Quality Improvement Methods|Not yet recruiting||N/A|300|Anticipated|Chelsea and Westminster NHS Foundation Trust||3|||f||||f||||||||Yes||2017-10-10 21:47:54.025839|2017-10-10 21:47:54.025839
NCT02907528|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-14|||January 2014||2014-01-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Interventional|||Furcation Therapy With Enamel Matrix Derivative|Furcation Therapy With Enamel Matrix Derivative: Effects on the Subgingival Microbiome|Completed||N/A|39|Actual|Ohio State University Comprehensive Cancer Center||3|||f||||f||||||||No||2017-10-10 21:47:54.129315|2017-10-10 21:47:54.129315
NCT02907515|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-15|||February 2016||2016-02-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Interventional|MCRB||Maintenance and Cost Effectiveness of Cendres Metaux Locator (CM-LOC) Resin Matrix Versus Ball Nylon Matrix Attachment Retaining Single Implant Mandibular Complete Overdentures|Maintenance and Cost Effectiveness of CM-LOC Resin Matrix Versus Ball Nylon Matrix Attachment Retaining Single Implant Mandibular Complete Overdentures|Recruiting||N/A|112|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 21:47:54.198657|2017-10-10 21:47:54.198657
NCT02907502|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-10-04|||September 2016||2016-09-01|October 2017|2017-10-01|December 2026|Anticipated|2026-12-01|May 2021|Anticipated|2021-05-01||Interventional|TOMI||Toddler Milk Intervention Trial|Effects of Milk Protein Intake in Young Children on Early Growth and Later Obesity Risk: a Multicentre Randomized Clinical Trial|Recruiting||N/A|1618|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-10 21:47:54.278497|2017-10-10 21:47:54.278497
NCT02907489|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Triple Antibiotic Paste as an Intracanal Medication With an Anti-Inflammatory Drug on Post-Operative Pain of Asymptomatic Uniradicular Necrotic Teeth.|The Effect of Triple Antibiotic Paste as an Intracanal Medication With an Anti-Inflammatory Drug on Post-Operative Pain of Asymptomatic Uniradicular Necrotic Teeth (A Double Blind Randomized Clinical Trial).|Not yet recruiting||N/A|84|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:47:54.367304|2017-10-10 21:47:54.367304
NCT02907476|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-03-02|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Treatment of Depression With Yoga and Walking|The Treatment of Depression With Yoga and Walking|Recruiting||N/A|300|Anticipated|Boston University||2|||f||||t|f|f||||||No|There is a Data Safety Monitoring Plan that includes Independent Monitors with expertise in the areas of Clinical Care, Imaging and Statistics.|2017-10-10 21:47:54.438082|2017-10-10 21:47:54.438082
NCT02907463|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-06-12|||February 2016||2016-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Observational|MISSION||EDWARDS INTUITY Elite Valve System|Assessing Clinical Outcomes Using the EDWARDS INTUITY Elite Valve System in Isolated AVR Using Minimally InvaSive Surgery In a EurOpean Multi-ceNter, Active, Post-market Registry|Active, not recruiting||N/A|273|Actual|Edwards Lifesciences|||1||f||||t||||||||||2017-10-10 21:47:54.536189|2017-10-10 21:47:54.536189
NCT02907437|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-16|2016-09-19|||January 2015||2015-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|February 2017|Anticipated|2017-02-01||Interventional|||Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia|Minocycline add-on Medication to Antipsychotics in the Treatment of Schizophrenia Patients: A Double- Blind Randomized Controlled Trial|Recruiting||Phase 3|40|Anticipated|Beer Yaakov – Ness Ziona Mental Health Center||2|||f||||f||||||||Undecided||2017-10-10 21:47:54.72578|2017-10-10 21:47:54.72578
NCT02907424|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-15|||April 2016||2016-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|FLNS_SAM||Comparison of a Locally Produced RUTF With a Commercial RUTF in the Treatment of SAM|Comparison of a Locally Produced RUTF With a Commercial RUTF in the Treatment of SAM in Cambodia|Recruiting||N/A|120|Anticipated|Institut de Recherche pour le Developpement||2|||f||||f||||||||Yes||2017-10-10 21:47:54.823219|2017-10-10 21:47:54.823219
NCT02907411|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-14|||September 1, 2016||2016-09-01|September 2017|2017-09-01|March 18, 2017|Actual|2017-03-18|March 18, 2017|Actual|2017-03-18||Interventional|QUADRIVAS||Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS)|Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS)|Completed||N/A|7|Actual|University of Arizona||1|||f||||f||||||||||2017-10-10 21:47:54.949022|2017-10-10 21:47:54.949022
NCT02907398|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-03|||October 19, 2016|Actual|2016-10-19|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01|12 Months|Observational [Patient Registry]|||Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry|Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry|Recruiting||N/A|2500|Anticipated|Inspire Medical Systems, Inc.|||1||f||||f||||||||||2017-10-10 21:47:55.048081|2017-10-10 21:47:55.048081
NCT02907385|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-06-05|||November 2016||2016-11-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing|Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study|Recruiting||Phase 3|736|Anticipated|LifeBond Ltd.||2|||f||||t||||||||||2017-10-10 21:47:55.151273|2017-10-10 21:47:55.151273
NCT02907372|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-09-19|||November 2016||2016-11-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|December 2018|Anticipated|2018-12-01||Interventional|COG-PRO||Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer|Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer|Recruiting||N/A|222|Anticipated|Centre Francois Baclesse||1|||f||||f||||||||||2017-10-10 21:47:55.293606|2017-10-10 21:47:55.293606
NCT02907346|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-12-05|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Reinforcement Approach to Increase Use of CGM|A Reinforcement Approach to Increase Use of CGM|Recruiting||N/A|20|Anticipated|Yale University||1|||f||||f||||||||No||2017-10-10 21:47:57.289769|2017-10-10 21:47:57.289769
NCT02907333|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Testing Use of Condoms on Regression of Cervical Intraepithelial Neoplasia|Use of Condoms in Prevention of Progression of Cervical Intraepithelial Neoplasia: A Randomized Controlled Trial.|Recruiting||N/A|700|Anticipated|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 21:47:57.391001|2017-10-10 21:47:57.391001
NCT02907320|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-02-17|||December 2016|Anticipated|2016-12-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||EXPLORATORY ASSESSMENT OF THE EFFECTS OF CYCLO 3 ® FORT (Ruscus Extract, Hesperidin Methyl Chalcone, Ascorbic Acid) OR MICRONISED PURIFIED FLAVONOID FRACTION ON VASCULAR PARAMETERS AND BIOMARKERS IN WOMEN SUFFERING FROM CHRONIC VENOUS DISEASE (CEAP C2 OR C3), OVER 8 WEEKS|EXPLORATORY ASSESSMENT OF THE EFFECTS OF CYCLO 3 ® FORT (Ruscus Extract, Hesperidin Methyl Chalcone, Ascorbic Acid) OR MICRONISED PURIFIED FLAVONOID FRACTION ON VASCULAR PARAMETERS AND BIOMARKERS IN WOMEN SUFFERING FROM CHRONIC VENOUS DISEASE (CEAP C2 OR C3), OVER 8 WEEKS|Withdrawn||Phase 2|0|Actual|Pierre Fabre Medicament||3|||f||||f|f|f||||||No||2017-10-10 21:47:57.53443|2017-10-10 21:47:57.53443
NCT02907307|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-09-14|||May 2017||2017-05-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis|Comparative Study of the Efficacy and Safety of LactiSal 1% Vaginal Gel and LactSal 50 mg Vaginal Tablet Versus Clotrimazole 100 mg Vaginal Tablet in the Treatment of Vulvovaginal Candidiasis (VVC)|Not yet recruiting||Phase 3|300|Anticipated|Medinova AG||3|||f||||t||||||||Undecided||2017-10-10 21:47:57.666985|2017-10-10 21:47:57.666985
NCT02907294|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-09-15|||March 2016||2016-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||"Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 After Multiple Oral Doses in Healthy Volunteers"|"Randomized, Double Blind, Placebo Controlled, Parallel Groups Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 (160 mg and 320 mg) After Multiple Oral Doses in Healthy Volunteers"|Terminated||Phase 1|8|Actual|Palobiofarma SL||2||change in the therapeutic indication|f||||f||||||||No||2017-10-10 21:47:57.788922|2017-10-10 21:47:57.788922
NCT02907281|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-24|||May 2012||2012-05-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|OCTIMS||Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis|A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis|Active, not recruiting||Phase 3|420|Actual|Novartis|||2||f||||f||||||||Yes||2017-10-10 21:47:57.914959|2017-10-10 21:47:57.914959
NCT02907086|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||August 2016||2016-08-01|September 2016|2016-09-01||||August 2020|Anticipated|2020-08-01||Observational|||Circulating Tumor Material in Colorectal Cancer and Melanoma|Protocol to Permit the Acquisition of Circulating Tumor Material in Colorectal Cancer and Melanoma|Recruiting||N/A|110|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-10 21:48:00.082056|2017-10-10 21:48:00.082056
NCT02907255|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-01-20|||October 2010||2010-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VIGILANCE||Vital Sign Monitoring With Continuous Pulse Oximetry and Wireless Clinician Notification After Surgery|Vital Sign Monitoring With Continuous Pulse Oximetry and Wireless Clinician Notification After Surgery|Recruiting||N/A|2000|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 21:47:58.266182|2017-10-10 21:47:58.266182
NCT02907242|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-09-15|||May 2016||2016-05-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||Revealed Versus Concealed Cerebroplacental Ratio|Revealed Versus Concealed Criteria for Placental Insufficiency in Unselected Obstetric Population in Late Pregnancy: a Multicenter Randomized Controlled Trial|Recruiting||N/A|11582|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||Yes||2017-10-10 21:47:58.392542|2017-10-10 21:47:58.392542
NCT02907229|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-15|||May 2016||2016-05-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|NCVC-CS1_UAN||Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms|Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms: a Multicenter, Uncontrolled, Exploratory Trial|Recruiting||N/A|12|Anticipated|National Cerebral and Cardiovascular Center||1|||f||||t||||||||No||2017-10-10 21:47:58.513497|2017-10-10 21:47:58.513497
NCT02907203|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-07-12|||September 2017||2017-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:47:58.759741|2017-10-10 21:47:58.759741
NCT02907190|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-19|||March 2016||2016-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MED-beans||Glycemic and Insulinemic Impact of Selected Canadian Beans|Glycemic and Insulinemic Impact of Selected Canadian Beans|Completed||N/A|18|Actual|Guelph Food Research Centre||2|||f||||f||||||||No||2017-10-10 21:47:58.804072|2017-10-10 21:47:58.804072
NCT02907164|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Using Social Norms to Encourage People to Exercise More|Using Social Norms to Encourage People to Exercise More|Enrolling by invitation||N/A|15000|Anticipated|Washington University School of Medicine||4|||f||||||||||||||2017-10-10 21:47:59.426873|2017-10-10 21:47:59.426873
NCT02907151|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|EDUCONSULT||Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education|Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education of Patients on Anticoagulants During a Routine Inspection by the Cardiologist.|Recruiting||N/A|160|Anticipated|University Hospital, Montpellier|||2||f||||t||||||||Undecided||2017-10-10 21:47:59.523201|2017-10-10 21:47:59.523201
NCT02907138|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Medical Yoga for Patients With Stress-related Symptoms||Not yet recruiting||N/A|40|Anticipated|Vastra Gotaland Region||2|||f||||||||||||||2017-10-10 21:47:59.608591|2017-10-10 21:47:59.608591
NCT02907125|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-05-08|||June 15, 2016||2016-06-15|May 2017|2017-05-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|SEHER+||Extended Evaluation of School-based Health Promotion Programmes in Bihar, India|Strengthening the Evidence Base on Effective scHool Based intErventions for pRomoting Adolescent Health (SEHER)|Completed||N/A|29527|Actual|Sangath||3|||f||||t||||||||Yes||2017-10-10 21:47:59.685426|2017-10-10 21:47:59.685426
NCT02907112|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-06-13|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ELM||Impact of Reducing Dietary Intake of Red and Processed Meat Intake on Fasting Lipemia in Healthy Participants|Impact of Reducing Dietary Intake of Red and Processed Meat Intake on Fasting Lipemia in Healthy Participants|Completed||N/A|37|Actual|University of Nottingham||2|||f||||f||||||||No||2017-10-10 21:47:59.789254|2017-10-10 21:47:59.789254
NCT02907073|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-12-29|||September 2016||2016-09-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||PET (Positron Emission Tomography) Imaging Studies With NIS Reporter|First In-human PET Imaging Studies With NIS Reporter [18F]BF4|Active, not recruiting||Phase 1/Phase 2|28|Anticipated|Mayo Clinic||3|||f||||f||||||||No||2017-10-10 21:48:00.177644|2017-10-10 21:48:00.177644
NCT02907060|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-02-23|||January 27, 2017|Actual|2017-01-27|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|January 2020|Anticipated|2020-01-01||Interventional|||Mechanical cervicAl ripeninG for Women With PrOlongedPregnancies|Propess® Versus Double Balloon for Cervical Ripening of Prolonged Pregnancies: a Randomised Controlled Trial|Recruiting||Phase 3|1220|Anticipated|University Hospital, Tours||2|||f||||f|f|f||||||||2017-10-10 21:48:00.278178|2017-10-10 21:48:00.278178
NCT02907047|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-19|||March 2016||2016-03-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||Tourniquet vs. no Tourniquet During Total Knee Arthroplasty||Recruiting||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-10 21:48:00.481288|2017-10-10 21:48:00.481288
NCT02907034|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-19|||January 2017||2017-01-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|ReV-UTIL||Valuation of Health State Using Virtual Reality|Valuation of Health States in the French General Population: Role and Interest of an Innovative Approach Based on Virtual Reality|Not yet recruiting||N/A|140|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:48:00.56887|2017-10-10 21:48:00.56887
NCT02907021|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-19|||November 2016||2016-11-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|SCHOLAR||Safety of Continuing CHemotherapy in Overt Left Ventricular Dysfunction Using Antibodies to HER-2|A Phase I Clinical Study to Examine the Safety of Continued Treatment With Trastuzumab for Individuals With Overt Left Ventricular Dysfunction|Not yet recruiting||Phase 1|20|Anticipated|Population Health Research Institute||1|||f||||f||||||||Undecided||2017-10-10 21:48:00.664306|2017-10-10 21:48:00.664306
NCT02907008|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-15|||December 2015||2015-12-01|September 2016|2016-09-01||||May 2017|Anticipated|2017-05-01||Observational|HIGH SLEEP||Sleep Quality and Risk of Intubation in Intensive Care Units Patients With Hypoxemic Acute Respiratory Failure|Sleep Quality and Risk of Intubation in Intensive Care Units Patients With Hypoxemic Acute Respiratory Failure|Recruiting||N/A|35|Anticipated|Poitiers University Hospital|||1||f||||||||||||||2017-10-10 21:48:00.740072|2017-10-10 21:48:00.740072
NCT02906995|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-06-06|||May 25, 2017|Actual|2017-05-25|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers|An Open-Label Pseudorandomized, Two Way Crossover Comparison of the Single-Dose Pharmacokinetics of Nicotine 4 mg Sublingual Tablets Versus Nicorette Lozenge 4 mg in Healthy Smokers Under Fasted Conditions|Recruiting||Phase 1|24|Anticipated|Friends Research Institute, Inc.||2|||f||||f|f|f|||f|||Yes|De-identified individual data may be shared with investigators who send the PI a data analysis plan.|2017-10-10 21:48:00.807917|2017-10-10 21:48:00.807917
NCT02906982|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||October 2015||2015-10-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Evaluating the Efficacy of a Gum Health Formulation on Teeth Whitening in Patients With Gingivitis and Periodontitis|A Randomized Trial Evaluating the Efficacy of a Gum Health Formulation on Teeth Whitening in Patients With Gingivitis and Periodontitis|Completed||N/A|30|Actual|Glo Science, Inc.||3|||f||||f||||||||||2017-10-10 21:48:00.909483|2017-10-10 21:48:00.909483
NCT02906969|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-09-15|||March 2012||2012-03-01|September 2016|2016-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Colonoscopy Educational Video Upon Inner City Population|Educational Colonoscopy Video Enhances Bowel Preparation Quality and Comprehension in an Inner City Population|Completed||N/A|104|Actual|Drexel University||2|||f||||t||||||||No||2017-10-10 21:48:00.999435|2017-10-10 21:48:00.999435
NCT02906956|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|||Music and Adherence Home Programs Post Stroke|Music and Adherence in Upper Extremity Home Programs Post Stroke|Recruiting||Early Phase 1|8|Anticipated|Duquesne University||1|||f||||f||||||||Undecided||2017-10-10 21:48:01.06308|2017-10-10 21:48:01.06308
NCT02906943|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-08-01|||August 2016||2016-08-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Observational|OCTANE||Ontario-wide Cancer TArgeted Nucleic Acid Evaluation|Ontario-wide Cancer TArgeted Nucleic Acid Evaluation|Recruiting||N/A|10000|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     Archival tumor tissue 2 tubes of whole blood   "|||2017-10-10 21:48:01.150678|2017-10-10 21:48:01.150678
NCT02906904|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-14|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|NOCISOMNIE||Pain Sensitivity in NREM Parasomnia (NOCISOMNIE)|Objective Measures of Pain Sensitivity in NREM Sleep Parasomnia|Not yet recruiting||N/A|30|Anticipated|University Hospital, Montpellier||2|||f||||||||||||||2017-10-10 21:48:02.004906|2017-10-10 21:48:02.004906
NCT02905084|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||September 2015||2015-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Observational|Physios||Multi-physics Modeling the Physiology of a Patient in Critical Condition||Recruiting||N/A|1000|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||No||2017-10-10 21:48:18.794828|2017-10-10 21:48:18.794828
NCT02906891|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-02-28|||May 2016||2016-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion|A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion|Terminated||N/A|13|Actual|InSpark Technologies, Inc.||1||Insufficient resources to complete study|f||||f||||||||Undecided||2017-10-10 21:48:02.136542|2017-10-10 21:48:02.136542
NCT02906878|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-09-19|||June 2016||2016-06-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|PLATCAT||Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter|Evaluation of the Effectiveness and Security of the Prophylactic Platelet Transfusion in Thrombocytopenic Patients Requiring the Placement of a Central Venous Catheter|Recruiting||N/A|30|Anticipated|University Hospital, Angers|||1||f||||f||||||||No||2017-10-10 21:48:02.267699|2017-10-10 21:48:02.267699
NCT02906865|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||January 2002||2002-01-01|September 2016|2016-09-01|January 2040|Anticipated|2040-01-01|January 2020|Anticipated|2020-01-01|20 Years|Observational [Patient Registry]|PHAS||Proximal Hamstring Avulsion Surgery Cohort Study||Recruiting||N/A|1000|Anticipated|Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport|||1||f||||f||||||||Undecided||2017-10-10 21:48:02.355219|2017-10-10 21:48:02.355219
NCT02906852|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-03-31|||August 2016||2016-08-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing|A Prospective Study to Evaluate the Performance of Inivata Liquid Biopsy Compared With Standard Tissue Biopsy for Detection of Genomic Alterations in Patients With Advanced Non Small Cell Lung Cancer|Recruiting||N/A|310|Anticipated|Inivata|||1||f||||f||||||Samples With DNA|"     A 40ml blood sample will be taken, from which Plasma and ultimately DNA/RNA will be prepared.   "|No||2017-10-10 21:48:02.468319|2017-10-10 21:48:02.468319
NCT02906839|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-09|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|January 2021|Anticipated|2021-01-01||Interventional|SAAFIR||Sleep Apnea and Atrial Fibrillation Recurrence|Effect of Sleep Apnea Screening and Treatment on Atrial Fibrillation Recurrence : a Randomized Controlled Trial|Recruiting||N/A|280|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||Undecided||2017-10-10 21:48:02.697719|2017-10-10 21:48:02.697719
NCT02906826|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-14|||August 2016||2016-08-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Adherence to Airway Clearance. Novel Approaches to Improving Adherence|Adherence to Airway Clearance. Novel Approaches to Improving Adherence|Recruiting||N/A|20|Anticipated|University of British Columbia||2|||f||||f||||||||No|There is no plan to share data with individual participants,|2017-10-10 21:48:02.841599|2017-10-10 21:48:02.841599
NCT02906813|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants|A Phase 1 Bioavailability and Food Effect Study to Compare Tablet Versus Solution Formulation and to Assess the Effect of Food on the Bioavailability of a Single TAK-935 Dose in Healthy Subjects|Completed||Phase 1|9|Anticipated|Takeda||3|||f||||f||||||||||2017-10-10 21:48:02.986109|2017-10-10 21:48:02.986109
NCT02906800|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-02-02|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|DIGHANC||Potentiation of Cisplatin-based Chemotherapy by Digoxin in Advanced Unresectable Head and Neck Cancer Patients|Potentiation of Cisplatin-based Chemotherapy by Digoxin in Advanced Unresectable Head and Neck Cancer Patients|Recruiting||Phase 1/Phase 2|15|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 21:48:03.08563|2017-10-10 21:48:03.08563
NCT02906774|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Fecal Transplant for MDR Pathogen Decolonization|A Prospective, Case-series Study of Fecal Microbiota Transplantation for the Selective Intestinal Decolonization of Multidrug-resistant, Pathogenic Enterobacteriaceae|Not yet recruiting||N/A|36|Anticipated|University of British Columbia|||1||f||||f||||||Samples With DNA|"     Stool specimens from FMT donors and recipients.   "|Undecided||2017-10-10 21:48:03.335732|2017-10-10 21:48:03.335732
NCT02906761|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-14|||November 2016||2016-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|June 2020|Anticipated|2020-06-01||Interventional|ASTHMIRINE||Aspirin for Uncontrolled Asthma|Aspirin for Uncontrolled Asthma : a Randomized Controlled Study|Not yet recruiting||Phase 3|180|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-10 21:48:03.414104|2017-10-10 21:48:03.414104
NCT02906735|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-18|||September 2016||2016-09-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Observational|PEDKnee||Changes of Plantar Pressure After Knee Reconstructive Surgery|Evaluation of Static and Dynamic Foot Pressure Measurement After Implantation of Knee Joint Prostheses or Alignment Surgeries of the Knee|Recruiting||N/A|50|Anticipated|Technische Universität München|||1||f||||f||||||||Undecided||2017-10-10 21:48:03.621502|2017-10-10 21:48:03.621502
NCT02906722|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-02|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|COLIVAP||Nebulized and Intravenous Colistin in Ventilator Associated-pneumonia|Efficacy of Nebulized Versus Intravenous Colimycin for Treating Ventilator-associated Pneumonia Caused by Gram-negative Multidrug-resistant Bacteria: a Prospective, Multicenter, Randomized and Double-blind Study|Recruiting||Phase 3|196|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:48:03.699515|2017-10-10 21:48:03.699515
NCT02906709|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-09-26|||October 17, 2016|Actual|2016-10-17|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)|A Phase IV, Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double Blind Trial and Subsequent Open-Label, Extension Trial to Assess the Safety and Efficacy of Addition of Omarigliptin in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Monotherapy in Addition to Diet and Exercise Therapy|Active, not recruiting||Phase 4|180|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 21:48:03.815411|2017-10-10 21:48:03.815411
NCT02906696|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-03-01|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Bosutinib Dose-Optimization Study in Chronic Myeloid Leukemia (CML)|An Open-Label Phase II Dose Optimization Study of Bosutinib at a Starting Dose of 400 mg Daily for Adult Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase Post Frontline Tyrosine Kinase Inhibitor (TKI) Failure|Recruiting||Phase 2|42|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:48:03.894252|2017-10-10 21:48:03.894252
NCT02906683|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-02-03|||October 2016||2016-10-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence|A Phase IIa Study of TAS-303 in Female Patients With Stress Urinary Incontinence|Recruiting||Phase 2|250|Anticipated|Taiho Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-10 21:48:03.980567|2017-10-10 21:48:03.980567
NCT02906670|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-29|||October 2016||2016-10-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies|An Open-label, Multicenter, Phase 1a/2a Trial Investigating the Safety, Tolerability and Antitumor Activity of Multiple Doses of Sym013, a mAb Mixture Targeting EGFR, HER2 and HER3, in Patients With Advanced Epithelial Malignancies|Recruiting||Phase 1/Phase 2|131|Anticipated|Symphogen A/S||6|||f||||f|t|f||||||||2017-10-10 21:48:04.056661|2017-10-10 21:48:04.056661
NCT02906657|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-05-02|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|CONCIPAGE||Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized Elderly|Development of Medication Reconciliation Using Electronic Pharmaceutical Record: a National Multicenter, Cluster-randomized, Two-period Crossover Study in Elderly Hospitalized in Geriatrics, Internal Medicine and Orthopedic Surgery|Recruiting||N/A|2000|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 21:48:04.148528|2017-10-10 21:48:04.148528
NCT02906644|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-07-17|||November 8, 2016|Actual|2016-11-08|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|LorNic||Combination Nicotine Patch / Lorcaserin for Smoking Cessation|Combination Nicotine Patch / Lorcaserin for Smoking Cessation|Recruiting||Phase 2|300|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 21:48:04.228779|2017-10-10 21:48:04.228779
NCT02906631|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-07-31|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|ENCEPHALITICA||Epidemiology and Prognosis of Encephalitis in Intensive Care|Epidemiology and Prognosis of Encephalitis in Intensive Care|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f|f|f||||Samples Without DNA|"     Blood and cerebrospinal fluid samples   "|||2017-10-10 21:48:04.421778|2017-10-10 21:48:04.421778
NCT02906618|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-01-24|||October 4, 2016|Actual|2016-10-04|January 2017|2017-01-01|November 11, 2016|Actual|2016-11-11|November 11, 2016|Actual|2016-11-11||Interventional|||Study of LY3039478 in Healthy Participants|An Absolute Bioavailability Study of LY3039478 in Healthy Subjects Using the Intravenous Tracer Method|Completed||Phase 1|12|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:48:04.555207|2017-10-10 21:48:04.555207
NCT02906605|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-11-18|||October 2016||2016-10-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer|An Open-label, Randomized, Phase 2 Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer|Withdrawn||Phase 2|0|Actual|Janssen Research & Development, LLC||2||Study start delayed due to pending collection and analysis of additional phase 1 data.|f||||t||||||||||2017-10-10 21:48:04.652335|2017-10-10 21:48:04.652335
NCT02906592|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-05-05|||January 2017||2017-01-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|GOAL||Using a Geriatric Oncology Assessment to Link With Services|Using a Geriatric Oncology Assessment to Link With Services (GOAL)|Recruiting||N/A|60|Anticipated|Duke University|||1||f||||f||||||||No||2017-10-10 21:48:04.759919|2017-10-10 21:48:04.759919
NCT02906579|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-08-16|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension|An Open-label, Phase 2a Trial to Evaluate the Effect of Escalating Doses of IW-1973 on Tolerability, Endothelial Function, and Hemodynamics in Patients With Stable Type 2 Diabetes and Hypertension|Completed||Phase 2|11|Actual|Ironwood Pharmaceuticals, Inc.||6|||f||||||||||||||2017-10-10 21:48:04.865198|2017-10-10 21:48:04.865198
NCT02906566|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-06-20|||November 2015||2015-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Retinol on Human Skin Aging in East Asian Descent|Discovery of Effects of Retinol on Human Skin Aging in Individuals of East Asian Descent|Recruiting||Phase 4|110|Anticipated|Stanford University||2|||f||||f||||||||Undecided||2017-10-10 21:48:05.04907|2017-10-10 21:48:05.04907
NCT02906553|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-15|||September 2016||2016-09-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|NOC||The Role of Nitric Oxide in Cognition in Schizophrenia|The Role of Nitric Oxide in Cognition in Schizophrenia; The NOC Study (Nitric Oxide in Cognition)|Not yet recruiting||N/A|36|Anticipated|King's College London||2|||f||||f||||||||No||2017-10-10 21:48:05.199197|2017-10-10 21:48:05.199197
NCT02906540|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-14|||May 2015||2015-05-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Transpubic Symphysis Reset for Treatment of Low Back Pain|Transpubic Symphysis Reset for Treatment of Low Back Pain: a Stratified, Randomized, Controlled Clinical Trial|Completed||N/A|100|Actual|Shengjing Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:48:05.300588|2017-10-10 21:48:05.300588
NCT02906527|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-14|||October 2016||2016-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|Presage-Aco||Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)|Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF) : An Observational Study Conducted on the French Health Insurance Database (SNIIRAM)|Not yet recruiting||N/A|150000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||Undecided||2017-10-10 21:48:05.416945|2017-10-10 21:48:05.416945
NCT02906514|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-20|||September 2016||2016-09-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|OPTIMUS-PRIME||Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : Pilot Study in Adult Elective Conventional Cardiac Surgery|Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : a Double Blind Randomized Pilot Study in Adult Elective Conventional Cardiac Surgery|Not yet recruiting||Phase 3|30|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 21:48:05.521686|2017-10-10 21:48:05.521686
NCT02906501|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-14|||September 2016||2016-09-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|||Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances|Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral|Not yet recruiting||N/A|45|Anticipated|Shalvata Mental Health Center|||3||f||||f||||||||Undecided||2017-10-10 21:48:05.669494|2017-10-10 21:48:05.669494
NCT02906488|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-08-02|||September 12, 2016||2016-09-12|August 2017|2017-08-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2022|Anticipated|2022-01-31||Observational|||Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease|Special Drug Use Results Survey of Safety and Efficacy of Long-term (104 Weeks) Use of Duodopa Enteral Solution in Patients With Parkinson's Disease in Actual Usage Condition|Recruiting||N/A|150|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:48:05.777408|2017-10-10 21:48:05.777408
NCT02906475|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-12-09|||October 2016||2016-10-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|ADAPI||Atopic Dermatitis in Atopy Predisposed Infants|A Randomized Pragmatic Parallel Group Trial to Investigate the Effectiveness of a Standardized Skin Care Regimen to Prevent the Development of Atopic Dermatitis in Atopy Predisposed Infants|Recruiting||N/A|160|Anticipated|HiPP GmbH & Co. Vertrieb KG||2|||f||||f||||||||No||2017-10-10 21:48:05.938034|2017-10-10 21:48:05.938034
NCT02906462|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-15|||November 2013||2013-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MAHO2||Impact of an Early Palliative Approach|"Impact of an Early and Collegial Consideration of Patients' Vulnerability Comparing to Usual Care. Cluster Randomized Control Study Mort-A-l'Hôpital 2"|Active, not recruiting||N/A|1200|Anticipated|Hopital Foch||2|||f||||f||||||||||2017-10-10 21:48:06.038323|2017-10-10 21:48:06.038323
NCT02906449|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2016-09-19|||October 2016||2016-10-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|IPCPE-Mind||Investigating the Physiological, Cognitive, and Psychological Effects of a Cognitive-Based Intervention|Investigating the Physiological, Cognitive, and Psychological Effects of a Cognitive-Based Intervention|Not yet recruiting||N/A|70|Anticipated|Brock University||2|||f||||f||||||||No|Only congregate/group statistical data will be shared and published|2017-10-10 21:48:06.183156|2017-10-10 21:48:06.183156
NCT02906436|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2017-04-19|||February 2011||2011-02-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ExVivo||Ex-Vivo Lung Reconditioning|Pilot Study of Lung Transplantation After Ex-Vivo Lung Reconditioning|Completed||N/A|45|Actual|Hopital Foch||1|||f||||t||||||||||2017-10-10 21:48:06.270752|2017-10-10 21:48:06.270752
NCT02906423|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-01-10|||July 2012||2012-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Results From a Health System-wide Implementation of a Quality of Life Questionnaire||Completed||N/A|43000|Actual|Allina Health System|||1||f||||||||||||||2017-10-10 21:48:06.35036|2017-10-10 21:48:06.35036
NCT02906410|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-07-25|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Dynamic Presentation of Calorie Information|Dynamic Presentation of Calorie Information|Enrolling by invitation||N/A|1000|Anticipated|University of Pennsylvania||6|||f||||f||||||||||2017-10-10 21:48:06.44276|2017-10-10 21:48:06.44276
NCT02906397|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-15|2017-07-20|||March 30, 2017|Actual|2017-03-30|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)|A Pilot Study of Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Patients With Advanced Hepatocellular Carcinoma (HCC)|Recruiting||Phase 1|15|Anticipated|University of Pennsylvania||1|||f||||f|t|t|f|f||||||2017-10-10 21:48:06.531442|2017-10-10 21:48:06.531442
NCT02906384|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-06|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)|Memory Preservation and Functional Brain Magnetic Resonance Imaging Changes With Conformal Avoidance of the Hippocampal Neural Stem-cell Compartment During Prophylactic Cranial Irradiation for Small Cell Lung Cancer Patients: A Prospective, Randomized Phase-II Study|Recruiting||Phase 2|154|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||No||2017-10-10 21:48:06.633453|2017-10-10 21:48:06.633453
NCT02906371|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-28|||August 2016||2016-08-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome|A Two Cohort Pilot Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome (CRS) Management in Pediatric Patients With CD19 Expressing Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (ALL)|Recruiting||N/A|39|Anticipated|University of Pennsylvania||2|||f||||t||||||||Undecided||2017-10-10 21:48:06.73918|2017-10-10 21:48:06.73918
NCT02906345|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2017-04-19|||September 2016||2016-09-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|TPEMOF||TPE in Septic Patients and Influence on Organ Failure|"Analyses on the Effectiveness and Technical Optimization of Therapeutic Plasma Exchange for Patients With Septic Shock, With Special Emphasis on Influencing the Kidney, Liver and Nervous System Through the Extracorporeal Therapy"|Recruiting||N/A|30|Anticipated|University of Rostock||3|||f||||t||||||||No|No.|2017-10-10 21:48:06.932045|2017-10-10 21:48:06.932045
NCT02906332|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-08-08|||December 12, 2016|Actual|2016-12-12|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)|A Phase II Trial of the Anti -PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) + Lenalidomide + Dexamethasone as Post Autologous Transplant Consolidation in Patients With High-risk Multiple Myeloma|Active, not recruiting||Phase 2|16|Actual|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-10 21:48:07.014976|2017-10-10 21:48:07.014976
NCT02906319|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-14|||September 2015||2015-09-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Vitamin D and HbA1c Levels in Diabetic Patients With CKD|Association Between Serum 25-hydroxyvitamin D Levels and Glycated Haemoglobin in Diabetic Patients With Chronic Kidney Disease|Completed||N/A|100|Actual|University of Malaya|||1||f||||f||||||||Yes|A dataset of participants' clinical characteristics and biochemical tests result. The data was obtained directly from the participants and via Laboratory Information System. It is ready for submission.|2017-10-10 21:48:07.143188|2017-10-10 21:48:07.143188
NCT02906306|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-01-30|||September 2014||2014-09-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Individual and Group Occupational Therapy on General Self-Efficacy, Psychological Well-Being, Personal Independence and Occupational Therapy in Older Adults|EFFECTS OF INDIVIDUAL AND GROUP OCCUPATIONAL THERAPY ON GENERAL SELF-EFFICACY AND PSYCHOLOGICAL WELL-BEING IN OLDER ADULTS|Completed||N/A|112|Actual|University of Malaga||2|||f||||f||||||||||2017-10-10 21:48:07.199886|2017-10-10 21:48:07.199886
NCT02906293|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-08-23|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||AbStats: Assessing Post-Prandial Intestinal Event Rates in Healthy Individuals|AbStats: Assessing Post-Prandial Intestinal Event Rates in Healthy Individuals|Active, not recruiting||N/A|50|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 21:48:07.274463|2017-10-10 21:48:07.274463
NCT02906280|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-09-19|||May 2016||2016-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||RCT Comparing 19Ga vs 22Ga EBUS-TBNA Needles in Carcinoma.|Randomized Controlled Trial Comparing the Performance of 19 Gauge Versus 22 Gauge EBUS-TBNA Needles in Lung Carcinoma|Recruiting||Phase 3|78|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||No||2017-10-10 21:48:07.347905|2017-10-10 21:48:07.347905
NCT02906267|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-07-13|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|UGV||Ultrasonographic Comparison of Gastric Volume After Three Modes of Positive Facemask During Induction of Anaesthesia|Ultrasonographic Comparison of Gastric Volume After Three Modes of Positive Facemask. A Prospective Randomized Study.|Recruiting||N/A|123|Anticipated|University Hospital, Brest||3|||f||||f||||||||||2017-10-10 21:48:07.421324|2017-10-10 21:48:07.421324
NCT02906254|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-14|||February 2014||2014-02-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ANTIBIOSTOP||Early Antibiotic Discontinuation in FUO|Early Discontinuation of Empirical Antibacterial Therapy in Febrile Neutropenia: Prospective Observational Study (ANTIBIOSTOP)|Completed||N/A|123|Actual|University Hospital, Brest|||2||f||||f||||||||Undecided||2017-10-10 21:48:07.496064|2017-10-10 21:48:07.496064
NCT02906241|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||PACCT: Partnering Around Cancer Clinical Trials|PACCT: Partnering Around Cancer Clinical Trials|Recruiting||N/A|464|Anticipated|Barbara Ann Karmanos Cancer Institute||3|||f||||f||||||||||2017-10-10 21:48:07.565374|2017-10-10 21:48:07.565374
NCT02906228|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-19|||April 2014||2014-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|EMF60+women||Radiofrequency Electromagnetic Field (RF-EMF) Effects on Brain Activity During Sleep and Waking in Healthy Elderly Women|Einfluss Hochfrequenter Elektromagnetischer Felder Auf Gehirnaktivität, Schlaf Und Kognitive Leistungsfähigkeit älterer Frauen|Recruiting||N/A|30|Anticipated|The Federal Office for Radiation Protection, Germany||3|||f||||f||||||||No||2017-10-10 21:48:07.660805|2017-10-10 21:48:07.660805
NCT02906215|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-09-14|||September 2016||2016-09-01|August 2016|2016-08-01||||June 2019|Anticipated|2019-06-01||Interventional|||Mobile Application to Improve Care Coordination Among HIV Clinic and Substance Use Treatment Providers|Mobile Application to Improve Care Coordination Among HIV Clinic and Substance Use Treatment Providers|Not yet recruiting||Phase 1|78|Anticipated|Rhode Island Hospital||1|||f||||f||||||||No||2017-10-10 21:48:07.739262|2017-10-10 21:48:07.739262
NCT02906202|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-04-07|||July 2016||2016-07-01|April 2017|2017-04-01||||January 2020|Anticipated|2020-01-01||Interventional|||A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia|A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects With Transfusion-dependent β-Thalassemia, Who do Not Have β0/β0 Genotype, by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral βA-T87Q-Globin Vector in Subjects ≥12 and ≤50 Years of Age|Recruiting||Phase 3|15|Anticipated|bluebird bio||1|||f||||t||||||||||2017-10-10 21:48:07.810445|2017-10-10 21:48:07.810445
NCT02906189|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2016-09-14|||September 2016||2016-09-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Safety of Magnetic Resonance Imaging in Non-MRI Conditional Pacemakers and ICD Devices|Safety of Magnetic Resonance Imaging in Non-MRI Conditional Pacemakers and ICD Devices|Recruiting||N/A|1500|Anticipated|Banner Health|||1||f||||f||||||||No||2017-10-10 21:48:07.894446|2017-10-10 21:48:07.894446
NCT02906176|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM|A Clinical Trail to Investigate the Influence of SLCO2B1 Polymorphism on the Pharmacokinetic Characteristics of Voriconazole in CYP2C19 Poor Metabolizers|Recruiting||Phase 1|12|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:48:08.079045|2017-10-10 21:48:08.079045
NCT02906163|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-16|||October 2016||2016-10-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy|First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy|Not yet recruiting||Phase 1/Phase 2|188|Anticipated|SciClone Pharmaceuticals||3|||f||||t||||||||Undecided||2017-10-10 21:48:08.221315|2017-10-10 21:48:08.221315
NCT02906150|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|||Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type|Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) Chemotherapy Plus Cisplatin (or Carboplatin) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type|Not yet recruiting||Phase 2|140|Anticipated|SciClone Pharmaceuticals||2|||f||||t||||||||||2017-10-10 21:48:08.36341|2017-10-10 21:48:08.36341
NCT02906137|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-03-30|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|GALT||Gut-Associated Lymphocyte Trafficking|Altered Homing of T Lymphocytes to the Gut and Poor Immune Reconstitution of the Intestinal Mucosa in Treated HIV-infected Individuals|Recruiting||N/A|70|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||f|f|f||||||No||2017-10-10 21:48:08.50873|2017-10-10 21:48:08.50873
NCT02906111|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-14|||November 2016||2016-11-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|VSaE||Vaginal Estriol Before and Vaginal Surgery for Prolapse|Effects on Vaginal Health and Quality of Life in Postmenopausal Women Using Ultra Low Topic Estriol Before Vaginal Surgery for Pelvic Statics Disorders|Not yet recruiting||Phase 4|88|Anticipated|Policlinico Universitario, Catania||2|||f||||f||||||||No||2017-10-10 21:48:08.815698|2017-10-10 21:48:08.815698
NCT02906098|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-14|||January 2016||2016-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intervention Study of Oral Health Education Programs Directed to Adolescents|A Randomized Clinical Field Study on Behavioral Interventions to Increase Adolescent's Motivation for Self Performed Periodontal Infection Control|Recruiting||N/A|450|Anticipated|Göteborg University||2|||f||||f||||||||No||2017-10-10 21:48:08.920967|2017-10-10 21:48:08.920967
NCT02906085|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2016-09-14|||October 2016||2016-10-01|September 2016|2016-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Endothelin-1 as a Potential Trigger of Migraine Aura|Investigations of the Endogenous Vasoconstrictor and Neuromodulator Peptide Endothelin-1 as a Potential Trigger of Migraine Aura|Not yet recruiting||N/A|24|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-10 21:48:09.038235|2017-10-10 21:48:09.038235
NCT02906072|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-05-26|||January 2011||2011-01-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|LFPBDS||Low Fat Plant-based Diet Effects on Body Composition Indices|Effects of an ad Libitum Consumed Low-fat Plant-based Diet Supplemented With Plant-based Meal Replacements on Body Composition Indices|Completed||N/A|325|Actual|Barbara Jakše s.p.||2|||f||||f||||||||Yes|Data will be open to public if demanded by the publication/journal.|2017-10-10 21:48:09.127464|2017-10-10 21:48:09.127464
NCT02906059|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-12-07|||September 2016||2016-09-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer|A Phase Ib Study Combining Irinotecan With AZD1775, a Selective Wee 1 Inhibitor, in RAS (KRAS or NRAS) or BRAF Mutated Metastatic Colorectal Cancer Patients Who Have Progressed on First Line Therapy|Recruiting||Phase 1|32|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 21:48:09.216235|2017-10-10 21:48:09.216235
NCT02906046|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-14|||April 2012||2012-04-01|January 2013|2013-01-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|||Weight in Lower Limbs Improves Gait Ataxia of in Machado-Joseph Disease Patients|Weight in Lower Limbs Improves Gait Ataxia Of in Machado-Joseph Disease Patients: A Randomized Crossover Trial|Completed||N/A|20|Actual|Federal University of Health Science of Porto Alegre||3|||f||||||||||||||2017-10-10 21:48:09.316423|2017-10-10 21:48:09.316423
NCT02906033|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of A New Perioperative Practice Model on Patient, Nursing And Organisational Outcomes|The Effect of A New Perioperative Practice Model on Patient, Nursing And Organisational Outcomes|Recruiting||N/A|490|Anticipated|Hospital District of Helsinki and Uusimaa||2|||f||||f||||||||No||2017-10-10 21:48:09.392199|2017-10-10 21:48:09.392199
NCT02906007|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-11|||August 18, 2017|Actual|2017-08-18|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in HIV-Infected and HIV-Uninfected Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis|A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) in Combination With Optimized Individualized Multidrug-Resistant Tuberculosis (MDR-TB) Therapy in HIV-Infected and HIV-Uninfected Infants, Children and Adolescents With MDR-TB Disease|Recruiting||Phase 1/Phase 2|72|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t|t|f||||||||2017-10-10 21:48:09.613003|2017-10-10 21:48:09.613003
NCT02905994|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-02-15|||September 2016||2016-09-01|February 2017|2017-02-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia|"A Phase I Trial of Volasertib (BI 6727), an Intravenous Polo-Like Kinase Inhibitor, in Combination With 7+3 Induction Chemotherapy for Patients With Acute Myeloid Leukemia"|Withdrawn||Phase 1|0|Actual|Massachusetts General Hospital||1||Funding Withdrawn|f||||t||||||||No||2017-10-10 21:48:09.719828|2017-10-10 21:48:09.719828
NCT02905981|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-26|||January 17, 2017||2017-01-17|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Triferic IRIDA Protocol|Triferic (Ferric Pyrophosphate Citrate) Administered Orally With Shohl's Solution for the Treatment of Iron-Refractory Iron-Deficiency Anemia|Active, not recruiting||Phase 2|28|Anticipated|Rockwell Medical Technologies, Inc.||3|||f||||f|t|f||||||||2017-10-10 21:48:09.829052|2017-10-10 21:48:09.829052
NCT02905968|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-14|||January 2016||2016-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Transanual Tube Placement in Low Anterior Resection (LAR) for Rectal Cancer|The Safety and Effect of Transanual Tube Placement in Low Anterior Resection (LAR) for Rectal Cancer to Prevent Anastomotic Leak: Randomized Control Trial Study|Recruiting||Phase 2/Phase 3|520|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 21:48:09.922829|2017-10-10 21:48:09.922829
NCT02905955|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Vacuumtherapy After Venous Hybrid Procedures|Negative Pressure Wound Management (NPWT) System for Inguinal Wounds After Venous Hybrid Procedures|Recruiting||Phase 4|40|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||Undecided||2017-10-10 21:48:10.016724|2017-10-10 21:48:10.016724
NCT02905942|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-16|||December 2015||2015-12-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation|A Single Center Randomized Controlled Trial of the Efficacy and Safety of PEG-rhG-CSF After Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Patients|Recruiting||Phase 4|96|Anticipated|Peking University||2|||f||||||||||||||2017-10-10 21:48:10.115168|2017-10-10 21:48:10.115168
NCT02905929|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-09-28|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|October 2019|Anticipated|2019-10-01||Interventional|||Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease|Randomized Control Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease|Recruiting||N/A|250|Anticipated|University of California, San Diego||2|||f||||f|f|f||||||||2017-10-10 21:48:10.193237|2017-10-10 21:48:10.193237
NCT02905916|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-16|||June 2016||2016-06-01|September 2016|2016-09-01||||June 2018|Anticipated|2018-06-01||Interventional|||The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy||Recruiting||Phase 4|217|Anticipated|Peking University||1|||f||||||||||||||2017-10-10 21:48:10.320524|2017-10-10 21:48:10.320524
NCT02905903|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-02-22|||February 2016||2016-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An In Vivo Model for Postinflammatory Hyperpigmentation|An In Vivo Model for Postinflammatory Hyperpigmentation: Part II|Recruiting||N/A|30|Anticipated|Henry Ford Health System||1|||f||||f||||||||No||2017-10-10 21:48:10.408055|2017-10-10 21:48:10.408055
NCT02905890|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-11|||January 2017||2017-01-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|HCBV||The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis|Hormonal Contraception and Bacterial Vaginosis (HCBV): The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis Among Women at High Risk for HIV Infection in Kampala, Uganda|Not yet recruiting||Phase 4|525|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||Yes|Anonymised data from consenting participants will be made available to third parties in line with Open Access data requirements after a period of exclusive use by the study investigators|2017-10-10 21:48:10.495847|2017-10-10 21:48:10.495847
NCT02905877|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||The Pathophysiology of Functional Neurological Disorders|The Pathophysiology of Functional Neurological Disorders|Recruiting||N/A|100|Anticipated|University College, London|||3||f||||f||||||||No||2017-10-10 21:48:10.653887|2017-10-10 21:48:10.653887
NCT02905864|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-07-03|||November 2016||2016-11-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|LOSEIT||Liraglutide 3 mg for Knee Osteoarthritis|Effect of Liraglutide on Body Weight and Pain in Overweight or Obese Patients With Knee Osteoarthritis: A Randomised, Double Blind, Placebo-controlled, Parallel Group, Single-centre Trial|Recruiting||Phase 4|150|Anticipated|Parker Research Institute||2|||f||||t||||||||||2017-10-10 21:48:10.808513|2017-10-10 21:48:10.808513
NCT02905851|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-05-24|||May 2016||2016-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris|Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris|Recruiting||N/A|50|Anticipated|University of California, Davis||2|||f||||f||||||||No||2017-10-10 21:48:10.937287|2017-10-10 21:48:10.937287
NCT02905838|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-10-05|||December 2010||2010-12-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Comparison of Two Implant Prosthetic Pathways|Comparison of the Esthetic and Clinical Performance of Implant Supported All Ceramic Crowns Using Two Different Ceramic Abutment Types|Active, not recruiting||N/A|40|Actual|University of Bern||2|||f||||||||||||||2017-10-10 21:48:11.056716|2017-10-10 21:48:11.056716
NCT02905825|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-09-28|||May 18, 2017||2017-05-18||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:48:11.115811|2017-10-10 21:48:11.115811
NCT02905812|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-13|||November 2016||2016-11-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|REPOSE||Pilot Clinical Trial of an Integrative Intervention to Improve Critically Ill Patients' Delirium and Related Outcomes|Relaxation for Critically Ill Patient Outcomes and Stress-coping Enhancement (REPOSE 1.0): Pilot Clinical Trial of an Integrative Intervention to Improve Critically Ill Patients' Delirium and Related Outcomes|Not yet recruiting||N/A|120|Anticipated|University of Alberta||2|||f||||t||||||||Undecided||2017-10-10 21:48:11.156404|2017-10-10 21:48:11.156404
NCT02905799|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-03-21|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Interventional|ARTHROL||Resveratrol in Knee Osteoarthritis|Evolution of Pain at Three Months by Oral Resveratrol in Primary Knee Osteoarthritis: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial|Not yet recruiting||Phase 3|160|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 21:48:11.248993|2017-10-10 21:48:11.248993
NCT02905786|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-16|||December 2016||2016-12-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Protocol of a Pilot Study to Optimize Care for Heart Failure Patients in Primary Care|Implementation of a Multifaceted Intervention to Optimize Care for Heart Failure Patients in Primary Care: Protocol of a Pilot Study|Not yet recruiting||N/A|200|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||Undecided||2017-10-10 21:48:11.333804|2017-10-10 21:48:11.333804
NCT02905773|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-18|||March 2015||2015-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Postoperative Pain After the Removal of Root Canal Filling Material|Postoperative Pain After the Removal of Root Canal Filling Material Using Different Techniques in Teeth With Failed Root Canal Therapy: A Randomized Clinical Trial|Completed||Early Phase 1|135|Actual|TC Erciyes University||2|||f||||||||||||||2017-10-10 21:48:11.410107|2017-10-10 21:48:11.410107
NCT02905760|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-09-16|||December 2016||2016-12-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|FAMIE||Efficacy of Furosemide Versus Vascular Filling in Patients With Acute Myocardial Infarction|Efficacy of Furosemide Versus Vascular Filling in Patients With Acute Myocardial Infarction With Right Ventricular Extension: A Multicentric Randomized Controlled Trial|Not yet recruiting||Phase 3|88|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 21:48:11.461583|2017-10-10 21:48:11.461583
NCT02905747|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-17|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Medical Exercise Therapy on Pain, Function and Physical Activity in Patients With Knee Osteoarthritis|The Effect of Medical Exercise Therapy on Pain, Function and Physical Activity in Patients With Knee Osteoarthritis|Recruiting||N/A|20|Anticipated|Norwegian University of Science and Technology||1|||f||||f|f|f||||||||2017-10-10 21:48:11.53902|2017-10-10 21:48:11.53902
NCT02905734|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-02|||January 3, 2017|Actual|2017-01-03|April 2017|2017-04-01|October 3, 2019|Anticipated|2019-10-03|April 3, 2019|Anticipated|2019-04-03||Interventional|SUBNIGAV||Nicotine Replacement Therapy in Nicotine-dependent Arrestees|Nicotine Replacement Therapy in Nicotine-dependent Arrestees: a Monocentric Randomized Simple Blind Study|Recruiting||Phase 4|1000|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 21:48:13.145123|2017-10-10 21:48:13.145123
NCT02905721|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-07-24|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|MYOCARDITESCAN||Evaluation of Spectral Cardiac CT for the Diagnosis of Acute Myocarditis|Evaluation of Spectral Cardiac CT for the Diagnosis of Acute Myocarditis|Not yet recruiting||N/A|136|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t|f|f||||||||2017-10-10 21:48:13.240673|2017-10-10 21:48:13.240673
NCT02905708|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-09-13|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|June 29, 2017|Actual|2017-06-29||Interventional|||Efficacy of Warming Garment in the Perioperative Period With Integrated Chemical Heat Packs to Maintain Normothermia|Efficacy Warming Garment to Maintain Normothermia Using Integrated Chemical Heat Pack Construction, in the Perioperative Period, for Surgery Less Than 12 Hours Duration|Completed||N/A|48|Actual|Dr K Services PC||2|||f||||t||||||||||2017-10-10 21:48:13.308835|2017-10-10 21:48:13.308835
NCT02905695|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-14|||January 2011||2011-01-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|January 2015|Actual|2015-01-01||Interventional|EPISIO||Post-partum Perineal Pain - Chirocaine®|Contribution of the Local Infiltration of Chirocaine® in the Management of the Post-partum Perineal Pain After Episiotomy or First-degree Tear|Completed||Phase 4|110|Actual|Hopital Foch||2|||f||||f||||||||No||2017-10-10 21:48:13.388728|2017-10-10 21:48:13.388728
NCT02905682|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-10-05|||September 2016|Actual|2016-09-01|October 2017|2017-10-01|September 27, 2017|Actual|2017-09-27|September 27, 2017|Actual|2017-09-27||Interventional|||Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects|A Randomised, Double-blind, Placebo-controlled, Multi-centre Trial Investigating the Efficacy and Safety of Desmopressin (FE 992026) Orally Disintegrating Tablets During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects|Completed||Phase 3|190|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-10 21:48:13.464452|2017-10-10 21:48:13.464452
NCT02905669|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-08-08|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|NormaFLIP||Normal Values for Esophageal and Pyloric Impedance Planimetry Under General Anesthesia (NormaFLIP)|Measurement of Contractile Activity and Distensibility of the Esophago-gastric Junction, of the Esophagus and of the Pylorus: Normal Values in Controls Under General Anesthesia (NormaFLIP Study)|Not yet recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 21:48:13.561049|2017-10-10 21:48:13.561049
NCT02905656|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-12|||September 2016||2016-09-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PACE||Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit|Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit (PACE)|Recruiting||N/A|828|Anticipated|University of Tennessee||4|||f||||t||||||||No||2017-10-10 21:48:13.64889|2017-10-10 21:48:13.64889
NCT02905643|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Observational|||Discerning Pseudoprogression vs True Tumor Growth in GBMs|The Use of Peak Height and Percentage Signal Recovery for Evaluation and Determination of Pseudoprogression in Glioblastoma Patients|Enrolling by invitation||N/A|32|Anticipated|St. Vincent Health|||1||f||||f||||||||Undecided|Undecided|2017-10-10 21:48:13.754421|2017-10-10 21:48:13.754421
NCT02905630|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-13|||January 2014||2014-01-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|SYNDEX||The Syndrome X-ercise Study SYNDEX|Effect of Aerobic High-intensity Exercise Training on Coronary Flow Reserve and Endothelial Function in Individuals With Chest Pain and Normal Coronary Angiogram|Recruiting||N/A|30|Anticipated|Helse Stavanger HF||2|||f||||f||||||||No||2017-10-10 21:48:13.820382|2017-10-10 21:48:13.820382
NCT02905617|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-05-05|||August 2016||2016-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Post Market Clinical Experience Study of Sientra 207 Breast Implants|Post Market Clinical Experience Study of the Sientra 207 High-Strength Cohesive Plus (HSC+) Breast Implants in Primary and Revision Augmentation Participants|Recruiting||N/A|180|Anticipated|Sientra, Inc.|||2||f||||f||||||||No||2017-10-10 21:48:13.900325|2017-10-10 21:48:13.900325
NCT02905604|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|MA-SCH-DEP||Magnetic Stimulation of the Brain in Schizophrenia or Depression|Magnetic Stimulation of the Brain in Schizophrenia or Depression: A Randomized, Double Blind, Sham Controlled Trial of Repetitive Transcranial Magnetic Stimulation in Schizophrenia or Depression|Recruiting||N/A|80|Anticipated|Uppsala University||2|||f||||t||||||||No||2017-10-10 21:48:14.066328|2017-10-10 21:48:14.066328
NCT02905591|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-02-17|||July 31, 2017|Anticipated|2017-07-31|February 2017|2017-02-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|XACT-LUNG||A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC|A Phase 2 Trial of Pharmacological Ascorbate With Concurrent Chemotherapy and Radiation Therapy Followed by Consolidation Chemotherapy for Non-small Cell Lung Cancer|Not yet recruiting||Phase 2|46|Anticipated|University of Iowa||1|||f||||t|t|f||||||Yes|Data will be shared using clinicaltrials.gov reports and per the NIH data sharing plan on file with the grants.|2017-10-10 21:48:14.192201|2017-10-10 21:48:14.192201
NCT02905578|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-02-17|||July 31, 2017|Anticipated|2017-07-31|February 2017|2017-02-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|PACMANv2||A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer|A Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)|Not yet recruiting||Phase 2|30|Anticipated|University of Iowa||1|||f||||t|t|f||||||Yes|Data will be shared through results reporting on clincialtrials.gov|2017-10-10 21:48:14.320466|2017-10-10 21:48:14.320466
NCT02905565|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-04-03|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|||n-Butylphthalide (NBP) Softgel Capsules in Stroke Patients|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Add-On to Standard-of-Care Study of n-Butylphthalide (NBP) Softgel Capsules for Treatment of Mild to Moderate Acute Ischemic Stroke in Adult Subjects|Not yet recruiting||Phase 2|400|Anticipated|CSPC-NBP Pharmaceutical Co., Ltd.||2|||f||||t|t|f||||||No||2017-10-10 21:48:14.429486|2017-10-10 21:48:14.429486
NCT02905552|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-12-20|||September 2016||2016-09-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|MYRIFIC||Myelodysplasic Syndromes and Risk Factors for Infection|Myelodysplasic Syndromes and Risk Factors for Infection : A Case / Control Study|Recruiting||N/A|320|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 21:48:14.542677|2017-10-10 21:48:14.542677
NCT02905539|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||July 2016||2016-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|HOMe_aFers_1||A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer|A Randomized, Double-blind Comparative Study Comparing Ferric Carboxymaltose (Ferinject) and Iron Isomaltoside 1000 (Monofer) for Iron Substitution in Iron-deficiency Anemia|Recruiting||Phase 4|60|Anticipated|Saarland University||2|||f||||f||||||||Undecided||2017-10-10 21:48:14.666134|2017-10-10 21:48:14.666134
NCT02905526|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-20|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||An Intervention Delivered by App Instant Messaging to Increase Use of Effective Contraception Among Young Women in Bolivia|A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase Use of Effective Contraception Among Young Women in Bolivia|Active, not recruiting||N/A|645|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f|f|f||||||||2017-10-10 21:48:14.847453|2017-10-10 21:48:14.847453
NCT02905513|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-20|||November 16, 2016|Actual|2016-11-16|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|July 31, 2017|Actual|2017-07-31||Interventional|||An Intervention Delivered by App Instant Messaging to Increase the Acceptability of Effective Contraception Among Young People in Tajikistan|A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase the Acceptability of Effective Contraception Among Young People in Tajikistan|Active, not recruiting||N/A|580|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-10 21:48:14.983671|2017-10-10 21:48:14.983671
NCT02905500|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-14|||January 2014||2014-01-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|AVIRON||Estimation of Disability Adjusted Life Years in Reunion Island and Comparison to Metropolitan France and Other Countries in the Indian Ocean Zone|Estimation Des années de Vie ajustées Sur l'incapacité à La réunion et Comparaison à la France métropolitaine et Aux Pays de la Zone Océan Indien|Active, not recruiting||N/A|800000|Anticipated|Centre Hospitalier Universitaire de la Réunion|||1||f||||f||||||||||2017-10-10 21:48:15.097104|2017-10-10 21:48:15.097104
NCT02905487|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-14|||January 2015||2015-01-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Observational|ADIPOGEST||Relationship Between Gestational Diabetes Mellitus and Inflammatory Adipocytokins in Obese Mothers and Their Newborn at Delivery|Relation Entre diabète Gestationnel et Adipocytokines Inflammatoires Chez Des mères obèses et Leur Nouveau-né à l'Accouchement|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de la Réunion|||2||f||||t||||||Samples Without DNA|"     Leptin, adiponeptin, TNF-alpha, Interleukin-6, CRP and C-peptide blood levels   "|||2017-10-10 21:48:15.159565|2017-10-10 21:48:15.159565
NCT02905474|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-19|||May 2016||2016-05-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Mobile Health Technology for Chronic Kidney Disease Patients: Medication Management|Harnessing Mobile Health Technology to Personalize the Care of Chronic Kidney Disease Patients: Medication Domain Randomized Controlled Trial|Recruiting||N/A|182|Anticipated|University Health Network, Toronto||2|||f||||f||||||||Yes||2017-10-10 21:48:15.240313|2017-10-10 21:48:15.240313
NCT02905461|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-20|||December 8, 2016|Actual|2016-12-08|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||An Intervention Delivered by Text Message to Increase the Acceptability of Effective Contraception Among Young Women in Palestine|A Randomised Controlled Trial of an Intervention Delivered by Text Message to Increase the Acceptability of Effective Contraception Among Young Women in Palestine|Active, not recruiting||N/A|586|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-10 21:48:15.335744|2017-10-10 21:48:15.335744
NCT02905448|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-14|||January 2016||2016-01-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|LFPBDS2||Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases|Low Fat Plant-Based Supplemented Diet Effects on Variety of Risk Factors for Chronic Non-communicable Diseases|Active, not recruiting||N/A|30|Anticipated|Barbara Jakše s.p.||1|||f||||f||||||||Yes|Data will be open to public if demanded by the publication/journal.|2017-10-10 21:48:15.424204|2017-10-10 21:48:15.424204
NCT02905435|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-29|||November 2016||2016-11-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Assessment of Safety and Effectiveness of Biodegradable Temporizing Matrix in the Treatment of Deep Burn Skin Injuries|A Traditional Feasibility Study to Assess the Safety and Effectiveness of the Biodegradable Temporizing Matrix (BTM) in the Treatment of Deep Burn Skin Injuries.|Recruiting||N/A|10|Anticipated|PolyNovo Biomaterials Pty Ltd.||1|||f||||t||||||||||2017-10-10 21:48:15.520189|2017-10-10 21:48:15.520189
NCT02905422|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-13|||January 2016||2016-01-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Healthy Eating, Activity, & Lifestyle Training Headquarters: II Pilot Project|Healthy Eating, Activity, & Lifestyle Training Headquarters: II (H.E.A.L.T.H -II) Pilot Project|Recruiting||N/A|80|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||No||2017-10-10 21:48:15.648659|2017-10-10 21:48:15.648659
NCT02905409|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Study of Surgery in Patients With Idiopathic Macular Hole|A Randomized, Double-masked, Multicenter, Controlled Study of Effects of Internal Membrane Peeling Surgery in Patients With Idiopathic Macular Hole Measured by Optical Coherence Tomography.|Recruiting||Phase 4|228|Anticipated|Peking University People's Hospital||2|||f||||||||||||||2017-10-10 21:48:15.743553|2017-10-10 21:48:15.743553
NCT02905396|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-09-16|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SFN-SCS||Spinal Cord Stimulation in Small Fibre Neuropathy|Spinal Cord Stimulation in Small Fibre Neuropathy: A Pilot Study|Not yet recruiting||N/A|20|Anticipated|Academisch Ziekenhuis Maastricht||1|||f||||t||||||||||2017-10-10 21:48:15.852848|2017-10-10 21:48:15.852848
NCT02905370|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-07-13|||September 2016||2016-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Progressing Home Health Rehabilitation for Older Adults|Progressing Home Health Rehabilitation Paradigms for Older Adults|Recruiting||N/A|200|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 21:48:16.157001|2017-10-10 21:48:16.157001
NCT02905357|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-01-05|||August 2016||2016-08-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|HARP||Women's Heart Attack Research Program- Imaging Study|Women's Heart Attack Research Program- Imaging Study|Recruiting||N/A|500|Anticipated|New York University School of Medicine|||2||f||||t||||||Samples With DNA|"     blood collection in platelet substudy   "|Yes|De-identified data will be shared after the end of the study.|2017-10-10 21:48:16.277113|2017-10-10 21:48:16.277113
NCT02905344|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||February 2015||2015-02-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Effectiveness of Using 3D Printed Models to Educate Otolaryngology (Ear, Nose, Nose and Throat (ENT)) Patients About Surgery: A Survey|The Effectiveness of Using 3D Printed Anatomically Accurate Models to Educate Patients About Surgery: A Survey|Completed||N/A|100|Actual|University of Notre Dame|||2||f||||f||||||||Yes|The data will be freely shared upon email request.|2017-10-10 21:48:16.406103|2017-10-10 21:48:16.406103
NCT02905331|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-05|||February 28, 2017|Actual|2017-02-28|September 2017|2017-09-01|July 17, 2018|Anticipated|2018-07-17|September 14, 2017|Anticipated|2017-09-14||Interventional|||Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis|A Phase 3, Multicenter, Randomized, Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) Delivered Via a SelfDose (TM) Device in the Treatment of Subjects With Moderate to Severe Plaque-Type Psoriasis|Active, not recruiting||Phase 3|78|Actual|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 21:48:16.492597|2017-10-10 21:48:16.492597
NCT02905305|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-16|||December 2013||2013-12-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Cochlear Implant With Anti-Inflammatory Agent|Pilot Evaluation of Combined Investigational Device: CI4CID With Controlled Dosage of Dexamethasone|Recruiting||N/A|48|Anticipated|The Hearing Cooperative Research Centre||2|||f||||f||||||||No||2017-10-10 21:48:16.766897|2017-10-10 21:48:16.766897
NCT02905292|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|June 2017|Anticipated|2017-06-01||Observational|||Inactivity, Balance Problems and Fall Risk in Institutionalized Frail Elderly|Inactivity, Balance Problems and Fall Risk in Institutionalized Frail Elderly: What is the Impact of Benign Paroxysmal Positional Vertigo (BPPV) and Treatment Effectiveness?|Recruiting||N/A|400|Anticipated|Hasselt University|||1||f||||f||||||||Undecided||2017-10-10 21:48:16.901276|2017-10-10 21:48:16.901276
NCT02905279|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-09-13|||June 2016||2016-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Spider Phobia Opposite Action Treatment Study|Enhancing Exposure Therapy for Spider Phobia With the Use of Threat-Relevant and Threat-Irrelevant Opposite Actions|Recruiting||N/A|120|Anticipated|University of Texas at Austin||4|||f||||f||||||||No||2017-10-10 21:48:17.039544|2017-10-10 21:48:17.039544
NCT02905266|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-10-03|||October 27, 2016|Actual|2016-10-27|October 2017|2017-10-01|November 17, 2020|Anticipated|2020-11-17|October 22, 2017|Anticipated|2017-10-22||Interventional|||A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma|Phase IIIb, Randomized, Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Previously Untreated Unresectable or Metastatic Melanoma|Active, not recruiting||Phase 3|102|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f|||t|||||2017-10-10 21:48:17.152098|2017-10-10 21:48:17.152098
NCT02905253|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-07-06|||September 12, 2016|Actual|2016-09-12|July 2017|2017-07-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20||Interventional|||A Study to Evaluate if AC-084 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects|A Three-part Single-center, Phase 1 Study to Assess the Tolerability, Safety, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of Ascending Single and Multiple Doses of AC-084 in Healthy Subjects and to Investigate the Pharmacokinetics of a Single Dose of AC-084 in Healthy CYP2C9 Poor Metabolizers|Recruiting||Phase 1|94|Anticipated|Actelion||5|||f||||f||||||||||2017-10-10 21:48:17.287292|2017-10-10 21:48:17.287292
NCT02905227|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-01-27|||September 2016||2016-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder|A Phase 1 Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder in Chronic Smokers and People With Mild or Moderate Asthma Compared to Healthy Volunteers|Completed||Phase 1|60|Actual|Acorda Therapeutics||1|||f||||f||||||||||2017-10-10 21:48:17.669694|2017-10-10 21:48:17.669694
NCT02905214|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-14|||January 2016||2016-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)|Coroflex ISAR 2000 Extended Postmarket Surveillance Non-Interventional Study|Recruiting||N/A|2000|Anticipated|B. Braun Melsungen AG|||1||f||||f||||||||Undecided||2017-10-10 21:48:17.781752|2017-10-10 21:48:17.781752
NCT02905201|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-02-06|||September 2016||2016-09-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|August 2017|Anticipated|2017-08-01||Observational|TOGETHER||A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)|A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Exposed to Abiraterone Acetate (TOGETHER)|Withdrawn||N/A|0|Actual|Janssen Research & Development, LLC|||1|The protocol was cancelled due timelines be not compatible with business strategy in Colombia.|f||||f||||||||||2017-10-10 21:48:17.886277|2017-10-10 21:48:17.886277
NCT02905188|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-21|||January 2018||2018-01-01|September 2016|2016-09-01|January 2036|Anticipated|2036-01-01|February 2021|Anticipated|2021-02-01||Interventional|GLYCAR||Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)|Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells as Immunotherapy for Patients With Hepatocellular Carcinoma|Not yet recruiting||Phase 1|14|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 21:48:17.968009|2017-10-10 21:48:17.968009
NCT02905175|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-01-12|||January 2015||2015-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|||Rheumatoid Arthritis Patients and Porphyromonas Gingivalis|Porphyromonas Gingivalis Contribution in Rheumatoid Arthritis (RA).|Recruiting||N/A|5|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||Samples Without DNA|"     blood sample and synovial tissue   "|No||2017-10-10 21:48:18.063839|2017-10-10 21:48:18.063839
NCT02905162|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2016-09-23|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia|Z 31601 - Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia|Not yet recruiting||N/A|552|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 21:48:18.15467|2017-10-10 21:48:18.15467
NCT02905149|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-01|||August 2, 2016|Actual|2016-08-02|August 2017|2017-08-01|July 8, 2017|Actual|2017-07-08|June 8, 2017|Actual|2017-06-08||Interventional|||Impact of the Serratus Plane Block in Pain and the Use of Opioids in Breast Surgery|Impact of the Serratus Plane Block in Pain and the Use of Opioids in Breast|Completed||Phase 4|60|Actual|Instituto de Investigacion Sanitaria La Fe||2|||f||||f||||||||||2017-10-10 21:48:18.228162|2017-10-10 21:48:18.228162
NCT02905136|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|MECANO||Mechanisms of Auto-immune Encephalitis|Mechanisms of Auto-immune Encephalitis|Not yet recruiting||N/A|250|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     serum, whole blood, cerebrospinal fluid   "|||2017-10-10 21:48:18.315158|2017-10-10 21:48:18.315158
NCT02905123|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-02-07|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Brief Internet Intervention for Hazardous Alcohol Use|Brief Internet Intervention for Hazardous Alcohol Use|Completed||N/A|423|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 21:48:18.408498|2017-10-10 21:48:18.408498
NCT02905110|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-08-17|||October 2016||2016-10-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors|Combination Intraventricular Chemotherapy Pilot Study: Methotrexate and Etoposide Infusions Into the Fourth Ventricle or Resection Cavity in Children With Recurrent Posterior Fossa Brain Tumors|Recruiting||Early Phase 1|10|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 21:48:18.478608|2017-10-10 21:48:18.478608
NCT02905097|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-06-15|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2024|Anticipated|2024-08-01|August 2024|Anticipated|2024-08-01||Observational|||Post-marketing Surveillance Study of the Triathlon Tritanium Baseplate|Five Year Survival and Functional Assessment of the Triathlon Cementless Total Knee System Using the Tritanium Tibial Baseplate|Not yet recruiting||N/A|100|Anticipated|Golden Jubilee National Hospital|||1||f||||f||||||||No||2017-10-10 21:48:18.593221|2017-10-10 21:48:18.593221
NCT02905071|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-22|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|SERENAT||Validation of a Scale of Well-being at Work|Study of the Psychometric Properties of the Scale of Well-being at Work: The Serenat Study|Recruiting||N/A|250|Anticipated|University Hospital, Lille||4|||f||||f||||||||||2017-10-10 21:48:18.865554|2017-10-10 21:48:18.865554
NCT02905058|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-06-29|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|May 2017|Actual|2017-05-01||Interventional|||Efficacy of Ketoprofen Before Intrauterine Device Insertion|Effect of Oral Ketoprofen on Intra Uterine Device Insertion Pain: A Randomized Controlled Trial|Recruiting||Phase 3|100|Anticipated|Assiut University||2|||f||||t||||||||Yes||2017-10-10 21:48:18.973958|2017-10-10 21:48:18.973958
NCT02905045|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-04-07|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy of Ketoprofen Before Hysterosalpingography|Effect of Oral Ketoprofen on Hysterosalpingography Pain: A Randomized Controlled Trial|Recruiting||Phase 3|100|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:48:19.060231|2017-10-10 21:48:19.060231
NCT02905032|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-01-27|||September 2016||2016-09-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|SDM4Afib||SDM for Stroke Prevention in Atrial Fibrillation|Shared Decision Making for Stroke Prevention in Atrial Fibrillation (SDM4Afib): A Randomized Trial|Enrolling by invitation||N/A|900|Anticipated|Mayo Clinic||2|||f||||t||||||||No||2017-10-10 21:48:19.148868|2017-10-10 21:48:19.148868
NCT02905019|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-01|||August 2016||2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP|A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of Adjuvanted R21 at Two Different Doses and the Combination Malaria Vaccine Candidate Regimen of Adjuvanted R21 + ChAd63 and MVA Encoding ME-TRAP.|Recruiting||Phase 1/Phase 2|70|Anticipated|University of Oxford||9|||f||||t||||||||||2017-10-10 21:48:19.251698|2017-10-10 21:48:19.251698
NCT02905006|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-08-31|||August 2016||2016-08-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Ranging Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|250|Actual|UCB Pharma||6|||f||||t||||||||||2017-10-10 21:48:19.370191|2017-10-10 21:48:19.370191
NCT02904993|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-11-15|||May 2016||2016-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|DA THA pain||Study Comparing Regional Anesthetic Blocks and Periarticular Infiltration for the Management of Post-operative Pain After Direct Anterior Total Hip Arthroplasty|Prospective Randomized Study Comparing Regional Anesthetic Blocks and Periarticular Infiltration for the Management of Post-operative Pain After Direct Anterior Total Hip Replacement|Terminated||N/A|9|Actual|Mayo Clinic||2||PI left the institution.|f||||f||||||||No||2017-10-10 21:48:19.568969|2017-10-10 21:48:19.568969
NCT02904980|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-13|||February 2015||2015-02-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Effects of a Group-based Gaze Training Intervention for Children With Developmental Coordination Disorder|A Randomised Controlled Trial of a Group-based, Gaze Training Intervention for Children With Developmental Coordination Disorder|Completed||N/A|23|Actual|Manchester Metropolitan University||2|||f||||f||||||||No||2017-10-10 21:48:19.647304|2017-10-10 21:48:19.647304
NCT02904967|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||January 2013||2013-01-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome||Recruiting||N/A|1500|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:48:19.738768|2017-10-10 21:48:19.738768
NCT02904954|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-09-07|||December 2, 2016|Actual|2016-12-02|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and II Non-small Cell Lung Cancer|A Randomized Phase 2 Trial of Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II, and IIIA Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|60|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-10 21:48:19.816719|2017-10-10 21:48:19.816719
NCT02904941|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns|Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns: A Randomised Trial|Active, not recruiting||N/A|60|Anticipated|Universidad de Valparaiso||2|||f||||f||||||||No||2017-10-10 21:48:19.914704|2017-10-10 21:48:19.914704
NCT02904928|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-09-13|||August 2015||2015-08-01|May 2015|2015-05-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Observational|iPOD||Incidence and Perioperative Factors Associated With Postoperative Delirium|Incidence and Perioperative Factors Associated With Postoperative Delirium Among Surgical Patients in Mulago National Referral Hospital|Completed||N/A|437|Actual|Makerere University|||1||f||||t||||||||||2017-10-10 21:48:20.020587|2017-10-10 21:48:20.020587
NCT02904915|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||November 2016||2016-11-01|September 2016|2016-09-01||||November 2017|Anticipated|2017-11-01||Interventional|||Paracervical Block Versus No Paracervical Block During IUD Insertion|Paracervical Block Versus No Paracervical Block During IUD Insertion|Not yet recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 21:48:20.087453|2017-10-10 21:48:20.087453
NCT02904902|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-09-12|||September 6, 2016||2016-09-06|September 2017|2017-09-01|May 8, 2019|Anticipated|2019-05-08|May 8, 2019|Anticipated|2019-05-08||Interventional|||Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa|A Phase 3 Multicenter, Open-label, Single Arm Study of the Safety and Efficacy of Adalimumab in Japanese Subjects With Moderate to Severe Hidradenitis Suppurativa|Active, not recruiting||Phase 3|15|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-10 21:48:20.213485|2017-10-10 21:48:20.213485
NCT02904889|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-25|||September 2016||2016-09-01|December 2016|2016-12-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Stimulating Engagement in Daily and Physical Activities Among Older Adults Receiving Homecare Services (Part of Basic Care Revisited)|Stimulating Engagement in Daily and Physical Activities Among Older Adults Receiving Homecare Services: An Exploratory Trial (Part of Basic Care Revisited)|Completed||N/A|40|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 21:48:20.32793|2017-10-10 21:48:20.32793
NCT02904876|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-07|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|TYSADIFF||Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis|Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis|Recruiting||Phase 4|100|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 21:48:20.4201|2017-10-10 21:48:20.4201
NCT02904863|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||February 2013||2013-02-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|SHU||Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults||Recruiting||N/A|48|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:48:20.520432|2017-10-10 21:48:20.520432
NCT02904850|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-09-13|||June 2014||2014-06-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Validation of a Kinetic Model of Erlotinib|Validation of a Kinetic Model of Erlotinib|Recruiting||N/A|50|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 21:48:20.600243|2017-10-10 21:48:20.600243
NCT02904837|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-07-31|||March 2015|Actual|2015-03-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Mental Practice Combined With Physical Practice to Improve the Gait Performance of People With Parkinson's Disease|Mental Practice Combined With Physical Practice to Improve the Gait Performance of People With Parkinson's Disease: A Multicentre Randomized Controlled Trial Protocol|Recruiting||N/A|150|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 21:48:20.688405|2017-10-10 21:48:20.688405
NCT02904824|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-09-13|||July 2012||2012-07-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|September 2014|Actual|2014-09-01||Interventional|||Injection Laryngoplasty Using Autologous Fat Enriched With Adipose Derived Regenerative Stem Cells (ADRC)|Injection Laryngoplasty Using Autologous Fat Enriched With Adipose Derived Regenerative Stem Cells (ADRC) vs Centrifuged Autologous Fat (CAF), for the Functional Reconstruction of the Glottal Gap After Unilateral Vocal Cord Paralysis|Completed||Phase 1/Phase 2|16|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||t||||||||No||2017-10-10 21:48:20.778772|2017-10-10 21:48:20.778772
NCT02904811|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-05-09|||January 10, 2017|Actual|2017-01-10|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|i-PREDICT||Prevention of Diseases Induced by Chlamydia Trachomatis|Prevention of Diseases Induced by Chlamydia Trachomatis|Recruiting||N/A|4000|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:48:20.859354|2017-10-10 21:48:20.859354
NCT02904798|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-09-13|||July 2015||2015-07-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||The Effects of Visible Light on the Skin After Administration of Oral Polypodium Leucotomos||Recruiting||N/A|22|Anticipated|Henry Ford Health System||1|||f||||f||||||||||2017-10-10 21:48:20.949123|2017-10-10 21:48:20.949123
NCT02904785|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-09-13|||May 2016||2016-05-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis|The Efficacy of Extracorporeal Focused Shock Wave Therapy for Patients With Primary Knee Osteoarthritis|Recruiting||Phase 2|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:48:21.045417|2017-10-10 21:48:21.045417
NCT02904772|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-14|||October 2016||2016-10-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Interventional|||Alipogene Tiparvovec for the Treatment of LPLD Patients|An Open Label, Multi-centre Trial of Alipogene Tiparvovec for the Treatment of LPLD Patients|Withdrawn||Phase 2|0|Actual|UniQure Biopharma B.V.||2||"uniQure, has decided not to renew the Marketing Authorization of Glybera in the EU. This   decision is not related to any safety, efficacy or quality issue"|f||||f||||||||||2017-10-10 21:48:21.154495|2017-10-10 21:48:21.154495
NCT02904759|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-14|2017-10-05|||September 2016|Actual|2016-09-01|October 2017|2017-10-01|September 29, 2017|Actual|2017-09-29|September 29, 2017|Actual|2017-09-29||Interventional|||Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects|A Randomised, Double-blind, Placebo-controlled, Multi-centre Trial Investigating the Efficacy and Safety of Desmopressin (FE 992026) Orally Disintegrating Tablets During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects|Completed||Phase 3|342|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-10-10 21:48:21.243396|2017-10-10 21:48:21.243396
NCT02904746|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-05-03|||October 2016||2016-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Intervention to Increase Treatment Engagement Among Individuals Referred for Post-Crisis Mental Health Services|A Brief, Trauma-Informed Intervention to Increase Treatment Engagement Among Individuals Referred for Post-Crisis Mental Health Services|Suspended||N/A|156|Anticipated|University of Manitoba||2||Unable to successfully recruit participants using current study design.|f||||f||||||||No||2017-10-10 21:48:21.321545|2017-10-10 21:48:21.321545
NCT02904733|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|EMERGE||Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)|Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)|Not yet recruiting||N/A|3900|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-10 21:48:21.400974|2017-10-10 21:48:21.400974
NCT02904720|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||October 2015||2015-10-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|PCVDDPWS||Prevalence and Consequences of Vitamin D Deficiency in Pregnant Women in Switzerland|Prevalence and Consequences of Vitamin D Deficiency in Pregnant Women in Switzerland|Completed||N/A|1199|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||No||2017-10-10 21:48:21.485253|2017-10-10 21:48:21.485253
NCT02904707|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-13|||February 2015||2015-02-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ULCERALGIQUE||Interest of Skin Graft Pellets in the Management of Ulcers Algic|Interest of Skin Graft Pellets in the Management of Ulcers Algic|Completed||N/A|50|Actual|Groupe Hospitalier Paris Saint Joseph||2|||f||||t||||||||Undecided||2017-10-10 21:48:21.574901|2017-10-10 21:48:21.574901
NCT02904694|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-12-08|||March 2014||2014-03-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|2 Years|Observational [Patient Registry]|SDR||Selective Dorsal Rhizotomy (SDR) Database|Commissioning Through Evaluation: Selective Dorsal Rhizotomy Database|Enrolling by invitation||N/A|160|Anticipated|King's College London|||1||f||||t||||||||Undecided||2017-10-10 21:48:21.656101|2017-10-10 21:48:21.656101
NCT02904681|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-04|||December 1, 2014|Actual|2014-12-01|September 2017|2017-09-01|April 15, 2016|Actual|2016-04-15|January 30, 2015|Actual|2015-01-30||Observational|DRC||Multicenter Retrospective Evaluation of the Surgical Management of Spinal Growth Dystrophy|Multicenter Retrospective Evaluation of the Surgical Management of Spinal Growth Dystrophy|Completed||N/A|16|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||||||2017-10-10 21:48:21.70783|2017-10-10 21:48:21.70783
NCT02904668|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-12-28|||September 2016||2016-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Self-administered Program in Chronic Neck Pain|Effects of a Self-administered Program in Patients With Chronic Neck Pain|Completed||N/A|40|Actual|Universidad de Granada||2|||f||||f||||||||Undecided||2017-10-10 21:48:21.772037|2017-10-10 21:48:21.772037
NCT02904655|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-21|||September 2012||2012-09-01|September 2016|2016-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Healthy Eating Better Breathing: A Feeding Study in Patients With Asthma|Dietary Interventions in Asthma Treatment:Healthy Eating Better Breathing Asthma Diet Pilot Study|Completed||N/A|19|Actual|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 21:48:21.839117|2017-10-10 21:48:21.839117
NCT02904642|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||November 2016||2016-11-01|September 2016|2016-09-01||||October 2017|Anticipated|2017-10-01||Interventional|M-SIMI||Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial|Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial|Not yet recruiting||N/A|537|Anticipated|Johns Hopkins Bloomberg School of Public Health||3|||f||||f||||||||No||2017-10-10 21:48:21.924213|2017-10-10 21:48:21.924213
NCT02904616|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-11-30|||January 2015||2015-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|PHOTOFLUO||Validation of a Medical Device, a Mobile Spectrofluorimeter, Measuring Skin Autofluorescence in Healthy Volunteers.|Validation of a Medical Device, a Mobile Spectrofluorimeter, Measuring Skin Autofluorescence in Healthy Volunteers|Completed||N/A|32|Actual|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 21:48:22.235866|2017-10-10 21:48:22.235866
NCT02904603|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-20|||November 2014||2014-11-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Observational|IMHC||Immune Monitoring of Hepatitis C Under DAA Therapy|Prospective Monitoring of Immune Parameters in Patients With Hepatitis C Under Treatment With Direct Acting Antivirals|Recruiting||N/A|100|Anticipated|University of Regensburg|||1||f||||f||||||Samples With DNA|"     Serum probes   "|No||2017-10-10 21:48:22.311754|2017-10-10 21:48:22.311754
NCT02904590|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-11-30|||October 2016||2016-10-01|November 2016|2016-11-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01|5 Years|Observational [Patient Registry]|INFEII||A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease|A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease|Recruiting||N/A|1204|Anticipated|Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa|||1||f||||t||||||Samples With DNA|"     blood sample of 10 cc   "|No||2017-10-10 21:48:22.393429|2017-10-10 21:48:22.393429
NCT02904564|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|MMP||Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation|Conventional Microneedling Compared to Microneedling Associated With 5-FU Infusion (Microinfusion of Medication Into the Skin - MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation|Recruiting||Phase 4|25|Anticipated|Clinica Dermatologica Arbache ltda||2|||f||||t||||||||No||2017-10-10 21:48:22.804604|2017-10-10 21:48:22.804604
NCT02904551|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-16|||February 2012||2012-02-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Gingival Augmentation Around Implants During Maintenance|Free Gingival Grafts for Implants Exhibiting Lack of Keratinized Gingiva: A Prospective Controlled Randomized Clinical Study|Completed||N/A|30|Actual|University of Maryland Baltimore Dental School||2|||f||||f||||||||No|IPD will not be shared. The results will be published.|2017-10-10 21:48:22.903743|2017-10-10 21:48:22.903743
NCT02904538|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-06-15|||November 22, 2016|Actual|2016-11-22|June 2017|2017-06-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|ADRIATIC||Perineural Versus Systemic Dexamethasone to Prolong Regional Anesthesia in Front Foot Surgery|Perineural Versus Systemic Dexamethasone to Prolong Regional Anesthesia in Front Foot Surgery|Completed||Phase 3|100|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 21:48:22.988355|2017-10-10 21:48:22.988355
NCT02904525|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-09-13|||June 2015||2015-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|XENOGBM||Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model|Towards Patient-specific Treatments in Glioblastoma: Comparison and Validation of High-resolution Imaging and Molecular Profiles of Human Glioblastoma and Respective Paired Orthotopic Xenografts in the Mouse|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||Undecided||2017-10-10 21:48:23.078086|2017-10-10 21:48:23.078086
NCT02904499|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-13|||December 2013||2013-12-01|September 2016|2016-09-01||||September 2016|Actual|2016-09-01||Observational|DABI-SURV||Use of Public Health Surveillance Models in the French National Health System Database|Use of Public Health Surveillance Models in the French National Health System Database: A Tool for an Ongoing Monitoring of Adverse Drug Reaction? The Case of Dabigatran|Recruiting||N/A|3000000|Anticipated|Centre Hospitalier Universitaire de la Réunion|||2||f||||||||||||||2017-10-10 21:48:23.259291|2017-10-10 21:48:23.259291
NCT02904486|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-13|||January 2017||2017-01-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Effectiveness of Modified Health Belief Model Based Intervention to Reduce Body Mass Index|Effectiveness of Modified Health Belief Model Based Intervention to Reduce Body Mass|Not yet recruiting||N/A|232|Anticipated|Chulalongkorn University||2|||f||||t||||||||Yes||2017-10-10 21:48:23.34858|2017-10-10 21:48:23.34858
NCT02904473|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-07-31|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Goals for Reaching Optimum Wellness (GROWell)|Goals for Reaching Optimum Wellness (GROWell): A Pilot Study of a Dietary Intervention During Pregnancy|Enrolling by invitation||N/A|50|Anticipated|Duke University||3|||f||||f||||||||||2017-10-10 21:48:23.431311|2017-10-10 21:48:23.431311
NCT02904460|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-13|||September 2015||2015-09-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|DEXDOR||Dexmedetomidine for Morphine Consumption Reduction (DEXDOR)|Assessment of the Reducting Effect of Dexmedetomidine on the Morphine Use for Severe Burned Patients|Completed||N/A|32|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||||2017-10-10 21:48:23.503443|2017-10-10 21:48:23.503443
NCT02904447|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Pedobar Pressure Mid-term After Hemiarthroplasty With HemiCap for Hallux Rigidus|Pedobar Pressure Mid-term After Hemiarthroplasty With HemiCap for Hallux Rigidus|Recruiting||N/A|90|Anticipated|Copenhagen University Hospital, Hvidovre|||1||f||||t||||||||Undecided||2017-10-10 21:48:23.578922|2017-10-10 21:48:23.578922
NCT02904434|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-09-15|||September 2016||2016-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|GIVE||Gastrointestinal Implications of Voriconazole Exposure|Gastrointestinal Implications of Voriconazole Exposure: Determining Age-dependent Differences in Intestinal Metabolism Affecting Oral Bioavailability of Voriconazole in Children|Recruiting||N/A|45|Anticipated|Children's Hospital of Philadelphia|||1||f||||f||||||Samples Without DNA|"     Blood will be drawn during 12 hours following voriconazole administration. Samples will be     analyzed for voriconazole concentrations.   "|||2017-10-10 21:48:23.655264|2017-10-10 21:48:23.655264
NCT02904421|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-13|||October 2016||2016-10-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||6 Years Study on Changes in Bone Quality, Bone Turnover and Curve Severity in AIS With and Without Calcium and Vit-D Supplementation|A Six Years Longitudinal Cohort Study on the Changes in Bone Density, Bone Quality and Its Association With Bone Turnover Markers and Curve Severity in Adolescent Idiopathic Scoliosis With and Without 2 Years of Calcium and Vit-D Supplementation|Enrolling by invitation||N/A|330|Anticipated|Chinese University of Hong Kong|||3||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 21:48:23.743583|2017-10-10 21:48:23.743583
NCT02904408|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-21|||June 2016||2016-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality of Life|Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality|Recruiting||N/A|120|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||No||2017-10-10 21:48:23.834519|2017-10-10 21:48:23.834519
NCT02904395|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||April 2014||2014-04-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|April 2014|Actual|2014-04-01||Observational|DEPIPOMP1||Feasability and Interest of Screening for Infantile Pompe's Diseases at Birth|Feasability and Interest of Screening for Infantile Pompe's Diseases at Birth|Completed||N/A|3413|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||Samples With DNA|"     filter paper with blood to look for enzyme activity and if enzyme activity low, PCR looking     for the signature mutations for infantile Pompe's Disease   "|No||2017-10-10 21:48:23.927552|2017-10-10 21:48:23.927552
NCT02904382|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-07-13|||November 2015||2015-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:48:23.979886|2017-10-10 21:48:23.979886
NCT02904369|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-02-14|||October 2016||2016-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||PK and PD Study of Oral F/TAF for HIV Prevention|Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition|Recruiting||Phase 1|72|Anticipated|CONRAD||3|||f||||f||||||||No||2017-10-10 21:48:24.027232|2017-10-10 21:48:24.027232
NCT02904356|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-07-23|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) for Obsessive-Compulsive Disorder (OCD)|Repetitive Transcranial Magnetic Stimulation (rTMS) for Obsessive-Compulsive Disorder (OCD)|Recruiting||N/A|15|Anticipated|Columbia University||1|||f||||t|f|t|f|f||||||2017-10-10 21:48:24.132639|2017-10-10 21:48:24.132639
NCT02904343|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of Domestic Hemodialysis Machine: A Multi-center Clinical Study|Evaluation of Domestic Hemodialysis Machine (WEGO DBB-27C) : A Multi-center Clinical Study|Not yet recruiting||Phase 3|200|Anticipated|Chinese PLA General Hospital||2|||f||||||||||||||2017-10-10 21:48:24.222598|2017-10-10 21:48:24.222598
NCT02904330|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-10-14|||July 2016||2016-07-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||K1-70 - A Study in Subjects With Graves' Disease|K1-70 - A Phase I, Single Ascending Intramuscular Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Subjects With Graves' Disease|Recruiting||Phase 1|36|Anticipated|AV7 Limited||1|||f||||f||||||||No||2017-10-10 21:48:24.292875|2017-10-10 21:48:24.292875
NCT02904317|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-09-13|||August 2015||2015-08-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Observational|||Misoprostol for Labour Induction|The Misoprostol Vaginal Insert Compared With Oral Misoprostol for Labour Induction in Term Pregnancies: a Pair-matched Case-control Study|Completed||N/A|138|Actual|Asklepios Kliniken Hamburg GmbH|||2||f||||f||||||||No||2017-10-10 21:48:24.381338|2017-10-10 21:48:24.381338
NCT02904304|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-02-14|||January 2018|Anticipated|2018-01-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu|National Clinical Trial,Phase III, Multicenter, Randomized, Prospective, Double-blind, Parallel, Placebo-controlled, to Evaluate the Efficacy, Safety and Superiority of Decongex Gripe in the Treatment of Symptoms Associated With Common Cold|Not yet recruiting||Phase 3|150|Anticipated|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f|f|f||||||||2017-10-10 21:48:24.442005|2017-10-10 21:48:24.442005
NCT02904291|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-17|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|October 2026|Anticipated|2026-10-01|October 2017|Anticipated|2017-10-01||Observational|BAR-MEDS||Bariatric Surgery and Pharmacokinetics of Medication|BAR-MEDS: Bariatric Surgery and Pharmacokinetics of Medication|Recruiting||N/A|12|Anticipated|Norwegian University of Science and Technology|||1||f||||f|f|f||||||||2017-10-10 21:48:24.527503|2017-10-10 21:48:24.527503
NCT02904278|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|May 2018|Anticipated|2018-05-01||Interventional|||Novel Mobile Device Application to Improve Adherence|Randomized, Controlled Trial of a Novel Mobile Device Application to Improve Adherence in Children Greater Than 11 Years of Age After Cardiac Transplantation (CTOTC-10)|Not yet recruiting||Phase 2|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 21:48:24.597063|2017-10-10 21:48:24.597063
NCT02904265|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-19|||September 2016||2016-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome|Non-inferiority Prospective Randomized Trial of Acetazolamide Versus Diazepam in Patients With Continuous Spike and Wave in Sleep (CSWS)/Landau Kleffner Syndrome (LKS)|Enrolling by invitation||Phase 2/Phase 3|100|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 21:48:24.689524|2017-10-10 21:48:24.689524
NCT02904252|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-03-21|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|||The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital|The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital|Completed||N/A|158|Actual|Mahidol University|||1||f||||f||||||Samples With DNA|"     Clotted blood and serum   "|No|Due to patients confidentiality in study protocol. The individual level data will not be released.|2017-10-10 21:48:24.784423|2017-10-10 21:48:24.784423
NCT02904239|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-20|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CaPaCT||Cardiac Pathologies in Standard Thoracic CT Imaging|Evaluation of Cardiac Pathologies in Standard Thoracic CT Imaging [CaPaCT]|Recruiting||N/A|217|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-10 21:48:24.863372|2017-10-10 21:48:24.863372
NCT02904226|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-06-03|||August 2016||2016-08-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|October 2018|Anticipated|2018-10-01||Interventional|ICONIC||Dose Escalation and Expansion of JTX-2011 Alone or in Combination With Anti-PD-1 in Subjects With Advanced Solid Tumors|Phase 1/2 Multicenter Trial of ICOS Agonist Monoclonal Antibody (mAb) JTX-2011 Alone or in Combination With Nivolumab in Adult Subjects With Advanced Refractory Solid Tumor Malignancies|Recruiting||Phase 1/Phase 2|282|Anticipated|Jounce Therapeutics, Inc.||4|||f||||f||||||||No||2017-10-10 21:48:24.941461|2017-10-10 21:48:24.941461
NCT02904213|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-03-06|||September 16, 2016|Actual|2016-09-16|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|December 19, 2016|Actual|2016-12-19||Interventional|||Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks|A Bridging Study to Evaluate Safety of ComBe Five (Liquid) (Combined Pentavalent DTwP-rHepB-Hib Vaccine) Made in India, in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks|Recruiting||N/A|330|Anticipated|Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products||1|||f||||f||||||||Undecided||2017-10-10 21:48:25.080976|2017-10-10 21:48:25.080976
NCT02904200|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-15|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Clinical Investigation of Two Different Wound Dressings|A Prospective, Randomized, Controlled Clinical Investigation, Comparing Trauma to Peri-Wound Skin and Pain When Using Two Different Wound Dressings|Completed||Phase 4|2|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-10 21:48:25.160721|2017-10-10 21:48:25.160721
NCT02904187|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-13|||March 2010||2010-03-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Cerebral Activation and Bilateral Stimulation by Cochlear Implantation in Bilateral Deaf Adults|Cerebral Activation and Bilateral Stimulation by Cochlear Implantation in Bilateral Deaf Adults|Recruiting||N/A|180|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 21:48:25.223944|2017-10-10 21:48:25.223944
NCT02904174|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||December 2014||2014-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|HLP||Healthy Living Programme for Older Adults|Healthy Living Programme (HLP): Diet, Drug and Fall Prevention for Community-dwelling Frail Older Adults|Completed||N/A|122|Actual|The Hong Kong Polytechnic University||1|||f||||f||||||||No||2017-10-10 21:48:25.288289|2017-10-10 21:48:25.288289
NCT02904161|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-03-21|||August 2012||2012-08-01|September 2016|2016-09-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With Cancer||Completed||N/A|137|Actual|MiCareo Taiwan Co., Ltd.|||2||f||||f||||||||Undecided||2017-10-10 21:48:25.356584|2017-10-10 21:48:25.356584
NCT02904148|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||October 2016||2016-10-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|ERIAMS||Passive Mobilisation of Region of Shoulder Joints for Hemiplegic Patient||Not yet recruiting||Phase 2|30|Anticipated|Centre Hospitalier Universitaire de la Réunion||1|||f||||f||||||||No||2017-10-10 21:48:25.410975|2017-10-10 21:48:25.410975
NCT02904135|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-03-21|||February 2014||2014-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients|Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients|Completed||N/A|141|Actual|MiCareo Taiwan Co., Ltd.|||2||f||||f||||||||Undecided||2017-10-10 21:48:25.46784|2017-10-10 21:48:25.46784
NCT02904109|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-02-28|||September 13, 2016|Actual|2016-09-13|February 2017|2017-02-01|February 28, 2017|Actual|2017-02-28|February 21, 2017|Actual|2017-02-21||Interventional|Tricross-Basel||Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress|Randomized Placebo Controlled Phase II Cross Over Study on the Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress|Completed||Phase 2|41|Actual|University of Basel||2|||f||||f||||||||||2017-10-10 21:48:25.595025|2017-10-10 21:48:25.595025
NCT02904096|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-21|||June 10, 2016|Actual|2016-06-10|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Radiesse® Safety Study For the Treatment of Hands|Radiesse® Post Approval Safety Study For the Treatment of Hands With Moderate to Very Severe Dorsal Volume Loss|Active, not recruiting||N/A|250|Anticipated|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 21:48:25.678835|2017-10-10 21:48:25.678835
NCT02904083|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||June 2017||2017-06-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|CONCORDE||Study of the Effectiveness of Specific Training of Health Professionals on Adherence in Bipolar Disorder||Not yet recruiting||N/A|300|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:48:25.878163|2017-10-10 21:48:25.878163
NCT02904070|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||March 2014||2014-03-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|PARTOSURE-OI||Interest of Placental Alpha-microglobulin-1 Detection Test to Assess Risk of Premature Delivery in Reunion Island||Recruiting||Phase 4|300|Anticipated|Centre Hospitalier Universitaire de la Réunion||1|||f||||f||||||||No||2017-10-10 21:48:26.040054|2017-10-10 21:48:26.040054
NCT02904057|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-06-07||2017-06-07|January 2016||2016-01-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of the MJGS Following Radiesse (+) Injection Into the Jawline|Evaluation of the Merz Jawline Grading Scale (MJGS) Following Radiesse (+)® Correction of Subcutaneous Volume Loss and Contour Deficits of the Jawline - a Canadian Pilot Study|Completed||N/A|29|Actual|Merz Pharmaceuticals, LLC||2|||f||||f|f|t|f|f||||No||2017-10-10 21:48:26.148073|2017-10-10 21:48:26.148073
NCT02904044|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||September 2012||2012-09-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Observational|TsColEPS||Sport Injuries During Physical Activity Lessons in Secondary School in South of Reunion Island|Etude Des Traumatismes Sportifs Lors Des Cours d'éducation Physique et Sportive Chez Les collégiens Dans le Sud de l'Ile de La Reunion|Completed||N/A|1000|Actual|Centre Hospitalier Universitaire de la Réunion|||2||f||||t||||||||Undecided||2017-10-10 21:48:26.247032|2017-10-10 21:48:26.247032
NCT02904031|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-07-30|||July 2016||2016-07-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|PANDA||Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients|Randomized Phase II Study of First-Line FOLFOX Plus Panitumumab Versus 5FU Plus Panitumumab in RAS And BRAF Wild-Type Metastatic Colorectal Cancer Elderly Patients|Recruiting||Phase 2|180|Anticipated|Gruppo Oncologico del Nord-Ovest||2|||f||||f||||||||||2017-10-10 21:48:26.339185|2017-10-10 21:48:26.339185
NCT02904018|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-13|||March 2014||2014-03-01|February 2014|2014-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|EDENT2||Validation Study of Oral Teleconsultation|Validation Study of Oral Teleconsultation - Study EDENT2|Completed||N/A|700|Actual|University Hospital, Montpellier|||1||f||||t||||||||Undecided||2017-10-10 21:48:26.451183|2017-10-10 21:48:26.451183
NCT02904005|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-13|||March 2015||2015-03-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|SECS||Predictors of Suicidal Behavior in Depression|National Multicentric Study on the Predictive Factors for Suicidal Behavior During a Major Depressive Episode|Recruiting||N/A|2000|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:48:26.518579|2017-10-10 21:48:26.518579
NCT02903992|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-09-13|||May 2016||2016-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|SAF||SArcopenia Prevalence in Frail Older Adults. SAF Study|SArcopenia Prevalence in Frail Older Adults: SAF Study|Recruiting||N/A|300|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||Undecided||2017-10-10 21:48:26.627639|2017-10-10 21:48:26.627639
NCT02903979|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-05-03|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|February 2017|Actual|2017-02-01||Interventional|||Impact of Different Restorative Treatments for Deep Caries Lesion in Primary Teeth||Recruiting||N/A|128|Anticipated|Universidade Ibirapuera||2|||f||||||||||||||2017-10-10 21:48:26.739607|2017-10-10 21:48:26.739607
NCT02903966|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-07-06|||November 15, 2016||2016-11-15|July 2017|2017-07-01|April 10, 2019|Anticipated|2019-04-10|April 10, 2019|Anticipated|2019-04-10||Interventional|||GSK2982772 Study in Ulcerative Colitis Patients|A Multicentre, Randomised, Double-blind (Sponsor Unblinded), Placebo-controlled Study With Open Label Extension to Investigate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2982772 in Subjects With Active Ulcerative Colitis|Recruiting||Phase 2|36|Anticipated|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 21:48:26.85174|2017-10-10 21:48:26.85174
NCT02903953|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-13|||January 2012||2012-01-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|RECHNONU||Clinical Research Outside of Teaching Hospitals (RECHNONU)|Clinical Research Outside of Teaching Hospitals : Current Situation in North-eastern France|Completed||N/A|129|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||No||2017-10-10 21:48:27.078728|2017-10-10 21:48:27.078728
NCT02903940|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy|The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy|Not yet recruiting||N/A|40|Anticipated|St. Jude Medical||1|||f||||f||||||||No||2017-10-10 21:48:27.147987|2017-10-10 21:48:27.147987
NCT02903927|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-13|||May 2014||2014-05-01|September 2016|2016-09-01||||January 2015|Actual|2015-01-01||Interventional|LUCIOL||Prospective Comparative Randomized Clinical Trial to Evaluate the Visual Performance of Two Monofocal Intraocular Lenses||Active, not recruiting||N/A|||Carl Zeiss Meditec AG||2|||f||||f||||||||||2017-10-10 21:48:27.233229|2017-10-10 21:48:27.233229
NCT02903914|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-05-26|||September 2016||2016-09-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Arginase Inhibitor CB-1158 in Patients With Solid Tumors|Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Arginase Inhibitor CB-1158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors|Recruiting||Phase 1|236|Anticipated|Calithera Biosciences, Inc||7|||f||||f||||||||No||2017-10-10 21:48:27.306514|2017-10-10 21:48:27.306514
NCT02903901|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||June 2015||2015-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Melatonin for Prevention of Post- Operative Delirium Pilot Study Protocol|Melatonin for Prevention of Post- Operative Delirium Pilot Study Protocol|Withdrawn||Phase 4|0|Actual|Loyola University||2||Investigator found that a new study drug that is FDA approved would be superior to melatonin|f||||f||||||||||2017-10-10 21:48:27.459208|2017-10-10 21:48:27.459208
NCT02903888|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-28|||September 8, 2016|Actual|2016-09-08|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|October 31, 2017|Anticipated|2017-10-31||Observational|ANALIA||A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years|A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years|Recruiting||N/A|1000|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 21:48:27.551638|2017-10-10 21:48:27.551638
NCT02903875|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-13|||April 2013||2013-04-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|PETAL||Therapeutic Education Program for Laryngectomised Patients and Their Close Relations|Therapeutic Education Program Aimed at Improving the Quality of Life of Laryngectomised Patients and Their Close Relatives|Active, not recruiting||N/A|40|Anticipated|University Hospital, Caen|||4||f||||f||||||||No||2017-10-10 21:48:27.666857|2017-10-10 21:48:27.666857
NCT02903862|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-09-13|||July 2016||2016-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|HeB||Health-eBrain Study|Caregivers Virtual Health eBrain Study II|Recruiting||N/A|||AnthroTronix, Inc.||2|||f||||f||||||||No||2017-10-10 21:48:27.778722|2017-10-10 21:48:27.778722
NCT02903849|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-05-08|||September 2016||2016-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Using Self-Motivating Messages to Encourage People to Exercise More|Using Self-Motivating Messages to Encourage People to Exercise More|Completed||N/A|324|Actual|Washington University School of Medicine||2|||f||||||||||||||2017-10-10 21:48:27.922858|2017-10-10 21:48:27.922858
NCT02903836|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-06-08|||September 2016||2016-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase II Study of Oral Nafithromycin in CABP|A Phase II, Randomized, Double-Blind, Multicenter, Comparative Study to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Oral Nafithromycin Versus Oral Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia (CABP) in Adults|Active, not recruiting||Phase 2|230|Actual|Wockhardt||3|||f||||||||||||||2017-10-10 21:48:28.017978|2017-10-10 21:48:28.017978
NCT02903823|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ITB||Intrathecal Baclofen (ITB) Delivery Location and Its Effect on Spasticity|Intrathecal Baclofen (ITB) Delivery Location and Its Effect on Spasticity|Recruiting||Phase 4|20|Anticipated|Vanderbilt University||1|||f||||f||||||||Undecided||2017-10-10 21:48:28.1205|2017-10-10 21:48:28.1205
NCT02903810|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-10-11|||September 2016||2016-09-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy|A Phase I/II Study of Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB Chimeric Antigen Receptor T-Cells in Patients With Refractory or Recurrent CD19/22+ B-lineage Leukemia/Lymphoma|Recruiting||Phase 1/Phase 2|20|Anticipated|Xuzhou Medical University||1|||f||||f||||||||||2017-10-10 21:48:28.218525|2017-10-10 21:48:28.218525
NCT02903797|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Observational|||Irisin Hormone Levels in Endometrial Hyperplasia|The Relation Between Serum Irisin Hormone Level and Endometrial Hyperplasia|Recruiting||N/A|80|Anticipated|Kayseri Education and Research Hospital|||2||f||||||||||||||2017-10-10 21:48:28.312708|2017-10-10 21:48:28.312708
NCT02903784|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-16|||September 2012||2012-09-01|May 2011|2011-05-01|September 2016|Actual|2016-09-01|February 2015|Actual|2015-02-01||Interventional|BNL||Neural Basis of Language Processing|The Neural Basis of Language: A New Lighting. Study of Semantic Processing in MRI Mutimodale and Direct Electrical Stimulation|Completed||N/A|63|Actual|University Hospital, Montpellier||2|||f||||t||||||||Undecided||2017-10-10 21:48:28.403553|2017-10-10 21:48:28.403553
NCT02903771|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-06-19|||November 2016||2016-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.|Phase I Study of Intra-peritoneal Cantrixil in Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.|Recruiting||Phase 1|60|Anticipated|Novogen Ltd||1|||f||||t||||||||No||2017-10-10 21:48:28.499706|2017-10-10 21:48:28.499706
NCT02903758|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||January 2000||2000-01-01|September 2016|2016-09-01|December 2008|Actual|2008-12-01|January 2000|Actual|2000-01-01||Observational|MixMal||Frequency and Distribution of Mixed Falciparum-vivax Infections in French Guiana||Completed||N/A|400|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||Samples Without DNA|"     malaria parasites   "|No||2017-10-10 21:48:28.618466|2017-10-10 21:48:28.618466
NCT02903745|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||January 2011||2011-01-01|September 2016|2016-09-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Observational|CAPADO||Knowledge Attitudes Beliefs and Practices Regarding HIV Among Teenagers in French Guiana||Completed||N/A|1603|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||||||2017-10-10 21:48:28.67711|2017-10-10 21:48:28.67711
NCT02903732|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||September 2015||2015-09-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|September 2015|Actual|2015-09-01|10 Years|Observational [Patient Registry]|REGUYAUT||Autism Registry for French Guiana|Autism Registry for French Guiana|Recruiting||N/A|400|Anticipated|Centre Hospitalier de Cayenne|||1||f||||f||||||||||2017-10-10 21:48:28.729439|2017-10-10 21:48:28.729439
NCT02903719|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effect of Phrenic Nerve Block on Postoperative Shoulder Pain in Patients for Liver Resection.|The Effect of Phrenic Nerve Block on Postoperative Shoulder Pain in Patients for Liver Resection - a Double Blinded Randomised Controlled Trial.|Recruiting||Phase 4|30|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-10 21:48:28.787997|2017-10-10 21:48:28.787997
NCT02894749|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-05-18|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|EVAR||Evaluation of 3D Rotational Angiography After EVAR|Evaluation of 3D Rotational Angiography After EVAR|Not yet recruiting||N/A|60|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:49:53.324301|2017-10-10 21:49:53.324301
NCT02903706|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-13|||October 2014||2014-10-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|ORPAL||Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French Guiana|Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French Guiana|Completed||N/A|421|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||Samples Without DNA|"     blood sample (5 ml) for Plasmodium PCR   "|||2017-10-10 21:48:28.897898|2017-10-10 21:48:28.897898
NCT02903693|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||September 2012||2012-09-01|September 2016|2016-09-01|June 2013|Actual|2013-06-01|September 2012|Actual|2012-09-01||Observational|DepCol||Cervical Cancer in French Guiana: Screening Between 2006-2011|Cervical Cancer in French Guiana: Screening Between 2006-2011. Description of the Population With Invasive Cervical Cancer Between 2003-2008|Completed||N/A|91458|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||||||2017-10-10 21:48:28.951546|2017-10-10 21:48:28.951546
NCT02903680|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-06|||May 2014||2014-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||RCT of IV Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Paediatric ED|Randomised Controlled Trial of Intravenous Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Pediatric Emergency Department|Recruiting||Phase 1|116|Anticipated|St. Justine's Hospital||2|||f||||t||||||||No||2017-10-10 21:48:29.013151|2017-10-10 21:48:29.013151
NCT02903667|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-12|||March 2015||2015-03-01|September 2016|2016-09-01|March 2021|Anticipated|2021-03-01|November 2016|Anticipated|2016-11-01||Interventional|Biomaterial||Biomaterial to Counteract Ridge Reduction Following the Removal of Multiple Adjacent Teeth.|Biomaterial to Counteract Ridge Reduction Following the Removal of Multiple Adjacent Teeth. A Prospective Randomized Controlled Study.|Recruiting||Phase 2|40|Anticipated|Institute Franci||2|||f||||f||||||||Undecided||2017-10-10 21:48:29.172934|2017-10-10 21:48:29.172934
NCT02903654|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||April 2014||2014-04-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|May 2014|Actual|2014-05-01||Observational|DEPIPOMP2||Prevalence of Heterozygote Mothers for Pompe's Disease Among Mothers Having Delivered in French Guiana|Prevalence of Heterozygote Mothers for Pompe's Disease Among Mothers Having Delivered in French Guiana|Completed||N/A|925|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||Samples With DNA|"     filter paper   "|||2017-10-10 21:48:29.259887|2017-10-10 21:48:29.259887
NCT02903641|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-02-25|||July 2016||2016-07-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Money or Knowledge? Behavioral Aspects of Malnutrition|Money or Knowledge? Behavioral Aspects of Malnutrition|Completed||N/A|506|Actual|Harvard School of Public Health||4|||f||||f||||||||||2017-10-10 21:48:29.314908|2017-10-10 21:48:29.314908
NCT02903628|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-12|||June 2012||2012-06-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||The Model Building and Empirical Research of Eye Health Interventions for Children|Vice-president, Nurse, Principal Investigator|Completed||N/A|1517|Actual|Wenzhou Medical University||1|||f||||t||||||||Undecided||2017-10-10 21:48:29.388728|2017-10-10 21:48:29.388728
NCT02903615|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-11-07|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Optimising Health in Type 1 Diabetes|The Optimal Diet for Optimising Health in Type 1 Diabetes|Recruiting||N/A|20|Anticipated|Garvan Institute of Medical Research||2|||f||||f||||||||Undecided||2017-10-10 21:48:29.466902|2017-10-10 21:48:29.466902
NCT02903602|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-15|||October 2010||2010-10-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Sharing Histories: Test of a Teaching Method for Community Health Workers|"Health in the Hands of Women: Test of a Community Health Worker Teaching Method Sharing Histories"|Completed||N/A|600|Actual|Future Generations Graduate School||2|||f||||f||||||||Yes|Data set available to researchers by contacting Principal Investigator|2017-10-10 21:48:29.55446|2017-10-10 21:48:29.55446
NCT02903589|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||January 2012||2012-01-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Observational|CAPMARONI||Knowledge Attitudes, Beliefs, and Practices Regarding HIV in Populations Living on the Maroni River||Completed||N/A|836|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||||||2017-10-10 21:48:29.627686|2017-10-10 21:48:29.627686
NCT02903576|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-08|||August 2015||2015-08-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Stem Cell Therapy for Outer Retinal Degenerations|Stem Cell Derived Retinal Pigmented Epithelium Implantation in Patients With Outer Retinal Degenerations: Phase I/II Clinical Trial|Recruiting||Phase 1/Phase 2|18|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 21:48:29.684505|2017-10-10 21:48:29.684505
NCT02903563|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-13|||January 2009||2009-01-01|September 2016|2016-09-01|December 2010|Actual|2010-12-01|January 2009|Actual|2009-01-01||Observational|CAPProstit||Knowledge Attitudes Beliefs and Practices Relative to HIV Among Sex Workers in French Guiana||Completed||N/A|256|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||||No||2017-10-10 21:48:29.760722|2017-10-10 21:48:29.760722
NCT02903550|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||August 2015||2015-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Usefulness of Non EPI-DWI-MRI / CT 3D Static Co-registration Prior to Surgery of Cholesteatomas|Usefulness of Non EPI-DWI-MRI / CT 3D Static Co-registration Prior to Surgery of Cholesteatomas|Recruiting||N/A|20|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||Undecided||2017-10-10 21:48:29.812292|2017-10-10 21:48:29.812292
NCT02903537|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|TOLERVIT-MS||Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)|Tolerance-Induction With Dendritic Cells Treated With Vitamin-D3 and Loaded With Myelin Peptides, in Multiple Sclerosis Patients (TOLERVIT-MS)|Not yet recruiting||Phase 1|16|Anticipated|Fundació Institut Germans Trias i Pujol||4|||f||||t||||||||Undecided||2017-10-10 21:48:29.874022|2017-10-10 21:48:29.874022
NCT02903524|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer|The Efficacy and Safety of Doxorubicin Hydrochloride Liposome Injection Plus Cyclophosphamide Compared to Pirarubicin Plus Cyclophosphamide as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer ：a Randomised Multicentre, Open-label Trial|Recruiting||Phase 4|300|Anticipated|Hebei Medical University Fourth Hospital||2|||f||||f||||||||||2017-10-10 21:48:31.656032|2017-10-10 21:48:31.656032
NCT02903511|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-07-17|||November 2016||2016-11-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Feasibility Study of Metformin Therapy in ADPKD|Feasibility Study of Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease.|Recruiting||Phase 2|50|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 21:48:31.731302|2017-10-10 21:48:31.731302
NCT02903498|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-10-11|||August 2009||2009-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||The Maintenance Treatment of UFT in Advanced Gastric Cancer|Phase II Study of the Maintenance Treatment of UFT (Uracil and Tegafur) After First-line|Completed||Phase 2|58|Actual|Fudan University||2|||f||||f||||||||||2017-10-10 21:48:31.827001|2017-10-10 21:48:31.827001
NCT02903485|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-02-03|||December 2015||2015-12-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CATARIDE||Bypassing Anesthesiologist Assessment Before Cataract Surgery: a Non Inferiority Study||Recruiting||N/A|900|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 21:48:31.90808|2017-10-10 21:48:31.90808
NCT02903459|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-11-17|||June 2016||2016-06-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|October 2016|Actual|2016-10-01||Observational|||Analyze the Relationship Between the Density of Fat Tissue and Cellulite With the Lumbar Lordosis Degree|Analyze the Relationship Between the Density of Abdominal Visceral and Subcutaneous Fat and Cellulite With the Lumbar|Recruiting||N/A|20|Anticipated|Escola Superior de Tecnologia da Saúde do Porto|||4||f||||t||||||||Undecided||2017-10-10 21:48:32.101699|2017-10-10 21:48:32.101699
NCT02903446|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-27|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions|Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions in Gout: A Pilot Study|Recruiting||Phase 2|20|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f|||f|||||2017-10-10 21:48:32.209858|2017-10-10 21:48:32.209858
NCT02903433|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-28|||April 20, 2017|Actual|2017-04-20|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Avocado Intake on the Nutritional Status of Families|Effects of Avocado Intake on the Nutritional Status of Families|Recruiting||N/A|70|Anticipated|University of California, San Diego||2|||f||||f|f|f||||||||2017-10-10 21:48:32.294318|2017-10-10 21:48:32.294318
NCT02903420|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-02-07|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|July 2022|Anticipated|2022-07-01|June 2018|Anticipated|2018-06-01||Interventional|||A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)|A Clinical Trial for Transcatheter Aortic Valve Implantation in Chronic Dialysis Patients With Aortic Valve Stenosis|Recruiting||Phase 3|30|Anticipated|Edwards Lifesciences||1|||f||||t||||||||Undecided||2017-10-10 21:48:32.399141|2017-10-10 21:48:32.399141
NCT02903407|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-10-02|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU|Pain, Agitation and Delirium Protocol in Ventilated Patients in the Duke CICU|Recruiting||Phase 4|250|Anticipated|Duke University||2|||f||||t|t|f|||t|||||2017-10-10 21:48:32.609161|2017-10-10 21:48:32.609161
NCT02903394|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-04-24|||October 27, 2016|Actual|2016-10-27|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Coherence Imaging of the Cervical Epithelium|Coherence Imaging of the Cervical Epithelium|Enrolling by invitation||N/A|100|Anticipated|Duke University||1|||f||||||||||||||2017-10-10 21:48:32.744178|2017-10-10 21:48:32.744178
NCT02903368|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-05-17|||October 2016||2016-10-01|May 2017|2017-05-01|March 2024|Anticipated|2024-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy|Phase II Randomized Study Of Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide For Intermediate-High Risk Prostate Cancer Undergoing Prostatectomy|Recruiting||Phase 2|120|Anticipated|Dana-Farber Cancer Institute||4|||f||||t||||||||No||2017-10-10 21:48:33.027597|2017-10-10 21:48:33.027597
NCT02903355|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-12-20|||September 2013||2013-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)|Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)|Terminated||Phase 3|266|Actual|Southern Illinois University||2|||f||||t||||||||No||2017-10-10 21:48:33.196584|2017-10-10 21:48:33.196584
NCT02903342|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-12-16|||June 2016||2016-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Fever and Febrile Support for Parents and Carers of Children 2016|Fever and Febrile Support for Parents and Carers of Children 2016|Completed||N/A|100|Actual|University College Cork||2|||f||||f||||||||No||2017-10-10 21:48:33.31412|2017-10-10 21:48:33.31412
NCT02903329|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-02-06|||September 2013||2013-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|MUM||Comparison of Two Detoxification Protocols for Treatment of Medication-overuse Headache|Efficacy of Restricted Acute Medication Intake Compared to no Acute Medication Intake During a Two Months Detoxification Period in Medication-overuse Headache|Recruiting||N/A|100|Anticipated|Danish Headache Center||2|||f||||f||||||||No||2017-10-10 21:48:33.405112|2017-10-10 21:48:33.405112
NCT02903316|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles|Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles and Investigation of a Novel Mini Fluid Challenge Ability to Predict Fluid Responsiveness|Recruiting||N/A|60|Anticipated|University of Aarhus|||1||f||||t||||||||No|No consent for sharing personal data.|2017-10-10 21:48:33.527787|2017-10-10 21:48:33.527787
NCT02903303|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Hypnosis as a Potentiation Technique for the Interventional Treatment of Chronic Lumbar Pain|Pilot Study : Hypnosis as a Potentiation Technique for the Interventional Treatment of Chronic Lumbar Pain|Not yet recruiting||N/A|8|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||No|Participant data will remain accessible only for the people working in this study. However, the results will be shown in the context of a master degree in medicine of Mr Florent Schroeter.|2017-10-10 21:48:33.630289|2017-10-10 21:48:33.630289
NCT02903290|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-08-10|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2017|Actual|2017-01-01||Interventional|||Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene|Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene|Recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 21:48:33.721568|2017-10-10 21:48:33.721568
NCT02903277|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-09-12|||November 2016||2016-11-01|August 2016|2016-08-01|November 2021|Anticipated|2021-11-01|November 2016|Anticipated|2016-11-01||Observational|||National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent|National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent|Not yet recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||||2017-10-10 21:48:33.811401|2017-10-10 21:48:33.811401
NCT02903264|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-12|||January 2007||2007-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Gestational Diabetes Mellitus, Obesity and Periodontal Disease|Gestational Diabetes Mellitus, Obesity and Periodontal Disease: a Cross Sectional Study|Completed||N/A|67|Actual|University of Sao Paulo|||2||f||||t||||||||No||2017-10-10 21:48:33.869973|2017-10-10 21:48:33.869973
NCT02903251|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-02-22|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Oxytocin and Alcohol Withdrawal and Dependence|Acute and Long-term Effects of Intranasal Oxytocin in Alcohol Withdrawal and Dependence: A Prospective Randomized Parallel Group Placebo-controlled Trial|Recruiting||Phase 3|40|Anticipated|Norwegian University of Science and Technology||2|||f||||t||||||||Undecided||2017-10-10 21:48:33.962321|2017-10-10 21:48:33.962321
NCT02903238|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-01-17|2016-09-27||July 2011||2011-07-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Brain Morphometry in OA Patients Treated With Duloxetine|Brain Morphometric Study in Knee Osteoarthritis Patients Treated With Duloxetine|Completed||N/A|21|Actual|Northwestern University||1|||f||||f||||||||Yes|The data will be available at http://OpenfMRI.org|2017-10-10 21:48:34.094239|2017-10-10 21:48:34.094239
NCT02903225|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-12|||April 2010||2010-04-01|September 2016|2016-09-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|REINCA||Clinical Value of Heart Rate Variability Indexes to Predict Outcomes After Exercise Training in Chronic Heart Failure|Clinical Value of Heart Rate Variability Indexes to Predict Outcomes After Exercise Training in Chronic Heart Failure|Completed||Phase 4|40|Actual|Universidad de la Republica||2|||f||||f||||||||No||2017-10-10 21:48:34.293123|2017-10-10 21:48:34.293123
NCT02903212|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-07-28|||March 2018|Anticipated|2018-03-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|APO-RA||Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis|Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis|Not yet recruiting||Phase 1/Phase 2|22|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t|f|f||||||||2017-10-10 21:48:34.370099|2017-10-10 21:48:34.370099
NCT02903199|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-09-12|||July 2015||2015-07-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|February 2016|Actual|2016-02-01||Interventional|||Whey Protein Effect on Glycaemic and Appetite Responses in T2D|The Effect of Pre-meal Whey Protein on Glycaemic and Appetite Responses in Type II Diabetic Males|Active, not recruiting||N/A|11|Actual|Northumbria University||3|||f||||f||||||||Undecided||2017-10-10 21:48:34.43505|2017-10-10 21:48:34.43505
NCT02903186|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SMS||Multi-site Trial Using SMS to Improve Infant Weight|Multi-site Trial Using Short Mobile Messages (SMS) to Improve Infant Weight in Low-income Minorities|Active, not recruiting||N/A|200|Anticipated|University of Puerto Rico||2|||f||||f||||||||Undecided||2017-10-10 21:48:34.639429|2017-10-10 21:48:34.639429
NCT02903173|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-10-02|||February 2015||2015-02-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||An Observational Study of Post-cesarean Delivery Respiratory Patterns Using a Non-invasive Minute Ventilation Monitor (Exspiron ™ System)|An Observational Study of Post-cesarean Delivery Respiratory Patterns Using a Non-invasive Minute Ventilation Monitor (Exspiron ™ System)|Recruiting||N/A|100|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 21:48:34.733396|2017-10-10 21:48:34.733396
NCT02903147|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-15|||June 2010||2010-06-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Efficacy of a Functional Meta-Cognitive Intervention to Improve Human Factors of Professional Drivers|The Efficacy of a Functional Meta-Cognitive Intervention to Improve Human Factors of Professional Drivers|Completed||N/A|77|Actual|Tel Aviv University||2|||f||||f||||||||Undecided||2017-10-10 21:48:34.96067|2017-10-10 21:48:34.96067
NCT02903134|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||September 2014||2014-09-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Early Risk of Asthma in Children Exposed to In-utero Maternal Obesity|Early Risk of Asthma in Children Exposed to In-utero Maternal Obesity: An Epigenetic-mediated Programming of Immune Function|Enrolling by invitation||N/A|240|Anticipated|Pontificia Universidad Catolica de Chile|||1||f||||f||||||Samples With DNA|"     Maternal blood sample, cord blood sample and skin prick test.   "|No||2017-10-10 21:48:35.046521|2017-10-10 21:48:35.046521
NCT02903121|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-05-06|||January 20, 2017|Actual|2017-01-20|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|Tamoxifen/BTB||Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users|Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users|Recruiting||Phase 2|100|Anticipated|Oregon Health and Science University||2|||f||||t|t|f|||f|||No||2017-10-10 21:48:35.108009|2017-10-10 21:48:35.108009
NCT02903108|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2016-09-15|||May 2015||2015-05-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis|Clinical Efficacy of Subgingivally Delivered 0.75% Boric Acid Gel As An Adjunct to Mechanotherapy in Chronic Periodontitis: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|39|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||||||||||||2017-10-10 21:48:35.22451|2017-10-10 21:48:35.22451
NCT02903095|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-07-25|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Single Ascending Dose Study of TD-1439 in Healthy Subjects|A Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−1439 in Healthy Subjects|Completed||Phase 1|66|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||||2017-10-10 21:48:35.315358|2017-10-10 21:48:35.315358
NCT02903082|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-07-17|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MDSC||Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?|Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?|Recruiting||N/A|60|Anticipated|University Hospital, Limoges|||2||f||||f||||||Samples With DNA|"     Residue of blood further to NFS for case      Bone marrow collected during myelogram routinely performed during hospitalization in ICU      Blood samples collected routinely as part of a preoperative workup for control      Bone marrow collected during a myelogram carried out for hematological pathology workup for     control   "|||2017-10-10 21:48:35.41587|2017-10-10 21:48:35.41587
NCT02903069|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-09-21|||August 2016||2016-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer|Phase 1b, Multicenter, Open-Label Study of Marizomib Combined With Temozolomide and Radiotherapy in Patients With Newly Diagnosed WHO Grade IV Malignant Glioma|Recruiting||Phase 1|60|Anticipated|Triphase Research and Development I Corporation||4|||f||||f||||||||||2017-10-10 21:48:35.529598|2017-10-10 21:48:35.529598
NCT02903056|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|1 Year|Observational [Patient Registry]|||The Findings of MR Imaging in Rett Syndrome|The Findings of Resting-state Functional Magnetic Resonance Imaging , Susceptibility Weighted Imaging and Diffusion Spectrum Imaging in Rett Syndrome|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||No||2017-10-10 21:48:35.708482|2017-10-10 21:48:35.708482
NCT02903043|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-05-09|||February 2013||2013-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|April 2015|Actual|2015-04-01|1 Day|Observational [Patient Registry]|||Expression of miR-204 and Consequences on Capillarization in Limb Muscles of Patients With COPD|Expression of miR-204 and Consequences on Capillarization in Limb Muscles of Patients With Chronic Obstructive Pulmonary Disease|Active, not recruiting||N/A|100|Anticipated|Laval University|||2||f||||f||||||Samples With DNA|"     Blood sample ad muscle biopsy of vastus lateralis (quadriceps)   "|Undecided||2017-10-10 21:48:35.805941|2017-10-10 21:48:35.805941
NCT02903030|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-01-09|||August 2016||2016-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Probiotics for Quality of Life in Autism Spectrum Disorders|Probiotics for Quality of Life in Autism Spectrum Disorders|Recruiting||Early Phase 1|12|Anticipated|Ohio State University||2|||f||||||||||||||2017-10-10 21:48:35.894886|2017-10-10 21:48:35.894886
NCT02903017|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage|Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage: A Double-Blind, Randomized, Placebo-Controlled Trial|Recruiting||Phase 4|114|Anticipated|Kocaeli University||2|||f||||t||||||||||2017-10-10 21:48:36.003571|2017-10-10 21:48:36.003571
NCT02903004|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-12|||April 2016||2016-04-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|Mito23||Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23|Randomized Phase III Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype patients_MITO-23|Recruiting||Phase 3|244|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||No||2017-10-10 21:48:36.142595|2017-10-10 21:48:36.142595
NCT02902991|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-12|||June 2016||2016-06-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||The Study on the Clinical Utility of Liquid Biopsy in Breast Cancer||Active, not recruiting||N/A|200|Anticipated|Peking Union Medical College|||1||f||||||||||Samples With DNA|"     Circulating tumor cells,circulating tumor DNA and other liquid biopsy biomarkers   "|||2017-10-10 21:48:36.280967|2017-10-10 21:48:36.280967
NCT02902978|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-29|||September 26, 2016|Actual|2016-09-26|September 2017|2017-09-01|April 26, 2017|Actual|2017-04-26|February 28, 2017|Actual|2017-02-28||Interventional|||A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects|A Phase 1 Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects|Completed||Phase 1|56|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-10 21:48:36.332278|2017-10-10 21:48:36.332278
NCT02902965|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-06-09|||September 2016||2016-09-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma|An Open-label Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma|Active, not recruiting||Phase 2|125|Anticipated|Pharmacyclics LLC.||1|||f||||f||||||||No||2017-10-10 21:48:36.417188|2017-10-10 21:48:36.417188
NCT02902952|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-06-01|||October 2016||2016-10-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|PETRA||Physical Exercise to Reduce Anxiety in Underserved Children With ASD|Physical Exercise to Reduce Anxiety in Underserved Children With Autism Spectrum Disorders|Recruiting||N/A|60|Anticipated|University of California, Irvine||2|||f||||t||||||||Undecided||2017-10-10 21:48:36.59118|2017-10-10 21:48:36.59118
NCT02902939|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-24|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|MyDeCCS||Myeloid-Derived Supressor Cells in Cardiac Surgery Patients|Myeloid-Derived Supressor Cells in Uncomplicated vs Complicated Patients After Cardiac Surgery|Recruiting||Phase 4|100|Anticipated|Research Institute for Complex Problems of Cardiovascular Diseases, Russia||2|||f||||f||||||||No||2017-10-10 21:48:36.675853|2017-10-10 21:48:36.675853
NCT02902926|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Microbiota and Quality of Life for a Low FODMAPs and Standard Dietary in Irritable Bowel Syndrome Patients|Comparison of Microbiota and Quality of Life for a Low FODMAPs Versus Standard Dietary Advice in Patients With Irritable Bowel Syndrome|Recruiting||N/A|120|Anticipated|Yangzhou University||2|||f||||t||||||||No||2017-10-10 21:48:36.771039|2017-10-10 21:48:36.771039
NCT02902913|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-12|||January 2015||2015-01-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity|Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity in Healthy Humans|Completed||N/A|9|Actual|University of California, Davis||4|||f||||f||||||||No||2017-10-10 21:48:36.867937|2017-10-10 21:48:36.867937
NCT02902900|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-05|||September 25, 2015|Actual|2015-09-25|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|MIROIR||An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice|Observational Cohort Study Evaluating the Use and Efficacy of Pomalidomide in Patients With Multiple Myeloma in Routine Clinical Practice|Recruiting||N/A|3000|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 21:48:36.979769|2017-10-10 21:48:36.979769
NCT02902887|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-10-12|||August 2016||2016-08-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Monitored Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia|A Clinical Trial of Observation Versus Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia|Recruiting||N/A|60|Anticipated|Salus University||2|||f||||f||||||||No||2017-10-10 21:48:37.435877|2017-10-10 21:48:37.435877
NCT02902874|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-01-25|||April 2010||2010-04-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|Immuno ALCL||Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +|Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +|Recruiting||N/A|250|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||No||2017-10-10 21:48:37.540073|2017-10-10 21:48:37.540073
NCT02902861|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-09-15|||February 2013||2013-02-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|September 2014|Actual|2014-09-01||Interventional|METOP||Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)|An International Prospective, Double-blind, Placebo-controlled Phase III Randomised Controlled Trial (RCT) in Patients With Moderate to Severe Psoriasis Are Treated With Subcutaneous (s.c.) Methotrexate Using an Optimized Treatment Schedule.|Completed||Phase 3|120|Actual|Sciderm GmbH||2|||f||||f||||||||No||2017-10-10 21:48:37.669973|2017-10-10 21:48:37.669973
NCT02902848|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||March 2015||2015-03-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Observational|COAGHEMO||Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow||Recruiting||N/A|30|Anticipated|University Hospital, Brest|||1||f||||||||||||||2017-10-10 21:48:37.781502|2017-10-10 21:48:37.781502
NCT02902835|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|BUPFAST||BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3|BUPrenorphine Facilitated Access and Supportive Treatment--AIM 3|Not yet recruiting||N/A|72|Anticipated|Montefiore Medical Center||2|||f||||f||||||||No||2017-10-10 21:48:37.847458|2017-10-10 21:48:37.847458
NCT02902822|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-11-08|||October 2016||2016-10-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo|Tele-dermatology of Skin Cancer: a Randomized Trial Comparing Remote Assessment With Conventional Visits in a Cohort of Local Health Authority Employees in the Province of Bergamo (the Shoot the Mole Study)|Recruiting||Phase 2|500|Anticipated|Centro Studi Gised||2|||f||||f||||||||||2017-10-10 21:48:37.947353|2017-10-10 21:48:37.947353
NCT02902809|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-28|||November 11, 2016|Actual|2016-11-11|September 2017|2017-09-01|May 9, 2018|Anticipated|2018-05-09|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma|A 52-Week, Open-Label, Multicentre Study to Evaluate the Safety of Tralokinumab in Japanese Adults and Adolescents With Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist|Active, not recruiting||Phase 3|28|Actual|AstraZeneca||1|||f||||f|f|f||||||||2017-10-10 21:48:38.053144|2017-10-10 21:48:38.053144
NCT02902796|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of 1000 Hertz (Hz), Burst, and Standard Spinal Cord Stimulation in Chronic Pain Relief|Randomized Controlled Cross Over Study to Compare the Efficacy of 1000 Hertz (Hz), Burst, and Standard Spinal Cord Stimulation in Chronic Axial Pain Relief|Recruiting||Phase 4|22|Anticipated|The Center for Clinical Research, Winston-Salem, NC||2|||f||||f||||||||No|No individual data will be shared. Only the pooled data will be shared with public and at the scientific meetings.|2017-10-10 21:48:38.152388|2017-10-10 21:48:38.152388
NCT02902783|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|DONATE-Pilot||DONATE-Pilot Study on ICU Management of Deceased Organ Donors|DONATE-Pilot Study: Prospective Observational Study of the ICU Management of Deceased Organ Donors|Recruiting||N/A|135|Anticipated|McMaster University|||1||f||||f||||||||No||2017-10-10 21:48:38.257643|2017-10-10 21:48:38.257643
NCT02902770|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-09-29|||October 2016||2016-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Intravenous Lidocaine and Ketorolac for Pain Management|A Randomized Trial Comparing the Combination of Intravenous Lidocaine and Ketorolac to Either Analgesics Alone for ED Patients With Acute Renal Colic|Enrolling by invitation||Phase 4|300|Anticipated|Maimonides Medical Center||3|||f||||f||||||||||2017-10-10 21:48:38.353936|2017-10-10 21:48:38.353936
NCT02902757|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-12|||August 25, 2015|Actual|2015-08-25|September 2017|2017-09-01|August 25, 2022|Anticipated|2022-08-25|August 25, 2021|Anticipated|2021-08-25||Interventional|||FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma|Very Early Response Monitoring in Patients With Glioblastoma Undergoing Therapy Using FDG PET/CT|Recruiting||N/A|50|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 21:48:38.461478|2017-10-10 21:48:38.461478
NCT02902744|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-08-21|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Interventional|FAD||Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study|Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study|Withdrawn||Phase 4|0|Actual|Johns Hopkins University||1||"The study was withdrawn due to difficult recruitment of patients for the study; No participants   were enrolled in the study."|f||||f|t|f|||f|||||2017-10-10 21:48:38.569985|2017-10-10 21:48:38.569985
NCT02902731|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-09-12|||November 2016||2016-11-01|September 2016|2016-09-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|GiAnT||Giant Cell Arteritis and Anakinra Trial|Randomized, Controlled, Double-blind Study of Anakinra Against Placebo in Addition to Steroids in Giant Cell Arteritis|Not yet recruiting||Phase 3|70|Anticipated|University Hospital, Caen||2|||f||||t||||||||Undecided|It will be planify|2017-10-10 21:48:38.659919|2017-10-10 21:48:38.659919
NCT02902718|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-02-28|||February 28, 2017|Actual|2017-02-28|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|SR3-Me||MĒ Device for At-Home Skin Rejuvenation|Evaluation of the Safety and Efficacy of the Mē Device for At-Home Skin Rejuvenation Treatment - A Pilot Study|Recruiting||N/A|10|Anticipated|Iluminage Ltd.||1|||f||||t|f|t|f||f|||No||2017-10-10 21:48:38.761223|2017-10-10 21:48:38.761223
NCT02902705|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||September 2009||2009-09-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|MODAIR||Adipose Tissue & Uremia|Morphological and Functional Changes in White Adipose Tissue in Nondiabetic Chronic Kidney Disease Patients|Completed||N/A|23|Actual|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 21:48:38.852032|2017-10-10 21:48:38.852032
NCT02902692|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-12|||April 2016||2016-04-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Mindfulness for Older Adults With Cognitive Concerns|Examining the Effects of a Brief Mindfulness Based Intervention (BMBI) on Mood and Cognitive Functioning in an Older Adult Population|Recruiting||N/A|90|Anticipated|King's College London||1|||f||||t||||||||No||2017-10-10 21:48:38.923181|2017-10-10 21:48:38.923181
NCT02902679|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-07-25|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment|An Open-label Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment|Completed||Phase 1|6|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 21:48:39.014964|2017-10-10 21:48:39.014964
NCT02902666|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-12|||April 2016||2016-04-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Bioequivalence Study of One Tablet of Paracetamol 1000 mg + Codeine 30 mg vs. Two Tablets of Paracetamol 500 mg + Codeine 30 mg|A Single Dose Bioequivalence Study of Test Product (One Tablet of Paracetamol 1000 mg + Codeine 30 mg, Manufactured by A.C.R.A.F. S.p.A.) vs. Two Tablets of the Reference Product (Paracetamol 500 mg + Codeine 30 mg) in Healthy Volunteers|Completed||Phase 1|46|Actual|Aziende Chimiche Riunite Angelini Francesco S.p.A||2|||f||||f||||||||No||2017-10-10 21:48:39.108442|2017-10-10 21:48:39.108442
NCT02902653|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-11-14|||September 2016||2016-09-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction|Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction: Randomized Clinical Trial|Recruiting||Phase 4|372|Anticipated|Basque Health Service||3|||f||||f||||||||||2017-10-10 21:48:39.184057|2017-10-10 21:48:39.184057
NCT02902640|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-05-16|||November 14, 2016|Actual|2016-11-14|May 2017|2017-05-01|June 24, 2017|Anticipated|2017-06-24|June 24, 2017|Anticipated|2017-06-24||Observational|||An Observational Study to Assess Safety of Sulfamethoxazole + Trimethoprim + Guaifenesin (Balsamic Bactrim) in Adult Participants With Acute Bronchitis|A Pilot, Multicentric and Observational Study of Safety of Sulfamethoxazole + Trimethoprim + Guaifenesin (Balsamic Bactrim) in Adult Patients With Acute Bronchitis|Recruiting||N/A|50|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 21:48:39.282834|2017-10-10 21:48:39.282834
NCT02902627|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-01-25|||August 2012||2012-08-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|August 2016|Actual|2016-08-01||Interventional|ANIONCO||Pain in Oncolgy: Evaluation of a Non Invasive Monitoring Device (ANI). A Monocentric Prospective Study|Pain in Oncolgy: Evaluation of a Non Invasive Monitoring Device (ANI). A Monocentric Prospective Study|Active, not recruiting||N/A|80|Actual|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:48:39.373333|2017-10-10 21:48:39.373333
NCT02902614|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-12|||January 2015||2015-01-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Side of Embryo Biopsy Interfering Implantation Potential|Effect of Embryo Biopsy Side on Post Biopsy Blastocyst Structurs and Implantation|Active, not recruiting||N/A|100|Actual|Al Baraka Fertility Hospital||2|||f||||t||||||||Yes|After abstract submission or after final approval for scientific paper|2017-10-10 21:48:39.441838|2017-10-10 21:48:39.441838
NCT02902601|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-06-27|||October 17, 2016|Actual|2016-10-17|June 2017|2017-06-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Subjects With Major Depressive Disorder|Completed||Phase 1|70|Actual|Janssen Research & Development, LLC||3|||f||||f||f||||||||2017-10-10 21:48:39.539088|2017-10-10 21:48:39.539088
NCT02902588|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-05-22|||August 1, 2015|Actual|2015-08-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|NM-BBBP||Blood-brain Barrier Permeability Study in Adults With Meningitis|The Use of Near Infrared Spectroscopy and Magnetic Resonance Imaging Technique in the Evaluation of the Permeability of Blood-brain Barrier in Adults With Meningitis|Recruiting||N/A|40|Anticipated|Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences||3|||f||||f||||||||Undecided||2017-10-10 21:48:39.641026|2017-10-10 21:48:39.641026
NCT02902575|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-11|||September 2016||2016-09-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant Chemotherapy||Enrolling by invitation||Phase 2|80|Anticipated|Fujian Medical University||1|||f||||t||||||||||2017-10-10 21:48:39.729238|2017-10-10 21:48:39.729238
NCT02902562|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-09|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CEUS||Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound|Quantitative Assessment of Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound|Not yet recruiting||Early Phase 1|25|Anticipated|University of Southern California||1|||f||||f||||||||Undecided||2017-10-10 21:48:39.802045|2017-10-10 21:48:39.802045
NCT02902549|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-09-12|||October 2015||2015-10-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Observational|||Real-time Quantitative Optical Perfusion Imaging in Surgery|Real-time Quantitative Optical Perfusion Imaging in Surgery: a Prospective, Observational, In-vivo, Human, Single-center Study|Recruiting||N/A|40|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-10 21:48:39.875907|2017-10-10 21:48:39.875907
NCT02902536|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-03-06|||August 2015|Actual|2015-08-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|||Tissue Repository for Studies of Myasthenia Gravis|Tissue Repository for Studies of Myasthenia Gravis|Active, not recruiting||N/A|300|Anticipated|Johns Hopkins University|||3||f||||t||||||Samples With DNA|"     We will collect patient blood.   "|No||2017-10-10 21:48:39.953363|2017-10-10 21:48:39.953363
NCT02902523|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01||||October 2016|Anticipated|2016-10-01||Interventional|||Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers||Not yet recruiting||Phase 1|50|Anticipated|Huons Co.,Ltd.||2|||f||||||||||||||2017-10-10 21:48:40.022888|2017-10-10 21:48:40.022888
NCT02902510|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-14|||April 2015||2015-04-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Therapeutic Yoga to Improve Function in Parkinson's Disease|Therapeutic Yoga to Improve Function in Parkinson's Disease|Completed||N/A|30|Actual|Clemson University||2|||f||||f||||||||No||2017-10-10 21:48:40.121416|2017-10-10 21:48:40.121416
NCT02902497|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-09-14|||March 2014||2014-03-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Observational|||Impact of the Surgical Experience on Cochleostomy Location: A Comparative Temporal Bone Study Between Endaural and Posterior Tympanotomy Approaches for Cochlear Implantation|Impact of the Surgical Experience on Cochleostomy Location: A Comparative Temporal Bone Study Between Endaural and Posterior Tympanotomy Approaches for Cochlear Implantation|Completed||N/A|24|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 21:48:40.190378|2017-10-10 21:48:40.190378
NCT02902484|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-11-22|||January 2017||2017-01-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer|A Phase 1b and Pharmacodynamic Study of Nintedanib Monotherapy for Advanced Pancreatic Cancer|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:48:40.34223|2017-10-10 21:48:40.34223
NCT02902471|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-04-19|||June 2011||2011-06-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|OSCILLOMOELL||Forced Oscillations for Diagnosis Help in Bronchiolitis Obliterans Syndrome in Post Bone Marrow Transplantation|Functional Evaluation of Distal Airways by Forced Oscillations: Diagnosis Help in Bronchiolitis Obliterans Syndrome in Post Bone Marrow Transplantation|Completed||N/A|110|Actual|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:48:40.434104|2017-10-10 21:48:40.434104
NCT02902458|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-12|||September 2014||2014-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|PEACE||Psychological Intervention modifiEs Outcome of Patients With implAntable Cardioverter dEfibrillator: The PEACE Study|Psychological Intervention modifiEs Outcome of Patients With implAntable Cardioverter dEfibrillator: The PEACE Study|Completed||N/A|18|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||No||2017-10-10 21:48:40.528933|2017-10-10 21:48:40.528933
NCT02902445|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|Gastrovimc||Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)|Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation) Evaluation of Individual Genetic Susceptibility in Severe Gastro-enteritis Rotavirus: Role of HBGA Polymorphisms & Biotechnology Improvement of RVA Vaccines|Not yet recruiting||N/A|800|Anticipated|Nantes University Hospital|||2||f||||f||||||Samples With DNA|"     Oral swab   "|Undecided||2017-10-10 21:48:40.631634|2017-10-10 21:48:40.631634
NCT02902432|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-03-28|||June 2016||2016-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Trial of Endostar in Patients With Carcinoma of the Head and Neck||Recruiting||Phase 2|24|Anticipated|China International Medical Foundation||2|||f||||f||||||||Undecided||2017-10-10 21:48:40.710406|2017-10-10 21:48:40.710406
NCT02902419|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-14|||August 2011||2011-08-01|September 2016|2016-09-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of Timing of Removal of Wound Dressing on Surgical Site Infection Rate After Cesarean Delivery|The Effect of Timing of Removal of Wound Dressing on Surgical Site Infection Rate After Cesarean Delivery|Completed||N/A|602|Actual|Albany Medical College||2|||f||||f||||||||No||2017-10-10 21:48:40.803088|2017-10-10 21:48:40.803088
NCT02902406|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01||||April 2018|Anticipated|2018-04-01||Observational|||Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study|Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study|Recruiting||N/A|300|Anticipated|National Taiwan University Hospital|||2||f||||||||||||||2017-10-10 21:48:40.895118|2017-10-10 21:48:40.895118
NCT02902393|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-14|||July 2016||2016-07-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|ROTEMPredict||Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke|Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke|Recruiting||N/A|64|Anticipated|University Hospital, Caen|||1||f||||||||||||||2017-10-10 21:48:40.961889|2017-10-10 21:48:40.961889
NCT02902380|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-11|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery||Recruiting||N/A|52|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 21:48:41.054687|2017-10-10 21:48:41.054687
NCT02902367|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2017-09-17|||November 2016||2016-11-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|SMS/TIA||Sms-guided Training After Acute Stroke or Transient Ischemic Attack - a Randomized Controlled Trial|Effects of Sms-guided Outdoor Walking and Strength Training After Acute Stroke and TIA - a Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Uppsala County Council, Sweden||2|||f||||f||||||||||2017-10-10 21:48:41.14545|2017-10-10 21:48:41.14545
NCT02902354|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-03-03|||September 2016||2016-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Changes in Central Arterial Pressure of Normotensive Women Taking Nifedipine for Tocolysis|Changes in Central Arterial Pressure of Normotensive Women Taking Nifedipine for Tocolysis|Withdrawn||N/A|0|Actual|St. Louis University||1|||f||||f||||||||No||2017-10-10 21:48:41.245974|2017-10-10 21:48:41.245974
NCT02902341|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-09-15|||January 2013||2013-01-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The CoCoS Interventional Trial: Caloric Control in Cardiac Surgery Patients|The CoCoS Interventional Trial: Caloric Control in Cardiac Surgery Patients|Completed||N/A|351|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||Yes|Publication without revealing patient ID's.|2017-10-10 21:48:41.311465|2017-10-10 21:48:41.311465
NCT02902328|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Accuracy Evaluation for SIS Software-based Visualization of Anatomical Brain Structures|Accuracy Evaluation for Software-based Visualization of Anatomical Brain Structures Using Surgical Information Sciences Inc. Algorithms|Completed||N/A|30|Actual|Surgical Information Sciences Inc.|||1||f||||f||||||||No||2017-10-10 21:48:41.407995|2017-10-10 21:48:41.407995
NCT02902315|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-07-12|||January 4, 2017|Actual|2017-01-04|July 2017|2017-07-01|July 12, 2017|Actual|2017-07-12|July 10, 2017|Actual|2017-07-10||Interventional|||Antioxidants Combined With Cryotherapy on Inflammatory Response After Resistance Exercise in Untrained Volunteers|Vitamins C and E Combined With Cryotherapy on the Pain, Oxidative Stress and Inflammatory Response After Resistance Exercise Session in Untrained Volunteers|Completed||N/A|26|Actual|Universidade Federal de Santa Maria||4|||f||||f||||||||||2017-10-10 21:48:41.469018|2017-10-10 21:48:41.469018
NCT02902302|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-12|||May 2016||2016-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet|Bioequivalence Study of a New Formulation of Ibuprofen 400 mg/10 mL Oral Suspension vs. the Reference Product MOMENTACT 400 mg Film-coated Tablet in Healthy Volunteers|Completed||Phase 1|60|Actual|Aziende Chimiche Riunite Angelini Francesco S.p.A||2|||f||||f||||||||No||2017-10-10 21:48:41.606785|2017-10-10 21:48:41.606785
NCT02902289|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-12|||June 2016||2016-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet|Bioequivalence Study of a New Formulation of Ibuprofen 200 mg/5 mL Oral Suspension vs. the Reference Product MOMENT 200 mg Coated Tablet in Healthy Volunteers|Completed||Phase 1|60|Actual|Aziende Chimiche Riunite Angelini Francesco S.p.A||2|||f||||f||||||||No||2017-10-10 21:48:41.70859|2017-10-10 21:48:41.70859
NCT02902276|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-14|||July 2016||2016-07-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|CITRANS||Link Between Plasma Citrulline and Lipopolysaccharide Concentrations in the Critically Ill|Link Between Plasma Citrulline and Lipopolysaccharide Concentrations in the Critically Ill|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||Samples Without DNA|"     2000 microliters of plasma will be stored at -80°C for future analyses (lipopolysaccharide     concentration, cytokines).   "|No||2017-10-10 21:48:41.802765|2017-10-10 21:48:41.802765
NCT02902263|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-12|||January 2014||2014-01-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Observational|TRATT||Inter-Hospital Transfer to a Vascular Neurology Unit After Telethrombolysis|Inter-Hospital Transfer to a Vascular Neurology Unit After Telethrombolysis in France Comté|Completed||N/A|79|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||t||||||||Undecided||2017-10-10 21:48:41.884451|2017-10-10 21:48:41.884451
NCT02902250|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2017-07-23|||June 8, 2017|Actual|2017-06-08|July 2017|2017-07-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||The Comparative Study About the Effect of Vertebral Body Decompression Procedure|The Comparative Study About the Effect of Vertebral Body Decompression Procedure and Conservative Treatment for Benign Vertebral Compression Fracture - Prospective Randomized Control Study|Recruiting||N/A|80|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:48:41.984398|2017-10-10 21:48:41.984398
NCT02902237|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-09-08|||March 1, 2017|Actual|2017-03-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||tTF-NGR Study Phase I|Phase I Study of tTF-NGR in Patients With Recurrent or Refractory Malignant Tumors and Lymphomas Beyond All Standard Treatments|Recruiting||Phase 1|20|Anticipated|University Hospital Muenster||1|||f||||t|f|f||||||||2017-10-10 21:48:42.118173|2017-10-10 21:48:42.118173
NCT02902224|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||April 2014||2014-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Glucose and Fructose Stimulated Brain Activity in Obese Subjects Before and After Bariatric Surgery|Glucose and Fructose Stimulated Brain Activity in Obese Subjects Before and After Bariatric Surgery|Completed||N/A|15|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||Undecided||2017-10-10 21:48:42.198851|2017-10-10 21:48:42.198851
NCT02902211|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-27|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Improving Mobility in Peripheral Artery Disease Using an Ankle Foot Orthosis|Improving Mobility in Peripheral Artery Disease Using an Ankle Foot Orthosis|Recruiting||N/A|50|Anticipated|University of Nebraska||2|||f||||f|f|t|f|f||||||2017-10-10 21:48:42.271782|2017-10-10 21:48:42.271782
NCT02902198|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-08-30|||December 2014||2014-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Taste Physiology in Obese Volunteers Before and After Bariatric Surgery|Taste Physiology in Obese Volunteers Before and After Bariatric Surgery|Recruiting||N/A|16|Anticipated|University Hospital, Basel, Switzerland||8|||f||||f||||||||||2017-10-10 21:48:42.357784|2017-10-10 21:48:42.357784
NCT02902172|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-08-29|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||NSAID Use in Postpartum Hypertensive Women|NSAID Use in Postpartum Hypertensive Women|Enrolling by invitation||Early Phase 1|1800|Anticipated|St. Louis University||2|||f||||f|t|f|||f|||||2017-10-10 21:48:42.537004|2017-10-10 21:48:42.537004
NCT02902159|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-02|||September 2016||2016-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|REBOOT||RCT of the Effectiveness of Big White Wall Compared to Other Online Support|Randomised Controlled Trial of an Established Direct to Public Peer Support and E-therapy Programme (Big White Wall) Versus Information to Aid Self-management of Depression and Anxiety.|Recruiting||N/A|2200|Anticipated|University of Nottingham||2|||f||||t||||||||No||2017-10-10 21:48:42.621119|2017-10-10 21:48:42.621119
NCT02902146|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-25|||September 2016||2016-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|BEAM||Bougie Use in Emergency Airway Management|Bougie Use in Emergency Airway Management|Recruiting||N/A|374|Anticipated|Minneapolis Medical Research Foundation||2|||f||||t||||||||||2017-10-10 21:48:42.718549|2017-10-10 21:48:42.718549
NCT02902133|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-31|||September 2016||2016-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Acetazolamide to Prevent Post Operative CSF Leak|Pilot Study of Acetazolamide to Prevent Post Operative Cerebrospinal Fluid (CSF) Leak in Patients Undergoing Endoscopic Skull Base Surgery|Recruiting||N/A|12|Anticipated|University of Miami||1|||f||||f||||||||||2017-10-10 21:48:42.805834|2017-10-10 21:48:42.805834
NCT02902120|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-05-13|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant|Host Mechanisms Involved in Achieving SVR Using Grazoprevir and Elbasvir in Treatment of Chronic Hepatitis C in Patients With CKD Before and After Renal Transplantation|Recruiting||Phase 4|50|Anticipated|University of Maryland||2|||f||||t|t|f||||||Undecided||2017-10-10 21:48:42.889741|2017-10-10 21:48:42.889741
NCT02902107|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-05|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet|A Pilot Feasibility Trial of Unidirectional Low Dose Rate Brachytherapy for Patients With Abdominal and Pelvic Malignancy Undergoing Surgical Resection Requiring Intraoperative Radiation Therapy|Recruiting||Phase 1|10|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:48:43.005691|2017-10-10 21:48:43.005691
NCT02902094|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-09-09|||January 2016||2016-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|DeVA||Drug Eluting Balloon Venoplasty in AV Fistula Stenosis|Improving Outcomes in Fistula Intervention: A Prospective, Patient Blinded, Phase 3, Randomised Controlled Trial of Drug Eluting Balloons in the Angioplasty of Native Haemodialysis Access Arteriovenous Fistula Outflow Stenosis (DeVA)|Recruiting||N/A|186|Anticipated|University Hospital Birmingham||2|||f||||t||||||||No||2017-10-10 21:48:43.12708|2017-10-10 21:48:43.12708
NCT02902081|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-30|||February 2013||2013-02-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|CAS||Cannabidiol and Emotional Stimuli|Effects of Cannabidiol on Responses to Emotional Stimuli|Completed||N/A|38|Actual|University of Chicago||4|||f||||||||||||||2017-10-10 21:48:43.23156|2017-10-10 21:48:43.23156
NCT02902068|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-09-11|||May 2016||2016-05-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Hemodynamic Monitoring in Women Throughout Cesarean Sections|Maternal Hemodynamic Monitoring in Women Undergoing Cesarean Section by Use of NICaS Cardiac Impedance|Recruiting||N/A|200|Anticipated|Rabin Medical Center|||1||f||||f||||||||Undecided|"In this study the investigators would like to monitor cardiac output by the use of NICaS bioimpedance in women undergoing cesarean section delivery.
This study is a purely observational study, it will not have any clinical intervention nor will it interfere with standard cesarean delivery protocols in any way."|2017-10-10 21:48:43.312943|2017-10-10 21:48:43.312943
NCT02902055|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-02|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|PAN||Paediatric Ards Neuromuscular Blockade Study|Life-threatening Acute Respiratory Failure in Children: to Breathe or Not to Breathe Spontaneously, That's the Question|Not yet recruiting||Phase 4|178|Anticipated|University Medical Center Groningen||2|||f||||t|f|f||||||Yes||2017-10-10 21:48:43.398021|2017-10-10 21:48:43.398021
NCT02902042|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-16|||December 2016||2016-12-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|IMMU-TARGET||Open Label, Multicentre Study of Encorafenib + Binimetinib + PD (Programmed Cell Death Protein) -1 Antibody Pembrolizumab|A Randomized Phase I / II Open Label, Multicentre Study of Encorafenib Plus Binimetinib and PD-1 Antibody Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma|Not yet recruiting||Phase 1/Phase 2|140|Anticipated|University Hospital, Essen||2|||f||||f||||||||No||2017-10-10 21:48:43.461484|2017-10-10 21:48:43.461484
NCT02902029|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-12-21|||November 2016||2016-11-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|ImmunoCobiVem||Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma|A Phase II, Open-label, Randomized-controlled Trial Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody Atezolizumab for the Treatment in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma|Recruiting||Phase 2|176|Anticipated|University Hospital, Essen||2|||f||||f||||||||No||2017-10-10 21:48:43.563563|2017-10-10 21:48:43.563563
NCT02902016|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||October 2015||2015-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies|Modulation of Lactase Expression by a New Synthetic PPARgamma Ligand in Ex-vivo Cultures of Duodenal Biopsies|Recruiting||N/A|40|Anticipated|University Hospital, Lille||1|||f||||t||||||||Undecided||2017-10-10 21:48:43.678747|2017-10-10 21:48:43.678747
NCT02902003|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-11-02|||September 2016||2016-09-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|TPC||Testing Relationship Skills Education Services With a Robust Economic Security Component|Testing the Effectiveness of Offering Relationship Skills Education Services With a Robust Economic Security Component to Low-income Couples Raising Children.|Enrolling by invitation||N/A|2000|Anticipated|Mathematica Policy Research, Inc.||2|||f||||f||||||||No||2017-10-10 21:48:43.755722|2017-10-10 21:48:43.755722
NCT02901990|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-06-04|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Observational|||Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine|Observational Cohort Study to Evaluate Immunogenicity, Protection, and Persistence of Antibody to Mumps in 3-7 Years' Children Received One-dose Mumps-containing Vaccine|Completed||N/A|7901|Actual|Jiangsu Province Centers for Disease Control and Prevention|||2||f||||t|f|f||||Samples Without DNA|"     blood samples   "|No||2017-10-10 21:48:43.820398|2017-10-10 21:48:43.820398
NCT02901977|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-10|||March 2011||2011-03-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|DoRa||Doxazosin and Ramipril in Hypertension|On the Antithrombotic Effects of Doxazosin and Ramipril in Essential Hypertension|Completed||Phase 4|71|Actual|Karolinska Institutet||2|||f||||f||||||||No||2017-10-10 21:48:43.895014|2017-10-10 21:48:43.895014
NCT02901964|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of Strengthening the Hip Abductor in Patients With Knee Osteoarthritis: Randomized Controlled Trial|Effect of Strengthening the Hip Abductor in Patients With Knee Osteoarthritis: Randomized Controlled Trial|Recruiting||N/A|66|Anticipated|Universidade Federal do Ceara||2|||f||||t||||||||No|IPD will not be shared.|2017-10-10 21:48:43.974815|2017-10-10 21:48:43.974815
NCT02901951|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2017-06-15|||October 11, 2016|Actual|2016-10-11|June 2017|2017-06-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix™-B|Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated 20 to 30 Years Ago With Engerix™-B (NCT01627340)|Completed||Phase 4|106|Actual|GlaxoSmithKline||1|||f|||||f|f||||||||2017-10-10 21:48:44.08294|2017-10-10 21:48:44.08294
NCT02901938|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-14|||January 2016||2016-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Feasibility of Implantation of Cemented Femoral Stem for Osteoporotic Femoral Neck Fracture in Elderly Patients|Feasibility of Implantation of Cemented Femoral Stem in the Treatment of Osteoporotic Femoral Neck Fracture in Elderly Patients: a Randomized Controlled Trial|Active, not recruiting||N/A|100|Actual|Qinghai University||2|||f||||t||||||||Undecided||2017-10-10 21:48:44.164942|2017-10-10 21:48:44.164942
NCT02901925|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-12|||December 2016||2016-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ABY-029||A Microdose Evaluation Study of ABY-029 in Recurrent Glioma|A Phase 0 Open Label, Single-center Clinical Trial of ABY-029, an Anti-EGFR Fluorescence Imaging Agent Via Single Intravenous Injection to Subjects With Recurrent Glioma|Recruiting||Early Phase 1|12|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||No||2017-10-10 21:48:44.23347|2017-10-10 21:48:44.23347
NCT02901912|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-09-09|||September 2014||2014-09-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Observational|||Comparison of Gut Microbiota in Sedentary and Active Women|Effect of Diet and Exercise in the Gut Microbiota of Premenopausal Women:Correlation With Inflammatory and Oxidative Stress Parameters|Completed||N/A|40|Actual|Universidad Europea de Madrid|||2||f||||f||||||Samples With DNA|"     Bacterial DNA extracted from feces   "|Undecided||2017-10-10 21:48:44.457688|2017-10-10 21:48:44.457688
NCT02901899|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-17|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|August 2019|Anticipated|2019-08-01||Interventional|||Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|An Open Label Phase II Trial of Guadecitabine and Pembrolizumab in Platinum Resistant Recurrent Ovarian Cancer|Recruiting||Phase 2|38|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 21:48:44.555203|2017-10-10 21:48:44.555203
NCT02901886|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2017-08-30|||October 2016||2016-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||REU-stop - Effect of Intensive Smoking Cessation Intervention on Smoking Cessation and Disease Activity in Patients With Rheumatoid Arthritis.|REU-stop - Effect of Intensive Smoking Cessation Intervention on Smoking Cessation and Disease Activity in Patients With Rheumatoid Arthritis.|Recruiting||N/A|150|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||f|f|f||||||||2017-10-10 21:48:44.737732|2017-10-10 21:48:44.737732
NCT02901873|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||June 2016||2016-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||EIS in Thyroid and Parathyroid Surgery|Phase 1 Study of Electrical Impedance Spectroscopy in Thyroid and Parathyroid Surgery|Recruiting||Phase 1|50|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:48:44.872835|2017-10-10 21:48:44.872835
NCT02901860|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-09-30|||January 2012||2012-01-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Shift Work and Risk of Cardio-vascular Disease|Impact of Shift Work on Risk of Cardiovascular Disease and Diabetes: A Cross-sectional Study|Completed||N/A|86|Actual|University of Chicago|||2||f||||f||||||Samples With DNA|"     All blood samples, with the exception of blood work which is sent to the hospital clinical     labs, will be identified only with the subject study code.   "|||2017-10-10 21:48:44.976541|2017-10-10 21:48:44.976541
NCT02901847|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-04|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|PodPAD||To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities.|To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities.|Recruiting||N/A|20|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f|f|f||||||No||2017-10-10 21:48:45.076155|2017-10-10 21:48:45.076155
NCT02901834|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-20|||April 2015||2015-04-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|||PainSquad+: A Smartphone App to Support Real-time Pain Management for Adolescents With Cancer|PainSquad+: A Smartphone App to Support Real-time Pain Management for Adolescents|Completed||N/A|40|Actual|The Hospital for Sick Children|||1||f||||t||||||||||2017-10-10 21:48:45.176598|2017-10-10 21:48:45.176598
NCT02901821|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-17|||January 2016||2016-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Predicting Concussion Outcomes With Salivary miRNA|Predicting Concussion Outcomes With Salivary miRNA|Recruiting||N/A|150|Anticipated|Milton S. Hershey Medical Center|||2||f||||t||||||Samples Without DNA|"     salivary RNA   "|||2017-10-10 21:48:45.255508|2017-10-10 21:48:45.255508
NCT02901808|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-10-03|||January 2008||2008-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Observational|IRRE NOMI||Registeranalysis for the Examination of NOMI|Interdisciplinary Retrospective Registeranalysis for the Examination of Non-occlusive Mesenteric Ischemia (NOMI)|Active, not recruiting||N/A|10000|Actual|Saarland University|||2||f||||f||||||||||2017-10-10 21:48:45.360062|2017-10-10 21:48:45.360062
NCT02901795|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-10-03|||December 2014||2014-12-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|AiRPM||Early Detection of Chorioamnionitis in Preterm Premature Rupture of Membranes|Fetal Heart Rate Variability Analysis for the Early Detection of Chorioamnionitis During Preterm Premature Rupture of Membranes|Recruiting||N/A|80|Anticipated|Rennes University Hospital|||1||f||||f||||||||||2017-10-10 21:48:45.473008|2017-10-10 21:48:45.473008
NCT02901782|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-02-09|||January 2013||2013-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Application of Personalized Titanium Plate in the Bone Tumors Around the Knee|Personalized Titanium Plate Improves Clinical Outcome in Microwave Ablation of Bone Tumors Around the Knee|Completed||N/A|12|Actual|Guangzhou General Hospital of Guangzhou Military Command||1|||f||||f||||||||No||2017-10-10 21:48:45.574012|2017-10-10 21:48:45.574012
NCT02901769|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-09|||February 2013||2013-02-01|September 2016|2016-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|EMODES||Emotional Prosody Recognition and Decision Making Inf fMRI and Vulnerability to Suicide|Emotional Prosody Recognition and Decision Making Inf fMRI and Vulnerability to Suicide|Recruiting||N/A|80|Anticipated|Rennes University Hospital||4|||f||||||||||||||2017-10-10 21:48:45.663294|2017-10-10 21:48:45.663294
NCT02901756|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-27|||January 2015||2015-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||A Combination of Coenzyme Q10, Feverfew and Magnesium for Migraine Prophylaxis : a Prospective Observational Study||Completed||N/A|132|Actual|Pileje|||1||f||||f||||||||No||2017-10-10 21:48:45.752872|2017-10-10 21:48:45.752872
NCT02901743|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-09|||April 2015||2015-04-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|ETGPGK||Effect on Teeth and Gum Cleaning in Patients With Gum and Kidney Disease|"Efficacy of Nonsurgical Periodontal Therapy in Patients With Chronic Renal Disease and Periodontitis: A Biochemical and Microbiological Assay"|Completed||Phase 4|40|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||f||||||||No||2017-10-10 21:48:45.829155|2017-10-10 21:48:45.829155
NCT02901730|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-11|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Study of LPI With Different Laser Wavelengths|Clinical Study of Laser Peripheral Iridoplasty With Different Laser Wavelengths|Active, not recruiting||N/A|30|Anticipated|First Affiliated Hospital of Fujian Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:48:45.916363|2017-10-10 21:48:45.916363
NCT02901717|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI|Efficacy and Safety of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection|Not yet recruiting||Phase 3|700|Anticipated|Leonard-Meron Biosciences, Inc.||2|||f||||t|t|f||||||||2017-10-10 21:48:46.021531|2017-10-10 21:48:46.021531
NCT02901704|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-14|||December 2016||2016-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|Iberis-HTN||Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension|A Prospective, Multi-centers, Randomized,Controlled, Blinded,Superiority Trial of Renal Denervation Using Iberis MultiElectrode Renal Denervation System for the Treatment of Primary Hypertension.|Not yet recruiting||Phase 3|216|Anticipated|Shanghai AngioCare Medical||2|||f||||f||||||||Undecided||2017-10-10 21:48:46.113694|2017-10-10 21:48:46.113694
NCT02901691|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||June 2016||2016-06-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||RHYTHMIC STIMULUS EFFECTS ON NEURONAL OSCILLATORY ACTIVITY AND SPEACHES CAPABILITIES IN DEAF CHILDREN||Recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:48:46.197041|2017-10-10 21:48:46.197041
NCT02901678|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2017-02-22|||November 2015||2015-11-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of Different Force Magnitudes on Maxillary Posterior Segment Intrusion|The Effect of Two Different Force Magnitudes on Maxillary Posterior Segment Intrusion in Adult Patients With Skeletal Open Bite Using Temporary Anchorage Devices- A Randomized Clinical Trial|Recruiting||N/A|22|Anticipated|Cairo University||2|||f||||t||||||||No|Participants data will not be exposed except for research committee|2017-10-10 21:48:46.283075|2017-10-10 21:48:46.283075
NCT02901665|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-07-24|||October 2014||2014-10-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes|Impact of Increased Parent Presence in the NICU on Parent & Infant Outcomes|Recruiting||N/A|90|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-10 21:48:46.367847|2017-10-10 21:48:46.367847
NCT02901652|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-09-10|||September 2016||2016-09-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome|Comparison of Nasal Intermittent Positive Airway Pressure and Nasal Bi-level Positive Airway Pressure Methods in Preterm Infants With Respiratory Distress Syndrome With Gestational Age of 26-30 Weeks|Not yet recruiting||Phase 4|160|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||t||||||||||2017-10-10 21:48:46.475157|2017-10-10 21:48:46.475157
NCT02901639|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2016-09-10|||September 2016||2016-09-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Postpartum Contraception Counseling on the Rate of Unintended Pregnancy|Influence of Immediate Postpartum Contraception Counseling on the Rate of Unintended Pregnancy in Primigravida: A Randomized Controlled Study|Recruiting||N/A|300|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:48:46.552289|2017-10-10 21:48:46.552289
NCT02901626|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-06-07|||February 14, 2017|Actual|2017-02-14|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|August 2020|Anticipated|2020-08-01||Interventional|TOPS||A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix|A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix|Recruiting||N/A|850|Anticipated|The George Washington University Biostatistics Center||2|||f||||t|f|t|t|f||||Yes|The data will be shared after the completion of the trial and publication of the main analyses per NIH policy. When made available, requests for the dataset(s) can be sent to mfmudatasets@bsc.gwu.edu.|2017-10-10 21:48:46.641884|2017-10-10 21:48:46.641884
NCT02901613|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2017-02-10|||August 2016||2016-08-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Prophylactic Post-Cesarean Incisional Negative-pressure Wound Therapy in Morbidly Obese Patients||Recruiting||N/A|186|Anticipated|Albany Medical College||2|||f||||||||||||||2017-10-10 21:48:46.819462|2017-10-10 21:48:46.819462
NCT02901600|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||June 2013||2013-06-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Observational|DMBT1||Expression of DMBT1 in Colorectal Cancer Patients|Modification of the Expression and the Localization of DMBT1 (Deleted in Malignant Brain Tumor 1) in Colorectal Cancer|Completed||N/A|145|Actual|Lille Catholic University|||3||f||||f||||||||No||2017-10-10 21:48:46.900762|2017-10-10 21:48:46.900762
NCT02901587|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-03-31|||September 2016|Actual|2016-09-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder|Interventional, Randomised, Double-blind, Parallel-group, Active-control, Multiple-dose Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder|Recruiting||Phase 1|120|Anticipated|H. Lundbeck A/S||3|||f||||f||||||||No||2017-10-10 21:48:46.977674|2017-10-10 21:48:46.977674
NCT02901574|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-05-18|||August 2016||2016-08-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|||Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment|Cerebellar Transcranial Direct Current Stimulation to Augment Chronic Aphasia Treatment|Recruiting||N/A|50|Anticipated|Johns Hopkins University||2|||f||||||||||||Yes|"Upon completion of the projects and dissemination of primary study results, the analysis data files will be made available to the public, along with the final version of the study protocol, the data dictionary, and brief instructions (read me file). The public use data files and the accompanying documents will be made available through the National Technical Information Service (NTIS)."|2017-10-10 21:48:47.0531|2017-10-10 21:48:47.0531
NCT02901561|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2017-03-12|||September 2016||2016-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Comparison Between 2 Doses of Misoprostol Before Intrauterine Device|Comparison Between 2 Different Doses of Vaginal Misoprostol Before Intrauterine Device Insertion in Parous Women|Completed||Phase 2/Phase 3|212|Actual|Assiut University||2|||f||||t||||||||Yes||2017-10-10 21:48:47.140203|2017-10-10 21:48:47.140203
NCT02901548|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-05-23|||February 16, 2017|Actual|2017-02-16|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder|A Phase 2 Study of Check Point Inhibitor, Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refractory Urothelial Carcinoma in Situ (CIS) of the Bladder|Recruiting||Phase 2|34|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 21:48:47.206886|2017-10-10 21:48:47.206886
NCT02901535|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-01-16|||April 2015||2015-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|RESPIRANET-C||Tele-spirometry in Primary Care-Randomized Clinical Trial Cluster:Telemedicine in Chronic Obstructive Pulmonary Disease|Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Multifaceted Intervention in Symptoms Patients With Respiratory Illness|Recruiting||N/A|240|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:48:47.297755|2017-10-10 21:48:47.297755
NCT02901522|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-01-16|||May 2015||2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|RESPIRANET-A||Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Telemedicine in Asthma|Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Multifaceted Intervention in Symptoms Patients With Respiratory Illness.|Recruiting||N/A|120|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:48:47.40121|2017-10-10 21:48:47.40121
NCT02901509|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||June 2016||2016-06-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Observational|QoLCHIK||Impact of the Chikungunya Outbreak in Reunion Island on the Quality of Life After 10 Years|Epidémie de Chikungunya à l'île de La Réunion : Effet à Dix Ans de l'Infection Sur la qualité de Vie Dans la Cohorte TELECHIK|Recruiting||N/A|440|Anticipated|Centre Hospitalier Universitaire de la Réunion|||2||f||||t||||||||No||2017-10-10 21:48:47.499698|2017-10-10 21:48:47.499698
NCT02901483|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-06-26|||October 11, 2016|Actual|2016-10-11|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer|A Phase 1b/2 Study of PEP503 (Radioenhancer) With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer|Recruiting||Phase 1/Phase 2|42|Anticipated|PharmaEngine||1|||f||||||||||||||2017-10-10 21:48:47.777424|2017-10-10 21:48:47.777424
NCT02901457|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2017-01-13|||August 2016||2016-08-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||"The Healthy Body Image (HBI) Program: A Program to Promote a Positive Body Image"|"The Healthy Body Image (HBI) Program: A Program to Promote a Positive Body Image. A School-based Randomized Controlled Trial"|Active, not recruiting||N/A|4193|Actual|Norwegian School of Sport Sciences||2|||f||||f||||||||Undecided||2017-10-10 21:48:47.921283|2017-10-10 21:48:47.921283
NCT02901444|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-10-04|||March 2015||2015-03-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Observational Study on Changing the Quality of Life in Daily Life Activities After Clinical Approach Positioning the Wheelchair||Completed||N/A|10|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:48:48.003576|2017-10-10 21:48:48.003576
NCT02901431|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-25|||November 21, 2016|Actual|2016-11-21|September 2017|2017-09-01|April 18, 2019|Anticipated|2019-04-18|April 18, 2019|Anticipated|2019-04-18||Interventional|||A Study to Investigate the Efficacy and Safety of RO5285119 in Participants With Autism Spectrum Disorder (ASD)|A Phase II Multi-center, Randomized, Double-blind, 24-Week, 3-Arm, Parallel Group, Placebo-controlled Study to Investigate the Efficacy and Safety of RO5285119 in Children and Adolescents Age 5-17 With Autism Spectrum Disorder (ASD)|Recruiting||Phase 2|300|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 21:48:48.052716|2017-10-10 21:48:48.052716
NCT02901418|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-18|||July 2015||2015-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High Risk|According to the Venous Blood HBsAg State of Neonatus at Birth, Discussing the Efficiency of Personalized Blocking Method of HBV Maternal-neonatal Transmission in High-risk Newborns|Recruiting||N/A|406|Anticipated|Beijing Ditan Hospital|||2||f||||f||||||Samples With DNA|"     At the age of seven months, we extract venous blood of these children, separate the serums     and collect the PBMC. Then, the serums are applied to test HBsAg, AntiHBs and HBVDNA which we     adopt to analyse HLA classⅠand class Ⅱ gene polymorphism.   "|||2017-10-10 21:48:48.179821|2017-10-10 21:48:48.179821
NCT02901405|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-04-09|||September 2016||2016-09-01|April 2017|2017-04-01|October 1, 2020|Anticipated|2020-10-01|September 2019|Anticipated|2019-09-01||Interventional|||NPWT in Soft Tissue Sarcoma Surgery|Negative Pressure Dressings Versus Non-negative Pressure Dressing for Wound Care Following Soft Tissue Sarcoma Excision|Recruiting||N/A|160|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||||||||||||2017-10-10 21:48:48.296086|2017-10-10 21:48:48.296086
NCT02901392|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2016-09-12|||April 2004||2004-04-01|September 2016|2016-09-01|April 2031|Anticipated|2031-04-01|April 2019|Anticipated|2019-04-01|15 Years|Observational [Patient Registry]|||Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment|Fundación Instituto Valenciano de Oncología Prospective Registry for Patients Undergoing Male Sling or Artificial Urinary Sphincter After Prostatectomy or Radiation Therapy for Prostate Cancer.|Recruiting||N/A|400|Anticipated|Fundación Instituto Valenciano de Oncología|||4||f||||f||||||||No||2017-10-10 21:48:49.972053|2017-10-10 21:48:49.972053
NCT02901379|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-14|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of 80-mg Atorvastatin on Myocardial Edema|Effect of 80-mg Atorvastatin on Myocardial Edema Following Coronary Artery Bypass Surgery in Relation With Follistatin-Like Protein-1|Not yet recruiting||Phase 3|30|Anticipated|National Cardiovascular Center Harapan Kita Hospital Indonesia||2|||f||||t||||||||No||2017-10-10 21:48:50.093731|2017-10-10 21:48:50.093731
NCT02901366|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-08-01|||September 2016||2016-09-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Mass Balance Study of FYU-981|Plasma Concentration, Excretion and Mass Balance Orally Administered 14C-FYU-981 in Healthy Male Subjects|Active, not recruiting||Phase 2|6|Actual|Fuji Yakuhin Co., Ltd.||1|||f||||f||||||||||2017-10-10 21:48:50.182574|2017-10-10 21:48:50.182574
NCT02901353|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-14|||September 2016||2016-09-01|September 2016|2016-09-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01|24 Months|Observational [Patient Registry]|Morpheus||A Prospective, Single-arm, Multi-centre, Observational, Real World Registry|A Prospective, Single-arm, Multi-centre, Observational, Real World Registry to Evaluate Safety and Performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for Very Long Coronary Lesions|Not yet recruiting||Phase 4|400|Anticipated|Meril Life Sciences Pvt. Ltd.|||1||f||||f||||||||Yes||2017-10-10 21:48:50.269995|2017-10-10 21:48:50.269995
NCT02901340|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-14|||August 2016||2016-08-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Fetal Renal Artery Doppler Indices in Borderline Isolated Oligohydramnios|Third Trimester Fetal Renal Artery Doppler Indices in Borderline Idiopathic Isolated Oligohydramnios and Relationship Between Neonatal Outcomes|Recruiting||N/A|140|Anticipated|Kayseri Education and Research Hospital|||2||f||||||||||||||2017-10-10 21:48:50.343956|2017-10-10 21:48:50.343956
NCT02901327|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-09-19|||March 2015||2015-03-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|CMLBP||Multifidus Activation, Pain and Functional Disability in Individuals With Chronic Low Back Pain|Effects of Lumbar Stabilisation Exercise and Treadmill Walk on Multifidus Activation, Pain and Functional Disability in Individuals With Chronic Low Back Pain|Completed||N/A|53|Actual|Bayer University Kano, Nigeria||2|||f||||f||||||||No||2017-10-10 21:48:50.452024|2017-10-10 21:48:50.452024
NCT02901314|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-07-19|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01||||June 2019|Anticipated|2019-06-01||Interventional|MyROAD||My Recordable On-Demand Audio Discharge Instructions|My Recordable On-Demand Audio Discharge Instructions (MyROAD)|Recruiting||N/A|1066|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 21:48:51.117178|2017-10-10 21:48:51.117178
NCT02901301|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2017-01-09|||October 2016||2016-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer|A Phase Ib/II Study of First Line Pembrolizumab in Combination With Trastuzumab, Capecitabine, and Cisplatin in HER2 Positive Gastric Cancer|Recruiting||Phase 1/Phase 2|49|Anticipated|Yonsei University||1|||f||||t||||||||Undecided||2017-10-10 21:48:51.240335|2017-10-10 21:48:51.240335
NCT02901288|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-03-16|||August 2016||2016-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis|Shortened Regimens for First Diagnosed Smear Positive Drug Susceptible Pulmonary Tuberculosis: a Randomised Controlled Non-inferiority Trial|Recruiting||Phase 4|3900|Anticipated|Beijing Chest Hospital||3|||f||||f||||||||No||2017-10-10 21:48:51.356033|2017-10-10 21:48:51.356033
NCT02901262|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-03-02|||January 2016||2016-01-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01|10 Days|Observational [Patient Registry]|CrazyEEG||Continuous Quantified EEG in NeuroIntensive Care|Utility of Continuous Electroencephalogram and Derived Variables in NeuroIntensive Care|Completed||N/A|15|Actual|Azienda Ospedaliera San Gerardo di Monza|||1||f||||f||||||||No||2017-10-10 21:48:51.837946|2017-10-10 21:48:51.837946
NCT02901249|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-11|||May 2010||2010-05-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional|||Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder|Assessment of Cost- Effectiveness Interventions and the Quality of Life in Patients With Major Depression Through Resources Available in Brazilian Public Health|Completed||Phase 4|68|Actual|Federal University of Rio Grande do Sul||1|||f||||t||||||||No||2017-10-10 21:48:51.932931|2017-10-10 21:48:51.932931
NCT02901236|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-10|||January 2014||2014-01-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01||Interventional|AvastinvsMMC||Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma|Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma: A Randomized Pilot Trial.|Completed||Phase 2/Phase 3|40|Actual|Athens Vision Eye Institute||2|||f||||t||||||||Yes|Result will be submitted for publication to a peer review journal as soon as they become available. They will also be presented at national and international meetings.|2017-10-10 21:48:52.042809|2017-10-10 21:48:52.042809
NCT02901223|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-10|||September 2012||2012-09-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|September 2013|Actual|2013-09-01||Interventional|||The Impact of Oncoplastic Breast Surgery on the Oncological Safety and Patient Satisfaction|Oncoplastic Breast Surgery Allow Tumor Resection With More Oncological Safety Than Standard Quadrantectomy With Nice Cosmetic Results and Better Quality of Life|Completed||N/A|70|Actual|Ain Shams University||2|||f||||t||||||||Undecided||2017-10-10 21:48:52.145927|2017-10-10 21:48:52.145927
NCT02901210|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-09-10|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||A Modified Technique to Facilitate Pealing of the Rectal Mucosa in Delorme Operation||Completed||N/A|25|Actual|Ain Shams University||1|||f||||t||||||||Undecided||2017-10-10 21:48:52.238535|2017-10-10 21:48:52.238535
NCT02901197|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-09|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|CapABLE||Capnography At the Bedside: Leading Educational Efforts|Capnography At the Bedside: Leading Educational Efforts (CapABLE Trial)|Not yet recruiting||N/A|50|Anticipated|Yale University||2|||f||||t||||||||Undecided||2017-10-10 21:48:52.314441|2017-10-10 21:48:52.314441
NCT02901184|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-28|||December 2017|Anticipated|2017-12-01|March 2017|2017-03-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Interventional|SPIRRIT||Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction|Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction, SPIRRIT-HFPEF|Not yet recruiting||Phase 4|3500|Anticipated|Uppsala University||2|||f||||t|f|f||||||Yes||2017-10-10 21:48:52.403502|2017-10-10 21:48:52.403502
NCT02901171|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-23|||September 2016||2016-09-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation|The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation: a Randomised Controlled Trial Investigating Its Efficacy, Mediators and Moderators|Recruiting||N/A|150|Anticipated|University College Dublin||3|||f||||||||||||||2017-10-10 21:48:52.519274|2017-10-10 21:48:52.519274
NCT02901158|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-14|||September 2016||2016-09-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Esophageal Manometry in Mechanically Ventilated Patients|Esophageal Manometry in Mechanically Ventilated Patients|Recruiting||N/A|20|Anticipated|Sahlgrenska University Hospital, Sweden|||2||f||||f||||||||No||2017-10-10 21:48:52.627826|2017-10-10 21:48:52.627826
NCT02901145|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-11|2016-09-14|||November 2016||2016-11-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|November 2019|Anticipated|2019-11-01||Interventional|||Nivolumab in Relapsed Pediatric Solid Tumors|A Phase I/II Clinical Trial of Nivolumab in Progressive/Relapsed Pediatric Solid Tumors|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||No||2017-10-10 21:48:52.712233|2017-10-10 21:48:52.712233
NCT02901132|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-04-09|||March 2013|Actual|2013-03-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|March 2017|Actual|2017-03-01||Observational|||Association Between Different Parameters of Nutritional Assessment and Clinical Outcomes in Cancer Patients|Association Between Different Parameters of Nutritional Assessment and Clinical Outcomes in Cancer Patients|Active, not recruiting||N/A|120|Actual|Federal University of Minas Gerais|||2||f||||t|f|f||||Samples With DNA|"     Samples of abdominal rectal muscles.   "|Yes|Scientific publications|2017-10-10 21:48:52.801908|2017-10-10 21:48:52.801908
NCT02901119|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-09|||July 2014||2014-07-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Whey Protein Consumption by Patients Waiting for Liver Transplantation|Effects of Whey Protein Consumption by Patients Waiting for Liver Transplantation|Recruiting||N/A|30|Anticipated|Federal University of Minas Gerais||2|||f||||t||||||||No||2017-10-10 21:48:52.879284|2017-10-10 21:48:52.879284
NCT02901106|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-05-24|||May 23, 2017|Actual|2017-05-23|May 2017|2017-05-01|August 2023|Anticipated|2023-08-01|August 2019|Anticipated|2019-08-01||Interventional|SURV-SEP||Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate|Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate SURV-SEP|Recruiting||Phase 4|250|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f|||||f|f||||||||2017-10-10 21:48:52.956467|2017-10-10 21:48:52.956467
NCT02901093|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-03-08||||||March 2017|2017-03-01||||December 2015|Actual|2015-12-01||Observational|QUIPROCOS||Quantification of Prosthesis Penetration With Conebeam in Otosclerosis|Early Postoperative Imaging of the Labyrinth by Cone Beam CT After Stapes Surgery for Otosclerosis With Correlation to Audiovestibular Outcome|Completed||N/A|80|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:48:53.043445|2017-10-10 21:48:53.043445
NCT02900911|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-19|||May 2016||2016-05-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ReDyOR||Swallowing Rehabilitation in Patients With Head and Neck Cancer Receiving Radiotherapy|Effects of Prophylactic Swallowing Exercises on Dysphagia and Quality of Life in Patients With Head and Neck Cancer Receiving Radiotherapy: A Randomized Clinical Trial|Recruiting||N/A|70|Anticipated|Parc de Salut Mar||2|||f||||f||||||||||2017-10-10 21:48:54.71755|2017-10-10 21:48:54.71755
NCT02901080|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-09|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical and Cost Effectiveness of Alpha-Stim AID CES|Naturalistic Study of Alpha-Stim in Patients With a Primary Working Diagnosis of Moderate-to-severe Generalised Anxiety Disorder Who Did Not Improve With Low Intensity Psychological Therapy Intervention|Recruiting||N/A|120|Anticipated|Electromedical Products International, Inc.||1|||f||||f||||||||Yes|Anonymised data will form part of the final study report which will be used for submission to the UK National Institute for Clinical Excellence.|2017-10-10 21:48:53.111735|2017-10-10 21:48:53.111735
NCT02901067|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-02-14|||February 3, 2017|Actual|2017-02-03|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|STAT||STAT-STatin and Aspirin in Trauma|STAT (STatins and Aspirin in Trauma) Trial: A Phase II, Pragmatic, Prospective, Randomized, Double-blind, Adaptive Clinical Trial Examining the Efficacy of Statins and Aspirin in the Reduction of Acute Lung Injury and Venous Thromboembolism in Patients With Fibrinolysis Shutdown|Recruiting||Phase 2|440|Anticipated|Denver Health and Hospital Authority||2|||f||||t|t|f||||||||2017-10-10 21:48:53.203495|2017-10-10 21:48:53.203495
NCT02901054|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2017-04-19|||August 2016||2016-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||CSF Pharmacokinetics of Ondansetron|Investigation of Cerebrospinal Fluid (CSF) Pharmacokinetics of Ondansetron|Completed||N/A|19|Actual|Washington University School of Medicine||1|||f||||f||||||||No||2017-10-10 21:48:53.29146|2017-10-10 21:48:53.29146
NCT02901041|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-07-19|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2021|Anticipated|2021-08-01|February 2021|Anticipated|2021-02-01||Interventional|||Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism|Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism|Not yet recruiting||Phase 3|100|Anticipated|Boston University Charles River Campus||2|||f||||t|t|f||||||||2017-10-10 21:48:53.494806|2017-10-10 21:48:53.494806
NCT02901028|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-09-09|||April 2013||2013-04-01|September 2016|2016-09-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Innovative Concussion Prevention Device|Safety Testing of an Innovative Concussion Prevention Device|Completed||N/A|20|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No|Results will be published however individual participant data will remain secure|2017-10-10 21:48:53.641681|2017-10-10 21:48:53.641681
NCT02901015|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-09|||April 2013||2013-04-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|EVACO||Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning|Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning (EVACO)|Active, not recruiting||N/A|160|Actual|Versailles Hospital||2|||f||||f||||||||||2017-10-10 21:48:53.738442|2017-10-10 21:48:53.738442
NCT02901002|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-01-25|||January 6, 2017|Actual|2017-01-06|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Body Perception and Complex Regional Pain Syndrome|Body Perception and Complex Regional Pain Syndrome : a Case-control Study|Recruiting||N/A|24|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||||No||2017-10-10 21:48:53.843488|2017-10-10 21:48:53.843488
NCT02900989|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-07-06|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ASQ-Fr||Validation of the French Version of Ask Suicide-Screening Questions (ASQ) in Adolescents Managed in Pediatric Emergency Unit|"Etude de Validation de la Version française d'un Questionnaire  Ask Suicide-Screening Questions  (ASQ) Dans Une Population de Patients Adolescents Pris en Charge en unité d'Urgences pédiatriques"|Completed||N/A|200|Actual|Centre Hospitalier Universitaire de la Réunion||2|||f||||t||||||||||2017-10-10 21:48:53.940474|2017-10-10 21:48:53.940474
NCT02900976|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-05-22|||March 6, 2017|Actual|2017-03-06|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive Cluster of Differentiation(CD) 20-Positive Post-Transplant Lymphoproliferative Disorder|A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)|Active, not recruiting||Phase 2|90|Anticipated|Children's Oncology Group||2|||f||||t|t|f||||||||2017-10-10 21:48:54.02845|2017-10-10 21:48:54.02845
NCT02900963|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-07-19|||April 2014||2014-04-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|August 2018|Anticipated|2018-08-01||Interventional|NUTRINECK||Nutritional Status Assessment in Head and Neck Cancer Patients Receiving Radiotherapy or Chemo-radiotherapy|Nutritional Assessment of Locally Advanced Head and Neck Cancer Patients Who Underwent Exclusive or Adjuvant Radiotherapy or Chemo-radiotherapy|Recruiting||N/A|280|Anticipated|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 21:48:54.158815|2017-10-10 21:48:54.158815
NCT02900950|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-09|||June 2012||2012-06-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|MPM||Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer|Multicolour Versus Monocolour Inking Specimens After Pancreaticoduodenectomy for Periampullary Cancer: a Single Center Prospective Randomised Clinical Trial.|Completed||N/A|68|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||No||2017-10-10 21:48:54.272121|2017-10-10 21:48:54.272121
NCT02900937|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-11-22|||October 2016||2016-10-01|November 2016|2016-11-01|June 2022|Anticipated|2022-06-01|March 2018|Anticipated|2018-03-01||Interventional|RENASCENT III||Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III)|Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial III|Recruiting||Phase 2|70|Anticipated|Amaranth Medical Inc.||1|||f||||t||||||||Undecided||2017-10-10 21:48:54.376518|2017-10-10 21:48:54.376518
NCT02900924|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-10-02|||September 2016||2016-09-01|October 2017|2017-10-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Observational|MIMICS-3D||Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D|A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Self-Expanding Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D|Recruiting||N/A|500|Anticipated|Veryan Medical Ltd.|||1||f||||t||||||||||2017-10-10 21:48:54.562646|2017-10-10 21:48:54.562646
NCT02900703|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-09|||February 2007||2007-02-01|September 2016|2016-09-01||||February 2017|Anticipated|2017-02-01||Observational|Rotavirus||Surveillance of Rotavirus Gastroenteritis|Epidemiological Surveillance of Rotavirus Gastroenteritis With a Perspective of Vaccination|Recruiting||N/A|9000|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:48:56.217008|2017-10-10 21:48:56.217008
NCT02900898|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-13|||August 2014||2014-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2016|Actual|2016-08-01||Interventional|||Exercise and Mediterranean Diet on Body Composition, Disease Activity and Inflammatory Markers in Rheumatoid Arthritis|Effect of a Dynamic Exercise Program in Combination With a Mediterranean Diet on Body Composition, Strength, Inflammatory Markers, Joint Mobility and Disease Activity in Women With Rheumatoid Arthritis|Recruiting||N/A|120|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||4|||f||||t||||||||Undecided||2017-10-10 21:48:54.823872|2017-10-10 21:48:54.823872
NCT02900885|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-09|||January 2012||2012-01-01|September 2016|2016-09-01||||March 2015|Actual|2015-03-01||Observational|EXCYCLO||Study of Ocular Torsion in Patients Suffering From Palsy of the Superior Rectus Extraocular Muscle||Completed||N/A|34|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:48:54.929555|2017-10-10 21:48:54.929555
NCT02900872|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-09|||January 2009||2009-01-01|September 2016|2016-09-01||||October 2015|Actual|2015-10-01||Observational|TIPIC||Systematic Chart Review of Carotidynia Patients|Systematic Chart Review of Carotidynia Patients|Completed||N/A|14|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:48:54.977878|2017-10-10 21:48:54.977878
NCT02900859|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-09|||January 2006||2006-01-01|September 2016|2016-09-01||||April 2015|Actual|2015-04-01||Observational|RetroG4||Infraorbital Nerve Involvement on Magnetic Resonance Imaging in European Patients With IgG4-related Ophthalmic Disease||Completed||N/A|132|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:48:55.038708|2017-10-10 21:48:55.038708
NCT02900846|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-01-29|||January 2003||2003-01-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Observational|GLIR||Colour Doppler Flow Imaging in Lacrimal Gland Lesions|Usefulness of Colour Doppler Flow Imaging in the Management of Lacrimal Gland Lesions|Completed||N/A|51|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:48:55.088603|2017-10-10 21:48:55.088603
NCT02900833|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-02-08|||March 24, 2016|Actual|2016-03-24|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|NEUTROSTROKE||Impact of Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy||Recruiting||N/A|440|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:48:55.139941|2017-10-10 21:48:55.139941
NCT02900820|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-09|||January 2017||2017-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|STOP-AB||Safety of Discontinuing Patient Antibiotic Treatment|Safety of Discontinuing Patient Antibiotic Treatment When Physicians no Longer Consider it Necessary|Not yet recruiting||N/A|430|Anticipated|Spanish Society of Family and Community Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:48:55.226801|2017-10-10 21:48:55.226801
NCT02900807|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-02-08|||December 2014||2014-12-01|September 2016|2016-09-01||||February 2018|Anticipated|2018-02-01||Observational|AIRWAY||CT-scan Airways Mensuration - Correlation to External Measurements||Recruiting||N/A|180|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:48:55.333561|2017-10-10 21:48:55.333561
NCT02900768|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2016-09-09|||September 2016||2016-09-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|Ex-BMT||Effects of Exercise on Allogeneic Stem Cell Transplant|Evaluating Effects on Quality of Life of a Partially Supervised Exercise Program Following Allogeneic Stem Cell Transplantation|Not yet recruiting||N/A|120|Anticipated|University of British Columbia||2|||f||||t||||||||Undecided||2017-10-10 21:48:55.588265|2017-10-10 21:48:55.588265
NCT02900755|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-12-28|||December 2016||2016-12-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|||Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy|Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy|Recruiting||Phase 4|30|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 21:48:55.673911|2017-10-10 21:48:55.673911
NCT02900742|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-09-09|||March 2013||2013-03-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer|Study of Chinese Medicine Plus Chemotherapy Maintenance Versus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer: A Randomized Double-blind Controlled Clinical Trial|Enrolling by invitation||Phase 3|100|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-10 21:48:55.747102|2017-10-10 21:48:55.747102
NCT02900729|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-09|||October 2016||2016-10-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|||Randomized Controlled Trial of Renal Denervation for Resistant Hypertension|A Prospective Multicenter Randomized Controlled Trial of Efficacy and Safety of Renal Denervation for Resistant Hypertension|Not yet recruiting||Phase 3|254|Anticipated|Shanghai WiseGain Medical Devices Co., Ltd.||2|||f||||f||||||||No||2017-10-10 21:48:55.935209|2017-10-10 21:48:55.935209
NCT02900716|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2020|Anticipated|2020-12-01||Interventional|||Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas|A Phase Ia/Ib Study of a Novel BTK Inhibitor, DTRMWXHS-12, and Combination Products, DTRM-505 and DTRM-555, in Patients With Chronic Lymphocytic Leukemia or Other B-cell Lymphomas|Recruiting||Phase 1|50|Anticipated|Zhejiang DTRM Biopharma||3|||f||||||||||||||2017-10-10 21:48:56.117251|2017-10-10 21:48:56.117251
NCT02900690|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-09|||June 2015||2015-06-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Observational|||Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy||Active, not recruiting||N/A|84|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-10 21:48:56.294728|2017-10-10 21:48:56.294728
NCT02900677|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-09|||August 2015||2015-08-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery|Developing and Testing the Effects of Patient-centered Prehabilitation Program on Improving Fatigue, Nutritional Status, and Quality of Life in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery|Recruiting||N/A|168|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:48:56.355987|2017-10-10 21:48:56.355987
NCT02900664|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-10-02|||August 23, 2016|Actual|2016-08-23|October 2017|2017-10-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)|Phase Ib, Open-label, Multi-center Study to Characterize the Safety, Tolerability and Pharmacodynamics (PD) of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)|Recruiting||Phase 1|432|Anticipated|Novartis||12|||f||||f|t|f||||||||2017-10-10 21:48:56.448896|2017-10-10 21:48:56.448896
NCT02900651|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-14|||October 3, 2016|Actual|2016-10-03|September 2017|2017-09-01|August 5, 2019|Anticipated|2019-08-05|February 8, 2018|Anticipated|2018-02-08||Interventional|||Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies|A Phase I/II, Multicenter, Open-label Study of MAK683 in Adult Patients With Advanced Malignancies|Recruiting||Phase 1/Phase 2|113|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:48:56.662931|2017-10-10 21:48:56.662931
NCT02900638|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Health Effects of Mentoring|Pilot Study of Physical Health Effects of Cities Mentor Project|Recruiting||N/A|120|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 21:48:56.794102|2017-10-10 21:48:56.794102
NCT02900625|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-13|||May 2013||2013-05-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|VMRDO||Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues|Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues|Recruiting||N/A|240|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||||||||||||2017-10-10 21:48:56.88503|2017-10-10 21:48:56.88503
NCT02900612|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-09|||December 2015||2015-12-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Two Aquatic Training Models in Physiological Parameters of Elderly Dyslipidemic Women.|Effects of Two Aquatic Training Models in Physiological Parameters of Elderly Dyslipidemic Women: a Randomized Controlled Clinical Trial.|Completed||N/A|45|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||Undecided||2017-10-10 21:48:57.45514|2017-10-10 21:48:57.45514
NCT02900599|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-09|||February 2015||2015-02-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|February 2015|Actual|2015-02-01||Observational|PREDIVI||Predicting Treatment and Care Difficulties Among HIV Infected Patients||Completed||N/A|111|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||||||2017-10-10 21:48:57.573184|2017-10-10 21:48:57.573184
NCT02900586|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-09|||May 2016||2016-05-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|COM-Patient||Behavior and Knowledges of Patients Enrolled Into SIOUX Study|Understand the Behavior and the Knowledges of Patients Enrolled Into SIOUX Study|Recruiting||N/A|20|Anticipated|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||No||2017-10-10 21:48:57.644752|2017-10-10 21:48:57.644752
NCT02900573|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-09|||May 2010||2010-05-01|August 2016|2016-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|PERCEPAL||Withdrawal of Artificial Nutrition at the End of Life (PERCEPAL)|Caregivers Confronted With the Withdrawal of Artificial Nutrition at the End of Life: Perception and Experienced Difficulties|Completed||N/A|289|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||No||2017-10-10 21:48:57.736281|2017-10-10 21:48:57.736281
NCT02900560|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-04-12|||December 20, 2016|Actual|2016-12-20|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer|Phase II Randomized Study of Pembrolizumab With or Without Epigenetic Modulation With CC-486 in Patients With Platinum-resistant Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Recruiting||Phase 2|20|Anticipated|Translational Research in Oncology||4|||f||||f||||||||No||2017-10-10 21:48:57.804548|2017-10-10 21:48:57.804548
NCT02900547|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-09-09|||July 2015||2015-07-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|PREMEDIC||Blind Assessment of the Concordance Between the Administered Treatment and the Recommendations of a Medical Algorithm Decision Support Software in Systolic Heart Failure|Blind Assessment of the Concordance Between the Administered Treatment and the Recommendations of a Medical Algorithm Decision Support Software in Systolic Heart Failure|Recruiting||N/A|300|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||||2017-10-10 21:48:57.935225|2017-10-10 21:48:57.935225
NCT02900534|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-21|||May 2016||2016-05-01|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|LIVIA||Internet-based Self-help After Spousal Bereavement or Divorce|Evaluation of a Randomised Guided Internet-based Self-help Intervention for Older Adults Who Seek Support for Coping With Prolonged Grief Symptoms After Marital Bereavement or Divorce - LIVIA|Active, not recruiting||N/A|110|Actual|University of Bern||2|||f||||f||||||||||2017-10-10 21:48:58.042944|2017-10-10 21:48:58.042944
NCT02900521|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-09|||January 2008||2008-01-01|September 2016|2016-09-01|December 2026|Anticipated|2026-12-01|August 2016|Actual|2016-08-01|10 Years|Observational [Patient Registry]|BREST||Population-based Brest Stroke Registry|The Brest Registry of Stroke|Recruiting||N/A|900|Anticipated|University Hospital, Brest|||1||f||||t||||||||Yes||2017-10-10 21:48:58.166207|2017-10-10 21:48:58.166207
NCT02900508|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-08|||October 2014||2014-10-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Virtual Reality-based Training in Cerebellar Ataxia||Completed||N/A|16|Actual|National Yang Ming University||2|||f||||||||||||||2017-10-10 21:48:58.275241|2017-10-10 21:48:58.275241
NCT02900495|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2017-05-11|||August 2016||2016-08-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children|Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children|Recruiting||N/A|128|Anticipated|Northwell Health||4|||f||||t||||||||No|No plans to share this information|2017-10-10 21:48:58.364807|2017-10-10 21:48:58.364807
NCT02900482|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-08-02|||November 23, 2012||2012-11-23|August 2017|2017-08-01|May 23, 2020|Anticipated|2020-05-23|May 23, 2019|Anticipated|2019-05-23||Observational|GENETHIP||Research for Genetic Factors Involved in Congenital Dislocation of Hip: Genome-wide Association Study in Grand West France|Research for Genetic Factors Involved in Congenital Dislocation of Hip: Genome-wide Association Study in Grand West France|Recruiting||N/A|1200|Anticipated|University Hospital, Brest|||3||f||||t||||||||||2017-10-10 21:48:58.501521|2017-10-10 21:48:58.501521
NCT02900469|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-03-02|||October 2016||2016-10-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Presurgical Trial of Denosumab in Breast Cancer|Pre-surgical Evaluation of Denosumab in Patients With Operable Invasive Breast Cancer|Recruiting||Early Phase 1|35|Anticipated|New York University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 21:48:58.579181|2017-10-10 21:48:58.579181
NCT02900456|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-08|||January 2015||2015-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01|1 Year|Observational [Patient Registry]|CP-GARO||The Intra-Aortic Balloon Pumps Insertion Registry on Behalf of the Groupe Des Angioplasticiens de la Région Ouest|The Intra-Aortic Balloon Pumps Insertion Registry on Behalf of the Groupe Des Angioplasticiens de la Région Ouest|Recruiting||N/A|200|Anticipated|Rennes University Hospital|||1||f||||f||||||||No||2017-10-10 21:48:58.693498|2017-10-10 21:48:58.693498
NCT02900443|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-01-09|||January 2017||2017-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|CAMARO||Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune Hepatitis|A Randomised, Open-label Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Naive Autoimmune Hepatitis|Recruiting||Phase 4|70|Anticipated|Radboud University||2|||f||||t||||||||Undecided||2017-10-10 21:48:58.869171|2017-10-10 21:48:58.869171
NCT02900430|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-09|||January 2009||2009-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|IA-AML||Invasives Aspergillosis in Acute Myeloid Leukemia|The Incidence of Invasive Aspergillosis in Acute Myeloid Leukemia|Completed||N/A|246|Actual|University Hospital, Brest|||2||f||||f||||||||No||2017-10-10 21:48:59.00201|2017-10-10 21:48:59.00201
NCT02900417|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes|Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes|Not yet recruiting||N/A|9|Anticipated|Second Affiliated Hospital of Soochow University||1|||f||||t||||||||Undecided||2017-10-10 21:48:59.096665|2017-10-10 21:48:59.096665
NCT02900404|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-04-28|||February 15, 2017|Anticipated|2017-02-15|April 2017|2017-04-01|March 31, 2017|Anticipated|2017-03-31|March 31, 2017|Anticipated|2017-03-31||Observational|VeriXAPPORT||Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm|VeriXAPPORT: Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm|Withdrawn||N/A|0|Actual|Bayer|||2|due to release of competing App|f||||f|f|f||||||||2017-10-10 21:48:59.167606|2017-10-10 21:48:59.167606
NCT02900391|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-08|||March 2016||2016-03-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|EPIGER||Urgent Care for the Elderly: Impairment and Home Care Services|Urgent Care for the Elderly: Impairment and Home Care Services|Completed||N/A|3200|Actual|European Georges Pompidou Hospital|||1||f||||f||||||||No||2017-10-10 21:48:59.250363|2017-10-10 21:48:59.250363
NCT02900378|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-10-03|||December 20, 2016|Actual|2016-12-20|October 2017|2017-10-01|July 5, 2018|Anticipated|2018-07-05|July 5, 2018|Anticipated|2018-07-05||Interventional|OUTSTEP-HF||randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure|A Multi-center, Prospective, Randomized, Double-blind Study to Assess the Impact of Sacubitril/Valsartan vs. Enalapril on Daily Physical Activity Using a Wrist Worn Actigraphy Device in Adult Chronic Heart Failure Patients|Recruiting||Phase 3|600|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 21:48:59.3102|2017-10-10 21:48:59.3102
NCT02900365|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-09-08|||March 2014||2014-03-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Early Vs Late Post Traumatic Cataract Surgery|Early Vs Late Post Traumatic Cataract Surgery and Intraocular Lens Implantation|Completed||N/A|60|Actual|Farabi Eye Hospital||2|||f||||t||||||||No||2017-10-10 21:48:59.775608|2017-10-10 21:48:59.775608
NCT02900352|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|Z-Comp||Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action|Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action|Recruiting||Phase 1|160|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 21:48:59.867885|2017-10-10 21:48:59.867885
NCT02900339|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-04-10|||April 2013||2013-04-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|OSS-IRM||Magnetic Resonance Imaging (MRI) Sequences Optimization in Healthy Subjects|MRI Sequences Optimization in Healthy Subjects|Recruiting||N/A|400|Anticipated|Rennes University Hospital||1|||f||||f||||||||No||2017-10-10 21:48:59.976321|2017-10-10 21:48:59.976321
NCT02900326|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-09-13|||May 2015||2015-05-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Mindfulness-based Stress Reduction (MBSR) Program Combined With Endurance Exercise Training: a Help in Treatment for Breast Cancer?|Effect of a Mindfulness-based Stress Reduction (MBSR) Program Combined With Endurance Exercise Training: a Help to Improve Exercise Capacity and Quality of Life in Breast Cancer?|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||4|||f||||f||||||||No||2017-10-10 21:49:00.071988|2017-10-10 21:49:00.071988
NCT02900313|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-29|||October 2015||2015-10-01|June 2015|2015-06-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|PhosphoIRA||Serum Phosphatemia Predictive Marker for AKI Diagnosis After Cardiac Surgery|Predictive Interest of Serum Phosphorus Level in the Early Diagnosis of Acute Renal Insufficiency in Post-operative Immediate at Patients Having Benefited From a Cardiac Surgery.|Completed||N/A|264|Actual|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-10 21:49:00.189706|2017-10-10 21:49:00.189706
NCT02900300|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-13|||October 2016||2016-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|BOTAN||A Biobank for Diaphragm Muscular Fiber|Constitution of a Biobank to Optimize in Vitro an Antioxydant Treatment for Diaphragm Dysfunction Induced by Mechanical Ventilation|Not yet recruiting||N/A|10|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||Undecided||2017-10-10 21:49:00.283487|2017-10-10 21:49:00.283487
NCT02900287|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-13|||January 2015||2015-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Observational|SUCRE||Cancer Survival in Reunion Island , 1998-2008 (SUCRE)|Survie Des Personnes Atteintes de Cancer à la Réunion, 1998-2008 (SUCRE)|Active, not recruiting||N/A|18000|Anticipated|Centre Hospitalier Universitaire de la Réunion|||1||f||||f||||||||No||2017-10-10 21:49:00.339892|2017-10-10 21:49:00.339892
NCT02900274|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-07-20|||September 2016||2016-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||"All Comers Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Extended)"|"All Comers Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes After Plain Old Balloon Angioplasty (POBA) and/or Drug Coated Balloon (DCB) Treatment in the Infra-inguinal Position With the objectiVE to Implant Multiple Stent Segments"|Recruiting||N/A|500|Anticipated|B. Braun Melsungen AG|||1||f||||t||||||||||2017-10-10 21:49:00.407931|2017-10-10 21:49:00.407931
NCT02900261|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Observational|||Study on Sodium and Caffeine in Children and Adolescents|Comparison of Methods to Measure the Consumption of Sodium and Caffeine in Children|Recruiting||N/A|100|Anticipated|University of Lausanne Hospitals|||1||f||||f||||||Samples Without DNA|"     Urine samples   "|Yes|The results of this study will be published in an article. The full dataset will be made available in the DATA@IUMSP repository, http://data.iumsp.ch.|2017-10-10 21:49:00.515922|2017-10-10 21:49:00.515922
NCT02900248|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-10-02|||October 2, 2017|Actual|2017-10-02|October 2017|2017-10-01|October 2024|Anticipated|2024-10-01|October 2021|Anticipated|2021-10-01|5 Years|Observational [Patient Registry]|N1||CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice|Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)|Recruiting||N/A|100000|Anticipated|CureOne|||1||f||||t|f|f||||||||2017-10-10 21:49:00.626393|2017-10-10 21:49:00.626393
NCT02900235|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-01-29|||August 2016||2016-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mass Balance Study of MT-3995|An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-MT-3995 After a Single Oral Dose to Healthy Male Subjects|Completed||Phase 1|9|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-10 21:49:00.781654|2017-10-10 21:49:00.781654
NCT02900222|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-04-19|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Choroid Plexus Cauderization in Patients With Hydrocephalus|Study of Endoscopic Choroid Plexus Cauterization for Adult Patients With Hydrocephalus and Risk Factors for Perioperative Complications Following Shunt Surgery.|Recruiting||N/A|10|Anticipated|University of Miami||1|||f||||f||||||||No||2017-10-10 21:49:00.864666|2017-10-10 21:49:00.864666
NCT02900209|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-05-02|||October 2016||2016-10-01|May 2017|2017-05-01||||August 2017|Anticipated|2017-08-01||Observational|||Influenza Vaccination and COPD Phenotypes|Responses of the Immune System to Influenza Vaccination in Phenotypes of Chronic Obstructive Pulmonary Disease|Active, not recruiting||N/A|54|Actual|University of Lincoln|||3||f||||f||||||Samples Without DNA|"     Venous blood samples will be collected in K3EDTA and serum vacutainer tubes. Saliva samples     will be obtained while participant is seated with the head tilted slightly forward and     passively dribbling into a pre-weighed sterile tube (keeping orofacial movement to a     minimum).      Whole blood samples will be used on the day of collection and analysed before being     appropriately disposed of on the same day. Blood samples will be centrifuged with plasma and     serum frozen at -80c for later analysis. Saliva samples will also be centrifuged with     supernatant frozen at -80c for later analysis.   "|No||2017-10-10 21:49:00.943283|2017-10-10 21:49:00.943283
NCT02900196|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of a Fresh Fermented Dairy Drink Product Consumption on Antibiotic Associated Diarrhea and Gastro-Intestinal Disorders||Recruiting||N/A|295|Anticipated|Danone Research||2|||f||||t||||||||||2017-10-10 21:49:01.039651|2017-10-10 21:49:01.039651
NCT02900183|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-05-17|||October 2016|Anticipated|2016-10-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels|An Open-Label, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Effect on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels of ARC-AAT as Evidenced by Changes in Liver Biopsy in Patients With Alpha-1 Antitrypsin Deficiency (AATD)|Withdrawn||Phase 2|0|Actual|Arrowhead Pharmaceuticals||1||Company decision to not initiate trial|f||||f||||||||No||2017-10-10 21:49:01.141475|2017-10-10 21:49:01.141475
NCT02900170|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-06-22|||July 2016||2016-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?|Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?|Recruiting||N/A|40|Anticipated|Albert Einstein Healthcare Network|||1||f||||f||||||||No||2017-10-10 21:49:01.241051|2017-10-10 21:49:01.241051
NCT02900157|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-28|||August 9, 2016|Actual|2016-08-09|September 2017|2017-09-01|January 9, 2018|Anticipated|2018-01-09|January 9, 2018|Anticipated|2018-01-09||Interventional|||Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors|A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|42|Actual|MedImmune LLC||1|||f||||f||||||||||2017-10-10 21:49:01.345315|2017-10-10 21:49:01.345315
NCT02900144|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-01-06|||September 2016||2016-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|M_CBIT||Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)|Modified Comprehensive Behavioral Intervention for Tics: Treating Children With Tic Disorders, Co-occurring ADHD and Psychosocial Impairment|Recruiting||N/A|20|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 21:49:01.492673|2017-10-10 21:49:01.492673
NCT02900131|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-05-30|||September 19, 2016|Actual|2016-09-19|May 2017|2017-05-01|March 16, 2017|Actual|2017-03-16|March 16, 2017|Actual|2017-03-16||Interventional|||Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients|Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients: a Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 2|34|Actual|Kyung Hee University Hospital at Gangdong||3|||f||||t||||||||Undecided||2017-10-10 21:49:01.698182|2017-10-10 21:49:01.698182
NCT02900118|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||August 2012||2012-08-01|September 2016|2016-09-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Observational|||Imaging Evaluation of the Therapeutic Response of Breast Cancer Bone Metastasis (EMOS)|Imaging Evaluation of the Therapeutic Response of Breast Cancer Bone Metastasis|Completed||N/A|28|Actual|Centre Oscar Lambret|||3||f||||f||||||||No||2017-10-10 21:49:01.810077|2017-10-10 21:49:01.810077
NCT02900105|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-15|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia.|Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia.|Completed||Phase 3|28|Actual|KK Women's and Children's Hospital||1|||f||||||||||||||2017-10-10 21:49:01.909809|2017-10-10 21:49:01.909809
NCT02900092|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-01|||November 2016||2016-11-01|March 2017|2017-03-01||||August 2018|Anticipated|2018-08-01||Interventional|||Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone|Treatment-Resistant Depression Augmentation Therapy With An Analog of the Neuroactive Steroid Allopregnanolone: A Pilot Study|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-10 21:49:01.991996|2017-10-10 21:49:01.991996
NCT02900079|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-18|||February 1, 2018|Anticipated|2018-02-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01|6 Months|Observational [Patient Registry]|JOKA-I||Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International Travelers|New Tools for Diagnosis and Management of Febrile Illness in Travelers to the Tropics: a Cohort Study- JOKA I|Suspended||N/A|4500|Anticipated|Institute of Tropical Medicine, Belgium|||1|delays in obtaining study materials|f||||t||||||Samples Without DNA|"     sera, capillary blood   "|||2017-10-10 21:49:02.075667|2017-10-10 21:49:02.075667
NCT02900066|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-09-08|||February 2016||2016-02-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01|6 Months|Observational [Patient Registry]|JOKA-II||Filter Paper Blood Spots Collected During Fever as a Source for Post-travel Diagnosis in Travelers|Filter Paper Blood Spots Collected During Fever as a Source for Post-travel Diagnosis of Arboviral and Rickettsial Infections in a Cohort of Travelers|Recruiting||N/A|4500|Anticipated|Institute of Tropical Medicine, Belgium|||1||f||||t||||||Samples Without DNA|"     sera, capillary blood   "|No||2017-10-10 21:49:02.163584|2017-10-10 21:49:02.163584
NCT02900053|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-02|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|T-TREAt||Post-traumatic Stress Disorder Treatment Using Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy : a Two-arm Randomized Controlled Multicentric Study.|Post-traumatic Stress Disorder Treatment Using Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy : a Two-arm Randomized Controlled Multicentric Study - T-TREAt|Recruiting||N/A|64|Anticipated|University Hospital, Tours||2|||f||||f||||||||No||2017-10-10 21:49:02.240764|2017-10-10 21:49:02.240764
NCT02900040|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-14|||January 1994||1994-01-01|September 2016|2016-09-01|January 2050|Anticipated|2050-01-01|January 2050|Anticipated|2050-01-01|30 Years|Observational [Patient Registry]|DIVAT||Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation|The French DIVAT: a Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation|Recruiting||N/A|30000|Anticipated|Nantes University Hospital|||1||f||||t||||||Samples With DNA|"     peripheral blood cells, serum, plasma, urine, m-RNA, and DNA of recipients and donors   "|||2017-10-10 21:49:02.3474|2017-10-10 21:49:02.3474
NCT02900027|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-02-06|||September 2016||2016-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides|Placebo-Controlled, Dose-Escalation Study to Assess Safety, Tolerability, PK and PD of a GalNAc3 Conjugated Antisense Oligonucleotide Targeting ApoC-III, Administered Subcutaneously to Healthy Volunteers With Elevated Triglycerides|Recruiting||Phase 1|56|Anticipated|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 21:49:02.427956|2017-10-10 21:49:02.427956
NCT02900014|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-13|||August 2015||2015-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Validation of a Production Method of Stem Cell Isolated From the Nasal Cavity for an Innovative Cell Therapy of Cleft Palate||Recruiting||N/A|5|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:49:02.518686|2017-10-10 21:49:02.518686
NCT02900001|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-29|||December 1, 2016|Actual|2016-12-01|September 2017|2017-09-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|DEAR-OLD||Routinely Deferred Versus Early Intervention in Elderly Patients With Non-ST-elevation Myocardial Infarction|Routinely Deferred Versus Early Invasive Strategy in Chinese Patients of 75 Years or Older With Non-ST-elevation Myocardial Infarction - a Multicenter, Open-label, Randomized Controlled Clinical Trial.|Recruiting||N/A|696|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-10 21:49:02.585583|2017-10-10 21:49:02.585583
NCT02899806|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-07-31|||September 2015||2015-09-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2015|Actual|2015-10-01||Interventional|VIDEOCLIP||Impact of a Video Explaining Epidural Analgesia in Obstetrics|Impact of a Video Explaining Epidural Analgesia in Obstetrics in Terms of Satisfaction, Understanding and Anxiety: A Prospective Randomised Trial|Active, not recruiting||N/A|301|Actual|Centre Hospitalier Intercommunal Creteil||2|||f||||f||||||||||2017-10-10 21:49:04.456171|2017-10-10 21:49:04.456171
NCT02899975|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-09-13|||January 2016||2016-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|WTCValIII||Interventional Validation Study (WeTakeCare-Project)|Interventional Study to Validate a Investigational Fitness and Information Software for Healthy Elderly and Their Informal Caregivers Within the Scope of the EU (European Union) (AAL: Ambient Active Living) Project WeTakeCare|Completed||N/A|13|Actual|Zurich University of Applied Sciences||1|||f||||f||||||||No||2017-10-10 21:49:02.826358|2017-10-10 21:49:02.826358
NCT02899962|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-08-28|||February 15, 2017|Actual|2017-02-15|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris|LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris|Recruiting||Phase 3|832|Anticipated|LEO Pharma||2|||f||||f|t|f||||||||2017-10-10 21:49:02.901215|2017-10-10 21:49:02.901215
NCT02899949|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-06|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin|Real-world Data on Dapagliflozin: Characteristics and Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin|Completed||N/A|212|Actual|Lawson Health Research Institute|||1||f||||f||||||||No||2017-10-10 21:49:03.250768|2017-10-10 21:49:03.250768
NCT02899936|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-03-27|||July 2016||2016-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis|Community Based Safety Study of 2-drug (Diethylcarbamazine and Albendazole) Versus 3-drug (Ivermectin, Diethylcarbamazine and Albendazole) Therapy for Lymphatic Filariasis|Recruiting||N/A|38000|Anticipated|Washington University School of Medicine||2|||f||||t||||||||Yes|Datasets used for published results will be shared publically through a journal or other open source data repository so that the broader scientific community can access it. Only de-identified data will be shared publicly.|2017-10-10 21:49:03.335666|2017-10-10 21:49:03.335666
NCT02899923|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-08|||January 2010||2010-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|REGIBUL||Register of Autoimmune Bullous Dermatoses|Register of Autoimmune Bullous Dermatoses|Recruiting||N/A|750|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 21:49:03.471004|2017-10-10 21:49:03.471004
NCT02899910|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-12-30|||June 2013||2013-06-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Nutrition and Exercise Study to Understand Metabolic Syndrome|Nutrition and Exercise Study to Understand Metabolic Syndrome|Completed||Phase 2|67|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||No||2017-10-10 21:49:03.563567|2017-10-10 21:49:03.563567
NCT02899897|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|DYSPRED||Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysfunction|Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysfunction: a Multicentre Prospective Study|Active, not recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:49:03.661965|2017-10-10 21:49:03.661965
NCT02899884|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-05-18|||November 14, 2016|Actual|2016-11-14|May 2017|2017-05-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Observational|||Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain|Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain|Recruiting||N/A|13200|Anticipated|Takeda|||1||f||||f||||||||||2017-10-10 21:49:03.744029|2017-10-10 21:49:03.744029
NCT02899871|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-11-29|||September 2014||2014-09-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|ArthralgieMICI||Joint Pain Occurring During Anti-TNF Therapy in Chronic Inflammatory Bowel Disease|Joint Pain Occurring During Anti-TNF Therapy in Chronic Inflammatory Bowel Disease|Completed||N/A|99|Actual|Centre Hospitalier Universitaire, Amiens|||2||f||||||||||||||2017-10-10 21:49:03.934642|2017-10-10 21:49:03.934642
NCT02899858|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-08|||January 2015||2015-01-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ISMS||Restoration of Standing and Walking With ISMS in Humans|Restoration of Standing and Walking With ISMS in Humans|Recruiting||N/A|2|Anticipated|Vanderbilt University||1|||f||||t||||||||Yes|Data will be shared with the DSMB when screening and recruiting subjects and when a subject exits the study|2017-10-10 21:49:04.023276|2017-10-10 21:49:04.023276
NCT02899845|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-09|||November 2015||2015-11-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||"Study of Improving Gait Parameters When Using a Cane in Light Touch Condition in Elderly People With and Without Walking Difficulties"||Recruiting||N/A|24|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:49:04.162406|2017-10-10 21:49:04.162406
NCT02899832|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||December 2012||2012-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SPASMES-NIRS||A Study of Hemodynamic Changes Using Near Infra-red Spectrometry (NIRS) in Infantile Epilepsy Spasms|A Study of Hemodynamic Changes Using Near Infra-red Spectrometry (NIRS) in Infantile Epilepsy Spasms|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:49:04.26787|2017-10-10 21:49:04.26787
NCT02899819|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||February 2011||2011-02-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|MecoExpo||MecoExpo Study Protocol|MecoExpo Study Protocol|Completed||N/A|1020|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-10 21:49:04.363681|2017-10-10 21:49:04.363681
NCT02899780|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2017-04-05|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light|Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light|Recruiting||N/A|10|Anticipated|Ultraviolet Interventions||1|||f||||f||||||||No||2017-10-10 21:49:04.623046|2017-10-10 21:49:04.623046
NCT02899767|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-08|||January 2014||2014-01-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Observational|||Transfusion in Adult Acute Myeloid Leukemia|Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukemia|Completed||N/A|1067|Actual|Hospices Civils de Lyon|||1||f||||||||||||||2017-10-10 21:49:04.704163|2017-10-10 21:49:04.704163
NCT02899754|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-04-14|||July 2018|Anticipated|2018-07-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|VA-LCSDecTool||Lung Cancer Screening Decisions|Incorporating Veterans Preferences Into Lung Cancer Screening Decisions|Not yet recruiting||N/A|200|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 21:49:04.764726|2017-10-10 21:49:04.764726
NCT02899741|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-10-05|||August 2016||2016-08-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study||Recruiting||Phase 2|30|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 21:49:04.874116|2017-10-10 21:49:04.874116
NCT02899728|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-13|2017-09-04|||April 7, 2017|Actual|2017-04-07|May 2017|2017-05-01|April 7, 2020|Anticipated|2020-04-07|April 7, 2020|Anticipated|2020-04-07||Interventional|||Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer|A Phase II Study of Olaparib Plus Cediranib in Combination With Standard Therapy for Small Cell Lung Cancer|Suspended||Phase 2|132|Anticipated|National Cancer Institute (NCI)||2||Other - Pending response to FDA comments|f||||t|t|f||||||||2017-10-10 21:49:04.978895|2017-10-10 21:49:04.978895
NCT02899702|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-08|||January 2017||2017-01-01|August 2016|2016-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|IGHN2||Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children|Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children: a Multicentre European Randomized Controlled Trial|Not yet recruiting||Phase 4|156|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||No||2017-10-10 21:49:05.146503|2017-10-10 21:49:05.146503
NCT02899689|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01||||October 2018|Anticipated|2018-10-01||Interventional|||Induction of Labor in Women With Unfavorable Cervix: Dilapan Versus Foley Bulb|Induction of Labor in Women With Unfavorable Cervix: Randomized Control Study Comparing Dilapan to Foley Bulb|Recruiting||N/A|420|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||No||2017-10-10 21:49:05.238782|2017-10-10 21:49:05.238782
NCT02899676|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-08|||March 2014||2014-03-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Cerebral Bases of Arithmetics Processing|Neural Bases of Arithmetic Processing: MRIf Study in Adults and Children|Recruiting||N/A|90|Anticipated|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-10 21:49:05.322754|2017-10-10 21:49:05.322754
NCT02899663|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-13|||January 2015||2015-01-01|September 2016|2016-09-01||||August 2015|Actual|2015-08-01||Observational|SWIGLI||MRI Detection of Microbleeds in Glioma Patients|Detection of Microbleeds With MRI (SWI Sequences) in Glioma Patients|Completed||N/A|58|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:49:05.402595|2017-10-10 21:49:05.402595
NCT02899650|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-18|||August 2016||2016-08-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Rates of Recovery From Strenuous Exercise in Physically Active Older Adults|Rates of Recovery From Strenuous Exercise in Physically Active Older Adults|Recruiting||N/A|60|Anticipated|University of Texas at Austin||4|||f||||f||||||||||2017-10-10 21:49:05.451068|2017-10-10 21:49:05.451068
NCT02899637|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-13|||October 2016||2016-10-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Transcranial Magnetic Stimulation in Incomplete Spinal Cord Injury|Effects of High-Frequency Transcranial Magnetic Stimulation on Functional Performance of Subjects With Incomplete Spinal Cord Injury: Study Protocol for a Randomized Controlled Trial|Not yet recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 21:49:05.542113|2017-10-10 21:49:05.542113
NCT02899624|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-09|||January 2014||2014-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Whole Exome Sequencing in Bicuspid Aortic Valve Patients||Recruiting||N/A|427|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||No||2017-10-10 21:49:05.625968|2017-10-10 21:49:05.625968
NCT02899611|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures|A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization|Recruiting||Phase 1/Phase 2|12|Anticipated|Cerebral Therapeutics LLC||1|||f||||t||||||||No||2017-10-10 21:49:05.709654|2017-10-10 21:49:05.709654
NCT02899598|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-09|||July 2013||2013-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|||Genotyping of Human Platelet Alloantigens : Non-invasive Prenatal Diagnosis||Active, not recruiting||N/A|48|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:49:05.80154|2017-10-10 21:49:05.80154
NCT02899585|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-14|||January 2015||2015-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|EIVA||Expression of a Need of Implication for the Vulnerable Patient and His Adaptation||Recruiting||N/A|610|Anticipated|Hopital Foch||2|||f||||t||||||||Yes||2017-10-10 21:49:05.910769|2017-10-10 21:49:05.910769
NCT02899572|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-14|||June 2015||2015-06-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|RADOTES||Impact of a Sexology Consultation on Disease Control of Type 2 Male Diabetics With Erectile Dysfunction|Impact of a Sexology Consultation on Diabetes Disease Control of Type 2 Male Diabetics With Erectile Dysfunction: a Monocentric Randomised Comparative Study|Recruiting||N/A|64|Anticipated|Centre Hospitalier Universitaire de la Réunion||2|||f||||t||||||||No||2017-10-10 21:49:06.01186|2017-10-10 21:49:06.01186
NCT02899559|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Messages and Plans to Increase Gym Utilization||Not yet recruiting||N/A|1000|Anticipated|University of Pennsylvania||3|||f||||f||||||||||2017-10-10 21:49:06.092262|2017-10-10 21:49:06.092262
NCT02899546|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-13|||November 2015||2015-11-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Observational|Septi-PICC||Study of Peripherally Inserted Central Catheter (PICC)-Related Infections in a Tropical Area|Suivi Prospectif Des Complications Infectieuses liées Aux PICC Lines en Milieu Tropical|Recruiting||N/A|400|Anticipated|Centre Hospitalier Universitaire de la Réunion|||1||f||||t||||||||||2017-10-10 21:49:06.180309|2017-10-10 21:49:06.180309
NCT02899533|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-03-15|||July 2016||2016-07-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||[18F]FES PET/CT in PAH|[18F]Fluoroestradiol (FES) PET/CT Imaging To Evaluate In Vivo ER In Patients With Pulmonary Arterial Hypertension|Recruiting||Phase 1|10|Anticipated|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 21:49:06.261172|2017-10-10 21:49:06.261172
NCT02899507|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-09-08|||September 2013||2013-09-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Prophylactic Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest|Prophylactic Versus Clinically-driven Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest|Completed||Phase 4|60|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||No||2017-10-10 21:49:06.445583|2017-10-10 21:49:06.445583
NCT02899494|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-14|||October 2012||2012-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|NaitreEnchan||"Effect of the Adjusted Vocal Expression Method on the Satisfaction of Parturients About Their Childbirth"|"Effect of the Adjusted Vocal Expression Method on the Satisfaction of Parturients About Their Childbirth (NaîtreEnchanté)"|Recruiting||N/A|300|Anticipated|Hopital Foch||2|||f||||f||||||||No||2017-10-10 21:49:06.546343|2017-10-10 21:49:06.546343
NCT02899481|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-09-13|||July 2016||2016-07-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Role of Intrapartum Ultrasound in Instrumental Delivery|Role of Intrapartum Ultrasound in the Efficacy of an Instrumental Delivery|Recruiting||N/A|600|Anticipated|University of Lisbon||2|||f||||t||||||||Undecided||2017-10-10 21:49:06.63953|2017-10-10 21:49:06.63953
NCT02899468|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-16|||January 2016||2016-01-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of a Novel Integrative and Intensive Virtual Rehabilitation Program for Service Members Post TBI|Evaluation of a Novel Integrative and Intensive Virtual Rehabilitation Program for Service Members Post TBI|Recruiting||N/A|20|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-10-10 21:49:06.724824|2017-10-10 21:49:06.724824
NCT02899442|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-08|||September 2015||2015-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|Heart-Of-Night||Cardiovascular Risk Prevention Among Night Workers|Cardiovascular Risk Prevention Among Night Workers|Recruiting||N/A|3056|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||Undecided||2017-10-10 21:49:08.704404|2017-10-10 21:49:08.704404
NCT02899429|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-08|||December 2014||2014-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECHOPSO||Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients With Atypical Form of Psoriasis|Systematic Descriptive Experimental Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients Presenting an Atypical Form of Psoriasis|Completed||N/A|50|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:49:08.811746|2017-10-10 21:49:08.811746
NCT02899416|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-21|||February 23, 2017|Actual|2017-02-23|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|BELINDA||Better Life by Nutrition During Adulthood|Better Life by Nutrition During Adulthood : Identification of Factors Present in Adolescence Cardiovascular Risk in Young Adults|Recruiting||N/A|330|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||Samples With DNA|"     DNA used for telemore length   "|||2017-10-10 21:49:08.876497|2017-10-10 21:49:08.876497
NCT02899403|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-06-06|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PharmacogWP3||Neurophysiological Correlates of Cognitive Tasks in Healthy Volunteers -WP3 P003|Neurophysiological Correlates of Cognitive Tasks in Healthy Volunteers -A Pilot Study WP3 P003|Enrolling by invitation||N/A|20|Anticipated|University Hospital, Lille||1|||f||||f|f|f||||||No||2017-10-10 21:49:08.983347|2017-10-10 21:49:08.983347
NCT02899390|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-07-20|||September 2016||2016-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes|Adaptation and Evaluation of a Diabetes Prevention Program About Parameters of Obesity, Physical Activity and Biochemical Parameters in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes|Completed||N/A|14|Actual|Centro de Investigación en Alimentación y Desarrollo A.C.||1|||f||||f||||||||||2017-10-10 21:49:09.079089|2017-10-10 21:49:09.079089
NCT02899377|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-09-14|||November 18, 2016|Actual|2016-11-18|September 2017|2017-09-01|May 18, 2018|Anticipated|2018-05-18|May 18, 2018|Anticipated|2018-05-18||Interventional|||A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts|A Pilot Study to Evaluate Molecular Imaging Methods in Primary Sjögren's Syndrome|Recruiting||Phase 1|16|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 21:49:09.178697|2017-10-10 21:49:09.178697
NCT02899364|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|GIPS-IV||Sodium Thiosulfate to Preserve Cardiac Function in STEMI|Groningen Intervention Study for the Preservation of Cardiac Function With Sodium Thiosulfate After ST-segment Elevation Myocardial Infarction|Not yet recruiting||Phase 2|380|Anticipated|University Medical Center Groningen||2|||f||||t||||||||No||2017-10-10 21:49:09.317663|2017-10-10 21:49:09.317663
NCT02899351|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-06-13|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||The Evaluation of a Noninvasive Respiratory Monitor in Intubated Infants|The Evaluation of a Noninvasive Respiratory Monitor in Intubated Infants|Recruiting||N/A|30|Anticipated|Boston Children’s Hospital|||1||f||||||||||||||2017-10-10 21:49:09.619208|2017-10-10 21:49:09.619208
NCT02899338|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-03-14|||September 2016||2016-09-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Pharmakokinetics and Safety of BI 695501|Randomized, Single-dose, Parallel-arm, Open-label Phase I Trial to Compare the Pharmacokinetics, Safety and Tolerability of BI 695501 Administered Subcutaneously Via Prefilled Syringe or Autoinjector|Completed||Phase 1|162|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:49:09.701041|2017-10-10 21:49:09.701041
NCT02899325|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2016-09-13|||October 2016||2016-10-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Observational|||FDGal PET/CT to Detect Hepatocellular Carcinoma|A Single-blind Study to Evaluate the Efficacy and Safety of 18F-Fluorodeoxygalactose (18F-FDGal) Compared to 18F-Fluorodeoxyglucose (18F-FDG) to Detect Hepatocellular Carcinoma Via PET/CT in Patients With Cirrhosis or Chronic Liver Disease|Not yet recruiting||N/A|200|Anticipated|British Columbia Cancer Agency|||1||f||||t||||||||No|There is no plan to share individual participant data.|2017-10-10 21:49:09.789295|2017-10-10 21:49:09.789295
NCT02899312|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-09|2017-07-18|||March 16, 2017|Actual|2017-03-16|September 2016|2016-09-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Observational|||PSMA PET/CT for Assessment of Recurrent Prostate Cancer|Fluorine-18 - 2-(3-(1-carboxy-5-[(6-[18F]Fluoro-pyridine-3-carbonyl)-Amino]-Pentyl)-Ureido)-Pentanedioic Acid (18F-DCFPyL) Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of Recurrent Prostate Cancer|Recruiting||N/A|200|Anticipated|British Columbia Cancer Agency|||1||f||||f||||||||||2017-10-10 21:49:09.883233|2017-10-10 21:49:09.883233
NCT02899299|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-26|||October 25, 2016|Actual|2016-10-25|September 2017|2017-09-01|September 28, 2021|Anticipated|2021-09-28|October 4, 2020|Anticipated|2020-10-04||Interventional|CheckMate743||Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients|A Phase III, Randomized, Open Label Trial of Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma|Recruiting||Phase 3|600|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 21:49:09.996365|2017-10-10 21:49:09.996365
NCT02899286|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-07-27|||September 2016||2016-09-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase II Open-label Study of the Efficacy and Safety of Recombinant Human Arginase 1 (PEG-BCT-100) in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Active, not recruiting||Phase 2|25|Anticipated|Bio-Cancer Treatment International Limited||1|||f||||t||||||||||2017-10-10 21:49:10.555049|2017-10-10 21:49:10.555049
NCT02899273|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01|1 Day|Observational [Patient Registry]|ECC-ET||Perception of Early Childhood Caries|Perception of Early Childhood Caries - an Eye-tracking Study|Not yet recruiting||N/A|40|Anticipated|University of Göttingen|||2||f||||f||||||||Undecided||2017-10-10 21:49:10.64946|2017-10-10 21:49:10.64946
NCT02899260|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-20|||August 2016||2016-08-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Using the Peanut Exercise Ball to Reduce Cesarean Section Rates: A Randomized Controlled Trial|Using the Peanut Exercise Ball to Reduce Cesarean Section Rates: A Randomized Controlled Trial|Recruiting||N/A|2004|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||Yes|Plan to make individual data available on clinical trials.gov at conclusion of study.|2017-10-10 21:49:10.72313|2017-10-10 21:49:10.72313
NCT02899247|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-13|||April 2011||2011-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|October 2011|Actual|2011-10-01||Interventional|||A 5-year Clinical Trial Assessing the Effects of a Surface Sealant on Composite Resin Class I Restorations||Completed||Phase 4|10|Actual|Universidade Federal de Sergipe||2|||f||||||||||||||2017-10-10 21:49:10.817095|2017-10-10 21:49:10.817095
NCT02899234|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Acute Cardiorespiratory Effects of E-cigarette Inhalation|Acute Health Effects of Exposure to Active E-cigarette Inhalation in Healthy Volunteers|Recruiting||N/A|20|Anticipated|Umeå University||2|||f||||f||||||||Undecided||2017-10-10 21:49:10.980058|2017-10-10 21:49:10.980058
NCT02899221|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01||||September 2020|Anticipated|2020-09-01||Interventional|||Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation|Phase I Study of Hyperthermia Combined With High Dose Rate Salvage Radiotherapy for the Treatment of Radiation Recurrent Prostate Cancer|Not yet recruiting||Phase 1|24|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 21:49:11.083522|2017-10-10 21:49:11.083522
NCT02899208|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-06-28|||September 2016||2016-09-01|June 2017|2017-06-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Observational|||Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients?|Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients?|Completed||N/A|40|Actual|Zealand University Hospital|||1||f||||t||||||||No||2017-10-10 21:49:11.168251|2017-10-10 21:49:11.168251
NCT02899195|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-30|||June 13, 2017|Actual|2017-06-13|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|PrE0505||Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma|Open Label, Phase II Study of Anti - Programmed Death - Ligand 1 Antibody, Durvalumab (MEDI4736), in Combination With Chemotherapy for the First-Line Treatment of Unresectable Mesothelioma|Recruiting||Phase 2|55|Anticipated|PrECOG, LLC.||2|||f||||t|t|f||||||||2017-10-10 21:49:11.252874|2017-10-10 21:49:11.252874
NCT02899182|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-09-13|||April 2016||2016-04-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Mixture Nitrous Oxide - Oxygen 50-50% in Transrectal Prostate Biopsy Guided by Ultrasound|Mixture Nitrous Oxide - Oxygen 50-50% in Transrectal Prostate Biopsy Guided by Ultrasound|Recruiting||Phase 1/Phase 2|84|Anticipated|Universidade Federal Fluminense||2|||f||||f||||||||No||2017-10-10 21:49:11.450979|2017-10-10 21:49:11.450979
NCT02899169|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-13|||September 2016||2016-09-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)|Treatment of Non-high-risk Acute Promyelocytic Leukemia With Realgar-Indigo Naturalis Formula (RIF) and All-trans Retinoid Acid (ATRA)|Recruiting||Phase 3|110|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||Undecided||2017-10-10 21:49:11.54624|2017-10-10 21:49:11.54624
NCT02899156|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-05-24|||March 2016||2016-03-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|FLYP||Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Toxicity|Effect of Flumazenil on Hypoactive Delirium Secondary to Benzodiazepine Toxicity in the ICU|Recruiting||Phase 4|80|Anticipated|University of California, Davis||2|||f||||t||||||||Undecided||2017-10-10 21:49:11.701453|2017-10-10 21:49:11.701453
NCT02899143|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2018|Anticipated|2018-09-01||Interventional|||Short-course Antimicrobial Therapy in Sepsis|Trial of Short-Course Antimicrobial Therapy for Sepsis in Intensive Care|Recruiting||Phase 2|320|Anticipated|Ospedale Santa Maria delle Croci||2|||f||||t||||||||||2017-10-10 21:49:11.864492|2017-10-10 21:49:11.864492
NCT02899130|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Polyherbal Formulation in Chronic Inactive Carriers of Hepatitis B Virus|Antiviral Effect of 3 Herbs in Chronic Inactive Carriers of Hepatitis B Virus. - A Randomized Placebo Controlled Clinical Trial|Recruiting||N/A|80|Anticipated|Organic India||2|||f||||t||||||||Undecided||2017-10-10 21:49:11.967913|2017-10-10 21:49:11.967913
NCT02899117|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-02-15|||August 2014||2014-08-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|||Yoga Intervention to Improve Pediatric Cancer Patients' Sleep & Life Quality and Parents' Well-Being|Pilot Yoga Intervention to Improve Pediatric Cancer Patients' Sleep & Life Quality and Parents' Well-Being|Completed||N/A|23|Actual|Connecticut Children's Medical Center||1|||f||||f||||||||No||2017-10-10 21:49:12.059498|2017-10-10 21:49:12.059498
NCT02899091|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of CB-AC-02 in Patients With Alzheimer's Disease|A Randomized, Double-blind, Placebo-controlled, Phase I / IIa Clinical Trial for Evaluation of Safety and Potential Therapeutic Effect After Transplantation of CB-AC-02 in Patients With Alzheimer's Disease|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|CHABiotech CO., Ltd||2|||f||||t||||||||||2017-10-10 21:49:12.24651|2017-10-10 21:49:12.24651
NCT02899078|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|||Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer|Phase Ib/II Trial of Ibrutinib Plus Nivolumab in Patients With Previously-Treated Metastatic Renal Cell Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 21:49:12.346811|2017-10-10 21:49:12.346811
NCT02899065|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-10-03|||May 8, 2017|Actual|2017-05-08|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|Influenza||Evaluation of the Cepheid Genexpert Flu/RSV Assay for Management of Influenza in the Emergency Department|Evaluation of the Cepheid Genexpert Flu/RSV Assay for Management of Influenza in the Emergency Department|Recruiting||N/A|200|Anticipated|University of California, Davis||2|||f||||f|f|t|f|f||||||2017-10-10 21:49:12.448846|2017-10-10 21:49:12.448846
NCT02899052|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-29|||January 19, 2017|Actual|2017-01-19|September 2017|2017-09-01|December 22, 2020|Anticipated|2020-12-22|March 27, 2020|Anticipated|2020-03-27||Interventional|||Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (MM)|A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 2|40|Anticipated|AbbVie||1|||t||||f|t|f||||||||2017-10-10 21:49:12.56339|2017-10-10 21:49:12.56339
NCT02899039|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-12|||July 2012||2012-07-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|G4-FH||Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease|Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease|Completed||N/A|75|Actual|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-10 21:49:12.688418|2017-10-10 21:49:12.688418
NCT02899026|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-05-22|||March 15, 2018|Anticipated|2018-03-15|May 2017|2017-05-01|August 26, 2021|Anticipated|2021-08-26|August 26, 2020|Anticipated|2020-08-26||Interventional|||Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Sirukumab in Subjects With Polymyalgia Rheumatica|Not yet recruiting||Phase 3|150|Anticipated|GlaxoSmithKline||3|||f||||t|t|f||||||No||2017-10-10 21:49:12.76316|2017-10-10 21:49:12.76316
NCT02899013|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-05|||July 2015||2015-07-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|LAPCROHN||Description of Perianal Lesions in a Cohort of Crohn's Disease Patients|Description of Perianal Lesions in a Cohort of Crohn's Disease Patients|Completed||N/A|200|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||||||2017-10-10 21:49:12.884962|2017-10-10 21:49:12.884962
NCT02899000|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-12-22|||July 2016||2016-07-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Treatment for Severe Inflammatory Acne Subjects|Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Doxycycline in Severe Inflammatory Acne (Non-Nodulocystic) Subjects|Active, not recruiting||Phase 4|180|Anticipated|Galderma Laboratories, L.P.||1|||f||||f||||||||No||2017-10-10 21:49:12.959255|2017-10-10 21:49:12.959255
NCT02898987|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-08|||January 2016||2016-01-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|Dataids_PEC||Quality of Care in French HIV Infected Patients|Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients|Enrolling by invitation||N/A|30000|Actual|DatAids|||1||f||||f||||||||No||2017-10-10 21:49:13.076051|2017-10-10 21:49:13.076051
NCT02898974|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-07-18|||September 2016||2016-09-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Observational|||Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis|Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study|Recruiting||N/A|32|Anticipated|Colorado State University|||2||f||||f||||||||||2017-10-10 21:49:13.157783|2017-10-10 21:49:13.157783
NCT02898961|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-02-02|||October 2014||2014-10-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Aminoside_II||Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis|Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis|Completed||Phase 4|63|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||||||||||||2017-10-10 21:49:13.406054|2017-10-10 21:49:13.406054
NCT02898948|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||February 2016||2016-02-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|PCT-MI||Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department|Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department|Recruiting||N/A|133|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:49:13.506522|2017-10-10 21:49:13.506522
NCT02898935|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08||||||September 2016|2016-09-01||||April 2018|Anticipated|2018-04-01||Observational|ELEC3D||Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy||Not yet recruiting||N/A|30|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:49:13.626905|2017-10-10 21:49:13.626905
NCT02898909|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-02-06|||November 15, 2016|Actual|2016-11-15|February 2017|2017-02-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|SLICES||Comparison of Two Fragmentation Modalities in Femtosecond Laser-assisted Cataract Surgery||Recruiting||N/A|60|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 21:49:13.787651|2017-10-10 21:49:13.787651
NCT02898896|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||September 2016||2016-09-01|January 2016|2016-01-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|||Coronary Artery Disease (CAD) in Suppressed HIV-infected|Asymptomatic Obstructive Coronary Artery Disease (CAD) in Suppressed HIV-infected Patients ≥ 45 Years and 2 or More CV Risk Factors. Associations With Persistent Immune Activation and Microbial Translocation|Not yet recruiting||N/A|200|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:49:13.887071|2017-10-10 21:49:13.887071
NCT02898883|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-12|||October 2015||2015-10-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|BRACE||Building Resilience After Childhood Emergencies (BRACE)|Building Resilience After Childhood Emergencies (BRACE): A Randomized Trial Examining Efficacy and Feasibility|Recruiting||N/A|100|Anticipated|Case Western Reserve University||2|||f||||f||||||||No||2017-10-10 21:49:13.976671|2017-10-10 21:49:13.976671
NCT02898857|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|NOTCH||Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma|CHEMO RESISTANCE TO PLATINUM COMPOUNDS AND NOTCH PATHWAYS IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHRERAPY FOR LOCALLY ADVANCED ADENOCARCINOMA OF THE LUNG.|Recruiting||N/A|18|Anticipated|University Hospital, Montpellier|||3||f||||t||||||||Undecided||2017-10-10 21:49:14.139896|2017-10-10 21:49:14.139896
NCT02898844|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||October 2013||2013-10-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Randomized Controlled Experiment of Dieting in Pairs|Randomized Controlled Experiment of Dieting in Pairs|Completed||N/A|164|Actual|University of California, Los Angeles||3|||f||||f||||||||Undecided||2017-10-10 21:49:14.230283|2017-10-10 21:49:14.230283
NCT02898831|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-20|||April 2016||2016-04-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Cold Compress for Pain Associated With Intrauterine Device Insertion|Cold Compress for Pain Associated With Intrauterine Device Insertion: A Randomized Controlled Trial|Recruiting||N/A|138|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||Yes|Plan to make data visable on clinicaltrials.gov at the conclusion of the study.|2017-10-10 21:49:14.320418|2017-10-10 21:49:14.320418
NCT02898818|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-04-27|||April 19, 2017|Actual|2017-04-19|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01|5 Years|Observational [Patient Registry]|||Vaginal and Oral Microbiome Crosstalk|EMMI - Emättimen Mikrobiomi - Emättimen ja Suun Limakalvojen Vuorovaikutus|Recruiting||N/A|520|Anticipated|Turku University Hospital|||5||f||||f||||||Samples With DNA|"     swab sample from vaginal ja oral smear, including microbes and epithelial cells   "|Undecided||2017-10-10 21:49:14.41591|2017-10-10 21:49:14.41591
NCT02898805|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||January 2016||2016-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|LopiWEB||Effects of LopiGLIK® on Cardiovascular Risk|Effects of a New Combination of Nutraceutics (LopiGLIK®) on Cardiovascular Risk|Recruiting||N/A|600|Anticipated|Federico II University||2|||f||||t||||||||Yes|Data available to principal investigator|2017-10-10 21:49:14.513702|2017-10-10 21:49:14.513702
NCT02898792|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||July 2016||2016-07-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|AROSA||Remifentanil in Adults With OSA|Opioid Sensitivity in Adults With Treated and Untreated Obstructive Sleep Apnea|Recruiting||Early Phase 1|60|Anticipated|Washington University School of Medicine||3|||f||||f||||||||No||2017-10-10 21:49:14.621377|2017-10-10 21:49:14.621377
NCT02898779|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-07-20|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1|Development of Safer Drugs for Malaria in U.S. Troops, Civilian Personnel, and Travelers: Clinical Evaluation of Primaquine Enantiomer|Recruiting||Phase 1|36|Anticipated|University of Mississippi, Oxford||2|||f||||f|t|f||||||||2017-10-10 21:49:14.752899|2017-10-10 21:49:14.752899
NCT02898766|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-10-10|||August 2016||2016-08-01|September 2016|2016-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Glycemic Response to Two Enteral Formulas in Persons With Type 2 Diabetes Mellitus|Plasma Glucose and Insulin Response to Two Enteral Formulas in Persons With Type 2 Diabetes Mellitus|Completed||N/A|12|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 21:49:14.884856|2017-10-10 21:49:14.884856
NCT02898753|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-20|||June 21, 2017|Actual|2017-06-21|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Patients With Late-Onset Pompe Disease|A Twelve-Month, Open-Label, Randomized, Parallel Active Control, Single and Repeat Dose, Dose-escalation Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of VAL-1221 Delivered Intravenously (IV) in Ambulatory and Ventilator-free Patients With Late-Onset Glycogen Storage Disease-II (GSD-II) (Pompe Disease)|Recruiting||Phase 1/Phase 2|12|Anticipated|Valerion Therapeutics, LLC||4|||f||||t|t|f||||||||2017-10-10 21:49:14.975908|2017-10-10 21:49:14.975908
NCT02898740|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-05-25|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Telephone-linked Home-based Exercise Training in PD|Telephone-linked Home-based Exercise Training in PD|Recruiting||Phase 3|40|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 21:49:15.129511|2017-10-10 21:49:15.129511
NCT02898727|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-07-10|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|Local HER-O||A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer|A Phase II Study of Local Therapy Only (Stereotactic Radiosurgery and/or Surgery) for Treatment of up to 5 Brain Metastases From HER2 Positive Breast Cancer|Not yet recruiting||Phase 2|50|Anticipated|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||t|f|f||||||||2017-10-10 21:49:15.23857|2017-10-10 21:49:15.23857
NCT02898714|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-10-24|||July 2016||2016-07-01|October 2016|2016-10-01||||August 2019|Anticipated|2019-08-01||Observational|FUTURE||Flash Glucose Monitoring Study for Diabetes|The Impact of Flash Glucose Monitoring on Clinical Outcome Parameters in Diabetes Patients|Recruiting||N/A|1100|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||No||2017-10-10 21:49:15.326065|2017-10-10 21:49:15.326065
NCT02898701|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-07-05|||September 2016||2016-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Does Overpractice Improve Motor Learning?|Does Practice Beyond Performance Plateau Improve Motor Learning in Healthy Adults?|Recruiting||N/A|65|Anticipated|University of Utah||3|||f||||f||||||||||2017-10-10 21:49:15.416711|2017-10-10 21:49:15.416711
NCT02898688|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-07-17|||June 12, 2017|Actual|2017-06-12|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||P3+ Intervention Phase|A Comprehensive Pre-Natal Intervention to Increase Vaccine Coverage (P3+): Practice, Provider, Patient Level Interventions|Recruiting||N/A|1896|Anticipated|Emory University||4|||f||||f|f|f||||||||2017-10-10 21:49:15.534374|2017-10-10 21:49:15.534374
NCT02898675|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-08|||October 2014||2014-10-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|June 2015|Actual|2015-06-01||Interventional|||Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing|Investigation of the Contributions of Platelet Rich Fibrin Combined With Open Flap Debridement on Periodontal Healing|Completed||N/A|26|Actual|Ataturk University||2|||f||||t||||||||||2017-10-10 21:49:15.716669|2017-10-10 21:49:15.716669
NCT02898662|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-21|||October 12, 2016|Actual|2016-10-12|September 2017|2017-09-01|September 3, 2018|Anticipated|2018-09-03|September 3, 2018|Anticipated|2018-09-03||Interventional|INCONTRO||AZD1419 Ph2a Study|A Phase 2 Placebo-Controlled, Randomized, Double Blind, Adaptive Dose Trial of the Safety and Efficacy of Inhaled AZD1419 in Adults With Eosinophilic, Moderate to Severe Asthma|Active, not recruiting||Phase 2|67|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-10 21:49:15.794247|2017-10-10 21:49:15.794247
NCT02898649|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||December 2015||2015-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer||Recruiting||N/A|100|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-10 21:49:15.903663|2017-10-10 21:49:15.903663
NCT02898636|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||September 2016||2016-09-01|September 2015|2015-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Identification of Biomarkers in the Legal Medical Skin Wounds|Identification of Protein Markers of Vitality in Skin Wounds by Forensic Multiplex Analysis|Recruiting||N/A|50|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||Undecided||2017-10-10 21:49:15.987064|2017-10-10 21:49:15.987064
NCT02898623|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||December 2013||2013-12-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|MycoTB||Serological Test for the Diagnosis of TB|Performances of Immunoassays Based on the Detection of Antibodies Directed Against Mycobacterium Tuberculosis Antigen for the Diagnosis of Active Tuberculosis in Adults|Recruiting||N/A|1000|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 21:49:16.061335|2017-10-10 21:49:16.061335
NCT02898610|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-21|||December 12, 2016||2016-12-12|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|CONVINCE||Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke|CONVINCE - (COlchicine for preventioN of Vascular Inflammation in Non- CardioEmbolic Stroke) - a Randomised Clinical Trial of Low-dose Colchicine for Secondary Prevention After Stroke|Recruiting||Phase 3|2623|Anticipated|University College Dublin||2|||f||||t||||||||||2017-10-10 21:49:16.16657|2017-10-10 21:49:16.16657
NCT02898597|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-20|||June 2016||2016-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|SoCIWHIV||Smoking Cessation Intervention for Women Living With HIV|Smoking Cessation Intervention for Women With HIV/AIDS|Recruiting||N/A|50|Anticipated|University of Massachusetts, Boston||2|||f||||f||||||||||2017-10-10 21:49:16.327556|2017-10-10 21:49:16.327556
NCT02898584|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-19|||October 2016||2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care|Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care|Active, not recruiting||N/A|16|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 21:49:16.423546|2017-10-10 21:49:16.423546
NCT02898571|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||July 2016||2016-07-01|September 2016|2016-09-01||||January 2017|Anticipated|2017-01-01||Interventional|||Cross-over Double-blind Intervention to Investigate the Effects of Defined Antioxidant-containing Drinks on Time Course of Antioxidant Capacity|Cross-over Double-blind Intervention to Investigate the Effects of Defined Antioxidant-containing Drinks on Time Course of Antioxidant Capacity|Recruiting||N/A|10|Anticipated|Newcastle University||3|||f||||f||||||||||2017-10-10 21:49:16.499931|2017-10-10 21:49:16.499931
NCT02898558|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Body Representation in Movement|Effect of Body Representation in Movement|Enrolling by invitation||N/A|14|Anticipated|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 21:49:16.757571|2017-10-10 21:49:16.757571
NCT02898545|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-07-28|||September 2016||2016-09-01|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|Recurrent AF||Recurrent Atrial Fibrillation|Recurrent Atrial Fibrillation|Completed||N/A|1|Actual|University of Cincinnati||2|||f||||f|f|t|f|f||||||2017-10-10 21:49:16.863658|2017-10-10 21:49:16.863658
NCT02898532|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-14|||January 2016||2016-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Children With ADHD and ADHD-like Symptoms and Target Shooting Sport in Danish Shooting Associations.|The Influence of Participating in Target Shooting Sport on Inattentive, Hyperactive and Impulsive Symptoms in Children - A Controlled Study of Best Practice.|Recruiting||N/A|98|Anticipated|University of Southern Denmark||2|||f||||t||||||||Undecided||2017-10-10 21:49:16.943025|2017-10-10 21:49:16.943025
NCT02898519|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||October 2016||2016-10-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Observational|SERO7LEPTO||Immune Response After Leptospirosis Infection|Serological Response in Patients Infected by Leptospirosis 1 to 7 Years Earlier|Not yet recruiting||N/A|175|Anticipated|Centre Hospitalier Universitaire de la Réunion|||1||f||||f||||||Samples Without DNA|"     Plasma   "|No||2017-10-10 21:49:17.03845|2017-10-10 21:49:17.03845
NCT02898506|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Incretin-based Therapy in Late Preclinical Type 1 Diabetes|Incretin-based Therapy in Late Preclinical Type 1 Diabetes|Enrolling by invitation||Phase 2|82|Anticipated|University of Oulu||2|||f||||t||||||||||2017-10-10 21:49:17.118521|2017-10-10 21:49:17.118521
NCT02898493|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CreoQol||Translation, Cultural Adaptation and Validation of the Creole Versions of the EQ-5D and the SF-36 Questionnaires in Patients With Type II Diabetes in Reunion Island, Martinique and Guadeloupe|Translation, Cultural Adaptation and Validation of the Creole Versions of the EQ-5D and the SF-36 Questionnaires in Patients With Type II Diabetes in Reunion Island,|Recruiting||N/A|750|Anticipated|Centre Hospitalier Universitaire de la Réunion|||1||f||||f||||||||||2017-10-10 21:49:17.241727|2017-10-10 21:49:17.241727
NCT02898480|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning|Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning|Not yet recruiting||N/A|20|Anticipated|University of Aarhus||1|||f||||||||||||||2017-10-10 21:49:17.32933|2017-10-10 21:49:17.32933
NCT02898467|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||October 2016||2016-10-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Observational|MADI||Atherothrombosis Markers in Diabetics|Comparison of Atherothrombosis Markers From Aortic Atheroma in Diabetic and Non-diabetic Patients|Not yet recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de la Réunion|||2||f||||f||||||Samples With DNA|"     plasma and serum samples carotid endarterectomy samples urinary samples   "|No||2017-10-10 21:49:17.404195|2017-10-10 21:49:17.404195
NCT02898441|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||January 2014||2014-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Early Stage Lung Cancer Screening With Low-dose Computed Tomographic|Community-based Early Stage Lung Cancer Screening With Low-dose Computed Tomography in China|Recruiting||N/A|6000|Anticipated|Shanghai Chest Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:49:17.894364|2017-10-10 21:49:17.894364
NCT02898415|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-01|||June 2015||2015-06-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Observational|AFP-UTS||Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)|Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) With Pre-transplant Radiology Assessment and Alpha-fetoprotein (α-fp)|Completed||N/A|1018|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||1||f||||f|f|f||||||||2017-10-10 21:49:18.075715|2017-10-10 21:49:18.075715
NCT02898402|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||January 2014||2014-01-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|E-Q-RUN||Study on Seroprevalence and Risk Factors of Coxiella Burnetii (Q Fever) in the South of Reunion Island|Study on Seroprevalence and Risk Factors of Coxiella Burnetii (Q Fever) in the South of Reunion Island|Completed||N/A|3500|Actual|Centre Hospitalier Universitaire de la Réunion|||1||f||||f||||||||No||2017-10-10 21:49:18.162974|2017-10-10 21:49:18.162974
NCT02898389|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||June 2016||2016-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|CritiDop||Influence of Chronic Vascular Diseases on Transcranial Doppler Profiles in Critically Ill Patients|Influence of Chronic Vascular Diseases on Transcranial Doppler Profiles in Critically Ill Patients|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-10 21:49:18.226514|2017-10-10 21:49:18.226514
NCT02898376|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-04-27|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|FIBROTHERME||Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer|Evaluation of the Clinical Benefit of a Spa Care on the Evolution of Late Fibrosis After Postoperative Radiotherapy for Breast Cancer in Remission|Not yet recruiting||Phase 3|142|Anticipated|Institut de Cancérologie de Lorraine||2|||f||||f|f|f||||||No||2017-10-10 21:49:18.327498|2017-10-10 21:49:18.327498
NCT02898363|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-01-30|||March 2013||2013-03-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|ONCODEFI||Awareness on Cancer in Persons With Intellectual Disabilities|Awareness on Cancer in Persons With Intellectual Disabilities|Completed||N/A|80|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:49:18.518165|2017-10-10 21:49:18.518165
NCT02898350|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-13|||February 2013||2013-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|February 2016|Actual|2016-02-01||Interventional|||Surgical Scar Treatment With the Pulsed Dye Laser in Combination With a CO2 Laser|Multi-Center Study to Compare the Safety and Efficacy of Clearance of Surgical Scars With the Pulse Dye Laser in Combination With a CO2 Laser in a Split Scar Evaluation|Completed||N/A|25|Actual|Syneron Medical||4|||f||||f||||||||Undecided||2017-10-10 21:49:18.594535|2017-10-10 21:49:18.594535
NCT02898337|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-21|||November 2016|Actual|2016-11-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Methadone-Induced QT Interval Prolongation in a Narcotic Treatment Center|Methadone-Induced QT Interval Prolongation in a Narcotic Treatment Center: Identifying Patients at Risk and Simplifying ECG Monitoring|Recruiting||N/A|170|Anticipated|Indiana University|||2||f||||f||||||Samples With DNA|"     Blood samples for determination of cytochrome P-450 2B6 genotype   "|||2017-10-10 21:49:18.691549|2017-10-10 21:49:18.691549
NCT02898324|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-02-07|||May 2016||2016-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|KiVa-Chile||KiVa Anti-bullying Program in Chile: Evaluation of Effectiveness With and Without the Digital Game Component|KiVa Anti-bullying Program in Chile: Evaluation of Effectiveness With and Without the Digital Game Component|Enrolling by invitation||N/A|4485|Anticipated|Universidad Los Andes, Chile||3|||f||||f||||||||||2017-10-10 21:49:18.788021|2017-10-10 21:49:18.788021
NCT02898311|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-09-07|||July 2016||2016-07-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|February 2017|Anticipated|2017-02-01||Interventional|1T1T||One-Tooth One-Time (1T1T) A Straightforward Approach to Replace Missing Teeth in the Posterior Region: a Case Series|One-Tooth One-Time (1T1T) A Straightforward Approach to Replace Missing Teeth in the Posterior Region: a Case Series|Recruiting||N/A|||University Hospital of Liege|||||f||||f||||||||||2017-10-10 21:49:18.880852|2017-10-10 21:49:18.880852
NCT02898298|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-07|||August 2016||2016-08-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ERICA||Positive Emotion Regulation Training in Children, Adolescents and Young Adults With and Without Developmental Disorder|Positive Emotion Regulation Training in Children, Adolescents and Young Adults With and Without Developmental Disorder|Recruiting||N/A|120|Anticipated|University of Geneva, Switzerland||2|||f||||f||||||||Undecided||2017-10-10 21:49:18.949329|2017-10-10 21:49:18.949329
NCT02898285|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-11-02|||August 2016||2016-08-01|November 2016|2016-11-01||||December 2020|Anticipated|2020-12-01||Interventional|||Promoting Sport Participation During Early Parenthood|Promoting Sport Participation During Early Parenthood|Recruiting||N/A|240|Anticipated|University of Victoria||3|||f||||||||||||||2017-10-10 21:49:19.051041|2017-10-10 21:49:19.051041
NCT02898272|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-09-07|||August 2016||2016-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||SCCOR Minorities Observational Study||Enrolling by invitation||N/A|96|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"     blood specimens will be obtained and stored for later analysis, which may include measurement     of proteins, RNA expression, DNA.   "|||2017-10-10 21:49:19.1515|2017-10-10 21:49:19.1515
NCT02898259|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-06-09|||February 20, 2017|Actual|2017-02-20|June 2017|2017-06-01|June 2024|Anticipated|2024-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma|A Phase IB/II Trial of Lenalidomide (Revlimid®), Ixazomib and Rituximab (RIXAR) as Front-line Therapy for High Risk Indolent B Cell Lymphoma|Recruiting||Phase 1/Phase 2|42|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:49:19.212105|2017-10-10 21:49:19.212105
NCT02898246|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-05-12|||November 2016||2016-11-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Fear of Activity in Situations (FActS) - Study 2016|Fear of Activity in Situations (FActS) - Heart Failure Study 2016|Recruiting||N/A|260|Anticipated|University of Trier|||1||f||||f||||||||No||2017-10-10 21:49:19.321479|2017-10-10 21:49:19.321479
NCT02898233|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-06-15|||February 2016||2016-02-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|CBT/LLLT||Augmenting Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder With Low-Level Light Therapy|Augmenting Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder With Low-Level Light Therapy|Recruiting||N/A|200|Anticipated|University of Texas at Austin||3|||f||||f||||||||Undecided||2017-10-10 21:49:19.410934|2017-10-10 21:49:19.410934
NCT02898220|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-07|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Trans-MAPP II Study of Urologic Chronic Pelvin Pain|Trans-MAPP Study of Urologic Chronic Pelvic Pain: Control Study Protocol|Recruiting||N/A|72|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Biologic specimens collected during the course of the study include urine, blood, saliva, and     rectal and vaginal swabs.   "|Yes|Plans are still to be finalized|2017-10-10 21:49:19.525852|2017-10-10 21:49:19.525852
NCT02898207|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-12|2017-09-04|||May 19, 2017|Actual|2017-05-19|July 2017|2017-07-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer|A Phase 1 Study of PARP Inhibitor Olaparib and HSP90 Inhibitor AT13387 for Treatment of Advanced Solid Tumors With Expansion in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, Peritoneal Cancer, or Recurrent Triple-Negative Breast Cancer|Recruiting||Phase 1|40|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:49:19.630699|2017-10-10 21:49:19.630699
NCT02898194|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-10|2017-08-04|||August 28, 2016||2016-08-28|August 1, 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Focus Groups to Determine Surrogates Views Regarding Patient Preference Predictors|Focus Groups to Determine Surrogates Views Regarding Patient Preference Predictors|Not yet recruiting||Early Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:49:19.756438|2017-10-10 21:49:19.756438
NCT02898168|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-06-13|||May 2016||2016-05-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|RALLY||The Therapeutic Effects of Peroneal Nerve Functional Electric Stimulation for Lower Extremity in Patients With Sub-acute Post-stroke Hemiplegia|The Therapeutic Effects of Peroneal Nerve Functional Electric Stimulation for Lower Extremity in Patients With Sub-acute Post-stroke Hemiplegia A Randomized Controlled Study|Recruiting||N/A|200|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t||||||||||2017-10-10 21:49:19.922917|2017-10-10 21:49:19.922917
NCT02898155|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-12-09|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|HPE-LR||Potentially Avoidable Hospitalisation in France|Are Potentially Avoidable Hospitalizations a Good Measure of Access To Primary Care in France?|Recruiting||N/A|12000|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 21:49:20.207745|2017-10-10 21:49:20.207745
NCT02898142|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-09-28|||February 2012||2012-02-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|February 2015|Actual|2015-02-01||Interventional|TRIGPP||Intestines and Liver Contribution to Fasting Postprandial Hypertriglyceridemia|Evaluation of Intestinal and Hepatic Parts in Fasting Postprandial Hypertriglyceridemia in Patients With or Without Metabolic Syndrome|Completed||N/A|39|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:49:20.333362|2017-10-10 21:49:20.333362
NCT02898129|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-03|||September 2016||2016-09-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Evaluating the Relationship Between Environmental Risk Factors in Housing Types and Chronic Respiratory Diseases in Ho Chi Minh City|Evaluating the Relationship Between Environmental Risk Factors in Housing Types and Chronic Respiratory Diseases in Ho Chi Minh City|Completed||N/A|1500|Actual|Brugmann University Hospital||4|||f||||f||||||||||2017-10-10 21:49:20.475524|2017-10-10 21:49:20.475524
NCT02898116|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-08-27|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study of ALK Inhibitor, Ensartinib, and Anti-PD-L1, Durvalumab, in Subjects With ALK-rearranged Non-small Cell Lung Cancer|A Phase 1/2 Study of ALK Inhibitor, Ensartinib (X-396), and Anti-PD-L1, Durvalumab (MEDI4736), in Subjects With ALK-rearranged (ALK-positive) Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|32|Anticipated|Ludwig Institute for Cancer Research||2|||f||||f|t|f||||||||2017-10-10 21:49:20.61581|2017-10-10 21:49:20.61581
NCT02898103|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-04-13|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|pPNS||Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Analgesia|Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Analgesia|Enrolling by invitation||N/A|40|Anticipated|University of California, San Diego||2|||f||||f|f|t|f|f|f|||No||2017-10-10 21:49:20.780879|2017-10-10 21:49:20.780879
NCT02898077|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-10-03|||March 2, 2017|Actual|2017-03-02|October 2017|2017-10-01|March 21, 2021|Anticipated|2021-03-21|October 21, 2019|Anticipated|2019-10-21||Interventional|||A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine|Recruiting||Phase 3|450|Anticipated|Eli Lilly and Company||2|||f||||f|t|f|||t|||||2017-10-10 21:49:21.052477|2017-10-10 21:49:21.052477
NCT02898064|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MAPP||Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace|Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace - a Feasibility Study|Not yet recruiting||N/A|80|Anticipated|University Hospitals of North Midlands NHS Trust||2|||f||||f||||||||No|Only anonymised patient data would be published|2017-10-10 21:49:21.349951|2017-10-10 21:49:21.349951
NCT02898051|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-02-27|||August 2011||2011-08-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|aXa||Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism|Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism|Active, not recruiting||N/A|370|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     Biospecimen Description      The total volume of blood collected for the study will be 44 mL for cancer patients and non     cancer patients for the measurement of the following parameters:        -  anti-Xa activity;        -  heparanase;        -  platelet factor 4;        -  tissue factor;        -  tissue factor pathway inhibitor (TFPI);        -  P-selectin.   "|||2017-10-10 21:49:21.466089|2017-10-10 21:49:21.466089
NCT02898038|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-08|||November 2015||2015-11-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Acceptability and Tolerance Study of a New Oral Nutritional Supplement (ONS)|Tolerance and Acceptability of AYMES PARIS|Completed||N/A|16|Actual|Aymes International Limited||1|||f||||f||||||||No||2017-10-10 21:49:21.581366|2017-10-10 21:49:21.581366
NCT02898025|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-05-04|||November 2015||2015-11-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|March 2017|Actual|2017-03-01||Interventional|||Low Level Laser Therapy and Interferential Current in Osteoarthritis|Low Level Laser Therapy and Interferential Current in Patients With Knee Osteoarthritis: Randomized Controlled Trial|Recruiting||N/A|168|Anticipated|Universidade Cidade de Sao Paulo||4|||f||||f||||||||Undecided||2017-10-10 21:49:21.657946|2017-10-10 21:49:21.657946
NCT02898012|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-09-07|||October 2010||2010-10-01|July 2016|2016-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|ATAG||Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status|Temozolomide Plus Bevacizumab Chemotherapy in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status (KPS<70)|Completed||Phase 2|70|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||No||2017-10-10 21:49:21.771762|2017-10-10 21:49:21.771762
NCT02897999|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-23|||September 2016||2016-09-01|August 2017|2017-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers|A Placebo-Controlled, Blinded, Dose-Escalation, Study to Assess the Safety and Pharmacodynamics of Single and Multiple Doses of QBKPN (Inactivated Klebsiella Pneumoniae) Site Specific Immunomodulator (SSI), Administered Subcutaneously to Healthy Male and Female Volunteers|Withdrawn||Phase 1|0|Actual|Qu Biologics Inc.||10|||f||||t||||||||||2017-10-10 21:49:21.879217|2017-10-10 21:49:21.879217
NCT02897986|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||January 2017||2017-01-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|PROVIN||Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors||Not yet recruiting||Phase 1|54|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-10 21:49:21.970866|2017-10-10 21:49:21.970866
NCT02897973|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-07|||September 2011||2011-09-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||The Impact of Unilateral Lower Limb Amputation on Spinal Loads|Spinal Loads During Activities of Daily Living: Influences of Unilateral Lower-limb Amputation|Completed||N/A|173|Actual|University of Kentucky|||3||f||||f||||||||||2017-10-10 21:49:22.057235|2017-10-10 21:49:22.057235
NCT02897960|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-08-14|||October 2016|Actual|2016-10-01|August 2016|2016-08-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Observational|WheezSmart||Wheezing Diagnosis Using a Smartphone|Wheezing Diagnosis Using a Smartphone in Infants Referred for Bronchiolitis|Completed||N/A|600|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 21:49:22.142383|2017-10-10 21:49:22.142383
NCT02897947|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-07|||January 2011||2011-01-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01|1 Year|Observational [Patient Registry]|||Outcome of Surgery for Lumbar Spinal Stenosis - a Comparison of Data From Three National Quality Registries|Outcome of Surgery for Lumbar Spinal Stenosis - a Comparison of Data From Three National Quality Registries|Completed||N/A|7500|Actual|St. Olavs Hospital|||3||f||||f||||||||No||2017-10-10 21:49:22.216487|2017-10-10 21:49:22.216487
NCT02897934|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-05-04|||August 2016||2016-08-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|||CWI and Discharge After Breast Cancer Surgery|Continuous Wound Infiltration and 23 Hour Discharge Following Major Breast Cancer Surgery|Enrolling by invitation||N/A|10|Anticipated|University College Cork|||1||f||||f||||||||No|Only pooled data will be shared/reported|2017-10-10 21:49:22.293685|2017-10-10 21:49:22.293685
NCT02897921|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-13|||October 2016||2016-10-01|September 2016|2016-09-01|August 2021|Anticipated|2021-08-01|May 2020|Anticipated|2020-05-01||Observational|CICS||Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy (CICS)|Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy|Not yet recruiting||N/A|240|Anticipated|Rigshospitalet, Denmark|||2||f||||t||||||Samples With DNA|"     Blood samples   "|No|No plan|2017-10-10 21:49:22.365148|2017-10-10 21:49:22.365148
NCT02897908|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2017-10-03|||October 28, 2016|Actual|2016-10-28|October 2017|2017-10-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01|1 Day|Observational [Patient Registry]|||Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database|Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database|Recruiting||N/A|1000|Anticipated|State University of New York at Buffalo|||1||f||||f||||||||||2017-10-10 21:49:22.463473|2017-10-10 21:49:22.463473
NCT02897895|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2016-09-12|||December 2016||2016-12-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|CalciMo-TP||Study to Evaluate the Value of the Follow-up of CALCIneurin Activity to MOdulate Calcineurin Inhibitors-induced Immunosuppression in Lung Transplantation||Not yet recruiting||N/A|134|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 21:49:22.550158|2017-10-10 21:49:22.550158
NCT02897882|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-05-19|||May 2010|Actual|2010-05-01|May 2017|2017-05-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|MUCODOULEUR||Acute and Chronic Pain in Lung Transplantation: Prevalence, Associated Factors, Taken Care|Acute and Chronic Pain in Lung Transplantation: Prevalence, Associated Factors, Medical Care|Completed||N/A|94|Actual|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:49:22.64516|2017-10-10 21:49:22.64516
NCT02897869|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-01-31|||April 2016||2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||DDI Study to Investigate Interaction Between Amikacin and POL7080|A Single-center, Open-label, Two Sequence, Crossover Study to Investigate the Interaction Between Amikacin and POL7080 in Healthy Subjects|Completed||Phase 1|14|Actual|Polyphor Ltd.||2|||f||||f||||||||||2017-10-10 21:49:23.220951|2017-10-10 21:49:23.220951
NCT02897856|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2017-02-22|||December 2015||2015-12-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures|Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures: A Randomized Controlled Trial|Recruiting||Phase 4|150|Anticipated|Hamad Medical Corporation||2|||f||||f||||||||No||2017-10-10 21:49:23.294046|2017-10-10 21:49:23.294046
NCT02897843|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Transcranial Direct Current Stimulation on Cognitive Side Effects of Electroconvulsive Therapy|The Effect of Transcranial Direct Current Stimulation on Cognitive Side Effects of Electroconvulsive Therapy|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Northwell Health||2|||f||||f||||||||Undecided||2017-10-10 21:49:23.374063|2017-10-10 21:49:23.374063
NCT02897830|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-07-11|||September 2016||2016-09-01|July 2017|2017-07-01|April 2021|Anticipated|2021-04-01|April 2018|Anticipated|2018-04-01||Interventional|IFM2014-03||Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma|Evaluation of Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Followed by Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma Patients ≤65 Years Eligible for High Dose Therapy|Recruiting||Phase 2|46|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 21:49:23.453433|2017-10-10 21:49:23.453433
NCT02897817|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-16|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|APRim||Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis|Treatment Adherence in Patients With Rheumatoid Arthritis Previously Treated With Oral or Injectable Methotrexate and Requiring a New Treatment With Injectable Methotrexate|Active, not recruiting||N/A|560|Anticipated|Nordic Pharma SAS|||2||f||||f||||||||||2017-10-10 21:49:23.599307|2017-10-10 21:49:23.599307
NCT02897804|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-03-23|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|November 2016|Actual|2016-11-01||Interventional|||Engineering an Online STI Prevention Program|Engineering an Online STI Prevention Program|Recruiting||N/A|13773|Anticipated|Penn State University||32|||f||||f||||||||No||2017-10-10 21:49:23.697278|2017-10-10 21:49:23.697278
NCT02897791|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-09-07|||August 2015||2015-08-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|stroke||Main Idea Perception of Written Stories and in Pictures Among Impaired Right Hemisphere Patients|Main Idea Perception of Written Stories and in Pictures Among Impaired Right Hemisphere Patients|Enrolling by invitation||N/A|40|Anticipated|Sheba Medical Center||2|||f||||t||||||||||2017-10-10 21:49:23.883908|2017-10-10 21:49:23.883908
NCT02897778|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2017-04-14|||August 2016|Actual|2016-08-01|September 2016|2016-09-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors|A Phase 1 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors|Completed||Phase 1|37|Actual|Syndax Pharmaceuticals||2|||f||||f||||||||No|Data will be reviewed throughout the study by the sponsor, CRO assisting with SAE management, and routine monitoring to safeguard the interests of trial patients and to assess the safety of the interventions administered during the trial|2017-10-10 21:49:23.942673|2017-10-10 21:49:23.942673
NCT02897765|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-07-12|||October 2016||2016-10-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer|An Open-label, Phase IB Study of NEO-PV-01 + Adjuvant With Nivolumab in Patients With Melanoma, Non-Small Cell Lung Carcinoma or Transitional Cell Carcinoma of the Bladder|Recruiting||Phase 1|90|Anticipated|Neon Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 21:49:24.055706|2017-10-10 21:49:24.055706
NCT02897752|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-13|||January 2016||2016-01-01|June 2017|2017-06-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|PLEASURE||Clinical Effects of Peroneal Nerve Functional Electrical Stimulation (WalkAide[R]) for Chronic Stroke Patients|Clinical Effects of Peroneal Nerve Functional Electrical Stimulation (WalkAide[R]) for the Lower Extremities in Chronic Stroke Patients With Hemiplegia: A Multicenter, Prospective, Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t||||||||||2017-10-10 21:49:24.184741|2017-10-10 21:49:24.184741
NCT02897739|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-09-07|||August 2015||2015-08-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01|4 Months|Observational [Patient Registry]|TERRIFIC||Pathogenesis of Acute Stress Induced (Tako-tsubo) Cardiomyopathy: Energy Shut-Down or Intense Inflammation?|Pathogenesis of Acute Stress Induced (Tako-tsubo) Cardiomyopathy: Energy Shut-Down or Intense Inflammation? The TERRIFIC Study|Recruiting||N/A|53|Anticipated|University of Aberdeen|||2||f||||f||||||Samples With DNA|"     EDTA blood samples, EDTA Plasma and Serum to be retained.   "|No||2017-10-10 21:49:26.141694|2017-10-10 21:49:26.141694
NCT02897726|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-08-06|||March 24, 2017|Actual|2017-03-24|August 2017|2017-08-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Interventional|||A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402|A Clinical Trial to Evaluate the Pharmacokinetics and Safety of NVP-1402 in Healthy Male Subjects|Completed||Phase 1|38|Actual|Navipharm Corporation||2|||f||||f|f|f||||||||2017-10-10 21:49:26.248345|2017-10-10 21:49:26.248345
NCT02897713|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Feasibility, Safety, and Outcomes of Intensive Enteral Nutrition in Patients With Mechanical Ventilation|Feasibility, Safety and Outcomes of Intensive Enteral Nutrition in Mechanical-ventilated Patients: a Multicenter, Parallel Randomized Trial|Recruiting||N/A|400|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||No||2017-10-10 21:49:26.320674|2017-10-10 21:49:26.320674
NCT02897505|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-07-06|||October 2016||2016-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Music Workshops in the EMPOWER Clinic|Evaluating the Effect of Music on Emotional Regulation Among Survivors of Sexual Violence|Enrolling by invitation||N/A|30|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 21:49:27.934123|2017-10-10 21:49:27.934123
NCT02897700|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-12|||January 2013||2013-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|COC-IDCB||Clinical Outcome of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast|A Phase I/II Multi-Center Study to Evaluate the Safety, Tolerability, and Efficacy of Chemotherapeutic Regiments in Surgical Patients With Infiltrating Ductal Carcinoma of Breast|Recruiting||Phase 1/Phase 2|300|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||t||||||||Yes|Output data from this clinical study will be be made available to the public appropriately upon complete of the primary investigation, according to the original plan.|2017-10-10 21:49:26.41183|2017-10-10 21:49:26.41183
NCT02897687|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-09-07|||April 2013||2013-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2014|Actual|2014-06-01||Interventional|FBREX||Facebook for Social Skills Training in Autism: Project Rex Connect|Project Rex Connect: The Utilization of an Online Social Network by an Interprofessional Team to Aid in Skill Acquisition for Patients With Autism Spectrum Disorders|Completed||N/A|12|Actual|Medical University of South Carolina||2|||f||||t||||||||Yes||2017-10-10 21:49:26.524131|2017-10-10 21:49:26.524131
NCT02897674|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-09-07|||February 2016||2016-02-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|PalmOil||Effect of Palm Olein Intake on Lipid Profile and Fat Deposition|The Chemical Structure of a Lipid Determines Its Effect on Blood Lipid Profile and Fat Deposition|Recruiting||N/A|60|Anticipated|Imperial College London||2|||f||||t||||||||No||2017-10-10 21:49:26.617759|2017-10-10 21:49:26.617759
NCT02897661|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-01-26|||August 2016||2016-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Fecal Microbiota Transplantation Improves Nutritional State of Patients With Crohn's Disease|Fecal Microbiota Transplantation Combined Enteral Nutrition Therapy Contribute to Nutritional Improvement of Patients With Crohns' Disease|Recruiting||Phase 2/Phase 3|60|Anticipated|The Second Hospital of Nanjing Medical University||3|||f||||||||||||||2017-10-10 21:49:26.705024|2017-10-10 21:49:26.705024
NCT02897648|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-06|||June 2015||2015-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|BETALACUTANE||Evaluation of Pharmacokinetic / Pharmacodynamic and Tolerance Assessment of Dermal Administration of Beta-lactams in the Elderly|Evaluation of Pharmacokinetic / Pharmacodynamic and Tolerance Assessment of Dermal Administration of Beta-lactams in the Elderly|Suspended||N/A|10|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||||2017-10-10 21:49:26.807275|2017-10-10 21:49:26.807275
NCT02897635|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|IACS2||Integrative Approaches For Cancer Survivorship 2: Project 1|Developing an Integrative Ayurvedic Intervention for Breast Cancer Survivorship|Recruiting||N/A|20|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 21:49:26.869977|2017-10-10 21:49:26.869977
NCT02897622|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-09-07|||April 2014||2014-04-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|SEED||Severe and Enduring Eating Disorder Patients at Stockholms Center for Eating Disorders in Sweden|Severe and Enduring Eating Disorder Patients at Stockholms Center for Eating Disorders in Sweden|Recruiting||N/A|30|Anticipated|Karolinska Institutet||1|||f||||f||||||||No||2017-10-10 21:49:27.051862|2017-10-10 21:49:27.051862
NCT02897609|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-07|||April 2014||2014-04-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|BETAL||Clinical Evaluation of Beta-Lacta ™ Test in Urinary Infections|Clinical Evaluation of Beta-Lacta ™ Test in Urinary Infections|Completed||N/A|200|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||Undecided||2017-10-10 21:49:27.13923|2017-10-10 21:49:27.13923
NCT02897596|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-07|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|EARLY-HEP-C||Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients|Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients|Not yet recruiting||Phase 3|62|Anticipated|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-10 21:49:27.234795|2017-10-10 21:49:27.234795
NCT02897583|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-09-12|||February 2015||2015-02-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||YAG Vitreolysis for Floaters|A Prospective Randomized Controlled Trial Evaluating the Safety and Efficacy of YAG Vitreolysis Versus Sham for Symptomatic Weiss Ring Due to Posterior Vitreous Detachment|Completed||N/A|52|Actual|Ophthalmic Consultants of Boston||2|||f||||||||||||||2017-10-10 21:49:27.33303|2017-10-10 21:49:27.33303
NCT02897570|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-13|||October 2013||2013-10-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Metabolic and Neurofunctional Responses to Breakfasts|Effect of Glucose Versus Mixed Breakfast on Metabolic and Neurofunctional Responses in Healthy Individuals|Completed||N/A|12|Actual|Ospedale San Donato||4|||f||||t||||||||||2017-10-10 21:49:27.415362|2017-10-10 21:49:27.415362
NCT02897557|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-04-25|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Insulet Artificial Pancreas Early Feasibility Study|A Prospective Early Feasibility Study to Assess the Performance of the Insulet Artificial Pancreas (AP) System Using the OmniPod® Insulin Management System and the Dexcom G4® Share™ AP System|Completed||N/A|59|Actual|Insulet Corporation||1|||f||||f|f|t|f|f||||No||2017-10-10 21:49:27.533555|2017-10-10 21:49:27.533555
NCT02897544|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|IACS2||Integrative Approaches for Cancer Survivorship 2: Project 2|Developing a Health Education Intervention for Breast Cancer Survivorship|Recruiting||N/A|20|Anticipated|University of California, San Francisco||1|||f||||t||||||||No||2017-10-10 21:49:27.635551|2017-10-10 21:49:27.635551
NCT02897531|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-10-30|||September 2016||2016-09-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison Between End-to-side and Side-to-side Anastomosis After Laparoscopic Right Hemicolectomy|A Comparison of Surgical Outcomes Between End-to-side and Side-to-side Anastomosis After Laparoscopic Right Hemicolectomy: A Prospective Randomized Controlled Trial|Recruiting||Phase 3|130|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 21:49:27.7428|2017-10-10 21:49:27.7428
NCT02897518|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-01-04|||January 2015||2015-01-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Videolaryngoscopes for Tracheal Intubation|Comparison Between Imago V-Blade and Glidescope During Endotracheal Intubation: a Feasibility Study|Completed||N/A|45|Actual|Federico II University||2|||f||||f||||||||||2017-10-10 21:49:27.850682|2017-10-10 21:49:27.850682
NCT02897492|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-12|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain|Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain|Not yet recruiting||N/A|500|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||Yes||2017-10-10 21:49:28.009819|2017-10-10 21:49:28.009819
NCT02897479|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-07-14|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|PSC||A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma|A Phase II, Open-label Study to Evaluate the Efficacy and Safety of HMPL-504 in Locally Advanced/Metastatic MET-Mutation-Positive Pulmonary Sarcomatoid Carcinomas|Recruiting||Phase 2|45|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||||2017-10-10 21:49:28.062748|2017-10-10 21:49:28.062748
NCT02897466|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-07|||January 2017||2017-01-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|AB-DIRECT2||Impact of Direct Antimicrobial Susceptibility Testing on Respiratory Sample of Intensive Care Patient With Suspected VAP|Impact of Susceptibility Testing Directly on the Deep Respiratory Samples of Patients Suspected Pneumonia Ventilator ( VAP ) Late ( > 5 Days) in Intensive Care Unit on the Adequacy of Antibiotic Treatment to Carbapenems Sparing on Day 1|Not yet recruiting||N/A|180|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-10 21:49:28.14552|2017-10-10 21:49:28.14552
NCT02897453|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-09-07|||July 2016||2016-07-01|July 2016|2016-07-01|December 2023|Anticipated|2023-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy Study of Spinal Tethering|Retrospective Review With Prospective Surveillance of Safety and Efficacy in a Clinical Series of Spinal Tethering Patients|Recruiting||Phase 2|55|Anticipated|Zimmer Biomet||1|||f||||t||||||||Undecided||2017-10-10 21:49:28.246854|2017-10-10 21:49:28.246854
NCT02897440|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-07|||October 2016||2016-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Full Versus Partial Repairing of Soft Tissue Surrounding the Hip in Arthroplasty for Femoral Neck Fractures|Full Repairing Versus Partial Repairing of Soft Tissue Surrounding the Hip Joint in Hip Arthroplasty for Femoral Neck Fractures|Not yet recruiting||N/A|30|Anticipated|First Hospitals affiliated to the China PLA General Hospital|||2||f||||f||||||||No||2017-10-10 21:49:28.345197|2017-10-10 21:49:28.345197
NCT02897427|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-07-06|||March 28, 2017|Actual|2017-03-28|July 2017|2017-07-01|March 2027|Anticipated|2027-03-01|March 2027|Anticipated|2027-03-01||Interventional|||HOUSTON - HPV-related Oropharyngeal and Uncommon Cancers Screening Trial Of Men|HPV-Related Oropharyngeal and Uncommon Cancers Screening Trial Of Men (HOUSTON Study)|Recruiting||N/A|3000|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|f|f||||||||2017-10-10 21:49:28.425319|2017-10-10 21:49:28.425319
NCT02897414|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-09-07||||||September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Observational|||ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases|Extended Release/Long Acting (ER/LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Medical Examiner Surveillance Monitoring Protocol|Enrolling by invitation||N/A|13015|Anticipated|ER/LA Opioid REMS Program Companies (RPC)|||5||f||||||||||||||2017-10-10 21:49:28.58901|2017-10-10 21:49:28.58901
NCT02897401|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-07|||September 2016||2016-09-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|CANICE||Determination of Carcinogens Nicotine in Electronic Cigarettes Users|Determination of Carcinogens Nicotine in Electronic Cigarettes Users|Not yet recruiting||N/A|80|Anticipated|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||No||2017-10-10 21:49:28.664076|2017-10-10 21:49:28.664076
NCT02897388|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-07|||November 2014||2014-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Quality Improvement Initiative to Increase Breast Milk Use in a Chinese NICU: a Pilot Study|A Quality Improvement Initiative to Increase Breast Milk Use in a Chinese Neonatal Intensive Care Unit (NICU): a Pilot Study|Completed||N/A|325|Actual|Children's Hospital of Fudan University||2|||f||||t||||||||No|cause all the patients' data is privacy|2017-10-10 21:49:28.773789|2017-10-10 21:49:28.773789
NCT02897375|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-11-09|||October 2016||2016-10-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors|A Phase 1 Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies|Recruiting||Phase 1|90|Anticipated|Emory University||2|||f||||t||||||||Yes||2017-10-10 21:49:28.992255|2017-10-10 21:49:28.992255
NCT02897362|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-07-25|||August 2016||2016-08-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|||Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD|Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD|Recruiting||N/A|60|Anticipated|Duke University|||2||f||||f||||||||||2017-10-10 21:49:29.121455|2017-10-10 21:49:29.121455
NCT02897349|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-10-03|||September 30, 2016|Actual|2016-09-30|October 2017|2017-10-01|August 31, 2018|Anticipated|2018-08-31|August 24, 2018|Anticipated|2018-08-24||Interventional|||Linagliptin Add-on to Insulin Background Therapy|A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Linagliptin, Administered Orally Once Daily, in Combination With Insulin Therapy for 24 Weeks in Chinese Type 2 Diabetes Mellitus Patients With Insufficient Glycaemic Control|Recruiting||Phase 3|206|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:49:29.219916|2017-10-10 21:49:29.219916
NCT02897336|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-07|||July 2016||2016-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|HiatUS||Ultrasound-guided Caudal or Interlaminar Corticosteroid Epidural Injection for Sciatica|Ultrasound-guided Caudal or Interlaminar Injection? A Comparative Study of Epidural Corticosteroid Injections in the Treatment of Lumbar Disk Herniation-related Sciatica|Recruiting||Phase 4|60|Anticipated|University Hospital, Caen||2|||f||||f||||||||No||2017-10-10 21:49:29.377259|2017-10-10 21:49:29.377259
NCT02897323|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-07|||October 2016||2016-10-01|September 2016|2016-09-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|CARL||Northwest Adult Congenital Heart Disease Observatory|Northwest Inter Hospital Adult Congenital Heart Disease Observatory|Not yet recruiting||N/A|4000|Anticipated|University Hospital, Caen|||1||f||||f||||||||Undecided||2017-10-10 21:49:29.470382|2017-10-10 21:49:29.470382
NCT02896933|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-07||||||September 2016|2016-09-01||||January 2015|Actual|2015-01-01||Observational|MARCHE||Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple Sclerosis||Completed||N/A|64|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:49:32.614258|2017-10-10 21:49:32.614258
NCT02897310|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-07|||November 2014||2014-11-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|PROVEER||Outcomes of Critically Ill Patients With Severe Acute Kidney Injury Requiring Renal Replacement Therapy|Outcomes of Critically Ill Patients With Severe Acute Kidney Injury Requiring Renal Replacement Therapy|Completed||N/A|245|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:49:29.543939|2017-10-10 21:49:29.543939
NCT02897297|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-07|||September 2015||2015-09-01|September 2016|2016-09-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Observational|OBENE||Myeloproliferative Neoplastic Diseases Observatory From Brest|Observatoire Brestois Des Néoplasies Myéloprolifératives|Recruiting||N/A|1000|Anticipated|University Hospital, Brest|||1||f||||f||||||||No||2017-10-10 21:49:29.634608|2017-10-10 21:49:29.634608
NCT02897284|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-09-07|||May 2015||2015-05-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Mind-Care||Mindfulness for Burnout Prevention in Primary Care Providers|Evaluation of Mindfulness-based Self-care Programs for the Prevention of Burnout Among Primary Care Providers: Psychological, Inflammatory and Epigenetic Effects|Completed||N/A|400|Actual|Centro Mente Aberta de Mindfulness||3|||f||||f||||||||No||2017-10-10 21:49:29.733899|2017-10-10 21:49:29.733899
NCT02897271|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-01-20|||August 2016||2016-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort|Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort|Recruiting||N/A|300|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||||Undecided||2017-10-10 21:49:29.856937|2017-10-10 21:49:29.856937
NCT02897258|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-07|||January 2013||2013-01-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|T2HD||Thrombosis and Haemorrhage in Chronic Hemodialysis Patients|Thrombosis and Haemorrhage in Chronic Hemodialysis Patients - T2HD|Completed||N/A|600|Actual|Central Hospital, Nancy, France|||4||f||||f||||||||No||2017-10-10 21:49:29.995511|2017-10-10 21:49:29.995511
NCT02897245|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-12|||December 2012||2012-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|A-STIM||A Study for Tyrosine Kinase Inhibitors Discontinuation|An Observational Study for CML Patients Who Discontinued Tyrosine Kinase Inhibitors Intentionally After Achieving a Deep Molecular Response|Recruiting||N/A|200|Anticipated|Versailles Hospital|||1||f||||f||||||||No||2017-10-10 21:49:30.067497|2017-10-10 21:49:30.067497
NCT02897232|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-03-06|||July 2016||2016-07-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|March 2017|Actual|2017-03-01||Observational|||Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination|Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination|Active, not recruiting||N/A|400|Anticipated|Louisiana State University Health Sciences Center Shreveport|||2||f||||f||||||||No|Only aggregate data will be shared.|2017-10-10 21:49:30.153881|2017-10-10 21:49:30.153881
NCT02897219|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-25|||August 29, 2016|Actual|2016-08-29|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|July 22, 2017|Actual|2017-07-22||Interventional|||A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus|Phase III Study of ASP1941 Double-blind, Parallel-group Study in Combination With Insulin in Patients With Type 1 Diabetes Mellitus|Active, not recruiting||Phase 3|175|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-10 21:49:30.259942|2017-10-10 21:49:30.259942
NCT02897206|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-06-18|||October 2014||2014-10-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|IMPROWE||Imipenem Prophylaxis in Patients With Acute Pancreatitis|Imipenem Prophylaxis of Infectious Complications in Patients With Acute Pancreatitis|Completed||Phase 4|98|Actual|University Hospital Rijeka||2|||f||||f||||||||No||2017-10-10 21:49:30.42542|2017-10-10 21:49:30.42542
NCT02897193|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-22|||August 2016||2016-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Central Incisors Narrow Implants in Alternative to Bone Augmentation With 4.2 mm Implants .|3.2 mm Diameter Implants and Soft Tissue Grafts in Alternative to Horizontal Bone Augmentation for Placing 4.2 mm Diameter Implants at Central Incisors. A Multicenter Randomised Controlled Trial|Recruiting||Phase 4|42|Anticipated|Alpha - Bio Tec Ltd.||2|||f||||f||||||||||2017-10-10 21:49:30.523434|2017-10-10 21:49:30.523434
NCT02897180|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-09-03|||March 10, 2017|Actual|2017-03-10|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|October 2020|Anticipated|2020-10-01||Interventional|||Efficacy of Nyaditum Resae(R) Against Active TB in Georgia|Double-blind, Randomized, Masked, Placebo-controlled, Clinical Trial to Investigate the Efficacy of the Nutraceutical Nyaditum Resae(R) Administered to Contacts of Active Tuberculosis in Georgia.|Recruiting||Phase 2/Phase 3|3300|Anticipated|Fundació Institut Germans Trias i Pujol||2|||f||||t|f|f||||||||2017-10-10 21:49:30.615708|2017-10-10 21:49:30.615708
NCT02897167|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-03-13|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|PAFIP_TLR||Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients|Retrospective and Prospective Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Patients With Schizophrenia: a Comparative Effect of Risperidone vs Aripiprazole|Enrolling by invitation||N/A|150|Anticipated|Fundación Marques de Valdecilla|||3||f||||f|f|f||||Samples Without DNA|"     Serum and peripheral blood mononuclear cell (PBMC)   "|No||2017-10-10 21:49:30.712147|2017-10-10 21:49:30.712147
NCT02897154|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-27|||May 2016||2016-05-01|January 2017|2017-01-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Observational|||Clinical Evaluation of i-STAT Analyzer|Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium|Recruiting||N/A|120|Anticipated|Abbott Point of Care|||1||f||||f||||||||No||2017-10-10 21:49:30.804214|2017-10-10 21:49:30.804214
NCT02897141|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-05-11|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|mVIP||mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV)|Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV|Active, not recruiting||N/A|80|Actual|Columbia University||2|||f||||f||||||||No||2017-10-10 21:49:30.879652|2017-10-10 21:49:30.879652
NCT02897128|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-09-26|||July 2016||2016-07-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma|Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma|Recruiting||N/A|60|Anticipated|The Cleveland Clinic|||1||f||||f||||||||||2017-10-10 21:49:30.963548|2017-10-10 21:49:30.963548
NCT02897115|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-07-28|||September 12, 2016||2016-09-12|July 2017|2017-07-01|April 10, 2020|Anticipated|2020-04-10|September 13, 2019|Anticipated|2019-09-13||Interventional|STRIKE||A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment|STRIKE - Treating Patients With Early Axial Spondyloarthritis to Target - a 1 Year Randomized Controlled Study Taking an Intense Treatment Approach Versus Routine Treatment|Recruiting||Phase 4|240|Anticipated|AbbVie||2|||f||||f||||||||||2017-10-10 21:49:31.100175|2017-10-10 21:49:31.100175
NCT02897102|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-06|||April 2013||2013-04-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effects of a Training Program Based on Abacus and Other Activities in Healthy Older Adults|Effects of a Training Program Based on Abacus and Other Activities in Healthy Older Adults|Completed||N/A|88|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||No||2017-10-10 21:49:31.2343|2017-10-10 21:49:31.2343
NCT02897089|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-07-17|||October 31, 2017|Anticipated|2017-10-31|July 2017|2017-07-01|December 30, 2020|Anticipated|2020-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||Effectiveness of Fissure Sealants Bonded With Different Universal Adhesives|Clinical Performance of Fissure Sealants Bonded With Total and Self-etch Modes of Universal Adhesive Agents|Not yet recruiting||N/A|100|Anticipated|Hacettepe University||8|||f||||f|f|f||||||||2017-10-10 21:49:31.302115|2017-10-10 21:49:31.302115
NCT02897076|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-01-13|||January 2017||2017-01-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|BETADOSE||Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth|Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth: a Randomized, Multicentre, Double Blind Placebo-controlled Non Inferiority Trial|Recruiting||Phase 3|3142|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:49:31.486642|2017-10-10 21:49:31.486642
NCT02897063|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-01-16|||September 2016||2016-09-01|January 2017|2017-01-01|August 2021|Anticipated|2021-08-01|March 2021|Anticipated|2021-03-01||Interventional|||Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure|The Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Aim 2 of RDCRN (Rare Diseases Clinical Research Network) Project 2|Recruiting||Phase 1|34|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 21:49:31.606035|2017-10-10 21:49:31.606035
NCT02897050|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-03-23|||September 2016||2016-09-01|March 2017|2017-03-01|September 2023|Anticipated|2023-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer|Phase II Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer|Recruiting||Phase 2|186|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||Undecided||2017-10-10 21:49:31.739229|2017-10-10 21:49:31.739229
NCT02897037|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-11-25|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Bivalirudin in Acute Myocardial Infarction|Bivalirudin vs Heparin During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomised Controlled Trial|Recruiting||Phase 3|380|Anticipated|Shenzhen Salubris Pharmaceuticals Co., Ltd.||2|||f||||t||||||||Undecided||2017-10-10 21:49:31.892628|2017-10-10 21:49:31.892628
NCT02897024|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-01-18|||September 2016||2016-09-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|ACHIEVE||A Comparison: High Intense Periodic vs. Every Week Therapy in Children With Cerebral Palsy (ACHIEVE)|A Comparison: High Intense Periodic vs. Every Week Therapy in Children With Cerebral Palsy (ACHIEVE)|Recruiting||N/A|300|Anticipated|Ohio State University||2|||f||||t||||||||||2017-10-10 21:49:31.992846|2017-10-10 21:49:31.992846
NCT02897011|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-10-26|||September 2016||2016-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|2 wk MTX||2-week dc of MTX and Influenza Vaccination in RA|Effect of Two-week Discontinuation of Methotrexate on Efficacy of Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial|Recruiting||N/A|318|Anticipated|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:49:32.078861|2017-10-10 21:49:32.078861
NCT02896998|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-11|||September 2016||2016-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|RODEO||Routine Versus on Demand Removal of the Syndesmotic Screw|Routine Versus on Demand Removal of the Syndesmotic Screw|Recruiting||N/A|193|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-10 21:49:32.174086|2017-10-10 21:49:32.174086
NCT02896972|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-01-09|||April 2012||2012-04-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes|Efficacy of Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes|Completed||N/A|32|Actual|Kyorin University||2|||f||||f||||||||Undecided||2017-10-10 21:49:32.390879|2017-10-10 21:49:32.390879
NCT02896959|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-07|||October 2016||2016-10-01|September 2016|2016-09-01||||June 2019|Anticipated|2019-06-01||Interventional|||How Much is Too Much: Assessing Varying Pressure Pump Pressures in Post Operative Pain Control in Shoulder Arthroscopy.|How Much is Too Much: Assessing Varying Pressure Pump Pressures in Post Operative Pain Control in Shoulder Arthroscopy.|Not yet recruiting||N/A|100|Anticipated|Lawson Health Research Institute||3|||f||||||||||||||2017-10-10 21:49:32.463892|2017-10-10 21:49:32.463892
NCT02896946|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-07|||February 2011||2011-02-01|August 2016|2016-08-01||||April 2014|Actual|2014-04-01||Interventional|PANDA||Diffusion MRI for Pancreatic Adenocarcinoma|Use of Diffusion-weighted MRI for the Detection of Liver Metastases in Potentially Resectable Pancreatic Adenocarcinomas: a Prospective Multicenter Study|Completed||N/A|118|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 21:49:32.535697|2017-10-10 21:49:32.535697
NCT02896907|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-05-10|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery|A Pilot Study of Intravenous Ascorbic Acid and Folfirinox in the Treatment of Advanced Pancreatic Cancer|Recruiting||Early Phase 1|8|Anticipated|Thomas Jefferson University||1|||f||||t|t|f|||t|||||2017-10-10 21:49:32.863667|2017-10-10 21:49:32.863667
NCT02896894|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-12|||July 2016||2016-07-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Evaluate the Value of Telehomecare for Mental Health|Evaluate the Value of Telehomecare for Mental Health|Completed||N/A|975|Actual|Women's College Hospital||4|||f||||t||||||||||2017-10-10 21:49:33.000908|2017-10-10 21:49:33.000908
NCT02896881|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-03-03|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|MAV-IRM||Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations|Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations (MAV-IRM)|Recruiting||N/A|75|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 21:49:33.091982|2017-10-10 21:49:33.091982
NCT02896868|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-09-01|||November 8, 2016|Actual|2016-11-08|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study of LY3041658 in Participants With Skin Diseases|A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients With Skin Diseases|Recruiting||Phase 1|60|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:49:33.159195|2017-10-10 21:49:33.159195
NCT02896855|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2017-09-15|||September 13, 2016|Actual|2016-09-13|September 2017|2017-09-01|November 14, 2020|Anticipated|2020-11-14|November 14, 2020|Anticipated|2020-11-14||Interventional|||A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC)|A Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Pertuzumab+Herceptin+Docetaxel Versus Placebo+Herceptin+Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer|Recruiting||Phase 3|240|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 21:49:33.271851|2017-10-10 21:49:33.271851
NCT02896842|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-07|||September 2010||2010-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|March 2015|Actual|2015-03-01||Interventional|OPTIMIMATINIB||A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML|A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate (Glivec®) Plasmatic Through Level in Patients Newly Diagnosed With Chronic Phase Chronic Myelogenous Leukaemia (CP-CML).|Active, not recruiting||Phase 2|139|Actual|Versailles Hospital||3|||f||||f||||||||No||2017-10-10 21:49:33.405405|2017-10-10 21:49:33.405405
NCT02896829|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-10-04|||April 2013||2013-04-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|STIM-FU||Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia|Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia|Active, not recruiting||N/A|98|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 21:49:33.52032|2017-10-10 21:49:33.52032
NCT02896816|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-03-20|||May 2016||2016-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease|EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease|Recruiting||N/A|40|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||f||||||||No||2017-10-10 21:49:33.623912|2017-10-10 21:49:33.623912
NCT02896803|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-01-11|||August 2016||2016-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PanFLOX||Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer|A Phase II Trial of Bolus Fluorouracil and Oxaliplatin (mFLOX) as First-line Regimen for Patients With Unresectable or Metastatic Pancreatic Cancer Not Eligible for Infusional Fluorouracil, Irinotecan and Oxaliplatin|Recruiting||Phase 2|37|Anticipated|Instituto do Cancer do Estado de São Paulo||1|||f||||f||||||||No||2017-10-10 21:49:33.699847|2017-10-10 21:49:33.699847
NCT02896790|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-25|||March 9, 2015|Actual|2015-03-09|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|MODAP||From the Model to the Adaptation of a Therapeutic Education Program (TEP) in Cancer Research|From the Model to the Adaptation of a Therapeutic Education Program in Cancer Research: the Case of Renal Cancer Patients Treated by Oral Treatments, Multidisciplinary Approach|Completed||N/A|24|Actual|University Hospital, Bordeaux|||2||f||||f||||||||||2017-10-10 21:49:33.777482|2017-10-10 21:49:33.777482
NCT02896777|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-05-14|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Comparing Three Different pH Arms for Human Embryo Culture ex Vivo|Comparing Three Different Ex Vivo pH Levels of Human Embryo Culture on Live Birth|Not yet recruiting||N/A|2000|Anticipated|Ibn Sina Hospital||3|||f||||t|f|f||||||No||2017-10-10 21:49:33.859134|2017-10-10 21:49:33.859134
NCT02896764|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-07|||October 2014||2014-10-01|September 2016|2016-09-01||||February 2015|Actual|2015-02-01||Interventional|ECCO1||Interest of the Cone-beam Computed Tomography in the Imagery of the Middle Ear||Completed||N/A|61|Actual|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 21:49:33.942441|2017-10-10 21:49:33.942441
NCT02896751|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-27|||August 2016||2016-08-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of a 3D Printer to Make Custom Sleep Masks for Positive Airway Pressure Treatment|Custom 3-D Printed Noninvasive Ventilation Mask|Recruiting||N/A|20|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||Yes|Data will be shared with treating sleep physicians to improve care|2017-10-10 21:49:34.003859|2017-10-10 21:49:34.003859
NCT02896712|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-14|||January 2016||2016-01-01|September 2016|2016-09-01||||January 2020|Anticipated|2020-01-01||Interventional|||Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention|"Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention (Adaptive Trial)"|Recruiting||Phase 2|160|Anticipated|The University of Texas Health Science Center, Houston||6|||f||||t||||||||No||2017-10-10 21:49:34.261273|2017-10-10 21:49:34.261273
NCT02896699|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-01-26|||March 2016||2016-03-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Advanced HIV Prevention (PrEP Chicago)|Advanced HIV Prevention (PrEP Chicago)|Recruiting||N/A|240|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-10 21:49:34.36137|2017-10-10 21:49:34.36137
NCT02896686|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-09-09|||October 2016||2016-10-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|ILEOMESH||Efficacy of an Onlay Mesh for Prevention of Incisional Hernia After Loop Ileostomy Closure|Multicentric, Prospective, Randomized and Simple Blind Study to Determine the Efficacy of the Placement of an Onlay Mesh for Prevention of Incisional Hernia After Loop Ileostomy Closure in Patients With a Prior Rectal Resection for Cancer|Not yet recruiting||Phase 4|157|Anticipated|Hospital Universitari Joan XXIII de Tarragona.||2|||f||||t||||||||No||2017-10-10 21:49:34.586706|2017-10-10 21:49:34.586706
NCT02896673|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-06|||June 2011||2011-06-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of the Diagnostic Performance of Electrical Impedance Tomography to Detect Situations at Risk of Lesions Induced by Conventional Mechanical Ventilation in ARDS|Evaluation of the Diagnostic Performance of Electrical Impedance Tomography (EIT) to Detect Situations at Risk of Lesions Induced by Conventional Mechanical Ventilation in Acute Respiratory Distress Syndrome (ARDS)|Recruiting||N/A|10|Anticipated|Hospices Civils de Lyon||1|||f||||||||||||||2017-10-10 21:49:34.677395|2017-10-10 21:49:34.677395
NCT02896660|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-06|||September 2016||2016-09-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|PRINCE||Probuphine Innovations for Clinical Effectiveness (PRINCE)|Activity Monitors for Opioid Dependence Treated With Probuphine|Not yet recruiting||N/A|15|Anticipated|Healthcare Innovation Technology Lab||1|||f||||f||||||||No|All participant data will be anonymous and reported in aggregate.|2017-10-10 21:49:34.775092|2017-10-10 21:49:34.775092
NCT02896647|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-07|2016-09-07||||||September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Observational|ESPOIR||3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord Lesions||Not yet recruiting||N/A|52|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:49:34.864556|2017-10-10 21:49:34.864556
NCT02896634|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-30|||October 2015||2015-10-01|October 2015|2015-10-01|September 2018|Anticipated|2018-09-01|March 2017|Anticipated|2017-03-01||Observational|BUVAMASS||Analysis by Clinical Mass Spectrometry of Bloodstains|Use of Dried Blood Spot for Clinical Mass Spectrometry Analysis|Active, not recruiting||N/A|160|Actual|University Hospital, Montpellier|||4||f||||t||||||Samples Without DNA|"     Dried whole blood spots on filter paper and plasma   "|Undecided||2017-10-10 21:49:34.927164|2017-10-10 21:49:34.927164
NCT02896621|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-09-06|||April 2015||2015-04-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|DOSA-2||Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep Apnea|Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep Apnea: Protocol for a Randomized Controlled Trial|Recruiting||Phase 3|53|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||Undecided||2017-10-10 21:49:35.012007|2017-10-10 21:49:35.012007
NCT02896608|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-02-03|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|EXCIDRAH||Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome|Neuronal Excitability of Hyperpolarization-activated Cyclic Nucleotide-gated (HCN1) Channel Mutations in Dravet Syndrome|Recruiting||N/A|45|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||3||f||||||||||||||2017-10-10 21:49:35.147236|2017-10-10 21:49:35.147236
NCT02896595|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-01-05|||September 2016||2016-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation|General Anesthesia With Endotracheal Tube Versus Laryngeal Mask Airway in Patients Undergoing Catheter Ablation for Atrial Fibrillation, a Non-inferiority Trial|Recruiting||N/A|96|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||No||2017-10-10 21:49:35.278125|2017-10-10 21:49:35.278125
NCT02896582|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-12|||October 2016||2016-10-01|September 2016|2016-09-01|March 2025|Anticipated|2025-03-01|March 2019|Anticipated|2019-03-01||Interventional|LyMa101||Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance|Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance|Not yet recruiting||Phase 2|83|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||f||||||||No||2017-10-10 21:49:35.403023|2017-10-10 21:49:35.403023
NCT02896569|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-03-27|||August 2016||2016-08-01|March 2017|2017-03-01|February 27, 2017|Actual|2017-02-27|December 2016|Actual|2016-12-01||Interventional|||Tolerability of Using a Post-Treatment Topical Adjuvant Combination Following Fractional Radiofrequency Ablation|Clinical Evaluation of the Tolerability of Using a Post Treatment Topical Adjuvant Combination Following Fractional Radiofrequency Ablation Using the Venus Viva|Completed||N/A|51|Actual|Venus Concept||2|||f||||f||||||||No||2017-10-10 21:49:35.655971|2017-10-10 21:49:35.655971
NCT02896556|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-01-29|||August 2016||2016-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluation of Esthetic Performance of Resin Infiltration Technique on Enamel Lesions|Evaluation of Esthetic Performance of Resin Infiltration Technique on Hypomineralized and Demineralized Enamel Lesions|Recruiting||N/A|200|Anticipated|Hacettepe University||1|||f||||f||||||||Undecided||2017-10-10 21:49:35.752982|2017-10-10 21:49:35.752982
NCT02896543|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-07-29|||September 2016||2016-09-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01|12 Months|Observational [Patient Registry]|||The Relationship of Change of Dendritic Cells Fractalkine and P-selectin Patients With Acute Myocardial Infarction|The Relationship of Change of Dendritic Cells Fractalkine and P-selectin in Patients With Acute Myocardial Infarction|Completed||N/A|45|Actual|The First Affiliated Hospital of Dalian Medical University|||2||f||||t||||||||||2017-10-10 21:49:35.863095|2017-10-10 21:49:35.863095
NCT02896530|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-06|||May 2015||2015-05-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|TAMICI||Arterial Thrombosis and Inflammatory Bowel Disease: a Series of 6 Cases and Literature Review|Arterial Thrombosis and Inflammatory Bowel Disease: a Series of 6 Cases and Literature Review|Completed||N/A|6|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||||Undecided||2017-10-10 21:49:35.972426|2017-10-10 21:49:35.972426
NCT02896517|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-07|||October 1, 2016|Actual|2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|June 30, 2017|Actual|2017-06-30||Observational|RHABDURGENCE||Support for the Rhabdomyolysis in an Emergency Department|Support for the Rhabdomyolysis in an Emergency Department|Active, not recruiting||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:49:36.047306|2017-10-10 21:49:36.047306
NCT02896504|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-10-13|||September 2013||2013-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients|Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients|Recruiting||N/A|60|Anticipated|Kessler Foundation|||3||f||||f||||||||Undecided||2017-10-10 21:49:36.105835|2017-10-10 21:49:36.105835
NCT02896491|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-09-12|||May 2016||2016-05-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|EMF60+males||RF-EMF Effects on the CNS in Elderly Men|Radiofrequency Electromagnetic Fields (RF-EMF) Effects on Brain Activity During Wake and Sleep in Healthy Elderly Males|Recruiting||N/A|30|Anticipated|The Federal Office for Radiation Protection, Germany||3|||f||||f||||||||Undecided||2017-10-10 21:49:36.204588|2017-10-10 21:49:36.204588
NCT02896478|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-09|||January 2015||2015-01-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|PRIMAC||Securing and Optimizing the Patient's Drug Therapy With Cancer: Clinical Pharmacy and Articulation With the City|Securing and Optimizing the Patient's Drug Therapy With Cancer: Clinical Pharmacy and Articulation With the City|Completed||N/A|23|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||||Undecided||2017-10-10 21:49:36.296134|2017-10-10 21:49:36.296134
NCT02896465|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Human Milk Oligosaccharides and Childhood Diarrhoea|Treatment of Acute Childhood Diarrhoea With Human Milk Oligosaccharides and Impact on Gut Micro Biota Dysbiosis and Nutritional Status|Recruiting||N/A|495|Anticipated|Nestlé||3|||f||||f||||||||No||2017-10-10 21:49:36.361711|2017-10-10 21:49:36.361711
NCT02896452|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-04-10|||October 1, 2016|Actual|2016-10-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|April 2018|Anticipated|2018-04-01||Observational|PCOS||Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome|Astronaut Vision Issues and One Carbon Metabolism: Expanded Polymorphism Evaluation and Evaluation in a Potential Analog Population|Recruiting||N/A|80|Anticipated|National Aeronautics and Space Administration (NASA)|||4||f||||f||||||Samples Without DNA|"     The Mayo Clinic/NASA would like to keep the samples for future research. The subjects can     still take part in the current study even if they don't want their sample to be used for     future research. If the subject agrees to give their sample it will become the property of     NASA. Some future studies may examine the DNA. The PI would contact the subject if there are     findings which would be useful for the subjects' health care. The subject would be given     general information on the potential risks, benefits, and costs of choosing to learn about     the findings.   "|Yes|Data will be provided upon subject request.|2017-10-10 21:49:36.472552|2017-10-10 21:49:36.472552
NCT02896439|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-09|||October 2016||2016-10-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PESCIATIQUE||Protocol for Evaluation Effectiveness Monitoring Neurophysiological Per-operative in Surgery Traumatic Acetabular|Protocol for Evaluation Effectiveness Monitoring Neurophysiological Per-operative in Surgery Traumatic Acetabular|Not yet recruiting||N/A|30|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||Undecided||2017-10-10 21:49:36.579002|2017-10-10 21:49:36.579002
NCT02896426|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Collaborative Problem Solving vs. Positive Solutions for Families in Preschool Parent Groups|Comparison of Collaborative Problem Solving (CPS) and Positive Solutions for Families Groups for Parents of Head Start Preschoolers|Enrolling by invitation||N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 21:49:36.656037|2017-10-10 21:49:36.656037
NCT02896413|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-06|||May 2016||2016-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection||Recruiting||N/A|100|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 21:49:36.750069|2017-10-10 21:49:36.750069
NCT02896400|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-01-25|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Optimizing Tobacco Dependence Treatment in the Emergency Department|Optimizing Tobacco Dependence Treatment in the Emergency Department|Recruiting||N/A|1056|Anticipated|Yale University||16|||f||||f||||||||No||2017-10-10 21:49:36.838102|2017-10-10 21:49:36.838102
NCT02896387|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-05-12|||March 3, 2017|Actual|2017-03-03|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|PRIMAculture||Ability of a Molecule (Prima) to Restore Physiological Differentiation in Epithelium Expressing Gene p63|Ex Vivo and in Vitro Assessment of the Pharmacological Properties of Molecule Prima in the Restoration of Physiological Differentiation of Gene p63 Dependant Epithelium|Recruiting||N/A|60|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||Undecided||2017-10-10 21:49:36.955641|2017-10-10 21:49:36.955641
NCT02895984|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-06|||July 2015||2015-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Reducing Hazardous Alcohol Use in Social Networks Using Targeted Intervention|Reducing Hazardous Alcohol Use in Social Networks Using Targeted Intervention|Enrolling by invitation||N/A|1280|Anticipated|Brown University||2|||f||||||||||||||2017-10-10 21:49:40.224898|2017-10-10 21:49:40.224898
NCT02896374|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-06|||March 2013||2013-03-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SERC||Normal and Abnormal ERP During ToM and Emotional Conflicts in Schizophrenia|Normal and Abnormal Event Related Potentials During Attribution of Intentions to Others and Resolution of Emotional Conflicts in Schizophrenia|Active, not recruiting||N/A|100|Anticipated|Versailles Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:49:37.022826|2017-10-10 21:49:37.022826
NCT02896361|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-05|||July 2016||2016-07-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|BOSS||Burst Optimized Stimulation Study|Burst Optimized Stimulation Study|Completed||N/A|29|Actual|St. Jude Medical||3|||f||||f||||||||||2017-10-10 21:49:37.090288|2017-10-10 21:49:37.090288
NCT02896348|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-03-20|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|June 2019|Anticipated|2019-06-01||Interventional|||Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors|Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors|Not yet recruiting||N/A|40|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:49:37.171451|2017-10-10 21:49:37.171451
NCT02896335|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-28|||November 2016||2016-11-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Palbociclib In Progressive Brain Metastases|A Phase 2 Study of Palbociclib in Progressive Brain Metastases Harboring Alterations in the CDK Pathway|Recruiting||Phase 2|30|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 21:49:37.257022|2017-10-10 21:49:37.257022
NCT02896322|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-09-09|||June 2013||2013-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|September 2016|Actual|2016-09-01||Interventional|||Cyberknife After Breast Conservative Surgery|Partial Breast Irradiation With Cyber Knife After Breast Conserving Surgery: A Pilot Study in Early Breast Cancer|Recruiting||N/A|80|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||||||||||||2017-10-10 21:49:37.340961|2017-10-10 21:49:37.340961
NCT02896309|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-09|||September 2016||2016-09-01|September 2016|2016-09-01||||March 2019|Anticipated|2019-03-01||Interventional|BIC||The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity|The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity|Not yet recruiting||N/A|45|Anticipated|Erasmus Medical Center||3|||f||||||||||||||2017-10-10 21:49:37.412099|2017-10-10 21:49:37.412099
NCT02896283|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2016-09-06|||February 2012||2012-02-01|September 2016|2016-09-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Effect of Low-Level Laser on Pain and Healing of Donor Site Following Free Gingival Graft|The Effect of Low-Level Laser Therapy on Patient`s Pain and Healing of Palatal Donor Site Following Free Gingival Graft: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|12|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 21:49:37.583954|2017-10-10 21:49:37.583954
NCT02896270|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-06-16|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|VAIN||Valproic Acid for Idiopathic Nephrotic Syndrome|A Prospective Interventional Pilot Study on the Use of Valproic Acid for Treatment of Idiopathic Nephrotic Syndrome|Recruiting||Phase 2/Phase 3|15|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||t||||||||Yes|The data of this pilot study will be submitted for publication as soon as the anticipated 15 subjects have completed the study.|2017-10-10 21:49:37.66677|2017-10-10 21:49:37.66677
NCT02896257|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-09-11|||September 6, 2016|Actual|2016-09-06|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|November 6, 2018|Anticipated|2018-11-06||Interventional|DISCUSS COPD||De-implementing Inhaled Steroids to Improve Care and Safety in COPD|De-implementing Inhaled Steroids to Improve Care and Safety in COPD (DISCUSS COPD) (QUE 15-471)|Enrolling by invitation||N/A|450|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:49:37.757229|2017-10-10 21:49:37.757229
NCT02896218|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-11-12|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Month|Observational [Patient Registry]|VCMTDMinCI||Therapeutic Monitoring of Vancomycin in Critical Ill Patients: a Registry|Therapeutic Monitoring of Vancomycin in Critical Ill Patients: a Registry|Recruiting||N/A|400|Anticipated|Peking University Third Hospital|||2||f||||t||||||||No||2017-10-10 21:49:38.053752|2017-10-10 21:49:38.053752
NCT02896205|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-11-04|||October 2016||2016-10-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|MYILD||Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease|A Randomized Controlled Trial to Compare the Efficacy of Oral Mycophenolate Mofetil With Placebo in Patients With Systemic Sclerosis Related Early Interstitial Lung Disease|Recruiting||Phase 3|60|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||No||2017-10-10 21:49:38.167902|2017-10-10 21:49:38.167902
NCT02895997|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-06|||June 2016||2016-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Turning Night Into Day: Transcontinental Provision of Telehealth By and For the Emory Community|Turning Night Into Day: Transcontinental Provision of Telehealth By and For the Emory Community|Recruiting||N/A|7|Anticipated|Emory University||1|||f||||f||||||||Yes|Data will be shared with future researchers.|2017-10-10 21:49:40.118776|2017-10-10 21:49:40.118776
NCT02896192|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-07-13|||February 14, 2017|Actual|2017-02-14|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Setmelanotide for the Treatment of Early-Onset POMC Deficiency Obesity|An Open Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of RM-493, a MC4R Agonist, in Early Onset POMC Deficiency Obesity Due to Bi-Allelic Loss-of-Function POMC or PCSK1 Genetic Mutation|Recruiting||Phase 2/Phase 3|10|Anticipated|Rhythm Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:49:38.274063|2017-10-10 21:49:38.274063
NCT02896179|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-22|||November 2016||2016-11-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|GE-O-VR||Virtual Reality and Robot Assisted Gait Training in Patients With Multiple Sclerosis|The Effects of an Innovative Combined Virtual Reality and Robot Assisted Gait Training on Cognitive and Walking Functions in Patients With Multiple Sclerosis: A Randomized Control Trial|Not yet recruiting||N/A|20|Anticipated|Universita di Verona||2|||f||||t||||||||No||2017-10-10 21:49:38.51383|2017-10-10 21:49:38.51383
NCT02896166|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2017-06-13|||September 2016||2016-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer|Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer|Not yet recruiting||Phase 3|150|Anticipated|Shandong Provincial Hospital||1|||f||||t||||||||No||2017-10-10 21:49:38.638947|2017-10-10 21:49:38.638947
NCT02896153|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-09-06|||December 2014||2014-12-01|September 2016|2016-09-01||||July 2015|Actual|2015-07-01||Observational|HYPNOSIS||Current Situation on the Consumption of Hypnotic Substances at the Pharmacy|Current Situation on the Consumption of Hypnotic Substances at the Pharmacy|Completed||N/A|657|Actual|Nantes University Hospital|||1||f||||||||||||||2017-10-10 21:49:38.740458|2017-10-10 21:49:38.740458
NCT02896140|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-09-06|||April 2016||2016-04-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors|The Effect of Dairy Product Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors in Patients Enrolled in the Joslin Weight Achievement and Intensive Treatment (Why WAIT) Program: A Prospective Cohort Study|Recruiting||N/A|50|Anticipated|Joslin Diabetes Center|||1||f||||f||||||Samples With DNA|"     Serum   "|Undecided||2017-10-10 21:49:38.813774|2017-10-10 21:49:38.813774
NCT02896127|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-18|||October 18, 2016|Actual|2016-10-18|September 2017|2017-09-01|May 3, 2019|Anticipated|2019-05-03|May 1, 2018|Anticipated|2018-05-01||Interventional|||Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis|A Randomized, Double-blind, Placebo-controlled, Phase III Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes, to Compare Efficacy at 16 Weeks With Placebo and to Assess Safety and Tolerability up to 52 Weeks in Subjects With Active Ankylosing Spondylitis|Recruiting||Phase 3|600|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 21:49:38.963485|2017-10-10 21:49:38.963485
NCT02896114|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-03-17|||September 2016||2016-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Retrospective Study of Surgical Treatment of Congenital Pseudarthrosis of Tibia in China|A Retrospective Study of Surgical Treatment of Congenital Pseudarthrosis of Tibia in China: a Muti-centre Study|Recruiting||N/A|150|Anticipated|Hunan Children's Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:49:39.217789|2017-10-10 21:49:39.217789
NCT02896101|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-06-28|||August 2016||2016-08-01|December 2016|2016-12-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).|Completed||Phase 3|755|Actual|Glenmark Pharmaceuticals Ltd. India||3|||f||||f||||||||||2017-10-10 21:49:39.3341|2017-10-10 21:49:39.3341
NCT02896088|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-06|||September 2015||2015-09-01|November 2014|2014-11-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Observational|sealants||Effectiveness of Sealants on Molars|Prevention of Dental Caries in Primary Molars on Sealants|Recruiting||N/A|200|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||Undecided||2017-10-10 21:49:39.485528|2017-10-10 21:49:39.485528
NCT02896075|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-18|||August 2016||2016-08-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Mirthful Laughter and Muscle Soreness / Pain|Social Laughter's Effect on Pain Tolerance|Recruiting||N/A|30|Anticipated|University of Texas at Austin||2|||f||||f||||||||||2017-10-10 21:49:39.571409|2017-10-10 21:49:39.571409
NCT02896062|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-06|||October 2014||2014-10-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Development and Evaluation of a Sleep-coaching Program||Recruiting||N/A|48|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||Undecided||2017-10-10 21:49:39.674105|2017-10-10 21:49:39.674105
NCT02896049|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-09|||November 2016||2016-11-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|1 Month|Observational [Patient Registry]|||Celsius TCS Hyperthermia System PMCF Trial|Celsius TCS Hyperthermia System Post Market Clinical Follow-Up (PMCF) Trial - Vigilance Registry|Not yet recruiting||N/A|5000|Anticipated|Celsius42 GmbH|||1||f||||t||||||||No||2017-10-10 21:49:39.754184|2017-10-10 21:49:39.754184
NCT02896036|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-09-09|||August 2016||2016-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Veress Entry With/Without Concomitant CO2|Laparoscopic Entry Technique With a Veress Needle Insertion With and Without Concomitant CO2 Insufflation - Does it Matter?|Recruiting||N/A|90|Anticipated|University of South Florida||2|||f||||t||||||||No||2017-10-10 21:49:39.838406|2017-10-10 21:49:39.838406
NCT02896023|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-06|||September 2016||2016-09-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Predictors of Ovarian Reserve in Infertile Women|Sonographic and Laboratory Predictors of Ovarian Reserve in Infertile Women|Not yet recruiting||Phase 4|100|Anticipated|Cairo University||2|||f||||t||||||||Yes||2017-10-10 21:49:39.937499|2017-10-10 21:49:39.937499
NCT02896010|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-08-10|||July 2016||2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes|Effectiveness of a Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes: Rationale and Study Protocol - Pilot Study|Active, not recruiting||N/A|75|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 21:49:40.027115|2017-10-10 21:49:40.027115
NCT02895958|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-29|||October 23, 2017|Anticipated|2017-10-23|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||The Dublin Zepatier Study|Open Label Study of the Safety and Efficacy of FDC Zepatier (Elbasvir+Grazoprevir +/- Ribavirin)Administered in a Community Based Setting to HCV Infected G1/4 Treatment naïve Patients on Stable Opiate Substitution Therapy With Cirrhotic and Non-cirrhotic Liver Disease|Not yet recruiting||Phase 4|60|Anticipated|Mater Misericordiae University Hospital||1|||f|||||f|f|||f|||||2017-10-10 21:49:40.378505|2017-10-10 21:49:40.378505
NCT02895945|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-04-18|||December 22, 2016|Actual|2016-12-22|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||BAX 802 in CHA With Inhibitors|A Phase 3, Multicenter, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects With Congenital Hemophilia A With Factor VIII Inhibitors Undergoing Surgical or Other Invasive Procedures|Recruiting||Phase 3|15|Anticipated|Baxalta US Inc.||1|||f||||f||||||||||2017-10-10 21:49:40.468336|2017-10-10 21:49:40.468336
NCT02895932|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-08-22|||January 2015||2015-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Serotonin and Amyloidopathy|Serotonin and Amyloidopathy|Active, not recruiting||N/A|27|Actual|University of Michigan||2|||f||||t||||||||||2017-10-10 21:49:40.591896|2017-10-10 21:49:40.591896
NCT02895919|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-06|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Bedside Inoculation of Ascitic Fluid in Diagnostic Paracentesis|Is Bedside Inoculation of Ascitic Fluid in Diagnostic Paracentesis Associated With a Higher Sensitivity for Positive Cultures? Prospective Observational Trial|Not yet recruiting||N/A|460|Anticipated|Medical College of Wisconsin|||2||f||||t||||||||Yes||2017-10-10 21:49:40.674026|2017-10-10 21:49:40.674026
NCT02895906|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-04-26|||November 28, 2016|Actual|2016-11-28|April 2017|2017-04-01|April 20, 2017|Actual|2017-04-20|April 13, 2017|Actual|2017-04-13||Interventional|||Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions|A 5-Week, Multi-center, Open-label Study to Assess the Safety and Efficacy of NFC-1 in Subjects Aged 12-17 Years With 22q11.2 Deletion Syndrome and Commonly Associated Neuropsychiatric Conditions (Anxiety, ADHD, ASD)|Completed||Phase 1|2|Actual|Aevi Genomic Medicine||1|||f||||t||||||||Undecided||2017-10-10 21:49:40.784124|2017-10-10 21:49:40.784124
NCT02895893|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-05-19|||July 2016||2016-07-01|July 2016|2016-07-01|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Interventional|PrepSmart||PrEP SMART Phase I Trial|PrEP SMART PHASE I TRIAL|Completed||Phase 1|12|Actual|Duke University||1|||f||||f||||||||Undecided||2017-10-10 21:49:40.871724|2017-10-10 21:49:40.871724
NCT02895880|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-05-24|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing|A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing|Recruiting||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-10 21:49:40.952971|2017-10-10 21:49:40.952971
NCT02895867|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-09-06|||May 2016||2016-05-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes|Effect of Consumption of Dairy Products on Glycemic Control, Body Weight and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Randomized Controlled Clinical Study|Recruiting||N/A|108|Anticipated|Joslin Diabetes Center||3|||f||||f||||||||No||2017-10-10 21:49:41.036145|2017-10-10 21:49:41.036145
NCT02895854|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-09-06|||January 2013||2013-01-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|BRAVEROBO||LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients|LDR Brachytherapy Versus Hypofractionated SBRT for Low and Intermediate Risk Prostate Cancer Patients|Active, not recruiting||N/A|44|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-10-10 21:49:41.119498|2017-10-10 21:49:41.119498
NCT02895841|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-06-22|||August 2016||2016-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN)|Patient-Empowered Mobile Technology in Hospitalized Patients: Technology Resources to Understand Pain Assessment in Patients With Pain (TRU-PAIN)|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||t||||||||No||2017-10-10 21:49:41.189407|2017-10-10 21:49:41.189407
NCT02895828|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-08-25|||August 2016||2016-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of Core Stabilization and Strengthening Exercise on Quality of Life in Clinical Lumbar Instability|Clinical Practice Guideline With Core Stabilization and Strengthening Exercise Programs for Low Back Pain With Clinical Lumbar Instability|Recruiting||N/A|30|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-10-10 21:49:41.256635|2017-10-10 21:49:41.256635
NCT02895815|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-09-18|||April 9, 2018|Anticipated|2018-04-09|September 2017|2017-09-01|August 19, 2022|Anticipated|2022-08-19|February 20, 2021|Anticipated|2021-02-20||Interventional|||Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)|A Phase 2, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Subretinal Administration of CNTO 2476 in Subjects With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)|Not yet recruiting||Phase 2|60|Anticipated|Janssen Pharmaceutical K.K.||3|||f||||f|t|f|||t|||||2017-10-10 21:49:41.329115|2017-10-10 21:49:41.329115
NCT02895802|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2017-02-07|||August 2016||2016-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Assessing the Feasibility of the Use of Visual Aids in Patient Education in Adults With Down Syndrome (DS)|Assessing the Feasibility of the Use of Visual Aids in Patient Education in Adults With Down Syndrome (DS)|Active, not recruiting||N/A|40|Actual|Advocate Health Care||4|||f||||f||||||||No||2017-10-10 21:49:41.482557|2017-10-10 21:49:41.482557
NCT02895789|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|May 2020|Anticipated|2020-05-01|July 2019|Anticipated|2019-07-01||Observational|||Oxidative Capacity and Exercise Tolerance in Ambulatory SMA|Evaluation of Oxidative Capacity and Exercise Tolerance in Ambulatory Patients With Spinal Muscular Atrophy (SMA)|Recruiting||N/A|42|Anticipated|Columbia University|||3||f||||f||||||||Undecided||2017-10-10 21:49:41.558419|2017-10-10 21:49:41.558419
NCT02895776|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-09-05|||December 22, 2015|Actual|2015-12-22|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|AMAS||Risk Factors of Conversion From Local to General Sedation in Endovascular Stroke Therapy|Search for Risk Factors of Conversion From Local to General Sedation in Emergency Endovascular Therapy for Acute Stroke|Recruiting||N/A|320|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||f||||||||||2017-10-10 21:49:41.635085|2017-10-10 21:49:41.635085
NCT02895763|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-22|||June 2006||2006-06-01|September 2016|2016-09-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Observational|QoLNMD||Quality of Life in Neuromuscular Disease|Development of a New Scale of Quality of Life, Specific of Neuro Muscular Diseases and More Specifically of Steinert Disease, by the Rasch Model Methods.|Completed||N/A|159|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:49:41.696501|2017-10-10 21:49:41.696501
NCT02895750|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-09-06|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|METXR/CKD||Efficacity and Safety of Metformin XR in CKD Stage 1 to 3|Efficacity and Safety of Metformin XR in CKD Stage 1 to 3|Not yet recruiting||Phase 2|36|Anticipated|Centre Hospitalier Universitaire, Amiens||3|||f||||||||||||||2017-10-10 21:49:41.760741|2017-10-10 21:49:41.760741
NCT02895737|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-06|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2019|Anticipated|2019-09-01||Interventional|PROTECT||PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Claret Sentinel™ Device|PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Claret Sentinel™ Device|Recruiting||N/A|328|Anticipated|Deutsches Herzzentrum Muenchen||4|||f||||||||||||||2017-10-10 21:49:41.83878|2017-10-10 21:49:41.83878
NCT02895724|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|HBOT-LYCA||Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial|Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial|Enrolling by invitation||Phase 2|20|Anticipated|Danish Cancer Society||2|||f||||t||||||||Undecided||2017-10-10 21:49:41.907739|2017-10-10 21:49:41.907739
NCT02895711|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-06|||September 2010||2010-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Radiation Dose of Pediatric Patients During Ureteroscopy|Radiation Doses of Pediatric Patients During Ureteroscopy and Percutaneous Nephrolithotomy|Recruiting||N/A|500|Anticipated|Children's Hospital of Pittsburgh|||1||f||||f||||||||No||2017-10-10 21:49:41.969042|2017-10-10 21:49:41.969042
NCT02895698|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-06|||November 2014||2014-11-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effects of Myofascial Trigger Point Dry Cupping on Plantar Heel Pain|Effects of Myofascial Trigger Point Dry Cupping on Plantar Heel Pain|Completed||N/A|70|Actual|Dammam University||2|||f||||f||||||||No||2017-10-10 21:49:42.037892|2017-10-10 21:49:42.037892
NCT02895685|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-09|||August 2016||2016-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Group Dynamics in Surgical Skill Training|The Effect of Group Dynamics in Surgical Skill Training|Enrolling by invitation||N/A|80|Anticipated|Copenhagen Academy for Medical Education and Simulation||2|||f||||f||||||||No||2017-10-10 21:49:42.112704|2017-10-10 21:49:42.112704
NCT02895672|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-01-31|||August 2016||2016-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||GLP-1/Basal Insulin Combination Therapy|A Real-world, Observational Study of GLP-1 Therapy Added to Basal Insulin in Patients With Type 2 Diabetes Mellitus|Completed||N/A|150|Actual|Albany College of Pharmacy and Health Sciences|||2||f||||f||||||||Undecided||2017-10-10 21:49:44.059638|2017-10-10 21:49:44.059638
NCT02895659|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-06-14|||December 1, 2016|Actual|2016-12-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|Hemacetat||Fluid Management in Patients Undergoing Cardiac Surgery|Fluid Management in Patients Undergoing Cardiac Surgery - Effects of an Acetate Versus Lactate Buffered Balanced Infusion Solution on Hemodynamic Stability, a Randomized Controlled Double-blind Trial|Recruiting||Phase 4|144|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||No||2017-10-10 21:49:44.123112|2017-10-10 21:49:44.123112
NCT02895646|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-02-02|||June 2012||2012-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|PANGENOMIC-BL||Genomic Study of Genetic Polymorphisms Involved in Immediate Allergic Reactions to Beta-lactam Antibiotics|Genomic Study of Genetic Polymorphisms Involved in Immediate Allergic Reactions to Beta-lactam Antibiotics|Active, not recruiting||N/A|2356|Actual|Central Hospital, Nancy, France|||2||f||||f||||||Samples With DNA|"     Serum, plasma and DNA   "|No||2017-10-10 21:49:44.209232|2017-10-10 21:49:44.209232
NCT02895633|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||November 2009||2009-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|TUMOSTEO||Osteoarticular Tumor Characterization by Advanced Imaging|Osteoarticular Tumor Characterization by Advanced Imaging|Recruiting||N/A|1090|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:49:44.29446|2017-10-10 21:49:44.29446
NCT02895620|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CEPHEID||Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC|Evaluation of the Effect of a Complex Inflammatory Milieu Induced by BCG Treatment in Urines of Patients With Non-muscle-invasive Bladder Cancer on the Xpert® Bladder Cancer Assay|Recruiting||N/A|24|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||No||2017-10-10 21:49:44.387836|2017-10-10 21:49:44.387836
NCT02895607|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-08|||December 2014||2014-12-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|DIDTGENOU||Evaluation of Outpatient Surgery in the Anterior Cruciate Ligament Reconstructions With Hamstring Hospital|Prospective Evaluation of Outpatient Surgery in the Anterior Cruciate Ligament Reconstructions With Hamstring Hospital|Completed||N/A|9|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||Undecided||2017-10-10 21:49:44.465936|2017-10-10 21:49:44.465936
NCT02895594|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-09|||January 2012||2012-01-01|September 2016|2016-09-01||||May 2015|Actual|2015-05-01||Observational|TROMAC||Outcome of Surgery for Idiopathic Macular Holes||Completed||N/A|59|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:49:44.526375|2017-10-10 21:49:44.526375
NCT02894619|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Observational|PerineoMuco||Urinary and Anorectal Functional Disorders and Their Impact on CF Adults (PerineoMucoRMO)|Assessment of the Prevalence and Severity of Urinary and Ano-rectal Functional Disorders and Their Impact on Quality of Life and Sexuality on CF Adults of the North-West CF Network|Not yet recruiting||N/A|175|Anticipated|Fondation Ildys|||1||f||||f||||||||No||2017-10-10 21:49:44.576464|2017-10-10 21:49:44.576464
NCT02894606|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-08|||February 2015||2015-02-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|THYMO B||Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients||Recruiting||N/A|40|Anticipated|University Hospital, Brest|||2||f||||||||||Samples With DNA|"     Whole blood   "|||2017-10-10 21:49:44.66878|2017-10-10 21:49:44.66878
NCT02894593|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-12-14|||January 2015||2015-01-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|October 2015|Actual|2015-10-01||Interventional|||Alcohol-free Essential Oils Containing Mouthrinse Efficacy on 3-day Supragingival Plaque Regrowth|Alcohol-free Essential Oils Containing Mouthrinse Efficacy on 3-day Supragingival Plaque Regrowth: a Randomized Crossover Clinical Trial|Completed||N/A|21|Actual|University of L'Aquila||4|||f||||t||||||||No||2017-10-10 21:49:44.758667|2017-10-10 21:49:44.758667
NCT02894580|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-05|||January 2015||2015-01-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|PREV-DEATH||Primary Prevention of Sudden Cardiac Death (PREV-DEATH)|Primary Prevention of Sudden Cardiac Death in Real Life: Differences With the Pivotal Studies and Their Consequences|Completed||N/A|336|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||No||2017-10-10 21:49:44.956537|2017-10-10 21:49:44.956537
NCT02894567|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-06-30|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of Directional Recording and Stimulation Using spiderSTN|Evaluation of Directional Recording and Stimulation Using the spiderSTN During the Implantation of DBS Leads|Terminated||N/A|6|Actual|Aleva Neurotherapeutics SA||1||"This study was structured in 2 phases, and was stopped after the first phase. The collected   data will be used to improve the device and prepare future studies."|f||||f||||||||||2017-10-10 21:49:45.028567|2017-10-10 21:49:45.028567
NCT02894554|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-09-05|||July 2014||2014-07-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|||Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment.|A Single-Center, Open-Label Study to Evaluate the Renal Function Improvement in Lamivudine Long Term Used HBsAg Positive Kidney Transplantation Patients After Switch to Telbivudine Treatment.|Terminated||Phase 4|19|Actual|National Taiwan University Hospital||2||clinical myalgia|f||||f||||||||Yes||2017-10-10 21:49:45.116506|2017-10-10 21:49:45.116506
NCT02894541|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-02-21|||August 2016|Actual|2016-08-01|August 2016|2016-08-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519|A Randomized, Open-label, Single Dose, 1-sequence, 3-treatment, 3-period Crossover Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 in Healthy Male Subjects|Completed||Phase 1|48|Actual|Chong Kun Dang Pharmaceutical||4|||f||||f||||||||No||2017-10-10 21:49:45.197313|2017-10-10 21:49:45.197313
NCT02895581|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-06|||January 2006||2006-01-01|September 2016|2016-09-01||||January 2015|Actual|2015-01-01||Observational|LEMPMAR||Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy||Completed||N/A|34|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:49:45.295551|2017-10-10 21:49:45.295551
NCT02895568|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-06-07|||October 2016||2016-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers|Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers in Komé, Doba, Republic of Chad|Recruiting||N/A|400|Anticipated|University of Oxford|||1||f||||f||||||Samples Without DNA|"     A dried blood spot sample for study analyses will be collected at the time of blood     collection for malaria diagnostic testing.   "|Undecided||2017-10-10 21:49:45.350025|2017-10-10 21:49:45.350025
NCT02895555|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-09-08|||March 2012||2012-03-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumentated Posterolateral Fusionin The IVANOS-study|RCT Comparing i-FACTOR and Allograft in Spinal Fusion Surgery|Completed||Phase 4|102|Actual|Sygehus Lillebaelt||2|||f||||t||||||||Yes||2017-10-10 21:49:45.44987|2017-10-10 21:49:45.44987
NCT02895542|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-08-11|||December 20, 2016|Actual|2016-12-20|August 2017|2017-08-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Observational|||Preparatory Work to Assess Adherence to Oral Chemotherapy|Preparatory Work to Assess Adherence to Oral Chemotherapy Among Patients With Chronic Myeloid Leukemia|Completed||N/A|86|Actual|Wake Forest University Health Sciences|||1||f||||t|f|f||||||||2017-10-10 21:49:45.54999|2017-10-10 21:49:45.54999
NCT02895529|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-09-05|||November 30, 2016|Actual|2016-11-30|September 2017|2017-09-01|August 15, 2018|Anticipated|2018-08-15|March 5, 2018|Anticipated|2018-03-05||Interventional|||A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy|A Multicenter, Randomized Trial Comparing The Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Subjects With Hematological Malignancy|Recruiting||Phase 4|408|Anticipated|Xian-Janssen Pharmaceutical Ltd.||2|||f||||t||f||||||||2017-10-10 21:49:45.630475|2017-10-10 21:49:45.630475
NCT02895516|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-01-11|||October 2016||2016-10-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Ease of Use, Tolerability, Efficacy and Safety of the Vibrant Capsule Administered in the Home Environment|A Prospective, Open-label, Single-arm Study to Assess the Ease of Use, Tolerability, Efficacy and Safety of the Vibrant Capsule Administered in the Home Environment.|Withdrawn||Phase 2|0|Actual|Vibrant Ltd.||1|||f||||f||||||||No||2017-10-10 21:49:45.787292|2017-10-10 21:49:45.787292
NCT02895503|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-06|||January 2012||2012-01-01|September 2016|2016-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment|The Effect of Yoga and Exercise on the Quality of Life of Patients With Non-Small Cell Lung Cancer|Terminated||N/A|1|Actual|Virginia Commonwealth University||2||Lack of accrual/Slow accrual|f||||f||||||||No||2017-10-10 21:49:45.856192|2017-10-10 21:49:45.856192
NCT02895490|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-19|||January 2014||2014-01-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|||Communication Training in Promoting Employment Retention Among Cancer Patients|Using Communication Training to Promote Employment Retention Among Cancer Survivors|Terminated||N/A|8|Actual|Virginia Commonwealth University||2||Grant ended/funding unavailable|f||||t||||||||||2017-10-10 21:49:45.956133|2017-10-10 21:49:45.956133
NCT02895477|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-01-27|||July 2016||2016-07-01|January 2017|2017-01-01|January 20, 2017|Actual|2017-01-20|December 2016|Actual|2016-12-01||Interventional|||Quest Sound Recover (SR2) vs. Venture SR2||Completed||N/A|23|Actual|Sonova AG||2|||f||||||||||||||2017-10-10 21:49:46.043646|2017-10-10 21:49:46.043646
NCT02895464|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-08-17|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility of Home-based Preoperative Exercise in Older People|Preoperative Home-based Exercise in Older People Before Colorectal Surgery - a Feasibility Study|Recruiting||N/A|30|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 21:49:46.113672|2017-10-10 21:49:46.113672
NCT02895451|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-05|||January 2016||2016-01-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|ECRA||Behavioral Interventions for Improvement of Adherence at Exercise-based Cardiac Rehabilitation (ECRA)|Behavioral Interventions for Improvement of Adherence at Exercise-based Cardiac Rehabilitation (ECRA)|Recruiting||N/A|160|Anticipated|Linkoeping University||2|||f||||t||||||||No||2017-10-10 21:49:46.199254|2017-10-10 21:49:46.199254
NCT02895438|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-01-20|||April 2014||2014-04-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Non Coeliac Gluten Sensitivity in Children|Does Non Coeliac Gluten Sensitivity (NCGS) Exist in Children? A Double-Blind Randomized Placebo-Controlled Trial|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 21:49:46.302006|2017-10-10 21:49:46.302006
NCT02895425|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-08|||January 2011||2011-01-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2011|Actual|2011-01-01|10 Years|Observational [Patient Registry]|REIN||Registry for End Stage Renal Failure|Réseau, Epidémiologie, Information, Néphrologie (Network Epidemiology Information Nephrology)|Recruiting||N/A|1000|Anticipated|Centre Hospitalier de Cayenne|||1||f||||f||||||||No||2017-10-10 21:49:46.378913|2017-10-10 21:49:46.378913
NCT02895412|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-09-05|||August 2016||2016-08-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|INTACT-WT1||Infection and Tumour Antigen Cellular Therapy|A Clinical Trial of Donor-derived WT1 Specific T Cells for Prevention of Relapse in Combination With Multiple Pathogen Specific T Cells for Prevention of Infection in Patients Undergoing Allogeneic Haemopoietic Stem Cell Transplant for AML|Recruiting||Phase 1|20|Anticipated|University of Sydney||1|||f||||t||||||||No||2017-10-10 21:49:46.575846|2017-10-10 21:49:46.575846
NCT02895399|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||December 2012||2012-12-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|EPHaVI||Epidemiology of Human Papillomavirus Infection Among Women Living on the Maroni and the Oyapock Rivers|Epidémiologie de l'Infection à Human Papilloma Virus Chez Les Femmes Vivant Sur Les Fleuves Maroni et Oyapock|Completed||N/A|643|Actual|Centre Hospitalier de Cayenne|||1||f||||f||||||Samples With DNA|"     Cervico-Vaginal Smears   "|||2017-10-10 21:49:46.68149|2017-10-10 21:49:46.68149
NCT02895386|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-09-13|||March 22, 2017|Actual|2017-03-22|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|CONTROL HTN-2||A Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension|A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension|Recruiting||N/A|500|Anticipated|ROX Medical, Inc.||2|||f||||t|f|t|t|f||||||2017-10-10 21:49:46.755922|2017-10-10 21:49:46.755922
NCT02895373|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-09-12|||July 2016||2016-07-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|ECMO_PGE1||PGE1 as Additive Anticoagulant in ECMO-Therapy|A Prospective Randomized, Double Blind Study on Safety and Efficacy of Alprostadil as Additional Anticoagulant in Patients With Veno- Venous Extracorporeal Membrane Oxygenation (ECMO)|Recruiting||Phase 2|114|Anticipated|Medical University of Vienna||2|||f||||f||||||||No|Data will be published in a peer-reviewed journal, individual data will not be made publicly available except by a direct request to the PI (in an anonymized fashion)|2017-10-10 21:49:46.910779|2017-10-10 21:49:46.910779
NCT02895360|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||August 2016||2016-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase 1/2a Study of BAL101553 Administered as 48-hour Intravenous Infusions in Adult Patients With Advanced Solid Tumors|An Open-label Phase 1/2a Study of BAL101553 Administered as Intravenous 48-hour Infusions in Adult Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|82|Anticipated|Basilea Pharmaceutica||1|||f||||f||||||||||2017-10-10 21:49:47.063822|2017-10-10 21:49:47.063822
NCT02895347|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-03-07|2016-12-14||December 2015||2015-12-01|September 2016|2016-09-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|||Proficiency Based Robotics Training Curriculum: Skill Acquisition & Transferability of Skills to Live Porcine Models|Proficiency Based Robotics Training Curriculum: Skill Acquisition & Transferability of Skills|Completed||N/A|36|Actual|George Washington University||2|||f||||f||||||||Yes|Results will be submitted for Association of Processors of Gynecology and Obstetrics Annual Meeting as well as to journals for publication.|2017-10-10 21:49:47.218674|2017-10-10 21:49:47.218674
NCT02895334|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-07-10|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|||MyHeartBaby: An Initial Evaluation of the MyHeartBaby Psychosocial Telemedicine Program|An Initial Evaluation of the MyHeartBaby Psychosocial Telemedicine Program|Completed||N/A|25|Actual|Emory University||2|||f||||f||||||||||2017-10-10 21:49:47.502086|2017-10-10 21:49:47.502086
NCT02895321|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Nano-hydroxyapatite With Potassium Nitrate in the Therapy of the Dental Sensitivity|Randomized Clinical Trial to Evaluate the Efficacy of Nano-hydroxyapatite Combined With the Potassium Nitrate for the Treatment of Dental Sensitivity|Completed||Phase 4|35|Anticipated|Università degli Studi di Sassari||1|||f||||t||||||||No|Not a plan for data sharing has been established. But, for anyone researcher would like to have this information, simply they may request them to us directly.|2017-10-10 21:49:47.599679|2017-10-10 21:49:47.599679
NCT02895308|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-09|||January 2015||2015-01-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|November 2015|Actual|2015-11-01||Interventional|AIDAII||Motivation and Adherence to Psychotherapy Assignments|Differences in Motivation and Adherence to a Prescribed Assignment After Face-to-face and Online Psychoeducation: an Experimental Study|Completed||N/A|100|Actual|Uppsala University||2|||f||||f||||||||No||2017-10-10 21:49:47.703315|2017-10-10 21:49:47.703315
NCT02895295|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|CHOICE||Evaluating a Patient-Centered Tool to Help Medicare Beneficiaries Choose Prescription Drug Plans||Enrolling by invitation||N/A|915|Anticipated|Stanford University||3|||f||||f||||||||||2017-10-10 21:49:47.814386|2017-10-10 21:49:47.814386
NCT02895282|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-09-05|||October 2014||2014-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|ONTIME-JR||Chronobiology and Childhood Obesity in a Mediterranean Spanish Population|Chronobiology and Childhood Obesity in a Mediterranean Spanish Population (ONTIME-JR: Obesity, Nutrigenomics, Timing, Mediterranean, Junior)|Recruiting||N/A|500|Anticipated|Universidad de Murcia|||1||f||||t||||||Samples With DNA|"     saliva   "|No||2017-10-10 21:49:47.922071|2017-10-10 21:49:47.922071
NCT02895269|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2017-06-11|||September 2016||2016-09-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|COSIMPO||COllaborative Shared Care to IMprove Psychosis Outcome|Partnership for Mental Health Development in Sub-Saharan Africa: COllaborative Shared Care to IMprove Psychosis Outcome|Recruiting||N/A|500|Anticipated|University of Ibadan||2|||f||||t||||||||No||2017-10-10 21:49:48.046502|2017-10-10 21:49:48.046502
NCT02895256|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-04|||April 2016||2016-04-01|September 2016|2016-09-01||||April 2021|Anticipated|2021-04-01||Observational|||Long-term Prognosis of Cluster Headache: a Retrospective Cohort Study||Recruiting||N/A|70|Anticipated|Samsung Medical Center|||1||f||||||||||||||2017-10-10 21:49:48.165882|2017-10-10 21:49:48.165882
NCT02895243|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2016-09-06|||June 2016||2016-06-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist|Prehabilitation for Adults With End Stage Renal Disease on the Kidney Transplant Waitlist|Enrolling by invitation||N/A|90|Anticipated|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||No||2017-10-10 21:49:48.235822|2017-10-10 21:49:48.235822
NCT02895230|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-04-10|||April 2015||2015-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ADTCR||Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study|Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study|Recruiting||N/A|2700|Anticipated|Rennes University Hospital|||1||f||||f||||||||No||2017-10-10 21:49:48.302591|2017-10-10 21:49:48.302591
NCT02895217|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-09-05|||June 2016||2016-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Aquatic Exercise and Metabolism in Women|Evaluation of Energy Balance During Aquatic Cycling Exercise in Premenopausal Women: Effect of Body Composition Status|Recruiting||N/A|40|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 21:49:48.387399|2017-10-10 21:49:48.387399
NCT02895204|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-02-09|||October 2015||2015-10-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Fermented Maillard Reacted Whey Protein on Immune Function|The Immune-enhancing Effect of Supplementation With Fermented Maillard Reacted Whey Protein in Nondiabetic and Nonobese Subjects|Completed||N/A|80|Actual|Yonsei University||2|||f||||||||||||||2017-10-10 21:49:48.466887|2017-10-10 21:49:48.466887
NCT02895191|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-03-28|||August 2016||2016-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)|A Randomized, Blind, Placebo-controlled, Parallel Group, Multi-center Study to Evaluate the Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)|Enrolling by invitation||Phase 2|60|Anticipated|Techpool Bio-Pharma Co., Ltd.||4|||f||||t||||||||Undecided||2017-10-10 21:49:48.553906|2017-10-10 21:49:48.553906
NCT02895178|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-09-04|||May 2014||2014-05-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Lifestyles Of Health And Sustainability for Breast Cancer Survivors|Lifestyle Intervention for Breast Cancer Survivors|Recruiting||N/A|60|Anticipated|Wonju Severance Christian Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:49:48.644263|2017-10-10 21:49:48.644263
NCT02895165|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-05|||November 2012||2012-11-01|September 2016|2016-09-01|November 2032|Anticipated|2032-11-01|November 2017|Anticipated|2017-11-01|15 Years|Observational [Patient Registry]|PREFER||PREgnancy and FERtility Registry|An Italian Multicenter Prospective Cohort Study on Fertility Preservation and Pregnancy Issues in Young Breast Cancer Patients: PREgnancy and FERtilty (PREFER)|Recruiting||N/A|1000|Anticipated|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|||1||f||||f||||||||Undecided||2017-10-10 21:49:48.743437|2017-10-10 21:49:48.743437
NCT02895152|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-05|||August 2016||2016-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Activity Monitor Use in COPD Patients Undergoing Rehabilitation|The Role of Activity Monitors in Improving Physical Activity in COPD Patients Participating in Pulmonary Rehabilitation|Recruiting||N/A|20|Anticipated|Salford Royal NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:49:48.881769|2017-10-10 21:49:48.881769
NCT02895139|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-02-27|||July 2016||2016-07-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|AMinO||Evaluation of Additive Manufacture in the Production of Orthotic Insoles|Efficacy of Additive Manufactured Orthotic Insoles for the Reduction of Forefoot Plantar Pressure in the Diabetic Foot.|Completed||N/A|25|Actual|University of Salford||3|||f||||t||||||||No||2017-10-10 21:49:48.968493|2017-10-10 21:49:48.968493
NCT02895126|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-08|||April 2014||2014-04-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||"Assessment of the Appui Parental: A Program of Early Support to Parenthood"|"Assessment of the Appui Parental: A Program of Early Support to Parenthood"|Recruiting||N/A|88|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 21:49:49.161542|2017-10-10 21:49:49.161542
NCT02894736|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-02-01|||March 2016||2016-03-01|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|HAT-DCS||Home-Administered Trial of Direct Current Stimulation|Home-administered Transcranial Direct Current Stimulation (tDCS) Treatment for Depression|Recruiting||N/A|36|Anticipated|The University of New South Wales||1|||f||||f||||||||||2017-10-10 21:49:53.438701|2017-10-10 21:49:53.438701
NCT02895113|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-08|||January 2017||2017-01-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|LEDA||Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes|Effect of Aspirin on Renal Disease Progression in Patients With Type 2 Diabetes: a Multicentre Double-blind, Placebo-controlled, Randomised Trial. The LEDA (renaL disEase Progression by Aspirin in Diabetic pAtients) Study.|Not yet recruiting||Phase 3|418|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||No||2017-10-10 21:49:49.26299|2017-10-10 21:49:49.26299
NCT02895100|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2017-10-05|||December 2016||2016-12-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis|A Phase 2b Randomised, Double-blind, Placebo-controlled, Parallel, Adaptive 2-Stage, Multi-Centre Study to Evaluate the Safety and Efficacy of Oral PTG-100 Induction in Subjects With Moderate to Severe Active Ulcerative Colitis|Recruiting||Phase 2|240|Anticipated|Protagonist Therapeutics||4|||f||||t||||||||||2017-10-10 21:49:49.40203|2017-10-10 21:49:49.40203
NCT02895087|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-01-30|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Observational|CHRONOS||Study to Explore Natural Daily Variation and Impact of Stress in HIV Levels|Circadian HIV RNA Oscillations and Outcomes of Stress|Active, not recruiting||N/A|40|Actual|The Peter Doherty Institute for Infection and Immunity|||2||f||||f||||||Samples With DNA|"     Part 1: Diurnal Variation cohort (total 15 participants) - no longer recruiting Blood samples      Part 2: Stress cohort (total 20 participants) - no longer recruiting Blood samples Saliva     Samples   "|No||2017-10-10 21:49:49.826568|2017-10-10 21:49:49.826568
NCT02895074|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-05|||August 2014||2014-08-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Subfoveal Choroidal Thickness After Surgery for Age-related Cataracts|Subfoveal Choroidal Thickness After Femtosecond Laser-assisted Cataract Surgery for Age-related Cataracts|Completed||N/A|40|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 21:49:49.910172|2017-10-10 21:49:49.910172
NCT02895061|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2017-05-29|||January 2015||2015-01-01|January 2015|2015-01-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.|Effectiveness Between Daily Versus Pulse Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients: A Randomized Controlled Trial and Multicenter Study|Completed||N/A|502|Actual|Phramongkutklao College of Medicine and Hospital||2|||f||||t||||||||No||2017-10-10 21:49:50.012948|2017-10-10 21:49:50.012948
NCT02895048|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-09-05|||September 2011||2011-09-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Observational|CCM-HF||Effects of CCM-therapy in Patients With Heart Failure|Clinical Effects of Cardiac Contractility Modulation (CCM) With the OPTIMIZER III System in Subjects With Heart Failure Caused by Left Ventricular Dysfunction|Completed||N/A|184|Actual|Stiftung Institut fuer Herzinfarktforschung|||2||f||||f||||||||No||2017-10-10 21:49:50.09515|2017-10-10 21:49:50.09515
NCT02895035|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2017-03-21|||September 2016||2016-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Comparison of Epinephrine and Phenylephrine/Ketorolac (Omidria®) Additives With Regards to Intraoperative Pupil Size|Prospective Comparison of Epinephrine and Phenylephrine/Ketorolac (Omidria®) Additives With Regards to Intraoperative Pupil Size|Enrolling by invitation||Phase 4|106|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 21:49:50.183081|2017-10-10 21:49:50.183081
NCT02895022|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-09-05|||September 2016||2016-09-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|EpiConCES||EpiConCES - Epidural Lidocaine for Conversion to CaEsarean Section|Determination of ED95 of 2% Lidocaine With Epinephrine for Converting Analgesia Epidural Anesthesia in Surgical Epidural in the Labor Current Cesarean|Not yet recruiting||N/A|40|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 21:49:50.274048|2017-10-10 21:49:50.274048
NCT02895009|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2016-09-20|||September 2016||2016-09-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|HCPATRI||Hemostatic Compression Patterns After Transradial Coronary Intervention|A Randomized Comparison of TR Band Hemostatic Compression Patterns After Transradial Coronary Intervention|Not yet recruiting||N/A|200|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||||2017-10-10 21:49:50.404482|2017-10-10 21:49:50.404482
NCT02894996|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-04|2017-08-08|||September 28, 2016|Actual|2016-09-28|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PEDIFLUID||Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient?|Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Elective Pediatric Anesthetized Patient?|Recruiting||N/A|61|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 21:49:50.504309|2017-10-10 21:49:50.504309
NCT02894983|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-14|||June 2016||2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Conservative Treatment of Distal Radius Fracture in Elderly in Randomized Controlled Trial|Comparison of Volar-flexion, Ulnar-deviation and Functional Position Cast Immobilization in the Non-operative Treatment of Distal Radius Fracture in Elderly Patients: a Pragmatic Randomized Controlled Trial|Active, not recruiting||N/A|114|Actual|Tampere University Hospital||2|||f||||||||||||||2017-10-10 21:49:50.619817|2017-10-10 21:49:50.619817
NCT02894970|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-04|||October 2016||2016-10-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation|A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation|Not yet recruiting||N/A|120|Anticipated|Shaare Zedek Medical Center|||6||f||||t||||||||Undecided||2017-10-10 21:49:50.744244|2017-10-10 21:49:50.744244
NCT02894957|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-09-04|||December 2016||2016-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||"Varenicline for Gradual vs. Abrupt Smoking Cessation in Low-motivated COPD Smokers"|"Varenicline for Gradual vs. Abrupt Smoking Cessation in Low-motivated COPD Smokers: A Randomized Pilot Study"|Not yet recruiting||Phase 4|250|Anticipated|Shaare Zedek Medical Center||2|||f||||t||||||||No||2017-10-10 21:49:50.854917|2017-10-10 21:49:50.854917
NCT02894723|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-09-04|||September 2016||2016-09-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|LAHN||L-arginine Treatment in Mild Hypertension|Efficacy of L-arginine Treatment on Blood Pressure Control Patients With Stage 1 Hypertension|Not yet recruiting||Phase 4|40|Anticipated|Meir Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:49:53.576663|2017-10-10 21:49:53.576663
NCT02894931|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Dietary Interventions on Serum and Macrophage Atherogenicity|Effects of Dietary Interventions (Sugars, Amino Acids and Artificial Sweeteners) on Serum and Macrophage Atherogenicity|Recruiting||N/A|90|Anticipated|Rambam Health Care Campus||15|||f||||t||||||||Undecided||2017-10-10 21:49:51.673788|2017-10-10 21:49:51.673788
NCT02894918|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAs|A Randomized, Open-label, Multi-center Clinical Trial to Evaluate Addition of Peginterferon Alfa-2a to CHB Patients Treated With NAs and Achieved HBV DNA<15 IU/ml、HBeAg<100 PEIU/ml、HBsAg Positive and HBsAg<1500 IU/ml.|Active, not recruiting||Phase 4|114|Anticipated|Henan Provincial Hospital||2|||f||||f||||||||No||2017-10-10 21:49:51.8425|2017-10-10 21:49:51.8425
NCT02894905|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-06|2017-03-28|||September 13, 2016|Actual|2016-09-13|March 2017|2017-03-01|November 30, 2017|Anticipated|2017-11-30|March 31, 2017|Anticipated|2017-03-31||Interventional|||A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335|An Open-label, Single-dose Study to Evaluate the Effect of Renal Impairment on the Single-dose Pharmacokinetics of AL-335|Recruiting||Phase 1|32|Anticipated|Janssen Research & Development, LLC||4|||f||||f|t|||||||||2017-10-10 21:49:51.961056|2017-10-10 21:49:51.961056
NCT02894892|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Intragastric pH and Bismuth Effect for H. Pylori Eradication|Intragastric pH and Bismuth Effect for H. Pylori Eradication|Not yet recruiting||Phase 4|35|Anticipated|National Taiwan University Hospital||7|||f||||f||||||||||2017-10-10 21:49:52.06554|2017-10-10 21:49:52.06554
NCT02894879|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-13|||September 2016||2016-09-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effectiveness Of Modified Chest PT Technidue In Pre And Post-Operative Program In Patients Open Heart Surgery|Effectiveness of Modified Chest Physical Therapy Techniques Using New Device in Pre and Post-operative Program in Patients Undergoing Open Heart Surgery.|Recruiting||N/A|48|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-10-10 21:49:52.210899|2017-10-10 21:49:52.210899
NCT02894866|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-11-07|||October 2016||2016-10-01|August 2016|2016-08-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy|Effect of Hyperbaric Oxygen Therapy on Neonatal Hypoxic-Ischemic Encephalopathy|Recruiting||N/A|250|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||No||2017-10-10 21:49:52.329347|2017-10-10 21:49:52.329347
NCT02894853|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-09-13|||June 2016||2016-06-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|LEMA||Lung Cancer Early Molecular Assessment Trial|Lung Cancer Early Molecular Assessment Trial|Recruiting||N/A|1297|Anticipated|The Netherlands Cancer Institute|||1||f||||f||||||Samples With DNA|"     both tissue and blood samples will be used   "|||2017-10-10 21:49:52.459432|2017-10-10 21:49:52.459432
NCT02894840|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-07-06|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|||Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults|A Phase I/II Randomized Double Blind Controlled Study to Evaluate the Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Split Virion Influenza Vaccine in Healthy Thai Adults Aged Between 18 Years to 49 Years|Completed||Phase 1/Phase 2|340|Actual|Mahidol University||2|||f||||t||||||||||2017-10-10 21:49:52.556073|2017-10-10 21:49:52.556073
NCT02894827|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-05||||||September 2016|2016-09-01||||September 2015|Actual|2015-09-01||Observational|MEDICANUT2||The Effect of When Medication is Taken on Nutritional Status in Hospitalized Patients Older Than 65 Years|The Effect of When Medication is Taken on Nutritional Status in Hospitalized Patients Older Than 65 Years|Completed||N/A|30|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 21:49:52.654683|2017-10-10 21:49:52.654683
NCT02894814|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-06-01|||April 2016||2016-04-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||My Health - My Medication. Patient Involvement in Administration of Medication|My Health - My Medication. A Controlled Investigation of Patient Involvement in Administration of Medication in Hospitalized Medical Patients|Completed||N/A|329|Actual|Central Jutland Regional Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:49:52.737916|2017-10-10 21:49:52.737916
NCT02894801|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-05|||January 2013||2013-01-01|September 2016|2016-09-01||||December 2013|Actual|2013-12-01||Observational|MRS||Multistate Relative Survival Model|Multistate Relative Survival Modeling of Colorectal Cancer Progression and Mortality|Completed||N/A|5194|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:49:52.826205|2017-10-10 21:49:52.826205
NCT02894788|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-05|||March 2015||2015-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|PoIS||Postoperative Intensive Care Surveillance|POSTOPERATIVE INTENSIVE CARE SURVEILLANCE. A Tool to Optimize ICU-beds Management?|Completed||N/A|2498|Actual|Istituto Clinico Humanitas|||2||f||||f||||||||No||2017-10-10 21:49:52.900277|2017-10-10 21:49:52.900277
NCT02894775|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-08|||January 2013||2013-01-01|September 2016|2016-09-01||||December 2013|Actual|2013-12-01||Observational|INDICT||Factors Influencing Inclusion in Digestive Cancer Clinical Trials|Factors Influencing Inclusion in Digestive Cancer Clinical Trials: A Population-based Study|Completed||N/A|408|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 21:49:52.977458|2017-10-10 21:49:52.977458
NCT02894762|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-08|||January 2015||2015-01-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Observational|||Performance Evaluation of In-Vitro Diagnostic Device|Performance Evaluation of In-Vitro Diagnostic Device|Recruiting||N/A|120|Anticipated|Lite-On Technology Corporation H.S.P.B|||1||f||||||||||||||2017-10-10 21:49:53.071748|2017-10-10 21:49:53.071748
NCT02894710|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ELICO||Intravenous Lidocaine in Carcinologic ENT Surgery: A Trial for Evaluation of Opioid Saving Strategy and Chronic Post-surgical Pain (ELICO)|Intravenous Lidocaine in Carcinologic ENT Surgery: A Randomized Controlled Trial for Evaluation of Opioid Saving Strategy and Chronic Post-surgical Pain|Recruiting||Phase 3|128|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 21:49:53.753162|2017-10-10 21:49:53.753162
NCT02894697|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||September 2016||2016-09-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Clinical Significance of Pre-interventional Optical Coherence Tomography in Bioresorbable Vascular Scaffold Implantation||Not yet recruiting||N/A|340|Anticipated|Yonsei University||2|||f||||t||||||||No||2017-10-10 21:49:53.87659|2017-10-10 21:49:53.87659
NCT02894684|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-11-25|||November 2016||2016-11-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|AZTEC-CF||Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis|Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis. An Randomised, Crossover Pilot Study of AZLI Plus Intravenous Colistin® Versus Standard Dual Intravenous Therapy|Recruiting||Phase 4|16|Anticipated|Liverpool Heart and Chest Hospital NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:49:53.979509|2017-10-10 21:49:53.979509
NCT02894671|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-09-05|||February 2015||2015-02-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|IMAandGENDER||Ischemia Modified Albumin (IMA) Expression in the Male and Female Population|Ischemia Modified Albumin (IMA) Expression in the Male and Female Population|Completed||N/A|100|Actual|Istituto Ortopedico Rizzoli|||4||f||||f||||||Samples Without DNA|"     Serum vials   "|No||2017-10-10 21:49:54.117069|2017-10-10 21:49:54.117069
NCT02894658|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-04-17|||August 2016||2016-08-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Lipiflow Versus Warm Compresses in Parkinson's Disease|Prospective Fellow Eye Comparison of Traditional Meibomian Gland Disease Treatment Versus a Single Thermal Pulsation Treatment in Patients With Parkinsons Disease|Suspended||N/A|25|Anticipated|Wake Forest University Health Sciences||2||lack of equipment|f||||f||||||||No||2017-10-10 21:49:54.217713|2017-10-10 21:49:54.217713
NCT02894645|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-29|||October 2008||2008-10-01|September 2016|2016-09-01||||October 2018|Anticipated|2018-10-01||Interventional|||Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study|Ma-Spore ALL 2010 Study|Recruiting||Phase 4|500|Anticipated|National University Hospital, Singapore||3|||f||||t||||||||||2017-10-10 21:49:54.33971|2017-10-10 21:49:54.33971
NCT02894632|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-05|||July 2013||2013-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|MARMOT||MR Compatible Accelerometer for Respiratory MOTion Measurement|MR Compatible Accelerometer for Respiratory MOTion Measurement|Completed||N/A|24|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:49:54.53535|2017-10-10 21:49:54.53535
NCT02894528|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-03|||July 2013||2013-07-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of a Synthetic Bone Substitute for Ridge Preservation|Evaluation of a Synthetic Bone Substitute Associated With Absorbable Collagen Membrane for Ridge Preservation After Tooth Extraction. Clinical and Tomographic Randomized Study in Humans.|Completed||Phase 4|15|Actual|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 21:49:54.624417|2017-10-10 21:49:54.624417
NCT02894515|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-11-10|||September 2016||2016-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Bioequivalence Study of Idalopirdine in Healthy Subjects|Interventional, Randomised, Open-label, Two-way Crossover, Single-dose Bioequivalence Study of Idalopirdine in Healthy Subjects Comparing the 10 mg Commercial Tablet (Test) to the 10 mg Clinical Tablet (Reference)|Withdrawn||Phase 1|0|Actual|H. Lundbeck A/S||2||The study was withdrawn based on new efficacy data from another study|f||||f||||||||||2017-10-10 21:49:54.707138|2017-10-10 21:49:54.707138
NCT02894502|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-05-02|||June 2014||2014-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MOTIVATE-HF||MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients|MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients (MOTIVATE-HF): Study Protocol of a Three-arm Multicenter Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|University of Rome Tor Vergata||3|||f||||t||||||||Yes|In case there will be the possibility to share the data, this will be done after data de-identification|2017-10-10 21:49:54.815213|2017-10-10 21:49:54.815213
NCT02894489|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Changes of Visual Function, Ocular Surface Structures and Physiology After Long-Termed Contact Lens Wear|Changes of Visual Function, Ocular Surface Structures and Physiology After Long-Termed Contact Lens Wear|Recruiting||N/A|40|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||Yes|for publication|2017-10-10 21:49:54.951872|2017-10-10 21:49:54.951872
NCT02894476|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-05|||April 2014||2014-04-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Observational|SUBUSQOL||Substance Dependence Satisfaction With Care and Quality Of Life|Satisfaction With Care and Quality of Life in Subjects With Substance Dependence|Recruiting||N/A|600|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 21:49:55.068399|2017-10-10 21:49:55.068399
NCT02894463|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-08|||November 2014||2014-11-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|MEOPAeDent||Study Aimed at Detecting Potential Abuse of Nitrous Oxide in Children During Dental Care|Uncontrolled Prospective Single-center Study Aimed at Detecting Potential Abuse of Nitrous Oxide in Children During Dental Care|Completed||N/A|76|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:49:55.179211|2017-10-10 21:49:55.179211
NCT02894450|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-08|||December 2014||2014-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|AOD-SA||Study of Clinical and Laboratory Variables Associated With a Direct Oral Anticoagulant Bioassay Higher Among Those Aged Over 75 Years|Study of Clinical and Laboratory Variables Associated With a Direct Oral Anticoagulant Bioassay (Xaban) Higher Among Those Aged Over 75 Years, as AOD for Atrial Fibrillation|Completed||N/A|70|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:49:55.259838|2017-10-10 21:49:55.259838
NCT02894437|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-08|||November 2015||2015-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|QUALIPREPS||Qualitative Study of Preventive Organization of the Pelvic Bedsores Injured Spinal Cord|Qualitative Study of Preventive Organization of the Pelvic Bedsores Injured Spinal Cord: Building a Conceptual Framework Based on the Perceptions and Behaviors of Patients and Professionals Involved|Recruiting||N/A|45|Anticipated|Nantes University Hospital|||2||f||||f||||||||||2017-10-10 21:49:55.340936|2017-10-10 21:49:55.340936
NCT02894424|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-04-18|||February 23, 2017|Actual|2017-02-23|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|MICROCOL||Effect of the Membrane Blue Dual® Dye on the Retinal Sensitivity in Macular Hole Surgery|Pilot Study of the Effect on the Retinal Sensitivity of the Membrane Blue Dual® Dye Used for Peeling of the Internal Limiting Membrane in Macular Hole Surgery|Recruiting||N/A|50|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f|||||f|f||||||||2017-10-10 21:49:55.471337|2017-10-10 21:49:55.471337
NCT02894411|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-02-07|||December 21, 2016|Actual|2016-12-21|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Observational|EXCYCLOTORSION||Routine Care Study Evaluating Ocular Torsion||Recruiting||N/A|150|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:49:55.553547|2017-10-10 21:49:55.553547
NCT02894398|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-06-19|||September 2016||2016-09-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|June 2019|Anticipated|2019-06-01||Interventional|INGE-B||Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant|Open-label, Multi-center, sINGlE Arm Clinical Study to Evaluate Efficacy/QoL in Women With HR+, HER2-, Regionally Recurrent or Metastatic Breast Cancer Receiving Palbociclib With an AI or Fulvestrant After Prior Endocrine Therapy|Recruiting||Phase 2|360|Anticipated|iOMEDICO AG||1|||f||||f||||||||No||2017-10-10 21:49:55.645026|2017-10-10 21:49:55.645026
NCT02894385|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-25|||September 13, 2016|Actual|2016-09-13|September 2017|2017-09-01|December 3, 2018|Anticipated|2018-12-03|September 28, 2018|Anticipated|2018-09-28||Interventional|||Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)|A Phase I, Non-randomized, Open-label, Single-dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of BAY 1841788 (ODM-201) in Male Subjects With Hepatic Impairment, Renal Impairment and Normal Hepatic and Renal Function|Recruiting||Phase 1|60|Anticipated|Bayer||6|||f||||f|f|f||||||||2017-10-10 21:49:56.051189|2017-10-10 21:49:56.051189
NCT02894372|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-03-08|||January 2015||2015-01-01|March 2017|2017-03-01|December 30, 2016|Actual|2016-12-30|November 1, 2016|Actual|2016-11-01||Interventional|||Faringomoss Effectiveness in Inhibiting Acute Throat Pain and Discomfort|Faringomoss Effectiveness in Inhibiting Acute Throat Pain and Discomfort|Completed||N/A|96|Actual|Lithuanian University of Health Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:49:56.179764|2017-10-10 21:49:56.179764
NCT02894359|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-07-26|||October 27, 2016|Actual|2016-10-27|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|STICOB||Computer Modelling of the Cervical Spine Movements in Cervical Dystonia||Recruiting||N/A|20|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:49:56.294769|2017-10-10 21:49:56.294769
NCT02894346|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-09|||January 2017||2017-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|MTL||Moving Towards Learning: Understanding Teachers' Motivation|Moving Towards Learning: Understanding Teachers' Motivation for Using Physical Activity as a Tool for Learning|Not yet recruiting||N/A|500|Anticipated|University of Southern Denmark|||1||f||||f||||||||Undecided||2017-10-10 21:49:56.437681|2017-10-10 21:49:56.437681
NCT02894333|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||December 2015||2015-12-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Observational|IDEOMOT||Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.||Recruiting||N/A|40|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:49:56.556464|2017-10-10 21:49:56.556464
NCT02894320|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-02-08|||March 2015||2015-03-01|February 2017|2017-02-01||||June 2016|Actual|2016-06-01||Observational|DYNIDEO||The Impact of Parkinson's Disease on Internal Preactivation of Sensory Effects of Intention-based Actions. A Subliminal Priming Study||Terminated||N/A|28|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:49:56.652494|2017-10-10 21:49:56.652494
NCT02894307|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-03-17||||||March 2017|2017-03-01||||||||Expanded Access|RAMV||Rivaroxaban or Apixaban in Mechanical Valves: RAMV|Evaluation of Thromboembolic Events in Patients With Bileaflet Mechanical Valves Before and After Rivaroxaban or Apixaban: RAMV Study|Available||N/A|||Hospital Ana Nery|||||f||||||||||||||2017-10-10 21:49:56.739923|2017-10-10 21:49:56.739923
NCT02894294|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-13|||July 2014||2014-07-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01|6 Months|Observational [Patient Registry]|||Evaluation of Seasonal Malaria Chemoprevention in Kita|Measuring the Impact of Seasonal Malaria Chemoprevention as Part of Routine Malaria Control in Kita, Mali|Completed||N/A|1162|Actual|University of Bamako|||2||f||||f||||||||Yes|Data will be available upon request to the Principal Investigator|2017-10-10 21:49:56.815217|2017-10-10 21:49:56.815217
NCT02894281|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-07-06|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|PCT||Pupillometry Dynamic Measures in Patients Without Ocular or Neurological Disease||Completed||N/A|22|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:49:56.919571|2017-10-10 21:49:56.919571
NCT02894268|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-09|||May 2016||2016-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy|Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy as Rescue Treatment for Helicobacter Pylori Infection After Failure of Several Therapy|Recruiting||Phase 4|300|Anticipated|Sir Run Run Shaw Hospital||2|||f||||t||||||||No||2017-10-10 21:49:57.003861|2017-10-10 21:49:57.003861
NCT02894255|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents||Enrolling by invitation||Phase 4|100|Anticipated|Teikyo University||1|||f||||||||||||||2017-10-10 21:49:57.108467|2017-10-10 21:49:57.108467
NCT02894242|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-04-02|||September 2016||2016-09-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA)|The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA)|Completed||N/A|22|Actual|Fisher and Paykel Healthcare||1|||f||||t||||||||No|For product development purposes only. Data will be deidentified.|2017-10-10 21:49:57.167636|2017-10-10 21:49:57.167636
NCT02894229|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Stress Reduction Intervention Study|The Mindfulness Intervention and Repeated Acute Stress (MIRAS) Study|Enrolling by invitation||N/A|150|Anticipated|Ohio University||3|||f||||f||||||||No||2017-10-10 21:49:57.251819|2017-10-10 21:49:57.251819
NCT02894216|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-05-10|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Observational|||Qualitative Radionuclide Shuntography for Adult Patients With Suspected V-P Shunt Malfunction|Clinical Value of Radionuclide Shuntography by Qualitative Methods in Hydrocephalic Adult Patients With Suspected Ventriculoperitoneal Shunt Malfunction|Completed||N/A|69|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||||No||2017-10-10 21:49:57.357484|2017-10-10 21:49:57.357484
NCT02894203|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-03|||September 2016||2016-09-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Psychobiological Effects of Meditation on Offenders With Psychopathy|Psychological and Biological Effects of Intensive Mindfulness Meditation on Offenders With Dangerous and Severe Personality Disorder: A Randomised Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Coventry University||3|||f||||f||||||||Undecided||2017-10-10 21:49:57.420244|2017-10-10 21:49:57.420244
NCT02894190|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Development and Validation of the BVQ|Development and Validation of the Beliefs About Ventilation Questionnaire (BVQ)|Recruiting||N/A|400|Anticipated|Fondazione Don Carlo Gnocchi Onlus|||1||f||||t||||||||No||2017-10-10 21:49:57.490841|2017-10-10 21:49:57.490841
NCT02894177|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-09-10|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|tcPCO2||Transcutaneous Carbon Dioxide Pressure (tcPCO2) Monitoring for the Prediction of Extubation Failure in the ICU|Is Transcutaneous Carbon Dioxide Pressure (tcPCO2) Monitoring During Spontaneous Breathing Trials Useful to Predict Extubation Failure in Mechanically Ventilated Patients in the ICU?|Recruiting||N/A|130|Anticipated|Versailles Hospital||1|||f||||f|f|f||||||||2017-10-10 21:49:57.56897|2017-10-10 21:49:57.56897
NCT02894164|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2017-08-22|||January 2008||2008-01-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2011|Actual|2011-12-01|2 Years|Observational [Patient Registry]|||Evaluating the Role of Cystatin C and Creatinine as Markers of Renal Recovery in Critically Ill Patients After Acute Kidney Injury.|Evaluating the Role of Cystatin C and Creatinine as Markers of Renal Recovery in Critically Ill Patients After Acute Kidney Injury.|Completed||N/A|336|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 21:49:57.657129|2017-10-10 21:49:57.657129
NCT02894151|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-03|||April 2015||2015-04-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients||Completed||Phase 2|50|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 21:49:57.885959|2017-10-10 21:49:57.885959
NCT02894138|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-12|||September 2016||2016-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|OPTIMAL||Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study|Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study|Recruiting||Phase 3|80|Anticipated|Vastra Gotaland Region||3|||f||||f||||||||No||2017-10-10 21:49:57.985577|2017-10-10 21:49:57.985577
NCT02894125|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-09|||July 2015||2015-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Observational|||"Evaluation of the Effectiveness of a SPA Therapy to Neyrac-les-Bains to the Old Subject (60-80 Years Old) With a Chronic Low Back Pain."|"Evaluation of the Effectiveness of a SPA Therapy to Neyrac-les-Bains to the Old Subject (60-80 Years Old) With a Chronic Low Back Pain."|Completed||N/A|100|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 21:49:58.119399|2017-10-10 21:49:58.119399
NCT02894112|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-02|||April 2013||2013-04-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal|Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal|Completed||N/A|30|Actual|University of Texas at Austin||2|||f||||f||||||||No||2017-10-10 21:49:58.223293|2017-10-10 21:49:58.223293
NCT02894099|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-09-02|||August 2015||2015-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Cardiovascular Risk in Sedentary Elderly During Prolonged Sitting Time Versus Intermittent Sitting Time|Blood Glucose, Insulin Response and Inflammatory Markers in Sedentary Elderly During Prolonged Sitting Time Versus Intermittent Sitting Time|Recruiting||N/A|16|Anticipated|University of Sao Paulo||4|||f||||f||||||||No||2017-10-10 21:49:58.335431|2017-10-10 21:49:58.335431
NCT02894086|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-08|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PMSIApp||A Retrospective Study of the Feasibility of Ambulatory Appendicectomy for Acute Appendicitis (Based on Data From the PMSI French National Hospital Information System) in the Adults Hospitalized Between December 2013 and December 2014|A Retrospective Study of the Feasibility of Ambulatory Appendicectomy for Acute Appendicitis (Based on Data From the PMSI French National Hospital Information System) in the Adults Hospitalized Between December 2013 and December 2014|Recruiting||N/A|80000|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:49:58.451882|2017-10-10 21:49:58.451882
NCT02894073|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|VEINVIEW||Interest of a Skin Transilluminator (Such as the VeinViewer®Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient|Interest of a Skin Transilluminator (Such as the VeinViewer®Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient: a Randomized, Controlled Pilot Study|Not yet recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 21:49:58.54392|2017-10-10 21:49:58.54392
NCT02894060|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||June 2014||2014-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BIOKID||A Study of Immunological Biomarkers as Predictors of Cardiovascular Events|A Study of Immunological Biomarkers as Predictors of Cardiovascular Events|Completed||N/A|84|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-10 21:49:58.631496|2017-10-10 21:49:58.631496
NCT02894047|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||July 2013||2013-07-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|CASPER||Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years|Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years|Completed||N/A|42|Actual|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||Samples Without DNA|"     blood   "|||2017-10-10 21:49:58.71951|2017-10-10 21:49:58.71951
NCT02894034|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||August 2013||2013-08-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|GAINE||Is the Measured Diameter of the Optic Nerve Sheath by Cerebral Scan in Patients With Early-phase Meningeal Hemorrhage, Due to a Ruptured Aneurysm, a Prognostic 6-month Mortality Factor ?|Is the Measured Diameter of the Optic Nerve Sheath by Cerebral Scan in Patients With Early Phase Meningeal Hemorrhage Due to a Ruptured Aneurysm a Prognostic 6-month Mortality Factor?|Recruiting||N/A|128|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:49:58.800057|2017-10-10 21:49:58.800057
NCT02894021|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-05|2016-09-05|||May 2013||2013-05-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|PRELYMCA||PREvention of Post-mastectomy LYMphoceles by PAdding|PREvention of Post-mastectomy LYMphoceles by PAdding. A Randomized Prospective Multicenter Study|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 21:49:58.886514|2017-10-10 21:49:58.886514
NCT02894008|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-12-09|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|Leish2a||A Study of a New Leishmania Vaccine Candidate ChAd63-KH|A Phase IIa Safety Study to Assess the Safety and Immunogenicity of a New Leishmania Vaccine Candidate ChAd63-KH|Recruiting||Phase 2|24|Anticipated|University of York||2|||f||||t||||||||Undecided||2017-10-10 21:49:58.985265|2017-10-10 21:49:58.985265
NCT02893995|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-05-08|||February 2017|Anticipated|2017-02-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension|A 16-Week, Open-Label, Multi-Center, Parallel, Randomized Controlled Study to Compare the Safety, Tolerability, Pharmacokinetics and Efficacy of Slow and Rapid Dose Titration Regimens of Subcutaneous Remodulin Therapy in Subjects With Pulmonary Arterial Hypertension|Withdrawn||Phase 4|0|Actual|United Therapeutics||2||Business decision|f||||f|t|f|||t|||||2017-10-10 21:49:59.084777|2017-10-10 21:49:59.084777
NCT02893982|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-08|||October 2016||2016-10-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||High Dose Rate Brachyablation of Primary Liver Lesions|A Phase I Therapeutic Dose Escalation Study Using Percutaneous Image-Guided Navigation for High Dose Rate Brachyablation of Primary Liver Lesions|Not yet recruiting||Phase 1|45|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 21:49:59.213716|2017-10-10 21:49:59.213716
NCT02893969|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-07-13|||March 6, 2017|Actual|2017-03-06|July 2017|2017-07-01|November 2038|Anticipated|2038-11-01|January 2019|Anticipated|2019-01-01||Interventional|PedCARE||Pediatric Concussion Assessment of Rest and Exertion|Multicentre, Randomized Clinical Trial of Pediatric Concussion Assessment of Rest and Exertion (PedCARE): A Study to Determine When to Resume Physical Activities Following Concussion in Children|Recruiting||N/A|350|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||t|f|f||||||||2017-10-10 21:49:59.298091|2017-10-10 21:49:59.298091
NCT02893956|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-09-02|||April 2014||2014-04-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Conditions of Realization of the Echocardiography in Newborns|Does Postural Support During Echocardiography Modify Hemodynamic Features and Discomfort Induced by the Examination in Very Premature Neonates?|Completed||N/A|30|Actual|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:49:59.400728|2017-10-10 21:49:59.400728
NCT02893943|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-26|||January 2017|Actual|2017-01-01|May 2017|2017-05-01||||July 2017|Actual|2017-07-01||Interventional|||Impact of Probiotics on Weight Control and Body Composition in Overweight and Obese Individuals|Impact of Probiotics on Weight Control and Body Composition in Overweight and Obese Individuals|Active, not recruiting||N/A|30|Anticipated|University of Manitoba||2|||f||||||||||||||2017-10-10 21:49:59.492409|2017-10-10 21:49:59.492409
NCT02893917|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-08|2017-09-12|||December 23, 2016|Actual|2016-12-23|September 2017|2017-09-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer|A Randomized Phase 2 Study of Cediranib in Combination With Olaparib Versus Olaparib Alone in Men With Metastatic Castration Resistant Prostate Cancer|Recruiting||Phase 2|84|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 21:50:03.046027|2017-10-10 21:50:03.046027
NCT02893904|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-05-02|||January 2005||2005-01-01|May 2017|2017-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||EEG Profiles During General Anesthesia : a Comparative Study Between Sevoflurane and Propofol|Electroencephalographic Profiles During General Anesthesia : a Comparative Study Between Sevoflurane and Propofol.|Completed||N/A|73|Actual|Hôpital Armand Trousseau||2|||f||||f||||||||No||2017-10-10 21:50:03.197594|2017-10-10 21:50:03.197594
NCT02893891|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-07-03|||March 2012||2012-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Metabolic Changes After Bariatric Surgery|Metabolic Changes of Fat and Bone Tissue After Radical Bariatric Surgery|Recruiting||N/A|150|Anticipated|University Hospital Ostrava||3|||f||||f||||||||||2017-10-10 21:50:03.281275|2017-10-10 21:50:03.281275
NCT02893878|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-03-03|||September 2016||2016-09-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines|Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-10 21:50:03.398385|2017-10-10 21:50:03.398385
NCT02893865|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-01-31|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|CardioX SAS||Evolution of Oxidative Stress in Coronary Patients With Moderate Sleep Apnea Syndrome After Treatment With Continuous Positive Airway Pressure|Evolution of Oxidative Stress in Coronary Patients With Moderate Sleep Apnea Syndrome After Treatment With Continuous Positive Airway Pressure|Recruiting||N/A|40|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 21:50:03.479363|2017-10-10 21:50:03.479363
NCT02893852|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-04-09|||May 12, 2016||2016-05-12|April 2017|2017-04-01|April 2, 2018|Anticipated|2018-04-02|September 12, 2017|Anticipated|2017-09-12||Interventional|||Effects of CO-OP Approach on Activity and Participation of Brazilian Children With Developmental Coordination Disorder|Effects of the Cognitive Orientation to Daily Occupational Performance Approach on Activity and Participation of Brazilian Children With Developmental Coordination Disorder|Recruiting||Phase 1|20|Anticipated|Federal University of Minas Gerais||2|||f||||||||||||||2017-10-10 21:50:03.598593|2017-10-10 21:50:03.598593
NCT02893839|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-02|||February 2013||2013-02-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of Allergy to Potato in a Large Cohort|Study of Sensitization to Potato in Patients Consulting at the Allergy Unit in Montpellier|Completed||N/A|2000|Actual|University Hospital, Montpellier||1|||f||||||||||||||2017-10-10 21:50:03.711863|2017-10-10 21:50:03.711863
NCT02893826|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-06-09|||September 2016||2016-09-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH|Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage|Recruiting||Phase 1|12|Anticipated|Edge Therapeutics Inc||2|||f||||||||||||Undecided||2017-10-10 21:50:03.786843|2017-10-10 21:50:03.786843
NCT02893813|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-14|||November 2015||2015-11-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|ECTROPALP||Comparison Between Two Surgical Methods for Eyelid Ectropion: Tarsal Strip Alone Versus Tarsal Strip With Punctoplasty (Three Snips With or Without Diamond-shaped Resection)||Completed||N/A|22|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||||||||||||2017-10-10 21:50:04.053434|2017-10-10 21:50:04.053434
NCT02893800|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-29|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|VODINO||Validation and Optimization of the Individual Benefits of Locating Systems in Dementia Care|Assistive Technology for Dementia: Validation and Optimization of the Individual Benefits of Locating Systems in Dementia Care (VODINO)|Completed||N/A|40|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 21:50:04.117577|2017-10-10 21:50:04.117577
NCT02893787|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-01-11|||September 2014||2014-09-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|SPECKLEANTHRA||Study of Myocardial Function by Speckle Tracking After Cancer Treatment With Anthracyclines in Childhood|Study of Myocardial Function by Speckle Tracking After Cancer Treatment With Anthracyclines in Childhood|Recruiting||N/A|196|Anticipated|University Hospital, Montpellier|||2||f||||f||||||||Undecided||2017-10-10 21:50:04.217073|2017-10-10 21:50:04.217073
NCT02893774|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-02|||March 2015||2015-03-01|August 2016|2016-08-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|ELCCA-II||Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer|Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer|Recruiting||N/A|402|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||f||||||||No||2017-10-10 21:50:04.342327|2017-10-10 21:50:04.342327
NCT02893761|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-02|||January 1990||1990-01-01|September 2016|2016-09-01||||January 2015|Actual|2015-01-01||Observational|||Bergonie Institute Breast Cancer Database||Active, not recruiting||N/A|21439|Anticipated|Institut Bergonié|||1||f||||f||||||||No||2017-10-10 21:50:04.436387|2017-10-10 21:50:04.436387
NCT02893748|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-07|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy|HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy|Not yet recruiting||N/A|80|Anticipated|HyGIeaCare, Inc.||2|||f||||t||||||||Undecided||2017-10-10 21:50:04.50786|2017-10-10 21:50:04.50786
NCT02893735|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-09-07|||December 2011||2011-12-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Clinical Comparison of Two Resin Composites on Diastema Closure and Reshaping at Four Years|A Prospective 4-year Clinical Study Evaluating Two Resin Composites on Diastema Closure and Reshaping|Completed||N/A|23|Actual|Hacettepe University||2|||f||||t||||||||Yes||2017-10-10 21:50:04.629837|2017-10-10 21:50:04.629837
NCT02893722|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-07|||January 2017||2017-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||A Randomized Double Blind Comparison of Atosiban in Patients With RIF Undergoing IVF Treatment|A Randomized Double Blind Comparison of Atosiban in Patients With Repeated Implantation Failure Undergoing IVF Treatment|Not yet recruiting||Phase 1|200|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||f||||||||No||2017-10-10 21:50:04.751924|2017-10-10 21:50:04.751924
NCT02893709|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-03|||June 2015||2015-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|FAMES||Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)|Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)|Completed||N/A|36|Actual|Changi General Hospital||1|||f||||t||||||||No||2017-10-10 21:50:04.869744|2017-10-10 21:50:04.869744
NCT02893696|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-07|||October 2016||2016-10-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|||Extra Sitting Time After Spinal Anesthesia for Cesarean Section and Fetal Well-being|The Effect of Sitting After Spinal Injection of Hyperbaric Local Anesthetic on Fetal Acid-base Balance After Cesarean Delivery|Not yet recruiting||N/A|787|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 21:50:04.983042|2017-10-10 21:50:04.983042
NCT02893683|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-09-13|||December 19, 2013|Actual|2013-12-19|September 2017|2017-09-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Observational|valid-PVLT||Paris Visual Learning Test: a New French Task for Assess Visual Learning and Memory to Multiple Sclerosis Patients|Paris Visual Learning Test (PVLT): a New French Task for Assess Visual Learning and Memory to Multiple Sclerosis Patients|Completed||N/A|50|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:50:05.095091|2017-10-10 21:50:05.095091
NCT02893670|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-07-01|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|TRANSIT||Tailored Transition for IBD Adolescents|Tailored Re-evaluation for Adolescents With Inflammatory Bowel Disease in Transition (TRANSIT) Trial|Recruiting||N/A|64|Anticipated|Schneider Children's Medical Center, Israel||1|||f||||t|f|f||||||||2017-10-10 21:50:05.172451|2017-10-10 21:50:05.172451
NCT02893657|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-10-04|||October 9, 2017|Anticipated|2017-10-09|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01|5 Days|Observational [Patient Registry]|||The Role and Dynamics of Liver Dysfunction in Patients Undergoing Cardiac Surgery|The Role and Dynamics of Liver Dysfunction in Patients Undergoing Cardiac Surgery|Recruiting||N/A|150|Anticipated|Semmelweis University Heart and Vascular Center|||1||f||||f||||||||||2017-10-10 21:50:05.268287|2017-10-10 21:50:05.268287
NCT02893644|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-03-17|||May 26, 2014|Actual|2014-05-26|March 2017|2017-03-01|March 15, 2017|Actual|2017-03-15|July 26, 2016|Actual|2016-07-26||Observational|PACO||Optical Coherence Pachymetry to Evaluate Central Corneal Ablation Depth in Myopic Femtosecond Laser in Situ Keratomileusis|Optical Coherence Pachymetry (OCP) to Evaluate Central Corneal Ablation Depth in Myopic Femtosecond Laser in Situ Keratomileusis (LASIK)|Completed||N/A|50|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:50:05.35106|2017-10-10 21:50:05.35106
NCT02893631|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-02-03|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|HEMOLYSE||Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke|Assessment of Hemostasis Disorders in Tissue Plasminogen Activator Treated (rtPA-treated) Patients Requiring Endovascular Treatment for Ischemic Stroke|Recruiting||N/A|120|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:50:05.404924|2017-10-10 21:50:05.404924
NCT02893618|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-07|||July 2017||2017-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)|A 5 Treatment Period Crossover Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)|Not yet recruiting||Phase 2|32|Anticipated|Essentialis, Inc.||5|||f||||f||||||||Undecided||2017-10-10 21:50:05.475468|2017-10-10 21:50:05.475468
NCT02893605|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-07-18|||March 2014||2014-03-01|August 2016|2016-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|SLA_Vit_D||Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis|Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis|Completed||N/A|800|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-10 21:50:05.566856|2017-10-10 21:50:05.566856
NCT02893592|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-14|||October 2015||2015-10-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Observational|MYOPAS||Efficiency, Predictability and Security of the Trans-epithelial Photorefractive Keratectomy|Efficiency, Predictability and Security of the Trans-epithelial Photorefractive Keratectomy (Trans-PRK) for Low and Medium Myopia and Astigmatism: Retrospective Study About 118 Eyes|Completed||N/A|118|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||No||2017-10-10 21:50:05.632832|2017-10-10 21:50:05.632832
NCT02893579|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-09-08|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stress Reduction Intervention for Women With Ischemic Heart Disease|Smartphone-delivered Stress Reduction Intervention for Women With Ischemic Heart Disease|Not yet recruiting||N/A|60|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:50:05.680003|2017-10-10 21:50:05.680003
NCT02893566|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-05|||September 29, 2016|Actual|2016-09-29|August 2017|2017-08-01|February 28, 2017|Actual|2017-02-28|January 5, 2017|Actual|2017-01-05||Interventional|||Mi Band Step Challenge to Improve Body Composition in Overweight University Students|Effects of A Mi Band Step Challenge on Improving Physical Activity, Sedentary Behavior, and Body Composition in Overweight University Students|Completed||N/A|49|Actual|China Medical University Hospital||1|||f||||t||||||||||2017-10-10 21:50:05.764748|2017-10-10 21:50:05.764748
NCT02893553|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury|The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury|Recruiting||Phase 2|50|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:50:05.850454|2017-10-10 21:50:05.850454
NCT02893540|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC|Capecitabine Metronomic Chemotherapy Versus Conventional Chemotherapy as Maintenance Treatment in Metastatic Colorectal Cancer|Recruiting||Phase 2/Phase 3|250|Anticipated|Ruijin Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:50:06.109027|2017-10-10 21:50:06.109027
NCT02893527|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-16|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|EPARS-SEIN||Implementation and Evaluation of a Social Journey Accompanied in Breast Cancer Diagnosis (EPARS SEIN)|Implementation and Evaluation of a Social Journey Accompanied for Women With Breast Cancer Diagnosis|Active, not recruiting||Phase 3|200|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||f||||||||||2017-10-10 21:50:06.200291|2017-10-10 21:50:06.200291
NCT02893501|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-15|||September 2016||2016-09-01|August 2017|2017-08-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Observational|||Infant Microbiome in Diaper Rash|An Exploratory Study to Evaluate the Microbial Consortia of Infants (9-12 Months) Experiencing Diaper Rash and When Healthy|Completed||N/A|25|Actual|Kimberly-Clark Corporation|||1||f||||f||||||None Retained|"     swabs and tape strips of the diaper rash area will be analyzed   "|||2017-10-10 21:50:06.392308|2017-10-10 21:50:06.392308
NCT02893488|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-08-03|||September 1, 2016||2016-09-01|August 2017|2017-08-01|November 25, 2016|Actual|2016-11-25|November 1, 2016|Actual|2016-11-01||Interventional|||Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet|A Phase I, Single Dose, Five-period Crossover Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet as Compared to a Co-dose of TIVICAY and EPZICOM in Healthy Subjects|Completed||Phase 1|20|Actual|ViiV Healthcare||5|||f||||f||||||||||2017-10-10 21:50:06.479483|2017-10-10 21:50:06.479483
NCT02893475|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-02|||January 2012||2012-01-01|September 2016|2016-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|QUAVIREIN_RDDV||Impact of Preemptive Living Donor Renal Transplantation on Quality of Life , Occupational Rehabilitation and Societal Participation of Transplant Recipients|Impact de la durée de Dialyse Avant Greffe rénale Avec Donneur Vivant Sur la qualité de Vie et la réinsertion Professionnelle Des Receveurs|Completed||N/A|534|Actual|Central Hospital, Nancy, France|||1||f||||t||||||||No||2017-10-10 21:50:06.59897|2017-10-10 21:50:06.59897
NCT02893462|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-07|||December 2015||2015-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|REASTOC||Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care|Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care|Recruiting||N/A|1500|Anticipated|University Hospital, Brest|||1||f||||f||||||||Yes|Ananymized warehouse platform will be shared to other researchers all over the world|2017-10-10 21:50:06.651366|2017-10-10 21:50:06.651366
NCT02893449|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-05|2016-09-02|||April 2009||2009-04-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Psychiatry Study: Parkinson Disease|Improvement of Social Adaptation After Pre-operative Cognitive Remediation in Parkinson's Patients Profiting From a Bilateral Subthalamic Stimulation|Completed||N/A|73|Actual|Central Hospital, Nancy, France||3|||f||||t||||||||||2017-10-10 21:50:06.723313|2017-10-10 21:50:06.723313
NCT02893436|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-02|||April 2014||2014-04-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|DBS PREDICTION||Time Prediction for Complete Recovery From Neuromuscular Blockade After Visual Recovery With Double Burst Stimulation|Time Prediction for Complete Recovery From Neuromuscular Blockade After Visual Recovery With Double Burst Stimulation|Recruiting||N/A|50|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||Undecided||2017-10-10 21:50:06.838213|2017-10-10 21:50:06.838213
NCT02893423|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2016-09-07|||January 2013||2013-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|TAPROPI||Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia|The Dose Dependent Effect of Ropivacaine Transversus Abdominis Plane Blocks on Postoperative Analgesia After Cesarean Section|Recruiting||N/A|300|Anticipated|Maimonides Medical Center||3|||f||||f||||||||Undecided||2017-10-10 21:50:06.909698|2017-10-10 21:50:06.909698
NCT02893410|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-02|||December 2014||2014-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|OUEST||Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients|Etude de l'Observance thérapeutique et Des Effets Secondaires Des Traitements Chez Les Patients traités Pour Polyglobulie de Vaquez et thrombocytémie Essentielle|Completed||N/A|286|Actual|University Hospital, Brest|||1||f||||f||||||||No||2017-10-10 21:50:07.014702|2017-10-10 21:50:07.014702
NCT02893397|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-05-10|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Pre-Surgical Supervised Exercise for Bone Cancer Patients|Pre-Surgical Supervised Exercise for Bone Cancer Patients|Recruiting||N/A|30|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 21:50:07.081238|2017-10-10 21:50:07.081238
NCT02893384|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-09-01|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Local Anesthetic for Total Mastectomy Surgery|Analgesic Effects of Local Anesthetic Serratus Plane Infiltration for Total Mastectomy Surgery: A Pilot Study|Not yet recruiting||Phase 4|40|Anticipated|University Health Network, Toronto||2|||f||||f||||||||Yes|publication|2017-10-10 21:50:07.166898|2017-10-10 21:50:07.166898
NCT02893358|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-02|||November 2016||2016-11-01|September 2016|2016-09-01||||November 2018|Anticipated|2018-11-01||Interventional|ANTI-MASK||Antihypertensive Treatment in Masked Hypertension for Target Organ Protection||Not yet recruiting||Phase 4|300|Anticipated|Shanghai Institute of Hypertension||2|||f||||||||||||||2017-10-10 21:50:07.359|2017-10-10 21:50:07.359
NCT02893345|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-10-04|||August 8, 2015|Actual|2015-08-08|September 2017|2017-09-01|November 15, 2017|Anticipated|2017-11-15|August 15, 2017|Actual|2017-08-15||Interventional|||Safe@Home: A Self-Management Program for Individuals With TBI and Their Families|Safe@Home: A Self-Management Program for Individuals With Traumatic Brain Injury and Their Families|Active, not recruiting||Phase 2|60|Actual|Shepherd Center, Atlanta GA||2|||f||||f||||||||||2017-10-10 21:50:07.45033|2017-10-10 21:50:07.45033
NCT02893332|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-07|||March 2016||2016-03-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|Sindas||Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)|Tyrosine-kinase Inhibitor （TKI） With or Without SBRT in Newly Diagnosed Advanced Staged Lung Adenocarcinoma|Recruiting||Phase 3|200|Anticipated|Sichuan Provincial People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:50:07.542244|2017-10-10 21:50:07.542244
NCT02893319|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-06|||June 2014||2014-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2016|Actual|2016-07-01||Interventional|RIF||Maternal and Infant Growth Study|Role of Infant Feeding, Childhood Food Habits and Early Childhood Adiposity (RIF)|Active, not recruiting||N/A|115|Actual|University of Georgia||3|||f||||f||||||||||2017-10-10 21:50:07.63125|2017-10-10 21:50:07.63125
NCT02893306|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-09-01|||March 2012||2012-03-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|DMT1-MSC||MSC Administration for the Management of Type 1 Diabetic Patients|Phase 2 Study of Intravenous Administration of Allogeneic Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus.|Active, not recruiting||Phase 2|10|Actual|Universidad del Desarrollo||1|||f||||f||||||||Yes|Data will be publish in a peer review journal|2017-10-10 21:50:07.701216|2017-10-10 21:50:07.701216
NCT02893293|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-09-02|||May 2015||2015-05-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|||Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI|Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI|Recruiting||Phase 4|20|Anticipated|Stanford University||2|||f||||t||||||||No||2017-10-10 21:50:07.793734|2017-10-10 21:50:07.793734
NCT02893280|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-15|||April 2015||2015-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|ACSSLAP||Acute Coronary Syndrome Sri Lanka Audit Project|Improving Care for Patients With Acute Coronary Syndrome: Acute Coronary Syndrome Sri Lanka Audit Project (ACSSLAP)|Withdrawn||N/A|0|Actual|University of Colombo|||1|Due to an incompatibility with the local procedures|f||||t||||||||Yes|Data will be documented on September 17th, 2016|2017-10-10 21:50:07.877416|2017-10-10 21:50:07.877416
NCT02893267|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-01|||January 2017||2017-01-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Multimodal Treatment for Hemiplegic Shoulder Pain|Multimodal Treatment for Hemiplegic Shoulder Pain|Recruiting||N/A|132|Anticipated|MetroHealth Medical Center||3|||f||||t||||||||||2017-10-10 21:50:07.948455|2017-10-10 21:50:07.948455
NCT02893254|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis|A Multicenter, Randomized, Double-blind, Parallel-controlled Phase 3 Study Evaluating the Efficacy and Safety of Recombinant Human Monoclonal Antibody Against Human Tumor Necrosis Factor-α (IBI303) Compared to Adalimumab in Patients With Active Ankylosing Spondylitis|Not yet recruiting||Phase 3|400|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||2|||f||||f||||||||||2017-10-10 21:50:08.064778|2017-10-10 21:50:08.064778
NCT02893241|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-05-16|||April 30, 2016|Actual|2016-04-30|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|July 31, 2017|Anticipated|2017-07-31||Observational|||Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting|Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting: a Multicenter, Prospective, Non-interventional Study|Enrolling by invitation||N/A|1870|Anticipated|Teva Pharmaceutical Industries|||2||f||||f||||||||||2017-10-10 21:50:08.184271|2017-10-10 21:50:08.184271
NCT02893228|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-05-07|||October 2016||2016-10-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Does Saline Injection Around Phrenic Nerve Reduce Incidence of Diaphragmatic Paresis Following Interscalene Block?|Does Saline Injection Around Phrenic Nerve Reduce Incidence of Diaphragmatic Paresis Following Interscalene Block?|Recruiting||Phase 4|36|Anticipated|The Adelaide and Meath Hospital, incorporating The National Children's Hospital||2|||f||||f|f|f||||||No||2017-10-10 21:50:08.35491|2017-10-10 21:50:08.35491
NCT02893215|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-11-02|||November 2016||2016-11-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01|2 Years|Observational [Patient Registry]|||Silent Atrial Fibrillation - Screening of High-risk Groups for Atrial Fibrillation (The Silence Study)|Silent Atrial Fibrillation - Screening of High-risk Groups for Atrial Fibrillation (The Silence Study)|Recruiting||N/A|1622|Anticipated|Hvidovre University Hospital|||2||f||||t||||||||No|The ethical approval do not allow us to share individualised data.|2017-10-10 21:50:08.565367|2017-10-10 21:50:08.565367
NCT02893202|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-07|||August 2013||2013-08-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|THRICF||Equine Assisted Activities on PTSD, Quality of Life and Functioning in Veterans With PTSD: An ICF Approach (THRICF)|Examination of the Effects of Equine Assisted Activities [EAA] on Symptoms, Quality of Life and Functioning in Veterans With PTSD: An International Classification of Functioning, Disability and Health [ICF] Approach|Completed||N/A|89|Actual|Baylor University||5|||f||||f||||||||No||2017-10-10 21:50:08.701308|2017-10-10 21:50:08.701308
NCT02893189|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-09|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|October 2021|Anticipated|2021-10-01|October 2018|Anticipated|2018-10-01||Interventional|CARD||CAR19 Donor Lymphocytes for Relapsed CD19+ Malignancies Following Allogeneic Transplantation|Chimeric Antigen Receptor (CAR)19 Donor Lymphocytes for Relapsed Cluster of Differentiation (CD)19+ Malignancies Following Allogeneic Transplantation (CARD)|Recruiting||Phase 1|12|Anticipated|University College, London||1|||f||||t|f|f||||||Undecided||2017-10-10 21:50:08.783714|2017-10-10 21:50:08.783714
NCT02893176|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-09-01|||September 2016||2016-09-01|September 2016|2016-09-01||||February 2020|Anticipated|2020-02-01||Interventional|||Macitentan in the Treatment of Organ Rejection After Lung Transplantation|Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation|Not yet recruiting||Phase 4|20|Anticipated|University of California, Los Angeles||2|||f||||f||||||||Undecided||2017-10-10 21:50:08.869352|2017-10-10 21:50:08.869352
NCT02893163|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-01|||August 2016||2016-08-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|CHANGECaAB||CHANGE Cancer Alberta: A Primary Care Program for Cancer Prevention and Screening|CHANGE (Canadian Health Advanced by Nutrition and Graded Exercise) Cancer Alberta: A Primary Care Program for Cancer Prevention and Screening|Enrolling by invitation||N/A|800|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-10 21:50:08.978478|2017-10-10 21:50:08.978478
NCT02893150|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-03-30|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MindEat||Mindfulness Intervention for Overweight Primary Care Patients|Mindfulness as a Complementary Intervention for Overweight Primary Care Patients: Study Protocol for a Randomized Controlled Trial|Not yet recruiting||N/A|240|Anticipated|Centro Mente Aberta de Mindfulness||3|||f||||f|f|f||||||Undecided||2017-10-10 21:50:09.081839|2017-10-10 21:50:09.081839
NCT02893137|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-01-09|||October 2016||2016-10-01|August 2016|2016-08-01||||October 2019|Anticipated|2019-10-01||Interventional|||Enhancing Optune Therapy With Targeted Craniectomy|Enhancing Optune Therapy of Recurrent Glioblastoma Multiforme Using Targeted Surgical Skull Remodeling|Recruiting||Phase 1|15|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-10-10 21:50:09.240438|2017-10-10 21:50:09.240438
NCT02893124|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2016-09-02|||August 2016||2016-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg|The Optimizing Treatment of Peginterferon Alpha in HBeAg-negative Chronic Hepatitis B Virus Patients With Low Level HBsAg|Active, not recruiting||Phase 4|200|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||Undecided||2017-10-10 21:50:09.349392|2017-10-10 21:50:09.349392
NCT02893111|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-09-02|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder|Single-center, Open Label Trial of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder|Active, not recruiting||Phase 2|5|Actual|Tianjin Medical University General Hospital||1|||f||||t||||||||No||2017-10-10 21:50:09.436256|2017-10-10 21:50:09.436256
NCT02893098|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-09-01|||August 2016||2016-08-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee||Recruiting||Phase 3|232|Anticipated|Huons Co.,Ltd.||2|||f||||||||||||||2017-10-10 21:50:09.519855|2017-10-10 21:50:09.519855
NCT02893085|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-12-27|||September 2015||2015-09-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|ONCOBIL||Pancreatico-biliary Tumor Mutation Profiling in Bile Samples|Tumor Mutation Profiling in Bile Samples From Patients With Biliary Strictures Related to Pancreatico-biliary Cancers|Completed||N/A|100|Actual|CHU de Reims|||2||f||||||||||||||2017-10-10 21:50:09.603511|2017-10-10 21:50:09.603511
NCT02893072|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-09-01|||November 2015||2015-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study|Individualized Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes|Recruiting||N/A|500|Anticipated|The Third Xiangya Hospital of Central South University||1|||f||||t||||||||Yes|During and after our experiment, investigators will share the development in the website.|2017-10-10 21:50:09.670939|2017-10-10 21:50:09.670939
NCT02893059|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-07|||September 2017||2017-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|CORD||Evaluation of a Data Collection Tool in Clinical Research: Comparison Between the Data Collected by Patient Diary and Data From Medical Administrative Databases||Not yet recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:50:09.751893|2017-10-10 21:50:09.751893
NCT02893046|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-01|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Observational|ParcoursVHC||HCV Care Pathway in Ile-de-France|HCV Care Pathway in Ile-de-France|Not yet recruiting||N/A|1000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 21:50:09.803475|2017-10-10 21:50:09.803475
NCT02893033|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-06-19|||August 2014||2014-08-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Neuromodulation With rTMS in Dysphagic Patients With Stroke|Neuromodulation With rTMS in Dysphagic Patients With Stroke|Completed||N/A|5|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||No||2017-10-10 21:50:09.880158|2017-10-10 21:50:09.880158
NCT02893020|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-14|||October 2016||2016-10-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Observational|ETRE||Emotional Experience and Burnout in Physician|National Study of the Psychological Consequences Resulting From the Practice of Invasive Therapeutic Interventions: Mixed Evaluation, Qualitative and Quantitative, of Burn Out Among Digestive Surgeons, Gastroenterologists and Radiologists|Not yet recruiting||N/A|3390|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||Undecided||2017-10-10 21:50:09.944387|2017-10-10 21:50:09.944387
NCT02893007|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2016-09-11|||March 2010||2010-03-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Brief Family-centered Care Program for Bipolar Disorder|A Randomized Controlled Trial of a Brief Family-centered Care Program for Hospitalized Patients With Bipolar Disorder and Their Caregivers|Completed||N/A|47|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||No||2017-10-10 21:50:09.998973|2017-10-10 21:50:09.998973
NCT02892994|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-09-01|||April 2016||2016-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia|Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: A Randomized Double Blinded Investigational Trial|Completed||N/A|23|Actual|State University of New York at Buffalo||2|||f||||f||||||||No||2017-10-10 21:50:10.075697|2017-10-10 21:50:10.075697
NCT02892981|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-09-02|||January 2015||2015-01-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||Dead Space Evaluation in Pulmonary Hypertension|Dead Space Evaluation During Exercise in Patients With Pulmonary Hypertension|Completed||N/A|18|Actual|Centro Cardiologico Monzino||1|||f||||||||||||||2017-10-10 21:50:10.157747|2017-10-10 21:50:10.157747
NCT02892968|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-09-01|||September 2016||2016-09-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|September 2020|Anticipated|2020-09-01||Interventional|EDU-RAPID||ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients|ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients (EDU-RAPID) Multi-center Stepped Wedge Cluster Randomized Trial|Not yet recruiting||N/A|800|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||No||2017-10-10 21:50:10.227728|2017-10-10 21:50:10.227728
NCT02892955|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-05-16|||September 2016||2016-09-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|MOMENTUM 3 CAP||MOMENTUM 3 Continued Access Protocol|MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ Continued Access Protocol|Recruiting||N/A|1000|Anticipated|St. Jude Medical||1|||f||||t||||||||||2017-10-10 21:50:10.363967|2017-10-10 21:50:10.363967
NCT02889250|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-13|2017-09-27|||June 2018|Anticipated|2018-06-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|DRIVER||Deep Brain Stimulation to Relieve Depression|Deep Brain Stimulation to Relieve Depression|Not yet recruiting||Phase 3|6|Anticipated|University of Pittsburgh||1|||f||||t|f|t|f|||||||2017-10-10 21:50:53.524097|2017-10-10 21:50:53.524097
NCT02892942|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-07-24|||January 13, 2017|Actual|2017-01-13|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|NATOS||NATural Ovarian Stimulation|An Innovative Controlled Ovarian Hyperstimulation (COH) Protocol That Combines Large Oocyte Availability and Physiologic Estrogenic Environment for Good Prognosis In Vitro Fertilization and Embryo Transfer (IVF-ET) Patients|Recruiting||Phase 4|320|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 21:50:10.897269|2017-10-10 21:50:10.897269
NCT02892929|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-02|||May 2016||2016-05-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Motivational Interview as a Strategy in the Reduction of Blood Pressure.|Effect of Motivational Interview as a Strategy in the Reduction of Blood Pressure in Hypertensive Patients in Specialist Clinic- Randomized Clinical Trial.|Recruiting||N/A|120|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:50:10.995746|2017-10-10 21:50:10.995746
NCT02892916|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-09-01|||October 2016||2016-10-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|POCK||Ketamine and Postoperative Cognitive Dysfunction|The Prevention of Post Operative Cognitive Dysfunction by Ketamine: a Prospective Multicenter Randomized Blinded Placebo-controlled Trial in Elderly Patients Undergoing Elective Orthopaedic Surgery|Not yet recruiting||Phase 3|900|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 21:50:11.07931|2017-10-10 21:50:11.07931
NCT02892890|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-07|||October 2016||2016-10-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|EXPRET||Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin||Not yet recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-10 21:50:11.362339|2017-10-10 21:50:11.362339
NCT02892877|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-09-02|||November 1999||1999-11-01|August 2016|2016-08-01|November 2029|Anticipated|2029-11-01|November 2029|Anticipated|2029-11-01|18 Months|Observational [Patient Registry]|French GTDC||The French National Reference Centre of GTD|The French National Reference Centre of Gestational Trophoblastic Disease|Recruiting||N/A|25500|Anticipated|Hospices Civils de Lyon|||5||f||||f||||||||||2017-10-10 21:50:11.462913|2017-10-10 21:50:11.462913
NCT02892864|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|October 2020|Anticipated|2020-10-01||Interventional|RVPF||Virtual Rehabilitation Program in Peripheral Facial Paralysis|Relevance of a Virtual Rehabilitation Program in Peripheral Facial Paralysis|Not yet recruiting||N/A|90|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||||2017-10-10 21:50:11.613233|2017-10-10 21:50:11.613233
NCT02892851|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-01|||March 2014||2014-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|STUC||Deep Brain Stimulation of the Sub-Thalamic Nucleus to Treat Severe and Treatment-resistant Cocaine Addiction.|A Pilot Study of Deep Brain Stimulation of the Sub-thalamic Nucleus to Treat Treatment-resistant Cocaine Addiction With Severe Somatic or Psychiatric Complications|Recruiting||N/A|2|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||No||2017-10-10 21:50:11.807853|2017-10-10 21:50:11.807853
NCT02892838|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-02|||September 2003||2003-09-01|July 2016|2016-07-01|December 2011|Actual|2011-12-01|November 2008|Actual|2008-11-01||Interventional|||Should my New Knee Rotate?|Should my New Knee Rotate? A Randomised, Controlled Clinical Trial to Compare Fixed and Mobile Bearing Total Knee Arthroplasties Using the SCORPIO PS and SCORPIO+ PS Knee Systems|Completed||Phase 4|106|Actual|Maastricht University Medical Center||2|||f||||t||||||||No||2017-10-10 21:50:11.940572|2017-10-10 21:50:11.940572
NCT02892825|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-01|||September 2016||2016-09-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|MUSICATOP||Music Listening for Cataract Surgery|Impact of Music on Hypertension During Cataract Surgery Performed Under Topical Anaesthesia|Not yet recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:50:12.07537|2017-10-10 21:50:12.07537
NCT02892812|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-06-23|||September 2016||2016-09-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults|A Single-blind, Single-center, Randomized, Active-controlled, Parallel Group, Phase I Study to Evaluate the Safety and Immunogenicity of Intramuscular Single Injection With LBVE013 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), LBVE014 (Pneumococcal 14-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) or Prevnar13 in Healthy Adults|Completed||Phase 1|63|Actual|LG Life Sciences||3|||f||||f||||||||Undecided||2017-10-10 21:50:12.211837|2017-10-10 21:50:12.211837
NCT02892799|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-04-04|||July 2016||2016-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|DECAF-LITE||Diuresis Using Echocardiography, CVP, and FACTT-Lite|Diuresis Using Echocardiography, CVP, and FACTT-Lite|Active, not recruiting||N/A|80|Anticipated|Intermountain Health Care, Inc.||3|||f||||f||||||||No||2017-10-10 21:50:12.310189|2017-10-10 21:50:12.310189
NCT02892773|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2017-06-14|||January 2017||2017-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Comparing the Effectiveness of Lung Expansion Therapy in Adult Human Subjects|A Randomized Controlled Trial Comparing the Effectiveness of Lung Expansion Therapy Following Upper Abdominal Surgery in Adult Human Subjects|Recruiting||N/A|120|Anticipated|University of Virginia||2|||f||||f||||||||Yes|Intend to submit overall study findings to peer reviewed medical journal after study completion.|2017-10-10 21:50:12.50257|2017-10-10 21:50:12.50257
NCT02892760|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-04-20|||February 13, 2017|Actual|2017-02-13|April 2017|2017-04-01|February 28, 2019|Anticipated|2019-02-28|February 2019|Anticipated|2019-02-01||Interventional|||Clinical Algorithm for Post-Stroke Gait Training With C-Brace|Clinical Algorithm for Post-Stroke Gait Training With C-Brace|Recruiting||N/A|15|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f|f|t|f|f||||||2017-10-10 21:50:12.62552|2017-10-10 21:50:12.62552
NCT02892747|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-11-18|||September 2016||2016-09-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|NUTRICOEUR||Dietetics Education Focused on Malnutrition Prevention|Impact of Dietetics Education Focused on Prevention of Malnutrition, on Reducing Morbidity and Improving Life Quality of Patients With Chronic Heart Failure (CHF): A Randomized Controlled Multicenter Clinical Trial|Recruiting||N/A|295|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 21:50:12.741949|2017-10-10 21:50:12.741949
NCT02892734|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-06|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|April 2019|Anticipated|2019-04-01||Interventional|||Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer|A Phase II Window of Opportunity Trial of Ipilimumab and Nivolumab in Metastatic Recurrent HER2- Inflammatory Breast Cancer (IBC) The Win Trial|Recruiting||Phase 2|29|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 21:50:12.851919|2017-10-10 21:50:12.851919
NCT02892721|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-02|||October 2016||2016-10-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PERFECTS||Performance and Evaluation for CT Colonography Screening|Performance and Evaluation for CT Colonography Screening|Not yet recruiting||N/A|106|Anticipated|London North West Healthcare NHS Trust||2|||f||||t||||||||Yes|Anonymised participant data will be included in the research analysis.|2017-10-10 21:50:12.988322|2017-10-10 21:50:12.988322
NCT02892708|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-09-01|||April 2008||2008-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CSA||Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over|Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over|Recruiting||Phase 3|135|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 21:50:13.111043|2017-10-10 21:50:13.111043
NCT02892695|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-12-04|||September 2016||2016-09-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma|PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Relapsed or Refractory Leukemia and Lymphoma|Recruiting||Phase 1/Phase 2|10|Anticipated|PersonGen BioTherapeutics (Suzhou) Co., Ltd.||1|||f||||t||||||||Yes||2017-10-10 21:50:13.196999|2017-10-10 21:50:13.196999
NCT02892682|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-01-16|||July 2016||2016-07-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|Angiocoag||The Role of the Coagulation Pathways in Recurrent Angioedema|The Role of the Coagulation Pathways in Recurrent Angioedema|Recruiting||N/A|132|Anticipated|University Hospital, Montpellier||4|||f||||f||||||||No||2017-10-10 21:50:13.29741|2017-10-10 21:50:13.29741
NCT02892669|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-02|||January 2017||2017-01-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||Predictive Value of Heart Rate Variability on Outcome in Patients Admitted to the Intensive Care Department|Predictive Value of Heart Rate Variability on Outcome in Patients Admitted to the Intensive Care Department|Not yet recruiting||N/A|300|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||No||2017-10-10 21:50:13.384303|2017-10-10 21:50:13.384303
NCT02892656|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-06-20|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|2 Weeks|Observational [Patient Registry]|||Reliability of Four Questionnaires Used on a Low Back Pain Population|Reliability of Four Questionnaires Used on a Low Back Pain Population|Not yet recruiting||N/A|50|Anticipated|Sano|||1||f||||f||||||||No||2017-10-10 21:50:13.45542|2017-10-10 21:50:13.45542
NCT02892643|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-07|||October 2016||2016-10-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy|Multicenter Prospective Randomized Controlled Trial of Comparing Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy for Upper Third Early Gastric Cancer (KLASS-05)|Recruiting||N/A|138|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-10 21:50:13.532151|2017-10-10 21:50:13.532151
NCT02892630|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-09-01|||January 2014||2014-01-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2015|Actual|2015-04-01||Observational|TIGRO||Immune Thrombocytopenia in Pregnancy|Immune Thrombocytopenia in Pregnancy: Evolution and Prognostic Factors According to a Prospective Observational Comparative Multicenter National French Study|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||||No||2017-10-10 21:50:13.646845|2017-10-10 21:50:13.646845
NCT02892617|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-01|||December 2014||2014-12-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|DISCO-PROP||Evaluation of the Prevalence of Germs Slow Growth in the Intervertebral Disc (IVD) During Spinal Surgery|Evaluation of the Prevalence of Germs Slow Growth in the Intervertebral Disc (IVD) During Spinal Surgery: a Single-center Prospective Observational Study|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     Disc   "|||2017-10-10 21:50:13.752229|2017-10-10 21:50:13.752229
NCT02892604|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|IDCLTraining||Study the Feasibility of Permanent Use of inControl for the Treatment of Type 1 Diabetes|Pilot Evaluation Study of the Feasibility of a Permanent Use in Free-life of inControl Artificial Pancreas System for the Treatment of Type 1 Diabetes|Recruiting||N/A|5|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:50:13.822005|2017-10-10 21:50:13.822005
NCT02892591|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-06-14|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Cannabis Versus Oxycodone for Pain Relief|A Double-Blind, Placebo-Controlled Crossover Study Comparing the Analgesic Efficacy of Cannabis Versus Oxycodone|Recruiting||Phase 3|100|Anticipated|University of Colorado, Denver||3|||f||||f|t|f||||||||2017-10-10 21:50:13.908118|2017-10-10 21:50:13.908118
NCT02892578|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-07|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Systematic Screening With Electrocardiogram for Unknown Atrial Fibrillation in 65 Years Old and Above People in Nursing Home|Systematic Screening With Electrocardiogram for Unknown Atrial Fibrillation in 65 Years Old and Above People in Nursing Home|Recruiting||N/A|287|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:50:14.025694|2017-10-10 21:50:14.025694
NCT02892565|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-08|||September 2005||2005-09-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|TACT||Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)|Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System): Marker of Venous Thrombosis Risk in Systemic Lupus and Antiphospholipid Syndrome? Case-control Study|Completed||N/A|122|Actual|Central Hospital, Nancy, France||2|||f||||f||||||||No||2017-10-10 21:50:14.097493|2017-10-10 21:50:14.097493
NCT02892552|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-02|||March 2013||2013-03-01|August 2016|2016-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|COCOBE||Cone Beam CT Versus Multislice CT in the Postoperative Assessment of Cochlear Implantation|Cone Beam CT Versus Multislice CT: Radiologic Diagnostic Agreement in the Postoperative Assessment of Cochlear Implantation|Completed||N/A|9|Actual|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 21:50:14.163135|2017-10-10 21:50:14.163135
NCT02892539|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Observational|EARTH||Evaluation of Radiation Exposure and Risk Factors During Coronary Angiography|A Prospective Multicenter Case Study to Evaluate Radiation Exposure and Risk Factors in Patients During Coronary Angiography|Recruiting||N/A|4000|Anticipated|The Second Hospital of Hebei Medical University|||1||f||||t||||||||||2017-10-10 21:50:14.23571|2017-10-10 21:50:14.23571
NCT02892526|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-02|||December 2014||2014-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|PLAIES VITALES||Wound Vitality Markers in Forensic Pathology|Wound Vitality Markers in Forensic Pathology|Recruiting||N/A|57|Anticipated|Central Hospital, Nancy, France|||2||f||||f||||||Samples With DNA|"     Cutaneous tissue   "|No||2017-10-10 21:50:14.305885|2017-10-10 21:50:14.305885
NCT02892513|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-25|||November 2016||2016-11-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Auricular Percutaneous Electrical Nerve Field Stimulation for Postoperative Pain Control in Adults|Auricular Percutaneous Electrical Nerve Field Stimulation for Postoperative Pain Control in Adults|Recruiting||N/A|50|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-10 21:50:14.37431|2017-10-10 21:50:14.37431
NCT02892500|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-10-04|||April 2016||2016-04-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Investigation of Corticosteroid Versus Placebo Injection in Patients With Syndesmotic Ligament Injury or High Ankle Sprain|Single-site, Double Blinded, Randomized Investigation of Corticosteroid Versus Placebo Injection Under Ultrasound Guidance in Patients With Syndesmotic Ligament Injury or High Ankle Sprain|Recruiting||Phase 2|58|Anticipated|Sanford Health||2|||f||||f||||||||||2017-10-10 21:50:14.450347|2017-10-10 21:50:14.450347
NCT02892487|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-02-03|||December 2016||2016-12-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|RORC||Evaluation of an Active Swallowing Rehabilitation on Quality of Life of Patients Treated by Radiotherapy for Head and Neck Cancer|Evaluation of an Active Swallowing Rehabilitation on Quality of Life of Patients Treated by Radiotherapy for Head and Neck Cancer|Recruiting||N/A|420|Anticipated|Rennes University Hospital||2|||f||||f||||||||No||2017-10-10 21:50:14.557216|2017-10-10 21:50:14.557216
NCT02892474|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-05|||August 2016||2016-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Observational|||HCR vs. CABG Study|Hybrid Coronary Revascularization Versus Coronary Artery Bypass Surgery for Treatment of Multivessel Coronary Disease|Active, not recruiting||N/A|50|Anticipated|Emory University|||2||f||||f||||||||||2017-10-10 21:50:14.695782|2017-10-10 21:50:14.695782
NCT02892461|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-09-01|||July 2016||2016-07-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Umbilical Cord Milking on Iron Related Health Outcomes for Cesarean-Delivered Infants|Effect of Umbilical Cord Milking on Iron Related Health Outcomes for Cesarean-Delivered Infants: A Randomized Controlled Trial|Recruiting||N/A|450|Anticipated|Peking University||2|||f||||t||||||||Undecided||2017-10-10 21:50:14.780879|2017-10-10 21:50:14.780879
NCT02892448|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-09-09|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CardiacMRI||Cardiac MRI for Metal on Metal Hip Resurfacing|Cardiac MRI for Metal on Metal Orthopaedic Prostheses|Not yet recruiting||N/A|20|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||Undecided|Not certain at this point. TBD.|2017-10-10 21:50:14.877572|2017-10-10 21:50:14.877572
NCT02892435|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-09-01|||November 2014||2014-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prevena™ Incision Management System vs Conventional Management for Wound Healing|Wound Healing After Dirty/Contaminated Emergency Abdominal Surgery: Prevena™ Incision Management System vs Conventional Management|Recruiting||Phase 2|120|Anticipated|Ospedale Misericordia e Dolce||2|||f||||f||||||||No||2017-10-10 21:50:14.952564|2017-10-10 21:50:14.952564
NCT02892422|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-25|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|Debut||Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia|Interventional, Open-label, Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia|Enrolling by invitation||Phase 3|400|Anticipated|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-10 21:50:15.060323|2017-10-10 21:50:15.060323
NCT02892409|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-07-19|||September 21, 2016|Actual|2016-09-21|July 2017|2017-07-01|May 11, 2017|Actual|2017-05-11|May 11, 2017|Actual|2017-05-11||Interventional|||TAK-438 Bismuth Drug Interaction Study|A Phase 1, Double-Blind, Parallel Group Study to Evaluate the Safety and Pharmacokinetics of Quadruple Therapy (Bismuth, Clarithromycin, and Amoxicillin) With TAK-438 Versus Quadruple Therapy With Lansoprazole|Completed||Phase 1|30|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 21:50:15.243541|2017-10-10 21:50:15.243541
NCT02892227|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-06-14|||November 15, 2016|Actual|2016-11-15|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|JECICA||"Management of Acute Heart Failure: Contribution of Ultrasound Daily in Bed Patient Adjustment on Therapy With Impact Measure on re Hospital Rate During 30 Days"||Recruiting||N/A|250|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||||||||||||2017-10-10 21:50:17.093752|2017-10-10 21:50:17.093752
NCT02892396|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Observational|||Influence of Electronic Cigarettes in the Evaluation of the Inflammatory Response in Patients With a Diagnosis of COPD|Influence of Electronic Cigarettes in the Evaluation of the Inflammatory Response in Patients With a Diagnosis of COPD|Not yet recruiting||N/A|20|Anticipated|Fundacio Catalana de Pneumologia|||2||f||||f||||||Samples Without DNA|"     -  Blood sample for study of inflammatory mediators.        -  Induced sputum culture   "|No||2017-10-10 21:50:15.321593|2017-10-10 21:50:15.321593
NCT02892383|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-09-15|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|February 1, 2023|Anticipated|2023-02-01|August 1, 2022|Anticipated|2022-08-01||Observational|QoL-MM||Quality of Life the Danish Multiple Myeloma Patients|Quality of Life in Danish Multiple Myeloma Patients|Recruiting||N/A|800|Anticipated|Odense University Hospital|||1||f||||f||||||||||2017-10-10 21:50:15.386966|2017-10-10 21:50:15.386966
NCT02892370|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-07|||August 2016||2016-08-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects|An Open Label, Randomized, Two-period, Crossover Study to Assess the Effect of Food on SHR0302 and Mass Balance in Healthy Volunteers|Recruiting||Phase 1|14|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 21:50:15.559161|2017-10-10 21:50:15.559161
NCT02892357|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-18|||January 2017||2017-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease|Efficacy of Traditional Chinese Medicine Jianpi Qinghua Granule Combined With Low Dose Omeprazole in Patients With Non-erosive Reflux Disease (NERD)|Not yet recruiting||Phase 2|204|Anticipated|Xiyuan Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 21:50:15.761296|2017-10-10 21:50:15.761296
NCT02892344|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-06-13|||May 17, 2010|Actual|2010-05-17|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma|A Multi-center, Randomized, 12-week Treatment, Doubleblind Study to Assess the Efficacy and Safety of QMF149 (150/80 Microgram) Compared With MF Twisthaler® (200 Microgram) in Adult and Adolescent Patients With Asthma|Recruiting||Phase 3|1000|Anticipated|Novartis||2|||f||||t|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:50:15.921169|2017-10-10 21:50:15.921169
NCT02892331|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|HI-PACE||Effects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans|The High Intensity Exercise to Promote Accelerated Improvements in CardiorEspiratory Fitness (HI-PACE) Study|Recruiting||N/A|60|Anticipated|East Carolina University||3|||f||||f||||||||No||2017-10-10 21:50:16.186977|2017-10-10 21:50:16.186977
NCT02892305|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-10-02|||January 1, 2018|Anticipated|2018-01-01|October 2017|2017-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Observational|||Hepatic Resection for Metastatic Pancreatic Adenocarcinoma|Hepatic Resection for Metastatic Pancreatic Adenocarcinoma at Duke University Medical Center|Not yet recruiting||N/A|50|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 21:50:16.46777|2017-10-10 21:50:16.46777
NCT02892292|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-02|||July 2014||2014-07-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|NGS HLA||NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells|Next Generation Sequencing (NGS) Application for HLA Typing of Donors and Recipients of Hematopoietic Stem Cells|Completed||N/A|300|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:50:16.573772|2017-10-10 21:50:16.573772
NCT02892279|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Sympathetic Nerve Activation Evoked by Diesel Exhaust Exposure|Sympathetic Nerve Activation Evoked by Diesel Exhaust Exposure|Recruiting||N/A|14|Anticipated|Umeå University||1|||f||||f||||||||Undecided||2017-10-10 21:50:16.645741|2017-10-10 21:50:16.645741
NCT02892266|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-06-09|||September 2016||2016-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CTOTC-11||Post‐Traumatic Stress Symptoms (PTSS) in Transplant Recipients|Prevalence and Correlates of Post-Traumatic Stress Symptoms (PTSS) in Adolescent Solid Organ Transplant Recipients (CTOTC-11)|Recruiting||N/A|120|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples Without DNA|"     Blood   "|||2017-10-10 21:50:16.749093|2017-10-10 21:50:16.749093
NCT02892253|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-11-15|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Parathyroid Autofluorescence Visualization in Thyroid Surgery: Impact on Postoperative Hypocalcemia|Parathyroid Autofluorescence Visualization in Thyroid Surgery: Impact on Postoperative Hypocalcemia. A Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Hôpital Européen Marseille||2|||f||||t||||||||No||2017-10-10 21:50:16.925009|2017-10-10 21:50:16.925009
NCT02892240|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-07|||December 1, 2014|Actual|2014-12-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 1, 2017|Actual|2017-01-01||Observational|PTHPOSTCOTYL||Retrospective Evaluation of Total Hip Replacement After Acetabular Fractures|Retrospective Evaluation of Total Hip Replacement After Acetabular Fractures|Active, not recruiting||N/A|300|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:50:17.02245|2017-10-10 21:50:17.02245
NCT02892214|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-03-31|||November 30, 2016|Actual|2016-11-30|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01|12 Months|Observational [Patient Registry]|||The Reciprocal Relations Between Psychosocial Characteristics and the Progression of Vestibulodynia|The Reciprocal Relations Between Psychosocial Characteristics and the Progression of Vestibulodynia, and the Mental Health of the Patient|Recruiting||N/A|120|Anticipated|Meir Medical Center|||3||f||||t||||||||No||2017-10-10 21:50:17.188084|2017-10-10 21:50:17.188084
NCT02892201|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-05-22|||September 2016||2016-09-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Pembrolizumab in HNSCC With Residual Disease After Radiation|A Phase II Study of Pembrolizumab for Patients With Head and Neck Squamous Cell Carcinoma With Residual Disease Following Definitive Chemoradiation|Recruiting||Phase 2|24|Anticipated|Yale University||1|||f||||t||||||||No||2017-10-10 21:50:17.299156|2017-10-10 21:50:17.299156
NCT02892188|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-01|||January 2013||2013-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|SIOUX||Physician-Pharmacist Collaboration for Osteoporotic Patient Follow-up|Assessment of the Follow-up of Osteoporotic Patients by a Physician-pharmacist Collaboration|Active, not recruiting||N/A|120|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||No||2017-10-10 21:50:17.405133|2017-10-10 21:50:17.405133
NCT02892175|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2016-09-07|||May 2015||2015-05-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|DIRFIN||Can the Vascular Physician Sensitize Patients to Redaction of Advance Directives on End of Life?|Can the Vascular Physician Sensitize Patients to Redaction of Advance Directives on End of Life?|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||Undecided||2017-10-10 21:50:17.47234|2017-10-10 21:50:17.47234
NCT02892162|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-09-18|||August 2016||2016-08-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|CLEAR-AF||Catheter Ablation Therapy for Persistent Atrial Fibrillation|Catheter Ablation Therapy for Persistent Atrial Fibrillation: Value of Additional Linear Ablation on Left Atrial Anterior Wall|Recruiting||N/A|214|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t||||||||No||2017-10-10 21:50:17.539106|2017-10-10 21:50:17.539106
NCT02892149|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-02|2017-09-14|||August 2016||2016-08-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-dependent Chronic Kidney Disease (DD-CKD)|Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE-CONVERSION)|Recruiting||Phase 3|2200|Anticipated|Akebia Therapeutics||2|||f||||t||||||||||2017-10-10 21:50:17.673172|2017-10-10 21:50:17.673172
NCT02892136|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-09-01|||May 2013||2013-05-01|September 2016|2016-09-01|December 2026|Anticipated|2026-12-01|May 2026|Anticipated|2026-05-01||Observational|||Technical Development for Pediatric Cardiovascular MRI|Technical Development for Pediatric Cardiovascular MRI|Recruiting||N/A|5000|Anticipated|Children's Research Institute|||1||f||||f||||||||No||2017-10-10 21:50:18.204318|2017-10-10 21:50:18.204318
NCT02892123|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-11|||September 2016||2016-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trial of ZW25 in Patients With Advanced HER2-expressing Cancers|Phase I Trial of ZW25 in Patients With Locally Advanced (Unresectable) and/or Metastatic HER2-expressing Cancers|Recruiting||Phase 1|99|Anticipated|Zymeworks Inc.||1|||f||||f||||||||||2017-10-10 21:50:18.309904|2017-10-10 21:50:18.309904
NCT02892110|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-03-14|||February 13, 2017|Actual|2017-02-13|March 2017|2017-03-01|June 13, 2019|Anticipated|2019-06-13|December 13, 2018|Anticipated|2018-12-13||Interventional|||Varenicline Treatment for Cannabis Use Disorder|Advancing Varenicline as a Treatment for Cannabis Use Disorder|Recruiting||Phase 2|72|Anticipated|Medical University of South Carolina||2|||f||||t|t|f||||||No||2017-10-10 21:50:18.401428|2017-10-10 21:50:18.401428
NCT02892097|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-09-01|||July 2016||2016-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) and Task-Specific Practice for Post-stroke Neglect|Examining the Effects of Transcranial Direct Current Stimulation and Task-specific Practice on Cortical Modulation Among Individuals With Unilateral Spatial Neglect Post Stroke|Recruiting||Phase 1|14|Anticipated|Medical University of South Carolina||3|||f||||f||||||||No||2017-10-10 21:50:18.511719|2017-10-10 21:50:18.511719
NCT02892084|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-09-07|||April 2013||2013-04-01|April 2016|2016-04-01||||March 2018|Anticipated|2018-03-01||Interventional|||Augmentation of Locomotor Adaptation Post-Stroke|Augmentation of Locomotor Adaptation Post-Stroke|Recruiting||Phase 1|40|Anticipated|Medical University of South Carolina||2|||f||||f||||||||Yes||2017-10-10 21:50:18.638188|2017-10-10 21:50:18.638188
NCT02892071|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-09-07|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma|Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma|Not yet recruiting||Phase 1|20|Anticipated|University of Pittsburgh||3|||f||||f||||||||Undecided||2017-10-10 21:50:20.968939|2017-10-10 21:50:20.968939
NCT02892058|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-13|||April 2015||2015-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2016|Actual|2016-12-01||Observational|FLARE-OA||Self-assessment of Flare in Osteoarthritis of Lower Limbs|Development of a Tool for the Self-assessment of Flare in Patients With Osteoarthritis of Lower Limbs|Enrolling by invitation||N/A|600|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||||2017-10-10 21:50:21.078539|2017-10-10 21:50:21.078539
NCT02892045|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-02|||May 2016||2016-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|NMT1||Mindray Neuromuscular Transmission Transducer|Sensitivity and Specificity of the New Neuromuscular Transmission Mindray Module Versus the Relaxometer Mechanomyograph and TOF-Watch Kinemyograph for Neuromuscular Block Monitoring|Recruiting||N/A|100|Anticipated|Medical University of Graz|||4||f||||f||||||||||2017-10-10 21:50:21.168795|2017-10-10 21:50:21.168795
NCT02892032|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-01|||August 2016||2016-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Attention Training Trial|Mobile Based Attention Bias Modification Training for Chronic Pain|Recruiting||N/A|80|Anticipated|York University||2|||f||||f||||||||Undecided||2017-10-10 21:50:21.260966|2017-10-10 21:50:21.260966
NCT02891694|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-02-06|||December 2, 2016|Actual|2016-12-02|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|MERCURE||Metalloproteinases and Recurrent Corneal Erosion Syndrome||Recruiting||N/A|20|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:50:24.53678|2017-10-10 21:50:24.53678
NCT02892019|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-11|||April 18, 2017|Actual|2017-04-18|May 2017|2017-05-01|April 17, 2018|Anticipated|2018-04-17|February 28, 2018|Anticipated|2018-02-28||Interventional|||Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma|A Multicenter, Randomized, Double-blind, Active-controlled, 2 Week Treatment, Parallel-group Study to Assess the Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma|Recruiting||Phase 2|80|Anticipated|Novartis||2|||f||||f|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:50:21.333888|2017-10-10 21:50:21.333888
NCT02892006|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-09-08|||November 30, 2016|Actual|2016-11-30|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||LOL: It's All Improv After Cancer! The Impact of Improvisational Comedy on Well-Being Among Patients With Cancer|LOL: It's All Improv After Cancer! The Impact of Improvisational Comedy on Well-Being Among Patients With Cancer|Recruiting||N/A|18|Anticipated|Cedars-Sinai Medical Center||1|||f||||f|f|f||||||||2017-10-10 21:50:21.437304|2017-10-10 21:50:21.437304
NCT02891993|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2017-07-14|||September 2016||2016-09-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer|Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer|Active, not recruiting||N/A|150|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 21:50:21.524398|2017-10-10 21:50:21.524398
NCT02891980|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-01-26||||||July 25, 2016|2016-07-25||||January 5, 2018|Anticipated|2018-01-05||Interventional|||MVA-BN®-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers|A Phase I Trial to Utilize Systems Biology Approaches to Examine the Safety, Immunogenicity, and 'Omics Response to MVA-BN®-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers|Not yet recruiting||Phase 1|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f|||||t|f|||f|||||2017-10-10 21:50:21.610131|2017-10-10 21:50:21.610131
NCT02891967|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-07|||January 2018||2018-01-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||One-year Clinical Evaluation of Bulk-fill Versus Conventional Incremental Posterior Restoration by FDI Criteria|One-year Clinical Evaluation of Bulk-fill Resin Composite Using FDI Criteria in Comparison to Conventional Incremental Posterior Restoration|Not yet recruiting||N/A|69|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:50:21.706632|2017-10-10 21:50:21.706632
NCT02891954|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-22|||September 2016||2016-09-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Genetics of Response to Canagliflozin|Pharmacogenomics to Predict Responses to SGLT2 Inhibitors|Enrolling by invitation||Phase 1|650|Anticipated|University of Maryland||1|||f||||f||||||||||2017-10-10 21:50:21.821054|2017-10-10 21:50:21.821054
NCT02891941|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-09-01|||June 2013||2013-06-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01|6 Months|Observational [Patient Registry]|||Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury|Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury|Terminated||N/A|10|Actual|Johns Hopkins University|||1|Funding withdrawn|f||||t||||||Samples With DNA|"     whole blood, plasma   "|||2017-10-10 21:50:21.972285|2017-10-10 21:50:21.972285
NCT02891928|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-01|||December 2014||2014-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|EROD||Evaluation of Rocker sOles in Diabetis|Comparative Evaluation of Standard Wearing Shoes With Rocker Sole Shoes in Diabetic Patients With Neuropathy|Completed||Phase 4|25|Actual|University Hospital, Brest||2|||f||||f||||||||No|Data are not planned to be shared|2017-10-10 21:50:22.048491|2017-10-10 21:50:22.048491
NCT02891902|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-07|||October 2013||2013-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|BacterHy||Impact of Dedicated Hygienist Staff on the Occurrence of Intensive Care Unit -Aquired Bloodstream Infections|Impact of Dedicated Hygienist Staff on the Occurrence of Intensive Care Unit -Aquired Bloodstream Infections|Completed||N/A|4000|Actual|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||No||2017-10-10 21:50:22.251239|2017-10-10 21:50:22.251239
NCT02891889|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-07|||November 2015||2015-11-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|BAT||Description of the Appearance of Brown Fat in Scanner|Description of the Appearance of Brown Fat in Scanner|Completed||N/A|200|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:50:22.322025|2017-10-10 21:50:22.322025
NCT02891863|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-04-18|2017-03-06||September 2015||2015-09-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|LEVER||Low Energy Therapy to Convert Ventricular Tachycardias|Low Energy Therapy Application to Convert Ventricular Tachycardias (LEVER)|Terminated||Early Phase 1|9|Actual|Boston Scientific Corporation||1||Futility|f||||f||||||||No|Acute feasibility study of possible new product feature, confidential information|2017-10-10 21:50:22.452589|2017-10-10 21:50:22.452589
NCT02891681|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-14|||November 29, 2016|Actual|2016-11-29|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment|Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment|Recruiting||Phase 1|50|Anticipated|Washington University School of Medicine||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:50:24.612876|2017-10-10 21:50:24.612876
NCT02891850|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-09-18|||January 12, 2017|Actual|2017-01-12|September 2017|2017-09-01|August 30, 2019|Anticipated|2019-08-30|July 31, 2019|Anticipated|2019-07-31||Interventional|REPLACE||Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy|A Prospective, Randomized, International, Multicenter, Double-arm, Controlled, Open-label Study of Riociguat in Patients With Pulmonary Arterial Hypertension (PAH) Who Are on a Stable Dose of Phosphodiesterase-5 Inhibitors (PDE-5i) With or Without Endothelin Receptor Antagonist (ERA), But Not at Treatment Goal|Recruiting||Phase 4|218|Anticipated|Bayer||2|||f||||f|t|f||||||||2017-10-10 21:50:22.644706|2017-10-10 21:50:22.644706
NCT02891837|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-09-08|||August 2016||2016-08-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects|A Phase III Double-Blind, Randomized, Placebo Controlled, Multi-Center Clinical Study to Evaluate the Efficacy and Safety of Intravenous L-citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Subjects Undergoing Surgery for Congenital Heart Defects|Recruiting||Phase 3|190|Anticipated|Asklepion Pharmaceuticals, LLC||2|||f||||t||||||||||2017-10-10 21:50:22.921655|2017-10-10 21:50:22.921655
NCT02891811|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-08|||March 10, 2017|Actual|2017-03-10|September 2017|2017-09-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Interventional|||Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy|A Randomized Phase II, 2-armed Study in Transplant Ineligible (TI) Patients With Newly Diagnosed Multiple Myeloma (NDMM) Comparing Carfilzomib + Thalidomide + Dexamethasone (KTd) Versus Carfilzomib + Lenalidomide + Dexamethasone (KRd) Induction Therapy With Respect to Response Rates and Investigating a Carfilzomib (K) Monotherapy Maintenance Strategy|Recruiting||Phase 2|146|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||2|||f||||f|f|f||||||||2017-10-10 21:50:23.492815|2017-10-10 21:50:23.492815
NCT02891798|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-09-20|||October 2016||2016-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||4-drug Nerve Block Versus Plain Local Anesthetic for Knee and Hip Arthroplasty Analgesia in Veterans|4-drug Nerve Block Versus Plain Local Anesthetic for Knee and Hip Arthroplasty Analgesia in Veterans|Recruiting||Phase 3|200|Anticipated|VA Pittsburgh Healthcare System||2|||f||||t||||||||||2017-10-10 21:50:23.711573|2017-10-10 21:50:23.711573
NCT02891785|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-02-17|||January 2017||2017-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|EvANtiPain||Praxis Evaluation of a Pain Self-management Support Intervention for Oncology Patients: A Stepped Wedge Design Study|"Evaluation of the Project Improvement of Nurse-led Self-management Support for Patients With Cancer-related Pain: An Accompanying Cluster Randomized Study With a Stepped Wedge Design"|Recruiting||N/A|300|Anticipated|University of Vienna||2|||f||||f||||||||No||2017-10-10 21:50:23.823729|2017-10-10 21:50:23.823729
NCT02891772|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-12|||August 2016||2016-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Observational|||Carotid Artery Corrected Flow Time Measured by Ultrasonography as a Predictor of Hypotension After Induction of General Anesthesia|Carotid Artery Corrected Flow Time Measured by Ultrasonography as a Predictor of Hypotension After Induction of General Anesthesia|Recruiting||N/A|94|Anticipated|Yonsei University|||1||f||||f||||||||No||2017-10-10 21:50:23.937022|2017-10-10 21:50:23.937022
NCT02891759|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-04-11|||January 31, 2017|Actual|2017-01-31|April 2017|2017-04-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Compare Outcomes Between Two Acellular Dermal Matrices|A Single-Blinded Randomized Prospective Trial to Compare Outcomes Between Two Acellular Dermal Matrices Used for Immediate, Post-Mastectomy Breast Reconstruction|Recruiting||Phase 2|180|Anticipated|Washington University School of Medicine||2|||f||||t|f|f||||||No||2017-10-10 21:50:24.027295|2017-10-10 21:50:24.027295
NCT02891746|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-09-01|||September 2016||2016-09-01|May 2016|2016-05-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Observational|||Maternal and Neonatal Microbiome|The Neonatal Microbiome and Its Influence on the Post-partum Period|Not yet recruiting||N/A|400|Anticipated|Hadassah Medical Organization|||2||f||||f||||||||Undecided||2017-10-10 21:50:24.178863|2017-10-10 21:50:24.178863
NCT02891733|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-05|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|NTS||Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas|Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas|Recruiting||N/A|400|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||||||2017-10-10 21:50:24.264407|2017-10-10 21:50:24.264407
NCT02891720|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-01|||June 2017||2017-06-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Feasibility of an Ingestible Sensor System to Measure PrEP Adherence in YMSM|Feasibility of an Ingestible Sensor System to Measure PrEP Adherence in YMSM|Not yet recruiting||N/A|100|Anticipated|Hektoen Institute for Medical Research||2|||f||||f||||||||Yes|Findings from this study will provide pharmacokinetic data along with evidence of the feasibility and acceptability of the novel Proteus adherence monitoring system for use among young MSM who are highly vulnerable to HIV infection. Audiences for dissemination are: 1) scientists; 2) primary and secondary prevention practitioners; and 3) YMSM, their partners, and their friends/families. Traditional dissemination vehicles will be used including manuscripts and presentations at international and national meetings. To facilitate integration of the findings into the public health arena, the protocol team will work closely with their YAB and present findings in forums attended by community-based organizations, such as local PrEP trainings and workshops.|2017-10-10 21:50:24.346205|2017-10-10 21:50:24.346205
NCT02891707|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-16|||May 2016||2016-05-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|MDORP||Mobile Device Outcomes-based Rehabilitation Program||Recruiting||Phase 1/Phase 2|150|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-10-10 21:50:24.421724|2017-10-10 21:50:24.421724
NCT02891668|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-09-01|||May 2015||2015-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|HYMAQ||Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition|Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition|Recruiting||N/A|74|Anticipated|Herlev Hospital|||2||f||||t||||||Samples Without DNA|"     Blood   "|Undecided||2017-10-10 21:50:24.716285|2017-10-10 21:50:24.716285
NCT02891655|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-02-06|||December 2, 2016|Actual|2016-12-02|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|KERMIT||KERatoconus and Metalloproteinases InvesTigation||Recruiting||N/A|20|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:50:24.802482|2017-10-10 21:50:24.802482
NCT02891642|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-01|||September 2016||2016-09-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid|Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid|Not yet recruiting||N/A|1000|Anticipated|The First Affiliated Hospital with Nanjing Medical University|||1||f||||t||||||Samples With DNA|"     body fluid for immunomagnetic separation   "|Undecided||2017-10-10 21:50:24.872838|2017-10-10 21:50:24.872838
NCT02891629|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-02-07|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Safety and Feasibility of the EyeControl Device|Safety and Feasibility of the EyeControl Device (Eye-based Communication Device) for ALS Patients|Active, not recruiting||N/A|15|Anticipated|Eyefree Assisting Communication Ltd||2|||f||||f||||||||Undecided||2017-10-10 21:50:24.948139|2017-10-10 21:50:24.948139
NCT02891616|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-02-16|||October 10, 2016|Actual|2016-10-10|February 2017|2017-02-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||18F-FLT PET Imaging in Patients With Advanced Melanoma|Early Assessment of Response to Dual Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma Using 18F-FLT PET/CT and PET/MR|Recruiting||Phase 1|30|Anticipated|Washington University School of Medicine||1|||f||||f|t|t|f|f||||No||2017-10-10 21:50:25.002297|2017-10-10 21:50:25.002297
NCT02891603|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-08-18|||March 30, 2017|Actual|2017-03-30|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression|A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression|Recruiting||Phase 1/Phase 2|60|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 21:50:25.100995|2017-10-10 21:50:25.100995
NCT02891590|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-21|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphomas|Phase Ia Study of the Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphoma|Recruiting||Phase 1|36|Anticipated|Zhejiang DTRM Biopharma||1|||f||||||||||||||2017-10-10 21:50:25.199967|2017-10-10 21:50:25.199967
NCT02891577|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-06|||March 2016||2016-03-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|ECHO-RCF||Study of Ultrasonographic Cava Femoral Ratio in the Critically Ill Patient With Shock|Study of Ultrasonographic Cava Femoral Ratio in the Critically Ill Patient With Shock|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||Samples Without DNA|"     Analysis of plasma creatinine, aspartate aminotransferase, and arterial blood gases.   "|No||2017-10-10 21:50:25.272461|2017-10-10 21:50:25.272461
NCT02891564|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-15|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Computerized Intervention Targeting Cognitive Control Deficits in Depressed Adults|Computerized Intervention Targeting Cognitive Control Deficits in Depressed|Recruiting||N/A|30|Anticipated|University of Washington||1|||f||||t||||||||Yes|We will make de-identified data available to all parties interested.|2017-10-10 21:50:25.338065|2017-10-10 21:50:25.338065
NCT02891551|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-09-01|||May 2012||2012-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|OCEAN||An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands|A Non-interventional Observational Post Authorization Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands (OCEAN)|Completed||N/A|209|Actual|Celgene Corporation|||1||f||||f||||||||||2017-10-10 21:50:25.589444|2017-10-10 21:50:25.589444
NCT02891538|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-13|||January 31, 2017|Actual|2017-01-31|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients|A Pilot Study to Evaluate the Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients With Curative Resections.|Recruiting||Early Phase 1|50|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t|t|f||||||||2017-10-10 21:50:25.697001|2017-10-10 21:50:25.697001
NCT02891525|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-01|||March 2015||2015-03-01|June 2016|2016-06-01||||February 2016|Actual|2016-02-01||Interventional|||The Influence of Sweet Substrates on Hunger, Gastrointestinal Hormones and the Migrating Motor Complex|The Effect of Caloric and Non-caloric Sweeteners on Hunger, Gastrointestinal Hormones as Well as on Antral and Duodenal Motility|Completed||N/A|12|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||||2017-10-10 21:50:25.798213|2017-10-10 21:50:25.798213
NCT02891512|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-11-21|||July 2015||2015-07-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||"Very Low Frequency Magnetic Fields Versus the Supplement Xinepa in the Treatment of the Carpal Tunnel Syndrome"|"Effectiveness of Very Low Frequency Magnetic Fields Versus the Supplement Xinepa in the Treatment of the Carpal Tunnel Syndrome: Randomized Double-blind Controlled Clinical Trial."|Completed||N/A|31|Actual|University of Roma La Sapienza||2|||f||||t||||||||Undecided||2017-10-10 21:50:25.877725|2017-10-10 21:50:25.877725
NCT02891499|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-04-06|||March 2016||2016-03-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|February 2017|Actual|2017-02-01||Interventional|||Influence of Low-level Laser Therapy on Stability and Displacement of Orthodontic Miniscrew Implants|Effect of Low-level Laser Therapy on Stability and Displacement of Orthodontic Miniscrew Implants With Mediate and Immediate Force Application|Active, not recruiting||N/A|29|Anticipated|University of Sao Paulo||4|||f||||f||||||||||2017-10-10 21:50:25.966697|2017-10-10 21:50:25.966697
NCT02891486|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-02-07|||June 2011||2011-06-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Analysis of the Incidence of Post-Operative Wound Infections After Spine Surgery|Analysis of the Incidence of Post-Operative Wound Infections After Spine Surgery - a Prospective Study|Completed||N/A|6959|Actual|University of Miami|||1||f||||f||||||||No||2017-10-10 21:50:26.044445|2017-10-10 21:50:26.044445
NCT02891473|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-07-03|||July 2015||2015-07-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||A Rehabilitative Approach in Patients With Parkinson's Disease|Impact of Mézières Rehabilitative Method in Patients With Parkinson's Disease: a Randomized Controlled Trial|Completed||N/A|36|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-10 21:50:26.120868|2017-10-10 21:50:26.120868
NCT02891460|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-07|||January 2013||2013-01-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|February 2014|Actual|2014-02-01||Interventional|||Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients|Evaluation of the Clinical Response of Mitomycin-C (MMC) Embedded in Hydrogel (TC-3) in Comparison to Mitomycin C in Saline, When Administered Intravesically, Pre-TURBT in Non Muscle Invasive Bladder Cancer (NMIBC) Patients. Muscle Invasive Bladder Cancer (NMIBC) Patients|Completed||N/A|18|Actual|UroGen Pharma Ltd.||2|||f||||f||||||||||2017-10-10 21:50:26.209019|2017-10-10 21:50:26.209019
NCT02891447|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01||||September 2019|Anticipated|2019-09-01||Interventional|||Study of Cytoreduction, Gastrectomy, & Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology|A Phase II Study of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology|Recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 21:50:26.335234|2017-10-10 21:50:26.335234
NCT02891434|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-04-08|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy|Analysis of Interaction of Different Devices in a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy|Completed||N/A|120|Actual|University of Sao Paulo||6|||f||||f||||||||Undecided||2017-10-10 21:50:26.424941|2017-10-10 21:50:26.424941
NCT02891421|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-01|||May 2013||2013-05-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Therapeutic Horsemanship in Veterans|Effects of Equine Assisted Activities on PTSD Symptoms, Coping Self-efficacy, Emotion Regulation, and Social Engagement in U.S. Military Veterans|Completed||N/A|38|Actual|University of Missouri-Columbia||2|||f||||||||||||||2017-10-10 21:50:26.526953|2017-10-10 21:50:26.526953
NCT02891408|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-25|||September 23, 2016|Actual|2016-09-23|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|HI||Pharmacokinetics of GS-0976 in Adults With Normal and Impaired Hepatic Function|A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-0976 in Subjects With Normal and Impaired Hepatic Function|Recruiting||Phase 1|60|Anticipated|Gilead Sciences||3|||f||||f|t|f||||||||2017-10-10 21:50:26.611666|2017-10-10 21:50:26.611666
NCT02891395|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-08-24|||December 2012||2012-12-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|DoubleITK||Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host|Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host (Graft Versus Host, GVH) Did Not Respond to Imatinib Mesylate.|Active, not recruiting||Phase 2|65|Actual|University Hospital, Lille||1|||f||||f||||||||||2017-10-10 21:50:26.710488|2017-10-10 21:50:26.710488
NCT02891382|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-08-31|||July 2016||2016-07-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|REDEEM-Pilot||Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes Mellitus|Feasibility Study on the Impact of Economic Incentives for Weight Loss to Improve the Management of Type 2 Diabetes Mellitus: REDEEM Feasibility Study|Completed||N/A|54|Actual|Universidad Peruana Cayetano Heredia||3|||f||||f||||||||||2017-10-10 21:50:26.837258|2017-10-10 21:50:26.837258
NCT02891369|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-01|||February 2015||2015-02-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|BEVASCITE||Retrospective Analysis of Patients Treated With Bevacizumab in GHPSJ Intraperitoneal for the Treatment of Refractory Malignant Ascites|Retrospective Analysis of Patients Treated With Bevacizumab in GHPSJ Intraperitoneal for the Treatment of Refractory Malignant Ascites|Completed||N/A|30|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||||Undecided||2017-10-10 21:50:26.9416|2017-10-10 21:50:26.9416
NCT02891356|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-08-22|||July 2013|Actual|2013-07-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|AMOS||Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years|Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years and Relationship Between Bone Loss and Adipokines.|Recruiting||N/A|180|Anticipated|University Hospital, Lille|||1||f||||f||||||||||2017-10-10 21:50:27.011011|2017-10-10 21:50:27.011011
NCT02891343|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-08-22|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Hypoxia||Effect of Hypoxia on Cognitive Assessment and Cerebral Activity in Healthy Volunteers|Effect of Hypoxia on Cognitive Assessment and Cerebral Activity in Healthy Volunteers WP1 P002 PHARMACOG|Recruiting||N/A|20|Anticipated|University Hospital, Lille||1|||f||||f||||||||||2017-10-10 21:50:27.101857|2017-10-10 21:50:27.101857
NCT02891330|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-18|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|IRCO||Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity|Assessing the Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity With the Risk of Occurrence of Dumping Syndrome After Gastric Bypass.|Recruiting||N/A|118|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:50:27.19457|2017-10-10 21:50:27.19457
NCT02891317|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||September 2016||2016-09-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma|Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma|Not yet recruiting||N/A|75|Anticipated|University of North Carolina, Chapel Hill|||3||f||||t||||||||No||2017-10-10 21:50:27.285278|2017-10-10 21:50:27.285278
NCT02891304|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-03-17|||July 2016||2016-07-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|EnCompAS||Trial Evaluating Endoscopy Competence Among Gastroenterology Trainees in the Era of the Next Accreditation System.|A Prospective Multi-center Randomized Controlled Trial Evaluating Endoscopy Competence Among Gastroenterology Trainees in the Era of the Next Accreditation System.|Enrolling by invitation||N/A|220|Anticipated|University of Colorado, Denver|||2||f||||f||||||||||2017-10-10 21:50:27.355301|2017-10-10 21:50:27.355301
NCT02891291|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-20|||June 2016||2016-06-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Optical Tomographic Scanner for Skin Lesions|Optical Tomographic Scanner for Skin Lesions|Recruiting||N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     skin tissue sample   "|No|No plan to share data.|2017-10-10 21:50:27.426484|2017-10-10 21:50:27.426484
NCT02891278|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-01|||July 2016||2016-07-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML|The Clinical Application of Tumor Reversion: A Phase I Study of Sertraline (Zoloft) in Combination With Timed-sequential Cytosine Arabinoside (Ara-C) in Adults With Relapsed and Refractory Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|36|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-10 21:50:27.491201|2017-10-10 21:50:27.491201
NCT02891265|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-19|||April 2013||2013-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Smoking Cessation Intervention Within the Fracture Clinic|Smoking Cessation Intervention Within the Fracture Clinic|Recruiting||N/A|182|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 21:50:27.589351|2017-10-10 21:50:27.589351
NCT02891252|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-01|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized Investigation of Thyroid Operation as Day Surgery|Randomized Investigation of Thyroid Operation as Day Surgery|Recruiting||N/A|86|Anticipated|Zealand University Hospital||2|||f||||t||||||||Yes|v|2017-10-10 21:50:27.665878|2017-10-10 21:50:27.665878
NCT02891239|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||785nm Picosecond Laser for Treatment of Benign Pigmented Lesions|Clinical Study to Evaluate the Performance of the PicoWay 1064 nm/ 785 nm/ 532nm Picosecond Laser for Treatment of Benign Pigmented Lesions|Recruiting||N/A|60|Anticipated|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 21:50:27.741287|2017-10-10 21:50:27.741287
NCT02891226|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-10-03|||December 2016||2016-12-01|October 2017|2017-10-01|April 2021|Anticipated|2021-04-01|March 2019|Anticipated|2019-03-01||Interventional|SERENITY||A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease|A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)|Recruiting||Phase 2|180|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 21:50:27.849022|2017-10-10 21:50:27.849022
NCT02891213|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-22|||November 2016||2016-11-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Observational|R-PA14098||Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.|Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.|Not yet recruiting||N/A|150|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 21:50:28.554733|2017-10-10 21:50:28.554733
NCT02891200|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-08-23|||April 17, 2017|Actual|2017-04-17|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of a Peer Support Program Amongst COPD Patients and Their Caregivers|Comparing Effectiveness of Self-management and Peer Support Communication Programs Amongst Chronic Obstructive Pulmonary Disease (COPD) Patients and Their Family Caregivers|Recruiting||N/A|290|Anticipated|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-10 21:50:28.651981|2017-10-10 21:50:28.651981
NCT02891187|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-07-18|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|OPTIONs||Visits Versus Telephone Calls for Postoperative Care|Outpatient Visits Versus Telephone Interviews for Postoperative Care: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-10-10 21:50:28.762527|2017-10-10 21:50:28.762527
NCT02891174|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Interventional|||The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy|A Randomized-controlled Trial to Assess the Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy|Recruiting||Phase 4|40|Anticipated|University of Michigan||2|||f||||f||||||||No||2017-10-10 21:50:28.885644|2017-10-10 21:50:28.885644
NCT02891161|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-13|||November 2016||2016-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|DUART||Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder|Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: Big Ten Cancer Research Consortium BTCRC-GU15-023|Recruiting||Phase 1/Phase 2|42|Anticipated|Big Ten Cancer Research Consortium||2|||f||||t||||||||||2017-10-10 21:50:28.987896|2017-10-10 21:50:28.987896
NCT02891148|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-01-23|||September 2016||2016-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Single Rising Dose Study of BI 690517 in Healthy Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 690517 in Healthy Male Subjects|Completed||Phase 1|50|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 21:50:29.117106|2017-10-10 21:50:29.117106
NCT02891135|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-04-19|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|February 28, 2019|Anticipated|2019-02-28|July 31, 2018|Anticipated|2018-07-31||Interventional|SLATE||Simplified Algorithm for Treatment Eligibility|Randomized Evaluation of a Simplified Clinical Algorithm for Identifying Patients Eligible for Immediate Initiation of Antiretroviral Therapy for HIV|Recruiting||N/A|960|Anticipated|Boston University||2|||f||||f|f|f||||||Yes|Data will be retained in secure study databases until completion of the study, including completion of all data analysis and report writing associated with the study and closing of the IRB-approved protocol. Study data sets and other electronic files containing study data will then have all identifiers removed and where possible will be made available for use of other researchers through a repository such as Dryad.|2017-10-10 21:50:29.203915|2017-10-10 21:50:29.203915
NCT02891122|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-01|||October 2014||2014-10-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|JEÛNE PREOP||Effect of the Duration of Preoperative Fasting on Hypotension Induced by General Anesthesia in the Elderly Person|The Influence of Duration of Fluid Abstinence on Hypotension During General Anaesthesia Induction for Traumatic Hip Surgery in the Elderly|Completed||N/A|56|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:50:29.326888|2017-10-10 21:50:29.326888
NCT02891109|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-01|||January 2015||2015-01-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|PTIREG||Regulatory B Cells and Chronic Immune Thrombocytopenia|The Role of Regulatory B Cells in the Chronic Immune Thrombocytopenia|Completed||N/A|36|Actual|University Hospital, Brest|||2||f||||f||||||||No||2017-10-10 21:50:29.408416|2017-10-10 21:50:29.408416
NCT02891096|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-11-21|||October 2016||2016-10-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|RESCOM||Inspiratory Strength and Respiratory Complications After SCI Injury|Inspiratory Muscle Strength and Respiratory Complications After Spinal Cord Injury: a Multicenter, Prospective Cohort Study|Recruiting||N/A|625|Anticipated|Swiss Paraplegic Centre Nottwil|||1||f||||t||||||||Yes|In general, only the study investigators have access to the full study dataset in order to ensure that the overall results are not disclosed by an individual study site prior to the main publication. Site investigators are allowed to access the full dataset if a formal request describing their plans is approved by the study investigators.|2017-10-10 21:50:29.533152|2017-10-10 21:50:29.533152
NCT02891083|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-06|||January 2016||2016-01-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer|Multi-center Prospective Randomized Controlled Clinical Trial of Postoperative Adjuvant Chemotherapy, Adjuvant Radiotherapy, or Surgery Alone for High-risk Histological Node Negative Patients With Thoracic Esophageal Squamous Cell Carcinoma|Recruiting||Phase 3|486|Anticipated|Shanghai Chest Hospital||3|||f||||f||||||||No||2017-10-10 21:50:29.6951|2017-10-10 21:50:29.6951
NCT02891070|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-07|||September 29, 2016|Actual|2016-09-29|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Efficacy and Safety of FS VH S/D 500 S-apr as an Adjunct to Sutured Dural Repair in Cranial Surgery|A Randomised Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated (FS VH S/D 500 S-apr) Compared to DuraSeal Dural Sealant as an Adjunct to Sutured Dural Repair in Cranial Surgery.|Recruiting||Phase 3|224|Anticipated|Baxter Healthcare Corporation||2|||f||||t||||||||||2017-10-10 21:50:29.845739|2017-10-10 21:50:29.845739
NCT02891057|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-01|||August 2016||2016-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Sun Protection Factor Assay (SPF Assay 104/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:50:30.059462|2017-10-10 21:50:30.059462
NCT02891044|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-30|||August 2016||2016-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Sun Protection Factor Assay (SPF Assay 105/2016)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|12|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:50:30.13988|2017-10-10 21:50:30.13988
NCT02891031|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-10-03|||February 10, 2017|Actual|2017-02-10|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SomaghUricA||The Effects of Rhus Coriaria L. on Serum Uric Acid Levels|The Effects of Rhus Coriaria L. on Serum Uric Acid Levels|Recruiting||N/A|76|Anticipated|Shiraz University of Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 21:50:30.218565|2017-10-10 21:50:30.218565
NCT02891018|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-07|||December 2015||2015-12-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter|A Multicenter, Prospective and Randomized Controlled Clinical Study (VasoguardTM Trial II) That Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter (VasoguardTM) in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter (SeQuent Please)|Recruiting||Phase 3|260|Anticipated|Shandong Branden Med.Device Co.,Ltd||2|||f||||||||||||||2017-10-10 21:50:30.330099|2017-10-10 21:50:30.330099
NCT02891005|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-07|||December 2015||2015-12-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter (VasoguardTM) in the Treatment of Small Coronary Vessel Stenosis With a Common Coronary Balloon Catheter (Maverick2)|A Multicenter, Prospective and Randomized Controlled Clinical Study (VasoguardTM Trial I) That Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter (VasoguardTM) in the Treatment of Small Coronary Vessel Stenosis With a Common Coronary Balloon Catheter (Maverick2)|Recruiting||Phase 3|230|Anticipated|Shandong Branden Med.Device Co.,Ltd||2|||f||||||||||||||2017-10-10 21:50:30.438482|2017-10-10 21:50:30.438482
NCT02890992|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-25|||September 15, 2016|Actual|2016-09-15|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|August 3, 2017|Actual|2017-08-03||Interventional|ODYSSEY KIDS||An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia|An 8-Week Open-Label, Sequential, Repeated Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Followed by an Extension Phase|Active, not recruiting||Phase 2|30|Anticipated|Sanofi||6|||f||||t||||||||||2017-10-10 21:50:30.546963|2017-10-10 21:50:30.546963
NCT02890979|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-05-09|||August 2016||2016-08-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease|Next Generation Sequencing of Esophageal Cytology for the Early Detection of Esophageal Cancer|Recruiting||N/A|30|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 21:50:30.72852|2017-10-10 21:50:30.72852
NCT02890966|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-03-29|||July 2016||2016-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Multiple Dose Study of SHR4640 in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of SHR4640 in Healthy Subjects|Completed||Phase 1|48|Actual|Jiangsu HengRui Medicine Co., Ltd.||4|||f||||f||||||||Undecided||2017-10-10 21:50:30.844919|2017-10-10 21:50:30.844919
NCT02890953|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-04-03|||March 28, 2017|Actual|2017-03-28|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)|Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of IVH in Premature Infants (Phase 2a)|Recruiting||Phase 2|22|Anticipated|Samsung Medical Center||2|||f|||||f|f||||||||2017-10-10 21:50:30.938367|2017-10-10 21:50:30.938367
NCT02890940|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-08-16|||August 2016||2016-08-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Bridging the Gap: Using Video Art to Document the Human Face of Disease & Predict Quality of Life Assessments in Brain Tumor Patients|Bridging the Gap: Using Video Art to Document the Human Face of Disease & Predict Quality of Life Assessments in Brain Tumor Patients|Enrolling by invitation||N/A|50|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 21:50:31.006608|2017-10-10 21:50:31.006608
NCT02890927|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|G-COACH||Geriatric-CO-mAnagement for Cardiology Patients in the Hospital|Quasi-experimental Before-and-after Study to Compare the Effectiveness of Geriatric Co-management on Preventing Functional Decline as Compared to Standard of Care in Older Cardiology Patients|Recruiting||N/A|454|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||Undecided||2017-10-10 21:50:31.073288|2017-10-10 21:50:31.073288
NCT02890914|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-06|||September 2012||2012-09-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Transvaginal Ultrasound Training for Obstetrics and Gynecology Residents|Transvaginal Ultrasound Training for the Obstetrics and Gynecology Resident: A Multi-Site Randomized Controlled Trial of Educational DVD|Completed||N/A|57|Actual|Thomas Jefferson University||2|||f||||f||||||||No||2017-10-10 21:50:31.185272|2017-10-10 21:50:31.185272
NCT02890901|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-01-31|||October 13, 2016|Actual|2016-10-13|August 2016|2016-08-01|March 30, 2018|Anticipated|2018-03-30|October 11, 2017|Anticipated|2017-10-11||Observational|SEPTICOLI||Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications|Prognostic Factors of Escherichia Coli Bloodstream Infections in the Face of Emerging Multi-resistance, Severity Score and Therapeutic Implications|Recruiting||N/A|500|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||Undecided||2017-10-10 21:50:31.282716|2017-10-10 21:50:31.282716
NCT02890888|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-05-01|||November 2014||2014-11-01|August 2016|2016-08-01|June 1, 2018|Anticipated|2018-06-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Effect of Hyperbaric Oxygen on Functional Connectivity in Patients With Cerebral Small Vessel Disease|The Effect of Hyperbaric Oxygen on the Functional Connectivity of Resting State Neural Networks in Patients With Cerebral Small Vessel Disease|Recruiting||N/A|20|Anticipated|St. Luke's Hospital, Chesterfield, Missouri||1|||f||||f||||||||No||2017-10-10 21:50:31.358215|2017-10-10 21:50:31.358215
NCT02890875|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||August 2016||2016-08-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections|Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections|Recruiting||N/A|40|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 21:50:31.452222|2017-10-10 21:50:31.452222
NCT02890862|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-31|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Three-dimensional Kinematic Motion Analysis of Finger and Wrist During Daily Activities|Three-dimensional Kinematic Motion Analysis of Finger and Wrist During Daily|Recruiting||N/A|50|Anticipated|University of Zurich|||4||f||||t||||||||No||2017-10-10 21:50:31.544709|2017-10-10 21:50:31.544709
NCT02890849|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-31|||October 2016||2016-10-01|August 2016|2016-08-01||||June 2019|Anticipated|2019-06-01||Interventional|RadImm01||Clinical Research for the Consistency Analysis of PD-L1 in Cancer Tissue and Plasma Exosome|Clinical Research for the Consistency Analysis of PD-L1 in Cancer Tissue and Plasma Exosome|Not yet recruiting||N/A|60|Anticipated|Xinqiao Hospital of Chongqing||1|||f||||||||||||||2017-10-10 21:50:31.614233|2017-10-10 21:50:31.614233
NCT02890836|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||February 2016||2016-02-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Observational|||Blood Pressure, Antihypertensive Treatment and Preeclampsia in Pregnant Wom-en With Pre-existing Diabetes|Blood Pressure, Antihypertensive Treatment and Preeclampsia in Pregnant Wom-en With Pre-existing Diabetes|Recruiting||N/A|500|Anticipated|Rigshospitalet, Denmark|||2||f||||f||||||||Undecided||2017-10-10 21:50:31.672076|2017-10-10 21:50:31.672076
NCT02890823|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-06|||July 2015||2015-07-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Three Different Doses of Oral Cholecalciferol on 25-Hydroxyvitamin D Changes Among Epilepsy Patients With Hypovitaminosis D|EFFECT OF THREE DIFFERENT DOSES OF ORAL CHOLECALCIFEROL (1000 IU, 3000 IU AND 6000 IU DAILY) ON SERUM 25-HYDROXYVITAMIN D CHANGES AMONG EPILEPSY PATIENTS WITH HYPOVITAMINOSIS D: A RANDOMIZED PROSPECTIVE STUDY|Completed||Phase 4|210|Actual|Chulalongkorn University||6|||f||||t||||||||||2017-10-10 21:50:31.933975|2017-10-10 21:50:31.933975
NCT02890810|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-31|||July 2016||2016-07-01|August 2016|2016-08-01||||July 2018|Anticipated|2018-07-01||Interventional|||Predicting Analgesic Response to Acupuncture: A Practical Approach|Predicting Analgesic Response to Acupuncture: A Randomized, Placebo-Controlled, Subject and Assessor Blinded, 100-Subject Clinical Trial of Electro-Acupuncture in the Treatment of Chronic Low Back Pain|Recruiting||N/A|100|Anticipated|Stanford University||2|||f||||t||||||||Undecided||2017-10-10 21:50:32.074796|2017-10-10 21:50:32.074796
NCT02890797|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-31|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BronchioIUS||Assessment of Thoracic Echography for Pleuroparenchymatous Anomaly Diagnosis Complicating Bronchiolitis: BronchioIUS|Evaluation of Thoracic Echography for Pleuroparenchymatous Anomaly Diagnosis Complicating Bronchiolitis: BronchioIUS|Not yet recruiting||Phase 4|500|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 21:50:32.23968|2017-10-10 21:50:32.23968
NCT02890784|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-05|||August 2016||2016-08-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|DasaHIT||Dasatinib Holiday for Improved Tolerability|Treatment Optimization for Patients With Chronic Myeloid Leukemia (CML) With Treatment naïve Disease (1st Line) and Patients With Resistance or Intolerance Against Alternative Abl-Kinase Inhibitors (≥2nd Line)|Recruiting||Phase 3|306|Anticipated|University of Jena||2|||f||||t||||||||No||2017-10-10 21:50:32.365409|2017-10-10 21:50:32.365409
NCT02890771|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-03-14|||January 2016||2016-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy of Turmeric in Gingival Massaging and Adjunct to Scaling and Root Planing in Chronic Periodontitis Patient|To Evaluate the Efficacy of Whole Turmeric Powder in Gingival Massaging and as an Adjunct to Scaling and Root Planing in Patients With Chronic Periodontitis|Completed||N/A|91|Actual|Government College of Dentistry, Indore||3|||f||||t||||||||Undecided||2017-10-10 21:50:32.601422|2017-10-10 21:50:32.601422
NCT02890758|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-03-30|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803|Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT-803|Not yet recruiting||Phase 1|54|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:50:32.740507|2017-10-10 21:50:32.740507
NCT02890745|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01||||May 2017|Anticipated|2017-05-01||Interventional|EMPOX||The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes|EMPOX - A Randomised, Double-blinded, Placebo Controlled Study That Evaluates the Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes|Recruiting||Phase 2|34|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 21:50:32.885134|2017-10-10 21:50:32.885134
NCT02890732|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-31|||January 2017||2017-01-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|AppET-Coeur||Evaluation of a Prototype Smartphone Application of Personalized Care for Coronary Artery Disease|Implementation and Evaluation of a Prototype Smartphone Application of Personalized Care of Patients After Hospitalization for Coronary Artery Disease|Not yet recruiting||Phase 1|100|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||Yes||2017-10-10 21:50:33.004743|2017-10-10 21:50:33.004743
NCT02890719|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-31|||September 2016||2016-09-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|EGRADICATE||Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.||Not yet recruiting||Phase 3|30|Anticipated|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||No||2017-10-10 21:50:33.087874|2017-10-10 21:50:33.087874
NCT02890706|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-05-29|||July 2016||2016-07-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|InSPECT-DECT||Iodine Mapping Using Subtraction in Pulmonary Embolism CT Versus Dual-Energy CT|Iodine Mapping Using Subtraction in Pulmonary Embolism Computed Tomography Versus Dual Energy Computed Tomography|Active, not recruiting||N/A|41|Actual|Radboud University||1|||f||||f||||||||Undecided||2017-10-10 21:50:33.19933|2017-10-10 21:50:33.19933
NCT02890693|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-10-10|||September 2016||2016-09-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|MySweetHeart||Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus and Their Offspring|Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus (GDM) and Their Offspring: MySweetHeart Trial|Recruiting||N/A|200|Anticipated|University of Lausanne Hospitals||2|||f||||t||||||||Undecided||2017-10-10 21:50:33.320788|2017-10-10 21:50:33.320788
NCT02890680|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-04-10|||August 2016||2016-08-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery|Randomized Double Blind Clinical Trial Evaluation of Bone Regeneration After Impacted Third Molar Surgery With the of Platelet-rich Fibrin: Pilot Study|Completed||N/A|20|Actual|Rio de Janeiro State University||2|||f||||t||||||||||2017-10-10 21:50:33.46885|2017-10-10 21:50:33.46885
NCT02890667|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-06|||May 2015||2015-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Evaluation of Algorithms to Identify Incident Cancer Cases by Using French Health Administrative Databases|A Population Based Observational Study Conducted on the French Administrative Databases to Estimate Cancer Incidence Using Outpatient Care and Hospital Discharge|Completed||N/A|447694|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||Undecided||2017-10-10 21:50:33.559484|2017-10-10 21:50:33.559484
NCT02890654|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-08-31|||September 2015||2015-09-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|SQUAD||Scoliosis and Quality of Life of Adolescents|Idiopathic Scoliosis Surgery in Adolescents ; Earnings a Multidisciplinary Management of Pain and Quality of Life|Recruiting||N/A|120|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||Undecided||2017-10-10 21:50:33.651061|2017-10-10 21:50:33.651061
NCT02890641|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||December 2015||2015-12-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Observational|GENEPHY||Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies||Recruiting||N/A|300|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:50:33.767204|2017-10-10 21:50:33.767204
NCT02890628|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-03-13|||September 2016||2016-09-01|March 2017|2017-03-01|September 21, 2016|Actual|2016-09-21|September 21, 2016|Actual|2016-09-21||Observational|||Teenage Pregnancies in Refugee and Migrant Adolescents on the Thai-Myanmar Border|Perceptions and Experiences of Teenage Pregnancies in Refugee and Migrant Adolescents on the Thai-Myanmar Border|Completed||N/A|54|Actual|University of Oxford|||4||f||||f||||||||Yes||2017-10-10 21:50:33.855355|2017-10-10 21:50:33.855355
NCT02890615|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-29|||July 2016||2016-07-01|September 2016|2016-09-01||||February 2018|Anticipated|2018-02-01||Interventional|CanDirect||CanDirect: Effectiveness of a Telephone-supported Depression Self-care Intervention for Cancer Survivors|Effectiveness of a Telephone-supported Depression Self-care Intervention for Cancer Survivors|Recruiting||N/A|286|Anticipated|McGill University||2|||f||||||||||||||2017-10-10 21:50:33.932006|2017-10-10 21:50:33.932006
NCT02890602|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-30|||September 2012||2012-09-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Erythropoietin for Management of Anemia Caused by Chemotherapy|A Phase Ⅱ Study of Erythropoietin for Management of Anemia Caused by Chemotherapy in Patients With Diffuse Large B-cell Lymphoma|Active, not recruiting||Phase 2|53|Actual|Kosin University Gospel Hospital||1|||f||||f||||||||||2017-10-10 21:50:34.026815|2017-10-10 21:50:34.026815
NCT02890589|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-09-06|||July 2016||2016-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|COVER-AMI||Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction|Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction: An Intracoronary Optical Coherence Tomography Randomized Study|Recruiting||Phase 4|20|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 21:50:34.101821|2017-10-10 21:50:34.101821
NCT02890576|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-31|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|COCHLESURV||Organization of Ambulatory Telemonitoring of People With Hearing Loss and Having a Cochlear Implant COCHLESURV|Organization of Ambulatory Telemonitoring of People With Hearing Loss and Having a Cochlear Implant COCHLESURV|Not yet recruiting||N/A|30|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||No||2017-10-10 21:50:34.199097|2017-10-10 21:50:34.199097
NCT02890563|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy|Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy|Recruiting||N/A|200|Anticipated|Oulu University Hospital||2|||f||||||||||||||2017-10-10 21:50:34.277125|2017-10-10 21:50:34.277125
NCT02890550|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-31|||April 2014||2014-04-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Clinical Study of a Single Ciliopathy: Alström Syndrome|Clinical Study of a Single Ciliopathy: Alström Syndrome|Recruiting||N/A|90|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||Samples With DNA|"     Whole blood, serum, urine, tissue (skin biopsy, adipose tissue)   "|No||2017-10-10 21:50:34.368572|2017-10-10 21:50:34.368572
NCT02890537|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-31|||October 2003||2003-10-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|May 2011|Actual|2011-05-01||Interventional|PREOB-ON2||Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head|Treatment of Osteonecrosis of the Femoral Head by Implantation of Preosteoblastic Cells: a Randomized, Controlled, Single Blind Pilot Study|Completed||Phase 2|82|Actual|Erasme University Hospital||2|||f||||f||||||||No||2017-10-10 21:50:34.478884|2017-10-10 21:50:34.478884
NCT02890524|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-05-01|||July 2014||2014-07-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Tokushima Night Guard for Recurrent Aphthous Stomatitis|Effects of a Night Guard on Aphthous Stomatitis|Recruiting||Early Phase 1|20|Anticipated|University of Tokushima||2|||f||||t||||||||Undecided||2017-10-10 21:50:34.551063|2017-10-10 21:50:34.551063
NCT02890511|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-02-09|||August 2010||2010-08-01|February 2017|2017-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer|A Study of DHP107, a Novel Oral Paclitaxel Formulation, to Determine Maximum Tolerated Dose and Recommended Dose for Phase II Trial in Patients With Advanced Solid Cancer|Completed||Phase 1/Phase 2|28|Actual|Daehwa Pharmaceutical Co., Ltd.||1|||f||||f||||||||No||2017-10-10 21:50:34.625884|2017-10-10 21:50:34.625884
NCT02890498|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-09||||||August 2016|2016-08-01||||June 2016|Actual|2016-06-01||Observational|||Vaginal Microbiota as a Decisive Factor in Vaginal Prosthetic Surgery||Completed||N/A|41|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:50:34.705803|2017-10-10 21:50:34.705803
NCT02890485|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-18|||August 2016||2016-08-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Dry Needling and Knee Pain|The Effects of Dry Needling on Patients With Knee Pain|Recruiting||N/A|120|Anticipated|Ohio State University||5|||f||||f||||||||||2017-10-10 21:50:34.818867|2017-10-10 21:50:34.818867
NCT02890472|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-31|||October 2016||2016-10-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|||Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study|Research of Thymix Dysgenesis in Prenatal Examination of Deletion 22q11 Syndrome|Enrolling by invitation||N/A|120|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||Yes||2017-10-10 21:50:34.92823|2017-10-10 21:50:34.92823
NCT02890459|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-07-13|||April 2016||2016-04-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|IBIS-Health||Innovative Behavioral Economics Incentives Strategies for Health|Innovative Incentive Strategies for Sustainable HIV Testing and Antiretroviral Treatment|Recruiting||N/A|3000|Anticipated|University of California, San Francisco||8|||f||||f|f|f||||||||2017-10-10 21:50:34.985674|2017-10-10 21:50:34.985674
NCT02890433|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-31|||June 2015||2015-06-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PSBMR||Standard Precautions Versus Contact Additional Precautions Against Multi-drug Resistant Bacteria in Intensive Care Unit (PSBMR)|Are Standard Precautions as Efficient as Contact Additional Precautions Against the Transmission of Multi-drug Resistant Bacteria in Intensive Care Unit ?|Completed||N/A|3124|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||||2017-10-10 21:50:35.179655|2017-10-10 21:50:35.179655
NCT02890420|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||January 2015||2015-01-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|NUTRI-STAT||Nutritional Status Of Under-Six Children: Epidemiology Study (NUTRI-STAT)||Completed||N/A|262|Actual|Centre Hospitalier Régional Metz-Thionville|||2||f||||f||||||||No||2017-10-10 21:50:35.231842|2017-10-10 21:50:35.231842
NCT02890407|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2016-09-06|||January 2009||2009-01-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Genetics of Aortic Stenosis: From Family Forms to the Common Forms|Genetics of Aortic Stenosis: From Family Forms to the Common Forms|Completed||N/A|1987|Actual|Nantes University Hospital|||1||f||||f||||||||No||2017-10-10 21:50:35.282657|2017-10-10 21:50:35.282657
NCT02890394|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-31|||March 2016||2016-03-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Effectiveness of the Suboccipital Inhibition Technique in Patients With Mechanical Neck Pain|Effectiveness of the Suboccipital Inhibition Technique in Patients With Mechanical Neck Pain: a Pilot Study|Active, not recruiting||N/A|60|Actual|University of Alcala||4|||f||||f||||||||No||2017-10-10 21:50:35.344316|2017-10-10 21:50:35.344316
NCT02890199|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Local Anesthesia on Postoperative Pain Following Sacrospinous Ligament Fixation|Effect of Local Anesthesia on Postoperative Pain Following Sacrospinous Ligament Fixation|Recruiting||N/A|30|Anticipated|Hartford Hospital||2|||f||||f||||||||No||2017-10-10 21:50:42.949678|2017-10-10 21:50:42.949678
NCT02890381|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-06-19|||September 2016||2016-09-01|June 2017|2017-06-01|April 24, 2017|Actual|2017-04-24|April 24, 2017|Actual|2017-04-24||Interventional|||Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age|Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age|Completed||Phase 1|17|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 21:50:35.40984|2017-10-10 21:50:35.40984
NCT02890368|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-09-13|||September 2016||2016-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides|A Phase 1 Dose Escalation Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Percutaneously-Accessible Solid Tumors and Mycosis Fungoides|Recruiting||Phase 1|54|Anticipated|Trillium Therapeutics Inc.||1|||f||||t||||||||||2017-10-10 21:50:35.501373|2017-10-10 21:50:35.501373
NCT02890342|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-03|2017-06-30|||July 28, 2016||2016-07-28|May 26, 2017|2017-05-26|August 1, 2030|Anticipated|2030-08-01|August 1, 2030|Anticipated|2030-08-01||Observational|||Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia|The Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:50:41.826173|2017-10-10 21:50:41.826173
NCT02890329|ClinicalTrials.gov processed this data on October 10, 2017|2016-09-01|2017-09-04|||April 14, 2017|Actual|2017-04-14|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia|A Phase 1 Study of Ipilimumab in Combination With Decitabine in Relapsed or Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia|Recruiting||Phase 1|48|Anticipated|National Cancer Institute (NCI)||2|||f||||f|t|f||||||||2017-10-10 21:50:41.908713|2017-10-10 21:50:41.908713
NCT02890316|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-31|||July 2016||2016-07-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Assessment of Fatigue During Radiotherapy for Breast Cancer With and Without Homeopathy Treatment|Cognitive and Emotional Assessment of Fatigue During Radiotherapy for Breast Cancer With and Without Homeopathy Treatment|Recruiting||Phase 1/Phase 2|64|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 21:50:42.049928|2017-10-10 21:50:42.049928
NCT02890290|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-09|||September 2016||2016-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect Study of Marine Protein Hydrolysates to Prevent Loss of Muscle Mass and Physical Function in Frail Elderly|Nutrition and Sarcopenia in Frail Elderly: a Randomized Controlled Trial of the Effects of Marine Protein Hydrolysates to Improve Physical Performance.|Enrolling by invitation||N/A|100|Anticipated|Molde University College||2|||f||||f||||||||Undecided|IPD may not be made available, to protect patients anonymity|2017-10-10 21:50:42.185116|2017-10-10 21:50:42.185116
NCT02890277|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2017-01-11|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nonneoplastic Epithelial Disorders of Vulva and High Intensity Focused Ultrasound|Treatment of Nonneoplastic Epithelial Disorders of Skin and Mucosa of Vulva With High Intensity Focused Ultrasound|Recruiting||N/A|120|Anticipated|Jinan Military General Hospital||1|||f||||||||||||||2017-10-10 21:50:42.253412|2017-10-10 21:50:42.253412
NCT02890264|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-06|||January 2005||2005-01-01|September 2016|2016-09-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Observational|||Monitoring the Quality of Life of Patients With End-stage Renal Disease (QV-REIN)|Monitoring the Quality of Life of Patients With End-stage Renal Disease (QV-REIN) - Dialysis|Completed||N/A|1000|Actual|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 21:50:42.475231|2017-10-10 21:50:42.475231
NCT02890251|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-31|||February 2016||2016-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Observational|PREMAVISION||Visual Maturation in Premature Newborns According to Factors Influencing Its Development|Visual Maturation in Premature Newborns According to Factors Influencing Its Development|Completed||N/A|69|Actual|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 21:50:42.540017|2017-10-10 21:50:42.540017
NCT02890238|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Sildenafil Effect After Ovulation Induction|Effect of Sildenafil Citrate on Pregnancy Rate in Women Undergoing Induction of Ovulation|Not yet recruiting||Phase 4|100|Anticipated|Cairo University||2|||f||||t||||||||Yes||2017-10-10 21:50:42.619666|2017-10-10 21:50:42.619666
NCT02890225|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-31|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison Of External Physical Vibration Lithecbole(EPVL) In Different Time After Retrograde Intrarenal Surgery(RIRS)|Study On The Effect Of Renal Residual Stones Treated By External Physical Vibration Lithecbole(EPVL) In Different Time After Retrograde Intrarenal Surgery(RIRS):A Multi-center Prospective Randomized Controlled Trial|Recruiting||N/A|357|Anticipated|Second Affiliated Hospital of Zhengzhou University||3|||f||||t||||||||No||2017-10-10 21:50:42.729536|2017-10-10 21:50:42.729536
NCT02890212|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-05-02|||August 2005||2005-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Selenium as Augmentation Treatment for Sertraline Resistant Major Depression|Double Blind, Placebo Controlled Pilot Study to Evaluate the Use of Selenium as an Augmentation Treatment for Sertraline Resistant Major Depression|Recruiting||N/A|60|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 21:50:42.835993|2017-10-10 21:50:42.835993
NCT02890186|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-31|||April 2016||2016-04-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index|Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index in Anterior Cervical Decompression and Fusion With Internal Fixation|Recruiting||Phase 4|60|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-10 21:50:43.062846|2017-10-10 21:50:43.062846
NCT02890173|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-10|||September 2016||2016-09-01|August 2017|2017-08-01|July 11, 2017|Actual|2017-07-11|July 11, 2017|Actual|2017-07-11||Interventional|ESAX-HTN||Study of CS-3150 in Patients With Essential Hypertension|A Double Blind Study of CS-3150 to Evaluate Efficacy and Safety Compared to Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)|Completed||Phase 3|1001|Actual|Daiichi Sankyo, Inc.||3|||f||||f|f|f||||||||2017-10-10 21:50:43.198554|2017-10-10 21:50:43.198554
NCT02890160|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-07|||October 2016||2016-10-01|September 2016|2016-09-01|October 2022|Anticipated|2022-10-01|October 2017|Anticipated|2017-10-01||Interventional|FUTURE-II||A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II|A Randomized Trial of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease: FUTURE-II|Not yet recruiting||N/A|610|Anticipated|Shanghai MicroPort Medical (Group) Co., Ltd.||2|||f||||t||||||||Undecided||2017-10-10 21:50:43.310975|2017-10-10 21:50:43.310975
NCT02890147|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-12-09|||May 2015||2015-05-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|PRECISESADST||Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control|Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control|Recruiting||N/A|666|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||t||||||Samples With DNA|"     Blood and urine   "|Undecided||2017-10-10 21:50:43.417789|2017-10-10 21:50:43.417789
NCT02890134|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-12-09|||June 2015||2015-06-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|PRECISESADSI||Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort|Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort|Recruiting||N/A|200|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||t||||||Samples With DNA|"     Blood and urine   "|Undecided||2017-10-10 21:50:43.613826|2017-10-10 21:50:43.613826
NCT02890121|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-12-09|||May 2015||2015-05-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|PRECISESADS||Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:|Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Cross Sectional Cohort|Recruiting||N/A|2000|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||t||||||Samples With DNA|"     Blood and urine   "|Undecided||2017-10-10 21:50:43.779233|2017-10-10 21:50:43.779233
NCT02890095|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||January 2016||2016-01-01|August 2016|2016-08-01|January 2028|Anticipated|2028-01-01|January 2018|Anticipated|2018-01-01||Interventional|POPCASE||Persistent Organic Pollutants and Breast Cancers (POPCASE)|Prospective, Multicenter, Epidemiological Case-control Study, to Establish a Possible Correlation Between Persistent Chemical Contaminants (POPs) and Breast Cancer.|Recruiting||Phase 2|800|Anticipated|Institut Cancerologie de l'Ouest||2|||f||||f||||||||No||2017-10-10 21:50:44.059281|2017-10-10 21:50:44.059281
NCT02890082|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-06|||February 2014||2014-02-01|August 2016|2016-08-01|February 2023|Anticipated|2023-02-01|March 2018|Anticipated|2018-03-01||Interventional|PRESAGE||Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer|Pilot Study of Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, and Freezing Oocyte or Embryo Prior Chemotherapy for Breast Cancer|Recruiting||Phase 2|100|Anticipated|Institut Cancerologie de l'Ouest||3|||f||||f||||||||No||2017-10-10 21:50:44.146816|2017-10-10 21:50:44.146816
NCT02890069|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-29|||October 14, 2016|Actual|2016-10-14|September 2017|2017-09-01|May 12, 2019|Anticipated|2019-05-12|May 12, 2019|Anticipated|2019-05-12||Interventional|||A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat|Phase Ib, Open-label, Multi-center Study to Characterize the Safety, Tolerability and Pharmacodynamics (PD) of PDR001 in Combination With LCL161, Everolimus (RAD001) or Panobinostat (LBH589)|Recruiting||Phase 1|350|Anticipated|Novartis||9|||f||||f|t|f||||||||2017-10-10 21:50:44.337472|2017-10-10 21:50:44.337472
NCT02890056|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-06-02|||September 2016||2016-09-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||A Community-based Study to Target Childhood Obesity|A Culturally-tailored Narrative Intervention to Target Disparities in Obesity|Enrolling by invitation||N/A|216|Anticipated|Boston University||2|||f||||f|f|f||||||No||2017-10-10 21:50:44.54036|2017-10-10 21:50:44.54036
NCT02890043|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-09-09|||January 2016||2016-01-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Clinical Trial for the Application of Tirobot System|Clinical Trial for the Application of Tirobot System|Completed||Phase 3|88|Actual|Beijing Jishuitan Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:50:44.616947|2017-10-10 21:50:44.616947
NCT02890030|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-09-27|||May 2015||2015-05-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Platinum Study Comparison Group|Sequelae of Treatment in Survivors of Testicular Cancer Creation of a Non-exposed Comparison Group for the Platinum Study|Recruiting||N/A|109|Anticipated|Indiana University|||1||f||||t||||||||||2017-10-10 21:50:44.715404|2017-10-10 21:50:44.715404
NCT02890017|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-07-31|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|HOTELAMBU||Medico-economical Evaluation of Patient-hotel in Urology|Medico-economical Evaluation of Patient-hotel in Urology|Recruiting||N/A|46|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:50:44.792778|2017-10-10 21:50:44.792778
NCT02890004|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-31|||March 2015||2015-03-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|ProReSHA||Observational Study of Patients With Subarachnoid Hemorrhage|A Prospective, Observational Registry of Patient With Subarachnoid Hemorrhage in Neurocritical Care Unit|Recruiting||N/A|1000|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||No||2017-10-10 21:50:44.877751|2017-10-10 21:50:44.877751
NCT02889991|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-11|||May 2016||2016-05-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|INA-DMD||Evolution of Myofascial Pain, Post-dry Needling. Repair and Measuring With Elastography, of Myofascial Tissue.|Comparative Study, Between Dry Needling Techniques, in the Evolution of Myofascial Pain Shoulder in Athletes. Elastography as Indicator in the Repair of Myofascial Tissue, Post-dry Needling.|Recruiting||N/A|88|Anticipated|Basque Country University||4|||f||||t||||||||||2017-10-10 21:50:45.07943|2017-10-10 21:50:45.07943
NCT02889978|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-07-10|||August 2016||2016-08-01|July 2017|2017-07-01|August 2022|Anticipated|2022-08-01|October 2017|Anticipated|2017-10-01||Observational|CCGA||The Circulating Cell-free Genome Atlas Study|The Circulating Cell-free Genome Atlas Study|Recruiting||N/A|10000|Anticipated|GRAIL, Inc.|||2||f||||f||||||Samples With DNA|"     Plasma, white blood cells, formalin fixed, paraffin embedded (FFPE) tumor tissue   "|||2017-10-10 21:50:45.244323|2017-10-10 21:50:45.244323
NCT02889965|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-06|||January 2011||2011-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|OFSEP||The French Multiple Sclerosis Registry|The French Multiple Sclerosis Registry|Recruiting||N/A|54000|Anticipated|Hospices Civils de Lyon|||3||f||||f||||||||No||2017-10-10 21:50:45.692358|2017-10-10 21:50:45.692358
NCT02889952|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-06|||January 2015||2015-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Observational|||Clinical Impact of Parathyroid Autofluorescence Visualization During Thyroid Surgery|Parathyroid Autofluorescence Visualization During Thyroid Surgery: Impact on Postoperative Hypocalcemia|Completed||N/A|297|Actual|Hôpital Européen Marseille|||4||f||||f||||||||No||2017-10-10 21:50:45.772274|2017-10-10 21:50:45.772274
NCT02889939|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-09-06|||September 2012||2012-09-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|July 2015|Actual|2015-07-01||Interventional|||High-intensity Training in an Enriched Environment in Late Phase After Stroke|The Impact of High-intensity, Task Specific Training Combined With Environmental Enrichment for Individuals in a Late Phase After Stroke - a Randomized Controlled Trial|Recruiting||Phase 2|41|Anticipated|Göteborg University||2|||f||||f||||||||Undecided||2017-10-10 21:50:45.856331|2017-10-10 21:50:45.856331
NCT02889926|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-09-07|||February 10, 2017|Actual|2017-02-10|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ULCERINFECTE||Utility of Samples in Bacteriological Prospective Series of Ulcers Leg Infected Clinically|Utility of Samples in Bacteriological Prospective Series of Ulcers Leg Infected Clinically|Recruiting||N/A|100|Anticipated|Groupe Hospitalier Paris Saint Joseph||2|||f||||t|f|f||||||||2017-10-10 21:50:45.972826|2017-10-10 21:50:45.972826
NCT02889913|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-31|||January 2015||2015-01-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|BIOPULCER||When Asking the Indication of a Skin Biopsy From a Patient With a Leg Ulcer in Primary Care?|When Asking the Indication of a Skin Biopsy From a Patient With a Leg Ulcer in Primary Care? Retrospective Study of 100 Consecutive Biopsies|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:50:46.057295|2017-10-10 21:50:46.057295
NCT02889900|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-18|||January 17, 2017|Actual|2017-01-17|September 2017|2017-09-01|June 7, 2019|Anticipated|2019-06-07|June 7, 2019|Anticipated|2019-06-07||Interventional|CONCERTO||Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer|A Single Arm, Open-label, Phase IIb Study to Assess the Efficacy and Safety of the Combination of Cediranib and Olaparib Tablets in Women With Recurrent Platinum Resistant Epithelial Ovarian Cancer, Including Fallopian Tube and/or Primary Peritoneal Cancer Who do Not Carry a Deleterious or Suspected Deleterious Germline BRCA Mutation|Recruiting||Phase 2|100|Anticipated|AstraZeneca||1|||t||||f||||||||||2017-10-10 21:50:46.13603|2017-10-10 21:50:46.13603
NCT02889887|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-06|||March 2016||2016-03-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|June 2016|Actual|2016-06-01|1 Day|Observational [Patient Registry]|||Relationship Between Sensory Processing and Motor Development|The Investigation of Relationship Between Sensory Processing and Motor Development in Preterm Infants|Active, not recruiting||N/A|60|Actual|Gazi University|||1||f||||f||||||||No||2017-10-10 21:50:46.315131|2017-10-10 21:50:46.315131
NCT02889874|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-10-03|||August 21, 2017|Actual|2017-08-21|October 2017|2017-10-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|EXPERT||EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer|A Randomised Phase III Trial of Adjuvant Radiation Therapy Versus Observation Following Breast Conserving Surgery and Endocrine Therapy in Patients With Molecularly Characterised Luminal A Early Breast Cancer|Recruiting||N/A|1167|Anticipated|Breast Cancer Trials, Australia and New Zealand||2|||f||||t|f|f||||||||2017-10-10 21:50:46.38273|2017-10-10 21:50:46.38273
NCT02889861|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-03-23|||January 18, 2016|Actual|2016-01-18|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|July 2020|Anticipated|2020-07-01||Interventional|||IMCgp100-401 Rollover Study|An Open-label, Multi-center, Rollover Study in Patients With Advanced Melanoma After Completing an IMCgp100 Clinical Study|Recruiting||Phase 1/Phase 2|60|Anticipated|Immunocore Ltd||1|||f||||f||||||||||2017-10-10 21:50:46.545311|2017-10-10 21:50:46.545311
NCT02889848|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-06-16|||September 2016||2016-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)|An Open Label, Dose Escalation Study to Assess Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) in Subjects With Uterine Leiomyoma (Fibroids)|Recruiting||Phase 1|15|Anticipated|Advance Biofactures Corporation||5|||f||||f||||||||No||2017-10-10 21:50:46.644419|2017-10-10 21:50:46.644419
NCT02889835|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-27|||March 22, 2016|Actual|2016-03-22|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Clinical Performance of Incremental and Bulk Fill Composites in Class II Restorations|"Clinical Performance of an Incrementally Placed Highly Filled Composite, an Incrementally Placed Flowable Composite, and a Bulk Filled Composite in Class II Restorations"|Recruiting||N/A|50|Anticipated|3M||3|||f||||f||||||||||2017-10-10 21:50:46.719252|2017-10-10 21:50:46.719252
NCT02889822|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-12|||March 2010||2010-03-01|August 2016|2016-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers|The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers|Completed||Phase 1|44|Actual|Guangzhou Yipinhong Pharmaceutical CO.,LTD||1|||f||||f||||||||||2017-10-10 21:50:46.814075|2017-10-10 21:50:46.814075
NCT02889809|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-14|||October 1, 2016||2016-10-01|September 2017|2017-09-01|October 31, 2021|Anticipated|2021-10-31|October 1, 2021|Anticipated|2021-10-01||Interventional|||Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year|Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg Once Daily on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma|Recruiting||Phase 4|450|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 21:50:46.889513|2017-10-10 21:50:46.889513
NCT02889796|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-09-22|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|April 2019|Anticipated|2019-04-01||Interventional|||Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate|A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks in Combination With Methotrexate to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate|Recruiting||Phase 3|1650|Anticipated|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 21:50:47.225769|2017-10-10 21:50:47.225769
NCT02889783|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-06|||January 2015||2015-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Urethral Sensory Profile: a New Technique to Evaluate Urethral Sensation Prospective Evaluation in Patients With or Without Neurological Disorders|Urethral Sensory Profile: a New Technique to Evaluate Urethral Sensation Prospective Evaluation in Patients With or Without Neurological Disorders|Completed||N/A|183|Actual|Groupe de Recherche Clinique en Neuro-Urologie|||1||f||||f||||||||No||2017-10-10 21:50:47.805294|2017-10-10 21:50:47.805294
NCT02889770|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-06|||September 2013||2013-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Observational|||Dead Space Monitoring With Volumetric Capnography in ARDS Patients|Dead Space Monitoring During PEEP Titration in Patients With Hypoxemia Secondary to Acute Respiratory Distress Syndrome|Completed||N/A|10|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||Undecided||2017-10-10 21:50:47.90279|2017-10-10 21:50:47.90279
NCT02889757|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-09|||January 2017||2017-01-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||The Protective Effect for Liver Organ in Patients With Anti-TB Drugs Using of Acetylcysteine (NAC)|the Safety and Effect in TB Patients With NAC|Not yet recruiting||Phase 4|400|Anticipated|Far Eastern Memorial Hospital||3|||f||||t||||||||No||2017-10-10 21:50:47.969034|2017-10-10 21:50:47.969034
NCT02889744|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-09-21|||March 2016||2016-03-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest|Comparison of Cerebral Tissue Oxygen Saturation (SctO2) Between 36℃ and 33℃ of Targeted Temperature Management (TTM) After Cardiac Arrest|Recruiting||N/A|66|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 21:50:48.070297|2017-10-10 21:50:48.070297
NCT02889731|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-08-30|||June 2004||2004-06-01|August 2016|2016-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||"The Suicide Guard Rail: A Structural Intervention for Hospitals Avoid Suicides by Jumping From Heights Buildings"||Completed||N/A|10|Actual|Kantonsspital Baden|||1||f||||||||||||||2017-10-10 21:50:48.18726|2017-10-10 21:50:48.18726
NCT02889718|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-30|||February 2015||2015-02-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|CONCERT||Anesthesia Feasibility Study With the CONCERT-CL® Station|Anesthesia Feasibility Study With the CONCERT-CL® Station: Administration of Hypnotic in Closed Loop and Administration of Morphine in TCI Mode, at Constant Concentration, After Initial Calibration With a Pupillometer|Recruiting||Phase 2|60|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||f||||||||No||2017-10-10 21:50:48.243423|2017-10-10 21:50:48.243423
NCT02889705|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-31|||August 2012||2012-08-01|August 2016|2016-08-01||||July 2015|Actual|2015-07-01||Observational|||Echotexture in Following Muscle Fibrosis|Longitudinal Follow-up of Muscle Echotextures in Infants With Congenital Muscular Torticollis|Completed||N/A|50|Actual|Chang Gung Memorial Hospital|||1||f||||||||||||||2017-10-10 21:50:48.326843|2017-10-10 21:50:48.326843
NCT02889692|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-09-02|||March 2013||2013-03-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma|Study of Chinese Medicine Plus Targeted Therapy Maintenance Versus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma: A Randomized Double-blind Controlled Clinical Trial|Enrolling by invitation||Phase 3|200|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-10 21:50:48.392731|2017-10-10 21:50:48.392731
NCT02889679|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Underwater Resection of Non-pedunculated Colorectal Lesions|Underwater Resection of Non-pedunculated Colorectal Lesions: A Randomized Controlled Trial|Recruiting||N/A|600|Anticipated|VA Northern California Health Care System||2|||f||||f||||||||No||2017-10-10 21:50:48.481904|2017-10-10 21:50:48.481904
NCT02889666|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-02|||January 2008||2008-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|CCODG-NSCLC||Cisplatin, Carboplatin, Oxaliplatin, Docetaxel and Gemcitabine Plus Surgery for Recurrent Non-Small Cell Lung Cancer|A Multi-Center and Randomized Control Trial of Cisplatin, Carboplatin, Oxaliplatin, Docetaxel and Gemcitabine Plus Surgery as Treatment for Relapsed and Refractory Non-Small Cell Lung Cancer|Recruiting||Phase 1|500|Anticipated|Shanghai Jiao Tong University School of Medicine||8|||f||||t||||||||Yes|Yes, there is plan to make individual participant data (IPD) available. According to the medical administration committee of our hospitals, these data will be made generally public upon the completion of the primary studies (anticipated to be July, 2017).|2017-10-10 21:50:48.57311|2017-10-10 21:50:48.57311
NCT02889653|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-01-19|||October 2016||2016-10-01|January 2017|2017-01-01||||March 2020|Anticipated|2020-03-01|2 Years|Observational [Patient Registry]|BAT2||The Bleeding With Antithrombotic Therapy Study 2|The Bleeding With Antithrombotic Therapy Study 2|Recruiting||N/A|6000|Anticipated|National Cerebral and Cardiovascular Center|||1||f||||f||||||||Undecided||2017-10-10 21:50:48.696365|2017-10-10 21:50:48.696365
NCT02889627|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-05-24|||June 2016||2016-06-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Fecal Microbiota Transplantation for Epilepsy|Efficacy and Safety of Fecal Microbiota Transplantation for Epilepsy|Recruiting||Phase 2/Phase 3|100|Anticipated|The Second Hospital of Nanjing Medical University||2|||f||||t||||||||||2017-10-10 21:50:48.882942|2017-10-10 21:50:48.882942
NCT02889614|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-07-11|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|July 31, 2015|Actual|2015-07-31|July 31, 2015|Actual|2015-07-31||Observational|HYPOPSY||Prevalence Assessment and Characterization of Psychological Disorders Associated With Hypobetalipoproteinemia|Prevalence Assessment and Characterization of Psychological Disorders Associated With Hypobetalipoproteinemia|Completed||N/A|3000|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:50:48.95998|2017-10-10 21:50:48.95998
NCT02889601|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-16|||February 2013|Actual|2013-02-01|August 2017|2017-08-01|December 31, 2015|Actual|2015-12-31|December 31, 2013|Actual|2013-12-31||Observational|DAPHNE||DAPHNE Scale Validation in Frontotemporal Lobar Degeneration|Psycho-behavioral Disorders in Frontotemporal Lobar Degeneration: Validation of a Quantification and Follow-up Scale|Completed||N/A|89|Actual|Nantes University Hospital|||2||f||||f||||||||||2017-10-10 21:50:49.026045|2017-10-10 21:50:49.026045
NCT02889588|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-02-07|||June 2015||2015-06-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|CRIVO||Visual and Optics Impact of Refractive Surgery||Active, not recruiting||N/A|60|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:50:49.087637|2017-10-10 21:50:49.087637
NCT02889575|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-05|||April 2012||2012-04-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|October 2014|Actual|2014-10-01||Observational|PIIINP-NGAL||Predictive Value of PIIINP and Urinary NGAL in Renal Function Recovery|Prospective Multicenter Study to Assess the Predictive Value of PIIINP and Urinary NGAL in Renal Function Recovery During Acute Tubular Necrosis|Completed||N/A|287|Actual|Nantes University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:50:49.219609|2017-10-10 21:50:49.219609
NCT02889562|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-06-28|||September 2016||2016-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation|Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation: a Prospective, Controlled, Randomized Pilot Study|Recruiting||Phase 2/Phase 3|56|Anticipated|Sanford Health||2|||f||||||||||||||2017-10-10 21:50:49.286833|2017-10-10 21:50:49.286833
NCT02889549|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-02-20|||August 2016||2016-08-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Interventional|||Effects of Different Doses of Ticagrelor on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease|Effects of Different Doses of Ticagrelor and Standard-dose Clopidogrel on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery Disease|Recruiting||Phase 2/Phase 3|60|Anticipated|First Affiliated Hospital of Harbin Medical University||4|||f||||||||||||||2017-10-10 21:50:49.393165|2017-10-10 21:50:49.393165
NCT02889536|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-10-20|||June 2016||2016-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Living With a Parastomal Bulge - a Phenomenological-hermeneutic Study of Patients Lived Experiences|Living With a Parastomal Bulge - a Phenomenological-hermeneutic Study of Patients Lived Experiences|Completed||N/A|20|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||No||2017-10-10 21:50:49.47346|2017-10-10 21:50:49.47346
NCT02889523|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-07-11|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|December 2017|Anticipated|2017-12-01||Interventional|Epi-RCHOP||Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients Treated by Chemiotherapy|A Phase Ib-II Study of Tazemetostat (EPZ-6438) in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) Patients With Poor Prognosis Treated by Rituximab-Cyclophosphamide-Vincristine-Doxorubicin-Prednisolone Chemiotherapy (R-CHOP)|Recruiting||Phase 1/Phase 2|133|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-10 21:50:49.543962|2017-10-10 21:50:49.543962
NCT02889510|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-05|||July 2016||2016-07-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus|Multicentre Randomized Double Blind, Crossover, Placebo Controlled Clinical Trial to Evaluate the Effect of Liraglutide on Lung Function in Patients With Type 2 Diabetes Mellitus (LIRALUNG Study)|Recruiting||Phase 3|76|Anticipated|Lecube, Albert, M.D.||2|||f||||f||||||||No||2017-10-10 21:50:49.673011|2017-10-10 21:50:49.673011
NCT02889497|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-06|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months||Not yet recruiting||Phase 4|20900|Anticipated|Beijing Chaoyang District Centre for Disease Control and Prevention||3|||f||||||||||||||2017-10-10 21:50:49.791185|2017-10-10 21:50:49.791185
NCT02889484|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-30|||January 2011||2011-01-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01|1 Year|Observational [Patient Registry]|||Outcome of Surgery for Sciatica - a Comparison of Data From Three National Quality Registries|Outcome of Surgery for Sciatica - a Comparison of Data From Three National Quality Registries|Completed||N/A|7500|Actual|Karolinska Institutet|||3||f||||f||||||||No||2017-10-10 21:50:49.869355|2017-10-10 21:50:49.869355
NCT02889471|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-02-06|||April 2015||2015-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Routine Nasobiliary Insertion During ERCP in High Risk Patients.|Routine Nasobiliary Insertion During ERCP to Prevent, Diagnose and Treat of Biliary Injury in High Risk Patients.|Completed||Phase 2|110|Actual|Minia University||2|||f||||||||||||||2017-10-10 21:50:49.947881|2017-10-10 21:50:49.947881
NCT02889458|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-05|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|10 Years|Observational [Patient Registry]|||Hong Kong Breast Cancer Study|Preventing Breast Cancer in Hong Kong Chinese Women Through Personalized Risk Stratification and Characterization: an Epidemiologic Modeling Study and the Development of a Biorepository of Cases and Controls|Not yet recruiting||N/A|7000|Anticipated|The University of Hong Kong|||2||f||||||||||Samples With DNA|"     Blood, normal breast tissue, and tumour tissue.   "|No||2017-10-10 21:50:50.013183|2017-10-10 21:50:50.013183
NCT02889055|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-04-04|||September 2015||2015-09-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|MIRUS||Evaluation of Mirus™ for Sedation in Resuscitation|Evaluation of Mirus™ for Sedation in Resuscitation|Recruiting||N/A|70|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||No||2017-10-10 21:50:55.083744|2017-10-10 21:50:55.083744
NCT02889445|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-05-11|||February 2016||2016-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Expanded Access|||A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers|A Phase I Trial to Evaluate Safety and Tolerance of Intravenous 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Adolescent and Young Adults (AYA) Subjects With Cancers|Available||N/A|||DEKK-TEC, Inc.|||||||||||||||||||2017-10-10 21:50:50.084512|2017-10-10 21:50:50.084512
NCT02889432|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-05|||June 2016||2016-06-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of Oral Melatonin on Neurosensory Recovery Following Facial Osteotomies|Effects of Oral Melatonin on Neurosensory Recovery Following Facial Osteotomies - A Randomised, Controlled Clinical Trial|Recruiting||Phase 2|40|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 21:50:50.142333|2017-10-10 21:50:50.142333
NCT02889419|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-02|||January 2017||2017-01-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|KML||Benefits Evaluation of Selfia® Adapted Underwear for MS Patients Performing Self-catheterization|Benefits Evaluation of Selfia® Adapted Underwear for Multiple Sclerosis Patients With Severe to Moderate Handicap Performing Self-catheterization : a Multicenter, Prospective, Uncontrolled and Before/After Study.|Not yet recruiting||N/A|150|Anticipated|Lille Catholic University||1|||f||||f||||||||No||2017-10-10 21:50:50.240961|2017-10-10 21:50:50.240961
NCT02889406|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-09-02|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|OBEMAT||Motivation Approach for Childhood Obesity Treatment|Clinical and Metabolic Efficacy of the Motivational Approach, Coordinated Between Primary Care and the Clinical Health Services for Childhood Obesity Treatment: Randomized Clinical Trial|Not yet recruiting||N/A|334|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||No||2017-10-10 21:50:50.337438|2017-10-10 21:50:50.337438
NCT02889393|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-09-23|||January 2017||2017-01-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Teduglutide for Enterocutaneous Fistula (ECF)|Teduglutide for Treatment of Enterocutaneous Fistula (ECF) - a Pilot Study to Demonstrate Safety and Feasibility|Not yet recruiting||Phase 1|10|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 21:50:50.397763|2017-10-10 21:50:50.397763
NCT02889380|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-05-17|||August 29, 2016|Actual|2016-08-29|May 2017|2017-05-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Observational|FASSION||A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment|A Retrospective Study in Chinese Good Prognosis Patients Undergoing ART Treatment to Investigate the Factors Associated With the Pregnancy Outcome of GnRH Antagonist IVF/ICSI Cycles|Completed||N/A|3000|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-10 21:50:50.471023|2017-10-10 21:50:50.471023
NCT02889367|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-04-07|||September 12, 2016|Actual|2016-09-12|April 2017|2017-04-01|March 4, 2017|Actual|2017-03-04|March 4, 2017|Actual|2017-03-04||Interventional|||A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy Participants|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Tablet Formulation Under Fed Conditions in Healthy Subjects|Completed||Phase 1|60|Actual|Janssen Research & Development, LLC||3|||f||||f|t|||||||||2017-10-10 21:50:52.290768|2017-10-10 21:50:52.290768
NCT02889354|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-08-22|||August 2016||2016-08-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type|Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type: a Pilot Study|Completed||N/A|40|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 21:50:52.379386|2017-10-10 21:50:52.379386
NCT02889341|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-01|||October 22, 2013|Actual|2013-10-22|December 2016|2016-12-01|March 2017|Actual|2017-03-01|May 26, 2015|Actual|2015-05-26||Interventional|DHA||Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility|Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility|Completed||N/A|60|Actual|IVI Sevilla||4|||f||||f||||||||||2017-10-10 21:50:52.465117|2017-10-10 21:50:52.465117
NCT02889328|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-07-13|||September 2016||2016-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs|Phase II Study of Continuous Dosing of Regorafenib in Patients With Gastrointestinal Stromal Tumors (GISTs) After Failure of Imatinib and Sunitinib|Recruiting||Phase 2|25|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-10 21:50:52.543309|2017-10-10 21:50:52.543309
NCT02889315|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||November 2013||2013-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2016|Actual|2016-08-01||Observational|||LenusPro Pump in PAH Treated With Treprostinil|Assessment of Safety and Efficacy of Implantable Pump (LenusPro) in Patients With Pulmonary Arterial Hypertension Treated With Treprostinil.|Recruiting||N/A|20|Anticipated|Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Med|||1||f||||f||||||||Undecided||2017-10-10 21:50:52.638382|2017-10-10 21:50:52.638382
NCT02889302|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-11-11||||||November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Interventional|||An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)||Recruiting||Phase 3|||Kissei Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 21:50:52.718239|2017-10-10 21:50:52.718239
NCT02889289|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-03-28|2016-10-05||May 2015||2015-05-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Using the Xbox Kinect for Chronic TBI|Balance and Endurance Outcomes for Chronic TBI Using the Xbox Kinect|Completed||N/A|1|Actual|Washington D.C. Veterans Affairs Medical Center|Small number of subjects; Potentially variable cardiovascular data due to participant lifestyle|1|||f||||f||||||||Yes||2017-10-10 21:50:52.837769|2017-10-10 21:50:52.837769
NCT02889276|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-03-20|||February 20, 2017|Actual|2017-02-20|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|RETRACE||Effects of Functional Exercise on Fitness and QoL in Cancer Survivors|Effects of a 12-week Functional Resistance Training Programme on Physical Fitness and Health-related Quality of Life in Colorectal Cancer Survivors|Recruiting||N/A|36|Anticipated|University of Portsmouth||2|||f||||t|f|f||||||No|No individual participant data will be shared|2017-10-10 21:50:53.171345|2017-10-10 21:50:53.171345
NCT02889237|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-08-30|||October 2014||2014-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Fracture Healing Assessed by HR-pQCT After Administration of Calcium and Vitamin D|Assessment of Fracture Healing by High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) and Bone Strength Analysis in Standard Care and After Immediate Administration of Calcium and Vitamin D Supplementation|Recruiting||N/A|80|Anticipated|VieCuri Medical Centre||4|||f||||f||||||||||2017-10-10 21:50:53.618347|2017-10-10 21:50:53.618347
NCT02889224|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||February 2012||2012-02-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|VISECA||In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man|In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man|Completed||N/A|40|Actual|University Hospital, Bordeaux||4|||f||||f||||||||No||2017-10-10 21:50:53.783912|2017-10-10 21:50:53.783912
NCT02889211|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-08|||August 2016||2016-08-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Brain Function in Depression and Insulin Resistance|Brain Function in Depression and Insulin Resistance|Recruiting||N/A|60|Anticipated|University of Pittsburgh||4|||f||||f||||||||||2017-10-10 21:50:53.926183|2017-10-10 21:50:53.926183
NCT02889198|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-02-15|||May 2014||2014-05-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Pilot Study Evaluating Go NAP SACC's Web-based Nutrition Tool for Child Care|Evaluation of Go NAP SACC: A Pilot Study Evaluating the Nutrition Tool of the Web-based Tool Based on the NAP SACC Program|Completed||N/A|102|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:50:54.024051|2017-10-10 21:50:54.024051
NCT02889185|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-03-01|||April 2016||2016-04-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|IMO||Multimodal Imaging in Central Serous Chorioretinopathy||Recruiting||N/A|7|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:50:54.107462|2017-10-10 21:50:54.107462
NCT02889172|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-09-05|||February 2015||2015-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|DM||Intervention for Reducing Psychiatric Symptoms and Metabolic Variables in Patients With Diabetes Mellitus (DM)|Brief Intervention for Reducing Depressive and Anxiety Symptoms and Their Impact on Metabolic Variables in Patients With Type II Diabetes Mellitus and Obesity|Recruiting||N/A|70|Anticipated|Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente||2|||f||||t||||||||Undecided||2017-10-10 21:50:54.189291|2017-10-10 21:50:54.189291
NCT02889159|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-05-18|||June 6, 2016|Actual|2016-06-06|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immunologic Profile of Chronically Photodamaged Skin|Immunologic Profile of Chronically Photodamaged Skin|Recruiting||N/A|28|Anticipated|University of Michigan||5|||f||||f||||||||No||2017-10-10 21:50:54.280479|2017-10-10 21:50:54.280479
NCT02889146|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-09-11|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Progressive Mobility Program and Technology to Improve the Level of Physical Activity and Functionality of ICU Patients|Using a Progressive Mobility Program and Technology to Increase the Level of Physical Activity and Its Benefits in Respiratory, Muscular System and Functionality of ICU Patients: a Randomized Clinical Trial|Recruiting||N/A|98|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||||2017-10-10 21:50:54.383935|2017-10-10 21:50:54.383935
NCT02889133|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-03-20|||January 2017||2017-01-01|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|DIDS||Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality|A Randomized Trial to Determine if RBCs From Donors With Iron Deficient Erythropoiesis Have Decreased Post-transfusion RBC Recovery and Whether Iron Repletion Improves Recovery|Enrolling by invitation||N/A|60|Anticipated|Columbia University||2|||f||||t||||||||No||2017-10-10 21:50:54.490819|2017-10-10 21:50:54.490819
NCT02889120|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||September 2013||2013-09-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|TELEPRES||Assessment of Drug Prescription by Phone|Telemedicine Performed by General Practitioners in Medical Call Centres:Quality Assessment of Drug Prescription by Phone|Completed||N/A|1263|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||t||||||||No||2017-10-10 21:50:54.637523|2017-10-10 21:50:54.637523
NCT02889107|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-30|||April 2013||2013-04-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Auditory Rehabilitation in Stroke Patients With Auditory Processing Disorders|Long-term Use Benefits of Personal Frequency-modulated Systems for Speech in Noise Perception in Stroke Patients With Auditory Processing Deficits- 'a Non-randomised|Completed||N/A|9|Actual|University College, London||2|||f||||t||||||||Yes||2017-10-10 21:50:54.692831|2017-10-10 21:50:54.692831
NCT02889094|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-02|||October 2016||2016-10-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|COVViB||French HIV-HBV Cohort|Multi-center Study Evaluating Persistence of Hepatitis B Virus Replication, Long-term Prognostic Indicators and Their Clinical Relevance in Patients Co-infected With the Human Immunodeficiency Virus and Chronic Hepatitis B|Enrolling by invitation||N/A|200|Anticipated|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba|||1||f||||t||||||Samples Without DNA|"     Serum and plasma samples will be stored for quantification of biochemical parameters.      Liver tissue (for individuals receiving liver biopsies) will be stored for quantification of     intracellular HBV DNA replication.   "|Yes|Data will only be made available upon official request, pending approval by the Scientific Committee.|2017-10-10 21:50:54.772638|2017-10-10 21:50:54.772638
NCT02889081|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-10-27|||June 2016||2016-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01|12 Months|Observational [Patient Registry]|MKNFOAD||Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)|Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis|Recruiting||N/A|460|Anticipated|Children's Hospital of Fudan University|||2||f||||t||||||Samples With DNA|"     Maternal venous blood and offspring's cord blood   "|Undecided||2017-10-10 21:50:54.864964|2017-10-10 21:50:54.864964
NCT02889068|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2017-07-27|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|January 30, 2017|Actual|2017-01-30|September 30, 2016|Actual|2016-09-30||Observational|NGS-DI||Targeted Next Generation Sequencing and Intellectual Disability|Targeted Next Generation Sequencing and Intellectual Disability|Completed||N/A|40|Actual|Central Hospital, Nancy, France|||1||f||||f||||||Samples With DNA|"     Frozen DNA from blood   "|||2017-10-10 21:50:54.986161|2017-10-10 21:50:54.986161
NCT02889042|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-30|||July 2016||2016-07-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|July 2016|Actual|2016-07-01||Interventional|Phenot IMVr||Repeated Voluntary Drug Intoxication (IMVr): Characterization of a New Addictive Behavior by Clinical Phenotyping and Functional Imaging||Recruiting||N/A|80|Anticipated|University Hospital, Grenoble||4|||f||||f||||||||Undecided||2017-10-10 21:50:55.171069|2017-10-10 21:50:55.171069
NCT02889029|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-30|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|DASCAS||Management of Complex Airway Stenoses With Dedicated Tailored Stents Wrought by 3D Computer-assisted Conception|Management of Complex Airway Stenoses With Dedicated Tailored Stents Wrought by 3D Computer-assisted Conception|Not yet recruiting||Phase 1|10|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||No||2017-10-10 21:50:55.314585|2017-10-10 21:50:55.314585
NCT02889016|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-10-05|||March 2013||2013-03-01|October 2016|2016-10-01|March 2028|Anticipated|2028-03-01|March 2028|Anticipated|2028-03-01||Observational|||Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS||Recruiting||N/A|500|Anticipated|Stanford University|||2||f||||f||||||Samples With DNA|"     Peripheral blood mononuclear cells (PBMCs) are collected from patients during flares and     remissions. Samples will be used for genome-wide association studies (GWAS), time-of-flight     mass spectrometry (CyTOF), TCR analyses, antibody profiling, and monocyte characterizations.   "|Yes|Data is available upon request as allowed by the Stanford Institutional Review board.|2017-10-10 21:50:55.473822|2017-10-10 21:50:55.473822
NCT02889003|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-30|||October 2016||2016-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PIO2STOP||Second STOP After Pioglitazone Priming in CML Patients|Combination Study of Pioglitazone and Tyrosine Kinase Inhibitors (TKIs) in Chronic Myeloid Leukemia Patients After Failure of a First TKIs Discontinuation Attempt in Order to Prepare a New Stop|Not yet recruiting||Phase 2|26|Anticipated|Versailles Hospital||1|||f||||t||||||||Yes||2017-10-10 21:50:55.559706|2017-10-10 21:50:55.559706
NCT02888990|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-30|||August 2007||2007-08-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|May 2011|Actual|2011-05-01||Interventional|EWALLPH01||Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia|An Open Label Phase II Study to Evaluate the Efficacy and Safety of Induction and Consolidation Therapy With Dasatinib in Combination With Chemotherapy in Patients Aged 55 Years and Over With Philadelphia Chromosome Positive (Ph+ or BCR-ABL+) Acute Lymphoblastic Leukemia (ALL).|Completed||Phase 2|71|Actual|Versailles Hospital||1|||f||||f||||||||No||2017-10-10 21:50:55.641718|2017-10-10 21:50:55.641718
NCT02888977|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-30|||December 2012||2012-12-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|EWALL_OBS||Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL|An Observatory for Patients Aged 55 Years and Over With Philadelphia Chromosome Positive (Ph+ or BCR-ABL+) Acute Lymphoblastic Leukemia (ALL) and Treated With the Combination of Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy.|Recruiting||N/A|100|Anticipated|Versailles Hospital|||1||f||||f||||||||No||2017-10-10 21:50:55.848321|2017-10-10 21:50:55.848321
NCT02888964|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-07|||December 2009||2009-12-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2012|Actual|2012-02-01||Interventional|ACTIM||Pioglityazone and Imatinib for CML Patients|A Study to Assess Efficacy and Safety of Pioglitazone as Add-On Therapy to Imatinib Mesylate in CP-CML Patients in Major Molecular Response|Completed||Phase 2|27|Actual|Versailles Hospital||1|||f||||f||||||||||2017-10-10 21:50:55.935883|2017-10-10 21:50:55.935883
NCT02888951|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting Instructions|Do Standard Preoperative Fasting Instructions Ensure an Empty Stomach in Diabetic Patients? A Prospective Comparative Cohort Study|Recruiting||N/A|260|Anticipated|University Health Network, Toronto|||2||f||||f||||||||Undecided|It is undecided at this time whether data will be shared.|2017-10-10 21:50:56.037227|2017-10-10 21:50:56.037227
NCT02888938|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||January 2015||2015-01-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|Passerelle||Diagnosis of Structural Sacroiliitis in Patients With Suspicion of Spondyloarthritis (EchoSPA)|Performance of Pelvic Radiograph, CT -Scan and MRI of the Sacroiliac Joints to Diagnose Structural Sacroiliitis in a Large Cohort of Patients With Suspicion of Spondyloarthritis|Recruiting||N/A|173|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 21:50:56.132378|2017-10-10 21:50:56.132378
NCT02888925|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||August 2013||2013-08-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|August 2017|Anticipated|2017-08-01||Interventional|ATENA-F||Anterior Temporal Epilepsy Neuropsychological Assessment of Faces|Evaluation of Neuropsychological Effects of Drug-resistant Anterior Temporal Epilepsy and Anterior Temporal Lobectomy in Face Perception|Recruiting||N/A|80|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||No||2017-10-10 21:50:56.234116|2017-10-10 21:50:56.234116
NCT02888912|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-30|||May 2009||2009-05-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Clinical Performance of a Glass-ionomer Restorative System: A 6-year Evaluation|Randomized, Controlled Trial of Glass Ionomer System vs Composite Posterior Restorations|Completed||N/A|54|Actual|Hacettepe University||2|||f||||t||||||||Yes||2017-10-10 21:50:56.348861|2017-10-10 21:50:56.348861
NCT02888899|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-30|||March 2016||2016-03-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Tibial Nerve Stimulation in Combination With Biofeedback|Percutaneous Tibial Nerve Stimulation in Combination With Biofeedback in Patients With Fecal Incontinence - A Randomized Controlled Trial|Recruiting||N/A|||University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-10 21:50:56.436651|2017-10-10 21:50:56.436651
NCT02888886|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||July 2007||2007-07-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|BPCO||Role of Systemic Inflammation in Increase of Cardio-vascular Risk in Chronic Obstructive Pulmonary Disease|Role of Systemic Inflammation in Increase of Cardio-vascular Risk in Chronic Obstructive Pulmonary Disease|Completed||N/A|89|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:50:56.52921|2017-10-10 21:50:56.52921
NCT02888873|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-30|||May 2014||2014-05-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Comparison of Two Universal Composites in Posterior Teeth|Prospective, Randomized, Controlled, Double Blind Trial of Two Universal Composites in Posterior Teeth|Completed||N/A|40|Actual|Hacettepe University||2|||f||||t||||||||Yes||2017-10-10 21:50:56.606496|2017-10-10 21:50:56.606496
NCT02888860|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-08-22|||February 2014|Actual|2014-02-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01|15 Days|Observational [Patient Registry]|Candigene||Innate Immunity Gene Polymorphisms and Yeast Colonization|Analysis of TLRs and Lectin Gene Polymorphisms. Impact on Yeast Colonization in Hospitalized Patients and on Adaptive Response Against Yeast Glycans|Recruiting||N/A|2200|Anticipated|University Hospital, Lille|||5||f||||f||||||Samples With DNA|"     whole blood, serum, yeast strains, PBMCs   "|||2017-10-10 21:50:56.706389|2017-10-10 21:50:56.706389
NCT02888847|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-31|2016-08-31|||October 2016||2016-10-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||High Light Intensity Bleaching Versus Descending Light Intensities Bleaching on Post Bleaching Teeth Sensitivity|Effect of High Light Intensity Bleaching Protocol Versus Descending Light Intensities Bleaching Protocol on Post Bleaching Teeth Sensitivity: A Randomized Clinical Trial|Not yet recruiting||N/A|18|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:50:56.826158|2017-10-10 21:50:56.826158
NCT02888834|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-02|||January 2013||2013-01-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Observational|SADR||Serious Adverse Drug Reaction and Their Preventability|Serious Adverse Drug Reaction and Their Preventability in the Elderly Over 65 Years|Completed||N/A|100|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:50:56.897356|2017-10-10 21:50:56.897356
NCT02888821|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CLS-FUERTE||School-Home Program for Mexican Children With Attention and Behavioral Concerns|School-Home Program for Mexican Children With Attention and Behavioral Concerns|Not yet recruiting||N/A|32|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 21:50:56.976024|2017-10-10 21:50:56.976024
NCT02888808|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-30|||March 2013||2013-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Relationship of Obesity With GERD Among Nigerians|Relationship Between Body Mass Index, Waist Circumference, Waist Hip Ratio and Erosive Gastroesophageal Reflux Disease in a Tertiary Centre in Nigeria: a Case Control Study|Completed||N/A|160|Actual|Obafemi Awolowo University Teaching Hospital|||2||f||||f||||||||No||2017-10-10 21:50:57.037294|2017-10-10 21:50:57.037294
NCT02888795|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-13|||February 19, 2016|Actual|2016-02-19|September 2017|2017-09-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||Identification of Response to Hypertonic Dextrose Prolotherapy Markers in Knee Osteoarthritis Patients by Cytokine Array|Identification of Early Response to Hypertonic Dextrose Prolotherapy Markers in Knee Osteoarthritis Patients by an Inflammation-related Cytokine Array|Completed||N/A|12|Actual|National Yang-Ming University Hospital||1|||f||||t||||||||||2017-10-10 21:50:57.105412|2017-10-10 21:50:57.105412
NCT02888782|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-05-17|||December 8, 2016|Actual|2016-12-08|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Optimizing Medication Therapy for Patients Recently Discharged From Hospital|Optimizing Medication Therapy Outcomes for Complex Patients Transitioning From Acute to Primary Care|Recruiting||N/A|550|Anticipated|Memorial University of Newfoundland||2|||f||||f||||||||No||2017-10-10 21:50:57.173718|2017-10-10 21:50:57.173718
NCT02888769|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-04-26|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Cardiovascular Health and Texting Messaging (CHAT) Study|Effectiveness of Text Messaging on Risk Factors Control and Medication Adherence Among Coronary Heart Disease Patients Without Diabetes in Cardiovascular Health and Texting Messaging (CHAT) Study|Recruiting||N/A|600|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||f||||||||Undecided||2017-10-10 21:50:57.267657|2017-10-10 21:50:57.267657
NCT02888756|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-10|||April 4, 2017|Actual|2017-04-04|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|iHIVARNA-01||iHIVARNA Clinical Trial in HIV Infected Individuals|A Phase IIa Randomized, Placebo Controlled, Double Blinded Study to Evaluate the Safety and Immunogenicity of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy|Recruiting||Phase 2|70|Anticipated|Erasmus Medical Center||3|||f||||t|f|f||||||||2017-10-10 21:50:57.354767|2017-10-10 21:50:57.354767
NCT02888730|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-07-28|||February 16, 2017|Actual|2017-02-16|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|AVASMUC||Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients|Efficacy of Antibiotic (Tobramycin) Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients: A Multicenter Double-blind Randomized Controlled Trial|Recruiting||Phase 3|86|Anticipated|Centre Hospitalier Intercommunal Creteil||2|||f||||t|f|f||||||||2017-10-10 21:50:57.819568|2017-10-10 21:50:57.819568
NCT02888717|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-02|||April 2015||2015-04-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|GYNOSNA||Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers|Concordance Study of Molecular Biology Analysis for Para-aortic Nodes in the Ultra-staging of Advanced Cervical Cancers (GYNOSNA)|Recruiting||Phase 2|20|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||f||||||||No||2017-10-10 21:50:58.065016|2017-10-10 21:50:58.065016
NCT02888704|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-08-17|||July 2016||2016-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis|Phase I Clinical Trial to Evaluate the Safety, Tolerance, and Exploratory Efficacy of ADSTEM Inj. in Patients With Moderate to Severe, Subacute and Chronic Atopic Dermatitis|Active, not recruiting||Phase 1|13|Actual|EHL Bio Co., Ltd.||1|||f||||f||||||||||2017-10-10 21:50:58.176842|2017-10-10 21:50:58.176842
NCT02888691|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-03-15|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HiLo12||Low Carbohydrate Diet vs. High Carbohydrate Diet in Type 1 Diabetes|Low Carbohydrate Diet vs. High Carbohydrate Diet in Type 1 Diabetes: A Randomized Crossover Study|Active, not recruiting||N/A|14|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-10 21:50:58.296521|2017-10-10 21:50:58.296521
NCT02888678|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-04-14|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ASPIRES||Evaluation of an Integrated Economic Strengthening and HIV Prevention Program for Vulnerable Youth in South Africa|A Randomized Study Evaluating an Intervention Integrating Economic Strengthening and HIV Prevention Programs for Vulnerable Youth in South Africa|Active, not recruiting||N/A|1773|Actual|FHI 360||4|||f||||f||||||||No||2017-10-10 21:50:58.453735|2017-10-10 21:50:58.453735
NCT02888665|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01||||August 2018|Anticipated|2018-08-01||Interventional|||Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery|A Trial of Pembrolizumab in Combination With Doxorubicin as Treatment for Patients With Advanced Sarcomas|Recruiting||Phase 1/Phase 2|47|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-10 21:50:58.59589|2017-10-10 21:50:58.59589
NCT02888652|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-02|||January 2016||2016-01-01|August 2016|2016-08-01||||September 2018|Anticipated|2018-09-01|1 Year|Observational [Patient Registry]|||Study on the Registration of Coronary Heart Disease Patients Undergoing PCI|Multivariate Analysis of Platelet Reactivity Variety in Patients With Coronary Heart Disease After PCI|Recruiting||N/A|1000|Anticipated|The Third Xiangya Hospital of Central South University|||1||f||||t||||||Samples With DNA|"     Preservation after use   "|||2017-10-10 21:50:58.732491|2017-10-10 21:50:58.732491
NCT02888639|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-30|||December 2009||2009-12-01|August 2016|2016-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|EPHEYL||Pharmacoepidemiological Study of Secondary Hyperparathyroidism in Lorraine|EPHEYL: Étude PHarmacoÉpidémiologique de l'hYperparathyroïdie Secondaire en Lorraine|Completed||N/A|305|Actual|Central Hospital, Nancy, France|||1||f||||t||||||Samples Without DNA|"     Blood sampling   "|No||2017-10-10 21:50:58.835216|2017-10-10 21:50:58.835216
NCT02888626|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Study of a Novel Microlens Array Device for Skin Rejuvenation|A Single-Center, Open-Label Pilot Study of a Novel Microlens Array Device for Skin Rejuvenation|Recruiting||N/A|20|Anticipated|Cutera Inc.||1|||f||||f||||||||||2017-10-10 21:50:58.900719|2017-10-10 21:50:58.900719
NCT02888613|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-08-30|||January 2017||2017-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|RAMini||Mini-laparotomy Versus Mini Lumbotomy|Prospective Randomized Study of Two Aortic Surgical Approaches: Mini-laparotomy Versus Mini Lumbotomy|Not yet recruiting||N/A|300|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||No||2017-10-10 21:50:58.992892|2017-10-10 21:50:58.992892
NCT02888600|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Stress Management Training for Healthy Aging|Stress Management Training for Healthy Aging|Recruiting||N/A|188|Anticipated|Carnegie Mellon University||2|||f||||t||||||||No||2017-10-10 21:50:59.117531|2017-10-10 21:50:59.117531
NCT02888587|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-05-31|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Observational|||The Innervation of Human Gut Sensory Epithelial Cells|The Innervation of Human Gut Sensory Epithelial Cells|Not yet recruiting||N/A|50|Anticipated|Duke University|||2||f||||f||||||Samples Without DNA|"     To obtain endoscopic and colonoscopic biopsies to harvest and culture intestinal crypts from     human tissue to produce organoids. These organoids will be used to study the biology of     innervated sensory epithelial cells.   "|No|Data stays at Duke Medical Center.|2017-10-10 21:50:59.261211|2017-10-10 21:50:59.261211
NCT02888574|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-02|||November 2016||2016-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain|Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain|Not yet recruiting||Phase 2/Phase 3|50|Anticipated|University of Calgary||2|||f||||f||||||||Undecided||2017-10-10 21:50:59.326985|2017-10-10 21:50:59.326985
NCT02888561|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||October 2016||2016-10-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Haemodynamic Effects of Dobutamine and Nitrite in LV Dysfunction|The Impact of Dobutamine and Nitrite on Myocardial Supply and Demand in Heart Failure|Not yet recruiting||N/A|45|Anticipated|King's College London|||1||f||||f||||||||No||2017-10-10 21:50:59.433746|2017-10-10 21:50:59.433746
NCT02888548|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-06|||June 2016||2016-06-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Interventional|ORTHOX||Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox)|Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing the Antispastic Efficacy and Safety of Dynamic Night Hand Splinting in Adults With Post-stroke Hemiplegia Treated by Botulimum Toxin (Dysport®) - (a Pilot Study)|Recruiting||Phase 4|30|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:50:59.517958|2017-10-10 21:50:59.517958
NCT02888535|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-08-16|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2017|Actual|2017-07-01|6 Months|Observational [Patient Registry]|ICUSPID||Intensive Care Unit and Secondary and Primary Immune Deficiency|Intensive Care Unit and Secondary and Primary Immune Deficiency|Recruiting||N/A|16|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 21:50:59.614698|2017-10-10 21:50:59.614698
NCT02888522|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-30|||June 2016||2016-06-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|August 2016|Actual|2016-08-01||Observational|IMODLAM||Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML|Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML|Recruiting||N/A|60|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 21:50:59.728515|2017-10-10 21:50:59.728515
NCT02888509|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||June 2015||2015-06-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Neural and Cognitive Mechanisms of Depression and Anxiety: a Multimodal MRI Study|Neural and Cognitive Mechanisms of Depression and Anxiety: a Multimodal MRI Study|Recruiting||N/A|150|Anticipated|University of Electronic Science and Technology of China|||4||f||||t||||||||Undecided||2017-10-10 21:50:59.811722|2017-10-10 21:50:59.811722
NCT02888496|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-30|||January 2015||2015-01-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|TENOR-IMMUNO||Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica|Caractérisation Des Anomalies Immunologiques au Cours de la Pseudopolyarthrite rhizomélique et Effets du Traitement Par Tocilizumab|Completed||N/A|40|Actual|University Hospital, Brest|||2||f||||f||||||Samples Without DNA|"     Serum   "|No||2017-10-10 21:50:59.899861|2017-10-10 21:50:59.899861
NCT02888483|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-05-26|||July 2016||2016-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|PEAKS||PEAKS: Validation of Mobile Technologies|PEAKS: Validation of Mobile Technologies for Clinical Assessment, Monitoring and Intervention|Recruiting||N/A|150|Anticipated|University of Florida|||1||f||||f||||||||Yes||2017-10-10 21:50:59.987052|2017-10-10 21:50:59.987052
NCT02888470|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||June 2013||2013-06-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Administration of Amino-glycoside in ICU Patients : Clinical Practices in 2013|Administration of Amino-glycoside in ICU Patients : Clinical Practices in 2013|Completed||N/A|90|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:51:00.129072|2017-10-10 21:51:00.129072
NCT02888457|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||October 2015||2015-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers|Assessment of the Nasopharyngeal Carriage of Streptococcus Pneumoniae (Sp) and Other Common Pathogens in Infants (6-30 Months of Age) With Acute Otitis Media and in Healthy Infants (6-30 Months of Age) Attending Day-care Centers|Recruiting||N/A|5000|Anticipated|Universiteit Antwerpen||2|||f||||f||||||||No||2017-10-10 21:51:00.191861|2017-10-10 21:51:00.191861
NCT02888444|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-05-10|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SPACE||Smoking Relapse Prevention Among COPD Ex-smokers|Smoking Relapse Prevention Among COPD Ex-smokers|Not yet recruiting||Phase 3|262|Anticipated|University of Auckland, New Zealand||2|||f||||t|f|f||||||No||2017-10-10 21:51:00.296859|2017-10-10 21:51:00.296859
NCT02888431|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Correlation of Arterial and Venous Lactate and Base Deficit Values||Completed||N/A|50|Actual|Nationwide Children's Hospital|||2||f||||f||||||||Undecided||2017-10-10 21:51:00.390246|2017-10-10 21:51:00.390246
NCT02888418|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-30|||October 2016||2016-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17|Random, Double Blind, Placebo Controlled Phase I Clinical Trials to Estimate the Safety and Preliminary Immunogenicity of Tetravalent Recombinant Human Papilloma Virus Vaccine (6,11,16,18 Type)(Hansenula Polymorpha) in Women of 9 to 30 Years Old and Men of 9 to 17 Years Old|Not yet recruiting||Phase 1|135|Anticipated|Beijing Chaoyang District Centre for Disease Control and Prevention||6|||f||||||||||||||2017-10-10 21:51:00.478415|2017-10-10 21:51:00.478415
NCT02888405|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-30|||November 2015||2015-11-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Acute Dietary Changes on Estimates of Body Composition|Effects of Acute Dietary Changes on Estimates of Body Composition|Completed||N/A|48|Actual|Baylor University||2|||f||||f||||||||No||2017-10-10 21:51:00.55523|2017-10-10 21:51:00.55523
NCT02888392|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-06-29|||December 18, 2015|Actual|2015-12-18|June 2017|2017-06-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||The Effect of Zespri Green Kiwifruit on Digestive and Gut Health Functions|The Effect of Zespri Green Kiwifruit on Digestive and Gut Health Functions: a Multi-country, Randomized, Cross-over Clinical Intervention|Completed||N/A|60|Actual|Zespri International Limited||2|||f||||f||||||||||2017-10-10 21:51:00.614116|2017-10-10 21:51:00.614116
NCT02888379|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-07-06|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|June 28, 2017|Actual|2017-06-28|June 28, 2017|Actual|2017-06-28||Interventional|TOP2||Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis|A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Symptomatic Ulcerative Colitis Patients With Moderate to Severe Disease Activity|Completed||Phase 2|77|Actual|Topivert Pharma Ltd||2|||f||||f||||||||||2017-10-10 21:51:00.698884|2017-10-10 21:51:00.698884
NCT02888366|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-04-13|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|||A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer|A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer|Recruiting||N/A|2000|Anticipated|Menssana Research, Inc.|||1||f||||f||||||||Undecided||2017-10-10 21:51:00.84195|2017-10-10 21:51:00.84195
NCT02888353|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-07-18|||December 2015||2015-12-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Magnetic Resonance Imaging (MRI) in Patients With Pacemakers and Implanted Cardioverter Defibrillators|An Expanded Evaluation of the Safety of Clinically Indicated Magnetic Resonance Imaging (MRI) in Patients With Pacemakers and Implanted Cardioverter Defibrillators|Enrolling by invitation||N/A|1700|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 21:51:00.928801|2017-10-10 21:51:00.928801
NCT02888340|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-05-09|||April 2016||2016-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Acupuncture in the Emergency Department|A Randomized Controlled Trial of Acupuncture in the Emergency Department: A Pilot Study|Active, not recruiting||N/A|100|Anticipated|Allina Health System||2|||f||||f||||||||No||2017-10-10 21:51:01.103544|2017-10-10 21:51:01.103544
NCT02888327|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-09-15|||July 31, 2016|Actual|2016-07-31|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|May 31, 2017|Actual|2017-05-31||Interventional|||A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872|A Phase-1, Open-label, Four Group, Fixed-Sequence Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir, JNJ-63623872, and Probes for P-glycoprotein, CYP3A and OATP1B1 in Healthy Volunteers|Completed||Phase 1|68|Actual|Alios Biopharma Inc.||4|||f||||f||f||||||||2017-10-10 21:51:01.23691|2017-10-10 21:51:01.23691
NCT02888314|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2016-10-06|||August 2016||2016-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|Pokemon||Pokemon Go and Physical Activity|Pokemon Go and Physical Activity Online Survey|Completed||N/A|167|Actual|Duke University|||1||f||||f||||||||No||2017-10-10 21:51:01.377981|2017-10-10 21:51:01.377981
NCT02888301|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-09-12|||June 12, 2015|Actual|2015-06-12|August 2017|2017-08-01|June 12, 2021|Anticipated|2021-06-12|June 12, 2020|Anticipated|2020-06-12||Interventional|||18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions|The Biodistribution of [18F]-Clofarabine in Cancer Patients Before and After Interventions That Increase the Activity of Deoxycytidine Kinase|Recruiting||N/A|30|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 21:51:01.467687|2017-10-10 21:51:01.467687
NCT02888288|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-09-07|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Integrating Mental Health Into a HIV Clinic to Improve Outcomes Among Tanzanian Youth|Integrating Mental Health Into a HIV Clinic to Improve Outcomes Among Tanzanian Youth|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||f||||||||No||2017-10-10 21:51:01.607571|2017-10-10 21:51:01.607571
NCT02888275|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-06-14|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Dexmedetomidine in Pediatric Cardiac Surgery|The Renal Protective Effect of the Dexmedetomidine in Pediatric Patients Undergoing Cardiac Surgery|Recruiting||N/A|144|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:51:01.730392|2017-10-10 21:51:01.730392
NCT02888262|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-01|||January 2016||2016-01-01|August 2016|2016-08-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|BIO||The Bipolar Illness Onset Study (the BIO Study)|The Bipolar Illness Onset Study (the BIO Study)|Recruiting||N/A|600|Anticipated|Mental Health Services in the Capital Region, Denmark|||3||f||||f||||||Samples With DNA|"     Blood Urine Hair   "|No||2017-10-10 21:51:01.827789|2017-10-10 21:51:01.827789
NCT02888249|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-29|||January 2017||2017-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Behavioral Economic Purchasing Decisions for Cigarettes of Varied Compositions|Behavioral Economic Purchasing Decisions for Cigarettes of Varied Compositions|Not yet recruiting||N/A|115|Anticipated|Johns Hopkins University||4|||f||||f||||||||No||2017-10-10 21:51:01.939703|2017-10-10 21:51:01.939703
NCT02888236|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-25|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|July 6, 2017|Actual|2017-07-06|June 20, 2017|Actual|2017-06-20||Interventional|||LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris|LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris|Completed||Phase 2|36|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 21:51:02.044633|2017-10-10 21:51:02.044633
NCT02888223|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||September 2016||2016-09-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|||Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A|Pharmacokinetic Comparison of SCT800 (B-domain Deleted Recombinant Factor VIII) With Xyntha in Previously Treated Patients With Hemophilia A: a Phase I, Open-label, Randomized, Crossover Study|Not yet recruiting||Phase 1|16|Anticipated|Sinocelltech Ltd.||2|||f||||f||||||||No||2017-10-10 21:51:02.138054|2017-10-10 21:51:02.138054
NCT02888210|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-10-04|||September 2016||2016-09-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery|Open Label, Phase/3 Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery|Recruiting||Phase 3|110|Anticipated|Santen Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 21:51:02.232567|2017-10-10 21:51:02.232567
NCT02888197|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-06-01|||August 3, 2016|Actual|2016-08-03|June 2017|2017-06-01|March 16, 2017|Actual|2017-03-16|March 15, 2017|Actual|2017-03-15||Observational|||Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization|A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis|Completed||N/A|32|Actual|Cidara Therapeutics Inc.|||1||f||||f||||||Samples Without DNA|"     Candida isolates   "|Undecided||2017-10-10 21:51:02.32591|2017-10-10 21:51:02.32591
NCT02888184|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-01|||January 2010||2010-01-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Identification of Neurological Prognostic Markers of Cardiac Arrest Patients Alive on 3rd Day|Neuron Specific Enolase and Glasgow Motor Score Remain Useful Tools for Assessing Neurological Prognosis After Out-of-hospital Cardiac Arrest Treated With Therapeutic Hypothermia|Completed||N/A|130|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||||||||||||2017-10-10 21:51:02.484281|2017-10-10 21:51:02.484281
NCT02888171|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-03-21|||August 2016||2016-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency|Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With Moderate to Severe Chronic Kidney Disease (CKD) With Iron Deficiency|Recruiting||N/A|60|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||No||2017-10-10 21:51:02.58694|2017-10-10 21:51:02.58694
NCT02888158|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||February 2012||2012-02-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|LAPRA||Laparoscopic Training With and Without Robotic Assistance for Surgical Internes: a Randomized Study|Laparoscopic Training With and Without Robotic Assistance for Surgical Internes: a Randomized Study|Completed||N/A|34|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 21:51:02.741297|2017-10-10 21:51:02.741297
NCT02888145|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||August 2013||2013-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|OVAGRAFT||Investigating Minimal Residual Disease in Autopreserved Ovarian Tissue in Cases of Neoplastic Pathology|Investigating Minimal Residual Disease in Autopreserved Ovarian Tissue in Cases of Neoplastic Pathology|Recruiting||N/A|240|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 21:51:02.866964|2017-10-10 21:51:02.866964
NCT02888132|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-29|||April 2016||2016-04-01|August 2016|2016-08-01||||May 2018|Anticipated|2018-05-01||Interventional|||Echocardiography-guided Transthoracic Radio Frequency/Laser Ablation for Ventricular Septum of Hypertrophic Obstructive Cardiomyopathy||Recruiting||N/A|10|Anticipated|Xijing Hospital||1|||f||||||||||||||2017-10-10 21:51:03.00529|2017-10-10 21:51:03.00529
NCT02888119|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-07-20|||July 2016||2016-07-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Imaging Biomarkers of Knee Osteoarthritis|Imaging Biomarkers of Knee Osteoarthritis|Recruiting||N/A|90|Anticipated|New York University School of Medicine||3|||f||||f|f|f||||||||2017-10-10 21:51:03.144264|2017-10-10 21:51:03.144264
NCT02887924|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-09-10|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||SLI MANEUVER and RESPIRATORY MORBIDITIES|THE EFFECT OF SUSTAINED LUNG INFLATION MANEUVER APPLIED THROUGH NASAL PRONG ON EARLY AND LATE RESPIRATORY MORBIDITIES IN PRETERM INFANTS|Not yet recruiting||Phase 4|250|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:51:04.790226|2017-10-10 21:51:04.790226
NCT02888106|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-08-16|||April 2016||2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent|A Multicenter, Open-label, Randomised, Comparative, Parallel-Arm, Phase II Study to Assess Efficacy and Safety of Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent|Active, not recruiting||Phase 2|60|Actual|Hepatera Ltd.||4|||f||||f||||||||||2017-10-10 21:51:03.303509|2017-10-10 21:51:03.303509
NCT02888093|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-07-06|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension|A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension|Recruiting||N/A|44|Anticipated|University of Iowa||2|||f||||f||||||||||2017-10-10 21:51:03.412815|2017-10-10 21:51:03.412815
NCT02888080|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-06-26|||December 19, 2016|Actual|2016-12-19|June 2017|2017-06-01|July 27, 2018|Anticipated|2018-07-27|July 27, 2018|Anticipated|2018-07-27||Interventional|||Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis|A Multiple-dose, Subject and Investigator Blinded, Placebo-controlled, Parallel Design Study to Assess the Efficacy, Safety and Tolerability of ACZ885(Canakinumab) in Patients With Pulmonary Sarcoidosis|Recruiting||Phase 2|38|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:51:03.499713|2017-10-10 21:51:03.499713
NCT02888067|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-29|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation With Moderate vs. Deep Neuromuscular Block|Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation in Patients With Moderate vs. Deep Neuromuscular Block|Recruiting||Phase 1|30|Anticipated|McGill University Health Center||2|||f||||f|f|f||||||||2017-10-10 21:51:03.659681|2017-10-10 21:51:03.659681
NCT02888054|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-06-15|||August 30, 2016|Actual|2016-08-30|June 2017|2017-06-01|February 1, 2017|Actual|2017-02-01|October 18, 2016|Actual|2016-10-18||Interventional|||Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence|A Phase 1, Randomized, Open-Label, Replicate, Crossover Study to Assess the Bioequivalence of Lesinurad/Allopurinol Fixed-Dose Combination Tablets and Coadministered Lesinurad and Allopurinol Tablets in Fed Healthy Adult Subjects|Completed||Phase 1|28|Actual|Ardea Biosciences, Inc.||4|||f||||f||||||||||2017-10-10 21:51:03.775403|2017-10-10 21:51:03.775403
NCT02888041|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-04-13|||December 2016||2016-12-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|RE-DINO||Is There an Interest in Repeating the Vaginal Administration of Dinoprostone (Propess®), to Promote Induction of Labor of Pregnant Women at Term?|Is There an Interest in Repeating the Vaginal Administration of Dinoprostone (Propess®), to Promote Induction of Labor of Pregnant Women at Term?|Recruiting||Phase 3|360|Anticipated|University Hospital, Limoges||2|||f||||t||||||||No||2017-10-10 21:51:03.874945|2017-10-10 21:51:03.874945
NCT02888028|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-08-29|||May 2011||2011-05-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Quality of Life and Device Acceptance in Patients With ICD Undergoing Remote ICD FU|Quality of Life and Device Acceptance in Patients With Implantable Cardioverter-defibrillators Undergoing Remote ICD Follow-up|Completed||N/A|182|Actual|Klinikum der Universitaet Muenchen||2|||f||||f||||||||No||2017-10-10 21:51:04.000177|2017-10-10 21:51:04.000177
NCT02888015|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-29|||January 2017||2017-01-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Benefits of Upper Extremity Exercises|Does the Use of an Upper Extremity Exercise Program Improve Activity Tolerance and Increase Independence With ADL's|Not yet recruiting||N/A|10|Anticipated|State University of New York - Upstate Medical University||1|||f||||f||||||||No||2017-10-10 21:51:04.111312|2017-10-10 21:51:04.111312
NCT02888002|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-08-29|||November 2015||2015-11-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|IMS||Internet-based vs Face-to-face Treatment for Alcohol Dependence|Internet-based vs Face-to-face Treatment for Alcohol Dependence: A Randomised, Controlled Non-inferiority Trial|Recruiting||N/A|600|Anticipated|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 21:51:04.194874|2017-10-10 21:51:04.194874
NCT02887989|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-07-31|||November 21, 2016||2016-11-21|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|September 21, 2017|Anticipated|2017-09-21||Interventional|||Virtual Reality for Pain Management|Immersive Virtual Reality Intervention for Non-Opioid Pain Management: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-10 21:51:04.304438|2017-10-10 21:51:04.304438
NCT02887976|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-01|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201|An Open-label Extension (OLE), Expanded Access Study, to Assess Long-term Safety of SoluMatrix™ Abiraterone Acetate 500mg (4 x 125 mg qd) With Methylprednisolone (4mg Bid) in Patients Who Completed Study Number CHL-AA-201|Not yet recruiting||Phase 3|15|Anticipated|GU Research Network, LLC||1|||f||||f||||||||Yes|Peer reviewed Journal and/or professional meeting.|2017-10-10 21:51:04.394835|2017-10-10 21:51:04.394835
NCT02887963|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-03-24|||September 2016||2016-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Observational|EIDACPW||Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia in Chinese Pregnant Women|Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia Among Pregnant Women: A National Multicenter Survey in China|Completed||N/A|12000|Actual|West China Hospital|||1||f||||t||||||||Undecided||2017-10-10 21:51:04.506269|2017-10-10 21:51:04.506269
NCT02887950|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-01|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause|Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Overweight Menopausal Women: a Pragmatic, Randomised Clinical Trial.|Recruiting||N/A|144|Anticipated|IRCCS Policlinico S. Matteo||3|||f||||f||||||||Undecided||2017-10-10 21:51:04.607105|2017-10-10 21:51:04.607105
NCT02887937|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-06|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Cystic Breast Masses by Contrast Enhanced Ultrasound (CEUS)|Qualitative and Quantitative Analysis of Cystic Breast Masses by Contrast Enhanced Ultrasound: Is Biopsy Necessary?|Not yet recruiting||N/A|135|Anticipated|University of Southern California|||4||f||||f||||||||Undecided||2017-10-10 21:51:04.700538|2017-10-10 21:51:04.700538
NCT02887911|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-21|||December 22, 2015|Actual|2015-12-22|August 2017|2017-08-01||||July 2020|Anticipated|2020-07-01||Observational|CAARS||Characterization of Adults for Asthma Microbiome Research Studies|Characterization of Adults for Asthma Microbiome Research Studies (CAARS)|Recruiting||N/A|200|Anticipated|University of Michigan|||4||f||||t||||||Samples With DNA|"     Biospecimen samples will be retained indefinitely in a coded manner. It is anticipated that     samples from this research study will be used in future research projects.   "|||2017-10-10 21:51:04.845423|2017-10-10 21:51:04.845423
NCT02887898|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Interventional|BolusCal2||Efficacy of Automated Bolus Calculation in Type 2 Diabetes|Efficacy of Advanced Carbohydrate Counting and Automated Bolus Calculation in Insulin-treated Type 2 Diabetes Patients: The BolusCal2 Study|Recruiting||N/A|126|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-10 21:51:04.909133|2017-10-10 21:51:04.909133
NCT02887872|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-29|||May 2011||2011-05-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|December 2012|Actual|2012-12-01||Interventional|||Electrical Stimulation and a Dynamic Orthosis for Stroke Recovery|Combining Electrical Stimulation and a Dynamic Hand Orthosis for Functional Recovery in Chronic Stroke|Completed||N/A|4|Actual|The University of Texas Medical Branch, Galveston||1|||f||||f||||||||No|Individual data are confidential.|2017-10-10 21:51:05.102589|2017-10-10 21:51:05.102589
NCT02887859|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-05-25|||December 20, 2016|Actual|2016-12-20|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD|A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-Popliteal Bypass in Patients With Peripheral Arterial Disease|Recruiting||Phase 2|20|Anticipated|Humacyte, Inc.||1|||f||||t||||||||No||2017-10-10 21:51:05.225703|2017-10-10 21:51:05.225703
NCT02887846|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-09-10|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparing HHHFNC and nCPAP Ventilation Methods for the Prevention of Extubation Failure in Preterm Infants|Comparing Heated Humidified High-flow Nasal Cannula Therapy and Nasal Continuous Positive Airway Pressure (nCPAP) Ventilation Methods for the Prevention of Extubation Failure in Preterm Infants Less Than 32 Weeks' Gestational Age: Randomized Clinical Trial|Not yet recruiting||Phase 4|200|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||t||||||||||2017-10-10 21:51:05.317483|2017-10-10 21:51:05.317483
NCT02887833|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-10-14|||October 2016||2016-10-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Observational|TiBoP||Thermal Testing in Bone Pain (TiBoP)|An Exploratory Study to Develop and Evaluate a Simple Bedside Tool for Community Use to Identify Who is Most Likely to Benefit From Palliative Radiotherapy for Cancer Induced Bone Pain: Thermal Testing in Bone Pain (TiBoP)|Recruiting||N/A|144|Anticipated|University of Edinburgh|||1||f||||f||||||Samples With DNA|"     Blood; Urine   "|No||2017-10-10 21:51:05.394044|2017-10-10 21:51:05.394044
NCT02887820|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO)|A Pilot Study in Feasibility and Safety: Point of Care Testing With Thromboelastography (TEG) for Blood Product Transfusion in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO)|Not yet recruiting||N/A|50|Anticipated|University of Pittsburgh||1|||f||||f|f|t|f|f||||||2017-10-10 21:51:05.504246|2017-10-10 21:51:05.504246
NCT02887807|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-29|||January 2017||2017-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|CYRUS II||CYclosporine A in Shockable Out-of-hospital Cardiac Arrest ResUScitation|CYclosporine A in Shockable Out-of-hospital Cardiac Arrest ResUScitation|Not yet recruiting||Phase 3|520|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||No||2017-10-10 21:51:05.599938|2017-10-10 21:51:05.599938
NCT02887794|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|AUDISCHIZ||Basic Auditory Processing and Auditory Hallucinations|Basic Auditory Processing and Acoustico-verbal Hallucinations: a Pathophysiological Study|Recruiting||N/A|30|Anticipated|Hôpital le Vinatier||1|||f||||f||||||||No||2017-10-10 21:51:05.809944|2017-10-10 21:51:05.809944
NCT02887781|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||October 2014||2014-10-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Observational|TSAR||Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France|Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France|Recruiting||N/A|150|Anticipated|University Hospital, Brest|||1||f||||||||||Samples With DNA|"     Whole Blood   "|||2017-10-10 21:51:05.944378|2017-10-10 21:51:05.944378
NCT02887768|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-08-29|||January 2016||2016-01-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|EIR||Epicardial Infarct Repair Using CorMatrix®-ECM: Clinical Feasibility Study|Cardial Infarct Repair Using CorMatrix®-ECM: Clinical Feasibility Study|Recruiting||Phase 1|8|Anticipated|University of Calgary||1|||f||||f||||||||Yes|Individual patient data will only be shared with that patient. De-identified and compiled data will be used for analysis and publication.|2017-10-10 21:51:06.051821|2017-10-10 21:51:06.051821
NCT02887755|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-16|||December 2015||2015-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Assessing the Feasibility of a Novel Non-Invasive Sensor for Guiding Wounded Warrior Rehabilitation||Recruiting||N/A|20|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||1|||f||||f||||||||||2017-10-10 21:51:06.177861|2017-10-10 21:51:06.177861
NCT02887742|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-01-09|||October 2010||2010-10-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|QT_DIAL||Epidemiologic Study and Impact Study of a Dialysis Solution Change on the Electrocardiographic Profile of Patient|Epidemiologic Study and Impact Study of a Dialysis Solution Change on the Electrocardiographic Profile of Patient|Completed||N/A|57|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:51:06.300374|2017-10-10 21:51:06.300374
NCT02887729|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-09-01|||June 2010||2010-06-01|August 2016|2016-08-01||||January 2020|Anticipated|2020-01-01||Observational|GENKYST||Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease)||Recruiting||N/A|4000|Anticipated|University Hospital, Brest|||1||f||||||||||Samples With DNA|"     whole blood   "|||2017-10-10 21:51:06.403953|2017-10-10 21:51:06.403953
NCT02887716|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2016-08-30|||August 2015||2015-08-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|FATFRAC||Mapping the Lumbar Spine Marrow Adiposity|Mapping the Lumbar Spine Marrow Adiposity|Completed||N/A|50|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:51:06.666994|2017-10-10 21:51:06.666994
NCT02887703|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-04-25|||September 2016||2016-09-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Augmenting Balance in Individuals With Cerebellar Ataxias|Augmenting Balance in Individuals With Cerebellar Ataxias|Recruiting||N/A|10|Anticipated|University of Michigan||2|||f||||f||||||||Undecided||2017-10-10 21:51:06.756926|2017-10-10 21:51:06.756926
NCT02887690|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-17|||December 2013||2013-12-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|MPL||Pilot Project to Evaluate the Revolutionizing Prosthetics Modular Prosthetic Limb System for Upper Extremity Amputees|Pilot Project to Evaluate the Revolutionizing Prosthetics Modular Prosthetic Limb System for Upper Extremity Amputees|Recruiting||N/A|12|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||1|||f||||||||||||||2017-10-10 21:51:06.912041|2017-10-10 21:51:06.912041
NCT02887677|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-29|||October 2016||2016-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.|A Study of the Effects of Dapagliflozin on Ambulatory Aortic Pressure, Arterial Stiffness and Urine Albumin Excretion in Patients With Type 2 Diabetes|Not yet recruiting||Phase 4|160|Anticipated|Hellenic Society for Medical Education||2|||f||||f||||||||No||2017-10-10 21:51:07.013786|2017-10-10 21:51:07.013786
NCT02887664|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-29|||September 2016||2016-09-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Observational|||The Correlation Between the n-6:n-3 Ratio and Inflammatory Markers in Small for Gestational Age (SGA) Infants Compared With Appropriate for Gestational Age (AGA) Infants|The Correlation Between the n-6:n-3 Ratio and Inflammatory Markers in Small for Gestational Age (SGA) Infants Compared With Appropriate for Gestational Age (AGA) Infants|Not yet recruiting||N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||f||||||Samples With DNA|"     Whole blood   "|No||2017-10-10 21:51:07.189326|2017-10-10 21:51:07.189326
NCT02887651|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-29|||October 2016||2016-10-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|C-O-MET||Cavity Boost Radiation Therapy vs. Observation in Cerebral Metastases After Complete Surgical Resection|Cavity Boost Radiation Therapy vs. Observation in Cerebral Metastases After Complete Surgical Resection|Not yet recruiting||Phase 2/Phase 3|108|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||Undecided||2017-10-10 21:51:07.262205|2017-10-10 21:51:07.262205
NCT02887638|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-29|||November 2016||2016-11-01|August 2016|2016-08-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|PRA||Headache Analysis and Intervention|Posture-related Headache: Profile Analysis and Intervention|Not yet recruiting||N/A|152|Anticipated|Hasselt University||2|||f||||f||||||||Undecided||2017-10-10 21:51:07.360992|2017-10-10 21:51:07.360992
NCT02887625|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-29|||February 2015||2015-02-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM|Efficacy and Durability of Glucagon Like Peptide 1 Receptor Agonists (GLP-1 RA)/Thiazolidinedione Versus Basal Bolus Insulin Therapy in Poorly Controlled Type 2 Diabetic Patients (T2DM) Patients on Sulfonylurea Plus Metformin|Recruiting||N/A|410|Anticipated|Hamad Medical Corporation||2|||f||||f||||||||No||2017-10-10 21:51:07.462942|2017-10-10 21:51:07.462942
NCT02887612|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2017-06-12|||September 2016||2016-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||ctDNA for Prediction of Relapse in Gastric Cancer|A Prospective Study of Blood Circulating Tumor DNA for the Prediction of Postoperative Relapse in Early and Intermediate-Stage Gastric Cancer|Recruiting||N/A|200|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     Blood   "|Undecided||2017-10-10 21:51:07.563076|2017-10-10 21:51:07.563076
NCT02887599|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities||Recruiting||N/A|200|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 21:51:07.662307|2017-10-10 21:51:07.662307
NCT02887586|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-01|||August 2016||2016-08-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effectiveness and Mechanism Study of Auricular Needling in Treating Cancer Induced Anorexia|The Effectiveness and Mechanism Study of Auricular Needling in Treating Cancer Induced Anorexia|Not yet recruiting||N/A|60|Anticipated|Xiyuan Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||Undecided||2017-10-10 21:51:07.745646|2017-10-10 21:51:07.745646
NCT02887573|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2017-02-04|||January 2014||2014-01-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Free-residue Nutrients for the Bowel Preparation of Colon Capsule Endoscopy|Free-residue Nutrients for the Bowel Preparation of Colon Capsule Endoscopy|Active, not recruiting||Phase 4|62|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||f||||||||Undecided||2017-10-10 21:51:07.851868|2017-10-10 21:51:07.851868
NCT02887560|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-09-16|||July 2016||2016-07-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ETO VD PERIOP||Comparison by Transoesophageal Assessement of Systolic Right Ventricle Function Measures in Perioperative Care of Pulmonary Transplant.|Comparison by Transoesophageal Assessement of Systolic Right Ventricle Function Measures in Perioperative Care of Pulmonary Transplant.|Recruiting||N/A|33|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||No||2017-10-10 21:51:07.964931|2017-10-10 21:51:07.964931
NCT02887547|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-08-30|||August 2016||2016-08-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Cytokine Evaluation of Accelerated Tooth Movement|Cytokine Expression in Gingival Crevicular Fluid and Accelerated Tooth Movement|Active, not recruiting||N/A|25|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 21:51:08.04365|2017-10-10 21:51:08.04365
NCT02887534|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-29|||November 2016||2016-11-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain|A Randomized, Double-blind, Active and Placebo-controlled, Study of SPARC1401 in Subjects With Moderate to Severe Acute Low Back Pain|Not yet recruiting||Phase 2|400|Anticipated|Sun Pharma Advanced Research Company Limited||5|||f||||f||||||||No||2017-10-10 21:51:08.119776|2017-10-10 21:51:08.119776
NCT02887521|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-30|2017-09-29|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Pulmonary Rehabilitation Before Lung Cancer Resection|Pulmonary Rehabilitation Before Lung Cancer Resection|Recruiting||Phase 3|194|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t|f|f||||||||2017-10-10 21:51:08.222518|2017-10-10 21:51:08.222518
NCT02887508|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-29|||December 2010||2010-12-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|HINTS||HIV Internet Sex Study: Internet-based STI/HIV Prevention for HIV+ Internet Users|Internet-based STI/HIV Prevention for HIV+ Internet Users|Completed||N/A|170|Actual|University of Connecticut||2|||f||||t||||||||No||2017-10-10 21:51:08.340521|2017-10-10 21:51:08.340521
NCT02887495|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-08-29|||July 2014||2014-07-01|August 2016|2016-08-01||||July 2024|Anticipated|2024-07-01||Observational|||The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)||Recruiting||N/A|600|Anticipated|George Washington University|||1||f||||f||||||||||2017-10-10 21:51:08.40879|2017-10-10 21:51:08.40879
NCT02887482|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-06-13|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of GLS-5700 in Dengue Virus Seropositive Adults|Phase I, Placebo-Controlled, Double-Blind Study To Evaluate The Safety, Tolerability, AND Immunogenicity Of GLS-5700, Administered ID Followed By Electroporation In Dengue Virus-Seropositive Adults|Active, not recruiting||Phase 1|160|Anticipated|GeneOne Life Science, Inc.||2|||f||||t||||||||No||2017-10-10 21:51:08.478895|2017-10-10 21:51:08.478895
NCT02887469|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-07-10|||August 2016||2016-08-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy and Safety of Rapid Intermittent Compared With Slow Continuous Correction in Severe Hyponatremia Patients|Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction With Hypertonic Saline in Patient With Moderately Severe or Severe Symptomatic Severe Hyponatremia (SALSA Trial)|Recruiting||Phase 4|178|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 21:51:08.561052|2017-10-10 21:51:08.561052
NCT02887456|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-08-08|||September 2016||2016-09-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Endodontic Treatment of Primary Teeth Using Mineral Trioxide Aggregate Paste|Endodontic Treatment of Primary Teeth Using Mineral Trioxide Aggregate Paste - Protocol of a Phase 2 Randomized Clinical Trial|Completed||Phase 2|39|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 21:51:08.667417|2017-10-10 21:51:08.667417
NCT02887443|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-10-04|||September 2016||2016-09-01|October 2017|2017-10-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study to Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate|An Open-label Study to Assess the Potential for Pre-systemic Inhibition of Cytochrome P450 3A4 (CYP3A) by Idebenone in Healthy Male Subjects Using Midazolam as a Substrate|Completed||Phase 1|32|Actual|Santhera Pharmaceuticals||1|||f||||||||||||||2017-10-10 21:51:08.742917|2017-10-10 21:51:08.742917
NCT02887430|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-06|||September 2016||2016-09-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Interventional|||Foot Reflexology Therapy and Non-specific Low Back Pain|The Effect of Foot Reflexology Therapy on Pain Intensity and Health-related Quality of Life in People With Non-specific Low Back Pain|Not yet recruiting||Early Phase 1|100|Anticipated|Universiti Sultan Zainal Abidin||2|||f||||f||||||||Undecided||2017-10-10 21:51:08.812133|2017-10-10 21:51:08.812133
NCT02887417|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-07-31|||January 2016||2016-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|GPAS||Glioblastoma Platelet Activation Study||Completed||N/A|21|Actual|University Medicine Greifswald|||2||f||||f||||||Samples With DNA|"     blood   "|||2017-10-10 21:51:08.871409|2017-10-10 21:51:08.871409
NCT02887391|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-29|||January 2016||2016-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Comparing Nutritional Status of In-centre Nocturnal Hemodialysis Patients to Conventional Hemodialysis Patients|Comparing Nutritional Status of In-centre Nocturnal Hemodialysis Patients to Conventional Hemodialysis Patients: A Prospective Cohort Study|Enrolling by invitation||N/A|20|Anticipated|University of Calgary|||2||f||||f||||||||Undecided|Individual participant data will not be shared|2017-10-10 21:51:09.061696|2017-10-10 21:51:09.061696
NCT02887378|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-11-29|||September 2014||2014-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|PincesChaude||Protocol for Anatomopathologic Analysis of Biopsies Using Hot Clamps|Protocol for Anatomopathologic Analysis of Biopsies Using Hot Clamps|Completed||N/A|46|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 21:51:09.14288|2017-10-10 21:51:09.14288
NCT02887365|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-09-05|||September 2014||2014-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer|A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II Microsatellite-Stable or Low-Level Microsatellite-Instability Colon Cancer|Recruiting||Phase 4|300|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 21:51:09.211456|2017-10-10 21:51:09.211456
NCT02887352|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-02-07|||March 2014||2014-03-01|February 2017|2017-02-01||||May 2018|Anticipated|2018-05-01||Observational|E3C-DIFSEP||French Adaptation of the California Card Sorting Task (CCST) in Multiple Sclerosis|French Adaptation of the CCST (California Card Sorting Task). Comparison of 3 Packages to CCST With Multiple Sclerosis (MS) Patients|Recruiting||N/A|48|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:51:09.28277|2017-10-10 21:51:09.28277
NCT02887339|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-01-25|||March 2013||2013-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|ELSI||Ethical, Legal, and Social Issues Substudy in Relation to the GTEx Project|Ethical, Legal, and Social Issues Substudy in Relation to the Genotype-Tissue Expression Project|Active, not recruiting||N/A|512|Actual|Temple University||2|||f||||f||||||||No||2017-10-10 21:51:09.337524|2017-10-10 21:51:09.337524
NCT02887326|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-01|||September 2016||2016-09-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Keratoconus - Biomarkers and Questionnaire|Keratoconus - Biomarkers and Questionnaire|Not yet recruiting||N/A|287|Anticipated|University of Aarhus|||7||f||||t||||||Samples With DNA|"     Tear fluid, saliva and blood.   "|No||2017-10-10 21:51:09.414701|2017-10-10 21:51:09.414701
NCT02887313|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-08-29|||July 2016||2016-07-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|July 2018|Anticipated|2018-07-01||Interventional|FOTAC||FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Single Arm Phase II Study|Totally Neoadjuvant Chemoradiation Therapy With mFOLFOX6 in Locally Advanced Rectal Cancer: A Single Arm Phase II Study|Recruiting||Phase 2|50|Anticipated|Sun Yat-sen University||1|||f||||f||||||||Yes||2017-10-10 21:51:09.469771|2017-10-10 21:51:09.469771
NCT02887300|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-02-13|||January 31, 2017|Actual|2017-01-31|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 23, 2017|Anticipated|2017-06-23||Interventional|||Mantra Meditation to Reduce Emotional Exhaustion in Emergency Department Staff|Feasibility Pilot Study to Examine the Role of Mantra Meditation at Reducing Burn Out and Emotional Exhaustion in Emergency Department Staff|Active, not recruiting||N/A|58|Actual|St. James's Hospital, Ireland||2|||f||||t|f|f||||||Yes|Patient identity will be coded by a designated data controller from the Wellcome/Health Research Board Clinical Research Facility, St James' Hospital. Therefore, only individual participant data in the form of coded data will be shared via academic publications only.|2017-10-10 21:51:09.546723|2017-10-10 21:51:09.546723
NCT02887287|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-01|||July 2013||2013-07-01|August 2016|2016-08-01||||October 2015|Actual|2015-10-01||Observational|||Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease||Completed||N/A|48|Actual|Sun Yat-sen University|||1||f||||||||||||||2017-10-10 21:51:09.628568|2017-10-10 21:51:09.628568
NCT02887274|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-29|||July 2013||2013-07-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SIRCSS||Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis|Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis|Recruiting||N/A|300|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||Samples Without DNA|"     Serum immunological biomarkers including cytokines, blood cell counts, and biochemistry     profiles.   "|Undecided||2017-10-10 21:51:09.680558|2017-10-10 21:51:09.680558
NCT02887261|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-08-29|||May 2016||2016-05-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BPIP||"Study on Indications of Bard PowerPort Isp Implantable Port"|"Study on Indications of Bard PowerPort Isp Implantable Port: Image Accuracy in Resectable Esophageal Cancer Patients"|Enrolling by invitation||N/A|128|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||Yes||2017-10-10 21:51:11.66605|2017-10-10 21:51:11.66605
NCT02887248|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-04-18|||January 12, 2017|Actual|2017-01-12|April 2017|2017-04-01|December 30, 2019|Anticipated|2019-12-30|December 20, 2018|Anticipated|2018-12-20||Interventional|||Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma|Phase II Study of Nanoparticle Albumin-bound Paclitaxel Plus Gemcitabine as First-line Therapy for the Treatment of Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma|Recruiting||Phase 2|55|Anticipated|SCRI Development Innovations, LLC||1|||f||||f|t|f|||f|||||2017-10-10 21:51:11.785244|2017-10-10 21:51:11.785244
NCT02887235|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-27|||March 2016||2016-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer|Food as Medicine: A Phase III Randomized Controlled Trial of Home Delivered, Medically Tailored Meals (HDMTM) on Quality of Life in Metastatic Lung and Non-colorectal GI Cancer Patients|Recruiting||N/A|180|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:51:11.888531|2017-10-10 21:51:11.888531
NCT02887222|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-05-23|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor-3|Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 5 ml of Bupivacaine 0.125% Plus Fentanyl 2 mcg/ml|Completed||N/A|40|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||6|||f||||f||||||||No||2017-10-10 21:51:11.968157|2017-10-10 21:51:11.968157
NCT02887196|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-03-14|||December 2016||2016-12-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|CARE||Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment|Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment|Recruiting||N/A|25|Anticipated|Pennington Biomedical Research Center|||1||f||||f||||||Samples Without DNA|"     Plasma and serum will be stored for future research   "|Undecided||2017-10-10 21:51:12.164572|2017-10-10 21:51:12.164572
NCT02887183|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-07-26|||October 25, 2016|Actual|2016-10-25|July 2017|2017-07-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|PROVE-HF||Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.|A 52 Week, Open Label Evaluation of the Effects of Sacubitril/Valsartan (LCZ696) Therapy on Biomarkers, Myocardial Remodeling and Patient-reported Outcomes in Heart Failure With Reduced Left Ventricular Ejection Fraction.|Recruiting||Phase 4|830|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 21:51:12.240366|2017-10-10 21:51:12.240366
NCT02887170|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-28|||January 1994||1994-01-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||The 10-years REPEATERS Cohort of French Adolescents|Recurrence of Suicide Attempt in Adolescents Lost to Contact Early by Clinicians : The 10-years REPEATERS Cohort of French Adolescents|Recruiting||N/A|246|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||Yes|open to partnership|2017-10-10 21:51:12.457879|2017-10-10 21:51:12.457879
NCT02887157|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-06-30|||March 2016||2016-03-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Analyzing Retinal Microanatomy in ROP|Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care|Recruiting||N/A|160|Anticipated|Duke University|||3||f||||t||||||Samples Without DNA|"     Serum or plasma will be collected from scavenged blood (residual in the laboratory) collected     as part of clinically indicated care. These samples will undergo neuroinflammatory biomarker     testing to identify central nervous system cellular injury.   "|||2017-10-10 21:51:12.560405|2017-10-10 21:51:12.560405
NCT02887144|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-08-29|||January 2016||2016-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|CP257||Investigating the Safety and Performance of SenSura Test Product in Subjects With Ileostomy|Investigating the Safety and Performance of SenSura Test Product in Subjects With Ileostomy|Completed||N/A|72|Actual|Coloplast A/S||2|||f||||f||||||||No||2017-10-10 21:51:12.697926|2017-10-10 21:51:12.697926
NCT02887131|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-09-02|||November 2011||2011-11-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|IDIS||Dynamic Imaging of the Subtalar Instability|Evaluation of Dynamic Computed Tomography Anatomy of Ankle in Inversion / Eversion Mouvement in Subtalar Instability.|Completed||N/A|60|Actual|Central Hospital, Nancy, France||3|||f||||f||||||||No||2017-10-10 21:51:12.776019|2017-10-10 21:51:12.776019
NCT02887118|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-31|||December 2015||2015-12-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|DREPADENSE||Dense Red Blood Cells in Sickle Cell Children|Quantitative and Prognostic Evaluation of Dense Red Blood Cells in Sickle Cell Children: Single-center Study From the Creteil (France) Pediatric Cohort|Active, not recruiting||N/A|100|Anticipated|Centre Hospitalier Intercommunal Creteil|||1||f||||f||||||Samples Without DNA|"     blood samples to study dense red blood cells   "|||2017-10-10 21:51:12.86516|2017-10-10 21:51:12.86516
NCT02887105|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-07|||December 2012||2012-12-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|MEMOIRE ET EMO||Memory and Emotion in Acute and Chronic Phases of Cerebrovascular Accident|Memory and Emotion in Acute and Chronic Phases of Cerebrovascular Accident|Completed||N/A|76|Actual|Central Hospital, Nancy, France|||1||f||||f||||||||||2017-10-10 21:51:12.964029|2017-10-10 21:51:12.964029
NCT02887092|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-29|||April 2007||2007-04-01|August 2016|2016-08-01|March 2011|Actual|2011-03-01|March 2009|Actual|2009-03-01||Observational|PRO-ART||Determinants of Functional Ability, Perceived Health, and Interaction With Multimorbidity in Hip and Knee Osteoarthritis|Determinants of Functional Ability and Perceived Health, and Interaction With Multimorbidity in Hip and Knee Osteoarthritis|Completed||N/A|881|Actual|Central Hospital, Nancy, France|||1||f||||t||||||||Yes||2017-10-10 21:51:13.075792|2017-10-10 21:51:13.075792
NCT02887079|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-29|||January 2014||2014-01-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|EMBOL-EI||Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis|Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis|Recruiting||N/A|200|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||Samples Without DNA|"     serum and plasma   "|||2017-10-10 21:51:13.143989|2017-10-10 21:51:13.143989
NCT02887066|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-06|||September 2014||2014-09-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|CHEST||Observatory on Emergency Care for Acute Coronary Syndrome in Grand Est of France|Observatory on Emergency Care for Acute Coronary Syndrome in Grand Est of France|Active, not recruiting||N/A|580|Actual|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 21:51:13.225745|2017-10-10 21:51:13.225745
NCT02887053|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-09-14|||November 2008||2008-11-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|METHODO||Methodological Developments for Magnetic Resonance Imaging (MRI)||Recruiting||N/A|1650|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:51:13.293799|2017-10-10 21:51:13.293799
NCT02887040|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-26|||June 1, 2018|Anticipated|2018-06-01|August 2017|2017-08-01|June 2023|Anticipated|2023-06-01|June 2021|Anticipated|2021-06-01||Interventional|DIPG||Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma|A Randomized Phase 3 Study of Combination Antineoplaston Therapy [Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal)] Plus Radiation Therapy vs. Radiation Therapy Only in Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem Glioma|Not yet recruiting||Phase 3|92|Anticipated|Burzynski Research Institute||2|||f||||t|t|f||||||||2017-10-10 21:51:13.38075|2017-10-10 21:51:13.38075
NCT02887027|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-07-12|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Exercise, Mood and Stress Study|Developing an Ecological Momentary Exercise Intervention: Open Trial With Patients|Completed||Phase 1|4|Actual|Boston University Charles River Campus||3|||f||||f||||||||||2017-10-10 21:51:13.469331|2017-10-10 21:51:13.469331
NCT02887014|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-09-11|||October 2016||2016-10-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Specific Verbal vs. Usual Instructions for Inpatients Undergoing Colonoscopy|Providing Specific Verbal Instructions Improves Bowel Preparation of Inpatients Undergoing Colonoscopy: a Multi-center Single Blinded Randomized Study|Not yet recruiting||N/A|300|Anticipated|Attikon Hospital||2|||f||||f||||||||||2017-10-10 21:51:13.547303|2017-10-10 21:51:13.547303
NCT02887001|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-29|||June 2011||2011-06-01|July 2016|2016-07-01||||July 2012|Actual|2012-07-01||Interventional|ImpactPharma||Impact of Clinical Pharmacist on the Quality and Cost of the Therapeutic Management of Patients in Two Medical Services of a Teaching Hospital||Completed||N/A|500|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 21:51:13.64291|2017-10-10 21:51:13.64291
NCT02886988|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-01-24|||October 2016||2016-10-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Postoperative Prevention and Treatment of Median Sternotomy Scars With Botulinum Toxin Type A Injection|A Randomized, Placebo-Controlled, Double-Blind, Prospective Clinical Trial of Botulinum Toxin Type A in Prevention of Hypertrophic Scar Development in Median Sternotomy Wound|Recruiting||Phase 2/Phase 3|20|Anticipated|Xijing Hospital||2|||f||||t||||||||No||2017-10-10 21:51:13.710436|2017-10-10 21:51:13.710436
NCT02886975|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-26|||August 2016||2016-08-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Effects of Low Protein Diet in Preventing the Progression of Chronic Kidney Disease(CKD)---a Prospective Study|Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease(CKD)|Recruiting||N/A|100|Anticipated|The Third Xiangya Hospital of Central South University||1|||f||||t||||||||Yes|During the experiment, investigators will share the development in the website.|2017-10-10 21:51:13.810832|2017-10-10 21:51:13.810832
NCT02886962|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-07|||July 12, 2017|Actual|2017-07-12|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|AVKDIAL||Oral Anticoagulation in Haemodialysis Patients|Study of the Benefit / Risk Ratio of Oral Anticoagulation in Hemodialysis Patients With Atrial Fibrillation|Recruiting||Phase 4|855|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||||2017-10-10 21:51:13.915992|2017-10-10 21:51:13.915992
NCT02886949|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-08-26|||November 2011||2011-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Association Between Autoimmune or Inflammation and Thyroid Disease|The Relationship of Vascular Cell Adhesion Molecule 1, C-reactive Protein, Brain-derived Neurotrophic Factor, Orexin and Depressive Symptoms in the Subjects With Thyroid Disease|Recruiting||N/A|500|Anticipated|Taichung Veterans General Hospital|||1||f||||f||||||Samples With DNA|"     Blood samples and urine samples   "|No||2017-10-10 21:51:14.164744|2017-10-10 21:51:14.164744
NCT02886936|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||September 2015||2015-09-01|August 2016|2016-08-01||||September 2017|Anticipated|2017-09-01||Interventional|||Immediate Fit Using Innovative Technology Transtibial Prosthesis|Immediate Fit Using Innovative Technology Transtibial Prosthesis|Recruiting||N/A|30|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 21:51:14.254925|2017-10-10 21:51:14.254925
NCT02886923|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-04-21|||August 1, 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:51:14.341565|2017-10-10 21:51:14.341565
NCT02886910|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-29|||October 2016||2016-10-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|October 2019|Anticipated|2019-10-01||Interventional|CHORIS-RCT||Chorioamnionitis: Observation of at Risk Infants vs Standard Care|Chorioamnionitis: Observation of at Risk Infants vs Standard Care. Randomized Controlled Trial.|Not yet recruiting||N/A|1100|Anticipated|IRCCS Burlo Garofolo||2|||f||||f||||||||No||2017-10-10 21:51:14.384878|2017-10-10 21:51:14.384878
NCT02886897|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2016-08-26|||July 2016||2016-07-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors|A Phase II Study of Combinations of Dendritic Cells and Cytokine-induced Killer Cell （D-CIK) Immunotherapy And Anti-Programmed Death-1 In Refractory Solid Tumors|Recruiting||Phase 1/Phase 2|50|Anticipated|Sun Yat-sen University||1|||f||||f||||||||Undecided||2017-10-10 21:51:14.494368|2017-10-10 21:51:14.494368
NCT02886884|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-07-28|||July 26, 2017|Actual|2017-07-26|July 2017|2017-07-01|September 2024|Anticipated|2024-09-01|September 2023|Anticipated|2023-09-01||Interventional|ACESO||Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects|A Phase I/II Trial to Evaluate the Safety and Efficacy of Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Miami||2|||f||||t|t|f||||||||2017-10-10 21:51:14.612085|2017-10-10 21:51:14.612085
NCT02886871|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-01-12|||August 2016||2016-08-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Interventional|||CalFitness Smartphone-Delivered Physical Activity Intervention|Mobile Phone-Based Physical Activity Intervention on University Staff|Active, not recruiting||N/A|64|Actual|University of California, Berkeley||2|||f||||||||||||||2017-10-10 21:51:14.716417|2017-10-10 21:51:14.716417
NCT02886858|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-12|||February 13, 2017|Actual|2017-02-13|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||tDCS in the Prevention of Relapse After Electroconvulsive Therapy|tDCS as Continuation Treatment to Sustain Remission After Electroconvulsive Therapy in Depression|Recruiting||N/A|40|Anticipated|Hôpital le Vinatier||2|||f||||t|f|f||||||||2017-10-10 21:51:14.796076|2017-10-10 21:51:14.796076
NCT02886845|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Observational|||Genotyping 2 SNPs in Chinese Breast Cancers|Study of Two Single Nucleotide Polymorphisms in Chinese Breast Cancers|Recruiting||N/A|2000|Anticipated|The First Affiliated Hospital of the Fourth Military Medical University|||2||f||||f||||||Samples With DNA|"     whole blood   "|No||2017-10-10 21:51:14.889898|2017-10-10 21:51:14.889898
NCT02886832|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Evaluate the Effects of a Prostate Health Formulation|A Pilot, Open-label Study to Evaluate the Effects of a Prostate Health Formulation on Scores Attained From the International Prostate Symptom Score (I-PSS) Questionnaire Among Overall Healthy Male Participants Who Report Lower Urinary Tract Complaints|Recruiting||N/A|30|Anticipated|Supplement Formulators, Inc.||1|||f||||f||||||||No||2017-10-10 21:51:14.988557|2017-10-10 21:51:14.988557
NCT02886819|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-12-19|||May 2016||2016-05-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|WBV-IMR||Whole-body Vibration Induces a Short or Long Latency Muscular Reflex|Whole-body Vibration Induces a Short or Long Latency Muscular Reflex Depending on Vibration Intensity|Completed||N/A|11|Actual|Bagcilar Training and Research Hospital||1|||f||||f||||||||No||2017-10-10 21:51:15.140698|2017-10-10 21:51:15.140698
NCT02886806|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-01-03|||October 2016||2016-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Fully Automated Anesthesia, Analgesia and Fluid Management|Fully Automated Anesthesia, Analgesia and Fluid Management Using Multiple Physiologic Closed-Loop Systems in High-Risk Vascular Surgery: a Pilot Study|Completed||Phase 1|13|Actual|Erasme University Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:51:15.208262|2017-10-10 21:51:15.208262
NCT02886793|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||June 2016||2016-06-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PROCLAIM||Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects|Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||No||2017-10-10 21:51:15.328031|2017-10-10 21:51:15.328031
NCT02886780|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-01|||September 2016||2016-09-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|October 2017|Anticipated|2017-10-01||Interventional|||"Concentrated Exposure Treatment (cET) for for Obsessive Compulsive Disorder"|Concentrated Exposure Treatment (cET) for Obsessive Compulsive Disorder (OCD). A Randomized Controlled Trial (RCT)|Not yet recruiting||N/A|48|Anticipated|Haukeland University Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:51:15.414034|2017-10-10 21:51:15.414034
NCT02886754|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2017-07-24|||September 14, 2016|Actual|2016-09-14|July 2017|2017-07-01|September 16, 2016|Actual|2016-09-16|September 16, 2016|Actual|2016-09-16||Interventional|||Proficiency-Based Progression Training for Clinical Communication|The Effect of a Proficiency Based Progression Training Programme for Clinical Communication on ISBAR Performance|Completed||N/A|77|Actual|University College Cork||3|||f||||f||||||||||2017-10-10 21:51:15.595043|2017-10-10 21:51:15.595043
NCT02886741|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||February 2012||2012-02-01|August 2016|2016-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Ten-state Cluster-randomized Controlled Trial of the Institute for Health Improvement's Project JOINTS|Evaluation of a Multi-modal Network to Spread an Enhanced SSI Prevention Bundle|Completed||N/A|549|Actual|RAND||2|||f||||f||||||||No|Aggregate data provided upon request|2017-10-10 21:51:15.711807|2017-10-10 21:51:15.711807
NCT02886728|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-09-22|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|February 2020|Anticipated|2020-02-01||Interventional|||Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy|A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination With Methotrexate (MTX) to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Are Naïve to MTX Therapy|Recruiting||Phase 3|1200|Anticipated|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 21:51:15.8166|2017-10-10 21:51:15.8166
NCT02886715|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-08|||August 2016||2016-08-01|August 2017|2017-08-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Interventional|||A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris|A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris|Completed||Phase 3|1110|Actual|Fougera Pharmaceuticals Inc.||3|||f||||f||||||||||2017-10-10 21:51:16.370236|2017-10-10 21:51:16.370236
NCT02886702|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-08|||August 2016||2016-08-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis|A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both Active Treatments to a Vehicle Control in the Treatment of Stable Plaque Psoriasis|Completed||Phase 3|855|Actual|Fougera Pharmaceuticals Inc.||3|||f||||f||||||||||2017-10-10 21:51:16.520444|2017-10-10 21:51:16.520444
NCT02886689|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-29|||January 2007||2007-01-01|August 2016|2016-08-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Observational|||C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France|C.O.R.P.U.S. : Observational Cohort of Active Rheumatoid Arthritis, Spondylarthropathy and Idiopathic Juvenile Arthritis in France|Completed||N/A|5400|Actual|Central Hospital, Nancy, France|||2||f||||t||||||||Yes|open to partnership|2017-10-10 21:51:16.701051|2017-10-10 21:51:16.701051
NCT02886676|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-08-31|||May 2015||2015-05-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Arthrospira Platensis (Spirulina) as an Adjunct to Scaling and Root Planing on Salivary Antioxidant Levels in Chronic Periodontitis Subjects||Completed||Phase 4|70|Actual|Tatyasaheb Kore Dental College||2|||f||||||||||||||2017-10-10 21:51:16.805706|2017-10-10 21:51:16.805706
NCT02886663|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-02-06|||December 13, 2016|Actual|2016-12-13|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 13, 2018|Anticipated|2018-06-13||Interventional|REVOIR||Visual Field Restoration in Patients With Post-stroke Homonymous Hemianopsia|Visual Field Restoration in Patients With Post-stroke Homonymous Hemianopsia|Recruiting||N/A|104|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 21:51:16.886697|2017-10-10 21:51:16.886697
NCT02886650|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-01|||December 2015||2015-12-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Interventional|COAG||Impact of Thermocoagulation During Invasive EEG Monitoring in Children With Focal Drug-resistant Epilepsies||Recruiting||N/A|||Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 21:51:16.97777|2017-10-10 21:51:16.97777
NCT02886637|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-08-31|||July 2015||2015-07-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Effects of Immune Function on Prognositic Outcome in Critical Ill Patients With Acinetobacter Baumannii Infection|Effects of Immune Function on Prognositic Outcome in Critical Ill Patients With Acinetobacter Baumannii Infection|Completed||N/A|40|Actual|Southeast University, China|||1||f||||f||||||||Yes|we would like to share our data. Someone who need data can contact us with Email.|2017-10-10 21:51:17.116851|2017-10-10 21:51:17.116851
NCT02886624|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-07-11|||May 24, 2017|Actual|2017-05-24|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SAHIV||Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4 in HIV-infected Patients|Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4 in HIV-infected Patients: Efficacy and Tolerability of Grazoprevir 100mg/Elbasvir 50mg During 8 Weeks|Recruiting||Phase 2|50|Anticipated|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba||1|||f||||t|f|f||||||||2017-10-10 21:51:17.189637|2017-10-10 21:51:17.189637
NCT02886611|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-02-06|||December 15, 2015|Actual|2015-12-15|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 15, 2019|Anticipated|2019-12-15||Observational|SILOG||Limbal Stem Cell Deficiency of Genetic Origin: Genotype-phenotype Correlation||Recruiting||N/A|60|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:51:17.330569|2017-10-10 21:51:17.330569
NCT02886585|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-08-28|||October 2016||2016-10-01|August 2017|2017-08-01|January 2024|Anticipated|2024-01-01|April 2020|Anticipated|2020-04-01||Interventional|||Pembrolizumab In Central Nervous System Metastases|Phase II Trial of Pembrolizumab in Central Nervous System Metastases From Multiple Histologies|Recruiting||Phase 2|102|Anticipated|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-10 21:51:17.481952|2017-10-10 21:51:17.481952
NCT02886559|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-01|||June 2016||2016-06-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Chidamide Plus DCAG for Relapsed/Refractory AML||Recruiting||Phase 1/Phase 2|100|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||Yes||2017-10-10 21:51:17.742215|2017-10-10 21:51:17.742215
NCT02886546|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-09-10|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy||Not yet recruiting||N/A|42|Anticipated|Hallym University Kangnam Sacred Heart Hospital||1|||f||||||||||||||2017-10-10 21:51:17.837313|2017-10-10 21:51:17.837313
NCT02886533|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-02-14|||January 1, 2013||2013-01-01|February 2017|2017-02-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|SACHA||Major Bleeding Risk Associated With Antithrombotics|Major Bleeding Risk Associated With Antithrombotics : The SACHA (Surveillance Des Accidents Hémorragiques Graves Sous Antithrombotiques) Study|Completed||N/A|6484|Actual|Rennes University Hospital|||1||f||||f||||||||No||2017-10-10 21:51:17.913739|2017-10-10 21:51:17.913739
NCT02886520|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2016-09-01|||April 2016||2016-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Comparative Study of PDVF and Polypropylene Transobturator Suburethral Tapes|Multicentric Randomized Clinical Trial Comparing Polyvinylidene Fluoride and Polypropylene Transobturator Suburethral Tapes in the Treatment of Female Stress Urinary Incontinence.|Recruiting||Phase 4|282|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||No||2017-10-10 21:51:18.033445|2017-10-10 21:51:18.033445
NCT02886507|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||March 2012||2012-03-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects of NSK-SD (Nattokinase) on Blood Pressure|Effects of NSK-SD (Nattokinase) on Blood Pressure. A Randomized, Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 4|79|Actual|Natural Immune Systems Inc||2|||f||||f||||||||Yes|Manuscript publication.|2017-10-10 21:51:18.211559|2017-10-10 21:51:18.211559
NCT02886494|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-04-05|||December 2016||2016-12-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia|A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia|Recruiting||Phase 2|60|Anticipated|Charsire Biotechnology Corp.||2|||f||||f||||||||Undecided||2017-10-10 21:51:18.299013|2017-10-10 21:51:18.299013
NCT02886481|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-11-29|||January 2014||2014-01-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|NERLICORDE||Electrophysiologic Study of Perioperative Monitoring of the Recurrent Laryngeal Nerve: Impaired Vocal Cord Movement After Thyroidectomy|Electrophysiologic Study of Perioperative Monitoring of the Recurrent Laryngeal Nerve: Impaired Vocal Cord Movement After Thyroidectomy|Completed||N/A|133|Actual|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||||||2017-10-10 21:51:18.425704|2017-10-10 21:51:18.425704
NCT02886468|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-29|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DEEP||DEpth of EPinephrine Delivery With Auto-injectors Devices|Determinants of Muscle - Skin Distance at the Injection Site in Patients With an Indication for the Use of Epinephrine Auto- Injector Pens|Recruiting||N/A|100|Anticipated|Centre Hospitalier Régional Metz-Thionville||1|||f||||t||||||||||2017-10-10 21:51:18.505541|2017-10-10 21:51:18.505541
NCT02886455|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-10-12|||September 2016||2016-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluation of the Influence of Output on Skin Covered by Newly Developed Adhesives||Completed||N/A|4|Actual|Coloplast A/S||1|||f||||f||||||||||2017-10-10 21:51:18.583735|2017-10-10 21:51:18.583735
NCT02886442|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-10-12|||August 2016||2016-08-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Pilot Evaluation of Adhesives and How They Are Impacted by Output||Completed||N/A|4|Actual|Coloplast A/S||1|||f||||f||||||||||2017-10-10 21:51:18.660315|2017-10-10 21:51:18.660315
NCT02886429|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-27|2017-07-22|||August 2016||2016-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Post- Thoracotomy Paravertebral Block|Safety and Efficacy of Ultrasound Guided Paravertebral Dexmedetomidine for Postoperative Pain Relief in Video Assisted Thoracoscopy Surgery|Recruiting||Phase 2|60|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 21:51:18.744558|2017-10-10 21:51:18.744558
NCT02886416|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-01|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|"ImmunoCo27"||Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity|Study of Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity, for 27 Years of Natural Evolution and on Treatment|Not yet recruiting||N/A|28|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f||||||Samples With DNA|"     frozen PBMC   "|Yes|Scientific publication|2017-10-10 21:51:18.859749|2017-10-10 21:51:18.859749
NCT02886403|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||November 2015||2015-11-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Evaluation of the Influence of Output on a Newly Develop Adhesive||Completed||N/A|5|Actual|Coloplast A/S||1|||f||||f||||||||||2017-10-10 21:51:18.935731|2017-10-10 21:51:18.935731
NCT02886390|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2016-08-28|||September 2016||2016-09-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|rtPA-RIC||r-tPA Thrombolytic Therapy in Combination With Remote Ischemic Conditioning for Acute Ischemic Stroke Recovery||Not yet recruiting||N/A|60|Anticipated|Capital Medical University||2|||f||||f||||||||||2017-10-10 21:51:19.022282|2017-10-10 21:51:19.022282
NCT02886377|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-26|||November 2013||2013-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|August 2016|Actual|2016-08-01||Observational|||The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset|The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset|Recruiting||N/A|300|Anticipated|Zhongshan Ophthalmic Center, Sun Yet-sen University|||3||f||||t||||||||Undecided||2017-10-10 21:51:19.112101|2017-10-10 21:51:19.112101
NCT02886364|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2017-07-31|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|SCC-Chiapas||Adapted Safe Childbirth Checklist in Chiapas, Mexico|Evaluation of the Adapted Safe Childbirth Checklist and Respectful Care in Rural Community Hospitals and Maternity Centers in Chiapas, Mexico: A Mixed Methods Convergent Intervention Study|Completed||N/A|287|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 21:51:19.330472|2017-10-10 21:51:19.330472
NCT02886351|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2016-08-31|||January 2017||2017-01-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||High-Concentration Nitrous Oxide for Dental Procedural Sedation in Children|High-Concentration Nitrous Oxide for Dental Procedural Sedation in Children|Not yet recruiting||N/A|30|Anticipated|Bnai Zion Medical Center||1|||f||||t||||||||Yes||2017-10-10 21:51:19.437072|2017-10-10 21:51:19.437072
NCT02886338|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-04-25|2016-11-29||September 2016||2016-09-01|June 2016|2016-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study of the Feasibility of Magnetic Navigated Capsule Endoscope in the Upper Gastrointestinal Tract Examination|Study of the Feasibility of Magnetic Navigated Capsule Endoscope in the Upper Gastrointestinal Tract Examination|Completed||N/A|10|Actual|Taipei Medical University WanFang Hospital||1|||f||||f||||||||No||2017-10-10 21:51:19.533164|2017-10-10 21:51:19.533164
NCT02886325|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-26|||September 2016||2016-09-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||A Community Based Approach to Reducing Rural Cancer Disparities|A Community Based Approach to Reducing Rural Cancer Disparities|Not yet recruiting||N/A|60|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 21:51:19.767263|2017-10-10 21:51:19.767263
NCT02886312|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-26|||August 2015||2015-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of Oxygen Delivery Through Nasal Cannula in Volunteers||Completed||N/A|30|Actual|University of Utah|||||f||||||||||||||2017-10-10 21:51:19.923309|2017-10-10 21:51:19.923309
NCT02886299|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-09-01|||October 2013||2013-10-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis|Comparative Study of Effects and Safety of Intermittent Low Dose Therapy of Fenofibrate and Simvastatin on Chronic Hemodialysis Patients|Completed||Phase 4|60|Actual|Cairo University||2|||f||||||||||||||2017-10-10 21:51:20.024426|2017-10-10 21:51:20.024426
NCT02886286|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-31|||May 2016||2016-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain|Randomized, Double Blind, Cross Over Study Comparing Effectiveness of Traditional Opioids Versus Opioids in Admixture With Bupivacaine Upon Self-administration of Boluses Via a Personal Therapy Manager (PTM) in Intrathecal Pumps|Recruiting||Phase 4|17|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 21:51:20.119648|2017-10-10 21:51:20.119648
NCT02886273|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-31|||January 2007||2007-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2010|Actual|2010-12-01|1 Month|Observational [Patient Registry]|DIFAD-SCA||DIagnostics, Fatty Acids and Vitamin D in SCA|DIagnostics, RBC Levels of n-3 Fatty Acids and Serum Vitamin D in Patients With Out-of-Hospital Cardiac Arrest (OHCA)|Active, not recruiting||N/A|77|Actual|Helse Stavanger HF|||4||f||||f||||||Samples Without DNA|"     20 ml of EDTA-blood for preparation of red blood cells and plasma will be harvested during     resuscitation or immediately after return of spontaneous circulation (ROSC) from a peripheral     venous catheter (PVC) or arterial line. After hospital admission blood samples will be     collected from survivors according to general routines at our hospital. For survivors an     extra set of blood samples consisting of 6 ml EDTA-blood, 6 ml citrate-blood and 6 ml serum     will be taken after 8-12 hours and 24-48 hours. After centrifugation, aliquots of each sample     will be immediately frozen and stored at -80 degrees Celcius for later analysis.   "|No||2017-10-10 21:51:20.243254|2017-10-10 21:51:20.243254
NCT02886260|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-29|||September 2012||2012-09-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Observational|KEOPS||Establishing a Descriptive Cohort of Patients Cared for Operation on the Spine||Recruiting||N/A|250|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:51:20.375073|2017-10-10 21:51:20.375073
NCT02886247|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||June 1994||1994-06-01|August 2016|2016-08-01||||June 2018|Anticipated|2018-06-01||Observational|NFPTR||Pancreatic Cancer Registry: For Any Person With a Personal or Family History|National Familial Pancreas Tumor Registry|Recruiting||N/A|12000|Anticipated|Johns Hopkins University|||1||f||||t||||||Samples With DNA|"     blood and saliva   "|||2017-10-10 21:51:20.492207|2017-10-10 21:51:20.492207
NCT02886234|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-28|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|HIP||Health Improvement Project - Providence|Mindfulness Training to Improve ART Adherence and Reduce Risk Behavior Among Persons Living With HIV|Recruiting||N/A|50|Anticipated|The Miriam Hospital||2|||f||||t||||||||||2017-10-10 21:51:20.605295|2017-10-10 21:51:20.605295
NCT02886221|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-26|||May 2010||2010-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|May 2012|Actual|2012-05-01||Interventional|MISHV||Functional and Radiographic Outcomes of Hallux Valgus Correction by Mini-invasive Surgery With Reverdin-Isham Percutaneous Osteotomy|Functional and Radiographic Outcomes of Hallux Valgus Correction by Mini-invasive Surgery With Reverdin-Isham Percutaneous Osteotomy: a Longitudinal Prospective Study With a 48-month Follow-up|Completed||N/A|80|Actual|University of Padua||1|||f||||f||||||||Yes|Age, Gender, Radiological parameters and images.|2017-10-10 21:51:20.757792|2017-10-10 21:51:20.757792
NCT02886208|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-04-27|||July 2016||2016-07-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Health Outcomes of Teens Participating in Summer Employment Immersion Programs|Health Outcomes of Teens Participating in Summer Employment Immersion Programs|Completed||N/A|83|Actual|Indiana University||1|||f||||f||||||||Yes|Data will be published in a medical journal. There is no plan to make individual participant data available.|2017-10-10 21:51:20.878422|2017-10-10 21:51:20.878422
NCT02886195|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|effect||EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC|EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC|Enrolling by invitation||Phase 3|120|Anticipated|Fujian Cancer Hospital||3|||f||||f||||||||Undecided|Depending on the process of the study|2017-10-10 21:51:20.976216|2017-10-10 21:51:20.976216
NCT02886182|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-27|||August 2016||2016-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Observational|||Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB Infection|Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With Chronic Hepatitis B Virus Infection|Recruiting||N/A|200|Anticipated|Beijing Ditan Hospital|||2||f||||f||||||Samples Without DNA|"     Keeping the serum samples frozen at - 80℃low temperature refrigerator preservation to detect     cytokine by high flux liquid chip technology (Luminex)   "|||2017-10-10 21:51:21.064684|2017-10-10 21:51:21.064684
NCT02886169|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-05-08|||March 2016||2016-03-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|September 2016|Actual|2016-09-01||Interventional|ESISOPI||Effectiveness of Sacha Inchi Supplementation on Postprandial Inflammation|Effect of Supplementation of a High-fat Meal With Sacha Inchi Oil on Postprandial Metabolic and Inflammatory Responses in Adults With Low Physical Activity and Without Abdominal Obesity|Active, not recruiting||N/A|42|Actual|Universidad Icesi||2|||f||||f||||||||Yes||2017-10-10 21:51:21.172198|2017-10-10 21:51:21.172198
NCT02886156|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-27|||September 2016||2016-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Effects of CPAP on Cognitive Function, Neurocognitive Architecture and Function in Patients With OSA: The SMOSAT Trial|Effects of Continuous Positive Airway Pressure on Cognitive Function, Neurocognitive Architecture and Function in Patients With Obstructive Sleep Apnea: The Shanghai Multicenter Obstructive Sleep Apnea Therapy Trial|Not yet recruiting||N/A|148|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||2|||f||||t||||||||Yes|Department of Epidemiology, School of Public Health, Shanghai Jiao Tong University|2017-10-10 21:51:21.280321|2017-10-10 21:51:21.280321
NCT02886143|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-28|||October 2015||2015-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Active vs. Passive Voiding Trials on Time to Discharge, Urinary Tract Infection, and Urinary Retention|Effect of Active vs. Passive Voiding Trials on Time to Patient Discharge, Rate of Urinary Tract Infection, and Rate of Urinary Retention: a Randomized, Controlled Clinical Trial|Completed||Phase 3|274|Actual|University of Virginia||2|||f||||f||||||||No||2017-10-10 21:51:21.37881|2017-10-10 21:51:21.37881
NCT02886130|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-04-19|||August 29, 2016|Actual|2016-08-29|April 2017|2017-04-01|December 20, 2016|Actual|2016-12-20|December 20, 2016|Actual|2016-12-20||Interventional|VolleyAGPC||Alpha-GPC and Physical and Cognitive Performances in Volleyball Players.|Effects of Alpha-glycerylphosphorylcholine on Physical and Cognitive Performances in Varsity Volleyball Players|Completed||N/A|28|Actual|Université de Montréal||2|||f||||f||||||||Yes|Individual data obtained from vertical jump assessments and during the cognitive switch task will be communicated to each athlete.|2017-10-10 21:51:21.465988|2017-10-10 21:51:21.465988
NCT02886117|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||October 2014||2014-10-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|HEMOSTASE||Auto-administered Questionnaire by Screening of Disorder of the Haemostasis in Preoperative|Creation and Evaluation of a Auto-administered Questionnaire by Screening of Disorder of the Haemostasis in Preoperative|Completed||N/A|2511|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:51:21.568943|2017-10-10 21:51:21.568943
NCT02886104|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-28|||August 2016||2016-08-01|August 2016|2016-08-01|July 2026|Anticipated|2026-07-01|July 2021|Anticipated|2021-07-01||Interventional|HELARC||Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis|Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis (HELARC) ------ a Randomized Controlled Multicenter Clinical Study|Recruiting||N/A|548|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:51:21.648437|2017-10-10 21:51:21.648437
NCT02886091|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2016-08-31|||August 2014||2014-08-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|KELOIDS SCARS||Observational Study of Keloids Scars Treated by Shaving and Cryosurgery||Recruiting||N/A|25|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:51:21.764099|2017-10-10 21:51:21.764099
NCT02886078|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-06-15|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Dorsal Versus Volar Approach for CapFlex-PIP© Implantation|Dorsal Versus Volar Approach for CapFlex-PIP© Implantation: a Randomized Controlled Trial|Terminated||N/A|3|Actual|Schulthess Klinik||2||Insufficient recruitment|f||||f||||||||No|No plan to share data|2017-10-10 21:51:21.843863|2017-10-10 21:51:21.843863
NCT02886065|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-28|2017-01-18|||November 2016||2016-11-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study of PVX-410, a Cancer Vaccine, and Durvalumab +/- Lenalidomide for Smoldering MM|A Phase 1b Study of PVX-410, a Multi-Peptide Cancer Vaccine, and Durvalumab (Anti-PDL1) With and Without Lenalidomide for Patients With Smoldering Multiple Myeloma|Recruiting||Phase 1|26|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||No||2017-10-10 21:51:21.920739|2017-10-10 21:51:21.920739
NCT02886052|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-09-05|||September 2016||2016-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Internet-based Cognitive Behavior Therapy for Insomnia for Parents Who Have Lost a Child|Therapist Guided Internet Cognitive Behavioral Therapy (ICBT) for Insomnia for Bereaved Parents: a Randomized Controlled Trial (RCT)|Enrolling by invitation||N/A|60|Anticipated|Ersta Sköndal University College||2|||f||||f||||||||No||2017-10-10 21:51:22.027532|2017-10-10 21:51:22.027532
NCT02886039|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-26|||June 2014||2014-06-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|CA-EEG||Predictive Electrophysiological Score of the Neurological Prognosis Post Cardiac Arrest|Predictive Electrophysiological Score of the Neurological Prognosis Post Cardiac Arrest|Recruiting||N/A|400|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Yes||2017-10-10 21:51:22.098196|2017-10-10 21:51:22.098196
NCT02886026|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-08-26|||June 2016||2016-06-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|LaserIII||Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors|Is Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors (LMD-BT) as Good as Conventional Inpatient PDD Guided Transurethral Tumor Resection in Patients With Low Grade Non-invasive (Ta) Bladder Tumors?|Recruiting||N/A|248|Anticipated|University Hospital Bispebjerg and Frederiksberg||2|||f||||t||||||||No||2017-10-10 21:51:22.176704|2017-10-10 21:51:22.176704
NCT02886013|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-08-28|||January 2013||2013-01-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Observational|||FTO rs9939609 and PPARy rs1801282 Polymorphisms in Mexican Adolescents|FTO rs9939609 and PPARy rs1801282 Polymorphisms in Mexican Adolescents With Overweight and Obesity at High Risk for Developing Diabetes|Completed||N/A|71|Actual|Asociación Científica Latina A.C.|||1||f||||f||||||Samples With DNA|"     3 mL of venous blood (Vacutainer tubes) were taken in fasting. A sample remained frozen at     -70°C (900 series Thermo Scientific) until DNA extraction.      Genotyping DNA extraction was performed in the Magna Pure LC 2.0 Instrument (Roche, Germany)     using the MagNA Pure LC DNA Isolation Kit 1 (Roche, Germany).   "|No||2017-10-10 21:51:22.253069|2017-10-10 21:51:22.253069
NCT02885987|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-08-22|||August 3, 2017|Actual|2017-08-03|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Use of Accessory Device AmplifEYE During Average Risk Screening Colonoscopy to Increase Adenoma Detection Rate|Use of Accessory Device AmplifEYE During Average Risk Screening Colonoscopy to Increase Adenoma Detection Rate|Recruiting||N/A|370|Anticipated|Loma Linda University||2|||f||||f|f|t|f||t|||||2017-10-10 21:51:22.331348|2017-10-10 21:51:22.331348
NCT02885974|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-03-10|||December 2016||2016-12-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|July 2018|Anticipated|2018-07-01||Interventional|BLAST||Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer|Pilot Study of Celecoxib Combined With Gemcitabine and Cisplatin for Neoadjuvant Treatment of Localized, Muscle-Invasive Bladder Cancer|Recruiting||Phase 1|15|Anticipated|Baylor College of Medicine||1|||f||||t||||||||No||2017-10-10 21:51:22.436928|2017-10-10 21:51:22.436928
NCT02885961|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-26|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Interventional|||The Coagulation Cascade in Idiopathic Pulmonary Fibrosis|Investigating the Role of the Coagulation Cascade in Idiopathic Pulmonary Fibrosis|Not yet recruiting||N/A|12|Anticipated|University College, London||1|||f||||f||||||||No||2017-10-10 21:51:22.547591|2017-10-10 21:51:22.547591
NCT02885948|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-08-26|||April 2016||2016-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Interventional|NAPRESSIM||The Use of Low Dose Prophylactic Naloxone Infusion to Prevent Respiratory Depression With Intrathecal Morphine.|The NAPRESSIM Trial. The Use of Low Dose Prophylactic Naloxone Infusion to Prevent Respiratory Depression With Intrathecal Morphine.|Recruiting||Phase 4|86|Anticipated|University College Dublin||2|||f||||f||||||||Undecided||2017-10-10 21:51:22.620189|2017-10-10 21:51:22.620189
NCT02885935|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-26|||April 2013||2013-04-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Dairy Macronutrient Effects on the Metabolic Syndrome||Completed||N/A|12|Actual|University of Arkansas||2|||f||||f||||||||||2017-10-10 21:51:22.711242|2017-10-10 21:51:22.711242
NCT02885922|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-12-29|||September 2016||2016-09-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients|The Effects of add-on Anti-diabetic Drugs on Inflammation and Energy Homeostasis in Type 2 Diabetic Patients|Recruiting||N/A|6000|Anticipated|Taichung Veterans General Hospital|||1||f||||f||||||Samples With DNA|"     The genetic studies will be applied for efficacy and adverse effect of anti-diabetic drugs.   "|No|No plan to make individual participant data (IPD) available|2017-10-10 21:51:22.771888|2017-10-10 21:51:22.771888
NCT02885909|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-12-29|||September 2016||2016-09-01|August 2016|2016-08-01|December 2025|Anticipated|2025-12-01|September 2021|Anticipated|2021-09-01||Interventional|||Inpatient Blood Glucose Control in Taichung Veterans General Hospital|The Effects of Glucose Control and Monitor on Inflammation in the Hospitalized Patients With Hyperglycemia|Recruiting||Phase 4|600|Anticipated|Taichung Veterans General Hospital||3|||f||||f||||||||No|No plan to make individual participant data (IPD) available|2017-10-10 21:51:22.850271|2017-10-10 21:51:22.850271
NCT02885896|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-08|||March 2018|Anticipated|2018-03-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|PLATEL-EVAL||Assessing the Impact of a Call Center Providing Standardized Pediatric Advice (PLATEL-EVAL)|Cluster-randomized Controlled Study Evaluating the Impact of a Call Center Providing Standardized Pediatric Advices Based on the Number of Unscheduled and Medically Unjustified Consultations|Not yet recruiting||N/A|1000|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 21:51:22.935|2017-10-10 21:51:22.935
NCT02885883|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-26|||July 2011||2011-07-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|January 2015|Actual|2015-01-01||Interventional|QUAFI||Non-invasive Quantification of Atrial Fibrosis by MRI in Atrial Fibrillation|Non-invasive Quantification of Atrial Fibrosis by MRI in Atrial Fibrillation|Active, not recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-10 21:51:23.007442|2017-10-10 21:51:23.007442
NCT02885870|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-31|||April 2016||2016-04-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|SPINE2||Combination of Multiparametric MRI and Electrophysiology for the Development of New Biomarkers in Spinal Cord Diseases|Combination of Multiparametric MRI and Electrophysiology for the Development of New Biomarkers in Spinal Cord Diseases|Recruiting||N/A|105|Anticipated|Institut de Recherche sur la Moelle épinière et l'Encéphale||2|||f||||f||||||||Undecided||2017-10-10 21:51:23.076232|2017-10-10 21:51:23.076232
NCT02885857|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-08-26|||June 2015||2015-06-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease|Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease|Recruiting||Phase 4|1500|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 21:51:23.154674|2017-10-10 21:51:23.154674
NCT02885844|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-08-26|||September 2014||2014-09-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|SpaceInVision||Effects of Inverted Vision on Pointing and Grasping in Parabolic Flight|Effects of Inverted Vision on Pointing and Grasping in Parabolic Flight|Recruiting||N/A|18|Anticipated|University Hospital, Caen||2|||f||||f||||||||No||2017-10-10 21:51:23.276449|2017-10-10 21:51:23.276449
NCT02885831|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-04-28|||December 8, 2016|Actual|2016-12-08|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|BBH||Early Abduction Splintage on Stable Hips in Infants With Developmental Dysplasia of the Hip|Early Abduction Splintage on Stable Hips in Infants With Developmental Dysplasia of the Hip : Improvement or Overtreatment ?|Recruiting||N/A|90|Anticipated|University Hospital, Brest|||2||f||||f||||||||||2017-10-10 21:51:23.350426|2017-10-10 21:51:23.350426
NCT02885818|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-01-31|||October 2014||2014-10-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|ABATACEPT_B||Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis|Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis|Recruiting||N/A|20|Anticipated|University Hospital, Brest|||1||f||||f||||||Samples Without DNA|"     Serum   "|No||2017-10-10 21:51:23.42984|2017-10-10 21:51:23.42984
NCT02885805|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-26|||June 2015||2015-06-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Sun Protection Factor (SPF) Efficacy Assay|Sun Protection Factor (SPF) Efficacy Assay|Completed||N/A|11|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:51:23.672816|2017-10-10 21:51:23.672816
NCT02885792|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Coronary Artery Disease in Patients Suffering From Schizophrenia|Coronary Artery Disease as a Cause of Morbidity and Mortality in Patients Suffering From Schizophrenia: Epidemiology and Status to Provide Prevention, Interventions and Treatment|Recruiting||N/A|300|Anticipated|Aalborg Universitetshospital||2|||f||||f||||||||No||2017-10-10 21:51:23.777201|2017-10-10 21:51:23.777201
NCT02885779|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-26|||May 2015||2015-05-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ANTATROC||Comparison of 2 Techniques of Invasive Mini Surgery: Coelioscopy Mini-trocar and Monotrocar in the Adnexa no Carcinologic Surgery : Forward-looking Observational Study.|Comparison of 2 Techniques of Invasive Mini Surgery: Coelioscopy Mini-trocar and Monotrocar in the Adnexa no Carcinologic Surgery : Forward-looking Observational Study.|Completed||N/A|16|Actual|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:51:23.95595|2017-10-10 21:51:23.95595
NCT02885766|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-26|||July 2016||2016-07-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene|A Multicenter, Open Label Cohort Phase 1 Dose Finding Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 Mesylate for Oral Administration in Adult Patients With Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML), Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene|Recruiting||Phase 1/Phase 2|44|Anticipated|Fusion Pharma LLC||1|||f||||t||||||||||2017-10-10 21:51:24.057813|2017-10-10 21:51:24.057813
NCT02885753|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-02-16|||December 2016||2016-12-01|August 2016|2016-08-01|June 2023|Anticipated|2023-06-01|September 2018|Anticipated|2018-09-01||Interventional|OSCAR||Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver|Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver|Recruiting||Phase 3|268|Anticipated|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||Undecided||2017-10-10 21:51:24.213289|2017-10-10 21:51:24.213289
NCT02885740|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-26|||March 2010||2010-03-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|FACS||Role and Interactions of Adenosine, Receptors, Methionine Cycle Nutritional, Metabolic and Genetic Determinants in the Onset of Atrial Fibrillation in Normal Heart|Role and Interactions of Adenosine, Receptors, Methionine Cycle Nutritional, Metabolic and Genetic Determinants in the Onset of Atrial Fibrillation in Normal Heart|Recruiting||N/A|400|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||No||2017-10-10 21:51:24.528159|2017-10-10 21:51:24.528159
NCT02885727|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-17|||July 2017|Anticipated|2017-07-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|Panc-Durval+RT||"Durvalumab Plus Booster RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598)"|"Phase II Trial of in Situ Tumor Vaccination Using Durvalumab and Booster Radiation Therapy in Patients With Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Through First-line Chemotherapy"|Withdrawn||Phase 2|0|Actual|University of Maryland||1||Funding issues caused the study to not be opened the at local IRB|f||||t|t|f||||||||2017-10-10 21:51:24.656566|2017-10-10 21:51:24.656566
NCT02885714|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-03-07|||December 2016||2016-12-01|March 2017|2017-03-01|January 2029|Anticipated|2029-01-01|September 2019|Anticipated|2019-09-01||Interventional|||ACCURATE Trial - Operative Treatment of Acute Rotator Cuff Tear Related to Trauma|ACCURATE Trial - Operative Treatment of Acute Rotator Cuff Tear Related to Trauma; a Placebo-controlled Efficacy Trial|Recruiting||N/A|200|Anticipated|Turku University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:51:24.753122|2017-10-10 21:51:24.753122
NCT02885701|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||December 2010||2010-12-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Splinting After Mini-Open Carpal Tunnel Release|A Prospective, Randomized Controlled Study of Splinting After Mini-Open Carpal Tunnel Release|Completed||N/A|249|Actual|OrthoIllinois||3|||f||||f||||||||Undecided||2017-10-10 21:51:24.932434|2017-10-10 21:51:24.932434
NCT02885688|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-02-23|||October 2016||2016-10-01|February 2017|2017-02-01||||October 2018|Anticipated|2018-10-01||Interventional|||Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis|Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 21:51:25.108159|2017-10-10 21:51:25.108159
NCT02883933|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||January 2004||2004-01-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Observational|head neck-mel||Clinical and Histological Features of Head and Neck Melanoma|Clinical and Histological Features of Head and Neck Melanoma|Completed||N/A|1548|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:51:41.22533|2017-10-10 21:51:41.22533
NCT02885675|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-30|||March 2016||2016-03-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||An Observational Study of the Correlation Between miRNA in Peripheral Blood and Prognosis in Patients With ARDS|An Observational Study of the Correlation Between miRNA in Peripheral Blood and Prognosis in Patients With ARDS|Recruiting||N/A|80|Anticipated|Southeast University, China|||2||f||||||||||||||2017-10-10 21:51:25.198096|2017-10-10 21:51:25.198096
NCT02885662|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-08-10|||September 2016||2016-09-01|August 2017|2017-08-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||Study of CS-3150 in Patients With Primary Aldosteronism|A Study of CS-3150 to Evaluate Efficacy and Safety in Patients With Primary Aldosteronism|Completed||N/A|44|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-10 21:51:25.287261|2017-10-10 21:51:25.287261
NCT02885649|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-07-18|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Enzalutamide Before Surgery in Treating Patients With Kidney Cancer|Pilot Study of the Blockade of Androgens in Renal Cell Carcinoma Using Enzalutamide (BARE)|Not yet recruiting||Early Phase 1|20|Anticipated|Rutgers, The State University of New Jersey||1|||||||t|t|f||||||||2017-10-10 21:51:25.36812|2017-10-10 21:51:25.36812
NCT02885636|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-02-17|||September 2016||2016-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|BEAT HFpEF||Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial|Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial|Recruiting||Phase 3|30|Anticipated|Mayo Clinic||2|||f||||t||||||||No||2017-10-10 21:51:25.467674|2017-10-10 21:51:25.467674
NCT02885610|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-02-15|||December 2015||2015-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)|A Phase IIb , Placebo-Controlled ,Multi-Center, Randomized, Double-Blind, Dose-explorating Trial of RC18,a Recombinant Human B Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein in Subjects With Systemic Lupus Erythematosus (SLE).|Recruiting||Phase 2|160|Anticipated|RemeGen||4|||f||||f||||||||Undecided||2017-10-10 21:51:25.664238|2017-10-10 21:51:25.664238
NCT02885597|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-30|||December 2016||2016-12-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Juanbi Pill for Rheumatoid Arthritis|Juanbi Pill Combined With Methotrexate for Rheumatoid Arthritis: Multi-center Random Controlled Clinical Trials|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:51:25.76909|2017-10-10 21:51:25.76909
NCT02885584|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-30|||December 2013||2013-12-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||Conventional Mechanical Ventilation and High Frequency Percussive Ventilation: Comparison of Their Effects on Alveolar Recruitment and Distension by CT-scan in Early ARDS Patients||Active, not recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:51:25.891695|2017-10-10 21:51:25.891695
NCT02885571|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-26|||April 2016||2016-04-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Can Objective Compliance Monitoring Increase Mandibular Advancement Device Usage in Obstructive Sleep Apnea Patients|Can Objective Compliance Monitoring Increase Mandibular Advancement Device Usage in Obstructive Sleep Apnea Patients|Recruiting||N/A|40|Anticipated|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 21:51:25.954884|2017-10-10 21:51:25.954884
NCT02885558|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Role of Calcium Channels in Vascular Function|Role of T-type Calcium Channels in Vascular Function|Recruiting||N/A|60|Anticipated|University of Southern Denmark||2|||f||||t||||||||||2017-10-10 21:51:26.034058|2017-10-10 21:51:26.034058
NCT02885545|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-08-26|||September 2016||2016-09-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|STOP-HARM||The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial|The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial|Not yet recruiting||Phase 4|23|Anticipated|Population Health Research Institute||2|||f||||t||||||||Undecided||2017-10-10 21:51:26.114275|2017-10-10 21:51:26.114275
NCT02885532|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-26|||July 2015||2015-07-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Observational|||Capacity to Consent in Acutely Intoxicated Emergency Department Patients|The University of California, San Diego Brief Assessment of Capacity to Consent Instrument in Acutely Intoxicated Emergency Department Patients|Completed||N/A|417|Actual|Minneapolis Medical Research Foundation|||1||f||||t||||||||No||2017-10-10 21:51:26.214282|2017-10-10 21:51:26.214282
NCT02885519|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-04-06|||April 2016||2016-04-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|June 2018|Anticipated|2018-06-01||Interventional|IBBIS||Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Stress Disorders|Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Burnout, Adjustment Disorder or Psychological Stress in Denmark (the Danish IBBIS Study): A Multi-center Randomized Controlled Trial|Recruiting||N/A|603|Anticipated|Mental Health Centre Copenhagen||3|||f||||f||||||||Undecided||2017-10-10 21:51:26.281333|2017-10-10 21:51:26.281333
NCT02885506|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-28|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A FIH Study to Investigate the Safety, Tolerability and PK of P218|A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile and Food Effect of P218 in Healthy Adult Volunteers|Recruiting||Phase 1|72|Anticipated|Medicines for Malaria Venture||9|||f||||t||||||||||2017-10-10 21:51:26.378499|2017-10-10 21:51:26.378499
NCT02884726|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-15|||October 14, 2016|Actual|2016-10-14|September 2017|2017-09-01|March 5, 2018|Anticipated|2018-03-05|October 19, 2017|Anticipated|2017-10-19||Interventional|||Phase 1 Study of Mesothelin-ADC|A Phase 1 Study of the Safety and Tolerability of BMS 986148 in Subjects With Advanced and/or Metastatic Solid Tumors|Active, not recruiting||Phase 1|15|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 21:51:34.138075|2017-10-10 21:51:34.138075
NCT02885493|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||March 2015||2015-03-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|EVAMARAGEX||Evaluation of Dysfunction of the Basal Ganglia Before a Parkinsonian Walking in the Elderly: Risk of Falling and Confusional State|The Elderly 's Parkinsonian March : Risk Estimation Multiple Drops From an Evaluation Grid Covering the March, Executive Functions, Vision and Anxiety.|Recruiting||N/A|80|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||||No||2017-10-10 21:51:26.479632|2017-10-10 21:51:26.479632
NCT02885480|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-01|||December 2016||2016-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PUPS||Courses Emergency Psychiatric Strasbourg|ROUTE PATIENT CONSULTANT in OUTPATIENT CARE PSYCHIATRIC EMERGENCY SERVICES AND PUBLIC OF EUROMETROPOLE STRASBOURG|Not yet recruiting||N/A|500|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:51:26.624101|2017-10-10 21:51:26.624101
NCT02885467|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-08-28|||August 2013||2013-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty|Saphenous Nerve Brach Burial for Preventing Neuralgia After Total Knee Arthroplasty: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-10 21:51:26.719939|2017-10-10 21:51:26.719939
NCT02885454|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-01-20|||August 2016||2016-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female Participants|A Phase 1, Open-label Study in Healthy Female Subjects to Investigate the Effects of Odalasvir and AL-335 at Steady-state, Given as Single Agents and in Combination With Simeprevir, on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone|Completed||Phase 1|24|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 21:51:26.808327|2017-10-10 21:51:26.808327
NCT02885441|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-02-09|||September 2016||2016-09-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Acute Pancreatitis With Ketorolac|Treatment of Acute Pancreatitis With Ketorolac|Recruiting||Phase 4|50|Anticipated|Ilam University of Medical Sciences||2|||f||||f||||||||No||2017-10-10 21:51:26.888742|2017-10-10 21:51:26.888742
NCT02885428|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-12-05|||April 2015||2015-04-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Detection no Invasive of a Silent Myocardial Ischemia|Silent Myocardial Ischemia in Patients With Diabetes Type 2: Diagnostic Value of Myocardial Strains Left Ventricular Resting Echocardiography 2D and 3D, Compared to Stress Echocardiography|Recruiting||N/A|150|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:51:26.975251|2017-10-10 21:51:26.975251
NCT02885415|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-22|||August 2016||2016-08-01|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|August 5, 2017|Actual|2017-08-05||Observational|POMY||Prevalence of Myocardial Injury in Gastrointestinal Surgery Patients|Prevalence of Myocardial Injury in Gastrointestinal Surgery Patients - A Multi-center Prospective Cohort Study - POMY|Completed||N/A|101|Actual|National University of Ireland, Galway, Ireland|||1||f||||f||||||||||2017-10-10 21:51:27.043573|2017-10-10 21:51:27.043573
NCT02885402|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||October 2016||2016-10-01|August 2016|2016-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Functional Exploration of Cartilage in Patients With Osteoarthritis of the Knee Through MRI Sodium ( 23Na )||Not yet recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:51:27.120541|2017-10-10 21:51:27.120541
NCT02885389|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-26|||October 2010||2010-10-01|August 2016|2016-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Molecular Genetics in Infantile Spasms|Molecular Characterization of a Cohort of 73 Patients With Infantile Spasms Syndrome|Completed||N/A|41|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:51:27.18754|2017-10-10 21:51:27.18754
NCT02885376|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-30|||November 2014||2014-11-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Study of Dentoxol® Mouthrinse for Oral Mucositis|Phase II Study of Dentoxol® Mouthrinse for Oral Mucositis Secondary to Radiation Therapy for Head and Neck Cancer|Recruiting||Phase 2|140|Anticipated|Ingalfarma SpA||2|||f||||t||||||||No||2017-10-10 21:51:27.234964|2017-10-10 21:51:27.234964
NCT02885363|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-30|||December 2011||2011-12-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|NCVG||Prognosis of Isolated Left Ventricular Non-compaction in Adults||Recruiting||N/A|220|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||Undecided||2017-10-10 21:51:27.312728|2017-10-10 21:51:27.312728
NCT02885350|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-30|||September 2016||2016-09-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour|Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour|Not yet recruiting||Phase 4|80|Anticipated|Helsinki University Central Hospital||4|||f||||f||||||||No||2017-10-10 21:51:29.224833|2017-10-10 21:51:29.224833
NCT02885337|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-09-23|||August 2016||2016-08-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|Fit-Hips||Fit-Hips: Getting Fit for Hip Replacement|Fit-Hips: Getting Fit for Hip Replacement, A Pilot Randomized Control Trial|Recruiting||N/A|62|Anticipated|McMaster University||2|||f||||t||||||||No||2017-10-10 21:51:29.357104|2017-10-10 21:51:29.357104
NCT02885324|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-11|||May 18, 2017|Actual|2017-05-18|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in Children|Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in Children|Recruiting||Phase 2|10|Anticipated|Indiana University||1|||f||||t|t|f||||||||2017-10-10 21:51:29.478855|2017-10-10 21:51:29.478855
NCT02885311|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-03-17|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home|Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home|Recruiting||Phase 1/Phase 2|85|Anticipated|Northwell Health||4|||f||||t||||||||No||2017-10-10 21:51:29.587699|2017-10-10 21:51:29.587699
NCT02885298|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-30|||July 2014||2014-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Effect of Upright Patient Positioning on Intubation Success|Prospective Observational Study of the Effect of Upright Patient Positioning on Intubation Success Rates at Two Academic Emergency Departments|Completed||N/A|232|Actual|Indiana University|||3||f||||f||||||||No||2017-10-10 21:51:29.695939|2017-10-10 21:51:29.695939
NCT02885285|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-07-25|||August 2016||2016-08-01|July 2017|2017-07-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Interventional|PD&Exercise||The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease|The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease|Terminated||N/A|2|Actual|Dartmouth-Hitchcock Medical Center||4||Recruitment goal not met|f||||f||||||||||2017-10-10 21:51:29.789381|2017-10-10 21:51:29.789381
NCT02885272|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-07-11|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Dual Time Point FDG PET-MR Imaging Optimization for the Evaluation of Glioblastoma|Dual Time Point FDG PET-MR Imaging Optimization for the Evaluation of Glioblastoma|Recruiting||Early Phase 1|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 21:51:29.913403|2017-10-10 21:51:29.913403
NCT02885259|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-08-25|||September 2016||2016-09-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|HYMMNE||HyQvia in Multifocal Motor Neuropathy|Subcutaneous Immunoglobulin With rHuPH20 in Multifocal Motor Neuropathy|Not yet recruiting||N/A|20|Anticipated|UMC Utrecht||1|||f||||t||||||||No||2017-10-10 21:51:30.032213|2017-10-10 21:51:30.032213
NCT02885246|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-03-02|||July 2017||2017-07-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015|Prevalence, Strain Circulation and Disease Burden of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015|Not yet recruiting||N/A|1|Anticipated|GlaxoSmithKline|||1||f||||||||||||||2017-10-10 21:51:30.150784|2017-10-10 21:51:30.150784
NCT02885233|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-25|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis|Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis|Active, not recruiting||N/A|30|Anticipated|Oregon Health and Science University||2|||f||||f|f|f||||||||2017-10-10 21:51:30.330361|2017-10-10 21:51:30.330361
NCT02885220|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-08-25|||October 2015||2015-10-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|Go-Pro||Goal Directed Versus Conventional Weight Loss Program|A Randomized Controlled Trial Comparing Goal Directed Versus Conventional Weight Loss Program Post Laparoscopic Sleeve Gastrectomy|Recruiting||N/A|120|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||No||2017-10-10 21:51:30.428108|2017-10-10 21:51:30.428108
NCT02885207|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-08-25|||June 2015||2015-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|IBADEPIF||Interest Balance Auto-immune Population in Patients With Focal Epilepsy of Unknown Cause, Not Structural, Not Genetics, Newly Diagnosed|Interest Balance Auto-immune Population in Patients With Focal Epilepsy of Unknown Cause, Not Structural, Not Genetics, Newly Diagnosed|Recruiting||N/A|200|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||No||2017-10-10 21:51:30.52926|2017-10-10 21:51:30.52926
NCT02885194|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-10-12|||January 2015||2015-01-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Impact of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease|Impact of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease : Clinical and Neurophysiological Study|Completed||N/A|26|Actual|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 21:51:30.634918|2017-10-10 21:51:30.634918
NCT02885181|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-10-03|||September 21, 2016|Actual|2016-09-21|October 2017|2017-10-01|September 20, 2017|Actual|2017-09-20|August 22, 2017|Actual|2017-08-22||Interventional|||Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Proof-of-Concept Study to Evaluate Safety, Tolerability, and Efficacy of GS-9876 in Subjects With Active Rheumatoid Arthritis on Background Therapy With Methotrexate|Completed||Phase 2|83|Actual|Gilead Sciences||4|||f||||f|t|f||||||||2017-10-10 21:51:30.717315|2017-10-10 21:51:30.717315
NCT02885168|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||February 2008||2008-02-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|PCA||Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C|Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C|Completed||Phase 4|30|Actual|Central Hospital, Nancy, France||2|||f||||f||||||||No||2017-10-10 21:51:30.875105|2017-10-10 21:51:30.875105
NCT02885155|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||January 2007||2007-01-01|August 2016|2016-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension|Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension|Completed||N/A|50|Actual|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 21:51:30.999265|2017-10-10 21:51:30.999265
NCT02885142|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||November 2016||2016-11-01|August 2016|2016-08-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|MUCEM||Early Rectal Cancer: Endoscopic Submucosal Dissection or Transanal Endoscopic Microsurgery?||Not yet recruiting||N/A|400|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:51:31.075536|2017-10-10 21:51:31.075536
NCT02885129|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-13|||June 2014||2014-06-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|EGOMAC||Development of the General Scale Observance for Chronic Diseases|Development of the General Scale Observance for Chronic Diseases (EGOMAC)|Completed||N/A|397|Actual|Central Hospital, Nancy, France|||1||f||||f||||||||||2017-10-10 21:51:31.170278|2017-10-10 21:51:31.170278
NCT02885116|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|HÄMOFLOW||Effect of Nasal Highflow on Right Heart Function|Hemodynamic Effects of Nasal Highflow on Patients With Chronic Respiratory Insufficiency and Pulmonary Hypertension|Recruiting||N/A|50|Anticipated|University of Leipzig||2|||f||||f||||||||Undecided||2017-10-10 21:51:31.273678|2017-10-10 21:51:31.273678
NCT02885103|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-10-24|||August 2016||2016-08-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|AEROFLOW||Combination of NHF and Nebulizer on Lung Function in COPD|Effect of Nasal Highflow in Combination With a Nebulizer on Reversibility in Lung Function in Patients With COPD|Recruiting||N/A|20|Anticipated|University of Leipzig||2|||f||||f||||||||Undecided||2017-10-10 21:51:31.368264|2017-10-10 21:51:31.368264
NCT02885090|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-26|||February 2010||2010-02-01|August 2016|2016-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|RETT||New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization|Search for New Genes Involved in Molecular Etiology of Rett Syndrome Through Comparative Genomic Hybridization on DNA Microarrays|Completed||N/A|17|Actual|Central Hospital, Nancy, France||2|||f||||f||||||||No||2017-10-10 21:51:31.459308|2017-10-10 21:51:31.459308
NCT02885077|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-07-27|||May 2016||2016-05-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|June 2017|Actual|2017-06-01||Interventional|||Effects of High-intensity Inspiratory Muscle Training in Patients Undergoing Coronary Artery Bypass Grafting Surgery|Effects of High-intensity Inspiratory Muscle Training Associated With Aerobic and Resistance Exercise in Patients Undergoing Coronary Artery Bypass Grafting Surgery|Active, not recruiting||N/A|24|Actual|Universidade Federal de Santa Maria||2|||f||||t||||||||||2017-10-10 21:51:31.545874|2017-10-10 21:51:31.545874
NCT02885064|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||September 2016||2016-09-01|August 2016|2016-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Shifts in the Oral Biofilm of Patients With Known Oral Health Risk Factors|Shifts in the Oral Biofilm of Patients With Known Oral Health Risk Factors|Not yet recruiting||N/A|120|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     bacteria isolated from plaque and saliva; human genome   "|Undecided||2017-10-10 21:51:31.618225|2017-10-10 21:51:31.618225
NCT02885051|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-07-10|||January 16, 2017|Actual|2017-01-16|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|TRIPAIN||Evaluation of Pain in Preterm Newborn|Comparative Analysis of a Behavioral Level, Skin Conductance and Heart Rate Variability in Assessing the Pain in Preterm Newborn|Recruiting||N/A|200|Anticipated|University Hospital, Brest||1|||f||||f||||||||||2017-10-10 21:51:31.678356|2017-10-10 21:51:31.678356
NCT02885038|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-09-29|||January 2015||2015-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|TCP||Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies|Analyse de l'Effet Des caractéristiques de concentrés Plaquettaires Sur le Rendement Transfusionnel Chez Les Patients Ayant Une hémopathie Maligne et bénéficiant de Transfusions Plaquettaires à Titre Prophylactique|Completed||N/A|1101|Actual|Etablissement Français du Sang|||1||f||||f||||||||||2017-10-10 21:51:31.76886|2017-10-10 21:51:31.76886
NCT02885025|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-12|||October 1, 2016|Actual|2016-10-01|July 2017|2017-07-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||The Effect of Broccoli Sprout Extract on Allergy Rhinitis|Effects of Broccoli Sprout Extract on Allergic Rhinitis|Recruiting||Phase 2|475|Anticipated|VA Office of Research and Development||4|||f||||t|t|f|||f|||||2017-10-10 21:51:31.830257|2017-10-10 21:51:31.830257
NCT02885012|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-08-25|||June 2016||2016-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|Letairis||Crossover Study From Macitentan or Bosentan Over to Ambrisentan|A Safety and Clinical Efficacy Study Measuring Echocardiographic Composite Comparing Ambrisentan (Letairis®) After a Switch From Bosentan (Tracleer®) or Macintentan (Opsumit®) in Treatment of Pulmonary Arterial Hypertension (PAH)|Recruiting||Phase 4|50|Anticipated|Medical University of South Carolina||2|||f||||f||||||||No||2017-10-10 21:51:31.947723|2017-10-10 21:51:31.947723
NCT02884999|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-26|||May 2015||2015-05-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|APP||Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines|Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines|Completed||N/A|145|Actual|University Hospital, Brest|||1||f||||f||||||||No||2017-10-10 21:51:32.063886|2017-10-10 21:51:32.063886
NCT02884986|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-30|||January 2015||2015-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01||Interventional|||Analgesia in Inguinal Hernia Repair Using a Cyclooxygenase-2-specific Inhibitor|Randomised Controlled Trial - Multimodal Analgesia in Inguinal Hernia Repair Using a Cyclooxygenase-2-specific Inhibitor: A Randomised Controlled Trial|Completed||N/A|60|Actual|Bnai Zion Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:51:32.249523|2017-10-10 21:51:32.249523
NCT02884973|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-08-25|||July 2016||2016-07-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Prospective Evaluation of Changes in Tissue Oxygen Saturation in Brain and Kidney in Children Admitted to Intensive Care in the Postoperative Period of Cardiac Surgery||Not yet recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:51:32.335599|2017-10-10 21:51:32.335599
NCT02884960|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-30|||October 2016||2016-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization|Safety and Efficacy of Embozene® Microspheres for Uterine Fibroid Embolization Compared to Embosphere® Microspheres for Symptomatic Relief From Uterine Fibroids|Not yet recruiting||N/A|118|Anticipated|Community Care Physicians, P.C.||2|||f||||f||||||||No||2017-10-10 21:51:32.400478|2017-10-10 21:51:32.400478
NCT02884947|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-25|||May 2013||2013-05-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Observational|||Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI|Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI|Active, not recruiting||N/A|31|Actual|University College, London|||1||f||||f||||||||||2017-10-10 21:51:32.491799|2017-10-10 21:51:32.491799
NCT02884934|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||March 2013||2013-03-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|Padis-Ext||Six Years of Follow-up After Idiopathic Venous Throbmoembolism|Six Years of Follow-up After Extended Duration of Oral Anticoagulant Therapy for a First Episode of Idiopathic Pulmonary Embolism or Proximal Deep Vein Thrombosis.|Recruiting||N/A|748|Anticipated|University Hospital, Brest|||1||f||||t||||||||Undecided||2017-10-10 21:51:32.570238|2017-10-10 21:51:32.570238
NCT02884921|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-08-30|||April 2015||2015-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|April 2015|Actual|2015-04-01||Interventional|||Preemptive Analgesia Using Intravenous Paracetamol|Preemptive Analgesia Using Intravenous Paracetamol in Dental Sitting|Completed||N/A|87|Actual|Bnai Zion Medical Center||3|||f||||t||||||||Yes||2017-10-10 21:51:32.707404|2017-10-10 21:51:32.707404
NCT02884336|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-25|||May 2015||2015-05-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Lactobacillus Plantarum: Thumb Osteoarthritis Following Orange Peeling|Lactobacillus Plantarum: Thumb Osteoarthritis Following Orange Peeling|Completed||N/A|1|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:51:38.069944|2017-10-10 21:51:38.069944
NCT02884908|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-06-23|||September 2016||2016-09-01|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|April 2020|Anticipated|2020-04-01||Interventional|||Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD|Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD|Recruiting||Phase 3|252|Anticipated|University of Maryland||4|||f||||t||||||||Yes|"Following the NIH policy, and the Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources, the investigators will provide all of our research resources available for research purposes to qualified individuals within the scientific community after publication of our results.
Sharing of all of the research resources generated by this funded project will be in accordance with the federal rules or regulations imposed upon by the University of Maryland, Baltimore. The investigators will make the results available in accordance with the NIH Data Sharing policy. The investigators will analyze data and submit for peer reviewed publications in scientific journals. The investigators will also present the data in scientific meetings, symposia, or other scientific communications consistent with academic standards."|2017-10-10 21:51:32.788186|2017-10-10 21:51:32.788186
NCT02884895|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-01-31|||April 2017|Anticipated|2017-04-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||A Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Tube Suction Disposable|Establishing a Definitive Airway: A Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Tube Suction Disposable|Not yet recruiting||N/A|60|Anticipated|Bnai Zion Medical Center||2|||f||||t|f|t|f|||||Yes||2017-10-10 21:51:32.90426|2017-10-10 21:51:32.90426
NCT02884882|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-31|||December 2011||2011-12-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|KALISS||Emotions Analysis in Patients With Chronic Phase of Stroke Basal Ganglia|Emotions Analysis in Patients With Chronic Phase of Stroke Basal Ganglia: Neuropsychological and Neurophysiological Study of Changes in Emotional Experiences|Recruiting||N/A|180|Anticipated|University Hospital, Brest||2|||f||||f||||||||No||2017-10-10 21:51:32.98964|2017-10-10 21:51:32.98964
NCT02884869|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Mask Airway|Establishing a Definitive Airway: Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Mask Airway|Not yet recruiting||N/A|60|Anticipated|Bnai Zion Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:51:33.11015|2017-10-10 21:51:33.11015
NCT02884856|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||August 2014||2014-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|December 2014|Actual|2014-12-01||Observational|CPD||Color Perception in Dentistry (CPD)|Influence of Gender on Visual Shade Matching in Dentistry|Completed||N/A|100|Actual|Universidade de Passo Fundo|||2||f||||t||||||||No||2017-10-10 21:51:33.21299|2017-10-10 21:51:33.21299
NCT02884843|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|August 2016|Actual|2016-08-01||Interventional|||The New Intubating Laryngeal Tube Suction-Disposable|A Comparative Randomized Prospective Study Between the New Intubating Laryngeal Tube Suction-Disposable and the Ambu AuraGain in Blind and Fibreoptic-guided Intubation|Not yet recruiting||N/A|60|Anticipated|Bnai Zion Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:51:33.320668|2017-10-10 21:51:33.320668
NCT02884830|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-11-15|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nocturnal Continuous Positive Airway Pressure in Chronic Obstructive Pulmonary Disease Patients|Does Nocturnal Continuous Positive Airway Pressure Use Improves Sleep Quality in Chronic Obstructive Pulmonary Disease Patients?|Not yet recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire Saint Pierre||2|||f||||f||||||||No||2017-10-10 21:51:33.415149|2017-10-10 21:51:33.415149
NCT02884817|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||September 2015||2015-09-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Essential Oil+ELA, Plaque and Gingivitis|The Plaque- and Gingivitis Inhibiting Capacity of a Commercially Available Mouthwash Containing Essential Oils and Ethyl Lauroyl Arginate: A Parallel, Split-mouth, Double Blind, Randomized, Placebo-controlled Clinical Study|Completed||Phase 4|59|Actual|University of Oslo||3|||f||||f||||||||Yes|Via scientific journals|2017-10-10 21:51:33.50497|2017-10-10 21:51:33.50497
NCT02884804|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||November 2011||2011-11-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|HPP-IPF||Study of Biological Determinants of Bleeding Postpartum|Study of Biological Determinants of Bleeding Postpartum : Predictive Role in the Number of Immature Platelets|Completed||N/A|3599|Actual|University Hospital, Brest|||1||f||||f||||||Samples Without DNA|"     PLASMA   "|||2017-10-10 21:51:33.621699|2017-10-10 21:51:33.621699
NCT02884791|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-02-22|||February 2016||2016-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||FGF21 and Fructose Challenge in Humans|Fibroblast Growth Factor 21 and Fructose Challenge in Humans|Recruiting||N/A|50|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-10-10 21:51:33.693133|2017-10-10 21:51:33.693133
NCT02884778|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-25|||April 2016||2016-04-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Observational Evaluation of the Last Version of the PMD200TM|Evaluation of the Last Version of the PMD200TM and Its NoL Index in Patients Undergoing Laparotomies With Intraoperative Epidural Analgesia|Recruiting||N/A|30|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||No||2017-10-10 21:51:33.782901|2017-10-10 21:51:33.782901
NCT02884765|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-01-19|||January 2017|Actual|2017-01-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01|3 Months|Observational [Patient Registry]|BCFx||Bilateral Condylar Fractures Registry|International, Multicenter, Prospective Registry to Collect Data of Treatment Patterns in Patients With Bilateral Condylar Fracture (BCFx) of the Mandible|Recruiting||N/A|250|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f||||||||No||2017-10-10 21:51:33.891077|2017-10-10 21:51:33.891077
NCT02884752|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||December 2014||2014-12-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Observational|CAMPYLO||Retrospective Study of Bone Infection Due to Campylobacter Spp|Retrospective Study of Bone Infection Due to Campylobacter Spp|Completed||N/A|10|Actual|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 21:51:34.003786|2017-10-10 21:51:34.003786
NCT02884739|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-01|||January 2010||2010-01-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|CSA||Mental Healthcare in Older Adults With Schizophrenia|The Mortality and Its Associated Factors in Schizophrenia Patients Older Than 60 Years|Active, not recruiting||N/A|685|Actual|CHU de Reims|||2||f||||||||||||||2017-10-10 21:51:34.068977|2017-10-10 21:51:34.068977
NCT02884713|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-25|||June 2013||2013-06-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi Arabia|Efficacy of Levofloxacin-Doxycycline Based Rescue Therapy for Helicobacter Pylori Eradication: A Prospective Open-label Trial in Saudi Arabia|Completed||N/A|55|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||Undecided|Not decided yet.|2017-10-10 21:51:34.238336|2017-10-10 21:51:34.238336
NCT02884700|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-30|||September 2009||2009-09-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2011|Actual|2011-12-01||Observational|LEGIOGRE||Severe Legionellosis Cases Admitted to Grenoble University Hospital, 2006-2011.|Molecular Epidemiology of Legionellosis in Grenoble Region|Completed||N/A|82|Actual|University Hospital, Grenoble|||1||f||||f||||||Samples With DNA|"     Lower respiratory tract samples collected on a routine basis for microbiological analyses   "|No|Biological data are available at the bacteriology laboratory. Clinical data are available at the participating medical wards.|2017-10-10 21:51:34.345811|2017-10-10 21:51:34.345811
NCT02884687|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-31|||January 2015||2015-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|BONANTIBIO||Impact of Antimicrobial Stewardship in Hospital: Eight Years Review (BONANTIBIO)|Impact of Antimicrobial Stewardship in Hospital: Eight Years Review|Completed||N/A|18|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||||2017-10-10 21:51:34.417049|2017-10-10 21:51:34.417049
NCT02884674|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-08-30|||May 2015||2015-05-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|MAGTOC||Repetitive Transcranial Magnetic Stimulation in Obsessive Compulsive Disorder|Stimulation magnétique transcrânienne répétitive Dans le Traitement Des Troubles Obsessionnels Compulsifs|Recruiting||Phase 3|56|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 21:51:34.478251|2017-10-10 21:51:34.478251
NCT02884661|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-08-26|||October 2015||2015-10-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ACFA||First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments|Assessment of the Usual Choice for a First-line Treatment in Case of Atrial Fibrillation : Comparison Between Cardiology Department and Geriatric Unit.|Completed||N/A|100|Actual|Centre Hospitalier Régional Metz-Thionville|||2||f||||f||||||||||2017-10-10 21:51:34.606923|2017-10-10 21:51:34.606923
NCT02884648|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-06-16|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery|A Phase II Investigation of Bevacizumab for the Treatment of Second-Look Positive Epithelial Ovarian Cancer|Recruiting||Phase 2|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:51:34.672785|2017-10-10 21:51:34.672785
NCT02884635|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2017-09-28|||September 16, 2016|Actual|2016-09-16|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate|Phase IIa Study of ASP1707 A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Phase IIa Study of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)|Active, not recruiting||Phase 2|72|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-10 21:51:34.772169|2017-10-10 21:51:34.772169
NCT02884622|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-30|||June 2013||2013-06-01|March 2013|2013-03-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|METHYLCF||DNA Methylation and Lung Disease in Cystic Fibrosis|DNA Methylation and Lung Disease in Cystic Fibrosis|Completed||N/A|72|Actual|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 21:51:35.083702|2017-10-10 21:51:35.083702
NCT02884609|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-26|2016-09-14|||August 2014||2014-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|TEPASC||Tolerance and Efficiency of Paracetamol Subcutaneous Injection|Tolerance and Efficiency of Paracetamol bu Subcutaneous Releasing in Patients Hospitalized Into Palliative Care|Recruiting||N/A|150|Anticipated|Centre Hospitalier Régional Metz-Thionville|||1||f||||f||||||||No||2017-10-10 21:51:35.192603|2017-10-10 21:51:35.192603
NCT02884596|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-05-19|||June 2015||2015-06-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|||Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors|Anesthetic Success of Inferior Alveolar Nerve Block for Mandibular Molars With Symptomatic Irreversible Pulpitis in Women Taking Selective Serotonin Reuptake Inhibitors|Completed||N/A|70|Actual|Isfahan University of Medical Sciences|||1||f||||t||||||||No||2017-10-10 21:51:35.307244|2017-10-10 21:51:35.307244
NCT02884583|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-25|||March 2016||2016-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AAAli||Association Between Asthma and Food Allergy|Association Between Asthma and Food Allergy in Children and Adults|Recruiting||N/A|200|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 21:51:35.395143|2017-10-10 21:51:35.395143
NCT02884570|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-05-30|||April 2014||2014-04-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Observational|TRACH||Parental Mental Health After Tracheostomy in Early Childhood|Post-hospital Evaluation of Anxiety / Depression in Parents of Children Who Required Tracheostomy Before the Age of 1 Year|Recruiting||N/A|70|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||Undecided||2017-10-10 21:51:35.501551|2017-10-10 21:51:35.501551
NCT02884557|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-21|||May 2013||2013-05-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|NKT-CSP/MICI||NKT Role in the Regulation of the Inflammatory Bowel Disease|Evaluation of the Expression of Natural Killer T Cells (NKT) Marker in the Gut of Patients With Primary Sclerosing Cholangitis (PSC) Complicated by an Inflammatory Bowel Disease (IBD)|Recruiting||N/A|60|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||||2017-10-10 21:51:35.594897|2017-10-10 21:51:35.594897
NCT02884544|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-19|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|December 27, 2016|Actual|2016-12-27|December 18, 2016|Actual|2016-12-18||Interventional|HLD100-103||A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD|Phase II, Open-label, Dose-titration, Safety Study Designed to Determine the Evening Dose of a Novel Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) to Produce Optimal Clinical Effects in Children With ADHD|Completed||Phase 2|22|Actual|Ironshore Pharmaceuticals and Development, Inc||1|||f||||t||||||||||2017-10-10 21:51:35.705902|2017-10-10 21:51:35.705902
NCT02884531|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||October 2015||2015-10-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|HipOA||Patient Education and Basic Body Awareness Therapy in Hip Osteoarthritis: a Randomized Controlled Trial|Assessment and Treatment Responses to Patient Education and Basic Body Awareness Therapy in Hip Osteoarthritis: a Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|University of Bergen||2|||f||||t||||||||Yes|After the RCT has been completed, the plan is to enter data in a national register for patients with osteoarthritis, NOAR. The patients give their consent to this.|2017-10-10 21:51:35.805389|2017-10-10 21:51:35.805389
NCT02884518|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-30|||September 2016||2016-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|PADP||Predicting Antipsychotic Discontinuation in Psychosis|Predicting Successful Antipsychotic Discontinuation in the First Episode Psychosis by Using Positron Emission Tomography(PET) withPositron Emission Tomography With 3,4-dihydroxy-6-18-fluoro-l-phenylalanine ([18 Fluorine(F)]DOPA)|Not yet recruiting||N/A|38|Anticipated|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:51:36.015935|2017-10-10 21:51:36.015935
NCT02884505|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-11-30|||August 2016||2016-08-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Observational|||Improving the Assessment of Hypersomnolence|Improving the Assessment of Hypersomnolence|Not yet recruiting||N/A|200|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||||No||2017-10-10 21:51:36.139649|2017-10-10 21:51:36.139649
NCT02884492|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-12-07|||July 2016||2016-07-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Imaging Tau in Alzheimer's Disease and Normal Aging|Imaging Tau in Alzheimer's Disease and Normal Aging|Recruiting||Phase 2|60|Anticipated|Columbia University||2|||f||||f||||||||Undecided||2017-10-10 21:51:36.250004|2017-10-10 21:51:36.250004
NCT02884479|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-09-20|||August 2016||2016-08-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study|An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study|Recruiting||Phase 1/Phase 2|75|Anticipated|SciClone Pharmaceuticals||1|||f||||t||||||||Yes||2017-10-10 21:51:36.384338|2017-10-10 21:51:36.384338
NCT02884466|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-27|||October 2016||2016-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Two Multidisciplinary Rehabilitation Interventions in Patients With Chronic Low Back Pain|Comparison of Two Multidisciplinary Rehabilitation Interventions in Patients With Chronic Low Back Pain - A Randomised Controlled Clinical Trial|Enrolling by invitation||N/A|160|Anticipated|Sano||2|||f||||f||||||||No||2017-10-10 21:51:36.529563|2017-10-10 21:51:36.529563
NCT02884453|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-25|||July 2016||2016-07-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|iMYC||Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma|Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma|Recruiting||Phase 2|17|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||No||2017-10-10 21:51:36.668459|2017-10-10 21:51:36.668459
NCT02884440|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-09-04|||November 7, 2016|Actual|2016-11-07|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|TAP ALIF||Transverse Abdominis Plane Block for Anterior Approach Spine Surgery|Transverse Abdominis Plane Block for Anterior Approach Spine Surgery: A Prospective Randomized Study|Recruiting||Phase 2|46|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-10 21:51:36.787475|2017-10-10 21:51:36.787475
NCT02884427|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-04-15|2016-12-25||September 2015||2015-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Direct Current Cathode and Anode Effects and Changes in Handgrip Strength. Evaluation Through a Dynamometer Test|Direct Current Cathode and Anode Effects and Changes in Handgrip Strength in Healthy Subjects: Evaluation Through a Dynamometer Test.|Completed||N/A|150|Actual|Quiropraxia y Equilibrio||3|||f||||t||||||||No||2017-10-10 21:51:36.927256|2017-10-10 21:51:36.927256
NCT02884414|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-10-03|||August 2016||2016-08-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Gait Modifications and Cutaneous Stimulation|Analysis of Joint Mechanics in Response to Gait Modifications and Cutaneous Stimulation|Recruiting||N/A|45|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-10 21:51:37.436285|2017-10-10 21:51:37.436285
NCT02884401|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-09-18|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Peri-implant Bone Changes in Post-menopausal Osteoporotic Women|Radiographic Peri-implant Alveolar Bone Changes in Post-menopausal Osteoporotic Women|Recruiting||Phase 4|22|Anticipated|Queen Mary University of London||1|||f||||f||||||||||2017-10-10 21:51:37.554091|2017-10-10 21:51:37.554091
NCT02884388|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-30|||December 2015||2015-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Combined Nerve Block in Elderly Patients Subjected to Total Hip Replacement|Effects of a Combined Nerve Block on Intraoperative Stress and Postoperative Immune Function in Elderly Patients Subjected to Total Hip Replacement: Study Protocol for a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Qinghai University||2|||f||||t||||||||Undecided||2017-10-10 21:51:37.669049|2017-10-10 21:51:37.669049
NCT02884375|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-25|||September 2010||2010-09-01|August 2016|2016-08-01|November 2027|Anticipated|2027-11-01|November 2027|Anticipated|2027-11-01||Observational|ELCAPA||Elderly CAncer Patient|Elderly Cancer Patient: ELCAPA Cohort Survey|Recruiting||N/A|3000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 21:51:37.770225|2017-10-10 21:51:37.770225
NCT02884362|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-25|||January 2016||2016-01-01|July 2016|2016-07-01|June 2026|Anticipated|2026-06-01|January 2026|Anticipated|2026-01-01||Observational|||Prospective Melanoma Database|Creation of a Prospective Melanoma Database|Recruiting||N/A|10000|Anticipated|Institut Claudius Regaud|||1||f||||f||||||Samples With DNA|"     tumor sample   "|Undecided||2017-10-10 21:51:37.864012|2017-10-10 21:51:37.864012
NCT02884349|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-09-05|||October 2016||2016-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Relationship Between Component Position and RoM|An Investigation of the Relationship Between Total Hip Implant Position and Hip Range of Movement|Not yet recruiting||N/A|90|Anticipated|Golden Jubilee National Hospital||1|||f||||f||||||||No||2017-10-10 21:51:37.968289|2017-10-10 21:51:37.968289
NCT02884323|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-04-12|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study in Patients With Venous Leg Ulcers and Measuring the Effects of Using Geko™ Device|A Single Centre Open Label Pilot Study Measuring Lower Limb Physiology in Patients With Venous Leg Ulcers Using the Geko™ T-2 or gekoTM Plus [R-2] Neuromuscular Electro Stimulation Device|Recruiting||N/A|20|Anticipated|Firstkind Ltd||1|||f||||f||||||||Yes||2017-10-10 21:51:38.152553|2017-10-10 21:51:38.152553
NCT02884310|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-17|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|December 2014|Actual|2014-12-01||Interventional|||Interest of a Tetanus Test at a Fixed Remifentanil Concentration Before Laryngoscopy and Skin Incision|Interest of the Gradient of Nociceptive Indexes After a Tetanus (100 Hz, 60 Milliamperes, 30 Seconds) at a Fixed Remifentanil Effect Site Concentration to Adjust Remifentanil Before Tracheal Intubation and Skin Incision|Completed||Phase 4|48|Actual|Erasme University Hospital||2|||f||||f||||||||||2017-10-10 21:51:38.233362|2017-10-10 21:51:38.233362
NCT02884297|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-09-14|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|HOPE||HexafluOride, a Contrast Agent for Placenta Echo-angiography|Feasibility Study of the Measurement of the Placental Perfusion During the First Trimester of Pregnancy by 3D Doppler Echo-angiography With a Contrast Agent|Recruiting||Phase 3|40|Anticipated|Centre Hospitalier Régional Metz-Thionville||1|||f||||t||||||||Undecided||2017-10-10 21:51:38.309329|2017-10-10 21:51:38.309329
NCT02884284|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-25|||February 2015||2015-02-01|August 2016|2016-08-01|December 2025|Anticipated|2025-12-01|January 2025|Anticipated|2025-01-01||Observational|||Prospective and Retrospective Breast Cancer Database|Creation of a Prospective and Retrospective Breast Cancer Database|Recruiting||N/A|10000|Anticipated|Institut Claudius Regaud|||1||f||||f||||||Samples With DNA|"     blood samples and tumor samples of patients treated for breast cancer   "|No||2017-10-10 21:51:38.406521|2017-10-10 21:51:38.406521
NCT02884271|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-11-16|||March 2016||2016-03-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|CPR||Cardiopulmonary Resuscitation in Operating Room|Intraoperative Cardiac Arrest: Incidence and Outcome|Recruiting||N/A|7|Anticipated|Dokuz Eylul University|||2||f||||f||||||||Yes||2017-10-10 21:51:38.487895|2017-10-10 21:51:38.487895
NCT02884258|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-01-06|||January 2012||2012-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||In Vitro Fertilization (IVF) Results in Women Having Undergone Bariatric Surgery Versus Weight-matched Controls|Case-Control Study Comparing in Vitro Fertilization (IVF) Results in Women Having Undergone Bariatric Surgery and Weight-matched Patients Without Surgery|Recruiting||N/A|150|Anticipated|Clinique Mathilde|||2||f||||f||||||||No||2017-10-10 21:51:38.573416|2017-10-10 21:51:38.573416
NCT02884245|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-01|||October 2016||2016-10-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|PRESCORI||Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa|Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa in Women Older Than 38 Years Old Undergoing in Vitro Fertilization|Recruiting||Phase 3|360|Anticipated|Centre Hospitalier Intercommunal Creteil||2|||f||||f||||||||||2017-10-10 21:51:38.659568|2017-10-10 21:51:38.659568
NCT02884232|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||June 2012||2012-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|CERBois||Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort|Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort. Feasibility Evaluation|Completed||N/A|800|Actual|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 21:51:38.798874|2017-10-10 21:51:38.798874
NCT02884219|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-03-30|||December 23, 2016|Actual|2016-12-23|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|BeNeDuctus||Early Treatment Versus Expectative Management of PDA in Preterm Infants|Multi-center, Randomized Non-inferiority Trial of Early Treatment Versus Expectative Management of Patent Ductus Arteriosus in Preterm Infants (BeNeDuctus Trial - Belgium Netherlands Ductus Trial)|Recruiting||N/A|564|Anticipated|Radboud University||2|||f||||t|f|f||||||Yes|The data will be made available after an embargo period|2017-10-10 21:51:38.900481|2017-10-10 21:51:38.900481
NCT02884206|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-03-07|||November 23, 2016|Actual|2016-11-23|March 2017|2017-03-01|July 14, 2021|Anticipated|2021-07-14|July 12, 2021|Anticipated|2021-07-12||Interventional|PERSPECTIVE||Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Heart Failure and Preserved Ejection Fraction|A Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Heart Failure and Preserved Ejection Fraction|Recruiting||Phase 3|520|Anticipated|Novartis||2|||f||||t||||||||||2017-10-10 21:51:39.213787|2017-10-10 21:51:39.213787
NCT02884193|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-08-23|||September 2016||2016-09-01|August 2017|2017-08-01|May 2018||2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|QI||"Effectiveness of the Technique of Quick Icing (QI) on the Handgrip Strength Compared With the Use of Prolonged Cold and a Control"|"Effectiveness of the Technique of Quick Icing (QI) on the Isometric Handgrip Strength Compared With the Use of Prolonged Cold and a Control: Assessment Through Dynamometry"|Enrolling by invitation||N/A|300|Anticipated|Quiropraxia y Equilibrio||3|||f||||t||||||||||2017-10-10 21:51:39.344084|2017-10-10 21:51:39.344084
NCT02884180|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-06-01|||May 31, 2017|Actual|2017-05-31|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|DEXRAR||DEXRAR: DEXamethasone in Revision ARthroplasty|DEXRAR: DEXamethasone in Revision ARthroplasty: A Randomised, Blinded, 2-group Clinical Trial|Recruiting||Phase 4|108|Anticipated|Naestved Hospital||2|||f||||f|f|f||||||||2017-10-10 21:51:39.450546|2017-10-10 21:51:39.450546
NCT02884167|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-08-25|||June 2016||2016-06-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Observational|||Multidimensional Risk Factor Assessment in Constipation||Recruiting||N/A|200|Anticipated|Queen Mary University of London|||2||f||||||||||||||2017-10-10 21:51:39.595208|2017-10-10 21:51:39.595208
NCT02884154|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tumors||Enrolling by invitation||Phase 4|38|Anticipated|Pusan National University Hospital||1|||f||||||||||||||2017-10-10 21:51:39.685799|2017-10-10 21:51:39.685799
NCT02884141|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-01|||November 2009||2009-11-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|ARCADIA||Cross-sectional Study of Patients With Renal or Craniocervical Fibromuscular Dysplasia|Assessment of Renal and Cervical Artery DysplasIA|Completed||N/A|499|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Blood samples   "|Yes|Controlled access|2017-10-10 21:51:39.773501|2017-10-10 21:51:39.773501
NCT02884128|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-25|||January 2006||2006-01-01|August 2016|2016-08-01|July 2010|Actual|2010-07-01|August 2008|Actual|2008-08-01||Interventional|||A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors|A Multi-Center, Open-Label Phase I Dose-Escalation Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors|Completed||Phase 1|16|Actual|PharmaEngine||1|||f||||f||||||||No||2017-10-10 21:51:39.892002|2017-10-10 21:51:39.892002
NCT02884115|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-09-18|||August 2016||2016-08-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Serological Response to Retreatment of Serofast Early Syphilis Cases With Benzathine Penicillin|Randomized, Clinical Trial to Compare the Serological Response Rates of Serofast Early Syphilis Cases Retreated With Three Doses Benzathine Penicillin and Absence of Any Retreatment|Recruiting||Phase 4|150|Anticipated|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 21:51:39.991098|2017-10-10 21:51:39.991098
NCT02884102|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-04-25|||June 2015||2015-06-01|March 2017|2017-03-01|June 2023|Anticipated|2023-06-01|June 2023|Anticipated|2023-06-01||Observational|||MMRF Molecular Profiling Protocol|Clinical-grade Molecular Profiling of Patients With Multiple Myeloma and Related Plasma Cell Malignancies|Recruiting||N/A|500|Anticipated|Multiple Myeloma Research Foundation|||1||f||||t||||||Samples With DNA|"     bone marrow and peripheral blood samples will be obtained   "|||2017-10-10 21:51:40.091118|2017-10-10 21:51:40.091118
NCT02884089|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-12-23|||August 2016||2016-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy Participants|Effect of Abemaciclib on Metformin Pharmacokinetics and Iohexol Clearance|Completed||Phase 1|36|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 21:51:40.202772|2017-10-10 21:51:40.202772
NCT02884076|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Validation of Sodergren Score for Haemorrhoids in Malaysia|Validating the Ability of the Sodergren Score to Guide Management of Symptomatic Haemorrhoids in a Malaysian Population|Recruiting||N/A|500|Anticipated|University of Malaya|||1||f||||f||||||||No||2017-10-10 21:51:40.307165|2017-10-10 21:51:40.307165
NCT02884063|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-30|||May 2015||2015-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Observational|||Utilizing Free DNA in Embryo Culture for PGS|Utilizing Free DNA in Embryo Culture Media for Preimplantation Genetic Screening|Enrolling by invitation||N/A|100|Actual|Al Baraka Fertility Hospital|||2||f||||t||||||Samples With DNA|"     Blastomer for growing IVF embryos culture media with its free DNA   "|Yes|To publish it when it is completed|2017-10-10 21:51:40.389632|2017-10-10 21:51:40.389632
NCT02884050|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-01-09|||April 2009||2009-04-01|January 2017|2017-01-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Physiologic Effects of Topiramate on Cognition|Physiologic Effects of Topiramate on Cognition|Completed||Phase 1|11|Actual|University of Florida||2|||f||||f||||||||Undecided||2017-10-10 21:51:40.469516|2017-10-10 21:51:40.469516
NCT02884037|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-09|||May 2012||2012-05-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|May 2015|Actual|2015-05-01||Observational|||Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)|Could Rifaximin Modify the Pathogenesis of NAFLD? AMulticenter, Randomized, Double-Blind, Placebo-Controlled Trial|Completed||N/A|50|Actual|Mansoura University|||2||f||||t||||||||||2017-10-10 21:51:40.549708|2017-10-10 21:51:40.549708
NCT02884024|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||January 2011||2011-01-01|August 2016|2016-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Effects of Weight on Inflammation and Colon Cancer Risk|Study on the Effects of Weight on Inflammation and Colon Cancer Risk|Completed||N/A|43|Actual|Tufts University|||3||f||||f||||||||No||2017-10-10 21:51:40.635038|2017-10-10 21:51:40.635038
NCT02884011|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-04-11|||August 2016||2016-08-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|February 2017|Actual|2017-02-01||Observational|||Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock|Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock|Completed||N/A|133|Actual|Rush University Medical Center|||4||f||||f||||||||Undecided|To be determined|2017-10-10 21:51:40.715333|2017-10-10 21:51:40.715333
NCT02883998|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Formal vs. Home-Based Physical Therapy After Unicompartmental Knee Arthroplasty|Formal vs. Home-Based Physical Therapy After Unicompartmental Knee|Recruiting||N/A|44|Anticipated|Rush University Medical Center||2|||f||||f||||||||No||2017-10-10 21:51:40.79601|2017-10-10 21:51:40.79601
NCT02883985|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-20|||May 2000||2000-05-01|July 2017|2017-07-01||||September 2007|Actual|2007-09-01||Interventional|||Safety Study of the Hypo-fractionated (Large Doses) Radiation Therapy in Post-menopausal Women With Breast Cancers|Hypo-Fractionated Conformal Radiation Therapy to the Tumor Bed After Segmental Mastectomy|Completed||Phase 1/Phase 2|100|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 21:51:40.889404|2017-10-10 21:51:40.889404
NCT02883972|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-10-17|||September 2016||2016-09-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Childhood Influenza Immunisation Invitation Trial in Schools|Can Uptake of Childhood Influenza Immunisation Through Schools be Increased Through Behavioural-insight Informed Changes to the Invitation Process?|Enrolling by invitation||N/A|170000|Anticipated|Public Health England||4|||f||||f||||||||No||2017-10-10 21:51:40.989179|2017-10-10 21:51:40.989179
NCT02883959|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-06|||February 2013||2013-02-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2015|Actual|2015-10-01||Interventional|Painkiller||Evaluation of the Analgesic Effect of Music Therapy in Critically Ill Patients During Potentially Painful Nursing Procedures: a Pilot Study||Active, not recruiting||N/A|60|Actual|Versailles Hospital||2|||f||||f||||||||No||2017-10-10 21:51:41.084331|2017-10-10 21:51:41.084331
NCT02883946|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||June 2012||2012-06-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|February 2013|Actual|2013-02-01||Observational|RITUX-LEUKEMIA||Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study|Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study|Completed||N/A|41|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:51:41.150182|2017-10-10 21:51:41.150182
NCT02883920|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-29|||January 2007||2007-01-01|August 2016|2016-08-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Observational|VIN-ALLERGO||Work-related Respiratory Symptoms in Champagne Vineyard Workers|Work-related Respiratory Symptoms in Champagne Vineyard Workers|Completed||N/A|307|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:51:41.291692|2017-10-10 21:51:41.291692
NCT02883907|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||November 2016||2016-11-01|August 2016|2016-08-01||||March 2018|Anticipated|2018-03-01||Observational|AMROA||Advanced MR Imaging of Osteoarthritis||Not yet recruiting||N/A|15|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||2||f||||||||||||||2017-10-10 21:51:41.362642|2017-10-10 21:51:41.362642
NCT02883894|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||November 2009||2009-11-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2012|Actual|2012-04-01||Observational|Cyto-PB||Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid|Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid|Completed||N/A|120|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:51:41.423466|2017-10-10 21:51:41.423466
NCT02883881|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-14|||October 2015||2015-10-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|FROTT EYES||Correlation Between Eye Rubbing and Keratoconus Severity in a Treatment-naive Keratoconic Population||Completed||N/A|33|Actual|Centre Hospitalier Régional Metz-Thionville|||2||f||||||||||||||2017-10-10 21:51:41.491985|2017-10-10 21:51:41.491985
NCT02883868|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-14|||October 2015||2015-10-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|STROMA-CROSS||Stromal Demarcation Line: is it Predictive for Cross-Linking Efficiency?||Completed||N/A|36|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||||||||||||2017-10-10 21:51:41.554068|2017-10-10 21:51:41.554068
NCT02883855|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-14|||November 2015||2015-11-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|EP-GREFF||Impact of Graft Thickness on Visual Gain After Descemet's Stripping Automated Endothelial Keratoplasty||Completed||N/A|48|Actual|Centre Hospitalier Régional Metz-Thionville|||1||f||||||||||||||2017-10-10 21:51:41.614631|2017-10-10 21:51:41.614631
NCT02883842|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-04-26|||August 2016||2016-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study|Effectiveness of Text Messaging on Risk Factors Control and Medication Adherence Among Patients With Coronary Heart Disease and Diabetes in China: Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study|Recruiting||N/A|300|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||f||||||||Undecided||2017-10-10 21:51:41.663354|2017-10-10 21:51:41.663354
NCT02883829|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Web-Based Health Information on Risk Behavior for Youth With Type 1 Diabetes in College|Health Promotion in Transition: Effects of Web-Based Health Information on Disease Management and Risk Behavior for Youth With Type 1 Diabetes in College|Not yet recruiting||N/A|120|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:51:41.747193|2017-10-10 21:51:41.747193
NCT02883816|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-24|||August 2008||2008-08-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Early Assessment of Respiratory Function, Inflammation and Bronchial Reshuffle Among Newborns Screened for Cystic Fibrosis|Early Assessment of Respiratory Function, Inflammation and Bronchial Reshuffle Among Newborns Screened for Cystic Fibrosis|Completed||N/A|52|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 21:51:41.822896|2017-10-10 21:51:41.822896
NCT02883803|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||December 2016||2016-12-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|CSM choc||Effects of Administration of Mesenchymal Stem Cells on Organ Failure During the Septic Shock|Effects of Administration of Mesenchymal Stem Cells on Organ Failure During the Septic Shock: Pilot Study|Not yet recruiting||N/A|60|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||No||2017-10-10 21:51:41.88663|2017-10-10 21:51:41.88663
NCT02883790|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-08-25|||October 2015||2015-10-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients|Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled, Study to Evaluate the Effects of Melatonin (Somnage®- Food Supplement) in the Management on Sleep Quality and Mood Alteration in Cancer Patients|Recruiting||N/A|190|Anticipated|Helsinn Healthcare SA||2|||f||||f||||||||No||2017-10-10 21:51:41.977152|2017-10-10 21:51:41.977152
NCT02883777|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-29|||April 2016||2016-04-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of a High Protein and Low Glycemic Index Diet on Kidney Transplant Recipients|Effect of a High Protein and Low Glycemic Index Diet on Kidney Transplant|Enrolling by invitation||N/A|120|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:51:42.070944|2017-10-10 21:51:42.070944
NCT02883764|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-02-15|||May 2016||2016-05-01|February 2017|2017-02-01|December 2, 2016|Actual|2016-12-02|December 1, 2016|Actual|2016-12-01||Observational|||Cross-sectional Survey of Omega-3 Fatty Acid Blood Levels|Cross-sectional Survey of Omega-3 Fatty Acid Blood Levels|Completed||N/A|834|Actual|DSM Nutritional Products, Inc.|||1||f||||f||||||||Undecided||2017-10-10 21:51:42.160363|2017-10-10 21:51:42.160363
NCT02883751|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-29|||January 2017||2017-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Phototherapy in DM Amputation Ulcers.|Effects of Phototherapy on the Healing of Ulcers Following Minor Lower Extermity Amputations in Patients With Diabetes Mellitus - Protocol for a Randomized, Controlled, Double-blind, Clinical Trial|Not yet recruiting||N/A|40|Anticipated|University of Nove de Julho||2|||f||||t||||||||Undecided||2017-10-10 21:51:42.23816|2017-10-10 21:51:42.23816
NCT02883738|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-24|||March 2010||2010-03-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Evaluation the Effect of Muscle Functional Electrical Stimulation in the Upper Limb Tremor Invalidating||Completed||N/A|35|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 21:51:42.341646|2017-10-10 21:51:42.341646
NCT02883725|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-21|||November 2008||2008-11-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|REGATE||National Register of Oesophageal Atresia|National Register of Oesophageal Atresia|Recruiting||N/A|2500|Anticipated|University Hospital, Lille|||1||f||||f||||||||No||2017-10-10 21:51:42.401276|2017-10-10 21:51:42.401276
NCT02883712|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-22|||May 21, 2013|Actual|2013-05-21|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|RESISTANT||Study of Predictors of Response to Anti Epilepsy in Epilepsy|Study of Predictors of Response to Anti Epilepsy in Epilepsy|Recruiting||N/A|1000|Anticipated|University Hospital, Lille|||1||f||||f||||||Samples With DNA|"     plasmatic and serum samples for the dosage of the drugs Leucocytes for the intracellular     dosage of the drugs DNA for pharmacogenetics analysis of the metabolism and pharmacodynamic     targets of the drugs DNA for the genetic causes of epilepsy   "|||2017-10-10 21:51:42.571859|2017-10-10 21:51:42.571859
NCT02883699|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|TOP||Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study|Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study|Not yet recruiting||N/A|160|Anticipated|University Hospital Heidelberg||4|||f||||f||||||||No||2017-10-10 21:51:42.697517|2017-10-10 21:51:42.697517
NCT02883686|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-24|||July 2017||2017-07-01|August 2016|2016-08-01||||December 2019|Anticipated|2019-12-01||Interventional|M4M||Mom for Moms Study: Peer Delivery of Behavioral Activation for Depression During Pregnancy|The Effectiveness of Disseminating Behavioral Activation Using Peer Delivery for Pregnant Women With Depression|Not yet recruiting||N/A|140|Anticipated|University of Colorado, Boulder||2|||f||||t||||||||Yes|The investigators plan to comply with National Institute of Mental Health guidelines for data sharing.|2017-10-10 21:51:42.794507|2017-10-10 21:51:42.794507
NCT02883673|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-12-03|||November 2016||2016-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Effectiveness of the InPress Device in Treating Primary Postpartum Hemorrhage|Prospective, Single Arm Pivotal Clinical Trial Designed to Assess the Safety and Performance of the InPress Device in Treating Primary Postpartum Hemorrhage|Recruiting||N/A|150|Anticipated|InPress Technologies||1|||f||||f||||||||No||2017-10-10 21:51:43.03134|2017-10-10 21:51:43.03134
NCT02883660|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-08-24|||February 2013||2013-02-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Observational|||Genecept Assay and Adverse Effects of Antidepressants|Genecept Assay and Adverse Effects of Antidepressants|Recruiting||N/A|100|Anticipated|Thomas Jefferson University|||2||f||||f||||||||Yes|no plan to make IPD available|2017-10-10 21:51:43.180485|2017-10-10 21:51:43.180485
NCT02883647|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-08-24|||January 2014||2014-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b|Clinical Investigation About Therapeutic Effects and Long-term Follow-up After Ending Anti-hepatitis B Virus Therapy With Nucleos(t)Ide Analogs in Patients With Chronic Hepatitis b|Recruiting||N/A|100|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||2||f||||t||||||||||2017-10-10 21:51:43.300895|2017-10-10 21:51:43.300895
NCT02883634|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-30|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Specific or Non-Specific Manipulation for Patients With Back Pain|Short, Medium and Long Term Effects of Specific and Nonspecific Spinal Manipulative Therapy in Patients With Chronic Non-specific Low Back Pain: A Randomized Controlled Trial|Not yet recruiting||N/A|148|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||f||||||||Undecided|We are happy to share our data with researchers that would like to use it on an IPD.|2017-10-10 21:51:43.418378|2017-10-10 21:51:43.418378
NCT02883621|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-05-22|||September 2016||2016-09-01|May 2017|2017-05-01|May 22, 2017|Actual|2017-05-22|April 2017|Actual|2017-04-01||Interventional|Kappa-III||The Diagnostic Yield of Cap Assisted Upper Endoscopy in Esophagus|Comparison Between Standard Endoscopy and Cap Assisted Endoscopy for Diagnostic Yield in Esophagus|Completed||N/A|1000|Actual|Technische Universität München||2|||f||||f||||||||No||2017-10-10 21:51:43.538171|2017-10-10 21:51:43.538171
NCT02883608|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-05-22|||August 2016||2016-08-01|May 2017|2017-05-01|January 22, 2017|Actual|2017-01-22|October 2016|Actual|2016-10-01||Interventional|KappaII||Cap Assisted Forward-Viewing Endoscope vs Side-Viewing Endoscope for Examination of Major Duodenal Papilla|Cap Assisted Forward-Viewing Endoscope vs Side-Viewing Endoscope for Examination of Major Duodenal Papilla|Completed||N/A|63|Actual|Technische Universität München||2|||f||||f||||||||No||2017-10-10 21:51:43.637609|2017-10-10 21:51:43.637609
NCT02883595|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-24|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis|Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis|Recruiting||Phase 4|28|Anticipated|Sun Yat-sen University||2|||f||||f||||||||Undecided||2017-10-10 21:51:43.73245|2017-10-10 21:51:43.73245
NCT02883582|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-24|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Adjuvant Therapy for Severe Asthma by an Oxyhydrogen Generator With Nebulizer|Adjuvant Therapy for Severe Asthma by an Oxyhydrogen Generator With Nebulizer: A Multi-centric, Randomized, Parallel-control and Double-blinded Clinic Study on Effectiveness and Safety|Recruiting||N/A|150|Anticipated|Shanghai Asclepius Meditec Inc.||2|||f||||t||||||||Yes|The main evaluation index and the secondary evaluation index of all participants will be share in 3 months after the end of this study.|2017-10-10 21:51:43.866428|2017-10-10 21:51:43.866428
NCT02883569|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-11-26|||September 2016||2016-09-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|CES_SNS_LBP||Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain|Randomized Control Trial. Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain|Recruiting||N/A|1102|Anticipated|Seoul National University Hospital||8|||f||||t||||||||Undecided||2017-10-10 21:51:44.039894|2017-10-10 21:51:44.039894
NCT02883361|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-30|||October 2016||2016-10-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|MI for AIs||Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors|Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors|Not yet recruiting||Phase 2/Phase 3|128|Anticipated|University of Calgary||2|||f||||f||||||||Undecided||2017-10-10 21:51:45.697399|2017-10-10 21:51:45.697399
NCT02883543|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-29|||June 2016||2016-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation|Phase III Study of Icotinib With Concurrent Radiotherapy as First-line Treatment for Unresectable/Oligometastasis NSCLC With EGFR Activating Mutation: a Prospective, Multicentre, Open-label, Randomised Study|Active, not recruiting||Phase 3|330|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||3|||f||||t||||||||No||2017-10-10 21:51:44.314741|2017-10-10 21:51:44.314741
NCT02883530|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-02|||October 2016||2016-10-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study|Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study|Not yet recruiting||N/A|160|Anticipated|University of Leicester|||3||f||||f||||||Samples With DNA|"     Blood, Blood DNA, broncial bipsies and brushings Sputum   "|Undecided||2017-10-10 21:51:44.401032|2017-10-10 21:51:44.401032
NCT02883517|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-02-22|||November 2016|Actual|2016-11-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|MATULILA||Cell-free Circulating DNA in Primary Cutaneous Lymphomas|Detection of Somatic Mutations on Cell-free Circulating DNA in Potentially Aggressive Cutaneous Lymphomas|Recruiting||N/A|40|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||Samples With DNA|"     a collection of plasma collected at different times during the management of patients with     aggressive cutaneous lymphomas followed at the University Hospital of Bordeaux.      Collection of tumor tissue biopsies for Next Generation Sequencing analysis   "|No||2017-10-10 21:51:44.500923|2017-10-10 21:51:44.500923
NCT02883504|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-05|||November 2014||2014-11-01|August 2016|2016-08-01||||August 2016|Actual|2016-08-01||Interventional|EUROFILLING||Validation Study of the Accuracy of E/e' in Estimating Left Ventricular Filling Pressure|Validation Study of the Accuracy of E/e' in Estimating Left Ventricular Filling Pressure|Completed||N/A|85|Actual|Rennes University Hospital||1|||f||||||||||||||2017-10-10 21:51:44.613099|2017-10-10 21:51:44.613099
NCT02883491|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-04-21|||August 2016||2016-08-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|PE-SCOR||Pulmonary Embolism Short-term Clinical Outcomes Registry|Pulmonary Embolism Short-term Clinical Outcomes Registry (PE-SCOR)|Recruiting||N/A|880|Anticipated|Carolinas Healthcare System|||1||f||||f|f|f||||||No||2017-10-10 21:51:44.704426|2017-10-10 21:51:44.704426
NCT02883478|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-08-24|||August 2012||2012-08-01|August 2016|2016-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|CXL||Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).|A Randomized Study of Clinical and Structural Outcome of Corneal Collagen Crosslinking (CXL) With Conventional Versus Accelerated Ultraviolet-A Irradiation Using Riboflavin With Hydroxypropyl Methylcellulose (HPMC).|Active, not recruiting||Phase 1/Phase 2|40|Actual|Oslo University Hospital||2|||f||||t||||||||No||2017-10-10 21:51:44.811906|2017-10-10 21:51:44.811906
NCT02883465|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-08-25|||March 2015||2015-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|ECHODIAPH II||Ultrasound Diagnostic for Diaphragmatic Dysfunction in Reanimation|Ultrasound Diagnostic for Diaphragmatic Dysfunction in Reanimation and Influence Over Mechanical Ventilation Weaning Period|Recruiting||N/A|180|Anticipated|Centre Hospitalier Saint Joseph Saint Luc de Lyon||1|||f||||f||||||||||2017-10-10 21:51:44.894809|2017-10-10 21:51:44.894809
NCT02883452|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-05-09|||September 12, 2016|Actual|2016-09-12|August 2016|2016-08-01|September 28, 2019|Anticipated|2019-09-28|February 23, 2019|Anticipated|2019-02-23||Interventional|||A Phase I Study to Evaluate PK, Efficacy and Safety of CT-P13 SC in Patients With Active CD and UC|An Open-label, Randomized, Parallel-Group, Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety Between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients With Active Crohn's Disease and Active Ulcerative Colitis|Active, not recruiting||Phase 1|170|Anticipated|Celltrion||2|||f||||t||||||||No||2017-10-10 21:51:45.006816|2017-10-10 21:51:45.006816
NCT02883439|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|BIODYMF||Open Label Two -Treatment Half Side Comparative Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasoen Propionate|Open Label Two -Treatment Half Side Comparative Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasoen Propionate|Recruiting||N/A|24|Anticipated|University Hospital, Ghent||2|||f||||f||||||||No||2017-10-10 21:51:45.156101|2017-10-10 21:51:45.156101
NCT02883426|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-07-17|||September 2016||2016-09-01|July 2017|2017-07-01||||April 2018|Anticipated|2018-04-01||Interventional|||Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease|Evaluation of the Safety and Immunogenicity of Live Influenza A Vaccine H3N2v (6-2) AA ca Recombinant (A/Minnesota/11/2010 (H3N2v) x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H3N2v Disease|Active, not recruiting||Phase 1|83|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||t||||||||||2017-10-10 21:51:45.282178|2017-10-10 21:51:45.282178
NCT02883413|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-31|||August 2016||2016-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cognitive Remediation Therapy for Adolescents With Anorexia Nervosa|An Investigation of Cognitive Remediation Therapy as an Inpatient Intervention for Adolescents With Anorexia Nervosa|Enrolling by invitation||N/A|80|Anticipated|Children's Hospital of Philadelphia||3|||f||||f||||||||||2017-10-10 21:51:45.385861|2017-10-10 21:51:45.385861
NCT02883400|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-07-31|||December 2014||2014-12-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Spironolactone After Liver Transplant|Spironolactone to Prevent or Delay CNI Toxicity in Liver Transplant Recipients|Recruiting||Phase 4|36|Anticipated|Carolinas Healthcare System||2|||f||||f||||||||||2017-10-10 21:51:45.475116|2017-10-10 21:51:45.475116
NCT02883387|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-07-17|||September 2016||2016-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||CT-Angiography Prior to DIEP Flap Breast Reconstruction|CT-Angiography Prior to DIEP Flap Breast Reconstruction a Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||||2017-10-10 21:51:45.545649|2017-10-10 21:51:45.545649
NCT02883374|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-08-30|||November 2016||2016-11-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety|Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety|Recruiting||Phase 2|30|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 21:51:45.622547|2017-10-10 21:51:45.622547
NCT02883348|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-29|||October 2008||2008-10-01|August 2016|2016-08-01|January 2012|Actual|2012-01-01|October 2008|Actual|2008-10-01||Observational|SATISQOL||Satisfaction With Care and Quality of Life|Satisfaction With Care and Quality of Life After Hospital Stay for Chronic Disease|Completed||N/A|1520|Actual|Central Hospital, Nancy, France|||1||f||||t||||||||Yes|open to partnership|2017-10-10 21:51:45.771256|2017-10-10 21:51:45.771256
NCT02883335|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-25|||May 2003||2003-05-01|August 2016|2016-08-01||||January 2020|Anticipated|2020-01-01|30 Years|Observational [Patient Registry]|RelSEP||Lorraine Registry of Multiple Sclerosis|Lorraine Registry of Multiple Sclerosis|Recruiting||N/A|6000|Anticipated|Central Hospital, Nancy, France|||1||f||||t||||||||Yes|open to partnership|2017-10-10 21:51:45.823089|2017-10-10 21:51:45.823089
NCT02883322|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-25|||December 2010||2010-12-01|August 2016|2016-08-01||||September 2012|Actual|2012-09-01||Observational|APPROVALS||Adaptation Process of Patient-Reported Outcomes, an eVALuation Study|Adaptation Process of Patient-Reported Outcomes, an eVALuation Study|Completed||N/A|4000|Actual|Central Hospital, Nancy, France|||4||f||||f||||||||No||2017-10-10 21:51:45.897522|2017-10-10 21:51:45.897522
NCT02883309|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-28|||November 2013||2013-11-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Expanded Access|PTH-CKD0113||Efficacy of an Intradialysis Combined Training Program on Disability Level and Physical Performance.|Efficacy of an Intradialysis Combined Muscle Strength and Cardiorespiratory Capacity Training Program on Disability Level and Physical Performance, in Patients With Chronic Renal Failure at a Kidney Replacement Therapy Unit.|Approved for marketing||N/A|||Universidad Austral de Chile|||||f||||||||||||||2017-10-10 21:51:45.974904|2017-10-10 21:51:45.974904
NCT02883296|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||April 2011||2011-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|FISTULE||Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences|Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences|Active, not recruiting||N/A|15|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:51:46.057394|2017-10-10 21:51:46.057394
NCT02883283|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-08-24|||May 2013||2013-05-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|January 2014|Actual|2014-01-01||Interventional|||Epidural Loading Prior to Catheter Insertion|Epidural Loading Prior to Catheter Insertion: An Alternative to the Combined Spinal-epidural Technique?|Active, not recruiting||N/A|60|Actual|Ohio State University||2|||f||||f||||||||No||2017-10-10 21:51:46.175393|2017-10-10 21:51:46.175393
NCT02883270|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-09-01|||August 2014||2014-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome|Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome : A Randomized Controlled Trial|Completed||N/A|24|Actual|Tianjin Medical University General Hospital||2|||f||||t||||||||No||2017-10-10 21:51:46.271167|2017-10-10 21:51:46.271167
NCT02883257|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-07-07|||August 2016||2016-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical and Biological Markers of Response to Cognitive Behavioural Therapy for Depression|Clinical and Biological Markers of Response to Cognitive Behavioural Therapy for Depression|Active, not recruiting||N/A|40|Anticipated|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-10-10 21:51:46.386454|2017-10-10 21:51:46.386454
NCT02883244|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-05-17|||December 2016||2016-12-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Curved Soft-Picks on Plaque Accumulation on Patients With Gingivitis|Effect of Curved Design Soft-Picks on Plaque Accumulation on Patients With Signs of Gingivitis|Completed||N/A|50|Actual|Sunstar Americas||2|||f||||f|f|||||||No||2017-10-10 21:51:46.496229|2017-10-10 21:51:46.496229
NCT02883231|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||April 2016||2016-04-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance|Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance|Recruiting||N/A|60|Anticipated|Southeast University, China|||1||f||||t||||||||No||2017-10-10 21:51:46.588107|2017-10-10 21:51:46.588107
NCT02883218|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-09-21|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|CSIP||Observational Study to Understand the Impact of Community-acquired Sepsis Patients'Immunosuppression in Early Stage to Prognosis|Observational Study to Understand the Impact of Community-acquired Sepsis Patients'Immunosuppression in Early Stage to Prognosis|Completed||N/A|74|Actual|Southeast University, China|||1||f||||t||||||Samples Without DNA|"     whole blood, serum   "|||2017-10-10 21:51:46.670534|2017-10-10 21:51:46.670534
NCT02883205|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||January 2015||2015-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|TARIFF||Diagnosis of Fabry Disease: Impact of an Educational Brochure Intended for Cardiologist|Diagnosis of Fabry Disease: Impact of an Educational Brochure Intended for Cardiologist|Recruiting||N/A|50|Anticipated|University Hospital, Caen|||1||f||||f||||||||No||2017-10-10 21:51:46.726803|2017-10-10 21:51:46.726803
NCT02883192|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-30|||February 2016||2016-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||The Effect of Preventive Use of Ondansetron in the Cesarean Section Under Spinal Anesthesia|The Effect of Preventive Use of Ondansetron on the Blood Pressure and Vasopressor Consumption in the Cesarean Section Under Spinal Anesthesia|Recruiting||N/A|100|Anticipated|Bnai Zion Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:51:46.788848|2017-10-10 21:51:46.788848
NCT02883179|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-07-11|||October 2016||2016-10-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|LPPT||Pain Relief During Repair of Postpartum Perineal Tears|Topical Lidocaine-prilocaine Cream Versus Lidocaine Infiltration for Pain Relief During Repair of Postpartum Perineal Tears: A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|144|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 21:51:46.869161|2017-10-10 21:51:46.869161
NCT02883166|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-09-26|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|SNACK||Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake|Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake|Recruiting||Phase 1|24|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-10 21:51:46.941437|2017-10-10 21:51:46.941437
NCT02883153|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-06-16|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Interventional|||Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma|Zirconium-89-girentuximab PET/CT Imaging in Patients Suspected of Primary or Relapse Clear Cell Renal Cell Carcinoma: The Impact on Clinical Decision Making.|Completed||Phase 2/Phase 3|30|Actual|Radboud University||1|||f||||f||||||||No|Data will be published anonymously|2017-10-10 21:51:47.020393|2017-10-10 21:51:47.020393
NCT02883140|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-08-24|||September 2016||2016-09-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|PIGS||Imaging Study of 3D-CBCT Sialography and MRI Sialography in Non Tumor Salivary Diseases|Prospective, Pilot, Comparative, Monocentric Study of Diagnosis Capabilities of the Three-dimensional Cone-Beam CT Sialography (3D-CBCT Sialography) and MRI Sialography in Non-tumor Salivary Diseases|Not yet recruiting||N/A|50|Anticipated|Nantes University Hospital|||1||f||||f||||||||Undecided|Not applicable now.|2017-10-10 21:51:48.762088|2017-10-10 21:51:48.762088
NCT02883127|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-09-26|||August 2015||2015-08-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|August 28, 2018|Anticipated|2018-08-28||Observational|||Motivational Interviewing With Focus on Diet and Weight Gain in Pregnant Women With Type 2 Diabetes|The Effect of Motivational Interviewing With Focus on Diet and Weight Gain on Prevention of Excessive Fetal Growth in Pregnant Women With Type 2 Diabetes|Recruiting||N/A|300|Anticipated|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-10 21:51:48.839528|2017-10-10 21:51:48.839528
NCT02883114|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-12-19|||September 2016||2016-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults.|A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06648671 In Healthy Adults|Completed||Phase 1|12|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 21:51:48.971298|2017-10-10 21:51:48.971298
NCT02883101|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-07-03|||June 2015||2015-06-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||The Effects of Pulmonary Rehabilitation in Patients With Non-cystic Fibrosis Bronchiectasis|The Effects of Pulmonary Rehabilitation in Patients With Non-cystic Fibrosis Bronchiectasis: A Randomised Controlled Trial|Completed||N/A|60|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-10-10 21:51:49.066808|2017-10-10 21:51:49.066808
NCT02883088|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||January 2013||2013-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01|3 Years|Observational [Patient Registry]|CLIMA||Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome|Relationship Between Coronary Plaque Morphology of Left Anterior Descending Artery and Long Term Clinical Outcome: the CLIMA Study|Recruiting||N/A|700|Anticipated|San Giovanni Addolorata Hospital|||1||f||||t||||||||No||2017-10-10 21:51:49.141489|2017-10-10 21:51:49.141489
NCT02883075|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-24|||August 2016||2016-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Measurement of Hemodynamic Variables Under Spinal Anesthesia With Varied Positioning|Measurement of Hemodynamic Variables Under Spinal Anesthesia in a Patient Undergoing Cesarean Section With Varied Positioning - a Comparative Study|Not yet recruiting||N/A|90|Anticipated|The University of Texas Medical Branch, Galveston||3|||f||||t||||||||No||2017-10-10 21:51:49.293864|2017-10-10 21:51:49.293864
NCT02883062|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-29|2017-05-01|||May 25, 2017|Anticipated|2017-05-25|May 2017|2017-05-01|September 17, 2019|Anticipated|2019-09-17|August 31, 2018|Anticipated|2018-08-31||Interventional|||Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer|Atezolizumab (MPDL3280A) in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer (TNBC)|Not yet recruiting||Phase 2|60|Anticipated|National Cancer Institute (NCI)||2|||f||||t|t|f||||||||2017-10-10 21:51:49.374319|2017-10-10 21:51:49.374319
NCT02883036|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-24|||September 2016||2016-09-01|August 2016|2016-08-01||||September 2021|Anticipated|2021-09-01||Observational|||Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia|Changes of Mitochondrial Biogenesis and Metabolic Characteristics About Tigecycline to Treat Chronic Myeloid Leukemia in Vitro|Not yet recruiting||N/A|100|Anticipated|Nanfang Hospital of Southern Medical University|||2||f||||t||||||Samples With DNA|"     mononuclear cells of bone marrow and/or peripheral blood   "|Undecided||2017-10-10 21:51:50.748456|2017-10-10 21:51:50.748456
NCT02883023|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-06-26|||November 2016||2016-11-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Electrosclerotherapy for Capillary Malformations|Electrosclerotherapy as a Novel Treatment Option for Capillary Malformations: A Pilot Study|Recruiting||Phase 2|20|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||t||||||||No||2017-10-10 21:51:50.858596|2017-10-10 21:51:50.858596
NCT02883010|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-01-25|||January 2017|Anticipated|2017-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Comparison of Surgical Incision Complications in Patients Receiving PICO or Standard Care Following Colorectal Surgery|A Randomised Controlled Study to Compare Surgical Site Complication Incidence in Subjects Receiving PICO or Standard Care Following Colorectal Surgery|Withdrawn||Phase 4|0|Actual|Smith & Nephew, Inc.||2||Business decision|f||||f||||||||No||2017-10-10 21:51:50.963993|2017-10-10 21:51:50.963993
NCT02882997|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-24|||November 2013||2013-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|DDPHme/Hsp||An Interactive Computer Game, Called Duck Duck Punch, for Stroke Rehabilitation at Home and in a Rehabilitation Clinic|A Virtual Environment for Post-Stroke Upper Extremity Rehabilitation|Completed||Phase 1/Phase 2|40|Actual|Medical University of South Carolina||2|||f||||f||||||||Yes||2017-10-10 21:51:51.063346|2017-10-10 21:51:51.063346
NCT02882984|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-29|||March 2015||2015-03-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|Hybrid||Hypofractionated Brain Radiation In EGFR Mutated Adenocarcinoma Cranial Disease (Hybrid)|Comparing Whole Brain Radiation With Hypofractionated Stereotactic RadioSurgery (HFSRS) in Patients With NSCL Brain Metastases|Recruiting||Phase 3|325|Anticipated|Sichuan Provincial People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:51:51.201217|2017-10-10 21:51:51.201217
NCT02882971|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-10-14|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Objective Pain Score for Chronic Pain Clinic Patients|Objective Pain Score for Chronic Pain Clinic Patients|Recruiting||N/A|100|Anticipated|Milton S. Hershey Medical Center|||1||f||||f||||||||No||2017-10-10 21:51:51.350493|2017-10-10 21:51:51.350493
NCT02882958|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-30|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate|Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital|||1||f||||||||||||||2017-10-10 21:51:51.461798|2017-10-10 21:51:51.461798
NCT02882945|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||May 2015||2015-05-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Gene Polymorphism Associated With Macroangiopathy in Type 2 Diabetes Patients|Polymorphism Analysis of HLA-DRB1*04 Alleles in Patients With Type 2 Diabetic Macroangiopathy in Northeast Chinese|Completed||N/A|470|Actual|First Affiliated Hospital of Harbin Medical University|||3||f||||t||||||Samples With DNA|"     Laboratory analysis Blood samples were collected after over-night fasting, and serum was     stored at −20°C.   "|Undecided||2017-10-10 21:51:51.546198|2017-10-10 21:51:51.546198
NCT02882932|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2016-08-24|||December 2014||2014-12-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Comparative Evaluation of Intra-operative Peritoneal Lavage With Super Oxidized Solution and Normal Saline in Peritonitis Cases||Completed||Phase 2|290|Actual|Maharishi Markendeswar University||2|||f||||t||||||||No||2017-10-10 21:51:51.629367|2017-10-10 21:51:51.629367
NCT02882919|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Check Yourself v2.0|Improving Teen Health With Health Information Technology|Recruiting||N/A|300|Anticipated|Seattle Children's Hospital||2|||f||||f||||||||No||2017-10-10 21:51:51.710859|2017-10-10 21:51:51.710859
NCT02882906|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-25|||February 2016||2016-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Observational|||Myofascial Trigger Points in the Upper Limb in Stroke Patients|Myofascial Trigger Points Are Associated in the Upper Limb in Stroke Patients: a Cross Sectional Study|Completed||N/A|50|Actual|Fondazione Don Carlo Gnocchi Onlus|||1||f||||f||||||||No||2017-10-10 21:51:51.829982|2017-10-10 21:51:51.829982
NCT02882893|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines|Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines: Active Controlled, Double-blind, Randomized, Multi-center, Phase II/III Clinical Trial|Recruiting||Phase 2/Phase 3|238|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||No||2017-10-10 21:51:51.905783|2017-10-10 21:51:51.905783
NCT02882880|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-08-24|||July 2015||2015-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|LucoHybrid||Treatment Sleep Bruxism With the Luco Hybrid OSA Appliance|The Treatment of Sleep Bruxism With the Luco Hybrid OSA Appliance|Completed||N/A|51|Actual|Luco Hybrid OSA Appliance Inc.||2|||f||||f||||||||Yes|I wish to publish articles in the American Dental Association Journal and Sleep using this data.|2017-10-10 21:51:51.997181|2017-10-10 21:51:51.997181
NCT02882867|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Injuries in Swedish Youth Athletics. The KLUB-study.|Injuries in Swedish Youth Athletics. The KLUB-study.|Active, not recruiting||N/A|150|Anticipated|Linkoeping University|||1||f||||f||||||||No||2017-10-10 21:51:52.589057|2017-10-10 21:51:52.589057
NCT02882854|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Guanfacine for PONV and Pain After Sinus Surgery|Guanfacine for PONV and Pain After Sinus Surgery|Recruiting||N/A|80|Anticipated|Vanderbilt University||2|||f||||f||||||||No||2017-10-10 21:51:52.691459|2017-10-10 21:51:52.691459
NCT02882841|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2017-09-06|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MOBIDIC||MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients|MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients (MOBIDIC)|Active, not recruiting||N/A|300|Anticipated|Enterome||1|||f||||f||||||||||2017-10-10 21:51:52.867843|2017-10-10 21:51:52.867843
NCT02882828|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-06-15|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|ENVARSWITCH||PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)|Pharmacokinetic Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)|Recruiting||Phase 4|140|Anticipated|University Hospital, Limoges||1|||f||||f||||||||No||2017-10-10 21:51:52.968155|2017-10-10 21:51:52.968155
NCT02882815|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-09-01|||September 2014||2014-09-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PFO||Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder|Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale)|Recruiting||N/A|105|Anticipated|Lifetech Scientific (Shenzhen) Co., Ltd.||1|||f||||f||||||||||2017-10-10 21:51:53.263872|2017-10-10 21:51:53.263872
NCT02882802|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-07-31|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|April 1, 2020|Anticipated|2020-04-01|December 31, 2019|Anticipated|2019-12-31||Interventional|||Mindfulness Treatment for Anger in Veterans With PTSD|Effects of Stress on Reaction Time in Combat Exposed Military Veterans|Not yet recruiting||N/A|60|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:51:53.381428|2017-10-10 21:51:53.381428
NCT02882581|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-25|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Metformin in Breast Cancer, Visualized With Positron Emission Tomography|Metformin in Breast Cancer, Visualized With Positron Emission Tomography|Recruiting||Phase 1|10|Anticipated|Aarhus University Hospital||1|||f||||t||||||||No||2017-10-10 21:51:55.046082|2017-10-10 21:51:55.046082
NCT02882789|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-03-10|||September 2016||2016-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||IV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers|A Randomized, Single Blind, Single Dose, Phase I Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Intravenous Dosage Form of LCB01-0371 in Healthy Male Volunteers|Recruiting||Phase 1|24|Anticipated|LegoChem Biosciences, Inc||3|||f||||f||||||||Undecided||2017-10-10 21:51:53.480869|2017-10-10 21:51:53.480869
NCT02882776|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-24|||December 2013||2013-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Daily Ginger Drinking and Platelet Function|The Effect of Daily Ginger Drinking on Platelet's Function in the Saudi Population|Completed||N/A|40|Actual|King Abdullah International Medical Research Center||2|||f||||t||||||||Yes|Undecided|2017-10-10 21:51:53.572965|2017-10-10 21:51:53.572965
NCT02882763|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-09-02|||September 2011||2011-09-01|September 2016|2016-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|ZEPPELIN||Early Support From Birth Onwards: ZEPPELIN|Zurich Equity Prevention Project Parental Participation and Integration|Active, not recruiting||N/A|213|Actual|University of Applied Sciences of Special Needs Education||2|||f||||t||||||||Yes|After summer 2017 at the Swiss Centre of Expertise in the Social Sciences (FORS)|2017-10-10 21:51:53.669528|2017-10-10 21:51:53.669528
NCT02882750|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-08-24|||November 2016||2016-11-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Observational|LILAC||Effect on Patient Reported Outcomes of VATS and SABR (LILAC)|Curative Treatment Modalities of Early Stages Non-Small Cell Lung Cancer: Effect on Patient Reported Outcomes of Video Assisted Thoracoscopic (VATS) Resection and Stereotactic Ablative Body Radiotherapy (SABR)|Not yet recruiting||N/A|300|Anticipated|University of Leeds|||2||f||||f||||||||Undecided||2017-10-10 21:51:53.801283|2017-10-10 21:51:53.801283
NCT02882737|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-07-20|||September 2016||2016-09-01|September 2016|2016-09-01|July 11, 2017|Actual|2017-07-11|July 11, 2017|Actual|2017-07-11||Interventional|||The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus|The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus|Completed||N/A|14|Actual|Hvidovre University Hospital||3|||f||||t||||||||||2017-10-10 21:51:53.889246|2017-10-10 21:51:53.889246
NCT02882724|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-29|||January 2016||2016-01-01|August 2016|2016-08-01||||April 2016|Actual|2016-04-01||Interventional|||Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise Training|Effect Aquatic Exercise Training on Patients With Multiple Sclerosis|Completed||Phase 1|32|Actual|University of Isfahan||2|||f||||||||||||||2017-10-10 21:51:54.012714|2017-10-10 21:51:54.012714
NCT02882711|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-07|||August 2016||2016-08-01|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||The UTHealth Ketamine Project|A Naturalistic Study of Serial Infusion of Low-dose Ketamine for Treatment Resistant Depressive Disorders in an Academic Psychiatric Hospital: The UTHealth Ketamine Project|Enrolling by invitation||Phase 2|30|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||||||||||||2017-10-10 21:51:54.090856|2017-10-10 21:51:54.090856
NCT02882698|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-04-08|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Performance Analysis in Down Syndrome on Mobile Phone|Performance Analysis in Down Syndrome Through a Maze Game on Mobile Phone|Completed||N/A|100|Actual|University of Sao Paulo||4|||f||||f||||||||Undecided||2017-10-10 21:51:54.197143|2017-10-10 21:51:54.197143
NCT02882685|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-23|2016-10-24|||July 2016||2016-07-01|October 2016|2016-10-01|December 2026|Anticipated|2026-12-01|December 2018|Anticipated|2018-12-01||Interventional|RYSA||Comparison of Mini Gastric Bypass and Roux-en-Y Gastric Bypass|Comparison of Two Operative Techniques - Mini Gastric Bypass and Roux-en-Y Gastric Bypass in the Treatment of Severe Obesity|Recruiting||N/A|120|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||No||2017-10-10 21:51:54.295287|2017-10-10 21:51:54.295287
NCT02882672|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-29|||January 2016||2016-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Changes in Adiponectin and Cardiovascular Disease Risk Factors in Overweight Patients|Exercise-based Cardiac Rehabilitation|Completed||Phase 1|60|Actual|University of Isfahan||2|||f||||t||||||||No||2017-10-10 21:51:54.403744|2017-10-10 21:51:54.403744
NCT02882659|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-24|||August 2014||2014-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Interventional|||Dendritic Killer Cell-based Immunotherapy for Solid Tumors|Phase I Clinical Trial of Autologous Dendritic Killer Cell-based Immunotherapy for Solid Tumors|Active, not recruiting||Phase 1|18|Anticipated|FullHope Biomedical Co., Ltd.||1|||f||||t||||||||Undecided||2017-10-10 21:51:54.479077|2017-10-10 21:51:54.479077
NCT02882646|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-29|||April 2016||2016-04-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|BiADLER||Usability Testing of a Bilateral Activities of Daily Exercise Robot for Stroke Therapy|Usability Testing of a Bilateral Activities of Daily Exercise Robot for Stroke Therapy|Recruiting||N/A|18|Anticipated|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 21:51:54.572177|2017-10-10 21:51:54.572177
NCT02882633|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-07-25|||November 2015||2015-11-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy|Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy: A Non-inferiority Study|Recruiting||N/A|50|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 21:51:54.671236|2017-10-10 21:51:54.671236
NCT02882620|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-24|||October 2016||2016-10-01|August 2016|2016-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Enhancing Prevention Pathways Toward Tribal Colorectal Health|Enhancing Prevention Pathways Toward Tribal Colorectal Health|Not yet recruiting||N/A|1750|Anticipated|University of New Mexico||3|||f||||t||||||||Undecided||2017-10-10 21:51:54.76523|2017-10-10 21:51:54.76523
NCT02882607|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-09-09|||May 2009||2009-05-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|July 2014|Actual|2014-07-01||Interventional|||Peer Groups for Healthy Pregnancy & HIV Prevention for Young Malawian Women|Peer Groups for Healthy Pregnancy & HIV Prevention for Young Malawian Women|Completed||N/A|810|Actual|University of Illinois at Chicago||2|||f||||f||||||||No|Deidentified data will be made available 5 yrs. after study completion by request to the PI|2017-10-10 21:51:54.873905|2017-10-10 21:51:54.873905
NCT02882594|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-28|||March 2016||2016-03-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Testing the Reliability and Validity of the CIBA||Completed||N/A|384|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||||||||||||2017-10-10 21:51:54.95395|2017-10-10 21:51:54.95395
NCT02882568|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-08-24|||August 2014||2014-08-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|February 2016|Actual|2016-02-01||Interventional|ARIIBO||Analysis of Immune Response In Bacterial Infection of Obese Subject|Analysis of Immune Response In Bacterial Infection of Obese Subject|Active, not recruiting||N/A|15|Actual|Versailles Hospital||1|||f||||f||||||||||2017-10-10 21:51:55.135951|2017-10-10 21:51:55.135951
NCT02882555|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-24|||June 2012||2012-06-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|REFLEXE TOUX||Effect of Muscular Exercise on Cough Reflex|Effect of Muscular Exercise on Cough Reflex|Completed||N/A|60|Actual|Central Hospital, Nancy, France||2|||f||||f||||||||No||2017-10-10 21:51:55.204485|2017-10-10 21:51:55.204485
NCT02882542|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-25|||August 2018|Anticipated|2018-08-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 3 of 7)|Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach|Not yet recruiting||N/A|50|Anticipated|University of Bern||6|||f||||f|f|f||||||||2017-10-10 21:51:55.273275|2017-10-10 21:51:55.273275
NCT02882529|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-25|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|June 26, 2021|Anticipated|2021-06-26|June 26, 2018|Anticipated|2018-06-26||Interventional|||Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 2 of 7)|Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach|Recruiting||N/A|50|Anticipated|University of Bern||6|||f||||f|f|f||||||||2017-10-10 21:51:55.364216|2017-10-10 21:51:55.364216
NCT02882516|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-28|||March 9, 2017|Actual|2017-03-09|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 1 of 7)|Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach|Active, not recruiting||N/A|50|Actual|University of Bern||5|||f||||f|f|f||||||||2017-10-10 21:51:55.453656|2017-10-10 21:51:55.453656
NCT02882503|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-24|||June 2016||2016-06-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Small Benign Pancreatic Tumors|A Prospective Clinical Study of Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Small Benign Pancreatic Tumors|Recruiting||N/A|20|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:51:55.540239|2017-10-10 21:51:55.540239
NCT02882490|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||June 2014||2014-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Parent Behavioral Training for Disruptive Behaviors in Tourette Syndrome|Disruptive Behaviors in Children With Tourette Syndrome: the Role of Social Cognition and Efficacy of a Parent Behavioral Training Program|Recruiting||N/A|42|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||No||2017-10-10 21:51:55.614067|2017-10-10 21:51:55.614067
NCT02882477|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-08-24|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy|Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone, and Incretin Based Therapy|Not yet recruiting||Phase 2/Phase 3|20|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||No||2017-10-10 21:51:55.696794|2017-10-10 21:51:55.696794
NCT02882464|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-08-24|||April 2014||2014-04-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|PRF||Effect of Dose-dependent Platelet Rich Fibrin(PRF)|Evaluation of Dose-dependent Platelet-rich Fibrin Membrane Effect on Treatment of Gingival Recessions: A Randomized, Controlled, Parallel-designed Clinical Trial|Completed||N/A|21|Actual|Gazi University||3|||f||||f||||||||Undecided|There is no plan such as share participant individual data. If necessary, then information can be shared.|2017-10-10 21:51:55.798232|2017-10-10 21:51:55.798232
NCT02882451|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-06-09|||July 2016||2016-07-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Impact of Pinaverium Bromide on Bile Duct and Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography||Recruiting||N/A|200|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-10-10 21:51:56.006148|2017-10-10 21:51:56.006148
NCT02882438|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2016-08-26|||January 2016||2016-01-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|December 2016|Anticipated|2016-12-01||Interventional|||Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis|Glucosamine Sulphate and Ginkgo Biloba for Treating Tinea Pedis|Recruiting||Phase 1|30|Anticipated|Al-Azhar University||2|||f||||t||||||||Undecided||2017-10-10 21:51:56.111433|2017-10-10 21:51:56.111433
NCT02882425|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-02-14|||January 2015||2015-01-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects|Single-center, Open-label, Phase 1 Study Consisting of a Single-dose Pilot Phase and a Randomized, Two-way Crossover, Single-dose Main Phase to Investigate the Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Male Subjects|Completed||Phase 1|19|Actual|Actelion||3|||f||||f||||||||||2017-10-10 21:51:56.216419|2017-10-10 21:51:56.216419
NCT02882412|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-06-15|||March 2016||2016-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Effectiveness of Buprenorphine/Naloxone|Effectiveness of Buprenorphine/Naloxone in Patients With Chronic Pain and Iatrogenic Opioid Dependence|Recruiting||N/A|20|Anticipated|Radboud University|||1||f||||f||||||||Undecided||2017-10-10 21:51:56.310332|2017-10-10 21:51:56.310332
NCT02882399|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-26|||April 2013||2013-04-01|August 2016|2016-08-01||||April 2016|Actual|2016-04-01||Interventional|Shortystrap||Shortystrap Effectiveness in the Treatment of the Pathology Pubic and Abdominal Pathology in Athletes||Completed||Phase 2|49|Actual|Rennes University Hospital||1|||f||||||||||||||2017-10-10 21:51:56.428451|2017-10-10 21:51:56.428451
NCT02882386|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-24|||September 2012||2012-09-01|August 2016|2016-08-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|||Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements|Does Native Whey Induce Greater Blood Leucine Concentrations Than Other Whey Protein Supplements and Milk: A Randomized Controlled Trial?|Completed||N/A|13|Actual|Norwegian School of Sport Sciences||5|||f||||f||||||||Undecided||2017-10-10 21:51:56.509667|2017-10-10 21:51:56.509667
NCT02882373|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-25|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||L-Arginine For Anti- Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury|L-Arginine For Anti-VEGF Induced Kidney Injury|Not yet recruiting||Early Phase 1|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:51:56.616263|2017-10-10 21:51:56.616263
NCT02882360|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-08-24|||October 2016||2016-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Kerlix for Pregnant Women With Elevated BMI to Prevent Wound Infection by 6 Weeks Post Partum|The Use of Antimicrobial Gauze in Pregnant Women Undergoing C-section With BMI >40 to Decrease Wound Complications by 6 Weeks postpartum--a Small Feasibility Study|Not yet recruiting||Phase 4|40|Anticipated|Lawson Health Research Institute||4|||f||||f||||||||No||2017-10-10 21:51:56.726057|2017-10-10 21:51:56.726057
NCT02882347|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-09-09|||July 2015||2015-07-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)|The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)|Recruiting||Phase 3|20|Anticipated|Korea University Anam Hospital||1|||f||||||||||||||2017-10-10 21:51:56.825325|2017-10-10 21:51:56.825325
NCT02882334|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-05|||November 8, 2016|Actual|2016-11-08|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|FIDEX||Finger Individuation Training With a Training Device Versus Conventional Rehabilitation for Writer's Cramp|Effectiveness Study of Finger Individuation Training by Finger Force Manipulandum (FFM) Compared to Conventional Rehabilitation for Patients With Writer's Cramp|Recruiting||N/A|50|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 21:51:56.923155|2017-10-10 21:51:56.923155
NCT02882321|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-12|||September 29, 2016|Actual|2016-09-29|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Study of IACS-010759 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML)|Phase 1 Study of IACS-010759 in Subjects With Relapsed or Refractory Acute Myeloid|Recruiting||Phase 1|48|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 21:51:57.029253|2017-10-10 21:51:57.029253
NCT02882295|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-05|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Observational|LabyDys||Validation of the Zigzag Tracking Task Test for the Evaluation of Handwriting Difficulties in Writer's Cramp||Recruiting||N/A|40|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:51:57.276972|2017-10-10 21:51:57.276972
NCT02882282|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-15|||June 14, 2017|Actual|2017-06-14|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Interventional|||Study of Pembrolizumab (MK-3475) for High Risk Oral Intra-Epithelial Neoplasias|Personalized, Randomized, Phase 2 Study of Pembrolizumab (MK-3475) for High Risk Oral Intra-Epithelial Neoplasias|Recruiting||Phase 2|250|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:51:57.373404|2017-10-10 21:51:57.373404
NCT02882269|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-28|||December 2016||2016-12-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer|A Randomized Controlled Clinical Trial to Investigate the Effect of Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer|Not yet recruiting||Phase 2/Phase 3|400|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||No||2017-10-10 21:51:57.489441|2017-10-10 21:51:57.489441
NCT02882256|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-04|||June 2016||2016-06-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions in the Emergency Department|Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions for 3 Common Chief Complaints in the Emergency Department (ED)|Recruiting||N/A|200|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-10 21:51:57.587019|2017-10-10 21:51:57.587019
NCT02882243|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-24|||July 2016||2016-07-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|July 2019|Anticipated|2019-07-01||Observational|TLIF||FLXfit Post Market Outcome Study Protocol|Post Market Study on the Safety and Efficiency of FLXfit™ TLIF Interbody Fusion Device (Cage)|Enrolling by invitation||N/A|50|Anticipated|Foundation for Orthopaedic Research and Education|||1||f||||f||||||||Undecided|not at this time|2017-10-10 21:51:57.708048|2017-10-10 21:51:57.708048
NCT02882230|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-26|||September 2016||2016-09-01|August 2016|2016-08-01||||March 2017|Anticipated|2017-03-01||Observational|NEPAL||Evaluation of Neurologic and Psychiatric Adverse Events of Several Antiretroviral Drugs in Real Life Setting|Prospective Evaluation of Neurologic and Psychiatric Adverse Events of Rilpivirine, Elvitegravir, or Dolutegravir in a Real Life Setting|Not yet recruiting||N/A|400|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:51:57.80237|2017-10-10 21:51:57.80237
NCT02882217|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-05-17|||August 2016||2016-08-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8|Double-blind, Randomized, Dose-escalating, Placebo-controlled Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8 After Single and Multiple Oral Doses in Healthy Volunteers|Completed||Phase 1|32|Actual|EURRUS Biotech GmbH||4|||f||||f||||||||||2017-10-10 21:51:57.886591|2017-10-10 21:51:57.886591
NCT02882204|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-29|||March 1, 2016|Actual|2016-03-01|August 2017|2017-08-01|December 1, 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|TOPSY||Tracking Outcomes in Psychosis|Tracking Outcomes in Psychosis|Recruiting||N/A|168|Anticipated|Lawson Health Research Institute|||3||f||||f||||||||||2017-10-10 21:51:57.997733|2017-10-10 21:51:57.997733
NCT02882191|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-20|||November 2016||2016-11-01|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of the Efficacy and Safety of LevoCept|Evaluation of the Effectiveness, Safety and Tolerability of LevoCept (Levonorgestrel-Releasing Intrauterine System) for Long-Acting Reversible Contraception|Active, not recruiting||Phase 2|250|Anticipated|ContraMed LLC||1|||f||||f||||||||||2017-10-10 21:51:58.104771|2017-10-10 21:51:58.104771
NCT02882178|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-28|||November 2013||2013-11-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|CABOBS||Formal Consensus Method to Evaluate the Conformity of Prescription of a Recently Approved Chemotherapy Treatment in an Observatory Study||Completed||N/A|18|Actual|Institut Bergonié|||1||f||||f||||||||No||2017-10-10 21:51:58.222638|2017-10-10 21:51:58.222638
NCT02882165|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-26|||July 2015||2015-07-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|CASCADE||Clinical And Social Characteristics and Demographics in COPD|A Quantitative Study in Early Chronic Obstructive Pulmonary Disease, Using a Cluster Analysis, to Establish if Prospective, Individualised, Medical Intervention Alters Projected Clinical Course|Active, not recruiting||N/A|116|Actual|University of Southampton||2|||f||||f||||||||No||2017-10-10 21:51:58.302916|2017-10-10 21:51:58.302916
NCT02882152|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-12-23|2016-09-06||August 2011||2011-08-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Femoral/Sciatic Block for Knee Surgery|Continuous Femoral Nerve Blockade and Single Shot Sciatic Nerve Block Compared to Intrathecal Morphine for Total Knee Arthroplasty|Completed||N/A|40|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 21:51:58.412586|2017-10-10 21:51:58.412586
NCT02882139|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-02-02|||August 2016||2016-08-01|February 2017|2017-02-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01|3 Years|Observational [Patient Registry]|ELECTRA||International Electrical Storm Registry|Multicenter Registry on Patients Affected by Electrical Storm|Recruiting||N/A|500|Anticipated|Università Politecnica delle Marche|||1||f||||f||||||||||2017-10-10 21:51:58.685314|2017-10-10 21:51:58.685314
NCT02882126|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-05-08|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension|An Open-Label Extension Trial to Evaluate the Safety of Continued Therapy With Subcutaneous Remodulin® in Subjects With Pulmonary Arterial Hypertension Who Completed Study CVT-CV-003|Withdrawn||Phase 4|0|Actual|United Therapeutics||1||Business decision|f||||f|t|f|||t|||||2017-10-10 21:51:58.753825|2017-10-10 21:51:58.753825
NCT02882113|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-30|||July 2016||2016-07-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion|Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion From Tacrolimus (Bid) to Advagraf® (qd) in Stable Liver Transplant Recipients|Recruiting||Phase 4|60|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:51:58.852292|2017-10-10 21:51:58.852292
NCT02882100|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-07-03|||April 2016||2016-04-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|May 2017|Actual|2017-05-01||Interventional|||Adjuvanted Influenza Vaccination in U.S. Nursing Homes|Adjuvanted Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes|Active, not recruiting||Phase 4|700|Anticipated|Insight Therapeutics, LLC||2|||f||||f||||||||||2017-10-10 21:51:58.924396|2017-10-10 21:51:58.924396
NCT02882087|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-07-31|||October 2015||2015-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis|A Phase II, Placebo-Controlled, Multicenter, Dynamic Randomized, Double Blind Trial of RC18, a Recombinant Human B Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein in Subjects With Inadequate Response of TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis|Recruiting||Phase 2|60|Anticipated|RemeGen||2|||f||||f||||||||||2017-10-10 21:51:59.021192|2017-10-10 21:51:59.021192
NCT02882074|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-03-14|||June 2016||2016-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Endothelial Function After Cardiac Surgery|Does Plasma Volume Replacement With 5% Human Albumin Reduce Endothelial Injury and Glycocalyceal Disruption Compared With 6% Hydroxyethylstarch (130/0.4) in Patients Having Cardiac Surgery? A Substudy of the SHARP Clinical Trial|Recruiting||N/A|85|Anticipated|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-10 21:51:59.103052|2017-10-10 21:51:59.103052
NCT02882061|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-06-08|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Examination of Cervical Thoracic Differentiation Testing in Individuals With Neck Pain: A Pilot Study|Examination of Cervical Thoracic Differentiation Testing in Individuals With Neck Pain: A Pilot Study|Completed||N/A|48|Actual|University of New England||2|||f||||f||||||||No||2017-10-10 21:51:59.187768|2017-10-10 21:51:59.187768
NCT02882048|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Auricular Acupuncture to Facilitate Outpatient Opioid Weaning|A Randomized Controlled Trial of Auricular Acupuncture to Facilitate Outpatient Opioid Weaning|Recruiting||N/A|100|Anticipated|Vanderbilt University||2|||f||||f||||||||No||2017-10-10 21:51:59.262222|2017-10-10 21:51:59.262222
NCT02882035|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-26|||September 2014||2014-09-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Opioid Free Anesthesia: What About Patient Comfort?|Opioid Free Anesthesia: What About Patient Comfort?|Completed||Phase 4|66|Actual|Université Libre de Bruxelles||2|||f||||f||||||||Undecided||2017-10-10 21:51:59.356344|2017-10-10 21:51:59.356344
NCT02882022|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-26|||August 2016||2016-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluating Changes in Middle Ear Pressure Caused by CPAP|Evaluating Changes in Middle Ear Pressure Caused by CPAP|Recruiting||N/A|31|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-10 21:51:59.441752|2017-10-10 21:51:59.441752
NCT02882009|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-06-19|||August 31, 2016|Actual|2016-08-31|June 2017|2017-06-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|||A Study to Assess the Impact of Speed and Site of Subcutaneous Injection on Pain, Tolerability, Safety, and Pharmacokinetics of Gantenerumab in Healthy Participants|A Single-Center, Randomized, Open-Label, Parallel-Group, Placebo-Controlled, Cross-Over Study To Investigate the Impact of Speed of Injection and Site of Injection on Pain, Tolerability, Safety, and Pharmacokinetics Following Subcutaneous Administration of Gantenerumab in Healthy Volunteers|Completed||Phase 1|48|Anticipated|Hoffmann-La Roche||1|||f|||||t|f||||||||2017-10-10 21:51:59.518349|2017-10-10 21:51:59.518349
NCT02881996|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-08-26|||June 2014||2014-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||The Impact of IV Acetaminophen on Pain After Appendectomy for Perforated Appendicitis|Impact of IV Acetaminophen on Post-operative Pain After Laparoscopic Appendectomy for Perforated Appendicitis: A Prospective Randomized Trial|Completed||N/A|80|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||No||2017-10-10 21:51:59.5925|2017-10-10 21:51:59.5925
NCT02881983|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-24|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|REAL||Study of Mechanisms of Emotion Regulation in Alcohol-abstinent Patients|Study of Mechanisms of Emotion Regulation in Short- and Long-term Alcohol-abstinent Patients|Completed||N/A|112|Actual|University Hospital, Lille|||3||f||||f|f|f||||||||2017-10-10 21:51:59.870714|2017-10-10 21:51:59.870714
NCT02881970|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-24|||April 2017||2017-04-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|April 2020|Anticipated|2020-04-01||Interventional|NEOSTEM||Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells||Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||t||||||||No||2017-10-10 21:51:59.981996|2017-10-10 21:51:59.981996
NCT02881957|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-11-15|||October 2016||2016-10-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Hypovitaminosis D in Neurocritical Patients|Randomized Clinical Trial of Hypovitaminosis D Treatment in the Neurocritical Care Unit|Recruiting||Phase 2/Phase 3|436|Anticipated|University of Utah||2|||f||||t||||||||No||2017-10-10 21:52:00.0993|2017-10-10 21:52:00.0993
NCT02881944|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-03-20|||August 2016||2016-08-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of Diet on Gulf War Illness|Effect of Diet on Gulf War Illness|Recruiting||N/A|68|Anticipated|University of Utah||2|||f||||f|f|f||||||No||2017-10-10 21:52:00.250739|2017-10-10 21:52:00.250739
NCT02881931|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-07|||February 28, 2017|Actual|2017-02-28|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Observational|||FuRST 2.0 Cognitive Pre-Testing|FuRST 2.0: Cognitive Pre-Testing Study for a New Functional Rating Scale for Use in Huntington's Disease|Completed||N/A|75|Actual|CHDI Foundation, Inc.|||3||f||||f||||||||||2017-10-10 21:52:00.357553|2017-10-10 21:52:00.357553
NCT02881918|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-24|||September 2016||2016-09-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|CORISAT||Anti-tumor Specific Immune Response in Head and Neck Cancers|Anti-tumor Specific Immune Response in Head and Neck Cancers|Not yet recruiting||N/A|154|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||Samples With DNA|"     Blood sample   "|No||2017-10-10 21:52:00.454273|2017-10-10 21:52:00.454273
NCT02881905|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-09|||July 2016||2016-07-01|September 2016|2016-09-01|July 2021|Anticipated|2021-07-01|July 2017|Anticipated|2017-07-01||Interventional|||PeriImplant Soft Tissue and Marginal Bone Loss of Single Implant Mandibular Overdenture|Peri-Implant Soft Tissue Health and Marginal Bone Loss of Single Implant Mandibular Overdenture Retained by CM LOC Versus Ball Attachment: A Randomised Controlled Trial|Recruiting||N/A|36|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:52:00.551829|2017-10-10 21:52:00.551829
NCT02881892|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-26|||March 2012||2012-03-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|||Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients|Interleukin-6, Procalcitonin and Vascular Endothelial Growth Factor in Plasma and Dialysate Correlate With Peritoneal Solute Transport and Dialysis Adequacy in CAPD Patients|Completed||N/A|26|Actual|Bangkok Metropolitan Administration Medical College and Vajira Hospital|||1||f||||t||||||||No||2017-10-10 21:52:00.645368|2017-10-10 21:52:00.645368
NCT02881879|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-04-28|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites|An Open, Multicenter Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House|Active, not recruiting||Phase 1|43|Actual|Roxall Medicina España S.A||1|||f||||f||||||||No||2017-10-10 21:52:00.72487|2017-10-10 21:52:00.72487
NCT02881866|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-24|||October 2015||2015-10-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|FurosAH||Specificity of Dyspnoea Relief With Inhaled Furosemide|Specificity of Dyspnoea Relief With Inhaled Furosemide|Completed||Phase 1|16|Actual|Oxford Brookes University||2|||f||||f||||||||No||2017-10-10 21:52:00.807245|2017-10-10 21:52:00.807245
NCT02881853|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-07-06|||August 17, 2016|Actual|2016-08-17|July 2017|2017-07-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Interventional|||Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195|Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195|Completed||Phase 1|57|Actual|Xencor, Inc.||9|||f||||f||||||||||2017-10-10 21:52:00.906029|2017-10-10 21:52:00.906029
NCT02881840|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-24|||August 2016||2016-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Mass-balance Study of [14C]-APD421 in Healthy Volunteers|An Open Label, Single Dose, Single Period Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] APD421 Administered Via the Intravenous Route to Healthy Male Subjects|Completed||Phase 1|6|Actual|Acacia Pharma Ltd||1|||f||||f||||||||No||2017-10-10 21:52:01.00834|2017-10-10 21:52:01.00834
NCT02881827|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-26|||January 2014||2014-01-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|August 2016|Actual|2016-08-01||Interventional|||Saliva Analysis After Low-level Laser Therapy Application on the Masseter Muscle Located Above Parotid Salivary Gland|Biochemistry and Volumetric Analysis of Biofluid Salivary, Correlating the Flow, pH and Buffer Capacity With and Without Stimulation of the Masseter Muscle, Before and After Low-level Laser Irradiation|Active, not recruiting||N/A|30|Actual|Universidade do Vale do Paraíba||4|||f||||t||||||||Yes||2017-10-10 21:52:01.091532|2017-10-10 21:52:01.091532
NCT02881814|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-05-30|||May 30, 2017|Actual|2017-05-30|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|US-ADEPT||UltraSound for Accurate Decisions in Chest PhysioTherapy|Evaluation of the Impact of Lung and Diaphragm Ultrasound Findings on Clinical Decisions for Chest Physiotherapy in Patients Hospitalized in Intensive Care Units|Recruiting||N/A|150|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||t|f|f||||||Undecided||2017-10-10 21:52:01.201229|2017-10-10 21:52:01.201229
NCT02881801|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-23|||March 2015||2015-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Patterns of Physical Activity and Sedentary Time in Survivors of a Critical Illness During a Hospital Admission|Patterns of Physical Activity and Sedentary Time in Survivors of a Critical Illness During a Hospital Admission|Completed||N/A|40|Actual|University of South Australia|||1||f||||f||||||||No||2017-10-10 21:52:01.332684|2017-10-10 21:52:01.332684
NCT02881775|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis|Immediate Effects of rTMS on Corticospinal Excitability of the Quadriceps in People With Knee Osteoarthritis|Not yet recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:52:01.48431|2017-10-10 21:52:01.48431
NCT02881762|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-06-26|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|MAVERIC||Maraviroc Efficacy for Hepatitis C|A Pilot Study to Evaluate Anti-Hepatitis C Virus Effect of Maraviroc in Patients Co-infected With Human Immunodeficiency Virus (HIV) and Hepatitis C|Recruiting||Phase 4|10|Anticipated|University of Maryland||2|||f||||f|f|f|||f|||||2017-10-10 21:52:01.578421|2017-10-10 21:52:01.578421
NCT02881749|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-29|||September 2016||2016-09-01|August 2016|2016-08-01||||August 2020|Anticipated|2020-08-01||Interventional|||Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides|Phase II Study of Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides|Not yet recruiting||Phase 2|68|Anticipated|Thomas Jefferson University||1|||f||||||||||||||2017-10-10 21:52:01.675055|2017-10-10 21:52:01.675055
NCT02881736|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-24|||October 2013||2013-10-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2016|Actual|2016-03-01||Interventional|||Proprioceptive Deficits and Anomalies in Movement-error Processing in Chronic Stroke Patients||Active, not recruiting||N/A|45|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:52:01.759735|2017-10-10 21:52:01.759735
NCT02881723|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-24|||March 2013||2013-03-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|February 2015|Actual|2015-02-01||Interventional|||Obstructive Sleep Apnea Syndrome After Oropharyngeal Cancer Treatment||Active, not recruiting||N/A|51|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||Undecided||2017-10-10 21:52:01.835044|2017-10-10 21:52:01.835044
NCT02881710|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-26|||December 2014||2014-12-01|August 2016|2016-08-01||||March 2016|Actual|2016-03-01||Observational|ContraCHECK||Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient|Variation IGFBP7 Markers and TIMP2 Induced by Injection of Contrast Iodized Drug at the Intensive Care Patient|Completed||N/A|50|Actual|Nantes University Hospital|||1||f||||f||||||||No||2017-10-10 21:52:01.923043|2017-10-10 21:52:01.923043
NCT02881697|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-07-25|||September 2016||2016-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||mTOR and Adipose Tissue Inflammation|mTOR and Adipose Tissue Inflammation in Humans|Active, not recruiting||N/A|60|Anticipated|University Hospital, Basel, Switzerland|||2||f||||f||||||Samples With DNA|"     Adipose tissue   "|||2017-10-10 21:52:01.986216|2017-10-10 21:52:01.986216
NCT02881684|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Aspiration Therapy in Asian Patients|Weight Reduction by Aspiration Therapy in Asian Patients With Morbid Obesity|Recruiting||Phase 4|15|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 21:52:02.074671|2017-10-10 21:52:02.074671
NCT02881671|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-24|||January 2011||2011-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms|Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms|Recruiting||N/A|2600|Anticipated|Nantes University Hospital|||4||f||||f||||||Samples With DNA|"     whole blood   "|No||2017-10-10 21:52:02.19197|2017-10-10 21:52:02.19197
NCT02881658|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-08-24|2017-05-20||May 2016||2016-05-01|August 2017|2017-08-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C|The Effect of Soya Beverage Fortified With Plant Sterol on Major Serum Lipids in Normocholesterolemic, Healthy Southern Chinese Individuals|Completed||N/A|201|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 21:52:02.327233|2017-10-10 21:52:02.327233
NCT02881645|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-13|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PREVENIR||Prevention of Critical Incidents Related to the Nursing With Patients in Intensive Care Units|Prevention of Critical Incidents Related to the Nursing With Patients in Intensive Care Units PREVENIR Study.|Not yet recruiting||N/A|59400|Anticipated|Central Hospital, Nancy, France||2|||f||||t|f|f||||||||2017-10-10 21:52:02.835925|2017-10-10 21:52:02.835925
NCT02881632|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-08-23|||November 2015||2015-11-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Pneumacare SLP Validation in Infants and in Clinical Bronchiolitis|Pneumacare SLP Validation in Infants and in Clinical Bronchiolitis: Validation of Structured Light Plethysmography (SLP) in Healthy Infants and in Infants With Clinical Bronchiolitis|Completed||N/A|60|Actual|University Hospitals of North Midlands NHS Trust|||2||f||||f||||||||No||2017-10-10 21:52:02.913269|2017-10-10 21:52:02.913269
NCT02881619|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-23|||November 2014||2014-11-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Etodolac and Post-bleaching Sensitivity|Preemptive Use of Etodolac on Tooth Sensitivity Caused by In-office Bleaching: a Randomized, Triple-blind, Controlled Clinical Trial|Completed||Phase 4|50|Actual|Universidade Federal de Sergipe||2|||f||||f||||||||No||2017-10-10 21:52:03.005656|2017-10-10 21:52:03.005656
NCT02881606|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-11-14|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation of the Clinical Effectiveness of Naso-alveolar Molding (NAM) Versus Computer Aided Design NAM (CAD/NAM) in Infants With Bilateral Cleft Lip and Palate: A Randomized Clinical Trial||Not yet recruiting||N/A|26|Anticipated|Cairo University||2|||f||||t||||||||Yes||2017-10-10 21:52:03.086001|2017-10-10 21:52:03.086001
NCT02881593|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-09-06|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|ARTHROSCAN||Study of the Quality of Post Release on Scanners Operating in Minimally Invasive Arthrodesis|Study of the Quality of Post Release on Scanners|Not yet recruiting||N/A|100|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:52:03.149652|2017-10-10 21:52:03.149652
NCT02880098|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-26|||October 2016||2016-10-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|TnTc-us||Variations of High Sensitivity Troponin T in Neonates|Variations of High Sensitivity Troponin T in Neonates|Not yet recruiting||N/A|442|Anticipated|Centre Hospitalier René Dubos|||1||f||||f||||||||No||2017-10-10 21:52:17.210831|2017-10-10 21:52:17.210831
NCT02881580|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-24|||June 2015||2015-06-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|CYPHORACHI||Risk Factors for Proximal Junctional Kyphosis Assessment After Spinal Instrumentation|Risk Factors for Proximal Junctional Kyphosis Assessment After Spinal Instrumentation|Completed||N/A|314|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||Undecided||2017-10-10 21:52:03.221398|2017-10-10 21:52:03.221398
NCT02881554|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-06-29|||December 21, 2016|Actual|2016-12-21|June 2017|2017-06-01||||June 1, 2022|Anticipated|2022-06-01||Interventional|||Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery|Functional Liver Imaging With Sulfur Colloid SPECT/CT in Primary and Metastatic Liver Cancer Patients Receiving Liver-Directed Treatment: A Pilot Study|Recruiting||N/A|60|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 21:52:03.443266|2017-10-10 21:52:03.443266
NCT02881541|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2016-08-26|||October 2016||2016-10-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|IDEPROCTO||Study of the Benefit of a Nurse (IDE) Pre and Post-operative Framework in Proctology Outpatient Surgery|Study of the Benefit of a Nurse (IDE) Pre and Post-operative Framework in Proctology Outpatient Surgery|Not yet recruiting||N/A|100|Anticipated|Groupe Hospitalier Paris Saint Joseph||2|||f||||t||||||||Undecided||2017-10-10 21:52:03.543425|2017-10-10 21:52:03.543425
NCT02881528|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-08-23|||March 2016||2016-03-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|adAPT||Autoimmune Diabetes Accelerator Prevention Trial|Autoimmune Diabetes Accelerator Prevention Trial - adAPT Stage 1|Enrolling by invitation||Phase 4|90|Anticipated|University of Exeter||2|||f||||t||||||||No||2017-10-10 21:52:03.606251|2017-10-10 21:52:03.606251
NCT02881515|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-08-30|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Adverse Neurogenic Actions of Dietary Salt|Adverse Neurogenic Actions of Dietary Salt|Recruiting||N/A|76|Anticipated|University of Delaware||2|||f||||f||||||||||2017-10-10 21:52:03.720835|2017-10-10 21:52:03.720835
NCT02881502|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-23|||June 2016||2016-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Clinical Study of Relationship Between Granulocyte Activation, HDAC2 and Severe Asthma||Recruiting||N/A|60|Anticipated|Xijing Hospital|||3||f||||t||||||Samples With DNA|"     blood   "|Undecided||2017-10-10 21:52:03.813845|2017-10-10 21:52:03.813845
NCT02881489|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-08-23|||November 2015||2015-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|UwmBmmscALS||Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis|Evaluation of Mesenchymal Stem Cell Culturing Protocols in the Treatment of Amyotrophic Lateral Sclerosis|Enrolling by invitation||Phase 1|30|Anticipated|University of Warmia and Mazury||1|||f||||f||||||||Undecided||2017-10-10 21:52:03.889055|2017-10-10 21:52:03.889055
NCT02881476|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-08-23|||November 2015||2015-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|UwmWjmscAls||Therapeutic Treatment of Amyotrophic Lateral Sclerosis|Application of Wharton's Jelly-derived Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis|Enrolling by invitation||Phase 1|30|Anticipated|University of Warmia and Mazury||1|||f||||f||||||||Undecided||2017-10-10 21:52:03.951161|2017-10-10 21:52:03.951161
NCT02881463|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-09-12|||January 2013||2013-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PrehabOA||Prehabilitation Physical Activity in Persons With Osteoarthritis|Prehabilitation Physical Activity: Relationship With Muscle Function, Postural Stability and Postoperative Recovery in Persons With Osteoarthritis|Completed||Phase 4|45|Actual|University of Tartu||1|||f||||t||||||||Undecided||2017-10-10 21:52:04.016233|2017-10-10 21:52:04.016233
NCT02881450|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-08-23|||January 2012||2012-01-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Observational|PREMIA||Epidemiological Study of Inflammatory Myopathies in a French Region|Prevalence of Inflammatory Myopathies in Alsace|Completed||N/A|117|Actual|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 21:52:04.078696|2017-10-10 21:52:04.078696
NCT02881437|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-21|||November 11, 2016|Actual|2016-11-11|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia|Assessment of the IgG Trough Level in Subjects With Primary Immunodeficiency Switching From Standard Subcutaneous Immunoglobulin (SCIG) to Every Other Week HyQvia|Recruiting||Phase 4|22|Anticipated|University Hospital, Lille||1|||f||||f|f|f||||||||2017-10-10 21:52:04.140421|2017-10-10 21:52:04.140421
NCT02881424|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-22|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|FALCO||Study of Familiarity in Alcohol Dependence|Study of Familiarity in Alcohol Dependence : an Hyperfamiliarity for Faces|Recruiting||N/A|68|Anticipated|University Hospital, Lille|||2||f||||f||||||||||2017-10-10 21:52:04.458411|2017-10-10 21:52:04.458411
NCT02881411|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-07-11|||July 2016||2016-07-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Self Soft Tissue Therapy for Fibromyalgia Syndrome|Self Soft Tissue Therapy for Fibromyalgia Syndrome; Randomised Controlled Feasibility Study|Completed||N/A|20|Anticipated|University of the West of England||2|||f||||f||||||||||2017-10-10 21:52:04.584773|2017-10-10 21:52:04.584773
NCT02881398|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-23|||August 2014||2014-08-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|ASEF-VALUES||Mobile Health in Structural Heart Disease|A Randomized Trial of Pocket-Echocardiography Integrated Mobile Health Device Assessments in Modern Structural Heart Disease Clinics|Completed||Phase 2/Phase 3|253|Actual|Sri Sathya Sai Institute of Higher Medical Sciences||2|||f||||f||||||||Yes|Data will be made available to requesting investigators and 6 months after publication|2017-10-10 21:52:04.71081|2017-10-10 21:52:04.71081
NCT02881385|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-09-10|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation|Effects on Respiratory Patterns and Patient-ventilator Synchrony in Different Ventilator Using Pressure Support Ventilation|Not yet recruiting||N/A|45|Anticipated|Southeast University, China|||7||f||||f||||||||Undecided||2017-10-10 21:52:04.824404|2017-10-10 21:52:04.824404
NCT02881372|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-08-08|||July 12, 2017|Actual|2017-07-12|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||EoE Food Desensitization|Safety and Feasibility of Oral Food Desensitization in Children With Eosinophilic Esophagitis|Recruiting||N/A|5|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t|f|f||||||||2017-10-10 21:52:04.929171|2017-10-10 21:52:04.929171
NCT02881359|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-06-05|||October 2016||2016-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01|4 Weeks|Observational [Patient Registry]|||SEAL Registry - European Registry for the Effectiveness of LifeSeal® Kit|SEAL Registry - Observational, Retrospective and Prospective, One Arm, Registry Study for the Effectiveness of LifeSeal® Kit on Anastomotic Leaks in Patients Undergoing Low and Ultralow Anterior Resection|Recruiting||N/A|200|Anticipated|LifeBond Ltd.|||1||f||||f||||||||No||2017-10-10 21:52:05.11228|2017-10-10 21:52:05.11228
NCT02881346|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-03|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Efficacy and Tolerability of Enstilar® in Daily Practice|Prospective, Observational, Non-interventional, Multicenter Study on the Efficacy and Tolerability of Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in Patients With Plaque Psoriasis Under Daily Practice Conditions|Completed||N/A|410|Actual|LEO Pharma|||1||f||||f||||||||||2017-10-10 21:52:05.271061|2017-10-10 21:52:05.271061
NCT02881333|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|CNV-Seq||Various Type of Genetic Events in Patients With Intellectual Disability|Evaluation of Tools for the Simultaneous Detection of Point and Structural Mutations in Patients With Intellectual Disability|Not yet recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 21:52:05.404906|2017-10-10 21:52:05.404906
NCT02881320|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-28|||September 21, 2016|Actual|2016-09-21|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children|A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) Fixed Dose Combination (FDC) in HIV-1 Infected Virologically Suppressed Adolescents and Children|Active, not recruiting||Phase 2/Phase 3|100|Anticipated|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 21:52:05.487083|2017-10-10 21:52:05.487083
NCT02881307|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-05-12|||October 2016||2016-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Ultrasound Assessment of Rheumatoid Arthritis Patients Who Changed Diet|Ultrasound Assessment of Rheumatoid Arthritis Patients Who Changed Diet|Recruiting||N/A|60|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 21:52:05.677294|2017-10-10 21:52:05.677294
NCT02881294|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-09-21|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects|A Phase I, Single-center, Open-label, Single-dose Study to Evaluate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of Orally Administered SUVN-G3031 in Healthy Subjects|Completed||Phase 1|24|Actual|Suven Life Sciences Limited||3|||f||||t||||||||||2017-10-10 21:52:05.783567|2017-10-10 21:52:05.783567
NCT02881281|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-08-23|||May 2016||2016-05-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Development of Problem-solving Skills Among Female Adolescents by Application of Social Cognitive Theory in Parent-Child Relationship||Recruiting||N/A|120|Anticipated|Shiraz University of Medical Sciences||2|||f||||f||||||||||2017-10-10 21:52:05.873279|2017-10-10 21:52:05.873279
NCT02881268|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-11-03|||July 2015||2015-07-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Observational|IMPRIM||Study of Immunosuppression Biomarkers Acquired in Patients Hospitalized in Intensive Care Unit|Study of Immunosuppression Biomarkers Acquired in Patients Hospitalized in Intensive Care Unit|Recruiting||N/A|100|Anticipated|Rennes University Hospital|||2||f||||f||||||||No||2017-10-10 21:52:05.958993|2017-10-10 21:52:05.958993
NCT02881255|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-27|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|December 22, 2020|Anticipated|2020-12-22|August 22, 2018|Anticipated|2018-08-22||Interventional|ATLAS S-ICD||Avoid Transvenous Leads in Appropriate Subjects|Avoid Transvenous Leads in Appropriate Subjects|Recruiting||N/A|500|Anticipated|Population Health Research Institute||2|||f||||t|f|t|f|f|t|||||2017-10-10 21:52:06.054159|2017-10-10 21:52:06.054159
NCT02881242|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-09-12|||January 31, 2018|Anticipated|2018-01-31|September 2017|2017-09-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer|A Single-Arm, Open-Label, Two-Stage Phase II Study of the MEK 1/2 Inhibitor Trametinib in Men With Progressive Metastatic Castrate Resistant Prostate Cancer|Not yet recruiting||Phase 2|62|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t|t|f|||t|||||2017-10-10 21:52:06.203749|2017-10-10 21:52:06.203749
NCT02881216|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-25|||January 2015||2015-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Procedural Advantages of a Novel Drug-Eluting Coronary Stent|Procedural Advantages of a Novel Drug-Eluting Coronary Stent With Ultra-Thin Struts and Bioabsorbable Abluminal Polymer Coating in an All-Comers Registry|Completed||N/A|814|Actual|University Hospital Heidelberg||2|||f||||||||||||||2017-10-10 21:52:06.398709|2017-10-10 21:52:06.398709
NCT02879552|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-08-21|||December 2014||2014-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||TPS After Upper Blepharoplasty|Tarsal Platform Show After Upper Eyelid Blepharoplasty With or Without Brassiere Sutures|Completed||N/A|2|Actual|Instituto de Olhos de Goiania|||2||f||||t||||||||No||2017-10-10 21:52:21.653918|2017-10-10 21:52:21.653918
NCT02881203|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-28|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BRAVEHeart||Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart|BRAVEHeart - Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart|Not yet recruiting||N/A|40|Anticipated|University of Sydney||2|||f||||f||||||||Yes|Anonymised data will be made available to researchers upon request, once evidence of ethical approval has been provided.|2017-10-10 21:52:06.479466|2017-10-10 21:52:06.479466
NCT02881190|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2017-03-03|||November 2015||2015-11-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors|A Tolerance, Safety and Pharmacokinetic Ascending Dose Phase I Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive Malignant in Advanced Malignant Solid Tumors|Recruiting||Phase 1|50|Anticipated|RemeGen||1|||f||||f||||||||Undecided||2017-10-10 21:52:06.567414|2017-10-10 21:52:06.567414
NCT02881177|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-06-19|||January 2017||2017-01-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|OHM||Oxytocin HIV Meth Study|The Effects of Intranasal Oxytocin on Mixed HIV Sero-status, Methamphetamine-using Men Who Have Sex With Men|Recruiting||Phase 1|28|Anticipated|University of California, San Francisco||2|||f||||t||||||||Undecided||2017-10-10 21:52:06.639728|2017-10-10 21:52:06.639728
NCT02881164|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||July 2015||2015-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|November 2015|Actual|2015-11-01||Interventional|GIDMIR||Glycemic Index in Subjects With Diabetes Mellitus Insulin Requesting|Effect of Glycemic Index of a Preparation on Postprandial Metabolic Parameters and Satiety in Subjects With Type 2 Diabetes Mellitus Under Intensive Insulin Therapy: Controlled Clinical Trial|Completed||N/A|10|Actual|Universidad de Valparaiso||2|||f||||t||||||||No||2017-10-10 21:52:06.736247|2017-10-10 21:52:06.736247
NCT02881138|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2017-07-31|||November 2015||2015-11-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of RC48-ADC in Patients With HER2-Positive Advanced Malignant Solid Tumors||Recruiting||Phase 1|50|Anticipated|RemeGen||1|||f||||f||||||||||2017-10-10 21:52:06.910774|2017-10-10 21:52:06.910774
NCT02881125|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-06-27|||November 3, 2016|Actual|2016-11-03|June 2017|2017-06-01||||July 1, 2018|Anticipated|2018-07-01||Interventional|||Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma|A Phase 1 Study of Weekly Paclitaxel and Nortriptyline for Relapsed Small Cell Carcinoma|Recruiting||Phase 1|18|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 21:52:06.979979|2017-10-10 21:52:06.979979
NCT02881112|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-20|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies|An Open-Label, Non-Controlled Study to Evaluate Outcomes of Pulsed Electromagnetic Field (PEMF) Therapy in Subjects With Various Pain Etiologies|Active, not recruiting||N/A|180|Actual|Regenesis Biomedical, Inc.||1|||f||||f||||||||||2017-10-10 21:52:07.067878|2017-10-10 21:52:07.067878
NCT02881099|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-08-22|||February 2012||2012-02-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Observational|PRoBaND||Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)|Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)|Recruiting||N/A|3000|Anticipated|South Glasgow University Hospitals NHS Trust|||1||f||||t||||||Samples With DNA|"     DNA and -80 degrees Centrigrade frozen serum samples   "|Yes|Data sharing agreement in place with University of Oxford, England, and Critical Path Consortium, AZ, US|2017-10-10 21:52:07.14094|2017-10-10 21:52:07.14094
NCT02881086|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01|June 2025|Anticipated|2025-06-01|July 2021|Anticipated|2021-07-01||Interventional|||Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment|Treatment Optimization in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment - a Phase IV-trial With a Phase III-part to Evaluate Safety and Efficacy of Nelarabine in T-ALL Patients|Recruiting||Phase 3|900|Anticipated|Johann Wolfgang Goethe University Hospital||9|||f||||t||||||||No||2017-10-10 21:52:07.202637|2017-10-10 21:52:07.202637
NCT02881073|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-08-21|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|April 28, 2019|Anticipated|2019-04-28||Interventional|PARROT||Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia|PARROT Ireland: Placental Growth Factor in Assessment of Women With Suspected Pre-eclampsia to Reduce Maternal Morbidity: a Randomised Control Trial|Recruiting||N/A|3800|Anticipated|Irish Centre for Fetal and Neonatal Translational Research||2|||f||||t|f|f||||||||2017-10-10 21:52:07.352417|2017-10-10 21:52:07.352417
NCT02881060|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-07-20|||August 2016||2016-08-01|July 2017|2017-07-01|January 26, 2017|Actual|2017-01-26|January 26, 2017|Actual|2017-01-26||Interventional|ALCO1||The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes|The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes|Completed||Phase 4|12|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-10 21:52:07.473001|2017-10-10 21:52:07.473001
NCT02881047|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-07-31|||February 2014||2014-02-01|August 2017|2017-08-01||||August 2016|Actual|2016-08-01||Interventional|||Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures|Ablative Fractional Laser Resurfacing for the Treatment of Scars and Contractures Caused by Sclerotic Skin Changes Chronic Graft Versus Host Disease|Active, not recruiting||N/A|8|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 21:52:07.643445|2017-10-10 21:52:07.643445
NCT02881034|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-26|||February 2014||2014-02-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Ribavirin Bioavailability After Telaprevir Exposure|Ribavirin Bioavailability After Telaprevir Exposure in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy|Completed||N/A|37|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:52:07.701576|2017-10-10 21:52:07.701576
NCT02881021|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-05-19|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|November 30, 2017|Anticipated|2017-11-30||Interventional|||Effects of Kinesiotaping on Symptoms, Functional Limitations, and Underlying Deficits of Patients With Rotator Cuff Tendinopathy|Effects of Kinesiotaping Added to a Rehabilitation Program for Patients With Rotator Cuff Tendinopathy: Protocol of a Single-blind Randomized Controlled Trial Addressing Symptoms, Functional Limitations, and Underlying Deficits.|Recruiting||N/A|52|Anticipated|Laval University||2|||f||||f||||||||No||2017-10-10 21:52:07.765939|2017-10-10 21:52:07.765939
NCT02881008|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-16|||November 14, 2012|Actual|2012-11-14|August 2017|2017-08-01|October 4, 2014|Actual|2014-10-04|October 4, 2014|Actual|2014-10-04||Interventional|||Clinical Trial of Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B|A Phase 1b/2a Randomized, Open-label Clinical Trial of Daily Myrcludex B Versus Entecavir in Patients With HBeAg Negative Chronic Hepatitis B|Completed||Phase 1/Phase 2|48|Actual|Hepatera Ltd.||6|||f||||f||||||||||2017-10-10 21:52:07.855795|2017-10-10 21:52:07.855795
NCT02880995|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|DPTP||[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis|Positron Emission Tomography(PET) With 3,4-dihydroxy-6-18-fluoro-l-phenylalanine ([18 Fluorine(F)]DOPA) Determinants and Predictors of Treatment Response in Psychosis|Not yet recruiting||N/A|62|Anticipated|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:52:07.925721|2017-10-10 21:52:07.925721
NCT02880982|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-03-31|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|March 2022|Anticipated|2022-03-01|September 2021|Anticipated|2021-09-01||Interventional|ViDiKids||Trial of Vitamin D Supplementation in Cape Town Primary Schoolchildren|Trial of Vitamin D Supplementation in Cape Town Primary Schoolchildren|Recruiting||Phase 3|5400|Anticipated|Queen Mary University of London||2|||f||||t||||||||Undecided||2017-10-10 21:52:07.995511|2017-10-10 21:52:07.995511
NCT02880969|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-23|||June 2013||2013-06-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|December 2015|Actual|2015-12-01||Interventional|CQFD||Effect of Individual and Populational Determinants on End Stage Renal Disease Children Quality of Life, During Dialysis Period.||Active, not recruiting||N/A|136|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:52:08.091558|2017-10-10 21:52:08.091558
NCT02880956|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-24|2017-08-31|||October 17, 2016||2016-10-17|August 2017|2017-08-01|April 7, 2021|Anticipated|2021-04-07|December 16, 2020|Anticipated|2020-12-16||Interventional|||A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease|A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease|Recruiting||Phase 2|400|Anticipated|AbbVie||4|||f||||t||||||||||2017-10-10 21:52:08.15989|2017-10-10 21:52:08.15989
NCT02880943|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-11-07|||October 2016||2016-10-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|October 2020|Anticipated|2020-10-01||Interventional|EIFFEL||Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)|Phase I/II Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO®) in Renal Cell Carcinoma Patients With Bone Metastases.|Active, not recruiting||Phase 1/Phase 2|42|Anticipated|Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie||2|||f||||t||||||||No||2017-10-10 21:52:10.511902|2017-10-10 21:52:10.511902
NCT02880930|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-01-03|||December 2016||2016-12-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|OPTIVIT||Optimizing Vitamin D Status in Children With Wheeze / Asthma (OPTIVIT)|Optimizing Vitamin D Status in Children With Pre-school Wheeze or Asthma:a Pilot Study (OPTIVIT)|Recruiting||N/A|40|Anticipated|Queen Mary University of London||1|||f||||f||||||||No|No individual participant data will be available. Non-patient identifiable data will be presented in paper, abstract and presentation to conferences.|2017-10-10 21:52:10.659271|2017-10-10 21:52:10.659271
NCT02880917|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-07-07|||November 2015||2015-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Combined Treatment With tDCS and Cognitive Training in Patients With Fibromyalgia|Effects of Combined Treatment With tDCS and Cognitive Training on Attention and Working Memory in Patients With Fibromyalgia|Recruiting||N/A|40|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 21:52:10.812185|2017-10-10 21:52:10.812185
NCT02880891|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Effects of Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level Alterations Around Implants|School and Hospital of Somatology, Peking University|Not yet recruiting||N/A|20|Anticipated|Peking University||2|||f||||f||||||||No||2017-10-10 21:52:11.105839|2017-10-10 21:52:11.105839
NCT02880878|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-05-19|||December 2016||2016-12-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|ENRICH||ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)|ENRICH: A Multi-center, Randomized, Clinical Trial Comparing Standard Medical Management to Early Surgical Hematoma Evacuation Using Minimally Invasive Parafascicular Surgery (MIPS) in the Treatment of Intracerebral Hemorrhage (ICH).|Recruiting||N/A|300|Anticipated|Nico Corporation||2|||f||||t||||||||No||2017-10-10 21:52:11.190273|2017-10-10 21:52:11.190273
NCT02880865|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-18|||October 13, 2016|Actual|2016-10-13|September 2017|2017-09-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Interventional|JEV06||Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine|Immunogenicity and Safety of Concurrent Administration of Live, Attenuated SA 14-14-2 Japanese Encephalitis Vaccine and Measles-Mumps-Rubella Vaccine in Infants 9-12 Months of Age in the Philippines|Completed||Phase 4|628|Actual|PATH||2|||f||||t||||||||||2017-10-10 21:52:11.544651|2017-10-10 21:52:11.544651
NCT02880839|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-25|||September 2013||2013-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Digital Navigation Enhances Cervical Pedicle Screw Placement Accuracy and Safety|Digital Navigation Enhances Cervical Pedicle Screw Placement Accuracy and Safety: A Randomized Controlled Trial|Active, not recruiting||N/A|76|Actual|Nantong University||3|||f||||t||||||||Undecided||2017-10-10 21:52:11.776742|2017-10-10 21:52:11.776742
NCT02880826|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-25|||August 2013||2013-08-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|REA-C-SUR||Measurement of Care Safety Culture in French ICU, Correlation With the Characteristics of Morbi-mortality Reviews|Study on the Measurement of Care Safety Culture in French ICU, Correlation With the Characteristics of Morbi-mortality Reviews|Completed||N/A|4800|Actual|Nantes University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:52:11.862533|2017-10-10 21:52:11.862533
NCT02880813|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-28|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effects of Gastric or Duodenal Nutrient Infusion on Food Intake, Obesity and Comorbidities in Obese Individuals|The Effects of Gastric or Duodenal Nutrient Infusion on Food Intake, Obesity and Comorbidities in Obese Individuals|Recruiting||N/A|16|Anticipated|University of Michigan||2|||f||||t|f|f||||||||2017-10-10 21:52:11.918578|2017-10-10 21:52:11.918578
NCT02880800|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Does IVPCA Increase Opioid Consumption and Side Effects in Fast Track Orthopedic Procedures?|Does the Use of Intravenous Patient Controlled Analgesia (IVPCA) Increase Opioid Consumption and Side Effects in Fast Track Orthopedic Procedures?|Recruiting||N/A|80|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||No||2017-10-10 21:52:12.014188|2017-10-10 21:52:12.014188
NCT02880787|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-23|||November 2014||2014-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TOFScan||Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®|Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®|Recruiting||N/A|142|Anticipated|Central Hospital, Nancy, France||4|||f||||f||||||||No||2017-10-10 21:52:12.113064|2017-10-10 21:52:12.113064
NCT02880774|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||August 2015||2015-08-01|August 2016|2016-08-01|August 2016|Anticipated|2016-08-01|August 2016|Actual|2016-08-01||Interventional|THERAPY||Influence of Manual Therapy in Temporomandibular Joint Disorder|Influence of Manual Therapy in Temporomandibular Joint on the Mandibular Movement: Clinical Trial, Randomised, Placebo-controlled and Blind|Recruiting||Phase 1/Phase 2|24|Anticipated|University of Nove de Julho||2|||f||||t||||||||No||2017-10-10 21:52:12.219314|2017-10-10 21:52:12.219314
NCT02880761|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-27|||July 2016||2016-07-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|July 2018|Anticipated|2018-07-01||Interventional|||Cohort Study on A Following-up System of Native Arteriovenous Fistulae|Cohort Study on A Following-up System of Native Arteriovenous Fistulae in Chinese Patients Treated by Maintenance Hemodialysis|Recruiting||N/A|200|Anticipated|Capital Medical University||2|||f||||f||||||||Undecided||2017-10-10 21:52:12.308172|2017-10-10 21:52:12.308172
NCT02880748|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Water Exchange Method on Adenoma Miss Rates in Patients Undergoing Selective Polypectomy|Effect of Water Exchange Method on Adenoma Miss Rates in Patients Undergoing Selective Polypectomy: a Single-centered, Randomized Controlled Study|Recruiting||N/A|450|Anticipated|Fourth Military Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:52:12.392357|2017-10-10 21:52:12.392357
NCT02880735|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy|Effect of Noninvasive Mechanical Ventilation on Ventilatory Response in Patients With Myotonic Dystrophy Type 1|Recruiting||N/A|27|Anticipated|National Institute of Respiratory Diseases, Mexico||1|||f||||f||||||||Yes|Participant data to be shared will be: Results of functional testing and prescription ventilation.|2017-10-10 21:52:12.488863|2017-10-10 21:52:12.488863
NCT02880709|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-26|||November 2013||2013-11-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||The Effect of Special Diets in Hematological Cancer Patients|The Effect of Special Diets on Weight and Nutritional Intake in Haematological Cancer Patients|Completed||Phase 4|32|Actual|University of Copenhagen||2|||f||||t||||||||No||2017-10-10 21:52:12.656408|2017-10-10 21:52:12.656408
NCT02880696|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-08-23|||September 2016||2016-09-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|PREMATEMP||Perception of Temporal Regularity in Tactile Stimulation: a Diffuse Correlation Spectroscopy Study in Preterm Neonates|Perception of Temporal Regularity in Tactile Stimulation: a Diffuse Correlation Spectroscopy Study in Preterm Neonates|Not yet recruiting||N/A|40|Anticipated|University Hospital, Caen||2|||f||||f||||||||No||2017-10-10 21:52:12.72857|2017-10-10 21:52:12.72857
NCT02880683|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-10-12|||October 2015||2015-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|COAST-HF HNrCS||Cardiac Output Autonomic Stimulation Therapy for Heart Failure (COAST-HF) - Human NeuroCatheter Study|Cardiac Output Autonomic Stimulation Therapy for Heart Failure (COAST-HF) - Human NeuroCatheter Study|Completed||N/A|16|Actual|NeuroTronik Inc.||1|||f||||t||||||||Undecided||2017-10-10 21:52:12.815204|2017-10-10 21:52:12.815204
NCT02880670|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-11-15|||August 2016||2016-08-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects|Pharmacokinetics and Metabolism of [14C] BMS-986142 in Healthy Male Subjects|Completed||Phase 1|9|Actual|Bristol-Myers Squibb||1|||f||||f||||||||Undecided||2017-10-10 21:52:12.888423|2017-10-10 21:52:12.888423
NCT02880462|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-25|||September 2016||2016-09-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia|Phase 2 Study of the Effect of add-on Sulforaphane in Treatment of Schizophrenia|Not yet recruiting||Phase 2/Phase 3|180|Anticipated|Central South University||3|||f||||t||||||||Yes||2017-10-10 21:52:14.543015|2017-10-10 21:52:14.543015
NCT02880657|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|MELORUN560||Evaluation of SODB® (Superoxide Dismutase by Bionov®) in the Physical Condition Improvement in Healthy Subjects|Evaluation of SODB®, Associated With a Physical Training, in the Physical Condition Improvement in Healthy Subjects: Randomized Double-blind Study Versus Placebo|Not yet recruiting||N/A|42|Anticipated|Bionov||2|||f||||f||||||||Undecided||2017-10-10 21:52:12.956345|2017-10-10 21:52:12.956345
NCT02880644|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-31|||January 26, 2017|Actual|2017-01-26|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|24 Months|Observational [Patient Registry]|HERMES||Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept|Ultra-wide Fluorescein angiograpHy to Evaluate the Progression of Retinal ischeMia After aflibErcept Injections in patientS With Central Retinal Vein Occlusion in Real Life (HERMES Study)|Recruiting||N/A|50|Anticipated|Centre Hospitalier Intercommunal Creteil|||1||f||||t||||||||||2017-10-10 21:52:13.155545|2017-10-10 21:52:13.155545
NCT02880631|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-30|||August 2016||2016-08-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01|3 Years|Observational [Patient Registry]|||BAROSTIM THERAPY™ In Resistant Hypertension|BAROSTIM THERAPY™ In Resistant Hypertension: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System|Recruiting||N/A|500|Anticipated|CVRx, Inc.|||1||f||||f||||||||||2017-10-10 21:52:13.293127|2017-10-10 21:52:13.293127
NCT02880618|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-29|||July 2016||2016-07-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01|12 Months|Observational [Patient Registry]|HFrEF||BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction|BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System|Recruiting||N/A|500|Anticipated|CVRx, Inc.|||1||f||||f||||||||||2017-10-10 21:52:13.482504|2017-10-10 21:52:13.482504
NCT02880605|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-12|||August 2016||2016-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|1 Year|Observational [Patient Registry]|||Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization|Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization|Recruiting||N/A|4000|Anticipated|China National Center for Cardiovascular Diseases|||4||f||||t||||||||||2017-10-10 21:52:13.613453|2017-10-10 21:52:13.613453
NCT02880592|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-05-15|||August 2016||2016-08-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers|A Multi-center, Randomized Controlled Clinical Trial Evaluating the Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers|Recruiting||N/A|70|Anticipated|SerenaGroup, Inc.||2|||f||||f||||||||No||2017-10-10 21:52:13.69842|2017-10-10 21:52:13.69842
NCT02880579|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-22|||May 2013||2013-05-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|NTF||Neurothrombectomy France|Evaluation of Clinical Results of Treatment of Cerebral Artery Occlusion by Mechanical Thrombectomy, in the Acute Phase of Stroke|Completed||N/A|230|Actual|Nantes University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:52:13.831298|2017-10-10 21:52:13.831298
NCT02880566|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of Scalp Block on Hemodynamic Stability and Opioid Consumption During Craniotomy||Not yet recruiting||N/A|50|Anticipated|University Hospital of Liege||2|||f||||f||||||||No||2017-10-10 21:52:13.908256|2017-10-10 21:52:13.908256
NCT02880553|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-26|||August 23, 2016|Actual|2016-08-23|July 2017|2017-07-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Observational|QUALVIE-SEP||Disability, Perceived Social Support and Quality of Life in Multiple Sclerosis||Completed||N/A|150|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:52:13.971516|2017-10-10 21:52:13.971516
NCT02880540|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-06|||March 2016||2016-03-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Dexmedetomidine to Treat Bariatric Surgery-associated Pain|The Use of Dexmedetomidine as an Adjuvant for Perioperative Pain Management in Morbidly Obese Adolescents Undergoing Bariatric Surgery|Recruiting||Phase 3|50|Anticipated|Children's Research Institute||2|||f||||t||||||||Undecided||2017-10-10 21:52:14.049653|2017-10-10 21:52:14.049653
NCT02880527|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-23|||July 2014||2014-07-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|EPIDEMYOSITIS||Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy|Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy|Completed||N/A|187|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-10 21:52:14.16578|2017-10-10 21:52:14.16578
NCT02880514|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-03-19|||August 2016||2016-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FRONTIER||A Clinical Evaluation of Propel Mini Sinus Implant Placement in the Frontal Sinus Ostia Following In-office Dilation|A Clinical Evaluation of Propel Mini Sinus Implant Placement in the Frontal Sinus Ostia Following In-office Dilation|Active, not recruiting||N/A|100|Anticipated|Intersect ENT||2|||f||||f||||||||No||2017-10-10 21:52:14.233791|2017-10-10 21:52:14.233791
NCT02880501|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-23|||January 2015||2015-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Safety and Effectiveness of Proximal Femoral Nail Antirotation for the Treatment of Intertrochanteric Femoral Fracture|Safety and Effectiveness of Proximal Femoral Nail Antirotation for the Treatment of Intertrochanteric Femoral Fracture: Study Protocol for a Prospective Case Series|Active, not recruiting||N/A|20|Anticipated|Chaohu Hospital of Anhui Medical University||1|||f||||t||||||||Undecided||2017-10-10 21:52:14.335508|2017-10-10 21:52:14.335508
NCT02880488|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-23||||||August 2016|2016-08-01||||July 2015|Actual|2015-07-01||Observational|ASTEQ||Validation of a Questionnaire Assessing Quality of Life in Children With Amblyopia and Strabismus||Completed||N/A|294|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:52:14.406095|2017-10-10 21:52:14.406095
NCT02880475|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-22|||June 2014||2014-06-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients|An Open-label, Randomized, Single-dose, Parallel Group Study to Investigate the Pharmacokinetics of Oxycodone and Naloxone From OXN 5/2.5 and OXN 20/10 in Chinese Patients With Moderate to Severe Chronic Non-malignant Pain|Completed||Phase 1|30|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||1|||f||||f||||||||No||2017-10-10 21:52:14.465454|2017-10-10 21:52:14.465454
NCT02880449|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-14|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Promoting Physical Activity Among Older Women Living in Socio-economically Disadvantaged Areas|Promoting Physical Activity Among Older Women Living in Socio-economically Disadvantaged Areas Using a Social Practice Theory Based Intervention: A Pilot Trial|Completed||N/A|40|Actual|Queen's University, Belfast||2|||f||||f||||||||||2017-10-10 21:52:14.629889|2017-10-10 21:52:14.629889
NCT02880436|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-24|||January 2007||2007-01-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Association of Air Quality and Myocardial Infarction|Association of Air Quality and Myocardial Infarction|Completed||N/A|12000|Anticipated|Medical University of Graz|||1||f||||f||||||||||2017-10-10 21:52:14.700168|2017-10-10 21:52:14.700168
NCT02880423|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-25|||September 2016||2016-09-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|SCS||Salpingectomy During Cesarean Section|Salpingectomy During Cesarean Section, for Risk Reduction of Ovarian Cancer, Compared With Tubal Ligation- Morbidity and Long Term Complications|Not yet recruiting||N/A|100|Anticipated|Bnai Zion Medical Center||2|||f||||f||||||||No||2017-10-10 21:52:14.769466|2017-10-10 21:52:14.769466
NCT02880410|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-10-02|||August 15, 2017|Actual|2017-08-15|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|FLAG||Feasibility Study on LITT for Newly Diagnosed Glioblastoma|Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Newly Diagnosed Glioblastoma|Recruiting||Phase 1|45|Anticipated|Monteris Medical||1|||f||||t|f|t|f|f||||||2017-10-10 21:52:14.848648|2017-10-10 21:52:14.848648
NCT02880397|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-08-29|||August 2015||2015-08-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Garcinia Mangostana L.Pericarp Gel as a Local Drug Delivery in Treatment of Chronic Periodontitis|Clinical And Microbiological Efficacy Of 4% Garcinia Mangostana L.Pericarp Gel As A Local Drug Delivery In The Treatment Of Chronic Periodontitis: A Randomized Controlled Clinical Trial|Completed||N/A|50|Actual|Meenakshi Ammal Dental College and Hospital||2|||f||||t||||||||||2017-10-10 21:52:14.937318|2017-10-10 21:52:14.937318
NCT02880384|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-17|||January 2017||2017-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Pathogen Detection and Community Acquired Pneumonia|Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-Acquired Pneumonia|Recruiting||N/A|300|Anticipated|Providence Health & Services||1|||f||||f|f|f||||||||2017-10-10 21:52:15.008984|2017-10-10 21:52:15.008984
NCT02880371|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-07-18|||August 2016||2016-08-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors|A Study of ARRY-382 in Combination With Pembrolizumab, a Programmed Cell Death Receptor 1 (PD-1) Antibody, for the Treatment of Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|70|Anticipated|Array BioPharma||3|||f||||f||||||||||2017-10-10 21:52:15.081939|2017-10-10 21:52:15.081939
NCT02880358|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-08-23|||January 2011||2011-01-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|December 2015|Actual|2015-12-01||Observational|EPICAL2||Epidemiology and Prognostic of the Acute Heart Failure|Epidemiology and Prognostic of the Acute Heart Failure in Northeast of France|Active, not recruiting||N/A|2500|Anticipated|Central Hospital, Nancy, France|||1||f||||t||||||Samples With DNA|"     DNA, serum, whole blood and urine   "|||2017-10-10 21:52:15.222898|2017-10-10 21:52:15.222898
NCT02880345|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2018|Anticipated|2018-08-01||Interventional|||RADVAX™: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy|RADVAX™: A Pilot Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy|Not yet recruiting||N/A|14|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-10 21:52:15.282485|2017-10-10 21:52:15.282485
NCT02880332|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-02-09|||February 9, 2017|Actual|2017-02-09|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Pain Processing and Pain Neuroscience Education in Children With Chronic Abdominal Pain|Endogenous Pain Processing and Effectiveness of Pain Neuroscience Education in Children With Functional Abdominal Pain and Irritable Bowel Syndrome|Recruiting||N/A|66|Anticipated|Vrije Universiteit Brussel||2|||f||||f|f|f||||||No||2017-10-10 21:52:15.35324|2017-10-10 21:52:15.35324
NCT02880319|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|March 2024|Anticipated|2024-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Phase II Protocol Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone|Phase II Protocol Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone|Not yet recruiting||Phase 2|100|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-10 21:52:15.576144|2017-10-10 21:52:15.576144
NCT02880306|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-23|||July 2014||2014-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Observational|||Hepatocellular Carcinoma and Rheumatoid Arthritis|Hepatocellular Carcinoma and Rheumatoid Arthritis|Completed||N/A|741379|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||2||f||||t||||||||Yes|The Taiwan's National Health Insurance Research Database (NHIRD) between Jan 1, 1999, and June 30, 2009, and had follow-up data until Dec 31, 2009. The Taiwan's NHIRD contains health-care data gathered prospectively for 99% of Taiwan's population and approximately 22,600,000 individuals in 2007. The Taiwan's National Health Research Institutes (NHRI) maintained the NHIRD and provided it to the investigators for research purposes. De-identified data were further scrambled before being released to public access for research. The accuracy of diagnosis of major diseases in the NHIRD, such as stroke and acute coronary syndrome, has been validated previously.|2017-10-10 21:52:15.680323|2017-10-10 21:52:15.680323
NCT02880280|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism|Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin is Superior to Human Chorionic Gonadotropin in Therapeutic Efficacy in Adolescent Boys With Congenital Hypogonadotropic Hypogonadism|Recruiting||Phase 4|40|Anticipated|Beijing Children's Hospital||2|||f||||f||||||||No||2017-10-10 21:52:15.861952|2017-10-10 21:52:15.861952
NCT02880267|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-06-07|||May 2016||2016-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:52:15.951641|2017-10-10 21:52:15.951641
NCT02880254|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|Kurbo||A Study to Assess the Compliance and Impact on Weight of Kurbo, a Pediatric Centered Weight Loss App|A Study to Assess the Compliance and Impact on Weight of Kurbo, a Pediatric Centered Weight Loss App|Not yet recruiting||N/A|70|Anticipated|Baystate Medical Center||2|||f||||f||||||||Yes|De-identified individual participant data for all primary and secondary outcome measures will be made available within 1 year of study completion.|2017-10-10 21:52:15.992172|2017-10-10 21:52:15.992172
NCT02880241|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-10-04|||September 25, 2017|Actual|2017-09-25|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria|An Open Label Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose of MMV390048 in Adult Patients With Acute, Uncomplicated Plasmodium Vivax or Falciparum Malaria Monoinfection Over a 35 Day Period|Recruiting||Phase 2|102|Anticipated|Medicines for Malaria Venture||6|||f||||t|f|f||||||||2017-10-10 21:52:16.075267|2017-10-10 21:52:16.075267
NCT02880228|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-07-10|||September 16, 2016|Actual|2016-09-16|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant|Phase 2 Trial of Pembrolizumab, Lenalidomide, and Dexamethasone for Initial Therapy of Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation|Active, not recruiting||Phase 2|41|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 21:52:16.195526|2017-10-10 21:52:16.195526
NCT02880215|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-13|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Development of Attention Bias Modification for Depression|Development of Attention Bias Modification for Depression|Recruiting||N/A|150|Anticipated|University of Texas at Austin||3|||f||||t|f|f||||||||2017-10-10 21:52:16.332064|2017-10-10 21:52:16.332064
NCT02880202|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-08-28|||August 2016||2016-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|||Impact of Massage Therapy on the Quality of Life of Hospice Patients|Impact of Massage Therapy on the Quality of Life of Hospice Patients|Recruiting||N/A|60|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 21:52:16.427337|2017-10-10 21:52:16.427337
NCT02880189|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||September 2016||2016-09-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity|Combined Endoscopic Ultrasound Guided Core Liver Biopsy and Intragastric Balloon Placement for the Diagnosis and Management of Nonalcoholic Steatohepatitis and Obesity|Not yet recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 21:52:16.519931|2017-10-10 21:52:16.519931
NCT02880176|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-06-14|||August 2016||2016-08-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|STEPP||Steps to Eliminate Postoperative Problems|Steps to Eliminate Postoperative Problems|Recruiting||N/A|46|Anticipated|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 21:52:16.599756|2017-10-10 21:52:16.599756
NCT02880163|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-06-08|||December 2018|Anticipated|2018-12-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|REVIVE||REVIVE: Reducing Exsanguination Via In‐Vivo Expandable Foam|Reducing Exsanguination Via In‐Vivo Expandable Foam|Not yet recruiting||Phase 1|40|Anticipated|Arsenal Medical, Inc.||1|||f||||t|f|t|t|f||||Yes||2017-10-10 21:52:16.733766|2017-10-10 21:52:16.733766
NCT02880150|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-08-22|||May 2013||2013-05-01|August 2016|2016-08-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|ALTIPERF||Physiological Characteristics of High Altitude Climbers|Physiological Characteristics of High Altitude Climbers|Completed||N/A|20|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:52:16.79753|2017-10-10 21:52:16.79753
NCT02880137|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-05-10|||September 2016||2016-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy|(RTMPE for CAV) Real Time Myocardial Perfusion Echocardiography for Detection of Coronary Allograft Vasculopathy in Cardiac Transplant Patients|Recruiting||Phase 4|50|Anticipated|Mayo Clinic||1|||f||||t||||||||Yes|"Dr. Nowell Fine University of Calgary 1403 29th Street NW Canada
Researchers at University of Calgary are also conducting this study and will collaborate with Mayo Clinic on the research data.
Study identification number, subject Identification, or any other unique identifying number, characteristic, or code that the external party is unable to link to the identity of the subject. Dates: all elements of dates [month, day, and year] directly related to an individual, e.g. date of birth, death, or diagnosis, etc. City, county, precinct, zip code, and their equivalent geocodes."|2017-10-10 21:52:16.872324|2017-10-10 21:52:16.872324
NCT02880124|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2017-03-07|||July 2016||2016-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Maple Products and Exercise Performance|Ingestion of Maple Products During Exercise: Effects on Energy Metabolism and Time-trial Performance|Recruiting||N/A|105|Anticipated|Université de Montréal||7|||f||||f||||||||No||2017-10-10 21:52:16.970704|2017-10-10 21:52:16.970704
NCT02880111|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-08-21|||January 2016||2016-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|DMBT1||Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa|Comparison of Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients Colonized Patients Between Chronic and Non-chronic Patients Colonized With Pseudomonas Aeruginosa|Recruiting||N/A|60|Anticipated|University Hospital, Lille|||2||f||||f|f|f||||||||2017-10-10 21:52:17.120818|2017-10-10 21:52:17.120818
NCT02880085|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-08-22|||February 2015||2015-02-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|MarkerFAI||Marker for FAI Diagnosis|Use of a Marker for Cartilage Damage to Differentiate the Diagnosis of Femural Acetabular Impingement From Extraarticular Pathologies.|Completed||N/A|20|Actual|Istituto Ortopedico Rizzoli|||1||f||||f||||||Samples Without DNA|"     serum and urine samples   "|No||2017-10-10 21:52:17.295678|2017-10-10 21:52:17.295678
NCT02880072|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||March 2014||2014-03-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Absorption of Orally Ingested Phosphate in Refeeding Syndrome|Absorption of Orally Ingested Phosphate in Head and Neck Cancer Patients With and Without Refeeding Syndrome|Completed||Phase 4|12|Actual|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 21:52:17.377347|2017-10-10 21:52:17.377347
NCT02880059|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-23|||June 2016||2016-06-01|August 2016|2016-08-01|June 2021|Anticipated|2021-06-01|December 2017|Anticipated|2017-12-01||Observational|IESA||Incidence and Effects of Sleep Apnea on Intracerebral Aneurysms|Incidence and Effects of Sleep Apnea on Intracerebral Aneurysms - IESA-Study|Recruiting||N/A|200|Anticipated|University Hospital, Bonn|||1||f||||t||||||||No||2017-10-10 21:52:17.450652|2017-10-10 21:52:17.450652
NCT02880046|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||October 2016||2016-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|POLYTCANCER||Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies|Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies|Not yet recruiting||N/A|90|Anticipated|Central Hospital, Nancy, France|||3||f||||f||||||Samples With DNA|"     Frozen PBMC   "|No||2017-10-10 21:52:17.539377|2017-10-10 21:52:17.539377
NCT02880033|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-08|||February 2011||2011-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LymphoEnergy||Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes|Modulation of Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes of Patients With Parkinson's Disease or Amyotrophic Lateral Sclerosis|Active, not recruiting||N/A|90|Anticipated|University Hospital, Lille||3|||f||||f||||||||No||2017-10-10 21:52:17.613024|2017-10-10 21:52:17.613024
NCT02880020|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-12-20|||December 2016||2016-12-01|December 2016|2016-12-01||||September 2018|Anticipated|2018-09-01||Interventional|||Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery|A Randomized Phase 2 Study of Nivolumab Monotherapy Versus Nivolumab Combined With Ipilimumab in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor (GIST)|Recruiting||Phase 2|40|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 21:52:17.713422|2017-10-10 21:52:17.713422
NCT02880007|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-22|||June 2011||2011-06-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|TRIDICOL||Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer|A Prospective Open Label Phase II Study to Optimize the Dose in 3D Pulsed Dose Rate Brachytherapy in Patients With Locally Advanced Cervical Cancer|Recruiting||Phase 2|48|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 21:52:17.850718|2017-10-10 21:52:17.850718
NCT02879994|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-05-30|||September 15, 2016|Actual|2016-09-15|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer|A Phase II Study of Pembrolizumab in EGFR Mutant, Tyrosine Kinase Inhibitor Naïve Treatment Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|25|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 21:52:18.039984|2017-10-10 21:52:18.039984
NCT02879981|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-09-21|||November 10, 2016|Actual|2016-11-10|September 2017|2017-09-01|August 28, 2017|Actual|2017-08-28|August 28, 2017|Actual|2017-08-28||Observational|||A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis|A Pilot, Multicentric and Observational Study of Safety of Sulfamethoxazole + Trimethoprim + Guaifenesin (Balsamic Bactrim) in Pediatric Patients With Acute Bronchitis|Completed||N/A|51|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 21:52:18.143793|2017-10-10 21:52:18.143793
NCT02879968|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer|Correlation Between Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer|Recruiting||N/A|52|Anticipated|Prince of Songkla University|||1||f||||t||||||Samples Without DNA|"     serum squamous cell carcinoma antigen   "|No||2017-10-10 21:52:18.256772|2017-10-10 21:52:18.256772
NCT02879955|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-07-18|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Carbohydrates and Gut Hormones After Gastric Bypass Surgery|Effects of Carbohydrates on Gut Hormone Secretion After Gastric Bypass Surgery|Completed||N/A|20|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 21:52:18.353282|2017-10-10 21:52:18.353282
NCT02879942|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-22|||August 2016||2016-08-01|July 2016|2016-07-01||||May 2018|Anticipated|2018-05-01||Observational|||First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction|First-trimester Study of the Morphometric Characteristics of the Placenta to Assess the Risk of Preeclampsia and Intrauterine Growth Restriction in Singleton Pregnancies|Not yet recruiting||N/A|1250|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||||||||Samples Without DNA|"     Serum samples from the first blood test performed during pregnancy   "|||2017-10-10 21:52:18.439542|2017-10-10 21:52:18.439542
NCT02879929|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-13|||October 2005||2005-10-01|August 2017|2017-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|DyNaChron||Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction|Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction|Completed||N/A|759|Actual|Central Hospital, Nancy, France|||1||f||||f||||||||||2017-10-10 21:52:18.518068|2017-10-10 21:52:18.518068
NCT02879916|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-10-26|||October 2011||2011-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of an Interscalene Nerve Block With or Without Stellate Ganglion Block for Shoulder Surgery|Comparison of the Analgesic Effect of Levobupivacaine 0.5% Via Interscalene Nerve Block or Via Interscalene Nerve Block Combined With a Stellate Ganglion Block in Patients Undergoing Shoulder Arthroscopy With General Anaesthesia|Completed||Phase 4|30|Actual|University Hospital, Antwerp||2|||f||||f||||||||No||2017-10-10 21:52:18.567356|2017-10-10 21:52:18.567356
NCT02879903|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-28|||August 2016||2016-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Prevalence of Porphyromonas Gingivalis Fimbrial Subunit Genotype in Smokers and Nonsmokers After Periodontal Therapy|Prevalence of Porphyromonas Gingivalis Fimbrial Subunit Genotype in Smokers and Nonsmokers After Periodontal Therapy|Active, not recruiting||Early Phase 1|32|Anticipated|Universidade Federal Fluminense||2|||f||||t||||||||Yes|The result will be communicated verbally for each participant.|2017-10-10 21:52:18.625541|2017-10-10 21:52:18.625541
NCT02879890|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-25|||March 2009||2009-03-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|COMUTAR||Comorbidities and Indirect Health State Utility in Hip and Knee Osteoarthritis|Impact of Comorbidities on Measure of Indirect Utility Change in Hip and Knee Ostearthritis|Completed||N/A|878|Actual|Central Hospital, Nancy, France|||1||f||||t||||||||Yes|Open to partnership|2017-10-10 21:52:18.803315|2017-10-10 21:52:18.803315
NCT02879877|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-11|||July 11, 2016|Actual|2016-07-11|September 2017|2017-09-01|January 25, 2018|Anticipated|2018-01-25|January 25, 2018|Anticipated|2018-01-25||Interventional|||A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers|A Subject-blind, Investigator-blind, Randomized, Placebo-controlled, First-in-human Study Evaluating the Safety/Tolerability, Pharmacokinetics, Effect on Transglutaminase 2 Expression, and Occupancy of Single Ascending Intravenous and Subcutaneous Doses of UCB7858 in Healthy Subjects|Active, not recruiting||Phase 1|80|Anticipated|UCB Pharma||4|||f||||t||||||||||2017-10-10 21:52:18.862048|2017-10-10 21:52:18.862048
NCT02879864|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-23|||October 2016||2016-10-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|EFFLUX||Effect on Fatigue of Light (Lux) Therapy in Patients With Cancer|Effect on Fatigue of Light (Lux) Therapy in Patients With Cancer|Not yet recruiting||N/A|100|Anticipated|Groupe Hospitalier Paris Saint Joseph||2|||f||||t||||||||Undecided||2017-10-10 21:52:18.959106|2017-10-10 21:52:18.959106
NCT02879851|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-22|||January 2015||2015-01-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Observational|EFEL||Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ System|Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound ((Magnetic Resonance Imaging) Obtained in Vivo by the Koelis™ System|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon|||1||f||||||||||||||2017-10-10 21:52:19.061034|2017-10-10 21:52:19.061034
NCT02879838|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|ARPEIGE||Occupational Respiratory Allergies and Gene-environment Interactions|Occupational Respiratory Allergies and Gene-environment Interactions|Not yet recruiting||N/A|400|Anticipated|Central Hospital, Nancy, France|||3||f||||f||||||Samples With DNA|"     Blood sample for collection of human biological material for genotyping analysis   "|No||2017-10-10 21:52:19.147767|2017-10-10 21:52:19.147767
NCT02879825|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-07-18|||December 20, 2016|Actual|2016-12-20|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|STAMP||Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)|Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse|Recruiting||N/A|230|Anticipated|Central Hospital, Nancy, France||4|||f||||f||||||||||2017-10-10 21:52:19.272368|2017-10-10 21:52:19.272368
NCT02879812|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2017-09-21|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|ASCENT||Disparities in National Kidney Allocation Policy|Allocation System Changes for Equity in kidNey Transplantation (ASCENT) Study|Active, not recruiting||N/A|655|Actual|Emory University||2|||f||||t||||||||||2017-10-10 21:52:19.386006|2017-10-10 21:52:19.386006
NCT02879799|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-08-25|||September 2015||2015-09-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|FICare||Family Integrated Care (FICare) in Level II NICUs|Family Integrated Care (FICare) in Level II NICUs: An Innovative Program for Alberta|Recruiting||N/A|824|Anticipated|University of Calgary||2|||f||||f||||||||Yes|Negotiations are underway to reposit data with the Alberta Centre for Child, Family and Community Research, Secondary Analyses to Generate Evidence (SAGE)|2017-10-10 21:52:19.51178|2017-10-10 21:52:19.51178
NCT02879786|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-23|2016-08-23|||July 2011||2011-07-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|EQUIDYS||Study of Hierarchy of Afferents in Postural Control of Children With Dyslexia|Study of Hierarchy of Afferents in Postural Control of Children With Dyslexia|Completed||N/A|68|Actual|Central Hospital, Nancy, France||3|||f||||f||||||||No||2017-10-10 21:52:19.713164|2017-10-10 21:52:19.713164
NCT02879773|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-22|||February 2016||2016-02-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Observational|CURVE||Computed Tomography Assessment of Regional Ventilation (CURVE)|An Observational Study of Non Contrast Computed Tomography in Assessment of Regional Ventilation of the Lung.|Recruiting||N/A|132|Anticipated|Heart of England NHS Trust|||3||f||||f||||||||Undecided||2017-10-10 21:52:19.813149|2017-10-10 21:52:19.813149
NCT02879760|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-09-01|||March 8, 2017|Actual|2017-03-08|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|January 2020|Anticipated|2020-01-01||Interventional|||Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients|A Phase 1/2 Trial of MG1 Maraba Expressing MAGE-A3 (MG1-MAGEA3), With Adenovirus Vaccine Expressing MAGE-A3 (Ad-MAGEA3), in Combination With Pembrolizumab in Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|61|Anticipated|Turnstone Biologics, Inc.||1|||f||||f|f|f||||||||2017-10-10 21:52:19.927768|2017-10-10 21:52:19.927768
NCT02879747|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-22|||December 2003||2003-12-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|MAINTENANCE||Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children|Individualizing the Dose of Growth Hormone (GH) to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children Within TR 98-0198-003|Completed||Phase 2/Phase 3|99|Actual|Göteborg University||2|||f||||t||||||||||2017-10-10 21:52:20.091679|2017-10-10 21:52:20.091679
NCT02879734|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-06|||August 2016|Actual|2016-08-01|August 2016|2016-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Prophylactic Omentopexy During Laparoscopic Insertion of Peritoneal Dialysis Catheter|Comparison Between Performing Prophylactic Omentopexy and Lack of Omentopexy During Laparoscopic Insertion of Peritoneal Dialysis Catheters in Terms of Complications and Catheter Function|Completed||N/A|40|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 21:52:20.189491|2017-10-10 21:52:20.189491
NCT02879721|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-08-22|||October 2009||2009-10-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Expression and Function of the Renin-Angiotensin System in the Esophagus|The Renin-angiotensin System (RAS) in Barrett's Esophagus as Future Biomarkers for Dysplasia and Cancer? A Randomized Controlled Trial|Completed||Early Phase 1|33|Actual|Göteborg University||3|||f||||f||||||||No||2017-10-10 21:52:20.267538|2017-10-10 21:52:20.267538
NCT02879682|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-22|||August 2016||2016-08-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|Motorstim||nTMS for Motor Mapping of Rolandic Lesions|Randomized Controlled Multicenter Trial on the Impact of Presurgical Navigated Transcranial Magnetic Stimulation for Motor Mapping of Rolandic Lesions|Not yet recruiting||Phase 3|330|Anticipated|Technische Universität München||2|||f||||f||||||||No||2017-10-10 21:52:20.613835|2017-10-10 21:52:20.613835
NCT02879669|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-28|||June 2016||2016-06-01|September 2017|2017-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma|A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma|Recruiting||Phase 1/Phase 2|30|Anticipated|Targovax ASA||2|||f||||||||||||||2017-10-10 21:52:20.711241|2017-10-10 21:52:20.711241
NCT02879656|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Non-operative Treatment Versus Volar Locking Plate in Treatment of Distal Radius Fracture in Patients Over 65 Years|Non-operative Treatment Versus Surgery With Volar Locking Plate in Treatment of Distal Radius Fracture in 65-year-old and Older Patients - a Prospective, Randomized Controlled Trial|Not yet recruiting||N/A|208|Anticipated|Tampere University Hospital||2|||f|||||f|f||||||||2017-10-10 21:52:20.824969|2017-10-10 21:52:20.824969
NCT02879643|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-09|||January 31, 2017|Actual|2017-01-31|January 2017|2017-01-01|May 1, 2021|Anticipated|2021-05-01|August 31, 2020|Anticipated|2020-08-31||Interventional|||Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL|A Pilot Study of Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapse of Acute Lymphoblastic Leukemia|Recruiting||Phase 1|30|Anticipated|Therapeutic Advances in Childhood Leukemia Consortium||1|||f||||t|t|f||||||||2017-10-10 21:52:20.93372|2017-10-10 21:52:20.93372
NCT02879630|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-22|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity|Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity|Recruiting||N/A|20|Anticipated|West Virginia University|||2||f||||t||||||||||2017-10-10 21:52:21.128237|2017-10-10 21:52:21.128237
NCT02879617|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-05|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|September 15, 2019|Anticipated|2019-09-15|May 15, 2019|Anticipated|2019-05-15||Interventional|||A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients|A Phase II Clinical Trial Evaluating the Safety and Efficacy of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Patients With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2|Recruiting||Phase 2|50|Anticipated|University of Pittsburgh||1|||f||||t|t|f||||||||2017-10-10 21:52:21.231831|2017-10-10 21:52:21.231831
NCT02879604|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|Grecco||Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia|Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia|Not yet recruiting||N/A|210|Anticipated|University Hospital, Montpellier||2|||f||||f|f|f||||||||2017-10-10 21:52:21.31094|2017-10-10 21:52:21.31094
NCT02879591|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-24|||April 2014||2014-04-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|ALTEREGO||Enhancing Social Interaction With an AlterEgo Artificial Agent|Enhancing Social Interaction With an AlterEgo Artificial Agent|Recruiting||N/A|246|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:52:21.398755|2017-10-10 21:52:21.398755
NCT02879578|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-03-14|||July 2016||2016-07-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome||Enrolling by invitation||Phase 2|180|Anticipated|Neurocrine Biosciences||1|||f||||t||||||||||2017-10-10 21:52:21.478339|2017-10-10 21:52:21.478339
NCT02879565|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-22|||September 2011||2011-09-01|August 2016|2016-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|REVE||Families Expectations and Hope Raised by an Evaluation of Consciousness in Patients in a Vegetative State|Families Expectations and Hope Raised by an Evaluation of Consciousness in Patients With an Unresponsive Wakefulness Syndrome|Completed||N/A|13|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 21:52:21.57296|2017-10-10 21:52:21.57296
NCT02879539|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-08-21|||March 2015||2015-03-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Cochlear Implant Low Power Strategy|Clinical Assessment of a Low Power Strategy for Cochlear Implant Recipients|Recruiting||N/A|38|Anticipated|The Hearing Cooperative Research Centre||1|||f||||f||||||||No||2017-10-10 21:52:21.73237|2017-10-10 21:52:21.73237
NCT02879526|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2016-08-21|||August 2016||2016-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Chidamide Combined With Cyclophosphamide、Prednisone、Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma|Chidamide Combined With Cyclophosphamide、Prednisone、Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma :a Phase II,Single-arm,Open-label, Muti-center Study|Recruiting||Phase 2|45|Anticipated|The First Affiliated Hospital with Nanjing Medical University||1|||f||||t||||||||Yes||2017-10-10 21:52:21.822802|2017-10-10 21:52:21.822802
NCT02879513|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2017-03-26|||January 2014||2014-01-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response to Neoadjuvant Chemotherapy|A Randomized Phase III Trial of Comparing Combination Administration of Paclitaxel and Cisplatin Versus CEF as Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response to Neoadjuvant Chemotherapy|Recruiting||Phase 3|290|Anticipated|RenJi Hospital||3|||f||||t||||||||||2017-10-10 21:52:21.914638|2017-10-10 21:52:21.914638
NCT02879500|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||November 2015||2015-11-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Observational|||Network Meta-analyses of Artificially Sweetened Beverages Versus Water and Risk of Obesity|Artificially Sweetened Beverages Versus Water and Risk of Obesity: A Series of Systematic Reviews and Network Meta-analyses of Randomized Controlled Trials and Prospective Cohort Studies|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||No||2017-10-10 21:52:22.013571|2017-10-10 21:52:22.013571
NCT02879487|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-11|||August 2016||2016-08-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Vaginal Cuff Dehiscence at Total Laparoscopic Hysterectomy|Vaginal Cuff Dehiscence After Two Different Colpotomy Techniques at Total Laparoscopic Hysterectomy; a Randomized Clinical Trial|Recruiting||N/A|200|Anticipated|Ankara University||2|||f||||f||||||||Yes||2017-10-10 21:52:22.082917|2017-10-10 21:52:22.082917
NCT02879474|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-22|||August 2010||2010-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Observational|||Study of Risk Factors and Clinical Characterization of Rapidly Growing Melanoma||Active, not recruiting||N/A|472|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||No||2017-10-10 21:52:22.164908|2017-10-10 21:52:22.164908
NCT02879461|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-02-14|||January 1, 2015||2015-01-01|February 2017|2017-02-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2016|Actual|2016-08-01||Interventional|Stenosis||Surgical Decompression Associated With Physical Therapy and Physical Therapy Isolated in Patients With Lumbar Stenosis.|Prospective Study Comparing Surgical Decompression Associated With Physical Therapy And Physical Therapy Isolated In Patients With Lumbar Canal Stenosis|Active, not recruiting||N/A|62|Actual|Federal University of São Paulo||2|||f||||t||||||||Yes||2017-10-10 21:52:22.232343|2017-10-10 21:52:22.232343
NCT02879448|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-09-15|||August 2016||2016-08-01|September 2017|2017-09-01|December 2023|Anticipated|2023-12-01|February 2020|Anticipated|2020-02-01||Interventional|Amulet IDE||AMPLATZER™ Amulet™ LAA Occluder Trial|AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial|Recruiting||N/A|1600|Anticipated|St. Jude Medical||2|||f||||t||||||||||2017-10-10 21:52:22.333808|2017-10-10 21:52:22.333808
NCT02879435|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-08-22|||June 2016||2016-06-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Management of Postoperative Pain With Preemptive Analgesia in Cesarean Section|Management of Postoperative Pain With Preemptive Analgesia in Cesarean Section|Recruiting||N/A|120|Anticipated|Mercy Hospital and Medical Center, Illinois||2|||f||||f||||||||No||2017-10-10 21:52:23.018853|2017-10-10 21:52:23.018853
NCT02879422|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||October 2013||2013-10-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|REDIAGEN||Genetic Markers and Proliferative Diabetic Retinopathy|Study of the Association Between Genetic Markers (Endothelial Lipase and Aldose Reductase) and Proliferative Diabetic Retinopathy|Recruiting||N/A|310|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:52:23.127795|2017-10-10 21:52:23.127795
NCT02879409|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-01|||November 2016||2016-11-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||HbA1c Variability in Type II Diabetes|Does Glycated Hemoglobin Variability in Type 2 Diabetes Differ Depending on the Diabetes Treatment Threshold Used in the Qatari Population: Implication on Diabetes Complication Risk?|Recruiting||N/A|150|Anticipated|Weill Cornell Medical College in Qatar||2|||f||||t||||||||No||2017-10-10 21:52:23.250778|2017-10-10 21:52:23.250778
NCT02879396|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|PA4LE||Preventing Avoidable Admissions Among Assisted Living Elders|Preventing Avoidable Admissions Among Assisted Living Elders (PA4LE)|Not yet recruiting||N/A|50|Anticipated|University of Arizona||1|||f||||f||||||||||2017-10-10 21:52:23.434019|2017-10-10 21:52:23.434019
NCT02879383|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-11|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Effect of DMR Using the Revita System in the Treatment of Type 2 Diabetes (T2D)|Evaluation of the Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)|Recruiting||N/A|110|Anticipated|Fractyl Laboratories, Inc.||2|||f||||t|f|f||||||||2017-10-10 21:52:23.528724|2017-10-10 21:52:23.528724
NCT02879370|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-08-20|||January 2013||2013-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|TICRANT||Transanal Inspection and Management of Low ColoRectal Anastomosis Performed With a New Technique|"Transanal Inspection and Management of Low ColoRectal Anastomosis Performed With a New Technique: the TICRANT Study"|Recruiting||N/A|100|Anticipated|University of Rome Tor Vergata||1|||f||||t||||||||Undecided||2017-10-10 21:52:23.697358|2017-10-10 21:52:23.697358
NCT02879357|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-08-08|||March 2014||2014-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|iCMP||Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients|Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients|Active, not recruiting||N/A|194|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 21:52:23.825675|2017-10-10 21:52:23.825675
NCT02879344|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-03-31|||January 2013||2013-01-01|August 2016|2016-08-01|March 2017|Actual|2017-03-01|January 2016|Actual|2016-01-01||Interventional|||Extra Corporeal Membrane Oxygenation in the Acute Respiratory Distress Syndrome: Utility of a Biomarker to Assess the Membrane Efficiency in Improving Oxygenation||Completed||N/A|20|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:52:23.923574|2017-10-10 21:52:23.923574
NCT02879331|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-14|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|CYCLONE||Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils|Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils|Recruiting||N/A|35|Anticipated|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz||2|||f||||f||||||||||2017-10-10 21:52:24.013122|2017-10-10 21:52:24.013122
NCT02879305|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-07-10|||June 14, 2014|Actual|2014-06-14|July 2017|2017-07-01|April 14, 2020|Anticipated|2020-04-14|April 14, 2020|Anticipated|2020-04-14||Interventional|||Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)|A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Erythropoietin-stimulating Agents|Recruiting||Phase 3|3000|Anticipated|GlaxoSmithKline||2|||f||||t|t|f||||||||2017-10-10 21:52:24.46218|2017-10-10 21:52:24.46218
NCT02879292|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-24|||December 2016||2016-12-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Observational|||Post-operative Outcomes in the Pyloromyotomy Procedure Under Spinal Anesthesia|Post-operative Outcomes in the Pyloromyotomy Procedure Under Spinal Anesthesia: A Retrospective Study in 100 Cases|Not yet recruiting||N/A|92|Anticipated|Bnai Zion Medical Center|||1||f||||t||||||||Yes||2017-10-10 21:52:28.345471|2017-10-10 21:52:28.345471
NCT02879279|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-08-02|||May 2016||2016-05-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Multi-segmental Robotic and Technological Upper Limb Rehabilitation in Stroke|Efficacy of a Multi-segmental Robotic and Technological Upper Limb Rehabilitation Program, Compared With Traditional Therapy, in Individuals With Acute and Sub-acute Stroke: a Multicenter, Randomized, Controlled Clinical Trial.|Recruiting||N/A|344|Anticipated|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||||2017-10-10 21:52:28.426704|2017-10-10 21:52:28.426704
NCT02879266|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-03-20|||February 1, 2016|Actual|2016-02-01|March 2017|2017-03-01||||September 30, 2017|Anticipated|2017-09-30||Interventional|||Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age|Phase I Evaluation of the Safety and Immunogenicity of an Investigational Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naïve Adults 50 - 70 Years of Age|Recruiting||Phase 1|28|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 21:52:28.523945|2017-10-10 21:52:28.523945
NCT02879253|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-08-09|||December 24, 2015|Actual|2015-12-24|August 2017|2017-08-01|July 11, 2016|Actual|2016-07-11|July 11, 2016|Actual|2016-07-11||Observational|NEMROfentes3D||Evaluation of Inter-patient Variability Size of the Nasal Cavity, Based on CT Scans|Evaluation of Inter-patient Variability Size of the Nasal Cavity, Based on CT Scans|Completed||N/A|36|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 21:52:28.600666|2017-10-10 21:52:28.600666
NCT02879240|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-06-05|||August 2016||2016-08-01|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|DISTRACT||Animated Cartoons and Cooperation in Young Children Receiving Inhaled Medications|Effectiveness of Animated Cartoons for Improving Cooperation During the Delivery of Inhaled Treatments to Young Children With Asthma|Completed||N/A|11|Actual|Hôpital Necker-Enfants Malades||2|||f||||f||||||||||2017-10-10 21:52:28.655321|2017-10-10 21:52:28.655321
NCT02879227|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-22|||January 2010||2010-01-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Chronos||Radiochemotherapy in Elderly Patients With Oesophagus Cancer|Phase II of Radiochemotherapy in Elderly Patients With Oesophagus Cancer|Completed||Phase 2|23|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||Yes||2017-10-10 21:52:28.734607|2017-10-10 21:52:28.734607
NCT02879214|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-24|||December 2015||2015-12-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|Side||Simultaneously Integrated Dose Escalation for Locally Advanced Cervical Cancer|Simultaneously Integrated Dose Escalation for Locally Advanced Cervical Cancer (SIDE, Advanced Squamous Cervical Cancer Trial)|Recruiting||Phase 2|50|Anticipated|Sichuan Provincial People's Hospital||1|||f||||t||||||||||2017-10-10 21:52:28.806059|2017-10-10 21:52:28.806059
NCT02879201|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-22|||January 2009||2009-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2009|Actual|2009-06-01||Interventional|||Continuous Venovenous Hemodiafiltration Versus Sustained Low-efficiency Hemodialysis for Critically Ill Patients With Acute Kidney Injury in Intensive Care Unit|Continuous Venovenous Hemodiafiltration Versus Sustained Low-efficiency Hemodialysis for Critically Ill Patients With Acute Kidney Injury in Intensive Care Unit|Completed||N/A|27|Actual|Bangkok Metropolitan Administration Medical College and Vajira Hospital||2|||f||||t||||||||No||2017-10-10 21:52:28.879334|2017-10-10 21:52:28.879334
NCT02879188|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-10-28|||October 2016||2016-10-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|PT on POD 0||Ambulation Versus Standing on Postoperative Day 0|Ambulation Versus Standing on Postoperative Day 0: A Randomized, Controlled Trial|Recruiting||N/A|200|Anticipated|Rush University Medical Center||2|||f||||f||||||||No||2017-10-10 21:52:29.076284|2017-10-10 21:52:29.076284
NCT02879175|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-02-08|||September 8, 2016|Actual|2016-09-08|February 2017|2017-02-01|September 2031|Anticipated|2031-09-01|September 2031|Anticipated|2031-09-01||Observational|FUSAC||Patients' Follow-up After Subarachnoid Haemorrhage Caused by Ruptured Intracranial Aneurysms||Recruiting||N/A|400|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:52:29.17812|2017-10-10 21:52:29.17812
NCT02879162|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-09-11|||October 19, 2016||2016-10-19|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours|A Phase II Study of Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours|Recruiting||Phase 2|160|Anticipated|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-10 21:52:29.268704|2017-10-10 21:52:29.268704
NCT02879149|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-11|||August 2016||2016-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft|A Prospective, Controlled, Multi-Center, Post-Approval Trial to Evaluate the Long-term Safety and Effectiveness of AUGMENT® Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Foot and Ankle Fusions|Recruiting||N/A|150|Anticipated|BioMimetic Therapeutics|||2||f||||f||||||Samples Without DNA|"     Serum Samples for antibody testing.   "|||2017-10-10 21:52:29.407924|2017-10-10 21:52:29.407924
NCT02879136|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-04-27|||December 2016||2016-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|TAME-PD||TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease|TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease: A Single Center, Randomized Pilot Study|Recruiting||Early Phase 1|42|Anticipated|The Cleveland Clinic||3|||f||||f||||||||No||2017-10-10 21:52:29.588097|2017-10-10 21:52:29.588097
NCT02879123|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-02-08|||November 12, 2015|Actual|2015-11-12|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|AVC-endovasc||Assessment of Patients' Early Neurological Clinical Recovery, 3 Months After Endovascular Treatment of an Acute Ischemic Stroke||Recruiting||N/A|4000|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:52:29.703743|2017-10-10 21:52:29.703743
NCT02879097|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-22|||December 2016||2016-12-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC|Efficacy, Safety & Immunogenicity Study of CBT124 & EU-sourced Avastin® in Combination With Carboplatin and Paclitaxel in First-line Treatment in (NSCLC)|Not yet recruiting||Phase 3|200|Anticipated|Cipla BioTec Pvt. Ltd.||2|||f||||t||||||||Undecided|Study CBT124/CT/002 does not have a FDA regulated intervention.|2017-10-10 21:52:29.924323|2017-10-10 21:52:29.924323
NCT02879084|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis|Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis|Not yet recruiting||N/A|36|Anticipated|CHU de Quebec-Universite Laval|||1||f||||f||||||||No||2017-10-10 21:52:30.020651|2017-10-10 21:52:30.020651
NCT02879071|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-02-08|||November 26, 2015||2015-11-26|February 2017|2017-02-01|November 2030|Anticipated|2030-11-01|November 2030|Anticipated|2030-11-01||Observational|MAV-endovasc||Long Term Follow-up After Embolization of Brain Arteriovenous Malformations||Recruiting||N/A|1000|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:52:30.092474|2017-10-10 21:52:30.092474
NCT02879058|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-11|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Intraoperative Ultrasound in Laparoscopic or Robotic Myomectomy Patients|The Effect of Intraoperative Contact Sonography on Quality of Life Following Laparoscopic or Robotic Myomectomy|Recruiting||N/A|140|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-10 21:52:30.160359|2017-10-10 21:52:30.160359
NCT02879045|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2017-05-04|||August 2016||2016-08-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of 2 Body Oil in Prevention of Striae Gravidarum|The Effect of Elasticity Belly® Oil and Clarins® Tonic Body Treatment Oil in Prevention of Striae Gravidarum: A Randomized Controlled Clinical Trial|Recruiting||Phase 2/Phase 3|50|Anticipated|Shanghai Changning Maternity & Infant Health Hospital||1|||f||||f||||||||No||2017-10-10 21:52:30.269813|2017-10-10 21:52:30.269813
NCT02879032|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-07-11|||July 2016||2016-07-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||A Comparative Study of Different Treadmill Scores to Diagnose Coronary Artery Disease Among Patients Attending Bangabandhu Medical University||Completed||N/A|140|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh|||1||f||||t||||||||||2017-10-10 21:52:30.358687|2017-10-10 21:52:30.358687
NCT02879019|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-24|||January 2017||2017-01-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|GrEnADa||Walking Training in Peripheral Artery Disease (GrEnADa Sub-study)|12 Weeks of Walking Exercise Training in Women With Peripheral Artery Disease: A Sub-study of GrEnADa-project|Not yet recruiting||N/A|34|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-10 21:52:30.446548|2017-10-10 21:52:30.446548
NCT02879006|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-16|||August 2016||2016-08-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy|Double-Blind, Placebo-Controlled Phase 2 Study to Assess Safety and Efficacy of Chinese Herbal Therapy and Multiple Food Allergen Oral Immunotherapy|Recruiting||Phase 2|34|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-10 21:52:30.54601|2017-10-10 21:52:30.54601
NCT02878993|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-01-06|||August 2016||2016-08-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|EMG||Predicting Infant Extubation Using Diaphragm Surface Electromyography|Predicting Infant Extubation Using Diaphragm Surface Electromyography|Recruiting||N/A|72|Anticipated|King's College London|||1||f||||f||||||||No||2017-10-10 21:52:30.654728|2017-10-10 21:52:30.654728
NCT02878980|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-14|||September 2, 2016|Actual|2016-09-02|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients|An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients|Enrolling by invitation||N/A|10|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 21:52:30.739525|2017-10-10 21:52:30.739525
NCT02878967|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-02-08|||November 25, 2015|Actual|2015-11-25|February 2017|2017-02-01|November 2030|Anticipated|2030-11-01|November 2030|Anticipated|2030-11-01||Observational|ANENDOVASC||Standardized Long Term Follow-up of Patients After Endovascular Embolization of a Brain Aneurysm||Recruiting||N/A|2000|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:52:30.841264|2017-10-10 21:52:30.841264
NCT02878954|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-22|||January 2017||2017-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|GrEnADa||Exercise in Peripheral Artery Disease|Exercise in Peripheral Artery Disease - Gender-specific Differences and Unexplored Opportunities in Women: the GrEnADa-project|Not yet recruiting||N/A|160|Anticipated|Katholieke Universiteit Leuven||3|||f||||f||||||||||2017-10-10 21:52:30.907661|2017-10-10 21:52:30.907661
NCT02878941|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-04-25|||May 2017|Anticipated|2017-05-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Synovial Fluid Analysis of Intraarticular Elbow Fracture|Synovial Fluid Analysis of Intraarticular Elbow Fracture|Not yet recruiting||N/A|20|Anticipated|Duke University||1|||f|||||f|f||||||Undecided||2017-10-10 21:52:31.084979|2017-10-10 21:52:31.084979
NCT02878928|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-12-16|||May 2016||2016-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety|A Prospective, Multi-Center, Randomized Clinical Study to Evaluate the Clinical Impact of Pharmacogenetic-Guided Treatment for Depression & Anxiety|Completed||N/A|579|Actual|AltheaDx||2|||f||||f||||||||No||2017-10-10 21:52:31.15345|2017-10-10 21:52:31.15345
NCT02878915|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-02-08|||November 17, 2015|Actual|2015-11-17|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|FAP-ECHO||Assessing the Interest of Ultrasound-guided Femoral Arterial Puncture for Interventional Neuro-radiology in Children||Recruiting||N/A|150|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f||||||||No||2017-10-10 21:52:31.293114|2017-10-10 21:52:31.293114
NCT02878902|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-24|||January 2013||2013-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|2 Years|Observational [Patient Registry]|ICoDU||Impact of the Implementation of CKD Coordination Function on Dialysis Initiation Frequency in Emergency|Impact of the Implementation of a Chronic Kidney Disease (CKD) Coordination Function on Dialysis Initiation Frequency in Emergency|Completed||N/A|200|Actual|University Hospital, Caen|||2||f||||f||||||||No||2017-10-10 21:52:31.378402|2017-10-10 21:52:31.378402
NCT02878889|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-01-10|||August 2016||2016-08-01|January 2017|2017-01-01||||June 2019|Anticipated|2019-06-01||Interventional|||A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.||Recruiting||Phase 2|53|Anticipated|Zhejiang Cancer Hospital||1|||f||||||||||||||2017-10-10 21:52:31.456633|2017-10-10 21:52:31.456633
NCT02878876|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-22|||January 2016||2016-01-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People|Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People|Completed||Phase 4|600|Actual|a2 Milk Company Ltd.||2|||f||||t||||||||No||2017-10-10 21:52:31.551355|2017-10-10 21:52:31.551355
NCT02878863|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-10|||August 2016||2016-08-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis|Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Treatment of Auto-immune Hepatitis|Withdrawn||Phase 3|0|Actual|West China Hospital||2|||f||||t||||||||||2017-10-10 21:52:31.624919|2017-10-10 21:52:31.624919
NCT02878850|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-25|||January 10, 2017|Actual|2017-01-10|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|TEMPLE||Effect of Targeted Blood Pressures in Participants With Acute Spinal Cord Injury|Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury (TEMPLE)|Recruiting||N/A|152|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-10 21:52:31.720594|2017-10-10 21:52:31.720594
NCT02878837|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-08-17|||January 2016||2016-01-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Dexmedetomidine vs Midazolam for Intraoperative Sedation|Dex vs Dazzle: Dexmedetomidine vs Midazolam for Intraoperative Sedation|Completed||Phase 4|120|Actual|Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo||2|||f||||f||||||||||2017-10-10 21:52:31.838493|2017-10-10 21:52:31.838493
NCT02878824|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-06-01|||July 2016||2016-07-01|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|May 2017|Actual|2017-05-01||Observational|||Role of Ethnicity and Environment on Regulation of Response Towards Sensory Stimulation in Children|Role of Ethnicity and Environment on Regulation of Response Towards Sensory Stimulation in Children: A Neurophysiological Study|Completed||N/A|128|Actual|The Hong Kong Polytechnic University|||4||f||||f||||||||Undecided||2017-10-10 21:52:31.951537|2017-10-10 21:52:31.951537
NCT02878811|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-07-16|||August 2016||2016-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||China PEACE 5p-HF Study|China Patient-centered Evaluative Assessment of Cardiac Events (PEACE): Prospective Study of Patients With Heart Failure (HF)|Not yet recruiting||N/A|5000|Anticipated|China National Center for Cardiovascular Diseases|||1||f||||t||||||Samples With DNA|"     Retention: Samples With DNA Description: the investigators will collect plasma, serum, DNA,     RNA, and urine at baseline and during follow-ups.   "|||2017-10-10 21:52:32.045989|2017-10-10 21:52:32.045989
NCT02878798|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-05-02|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TopCSPN||Topiramate for Cryptogenic Sensory Peripheral Neuropathy|Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy (CSPN)|Not yet recruiting||Phase 2|125|Anticipated|University of Utah||2|||f||||t|f|f||||||||2017-10-10 21:52:32.143029|2017-10-10 21:52:32.143029
NCT02878785|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-31|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|1565GCC||Decitabine and Talazoparib in Untreated AML and R/R AML|Multicenter Phase 1/2 Study of Combination Therapy w/ DNA Methyltransferase Inhibitor Decitabine & Poly ADP Ribose Polymerase Inhibitor Talazoparib for Untreated AML in Adults Unfit for Cytotoxic Chemotherapy or R/R AML|Recruiting||Phase 1/Phase 2|171|Anticipated|University of Maryland||1|||f||||t||||||||Undecided||2017-10-10 21:52:32.230866|2017-10-10 21:52:32.230866
NCT02878772|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-24|||May 2014||2014-05-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients|Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke|Completed||Phase 2/Phase 3|60|Actual|Tianjin Medical University General Hospital||2|||f||||t||||||||Yes||2017-10-10 21:52:32.327392|2017-10-10 21:52:32.327392
NCT02878759|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-21|||August 2016||2016-08-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Wristbot: A Novel Device for the Assessment of Proprioceptive Deficits After Stroke|Wristbot: A Novel Device for the Assessment of Proprioceptive Deficits After Stroke.|Not yet recruiting||N/A|50|Anticipated|Tan Tock Seng Hospital||1|||f||||f||||||||No||2017-10-10 21:52:32.41655|2017-10-10 21:52:32.41655
NCT02878746|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-21||||||August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Robotic Mirror Therapy System for Functional Recovery of Hemiplegic Arms|Robotic Mirror Therapy System for Functional Recovery of Hemiplegic Arms|Recruiting||N/A|16|Anticipated|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 21:52:32.509251|2017-10-10 21:52:32.509251
NCT02878733|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-19|||January 2012||2012-01-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Albumin Administration and Outcomes in Cardiac Surgery|Association Between Albumin Administration and Improved Survival and Organ Function in Adult Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Completed||N/A|6249|Actual|Vanderbilt University|||2||f||||f||||||||No|Individual data are de-identified|2017-10-10 21:52:32.616525|2017-10-10 21:52:32.616525
NCT02878720|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-24|||January 2016||2016-01-01|August 2016|2016-08-01||||June 2017|Anticipated|2017-06-01||Interventional|||Combining Non-Invasive Vagus Nerve Stimulation and Robotic Training in Upper Limb-Impaired Chronic Stroke Patients|Combining Non-Invasive Vagus Nerve Stimulation and Robotic Training in Upper Limb-Impaired Chronic Stroke Patients|Recruiting||N/A|50|Anticipated|Campus Bio-Medico University||2|||f||||f||||||||No||2017-10-10 21:52:32.692294|2017-10-10 21:52:32.692294
NCT02878707|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-21|||August 2016||2016-08-01|August 2016|2016-08-01||||September 2018|Anticipated|2018-09-01||Interventional|||The Neuroprotective Effects of Dexmedetomidine During Brain Surgery|The Neuroprotective Effects of Dexmedetomidine During Brain Surgery|Recruiting||N/A|160|Anticipated|National Taiwan University Hospital||2|||f||||||||||||||2017-10-10 21:52:32.782608|2017-10-10 21:52:32.782608
NCT02878694|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-08-22|||July 2016||2016-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|TTT-PT-DOP||Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft|Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft|Active, not recruiting||Phase 2/Phase 3|10|Anticipated|University Hospital, Caen||1|||f||||t||||||||No||2017-10-10 21:52:32.869379|2017-10-10 21:52:32.869379
NCT02878681|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-04-27|||September 2016|Anticipated|2016-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TIDE DME||24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.|A 24-week, Randomized, Single-masked, Multicenter, Phase IV Study to Compare sysTemic VEGF Levels Following Monthly Intravitreal Injections of 0.5 mg Ranibizumab Versus 2 mg Aflibercept Until Week 24 in Patients With Visual Impairment DuE to Diabetic Macular Edema (TIDE DME).|Withdrawn||Phase 4|0|Actual|Novartis||3|||f||||f||||||||||2017-10-10 21:52:32.958722|2017-10-10 21:52:32.958722
NCT02878668|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||April 2016||2016-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||The Value of Infectious Biomarkers for Prediction of Complication After Hepatopancreatobiliary Surgery|The Predictor of Infectious Complication After Hepatopancreatobiliary Surgery and Monitoring Indicator of Anti-infectious Therapy|Recruiting||N/A|700|Anticipated|Shanghai Zhongshan Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:52:33.041505|2017-10-10 21:52:33.041505
NCT02878655|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-08-22|||February 2015||2015-02-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Observational|QDV2b||Evaluation of the Overall Quality of Life After the Neck Dissection Retro-spinal Sector (IIb), in Squamous Cell Carcinomas Clinical and Radiological N0 VADS||Recruiting||N/A|60|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 21:52:33.15419|2017-10-10 21:52:33.15419
NCT02878642|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-01-31|||May 2015|Actual|2015-05-01|January 2017|2017-01-01|December 2017||2017-12-01|December 2017|Anticipated|2017-12-01||Observational|DOLUTECAPS||Adherence to Dolutegravir and Outcome|Cohort Study to Assess Electronic-caps Defined Adherence Patterns - Virological Outcome Relationship Amongst HIV-1 Infected Subjects Receiving Dolutegravir-Based Antiretroviral Therapy)|Recruiting||N/A|120|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 21:52:33.209046|2017-10-10 21:52:33.209046
NCT02878629|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||July 2016||2016-07-01|August 2016|2016-08-01||||September 2019|Anticipated|2019-09-01||Observational|||Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas||Recruiting||N/A|290|Anticipated|ONIRIS|||1||f||||||||||||||2017-10-10 21:52:33.266428|2017-10-10 21:52:33.266428
NCT02878616|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-02|||August 26, 2016|Actual|2016-08-26|August 2017|2017-08-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|||Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316|Open-label, Parallel-group, Drug-drug Interaction Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316|Completed||Phase 1|8|Actual|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:52:33.331175|2017-10-10 21:52:33.331175
NCT02878603|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-07|||August 2016||2016-08-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)|Prospective Follow-up Study for Patients Who Completed Study ALX0681-C301 (HERCULES) to Evaluate Long-term Safety and Efficacy of Caplacizumab (Post-HERCULES)|Recruiting||Phase 3|92|Anticipated|Ablynx||1|||f||||t||||||||||2017-10-10 21:52:33.402594|2017-10-10 21:52:33.402594
NCT02878590|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-08-16|||September 2016||2016-09-01|August 2017|2017-08-01||||November 2017|Anticipated|2017-11-01||Interventional|||Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)|Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea|Recruiting||N/A|10|Anticipated|InnoMed Healthscience Inc.||1|||f||||f||||||||||2017-10-10 21:52:33.733888|2017-10-10 21:52:33.733888
NCT02878577|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||September 2016||2016-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|TBI||Monitoring the Alterations That Occur in the Brain Following Traumatic Brain Injury|Monitoring Alterations Following Traumatic Brain Injury Using Clinical Evaluation, Neuropsychological Assessments, Structural and Functional MRI and EEG Analysis|Not yet recruiting||N/A|90|Anticipated|ElMindA Ltd|||2||f||||f||||||||No||2017-10-10 21:52:33.823521|2017-10-10 21:52:33.823521
NCT02878564|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-26|||March 2016||2016-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology|Effect of Schistosomiasis Mansoni and Its Treatment on HIV Susceptibility and Female Genital Immunology|Completed||Phase 4|34|Actual|University of Toronto||1|||f||||f||||||||No||2017-10-10 21:52:33.935298|2017-10-10 21:52:33.935298
NCT02878551|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|PrehabPilote||Evaluation of the Benefits of a Prehabilitation Program : Pilot Study|Evaluation of the Benefits of a Program of Prehabilitation: Pilot Study|Recruiting||N/A|50|Anticipated|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:52:34.031459|2017-10-10 21:52:34.031459
NCT02878538|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-08-21|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|April 2023|Anticipated|2023-04-01|April 2022|Anticipated|2022-04-01||Interventional|||A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment|An N of One Clinical Trial to Pilot the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment|Not yet recruiting||Early Phase 1|10|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t|t|f||||||||2017-10-10 21:52:34.115747|2017-10-10 21:52:34.115747
NCT02878525|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-21|2017-05-23|||October 2016||2016-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|LIGB||Laparoscopic Internal Gastric Banding, New Simple and Costless Weight Loss Procedure|Study the Effectiveness and Safety of Laparoscopic Internal Gastric Banding, New Simple and Costless Weight Loss Procedure, in Comparison to Laparoscopic Sleeve Gastrectomy|Recruiting||N/A|140|Anticipated|Minia University||2|||f||||t||||||||Undecided||2017-10-10 21:52:34.22377|2017-10-10 21:52:34.22377
NCT02878512|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-08-21|||June 2009||2009-06-01|August 2016|2016-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|AnesthesiaPCNL||Segmental Epidural Anesthesia (SEA) V/S General Anesthesia for PCNL|Comparative Evaluation of General Anesthesia (SEA) Using 0.5% Bupivacaine and Segmental Epidural Anesthesia (GA) for Percutaneous Nephro Lithotomy - A Retrospective Analysis|Completed||Phase 4|60|Actual|Maharashtra University of Health Sciences||2|||f||||t||||||||No||2017-10-10 21:52:34.781743|2017-10-10 21:52:34.781743
NCT02878499|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-08-19|||December 2012||2012-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Do Sleep and Circadian Rhythm Disturbances Impact the Cognitive and Behavioural Development of Children With Autism?|Do Sleep and Circadian Rhythm Disturbances Impact the Cognitive and Behavioural Development of Children With Autism?|Recruiting||N/A|105|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 21:52:34.873746|2017-10-10 21:52:34.873746
NCT02878486|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-22|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|ReST-MCI||Intervention to Reduce Sedentary Time|Intervention to Reduce Sitting Time in Mild Cognitive Impairment|Recruiting||N/A|30|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:52:34.97775|2017-10-10 21:52:34.97775
NCT02878473|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-22|||January 2017||2017-01-01|August 2016|2016-08-01|January 2028|Anticipated|2028-01-01|January 2025|Anticipated|2025-01-01||Interventional|LT for iCCA||Liver Transplantation for Early Intrahepatic Cholangiocarcinoma|Liver Transplantation for the Treatment of Early Stages of Intrahepatic Cholangiocarcinoma in Cirrhotics|Not yet recruiting||Phase 2|30|Anticipated|University Health Network, Toronto||1|||f||||t||||||||Undecided||2017-10-10 21:52:35.077082|2017-10-10 21:52:35.077082
NCT02878460|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-04-28|||April 27, 2017|Actual|2017-04-27|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ORI2||ORI2 : ORI for hyperOxia Reduction in ICU|ORI2 : ORI for hyperOxia Reduction in ICU|Recruiting||N/A|60|Anticipated|University Hospital, Angers||2|||f||||f|f|f||||||No||2017-10-10 21:52:35.162395|2017-10-10 21:52:35.162395
NCT02878447|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-08-19|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Utility of Radiotherapy in the Management of Haemoptysis Secondary to Aspergillomata and Structural Lung Diseases|The Utility of External Beam Radiotherapy for Haemoptysis Secondary to Aspergillomata and Structural Lung Diseases in Patients Who Are Refractory to Medical Management and Not Surgical Candidates: A Pilot Study|Recruiting||N/A|40|Anticipated|University of Stellenbosch||2|||f||||f||||||||No||2017-10-10 21:52:35.261073|2017-10-10 21:52:35.261073
NCT02878434|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-22|||July 2016||2016-07-01|August 2016|2016-08-01||||July 2026|Anticipated|2026-07-01|5 Years|Observational [Patient Registry]|||Fertility Preservation in Young Women With Cancer|Fertility Preservation in Young Women With Cancer: an International Registration Study From the International Network on Cancer, Infertility and Pregnancy (INCIP)|Recruiting||N/A|2000|Anticipated|University Hospital, Gasthuisberg|||2||f||||f||||||||Undecided||2017-10-10 21:52:35.356864|2017-10-10 21:52:35.356864
NCT02878421|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|VESUVIUS||Vascular EffectS of regUlar Cigarettes Versus electronIc Cigarette USe|Vascular Effects of Regular Cigarettes Versus electronIc Cigarette Use|Recruiting||N/A|135|Anticipated|University of Dundee||3|||f||||f||||||||Undecided||2017-10-10 21:52:35.459439|2017-10-10 21:52:35.459439
NCT02878408|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-29|||November 2014||2014-11-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|November 2019|Anticipated|2019-11-01||Interventional|I-Give||Immuno-Genetic, Inflammation, Retro-Virus, Environment|Immuno-Génétique, Inflammation, Retro-Virus, Environnement|Recruiting||N/A|900|Anticipated|Fondation FondaMental||5|||f||||f||||||||No||2017-10-10 21:52:35.561871|2017-10-10 21:52:35.561871
NCT02878395|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|January 2021|Anticipated|2021-01-01|September 2020|Anticipated|2020-09-01||Observational|PREDIPOSTOP||Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases|Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases: Prediction of Post-operating Natural History of Crohn's Disease|Not yet recruiting||N/A|30|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||Samples With DNA|"     Ileocolic resection with last loops of small intestine, colon portion and corresponding     mesenteric-colic fat.   "|No||2017-10-10 21:52:35.655246|2017-10-10 21:52:35.655246
NCT02878382|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-05-03|||October 2016||2016-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|PDT||Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT|Efficacy of Calcipotriol Assisted MAL-PDT Versus Conventional MAL-PDT for Actinic Keratosis: a Randomized and Controlled Study|Completed||N/A|20|Actual|University of Sao Paulo||2|||f||||t||||||||Yes||2017-10-10 21:52:35.736725|2017-10-10 21:52:35.736725
NCT02878369|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||April 2014||2014-04-01|August 2016|2016-08-01||||March 2016|Actual|2016-03-01||Observational|RER D||Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test|Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test|Recruiting||N/A|140|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:52:35.820272|2017-10-10 21:52:35.820272
NCT02878356|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-08-21|||January 2013||2013-01-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Acquisition of MI Competence Trough the Training Methods Used in the Swedish County Councils and Municipalities|Acquisition of MI Competence Trough the Training Methods Used in the Swedish County Councils and Municipalities|Completed||N/A|174|Actual|Karolinska Institutet||3|||f||||f||||||||No|No individual participant data will be available.|2017-10-10 21:52:35.898855|2017-10-10 21:52:35.898855
NCT02878343|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-03-07|||September 2014||2014-09-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||The Healthy Weigh Study|A Randomized Controlled Trial of Incentives Versus Environmental Strategies for Weight Loss|Active, not recruiting||N/A|344|Actual|University of Pennsylvania||4|||f||||t||||||||Yes||2017-10-10 21:52:35.996688|2017-10-10 21:52:35.996688
NCT02878330|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-10-04|||November 3, 2016|Actual|2016-11-03|October 2017|2017-10-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|MEDI8897 Ph2b||A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.|A Phase 2b Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants|Recruiting||Phase 2|1500|Anticipated|MedImmune LLC||2|||f||||t||||||||||2017-10-10 21:52:36.112659|2017-10-10 21:52:36.112659
NCT02878317|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-19|||August 2016||2016-08-01|August 2016|2016-08-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|AGED||Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.|Association of Advanced Glycation End-product Accumulation and Adverse Outcomes in Peritoneal Dialysis and Haemodialysis Patients and the Impact of a Dietetic Intervention on Skin Autofluorescence|Not yet recruiting||N/A|82|Anticipated|University of Nottingham||2|||f||||f||||||||No||2017-10-10 21:52:36.531856|2017-10-10 21:52:36.531856
NCT02878304|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-22|||March 2013||2013-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ProHand||Biomarkers for Prediction of Hand Function After Stroke - The ProHand Study|Recovery of Hand Function After Stroke- a Longitudinal Study Using Novel Methods to Quantify Hand Function and Connectivity in Brain Networks|Recruiting||N/A|100|Anticipated|Danderyd Hospital|||1||f||||f||||||||||2017-10-10 21:52:36.650948|2017-10-10 21:52:36.650948
NCT02878291|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||June 2016||2016-06-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months|A Single-center, Open, Phase I Clinical Trial to Evaluate Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months|Recruiting||Phase 1|200|Anticipated|Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd||2|||f||||f||||||||No||2017-10-10 21:52:37.172131|2017-10-10 21:52:37.172131
NCT02878278|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation|Research About the Differences Between Chidamide Taken Daily and Twice a Week in Pharmacokinetics|Not yet recruiting||Phase 2|24|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Yes|The data of the trial would be accessable on the corresponding website after the trial is finished.|2017-10-10 21:52:37.250494|2017-10-10 21:52:37.250494
NCT02878265|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-19|||November 2011||2011-11-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Vitamin A With and Without Zinc and Multivitamin Supplementation on Malaria Morbidity in Ghanaian Children|The Effect of Vitamin A With and Without Zinc and Multivitamin Supplementation on Malaria Morbidity in Ghanaian Children|Completed||Phase 3|547|Actual|University of Ghana||3|||f||||f||||||||Yes|To meet the participants and explain the results of their data to them|2017-10-10 21:52:37.329476|2017-10-10 21:52:37.329476
NCT02878252|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-05-15|||October 4, 2016|Actual|2016-10-04|May 2017|2017-05-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Observational|||Non-interventional Study of COPD Patients With Asthma Overlap Syndrome in Viet Nam and Taiwan|A Cross-sectional Study to Determine the Proportion and Clinical Characteristics of COPD Patients With Asthma Symptoms in Asia (ACOS) and Describe Current Practices in Diagnosis and Management|Completed||N/A|350|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-10 21:52:37.521042|2017-10-10 21:52:37.521042
NCT02878239|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||The Three-dimensional Gait Analysis of Medial Knee Osteoarthritis|The Relationship Between the Imaging Assessment Based on Kellgren-Lawrence Scores and In Vivo 3D Knee Kinematic Characteristics in Chinese Patients With Medial Knee Osteoarthritis During Walking Using a New Portal Gait System.|Completed||N/A|136|Actual|Guangzhou General Hospital of Guangzhou Military Command|||4||f||||f||||||||No||2017-10-10 21:52:37.617848|2017-10-10 21:52:37.617848
NCT02878226|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|||Outcomes of Uterine Rupture|Uterine Rupture: Prevalence and Feto-maternal Outcomes in Assiut Women Health Hospital|Recruiting||N/A|100|Anticipated|Assiut University|||1||f||||t||||||||Undecided||2017-10-10 21:52:37.723159|2017-10-10 21:52:37.723159
NCT02878213|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-14|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DURABLE-I||DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness|DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness|Recruiting||N/A|24|Anticipated|EP Dynamics Research Ltd||1|||f||||f||||||||||2017-10-10 21:52:37.805913|2017-10-10 21:52:37.805913
NCT02878200|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-11-17|||November 2016||2016-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|RHOST||RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission|Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission: a Cluster Randomized Trial|Recruiting||N/A|8000|Anticipated|Medical Research Council Unit, The Gambia||2|||f||||t||||||||||2017-10-10 21:52:37.91874|2017-10-10 21:52:37.91874
NCT02878187|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-05-18|||January 15, 2017|Actual|2017-01-15|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Observational|||Uterine Cavity and Blood Flow After Conservative Management of Placenta Previa/Accreta|Evaluation of the Uterine Cavity and Blood Flow After Conservative Management of Placenta Previa/Accreta|Recruiting||N/A|100|Anticipated|Assiut University|||2||f||||t||||||||Yes||2017-10-10 21:52:38.031794|2017-10-10 21:52:38.031794
NCT02878174|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||August 2016||2016-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Site of Puncture in Prelocation Technique of the Internal Jugular Venous Catheterization|The Site of Puncture in Ultrasound-guided Prelocation Technique of the Internal Jugular Venous Catheterization: Non-inferiority Randomized Clinical Trial|Not yet recruiting||N/A|320|Anticipated|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 21:52:38.138152|2017-10-10 21:52:38.138152
NCT02878161|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-21|||January 2016||2016-01-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||"Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World"|"Screening Protein Predictive of Response to Tumor Necrosis Factor-α Inhibitors Treatment in Chinese Rheumatoid Arthritis From Real World and Investigating Its Mechanism Through Signal Pathway"|Enrolling by invitation||Phase 4|240|Anticipated|Central South University||3|||f||||f||||||||No||2017-10-10 21:52:38.226574|2017-10-10 21:52:38.226574
NCT02878148|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|IMAGENCO||Conditional Imaging Prescription Strategy for Exploration of Acute Uncomplicated Renal Colic|Conditional Imaging Prescription Strategy as an Alternative to Systematic Unenhanced Computed Tomography for Exploration of Acute Uncomplicated Renal Colic With Lower Radiation Exposure|Not yet recruiting||N/A|180|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 21:52:38.41199|2017-10-10 21:52:38.41199
NCT02878135|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-07-31|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Fast Versus Slow Application of Vulsellum During Intrauterine Device Insertion|the Effect of Slow Versus Fast Application of Vulsellum on Pain Perception During Intrauterine Device Insertion|Completed||N/A|200|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 21:52:38.517963|2017-10-10 21:52:38.517963
NCT02878122|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||March 2015||2015-03-01|July 2016|2016-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|FaCliBioCCo||Study of Predictive Factors of Chemoresistance in Ovarian Cancer|Study of Predictive Factors of Chemoresistance in Ovarian Cancer|Recruiting||N/A|600|Anticipated|Rennes University Hospital|||1||f||||f||||||Samples Without DNA|"     surgical sampling, blood plasma   "|No||2017-10-10 21:52:38.62601|2017-10-10 21:52:38.62601
NCT02878109|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2017-09-13|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|DCE-MRI||DCE-MRI for Assessment of Response to TACE of HCC|Dynamic Contrast-enhanced Magnetic Resonance Imaging for Assessment of Response to Transarterial Chemoembolization of Hepatocellular Carcinoma|Recruiting||N/A|30|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-10-10 21:52:38.743725|2017-10-10 21:52:38.743725
NCT02878096|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-10-12|||July 2016||2016-07-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study|An Open-Label, 2-Part Sequential Dose Study Designed to Assess the Absolute Bioavailability, Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1404 Administered to Healthy Male Subjects|Completed||Phase 1|6|Actual|Sanwa Kagaku Kenkyusho Co., Ltd.||1|||f||||t||||||||No||2017-10-10 21:52:38.863836|2017-10-10 21:52:38.863836
NCT02878083|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-27|||October 2016||2016-10-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|DETECT||Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)|Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)|Not yet recruiting||N/A|25|Anticipated|Nantes University Hospital||1|||f||||f||||||||No||2017-10-10 21:52:38.981119|2017-10-10 21:52:38.981119
NCT02878070|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-22|||January 2015||2015-01-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||My Care My Call: Peer-Led Health Empowerment Training in Chronic Spinal Cord Injury|My Care My Call: Peer-Led Health Empowerment Training For People With Chronic Spinal Cord Injury|Completed||N/A|86|Actual|Boston University||2|||f||||f||||||||No||2017-10-10 21:52:39.114317|2017-10-10 21:52:39.114317
NCT02878057|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-22|2016-08-24|||May 2016||2016-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer|Multicenter Phase II Study of Apatinib in Patients With HER-2 Negative Advanced Breast Cancer With Chest Wall Metastasis|Active, not recruiting||Phase 2|30|Anticipated|Beijing Cancer Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:52:39.195658|2017-10-10 21:52:39.195658
NCT02878031|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-07-27|||October 2016||2016-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Community Case Management of Chest Indrawing Pneumonia|Community Case Management of Chest Indrawing Pneumonia With Oral Amoxicillin in Children Aged 2-59 Months Old by Community Oriented Resources Persons (CORPs) in Niger State, Nigeria|Recruiting||Phase 4|308|Anticipated|Malaria Consortium||1|||f||||t||||||||||2017-10-10 21:52:39.387877|2017-10-10 21:52:39.387877
NCT02878018|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-07-10|||September 2016||2016-09-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|August 2017|Anticipated|2017-08-01|3 Months|Observational [Patient Registry]|CSTCMDTCHSPN||Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis|Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis|Enrolling by invitation||N/A|500|Anticipated|Liaoning University of Traditional Chinese Medicine|||2||f||||t||||||Samples With DNA|"     We will retain the blood of each patient to do some research of lncRNA with     patients'permission.Try to find some relationship between lncRNA and HSPN disease.We also     retain the urine and coated tongue to establish the biospecimen repository for our     patients.When they grow up,these spicimens may help them to understand their bodies more     correctly.   "|||2017-10-10 21:52:39.497859|2017-10-10 21:52:39.497859
NCT02878005|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-24|||August 2016||2016-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|August 2016|Anticipated|2016-08-01||Interventional|||A Comparison Between the Intubating Laryngeal Tube Suction and the Ambu AuraGain|A Prospective and Randomized Study Comparing the New Intubating Laryngeal Tube Suction and the Ambu AuraGain in Adult Patients|Not yet recruiting||N/A|60|Anticipated|Bnai Zion Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:52:39.580427|2017-10-10 21:52:39.580427
NCT02877992|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-19|||January 2014||2014-01-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Interventional|||Tachykinin and Kisspeptin Expression in Human Granulosa and Cumulus Cells|Development of a New Diagnostic Tool to Assess Oocyte Quality Based on Tachykinin and Kisspeptin Expression Analysis in Human Granulosa and Cumulus Cells|Recruiting||N/A|300|Anticipated|IVI Sevilla||5|||f||||||||||||||2017-10-10 21:52:39.64649|2017-10-10 21:52:39.64649
NCT02877979|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-22|||November 18, 2015|Actual|2015-11-18|August 2017|2017-08-01|August 26, 2016|Actual|2016-08-26|August 26, 2016|Actual|2016-08-26||Interventional|||Evaluate the Safety & Assess Local and Systemic PK of DS003 Vaginal Tablets Administered to Healthy HIV-negative Women|A Double-blind, Randomised, Placebo-controlled, Dose Escalation Trial to Evaluate the Safety and to Assess Local and Systemic Pharmacokinetics of DS003 Vaginal Tablets Administered to Healthy HIV-negative Women|Completed||Phase 1|36|Actual|International Partnership for Microbicides, Inc.||2|||f||||f||||||||||2017-10-10 21:52:39.748388|2017-10-10 21:52:39.748388
NCT02877966|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-19|||October 2016||2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer|Evaluation of the Effects of a Stoichiometric Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer: a Randomized, Double Blind, Placebo-controlled, Multicenter Study|Withdrawn||N/A|0|Actual|Helsinn Healthcare SA||2||Change of Trial Sponsor|f||||f||||||||No||2017-10-10 21:52:39.804876|2017-10-10 21:52:39.804876
NCT02877953|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-23|||January 2013||2013-01-01|August 2016|2016-08-01||||September 2015|Actual|2015-09-01||Interventional|||Transitional Care Interventions for Patients With Cirrhosis Post-TIPS|Transitional Care Interventions Post-TIPS|Enrolling by invitation||N/A|76|Anticipated|Shihezi University||2|||f||||f||||||||Undecided|According to the actual situation to decide whether to share data|2017-10-10 21:52:39.875834|2017-10-10 21:52:39.875834
NCT02877927|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-13|||August 2016||2016-08-01|July 2017|2017-07-01|June 6, 2017|Actual|2017-06-06|May 26, 2017|Actual|2017-05-26||Interventional|||Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI|A Phase 3 Randomized, Double-Blind, Multi-Center Study to Compare the Safety and Efficacy of Oral Omadacycline to Oral Linezolid for Treating Adult Subjects With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|Completed||Phase 3|735|Actual|Paratek Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-10 21:52:40.009937|2017-10-10 21:52:40.009937
NCT02877914|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-20|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||China PEACE 5r-HF Study|China Patient-centered Evaluative Assessment of Cardiac Events (PEACE): Retrospective Study of Patients With Heart Failure (HF)|Not yet recruiting||N/A|10000|Anticipated|China National Center for Cardiovascular Diseases|||1||f||||t||||||||Undecided||2017-10-10 21:52:40.212969|2017-10-10 21:52:40.212969
NCT02877901|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-28|||May 2016||2016-05-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder|Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder. A Randomized Placebo-controlled Crossover Study|Enrolling by invitation||Phase 2/Phase 3|120|Actual|Mansoura University||2|||f||||||||||||||2017-10-10 21:52:40.28738|2017-10-10 21:52:40.28738
NCT02877888|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-10-29|||August 2016||2016-08-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Cost Effectiveness of Fluoride Varnish in Prevention of Dental Caries in School Children|Cost Effectiveness of Sodium Fluoride Varnish Application in Prevention of Dental Caries in School Children Between Age of 6 and 7 Years|Active, not recruiting||Phase 1/Phase 2|320|Anticipated|University of Peradeniya||2|||f||||f||||||||Yes||2017-10-10 21:52:40.35764|2017-10-10 21:52:40.35764
NCT02877875|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-08-19|||January 2015||2015-01-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Student Outcomes of Integrative Mental Health Services|Student Outcomes of Integrative Mental Health Services|Recruiting||N/A|168|Anticipated|Harvard University||2|||f||||t||||||||||2017-10-10 21:52:40.43349|2017-10-10 21:52:40.43349
NCT02877862|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-08-24|||February 2016||2016-02-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|mAGIC||Mobile Phone Technology to Increase Genetic Counseling|Mobile Phone Technology to Increase Genetic Counseling for Women With Ovarian Cancer and Their Families|Recruiting||N/A|104|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 21:52:40.554523|2017-10-10 21:52:40.554523
NCT02877849|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-09-13|||October 2016||2016-10-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|||Brain Functional Connectivity in Alcohol Use Disorder|Brain Functional Connectivity During Early Recovery in Alcohol Use Disorder as a Marker for Relapse|Not yet recruiting||N/A|82|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||Yes|As requested|2017-10-10 21:52:40.624761|2017-10-10 21:52:40.624761
NCT02877836|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-12-20|||September 2014||2014-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|IRMF-DIFF||Functional MRI and DTI in the Preoperative Assessment of Dystonia|Functional Magnetic Resonance and Diffusion Tensor Imaging in the Preoperative Assessment of Dystonia|Recruiting||N/A|40|Anticipated|University Hospital, Montpellier||4|||f||||f||||||||No||2017-10-10 21:52:40.69827|2017-10-10 21:52:40.69827
NCT02877810|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-01|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Evidence-Based Tele-Emergency Network Grant Program|Evidence-Based Tele-Emergency Network Grant Program|Recruiting||N/A|400|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 21:52:42.720582|2017-10-10 21:52:42.720582
NCT02877797|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-08-19|||February 2016||2016-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|Kappa-I||Cap Assisted Upper Endoscopy to Visualize the Major Duodenal Papilla|The Use of Cap Assisted Forward Viewing Esophagogastroduodenoscopy to Examine the Major Duodenal Papilla|Completed||N/A|101|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-10 21:52:42.823213|2017-10-10 21:52:42.823213
NCT02877784|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-31|||October 2016||2016-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Screening in Oculopharyngeal Muscular Dystrophy|Determination of Accurate Screening Tools for Dysphagia in Oculopharyngeal Muscular Dystrophy|Recruiting||Early Phase 1|15|Anticipated|University of Florida||1|||f||||t|t|f||||||||2017-10-10 21:52:42.905628|2017-10-10 21:52:42.905628
NCT02877771|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study||Completed||Phase 1|10|Actual|Tandem Diabetes Care, Inc.||1|||f||||||||||||||2017-10-10 21:52:43.042959|2017-10-10 21:52:43.042959
NCT02877758|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|REDUCEAGE||Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging|Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging - A Randomized Controlled Double Blind Study|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Tomorrowlabs GmbH||2|||f||||t||||||||No||2017-10-10 21:52:43.131111|2017-10-10 21:52:43.131111
NCT02877745|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-24|||July 2016||2016-07-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|CONSIDER-AF||Impact of Sleep-disordered Breathing on Atrial Fibrillation and Perioperative Complications of Coronary Artery Bypass Grafting Surgery|ImpaCt of Sleep-disOrdered breathiNg on Atrial Fibrillation and Perioperative complicationS In Patients unDERgoing Coronary Artery Bypass graFting Surgery|Recruiting||N/A|1200|Anticipated|University Hospital Regensburg|||2||f||||f||||||||||2017-10-10 21:52:43.250538|2017-10-10 21:52:43.250538
NCT02877732|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-04-26|||July 2016||2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|ETA-TV||EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2|EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2|Terminated||N/A|100|Actual|Stanford University||2||The funding sponsor elected to terminate the study.|f||||f||||||||||2017-10-10 21:52:43.352042|2017-10-10 21:52:43.352042
NCT02877719|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-19|||February 2012||2012-02-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||The Effect of Poverty on Psychological Well-being of Children|The Effect of Poverty and Income Disparity on the Psychological WellBeing of Hong Kong Children|Completed||N/A|1725|Actual|The University of Hong Kong|||2||f||||t||||||||No||2017-10-10 21:52:43.498184|2017-10-10 21:52:43.498184
NCT02877706|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2016-08-18|||June 2013||2013-06-01|August 2016|2016-08-01|June 2023|Anticipated|2023-06-01|June 2023|Anticipated|2023-06-01|10 Years|Observational [Patient Registry]|CARMEN||Cytopenias Autoimmune: Midi-Pyrenees Register|Cytopenias Autoimmune: Midi-Pyrenees Register|Recruiting||N/A|800|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||Undecided||2017-10-10 21:52:43.582173|2017-10-10 21:52:43.582173
NCT02877693|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-03-10|||October 2016||2016-10-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|February 2020|Anticipated|2020-02-01||Interventional|ASIA MRI ICD||A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging|A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging|Recruiting||N/A|396|Anticipated|St. Jude Medical||1|||f||||f||||||||Undecided||2017-10-10 21:52:43.808077|2017-10-10 21:52:43.808077
NCT02877680|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-22|||July 31, 2017|Actual|2017-07-31|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|T1DoingWell||Strengths-Based Behavioral mHealth App for Parents of Adolescents With Type 1 Diabetes-Pilot Study|Development and Pilot of a Strengths-Based Behavioral mHealth Intervention to Promote Resilience in Adolescents With Type 1 Diabetes|Recruiting||N/A|82|Anticipated|Baylor College of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:52:43.944356|2017-10-10 21:52:43.944356
NCT02877667|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-05-03|||July 2016||2016-07-01|August 2016|2016-08-01|April 30, 2017|Actual|2017-04-30|April 19, 2017|Actual|2017-04-19||Interventional|SOL1601||Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol|Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol|Completed||Phase 1|40|Actual|Soliton||1|||f||||f||||||||No||2017-10-10 21:52:44.083596|2017-10-10 21:52:44.083596
NCT02877277|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-26|||August 2016||2016-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|EVITA-Pilot||Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study|Restoring Physiological Vitamin C Levels to the Normal Range: Influence on Epigenetic Regulation in Normal and Malignant Hematopoiesis|Recruiting||N/A|40|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 21:52:47.415002|2017-10-10 21:52:47.415002
NCT02877654|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|BISII||Is There Any Correlation Between Plasmatic Zonulin and Expression of Intestinal Tight Junction Proteins in IBS Patients?|Assessment of Intestinal Barrier in Irritable Bowel Syndrome Patients : Is There Any Correlation Between Plasmatic Zonulin and Expression of Intestinal Tight Junction Proteins ?|Recruiting||N/A|112|Anticipated|University Hospital, Rouen||1|||f||||f||||||||No||2017-10-10 21:52:44.173725|2017-10-10 21:52:44.173725
NCT02877641|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-02-14|||April 16, 2014|Actual|2014-04-16|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Cholecalciferol Supplementation in Strengthening Inspiratory Muscles in Cholecalciferol-Deficient Patients With Chronic Obstructive Pulmonary Disease|Effect of Once Daily Oral Vitamin D3 Supplementation on Inspiratory Muscle Strength in Vitamin D3-Deficient COPD Patients|Terminated||Phase 2|4|Actual|Roswell Park Cancer Institute||2||low accrual|f||||t||||||||||2017-10-10 21:52:44.281932|2017-10-10 21:52:44.281932
NCT02877628|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-21|||October 2015||2015-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|OPTILTH||Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation|Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation|Recruiting||N/A|100|Anticipated|Rennes University Hospital|||1||f||||f||||||||||2017-10-10 21:52:44.392112|2017-10-10 21:52:44.392112
NCT02877615|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-23|||December 19, 2016|Actual|2016-12-19|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event|Randomized Efficacy and Safety Trial With Oral S 44819 After Recent Ischemic Cerebral Event. International, Multi-centre, Randomized, Doubleblind Placebo-controlled Phase II Study. (RESTORE BRAIN Study)|Recruiting||Phase 2|580|Anticipated|Servier||3|||f||||t|f|f||||||||2017-10-10 21:52:44.51597|2017-10-10 21:52:44.51597
NCT02877602|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-02-21|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Patient Understanding of LiverMultiScan|Patient Understanding of LiverMultiScan|Active, not recruiting||N/A|101|Actual|Perspectum Diagnostics Ltd|||1||f||||f||||||||No||2017-10-10 21:52:44.781994|2017-10-10 21:52:44.781994
NCT02877589|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-23|||May 2012||2012-05-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|July 2013|Actual|2013-07-01||Observational|HepScreen||Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors|Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors|Completed||N/A|450|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:52:44.863297|2017-10-10 21:52:44.863297
NCT02877576|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-23|||May 2016||2016-05-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|REUNIE||Single Neurons Responses During Visual Recognition in Epileptic Patients|Study of Cerebral Mechanisms of Visual Recognition With Single-unit Recordings of Intra-cerebral Neurons in Epileptic Patients|Recruiting||N/A|20|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:52:44.932319|2017-10-10 21:52:44.932319
NCT02877563|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-20|2016-12-28|||January 2017||2017-01-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Contrast Ultrasound Assessment of Perfusion Changes After Peripheral Artery Revascularization||Not yet recruiting||N/A|30|Anticipated|Oregon Health and Science University|||1||f||||f||||||||No||2017-10-10 21:52:45.056793|2017-10-10 21:52:45.056793
NCT02877550|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-02-17|||February 7, 2017|Actual|2017-02-07|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients|A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients|Recruiting||Phase 1|25|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f|f|f||||||No||2017-10-10 21:52:45.133782|2017-10-10 21:52:45.133782
NCT02877537|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-19|||October 2008||2008-10-01|August 2016|2016-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|SALBUTAMOL||Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis|Measurements of Change of Respiratory Admittance Induced by Salbutamol for Pediatric Asthma Diagnosis|Completed||Phase 4|177|Actual|Central Hospital, Nancy, France||3|||f||||f||||||||No||2017-10-10 21:52:45.254892|2017-10-10 21:52:45.254892
NCT02877524|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-19|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|PSV vs ASV for||Trial to Study Intubation Rates of Non-invasive Ventilation Using Pressure Support Ventilation (PSV) Versus Adaptive Support Ventilation (ASV) Mode in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease||Recruiting||N/A|100|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t|f|f||||||||2017-10-10 21:52:45.344209|2017-10-10 21:52:45.344209
NCT02877511|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-09-14|||August 2016||2016-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Supervised Outdoor-Use Test For Sunscreen Products in Adults|Supervised Outdoor-Use Test For Sunscreen Products in Adults|Completed||N/A|102|Actual|Bayer||2|||f||||f||||||||||2017-10-10 21:52:45.550725|2017-10-10 21:52:45.550725
NCT02877498|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-31|||August 2016||2016-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|ASV vs VCV in||A Study to Compare Adaptive Support Ventilation vs. Volume Controlled Ventilation for Management of Respiratory Failure in Patients With Neuroparalytic Snake Envenomation|A Study to Compare Adaptive Support Ventilation vs. Volume Controlled Ventilation for Management of Respiratory Failure in Patients With Neuroparalytic Snake Envenomation|Recruiting||N/A|50|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 21:52:45.639388|2017-10-10 21:52:45.639388
NCT02877485|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation|The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation|Recruiting||Phase 4|60|Anticipated|Stanford University||2|||f||||f||||||||Yes|The investigators plan to analyze and list deidentified patient data, including pre- and post-steroid and placebo NOSE scores, as well as post-surgery NOSE scores, if applicable|2017-10-10 21:52:45.746108|2017-10-10 21:52:45.746108
NCT02877472|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-19|||May 2015||2015-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|October 2016|Anticipated|2016-10-01||Interventional|||Porous Tantalum Rods Improve the Hip Joint Function of Patients With Avascular Necrosis of the Femoral Head|Porous Tantalum Rods Improve the Hip Joint Function of Patients With Avascular Necrosis of the Femoral Head After Femoral Neck Fracture Surgery: a Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Qinghai University||2|||f||||t||||||||Undecided||2017-10-10 21:52:45.856421|2017-10-10 21:52:45.856421
NCT02877459|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-09-19|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|November 2017|Anticipated|2017-11-01||Interventional|STAGE||Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System|A Multicenter, Prospective, Single-Arm Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System - the AeriSeal-STAGE Trial|Active, not recruiting||N/A|14|Actual|Pulmonx, Inc.||1|||f||||t||||||||||2017-10-10 21:52:45.953415|2017-10-10 21:52:45.953415
NCT02877446|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-08-18|||January 2016||2016-01-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|SOFCAR||South Of France Cardiac Assist Registry|Observatoire Des Assistances Monoventriculaires Gauches du Grand Sud|Recruiting||N/A|200|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||Undecided|ND|2017-10-10 21:52:46.046416|2017-10-10 21:52:46.046416
NCT02877433|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-03-10|||August 2016||2016-08-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|||4 mm Implants in Fixed Cross-Arch Prostheses|Clinical Performance of 4 mm Short Distal Implants in Fixed Cross-Arch Prostheses - An Open, Randomized, Controlled Study|Recruiting||N/A|40|Anticipated|Institut Straumann AG||2|||f||||f||||||||No||2017-10-10 21:52:46.133594|2017-10-10 21:52:46.133594
NCT02877420|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-28|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Impact of a Simulation-based Training Curriculum of Non-technical Skills on Colonoscopy Performance|Impact of a Simulation-based Training Curriculum of Non-technical Skills on Colonoscopy Performance|Completed||N/A|42|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-10-10 21:52:46.263114|2017-10-10 21:52:46.263114
NCT02877407|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-24|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PROLAPSE||Laparoscopic/Robotic-assisted Hysteropexy Versus Vaginal Hysterectomy for the Treatment of Uterovaginal Prolapse|A Randomized Controlled Study of Laparoscopic/Robotic-assisted Hysteropexy Versus Vaginal Hysterectomy for the Treatment of Uterovaginal Prolapse|Recruiting||N/A|146|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:52:46.389436|2017-10-10 21:52:46.389436
NCT02877394|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-07-05|||September 2016||2016-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Use of a Squatting Assist Device in Patients With Constipation|Use of a Squatting Assist Device in Patients With Constipation|Recruiting||N/A|85|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 21:52:46.469503|2017-10-10 21:52:46.469503
NCT02877381|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-03-09|||April 2016||2016-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Tranexamic Acid in Revision Total Joint Arthroplasty|Tranexamic Acid in Revision Total Joint Arthroplasty: A Prospective Randomized Controlled Trial|Recruiting||Phase 4|320|Anticipated|Rush University Medical Center||4|||f||||f||||||||Undecided||2017-10-10 21:52:46.564576|2017-10-10 21:52:46.564576
NCT02877368|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-23|||May 2014||2014-05-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|SARCO-GIST||Sarcopenia in Patients With Gastrointestinal Stromal Tumours|Sarcopenia in Patients With Gastrointestinal Stromal Tumours|Completed||N/A|31|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:52:46.69528|2017-10-10 21:52:46.69528
NCT02877355|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-30|||August 22, 2016|Actual|2016-08-22|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.|Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes|Recruiting||Phase 1|52|Anticipated|Novo Nordisk A/S||1|||f||||f|f|f||||||||2017-10-10 21:52:46.773841|2017-10-10 21:52:46.773841
NCT02877342|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-23|||March 2016||2016-03-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Observational|||Pre-hospital Notification of Injured Patients Presenting to Trauma Centres in India|Reducing the Burden of Injury in India and Australia Through Development and Piloting of Improved Systems of Care - Prehospital Notification and Structured Handover on Hospital Arrival|Recruiting||N/A|500|Anticipated|National Trauma Research Institute|||2||f||||f||||||||No||2017-10-10 21:52:46.864851|2017-10-10 21:52:46.864851
NCT02877329|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2016-08-19|||February 2014||2014-02-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Internet-delivered ACT for Treating the Psychological Effects of Hearing Loss|Internet-delivered ACT for Treating the Psychological Effects of Hearing Loss|Completed||N/A|58|Actual|Linkoeping University||2|||f||||f||||||||No||2017-10-10 21:52:46.987424|2017-10-10 21:52:46.987424
NCT02877316|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-24|||October 2016||2016-10-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|MYPLAN||MYPLAN - Effectiveness of a Safety Plan App to Manage Crisis of Persons at Risk of Suicide|MYPLAN - Effectiveness of a Safety Plan App to Manage Crisis of Persons at Risk of Suicide - a Multi-center, Superiority Randomized Clinical Trial|Not yet recruiting||N/A|546|Anticipated|Mental Health Services in the Capital Region, Denmark||2|||f||||t||||||||Undecided||2017-10-10 21:52:47.072533|2017-10-10 21:52:47.072533
NCT02877303|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-06-20|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Hyper-CVAD Regimen in Sequential Combination With Blinatumomab as Frontline Therapy for Adults With B-Cell Lineage Acute Lymphocytic Leukemia|Phase II Study of the Hyper-CVAD Regimen in Sequential Combination With Blinatumomab as Frontline Therapy for Adults With B-Cell Lineage Acute Lymphocytic Leukemia (ALL)|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:52:47.157865|2017-10-10 21:52:47.157865
NCT02877290|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-03|||August 2016||2016-08-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle in Hypercapnic COPD Patients|The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle Tissue, Cardiovascular System and Exercise Capacity in Hypercapnic COPD Patients|Recruiting||N/A|20|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-10 21:52:47.326281|2017-10-10 21:52:47.326281
NCT02877264|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-23|||June 2016||2016-06-01|August 2016|2016-08-01||||August 2016|Actual|2016-08-01||Interventional|||A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy Volunteers|A Randomized, Single-Center, Open-Label, Three-Period, Six-Sequence, Crossover, Comparative Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Product Formulations in Healthy Volunteers|Completed||Phase 1|48|Actual|Aviragen Therapeutics||3|||f||||f||||||||||2017-10-10 21:52:47.505214|2017-10-10 21:52:47.505214
NCT02877251|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-15|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01|1 Year|Observational [Patient Registry]|REMMITE||Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease|Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease|Not yet recruiting||N/A|500|Anticipated|Registro Mexicano Multidisciplinario De Pacientes Con Enfermedad Tromboembolica Venosa|||3||f||||t||||||||||2017-10-10 21:52:47.586593|2017-10-10 21:52:47.586593
NCT02877238|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-05-16|||August 2016||2016-08-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Remote Preconditioning and Myocardial Protection|Protection by Remote Ischemic Preconditioning During Congenital Cardiac Defects Repair Surgery With Sevoflurane But Not Propofol -A Clinical Trial|Completed||Phase 2|91|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 21:52:47.65279|2017-10-10 21:52:47.65279
NCT02877225|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-03-08|||August 29, 2016|Actual|2016-08-29|March 2017|2017-03-01|November 11, 2016|Actual|2016-11-11|November 11, 2016|Actual|2016-11-11||Interventional|||Study to Assess the Bioequivalence of Ibrutinib 140 Milligram (mg) Tablet to 140 mg IMBRUVICA Capsule|A Single-Dose, Open-Label, Randomized, Replicate Crossover Study in Healthy Adult Subjects to Assess the Bioequivalence of an Ibrutinib 140-mg Tablet Compared to the IMBRUVICA 140-mg Capsule|Completed||Phase 1|103|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 21:52:47.730905|2017-10-10 21:52:47.730905
NCT02877212|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-23|||July 2016||2016-07-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients|Association of FC Gamma RIIIA Polymorphism and Thrombopoietin (THPO) Expression With Response to TPO Agonists in Refractory ITP and the Impact of Therapy on B and T Cells Subsets in the Patients With Mutated Genotypes|Recruiting||Phase 3|75|Anticipated|Armed Forces Bone Marrow Transplant Center, Rawalpindi, Pakistan||1|||f||||t||||||||Undecided||2017-10-10 21:52:47.802115|2017-10-10 21:52:47.802115
NCT02877199|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-25|||June 2014||2014-06-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy|Anti-E1E2 Antibodies for the Prediction of Virological Response to Triple Therapy in Treatment-experienced Hepatitis C Virus-cirrhosis Cases|Completed||N/A|19|Actual|Hospices Civils de Lyon|||1||f||||||||||||||2017-10-10 21:52:48.013634|2017-10-10 21:52:48.013634
NCT02877186|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-19|||February 2015||2015-02-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effects of Non-nutritive Sweeteners on the Composition of the Gut Microbiome|Effects of Non-nutritive Sweeteners on the Composition of the Gut Microbiome|Active, not recruiting||N/A|22|Actual|George Washington University||2|||f||||||||||||||2017-10-10 21:52:48.101499|2017-10-10 21:52:48.101499
NCT02877173|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-03-08|||August 2016||2016-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans|Efficacy and Safety of Alprostadil Liposomes for Injection in the Treatment of Atherosclerotic Occlusive Disease of the Lower Extremities—A Phase II Multi-center Randomised Controlled Trial|Recruiting||Phase 2|160|Anticipated|Guangzhou Yipinhong Pharmaceutical CO.,LTD||2|||f||||t||||||||No||2017-10-10 21:52:48.178912|2017-10-10 21:52:48.178912
NCT02877160|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-06-21|||June 30, 2016|Actual|2016-06-30|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|February 28, 2017|Actual|2017-02-28||Interventional|||A Study to Assess the PK of AL-794 Formulations in Healthy Subjects|A Phase 1, Single-Center, Randomized, Open-Label, Single-Dose, Crossover Study to Assess the Pharmacokinetics, Including Food Effect, of AL-794 Formulations in Healthy Subjects|Completed||Phase 1|31|Actual|Alios Biopharma Inc.||3|||f||||f||f||||||||2017-10-10 21:52:48.297359|2017-10-10 21:52:48.297359
NCT02877147|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-23|||January 2011||2011-01-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|SEBTC||The Evaluation of the Summer EBT for Children Demonstration|The Evaluation of the Summer Electronic Benefits for Children Demonstration|Completed||N/A|85000|Actual|Abt Associates||3|||f||||f||||||||Yes|Contract deliverables include restricted and public use data sets|2017-10-10 21:52:48.393929|2017-10-10 21:52:48.393929
NCT02877134|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-10-03|||August 25, 2016|Actual|2016-08-25|October 2017|2017-10-01|August 6, 2020|Anticipated|2020-08-06|November 1, 2019|Anticipated|2019-11-01||Interventional|TRIDENT||Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease|A Phase 2b, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study to Evaluate the Safety and Efficacy of JnJ-64304500 in Subjects With Moderately to Severely Active Crohn's Disease|Recruiting||Phase 2|450|Anticipated|Janssen Research & Development, LLC||7|||f||||t||f||||||||2017-10-10 21:52:48.52057|2017-10-10 21:52:48.52057
NCT02877121|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-12-16|||June 2016||2016-06-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Respiratory Muscle Function and Neural Respiratory Drive in Interstitial Lung Disease||Completed||N/A|50|Actual|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||t||||||||Undecided||2017-10-10 21:52:49.01878|2017-10-10 21:52:49.01878
NCT02877108|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-08-23|||April 2016||2016-04-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Naturalistic Adasuve Clinical Trial Study|An Observational Study of Anti-Psychotic Medication for the Treatment of Agitation in the Emergency Department|Recruiting||Phase 1|100|Anticipated|Mt Sinai Hospital, Chicago|||2||f||||t||||||||Yes|The investigators will publish findings once data enrollment and data analysis is complete.|2017-10-10 21:52:49.097442|2017-10-10 21:52:49.097442
NCT02877095|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-26|||December 19, 2016|Actual|2016-12-19|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|SUBQ-Pilot||Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot|Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Pilot Study|Recruiting||Phase 1|40|Anticipated|Duke University||1|||f||||t||||||||||2017-10-10 21:52:49.190766|2017-10-10 21:52:49.190766
NCT02877082|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-08-04|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients|Phase II Trial of Low Toxicity GVHD Prevention and Enhanced Immune Recovery With Tacrolimus, Bortezomib and Thymoglobulin® TBT|Terminated||Phase 2|5|Actual|Emory University||1|||f||||t||||||||||2017-10-10 21:52:49.290027|2017-10-10 21:52:49.290027
NCT02877069|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-10-20|||September 2015||2015-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|January 2016|Actual|2016-01-01||Interventional|||Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions|A Prospective, Single-arm Study of the Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions Such as Fine Lines and for Improvement of Skin Quality|Completed||Phase 4|134|Actual|Allergan||1|||f||||f||||||||||2017-10-10 21:52:49.407386|2017-10-10 21:52:49.407386
NCT02877056|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-21|||August 2005|Actual|2005-08-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|||Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer|Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer|Recruiting||N/A|250|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     Tissue samples taken from tumor and normal colorectal tissue during standard endoscopy.      Up to eight biopsy samples of the tumor as well as up to six biopsies of the grossly normal     colorectum obtained.   "|||2017-10-10 21:52:49.485292|2017-10-10 21:52:49.485292
NCT02877043|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-19|||December 2015||2015-12-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Observational|ResPul||Study of the Quality of Lung Resection|Measurement of the Quality: Application to Lung Resection for Cancer Using a National PMSI Database|Active, not recruiting||N/A|72000|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:52:49.559607|2017-10-10 21:52:49.559607
NCT02877030|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-18|||March 2016||2016-03-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus|Sensorimotor Exercises in Virtual Reality Platform and Balance in Individuals With Human T-lymphotropic Virus|Recruiting||N/A|42|Anticipated|Pedreira, Érika, M.D.||3|||f||||t||||||||No||2017-10-10 21:52:49.625548|2017-10-10 21:52:49.625548
NCT02877017|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Family Engagement in Safety Reporting|Family Engagement in Safety Reporting|Not yet recruiting||N/A|3500|Anticipated|Boston Children’s Hospital||2|||f||||f|f|f||||||||2017-10-10 21:52:49.712311|2017-10-10 21:52:49.712311
NCT02877004|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-29|||September 2016||2016-09-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|LLLT||LLLT for Reducing Waste Circumference and Weight|A Feasibility Study Addressing the Frequency of Low Level Laser Therapy for Reducing Central Adiposity and Weight in Overweight Individuals|Active, not recruiting||Phase 3|75|Anticipated|Mayo Clinic||3|||f||||f||||||||||2017-10-10 21:52:49.784324|2017-10-10 21:52:49.784324
NCT02876991|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-19|||February 2016||2016-02-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|FNa-CHOLINE||Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma|Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma|Recruiting||N/A|110|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:52:49.860578|2017-10-10 21:52:49.860578
NCT02876978|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-23|||March 2016||2016-03-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma|Preliminary Clinical Study of Autologous T Cells Modified Chimeric Antigen Receptor (CAR) Targeting GPC3 for the Treatment of Recurrent or Refractory Lung Squamous Cell Carcinoma|Recruiting||Phase 1|20|Anticipated|Carsgen Therapeutics, Ltd.||1|||f||||f||||||||No||2017-10-10 21:52:49.941323|2017-10-10 21:52:49.941323
NCT02876965|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-07-24|||August 2016|Actual|2016-08-01|August 2016|2016-08-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Change on Sleep Quality of Patients With Fibromyalgia Subjected to a Protocol Based on Physical Exercise and Stretching|Change on Sleep Quality of Patients With Fibromyalgia Subjected to a Combined Protocol Based on Physical Exercise and Muscle Stretching|Completed||N/A|40|Actual|Cardenal Herrera University||2|||f||||f||||||||||2017-10-10 21:52:50.025858|2017-10-10 21:52:50.025858
NCT02876952|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-06-18|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|INTERFARCT||High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients|Effects of Combined High Intensity Aerobic Interval Training Program and Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients: INTERFARCT Controlled Trial|Recruiting||N/A|135|Anticipated|Basque Country University||3|||f||||t||||||||No|Data won't be shared|2017-10-10 21:52:50.113668|2017-10-10 21:52:50.113668
NCT02876939|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-07-12|||November 2016||2016-11-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy|Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy|Enrolling by invitation||N/A|30|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 21:52:50.231043|2017-10-10 21:52:50.231043
NCT02876926|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-19|||July 2016||2016-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|(eTEST)||Evaluating a Real-Time, Remote Monitoring System for Home-Based HIV Testing|Exploring Use of a Real-time, Remote Monitoring and Follow-up System for Home-based, HIV Self-testing Among High-risk Men Who Have Sex With Men (MSM)|Recruiting||N/A|60|Anticipated|Brown University||3|||f||||f||||||||No||2017-10-10 21:52:50.30542|2017-10-10 21:52:50.30542
NCT02876913|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-04|||August 24, 2016|Actual|2016-08-24|September 2017|2017-09-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Observational|||Evaluation on the Proper Size of the Nasotracheal Tube and Depth in Nasotracheal Intubation: a Preliminary Study||Completed||N/A|40|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 21:52:50.378575|2017-10-10 21:52:50.378575
NCT02876900|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-04-10|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|HP-3070||Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.|A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, 6-Week, In-Patient Study to Assess Efficacy and Safety of HP-3070 in Subjects Diagnosed With Schizophrenia|Recruiting||Phase 3|612|Anticipated|Noven Pharmaceuticals, Inc.||2|||f||||f||||||||Yes||2017-10-10 21:52:50.431115|2017-10-10 21:52:50.431115
NCT02876887|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-06-19|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|COCOA-PAD||Cocoa to Improve Walking Performance in Peripheral Artery Disease|Cocoa to Improve Walking Performance in Peripheral Artery Disease|Recruiting||N/A|44|Anticipated|Northwestern University||2|||f||||t||||||||Undecided||2017-10-10 21:52:50.513505|2017-10-10 21:52:50.513505
NCT02876874|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-08-18|||December 2014||2014-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|7 Days|Observational [Patient Registry]|||Relationship Between the Activity of Rheumatoid Arthritis and Lymph Node Morphology and Lymphatics Drainage|the Relationship Between the Activity of Rheumatoid Arthritis（RA） and Popliteal/Epitrochlear Lymph Node Morphology and the Drainage of Hand/Foot Superficial Lymphatic Vessels|Recruiting||N/A|21|Anticipated|Shanghai University of Traditional Chinese Medicine|||2||f||||t||||||Samples Without DNA|"     Peripheral blood 10ml for the analysis of cytokines,such as IL-1/6, TNF-α,VEGF-3     recepter,VEGFRC/E, et al.   "|No||2017-10-10 21:52:50.722657|2017-10-10 21:52:50.722657
NCT02876861|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2016-09-06|||February 2014||2014-02-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC|Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade Upper Tract Urothelial Carcinoma|Recruiting||Phase 2|50|Anticipated|Xiangya Hospital of Central South University||2|||f||||t||||||||Undecided||2017-10-10 21:52:50.842201|2017-10-10 21:52:50.842201
NCT02876848|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-18|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)|Adjuvant Endocrine Therapy in Breast Therapy in Breast Cancer: A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)|Not yet recruiting||N/A|120|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 21:52:50.953172|2017-10-10 21:52:50.953172
NCT02876822|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-05-02|||August 2016||2016-08-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||High Dose Vitamin D Replacement in Patients Undergoing Hematopoietic Stem Cell Transplantation|Safety and Efficacy of Single, High Dose Vitamin D Replacement in Patients Undergoing Hematopoietic Stem Cell Transplantation|Active, not recruiting||N/A|10|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||No||2017-10-10 21:52:53.871733|2017-10-10 21:52:53.871733
NCT02876809|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-13|||October 2016||2016-10-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|AGE-100||A Model for Healthy Aging: Moscow Centenarians (AGE-100)|A Model for Healthy Aging: Moscow Centenarians (AGE-100)|Recruiting||N/A|100|Anticipated|Pirogov Russian National Research Medical University|||1||f||||f||||||Samples With DNA|"     Samples with DNA will be taken for telomere lenth, metabolome and metagenome definition   "|Undecided||2017-10-10 21:52:53.95756|2017-10-10 21:52:53.95756
NCT02876796|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-19|||August 2015||2015-08-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects|A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Pharmacodynamic Effects of A Single Oral Dose of NDI-010976 in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-10 21:52:54.050971|2017-10-10 21:52:54.050971
NCT02876783|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-12-27|||July 2012||2012-07-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|12 Months|Observational [Patient Registry]|||Analysis of Stroke Rehabilitation Outcomes|Analysis of Stroke Rehabilitation Outcomes|Active, not recruiting||N/A|273|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-10-10 21:52:54.164187|2017-10-10 21:52:54.164187
NCT02876770|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-18|||December 2012||2012-12-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|MSP||Melatonin Supplementation and Performance|Nocturnal Melatonin Ingestion Ameliorates Short Term Maximal Performances on the Following Day|Terminated||Early Phase 1|12|Actual|University of Sfax||2|||f||||||||||||||2017-10-10 21:52:54.299954|2017-10-10 21:52:54.299954
NCT02876744|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-07-26|||April 13, 2017|Actual|2017-04-13|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Observational|CORISMAP||Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes|Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes|Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f|f|f||||||||2017-10-10 21:52:54.459869|2017-10-10 21:52:54.459869
NCT02876731|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-18|||July 2013||2013-07-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|IMMETAOS||Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)|Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases|Completed||N/A|13|Actual|Institut Jean-Godinot||1|||f||||t||||||||Undecided||2017-10-10 21:52:54.610693|2017-10-10 21:52:54.610693
NCT02873143|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-01-26|||September 2016||2016-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||5 Year Follow-up of Adolescents With Knee Pain|5 Year Follow-up of Adolescents With Knee Pain - a Prospective Cohort Study of 504 Adolescents|Completed||N/A|540|Actual|Aalborg University|||1||f||||f||||||||Undecided||2017-10-10 21:53:26.66513|2017-10-10 21:53:26.66513
NCT02876705|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-10-10|||September 2016||2016-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Spatiotemporal Patterns of Pain During Exercise|Spatiotemporal Patterns of Pain and Discomfort During Exhausting Exercise|Completed||Early Phase 1|10|Actual|Institut Nacional d'Educacio Fisica de Catalunya||1|||f||||t||||||||Yes|25th of October 2016, all files will be available from the database https://figshare.com/|2017-10-10 21:52:54.762102|2017-10-10 21:52:54.762102
NCT02876692|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2016-08-30|||January 2016||2016-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|Xi'anCri||Prediction and Management of Delayed Graft Function Based on Donor Criteria and LifePort Platform|Prediction and Management of Delayed Graft Function Based on Donor Criteria and LifePort Platform|Recruiting||N/A|1000|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||1||f||||t||||||||No||2017-10-10 21:52:54.834348|2017-10-10 21:52:54.834348
NCT02876679|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-03-21|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|ATG-CyGVHD||Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT|Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT|Recruiting||Phase 2|88|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||No||2017-10-10 21:52:54.920247|2017-10-10 21:52:54.920247
NCT02876666|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-07-26|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Spinal Cord Injury Virtual Coach RCT|Spinal Cord Injury Virtual Coach to Promote Self-Care in Pressure Ulcer Prevention|Completed||N/A|40|Actual|Boston University||2|||f||||f|f|f||||||||2017-10-10 21:52:55.02258|2017-10-10 21:52:55.02258
NCT02876653|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-18|||March 2011||2011-03-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|SAOS||Accelerated Aging in Middle-Aged Men With Sleep-disordered Breathing.|Accelerated Aging in Middle-Aged Men With Sleep-disordered Breathing.|Completed||N/A|53|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 21:52:55.101365|2017-10-10 21:52:55.101365
NCT02876640|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-19|2017-09-26|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer|Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect|Not yet recruiting||Phase 1|40|Anticipated|National Cancer Institute (NCI)||1|||f||||t|t|f||||||||2017-10-10 21:52:55.172864|2017-10-10 21:52:55.172864
NCT02876627|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-18|||February 2015||2015-02-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Interventional|||Effect Aerobic Training on Women With Breast Cancer After Chemotherapy|The Effect of 12 Weeks of Aerobic Training Program on Erythrocyte Levels in Women With Breast Cancer After Chemotherapy|Completed||Phase 1|30|Actual|University of Isfahan||1|||f||||||||||||||2017-10-10 21:52:55.27159|2017-10-10 21:52:55.27159
NCT02876614|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-18|||January 2005||2005-01-01|August 2016|2016-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|VERTICAL||Value of Radionuclide Cisternography|VALUE OF RADIONUCLIDE CISTERNOGRAPHY IN PATIENTS WITH CEREBROSPINAL FLUID LEAK|Completed||N/A|113|Actual|Hospices Civils de Lyon|||1||f||||f||||||||No||2017-10-10 21:52:55.32099|2017-10-10 21:52:55.32099
NCT02876601|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-08-28|||April 18, 2017|Actual|2017-04-18|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|LPS_DF||Defibrotide in the Human Endotoxemia Model --‐ an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide|Defibrotide in the Human Endotoxemia Model -- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide|Recruiting||Phase 4|20|Anticipated|Medical University of Vienna||2|||f||||f|f|f|||f|||||2017-10-10 21:52:55.384821|2017-10-10 21:52:55.384821
NCT02876588|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-17|||April 2016||2016-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Risk of Wrong-Patient Errors With Multiple Records Open|Assessing the Risk of Wrong-Patient Errors in an Electronic Health Record That Allows Multiple Records Open|Recruiting||N/A|5000|Anticipated|Montefiore Medical Center||2|||f||||t||||||||No||2017-10-10 21:52:55.48363|2017-10-10 21:52:55.48363
NCT02876575|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-16|||February 13, 2017|Actual|2017-02-13|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of BiZact™ on Adults Undergoing Tonsillectomy|A Prospective, Multi-center, Single Arm Non-comparative Pilot Study of BiZact™ on Adults Undergoing Tonsillectomy|Recruiting||N/A|48|Anticipated|Medtronic - MITG||1|||f||||f|f|t|f|f|t|||||2017-10-10 21:52:55.563662|2017-10-10 21:52:55.563662
NCT02876562|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-17|||November 2015||2015-11-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Comparision of Collagen Matrix and Connective Tissue Graft With Modified Coronally Advanced Tunnel for Root Coverage|Comparitive Evaluation of Modified Coronally Advanced Tunnel Collagen Matrix Versus Connective Tissue Graft for Root Coverage in Multiple Gingival Recessions-A Randomised Controlled Clinical Trial|Recruiting||Phase 4|32|Anticipated|Krishnadevaraya College of Dental Sciences & Hospital||2|||f||||||||||||||2017-10-10 21:52:55.65063|2017-10-10 21:52:55.65063
NCT02876549|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-22|||August 2016||2016-08-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|GAP||G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria|G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria|Not yet recruiting||Phase 4|1000|Anticipated|University of Oxford||2|||f||||f||||||||No||2017-10-10 21:52:55.725751|2017-10-10 21:52:55.725751
NCT02876536|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2016-08-22|||June 2016||2016-06-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients|Effect of Transcutaneous Electrical Nerve Stimulation on Cognitive Disorders in Multiple Sclerosis Patients|Recruiting||N/A|20|Anticipated|Isfahan University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:52:55.811258|2017-10-10 21:52:55.811258
NCT02876523|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-01-30|||February 2015||2015-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|HILARIUM||Biliary Hilar Drainage Managed by Endoscopy||Recruiting||N/A|50|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:52:55.873392|2017-10-10 21:52:55.873392
NCT02876510|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-07|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|February 28, 2019|Anticipated|2019-02-28||Interventional|ACTolog||ACTolog in Patients With Solid Cancers|Phase I Adoptive Cellular Therapy Trial With Endogenous CD8+ T-cells (ACTolog; IMA101) in Patients With Relapsed and/or Refractory Solid Cancers|Recruiting||Phase 1|31|Anticipated|Immatics US, Inc.||1|||f||||t|t|t|t|f||||||2017-10-10 21:52:55.944907|2017-10-10 21:52:55.944907
NCT02876497|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-09-12|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Macrophages||Study of Trans-tissular Migration of Macrophages Associated to Human Breast Cancer|Study of Trans-tissular Migration of Macrophages Associated to Human Breast Cancer|Not yet recruiting||N/A|200|Anticipated|Institut Claudius Regaud||1|||f||||t||||||||Yes|Specific data base|2017-10-10 21:52:56.054942|2017-10-10 21:52:56.054942
NCT02876484|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-08-22|||June 2016||2016-06-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass|Effects of Chenodeoxycholic Acid and Colesevelam on GLP-1 Secretion, During a Meal, After Roux-en-Y Gastric Bypass|Recruiting||Phase 4|12|Anticipated|Hvidovre University Hospital||3|||f||||t||||||||Yes||2017-10-10 21:52:56.118146|2017-10-10 21:52:56.118146
NCT02876471|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-03-28|||March 2016||2016-03-01|March 2017|2017-03-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|||Continuous Monitoring Nocturnal Beat-to-beat Blood Pressure Fluctuation in OSA With or Without Hypertension|Huai'an First People's Hospital,Nanjing Medical University|Completed||N/A|198|Actual|Huai'an No.1 People's Hospital||2|||f||||f||||||||No||2017-10-10 21:52:58.031643|2017-10-10 21:52:58.031643
NCT02876458|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-01-24|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|EMERGE||EMERGEncy Versus Delayed Coronary Angiogram in Survivors of Out-of-hospital Cardiac Arrest|EMERGEncy Versus Delayed Coronary Angiogram in Survivors of Out-of-hospital Cardiac Arrest With no Obvious Non Cardiac Cause of Arrest|Recruiting||N/A|970|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 21:52:58.119987|2017-10-10 21:52:58.119987
NCT02876445|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-18|||March 2011||2011-03-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PHRI-HD||Caregiver Burden in Huntington's Disease|Assessment Study on Family Burden in Overall Care of Patient With Huntington Disease|Completed||N/A|179|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 21:52:58.217183|2017-10-10 21:52:58.217183
NCT02876432|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-23|||February 2009||2009-02-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Evaluating Acupuncture Relationship With the Catecholaminergic Pathway|Evaluating Acupuncture in the Treatment of Low Back Pain in Athletes and the Relationship With the Catecholaminergic Pathway|Completed||N/A|30|Actual|Universidad Autónoma Benito Juárez de Oaxaca||3|||f||||t||||||||Yes||2017-10-10 21:52:58.299165|2017-10-10 21:52:58.299165
NCT02876419|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-02-06|||August 2016||2016-08-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|August 2019|Anticipated|2019-08-01||Observational|||A Long Term Follow-up Study of Patients From the REP 301 Protocol|A Long Term Follow-up Study of Patients From the REP 301 Protocol|Active, not recruiting||N/A|11|Actual|Replicor Inc.|||1||f||||f||||||Samples Without DNA|"     Frozen serum containing viral DNA / RNA   "|Undecided||2017-10-10 21:52:58.378799|2017-10-10 21:52:58.378799
NCT02876406|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01|28 Days|Observational [Patient Registry]|||ΔvapCO2 / Cav02 Ratio as a Prognostic Marker and Predictor of Complications After Cardiac Surgery|Using the ΔvapCO2 / Cav02 Ratio as a Prognostic Marker and Predictor of Complications After Cardiac Surgery|Recruiting||N/A|150|Anticipated|Hospital San Carlos, Madrid|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 21:52:58.460089|2017-10-10 21:52:58.460089
NCT02876393|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-08-22|||November 2014||2014-11-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Observational|||A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema|A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema|Recruiting||N/A|258|Anticipated|Queen's University, Belfast|||2||f||||f||||||||||2017-10-10 21:52:58.548656|2017-10-10 21:52:58.548656
NCT02876380|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-01|||November 2014||2014-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|Fetal LQTS||Prospective Identification of Long QT Syndrome in Fetal Life|Prospective Identification of Long QT Syndrome in Fetal Life|Recruiting||N/A|600|Anticipated|University of Colorado, Denver|||2||f||||f||||||||||2017-10-10 21:52:58.617478|2017-10-10 21:52:58.617478
NCT02876367|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Observational|||The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents|The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents|Not yet recruiting||N/A|1200|Anticipated|University of Oxford|||2||f||||f||||||Samples Without DNA|"     Group 1: 10 ml of blood will be collected from the participant.      Group 2: 0.2 ml of blood will be collected from the participant.   "|Yes||2017-10-10 21:52:58.697449|2017-10-10 21:52:58.697449
NCT02876354|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-18|||August 2016||2016-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K2 Deficiency Involved?|Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K2 Deficiency Involved?|Completed||Phase 4|50|Actual|Saint-Joseph University||1|||f||||t||||||||Yes||2017-10-10 21:52:58.873175|2017-10-10 21:52:58.873175
NCT02876341|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-04-11|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|February 2017|Actual|2017-02-01||Observational|||Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic Shock|Evaluating the Effect of Chronic Antihypertensive Therapy on New Onset Atrial Fibrillation and Clinical Outcomes in Septic Shock|Completed||N/A|133|Actual|Rush University Medical Center|||2||f||||f||||||||Undecided|To be determined|2017-10-10 21:52:58.966744|2017-10-10 21:52:58.966744
NCT02876328|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-07-10|||March 31, 2017|Actual|2017-03-31|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PREVAC||Partnership for Research on Ebola VACcinations|Partnership for Research on Ebola VACcinations (PREVAC)|Recruiting||Phase 2|5500|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t|t|f||||||||2017-10-10 21:52:59.067344|2017-10-10 21:52:59.067344
NCT02876315|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-06-22|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Combinatorial Nutritional Supplementation on Immune Function in Healthy Older Adults|The Effect of Combinatorial Nutritional Supplementation on Immune Function in Healthy Older Adults|Recruiting||N/A|40|Anticipated|Oregon State University||2|||f||||f|f|f||||||No||2017-10-10 21:52:59.215651|2017-10-10 21:52:59.215651
NCT02876302|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-08-25|||April 26, 2017|Actual|2017-04-26|June 2017|2017-06-01|February 2024|Anticipated|2024-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer|Phase II Study Of Combination Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer|Recruiting||Phase 2|64|Anticipated|Dana-Farber Cancer Institute||3|||f||||t|t|f|||f|||||2017-10-10 21:52:59.337822|2017-10-10 21:52:59.337822
NCT02876289|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-23|||May 2014||2014-05-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|PERLYON||Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon)|Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon)|Completed||N/A|110|Actual|Hospices Civils de Lyon|||1||f||||f||||||||No||2017-10-10 21:52:59.467179|2017-10-10 21:52:59.467179
NCT02876263|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-22|||September 2007||2007-09-01|August 2016|2016-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Noninvasive Neuromonitoring of Surgery of the Thoracic Aorta|Noninvasive Neuromonitoring of Surgery of the Thoracic Aorta|Completed||N/A|61|Actual|Helsinki University|||3||f||||f||||||||No||2017-10-10 21:52:59.642332|2017-10-10 21:52:59.642332
NCT02876250|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-29|||January 2017||2017-01-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CsA Poumon||Postconditioning by Cyclosporin A in Pulmonary Transplantation|Postconditioning by Cyclosporin A in Pulmonary Transplantation|Not yet recruiting||Phase 3|100|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 21:52:59.730467|2017-10-10 21:52:59.730467
NCT02876237|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-17|||February 2015||2015-02-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|PROGERAD||Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer|Patient Over 75 Years With Prostate Cancer: Geriatric Determinants of General Repercussion of Radiotherapy With Curative Intent|Recruiting||N/A|200|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||f||||||||||2017-10-10 21:52:59.831931|2017-10-10 21:52:59.831931
NCT02876224|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-09-28|||September 30, 2016|Actual|2016-09-30|September 2017|2017-09-01|August 15, 2019|Anticipated|2019-08-15|December 15, 2018|Anticipated|2018-12-15||Interventional|||Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors|A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors|Recruiting||Phase 1|33|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 21:52:59.947549|2017-10-10 21:52:59.947549
NCT02876211|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||December 2014||2014-12-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|PIERAID||Paricalcitol Improves Anemia of Inflammation|Benefits of the Paricalcitol (Selective Vitamin D Receptor Activator) on Anemia of Inflammation in Dialysis Patients Under Erythropoiesis-stimulating Agents Treatment.|Recruiting||Phase 4|46|Anticipated|Hospital Son Espases||2|||f||||t||||||||Yes||2017-10-10 21:53:00.073653|2017-10-10 21:53:00.073653
NCT02876198|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-02-17|||July 1, 2016|Actual|2016-07-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|IVT-RNFL||Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF||Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:53:00.198437|2017-10-10 21:53:00.198437
NCT02876185|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-06-21|||April 8, 2016|Actual|2016-04-08|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|GLAUS||Evaluation of the Possibility to Delegate Glaucoma Surveillance to Orthoptists in Hospital||Recruiting||N/A|160|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:53:00.284836|2017-10-10 21:53:00.284836
NCT02876172|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-07|||October 2016||2016-10-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||MDMA-assisted and Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads With One Member With Chronic PTSD|Phase 1/2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic Posttraumatic Stress Disorder (PTSD)|Recruiting||Phase 1/Phase 2|20|Anticipated|Multidisciplinary Association for Psychedelic Studies||1|||f||||f||||||||||2017-10-10 21:53:00.377836|2017-10-10 21:53:00.377836
NCT02876159|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-23|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 28, 2018|Anticipated|2018-06-28||Interventional|FLU1||The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination|The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination|Active, not recruiting||Phase 4|40|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 21:53:00.481586|2017-10-10 21:53:00.481586
NCT02876146|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-22|||June 2012||2012-06-01|July 2016|2016-07-01|June 2023|Anticipated|2023-06-01|June 2020|Anticipated|2020-06-01||Interventional|EchinoVISTA||Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole|Alveolar Echinococcosis: Parasite Viability and Innovative Markers for Follow-up of Patients Treated With Albendazole - EchinoVISTA Prospective Clinical Study|Active, not recruiting||N/A|50|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:53:00.557367|2017-10-10 21:53:00.557367
NCT02876133|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-01-12|||November 2016||2016-11-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Narrow Band Imaging Versus White Light for Colonoscopy Serrate Lesions Detection|Improving Colorectal Cancer Screening: Using Narrow Band Imaging for Colonic Sessile Serrated Lesions|Recruiting||N/A|987|Anticipated|Hospital Beatriz Ângelo||2|||f||||f||||||||No||2017-10-10 21:53:00.754639|2017-10-10 21:53:00.754639
NCT02876120|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-01-03|||September 2016||2016-09-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|START||The STavanger osteoARThritis Study|The STavanger osteoARThritis Study in Primary Health Care|Enrolling by invitation||N/A|200|Anticipated|Diakonhjemmet Hospital||1|||f||||f||||||||No||2017-10-10 21:53:00.87158|2017-10-10 21:53:00.87158
NCT02876107|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-06-28|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||A Phase II Study of Using Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by Anthracycline-Containing Regimen (AC) for New Triple-Negative Inflammatory Breast Cancer (TN-IBC)|A Randomized Phase II Study of Neoadjuvant Carboplatin/Paclitaxel (CT) Versus Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by Anthracycline-Containing Regimen for Newly Diagnosed Primary Triple-Negative Inflammatory Breast Cancer|Recruiting||Phase 2|72|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 21:53:00.973196|2017-10-10 21:53:00.973196
NCT02876094|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-08-01|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|SMA||Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy|A Pilot, Open-Label, Dose Response Study Investigating the Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy (SMA)|Not yet recruiting||Phase 2|12|Anticipated|Children's Hospital of Eastern Ontario||1|||f||||t|f|f||||||||2017-10-10 21:53:01.132091|2017-10-10 21:53:01.132091
NCT02876081|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-09-07|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 1, 2017|Actual|2017-09-01||Interventional|THEN||Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma, Harboring Wild-type EGFR, Expressing the Neurotensin - Neurotensin Receptor Complex|Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma, Harboring Wild-type EGFR, Expressing the Neurotensin - Neurotensin Receptor Complex|Withdrawn||Phase 2|0|Actual|Groupe Hospitalier Paris Saint Joseph||1||medical decision|f||||t|f|f||||||||2017-10-10 21:53:01.236455|2017-10-10 21:53:01.236455
NCT02876055|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-11-01|||November 2016||2016-11-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Analgesic Efficacy of Interscalene Nerve Block Versus Local Infiltration Analgesia Following Total Shoulder Arthroplasty|Prospective, Randomized Controlled Trial Comparing Analgesic Efficacy of Single Injection vs. Continuous Interscalene Blockade vs. Local Infiltration Analgesia for Patients Undergoing Primary Total Shoulder Arthroplasty|Recruiting||Phase 4|129|Anticipated|Mayo Clinic||3|||f||||f||||||||No||2017-10-10 21:53:01.308317|2017-10-10 21:53:01.308317
NCT02876042|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-29|||July 2016||2016-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|6 Months|Observational [Patient Registry]|HFpEF||BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction|BAROSTIM THERAPY ™ in Heart Failure With Preserved Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System|Recruiting||N/A|70|Anticipated|CVRx, Inc.|||1||f||||f||||||||||2017-10-10 21:53:01.438993|2017-10-10 21:53:01.438993
NCT02876029|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-26|||September 2014||2014-09-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Food Design for Improved Day-long Glycaemic Regulation|The Effect on Glucose Tolerance at a Second Meal Provided After Breakfast Meal Giving Late Increment in Postprandial Glycaemia|Completed||N/A|20|Actual|Lund University||2|||f||||f||||||||No||2017-10-10 21:53:01.537041|2017-10-10 21:53:01.537041
NCT02876016|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||December 2016||2016-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EBA||Cerebral Bases Bodily Representations|Cerebral Bases Bodily Representations: Imaging Approach by Functional Magnetic Resonance, Cortical Stimulation Corticographie and Surgery Awake|Not yet recruiting||N/A|20|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:53:01.634136|2017-10-10 21:53:01.634136
NCT02876003|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-02-22|||September 2016||2016-09-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma|An Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy, Safety and CNS Exposure of G-202 in Patients With PSMA Positive Recurrent or Progressive Glioblastoma|Withdrawn||Phase 2|0|Actual|GenSpera, Inc.||1||This study has been withdrawn prior to enrollment.|f||||f||||||||No||2017-10-10 21:53:01.71828|2017-10-10 21:53:01.71828
NCT02875990|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||September 2016||2016-09-01|August 2016|2016-08-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01||Interventional|Xac03||Characterization of Immunosuppressive Signing of Cervical Cancer|Characterization of Immunosuppressive Signing of Cervical Cancer|Not yet recruiting||N/A|50|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:53:01.821786|2017-10-10 21:53:01.821786
NCT02875977|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-09-05|||August 2016||2016-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Does a Patient Education Video Augment Pelvic Floor Physical Therapy Compliance?|Does a Patient Education Video Augment Pelvic Floor Physical Therapy Compliance?|Active, not recruiting||N/A|200|Actual|Loyola University||2|||f||||f||||||||||2017-10-10 21:53:01.911158|2017-10-10 21:53:01.911158
NCT02875964|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||October 2012||2012-10-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|MEG-SEEG||Definition of Links Between Non-invasives Methods and Intracerebral EEG With Simultaneous Recordings.|Definition of Links Between Non-invasives Methods and Intracerebral EEG With Simultaneous Recordings.|Recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:53:01.998324|2017-10-10 21:53:01.998324
NCT02875951|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-18|||September 2015||2015-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|IPSOC-mamma||Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer|Prospective, Non-interventional, Non-controlled Multicenter Observational Study to Evaluate Aspects of Pharmaceutical Care and the Treatment of Postmenopausal Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer Treated With Everolimus and Exemestane.|Recruiting||N/A|100|Anticipated|Katholieke Universiteit Leuven|||1||f||||f||||||||No||2017-10-10 21:53:02.078736|2017-10-10 21:53:02.078736
NCT02875938|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-20|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|EMRA1||Effect of Music on Reading Comprehension for Patients With Aphasia|Effect of Music on Reading Comprehension for Patients With Aphasia|Completed||N/A|1|Actual|Carilion Clinic||1|||f||||f||||||||||2017-10-10 21:53:02.158535|2017-10-10 21:53:02.158535
NCT02875574|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-01-18|||November 2016||2016-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|UK_DR-TB||Improving the Management of Drug Resistant Tuberculosis in the UK|Improving the Management of Drug Resistant Tuberculosis in the UK|Recruiting||N/A|1282|Anticipated|University College, London|||1||f||||f||||||||||2017-10-10 21:53:05.064745|2017-10-10 21:53:05.064745
NCT02875925|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-06-01|||December 2015||2015-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Outcomes Study of MTM in a Medicare ACO|Pharmacist-provided Medication Management in Medicare-ACO Patients Taking Medications Associated With Medication-related Hospitalization or Emergency Visits in the Elderly|Recruiting||N/A|100|Anticipated|HealthEast Care System||2|||f||||f||||||||Yes||2017-10-10 21:53:02.253002|2017-10-10 21:53:02.253002
NCT02875912|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-07-11|||September 2015||2015-09-01|July 2017|2017-07-01|June 12, 2017|Actual|2017-06-12|March 12, 2017|Actual|2017-03-12||Interventional|FCR||Prospective Evaluation of Family Care Rituals in the ICU|PROSPECTIVE EVALUATION OF FAMILY CARE RITUALS IN THE ICU AND VALIDATION OF THE END-of-Life ScorING-System (ENDING-S), a Multicenter, Multinational Trial|Completed||N/A|452|Actual|Brown University||2|||f||||f||||||||||2017-10-10 21:53:02.343008|2017-10-10 21:53:02.343008
NCT02875899|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-05-03|||February 7, 2017|Actual|2017-02-07|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|14 Days|Observational [Patient Registry]|SAVE||Surfacer System to Facilitate Access in Venous Occlusions|Surfacer System to Facilitate Access in Venous Occlusions|Recruiting||N/A|30|Anticipated|Bluegrass Vascular Technologies|||1||f||||t||||||||Undecided||2017-10-10 21:53:02.472641|2017-10-10 21:53:02.472641
NCT02875886|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-06|||September 2016||2016-09-01|September 2016|2016-09-01||||March 2019|Anticipated|2019-03-01||Interventional|DD||DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease|DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease|Not yet recruiting||Phase 4|22|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-10-10 21:53:02.561332|2017-10-10 21:53:02.561332
NCT02875873|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-06-21|||May 27, 2017|Actual|2017-05-27|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BaSICS||Balanced Solution Versus Saline in Intensive Care Study|Balanced Solution Versus Saline in Intensive Care Study|Recruiting||Phase 3|11000|Anticipated|Hospital do Coracao||4|||f||||t|f|f||||||Yes|Data will be publicly available two years after trial results have been published|2017-10-10 21:53:02.646602|2017-10-10 21:53:02.646602
NCT02875860|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-22|||January 2017||2017-01-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|TOTAL||'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial|TOTAL TRIAL: Randomized Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) Versus Expectant Management During Pregnancy in Fetuses With Left-Sided and Isolated Congenital Diaphragmatic Hernia and Moderate Pulmonary Hypoplasia|Recruiting||Phase 2|20|Anticipated|Baylor College of Medicine||2|||f||||t||||||||Yes|Our study is part of a multi-center study, led by Universitare Ziekenhuizen Leuven, Study Chair: Jan A. Deprest, MD PhD; NCT00763737. Transmission of data to collaborators will occur over secure and encrypted email and SSL web portals. Personal Health Information (PHI) will not be reused or disclosed to (shared with) any other person or entity, except as required by law, for authorized oversight of the research study, or for other research for which the use or disclosure of the PHI would be permitted under the Privacy Rule. Randomization will be done via a purpose-designed website, hosted by the lead site. Data of individual patients will be accessible via the website to the treating physicians. Only the central data manager and statistician have general overview of the data. Data gathered won't be disclosed prior to closure and reporting of this study, in order not to compromise recruitment and unbiased conduction of the trial. By participating in this study, partners agree to this.|2017-10-10 21:53:02.754879|2017-10-10 21:53:02.754879
NCT02875847|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-06-20|||September 2016||2016-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of HMOs on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in IBS Patients|The Effects of Human Milk Oligosaccharides on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in Irritable Bowel Syndrome: a Parellell, Double-blind, Randomised, Placebo-controlled Study|Recruiting||Phase 2|60|Anticipated|Glycom A/S||3|||f||||f||||||||No||2017-10-10 21:53:02.878259|2017-10-10 21:53:02.878259
NCT02875821|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-06-22|||April 26, 2016|Actual|2016-04-26|June 2017|2017-06-01|June 7, 2017|Actual|2017-06-07|June 7, 2017|Actual|2017-06-07||Interventional|||Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone||Completed||Phase 4|44|Actual|Yonsei University||2|||f||||f||||||||Undecided||2017-10-10 21:53:03.138608|2017-10-10 21:53:03.138608
NCT02875808|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-07-31|||August 2014||2014-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Observational|||Cerebrospinal Fluid IL-6, IL-8 and PCT as Early Marker of an Intrathecal Infection in Neurosurgical Patients|Early Detection of CSF Infection in Neurosurgical Patients|Recruiting||N/A|50|Anticipated|University Medicine Greifswald|||1||f||||f||||||Samples With DNA|"     cerebrospinal fluid and blood   "|||2017-10-10 21:53:03.360412|2017-10-10 21:53:03.360412
NCT02875795|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|C2SI||Carcinologic Speech Severity Index|A Speech Disorders Severity Index to Measure the Impact of Oral and Pharyngeal Cavity on Speech Production|Not yet recruiting||N/A|103|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 21:53:03.43071|2017-10-10 21:53:03.43071
NCT02875782|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-22|||January 2011||2011-01-01|August 2016|2016-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Brief Intervention to Promote Smoking Cessation in DM Smokers|Brief Intervention to Promote Smoking Cessation and Improve Glycemic Control in DM Smokers With Type 2 Diabetes: a Randomized Controlled Trial|Completed||N/A|557|Actual|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 21:53:03.504442|2017-10-10 21:53:03.504442
NCT02875769|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-18|||February 2015||2015-02-01|January 2015|2015-01-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Pre-procedural Mouthwash in Reducing Bacteria in Dental Aerosols|Effectiveness of a Pre-procedural Mouthwash in Reducing Bacteria in Dental Aerosols and Splatters: a Randomized Clinical Trial|Completed||Phase 3|60|Actual|University of Guarulhos||4|||f||||f||||||||Yes|September 2016|2017-10-10 21:53:03.597126|2017-10-10 21:53:03.597126
NCT02875756|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-22|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of the Number of Needle Revolutions Inside the Node on the Diagnostic Yield of EBUS-TBNA in Sarcoidosis|A Study Evaluating the Effect of the Number of Needle Revolutions Inside the Node on the Diagnostic Yield of EBUS-TBNA in Sarcoidosis|Recruiting||Phase 2/Phase 3|150|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||Undecided||2017-10-10 21:53:03.721024|2017-10-10 21:53:03.721024
NCT02875743|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-10-18|||November 2016||2016-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||King's Invasive Aspergillosis Study II|Incidence of Invasive Fungal Disease in Patients Receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole Prophylaxis|Not yet recruiting||Phase 4|150|Anticipated|King's College Hospital NHS Trust||1|||f||||f||||||||||2017-10-10 21:53:03.809256|2017-10-10 21:53:03.809256
NCT02875730|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-12-09|||November 2016||2016-11-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|LAMDE||A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement|A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium|Recruiting||Phase 4|10|Anticipated|Aspire Foundation||1|||f||||t||||||||No||2017-10-10 21:53:03.891102|2017-10-10 21:53:03.891102
NCT02875717|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-18|||January 2009||2009-01-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy|Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy|Completed||N/A|500|Actual|Kantonsspital Winterthur KSW|||3||f||||f||||||||Undecided||2017-10-10 21:53:03.979888|2017-10-10 21:53:03.979888
NCT02875704|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-01-17|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy|Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy|Recruiting||N/A|160|Anticipated|Johns Hopkins University|||2||f||||f||||||Samples Without DNA|"     Samples will only be used for measurement of biomarkers of oxidative stress   "|No||2017-10-10 21:53:04.080285|2017-10-10 21:53:04.080285
NCT02875691|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2016-08-18|||September 2015||2015-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Green Tea on Treatment of Lupus|The Effect of Green Tea Extract on Some Inflammatory Biomarkers(IL 6, IL1β,TNF α,CRP), Serum Total Antioxidant Capacity(TAC), MDA and Disease Activity in Patients With Systemic Lupus Erythematous|Completed||Phase 2|68|Actual|Ahvaz Jundishapur University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:53:04.176203|2017-10-10 21:53:04.176203
NCT02875678|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-05|||November 22, 2016|Actual|2016-11-22|September 2017|2017-09-01|August 7, 2017|Actual|2017-08-07|August 7, 2017|Actual|2017-08-07||Interventional|||A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia|A Single-Dose Study to Evaluate the Effects of ABX-1431 on Gastric Accommodation and Nutrient Volume Tolerance in Patients With Functional Dyspepsia|Terminated||Phase 1|4|Actual|Abide Therapeutics||2||recruitment challenges|f||||f||||||||||2017-10-10 21:53:04.267071|2017-10-10 21:53:04.267071
NCT02875665|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-04-12|||April 2016||2016-04-01|September 2016|2016-09-01|September 30, 2017|Anticipated|2017-09-30|September 2017|Anticipated|2017-09-01||Interventional|||Feasibility Study of the Use of the gekoTM Device for Faecal Incontinence in Older People Living at Home or in Care Homes|Feasibility Study of the Use of the gekoTM Device for Faecal Incontinence in Older People Living at Home or in Care Homes|Recruiting||N/A|50|Anticipated|Firstkind Ltd||1|||f||||f||||||||No||2017-10-10 21:53:04.351586|2017-10-10 21:53:04.351586
NCT02875652|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-26|||April 2013||2013-04-01|August 2016|2016-08-01||||April 2019|Anticipated|2019-04-01||Interventional|ctDNA MU||Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)|Study of Circulating Tumoral DNA Evolution in Plasma in Choroidal Melanoma|Active, not recruiting||N/A|800|Actual|Institut Curie||1|||f||||f||||||||||2017-10-10 21:53:04.444703|2017-10-10 21:53:04.444703
NCT02875639|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-17|||June 2016||2016-06-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)||Recruiting||Phase 2|180|Anticipated|The First Affiliated Hospital of Henan University of Traditional Chinese Medicine||5|||f||||t||||||||No||2017-10-10 21:53:04.540772|2017-10-10 21:53:04.540772
NCT02875626|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-10-21|||September 2016||2016-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer|Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer (FLUO-BREAST)|Recruiting||N/A|80|Anticipated|Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie||1|||f||||f||||||||No||2017-10-10 21:53:04.670972|2017-10-10 21:53:04.670972
NCT02875613|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-10-11|||September 2016||2016-09-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer|An Open-label, Single-arm, Multi-institutional Phase II Trial of Avelumab for Recurrent, Metastatic Nasopharyngeal Carcinoma|Recruiting||Phase 2|39|Anticipated|University of California, San Diego||1|||f||||t||||||||No||2017-10-10 21:53:04.756607|2017-10-10 21:53:04.756607
NCT02875600|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Magnetic Resonance Flow Measurements of Mesenteric Arteries and Veins and Portal Vein|Magnetic Resonance Flow Measurements of Mesenteric Arteries and Veins and Portal Vein With Food Stimulation in Patients Suspected of Chronic Gastro-intestinal Ischemia|Not yet recruiting||N/A|62|Anticipated|Erasmus Medical Center||1|||f||||f||||||||No||2017-10-10 21:53:04.855555|2017-10-10 21:53:04.855555
NCT02875587|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-05-26|||October 2016||2016-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome|Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome. A Randomized Controlled Trial|Recruiting||Phase 2|170|Anticipated|Aljazeera Hospital||2|||f||||t||||||||No||2017-10-10 21:53:04.964777|2017-10-10 21:53:04.964777
NCT02871856|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-11-07|||January 2017||2017-01-01|November 2016|2016-11-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|ILST||International Lung Screen Trial (ILST)|International Lung Screen Trial|Not yet recruiting||Phase 2|||The University of Queensland||1|||f||||t||||||||No||2017-10-10 21:53:38.776396|2017-10-10 21:53:38.776396
NCT02875561|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-03-27|||March 26, 2017|Actual|2017-03-26|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia|A Randomized Controlled Trial of Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia|Recruiting||N/A|150|Anticipated|University of Colorado, Denver||2|||f||||f|f|t|f|f||||No||2017-10-10 21:53:05.144858|2017-10-10 21:53:05.144858
NCT02875548|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-09-11|||August 2016||2016-08-01|September 2017|2017-09-01|April 2024|Anticipated|2024-04-01|December 2023|Anticipated|2023-12-01||Interventional|TRuST||Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study|Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study|Recruiting||Phase 2|300|Anticipated|Epizyme, Inc.||1|||f||||f||||||||||2017-10-10 21:53:05.238542|2017-10-10 21:53:05.238542
NCT02875535|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-21|||May 2016||2016-05-01|September 2016|2016-09-01|April 2021|Anticipated|2021-04-01|December 2020|Anticipated|2020-12-01||Interventional|RLAS||Reducing LGBTQ Adolescent Suicide|Implementing School Nursing Strategies to Reduce Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Adolescent Suicide|Enrolling by invitation||N/A|40|Anticipated|Pacific Institute for Research and Evaluation||2|||f||||t||||||||No||2017-10-10 21:53:05.321825|2017-10-10 21:53:05.321825
NCT02875522|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-17|||January 2012||2012-01-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effects of Aerobic Exercise Training on Vascular, Cardiac and Cerebral Vascular Function in COPD|The Effects of Aerobic Exercise Training on Peripheral Vascular, Cardiac and Cerebral Vascular Function in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|58|Actual|University of British Columbia||2|||f||||||||||||||2017-10-10 21:53:05.394465|2017-10-10 21:53:05.394465
NCT02875509|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-22|||March 1998||1998-03-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|March 1999|Actual|1999-03-01|16 Years|Observational [Patient Registry]|||Wound Inflammatory Cells After Cardiac Surgery|Wound Infammatory Cells After Cardiac Surgery and the Patients´Survival. A Sixteen Years Follow-up Study|Completed||N/A|100|Actual|Turku University Hospital|||1||f||||f||||||||No||2017-10-10 21:53:05.481295|2017-10-10 21:53:05.481295
NCT02875496|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|December 2022|Anticipated|2022-12-01|August 2022|Anticipated|2022-08-01||Observational|(BNA™)||Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain|Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain: Brain Network Activation Analysis (BNA™) for the Adult and Elderly Population Using Evoked Response Potentials|Recruiting||N/A|2000|Anticipated|ElMindA Ltd|||4||f||||f||||||||No||2017-10-10 21:53:05.529166|2017-10-10 21:53:05.529166
NCT02875483|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-05-10|||September 12, 2016|Actual|2016-09-12|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ExITS||Expedited Interval Tubal Scheduling|Expedited Interval Tubal Scheduling: An Intervention to Increase Rates of Completion of Tubal Sterilization Within 6 Months Post-partum|Recruiting||N/A|122|Anticipated|Thomas Jefferson University||2|||f||||f||||||||No||2017-10-10 21:53:05.6025|2017-10-10 21:53:05.6025
NCT02875470|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-17|||October 2013||2013-10-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|||Burs Versus Curettes in Root Planing.|Diamond Burs Versus Gracey Curettes and Efficacy of Root Planing in Chronic Periodontitis Patients|Completed||Phase 1|12|Actual|Ege University||2|||f||||t||||||||Yes|De-identified individual data for all outcome measures will be made available within 3 years of study completion.|2017-10-10 21:53:05.67203|2017-10-10 21:53:05.67203
NCT02875457|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|September 2023|Anticipated|2023-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin|A Randomized Controlled Study of Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide and Cisplatin Chemotherapy|Not yet recruiting||Phase 3|100|Anticipated|Third Military Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:53:05.745731|2017-10-10 21:53:05.745731
NCT02875444|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-09-06|||January 2013||2013-01-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|AAA-angioCT||Measurement of Maximum Diameter of Native Abdominal Aortic Aneurysm by Angio-CT|Measurement of Maximum Diameter of Native Abdominal Aortic Aneurysm by Angio-computed Tomography|Completed||N/A|46|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:53:05.812352|2017-10-10 21:53:05.812352
NCT02875431|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01|3 Months|Observational [Patient Registry]|C5registry||Multicentric Registry for the Detection of C5 Palsy After Anterior Cervical Discectomy and Fusion|Registry for the Detection of C5 Palsy After ACDF|Recruiting||N/A|1087|Anticipated|Technische Universität München|||1||f||||f||||||||No||2017-10-10 21:53:05.866861|2017-10-10 21:53:05.866861
NCT02875418|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-18|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Comparing Two Methods of Contractions Monitoring for Clinical Decision Making Regarding Treatment Among Pregnant Women With Preterm Contractions.|A Study Aimed at Comparing Two Methods of Contractions Monitoring (Electrical Uterine Monitor - EUM vs. Tocodynamometer) for Clinical Decision Making Regarding Treatment Among Pregnant Women With Preterm Contractions.|Not yet recruiting||Phase 3|1500|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||No||2017-10-10 21:53:05.934184|2017-10-10 21:53:05.934184
NCT02875405|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PALACS||Prevention of AtriaL Fibrillation After Cardiac Surgery|Single, High Volume Center, Randomized, Control Trial of Posterior Left Pericardiotomy for the Prevention of Postoperative Atrial Fibrillation After Cardiac Surgery|Not yet recruiting||N/A|250|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-10 21:53:05.998811|2017-10-10 21:53:05.998811
NCT02875392|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-02-06|||November 2016||2016-11-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)|Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)|Recruiting||N/A|60|Anticipated|Taipei Medical University WanFang Hospital||2|||f||||f||||||||No||2017-10-10 21:53:06.09368|2017-10-10 21:53:06.09368
NCT02875379|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-03-20|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Clinical Comparison of Different Humidification Strategies During Noninvasive Ventilation With Helmet|Clinical Comparison of Different Humidification Strategies During Noninvasive Ventilation With Helmet|Recruiting||N/A|20|Anticipated|Catholic University of the Sacred Heart||4|||f||||f|f|f||||||Undecided||2017-10-10 21:53:06.172523|2017-10-10 21:53:06.172523
NCT02875366|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-05-30|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of the Effects of Lumacaftor/Ivacaftor on Exercise Tolerance in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|A Phase 4, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study of the Effect of Lumacaftor/Ivacaftor Combination Therapy on Exercise Tolerance in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|Active, not recruiting||Phase 4|66|Anticipated|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-10 21:53:06.251894|2017-10-10 21:53:06.251894
NCT02875353|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-16|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2022|Anticipated|2022-01-31||Interventional|||Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding|Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding.|Recruiting||N/A|330|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|t|||No||2017-10-10 21:53:06.346645|2017-10-10 21:53:06.346645
NCT02875340|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-09-27|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer|A Phase II Study to Assess the Efficacy, Safety and Tolerability of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of at Least One Prior Chemotherapeutic Regimen|Completed||Phase 2|8|Actual|ValiSeek Limited||1|||f||||f||||||||||2017-10-10 21:53:06.437734|2017-10-10 21:53:06.437734
NCT02875327|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-07-26|||August 4, 2016||2016-08-04|July 17, 2017|2017-07-17|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Observational|||Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data|Linkage of Medicaid Enrollment Lnformation to Surveillance, Epidemiology and End Results Data|Active, not recruiting||N/A|3217145|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:53:06.607187|2017-10-10 21:53:06.607187
NCT02875314|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-06-26|||September 2015||2015-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors|HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Clinical and Molecular Risk-Tailored Intensive and Compressed Induction Chemotherapy Followed by Consolidation With Randomization to Either Single Cycle or to Three Tandem Cycles of Marrow-Ablative Chemotherapy With Autologous Hematopoietic Progenitor Cell Rescue|Recruiting||Phase 4|250|Anticipated|Nationwide Children's Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:53:06.679574|2017-10-10 21:53:06.679574
NCT02875301|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-29|||September 2018|Anticipated|2018-09-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|IGNITE||Investigating Gains in Neurocognition in an Intervention Trial of Exercise|Investigating Gains in Neurocognition in an Intervention Trial of Exercise|Not yet recruiting||Phase 3|639|Anticipated|University of Pittsburgh||3|||f||||t|f|f||||||||2017-10-10 21:53:06.830543|2017-10-10 21:53:06.830543
NCT02875288|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-03-07|||December 2015||2015-12-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures|Prospective Randomized Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures|Recruiting||N/A|60|Anticipated|United States Naval Medical Center, San Diego||2|||f||||f||||||||Undecided||2017-10-10 21:53:06.970208|2017-10-10 21:53:06.970208
NCT02875275|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-08-01|||January 12, 2016|Actual|2016-01-12|August 2017|2017-08-01|June 27, 2016|Actual|2016-06-27|June 27, 2016|Actual|2016-06-27||Interventional|||Liquid or Solid State of Food on Glycaemia, Lipaemia and Insulinaemia|Liquid or Solid State of Food on Glycaemia, Lipaemia and Insulinaemia|Completed||N/A|23|Actual|Clinical Nutrition Research Centre, Singapore||6|||f||||f||||||||||2017-10-10 21:53:07.059125|2017-10-10 21:53:07.059125
NCT02875262|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-26|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|December 1, 2017|Anticipated|2017-12-01||Interventional|DASH||Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial|Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Radboud University||2|||f||||t|f|f||||||||2017-10-10 21:53:07.143264|2017-10-10 21:53:07.143264
NCT02875249|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2016-08-26|||November 2010||2010-11-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|EMAAD||Intestinal Microbiome and Chemotherapy|Chemotherapy-driven Dysbiosis in the Intestinal Microbiome|Completed||N/A|40|Actual|Nantes University Hospital|||1||f||||f||||||Samples Without DNA|"     stool of patients for bacterial analysis   "|No||2017-10-10 21:53:07.236207|2017-10-10 21:53:07.236207
NCT02875236|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-22|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)|Efficacy and Safety of OctaplasLG Administration vs. Crystalloids (Standard) in Patients With Septic Shock - a Randomized, Controlled, Open-label Investigator-initiated Pilot Trial|Recruiting||Phase 4|40|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||No|All data from the study will be made public in a peer review journal after last inclusion. But no individual participant data (IPD) will be public.|2017-10-10 21:53:07.292454|2017-10-10 21:53:07.292454
NCT02875223|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-09-27|||August 31, 2016|Actual|2016-08-31|September 2017|2017-09-01|June 18, 2021|Anticipated|2021-06-18|March 24, 2021|Anticipated|2021-03-24||Interventional|||A Safety and Efficacy Study of CC-90011 in Subjects With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas|A Phase 1, Open-label, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetic and Preliminary Efficacy of CC-90011 in Subjects With Advanced Solid Tumors and Non-Hodgkin Lymphomas|Recruiting||Phase 1|115|Anticipated|Celgene||1|||f||||f||||||||||2017-10-10 21:53:07.386136|2017-10-10 21:53:07.386136
NCT02875210|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-17|||July 2015||2015-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|LAXIMETRIE||Comparative Study of Anterior Tibial Translation Measurement by Four Laximeters in Anterior Cruciate Ligament Ruptures|Comparative Study of Anterior Tibial Translation Measurement by Four Different Laximeters in Anterior Cruciate Ligament Ruptures|Active, not recruiting||N/A|43|Actual|Versailles Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:53:07.484817|2017-10-10 21:53:07.484817
NCT02875197|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-09-28|||August 2016||2016-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Comparing Running-Specific and Traditional Prostheses During Running: Assessing Performance and Risk|Comparing Running-Specific and Traditional Prostheses During Running: Assessing Performance and Risk|Recruiting||N/A|40|Anticipated|Regis University|||2||f||||f||||||||||2017-10-10 21:53:07.567034|2017-10-10 21:53:07.567034
NCT02875184|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-02-22|||September 2016||2016-09-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|REWARD||A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands|Observational Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands|Recruiting||N/A|200|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 21:53:07.699574|2017-10-10 21:53:07.699574
NCT02875171|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-01-30|||October 2011||2011-10-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|May 2015|Actual|2015-05-01||Observational|Anthracardio||Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity|Assessment of Global Longitudinal Strain at Low Dose Anthracycline-based Chemotherapy for the Prediction of Subsequent Cardiotoxicity|Completed||N/A|86|Actual|Versailles Hospital|||1||f||||f||||||||No||2017-10-10 21:53:07.817183|2017-10-10 21:53:07.817183
NCT02875158|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-22|||August 2016||2016-08-01|July 2016|2016-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Cyclophotocoagulation in Glaucoma|Modified Settings for Transscleral Cyclophotocoagulation of the Ciliary Body in Glaucoma : A Randomized Controlled Trial|Not yet recruiting||N/A|50|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f||||||||No||2017-10-10 21:53:07.937595|2017-10-10 21:53:07.937595
NCT02875145|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-17|||August 2014||2014-08-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|IGREC||Impact of Cataract Surgery on Keratoplasty Graft Survival|Impact of Cataract Surgery on Keratoplasty Graft Survival|Completed||N/A|453|Actual|Centre Hospitalier Universitaire de Besancon|||2||f||||f||||||||No||2017-10-10 21:53:08.062477|2017-10-10 21:53:08.062477
NCT02875132|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-02-16|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma|An Open-label Phase II Study of Pembrolizumab in East Asian Patients With Advanced/Metastatic Acral Lentiginous Melanoma|Recruiting||Phase 2|28|Anticipated|Chinese University of Hong Kong||1|||f||||f|f|f||||||No||2017-10-10 21:53:08.18474|2017-10-10 21:53:08.18474
NCT02875119|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-08-11|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women|A Phase 1 Trial to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PC-6500 (Griffithsin [GRFT] in a Carrageenan Gel) in Healthy Women|Not yet recruiting||Phase 1|36|Anticipated|Population Council||2|||f||||f|t|f||||||||2017-10-10 21:53:08.315135|2017-10-10 21:53:08.315135
NCT02875106|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-18|2017-09-13|||September 30, 2017|Anticipated|2017-09-30|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|BAYathlon||A Digital Non-interventional Atrial Fibrillation (AF) Screening Study With Commercial Pulse Detection Systems|BAYathlon - a Digital Non-interventional AF Screening Study to Identify Commercial Pulse Detection Systems (CPDS) Detecting AF and Sinus Rhythm Parallel to ECG Recording Within Routine Clinical Setting|Not yet recruiting||N/A|160|Anticipated|Bayer|||2||f||||f|f|f||||||||2017-10-10 21:53:08.392413|2017-10-10 21:53:08.392413
NCT02875093|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-08-16|||September 2016||2016-09-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML|Phase 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia|Recruiting||Phase 1|22|Anticipated|Polaris Group||1|||f||||f||||||||||2017-10-10 21:53:08.477599|2017-10-10 21:53:08.477599
NCT02875080|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-03-09|||August 2016||2016-08-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects|A Single-center, Open-label, Randomized, Three-way, Crossover Trial to Evaluate the Bioavailability of Brexpiprazole (OPC-34712) Orally Disintegrating Tablets Relative to Brexpiprazole (OPC-34712) Conventional Tablets in Healthy Male Subjects|Active, not recruiting||Phase 1|18|Anticipated|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-10 21:53:08.556857|2017-10-10 21:53:08.556857
NCT02875067|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-07-06|||August 2016||2016-08-01|July 2017|2017-07-01|August 2023|Anticipated|2023-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma|A Phase I/II Study of the Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma|Recruiting||Phase 1/Phase 2|29|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 21:53:08.625826|2017-10-10 21:53:08.625826
NCT02875054|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-04-19|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Camp High 5: Evaluation of the Effect on Upper Limb Function|Camp High 5 2016: Evaluation of the Effect on Upper Limb Function|Completed||N/A|10|Actual|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:53:08.735144|2017-10-10 21:53:08.735144
NCT02875041|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-08-25|||August 2016||2016-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease|Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease: A Feasibility and Pilot Study (Locom-TMS)|Recruiting||Early Phase 1|36|Anticipated|New York University School of Medicine||2|||f||||f|f|t|f|f||||||2017-10-10 21:53:08.803096|2017-10-10 21:53:08.803096
NCT02874833|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-17|||July 2016||2016-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|EXDEP||Exercise for Depression|The Efficacy of Exercise in Depressive Episodes of Unipolar Depression and Bipolar Affective Disorders|Recruiting||N/A|20|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-10 21:53:10.127529|2017-10-10 21:53:10.127529
NCT02875028|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-03-27|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Vorapaxar in the Human Endotoxemia Model|Vorapaxar in the Human Endotoxemia Model A Randomized, Double‐Blind, Crossover Study|Completed||Phase 4|16|Actual|Medical University of Vienna||2|||f||||f||||||||No|A manuscript will be published in a peer-reviewed journal, individual data will not be presented unless directly requested from the PI (anonymized data may be made publicly available)|2017-10-10 21:53:08.887404|2017-10-10 21:53:08.887404
NCT02875015|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-08-30|||April 2016||2016-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Liposomal Bupivacaine vs. Bupivacaine Hydrochloride and Lidocaine During Suburethral Sling Placement|Liposomal Bupivacaine vs. Bupivacaine Hydrochloride and Lidocaine During Suburethral Sling Placement: a Randomized Control Trial|Recruiting||N/A|80|Anticipated|Atlantic Health System||2|||f||||t||||||||No||2017-10-10 21:53:08.973771|2017-10-10 21:53:08.973771
NCT02875002|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-23|||October 2016||2016-10-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas|Phase 1 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas|Not yet recruiting||Phase 1|25|Anticipated|Yale University||1|||f||||f||||||||No||2017-10-10 21:53:09.069572|2017-10-10 21:53:09.069572
NCT02874976|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-04-25|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Phototherapy Applied in Combination With Aerobic Training|Phototherapy Applied in Combination With Aerobic Training: Evaluation of Different Irradiation Protocols|Completed||N/A|96|Actual|University of Nove de Julho||4|||f||||t||||||||No||2017-10-10 21:53:09.235967|2017-10-10 21:53:09.235967
NCT02874963|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-17|||November 2015||2015-11-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||FM-SRP and Tooth Extraction Improve Type 2 Diabetes Mellitus in Periodontitis|Impact of Combined Non-surgical and Surgical Periodontal Treatment in Patients With Type 2 Diabetes Mellitus|Recruiting||N/A|160|Anticipated|University Clinical Centre of Kosova||2|||f||||f||||||||Undecided||2017-10-10 21:53:09.324914|2017-10-10 21:53:09.324914
NCT02874950|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-19|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Effective Methods of Reducing Lower Back, Neck and Shoulder Pain Among Office Workers|Effect of Exercise Training and Ergonomic Modification on Musculoskeletal Disorders Among Office Workers|Completed||Phase 1|142|Actual|Universiti Putra Malaysia||4|||f||||t||||||||Undecided|We have not decided about it yet.|2017-10-10 21:53:09.429603|2017-10-10 21:53:09.429603
NCT02874937|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-08-17|||February 2015||2015-02-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|POST6||A Proof of Principal Study of Atomoxetine for the Prevention of Vasovagal Syncope|A Proof of Principal Study of Atomoxetine for the Prevention of Vasovagal Syncope (POST 6)|Recruiting||Phase 2|64|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 21:53:09.500582|2017-10-10 21:53:09.500582
NCT02874924|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-08-19|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the Elderly|Effect of Mammalian Target of Rapamycin Inhibition and Other Metabolism Modulating Interventions on the Elderly: Immune, Cognitive, and Functional Consequences|Recruiting||Phase 2|20|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||Undecided||2017-10-10 21:53:09.593647|2017-10-10 21:53:09.593647
NCT02874911|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||September 2012||2012-09-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|September 2014|Actual|2014-09-01||Interventional|Move'n Fun||Coordination Training With Complete Body Video Games in Children and Adults With Degenerative Ataxias|Coordination Training With Complete Body Video Games in Children and Adults With Degenerative Ataxias|Completed||N/A|10|Actual|University Hospital Tuebingen||1|||f||||f||||||||No||2017-10-10 21:53:09.661959|2017-10-10 21:53:09.661959
NCT02874898|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-11-04|||June 2016||2016-06-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|STEP||Short-Term Exposure for PTSD|Marijuana Use, Extinction Learning, and Exposure Therapy in Individuals With PTSD|Recruiting||N/A|72|Anticipated|University of Washington||2|||f||||t||||||||No||2017-10-10 21:53:09.730593|2017-10-10 21:53:09.730593
NCT02874885|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-17|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Observational|||Circulating Tumor Cells in Patients With Rectal Cancer|Circulating Tumor Cells in Patients With Rectal Cancer|Recruiting||N/A|520|Anticipated|M.D. Anderson Cancer Center|||4||f||||f|f|f||||Samples With DNA|"     Blood (about 2 tablespoons) collected to study the level of circulating tumor cells (CTCs),   "|||2017-10-10 21:53:09.812294|2017-10-10 21:53:09.812294
NCT02874872|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-19|||September 2016||2016-09-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|OASIS||Building a Novel Antibiotic Stewardship Intervention for Nursing Homes||Not yet recruiting||Phase 4|5980|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||No||2017-10-10 21:53:09.898722|2017-10-10 21:53:09.898722
NCT02874859|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-04-10|||September 2016||2016-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|MODEVA||Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema|Aflibercept Injection for Treatment of Diabetic Macular Edema|Recruiting||N/A|50|Anticipated|Lille Catholic University|||1||f||||f||||||||No||2017-10-10 21:53:09.967819|2017-10-10 21:53:09.967819
NCT02874846|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-12||2016-09-27|July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution||Completed||Phase 2|12|Actual|Aerie Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 21:53:10.057057|2017-10-10 21:53:10.057057
NCT02874820|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-31|||July 2016||2016-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|I2PETPG||I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD|I2PETPG - Quantification and Localisation of Imidazoline2 Binding Sites in a Group of Participants Diagnosed With Alzheimer's Disease Using 11C‑BU99008: a Positron Emission Tomography Study|Recruiting||Early Phase 1|8|Anticipated|Imperial College London||1|||f||||f||||||||||2017-10-10 21:53:10.219632|2017-10-10 21:53:10.219632
NCT02874807|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-25|||August 2016||2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|SAND||Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study|Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study|Enrolling by invitation||Phase 2/Phase 3|93|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-10 21:53:10.306047|2017-10-10 21:53:10.306047
NCT02874794|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-08-01|||August 17, 2016|Actual|2016-08-17|August 2017|2017-08-01|March 7, 2019|Anticipated|2019-03-07|March 7, 2019|Anticipated|2019-03-07||Interventional|EVALUATE-HF||Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction|A Multicenter, Randomized, Double-blind, Double-dummy, Parallel Group, Active-controlled, Forced-titration, 12-week Comparison of Combined Angiotensin-neprilysin Inhibition With Sacubitril and Valsartan Versus Enalapril on Changes in Central Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)|Recruiting||Phase 4|432|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 21:53:10.530285|2017-10-10 21:53:10.530285
NCT02874781|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-12-12|||July 2016||2016-07-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Microcirculation of Patients With Kidney Transplant|Sublingual Microcirculation Data of Patients With Kidney Transplant|Completed||N/A|40|Actual|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 21:53:10.793124|2017-10-10 21:53:10.793124
NCT02874768|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-19|||August 2016||2016-08-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison Between Dexmedetomidine and Propofol for Patients in the Intensive Care Unit After Abdominal Surgery|Comparison Between Dexmedetomidine and Propofol for Postoperative Sedation of Patients in the Intensive Care Unit After Abdominal Surgery: Microcirculation, Kidney Injury, and Intestinal Injury|Not yet recruiting||Phase 4|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 21:53:10.874032|2017-10-10 21:53:10.874032
NCT02874755|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-08-28|||January 2015||2015-01-01|August 2017|2017-08-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Interventional|||Quality of Tuberculosis Care in Mumbai, India|An Impact Evaluation of the Private Provider Interface Agency Program on Quality of Tuberculosis Care: A Standardized Patient Study in Mumbai, India|Completed||N/A|300|Anticipated|McGill University||2|||f||||f||||||||||2017-10-10 21:53:10.974271|2017-10-10 21:53:10.974271
NCT02874729|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-11-23|||November 2016||2016-11-01|August 2016|2016-08-01||||March 2021|Anticipated|2021-03-01||Observational|||Assay Development for Cancer Biomarkers|Development of Novel Assays to Evaluate and Measure Circulating Cancer Biomarkers|Not yet recruiting||N/A|400|Anticipated|King's College London|||2||f||||f||||||||No||2017-10-10 21:53:11.336518|2017-10-10 21:53:11.336518
NCT02874716|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-03-21|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|July 31, 2016|Actual|2016-07-31||Interventional|||Quality of Tuberculosis Care in Urban Patna, India|An Impact Evaluation of the Private Provider Interface Agency Program on Quality of Tuberculosis Care: A Standardized Patient Study in Patna, India|Completed||N/A|321|Anticipated|McGill University||2|||f||||f||||||||||2017-10-10 21:53:11.44622|2017-10-10 21:53:11.44622
NCT02874703|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-03-09|||August 2016||2016-08-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Mechanisms of Diastolic Dysfunction Among Persons With HIV Compared With Non-HIV Control Subjects|Mechanisms of Diastolic Dysfunction Among Persons With HIV Compared With Non-HIV Control Subjects|Recruiting||N/A|34|Anticipated|Massachusetts General Hospital|||2||f||||||||||Samples Without DNA|"     whole blood, plasma and serum   "|||2017-10-10 21:53:11.541513|2017-10-10 21:53:11.541513
NCT02874690|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-08-24|||February 2016||2016-02-01|August 2016|2016-08-01||||October 2018|Anticipated|2018-10-01||Interventional|SAT||Stimulant Autism Test|Title: Eye Tracking as a Predictor of Methylphenidate Response in Autism With Co-morbid Attention Deficit Hyperactivity Disorder|Recruiting||Phase 2|60|Anticipated|Children's Hospital Medical Center, Cincinnati||3|||f||||f||||||||||2017-10-10 21:53:11.623582|2017-10-10 21:53:11.623582
NCT02874677|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|March 2019|Anticipated|2019-03-01||Interventional|AEROSEP||A Reeducation Program to Effort to Improve the Walking of Multiple Sclerosis Patients|Effects of an Endurance Training Program at Ventilatory Threshold on the Walking Distance of Ambulatory Patients With Multiple Sclerosis|Not yet recruiting||N/A|88|Anticipated|Lille Catholic University||2|||f||||f|f|f||||||||2017-10-10 21:53:11.720988|2017-10-10 21:53:11.720988
NCT02874651|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-10-29|||October 2016||2016-10-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|ADVANCE||ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy|ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy With or Without Chemotherapy|Recruiting||Phase 2|103|Anticipated|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 21:53:12.023297|2017-10-10 21:53:12.023297
NCT02874638|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-05-01|||September 2016||2016-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|EA3||Effect of Non-essential Amino Acids on Protein Requirements for Endurance Athletes|Effect of Non-essential Amino Acids on Protein Requirements for Endurance Athletes Using Indicator Amino Acid Oxidation Method.|Active, not recruiting||N/A|8|Anticipated|University of Toronto||4|||f||||f||||||||No||2017-10-10 21:53:12.146896|2017-10-10 21:53:12.146896
NCT02874625|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-22|||January 2017||2017-01-01|August 2016|2016-08-01||||January 2019|Anticipated|2019-01-01||Interventional|||RCT to Evaluate Biocompatibility of Resin-based Dental Materials|Randomized Clinical Trial in Children to Evaluate the Biocompatibility of Resin-based Dental Materials|Not yet recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 21:53:12.229558|2017-10-10 21:53:12.229558
NCT02874612|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-08-17|||August 2015||2015-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Psychosocial Functioning in Young Adults With Type 1 Diabetes|Young Adults With Type 1 Diabetes: Psychosocial Influences in Heath Outcomes for Young Adults Transitioning to Adult Care Project|Enrolling by invitation||N/A|120|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||Yes|Only de-identified data will be shared with the collaborating institutions and is outlined in the consenting process.|2017-10-10 21:53:12.309294|2017-10-10 21:53:12.309294
NCT02874599|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||October 2016||2016-10-01|August 2016|2016-08-01||||January 2019|Anticipated|2019-01-01||Interventional|||Cohort Biomonitoring Study to Evaluate the Biocompatibilty of Resin-based Dental Materials|Cohort Biomonitoring Study to Evaluate the Biocompatibilty of Resin-based Dental Materials|Not yet recruiting||N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||No||2017-10-10 21:53:12.395587|2017-10-10 21:53:12.395587
NCT02874586|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis|Plasma Exchange Combination of Immunosuppressive Regimens for the Remission of Auto-immune Hepatitis|Recruiting||N/A|20|Anticipated|West China Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:53:12.475785|2017-10-10 21:53:12.475785
NCT02874573|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-06-22|||September 2016||2016-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Tocilizumab in Schizophrenia|A Randomized Controlled Trial of Adjunctive Tocilizumab in Schizophrenia|Recruiting||Phase 1|20|Anticipated|Augusta University||2|||f||||t||||||||||2017-10-10 21:53:12.569307|2017-10-10 21:53:12.569307
NCT02874560|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-04-10|||August 12, 2014|Actual|2014-08-12|April 2017|2017-04-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia|Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia|Active, not recruiting||N/A|362|Anticipated|Janssen-Cilag Ltd.|||1||f||||f|f|||||||||2017-10-10 21:53:12.663553|2017-10-10 21:53:12.663553
NCT02874547|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-27|||April 14, 2014|Actual|2014-04-14|September 2017|2017-09-01|October 15, 2017|Anticipated|2017-10-15|September 14, 2016|Actual|2016-09-14||Interventional|||Community Health Workers Using Patient Stories to Support Hypertension Management|Community Health Workers Using Patient Stories to Support Hypertension|Active, not recruiting||N/A|171|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-10 21:53:12.736016|2017-10-10 21:53:12.736016
NCT02874534|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-12|||June 22, 2017|Actual|2017-06-22|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Development of a Novel Transdiagnostic Intervention for Anhedonia|Development of a Novel Transdiagnostic Intervention for Anhedonia|Recruiting||N/A|210|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|f||||||||2017-10-10 21:53:12.813715|2017-10-10 21:53:12.813715
NCT02874521|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||March 2014||2014-03-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Low-frequency Electrical Muscle Stimulation vs Cycle Training During Haemodialysis|Effects of Intra-dialytic Low-frequency Electrical Muscle Stimulation and Cycle Training on Cardiorespiratory Function and Muscular Strength: a Pilot Randomized Controlled Trial|Completed||N/A|63|Actual|University Hospitals Coventry and Warwickshire NHS Trust||3|||f||||f||||||||No||2017-10-10 21:53:12.896629|2017-10-10 21:53:12.896629
NCT02874508|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-03-28|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|LeukoCAPE||Leukocytes and Perioperative Cardio Vascular Events|Association of Circulating Leukocyte Subpopulations and Cardio Vascular Events in the Perioperative Period|Completed||N/A|40|Actual|University Hospital Heidelberg|||1||f||||f||||||Samples Without DNA|"     Plasma   "|No||2017-10-10 21:53:12.98049|2017-10-10 21:53:12.98049
NCT02874495|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-16|||January 2012||2012-01-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|Douleur IRMf||Anticipation Effect on Painful Phenomenons Linked to Rectal Distension for Patients With a Crohn's Disease in Remission|Anticipation Effect on Painful Phenomenons Linked to Rectal Distension for Patients With a Crohn's Disease in Remission: Functional MRI Study|Recruiting||N/A|44|Anticipated|University Hospital, Grenoble|||2||f||||f||||||||||2017-10-10 21:53:13.052419|2017-10-10 21:53:13.052419
NCT02874482|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-22|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|SAILLANCE1||Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia|Study of Cognitive and Emotional Factors Influencing the Visual Exploration Among Patients With Schizophrenia|Recruiting||N/A|85|Anticipated|University Hospital, Lille|||2||f||||f|f|f||||||||2017-10-10 21:53:13.193501|2017-10-10 21:53:13.193501
NCT02874469|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-05-18|||December 31, 2014|Actual|2014-12-31|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|COREABOR||Impact of an Intensive Care Diary on Post-traumatic Stress Disorder After a Resuscitated Sudden Death|Impact of an Intensive Care Diary on Post-traumatic Stress Disorder on Patients After a Resuscitated Sudden Death and His Relatives|Recruiting||N/A|330|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:53:13.269059|2017-10-10 21:53:13.269059
NCT02874456|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-01-25|||May 2016||2016-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|ZIKSPERM||Pilot Study to Detect Zika Virus in Sperm|Pilot Study to Detect Zika Virus in Sperm|Active, not recruiting||N/A|15|Actual|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 21:53:13.43395|2017-10-10 21:53:13.43395
NCT02874443|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-04-04|||October 2016||2016-10-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|REDUCED||The REDUCED Trial: REDucing the Utilization of CEsarean Sections for Dystocia|The REDUCED Trial: REDucing the Utilization of CEsarean Sections for Dystocia|Recruiting||N/A|40000|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-10 21:53:13.500287|2017-10-10 21:53:13.500287
NCT02874430|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-15|||June 2016||2016-06-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|February 2021|Anticipated|2021-02-01||Interventional|||Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer|A Phase II Study of Metformin in Combination With Doxycycline in Patients With Localized Breast and Uterine Cancer|Recruiting||Phase 2|74|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 21:53:13.580124|2017-10-10 21:53:13.580124
NCT02874417|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-16|||September 2013||2013-09-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Computerized Psychoeducation for Anxiety Sensitivity||Completed||N/A|54|Actual|Florida State University||2|||f||||f||||||||Undecided||2017-10-10 21:53:13.692561|2017-10-10 21:53:13.692561
NCT02874404|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-07-07|||October 2016||2016-10-01|July 2017|2017-07-01|August 30, 2021|Anticipated|2021-08-30|August 2020|Anticipated|2020-08-01||Interventional|||TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|A Single-Center Phase IIa Study Evaluating the Safety and Tolerability of TGR-1202 and Ibrutinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Trial of the Lymphoma Precision Medicine Laboratory|Recruiting||Phase 2|24|Anticipated|University of Nebraska||3|||f||||t||||||||||2017-10-10 21:53:13.751359|2017-10-10 21:53:13.751359
NCT02874391|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-01-19|||September 2016||2016-09-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|PerFAV||Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients||Recruiting||N/A|50|Anticipated|University Hospital, Angers|||2||f||||||||||||||2017-10-10 21:53:13.844801|2017-10-10 21:53:13.844801
NCT02874378|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-01-18|||October 2016||2016-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Effects of Dexmedetomidine on Postoperative Renal Function Recovery After Kidney Transplantation in Adult Patients|Effects of Dexmedetomidine on Postoperative Renal Function Recovery After Kidney Transplantation in Adult Patients: Double-Blinded, Randomised Controlled Trial|Recruiting||N/A|100|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||t||||||||Undecided||2017-10-10 21:53:13.904987|2017-10-10 21:53:13.904987
NCT02874365|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-12-05|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BIODIGE||Intestinal Stem Cells Characterization|Intestinal Stem Cells Characterization in Intestinal Organoid Culture From Inflammatory Bowel Disease and Intestinal Polyposis Patients|Recruiting||N/A|120|Anticipated|University Hospital, Toulouse||4|||f||||f||||||||No||2017-10-10 21:53:13.996627|2017-10-10 21:53:13.996627
NCT02874352|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-22|||October 2016||2016-10-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Incidence of Dysphagia in Intensive Care Patients With Tracheostomy|Incidence of Dysphagia in Intensive Care Patients With Tracheostomy Using High Resolution Pharyngoesophageal Manometry and Impedance|Not yet recruiting||N/A|30|Anticipated|Region Örebro County||2|||f||||f||||||||No||2017-10-10 21:53:14.074015|2017-10-10 21:53:14.074015
NCT02874339|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-11-10|||September 2016||2016-09-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|September 2018|Anticipated|2018-09-01||Interventional|OPTICAP||High Flow Nasal Oxygen Versus VNI in Acute Hypercapnic Cardiogenic Pulmonary Edema|High Flow Nasal Oxygen Versus VNI for Emergency Department Treatment of Acute Hypercapnic Cardiogenic Pulmonary Edema With Respiratory Failure: a Multicenter Randomized Non Inferiority Trial|Recruiting||N/A|250|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||Undecided||2017-10-10 21:53:14.157736|2017-10-10 21:53:14.157736
NCT02874326|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-03-30|||October 2016|Actual|2016-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|ROW||Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber|An Uncontrolled, Pilot-study Assessing the Efficacy of Octreotide Long-acting Release to Decrease Transfusion Requirements and Endoscopy Frequency in Patients With Rendu-Osler-Weber and Gastrointestinal Bleeding|Recruiting||Phase 2|15|Anticipated|Radboud University||1|||f||||f||||||||No||2017-10-10 21:53:15.971791|2017-10-10 21:53:15.971791
NCT02874313|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|RetinAS||CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea|Effect of Continuous Positive Airway Pressure on the Progression of Vascular Retinal Disease in Patients With Sleep Apnea and Non-proliferative Diabetic Retinopathy. A Randomized Clinical Trial|Recruiting||Phase 4|114|Anticipated|Hospital Universitario La Paz||2|||f||||f||||||||No||2017-10-10 21:53:16.093075|2017-10-10 21:53:16.093075
NCT02874300|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|PrAISED||Promoting Activity, Independence and Stability in Early Dementia|Promoting Activity, Independence and Stability in Early Dementia|Not yet recruiting||N/A|60|Anticipated|Nottingham University Hospitals NHS Trust||3|||f||||f||||||||No||2017-10-10 21:53:16.231175|2017-10-10 21:53:16.231175
NCT02874287|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-16|||August 2016||2016-08-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|CHANGAN||Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease.|Hydroxychloroquine Assessment of Management Study in Coronary Artery Disease After Angiography.|Not yet recruiting||Phase 4|26|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||||2017-10-10 21:53:16.31681|2017-10-10 21:53:16.31681
NCT02874274|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-06-21|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VAX-PD||Vaccination Uptake (VAX) in PD|Vaccination Uptake in Parkinson's Disease|Recruiting||N/A|60|Anticipated|New York University School of Medicine||2|||f||||||||||||||2017-10-10 21:53:16.427955|2017-10-10 21:53:16.427955
NCT02874261|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-28|||May 2015||2015-05-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease|Effects of Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease|Completed||N/A|10|Actual|New York Institute of Technology||1|||f||||f||||||||||2017-10-10 21:53:16.54722|2017-10-10 21:53:16.54722
NCT02874248|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-04-20|||May 2016||2016-05-01|August 2016|2016-08-01|November 21, 2016|Actual|2016-11-21|November 21, 2016|Actual|2016-11-21||Interventional|||E4/DRSP Single and Multiple Dose PK and Early QT Study|A Randomized, Double-blind, Placebo-controlled, Parallel, Single Center Study to Investigate the Pharmacokinetics, Safety, Tolerability, and QT Concentration-effect Modelling of Estetrol in Combination With Drospirenone After Single and Multiple Dosing in Healthy Women|Completed||Phase 1|55|Actual|Estetra||8|||f||||f||||||||No||2017-10-10 21:53:16.659538|2017-10-10 21:53:16.659538
NCT02874235|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-28|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Interventional|RCT-KTF||Music Therapy and Treatment as Usual|Music Therapy Versus Treatment as Usual: A Randomized Non-inferiority Study With Traumatized Refugees Diagnosed With PTSD|Enrolling by invitation||N/A|70|Anticipated|Psychiatric Research Unit, Region Zealand, Denmark||2|||f||||f||||||||||2017-10-10 21:53:16.782056|2017-10-10 21:53:16.782056
NCT02874222|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-19|||May 2015||2015-05-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|AIMSS||A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms|E1Z11 A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor, AIMSS|Recruiting||N/A|10|Anticipated|United States Naval Medical Center, San Diego|||3||f||||t||||||Samples With DNA|"     whole blood   "|Yes||2017-10-10 21:53:16.888353|2017-10-10 21:53:16.888353
NCT02874209|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||September 2015||2015-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral Sclerosis||Recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:53:17.092595|2017-10-10 21:53:17.092595
NCT02874196|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||July 2012||2012-07-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PLIDET||Prosthesis Loosening Imaging With Dual Energy and Tomosynthesis|Study of Diagnostic Performances of Dual Energy Imaging With Flat Detectors and Tomosynthesis in Identification of Loosening of Painful Hip Prosthesis|Completed||N/A|66|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:53:17.202943|2017-10-10 21:53:17.202943
NCT02874183|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-16|||August 2016||2016-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pharmacist Role in HF Patients Transition of Care|Pharmacist Role in HF Patients Transition of Care: Randomized Clinical Trial (RCT)|Not yet recruiting||N/A|120|Anticipated|Nova Southeastern University||2|||f||||f||||||||||2017-10-10 21:53:17.324276|2017-10-10 21:53:17.324276
NCT02874170|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||July 2015||2015-07-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of the Function and Muscle Metabolism in Drepanocytose Affected Patient During a Moderate Intensity Exercise||Recruiting||N/A|45|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:53:17.450097|2017-10-10 21:53:17.450097
NCT02874157|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||October 2012||2012-10-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Observational|||Evaluation of Methods for Diagnosis of Cytomegalovirus Pneumonia in Mechanically Ventilated Patient||Recruiting||N/A|450|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||No||2017-10-10 21:53:17.550359|2017-10-10 21:53:17.550359
NCT02874144|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-16|||June 2016||2016-06-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|E1416||Anti-Inflammatory Agent in Sinusitis|A Phase 2A, Single-Center, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy of an Anti-Inflammatory Agent in Patients With Sinusitis|Enrolling by invitation||Phase 2|60|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 21:53:17.636681|2017-10-10 21:53:17.636681
NCT02874131|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-27|||April 2015||2015-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Behavioral Activation + Cognitive Processing Therapy for PTSD and Comorbid MDD|Behavioral Activation + Cognitive Processing Therapy for Posttraumatic Stress Disorder and Comorbid Major Depressive Disorder|Recruiting||N/A|80|Anticipated|United States Naval Medical Center, San Diego||2|||f||||t||||||||||2017-10-10 21:53:17.725027|2017-10-10 21:53:17.725027
NCT02874118|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||August 2012||2012-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|March 2015|Actual|2015-03-01||Interventional|Visage 3||Search for Fragility Indicators Among People Aged 50+ With Chronic HIV Infection||Active, not recruiting||N/A|510|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:53:17.849319|2017-10-10 21:53:17.849319
NCT02874105|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||September 2016||2016-09-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|SCAPULEO||Glenohumeral Re-centering During Closed Kinetic Chain for Shoulder Physiotherapy. A Prospective and Randomized Study.|Glenohumeral Re-centering During Closed Kinetic Chain for Shoulder Physiotherapy. A Prospective and Randomized Study.|Not yet recruiting||Phase 3|120|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:53:17.938973|2017-10-10 21:53:17.938973
NCT02874092|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-05-03|||November 15, 2016|Actual|2016-11-15|May 2017|2017-05-01|November 15, 2018|Anticipated|2018-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|TIMERA||Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis|Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis|Recruiting||Phase 4|35|Anticipated|New York University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 21:53:18.039155|2017-10-10 21:53:18.039155
NCT02874079|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-10-04|||December 2015||2015-12-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|MICROPB||Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid|Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid|Recruiting||N/A|100|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:53:18.145488|2017-10-10 21:53:18.145488
NCT02874066|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-23|||March 13, 2017|Actual|2017-03-13|August 2017|2017-08-01|May 13, 2018|Anticipated|2018-05-13|March 13, 2018|Anticipated|2018-03-13||Interventional|PIVOTAL||PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis|Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for Treatment-Naive and Treatment-Experienced Non-Cirrhotic Patients With Hepatitis C Virus Genotype 1b Receiving Hemodialysis|Recruiting||Phase 4|50|Anticipated|National Taiwan University Hospital||1|||f||||f|f|f||||||||2017-10-10 21:53:18.235158|2017-10-10 21:53:18.235158
NCT02874053|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-04|||August 4, 2016||2016-08-04|July 28, 2017|2017-07-28|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|||The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk Tradeoffs|The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk Tradeoffs|Not yet recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:53:18.399481|2017-10-10 21:53:18.399481
NCT02874040|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||April 2013||2013-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Phase II Evaluating Endoresection of the Tumor Scar or Transpupillary Thermotherapy When Endoresection is Not Feasible After Proton Beam Therapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)|Phase II Evaluating Endoresection of the Tumor Scar or Transpupillary Thermotherapy When Endoresection is Not Feasible After Proton Beam Therapy for the Treatment of Large Uveal Melanomas|Recruiting||Phase 2|90|Anticipated|Institut Curie||1|||f||||f||||||||No||2017-10-10 21:53:18.48416|2017-10-10 21:53:18.48416
NCT02874027|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-21|||August 2016||2016-08-01|August 2016|2016-08-01||||May 2017|Anticipated|2017-05-01||Observational|||The Clinical Research on the Relationship Between Depression and Gut Microbiota in TBI Patients|The Clinical Research on the Relationship Between Depression and Gut Microbiota in TBI Patients|Recruiting||N/A|50|Anticipated|General Hospital of Ningxia Medical University|||2||f||||t||||||||No||2017-10-10 21:53:18.57919|2017-10-10 21:53:18.57919
NCT02874014|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-05-23|||July 2016||2016-07-01|May 2017|2017-05-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Prospective Evaluation of Hypofractionation Proton Beam Therapy With Concurrent Treatment of the Prostate and Pelvic Nodes for Clinically Localized, High Risk or Unfavorable Intermediate Risk Prostate Cancer|Prospective Evaluation of Hypofractionation Proton Beam Therapy With Concurrent Treatment of the Prostate and Pelvic Nodes for Clinically Localized, High Risk or Unfavorable Intermediate Risk Prostate Cancer|Recruiting||N/A|51|Anticipated|Mayo Clinic||1|||f||||||||||||||2017-10-10 21:53:18.688272|2017-10-10 21:53:18.688272
NCT02874001|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-16|||July 2015||2015-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|PO-BADO||French Validation of an Interview Guide to Cancer Announcement : the Psycho Oncology Basic Documentation|French Validation of an Interview Guide to the Announcement of Cancer: the Psycho Oncology Basic Documentation|Completed||N/A|450|Actual|Institut Bergonié|||1||f||||f||||||||No||2017-10-10 21:53:18.770001|2017-10-10 21:53:18.770001
NCT02873988|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-16|||March 2012||2012-03-01|August 2016|2016-08-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Observational|EPITHREGENCOPD||Regeneration of Bronchial Epithelium During Chronic Obstructive Pulmonary Disease|Regeneration of Bronchial Epithelium During Chronic Obstructive Pulmonary Disease|Completed||N/A|25|Actual|CHU de Reims|||2||f||||||||||||||2017-10-10 21:53:18.838058|2017-10-10 21:53:18.838058
NCT02873975|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-01|||October 2016||2016-10-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency|A Phase II Study of the CHK1 Inhibitor LY2606368 in Patients With Advanced Solid Tumors Exhibiting Replicative Stress or Homologous Recombination Repair Deficiency|Recruiting||Phase 2|38|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 21:53:18.91934|2017-10-10 21:53:18.91934
NCT02873962|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-07-25|||November 10, 2016|Actual|2016-11-10|July 2017|2017-07-01|February 2024|Anticipated|2024-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A Phase II Study Of Nivolumab/ Bevacizumab|A Phase II Study With A Safety Lead-In Of Nivolumab In Combination With Bevacizumab For The Treatment Of Relapsed Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer|Recruiting||Phase 2|38|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 21:53:19.060452|2017-10-10 21:53:19.060452
NCT02873949|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-19|||April 2016||2016-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|TREM||Analysis of Soluble TREM (Triggering Receptor Expressed on Myeloid Cells)-1 and -2 in Crevicular Fluid and Associated Bacterial Flora in Patients Affected by Periodontitis|Analysis of Soluble TREM (Triggering Receptor Expressed on Myeloid Cells)-1 and -2 in Crevicular Fluid and Associated Bacterial Flora in Patients Affected by Periodontitis|Recruiting||N/A|40|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||No||2017-10-10 21:53:19.253191|2017-10-10 21:53:19.253191
NCT02873936|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-22|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment|A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 24 Weeks in Combination With Conventional Synthetic Disease-modifying Anti-rheumatic Drug(s) (csDMARDs) to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic DMARD(s) Treatment|Recruiting||Phase 3|423|Anticipated|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:53:19.395973|2017-10-10 21:53:19.395973
NCT02873923|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-16|||October 2012||2012-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|DATECAN||Variability of Definitions for Survival Endpoints and Surrogate Properties for OS: a Meta-analysis|Survival Endpoints in Randomized Clinical Trials: Meta-analyses for the Assessment of the Impact Various Definitions on Trials' Results and of Surrogate Properties for OS|Active, not recruiting||N/A|18|Actual|Institut Bergonié|||2||f||||f||||||||No||2017-10-10 21:53:19.785275|2017-10-10 21:53:19.785275
NCT02873910|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-16|||July 2016||2016-07-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Influence of IQPAS-119 on Post-Marathon Susceptibility to Infections and Others|Randomized, Double-Blind, Placebo-Controlled, Monocentric, Parallel-Group Study to Evaluate the Influence of IQPAS-119 on Post-Marathon Susceptibility to Infections and Influence on Other Complaints and Its Tolerability: A Pilot Study|Recruiting||N/A|80|Anticipated|InQpharm Group||2|||f||||f||||||||No||2017-10-10 21:53:19.868667|2017-10-10 21:53:19.868667
NCT02873897|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-16|||December 2015||2015-12-01|July 2016|2016-07-01||||February 2017|Anticipated|2017-02-01||Interventional|OPTIFEL||Acceptability of Products and Eating Pleasure in Elderly People Living at Home or in Establishment Hosting For the Dependant Elderly (EHPAD) (Old-people's Home)|Acceptability of Products and Eating Pleasure in Elderly People Living at Home or in an EHPAD|Recruiting||N/A|520|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:53:19.964797|2017-10-10 21:53:19.964797
NCT02873884|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-19|||October 2016||2016-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|6 Months|Observational [Patient Registry]|CAMAT||Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT)|Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT)|Not yet recruiting||N/A|30|Anticipated|University Hospital, Caen|||2||f||||||||||||||2017-10-10 21:53:20.060045|2017-10-10 21:53:20.060045
NCT02873871|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-08-01|||November 2015||2015-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of 2 Hemostasis Techniques After Transradial Coronary|Effect of Two Compression Devices on the Occurrence of Artery Occlusion After Transradial Cardiac Catheterization: Randomized Clinical Trial|Recruiting||N/A|600|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 21:53:20.13551|2017-10-10 21:53:20.13551
NCT02873858|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-16|||December 2010||2010-12-01|July 2016|2016-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|AUPALESENS||Elucidation of Sensory Characteristics and Food Preferences in the Elderly|Elucidation of Sensory Characteristics and Food Preferences in the Elderly|Completed||N/A|611|Actual|Centre Hospitalier Universitaire Dijon||4|||f||||||||||||||2017-10-10 21:53:20.223649|2017-10-10 21:53:20.223649
NCT02873845|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-16|||May 2014||2014-05-01|July 2016|2016-07-01||||December 2020|Anticipated|2020-12-01||Observational|APPACH||Role of the Spouse/Partner of Persons Treated With Chemotherapy for Colon Cancer|Role of the Spouse/Partner of Persons Treated With Chemotherapy for Colon Cancer - Preliminary Validation of the Caregiver Objective Burden‐Quality of Life (COBQoL) Questionnaire|Recruiting||N/A|12|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 21:53:20.304182|2017-10-10 21:53:20.304182
NCT02873832|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-16|||January 2015||2015-01-01|July 2016|2016-07-01||||April 2016|Actual|2016-04-01||Observational|HSP-SMP||Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS)|Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS): Fundamental Observational in Vitro Study Using Samples From a Collection|Completed||N/A|37|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 21:53:20.382282|2017-10-10 21:53:20.382282
NCT02873819|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-27|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence in HLA-A2+ Patients With High-Risk Squamous Cell Carcinoma of the Oral Cavity|Recruiting||Phase 2|80|Anticipated|Gliknik Inc.||2|||f||||t|t|f||||||||2017-10-10 21:53:20.481544|2017-10-10 21:53:20.481544
NCT02873806|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-19|||March 2013||2013-03-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|April 2015|Actual|2015-04-01||Interventional|||Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents|A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated With Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperative Topical Prostaglandin|Active, not recruiting||Phase 4|53|Actual|Glaukos Corporation||1|||f||||f||||||||No||2017-10-10 21:53:20.665526|2017-10-10 21:53:20.665526
NCT02873793|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-16|||April 2015||2015-04-01|July 2016|2016-07-01||||April 2018|Anticipated|2018-04-01||Observational|SEMINOMES||Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle|Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle|Recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire Dijon|||3||f||||||||||Samples Without DNA|"     Extraction of total RNA from healthy and tumour tissues   "|||2017-10-10 21:53:20.75711|2017-10-10 21:53:20.75711
NCT02873780|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-01-30|||July 2016||2016-07-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients|Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in Chronic Obstructive Pulmonary Disease Patients|Completed||N/A|50|Actual|Centre Hospitalier des Pays de Morlaix|||1||f||||t||||||||Yes||2017-10-10 21:53:20.827106|2017-10-10 21:53:20.827106
NCT02873767|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-02-08|||August 2016||2016-08-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers|A Subject-Blind, Investigator-Blind, Randomized, Placebo-Controlled, First-In-Human Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Subcutaneous Doses of UCB4019 in Healthy Subjects|Completed||Phase 1|32|Actual|UCB Pharma||5|||f||||t||||||||||2017-10-10 21:53:20.895042|2017-10-10 21:53:20.895042
NCT02873754|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-07-14|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)|Mobile Health Intervention to Help Low-Income Smokers Quit Smoking and Increase Physical Activity|Active, not recruiting||N/A|5|Actual|Duke University||1|||f||||f||||||||||2017-10-10 21:53:20.977696|2017-10-10 21:53:20.977696
NCT02873741|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-09-20|||July 2016||2016-07-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|ANCAR-WIHS||New Strategies to Assess Anal Cancer Risk In Women|New Strategies to Assess Anal Cancer Risk In Women|Recruiting||N/A|200|Anticipated|Emory University||1|||f||||f||||||||||2017-10-10 21:53:21.076915|2017-10-10 21:53:21.076915
NCT02873728|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2016-08-17|||November 2016||2016-11-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|||Remote Ischemic Conditioning for Treatment of Chronic Wounds|Remote Ischemic Conditioning for Treatment of Chronic Wounds|Not yet recruiting||N/A|200|Anticipated|Soroka University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 21:53:21.164877|2017-10-10 21:53:21.164877
NCT02873715|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-05-08|||June 2017|Anticipated|2017-06-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|PLAN||Primary Care Pediatrics Learning Activity and Nutrition With Families|The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care Centers|Not yet recruiting||N/A|1284|Anticipated|State University of New York at Buffalo||2|||f||||t|f|f||||||No||2017-10-10 21:53:21.382519|2017-10-10 21:53:21.382519
NCT02873702|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-08-28|||December 31, 2016|Actual|2016-12-31|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|June 29, 2018|Anticipated|2018-06-29||Interventional|||Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis|A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole (60 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis, and Maintenance of Healing in Subjects With Healed Erosive Esophagitis With Dexlansoprazole (30 mg QD) and Placebo|Active, not recruiting||Phase 3|61|Actual|Takeda||4|||f||||f|f|f||||||||2017-10-10 21:53:21.512067|2017-10-10 21:53:21.512067
NCT02873689|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-17|2017-06-01|||December 31, 2016|Actual|2016-12-31|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients|A Phase 3 Double Blind Study to Evaluate the Efficacy and Safety of Dexlansoprazole (30 mg QD) Compared to Placebo on Heartburn Relief in Patients With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD)|Recruiting||Phase 3|200|Anticipated|Takeda||2|||f||||f||||||||||2017-10-10 21:53:21.682829|2017-10-10 21:53:21.682829
NCT02873676|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-08-16|||March 2016||2016-03-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Prevalence and Effect of Lifestyle Modification on Clinical Outcomes and Cost-effectiveness Ratio for Sarcopenia|Prevalence and the Effect of Lifestyle Modification Project (LMP) on Clinical Outcomes and Cost-effectiveness Ratio for Sarcopenia in Chinese Adults and Elderly: a Multicenter Randomized Controlled Trail|Recruiting||N/A|200|Anticipated|Peking Union Medical College Hospital||4|||f||||t||||||||||2017-10-10 21:53:21.862248|2017-10-10 21:53:21.862248
NCT02873663|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2016-08-16|||December 2010||2010-12-01|August 2016|2016-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease|Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease|Active, not recruiting||N/A|140|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 21:53:21.964199|2017-10-10 21:53:21.964199
NCT02873637|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-02-02|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|KTSS||Adductor Under Sartorial Canal Catheter (KTT) Versus Femoral Catheter (KTF) in a Quick Rehabilitation Process After Total Knee Replacement|Adductor Under Sartorial Canal Catheter (KTT) Versus Femoral Catheter (KTF) in a Quick Rehabilitation Process After Total Knee Replacement: A Controlled, Randomized Study (KTSS)|Recruiting||Phase 4|44|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||No||2017-10-10 21:53:22.176691|2017-10-10 21:53:22.176691
NCT02873624|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Incidence of Acute Kidney Injury After Laparoscopic Cholecystectomy|Incidence of Acute Kidney Injury After Laparoscopic Cholecystectomy|Not yet recruiting||N/A|100|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||t||||||||Yes||2017-10-10 21:53:22.267253|2017-10-10 21:53:22.267253
NCT02873611|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-08-18|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Estimation of the Localization Accuracy of the Genicular Ablation Procedure Applied for Chronic Pain Suppression|Estimation of the Localization Accuracy of the Genicular Ablation Procedure Applied for Chronic Pain Suppression|Not yet recruiting||N/A|30|Anticipated|TPM Medical Systems Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:53:22.335555|2017-10-10 21:53:22.335555
NCT02873598|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-07-26|||November 29, 2016|Actual|2016-11-29|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer|A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer|Recruiting||Phase 1|34|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-10 21:53:22.411052|2017-10-10 21:53:22.411052
NCT02873585|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-15|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 30, 2018|Anticipated|2018-01-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Conventional Bite Wing Radiography Versus Stationary Intraoral Tomosynthesis, a Comparison Study|Clinical Evaluation and Patient Experience of a Stationary Intraoral Tomosynthesis (s-IOT) Unit Using a Carbon Nanotube X-ray Source Array|Not yet recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t|f|f|||f|||||2017-10-10 21:53:22.513742|2017-10-10 21:53:22.513742
NCT02873572|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-16|||April 2010||2010-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GambleMMORe||Vulnerability Markers in Pathological Gambling|Marqueurs de vulnérabilité Aux Jeux Pathologiques|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire de Besancon||4|||f||||f||||||||No||2017-10-10 21:53:22.593234|2017-10-10 21:53:22.593234
NCT02873559|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-28|||November 2016||2016-11-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|PROGRESS||Effect of PROGRESSive Training and Teststerone in Older Frail Men|Effect of PROGRESSive Resistance Training, Protein Supplements and Testosterone in Older Frail Men With Testosterone Deficiency (PROGRESS Trial)|Recruiting||Phase 2/Phase 3|196|Anticipated|University Hospital, Gentofte, Copenhagen||4|||f||||f||||||||||2017-10-10 21:53:22.699799|2017-10-10 21:53:22.699799
NCT02873533|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-19|||March 2013||2013-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MEGERIA||Modification of the Quality of Life Based on Objective Geriatric Tests|Pilot Project - Prospective Longitudinal Cohort of Patients Over 70 Years With Malignant Solid Tumors: Modification of Quality of Life Based on Objective Geriatric Tests|Recruiting||N/A|330|Anticipated|Centre Antoine Lacassagne||1|||f||||f||||||||Undecided||2017-10-10 21:53:22.968316|2017-10-10 21:53:22.968316
NCT02873520|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-06|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer|Clinical Study Using Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Ningbo Cancer Hospital||2|||f||||||||||||||2017-10-10 21:53:23.043747|2017-10-10 21:53:23.043747
NCT02873507|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-06-01|||May 2018|Anticipated|2018-05-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prediction of Donor Liver Adipose Content by Magnetic Resonance Imaging|Pilot Study for the Prediction of Donor Liver Adipose Content by Magnetic Resonance Imaging|Not yet recruiting||N/A|100|Anticipated|Vanderbilt University Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:53:23.137168|2017-10-10 21:53:23.137168
NCT02873494|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-08-16|||February 2013||2013-02-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|PF-ECHO||PHYSIOFLOW/Comparison of Cardiac Output Measurement|Impedance Cardiography by PhysioFlow® for Non-invasive Cardiac Output Monitoring: a Comparison With Trans-thoracic Echocardiography in Pediatric Intensive Care Patients.|Completed||N/A|43|Actual|University Hospital, Lille|||1||f||||f||||||||No||2017-10-10 21:53:23.225554|2017-10-10 21:53:23.225554
NCT02873468|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-01-20|||July 2017|Anticipated|2017-07-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Three Doses of Oral Fluticasone Propionate in Adults With Eosinophilic Esophagitis|Clinical Study, Multicentre, Parallel, Double-blind, Randomized for the Dose to Evaluate the Safety and Efficacy of Three Doses of Oral Fluticasone Propionate Compared to Placebo in Adults With Eosinophilic Esophagitis|Not yet recruiting||Phase 2/Phase 3|272|Anticipated|EMS||4|||f||||t|f|f||||||||2017-10-10 21:53:23.37452|2017-10-10 21:53:23.37452
NCT02873455|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-04-24|||August 2016||2016-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Effects of Video Information on Preoperative Anxiety in Patients With Colorectal Cancer|Effects of Video Information on Preoperative Anxiety in Patients With Colorectal Cancer|Enrolling by invitation||N/A|32|Anticipated|Seoul National University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:53:23.45625|2017-10-10 21:53:23.45625
NCT02873442|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-06|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer|Clinical Study Using Precision Cell Immunotherapy Combination With Transcatheter Arterial Chemoembolization in Advanced Liver Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Ningbo Cancer Hospital||2|||f||||||||||||||2017-10-10 21:53:23.518912|2017-10-10 21:53:23.518912
NCT02873429|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-04-21|2017-02-28||February 2015||2015-02-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|HEALpain||Measuring the Context of Healing in Chronic Pain Treatment|Measuring the Context of Healing: Using PROMIS in Chronic Pain Treatment|Completed||N/A|218|Actual|University of Pittsburgh|||2||f||||f||||||||Undecided||2017-10-10 21:53:23.61132|2017-10-10 21:53:23.61132
NCT02873416|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-06|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer|Clinical Study Using Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Ningbo Cancer Hospital||2|||f||||f||||||||No||2017-10-10 21:53:23.984924|2017-10-10 21:53:23.984924
NCT02873403|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-03-01|||March 2017|Anticipated|2017-03-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Novel 3D Printed Knee Brace for Medial Knee Osteoarthritis|A 3D Printed Knee Brace to Improve Symptoms, Biomechanics and Daily Life Among Medial Knee Osteoarthritis Patients|Recruiting||N/A|10|Anticipated|Peacocks Medical Group||2|||f|||||f|f||||||||2017-10-10 21:53:24.064843|2017-10-10 21:53:24.064843
NCT02873390|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-10-06|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor|A Clinical Study of PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor|Recruiting||Phase 1/Phase 2|20|Anticipated|Ningbo Cancer Hospital||1|||f||||f||||||||No||2017-10-10 21:53:24.151379|2017-10-10 21:53:24.151379
NCT02873377|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-27|||April 13, 2017|Actual|2017-04-13|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Smoking Cessation in Hispanic Construction Workers|A Novel Worksite Smoking Cessation Intervention for Hispanic Construction Workers|Recruiting||Phase 4|126|Anticipated|University of Miami||2|||f||||f|t|f|||f|||No||2017-10-10 21:53:24.230696|2017-10-10 21:53:24.230696
NCT02873364|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||August 2016||2016-08-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria|High Dose Vitamin D Supplementation in Treatment of Chronic Spontaneous Urticaria|Recruiting||Phase 3|80|Anticipated|Shiraz University of Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 21:53:24.324058|2017-10-10 21:53:24.324058
NCT02873351|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-05-02|||September 2019|Anticipated|2019-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration|Pilot Study of L-DOPA Safety and Tolerability in Patients With AMD, and Proof of Concept That L-DOPA Improves Surrogate Biomarkers in Patients With Moderate to Advanced AMD|Suspended||Phase 2|104|Anticipated|Snyder, Robert W., M.D., Ph.D., P.C.||2||"Decided to do studies in patients with AMD rather than study surrogate markers in patients   without AMD."|f||||f|t|f||||||No||2017-10-10 21:53:24.406101|2017-10-10 21:53:24.406101
NCT02873338|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-09-13|||August 2016||2016-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Randomized Study of CX-01 Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia|A Randomized, Phase II Study of CX-01 Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia|Recruiting||Phase 2|160|Anticipated|Cantex Pharmaceuticals||4|||f||||t||||||||||2017-10-10 21:53:24.493129|2017-10-10 21:53:24.493129
NCT02873325|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-08-18|||May 2016||2016-05-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01|12 Months|Observational [Patient Registry]|EPROS||Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT|European Patient Registry on Salvage Antiviral Treatment for Patients Experiencing Adenovirus and / or Cytomegalovirus Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||N/A|120|Anticipated|Cell Medica Ltd|||1||f||||f||||||||Yes||2017-10-10 21:53:24.829841|2017-10-10 21:53:24.829841
NCT02873312|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-07-11|||February 10, 2017|Actual|2017-02-10|July 2017|2017-07-01|March 15, 2018|Anticipated|2018-03-15|November 30, 2017|Anticipated|2017-11-30||Interventional|||Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial|Prospective, Multi-Center, Randomized, Double-Blinded Trial of Percutaneous Tibial Nerve Stimulation With the Bioness StimRouter Neuromodulation System Versus Sham in the Treatment of Overactive Bladder (OAB)|Recruiting||N/A|120|Anticipated|Bioness Inc||2|||f||||f|f|t|t|f||||||2017-10-10 21:53:24.911019|2017-10-10 21:53:24.911019
NCT02873299|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-08-18|||April 2012||2012-04-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|rTMS||High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in PTSD|High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in Post Traumatic Stress Disorder|Completed||Early Phase 1|37|Actual|United States Naval Medical Center, San Diego||3|||f||||t||||||||No||2017-10-10 21:53:25.065742|2017-10-10 21:53:25.065742
NCT02873286|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-20|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults|A Randomized, Single-blind, Placebo Controlled, Dose-ranging Phase II Trial in ≥ 55 Year Old Adults to Evaluate the Safety and Immunogenicity of the Recombinant MVA-BN-RSV Vaccine|Active, not recruiting||Phase 2|400|Anticipated|Bavarian Nordic||5|||f||||t||||||||||2017-10-10 21:53:25.140696|2017-10-10 21:53:25.140696
NCT02873273|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2018|Anticipated|2018-08-01||Interventional|||Study of a Steroid Delivery System for Pain Relief Treatment in Patients With Knee Osteoarthritis|A Pilot Study of a Dexamethasone Implant System in Humans|Recruiting||Phase 1|6|Anticipated|Hospital for Special Surgery, New York||1|||f||||t||||||||No||2017-10-10 21:53:25.244767|2017-10-10 21:53:25.244767
NCT02873260|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-15||||||September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30|A Phase 1 Evaluation of the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30|Recruiting||Phase 1|48|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 21:53:25.34017|2017-10-10 21:53:25.34017
NCT02873247|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-08-18|||September 2015||2015-09-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Observational|Helipro||Standardize Communication With General Practitioner & Patient for Improved Eradication of Helicobacter Pylori|Prospective Analysis of the Eradication Percentage of Helicobacter Pylori, to Evaluate the Effect of Standardized Eradication Schemes and Active Communication With the General Practitioner and Patient.|Recruiting||N/A|100|Anticipated|Algemeen Ziekenhuis Maria Middelares|||1||f||||f||||||||||2017-10-10 21:53:25.440856|2017-10-10 21:53:25.440856
NCT02873234|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-18|||June 2016||2016-06-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||A Study of Chinese Medicine Treating Depression|A Multicentre Prospective Cohort Study of Traditional Chinese Medicine Treating Depression With The Use of Cloud Data|Recruiting||N/A|4600|Anticipated|The Third Affiliated Hospital of Beijing University of Chinese Medicine|||3||f||||t||||||||No||2017-10-10 21:53:25.522519|2017-10-10 21:53:25.522519
NCT02873221|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-07-26|||September 13, 2016|Actual|2016-09-13|July 2017|2017-07-01|October 24, 2018|Anticipated|2018-10-24|October 24, 2018|Anticipated|2018-10-24||Interventional|||An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine|A Multicenter, Randomized, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura|Active, not recruiting||Phase 3|1254|Actual|Allergan||3|||f||||t|t|f||||||||2017-10-10 21:53:25.661921|2017-10-10 21:53:25.661921
NCT02873208|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-15|||August 2016||2016-08-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia|A Phase 3, Multicenter Study to Assess the Long-Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia|Enrolling by invitation||Phase 3|540|Anticipated|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 21:53:26.09405|2017-10-10 21:53:26.09405
NCT02873195|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-03-24|||April 2017|Anticipated|2017-04-01|August 2016|2016-08-01|November 2025|Anticipated|2025-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer|BACCI: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Capecitabine Bevacizumab Plus Atezolizumab Versus Capecitabine Bevacizumab Plus Placebo in Patients With Refractory Metastatic Colorectal Cancer|Not yet recruiting||Phase 2|135|Anticipated|Academic and Community Cancer Research United||2|||f||||t|t|f||||||||2017-10-10 21:53:26.266324|2017-10-10 21:53:26.266324
NCT02873182|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-16|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility Study|Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility Study|Not yet recruiting||N/A|20|Anticipated|Allina Health System||1|||f||||f||||||||No||2017-10-10 21:53:26.427261|2017-10-10 21:53:26.427261
NCT02873169|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-03-27|||September 2015||2015-09-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|ASSIST-ICD||Determination of Risk Factors of Ventricular Arrhythmias (VAs) After Implantation of Continuous Flow Left Ventricular Assist Device With Continuous Flow Left Ventricular Assist Device (CF-LVAD)|Interest of Implantable Cardioverter-defibrillator in Primary Prevention in Patient With Continuous Flow Left Ventricular Assist Device (CF-LVAD)|Completed||N/A|659|Actual|Rennes University Hospital|||1||f||||f||||||||No||2017-10-10 21:53:26.500705|2017-10-10 21:53:26.500705
NCT02873156|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-02-24|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects|Recruiting||Phase 1|32|Anticipated|Eisai Inc.||2|||f||||f||||||||||2017-10-10 21:53:26.589421|2017-10-10 21:53:26.589421
NCT02873130|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2018|Anticipated|2018-08-01||Interventional|||Effectiveness of Telepractice by Smartphone App Technology in Preventing Voice Problems|Effectiveness of Telepractice by Smartphone App Technology in Preventing Voice Problems|Recruiting||N/A|90|Anticipated|West Chester University of Pennsylvania||3|||f||||||||||||||2017-10-10 21:53:26.744352|2017-10-10 21:53:26.744352
NCT02873117|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-02-14|||December 2014||2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CANARI||Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers|Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers|Recruiting||N/A|150000|Anticipated|Rennes University Hospital|||2||f||||f||||||||||2017-10-10 21:53:26.821435|2017-10-10 21:53:26.821435
NCT02873091|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-12-27|||September 2016||2016-09-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of Programmed Intermittent Epidural Bolus With Continuous Epidural Infusion for Labor Epidural Analgesia|Comparison of Programmed Intermittent Epidural Bolus With Continuous Epidural Infusion for Labor Epidural Analgesia|Recruiting||N/A|186|Anticipated|Nanjing Maternity and Child Health Care Hospital||3|||f||||t||||||||No||2017-10-10 21:53:26.966643|2017-10-10 21:53:26.966643
NCT02873078|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-06-01|||August 2016||2016-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Internet-Delivered CBT for Children With Functional Abdominal Pain Disorders|Internet-Delivered Cognitive Behavior Therapy for Children With Functional Abdominal Pain Disorders - a Randomized Controlled Trial|Active, not recruiting||N/A|91|Actual|Karolinska Institutet||2|||f||||f||||||||No||2017-10-10 21:53:27.057116|2017-10-10 21:53:27.057116
NCT02873065|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-16|||September 2014||2014-09-01|July 2016|2016-07-01|June 2015||2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori||Completed||Phase 4|||Livzon Pharmaceutical Group Inc.||2|||f||||||||||||||2017-10-10 21:53:27.154734|2017-10-10 21:53:27.154734
NCT02873052|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-21|||September 2015||2015-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||MyoVista Measurements in Patients With Atherosclerosis and CAD|MyoVista Measurements in Patients With Atherosclerosis and CAD|Recruiting||N/A|200|Anticipated|Los Angeles Biomedical Research Institute|||1||f||||t||||||Samples Without DNA|"     Cholesterol measurements, Inflammatory markers (Interleukin-6 and C-reactive protein).   "|Yes|Data will be tabulated and analysed. Study site will not share any of the subject identifiers.|2017-10-10 21:53:27.219638|2017-10-10 21:53:27.219638
NCT02873039|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-29|||July 2016||2016-07-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|November 2017|Anticipated|2017-11-01||Observational|CRAB-PH||Correlation Between Estimated Right Atrial Pressure and BNP in Pulmonary HTN (CRAB-PH)|Correlation Between Estimated Right Atrial Pressure and BNP in Pulmonary Hypertension (CRAB-PH)|Recruiting||N/A|150|Anticipated|Louisiana State University Health Sciences Center in New Orleans|||1||f||||f||||||||||2017-10-10 21:53:27.292056|2017-10-10 21:53:27.292056
NCT02873026|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-08-16|||June 2014||2014-06-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ASCOT||Adjunctive Steroid Combination in Ocular Trauma (ASCOT) Study|A Phase 3 Multi-centre Double-masked Randomised Controlled Trial of Adjunctive Intraocular and Periocular Steroid (Triamcinolone Acetonide) Versus Standard Treatment in Eyes Undergoing Vitreoretinal Surgery for Open Globe Trauma.|Recruiting||Phase 3|300|Anticipated|Moorfields Eye Hospital NHS Foundation Trust||2|||f||||t||||||||Undecided||2017-10-10 21:53:27.497655|2017-10-10 21:53:27.497655
NCT02873013|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-16|||March 2016||2016-03-01|August 2016|2016-08-01|March 2026|Anticipated|2026-03-01|March 2019|Anticipated|2019-03-01||Observational|||Asia Study Group of Prostate Cancer (A-CaP Study)|Research Concerning Background Factors at Time of Diagnosis and Initial Treatment and Treatment Progress Cancer Patients in Asia|Enrolling by invitation||N/A|20000|Anticipated|Japan Study Group of Prostate Cancer|||1||f||||f||||||||No||2017-10-10 21:53:27.609644|2017-10-10 21:53:27.609644
NCT02873000|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-04-14|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Incentive Spirometry in Non-critically Ill Hospitalized Patients With Acute Respiratory Failure|A Prospective Randomized Trial of Incentive Spirometry in Non-critically Ill Hospitalized Patients With Shortness of Breath|Not yet recruiting||N/A|100|Anticipated|Jewish Hospital, Cincinnati, Ohio||2|||f||||t|f|f||||||Undecided||2017-10-10 21:53:27.709159|2017-10-10 21:53:27.709159
NCT02872987|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-30|||February 2009||2009-02-01|August 2016|2016-08-01||||December 2025|Anticipated|2025-12-01|15 Years|Observational [Patient Registry]|GMALL registry||GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial|Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult ALL Patients and Related Diseases Associated With a Prospective Collection of Biomaterial|Recruiting||N/A|10000|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f|||||||"     Collection of biomaterial (bone marrow and peripheral blood) The biomaterial samples are     stored pseudonymized in the laboratory of the medical clinic II of the university hospital     Frankfurt am Main. The collection intends to give physicians and scientists the possibility     to have access to biomaterial for ALL related research projects.      For consignment of samples for research projects a request for use has to be placed to the     GMALL Biobank. The scientific panel of the GMALL Biobank decides about the assignment of the     samples.   "|No||2017-10-10 21:53:27.825449|2017-10-10 21:53:27.825449
NCT02872974|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-19|||August 2016||2016-08-01|September 2016|2016-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||Gestational Diabetes and Offspring's Cardiovascular Health: MySweetHeart Cohort|Consequences of Maternal Gestational Diabetes on Offspring's Cardiovascular Health: MySweetHeart Cohort|Recruiting||N/A|200|Anticipated|University of Lausanne Hospitals|||2||f||||f||||||Samples Without DNA|"     Not available   "|Yes|Plan to share data has to be defined|2017-10-10 21:53:28.057433|2017-10-10 21:53:28.057433
NCT02872961|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-05-02|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|SIBO||SIBO, Immune Activation, and FGIDs in Children|Relationship Between Small Intestinal Bacterial Overgrowth (SIBO) and Immune System Activation in Childhood Abdominal Pain-Related Functional Gastrointestinal Disorders (FGIDs)|Active, not recruiting||N/A|55|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||f||||||Samples With DNA|"     Small intestinal aspirate (fluid) will have bacterial DNA extracted   "|Undecided||2017-10-10 21:53:28.177183|2017-10-10 21:53:28.177183
NCT02872948|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-16|||August 2015||2015-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Observational|DIgiT21||Diagnosis Accuracy of Noninvasive Screening by PCR Digital for Down Syndrom|Diagnosis Accuracy of Noninvasive Screening by PCR Digital for Down Syndrom|Recruiting||N/A|1260|Anticipated|University Hospital, Grenoble|||2||f||||f||||||Samples With DNA|"     It is DNA samples of 100 pregnancies including 70 euploïdes foeti and 30 trisomies 21, the     diagnosis of which will beforehand have been made by the foetal karyotype.   "|||2017-10-10 21:53:28.274027|2017-10-10 21:53:28.274027
NCT02872935|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-18|||May 2015||2015-05-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Minimizing Nausea and Vomiting During Spinals for CS|Randomized Double Control Study to Assess the Efficacy of Administering 1 ml of Glycopyrrolate With the Spinal Dose in Minimizing Nausea and Vomiting in Patients Undergoing Cesarean Section Under Spinal Anesthesia|Recruiting||Phase 4|100|Anticipated|University of Iowa||2|||f||||t||||||||No|Do not plan to share data|2017-10-10 21:53:28.386823|2017-10-10 21:53:28.386823
NCT02872922|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-09-20|||December 10, 2016|Actual|2016-12-10|September 2017|2017-09-01|September 20, 2017|Actual|2017-09-20|September 20, 2017|Actual|2017-09-20||Interventional|||Effects of Low Intensity Therapeutic Ultrasound on Endothelial Function|Effects of Therapeutic Ultrasound on Endothelial Function of Patients With Type 2 Diabetes Mellitus: Randomized Clinical Trial|Completed||N/A|22|Actual|Universidade Federal de Santa Maria||3|||f||||f||||||||||2017-10-10 21:53:28.519003|2017-10-10 21:53:28.519003
NCT02872909|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-05-01|||October 2011||2011-10-01|May 2017|2017-05-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer|A Randomized Assessor-blinded Comparison of Low Irradiance and Conventional Irradiance Photodynamic Therapy (PDT) for Superficial Non-melanoma Skin Cancer|Completed||N/A|50|Actual|University of Dundee||2|||f||||f||||||||Yes|peer reviewed publications and presentations at international and national meetings|2017-10-10 21:53:28.616116|2017-10-10 21:53:28.616116
NCT02872896|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-01-04|||October 2016||2016-10-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Noninvasive Beat-to-Beat ClearSight Blood Pressure Monitoring|The Role of Noninvasive Beat-to-Beat ClearSight Blood Pressure Monitoring During Non-cardiac Surgery|Recruiting||N/A|320|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 21:53:28.715373|2017-10-10 21:53:28.715373
NCT02872883|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||A Pilot RCT on the Management of Term Prelabour Rupture of Membranes|"Active vs Expectant Management and Routine vs Only-when-necessary Vaginal Examinations During Labour for Prelabour Rupture of Membranes at Term, a Pilot RCT Study"|Recruiting||N/A|120|Anticipated|University of Central Lancashire||4|||f||||t||||||||No||2017-10-10 21:53:28.804448|2017-10-10 21:53:28.804448
NCT02872870|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-16|||March 2012||2012-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2015|Actual|2015-03-01||Observational|LANGAGE||Developmental Language Difficulties: Behavioural and Electrophysiological Studies|Developmental Language Difficulties: Behavioural and Electrophysiological Studies of the Connections Between Spoken and Written Language and Specificity of These Disorders|Completed||N/A|196|Actual|Lille Catholic University|||3||f||||f||||||||No||2017-10-10 21:53:28.919235|2017-10-10 21:53:28.919235
NCT02872857|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-05-02|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|SAHRANG||Subarachnoid Hemorrhage Recovery And Galantamine|A Pilot Parallel Double-Blind, Randomized Trial of Galantamine for Subarachnoid Hemorrhage|Recruiting||Phase 1/Phase 2|60|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||t||||||||||2017-10-10 21:53:29.024766|2017-10-10 21:53:29.024766
NCT02872844|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-18|||November 2016||2016-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:53:29.120513|2017-10-10 21:53:29.120513
NCT02872831|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-10-17|||July 2016||2016-07-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle|Prospective Randomized Study of Utilizing the 22-gauge Standard FNA Needle Compared to the SharkCore™ 22-gauge Fine Needle Biopsy (FNB) Needle in Patients With Solid Mass Lesions of the Gastrointestinal Tract|Recruiting||N/A|376|Anticipated|Thomas Jefferson University||2|||f||||t||||||||No||2017-10-10 21:53:29.165556|2017-10-10 21:53:29.165556
NCT02872818|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-22|||October 2014||2014-10-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia|The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia|Completed||Phase 4|40|Actual|Kayseri Education and Research Hospital||3|||f||||||||||||||2017-10-10 21:53:29.263131|2017-10-10 21:53:29.263131
NCT02872805|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-19|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|ADAPT||Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study|Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study|Not yet recruiting||N/A|300|Anticipated|University of Maryland||2|||f||||t|f|f||||||||2017-10-10 21:53:29.346431|2017-10-10 21:53:29.346431
NCT02872792|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-29|||December 14, 2016|Actual|2016-12-14|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|MUEVELO||Early Mobilisation in Intensive Care Unit : Interest of Cyclo-ergometry in Patients With Septic Chock|Early Mobilisation in Intensive Care Unit : Interest of Cyclo-ergometry in Patients With Septic Chock|Recruiting||N/A|234|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 21:53:29.424659|2017-10-10 21:53:29.424659
NCT02872779|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-21|||August 2016||2016-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|COCA-MACS||Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer|Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer|Recruiting||N/A|74|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 21:53:29.505098|2017-10-10 21:53:29.505098
NCT02872766|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-16|||January 2016||2016-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|June 2018|Anticipated|2018-06-01||Interventional|CXLMyopie||Evaluation of the Safety and Efficacy of Corneal Cross Linking for the Treatment of Myopia.|A Pilot Evaluation of the Safety and Efficacy of Topographically Customized Corneal Cross Linking for the Treatment of Myopia.|Recruiting||Phase 2|43|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||No||2017-10-10 21:53:29.585283|2017-10-10 21:53:29.585283
NCT02872753|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-12|||March 16, 2017|Actual|2017-03-16|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|November 2020|Anticipated|2020-11-01||Interventional|ACP-MEN||Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy|Intra-operative ACP Injection Following Partial Meniscectomy: a Randomized Controlled Trial|Recruiting||Phase 4|90|Anticipated|Istituto Ortopedico Rizzoli||2|||f||||t|f|f||||||||2017-10-10 21:53:29.670881|2017-10-10 21:53:29.670881
NCT02872740|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-18|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Gastric Arterial Embolization for Weight Loss|Gastric Arterial Embolization for Weight Loss|Not yet recruiting||N/A|10|Anticipated|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 21:53:29.764295|2017-10-10 21:53:29.764295
NCT02872727|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-11-10|||January 2017||2017-01-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|NPAF2||Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function:|Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function: Cohort Follow-up Study|Not yet recruiting||N/A|350|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:53:29.827967|2017-10-10 21:53:29.827967
NCT02872714|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-13|||August 2016||2016-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Urothelial Carcinoma|A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations|Recruiting||Phase 2|100|Anticipated|Incyte Corporation||1|||f||||f||||||||||2017-10-10 21:53:29.902271|2017-10-10 21:53:29.902271
NCT02872701|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-05|||May 4, 2017|Actual|2017-05-04|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules|A Phase 2, Single Dose, Open-Label, Exploratory Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules|Recruiting||Phase 2|110|Anticipated|On Target Laboratories, LLC||1|||f||||f|t|t|f|f||||Undecided||2017-10-10 21:53:30.233278|2017-10-10 21:53:30.233278
NCT02872688|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-09-12|||August 2016||2016-08-01|September 2017|2017-09-01|April 13, 2017|Actual|2017-04-13|December 19, 2016|Actual|2016-12-19||Interventional|||Influence of GanedenBC30 (Bacillus Coagulans GBI-30, 6086) on the Gut Microbiome in Healthy Adults|A Baseline Controlled, Open Label, Single-arm Study to Investigate the Influence of GanedenBC30 (Bacillus Coagulans GBI-30, 6086) on the Gut Microbiome in Healthy Adults|Completed||N/A|30|Actual|Nutrasource Diagnostics Inc.||1|||f||||f||||||||||2017-10-10 21:53:30.323512|2017-10-10 21:53:30.323512
NCT02872675|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-08|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||The Effects of Prebiotics on Gut Bacterial Parameters, Immune Function & Exercise-Induced Airway Inflammation.|The Effects of HOST-DM059 Prebiotic Supplementation on Gut Bacterial Metabolites, and Markers of Systemic Inflammation in Adults With and Without Hyperpnoea-Induced Bronchoconstriction: A Double-Blind, Placebo-Controlled, Crossover Trial.|Not yet recruiting||N/A|38|Anticipated|Nottingham Trent University||2|||f||||f|f|f||||||||2017-10-10 21:53:30.394242|2017-10-10 21:53:30.394242
NCT02872662|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT|Individual Molecular Minimal Residual Disease (MRD) Monitoring for Patients With MDS and Mixed MDS/MPN Treated With Allogeneic Stem Cell Transplantation|Not yet recruiting||N/A|200|Anticipated|Nordic MDS Group|||1||f||||f||||||||Yes|Mutational data, MRD and clinical data is planned to be published|2017-10-10 21:53:30.51012|2017-10-10 21:53:30.51012
NCT02872649|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-08-15|||January 2013||2013-01-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|June 2015|Actual|2015-06-01||Interventional|||Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)|Pilot-Trial: Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device|Terminated||Phase 2|16|Actual|Medical University of Vienna||2||safety reasons|f||||t||||||||No||2017-10-10 21:53:30.567241|2017-10-10 21:53:30.567241
NCT02872636|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-08-25|||March 23, 2017|Actual|2017-03-23|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|PILLAR||Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter|Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter|Recruiting||N/A|15|Anticipated|Minnetronix||1|||f||||t|f|t|t|||||||2017-10-10 21:53:30.670081|2017-10-10 21:53:30.670081
NCT02872623|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-29|||March 2015||2015-03-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|enteroMRI-TSI||EnteroCT With Enteroclysis Versus Enterography-MRI for the Diagnosis of Tumors of the Small Intestine: a Pilot Study|EnteroCT With Enteroclysis Versus Enterography-MRI for the Diagnosis of Tumors of the Small Intestine: a Pilot Study|Recruiting||N/A|40|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:53:32.517762|2017-10-10 21:53:32.517762
NCT02872610|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-11-16|||August 2016||2016-08-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Self-help Online Against Suicidal Thoughts (SOS) Trial|The Self-help Online Against Suicidal Thoughts (SOS) Trial - a Danish Randomized Wait-list Controlled Trial for People With Suicidal Thoughts|Recruiting||N/A|438|Anticipated|Mental Health Services in the Capital Region, Denmark||2|||f||||f||||||||Yes|A de-identified dataset generated during the study and the statistical code used for the analysis will be available upon request, once the data has been collected and analyzed by the research group.|2017-10-10 21:53:32.594148|2017-10-10 21:53:32.594148
NCT02872597|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-05-01|||September 5, 2016|Actual|2016-09-05|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus|A Phase I, Single Center, Placebo-Controlled, Blinded Pilot Study of Ipratropium Bromide in Children Admitted to the Intensive Care Unit With Status Asthmaticus|Recruiting||Phase 1|30|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||No||2017-10-10 21:53:32.722148|2017-10-10 21:53:32.722148
NCT02872584|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-18|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|FFA&steroids||Serum FFA Desaturase Activity Index in Patients on High Dose Corticosteroids|Serum Free Fatty Acids Desaturase Activity Indices in Sera of Patients on Long-term High-dose Corticosteroid Treatment|Not yet recruiting||N/A|20|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples Without DNA|"     serum   "|Yes||2017-10-10 21:53:32.834532|2017-10-10 21:53:32.834532
NCT02872571|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-02-01|||April 2013|Actual|2013-04-01|February 2017|2017-02-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|AUTOGRAFTIM||Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy|Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy|Recruiting||Phase 1/Phase 2|35|Anticipated|University Hospital, Lille||1|||f||||f||||||||No||2017-10-10 21:53:32.899572|2017-10-10 21:53:32.899572
NCT02872558|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-07-13|||March 26, 2017|Actual|2017-03-26|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Shared Decision Making in Parents of Children With Acute Otitis Media|Shared Decision Making in Parents of Children With Acute Otitis Media: The Acute Otitis Media Choice Trial|Recruiting||N/A|400|Anticipated|Mayo Clinic||2|||f||||t|f|f||||||||2017-10-10 21:53:32.990168|2017-10-10 21:53:32.990168
NCT02872545|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-16|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|D-SPECT BIKER||Influence of Patient Position on Attenuation Artifacts Observed in D-SPECT Camera Myocardial Tomoscintigraphy|Influence of Patient Position on Attenuation Artifacts Observed in D-SPECT Camera Myocardial Tomoscintigraphy|Recruiting||N/A|80|Anticipated|Central Hospital, Nancy, France||3|||f||||f||||||||No||2017-10-10 21:53:33.070009|2017-10-10 21:53:33.070009
NCT02872532|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-10-03|||August 16, 2016|Actual|2016-08-16|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Testicular Tissue Cryopreservation in Children|Testicular Tissue Cryopreservation for Fertility Preservation in Males Facing Fertility Threatening Diagnoses or Treatment Regimens|Recruiting||N/A|100|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 21:53:33.154048|2017-10-10 21:53:33.154048
NCT02872519|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-16|||October 2016||2016-10-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||PET Imaging of Ovarian Carcinoma With 18F-FSPG|PET Imaging of Ovarian Carcinoma With 18F-FSPG|Not yet recruiting||N/A|20|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||||||||||||2017-10-10 21:53:33.224513|2017-10-10 21:53:33.224513
NCT02872506|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-06-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|CASINO||Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical Resection|Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical Resection|Not yet recruiting||N/A|50|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 21:53:33.409487|2017-10-10 21:53:33.409487
NCT02872493|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-20|||August 2016||2016-08-01|August 2016|2016-08-01|July 2027|Anticipated|2027-07-01|July 2027|Anticipated|2027-07-01||Observational|||Small Bowel Length and Bariatric Surgery Outcomes|Observational Study of the Effect of Small Intestine Length on Bariatric Surgical Patient Outcomes|Recruiting||N/A|300|Anticipated|Vanderbilt University|||2||f||||f||||||||No||2017-10-10 21:53:33.50692|2017-10-10 21:53:33.50692
NCT02872480|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-02-15|||August 2016||2016-08-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|ACTIVE||Acute Concussion Therapy Intervention Training in Healthy and Concussed Participants|The Effect of ACTIVE Training in Improving Clinical Outcomes in Healthy and Acutely Concussed College-aged Participants|Completed||N/A|45|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:53:33.621238|2017-10-10 21:53:33.621238
NCT02872467|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-05-26|||May 2016||2016-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|NOX||Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology|Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology|Recruiting||Phase 1|32|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 21:53:33.709972|2017-10-10 21:53:33.709972
NCT02872454|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-08-16|||April 2015||2015-04-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|TEXT4U||Psychotherapeutic Text Messaging for Depression Pilot Study|Psychotherapeutic Text Messaging for Depression Pilot Study|Completed||N/A|190|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 21:53:33.805238|2017-10-10 21:53:33.805238
NCT02872441|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-10-20|||January 2017||2017-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|TIFOLH4||Characterization of Tissular T Follicular Helper Cells in IgG4-RD|Characterization of Tissular T Follicular Helper Cells in IgG4-RD|Not yet recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:53:33.88185|2017-10-10 21:53:33.88185
NCT02872428|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-25|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)|A Phase 1, Single Ascending Dose, Double Blind, Placebo Controlled Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1) or Trauma Patients(Part 2)|Enrolling by invitation||Phase 1|12|Anticipated|University of Michigan||2|||f||||t|t|f||||||||2017-10-10 21:53:33.962572|2017-10-10 21:53:33.962572
NCT02872415|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-11-02|||January 2017||2017-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|NOBOBO||Effect of Site on Pain in Preterm Neonates|Impact of Alternative Blood Glucose Testing Site (Forearm) on Pain Reduction in Preterm Neonates.|Not yet recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 21:53:34.043756|2017-10-10 21:53:34.043756
NCT02872402|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-05|||December 2016||2016-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|August 2021|Anticipated|2021-08-01||Interventional|DEPART||Feasibility of a Postpartum Lifestyle Intervention on the Cardiometabolic Risk Profile of GDM Women|Feasibility of a Lifestyle Intervention Early After Delivery on the Cardiometabolic Risk Profile of Women With Recent Gestational Diabetes|Recruiting||N/A|30|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 21:53:34.117947|2017-10-10 21:53:34.117947
NCT02872389|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Power Spectral Analysis of EEG During Equi-MAC Inhalation Anesthesia|Power Spectral Analysis of the Electroencephalogram During Equi-MAC Sevoflurane vs. Desflurane Anesthesia: A Randomized Controlled Trial|Recruiting||Phase 3|90|Anticipated|Kangbuk Samsung Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:53:34.206604|2017-10-10 21:53:34.206604
NCT02872376|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-15|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|RIDART-1||Clinical Burden of Anemia in Inflammatory Bowel Disease (RIDART1)|Clinical Burden of Anemia in Inflammatory Bowel Disease: Role of Iron Deficiency And Iron Replacement Therapy, Observational Study (RIDART-1)|Not yet recruiting||N/A|2000|Anticipated|IRCCS Policlinico S. Matteo|||1||f||||||||||||||2017-10-10 21:53:34.286238|2017-10-10 21:53:34.286238
NCT02872363|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-11|||August 9, 2016|Actual|2016-08-09|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|November 8, 2016|Actual|2016-11-08||Interventional|||Does the Wording of Text Message Reminders Improve Uptake in Breast Screening?|Does the Wording of Text Message Reminders Improve Uptake in Breast Screening? A Randomised Controlled Trial|Recruiting||N/A|12000|Anticipated|Imperial College Healthcare NHS Trust||3|||f||||f||||||||No|There is no intention to make individual participant data available. Data will be analysed at aggregate level.|2017-10-10 21:53:34.340976|2017-10-10 21:53:34.340976
NCT02872350|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-16|||October 2016||2016-10-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|ECUN||Prognostic Contribution of Abdominal Ultrasound in Necrotizing Enterocolitis in Preterm Infants Less Than 33SA.||Not yet recruiting||N/A|95|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:53:34.434399|2017-10-10 21:53:34.434399
NCT02872337|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-18|||February 2015||2015-02-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Pre-operative One-on-One Physical Therapy Education Improves Postoperative Function and Patient Satisfaction After Total Joint Arthroplasty|One-on-One Physical Therapy Education Improves Postoperative Function and Patient Satisfaction After TJA|Completed||N/A|126|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-10 21:53:34.50167|2017-10-10 21:53:34.50167
NCT02872324|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-16|||October 2016||2016-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|MBCT||Evaluation of the Impact of the Level of Mindfulness on the Management of Patients With Recurrent Depressive Disorders by the Mindfulness Based Cognitive Therapy ( MBCT ): an Exploratory Study|Evaluation of the Impact of the Level of Mindfulness on the Management of Patients With Recurrent Depressive Disorders by the Mindfulness Based Cognitive Therapy ( MBCT ): an Exploratory Study|Not yet recruiting||N/A|66|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:53:34.55717|2017-10-10 21:53:34.55717
NCT02872311|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-08-01|||September 2016||2016-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|OLIVE||Open-Label Influenza Vaccine Evaluation|Open-Label, Randomized Study of Immune Response to Licensed Influenza Vaccines in Adults 65-74 Years of Age (US Flu Vaccine Effectiveness Serologic Study, 2016-17 and 2017-18)|Enrolling by invitation||N/A|210|Anticipated|Marshfield Clinic Research Foundation||5|||f||||f||||||||||2017-10-10 21:53:34.634999|2017-10-10 21:53:34.634999
NCT02872298|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-09-22|||October 2016||2016-10-01|August 2016|2016-08-01|October 2020|Anticipated|2020-10-01|May 2018|Anticipated|2018-05-01||Interventional|RELIEF-1||Evaluating the Safety and Feasibility of TLD for the Treatment of Moderate to Severe Refractory Asthma|A pRospective, Multicenter, Single-arm Study EvaLuating the Safety and feasIbility of Targeted Lung Denervation (TLD) for the trEatment of Moderate to Severe reFractory Asthma|Not yet recruiting||Phase 1|30|Anticipated|Nuvaira, Inc.||1|||f||||t||||||||No||2017-10-10 21:53:34.725824|2017-10-10 21:53:34.725824
NCT02872285|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-08||2017-09-08|December 5, 2016|Actual|2016-12-05|September 2017|2017-09-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis|A Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of LYC-30937-EC in Subjects With Moderate Chronic Plaque-Type Psoriasis|Completed||Phase 2|33|Actual|Lycera Corp.||2|||f||||t||||||||||2017-10-10 21:53:34.832853|2017-10-10 21:53:34.832853
NCT02872272|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-16|||January 2017||2017-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|AMIKACINE||Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population|Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population|Not yet recruiting||Phase 4|75|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:53:34.91468|2017-10-10 21:53:34.91468
NCT02872259|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-29|||January 2017||2017-01-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma|A Phase Ib/II Randomised Open Label Study of BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib Compared to Pembrolizumab or Dabrafenib/Trametinib Alone, in Patients With Advanced Non-resectable (Stage IIIc) or Metastatic (Stage IV) Melanoma|Recruiting||Phase 1/Phase 2|92|Anticipated|Haukeland University Hospital||4|||f||||t||||||||||2017-10-10 21:53:35.033736|2017-10-10 21:53:35.033736
NCT02872246|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-17|||May 2015||2015-05-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) - Assay|Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay|Completed||N/A|11|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:53:35.212559|2017-10-10 21:53:35.212559
NCT02872233|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-17|||May 2015||2015-05-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay|Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay|Completed||N/A|6|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:53:35.295853|2017-10-10 21:53:35.295853
NCT02872220|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-08-17|||March 2015||2015-03-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||To Test for Photo Allergy Reaction of Sunscreens|A Randomized Study to Assess the Potential for Photoallergy of SPF 50 Y65 110, SPF 50 Y51 002 and SPF 15 V27 104 in Human Subjects|Completed||N/A|56|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:53:35.382243|2017-10-10 21:53:35.382243
NCT02872207|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-17|||February 2015||2015-02-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of the Stinging Potential in Human Eyes|Evaluation of the Stinging Potential in Human Eyes|Completed||N/A|40|Actual|Bayer||2|||f||||f||||||||||2017-10-10 21:53:35.469421|2017-10-10 21:53:35.469421
NCT02872194|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-17|||September 2014||2014-09-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of the Stinging Potential of Products in Human Eyes|Evaluation of the Stinging Potential of Products in Human Eyes|Completed||N/A|21|Actual|Bayer||3|||f||||f||||||||||2017-10-10 21:53:35.559311|2017-10-10 21:53:35.559311
NCT02872181|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-08-15|||April 2016||2016-04-01|August 2016|2016-08-01||||May 2017|Anticipated|2017-05-01||Interventional|||An Evaluation of Maternal Position During Cesarean Delivery|A Randomized Controlled Trial Evaluating Maternal Tilt During Cesarean Section|Recruiting||N/A|120|Anticipated|Hartford Hospital||3|||f||||||||||||||2017-10-10 21:53:35.656541|2017-10-10 21:53:35.656541
NCT02872168|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-18|||June 2015||2015-06-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|PYPARK||Identification of a New Metabolite of Furosemide in Humans|Identification of a New Metabolite of Furosemide in Humans|Completed||N/A|30|Actual|Henri Mondor University Hospital|||1||f||||f||||||Samples Without DNA|"     Urine sample   "|No||2017-10-10 21:53:35.760703|2017-10-10 21:53:35.760703
NCT02872155|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-09-02|||September 2016||2016-09-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|NICIR||Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT)||Not yet recruiting||Phase 3|264|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||Undecided||2017-10-10 21:53:35.82216|2017-10-10 21:53:35.82216
NCT02872142|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-09-12|||July 2016||2016-07-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Efficacy and Safety of Plasma Exchange With Albutein® 5% in Patients With Amyotrophic Lateral Sclerosis|Pilot Study to Evaluate the Efficacy and Safety of Plasma Exchange With Albutein® 5% in Patients With Amyotrophic Lateral Sclerosis|Recruiting||Phase 2|10|Anticipated|Grifols Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 21:53:35.906711|2017-10-10 21:53:35.906711
NCT02872129|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-02-01|||May 2016||2016-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||12-years Follow-up on 166 Female Patients With Fibromyalgia or Chronic Widespread Pain|12-years Follow-up on 166 Female Patients With Fibromyalgia or Chronic Widespread Pain|Recruiting||N/A|166|Anticipated|Göteborg University|||1||f||||f||||||||No||2017-10-10 21:53:35.99684|2017-10-10 21:53:35.99684
NCT02872116|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-10-03|||October 4, 2016|Actual|2016-10-04|October 2017|2017-10-01|October 11, 2020|Anticipated|2020-10-11|July 11, 2019|Anticipated|2019-07-11||Interventional|CheckMate649||Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer|A Randomized, Multicenter, Open-Label, Phase 3 Study of Nivolumab Plus Ipilimumab or Nivolumab in Combination With Oxaliplatin Plus Fluoropyrimidine Versus Oxaliplatin Plus Fluoropyrimidine in Subjects With Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer|Recruiting||Phase 3|1266|Anticipated|Bristol-Myers Squibb||5|||f||||t|t|f||||||||2017-10-10 21:53:36.138283|2017-10-10 21:53:36.138283
NCT02872103|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-08-22|||August 2016||2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy|A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo Controlled Clinical Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy|Recruiting||Phase 3|120|Anticipated|Generon (Shanghai) Corporation Ltd.||2|||f||||f||||||||||2017-10-10 21:53:36.782094|2017-10-10 21:53:36.782094
NCT02872090|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-18|||March 2016||2016-03-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|LAB-Card||Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in COPD|Effects of Long Acting Bronchodilators on CARDiac Autonomic Nervous System Control in Patients With COPD|Recruiting||Phase 4|48|Anticipated|Centre Hospitalier Universitaire de Besancon||4|||f||||t||||||||No||2017-10-10 21:53:36.869431|2017-10-10 21:53:36.869431
NCT02872077|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|AA NAS RCT||Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome|Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome: A Randomized Controlled Trial|Not yet recruiting||Phase 1/Phase 2|48|Anticipated|University of South Florida||2|||f||||f||||||||No||2017-10-10 21:53:37.019433|2017-10-10 21:53:37.019433
NCT02872064|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-03-16|||January 2013|Actual|2013-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Treatment of Primary Breast Cancer Using PDT|A Phase I/IIa, Open Label, Single Site Light Dose Escalation Trial of Single Dose Verteporfin Photodynamic Therapy (PDT) in Primary Breast Cancer|Recruiting||N/A|40|Anticipated|University College, London||1|||f||||t||||||||Yes|All requests for data sharing will adhere to the UCL Surgical & Interventional Trials Unit (SITU) data sharing agreement policy. UCL Medical School is supportive of data sharing and will endeavour to assist in requests for data sharing. These data will be held at UCL on secure servers and will not be released to any third parties until the final study report has been published. All requests for access to the data will be formally requested through the use of a SITU data request form which will state the purpose, analysis and publication plans together with the named collaborators. All requests are dealt with on a case by case basis. All requests will be logged and those successful will have a data transfer agreement which will specify appropriate acknowledgement of the Royal Free Hospital, the sponsor, and funders.|2017-10-10 21:53:37.163646|2017-10-10 21:53:37.163646
NCT02871661|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-15|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Physical Therapy as Adjuvant Treatment of Vulvodynia: a Randomized Controled Trial|Physical Therapy as Adjuvant Treatment of Vulvodynia: a Randomized Controled Trial|Recruiting||Phase 3|58|Anticipated|University of Campinas, Brazil||3|||f||||t||||||||No||2017-10-10 21:53:40.520006|2017-10-10 21:53:40.520006
NCT02872051|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-04-06|||April 2016||2016-04-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|June 2018|Anticipated|2018-06-01||Interventional|IBBIS||Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression|Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression in Denmark (the Danish IBBIS Study): A Multi-center Randomized Controlled Trial|Recruiting||N/A|603|Anticipated|Mental Health Centre Copenhagen||3|||f||||f||||||||Undecided||2017-10-10 21:53:37.271389|2017-10-10 21:53:37.271389
NCT02872038|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-15|||August 2015||2015-08-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis|A Multicenter, Randomized, Controlled Trial Comparing Cefepime Monotherapy Versus Combination of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-associated Peritonitis|Recruiting||Phase 4|236|Anticipated|Chulalongkorn University||2|||f||||||||||||||2017-10-10 21:53:37.390594|2017-10-10 21:53:37.390594
NCT02872025|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-18|||August 2016||2016-08-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Pembrolizumab in High-risk Ductal Carcinoma in Situ (DCIS)|Testing the Ability of Pembrolizumab to Alter the Tumor Immune MicroEnvironment (TIME) of High Risk DCIS|Active, not recruiting||Early Phase 1|48|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 21:53:37.501128|2017-10-10 21:53:37.501128
NCT02872012|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-07-06|||March 2016||2016-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:53:37.605747|2017-10-10 21:53:37.605747
NCT02871999|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trial on Acupuncture Adjuvant Treatment in the Pain After the Surgery of Gastrointestinal Carcinoma||Not yet recruiting||N/A|120|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:53:37.650909|2017-10-10 21:53:37.650909
NCT02871986|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-15|||September 2016||2016-09-01|June 2016|2016-06-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Observational|||Pubertal Induction in Individuals With Hypogonadism|Variability of Uterine and Breast Development in Response to Exogenous Oestrogen During Induction of Puberty in Individuals With Hypogonadism.|Not yet recruiting||N/A|24|Anticipated|University College, London|||1||f||||t||||||Samples With DNA|"     Blood samples   "|Yes|Peer Review Journals|2017-10-10 21:53:37.743099|2017-10-10 21:53:37.743099
NCT02871973|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-05-01|||July 2016||2016-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Primary Care-based Program to Enhance Positive Parenting Practices|Sit Down and Play: A Primary Care-Based Program to Promote Positive Parenting Practices|Active, not recruiting||Phase 1|40|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||Undecided||2017-10-10 21:53:37.83564|2017-10-10 21:53:37.83564
NCT02871960|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-06-19|||July 2016||2016-07-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|ESSIMIC||Surgical Stress and Colorectal Surgery|Evaluation of Surgical Stress and Immune Response After Minimally Invasive Colorectal Surgery (ESSIMIC)|Active, not recruiting||N/A|126|Anticipated|Federico II University||2|||f|||||f|f||||||Undecided||2017-10-10 21:53:37.919632|2017-10-10 21:53:37.919632
NCT02871947|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-08-16|||March 2016||2016-03-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Observational|||Epidemiology and Cytokines Analysis of Severe Asthma Patients in Taiwan|Epidemiology and Cytokines Analysis of Severe Asthma Patients in Taiwan|Recruiting||N/A|70|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||f||||||Samples Without DNA|"     blood   "|No||2017-10-10 21:53:38.007816|2017-10-10 21:53:38.007816
NCT02871934|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2017-09-08|||August 1, 2016|Actual|2016-08-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|IPICC||Integrating Pharmacogenetics In Clinical Care|Clinical Safety and Efficacy of Pharmacogenetics in Veteran Care|Enrolling by invitation||N/A|408|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:53:38.120584|2017-10-10 21:53:38.120584
NCT02871921|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-29|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|I-CONECT||Internet-based Conversational Engagement Clinical Trial|Internet-based Conversational Engagement Clinical Trial|Not yet recruiting||N/A|360|Anticipated|Oregon Health and Science University||2|||f||||t|f|f||||||||2017-10-10 21:53:38.228903|2017-10-10 21:53:38.228903
NCT02871908|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-16|2016-12-27|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial|Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial|Recruiting||Phase 4|250|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-10 21:53:38.323979|2017-10-10 21:53:38.323979
NCT02871895|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-08-17|||July 2013||2013-07-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|BCSS||Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis|Application of Biomarkers Change to Predict Outcome of Patients With Severe Sepsis|Recruiting||N/A|300|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||Samples Without DNA|"     Serum immunological biomarkers including cytokines, blood cell counts,and biochemistry     profiles   "|Undecided||2017-10-10 21:53:38.421065|2017-10-10 21:53:38.421065
NCT02871882|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-04-03|||August 2016||2016-08-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus|Effect of Delayed-Release Bile Acid on Insulin Sensitivity, Gastric Emptying and Body Weight in Overweight or Obese Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 2|24|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||No||2017-10-10 21:53:38.519302|2017-10-10 21:53:38.519302
NCT02871869|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-07-12|||September 2016||2016-09-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma|Cinobufacini Tablets Combined With R-CHOP Protocol (Rituximab + Vindesine + Cyclophosphamide + Epirubicin + Prednisone)/CHOP in Treatment of Diffuse Large B Cell Lymphoma: A Phase II Randomized, Controlled and Multi-center Study|Recruiting||Phase 2/Phase 3|316|Anticipated|Xinjiang Medical University||4|||f||||t||||||||||2017-10-10 21:53:38.641224|2017-10-10 21:53:38.641224
NCT02871843|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-07-02|||February 14, 2017|Actual|2017-02-14|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|G-FORCE-1||Phase 1 Two Part Dose Escalation Trial of RRx-001 + Radiation + Temozolomide and RRx-001 + Temozolomide Post-RT In Newly Diagnosed Glioblastoma and Anaplastic Gliomas|G-FORCE-1: An Open-Label Phase 1 Two Part Dose Escalation Trial of RRx-001 Concurrent With Radiation and Temozolomide and RRx-001 + Temozolomide Post-RT In Newly Diagnosed Glioblastoma and Anaplastic Gliomas With Intact 1p/19q Chromosomes|Recruiting||Phase 1|39|Anticipated|EpicentRx, Inc.||1|||f||||f|t|f||||||||2017-10-10 21:53:38.864897|2017-10-10 21:53:38.864897
NCT02871830|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-15|||January 2014||2014-01-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|WISH project||Effects of a Peer-led Walking In ScHools Intervention|Effects of a Peer-led Walking In ScHools Intervention on Physical Activity Levels of Adolescent Girls: a School-based Cluster Randomised Controlled Trial|Completed||N/A|200|Actual|University of Ulster||2|||f||||f||||||||No||2017-10-10 21:53:38.97569|2017-10-10 21:53:38.97569
NCT02871817|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-09-19|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CLEAR||A Comparison of the Paxos Mobile App to Standard Vision Assessment Tools|The Correlation of Paxos Checkup Mobile App to Standard in Office Visual Assessement|Recruiting||N/A|137|Anticipated|Digisight Technologies, Inc.|||1||f||||f||||||||||2017-10-10 21:53:39.047584|2017-10-10 21:53:39.047584
NCT02871804|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|COSMOS-DP||Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy|Comparison of Resection During Distal Pancreatectomy of the Splenic Vein Either Together With the Pancreatic Parenchyma or After Isolation: A Multicentre, Prospective, Randomized Phase III Trial|Recruiting||Phase 3|304|Anticipated|Wakayama Medical University||2|||f||||t||||||||No||2017-10-10 21:53:39.136171|2017-10-10 21:53:39.136171
NCT02871791|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-03-24|||August 24, 2016|Actual|2016-08-24|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|October 2019|Anticipated|2019-10-01||Interventional|||Palbociclib With Everolimus + Exemestane In BC|A Phase 1b/2a Study Of Palbociclib In Combination With Everolimus And Exemestane In Postmenopausal Women With Estrogen Receptor Positive and HER2 Negative Metastatic Breast Cancer|Recruiting||Phase 1/Phase 2|32|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:53:39.243213|2017-10-10 21:53:39.243213
NCT02871765|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-15|||January 2010||2010-01-01|July 2016|2016-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Educational Effectiveness for Atrial Fibrillation Patients Under Warfarin Treatment|The Educational Effectiveness for Atrial Fibrillation Patients Under Warfarin Treatment|Completed||N/A|122|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||Yes|Investigators are going to publish research results.|2017-10-10 21:53:39.488515|2017-10-10 21:53:39.488515
NCT02871752|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-17|||December 2015||2015-12-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|REASSUREME||Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education|Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education|Recruiting||N/A|600|Anticipated|Northwestern University||2|||f||||f||||||||Undecided||2017-10-10 21:53:39.566721|2017-10-10 21:53:39.566721
NCT02871739|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-15|||July 2016||2016-07-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians|A Pilot Randomized Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians|Enrolling by invitation||N/A|40|Anticipated|Massachusetts General Hospital||4|||f||||f||||||||No||2017-10-10 21:53:39.7075|2017-10-10 21:53:39.7075
NCT02871726|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-15|||January 2016||2016-01-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Transrectal Ultrasound Robot-Assisted Prostate Biopsy||Recruiting||Early Phase 1|5|Anticipated|Johns Hopkins University||1|||f||||t||||||||No||2017-10-10 21:53:39.801215|2017-10-10 21:53:39.801215
NCT02871713|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-06-20|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||A Randomized Controlled Trial Comparing Intrathecal Morphine With Quadratus Lumborum Block for Post-cesarean Delivery Analgesia|A Randomized Controlled Trial Comparing Intrathecal Morphine With Quadratus Lumborum Block as Part of a Multimodal Analgesia Strategy for Post-cesarean Delivery Analgesia|Recruiting||N/A|76|Anticipated|Nova Scotia Health Authority||3|||f||||f|f|f||||||||2017-10-10 21:53:39.883838|2017-10-10 21:53:39.883838
NCT02871700|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-05-21|||August 2016||2016-08-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Comparative Efficacy Study of Action Observation Therapy and Mirror Therapy After Stroke|Comparative Efficacy Study of Action Observation Therapy and Mirror Therapy After Stroke: Rehabilitation Outcomes and Neural Mechanisms by MEG|Recruiting||N/A|90|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:53:39.969678|2017-10-10 21:53:39.969678
NCT02871687|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-14|||April 2016||2016-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Effect of Statin Use on Aldosterone Secretion|Effect of Statin Use on Aldosterone Secretion|Recruiting||Phase 1|67|Anticipated|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-10 21:53:40.288559|2017-10-10 21:53:40.288559
NCT02871674|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-01-31|||October 2016||2016-10-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Good Night Project: Behavioural Sleep Interventions for Children With ADHD: A Randomised Controlled Trial|Good Night Project: Behavioural Sleep Interventions for Children With ADHD: A Randomised Controlled Trial|Enrolling by invitation||N/A|60|Anticipated|University of Leeds||2|||f||||f||||||||||2017-10-10 21:53:40.404931|2017-10-10 21:53:40.404931
NCT02871648|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-14|||January 2016||2016-01-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production|The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production|Recruiting||Phase 1|20|Anticipated|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-10 21:53:40.687705|2017-10-10 21:53:40.687705
NCT02871635|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-10-03|||September 28, 2016|Actual|2016-09-28|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Non-inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity|Recruiting||Phase 3|286|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:53:40.828502|2017-10-10 21:53:40.828502
NCT02871622|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-15|||September 2016||2016-09-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM|A Post-market Registry of the BioMatrix Alpha TM (Cobalt Chromium Biolimus A9TM (BA9TM) Drug-eluting Stent)|Not yet recruiting||N/A|2000|Anticipated|Biosensors Europe SA|||1||f||||t||||||||No|Not planned|2017-10-10 21:53:41.168377|2017-10-10 21:53:41.168377
NCT02871609|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-15|||July 2016||2016-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Assessment of Longterm Ureteral Stenting|Longterm Ureteral Stenting: Assessment of Stent- Associated Morbidity, Associated Costs and Impact of Biofilms|Recruiting||N/A|85|Anticipated|Cantonal Hospital of St. Gallen|||1||f||||f||||||||No||2017-10-10 21:53:41.283047|2017-10-10 21:53:41.283047
NCT02871596|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-02-21|||August 2016||2016-08-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds|Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds - a Randomized, Placebo-controlled, Double-blind, Cross-over Study|Completed||N/A|27|Actual|Pharmanex||6|||f||||f||||||||No||2017-10-10 21:53:41.454259|2017-10-10 21:53:41.454259
NCT02871583|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-12|||December 2013||2013-12-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|||Effect of Inguinal Hernia Repair on Isokinetic Muscle Strength|The Evaluation of Trunk Muscle Strength, Quality of Life, and Neuropathic Pain Component After Two Different Inguinal Hernia Repair Techniques; A Prospective Controlled Trial|Completed||N/A|100|Actual|Konya Training and Research Hospital||3|||f||||f||||||||Yes||2017-10-10 21:53:41.618535|2017-10-10 21:53:41.618535
NCT02871570|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-05-03|||September 21, 2016|Actual|2016-09-21|May 2017|2017-05-01|March 23, 2017|Actual|2017-03-23|February 26, 2017|Actual|2017-02-26||Interventional|||A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function|A Phase 1, Non-randomized, Open-label, Parallel-group Single-dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Intravenous Rivipansel (Pf-06460031) In Subjects With Moderate Hepatic Impairment And In Healthy Subjects With Normal Hepatic Function|Completed||Phase 1|16|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 21:53:41.745957|2017-10-10 21:53:41.745957
NCT02871557|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-15|||January 2012||2012-01-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|January 2012|Actual|2012-01-01||Observational|SAFMACohort||Frailty and the Elderly in Martinique|Frail Elderly Subjects Martinique: Adverse Outcome After Hospitalisation in Geriatric Department|Completed||N/A|287|Actual|Société Martiniquaise de Gérontologie et Gériatrie|||1||f||||f||||||||No||2017-10-10 21:53:41.900183|2017-10-10 21:53:41.900183
NCT02871544|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-17|||June 2015||2015-06-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Predictive Value of Dynamic Combination of BNP and NGAL for the Prognosis of Patients With Sepsis|Predictive Value of Dynamic Combination of B-type Natriuretic Peptide and Neutrophil Gelatinase-associated Lipocalin for the Prognosis of Patients With Sepsis|Completed||N/A|124|Actual|Southeast University, China||4|||f||||t||||||||Undecided||2017-10-10 21:53:42.017111|2017-10-10 21:53:42.017111
NCT02871531|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-15|||November 2016||2016-11-01|August 2016|2016-08-01||||November 2019|Anticipated|2019-11-01||Interventional|||Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria|A Randomized Controlled Trial Comparing Pneumatic Retinopexy Versus Vitrectomy for the Management of Primary Retinal Detachment in Patients With Extended Criteria; Anatomical Success, Functional Success and Impact on Patient Quality of Life|Not yet recruiting||N/A|178|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 21:53:42.1409|2017-10-10 21:53:42.1409
NCT02871518|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-11-08|||August 2016||2016-08-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma|A Randomized Phase II Non-inferiority Study of Two Cycles Versus Three Cycles of Cisplatin Based Concurrent Chemoradiotherapy for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma Based on Pretreatment Plasma EBV DNA Level|Recruiting||Phase 2|236|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:53:42.296051|2017-10-10 21:53:42.296051
NCT02871505|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-18|||August 2016||2016-08-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||The Association Between Molecular Typing of Treponema Pallidum and Treatment Efficacy and Clinical Findings||Recruiting||Phase 4|150|Anticipated|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 21:53:42.409977|2017-10-10 21:53:42.409977
NCT02871284|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-08-12|||April 2016||2016-04-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|PIC||Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training|Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training|Recruiting||Phase 2/Phase 3|246|Anticipated|German Cancer Research Center||3|||f||||f||||||||Yes|Pooling Initiative with the STOP Trial|2017-10-10 21:53:44.485182|2017-10-10 21:53:44.485182
NCT02871479|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-10-04|||April 21, 2017|Actual|2017-04-21|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis|A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product, Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis|Active, not recruiting||Phase 2|72|Anticipated|Santalis Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:53:42.630037|2017-10-10 21:53:42.630037
NCT02871466|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-18|||January 2010||2010-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Stem Cells Therapy in Advanced Heart Failure|Intra Cardiac Autologous Stem Cells Infusion May Improve Clinical Outcomes in Failing Heart Subjects Refractory to Maximal Drug Therapy and Internal Cardioverter With a Defibrillator (ICD) Recipients|Completed||Phase 4|30|Actual|"University of Campania Luigi Vanvitelli"||1|||f||||t||||||||No||2017-10-10 21:53:42.74393|2017-10-10 21:53:42.74393
NCT02871453|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2017-01-10|||January 2015||2015-01-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluating the Therapeutic Effect of Scalp Acupuncture Treatment for Motor Dysfunction in Ischemic Stroke Patients|Scalp Acupuncture for Motor Dysfunction in Ischemic Stroke: a Randomized, Controlled Trial|Recruiting||N/A|116|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:53:42.816475|2017-10-10 21:53:42.816475
NCT02871440|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-08-15|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye|A Two Comparator, Controlled Phase 3 Study of OM3 Tear Formulation Versus OPTIVE ADVANCED Unit Dose and OPTIVE Unit Dose Eye Drops in Patients With and Without Evaporative Dry Eye.|Active, not recruiting||Phase 3|57|Actual|The University of New South Wales||3|||f||||f||||||||||2017-10-10 21:53:42.948105|2017-10-10 21:53:42.948105
NCT02871427|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-06-29|||August 2016||2016-08-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder|An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder|Enrolling by invitation||Phase 2|80|Anticipated|Axovant Sciences Ltd.||1|||f||||||||||||||2017-10-10 21:53:43.026092|2017-10-10 21:53:43.026092
NCT02871414|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-02-16|||July 2015||2015-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||REST: Restoring Effective Sleep Tranquility in College Veterans With Service-Related Injuries|REST: Restoring Effective Sleep Tranquility in College Veterans With Service-Related Injuries|Completed||N/A|24|Actual|Colorado State University||2|||f||||f||||||||Undecided||2017-10-10 21:53:43.138777|2017-10-10 21:53:43.138777
NCT02871401|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-17|||September 2016||2016-09-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)|A Phase One-B (1B) Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)|Not yet recruiting||Phase 1|30|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-10-10 21:53:43.221011|2017-10-10 21:53:43.221011
NCT02871388|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-20|||May 30, 2017|Actual|2017-05-30|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Addressing Modifiable Breast Cancer Risk Factors With Project CONECT|Addressing Modifiable Breast Cancer Risk Factors With Project CONECT [Connect Online to Engage Change Tool]|Recruiting||N/A|30|Anticipated|Virginia Commonwealth University||2|||f||||t|f|f||||||||2017-10-10 21:53:43.35955|2017-10-10 21:53:43.35955
NCT02871362|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-11-10|||January 2017||2017-01-01|August 2016|2016-08-01||||May 2017|Anticipated|2017-05-01||Interventional|||Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol: A Pilot Study|Not yet recruiting||N/A|54|Anticipated|InQpharm Group||2|||f||||f||||||||No||2017-10-10 21:53:43.559766|2017-10-10 21:53:43.559766
NCT02871349|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-08-03|||August 2016||2016-08-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response|Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response|Recruiting||Early Phase 1|96|Anticipated|University of Missouri-Columbia||2|||f||||||||||||||2017-10-10 21:53:43.648413|2017-10-10 21:53:43.648413
NCT02871336|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-12|||November 2014||2014-11-01|August 2016|2016-08-01||||November 2030|Anticipated|2030-11-01|5 Years|Observational [Patient Registry]|CHIRPAN||Pancreatic Surgical Database||Recruiting||N/A|1500|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||||2017-10-10 21:53:43.759072|2017-10-10 21:53:43.759072
NCT02871323|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-10|||September 2016||2016-09-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|November 2018|Anticipated|2018-11-01||Interventional|||Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis|A Phase 1, Single Arm, Single Center Pilot Study of Medi4736, an Anti-Pdl1 Therapy, for Patients With Myelofibrosis|Active, not recruiting||Phase 1|10|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 21:53:43.832927|2017-10-10 21:53:43.832927
NCT02871310|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-11-21|||February 2017||2017-02-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Vasoactive Effects of IQP-AS-118 in Healthy Individuals|Randomized, Double-Blind, Placebo-Controlled, Monocenter, Crossover Investigation to Evaluate the Vasoactive Effects of IQP-AS-118 in Healthy Individuals: A Pilot Study|Not yet recruiting||N/A|30|Anticipated|InQpharm Group||2|||f||||f||||||||No||2017-10-10 21:53:43.91986|2017-10-10 21:53:43.91986
NCT02871271|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-17|||November 2016||2016-11-01|July 2016|2016-07-01||||January 2017|Anticipated|2017-01-01||Interventional|||Tolerability and Benefit of IQP-AS-121 on Fatigue and Mental Alertness|Open-Label Pilot Study to Evaluate the Tolerability and Benefit of IQP-AS-121 on Fatigue and Mental Alertness in Healthy Subjects|Not yet recruiting||N/A|40|Anticipated|InQpharm Group||1|||f||||f||||||||No||2017-10-10 21:53:44.658596|2017-10-10 21:53:44.658596
NCT02871258|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-10-03|||September 2016||2016-09-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||MetaNeb® Chest X-ray Study|Evaluation of The MetaNeb® System to Reduce Atelectasis Assessed by Chest X-ray|Recruiting||N/A|15|Anticipated|Hill-Rom||1|||f||||f||||||||||2017-10-10 21:53:44.80186|2017-10-10 21:53:44.80186
NCT02871245|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-04-13|||September 21, 2016|Actual|2016-09-21|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery||Recruiting||N/A|120|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||||||||||Undecided||2017-10-10 21:53:44.93719|2017-10-10 21:53:44.93719
NCT02871232|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-24||||||August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Observational|||Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers|Extended-Release (ER) and Long-Acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS): RADARS® System Surveillance Protocol|Enrolling by invitation||N/A|26500|Anticipated|ER/LA Opioid REMS Program Companies (RPC)|||2||f||||||||||||||2017-10-10 21:53:45.070765|2017-10-10 21:53:45.070765
NCT02871219|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-05-17|||December 6, 2016|Actual|2016-12-06|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Obinutuzumab and Lenalidomide in Previously Untreated Subjects With Follicular Lymphoma|A Phase II Study of Obinutuzumab and Lenalidomide in Previously Untreated Subjects With Follicular Lymphoma|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 21:53:45.160225|2017-10-10 21:53:45.160225
NCT02871206|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-01-06|||November 2016||2016-11-01|January 2017|2017-01-01||||December 2019|Anticipated|2019-12-01||Interventional|||Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children|A Randomized Controlled Trial of Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children|Recruiting||Phase 4|2500|Anticipated|McMaster University||2|||f||||||||||||||2017-10-10 21:53:45.29482|2017-10-10 21:53:45.29482
NCT02871193|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2017-02-08|||June 1, 2016|Actual|2016-06-01|February 2017|2017-02-01|January 20, 2017|Actual|2017-01-20|October 8, 2016|Actual|2016-10-08||Interventional|||Ultrasound-guided Thoracic Paravertebral Block Using Ropivacaine With/Without Dexamethasone in Elective Thoracotomy|Study of Ultrasound-guided Thoracic Paravertebral Block Using Ropivacaine With/Without Dexamethasone in Elective Thoracotomy|Completed||N/A|68|Actual|The First Affiliated Hospital of Anhui Medical University||3|||f||||t||||||||||2017-10-10 21:53:45.423876|2017-10-10 21:53:45.423876
NCT02871180|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-15|||March 2003||2003-03-01|August 2016|2016-08-01||||August 2016|Actual|2016-08-01||Interventional|||Late Night Snack and Insulin Glargine|A Late Night Snack May be Necessary to Prevent Nocturnal Hyperglycemia in Type 1-diabetic Patients Using Insulin Glargine (LANTUS)|Completed||N/A|20|Actual|Diabeteszentrum Bad Lauterberg im Harz||2|||f||||f||||||||No||2017-10-10 21:53:45.547043|2017-10-10 21:53:45.547043
NCT02871167|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-01-11|||December 2016||2016-12-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|CHACRY-1501||Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation|Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)|Recruiting||N/A|120|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||No||2017-10-10 21:53:45.661884|2017-10-10 21:53:45.661884
NCT02871154|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2016-08-17|||January 2017||2017-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DelOPU||Extending the hCG OPU Interval|Extending the Time Period Between the Injection of Chorionic Gonadotropin and Oocyte Pick-up as a Solution to Low Rate of Mature Oocyte and Poor Results in Assisted Reproduction|Not yet recruiting||N/A|20|Anticipated|The Baruch Padeh Medical Center, Poriya||1|||f||||f||||||||Yes|Study results|2017-10-10 21:53:45.773835|2017-10-10 21:53:45.773835
NCT02871141|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-17|||September 2016||2016-09-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01|6 Months|Observational [Patient Registry]|||Multimodal Imaging of ECT Effects|Effects of Electroconvulsive Therapy on Neuronal, Immunological and Hormonal Parameters in Patients With Affective Disorders|Not yet recruiting||N/A|160|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||Samples Without DNA|"     whole blood   "|No||2017-10-10 21:53:45.848217|2017-10-10 21:53:45.848217
NCT02871128|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2016-08-15|||July 2015||2015-07-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Evaluation of Natureheme-iron on Iron Absorption Effect and Anti-oxidation Functions|Evaluation of Natureheme-iron on Iron Absorption Effect and Anti-oxidation Functions- a Double-blind, Randomized, Placebo-controlled Trial|Enrolling by invitation||N/A|60|Anticipated|Chung Shan Medical University||3|||f||||t||||||||||2017-10-10 21:53:45.939906|2017-10-10 21:53:45.939906
NCT02871115|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-13|2017-04-20|||January 2017||2017-01-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Pilot Study of a Pharmacy Intervention for Older Adults With Cancer|Pilot Study of a Pharmacy Intervention for Older Adults With Cancer|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 21:53:46.055703|2017-10-10 21:53:46.055703
NCT02871102|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-20|||August 2016||2016-08-01|September 2017|2017-09-01||||June 2018|Anticipated|2018-06-01||Interventional|||Stress Index to Individualize Mechanical Ventilation in ARDS|Right-Sizing Tidal Volume in ARDS: Using the Stress Index to Optimize Mechanical Ventilation to Individual Respiratory Mechanics|Recruiting||N/A|10|Anticipated|Vanderbilt University Medical Center||1|||f||||t||||||||||2017-10-10 21:53:46.166482|2017-10-10 21:53:46.166482
NCT02871089|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-05-04|||January 2017||2017-01-01|May 2017|2017-05-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|CLOuD||Closed Loop From Onset in Type 1 Diabetes|An Open-label, Multicentre, Randomised, Single-period, Parallel Design Study to Assess the Effect of Closed Loop Insulin Delivery From Onset of Type 1 Diabetes in Youth on Residual Beta Cell Function Compared to Standard Insulin Therapy|Recruiting||Phase 2|96|Anticipated|University of Cambridge||2|||f||||t||||||||||2017-10-10 21:53:46.280375|2017-10-10 21:53:46.280375
NCT02871076|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-12|||September 2016||2016-09-01|August 2016|2016-08-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Acupuncture for Post-Traumatic Stress in Combat Veterans|Acupuncture for Post-Traumatic Stress in Combat Veterans|Not yet recruiting||N/A|90|Anticipated|Southern California Institute for Research and Education||2|||f||||t||||||||||2017-10-10 21:53:46.429447|2017-10-10 21:53:46.429447
NCT02871063|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-10-02|||August 1, 2016|Actual|2016-08-01|October 2017|2017-10-01|October 1, 2016|Actual|2016-10-01|September 1, 2016|Actual|2016-09-01|2 Years|Observational [Patient Registry]|||Effect of Altitude on the Evolution of Acute Respiratory Distress Syndrome||Completed||N/A|170|Actual|Red Latinoamericana de Medicina Intensiva de Altura|||2||f||||||||||||||2017-10-10 21:53:46.507706|2017-10-10 21:53:46.507706
NCT02871050|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-15|2017-07-12|||June 2016||2016-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|"Castlebank"||Castleman Disease Collaborative Network Biobank|The Castleman Disease Collaborative Network Biobank: A Collection of Biospecimens and Clinical Data to Facilitate Research|Recruiting||N/A|200|Anticipated|Castleman Disease Collaborative Network|||1||f||||t||||||Samples With DNA|"     Lymph node and/or bone marrow slides and/or tissue blocks, saliva, whole blood, and serum     will be collected both prospectively and retrospectively.   "|||2017-10-10 21:53:46.57078|2017-10-10 21:53:46.57078
NCT02871037|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-06-20|||August 12, 2016|Actual|2016-08-12|June 2017|2017-06-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|||Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects|A Phase 1, 3-part Study Of Pf-05221304 In Healthy Adults: Part 1 - Randomized, Double-blind, Placebo-controlled Assessment Of Safety And Pharmacokinetics Of Single, Escalating, Oral Doses; Part 2 - Randomized, Double-blind, Placebo-controlled Assessment Of Safety And Pharmacokinetics Of Repeated, Escalating, Oral Doses; Conditional Part 3 - Effect Of Food On The Pharmacokinetics Of Pf-05221304|Completed||Phase 1|96|Actual|Pfizer||7|||f||||f||||||||||2017-10-10 21:53:46.672829|2017-10-10 21:53:46.672829
NCT02871024|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2018|Anticipated|2018-08-01||Interventional|||Efficacy of Polymyxin B Hemoperfusion on Severe Sepsis Secondary to Pneumonia or Urinary Tract Infection|Efficacy of Polymyxin B Hemoperfusion on Severe Sepsis Secondary to Pneumonia or Urinary Tract Infection: A Single-arm Clinical Trial|Recruiting||Phase 2|20|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:53:46.77879|2017-10-10 21:53:46.77879
NCT02871011|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|||Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot|A Blinded Placebo Controlled Clinical Trial To Evaluate Fungicidal Activity With The Topical Application Of Nitric Oxide Releasing Solution (Nors) In Subjects With Moderate To Severe Tinea Pedis (Athlete's Foot)|Recruiting||Phase 2|60|Anticipated|Nitric Solutions Inc.||2|||f||||f||||||||Undecided||2017-10-10 21:53:46.871332|2017-10-10 21:53:46.871332
NCT02870998|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-03-01|||June 2016||2016-06-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Impacts of a Continuing Education Activity Targeted at COPD Case Managers|Comparing the Impacts of Two Versions of a Continuing Education Activity Targeted at COPD Case Managers on Educational Outcomes|Recruiting||N/A|300|Anticipated|Laval University||2|||f||||f||||||||Yes|The datasets during and/or analysed during the current study will be available from the principal investigator on reasonable request.|2017-10-10 21:53:46.959543|2017-10-10 21:53:46.959543
NCT02870985|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-17|||July 2015||2015-07-01|August 2016|2016-08-01||||September 2021|Anticipated|2021-09-01||Interventional|BIOFLOW-VI||BIOTRONIK Orsiro Pre-Marketing Registration|BIOTRONIK-Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With de Novo Coronary Artery Lesions-VI|Recruiting||Phase 3|440|Anticipated|Biotronik (Beijing) Medical Device Ltd.||2|||f||||t||||||||No||2017-10-10 21:53:47.031696|2017-10-10 21:53:47.031696
NCT02870972|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-04-17|||August 2016||2016-08-01|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|APeX-1||Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema|A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel-group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BCX7353 as a Preventative Treatment to Reduce the Frequency of Attacks in Subjects With Hereditary Angioedema|Recruiting||Phase 2|70|Anticipated|BioCryst Pharmaceuticals||5|||f||||t||||||||Yes||2017-10-10 21:53:47.121231|2017-10-10 21:53:47.121231
NCT02870959|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-08-29|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:53:47.26689|2017-10-10 21:53:47.26689
NCT02870946|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-12|||August 2016||2016-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Simultaneous Renal Replacement Therapy on Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock Patients||Recruiting||N/A|262|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||||2017-10-10 21:53:47.302252|2017-10-10 21:53:47.302252
NCT02870933|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-09-13|||January 2016||2016-01-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation in Patient Following CABG Surgery|The Effect of Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation to Myocardial Perfusion in Patient Following Coronary Artery Bypass Grafting|Recruiting||Phase 4|30|Anticipated|National Cardiovascular Center Harapan Kita Hospital Indonesia||2|||f||||t||||||||||2017-10-10 21:53:47.398148|2017-10-10 21:53:47.398148
NCT02870920|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-06-29|||August 10, 2016|Actual|2016-08-10|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care Alone in Patients With Advanced Colorectal Adenocarcinoma Refractory to Standard Therapies|A Phase II Randomized Study of Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care Alone in Patients With Advanced Colorectal Adenocarcinoma Refractory to Standard Therapies|Active, not recruiting||Phase 2|179|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-10 21:53:47.52159|2017-10-10 21:53:47.52159
NCT02870907|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-12|||March 2010||2010-03-01|July 2016|2016-07-01|September 2026|Anticipated|2026-09-01|March 2026|Anticipated|2026-03-01||Interventional|||Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)|Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated|Recruiting||Phase 2|125|Anticipated|Institut Curie||4|||f||||t||||||||No||2017-10-10 21:53:47.705195|2017-10-10 21:53:47.705195
NCT02870894|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Electrical Impedance Tomography for Quantification of Pulmonary Edema in Acute Respiratory Distress Syndrome Patients||Recruiting||N/A|22|Anticipated|Sichuan Provincial People's Hospital|||1||f||||t||||||||||2017-10-10 21:53:47.993667|2017-10-10 21:53:47.993667
NCT02870881|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-08-29|||August 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:53:48.058234|2017-10-10 21:53:48.058234
NCT02870868|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-07-18|||September 2016||2016-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Breathing Interventions for Relaxation: Dosing Through Extended Exhale||Recruiting||N/A|100|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 21:53:49.719335|2017-10-10 21:53:49.719335
NCT02870842|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-08-23|||September 2016||2016-09-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Fraction of Inspired Oxygen and Atelectasis in Children|Effects of Fraction of Inspired Oxygen on Atelectasis in Mechanically Ventilated Children|Completed||N/A|86|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 21:53:49.878511|2017-10-10 21:53:49.878511
NCT02870829|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-10-02|||July 2016|Actual|2016-07-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|TReVasc-HDK||Treatment to Reduce Vascular Calcification In Hemodialysis Patients Using Vitamin K|Treatment to Reduce Vascular Calcification In Hemodialysis Patients Using Vitamin K|Active, not recruiting||Phase 2|178|Actual|National University Health System, Singapore||2|||f||||t||||||||||2017-10-10 21:53:49.966813|2017-10-10 21:53:49.966813
NCT02870816|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2016-08-16|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Prospective, Comparitive, Randomized Study of Allograft Versus Skin Substitute in Non-healing Diabetic Foot Ulcers|A Prospective, Randomized, Multi-Center Comparative Study of Amniotic Membrane Wound Graft Application Versus Tissue Engineered Skin Substitute in the Management of Non Healing Diabetic Foot Ulcers|Recruiting||N/A|60|Anticipated|Professional Education and Research Institute||2|||f||||f||||||||No||2017-10-10 21:53:50.065101|2017-10-10 21:53:50.065101
NCT02870803|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-04-21|||July 2016||2016-07-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Observational|||OCT-angiography in Diabetic Patients|OCT-angiography in Diabetic Patients: Qualitative Changes of the Intermediate and Deep Capillary Plexuses After Resolution of Macular Edema by Intravitreal Pharmacotherapy|Recruiting||N/A|20|Anticipated|Retina Clinic, Sao Paulo, Brazil|||1||f||||t||||||||No||2017-10-10 21:53:50.166376|2017-10-10 21:53:50.166376
NCT02870790|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-14|2017-09-08|||March 2016||2016-03-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|EPIC-NSW||Expanded PrEP Implementation in Communities in NSW|Impact of the Rapid Expansion of Pre-exposure Prophylaxis (PrEP) on HIV Incidence, in a Setting With High HIV Testing and Antiretroviral Treatment Coverage, to Achieve the Virtual Elimination of HIV Transmission by 2020: a NSW HIV Strategy Implementation Project|Recruiting||Phase 3|3700|Anticipated|Kirby Institute||1|||f||||t||||||||||2017-10-10 21:53:50.259007|2017-10-10 21:53:50.259007
NCT02870764|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-13|2016-09-11|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|DOLPHIN||The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris|A Randomized, Double-blind, Placebo-controlled Trial of Dan-shen Extract in Patients With Stable Angina Pectoris|Recruiting||Phase 4|156|Anticipated|Taizhou Fourth People's Hospital||2|||f||||t||||||||Undecided|We could provide individual participant data without leaking the patients' personal information if needed.|2017-10-10 21:53:50.710261|2017-10-10 21:53:50.710261
NCT02870751|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-13|2016-08-22|||May 2016||2016-05-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ETECvacWP2||Human Challenge Model With ST-only Enterotoxigenic Escherichia Coli|Developing A Human Challenge Model For Evaluating Vaccines Against ST-producing Enterotoxigenic Escherichia Coli|Recruiting||Phase 1|30|Anticipated|University of Bergen||1|||f||||t||||||||Yes|Data and samples may be shared with current and future partners|2017-10-10 21:53:50.849801|2017-10-10 21:53:50.849801
NCT02870738|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-09-15|||April 21, 2017|Actual|2017-04-21|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Bladder Directed vs. Pelvic Floor Therapy in IC/BPS|Comparison of Bladder Directed and Pelvic Floor Therapy in Women With Interstitial Cystitis/Bladder Pain Syndrome|Recruiting||Phase 2|128|Anticipated|William Beaumont Hospitals||2|||f||||f|t|f|||f|||||2017-10-10 21:53:50.957903|2017-10-10 21:53:50.957903
NCT02870725|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-07-03|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|June 22, 2017|Actual|2017-06-22||Interventional|||CBT Depression Intervention for Co-Occurring Chronic Headache|A Cognitive Behavioral Therapy (CBT) Depression Intervention in Persons With Co-Occurring Chronic Headache|Completed||N/A|22|Actual|University of Georgia||2|||f||||f||||||||||2017-10-10 21:53:51.092264|2017-10-10 21:53:51.092264
NCT02870712|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-12|||October 2016||2016-10-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ImSOLENCE||Randomized Controlled Trial of the Effectiveness of Perineal Pain and Security of the Suture Led by the Result of Hemostasis Versus Manual Compression Routine Suture Perineal Tears of First Degree During Childbirth|Randomized Controlled Trial of the Effectiveness of Perineal Pain and Security of the Suture Led by the Result of Hemostasis Versus Manual Compression Routine Suture Perineal Tears of First Degree During Childbirth, ImSOLENCE Study|Not yet recruiting||Phase 2|112|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||Undecided||2017-10-10 21:53:51.225521|2017-10-10 21:53:51.225521
NCT02870686|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-13|2016-12-13|||May 2013||2013-05-01|June 2016|2016-06-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||EUS Guided ERCP in Bile Duct Stone Removal|A Prospective Randomized Trial Comparing EUS Guided ERCP Without Fluoroscopy With Standard ERCP in Common Bile Duct Stone Removal|Completed||N/A|114|Actual|Prince of Songkla University||2|||f||||t||||||||No|The individual data of patients participating in the study are not available for public sharing since we did not obtain the consent to share the data of patient|2017-10-10 21:53:51.453969|2017-10-10 21:53:51.453969
NCT02870673|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-18|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome|Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome|Not yet recruiting||Phase 2/Phase 3|72|Anticipated|Taipei Medical University Hospital||3|||f||||f||||||||No||2017-10-10 21:53:51.568966|2017-10-10 21:53:51.568966
NCT02870660|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-13|||August 2016||2016-08-01|August 2016|2016-08-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01|5 Years|Observational [Patient Registry]|||Familial Hypercholesterolemia Amongst Patients With Acute Coronary Syndrome|Identification of Familial Hypercholesterolemia Amongst Patients With Premature Acute Coronary Syndrome, Follow-up and Treatment|Recruiting||N/A|500|Anticipated|Isfahan University of Medical Sciences|||1||f||||||||||Samples With DNA|"     Plasma, buffy coat, blood.   "|||2017-10-10 21:53:51.676495|2017-10-10 21:53:51.676495
NCT02870647|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-12|||November 2016||2016-11-01|July 2016|2016-07-01|March 2020|Anticipated|2020-03-01|June 2019|Anticipated|2019-06-01||Interventional|SYNCHRO||Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure Patients|Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure Patients|Not yet recruiting||Phase 4|302|Anticipated|LivaNova||1|||f||||f||||||||||2017-10-10 21:53:51.761964|2017-10-10 21:53:51.761964
NCT02870634|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-03-06|||October 2016||2016-10-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND|A Phase 1 Single and Multiple Dose Escalation and Pharmacokinetic Study of Cu(II)ATSM Administered Orally to Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease|Recruiting||Phase 1|50|Anticipated|Collaborative Medicinal Development Pty Limited||1|||f||||t||||||||Undecided||2017-10-10 21:53:51.849485|2017-10-10 21:53:51.849485
NCT02870621|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-12|||July 2012||2012-07-01|July 2016|2016-07-01||||September 2016|Anticipated|2016-09-01||Observational|||Volume of Perirenal Fat and Chronic Kidney Disease||Recruiting||N/A|12|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 21:53:51.959863|2017-10-10 21:53:51.959863
NCT02870608|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-12|||April 2016||2016-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Interventional|ELASTOMAP||Interest of Measuring Lung Elasticity ELASTOgraphy in the Fetus in the Case of PreMAture Childbirth Threat|Interest of Measuring Lung Elasticity ELASTOgraphy in the Fetus in the Case of PreMAture Childbirth Threat|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||No||2017-10-10 21:53:52.049151|2017-10-10 21:53:52.049151
NCT02870595|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-12|||June 2014||2014-06-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Use of Micro Vibratory Stimulation Technique to Control the Pain of Digit Block Anesthesia|The Use of Micro Vibratory Stimulation Technique to Control the Pain of Digit Block Anesthesia|Completed||N/A|25|Actual|Christus Spohn Memorial Medical Center||2|||f||||f||||||||Yes|Data to be published|2017-10-10 21:53:52.149029|2017-10-10 21:53:52.149029
NCT02870556|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-12|||September 2016||2016-09-01|August 2016|2016-08-01||||September 2018|Anticipated|2018-09-01||Interventional|||Effect of Cervical Epidural Analgesia on the Occurrence of Pharyngocutaneous Fistula|Effect of Cervical Epidural Analgesia on the Occurrence of Pharyngocutaneous Fistula Following Salvage Laryngectomy and Reconstruction With Pectoralis Major Myocutaneous Flap|Not yet recruiting||N/A|46|Anticipated|Assiut University||2|||f||||f||||||||Undecided||2017-10-10 21:53:53.584938|2017-10-10 21:53:53.584938
NCT02870543|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-12|||September 2014||2014-09-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy of Phytolacca Decandra and Melissa Officinalis in Children With Nocturnal Bruxism|Efficacy of Phytolacca Decandra and Melissa Officinalis in Children With Nocturnal Bruxism: a Controlled and Randomized Clinical Trial|Active, not recruiting||Phase 3|52|Anticipated|Universidade Federal do Rio de Janeiro||4|||f||||t||||||||Undecided||2017-10-10 21:53:53.883832|2017-10-10 21:53:53.883832
NCT02870530|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Division-less Gastric Bypass, Step to Decrease Cost and Early Nightmare of Bariateric Surgery|Division-less Gastric Bypass, True Mini Gastric Bypass, Step to Decrease Cost and Early Nightmare of Bariateric Surgery|Recruiting||Phase 2|50|Anticipated|Minia University||2|||f||||t||||||||Undecided||2017-10-10 21:53:54.030206|2017-10-10 21:53:54.030206
NCT02870517|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-01-06|||November 2016||2016-11-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pre-operative Stress Reduction With Music|The Effect of Music on Pre-operative Stress in Pediatric Orthopedic Patients|Recruiting||N/A|212|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||No||2017-10-10 21:53:54.171589|2017-10-10 21:53:54.171589
NCT02870504|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-09-11|||July 2016||2016-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Study of LPI on Different Sites of Iris|Clinical Study of Laser Peripheral Iridoplasty on Different Sites of Iris|Active, not recruiting||N/A|60|Anticipated|First Affiliated Hospital of Fujian Medical University||3|||f||||t||||||||Undecided||2017-10-10 21:53:54.284825|2017-10-10 21:53:54.284825
NCT02870491|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-11-17|||August 2016||2016-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Working With Community Health Workers to Increase ORS Use in Uganda|Working With Community Health Workers to Increase Oral Rehydration Salt and Zinc Use to Treat Child Diarrhea in Uganda: A Cluster Randomized Controlled Trial|Active, not recruiting||N/A|9600|Anticipated|University of California, Berkeley||4|||f||||f||||||||Yes|Data will be made available to the public after the results are published|2017-10-10 21:53:54.399149|2017-10-10 21:53:54.399149
NCT02870478|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-05-04|||July 2016||2016-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effects of Low Concentration Atropine on Pupil Size and Accommodation|A Study of Time and Dose-dependent Effect of Low Concentration Atropine on Accommodation and Pupil Size|Active, not recruiting||Phase 3|40|Anticipated|University of California, Berkeley||4|||f||||f||||||||Undecided||2017-10-10 21:53:54.506254|2017-10-10 21:53:54.506254
NCT02870465|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-05-04|||September 2016||2016-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Hand K-wire Infections in Operating Room Versus Ambulatory Setting|K-wire Infections in Operating Room Sterility Versus Ambulatory Setting Field Sterility: A Prospective Cohort Study|Recruiting||N/A|1040|Anticipated|Horizon Health Network|||2||f||||f||||||||No|Patient information will be recorded using a corresponding number based on their order of presentation. The data will be presented or published as an average of all patients in the study.|2017-10-10 21:53:54.596196|2017-10-10 21:53:54.596196
NCT02870452|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||November 2016||2016-11-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PSY_HaEMOPEQ||Effectiveness of Psychological Interventions in Haemophilia|Effectiveness of Two Psychological Interventions for Prevention and Management of Pain, Emotional Regulation and Promotion of Quality of Life in People With Haemophilia: a Randomized Controlled Trial|Not yet recruiting||N/A|66|Anticipated|University of Minho||3|||f||||f||||||||No||2017-10-10 21:53:54.745991|2017-10-10 21:53:54.745991
NCT02870439|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-16|||October 2012||2012-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|HIF||Testing an Innovative Biomarker: Expression of HIF-1α and Its Isoforms in the Blood and Skin Tissue of Major Burns||Recruiting||N/A|45|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||No||2017-10-10 21:53:54.892979|2017-10-10 21:53:54.892979
NCT02870426|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-04|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2023|Anticipated|2023-07-01|June 2021|Anticipated|2021-06-01||Observational|||Collection and Characterisation of Human Olfactory Ensheathing Cells|Collection and Characterisation of Human Olfactory Ensheathing Cells|Not yet recruiting||N/A|50|Anticipated|St George's, University of London|||1||f||||f||||||Samples Without DNA|"     Cells and tissue from olfactory ensheathing cells   "|||2017-10-10 21:53:54.980914|2017-10-10 21:53:54.980914
NCT02870413|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-26|||October 2016||2016-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Expanding Rural Access to Breastfeeding Support Via Telehealth: The Tele-MILC Trial||Recruiting||N/A|200|Anticipated|RAND||2|||f||||f||||||||||2017-10-10 21:53:55.079153|2017-10-10 21:53:55.079153
NCT02870400|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-02-16|||July 2016||2016-07-01|February 2017|2017-02-01|January 12, 2017|Actual|2017-01-12|January 12, 2017|Actual|2017-01-12||Interventional|||A Study to Examine the Safety and Tolerability of Single Ascending Doses of REGN2477|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Intravenously and Subcutaneously Administered REGN2477 in Healthy Women Not of Childbearing Potential|Completed||Phase 1|41|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 21:53:55.159896|2017-10-10 21:53:55.159896
NCT02870387|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-12-02|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Inpatient Consultation for High-Risk Chronically Ill Children Receiving Care in an Enhanced Medical Home|Inpatient Consultation for High-Risk Chronically Ill Children Receiving Care in an Enhanced Medical Home: a Pilot Quality Improvement Study|Recruiting||N/A|180|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-10-10 21:53:55.236242|2017-10-10 21:53:55.236242
NCT02870374|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-12|||January 2012||2012-01-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|March 2015|Actual|2015-03-01||Observational|ReTransQol||For a Better Interpretation of Quality of Life Scores of Kidney Transplant Patients: Determination of the Minimum Significant Change RetransQol||Active, not recruiting||N/A|2000|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||No||2017-10-10 21:53:55.340484|2017-10-10 21:53:55.340484
NCT02870361|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-06-07|||August 2016||2016-08-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Influence of Central Nervous Insulin Sensitivity on Insulin Secretion|Einfluss Der zentralnervösen Insulinsensitivität Auf Die Insulinsekretion|Recruiting||N/A|20|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||No||2017-10-10 21:53:55.409175|2017-10-10 21:53:55.409175
NCT02870348|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)|A Multi-Center, Open-Label Study to Evaluate the Long-term Safety of Weekly Intravenous Infusions of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency|Enrolling by invitation||Phase 1/Phase 2|3|Anticipated|Grifols Therapeutics Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:53:55.499|2017-10-10 21:53:55.499
NCT02869958|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-09-04|||November 3, 2016|Actual|2016-11-03|August 2017|2017-08-01|May 13, 2019|Anticipated|2019-05-13|May 13, 2019|Anticipated|2019-05-13||Interventional|PANAME||Digital Action Plan for Asthma Attacks|Digital Action Plan for Asthma Exacerbations (PANAME)|Recruiting||N/A|510|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 21:53:59.106379|2017-10-10 21:53:59.106379
NCT02870335|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-06-24|||August 2016||2016-08-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|MTPNFHockeyP||Manual Therapy and Proprioceptive Neuromuscular Facilitation in Field Hockey Players.|Effectiveness of a Protocol Manual Therapy and Proprioceptive Neuromuscular Facilitation in Field Hockey Players.|Completed||N/A|47|Actual|University of Valencia||2|||f||||f||||||||No||2017-10-10 21:53:55.57652|2017-10-10 21:53:55.57652
NCT02870322|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-12|||July 2016||2016-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|FAVORx||Fruit And Vegetable Or Recreation Prescriptions for UW-Madison Students|Measuring the Feasibility of Fruit and Vegetable or Recreation Prescriptions Among UW-Madison Students|Recruiting||N/A|30|Anticipated|University of Wisconsin, Madison||3|||f||||f||||||||No||2017-10-10 21:53:55.653332|2017-10-10 21:53:55.653332
NCT02870309|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-06-30|||January 2016||2016-01-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Safety and Pharmacokinetics of Alpha-1 MP in Patients With Alpha1-Antitrypsin Deficiency|Phase I/II Multicenter, Open-label Trial to Evaluate the Safety and Pharmacokinetics of Alpha-1 MP in Patients With Alpha1-Antitrypsin Deficiency|Completed||Phase 1/Phase 2|4|Actual|Grifols Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 21:53:55.736139|2017-10-10 21:53:55.736139
NCT02870296|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-21|||August 2016||2016-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Anticoagulation Medical Home|Anticoagulation Medical Home for High-Risk Patients With Venous Thromboembolism: Patient Education, Anticoagulant Decision-Making, and Patient Self-Efficacy in the Home Coordinated by the UMass Anticoagulation Team|Enrolling by invitation||N/A|200|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-10 21:53:55.80866|2017-10-10 21:53:55.80866
NCT02870283|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-08-12|||May 2010||2010-05-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional|||Cost- Effectiveness and Quality of Life Assessment in Mood Disorder|Assessment of Cost- Effectiveness Interventions and the Quality of Life in Patients With Mood Disorders Through Resources Available in Brazilian Public Health|Completed||Phase 4|107|Actual|Federal University of Rio Grande do Sul||3|||f||||t||||||||No||2017-10-10 21:53:55.880991|2017-10-10 21:53:55.880991
NCT02870270|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-18|||January 2008||2008-01-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Prospective Studies on Oral Health and Quality of Life in Head and Neck Cancer Patients|Prospective Studies on Saliva, Microflora, Diet, Oral Status and Quality of Life in Subjects Undergoing Radiation Therapy in the Head and Neck Region|Completed||N/A|33|Actual|Göteborg University|||1||f||||f||||||Samples With DNA|"     Minor salivary gland secretion, stimulated whole saliva   "|No||2017-10-10 21:53:55.954267|2017-10-10 21:53:55.954267
NCT02870244|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-19|||February 2015||2015-02-01|August 2016|2016-08-01|September 2028|Anticipated|2028-09-01|September 2028|Anticipated|2028-09-01||Interventional|||Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes|Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes: A Phase 1b Study|Recruiting||Phase 1|18|Anticipated|Loyola University||1|||f||||t||||||||Undecided||2017-10-10 21:53:56.105207|2017-10-10 21:53:56.105207
NCT02870231|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-09-08|||August 18, 2016|Actual|2016-08-18|September 2017|2017-09-01|September 3, 2017|Actual|2017-09-03|September 3, 2017|Actual|2017-09-03||Interventional|||Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity|A Multiple Dose Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity|Completed||Phase 1|187|Actual|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 21:53:56.186584|2017-10-10 21:53:56.186584
NCT02870218|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-28|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|DUAL||Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use|Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use|Not yet recruiting||Phase 2|320|Anticipated|Rose Research Center, LLC||5|||f||||f|t|f|||f|||||2017-10-10 21:53:56.262018|2017-10-10 21:53:56.262018
NCT02870205|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-05-03|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|GSP 301-304||Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)|A Double-Blind, Randomized, Parallel-Group Seasonal Allergic Rhinitis (SAR) Study to Evaluate the Efficacy, Safety and Tolerability of GSP 301 Nasal Spray Compared With Placebo Nasal Spray and Individual Monotherapy Formulations (Olopatadine Hydrochloride Nasal Spray and Mometasone Furoate Nasal Spray) in Adult and Adolescent Subjects (12 Years of Age and Older)|Completed||Phase 3|1176|Actual|Glenmark Specialty S.A.||4|||f||||||||||||||2017-10-10 21:53:56.362495|2017-10-10 21:53:56.362495
NCT02870192|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-12|||January 2017||2017-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||Intra-operative Adverse Events During Laparoscopic Ventral Mesh Rectopexy|Intra-operative Adverse Events During Laparoscopic Ventral Mesh Rectopexy|Not yet recruiting||N/A|200|Anticipated|University of Rome Tor Vergata||1|||f||||t||||||||Undecided||2017-10-10 21:53:56.626548|2017-10-10 21:53:56.626548
NCT02870179|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-04-19|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry|Oxitone Sp02 Hypoxia Test Versus Reference Pulse Oximetry|Completed||N/A|11|Actual|Oxitone Medical Ltd.|||1||f||||f||||||||||2017-10-10 21:53:56.707886|2017-10-10 21:53:56.707886
NCT02870166|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||July 2012||2012-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|GENEZINC||Genetic Study of Severe Zinc Deficiencies|Genetic Study Explanatory Severe Zinc Deficiencies : Multicenter, Genetics, Controlled and Prospective Study|Completed||N/A|96|Actual|Nantes University Hospital|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-10 21:53:56.80502|2017-10-10 21:53:56.80502
NCT02870153|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||January 2013||2013-01-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer|A Randomized Phase II Study of Oxaliplatin and S-1 (SOX) Versus Oxaliplatin and Capecitabine (XELOX) in Patients With Peritoneal Metastasis of Colorectal Cancer|Recruiting||Phase 2|60|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||Yes||2017-10-10 21:53:56.885367|2017-10-10 21:53:56.885367
NCT02870140|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-07-21|||October 21, 2016|Actual|2016-10-21|July 2017|2017-07-01|July 3, 2020|Anticipated|2020-07-03|July 3, 2018|Anticipated|2018-07-03||Interventional|TALENT||Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent|A Prospective Multicenter Randomized Post Market All-comer Trial to Assess the Safety and Effectiveness of the SUPRAFLEX Sirolimus-eluting Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)|Active, not recruiting||N/A|1430|Anticipated|ECRI bv||2|||f||||t||||||||||2017-10-10 21:53:57.585461|2017-10-10 21:53:57.585461
NCT02870127|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-17|||March 2013||2013-03-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Clinical Investigation and Molecular Forms of Family Disease of Varicose|Genetic Study of Varicose Disease by Sequencing Exome|Recruiting||N/A|340|Anticipated|Nantes University Hospital|||1||f||||f||||||Samples With DNA|"     blood samples and venous tissues of patients   "|Undecided||2017-10-10 21:53:57.736167|2017-10-10 21:53:57.736167
NCT02870114|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-05-23|||September 2016||2016-09-01|May 2017|2017-05-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Observational|||National Survey of People With Haemophilia in Portugal|Sociodemographic, Clinic and Psychosocial Aspects of People With Haemophilia in Portugal: a National Survey|Completed||N/A|146|Actual|University of Minho|||1||f||||f||||||||No||2017-10-10 21:53:57.826949|2017-10-10 21:53:57.826949
NCT02870101|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-16|||April 10, 2017|Actual|2017-04-10|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|pNAAT||Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT|Performance of Nucleic Acid Amplification Tests for the Detection of Neisseria Gonorrhoeae and Chlamydia Trachomatis in Extragenital Sites|Recruiting||N/A|2500|Anticipated|Duke University||8|||f||||f|f|t|f|f|f|||||2017-10-10 21:53:57.916335|2017-10-10 21:53:57.916335
NCT02870088|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-08-11|||July 2014||2014-07-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Effect of Breaking Prolonged Sitting on Adipose Tissue and Metabolism||Completed||N/A|11|Actual|University of Bath||2|||f||||f||||||||Undecided||2017-10-10 21:53:58.08358|2017-10-10 21:53:58.08358
NCT02870075|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-08-11|||May 2013||2013-05-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|October 2014|Actual|2014-10-01||Interventional|||The Influence of Different Dietary Status on the Acute Responses to Exercise||Completed||N/A|10|Actual|University of Bath||2|||f||||f||||||||Undecided||2017-10-10 21:53:58.162679|2017-10-10 21:53:58.162679
NCT02870062|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Impact of Daily Bathing With Chlorhexidine in the Critical Patient|Impact of Daily Bathing With Chlorhexidine in the Critical Patient: Colonization and Environment|Active, not recruiting||Phase 1|40|Actual|Universidad Autonoma de Nuevo Leon||2|||f||||f||||||||No|Individual participant data will not be available. Individual data will remain confidential, according to our ethical committee regulations.|2017-10-10 21:53:58.235029|2017-10-10 21:53:58.235029
NCT02870049|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-16|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Study to Increase Colorectal Screening|A RCT of Outreach and Inreach Strategies for Boosting CRC Screening in a Federally-Qualified Health Center|Enrolling by invitation||N/A|648|Anticipated|University of California, San Diego||4|||f||||f||||||||No||2017-10-10 21:53:58.363041|2017-10-10 21:53:58.363041
NCT02870036|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-07-11|||October 2016||2016-10-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors||Recruiting||Phase 1|243|Anticipated|ShangHai HaiHe Pharmaceutical||6|||f||||t||||||||||2017-10-10 21:53:58.458632|2017-10-10 21:53:58.458632
NCT02870023|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-22|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||How Does Strength Training and Balance Training Affect Gait Function and Fatigue in Patients With Multiple Sclerosis?|How Does Strength Training and Balance Training Affect Gait Function and Fatigue in Patients With Multiple Sclerosis?|Recruiting||N/A|90|Anticipated|University of Aarhus||3|||f||||f||||||||Undecided||2017-10-10 21:53:58.613544|2017-10-10 21:53:58.613544
NCT02870010|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-18|||February 2010||2010-02-01|August 2016|2016-08-01||||May 2012|Actual|2012-05-01||Interventional|IDASPHERE||Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres|Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres (DC Bead™) Loaded With Idarubicin (Zavedos®): Phase 1 Study|Completed||Phase 1|21|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 21:53:58.736488|2017-10-10 21:53:58.736488
NCT02869997|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-12|||August 2012||2012-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|September 2014|Actual|2014-09-01||Interventional|SACRE||Evaluation of the Prognostic Value of the Suppression Ratio Evaluated by BIS Among Patients Admitted to the ICU for Cardiac Arrest|Evaluation of the Prognostic Value of the Suppression Ratio Evaluated by BIS Among Patients Admitted to the ICU for Cardiac Arrest|Active, not recruiting||N/A|102|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:53:58.809438|2017-10-10 21:53:58.809438
NCT02869984|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01||||October 2018|Anticipated|2018-10-01||Interventional|||Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome||Not yet recruiting||Early Phase 1|100|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 21:53:58.883644|2017-10-10 21:53:58.883644
NCT02869971|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-13|||August 2016||2016-08-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|November 2019|Anticipated|2019-11-01||Interventional|PARTEM||Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia|Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia|Recruiting||Phase 3|90|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-10 21:53:58.955983|2017-10-10 21:53:58.955983
NCT02869945|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-12|||September 2016||2016-09-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|DATACOMT||Compensation Mechanisms in Parkinson's Disease|Dopaminergic Denervation and COMT Polymorphism in de Novo Patients With Parkinson's Disease|Not yet recruiting||N/A|51|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||No||2017-10-10 21:53:59.213879|2017-10-10 21:53:59.213879
NCT02869932|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-08-12|||March 2012||2012-03-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|DPAM||Prospective Study of the Phenotypic Expression of Cystic Fibrosis (CF) Screened Positive Newborns With an Atypical Form of CF (DPAM)|Prospective Study of the Phenotypic Expression of Cystic Fibrosis (CF) Screened Positive Newborns With an Atypical Form of CF (DPAM)|Completed||N/A|130|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 21:53:59.305299|2017-10-10 21:53:59.305299
NCT02869919|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-02-20|||April 2016||2016-04-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|VID-AKI||Vitamin D in Critically Ill Patients With Acute Kidney Injury|Vitamin D Levels in Critically Ill Patients With Acute Kidney Injury|Recruiting||N/A|236|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||2||f||||f||||||||No|No We are not planning to make individual participant data available|2017-10-10 21:53:59.377473|2017-10-10 21:53:59.377473
NCT02869906|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-16|||September 2015||2015-09-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|WAVE||Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Non Culprit Lesions in Patients With ST-segment Elevation Myocardial Infarction|Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Non Culprit Lesions in Patients With ST-segment Elevation Myocardial Infarction|Recruiting||N/A|60|Anticipated|Azienda Ospedaliera San Camillo Forlanini|||1||f||||t||||||||Undecided||2017-10-10 21:53:59.482239|2017-10-10 21:53:59.482239
NCT02869893|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2017-05-03|||August 10, 2016|Actual|2016-08-10|May 2017|2017-05-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|||MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics|Magnetic Resonance Cholangiopancreatography (MRCP): A Reliable, Non Invasive Method for Staging Chronic Pancreatitis From Minimal Change Disease to the Advanced Stages in Pediatrics|Completed||N/A|57|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||No||2017-10-10 21:53:59.554946|2017-10-10 21:53:59.554946
NCT02869880|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Trial of Enhanced Pre-Consent Discussion|Trial of Enhanced Pre-Consent Discussion|Not yet recruiting||N/A|450|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||No||2017-10-10 21:53:59.646823|2017-10-10 21:53:59.646823
NCT02869867|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-03-23|||February 2, 2017|Actual|2017-02-02|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|February 2019|Anticipated|2019-02-01||Interventional|DIDOCAP||Does the Application of Cold Decreases the Pain Associated in the Pose of a Patch of Capsaicine at High Concentration on the Carrier Patients of Localized Neuropathic Pains ? - DIDOCAP|Does the Application of Cold Decreases the Pain Associated in the Pose of a Patch of Capsaicine at High Concentration on the Carrier Patients of Localized Neuropathic Pains ? - DIDOCAP|Recruiting||N/A|100|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||f|f|f||||||||2017-10-10 21:53:59.717379|2017-10-10 21:53:59.717379
NCT02869854|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-26|||September 30, 2016|Actual|2016-09-30|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 31, 2018|Anticipated|2018-12-31||Interventional|FAR-MIND||Increased Physical Activity Through Mindfulness|Increased Physical Activity Through Mindfulness- a Randomized Clinical Trail in Primary Health Care|Recruiting||N/A|90|Anticipated|Region Skane||3|||f||||f||||||||||2017-10-10 21:53:59.802924|2017-10-10 21:53:59.802924
NCT02869841|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-04-12|||January 2012||2012-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Interventional|Rektus-puu||Efficacy of Rectal Sheath Analgesia After Midline Laparotomy|Efficacy of Rectal Sheath Analgesia After Midline Laparotomy|Active, not recruiting||Phase 4|80|Anticipated|Kuopio University Hospital||4|||f||||t||||||||No||2017-10-10 21:53:59.885274|2017-10-10 21:53:59.885274
NCT02869828|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-06-16|||June 2015||2015-06-01|June 2016|2016-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|TEMP CORE BLOC||Central Temperature Monitoring by Zero-heath-flux a Non-invasive Technic Compared to Two Invasive Technic During Surgery||Completed||N/A|50|Actual|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 21:53:59.961757|2017-10-10 21:53:59.961757
NCT02869815|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-11|||August 2016||2016-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Observational|||ICG and Blue Dye Guided Sentinel Lymph Node Biopsy in Patients Underwent Neoadjuvant Therapy|Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Using the Navigation of the Combination of Indocyanine and Blue Dye in Patients With Breast Cancer|Not yet recruiting||Phase 2|150|Anticipated|Peking University People's Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:54:00.027005|2017-10-10 21:54:00.027005
NCT02869802|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-04-13|||September 2016||2016-09-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Observational|PanGen||Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis|Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis|Recruiting||N/A|120|Anticipated|British Columbia Cancer Agency|||2||f||||||||||Samples With DNA|"     Fresh tumour tissue biopsy samples Archival tumour tissue samples Whole blood samples Plasma     samples Serum samples Urine samples   "|||2017-10-10 21:54:00.125021|2017-10-10 21:54:00.125021
NCT02869789|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-09-26|||September 14, 2016|Actual|2016-09-14|September 2017|2017-09-01|October 5, 2021|Anticipated|2021-10-05|September 9, 2018|Anticipated|2018-09-09||Interventional|||An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers|A Phase Illb/IV Safety Trial of Flat Dose Nivolumab In Combination With Ipilimumab in Participants With Non-Small Cell Lung Cancer|Recruiting||Phase 3|1000|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 21:54:00.462159|2017-10-10 21:54:00.462159
NCT02869776|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-08-09|||September 2016||2016-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|July 26, 2017|Actual|2017-07-26||Interventional|||Integrating HCV and HIV Screening During the Era of HIV Antigen Testing|Integrating HCV and HIV Screening During the Era of HIV Antigen Testing|Active, not recruiting||N/A|200|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:54:01.2333|2017-10-10 21:54:01.2333
NCT02869763|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-10-04|||May 2016|Actual|2016-05-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|November 2016|Actual|2016-11-01||Interventional|PROFETHYL/2||Dose-response Effect of Alcohol Ingestion on Steroid Profile|Dose-response Effect of Alcohol Ingestion on Steroid Profile: Gender and Ethnic Aspects|Completed||N/A|12|Actual|Parc de Salut Mar||3|||f||||f||||||||||2017-10-10 21:54:01.347237|2017-10-10 21:54:01.347237
NCT02869750|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-08-13|||November 2016||2016-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Evaluation of Adipokines in Obese and Non-obese Egyptian Women With Polycystic Ovary Syndrome|Evaluation of Adipokines ( Ghrelin, Resistin and Adiponectin), in Obese and Non-obese Egyptian Women With Polycystic Ovary Syndrome|Recruiting||N/A|75|Anticipated|Ain Shams University|||3||f||||t||||||||||2017-10-10 21:54:01.496129|2017-10-10 21:54:01.496129
NCT02869737|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-12|||January 2015||2015-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|Coaguchek||Utility of Point-of-care Device for Rapid Determination of Cogulopathy in Trauma Patients|Utility of Point-of-care Device for Rapid Determination of Cogulopathy in Trauma Patients|Completed||N/A|100|Actual|University Hospital, Grenoble|||1||f||||f||||||||No||2017-10-10 21:54:01.588725|2017-10-10 21:54:01.588725
NCT02869724|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-12|||March 2014||2014-03-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|DEFIMED-1||Divided Drug Delivery|Divided Drug Delivery : a Way to Prevent Repeated Volutary Drug Intoxications.|Recruiting||N/A|30|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:54:01.666335|2017-10-10 21:54:01.666335
NCT02869711|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-12|||July 2011||2011-07-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Observational|ImpactFA||Impact of a Training-action About Projects Leading for the Improvement of Care Quality in Managing Practice of Health Executive|Impact of a Training-action About Projects Leading for the Improvement of Care Quality in Managing Practice of Health Executive|Recruiting||N/A|27|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 21:54:01.802294|2017-10-10 21:54:01.802294
NCT02869698|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-01-18|||June 2009||2009-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|ISDETSEEG||Spectral Dynamic Imaging of Cognitive Functions in Epileptic Patients Explored Stereoelectroencephalography|Spectral Dynamic Imaging of Cognitive Functions in Epileptic Patients Explored|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 21:54:01.884112|2017-10-10 21:54:01.884112
NCT02869685|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-30|||October 2016||2016-10-01|August 2016|2016-08-01||||June 2019|Anticipated|2019-06-01||Interventional|RadImm02||Clinical Research for the Consistency Analysis of PD-L1 in Lung Cancer Tissue and Plasma Exosome Before and After Radiotherapy|Clinical Research for the Consistency Analysis of PD-L1 in Lung Cancer Tissue and Plasma Exosome Before and After Radiotherapy|Not yet recruiting||N/A|60|Anticipated|Xinqiao Hospital of Chongqing||1|||f||||||||||||||2017-10-10 21:54:01.974902|2017-10-10 21:54:01.974902
NCT02869672|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-16|||July 2016||2016-07-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||Safety and Immunogenicity Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old||Enrolling by invitation||Phase 3|1200|Anticipated|Beijing Chaoyang District Centre for Disease Control and Prevention||6|||f||||||||||||||2017-10-10 21:54:02.040427|2017-10-10 21:54:02.040427
NCT02869659|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-03-10|||October 2016||2016-10-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|VEGGIE||Valued EpiGenetic Glycemic ImprovEments Through Weight Loss|Valued EpiGenetic Glycemic ImprovEments Through Weight Loss|Recruiting||N/A|200|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 21:54:02.114943|2017-10-10 21:54:02.114943
NCT02869646|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-07|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|September 30, 2021|Anticipated|2021-09-30|September 1, 2020|Anticipated|2020-09-01||Interventional|PTSD ACU||Acupuncture for PTSD|Acupuncture for PTSD in Combat Veterans|Not yet recruiting||N/A|90|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 21:54:02.204477|2017-10-10 21:54:02.204477
NCT02869633|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-10-03|||September 2016||2016-09-01|October 2017|2017-10-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant|Optimizing Post-allogeneic Hematopoietic Cell Transplant Outcomes for Lymphoma Using Ibrutinib|Recruiting||Phase 2|75|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 21:54:02.301365|2017-10-10 21:54:02.301365
NCT02869620|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2010||2010-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Thyroid Cancer Database|Institut Paoli Calmettes Thyroid Cancer Database|Recruiting||N/A|3000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:02.400534|2017-10-10 21:54:02.400534
NCT02869607|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-16|||January 1995||1995-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Breast Cancer Database|Institut Paoli Calmettes Breast Cancer Database|Recruiting||N/A|45000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:02.472576|2017-10-10 21:54:02.472576
NCT02869594|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2010||2010-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Prostate Cancer Database|Institut Paoli Calmettes Prostate Cancer Database|Recruiting||N/A|10000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:02.552532|2017-10-10 21:54:02.552532
NCT02869581|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2000||2000-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli-Calmettes Pancreatic Neoplasms Database|Institut Paoli-Calmettes Pancreatic Neoplasms Database|Recruiting||N/A|8500|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:02.6367|2017-10-10 21:54:02.6367
NCT02869568|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2000||2000-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Ovarian Cancer Database||Recruiting||N/A|6000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:02.708696|2017-10-10 21:54:02.708696
NCT02869555|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2010||2010-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Multiple Myeloma Database|Institut Paoli Calmettes Multiple Myeloma Database|Recruiting||N/A|5000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:02.776531|2017-10-10 21:54:02.776531
NCT02869542|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2000||2000-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Lymphoma Database|Institut Paoli Calmettes Breast Cancer Database|Recruiting||N/A|16000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:02.857205|2017-10-10 21:54:02.857205
NCT02869529|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2006||2006-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Chronic Lymphatic Leukemia Database|Institut Paoli Calmettes Chronic Lymphatic Leukemia Database|Recruiting||N/A|4200|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:02.938744|2017-10-10 21:54:02.938744
NCT02869516|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-16|||January 1995||1995-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Acute Leukemia Database|Institut Paoli Calmettes Acute Leukemia Database|Recruiting||N/A|27000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:03.008754|2017-10-10 21:54:03.008754
NCT02869503|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2001||2001-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Colorectal Cancer Database|Institut Paoli Calmettes Colorectal Cancer Database|Recruiting||N/A|22000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:03.072345|2017-10-10 21:54:03.072345
NCT02869490|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2002||2002-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Cervical Cancer Database||Recruiting||N/A|6000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:03.139356|2017-10-10 21:54:03.139356
NCT02869477|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||January 2002||2002-01-01|August 2016|2016-08-01|December 2030|Anticipated|2030-12-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|||Institut Paoli Calmettes Cardia Cancer Database|Institut Paoli Calmettes Cardia Cancer Database|Recruiting||N/A|2000|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||No||2017-10-10 21:54:03.202337|2017-10-10 21:54:03.202337
NCT02869464|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-08-15|||April 2014||2014-04-01|August 2016|2016-08-01||||April 2017|Anticipated|2017-04-01|30 Days|Observational [Patient Registry]|BAAS||UVA Brain and Aortic Aneurysm Study|The University of Virginia Brain and Aortic Aneurysm Study|Recruiting||N/A|360|Anticipated|University of Virginia|||2||f||||f||||||Samples With DNA|"     Approximately 3 mL of blood are obtained via venipuncture at the time of subject consent for     banking and future research.   "|No|Summary data will be shared and published.|2017-10-10 21:54:03.265602|2017-10-10 21:54:03.265602
NCT02869451|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-07-14|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Mobile Contingency Management for Marijuana and Cessation|Mobile Contingency Management for Concurrent Abstinence From Cannabis and Cigarette Smoking: A Pilot Study|Active, not recruiting||N/A|7|Actual|Duke University||1|||f||||f||||||||||2017-10-10 21:54:03.370373|2017-10-10 21:54:03.370373
NCT02869425|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-04-28|||July 2016||2016-07-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS|A Randomized, Double-Blind, Parallel-Group Study to Assess the Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With Multiple Sclerosis|Suspended||Phase 3|120|Anticipated|Osmotica Pharmaceutical US LLC||2||suspended due to inability to enroll subjects|f||||f||||||||No||2017-10-10 21:54:03.629698|2017-10-10 21:54:03.629698
NCT02869412|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-04-10|||January 2015||2015-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation Therapy|A Physical Activity Behavior Change Guide for Prostate Cancer Patients (iTRAIN Study)|Recruiting||N/A|120|Anticipated|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-10-10 21:54:03.719219|2017-10-10 21:54:03.719219
NCT02869399|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-22|||November 2015||2015-11-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|DietINT||Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention|A Randomized Phase II Study for Tertiary Prevention of Squamocellular Cancer of Head and Neck (SCCHN) With a Dietary Intervention|Recruiting||Phase 2|350|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||Yes|Abstracts and posters to National and International Congresses and results publication on idexes papers|2017-10-10 21:54:03.816859|2017-10-10 21:54:03.816859
NCT02869386|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-08-25|||August 2016||2016-08-01|August 2017|2017-08-01|August 2024|Anticipated|2024-08-01|September 2019|Anticipated|2019-09-01||Interventional|B_PROUD||Berlin PRehospital Or Usual Delivery of Acute Stroke Care|Berlin PRehospital Or Usual Delivery of Acute Stroke Care - Functional Outcomes After Advanced Prehospital Stroke Care|Recruiting||N/A|1500|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 21:54:04.04199|2017-10-10 21:54:04.04199
NCT02869373|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-12|||April 2015||2015-04-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Spinal Stabilization Exercise Effects in Hypermobility|Assistant Professor|Completed||Phase 2|38|Actual|Ataturk Training and Research Hospital||2|||f||||||||||||||2017-10-10 21:54:04.185944|2017-10-10 21:54:04.185944
NCT02869360|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2016-08-30|||October 2016||2016-10-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Observational|||Correlation Between PET and Advanced MRI in Multiple Sclerosis|PILOT STUDY OF POSITRON EMISSION TOMOGRAPHY (PET) IMAGING: CORRELATIONS WITH ADVANCED MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS|Not yet recruiting||N/A|20|Anticipated|University of British Columbia|||2||f||||f||||||||||2017-10-10 21:54:04.274937|2017-10-10 21:54:04.274937
NCT02869347|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-01-18|||January 2017||2017-01-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|PROTECT||Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects|Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Contrast-induced Nephropathy in High-risk Subjects (PROTECT): a Randomized, Placebo-controlled, Double-blind Single-center Trial|Recruiting||Phase 2|80|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||Undecided||2017-10-10 21:54:04.346207|2017-10-10 21:54:04.346207
NCT02869334|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-11|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Remediation of Auditory Recognition in Schizophrenia With tDCS|Remediation of Auditory Recognition in Schizophrenia With Transcranial Direct Current Stimulation (tDCS)|Recruiting||N/A|45|Anticipated|New York State Psychiatric Institute||3|||f||||f||||||||No||2017-10-10 21:54:04.465411|2017-10-10 21:54:04.465411
NCT02869321|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-19|||May 2015||2015-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ANTALGIP||Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy|Evaluation of Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy|Recruiting||Phase 4|60|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||No||2017-10-10 21:54:04.589317|2017-10-10 21:54:04.589317
NCT02869308|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-16|||January 2014||2014-01-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|FEVED||Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy|Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy: Comparison Between Measurements Obtained With Conventional Planar Scintigraphy (E-CAM Camera) and Tomoscintigraphy Recorded by a CZT Semiconductor Camera (D-SPECT)|Recruiting||N/A|100|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:54:04.722666|2017-10-10 21:54:04.722666
NCT02869295|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-27|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NKTR-214||A Phase 1 Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors|A Phase 1, Open-Label, Multicenter, Dose Escalation And Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies|Recruiting||Phase 1|40|Anticipated|Nektar Therapeutics||1|||f||||f||||||||||2017-10-10 21:54:04.842117|2017-10-10 21:54:04.842117
NCT02869282|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-16|||June 2011||2011-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CHEMOPROST||STUDY OF THE EXPRESSION OF CIRCULATING AND INTRA-TUMORAL CHEMOKINES IN PATIENTS WITH PROSTATE CANCER|TUDY OF THE EXPRESSION OF CIRCULATING AND INTRA-TUMORAL|Recruiting||N/A|145|Anticipated|Institut Bergonié|||1||f||||f||||||Samples Without DNA|"     Additional blood and urine samples (8 ml blood and 20 ml urine tubes)   "|No||2017-10-10 21:54:04.951112|2017-10-10 21:54:04.951112
NCT02869269|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-11|||October 2015||2015-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||A Study of Circulating Immune Cell Activity Changes in Blood of Colorectal Cancer Patients|A Study of Circulating Immune Cell Activity Changes in Blood of Colorectal Cancer Patients|Recruiting||N/A|300|Anticipated|Konkuk University Medical Center|||2||f||||f||||||Samples Without DNA|"     whole blood   "|No||2017-10-10 21:54:05.06124|2017-10-10 21:54:05.06124
NCT02869256|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-16|||January 2014||2014-01-01|August 2016|2016-08-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|LMC||Regional Central Database Recording of Chronic Myeloid Leukemia|Regional Central Database Recording of Chronic Myeloid Leukemia|Recruiting||N/A|400|Anticipated|Institut Bergonié|||1||f||||f||||||||No||2017-10-10 21:54:05.152238|2017-10-10 21:54:05.152238
NCT02869243|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-10-03|||July 18, 2017|Actual|2017-07-18|October 2017|2017-10-01|September 11, 2018|Anticipated|2018-09-11|June 12, 2018|Anticipated|2018-06-12||Interventional|||A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients|A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via Convection-Enhanced Delivery In Patients With Progressive And/Or Multiple Recurrent Glioblastoma Multiforme|Recruiting||Phase 1|15|Anticipated|Stemgen||1|||f||||t|f|f||||||||2017-10-10 21:54:05.247693|2017-10-10 21:54:05.247693
NCT02869230|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-08-11|||March 2006||2006-03-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|June 2011|Actual|2011-06-01||Interventional|ROLLvsWGLL||ROLL vs WGLL for Non-palpable Breast Lesions|Radioguided Occult Lesion Localization (ROLL) is Superior a to the Wire-Guided Lesion Localization (WGLL)? Randomized Controlled Clinical Trial|Completed||Phase 2|129|Actual|Instituto Nacional de Cancerologia, Columbia||2|||f||||t||||||||||2017-10-10 21:54:05.358031|2017-10-10 21:54:05.358031
NCT02869217|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-19|||September 2016||2016-09-01|September 2017|2017-09-01||||March 2018|Anticipated|2018-03-01||Interventional|||Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors|Phase Ib Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors|Recruiting||Phase 1|15|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 21:54:05.432975|2017-10-10 21:54:05.432975
NCT02869204|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-11|||September 2016||2016-09-01|August 2016|2016-08-01||||February 2017|Anticipated|2017-02-01||Interventional|||The Effect of a Local Injection of a Platelet Concentrate on Infection and Healing of Surgical Wounds|The Effect of L-PRP on Wound Healing and Wound Infection After Pancreaticoduodenectomy / Whipples Surgery|Not yet recruiting||N/A|40|Anticipated|University of Copenhagen||2|||f||||||||||||||2017-10-10 21:54:05.528755|2017-10-10 21:54:05.528755
NCT02869191|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-02-27|||October 2012||2012-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2015|Actual|2015-11-01||Observational|||Blood Cultures's Profitability in Intensive Care Unit|Blood Cultures's Profitability in Intensive Care Unit|Active, not recruiting||N/A|900|Anticipated|Hospital Universitario Getafe|||2||f||||f||||||||No||2017-10-10 21:54:05.61315|2017-10-10 21:54:05.61315
NCT02869178|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2016-08-11|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2016|Anticipated|2016-08-01||Observational|||Strain X Cardiopulmonary Test|Analysis Of Strain Myocardial Associated With The Exercise Tolerance In Patients With Heart Failure Systolic|Recruiting||N/A|26|Anticipated|Universidade Federal de Pernambuco|||1||f||||t||||||||||2017-10-10 21:54:05.684064|2017-10-10 21:54:05.684064
NCT02868645|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-23|||June 2016||2016-06-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PERIOSTINE||Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia|Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia|Recruiting||N/A|200|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 21:54:12.012916|2017-10-10 21:54:12.012916
NCT02869165|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-04-26|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Vaginal and Urinary Microbiome Trial|The Effects of Vaginal Estrogen and a Nonhormonal Alternative on the Vaginal and Urinary Microbiome in Women With Genitourinary Syndrome of Menopause: A Randomized Controlled Trial|Recruiting||Phase 4|94|Anticipated|University of Louisville||2|||f||||f|t|f|||f|||No||2017-10-10 21:54:05.760718|2017-10-10 21:54:05.760718
NCT02869152|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-10-27|||August 2016||2016-08-01|October 2016|2016-10-01||||March 2019|Anticipated|2019-03-01||Interventional|||Sentinel Lymph Node Mapping in Rectal Cancer|Novel Sentinel Lymph Node Mapping Technique in Early Stage Rectal Cancer|Recruiting||N/A|26|Anticipated|University of Virginia||1|||f||||t||||||||||2017-10-10 21:54:05.893084|2017-10-10 21:54:05.893084
NCT02869139|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-11|||April 2014||2014-04-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Package of Mentholated Measures for the Relief of Thirst in the Anesthesia Recovery Room|Package of Mentholated Measures for the Relief of Thirst in the Anesthesia Recovery Room: Randomized Clinical Trial|Completed||N/A|120|Actual|Universidade Estadual de Londrina||2|||f||||t||||||||Yes||2017-10-10 21:54:05.997216|2017-10-10 21:54:05.997216
NCT02869126|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||September 2012||2012-09-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|D-SPECT BIS||Stress and Rest Myocardial Tomoscintigraphies Using Mono- or Double-isotope Protocol With a Semiconductor Camera|Study of the Concordance Between a Traditional Protocol of Stress and Rest Myocardial Tomoscintigraphy Using 99mTc-sestamibi and a Double Isotope Protocol Using Thallium-201 and 99mTc-sestamibi, With a Semiconductor Camera|Completed||N/A|118|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:54:06.068541|2017-10-10 21:54:06.068541
NCT02869113|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-12|||January 2015||2015-01-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes|Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes|Completed||N/A|65|Actual|Bayer||3|||f||||f||||||||||2017-10-10 21:54:06.145106|2017-10-10 21:54:06.145106
NCT02869100|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||January 2013||2013-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|FNa||Comparison of Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging of Spine and Sacroiliac Joints for Detection of Inflammatory Lesions in Spondyloarthritis Patients|Comparison of Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging of Spine and Sacroiliac Joints for Detection of Inflammatory Lesions in Patients Affected by Spondyloarthritis|Completed||N/A|26|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:54:06.22803|2017-10-10 21:54:06.22803
NCT02869087|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-02-24|||August 2016||2016-08-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|November 2017|Anticipated|2017-11-01||Interventional|DESappear||The DESappear Study: Drug Eluting Scaffold|DESappear Study: Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization|Recruiting||N/A|60|Anticipated|Elixir Medical Corporation||1|||f||||t||||||||Undecided||2017-10-10 21:54:06.322794|2017-10-10 21:54:06.322794
NCT02869074|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-10-03|||October 3, 2017|Actual|2017-10-03|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01|3 Years|Observational [Patient Registry]|PCM-EVW-ES||Molecular and Clinical Profile of Von Willebrand Disease in Spain|Molecular and Clinical Profile of Von Willebrand Disease (VWD) in Spain (PCM-EVW-ES). Recruitment Extension, Further Data Analysis, Improvement of Registry Platform, Diagnosis and Management of VWD Application Development|Recruiting||N/A|400|Anticipated|Spanish Society of Thrombosis and Haemostasis|||1||f||||t||||||Samples With DNA|"     EDTA-Blood 5 mL Citrated Blood 5 mL   "|||2017-10-10 21:54:06.447634|2017-10-10 21:54:06.447634
NCT02869061|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-11|||January 2016||2016-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture|Effectiveness and Safety of Local Endoscopically-assisted Administration of Autologous Adipose-derived Regenerative Cells for Reduction of Risk of Postoperative Bladder Neck Contracture in Male Patients|Enrolling by invitation||Phase 1/Phase 2|12|Anticipated|Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation||1|||f||||f||||||||Undecided||2017-10-10 21:54:06.540507|2017-10-10 21:54:06.540507
NCT02869048|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-10-04|||June 2016||2016-06-01|October 2017|2017-10-01|June 2026|Anticipated|2026-06-01|June 2026|Anticipated|2026-06-01||Observational|||Amyotrophic Lateral Sclerosis and the Innate Immune System|Amyotrophic Lateral Sclerosis and the Innate Immune System|Recruiting||N/A|375|Anticipated|Rigshospitalet, Denmark|||3||f||||t||||||Samples With DNA|"     Serum, EDTA-plasma, Hirudin-plasma, Heparin-plasma and RNAlater samples (with fullblood) will     be kept in biobank as well as analyzed according design and methods of Clinical study 1+2+3.      Spinal liquid sample will also be kept in biobank (Clinical Study 2+3).      10 muscle biopsies from ALS patients will be analyzed (Clinical study 4)   "|||2017-10-10 21:54:06.641458|2017-10-10 21:54:06.641458
NCT02869035|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-05-31|||August 2016||2016-08-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Treatment Outcome in Major Depressive Disorder|Predicting Treatment Outcome in Major Depressive Disorder|Recruiting||Phase 1|100|Anticipated|Rigshospitalet, Denmark||3|||f||||t||||||||Yes|Via database of Center for Integrated Molecular Brain Imaging (Knudsen et al 2016, NeuroImage) data will be available for neuroscience research community contingent on approval by scientific board.|2017-10-10 21:54:06.821465|2017-10-10 21:54:06.821465
NCT02869022|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-08-28|||September 2015||2015-09-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation|A Prospective, Randomized, Single Blind, Multicenter Phase III Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation|Recruiting||Phase 3|90|Anticipated|Dr. F. Köhler Chemie GmbH||2|||f||||t||||||||||2017-10-10 21:54:06.954644|2017-10-10 21:54:06.954644
NCT02869009|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-04-10|||November 2016||2016-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|ATAMIS||Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke|Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a Parallel Randomized, Open-label, Multicenter, Prospective Study|Recruiting||Early Phase 1|3000|Anticipated|General Hospital of Shenyang Military Region||2|||f||||t||||||||No||2017-10-10 21:54:07.056024|2017-10-10 21:54:07.056024
NCT02868996|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-04-25|||September 2016||2016-09-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||An Open Label, Phase 1b, Ascending Dose Study of DM199|An Open Label, Phase 1b, Single CENTER, Ascending Dose Study TO ASSESS THE SAFETY AND TOLERABILITY of DM199 With a Comparative Pharmacokinetic Study of DM199 Administered Intravenously and a Bioavailability Assessment of Subcutaneous Administration of DM199 in Normal Healthy Subjects|Completed||Phase 1|36|Actual|DiaMedica USA Inc.||6|||f||||t||||||||Yes||2017-10-10 21:54:07.161465|2017-10-10 21:54:07.161465
NCT02868983|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-15|||April 2016||2016-04-01|August 2016|2016-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|IBHPC||Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems|Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems|Enrolling by invitation||N/A|3000|Anticipated|University of Vermont||2|||f||||t||||||||Yes|A complete, cleaned, de-identified copy of the final dataset used in conducting the final analyses will be made available within one year after the completion of the study. It will include a data dictionary with response and missing values defined as well as a complete set of survey instruments (excluding copyright protected material not licensed for transfer). The data will be available as an encrypted Stata data set or comma-separated file. The investigators will not make data from qualitative results available because of the potential for identifying individuals.|2017-10-10 21:54:07.237178|2017-10-10 21:54:07.237178
NCT02868970|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-04-26|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study to Evaluate Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction|Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction: A Prospective, Controlled Community Embedded Study With Vaccines With Low Coverage Rates (The Improve ACCESS Study)|Enrolling by invitation||Phase 4|2384|Anticipated|Dalhousie University||1|||f||||f|f|f||||||No||2017-10-10 21:54:07.32658|2017-10-10 21:54:07.32658
NCT02868957|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-15|||January 2014||2014-01-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Repetition Improves Precision and Trueness of Digital Intraoral Scans|Standardization of Evaluation Protocol for the Performance Comparison of Digital Intra-oral Scanners|Completed||N/A|20|Actual|Seoul National University Gwanak Dental Hospital||3|||f||||t||||||||Yes|The three dimensional data in .stl format and the time required for the full arch intra-oral scan of the patient will be provided. These data can be provided after the approval of uploaded documents for our clinical trial. The data can be provided via shared files to the individuals who want IPD in this study.|2017-10-10 21:54:07.397033|2017-10-10 21:54:07.397033
NCT02868944|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-09-06|||August 2014||2014-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|MASEA||Interest of the Injection of Morphine, in Addition to a Local Anesthetic When Performing a Combined Spinal-epidural for Labor Analgesia|Interest of the Injection of Morphine, in Addition to a Local Anesthetic When Performing a Combined Spinal-epidural for Labor Analgesia|Recruiting||Phase 3|260|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:54:09.347972|2017-10-10 21:54:09.347972
NCT02868931|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-10|||April 1, 2016|Actual|2016-04-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|INPUT||Evaluation of a Diabetes Treatment and Education Program for Insulin Pump Therapy (INPUT)|Evaluation of a Newly Developed Treatment and Education Program (INPUT) for Diabetic Patients Performing an Insulin Pump Therapy|Completed||N/A|268|Actual|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||f||||||||||2017-10-10 21:54:09.449267|2017-10-10 21:54:09.449267
NCT02868918|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2016-08-15|||January 2017||2017-01-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions|Clinical and Radiographical Evaluation of New Bioactive Dentine Substitute (Biodentine) Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions -Randomized Clinical Trial|Not yet recruiting||Phase 2|50|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 21:54:09.537048|2017-10-10 21:54:09.537048
NCT02868905|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|Oba||Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women|Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women - Pilot Study|Not yet recruiting||N/A|160|Anticipated|Central Hospital, Nancy, France||4|||f||||f||||||||||2017-10-10 21:54:09.631334|2017-10-10 21:54:09.631334
NCT02868892|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-22|||July 2015||2015-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas|A Phase II Study of Pemetrexed in Recurrent Cervical Adenocarcinomas|Terminated||Phase 2|6|Actual|Western Regional Medical Center||1||departure of PI from institution and poor population for study participation|f||||t||||||||||2017-10-10 21:54:09.721164|2017-10-10 21:54:09.721164
NCT02868879|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-10-04|||December 2006|Actual|2006-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Anatomical and Structural Connectivity in Two Psychotic Phenotypes : Periodic Catatonia and Cataphasia|Anatomical and Structural Connectivity in Schizophrenias|Recruiting||N/A|150|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||||||2017-10-10 21:54:09.796994|2017-10-10 21:54:09.796994
NCT02868866|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-18|||January 2015||2015-01-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|November 2018|Anticipated|2018-11-01||Interventional|||Dissemination and Implementation of Faith, Activity, and Nutrition|Faith, Activity, and Nutrition: Dissemination in Underserved Communities|Enrolling by invitation||N/A|900|Anticipated|University of South Carolina||2|||f||||f||||||||||2017-10-10 21:54:09.89697|2017-10-10 21:54:09.89697
NCT02868853|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-06-13|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|2-SMART||Self-Monitoring Assessment in Real Time|Self-Monitoring Assessment in Real Time: 2-SMART|Completed||N/A|44|Actual|University of South Carolina||2|||f||||f||||||||Undecided||2017-10-10 21:54:09.9978|2017-10-10 21:54:09.9978
NCT02868840|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-11|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|March 30, 2017|Actual|2017-03-30||Interventional|TCSR||Tai Chi for Stroke Rehabilitation on Balance and Cognition|Evaluating the Effect of Tai Chi Applied Stroke Rehabilitation on Physical and Cognitive Functioning|Completed||N/A|50|Actual|Chungnam National University||2|||f||||t||||||||||2017-10-10 21:54:10.110498|2017-10-10 21:54:10.110498
NCT02868827|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-11|||October 2016||2016-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.|Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency in Intensive Care Unit- A Randomized Controlled Trial.|Not yet recruiting||Phase 2/Phase 3|430|Anticipated|King Abdullah Medical City||2|||f||||t||||||||Undecided||2017-10-10 21:54:10.234353|2017-10-10 21:54:10.234353
NCT02868814|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-11|||May 2016||2016-05-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia|The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia|Recruiting||Phase 3|240|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||Undecided||2017-10-10 21:54:10.470866|2017-10-10 21:54:10.470866
NCT02868801|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-08-11|||March 2015||2015-03-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|EASOPSRTFP||Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia|Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia -A Multicenter,Randomized, Double-blind, Placebo-controlled Trial|Recruiting||Phase 3|280|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||4|||f||||f||||||||Undecided||2017-10-10 21:54:10.606111|2017-10-10 21:54:10.606111
NCT02868788|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-17|||July 2016||2016-07-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Anti-inflammatory Effects of the Fiber|Anti-inflammatory and ROS Suppressive Effects of the Fiber Supplementation to a High Fat High Calorie Meal in Patients With Type 2 Diabetes|Recruiting||N/A|15|Anticipated|University at Buffalo||2|||f||||f||||||||No||2017-10-10 21:54:10.816017|2017-10-10 21:54:10.816017
NCT02868775|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-01-04|||September 2016||2016-09-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Observational|||A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome|A Pilot Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome|Recruiting||N/A|60|Anticipated|Philadelphia Urosurgical Associates|||1||f||||f||||||Samples With DNA|"     Bladder biopsies   "|No||2017-10-10 21:54:10.966575|2017-10-10 21:54:10.966575
NCT02868762|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-08-30|||July 2016||2016-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01|12 Months|Observational [Patient Registry]|||Correlation of the Neck Disability Index (NDI) and Voice Handicap Index (VHI) in Neck Pain Patients and Patients With Voice Disorders|Correlation of the Neck Disability Index (NDI) and Voice Handicap Index (VHI) in Neck Pain Patients and Patients With Voice Disorders|Recruiting||N/A|175|Anticipated|University of Zurich|||1||f||||f||||||||No||2017-10-10 21:54:11.07852|2017-10-10 21:54:11.07852
NCT02868749|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-05-08|||March 22, 2017|Actual|2017-03-22|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue|Comparative Clinical, Histological and Ultrasound Pilot Study of Two Hyaluronic Acid Gel Fillers, Designed for Deep Injection, in Adipose Tissue|Recruiting||N/A|5|Anticipated|Vandeputte, Joan, M.D.||2|||f||||f|f|f||||||Yes|pilot study on 5 patients: min, max, average measurements will be published|2017-10-10 21:54:11.173335|2017-10-10 21:54:11.173335
NCT02868736|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||July 2016||2016-07-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|||Clinical Validation of CD Diagnostics Synovasure PJI ELISA Test and Synovasure PJI Lateral Flow Test for Detection of Periprosthetic Joint Infection in Synovial Fluid||Recruiting||N/A|3000|Anticipated|CD Diagnostics|||1||f||||f||||||||||2017-10-10 21:54:11.327108|2017-10-10 21:54:11.327108
NCT02868723|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-08-14|||October 2016||2016-10-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|PROMOTE-HEALTH||PROspective Study to OPTimize thE HEALTH of Patients With TIAs (Transient Ischemic Attacks) and Stroke Admitted to the Hamad General Hospital|PROspective Study to OPTimize thE HEALTH of Patients With TIAS (Transient Ischemic Attack) and Stroke Admitted to the Hamad General Hospital|Not yet recruiting||N/A|400|Anticipated|Hamad Medical Corporation||2|||f||||t||||||||Undecided||2017-10-10 21:54:11.431209|2017-10-10 21:54:11.431209
NCT02868710|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-05-11|||September 2016||2016-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Individual Variability to Aerobic Exercise Training|The Incidence of Training Responsiveness to Cardiorespiratory Fitness and Cardiometabolic Measurements Following Individualized and Standardized Exercise Prescription|Recruiting||N/A|60|Anticipated|Western State Colorado University||3|||f||||f||||||||||2017-10-10 21:54:11.551159|2017-10-10 21:54:11.551159
NCT02868697|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-14|||November 2013||2013-11-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar|Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar|Completed||Phase 4|170|Actual|Hamad Medical Corporation||2|||f||||f||||||||Yes||2017-10-10 21:54:11.653502|2017-10-10 21:54:11.653502
NCT02868684|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-14|||August 2016||2016-08-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study||Not yet recruiting||N/A|120|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||t||||||||Undecided||2017-10-10 21:54:11.733105|2017-10-10 21:54:11.733105
NCT02868671|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-14|||August 2016||2016-08-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Acupuncture for Mild Traumatic Brain Injury With Post-traumatic Stress Disorder : A Functional Magnetic Resonance Imaging Study|Acupuncture Intervention in Subacute Mild Traumatic Brain Injury With Post-traumatic Stress Disorder: A Randomized Controlled Trial|Not yet recruiting||Phase 1|120|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||3|||f||||t||||||||Yes||2017-10-10 21:54:11.811081|2017-10-10 21:54:11.811081
NCT02868658|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|AFP||Asymptomatic Flu Project|Incidence of Symptomatic and Asymptomatic Influenza Among Healthcare Workers : A Multicenter Cohort Study|Not yet recruiting||N/A|250|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 21:54:11.909315|2017-10-10 21:54:11.909315
NCT02865317|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-08-09|||October 2016||2016-10-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Cortical Effects of Peripheral Nerve Injury At Birth|Investigating the Long-Term Cortical Effects of Peripheral Nerve Injury At Birth|Not yet recruiting||N/A|15|Anticipated|Gazi University|||1||f||||f||||||||No||2017-10-10 21:54:44.866707|2017-10-10 21:54:44.866707
NCT02868632|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-07|||August 7, 2016|Actual|2016-08-07|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer|A Phase I Study of Immune Checkpoint Inhibition (Anti-CTLA4 and/or Anti-PD-L1) in Combination With Radiation Therapy in Patients With Unresectable and Non-metastatic Pancreatic Cancer|Recruiting||Phase 1|36|Anticipated|New York University School of Medicine||3|||f||||t|t|f||||||||2017-10-10 21:54:12.105971|2017-10-10 21:54:12.105971
NCT02868619|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-04-10|||September 2014||2014-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|BED||Binge Eating Disorder and Obesity : Functional MRI Study|Binge Eating Disorder and Obesity : Reward System Abnormalities in Response to Food Stimuli and Research Operability by Deep Brain Stimulation Criteria: Functional MRI Study|Recruiting||N/A|33|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:54:12.239867|2017-10-10 21:54:12.239867
NCT02868606|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-12-27|||July 2015||2015-07-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Observational|||Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital|Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital|Active, not recruiting||N/A|41400|Anticipated|Winthrop University Hospital|||4||f||||f||||||||No||2017-10-10 21:54:12.35343|2017-10-10 21:54:12.35343
NCT02868593|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||January 2014||2014-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|MENINGITE||Etiology of Orphan Community-based Meningitis and Meningo-encephalitis.||Recruiting||N/A|1800|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:54:12.57385|2017-10-10 21:54:12.57385
NCT02868580|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-13|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|Lighthouse||Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).|Phase 2a Open Label Study, Safety and Tolerability of Combination Antiretroviral Therapy (Triumeq) in Participants With Amyotrophic Lateral Sclerosis (ALS) - The Lighthouse Project.|Active, not recruiting||Phase 2|40|Actual|Neuroscience Trials Australia||1|||f||||t||||||||||2017-10-10 21:54:12.680534|2017-10-10 21:54:12.680534
NCT02868567|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-11-04|||March 2016||2016-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Use of Dalfampridin in Primary Lateral Sclerosis|A Multicenter, 18-week Open Label Safety and Efficacy Trial of Dalfampridine in Primary Lateral Sclerosis|Recruiting||Phase 1|35|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 21:54:12.807353|2017-10-10 21:54:12.807353
NCT02868554|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-13|||August 2016||2016-08-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Accelerated Invisalign Therapy in Conjunction With Acceledent Aura|Orthodontic Tooth Movement With Accelerated Invisalign Therapy Using Acceledent Aura: A Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-10 21:54:12.915842|2017-10-10 21:54:12.915842
NCT02868541|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||September 2013||2013-09-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Observational|EMIRATH||Assessment of Pharyngeal Carriage of Microorganisms Responsible for Transmissible Acute Respiratory Infections in HAJJ Pilgrims.||Recruiting||N/A|420|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||Undecided||2017-10-10 21:54:13.041696|2017-10-10 21:54:13.041696
NCT02868528|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-05-09|||September 23, 2016|Actual|2016-09-23|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of Preimplantation Genetic Screening With Next Generation Sequencing Technology on Advanced Age Women|A Prospective Randomized Controlled Study of Preimplantation Genetic Screening With Next Generation Sequencing Technology on Advanced Age Women|Recruiting||N/A|238|Anticipated|Reproductive & Genetic Hospital of CITIC-Xiangya||2|||f||||||||||||||2017-10-10 21:54:13.138725|2017-10-10 21:54:13.138725
NCT02868515|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-19|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|November 15, 2016|Actual|2016-11-15|November 15, 2016|Actual|2016-11-15||Interventional|||The Effect of Hot Cereal on Digestive Health in Children|A Clinical Trial to Assess the Effect of Hot Cereal on Digestive Health in Children|Completed||N/A|20|Actual|PepsiCo Global R&D||1|||f||||f||||||||||2017-10-10 21:54:13.230849|2017-10-10 21:54:13.230849
NCT02868502|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-14|||September 2016||2016-09-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma|The Effect of Trabeculectomy, Glaucoma Drainage Device, Cyclophotocoagulation, and Ocular Hypotensive Eye-drops on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma|Not yet recruiting||N/A|150|Anticipated|Meir Medical Center|||6||f||||f||||||||Undecided||2017-10-10 21:54:13.331813|2017-10-10 21:54:13.331813
NCT02868489|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-06-28|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Bacillus Coagulans and Galactomannans on Obese Patients Undergoing Sleeve Gastrectomy|Effect of Bacillus Coagulans and Galactomannans on Obese Patients Undergoing Sleeve Gastrectomy|Recruiting||N/A|60|Anticipated|Loma Linda University||2|||f||||f||||||||Undecided||2017-10-10 21:54:13.494879|2017-10-10 21:54:13.494879
NCT02868476|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-11|||August 2016||2016-08-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|July 2017|Anticipated|2017-07-01|5 Years|Observational [Patient Registry]|||Long Period Observation of Biochemical Survey and Ultrasonography in Thyroid Diseases and Subclinical Thyroid Diseases|Long Period Observation of Biochemical Survey and Ultrasonography in Thyroid Diseases and Subclinical Thyroid Diseases|Not yet recruiting||N/A|800|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:54:13.634142|2017-10-10 21:54:13.634142
NCT02868463|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-22|||June 2016||2016-06-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|BEMOR||Bladder Environment: Microbiome Oxygen Relationship|Bladder Environment: Microbiome Oxygen Relationship|Recruiting||N/A|100|Anticipated|Loyola University|||1||f||||f||||||Samples With DNA|"     Urine samples will be frozen and stored in the event additional analysis is necessary   "|||2017-10-10 21:54:13.704464|2017-10-10 21:54:13.704464
NCT02868450|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||June 2013||2013-06-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|WHIPPLE||Chronic Infection With Tropheryma Whipplei: Risk Factors Related to the Host||Recruiting||N/A|225|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:54:13.800411|2017-10-10 21:54:13.800411
NCT02868437|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-14|||September 2016||2016-09-01|August 2016|2016-08-01||||January 2017|Anticipated|2017-01-01||Interventional|||Effectiveness of Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion|Effectiveness of Self-cross-linked Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion|Not yet recruiting||Phase 4|60|Anticipated|Istanbul University||2|||f||||f||||||||||2017-10-10 21:54:13.90834|2017-10-10 21:54:13.90834
NCT02868424|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-06-14|||February 13, 2016|Actual|2016-02-13|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation|Early Phase I Study of the Safety and Preliminary Efficacy of Human Fetal Retinal Pigment Epithelial(fRPE) Cells Subretinal Transplantation in Age-Related Macular Degeneration(AMD) Patients|Active, not recruiting||Early Phase 1|6|Actual|The First Affiliated Hospital with Nanjing Medical University||1|||f||||t||||||||Yes||2017-10-10 21:54:14.011673|2017-10-10 21:54:14.011673
NCT02868411|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||June 2013||2013-06-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Improving the Diagnosis of Traveller's Fevers in Point Of Care (POC)||Recruiting||N/A|1440|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:54:14.107587|2017-10-10 21:54:14.107587
NCT02868398|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-08-16|||June 2016||2016-06-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01|1 Year|Observational [Patient Registry]|Switch||Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab|Efficacy and Safety of Golimumab in Maintaining Deep Remission and Quality of Life in Ulcerative Colitis Patients in Deep Prolonged Remission With Infliximab. An Open Label, Non Interventional One Year Study.|Recruiting||N/A|50|Anticipated|Evangelismos Hospital|||1||f||||t||||||||||2017-10-10 21:54:14.203453|2017-10-10 21:54:14.203453
NCT02868385|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-10|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RePST||Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)|Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST): An Open Label, Randomized Controlled Trial of Single vs. Multiple Treatments of Praziquantel in Intestinal African Schistosomiasis in Côte d'Ivoire|Not yet recruiting||Phase 4|1000|Anticipated|Leiden University Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:54:14.291533|2017-10-10 21:54:14.291533
NCT02868372|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-14|||September 2016||2016-09-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Swabbing of Subcutaneous Tissues of Cesarean Section Wounds With Povidone Iodine|The Efficacy of Swabbing of Subcutaneous Tissues of Cesarean Section Wounds With Povidone Iodine to Prevent Postoperative Wound Infection: A Randomized Controlled Clinical Trial|Not yet recruiting||N/A|538|Anticipated|Assiut University||2|||f||||f||||||||No||2017-10-10 21:54:14.407394|2017-10-10 21:54:14.407394
NCT02868359|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-18|||October 14, 2016|Actual|2016-10-14|September 2017|2017-09-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Observational|||PROs in Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain Treated With Pregabalin|Patient-reported-outcomes In Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain (Neuropathic Component) Treated With Pregabalin In Primary Care Settings|Recruiting||N/A|360|Anticipated|Pfizer|||2||f||||f||||||||||2017-10-10 21:54:14.498088|2017-10-10 21:54:14.498088
NCT02868346|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||March 2013||2013-03-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Improving the Diagnosis of Sexually Transmitted Infections in Emergency Rooms||Recruiting||N/A|4320|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:54:14.641961|2017-10-10 21:54:14.641961
NCT02868333|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||May 2012||2012-05-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2016|Actual|2016-01-01||Observational|CEREDIH||Determinants of Health Status and Quality of Life in Patients With Primary Immunodeficiencies Inhereted Diagnosed During Childhood|Determinants of Health Status and Quality of Life in Patients With Primary Immunodeficiencies Inhereted Diagnosed During Childhood|Active, not recruiting||N/A|1780|Actual|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||No||2017-10-10 21:54:14.738721|2017-10-10 21:54:14.738721
NCT02868320|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||April 2014||2014-04-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||SMS Technology for the Promotion of Diabetes Education and Self-Management in Egypt|SMS Technology for the Promotion of Diabetes Education and Self-Management|Completed||N/A|73|Actual|Hannover Medical School||2|||f||||||||||||||2017-10-10 21:54:14.802139|2017-10-10 21:54:14.802139
NCT02868307|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||July 2012||2012-07-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2016|Actual|2016-01-01||Interventional|SCHIFT||Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their Caregivers||Active, not recruiting||N/A|200|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:54:14.901183|2017-10-10 21:54:14.901183
NCT02868294|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||September 2011||2011-09-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|Fassier-Duval||Preventive Fixation of Lower Limbs in Osteogenesis Imperfecta (Brittle Bone Disease) With the Highlight of the Fassier-Duval|Preventive Fixation of Lower Limbs in Osteogenesis Imperfecta (Brittle Bone Disease) With the Highlight of the Fassier-Duval|Recruiting||N/A|10|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:54:14.966075|2017-10-10 21:54:14.966075
NCT02868281|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-06-29|||August 26, 2016||2016-08-26|June 2017|2017-06-01|December 6, 2018|Anticipated|2018-12-06|December 6, 2018|Anticipated|2018-12-06||Interventional|||Asthma Control Test Guided Treatment in Chinese Subjects|The Effectiveness of Asthma Control Test Guided Treatment Compared With Usual Care in China Adult Asthma Patients|Recruiting||Phase 4|528|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 21:54:15.059737|2017-10-10 21:54:15.059737
NCT02868268|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-11|||August 2016||2016-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Neuroblastoma Precision Trial|N2015-01: Neuroblastoma Precision Trial|Recruiting||N/A|90|Anticipated|New Approaches to Neuroblastoma Therapy Consortium|||1||f||||t||||||Samples With DNA|"     Blood obtained (any time prior to and up to the day of biopsy) Biopsy of soft tissue, bone,     bone marrow Specimens tumor content for genetic +/- IHC analysis.   "|||2017-10-10 21:54:15.174528|2017-10-10 21:54:15.174528
NCT02868255|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|MDScan||Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma|Myeloid Derived Suppressor Cells Control by SIRP-alpha: Investigation in Hepatocellular Carcinoma|Not yet recruiting||N/A|90|Anticipated|Nantes University Hospital|||3||f||||f||||||Samples Without DNA|"     Blood and ascites will be analyzed for various cell populations by flow cytometry (different     myeloid subsets including polymorphonuclear cells, MDSC and monocytes, T cell sub-populations     including Tregs, CD8 and CD4 T cells, , B cells, and immature and mature NK cell). Myeloid     infiltrate will be also evaluated by immunochemistry staining of CD68, CD163, CD206 and SIRPα     of HCCs from the tumour bank.   "|No||2017-10-10 21:54:15.289474|2017-10-10 21:54:15.289474
NCT02868242|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-09-13|||August 28, 2016|Actual|2016-08-28|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|Egypt Peds||Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy|A Phase 2, Open-label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Subjects Undergoing Cancer Chemotherapy|Recruiting||Phase 2|40|Anticipated|Gilead Sciences||1|||f||||f||f||||||||2017-10-10 21:54:15.368532|2017-10-10 21:54:15.368532
NCT02868229|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||August 2016||2016-08-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001|A Phase 1/2 Randomized, Double-blind, Placebo Controlled, Cohort Dose-escalation Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001|Recruiting||Phase 1/Phase 2|60|Anticipated|Corvidia Therapeutics||2|||f||||t||||||||No||2017-10-10 21:54:15.617857|2017-10-10 21:54:15.617857
NCT02868216|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||September 2015||2015-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|September 2015|Actual|2015-09-01||Interventional|MAPAMI||MANAGING ANGER IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (MAPAMI)|MANAGING ANGER IN PATIENTS WITH ST SEGMENT ELEVATION ACUTE MYOCARDIAL INFACTION: A RANDOMIZED CLINICAL TRIAL|Unknown status|Enrolling by invitation|Phase 1|100|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 21:54:15.725195|2017-10-10 21:54:15.725195
NCT02868203|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-15|||August 2016||2016-08-01|May 2016|2016-05-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||OCT Based Edge and In-stent Vascular Response After Cordimax Stent in patIents With NSTE-ACS|Optical Coherence tOmography Based Edge and In-stent Vascular Response After a Novel bioDegradable Polymer sIrolimus-eLuting Stent in patIents With Non-ST Elevation acuTe Coronary sYndrome (NSTE ACS)|Not yet recruiting||Phase 4|80|Anticipated|Xijing Hospital||2|||f||||t||||||||Yes||2017-10-10 21:54:15.800076|2017-10-10 21:54:15.800076
NCT02868190|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||March 2013||2013-03-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2015|Actual|2015-03-01||Interventional|||Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication|A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication (Prostaglandin) Treated With Two Trabecular Micro-bypass Stents (iStent Inject)|Active, not recruiting||Phase 4|57|Actual|Glaukos Corporation||1|||f||||f||||||||No||2017-10-10 21:54:15.888169|2017-10-10 21:54:15.888169
NCT02868177|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-07-12|||January 2016||2016-01-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|VALEDIA-ONE||Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes|Totum-63 Effect on Glucose and Lipid Homeostasis in People With Abdominal Obesity Associated With Impaired Glucose Tolerance or Untreated Type 2 Diabetes and Hypertriglyceridemia|Recruiting||Phase 2/Phase 3|80|Anticipated|Valbiotis||2|||f||||t||||||||||2017-10-10 21:54:15.982742|2017-10-10 21:54:15.982742
NCT02868164|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.|Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.|Recruiting||N/A|120|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 21:54:16.170932|2017-10-10 21:54:16.170932
NCT02868151|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2017-07-12|||August 2016||2016-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers|Effect of Ascorbic Acid Oral Supplementation in Assessing the Severity of Oral Mucositis in Chemo-radiation Therapy of Head and Neck Cancers.|Recruiting||Phase 2/Phase 3|180|Anticipated|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||3|||f||||t||||||||||2017-10-10 21:54:16.291464|2017-10-10 21:54:16.291464
NCT02868138|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-13|||May 2016||2016-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Study of Hydroxyurea to Treat Sickle Cell Disease|Evaluation of Clinical Effectiveness, Quality of Life, and Compliance in Patients With Sickle Cell Disease Receiving Hydroxyurea|Completed||N/A|50|Actual|Mersin University|||1||f||||f||||||||Yes||2017-10-10 21:54:16.401364|2017-10-10 21:54:16.401364
NCT02868125|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-13|||May 2016||2016-05-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Radiography Protocol in the Acute Phase After Proximal Femur Internal Fixation- Self Assessment and Recommendations|Radiography Protocol in the Acute Phase After Proximal Femur Internal Fixation- Self Assessment and Recommendations|Active, not recruiting||N/A|300|Actual|Meir Medical Center|||1||f||||f||||||||No|no data will be shared|2017-10-10 21:54:16.47803|2017-10-10 21:54:16.47803
NCT02868112|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2017-04-20|||October 2016||2016-10-01|April 2017|2017-04-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Transdisciplinary Intervention Integrating Geriatric And Palliative Care With Oncology Care For Older Adults With Cancer|Pilot Study Of A Transdisciplinary Intervention Integrating Geriatric And Palliative Care With Oncology Care For Older Adults With Cancer|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 21:54:16.577434|2017-10-10 21:54:16.577434
NCT02867904|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-13|||August 2017||2017-08-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder Surgery|Efficacy of Intra-operative Subacromial Corticosteroid Injections on Surgical Outcomes After Arthroscopic Shoulder Surgery|Not yet recruiting||Phase 4|40|Anticipated|University of South Dakota||2|||f||||||||||||||2017-10-10 21:54:18.08056|2017-10-10 21:54:18.08056
NCT02868099|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-08-15|||September 2015|Actual|2015-09-01|August 2016|2016-08-01|June 2017|Actual|2017-06-01|February 2017|Actual|2017-02-01||Interventional|||Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)|A Multi-center, Randomized, Placebo-controlled, Double-blinded Then Open 2 Stages Clinical Trial to Evaluate the Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)|Completed||Phase 3|203|Actual|Kyowa Hakko Kirin China Pharmaceutical Co.,LTD.||2|||f||||f||||||||||2017-10-10 21:54:16.701441|2017-10-10 21:54:16.701441
NCT02868086|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-02-06|||October 21, 2016|Actual|2016-10-21|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|REPERM-OCT||The Impact of Two Strategies in the Monitoring of Exudative ARMD on the Visual Acuity (by OCT B Scan or OCT Angiography)||Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 21:54:16.786342|2017-10-10 21:54:16.786342
NCT02868073|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-04-06|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine|A Phase 1, Randomized, Double-Blind, Placebo-controlled, Dose-ranging Trial to Determine the Safety and Immunogenicity of an Adenoviral-vector Based Norovirus Vaccine (VXA‑G1.1-NN) Expressing GI.1 VP1 and dsRNA Adjuvant Administered Orally to Healthy Volunteers|Active, not recruiting||Phase 1|66|Actual|Vaxart||3|||f||||f||||||||No||2017-10-10 21:54:16.881287|2017-10-10 21:54:16.881287
NCT02868047|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-08-13|||September 2010||2010-09-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|September 2014|Actual|2014-09-01||Observational|||Establishing Standards for Normal Pancreatic EUS|Establishing Standards for Normal Pancreatic EUS|Completed||N/A|54|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||f||||||||No||2017-10-10 21:54:17.062935|2017-10-10 21:54:17.062935
NCT02868034|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-05-04|||February 22, 2017|Actual|2017-02-22|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Optimization of Spinal Manipulative Therapy Protocols|Optimization of Spinal Manipulation Therapy (SMT) Protocols|Recruiting||Phase 2|280|Anticipated|University of Utah||8|||f||||t|f|f||||||||2017-10-10 21:54:17.142332|2017-10-10 21:54:17.142332
NCT02868021|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-09-14|||December 12, 2016|Actual|2016-12-12|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|BFR||Blood Flow Restriction Exercise Study|Blood Flow Restriction Exercise for Older Adults Undergoing Knee Replacement Surgery|Recruiting||N/A|30|Anticipated|University of Florida||2|||f||||t||||||||||2017-10-10 21:54:17.263358|2017-10-10 21:54:17.263358
NCT02868008|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-13|||June 2016||2016-06-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|MITASREAVM||Multimodal Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations|The Efficacy of Multimodal Magnetic Resonance Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations|Recruiting||N/A|400|Anticipated|Beijing Tiantan Hospital||1|||f||||t||||||||No||2017-10-10 21:54:17.371529|2017-10-10 21:54:17.371529
NCT02867995|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-07-12|||March 23, 2017|Actual|2017-03-23|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center|Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center|Recruiting||N/A|50|Anticipated|Boston Medical Center||2|||f||||t|f|t|f|f|f|||||2017-10-10 21:54:17.467723|2017-10-10 21:54:17.467723
NCT02867982|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-08-13|||July 2016||2016-07-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Platform Switched Implant and Bone Level Alteration|Influence of Soft Tissue Thickness and Insertion Depth of Platform Switched Implants on Crestal Bone Level Alteration|Active, not recruiting||N/A|36|Anticipated|Beijing University Health Science Center||2|||f||||f||||||||Yes||2017-10-10 21:54:17.568178|2017-10-10 21:54:17.568178
NCT02867969|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||August 2016||2016-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|SlowSCA||Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial|Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial|Recruiting||N/A|26|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||No||2017-10-10 21:54:17.676174|2017-10-10 21:54:17.676174
NCT02867956|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-13|||August 2016||2016-08-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer|A Phase II Study of Apatinib In Combination With Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer|Recruiting||Phase 2|68|Anticipated|Sun Yat-sen University||1|||f||||t||||||||Yes||2017-10-10 21:54:17.767376|2017-10-10 21:54:17.767376
NCT02867930|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-08-13|||June 2016||2016-06-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|KDTEE||Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography|Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Out-patients Undergoing Diagnostic Trans-esophageal Echocardiography: A Randomized Controlled Trial|Recruiting||Phase 4|50|Anticipated|Postgraduate Institute of Medical Education and Research, Chandigarh||2|||f||||f||||||||Undecided||2017-10-10 21:54:17.919609|2017-10-10 21:54:17.919609
NCT02867917|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-13|||November 2016||2016-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Taste and Palatability in Fiber Supplements|Comparison of Taste and Texture of Metamucil, Volcolon and Psyllium Orange Generic|Not yet recruiting||N/A|100|Anticipated|VU University Medical Center||1|||f||||||||||||||2017-10-10 21:54:18.002271|2017-10-10 21:54:18.002271
NCT02867891|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-01-16|||March 2001||2001-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|SIRA||Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial|Multicenter, Observational Trial to Determine the Response Rate of Sorafenib and Donor Lymphocyte Infusions (DLI) Versus Best Available Treatment (BAT) in FLT3-ITD-mutant AML Relapse After Allogeneic Hematopoietic Cell Transplantation|Completed||N/A|396|Actual|University of Freiburg|||4||f||||f||||||Samples Without DNA|"     Serum cytokine levels (IL-15, IFN-gamma, IL-6)   "|No||2017-10-10 21:54:18.184456|2017-10-10 21:54:18.184456
NCT02867878|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-12|||August 2016||2016-08-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|TITAN||Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome|Rapid Recovery of Left Ventricular Function in Patients With Takotsubo Syndrome Undergoing Systemic Infusion of Adenosine: a Randomized Controlled Trial (TITAN Study)|Recruiting||Phase 2|40|Anticipated|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-10 21:54:18.243963|2017-10-10 21:54:18.243963
NCT02867865|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-13|||August 2016||2016-08-01|July 2016|2016-07-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|POLCAGB||Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers|Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers|Not yet recruiting||Phase 2/Phase 3|314|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:54:18.329469|2017-10-10 21:54:18.329469
NCT02867852|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-22|||March 2015||2015-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SG-ABI14||Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers|Phase II Trial of Abiraterone Acetate in Patients With Relapsed and/or Metastatic, Castration Resistant Salivary Gland Cancers|Recruiting||Phase 2|24|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||Yes|Abstract presentation to National and International congresses and final data publication on indexed papers|2017-10-10 21:54:18.411672|2017-10-10 21:54:18.411672
NCT02867839|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-19|||August 2016||2016-08-01|August 2016|2016-08-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|RESCUE-GC||Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer|A Randomized, Multicentral, Controlled, Phase III Study to Compare Adjuvant Chemotherapy With S-1 Plus Oxaliplatin to S-1 Alone After Curative Distal Gastrectomy in Locally Advanced Gastric Cancer|Not yet recruiting||Phase 3|564|Anticipated|Beijing Cancer Hospital||2|||f||||f||||||||No||2017-10-10 21:54:18.483307|2017-10-10 21:54:18.483307
NCT02867826|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The Use of Cap-assisted Forward Viewing Endoscopy for Examination of the Ampulla of Vater|The Use of Cap-assisted Forward Viewing Endoscopy for Examination of the Ampulla of Vater|Not yet recruiting||Phase 2|120|Anticipated|Barretos Cancer Hospital||1|||f||||f||||||||No||2017-10-10 21:54:18.609483|2017-10-10 21:54:18.609483
NCT02867813|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-06-09|||September 2, 2016|Actual|2016-09-02|June 2017|2017-06-01|September 29, 2021|Anticipated|2021-09-29|September 29, 2021|Anticipated|2021-09-29||Interventional|||Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension|A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Patients With Clinically Evident Cardiovascular Disease|Active, not recruiting||Phase 3|5038|Actual|Amgen||1|||f||||f||||||||||2017-10-10 21:54:18.696472|2017-10-10 21:54:18.696472
NCT02867800|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-07-12|||July 2016||2016-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease|Abatacept for Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease: a Sickle Transplant Alliance for Research Trial|Recruiting||Phase 1|10|Anticipated|Columbia University||1|||f||||t|t|f||||||||2017-10-10 21:54:19.300471|2017-10-10 21:54:19.300471
NCT02867787|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-17|||March 2014||2014-03-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|Botox shoulder||Study of the Treatment of Tendinopathy Unruptured of Rotator Cuff by Intramuscular Injection of Botulinum Toxin||Recruiting||Phase 2|40|Anticipated|Versailles Hospital||1|||f||||f||||||||||2017-10-10 21:54:19.49129|2017-10-10 21:54:19.49129
NCT02867774|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-08-15|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|IPA-CPP||Impact of Physical Activity for Chronic Pelvic Pain|Impact of Physical Activity for Chronic Pelvic Pain|Recruiting||N/A|25|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-10 21:54:19.583033|2017-10-10 21:54:19.583033
NCT02867761|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-09-13|||August 29, 2017|Actual|2017-08-29|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|RETHINC||RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative|RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative|Recruiting||Phase 3|580|Anticipated|University of Michigan||2|||f||||t|t|f|||f|||||2017-10-10 21:54:19.705564|2017-10-10 21:54:19.705564
NCT02867748|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-08-18|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings||Not yet recruiting||Phase 4|100|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||||||||||||2017-10-10 21:54:19.811771|2017-10-10 21:54:19.811771
NCT02867735|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-05|||September 22, 2016|Actual|2016-09-22|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema|A Randomized, Single-masked, Sham-control, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema From Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (AMD), or Retinal Vein Occlusions (RVO)|Recruiting||Phase 1|28|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 21:54:19.92105|2017-10-10 21:54:19.92105
NCT02867345|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-12|||November 2016||2016-11-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|||PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer|A Dose-escalation Phase I Trial of PD-1 Knockout Engineered T Cells for the Treatment of Castration Resistant Prostate Cancer|Not yet recruiting||Phase 1|20|Anticipated|Peking University||2|||f||||t||||||||Undecided|Plan to open|2017-10-10 21:54:24.740544|2017-10-10 21:54:24.740544
NCT02867722|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-12|||September 2016||2016-09-01|August 2016|2016-08-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|DaylightPDT||Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States|Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States|Not yet recruiting||N/A|40|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||No|Data will be aggregated and analyzed|2017-10-10 21:54:20.045441|2017-10-10 21:54:20.045441
NCT02867709|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-12|2017-09-06|||August 26, 2016|Actual|2016-08-26|September 2017|2017-09-01|December 14, 2017|Anticipated|2017-12-14|December 14, 2017|Anticipated|2017-12-14||Interventional|||Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine|Recruiting||Phase 3|1650|Anticipated|Allergan||3|||f||||t|t|f||||||||2017-10-10 21:54:20.157835|2017-10-10 21:54:20.157835
NCT02867696|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-08-22|||January 2015||2015-01-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of a Technology-Based Intervention on Weight Change Post-Bariatric Surgery|Effect of a Technology-Based Intervention on Weight Change Post-Bariatric Surgery|Recruiting||N/A|30|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 21:54:20.506098|2017-10-10 21:54:20.506098
NCT02867683|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-30|||October 2013||2013-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vibrotactile Feedback During Vestibular Therapy|The Effects of Vibrotactile Feedback During Vestibular Rehabilitation|Recruiting||N/A|30|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 21:54:20.623518|2017-10-10 21:54:20.623518
NCT02867670|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-15|||July 2013||2013-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||TMS as a Biological Marker of Neuroplasticity|TMS as a Biological Marker of Neuroplasticity|Recruiting||N/A|75|Anticipated|University of Pennsylvania|||2||f||||||||||Samples With DNA|"     The investigators are asking participants to provide a saliva sample which will later be     genotyped for the BDNF protein.      Saliva samples are optional.   "|||2017-10-10 21:54:20.723133|2017-10-10 21:54:20.723133
NCT02867657|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-07-10|||June 2016||2016-06-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Bringing the Practice of Mindfulness Into Nature - Preventing Mental Fatigue in Healthcare Professionals.|Enhancement of Presence, Compassion and Resilience Bringing the Practice of Mindfulness Into Nature - Preventing Mental Fatigue in Healthcare Professionals.|Recruiting||N/A|72|Anticipated|VIA University College||3|||f||||f||||||||||2017-10-10 21:54:20.833242|2017-10-10 21:54:20.833242
NCT02867644|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-12-05|||November 2016||2016-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|HYCOREMA||Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer|Randomized Trial Comparing the Contribution of Conversational Hypnosis Versus Standard Care on Patient Anxiety During a Preoperative Breast Tracking|Recruiting||Phase 2|334|Anticipated|Institut de Cancérologie de Lorraine||2|||f||||f||||||||No||2017-10-10 21:54:20.923509|2017-10-10 21:54:20.923509
NCT02867631|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-07-21|||January 2014||2014-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Postpartum Weight Retention|A Randomized Controlled Trial (RCT) of an Intervention to Combat Postpartum Weight Retention|Active, not recruiting||N/A|175|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 21:54:21.019024|2017-10-10 21:54:21.019024
NCT02867618|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-05-18|||October 16, 2016|Actual|2016-10-16|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma|Phase I/II Study of Carfilzomib and a PI3Kdelta Inhibitor TGR-1202 in the Treatment of Patients With Relapsed or Refractory Lymphoma|Recruiting||Phase 1/Phase 2|42|Anticipated|Columbia University||1|||f||||t|t|f||||||No||2017-10-10 21:54:21.114754|2017-10-10 21:54:21.114754
NCT02867605|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-04-17|||July 2016||2016-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|February 24, 2017|Actual|2017-02-24||Observational|||Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health||Active, not recruiting||N/A|22|Actual|The Cleveland Clinic|||1||f||||||||||||||2017-10-10 21:54:21.202503|2017-10-10 21:54:21.202503
NCT02867579|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-06|||April 2013||2013-04-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|Denial-attach||Pregnancy Denial and Attachment|Pregnancy Denial and Attachment|Recruiting||N/A|130|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:54:21.773169|2017-10-10 21:54:21.773169
NCT02867566|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-04-14|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients|A Multicenter, Randomized, Double-blind, Controlled, Phase III Study to Evaluate the Efficacy and Safety of IBI301 (Recombinant Chimeric Anti-CD20 Monoclonal Antibody ) in Combination With CHOP Regimen Versus Rituximab in Combination With CHOP Regimen in Treatment-naïve Patients With Diffuse Large B-cell Lymphoma (DLBCL)|Recruiting||Phase 3|400|Anticipated|Innovent Biologics (Suzhou) Co. Ltd.||2|||f||||f||||||||||2017-10-10 21:54:21.848939|2017-10-10 21:54:21.848939
NCT02867553|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-06|||October 2011||2011-10-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|RADIO-LYMPH||Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions|Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions|Active, not recruiting||Phase 3|36|Actual|CHU de Reims||2|||f||||||||||||||2017-10-10 21:54:22.121566|2017-10-10 21:54:22.121566
NCT02867540|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||November 2014||2014-11-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|MRI-CROHN||Comparison of Endoscopy and Diffusion-weighted Enterography-MRI for the Diagnosis of Crohn's Disease Recurrence Following Ileocolic Resection: a Pilot Study|Comparison of Endoscopy and Diffusion-weighted Enterography-MRI for the Diagnosis of Crohn's Disease Recurrence Following Ileocolic Resection: a Pilot Study|Recruiting||N/A|40|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:54:22.25059|2017-10-10 21:54:22.25059
NCT02867527|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-10|||January 2014||2014-01-01|August 2016|2016-08-01|January 2029|Anticipated|2029-01-01|January 2029|Anticipated|2029-01-01|15 Years|Observational [Patient Registry]|BDD_GLAUCOME||Prospective Constitution of Database Gathering Data of Patients Suffering From Glaucoma Followed at University Hospital of Grenoble|Prospective Constitution of Database Gathering Data of Patients Suffering From Glaucoma Followed at University Hospital of Grenoble|Recruiting||N/A|400|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||No||2017-10-10 21:54:22.386233|2017-10-10 21:54:22.386233
NCT02867514|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||March 2014||2014-03-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|TabaSCo||Effect of the Transcranial Direct Current Stimulation (tDCS) on Dependent Smoking People|Evaluation de l'Effet de la Stimulation Transcranienne en Courant Continu Chez Les Personnes Tabagiques dépendantes|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Besancon||4|||f||||f||||||||No||2017-10-10 21:54:22.485848|2017-10-10 21:54:22.485848
NCT02867501|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-03-31|||May 2016||2016-05-01|March 2017|2017-03-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Observational|||Venous Distension in Patients With Aneurysmatic Arterial Disease|Venous Distension in Patients With Aneurysmatic Arterial Disease Compared to the Venous Distension in Patients With Arterial Occlusive Disease|Completed||N/A|98|Actual|Kantonsspital Baselland Bruderholz|||3||f||||f||||||||||2017-10-10 21:54:23.321543|2017-10-10 21:54:23.321543
NCT02867488|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||April 2009||2009-04-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|November 2009|Actual|2009-11-01||Interventional|||Dose-response Effects of Soybean Oil in Salad Dressing on Carotenoid/Fat-soluble Vitamin Bioavailability in Salad Vegetables||Completed||N/A|||Iowa State University|||||f||||||||||||||2017-10-10 21:54:23.420579|2017-10-10 21:54:23.420579
NCT02867475|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||October 2013||2013-10-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|RESCA||REduction of Physical Inactivity Facing the CAncer|Physical Activity in Patients With Cancer: Epidemiological Study of Patients' Beliefs and Promotional Messages Efficiency|Completed||N/A|422|Actual|Centre Antoine Lacassagne||1|||f||||f||||||||Undecided||2017-10-10 21:54:23.489982|2017-10-10 21:54:23.489982
NCT02867462|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-02-02|||April 2013||2013-04-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|INFORTH||Information Consultation by Radiotherapy Manipulator|Information Consultation by a Manipulator Radiotherapy: Impact on Information to Patients Treated With Radiotherapy for Cancer|Recruiting||N/A|340|Anticipated|Centre Antoine Lacassagne||2|||f||||f||||||||Undecided||2017-10-10 21:54:23.594287|2017-10-10 21:54:23.594287
NCT02867449|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-08-10|||June 2016||2016-06-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|||Metacognitive Therapy for Obsessive-Compulsive Disorder|A Non-Inferiority Trial of Metacognitive Therapy Versus Exposure and Response Prevention for Individuals With Obsessive-Compulsive Disorder|Recruiting||N/A|70|Anticipated|University of Leipzig||2|||f||||f||||||||Undecided||2017-10-10 21:54:23.699245|2017-10-10 21:54:23.699245
NCT02867436|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-08-10|||March 2016||2016-03-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of Gluten-free Diet on New Onset Type 1 Diabetes (T1D)|The Effect of Gluten-free Diet on Residual Beta-cell Capacity, Immune Function and Gut Microbiome in Children With Newly Diagnosed Type 1 Diabetes (T1D)|Recruiting||N/A|60|Anticipated|University Hospital, Motol||2|||f||||f||||||||||2017-10-10 21:54:23.857747|2017-10-10 21:54:23.857747
NCT02867423|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-16|||February 2011||2011-02-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CYBERBOOST||Hypofractionated Radiation by CyberKnife as a Mean of the Tumor Site's Radiation After Conventional Breast Radiation.|PHASE II STUDY : Hypofractionated Radiation by CyberKnife as a Mean of Radiation of the Tumor Site After Conventional Breast Radiation.|Recruiting||Phase 2|29|Anticipated|Centre Antoine Lacassagne||1|||f||||t||||||||Undecided||2017-10-10 21:54:23.987405|2017-10-10 21:54:23.987405
NCT02867410|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-11-01|||November 2016||2016-11-01|November 2016|2016-11-01||||December 2016|Anticipated|2016-12-01||Observational|||Which Infants in a Neonatal Unit Are at Most Risk of Feeding Difficulties?|Which Infants in a Neonatal Unit Are at Most Risk of Feeding Difficulties?|Recruiting||N/A|506|Anticipated|University of Central Lancashire|||1||f||||f||||||||No||2017-10-10 21:54:24.081477|2017-10-10 21:54:24.081477
NCT02867397|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-12|||January 2012||2012-01-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors|A Phase 1, Open-Label, Non-Randomized, Dose-Finding, Safety and Tolerability Study of Orally Administered Teysuno (S-1) in Combination With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|25|Actual|Disphar International B.V.||1|||f||||||||||||||2017-10-10 21:54:24.167601|2017-10-10 21:54:24.167601
NCT02867384|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-06-07|||November 29, 2016|Actual|2016-11-29|June 2017|2017-06-01|February 2024|Anticipated|2024-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation|A Randomized Phase 2 Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation|Recruiting||Phase 2|200|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-10 21:54:24.242857|2017-10-10 21:54:24.242857
NCT02867371|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2017-07-07|||August 2016||2016-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EAST2||Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2|Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2|Recruiting||N/A|200|Anticipated|Broncus Medical Inc||1|||f||||f||||||||||2017-10-10 21:54:24.36835|2017-10-10 21:54:24.36835
NCT02867358|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-06-29|||September 2016||2016-09-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||A Clinical Trial of KT07 Capsule in the U.S.A|A Multi-center, Randomized, Double-blind, and Placebo-controlled Phase II Clinical Study to Investigate the Safety and Efficacy of Two Doses of KT07 Compared to Placebo in Subjects With Acute Uncomplicated Influenza|Recruiting||Phase 2|420|Anticipated|Yiling Pharmaceutical Inc.||3|||f||||f||||||||Undecided||2017-10-10 21:54:24.509548|2017-10-10 21:54:24.509548
NCT02867332|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-11|||November 2016||2016-11-01|August 2016|2016-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.|A Dose-escalation Phase I Trial of PD-1 Knockout Engineered T Cells for the Treatment of Metastatic Renal Cell Carcinoma|Not yet recruiting||Phase 1|20|Anticipated|Peking University||2|||f||||t||||||||Undecided|plan to do|2017-10-10 21:54:24.841284|2017-10-10 21:54:24.841284
NCT02867319|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-15|||March 2016||2016-03-01|August 2016|2016-08-01||||July 2016|Actual|2016-07-01||Interventional|||Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old||Completed||Phase 1|60|Actual|Beijing Chaoyang District Centre for Disease Control and Prevention||3|||f||||||||||||||2017-10-10 21:54:24.93119|2017-10-10 21:54:24.93119
NCT02867306|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-12|||July 2016||2016-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis|A Phase 1 Open-label, Single-sequence, Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis|Completed||Phase 1|10|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-10 21:54:24.990238|2017-10-10 21:54:24.990238
NCT02867293|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-08-12|||January 2013||2013-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|AscitesLDLT||Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.|Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.|Completed||N/A|80|Actual|Mansoura University||2|||f||||t||||||||Yes||2017-10-10 21:54:25.089181|2017-10-10 21:54:25.089181
NCT02867280|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-08-11|||June 2016||2016-06-01|August 2016|2016-08-01|June 2023|Anticipated|2023-06-01|June 2023|Anticipated|2023-06-01||Interventional|||Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection|A Prospective Multicenter Non-randomized Controlled Study of Sorafenib (Nexavar) Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection|Recruiting||Phase 3|400|Anticipated|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 21:54:25.157813|2017-10-10 21:54:25.157813
NCT02867267|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-03-27|||February 17, 2017|Actual|2017-02-17|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|August 2019|Anticipated|2019-08-01||Interventional|TESTS||The Efficacy and Safety of Ta1 for Sepsis|The Efficacy and Safety of Thymosin Alpha 1 for Sepsis: a Multicenter , Double-Blinded, Randomized and Controlled Clinical Trial|Recruiting||Phase 3|1106|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Yes||2017-10-10 21:54:25.262026|2017-10-10 21:54:25.262026
NCT02867254|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-10|||January 2014||2014-01-01|July 2015|2015-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|diabetic||Candida Albicans in Periodontal and Endodontic Lesions in Diabetic and Normoglycemic Patients|Investigations of the Prevalence and Virulence of Candida Albicans in Periodontal and Endodontic Lesions in Diabetic and Normoglycemic Patients|Completed||N/A|30|Actual|Universidade Federal Fluminense|||2||f||||f||||||||Yes||2017-10-10 21:54:25.409574|2017-10-10 21:54:25.409574
NCT02867228|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-07-25|||September 2016|Actual|2016-09-01|August 2016|2016-08-01|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Interventional|||Noninvasive Estimation of Work of Breathing|Noninvasive Estimation of Work of Breathing|Terminated||N/A|5|Actual|Respironics, California, Inc.||1||Resources to be able to screen and enroll patients are no longer available.|f||||f||||||||||2017-10-10 21:54:25.545472|2017-10-10 21:54:25.545472
NCT02867215|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-10|||September 2015||2015-09-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Barleybread||Barley Bread and Metabolic Disease|Whole Barley Bread: Effect on the Risk of Metabolic Disease and Other Health Effects|Completed||N/A|14|Actual|University of Copenhagen||2|||f||||f||||||||Yes||2017-10-10 21:54:25.624758|2017-10-10 21:54:25.624758
NCT02867202|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-08-10|||June 2015||2015-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Comparing the Efficacy of Intrauterine Balloon and Intrauterine Contraceptive Device for the Therapy of Uterine Adhesion|A Randomized Clinical Trial to Assess the Efficacy of Intrauterine Balloon Compared to Intrauterine Contraceptive Device in the Therapy for Uterine Adhesion After Hysteroscopic Adhesiolysis|Recruiting||N/A|200|Anticipated|Wenzhou Medical University||2|||f||||t||||||||No||2017-10-10 21:54:25.776929|2017-10-10 21:54:25.776929
NCT02867189|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-11|||September 2015||2015-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Developing an Atlas to Teach Nurses to Clean Micro-instruments Used in Cataract Surgery: Effect on Patient Safety|Developing an Atlas to Teach Nurses to Clean Micro-instruments Used in Cataract|Completed||N/A|120|Actual|Tianjin Medical University Eye Hospital||2|||f||||t||||||||No||2017-10-10 21:54:25.874976|2017-10-10 21:54:25.874976
NCT02867176|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-10|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Pain Management in Corneal Collagen Crosslinking for Keratoconus|Pain Management in Corneal Collagen Crosslinking for Keratoconus: Prospective Randomized Study|Completed||Phase 4|25|Actual|Instituto de Oftalmología Fundación Conde de Valenciana||2|||f||||f||||||||No||2017-10-10 21:54:25.937274|2017-10-10 21:54:25.937274
NCT02867163|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Tranexamic Acid and Blood Clots in Knee Surgery|Does the Intraoperative Administration of Tranexamic Acid (TXA) Increase the Incidence of Deep Venous Thrombosis in Total Knee Arthroplasty?|Recruiting||N/A|30|Anticipated|University of New Mexico|||1||f||||f||||||||No||2017-10-10 21:54:26.00614|2017-10-10 21:54:26.00614
NCT02867150|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-06-16|2016-08-18||October 2015||2015-10-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Retrospective Analysis of the Effects of Red Light Therapy on Body Contouring|A Retrospective Analysis of the Effects of Red Light Therapy on Body Contouring|Completed||N/A|58|Actual|Ward Photonics LLC||1|||f||||t||||||||No|No current plan to share data.|2017-10-10 21:54:26.088929|2017-10-10 21:54:26.088929
NCT02867137|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-02-20|||February 15, 2017|Actual|2017-02-15|July 2016|2016-07-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|PreTBI I||Biomarkers in Prehospital Rule-out of Intracranial Lesions in TBI Patients|Diagnostic Potential of S100B and GFAP in Prehospital Rule-out of Intracranial Lesions in Patients Suffering Mild Traumatic Brain Injury (TBI)|Recruiting||N/A|500|Anticipated|University of Aarhus|||1||f||||t||||||Samples With DNA|"     Blood samples   "|No||2017-10-10 21:54:26.236469|2017-10-10 21:54:26.236469
NCT02867124|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Long-acting Naltrexone for Pre-release Prisoners|Long-acting Naltrexone for Pre-release Prisoners: A Randomized Trial of Mobile Treatment|Recruiting||Phase 3|240|Anticipated|Friends Research Institute, Inc.||2|||f||||t||||||||||2017-10-10 21:54:26.312178|2017-10-10 21:54:26.312178
NCT02867111|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|SSA||Sperm Selection for Infertility Treatment (SSA)|Application of the Sperm Selection Assay in Assisted in Reproductive Technology|Not yet recruiting||N/A|150|Anticipated|Universidad Nacional de Córdoba||3|||f||||f||||||||No||2017-10-10 21:54:26.395552|2017-10-10 21:54:26.395552
NCT02867098|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-05-01|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|October 21, 2016|Actual|2016-10-21|October 21, 2016|Actual|2016-10-21||Interventional|||XmAb5871 Bioavailability Study|Pharmacokinetics and Relative Bioavailability of XmAb®5871 Administered Either Intravenously or Subcutaneously|Completed||Phase 1|50|Actual|Xencor, Inc.||5|||f||||f||||||||No||2017-10-10 21:54:26.493239|2017-10-10 21:54:26.493239
NCT02867085|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-10|||January 2017||2017-01-01|August 2016|2016-08-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01|5 Years|Observational [Patient Registry]|||Study Investigating the Interactions of Bone and Hematopoiesis in the Elderly|A Prospective Longitudinal Cohort Study to Investigate the Interactions of Bone and Hematopoiesis in the Elderly|Not yet recruiting||N/A|356|Anticipated|Technische Universität Dresden|||2||f||||f||||||||||2017-10-10 21:54:28.519421|2017-10-10 21:54:28.519421
NCT02867072|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-13|||January 2004||2004-01-01|August 2016|2016-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Laparoscopic Versus Open Appendectomy|Laparoscopic Versus Open Appendectomy: A Retrospective Cohort Study Assessing Outcomes and Cost-effectiveness|Completed||Phase 4|593|Actual|University of Catania||2|||f||||||||||||||2017-10-10 21:54:28.668652|2017-10-10 21:54:28.668652
NCT02867059|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|SJ733IBSMCS||SJ733 Induced Blood Stage Malaria Challenge Study|A Proof-of-concept Study to Assess the Effect of (+)-SJ000557733 (SJ733) Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants|Recruiting||Phase 1|16|Anticipated|Medicines for Malaria Venture||2|||f||||f||||||||No||2017-10-10 21:54:28.757545|2017-10-10 21:54:28.757545
NCT02867046|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-12|||July 2016||2016-07-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||The Incidence of the Intravascular Injection During S1 Transforaminal Epidural Steroid Injection in Two Approaches: Medial vs Lateral in Anteroposterior View||Recruiting||N/A|170|Anticipated|Yonsei University||2|||f||||||||||||||2017-10-10 21:54:28.84959|2017-10-10 21:54:28.84959
NCT02867020|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-10|||January 2017||2017-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels|Phase II Randomized Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels|Not yet recruiting||Phase 2|126|Anticipated|Latin American Cooperative Oncology Group||3|||f||||||||||||||2017-10-10 21:54:29.162294|2017-10-10 21:54:29.162294
NCT02867007|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-07-13|||August 2016||2016-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors|Multicenter, Open-label, Phase 1, Dose-escalation, Cohort-expansion, First-in-Human Study of KHK2455 Administered as Monotherapy and in Combination With Mogamulizumab in Adult Subjects With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|50|Anticipated|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||f||||||||||2017-10-10 21:54:29.485974|2017-10-10 21:54:29.485974
NCT02866994|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-10-25|||June 2015||2015-06-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|PCO||Project Connect Online: An Internet-based Intervention for Women With Breast Cancer|Project Connect: Enhancing Connections During Metastatic Breast Cancer (PCO)|Recruiting||N/A|64|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 21:54:29.580064|2017-10-10 21:54:29.580064
NCT02866981|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-12|||February 2014||2014-02-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Observation for Patients With Asymptomatic CNS Metastatic Disease|Observation for Patients With Asymptomatic CNS Metastatic Disease|Recruiting||Phase 2|44|Anticipated|The Cooper Health System||1|||f||||f||||||||No||2017-10-10 21:54:29.674095|2017-10-10 21:54:29.674095
NCT02866968|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-10|||July 2016||2016-07-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|FLAPS||Clinical Outcomes of Femtosecond Laser-assisted Pterygium Surgery (FLAPS)|Clinical Outcomes of Femtosecond Laser-assisted Pterygium Surgery (FLAPS)|Recruiting||N/A|30|Anticipated|Singapore Eye Research Institute||1|||f||||t||||||||||2017-10-10 21:54:29.801183|2017-10-10 21:54:29.801183
NCT02866955|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-04-27|||June 2011||2011-06-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|EFESE||Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.||Recruiting||Phase 2|100|Anticipated|Institut de Cancérologie de Lorraine||2|||f||||t|f|f|||f|||No||2017-10-10 21:54:29.889871|2017-10-10 21:54:29.889871
NCT02863653|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-08|||June 2009||2009-06-01|July 2016|2016-07-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Observational|||Participation Restrictions in Rheumatoid Arthritis|Factors Associated With Participation Restrictions in Individuals With Rheumatoid Arthritis|Completed||N/A|81|Actual|Federal University of Minas Gerais|||1||f||||f||||||||No||2017-10-10 21:54:59.143443|2017-10-10 21:54:59.143443
NCT02866942|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-03-02|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|SNIFFLE-4||Safety of Nasal Influenza Immunisation in Children With Asthma|Safety of Nasal Influenza Immunisation in Children With Asthma - The SNIFFLE-4 Study|Completed||Phase 4|479|Actual|Imperial College London||2|||f||||t||||||||No||2017-10-10 21:54:30.063448|2017-10-10 21:54:30.063448
NCT02866929|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-02-10|||September 2016||2016-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Biotype Enhancing Strategy For The Patient Undergoing Accelerated Orthodontics|Molecular Evaluation of Inflammatory and Bone Remodeling Markers in Gingival Crevicular Fluid After Selective Alveolar Decortication|Enrolling by invitation||Phase 4|40|Anticipated|CES University||4|||f||||||||||||||2017-10-10 21:54:30.156241|2017-10-10 21:54:30.156241
NCT02866916|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-11-23|||June 2017||2017-06-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|PROSTIRNA||Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA)|Phase I Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer|Not yet recruiting||Phase 1|42|Anticipated|Institut Claudius Regaud||1|||f||||t||||||||||2017-10-10 21:54:30.238813|2017-10-10 21:54:30.238813
NCT02866903|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-20|||May 18, 2017|Actual|2017-05-18|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|IPOXA||Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis|IPOXA, Phase I/II Dose Escalation Trial Aiming to Evaluate the Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis of Colorectal Origin and Uncertain Resectability.|Recruiting||Phase 1/Phase 2|47|Anticipated|Hospices Civils de Lyon||1|||f||||t|f|f||||||||2017-10-10 21:54:30.339012|2017-10-10 21:54:30.339012
NCT02866890|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-10|||December 2016||2016-12-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|||The New Laryngeal Tube Suction-Disposable for Childrens|The New Laryngeal Tube Suction-Disposable for Childrens. An Observational Study|Not yet recruiting||N/A|90|Anticipated|Bnai Zion Medical Center||3|||f||||t||||||||Yes||2017-10-10 21:54:30.457438|2017-10-10 21:54:30.457438
NCT02866877|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-04-26|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage|Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage|Recruiting||N/A|20|Anticipated|University of Colorado, Denver|||1||f|||||f|f|||f|||||2017-10-10 21:54:30.530878|2017-10-10 21:54:30.530878
NCT02866864|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-03-02|||August 24, 2016|Actual|2016-08-24|March 2017|2017-03-01|September 1, 2016|Actual|2016-09-01|August 26, 2016|Actual|2016-08-26||Observational|||Animal Allergy in Korean Veterinary Researcher|Sensitization to Animal Allergens and Allergic Symptoms During Exposure to Animal Allergens in Korean Veterinary Researcher|Completed||N/A|135|Actual|Gachon University Gil Medical Center|||2||f||||t||||||||No|Individual participant will be informed of results of questionnaires and skin prick test immediately after they complete questionnaires and skin prick test|2017-10-10 21:54:30.626331|2017-10-10 21:54:30.626331
NCT02866851|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-10|||September 2015||2015-09-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|BioConnect||Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy|Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy|Recruiting||N/A|217|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||f||||||||||2017-10-10 21:54:30.718775|2017-10-10 21:54:30.718775
NCT02866838|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-02-13|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TICH-NOAC||Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist|Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist Oral Anticoagulants (NOAC) With Tranexamic Acid|Recruiting||Phase 2/Phase 3|109|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t|f|f||||||Undecided||2017-10-10 21:54:30.807725|2017-10-10 21:54:30.807725
NCT02866825|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-02-14|||May 2016||2016-05-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|CARDIAC||Studying Complement Inhibition in Complex Cardiac Surgery|A Phase II Randomized, Placebo-controlled, Double-blind, Dose-escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamic Dose Response Relationship of IFX-1 in Patients Undergoing Complex Cardiac Surgery|Completed||Phase 2|116|Actual|InflaRx GmbH||2|||f||||t||||||||No||2017-10-10 21:54:30.912828|2017-10-10 21:54:30.912828
NCT02866812|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-10|||March 2016||2016-03-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|DEP-AIC||Prevalence and Factors Associated With the Occurrence of Depression Six Months After an Endovascular Treatment of Intracranial Aneurysm|Prevalence and Factors Associated With the Occurrence of Depression Six Months After an Endovascular Treatment of Intracranial Aneurysm|Recruiting||N/A|145|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:54:31.13485|2017-10-10 21:54:31.13485
NCT02866799|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-10-05|||November 2016|Actual|2016-11-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|Multi-PAP||Multi-PAP RCT: Improving Prescription in Primary Care Patients With Multimorbidity and Polypharmacy|Effectiveness of an Intervention for Improving Drug Prescription in Primary Care Patients With Multimorbidity and Polypharmacy: Study Protocol of a Cluster Randomized Clinical Trial (Multi-PAP Project)|Active, not recruiting||N/A|400|Anticipated|Instituto Aragones de Ciencias de la Salud||2|||f||||t||||||||||2017-10-10 21:54:31.220071|2017-10-10 21:54:31.220071
NCT02866786|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-07-23|||August 15, 2016|Actual|2016-08-15|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|April 20, 2017|Actual|2017-04-20||Interventional|||The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS|The Effects of Treatment With Oral Contraceptive Pill Containing Ethinyl Estradiol-Cyproterone Acetate and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in Polycystic Ovarian Syndrome|Active, not recruiting||Phase 4|101|Actual|S.C.B. Medical College and Hospital||2|||f||||t||||||||||2017-10-10 21:54:31.334295|2017-10-10 21:54:31.334295
NCT02866422|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-10|||March 2014||2014-03-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Development of an Instrument That Monitors Behaviors Associated With OCD|Development of an Instrument That Monitors Behaviors Associated With OCD|Completed||N/A|40|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-10 21:54:34.153386|2017-10-10 21:54:34.153386
NCT02866773|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-10|||January 2016||2016-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Community-based Family Holistic Health Promotion Project in Hong Kong: A Cluster Randomized Controlled Trial (cRCT)|Family Holistic Health Community Promotion, A Community-based Research to Promote Healthy Diet and Physical Activity in Hong Kong Island: A Cluster Randomized Controlled Trial (cRCT)|Recruiting||N/A|1200|Anticipated|The University of Hong Kong||8|||f||||t||||||||No||2017-10-10 21:54:31.457772|2017-10-10 21:54:31.457772
NCT02866760|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-10|||July 2016||2016-07-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Helping In-patients to Quit Smoking by Understanding Their Risk Perception, Behavior, and Attitudes Related to Smoking|Helping In-patients to Quit Smoking by Understanding Their Risk Perception, Behavior, and Attitudes Related to Smoking|Recruiting||N/A|412|Anticipated|The University of Hong Kong|||1||f||||f||||||||No||2017-10-10 21:54:31.602981|2017-10-10 21:54:31.602981
NCT02866747|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-03-15|||January 17, 2017|Actual|2017-01-17|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01||Interventional|STERIMGLI||A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma|A Phase I/II Multicenter Trial Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and the Anti-Programmed Death-ligand 1 (PD-L1) Durvalumab (Medi4736) for Patients With Recurrent Glioblastoma (STERIMGLI)|Recruiting||Phase 1/Phase 2|62|Anticipated|Institut Claudius Regaud||2|||f||||t||||||||||2017-10-10 21:54:31.699569|2017-10-10 21:54:31.699569
NCT02866734|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Diabetic Retinopathy Screening in Private Practice|The Feasibility of Screening for Diabetic Retinopathy in Private Practice Hong Kong|Not yet recruiting||N/A|1500|Anticipated|The University of Hong Kong||3|||f||||t||||||||No||2017-10-10 21:54:31.841171|2017-10-10 21:54:31.841171
NCT02866721|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-03-08|||August 2016||2016-08-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|CEASE-CF||Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis|A Phase I, Single Center, Open Label, Single Dose, Dose Escalation Study Assessing the Safety and Tolerability of AllogeneiC MEsenchymAl Stem CEll Infusion in Adults With Cystic Fibrosis-CEASE CF|Recruiting||Phase 1|15|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||t||||||||Undecided||2017-10-10 21:54:31.93689|2017-10-10 21:54:31.93689
NCT02866708|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-03|||July 1, 2016||2016-07-01|September 2017|2017-09-01|April 20, 2017|Actual|2017-04-20|April 2017|Actual|2017-04-01||Interventional|||The Effects of Intermittent Negative Pressure on Wound Healing and Peripheral Circulation in Spinal Cord Injured Subjects|Acute and Long-term Clinical Effects of Intermittent Negative Pressure on Wound Healing in Spinal Cord and the Peripheral Circulation in Spinal Cord Injured Subjects|Completed||N/A|9|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 21:54:32.048386|2017-10-10 21:54:32.048386
NCT02866695|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-05-02|||October 6, 2016|Actual|2016-10-06|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients|Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of Actinic Keratosis on the Face in Solid Organ Transplant Recipients|Recruiting||Phase 4|20|Anticipated|University of California, San Francisco||1|||f||||f||||||||Yes|Individual participant data may be shared with authorized representatives of the study sponsor LEO Pharma, Inc., The University of California, FDA|2017-10-10 21:54:32.132049|2017-10-10 21:54:32.132049
NCT02866682|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Phase 4, Open Label Multi-Center, Prospective, Randomized Study of Comparing the Efficacy and Safety of Generic vs. Brand Tacrolimus on Kidney Transplant Outcomes in De Novo in Kidney, Heart and Liver Transplant Recipients|Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response|Not yet recruiting||Phase 4|300|Anticipated|University of California, Los Angeles||4|||f||||t||||||||Yes||2017-10-10 21:54:32.223689|2017-10-10 21:54:32.223689
NCT02866669|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-08-30|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|February 2020|Anticipated|2020-02-01||Interventional|||Southeastern Collaboration to Improve Blood Pressure Control|Collaboration to Improve Blood Pressure in the US Black Belt-addressing the Triple Threat|Recruiting||N/A|2000|Anticipated|University of Alabama at Birmingham||4|||f||||t|f|f||||||||2017-10-10 21:54:32.330099|2017-10-10 21:54:32.330099
NCT02866656|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-08-12|||September 2016||2016-09-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||The Clinical Research of Low Intensity Continuous Ultrasonic on Lower Limb Arteriosclerosis Occlusion（ASO） Syndrome|The Clinical Research of Low Intensity Continuous Ultrasonic on Lower Limb Arteriosclerosis Occlusion(ASO) Syndrome|Not yet recruiting||N/A|90|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 21:54:32.43365|2017-10-10 21:54:32.43365
NCT02866643|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-04-26|||October 2016||2016-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|LADII||Labor and Delivery Implant Insertion: A Randomized Controlled Trial||Recruiting||Phase 3|82|Anticipated|Stanford University||2|||f||||f||||||||No||2017-10-10 21:54:32.520664|2017-10-10 21:54:32.520664
NCT02866630|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-06-30|||July 20, 2017|Anticipated|2017-07-20|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|SEVO-DES||Coronary Sinus Blood Sevoflurane and Desflurane Concentration and Lactate Changes in Patients Undergoing Heart Surgery|Coronary Sinus Blood Sevoflurane and Desflurane Concentration and Lactate Changes in Patients Undergoing Heart Surgery|Not yet recruiting||N/A|60|Anticipated|University of Malaya|||2||f||||f||||||||||2017-10-10 21:54:32.647642|2017-10-10 21:54:32.647642
NCT02866617|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-08-10|||October 2015||2015-10-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Randomized Controlled Clinical Trial Of Oral Health-Related Quality Of Life In Patients Wearing Vacuum Formed Thermoplastic Retainers Constructed On Conventional Stone Models And On 3D Reconstructed Orthodontic Study Model||Recruiting||N/A|24|Anticipated|University of Malaya||2|||f||||||||||||||2017-10-10 21:54:32.727731|2017-10-10 21:54:32.727731
NCT02865863|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-12|||July 2014||2014-07-01|August 2016|2016-08-01||||October 2015|Actual|2015-10-01||Interventional|||A Study to Evaluate the Effect of a Study Product on Quality of Life and Mood|Safety and Efficacy Profile of the Eurycomalongifoliawaterextract (Physta®)+Multivitamin Study Product|Completed||Phase 2|86|Actual|KGK Synergize Inc.||2|||f||||||||||||||2017-10-10 21:54:39.046774|2017-10-10 21:54:39.046774
NCT02866604|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|FLUID||Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)|Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)|Not yet recruiting||N/A|160|Anticipated|University of Malaya||2|||f||||t||||||||No||2017-10-10 21:54:32.827685|2017-10-10 21:54:32.827685
NCT02866578|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-07-06|||July 2016||2016-07-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|PROVECS||Open Lung Protective Ventilation in Cardiac Surgery|Open Lung Protective Ventilation During Cardiac Surgery With Cardiopulmonary Bypass : a Randomized Controlled Trial|Recruiting||N/A|494|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 21:54:32.995053|2017-10-10 21:54:32.995053
NCT02866565|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-10|||February 2017||2017-02-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|February 2019|Anticipated|2019-02-01||Interventional|REGENDER||Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs||Not yet recruiting||Phase 2|45|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||t||||||||||2017-10-10 21:54:33.084211|2017-10-10 21:54:33.084211
NCT02866552|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-10|||January 2017||2017-01-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|SCLERADECIII||SCLERoderma et Adipose-DErived Stroma Cells||Not yet recruiting||Phase 2|44|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-10-10 21:54:33.167104|2017-10-10 21:54:33.167104
NCT02866539|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes|A Polyherbal for Control of Blood Sugar in Subjects With Impaired Glucose Tolerance and/or Early Type 2 Diabetes. A Randomized Placebo Controlled Study of a Polyherbal (Whole Herb Formulation)|Recruiting||N/A|200|Anticipated|Organic India||2|||f||||t||||||||Undecided||2017-10-10 21:54:33.251748|2017-10-10 21:54:33.251748
NCT02866526|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-02-23|||February 13, 2017|Actual|2017-02-13|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|TRANSHEMO||Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia|Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO|Recruiting||N/A|567|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f|f|f||||||||2017-10-10 21:54:33.333507|2017-10-10 21:54:33.333507
NCT02866513|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-10|||February 2016||2016-02-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Transpulmonary Pressure and Airway Pressure Release Ventilation (APRV).|Incidence of High Levels of Transpulmonary Pressure During the Use of Airway Pressure Release Ventilation.|Recruiting||N/A|20|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:54:33.511588|2017-10-10 21:54:33.511588
NCT02866500|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-08-10|||January 2015||2015-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|VADS||Oral State of Patients Affected by an Oral Cancer Before and After Radiotherapy - 3-years Prospective Study|Oral State of Patients Affected by an Oral Cancer Before and After Radiotherapy - 3-years Prospective Study|Recruiting||N/A|150|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:54:33.603284|2017-10-10 21:54:33.603284
NCT02866487|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-24|||August 2016||2016-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|November 2018|Anticipated|2018-11-01||Observational|NAIL-5||Lung Fluid and Peripheral Blood Neutrophil IL-5 Surface Receptor in Children With Asthma|Lung Fluid and Peripheral Blood Neutrophil IL-5 Surface Receptor in Children With Asthma|Recruiting||N/A|90|Anticipated|University of Virginia|||2||f||||f||||||Samples With DNA|"     Venous blood, bronchoalveolar (BAL) fluid, nasal wash/absorbent pad fluid, and nasal scraping     epithelial cells will be collected for study analyses with leftover samples banked for future     research   "|No||2017-10-10 21:54:33.680062|2017-10-10 21:54:33.680062
NCT02866474|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-12||||||July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|RENES+||Efficacy of the Implementation of a Food and Nutritional Support Strategy Adapted to Dependent Elderly Subjects|Efficacy of the Implementation of a Food and Nutritional Support Strategy Adapted to Dependent Elderly Subjects: Controlled Trial.|Not yet recruiting||N/A|400|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:54:33.768151|2017-10-10 21:54:33.768151
NCT02866461|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Endogenous Opioid Systems and Symptom Change in Fibromyalgia|Endogenous Opioid Systems and Symptom Change in Fibromyalgia|Not yet recruiting||N/A|80|Anticipated|University of Utah|||1||f||||f||||||Samples With DNA|"     Blood will be sampled at baseline to test for genes that may be associated with the function     of the chemical signals between nerve cells, function of hormones, and symptoms. The genetic     portion of the study is optional.   "|||2017-10-10 21:54:33.848179|2017-10-10 21:54:33.848179
NCT02866448|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-11-28|||August 2016||2016-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|QUAP||Impact of isoQUercetin and Aspirin on Platelet Function|The Impact of Isoquercetin and Aspirin on Platelet Function|Withdrawn||N/A|0|Actual|University of Reading||4||Funding delayed beyond acceptable start date|f||||f||||||||No|Data will be averaged (some will also be normalized) before publishing, IPD (Individual Participant Data) will not be made available|2017-10-10 21:54:33.938204|2017-10-10 21:54:33.938204
NCT02866435|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-09-29|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes|Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes|Recruiting||Early Phase 1|120|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|t|f|||f|||||2017-10-10 21:54:34.041906|2017-10-10 21:54:34.041906
NCT02866409|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-10|||November 2013||2013-11-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Scalp Block Versus Scalp Infiltration With Dexmedetomidine and Local Anesthetic for Post Craniotomy Pain|Efficacy of Dexmedetomidine as an Adjuvant to Local Anesthetic Agent in Scalp Block and Scalp Infiltration to Control Post Craniotomy Pain|Completed||Phase 2|150|Actual|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||Undecided||2017-10-10 21:54:34.24139|2017-10-10 21:54:34.24139
NCT02866396|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-11-06|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|PREGAB||Impact of Pregabalin in Chronic Users vs. a Perioperative Limited Prescription on Oxycodone Requirement|Postoperative Oxycodone Consumption After Spinal Surgery in Pregabalin-treated Patients Compared to a 48-h Perioperative Administration: a Prospective, Observational Study|Recruiting||N/A|70|Anticipated|Private Hospital Sevigne|||2||f||||f||||||||No||2017-10-10 21:54:34.410388|2017-10-10 21:54:34.410388
NCT02866383|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|CheckPAC||Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer Patients|A Prospective Randomized, Open-label Phase 2 Study of Immune Checkpoint Inhibition, Nivolumab With or Without Ipilimumab in Combination With Radiation Therapy in Pretreated Patients With Metastatic Pancreatic Cancer.|Recruiting||Phase 2|80|Anticipated|Herlev Hospital||2|||f||||f||||||||No||2017-10-10 21:54:34.528766|2017-10-10 21:54:34.528766
NCT02866370|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-10|||April 2015||2015-04-01|July 2016|2016-07-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|NiCCC||Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium|A Randomised Phase II Study Of Nintedanib (BIBF1120) Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium|Recruiting||Phase 2|120|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||t||||||||Yes|It is proposed that data generated by the study will be available 2 years after completion of the trial, or after publication of the first major paper describing the dataset, whichever occurs sooner.|2017-10-10 21:54:34.63847|2017-10-10 21:54:34.63847
NCT02866357|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-05|||August 2016||2016-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Respiratory Pathogens of Patients With Asthma and COPD Exacerbations|Multiplex Molecular Detection of Respiratory Pathogens of Adult Patients Admitted to Hospital for Exacerbation of Asthma and Chronic Obstructive Pulmonary Disease and Their Clinical Outcomes.|Recruiting||N/A|1000|Anticipated|Chinese University of Hong Kong|||1||f||||f||||||Samples Without DNA|"     Nasopharyngeal aspirate   "|||2017-10-10 21:54:34.812891|2017-10-10 21:54:34.812891
NCT02866344|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-07-18|||August 2016||2016-08-01|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases|Prospective Randomized Comparison of Resection and Microwave Ablation for Resectable Colorectal Cancer Liver Metastases|Recruiting||N/A|164|Anticipated|Carolinas Healthcare System||2|||f||||t|f|f||||||||2017-10-10 21:54:34.887298|2017-10-10 21:54:34.887298
NCT02866331|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-10|||July 2016||2016-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||G-CSF and Autologous Cord Blood Infusion in Cerebral Palsy|Phase II, Randomized, Double-blind Clinical Trial for Efficacy of G-CSF and Autologous Cord Blood Infusion in Children With Cerebral Palsy|Recruiting||Phase 2|88|Anticipated|Hanyang University Seoul Hospital||4|||f||||t||||||||Yes||2017-10-10 21:54:34.993029|2017-10-10 21:54:34.993029
NCT02866318|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|LCCUSUMLVEF||Learning Curve CUSUM of LV Ejection Fraction by Visual Estimation in Novice Practitioners|CUSUM Analysis in the Assessment of Novice Practitioners' Visual Estimation in LV Ejection Fraction With Echocardiographic Images|Recruiting||N/A|100|Anticipated|Hanyang University|||1||f||||t||||||||Yes||2017-10-10 21:54:35.089823|2017-10-10 21:54:35.089823
NCT02866305|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-09|2016-08-14|||March 2009||2009-03-01|August 2016|2016-08-01|December 2024|Anticipated|2024-12-01|December 2017|Anticipated|2017-12-01||Interventional|TOPP||Study Designed to Optimize the Treatment of Primary Pneumothorax|Thoracoscopic Treatment of Primary Pneumothorax - A National Randomised Controlled Trial|Recruiting||Early Phase 1|300|Anticipated|Odense University Hospital||4|||f||||t||||||||No||2017-10-10 21:54:35.179977|2017-10-10 21:54:35.179977
NCT02866292|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-12|||November 2014||2014-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||The Pelvic Floor Muscles Strength and Sexual Function in Primigravid and Non-pregnant Nulliparous|Is There Relationship Between the Pelvic Floor Muscles Strength and Sexual Function in Primigravid and Non-pregnant Nulliparous?|Completed||N/A|154|Actual|Federal University of Uberlandia|||2||f||||t||||||||||2017-10-10 21:54:35.302426|2017-10-10 21:54:35.302426
NCT02866279|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-07-26|||November 2016||2016-11-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial||Recruiting||Phase 4|375|Anticipated|Montefiore Medical Center||3|||f||||f||||||||||2017-10-10 21:54:35.370054|2017-10-10 21:54:35.370054
NCT02866266|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-10-04||||||October 2016|2016-10-01||||October 2015|Actual|2015-10-01||Observational|||ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning|Extended Release (ER) / Long-acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Assessment 5.1: Surveillance of Emergency Department Visits and Hospitalizations for Opioid Overdose and Poisoning Events|Active, not recruiting||N/A|183452|Actual|ER/LA Opioid REMS Program Companies (RPC)|||2||f||||||||||||||2017-10-10 21:54:35.444365|2017-10-10 21:54:35.444365
NCT02866253|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-13|||December 2014||2014-12-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|IVF||Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles|Dehydroepiandrosterone (DHEA)Supplementations Pre-IVF Cycles Improve the Outcome of Diminished Ovarian Reserve（DOR）Patients by the Increased Level of BMP-15(Bone Morphogenetic Protein 15) in Follicular Micro-environment|Completed||Phase 4|78|Actual|ShangHai Ji Ai Genetics & IVF Institute||2|||f||||t||||||||Yes||2017-10-10 21:54:35.505231|2017-10-10 21:54:35.505231
NCT02865512|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-11|||July 2016||2016-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Thoracic Epidurography Different Position|An Analysis of Thoracic Epidurography Contrast Patterns According to Two Different Position of Patient|Recruiting||N/A|70|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||f||||||||No||2017-10-10 21:54:41.829235|2017-10-10 21:54:41.829235
NCT02866240|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-07-10|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy|Safety and Therapeutic Measures of Cathodal Transcranial Direct Current Stimulation (Tdcs) in Patients With Refractory Focal Epilepsy|Recruiting||N/A|13|Anticipated|Neuroelectrics Corporation||1|||f||||t|f|t|t|||||||2017-10-10 21:54:35.569857|2017-10-10 21:54:35.569857
NCT02866227|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-07-20||2017-07-10|July 15, 2016|Actual|2016-07-15|July 19, 2017|2017-07-19|June 10, 2017|Actual|2017-06-10|June 10, 2017|Actual|2017-06-10||Interventional|||TOL-463 Phase 2 Study for Vaginitis|A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)|Completed||Phase 2|106|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-10 21:54:35.658845|2017-10-10 21:54:35.658845
NCT02866214|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-10-27|||August 2016||2016-08-01|August 2016|2016-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.|Evaluation of the Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.|Completed||Phase 2/Phase 3|50|Anticipated|Ain Shams University||2|||f||||||||||||||2017-10-10 21:54:35.77448|2017-10-10 21:54:35.77448
NCT02866201|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-10|||August 2013||2013-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|DIAVOY||Etiological Diagnosis of Traveler's Diarrhoea||Recruiting||N/A|7500|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:54:35.837315|2017-10-10 21:54:35.837315
NCT02866188|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|TFSRCASW||The Feasibility Study of Recognition of Cardiac Arrest Using a Smart Watch||Active, not recruiting||N/A|50|Anticipated|Hanyang University|||1||f||||t||||||||||2017-10-10 21:54:35.906044|2017-10-10 21:54:35.906044
NCT02866162|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-10|||September 2013||2013-09-01|August 2016|2016-08-01||||September 2015|Actual|2015-09-01||Observational|neutropenias||Screening for Genes in Patients With Congenital Neutropenia|Identification of the Molecular Bases of Syndromic Congenital Neutropenia With Development Anomalies|Completed||N/A|25|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:54:36.655728|2017-10-10 21:54:36.655728
NCT02866149|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-02-10|||July 2015||2015-07-01|February 2017|2017-02-01|July 2024|Anticipated|2024-07-01|July 2018|Anticipated|2018-07-01||Interventional|ALCINA||Analysis of Circulating Tumor Markers in the Blood (ALCINA)|Analysis of Circulating Tumor Markers in the Blood|Recruiting||N/A|620|Anticipated|Institut Curie||9|||f||||f||||||||No||2017-10-10 21:54:36.743751|2017-10-10 21:54:36.743751
NCT02866136|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-07-21|||February 2012||2012-02-01|July 2017|2017-07-01|February 2027|Anticipated|2027-02-01|February 2019|Anticipated|2019-02-01||Interventional|RETINO2011||Conservative Treatments of Retinoblastoma|Conservative Treatments of Retinoblastoma|Recruiting||Phase 2|133|Anticipated|Institut Curie||3|||f||||t||||||||||2017-10-10 21:54:36.928105|2017-10-10 21:54:36.928105
NCT02866123|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-12|||January 2015||2015-01-01|July 2016|2016-07-01||||May 2015|Actual|2015-05-01||Interventional|SNG echo||Verification of Correct Positioning of a Gastric Tube by Ultrasonography|Prospective Study to Evaluate Ultrasound Verification of the Correct Position of Gastric Tubes in Intensive Care|Terminated||N/A|19|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 21:54:37.099482|2017-10-10 21:54:37.099482
NCT02866110|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|IP5n||Training of Neural Responding in BPD|Training of Neural Responding With fMRI Neurofeedback in Borderline Personality Disorder|Recruiting||N/A|25|Anticipated|Central Institute of Mental Health, Mannheim||1|||f||||f||||||||Yes|Pseudonymized data will be shared with projects from the BrainTrain-network, http://www.braintrainproject.eu|2017-10-10 21:54:37.19677|2017-10-10 21:54:37.19677
NCT02866097|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-08-09|||March 2016||2016-03-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Integrated Community Case Management Study in Eastern Province, Zambia|Strengthening the Delivery of Integrated Community Case Management (iCCM) in Two Districts of Eastern Province, Zambia|Recruiting||N/A|3840|Anticipated|Zambia Center for Applied Health Research and Development||2|||f||||f||||||||Yes|The investigators will make the data available to outside parties upon receipt of an appropriate request detailing specific aims and an acceptable analysis plan.|2017-10-10 21:54:37.322414|2017-10-10 21:54:37.322414
NCT02866084|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-01-27|||September 28, 2016|Actual|2016-09-28|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Neuromodulation Treatment of Vestibular Migraines|Neuromodulation Treatment of Vestibular Migraines|Recruiting||N/A|10|Anticipated|University of Miami||1|||f||||f|f|f||||||Undecided||2017-10-10 21:54:37.45159|2017-10-10 21:54:37.45159
NCT02866071|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-05-11|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain|Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain|Not yet recruiting||Phase 3|225|Anticipated|University of Cincinnati||2|||f||||t|t|f||||||No||2017-10-10 21:54:37.5878|2017-10-10 21:54:37.5878
NCT02866058|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-12|||May 2011||2011-05-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2013|Actual|2013-07-01||Observational|||Outcomes of Cesarean Section vs Vaginal Delivery: Instrumental Variable Adjusted Analysis|Substantial Variability Between Traditional and Instrumental Variable Estimates of the Risk of Caesarean Section in Canada: a Population-based Cohort Study|Completed||N/A|1703590|Actual|Memorial University of Newfoundland|||2||f||||f||||||||No|The data provider does not allow sharing of investigator data, but data can be requested directly from them.|2017-10-10 21:54:37.683231|2017-10-10 21:54:37.683231
NCT02866045|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-09|||May 2016||2016-05-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs|Endoscopic Ultrasonography Guided Fine Needle Biopsy (EUS-FNB) vs. Single-incision Needle-knife (SINK) Biopsy for Diagnosis of Upper Gastrointestinal Subepithelial Lesions|Recruiting||Phase 3|104|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-10-10 21:54:37.752284|2017-10-10 21:54:37.752284
NCT02866032|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-10-18|||September 2016||2016-09-01|October 2016|2016-10-01||||July 2018|Anticipated|2018-07-01||Interventional|||Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)|A Multi-centre, Randomized, Two-armed, Parallel Group and Evaluator-blinded Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)|Recruiting||Phase 3|||Moberg Pharma AB||2|||f||||||||||||||2017-10-10 21:54:37.856704|2017-10-10 21:54:37.856704
NCT02866019|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-12|||June 2016||2016-06-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer|A Phase III, Multicenter, Open-label Study to Evaluate the Esophageal Stenosis Inhibition Effects and Safety of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer|Recruiting||Phase 3|9|Anticipated|CellSeed Inc.||1|||f||||f||||||||||2017-10-10 21:54:37.940403|2017-10-10 21:54:37.940403
NCT02866006|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer|Open-label, Dose-escalation, Multiple Dosing Study to Evaluate the Safety, Tolerability, Immune Response and Pre Efficacy of BVAC-C in Patients With Multiple Metastatic Progressive or Recurrent HPV Type 16 or 18 Positive Cervical Cancer After Failure to Standard Care|Recruiting||Phase 1|9|Anticipated|Cellid Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:54:38.046879|2017-10-10 21:54:38.046879
NCT02865993|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-12|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Betadine Irrigation in Cesarean Section|May Betadine Improve Cesarean Section Outcomes?|Completed||N/A|80|Actual|Campus Bio-Medico University||2|||f||||f||||||||Undecided||2017-10-10 21:54:38.134973|2017-10-10 21:54:38.134973
NCT02865980|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Effect of Washing With Clove Extract on Inflammation and Infection Place Logging Shaldon Needle|Effect of Washing With Clove Extract on Inflammation and Infection Place Logging Shaldon Needle|Recruiting||N/A|60|Anticipated|Mashhad University of Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 21:54:38.229993|2017-10-10 21:54:38.229993
NCT02865967|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-26|||August 2016||2016-08-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|||Developing and Implementing Asthma-Guidance and Prediction System (a-GPS) for Better Asthma Management|Enhancing Asthma Care and Outcome Through the Implementation of Asthma-Guidance and Prediction System (a-GPS) on Asthma Management Program: A Randomized Block Design|Recruiting||N/A|300|Anticipated|Mayo Clinic||6|||f||||f||||||||No|No plan to share IPD.|2017-10-10 21:54:38.339443|2017-10-10 21:54:38.339443
NCT02865954|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-10|||October 2016||2016-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|iball||Iball & Pelvic Floor Muscle Training|Use of Iball Mobile Health Technology in Pelvic Floor Muscle Training in the Postpartum Period: a Pilot Mixed Methods Study|Not yet recruiting||N/A|60|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 21:54:38.432459|2017-10-10 21:54:38.432459
NCT02865941|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-10|||September 2016||2016-09-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|TFO2||Target Fortification of Breast Milk: How Often Breast Milk Needs to be Measured?|Target Fortification of Breast Milk: The Effect of Different Schedules for Milk Analysis on the Growth and Development of Preterm Infants.|Not yet recruiting||N/A|56|Anticipated|McMaster Children's Hospital||2|||f||||f||||||||No||2017-10-10 21:54:38.505067|2017-10-10 21:54:38.505067
NCT02865928|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-05|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 1, 2018|Anticipated|2018-09-01||Interventional|||Serratus Plane Block for Postoperative Pain Control|Serratus Plane Block for Postoperative Pain Control After Breast Surgery|Recruiting||Phase 4|90|Anticipated|Northwell Health||2|||f||||f|t|f|||t|||||2017-10-10 21:54:38.607988|2017-10-10 21:54:38.607988
NCT02865915|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-28|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||MLE4901 vs. Placebo for the Treatment of PCOS|A Double-blind, Randomized, Parallel-group, Placebo-controlled Study of MLE4901 for the Treatment of Polycystic Ovary Syndrome (PCOS)|Terminated||Phase 2|55|Actual|Millendo Therapeutics, Inc.||2||The risk/benefit profile no longer indicated continued development.|f||||t||f||||||||2017-10-10 21:54:38.701521|2017-10-10 21:54:38.701521
NCT02865902|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-12|||September 2014||2014-09-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Low-level Laser Therapy in Enhancing Wound Healing and Preserving Tissue Thickness|Low-level Laser Therapy in Enhancing Wound Healing and Preserving Tissue Thickness at Free Gingival Graft Donor Sites: A Randomised Controlled Clinical Study|Completed||N/A|40|Actual|Karadeniz Technical University||2|||f||||f||||||||Undecided||2017-10-10 21:54:38.830944|2017-10-10 21:54:38.830944
NCT02865889|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-09|||September 2008||2008-09-01|August 2016|2016-08-01||||March 2013|Actual|2013-03-01||Observational|||Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications||Completed||N/A|343|Actual|Institut Paoli-Calmettes|||1||f||||f||||||||||2017-10-10 21:54:38.894799|2017-10-10 21:54:38.894799
NCT02865876|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-09|||June 2015||2015-06-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|August 2016|Actual|2016-08-01||Interventional|||Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis|Effectiveness of Corneal Accelerated Crosslinking Versus Conventional Treatment for Infectious Keratitis|Recruiting||Phase 3|264|Anticipated|Instituto de Oftalmología Fundación Conde de Valenciana||2|||f||||t||||||||Yes|Investigators describe demographic characteristics of the participants, such as age, gender, etiology, intervention group and the response variables, complications and corneal healing.|2017-10-10 21:54:38.964405|2017-10-10 21:54:38.964405
NCT02865850|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-14|||July 2016||2016-07-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)|Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction of Anemia in Subjects With Incident Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE - CORRECTION)|Recruiting||Phase 3|400|Anticipated|Akebia Therapeutics||2|||f||||t||||||||||2017-10-10 21:54:39.117534|2017-10-10 21:54:39.117534
NCT02865837|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-12-05|||September 2015||2015-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|VESICOL||Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer|Effect of Bladder Distension on Organs at Risk Doses in PDR 3D Image-guided Brachytherapy of Cervical Cancer|Completed||N/A|22|Actual|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 21:54:39.373049|2017-10-10 21:54:39.373049
NCT02865824|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-16|||January 2016||2016-01-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Polypectomy in Patients Taking Dual Antiplatelet Agents|Effects of Antiplatelets Discontinuation in Patients Receiving Polypectomy: Randomized Controlled Trial|Enrolling by invitation||N/A|180|Anticipated|Incheon St.Mary's Hospital||2|||f||||f||||||||No||2017-10-10 21:54:39.589737|2017-10-10 21:54:39.589737
NCT02865811|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-08-16|||September 15, 2016|Actual|2016-09-15|August 2017|2017-08-01|February 2024|Anticipated|2024-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer|A Phase II Study of Pembrolizumab Combined With Pegylated Liposomal Doxorubicin (PLD) For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer|Active, not recruiting||Phase 2|26|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 21:54:39.71059|2017-10-10 21:54:39.71059
NCT02865798|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-10|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||China Senile Valvular Heart Disease Cohort Study|Multicenter Prospective Cohort Study of Senile Hospitalized Patients With Valvular Heart Disease|Not yet recruiting||N/A|4000|Anticipated|China National Center for Cardiovascular Diseases|||1||f||||||||||Samples With DNA|"     A 6mL whole blood sample is collected in an EDTA vacuum tube.   "|||2017-10-10 21:54:39.833786|2017-10-10 21:54:39.833786
NCT02865785|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-11|||July 2016||2016-07-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure|Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure (A Randomized Controlled Trial)|Recruiting||Phase 1/Phase 2|320|Anticipated|Ain Shams University||2|||f||||t||||||||No||2017-10-10 21:54:39.906899|2017-10-10 21:54:39.906899
NCT02865772|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-09|||November 2014||2014-11-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Lamellar Body Counts on Gastric Aspirate in Healthy Term Newborns|Reference Ranges of Lamellar Body Counts on Gastric Aspirate in Healthy Term Newborns|Completed||N/A|248|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital|||1||f||||f||||||Samples Without DNA|"     gastric aspiration fluid   "|Undecided||2017-10-10 21:54:40.026536|2017-10-10 21:54:40.026536
NCT02865759|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-11-01|||October 2016||2016-10-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|February 2018|Anticipated|2018-02-01||Interventional|Mindfetal||Mindfetalness to Improve Pregnancy Outcome|Empowering Women to Shorten Pre-hospital Delay After Decreased Fetal Movements and Simultaneously Lower the Frequency of Unwarranted Visits - a Randomized Study|Recruiting||Phase 3|39000|Anticipated|Sophiahemmet University||2|||f||||f||||||||Undecided||2017-10-10 21:54:40.093943|2017-10-10 21:54:40.093943
NCT02865746|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-11|||July 2004||2004-07-01|August 2016|2016-08-01|December 2005|Actual|2005-12-01|May 2005|Actual|2005-05-01||Interventional|||Betamethasone to Control Postoperative Pain in Emergency Endodontic Care|Periapical Injection of Betamethasone to Control Postoperative Pain in Emergency Endodontic Care - A Randomized Double Blind Clinical Trial|Completed||N/A|120|Actual|Federal University of the Valleys of Jequitinhonha and Mucuri||2|||f||||t||||||||Undecided||2017-10-10 21:54:40.199213|2017-10-10 21:54:40.199213
NCT02865733|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-11|||August 2016||2016-08-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery|Randomized Single-blind Study of Intravenous Maintenance of Remodulin® for the Treatment of Pulmonary Hypertension After Fontan Operation|Not yet recruiting||Phase 3|20|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 21:54:40.301965|2017-10-10 21:54:40.301965
NCT02865720|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-08|||September 8, 2016|Actual|2016-09-08|September 2017|2017-09-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Interventional|||Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)|A Phase 3, Open-label, Single-period Study to Evaluate the Safety and Treatment Effect of Intravenous Administration of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)|Completed||Phase 3|8|Actual|Shire||2|||f||||||||||||||2017-10-10 21:54:40.393065|2017-10-10 21:54:40.393065
NCT02865707|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-05-02|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||Ulcerative Colitis Relapse Prevention by Prebiotics|Prevention of Ulcerative Colitis by Prebiotics: Efficacy and Protective Mechanisms|Recruiting||N/A|100|Anticipated|University of Alberta||2|||f||||t|f|f||||||No||2017-10-10 21:54:40.505987|2017-10-10 21:54:40.505987
NCT02865694|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-13|||August 2016||2016-08-01|August 2016|2016-08-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01|5 Years|Observational [Patient Registry]|||Developing and Implementing Familial Hypercholesterolemia Registry|Developing and Implementing Familial Hypercholesterolemia Registry in Isfahan, Iran: Cascade Screening, Management and Long-term Follow up.|Recruiting||N/A|500|Anticipated|Isfahan University of Medical Sciences|||1||f||||||||||Samples With DNA|"     Plasma, buffy coat, blood.   "|||2017-10-10 21:54:40.627114|2017-10-10 21:54:40.627114
NCT02865681|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-06-07|||July 1, 2016|Actual|2016-07-01|November 2016|2016-11-01|June 7, 2017|Actual|2017-06-07|June 7, 2017|Actual|2017-06-07||Interventional|||Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization|Protocol to Minimize Injections and Blood Draws for Women Undergoing Controlled Ovarian Hyperstimulation for in Vitro Fertilization|Completed||N/A|4|Anticipated|New Hope Fertility Center||2|||f||||t||||||||||2017-10-10 21:54:40.716877|2017-10-10 21:54:40.716877
NCT02865668|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-02-08|||August 2016||2016-08-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants|A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (50 mg/500 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 50 mg) in Healthy Fed and Fasted Subjects|Completed||Phase 1|44|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-10 21:54:40.821532|2017-10-10 21:54:40.821532
NCT02865655|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2016-08-10|||June 2016||2016-06-01|August 2016|2016-08-01||||June 2018|Anticipated|2018-06-01||Observational|||Cesarean Section Scar Evaluation by Saline Contrast Sonohysterography During Hysteroscopy|Cesarean Section Scar Evaluation by Saline Contrast Sonohysterography During Hysteroscopy|Recruiting||N/A|60|Anticipated|Shanghai First Maternity and Infant Hospital|||4||f||||||||||||||2017-10-10 21:54:40.909402|2017-10-10 21:54:40.909402
NCT02865629|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-11|||August 2016||2016-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar Offspring|N-acetylcysteine in the Treatment of Depressive Symptoms in Youth at High-risk for Bipolar Disorder: a Functional Connectivity Study|Recruiting||N/A|22|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-10 21:54:41.095094|2017-10-10 21:54:41.095094
NCT02865616|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-17|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 15, 2018|Anticipated|2018-03-15||Interventional|||MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)|A Phase I, Open-Label, Single-Centre Study of the Safety and Efficacy of MET-2 in Patients With Recurrent Clostridium Difficile Infection (CDI)|Not yet recruiting||Phase 1|20|Anticipated|NuBiyota||1|||f||||t|f|f||||||||2017-10-10 21:54:41.193826|2017-10-10 21:54:41.193826
NCT02865603|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-11-22|||May 2016||2016-05-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PAXGBGEE||Impact of PAX Good Behavior Game on Elementary School Students in Estonia|Effectiveness of a Universal Classroom-based Preventive Intervention (PAX GBG) in Estonia: A Matched-pair Cluster-randomized Controlled Trial|Active, not recruiting||N/A|705|Actual|National Institute for Health Development, Estonia||2|||f||||f||||||||No||2017-10-10 21:54:41.279934|2017-10-10 21:54:41.279934
NCT02865590|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2016-08-09|||June 2011||2011-06-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Clinical and Histological Evaluation of Deproteinizated Bovine Bone Allograft and Lyophilized Equine Bone Allograft for Sinus Lift.|Clinical and Histological Evaluation of Demineralized Bone Allograft and Lyophilized Equine Bone Allograft for Sinus Lift: Double Blind, Parallel, Randomized Clinical Trial.|Completed||Phase 4|23|Actual|University of L'Aquila||2|||f||||f||||||||||2017-10-10 21:54:41.365782|2017-10-10 21:54:41.365782
NCT02865577|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-09|||July 2016||2016-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|RiPAIR||Right Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic Resonance|Right Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic Resonance|Recruiting||N/A|86|Anticipated|University of Leicester|||3||f||||t||||||Samples Without DNA|"     Storage of plasma extracted from the blood for biomarker (characteristic biological     properties or molecules detected in blood that indicate normal or diseased processes in the     body) analysis at a future date to complement similar ethically approved research at     University of Leicester / University Hospitals of Leicester or other United Kingdom or     international academic partners. The plasma will be stored anonymously at -80°C indefinitely     atthe Leicester Respiratory Biomedical Research Unit.   "|No||2017-10-10 21:54:41.436723|2017-10-10 21:54:41.436723
NCT02865564|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-11|||September 2016||2016-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics|Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics on Emergence of Functional Gastrointestinal Disorders, Body Composition, Mineral Bone Density and Fecal Microbiota in Infancy|Not yet recruiting||N/A|100|Anticipated|University Medical Centre Ljubljana||2|||f||||f||||||||No||2017-10-10 21:54:41.520255|2017-10-10 21:54:41.520255
NCT02865551|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-23|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Interventional|||Urinary Retention After Vaginal Delivery With Epidural Anesthesia.|The Rate of Urinary Retention in Women After Vaginal Delivery With Epidural Anesthesia Who Underwent Prolonged Catheterization Compared With Intermittent Catheterization During Labor.|Not yet recruiting||N/A|160|Anticipated|Rambam Health Care Campus||2|||f||||f|f|f||||||||2017-10-10 21:54:41.614237|2017-10-10 21:54:41.614237
NCT02865538|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-12|||August 2016||2016-08-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|July 2017|Actual|2017-07-01||Interventional|||Evaluation of the Pharmacokinetics and Safety of NT-814 in Post-Menopausal Women With Vasomotor Symptoms|Evaluation of the Pharmacokinetics and Safety of NT-814 in Post-Menopausal Women With Vasomotor Symptoms|Active, not recruiting||Phase 1/Phase 2|80|Actual|Nerre Therapeutics Ltd.||2|||f||||f||||||||||2017-10-10 21:54:41.681063|2017-10-10 21:54:41.681063
NCT02865525|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-09|||March 2013||2013-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|QUILAM||Development and Validation of a Self-administered QUestionnaire to Identify Levers of Adhesion Behavior to Patient's Medication in Order to Adapt the Educational Monitoring.|QUILAM : Development and Validation of a Self-administered QUestionnaire to Identify Levers of Adhesion Behavior to Patient's Medication in Order to Adapt the Educational Monitoring|Recruiting||N/A|330|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||No||2017-10-10 21:54:41.755867|2017-10-10 21:54:41.755867
NCT02865499|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-08-11|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Acarbose Anti-aging Effects in Geriatric Subjects|Acarbose as a Safe Effective Modulator of Aging Deficits in Geriatric Subjects|Recruiting||Phase 2|10|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||Undecided||2017-10-10 21:54:41.901124|2017-10-10 21:54:41.901124
NCT02865486|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-10-04|||March 2016||2016-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|BioLE||Digestion of Biopolymer Based Lipid Emulsions|The Effect of Biopolymer Based Lipid Emulsions on GI Function, GI Peptide Response and Satiation in Healthy Volunteers; a Randomized, Double Blind, Unbalanced Three-way Crossover Study|Completed||N/A|21|Actual|University of Zurich||3|||f||||f||||||||No||2017-10-10 21:54:41.969237|2017-10-10 21:54:41.969237
NCT02865473|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-12-01|||April 2016||2016-04-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and PEX - a Pilot Study|Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and Pseudoexfoliation Syndrome - a Pilot Study|Recruiting||N/A|90|Anticipated|Medical University of Vienna||6|||f||||||||||||||2017-10-10 21:54:42.047667|2017-10-10 21:54:42.047667
NCT02865460|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-01|||July 24, 2017|Actual|2017-07-24|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||CoQ10 in Gulf War Illness|A Randomized, Double-blind Placebo-controlled Phase III Trial of Coenzyme Q10 in Gulf War Illness|Recruiting||Phase 3|200|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-10 21:54:42.125007|2017-10-10 21:54:42.125007
NCT02865447|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-08-25|||March 9, 2017|Actual|2017-03-09|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|July 2020|Anticipated|2020-07-01||Observational|||Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis|A Dual Energy X-ray Absorptiometry (DXA) Evaluation of Bone Density Changes After Hip Replacement. Performance of the PROFEMUR® PRESERVE Hip Stem in Total Hip Arthroplasty, Two-Year Clinical and DXA Analysis|Recruiting||N/A|25|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||||2017-10-10 21:54:42.27575|2017-10-10 21:54:42.27575
NCT02865434|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-09-22|||January 2017||2017-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA|An Evaluation of the Safety of Escalating Doses of Tc 99m Tilmanocept by Intravenous (IV) Injection and Skeletal Joint Imaging With SPECT in Subjects With Active Rheumatoid Arthritis (RA) and Healthy Controls|Recruiting||Phase 1|33|Anticipated|Navidea Biopharmaceuticals||11|||f||||f||||||||||2017-10-10 21:54:42.346646|2017-10-10 21:54:42.346646
NCT02865421|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-08-11|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|AGA||Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia|Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia|Not yet recruiting||Phase 2|88|Anticipated|King Edward Medical University||2|||f||||t||||||||No||2017-10-10 21:54:42.477118|2017-10-10 21:54:42.477118
NCT02865408|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-18|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|AA-ICU||Amino Acid Nutrition in the Critically-ill|Enhancing the Anabolic Effect of Nutrition in Critically Ill Patients by Administering Exogenous Amino Acids|Recruiting||N/A|30|Anticipated|McGill University Health Center||3|||f||||f|f|f|||f|||||2017-10-10 21:54:42.540582|2017-10-10 21:54:42.540582
NCT02865395|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-08-11|||March 2016||2016-03-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms|Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms and Urinary Discomfort in Patients Undergoing Lithotripsy|Enrolling by invitation||Phase 4|180|Anticipated|George Washington University||3|||f||||t||||||||No||2017-10-10 21:54:42.64284|2017-10-10 21:54:42.64284
NCT02865382|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-10-11|||September 2016||2016-09-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Detection of Colorectal Adenoma by Optical Enhancement Technology vs. High-Definition Colonoscopy|Detection of Colorectal Adenoma by Optical Enhancement Technology vs. High-Definition Colonoscopy: A Randomized Trial|Not yet recruiting||N/A|400|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 21:54:42.717334|2017-10-10 21:54:42.717334
NCT02865369|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-04|||September 2016||2016-09-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|RELIF-C||Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment|Regression of Liver Fibrosis Assessed by Transient Elastography After Daclatasvir and Asunaprevir Combined Treatment in Advanced Fibrotic/Cirrhotic Patients With Chronic Hepatitis C Genotype 1b Infection|Not yet recruiting||N/A|103|Anticipated|Soonchunhyang University Hospital|||1||f||||f||||||Samples Without DNA|"     8cc serum sample for the evaluation of direct liver fibrosis marker   "|No||2017-10-10 21:54:42.791406|2017-10-10 21:54:42.791406
NCT02865356|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-05|||September 2016||2016-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CYCLATOP||Topical Solution for the Treatment of Atopic Dermatitis|Evaluation of SP14019-F-01 Topical Solution for the Treatment of Atopic Dermatitis. Pilot Study (CYCLATOP STUDY)|Recruiting||Phase 2|36|Anticipated|Spherium Biomed||2|||f||||f||||||||||2017-10-10 21:54:42.912856|2017-10-10 21:54:42.912856
NCT02865343|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-22|||February 22, 2017|Actual|2017-02-22|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|NIV-Ex||Ventilatory Support to Improve Exercise Training in High Level Spinal Cord Injury|Ventilatory Support to Improve Exercise Training in High Level Spinal Cord Injury|Recruiting||N/A|30|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||f|f|t|f|f||||||2017-10-10 21:54:44.701534|2017-10-10 21:54:44.701534
NCT02865330|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-11-14|||July 2014||2014-07-01|November 2016|2016-11-01|July 2034|Anticipated|2034-07-01|June 2019|Anticipated|2019-06-01|15 Years|Observational [Patient Registry]|||Spanish Urological Association Registry of Patients on Active Surveillance||Recruiting||N/A|946|Anticipated|Fundación Instituto Valenciano de Oncología|||1||f||||f||||||None Retained|"     7.5 ml of blood sample Biopsy sample   "|Yes||2017-10-10 21:54:44.793771|2017-10-10 21:54:44.793771
NCT02865304|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-08-11|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients|The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative Metastatic Breast Cancer Patients|Not yet recruiting||Phase 3|80|Anticipated|Fujian Cancer Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:54:44.914516|2017-10-10 21:54:44.914516
NCT02865291|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-09|||December 2015||2015-12-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Safety and Effectiveness Evaluation of the ForConti Fecal Management System - Pilot Study|Safety and Effectiveness Evaluation of the ForConti Fecal Management System - Pilot Study|Enrolling by invitation||N/A|20|Actual|ForConti Medical||1|||f||||f||||||||No||2017-10-10 21:54:44.980258|2017-10-10 21:54:44.980258
NCT02865278|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-09|||March 2016||2016-03-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Interventional|BIOP||Bioavailability of the Polyphenols Contained in a Red Grape Extract-based Drink and Their Metabolic Effects|Evaluation of the Bioavailability of Polyphenols From a Red Grape Extract-based Drink and the Acute Effects of Its Consumption on Glucose and Lipid Response During the Subsequent Meal|Active, not recruiting||N/A|10|Actual|Federico II University||2|||f||||f||||||||No||2017-10-10 21:54:45.037378|2017-10-10 21:54:45.037378
NCT02865265|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-09|||March 2013||2013-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|March 2013|Actual|2013-03-01||Observational|||Pecs II Block and PaB Could be an Alternative in Breast Surgery|Association Between Ultrasound-guided Pecs II Block and Parasternal Block May Represent a Valid Alternative for the Management of Acute and Postoperative Pain Syndrome in Breast Cancer Surgery: a Retrospective Study|Completed||N/A|180|Actual|San Salvatore Hospital of L'Aquila|||1||f||||t||||||||No||2017-10-10 21:54:45.106437|2017-10-10 21:54:45.106437
NCT02865252|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-11|||October 2015||2015-10-01|August 2016|2016-08-01||||June 2016|Actual|2016-06-01||Interventional|||The Effect of Mobilization With Movement on Pain and Function Among Patients With Knee Osteoarthritis|The Effect of Mobilization With Movement on Pain and Function Among Patients With Knee Osteoarthritis|Completed||Phase 1|38|Actual|Dammam University||2|||f||||t||||||||||2017-10-10 21:54:45.170996|2017-10-10 21:54:45.170996
NCT02865239|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-01-18|||June 2015||2015-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|January 2016|Actual|2016-01-01||Interventional|EFIMED||Feasibility Study of Breast MRI in Decubitus Position||Completed||N/A|15|Actual|Institut de Cancérologie de Lorraine||2|||f||||f||||||||||2017-10-10 21:54:45.252909|2017-10-10 21:54:45.252909
NCT02865226|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||December 2015||2015-12-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|PVBS-USguided||Comparison of the Clinical Efficacy of 2 Paravertebral Block Strategies in Thoracic Surgery by Thoracotomy: by the Anesthetist (Paravertebral Block Guided by Ultrasound) and by the Thoracic Surgeon (Paravertebral Block Visual)|Comparison of the Clinical Efficacy of 2 Paravertebral Block Strategies in Thoracic Surgery by Thoracotomy: : by the Anesthetist (Paravertebral Block Guided by Ultrasound) and by the Thoracic Surgeon (Paravertebral Block Visual)|Recruiting||Phase 3|50|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:54:45.315923|2017-10-10 21:54:45.315923
NCT02865213|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-09|||January 2016||2016-01-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|August 2017|Actual|2017-08-01||Interventional|||Molar Intrusion in Open Bite Treatment|Assessment of Skeletal and Dentoalveolar Changes Resulting From Posterior Teeth Intrusion in Treatment of the Anterior Open Bite - a Randomized Controlled Trial|Active, not recruiting||N/A|45|Actual|Damascus University||3|||f||||t||||||||||2017-10-10 21:54:45.479816|2017-10-10 21:54:45.479816
NCT02865200|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-11|||February 2015||2015-02-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effectiveness of Dry Needling and Classic Physiotherapy Programs in The Patients Suffering From Chronic Low Back Pain Caused by Lumbar Disc Hernia||Completed||N/A|34|Actual|Eastern Mediterranean University||2|||f||||f||||||||No||2017-10-10 21:54:45.573322|2017-10-10 21:54:45.573322
NCT02865187|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-08-31|||February 6, 2017|Actual|2017-02-06|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|Vit D in PCOS||Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction|Evaluation of Vitamin D With and Without Hormonal Contraception on Sexual Function in Women With Polycystic Ovary Syndrome|Recruiting||N/A|60|Anticipated|Wright State University||2|||f||||f|f|f||||||||2017-10-10 21:54:45.642444|2017-10-10 21:54:45.642444
NCT02865174|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-09|||September 2016||2016-09-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty|Comparison of Topical Tranexamic Acid and Floseal® on Blood Loss After Total Knee Arthroplasty in Patients With a Thromboembolic Risk|Not yet recruiting||Phase 4|90|Anticipated|Chang Gung Memorial Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:54:45.755609|2017-10-10 21:54:45.755609
NCT02865161|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-11|2016-09-29|||February 2015||2015-02-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|AGATA||Amtolmetin Gaucil in Knee Osteoarthritis|Open-label, Multicenter, Observational (Non-interventional) Study of Efficacy and Tolerability of Amtolmetin GuAcil in Subjects With Knee osTeoArthrosis With Dyspepsia. (AGATA)|Completed||Phase 4|220|Actual|Dr. Reddy's Laboratories Limited|||1||f||||f||||||||Undecided|Under review|2017-10-10 21:54:45.875415|2017-10-10 21:54:45.875415
NCT02865148|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-06-23|||August 2016||2016-08-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Behavioral Symptom Management Program for Breast Cancer in Singapore and The US|Feasibility and Acceptability of A Behavioral Symptom Management Program for Patients With Advanced Breast Cancer in Singapore and The US|Recruiting||N/A|40|Anticipated|Duke-NUS Graduate Medical School||2|||f||||f||||||||No||2017-10-10 21:54:45.943799|2017-10-10 21:54:45.943799
NCT02865135|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-05-19|||December 2016||2016-12-01|May 2017|2017-05-01|May 2023|Anticipated|2023-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer|A Phase Ib/II Trial To Test The Safety And Efficacy Of Vaccination With HPV16-E711-19 Nanomer For The Treatment Of Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer In HLA-A*02 Positive Patients|Recruiting||Phase 1/Phase 2|44|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:54:46.026073|2017-10-10 21:54:46.026073
NCT02865122|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-18|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|GIFT||Safety and Efficacy Study in Infant With SBS|A Multi-Center, Randomized, Double-Blind, Three-Arm, Parallel-Group Trial to Assess the Efficacy and Safety of NTRA-9620 in Infants With Short Bowel Syndrome (SBS) Following Surgical Resection|Active, not recruiting||Phase 2/Phase 3|150|Anticipated|Nutrinia||3|||f||||t|t|f||||||||2017-10-10 21:54:46.126318|2017-10-10 21:54:46.126318
NCT02865109|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-08-24||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)|Expanded Access Program (EAP) to Provide Nusinersen to Patients With Infantile-onset Spinal Muscular Atrophy (SMA)|Available||N/A|||Biogen||||||||t|||||||||||2017-10-10 21:54:46.228914|2017-10-10 21:54:46.228914
NCT02865096|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-05|||March 1, 2016|Actual|2016-03-01|September 2017|2017-09-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Observational|||The Correlation of Women's Sexual Health and Marijuana Use|The Correlation of Women's Sexual Health and Marijuana Use|Completed||N/A|373|Actual|St. Louis University|||1||f||||f||||||||||2017-10-10 21:54:46.403809|2017-10-10 21:54:46.403809
NCT02865083|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-03-03|||June 1, 2016|Actual|2016-06-01|March 2017|2017-03-01|January 2, 2017|Actual|2017-01-02|January 2, 2017|Actual|2017-01-02||Interventional|Traxi||The Effect of a Self-Retaining Pannus Retractor in Obese Patients Undergoing Cesarean Section|The Effect of a Self-Retaining Pannus Retractor in Obese Patients Undergoing Cesarean Section|Terminated||N/A|4|Actual|St. Louis University||2||unable to reach enrollment goal|f||||f||||||||No||2017-10-10 21:54:46.467863|2017-10-10 21:54:46.467863
NCT02865070|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-05-26|||March 2016||2016-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||"A Smart, Always -On Health Monitoring System"|"A Smart, Always -On Health Monitoring System"|Recruiting||N/A|30|Anticipated|Northwestern University|||6||f||||f||||||||||2017-10-10 21:54:46.531603|2017-10-10 21:54:46.531603
NCT02865057|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-07|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|U/S||Assessment of Fetal Position in Active Labor|Ultrasound Examination as a Teaching Tool for Vaginal Exam Assessment of Fetal Position in Active Labor|Completed||N/A|12|Actual|St. Louis University|||2||f||||f||||||||||2017-10-10 21:54:46.617539|2017-10-10 21:54:46.617539
NCT02865044|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||March 2015||2015-03-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study to Evaluate the Acute Bioavailability of EPA and DHA From a DietarySupplement in Healthy Men and Women|A Randomized, Controlled, Crossover Study to Evaluate the Acute Bioavailability of Eicosapentaenoic Acid andDocosahexaenoic Acid From a DietarySupplement in Healthy Men and Women: A 72-Hour Study With Controlled Feeding|Completed||N/A|18|Actual|Calanus||2|||f||||f||||||||Undecided||2017-10-10 21:54:46.681807|2017-10-10 21:54:46.681807
NCT02865031|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2016-08-11|||August 2015||2015-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|Dacorin||Dacorin for Proliferative Vitreoretinopathy|Intravitreal Decorin Preventing Proliferative Vitreoretinopathy in Perforating Injuries: a Pilot Study.|Completed||Phase 1/Phase 2|15|Actual|Cairo University||1|||f||||t||||||||Undecided||2017-10-10 21:54:46.752396|2017-10-10 21:54:46.752396
NCT02865018|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-09|||April 2014||2014-04-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Neuromyelitis Optica (NMO) & Cetirizine|An Open Label, add-on Trial of Cetirizine for Patients With Neuromyelitis Optica|Completed||Phase 1/Phase 2|16|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||No||2017-10-10 21:54:46.816852|2017-10-10 21:54:46.816852
NCT02865005|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-12-19|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris|A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris|Completed||Phase 3|2361|Actual|Seegpharm S.A.||3|||f||||f||||||||No||2017-10-10 21:54:47.015408|2017-10-10 21:54:47.015408
NCT02864966|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-09-08|||May 2016||2016-05-01|December 2015|2015-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects|A 24 Hour Occlusive Single Patch Test to Assess, Under Dermatological Control, the Acute Cutaneous Tolerance of Pre Lubricated Kiss Condom on a Panel of Healthy Adult Subjects|Completed||N/A|33|Actual|Reckitt Benckiser Healthcare (UK) Limited||1|||f||||f||||||||||2017-10-10 21:54:47.579518|2017-10-10 21:54:47.579518
NCT02864953|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-09|||February 2017||2017-02-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|May 2019|Anticipated|2019-05-01||Interventional|CHARM||CIRARA in Large Hemispheric Infarction Analyzing Modified Rankin Scale (mRS) and Mortality (CHARM)|A Randomized, Multi-center, Prospective, Double-blind, Phase 3 Trial of CIRARA (Glyburide for Injection) in Subjects With a Large Hemispheric Infarction|Not yet recruiting||Phase 3|650|Anticipated|Remedy Pharmaceuticals, Inc.||2|||f||||t||||||||No||2017-10-10 21:54:47.658114|2017-10-10 21:54:47.658114
NCT02864940|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-12|||June 2016||2016-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|MASH||Memory Training in Aneurysmal Subarachnoid Hemorrhage Patients|MASH Study (Memory Training in Aneurysmal Subarachnoid Hemorrhage Patients)|Recruiting||N/A|108|Anticipated|Rush University Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:54:47.73926|2017-10-10 21:54:47.73926
NCT02864771|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|December 2050|Anticipated|2050-12-01|February 2019|Anticipated|2019-02-01||Observational|SMASH 1||Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias|Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias: A Multicenter, Observational Trial|Recruiting||N/A|1000|Anticipated|University Hospital, Akershus|||2||f||||t||||||Samples With DNA|"     Serum, plasma and DNA   "|Undecided||2017-10-10 21:54:48.849273|2017-10-10 21:54:48.849273
NCT02864927|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-28|||July 21, 2016|Actual|2016-07-21|June 2017|2017-06-01|February 19, 2019|Anticipated|2019-02-19|February 19, 2019|Anticipated|2019-02-19||Interventional|||Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea|Postmarketing Surveillance Study for Use of Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in the Republic of Korea|Active, not recruiting||Phase 4|1264|Actual|Sanofi||2|||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available the company continue to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 21:54:47.839242|2017-10-10 21:54:47.839242
NCT02864914|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-10-03|||March 15, 2016|Actual|2016-03-15|October 2017|2017-10-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Observational|||PASS to Assess Risk of Renal Injury, Hepatic Injury, Diabetic Ketoacidosis and Infections in Empagliflozin-treated Patients|Post-authorisation Safety Study in Patients With Type 2 Diabetes Mellitus to Assess the Risk of Acute Liver Injury, Acute Kidney Injury and Chronic Kidney Disease, Severe Complications of Urinary Tract Infection, Genital Infections, and Diabetic Ketoacidosis Among Patients Treated With Empagliflozin Compared to Patients Treated With Other SGLT2 Inhibitors or DPP-4 Inhibitors|Recruiting||N/A|15000|Anticipated|Boehringer Ingelheim|||3||f||||||||||||||2017-10-10 21:54:47.950199|2017-10-10 21:54:47.950199
NCT02864888|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-26|||June 1, 2018|Anticipated|2018-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DBSG||Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma|A Controlled, Study of the Effect of Combination Antineoplaston Therapy [Atengenal (A10) and Astugenal (AS2-1)] on the QT/QTc Interval In Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem Glioma|Not yet recruiting||Phase 3|30|Anticipated|Burzynski Research Institute||2|||f||||f|t|f||||||||2017-10-10 21:54:48.149056|2017-10-10 21:54:48.149056
NCT02864875|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-09|||August 2014||2014-08-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Coagulopathy Trauma-induced Guided by Thromboelastography in Politrauma Patients.|Treatment of Coagulopathy Trauma-induced Guided by Thromboelastography in Politrauma Patients. Comparative Study: Regular Care x Early Fibrinogen|Recruiting||Phase 4|32|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||No||2017-10-10 21:54:48.234709|2017-10-10 21:54:48.234709
NCT02864862|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-05-03|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation|Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation|Recruiting||Phase 4|42|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||f||||||||||2017-10-10 21:54:48.326073|2017-10-10 21:54:48.326073
NCT02864849|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-22|||August 2016||2016-08-01|December 2016|2016-12-01|April 2023|Anticipated|2023-04-01|August 2022|Anticipated|2022-08-01||Interventional|||Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer|Total Neoadjuvant Induction and Consolidation CapeOX Plus Neoadjuvant Intensity Modulated Radiotherapy With Concurrent Capecitabine for MRI Defined High-risk Rectal Cancer|Recruiting||Phase 2|75|Anticipated|Beijing Cancer Hospital||1|||f||||||||||||||2017-10-10 21:54:48.401899|2017-10-10 21:54:48.401899
NCT02864836|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-16|||November 2016||2016-11-01|August 2016|2016-08-01|November 2021|Anticipated|2021-11-01|November 2018|Anticipated|2018-11-01||Observational|ISOTOPE||Study of Copper Isotope in Head and Neck Cancer|Study of the ISotopic Repartition of cOpper in Head and Neck TumOral and lymPhomatous pathologiEs|Not yet recruiting||N/A|60|Anticipated|Lille Catholic University|||3||f||||f||||||Samples Without DNA|"     Blood Urine Saliva cancer tissue healthy tissue   "|No||2017-10-10 21:54:48.491119|2017-10-10 21:54:48.491119
NCT02864823|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-09|||March 2011||2011-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PCRNS||Perichondrium Autograft in Refractory Necrotizing Scleritis|Autologous Perichondrium Transplantation for Replacement of Stem Cells and Their Niche in the Treatment of Necrotizing Scleritis|Completed||N/A|20|Actual|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||1|||f||||f||||||||Undecided||2017-10-10 21:54:48.573424|2017-10-10 21:54:48.573424
NCT02864810|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-24|||August 2016||2016-08-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism|A Phase 1, Open-label, Non-randomized, Single Center Study to Assess Safety, Pharmacokinetics, Biodistribution, Internal Radiation Dosimetry and Diagnostic Performance of [18F]GP1 Positron Emission Tomography in Subjects With Venous or Arterial Thromboembolism|Recruiting||Phase 1|30|Anticipated|Asan Foundation||1|||f||||f||||||||No||2017-10-10 21:54:48.644729|2017-10-10 21:54:48.644729
NCT02864784|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-09|||October 2016||2016-10-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC|A Prospective, Multicenter, Randomized, Placebo-Controlled, Two-armed, Double-blind Pilot Study to Evaluate the Safety, Tolerability and Efficacy of ACC vs. Placebo for the Treatment of Subjects With Castrate Resistant Prostate Cancer With Bone Metastasis|Not yet recruiting||Phase 1|60|Anticipated|Amorphical Ltd.||2|||f||||f||||||||No||2017-10-10 21:54:48.779803|2017-10-10 21:54:48.779803
NCT02864758|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-22|||September 8, 2016|Actual|2016-09-08|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|BROTHER||Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France|Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in Daily Clinical Practice - A French Cohort Within the Nationwide Claims and Hospital Database|Recruiting||N/A|99999|Anticipated|Bayer|||3||f||||f|f|f||||||||2017-10-10 21:54:48.919115|2017-10-10 21:54:48.919115
NCT02864745|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-03-15|||October 4, 2016|Actual|2016-10-04|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|EMIR||Early Mobilization and Intensive Rehabilitation in the Critically Ill|Functional Electrical Stimulation-assisted Cycle Ergometry in Critically Ill: Linking Deranged Muscle Physiology to Long-term Functional Outcome|Recruiting||N/A|150|Anticipated|Charles University, Czech Republic||2|||f||||f||||||||No||2017-10-10 21:54:49.10705|2017-10-10 21:54:49.10705
NCT02864719|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-08-09|||July 2010||2010-07-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|CAF||An Intervention for Cardiac Arrest Survivors With Chronic Fatigue|An Intervention for Cardiac Arrest Survivors With Chronic Fatigue: A Feasibility Study|Completed||N/A|18|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 21:54:49.311059|2017-10-10 21:54:49.311059
NCT02864706|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-08-09|||August 2016||2016-08-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CRAD001ANO05||SCHEDULE Follow Up Visit 5-7 yr|5, 6 or 7 Year Follow-up Control After the SCHEDULE Study (SCANDINAVIAN HEART TRANSPLANT EVEROLIMUS DE NOVO STUDY WITH EARLY CNI AVOIDANCE)|Not yet recruiting||Phase 4|50|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 21:54:49.400731|2017-10-10 21:54:49.400731
NCT02864693|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-05-18|||June 2016||2016-06-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparative Effectiveness of Microprocessor Controlled and Carbon Fiber Prosthetic Feet in Transtibial Amputees|Comparative Effectiveness of Microprocessor Controlled and Carbon Fiber Energy Storing and Returning Prosthetic Feet in Persons With Unilateral Transtibial Amputation|Active, not recruiting||N/A|30|Anticipated|Ability Prosthetics and Orthotics, Inc.||2|||f||||f||||||||No||2017-10-10 21:54:49.498753|2017-10-10 21:54:49.498753
NCT02864680|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-09|||February 2014||2014-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|CAUSA MAP||Electrophysiological Study of the Functioning of Magnocellular Visual Pathway in Regular Cannabis Users|Electrophysiological Study of the Functioning of Magnocellular Visual Pathway in Regular Cannabis Users|Recruiting||N/A|190|Anticipated|Central Hospital, Nancy, France||4|||f||||f||||||||No||2017-10-10 21:54:49.600991|2017-10-10 21:54:49.600991
NCT02864667|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-09|||June 2016||2016-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Reader Study for Image Quality of Cone Beam Breast CT System|Reader Study for Image Quality of Cone Beam Breast CT System|Completed||N/A|10|Actual|Koning Corporation|||1||f||||f||||||||No||2017-10-10 21:54:49.720911|2017-10-10 21:54:49.720911
NCT02864654|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-11|||July 2016||2016-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia|Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia|Enrolling by invitation||Phase 1/Phase 2|9|Anticipated|Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation||1|||f||||f||||||||Undecided||2017-10-10 21:54:49.77508|2017-10-10 21:54:49.77508
NCT02864641|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-09|||July 2015||2015-07-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|OMMS||Mobile Technology and Online Tools to Track Adherence in Chronic Illness Patients|Mobile Technology and Online Tools to Track Adherence in Chronic Illness Patients|Completed||Phase 2|68|Actual|3-C Institute for Social Development||2|||f||||f||||||||||2017-10-10 21:54:49.874522|2017-10-10 21:54:49.874522
NCT02864628|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-07-20|||September 2018|Anticipated|2018-09-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.|A Partially Randomized, Partly Placebo Controlled Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA-BN® RSV Vaccine After Intranasal and Intramuscular Administration|Not yet recruiting||Phase 1|96|Anticipated|Bavarian Nordic||5|||f||||f|t|f||||||||2017-10-10 21:54:49.957793|2017-10-10 21:54:49.957793
NCT02864602|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||July 2016||2016-07-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||IV Dexamethasone for Prolongation of Peripheral Nerve Block|A Volunteer Study to Determine the Optimal Dose of IV Dexamethasone Required for Prolongation of Peripheral Nerve Block|Recruiting||Phase 3|18|Anticipated|University Health Network, Toronto||3|||f||||t||||||||Yes||2017-10-10 21:54:50.148126|2017-10-10 21:54:50.148126
NCT02864589|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-11-01|||August 2016||2016-08-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder|Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder: A Feasibility Study|Active, not recruiting||N/A|23|Actual|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 21:54:50.242557|2017-10-10 21:54:50.242557
NCT02863081|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-18|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|HOPES||Helping Older Persons Emerge Stronger|Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission|Completed||N/A|6|Actual|Ohio State University|||2||f||||f||||||||||2017-10-10 21:55:06.372138|2017-10-10 21:55:06.372138
NCT02864576|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Cognitive Remediation Plus Aerobic Exercise in Schizophrenia Treatment|Cognitive Remediation Plus Aerobic Exercise in Schizophrenia Treatment: a Randomized Controlled Study.|Recruiting||N/A|74|Anticipated|Parc de Salut Mar||2|||f||||f||||||||No||2017-10-10 21:54:50.333519|2017-10-10 21:54:50.333519
NCT02864563|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||October 2008||2008-10-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2016|Anticipated|2016-12-01||Interventional|PHRCNB07||Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification|Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification|Recruiting||N/A|500|Anticipated|Institut Curie||1|||f||||f||||||||No||2017-10-10 21:54:50.428765|2017-10-10 21:54:50.428765
NCT02864550|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-11|||November 2016||2016-11-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Interventional|||Oral Doxycycline for the Prevention of Syphilis in Men Who Have Sex With Men|A Randomized, Placebo-controlled Trial of Oral Doxycycline for the Prevention of Syphilis in Men Who Have Sex With Men (MSM)|Not yet recruiting||Early Phase 1|288|Anticipated|British Columbia Centre for Disease Control||2|||f||||t||||||||||2017-10-10 21:54:50.602476|2017-10-10 21:54:50.602476
NCT02864537|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-09|||January 2009||2009-01-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Self-management of Anticoagulation Treatment|Comparison Between Conventional Anticoagulation Treatment and Self-management of Anticoagulation Treatment|Completed||N/A|130|Actual|University of Bergen||2|||f||||f||||||||Undecided||2017-10-10 21:54:50.726665|2017-10-10 21:54:50.726665
NCT02864524|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-06-28|||August 2016||2016-08-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Manipulative and Massage Therapy in the Lower Thoracic and Cervical Spine in Subjects With Fibromyalgia Syndrome|Effects of Manipulative Therapy in the Lower Thoracic and Cervical Spine in Subjects With Fibromyalgia Syndrome|Active, not recruiting||N/A|64|Anticipated|Universidad de Almeria||2|||f||||f||||||||No||2017-10-10 21:54:50.807102|2017-10-10 21:54:50.807102
NCT02864511|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-10-10|||August 2016||2016-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Botulinum Toxin for Neck Rejuvenation|Nefertiti Lift for Neck Rejuvenation: Assessing Efficiency and Re-defining Patient Selection|Completed||N/A|30|Actual|St Joseph University, Beirut, Lebanon||1|||f||||||||||||||2017-10-10 21:54:50.888541|2017-10-10 21:54:50.888541
NCT02864498|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-03-23|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients|A Randomised, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Efficacy and Safety of Orally Administered DS107 in Patients With Moderate to Severe Atopic Dermatitis|Recruiting||Phase 2|300|Anticipated|DS Biopharma||3|||f||||f||||||||||2017-10-10 21:54:50.975568|2017-10-10 21:54:50.975568
NCT02864485|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-05-18|||August 2016||2016-08-01|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|September 2023|Anticipated|2023-09-01||Interventional|||Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases|Assessment of a Protocol Using a Combination of Neo-adjuvant Chemotherapy Plus Living Donor Liver Transplantation for Non-Resectable Liver Metastases From Colorectal Cancer|Recruiting||N/A|20|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 21:54:51.085888|2017-10-10 21:54:51.085888
NCT02864472|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-10|||September 2016||2016-09-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose|Comparison of Early Intervention of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV Patients With Initial Loading Dose|Not yet recruiting||Phase 4|40|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:54:51.185291|2017-10-10 21:54:51.185291
NCT02864459|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Role of Muscular Ultrasound in Predicting Weaning Success|The Role of Muscular Ultrasound in Predicting Weaning Success|Recruiting||N/A|114|Anticipated|Seoul National University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:54:51.260423|2017-10-10 21:54:51.260423
NCT02864446|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-10|||October 2012||2012-10-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction|The Clinical Utility of Urine Intestinal Fatty Acid Binding Protein in the Management of Very Low Birth Weight Infants With Meconium Obstruction|Completed||N/A|100|Actual|Seoul National University Hospital|||1||f||||t||||||Samples Without DNA|"     urine   "|Yes||2017-10-10 21:54:51.329636|2017-10-10 21:54:51.329636
NCT02864433|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-08-10|||October 2012||2012-10-01|August 2016|2016-08-01||||March 2014|Actual|2014-03-01||Observational|||Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts|Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts|Recruiting||N/A|1000|Anticipated|Brigham and Women's Hospital|||4||f||||f||||||Samples Without DNA|"     Stool samples from patients with acute watery diarrhea were collected and tested for cholera     by rapid test and also by culture.   "|||2017-10-10 21:54:51.386066|2017-10-10 21:54:51.386066
NCT02864420|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-07-07|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Hospitalization at Home: The Acute Care Home Hospital Program for Adults|Hospitalization at Home Pilot: The Acute Care Home Hospital Program for Adults|Completed||N/A|21|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 21:54:51.469225|2017-10-10 21:54:51.469225
NCT02864407|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-21|||December 19, 2016|Actual|2016-12-19|September 2017|2017-09-01|August 30, 2021|Anticipated|2021-08-30|August 30, 2021|Anticipated|2021-08-30||Observational|||Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease|A Regulatory Required Non Interventional Study to Monitor the Safety and Effectiveness of Once Daily Treatment of Orally Inhaled Vahelva Respimat (Tiotropium + Olodaterol Fixed Dose Combination 2.5µg/2.5µg Per Puff (2 Puffs Comprise One Medicinal Dose)) for Korean Patients With COPD (Chronic Obstructive Pulmonary Disease)|Recruiting||N/A|3000|Anticipated|Boehringer Ingelheim|||1||f|||||t|f|||f|||||2017-10-10 21:54:51.637763|2017-10-10 21:54:51.637763
NCT02864394|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-09-22|||September 7, 2016|Actual|2016-09-07|September 2017|2017-09-01|January 28, 2019|Anticipated|2019-01-28|January 14, 2019|Anticipated|2019-01-14||Interventional|||Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033)|A Multinational, Multicenter, Phase III, Randomized Open-label Trial of Pembrolizumab Versus Docetaxel in Previously Treated Subjects With Non-Small Cell Lung Cancer|Recruiting||Phase 3|740|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 21:54:51.719538|2017-10-10 21:54:51.719538
NCT02864381|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-10|2017-07-17|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|November 2017|Anticipated|2017-11-01||Interventional|||Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma|A Phase 2, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of GS-5745 Combined With Nivolumab Versus Nivolumab Alone in Subjects With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 2|144|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 21:54:51.859857|2017-10-10 21:54:51.859857
NCT02864368|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-03-29|||December 2016||2016-12-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|PERFORMANCE||Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens|Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens|Recruiting||Phase 1|45|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 21:54:52.158149|2017-10-10 21:54:52.158149
NCT02864355|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients|Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients|Recruiting||N/A|35|Anticipated|Medical University of South Carolina||2|||f||||t||||||||Undecided||2017-10-10 21:54:52.290143|2017-10-10 21:54:52.290143
NCT02864342|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-20|||August 12, 2016|Actual|2016-08-12|July 2017|2017-07-01|November 22, 2017|Anticipated|2017-11-22|November 22, 2017|Anticipated|2017-11-22||Interventional|||Adherence Study in COPD Patients|A Randomized Clinical Study to Assess the Impact of Symbicort® pMDI Medication Reminders on Adherence in COPD Patients|Active, not recruiting||Phase 4|138|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 21:54:52.397336|2017-10-10 21:54:52.397336
NCT02864329|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-08-09|||April 2014||2014-04-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Small RNA Pathways in Mammalian Gametogenesis|Small RNA Pathways in Mammalian Gametogenesis|Recruiting||N/A|300|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||Samples With DNA|"     Testicular tissue, penile tissue   "|No||2017-10-10 21:54:52.526025|2017-10-10 21:54:52.526025
NCT02864316|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-21|||December 2016||2016-12-01|September 2017|2017-09-01||||December 2019|Anticipated|2019-12-01||Interventional|||Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure|Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure|Recruiting||Phase 2|44|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 21:54:52.635916|2017-10-10 21:54:52.635916
NCT02864303|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-12-21|||June 2012||2012-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SalivALZ||Use of Saliva for Alzheimer's Disease Diagnosis|Predictive Value of the Aβ Peptides Salivary Dosage for Alzheimer's Disease Diagnosis|Recruiting||N/A|250|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:54:52.751392|2017-10-10 21:54:52.751392
NCT02864290|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-04-24|||November 10, 2016|Actual|2016-11-10|April 2017|2017-04-01|July 11, 2021|Anticipated|2021-07-11|July 12, 2019|Anticipated|2019-07-12||Interventional|||A Study to Evaluate Escalating Doses of AGS62P1 Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)|A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS62P1 Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|150|Anticipated|Astellas Pharma Inc||4|||f||||f||||||||Undecided||2017-10-10 21:54:52.882164|2017-10-10 21:54:52.882164
NCT02864277|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-09-12|||August 2016||2016-08-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|ERAS||Enhanced Recovery After Surgery Gynecology Oncology|Enhanced Recovery After Surgery (ERAS) Program Versus Conventional Perioperative Strategies in Patients Undergoing Gynecologic Oncologic Surgery: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 21:54:53.635691|2017-10-10 21:54:53.635691
NCT02864264|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-26|||September 14, 2016|Actual|2016-09-14|September 2017|2017-09-01|September 14, 2018|Anticipated|2018-09-14|September 13, 2018|Anticipated|2018-09-13||Interventional|||Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis|Double-Blind, Randomized, Placebo-Controlled, Single Ascending and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Target Engagement of BMS-986184 in Healthy Subjects and to Evaluate the Safety, Efficacy, Pharmacokinetics, Target Engagement, and Pharmacodynamics of BMS-986184 in Patients With Moderate to Severe Ulcerative Colitis|Recruiting||Phase 1|144|Anticipated|Bristol-Myers Squibb||4|||f||||f|t|f|||t|||||2017-10-10 21:54:53.768121|2017-10-10 21:54:53.768121
NCT02864251|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-09-26|||October 31, 2016|Actual|2016-10-31|September 2017|2017-09-01|December 31, 2023|Anticipated|2023-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|CheckMate722||A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy|Open-Label, Randomized Trial of Nivolumab (BMS-936558) Plus Pemetrexed/Platinum or Nivolumab Plus Ipilimumab (BMS-734016) vs Pemetrexed Plus Platinum in Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Subjects With Epidermal Growth Factor Receptor (EGFR) Mutation, T790M Negative Who Failed 1L EGFR Tyrosine Kinase Inhibitor Therapy|Recruiting||Phase 3|465|Anticipated|Bristol-Myers Squibb||3|||f||||t|t|f||||||||2017-10-10 21:54:53.911583|2017-10-10 21:54:53.911583
NCT02864238|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-08-10|||January 2013||2013-01-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||The Utility of Clinical Milestones Pathway in a Cardiovascular ICU|The Utility of an Electronic Based Milestone Pathway on the Care of Patients Undergoing Cardiac Valve Surgery|Completed||N/A|2401|Actual|Vanderbilt University|||2||f||||f||||||||No||2017-10-10 21:54:54.425872|2017-10-10 21:54:54.425872
NCT02863666|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-21|||August 2016||2016-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|VPAC||Verification of Prediction Algorithm|Verification of a Prediction Algorithm for Cardiopulmonary Patients Admitted to the Emergency Department (ED) (VPAC)|Recruiting||N/A|760|Anticipated|Zoll Medical Corporation|||1||f||||f||||||||||2017-10-10 21:54:59.006995|2017-10-10 21:54:59.006995
NCT02864225|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-11|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||To Compare the Efficacy Between 3 Fetal Monitoring Methods (EUM)|A Prospective, Blinded Clinical Study to Compare the Efficacy Between Three Fetal Monitoring Methods: Electro Uterine Monitor (EUM), Fetal Doppler and Scalp Electrode|Not yet recruiting||Phase 3|400|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||No||2017-10-10 21:54:54.504261|2017-10-10 21:54:54.504261
NCT02864212|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-08|||September 2014||2014-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Development of a Methodology to Design a High Order Sliding Mode Controller for Drug Dosage|Development of a Methodology to Design a High Order Sliding Mode Controller for Drug Dosage|Recruiting||N/A|30|Anticipated|Coordinación de Investigación en Salud, Mexico|||3||f||||f||||||||Undecided||2017-10-10 21:54:54.579142|2017-10-10 21:54:54.579142
NCT02864199|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2016-08-09|||February 2004||2004-02-01|August 2016|2016-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment|Non-Randomized, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Peginterferon Alfa-2a and Copegus Combination Therapy After Single and Multiple Doses in Patients With Chronic Hepatitis C and Moderate Renal Impairment, Severe Renal Impairment, or End-Stage Renal Disease Undergoing Hemodialysis|Completed||Phase 4|63|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-10 21:54:54.655428|2017-10-10 21:54:54.655428
NCT02864186|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-08|||January 2015||2015-01-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Benefits of the Use of a Support Bra in Women Undergoing Coronary Artery By-Pass Graft Surgery|A Randomized Study to Test the Hypothesis That a Support Bra Will Improve Healing and Quality of Life After Coronary Artery By-Pass Graft (CABG)|Recruiting||N/A|147|Anticipated|University of Sao Paulo||3|||f||||f||||||||No||2017-10-10 21:54:54.78234|2017-10-10 21:54:54.78234
NCT02864173|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-12|||August 2007|Actual|2007-08-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|October 2011|Actual|2011-10-01||Observational|GenPOCD||Whole Genome Single Nucleotide Polymorphisms in Elderly Patients With Postoperative Cognitive Dysfunction|Whole Genome Single Nucleotide Polymorphisms in Elderly Patients With Postoperative Cognitive Dysfunction|Active, not recruiting||N/A|63|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples With DNA|"     Whole blood sample   "|||2017-10-10 21:54:54.869937|2017-10-10 21:54:54.869937
NCT02864160|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-10-05|||September 2014||2014-09-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|ISLL||Integrated Second Language Learning for Chronic Care|Integrated Second Language Learning for Chronic Care: A Model to Improve Primary Care for Hispanics With Diabetes|Recruiting||N/A|200|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-10 21:54:54.934297|2017-10-10 21:54:54.934297
NCT02864147|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-11-22|||July 2016||2016-07-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)|"Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) Using a Novel Prime and Pull Strategy"|Recruiting||Phase 2|138|Anticipated|Yale University||3|||f||||t||||||||Undecided||2017-10-10 21:54:55.05626|2017-10-10 21:54:55.05626
NCT02864134|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-11-03|||August 2016||2016-08-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01|12 Months|Observational [Patient Registry]|||Optic Neuritis and Ganglion Cell Layer|Predictive Effect of Ganglion Cell Layer on Visual Acuity at 6 Months and on Visual Function at 1 Year After an Episode of Optic Neuritis|Recruiting||N/A|28|Anticipated|CHU de Quebec-Universite Laval|||1||f||||t||||||||No||2017-10-10 21:54:55.140523|2017-10-10 21:54:55.140523
NCT02864121|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-08-10|||December 2015||2015-12-01|August 2016|2016-08-01|March 2022|Anticipated|2022-03-01|December 2021|Anticipated|2021-12-01||Interventional|IDAHO||Oncogenous HPV DNA Integration (Intégration De l'ADN Des HPV Oncogènes)|Association Between High-risk HPV Genome Integration Detected by Molecular Combing and Cervical Lesions Severity and/or Evolution|Recruiting||Early Phase 1|3500|Anticipated|CHU de Reims||1|||f||||f||||||||||2017-10-10 21:54:55.198968|2017-10-10 21:54:55.198968
NCT02864108|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-08-29|||July 2016||2016-07-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Observational|HTP||The Crnic Institute Human Trisome Project Biobank|Research to Develop the Human Trisome Project Biobank|Recruiting||N/A|1000|Anticipated|University of Colorado, Denver|||2||f||||||||||Samples With DNA|"     blood, saliva, urine (optional), stool (optional)   "|||2017-10-10 21:54:55.263234|2017-10-10 21:54:55.263234
NCT02864095|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-07-26|||May 2015||2015-05-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effects of Low-dose Epinephrine Plus Tranexamic Acid on Perioperative Haemostasis and Inflammatory Reaction in Major Surgery||Recruiting||N/A|200|Anticipated|Southwest Hospital, China||3|||f||||t||||||||||2017-10-10 21:54:55.335212|2017-10-10 21:54:55.335212
NCT02864082|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-08-17|||January 2017||2017-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis|A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis|Recruiting||Phase 2|18|Anticipated|Patagonia Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 21:54:55.432606|2017-10-10 21:54:55.432606
NCT02864069|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-26|||September 2014||2014-09-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CBI||Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI|Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI|Recruiting||N/A|66|Anticipated|University of California, San Diego||3|||f||||||||||||||2017-10-10 21:54:55.528519|2017-10-10 21:54:55.528519
NCT02863874|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-21|||November 2015||2015-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of VicrylPlus® Versus Vicryl® for Repair of Perineal Tears|Comparison of VicrylPlus® Versus Vicryl® for Surgical Repair of Perineal Tears; a Prospectively Randomized Controlled Trial|Recruiting||N/A|948|Anticipated|Region Skane||2|||f||||f||||||||||2017-10-10 21:54:57.482546|2017-10-10 21:54:57.482546
NCT02863861|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-12-21|||September 2016||2016-09-01|December 2016|2016-12-01||||December 2016|Actual|2016-12-01||Interventional|||Sedation for Upper Gastrointestinal Endoscopy in Pediatric Patients|Comparative Study Between Propofol-Ketamine Combination and Dexmedetomidine-Ketamine Combination for Sedation in Upper Gastrointestinal Endoscopy in Paediatric Patients.|Completed||Phase 4|120|Actual|Ain Shams University||2|||f||||||||||||||2017-10-10 21:54:57.614262|2017-10-10 21:54:57.614262
NCT02864056|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-04-25|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|TACIT||The TACIT Trial: TAi ChI for People With demenTia|A Randomised Controlled Trial Comparing the Effectiveness of Tai Chi Alongside Usual Care With Usual Care Alone on the Postural Balance of Community-dwelling People With Dementia|Recruiting||N/A|300|Anticipated|Bournemouth University||2|||f||||f|f|f||||||Yes|A Data Management Plan will be prepared to facilitate access, sharing and preservation. This will be explicitly referred to in the Statistical Analysis Plan and in the resultant publication of the main trial outcome. This will include specific detail of how potential bona fide research teams will be able to access the following from the CI's institution (Bournemouth University) online repository after an embargo period of approximately 24 months from the publication of the main trial outcome paper.|2017-10-10 21:54:55.609407|2017-10-10 21:54:55.609407
NCT02864043|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-29|||September 2016||2016-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|DDP||Barrett's Dysplasia Detection Pilot Trial Using the NvisionVLE® Imaging System|Identification of Features Associated With Dysplasia Using the NvisionVLE® Imaging System Pilot Trial|Recruiting||N/A|100|Anticipated|NinePoint Medical||1|||f||||f||||||||||2017-10-10 21:54:55.706219|2017-10-10 21:54:55.706219
NCT02864030|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-04-03|||May 2014||2014-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment|Multicenter, Interventional, Single-arm, Phase IV Study Evaluating Tolerability of Eribulin and Its Relationship With a Set of Polymorphisms in an Unselected Population of Female Patients With Metastatic Breast Cancer|Recruiting||Phase 4|200|Anticipated|Oncologia Medica dell'Ospedale Fatebenefratelli||1|||f||||f||||||||No||2017-10-10 21:54:55.814714|2017-10-10 21:54:55.814714
NCT02864017|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-09-22|||September 2016||2016-09-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|Immunocitre||Immuno Nutrition by L-citrulline for Critically Ill Patients|Immuno Nutrition by L-citrulline for Critically Ill Patients|Recruiting||N/A|120|Anticipated|Rennes University Hospital||2|||f||||f||||||||No||2017-10-10 21:54:55.972512|2017-10-10 21:54:55.972512
NCT02864004|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-21|||March 3, 2017|Actual|2017-03-03|August 2017|2017-08-01|September 3, 2021|Anticipated|2021-09-03|March 3, 2020|Anticipated|2020-03-03||Interventional|EARLY-PUMP||Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)|Apomorphine Pump in Early Stage of Parkinson's Disease|Recruiting||Phase 3|192|Anticipated|Rennes University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:54:56.236943|2017-10-10 21:54:56.236943
NCT02863991|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-07|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|March 8, 2020|Anticipated|2020-03-08|March 8, 2019|Anticipated|2019-03-08||Interventional|||Oral ONC201 in Relapsed/Refractory Multiple Myeloma|Oral ONC201 in Relapsed/Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|42|Anticipated|Oncoceutics, Inc.||1|||f|||||t|f||||||||2017-10-10 21:54:56.447178|2017-10-10 21:54:56.447178
NCT02863978|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-05-26|||November 8, 2016|Actual|2016-11-08|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|Digi-NewB||Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a Database|Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a Database|Recruiting||N/A|1000|Anticipated|Rennes University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:54:56.536238|2017-10-10 21:54:56.536238
NCT02863965|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-08-08|||March 2016||2016-03-01|July 2016|2016-07-01||||October 2016|Anticipated|2016-10-01||Observational|||High Definition Endoscopy and Optic Enhancement Endoscopy in Gastric Neoplasia: A Prospective Study||Recruiting||N/A|200|Anticipated|Shandong University|||1||f||||t||||||||||2017-10-10 21:54:56.705437|2017-10-10 21:54:56.705437
NCT02863952|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-08-10|||September 2016||2016-09-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Quantitation of Left Ventricular Ejection Fraction Change From Early Exercise Gated Stress/Rest Tc-99m CZT-SPECT MPI|Quantitation of Left Ventricular Ejection Fraction Change From Early Exercise Gated Stress/Rest Tc-99m CZT-SPECT MPI|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center||1|||f||||t||||||||||2017-10-10 21:54:56.805168|2017-10-10 21:54:56.805168
NCT02863939|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-08-10|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NICAS||Quantitation of Cardiac Output Change by Impedance Cardiography in Subjects Undergoing Exercise Gated Stress/Rest Tc-99m CZT-SPECT MPI||Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 21:54:56.909732|2017-10-10 21:54:56.909732
NCT02863926|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-08|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MarrowCHAMP||Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)|Safety and Efficacy of Concentrated Autologous Concentrated Bone Marrow Aspirate (cBMA) in Preventing Wound Complications in Below Knee Amputation (BKA) (The MarrowCHAMP Study)|Active, not recruiting||Phase 1|6|Actual|Indiana University||3|||f||||t||||||||||2017-10-10 21:54:57.000776|2017-10-10 21:54:57.000776
NCT02863913|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer|A Dose-escalation Phase I Trial of PD-1 Knockout Engineered T Cells for the Treatment of Muscle-invasive Bladder Cancer|Not yet recruiting||Phase 1|20|Anticipated|Peking University||2|||f||||t||||||||Undecided|plan to share|2017-10-10 21:54:57.131661|2017-10-10 21:54:57.131661
NCT02863900|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||December 2016||2016-12-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|BREASTEROL||From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers|From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers|Not yet recruiting||N/A|350|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||No||2017-10-10 21:54:57.278133|2017-10-10 21:54:57.278133
NCT02863887|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-04-03|||June 2016||2016-06-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|LEAN||Lifestyle Changes Through Exercise and Nutrition|The Lifestyle Changes Through Exercise and Nutrition (LEAN) Project|Active, not recruiting||N/A|97|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||No||2017-10-10 21:54:57.370532|2017-10-10 21:54:57.370532
NCT02863848|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-08-08|||September 2012||2012-09-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|CONSTICHILD||Effect of Inulin-type Fructans on Constipated Children.|Effect of Inulin-type Fructans on Constipated Children. Pilot Study.|Completed||N/A|22|Actual|Institut Investigacio Sanitaria Pere Virgili||2|||f||||f||||||||Yes|Results about the pilot study will be published.|2017-10-10 21:54:57.698478|2017-10-10 21:54:57.698478
NCT02863835|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-08-18|||April 2016||2016-04-01|February 2017|2017-02-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|CLAD||Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients|Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients|Completed||N/A|50|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 21:54:57.783004|2017-10-10 21:54:57.783004
NCT02863822|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-19|||September 2016||2016-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.|A Prospective, Randomized, Investigator Blinded, Controlled Trial to Evaluate the Effectiveness of Dietary Modification in Patients With Functional Dyspepsia|Recruiting||N/A|225|Anticipated|Advocate Health Care||2|||f||||f||||||||||2017-10-10 21:54:57.900266|2017-10-10 21:54:57.900266
NCT02863809|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-08-15|||March 15, 2017|Actual|2017-03-15|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit|A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation|Recruiting||Phase 1/Phase 2|84|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||t|t|t|f|f||||||2017-10-10 21:54:58.01472|2017-10-10 21:54:58.01472
NCT02863796|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-08-08|||August 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:54:58.225577|2017-10-10 21:54:58.225577
NCT02863783|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||EUS Fiducial for Pancreas Surgery|Pilot Trial of Endoscopic Ultrasound Guided Coil Placement to Facilitate Intraoperative Assessment of Pancreas Tumors|Not yet recruiting||N/A|20|Anticipated|University of Southern California||1|||f||||t||||||||||2017-10-10 21:54:58.269477|2017-10-10 21:54:58.269477
NCT02863770|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-09-20|||July 2016||2016-07-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Interventional|||Contrast EUS of the Pancreas|Prospective Controlled Trial of Contrast Enhanced Endoscopic Ultrasound for Evaluation of Pancreas Lesions|Recruiting||N/A|75|Anticipated|University of Southern California||1|||f||||t||||||||No||2017-10-10 21:54:58.347788|2017-10-10 21:54:58.347788
NCT02863757|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-05-08|||August 2016||2016-08-01|May 2017|2017-05-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|||Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease|Disease Progression and Clinical Outcomes in Chronic Hepatitis B (CHB) Patients With Comorbid Nonalcoholic Fatty Liver Disease (NAFLD)|Recruiting||N/A|1500|Anticipated|Humanity and Health Research Centre|||3||f||||t||||||||No||2017-10-10 21:54:58.449692|2017-10-10 21:54:58.449692
NCT02863744|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-06|||December 2014||2014-12-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Estimation of MMP-8 Levels in GCF and Serum and Its Correlation With Wound Healing and Clinical Outcomes After Coronally Advanced Flap and Subepithelial Connective Tissue Graft for Root Coverage in Recession Defects: A CLINICO-BIOCHEMICAL STUDY|Estimation of MMP-8 Levels in GCF and Serum and Its Correlation With Wound Healing and Clinical Outcomes After Coronally Advanced Flap and Subepithelial Connective Tissue Graft for Root Coverage in Recession Defects: A CLINICO-BIOCHEMICAL STUDY|Suspended||Phase 4|15|Actual|Krishnadevaraya College of Dental Sciences & Hospital||1||6 month follow up for the patients in progress|f||||||||||||||2017-10-10 21:54:58.53559|2017-10-10 21:54:58.53559
NCT02863731|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-16|||January 2014||2014-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Alternating Postures on Cognitive Performance|Effect of Alternating Postures on Cognitive Performance|Completed||N/A|46|Actual|University of Applied Sciences Upper Austria||3|||f||||f||||||||No||2017-10-10 21:54:58.608644|2017-10-10 21:54:58.608644
NCT02863718|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-09-23|||April 2014||2014-04-01|September 2016|2016-09-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|CLL12||Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression|A Placebo-Controlled, Double-Blind, Randomized, Multicenter, Three Arm Phase III Trial to Compare the Efficacy and Safety of Ibrutinib vs. Placebo in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia Patients With Risk of Early Disease Progression|Recruiting||Phase 3|540|Anticipated|German CLL Study Group||3|||f||||t||||||||No||2017-10-10 21:54:58.689686|2017-10-10 21:54:58.689686
NCT02863705|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-16|||July 5, 2016|Actual|2016-07-05|July 2017|2017-07-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)|A 12-Month, Phase 4, Open Label, Multicenter, Trial to Assess the Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)|Active, not recruiting||Phase 4|117|Actual|Allergan||2|||f||||f|f|f||||||||2017-10-10 21:54:58.783002|2017-10-10 21:54:58.783002
NCT02863692|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-09-15|||August 2013||2013-08-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01|25 Years|Observational [Patient Registry]|CLL-Registry||Registry of the German CLL Study Group|Registry of the German CLL Study Group Long Term Follow-up of Patients With CLL, B-PLL, T-PLL, SLL,T or NK-LGL, HCL and Richter's Transformation|Recruiting||N/A|3000|Anticipated|German CLL Study Group|||1||f||||f||||||||Undecided||2017-10-10 21:54:58.871983|2017-10-10 21:54:58.871983
NCT02863640|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-02-06|||December 14, 2015||2015-12-14|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PARM||Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's Patients||Recruiting||N/A|385|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:54:59.191096|2017-10-10 21:54:59.191096
NCT02863627|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|NNUP||What Care Pathways for Newborns Consulting Pediatric Emergencies? Prospective Study Over One Year|What Care Pathways for Newborns Consulting Pediatric Emergencies? Prospective Study Over One Year Newborn Pediatric Emergencies (NNUP)|Recruiting||N/A|280|Anticipated|Fondation Lenval||1|||f||||f||||||||No||2017-10-10 21:54:59.2672|2017-10-10 21:54:59.2672
NCT02863614|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-05-07|||May 2015||2015-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Analgesia for Endometrial Scratching|Analgesia for Endometrial Scratching in Subfertile Women: a Randomized Controlled Trial|Enrolling by invitation||N/A|150|Anticipated|University of Sao Paulo||3|||f||||f||||||||||2017-10-10 21:54:59.35078|2017-10-10 21:54:59.35078
NCT02863601|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-06-05|||August 2016||2016-08-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Observational|||Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics|Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics|Recruiting||N/A|40|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Venous Blood, Hair, Urine, Saliva, Postpartum Breast Milk   "|||2017-10-10 21:54:59.415445|2017-10-10 21:54:59.415445
NCT02863588|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-07|||March 30, 2017|Actual|2017-03-30|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|TREXO||Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis|Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis|Recruiting||N/A|45|Anticipated|University Hospital, Strasbourg, France||1|||f||||f|f|f||||||||2017-10-10 21:54:59.480771|2017-10-10 21:54:59.480771
NCT02863562|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-04-03|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||Study of the Effect of Kinesio Taping and Proprioceptive Exercise on the Stability of Ankle in Amateur Soccer Players|Study of the Effect of Kinesio Taping and Proprioceptive Exercise on the Stability of Ankle in Amateur Soccer Players|Completed||N/A|46|Actual|University of Valencia||3|||f||||f||||||||No||2017-10-10 21:54:59.648969|2017-10-10 21:54:59.648969
NCT02863549|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-06|||July 2016||2016-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TVrepair||MitraClip for Severe TR|Transcatheter Treatment of Severe Tricuspid Regurgitation Using the MitraClip System|Not yet recruiting||N/A|100|Anticipated|Klinikum der Universitaet Muenchen||1|||f||||f||||||||No||2017-10-10 21:54:59.721423|2017-10-10 21:54:59.721423
NCT02863536|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-09-21|||September 2016||2016-09-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|POLARIS||A Study of the New Medical Device Polybactum®|A Multicenter, Open Label, Non-comparative, 3 Months Study to Assess the Performance and Safety of the New Medical Device Polybactum® in Reducing the Frequency of Recurrent Bacterial Vaginosis|Recruiting||Phase 3|55|Anticipated|Effik Italia S.p.A.||1|||f||||t||||||||||2017-10-10 21:54:59.790858|2017-10-10 21:54:59.790858
NCT02863523|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-08|||September 2014||2014-09-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|COMRADE||COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes|COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes|Active, not recruiting||N/A|139|Actual|East Carolina University||2|||f||||f||||||||||2017-10-10 21:55:01.832501|2017-10-10 21:55:01.832501
NCT02863510|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-08|||September 2013||2013-09-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney Disease|Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney Disease Using a Novel Non-iodinated Contrast Free Protocol|Completed||N/A|10|Actual|Heart of England NHS Trust||1|||f||||f||||||||||2017-10-10 21:55:01.943286|2017-10-10 21:55:01.943286
NCT02863497|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-08|||April 2016||2016-04-01|August 2016|2016-08-01||||March 2017|Anticipated|2017-03-01||Interventional|MIST||The Mindfulness, Incontinence and Sexual Function Treatment Study|The Mindfulness, Incontinence and Sexual Function Treatment Study|Recruiting||N/A|60|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 21:55:02.060389|2017-10-10 21:55:02.060389
NCT02863484|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-06|||May 2016||2016-05-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|OCS||Cavernous Sinus Dissection and Bleeding in Meningiomas|Dissection of the Outer Layer of the Lateral Wall of the Cavernous Sinus Decreases Bleeding as Compared to Direct Tumor Attack in Middle Fossa Meningiomas: A Randomized Controlled Trial|Recruiting||Phase 4|120|Anticipated|Kasr El Aini Hospital||2|||f||||f||||||||No||2017-10-10 21:55:02.196969|2017-10-10 21:55:02.196969
NCT02863471|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-11|||January 2016||2016-01-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|PanHIPEC||Open-label Pilot Phase I / II Study on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Macroscopically|Open-label Pilot Phase I / II Study on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Macroscopically Complete Resection (R0 / R1) of Adenocarcinomas of the Pancreas (PanHIPEC)|Recruiting||Phase 1/Phase 2|16|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||No||2017-10-10 21:55:02.320506|2017-10-10 21:55:02.320506
NCT02863458|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2016-08-06|||August 2016||2016-08-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|12 Years|Observational [Patient Registry]|||DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US|Effectiveness of DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the United States|Not yet recruiting||N/A|50000|Anticipated|The Cleveland Clinic|||1||f||||f||||||||Yes|share study data with Celgene and will plan to publish a manuscript upon completion of the study|2017-10-10 21:55:02.454355|2017-10-10 21:55:02.454355
NCT02863445|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-29|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|EC-Obesity||Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG|Improving the Effectiveness of Orally Dosed Emergency Contraceptives in Obese Women - Pharmacodynamics of 3.0mg LNG|Recruiting||Phase 4|80|Anticipated|Oregon Health and Science University||2|||f||||t|t|f||||||||2017-10-10 21:55:02.571929|2017-10-10 21:55:02.571929
NCT02863432|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-06-01|||July 2016||2016-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:55:02.677794|2017-10-10 21:55:02.677794
NCT02863406|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-08-10|||February 2014||2014-02-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|MINASARC01||Comparison of Characteristics of Bronchoalveolar Lavage Dusting and of Specific Questionnary Data in Healthy Volunteers and Patients Suffering From Sarcoidosis|MINASARC01: Comparison of Characteristics of Bronchoalveolar Lavage Dusting and of Specific Questionnary Data in Healthy Volunteers and Patients Suffering From Sarcoidosis: Pilot Study, Prospective, Multicenter, Multidisciplinary With Blind Analysis|Completed||N/A|40|Actual|Centre Hospitalier Saint Joseph Saint Luc de Lyon||2|||f||||f||||||||No||2017-10-10 21:55:03.248694|2017-10-10 21:55:03.248694
NCT02863393|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-29|||August 29, 2017|Actual|2017-08-29|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease|Intentional Diaphragmatic Breathing Exercise Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)|Withdrawn||N/A|0|Actual|Taipei Medical University WanFang Hospital||1||Couldnt find sponor for this study|f||||f|f|f||||||||2017-10-10 21:55:03.333439|2017-10-10 21:55:03.333439
NCT02863380|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-10-04|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Personalized rTMS for Resistant Depression|Validation of Personalized Antidepressant Treatment by Neuromodulation - Pilot Study|Recruiting||N/A|24|Anticipated|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-10-10 21:55:03.44386|2017-10-10 21:55:03.44386
NCT02863367|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-07|||August 2016||2016-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OECTAPGAMPC||A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer|A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer|Not yet recruiting||Phase 2|30|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:55:03.616007|2017-10-10 21:55:03.616007
NCT02863354|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-21|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|July 2019|Anticipated|2019-07-01||Interventional|RECOVERY||Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy|Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy|Active, not recruiting||Phase 2|40|Actual|Greater Houston Retina Research||2|||f||||f||||||||||2017-10-10 21:55:03.711851|2017-10-10 21:55:03.711851
NCT02863341|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-05-09|||November 2016||2016-11-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Nursing Home Team-Care Deprescribing Study|Nursing Home Team-Care Deprescribing Study|Active, not recruiting||N/A|295|Actual|Tan Tock Seng Hospital||4|||f||||||||||||||2017-10-10 21:55:03.827252|2017-10-10 21:55:03.827252
NCT02863328|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-13|||August 10, 2016|Actual|2016-08-10|September 2017|2017-09-01|March 12, 2018|Anticipated|2018-03-12|August 7, 2017|Actual|2017-08-07||Interventional|PIONEER 2||Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus|Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 3|816|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 21:55:03.924002|2017-10-10 21:55:03.924002
NCT02863315|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-25|||August 2016||2016-08-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effects of Anodal tsDCS on Chronic Neuropathic Pain After SCI|The Effects of Anodal Transcutaneous Spinal Direct Current Stimulation on Chronic Neuropathic Pain After Spinal Cord Injury: Pilot Study|Active, not recruiting||N/A|10|Anticipated|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 21:55:04.290391|2017-10-10 21:55:04.290391
NCT02863302|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2017-02-14|||January 1, 2017|Actual|2017-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients|Reflexology Treatment for Newly Diagnosed AML Patients, Can it Reduce GI Tract Side Effects, and Improve and Improve Patients Mood.|Recruiting||N/A|50|Anticipated|Rambam Health Care Campus||1|||f||||f|f|f||||||No||2017-10-10 21:55:04.39028|2017-10-10 21:55:04.39028
NCT02863289|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-04-25|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Observational|||The Outcomes of Proximal Humerus Fractures in Children|Proximal Humerus Fractures in Children: The Outcomes of Conservative Management|Completed||N/A|118|Actual|NHS Tayside|||1||f||||t||||||||No||2017-10-10 21:55:04.495794|2017-10-10 21:55:04.495794
NCT02863276|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-08|||December 2009||2009-12-01|August 2016|2016-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Modulating the Stress Response in Diabetes Mellitus Type 2 Patients Undergoing Colon Surgery|Modulating the Stress Response in Diabetes Mellitus Type 2 Patients Undergoing Colon Surgery|Completed||N/A|18|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-10 21:55:04.564306|2017-10-10 21:55:04.564306
NCT02863263|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-10|||July 29, 2016|Actual|2016-07-29|September 2017|2017-09-01|April 6, 2018|Anticipated|2018-04-06|April 6, 2018|Anticipated|2018-04-06||Interventional|||Efficacy and Safety of MedifoamⓇ and BetafoamⓇ in Pressure Ulcer|A Pilot Study to Evaluate Efficacy and Safety of Hydrophilic Polyurethane Foam Dressing in Patients With Pressure Ulcer|Recruiting||N/A|20|Anticipated|Mundipharma Pte Ltd.||2|||f||||f||||||||||2017-10-10 21:55:04.644398|2017-10-10 21:55:04.644398
NCT02863250|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-07|||March 2011||2011-03-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01|1 Year|Observational [Patient Registry]|ANZ-MTR||Australian and New Zealand Massive Transfusion Registry|Improving Outcomes for Patients With Critical Bleeding Requiring Massive Transfusion|Recruiting||N/A|5000|Anticipated|Monash University|||1||f||||t||||||||No||2017-10-10 21:55:04.746532|2017-10-10 21:55:04.746532
NCT02863237|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Predictors of Weaning Outcomes for Brain Injured Patients|Predictors of Weaning Outcomes for Brain Injured Patients: a Prospective, Observational Cohort Study|Recruiting||N/A|106|Anticipated|Capital Medical University|||2||f||||t||||||||Undecided||2017-10-10 21:55:04.828075|2017-10-10 21:55:04.828075
NCT02863224|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Observational|||Advanced Glycation End Products as a Biomarker for Accelerated Ageing|Advanced Glycation End Products as a Biomarker for Accelerated Ageing in Glaucomatous Optic Neuropathy|Recruiting||N/A|192|Anticipated|University of Plymouth|||4||f||||||||||Samples Without DNA|"     Plasma samples will be analysed within the study time frame. They will be used for this study     only and will be destroyed as per HTA guidelines once no longer needed for this study.   "|||2017-10-10 21:55:04.908351|2017-10-10 21:55:04.908351
NCT02863211|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01|5 Years|Observational [Patient Registry]|||The Assessment of Large and Small Artery Elasticity for the Early Detection of Cardiovascular Disease|The Assessment of Large and Small Artery Elasticity for the Early Detection of Cardiovascular Disease|Recruiting||N/A|1000|Anticipated|St. Boniface General Hospital Research Centre|||1||f||||f||||||Samples With DNA|"     Participants are asked to fast for the 12 hours prior to the blood draw at their appointment.     Approximately 10 mL of blood is collected by a phlebotomist. The samples are then centrifuged     so that the plasma can be separated and analyzed for total cholesterol, high-density     lipoprotein, low-density lipoprotein, triglycerides, and fasting glucose.   "|No|The anonymous information gathered from the data collection process will be summarized (e.g. means ± SD), disseminated into a report and shared with the St-Boniface Hospital Foundation, investigators of the study, and stakeholders involved in this study. The information may also be presented at conferences or published in peer-reviewed journals. Neither participants' names nor contact information will appear in any publications stemming from this research.|2017-10-10 21:55:04.989851|2017-10-10 21:55:04.989851
NCT02863198|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-01-24|2016-09-01||October 2013||2013-10-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|||Endometrial Injury for Unexplained Infertility|Endometrial Injury for Unexplained Infertility: Randomized Case-control Study|Completed||N/A|120|Actual|Benha University|No limitation or caveats|2|||f||||f||||||||No||2017-10-10 21:55:05.190041|2017-10-10 21:55:05.190041
NCT02863185|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-14|||May 2016||2016-05-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease|Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease|Active, not recruiting||Phase 4|72|Anticipated|Dong-A University||2|||f||||f||||||||||2017-10-10 21:55:05.657161|2017-10-10 21:55:05.657161
NCT02863172|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-08-14|||May 2012|Actual|2012-05-01|August 2017|2017-08-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Observational|||Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes|Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes|Recruiting||N/A|2000|Anticipated|M.D. Anderson Cancer Center|||3||f||||f|f|f||||Samples With DNA|"     Blood (about 2-3 tablespoons) drawn.   "|||2017-10-10 21:55:05.754063|2017-10-10 21:55:05.754063
NCT02863159|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-08-08|||August 2015||2015-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis Multifocal IOL 1-Piece Models in Bilateral Cataract Extraction|A Clinical Assessment of the Full Range of Functional Vision (Distance, Intermediate, Near) With Three Tecnis Multifocal IOL 1-Piece Models [+2.75D (ZKB00), +3.25D (ZLB00), +4.00D (ZMB00)] in Subjects Undergoing Bilateral Cataract Extraction|Recruiting||N/A|100|Anticipated|Dell Laser Consultants||2|||f||||f||||||||Undecided||2017-10-10 21:55:05.859572|2017-10-10 21:55:05.859572
NCT02863146|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-10-03|||May 2015|Actual|2015-05-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|July 2017|Actual|2017-07-01||Observational|||Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast Cancer|Efficacy of the Use of a Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Locally Advanced or Metastatic Breast Cancer Pretreated With Anthracyclines and Taxanes|Terminated||N/A|23|Actual|Centre Oscar Lambret|||1|Lack of enrollment|f||||f||||||||||2017-10-10 21:55:05.942402|2017-10-10 21:55:05.942402
NCT02863133|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||October 2016||2016-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|Ideale||Prospective Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions|Prospective, Multicenter, Multinational Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions IDEALE Study|Not yet recruiting||N/A|65|Anticipated|Antia Therapeutics AG||1|||f||||f||||||||Undecided||2017-10-10 21:55:06.023747|2017-10-10 21:55:06.023747
NCT02863107|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-08-17|||June 2012|Actual|2012-06-01|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Observational|||Young-Onset Microsatellite-Stable Colorectal Cancer|Young-Onset Microsatellite-Stable Colorectal Cancer|Recruiting||N/A|1000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     Participants have a one-time collection of whole blood (up to 40cc).   "|||2017-10-10 21:55:06.204161|2017-10-10 21:55:06.204161
NCT02863094|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-07|||May 2016||2016-05-01|September 2017|2017-09-01||||November 2018|Anticipated|2018-11-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Schizophrenia Patients With Auditory Hallucinations||Recruiting||N/A|30|Anticipated|Anhui Medical University||2|||f||||f||||||||||2017-10-10 21:55:06.287922|2017-10-10 21:55:06.287922
NCT02863068|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-10-02|||July 1, 2017|Actual|2017-07-01|October 2017|2017-10-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers|A Phase II Study of Topical Sodium Nitrite in Patients With Sickle Cell and Leg Ulcers|Recruiting||Phase 2|50|Anticipated|Montefiore Medical Center||2|||f||||t|t|f||||||||2017-10-10 21:55:06.455674|2017-10-10 21:55:06.455674
NCT02863055|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-10|||February 2017||2017-02-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|NEMO||Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma|Nintedanib as Maintenance Treatment of Pleural Malignant Mesothelioma (NEMO): a Randomized Double Blinded Phase II Study of the EORTC Lung Cancer Group|Not yet recruiting||Phase 2|116|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||No||2017-10-10 21:55:06.542567|2017-10-10 21:55:06.542567
NCT02863042|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-08-08|||May 2016||2016-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|AnkleFX||Is Deltoid Ligament Repair for Ankle Fracture Necessary?|Is Deltoid Ligament Repair in Supination-external Rotation Ankle Fractures Necessary? A Prospective Cohort Study.|Enrolling by invitation||N/A|30|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:55:06.746933|2017-10-10 21:55:06.746933
NCT02863029|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-15|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells|Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells|Recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||t||||||||Yes|Tissue samples will be sent to the Massachusetts Institute of Technology (MIT)|2017-10-10 21:55:06.830561|2017-10-10 21:55:06.830561
NCT02863016|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-05|||July 2016||2016-07-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|August 2016|Actual|2016-08-01||Observational|HEPHAESTUS||Effects of Postdilution Online Hemodiafiltration AcEtate-free Citrate dialySis Fluid on Inflammation Markers in TUscan Prevalent Hemodialysis patientS|tHe Effects of Postdilution Online Hemodiafiltration With AcEtate-free Citrate dialySis Fluid on Inflammation Markers in TUscan Prevalent Hemodialysis patientS: HEPHAESTUS Study|Recruiting||N/A|66|Anticipated|Ospedale Santa Maria Annunziata|||2||f||||f||||||||No||2017-10-10 21:55:06.926347|2017-10-10 21:55:06.926347
NCT02863003|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-08-08|||September 2016||2016-09-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|16 Years|Observational [Patient Registry]|||Multicenter Database of Patients With Germ Cell Tumor|Multicenter Database of Patients With Germ Cell Tumor in Order to Characterize Clinicopathologically and to Evaluate Cancer Treatment Outcomes|Not yet recruiting||N/A|1500|Anticipated|Latin American Cooperative Oncology Group|||1||f||||||||||||||2017-10-10 21:55:07.047809|2017-10-10 21:55:07.047809
NCT02862990|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-08-08|||May 2015||2015-05-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of the Attitude of Pre Menopausal Women With Breast Cancer Faced With the Risk of Fertility Loss Caused by Chemotherapy|Evaluation of the Attitude of Pre Menopausal Women With Breast Cancer Faced With the Risk|Recruiting||N/A|450|Anticipated|Latin American Cooperative Oncology Group|||1||f||||f||||||||Undecided||2017-10-10 21:55:07.159989|2017-10-10 21:55:07.159989
NCT02862977|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-01-20|||September 1, 2017|Anticipated|2017-09-01|January 2017|2017-01-01|June 29, 2018|Anticipated|2018-06-29|March 30, 2018|Anticipated|2018-03-30||Interventional|||Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine and Caffeine in Osteomuscular Treatment|Phase III, National, Multicenter, Randomized, Double-blind, Double-masked, Compare the Efficacy of Ketoprofen, Cyclobenzaprine and Caffeine Association Versus Cyclobenzaprine and Caffeine (Miosan Caf®) in the Treatment of Osteomuscular Pain in Adults|Not yet recruiting||Phase 3|414|Anticipated|EMS||2|||f||||t|f|f||||||||2017-10-10 21:55:07.288097|2017-10-10 21:55:07.288097
NCT02862964|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-08-08|||February 2016||2016-02-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Accuro Versus Traditional Landmark Palpation Technique to Determine Accurate Spinal Level for Procedures|Accuro Versus Traditional Landmark Palpation Technique to Determine Accurate Spinal Level for Procedures|Recruiting||N/A|106|Anticipated|University of Virginia|||1||f||||f||||||||No||2017-10-10 21:55:07.377321|2017-10-10 21:55:07.377321
NCT02862951|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-08-08|||May 2016||2016-05-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|Actiwatch||Sleep Efficiency and Quantification After Labor Epidural Analgesia|Sleep Efficiency and Quantification After Labor Epidural Analgesia|Enrolling by invitation||N/A|36|Anticipated|University of Virginia|||1||f||||f||||||||No||2017-10-10 21:55:07.473523|2017-10-10 21:55:07.473523
NCT02862938|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-09-14|||June 2016||2016-06-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Interventional|||Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration|A Randomized, Sham Controlled, Masked Phase II Study to Evaluate the Safety and Efficacy of Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for the Treatment of Glaucoma|Recruiting||Phase 2|60|Anticipated|Stanford University||2|||f||||t||||||||No||2017-10-10 21:55:07.554825|2017-10-10 21:55:07.554825
NCT02862925|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-01|||October 1, 2016|Actual|2016-10-01|April 2017|2017-04-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.|Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.|Completed||N/A|550|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 21:55:07.653683|2017-10-10 21:55:07.653683
NCT02862912|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||August 2016||2016-08-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Chloroprocaine Spinal Anesthesia for Cervical Cerclage (CP Spinal)|Chloroprocaine Versus Bupivacaine Spinal Anesthesia for Cervical Cerclage|Not yet recruiting||Phase 4|50|Anticipated|Columbia University||2|||f||||f||||||||Undecided||2017-10-10 21:55:07.755288|2017-10-10 21:55:07.755288
NCT02862899|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-04-13|||January 2015||2015-01-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CHIPOFIL||Use of a Heating Cable to Obtain Hyperthermia During Intraperitoneal Chemotherapy|Use of a Heating Cable to Obtain Hyperthermia During Intraperitoneal Chemotherapy|Completed||N/A|13|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 21:55:07.863391|2017-10-10 21:55:07.863391
NCT02862886|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-10|||July 2010||2010-07-01|May 2011|2011-05-01||||January 2013|Actual|2013-01-01||Interventional|STRESSOX||Study of the Effect of Beta-3 Adrenergic Receptor Agonists on Oxidative Stress and Signalling Pathways Implicated in Remodelling of the Uteroplacental Space: Experimental in Vitro Approach on Myometrial Tissue Explants|Study of the Effect of Beta-3 Adrenergic Receptor Agonists on Oxidative Stress and Signalling Pathways Implicated in Remodelling of the Uteroplacental Space: Experimental in Vitro Approach on Myometrial Tissue Explants|Completed||N/A|55|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 21:55:07.9377|2017-10-10 21:55:07.9377
NCT02862873|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-10|||March 2015||2015-03-01|June 2016|2016-06-01||||May 2015|Actual|2015-05-01||Interventional|ZORA||Interest of Intravenous Ondansetron in the Prevention of Spinal Anaesthesia-induced Hypotension in Caesarean Section|Iinterest of Intravenous Ondansetron in the Prevention of Spinal Anaesthesia-induced Hypotension in Caesarean Section: Double-blind Randomized Controlled Single-centre Study|Terminated||N/A|7|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:55:08.021991|2017-10-10 21:55:08.021991
NCT02862860|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-10|||May 2012||2012-05-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|Holter Gly||Search for a Link Between the Different Variables for Glycaemia and Oxidative Stress or Impaired HDL Function|Influence of Glycaemic Variability on Oxidative Stress and High-density Lipoprotein (HDL) Function in Type-1 Diabetes|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:55:08.119949|2017-10-10 21:55:08.119949
NCT02862847|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-10|||July 2015||2015-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|COSALE||Study of the Prevalence of Cosavirus and Salivirus Infections, Two New Genera of Picornaviridae, In Infants|Study of the Prevalence of Cosavirus and Salivirus Infections, Two New Genera of Picornaviridae, In Infants|Completed||N/A|615|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 21:55:08.212811|2017-10-10 21:55:08.212811
NCT02862834|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-10|||May 2013||2013-05-01|August 2016|2016-08-01||||September 2015|Actual|2015-09-01||Observational|poikiloderma||Screening for Genes in Patients With Poikiloderma|Towards an Improvement in Diagnosis and Genetic Counselling in Syndromic Poikiloderma|Completed||N/A|39|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:55:08.295106|2017-10-10 21:55:08.295106
NCT02862821|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-10|||September 2016||2016-09-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|BLUNDER||Biomarkers of Online Gambling Addiction|Biomarkers of Online Gambling Addiction: Biomarqueurs de la dépendance Aux Jeux d'Argent en Ligne|Not yet recruiting||N/A|73|Anticipated|Centre Hospitalier Universitaire de Besancon||3|||f||||f||||||||No||2017-10-10 21:55:08.375191|2017-10-10 21:55:08.375191
NCT02862808|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-10|||October 2016||2016-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|SHD-DI||Molecular Diagnosis of Syndromic or Isolated Severe Intellectual Disability Using Whole Exome Sequencing : a Pilot Study||Not yet recruiting||N/A|17|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 21:55:08.458819|2017-10-10 21:55:08.458819
NCT02862795|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-10|||April 2012||2012-04-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PAPILLAN||Human Papillomavirus Anal Infection|Human PapillomaVirus (HPV) Anal Infection: Study of Prevalence and Risk Factors Among 1000 Patients Benefiting From a Colonoscopy|Completed||N/A|500|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:55:08.537988|2017-10-10 21:55:08.537988
NCT02862782|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-10|||September 2016||2016-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles|Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles|Not yet recruiting||Phase 3|1000|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||No||2017-10-10 21:55:08.603254|2017-10-10 21:55:08.603254
NCT02862769|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-12-01|||January 2017||2017-01-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Intra-operative Lidocaine Infusion in Preventing CPSP Post VATs|The Role of Intra-operative Lidocaine Infusion in Preventing Chronic Post Surgical Pain After Video Assisted Thoracoscopic Surgery|Not yet recruiting||Phase 4|120|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 21:55:08.672485|2017-10-10 21:55:08.672485
NCT02862756|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-08|||October 2016||2016-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|ACET||Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms|Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms|Not yet recruiting||N/A|250|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:55:08.752286|2017-10-10 21:55:08.752286
NCT02862743|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|MELCIRC||Molecular Characterization of Advanced Stage Melanoma by Blood Sampling|Molecular Characterization of Advanced Stage Melanoma by Blood Sampling|Recruiting||N/A|80|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:55:08.818703|2017-10-10 21:55:08.818703
NCT02862730|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-18|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Interventional|||Four Way Crossover Closed Loop With Exercise Detection|A Randomized, Four-way, Cross-over Outpatient Study to Assess the Efficacy of a Dual-hormone Versus Insulin Alone Closed-loop System With Exercise Detection vs a Predictive Low Glucose Suspend System vs Current Care|Completed||N/A|25|Actual|Oregon Health and Science University||4|||f||||f||||||||||2017-10-10 21:55:08.891528|2017-10-10 21:55:08.891528
NCT02862717|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-08-10|||October 2016||2016-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Cost Utility Analysis of HD and CAPD in Ministry of Health Dialysis Centres, Malaysia|Cost Utility Analysis of End Stage Renal Disease Treatment in Ministry of Health Dialysis Centres, Malaysia: Haemodialysis Versus Continuous Ambulatory Peritoneal Dialysis|Active, not recruiting||N/A|180|Anticipated|National University of Malaysia|||2||f||||f||||||||||2017-10-10 21:55:08.986792|2017-10-10 21:55:08.986792
NCT02862379|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||September 2014||2014-09-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|CHUTE||Personalized Rehabilitation Program for Elderly Patients That Fall|Evaluation of a Personalized Rehabilitation Program for Elderly Patients That Fall : Impact on the Fear of Falling|Recruiting||N/A|60|Anticipated|Lille Catholic University||1|||f||||f||||||||No||2017-10-10 21:55:11.69072|2017-10-10 21:55:11.69072
NCT02862704|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||A Study of MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART)|An Open-label, Uncontrolled, Single-arm Pilot Study to Evaluate Safety and Efficacy of Intratumoral Delivery Mediated MG7-targeted Chimeric Antigen Receptor T Cells in Advanced MG7 Positive Liver Metastases|Recruiting||Phase 1/Phase 2|20|Anticipated|Xijing Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:55:09.068821|2017-10-10 21:55:09.068821
NCT02862691|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Percocet vs. Bupivicaine for Toothaches in the ED|A Comparison of the Analgesic Efficacy of Oral Opioid Medication vs. Injected Local Anesthetic in Emergency Department Patients With Toothache|Not yet recruiting||Phase 2|80|Anticipated|Stony Brook University||2|||f||||f||||||||Yes||2017-10-10 21:55:09.142214|2017-10-10 21:55:09.142214
NCT02862678|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-09-06|||April 2014||2014-04-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|ORODIFF||Predictive Value of Diffusion-weighted MRI Performed in Early Post-treatment in the Occurrence of Tumor Recurrence or Progression in Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy: a Pilot Study|Predictive Value of Diffusion-weighted MRI Performed in Early Post-treatment in the Occurrence of Tumor Recurrence or Progression in Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy: a Pilot Study|Recruiting||N/A|60|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:55:09.215588|2017-10-10 21:55:09.215588
NCT02862665|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-08|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Perioperative Iron Isomaltoside 1000 Administration on Transfusion Requirements in Patients Undergoing Complex Valvular Heart Surgery: a Randomized Clinical Trial||Not yet recruiting||N/A|214|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 21:55:09.28809|2017-10-10 21:55:09.28809
NCT02862652|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-03-31|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|THROMBLEUKEMIA||Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.|Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children|Completed||N/A|24|Actual|CHU de Reims||1|||f||||||||||||||2017-10-10 21:55:09.351925|2017-10-10 21:55:09.351925
NCT02862639|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-07-26|||February 2014||2014-02-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|VISCOSUPP-HIP||Efficacy of Viscosupplementation Associated With Intra-articular Corticosteroid Injection Versus Intra-articular Injection of Corticosteroids Alone in Osteoarthritis of Hip|Efficacy of Viscosupplementation Associated With Intra-articular Corticosteroid Injection Versus Intra-articular Injection of Corticosteroids Alone in Osteoarthritis of Hip|Completed||Phase 3|43|Actual|CHU de Reims||2|||f||||||||||||||2017-10-10 21:55:09.430253|2017-10-10 21:55:09.430253
NCT02862613|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-09-01|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer|Clinical Study Using Precision Cell Immunotherapy Combined With Transcatheter Arterial Chemoembolization in Advanced Liver Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Shanghai International Medical Center||2|||f||||f||||||||No||2017-10-10 21:55:09.564513|2017-10-10 21:55:09.564513
NCT02862600|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-08-02|2017-06-25||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|May 22, 2017|Actual|2017-05-22|April 28, 2017|Actual|2017-04-28||Interventional||Baseline data was collected on all enrolled subjects on Day 0.|Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure|A Phase 2, Multi-Center, Open-Label, Ascending Dose Study on the Efficacy, Safety and Tolerability of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure With Preserved Left Ventricular Function|Terminated||Phase 2|35|Actual|Heart Metabolics Limited|Early termination due to lack of efficacy in the first 15 subjects completing the study. Any conclusions regarding safety or efficacy a challenging in light of the small numbers of subjects studied.|1||Lack of Efficacy|f||||f|t|t|t|||||||2017-10-10 21:55:09.812502|2017-10-10 21:55:09.812502
NCT02862587|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-31|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer|Clinical Study Using Precision Cell Immunotherapy Combined With Transcatheter Arterial Chemoembolization in Advanced Liver Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Shanghai International Medical Center||2|||f||||f||||||||No||2017-10-10 21:55:10.147222|2017-10-10 21:55:10.147222
NCT02862574|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-08-15|||December 15, 2016|Actual|2016-12-15|August 2017|2017-08-01|August 7, 2017|Actual|2017-08-07|July 17, 2017|Actual|2017-07-17||Interventional|RA POC||Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis|Evaluation of the Efficacy and Safety of GS-5745 as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Subjects With Moderate to Severe Rheumatoid Arthritis|Terminated||Phase 2|15|Actual|Gilead Sciences||4||Discontinuation of development for this indication.|f||||t|t|f||||||||2017-10-10 21:55:10.24435|2017-10-10 21:55:10.24435
NCT02862561|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-09-01|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer|Clinical Study Using Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Shanghai International Medical Center||2|||f||||||||||||||2017-10-10 21:55:10.373395|2017-10-10 21:55:10.373395
NCT02862366|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-08|||October 2010||2010-10-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|MICROP-SMP||Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1-|Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of Chronic Philadelphia Negative Myeloproliferative Neoplasms|Completed||N/A|128|Actual|Lille Catholic University|||3||f||||f||||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 21:55:11.764115|2017-10-10 21:55:11.764115
NCT02862548|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-09-13|||September 15, 2016|Actual|2016-09-15|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant|A Phase 2, Randomized, Open Label Study to Evaluate the Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Subjects With Chronic HBV Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant|Active, not recruiting||Phase 2|51|Actual|Gilead Sciences||3|||f||||t|t|f|||t|||||2017-10-10 21:55:10.47041|2017-10-10 21:55:10.47041
NCT02862535|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2017-08-29|||September 20, 2016|Actual|2016-09-20|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma|A Phase 1b Study to Evaluate the Safety and Tolerability of Andecaliximab (GS-5745) as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Subjects With Gastric or Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 1|38|Anticipated|Gilead Sciences||4|||f||||f||f||||||||2017-10-10 21:55:10.571636|2017-10-10 21:55:10.571636
NCT02862522|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-08|||January 1992||1992-01-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Uric Acid Levels and Endothelial Functions|Clinical Follow-up of Patients With Assessment of Endothelial Dysfunction/Coronary Spasm|Completed||N/A|229|Actual|Mayo Clinic|||2||f||||f||||||||Undecided||2017-10-10 21:55:10.685823|2017-10-10 21:55:10.685823
NCT02862509|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2016-08-18|||November 2015||2015-11-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness of Budesonide Nasal Instillation in a Vertex-to-floor Position|Effectiveness of Budesonide Nasal Instillation in a Vertex-to-floor Position in Chronic Rhinosinusitis Patients Underwent Endoscopic Frontal Sinus Surgery: a Randomized, Controlled Trial.|Active, not recruiting||Phase 2|60|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-10-10 21:55:10.776676|2017-10-10 21:55:10.776676
NCT02862496|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-07|||June 2016||2016-06-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01|9 Months|Observational [Patient Registry]|||Bone Health in Hyperemesis Gravidarum|Urine N-telopeptide, Serum Vit D, Parathormone and Calcium Levels in Hyperemesis Gravidarum|Recruiting||N/A|60|Anticipated|Kayseri Education and Research Hospital|||2||f||||||||||||||2017-10-10 21:55:10.869278|2017-10-10 21:55:10.869278
NCT02862483|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-10|||March 2016||2016-03-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction||Recruiting||Phase 3|330|Anticipated|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||No||2017-10-10 21:55:10.962121|2017-10-10 21:55:10.962121
NCT02862470|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-05|||August 2016||2016-08-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01|52 Weeks|Observational [Patient Registry]|||Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients|Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients|Not yet recruiting||N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 21:55:11.067023|2017-10-10 21:55:11.067023
NCT02862457|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-19|||August 23, 2016|Actual|2016-08-23|September 2017|2017-09-01|January 31, 2020|Anticipated|2020-01-31|August 31, 2018|Anticipated|2018-08-31||Interventional|KEYNOTE-434||Study of INCB024360 Alone and In Combination With Pembrolizumab (MK-3475) in Solid Tumors (MK-3475-434)|A Phase I Study of INCB024360 Alone and In Combination With Pembrolizumab (MK-3475) in Patients With Advanced Solid Tumors (KEYNOTE-434)|Recruiting||Phase 1|42|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 21:55:11.140306|2017-10-10 21:55:11.140306
NCT02862444|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-07|||August 2016||2016-08-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||A Culturally Appropriate Intervention for Preventing and Reducing Postpartum Depression|The Effectiveness of a Culturally Appropriate Intervention for Preventing and Reducing Postpartum Depression Among Arab Women in Southern Israel|Not yet recruiting||N/A|382|Anticipated|Clalit Health Services|||1||f||||t||||||||Undecided||2017-10-10 21:55:11.250901|2017-10-10 21:55:11.250901
NCT02862431|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-23|||July 12, 2016|Actual|2016-07-12|June 2017|2017-06-01|November 29, 2016|Actual|2016-11-29|November 29, 2016|Actual|2016-11-29||Interventional|||Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM)|A Double-Blind, Randomized, Placebo-Controlled, Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Men and Women With Type 2 Diabetes Mellitus|Terminated||Phase 1|24|Actual|Janssen Research & Development, LLC||4||manufacturing-related issues|f||||f||f||||||||2017-10-10 21:55:11.321285|2017-10-10 21:55:11.321285
NCT02862418|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-08|2016-08-19|||October 2015||2015-10-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)|Lung Imaging With Ultra-short Echo Time MRI|Recruiting||N/A|150|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||||Yes|MRI results may be shared with treating physicians to support clinical decisions if images are felt to have clinical significance.|2017-10-10 21:55:11.422357|2017-10-10 21:55:11.422357
NCT02862405|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-08|||March 2011||2011-03-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|ACTIVIS||Perception of Objects and Natural Scenes in People With Vision Loss (ACTIVIS)|Evaluation of the Perception of Objects and Natural Scenes in People With Vision Loss (Loss of Central or Peripheral Vision)|Completed||N/A|260|Actual|Lille Catholic University|||3||f||||f||||||||No||2017-10-10 21:55:11.501384|2017-10-10 21:55:11.501384
NCT02862353|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-13|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|TITIM||Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic|Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic|Not yet recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     1 dry tube of 5 ml for TITIM test      1 dry tube of 7 ml for MAIPA test      1 dry tube of 5 ml for serum bank.   "|||2017-10-10 21:55:11.833445|2017-10-10 21:55:11.833445
NCT02862340|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-08|||January 2008||2008-01-01|August 2016|2016-08-01|February 2012|Actual|2012-02-01|January 2008|Actual|2008-01-01||Interventional|||Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation|Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation|Completed||N/A|60|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||No||2017-10-10 21:55:11.91351|2017-10-10 21:55:11.91351
NCT02862327|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-10-05|||December 1, 2016|Actual|2016-12-01|October 2017|2017-10-01|September 16, 2017|Actual|2017-09-16|March 16, 2017|Actual|2017-03-16||Interventional|ADEXA||Intravenous Dexamethasone for Ropivacaine Axillary Block|Intravenous Dexamethasone Versus Placebo for Ultrasound Guided Axillary Brachial Plexus Block With Ropivacaine: Randomised, Controlled, Clinical Trial|Completed||Phase 3|99|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-10 21:55:11.980198|2017-10-10 21:55:11.980198
NCT02862314|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-08|||February 2015||2015-02-01|August 2016|2016-08-01||||November 2017|Anticipated|2017-11-01||Interventional|PROPASPI||PROcalcitonin Pneumonia / Pneumonitis Associated With ASPIration||Recruiting||Phase 4|166|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||||||||||||2017-10-10 21:55:12.06875|2017-10-10 21:55:12.06875
NCT02862301|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-08|||April 2016||2016-04-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|EPIC||Epigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome|Epigenetic Evaluation of HAT/HDAC Activity in Peripheral Blood Mononuclear Cells From Patients With Clinically Isolated Syndrome and Analysis of the Relationship With the Pathophysiology and Disease Activity|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||No||2017-10-10 21:55:12.143845|2017-10-10 21:55:12.143845
NCT02862288|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||September 2012||2012-09-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|TherMO||Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.|Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.|Completed||Phase 1/Phase 2|30|Actual|Centre Hospitalier Universitaire de Besancon||3|||f||||f||||||||No||2017-10-10 21:55:12.226581|2017-10-10 21:55:12.226581
NCT02862275|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-09|2017-10-05|||February 23, 2017|Actual|2017-02-23|July 2017|2017-07-01|November 21, 2020|Anticipated|2020-11-21|November 21, 2020|Anticipated|2020-11-21||Interventional|||Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer|A Pilot Study of Atezolizumab (MPDL3280A) Following Adoptive Cell Transfer in Active Hematologic or Solid Tumor Malignancies|Recruiting||Phase 1|40|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:55:12.294973|2017-10-10 21:55:12.294973
NCT02862262|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-01-30|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients|A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients|Active, not recruiting||N/A|1000|Anticipated|Luminex Molecular Diagnostics|||3||f||||f||||||Samples With DNA|"     nasopharyngeal swab   "|Yes||2017-10-10 21:55:12.390191|2017-10-10 21:55:12.390191
NCT02862249|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-08-10|||October 2016||2016-10-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|PROFIT||Trial of Faecal Microbiota Transplantation in Cirrhosis|A Prospective, Randomised Placebo Controlled Feasibility Trial of Faecal Microbiota Transplantation in Cirrhosis|Not yet recruiting||Phase 3|32|Anticipated|King's College London||2|||f||||t||||||||Yes|All information, data and results obtained from study are confidential. Agreement from the Sponsor will be required prior to the public disclosure of any study-related data. It is expected that results from the study will be published in peer-reviewed scientific/medical journals and presented at scientific/clinical symposia and congresses. All publications and presentations relating to the study must be authorised by the CI.|2017-10-10 21:55:12.465713|2017-10-10 21:55:12.465713
NCT02862236|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-20|||February 21, 2017|Actual|2017-02-21|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Relationship Between Common Psychiatric Drugs and Stress, and Their Influence on Cognitive Functions in Healthy and Sub-clinically Anxious Populations|The Relationship Between Common Psychiatric Drugs and Stress, and Their Influence on Cognitive Functions in Healthy and Sub-clinically Anxious Populations|Recruiting||Phase 4|162|Anticipated|Technion, Israel Institute of Technology||3|||f||||f|f|f||||||||2017-10-10 21:55:12.540183|2017-10-10 21:55:12.540183
NCT02862223|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-01-06|||March 2012||2012-03-01|January 2017|2017-01-01||||March 2014|Actual|2014-03-01||Interventional|||A Study Investigating the Effects of Neprinol Study Product on Vascular Function|Neprinol for Cardiovascular Health|Completed||Phase 2|14|Actual|KGK Synergize Inc.||1|||f||||||||||||||2017-10-10 21:55:12.626821|2017-10-10 21:55:12.626821
NCT02862210|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2017-04-18|||January 27, 2017|Actual|2017-01-27|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|Lithium||Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia|Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia|Recruiting||Phase 2|60|Anticipated|Columbia University||2|||f||||t|t|f|||f|||Undecided||2017-10-10 21:55:12.705496|2017-10-10 21:55:12.705496
NCT02862197|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-21|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Invasive Monitoring of Pulmonary Artery Pressure (PAP) Among Dialysis Treated Patients|Invasive Monitoring of Pulmonary Artery Pressure (PAP) Among Dialysis Treated Patients|Recruiting||N/A|8|Anticipated|Joint Authority for Päijät-Häme Social and Health Care|||1||f||||f||||||||||2017-10-10 21:55:12.791512|2017-10-10 21:55:12.791512
NCT02862184|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-01-12|||July 2016||2016-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|FSFI||Female Sexual Dysfunction, Risks and Outcomes (FSFI)|Female Sexual Dysfunction, Risks and Outcomes (FSFI)|Withdrawn||N/A|0|Actual|St. Louis University|||1|No support staff|f||||f||||||||No||2017-10-10 21:55:12.8631|2017-10-10 21:55:12.8631
NCT02862171|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-29|||July 13, 2016|Actual|2016-07-13|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women|A Follow-On, Open-Label Trial To Assess Continued Safety Of And Adherence To The Dapivirine (25 Mg) Vaginal Ring-004 In Healthy, HIV-Negative Women|Recruiting||Phase 3|1400|Anticipated|International Partnership for Microbicides, Inc.||1|||f||||||||||||||2017-10-10 21:55:12.917909|2017-10-10 21:55:12.917909
NCT02862158|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-09-01|||August 2016||2016-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Frequency Doubling Technology (FDT) Mobile Visual Field Testing|Evaluation of Different Frequency Doubling Technology (FDT) Mobile Devices for Visual Field Assessment|Recruiting||N/A|500|Anticipated|University of Miami||1|||f||||f||||||||||2017-10-10 21:55:12.994503|2017-10-10 21:55:12.994503
NCT02862145|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-09-26|||August 2016||2016-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|MRX34-102||Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions|A Multicenter Phase 1B Pharmacodynamics Study of MRX34, MicroRNA miR-Rx34 Liposomal Injection, in Patients With Advanced Melanoma and Biopsy Accessible Lesions|Withdrawn||Phase 1/Phase 2|0|Actual|Mirna Therapeutics, Inc.||1||5 immune related serious adverse events in Phase 1 study|f||||t||||||||No||2017-10-10 21:55:13.071223|2017-10-10 21:55:13.071223
NCT02862132|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-03-27|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases|Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)|Recruiting||N/A|120|Anticipated|Shaare Zedek Medical Center||1|||f||||f||||||||Undecided||2017-10-10 21:55:13.143469|2017-10-10 21:55:13.143469
NCT02862119|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01|October 2028|Anticipated|2028-10-01|October 2019|Anticipated|2019-10-01||Interventional|FULL REVASC||Ffr-gUidance for compLete Non-cuLprit REVASCularization|Ffr-gUidance for compLete Non-cuLprit REVASCularization - a Registry-based Randomized Clinical Trial|Recruiting||N/A|4052|Anticipated|Karolinska University Hospital||2|||f||||t||||||||Yes|Individual participant data will be confidential. Only data on Group level will be presented in scientific publications.|2017-10-10 21:55:13.423382|2017-10-10 21:55:13.423382
NCT02862106|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2017-03-03|2016-11-20||September 2010||2010-09-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||The safety population|Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B|Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) in Treating Chronic Hepatitis B Patients|Completed||Phase 2|209|Actual|Chongqing Jiachen Biotechnology Ltd.||6|||f||||t||||||||Undecided||2017-10-10 21:55:13.563763|2017-10-10 21:55:13.563763
NCT02862093|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-10|||January 2010||2010-01-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|February 2013|Actual|2013-02-01||Interventional|||Transcranial Magnetic Stimulation in Alcohol Use Disorder|Transcranial Magnetic Stimulation in Alcohol Use Disorder: Effects on Dopamine Transporter and Alcohol Intake|Completed||Phase 3|14|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-10 21:55:14.806248|2017-10-10 21:55:14.806248
NCT02862080|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-08-05|||October 2016||2016-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:55:14.884255|2017-10-10 21:55:14.884255
NCT02862067|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-07-10|||July 2016||2016-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||SGLT2 Inhibition in Diabetes and Heart Failure|SGLT2 Inhibition in Diabetic Patients With Heart Failure With Reduced Ejection Fraction|Recruiting||N/A|31|Anticipated|Virginia Commonwealth University|||1||f||||f||||||||||2017-10-10 21:55:14.923882|2017-10-10 21:55:14.923882
NCT02862054|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2016-08-06|||January 2015||2015-01-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology||Recruiting||Phase 2/Phase 3|30|Anticipated|Beijing Friendship Hospital||1|||f||||t||||||||||2017-10-10 21:55:15.108348|2017-10-10 21:55:15.108348
NCT02862041|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-09|||July 2014||2014-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Effectiveness of Echogenic and Nonechogenic Needles in Ultrasound Guided Infraclavicular Brachial Plexus Block|Role of Echogenic Versus Nonechogenic Needles in Ultrasound Guided Infraclavicular Brachial Plexus Block Success Rate: A Comparative Study|Completed||N/A|60|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||Undecided||2017-10-10 21:55:15.197685|2017-10-10 21:55:15.197685
NCT02862028|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach)|A Clinical Study of PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach)|Recruiting||Phase 1/Phase 2|20|Anticipated|Shanghai International Medical Center||1|||f||||||||||||||2017-10-10 21:55:15.272757|2017-10-10 21:55:15.272757
NCT02862015|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-07|2016-09-04|||August 2016||2016-08-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|Oncothermia||Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer Patients|A Multicenter, Prospective, Randomized Clinical Trial of the Clinical Effectiveness of Oncothermia Combined With Standard Chemotherapy in Metastatic Pancreatic Cancer Patients|Recruiting||Phase 2|100|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 21:55:15.368185|2017-10-10 21:55:15.368185
NCT02862002|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-09|||August 2013||2013-08-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||"Measuring the Effects of Therapeutic Education Program Caratif Patient Under Strong Opioids Versus Standard Taking Charge of Patient Pain Receiving Opioid Therapy in Medical Oncology."|"Measuring the Effects of Therapeutic Education Program Caratif Patient Under Strong Opioids Versus Standard Taking Charge of Patient Pain Receiving Opioid Therapy in Medical Oncology."|Recruiting||N/A|200|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 21:55:15.477737|2017-10-10 21:55:15.477737
NCT02861989|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-05|||February 2014||2014-02-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|January 2015|Actual|2015-01-01||Observational|QUALIOP||Qualitative Study on Osteoporosis Representation and Management in the General Population and in General Practitioners.|Qualitative Study on Representations of Osteoporosis in the General and At-risk Population and in General Practitioners.|Active, not recruiting||N/A|114|Actual|Hospices Civils de Lyon|||5||f||||f||||||||||2017-10-10 21:55:15.576978|2017-10-10 21:55:15.576978
NCT02861976|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-05-02|||September 2016||2016-09-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01|6 Months|Observational [Patient Registry]|STOMP||Screening in Trauma for Opioid Misuse Prevention|Screening in Trauma for Opioid Misuse Prevention (STOMP): Screen Development and Pilot Implementation Study|Recruiting||N/A|295|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||||No||2017-10-10 21:55:15.668112|2017-10-10 21:55:15.668112
NCT02861963|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-08-06|||June 2016||2016-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients|Femoral Allogenic Vein Valved Conduit for Palliative Repair of Pulmonary Atresia With Ventricular Septal Defect|Recruiting||N/A|68|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||No||2017-10-10 21:55:15.746766|2017-10-10 21:55:15.746766
NCT02861950|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-06-02|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants?|Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants? A Multi-center Prospective Randomized Trial.|Recruiting||Phase 4|490|Anticipated|University of Colorado, Denver||2|||f||||f|t|f||||||No||2017-10-10 21:55:15.833854|2017-10-10 21:55:15.833854
NCT02861924|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-12-15|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|LAV||Locally Applied Pressure-induced Vasodilatation|Réponse à l'Application d'Une Pression Locale en Laser Speckle Imaging Locally Applied Pressure-induced Vasodilatation|Recruiting||N/A|45|Anticipated|University Hospital, Angers||1|||f||||f||||||||No||2017-10-10 21:55:16.014734|2017-10-10 21:55:16.014734
NCT02861911|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-09|||October 2015||2015-10-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|NEMS and FSHD||Effects of NMES on Muscle Function of Patients With FSHD: a Double-blind Randomized Controled Clinical Trial|Effects of NMES on Muscle Function of Patients With FSHD: a Double-blind Randomized Controlled Clinical Trial|Recruiting||N/A|36|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 21:55:16.092099|2017-10-10 21:55:16.092099
NCT02861898|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-01-30|||June 2016||2016-06-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma|Phase I/II Trial of Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma|Recruiting||Phase 1/Phase 2|33|Anticipated|Northwell Health||1|||f||||f||||||||No||2017-10-10 21:55:16.252565|2017-10-10 21:55:16.252565
NCT02861885|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-09|||October 2015||2015-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|Lesion SSL||Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right Colon|Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right Colon|Active, not recruiting||N/A|300|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:55:16.343722|2017-10-10 21:55:16.343722
NCT02861872|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-04|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Intra-peritoneal Chemotherapy in Ovarian Cancer|Predictive Factors and Pharmacokinetics of Intra-peritoneal Chemotherapy|Recruiting||N/A|15|Anticipated|Radboud University|||1||f||||f||||||Samples Without DNA|"     EDTA blood and IP fluid   "|Yes||2017-10-10 21:55:16.430716|2017-10-10 21:55:16.430716
NCT02861859|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-01-10|||December 2016||2016-12-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study|A Randomized Trial of Individualised Care Versus Standard Care for Breast Cancer Patients at High Risk for Chemotherapy Induced Nausea and Vomiting. The ILIAD Study|Recruiting||Phase 3|362|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||No||2017-10-10 21:55:16.513756|2017-10-10 21:55:16.513756
NCT02861846|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-04-24|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|March 1, 2021|Anticipated|2021-03-01|March 1, 2021|Anticipated|2021-03-01||Interventional|BIOMALEPSIE||Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy|Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy|Recruiting||N/A|90|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||Undecided||2017-10-10 21:55:16.607794|2017-10-10 21:55:16.607794
NCT02861833|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-05|||May 2013||2013-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Identifying Coping Strategies of Patients With Cancerous Wound After a Specific Nursing Accompaniment||Recruiting||N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 21:55:16.706023|2017-10-10 21:55:16.706023
NCT02861820|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-09-13|||July 2015||2015-07-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|||Functional Connectivity Changes During Early Recovery as a Marker for Relapse|Functional Connectivity Changes During Early Recovery as a Marker for Relapse|Recruiting||N/A|160|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-10 21:55:16.77634|2017-10-10 21:55:16.77634
NCT02859246|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-18|||September 2016||2016-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Mucinex® for Treatment of Filamentary Keratitis|Mucinex® for Treatment of Filamentary Keratitis|Recruiting||N/A|15|Anticipated|Massachusetts Eye and Ear Infirmary||1|||f||||f||||||||||2017-10-10 21:55:41.236887|2017-10-10 21:55:41.236887
NCT02861807|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-01-23|||November 2016||2016-11-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|MBItDCS||Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking|Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking: Efficacy and Mechanisms of Change|Recruiting||N/A|86|Anticipated|University of New Mexico||2|||f||||f||||||||Yes|The investigators will make the data publicly available given that it will be a unique data set that will not only allow for further exploration by alcohol researchers, but also allow for methods development by the broader research community. The investigators plan to release the data to the public once the primary manuscripts describing the main findings of the study have been accepted for publication. Anonymized and preprocessed EEG data as well as deidentified behavioral and questionnaire data will be shared with investigators from institutions with a Federal Wide Assurance; all investigators with whom the data is shared will be included in the annual progress report. To ensure accessibility of the data set, instructions for obtaining the data set will be included in publications of the data collected under this grant.|2017-10-10 21:55:16.857958|2017-10-10 21:55:16.857958
NCT02861794|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-08-09|||May 2016||2016-05-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Stability of Contemporary Knee Arthroplasty|Evaluation of Early Migration of Medially Stabilized Arthroplasty as a Predictor of Long Time Survivorship (Implant Design Study)|Recruiting||N/A|30|Anticipated|Oslo University Hospital||1|||f||||t||||||||No||2017-10-10 21:55:18.666488|2017-10-10 21:55:18.666488
NCT02861781|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-05|||January 2016||2016-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|COMET||Collection of Human Metabolic Tissues|Study of New Determinants of Type 2 Diabetes in Severe Obesity|Recruiting||N/A|270|Anticipated|University Hospital, Montpellier|||3||f||||f||||||||||2017-10-10 21:55:18.796481|2017-10-10 21:55:18.796481
NCT02861768|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-09|||March 2013||2013-03-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||Improving the Diagnostic of Tuberculosis|Improving the Diagnostic of Tuberculosis|Recruiting||N/A|36000|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:55:18.876376|2017-10-10 21:55:18.876376
NCT02861755|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-09-14|||August 2016||2016-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|MARIGOLD||Online Positive Emotion Skills Intervention for Symptoms of Depression|Online Positive Emotion Skills Intervention for Symptoms of Depression (MARIGOLD)|Recruiting||N/A|675|Anticipated|Northwestern University||2|||f||||||||||||||2017-10-10 21:55:18.957736|2017-10-10 21:55:18.957736
NCT02861742|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-10-03|||July 2016||2016-07-01|October 2017|2017-10-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|KALICOU3||Impact of Emotional Skills of Young Women and Their Partner on Adjustment to Cancer|Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer|Recruiting||N/A|800|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||||2017-10-10 21:55:19.088077|2017-10-10 21:55:19.088077
NCT02861729|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-05|||October 2016||2016-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Outcomes of Zirconia-reinforced Lithium Silicate Partial Coverage Crowns Compared to Lithium Disilicate Partial Coverage Crowns|Clinical Outcomes of Zirconia-reinforced Lithium Silicate Partial Coverage Crowns Compared to Lithium Disilicate Partial Coverage Crowns: A Randomized Controlled Clinical Trial|Not yet recruiting||N/A|46|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:55:19.484489|2017-10-10 21:55:19.484489
NCT02861716|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-09|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery|Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine for Postoperative Analgesia in Children Undergoing Major Abdominal Cancer Surgery|Recruiting||Phase 2|60|Anticipated|South Egypt Cancer Institute||3|||f||||t||||||||Yes|De-identified individual participant data for all primary outcome measures will be made available within 6 months of study completion|2017-10-10 21:55:19.596985|2017-10-10 21:55:19.596985
NCT02861703|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-08-05|||July 2015||2015-07-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Online vs In-Person Lifestyle Intervention for Weight Management and Improved Quality of Life in Breast Cancer Survivors|A Randomized Controlled Trial Evaluating the Efficacy of an Online Versus Face-to-Face Lifestyle Intervention for Healthy Weight Management and Improved Quality of Life in Breast Cancer Survivors|Recruiting||N/A|48|Anticipated|Sunnybrook Health Sciences Centre||3|||f||||f||||||||||2017-10-10 21:55:19.701986|2017-10-10 21:55:19.701986
NCT02861690|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-05|||January 2010||2010-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma|Phase II Study of Liposomal Paclitaxel With Nedaplatin as First-line in Advanced or Recurrent Esophageal Carcinoma|Completed||Phase 2|72|Actual|Sun Yat-sen University||1|||f||||t||||||||No||2017-10-10 21:55:19.807707|2017-10-10 21:55:19.807707
NCT02861677|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-09|||August 2016||2016-08-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|TGPIONEER||Impact of Clinical Pharmacy Service on Patient Care and Cost Saving|Impact of Clinical Pharmacy Service on Patient Care and Cost Saving|Not yet recruiting||N/A|576|Anticipated|Jimma University||2|||f||||f||||||||No||2017-10-10 21:55:19.895312|2017-10-10 21:55:19.895312
NCT02861664|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-01-18|||September 2016||2016-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Assessment of the Efficacy of an Experimental Occlusion Technology Dentifrice in Dentinal Hypersensitivity|A Study to Evaluate the Efficacy of an Experimental Occlusion Technology Dentifrice in the Relief of Dentinal Hypersensitivity|Completed||N/A|135|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 21:55:19.979289|2017-10-10 21:55:19.979289
NCT02861651|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-08-05|||March 2014||2014-03-01|July 2016|2016-07-01||||July 2015|Actual|2015-07-01||Observational|||Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing||Completed||N/A|40|Actual|Institut Paoli-Calmettes|||1||f||||f||||||||||2017-10-10 21:55:20.075727|2017-10-10 21:55:20.075727
NCT02858882|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-10-26|||February 2007||2007-02-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Vitamin D Status and Muscle Function|Vitamin D Status and Muscle Function Among Adolescent and Young Swimmers.|Completed||N/A|29|Actual|University of Copenhagen|||1||f||||f||||||||No||2017-10-10 21:55:44.093473|2017-10-10 21:55:44.093473
NCT02861638|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-05|||April 2014||2014-04-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Action Observation in Hip Replacement|Effects of Action Observation Therapy in Patients Recovering From Total Hip Arthroplasty: A Prospective Clinical Trial|Completed||N/A|30|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||No||2017-10-10 21:55:20.144375|2017-10-10 21:55:20.144375
NCT02861625|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-09-25|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Observational|CONDOL01||CONDOL01: Evaluation on the Experience of Bereavement, of a Medical Consultation, Proposed by a Letter of CONDOLence to the Patients' Relatives Versus Standard Practice After the Death of the Patient|CONDOL01: Evaluation on the Experience of Bereavement, of a Medical Consultation, Proposed by a Letter of CONDOLence to the Patients' Relatives Versus Standard Practice After the Death of the Patient: A Multicenter, Randomized Trial|Not yet recruiting||N/A|432|Anticipated|Institut Paoli-Calmettes|||2||f||||f||||||||||2017-10-10 21:55:20.230731|2017-10-10 21:55:20.230731
NCT02861612|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|||Nerve Transfers to Restore Hand Function in Spinal Cord Injury|Nerve Transfers to Restore Hand Function in Spinal Cord Injury|Recruiting||N/A|5|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||No||2017-10-10 21:55:20.306767|2017-10-10 21:55:20.306767
NCT02861599|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-05|||September 2015||2015-09-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Interventional|2000DYS9||Study of the Interest of Proprioceptive Therapy as a Complement to Speech Therapy in Children With Reading Difficulties|Study of the Interest of Proprioceptive Therapy as a Complement to Speech Therapy in Children With Reading Difficulties|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:55:20.423129|2017-10-10 21:55:20.423129
NCT02861573|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-21|||November 17, 2016|Actual|2016-11-17|September 2017|2017-09-01|April 18, 2020|Anticipated|2020-04-18|April 18, 2018|Anticipated|2018-04-18||Interventional|||Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)|Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)|Recruiting||Phase 1|180|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||f|t|f||||||||2017-10-10 21:55:20.666097|2017-10-10 21:55:20.666097
NCT02861560|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-03-02|||May 2016||2016-05-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers|A Case Series to Investigate the Safety and Efficacy of Weekly Application of Dehydrated Human Amnion/Chorion Membrane (dHACM) in the Treatment of Pressure Ulcers|Enrolling by invitation||N/A|10|Anticipated|MiMedx Group, Inc.||1|||f||||f||||||||No||2017-10-10 21:55:20.826035|2017-10-10 21:55:20.826035
NCT02861547|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-05|||May 2015||2015-05-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Observational|SCORE TC||Development and Validation of a Prognostic Score for Early Death in Head Injury Patients.|Development and Validation of a Prognostic Score for Early Death in Head Injury Patients in the Traumatic Brain Injury Intensive Care Unit of Dijon CHU|Recruiting||N/A|355|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:55:20.892185|2017-10-10 21:55:20.892185
NCT02861521|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-04-26|||August 2016||2016-08-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Reducing Recurrent Knee Flexion Contracture by Correcting Leg Length Discrepancy After Total Knee Arthroplasty for OA|Reducing Postoperative Knee Flexion Contracture Recurrence by Correcting Leg Length Discrepancy in the Non-surgical Knee in Patients Undergoing Total Knee Arthroplasty for Primary Osteoarthritis: A Feasibility Study|Recruiting||N/A|80|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No|Data will be reported in aggregate.|2017-10-10 21:55:21.516545|2017-10-10 21:55:21.516545
NCT02861508|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-05|||July 2016||2016-07-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Impact of Immediate Point-of-Care Ultrasound on Patients With Cardiopulmonary Symptoms in the Emergency Department|Impact of Immediate Point-of-Care Ultrasound on Patients With Cardiopulmonary Symptoms in the Emergency Department|Recruiting||N/A|500|Anticipated|Yale University||2|||f||||f||||||||No|No specific plans for now but would be open to sharing anonymized data.|2017-10-10 21:55:21.626159|2017-10-10 21:55:21.626159
NCT02861495|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-02-13|||September 30, 2016|Actual|2016-09-30|February 2017|2017-02-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Humeral Compression/Distraction Device|Humeral Compression/Distraction (CD) Device Used for Fixation of Humeral Fractures|Recruiting||N/A|40|Anticipated|Florida Orthopaedic Institute||1|||f||||f||||||||No|There is no plan to share data at this time.|2017-10-10 21:55:21.730514|2017-10-10 21:55:21.730514
NCT02861482|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-12-14|||January 2015||2015-01-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Early Usage of Bakri Ballon in Managing Postpartum Hemorrhage|Early Usage of Bakri Postpartum Ballon is More Effective for the Management of Postpartum Hemorrhage|Completed||N/A|472|Actual|First Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||No||2017-10-10 21:55:21.834842|2017-10-10 21:55:21.834842
NCT02861469|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-05|||February 2015||2015-02-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|CACTUS||Reasons of Transfer in Emergency Units of Patients in End of Life Situation.|Reasons of Transfer in Emergency Units of Patients in End of Life Situation.|Completed||N/A|21|Actual|Centre Hospitalier Universitaire de Besancon|||2||f||||f||||||||No||2017-10-10 21:55:21.955793|2017-10-10 21:55:21.955793
NCT02861456|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-01-30|||August 2016||2016-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain|Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain|Recruiting||N/A|20|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||No||2017-10-10 21:55:22.036759|2017-10-10 21:55:22.036759
NCT02861443|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-05|||August 2014||2014-08-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Observational|IrriQOL||Irrigation of the Large Intestine in the Patients With Colostomy : Epidemiology and Quality of Life|Irrigation of the Large Intestine in the Patients With Colostomy : Epidemiology and Quality of Life|Completed||N/A|1120|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:55:22.178777|2017-10-10 21:55:22.178777
NCT02861430|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-05|||April 2014||2014-04-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|April 2017|Anticipated|2017-04-01||Observational|UNMASK||Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology|Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology|Recruiting||N/A|388|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 21:55:22.236332|2017-10-10 21:55:22.236332
NCT02861417|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-01|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Timed Sequential Busulfan and Post Transplant Cyclophosphamide for Allogeneic Transplantation|Timed Sequential Busulfan and Post Transplant Cyclophosphamide for Allogeneic Transplantation|Recruiting||Phase 2|200|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 21:55:22.317689|2017-10-10 21:55:22.317689
NCT02861404|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-01|||April 2010||2010-04-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|October 2014|Actual|2014-10-01||Observational|BIOVRAIE||Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment|Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment|Terminated||N/A|406|Actual|Centre Hospitalier Universitaire de Besancon|||5||f||||f||||||||No||2017-10-10 21:55:22.488806|2017-10-10 21:55:22.488806
NCT02861391|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-03-29|||August 2016||2016-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of the Safety and Efficacy of Carbon Dioxide (CO2) Acupulse Laser Treatment on Urinary Stress Incontinence.|Evaluation of the Safety and Efficacy of CO2 Acupulse Laser Treatment on Women With Urinary Stress Incontinence.|Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||No||2017-10-10 21:55:22.568388|2017-10-10 21:55:22.568388
NCT02861378|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-10-13|||October 2015||2015-10-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Reversing the Effects of 2% Lidocaine|Reversing the Effects of 2% Lidocaine: A Randomized Controlled Trial|Completed||N/A|38|Actual|Dalhousie University||2|||f||||t||||||||Yes|Only in a publication in a dental journal|2017-10-10 21:55:22.643947|2017-10-10 21:55:22.643947
NCT02861365|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-29|||July 2013||2013-07-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Myocardial Perfusion and Scarring in Adults With Congenital Heart Disease|Quantitative Myocardial Perfusion, Myocardial Scarring and Their Contribution to Late Clinical Decompensation in Adults With Congenital Heart Disease|Active, not recruiting||N/A|20|Anticipated|Children's Research Institute|||1||f||||f||||||||||2017-10-10 21:55:22.728157|2017-10-10 21:55:22.728157
NCT02861352|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-09|||March 2011||2011-03-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Interventional|||An Evaluation of Zinc Status Biomarkers|Testing Novel Biomarkers of Zinc Status for Use in Human Zinc Supplementation Trials|Completed||N/A|18|Actual|Children's Hospital & Research Center Oakland||1|||f||||f||||||||No||2017-10-10 21:55:22.797981|2017-10-10 21:55:22.797981
NCT02861339|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-05|||February 2014||2014-02-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|OSCAR||Prevalence of Keratoconus in Inflammatory Bowel Diseases|Prevalence of Keratoconus in Inflammatory Bowel Diseases|Completed||N/A|201|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:55:22.876001|2017-10-10 21:55:22.876001
NCT02861326|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-05|||January 2014||2014-01-01|August 2016|2016-08-01||||January 2015|Actual|2015-01-01||Interventional|||RELATIONSHIP BETWEEN INITIAL PROBING DEPTH AND CHANGES IN CLINICAL PARAMETERS FOLLOWING NON-SURGICAL PERIODONTAL TREATMENT IN CHRONIC PERIODONTITIS PATIENTS||Completed||N/A|15|Actual|Marmara University||1|||f||||f||||||||No||2017-10-10 21:55:22.936323|2017-10-10 21:55:22.936323
NCT02861313|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-09|||January 2016||2016-01-01|August 2016|2016-08-01|April 2021|Anticipated|2021-04-01|September 2017|Anticipated|2017-09-01||Interventional|||Oral Health Related Quality of Life and Peri-implant Condition in Single Implant Overdenture|Oral Health Related Quality of Life and Peri-implant Condition in Single Implant Mandibular Overdenture Retained by CM LOC Versus Ball Attachment: A Randomized Controlled Trial|Recruiting||N/A|78|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:55:23.006537|2017-10-10 21:55:23.006537
NCT02861300|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-09-28|||August 2016||2016-08-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer|Phase I/II Study of CB-839 and Capecitabine in Patients With Advanced Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer|Recruiting||Phase 1/Phase 2|53|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 21:55:23.081226|2017-10-10 21:55:23.081226
NCT02861287|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-05|||January 2015||2015-01-01|August 2016|2016-08-01||||December 2015|Actual|2015-12-01||Observational|PLERIXAFOR||Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma|Economic Evaluation of the Use of Plerixafor for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma|Completed||N/A|60|Actual|Institut Paoli-Calmettes|||2||f||||f||||||||No||2017-10-10 21:55:23.301956|2017-10-10 21:55:23.301956
NCT02858674|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-27|||April 1, 2017|Actual|2017-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Health Information Technology in Heart Failure Care|Health Information Technology in Heart Failure Care|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 21:55:45.839903|2017-10-10 21:55:45.839903
NCT02861274|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-05|||January 2010||2010-01-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|ELICA||Electrophysiological Mechanisms and Inhibitory Cardiac Syncope|ELectrophysiological Mechanisms Underlying the Inhibitory CArdiac Syncope: Therapeutic and Prognostic Implications The ELICA Study|Completed||Phase 1|36|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||||||||||||2017-10-10 21:55:23.383358|2017-10-10 21:55:23.383358
NCT02861261|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-05|||July 2016||2016-07-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes||Recruiting||Phase 3|400|Anticipated|Shanghai Jiao Tong University School of Medicine||4|||f||||||||||||||2017-10-10 21:55:23.462686|2017-10-10 21:55:23.462686
NCT02861248|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-05|||March 2012||2012-03-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Fractional Microplasma Radiofrequency Technology for Non-hypertrophic Post-burn Scars in Asians: A Prospective Study of 95 Patients||Completed||N/A|95|Actual|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||Undecided||2017-10-10 21:55:23.580108|2017-10-10 21:55:23.580108
NCT02861235|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-05|||November 2009||2009-11-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|DSPECT||Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera|Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera According to Conditions of Examination Execution: Assessment of Infarction or Ischemia, Injected Dye and Sequence of Injections|Completed||N/A|276|Actual|Central Hospital, Nancy, France||6|||f||||f||||||||No||2017-10-10 21:55:23.668148|2017-10-10 21:55:23.668148
NCT02861222|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-05|||October 2010||2010-10-01|August 2016|2016-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|MYOCET||Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma|Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma|Completed||Phase 1|13|Actual|Central Hospital, Nancy, France||1|||f||||t||||||||No||2017-10-10 21:55:23.768226|2017-10-10 21:55:23.768226
NCT02861209|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-05|||November 2015||2015-11-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|CONTACT||Collaborative Network to Take Responsibility for Oral Anticancer Therapy|CONTACT: A Prospective Interventional Multicentre Before-after Study for the Implementation of a Care Pathway to Increase Self-management of Patients With Cancer Who Are Treated With Oral Anticancer Medications|Recruiting||N/A|228|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||No||2017-10-10 21:55:23.871103|2017-10-10 21:55:23.871103
NCT02861196|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-05|||September 2015||2015-09-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer||Recruiting||N/A|60|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||||||||||||2017-10-10 21:55:23.982925|2017-10-10 21:55:23.982925
NCT02861183|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-18|||December 2016||2016-12-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow)|A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow)|Not yet recruiting||Phase 3|168|Anticipated|Anika Therapeutics, Inc.||2|||f||||t||||||||No||2017-10-10 21:55:24.065247|2017-10-10 21:55:24.065247
NCT02861170|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-09-20|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|CALM||Effects of a Peri-operative Brief Mindfulness-based Intervention on Post-operative Pain and Disability|Effects of a Peri-operative Brief Mindfulness-based Intervention on Post-operative Pain and Disability Among Anxious Patients With Chronic Pain Undergoing Total Hip Arthroplasty - a Feasibility and Acceptability Pilot Randomized Controlled Trial|Not yet recruiting||N/A|30|Anticipated|Ottawa Hospital Research Institute||2|||f||||f|f|f||||||||2017-10-10 21:55:24.150419|2017-10-10 21:55:24.150419
NCT02861157|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-01-27|||July 1, 2015|Actual|2015-07-01|January 2017|2017-01-01|September 12, 2016|Actual|2016-09-12|September 12, 2016|Actual|2016-09-12||Interventional|OMMS||Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients|Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients|Completed||Phase 2|200|Anticipated|3-C Institute for Social Development||2|||f||||f||||||||||2017-10-10 21:55:24.251734|2017-10-10 21:55:24.251734
NCT02861144|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-09|||February 2011||2011-02-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Hanapū Study: Incentivized Partnerships to Reduce Diabetes Disparities|Partnerships for Cardiometabolic Disparities in Native and Pacific People|Completed||N/A|107|Actual|University of Hawaii||2|||f||||t||||||||No||2017-10-10 21:55:24.338841|2017-10-10 21:55:24.338841
NCT02861131|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-01-15|||January 2017||2017-01-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications|The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications in Patients 70 Years or Older and Scheduled for 3 Hour or Longer Surgery-A Randomized Controlled Trial|Enrolling by invitation||Phase 4|200|Anticipated|Oregon Health and Science University||2|||f||||f||||||||No||2017-10-10 21:55:24.416859|2017-10-10 21:55:24.416859
NCT02861118|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-05-04|||October 26, 2016|Actual|2016-10-26|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|October 31, 2017|Anticipated|2017-10-31||Observational|||A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease|Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease: VERNE Study|Recruiting||N/A|400|Anticipated|Takeda|||1||f||||f||||||||||2017-10-10 21:55:24.51208|2017-10-10 21:55:24.51208
NCT02861105|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-11|||January 2015||2015-01-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers|The Effect of LMWH on ICSI Outcome in Patients With Unexplained Infertility and Negative Immunological Markers; a Randomized Controlled Trial|Completed||Phase 4|716|Actual|Ain Shams University||2|||f||||t||||||||No||2017-10-10 21:55:24.646302|2017-10-10 21:55:24.646302
NCT02861092|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-10-17|||February 2015||2015-02-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Antibiotic-related Serious Adverse Events in Obese Patients Treated for Bone and Joint Infection|Antibiotic-related Serious Adverse Events in Obese Patients Treated for Bone and Joint Infection|Completed||N/A|76|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:55:24.731329|2017-10-10 21:55:24.731329
NCT02861079|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-12-06|||August 2016||2016-08-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Combined Transcervical Foley Catheter Balloon and Vaginal Prostaglandin E2 for Induction of Labor at Term: A Randomized Study|Compare Prostaglandin E2 Against to Combined Transcervical Foley Catheter Balloon and Vaginal Prostaglandin E2 for Induction of Labor at Term: A Randomized Study|Completed||Phase 2|250|Actual|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t||||||||Yes||2017-10-10 21:55:24.801838|2017-10-10 21:55:24.801838
NCT02861066|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-09-05|||August 2016||2016-08-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Abbreviating Mindfulness-Based Therapy for Depressive and Anxious Symptoms|Reducing Barriers to Mental Health Care: Abbreviating Mindfulness-Based Therapy for Depressive and Anxious Symptoms in a Heterogeneous Clinical Outpatient Group|Completed||N/A|54|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 21:55:24.885331|2017-10-10 21:55:24.885331
NCT02861053|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-08-29|||September 2016||2016-09-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|MICI||Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?|Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?|Recruiting||N/A|10|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 21:55:24.960834|2017-10-10 21:55:24.960834
NCT02861040|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-12-13|||August 2016||2016-08-01|December 2016|2016-12-01||||July 2018|Anticipated|2018-07-01||Interventional|||Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|A Phase I Clinical Trial Evaluating the Combination of Volasertib (BI-6727) With Vincristine Sulfate Liposomal Injections (VSLI) in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia|Withdrawn||Phase 1|0|Actual|Northwestern University||1|||f||||t||||||||||2017-10-10 21:55:25.060153|2017-10-10 21:55:25.060153
NCT02861027|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-08-04|||July 2015||2015-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|EFESGMRTHA||Effect of Functional Electrical Stimulation in Gluteus Medius in Rehabilitation After Total Hip Arthroplasty|Effect of Functional Electrical Stimulation in Gluteus Medius in Rehabilitation After Total Hip Arthroplasty: Randomized Clinical Trial|Completed||N/A|72|Actual|Federal University of Rio Grande do Sul||2|||f||||t||||||||No||2017-10-10 21:55:25.162286|2017-10-10 21:55:25.162286
NCT02861014|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-07-31|||September 9, 2016|Actual|2016-09-09|July 2017|2017-07-01|December 18, 2020|Anticipated|2020-12-18|December 18, 2020|Anticipated|2020-12-18||Interventional|||A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)|An Open-Label Study To Evaluate the Efficacy and Safety of Ocrelizumab in Patients With Relapsing Multiple Sclerosis Who Have A Suboptimal Response to an Adequate Course of Disease-Modifying Treatment|Active, not recruiting||Phase 3|681|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 21:55:25.269999|2017-10-10 21:55:25.269999
NCT02861001|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-03-22|||April 2016||2016-04-01|March 2017|2017-03-01|January 13, 2017|Actual|2017-01-13|January 13, 2017|Actual|2017-01-13||Interventional|VivaPDT||VivaSight-SL™ Versus Bronchoscopy for Percutaneous Tracheotomy|Prospective, Randomized Study in Ventilated Critically Ill Patients Receiving Percutaneous Tracheotomy. A Comparison of Periinterventional Visualization of Conventional Bronchoscopy and an Endotracheal Tube Mounted Camera (VivaSight-SL™)|Completed||N/A|56|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||No||2017-10-10 21:55:25.93923|2017-10-10 21:55:25.93923
NCT02860988|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-31|||July 2016||2016-07-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|ReFORM||Responsible Fatherhood Opportunities for Reentry & Mobility|Responsible Fatherhood Opportunities for Reentry & Mobility|Recruiting||N/A|500|Anticipated|Mountain Comprehensive Care Center||1|||f||||f||||||||||2017-10-10 21:55:26.049843|2017-10-10 21:55:26.049843
NCT02860975|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2017-03-19|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|MGH-nitrogen||Prolonged Hypoxic Breathing in Healthy Volunteers: a Safety Study|Physiological and Biochemical Response to Prolonged Exposure to Hypoxic Breathing in Healthy Volunteers|Recruiting||Phase 1|12|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||No||2017-10-10 21:55:26.137007|2017-10-10 21:55:26.137007
NCT02860962|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Trial of Dextromethorphan for Treatment of Major Depressive Disorder|A Double-Blind Placebo-Controlled Trial of Dextromethorphan for Treatment of Major Depressive Disorder|Not yet recruiting||Phase 1|30|Anticipated|Medical University of South Carolina||2|||f||||t||||||||Yes||2017-10-10 21:55:26.26108|2017-10-10 21:55:26.26108
NCT02860949|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-10-22|||April 2014||2014-04-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Multimodal Drug Infiltration in Total Knee Arthroplasty: Is Posterior Capsular Infiltration Worth the Risk?|Multimodal Drug Infiltration in Total Knee Arthroplasty: Is Posterior Capsular Infiltration Worth the Risk? A Prospective, Double-Blind, Randomized Controlled Trial|Completed||Phase 2|90|Actual|Thammasat University||2|||f||||t||||||||No||2017-10-10 21:55:26.345863|2017-10-10 21:55:26.345863
NCT02860936|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-05-15|||June 2015||2015-06-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|ACC-LEN14||Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14|Phase II Study on Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands of the Upper Aerodigestive Tract|Active, not recruiting||Phase 2|26|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||No|Only study results will be shared through publication on scientific indexed journals|2017-10-10 21:55:26.454013|2017-10-10 21:55:26.454013
NCT02860923|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|CRANIOEXE||Multicentre Double-blind Randomized Clinical Trial Assessing Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy|Multicentre Double-blind Randomized Clinical Trial Assessing Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy|Not yet recruiting||Phase 3|50|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||No||2017-10-10 21:55:26.546193|2017-10-10 21:55:26.546193
NCT02859428|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2017-06-30|||July 29, 2016||2016-07-29|June 6, 2017|2017-06-06|September 30, 2020|Anticipated|2020-09-30|August 20, 2020|Anticipated|2020-08-20||Observational|||Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31|Disease Natural History and Biomarkers of SPG3A, SPG4A and SPG31|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:55:39.794729|2017-10-10 21:55:39.794729
NCT02860910|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-10-03|||July 2016||2016-07-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|Conklin MWW||Cognitive Behavioral Group Therapy for the Management of Menopause Symptoms in Mood Disorders|Cross-Cultural Cognitive Behavioral Group Therapy: Evaluating the Effectiveness of a Manualized Cognitive Behavior Group Therapy Treatment for the Management of Menopause Symptoms in a Mood and Anxiety Disorder Population|Recruiting||N/A|60|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||t||||||||No||2017-10-10 21:55:26.709863|2017-10-10 21:55:26.709863
NCT02860897|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-08|||July 2016||2016-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery|Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery|Recruiting||Phase 4|96|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-10 21:55:26.803763|2017-10-10 21:55:26.803763
NCT02860884|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-04|||August 2014||2014-08-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Observational|NASH||Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease|Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease|Completed||N/A|136|Actual|Rennes University Hospital|||2||f||||f||||||||No||2017-10-10 21:55:26.888988|2017-10-10 21:55:26.888988
NCT02860871|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-04-24|||June 2014||2014-06-01|July 2016|2016-07-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Observational|SynoFAST||Use of Infrared Spectroscopy in Septic Arthritis Diagnosis|Use of Infrared Spectroscopy in Septic Arthritis Diagnosis|Completed||N/A|611|Actual|Rennes University Hospital|||1||f||||f||||||||No||2017-10-10 21:55:26.970347|2017-10-10 21:55:26.970347
NCT02860858|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-08-08|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)|Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)|Not yet recruiting||Phase 4|50|Anticipated|Rajavithi Hospital||1|||f||||f||||||||||2017-10-10 21:55:27.032882|2017-10-10 21:55:27.032882
NCT02860845|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-04|||July 2016||2016-07-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|DOBO||Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections|Multicenter Pilot Study to Compare the Efficacy of a Combination of Vaginal Capsules With Acid Boric, L.Gasseri and L.Rhamnosus Versus the Reference Medication in Patients With Vaginal Candidiasis or Bacterial Vaginosis|Recruiting||Phase 4|50|Anticipated|Laboratorios Ordesa||2|||f||||t||||||||Undecided||2017-10-10 21:55:27.106128|2017-10-10 21:55:27.106128
NCT02860832|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Relationships of Cyber-bullying and Bullying With Mental Health Among Taiwanese Adolescents|The Relationships of Cyber-bullying and Bullying With Self-esteem, Depression and Suicidal Ideation Among Taiwanese Adolescents: Mixed Method Study|Recruiting||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 21:55:27.199771|2017-10-10 21:55:27.199771
NCT02860819|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-04|||July 2016||2016-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer|Phase II Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer|Recruiting||Phase 2|43|Anticipated|National Cancer Institute, Slovakia||1|||f||||f||||||||Undecided||2017-10-10 21:55:27.281306|2017-10-10 21:55:27.281306
NCT02860806|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-08-30|||August 8, 2016|Actual|2016-08-08|August 2017|2017-08-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Interventional|||Safety, Tolerability, Pharmacokinetic and Absolute Bioavailability Study of JNJ-63623872 Administered as an Intravenous Infusion and a 600-Milligram (mg) Oral Dose in Healthy Adults|A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Absolute Bioavailability of JNJ-63623872 Administered as an Intravenous Infusion and a 600-mg Oral Dose in Healthy Adult Subjects|Completed||Phase 1|66|Actual|Janssen-Cilag International NV||10|||f||||f||f||||||||2017-10-10 21:55:27.397651|2017-10-10 21:55:27.397651
NCT02860793|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-09|||January 2014||2014-01-01|August 2016|2016-08-01||||April 2015|Actual|2015-04-01||Interventional|LAM-PTK7||Role of PTK-7 in Acute Myeloid Leukemias|Role of PTK-7 in Acute Myeloid Leukemias: Impact of PTK7 Serum Marker and ex Vivo Studies to Decipher the Role of PTK7|Completed||N/A|10|Actual|Institut Paoli-Calmettes||1|||f||||f||||||||No||2017-10-10 21:55:27.497798|2017-10-10 21:55:27.497798
NCT02860780|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-09-20|||August 10, 2016|Actual|2016-08-10|September 2017|2017-09-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer|A Phase 1 Dose-Escalation Study of LY2606368 in Combination With Ralimetinib in Patients With Advanced or Metastatic Cancer|Completed||Phase 1|70|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 21:55:27.576198|2017-10-10 21:55:27.576198
NCT02860754|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-08-08|||September 2016||2016-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||The Prognostic Capabilities Of A Preoperative Six-Minute Walk Test To Independently Inform Cardiovascular Risk After Major Noncardiac Surgery|The Prognostic Capabilities Of A Preoperative Six-Minute Walk Test To Independently Inform Cardiovascular Risk After Major Noncardiac Surgery: Prospective Cohort Study|Not yet recruiting||Phase 3|1000|Anticipated|McGill University Health Center||1|||f||||f||||||||||2017-10-10 21:55:27.767806|2017-10-10 21:55:27.767806
NCT02860741|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-03-07|||May 2016||2016-05-01|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|REJOICE||Reducing Depressive Symptoms Among Rural African Americans|Reducing Depressive Symptoms Among Rural African Americans|Recruiting||N/A|360|Anticipated|University of Arkansas||2|||f||||f||||||||No||2017-10-10 21:55:27.839142|2017-10-10 21:55:27.839142
NCT02860728|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2016-08-05|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Resistance Training to Prehabilitate Patients With Chronic Obstructive Pulmonary Disease|A Novel Individualized Resistance Training Program to Prehabilitate Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|20|Anticipated|University of British Columbia||1|||f||||||||||||||2017-10-10 21:55:27.937377|2017-10-10 21:55:27.937377
NCT02860702|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-16|||July 2016||2016-07-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology|A Randomized Controlled Trial to Evaluate Growth Velocity and Clinical Outcomes of Infants With Single Ventricle Physiology Fed an Exclusive Human Milk Diet With Early Nutritional Fortification Following Surgical Repair|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||No|It is a blinded study|2017-10-10 21:55:28.114604|2017-10-10 21:55:28.114604
NCT02860689|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-04|||March 2015||2015-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01|1 Day|Observational [Patient Registry]|||Predictive Factors for Male Sexual Dysfunction After Traumatic Spinal Cord Injury|Predictive Factors for Male Sexual Dysfunction After Traumatic Spinal Cord Injury|Completed||N/A|45|Actual|Universidade Federal de Pernambuco|||1||f||||t||||||||No||2017-10-10 21:55:28.242411|2017-10-10 21:55:28.242411
NCT02860676|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-02-27|||September 2016||2016-09-01|February 2017|2017-02-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961|A Phase 1 Extension Study to Determine the Safety of UC-961 (Cirmtuzumab) at the Recommended Phase 2 Dose for Retreatment of Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961|Enrolling by invitation||Phase 1|75|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-10 21:55:28.305665|2017-10-10 21:55:28.305665
NCT02860663|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-10-26|||August 2007||2007-08-01|October 2016|2016-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|VitD||Effect of Different Vitamin D Vitamers on Vitamin D Status|Effect of Different Vitamin D Vitamers on Vitamin D Status and Biomarkers for Bone Health and Cardiovascular Risk in Healthy Humans|Completed||N/A|14|Actual|University of Copenhagen||3|||f||||f||||||||Yes||2017-10-10 21:55:28.379778|2017-10-10 21:55:28.379778
NCT02860650|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-05-30|||August 29, 2016|Actual|2016-08-29|May 2017|2017-05-01|September 21, 2017|Anticipated|2017-09-21|May 15, 2017|Actual|2017-05-15||Interventional|||A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults|A Phase 1, First-in-human Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adult|Active, not recruiting||Phase 1|72|Actual|Janssen Vaccines & Prevention B.V.||5|||f||||t||f||||||||2017-10-10 21:55:28.450977|2017-10-10 21:55:28.450977
NCT02860637|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-13|||March 2015||2015-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Observational|||Level and Degree of Spinal Cord Injury and Its Impact on Male Sexual Function|Level and Degree of Spinal Cord Injury and Its Impact on Male Sexual Function|Completed||N/A|45|Actual|Universidade Federal de Pernambuco|||1||f||||t||||||||No||2017-10-10 21:55:28.529588|2017-10-10 21:55:28.529588
NCT02860624|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-08|||December 2011||2011-12-01|July 2016|2016-07-01||||April 2013|Actual|2013-04-01||Interventional|||Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients|Efficacy and Safety of Ilaprazole for GERD: A Randomized, Double-Blind, Esomeprazole-Controlled, Phase 3, Multicenter Trial in China|Completed||Phase 3|550|Actual|Livzon Pharmaceutical Group Inc.||2|||f||||||||||||||2017-10-10 21:55:28.59489|2017-10-10 21:55:28.59489
NCT02860611|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-08|||February 2013||2013-02-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Observational|||Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 Diabetes|Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 Diabetes|Completed||N/A|180|Actual|Istanbul Medeniyet University|||3||f||||f||||||Samples With DNA|"     Blood   "|No||2017-10-10 21:55:28.793693|2017-10-10 21:55:28.793693
NCT02860598|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-04|||December 2011||2011-12-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|EPREX/LAM-ALLO||Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy|Clinical Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy|Recruiting||N/A|104|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||||No||2017-10-10 21:55:28.889396|2017-10-10 21:55:28.889396
NCT02860585|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-25|||September 27, 2013|Actual|2013-09-27|August 2016|2016-08-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29||Observational|BREAST-HDCT||Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation||Completed||N/A|235|Actual|Institut Paoli-Calmettes|||1||f||||f||||||||||2017-10-10 21:55:28.980706|2017-10-10 21:55:28.980706
NCT02860572|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-02-22|||January 10, 2017|Actual|2017-01-10|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|RESPONSE||Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Critically Ill|Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Optimization Phase of Fluid Therapy in the Critically Ill (the RESPONSE Trial)|Recruiting||N/A|120|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:55:29.045587|2017-10-10 21:55:29.045587
NCT02860559|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-22|||September 2016||2016-09-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|||Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiencies|Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiencies|Not yet recruiting||Phase 1|8|Anticipated|Taiga Biotechnologies, Inc.||1|||f||||t||||||||No||2017-10-10 21:55:29.146225|2017-10-10 21:55:29.146225
NCT02860533|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-02-13|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|iPARRDeltaBP||iPhone App Compared to Standard Riva-Rocci (RR)-Measurement During Stress Testing|iPhone App Compared to Standard RR-measurement During Stress Testing|Completed||N/A|220|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||No||2017-10-10 21:55:29.39691|2017-10-10 21:55:29.39691
NCT02860520|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-11|||September 2015||2015-09-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|RP-SEQ-HD||Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing.|Clinical Implication of the Molecular Diagnostic Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing (RP-SEQ-HD)|Recruiting||N/A|450|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||Samples With DNA|"     Whole blood   "|No||2017-10-10 21:55:29.471108|2017-10-10 21:55:29.471108
NCT02860507|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-08|||August 2016||2016-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Study to Determine if Administration of Sugammadex Impacts Hospital Efficiency|A Randomized, Blinded-assessor, Single Center Study to Determine if Administration of Sugammadex, When Used to Reverse Deep Neuromuscular Blockade (NMB) After Open Abdominal Surgery, Impacts Hospital Efficiency|Enrolling by invitation||Phase 4|50|Anticipated|University of South Florida||2|||f||||f||||||||Yes||2017-10-10 21:55:29.576792|2017-10-10 21:55:29.576792
NCT02860494|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-04|||January 2017||2017-01-01|July 2016|2016-07-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|EVEROST||Topical Everolimus in Patients With Tuberous Sclerosis Complex|Topical Everolimus Versus Placebo for the Treatment of Facial Angiofibromas in Patients With Tuberous Sclerosis Complex. A Phase II/III, Multicentre, Randomized, Double-blind, Placebo-controlled Study of 3 Doses of Topical Everolimus.|Not yet recruiting||Phase 2/Phase 3|96|Anticipated|Hospices Civils de Lyon||4|||f||||t||||||||No||2017-10-10 21:55:29.662452|2017-10-10 21:55:29.662452
NCT02860481|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-18|||November 2013||2013-11-01|July 2016|2016-07-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|FRACTal||FSH-R : Diagnostic Application for Localized Tumors in Cancerology|FSH-R (Follicle-stimulating Hormone Receptor ): Diagnostic Application for Localized Tumors in Cancerology|Terminated||N/A|95|Actual|Institut Curie||2||no inclusions|f||||f||||||||No||2017-10-10 21:55:29.759793|2017-10-10 21:55:29.759793
NCT02860455|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-08|||February 2012||2012-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CO-OX||Role of Pulse Co-oximetry for Detecting Carbon Monoxide Poisoning in the Prehospital Emergency Medical Service Setting|Role of Pulse Co-oximetry in Prehospital Emergency Medical Service Management of Suspected Carbon Monoxide Poisoning : A Prospective Multicenter Study.|Recruiting||N/A|176|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 21:55:29.934864|2017-10-10 21:55:29.934864
NCT02860442|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-09-15|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Project Guard: Reducing Alcohol Misuse/Abuse in the National Guard|Early Intervention to Reduce Alcohol Misuse and Abuse in the Ohio Army National Guard|Enrolling by invitation||N/A|750|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t|f|f||||||||2017-10-10 21:55:30.065115|2017-10-10 21:55:30.065115
NCT02860429|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||September 2016||2016-09-01|August 2016|2016-08-01||||September 2017|Anticipated|2017-09-01||Interventional|||Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma||Not yet recruiting||Phase 4|120|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||f||||||||Undecided||2017-10-10 21:55:30.209014|2017-10-10 21:55:30.209014
NCT02860416|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||July 2016||2016-07-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Observational|BNA™||Additional Post Hoc Analysis and Clinical Data Collection|Additional Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology|Recruiting||N/A|10000|Anticipated|ElMindA Ltd|||1||f||||f||||||||No||2017-10-10 21:55:30.333223|2017-10-10 21:55:30.333223
NCT02860403|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-08|||February 2013||2013-02-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Motor Imagery for Reach-to-grasp Rehabilitation After Tetraplegia|Motor Imagery for Reach-to-grasp Rehabilitation After Tetraplegia|Completed||N/A|16|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-10 21:55:30.433404|2017-10-10 21:55:30.433404
NCT02860390|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-10-02|||May 2016||2016-05-01|October 2017|2017-10-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|DHAMP||Denver Health Asthma Management Program|Denver Health Asthma Management Program|Completed||N/A|154|Actual|Denver Health and Hospital Authority||5|||f||||f||||||||||2017-10-10 21:55:30.543571|2017-10-10 21:55:30.543571
NCT02860377|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|MatherVoice||Maternal Voice on Anesthetic Emergence Period|Effect of Recorded Maternal Voice on the Emergence of General Anesthesia on Pediatric Patients: a Pilot Study|Recruiting||N/A|10|Anticipated|Daegu Catholic University Medical Center||2|||f||||||||||||||2017-10-10 21:55:30.637753|2017-10-10 21:55:30.637753
NCT02860364|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-25|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Interventional|||Mild vs Moderate Hypothermia in Aortic Hemiarch Surgery|A Randomized Controlled Trial of Mild vs. Moderate Hypothermia on Patient Outcomes in Aortic Hemiarch Surgery With Anterograde Cerebral Perfusion|Not yet recruiting||N/A|100|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t|f|f||||||||2017-10-10 21:55:30.742986|2017-10-10 21:55:30.742986
NCT02860351|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-06|||August 10, 2016||2016-08-10|April 2017|2017-04-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Observational|||The Effect of Head Positioning on the Cross-sectional Area of the Subclavian Vein.|The Effect of Head Positioning on the Cross-sectional Area of the Subclavian Vein|Completed||N/A|42|Actual|SMG-SNU Boramae Medical Center|||1||f||||f||||||||No||2017-10-10 21:55:30.820811|2017-10-10 21:55:30.820811
NCT02860338|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-04|||January 2009||2009-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE|Retrospective Analysis of the Comparative Effectiveness of MCI and Dementia Treatment Protocols in a Community-based Specialty Dementia Practice|Completed||N/A|900|Actual|Clionsky Neuro Systems Inc.|||2||f||||f||||||||No||2017-10-10 21:55:30.888805|2017-10-10 21:55:30.888805
NCT02860325|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-09|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|Bio-NAVA||NIV-NAVA Versus Nasal Continuous Positive Airway Pressure (nCPAP) or Non Synchronized NIPPV|Non-invasive Neurally Adjusted Ventilatory Assist Versus nCPAP or Non Synchronized NIPPV in Preterm Infants Under 32 Weeks Gestational Age: A Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|Complejo Hospitalario Universitario Insular Materno Infantil||2|||f||||f||||||||Undecided||2017-10-10 21:55:30.997089|2017-10-10 21:55:30.997089
NCT02860312|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-04|||September 2016||2016-09-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|||Long Term Physical Activity for Hemodialysis Patients|Effects of One Year Perdialytic Physical Activity on Aerobic Capacities and Quality of Life in Hemodialysis Patients|Not yet recruiting||N/A|100|Anticipated|AURA Sante||2|||f||||t||||||||No||2017-10-10 21:55:31.11289|2017-10-10 21:55:31.11289
NCT02860299|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-08|||February 2015||2015-02-01|July 2016|2016-07-01||||January 2016|Actual|2016-01-01||Interventional|VERROU HEMOST||Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used|Evaluation of Systemic Leakage When a Heparin or Citrate Lock is Injected and Biological and Clinical Repercussions: Ancillary Study of the VERROU-REA Randomized Controlled Trial|Completed||Phase 4|76|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:55:31.213945|2017-10-10 21:55:31.213945
NCT02860286|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-08-01|||July 2016||2016-07-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma|A Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With Relapsed or Refractory Malignant Mesothelioma With BAP1 Loss of Function|Active, not recruiting||Phase 2|67|Anticipated|Epizyme, Inc.||1|||f||||t||||||||||2017-10-10 21:55:31.303413|2017-10-10 21:55:31.303413
NCT02860273|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-04|||April 2016||2016-04-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||High Flow Nasal Cannula and Exercise Testing in Chronic Obstructive Pulmonary Disease (COPD)|Exercise Capacity Testing in COPD Patients With High Flow Nasal Cannula|Recruiting||N/A|28|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||Yes||2017-10-10 21:55:31.423431|2017-10-10 21:55:31.423431
NCT02860260|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-08|||February 2011||2011-02-01|July 2016|2016-07-01||||January 2012|Actual|2012-01-01||Interventional|BDNF||Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Patients With Ischemic Stroke|Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Patients With Ischemic Stroke: Effect of Intravenous Fibrinolysis With Rt-PA|Completed||N/A|50|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:55:31.556027|2017-10-10 21:55:31.556027
NCT02860247|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-02-02|||May 2016||2016-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|MALDI-TRAc||Rapid Detection of Bacterial Resistance by MALDI-TOF MS and Antibiotic Savings|Rapid Detection of Bacterial Resistance by MALDI-TOF MS and Antibiotic Savings|Enrolling by invitation||N/A|333|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 21:55:31.627146|2017-10-10 21:55:31.627146
NCT02860234|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-23|||August 2016||2016-08-01|December 2016|2016-12-01|April 2023|Anticipated|2023-04-01|August 2022|Anticipated|2022-08-01||Observational|||Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment|Tailored Operative or Non-operative Management for MRI Defined Low-risk Rectal Cancer Following Neoadjuvant Intensity Modulated Radiotherapy With Concurrent Capecitabine Plus Consolidation CapeOX.|Recruiting||Phase 2|72|Anticipated|Beijing Cancer Hospital|||3||f||||||||||||||2017-10-10 21:55:31.682453|2017-10-10 21:55:31.682453
NCT02860221|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-07-25|||May 2015||2015-05-01|July 2017|2017-07-01|July 2017||2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Intravenous Versus Topical Administration of Low Dose Epinephrine Plus Combined Administration of Intravenous and Topical Tranexamic Acid (TXA)for Primary Total Knee Arthroplasty||Recruiting||N/A|210|Anticipated|Southwest Hospital, China||3|||f||||t||||||||||2017-10-10 21:55:31.780473|2017-10-10 21:55:31.780473
NCT02860208|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-19|||December 2013||2013-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Follow-Up After Surgical Treatment of Peri-implantitis|Follow-Up After Surgical Treatment of Peri-implantitis|Completed||N/A|100|Actual|Göteborg University|||1||f||||f||||||||No||2017-10-10 21:55:31.875711|2017-10-10 21:55:31.875711
NCT02860195|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-28|||September 2016||2016-09-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|March 2017|Actual|2017-03-01||Interventional|ALCOOCAPT||Evaluation of the Sensitivity of a Transdermal Device to Monitor the Sweat Alcohol Concentration|Evaluation of the Sensitivity of a Transdermal Device to Monitor the Sweat Alcohol Concentration|Completed||N/A|6|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:55:31.955421|2017-10-10 21:55:31.955421
NCT02860182|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-30|||January 2014||2014-01-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|January 2016|Actual|2016-01-01||Observational|||Mechanical Characterization of Ascending Aorta in Patients With and Without Aortic Dissection|Mechanical Characterization of Ascending Aorta in Patients With Acute Type A Dissection and in Healthy Control Group Combined to Structural and Ultrastructural Analysis of Aortic Tissue|Recruiting||N/A|90|Anticipated|Assistance Publique Hopitaux De Marseille|||2||f||||f||||||||||2017-10-10 21:55:32.028482|2017-10-10 21:55:32.028482
NCT02860156|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-06-06|||November 2016||2016-11-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Observational|HFN_HIV||Characterizing HIV-related Diastolic Dysfunction|Characterizing HIV-related Diastolic Dysfunction: A Cross Sectional Study Leveraging the NHLBI Heart Failure Clinical Research Network|Recruiting||N/A|200|Anticipated|Duke University|||3||f||||t||||||Samples Without DNA|"     Plasma   "|No||2017-10-10 21:55:32.199677|2017-10-10 21:55:32.199677
NCT02860143|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-03-13|||March 2015||2015-03-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Assessment of Ventilation Using Respiratory Volume Monitor Compared to Capnography During Intravenous Sedation|Assessment of Ventilation Using Respiratory Volume Monitor During Sedation With Intravenous Propofol as Compared to Capnography in Patients Receiving Intravenous Sedation.|Recruiting||N/A|50|Anticipated|Brigham and Women's Hospital|||1||f||||t||||||||No||2017-10-10 21:55:32.317738|2017-10-10 21:55:32.317738
NCT02860130|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-07|||September 13, 2016|Actual|2016-09-13|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)|Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)|Recruiting||Phase 3|160|Anticipated|Baxter Healthcare Corporation||2|||f||||t||||||||||2017-10-10 21:55:32.407028|2017-10-10 21:55:32.407028
NCT02860117|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-01-25|||May 2016||2016-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|January 2017|Actual|2017-01-01||Interventional|ccimb||Ketamine Continuous Infusion on Opioid Consumption and Pain Management in Severe Burned Patients|The Effectiveness of Ketamine Continuous Infusion on Opioid Consumption and Pain Management in Severe Burned Patients, a Randomized, Double-blind, Placebo-controlled Study|Recruiting||Phase 3|50|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:55:32.562113|2017-10-10 21:55:32.562113
NCT02860104|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-11-22|||December 2012||2012-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions|Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions: A Prospective Multicenter Study|Recruiting||Phase 2/Phase 3|500|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||Yes|cosmetics effect, volume reduction rate,complications|2017-10-10 21:55:32.672589|2017-10-10 21:55:32.672589
NCT02860091|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-06-05|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Blood Ropivacaine Concentrations Following Nerve Block in Infants and Toddlers Undergoing Esophageal Atresia Repair|Blood Ropivacaine Concentrations Following Paravertebral Nerve Block and Continuous Infusion in Infants and Toddlers Undergoing Staged Esophageal Atresia Repair|Not yet recruiting||N/A|20|Anticipated|Boston Children’s Hospital|||1||f||||t||||||Samples Without DNA|"     Post-analysis specimens will be frozen and retained for further analysis, if necessary.   "|No||2017-10-10 21:55:32.914024|2017-10-10 21:55:32.914024
NCT02860078|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-08-08|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|EICUS||Epidural Injection of Corticosteroids Under USG (EICUS)|Comparative Study of the Use of Ultrasonography (USG) or Isolated Use of Fluoroscopy for Sacral Epidural Puncture Corticosteroid Infiltration in Patients With Low Back Pain by Canal Stenosis Lumbar|Not yet recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Yes||2017-10-10 21:55:33.02417|2017-10-10 21:55:33.02417
NCT02860065|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-08-08|||September 30, 2016|Anticipated|2016-09-30|August 2017|2017-08-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||CPC-201 Alzheimer's Disease Type Dementia: PET Study|Phase II, Modified Single-Blind, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Cerebral Efficacy of CPC-201 in Patients With Alzheimer's Disease Type Dementia: PET Study|Withdrawn||Phase 2|0|Actual|Chase Pharmaceuticals Corporation||1|||f||||f||||||||||2017-10-10 21:55:33.136532|2017-10-10 21:55:33.136532
NCT02860052|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-01-03|||July 2016||2016-07-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||SB208 for the Treatment of Tinea Pedis|A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Ranging Study Assessing Efficacy and Safety of SB208 and Vehicle Gel in Subjects With Interdigital Tinea Pedis|Active, not recruiting||Phase 2|222|Actual|Novan, Inc.||4|||f||||f||||||||No||2017-10-10 21:55:33.248067|2017-10-10 21:55:33.248067
NCT02860039|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-01-05|||September 2016||2016-09-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant|Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients|Recruiting||Phase 2|200|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-10-10 21:55:33.366264|2017-10-10 21:55:33.366264
NCT02860026|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-05-26|||October 2016||2016-10-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas|Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas|Withdrawn||N/A|0|Actual|Mead Johnson Nutrition||2||Raw ingredient shortage. Future study start date - TBD|f||||f||||||||No||2017-10-10 21:55:33.546437|2017-10-10 21:55:33.546437
NCT02860013|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-04|||August 2016||2016-08-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|TCN||Telemedicine for Patients Suffering From Heart Failure (Danish Telecare North Trial)|"Effectiveness and Cost-effectiveness of Telemedicine for Heart Failure: The Danish TeleCare North Pragmatic Randomized Trial"|Not yet recruiting||N/A|600|Anticipated|Aalborg University||2|||f||||f||||||||No||2017-10-10 21:55:33.694636|2017-10-10 21:55:33.694636
NCT02860000|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-07-10|||July 6, 2017|Actual|2017-07-06|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer|Randomized Phase II Trial to Evaluate Alisertib Alone or Combined With Fulvestrant for Women With Advanced, Endocrine-Resistant Breast Cancer|Recruiting||Phase 2|96|Anticipated|Mayo Clinic||2|||f||||t|t|f||||||||2017-10-10 21:55:33.795076|2017-10-10 21:55:33.795076
NCT02859987|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-09|||August 2013||2013-08-01|August 2016|2016-08-01||||August 2014|Actual|2014-08-01||Interventional|||Randomized Controlled Trial of Ultrasound-guided Versus Landmark Technique for Peripherally Inserted Central Catheter (PICC) Placement||Completed||Phase 3|199|Actual|Equipo de Terapia Intravenosa||2|||f||||||||||||||2017-10-10 21:55:33.937817|2017-10-10 21:55:33.937817
NCT02859974|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-06-08|||September 2015||2015-09-01|June 2017|2017-06-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Interventional|PVFMDRespRet||Treatment of Paradoxical Vocal Fold Motion Disorder (PVFMD) With a Form of Respiratory Retraining Technique|Treatment of Exertion Induced Paradoxical Vocal Fold Motion Disorder (PVFMD) With a Form of Respiratory Retraining Technique|Completed||N/A|15|Actual|Boston Medical Center||1|||f||||f|f|f||||||Undecided||2017-10-10 21:55:34.030677|2017-10-10 21:55:34.030677
NCT02859961|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-02-01|||October 2016||2016-10-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection|A Phase 2b/3, Multicenter Study to Assess the Treatment Strategy of Using PRO 140 SC as Long-Acting Single-Agent Maintenance Therapy for 48 Weeks in Virologically Suppressed Subjects With CCR5-tropic HIV-1 Infection|Recruiting||Phase 2/Phase 3|300|Anticipated|CytoDyn, Inc.||1|||f||||t||||||||Undecided|TBD|2017-10-10 21:55:34.152589|2017-10-10 21:55:34.152589
NCT02859948|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-04|||May 2016||2016-05-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia|Phase I Open-Label, Sequential Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SKLB1028 When Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia|Recruiting||Phase 1|18|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||1|||f||||f||||||||No||2017-10-10 21:55:34.336964|2017-10-10 21:55:34.336964
NCT02859935|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-20|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SYNBASIN||A SYNdemic BASed INtervention for MSM With High Risk Behavior: Design of a Randomized Controlled Trial|A SYNdemic BASed Co-located Linkage to Care INtervention for Men Who Have Sex With Men With High Risk Behavior: Design of a Randomized Controlled Trial|Active, not recruiting||N/A|150|Anticipated|Public Health Service of Amsterdam||2|||f||||f||||||||||2017-10-10 21:55:34.445704|2017-10-10 21:55:34.445704
NCT02859922|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-16|||January 2009||2009-01-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|December 2010|Actual|2010-12-01||Interventional|||Comparison Between the Supreme Laryngeal Mask Airway and the Laryngeal Tube Suction During Spontaneous Ventilation|A Comparison Between the Supreme Laryngeal Mask Airway and the Laryngeal Tube Suction During Spontaneous Ventilation: A Randomized Prospective Study|Completed||N/A|180|Actual|Bnai Zion Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:55:34.534676|2017-10-10 21:55:34.534676
NCT02859909|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-11|||November 2016||2016-11-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)|An Open Label, Prospective, Randomized, Multicenter Study Investigating Clinical Efficacy and Safety of the Human Normal Immunoglobulin for Intravenous Administration BT595 in Patients With Chronic Primary Immune Thrombocytopenia (ITP)|Recruiting||Phase 3|40|Anticipated|Biotest||2|||f||||t||||||||||2017-10-10 21:55:34.628056|2017-10-10 21:55:34.628056
NCT02859883|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-03-01|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|FUSE-TM-Duo||Evaluation of Oesogastroduodenoscopy With Vision to 245 ° (Full Spectrum Endoscopy) to View the Main Disc and Accessory||Recruiting||N/A|70|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||||2017-10-10 21:55:34.875727|2017-10-10 21:55:34.875727
NCT02859870|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-16|||March 18, 2015|Actual|2015-03-18|August 2017|2017-08-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Observational|FUSETM-Colon||Evaluation of the Colonoscope With Vision to 330 ° (Full Spectrum Endoscopy) in the Detection of Colorectal Adenomas|Evaluation of the Colonoscope With Vision to 330 ° (Full Spectrum Endoscopy) in the Detection of Colorectal Adenomas|Completed||N/A|141|Actual|Institut Paoli-Calmettes|||1||f||||f||||||||||2017-10-10 21:55:34.953054|2017-10-10 21:55:34.953054
NCT02859857|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-04-27|||September 2016||2016-09-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors|Phase 1, Dose-Escalation, Open-label, Safety and Pharmacokinetic, First in Human Study of BXQ-350 Administered as a Single Agent by Intravenous Infusion in Adult Patients With Advanced Solid Tumors and Recurrent High-Grade Gliomas|Recruiting||Phase 1|40|Anticipated|Bexion Pharmaceuticals, LLC.||3|||f||||t||||||||No||2017-10-10 21:55:35.043893|2017-10-10 21:55:35.043893
NCT02859844|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01||||April 2019|Anticipated|2019-04-01||Interventional|||Transcutaneous Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction||Recruiting||Phase 3|100|Anticipated|Balgrist University Hospital||2|||f||||||||||||||2017-10-10 21:55:35.177913|2017-10-10 21:55:35.177913
NCT02859831|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-08||||||July 2016|2016-07-01||||February 2009|Actual|2009-02-01||Observational|SautourPHRCI08||Sautour PHRC IR 2008|Fungal Contamination of a Hospital Water System With Fusarium App.: Prospective Environmental and Medical Surveillance During a Construction Period|Completed||N/A|551|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 21:55:35.24413|2017-10-10 21:55:35.24413
NCT02859818|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-04|||December 2016||2016-12-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|ETPACAP||Description of the Evolution of a Cohort of Adolescents With Type 1 Diabetes Following Their Participation in Therapeutic Education Program Based on Social Cognitive Theory: Socio-cognitive Profile, Physiological Behaviour of Therapeutic Adherence and Quality of Life|Description of the Evolution of a Cohort of Adolescents With Type 1 Diabetes Following Their Participation in Therapeutic Education Program Based on Social Cognitive Theory: Socio-cognitive Profile, Physiological Behaviour of Therapeutic Adherence and Quality of Life|Not yet recruiting||N/A|168|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:55:35.308559|2017-10-10 21:55:35.308559
NCT02859805|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-04|||January 2011||2011-01-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|January 2013|Actual|2013-01-01||Observational|||Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's Patient|Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's Patient|Completed||N/A|255|Actual|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 21:55:35.383555|2017-10-10 21:55:35.383555
NCT02859792|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||December 2016||2016-12-01|August 2016|2016-08-01||||December 2019|Anticipated|2019-12-01||Interventional|RILUSCI||Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition|Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition: Adaptive, Multicenter, Placebo-controlled, Randomised, Double Blind Trial in a Rare Disorder|Not yet recruiting||Phase 2|90|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-10-10 21:55:35.437159|2017-10-10 21:55:35.437159
NCT02859779|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-06-09|||November 25, 2016|Actual|2016-11-25|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|BADET||Needs Assessment of Mediterranean Adolescents With Type 1 Diabetes About Therapeutic Education Sessions|Needs Assessment of Mediterranean Adolescents With Type 1 Diabetes About Therapeutic Education Sessions: A Qualitative Study|Recruiting||N/A|200|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:55:35.511511|2017-10-10 21:55:35.511511
NCT02859766|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-06-27|||December 7, 2016|Actual|2016-12-07|June 2017|2017-06-01|January 23, 2018|Anticipated|2018-01-23|January 23, 2018|Anticipated|2018-01-23||Interventional|||Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD|Evaluation of Safety and Systemic Pharmacokinetics After Single and Repeat Doses of Abicipar Pegol (AGN-150998) Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration|Active, not recruiting||Phase 1|30|Anticipated|Allergan||2|||f||||f||||||||||2017-10-10 21:55:35.571968|2017-10-10 21:55:35.571968
NCT02859753|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-04|||January 2014||2014-01-01|July 2016|2016-07-01||||October 2019|Anticipated|2019-10-01||Interventional|Thermoablation||Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation|Prospective Randomized Controlled Study Comparing Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy (MCT) Versus Percutaneous Radiofrequency Ablation (RFA) in Patients With Chronic Liver Disease and Hepatocellular Carcinoma|Recruiting||N/A|156|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:55:35.675104|2017-10-10 21:55:35.675104
NCT02859740|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||August 2013||2013-08-01|July 2016|2016-07-01||||March 2014|Actual|2014-03-01||Observational|SIGAM||Validation of the SIGAM/VF Mobility Grade|Validation of the SIGAM/VF Mobility Grade|Completed||N/A|70|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 21:55:35.74082|2017-10-10 21:55:35.74082
NCT02859727|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-06-01|||September 8, 2016|Actual|2016-09-08|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI|An Open-label Extension Study to Evaluate the Long Term Safety, Tolerability, Efficacy and Pharmacokinetics of CDZ173 in Patients With APDS/PASLI (Activated Phosphoinositide 3-kinase Delta Syndrome/p110δ-activating Mutation Causing Senescent T Cells, Lymphadenopathy and Immunodeficiency)|Recruiting||Phase 2/Phase 3|36|Anticipated|Novartis||1|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 21:55:35.79754|2017-10-10 21:55:35.79754
NCT02859714|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-04||||||July 2016|2016-07-01||||January 2017|Anticipated|2017-01-01||Observational|DACCOR||Detection of Colorectal Adenomas in Côte-d'Or|Detection of Colorectal Adenomas in Côte-d'Or: Impact of Organized Screening on Socio-geographic Disparities|Not yet recruiting||N/A|11600|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:55:35.921194|2017-10-10 21:55:35.921194
NCT02859701|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-25|||August 2016||2016-08-01|September 2017|2017-09-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|||Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Healthy Participants|A Phase 1, Double-Blind, Placebo-Controlled, Single Ascending and Multi Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Healthy Participants|Completed||Phase 1|51|Actual|Allakos, Inc.||2|||f||||f||||||||||2017-10-10 21:55:36.003901|2017-10-10 21:55:36.003901
NCT02859688|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||May 2015||2015-05-01|July 2016|2016-07-01||||July 2015|Actual|2015-07-01||Observational|REPAR||Can Epimutations be Inherited? How to Manage Patients With Imprinting-related Diseases Who Wish to Become Parents|Can Epimutations be Inherited? How to Manage Patients With Imprinting-related Diseases Who Wish to Become Parents|Completed||N/A|7|Actual|Centre Hospitalier Universitaire Dijon|||3||f||||||||||Samples With DNA|"     blood, sperm, saliva, skin biopsy   "|||2017-10-10 21:55:36.080223|2017-10-10 21:55:36.080223
NCT02859675|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-04|||October 2013||2013-10-01|June 2016|2016-06-01||||May 2015|Actual|2015-05-01||Observational|Smell&Crohn||Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's Disease|Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's Disease|Terminated||N/A|1|Actual|Centre Hospitalier Universitaire Dijon|||1|difficulties for patient enrolment|f||||||||||||||2017-10-10 21:55:36.146632|2017-10-10 21:55:36.146632
NCT02859662|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-08-04|||September 2016||2016-09-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|SCA-AAR||Abdominal Compartment Syndrome and Ruptured Aortic Aneurysm : Validation of a Predictive Test|Abdominal Compartment Syndrome and Ruptured Aortic Aneurysm : Validation of a Predictive Test|Not yet recruiting||N/A|165|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||t||||||||Yes||2017-10-10 21:55:36.208783|2017-10-10 21:55:36.208783
NCT02859649|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-08-04|||April 2016||2016-04-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|July 2016|Actual|2016-07-01||Interventional|GeSTWoM||Gestural Short Term and Working Memory Task|Gestural Short Term and Working Memory Task|Active, not recruiting||N/A|60|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:55:36.267997|2017-10-10 21:55:36.267997
NCT02859636|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||October 2012||2012-10-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|Pro-ICARD||Pronostic Value of Endothelial Dysfunction in Heart Failure|Pronostic Value of Endothelial Dysfunction in Heart Failure|Terminated||N/A|7|Actual|Centre Hospitalier Universitaire de Besancon|||1|Not enough inclusions|f||||t||||||Samples Without DNA|"     serum samples, endothelial progenitors   "|||2017-10-10 21:55:36.347827|2017-10-10 21:55:36.347827
NCT02859623|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-04|||January 2014||2014-01-01|July 2016|2016-07-01||||May 2015|Actual|2015-05-01||Observational|LpDC||Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)|Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN): a Retrospective Study of Patients Diagnosed in France From 2000 to 2013|Completed||N/A|86|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 21:55:36.394798|2017-10-10 21:55:36.394798
NCT02859610|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-04|||January 2014||2014-01-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|MicroCir||Microparticles in Cirrhosis and Portal Hypertension|Characterization of Microparticles in Cirrhosis and Portal Hypertension With Implications|Completed||N/A|100|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-10 21:55:36.458201|2017-10-10 21:55:36.458201
NCT02859597|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-04|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite|Randomized. Controlled Trial of the Utilization of High Flow Nasal Cannula for Oxygenation of Sedated Morbidly Obese Patients in the Endoscopy Suite|Not yet recruiting||N/A|50|Anticipated|Montefiore Medical Center||2|||f||||f||||||||No||2017-10-10 21:55:36.516989|2017-10-10 21:55:36.516989
NCT02859584|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-18|||August 2011||2011-08-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|CORT-HEPAT||ADRENAL FUNCTION IN PATIENTS WITH ACUTE HEPATITIS|ASSESSMENT OF ADRENAL FUNCTION IN PATIENTS WITH ACUTE HEPATITIS USING CONCENTRATION OF SERUM TOTAL CORTISOL, SERUM FREE AND SALIVARY CORTISOL|Completed||N/A|111|Actual|Centre Hospitalier Universitaire de Besancon||4|||f||||f||||||||||2017-10-10 21:55:36.587779|2017-10-10 21:55:36.587779
NCT02859571|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-06|||August 2016||2016-08-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Continuous Versus Intermittent Oxytocin for Induction of Labor: A Randomized Study||Recruiting||Phase 2|200|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t||||||||Yes||2017-10-10 21:55:38.543672|2017-10-10 21:55:38.543672
NCT02859558|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-05-01|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|EARLIER||Early ART to Limit Infection and Establishment of Reservoir|Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses|Recruiting||Phase 2|150|Anticipated|AIDS Clinical Trials Group||3|||f||||t|t|f||||||Undecided||2017-10-10 21:55:38.649726|2017-10-10 21:55:38.649726
NCT02859545|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-08-23|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|SUPER||Study to Understand Pain Experiences in Relationships|Study to Understand Pain Experiences in Relationships|Recruiting||N/A|120|Anticipated|Wayne State University||2|||f||||f||||||||||2017-10-10 21:55:38.813104|2017-10-10 21:55:38.813104
NCT02859532|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-28|||January 2017||2017-01-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|ClotStruct||Study of Elastographic Properties of the Clot by Technical SWIRE (Shear Wave Induced Resonance Elastography)|Study of Elastographic Properties of the Clot by Technical SWIRE (Shear Wave Induced Resonance Elastography)|Recruiting||N/A|30|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 21:55:38.930404|2017-10-10 21:55:38.930404
NCT02859519|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)||Recruiting||Phase 3|||Moberg Pharma AB||2|||||||||||||||||2017-10-10 21:55:39.014715|2017-10-10 21:55:39.014715
NCT02859506|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-04|||July 2015||2015-07-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Interventional|GREFFE||Eating Behaviour and Gustatory Sensitivity Before and After Liver Transplant in Cirrhotic Patients|Eating Behaviour and Gustatory Sensitivity Before and After Liver Transplant in Cirrhotic Patients|Recruiting||N/A|45|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f||||||||||||||2017-10-10 21:55:39.101477|2017-10-10 21:55:39.101477
NCT02859493|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-12-02|||August 2016||2016-08-01|December 2016|2016-12-01||||March 2017|Anticipated|2017-03-01||Interventional|||Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis|Evaluation of the Effect of Saccharomyces Cerevisiae on the Improvement of the Conventional Treatment for Vulvo-vaginal Infection to Candida Spp (Local Administration)|Recruiting||N/A|80|Anticipated|Lesaffre International||2|||f||||t||||||||No||2017-10-10 21:55:39.174677|2017-10-10 21:55:39.174677
NCT02859480|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-04|||September 2015||2015-09-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|ROSUVA-30||Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI|Effectiveness and Safety of Low-dose vs. High-dose Rosuvastatin on Long-term Cardiovascular Events in Korean Patients After Percutaneous Coronary Intervention: 30-month, Prospective, Single-center, Randomized Trial|Recruiting||Phase 4|300|Anticipated|Korea University Anam Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:55:39.248297|2017-10-10 21:55:39.248297
NCT02859467|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-06-28|||August 2016||2016-08-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Kinesio Taping and Inhibitory Treatment Techniques|Benefits of Kinesio Taping and Inhibitory Treatment Techniques in Patients With Fibromyalgia Syndrome|Active, not recruiting||N/A|64|Anticipated|Universidad de Almeria||2|||f||||f||||||||No||2017-10-10 21:55:39.471394|2017-10-10 21:55:39.471394
NCT02859454|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2017-07-26|||August 4, 2016||2016-08-04|July 14, 2017|2017-07-14|June 30, 2023|Anticipated|2023-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Avelumab for People With Recurrent Respiratory Papillomatosis|A Phase II Study of Avelumab in Subjects With Recurrent Respiratory Papillomatosis|Recruiting||Phase 2|40|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:55:39.570239|2017-10-10 21:55:39.570239
NCT02859441|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2017-07-18|||August 1, 2016||2016-08-01|July 11, 2017|2017-07-11|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab|A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab|Recruiting||Phase 1/Phase 2|7|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:55:39.685397|2017-10-10 21:55:39.685397
NCT02859415|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-06|2017-07-26|||July 21, 2016||2016-07-21|July 14, 2017|2017-07-14|August 3, 2028|Anticipated|2028-08-03|August 3, 2028|Anticipated|2028-08-03||Interventional|||Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases|Phase I/II Evaluation of Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in Patients With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases|Recruiting||Phase 1/Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 21:55:39.874197|2017-10-10 21:55:39.874197
NCT02859402|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-01-31|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|RRTCLAlloSCT||Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas|Allogeneic Stem Cell Transplantation With 3-days Busulfan Plus Fludarabine as Conditioning in Patients With Relapsed or Refractory T-, NK/T-cell Lymphomas|Recruiting||Phase 2|34|Anticipated|Keimyung University Dongsan Medical Center||1|||f||||f||||||||Yes|age,gender, disease type, stage, previous chemotherapy regimens, response to transplantation, patient survival, progression, toxicity profiles to the transpantation will be shared|2017-10-10 21:55:39.97582|2017-10-10 21:55:39.97582
NCT02859389|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-09-05|||August 18, 2016|Actual|2016-08-18|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome|Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome|Recruiting||N/A|80|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-10 21:55:40.087304|2017-10-10 21:55:40.087304
NCT02859376|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-08-03|||February 2016||2016-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Analgesic Efficacy of Different Doses of Sucrose During Blood Sampling in Preterm Infants|Analgesic Efficacy of Different Doses of Sucrose During Blood Sampling in Preterm Infants: Prospective, Randomized, Controlled, Double Blind, Clinical Trial|Recruiting||N/A|144|Anticipated|University Hospital Padova||2|||f||||t||||||||Undecided||2017-10-10 21:55:40.172682|2017-10-10 21:55:40.172682
NCT02859363|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-09|||March 2016||2016-03-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Observational|||Fabry Disease in Cerebrovascular Disease|Improving the Diagnostic Rate of Fabry Disease in Patients With Cerebrovascular Involvement in Taiwan- a Cohort Screening Program|Recruiting||N/A|700|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||No||2017-10-10 21:55:40.287491|2017-10-10 21:55:40.287491
NCT02859350|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-12-20|||November 2016||2016-11-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.|Age Escalation / De-escalation Study to Evaluate the Safety, Tolerability and Immunogenicity of a Radiation-attenuated Plasmodium Falciparum (Pf) Sporozoite Vaccine (PfSPZ Vaccine) in Equatoguinean Adults, Children and Infants, and Comparison With Non-attenuated Pf Sporozoites (PfSPZ Challenge) Administered Under Chloroquine Prophylaxis (PfSPZ-CVac Approach) for Efficacy Against Controlled Human Malaria Infection.|Recruiting||Phase 1|135|Anticipated|Sanaria Inc.||15|||f||||t||||||||||2017-10-10 21:55:40.374525|2017-10-10 21:55:40.374525
NCT02859337|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-08-29|||May 30, 2017|Actual|2017-05-30|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|UPA-Obesity||Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA|Improving the Effectiveness of Orally Dosed Emergency Contraceptives in Obese Women - PK and PD of 30mg and 60mg UPA|Recruiting||Phase 4|112|Anticipated|Oregon Health and Science University||3|||f||||t|t|f|||f|||||2017-10-10 21:55:40.500058|2017-10-10 21:55:40.500058
NCT02859324|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-06-16|||September 20, 2016|Actual|2016-09-20|June 2017|2017-06-01|June 23, 2020|Anticipated|2020-06-23|June 23, 2020|Anticipated|2020-06-23||Interventional|||A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)|A Phase 1/2, MultiCenter, Open-label, Dose Finding Study to Assess the Safety, Tolerability and Preliminary Efficacy of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellullar Carcinoma (HCC) Following First Line Treatment Failure|Recruiting||Phase 1/Phase 2|50|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 21:55:40.600492|2017-10-10 21:55:40.600492
NCT02859311|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-08-03|||April 2016||2016-04-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|TRED||A Pilot Feasibility Study in Recovered Heart Failure|A Pilot Feasibility Study in Recovered Heart Failure|Recruiting||Phase 4|50|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 21:55:40.721972|2017-10-10 21:55:40.721972
NCT02859298|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-02-01|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility Study and Predictive Value of the Uterine Cervix Polarimetric Imaging for the Management of the Threat of Premature Delivery.|Feasibility Study and Predictive Value of the Uterine Cervix Polarimetric Imaging for the Management of the Threat of Premature Delivery : The POLARMAP Project|Not yet recruiting||N/A|20|Anticipated|Brugmann University Hospital||2|||f||||f|f|f||||||||2017-10-10 21:55:40.813679|2017-10-10 21:55:40.813679
NCT02859285|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-20|||April 2016||2016-04-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|April 2018|Anticipated|2018-04-01||Interventional|||A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women|Sexual Function in Postmenopausal Women: A Double Blinded, Randomized Pilot Study Evaluating the Effects of Topical Clitoral Estradiol Cream|Recruiting||N/A|30|Anticipated|ProHealth Care, Inc||2|||f||||f||||||||||2017-10-10 21:55:40.906659|2017-10-10 21:55:40.906659
NCT02859272|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-11|||May 2012||2012-05-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Vaginal Vault Suspension During Benign Hysterectomy. A Questionnaire and Register-based Study.||Active, not recruiting||N/A|11000|Anticipated|Nykøbing Falster County Hospital|||1||f||||||||||||||2017-10-10 21:55:40.991354|2017-10-10 21:55:40.991354
NCT02859259|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-12|||August 12, 2016|Actual|2016-08-12|May 2017|2017-05-01|August 12, 2016|Actual|2016-08-12|August 12, 2016|Actual|2016-08-12||Interventional|||A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects|Relative Bioavailability Study of BMS-626529 Administered as Prodrug BMS-663068 From 150-mg Low-dose Extended-release Tablets Compared to 600-mg Reference Extended-release Tablet in Healthy Subjects|Completed||Phase 1|14|Actual|ViiV Healthcare||2|||f||||f|t|f||||||No||2017-10-10 21:55:41.049606|2017-10-10 21:55:41.049606
NCT02859233|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-02-01|||November 8, 2016|Actual|2016-11-08|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|PROPHYDRA||Role of Prophylaxis by Oral Fluid Supplementation in Prevention of Postdural Puncture Headache|Role of Prophylaxis by Oral Fluid Supplementation in Prevention of Postdural Puncture Headache: A Non-inferiority Randomized Controlled Trial|Recruiting||N/A|554|Anticipated|Nantes University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:55:41.329127|2017-10-10 21:55:41.329127
NCT02859220|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-08-03|||January 2006||2006-01-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|PTH||Study of the Influence of Dosages of 1-84 and 7-84 Fragments of Parathyroid Hormone Compared to Conventional Dosage on the Balance of Calcium and Phosphate in Hemodialysis (PTH)|Study of the Influence of Dosages of 1-84 and 7-84 Fragments of PTH Compared to Conventional Dosage on the Balance of Calcium and Phosphate in Hemodialysis|Completed||N/A|85|Actual|Nantes University Hospital||2|||f||||||||||||||2017-10-10 21:55:41.450652|2017-10-10 21:55:41.450652
NCT02859207|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-06-07|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|January 25, 2017|Actual|2017-01-25|December 6, 2016|Actual|2016-12-06||Interventional|||A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects|An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects|Completed||Phase 1|32|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-10 21:55:41.52657|2017-10-10 21:55:41.52657
NCT02859194|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-03|||March 2016||2016-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients||Recruiting||N/A|10|Anticipated|Yonsei University||1|||f||||f||||||||No||2017-10-10 21:55:41.624524|2017-10-10 21:55:41.624524
NCT02859181|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-05-01|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Protein Requirements for Active Adolescent Males (IAAO-AM)|Evaluation of Protein Requirements in Active Adolescent Males|Recruiting||N/A|7|Anticipated|University of Toronto||1|||f||||f|f|f||||||No||2017-10-10 21:55:41.712946|2017-10-10 21:55:41.712946
NCT02859168|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||June 2014||2014-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Myofascial Induction in Breast Cancer Survivors|Randomized, Single-blind, Placebo-controlled Cross-over Design of Myofascial Induction and Placebo Electrotherapy in Breast Cancer Survivors|Recruiting||Phase 1|21|Anticipated|Universidad de Granada||2|||f||||||||||||||2017-10-10 21:55:41.787425|2017-10-10 21:55:41.787425
NCT02859155|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-05|||January 2009||2009-01-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|February 2014|Actual|2014-02-01||Interventional|||Prognostic Factors Affecting Outcomes in Multivisceral en Bloc Resection for Colorectal Cancer|Prognostic Factors Affecting Outcomes in Multivisceral en Bloc Resection for Colorectal Cancer|Completed||N/A|105|Actual|University of Sao Paulo||1|||f||||f||||||||Yes||2017-10-10 21:55:41.872775|2017-10-10 21:55:41.872775
NCT02859142|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||October 2016||2016-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation|Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation|Not yet recruiting||Phase 4|180|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-10 21:55:41.946794|2017-10-10 21:55:41.946794
NCT02859129|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-16|||September 2013||2013-09-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ECLIPSEIII||Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)|An Open-Label, 2-Cohort Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®), to Assess the Dose Proportionality of Epanova™, and to Compare the Systemic Exposure of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Following Multiple Doses of Epanova™ and Vascepa® in Healthy Normal Subjects|Completed||Phase 1|114|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-10 21:55:42.05859|2017-10-10 21:55:42.05859
NCT02859116|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-01-12|||April 2016||2016-04-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Observational|ISTAR-T||Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors|Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors|Recruiting||N/A|104|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida|||1||f||||f||||||Samples With DNA|"     Collection of tissues from the digestive system of patients undergoing surgery for clinical     purposes. Tissue samples will be used to assess a mechanism of action (MOA) for the     regulation of gut hormone secretion and nutrient absorption. Patients will be also asked to     provide clinical/medical data and blood samples prior to their surgery.   "|No||2017-10-10 21:55:42.168314|2017-10-10 21:55:42.168314
NCT02859103|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-10-05|||June 1, 2017|Actual|2017-06-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment|A Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Before and After Treatment With Desvenlafaxine|Recruiting||Phase 4|60|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f|||f|||||2017-10-10 21:55:42.273971|2017-10-10 21:55:42.273971
NCT02859090|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-08-04|||August 2014||2014-08-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Interventional|HOTLYMPHO||Study of the Expression of Heat Shock Proteins in Populations of B Lymphocytes in Human Tonsils|Single-centre Study of the Expression of Heat Shock Proteins in the Lymphocytes From the Tonsils of Patients With Various Diseases Requiring Tonsillectomy|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 21:55:42.370172|2017-10-10 21:55:42.370172
NCT02859077|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-06|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism|EGFR-TKI With Chemotherapy as First Line Treatment in Stage IIIB/IV NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism|Not yet recruiting||Phase 3|100|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||1|||f||||t||||||||Yes|We will share the analysis data.|2017-10-10 21:55:42.455381|2017-10-10 21:55:42.455381
NCT02859064|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-07-10|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|April 30, 2019|Anticipated|2019-04-30||Interventional|||Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres|A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)|Recruiting||Phase 2|25|Anticipated|SCRI Development Innovations, LLC||1|||f||||f|t|t|f||f|||||2017-10-10 21:55:42.559633|2017-10-10 21:55:42.559633
NCT02859051|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-05|||July 2016||2016-07-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|November 2016|Anticipated|2016-11-01||Interventional|||MEDi Robot for Pain Management at Induction|Efficacy of a Preparation Intervention for the Management of Children's Pain and Fear During Induction: Help From a Robot Named MEDi|Recruiting||N/A|120|Anticipated|University of Calgary||2|||f||||f||||||||No||2017-10-10 21:55:42.674662|2017-10-10 21:55:42.674662
NCT02859038|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-23|2016-08-03|||December 2015||2015-12-01|August 2016|2016-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|SUNNY||Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)|Study of Upfront Surgery Versus Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery for Patients With Stage IIIC and IV Ovarian Cancer|Recruiting||Phase 3|456|Anticipated|Shanghai Gynecologic Oncology Group||2|||f||||t||||||||Undecided||2017-10-10 21:55:42.75818|2017-10-10 21:55:42.75818
NCT02859025|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-08-03|||January 2015||2015-01-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Concomitant Use of Buccal Fat Pad Derived Cells and Autogenous Bone in Alveolar Cleft Osteoplasty|Lateral Ramus Cortical Bone Plate in Alveolar Cleft Osteoplasty: Concomitant Use of Buccal Fat Pad Derived Cells and Autogenous Bone in a Preliminary Study|Completed||Phase 1|10|Actual|Shahid Beheshti University of Medical Sciences||3|||f||||f||||||||||2017-10-10 21:55:42.884451|2017-10-10 21:55:42.884451
NCT02859012|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-10|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|September 2017|Anticipated|2017-09-01||Interventional|AxitinibACC||Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma|Randomized Phase II Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma|Recruiting||Phase 2|60|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 21:55:42.957834|2017-10-10 21:55:42.957834
NCT02858999|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2016-11-30|||January 2010||2010-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|LPP||Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70|Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70: Phase II Multicentre Study|Completed||Phase 2|40|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-10 21:55:43.044442|2017-10-10 21:55:43.044442
NCT02858986|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-09-26|||September 19, 2016|Actual|2016-09-19|September 2017|2017-09-01|October 3, 2017|Anticipated|2017-10-03|August 29, 2017|Actual|2017-08-29||Interventional|||3D Versus 4K Laparoscopic Cholecystectomy|A Randomised Controlled Trial to Determine Whether a 3D Laparoscopic System Improves Surgeons' Performance During Laparoscopic Cholecystectomy When Compared to an Ultra-high Definition ('4K') Laparoscopic System|Active, not recruiting||N/A|120|Actual|Royal Surrey County Hospital||2|||f||||f||||||||||2017-10-10 21:55:43.136828|2017-10-10 21:55:43.136828
NCT02858960|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-04|||April 2016|Actual|2016-04-01|August 2016|2016-08-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||High Flow Nasal Cannula and Exercise in Chronic Obstructive Pulmonary Disease (COPD)|Comparing Exercise Capacity in Patients With COPD Using High Flow Nasal Cannula Oxygen vs The Venturi Mask|Completed||N/A|28|Actual|Hospital Italiano de Buenos Aires||2|||f||||t||||||||Yes||2017-10-10 21:55:43.277747|2017-10-10 21:55:43.277747
NCT02858947|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-03|||March 2011||2011-03-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Three-Year Clinical Evaluation of Class II Posterior Composite Restorations|Three-Year Clinical Evaluation of Class II Posterior Composite Restorations Placed With Different Techniques and Flowable Composite Linings in Endodontically Treated Teeth|Completed||N/A|37|Actual|Ondokuz Mayıs University||2|||f||||t||||||||No||2017-10-10 21:55:43.364671|2017-10-10 21:55:43.364671
NCT02858934|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-04-11|||March 8, 2017|Actual|2017-03-08|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Feasibility Study of Accelerated Preoperative Radiotherapy for Early Breast Cancer|Feasibility Study of Accelerated Preoperative Radiotherapy for Early Breast Cancer|Recruiting||N/A|24|Anticipated|Brugmann University Hospital||1|||f||||f|f|f||||||||2017-10-10 21:55:43.432971|2017-10-10 21:55:43.432971
NCT02858921|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|NeoTrio||Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma|A Phase II, Randomised, Open Label Study of Neoadjuvant Dabrafenib, Trametinib and / or Pembrolizumab in BRAF V600 Mutant Resectable Stage IIIB/C Melanoma|Not yet recruiting||Phase 2|60|Anticipated|Melanoma Institute Australia||3|||f||||t|f|f|||f|||||2017-10-10 21:55:43.534594|2017-10-10 21:55:43.534594
NCT02858908|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-03-15||||||March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy|A Single-Blind, Phase 2 Study To Evaluate The Safety And Efficacy Of Tideglusib 400mg Or 1000mg For The Treatment Of Adolescent And Adult Congenital And Juvenile-Onset Myotonic Dystrophy|Recruiting||Phase 2|||AMO Pharma Limited|||||f||||||||||||||2017-10-10 21:55:43.815886|2017-10-10 21:55:43.815886
NCT02858895|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-08|||October 2016|Actual|2016-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma|An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma|Recruiting||Phase 2|43|Anticipated|Medicenna Therapeutics, Inc.||1|||f||||t|t|||||||||2017-10-10 21:55:43.90317|2017-10-10 21:55:43.90317
NCT02858869|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-02-02|||October 2016||2016-10-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases|Pilot Study of Pembrolizumab and Stereotactic Radio-Surgery (SRS) for Patients With Melanoma or Non-Small Cell Lung Cancer (NSCLC) Brain Metastases (BM)|Recruiting||Phase 1|43|Anticipated|Emory University||3|||f||||t|t|f||||||||2017-10-10 21:55:44.174869|2017-10-10 21:55:44.174869
NCT02858856|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2017-09-14|||March 20, 2017|Actual|2017-03-20|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients|Sipjeondaebo-tang for Alleviating Fatigue Measured by Brief Fatigue Inventory and EORTC-QLQ-C30, BR23 Score Change Among Patients With Breast Carcinoma Receiving Chemotherapy|Recruiting||N/A|48|Anticipated|Kyunghee University Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:55:44.316055|2017-10-10 21:55:44.316055
NCT02858843|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia|A Study of the Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia in Persons With Cystic Fibrosis|Not yet recruiting||N/A|50|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:55:44.428716|2017-10-10 21:55:44.428716
NCT02858830|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-05-03|||August 2016||2016-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|FPL||Familial Partial Lipodystrophy Study|Genetic and Metabolic Basis of Familial Partial Lipodystrophy|Recruiting||N/A|12|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 21:55:44.521653|2017-10-10 21:55:44.521653
NCT02858817|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-03-29|||November 28, 2016|Actual|2016-11-28|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis|Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Atovaquone/Proguanil Chemoprophylaxis|Active, not recruiting||Phase 1|30|Actual|University Hospital Tuebingen||3|||f||||f||||||||Undecided||2017-10-10 21:55:44.629472|2017-10-10 21:55:44.629472
NCT02858804|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-08-03|||January 2016||2016-01-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|BDH-MCL01||EDOCH Alternating With DHAP for New Diagnosed Younger MCL|EDOCH Alternating With DHAP Regimen Combined Rituximab or Not to Treat New Diagnosed Younger (Age≤65 Years) Mantle Cell Lymphoma in China: A Multicentre Phase III Trial|Recruiting||Phase 4|55|Anticipated|Institute of Hematology & Blood Diseases Hospital||10|||f||||f||||||||Undecided||2017-10-10 21:55:44.73035|2017-10-10 21:55:44.73035
NCT02858791|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-05-12|||February 2013||2013-02-01|May 2017|2017-05-01|December 21, 2017|Anticipated|2017-12-21|December 21, 2017|Anticipated|2017-12-21||Observational|||MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension|MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension|Recruiting||N/A|100|Anticipated|Northwell Health|||2||f||||t||||||Samples Without DNA|"     Venous blood samples will be collected for analysis before and after completing     cardiopulmonary exercise test   "|||2017-10-10 21:55:44.893066|2017-10-10 21:55:44.893066
NCT02858778|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-03|||June 2016||2016-06-01|August 2016|2016-08-01||||January 2017|Anticipated|2017-01-01||Interventional|||Timing of Acute Palliative Care Consultation in Critically Ill Patients|A Randomized Allocation of Palliative Care Consultation in the Emergency Department Compared to Usual Practice|Active, not recruiting||N/A|120|Anticipated|Wayne State University||2|||f||||||||||||||2017-10-10 21:55:44.994561|2017-10-10 21:55:44.994561
NCT02858765|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-09-07|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|CHRONOSOMNO||Influence of Light on Sleep, Awakening, Electroencephalogram (EEG) and Cognitive Performances|Influence of Light on Sleep, Awakening, Electroencephalogram (EEG) and Cognitive Performances, and Medical Technology Assessment for Registration and Long-term EEG Analysis|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||4|||f||||f||||||||||2017-10-10 21:55:45.118398|2017-10-10 21:55:45.118398
NCT02858752|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-08|||October 6, 2016|Actual|2016-10-06|August 2017|2017-08-01|October 6, 2020|Anticipated|2020-10-06|October 6, 2020|Anticipated|2020-10-06||Interventional|MASK||Memory and Attention in Healthy Children|Memory, Auditory and Visual Attention in Healthy Children: Neurophysiological and Electrophysiological Aspects|Recruiting||N/A|400|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 21:55:45.238301|2017-10-10 21:55:45.238301
NCT02858739|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01|12 Months|Observational [Patient Registry]|||Biofreedom Stent in All Comer Population|Polymer Free Biolimus Eluting Stent Implantation In All Comers Population: Analysis Of Dapt Cessation And Clinical Outcome After Biofreedom Stent Implantation|Completed||N/A|1000|Actual|University of Roma La Sapienza|||1||f||||f||||||||No||2017-10-10 21:55:45.359494|2017-10-10 21:55:45.359494
NCT02858726|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-12-16|||June 2016||2016-06-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus|A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus|Recruiting||Phase 2/Phase 3|400|Anticipated|Cara Therapeutics, Inc.||4|||f||||t||||||||Undecided||2017-10-10 21:55:45.445093|2017-10-10 21:55:45.445093
NCT02858713|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-05|||January 9, 2017|Actual|2017-01-09|September 2017|2017-09-01|August 29, 2017|Actual|2017-08-29|April 29, 2017|Actual|2017-04-29||Interventional|||Adherence in Topical Treatment of Psoriasis|A Designed Patient-Centered Intervention to Improve Medical Adherence in Topical Treatment of Psoriasis|Completed||Phase 4|134|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-10 21:55:45.625335|2017-10-10 21:55:45.625335
NCT02858700|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-05|||April 2009||2009-04-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PCT_CORDON||Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection|Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection|Completed||N/A|550|Actual|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:55:45.705999|2017-10-10 21:55:45.705999
NCT02858687|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||February 2013||2013-02-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Improving the Diagnosis of Tonsillitis in Emergency Rooms||Recruiting||N/A|4320|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:55:45.772471|2017-10-10 21:55:45.772471
NCT02858648|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-05|||January 2013||2013-01-01|August 2016|2016-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Diabetes Go Mobile! Pilot Study|Diabetes Go Mobile! - A Pilot Study Testing the Effect of a Behavioral Intervention With Smart Phone Based Self-Monitoring on Glycemic Control and Vascular Inflammatory Markers|Completed||N/A|26|Actual|The University of Texas Health Science Center, Houston||3|||f||||f||||||||Undecided||2017-10-10 21:55:45.981441|2017-10-10 21:55:45.981441
NCT02858635|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-03|||September 2001||2001-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Molecular Genetics of Suicidal Behavior|Molecular Genetics of Suicidal Behavior: Study of Association Between Aggressive Impulsiveness and Genes of the Serotoninergic System|Active, not recruiting||N/A|1982|Actual|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:55:46.061698|2017-10-10 21:55:46.061698
NCT02858622|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Dual Transversus Abdominis Plane Block in Pediatric Renal Transplant: Effect on Pain Control|Unilateral Dual Transversus Abdominis Plane Block in Pediatric Renal Transplant: A Randomized Control Study|Recruiting||N/A|44|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-10 21:55:46.131971|2017-10-10 21:55:46.131971
NCT02858609|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||March 2013||2013-03-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Improving the Diagnosis of Diarrhoea in Emergency Rooms||Recruiting||N/A|4320|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:55:46.209715|2017-10-10 21:55:46.209715
NCT02858596|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-05|||January 2014||2014-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Semi-solid Feeding After Percutaneous Endoscopic Gastrostomy (PEG) on the Incidence of Aspiration Pneumonia and Postoperative Length of Stay|The Effect of Semi-solid Feeding After Percutaneous Endoscopic Gastrostomy (PEG) on Clinical Outcomes, Specifically the Incidence of Aspiration Pneumonia and Postoperative Length of Stay|Completed||N/A|136|Actual|Hiroshima Kyoritsu Hospital||2|||f||||t||||||||No||2017-10-10 21:55:46.272656|2017-10-10 21:55:46.272656
NCT02858583|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2017-08-07|||September 1, 2017|Anticipated|2017-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|SURV1VE||SI + CC Versus 3:1 C:V Ratio During Neonatal CPR|SURV1VE-Trial - Sustained Inflation and Chest Compression Versus 3:1 Chest Compression to Ventilation Ratio During Cardiopulmonary Resuscitation of Asphyxiated Newborns: A Randomized Controlled Trial|Not yet recruiting||N/A|118|Anticipated|University of Alberta||2|||f||||t|f|f||||||||2017-10-10 21:55:46.329707|2017-10-10 21:55:46.329707
NCT02858570|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-03|||November 2016||2016-11-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Conjugate Vaccine Against Meningococcus C a Brazilian Project|Immunogenicity, Reactogenicity and Safety Assessment of the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos / FIOCRUZ in Infants, Children and Adolescents|Not yet recruiting||Phase 2/Phase 3|1644|Anticipated|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||2|||f||||t||||||||No||2017-10-10 21:55:46.404273|2017-10-10 21:55:46.404273
NCT02858557|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-05|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases|The Effect of the Mediterranean Diet and the Specific Carbohydrate Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases|Not yet recruiting||N/A|70|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 21:55:46.469312|2017-10-10 21:55:46.469312
NCT02858544|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-03|||November 2013||2013-11-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|CIDI||Concussion in Motor Vehicle Accidents: The Concussion Identification Index|Concussion in Motor Vehicle Accidents: The Concussion Identification Index|Completed||N/A|1790|Actual|Clionsky Neuro Systems Inc.|||2||f||||f||||||||No||2017-10-10 21:55:46.542562|2017-10-10 21:55:46.542562
NCT02858531|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-06-26|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|PREDAFLU||Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics|Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics|Recruiting||N/A|760000|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 21:55:46.61686|2017-10-10 21:55:46.61686
NCT02858518|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-01-20|||March 2015||2015-03-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PREDIC-AGE||Risk of Bleeding and Anticoagulation in Atrial Fibrillation: What Predictive Criterion Used?|Risk of Bleeding and Anticoagulation in Atrial Fibrillation: What Predictive Criterion Used?|Completed||N/A|120|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     classical blood sample : NFS, ionograms, CRP, TSH, albumin, vitamin D, Calcium and     coagulation factors + tube for genetic study   "|No||2017-10-10 21:55:46.728874|2017-10-10 21:55:46.728874
NCT02858505|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-03|||August 2015||2015-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Impact of One Versus Two Amino Acid Chelated Iron Capsules on Prevention of Iron Deficiency Anemia in Non-anemic Women With Twin Gestations||Completed||Phase 2|120|Actual|Assiut University||2|||f||||f||||||||Yes||2017-10-10 21:55:46.798819|2017-10-10 21:55:46.798819
NCT02858479|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-01-19|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ALLO||Structural and Functional Brain Reorganization in Neuropathic Pain. Influences of the Loss of Sensitivity and the Atrophy Cortical on Activations Due to Stimulation Allodynic|Structural and Functional Brain Reorganization in Neuropathic Pain. Influences of the Loss of Sensitivity and the Atrophy Cortical on Activations Due to Stimulation Allodynic|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 21:55:47.201772|2017-10-10 21:55:47.201772
NCT02858466|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-01-19|||February 2014||2014-02-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CONNECT||Structural and Functional Brain Reorganization in Neuropathic Pain: Basal State of Local Cerebral Blood Flow and Functional Connectivity|Structural and Functional Brain Reorganization in Neuropathic Pain: Basal State of Local Cerebral Blood Flow and Functional Connectivity|Recruiting||N/A|75|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||No||2017-10-10 21:55:47.316829|2017-10-10 21:55:47.316829
NCT02858453|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-29|||July 2016||2016-07-01|September 2017|2017-09-01||||December 2017|Anticipated|2017-12-01||Interventional|LEADERSHIP 301||Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome|The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period|Recruiting||Phase 3|600|Anticipated|Aquinox Pharmaceuticals (Canada) Inc.||3|||f||||f||||||||||2017-10-10 21:55:47.432309|2017-10-10 21:55:47.432309
NCT02858440|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-24|||September 13, 2016|Actual|2016-09-13|July 2017|2017-07-01|November 25, 2018|Anticipated|2018-11-25|November 3, 2017|Anticipated|2017-11-03||Interventional|||A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia|Immunogenicity and Safety of GSK Biologicals' Combined Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus and Haemophilus Influenzae Type b (DTPa-IPV/Hib) Conjugate Vaccine|Active, not recruiting||Phase 3|235|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 21:55:47.778193|2017-10-10 21:55:47.778193
NCT02858414|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-02-14|||February 2015||2015-02-01|July 2016|2016-07-01||||December 2017|Anticipated|2017-12-01||Interventional|EURECA||Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients|Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients: EURECA (ERANET to Unravel New Roads to Eradication and a Cure for AIDS) Study|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:55:47.988377|2017-10-10 21:55:47.988377
NCT02858401|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-06-28|||January 29, 2015|Actual|2015-01-29|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults|A Phase 1b, Randomized, Blinded, Placebo-Controlled Dose-Escalation Study of the Safety and Biological Activity of GS-9620 in HIV-1 Infected, Virologically Suppressed Adults|Active, not recruiting||Phase 1|32|Actual|Gilead Sciences||5|||f||||t|t|f||||||||2017-10-10 21:55:48.078734|2017-10-10 21:55:48.078734
NCT02858375|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||March 2013||2013-03-01|August 2016|2016-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|QUALVESTO||Long-Term Assessment of Quality of Life and Effectiveness of Onabotulinumtoxina Injections in Provoked Vestibulodynia||Completed||N/A|21|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 21:55:48.275322|2017-10-10 21:55:48.275322
NCT02858362|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-06-13|||June 2016||2016-06-01|June 2017|2017-06-01||||June 2018|Anticipated|2018-06-01||Interventional|PhaseOut DMD||PoC Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With DMD|A Phase 2 Clinical Study to Assess the Activity and Safety of Utrophin Modulation With SMT C1100 in Ambulatory Paediatric Male Subjects With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 2|40|Actual|Summit Therapeutics||1|||f||||t||||||||||2017-10-10 21:55:48.339744|2017-10-10 21:55:48.339744
NCT02858349|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-11|||July 2016||2016-07-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Mechanisms of Walking Recovery After Stroke|Mechanisms of Walking Recovery After Stroke|Recruiting||N/A|10|Anticipated|University of Cincinnati||1|||f||||f||||||||||2017-10-10 21:55:48.456069|2017-10-10 21:55:48.456069
NCT02858336|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-05|2017-06-30|||July 29, 2016||2016-07-29|June 20, 2017|2017-06-20|July 1, 2021|Anticipated|2021-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study)|CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study)|Recruiting||Early Phase 1|50|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 21:55:48.546841|2017-10-10 21:55:48.546841
NCT02858323|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-06-30|||July 27, 2016||2016-07-27|June 20, 2017|2017-06-20|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Observational|||Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion|Complement (C1q) Binding to HLA Antibodies in a Solid-Phase Immunoassay and Clinical Effect on Platelet Transfusion|Completed||N/A|68|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:55:48.656272|2017-10-10 21:55:48.656272
NCT02858310|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-04|2017-10-03|||July 21, 2016||2016-07-21|September 25, 2017|2017-09-25|January 1, 2026|Anticipated|2026-01-01|December 31, 2020|Anticipated|2020-12-31||Interventional|||E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers|A Phase I Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 With or Without PD-1 Blockade for HPV-Associated Cancers|Recruiting||Phase 1|180|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:55:48.731185|2017-10-10 21:55:48.731185
NCT02858297|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-03|||May 2015||2015-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus|Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus: A Pilot, Randomized, Clinical and Immunohistochemical Trial|Completed||Phase 4|30|Actual|Ain Shams University||3|||f||||t||||||||Undecided||2017-10-10 21:55:48.834989|2017-10-10 21:55:48.834989
NCT02858284|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-02-06|||July 2016||2016-07-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension|A Multi-Center, Randomized, Double-Masked, 8-week Pilot Study Evaluating the Safety and Efficacy of the TUG (Therapeutic Ultrasound for Glaucoma) Compared to Sham in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension|Recruiting||N/A|25|Anticipated|EyeSonix||2|||f||||||||||||||2017-10-10 21:55:48.916902|2017-10-10 21:55:48.916902
NCT02858271|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-03|||July 2016||2016-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778|An Open-Label, Single-Dose, Phase 1 Study to Assess the Absorption, Metabolism, Excretion, and Pharmacokinetics of [14C]-AKB-9778 in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Aerpio Therapeutics||1|||f||||f||||||||Undecided||2017-10-10 21:55:48.995073|2017-10-10 21:55:48.995073
NCT02858258|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-03-06|||July 2016||2016-07-01|March 2017|2017-03-01|May 2026|Anticipated|2026-05-01|May 2021|Anticipated|2021-05-01||Interventional|||ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma|Autologous Transplantation After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma - a Randomized European Mcl Network Trial|Recruiting||Phase 3|870|Anticipated|European Mantle Cell Lymphoma Network||3|||f||||t||||||||No||2017-10-10 21:55:49.069405|2017-10-10 21:55:49.069405
NCT02858245|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-18|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|VELOCITY||A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device|A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device|Recruiting||N/A|36|Anticipated|Abbott Vascular|||1||f||||f||||||||No||2017-10-10 21:55:49.40328|2017-10-10 21:55:49.40328
NCT02858232|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-09|||August 2016||2016-08-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||MASCT-I Treatment for Advanced Solid Tumor|A Single Arm, Open, Phase I/II Clinical Study of MASCT-I Treatment for Advanced Solid Tumor|Not yet recruiting||Phase 1/Phase 2|46|Anticipated|The First People's Hospital of Lianyungang||1|||f||||||||||||||2017-10-10 21:55:49.516901|2017-10-10 21:55:49.516901
NCT02858206|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-08-05|||June 2016||2016-06-01|August 2016|2016-08-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma|Prospective, Non-randomised Phase Ⅱ Study of Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Locally Advanced Esophageal Carcinoma|Recruiting||Phase 2|120|Anticipated|Chinese Academy of Medical Sciences||4|||f||||t||||||||No||2017-10-10 21:55:49.668478|2017-10-10 21:55:49.668478
NCT02858193|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||July 2016||2016-07-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup|Two-way Crossover, Randomised, Single Dose and Two-stage Bioequivalence Phase I Study of Carbocysteine-L-lysine Salt 1.35 g Powder for Oral Solution Formulation Versus Carbocysteine-L-lysine Salt 90 mg/mL Syrup Formulation After Oral Administration to Healthy Volunteers of Both Sexes|Active, not recruiting||Phase 1|30|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||f||||||||No||2017-10-10 21:55:49.777947|2017-10-10 21:55:49.777947
NCT02858180|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-08-04|||December 2016||2016-12-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Hepatitis C Virus(HCV) Heart and Lung Study|A Multicenter, Open-label Study of Harvoni ® (Sofosbuvir Ledipasvir Fixed Dose Combination) in Subjects Infected With Chronic Hepatitis C and Advanced Heart Failure or Lung Disease|Recruiting||Phase 4|50|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 21:55:49.85535|2017-10-10 21:55:49.85535
NCT02858167|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-09-13|||February 2009||2009-02-01|September 2016|2016-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|BDD TEP FDG||Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations|Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations: Study of Principal Inter-individual Variation Factors|Completed||N/A|100|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||No||2017-10-10 21:55:49.959573|2017-10-10 21:55:49.959573
NCT02858154|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-03|||February 2016||2016-02-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants|Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen (O2) as a Treatment for Obstructive Sleep Apnea (OSA) in Infants|Recruiting||N/A|10|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||No||2017-10-10 21:55:50.026985|2017-10-10 21:55:50.026985
NCT02858141|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-03|||May 2015||2015-05-01|August 2016|2016-08-01||||May 2020|Anticipated|2020-05-01|5 Years|Observational [Patient Registry]|||Onco-geriatric Database of Patients With Pancreatic Cancer||Recruiting||N/A|300|Anticipated|Institut Paoli-Calmettes|||1||f||||f||||||||||2017-10-10 21:55:50.113273|2017-10-10 21:55:50.113273
NCT02858128|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-06|||October 2014||2014-10-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate Cancer|WHOLE-BODY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (WB-DW-MRI) VS CHOLINE-POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY (CHOLINE- PET/CT) for Selecting Treatments in Recurrent Prostate Cancer|Completed||N/A|46|Actual|Hospital Provincial de Castellon|||1||f||||f||||||||No||2017-10-10 21:55:50.186048|2017-10-10 21:55:50.186048
NCT02858115|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-05|||January 2014||2014-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Observational|||Use of Mini-fluid Challenge for Fluid Responsiveness Prediction During One-lung Ventilation||Completed||N/A|50|Actual|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 21:55:50.245964|2017-10-10 21:55:50.245964
NCT02858102|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-13|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|EXERTMG||Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental Disorders|Impact From Aerobic Exercise (a Program of Physical Activity) in the Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Severe Mental Disorders Including Depression, Bipolar Disorder and Psychosis: a Longitudinal Study|Recruiting||N/A|50|Anticipated|Fundación Marques de Valdecilla||2|||f||||f|f|f||||||No||2017-10-10 21:55:50.314014|2017-10-10 21:55:50.314014
NCT02858089|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-02|||August 23, 2016||2016-08-23||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:55:50.400174|2017-10-10 21:55:50.400174
NCT02858076|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-29|||November 2016||2016-11-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|October 2018|Anticipated|2018-10-01||Interventional|AB||Anti-VEGF vs. Prompt Vitrectomy for VH From PDR|Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy|Recruiting||Phase 2/Phase 3|200|Anticipated|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-10 21:55:50.443808|2017-10-10 21:55:50.443808
NCT02858063|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-03|||January 2010||2010-01-01|August 2016|2016-08-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Observational|KALICOU2||Psychometric Validation (Quality-of-life Scale) in Young Women With a Non Metastatic Breast Cancer and Her Partner|Psychometric Validation of a Subjective Quality-of-life Scale in Young Women With a Non Metastatic Breast Cancer and Her Partner (KALICOU 2 Protocol)|Completed||N/A|1045|Actual|Centre Oscar Lambret|||4||f||||f||||||||No||2017-10-10 21:55:50.894637|2017-10-10 21:55:50.894637
NCT02858050|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-05|||August 2016||2016-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Portal-724 MEMS for Medication Adherence Patients Taking HCV Medications||Not yet recruiting||N/A|40|Anticipated|Saint Michael's Medical Center|||2||f||||f||||||||||2017-10-10 21:55:50.976067|2017-10-10 21:55:50.976067
NCT02858037|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-29|||August 2016||2016-08-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women|A Phase 3B Open-Label Follow-on Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women|Recruiting||Phase 3|2500|Anticipated|International Partnership for Microbicides, Inc.||1|||f||||t|t|f||||||||2017-10-10 21:55:51.04573|2017-10-10 21:55:51.04573
NCT02858024|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-05|||January 12, 2015|Actual|2015-01-12|September 2017|2017-09-01|April 16, 2016|Actual|2016-04-16|April 16, 2016|Actual|2016-04-16||Interventional|||A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine|A Two-Cohort, Open-Label, Randomised, Three-Period Crossover Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine|Completed||Phase 1|16|Actual|International Partnership for Microbicides, Inc.||2|||f||||||||||||||2017-10-10 21:55:51.135553|2017-10-10 21:55:51.135553
NCT02858011|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-09|||September 2014||2014-09-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|Jigisemejiri||The Effect of a Cash Transfer Program on Household Welfare and Child Nutritional Status in Mali|The Effect of a Cash Transfer Program on Household Welfare and Child Nutritional Status in Mali|Recruiting||Phase 4|4320|Anticipated|International Food Policy Research Institute||3|||f||||f||||||||No||2017-10-10 21:55:51.24993|2017-10-10 21:55:51.24993
NCT02857998|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-02-20|||November 2016||2016-11-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A Study of HMPL-523 in Patients With Relapsed or Refractory Mature B-cell Neoplasms|A Phase I, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of HMPL-523 in Patients With Relapsed or Refractory Mature B-cell Neoplasms|Recruiting||Phase 1|92|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||No||2017-10-10 21:55:51.394205|2017-10-10 21:55:51.394205
NCT02857985|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-08-08|||February 2013||2013-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|EVATIAR||Evaluation of Infarct Size With 3D Rotational Angiography|Evaluation of Infarct Size With 3D Rotational Angiography|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 21:55:51.494714|2017-10-10 21:55:51.494714
NCT02857972|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-02-01|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Proof Of Concept Menstrual Hygiene Product-Wondaleaf®|Proof of Concept Study of Wondaleaf® As an Alternative to Menstrual Hygiene Product for Night Use Among Menstruating Women|Completed||N/A|36|Actual|Clinical Research Centre, Malaysia||1|||f||||f||||||||||2017-10-10 21:55:51.595977|2017-10-10 21:55:51.595977
NCT02857959|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-09-18|||August 2016||2016-08-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|June 2020|Anticipated|2020-06-01||Interventional|||One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis|Doctor of Medicine|Recruiting||Phase 4|150|Anticipated|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 21:55:51.699844|2017-10-10 21:55:51.699844
NCT02857946|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-04|||February 2016||2016-02-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)|Open Label, Randomized, Single Dose, Two-way Crossover Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets (Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||No||2017-10-10 21:55:51.795501|2017-10-10 21:55:51.795501
NCT02857933|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-08-02|||April 2016||2016-04-01|August 2016|2016-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|DRIVE||Daily and Weekly Rehabilitation Delivery for Young Children With Cerebral Palsy|Daily and Weekly Rehabilitation Delivery for Young Children With Cerebral Palsy|Recruiting||N/A|75|Anticipated|Ohio State University||3|||f||||t||||||||||2017-10-10 21:55:51.890036|2017-10-10 21:55:51.890036
NCT02857920|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-04|||August 2016||2016-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Combination of Bevacizumab and NK Immunotherapy for Recurrent Solid Tumors||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:55:51.990389|2017-10-10 21:55:51.990389
NCT02857907|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-03|||April 2010||2010-04-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|SIGAL||Anti-thymocyte Globulin-induced Immune Senescence|Anti-thymocyte Globulin-induced Immune Senescence|Completed||N/A|97|Actual|Centre Hospitalier Universitaire de Besancon|||2||f||||f||||||Samples Without DNA|"     Peripheral Blood Mononuclear Cells   "|No||2017-10-10 21:55:52.090498|2017-10-10 21:55:52.090498
NCT02857894|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-02-06|||November 5, 2015|Actual|2015-11-05|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|ATM||Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)|Identification of the Predisposing Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)|Recruiting||N/A|40|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:55:52.167578|2017-10-10 21:55:52.167578
NCT02857881|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-02-06|||October 13, 2015|Actual|2015-10-13|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|KERADES||Corneal De-epithelization Associated With a Therapeutic Photokeratectomy in Patients With Evolutive Keratoconus|Effect of Simple Corneal De-epithelization Associated With a Therapeutic Photokeratectomy in Patients With Evolutive Keratoconus|Recruiting||N/A|140|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 21:55:52.233639|2017-10-10 21:55:52.233639
NCT02857868|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-07-18|||May 3, 2016|Actual|2016-05-03|July 2017|2017-07-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Interventional|||A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects|A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function|Completed||Phase 1|32|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-10 21:55:52.317267|2017-10-10 21:55:52.317267
NCT02857855|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-02|||July 2016||2016-07-01|July 2016|2016-07-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|PSOLT||Postoperative Supplemental Oxygen in Liver Transplantation|The Impact of Postoperative Oxygen Therapy on the Results of Liver Transplantation|Enrolling by invitation||N/A|296|Anticipated|Medical University of Warsaw||2|||f||||f||||||||Undecided||2017-10-10 21:55:52.404602|2017-10-10 21:55:52.404602
NCT02857842|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|Cortico-cop||Corticosteroid Reduction in COPD|The Effect of Reduced Corticosteroid Therapy in Patients With Acute Exacerbation of COPD|Recruiting||Phase 4|318|Anticipated|Chronic Obstructive Pulmonary Disease Trial Network, Denmark||2|||f||||t||||||||Yes||2017-10-10 21:55:52.493455|2017-10-10 21:55:52.493455
NCT02857829|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-08-25|||September 2016||2016-09-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||The Effects of SPRINT, a Combination of Natural Ingredients, on Cognition in Healthy Young Volunteers|The Effects of SPRINT, a Combination of Natural Ingredients, on Cognition in Healthy Young Volunteers|Not yet recruiting||N/A|21|Anticipated|Nootrobox, Inc.||3|||f||||f||||||||No||2017-10-10 21:55:52.600127|2017-10-10 21:55:52.600127
NCT02857803|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-05|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Randomised Controlled Trial Comparing the Impact of Virtual Reality, Paper and Pencil and Conventional Methods on Stroke Rehabilitation|The Impact of Using an Interactive System, a Paper and Pencil Program or Conventional Methodologies in the Rehabilitation of Stroke Patients: a Randomised Controlled Trial|Recruiting||N/A|60|Anticipated|Universidade da Madeira||3|||f||||f||||||||||2017-10-10 21:55:52.780748|2017-10-10 21:55:52.780748
NCT02857790|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-04|||March 2012||2012-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|GlaMoRouS||Glasgow MRI and Rotablation Study|MRI Before and After Coronary Angioplasty With Rotational Atherectomy|Completed||N/A|58|Actual|NHS National Waiting Times Centre Board|||1||f||||f||||||||No||2017-10-10 21:55:52.872932|2017-10-10 21:55:52.872932
NCT02857777|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-03-12|||August 9, 2016|Actual|2016-08-09|March 2017|2017-03-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|||Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects|An Open-Label, Single-Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Elderly (>=65 Years of Age) Japanese, and Healthy Younger Adult Japanese Subjects (20 to 55 Years of Age, Inclusive)|Completed||Phase 1|37|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 21:55:52.928484|2017-10-10 21:55:52.928484
NCT02857764|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-08-29|||February 15, 2016|Actual|2016-02-15|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States|SGLT2 Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States|Completed||N/A|127690|Actual|Janssen Research & Development, LLC|||5||f||||f||||||||||2017-10-10 21:55:52.985969|2017-10-10 21:55:52.985969
NCT02857751|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-27|||June 2016||2016-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Outcomes Following Surf Therapy|Evaluation of Health Outcomes Following the NMCSD Surf Therapy Program|Recruiting||N/A|30|Anticipated|United States Naval Medical Center, San Diego|||5||f||||f||||||||||2017-10-10 21:55:53.041827|2017-10-10 21:55:53.041827
NCT02857738|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-03|||May 2015||2015-05-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Sun Protection Factor (SPF) - Static and Water Resistant Assay|Sun Protection Factor (SPF) - Static and Water Resistant Assay|Completed||N/A|12|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:55:53.11929|2017-10-10 21:55:53.11929
NCT02857725|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||May 2015||2015-05-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Sun Protection Factor (SPF) Assay|Sun Protection Factor (SPF) Assay|Completed||N/A|12|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:55:53.175047|2017-10-10 21:55:53.175047
NCT02857712|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-08-02|||December 2014||2014-12-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|SGC-AX14||Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14|Phase II Study on Inlyta® (Axitinib) in Recurrent and/or Metastatic Salivary Gland Cancers (SGCs) of the Upper Aerodigestive Tract|Recruiting||Phase 2|26|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||No|Only study results will be shared through publication on scientific indexed journals|2017-10-10 21:55:53.268133|2017-10-10 21:55:53.268133
NCT02857699|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-02|||April 2014||2014-04-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|QoL Phase I||Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.|Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.|Recruiting||N/A|250|Anticipated|Institut Curie|||1||f||||f||||||||No||2017-10-10 21:55:53.34803|2017-10-10 21:55:53.34803
NCT02857686|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-05|||October 2016||2016-10-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Forearm Tourniquet With Small Dose Intravenous Lidocaine|Forearm Tourniquet With Small Dose Intravenous Lidocaine as a Substitute to Conventional Intravenous Regional Anaesthesia|Not yet recruiting||N/A|60|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 21:55:53.408686|2017-10-10 21:55:53.408686
NCT02857673|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-02-08|||February 8, 2016|Actual|2016-02-08|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Medical Home-Based Intervention to Prevent Child Neglect in High-Risk Families|A Medical Home-Based Intervention to Prevent Child Neglect in High-Risk Families|Recruiting||N/A|250|Anticipated|Boston Medical Center||2|||f||||f||||||||No||2017-10-10 21:55:53.476299|2017-10-10 21:55:53.476299
NCT02857660|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-01|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|FRANSO||Effect of Whole Body Electromyostimulation and/or Protein Supplementation on Sarcopenic Obesity in 70+|Effect of Whole-body Electromyostimulation (WB-EMS) and/or Protein Supplementation on Sarcopenic Obesity in Community Dwelling Males 70+ With Sarcopenic Obesity|Completed||Phase 3|100|Actual|University of Erlangen-Nürnberg Medical School||3|||f||||f||||||||No||2017-10-10 21:55:53.577189|2017-10-10 21:55:53.577189
NCT02857647|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-03|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of an Information Video on Anxiety and Bariatric Surgery Knowledge Among Bariatric Surgery Candidates|The Effects of an Information Video on Anxiety and Bariatric Surgery Knowledge Among Bariatric Surgery Candidates|Not yet recruiting||N/A|200|Anticipated|Assuta Medical Center||2|||f||||||||||||||2017-10-10 21:55:53.662727|2017-10-10 21:55:53.662727
NCT02857634|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||July 2016||2016-07-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|HEXVISIO||Confocal Microscopy Dual Band in the Management of Bladder Cancer|Study of the Contribution of Confocal Microscopy Dual Band in the Management of Bladder Cancer|Recruiting||N/A|20|Anticipated|Lille Catholic University|||1||f||||f||||||Samples Without DNA|"     Using PDD, urothelial lesions will be resected. The samples will be immediately investigated     effect under confocal microscopy (Cellvizio dual band) in order to keep the fluoresceine     effect. After confocal microscopy samples will be fixed in formalin and prepare for the     pathologist that will confirm the diagnosis.   "|No||2017-10-10 21:55:53.733722|2017-10-10 21:55:53.733722
NCT02857621|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-08-13|||August 2016||2016-08-01|June 2016|2016-06-01|April 23, 2017|Actual|2017-04-23|April 23, 2017|Actual|2017-04-23||Observational|||Evaluation of Pressure Applying Efficiency in Multi-Layer Bandaging|Evaluation of Pressure Applying Efficiency in Multi-Layer Bandaging Among Physiotherapists Who Treat Lymphedema|Completed||N/A|37|Actual|Assuta Hospital Systems|||1||f||||f||||||||||2017-10-10 21:55:54.441144|2017-10-10 21:55:54.441144
NCT02857608|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-03-13|||September 2016||2016-09-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus|A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus|Withdrawn||Phase 2|0|Actual|Cardinal Health 414, LLC||1|||f||||f||||||||No||2017-10-10 21:55:54.492588|2017-10-10 21:55:54.492588
NCT02857595|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Energy Balancing Modeling and Mobile Technology to Support e-Weight Loss||Recruiting||N/A|30|Anticipated|The Miriam Hospital||3|||f||||||||||||||2017-10-10 21:55:54.556819|2017-10-10 21:55:54.556819
NCT02857582|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-02|||October 2014||2014-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile|Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile|Recruiting||Phase 2|60|Anticipated|Uppsala University||3|||f||||f||||||||No||2017-10-10 21:55:56.771317|2017-10-10 21:55:56.771317
NCT02857569|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-02|||March 2016||2016-03-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|NIVIPIT||A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma|A Randomized Phase I/II Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma|Recruiting||Phase 1/Phase 2|65|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||No||2017-10-10 21:55:56.872829|2017-10-10 21:55:56.872829
NCT02857556|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||April 2014||2014-04-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Interventional|DIALYSOX||Potential Biomarkers of the Severity of Endothelial Damage in End-stage Chronic Kidney Failure|Potential Biomarkers of the Severity of Endothelial Damage in End-stage Chronic Kidney Failure Evaluated at the Initiation of Intermittent or Peritoneal Dialysis|Recruiting||N/A|160|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:55:56.947651|2017-10-10 21:55:56.947651
NCT02857543|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-08-25|||June 2016||2016-06-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Plant-Based, American Heart Assoc. or Mediterranean Diets In 9-18 yo With BMI >95%, Cholesterol >169 and Their Parents|Plant-Based, No-Added-Fat or American Heart Association or Mediterranean Diets a Prospective Randomized Trial: Impact on Cardiovascular Risk in Obese Children With Hypercholesterolemia and in One of Their Parents|Recruiting||Early Phase 1|180|Anticipated|The Cleveland Clinic||3|||f||||f||||||||||2017-10-10 21:55:57.024969|2017-10-10 21:55:57.024969
NCT02857530|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-04|||August 2016||2016-08-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia|Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia|Not yet recruiting||Phase 2|250|Anticipated|Tianjin Medical University General Hospital||2|||f||||t||||||||No||2017-10-10 21:55:57.112703|2017-10-10 21:55:57.112703
NCT02857517|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-09|||June 2016||2016-06-01|August 2016|2016-08-01||||June 2018|Anticipated|2018-06-01||Interventional|||Intravitreal Conbercept for Idiopathic Choroidal Neovascularization|Intravitreal Conbercept for Idiopathic Choroidal Neovascularization|Recruiting||Phase 2|50|Anticipated|Tianjin Medical University Eye Hospital||1|||f||||||||||||||2017-10-10 21:55:57.191105|2017-10-10 21:55:57.191105
NCT02857478|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2016-08-04|||June 2015||2015-06-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users|To Assess the Safety of a Sunscreen Product, BAY 987519, Bayer Sponsored, CC Products|Completed||N/A|98|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:55:57.447487|2017-10-10 21:55:57.447487
NCT02857465|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-08-07|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|DEXAPER||Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome|Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome. A Randomized Double Blind Placebo Study|Not yet recruiting||Phase 3|114|Anticipated|Centre Hospitalier Universitaire de la Réunion||2|||f||||t|f|f||||||||2017-10-10 21:55:57.613286|2017-10-10 21:55:57.613286
NCT02857452|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||January 2009||2009-01-01|July 2016|2016-07-01||||February 2010|Actual|2010-02-01||Observational|FRESH COLA||Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire|Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire|Completed||N/A|162|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:55:57.714683|2017-10-10 21:55:57.714683
NCT02857439|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|CASH||Creating a Diagnostic Decision Rule for Shoulder Injury: CASH-trial|Creating a Diagnostic Decision Rule for Shoulder Injury: CASH-trial|Recruiting||N/A|280|Anticipated|Zaans Medisch Centrum||2|||f||||f||||||||Undecided||2017-10-10 21:55:57.786329|2017-10-10 21:55:57.786329
NCT02857426|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-10-04|||October 18, 2016|Actual|2016-10-18|October 2017|2017-10-01|December 6, 2019|Anticipated|2019-12-06|August 12, 2018|Anticipated|2018-08-12||Interventional|CheckMate 647||A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)|A Phase 2, Open-label, Single-arm, Two-cohort Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Relapsed/Refractory Primary Testicular Lymphoma (PTL)|Recruiting||Phase 2|65|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 21:55:57.891545|2017-10-10 21:55:57.891545
NCT02857413|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Observational|XEROSTOMIA||Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy|Assessment of Frequency of Xerostomia and Their Care Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy|Completed||N/A|42|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 21:55:58.200239|2017-10-10 21:55:58.200239
NCT02857400|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-07-07|||June 19, 2017|Actual|2017-06-19|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|CREDO||"Evaluation of an Organized Consultation Return Home of Patients With a Metastatic Cancer (CREDO)"|"Evaluation of an Organized Consultation Return Home of Patients With a Metastatic Cancer (CREDO)"|Recruiting||N/A|824|Anticipated|Institut Claudius Regaud||2|||f||||f|f|f||||||||2017-10-10 21:55:58.264836|2017-10-10 21:55:58.264836
NCT02857387|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-12-27|||October 2015||2015-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|MAVASCOR||Markers of Vascular Aging and Coronary Syndrome|Markers of Vascular Aging and Coronary Syndrome|Recruiting||N/A|65|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:55:58.373143|2017-10-10 21:55:58.373143
NCT02857374|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-03-30|||November 3, 2016|Actual|2016-11-03|March 2017|2017-03-01|June 21, 2020|Anticipated|2020-06-21|June 21, 2019|Anticipated|2019-06-21||Interventional|||Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy|Intravital Microscopy (IVM) During Sentinel Lymph Node (SLN) Biopsy for Melanoma|Recruiting||N/A|35|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-10 21:55:58.469041|2017-10-10 21:55:58.469041
NCT02857361|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-17|||July 2016||2016-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.|An Open Label, Two-way Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols in Healthy Volunteers Under Fasted Conditions.|Completed||Phase 2|10|Actual|iX Biopharma Ltd.||2|||f||||f||||||||No||2017-10-10 21:55:58.566463|2017-10-10 21:55:58.566463
NCT02857348|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-22|||October 2016||2016-10-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Trial of a Video Game Intervention to Recalibrate Physician Heuristics|A Randomized Controlled Trial of a Video Game Intervention to Recalibrate Physician Heuristics|Completed||N/A|368|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 21:55:58.640488|2017-10-10 21:55:58.640488
NCT02857335|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-02|||January 2016||2016-01-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Neurocognitive Outcome in Children Who Suffered From Idiopathic Increased Intracranial Hypertension (IIH)|Neurocognitive Outcome in Children Who Suffered From Idiopathic Increased Intracranial Hypertension (IIH)|Active, not recruiting||N/A|15|Actual|Hillel Yaffe Medical Center||1|||f||||t||||||||Yes||2017-10-10 21:55:58.70787|2017-10-10 21:55:58.70787
NCT02857322|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-02|||January 2017||2017-01-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|January 2020|Anticipated|2020-01-01||Interventional|VEPSY||Effectiveness Accompaniment Perioperative Patients With Psychiatric Illness on the Lives Perioperative|Effectiveness Accompaniment Perioperative Patients With Psychiatric Illness on the Lives Perioperative|Not yet recruiting||N/A|88|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:55:58.778096|2017-10-10 21:55:58.778096
NCT02857309|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-15|||February 2014||2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|IMPULSE-HF||Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure|Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure: A Randomized Efficacy Study|Terminated||N/A|50|Actual|Impulse Dynamics||2||Slow enrolment.|f||||f||||||||||2017-10-10 21:55:58.846645|2017-10-10 21:55:58.846645
NCT02857296|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-02|||January 2017||2017-01-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Observational|REDAP||Evaluative Research in the Process of Implementation of an Alternative Device to Hospitalization for People Homeless With Severe Psychiatric Disorders|Evaluative Research in the Process of Implementation of an Alternative Device to Hospitalization for People Homeless With Severe Psychiatric Disorders|Not yet recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 21:55:58.952056|2017-10-10 21:55:58.952056
NCT02857283|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-04-17|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|SNOZ||Human Biological Responses to Low Level Ozone|Human Biological Responses to Low Level Ozone|Recruiting||N/A|16|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 21:55:59.00438|2017-10-10 21:55:59.00438
NCT02857270|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-03|2017-07-29|||September 2016||2016-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer|A Phase 1 Study of an ERK1/2 Inhibitor (LY3214996) Administered Alone or in Combination With Other Agents in Advanced Cancer|Recruiting||Phase 1|136|Anticipated|Eli Lilly and Company||5|||f||||f||||||||||2017-10-10 21:55:59.195828|2017-10-10 21:55:59.195828
NCT02857257|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-04|||January 2015||2015-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ACHIM2||Transplantation of Anaerobic Cultured Human Intestinal Microbiota in Irritable Bowel Syndrome|Transplantation of Anaerobic Cultured Human Intestinal Microbiota in Irritable Bowel Syndrome|Recruiting||Phase 2|50|Anticipated|Uppsala University||1|||f||||f||||||||No||2017-10-10 21:55:59.358752|2017-10-10 21:55:59.358752
NCT02857244|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-10-25|||November 2016||2016-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients|A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients|Not yet recruiting||Phase 2|14|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 21:55:59.456211|2017-10-10 21:55:59.456211
NCT02857231|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-08-15|||August 7, 2017|Actual|2017-08-07|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Bioimpedance Spectroscopy Compared to CardioMEMS™|Bioimpedance Spectroscopy Compared to CardioMEMS™ Determined Pulmonary Artery Pressure Measurements|Recruiting||N/A|10|Anticipated|ImpediMed Limited|||1||f||||f||||||None Retained|"     Two blood samples for each participant with be taken, baseline and last study visit.   "|||2017-10-10 21:55:59.587527|2017-10-10 21:55:59.587527
NCT02857218|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-14|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer|A Pilot Study Using a Novel Imaging of Lymph Nodes in Patients With Locally Advanced Esophageal Cancer Using Ferumoxytol Enhanced MRI|Recruiting||Phase 2|7|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 21:55:59.672233|2017-10-10 21:55:59.672233
NCT02857205|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-08|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|MICROPRUNG||MICROPRUNG : Intestinal Microbiota Analysis in Patients With or Without Hirschsprung's Associated EnteroColitis|MICROPRUNG : Intestinal Microbiota Analysis in Patients With or Without Hirschsprung's Associated EnteroColitis|Recruiting||N/A|150|Anticipated|Rennes University Hospital||1|||f||||f||||||||||2017-10-10 21:55:59.78235|2017-10-10 21:55:59.78235
NCT02857192|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-08-02|||October 2015||2015-10-01|July 2016|2016-07-01||||April 2018|Anticipated|2018-04-01||Interventional|ACG et TREG||Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease|Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Giant Cell Arteritis (Horton's Disease)|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:55:59.879566|2017-10-10 21:55:59.879566
NCT02857179|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-02|||November 2007||2007-11-01|July 2016|2016-07-01|November 2032|Anticipated|2032-11-01|November 2032|Anticipated|2032-11-01||Observational|BARIASURG||Study of Bariatric Surgery|Prospective Cohort Study Monitoring Patients Undergoing Bariatric Surgery|Recruiting||N/A|5000|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:55:59.952545|2017-10-10 21:55:59.952545
NCT02857166|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-27|||March 2016||2016-03-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|December 2016|Actual|2016-12-01||Interventional|||Study of JS001 in Participants With Advanced Solid Tumors|Phase IA Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Recombinant Humanized Anti-PD-1 Monoclonal Antibody (JS001) in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|24|Anticipated|Shanghai Junshi Bioscience Co.,Ltd.||1|||f||||t||||||||||2017-10-10 21:56:00.04524|2017-10-10 21:56:00.04524
NCT02857153|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-15|||July 2016||2016-07-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of High vs. Low MAP Levels on Clinical Outcomes in Elderly Patients During Noncardiothoracic Surgery|Comparsion of the Effect of High Versus Low Mean Arterial Pressure (MAP) Levels on Clinical Outcomes in Elderly Patients During Noncardiothoracic Surgery Under General Anesthesia|Recruiting||N/A|322|Anticipated|The Second Clinical Medical College of Jinan University||2|||f||||t||||||||Undecided||2017-10-10 21:56:00.148879|2017-10-10 21:56:00.148879
NCT02857127|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-08-04|||July 2014||2014-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|December 2014|Actual|2014-12-01||Interventional|||Physical Activity Promotion in Primary Health Care Settings|Promoting Physical Activity for Vulnerable Adults and Elderly People: Evaluation of a Walking Program in Primary Care Settings|Completed||N/A|148|Actual|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-10 21:56:00.294753|2017-10-10 21:56:00.294753
NCT02857114|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-02|||February 2015||2015-02-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|ToucherDétente||Measuring the Effects of Touch Relaxation Painful Patients in Oncologie Nursing||Recruiting||N/A|104|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:56:00.375791|2017-10-10 21:56:00.375791
NCT02857101|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-04|||February 2015||2015-02-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Observational|Ca-DRISLA||Calprotectin for Rapid Diagnostic Infection Spontaneous of Ascites|The Ratio of Ascites Calprotectin to Total Protein is a Diagnostic and Prognostic Marker for Spontaneous Bacterial Peritonitis in Liver Cirrhosis|Recruiting||N/A|218|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 21:56:00.460174|2017-10-10 21:56:00.460174
NCT02857088|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-02|||February 2014||2014-02-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2014|Actual|2014-04-01||Interventional|PERODEP||Olfactory and Visual Perception in Depressed Patients|Study of the Emotional Reactivity to Olfactive and Visual Perception in Depressed Patients|Terminated||N/A|3|Actual|Centre Hospitalier Universitaire de Besancon||2||unavailable recording device and difficulty of patient inclusions|f||||f||||||||No||2017-10-10 21:56:00.541688|2017-10-10 21:56:00.541688
NCT02857075|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-04|||September 2013||2013-09-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|ABORDAGE||Development a Rhesus Type Compatibility Test by Means of an Antibody Able to Recognize RH1 Antigen Grafted on a Biochip|Enlargement of the SmarTTransfuser Biochip (ABO Compatibility) to the Detection of Rhesus (RH1)|Completed||N/A|45|Actual|Centre Hospitalier Universitaire de Besancon|||2||f||||f||||||||No||2017-10-10 21:56:00.627745|2017-10-10 21:56:00.627745
NCT02857062|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-02-06|||November 23, 2016|Actual|2016-11-23|January 2017|2017-01-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Interventional|||To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin|An Open Label, In-use Tolerance Study in Babies and Children With Dry/Atopic and Very Dry/Atopic Skin, to Evaluate the Acceptability and Skin Tolerability of E45 Eczema Repair Emollient for the Treatment of Atopic or Eczema Prone Skin|Completed||N/A|34|Actual|Reckitt Benckiser Healthcare (UK) Limited||1|||f||||f|f|f||||||No||2017-10-10 21:56:00.698941|2017-10-10 21:56:00.698941
NCT02857049|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-02|||February 2014||2014-02-01|July 2016|2016-07-01||||February 2017|Anticipated|2017-02-01||Interventional|||Effective Consumption of Oral Nutritional Supplements in Geriatrics: A Study Evaluating a Strategy Based on a Preliminary Degustation||Recruiting||N/A|220|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-10 21:56:00.774352|2017-10-10 21:56:00.774352
NCT02857036|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-02-28|||July 2013||2013-07-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|R&B||Rhythm and Depression|Characterization of Rhythmic Markers Associated With the Response to Antidepressants|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||No||2017-10-10 21:56:00.844723|2017-10-10 21:56:00.844723
NCT02857023|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-02|||October 2014||2014-10-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Interventional|||Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease|Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease|Recruiting||N/A|134|Anticipated|Children's Research Institute||2|||f||||||||||||||2017-10-10 21:56:00.931485|2017-10-10 21:56:00.931485
NCT02857010|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-08-04|||February 2016||2016-02-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|Liveradvance||Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure|Therapeutic Effects of Allogenic Mesenchymal Stem Cells in Cirrhotic Patients With Acute-on-chronic Liver Failure. A Double-blind Randomized Placebo-controlled Trial|Recruiting||Phase 1|30|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||Yes||2017-10-10 21:56:01.010554|2017-10-10 21:56:01.010554
NCT02856997|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-08-02|||September 2016||2016-09-01|July 2016|2016-07-01||||March 2019|Anticipated|2019-03-01||Interventional|||Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma|Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma: A Phase II Clinical Trial|Not yet recruiting||Phase 2|35|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||1|||f||||t||||||||Yes|the data of the trial would be open to the public after the trial is finished|2017-10-10 21:56:01.102568|2017-10-10 21:56:01.102568
NCT02856984|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-04-26|||June 2016||2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Zika in Infants and Pregnancy (ZIP)|International Prospective Observational Cohort Study of Zika in Infants|Recruiting||N/A|10000|Anticipated|RTI International|||2||f||||t||||||Samples Without DNA|"     maternal samples from urine, blood, genital secretions, saliva, and breast milk, and when     available amniotic fluid and tissue; infant urine, blood, and saliva   "|Yes|de-identified participant data will be entered into the National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (N-DASH) system.|2017-10-10 21:56:01.190448|2017-10-10 21:56:01.190448
NCT02856971|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-10-17|||December 2015||2015-12-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|March 2016|Actual|2016-03-01||Observational|||Knee Hinge Prosthesis Following TKA Infection|Rotating Hinge Knee Arthroplasty for Septic Revision After Total Knee Arthroplasty: a Retrospective Cohort About 50 Patients With 2 Years Follow up|Active, not recruiting||N/A|49|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:56:01.324279|2017-10-10 21:56:01.324279
NCT02856945|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||December 2015||2015-12-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Observational|KID||Knee Injury Decision|Clinical Criteria for Decision Support Regarding Emergency Radiography for Knee Acute Traumatism in Order to Identify Bone Fracture Among Children.|Recruiting||N/A|25|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:56:01.57802|2017-10-10 21:56:01.57802
NCT02856932|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-02||||||August 2016|2016-08-01||||September 2018|Anticipated|2018-09-01||Interventional|||Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients|Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients: Randomized Controlled Trial|Not yet recruiting||N/A|31|Anticipated|Cairo University||2|||f||||||||||||||2017-10-10 21:56:01.653448|2017-10-10 21:56:01.653448
NCT02856919|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-05|||June 13, 2016|Actual|2016-06-13|August 2016|2016-08-01|February 8, 2017|Actual|2017-02-08|February 8, 2017|Actual|2017-02-08||Interventional|BR14004||A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.|A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel (5 mg/g Brimonidine Tartrate) in Patients With Chronic Persistent Vascular Facial Erythema.|Completed||Phase 4|101|Actual|Galderma Brasil Ltda.||1|||f||||f||||||||||2017-10-10 21:56:01.733352|2017-10-10 21:56:01.733352
NCT02856906|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-08|||August 2016||2016-08-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||An Follow-up Study of Occlusal Adjustment for Orofacial Pain|An Follow-up Study of Occlusal Adjustment for Orofacial Pain|Recruiting||N/A|30|Anticipated|Fourth Military Medical University||1|||f||||f||||||||||2017-10-10 21:56:01.834086|2017-10-10 21:56:01.834086
NCT02856893|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-08-04|||March 2017||2017-03-01|August 2016|2016-08-01|March 2027|Anticipated|2027-03-01|December 2019|Anticipated|2019-12-01||Interventional|APPLE||Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)|APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR Mutant NSCLC Patients|Not yet recruiting||Phase 2|159|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||3|||f||||f||||||||||2017-10-10 21:56:01.966148|2017-10-10 21:56:01.966148
NCT02856880|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-07-31|2016-08-08||November 9, 2015|Actual|2015-11-09|July 2017|2017-07-01|December 11, 2015|Actual|2015-12-11|December 1, 2015|Actual|2015-12-01||Interventional|||A Study to Investigate the Antimicrobial Activity of 2 Test Toothpastes|A Study to Investigate the Antimicrobial Activity of Two Test Toothpastes in a Plaque Glycolysis and Regrowth Model|Completed||N/A|45|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-10-10 21:56:02.113782|2017-10-10 21:56:02.113782
NCT02856867|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-08|||December 2016||2016-12-01|May 2017|2017-05-01||||June 2019|Anticipated|2019-06-01||Interventional|MEGAN||Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)|Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN): A Randomized, Placebo-controlled, Triple-blind Phase II Study|Withdrawn||Phase 2|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-10 21:56:02.760485|2017-10-10 21:56:02.760485
NCT02856854|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-07-31|||July 2016||2016-07-01|July 2017|2017-07-01|July 25, 2017|Actual|2017-07-25|February 17, 2017|Actual|2017-02-17||Interventional|||A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine|A Phase 1b, Randomized, Double-Blinded, Multiple-Dose, Placebo Controlled, Crossover Study To Evaluate The Safety, Tolerability And Pharmacokinetic Effects Of A Metyrapone And Oxazepam Combination (EMB-001) When Co-Administered With Cocaine|Completed||Phase 1|18|Actual|Embera NeuroTherapeutics, Inc.||2|||f||||t||||||||||2017-10-10 21:56:02.850888|2017-10-10 21:56:02.850888
NCT02856841|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-02|||January 2015||2015-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer|The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Epithelial Ovarian Cancer|Completed||N/A|44|Actual|Cairo University|||2||f||||t||||||||Yes||2017-10-10 21:56:02.951026|2017-10-10 21:56:02.951026
NCT02856828|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-26|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Novel Use of an Enhanced Fluoroscopic Imaging Device to Reduce Radiation Exposure and Operative Time During Intramedullary Nailing of Hip Fractures|Novel Use of an Enhanced Fluoroscopic Imaging Device to Reduce Radiation Exposure and Operative Time During Intramedullary Nailing of Hip Fractures|Recruiting||N/A|50|Anticipated|Duke University||2|||f|||||f|t|f|f||||||2017-10-10 21:56:03.010385|2017-10-10 21:56:03.010385
NCT02856815|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-04|||December 2016||2016-12-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||"Clinical Trial to Evaluate the Efficacy and Safety of Immuncell-LC in the Patients Undergone TACE for Intermediate Stage Hepatocellular Carcinoma"|Randomized, Open-label, Multi-center and Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in the Patients Undergone TACE for Intermediate Stage Hepatocellular Carcinoma|Not yet recruiting||Phase 2|78|Anticipated|Green Cross Cell Corporation||2|||f||||f||||||||Undecided||2017-10-10 21:56:03.08839|2017-10-10 21:56:03.08839
NCT02856789|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-04-18|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|FAST||Determination of Fibrin Activity in Plasma on STA-R® Prototype|Determination of Fibrin Activity in Plasma on STA-R® Prototype|Recruiting||N/A|110|Anticipated|Diagnostica Stago R&D|||3||f||||f||||||Samples Without DNA|"     Fresh and frozen citrated Poor Platelets Plasma   "|No||2017-10-10 21:56:03.285834|2017-10-10 21:56:03.285834
NCT02856776|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-06-19|||November 1, 2016|Actual|2016-11-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Changes in Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages in Adults Who Are Vitamin D Insufficient|RCT Double Blinded Evaluation of Changes in Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages in Adults Who Are Vitamin D Insufficient|Recruiting||N/A|48|Anticipated|Boston University||4|||f||||t|f|f||||||Undecided||2017-10-10 21:56:03.403746|2017-10-10 21:56:03.403746
NCT02856763|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2016-08-04|||April 2013||2013-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|MICA||Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess|Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess A Multicenter Prospective, Observational Cohort Study|Recruiting||N/A|125|Anticipated|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives|||1||f||||f||||||||Undecided||2017-10-10 21:56:03.503485|2017-10-10 21:56:03.503485
NCT02856750|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-10-03|||October 2016||2016-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures|A Multicenter, Randomized Controlled Trial of the Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures|Recruiting||Early Phase 1|500|Anticipated|Denver Health and Hospital Authority||2|||f||||t||||||||||2017-10-10 21:56:03.575324|2017-10-10 21:56:03.575324
NCT02856737|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-07-07|||August 2016||2016-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Reducing Delirium in the Surgical Intensive Care Unit|Reducing Delirium in the Surgical Intensive Care Unit Through the Use of Eye Masks and Earplugs|Withdrawn||N/A|0|Actual|Boston Medical Center||1||inadequate personel|f||||f||||||||||2017-10-10 21:56:03.679152|2017-10-10 21:56:03.679152
NCT02856724|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-12-06|||August 2016||2016-08-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|PGE2||Early Amniotomy After Vaginal Prostaglandin E2 for Induction of Labor at Term: a Randomized Clinical Trial||Completed||Phase 2|200|Actual|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t||||||||Yes||2017-10-10 21:56:03.757383|2017-10-10 21:56:03.757383
NCT02856711|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-11-22|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Assessing the CenteringPregnancy Planning to Parent Innovation|Assessing the CenteringPregnancy Planning to Parent Innovation|Completed||N/A|41|Actual|Boston Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:56:03.843108|2017-10-10 21:56:03.843108
NCT02856698|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-16|||November 2016||2016-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|MIMO||MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial)|"Study Design and Rationale of A Multicenter, Open-Labeled, Randomized Controlled Trial Comparing MIdazolam Versus MOrphine in Acute Pulmonary Edema: MIMO Trial"|Not yet recruiting||Phase 4|136|Anticipated|Fundación Canaria Rafael Clavijo para la Investigación Biomédica||2|||f||||f||||||||No||2017-10-10 21:56:03.929516|2017-10-10 21:56:03.929516
NCT02856685|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-18|||August 2016||2016-08-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of Mitoxantrone Hydrochloride Liposome Infusion|A Phase 1/2 Study of Mitoxantrone Hydrochloride Liposome Infusion in Patients With Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|60|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||1|||f||||t||||||||Yes||2017-10-10 21:56:04.036142|2017-10-10 21:56:04.036142
NCT02856659|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-04|||September 2015||2015-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Evaluation of N6 Sound Processor in Group of Freedom Users|Evaluation of N6 Sound Processor in Group of Freedom Users|Completed||N/A|25|Actual|Cochlear|||1||f||||t||||||||Yes||2017-10-10 21:56:04.19481|2017-10-10 21:56:04.19481
NCT02856646|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-10-03|||September 21, 2016|Actual|2016-09-21|October 2017|2017-10-01|September 28, 2023|Anticipated|2023-09-28|September 28, 2023|Anticipated|2023-09-28||Observational|||Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices|Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices|Recruiting||N/A|500|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||Samples With DNA|"     Tissue   "|||2017-10-10 21:56:04.240879|2017-10-10 21:56:04.240879
NCT02856633|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-05-08|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|February 19, 2017|Actual|2017-02-19||Observational|||Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station|Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station|Completed||N/A|40|Actual|Cloud DX Inc.|||1||f||||f||||||||No||2017-10-10 21:56:04.324104|2017-10-10 21:56:04.324104
NCT02856620|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-04|||July 2016||2016-07-01|August 2016|2016-08-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Observational|SCRABLES||The Role of Cardiac Mechanics, Biomarkers and Frailty in Aortic Stenosis|The Role of Cardiac Mechanics, Circulating Biomarkers and Frailty in Aortic Stenosis in Predicting Outcomes After Aortic Valve Intervention.|Recruiting||N/A|450|Anticipated|Montreal Heart Institute|||6||f||||f||||||Samples Without DNA|"     NT-proBNP hs-TnT sST2 hs-CRP GDF-15   "|No||2017-10-10 21:56:04.402389|2017-10-10 21:56:04.402389
NCT02856607|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||February 2014||2014-02-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Observational|||Impact of Clinical Care Pathway on Prognosis and Therapeutic Medical Care of Infective Endocarditis|Impact of Clinical Care Pathway on Prognosis and Therapeutic Medical Care of Infective Endocarditis|Recruiting||N/A|300|Anticipated|Assistance Publique Hopitaux De Marseille|||3||f||||f||||||||||2017-10-10 21:56:04.508285|2017-10-10 21:56:04.508285
NCT02856581|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-09-29|||September 29, 2017|Actual|2017-09-29|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes|Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes|Recruiting||Phase 3|783|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t|t|f|||t|||||2017-10-10 21:56:04.853558|2017-10-10 21:56:04.853558
NCT02856568|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-05-25|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma|A Phase Ib, Open-Label, Dose- Escalation Trial of ACY-1215 in Combination With Gemcitabine and Cisplatin in Patients With Unresectable or Metastatic Cholangiocarcinoma|Withdrawn||Phase 1|0|Actual|Mayo Clinic||1||Site dropped study|f|||||t|f||||||||2017-10-10 21:56:04.980474|2017-10-10 21:56:04.980474
NCT02856555|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-03|||August 8, 2016|Actual|2016-08-08|August 2017|2017-08-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||GS-0976 in Adults With Nonalcoholic Steatohepatitis|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-0976 in Subjects With Nonalcoholic Steatohepatitis|Completed||Phase 2|127|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:56:05.173767|2017-10-10 21:56:05.173767
NCT02856542|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-06-08|||May 23, 2016|Actual|2016-05-23|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|ASAP PSO||Real-life Evaluation of the Daivobet® Gel Applicator|Real-life Evaluation of an Applicator, as a New Mode of Administration of Daivobet® Gel, on Adherence to Treatment and SAtisfaction of Patients With PSOriasis|Recruiting||N/A|2100|Anticipated|LEO Pharma|||1||f||||f||||||||No||2017-10-10 21:56:05.329184|2017-10-10 21:56:05.329184
NCT02856529|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2016-08-02|||June 2016||2016-06-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Basic Infection Control Skills License on Knowledge and Practice of Health Care Workers||Not yet recruiting||N/A|66|Anticipated|Madinah Saudi Board Community Medicine||2|||f||||t||||||||No||2017-10-10 21:56:05.418578|2017-10-10 21:56:05.418578
NCT02856516|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-10-10|||July 2016||2016-07-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus|Plasma Glucose and Insulin Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus|Completed||N/A|12|Actual|Nestlé||3|||f||||f||||||||No|Data will be presented in a peer reviewed manuscript|2017-10-10 21:56:05.496954|2017-10-10 21:56:05.496954
NCT02856503|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-09|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors|Phase I/II Study Evaluating Safety and Effects of Preoperative High-Dose Vitamin D on the Receptors, Biomarkers and Pathological Characteristics of High Grade DCIS or Invasive Breast Cancer.|Recruiting||Phase 1/Phase 2|44|Anticipated|University of Miami||4|||f||||t|t|f||||||||2017-10-10 21:56:05.600006|2017-10-10 21:56:05.600006
NCT02856490|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-08-21|||July 2016||2016-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:56:05.694533|2017-10-10 21:56:05.694533
NCT02856477|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||November 2007||2007-11-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Pharmacogeneti||Pharmacogenetic and Antidepressant Treatment in Elderly|Pharmacogenetic in the Therapeutic Strategy in Depressed Elderly|Terminated||N/A|28|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||No||2017-10-10 21:56:05.732014|2017-10-10 21:56:05.732014
NCT02856464|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||September 2016||2016-09-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|PRO-DLI||Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy|A Phase II Prospective Trial of Prophylactic Donor Lymphocyte Infusions for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy|Not yet recruiting||Phase 2|124|Anticipated|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-10 21:56:05.800034|2017-10-10 21:56:05.800034
NCT02856451|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-18|||January 31, 2016|Actual|2016-01-31|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Observational|||Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab|Case Series Analyses of the Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab|Active, not recruiting||N/A|60|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:56:05.866584|2017-10-10 21:56:05.866584
NCT02856438|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-01||||||September 2017|2017-09-01||||||||Expanded Access|||Early Patient Access Treatment Use Protocol CA204-220|An Expanded Access Program for Elotuzumab in Combination With Lenalidomide Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma in Japan|Available||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-10 21:56:05.940111|2017-10-10 21:56:05.940111
NCT02856425|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-04|||July 2016||2016-07-01|August 2016|2016-08-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|PEMBIB||Trial Of Pembrolizumab And Nintedanib|Phase Ib Trial Of Pembrolizumab And Nintedanib|Recruiting||Phase 1|18|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||8|||f||||f||||||||No||2017-10-10 21:56:06.059716|2017-10-10 21:56:06.059716
NCT02856412|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-09-20|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|October 1, 2019|Anticipated|2019-10-01||Interventional|||Improving Mind/Body Health and Functioning With Integrative Exercise|Improving Mind/Body Health and Functioning With Integrative Exercise|Not yet recruiting||N/A|104|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:56:06.215557|2017-10-10 21:56:06.215557
NCT02856399|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-03|||November 2014||2014-11-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Long-term Effects of Methadone for Cancer Pain|Long-term Effects of Methadone for Cancer Pain|Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:56:06.329205|2017-10-10 21:56:06.329205
NCT02856386|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||August 2016||2016-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Use of a Dietary Supplement to Support Digestive Health in Children With Chronic Diarrhea|Assessment of the Utility of a Dietary Supplement as an Adjunct to Standard of Care for Children With Chronic Diarrhea|Not yet recruiting||N/A|50|Anticipated|LiveLeaf Inc.||1|||f||||f||||||||No||2017-10-10 21:56:06.409281|2017-10-10 21:56:06.409281
NCT02856373|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-09-20|||March 3, 2015|Actual|2015-03-03|September 2017|2017-09-01|January 2024|Anticipated|2024-01-01|January 2023|Anticipated|2023-01-01||Interventional|Redress VT||Renal Nerve Stimulation and Renal Denervation in Patients With Sympathetic Ventricular Arrhythmias|Renal Nerve Stimulation and Renal Denervation in Patients With Sympathetic Ventricular Arrhythmias: an Investigator Initiated Trial|Recruiting||Phase 2|60|Anticipated|Diagram B.V.||6|||f||||f||||||||||2017-10-10 21:56:06.474382|2017-10-10 21:56:06.474382
NCT02856347|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-08-04|||March 22, 2017|Actual|2017-03-22|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|CMTpostopFDOPA||Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin|Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET ( Positron Emission Tomography) F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin|Recruiting||N/A|30|Anticipated|Institut Claudius Regaud||1|||f||||f|f|f||||||||2017-10-10 21:56:06.672094|2017-10-10 21:56:06.672094
NCT02856334|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-01|||January 2016||2016-01-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Observational|||Psychosocial Factors and Central Sensitization in Chronic Pelvic Pain|Psychosocial Factors and Central Sensitization in Chronic Pelvic Pain|Enrolling by invitation||N/A|100|Anticipated|University of Valencia|||2||f||||||||||||||2017-10-10 21:56:06.788469|2017-10-10 21:56:06.788469
NCT02856321|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-01|||January 2016||2016-01-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Observational|PerLE||PerLE (Peroneus Longus Evaluation): A Study Evaluating the Efficacy of Injection of Dysport in Peroneus Longus in Equinus Foot Deformity in Children With Cerebral Palsy||Recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 21:56:06.873831|2017-10-10 21:56:06.873831
NCT02856308|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-08-08|||March 2014||2014-03-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Hairstetics Hair Implant Device Safety and Efficacy|Safety and Efficacy Evaluation of Hairstetics Hair Implant in Subjects Affected With Hair Loss - a Clinical Study|Recruiting||N/A|100|Anticipated|Hairstetics||1|||f||||f||||||||||2017-10-10 21:56:06.944098|2017-10-10 21:56:06.944098
NCT02856295|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-08-03|||August 2016||2016-08-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||anti10a Levels in Women Treated With LMWH in the Postpartum Period|anti10a Levels in Women Treated With LMWH in the Postpartum Period for Preventing Vein Thrombosis Events: A Comparison of Two Doses|Not yet recruiting||Phase 4|116|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||Yes||2017-10-10 21:56:07.032411|2017-10-10 21:56:07.032411
NCT02856282|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-06-15|||April 4, 2016||2016-04-04|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Drug Utilization Study for Pirinase Hayfever Relief|Drug Utilization Study for Pirinase Hayfever Relief for Adults 0.05% Nasal Spray|Active, not recruiting||N/A|1537|Anticipated|GlaxoSmithKline|||1||f||||f||||||||||2017-10-10 21:56:07.115188|2017-10-10 21:56:07.115188
NCT02856269|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-06|||September 2016||2016-09-01|July 2017|2017-07-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Zinc Supplementation and Cardiovascular Risk in HIV|Zinc Supplementation and Cardiovascular Risk in HIV|Recruiting||N/A|50|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 21:56:07.178738|2017-10-10 21:56:07.178738
NCT02856256|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-05-29|||November 12, 2015|Actual|2015-11-12|May 2017|2017-05-01|May 29, 2017|Actual|2017-05-29|May 29, 2017|Actual|2017-05-29||Interventional|REDCHO||Study of the Choroidal Thickness Variations After Ingestion of RedBull® Energy Drink||Completed||N/A|20|Actual|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 21:56:07.261914|2017-10-10 21:56:07.261914
NCT02856243|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-28|||November 2013||2013-11-01|July 2016|2016-07-01||||December 2016|Anticipated|2016-12-01||Observational|||Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis|Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis|Recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||||||||||||2017-10-10 21:56:07.32305|2017-10-10 21:56:07.32305
NCT02856230|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-01-13|||November 2016||2016-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|RANGER-BTK||An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)|An Efficacy and Safety Study to Evaluate Ranger Drug-eluting Balloon for Below the Knee Angioplasty in Patients With Critical Limb Ischemia|Recruiting||Phase 2/Phase 3|30|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 21:56:07.38588|2017-10-10 21:56:07.38588
NCT02856217|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-11-02|||August 2016||2016-08-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Impact of Tunneling During Minimally Invasive Sacrocolpopexy|Comparison of the Tunneling or Non-tunneling During Minimally Invasive Sacrocolpopexy in Terms of Lower Urinary Tract and Bowel Symptoms.|Enrolling by invitation||N/A|60|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||Undecided||2017-10-10 21:56:07.479784|2017-10-10 21:56:07.479784
NCT02856204|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-26|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Observational|||Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia|Shotgun Sequencing for Etiologic Diagnosis of Febrile Neutropenia|Recruiting||N/A|70|Anticipated|Stanford University|||1||f||||||||||Samples With DNA|"     blood samples   "|||2017-10-10 21:56:07.55335|2017-10-10 21:56:07.55335
NCT02856191|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-03|||January 2011||2011-01-01|July 2016|2016-07-01||||September 2011|Actual|2011-09-01||Interventional|FACS||Study on the Frequency of de Novo Atrial Fibrillation in Septic Shock in Medical Intensive Care|Prospective Study on the Frequency of de Novo Atrial Fibrillation in Septic Shock in Medical Intensive Care|Completed||N/A|100|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 21:56:07.63874|2017-10-10 21:56:07.63874
NCT02856178|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-01|||September 2016||2016-09-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|SAFEGUARD||Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients|An Open Label Phase IIa Clinical Study to Evaluate the Safety and Pharmacokinetics of Intravenous and Oral F901318 (Combined With Caspofungin) for Antifungal Prophylaxis in Patients Undergoing Chemotherapy for Acute Myeloid Leukaemia|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|F2G Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:56:07.695779|2017-10-10 21:56:07.695779
NCT02856165|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-02-27|||October 2016||2016-10-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|BRONCHOPTI||High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis|High-flow Nasal Oxygen Therapy (Optiflow) in Hospitalized Infant With Moderate-to-severe Bronchiolitis: Multicentric Randomized Controlled Trial|Recruiting||N/A|276|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-10 21:56:07.777121|2017-10-10 21:56:07.777121
NCT02856152|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-03-03|||June 2016||2016-06-01|March 2017|2017-03-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||A Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Participants|A Single-dose, Open-label, Randomized, 4-way Crossover Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Subjects|Withdrawn||Phase 1|0|Actual|Genentech, Inc.||4||The molecule (GDC-276) is no longer in development.|f||||||||||||||2017-10-10 21:56:07.863464|2017-10-10 21:56:07.863464
NCT02856139|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||November 2014||2014-11-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Appearance of Far Peripheral Retina in Normal Eyes by Ultra-widefield Fluorescein Angiography|The Director of the Fundus Center of Zhongshan Ophthalmic Center|Completed||N/A|61|Actual|Sun Yat-sen University|||3||f||||f||||||||No||2017-10-10 21:56:07.943771|2017-10-10 21:56:07.943771
NCT02856126|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-12-27|||August 2016||2016-08-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||HAIC Versus TACE for Advanced HCC|The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Compared With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma With Major Portal Venous Tumor Thrombus.|Recruiting||Phase 3|162|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 21:56:08.012642|2017-10-10 21:56:08.012642
NCT02856113|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-04-27|||November 28, 2016|Actual|2016-11-28|April 2017|2017-04-01|June 11, 2021|Anticipated|2021-06-11|June 11, 2021|Anticipated|2021-06-11||Interventional|||Phase 3 Alogliptin Pediatric Study|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared With Placebo in Pediatric Subjects With Type 2 Diabetes Mellitus|Recruiting||Phase 3|200|Anticipated|Takeda||2|||f||||t|t|f||||||||2017-10-10 21:56:08.095242|2017-10-10 21:56:08.095242
NCT02856100|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||May 2016||2016-05-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|||Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer|Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer|Recruiting||N/A|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||1||f||||||||||||||2017-10-10 21:56:08.24946|2017-10-10 21:56:08.24946
NCT02856087|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-11-15|||November 2014||2014-11-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study|The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study|Completed||N/A|92|Actual|Seoul National University Hospital||3|||f||||f||||||||No||2017-10-10 21:56:08.548791|2017-10-10 21:56:08.548791
NCT02856061|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-04|||January 2016||2016-01-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Tracking Intervention Effects With Eye Tracking||Recruiting||N/A|72|Anticipated|Yale University||3|||f||||||||||||||2017-10-10 21:56:08.760195|2017-10-10 21:56:08.760195
NCT02856048|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-01-13|||November 2016||2016-11-01|January 2017|2017-01-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|PRESOV||Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer|Assessment of the Effect of a Co-treatment With GnRH Analogs on the Ovarian Reserve in Adolescents and Young Women Treated With Alkylating Agents for Cancer|Recruiting||Phase 2/Phase 3|160|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 21:56:08.853724|2017-10-10 21:56:08.853724
NCT02856035|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-11|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Novel Brain Signal Feedback Paradigm to Enhance Motor Learning After Stroke|Novel Brain Signal Feedback Paradigm to Enhance Motor Learning After Stroke|Recruiting||N/A|36|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:56:08.986174|2017-10-10 21:56:08.986174
NCT02856022|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-07-27|||July 2014|Actual|2014-07-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Comparison of Electrical Ilioinguinal Nerve Stimulation With Intravesical Irrigation for Bladder Pain Syndrome|A Comparison of the Efficacy of Electrical Ilioinguinal Nerve Stimulation and Intravesical Irrigation in Treating Patients With Bladder Pain Syndrome in Women|Completed||N/A|60|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-10 21:56:09.104601|2017-10-10 21:56:09.104601
NCT02855996|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-08|||August 2016||2016-08-01|August 2016|2016-08-01|August 2021|Anticipated|2021-08-01|May 2020|Anticipated|2020-05-01||Interventional|AVANCE||Evaluation of AVANCE Fathers in Action/Padres Activos Fatherhood Program||Not yet recruiting||N/A|1384|Anticipated|University of Texas at Austin||2|||f||||f||||||||No||2017-10-10 21:56:09.302744|2017-10-10 21:56:09.302744
NCT02855983|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-04-25|||August 2016||2016-08-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PRF||Perforating Fat Injections for Plantar Fasciosis|Perforating Fat Injections for Plantar Fasciosis|Recruiting||N/A|30|Anticipated|University of Pittsburgh||2|||f||||t||||||||Yes||2017-10-10 21:56:09.401448|2017-10-10 21:56:09.401448
NCT02855970|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-03|||February 2015||2015-02-01|July 2016|2016-07-01||||August 2015|Actual|2015-08-01||Interventional|QUALI STROKE||Validation of a French Quality of Life Questionnaire Adapted to Persons Who Have Suffered a Stroke|Development and Validation of a French Quality Of Life Scale Specific to Patients Who Have Suffered a Stroke|Completed||N/A|61|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 21:56:09.494796|2017-10-10 21:56:09.494796
NCT02855957|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-07-31|||June 2013||2013-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|July 2015|Actual|2015-07-01||Interventional|ALPHAPOOL||Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes|Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes|Completed||N/A|135|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 21:56:09.578514|2017-10-10 21:56:09.578514
NCT02855944|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-06-14|||September 2016||2016-09-01|June 2017|2017-06-01|June 2024|Anticipated|2024-06-01|June 2022|Anticipated|2022-06-01||Interventional|||ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients|ARIEL4 (Assessment of Rucaparib In Ovarian CancEr TriaL): A Phase 3 Multicenter, Randomized Study of Rucaparib Versus Chemotherapy in Patients With Relapsed, BRCA Mutant, High Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 3|345|Anticipated|Clovis Oncology, Inc.||2|||f||||t||||||||||2017-10-10 21:56:09.694967|2017-10-10 21:56:09.694967
NCT02855931|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||April 2016||2016-04-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Study to Compare Resection Versus Preservation of the Middle Turbinate in Surgery for Nasal Polyps|A Randomized Controlled Trial Comparing Partial Resection Versus Preservation of the Middle Turbinate in Surgery for Chronic Rhinosinusitis With Polyposis (CRSwP)|Recruiting||N/A|16|Anticipated|Université de Sherbrooke||2|||f||||||||||||||2017-10-10 21:56:10.031236|2017-10-10 21:56:10.031236
NCT02855918|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-01|||September 2016||2016-09-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|2BSB||Blood Biomarkers in Suicidal Behaviour|Modification of the Expression of ADARs and PDE8A Editing in Suicidal Behavior|Not yet recruiting||N/A|600|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:56:10.123477|2017-10-10 21:56:10.123477
NCT02855905|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-08-04|||January 2016||2016-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Year-round Health Enhancing Exercise and Coronary Artery Disease|Year-round Health Enhancing Exercise and Coronary Artery Disease: Randomized Controlled Study|Recruiting||N/A|18|Anticipated|University of Oulu||1|||f||||f||||||||Undecided||2017-10-10 21:56:10.218511|2017-10-10 21:56:10.218511
NCT02855892|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-11-20|||October 2015||2015-10-01|August 2016|2016-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH|A Randomized, Placebo-controlled, Single-blind, Parallel Design, Multi-center, Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)|Completed||Phase 2|161|Actual|GemVax & Kael||4|||f||||f||||||||Undecided||2017-10-10 21:56:10.326053|2017-10-10 21:56:10.326053
NCT02855879|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-01|||April 2015||2015-04-01|June 2016|2016-06-01||||July 2017|Anticipated|2017-07-01||Observational|IMPACT||Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG)|Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft, Consequences for Morbi/Mortality in the Short and Medium Term|Recruiting||N/A|240|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 21:56:10.437129|2017-10-10 21:56:10.437129
NCT02855866|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-04|||September 2013||2013-09-01|June 2016|2016-06-01||||June 2015|Actual|2015-06-01||Interventional|DEGLUTHYR||Interest of Cryotherapy or Cortisone Aerosol Therapy in Early Post-operative Swallowing Disorders Following Total Thyroidectomy|Interest of Cryotherapy or Cortisone Aerosol Therapy in Early Post-operative Swallowing Disorders Following Total Thyroidectomy|Completed||N/A|240|Actual|Centre Hospitalier Universitaire Dijon||3|||f||||||||||||||2017-10-10 21:56:10.504056|2017-10-10 21:56:10.504056
NCT02855853|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-01|||January 2016||2016-01-01|June 2016|2016-06-01||||January 2017|Anticipated|2017-01-01||Interventional|MAAMI||Study of the Impact of Implicit Motor Training in a Rehabilitation Programme in Frail Elderly Subjects|Study of the Impact of Implicit Motor Training Using a Virtual Reality System and Serious Games on a Tablet Computer in a Rehabilitation Programme in Frail Elderly Subjects|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:56:10.578504|2017-10-10 21:56:10.578504
NCT02855827|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-04|||May 2013||2013-05-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|PERIDATOR||Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft|Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft|Recruiting||N/A|240|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 21:56:10.710871|2017-10-10 21:56:10.710871
NCT02855814|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-01|||June 2010||2010-06-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|January 2015|Actual|2015-01-01||Observational|||Body Composition Reference Data for Preterm Infants|Body Composition Reference Data for Preterm Infants|Active, not recruiting||N/A|223|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||No||2017-10-10 21:56:10.770034|2017-10-10 21:56:10.770034
NCT02855801|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2017-02-14|||June 2013||2013-06-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|RhumatEx||Exercise Training in Patients With Rheumatoid Arthritis and Cryotherapy|Exercise Training in Patients With Rheumatoid Arthritis and Cryotherapy: Feasibility Study|Terminated||N/A|8|Actual|Centre Hospitalier Universitaire de Besancon||4|||f||||f||||||||No||2017-10-10 21:56:10.81758|2017-10-10 21:56:10.81758
NCT02855788|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-02|2016-08-02|||May 2015||2015-05-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Metronomic Chemotherapy in Advanced Gastric Cancer|Phase II Study of Metronomic Chemotherapy Using POLF Regimen in the Treatment of Advanced Gastric Cancer|Recruiting||Phase 2|40|Anticipated|Huashan Hospital||1|||f||||t||||||||Yes||2017-10-10 21:56:10.891298|2017-10-10 21:56:10.891298
NCT02855775|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-07-28|||March 2011||2011-03-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|June 2018|Anticipated|2018-06-01||Interventional|PK-MAB||Monoclonal Antibodies Elimination in Breast Cancer Patient|Study of the Relative Impact of the Neonatal Fc Receptor (FcRn) and the Therapeutic History on Monoclonal Antibodies Elimination. Proof of the Concept on Patients Treated by Bevacizumab or Trastuzumab in Breast Cancer|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-10 21:56:10.983585|2017-10-10 21:56:10.983585
NCT02855762|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-04|||September 8, 2016|Actual|2016-09-08|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder|Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder|Recruiting||N/A|60|Anticipated|University of Michigan||1|||f||||||||||||||2017-10-10 21:56:11.054457|2017-10-10 21:56:11.054457
NCT02855749|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-01-30|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Ultrasound Guided Percutaneous Tracheostomy|Comparison of 3 Techniques for Percutaneous Tracheostomy : Traditional Marking Technique, Ultrasonography Guided Long Axis Approach and Short Axis Approach|Completed||N/A|60|Actual|Erzincan University||3|||f||||f||||||||Undecided||2017-10-10 21:56:11.123896|2017-10-10 21:56:11.123896
NCT02855736|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-08-01|||September 2015||2015-09-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|POPS||Positive Psychology in Suicidal Patients|Effectiveness of Positive Psychology in Suicidal Patients: A Randomized Controlled Trial|Recruiting||N/A|206|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:56:11.241644|2017-10-10 21:56:11.241644
NCT02855723|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-01|||April 2008||2008-04-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SentiMERORL||Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable|Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx T1-T2N0 Operable : Comparison of the Reference Strategy Based on a the Systematic Lymph Node Dissection Versus the Strategy Based on the Technique of Sentinel Lymph Node.|Completed||N/A|307|Actual|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 21:56:11.322307|2017-10-10 21:56:11.322307
NCT02855710|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-01|||March 2016||2016-03-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|RGP||A Training of the Rhythmic Skills With a Serious Game to Improve Gait and Cognitive Abilities in Parkinson's Disease|Rhythm Game Park: a Training of the Rhythmic Skills With a Serious Game to Improve Gait and Cognitive Abilities in Parkinson's Disease|Recruiting||N/A|95|Anticipated|University Hospital, Montpellier||4|||f||||f||||||||No||2017-10-10 21:56:11.392988|2017-10-10 21:56:11.392988
NCT02855697|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-25|||November 2016||2016-11-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|January 2019|Anticipated|2019-01-01||Interventional|MOLTO||Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer|Single Arm Feasibility of Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer|Not yet recruiting||Early Phase 1|26|Anticipated|The Christie NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 21:56:11.470645|2017-10-10 21:56:11.470645
NCT02855671|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-08-03|||July 2016||2016-07-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Observational|||Infrared Imaging in Septic Illness|The Application of Infrared Thermal Imaging in the Diagnosis and Prognostication of Septic Illness in Adults|Not yet recruiting||N/A|105|Anticipated|University Hospitals, Leicester|||3||f||||||||||||||2017-10-10 21:56:11.714803|2017-10-10 21:56:11.714803
NCT02855658|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-08-01|||February 2014||2014-02-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|||Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome|Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome|Recruiting||Phase 2|90|Anticipated|China Medical University Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:56:13.865396|2017-10-10 21:56:13.865396
NCT02855645|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-11-14|||July 2016||2016-07-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||The Effects of Trichosanthes Root on Blood Sugar in Patients With Diabetes Mellitus||Recruiting||Phase 2/Phase 3|60|Anticipated|China Medical University Hospital||2|||f||||||||||||||2017-10-10 21:56:14.002454|2017-10-10 21:56:14.002454
NCT02855632|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-12-29|||August 2016||2016-08-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis|The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis|Recruiting||N/A|240|Anticipated|Sir Run Run Shaw Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:56:14.085323|2017-10-10 21:56:14.085323
NCT02855619|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-01-26|||October 15, 2016|Actual|2016-10-15|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|PREDRIC||Comparison of the Impact of Three Programs of Inspiratory Muscles.|Comparison of the Incidence of 3 Inspiratory Muscle Training Programs on Inspiratory Strength, on Difficult to Wean Patients in Intensive Care Unit: a Multi-centre Randomised Trial.|Recruiting||N/A|88|Anticipated|University Hospital, Bordeaux||3|||f||||f||||||||No||2017-10-10 21:56:14.179957|2017-10-10 21:56:14.179957
NCT02855606|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-01-31|||December 2015|Actual|2015-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Acceptability of HIV Oral PrEP Among MSM and TGW|Acceptability of HIV Oral Pre-Exposure Prophylaxis (PrEP) Among Men Have Sex With Men (MSM) and Transgender Women (TGW)|Recruiting||N/A|200|Anticipated|Chiang Mai University|||1||f||||||||||||||2017-10-10 21:56:14.265502|2017-10-10 21:56:14.265502
NCT02855593|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-08-09|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Observational|APPE||Exploring Patient and Physician Experiences of Medical Acupuncture|Exploring Patient and Physician Experiences of Medical Acupuncture|Completed||N/A|680|Actual|Mike O'Callaghan Federal Hospital|||2||f||||f||||||||||2017-10-10 21:56:14.332385|2017-10-10 21:56:14.332385
NCT02855580|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-01|||September 2016||2016-09-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|PGX||Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic|Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic|Active, not recruiting||N/A|71|Actual|University of Florida|||2||f||||t|f|f||||Samples With DNA|"     Whole blood   "|||2017-10-10 21:56:14.391176|2017-10-10 21:56:14.391176
NCT02855567|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-24|||July 2016||2016-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acupuncture for Post-Operative Pain Control for Patients Undergoing Gynecological Surgery|The Role of Acupuncture in Post-Operative Pain Management in Gynecological Patients|Active, not recruiting||N/A|110|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 21:56:14.467593|2017-10-10 21:56:14.467593
NCT02855554|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-03-21|||June 2014||2014-06-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Quantitative Cardiac Parametric Mapping (Myomapping)|Novel Magnetic Resonance Imaging Techniques for Quantitative Cardiac Parametric Mapping|Recruiting||N/A|240|Anticipated|Medical University of South Carolina||1|||f||||||||||||||2017-10-10 21:56:14.544445|2017-10-10 21:56:14.544445
NCT02855541|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-02-23|||August 2016||2016-08-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Health Effects of Increasing Muscle Activation While Sitting in Office Workers|Health Effects of Increasing Muscle Activation While Sitting in Office Workers|Active, not recruiting||N/A|25|Actual|University of Colorado, Boulder||1|||f||||t||||||||Undecided||2017-10-10 21:56:14.628272|2017-10-10 21:56:14.628272
NCT02855528|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-03-21|||December 2015||2015-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Tin Filter Calcium Scoring|Ultra Low-dose Coronary Artery Calcium Scoring Using Tin Filtration With Dual-source CT|Suspended||N/A|150|Anticipated|Medical University of South Carolina||1||Data Analysis, enrollment target reached|f||||||||||||||2017-10-10 21:56:14.811031|2017-10-10 21:56:14.811031
NCT02855515|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-05|||May 2016||2016-05-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea|The Role of Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea|Recruiting||N/A|120|Anticipated|University Hospital Ostrava||1|||f||||f||||||||No||2017-10-10 21:56:14.889645|2017-10-10 21:56:14.889645
NCT02855502|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2017-04-02|||November 2014||2014-11-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Investigation of the Effect of Systemic Steroids on Treatment and Prevention of Recurrent Tracheal Stenosis in Postoperative Patients||Completed||Phase 4|100|Actual|National Research Institute of Tuberculosis and Lung Disease, Iran||2|||f||||t||||||||Yes||2017-10-10 21:56:14.995359|2017-10-10 21:56:14.995359
NCT02855489|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-01|||November 2013||2013-11-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Condom Use Attitudes, Beliefs, and Behaviors||Completed||N/A|317|Actual|University of Colorado, Boulder||7|||f||||f||||||||No||2017-10-10 21:56:15.096949|2017-10-10 21:56:15.096949
NCT02855463|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||July 2011||2011-07-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|||Study of Giant Viruses of Amoebas Infections in Children Suffering From Gastroenteritis||Recruiting||N/A|1000|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||Undecided||2017-10-10 21:56:15.31314|2017-10-10 21:56:15.31314
NCT02855450|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-01-23|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|NGF-Glaucoma||Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma|An 8 Week Phase Ib, Monocentric, Randomized, Double-masked, Vehicle Controlled, Parallel Groups, Study With a 24 Week Follow-up Period to Evaluate the Safety and Potential Efficacy of a 180 μg/ml Recombinant Human Nerve Growth Factor (rhNGF) Eye Drops Solution Versus Vehicle in Patients With Glaucoma|Recruiting||Phase 1|60|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||f||||||||No||2017-10-10 21:56:15.395223|2017-10-10 21:56:15.395223
NCT02855437|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-29|||September 2016||2016-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Novel Methods for Ascertainment of Gout Flares -A Pilot Study|Novel Methods for Ascertainment of Gout Flares -A Pilot Study|Recruiting||N/A|45|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 21:56:15.506912|2017-10-10 21:56:15.506912
NCT02855424|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-08-04|||August 2016||2016-08-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of Leg Cycling Exercise Program at Low or Moderate Intensity for Individuals With Subacute Stroke|The Effect of Leg Cycling Exercise Program at Low or Moderate Intensity for Individuals With Subacute Stroke|Not yet recruiting||N/A|90|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||t||||||||No||2017-10-10 21:56:15.617189|2017-10-10 21:56:15.617189
NCT02855411|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-05|2017-07-28||August 2016|Actual|2016-08-01|September 2017|2017-09-01|September 26, 2016|Actual|2016-09-26|September 23, 2016|Actual|2016-09-23||Interventional||A total of 35 participants were screened. Study was terminated before any participants were treated.|A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)|A 12 Week, Phase 2, Randomized, Double-blind, Placebo Controlled, Parallel Group Study To Evaluate The Safety And Efficacy Of Pf-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (Cias)|Terminated||Phase 2|35|Actual|Pfizer|This study was terminated due to Pfizer portfolio prioritization. No participants had been randomized to receive study drug or placebo. There is no safety or efficacy data to report for this study.|3||"Terminated prematurely Sept 22, 2016 following an internal portfolio prioritization. It is not   due to any safety concern or change in benefit:risk assessment."|f||||t||||||||||2017-10-10 21:56:15.717479|2017-10-10 21:56:15.717479
NCT02855398|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-08-03|||April 2015||2015-04-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|DMK||Decision-Making and the Relationship to Food Intake in Kids|Understanding Decision-Making and the Relationship to Food Intake in Children 7 to 11 Years Old|Recruiting||N/A|84|Anticipated|Penn State University|||1||f||||f||||||||No||2017-10-10 21:56:16.034806|2017-10-10 21:56:16.034806
NCT02855385|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-03|||April 2013||2013-04-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01|60 Days|Observational [Patient Registry]|||Barriers to Care in Patients With Rectal Bleeding in Nigeria|Health-seeking Behavior and Barriers to Care in Patients With Rectal Bleeding in Nigeria|Completed||N/A|134|Actual|Obafemi Awolowo University Teaching Hospital|||2||f||||t||||||||Undecided|Yes|2017-10-10 21:56:16.135598|2017-10-10 21:56:16.135598
NCT02855372|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||October 2016||2016-10-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Observational|||Impact of the Age Difference Between the Donor and Recipient on the Morbidity and Mortality After Lung Transplantation. Study on a National Multicenter Cohort (COLT)||Not yet recruiting||N/A|800|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||No||2017-10-10 21:56:16.198012|2017-10-10 21:56:16.198012
NCT02855359|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-29|||August 2016||2016-08-01|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|September 2019|Anticipated|2019-09-01||Interventional|||Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma|An Open Label Phase 2 Study of Denintuzumab Mafodotin (SGN-CD19A) in Combination With RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) or RCHP (Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone) Compared With RCHOP Alone as Frontline Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) Grade 3b|Recruiting||Phase 2|160|Anticipated|Seattle Genetics, Inc.||4|||f||||t||||||||||2017-10-10 21:56:16.27751|2017-10-10 21:56:16.27751
NCT02855346|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-29|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|DAP/LNG||PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel|A Phase 1, Randomized, Double-Blind Pharmacokinetic and Safety Study of Dapivirine/Levonorgestrel Vaginal Rings|Recruiting||Phase 1|36|Anticipated|International Partnership for Microbicides, Inc.||2|||f||||f|t|f||||||||2017-10-10 21:56:16.716425|2017-10-10 21:56:16.716425
NCT02855333|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-08-03|||May 2014||2014-05-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|MER||Feasibility, Safety and QoL After Merendino Procedure|The Merendino Procedure for Benign or Early Malignant Lesions of the Distal Esophagus/Gastroesophageal Junction is Feasible, Safe and Provides Good QoL|Completed||N/A|26|Actual|Kantonsspital Liestal|||2||f||||f||||||||No||2017-10-10 21:56:16.81732|2017-10-10 21:56:16.81732
NCT02855320|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-03-21|||January 27, 2017|Actual|2017-01-27|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|BIOSAFE||Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of Patients With Arthritis Treated Par Biologics|Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of Patients With Arthritis Treated Par Biologics|Recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||Undecided||2017-10-10 21:56:16.903151|2017-10-10 21:56:16.903151
NCT02855307|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-08-10|||September 2016||2016-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes|A Single-blind, Randomized, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy at Preventing Hypoglycemia During Unannounced and Announced Exercise in Adults With Type 1 Diabetes|Recruiting||Phase 2|37|Anticipated|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-10 21:56:17.009729|2017-10-10 21:56:17.009729
NCT02855294|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||January 2015||2015-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Effect of Oral Contraceptives on Women Balance|The Effect of Oral Contraceptives on Dynamic Balance in Women|Completed||Phase 4|100|Actual|Cairo University||2|||f||||t||||||||Yes||2017-10-10 21:56:17.148305|2017-10-10 21:56:17.148305
NCT02855281|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-01|||August 2016||2016-08-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer|Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer|Not yet recruiting||N/A|50|Anticipated|Wissenschaftliches Institut Bethanien e.V|||1||f||||f||||||||No||2017-10-10 21:56:17.22903|2017-10-10 21:56:17.22903
NCT02855268|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-11-07|||August 2016||2016-08-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|HERA||Study of Weekly RG-012 Injections in Patients With Alport Syndrome|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, Dose Selection, and Preliminary Efficacy of Weekly RG 012 Injections in Patients With Alport Syndrome|Active, not recruiting||Phase 2|30|Anticipated|Regulus Therapeutics Inc.||3|||f||||t||||||||No||2017-10-10 21:56:17.305929|2017-10-10 21:56:17.305929
NCT02855255|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-04-28|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study Comparing Two Stop Smoking Intervention Efficacies|Comparing the 24 Week Efficacy of Allen Carr's Easyway to Stop Smoking and NHS 1-1 Counselling Provision|Recruiting||N/A|620|Anticipated|London South Bank University||2|||f||||t|f|f||||||Yes|Data will be shared at participant by participant level in an anonymous form via it being lodged with an appropriate data repository, alongside London South Bank University's own repository.|2017-10-10 21:56:17.398036|2017-10-10 21:56:17.398036
NCT02855242|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-03-15|||April 2016||2016-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Gut Microbiota Changes in Obese Individuals Undergoing Dedicated Lifestyle Modification Programs|Gut Microbiota Changes in Obese Individuals Undergoing Dedicated Lifestyle Modification Programs|Recruiting||N/A|1000|Anticipated|Mayo Clinic||2|||f||||f||||||||Yes|Data may be shared with Mayo Clinic research staff involved in this study; outside academic institutions, as specified in the protocol; and the Mayo Clinic Institutional Review Board that oversees the research.|2017-10-10 21:56:17.509665|2017-10-10 21:56:17.509665
NCT02839616|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01|5 Years|Observational [Patient Registry]|IRLT||Institutional Registry of Liver Transplantation|Institutional Registry of Liver Transplantation|Recruiting||N/A|500|Anticipated|Hospital El Cruce|||1||f||||f||||||||||2017-10-10 21:58:44.338263|2017-10-10 21:58:44.338263
NCT02855229|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-01-09|||November 2016||2016-11-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains|Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains|Recruiting||N/A|80|Anticipated|Mclean Hospital|||1||f||||f||||||||No||2017-10-10 21:56:17.604775|2017-10-10 21:56:17.604775
NCT02855216|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-10-24|||August 2016||2016-08-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Effects of Two Sub-occipital Techniques on Limited Mobility According to the Flexion-rotation Test|Comparative Study of the Effects of Two Sub-occipital Techniques on Healthy Subjects With Limited Mobility According to the Flexion-rotation Test|Recruiting||Phase 1/Phase 2|32|Anticipated|Universidad de Zaragoza||2|||f||||f||||||||No||2017-10-10 21:56:17.685906|2017-10-10 21:56:17.685906
NCT02855203|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-01|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2019|Anticipated|2019-08-01||Interventional|RAPPORT||Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours|Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||No||2017-10-10 21:56:17.783138|2017-10-10 21:56:17.783138
NCT02855190|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-10|||November 2015||2015-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparative Study With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection|Pilot Comparative Study of PET/MR and PET/CT With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection|Enrolling by invitation||N/A|50|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||Yes||2017-10-10 21:56:17.88331|2017-10-10 21:56:17.88331
NCT02855177|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-05-03|||August 24, 2016|Actual|2016-08-24|May 2017|2017-05-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|||A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Assess The Safety, Tolerability, And Pharmacokinetics With 2-weeks Of Dosing Of Pf-06427878 In Overweight-obese, Otherwise Healthy Adult Subjects|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 21:56:17.978817|2017-10-10 21:56:17.978817
NCT02855164|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-09|||August 1, 2016|Actual|2016-08-01|May 2017|2017-05-01|April 17, 2018|Anticipated|2018-04-17|December 1, 2017|Anticipated|2017-12-01||Interventional|FLIGHT-FXR||Safety, Tolerability and Efficacy Study of 12 Weeks LJN452 Treatment in NASH Patients|A Randomized, Double-blind, Placebo Controlled, 2-part, Adaptive Design, Multicenter 12-week Study to Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Non-alcoholic Steatohepatitis (NASH)|Recruiting||Phase 2|250|Anticipated|Novartis||8|||f||||t||||||||||2017-10-10 21:56:18.101245|2017-10-10 21:56:18.101245
NCT02855151|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-01|||January 2013||2013-01-01|August 2016|2016-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01|2 Days|Observational [Patient Registry]|||EUS for Gastrointestinal Disorders: a Registry||Recruiting||N/A|10000|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||||No||2017-10-10 21:56:18.30747|2017-10-10 21:56:18.30747
NCT02855138|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-04|||January 2015||2015-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Isotretinoin on The Gonads and Hirsutism|The Effects of Oral Isotretinoin in Women With Acne and Polycystic Ovary Syndrome|Completed||Phase 4|80|Actual|Kayseri Education and Research Hospital||2|||f||||||||||||||2017-10-10 21:56:18.375571|2017-10-10 21:56:18.375571
NCT02855125|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-09-23|||August 2016||2016-08-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Interventional|||A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1|A Randomized, Open-Label, Multi-Center, International Phase 2 Study of TAS-114 in Combination With S-1 in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Recruiting||Phase 2|124|Anticipated|Taiho Oncology, Inc.||2|||f||||f||||||||||2017-10-10 21:56:18.440427|2017-10-10 21:56:18.440427
NCT02855112|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-01|||June 2015||2015-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients|The Effectiveness of Allogeneic Adipose Derived Mesenchymal Stem Cells (ADMSCs) in the Phenotypic Changes of Werdnig Hoffman Patients|Recruiting||Phase 1/Phase 2|10|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:56:18.571111|2017-10-10 21:56:18.571111
NCT02855099|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-08-03|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Can Rehabilitation After TAVI Precipitate Recovery and Improve Prognosis||Not yet recruiting||N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 21:56:18.786197|2017-10-10 21:56:18.786197
NCT02855086|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-08-22|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|November 22, 2016|Actual|2016-11-22|November 8, 2016|Actual|2016-11-08||Interventional|||Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery|Open-Label Study Evaluating Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Neoplasms During Neurosurgical Procedures|Terminated||Phase 1/Phase 2|3|Actual|Stanford University||2||logistics|f||||t||||||||||2017-10-10 21:56:18.858983|2017-10-10 21:56:18.858983
NCT02855073|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-08-01|||July 2014||2014-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects|A Randomized, Single-blind, Parallel Group ,Phase II Clinical Trial to Compare ReJoinTM (Autologous Adipose-derived Mesenchymal Progenitor Cells)to Sodium Hyaluronate Injection for the Patients With Knee Osteoarthritis Cartilage Defects|Recruiting||Phase 2|28|Anticipated|Cellular Biomedicine Group Ltd.||2|||f||||t||||||||Undecided||2017-10-10 21:56:18.96749|2017-10-10 21:56:18.96749
NCT02855060|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-07-19|||July 2016||2016-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PATCH||Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis|Pre-hospital Advanced Therapies for Control of Hemorrhage (PATCH) - Pelvis|Recruiting||N/A|75|Anticipated|Carolinas Healthcare System||2|||f||||t||||||||||2017-10-10 21:56:19.060921|2017-10-10 21:56:19.060921
NCT02854865|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-04-26|||January 2015||2015-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|TEE||Specke Tracking Echocardiography And Filling Pressures|Feasibility of Speckle Tracking Echocardiography for Estimation of Left Ventricular Filling Pressures in Cardiac Surgery Patients: a Transoesophageal Study|Recruiting||N/A|30|Anticipated|Medical University of Vienna|||1||f||||f||||||||No||2017-10-10 21:56:20.32799|2017-10-10 21:56:20.32799
NCT02855047|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||July 2005||2005-07-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|September 2007|Actual|2007-09-01||Observational|NOH-ANGIO||The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations|The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations|Completed||N/A|513|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:56:19.157089|2017-10-10 21:56:19.157089
NCT02855034|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-01|||May 2016||2016-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|TCOP100||Evaluation of Discriminating Power of Two Biomarkers in the Evaluation of Cerebral Lesions Due to Head Injuries in Infants and Children|Evaluation of Discriminating Power of Two Biomarkers (Protein 100B/Copeptine) in the Evaluation of Cerebral Lesions Due to Head Injuries in Infants and Children|Recruiting||N/A|220|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:56:19.226911|2017-10-10 21:56:19.226911
NCT02855021|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-31|||September 2016||2016-09-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PREDEMPARK||Prediction of Dementia in Parkinson's Disease by Measuring Cerebral Metabolism With PET Scan|Prediction of Dementia in Parkinson's Disease by Measuring Cerebral Metabolism With PET Scan|Not yet recruiting||N/A|138|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||Undecided||2017-10-10 21:56:19.311466|2017-10-10 21:56:19.311466
NCT02855008|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-04-10|||April 5, 2016|Actual|2016-04-05|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|January 2020|Anticipated|2020-01-01||Interventional|STEPS||Steps to Effective Problem Solving in Group Homes|Steps to Effective Problem Solving in Group Homes for Individuals With Intellectual Disabilities|Recruiting||N/A|288|Anticipated|Rush University Medical Center||2|||f||||t||||||||Yes|The investigators will share aggregated data|2017-10-10 21:56:19.405597|2017-10-10 21:56:19.405597
NCT02854995|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-10-19|||October 2016||2016-10-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|BXO||Circumcision Versus Preputioplasty for BXO in Children|Circumcision Versus Preputioplasty for BXO in Children: A Feasibility Randomised Controlled Trial|Recruiting||N/A|30|Anticipated|Alder Hey Children's NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 21:56:19.524916|2017-10-10 21:56:19.524916
NCT02854982|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-01|||September 2015||2015-09-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|EPICAP-QALY||Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer|Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer|Enrolling by invitation||N/A|900|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||Undecided||2017-10-10 21:56:19.636108|2017-10-10 21:56:19.636108
NCT02854969|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-07-25|||May 2016||2016-05-01|August 2016|2016-08-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device|Randomized, Cross-over, Open, Unicentric Trial Evaluating Satisfaction With the Use of a Medical Device for the Epinephrine Auto-injector in Patients With Anaphylaxis|Completed||N/A|100|Actual|Adan Medical Innovation, SL||2|||f||||f||||||||||2017-10-10 21:56:19.695833|2017-10-10 21:56:19.695833
NCT02854956|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-11|||April 2011||2011-04-01|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|December 2015|Actual|2015-12-01||Interventional|XLMR||Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked|Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked|Recruiting||N/A|573|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 21:56:19.767554|2017-10-10 21:56:19.767554
NCT02854943|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||January 2000||2000-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis|The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis|Completed||N/A|258|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||No||2017-10-10 21:56:19.864659|2017-10-10 21:56:19.864659
NCT02854930|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||January 2017||2017-01-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||Near Death Experience (NDE) and Migraine|Near Death Experience (NDE) and Migraine|Not yet recruiting||N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 21:56:19.93273|2017-10-10 21:56:19.93273
NCT02854917|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-07-28|||July 2016||2016-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome|Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial: Further Study, Health Outcome|Active, not recruiting||N/A|20|Actual|New York University School of Medicine|||2||f||||f||||||||||2017-10-10 21:56:20.010394|2017-10-10 21:56:20.010394
NCT02854904|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-22|||August 2016||2016-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|eMUNODEX||Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion|Immune Effect of Dexmedetomidine as Immunomodulatory Anesthesic Agent in Patients Undergoing to Spinal Fusion: a Double-blind, Randomized and Placebo-controlled Clinical Trial|Recruiting||Phase 2/Phase 3|46|Anticipated|Sarah Network of Rehabilitation Hospitals||2|||f||||t||||||||Undecided|Cause the study not yet start.|2017-10-10 21:56:20.092599|2017-10-10 21:56:20.092599
NCT02854891|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-07-31|||August 2016||2016-08-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Observational|||Ambient Light Levels in the Kindergarten and Schools and the Relation to Refractive Development|Ambient Light Levels in the Kindergarten and Schools and the Relation to Refractive Development|Not yet recruiting||N/A|200|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||Yes||2017-10-10 21:56:20.198917|2017-10-10 21:56:20.198917
NCT02854878|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-31|||September 2016||2016-09-01|July 2016|2016-07-01||||September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Head Lice Infestation Using Novel Ultrasonic Comb||Not yet recruiting||Phase 1|23|Anticipated|ParaSonic Ltd.||1|||f||||||||||||||2017-10-10 21:56:20.260828|2017-10-10 21:56:20.260828
NCT02854852|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-05-17|||March 15, 2017|Actual|2017-03-15|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Photoplethysmography Detects Changes in Vascular Tone|Accuracy of Photoplethysmography to Detect Changes in Vascular Tone: a Doppler Study|Recruiting||N/A|50|Anticipated|Hospital Privado de Comunidad de Mar del Plata|||1||f||||t||||||||Yes||2017-10-10 21:56:20.413826|2017-10-10 21:56:20.413826
NCT02854839|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-01-18|||September 2016||2016-09-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma|Multi-center, Open, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of MG4101 in Hepatocellular Carcinoma After TACE|Recruiting||Phase 2|78|Anticipated|Green Cross LabCell Corporation||2|||f||||f||||||||Undecided||2017-10-10 21:56:20.490443|2017-10-10 21:56:20.490443
NCT02854826|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-31|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|SAFE||Systems Addressing Frail Elders (SAFE) Care Implementation|Systems Addressing Frail Elders (SAFE) Care Implementation|Active, not recruiting||N/A|330|Anticipated|Cedars-Sinai Medical Center|||3||f||||f||||||||No||2017-10-10 21:56:20.587097|2017-10-10 21:56:20.587097
NCT02854813|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-05-29|||January 2016||2016-01-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01|3 Months|Observational [Patient Registry]|||Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease|Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease|Completed||N/A|250|Actual|Ankara Training and Research Hospital|||2||f||||f||||||||Yes||2017-10-10 21:56:20.652814|2017-10-10 21:56:20.652814
NCT02854800|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-30|||July 2016||2016-07-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Smoking Cessation & Opioid Dependence Treatment Integration|Smoking Cessation & Opioid Dependence Treatment Integration: Does Timing Matter?|Recruiting||Phase 2/Phase 3|80|Anticipated|West Virginia University||1|||f||||f||||||||No||2017-10-10 21:56:20.713078|2017-10-10 21:56:20.713078
NCT02854787|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-08-02|||May 2016||2016-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|NorPN||Intravenous Bolus of Phenylephrine vs. Norepinephrine in Preventing Hypotension After Spinal Anesthesia|Intravenous Bolus of Phenylephrine vs. Norepinephrine in Preventing Hypotension After Spinal Anesthesia for Cesarean Section|Recruiting||Phase 4|120|Anticipated|University Tunis El Manar||2|||f||||f||||||||Undecided||2017-10-10 21:56:20.79721|2017-10-10 21:56:20.79721
NCT02854774|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-08-08|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Neural Mechanisms of Muscle Control in Individuals With Knee Pain|Neural Mechanisms of Muscle Control in Individuals With Knee Pain|Not yet recruiting||Phase 1|30|Anticipated|University of Southern California||2|||f||||f||||||||No||2017-10-10 21:56:20.88425|2017-10-10 21:56:20.88425
NCT02854761|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-02|||September 2016||2016-09-01|August 2016|2016-08-01||||September 2018|Anticipated|2018-09-01||Interventional|||Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)|Phase I Safety and Tolerability Study of EF-022 in Adult Subjects With Recurrent Respiratory Papillomatosis|Not yet recruiting||Phase 1|6|Anticipated|Efranat Ltd.||2|||f||||||||||||||2017-10-10 21:56:20.95517|2017-10-10 21:56:20.95517
NCT02854748|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-07|||August 2016||2016-08-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin|A Randomized, Open-label, Multiple Dosing, Crossover Study to Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin in Healthy Male Volunteers|Not yet recruiting||Phase 1|30|Anticipated|Chong Kun Dang Pharmaceutical||6|||f||||||||||||||2017-10-10 21:56:21.023607|2017-10-10 21:56:21.023607
NCT02854735|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-04|||February 2015||2015-02-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|TBCHNC||Total Body Composition in Detection of Nutrition Depletion in Head and Neck Patients|Non-invasive Total Body Composition in Early Detection of Nutrition Depletion, Changes in Body Physiology and Treatment Response in Head and Neck Patients Undergoing Concurrent Chemoradiotherapy|Recruiting||N/A|120|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||Undecided|Depending on IRB regulation|2017-10-10 21:56:21.104818|2017-10-10 21:56:21.104818
NCT02854722|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-30|||August 2016||2016-08-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|PMOP||The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP)|Phase 2 Study of Deferasirox-calcium-vitamin D3 to Treat Postmenopausal Osteoporosis (PMOP)|Not yet recruiting||Phase 2|10|Anticipated|Second Affiliated Hospital of Soochow University||2|||f||||t||||||||Undecided||2017-10-10 21:56:21.185692|2017-10-10 21:56:21.185692
NCT02854709|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2017-07-17|||July 2016||2016-07-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Effects of Sleep Extension on Glucose Metabolism in Chronically Sleep Deprived Individuals||Completed||N/A|21|Actual|Ramathibodi Hospital||2|||f||||f||||||||||2017-10-10 21:56:21.280198|2017-10-10 21:56:21.280198
NCT02854696|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-03-16|||July 2016||2016-07-01|March 2017|2017-03-01|December 2023|Anticipated|2023-12-01|March 2023|Anticipated|2023-03-01||Interventional|STABILOT||Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes|Health Economic Analysis of Islet Cell Transplantation for Patients With Severe Forms of Brittle Type 1 Diabetes|Recruiting||Phase 3|40|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||No||2017-10-10 21:56:21.343415|2017-10-10 21:56:21.343415
NCT02854683|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-07|||February 2016||2016-02-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients|Reducing Orthostatic Intolerance With Oral Rehydration in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|Recruiting||Phase 1|45|Anticipated|New York Medical College||2|||f||||t||||||||||2017-10-10 21:56:21.498232|2017-10-10 21:56:21.498232
NCT02854670|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-08-08|||January 2016||2016-01-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CAPSIVU||A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia||Recruiting||Phase 2/Phase 3|30|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 21:56:21.595484|2017-10-10 21:56:21.595484
NCT02851043|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-29|||August 2014||2014-08-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Non-Invasive Respiratory Monitor|Non-Invasive Respiratory Monitor|Recruiting||N/A|20|Anticipated|Nemours Children's Clinic||2|||f||||f||||||||No||2017-10-10 21:56:55.585962|2017-10-10 21:56:55.585962
NCT02854657|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-07-06|||May 2016||2016-05-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|PSW||Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners|A Comparison of Interventions to Teach Patients Skin Self-examination|Active, not recruiting||N/A|324|Actual|Northwestern University||4|||f||||t||||||||||2017-10-10 21:56:21.667134|2017-10-10 21:56:21.667134
NCT02854644|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-07-31|||September 2013||2013-09-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|October 2018|Anticipated|2018-10-01||Interventional|ERISA||Study of the Anti-tumoral Immune Response|Study of the Anti-tumoral Immune Response T Cells Cluster of Differentiation 4 (TCD4): Proof of the Concept in Breast Cancer and Glioma|Recruiting||N/A|644|Anticipated|Centre Hospitalier Universitaire de Besancon||4|||f||||f||||||||||2017-10-10 21:56:21.902716|2017-10-10 21:56:21.902716
NCT02854631|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-12|||August 31, 2016|Actual|2016-08-31|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)|A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination With Prednisolone Versus Prednisolone Alone in Subjects With Severe Alcoholic Hepatitis (AH)|Recruiting||Phase 2|120|Anticipated|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 21:56:22.00173|2017-10-10 21:56:22.00173
NCT02854618|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-03|||June 2015||2015-06-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|EVERIMMUN||Immune Response for Patients With Metastatic Breast Cancer Treated by Everolimus|Study of the Immune Response T Anti-tumoral Cluster of Differentiation 4 (CD4) for Patients Treated for a Metastatic Breast Cancer by Everolimus Within the Framework of Its Marketing Authorization|Recruiting||N/A|112|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:56:22.234915|2017-10-10 21:56:22.234915
NCT02854605|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-11|||October 26, 2016|Actual|2016-10-26|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)|Active, not recruiting||Phase 2|140|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:56:22.327877|2017-10-10 21:56:22.327877
NCT02854592|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-11-22|||December 2016||2016-12-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Observational|INTRECIS||Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset|Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset|Not yet recruiting||N/A|3000|Anticipated|General Hospital of Shenyang Military Region|||2||f||||t||||||||No||2017-10-10 21:56:22.496028|2017-10-10 21:56:22.496028
NCT02854579|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2016-07-30|||January 2013||2013-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy|Safety and Efficacy Study of Neural Progenitor Cell Transplantation and Paracrine Factors From Human Mesenchymal Stem Cells to Treat Newborn With Hypoxic-ischemic Encephalopathy|Recruiting||N/A|120|Anticipated|Navy General Hospital, Beijing||4|||f||||t||||||||No||2017-10-10 21:56:22.593539|2017-10-10 21:56:22.593539
NCT02854566|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-07-27|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Periprosthetic Fractures of the Femur Treated by Osteosynthesis|Periprosthetic Fractures of the Femur Treated by Osteosynthesis|Recruiting||N/A|36|Anticipated|Brugmann University Hospital|||1||f||||f||||||||||2017-10-10 21:56:22.730165|2017-10-10 21:56:22.730165
NCT02854553|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-08-02|||September 2016||2016-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||TAP Block Alone Versus TAPblock With Rectus Sheath Block in Liposuction Surgery|Transversus Abdominis Plane Block Alone Versus Transversus Abdominis Plane Block With Rectus Sheath Block as a Postoperative Analgesia in Anterior Abdominal Wall Liposuction Surgery|Not yet recruiting||N/A|48|Anticipated|Cairo University||3|||f||||f||||||||Undecided||2017-10-10 21:56:22.844299|2017-10-10 21:56:22.844299
NCT02854540|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2017-09-19|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis|Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis|Active, not recruiting||N/A|12|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-10 21:56:22.923606|2017-10-10 21:56:22.923606
NCT02854527|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-02-07|||August 2016||2016-08-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Transporter Cocktail Mutual Interaction|Investigation of Mutual Pharmacokinetic Interactions of Digoxin, Furosemide, Metformin, and Rosuvastatin Given All Together as a Probe Cocktail for Key Drug Transporters (an Open-label, Randomised, Single-dose, Five-way Crossover Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-10 21:56:23.011899|2017-10-10 21:56:23.011899
NCT02854514|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-30|2016-11-20|||April 2015||2015-04-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Predictive Value of Endometrial Cytokines in Endometrial Implantation in Cases of Intracytoplasmic Sperm Injection|Predictive Value of Endometrial Cytokines in Endometrial Implantation in Cases of Intracytoplasmic Sperm Injection|Recruiting||N/A|80|Anticipated|Benha University|||1||f||||t||||||||No||2017-10-10 21:56:23.107064|2017-10-10 21:56:23.107064
NCT02854501|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-01|||January 2015||2015-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders|Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Poor Placentation Disorders|Completed||N/A|230|Actual|Cairo University|||4||f||||t||||||Samples Without DNA|"     The plasma tHcy concentrations were measured by means of a fluorescence polarization     immunoassay   "|Yes||2017-10-10 21:56:23.192315|2017-10-10 21:56:23.192315
NCT02854488|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-05-15|||September 30, 2016|Actual|2016-09-30|May 2017|2017-05-01|August 31, 2024|Anticipated|2024-08-31|August 31, 2024|Anticipated|2024-08-31||Observational|||Yervoy Pregnancy Surveillance Study|A Global Enhanced Pharmacovigilance Pregnancy Surveillance Study of Pregnant Women Exposed to Yervoy With 5 -Year Pediatric Follow-up|Recruiting||N/A|10|Anticipated|Bristol-Myers Squibb|||1||f||||||||||||||2017-10-10 21:56:23.266356|2017-10-10 21:56:23.266356
NCT02854475|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-29|||July 2016||2016-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Confocal Raman Spectroscopy: in Vivo Measurement of Physiological Skin Parameters|Confocal Raman Spectroscopy: in Vivo Measurement of Physiological Skin Parameters - A Pilot Study|Completed||N/A|15|Actual|University of Vienna||1|||f||||f||||||||Undecided||2017-10-10 21:56:23.346642|2017-10-10 21:56:23.346642
NCT02854462|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-08|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Supporting Children's School Readiness.|A Randomised Control Trial to Test the Effect of Parents' Inference-eliciting Questions During Shared Book Reading on 4-year-olds' Listening Comprehension|Recruiting||N/A|120|Anticipated|University of Sheffield||2|||f||||f||||||||Yes|Yes. IPD will be archived in accordance with the guidelines and protocol of the University of Sheffield, the UK Data Archive and the ESRC's Research Data Policy. With parents' permission, data will be made available in a timely manner, after outcomes have been published together with appropriate metadata in line with ESRC policy around data archiving.|2017-10-10 21:56:23.420276|2017-10-10 21:56:23.420276
NCT02854449|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2016-08-01|||August 2016||2016-08-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|August 2017|Anticipated|2017-08-01|3 Months|Observational [Patient Registry]|TRHR||Tumor Response in Hypofractionated Radiotherapy|Biomarkers of Tumor Response in Hypofractionated Radiotherapy|Not yet recruiting||N/A|30|Anticipated|Peking University First Hospital|||1||f||||f||||||||No||2017-10-10 21:56:23.512128|2017-10-10 21:56:23.512128
NCT02854436|ClinicalTrials.gov processed this data on October 10, 2017|2016-08-01|2017-09-27|||August 31, 2016|Actual|2016-08-31|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|October 1, 2019|Anticipated|2019-10-01||Interventional|Galahad||An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies|A Phase 2 Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies|Suspended||Phase 2|160|Anticipated|Janssen Research & Development, LLC||1||"Current participants remain active and on study treatment; new enrollment may resume pending   review of data collected"|f||||f||f||||||||2017-10-10 21:56:23.585389|2017-10-10 21:56:23.585389
NCT02854423|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-07-29|||January 2007||2007-01-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|May 2012|Actual|2012-05-01||Observational|RUDI 2D||Comparison of Biodegradable Polymer vs Durable-polymer in Diabetic Patients|Long-term Comparison of Biodegradable Polymer Biolimus-eluting Stents and Durable-polymer Everolimus-eluting Stents in Patients With Diabetes Mellitus|Completed||N/A|1347|Actual|University of Roma La Sapienza|||2||f||||f||||||||||2017-10-10 21:56:23.812151|2017-10-10 21:56:23.812151
NCT02854410|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-23|2016-07-31|||August 2016||2016-08-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients|Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients Pre and Post Concurrent Chemo-radiation Therapy|Not yet recruiting||N/A|30|Anticipated|Capital Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:56:23.874426|2017-10-10 21:56:23.874426
NCT02854397|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-09-27|||February 2016||2016-02-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|BRADYKID||Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population||Recruiting||N/A|94|Anticipated|University Hospital, Grenoble|||3||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 21:56:23.954267|2017-10-10 21:56:23.954267
NCT02854384|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-03|||January 2015||2015-01-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Mobile Phone Radiation and Brain Rhythm in Epileptic Patients|Mobile Phone Radiation and Brain Rhythm in Epileptic Patients|Completed||N/A|60|Actual|Kasr El Aini Hospital|||2||f||||t||||||||Undecided||2017-10-10 21:56:24.105583|2017-10-10 21:56:24.105583
NCT02854371|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-03-14|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI|Evaluation of Hepatic Function Using Gd-EOB-DTPA Enhanced Liver Magnetic Resonance Imaging|Active, not recruiting||Phase 4|54|Actual|Seoul National University Hospital||1|||f||||t||||||||No||2017-10-10 21:56:24.156882|2017-10-10 21:56:24.156882
NCT02854358|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-02|||March 2015||2015-03-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy of Traditional Persian Medicine Preparation Versus Artificial Saliva for Radiation Induced Xerostomia||Completed||Phase 2|60|Actual|Shiraz University of Medical Sciences||2|||f||||||||||||||2017-10-10 21:56:24.246586|2017-10-10 21:56:24.246586
NCT02854345|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-04|||September 2014||2014-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|PARAT-CZT||Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera|Preliminary Study Concerning the Validity of Parathyroid Exploration on a Discovery NM 530c CZT Camera|Recruiting||N/A|90|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:56:24.311144|2017-10-10 21:56:24.311144
NCT02854332|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-29|||June 2015||2015-06-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DOLORIS||Analgesic Stimulation Non-invasive of the Motor Cortex|Evaluation of Repetitive Magnetic Stimulation Versus Direct Current Stimulation, in Chronic Neuropathic and Drug-resistant Pain Treatment|Recruiting||N/A|40|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:56:24.385832|2017-10-10 21:56:24.385832
NCT02854319|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-12|||September 7, 2016|Actual|2016-09-07|April 2017|2017-04-01|October 30, 2019|Anticipated|2019-10-30|June 30, 2019|Anticipated|2019-06-30||Interventional|REPRISE EDGE||REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System|REPRISE EDGE: REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System - Evaluation of Performance and Safety|Active, not recruiting||N/A|60|Actual|Boston Scientific Corporation||1|||f||||t|f|f||||||No||2017-10-10 21:56:24.488869|2017-10-10 21:56:24.488869
NCT02854306|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-29|||March 2013||2013-03-01|July 2016|2016-07-01||||September 2016|Anticipated|2016-09-01||Interventional|PConscience||Mindfulness in Preparation to Bariatric Surgery|Psycho-sensorial Mindfulness and Top-down Control : Mindfulness Program for Obese Patients in Preparation to Bariatric Surgery|Recruiting||N/A|100|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:56:24.579725|2017-10-10 21:56:24.579725
NCT02851030|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-13|||August 2016||2016-08-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|MPL||Move, Play, Learn! Creating Active Classrooms in Early Care and Education Centers|Move, Play, Learn! Creating Active Classrooms in Early Care and Education Centers|Completed||N/A|208|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 21:56:55.675797|2017-10-10 21:56:55.675797
NCT02854293|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-02|||May 2012||2012-05-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|QUEPAL||Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care Consultation|Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care Consultation|Completed||N/A|121|Actual|Institut Curie|||2||f||||t||||||||No||2017-10-10 21:56:24.687527|2017-10-10 21:56:24.687527
NCT02854280|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-02|||June 2013||2013-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|NEUROX||Brain During Effort : Effects of Hypoxia With Respiratory Patients|Brain During Effort : Effects of Hypoxia With Respiratory Patients|Recruiting||N/A|72|Anticipated|University Hospital, Grenoble||3|||f||||f||||||||||2017-10-10 21:56:24.768315|2017-10-10 21:56:24.768315
NCT02854267|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-04-13|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CANEVAS||Organ Procurement : Usefulness of a Guide for Meeting With the Next of Kin|Organ Procurement : Usefulness of a Guide for Meeting With the Next of Kin|Recruiting||N/A|180|Anticipated|Assistance Publique - Hôpitaux de Paris|||4||f||||f|f|f||||||Undecided||2017-10-10 21:56:24.911801|2017-10-10 21:56:24.911801
NCT02854254|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-29|||December 2012||2012-12-01|July 2016|2016-07-01||||October 2014|Actual|2014-10-01||Interventional|DOBUTAPICC||Peripherally Inserted Central Catheter Use for Dobutamine Infusion in Heart Failure Patients|Peripherally Inserted Central Catheters (PICC) Reduce Phlebitis Incidence in Heart Failure Patients Receiving Prolonged Intravenous Inotropic Infusion: a Randomized Trial.|Active, not recruiting||N/A|80|Anticipated|InCor Heart Institute||2|||f||||t||||||||||2017-10-10 21:56:24.979647|2017-10-10 21:56:24.979647
NCT02854241|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2017-02-12|||July 2016||2016-07-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance|Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging as a Surveillance Test for HCC in Patients With Liver Cirrhosis|Active, not recruiting||N/A|40|Actual|Seoul National University Hospital||1|||f||||f||||||||No||2017-10-10 21:56:25.247005|2017-10-10 21:56:25.247005
NCT02854228|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-29|||February 2007||2007-02-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2015|Actual|2015-12-01||Observational|PITUICARE-Lyon||PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon|PITUItary Carcinomas or Aggressive Tumors REgistry: Monocentric Study Form a Cohort of Patient Operated on for Pituitary Tumors in University Hospital of Lyon (France)|Recruiting||N/A|1300|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     DNA and pituitary tumor frozen sample (Neurobiotec Biological Resource Centre (BRC) of     Hospices Civils de Lyon (HCL))   "|||2017-10-10 21:56:25.355557|2017-10-10 21:56:25.355557
NCT02854215|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-04|||January 18, 2017|Actual|2017-01-18|March 2017|2017-03-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|CURSOC||Cost Utility of Radical Surgery in Ovarian Cancer|Cost Utility of Radical Surgery in Ovarian Cancer|Recruiting||N/A|200|Anticipated|Institut Claudius Regaud||1|||f||||f|f|f||||||||2017-10-10 21:56:25.467839|2017-10-10 21:56:25.467839
NCT02854202|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-08-02|||August 2012||2012-08-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|December 2014|Actual|2014-12-01||Interventional|PBD||High Protein Breakfast on Postprandial Glycemia in T2D (PBD)|Effect of High Protein Breakfast on Overall Postprandial Glycemia in Type 2 Diabetes|Active, not recruiting||N/A|60|Anticipated|Hospital de Clinicas Caracas||3|||f||||f||||||||No||2017-10-10 21:56:25.631981|2017-10-10 21:56:25.631981
NCT02854189|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-07-31|||January 2011||2011-01-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2013|Actual|2013-04-01||Interventional|||The Results of Oxford Unicompartmental Knee Arthroplasty in Patients With and Without Preoperative Genu Recurvatum|Department of Orthopaedics Faculty of Medicine Thammasat University Thailand|Completed||N/A|104|Actual|Thammasat University||2|||f||||t||||||||No||2017-10-10 21:56:25.734594|2017-10-10 21:56:25.734594
NCT02854176|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-02|||September 2016||2016-09-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Somatosensory Stimulation in Knee Osteoarthritis|Somatosensory Electrical Stimulation to Improve Motor Control in Patients Suffering From Knee Osteoarthritis|Not yet recruiting||Phase 2|20|Anticipated|University Medical Center Groningen||2|||f||||f||||||||No||2017-10-10 21:56:25.823207|2017-10-10 21:56:25.823207
NCT02854163|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-22|||October 2016||2016-10-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SATURN||Effect of Secukinumab in the Treatment of Psoriatic Arthritis|An Exploration of the Dynamic Interaction Between IL-17, IL-17 Inhibition With (Secukinumab) and Neutrophils in Psoriatic Arthritis in Vitro and ex Vivo With Exploratory Study on the Potential Role of Vitamin D|Recruiting||Phase 2|20|Anticipated|University of Liverpool||1|||f||||t||||||||Yes|via publication|2017-10-10 21:56:25.92973|2017-10-10 21:56:25.92973
NCT02854150|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-02|||September 2015||2015-09-01|July 2016|2016-07-01||||September 2017|Anticipated|2017-09-01||Observational|EXOSPINA||Improving Genetic Counseling for Patients With Spina Bifida Using Next Generation Sequencing|Improving Genetic Counseling for Patients With Spina Bifida Using Next Generation Sequencing|Active, not recruiting||N/A|100|Actual|Rennes University Hospital|||1||f||||||||||||||2017-10-10 21:56:26.072743|2017-10-10 21:56:26.072743
NCT02854137|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-07-29|||October 2015||2015-10-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes|Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes|Completed||N/A|23|Actual|Bayer||2|||f||||f||||||||||2017-10-10 21:56:26.142933|2017-10-10 21:56:26.142933
NCT02854124|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-31|2016-07-31|||September 2016||2016-09-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|DISSEMELA||Tracing Dissemination of Melanoma Cells in Healthy Tissues|Melanoma Cells Dissemination Study in Healthy Patients' Tissues|Not yet recruiting||N/A|214|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Primary melanoma, sentinel lymph node and peritumoral skin tissu   "|No||2017-10-10 21:56:26.239426|2017-10-10 21:56:26.239426
NCT02854098|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2017-03-29|||April 2015||2015-04-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01|1 Day|Observational [Patient Registry]|MobCon||The Comorbidity of Benign Hypermobility Joint Syndrome and Functional Constipation in Children|The Comorbidity of Benign Hypermobility Joint Syndrome and Functional Constipation in Children|Recruiting||N/A|400|Anticipated|Medical University of Warsaw|||2||f||||f||||||||No||2017-10-10 21:56:26.42777|2017-10-10 21:56:26.42777
NCT02854085|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-12|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Art Therapy and Music Reminiscence Activity in the Prevention of Cognitive Decline|Art Therapy and Music Reminiscence Activity in the Prevention of Cognitive Decline|Completed||N/A|68|Actual|National University, Singapore||3|||f||||f||||||||||2017-10-10 21:56:26.51756|2017-10-10 21:56:26.51756
NCT02854072|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-11-20|||November 2015||2015-11-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients|A Prospective, Randomized, Open-label, Multicenter, Parallel Design, Phase III Study to Assess the Efficacy and Safety of GV1001 Concurrent With Gemcitabine/Capecitabine Versus Gemcitabine/Capecitabine Alone in Treating Locally Advanced and Metastatic Pancreatic Cancer Patients|Recruiting||Phase 3|148|Anticipated|Samsung Pharmaceutical Co., Ltd.||2|||f||||t||||||||Undecided||2017-10-10 21:56:26.62017|2017-10-10 21:56:26.62017
NCT02854059|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-07-11|||September 2016||2016-09-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||IdeS in Asymptomatic Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients|A Phase II Pilot Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients With Low ADAMTS13 Activity|Terminated||Phase 1/Phase 2|2|Actual|Hansa Medical AB||1||Sponsor review of initial results demonstrates a non-favourable risk benefit|f||||t||||||||||2017-10-10 21:56:26.786362|2017-10-10 21:56:26.786362
NCT02854046|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-29|||August 2016||2016-08-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|CalciWest||Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome|Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome : a Multicentric, Retrospective Cohort|Not yet recruiting||N/A|225|Anticipated|Nantes University Hospital|||2||f||||f||||||||No||2017-10-10 21:56:26.886247|2017-10-10 21:56:26.886247
NCT02854033|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-10-04|||October 2016||2016-10-01|October 2017|2017-10-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|ADNI3||Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol|Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol|Recruiting||N/A|2000|Anticipated|University of Southern California|||3||f||||t||||||Samples With DNA|"     blood, urine, cerebrospinal fluid   "|||2017-10-10 21:56:26.989628|2017-10-10 21:56:26.989628
NCT02854007|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-29|||June 2016||2016-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|12 Months|Observational [Patient Registry]|REPARA-QALY||Costs, Effectiveness, QALYs, and Efficiency of Bioabsorbable Devices in Daily Clinical Practice|REgistry of PAtients Treated With bioabsoRbable Devices in dAily Clinical Practice: Costs, Effectiveness, QALYs, and Efficiency. REPARA-QALY Registry|Recruiting||N/A|1000|Anticipated|Sección Hemodinamica y Cardiologia Intervencionista|||1||f||||f||||||||No||2017-10-10 21:56:27.368437|2017-10-10 21:56:27.368437
NCT02853994|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-29|||September 2016||2016-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice|Assessment of Safety and Efficacy of the DEVOIR Sirolimus-Coated Balloon for the Treatment of Native Coronary Artery Lesions in the Real-world Clinical Practice|Not yet recruiting||N/A|500|Anticipated|MINVASYS|||1||f||||f||||||||||2017-10-10 21:56:27.441943|2017-10-10 21:56:27.441943
NCT02853981|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-08-02|||January 2015||2015-01-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|KK_HS||Clamp-crush Technique Versus Harmonic Scalpel in Living Donor Hepatectomy|Clamp-crush Technique Versus Harmonic Scalpel in Living Donor Hepatectomy. A Single Blinded Randomized Controlled Trial|Recruiting||Phase 2|60|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 21:56:27.493116|2017-10-10 21:56:27.493116
NCT02853968|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-06-26|||May 2016||2016-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Unlock the Cell: Castleman's Disease Flow Cytometry Study|Unlock the Cell: Intracellular Inflammatory Pathways and Flow Cytometry Study for Castleman's Disease|Recruiting||N/A|70|Anticipated|University of Pennsylvania|||2||f||||t||||||Samples With DNA|"     This research project will be collecting blood samples and/or buccal swabs. Patients will     also be given the option to consent for lymph node and bone marrow slides collected for the     registry that are determined to be unnecessary for the registry to be used for research     studies, such as genomic sequencing or immunohistochemistry.   "|Yes|Qualified Researchers, who apply for access to the data and are subsequently approved, will be given access to a limited dataset with direct identifiers removed in an Excel compatible file format or single SAS data files.|2017-10-10 21:56:27.569158|2017-10-10 21:56:27.569158
NCT02853955|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-08-31|||May 2016||2016-05-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Observational|MVRepair||MitraClip® After Surgical Mitral Valve Repair|MitraClip® for the Treatment of Recurrent Severe Mitral Regurgitation After Surgical Mitral Valve Repair|Recruiting||N/A|30|Anticipated|Klinikum der Universitaet Muenchen|||1||f||||f||||||||No||2017-10-10 21:56:27.656323|2017-10-10 21:56:27.656323
NCT02853942|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-07|||October 2016||2016-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial Spasm|The Research of Autologous Adipose Mesenchymal Stem Cell Transplantation for Treatment of Facial 、Auditory Nerve Dysfunction of Patients With Hemifacial Spasm After Microvascular Decompression.|Not yet recruiting||Early Phase 1|100|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||Yes||2017-10-10 21:56:27.727231|2017-10-10 21:56:27.727231
NCT02853929|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-09-26|||September 19, 2016|Actual|2016-09-19|September 2017|2017-09-01|May 13, 2019|Anticipated|2019-05-13|May 13, 2019|Anticipated|2019-05-13||Interventional|||Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery|Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Infanrix Hexa™ (217744) in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery|Recruiting||Phase 4|585|Anticipated|GlaxoSmithKline||2|||f|||||f|f||||||||2017-10-10 21:56:27.789733|2017-10-10 21:56:27.789733
NCT02853916|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-05-05|||August 2016||2016-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||Efficacy of a Brown Seaweed Powder for Glycemic Control|Efficacy of a Brown Seaweed Powder for Glycemic Control|Active, not recruiting||N/A|24|Anticipated|University of Manitoba||3|||f||||||||||||||2017-10-10 21:56:27.990909|2017-10-10 21:56:27.990909
NCT02853903|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-29|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors||Recruiting||Phase 2|200|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:56:28.056212|2017-10-10 21:56:28.056212
NCT02853890|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-07-29|||February 2016||2016-02-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|Epidol||"Management of Obstetrical Pain:  7 Days Survey of Obstetric Analgesia/Anesthesia in France"|" 7 Days Survey of Obstetric Analgesia/Anesthesia in France (EPIDOL)"|Recruiting||N/A|2500|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||No||2017-10-10 21:56:28.127749|2017-10-10 21:56:28.127749
NCT02853877|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-04-14|||August 2, 2016|Actual|2016-08-02|April 2017|2017-04-01|April 7, 2017|Actual|2017-04-07|January 4, 2017|Actual|2017-01-04||Interventional|HELP||Helping Employees Lose Pounds|Translating Insights From Behavioral Economics and Self-Determination Theory to Promote Sustained Weight Loss Among Obese Employees|Completed||N/A|62|Actual|University of Michigan||2|||f||||f|f|f||||||No||2017-10-10 21:56:28.197399|2017-10-10 21:56:28.197399
NCT02853864|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-10-23|||May 2016||2016-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Influence of Gender on Interaction of Propofol and Dexmedetomidine|Influence of Gender on Interaction of Propofol and Dexmedetomidine|Completed||Phase 4|120|Actual|Guangzhou General Hospital of Guangzhou Military Command||4|||f||||f||||||||No||2017-10-10 21:56:28.279706|2017-10-10 21:56:28.279706
NCT02853851|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-29|||January 2015||2015-01-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Observational|PS-ICU||Construction and Validation of a Stress Scale Specific to ICUs: Perceived Stressors in Intensive Care Units (PS-ICU)|Construction and Validation of a Stress Scale Specific to ICUs: Perceived Stressors in Intensive Care Units (PS-ICU)|Recruiting||N/A|160|Anticipated|Centre Hospitalier Universitaire de Besancon|||4||f||||f||||||||Yes|eCRF|2017-10-10 21:56:28.368827|2017-10-10 21:56:28.368827
NCT02853838|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-10-25|||March 2015||2015-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)|Effectiveness of Chest Physiotherapy in Infants Hospitalized With Acute Bronchiolitis SRV (+): a Randomized Controled Trial|Completed||N/A|204|Actual|Universidad del Desarrollo||2|||f||||f||||||||Undecided|Data will be made available, If journal where report will be published requires to give access to individual patient data|2017-10-10 21:56:28.459557|2017-10-10 21:56:28.459557
NCT02853825|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-15|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Interventional|JFCS:HFHC||RCT of the Jewish Family & Children's Services (JFCS) HFHC Program|Randomized Controlled Trial of the Jewish Family & Children's Service of the Suncoast, Inc.'s Healthy Families/Healthy Children Program|Recruiting||N/A|786|Anticipated|Jewish Family & Children's Service of the Suncoast, Inc.||2|||f||||f||||||||||2017-10-10 21:56:28.552181|2017-10-10 21:56:28.552181
NCT02853812|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-03|||March 2013||2013-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|ACCELA||Tinnitus Related Cerebral Activities|Tinnitus Related Cerebral Activities: Personalised Approach of the Tinnitus Treatment|Active, not recruiting||N/A|30|Actual|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:56:31.388107|2017-10-10 21:56:31.388107
NCT02853799|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-29|||August 2016||2016-08-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of the Effects of Intermittent and Continuous Enteral Feeding on Glucose-Insulin Dynamics in Critically Ill Medical Patients|Comparison of the Effects of Intermittent and Continuous Enteral Feeding on Glucose-Insulin Dynamics in Critically Ill Medical Patients|Not yet recruiting||Early Phase 1|20|Anticipated|San Antonio Military Medical Center||2|||f||||f||||||||||2017-10-10 21:56:31.481885|2017-10-10 21:56:31.481885
NCT02853786|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-29|||September 2016||2016-09-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|ISLODA||Language Environment in Children With Cochlear Implants|Influence of Language Environment in Children With Cochlear Implants|Not yet recruiting||N/A|90|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||No||2017-10-10 21:56:31.557603|2017-10-10 21:56:31.557603
NCT02853773|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-07-29|||February 2016||2016-02-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|SUGART||Effects of Consuming Artificial Sweeteners and Sugar on Cerebral and Physiological Responses|Acute Effects of Artificial Sweeteners and Sugar on the Brain Dynamics to Food Image Viewing. An Exploratory, Monocentric, Randomized Controlled Trial in Healthy Young Men|Recruiting||N/A|18|Anticipated|University of Lausanne||3|||f||||f||||||||No||2017-10-10 21:56:31.624848|2017-10-10 21:56:31.624848
NCT02853760|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-02|||May 2015||2015-05-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Affective Responses in Mountain Hiking|Affective Responses in Mountain Hiking: A Randomized Controlled Trial Focusing on Differences Between Indoor and Outdoor Activity|Completed||N/A|47|Actual|Universitaet Innsbruck||3|||f||||f||||||||||2017-10-10 21:56:31.712055|2017-10-10 21:56:31.712055
NCT02853747|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-24|||May 2016||2016-05-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Observational|ExAMIN YOUTH||Exercise and Arterial Modulation in Youth||Recruiting||N/A|1200|Anticipated|University of Basel|||1||f||||t||||||||||2017-10-10 21:56:31.773371|2017-10-10 21:56:31.773371
NCT02853734|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-18|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|July 2019|Anticipated|2019-07-01||Interventional|BACTERIOB||Inflammatory Status of Visceral Adipose Tissue in Obese Patients Related to Periodontitis Severity|Comparative Evaluation of the Inflammatory Status of Visceral Adipose Tissue From Obese Patients According to the Presence and Severity of Periodontitis|Not yet recruiting||N/A|122|Anticipated|Centre Hospitalier Universitaire de la Réunion||2|||f||||t|f|f||||||||2017-10-10 21:56:31.844377|2017-10-10 21:56:31.844377
NCT02853721|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-07-29|||January 2014||2014-01-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Early Prediction of Hypocalcaemia Following Thyroid Surgery|Early Prediction of Hypocalcaemia Following Thyroid Surgery: A Prospective Randomized Clinical Trial|Completed||N/A|150|Actual|University of Cagliari||2|||f||||f||||||||Undecided||2017-10-10 21:56:31.909808|2017-10-10 21:56:31.909808
NCT02853708|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-29|||June 2015||2015-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|coliST131||Epidemiology of ST131 in Besançon University Hospital|Epidemiology of ST131 in Besançon University Hospital|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||Samples Without DNA|"     Bacterial isolate   "|No||2017-10-10 21:56:31.974065|2017-10-10 21:56:31.974065
NCT02853695|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-29|||August 2016||2016-08-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Implementation of Hysteroscopy in Flanders and the Netherlands|Implementation of Hysteroscopy in Flanders and the Netherlands|Not yet recruiting||N/A|480|Anticipated|University Hospital, Ghent|||1||f||||||||||||||2017-10-10 21:56:32.040025|2017-10-10 21:56:32.040025
NCT02853682|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-01-30|||August 2016||2016-08-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|GLYNO||Characterization of Endothelial Dysfunction as a Function of Hyperaemia of the Brachial Artery During Cardiac Surgery|Characterization of Endothelial Dysfunction as a Function of Hyperaemia of the Brachial Artery During Cardiac Surgery|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire, Amiens|||2||f||||t||||||||No||2017-10-10 21:56:32.110681|2017-10-10 21:56:32.110681
NCT02853669|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-08-02|||July 2016||2016-07-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Adductor Canal Block Versus Lumbar Plexus Block for Post Operative Pain Management After Total Knee Replacement|Adductor Canal Block Versus Lumbar Plexus Block for Post Operative Pain Management After Total Knee Replacement|Recruiting||N/A|26|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 21:56:32.28425|2017-10-10 21:56:32.28425
NCT02853656|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-12-05|||August 2016||2016-08-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Time to Delivery of Preterm Birth|Time to Delivery of Preterm Birth|Recruiting||N/A|242|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 21:56:32.377404|2017-10-10 21:56:32.377404
NCT02853643|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-01-23|||July 2016||2016-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers|A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect in Healthy Volunteers|Completed||Phase 1|22|Actual|Asana BioSciences||3|||f||||f||||||||No||2017-10-10 21:56:32.459907|2017-10-10 21:56:32.459907
NCT02853630|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-29|||December 2013||2013-12-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus|A Multicentric, Randomized, Open Label Study on Comparison of Pancreatic Beta Cell Recovery and Preservation in Type 2 Diabetic Patients Treated With DPP-4 Inhibitor (Vildagliptin) and Metformin|Active, not recruiting||Phase 4|203|Actual|India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals||2|||f||||t||||||||Undecided||2017-10-10 21:56:32.546079|2017-10-10 21:56:32.546079
NCT02853617|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-08-15|||March 22, 2017|Actual|2017-03-22|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of AV0328 Administered to Healthy Adult Volunteers|A Phase I/II, Single and Repeat Dose, Dose Escalation Study of AV0328 Administered to Healthy Adult Volunteers|Active, not recruiting||Phase 1/Phase 2|16|Actual|Alopexx Vaccine, LLC||4|||f||||t|t|f|||f|||||2017-10-10 21:56:32.655278|2017-10-10 21:56:32.655278
NCT02853604|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-06-07|||September 2016||2016-09-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|AIM2CERV||Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer|Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV|Recruiting||Phase 3|450|Anticipated|Advaxis, Inc.||2|||f||||t||||||||No||2017-10-10 21:56:32.759169|2017-10-10 21:56:32.759169
NCT02853591|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-03|||October 2016||2016-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Pneumoinsufflation Modes and Pressure Settings in Gynecology|A Randomized-Controlled Trial of Conventional Pneumoinsufflation and Pressure-Barrier Insufflation at High and Low Pressures in Gynecologic Surgery|Recruiting||N/A|80|Anticipated|The Cleveland Clinic||4|||f||||f||||||||||2017-10-10 21:56:32.960374|2017-10-10 21:56:32.960374
NCT02853578|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-11|||March 2018|Anticipated|2018-03-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|Laennec||Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled|National Clinical Study, Multicentric, Single Arm to Evaluate the Efficacy and Safety of Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled|Not yet recruiting||Phase 3|80|Anticipated|Ache Laboratorios Farmaceuticos S.A.||1|||f||||f|f|f|||f|||||2017-10-10 21:56:33.08559|2017-10-10 21:56:33.08559
NCT02853565|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-09-20|||August 2016||2016-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme|A Phase I Study of CAN008 Plus Concomitant Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme|Recruiting||Phase 1|15|Anticipated|CANbridge Life Sciences Ltd.||1|||f||||t||||||||||2017-10-10 21:56:33.179979|2017-10-10 21:56:33.179979
NCT02853552|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-07-29|||October 2016||2016-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding|Use of Misoprostol by Families and Women as a First Aid Measure to Address Excessive Postpartum Bleeding in Home Deliveries|Not yet recruiting||Phase 4|4330|Anticipated|Gynuity Health Projects|||||f||||||||||||No||2017-10-10 21:56:33.282913|2017-10-10 21:56:33.282913
NCT02853539|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-29|||January 2011||2011-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Denoz||Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients|Denosumab Counteracts Metabolic Bone Disease in Chronic Intestinal Failure Patients: A Randomized, Controlled Clinical Trial|Completed||Phase 4|32|Actual|Stanley Dudrick's Memorial Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:56:33.355029|2017-10-10 21:56:33.355029
NCT02853526|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-29|||July 2015||2015-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV|Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis (PVT) and Cavernous Transformation of the Portal Vein (CTPV)|Recruiting||Phase 3|100|Anticipated|Sun Yat-sen University||2|||f||||f||||||||Undecided||2017-10-10 21:56:33.426552|2017-10-10 21:56:33.426552
NCT02853513|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-06-22|||July 2016||2016-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|November 2016|Actual|2016-11-01||Observational|BV13||Probabilistic Risk Modeling for Disorder Post Traumatic Stress (PTSD) After the Attacks in Paris In November 2015|Definition of a Probabilistic Model of the Evolution of an Acute Stress Disorder (ASD ) to a Posttraumatic Stress Disorder (PTSD): an Analytical Prospective Cohort Study of Patients Directly Involved in Attacks Terrorists of 13 November 2015|Enrolling by invitation||N/A|100|Anticipated|University Hospital, Tours|||1||f||||t||||||||Undecided||2017-10-10 21:56:33.514186|2017-10-10 21:56:33.514186
NCT02853500|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-14|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies|Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies|Recruiting||N/A|10|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 21:56:33.569706|2017-10-10 21:56:33.569706
NCT02853487|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Circadian Rhythm and Attack-timing in Episodic Cluster Headache Patients in- and Outside of Bout: an Actigraphic Study|Circadian Rhythm and Attack-timing in Episodic Cluster Headache Patients in- and Outside of Bout: an Actigraphic Study|Recruiting||N/A|36|Anticipated|Danish Headache Center|||2||f||||t||||||||Undecided||2017-10-10 21:56:33.655413|2017-10-10 21:56:33.655413
NCT02853474|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-07-18|||August 2016||2016-08-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|EPIC-1511||Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy|Impact of Early Palliative Care on Overall Survival of Patients With Metastatic Upper Gastrointestinal Cancers, Treated With First-line Chemotherapy: a Randomized Phase III Trial|Recruiting||Phase 3|480|Anticipated|Centre Oscar Lambret||2|||f||||f||||||||||2017-10-10 21:56:33.736229|2017-10-10 21:56:33.736229
NCT02853461|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-03|||June 2014||2014-06-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Biofilm Investigation on Bearing Components of Explanted Hip Joint Prosthesis|Biofilm Investigation on Ceramic, Metal and Polyethylene Bearing Components From Explanted Hip Joint Prosthesis|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||1||f||||t||||||||Yes||2017-10-10 21:56:33.995188|2017-10-10 21:56:33.995188
NCT02853448|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-04-12|||January 2016||2016-01-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of a Device That Separates Blood Cells From Serum/Plasma|Evaluation of a Device That Separates Blood Cells From Serum/Plasma for Analysis of Clinical Chemistries|Recruiting||N/A|10|Anticipated|Boston University||1|||f||||f|f|f||||||Undecided||2017-10-10 21:56:34.08288|2017-10-10 21:56:34.08288
NCT02853435|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-08|||August 4, 2016|Actual|2016-08-04|August 2017|2017-08-01|November 6, 2017|Anticipated|2017-11-06|November 6, 2017|Anticipated|2017-11-06||Interventional|||To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.|A Phase I, Multi-Center, Open-Label, Single-Dose, 2 Part Study to Evaluate the Relative Bioavailability of Three Formulations in Healthy Subjects, Food Effect on Tablet Formulation in Healthy Subjects, and Pharmacokinetics of Gepotidacin (GSK2140944) in Japanese and Chinese Subjects|Recruiting||Phase 1|67|Anticipated|GlaxoSmithKline||7|||f||||f||||||||||2017-10-10 21:56:34.177001|2017-10-10 21:56:34.177001
NCT02853422|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-02-17|||April 2016||2016-04-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|QUALINETS||Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours|A Study Evaluating The Clinical Utility Of The Health-Related Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours QUALINETS Study|Completed||N/A|199|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 21:56:34.322698|2017-10-10 21:56:34.322698
NCT02853409|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-07-28|||January 2014||2014-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PROS-PROSQoLI||Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer|Prospective Epidemiological Study to Determine the Variation in the Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer (PROS-PROSQoLI Study)|Completed||N/A|628|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 21:56:34.45526|2017-10-10 21:56:34.45526
NCT02853396|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||July 2016||2016-07-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study of an Cognitive Behaviour Therapy for Internalised Stigma Intervention for Inpatients With Psychosis|A Pilot of a Brief Cognitive Behaviour Therapy Formulation Focused Intervention for Internalised Stigma With Acute Inpatients That Experience Psychosis|Recruiting||N/A|30|Anticipated|University of Manchester||2|||f||||f||||||||||2017-10-10 21:56:34.557164|2017-10-10 21:56:34.557164
NCT02853383|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-12-26|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|3 Years|Observational [Patient Registry]|||Registry of COPD Patients From Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Moscow|Registry of COPD Patients Who Undergo Outpatient Treatment or Are Under Surveillance at Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Moscow|Recruiting||N/A|4050|Anticipated|Interregional Public Organization, Russian Respiratory Society|||1||f||||f||||||||No||2017-10-10 21:56:34.644899|2017-10-10 21:56:34.644899
NCT02853370|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-24|||July 2012||2012-07-01|August 2016|2016-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma|Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma. The International Extranodal Lymphoma Study Group (IELSG) 36 Phase II Prospective Study|Active, not recruiting||Phase 2|65|Actual|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||||||||||||2017-10-10 21:56:34.733353|2017-10-10 21:56:34.733353
NCT02853357|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-30|||October 2016||2016-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Thoracic Spine Manipulation for Individuals With Low Back Pain|Short-term Effects of Thoracic Spine Thrust Manipulation for Individuals With Low Back Pain: A Randomized Control Trial|Enrolling by invitation||N/A|108|Anticipated|University of Michigan||2|||f||||t||||||||No||2017-10-10 21:56:34.857391|2017-10-10 21:56:34.857391
NCT02853344|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-19|||September 30, 2016|Actual|2016-09-30|September 2017|2017-09-01|May 13, 2020|Anticipated|2020-05-13|May 13, 2020|Anticipated|2020-05-13||Interventional|||Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)|A Phase II Single-arm, Open-label Monotherapy Clinical Trial of Pembrolizumab (MK-3475) in Locally Advanced/Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-427)|Recruiting||Phase 2|255|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f|t|f||||||||2017-10-10 21:56:34.961033|2017-10-10 21:56:34.961033
NCT02853331|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-20|||September 16, 2016|Actual|2016-09-16|September 2017|2017-09-01|January 27, 2020|Anticipated|2020-01-27|January 27, 2020|Anticipated|2020-01-27||Interventional|||Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)|A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-426)|Recruiting||Phase 3|840|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t|t|f||||||||2017-10-10 21:56:35.135658|2017-10-10 21:56:35.135658
NCT02853318|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-25|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|August 3, 2018|Anticipated|2018-08-03|August 3, 2018|Anticipated|2018-08-03||Interventional|||Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Evaluation of Pembrolizumab in Combination With IV Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 2|40|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-10 21:56:35.345292|2017-10-10 21:56:35.345292
NCT02853292|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-29|||May 2016||2016-05-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|CRISTAMOX||Incidence, Risk Factors and Impact on Renal Function of the Appearance of Crystalluria Under High-dose Intravenous Amoxicillin|Incidence, Risk Factors and Impact on Renal Function of the Appearance of Crystalluria Under High-dose Intravenous Amoxicillin|Recruiting||N/A|153|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 21:56:35.856981|2017-10-10 21:56:35.856981
NCT02853279|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-28|||June 2011||2011-06-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Physical Activity and Intermittent Exercise Training for Cardiovascular and Cognitive Gain in Obese Women|The Effect of (i) Physical Activity and (ii) Continuous Versus Intermittent Exercise Training Upon Cardiovascular and Cognitive Function in Obese Women|Completed||N/A|25|Actual|University of Leeds||2|||f||||f||||||||No||2017-10-10 21:56:35.939317|2017-10-10 21:56:35.939317
NCT02853266|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-28|||September 2011||2011-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Observational|KAWASAKI Ac||Measurement of Antibodies in Adults With a History of Kawasaki Disease|Measurement of Antibodies in Adults With a History of Kawasaki Disease|Active, not recruiting||N/A|75|Actual|Hospices Civils de Lyon|||2||f||||f||||||Samples Without DNA|"     de-identified and study coded serum sample   "|||2017-10-10 21:56:36.037151|2017-10-10 21:56:36.037151
NCT02853253|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-01|||January 2017||2017-01-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|SMOF||Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and Medialipide|Rate of Bronchopulmonary Dysplasia in Preterms Neonates Less Than 29 Weeks' Gestational Age and / or With Birth Weight Less Than 1000 g: a Double Blind Randomized Controlled Multicenter Trial Comparing SMOFlipid and Medialipide|Not yet recruiting||Phase 4|484|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||No||2017-10-10 21:56:36.115206|2017-10-10 21:56:36.115206
NCT02853240|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-08-08|||October 24, 2016|Actual|2016-10-24|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|TOXIMUS_CP||Effect of Botulinum Toxin on Muscles of Children With Cerebral Palsy|Transversal Monocentric Study of the Anatomophysiological Effect of Botulinum Toxin on the Spastic Muscle of Children With Cerebral Palsy|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 21:56:36.20155|2017-10-10 21:56:36.20155
NCT02853227|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-03|||April 2014||2014-04-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|TBS||The Telemark Score: a Reliable Method for Evaluation of Results After Breast Surgery|The Telemark Breast Score is a Valid Method for the Evaluation of Outcome After Reconstructive Surgery of the Breast|Completed||N/A|376|Actual|Sykehuset Telemark|||2||f||||t||||||||No||2017-10-10 21:56:36.300659|2017-10-10 21:56:36.300659
NCT02853214|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-01|||February 6, 2008|Actual|2008-02-06|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|PreFamDys||Familial Dysglobulinemia|Identification of Genetic Factors Predisposing to Dysglobulinemia|Recruiting||N/A|3000|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 21:56:36.374608|2017-10-10 21:56:36.374608
NCT02853201|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Observational|MIME||Monitoring Intercostal Muscles After Extubation||Recruiting||N/A|110|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||No||2017-10-10 21:56:36.45873|2017-10-10 21:56:36.45873
NCT02853188|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-01-31|||December 2014||2014-12-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|FT-KBP||Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung|Does the Measure of the Plasma Tissue Factor Allow to Predict a Venous Thromboembolism Episode for Patients Presenting a Primitive Lung Cancer?|Recruiting||N/A|300|Anticipated|Hopital Foch||1|||f||||f||||||||No||2017-10-10 21:56:36.552047|2017-10-10 21:56:36.552047
NCT02853175|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-08-08|||January 2014||2014-01-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|MRAB||Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis|Diagnostic Accuracy of Lung MRI to Detect Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis|Completed||N/A|104|Actual|Hôpital Haut-Lévêque|||2||f||||t||||||||||2017-10-10 21:56:36.674041|2017-10-10 21:56:36.674041
NCT02853162|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-28|||June 2016||2016-06-01|July 2016|2016-07-01|June 2021|Anticipated|2021-06-01|September 2019|Anticipated|2019-09-01||Interventional|ARREST||Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)|Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)|Recruiting||Phase 2|30|Anticipated|UMC Utrecht||1|||f||||f||||||||Undecided||2017-10-10 21:56:36.771665|2017-10-10 21:56:36.771665
NCT02853149|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-02-15|||June 2016||2016-06-01|February 2017|2017-02-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|DRPP||A Lifestyle Intervention Targeting Enhanced Health and Function for Persons With Chronic SCI in Caregiver/Care-Receiver Relationships: Effects of Caregiver Co-Treatment|A Lifestyle Intervention Targeting Enhanced Health and Function for Persons With Chronic SCI in Caregiver/Care-Receiver Relationships: Effects of Caregiver Co-Treatment|Recruiting||N/A|120|Anticipated|University of Miami||3|||f||||t||||||||No||2017-10-10 21:56:36.889631|2017-10-10 21:56:36.889631
NCT02853136|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-06-14|||August 25, 2016|Actual|2016-08-25|June 2017|2017-06-01|October 25, 2016|Actual|2016-10-25|October 17, 2016|Actual|2016-10-17||Interventional|||Influence of Fluvoxamine on the Pharmacokinetics of BI 409306|Influence of Fluvoxamine on the Pharmacokinetics of BI 409306 After Oral Administration (Randomized, Open-label, Two-treatment, Two-sequence, Two-period Crossover Study)|Completed||Phase 1|18|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 21:56:37.03672|2017-10-10 21:56:37.03672
NCT02853123|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-18|||September 22, 2016|Actual|2016-09-22|August 2017|2017-08-01|August 14, 2017|Actual|2017-08-14|July 24, 2017|Actual|2017-07-24||Interventional|||Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients|A Randomised, Double-blind, Cross-over Study to Evaluate the Effect of 6 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (5/5 µg) Compared With Tiotropium (5 µg), Both Delivered by the Respimat® Inhaler, on Breathlessness During the Three Minute Constant Speed Shuttle Test (3min CSST) in Patients With Chronic Obstructive Pulmonary Disease (COPD). [OTIVATO TM]|Completed||Phase 4|106|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:56:37.1408|2017-10-10 21:56:37.1408
NCT02853110|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-28|||April 2016||2016-04-01|July 2016|2016-07-01|September 2022|Anticipated|2022-09-01|September 2017|Anticipated|2017-09-01||Interventional|Hypo-FLAME||Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer|Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer (Hypo-FLAME)|Recruiting||Phase 2|100|Anticipated|UMC Utrecht||1|||f||||f||||||||Undecided||2017-10-10 21:56:37.27579|2017-10-10 21:56:37.27579
NCT02853097|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-19|||June 14, 2016|Actual|2016-06-14|August 2017|2017-08-01|June 14, 2020|Anticipated|2020-06-14|June 14, 2019|Anticipated|2019-06-14||Observational|||Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients|Studies of Cell-Free DNA and RNA in Blood From Patients Being Treated for Prostate Cancer|Recruiting||N/A|300|Anticipated|University of Southern California|||1||f||||t|f|f||||Samples With DNA|"     Blood   "|||2017-10-10 21:56:37.380108|2017-10-10 21:56:37.380108
NCT02853084|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-01-03|||October 2015||2015-10-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|May 2017|Anticipated|2017-05-01||Interventional|||HL2351 CAPS Phase II Study|An Open Label, Single Arm Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of HL2351 in Patients With Cryopyrin Associated Periodic Syndromes|Terminated||Phase 2|8|Anticipated|Handok Pharmaceuticals Co., Ltd.||1||difficult of recruiting|f||||t||||||||Undecided||2017-10-10 21:56:37.503471|2017-10-10 21:56:37.503471
NCT02853071|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-02|||January 2017||2017-01-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|BEST||Efficacy and Safety of Estracyt® in Metastatic Breast Cancer|Efficacy and Safety of Estracyt® in Metastatic Breast Cancer Hormonal Estrogen Receptor (HER 2) Negative, Hormone Receptor (HR) Positive.|Not yet recruiting||Phase 2|132|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||Yes|The Committee shall meet twice a year|2017-10-10 21:56:37.608133|2017-10-10 21:56:37.608133
NCT02853058|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-28|||July 2016||2016-07-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|UADLAB||Uterine Artery Pulsatility Index and Materno Fetal Outcomes|Uterine Artery Pulsatility Index During Labor After 34 Weeks in the Prediction of Materno Fetal Outcomes|Recruiting||N/A|600|Anticipated|University Tunis El Manar||2|||f||||f||||||||Undecided||2017-10-10 21:56:37.696504|2017-10-10 21:56:37.696504
NCT02853045|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-07-17|||June 11, 2015|Actual|2015-06-11|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|PRINGEN||Comparison of Blood Pressure Control Achieved in Antihypertensive or Generic Drugs in Moderate to Severe Hypertensive Patients|Comparison of Blood Pressure Control Achieved in Antihypertensive or Generic Drugs in Moderate to Severe Hypertensive Patients|Recruiting||Phase 4|34|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 21:56:37.797485|2017-10-10 21:56:37.797485
NCT02853032|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-05|||July 5, 2017|Actual|2017-07-05|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Image-guided, Robotically Delivered TMS Treatment for Combat-Related PTSD|Image-guided, Robotically Delivered Transcranial Magnetic Stimulation Treatment for Combat-Related PTSD: a Double-Blind, Randomized Comparison to Sham TMS|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t|f|t|f|||||||2017-10-10 21:56:37.936752|2017-10-10 21:56:37.936752
NCT02853019|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-03-07|||February 2, 2017|Actual|2017-02-02|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Emotion and Motivation in Patients With Psychosis|Influence of Emotion and Motivation on Behaviour and Neural Activity in Patients With Psychosis|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||No||2017-10-10 21:56:38.063907|2017-10-10 21:56:38.063907
NCT02853006|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-28|||June 2015||2015-06-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ECTOPIC/MUTAS||Study on Fluids Associated to Lung Cancer|Study on Fluids Associated to Lung Cancer, of the Ectopic Expression of Cancer Testis Gene and Mutation as Diagnostics and Prognosis Biomarkers|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||3|||f||||f||||||||||2017-10-10 21:56:38.153881|2017-10-10 21:56:38.153881
NCT02852993|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-01|||September 2013||2013-09-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|STeF-BFC||Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté|Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté|Completed||N/A|16099|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 21:56:38.274944|2017-10-10 21:56:38.274944
NCT02852980|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-02-09|||July 2015||2015-07-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|January 2017|Actual|2017-01-01||Observational|ERD2-DIGERD||Estimate Rate of the Women Who Have Gestational Diabetes|Retrospective Study to Estimate Screening of the Type 2 Diabetes of Women Who Had Childbirth in the Hospital Center Rene Dubos and Having Gestational Diabetes|Active, not recruiting||N/A|384|Actual|Centre Hospitalier René Dubos|||1||f||||f||||||||No||2017-10-10 21:56:38.345948|2017-10-10 21:56:38.345948
NCT02852967|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-06-23|||August 2016||2016-08-01|June 2017|2017-06-01||||August 2018|Anticipated|2018-08-01||Interventional|||This Study is Being Conducted to Evaluate the Safety, Tolerability, and Efficacy of KD025 Administered Orally for 16 Weeks to Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy.|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Tolerability, and Efficacy of KD025 in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy|Recruiting||Phase 2|180|Anticipated|Kadmon Corporation, LLC||5|||f||||f||||||||No||2017-10-10 21:56:38.438007|2017-10-10 21:56:38.438007
NCT02852954|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-15|||August 2016|Actual|2016-08-01|August 2016|2016-08-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.|Determining Levels of Expression of Progesterone-Induced Blocking Factor in Endometrial Cancer Cells.|Completed||N/A|60|Actual|Kayseri Education and Research Hospital|||3||f||||||||||||||2017-10-10 21:56:38.607661|2017-10-10 21:56:38.607661
NCT02852941|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-09-12|||July 2016||2016-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Assessment of Volumetric Hemodynamic Parameters and Nutritional Status in Stable Renal Transplant Recipients|Assessment of Volumetric Hemodynamic Parameters and Nutritional Status in Stable Renal Transplant Recipients|Completed||N/A|80|Actual|Medical University of Warsaw|||2||f||||t||||||||No||2017-10-10 21:56:38.666573|2017-10-10 21:56:38.666573
NCT02852928|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-09-30|||December 2013|Actual|2013-12-01|September 2017|2017-09-01|December 2025|Anticipated|2025-12-01|December 2024|Anticipated|2024-12-01|10 Years|Observational [Patient Registry]|chILD-EU||European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank|Orphans Unite: chILD Better Together - European Management Platform for Childhood Interstitial Lung Diseases / chILD-EU - International Register and Biobank for Children´s Interstital Lung Disease|Recruiting||N/A|1000|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||t||||||||||2017-10-10 21:56:38.751597|2017-10-10 21:56:38.751597
NCT02852915|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-03|||October 2016||2016-10-01|August 2016|2016-08-01|October 2024|Anticipated|2024-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Laparoscopic Surgery for T4 Tumor of the Colon Cancer|Laparoscopic Surgery for T4 Tumor of the Colon Cancer: A Prospective, Multi-Center, Randomized, Open-Label, Parallel Group Clinical Trial|Not yet recruiting||Phase 3|1960|Anticipated|Fudan University||2|||f||||t||||||||No||2017-10-10 21:56:39.021759|2017-10-10 21:56:39.021759
NCT02852902|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-28|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2016|Actual|2016-10-01||Observational|INCREMENT-SOT||Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacteriaceae in Solid Organ Transplantation: an Observational Multinational Study.||Active, not recruiting||N/A|400|Anticipated|Spanish Network for Research in Infectious Diseases|||1||f||||t||||||||Yes|There will be a single registry of clinical data for this project. Data will be submitted by all centers to an electronic Clinical Research File (CRF). Once the deadline for data collection is close, data will be exported to a file which will be treated as confidential, complying with all guarantees for data protection according to Spanish legislation. Investigators from the consortium will have access to all data from their own institution at all times. Access to the whole database will be provided after specific requests for defined analysis and publications, always after approval by the Scientific Committee. This clinical file will be saved for an estimated period of three years in order to allow the necessary time for publication of results.|2017-10-10 21:56:39.107671|2017-10-10 21:56:39.107671
NCT02852876|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-07-29|||September 2005||2005-09-01|July 2016|2016-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food|A Double-Blind, Placebo-Controlled Single Dose Escalating Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2151 in Healthy Male Subjects, Followed by an Open, Two-Period Crossover Study to Assess the Effect of Fed Conditions on the Safety, Tolerability and Pharmacokinetics of ASP2151|Completed||Phase 1|72|Actual|Astellas Pharma Inc||11|||f||||f||||||||Undecided||2017-10-10 21:56:39.330975|2017-10-10 21:56:39.330975
NCT02852863|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-03-21|||July 2016||2016-07-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Identification of Changes in Gastric Volume and Content by Ultrasound Before and After Chewing Gum|Ultrasound Assessment of Changes in Gastric Volume and Content Before and After Chewing Gum|Completed||N/A|55|Actual|Fundación Santa Fe de Bogota||1|||f||||t||||||||Yes||2017-10-10 21:56:39.453861|2017-10-10 21:56:39.453861
NCT02852850|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Observational|||In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis|In Vivo Molecular Imaging With Infliximab Antibody With FITC Predicts Therapeutic Response in Ulcerative Colitis|Recruiting||N/A|30|Anticipated|Shandong University|||1||f||||t||||||||||2017-10-10 21:56:39.519754|2017-10-10 21:56:39.519754
NCT02852837|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-20|||September 26, 2016|Actual|2016-09-26|July 2017|2017-07-01|October 31, 2020|Anticipated|2020-10-31|November 30, 2018|Anticipated|2018-11-30||Interventional|||Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy|A Phase 1, Open-label, Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Subjects With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy|Recruiting||Phase 1|50|Anticipated|Janssen Research & Development, LLC||3|||f||||f||f||||||||2017-10-10 21:56:39.595668|2017-10-10 21:56:39.595668
NCT02852824|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-08-22|||August 10, 2016|Actual|2016-08-10|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Intravenous Doses of BI 655130 (Double-blind, Partially Randomised Within Dose Groups, Placebo-controlled Parallel Group Design) and One Single Intravenous Dose of BI 655130 (Single-blind, Partially Randomised, Placebo-controlled) in Healthy Male Subjects|Completed||Phase 1|40|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:56:39.698924|2017-10-10 21:56:39.698924
NCT02852811|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-08-01|||October 2009||2009-10-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|June 2011|Actual|2011-06-01||Interventional|||Reducing Menopausal Symptoms for Women During Menopause Using Group Education in a Primary Health Care Setting|Reducing Menopausal Symptoms for Women During Menopause Using Group Education in a Primary Health Care Setting: A Randomized Controlled Trial|Completed||N/A|131|Actual|Vastra Gotaland Region||2|||f||||f||||||||No||2017-10-10 21:56:39.779281|2017-10-10 21:56:39.779281
NCT02852798|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2016-08-02|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|||Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC|Clinical Study of Apatinib Mesylate Tablets Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR Wild-type, Non-squamous, Non-small-cell Lung Cancer|Not yet recruiting||N/A|60|Anticipated|Jiangsu ShengDiYa Medicine Co., Ltd.|||1||f||||t||||||||Undecided||2017-10-10 21:56:39.854347|2017-10-10 21:56:39.854347
NCT02852785|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-12-10|||January 2017||2017-01-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Observational|||3D Shoulder Kinematics During Throwing-related Movement Patterns Tasks in Upper Extremity Low-to-moderate/Moderate-to-high Loading Conditions|3D Shoulder Kinematics During Throwing-related Movement Patterns Tasks in Upper Extremity Low-to-moderate/Moderate-to-high Loading Conditions|Not yet recruiting||N/A|150|Anticipated|Universidade do Porto|||5||f||||f||||||||||2017-10-10 21:56:39.930182|2017-10-10 21:56:39.930182
NCT02852772|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-26|||July 2014||2014-07-01|July 2017|2017-07-01|November 7, 2016|Actual|2016-11-07|November 7, 2016|Actual|2016-11-07||Observational|ALCOVE||Does Micro-albuminuria is a Predictive Factor for Cognitive Impairment in Persons Living With HIV (PLHIV) Who Achieve cART-sustained Immunovirological Control ?|Does Micro-albuminuria is a Predictive Factor for Cognitive Impairment in Persons Living With HIV (PLHIV) Who Achieve cART-sustained Immunovirological Control ?|Completed||N/A|82|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 21:56:40.053105|2017-10-10 21:56:40.053105
NCT02852759|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-16|||August 2016||2016-08-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|CTPMIR||A Cold Physical Treatment to Manage Insulin Resistance|A Cold Physical Treatment to Manage Insulin Resistance|Recruiting||N/A|30|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||1|||f||||f||||||||Yes|Study result will be published after finishing the trial|2017-10-10 21:56:40.132277|2017-10-10 21:56:40.132277
NCT02852746|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-12-10|||January 2017||2017-01-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Observational|||Physical/Self-perceived Performance and 3D Shoulder Kinematics of Volleyball Attackers With/Without Shoulder Complaints and Scapular Dyskinesis|Physical/Self-perceived Performance and 3D Shoulder Kinematics of Volleyball Attackers With/Without Shoulder Complaints and Scapular Dyskinesis|Not yet recruiting||N/A|60|Anticipated|Universidade do Porto|||2||f||||f||||||||||2017-10-10 21:56:40.232454|2017-10-10 21:56:40.232454
NCT02852733|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-01|||June 2014||2014-06-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Observational|PUFPAE||Better Understand End-of-life Emergencies' Management Among Elderly in Nursing Homes: a Pilot Study in Brittany, France||Completed||N/A|602|Actual|Rennes University Hospital|||2||f||||||||||||||2017-10-10 21:56:40.335434|2017-10-10 21:56:40.335434
NCT02852720|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-02-15|||December 15, 2016|Actual|2016-12-15|February 2017|2017-02-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Pharmacokinetics of Levobupivacaine After Cesarean Section|Pharmacokinetics of Levobupivacaine and Epinephrine for Transversus Abdominis Plane (TAP) Block for Cesarean Section Postoperative Analgesia|Completed||Phase 4|12|Actual|Pontificia Universidad Catolica de Chile||1|||f||||f||||||||No||2017-10-10 21:56:40.418473|2017-10-10 21:56:40.418473
NCT02852707|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-07-26|||September 2017|Anticipated|2017-09-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|||Physical Performance and 3D Shoulder Kinematics of Asymptomatic Unilateral/Bilateral Overhead Athletes and Non-athletes|Physical Performance and 3D Shoulder Kinematics of Asymptomatic Unilateral/Bilateral Overhead Athletes and Non-athletes|Not yet recruiting||N/A|90|Anticipated|Universidade do Porto|||3||f||||f||||||||||2017-10-10 21:56:40.53802|2017-10-10 21:56:40.53802
NCT02852694|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-07-24|||February 28, 2017|Actual|2017-02-28|July 2017|2017-07-01|July 2022|Anticipated|2022-07-01|October 2021|Anticipated|2021-10-01||Interventional|RCT||Reduce Risk for Crohn's Disease Patients|Risk-stratified Randomized Controlled Trial in Paediatric Crohn Disease:Methotrexate vs Azathioprine or Adalimumab for Maintaining Remission in Patients at Low or High Risk for Aggressive Disease Course, respectively-a Treatment Strategy|Recruiting||Phase 4|312|Anticipated|PIBD-Net||3|||f||||t|f|f||||||||2017-10-10 21:56:40.661189|2017-10-10 21:56:40.661189
NCT02852681|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-07-28|||August 2015||2015-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers|A Study to Characterize the Effect of Food on the Bioavailability of 15 mg Estetrol (E4)/3 mg Drospirenone (DRSP) Tablets in Healthy Female Volunteers|Completed||Phase 1|28|Actual|Estetra||2|||f||||f||||||||No||2017-10-10 21:56:40.814273|2017-10-10 21:56:40.814273
NCT02852668|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-01|||June 2011||2011-06-01|July 2016|2016-07-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Power Training Versus Strength Training in the Elderly|Biomechanical Gait Indicators of Elderly Women in Response to Strength Training or Power Training|Completed||N/A|30|Actual|University of Sao Paulo||3|||f||||t||||||||No|Only group data will be available. These are to be published in scientific papers.|2017-10-10 21:56:40.890177|2017-10-10 21:56:40.890177
NCT02852655|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-14|||September 2016||2016-09-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|September 2017|Anticipated|2017-09-01||Interventional|||A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma|A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma|Active, not recruiting||N/A|35|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 21:56:40.983494|2017-10-10 21:56:40.983494
NCT02852642|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-28|||March 2016||2016-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Plyometric Training for Elderly Women|Structure and Musculoskeletal Function, Functional Capacity and Quality of Life of Elderly Women in Response to a Plyometric Training Model Based on the Stretch-shortening Cycle|Completed||N/A|37|Actual|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 21:56:41.097942|2017-10-10 21:56:41.097942
NCT02852629|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-15|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Observational|CBP-Aggrav||Assessment of a Tool for Decision Making in Case of Worsening Condition of Cancer Patients|Assessment of a Tool for Decision Making in Case of Worsening Condition of Cancer Patients|Completed||N/A|483|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 21:56:41.175382|2017-10-10 21:56:41.175382
NCT02852616|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-08-01|||December 2015||2015-12-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|TOP-NET||Trajectories of Psychopathology in Response to NET|Progression and Remittance of Traumatic Stress-related Symptoms During and After Narrative Exposure Therapy|Recruiting||N/A|100|Anticipated|University of Konstanz||2|||f||||t||||||||Undecided||2017-10-10 21:56:41.252164|2017-10-10 21:56:41.252164
NCT02852603|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-01|||August 2014||2014-08-01|July 2016|2016-07-01||||December 2018|Anticipated|2018-12-01||Observational|GenSTAND||Study on Genetically Affected Sporadic Thoracic Aortic Aneurysm and Dissection|Study on Genetically Affected Sporadic Thoracic Aortic Aneurysm and Dissection|Recruiting||N/A|500|Anticipated|Wuhan Asia Heart Hospital|||1||f||||f||||||Samples With DNA|"     Peripheral whole blood is obtained from patients. Serum, blood cell and DNA are separated and     stored for further study.   "|Undecided||2017-10-10 21:56:41.344657|2017-10-10 21:56:41.344657
NCT02852590|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-28|||November 2013||2013-11-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|EREMI||Relationship Between Adverse Drug Reactions and Unlicensed/ Off-label Drug Use in Hospitalized Children|Relationship Between Adverse Drug Reactions and Unlicensed/ Off-label Drug Use in Hospitalized Children: an Observational Multicenter Prospective Study|Completed||N/A|6227|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:56:41.437011|2017-10-10 21:56:41.437011
NCT02852577|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-28|||January 2000||2000-01-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|LTTPANIC||Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine|Long-term, Open, Naturalistic, Randomized Clinical Trial With Clonazepam and Paroxetine in Panic Disorder With or Without Agoraphobia|Completed||Phase 4|120|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||No||2017-10-10 21:56:41.509725|2017-10-10 21:56:41.509725
NCT02852564|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-17|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection|Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection|Completed||Phase 1|12|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-10 21:56:41.605209|2017-10-10 21:56:41.605209
NCT02852538|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-28|||February 2015||2015-02-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|NEW FED TR||Outcomes of a Skill-Based Program for Eating Disorders|An Innovative Family Based Treatment for Adults With Anorexia Nervosa Using Insights From Neurobiology|Recruiting||N/A|200|Anticipated|University of California, San Diego||1|||f||||t||||||||No||2017-10-10 21:56:41.784608|2017-10-10 21:56:41.784608
NCT02852525|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-07-28|||February 2014||2014-02-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|pCLE||Confocal Laser Probe to Treat Barrett's Esophagus|Real-Time Evaluation of Barrett's Esophagus by Confocal Laser Probe-based Microscopy|Completed||N/A|29|Actual|Ochsner Health System||1|||f||||f||||||||Undecided||2017-10-10 21:56:41.880885|2017-10-10 21:56:41.880885
NCT02852512|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-03|||March 2016||2016-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Trial Comparing Laparoscopic Vs Robotic-assisted Colposacropexy for Pelvic Organ Prolapse Repair|Perspective Randomized Trial Comparing Laparoscopic Vs Robotic-assisted Colposacropexy for Pelvic Organ Prolapse Repair|Recruiting||N/A|62|Anticipated|University Of Perugia||2|||f||||f||||||||No||2017-10-10 21:56:41.952926|2017-10-10 21:56:41.952926
NCT02852499|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-27|||July 2014||2014-07-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|February 2018|Anticipated|2018-02-01||Observational|SEPAGES-1337||Following of Atmospheric Pollution Exposure During Pregnancy and Effects on Health|SEPAGES : Following of Atmospheric Pollution Exposure During Pregnancy and Effects on Health|Active, not recruiting||N/A|1010|Actual|University Hospital, Grenoble|||3||f||||f||||||||||2017-10-10 21:56:42.058777|2017-10-10 21:56:42.058777
NCT02849301|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PWK||Cervical Pessary in Women With Arrested Preterm Labor and Short Cervix|Cervical Pessary in Women With Arrested Preterm Labor and Short Cervix|Recruiting||Phase 3|400|Anticipated|Federico II University||2|||f||||f||||||||||2017-10-10 21:57:12.959827|2017-10-10 21:57:12.959827
NCT02852486|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-09-10|||June 22, 2016|Actual|2016-06-22|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2018|Anticipated|2018-06-01||Interventional|EDI-PIO||Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response|Pilot Study of Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia With Deep Molecular Response - Evaluation of Pioglitazone in Treatment-free Remission (EDI-PIO)|Recruiting||Phase 2|30|Anticipated|University of Campinas, Brazil||1|||f||||f||||||||||2017-10-10 21:56:42.168671|2017-10-10 21:56:42.168671
NCT02852473|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-10-13|||July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Impact of Continuous Positive Airway Pressure on Breathing Motion Amplitude|Impact of Continuous Positive Airway Pressure on Breathing Motion Amplitude|Completed||Early Phase 1|10|Actual|Mayo Clinic||1|||f||||f||||||||Undecided||2017-10-10 21:56:42.294174|2017-10-10 21:56:42.294174
NCT02852460|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-28|||April 2016||2016-04-01|July 2016|2016-07-01||||September 2016|Anticipated|2016-09-01||Interventional|||The Influence of Rapid Recovery on Sleep Quality Following Total Hip Replacement Surgery||Recruiting||N/A|170|Anticipated|Southwest Hospital, China||2|||f||||||||||||||2017-10-10 21:56:42.361287|2017-10-10 21:56:42.361287
NCT02852447|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-02-22|||November 2014||2014-11-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|||The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve|The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve : A Prospective Study|Completed||N/A|30|Actual|Corporacion Parc Tauli|||1||f||||||||||Samples Without DNA|"     Blood   "|||2017-10-10 21:56:42.440535|2017-10-10 21:56:42.440535
NCT02852434|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-05-08|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation|Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation: A Randomized Controlled Trial|Completed||Phase 3|72|Actual|Stanford University||2|||f||||f||||||||No||2017-10-10 21:56:42.495212|2017-10-10 21:56:42.495212
NCT02852421|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-15|||August 2013||2013-08-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Single Versus Multiple Injection Ultrasound Guided Paravertebral Blocks|Randomized Prospective Study to Evaluate Efficacy and Safety of Single Versus Multiple Injection Ultrasound Guided Paravertebral Blocks for Breast Surgery|Completed||N/A|70|Actual|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 21:56:42.56131|2017-10-10 21:56:42.56131
NCT02852408|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-01|||January 2016||2016-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|||Liver Cauterization Increases the Postoperative Pain After Laparoscopic Cholecystectomy|Unintentional Liver Cauterization Increases the Postoperative Pain After Laparoscopic Cholecystectomy: A Prospective Controlled Blinded Trial|Completed||N/A|81|Actual|Umraniye Education and Research Hospital|||2||f||||||||||||||2017-10-10 21:56:42.640971|2017-10-10 21:56:42.640971
NCT02852395|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-09-22|||August 29, 2016|Actual|2016-08-29|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274|A First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274|Recruiting||Phase 1|160|Anticipated|Janssen-Cilag International NV||3|||f||||f||f||||||||2017-10-10 21:56:42.706145|2017-10-10 21:56:42.706145
NCT02852382|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-08-18|||April 2014||2014-04-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effects of Scalp Block on Haemodynamic Response and Postoperative Pain in Posterior Fossa Surgery|The Effects of Scalp Block on Haemodynamic Response and Postoperative Pain in|Completed||Phase 2|45|Actual|Istanbul University||3|||f||||f||||||||||2017-10-10 21:56:42.910047|2017-10-10 21:56:42.910047
NCT02852369|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-01|||June 2015||2015-06-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Task Oriented Training and Evaluation at Home (TOTE Home)|Task Oriented Training and Evaluation at Home (TOTE Home)|Completed||N/A|4|Actual|Rowe, Veronica, M.D.||1|||f||||f||||||||No||2017-10-10 21:56:43.021626|2017-10-10 21:56:43.021626
NCT02852356|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-19|||July 2016||2016-07-01|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|TiMMI||Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator|Prospective Observational and Validation Study Using Time-lapse Morphometry MIRI Imaging Incubator (TiMMI Study)|Recruiting||N/A|500|Anticipated|Ovation Fertility||4|||f||||f||||||||||2017-10-10 21:56:43.088086|2017-10-10 21:56:43.088086
NCT02852343|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-24|||December 2014||2014-12-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|OSNA-ORL||One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma|Etude de Concordance Entre la Technique OSNA et Les Techniques Classiques Pour la Recherche de métastases Ganglionnaires Des Cancers Des VADS|Active, not recruiting||N/A|26|Actual|Rennes University Hospital|||1||f||||||||||||||2017-10-10 21:56:43.185278|2017-10-10 21:56:43.185278
NCT02852330|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-07-19|||July 10, 2017|Actual|2017-07-10|July 2017|2017-07-01|July 10, 2019|Anticipated|2019-07-10|July 10, 2019|Anticipated|2019-07-10||Interventional|CLTD5663||Intracochlear Potentials: Volta Study|Intracochlear Potentials: Intraoperative and Post-operative Measurement Clinical Investigation|Recruiting||N/A|20|Anticipated|Cochlear||1|||f||||f|f|f||||||||2017-10-10 21:56:43.249805|2017-10-10 21:56:43.249805
NCT02852317|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-29|||February 2015||2015-02-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Observational|BUHD-SPINA||Urinary Markers of Detrusor Overactivity in Spina Bifida Patients|Urinary Markers of Detrusor Overactivity in Spina Bifida Patients|Recruiting||N/A|198|Anticipated|Rennes University Hospital|||4||f||||||||||||||2017-10-10 21:56:43.358942|2017-10-10 21:56:43.358942
NCT02852304|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-28|||October 2015||2015-10-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Observational|LALTH-1||Assessment of the Prevalence of Lysosomal Acid Lipase Deficiency in Patients Waiting for a Liver Transplant.|Assessment of the Prevalence of Lysosomal Acid Lipase Deficiency in Patients Waiting for a Liver Transplant.|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples Without DNA|"     Few drops of blood absorbed onto blotting paper for enzymatic analysis   "|||2017-10-10 21:56:43.441508|2017-10-10 21:56:43.441508
NCT02849288|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-12-16|||July 2016||2016-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Bigfoot Biomedical Clinical Research Center (CRC) Trial|Bigfoot Biomedical Clinical Research Center (CRC) Trial|Completed||Phase 1|20|Actual|Bigfoot Biomedical Inc.||1|||f||||f||||||||Undecided||2017-10-10 21:57:13.04645|2017-10-10 21:57:13.04645
NCT02852278|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-03-01|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Patient Centric Motor Neuron Disease Activities of Daily Living Scale|A Patient Centric Motor Neuron Disease Activities of Daily Living Scale|Enrolling by invitation||N/A|356|Anticipated|University of South Florida|||1||f||||f||||||||No||2017-10-10 21:56:43.654844|2017-10-10 21:56:43.654844
NCT02852265|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-17|||August 2016||2016-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Nexplanon and COC Combined Use Study|Nexplanon Use in Women Primarily Choosing a Combined Hormonal Contraceptive: a Proof of Concept Trial|Active, not recruiting||Phase 4|20|Actual|University of California, Davis||1|||f||||f||||||||||2017-10-10 21:56:43.766976|2017-10-10 21:56:43.766976
NCT02852252|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-21|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01|10 Years|Observational [Patient Registry]|||Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry|Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry Optional Sub-Study I: ICG Optional Sub-Study II: OTL38|Recruiting||N/A|50|Anticipated|University of Pennsylvania|||1||f||||t||||||||||2017-10-10 21:56:43.872645|2017-10-10 21:56:43.872645
NCT02852226|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-09-07|||May 2016||2016-05-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||CRUSH-PrEP for Women Project|Connecting Resources for Urban Sexual Health: CRUSH-PrEP for Women|Recruiting||N/A|50|Anticipated|University of California, San Francisco||1|||f||||f||||||||Yes|Access is restricted to those who successfully submit a protocol to the UCSF IRB.|2017-10-10 21:56:44.076908|2017-10-10 21:56:44.076908
NCT02852213|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-04|||July 2016||2016-07-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|AADC||A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients|SIngle-Stage, Open-Label, Safety and Efficacy Study of Adeno-Associated Virus Encoding Human Aromatic L-Amino Acid Decarboxylase by Magnetic Resonance MR-guided Infusion Into Midbrain in Pediatric Patients With AADC Deficiency|Recruiting||Phase 1|6|Anticipated|University of California, San Francisco||1|||f||||t||||||||Yes|The investigators will share pertinent information with the subjects care team such that standard of care for the subject can be maintained.|2017-10-10 21:56:44.195415|2017-10-10 21:56:44.195415
NCT02852200|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-07-28|||June 2012||2012-06-01|July 2016|2016-07-01|March 2013|Actual|2013-03-01|July 2012|Actual|2012-07-01||Observational|SEGAm||Screening for Frailty at Home|Screening for Frailty in Elderly Subjects Living at Home : Validation of the Modified Short Emergency Geriatric Assessment (SEGAm) Instrument|Terminated||N/A|167|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:56:44.329013|2017-10-10 21:56:44.329013
NCT02852187|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|MOBIS_US||Single Center Study Comparing MOBIS II ST vs MOBIS PEEK|Prospective, Randomized, Data Registry Study of MOBIS II Structural Titanium (ST) Interbody Cage Compared to MOBIS Peek Cage for the Treatment of Spondylolisthesis and Degenerative Disc Disease|Recruiting||N/A|50|Anticipated|Signus Medizintechnik GmbH||2|||f||||f||||||||No||2017-10-10 21:56:44.397668|2017-10-10 21:56:44.397668
NCT02852174|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-03|||May 2016||2016-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|VetCareReST||The Veteran Caregiver Reducing Stress Time (VetCareReST) Study|Mindfulness-Based Stress Reduction for Wounded Warrior Caregivers|Recruiting||N/A|136|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 21:56:44.490362|2017-10-10 21:56:44.490362
NCT02852161|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-18|||July 2016||2016-07-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|MACE||The Accuracy and Acceptability of Magnet Assisted Capsule Endoscopy in the Diagnosis of Esophageal Pathology: a Pilot Study|The Accuracy and Acceptability of Magnet Assisted Capsule Endoscopy in the Diagnosis of Esophageal Pathology: a Pilot Study|Recruiting||N/A|50|Anticipated|University of Nottingham||2|||f||||f||||||||||2017-10-10 21:56:44.570121|2017-10-10 21:56:44.570121
NCT02852148|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-18|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||ACTICOAT™ for the Treatment of Burns and Chronic Wounds|A Prospective, Non-comparative, Multicentre Study to Evaluate a Silver Coated Antimicrobial Barrier Wound Dressing (ACTICOAT™) in the Treatment of Burns and Chronic Wounds.|Recruiting||Phase 4|25|Anticipated|Smith & Nephew, Inc.||1|||f||||f||||||||||2017-10-10 21:56:44.655124|2017-10-10 21:56:44.655124
NCT02852135|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2017-03-07|||July 2016||2016-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of LMA Proseal and LMA Supreme for Efficient Ventilation During Lateral Positioned Laparoscopic Surgeres|Comparison of LMA Proseal and LMA Supreme for Efficient Ventilation During Lateral Positioned Laparoscopic Surgeries|Completed||N/A|186|Actual|Changhai Hospital||2|||f||||t||||||||||2017-10-10 21:56:44.781319|2017-10-10 21:56:44.781319
NCT02852122|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-01-03|||January 2015||2015-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Role of C-11 Choline PET in Patients With Prostate Cancer|The Role of C-11 Choline PET in Patients With Prostate Cancer|Completed||N/A|54|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-10 21:56:44.868359|2017-10-10 21:56:44.868359
NCT02849275|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|EPOCH||Effects of Probiotics on Cognition and Health|The Effects of Probiotics on Behavioral and Biological Markers of Cognition and Stress|Recruiting||N/A|36|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 21:57:13.118168|2017-10-10 21:57:13.118168
NCT02852109|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-07-28|||September 2016||2016-09-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Diffusion Tensor Imaging to Judge the Prognosis of Patients With Diffuse Axonal Injury|Diffusion Tensor Imaging to Judge the Prognosis of Patients With Diffuse Axonal|Not yet recruiting||N/A|30|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||||Yes||2017-10-10 21:56:44.953511|2017-10-10 21:56:44.953511
NCT02852096|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-07-28|||November 2015||2015-11-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks|Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks|Recruiting||N/A|600|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-10 21:56:45.025734|2017-10-10 21:56:45.025734
NCT02852083|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-01|||January 2016||2016-01-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Interventional|ModuLung||A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC|A Prospective Phase II, Randomized Multi-center Trial of a Combined Modularized Treatment With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Nivolumab in Patients With Squamous Cell Lung Cancer and Non- Squamous Cell Lung Cancer, Respectively After Platin Failure|Recruiting||Phase 2|86|Anticipated|University Hospital Regensburg||2|||f||||||||||||||2017-10-10 21:56:45.113387|2017-10-10 21:56:45.113387
NCT02852070|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-04-12|||July 2016||2016-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|BALFinder||Study Bronchoalveolar Lavage Fluid Driven Pathogenic Diagnosis of Lower Respiratory Tract Infections|Study Bronchoalveolar Lavage Fluid Driven Pathogenic Diagnosis of Lower Respiratory Tract Infections-A Prospective Multicenter Clinical Trial (BALFinder Study)|Recruiting||N/A|800|Anticipated|Capital Medical University||2|||f||||f||||||||No||2017-10-10 21:56:45.225703|2017-10-10 21:56:45.225703
NCT02852057|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-14|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effectiveness and Safety of Cosopt Loaded Contact Lenses|Effectiveness and Safety of Cosopt Loaded Contact Lenses|Not yet recruiting||Phase 1|50|Anticipated|University of Florida||1|||f||||f|t|f||||||||2017-10-10 21:56:45.314992|2017-10-10 21:56:45.314992
NCT02852044|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||The Influence of Sampling Site When Assessing Glucose Tolerance or Insulin Sensitivity With Oral Glucose Ingestion|The Influence of Sampling Site When Assessing Glucose Tolerance or Insulin Sensitivity With Oral Glucose Ingestion|Completed||N/A|10|Actual|University of Bath||2|||f||||f||||||||No||2017-10-10 21:56:45.37921|2017-10-10 21:56:45.37921
NCT02852031|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-25|||May 2016||2016-05-01|July 2017|2017-07-01|May 2028|Anticipated|2028-05-01|May 2026|Anticipated|2026-05-01|15 Months|Observational [Patient Registry]|NPC-QIC||National Collaborative to Improve Care of Children With Complex Congenital Heart Disease|National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) - A Collaborative Initiative to Improve Care of Children With Complex Congenital Heart Disease|Recruiting||N/A|1000|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-10 21:56:45.468369|2017-10-10 21:56:45.468369
NCT02852018|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-28|||January 2010||2010-01-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|GENECHOC||Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy|Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy|Recruiting||N/A|1500|Anticipated|Nantes University Hospital|||2||f||||f||||||||No||2017-10-10 21:56:45.790051|2017-10-10 21:56:45.790051
NCT02852005|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-10-02|||January 2017||2017-01-01|October 2017|2017-10-01||||April 2018|Anticipated|2018-04-01||Interventional|||Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205|A Phase 1 Clinical Trial to Evaluate the Immunogenicity of AIDSVAX B/E Bivalent gp120 Vaccine and MVA/HIV62B in Healthy, HIV-1-Uninfected Adult Participants Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205|Recruiting||Phase 1|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-10-10 21:56:45.898331|2017-10-10 21:56:45.898331
NCT02851992|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-02-21|||September 2012||2012-09-01|July 2016|2016-07-01|September 2025|Anticipated|2025-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem|A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem|Active, not recruiting||N/A|250|Actual|Zimmer Biomet||1|||f||||f||||||||No||2017-10-10 21:56:46.008708|2017-10-10 21:56:46.008708
NCT02851979|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-28|||January 2017||2017-01-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|PREMODEUR||Odors to Insufflate Life|"PREMODEUR. Odors to Insufflate Life. Implementation of a Controlled Olfactory Sensorial Method to Decrease Apneas in Premature Newborns. Proof of Concept Study. Latin-square Open Study With Blind Evaluation of Primary Outcome."|Not yet recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||6|||f||||t||||||||No||2017-10-10 21:56:46.070485|2017-10-10 21:56:46.070485
NCT02851966|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-28|||February 2016||2016-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Use of Semen TEX101 to Improve Sperm Retrieval Rates for Men With Non-obstructive Azoospermia|Use of Semen TEX101 to Improve Sperm Retrieval Rates for Men With Non-obstructive Azoospermia|Enrolling by invitation||N/A|60|Actual|Mount Sinai Hospital, Canada||1|||f||||f||||||||Undecided||2017-10-10 21:56:46.15721|2017-10-10 21:56:46.15721
NCT02851953|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-05-04|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Effectiveness and Safety Evaluation of Aqueduct -100 Device|Effectiveness and Safety Evaluation of Aqueduct -100 Device|Completed||N/A|41|Actual|Aqueduct Medical Ltd||1|||f||||f||||||||Undecided||2017-10-10 21:56:47.893215|2017-10-10 21:56:47.893215
NCT02851940|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-28|||September 2016||2016-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids|Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids: A Randomized Prospective Study|Not yet recruiting||N/A|30|Anticipated|American University of Beirut Medical Center||2|||f||||t||||||||Yes|In the publication|2017-10-10 21:56:48.047163|2017-10-10 21:56:48.047163
NCT02851927|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-08-21|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Rigid vs Semirigid Thoracoscopy in Exudative Pleural Effusions|Rigid 'Mini-thoracoscopy' vs Semirigid Thoracoscopy in Undiagnosed Exudative Pleural Effusions : A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-10 21:56:48.154208|2017-10-10 21:56:48.154208
NCT02851914|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-04|||July 21, 2015|Actual|2015-07-21|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SSRIs vs. TCAs for Depression in ALS Patients|An Open-Label Pilot Study Comparing the Efficacy of Selective Serotonin Re-Uptake Inhibitors (SSRIs) Versus Tricyclic Antidepressants (TCAs) for Treating Depression in Amyotrophic Lateral Sclerosis|Recruiting||Early Phase 1|40|Anticipated|St. Louis University||2|||f||||t||||||||||2017-10-10 21:56:48.239016|2017-10-10 21:56:48.239016
NCT02851901|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-28|||May 2012||2012-05-01|July 2016|2016-07-01||||May 2018|Anticipated|2018-05-01||Interventional|||Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial|Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial|Recruiting||Phase 3|187|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-10 21:56:48.330846|2017-10-10 21:56:48.330846
NCT02851888|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-11-05|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Use of Regional Anesthesia in Hip Arthroscopy|Use of Regional Anesthesia in Hip Arthroscopy|Recruiting||Phase 3|70|Anticipated|Georgetown University||2|||f||||t||||||||No||2017-10-10 21:56:48.413712|2017-10-10 21:56:48.413712
NCT02851875|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-05-01|||April 2016||2016-04-01|April 2017|2017-04-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01|10 Years|Observational [Patient Registry]|||Duke Scleroderma Clinic Patient Registry|Duke Scleroderma Clinic Patient Registry|Recruiting||N/A|1000|Anticipated|Duke University|||1||f||||f||||||||No||2017-10-10 21:56:48.514365|2017-10-10 21:56:48.514365
NCT02851862|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-05-12|||April 2016||2016-04-01|May 2017|2017-05-01||||April 2018|Anticipated|2018-04-01|6 Months|Observational [Patient Registry]|||A Natural History of Late Onset Tay-Sachs Disease|A Natural History of Late Onset Tay-Sachs Disease: MGH Site|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     Blood will be collected to establish lymphoblast cell lines. Cerebrospinal fluid will also be     collected from some subjects.   "|Yes|Data from this study will be stored in a computer data repository at the Massachusetts General Hospital (MGH) Neurological Clinical Research Institute (NCRI). The purpose of this data repository is to capture and store data for clinical research. The repository will combine data from multiple studies. Datasets will be shared with researchers who want to advance understanding of Neurological Disease. These datasets will not contain any personal identifiable information.|2017-10-10 21:56:48.588487|2017-10-10 21:56:48.588487
NCT02851849|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-02-23|||September 2016||2016-09-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 2|148|Actual|Ligand Pharmaceuticals||4|||f||||f||||||||No||2017-10-10 21:56:48.669491|2017-10-10 21:56:48.669491
NCT02851836|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-28|||October 2012||2012-10-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|MONRADO1||Attachment Image Data Set Validation in Adolescent|Validation of an Attachment Picture Set in School-adolescent|Completed||N/A|133|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:56:48.933537|2017-10-10 21:56:48.933537
NCT02851810|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-21|||December 2013||2013-12-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|MONRADO2||Oculomotor Markers and Attachment in Adolescents|Oculomotor and Neurophysiological Markers of Emotion Regulation and Attachment Styles in Adolescence|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:56:49.083984|2017-10-10 21:56:49.083984
NCT02851797|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-08-01|||June 1, 2017|Actual|2017-06-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy|Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy|Recruiting||Phase 3|213|Anticipated|Italfarmaco||2|||f||||t|t|f||||||||2017-10-10 21:56:49.186743|2017-10-10 21:56:49.186743
NCT02851784|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-08-01|||December 2009||2009-12-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma|Combination Therapy of Microwave Ablation and Expanding Activated Autologous Lymphocytes for Hepatocellular Carcinoma|Recruiting||Phase 2/Phase 3|50|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:56:49.418372|2017-10-10 21:56:49.418372
NCT02851771|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-01|||April 2013||2013-04-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Improving the Diagnosis of Pneumonia in Emergency Rooms|Improving the Diagnosis of Pneumonia in Emergency Rooms|Recruiting||N/A|4320|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-10 21:56:49.520121|2017-10-10 21:56:49.520121
NCT02851004|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-05-17|||October 2016||2016-10-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|October 2020|Anticipated|2020-10-01||Interventional|||Special Combination of BBI608 and Pembrolizumab|A Phase Ib/II Study of BBI608 in Combination With Pembrolizumab in Patients With Metastatic Colorectal Cancer|Recruiting||Phase 1/Phase 2|56|Anticipated|National Cancer Center Hospital East||1|||f||||t||||||||No||2017-10-10 21:56:55.816922|2017-10-10 21:56:55.816922
NCT02851745|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-07|||July 2015||2015-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DYDA2||Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry|Effects of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry|Recruiting||Phase 3|186|Anticipated|Heart Care Foundation||2|||f||||t||||||||||2017-10-10 21:56:49.68079|2017-10-10 21:56:49.68079
NCT02851732|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-28|||September 2016||2016-09-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|BRIDGE-CV||Brazilian inteRvention to Increase eviDence usaGe in practicE - Cardiovascular Prevention|A Cluster Randomized Trial Evaluating the Effect of a Multifaceted Intervention to Increase Evidence Based Strategies Usage for Cardiovascular Prevention.|Not yet recruiting||N/A|1687|Anticipated|Hospital do Coracao||2|||f||||f||||||||||2017-10-10 21:56:49.860276|2017-10-10 21:56:49.860276
NCT02851719|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-01|||March 2011||2011-03-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|March 2011|Actual|2011-03-01||Interventional|||Outpatient Biofeedback in Addition to Home Pelvic Floor Muscle Exercises|Outpatient Biofeedback in Addition to Home Pelvic Floor Muscle Training for Stress Urinary Incontinence: a Randomized Controlled Trial|Completed||N/A|72|Actual|Federal University of São Paulo||2|||f||||f||||||||Undecided|The individual participant data (IPD) collected in this study are being analyzed by the researchers to be available.|2017-10-10 21:56:49.927126|2017-10-10 21:56:49.927126
NCT02851706|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-29|2017-07-26|||July 21, 2016||2016-07-21|July 14, 2017|2017-07-14|April 5, 2100|Anticipated|2100-04-05|June 6, 2066|Anticipated|2066-06-06||Observational|||Natural History of and Specimen Banking for People With Tumors of the Central Nervous System|Evaluation of the Natural History of and Specimen Banking for Patients With Tumors of the Central Nervous System|Recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:56:50.002381|2017-10-10 21:56:50.002381
NCT02851693|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-06-26|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OCTSKIN||Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection|Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection|Not yet recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||No||2017-10-10 21:56:50.081537|2017-10-10 21:56:50.081537
NCT02851680|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-02|||September 2014||2014-09-01|June 2016|2016-06-01||||May 2015|Actual|2015-05-01||Interventional|BETA GLUCAN||Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.|Prospective Study on the Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.|Completed||N/A|476|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:56:50.167702|2017-10-10 21:56:50.167702
NCT02851667|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-29|||November 2010||2010-11-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||"Promoting Family Health, Happiness, and Harmony Through a Community-based Learning Family Campaign"|"Promoting Family Health, Happiness, and Harmony Through a Community-based Learning Family Campaign"|Completed||N/A|980|Actual|The University of Hong Kong||1|||f||||t||||||||||2017-10-10 21:56:50.229392|2017-10-10 21:56:50.229392
NCT02851654|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-03-03|||November 5, 2014|Actual|2014-11-05|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|BOSO||Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms|Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms (BOSO)|Recruiting||N/A|20|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:56:50.296833|2017-10-10 21:56:50.296833
NCT02851641|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-02-07|||September 2, 2015|Actual|2015-09-02|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|CANALHEMO||Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children||Recruiting||N/A|120|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:56:50.366632|2017-10-10 21:56:50.366632
NCT02851628|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-11|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||The Evaluation of an Alternative Sizing Model in Comparison of a Conventional Sizing Model for Full Face Masks in the Treatment of OSA in Terms of Performance and Comfort|The Evaluation of an Alternative Sizing Model in Comparison of a Conventional Sizing Model for Full-face Masks in the Treatment of OSA in Terms of Performance and Comfort|Not yet recruiting||N/A|38|Anticipated|Fisher and Paykel Healthcare||2|||f||||t|f|f||||||||2017-10-10 21:56:50.546082|2017-10-10 21:56:50.546082
NCT02851615|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-28|||April 2016||2016-04-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|SCThrive||Improving Self-Management in Adolescents With Sickle Cell Disease|SCThrive: Improving Self-Management in Adolescents With Sickle Cell Disease|Recruiting||N/A|64|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||No||2017-10-10 21:56:50.647234|2017-10-10 21:56:50.647234
NCT02851602|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-29|||November 2013||2013-11-01|June 2016|2016-06-01||||November 2015|Actual|2015-11-01||Interventional|SPHINGO||Phospholipid and Sphingolipid Composition of High-density Lipoproteins (HDL) in Obese Non-diabetic Patients With Metabolic Syndrome|Phospholipid and Sphingolipid Composition of High-density Lipoproteins (HDL) in Obese Non-diabetic Patients With Metabolic Syndrome|Completed||N/A|100|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 21:56:50.74141|2017-10-10 21:56:50.74141
NCT02851589|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-28|||July 2016||2016-07-01|July 2016|2016-07-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma|Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma|Recruiting||Phase 1/Phase 2|10|Anticipated|PersonGen BioTherapeutics (Suzhou) Co., Ltd.||1|||f||||t||||||||Yes||2017-10-10 21:56:50.815565|2017-10-10 21:56:50.815565
NCT02851576|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-09-13|||August 2011||2011-08-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CTL-ADV||Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV)|Generation of Clinical Grade Adenovirus Specific T Cells for Adoptive Immunotherapy After Allogeneic Stem Cell Transplantation : Clinical Trial|Completed||Phase 1/Phase 2|14|Actual|Central Hospital, Nancy, France||1|||f||||t||||||||No||2017-10-10 21:56:50.912117|2017-10-10 21:56:50.912117
NCT02851563|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-12|||May 2016||2016-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||A Natural History Study of Canavan Disease|A Natural History Study of Canavan Disease: MGH Site|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||Yes|Data from this study will be stored in a computer data repository at the Massachusetts General Hospital (MGH) Neurological Clinical Research Institute (NCRI). The purpose of this data repository is to capture and store data for clinical research. The repository will combine data from multiple studies. Datasets will be shared with researchers who want to advance understanding of Neurological Disease. These datasets will not contain any personal identifiable information.|2017-10-10 21:56:50.999669|2017-10-10 21:56:50.999669
NCT02851550|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-29|||December 2015||2015-12-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|LALTH-2||Assessement of the Prevalence of Lysosomal Acid Lipase Deficiency in Liver Post-transplant Patients|Assessement of the Prevalence of Lysosomal Acid Lipase Deficiency in Liver Post-transplant Patients|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||||||||Samples Without DNA|"     Few drops of blood absorbed onto blotting paper for enzymatic analysis   "|||2017-10-10 21:56:51.087773|2017-10-10 21:56:51.087773
NCT02851537|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Observational|EPIRMEX||Magnetic Resonance Spectroscopy at Term-equivalent Age and Executive Functions at 5 Years of Age Corrected in Very Preterm Infants|Magnetic Resonance Spectroscopy at Term-equivalent Age and Executive Functions at 5 Years of Age Corrected in Very Preterm Infants|Not yet recruiting||N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 21:56:51.160913|2017-10-10 21:56:51.160913
NCT02851524|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-01|||June 2016||2016-06-01|July 2016|2016-07-01||||December 2016|Anticipated|2016-12-01||Interventional|POSTURODYN||Proof of Concept Study Concerning Vestibular Stimulation Using a New Method of Dynamic Posturography.|Proof of Concept Study Concerning Vestibular Stimulation Using a New Method of Dynamic Posturography.|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 21:56:51.22479|2017-10-10 21:56:51.22479
NCT02851511|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-27|||August 8, 2017|Actual|2017-08-08|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|ACT||Augmenting Cognitive Training In Older Adults|Augmenting Cognitive Training In Older Adults|Recruiting||N/A|360|Anticipated|University of Florida||4|||f||||f|f|f||||||||2017-10-10 21:56:51.294572|2017-10-10 21:56:51.294572
NCT02851498|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-29|||January 2015||2015-01-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||Use of Novel High-protein Food Products To Reduce Insulin Resistance|Use of Novel High-protein Food Products to Reduce Insulin Resistance in Adults With an Elevated Triglyceride/HDL Ratio|Active, not recruiting||N/A|39|Actual|Arizona State University||2|||f||||f||||||||Undecided||2017-10-10 21:56:51.385133|2017-10-10 21:56:51.385133
NCT02851485|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-10-03|||July 2016||2016-07-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Bioavailability Study With GLPG1972|Open-label Study to Compare the Bioavailability of an Oral Tablet of GLPG1972 Relative to an Oral Solution After Single-dose Intake in Healthy Subjects and to Evaluate the Effect of Food on the Oral Tablet|Completed||Phase 1|12|Actual|Galapagos NV||3|||f||||f||||||||||2017-10-10 21:56:51.451032|2017-10-10 21:56:51.451032
NCT02851472|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-29|||September 2016||2016-09-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|iNO-TRAGI||Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO|Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGAN) Neonates Using iNO|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|New York Medical College||2|||f||||t||||||||Yes|After publication of primary manuscript.|2017-10-10 21:56:51.543171|2017-10-10 21:56:51.543171
NCT02851459|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-03-09|||August 2016||2016-08-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Tailoring of Vaccine-Focused Messages: Moral Foundations|Tailoring of Vaccine-Focused Messages: Moral Foundations and Disease Salience - Part 1|Completed||N/A|850|Actual|Emory University||3|||f||||f||||||||No||2017-10-10 21:56:51.647883|2017-10-10 21:56:51.647883
NCT02851446|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-01|||October 2015||2015-10-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|DEVENTILATION||Prevalence and Risk Factors of Reventilation Syndrome in a Population of Patients Under Ventilation for Whatever Reason|Prevalence and Risk Factors of Dreentilation Syndrome in a Population of Patients Under Ventilation for Whatever Reason|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 21:56:51.762686|2017-10-10 21:56:51.762686
NCT02851407|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-10-03|||September 2016||2016-09-01|June 2017|2017-06-01|February 2021|Anticipated|2021-02-01|January 2021|Anticipated|2021-01-01||Interventional|||Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients|A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant|Recruiting||Phase 3|400|Anticipated|Jazz Pharmaceuticals||2|||f||||t||||||||||2017-10-10 21:56:52.065033|2017-10-10 21:56:52.065033
NCT02851017|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-08-03|||February 2011||2011-02-01|July 2016|2016-07-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Exergaming Versus Gym-based Exercise for Postural Control, Flow and Technology Acceptance|Exergaming (XBOX Kinect™) Versus Traditional Gym-based Exercise for Postural Control, Flow and Technology Acceptance in Healthy Adults: a Randomised Controlled Trial|Completed||N/A|44|Actual|Northumbria University||2|||f||||f||||||||Undecided||2017-10-10 21:56:55.744172|2017-10-10 21:56:55.744172
NCT02851381|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-10-06|||August 2016||2016-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|September 2016|Anticipated|2016-09-01||Interventional|||Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer|Compassionate Single Subject Use of FG-3019 in Locally Advanced, Unresectable Pancreatic Cancer (Emergency Use of a Test Article)|Withdrawn||N/A|0|Actual|Jonsson Comprehensive Cancer Center||1||The patient passed before treatment could be started|f||||f||||||||No||2017-10-10 21:56:52.483568|2017-10-10 21:56:52.483568
NCT02851368|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|NIFI-ICG||Near Infrared Fluorescence Imaging With Indocyanine Green|A Pilot Trial of Near Infrared Fluorescence Imaging With Indocyanine Green in the Detection and Diagnosis of Neoplastic Pulmonary Nodules|Recruiting||Early Phase 1|25|Anticipated|University of Pittsburgh||1|||f||||t||||||||No||2017-10-10 21:56:52.539047|2017-10-10 21:56:52.539047
NCT02851355|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-07-27|||September 2016||2016-09-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Follow-up Survey of Patients Who Were Treated for Medulloblastoma or Primitive Neuroectodermal Tumors of the Central Nervous in Norway||Enrolling by invitation||N/A|1|Anticipated|Oslo University Hospital|||1||f||||f||||||||No||2017-10-10 21:56:52.626115|2017-10-10 21:56:52.626115
NCT02851342|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-27|||April 2016||2016-04-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|April 2017|Anticipated|2017-04-01||Observational|||GTA-MEG as a Biomarker for Cognition in MS|Graph-theoretical Analysis of Magnetoencephalographic Recordings as a Biomarker for Cognitive Deterioration in Multiple Sclerosis|Recruiting||N/A|150|Anticipated|Universitair Ziekenhuis Brussel|||2||f||||f||||||||No||2017-10-10 21:56:52.682713|2017-10-10 21:56:52.682713
NCT02851329|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-01-17|||February 2015||2015-02-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|||Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors|Association of Computed Tomography Phenotypic Signature With Progression-free Survival in Stage IV EGFR-mutant Non-small Cell Lung Cancer Undergoing Tyrosine Kinase Inhibitors|Enrolling by invitation||N/A|500|Anticipated|Chinese Academy of Sciences|||1||f||||f||||||||Undecided||2017-10-10 21:56:52.868661|2017-10-10 21:56:52.868661
NCT02851316|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-29|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Whole Body Vibration on Running Biomechanics|The Effect of Whole Body Vibration on Running Biomechanics in Individuals With Anterior Cruciate Ligament Reconstruction|Recruiting||N/A|25|Anticipated|California State University, Fullerton||2|||f||||t||||||||No||2017-10-10 21:56:52.947448|2017-10-10 21:56:52.947448
NCT02851303|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-07-24|||October 2016||2016-10-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome||Recruiting||Phase 4|60|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-10-10 21:56:53.040786|2017-10-10 21:56:53.040786
NCT02851290|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-09-06|||July 2016||2016-07-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|July 2019|Anticipated|2019-07-01||Interventional|||Effect of Caudal and Penile Block on Hypospadias Repair Complications|Effect of Caudal and Penile Block on Hypospadias Repair Complications|Recruiting||N/A|358|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 21:56:53.14858|2017-10-10 21:56:53.14858
NCT02851277|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-07-18|||November 15, 2016|Actual|2016-11-15|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine|A Phase 1, Randomized, Placebo Controlled Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA LAMP Vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine|Recruiting||Phase 1|30|Anticipated|Astellas Pharma Inc||5|||f||||f||||||||||2017-10-10 21:56:53.247959|2017-10-10 21:56:53.247959
NCT02851264|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-28|||August 2016||2016-08-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Diagnostic Value of Optical Enhancement Technology in Early Esophageal Squamous Neoplasia|Diagnostic Value of Virtual Chromoendoscopy With Optical Enhancement Technology in Early Esophageal Squamous Neoplasia: A Prospective Comparative Study|Not yet recruiting||N/A|360|Anticipated|Shandong University|||1||f||||t||||||Samples With DNA|"     According to virtual chromoendoscopy with optical enhancement technology and Lugol iodine     chromoendoscopy ,endoscopic biopsies will be taken at suspicious lesions respectively .   "|||2017-10-10 21:56:53.373453|2017-10-10 21:56:53.373453
NCT02851251|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-07-28|||July 2016||2016-07-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Multicenter Neonatal Eye Disease Screening in China|Multicenter Neonatal Eye Disease Screening in China|Recruiting||N/A|25000|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||||Undecided||2017-10-10 21:56:53.452659|2017-10-10 21:56:53.452659
NCT02851238|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-11|||July 2016||2016-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Driving Pressure and Postoperative Pulmonary Complications|Driving Pressure Limited Ventilation Decreases Postoperative Pulmonary Complications in One-Lung Ventilation: Randomized Controlled Study|Recruiting||N/A|308|Anticipated|Samsung Medical Center||2|||f||||||||||||||2017-10-10 21:56:53.530843|2017-10-10 21:56:53.530843
NCT02851212|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-12-01|||August 2016||2016-08-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants|A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (150 mg/1000 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 2 x 500 mg]) Co-administered With Canagliflozin (1 x 100 mg + 1 x 50 mg) in Healthy Fed and Fasted Subjects|Completed||Phase 1|44|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-10 21:56:53.688224|2017-10-10 21:56:53.688224
NCT02851199|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Child Position on the Results of Hyperventilation During Routine Electroencephalography|The Effect of Child Position on the Results of Hyperventilation During Routine Electroencephalography|Recruiting||N/A|30|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:56:53.79867|2017-10-10 21:56:53.79867
NCT02851186|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-27|||August 2016||2016-08-01|July 2016|2016-07-01||||January 2018|Anticipated|2018-01-01||Interventional|||Acupuncture for Postoperative Pain After Abdominal Surgery for Gynecological Diseases|Combined Electroacupuncture and Auricular Acupuncture for Postoperative Pain After Abdominal Surgery for Gynecological Diseases: A Randomized Sham-controlled Trial|Not yet recruiting||N/A|72|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 21:56:54.456687|2017-10-10 21:56:54.456687
NCT02851173|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-08-21|||February 21, 2016|Actual|2016-02-21|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|LLLT||Cognitive Enhancement Through Transcranial Laser Therapy|Cognitive Enhancement Through Transcranial Laser Therapy|Recruiting||Phase 2|100|Anticipated|University of Texas at Austin||2|||f||||t||||||||||2017-10-10 21:56:54.547018|2017-10-10 21:56:54.547018
NCT02851160|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-27|||March 2015||2015-03-01|March 2015|2015-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|chemotherapy||Perceptions and Representations of Cancer Chemotherapy|Perceptions and Representations of Cancer Chemotherapy|Completed||N/A|75|Actual|University Hospital, Montpellier|||3||f||||f||||||||Undecided||2017-10-10 21:56:54.64393|2017-10-10 21:56:54.64393
NCT02851147|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-09-14|||May 2016||2016-05-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment|Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment|Completed||N/A|30|Actual|Topcon Medical Systems, Inc.|||1||f||||t||||||||Undecided||2017-10-10 21:56:54.713822|2017-10-10 21:56:54.713822
NCT02851134|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-22|||April 2015||2015-04-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|MC-WES||Search for New Genetic Mutations Major Effect in Crohn's Disease|Search for New Genetic Mutations Major Effect in Crohn's Disease|Recruiting||N/A|16|Anticipated|University Hospital, Lille|||2||f||||f||||||Samples With DNA|"     blood samples stools samples   "|||2017-10-10 21:56:54.791933|2017-10-10 21:56:54.791933
NCT02851121|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||March 2015||2015-03-01|July 2016|2016-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|PSM_EEG||Study of Neurophysiological Correlates of the Link Between Perception and Action|Study of Neurophysiological Correlates of the Link Between Perception and Action Through Varied Protocols of Sensorimotor Studies|Recruiting||N/A|250|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:56:54.899496|2017-10-10 21:56:54.899496
NCT02851108|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-05-11|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|BlueACTn||Methylene Blue Against Falciparum Malaria in Burkina Faso|Safety of Artesunate-amodiaquine Combined With Methylene Blue or Primaquine for Falciparum Malaria Treatment in African Children: A Randomised Controlled Trial|Completed||Phase 2|100|Actual|Heidelberg University||2|||f||||f||||||||Undecided||2017-10-10 21:56:55.039673|2017-10-10 21:56:55.039673
NCT02851095|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-03-01|||August 2016||2016-08-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants|A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (50 mg/1000 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 2 x 500 mg]) Coadministered With Canagliflozin (1 x 50 mg) in Healthy Fed and Fasted Subjects|Completed||Phase 1|44|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-10 21:56:55.139978|2017-10-10 21:56:55.139978
NCT02851082|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-02-21|||April 2016||2016-04-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|END-HEMO||Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study.|Protected by Nature: Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study.|Completed||N/A|18|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||Undecided||2017-10-10 21:56:55.242348|2017-10-10 21:56:55.242348
NCT02851069|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-15|||February 27, 2017|Actual|2017-02-27|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|outCome||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Colombia (outCome)|Recruiting||N/A|90|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 21:56:55.333375|2017-10-10 21:56:55.333375
NCT02851056|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-05-18|||August 26, 2016|Actual|2016-08-26|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)|Evaluating the Safety and Biological Activity of a Dendritic Cell Survivin Vaccine in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplantation|Recruiting||Early Phase 1|20|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 21:56:55.449265|2017-10-10 21:56:55.449265
NCT02850991|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-04-03|||May 2016||2016-05-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma|A Multicenter, Prospective, Randomized, Phase III Trial Evaluating High-dose Versus Standard-dose Radiation With Concurrent Chemotherapy for Thoracic Esophageal Squamous Cell Carcinoma|Recruiting||N/A|308|Anticipated|Beijing Cancer Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:56:55.898174|2017-10-10 21:56:55.898174
NCT02850965|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-08-23|||August 17, 2016|Actual|2016-08-17|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|August 16, 2017|Actual|2017-08-16||Interventional|||Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis|Efficacy, Safety, and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Parallel-Arm, Multiple-Dose, Active Comparator Trial|Active, not recruiting||Phase 3|318|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 21:56:56.051386|2017-10-10 21:56:56.051386
NCT02850952|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|Rehab MATRIX||Rehab MATRIX: Impact of a Nursing-Led Acuity Algorithm on Patient Safety and Healthcare Quality|Rehab MATRIX: Impact of a Nursing-Led Acuity Algorithm on Patient Safety and Healthcare Quality|Recruiting||N/A|1965|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f||||||||||2017-10-10 21:56:56.213098|2017-10-10 21:56:56.213098
NCT02850939|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-03|||August 2016||2016-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Adherence to EHT Among Breast Cancer Patients|Improving Adherence to Endocrine Hormonal Therapy Among Breast Cancer Patients|Recruiting||N/A|120|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 21:56:56.291268|2017-10-10 21:56:56.291268
NCT02850926|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-27|||August 2016||2016-08-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|Socheadgear||Effect of Soccer Head Gear to Reduce Concussions|The Effectiveness of Soccer Headgear to Reduce Concussion in Adolescents|Not yet recruiting||N/A|3000|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||Undecided||2017-10-10 21:56:56.425836|2017-10-10 21:56:56.425836
NCT02850913|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-02-22|||September 5, 2016|Actual|2016-09-05|February 2017|2017-02-01|August 5, 2020|Anticipated|2020-08-05|April 5, 2020|Anticipated|2020-04-05||Interventional|||Doxycycline for the Treatment of Nodding Syndrome|Doxycycline for the Treatment of Nodding Syndrome: A Phase II, Randomised Placebo Controlled Trial|Recruiting||Phase 2|230|Anticipated|Makerere University||2|||f||||t||||||||No||2017-10-10 21:56:56.626364|2017-10-10 21:56:56.626364
NCT02850900|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-01-09|||April 2016||2016-04-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Oral Psoriasis Treatment Adherence and Intervention Study|Oral Psoriasis Treatment Adherence and Intervention Study|Recruiting||Phase 3|40|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||Undecided|will determine at later date|2017-10-10 21:56:56.746893|2017-10-10 21:56:56.746893
NCT02850887|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-29|||July 2016||2016-07-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||Patient Positioning and Airway Management During ERCP|Patient Positioning and Airway Management During Endoscopic Retrograde Cholangiopancreatography ERCP and the Effect on Airway Complications and Procedure Outcomes in Patients With Risks for Anesthesia Adverse Events|Recruiting||N/A|250|Anticipated|Washington University School of Medicine||2|||f||||f||||||||No||2017-10-10 21:56:56.854237|2017-10-10 21:56:56.854237
NCT02850874|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-18|||February 2016||2016-02-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma|Hyperthermic Intraperitoneal Chemotherapy as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma: A Prospective, Phase II, Proof-of-concept Study|Withdrawn||Phase 2|0|Actual|Carolinas Healthcare System||2||no accrual rate|f||||t||||||||||2017-10-10 21:56:56.959698|2017-10-10 21:56:56.959698
NCT02850861|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-29|||January 2014||2014-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||A New Surgical Instrument in Treatment of Conlylar Fracture: Condylar Reductor|A New Surgical Instrument in Treatment of Conlylar Fracture: Condylar Reductor|Completed||N/A|2|Actual|West China Hospital||2|||f||||t||||||||||2017-10-10 21:56:57.072097|2017-10-10 21:56:57.072097
NCT02850848|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-07-27|||December 2015||2015-12-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pharmacokinetics of Two Formulations of Entecavir|A Randomized, Parallel, Single-Dose Study to Evaluate the Pharmacokinetics of a Test Formulation of Entigin Film Coated Tablet 0.5mg (Entecavir 0.5 mg), Compared to an Equivalent Dose of a Reference Drug Product (Baraclude 0.5mg Tablets) in Healthy Adult Subjects|Completed||Phase 4|39|Actual|Yung Shin Pharm. Ind. Co., Ltd.||2|||f||||||||||||||2017-10-10 21:56:57.153004|2017-10-10 21:56:57.153004
NCT02850835|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-08-09|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|July 2017|Actual|2017-07-01||Interventional|||Video Decision Aid in Latina Women With Pelvic Organ Prolapse|Role of Video Decision Aid in Pelvic Organ Prolapse Treatment Selection in Latina Women|Active, not recruiting||N/A|33|Actual|Texas Tech University Health Sciences Center, El Paso||2|||f||||f||||||||||2017-10-10 21:56:57.251432|2017-10-10 21:56:57.251432
NCT02850809|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-27|||October 2010||2010-10-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|RF-REIN||Evaluation of the Efficacy of Radiofrequency in the Treatment of Renal Tumors|Evaluation of the Efficacy of Radiofrequency Ablation in the Treatment of Renal Tumors: Prospective Observational Study|Completed||N/A|310|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 21:56:57.452977|2017-10-10 21:56:57.452977
NCT02850796|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-27|||June 2014||2014-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|Kg-Free||Kg-Free: an Acceptance, Mindfulness and Compassionate-based Intervention for Women Struggling With Their Weight|Kg-Free: an Acceptance, Mindfulness and Compassionate-based Intervention for Women Struggling With Their Weight: A Randomized Controlled Trial|Completed||N/A|73|Actual|University of Coimbra||2|||f||||f||||||||No||2017-10-10 21:56:57.550827|2017-10-10 21:56:57.550827
NCT02850783|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-29|||March 2015||2015-03-01|July 2016|2016-07-01||||January 2016|Actual|2016-01-01||Interventional|||SLN in Colon Cancer Using a Multimodal Tracer|Sentinel Lymph Node Identification in Colon Cancer Using a Radioactive and Fluorescent Tracer; a Feasibility Study|Completed||Phase 2/Phase 3|10|Actual|VU University of Amsterdam||1|||f||||t||||||||||2017-10-10 21:56:57.634798|2017-10-10 21:56:57.634798
NCT02850770|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-03-08|||April 2015||2015-04-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Physical Activity and Social Support Prompting Via Phone Messaging|Phone Messaging for Physical Activity and Social Support Prompting Among Low-Income Latino Patients: A Randomized Pilot Study|Completed||N/A|42|Actual|University of Southern California||3|||f||||f||||||||Undecided||2017-10-10 21:56:57.702817|2017-10-10 21:56:57.702817
NCT02850757|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-29|||August 2016||2016-08-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Comparison Between Modified William's Airway and U Shaped Guedl's Airway|Comparative Study Between Modified William's Airway (Fekry Airway ) Versus the U Shaped Guedl's Airway as Assessed Device for Fiberoptic Intubation.|Not yet recruiting||Phase 2|50|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 21:56:57.790048|2017-10-10 21:56:57.790048
NCT02850744|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-04-10|||December 2015||2015-12-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients|Open-label, Non-randomized, Two-stage Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Patients With Progressive Glioblastoma|Active, not recruiting||Phase 2|35|Anticipated|PIQUR Therapeutics AG||1|||f||||f||||||||No||2017-10-10 21:56:57.878912|2017-10-10 21:56:57.878912
NCT02850731|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Motorized Platform and Autonomy Among the Frail and Pre-frail Older Adult (PLATAUTONOMIE)|Motorized Platform and Autonomy Among the Frail and Pre-frail Older Adult|Not yet recruiting||Phase 2|228|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 21:56:58.018815|2017-10-10 21:56:58.018815
NCT02850718|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-08-18|||March 2016||2016-03-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer|A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer|Completed||Phase 3|48|Actual|iX Biopharma Ltd.||2|||f||||f||||||||No||2017-10-10 21:56:58.096738|2017-10-10 21:56:58.096738
NCT02850705|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-27|||January 2010||2010-01-01|July 2016|2016-07-01||||January 2018|Anticipated|2018-01-01|3 Years|Observational [Patient Registry]|NOMADMUS||The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)|The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)|Recruiting||N/A|650|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     Serum, CSF, DNA, PBMC   "|||2017-10-10 21:56:58.175411|2017-10-10 21:56:58.175411
NCT02850692|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-11-02|||April 2016||2016-04-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|ENDOTH-MUCO||Portal Hypertension and Systemic Endothelial Function||Recruiting||N/A|60|Anticipated|Hopital Foch||4|||f||||f||||||||No||2017-10-10 21:56:58.24732|2017-10-10 21:56:58.24732
NCT02850679|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-27|||April 2014||2014-04-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|FinCV2||FINnish CardioVersion Study II|Finnish Elective Cardioversion for Persistent Atrial Fibrillation Study|Completed||N/A|1342|Actual|University of Turku|||1||f||||f||||||||Undecided||2017-10-10 21:56:58.343097|2017-10-10 21:56:58.343097
NCT02850666|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-01-03|||July 2016||2016-07-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Social Skills in Children With ASD and Process Drama|Building Social Skills in Children With ASD Characteristics Through Process Drama|Active, not recruiting||N/A|11|Actual|University of Utah||1|||f||||f||||||||No||2017-10-10 21:56:58.410919|2017-10-10 21:56:58.410919
NCT02850653|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-29|||November 2007||2007-11-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|Targeted PCR||Targeted PCR and Acute Endophthalmitis|Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis|Recruiting||N/A|150|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:56:58.495544|2017-10-10 21:56:58.495544
NCT02850640|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-09-10|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|COMPASS||Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study|Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study|Recruiting||N/A|600|Anticipated|Duke-NUS Graduate Medical School|||1||f||||||||||||||2017-10-10 21:56:58.614386|2017-10-10 21:56:58.614386
NCT02850627|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-31|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients|The Effect of Tongguan Capsule for MicroRNA Profiles Between Qi-Stagnation and Qi-Deficiency in Coronary Heart Disease Patients With Blood Stasis Syndrome Undergoing Percutaneous Coronary Intervention|Recruiting||Phase 4|100|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-10 21:56:58.708299|2017-10-10 21:56:58.708299
NCT02850614|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-12-11|||September 2016||2016-09-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Interventional|||Incentivizing Physical Activity Using Gamification, A Pilot Study||Recruiting||N/A|100|Anticipated|University of Vermont||2|||f||||f||||||||Yes|Data will deposited in a repository after the study is finished.|2017-10-10 21:56:58.829437|2017-10-10 21:56:58.829437
NCT02850601|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-29|||November 2016||2016-11-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Dexamethasone Solution for the Treatment of Oral Lichen Planus|Dexamethasone Solution and Dexamethasone in Mucolox™ for the Treatment of Oral Lichen Planus|Not yet recruiting||Phase 2|22|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:56:58.918771|2017-10-10 21:56:58.918771
NCT02850588|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-02-07|||November 2016||2016-11-01|July 2016|2016-07-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01|1 Year|Observational [Patient Registry]|VQI-TCAR||SVS VQI TransCarotid Revascularization Surveillance Project|TransCarotid Revascularization Surveillance Project of the Society for Vascular Surgery Vascular Quality Initiative|Recruiting||N/A|5000|Anticipated|Society for Vascular Surgery Patient Safety Organization|||2||f||||t||||||||No||2017-10-10 21:56:59.004518|2017-10-10 21:56:59.004518
NCT02850575|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-29|||January 2014||2014-01-01|July 2016|2016-07-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|||Bone Fixation of Mpact Double Mobility Cup|Etude Prospective, Multicentrique, Non contrôlée, Non randomisée, Ouverte Pour l'évaluation de la Fixation Osseuse d'Une Cupule hémisphérique, le Mpact® Double Mobilité|Recruiting||N/A|150|Anticipated|Medacta International SA|||1||f||||||||||||||2017-10-10 21:56:59.093766|2017-10-10 21:56:59.093766
NCT02850562|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-10-05|||July 2016||2016-07-01|October 2017|2017-10-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Diet and Exercise Interventions to Increase Muscle Strength and Function|Diet and Exercise Interventions to Increase Muscle Strength and Function:A Randomized Controlled Trial|Completed||N/A|94|Actual|South Dakota State University||2|||f||||f||||||||||2017-10-10 21:56:59.16852|2017-10-10 21:56:59.16852
NCT02850549|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-27|||October 2011||2011-10-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Preliminary Neck Classification Study|Implementation of a Neck Pain Classification System: A Preliminary Analysis|Completed||N/A|17|Actual|St. Ambrose University||1|||f||||f||||||||No||2017-10-10 21:56:59.251178|2017-10-10 21:56:59.251178
NCT02850536|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-02-02|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HITM-SURE||CAR-T Hepatic Artery Infusions for CEA-Expressing Liver Metastases|Phase Ib Trial of CAR-T Hepatic Artery Infusions Delivered With the Surefire Infusion System (SIS) for CEA-Expressing Liver Metastases|Recruiting||Phase 1|5|Anticipated|Roger Williams Medical Center||1|||f||||t|t|f||||||||2017-10-10 21:56:59.37112|2017-10-10 21:56:59.37112
NCT02850523|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-27|||September 2016||2016-09-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|CBT-PA||Cognitive Behavioural Group Therapy for Perinatal Anxiety|Cognitive Behavioural Group Therapy for Perinatal Anxiety: A Randomized Controlled Trial|Not yet recruiting||N/A|80|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||No||2017-10-10 21:56:59.487546|2017-10-10 21:56:59.487546
NCT02850510|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-29|||January 2004||2004-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Evaluating a Shortened Version of the Incredible Years (IY) Basic Programme in a Non-clinical Community Sample|Evaluating a Shortened Version of the Incredible Years Basic Programme in a Non-clinical Community Sample|Completed||N/A|189|Actual|Regional centre for children and youth mental health and welfare||2|||f||||f||||||||Undecided||2017-10-10 21:56:59.567384|2017-10-10 21:56:59.567384
NCT02850497|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-16|||August 2013||2013-08-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CREBX-OCT||6-month Intracoronary Optical Coherence Tomography (OCT) Evaluation of Three New Generation Drug Eluting Stent|6-month Intracoronary Optical Coherence Tomography (OCT) Evaluation of Endothelization and Malapposition of Three New Generation Drug Eluting Stent: CRE8, Biomatrix and Xience|Completed||N/A|60|Actual|Azienda Ospedaliero-Universitaria Careggi||3|||f||||t||||||||Undecided|To date a decision has not been taken with regard to a possible plan to share data|2017-10-10 21:56:59.6355|2017-10-10 21:56:59.6355
NCT02850484|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-27|||March 2016||2016-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block|A Single-Dose, Randomized, Open-Label, 2-Treatment, 3-Period, 3-Sequence, 3-Way Crossover, Partial Replicate, Oral Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block|Completed||Phase 1|99|Actual|Intech Biopharm Ltd.||3|||f||||f||||||||Undecided||2017-10-10 21:56:59.7061|2017-10-10 21:56:59.7061
NCT02850471|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-29|||March 2015||2015-03-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|December 2015|Actual|2015-12-01||Interventional|||Pulmonary Protection of Transcutaneous Electrical Acupoint Stimulation in Gynecologic Laparoscopic Surgery|Pulmonary Protection of Transcutaneous Electrical Acupoint Stimulation in Gynecologic Laparoscopic Surgery|Suspended||Phase 1/Phase 2|100|Anticipated|Shengjing Hospital||2||we need more participants to complete the research|f||||t||||||||||2017-10-10 21:56:59.786924|2017-10-10 21:56:59.786924
NCT02850458|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-02-04|||February 2016||2016-02-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Observational|||Clinical Results of Implant-retained Mandibular Overdentures in Edentulous Patients|Clinical Results of Implant-retained Mandibular Overdentures in Edentulous Patients: A 5-year Retrospective Study|Recruiting||N/A|54|Anticipated|Fourth Military Medical University|||2||f||||t||||||||Yes||2017-10-10 21:56:59.872535|2017-10-10 21:56:59.872535
NCT02850445|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-29|||January 2012||2012-01-01|July 2016|2016-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients|Effects of Integrated Treatment for Chinese Patients With Schizophrenia: 1-year Follow-up|Recruiting||N/A|170|Anticipated|Guangzhou Psychiatric Hospital||2|||f||||||||||||||2017-10-10 21:56:59.954227|2017-10-10 21:56:59.954227
NCT02850432|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-04-06|||May 1, 2016|Actual|2016-05-01|April 2017|2017-04-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|CMRPADDM||Clinical and MRI Cardiac Biomarkers on Peripheral Arterial Disease in Patients With Long Term DM|The Evolution and Impact of Clinical and MRI Cardiac Biomarkers on Peripheral Arterial Disease in Patients With Long Term DM|Recruiting||N/A|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||f|f|f||||||Undecided|We have to see if this corresponds to the IRB regulation.|2017-10-10 21:57:00.048468|2017-10-10 21:57:00.048468
NCT02848118|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-03-08|||January 2015||2015-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Capnography Monitoring in the Bronchoscopic Sedation|Capnography Monitoring the Hypoventilation During Bronchoscopic Sedation|Completed||N/A|124|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:57:26.161995|2017-10-10 21:57:26.161995
NCT02850419|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-05-30|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|EURO-DIGNITY||Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients|Heat-Activated Target Therapy (Radiotherapy + Hyperthermia + Lyso-Thermosensitive Liposomal Doxorubicin) of Local-Regional Relapse in Breast Cancer Patients|Not yet recruiting||Phase 2|70|Anticipated|Celsion||1|||f||||t|t|f||||||||2017-10-10 21:57:00.168468|2017-10-10 21:57:00.168468
NCT02850406|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-04-20|||May 2016||2016-05-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease|A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Exploratory Treatment Effect of GBT440 in Pediatric Participants With Sickle Cell Disease|Recruiting||Phase 2|41|Anticipated|Global Blood Therapeutics||1|||f||||f||||||||No||2017-10-10 21:57:00.26244|2017-10-10 21:57:00.26244
NCT02850393|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|SUPTOC||Inhibitory Control of the Mind : Neural Bases and Impact for Obsessive-compulsive Disorders|Etude en Imagerie Par résonance magnétique Fonctionnelle et Structurelle Des mécanismes de Suppression mnésique Dans Les Troubles Obsessionnels Compulsifs|Not yet recruiting||N/A|48|Anticipated|University Hospital, Caen||2|||f||||t||||||||||2017-10-10 21:57:00.372181|2017-10-10 21:57:00.372181
NCT02850380|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-07-27|||September 2015||2015-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|Down||"Spatial Orientation and Motor Skills: How to Flip Switches Down in Weightlessness?"|"Spatial Orientation and Motor Skills: How to Flip Switches Down in Weightlessness?"|Recruiting||N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||No||2017-10-10 21:57:00.520241|2017-10-10 21:57:00.520241
NCT02850367|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-10-06|||February 2015||2015-02-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|NO-SUP||Effect of NO Precursors on Physiological Responses to Exercise|The Effect of NO Precursors on Physiological Responses to Exercise|Recruiting||N/A|111|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||No||2017-10-10 21:57:00.705946|2017-10-10 21:57:00.705946
NCT02850354|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-07-27|||October 2015||2015-10-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|GasEx||Gas Exchange and Cardiovascular Kinetics of Regulation - Effects of Short Term Changes in Gravity|Gas Exchange and Cardiovascular Kinetics of Regulation - Effects of Short Term Changes in Gravity|Recruiting||N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||No||2017-10-10 21:57:00.875875|2017-10-10 21:57:00.875875
NCT02850341|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-01-30|||July 2016||2016-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SAD||Step Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression|Step Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression - A Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||No||2017-10-10 21:57:00.989792|2017-10-10 21:57:00.989792
NCT02850328|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-08-16|||September 2014||2014-09-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|ForceGeneratio||Muscular Force Generation in Microgravity|Muscular Force Generation in Microgravity (ForceGeneration)|Recruiting||N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 21:57:01.166272|2017-10-10 21:57:01.166272
NCT02850315|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-16|||July 2015||2015-07-01|January 2017|2017-01-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|AODIS||Intracoronary Thrombus Assessed by OFDI After Successful Fibrinolysis And Its Impact On Myocardial Reperfusion|Assessment Of Intracoronary Thrombus By Optical Frequency Domain Imaging During Percutaneous Coronary Intervention After Successful Fibrinolysis And Its Impact On Myocardial Reperfusion|Completed||N/A|29|Actual|University Hospital, Caen|||1||f||||||||||||||2017-10-10 21:57:01.28147|2017-10-10 21:57:01.28147
NCT02850302|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-06-20|||November 2016|Actual|2016-11-01|July 2016|2016-07-01|November 2023|Anticipated|2023-11-01|May 2018|Anticipated|2018-05-01||Interventional|TRANSTEP||Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET||Recruiting||N/A|20|Anticipated|Centre Georges Francois Leclerc||1|||f||||f||||||||||2017-10-10 21:57:01.376532|2017-10-10 21:57:01.376532
NCT02850289|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-28|2017-10-02|||April 2006||2006-04-01|October 2017|2017-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin|A Prospective Study of Peginterferon Alfa-2a and Ribavirin: Outcomes Assessment in Chronic Hepatitis C Patients|Completed||N/A|385|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 21:57:01.529689|2017-10-10 21:57:01.529689
NCT02850276|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-07-21|||November 2015||2015-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ANGI||Autonomic Neuropathy, GI Motility, and Inflammation in HIV|Autonomic Neuropathy, Gastrointestinal Motility, and Inflammation in HIV|Recruiting||Early Phase 1|45|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-10 21:57:01.74131|2017-10-10 21:57:01.74131
NCT02850250|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-05-25|||July 2017|Anticipated|2017-07-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|PHOXEY||Pharmacokinetics of Post Operative Cefuroxime in Infants Undergoing Cardiac Surgery|Pharmacokinetics of Post Operative Cefuroxime in Infants Undergoing Cardiac Surgery|Not yet recruiting||N/A|20|Anticipated|Alder Hey Children's NHS Foundation Trust|||1||f||||t||||||Samples Without DNA|"     Blood sampling on admission to PICU - then at 1 hour pre and post cefuroxime for 3 doses (8     hours apart)   "|Undecided|Undecided as yet|2017-10-10 21:57:01.976447|2017-10-10 21:57:01.976447
NCT02850237|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-07-27|||April 2016||2016-04-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|CopernicusIb||Pre-Hospital Cerebral Oxygenation and End-Tidal CO2 During Cardiopulmonary Resuscitation (CPR)|Pre-Hospital Cerebral Oxygenation and End-Tidal CO2 During Cardiopulmonary Resuscitation (CPR)|Recruiting||N/A|30|Anticipated|Hasselt University|||1||f||||f||||||||||2017-10-10 21:57:02.045339|2017-10-10 21:57:02.045339
NCT02850224|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-09|||April 20, 2017|Actual|2017-04-20|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes|Pediatric Preventative Health Screenings - Obesity and Family-Centered|Recruiting||N/A|870|Anticipated|Henry Ford Health System||2|||f||||f|f|f||||||||2017-10-10 21:57:02.120781|2017-10-10 21:57:02.120781
NCT02850211|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-28|||September 2011||2011-09-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Selective COX-2 Inhibitor Provides Pain Control But Hinders Healing Following Arthroscopic Rotator Cuff Repair|A Selective COX-2 Inhibitor Provides Pain Control But Hinders Healing Following Arthroscopic Rotator Cuff Repair: A Prospective Randomized Comparison|Completed||Phase 4|180|Actual|Seoul National University Bundang Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:57:02.224855|2017-10-10 21:57:02.224855
NCT02850198|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-26|||August 2016||2016-08-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Randomized Controlled Study of the Effectiveness of Scalp Electroacupuncture in Improving Upper Limb Motor Function in Convalescent Phase of Ischemic Stroke.|A Randomized Controlled Study of the Effectiveness of Scalp Electroacupuncture in Improving Upper Limb Motor Function in Convalescent Phase of Ischemic Stroke.|Not yet recruiting||N/A|328|Anticipated|Shaanxi Hospital of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 21:57:02.315885|2017-10-10 21:57:02.315885
NCT02850185|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-28|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer|Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer: A Multi-centric, Randomized, Parallel-control and Double-blinded Clinic Study|Recruiting||N/A|140|Anticipated|Shanghai Asclepius Meditec Inc.||2|||f||||t||||||||Yes|the main evaluation index and the secondary evaluation index of all participants will be share in 3 months after the end of this study.|2017-10-10 21:57:02.400008|2017-10-10 21:57:02.400008
NCT02850172|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-09-25|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||"Effects of a Walk, Eat, & Breathe Nursing Intervention For Patients With Esophageal Cancer"|"Effects of a Walk, Eat, & Breathe Nursing Intervention For Patients With Esophageal Cancer: A Randomized Controlled Trial"|Recruiting||N/A|144|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 21:57:02.525234|2017-10-10 21:57:02.525234
NCT02850159|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-05-31|2017-04-24||September 2013||2013-09-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional||32 patients with Parkinson's disease|Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease|Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease|Completed||N/A|32|Actual|Samsung Medical Center||2|||f||||t||||||||No||2017-10-10 21:57:02.650106|2017-10-10 21:57:02.650106
NCT02850146|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|LEARN-Tau||18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study|18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study|Active, not recruiting||Phase 1|50|Anticipated|University of Southern California||1|||f||||t||||||||||2017-10-10 21:57:02.93749|2017-10-10 21:57:02.93749
NCT02850133|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-27|||August 2010||2010-08-01|July 2016|2016-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Aerobic Exercise and Blood Biochemical Factors in Spinal Cord Injury|Effect of Aerobic Exercise Training on the Blood Biochemical Factors and Peripheral Hemodynamics in Person With Spinal Cord Injury|Completed||N/A|32|Actual|National Taiwan University Hospital||1|||f||||f||||||||Yes|The study is registered in publicly accessible site.|2017-10-10 21:57:03.027887|2017-10-10 21:57:03.027887
NCT02850120|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-27|||April 2007||2007-04-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|SUI-mesh||Complications of Mesh Procedures for Stress Urinary Incontinence|Complications Following Tension-free Vaginal Tape (TVT), Trans-obturator Tape (TOT) and Suprapubic Sling (SS) Procedures for Stress Urinary Incontinence: 8-year Retrospective Cohort Study Using Hospital Episodes Statistics Data|Completed||N/A|101081|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||2||f||||f||||||||No|Hospital Episode Statistics data to reproduce results are available from the Health and Social Care Information Centre (HSCIC) via formal application process. Analytic code and its output will be shared.|2017-10-10 21:57:03.082368|2017-10-10 21:57:03.082368
NCT02850107|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||June 2016||2016-06-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|REALITY||DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions|The REALITY Study: DiRectional AthErectomy + Drug-CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions|Recruiting||N/A|150|Anticipated|VIVA Physicians||1|||f||||f||||||||No||2017-10-10 21:57:03.15393|2017-10-10 21:57:03.15393
NCT02850094|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||July 2014||2014-07-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|B-Well||The BWH Wellness Project|The Brigham and Women's Hospital Wellness Project|Completed||N/A|292|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 21:57:03.264378|2017-10-10 21:57:03.264378
NCT02850081|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-06-05|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|April 2022|Anticipated|2022-04-01|October 2021|Anticipated|2021-10-01||Interventional|STANCE||Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes|Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes|Recruiting||Phase 3|1000|Anticipated|Columbia University||3|||f||||t|t|f|||f|||No||2017-10-10 21:57:03.320995|2017-10-10 21:57:03.320995
NCT02850068|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-13|||January 25, 2017|Actual|2017-01-25|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|GAE||Geniculate Artery Embolization for the Treatment of Knee Pain|Geniculate Artery Embolization for the Treatment of Knee Pain Secondary to Osteoarthritis|Recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f|f|t|f|f||||||2017-10-10 21:57:03.449637|2017-10-10 21:57:03.449637
NCT02850055|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effectiveness of Manual Therapy in Patients With Tinnitus and Temporomandibular Joint Disorder.|Effectiveness Specific Manual Therapy in a Multimodal Physical Therapy Treatment in Patients With Tinnitus and Temporomandibular Joint Disorder.|Recruiting||N/A|64|Anticipated|Universidad Complutense de Madrid||2|||f||||f||||||||No||2017-10-10 21:57:03.608681|2017-10-10 21:57:03.608681
NCT02850042|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-04-18|||June 2013||2013-06-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Comparing Constraint-Induced Therapy and Occupation-Based Intervention for Optimal Stroke Recovery|Comparing Constraint-Induced Therapy and Occupation-Based Intervention for Optimal Stroke Recovery|Completed||Phase 2|16|Actual|University of Kentucky||2|||f||||f||||||||Undecided||2017-10-10 21:57:03.71388|2017-10-10 21:57:03.71388
NCT02850029|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-07-04|||May 2016||2016-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey|An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey|Recruiting||N/A|1000|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 21:57:03.787631|2017-10-10 21:57:03.787631
NCT02850016|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|ROADMAP||Romidepsin Plus 3BNC117 Phase 2a Study|A Phase 2a, Randomized Study of Romidepsin With or Without 3BNC117 to Evaluate the Effects on the HIV-1 Reservoir (ROADMAP)|Recruiting||Phase 2|30|Anticipated|Rockefeller University||2|||f||||t||||||||No||2017-10-10 21:57:04.107476|2017-10-10 21:57:04.107476
NCT02850003|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-09-20|||June 2016||2016-06-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel|A Phase 1b Open-Label Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel in Subjects With Acne Vulgaris Under Maximal Use Conditions|Completed||Phase 1|20|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-10 21:57:05.963981|2017-10-10 21:57:05.963981
NCT02849990|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-05|||March 9, 2017|Actual|2017-03-09|July 2017|2017-07-01|July 15, 2020|Anticipated|2020-07-15|July 15, 2018|Anticipated|2018-07-15||Interventional|||A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy|A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy|Recruiting||Phase 2|22|Anticipated|University of Washington||1|||f||||f|t|f||||||||2017-10-10 21:57:06.040178|2017-10-10 21:57:06.040178
NCT02849977|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-08-24|||September 28, 2016|Actual|2016-09-28|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers|Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers|Recruiting||N/A|5000|Anticipated|Rhythm Pharmaceuticals, Inc.|||1||f||||f||||||||||2017-10-10 21:57:06.195833|2017-10-10 21:57:06.195833
NCT02849964|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-28|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|VIgIE||Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French Regions|Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French Regions|Completed||N/A|6835|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 21:57:06.311478|2017-10-10 21:57:06.311478
NCT02849951|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-06-13|||July 2016||2016-07-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Interventional|PROTECT-3||A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)|A Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of a 12-week Add-on Treatment With LT-02 vs. Placebo in Subjects With Ulcerative Colitis Refractory to Standard Treatment With Mesalamine|Terminated||Phase 3|25|Actual|Prometheus Laboratories||2||LT-02 did not appear to help induce remission of UC|f||||f||||||||No||2017-10-10 21:57:06.40089|2017-10-10 21:57:06.40089
NCT02849938|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-04-27|||September 2016||2016-09-01|April 2017|2017-04-01|March 20, 2017|Actual|2017-03-20|January 31, 2017|Actual|2017-01-31||Interventional|||Evaluating the Value of Telehealth for Care of Children With Medical Complexity|Evaluating the Value of Telehealth for Care of Children With Medical Complexity|Completed||N/A|25|Actual|Advocate Health Care||2|||f||||t||||||||Yes|Will share overall project results through poster and/or oral presentations at local, regional and national meetings.|2017-10-10 21:57:06.703351|2017-10-10 21:57:06.703351
NCT02849925|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-31|||March 2015||2015-03-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|SealCaries||Sealing Microcavitated Carious Lesions|Randomized Controlled Clinical Trial on the Treatment of Caries Lesions Using Resin or Glass Ionomer Sealants in Permanent Teeth|Active, not recruiting||N/A|37|Actual|University of Talca||2|||f||||f||||||||No||2017-10-10 21:57:06.776061|2017-10-10 21:57:06.776061
NCT02849912|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-26|||April 2015||2015-04-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01|1 Day|Observational [Patient Registry]|SIMONAL||Signal Detection in Monoclonal and New Agents in Lymphoma|Detection of Long Term Toxicity of Monoclonal Agents Combined With Chemotherapy in Non-Hodgkin Lymphoma - the SIMONAL Project|Completed||N/A|1671|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 21:57:06.853369|2017-10-10 21:57:06.853369
NCT02849899|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-02|||January 2017||2017-01-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRODIG||Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period|Prevention of New Onset Diabetes After Transplantation by a Short Term Treatment of Vildagliptin in the Early Post-transplant Period|Not yet recruiting||Phase 3|186|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||No||2017-10-10 21:57:06.927733|2017-10-10 21:57:06.927733
NCT02849886|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-28|||October 13, 2017|Anticipated|2017-10-13|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|Side_by_Cide||T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.|Use of Genetically Modified T-lymphocytes Expressing the Inducible Human Caspase 9 Gene (iCASP9) and the Selection Gene ΔCD19 in Allogeneic Haematopoietic Transplantation.|Recruiting||Phase 1/Phase 2|12|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t|f|f||||||||2017-10-10 21:57:07.024256|2017-10-10 21:57:07.024256
NCT02849873|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-04-24|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream|Randomized Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied IDP-123 Lotion in Comparison With Tazorac Cream in Subjects With Moderate to Severe Acne Vulgaris Under Maximal Use Conditions|Completed||Phase 1|48|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 21:57:07.125945|2017-10-10 21:57:07.125945
NCT02849860|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-10-11|||February 2014||2014-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris|A Phase 1b Open-Label Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied IDP-121 Lotion in Subjects With Acne Vulgaris Under Maximal Use Conditions|Completed||Phase 1|20|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||No||2017-10-10 21:57:07.219268|2017-10-10 21:57:07.219268
NCT02849847|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||July 2016||2016-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:57:07.30954|2017-10-10 21:57:07.30954
NCT02849834|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-06-15|||November 2009||2009-11-01|June 2017|2017-06-01|November 21, 2016|Actual|2016-11-21|November 21, 2016|Actual|2016-11-21||Interventional|||Cortical Plasticity After Motor Cortex Stimulation in Healthy Subject and Chronic Pain Patients|Study of Sensory-motor Cortex Plasticity After Motor Cortex Stimulation in Healthy Subject and Chronic Pain Patients|Completed||N/A|65|Actual|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 21:57:07.365352|2017-10-10 21:57:07.365352
NCT02849821|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-26|||May 2014||2014-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2015|Actual|2015-09-01||Interventional|||The Altitude Inflammatory Bowel Disease Study|A Study on the Influence of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease (IBD): The Altitude IBD Study|Active, not recruiting||N/A|30|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 21:57:07.471487|2017-10-10 21:57:07.471487
NCT02849808|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-28|||January 2015||2015-01-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01|5 Years|Observational [Patient Registry]|BELIEvE||Long Term Cornea Graft Survival Study|Long Term Cornea Graft Survival Study (Étude Bisontine d'Estimation de la Survie à Long Terme à Partir Des données de Suivi Internes au CHRU : Evaluation Epidémiologie Clinique)|Recruiting||N/A|1200|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||Undecided||2017-10-10 21:57:07.563387|2017-10-10 21:57:07.563387
NCT02849795|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-07-31|||April 2014||2014-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADIPSO||Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis|Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis and Assessment of Their Relations With the Risk of Cardiovascular Disease|Recruiting||N/A|208|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:57:07.63916|2017-10-10 21:57:07.63916
NCT02849782|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-29|||February 2014||2014-02-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|FAMPISEP||Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.|Short and Long Term Fampridine Treatment in Persons With Multiple Sclerosis: Cognitive and Motor Performances|Recruiting||Phase 4|98|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||No||2017-10-10 21:57:07.749244|2017-10-10 21:57:07.749244
NCT02849769|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-28|||September 2015||2015-09-01|July 2016|2016-07-01||||December 2020|Anticipated|2020-12-01||Observational|||Magnetic Resonance (MR) Conditional Tachyarrhythmia Therapy Products Post-approval Study||Active, not recruiting||N/A|10979|Anticipated|Medtronic|||1||f||||f||||||||||2017-10-10 21:57:07.9085|2017-10-10 21:57:07.9085
NCT02849756|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-02-09|||February 2015||2015-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|DAAR||Future of the Older Patients After Intensive Care Unit|Future of the Older Patients After Intensive Care Unit|Active, not recruiting||N/A|240|Actual|Centre Hospitalier René Dubos|||1||f||||f||||||||No||2017-10-10 21:57:07.964292|2017-10-10 21:57:07.964292
NCT02849743|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-07-17|||October 2016||2016-10-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Intranasal Oxytocin in Hypothalamic Obesity|Intranasal Oxytocin to Promote Weight Loss in Children and Adolescents With Brain Tumors and Hypothalamic Obesity Syndrome|Recruiting||Phase 2|30|Anticipated|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-10 21:57:08.041832|2017-10-10 21:57:08.041832
NCT02849730|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-10-26|||July 2016||2016-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Epidural PCA Related Adverse Effects in Young and Elderly|Postoperative Pain and Patient-controlled Epidural Analgesia Related Adverse Effects in Young and Elderly Patients|Completed||N/A|2435|Actual|Severance Hospital|||2||f||||f||||||||No||2017-10-10 21:57:08.163736|2017-10-10 21:57:08.163736
NCT02849717|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-05-21|||March 2016||2016-03-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Pre-Habilitation Exercise Intervention|Pre-Habilitation Exercise Intervention for Patients Scheduled for Colorectal Surgical Resection|Recruiting||N/A|60|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 21:57:08.262111|2017-10-10 21:57:08.262111
NCT02849704|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-01|||July 2016||2016-07-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Fat Malabsorption in Chronic Pancreatitis|Diagnosing Pancreatic-Based Malabsorption in Patients With Chronic Pancreatitis|Recruiting||Phase 2|48|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 21:57:08.502327|2017-10-10 21:57:08.502327
NCT02849691|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-26|||January 2014||2014-01-01|July 2016|2016-07-01||||October 2015|Actual|2015-10-01||Observational|||Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding||Completed||N/A|747|Actual|Chinese PLA General Hospital|||4||f||||||||||||||2017-10-10 21:57:08.627011|2017-10-10 21:57:08.627011
NCT02849509|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-27|||June 20, 2016|Actual|2016-06-20|September 2017|2017-09-01|December 10, 2017|Anticipated|2017-12-10|December 10, 2017|Anticipated|2017-12-10||Observational|||Patient Convenience Study- NIS RELATE|Non-interventional Study Describing Patients' Perception on Anticoagulant Treatment and Treatment Convenience When Treated With Pradaxa or Vitamin K Antagonist for Stroke Prophylaxis in Atrial Fibrillation.|Active, not recruiting||N/A|1335|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-10 21:57:10.573427|2017-10-10 21:57:10.573427
NCT02849678|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-01-05|2016-08-02||January 2008||2008-01-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|November 2013|Actual|2013-11-01||Interventional||Patients undergoing elective laparoscopic bowel surgery with bilateral thoracic paravertebral continuous nerve blocks|A Pain Study Comparing Two Commonly Used Medications to Treat Pain After Bowel Surgery|A Comparison of Lidocaine Versus Ropivacaine for Bilateral Continuous Thoracic Paravertebral Nerve Blocks for Post-bowel Surgery Analgesia|Completed||N/A|68|Actual|University of Pittsburgh|This study did not provide information about the treatment drug mechanism of action, whether it is regional or systemic. Local anesthetic plasma concentration was not measured in this study either.|2|||f||||f||||||||Undecided|This data has been published.|2017-10-10 21:57:08.719977|2017-10-10 21:57:08.719977
NCT02849665|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-08-12|||October 1, 2016||2016-10-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Immediate Effect of Kangaroo Position in Electromyographic Activity and Microcirculation of Newborn Preterm|Immediate Effect of Kangaroo Position in Electromyographic Activity and Microcirculation of Newborn Preterm: A Randomized Clinical Trial.|Recruiting||N/A|50|Anticipated|Professor Fernando Figueira Integral Medicine Institute||2|||f||||f||||||||||2017-10-10 21:57:09.013372|2017-10-10 21:57:09.013372
NCT02849652|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-11-16|||July 2016||2016-07-01|November 2016|2016-11-01|April 2021|Anticipated|2021-04-01|July 2020|Anticipated|2020-07-01||Interventional|||Testing an Organizational Change Model to Address Smoking in Mental Healthcare|Testing an Organizational Change Model to Address Smoking in Mental Healthcare|Recruiting||N/A|980|Anticipated|University of Pennsylvania||2|||f||||f||||||||Yes|Once the final analyses are conducted to address the specific aims of this project, study data will be made available to other qualified researchers. The investigators plan to create a mechanism to allow such researchers to apply for access to these data.|2017-10-10 21:57:09.118934|2017-10-10 21:57:09.118934
NCT02849639|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-04-14|||April 4, 2017|Actual|2017-04-04|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|INCREASE||The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression|INtervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer's Symptomatic Expression: The INCREASE Study|Recruiting||Early Phase 1|90|Anticipated|University of Kentucky||2|||f||||t|f|f||||||Undecided||2017-10-10 21:57:09.250997|2017-10-10 21:57:09.250997
NCT02849626|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-09-27|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Interventional|||Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures|An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures|Recruiting||Phase 3|160|Anticipated|Eisai Inc.||1|||f||||t|t|||||||||2017-10-10 21:57:09.386795|2017-10-10 21:57:09.386795
NCT02849613|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-26|||March 2016||2016-03-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|May 2019|Anticipated|2019-05-01||Interventional|RESSTORE||Regenerative Stem Cell Therapy for Stroke in Europe|Regenerative Stem Cell Therapy for Stroke in Europe|Recruiting||Phase 2/Phase 3|400|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||Undecided||2017-10-10 21:57:09.728683|2017-10-10 21:57:09.728683
NCT02849600|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||December 2015||2015-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Retrospective Cohort Study of Vital Pulp Therapy in Young Permanent Teeth|Retrospective Cohort Study of Vital Pulp Therapy in Young Permanent Teeth|Active, not recruiting||N/A|130|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 21:57:09.861917|2017-10-10 21:57:09.861917
NCT02849587|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-01-25|||January 2017||2017-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Using a Field Performance Test on an iPad to Evaluate Driving Under the Influence of Cannabis|A Randomized, Controlled Trial of Cannabis in Healthy Volunteers Evaluating Simulated Driving, Field Performance Tests and Cannabinoid Levels|Recruiting||N/A|180|Anticipated|University of California, San Diego||3|||f||||t||||||||Undecided||2017-10-10 21:57:09.948176|2017-10-10 21:57:09.948176
NCT02849574|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-28|||January 2015||2015-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|January 2015|Actual|2015-01-01||Observational|COSMOS||Evaluation of Changes in Consumption of Drugs and Substances After Incarceration|Evaluation of Changes in Consumption of Drugs and Substances After Incarceration|Completed||N/A|629|Actual|Nantes University Hospital|||1||f||||f||||||||No||2017-10-10 21:57:10.097787|2017-10-10 21:57:10.097787
NCT02849561|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-26|||January 2014||2014-01-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|ACR||Evaluation of Prognosis Factors of Neurological Evolution in Cardiac Arrest|Evaluation of Prognosis Factors of Neurological Evolution in Cardiac Arrest : Prospective Study of Routine Care|Completed||N/A|82|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:57:10.175839|2017-10-10 21:57:10.175839
NCT02849548|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-08-07|||January 3, 2017|Actual|2017-01-03|July 2017|2017-07-01|March 31, 2021|Anticipated|2021-03-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder|Can Blocking the Orexin System Enhance Sleep's Benefits to Therapeutic Exposure for PTSD?|Recruiting||Phase 4|145|Anticipated|Howard University||2|||f||||f||||||||||2017-10-10 21:57:10.280841|2017-10-10 21:57:10.280841
NCT02849535|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-09-07|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|PRISM care||Impact of the PRISM-care Multidisciplinary Oncology Program on Secured Drug Intake of Patients With Kidney Cancer|Impact of the PRISM-care Multidisciplinary Oncology Program Versus Usual Care on Secured Drug Intake of Patients With Kidney Cancer, Through Self-management of Adverse Events Related to Oral Targeted Therapies, Control of Drug Interactions, and Sharing of the Information Between Ambulatory and Hospital Settings.|Not yet recruiting||N/A|190|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:57:10.370127|2017-10-10 21:57:10.370127
NCT02849522|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-03|||April 2014||2014-04-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01|12 Months|Observational [Patient Registry]|UKROPE||ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).|ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).|Active, not recruiting||N/A|300|Actual|Cedar, United Kingdom|||2||f||||f||||||||||2017-10-10 21:57:10.472109|2017-10-10 21:57:10.472109
NCT02849483|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-01-11|||July 2016||2016-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Ramosetron on Bowel Motility After Gynecological Surgery|Effect of Ramosetron on Postoperative Restoration of Bowel Motility After Gynecological Laparoscopic Surgery|Recruiting||Phase 4|88|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:57:11.218332|2017-10-10 21:57:11.218332
NCT02849470|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|STRAAND||AGA Biocellular Stem/Stromal Hair Regenerative Study|Biocellular Regenerative Therapy in Hair Loss: Use of High Density Platelet-Rich Plasma Concentrates and Cell-Enriched Emulsified Adipose-Derived Tissue Stromal Vascular Fraction|Recruiting||Phase 1/Phase 2|60|Anticipated|Healeon Medical Inc||3|||f||||t|f|f||||||Undecided||2017-10-10 21:57:11.323719|2017-10-10 21:57:11.323719
NCT02849457|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-05-24|||December 2016||2016-12-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex|Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex (PREVeNT Trial) A Randomized, Double-blind, Placebo-controlled Seizure Prevention Clinical Trial for Infants With TSC|Recruiting||Phase 2|80|Anticipated|University of Alabama at Birmingham||3|||f||||t||||||||Yes|De-identified data will be shared with National Database for Autism Research (NDAR)|2017-10-10 21:57:11.473259|2017-10-10 21:57:11.473259
NCT02849444|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-24|||September 23, 2012|Actual|2012-09-23|July 2017|2017-07-01|March 1, 2020|Anticipated|2020-03-01|October 31, 2018|Anticipated|2018-10-31||Observational|MIR50||A Study to Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance|Post-authorisation Observational Study for the Assessment of Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance <50 mL/Min/1.73 m2 (CrCl <50 mL/Min/1.73 m2)|Active, not recruiting||N/A|326|Actual|Celgene|||2||f||||f||||||||||2017-10-10 21:57:11.635977|2017-10-10 21:57:11.635977
NCT02849431|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-08-24|||July 2016||2016-07-01|July 2016|2016-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|MindIE||Mindfulness for Intense Emotions: A Feasibility Trial|Mindfulness Approach for Adults Experiencing Borderline Personality Disorder; Supporting the Management of Intense and Fluctuating Emotions, a Feasibility Study|Withdrawn||N/A|0|Actual|Canterbury Christ Church University||1||"Unforeseen feasibility issues arose that meant the study did not seem viable in the current   form."|f||||f||||||||No||2017-10-10 21:57:11.843321|2017-10-10 21:57:11.843321
NCT02849405|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-29|||September 2016||2016-09-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of the Capacity of a Camera to Identify Signs of Arteriosclerosis in Retinal Arterioles|Preliminary Evaluation of the Capacity of a Metabolic Hyperspectral Retinal Camera (MHRC) to Identify an Arteriosclerosis Spectral Signature in Retinal Arterioles|Not yet recruiting||N/A|60|Anticipated|Montreal Heart Institute||2|||f||||f||||||||No||2017-10-10 21:57:12.113919|2017-10-10 21:57:12.113919
NCT02849392|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-29|||March 2013||2013-03-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|CPsPistachio||Effects of Pistachio Consumption on Body Composition and Blood and Bone Indicators|Effects of Pistachio Consumption on Body Composition, Blood Lipids, Bone Density, Satiety, Inflammatory Markers, and Erythrocyte Membrane Incorporation of Fatty Acids (The Cal Polys Pistachio Study)|Completed||N/A|60|Actual|California State Polytechnic University, Pomona||2|||f||||f||||||||Yes|lipid and blood data|2017-10-10 21:57:12.225136|2017-10-10 21:57:12.225136
NCT02849379|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:57:12.315734|2017-10-10 21:57:12.315734
NCT02849366|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:57:12.434753|2017-10-10 21:57:12.434753
NCT02849353|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:57:12.544216|2017-10-10 21:57:12.544216
NCT02849340|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:57:12.667575|2017-10-10 21:57:12.667575
NCT02849327|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:57:12.772418|2017-10-10 21:57:12.772418
NCT02849314|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:57:12.860729|2017-10-10 21:57:12.860729
NCT02849262|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-27|2017-03-29|||July 2016||2016-07-01|March 2017|2017-03-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|||Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts|A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Parallel-Group Study to Explore the Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts|Completed||Phase 2|24|Actual|Cutanea Life Sciences, Inc.||2|||f||||f||||||||No||2017-10-10 21:57:13.204138|2017-10-10 21:57:13.204138
NCT02849249|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-04-28|||September 2015||2015-09-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense|A Prospective, Multicenter, Randomized, Controlled, Open Trial, Parallel Groups (1: 1), With Subcutaneous Polimerized Mix (100/100), in Patients With Rhinoconjunctivitis Sensitized to the Following Combination of Pollen: Timothy Grass and Olea Europaea, and Asministered by Different Schedules|Completed||Phase 1|52|Actual|Roxall Medicina España S.A||2|||f||||f||||||||||2017-10-10 21:57:13.284176|2017-10-10 21:57:13.284176
NCT02849236|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-08-22|||October 2016||2016-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||PECS I Block for Breast Subpectoral Implant Surgery|Analgesic Efficacy of the Pectoral Nerve Block Type 1 for Breast Subpectoral Implant Surgery: A Randomized Controlled Study|Recruiting||N/A|56|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 21:57:13.372067|2017-10-10 21:57:13.372067
NCT02849223|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2017-09-03|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury|Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury|Recruiting||Phase 2|32|Anticipated|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-10 21:57:13.458538|2017-10-10 21:57:13.458538
NCT02849210|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-04-28|||September 2015||2015-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea|A Phase I Multicenter, Open Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea|Active, not recruiting||Phase 1|49|Anticipated|Roxall Medicina España S.A||1|||f||||f||||||||||2017-10-10 21:57:13.550042|2017-10-10 21:57:13.550042
NCT02849197|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-26|||January 2011||2011-01-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Observational|||Study on Surgical Treatment of Pilonidal Sinus Disease|Comparative Analysis of the Same technique-the Same Surgeon Approach in the Surgical Treatment of Pilonidal Sinus Disease: A Retrospective Cohort Study|Completed||N/A|802|Actual|Bezmialem Vakif University|||3||f||||f||||||||No||2017-10-10 21:57:13.616206|2017-10-10 21:57:13.616206
NCT02849184|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-01-20|||January 17, 2017|Actual|2017-01-17|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|Super1||To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia|A Multi-center, Double-blind, Randomized, Parallel Design Study to Compare the Effectiveness of Suvorexant Versus Placebo on Sleep Pressure and Circadian Rhythm in Hypertensives With Insomnia: The Super 1 Study|Recruiting||Phase 4|80|Anticipated|Jichi Medical University||2|||f||||t||||||||No||2017-10-10 21:57:13.678121|2017-10-10 21:57:13.678121
NCT02849171|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-05-17|||July 2016||2016-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Assessing 18F-Fluorocholine (18F-FCH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas|Pilot Study of 18F-Fluorocholine (18F-FCH) PET in Assessing Post-Treatment True Tumor Progression From Pseudo-Progression in High-Grade Gliomas|Recruiting||N/A|6|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:57:13.781903|2017-10-10 21:57:13.781903
NCT02849158|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-23|||June 9, 2017|Actual|2017-06-09|August 2017|2017-08-01|June 30, 2023|Anticipated|2023-06-30|June 30, 2022|Anticipated|2022-06-30||Interventional|FibroRect||Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma|Interest in Studying Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma : Exploratory Study|Recruiting||N/A|10|Anticipated|Institut Curie||1|||f||||f|f|f||||||||2017-10-10 21:57:14.018658|2017-10-10 21:57:14.018658
NCT02849145|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-01-20|||September 2014|Actual|2014-09-01|January 2017|2017-01-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)|Study to Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (R0)|Recruiting||N/A|60|Anticipated|Institut Curie||1|||f||||f||||||||Yes||2017-10-10 21:57:14.118573|2017-10-10 21:57:14.118573
NCT02849132|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-26|||January 2016||2016-01-01|July 2016|2016-07-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients|Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)|Recruiting||Phase 4|1000|Anticipated|Beijing Friendship Hospital||1|||f||||||||||||||2017-10-10 21:57:14.233719|2017-10-10 21:57:14.233719
NCT02849119|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-26|||January 2016||2016-01-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Transperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial Nephrectomy|Comparison of Peri-operative Outcomes of Laparoscopic or Robotic Partial Nephrectomy for Small Renal Mass: Transperitoneal vs Retroperitoneal Approach|Unknown status|Recruiting|N/A|106|Anticipated|Samsung Medical Center||2|||f||||f||||||||No||2017-10-10 21:57:14.443897|2017-10-10 21:57:14.443897
NCT02849106|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-26|||May 2011||2011-05-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|CULTURE3D||Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer|Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer: a Preliminary Study|Completed||N/A|22|Actual|Institut Curie||1|||f||||f||||||||No||2017-10-10 21:57:14.545012|2017-10-10 21:57:14.545012
NCT02849093|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-07-26|||June 2016||2016-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|OCT||Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome.|Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome (OCT)|Active, not recruiting||N/A|60|Anticipated|Bedford Hospital NHS Trust|||3||f||||||||||||||2017-10-10 21:57:14.625726|2017-10-10 21:57:14.625726
NCT02849080|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-09-01|||September 20, 2016|Actual|2016-09-20|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|February 19, 2018|Anticipated|2018-02-19||Interventional|PIONEER 7||Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.|Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 3|500|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 21:57:14.711873|2017-10-10 21:57:14.711873
NCT02849067|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-28|||March 2015||2015-03-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Hemodynamic Responses of Stable Ischemic Heart Disease Patients to a Comedy Session|Hemodynamic Responses of Stable Ischemic Heart Disease Patients to a Comedy Session: Randomized Controlled Trial|Recruiting||N/A|36|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:57:14.996431|2017-10-10 21:57:14.996431
NCT02849054|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-15|||June 2016||2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CDH-ONV||CDH - Optimisation of Neonatal Ventilation|Optimisation of Neonatal Ventilation: Congenital Diaphragmatic Hernia - Determining the Appropriate Level of Volume Guarantee|Recruiting||N/A|18|Anticipated|King's College London||6|||f||||f||||||||||2017-10-10 21:57:15.127097|2017-10-10 21:57:15.127097
NCT02849041|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-09-05|||January 23, 2017|Actual|2017-01-23|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|DETeCTOR||Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells|Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells|Recruiting||N/A|300|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||t|f|f||||||||2017-10-10 21:57:15.23266|2017-10-10 21:57:15.23266
NCT02849028|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-26|||July 2016||2016-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Clinical Research on the Relationship Between Circadian Rhythm and Gut Microbiota in TBI Patients|The Clinical Research on the Relationship Between Circadian Rhythm and Gut Microbiota in TBI Patients|Recruiting||N/A|42|Anticipated|General Hospital of Ningxia Medical University|||2||f||||t||||||||No||2017-10-10 21:57:15.330932|2017-10-10 21:57:15.330932
NCT02849015|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-26|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver||Recruiting||Phase 1/Phase 2|10|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:57:15.437339|2017-10-10 21:57:15.437339
NCT02848989|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-07-26|||May 2016||2016-05-01|July 2016|2016-07-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors|Qigong Mind-Body Exercise For Persistent Post-Surgical Pain In Breast Cancer Survivors: A Pilot Study|Recruiting||Phase 1|21|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 21:57:15.628241|2017-10-10 21:57:15.628241
NCT02848976|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-26|||January 2009||2009-01-01|July 2016|2016-07-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01|2 Months|Observational [Patient Registry]|RE-SEP||Re-training to Effort (RE) According to the Severity of Multiple Sclerosis: Preliminary Assessments Based on Fatigue and Quality of Life|Re-training to Effort (RE) According to the Severity of Multiple Sclerosis: Preliminary Assessments Based on Fatigue and Quality of Life|Completed||N/A|32|Actual|Nantes University Hospital|||4||f||||f||||||||No||2017-10-10 21:57:15.726909|2017-10-10 21:57:15.726909
NCT02848963|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-04-19|||July 2016||2016-07-01|October 2016|2016-10-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Comparison of Ketamine-propofol Combinations|Effect of Ketamine-propofol Mixture on Postoperative Pain and Sedation-agitation|Completed||Phase 4|75|Actual|Cukurova University||3|||f||||f||||||||No||2017-10-10 21:57:15.808739|2017-10-10 21:57:15.808739
NCT02848950|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-07-26|||August 2016||2016-08-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Metformin on Fecundability in an ART(Assisted Reproductive Technology) Setting - the Correlation to Uterine Flows|The Effect of Metformin on Fecundability in Obese Women Undergoing ART - the Correlation to Uterine Flow Parameters A Prospective Randomized Controlled Trial|Not yet recruiting||Phase 2|100|Anticipated|The Baruch Padeh Medical Center, Poriya||2|||f||||f||||||||No||2017-10-10 21:57:15.894577|2017-10-10 21:57:15.894577
NCT02848937|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-26|||March 2013||2013-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Observational|CITRUS||Calcium Mass Balance and Dialytic Efficiency of a New cITRate-containing and Acetate-free Dialysis flUidS: CITRUS Study|Calcium Mass Balance and Dialytic Efficiency of a New cITRate-containing and Acetate-free Dialysis flUidS: CITRUS Study|Recruiting||N/A|62|Anticipated|Azienda Ospedaliera, Ospedale Civile di Legnano|||2||f||||f||||||||Undecided||2017-10-10 21:57:15.970237|2017-10-10 21:57:15.970237
NCT02848924|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-26|||January 2015||2015-01-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|ACETABULUM||Current Incidence and Treatments Performed of Fractures of the Acetabulum and Pelvis in France in 2013|Current Incidence and Treatments Performed of Fractures of the Acetabulum and Pelvis in France in 2013|Completed||N/A|200|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||||||2017-10-10 21:57:16.075785|2017-10-10 21:57:16.075785
NCT02848911|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-07-19|||October 2016||2016-10-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL|A Phase I Dose-escalation Study to Assess the Safety of AFM11 (CD19 x CD3 TandAb®) in Patients With Relapsed or Refractory Adult B-precursor Acute Lymphoblastic Leukemia|Recruiting||Phase 1|50|Anticipated|Affimed GmbH||1|||f||||t||||||||||2017-10-10 21:57:16.1547|2017-10-10 21:57:16.1547
NCT02848898|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-26|||August 2016||2016-08-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effects of Focal Vibration on Spasticity in Multiple Sclerosis Patients|The Effects of Focal Vibration on Central and Peripheral Spasticity in Multiple Sclerosis Patients. A Randomized, Multicenter, Double Blinded vs Placebo Study|Not yet recruiting||N/A|60|Anticipated|Federico II University||2|||f||||t||||||||No||2017-10-10 21:57:16.260235|2017-10-10 21:57:16.260235
NCT02848885|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-03|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effects of tDCS on Illness Awareness in Schizophrenia|The Clinical and Functional Imaging Effects of Transcranial Direct Current Stimulation (tDCS) on Illness Awareness in Schizophrenia|Recruiting||N/A|34|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 21:57:16.338857|2017-10-10 21:57:16.338857
NCT02848872|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-04-20|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01||Observational|TOP 1502||Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer|Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer|Recruiting||N/A|30|Anticipated|Duke University|||1||f||||f||||||Samples Without DNA|"     Resected NSCLC specimens (excess)   "|||2017-10-10 21:57:16.424352|2017-10-10 21:57:16.424352
NCT02848859|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-02-22|||March 2015||2015-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Improving Sleep for Healthy Hearts|Improving Sleep for Healthy Hearts|Completed||N/A|34|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 21:57:16.494208|2017-10-10 21:57:16.494208
NCT02848846|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-28|||June 2016||2016-06-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|NEBIAS||NEurocontrolled BIdirectional Artificial Upper Limb and Hand prosthesiS|NEurocontrolled BIdirectional Artificial Upper Limb and Hand prosthesiS|Recruiting||N/A|2|Anticipated|Catholic University of the Sacred Heart||1|||f||||||||||||||2017-10-10 21:57:16.574226|2017-10-10 21:57:16.574226
NCT02848833|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-21|||August 10, 2016|Actual|2016-08-10|September 2017|2017-09-01|August 11, 2020|Anticipated|2020-08-11|August 11, 2020|Anticipated|2020-08-11||Observational|||JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus|A Regulatory Requirement Non Interventional Study to Monitor the Safety and Effectiveness of JARDIANCE® (Empagliflozin, 10mg, 25mg, q.d.) in Korean Patients With Type 2 Diabetes Mellitus|Recruiting||N/A|3000|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 21:57:16.657359|2017-10-10 21:57:16.657359
NCT02848820|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|APAC||Initial Non-operative Treatment Strategy Versus Appendectomy Treatment Strategy for Simple Appendicitis in Children|Initial Non-operative Treatment Strategy Versus Appendectomy Treatment Strategy for Simple Appendicitis in Children Aged 7-17 Years Old - Antibiotics Versus Primary Appendectomy in Children With Simple Appendicitis: APAC Study|Recruiting||Phase 4|334|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||Undecided|Will follow|2017-10-10 21:57:16.732098|2017-10-10 21:57:16.732098
NCT02848807|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-07-25|||September 2014||2014-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Chemotherapy-related Toxicity, Nutritional Status and Quality of Life|Chemotherapy-related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients With or Without High Protein Nutritional Support. A Prospective, Randomized Study|Recruiting||N/A|100|Anticipated|University Clinical Centre, Gdansk||2|||f||||||||||||Yes|publication in nutritional and oncological journals, presentation on the congresses|2017-10-10 21:57:16.878456|2017-10-10 21:57:16.878456
NCT02848794|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-06-14|||July 2016||2016-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma|Phase I/IIa, Single-Arm, Open Study of Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma|Recruiting||Phase 1/Phase 2|40|Anticipated|The First People's Hospital of Lianyungang||1|||f||||f||||||||Undecided||2017-10-10 21:57:16.967505|2017-10-10 21:57:16.967505
NCT02848781|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-05-05|||February 2016||2016-02-01|May 2017|2017-05-01|February 2023|Anticipated|2023-02-01|February 2021|Anticipated|2021-02-01||Interventional|PAUSE-SCD||Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial|PAUSE-SCD: Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial|Recruiting||N/A|180|Anticipated|University of Chicago||3|||f||||f||||||||No||2017-10-10 21:57:17.055316|2017-10-10 21:57:17.055316
NCT02848768|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-27|||December 2014||2014-12-01|July 2016|2016-07-01||||March 2015|Actual|2015-03-01||Observational|RTKI||Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma|Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma|Completed||N/A|45|Actual|Rennes University Hospital|||1||f||||||||||||||2017-10-10 21:57:17.158204|2017-10-10 21:57:17.158204
NCT02848755|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-07-27|||April 2016||2016-04-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Brain Volumes of Very Low Birth Weight Infants Measured by Cranial Ultrasonography|Neonatal Cranial Ultrasonography for Measuring Brain Volumes of Very Low Birth Weight Infants|Recruiting||N/A|300|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||1||f||||f||||||||Yes||2017-10-10 21:57:17.214316|2017-10-10 21:57:17.214316
NCT02847650|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-09-29|||October 17, 2016|Actual|2016-10-17|September 2017|2017-09-01|June 27, 2018|Anticipated|2018-06-27|May 30, 2018|Anticipated|2018-05-30||Interventional|||Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease|A 15-week, Phase 2, Double Blind, Randomized, Placebo-controlled, Flexible Dose Study To Investigate The Efficacy, Safety And Tolerability Of Pf-06649751 In Subjects With Early Stage Parkinson's Disease|Recruiting||Phase 2|88|Anticipated|Pfizer||2|||f||||t|t|f||||||||2017-10-10 21:57:17.283026|2017-10-10 21:57:17.283026
NCT02847637|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-08-18|||September 27, 2016|Actual|2016-09-27|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|HAVEN 3||A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors|A Randomized, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Patients Without Inhibitors|Active, not recruiting||Phase 3|145|Actual|Hoffmann-La Roche||4|||f||||t|t|f||||||||2017-10-10 21:57:17.617907|2017-10-10 21:57:17.617907
NCT02847624|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||March 2014||2014-03-01|July 2016|2016-07-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD|Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD in Japan|Recruiting||N/A|1600|Anticipated|Otsuka Pharmaceutical Co., Ltd.|||1||f||||f||||||||Undecided||2017-10-10 21:57:17.860525|2017-10-10 21:57:17.860525
NCT02847611|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-28|||March 2016||2016-03-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|DYNAVAL||Validation of the Dynamometer LABIN|Validation of the Dynamometer LABIN|Recruiting||N/A|30|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 21:57:17.969305|2017-10-10 21:57:17.969305
NCT02847598|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-08-24|||October 20, 2016|Actual|2016-10-20|August 2017|2017-08-01|June 21, 2019|Anticipated|2019-06-21|March 5, 2019|Anticipated|2019-03-05||Interventional|LILAC||Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)|A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations|Recruiting||Phase 2|320|Anticipated|Biogen||6|||f||||t|t|f||||||||2017-10-10 21:57:18.105048|2017-10-10 21:57:18.105048
NCT02847585|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-02-24|||August 2016||2016-08-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Potential Role of Water-soluble Ubiquinol in Complementary Therapy for Pediatric Dilated Cardiomyopathy||Recruiting||N/A|25|Anticipated|Chung Shan Medical University||1|||f||||t||||||||No||2017-10-10 21:57:18.56138|2017-10-10 21:57:18.56138
NCT02847572|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-07-18|||January 2016||2016-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Multifocal IOL|A Clinical Assessment of Visual Performance of Combining the Tecnis Symfony Extended Range of Vision IOL (ZXR00) With the +3.25D Tecnis Multifocal 1-Piece IOL (ZLB00) in Subjects Undergoing Bilateral Cataract Extraction|Completed||N/A|50|Actual|Crystal Clear Vision||1|||f||||t||||||||||2017-10-10 21:57:18.660664|2017-10-10 21:57:18.660664
NCT02847559|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-09-06|||August 2016||2016-08-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|September 2019|Anticipated|2019-09-01||Interventional|||Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma|A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma|Recruiting||Phase 2|27|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 21:57:18.746949|2017-10-10 21:57:18.746949
NCT02847546|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-01-09|||September 2016||2016-09-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|True™Flow||Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation|Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation|Completed||N/A|25|Actual|C. R. Bard|||1||f||||f||||||||Undecided||2017-10-10 21:57:18.883199|2017-10-10 21:57:18.883199
NCT02847533|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-25|||September 2016||2016-09-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|InDep||Inflammatory Markers and Resistant Depression|Inflammatory Markers and Resistant Depression|Not yet recruiting||N/A|108|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||Undecided||2017-10-10 21:57:18.966538|2017-10-10 21:57:18.966538
NCT02847520|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||February 2015||2015-02-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|CHAPS||Validation of a Tool for Assessing Gambling Problems Related to the Practice of Poker: the Copenhagen Poker Screen (CHAPS)||Completed||N/A|729|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:57:19.108522|2017-10-10 21:57:19.108522
NCT02847507|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|VIhVhEpb||Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)|Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb): a Prospective Cohort Study|Recruiting||N/A|250|Anticipated|Centre Hospitalier de la côte Basque|||1||f||||f||||||Samples Without DNA|"     serological status for hepatitis E, hepatits B and hepatitis C, and biological follow up of     HIV patients including fibrotest for hepatis b/ or C positive patients   "|Undecided||2017-10-10 21:57:19.189032|2017-10-10 21:57:19.189032
NCT02847494|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-09-07|||September 2016||2016-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Corticosteroids for Acute Migraine in the Emergency Department|Corticosteroids for Acute Migraine. An ED-based, Randomized, Comparative Effectiveness Trial|Recruiting||Phase 4|220|Anticipated|Montefiore Medical Center||2|||f||||t||||||||No||2017-10-10 21:57:19.2773|2017-10-10 21:57:19.2773
NCT02848742|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:57:19.383942|2017-10-10 21:57:19.383942
NCT02848729|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||February 2016||2016-02-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Evaluate the Drug-Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen|A Randomized, 2-Way, Parallel, Single-Blind Pharmacokinetic Study to Evaluate the Interaction Between Intravenous Morphine and Orally or Intravenously Administered Acetaminophen in Healthy Subjects|Completed||Phase 4|50|Actual|Mallinckrodt||2|||f||||f||||||||||2017-10-10 21:57:19.421471|2017-10-10 21:57:19.421471
NCT02848716|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-27|||December 2016||2016-12-01|July 2016|2016-07-01|December 2026|Anticipated|2026-12-01|December 2021|Anticipated|2021-12-01||Interventional|LiLACs||Pretherapeutic Paraaortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Versus Definitive Chemoradiotherapy|A Phase III Randomized Study of Pretherapeutic Paraaortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy|Not yet recruiting||Phase 3|600|Anticipated|Institut Claudius Regaud||2|||f||||t||||||||Yes|Specific Case Report Form (CRF)|2017-10-10 21:57:19.489936|2017-10-10 21:57:19.489936
NCT02848703|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||July 2016||2016-07-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||"Study  COFLORES "|"Study  COFLORES :Imaging of Coronary Reserve Without Tracers"|Not yet recruiting||N/A|70|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 21:57:19.573479|2017-10-10 21:57:19.573479
NCT02848690|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-28|||November 2015||2015-11-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Educational Intervention for Sodium Restriction in Patients With Hypertension|The Effectiveness of an Educational Intervention for Sodium Restriction in Patients With Hypertension: Study Protocol for a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:57:19.651169|2017-10-10 21:57:19.651169
NCT02848677|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-08-01|||November 2015||2015-11-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||Serum Levels of Advanced Glycation End-products After Dietary Intervention in Hypertensive Patients|Serum Levels of Advanced Glycation End-products After Dietary Intervention in Hypertensive Patients: Study Protocol of a Randomized Clinical Trial.|Recruiting||Phase 2|120|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||No||2017-10-10 21:57:19.758526|2017-10-10 21:57:19.758526
NCT02848664|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-27|||August 2013||2013-08-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Use of the Passy Muir Swallowing Self Trainer|Study of the Use of the Passy Muir Swallowing Self Trainer by Persons With Dysphagia|Completed||Phase 1|11|Actual|James Madison University||1|||f||||t||||||||No||2017-10-10 21:57:19.846412|2017-10-10 21:57:19.846412
NCT02848651|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-09-27|||September 23, 2016|Actual|2016-09-23|September 2017|2017-09-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|B-F1RST||A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II Single-Arm Study of Atezolizumab Monotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Clinical Evaluation of Novel Blood-Based Diagnostics|Recruiting||Phase 2|150|Anticipated|Genentech, Inc.||1|||f||||||||||||||2017-10-10 21:57:19.919876|2017-10-10 21:57:19.919876
NCT02848638|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||July 2012||2012-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Observational|PET-Y90||Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization|Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization With Large Hepatocellular Carcinomas or Associated Portal Vein Thrombosis|Active, not recruiting||N/A|100|Anticipated|University of Washington|||1||f||||f||||||||No||2017-10-10 21:57:20.052725|2017-10-10 21:57:20.052725
NCT02848625|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||August 2016||2016-08-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|YES-IPF||Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis|Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis|Not yet recruiting||N/A|64|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 21:57:20.183447|2017-10-10 21:57:20.183447
NCT02848612|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||October 2015||2015-10-01|July 2016|2016-07-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Observational|ANTICONEURORAD||Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol|Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol|Active, not recruiting||N/A|412|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:57:20.256656|2017-10-10 21:57:20.256656
NCT02848599|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-26|||July 2016||2016-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Influence of Postoperative Analgesia on Systemic Inflammatory Response and POCD After Femoral Fractures Surgery|The Influence of Postoperative Analgesia on Systemic Inflammatory Response and Postoperative Cognitive Disfunction in Elderly Patients After Surgical Repair of Femoral Fractures|Recruiting||Phase 2|70|Anticipated|Osijek University Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:57:20.329606|2017-10-10 21:57:20.329606
NCT02848586|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-11-16|||August 2016||2016-08-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers|Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers|Recruiting||N/A|20|Anticipated|Duke University||2|||f||||f||||||||No||2017-10-10 21:57:20.442927|2017-10-10 21:57:20.442927
NCT02848573|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||April 2008||2008-04-01|July 2016|2016-07-01||||June 2016|Actual|2016-06-01||Observational|||the Correlation Between Non-invasive Indicators in Patients With Biliary Atresia|the Correlation Between Hepatic Fibrotic Scores and ADC and Other Non-invasive Indicators in Patients With Biliary Atresia|Completed||N/A|41|Actual|National Taiwan University Hospital|||1||f||||||||||||||2017-10-10 21:57:20.551147|2017-10-10 21:57:20.551147
NCT02848560|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-27|||March 2016||2016-03-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|August 2021|Anticipated|2021-08-01||Observational|||Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI|Validation of MRI as a Sensitive Tool to Longitudinally Monitor CF Lung Disease Progression and Response to CFTR Modulator Therapy in Young Children With CF|Recruiting||N/A|38|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||t||||||||Yes|MRI results will be shared with treating CF physicians to support clinical decisions.|2017-10-10 21:57:20.610437|2017-10-10 21:57:20.610437
NCT02848547|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-30|||January 2016||2016-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|||Post Trial Analysis of a Primary Prevention Study in Asian Indians|The Role of Information Technology in the Prevention of Type 2 Diabetes - An Extended Follow-up Study|Completed||N/A|537|Actual|India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals|||2||f||||f||||||Samples With DNA|"     Serum and blood cells are stored.   "|Undecided||2017-10-10 21:57:20.693697|2017-10-10 21:57:20.693697
NCT02848534|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-12-02|||February 2016||2016-02-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|RNL-MI||The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections|The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections|Active, not recruiting||N/A|342|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 21:57:20.744846|2017-10-10 21:57:20.744846
NCT02848508|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-27|||September 2016||2016-09-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|METsuiviIRC||Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study|Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study|Not yet recruiting||Phase 2|36|Anticipated|Centre Hospitalier Universitaire, Amiens||3|||f||||||||||||||2017-10-10 21:57:22.688933|2017-10-10 21:57:22.688933
NCT02848495|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-08-09|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|GAÏA||Biocollection on the Familial Forms of Intracranial Aneurysm|Genetic Study on the Familial Forms of Intracranial Aneurysm|Completed||N/A|411|Actual|Nantes University Hospital|||1||f||||f||||||Samples With DNA|"     For one patient included: Ethylenediaminetetraacetic acid (EDTA) tubes for DNA (20 mL blood)   "|||2017-10-10 21:57:22.778597|2017-10-10 21:57:22.778597
NCT02848482|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-27|||May 2017||2017-05-01|July 2016|2016-07-01||||May 2018|Anticipated|2018-05-01||Interventional|||Anti-infective Effect of Non-surgical Treatment With and Without Photodynamic Therapy on Initial Peri-implantitis||Not yet recruiting||Phase 3|54|Anticipated|Shanghai 9th People's Hospital||2|||f||||||||||||||2017-10-10 21:57:22.857667|2017-10-10 21:57:22.857667
NCT02848469|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||September 2013||2013-09-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Irish Omega-3 Study|Randomized Control Trial of Omega-3 Fatty Acids Compared to Placebo in the Prevention of Psychosis in Very High Risk Individuals|Recruiting||Phase 2|150|Anticipated|University College Cork||2|||f||||f||||||||||2017-10-10 21:57:22.937453|2017-10-10 21:57:22.937453
NCT02848456|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-04-17|||August 2014||2014-08-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Effects of Spinal Manipulation on Central Nervous System Activity Measured by Reflexive Calf Muscle Recruitment|The Effects of Spinal Manipulative Therapy on Postactivation Potentiation|Completed||N/A|20|Actual|University of Kentucky||3|||f||||f||||||||Yes|Shared data include the subjects' reflexive EMG amplitudes and peak torques of the gastrocnemius and soleus during the Hoffmann Reflex electrical stimulation protocol at the conclusion of each data collection session. These raw data are available in Appendix K of the PI's dissertation, which may be obtained at http://uknowledge.uky.edu/khp_etds/27/|2017-10-10 21:57:23.017127|2017-10-10 21:57:23.017127
NCT02848443|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-04-05|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer|Phase I Dose-escalation of S 95005 (TAS-102) in Combination With Oxaliplatin in Metastatic Colorectal Cancer|Recruiting||Phase 1|94|Anticipated|Servier||1|||f||||f||||||||||2017-10-10 21:57:23.136893|2017-10-10 21:57:23.136893
NCT02848430|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-22|||August 2016||2016-08-01|September 2017|2017-09-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Interventional|||Hop Botanical Dietary Supplements - Metabolism and Safety in Women|Hop Botanical Dietary Supplements - Metabolism and Safety in Women|Active, not recruiting||N/A|20|Anticipated|University of Illinois at Chicago||1|||f||||t||||||||||2017-10-10 21:57:23.276417|2017-10-10 21:57:23.276417
NCT02848417|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-25|||April 2016||2016-04-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|Glutathione||Glutathione vs. Curcumin Clinical Trial|Testing the Model: A Phase I/II Randomized Double Blind Placebo Control Trial of Targeted Therapeutics: Liposomal Glutathione and Curcumin|Recruiting||Phase 1/Phase 2|75|Anticipated|South Florida Veterans Affairs Foundation for Research and Education||3|||f||||t||||||||||2017-10-10 21:57:23.360168|2017-10-10 21:57:23.360168
NCT02848404|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-04-26|||June 2016||2016-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application|A Study of Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application in Mild Cognitive Impairment and Mild Alzheimer's Dementia (Baseline Study)|Enrolling by invitation||N/A|20|Actual|Seoul National University Bundang Hospital||1|||f||||t||||||||||2017-10-10 21:57:23.582812|2017-10-10 21:57:23.582812
NCT02848391|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-25|||January 2013||2013-01-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Hypobaric Flight Simulation in COPD Patients|Impact of Hypobaric Flight Simulation on Walking Endurance in COPD Patients|Recruiting||N/A|40|Anticipated|Krankenhaus Kloster Grafschaft||3|||f||||f||||||||No||2017-10-10 21:57:23.68557|2017-10-10 21:57:23.68557
NCT02848378|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-25|||May 2014||2014-05-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Observational|||Advanced Oxidation Protein Product and Monocyte Chemoattractant Protein-1 in Periodontal Disease|The Levels of Advanced Oxidation Protein Product and Monocyte Chemoattractant Protein-1 in Gingival Crevicular Fluid in Periodontal Disease and Health|Completed||N/A|75|Actual|Kırıkkale University|||3||f||||f||||||||No||2017-10-10 21:57:23.79097|2017-10-10 21:57:23.79097
NCT02848365|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-25|||June 2011||2011-06-01|July 2016|2016-07-01||||August 2016|Anticipated|2016-08-01||Interventional|||Incidence and Severity of Postoperative Sore Throat And Intubation Response by Using Different Devices for Endotracheal Intubation|Incidence and Severity of Postoperative Sore Throat And Intubation Response by Using Different Devices for Endotracheal Intubation|Recruiting||N/A|420|Anticipated|King Saud University||6|||f||||||||||||||2017-10-10 21:57:23.885472|2017-10-10 21:57:23.885472
NCT02848352|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-04-04|||June 2016||2016-06-01|July 2016|2016-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Role of Expectations in Experimentally Induced Sadness|The Role of Expectations in Experimentally Induced Sadness|Completed||N/A|128|Actual|Philipps University Marburg Medical Center||4|||f||||f||||||||No||2017-10-10 21:57:24.019067|2017-10-10 21:57:24.019067
NCT02848339|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-27|||May 2010||2010-05-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01|12 Months|Observational [Patient Registry]|ADAPTED||Aspirin Desensitization Registry in Patients With Aspirin Hypersensitivity|Aspirin DesensitizAtion in PatienTs With Coronary artEry Disease: Results of a Multi Center Registry: the ADAPTED Registry|Completed||N/A|330|Actual|Italian Society of Cardiology|||1||f||||f||||||||Yes||2017-10-10 21:57:24.100026|2017-10-10 21:57:24.100026
NCT02848326|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-07-03|||September 6, 2016|Actual|2016-09-06|July 2017|2017-07-01|December 9, 2017|Anticipated|2017-12-09|November 9, 2017|Anticipated|2017-11-09||Interventional|||Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral AGN-241689 in Episodic Migraine Prevention|A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention|Recruiting||Phase 2/Phase 3|810|Anticipated|Allergan||6|||f||||t|t|f||||||||2017-10-10 21:57:24.180728|2017-10-10 21:57:24.180728
NCT02848313|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-09-05|||November 3, 2016|Actual|2016-11-03|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration|An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration|Active, not recruiting||Phase 1|40|Actual|Stealth BioTherapeutics Inc.||1|||f||||f||||||||||2017-10-10 21:57:24.416349|2017-10-10 21:57:24.416349
NCT02848300|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-10-25|||July 2016||2016-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia|Evaluation of Local Pharmacokinetics and Tolerability of Bimatoprost Applied Topically to the Scalp of Male Patients With Androgenetic Alopecia|Completed||Phase 1|11|Actual|Allergan||1|||f||||f||||||||||2017-10-10 21:57:24.510908|2017-10-10 21:57:24.510908
NCT02848287|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||August 2016||2016-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Children|Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Preschool-aged Children Undergoing Adenotonsillectomy|Not yet recruiting||N/A|84|Anticipated|Ajou University School of Medicine||2|||f||||f||||||||No||2017-10-10 21:57:24.590415|2017-10-10 21:57:24.590415
NCT02848274|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-02-15|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome|Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome|Recruiting||N/A|2000|Anticipated|Stanford University|||1||f||||f|f|f||||Samples With DNA|"     tissue, blood   "|||2017-10-10 21:57:24.676729|2017-10-10 21:57:24.676729
NCT02848261|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-10-12|||July 2016||2016-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes|Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes|Recruiting||N/A|90|Anticipated|Stanford University||5|||f||||f||||||||Yes||2017-10-10 21:57:24.800068|2017-10-10 21:57:24.800068
NCT02848248|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-09-28|||August 2016||2016-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia|A Phase 1 Study of SGN-CD123A in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|102|Anticipated|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-10-10 21:57:24.914089|2017-10-10 21:57:24.914089
NCT02848235|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-27|||November 2016||2016-11-01|July 2016|2016-07-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Kenya Enhanced Mentor Mother ProgrAm (EMMA)|Implementing the PMTCT Standard of Care Under Routine Conditions With and Without the Enhanced Mentor Mother ProgrAm (EMMA): A Site-randomized Impact Evaluation Study Among Maternal and Child Health Clinics Supported by the South Rift Valley PEPFAR Program in Kenya|Not yet recruiting||N/A|360|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-10-10 21:57:25.228653|2017-10-10 21:57:25.228653
NCT02848209|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-03-16|||July 2016||2016-07-01|July 2016|2016-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Histological Skin Changes of Different Peeling Agents in Surgically Subcutaneous Undermined Skin|Histological Evaluation of Peeling Induced Skin Changes of Different Peeling Agents in Surgically Subcutaneous Undermined Skin Flaps in Facelift Patients|Completed||N/A|9|Actual|University Hospital Tuebingen||4|||f||||f||||||||No||2017-10-10 21:57:25.425454|2017-10-10 21:57:25.425454
NCT02848196|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-28|||July 2016||2016-07-01|July 2016|2016-07-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||An Image-guided SBRT for Adrenal Gland Metastasis in Oligometastatic Patients|A Phase II Trial of Image-guided Stereotactic Body Radiation Therapy (SBRT) for Adrenal Gland Metastasis in Oligometastatic Patients|Recruiting||Phase 2|37|Anticipated|Istituto Clinico Humanitas||1|||f||||t||||||||No||2017-10-10 21:57:25.526503|2017-10-10 21:57:25.526503
NCT02848183|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-26|||January 2016||2016-01-01|July 2016|2016-07-01||||December 2020|Anticipated|2020-12-01||Interventional|||Optimal Treatment Strategy Based on for Pediatric AML|Optimal Treatment Strategy Based on Prognostic Groups for Pediatric de Novo Acute Myeloid Leukemia|Recruiting||Phase 2|350||Samsung Medical Center||1|||f||||f||||||||No||2017-10-10 21:57:25.618933|2017-10-10 21:57:25.618933
NCT02848170|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2017-05-15|||August 2016||2016-08-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension|An Exploratory Study of CS-3150 to Evaluate the Relation Between Antihypertensive Effect and Baseline Factors Compared to Olmesartan Medoxomil in Patients With Essential Hypertension|Completed||N/A|40|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||Undecided||2017-10-10 21:57:25.736293|2017-10-10 21:57:25.736293
NCT02848157|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Dexmedetomidine as Adjunct to Pudendal Block for Pediatric Penile Surgery||Not yet recruiting||Phase 4|40|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 21:57:25.8501|2017-10-10 21:57:25.8501
NCT02848144|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-08-08|||September 26, 2014|Actual|2014-09-26|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PedIRIS||Pediatric Immune Response to Infectious Shock|Pediatric Immune Response to Infectious Shock|Recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 21:57:25.949862|2017-10-10 21:57:25.949862
NCT02848131|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-11|||July 2016||2016-07-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|April 2020|Anticipated|2020-04-01||Interventional|||Senescence in Chronic Kidney Disease|Senescence, Frailty, and Mesenchymal Stem Cell Functionality in Chronic Kidney Disease: Effect of Senolytic Agents|Recruiting||Phase 2|20|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 21:57:26.057414|2017-10-10 21:57:26.057414
NCT02848105|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-26|2016-07-29|||July 2016||2016-07-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD|Phase II Study of Valproic Acid With Methylprenisonlone for the Treatment of Grade II-IV Acute GVHD in Patients After Allogeneic Stem Cell Transplantation|Recruiting||Phase 2|55|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||Undecided||2017-10-10 21:57:26.258873|2017-10-10 21:57:26.258873
NCT02848092|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-07-27|||May 2016||2016-05-01|July 2016|2016-07-01|March 2021|Anticipated|2021-03-01|November 2020|Anticipated|2020-11-01||Interventional|||Improving ADHD Teen Driving|Improving ADHD Teen Driving|Recruiting||N/A|136|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||No||2017-10-10 21:57:26.368635|2017-10-10 21:57:26.368635
NCT02848079|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-07-24|||August 2016||2016-08-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|July 2019|Anticipated|2019-07-01||Interventional|||TAS-OX for Refractory Metastatic Colon Cancer|TAS-102 and Oxaliplatin (TAS-OX) for Refractory Metastatic Colon Cancer|Recruiting||Phase 1/Phase 2|68|Anticipated|Yale University||1|||f||||t||||||||||2017-10-10 21:57:26.470881|2017-10-10 21:57:26.470881
NCT02848066|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker|Open, Parallel, Single-Site Study to Evaluate Sensitivity and Specificity of Newly Defined Diagnosed-biomarker for Gastric Cancer Pts and Cancer-free Healthy Volunteers|Recruiting||N/A|355|Anticipated|Samsung Medical Center|||2||f||||f||||||||No||2017-10-10 21:57:26.586459|2017-10-10 21:57:26.586459
NCT02848053|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-10-03|||August 2016||2016-08-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||The Long-term Effect of Tianqi Capsule Interventions to Prevent Diabetes in the REDUCES Study: a 8-year Follow-up Study|The Long-term Effect of Tianqi Capsule Interventions to Prevent Diabetes in the REDUCES Study: a 8-year Follow-up Study|Not yet recruiting||N/A|420|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|||2||f||||t||||||||Undecided||2017-10-10 21:57:26.687737|2017-10-10 21:57:26.687737
NCT02848040|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-04-24|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Role of Faecal Bile Acids in the Management of Bile Acid Diarrhoea|The Role of Faecal Bile Acids in the Management of Bile Acid Diarrhoea|Recruiting||N/A|120|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||1|||f||||t||||||||No||2017-10-10 21:57:26.772629|2017-10-10 21:57:26.772629
NCT02848027|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-06-12|||September 2015||2015-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|KneeOA||Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment|Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment|Enrolling by invitation||Phase 3|400|Anticipated|Regenerative Sciences, LLC||1|||f||||f||||||||No||2017-10-10 21:57:26.853209|2017-10-10 21:57:26.853209
NCT02848014|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-04-04|||July 2016|Actual|2016-07-01|June 2016|2016-06-01|November 30, 2016|Actual|2016-11-30|November 2016|Actual|2016-11-01||Interventional|||The Effects of Interventions Aiming at Optimizing Expectations and Inducing Positive Emotions After an Acute Stressor|The Effects of Interventions Aiming at Optimizing Expectations and Inducing Positive Emotions After an Acute Stressor on Subjective and Objective Stress Paramaters|Completed||N/A|74|Actual|Philipps University Marburg Medical Center||3|||f||||f||||||||||2017-10-10 21:57:26.926139|2017-10-10 21:57:26.926139
NCT02848001|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-29|||November 14, 2016|Actual|2016-11-14|August 2017|2017-08-01|June 21, 2021|Anticipated|2021-06-21|August 5, 2019|Anticipated|2019-08-05||Interventional|||A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 1, Open-label, Dose Finding Study of CC-90009 in Subjects With Relapsed, Refractory Acute Myeloid Leukemia|Recruiting||Phase 1|78|Anticipated|Celgene||1|||f||||f||||||||||2017-10-10 21:57:26.998273|2017-10-10 21:57:26.998273
NCT02847988|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-05-01|||July 2016||2016-07-01|May 2017|2017-05-01|February 2022|Anticipated|2022-02-01|June 2021|Anticipated|2021-06-01||Interventional|||Facilitating Functional Independence in Patients Receiving Prolonged Mechanical Ventilation|Facilitating Functional Independence in Patients Receiving Prolonged Mechanical Ventilation|Recruiting||N/A|200|Anticipated|RML Specialty Hospital||2|||f||||t||||||||No||2017-10-10 21:57:27.096368|2017-10-10 21:57:27.096368
NCT02847975|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-07-25|||October 2013||2013-10-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Sodium Nitrate to Improve Blood Flow|Sodium Nitrate to Improve Blood Flow|Completed||Phase 1|11|Actual|Cedars-Sinai Medical Center||1|||f||||f||||||||Yes|Published http://www.ncbi.nlm.nih.gov/pubmed/26437761|2017-10-10 21:57:27.17357|2017-10-10 21:57:27.17357
NCT02847962|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-25|||February 2016||2016-02-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Interventional|||Newly Formulated, Extruded Fortified-blended Foods for Food Aid: the MFFAPP Tanzania Efficacy Study||Completed||N/A|2179|Actual|Kansas State University||7|||f||||f||||||||No||2017-10-10 21:57:27.245956|2017-10-10 21:57:27.245956
NCT02847936|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|July 2016|Actual|2016-07-01||Interventional|EPISIOVIC||Efficacy of Triclosan-coated Sutures in the Episiotomy|The Effect of Triclosan-coated Sutures for Reducing Risk of Surgical Site Infection After Episiotomy: A Prospective Randomized Controlled Trial|Recruiting||Phase 4|400|Anticipated|University Tunis El Manar||2|||f||||f||||||||No||2017-10-10 21:57:27.409101|2017-10-10 21:57:27.409101
NCT02847923|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-25|||October 2015||2015-10-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Software for Alternative Communication|Software for Alternative Communication|Completed||N/A|30|Actual|University of Mogi das Cruzes||1|||f||||f||||||||No||2017-10-10 21:57:27.635753|2017-10-10 21:57:27.635753
NCT02847910|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-08-10|||July 2016||2016-07-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||ClinicaI Observation of Induced Abortion With Disposable Tissue Suction Tube|ClinicaI Observation of Induced Abortion With Disposable Tissue Suction Tube|Recruiting||N/A|500|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||No||2017-10-10 21:57:27.731672|2017-10-10 21:57:27.731672
NCT02847897|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-03-29|||August 2016||2016-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Safety and Efficacy of Carbon Dioxide (CO2) Acupulse Laser Treatment on Vaginal Elasticity.|Evaluation of the Safety and Efficacy of Carbon Dioxide (CO2) Acupulse Laser for the Treatment of Vaginal Prolapse in Women.|Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||No||2017-10-10 21:57:27.837044|2017-10-10 21:57:27.837044
NCT02847884|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-07-27|||October 2015||2015-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Observational|IDeaL||IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study|IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study|Recruiting||N/A|30|Anticipated|University of Alberta|||1||f||||f||||||Samples Without DNA|"     Blood will be collected to determine IFX levels and serum cytokines. Stool will be collected     for calprotectin. Urine will be collected for metabolomics.      If a child undergoes endoscopy or surgery during the 8 weeks after beginning IFX, a specimen     will be collected for tissue cytokine assay.   "|Undecided||2017-10-10 21:57:27.932829|2017-10-10 21:57:27.932829
NCT02847871|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|PRISME-3P||Elderly Patient at Risk of Loss of Mobility, Exercise - Primary Care, Prevention, Care Pathways|Prevention of Loss of Mobility From a Care Pathway Focused on Exercise and Nutrition in Elderly Patients Over 70 Years, in Primary Care. Cluster Randomized Controlled Trial|Not yet recruiting||N/A|300|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 21:57:28.057376|2017-10-10 21:57:28.057376
NCT02847858|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-25|||August 2016||2016-08-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||Health-E You: Reducing Unintended Pregnancies Among Hispanic Adolescents|Health-E You: Reducing Unintended Pregnancies Among Hispanic Adolescents Using a Computer-based Intervention|Not yet recruiting||N/A|1400|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 21:57:28.166646|2017-10-10 21:57:28.166646
NCT02847845|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-27|||June 2016||2016-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Clinical Study About Improvement of Chronic Fatigue After Taking Red Ginseng|A Clinical Study About Improvement of Chronic Fatigue After Taking Red Ginseng|Recruiting||N/A|50|Anticipated|DongGuk University||2|||f||||t||||||||Undecided||2017-10-10 21:57:28.243797|2017-10-10 21:57:28.243797
NCT02847832|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-25|||October 2016||2016-10-01|July 2016|2016-07-01||||February 2019|Anticipated|2019-02-01||Observational|IOTA7||Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to Surgery|Prospective Validation and Comparison of Subjective Assessment, the International Ovarian Tumor Analysis (IOTA) ADNEX Model, Logistic Regression Model LR2, Simple Rules and the Risk of Malignancy Index (RMI) for Discrimination Between Benign and Malignant Adnexal Masses in the Hands of Ultrasound Examiners With Different Levels of Experience|Not yet recruiting||N/A|1700|Anticipated|Katholieke Universiteit Leuven|||1||f||||f||||||Samples Without DNA|"     serum for CA-125 measurement   "|||2017-10-10 21:57:28.364455|2017-10-10 21:57:28.364455
NCT02847819|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-04-24|||March 2016||2016-03-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|30 Days|Observational [Patient Registry]|||Vocal Cord Movement Assessment Using Airway Ultrasound.|Pre and Post-operative Evaluation of Vocal Cord Movement in Patients Undergoing Thyroid Surgery by Airway Ultrasound Scanning.|Recruiting||N/A|100|Anticipated|Rajiv Gandhi Cancer Institute & Research Center, India|||1||f||||t||||||||||2017-10-10 21:57:28.475306|2017-10-10 21:57:28.475306
NCT02847806|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-07-25|||January 2008||2008-01-01|July 2016|2016-07-01||||December 2015|Actual|2015-12-01||Interventional|STEROSENS||Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man||Active, not recruiting||Phase 3|12|Anticipated|University Hospital, Caen||3|||f||||f||||||||||2017-10-10 21:57:28.572877|2017-10-10 21:57:28.572877
NCT02847793|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-28|||April 2016||2016-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|ABMET||Attentional Bias Modification Through Eye-tracker Methodology (ABMET)|Changes in Selective Attentional Patterns Towards Emotional Stimuli by Using Eye-tracking Techniques: A New Intervention for Depression|Recruiting||N/A|40|Anticipated|Universidad Complutense de Madrid||2|||f||||f||||||||No||2017-10-10 21:57:28.65984|2017-10-10 21:57:28.65984
NCT02847780|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-04-24|||April 2016||2016-04-01|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Comparison of Two Technique for Assessment of Vocal Cord Movement by C-Mac Videolaryngoscope vs Airway Ultrasound.|Assessment of Vocal Cord Movement After Thyroid Surgery Using C-MAC Video-laryngoscope and Airway Ultrasound.|Recruiting||N/A|100|Anticipated|Rajiv Gandhi Cancer Institute & Research Center, India||2|||f||||t||||||||No||2017-10-10 21:57:28.782528|2017-10-10 21:57:28.782528
NCT02847767|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-25|||July 2016||2016-07-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Dynamic Contrast Enhanced HCC SABR Liver Study|Dynamic Contrast Enhanced Imaging of Patients Receiving SABR for Unresectable or Medically Inoperable Hepatocellular Carcinoma in BC|Not yet recruiting||N/A|20|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||No||2017-10-10 21:57:28.880493|2017-10-10 21:57:28.880493
NCT02847754|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-25|||August 2016||2016-08-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|DISPO-2||Differentiated Resistance Training of the Paravertebral Muscles in Patients With Unstable Spinal Bone Metastasis Under Concomitant Radiotherapy|Differentiated Resistance Training of the Paravertebral Muscles in Patients With Unstable Spinal Bone Metastasis Under Concomitant Radiotherapy|Not yet recruiting||Phase 2|60|Anticipated|Heidelberg University||2|||f||||f||||||||Undecided||2017-10-10 21:57:28.965023|2017-10-10 21:57:28.965023
NCT02847741|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-25|||June 2012||2012-06-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Predictive Nature of Total Cholesterol Threshold: Possible Link to Suicidal Behavior|Predictive Nature of Total Cholesterol Threshold: Possible Link to Suicidal Behavior|Active, not recruiting||N/A|555|Actual|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 21:57:29.080146|2017-10-10 21:57:29.080146
NCT02847728|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-06-26|||July 2016||2016-07-01|June 2017|2017-06-01|December 2024|Anticipated|2024-12-01|March 2024|Anticipated|2024-03-01||Observational|||Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice|Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice|Recruiting||N/A|1200|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||No||2017-10-10 21:57:29.21014|2017-10-10 21:57:29.21014
NCT02847715|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-08-04|||August 2016||2016-08-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|ePRIME||Electronic Patient Self-Reported Outcomes to Improve Cancer Management and Patient Experiences|Electronic Patient Self-Reported Outcomes to Improve Cancer Management and Patient Experiences: Implement the System for Remote Monitoring of Cancer Patients in Remission|Not yet recruiting||N/A|168|Anticipated|University of Leeds||2|||f||||f||||||||No||2017-10-10 21:57:29.525974|2017-10-10 21:57:29.525974
NCT02847702|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-03-29|||August 2016||2016-08-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee|A Phase 2a, Multicenter, Randomized, Double-blind, Placebo Controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of VM902A in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee|Suspended||Phase 2|240|Anticipated|Purdue Pharma LP||4||Informed consent form revision|f||||t||||||||No||2017-10-10 21:57:29.61714|2017-10-10 21:57:29.61714
NCT02847689|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-10-03|||July 2016||2016-07-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Listening to Mom in the NICU: Neural, Clinical and Language Outcomes|Listening to Mom in the Neonatal Intensive Care Unit (NICU): Neural, Clinical and Language Outcomes|Recruiting||Phase 1|42|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 21:57:29.76591|2017-10-10 21:57:29.76591
NCT02847676|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||August 2016||2016-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01|1 Day|Observational [Patient Registry]|||Differences in Peritoneal Stem Cells in Women With and Without Adhesions After Gynaecological Surgery|Differences in Peritoneal Stem Cells in Women With and Without Adhesions After Gynaecological Surgery|Not yet recruiting||N/A|40|Anticipated|Pius-Hospital Oldenburg|||4||f||||t||||||Samples With DNA|"     Peritoneal tissue samples taken from Adhesions, Peritoneal lining and omentum.   "|No||2017-10-10 21:57:29.862865|2017-10-10 21:57:29.862865
NCT02847663|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-10-04|||April 2016||2016-04-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|Cryotherapy||The Effect of Whole Body Cryotherapy on Recovery and Performance: a Randomized Controlled Trial|The Effect of Whole Body Cryotherapy on Recovery and Performance: a Randomized Controlled Trial|Active, not recruiting||N/A|90|Anticipated|University of Applied Sciences and Arts of Southern Switzerland||2|||f||||t||||||||||2017-10-10 21:57:29.945155|2017-10-10 21:57:29.945155
NCT02847481|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-03-02|||May 2016||2016-05-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS|A Pilot Study to Evaluate Fecal Microbiota Transplantation Engraftment in Irritable Bowel Syndrome|Recruiting||Phase 1|80|Anticipated|Beth Israel Deaconess Medical Center||4|||f||||t||||||||||2017-10-10 21:57:30.041117|2017-10-10 21:57:30.041117
NCT02847468|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-03-23|||September 2016||2016-09-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|PREMETHEP||Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib|Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib|Recruiting||N/A|87|Anticipated|Centre Georges Francois Leclerc||1|||f||||f|f|f||||||No||2017-10-10 21:57:30.124158|2017-10-10 21:57:30.124158
NCT02847455|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||August 2008||2008-08-01|July 2016|2016-07-01||||October 2009|Actual|2009-10-01||Interventional|||Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients|Efficacy and Safety of Ilaprazole for Acute Duodenal Ulcer: A Randomized,Double-Blind,Rabeprazole-Controlled,Multicenterand Phase3 Trial in China in China|Completed||Phase 2/Phase 3|408|Actual|Livzon Pharmaceutical Group Inc.||3|||f||||t||||||||||2017-10-10 21:57:30.203131|2017-10-10 21:57:30.203131
NCT02847442|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-03-30|||November 23, 2016|Actual|2016-11-23|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|OPTIPARK||Efficacy and Safety of Opicapone in Clinical Practice|Efficacy and Safety of Opicapone in Clinical Practice in Parkinson's Disease Patients With Wearing-off Motor Fluctuations|Recruiting||Phase 4|500|Anticipated|Bial - Portela C S.A.||1|||f||||f|f|f||||||Undecided||2017-10-10 21:57:30.416002|2017-10-10 21:57:30.416002
NCT02847429|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-07-24|||August 2016||2016-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Crenolanib in Subjects With Advanced or Metastatic Gastrointestinal Stromal Tumors With a D842V Mutation in the PDGFRA Gene|Recruiting||Phase 3|120|Anticipated|Arog Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 21:57:30.528767|2017-10-10 21:57:30.528767
NCT02847416|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-24|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|July 2017|Actual|2017-07-01||Interventional|PFBM||A Study of Pressure and Flow Characteristics During Inspiration and Expiration Using BreatheMAX® in Healthy Subjects|to Explore the Characteristics of Mean Airway Pressure, Oscillatory Amplitude and Power Spectral Density (PSD) of Oscillatory Airway Pressure That Generate by Various Loaded and Flow Rate During Expiration and Inspiration in Healthy Subjects|Recruiting||N/A|10|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-10-10 21:57:30.753582|2017-10-10 21:57:30.753582
NCT02847403|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-27|||February 2016||2016-02-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|DRINN||Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients|Long-acting Exenatide: a Tool to Stop Cognitive Decline in Dysglycemic Patients With Mild Cognitive Impairment?|Recruiting||Phase 3|40|Anticipated|Azienda Ospedaliero-Universitaria di Parma||2|||f||||f||||||||Yes||2017-10-10 21:57:30.851432|2017-10-10 21:57:30.851432
NCT02847390|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-17|||August 2015||2015-08-01|August 2017|2017-08-01|January 30, 2018|Anticipated|2018-01-30|January 30, 2018|Anticipated|2018-01-30||Observational|||Implementation and Evaluation of an Inpatient Diabetes Superuser Education Program|Implementation and Evaluation of an Inpatient Diabetes Superuser Education Program|Active, not recruiting||N/A|5400|Anticipated|Johns Hopkins University|||2||f||||t||||||||||2017-10-10 21:57:30.983073|2017-10-10 21:57:30.983073
NCT02847195|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-08|||December 2, 2014|Actual|2014-12-02|August 2017|2017-08-01|February 2, 2019|Anticipated|2019-02-02|February 2, 2019|Anticipated|2019-02-02||Interventional|Pupillomètre||Pupillometry in Pediatric Intensive Care Unit (PICU)|Evaluation of Pupillometry to Assess Analgesia in Children Unable to Communicate Verbally in Pediatric Intensive Care Unit (PICU)|Recruiting||N/A|400|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 21:57:32.801515|2017-10-10 21:57:32.801515
NCT02847377|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-06-20|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|IMKRUN 2||A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC|Exploratory Phase 0/1 of Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC|Recruiting||Early Phase 1|20|Anticipated|Centre Georges Francois Leclerc||1|||f||||f||||||||||2017-10-10 21:57:31.075077|2017-10-10 21:57:31.075077
NCT02847364|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-07-10|||February 2016||2016-02-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|GUMPI||Effect of Chewing Gum on Post-operative Ileus (GUMPI)|Does Chewing Gum Affect the Incidence of Post-operative Ileus in Patients Undergoing Spine Surgery?|Recruiting||N/A|100|Anticipated|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-10 21:57:31.151271|2017-10-10 21:57:31.151271
NCT02847351|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||July 2014||2014-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||A Mild Supplementation of Arabinoxylan Fiber Improves Homa Index in Overweight and Obese Subjects.|A Mild Supplementation of Arabinoxylan Fiber Improves Homa Index in Overweight and Obese Subjects. Results From a Randomized Cross Over Trial.|Active, not recruiting||N/A|19|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||f||||||||No||2017-10-10 21:57:31.260383|2017-10-10 21:57:31.260383
NCT02847338|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-01|||November 2016||2016-11-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|AIMHY-INFORM||Comparison of Optimal Hypertension Regimens|Comparison of Optimal Hypertension Regimens (Part of the Ancestry Informative Markers in Hypertension (AIMHY) Programme - AIMHY-INFORM)|Recruiting||Phase 4|1320|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 21:57:31.37493|2017-10-10 21:57:31.37493
NCT02847325|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-04-24|||May 2016||2016-05-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Study of AC0058TA in Healthy Male and Female Subjects|A Phase 1, Randomized Double-Blind, Placebo-Controlled, Single- and Multiple-Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of AC0058TA in Healthy Male and Female Subjects|Completed||Phase 1|56|Anticipated|ACEA Biosciences, Inc.||2|||f||||f||||||||No||2017-10-10 21:57:31.537337|2017-10-10 21:57:31.537337
NCT02847312|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Chronic Cardiovascular and Gut-bacteria Effects of Phenolic Rich Oats in Adults With Above Average Blood Pressure|Chronic Cardiovascular and Gut-bacteria Effects of Phenolic Rich Oats in Adults With Above Average Blood Pressure|Recruiting||N/A|30|Anticipated|University of Reading||3|||f||||f||||||||Yes|Publish|2017-10-10 21:57:31.633384|2017-10-10 21:57:31.633384
NCT02847299|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-04-19|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|TWOTECH||Comparison of a Hyperinflation Mode and Air Stacking on Neuromuscular Patients Under Volumetric Ventilation|Comparison of a Hyperinflation Mode and Air Stacking on Neuromuscular Patients Under Volumetric Ventilation|Completed||N/A|20|Actual|Centre d'Investigation Clinique et Technologique 805||2|||f||||f||||||||||2017-10-10 21:57:31.758496|2017-10-10 21:57:31.758496
NCT02847286|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-29|||September 1, 2015|Actual|2015-09-01|August 2017|2017-08-01|November 28, 2016|Actual|2016-11-28|November 28, 2016|Actual|2016-11-28||Interventional|||To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)|AN OPEN-LABEL, RANDOMISED TRIAL, WITH A THREE-PERIOD CROSSOVER PART IN HEALTHY HIV-NEGATIVE WOMEN TO ASSESS THE DRUG-DRUG INTERACTION POTENTIAL BETWEEN DAPIVIRINE VAGINAL RING-004, CONTAINING 25 MG OF DAPIVIRINE, AND CLOTRIMAZOLE 10 mg/g (1%) ADMINISTERED AS A VAGINAL CREAM, WITH A FOLLOW-ON PERIOD TO ASSESS THE EFFECT OF MULTIPLE RING REMOVALS AND RE-INSERTIONS DURING THE 28-DAY PERIOD OF THE DAPIVIRINE VAGINAL RING-004 USE ON THE SYSTEMIC AND LOCAL EXPOSURE AND RESIDUAL AMOUNT OF DAPIVIRINE IN USED RINGS|Completed||Phase 1|36|Actual|International Partnership for Microbicides, Inc.||3|||f||||t||||||||||2017-10-10 21:57:31.871932|2017-10-10 21:57:31.871932
NCT02847273|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-27|||September 2015||2015-09-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|NIRS-8||Peripheral Four-wavelength Near-infrared Spectroscopy Measurement: a Comparison Between EQUANOX and O3 in Cardiac Surgery|Peripheral Four-wavelength Near-infrared Spectroscopy Measurement: a Comparison Between EQUANOX and O3 in Cardiac Surgery|Completed||N/A|20|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:57:31.953031|2017-10-10 21:57:31.953031
NCT02847260|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-08|2017-08-08||April 2012||2012-04-01|August 2017|2017-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|RAPID||Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)|A 16 Week, Open Label, Multi-centre, Study to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of a Rapid Dose Titration Regimen of Subcutaneous Remodulin® Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 4|39|Actual|United Therapeutics||1|||f||||f||||||||||2017-10-10 21:57:32.038734|2017-10-10 21:57:32.038734
NCT02847247|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-11-23|||December 2016||2016-12-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|Endoscreen||Systemic Inflammatory Response to CCRE|Systemic Inflammatory Response to 20,000 EU Clinical Center Reference Endotoxin in Normal Adults|Not yet recruiting||Phase 1|18|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||No|for internal analysis only|2017-10-10 21:57:32.480178|2017-10-10 21:57:32.480178
NCT02847234|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||January 2015||2015-01-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Factors Associated With Complications of Cervical Necrotizing Fasciitis|Factors Associated With Complications of Cervical Necrotizing Fasciitis|Recruiting||N/A|350|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:57:32.563094|2017-10-10 21:57:32.563094
NCT02847221|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||November 2014||2014-11-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|CPF||Cough Peak Flow for Extubation Prediction|Assessing Cough Peak Flow (CPF) Using Ventilator built-in Flow-meter to Predict Extubation Success: A Single Centre Study|Completed||N/A|92|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:57:32.647315|2017-10-10 21:57:32.647315
NCT02847208|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||January 2014||2014-01-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Contraceptive Practices and Cervical Screening in Women With Cystic Fibrosis|Contraceptive Practices and Cervical Screening in Women With Cystic Fibrosis|Completed||N/A|155|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:57:32.71154|2017-10-10 21:57:32.71154
NCT02847182|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-06-27|||August 2016||2016-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|Duke ACT||Cord Blood Infusion for Children With Autism Spectrum Disorder|Efficacy of Intravenous Umbilical Cord Blood Infusion as Cell Therapy for Children With Autism Spectrum Disorder (ASD): Duke ACT|Enrolling by invitation||Phase 2|165|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 21:57:32.888679|2017-10-10 21:57:32.888679
NCT02847169|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-03-28|2017-03-28||September 2016||2016-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional||There was 1 protocol deviation. Therefore, of the 30 subjects who completed the study, data from one subject is not included in the analysis.|Clinical Performance of Toric Hydrogel Contact Lenses Following One Week of Daily Wear|Clinical Performance of Toric Hydrogel Contact Lenses Following One Week of Daily Wear|Completed||N/A|30|Actual|Coopervision, Inc.||2|||f||||f||||||||No||2017-10-10 21:57:32.993637|2017-10-10 21:57:32.993637
NCT02847156|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||January 2015||2015-01-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PREVIMUC||Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis.|Clinical and Microbiological Impact of Respiratory Viral Infections in the Short and Medium Term in Infants (<24 Months) With Cystic Fibrosis.|Completed||N/A|25|Actual|Hospices Civils de Lyon||1|||f||||||||||||||2017-10-10 21:57:33.394557|2017-10-10 21:57:33.394557
NCT02847143|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-21|||April 2015||2015-04-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|OTACLA||Ocytocine and Cerebral Activation in Relation With Attachement|A Cross Over Randomized Controlled Trial of the Effect of Nasal Ocytocine on Cerebral Activations in Relation With Attachement in the General Population|Recruiting||Phase 2|80|Anticipated|Centre Hospitalier Universitaire de Besancon||4|||f||||t||||||||||2017-10-10 21:57:33.465646|2017-10-10 21:57:33.465646
NCT02847130|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-02-14|||September 2016||2016-09-01|February 2017|2017-02-01||||March 2019|Anticipated|2019-03-01||Observational|||Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology|Use of Evidence-Based Supportive Care Clinical Practice Guidelines in Pediatric Oncology|Recruiting||N/A|550|Anticipated|Children's Oncology Group|||1||f||||||||||||||2017-10-10 21:57:33.569849|2017-10-10 21:57:33.569849
NCT02847117|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-09-21|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|||Bioavailability of the Microconstituents of Natural Chios Mastiha in Healthy Adults.|A Bioavailability Study of the Natural Chios Mastiha in Blood and Urine Samples of Healthy Adults.|Active, not recruiting||N/A|20|Anticipated|Harokopio University||1|||f||||f||||||||||2017-10-10 21:57:33.722059|2017-10-10 21:57:33.722059
NCT02847104|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-27|||February 2013||2013-02-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Observational|||Medical ICU Paper-based Dynamic Insulin Protocol|Impact of a Paper-based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target and Hypoglycemic Risk: a Stepped Wedge Trial in Medical ICU Patients|Completed||N/A|131|Actual|University Hospital, Caen|||2||f||||f||||||||Undecided||2017-10-10 21:57:33.793958|2017-10-10 21:57:33.793958
NCT02847091|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-06-16|||July 29, 2016|Actual|2016-07-29|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy|Post-marketing Clinical Study of Ipragliflozin; Multicenter, Open-label Study to Assess the Efficacy of Ipragliflozin Add-on in Reducing Insulin Dose in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy|Active, not recruiting||Phase 4|103|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-10 21:57:33.865158|2017-10-10 21:57:33.865158
NCT02847078|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-27|||September 2016||2016-09-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|SPASCPM||Smart Phone Application in the Secondary Clinical Prevention Management for Chinese Patients|Effects of a Smart Phone Application in the Secondary Clinical Prevention Management for Chinese Patients After Coronary Intervention Treatment: a Randomized Controlled Trial|Not yet recruiting||N/A|140|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||Undecided||2017-10-10 21:57:33.963441|2017-10-10 21:57:33.963441
NCT02847065|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-26|||November 2015||2015-11-01|July 2016|2016-07-01||||December 2016|Anticipated|2016-12-01||Observational|MoBaCo||The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421|Study Single-center, Uncontrolled, Retrospective, the Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum|Recruiting||N/A|180|Anticipated|Nantes University Hospital|||1||f||||||||||||||2017-10-10 21:57:34.214799|2017-10-10 21:57:34.214799
NCT02847052|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-26|||August 2014||2014-08-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|IL-22BP MICI||Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease||Completed||N/A|52|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:57:34.314787|2017-10-10 21:57:34.314787
NCT02847039|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-26||||||July 2016|2016-07-01||||January 2018|Anticipated|2018-01-01||Observational|||Early Repolarization Syndrome: Define the Risk, Stratify the Coverage and Understand the Causes - Clinical and Genetic Study|Early Repolarization Syndrome: Define the Risk, Stratify the Coverage and Understand the Causes - Clinical and Genetic Study|Recruiting||N/A|200|Anticipated|Nantes University Hospital|||1||f||||||||||||||2017-10-10 21:57:34.395482|2017-10-10 21:57:34.395482
NCT02847026|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-12-22|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|fIPV||Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study|Immunogenicity of a Booster Dose of Fractional Inactivated Poliovirus Vaccine (fIPV) Delivered Intradermally Concomitantly With Rotavirus Vaccines|Active, not recruiting||Phase 4|1144|Actual|Centers for Disease Control and Prevention||8|||f||||t||||||||No|De-identified individual participant data will not be shared beyond use by co-investigators.|2017-10-10 21:57:34.514074|2017-10-10 21:57:34.514074
NCT02847013|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-26|||September 2016||2016-09-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section||Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Milton S. Hershey Medical Center||2|||f||||||||||||Undecided||2017-10-10 21:57:35.567203|2017-10-10 21:57:35.567203
NCT02846285|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-22|||September 2013||2013-09-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|CASPeR||Causes of Low Digestive Bleeding in Proctology|Causes of Low Digestive Bleeding in Proctology|Completed||N/A|500|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:57:44.126076|2017-10-10 21:57:44.126076
NCT02847000|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-07|||December 20, 2016|Actual|2016-12-20|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer|p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Advanced Pancreatic Cancer That Has Progressed Through One or More Lines of Therapy|Recruiting||Early Phase 1|12|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:57:35.685239|2017-10-10 21:57:35.685239
NCT02846987|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-26|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Abemaciclib in Dedifferentiated Liposarcoma|Phase 2 Study of Abemaciclib (LY2835219) in Dedifferentiated Liposarcoma|Recruiting||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:57:35.839712|2017-10-10 21:57:35.839712
NCT02846974|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-23|2017-09-05|||June 2018|Anticipated|2018-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|||Calibration and Validation of High Quality Low-Cost 3D Printed Pulse Oximeter|Calibration and Validation of High Quality Low-Cost 3D Printed Pulse Oximeter|Not yet recruiting||N/A|300|Anticipated|Lawson Health Research Institute|||2||f||||||||||||||2017-10-10 21:57:35.960665|2017-10-10 21:57:35.960665
NCT02846961|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-23|2016-08-08|||July 2016||2016-07-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Observational|OACIS||Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease|Occurrence of Anti-drug Antibody and Change of Drug Level for 1 Year After CT-P13 Therapy and Their Impact on Clinical Outcomes in Moderate to Severe Inflammatory Bowel Disease (OACIS Study)|Recruiting||N/A|300|Anticipated|Kyungpook National University|||2||f||||f||||||||Undecided||2017-10-10 21:57:36.073316|2017-10-10 21:57:36.073316
NCT02846948|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-22|||January 2016||2016-01-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|September 1, 2017|Anticipated|2017-09-01||Interventional|ECHOCARD||The Impact of Focused Transthoracic Echocardiography in Urgent Abdominal Surgery for Septic Patients|The Impact of Extended Hemodynamic Monitoring by Focused Transthoracic Echocardiography in Urgent Abdominal Surgery for Septic Patients|Recruiting||N/A|160|Anticipated|Lithuanian University of Health Sciences||2|||f||||f||||||||||2017-10-10 21:57:36.177219|2017-10-10 21:57:36.177219
NCT02846935|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-04-25|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|||p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies|p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies|Recruiting||Early Phase 1|36|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 21:57:36.298091|2017-10-10 21:57:36.298091
NCT02846922|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-01-04|||August 2016||2016-08-01|January 2017|2017-01-01||||November 2016|Actual|2016-11-01||Observational|||Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure||Completed||N/A|394|Actual|Nanjing Medical University|||2||f||||f||||||||No||2017-10-10 21:57:36.952349|2017-10-10 21:57:36.952349
NCT02846909|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-23|2017-04-06|||April 2016||2016-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effect of Adjunctive Use of Vaginal Progesterone After Cerclage on Prevention of 2nd Trimester Miscarriage||Recruiting||Phase 2|80|Anticipated|Assiut University||2|||f||||f||||||||Yes||2017-10-10 21:57:37.039437|2017-10-10 21:57:37.039437
NCT02846896|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-31|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|September 2016|Actual|2016-09-01|10 Years|Observational [Patient Registry]|||The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland|The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland|Completed||N/A|501|Actual|Fondazione Epatocentro Ticino|||1||f||||||||||||||2017-10-10 21:57:37.117384|2017-10-10 21:57:37.117384
NCT02846883|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-09-29|||December 5, 2016|Actual|2016-12-05|September 2017|2017-09-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|VIVAAA||Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms|Mesenchymal Stem Cells Induce Regulatory T Cells in Patients With Aortic Aneurysm|Recruiting||Phase 1|36|Anticipated|VA Office of Research and Development||3|||f||||t|t|f|||f|||||2017-10-10 21:57:37.180474|2017-10-10 21:57:37.180474
NCT02846857|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-18|||June 2018|Anticipated|2018-06-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes|An Open-label, Randomized, Multicenter Study to Assess the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 15 Weeks in Free-living Outpatient Conditions in Adolescents and Adults With Type 1 Diabetes|Not yet recruiting||Phase 2|100|Anticipated|Institut de Recherches Cliniques de Montreal||3|||f||||t|f|f||||||||2017-10-10 21:57:37.389451|2017-10-10 21:57:37.389451
NCT02846844|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-28|||June 2010||2010-06-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Patients With Chemotherapy-induced Polyneuropathy Are Treated With an Integrated Program Including Massage, Mobilization in Posture and Transport Layers, Physical Exercises or With Whole-body Vibration Platform Training|Study Patients With Chemotherapy-induced Polyneuropathy Are Randomized for an Integrated Program (IP) Including Massage, Mobilization in Posture and Transport Layers, Physical Exercises or With Whole-body Vibration Platform Training|Completed||N/A|122|Actual|University of Ulm|||2||f||||f||||||||Yes||2017-10-10 21:57:37.516696|2017-10-10 21:57:37.516696
NCT02846831|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-07-03|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Closed-loop Control of Glucose Levels (Artificial Pancreas) for 2 Weeks in Adults With Type 1 Diabetes|An Open-label, Randomized, Three-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 2 Weeks in Free-living Outpatient Conditions in Patients With Type 1 Diabetes|Not yet recruiting||Phase 2|23|Anticipated|Institut de Recherches Cliniques de Montreal||3|||f||||t|f|f||||||||2017-10-10 21:57:37.589477|2017-10-10 21:57:37.589477
NCT02846818|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-26|||February 2015||2015-02-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Cerebral Energy State in Cardiac Surgery|Continuous Monitoring of Cerebral Energy State During Cardiac Surgery - A Novel Approach Utilizing Intravenous Microdialysis|Completed||N/A|10|Actual|Odense University Hospital||2|||f||||t||||||||Undecided|Undecided|2017-10-10 21:57:37.713963|2017-10-10 21:57:37.713963
NCT02846805|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-07-26|||May 2016||2016-05-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|TIMOEP||The Treatment of Implant-retained Mandibular Overdentures for Edentulous Patients|A Clinical Trial on Conventional Dentures and Implant-retained Mandibular Overdentures With Respect to Oral Functionality and Quality of Life in Edentulous Patients|Recruiting||N/A|53|Anticipated|Fourth Military Medical University||2|||f||||t||||||||No|secret|2017-10-10 21:57:37.805186|2017-10-10 21:57:37.805186
NCT02846792|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-08-29|||November 29, 2016|Actual|2016-11-29|August 2017|2017-08-01||||March 31, 2018|Anticipated|2018-03-31||Interventional|||Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer|A Phase I/II Clinical Trial of Nivolumab and Plinabulin for Patients With Advanced Stage Non-small Cell Lung Cancer That Have Progressed Through First Line Platinum Doublet Chemotherapy|Recruiting||Phase 1/Phase 2|39|Anticipated|University of Washington||1|||f||||f|t|f||||||||2017-10-10 21:57:37.889956|2017-10-10 21:57:37.889956
NCT02846779|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-11-02|||July 2016||2016-07-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|TARGIT-DM||Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes|Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes (TARGIT-DM)|Active, not recruiting||N/A|6000|Actual|Brigham and Women's Hospital||3|||f||||f||||||||No||2017-10-10 21:57:37.987215|2017-10-10 21:57:37.987215
NCT02846766|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-07-22|||June 2016||2016-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling|A Multicenter, Histology-Independent Study of the Fibroblast Growth Factor Receptor (FGFR) Inhibitor Lenvatinib (E7080) in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling|Not yet recruiting||Phase 2|39|Anticipated|University of California, San Diego||1|||f||||t||||||||No||2017-10-10 21:57:38.083675|2017-10-10 21:57:38.083675
NCT02846753|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-08-02|||September 2016||2016-09-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts|Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts|Not yet recruiting||N/A|80|Anticipated|Venus MedTech (HangZhou) Inc.||1|||f||||t||||||||No|The results of the study will be reported and disseminated in peer-reviewed scientific journals, internal reports, conference presentations and submissions to regulatory authorities. Nevertheless, all data used in the analysis and reporting of this clinical investigation will be without identifiable reference to individual patients. All the data will be anonymous.|2017-10-10 21:57:38.18647|2017-10-10 21:57:38.18647
NCT02846740|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-05-24|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|February 28, 2019|Anticipated|2019-02-28||Interventional|||Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.|Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients|Recruiting||N/A|78|Anticipated|University of Maryland||2|||f||||t|f|t|t|f|f|||Undecided||2017-10-10 21:57:38.261542|2017-10-10 21:57:38.261542
NCT02846727|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-05-01|||August 2016||2016-08-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Using Fluorescence Angiography to Detect Occult Shock|Using Fluorescence Angiography to Detect Occult Shock|Recruiting||N/A|20|Anticipated|Yale University|||2||f||||t||||||||Undecided||2017-10-10 21:57:38.353202|2017-10-10 21:57:38.353202
NCT02846714|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-26|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|FLARE||Family Lifestyle Actions and Risk Education Study|FLARE: Family Lifestyle Actions and Risk Education Study for Children With a Familial Risk for Melanoma|Recruiting||N/A|200|Anticipated|University of Utah||1|||f||||f||||||||No||2017-10-10 21:57:38.437093|2017-10-10 21:57:38.437093
NCT02846701|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-22|||August 2016||2016-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|DULOPLASM||Determination of the Antidepressant Duloxetine in Plasma to Improve the Knowledge of the Analgesic Action of Antidepressants on Chronic Neuropathic Pain|DULOPLASM Study: Pilot Study on Mechanisms of Analgesic Action of Duloxetine: Effective Dosage of Duloxetine at the Peak and at the Lowest Plasma Concentrations|Not yet recruiting||Phase 4|10|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||No||2017-10-10 21:57:38.536575|2017-10-10 21:57:38.536575
NCT02846688|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-25|||September 2014||2014-09-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa|Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal Mucosa.|Completed||N/A|15|Actual|Shandong University|||1||f||||t||||||Samples With DNA|"     The metagenome was obtained from biopsy specimen.   "|||2017-10-10 21:57:38.606888|2017-10-10 21:57:38.606888
NCT02846675|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-04-24|||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis|A Self-control Study: Safety and Efficacy of Autologous Adipose-Derived SVF Cells Delivered Intra-articularly in Patients With Osteoarthritis|Recruiting||Phase 1/Phase 2|50|Anticipated|Shanghai East Hospital||2|||f||||t||||||||Yes||2017-10-10 21:57:38.67344|2017-10-10 21:57:38.67344
NCT02846662|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-11-24|||September 2016||2016-09-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|Latin-MH||Effectiveness of a Mobile Technology Intervention for the Treatment of Depression|Randomized Clinical Trial to Evaluate the Effectiveness of an Intervention Using Mobile Technology for the Treatment of Depressive Symptoms in People With Diabetes or Hypertension|Recruiting||Phase 3|880|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Yes|One year after the end of the trial data will be available under request|2017-10-10 21:57:38.816246|2017-10-10 21:57:38.816246
NCT02845531|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2017-01-19|||November 29, 2016|Actual|2016-11-29|January 2017|2017-01-01|June 2023|Anticipated|2023-06-01|December 2022|Anticipated|2022-12-01||Interventional|VARIANT ICD||Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death||Recruiting||Phase 4|140|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||Undecided||2017-10-10 21:57:50.465871|2017-10-10 21:57:50.465871
NCT02846649|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-05-02|||August 2016||2016-08-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PIER1||A Text Messaging Program to Help Prevent Early Opioid Relapse|Feasibility and Acceptability of Using an Automated Text Messaging Program to Help Prevent Early Relapse Among Treatment-seeking Opioid Dependent Patients Discharged From the Emergency Department|Completed||N/A|20|Actual|University of Pittsburgh||1|||f||||t||||||||Yes|We will allow interested researchers access to a de-identified raw database|2017-10-10 21:57:38.901852|2017-10-10 21:57:38.901852
NCT02846636|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-27|||August 2014||2014-08-01|July 2016|2016-07-01|August 2025|Anticipated|2025-08-01|August 2025|Anticipated|2025-08-01||Observational|||Mpact Cup Performance After Total Hip Arthroplasty|Prospective, Multicentric, Non-controlled, Non-randomized Clinical Survey to Evaluate Mpact Cup Performance After Total Hip Arthroplasty|Recruiting||N/A|100|Anticipated|Medacta International SA|||1||f||||||||||||||2017-10-10 21:57:38.963562|2017-10-10 21:57:38.963562
NCT02846610|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2016-07-26|||September 2007||2007-09-01|July 2016|2016-07-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|30 Days|Observational [Patient Registry]|||Registry for Acute Pain Treatment|Improvement of Acute Pain Treatment With Systemic and Regional Anesthesia|Recruiting||N/A|250000|Anticipated|University Hospital, Saarland|||2||f||||f||||||||No||2017-10-10 21:57:39.118029|2017-10-10 21:57:39.118029
NCT02846597|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-22|||March 2013||2013-03-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Proper Pressure and Duration of Sustained Lung Inflation in Preterm Infants|Sustained Lung Inflation at Birth for Preterm Infants at Risk of Respiratory Distress Syndrome: the Proper Pressure and Duration: Prospective Randomized Study|Recruiting||N/A|100|Anticipated|Mansoura University Children Hospital||5|||f||||f||||||||Undecided||2017-10-10 21:57:39.21761|2017-10-10 21:57:39.21761
NCT02846584|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-09-06|||July 2016||2016-07-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies|a Clinical Research of Sequential CAR-T Bridging Hematopoietic Stem Cell Transplantation in the Treatment of Relapse/Refractory B-cell Malignancies|Active, not recruiting||Phase 2|100|Anticipated|Southwest Hospital, China||1|||f||||t||||||||No||2017-10-10 21:57:39.297809|2017-10-10 21:57:39.297809
NCT02846571|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-29|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye|Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|University of Miami||1|||f||||t|t|f||||||||2017-10-10 21:57:39.368542|2017-10-10 21:57:39.368542
NCT02846558|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-21|||August 2016||2016-08-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis (MS)|A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis|Completed||N/A|54|Actual|Johns Hopkins University||4|||f||||f||||||||||2017-10-10 21:57:39.476431|2017-10-10 21:57:39.476431
NCT02846545|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-10-03|||August 26, 2016|Actual|2016-08-26|October 2017|2017-10-01|March 25, 2020|Anticipated|2020-03-25|February 25, 2019|Anticipated|2019-02-25||Interventional|T1GER||A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes|SIMPONI® to Arrest β-cell Loss in Type 1 Diabetes|Recruiting||Phase 2|81|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 21:57:39.554833|2017-10-10 21:57:39.554833
NCT02846532|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2017-08-25|||November 16, 2016|Actual|2016-11-16|August 2017|2017-08-01|January 17, 2022|Anticipated|2022-01-17|January 17, 2022|Anticipated|2022-01-17||Interventional|UNIVERSE||Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure|A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age After the Fontan Procedure|Recruiting||Phase 3|100|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 21:57:41.605251|2017-10-10 21:57:41.605251
NCT02846519|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||February 2016||2016-02-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine|An Open-Label, Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Subjects and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine|Completed||Phase 1|66|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 21:57:41.800496|2017-10-10 21:57:41.800496
NCT02846506|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-12-05|||August 2016||2016-08-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants|A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) 1 x (150 mg/500 mg) With Respect to the Metformin XR Tablet (Locally Sourced From Canada [GLUMETZA, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 100 mg + 1 x 50 mg) in Healthy Fed and Fasted Subjects|Completed||Phase 1|44|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-10 21:57:41.891074|2017-10-10 21:57:41.891074
NCT02846493|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-24|||August 2016||2016-08-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome|Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome —— A Prospective, Randomized, Controlled Clinical Trial|Not yet recruiting||Phase 2|200|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 21:57:42.107985|2017-10-10 21:57:42.107985
NCT02846480|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-26|||June 2010||2010-06-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|December 2013|Actual|2013-12-01||Interventional|||Benefits of Peri-surgical Physical Therapy in the Management of III and IV Grades of Pelvic Organ Prolapse|Benefits of Peri-surgical Physical Therapy in the Management of III and IV Grades of Pelvic Organ Prolapse|Active, not recruiting||N/A|65|Anticipated|University of Alcala||2|||f||||f||||||||No||2017-10-10 21:57:42.223361|2017-10-10 21:57:42.223361
NCT02846467|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-08|||December 2013||2013-12-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|||Information Improvement for Surgical Patients Through Portable Video Media|Comparison of Understanding of Informed Consent Between Portable Video Media Versus Written Consent at Urological Surgeries.|Completed||N/A|193|Actual|Hospital Universitario Puerto Real||2|||f||||t||||||||Yes|The database with the demographic and results of the participant is going to be available during the next six months. The information will be send with an email request.|2017-10-10 21:57:42.32299|2017-10-10 21:57:42.32299
NCT02846454|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-05-02|||August 2016||2016-08-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|MIXSAT||Effects of Inulin and Arabinoxylan on Satiety, Energy/Food Intake and Changes in the Human Gut Microbiota|Investigating the Effects of a Composite Drink of Inulin and Arabinoxylan on Satiety, Energy/Food Intake and Changes in the Human Gut Microbiota|Recruiting||N/A|33|Anticipated|University of Reading||3|||f||||f||||||||Undecided||2017-10-10 21:57:42.434465|2017-10-10 21:57:42.434465
NCT02846441|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-27|||July 2011||2011-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Observational|||Interstage Assessment of Remnant Liver Function in ALPPS|Interstage Assessment of Remnant Liver Function in ALPPS: Can SPECT Hepatobiliary Scintigraphy Provide Any Additional Value in Predicting Risk of Posthepatectomy Liver Failure?|Completed||N/A|20|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||No||2017-10-10 21:57:42.572065|2017-10-10 21:57:42.572065
NCT02846428|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-07-25|||March 2004||2004-03-01|July 2016|2016-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer|An Open-Label, Multicenter, Randomized, Phase II Study to Evaluate the Efficacy and Safety of Two Combination Dose Regimens: Capecitabine + Epirubicin + Cyclophosphamide (CEX) Versus 5-FU + Epirubicin + Cyclophosphamide (FEC 100) as Neoadjuvant Therapy in Females Presenting With Operable Breast Cancer|Completed||Phase 2|182|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 21:57:42.677853|2017-10-10 21:57:42.677853
NCT02846415|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study|Play Intervention for Dementia for Promoting Cognitive Function|Not yet recruiting||N/A|38|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||No||2017-10-10 21:57:42.870878|2017-10-10 21:57:42.870878
NCT02846402|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-12-20|||September 2016||2016-09-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|HSPOT||Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda|The Causal Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda|Active, not recruiting||N/A|963|Anticipated|Harvard School of Public Health||3|||f||||f||||||||||2017-10-10 21:57:42.986838|2017-10-10 21:57:42.986838
NCT02846389|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-08|||June 21, 2016|Actual|2016-06-21|August 2017|2017-08-01|May 2026|Anticipated|2026-05-01|May 2026|Anticipated|2026-05-01||Interventional|||Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer|Randomized Controlled Trial of Exercise to Reduce Cancer Related Fatigue in Women Undergoing Radiation Treatment for Breast Cancer|Recruiting||N/A|80|Anticipated|Hackensack University Medical Center||2|||f||||f||||||||||2017-10-10 21:57:43.093813|2017-10-10 21:57:43.093813
NCT02846376|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2018|Anticipated|2018-08-01||Interventional|CPIT-002||Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant|Phase I Study of Single-agent and Combined Checkpoint Inhibition After Allogeneic Hematopoietic Stem Cell Transplantation in Patients at High Risk for Post-transplant Recurrence|Recruiting||Phase 1|21|Anticipated|Hackensack University Medical Center||3|||f||||t|t|f||||||||2017-10-10 21:57:43.225595|2017-10-10 21:57:43.225595
NCT02846363|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-27|||September 2014||2014-09-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|AVC - REACT||REACT AGAINST STROKE|REACT AGAINST STROKE|Completed||N/A|2649|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 21:57:43.392338|2017-10-10 21:57:43.392338
NCT02846350|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-07-09|||July 2016||2016-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Positive Connections: COPA2||Recruiting||N/A|456|Anticipated|University of Miami||2|||f||||t||||||||||2017-10-10 21:57:43.473528|2017-10-10 21:57:43.473528
NCT02846337|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-08-08|||March 31, 2017|Actual|2017-03-31|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|UF-CARE||Ultrafiltration Versus Medical Therapies in the Management of the Cardio Renal Syndrome|Ultrafiltration Versus Medical Therapies in the Management of the Cardio Renal Syndrome|Recruiting||N/A|154|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 21:57:43.566944|2017-10-10 21:57:43.566944
NCT02846324|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-04-06|||June 2016||2016-06-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF|A Phase II Randomized, Placebo-Controlled Study of GBT440 to Evaluate the Safety, Tolerability, Pharmacokinetics and Effect on Hypoxemia in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Recruiting||Phase 2|30|Anticipated|Global Blood Therapeutics||3|||f||||||||||||||2017-10-10 21:57:43.674757|2017-10-10 21:57:43.674757
NCT02846311|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-22|||January 2015||2015-01-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV|Prospective Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV|Completed||N/A|92|Actual|Groupe Hospitalier Paris Saint Joseph|||2||f||||t||||||||||2017-10-10 21:57:43.932421|2017-10-10 21:57:43.932421
NCT02846298|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-07|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU|Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU|Recruiting||N/A|100|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:57:44.022923|2017-10-10 21:57:44.022923
NCT02846272|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-22|||November 2015||2015-11-01|July 2016|2016-07-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|DTI/SEP||Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation|Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation|Recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f||||||||No||2017-10-10 21:57:44.200844|2017-10-10 21:57:44.200844
NCT02846259|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-25|2016-11-09|||January 2016||2016-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01|2 Years|Observational [Patient Registry]|CBROAUNACCI||The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia|The Clinical Benefit and Risk of Oral Aspirin for Patients Who Have Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia|Recruiting||N/A|2135|Anticipated|Beijing Tiantan Hospital|||1||f||||t||||||Samples With DNA|"     blood   "|No||2017-10-10 21:57:44.29356|2017-10-10 21:57:44.29356
NCT02846246|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-26|||September 2015||2015-09-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effects and Meaning of a Person-centred and Health-promoting Intervention in Home Care Services|The Effects and Meaning of a Person-centred and Health-promoting Intervention in Home Care Services: Study Protocol of a Non-randomised Controlled Trial|Enrolling by invitation||N/A|270|Anticipated|Umeå University||2|||f||||t||||||||No||2017-10-10 21:57:44.400438|2017-10-10 21:57:44.400438
NCT02846233|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-01|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?|Is the Stepping-down Approach a Better Option Than Multiple Daily Injections in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?|Not yet recruiting||N/A|40|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 21:57:44.498912|2017-10-10 21:57:44.498912
NCT02846220|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-04-25|||October 2016||2016-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Promoting Medication Adherence Among Older Adults With Hypertension|Overcoming Immunity to Change: A Feasibility Study of a New Method to Promote Medication Adherence Among Older Adults With Hypertension|Enrolling by invitation||N/A|36|Anticipated|Tulane University||2|||f||||t||||||||No||2017-10-10 21:57:44.637053|2017-10-10 21:57:44.637053
NCT02846207|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-07-24|||March 2016||2016-03-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Yiqi Huoxue Demolition and Recipes on Recovery Stage of Cerebral Infarction|Study of Effects and Mechanisms of Yiqi Huoxue Demolition and Recipes on Recovery Stage of Cerebral Infarction|Recruiting||N/A|360|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||4|||f||||t||||||||Undecided||2017-10-10 21:57:44.792493|2017-10-10 21:57:44.792493
NCT02846194|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-12-04|||July 2016||2016-07-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effects of Brief Guided Imagery for Chronic Pain in Patients Diagnosed With Fibromyalgia|Effects of Brief Guided Imagery for Chronic Pain in Patients Diagnosed With Fibromyalgia|Recruiting||N/A|80|Anticipated|Clalit Health Services||2|||f||||f||||||||Undecided||2017-10-10 21:57:44.941992|2017-10-10 21:57:44.941992
NCT02846181|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-11-21|||July 2016||2016-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405||Completed||Phase 1|6|Actual|Sanwa Kagaku Kenkyusho Co., Ltd.||1|||f||||||||||||||2017-10-10 21:57:45.071352|2017-10-10 21:57:45.071352
NCT02846168|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-07-26|||April 2016||2016-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Plasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention|The Association of Plasma Levels of GLP1 With Prognosis of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention|Recruiting||N/A|200|Anticipated|Chinese PLA General Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:57:45.16052|2017-10-10 21:57:45.16052
NCT02846155|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-26|||May 2016||2016-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Gastric Preparation of Magnetic-controlled Capsule Endoscopy|Gastric Preparation of Magnetic-controlled Capsule Endoscopy: A Prospective, Single Blinded and Randomized Controlled Trial|Recruiting||Phase 2|120|Anticipated|Changhai Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:57:45.245055|2017-10-10 21:57:45.245055
NCT02846142|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-22|||June 2016||2016-06-01|July 2016|2016-07-01||||January 2017|Anticipated|2017-01-01||Interventional|||Study to Assess the Safety, Tolerability, PK, ECG Effects, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers|A Single-center, Randomized, Placebo-Controlled Phase I Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, ECG Effects, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers|Recruiting||Phase 1|88|Anticipated|Proteostasis Therapeutics, Inc.||7|||f||||||||||||||2017-10-10 21:57:45.360685|2017-10-10 21:57:45.360685
NCT02846129|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-07-28|||October 2016||2016-10-01|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|July 3, 2017|Actual|2017-07-03||Observational|||Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery|Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery: A Retrospective Review|Completed||N/A|1057|Actual|Mahidol University|||1||f||||t||||||||||2017-10-10 21:57:45.477865|2017-10-10 21:57:45.477865
NCT02846116|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-10-15|||December 2016||2016-12-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Patient Satisfaction and Shade Matching of Vita Suprinity Versus Lithium Disilicate (E-max) Ceramic Crowns in Esthetic Zone|Evaluation of Patient Satisfaction and Shade Matching of Vita Suprinity Versus Lithium Disilicate (E-max) Ceramic Crowns in Esthetic Zone|Not yet recruiting||N/A|26|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:57:45.548484|2017-10-10 21:57:45.548484
NCT02846103|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-22|||December 2015||2015-12-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Telocap02||Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer|Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer|Recruiting||N/A|360|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:57:45.639385|2017-10-10 21:57:45.639385
NCT02846090|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-26|||August 2016||2016-08-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Dexmedetomidine as an Additive to Local Anaesthesia to Decrease Intraocular Pressure in Glaucoma Surgery|Dexmedetomidine as an Additive to Local Anaesthesia to Decrease Intraocular Pressure in Glaucoma Surgery|Not yet recruiting||N/A|105|Anticipated|Cairo University||3|||f||||f||||||||Undecided||2017-10-10 21:57:45.724555|2017-10-10 21:57:45.724555
NCT02846077|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-24|||September 2013||2013-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Multi-scale Modeling of Sleep Behaviors in Social Networks|Multi-scale Modeling of Sleep Behaviors in Social Networks|Recruiting||N/A|400|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||Samples Without DNA|"     Saliva   "|Undecided||2017-10-10 21:57:45.80475|2017-10-10 21:57:45.80475
NCT02846064|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-07-22|||October 2013||2013-10-01|July 2016|2016-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|DATOR||Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function|Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 21:57:45.890127|2017-10-10 21:57:45.890127
NCT02846051|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-28|||October 2015||2015-10-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|July 2016|Actual|2016-07-01||Interventional|VARISPORT||Effect of Intensive Sports Practice on Lower Limb Varicose Veins|Effect of Intensive Sports Practice on Lower Limb Varicose Veins|Recruiting||N/A|240|Anticipated|University of Franche-Comté||2|||f||||t||||||||Yes|If a venous pathology is detected during this study, the data are passed on to the doctor of the subject|2017-10-10 21:57:45.968247|2017-10-10 21:57:45.968247
NCT02846038|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-12|||September 9, 2016|Actual|2016-09-09|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Observational|||Understanding Communication in Healthcare to Achieve Trust (U-CHAT)|Understanding Communication in Healthcare to Achieve Trust (U-CHAT): A Prospective Longitudinal Investigation of Communication Between Pediatric Oncologists, Children/Adolescents With High-Risk Cancer, and Their Families at the Stressful Time-Points of Disease|Recruiting||N/A|176|Anticipated|St. Jude Children's Research Hospital|||6||f||||f|f|f||||||||2017-10-10 21:57:46.048341|2017-10-10 21:57:46.048341
NCT02846012|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-10-26|||May 2016||2016-05-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|NXGeM||Comparison of Culture Media for in Vitro Embryo Development|Prospective Observational Study Utilizing Next Generation Continuous Single Culture Media (CSCM2) for Comparative in Vitro Embryo Development and Outcome Data|Recruiting||N/A|300|Anticipated|Ovation Fertility||2|||f||||f||||||||No|Individual participant data will not be shared, however, collated data may be used for publication without patient identification.|2017-10-10 21:57:46.208692|2017-10-10 21:57:46.208692
NCT02845999|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-07-22|||November 2009||2009-11-01|March 2016|2016-03-01||||January 2013|Actual|2013-01-01||Interventional|NK-EGFR01||Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab|Allogenic Immunotherapy Based on Natural Killer Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab : a Phase I Trial|Completed||Phase 1|9|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||||||||||||2017-10-10 21:57:46.426693|2017-10-10 21:57:46.426693
NCT02845986|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-03-28|||July 2016||2016-07-01|March 2017|2017-03-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|CLASS-04||Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer|Safety and Feasibility of Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Locally Advanced Upper Third Gastric Cancer: A Multicenter Phase II Trial|Enrolling by invitation||Phase 2|251|Anticipated|Fujian Medical University||1|||f||||t||||||||No|There is no plan to make individual participant data (IPD) available.|2017-10-10 21:57:46.534052|2017-10-10 21:57:46.534052
NCT02845973|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-26|||June 2016||2016-06-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|||Study of Fecal Bacteria in Early Diagnosis of Colorectal Cancer||Recruiting||N/A|1000|Anticipated|Shanghai Jiao Tong University School of Medicine|||2||f||||f||||||Samples With DNA|"     feces of participants   "|No||2017-10-10 21:57:46.745484|2017-10-10 21:57:46.745484
NCT02845960|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-23|2016-07-26|||February 2016||2016-02-01|July 2016|2016-07-01||||August 2017|Anticipated|2017-08-01||Observational|||The Influence of Rapid Recovery on Sleep Quality Following Total Knee Replacement Surgery||Recruiting||N/A|170|Anticipated|Southwest Hospital, China|||2||f||||f||||||||No||2017-10-10 21:57:46.839895|2017-10-10 21:57:46.839895
NCT02845947|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-29|||August 2016||2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|MTPERT||Music Therapy During Pediatric Extubation Readiness Trials|Music Therapy During Pediatric Extubation Readiness Trials: A Pilot Study|Recruiting||N/A|140|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-10 21:57:46.92935|2017-10-10 21:57:46.92935
NCT02845934|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-07-28|||January 2014||2014-01-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|MODIMUCOR||Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis|Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis|Recruiting||N/A|52|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:57:47.051199|2017-10-10 21:57:47.051199
NCT02845921|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-23|||January 2016||2016-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Leg Elevation and Leg Wrapping in the Prevention of Propofol Induced Hypotension|Comparison of Leg Elevation and Leg Wrapping in the Prevention of Propofol Induced Hypotension: A Prospective Randomised Controlled Study|Recruiting||N/A|150|Anticipated|Nitte University||3|||f||||f||||||||Yes|Age, sex, weight, diagnosis, surgery, asa physical status, heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure|2017-10-10 21:57:47.171317|2017-10-10 21:57:47.171317
NCT02845908|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-31|||September 2016||2016-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC|A Phase 2 Study of POF(Paclitaxel/Oxaliplatin/5-Fluorouracil/Leucovorin) Versus FOLFOX Versus FOLFOX Plus Intraperitoneal Paclitaxel as a First-line Treatment in Advanced Gastric Cancer|Enrolling by invitation||Phase 2|90|Anticipated|Fujian Cancer Hospital||3|||f||||f||||||||||2017-10-10 21:57:47.390817|2017-10-10 21:57:47.390817
NCT02845895|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-22|||September 2014||2014-09-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|July 2016|Actual|2016-07-01||Observational|CompaS||Study to Compare Strategies to Improve Detection of Nutritional Disorders in Hospitalized Adults (Compass Project)|Study to Compare Strategies to Improve Detection of Nutritional Disorders in Hospitalized Adults (Compass Project)|Recruiting||N/A|900|Anticipated|University Hospital, Toulouse|||2||f||||f||||||||No||2017-10-10 21:57:47.502231|2017-10-10 21:57:47.502231
NCT02845882|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-27|||January 2016||2016-01-01|June 2016|2016-06-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|||LBL-2016 for Children or Adolescents in China|Modified BFM (Berlin-Frankfurt-Munster)Backbone Therapy for Chinese Children or Adolescents With Newly Diagnosed Lymphoblastic Lymphoma|Recruiting||Phase 2/Phase 3|150|Anticipated|Children's Cancer Group, China||3|||f||||t||||||||||2017-10-10 21:57:47.625122|2017-10-10 21:57:47.625122
NCT02845869|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2017-02-28|||March 1, 2017|Actual|2017-03-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|LLL&KP02||Evaluating Light Therapy for Treatment of Overuse Anterior Knee Pain|Evaluation of the Efficacy of Light Therapy for the Treatment of Anterior Knee Pain: A Prospective, Randomized, Double-Blind, Sham-Controlled Clinical Trial|Enrolling by invitation||N/A|40|Anticipated|Hebrew University of Jerusalem||2|||f||||t|f|t|f||f|||No||2017-10-10 21:57:47.767665|2017-10-10 21:57:47.767665
NCT02845856|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:57:47.845418|2017-10-10 21:57:47.845418
NCT02845843|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-11-28|||July 2016||2016-07-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MIRACLE||MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b|MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b: a Multicenter, Placebo-controlled, Double-blind Randomized Trial|Recruiting||Phase 2/Phase 3|80|Anticipated|King Abdullah International Medical Research Center||2|||f||||t||||||||Undecided||2017-10-10 21:57:47.956336|2017-10-10 21:57:47.956336
NCT02845830|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-28|||September 2016||2016-09-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Observational|||Trajectories of Quality of Life by the Elderly in Early Phase of Dementia|Trajectories of Quality of Life by the Elderly in Early Phase of Dementia|Not yet recruiting||N/A|580|Anticipated|Palacky University|||2||f||||f||||||||Undecided||2017-10-10 21:57:48.091879|2017-10-10 21:57:48.091879
NCT02845817|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-26|||September 2014||2014-09-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|DESA||Requests for Euthanasia and Assisted Suicide|Requests for Euthanasia and Assisted Suicide: a Prospective, Multicenter and Qualitative Study of Their Frequency and Characteristics, of Patients' Motivations and Their Evolution|Completed||N/A|31|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 21:57:48.178237|2017-10-10 21:57:48.178237
NCT02845804|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-26|||July 2015||2015-07-01|July 2016|2016-07-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01|3 Years|Observational [Patient Registry]|HOST-ALPINE||Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis|Harmonizing Optimal Strategy for Treatment of Coronary Atherosclerotic Lesions- Registry-based Study on the Effect and Safety of Xience Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerotic Lesions: HOST-Alpine Registry|Recruiting||N/A|1533|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-10 21:57:48.254369|2017-10-10 21:57:48.254369
NCT02845791|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||PRE-STARt Intervention - Trial of an Interactive Family Based Lifestyle Programme|Prevention Strategies for Adolescents at Risk of Diabetes - A Randomised Controlled Trial of an Interactive Family-based Lifestyle Programme|Not yet recruiting||N/A|270|Anticipated|University Hospitals, Leicester||2|||f||||f||||||||Yes|Non identifiable participant data will be only be shared with the study collaborators.|2017-10-10 21:57:48.451102|2017-10-10 21:57:48.451102
NCT02845778|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-24|||May 2016||2016-05-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|August 2016|Anticipated|2016-08-01||Interventional|||Pharmacokinetics of Melatonin Niosomes Oral Gel in Healthy Volunteers|Pharmacokinetics of Melatonin Niosomes Oral Gel in Healthy Volunteers|Recruiting||Phase 1/Phase 2|15|Anticipated|Khon Kaen University||3|||f||||f||||||||Undecided||2017-10-10 21:57:48.568219|2017-10-10 21:57:48.568219
NCT02845752|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2017-08-16|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease|A Randomized, Crossover, Placebo Controlled, Double-blind Trial of the Effect of STIOLTO™ RESPIMAT® on Central and Peripheral Components of Fatigue During Exercise in Chronic Obstructive Pulmonary Disease|Recruiting||Phase 4|20|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||f|t|f||||||||2017-10-10 21:57:48.75585|2017-10-10 21:57:48.75585
NCT02845739|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-29|||January 2011||2011-01-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PATRE||PApillomavirus in REnal Transplant Patient|Study of the Distribution of Genotypes of HPV at the Ano-genital Area and Peripheral Humoral Immune Response Before and After Kidney Transplantation|Active, not recruiting||N/A|58|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:57:48.851957|2017-10-10 21:57:48.851957
NCT02845726|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-08-23|||July 2016||2016-07-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 23, 2017|Actual|2017-08-23||Observational|||Biofilms on Short-term Indwelling Ureteral Stents|Biofilms on Short-term Indwelling Ureteral Stents: Influence on Associated Symptoms and Complications; Prediction by Urine Analysis; Current Bacterial Spectrum and Antibiotic Resistance|Active, not recruiting||N/A|85|Anticipated|Cantonal Hospital of St. Gallen|||1||f||||f||||||||||2017-10-10 21:57:48.930523|2017-10-10 21:57:48.930523
NCT02845713|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single Dose Treatment With Diethylcarbamazine, Albendazole and Ivermectin in Humans With and Without Wuchereria Bancrofti Infection in Côte d'Ivoire|Active, not recruiting||Phase 1|66|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||Yes||2017-10-10 21:57:49.006859|2017-10-10 21:57:49.006859
NCT02845687|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-06-02|||August 16, 2016|Actual|2016-08-16|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Observational|||Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program|Observational Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program|Recruiting||N/A|3000|Anticipated|Duke University|||1||f||||f||||||||No||2017-10-10 21:57:49.184792|2017-10-10 21:57:49.184792
NCT02845674|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2017-09-18|||July 29, 2016|Actual|2016-07-29|September 2017|2017-09-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca|An Open-Label Extension of a Randomized, Multicenter, Double-Masked, Vehicle-Controlled Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca|Completed||Phase 3|165|Actual|Ocular Technologies SARL||1|||f||||f|t|f||||||||2017-10-10 21:57:49.275518|2017-10-10 21:57:49.275518
NCT02845661|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-07-29|||June 2016||2016-06-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Correlation of Narcotrend Index and the Observer's Assessment of Alertness/Sedation (OAA/S) Scale|The Correlation of Narcotrend Index and OAA/S Scale in Monitoring Sedation Level With Different Doses of Dexmedetomidine|Recruiting||Phase 4|60|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||3|||f||||f||||||||||2017-10-10 21:57:49.330882|2017-10-10 21:57:49.330882
NCT02845648|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-27|||July 2010||2010-07-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Ability to Awaken in Nonmonosymptomatic Enuresis|The Ability to Awaken Can be Improved With Control of Lower Urinary Tract Symptoms in Children With Nonmonosymptomatic Enuresis|Completed||N/A|119|Actual|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 21:57:49.422156|2017-10-10 21:57:49.422156
NCT02845635|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-10-02|||September 29, 2017|Actual|2017-09-29|July 2017|2017-07-01|August 2025|Anticipated|2025-08-01|August 2025|Anticipated|2025-08-01||Observational|||MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis|MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis|Recruiting||N/A|2000|Anticipated|Duke University|||4||f||||f||||||||||2017-10-10 21:57:49.643764|2017-10-10 21:57:49.643764
NCT02845622|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-09-07|||June 2014||2014-06-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Hazelnuts and Cocoa on Metabolic Parameters and Vascular Reactivity|Effects of Hazelnuts and Cocoa on Metabolic Parameters and Vascular Reactivity in Healthy Subjects: A Randomized Controlled Study|Completed||N/A|61|Actual|Ospedale San Donato||6|||f||||t||||||||||2017-10-10 21:57:49.743651|2017-10-10 21:57:49.743651
NCT02845609|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-24|2016-08-10|||September 2016||2016-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SA-thrombo||Efficacy of Sialic Acid GNE Related Thrombocytopenia|A Phase 2 Study to Evaluate the Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Related Thrombocytopenia|Enrolling by invitation||Phase 2|5|Actual|Hadassah Medical Organization||1|||f||||f||||||||Undecided||2017-10-10 21:57:49.864696|2017-10-10 21:57:49.864696
NCT02845583|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-28|||February 2016||2016-02-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Observational|||Nursing Activities for High Complexity Oncologic Care Patients|Quantifying and Measuring the Economic Impact of Nursing Activities During the Hospital Stay of High Complexity Oncologic Care Patients|Recruiting||N/A|300|Anticipated|Catholic University of the Sacred Heart|||2||f||||t||||||||No||2017-10-10 21:57:50.118583|2017-10-10 21:57:50.118583
NCT02845570|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2017-04-12|||July 2016||2016-07-01|July 2016|2016-07-01||||August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB|Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB|Recruiting||Phase 1|8|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-10 21:57:50.192383|2017-10-10 21:57:50.192383
NCT02845557|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-23|||February 2013||2013-02-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Glucose Homeostasis and Incretin Effect T2DM in the Youth- a Study of the Malaysian Population|Glucose Homeostasis, Incretin Effect and Cardiovascular Risk Burden in T2DM in the Youth- a Study of the Malaysian Population|Completed||N/A|48|Actual|Penang Medical College|||2||f||||f||||||||Undecided||2017-10-10 21:57:50.282167|2017-10-10 21:57:50.282167
NCT02845544|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-09-07|||May 2016||2016-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Influence of Pilates-based Exercises on Postural Balance|Influence of Pilates-based Exercises on Static and Dynamic Postural Balance of Sedentary Adults|Completed||Early Phase 1|18|Actual|Universidade Federal de Pernambuco||2|||f||||f||||||||No||2017-10-10 21:57:50.38511|2017-10-10 21:57:50.38511
NCT02845518|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-26|||September 2016||2016-09-01|June 2016|2016-06-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|EVITA||Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)|EValuation of Cardiac Magnetic Resonance Imaging in Follow up assessmenT of Patients With Pulmonary Arterial Hypertension (EVITA)|Not yet recruiting||N/A|180|Anticipated|Central Hospital, Nancy, France||1|||f||||t||||||||No||2017-10-10 21:57:50.669834|2017-10-10 21:57:50.669834
NCT02845505|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-18|||August 2016||2016-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|IVUS-CAMS||Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion|Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion|Recruiting||N/A|500|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-10 21:57:50.735932|2017-10-10 21:57:50.735932
NCT02845492|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-28|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Evaluating Qigong as a Clinical Intervention for Cancer Survivors' Fatigue|Testing the Effects of Qigong on a Multi-System Neuro-muscular- Immune Model of Vigor in Cancer Survivorship|Recruiting||N/A|60|Anticipated|The Miriam Hospital||2|||f||||f||||||||Yes|Study data will be archived with with computer scripts into a package. These packages will be available to any investigator who requests them.|2017-10-10 21:57:50.85538|2017-10-10 21:57:50.85538
NCT02845479|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-08|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|POISE||The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I|Pioneering Pre- and Post-Operative Integrative Care to Improve Thoracic Cancer Quality of Care: The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I|Not yet recruiting||Phase 4|40|Anticipated|The Canadian College of Naturopathic Medicine||1|||f||||t|f|f||||||No||2017-10-10 21:57:50.961125|2017-10-10 21:57:50.961125
NCT02845466|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing|Proof of Concept Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing|Not yet recruiting||Phase 3|80|Anticipated|McMaster University||2|||f||||t|t|t|f|f|t|||||2017-10-10 21:57:51.068928|2017-10-10 21:57:51.068928
NCT02845453|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-25|||September 2016||2016-09-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Treatment With Quetiapine for Youth With Substance Use Disorders and Bipolar Disorder|A Randomized Controlled Trial of Quetiapine for the Treatment of Youth With Co-occurring Substance Use Disorders (SUDs) and Bipolar Disorder (BD)|Recruiting||Phase 4|56|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 21:57:51.172224|2017-10-10 21:57:51.172224
NCT02845440|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-26|||December 2016||2016-12-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness|Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness|Not yet recruiting||Phase 4|1300|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||Yes||2017-10-10 21:57:51.268081|2017-10-10 21:57:51.268081
NCT02845427|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-02-04|||February 2016||2016-02-01|February 2017|2017-02-01|January 1, 2019|Anticipated|2019-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Closed Suction Drain or Not After Total Hip Arthroplasty|Closed Suction Drain or Not After Total Hip Arthroplasty: A Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Assiut University||2|||f||||f||||||||Undecided||2017-10-10 21:57:51.384931|2017-10-10 21:57:51.384931
NCT02845414|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-10-04|||December 2016||2016-12-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of CD133KDEL Toxin in the Treatment for Solid Tumors|Phase I Study Of Stem-Cell Directed Deimmunized CD133KDEL Toxin In The Treatment Of Solid Tumors|Not yet recruiting||Phase 1|30|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||||||||||||2017-10-10 21:57:51.472463|2017-10-10 21:57:51.472463
NCT02845401|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-02-07|||December 2016|Actual|2016-12-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|BeNEG-DO||"The HBV eAg- Disease-Directly Offers Study: Treatment Withdrawal in Patients With Early-Antigen Negative Chronic HBV"|"BeNEG-DO: A Study of Clinical Outcomes, Immunologic Correlates and Genetic Predictors After Treatment Withdrawal in Early-Antigen Negative (HBeAg-) Chronic Hepatitis B Virus (HBV) Infection"|Recruiting||N/A|110|Anticipated|California Pacific Medical Center Research Institute||2|||f||||t||||||||Yes||2017-10-10 21:57:51.562762|2017-10-10 21:57:51.562762
NCT02845388|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-26|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Sildenafil Citrate in Frozen Embryo Transfer|Sildenafil Citrate for Endometrial Preparation in Frozen-thawed Embryo Transfer Cycles|Completed||Phase 2|90|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||Yes||2017-10-10 21:57:51.659651|2017-10-10 21:57:51.659651
NCT02845375|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-26|||September 2016||2016-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|BREATH||Effect of Neuromuscular Blockade and Reversal on Breathing|Effect of Neuromuscular Blockade and Reversal by Sugammadex Versus Neostigmine on Breathing When Hypoxic or Hypercapnic in Volunteers|Not yet recruiting||Phase 4|30|Anticipated|Leiden University Medical Center||3|||f||||t||||||||||2017-10-10 21:57:51.739506|2017-10-10 21:57:51.739506
NCT02845362|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-05-03|||August 2016||2016-08-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases|Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases|Recruiting||N/A|250|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||Undecided||2017-10-10 21:57:51.834777|2017-10-10 21:57:51.834777
NCT02845206|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-07-22|||February 2016||2016-02-01|February 2016|2016-02-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Bespoke vs Standard Instrumentation in TKR|Randomised Controlled Trial of Patient Specific Instrumentation vs Standard Instrumentation in Total Knee Arthroplasty|Recruiting||N/A|172|Anticipated|NHS Lothian||2|||f||||t||||||||Yes|Data available to bone fide researchers at the end of the study|2017-10-10 21:57:52.856362|2017-10-10 21:57:52.856362
NCT02845349|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-09-01|||October 2016||2016-10-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI)|Vortioxetine for the Treatment of Major Depression and Neuropsychiatric Co-morbidities After Traumatic Brain Injury (TBI)|Withdrawn||Phase 3|0|Actual|Johns Hopkins University||2||Funding withdrawn.|f||||t||||||||No|"Prior to the initiation of the study, a method will be developed for data collection. Each participant will have a study folder with a unique identifying number to contain the results of study tests and evaluations. Another folder will also be kept that will hold all consent forms and identifying demographic information. The folders will be reviewed monthly for inconsistencies. The data will be entered into a database maintained in the Neuropsychiatry Division of Johns Hopkins Bayview Medical Center, which is password protected and only the PI and her Research team will have access to the study folders and database.
The data monitoring committee will include Dr. Rao (PI), and members of the Data & Safety monitoring board: Drs. Christopher Marano, Paul Rosenberg and Jin Joo. All members of the Diagnostic and Statistical Manual of Mental Disorders (DSM) board are psychiatrists and faculty Johns Hopkins University. The 3 DSM members are not connected with the study."|2017-10-10 21:57:51.914838|2017-10-10 21:57:51.914838
NCT02845336|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-15|||March 5, 2017|Actual|2017-03-05|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Celecoxib for Thyroid Eye Disease|An Open Label Trial of Celecoxib in the Treatment of Mild Thyroid Eye Disease|Recruiting||Phase 2|40|Anticipated|Johns Hopkins University||2|||f||||f|t|f|||t|||||2017-10-10 21:57:51.997317|2017-10-10 21:57:51.997317
NCT02845323|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-07-28|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder|Randomized Phase II Study of Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder|Recruiting||Phase 2|44|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 21:57:52.091587|2017-10-10 21:57:52.091587
NCT02845310|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-07-16|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||The Effect of Intraoperative Goal Directed Restricted Fluid Therapy on Extravascular Lung Water|The Effect of Intraoperative Goal Directed Restricted Fluid Therapy Guided by Stroke Volume Variation Versus Standard Fluid Therapy on Extravascular Lung Water in Major Abdominal Operations: a Randomized Controlled Study|Completed||N/A|56|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 21:57:52.177238|2017-10-10 21:57:52.177238
NCT02845297|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-10-05|||July 2016|Actual|2016-07-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Phase 2 Study of Azacitidine in Combination With Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (≥65 Years) AML Patients|Phase 2 Study of Azacitidine in Combination With Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (≥65 Years) AML Patients|Recruiting||Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 21:57:52.248767|2017-10-10 21:57:52.248767
NCT02845284|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-22|||March 2016||2016-03-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||'HI-4-TU' Study: Health Improvement for Teen Ugandans Study|Enhanced HIV/Sexually Transmitted Infections and Pregnancy Prevention Study to Improve Adolescent Reproductive Health Services in Uganda|Recruiting||N/A|519|Anticipated|Johns Hopkins University||3|||f||||f||||||||No||2017-10-10 21:57:52.33654|2017-10-10 21:57:52.33654
NCT02845271|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-27|||July 21, 2016|Actual|2016-07-21|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|June 28, 2017|Actual|2017-06-28||Interventional|||Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the Knee|A Two Part Protocol Using Double Blind Placebo Control to Assess the Safety, Tolerability, and Pharmacokinetics of Single Escalating Intra-articular Doses Followed by Assessment of Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Intra-articular Dose of the TrkA Inhibitor, GZ389988, in Patients With Painful Osteoarthritis of the Knee|Completed||Phase 2|104|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 21:57:52.426203|2017-10-10 21:57:52.426203
NCT02845258|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-01-24|||January 2006||2006-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Treatment of Pancreatic Pseudocysts by Endoscopic Ultrasound-guided Drainage|Treatment of Pancreatic Pseudocysts by Endoscopic Ultrasound-guided Drainage|Recruiting||N/A|80|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||Samples With DNA|"     Pancreatic pseudocyst fluid aspirate for culture and biochemical analysis. No DNA analysis.   "|No||2017-10-10 21:57:52.525525|2017-10-10 21:57:52.525525
NCT02845245|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-20|||September 2016||2016-09-01|June 2017|2017-06-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|CIDUCT||Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques|CIDUCT: Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Surgical Planning and 3D Prototyping Techniques|Recruiting||N/A|40|Anticipated|Inova Health Care Services||2|||f||||t||||||||No|The investigators will publish results through conferences and journals; de-identified group data results.|2017-10-10 21:57:52.603306|2017-10-10 21:57:52.603306
NCT02845232|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-22|||March 2013||2013-03-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Observational|||Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly|Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly|Completed||N/A|214|Actual|Hospices Civils de Lyon|||3||f||||f||||||||||2017-10-10 21:57:52.700083|2017-10-10 21:57:52.700083
NCT02845219|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-06|||July 2016||2016-07-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females|A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females|Completed||Phase 1|25|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-10 21:57:52.781453|2017-10-10 21:57:52.781453
NCT02842398|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-05-04|||November 2010||2010-11-01|May 2017|2017-05-01||||January 2016|Actual|2016-01-01||Interventional|||Independent Walking Speed and Crossing a City Street||Completed||Early Phase 1|71|Actual|Blythedale Children's Hospital||2|||f||||f||||||||||2017-10-10 21:58:20.932792|2017-10-10 21:58:20.932792
NCT02845193|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-10|||November 2016||2016-11-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficiency of Novel Nasoalveolar Molding Method on Parents' Satisfaction in Unilateral Cleft Infants|Efficiency of A Novel (Modified Grayson) Technique for Nasoalveolar Molding and Taping on Parents' Satisfaction and Short Term Treatment Outcomes in Infants With Unilateral Complete Cleft Lip and Palate: A Randomized Controlled Trial|Recruiting||N/A|68|Anticipated|Cairo University||4|||f||||t||||||||Yes||2017-10-10 21:57:52.943713|2017-10-10 21:57:52.943713
NCT02845180|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-11-17|||November 2016||2016-11-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||In-Vivo Assessment of Adipose Allograft Extracellular Matrix in Abdominoplasty Patients|In-Vivo Assessment of Adipose Allograft Extracellular Matrix in Abdominoplasty Patients|Recruiting||N/A|10|Anticipated|Musculoskeletal Transplant Foundation||2|||f||||t||||||||Undecided|Decision to be made at study site appointment|2017-10-10 21:57:53.037762|2017-10-10 21:57:53.037762
NCT02845167|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-22|||September 2011||2011-09-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Preoperative Exercise on Postoperative Outcome in AAA Patients: Pilot Study|The Effect of Preoperative Exercise on Postoperative Outcome in AAA Patients: Pilot Study|Completed||N/A|21|Actual|Medway NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:57:53.118491|2017-10-10 21:57:53.118491
NCT02845154|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-24|||October 2015||2015-10-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|IPLDLT||Intermittent Portal and Graft Purge in Living Donor Liver Transplantation|Intermittent Anti-grade Portal and Graft Purge Ameliorates Post-reperfusion Syndrome in Living Donor Liver Transplantation Recipients. A Prospective, Randomised Controlled Trial|Recruiting||N/A|80|Anticipated|Mansoura University||2|||f||||f||||||||No||2017-10-10 21:57:53.193346|2017-10-10 21:57:53.193346
NCT02845141|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-13|2016-07-22|||March 2013||2013-03-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Synthetic Bone Graft Substitute vs. Autologous Spongiosa in Revision Anterior Cruciate Ligament Reconstruction|Synthetic Bone Graft Substitute (Actifuse) vs. Autologous Spongiosa for Tunnel Enlargement in Revision Anterior Cruciate Ligament Reconstruction - a Histological and Radiological Assessment|Recruiting||N/A|40|Anticipated|Berufsgenossenschaftliche Unfallklinik Ludwigshafen||2|||f||||t||||||||No||2017-10-10 21:57:53.310904|2017-10-10 21:57:53.310904
NCT02845128|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-26|||May 2016||2016-05-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|||Prospective Validation of the ROX Index|Prospective Validation of the ROX Index Utility in Predicting Failure of HFNC Treatment in Patients With Acute Respiratory Failure|Recruiting||N/A|200|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||2||f||||f||||||||No||2017-10-10 21:57:53.53595|2017-10-10 21:57:53.53595
NCT02845115|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-17|||February 2014||2014-02-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|IOM laser||Surgical Optimizing of a Middle Ear Implant (MET )With Laser Velocimetry in Patients With Moderate to Severe Hearing Loss in Case of Failure of Conventional Equipment|Pilot Study Evaluating Surgical Optimizing of a Middle Ear Implant (MET )With Laser Velocimetry in Patients With Moderate to Severe Hearing Loss in Case of Failure of Conventional Equipment|Completed||N/A|2|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 21:57:53.628776|2017-10-10 21:57:53.628776
NCT02845102|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-05-31|||August 2014|Actual|2014-08-01|May 2017|2017-05-01|May 21, 2017|Actual|2017-05-21|May 21, 2017|Actual|2017-05-21||Interventional|RA-CBT||Treating Comorbid Depression During Care Transitions Using Relational Agents|Treating Comorbid Depression During Care Transitions Using Relational Agents|Completed||N/A|4|Actual|Boston Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:57:53.744853|2017-10-10 21:57:53.744853
NCT02845089|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-08-02|||February 29, 2016|Actual|2016-02-29|August 2017|2017-08-01|August 15, 2017|Anticipated|2017-08-15|May 31, 2016|Actual|2016-05-31||Observational|||Treatment Patterns, Outcomes and Resource Use Study for Advanced Stage Non-Small Cell Lung Cancer (Squamous and Non-squamous) in the Kingdom of Saudi Arabia and United Arab Emirates|Treatment Patterns, Outcomes and Resource Use Study for Advanced Stage Non-Small Cell Lung Cancer (Squamous and Non-squamous) in the Kingdom of Saudi Arabia and United Arab Emirates|Active, not recruiting||N/A|382|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 21:57:53.918784|2017-10-10 21:57:53.918784
NCT02845076|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-07-22|||August 2016||2016-08-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|WEANIV||Weaning From Noninvasive Ventilation|Weaning From Noninvasive Ventilation|Not yet recruiting||N/A|141|Anticipated|Baskent University||3|||f||||t||||||||Undecided||2017-10-10 21:57:54.04|2017-10-10 21:57:54.04
NCT02845063|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-08-06|||May 2016||2016-05-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|ACE-REHAB||Effect of ACE Genotype on Cardiovascular Rehabilitation|Effects of ACE Genotype on Muscular and Functional Adaptations Following a Cardiovascular Rehabilitation Program|Recruiting||Phase 2|60|Anticipated|Balgrist University Hospital||4|||f||||t||||||||||2017-10-10 21:57:54.643436|2017-10-10 21:57:54.643436
NCT02845050|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-28|||July 2016||2016-07-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|September 2019|Anticipated|2019-09-01||Interventional|JaNEO||Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)|Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)|Not yet recruiting||Phase 1/Phase 2|42|Anticipated|Association of Urogenital Oncology (AUO)||1|||f||||t||||||||No||2017-10-10 21:57:54.863339|2017-10-10 21:57:54.863339
NCT02845037|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-22|||May 2007||2007-05-01|July 2016|2016-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Tolerability, Pharmacokinetics and Dopamine ß-hydroxylase (DßH) Inhibition Profile of BIA 5-453|A Rising Single Oral Dose Study to Investigate the Tolerability, Pharmacokinetics and Dopamine ß-hydroxylase (DßH) Inhibition Profile of BIA 5-453 in Healthy Male Volunteers|Completed||Phase 1|80|Actual|Bial - Portela C S.A.||10|||f||||f||||||||Undecided||2017-10-10 21:57:55.03727|2017-10-10 21:57:55.03727
NCT02845024|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-09-30|||September 2014||2014-09-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Non-surgical Periodontal Therapy Plus Doxycycline on HbA1c in Patients With Type 2 Diabetes Mellitus|The Effects of Non-surgical Periodontal Therapy Plus Doxycycline on HbA1c in Patients With Type 2 Diabetes Mellitus: A Randomized Clinical Trials|Completed||N/A|24|Actual|Islamic Azad University, Tehran||2|||f||||t||||||||Yes||2017-10-10 21:57:55.157875|2017-10-10 21:57:55.157875
NCT02845011|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-22|||August 2016||2016-08-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|CFA||Cardio First Angle Device Effect on the CPR Outcomes|Prospective Study of the Effect of Cardio First Angle (CFA) Device on CPR Outcomes|Not yet recruiting||N/A|1000|Anticipated|Baqiyatallah Medical Sciences University||1|||f||||t||||||||||2017-10-10 21:57:55.255774|2017-10-10 21:57:55.255774
NCT02844998|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-04|2017-07-06||January 2015||2015-01-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|PE||The Impact and Benefit of Physical Activity on Premature Ejaculation|The Impact and Benefit of Physical Activity on Premature Ejaculation: Results of a Prospective, Randomized, Placebo-controlled Trial|Completed||N/A|120|Actual|Ankara Training and Research Hospital||3|||f||||t||||||||||2017-10-10 21:57:55.366602|2017-10-10 21:57:55.366602
NCT02844985|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-08-04|||August 17, 2016|Actual|2016-08-17|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction|Genetic Markers in Sexual Addiction|Recruiting||N/A|1100|Anticipated|American Foundation for Addiction Research|||2||f||||f||||||Samples With DNA|"     Saliva specimens will be collected from all participants for genetic evaluation.   "|||2017-10-10 21:57:55.742836|2017-10-10 21:57:55.742836
NCT02844972|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-25|||June 2015||2015-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|DOFAMILIA||Interest of Pain Assessment by the Family of Patients in Limiting and Stopping Active Treatment Process Admitted in ER. Study DOFAMILA||Recruiting||N/A|200|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:57:55.893003|2017-10-10 21:57:55.893003
NCT02844959|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-25|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01|6 Months|Observational [Patient Registry]|ACtIVE-AF||Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation|Assessment of Course of Inflammatory Biomarkers Concentrations After Pulmonary Veins Isolation as a Prognostic Factor of Atrial Fibrillation Treatment Effectiveness (ACtIVE-AF Study)|Recruiting||N/A|120|Anticipated|Medical University of Warsaw|||1||f||||f||||||Samples Without DNA|"     From each patient 10 ml of venous blood will be collected twice - just before ablation and 24     hours afterwards - and centrifugated to obtain serum.   "|Yes||2017-10-10 21:57:55.977742|2017-10-10 21:57:55.977742
NCT02844946|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-08-14|||October 3, 2016|Actual|2016-10-03|August 2017|2017-08-01|December 3, 2018|Anticipated|2018-12-03|September 3, 2018|Anticipated|2018-09-03||Interventional|||One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology|One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology|Recruiting||N/A|40|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 21:57:56.079453|2017-10-10 21:57:56.079453
NCT02844933|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-10-04|||November 30, 2017|Anticipated|2017-11-30|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cannabidiol Oral Solution for The Treatment of Subjects With Prader-Willi Syndrome|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome|Not yet recruiting||Phase 2|66|Anticipated|INSYS Therapeutics Inc||2|||f|||||t|f||||||||2017-10-10 21:57:56.187962|2017-10-10 21:57:56.187962
NCT02844920|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-08-07|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|OPEN||Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids|Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids|Recruiting||N/A|60|Anticipated|Gynesonics|||1||f||||f|f|t|t|f|t|||||2017-10-10 21:57:56.269339|2017-10-10 21:57:56.269339
NCT02844907|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-09-29|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Regulation of Insulin Secretion by the GLP-1 Receptor|Regulation of Insulin Secretion by the GLP-1 Receptor|Not yet recruiting||Phase 4|40|Anticipated|Duke University||3|||f||||t|t|f||||||||2017-10-10 21:57:56.371052|2017-10-10 21:57:56.371052
NCT02844894|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-25|||June 2016||2016-06-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Hemodynamic Response to Intubation|The Effects of Preintubation Esmolol and and Dexmedotimidine on Ischmeia Modified Albumin Levels|Recruiting||Phase 4|60|Anticipated|Ufuk University||3|||f||||f||||||||No||2017-10-10 21:57:56.458806|2017-10-10 21:57:56.458806
NCT02844881|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-09|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Apatinib and MASCT in Patients With Advanced Solid Tumors|Phase I/IIa, Single-Arm, Open Study of Apatinib and MASCT in Patients With Advanced Solid Tumors|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|The First People's Hospital of Lianyungang||1|||f||||f||||||||Undecided||2017-10-10 21:57:56.539336|2017-10-10 21:57:56.539336
NCT02844868|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-04-27|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ESTIMAH||Evaluation of the Observance and the Tolerance of a Motor Training Program|Evaluation of the Observance and the Tolerance of a Motor Training Program Combining With Repetitive tDCS Sessions on Walking Performance of Hemiplegic Stroke Patients at the Subacute Stage Post Stroke. ESTIMAH Study|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||No||2017-10-10 21:57:56.624495|2017-10-10 21:57:56.624495
NCT02844855|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-01-11|||December 2016||2016-12-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|EMBODIMENT||Memory for Action in Neurological Patients|Memory for Action in Neurological Patients|Recruiting||N/A|99|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||Undecided||2017-10-10 21:57:56.730086|2017-10-10 21:57:56.730086
NCT02844842|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-04-28|||November 23, 2016||2016-11-23|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Observational|APOLO||"Evaluation of Tolerability and Safety of Allergovac Poliplus in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice"|"Evaluation of Tolerability and Safety of Allergovac Poliplus in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice"|Recruiting||N/A|220|Anticipated|Roxall Medicina España S.A|||2||f||||f||||||||||2017-10-10 21:57:56.831407|2017-10-10 21:57:56.831407
NCT02838290|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-01-30|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Occupational Distress in Doctors: The Effect of an Induction Programme||Completed||N/A|232|Actual|Birkbeck, University of London||2|||f||||||||||||No||2017-10-10 21:58:58.311581|2017-10-10 21:58:58.311581
NCT02844829|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-25|||July 2016||2016-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|IMPROD2_0||Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers|Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers|Recruiting||N/A|200|Anticipated|Turku University Hospital||1|||f||||f||||||||Undecided||2017-10-10 21:57:56.94986|2017-10-10 21:57:56.94986
NCT02844803|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01||||June 2017|Anticipated|2017-06-01||Interventional|||Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients|Pilot Study to Investigate the Effect of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients|Recruiting||Early Phase 1|20|Anticipated|DongGuk University||2|||f||||f||||||||No||2017-10-10 21:57:59.637405|2017-10-10 21:57:59.637405
NCT02844790|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2017-06-08|||July 25, 2016|Actual|2016-07-25|June 2017|2017-06-01|September 26, 2016|Actual|2016-09-26|September 26, 2016|Actual|2016-09-26||Interventional|||A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese Subjects|A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese Subjects|Completed||Phase 1|24|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-10 21:57:59.723136|2017-10-10 21:57:59.723136
NCT02844777|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-08|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis|Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Once-Daily Application of Topical VDA-1102 Ointment for 28 Days in Subjects With Actinic Keratosis|Completed||Phase 2|93|Actual|Vidac Pharma||3|||f||||f||||||||Undecided|A decision has not been made whether to share individual participant data.|2017-10-10 21:57:59.805473|2017-10-10 21:57:59.805473
NCT02844764|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-12-23|||July 2015||2015-07-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip|Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Hip|Recruiting||Phase 2|4000|Anticipated|VivaTech International, Inc.||1|||f||||t||||||||Undecided|Vivatech will monitor data and decide if/when data can be shared|2017-10-10 21:57:59.908964|2017-10-10 21:57:59.908964
NCT02844751|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-12-23|||July 2015||2015-07-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee|Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Knee|Recruiting||Phase 2|4000|Anticipated|VivaTech International, Inc.||2|||f||||t||||||||Undecided|VivaTech will monitor data and decide if/when data can be shared|2017-10-10 21:57:59.99355|2017-10-10 21:57:59.99355
NCT02844738|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-12-23|||July 2015||2015-07-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder|Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Shoulder|Recruiting||Phase 2|4000|Anticipated|VivaTech International, Inc.||1|||f||||t||||||||Undecided|VivaTech will monitor data and decide if/when data can be shared|2017-10-10 21:58:00.114315|2017-10-10 21:58:00.114315
NCT02844725|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-09-28|||May 2016||2016-05-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Stdy to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Laparoscopic or Robotic-assisted Laparoscopic Gastrectomy|Recruiting||Phase 2|60|Anticipated|Vivozon, Inc.||2|||f||||f||||||||||2017-10-10 21:58:00.328068|2017-10-10 21:58:00.328068
NCT02844712|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-25|||December 2014||2014-12-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|May 2016|Actual|2016-05-01||Interventional|NPVDPT||Negative Predictive Value of Drug Provocation Tests to Beta-lactams|Negative Predictive Value of Drug Provocation Tests to Beta-lactams|Terminated||N/A|750|Actual|University Hospital, Montpellier||1||End of the period of inclusion, NSN not achieved|f||||f||||||||||2017-10-10 21:58:00.443033|2017-10-10 21:58:00.443033
NCT02844699|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-09-19|||July 2016||2016-07-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer||Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Panacela Labs LLC||3|||f||||f||||||||||2017-10-10 21:58:00.521671|2017-10-10 21:58:00.521671
NCT02844686|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-22|||August 2016||2016-08-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Flow-Heart||Myocardial Flow Reserve and 99mTc-DTPA Cardiac Dynamic SPECT|Feasibility of Dynamic Cardiac SPECT With 99mTc-diethylenetriaminepenta-acetate (DTPA) for the Assessment of Myocardial Flow Reserve Using a Cadmium-Zinc-Telluride (CZT) Camera|Not yet recruiting||N/A|20|Anticipated|University Hospital, Caen||1|||f||||||||||||||2017-10-10 21:58:00.620768|2017-10-10 21:58:00.620768
NCT02844673|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-11-22|||October 2016||2016-10-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|mDOT||Mobile-Directly Observed Therapy on Adherence to Hydroxyurea|Effect of Mobile-Directly Observed Therapy (DOT) on Adherence to Hydroxyurea Treatment in Adult HbSS Patients at Muhimbili National Hospital (MNH) in Tanzania: a Pilot Study|Enrolling by invitation||Phase 4|100|Anticipated|Muhimbili University of Health and Allied Sciences||2|||f||||f||||||||Yes|Yes, investigators plan to share the database with one of the collaborators, University of Pittsburgh, USA|2017-10-10 21:58:00.688253|2017-10-10 21:58:00.688253
NCT02844660|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-03-14|||July 2016||2016-07-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers|A Multicenter, Prospective, Randomized, Controlled, Comparative Parallel Study of Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers|Recruiting||N/A|66|Anticipated|MiMedx Group, Inc.||2|||f||||t||||||||No||2017-10-10 21:58:00.775013|2017-10-10 21:58:00.775013
NCT02844647|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-09-07|||June 2016||2016-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer|Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer|Active, not recruiting||Phase 1|10|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 21:58:00.927707|2017-10-10 21:58:00.927707
NCT02844634|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-08-04|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DuDHS||Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM|Tenofovir/Emtricitabine With Immediate or Deferred Daily Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative Men Who Have Sex With Men: a Pilot Study of Dual Daily HIV and Syphilis PrEP. (The DuDHS Trial).|Not yet recruiting||Phase 4|50|Anticipated|British Columbia Centre for Disease Control||2|||f||||t||||||||No||2017-10-10 21:58:01.002742|2017-10-10 21:58:01.002742
NCT02844621|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-01-19|||May 2016|Actual|2016-05-01|July 2016|2016-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Proton Pump Inhibitors on Gut Microbiota and Systemic Inflammation in Older Adults|Comparison of Gut Microbiota Composition and Systemic Inflammatory Markers Prior to and Post-Proton Pump Inhibitor Use in Older Adults|Completed||Early Phase 1|25|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||||2017-10-10 21:58:01.105307|2017-10-10 21:58:01.105307
NCT02844595|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-21|||January 2016||2016-01-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Behavioural Activation Treatment for Smoking Cessation and Depressive Symptomatology: a Randomized Controlled Trial|Behavioural Activation Treatment for Smoking Cessation and Depressive Symptomatology: a Randomized Controlled Trial|Recruiting||N/A|250|Anticipated|University of Santiago de Compostela||3|||f||||||||||||||2017-10-10 21:58:01.29729|2017-10-10 21:58:01.29729
NCT02844569|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-04-07|||July 2016||2016-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction|A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction|Recruiting||N/A|24|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|t|f|||||No||2017-10-10 21:58:01.527922|2017-10-10 21:58:01.527922
NCT02844556|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-12-25|||September 2016||2016-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||International Multicenter Study on SMILE Surgery|International Multicenter Study on Small Incision Lenticule Extraction(SMILE) Surgery|Recruiting||N/A|1000|Anticipated|Tianjin Eye Hospital||2|||f||||t||||||||No||2017-10-10 21:58:01.642055|2017-10-10 21:58:01.642055
NCT02844543|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-04-26|||January 2016||2016-01-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|ETA-TV||EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1|EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1|Completed||N/A|150|Anticipated|Stanford University||1|||f||||f||||||||Yes|Data will be shared with the sponsor: Brain Trauma Foundation and US Department of Defense|2017-10-10 21:58:01.750999|2017-10-10 21:58:01.750999
NCT02844530|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-01-17||||||January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|RITEPRALL||Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL|Randomized Phase II Study Evaluating the Efficacy of 90Yttrium-epratuzumab Tetraxetan Radioimmunotherapy in Adults With CD22+ Relapsed/Refractory B-ALL|Withdrawn||Phase 2|0|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-10 21:58:01.834688|2017-10-10 21:58:01.834688
NCT02844517|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-08-31|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol|Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial Research Site Training Protocol|Recruiting||N/A|100|Anticipated|University of Virginia||1|||f||||t|f|t|t|f||||||2017-10-10 21:58:01.936191|2017-10-10 21:58:01.936191
NCT02844504|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-08-31|||May 2016||2016-05-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Neurophysiological Evaluation of Training Effect on Cancer-Related Weakness|Neurophysiological Evaluation of Training Effect on Cancer-Related Weakness|Recruiting||N/A|75|Anticipated|Kessler Foundation||3|||f||||f||||||||||2017-10-10 21:58:02.23086|2017-10-10 21:58:02.23086
NCT02844491|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-25|||January 2013||2013-01-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Observational|Epitopes-LNH01||Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B|Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B|Active, not recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Besancon|||2||f||||f||||||Samples Without DNA|"     -  Blood samples will be realized at inclusion and Peripheral Blood Mononuclear Cells          (PBMC) will be collected.        -  Tumor tissues will be collected if available.   "|||2017-10-10 21:58:02.36347|2017-10-10 21:58:02.36347
NCT02844478|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-06|||September 2016||2016-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging|Effect of Stress-Busting Program on Caregivers' Quality of Life, Stress/Immunity Bio-markers, and Cellular Aging|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 21:58:02.45202|2017-10-10 21:58:02.45202
NCT02844465|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-07-13|||November 2016||2016-11-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|SLATE||Stereotactic Laser Ablation for Temporal Lobe Epilepsy|Stereotactic Laser Ablation for Temporal Lobe Epilepsy|Recruiting||N/A|120|Anticipated|Medtronic Surgical Technologies||1|||f||||t||||||||||2017-10-10 21:58:02.614381|2017-10-10 21:58:02.614381
NCT02844452|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-21|||June 2016||2016-06-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Antipruritic Effect of Acupuncture in Patients With Atopic Dermatitis|Antipruritic Effect of Acupuncture in Patients With Atopic Dermatitis : the Protocol for Randomized, Sham-controlled Pilot Trial With Different Visit Frequency|Recruiting||N/A|50|Anticipated|Kyunghee University||4|||f||||t||||||||No|There is no plan.|2017-10-10 21:58:02.796785|2017-10-10 21:58:02.796785
NCT02844439|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-09-25|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma|A Phase 2, Multicenter Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma|Active, not recruiting||Phase 2|40|Actual|Kadmon Corporation, LLC||1|||f||||f||||||||||2017-10-10 21:58:02.900422|2017-10-10 21:58:02.900422
NCT02844426|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-09-29|||September 2015||2015-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Effect of a Synbiotic on Symptoms of Patients With STC|Effect of a Synbiotic on Symptoms of Patients With Slow Transit Constipation: A Prospective Randomized Trial|Completed||Phase 2|100|Actual|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 21:58:03.012151|2017-10-10 21:58:03.012151
NCT02844413|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-21|||December 2015||2015-12-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Physical Exercises Influence on Blood Pressure and Arterial Stiffness|The Influence of Regular Aerobic Interval Training on Blood Pressure and Arterial Stiffness Amongst Hypertensive Subjects|Completed||Phase 4|60|Actual|Jagiellonian University||2|||f||||f||||||||Undecided||2017-10-10 21:58:03.119059|2017-10-10 21:58:03.119059
NCT02844400|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-09-19|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation|Assessing Performance Status in Cancer Patients Using Cardiopulmonary Exercise Testing and Wearable Data Generation: A Prospective Observational Study|Recruiting||N/A|60|Anticipated|UNC Lineberger Comprehensive Cancer Center|||2||f||||t||||||||||2017-10-10 21:58:03.200058|2017-10-10 21:58:03.200058
NCT02844387|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-27|||May 2004||2004-05-01|July 2016|2016-07-01|December 2008|Actual|2008-12-01|November 2007|Actual|2007-11-01||Interventional|||Supplementation of L-arginine in Patients With Non-resectable Brain Metastases|Oral L-arginine Supplementation in Patients With Non-resectable Brain Metastases Treated With Radiation Therapy With Palliative Intent|Completed||Phase 1/Phase 2|70|Actual|Instituto de Oncología Ángel H. Roffo||2|||f||||f||||||||Yes||2017-10-10 21:58:03.30647|2017-10-10 21:58:03.30647
NCT02844374|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-25|||January 2014||2014-01-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|EPISTIM||Epileptogenic Zone's Cartography by Quantification of EEG's Signal and Intracerebral Stimulation.|Epileptogenic Zone's Cartography by Quantification of EEG's Signal and Intracerebral Stimulation.|Recruiting||N/A|45|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:03.407355|2017-10-10 21:58:03.407355
NCT02844361|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-25|||May 2016||2016-05-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|BDH-WM03||Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia|Autologous Stem-cell Transplantation Versus Conventional Chemotherapy for High Risk Waldenström Macroglobulinemia - a Prospective Multicentre Phase Ⅳ Trial From China|Recruiting||Phase 4|70|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||f||||||||Undecided|dependent on the local law|2017-10-10 21:58:03.531463|2017-10-10 21:58:03.531463
NCT02844348|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-10-06|||February 2016||2016-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|HYPNODIAL||Impact of Hypnosis on Pain Management During Dialysis on Patients Suffering From Arterial Disease|Impact of Hypnosis on the Management of Chronic and Breakthrough Pain of Chronic Dialysis Patients Suffering From Arterial Disease|Withdrawn||N/A|0|Actual|University Hospital, Grenoble||2||Enrollment problem|f||||f||||||||No||2017-10-10 21:58:03.625027|2017-10-10 21:58:03.625027
NCT02844335|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer||Recruiting||Phase 1/Phase 2|60|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:58:03.715541|2017-10-10 21:58:03.715541
NCT02844322|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-25|||May 2016||2016-05-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|BDH-WM01||The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia|The Efficacy of Cyclophosphamide Plus Dexamethasone Combinated With Rituximab or Bortezomib for the Newly Diagnosed Waldenström Macroglobulinemia - a Prospective Multicentre Randomized Control Trial From China|Recruiting||Phase 4|110|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||f||||||||Undecided|we will make the data publicly available according to the local law|2017-10-10 21:58:03.804065|2017-10-10 21:58:03.804065
NCT02844309|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-25|||May 2016||2016-05-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|BDH-WM02||The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM|The Efficacy of Thalidomide Plus Cyclophosphamide and Dexamethasone Following by Thalidomide and Prednisone Maintenance Therapy for the Newly Diagnosed Waldenström Macroglobulinemia - a Prospective Multicentre Phase Ⅳ Trial From China|Recruiting||Phase 4|44|Anticipated|Institute of Hematology & Blood Diseases Hospital||1|||f||||f||||||||Undecided|whether to publish primary data is dependent on the local law|2017-10-10 21:58:03.8928|2017-10-10 21:58:03.8928
NCT02844296|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-05-08|||October 2016||2016-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SHESC||Short-bout Handgrip Exercise for Smoking Cessation|Efficacy of a Short-bout Handgrip Exercise Intervention for Smoking Cessation: a Pilot Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|The University of Hong Kong||2|||f||||t||||||||Undecided||2017-10-10 21:58:03.97579|2017-10-10 21:58:03.97579
NCT02844283|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-21|||November 2016||2016-11-01|June 2016|2016-06-01||||July 2018|Anticipated|2018-07-01||Interventional|||Ad-HGF Treatment for Myocardial Infarction|Adenovirus Carrying Hepatocyte Growth Factor (Ad-HGF) Treatment for Myocardial Infarction|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||||||||||||2017-10-10 21:58:04.094421|2017-10-10 21:58:04.094421
NCT02844270|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study|The Feasibility, Safety and Efficacy Evaluation of Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System for the Treatment of Coronary Heart Disease: a First-in-man Study|Not yet recruiting||Phase 1|45|Anticipated|Shanghai Bio-heart Biological Technology Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:58:04.167888|2017-10-10 21:58:04.167888
NCT02844257|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-21|||January 2014||2014-01-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Observational|||Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia|Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia|Completed||N/A|1067|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:58:04.254088|2017-10-10 21:58:04.254088
NCT02844244|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-21|||December 2010||2010-12-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||"Training Workshop for Promoting Family Well-being Through a Community-based Learning Families Campaign"|"Training Workshop for Promoting Family Health, Happiness and Harmony Through a Community-based Learning Families Campaign"|Completed||N/A|32|Actual|The University of Hong Kong||1|||f||||t||||||||No||2017-10-10 21:58:04.316987|2017-10-10 21:58:04.316987
NCT02844231|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-21|||April 2010||2010-04-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Functional Imagery of Sleepwalking|Functional Imagery of Sleepwalking|Active, not recruiting||N/A|36|Anticipated|University Hospital, Montpellier||3|||f||||f||||||||||2017-10-10 21:58:04.385146|2017-10-10 21:58:04.385146
NCT02844218|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-21|||January 2014||2014-01-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia|Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia|Completed||N/A|183|Actual|Hospices Civils de Lyon|||3||f||||f||||||||||2017-10-10 21:58:04.453664|2017-10-10 21:58:04.453664
NCT02844205|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-08-31|||November 2015||2015-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Reproducibility of a New Practical Newborn Behavioral Observation Scale|Evaluation of the Reproducibility of a New Practical Newborn Behavioral Observation Scale in Order to Implement an Individualized Care Program|Recruiting||N/A|10|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||||2017-10-10 21:58:04.527374|2017-10-10 21:58:04.527374
NCT02844192|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-21|||October 2015||2015-10-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|July 2016|Actual|2016-07-01||Observational|PK-VANCO-ICU||Pharmacokinetics of Vancomycin in ICU Patients|Pharmacokinetics of Vancomycin in ICU Patients|Active, not recruiting||N/A|80|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:58:04.745928|2017-10-10 21:58:04.745928
NCT02844179|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-21|||July 2016||2016-07-01|August 2017|2017-08-01|June 27, 2017|Actual|2017-06-27|June 27, 2017|Actual|2017-06-27||Interventional|||(+)-Alpha-Dihydrotetrabenazine Phase I|(+)-Alpha-Dihydrotetrabenazine Phase I|Completed||Phase 1|6|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 21:58:04.819563|2017-10-10 21:58:04.819563
NCT02844166|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-21|||April 2016||2016-04-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|SURFACE||Support Surfaces to Prevent Pressure Injuries|The Effect of Support Surfaces in the Incidence of Pressure Injuries in Critically Ill Patients: a Randomized Clinical Trial|Recruiting||N/A|608|Anticipated|Universidade Estadual de Londrina||2|||f||||f||||||||No||2017-10-10 21:58:04.898579|2017-10-10 21:58:04.898579
NCT02844153|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-25|||March 2014||2014-03-01|July 2016|2016-07-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Observational|CKD-Met||Metformin Use in Chronic Kidney Disease: The CKD-Met Study|Metformin Use in Chronic Kidney Disease: The CKD-Met Study|Recruiting||N/A|1000|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:58:05.054734|2017-10-10 21:58:05.054734
NCT02844140|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-13|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|DE-CT||DE-CT in Lung Cancer Proton Therapy|DE-CT vs. SE-CT as Optimal Imaging During Treatment for Adaptive Proton Therapy in Stage III Non Small Cell Lung Cancer (NSCLC)|Withdrawn||N/A|0|Actual|Maastricht Radiation Oncology||1|||f||||f||||||||No||2017-10-10 21:58:05.160757|2017-10-10 21:58:05.160757
NCT02844127|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-09-18|||November 2016||2016-11-01|September 2017|2017-09-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Interventional|||Effect of Right Ventricular Lead Position on Defibrillation Threshold|Effect of Right Ventricular Lead Position on Defibrillation Threshold|Withdrawn||N/A|0|Actual|OhioHealth||2||Devices proposed for use in the protocol no longer used by physician|f||||f||||||||||2017-10-10 21:58:05.245323|2017-10-10 21:58:05.245323
NCT02844114|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-03-30|||January 2016||2016-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|LCKY2015-21(x)||Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy|Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy|Recruiting||Phase 2|60|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||t||||||||Yes|De-identified individual participant data for all primary and secondary outcome measures within 6 months of study completion.|2017-10-10 21:58:05.354167|2017-10-10 21:58:05.354167
NCT02844101|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-10-26|||July 2013||2013-07-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ACCELORIX2||Assess Whether Knowledge by the Younger of the Function of the Accelerometer Determines Its Amount of Physical Activity|Assess Whether Knowledge by the Children and Adolescents of the Function of the Accelerometer Determines Its Amount of Physical Activity|Completed||N/A|80|Actual|University Hospital, Lille||2|||f||||f||||||||No||2017-10-10 21:58:05.49846|2017-10-10 21:58:05.49846
NCT02844088|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-21|||March 2016||2016-03-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Evaluation of Vaccinal and Natural Immunity Against Meningococcus C|Evaluation of the Persistence in 2016 of Vaccinal Immunity Against Meningococcus C Among Children and Teenagers Who Received Meningococcus C Conjugate Vaccine in January 2002 During the Puy-de-Dôme Campaign and of Natural Immunity Among Unvaccinated People|Recruiting||N/A|300|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 21:58:05.571707|2017-10-10 21:58:05.571707
NCT02844075|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-01-24|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|May 2022|Anticipated|2022-05-01|May 2017|Anticipated|2017-05-01||Interventional|||A Phase II Trial of Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma||Recruiting||Phase 2|28|Anticipated|Yonsei University||1|||f||||t||||||||No||2017-10-10 21:58:05.667545|2017-10-10 21:58:05.667545
NCT02844062|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-22|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme|A Safety and Efficacy Study of Autologous Chimeric Antigen Receptor Engineered T Cells Redirected to EGFRvIII in Patients With Recurrent Glioblastoma Multiforme|Recruiting||Phase 1|20|Anticipated|Beijing Sanbo Brain Hospital||1|||f||||t||||||||Yes||2017-10-10 21:58:05.759563|2017-10-10 21:58:05.759563
NCT02844049|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-25|||September 2016||2016-09-01|June 2016|2016-06-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|EQOLOC||European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS|European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS Versus Best Medical Treatment|Not yet recruiting||Phase 2|60|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||No||2017-10-10 21:58:05.859579|2017-10-10 21:58:05.859579
NCT02844036|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-25|||June 2014||2014-06-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|OCT²EPH||Angioplasty of Distal Lesions for Carriers of Inoperable Post-embolic HTP|Angioplasty of Distal Lesions for Carriers of Inoperable Post-embolic HTP|Recruiting||N/A|30|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-10 21:58:06.045071|2017-10-10 21:58:06.045071
NCT02844023|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-22|||October 2015||2015-10-01|July 2016|2016-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|BioACG||Biomarkers in Giant Cells Arteritis|Biomarkers in Giant Cells Arteritis|Recruiting||N/A|100|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:58:06.174825|2017-10-10 21:58:06.174825
NCT02844010|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-22|||April 2015||2015-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|PneumoniePoids||Prospective Study to Quantify the Change in Weight at a Pneumonia|Prospective Study to Quantify the Change in Weight at a Pneumonia|Recruiting||N/A|188|Anticipated|University Hospital, Grenoble|||1||f||||f||||||Samples Without DNA|"     Weight is written down.   "|Undecided||2017-10-10 21:58:06.293006|2017-10-10 21:58:06.293006
NCT02843997|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-22|||February 2015||2015-02-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|EnBiGen||Endophenotype Characterization of a Family Psychiatric Disorder|Endophenotype Characterization of a Family Psychiatric Disorder of the Bipolar Spectrum, With an Autosomal Dominant Expression|Recruiting||N/A|29|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:06.399669|2017-10-10 21:58:06.399669
NCT02843984|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-21|||March 2011||2011-03-01|July 2016|2016-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Influence of Vaginal Lactoferrin on Amniotic Fluid Cytokines to Avoid Pregnancy Complications||Completed||N/A|60|Actual|Università degli Studi di Ferrara||3|||f||||f||||||||No||2017-10-10 21:58:06.530199|2017-10-10 21:58:06.530199
NCT02843971|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-07-22|||January 2015||2015-01-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PIO-WDT||Evaluation of the Water Drinking Test Response in Supine and Sitting Position Using the Continuous Measurement Device Sensimed Triggerfish Intraocular Pressure in Healthy Subjects|Evaluation of the Water Drinking Test Response in Supine and Sitting Position Using the Continuous Intraocular Pressure Measurement Device Sensimed Triggerfish in Healthy Subjects|Completed||N/A|16|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:06.604505|2017-10-10 21:58:06.604505
NCT02843958|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-09-29|||June 2013||2013-06-01|September 2016|2016-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|HEMOPTIC||Validation of a Portable Medical Device for Diagnostic in Vitro|Validation of a Portable Medical Device for Diagnostic in Vitro, Designed to Measure Blood Coagulation's Biological Parameters|Completed||N/A|40|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:06.713968|2017-10-10 21:58:06.713968
NCT02843945|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-08-17|||May 31, 2017|Actual|2017-05-31|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Initial Feasibility Study to Treat Pancreatic Cancer With a Planar LDR Source|Initial Feasibility Study to Evaluate the Safety and Efficacy of the Permanently Implantable LDR CivaSheet® in Combination With External Beam Radiation in the Treatment of Pancreatic Cancer|Recruiting||Phase 1/Phase 2|80|Anticipated|CivaTech Oncology||1|||f||||t|f|t|f|f|f|||||2017-10-10 21:58:06.795242|2017-10-10 21:58:06.795242
NCT02843932|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-07-22|||May 2015||2015-05-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|PERCMO-TNF||Subjective Perception of Motor Control During Psychogenic Disorders|Study of Subjective Perception of Motor Control During Psychogenic Disorders : Brain Mechanisms and Functional Imaging.|Recruiting||N/A|32|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:06.913493|2017-10-10 21:58:06.913493
NCT02843919|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-01-17|||December 2014||2014-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CARACOg||Characterization of Independant Task Neural Correlates of Different Levels of Mental Workload|Characterization of Independant Task Neural Correlates of Different Levels of Mental Workload|Recruiting||N/A|30|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:07.019894|2017-10-10 21:58:07.019894
NCT02843906|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-07-22|||July 2015||2015-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|BIPAGE||Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?|Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?|Recruiting||N/A|180|Anticipated|University Hospital, Grenoble||3|||f||||f||||||||||2017-10-10 21:58:07.13005|2017-10-10 21:58:07.13005
NCT02843893|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-22|||April 2012||2012-04-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PUPILLO REA||Evaluation of Pupillary Distension Reflexes, as a Tool for the Monitoring of Analgesia for Patients in Intensive Care.|Evaluation of Pupillary Distension Reflexes, as a Tool for the Monitoring of Analgesia for Patients in Intensive Care.|Completed||N/A|51|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:07.2491|2017-10-10 21:58:07.2491
NCT02843880|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-07-22|||March 2013||2013-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|CMV-Réa||Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study|Predictive Factors of Cytomegalovirus Reactivation or Cytomegalovirus Disease by Immunological Study of Immunocompetent Patients Hospitalized for Septic Shock|Terminated||N/A|1|Actual|University Hospital, Grenoble|||1|Problematic has become outdated in relation with current litterature advances.|f||||||||||||||2017-10-10 21:58:07.323751|2017-10-10 21:58:07.323751
NCT02843867|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-21|||November 2008||2008-11-01|July 2016|2016-07-01|September 2026|Anticipated|2026-09-01|September 2017|Anticipated|2017-09-01||Observational|ORLY-Est||Orientation of the Lymphocyte Response to the Occurrence of Atherosclerotic Complications After Kidney Transplantation|Influence de l'ORientation de la réponse LYmphocytaire Sur la Survenue de Complications athéromateuses après Transplantation rénale (étude ORLY-EST 2)|Recruiting||N/A|1000|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||Samples Without DNA|"     Serum Peripheral Blood Mononuclear Cells   "|Yes|Identified individual participant data for all outcome measures will be made available within 6 monts of study completion|2017-10-10 21:58:07.385487|2017-10-10 21:58:07.385487
NCT02843841|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-01-30|||December 2014||2014-12-01|July 2016|2016-07-01|March 1, 2017|Anticipated|2017-03-01|March 1, 2016|Actual|2016-03-01||Interventional|GABII||Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation|Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation|Active, not recruiting||N/A|63|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||No||2017-10-10 21:58:07.47815|2017-10-10 21:58:07.47815
NCT02843828|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-02-01|||September 2015||2015-09-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Gait Pattern Analysis and Feasibility of Gait Training With a Walking Assist Robot in Stroke Patients and Elderly Adults|Gait Pattern Analysis and Feasibility of Gait Training With a Newly Developed Walking Assist Robot in Stroke Patients and Elderly Adults|Completed||N/A|54|Anticipated|Samsung Medical Center||2|||f||||t||||||||No||2017-10-10 21:58:07.545092|2017-10-10 21:58:07.545092
NCT02843815|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:58:07.620749|2017-10-10 21:58:07.620749
NCT02843802|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:58:07.702032|2017-10-10 21:58:07.702032
NCT02843789|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-02-14|||March 2013||2013-03-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|ADIPRAT||Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy|Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy|Recruiting||Phase 4|132|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:58:07.777673|2017-10-10 21:58:07.777673
NCT02843776|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-07-19|||January 1, 2017|Actual|2017-01-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|December 31, 2017|Anticipated|2017-12-31||Observational|EPIDESA2||Requests for Euthanasia and Assisted Suicide|Requests for Euthanasia and Assisted Suicide : Epidemiological Study Conducted as Part of the Establishment of a Structured Network|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||t||||||||||2017-10-10 21:58:07.852853|2017-10-10 21:58:07.852853
NCT02843763|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|TRAK||Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer|Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Besancon||5|||f||||f||||||||No||2017-10-10 21:58:07.929641|2017-10-10 21:58:07.929641
NCT02843750|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-12-14|||June 2016||2016-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery|A Pilot Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery|Withdrawn||N/A|0|Actual|Mayo Clinic||1||Difficulty recruiting patients|f||||f||||||||No||2017-10-10 21:58:08.152299|2017-10-10 21:58:08.152299
NCT02843737|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-11|||November 21, 2014|Actual|2014-11-21|May 2017|2017-05-01|March 16, 2017|Actual|2017-03-16|December 2014|Actual|2014-12-01||Observational|SDI||Multicenter Observational Study to Validate a New Index for Sleep Fragmentation Analysis: Sleep Diversity Index (SDI)|Multicenter Observational Study to Validate a New Index for Sleep Fragmentation Analysis: Sleep Diversity Index (SDI)|Completed||N/A|300|Actual|Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer|||1||f||||f||||||||||2017-10-10 21:58:08.24586|2017-10-10 21:58:08.24586
NCT02843724|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Integrative Care for Type 2 Diabetes|Integrative Care for Type 2 Diabetes: Evaluating the Impact of Naturopathic Adjunctive Care for Diabetic Patients of a Family Health Team|Not yet recruiting||Phase 1/Phase 2|148|Anticipated|The Canadian College of Naturopathic Medicine||2|||f||||t||||||||No||2017-10-10 21:58:08.331953|2017-10-10 21:58:08.331953
NCT02843711|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-21|||January 2014||2014-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Observational|LUNG-EST||Molecular Analysis of 150 Lung Adenocarcinoma|Molecular Analysis of 150 Lung Adenocarcinoma With Corresponding Histopathological and Clinical Data Available|Active, not recruiting||N/A|152|Actual|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     Paraffin-embedded formalin fixed tumour sample   "|||2017-10-10 21:58:08.443912|2017-10-10 21:58:08.443912
NCT02843698|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-25|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|August 26, 2017|Actual|2017-08-26|August 26, 2017|Actual|2017-08-26||Interventional|||Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations|Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations: A Randomized Controlled Trial|Completed||Phase 4|42|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 21:58:08.518261|2017-10-10 21:58:08.518261
NCT02843685|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-21|||December 2002||2002-12-01|July 2016|2016-07-01||||December 2005|Actual|2005-12-01||Observational|||Regression Discontinuity Design to Evaluate of Drotrecogin Alpha Effectiveness|Regression Discontinuity Designs to Evaluate Real-world Effectiveness: a Case Study of Drotrecogin Alpha|Completed||N/A|12492|Actual|Boston Medical Center|||1||f||||f||||||||No|Individual participant data (IPD) is only available through consultation with the original PROGRESS registry study sponsor through https://www.clinicalstudydatarequest.com/|2017-10-10 21:58:08.607048|2017-10-10 21:58:08.607048
NCT02843672|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-08-09|||July 2016||2016-07-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|WeilvsDMMO||Operative Treatment Of Metatarsalgia: Triple Weil Osteotomy Or Distal Metatarsal Minimal Invasive Osteotomy (DMMO)?|Open Randomized Controlled Clinical Trial To Assess Functional Outcomes Between Two Therapeutic Options In The Surgical Treatment Of Metatarsalgia: Triple Weil Osteotomy (Two) And Distal Metatarsal Osteotomy Minimally Invasive (DMMO)|Recruiting||N/A|40|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||t||||||||No||2017-10-10 21:58:08.690986|2017-10-10 21:58:08.690986
NCT02843659|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-07-26|||October 18, 2016|Actual|2016-10-18|July 2017|2017-07-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|||Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome|A Phase II, Randomized, Multi-Center, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Subjects With Moderate to Severe Primary Sjögren's Syndrome|Terminated||Phase 2|80|Anticipated|Bristol-Myers Squibb||3||Inability to meet protocol objectives|f||||t|t|f||||||||2017-10-10 21:58:08.810014|2017-10-10 21:58:08.810014
NCT02843646|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-05-04|||July 2016||2016-07-01|May 2017|2017-05-01||||July 2019|Anticipated|2019-07-01||Interventional|||Investigating the Use of the WalkAide on a Child's Ability to Ascend/Descend Stairs and Curbs|Investigating the Use of the WalkAide on a Child's Ability to Ascend/Descend Stairs and Curbs|Recruiting||N/A|12|Anticipated|Blythedale Children's Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:58:09.008265|2017-10-10 21:58:09.008265
NCT02843633|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-09-05|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|February 2018|Anticipated|2018-02-01||Interventional|||LEADERS FREE II: BioFreedom™ Pivotal Study|A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding|Active, not recruiting||N/A|1200|Anticipated|Biosensors Europe SA||1|||f||||t|f|t|f|||||||2017-10-10 21:58:09.105911|2017-10-10 21:58:09.105911
NCT02843620|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-07-13|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Efficacy and Safety of b-2Cool on Adults With Joint Discomfort|Randomized Double-blind, Placebo Controlled Study to Asses the Efficacy and Safety of a Native Collagen Food Supplement on Joint Function, Ultrasound Evolution and Quality of Life of Adults With Moderate Knee Pain|Not yet recruiting||N/A|60|Anticipated|Bioiberica||2|||f||||t|f|f||||||||2017-10-10 21:58:09.376593|2017-10-10 21:58:09.376593
NCT02843607|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:58:09.470827|2017-10-10 21:58:09.470827
NCT02843594|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-22|||August 2016||2016-08-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Assess the Clinical Outcomes of Surgical Phaco Segmentation Techniques in Patients Undergoing Cataract Surgery||Recruiting||Phase 4|500|Anticipated|Iantech, Inc||3|||f||||f||||||||Yes||2017-10-10 21:58:09.56568|2017-10-10 21:58:09.56568
NCT02843581|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer||Recruiting||Phase 1/Phase 2|60|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||Yes||2017-10-10 21:58:09.647898|2017-10-10 21:58:09.647898
NCT02843568|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-10-10|||August 2016||2016-08-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Improving Pulmonary Function Following Radiation Therapy|Improving Pulmonary Function Following Radiation Therapy|Recruiting||N/A|120|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-10 21:58:09.746846|2017-10-10 21:58:09.746846
NCT02843555|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-07-21|||August 2008||2008-08-01|July 2016|2016-07-01|December 2025|Anticipated|2025-12-01|December 2022|Anticipated|2022-12-01||Observational|||Natural History of the Leukodystrophies|The Etiology, Pathogenesis, and Natural History of the Leukodystrophies|Recruiting||N/A|50|Anticipated|Baylor Research Institute|||1||f||||f||||||Samples With DNA|"     Blood, urine, skin   "|No||2017-10-10 21:58:09.876389|2017-10-10 21:58:09.876389
NCT02843542|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-21|||August 2016||2016-08-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI)|Localization of Parathyroid Adenoma by Fluorocholine Positron Emission Tomography/MRI (PET/MRI): A Prospective Pilot Study|Not yet recruiting||N/A|50|Anticipated|Assuta Medical Center||2|||f||||f||||||||No||2017-10-10 21:58:09.961389|2017-10-10 21:58:09.961389
NCT02843529|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-31|||November 2016||2016-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|AltoidaML||Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (Altoida™)|Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (Altoida™) as a Useful Neuromotor Biomarker for Alzheimer's Disease|Enrolling by invitation||N/A|500|Anticipated|Altoida||1|||f||||t||||||||Undecided|neuromotor data sharing|2017-10-10 21:58:10.06829|2017-10-10 21:58:10.06829
NCT02843516|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-21|||March 2009||2009-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Detection Rate of Atrial Fibrillation in Patients Implanted With ILRs|Detection Rate of Atrial Fibrillation in Patients Implanted With ILRs|Completed||N/A|500|Actual|Cambridge University Hospitals NHS Foundation Trust|||2||f||||f||||||||No||2017-10-10 21:58:10.178683|2017-10-10 21:58:10.178683
NCT02843503|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-01-23|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|FACT-CGM||Factors in Accuracy Studies Influencing Measured CGM Performance.|Factors in Accuracy Studies Influencing Measured CGM Performance: a Comparison of Measured Continuous Glucose Monitor Performance Using Venous, Arterialized-venous and Capillary Reference Glucose Samples.|Completed||N/A|21|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||No||2017-10-10 21:58:10.248982|2017-10-10 21:58:10.248982
NCT02843490|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-16|||August 2016||2016-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|CAPTAIN||Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration|Correlation of Functional and Structural Outcomes With Serum Antibody Profiles in Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial|Recruiting||Phase 4|70|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f||||||||No||2017-10-10 21:58:10.332436|2017-10-10 21:58:10.332436
NCT02843477|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-24|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Evaluation of Corrected Carotid Artery Flow Time as a Predictor of Fluid Responsiveness in Spontaneous Breathing Patients||Recruiting||N/A|54|Anticipated|Yonsei University|||1||f||||f||||||||No||2017-10-10 21:58:10.441828|2017-10-10 21:58:10.441828
NCT02843464|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-01-10|||December 2016||2016-12-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||Long-term Remote Ischemic Preconditioning Improve Long-term Prognosis of Acute Myocardial Infarction Patients Without Emergency Reperfusion Therapy||Not yet recruiting||N/A|220|Anticipated|Xuanwu Hospital, Beijing||2|||f||||||||||||||2017-10-10 21:58:10.510342|2017-10-10 21:58:10.510342
NCT02843451|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-21|||October 2016||2016-10-01|July 2016|2016-07-01||||October 2018|Anticipated|2018-10-01||Interventional|||Milk Thistle in Body Dysmorphic Disorder|Silymarin Treatment of Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled, Cross-Over Study|Not yet recruiting||Phase 2|15|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-10 21:58:10.583322|2017-10-10 21:58:10.583322
NCT02843438|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-22|||January 2010||2010-01-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|BIOLUVE||Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis|Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis|Completed||N/A|72|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:10.678451|2017-10-10 21:58:10.678451
NCT02843425|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-06-27|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial|The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial|Recruiting||N/A|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 21:58:10.778267|2017-10-10 21:58:10.778267
NCT02843412|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-22|||August 2016||2016-08-01|July 2016|2016-07-01||||May 2018|Anticipated|2018-05-01||Observational|||The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using Immunohistochemistry||Not yet recruiting||N/A|2000|Anticipated|Shanghai Zhongshan Hospital|||2||f||||||||||||||2017-10-10 21:58:10.858055|2017-10-10 21:58:10.858055
NCT02843399|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-01-23|||August 2016||2016-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy|Clinical and Economic Outcomes of Patients With Type 2 Diabetes Mellitus Initiating Bydureon and Glargine|Completed||N/A|2800|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-10-10 21:58:10.922898|2017-10-10 21:58:10.922898
NCT02843386|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-04-27|||June 23, 2009|Actual|2009-06-23|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01||Interventional|FOTEADJ||Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma|Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma|Active, not recruiting||Phase 3|302|Actual|Institut Curie||2|||f||||t||||||||No||2017-10-10 21:58:11.006073|2017-10-10 21:58:11.006073
NCT02843373|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Observational|||Brain-Based Biomarkers in Response to TMS in MDD|Longitudinal, Prospective Study to Examine the Brain-based Biomarkers of Response to Transcranial Magnetic Stimulation Treatment in Major Depressive Disorder|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||f||||||||No||2017-10-10 21:58:11.109966|2017-10-10 21:58:11.109966
NCT02843360|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-26|||May 2013||2013-05-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|NHIS||National Health Interview Survey in Taiwan|National Health Interview Survey in Taiwan|Completed||N/A|23296|Actual|National Health Research Institutes, Taiwan|||1||f||||f||||||||No||2017-10-10 21:58:11.197725|2017-10-10 21:58:11.197725
NCT02843347|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-04-03|||March 13, 2017|Actual|2017-03-13|April 2017|2017-04-01|October 2022|Anticipated|2022-10-01|October 2021|Anticipated|2021-10-01|2 Years|Observational [Patient Registry]|||STRIDE Biorepository|1503 BMT CTN STRIDE Biorepository|Recruiting||N/A|200|Anticipated|Emory University|||1||f||||||||||Samples With DNA|"     Blood will be collected, from participants who consent to the optional storage and future     genetic testing of the sample provided.   "|||2017-10-10 21:58:11.25039|2017-10-10 21:58:11.25039
NCT02843334|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-21|||May 2016||2016-05-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|FABRYDIAL||Study of the Prevalence of Fabry Disease in French Dialysis Patients|Study of the Prevalence of Fabry Disease in French Dialysis Patients|Recruiting||N/A|6000|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     blood drops will be collected during a hemodialysis session and deposited on an anonymized     blotting paper. Mutational analysis with sequencing of the whole GLA gene will be done to     confirm the diagnosis of Fabry disease   "|||2017-10-10 21:58:11.43207|2017-10-10 21:58:11.43207
NCT02843321|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-11-21|||August 2012||2012-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CYNTAX||Combined Infusion of Cytotoxic T-Lymphocytes and Vaccination|Combined Infusion of Cytotoxic T-Lymphocytes and Vaccination to Enhance Infection-Specific Immune Reconstitution Post-Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 1|12|Actual|University of Sydney||1|||f||||t||||||||No||2017-10-10 21:58:11.524383|2017-10-10 21:58:11.524383
NCT02843308|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-06-14|||September 2016||2016-09-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|BITS||Enhancing Treatment of Hoarding Disorder With Personalized In-Home Sorting and Decluttering Practice|Building Community-Academic Partnerships for the Evidence-Based Treatment of Hoarding Disorder|Recruiting||N/A|60|Anticipated|Stanford University||3|||f||||f||||||||No||2017-10-10 21:58:11.59948|2017-10-10 21:58:11.59948
NCT02843295|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-08-24|||September 2010||2010-09-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|CATAPULT||Catalytic Antibodies to Predict Uninvasively Late Transplant Failure|Catalytic Antibodies to Predict Uninvasively Late Transplant Failure|Completed||N/A|100|Actual|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 21:58:11.689389|2017-10-10 21:58:11.689389
NCT02843282|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-20|||April 2014||2014-04-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|September 2015|Actual|2015-09-01||Interventional|||Reasoning Training in Individuals With Bipolar Disorder|Brain & Cognitive Changes After Reasoning Training in Individuals With Bipolar Disorder|Active, not recruiting||Phase 1|27|Actual|The University of Texas at Dallas||1|||f||||f||||||||No|Not at this time|2017-10-10 21:58:11.914246|2017-10-10 21:58:11.914246
NCT02843269|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-20|||September 2014||2014-09-01|July 2016|2016-07-01|May 2025|Anticipated|2025-05-01|May 2016|Actual|2016-05-01||Interventional|FRIDOM||Multiple-component Workplace FRamed Intervention to Decrease Occupational Muscle Pain - FRIDOM|Multiple-component Workplace FRamed Intervention to Decrease Occupational Muscle Pain - FRIDOM. Background, Design and Conceptual Model of a Cluster Randomized Double-blinded Controlled Study Among Female Health Care Workers|Active, not recruiting||N/A|219|Anticipated|University of Southern Denmark||3|||f||||t||||||||Undecided||2017-10-10 21:58:12.024533|2017-10-10 21:58:12.024533
NCT02843256|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-07-20|||August 2016||2016-08-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|UEAIVN||Using Exhaled Air to Determine Changes in Nutritional Status of Patients on Intravenous Nutrition|Changes in CO2-13/CO2-12 Delta Value in Exhaled Breath to Examine Changes in Metabolism in Patients Being Fed Intravenous Nutrition|Not yet recruiting||N/A|20|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||||Undecided||2017-10-10 21:58:12.132157|2017-10-10 21:58:12.132157
NCT02843243|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-01-23|||December 2016||2016-12-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Validation of Different Risk Assessment Strategies in Normotensive Pulmonary Embolism|A Prospective, Multicenter Validation of Different Risk Assessment Strategies in Normotensive Patients With Acute Pulmonary Embolism|Recruiting||N/A|500|Anticipated|Azienda Ospedaliera Cosenza|||1||f||||f||||||||Yes||2017-10-10 21:58:12.220796|2017-10-10 21:58:12.220796
NCT02843230|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-08-29|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|||Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI|Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI|Recruiting||N/A|85|Anticipated|Massachusetts General Hospital|||3||f||||t||||||||||2017-10-10 21:58:12.306727|2017-10-10 21:58:12.306727
NCT02843217|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-20|||September 2010||2010-09-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Regional Native American Community Networks Program (RNACNP)|Innovations in Enhancing Colorectal Cancer Screening|Completed||N/A|||Washington State University||1|||f||||f||||||||||2017-10-10 21:58:12.448401|2017-10-10 21:58:12.448401
NCT02843204|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Anti-PD-L1 and NK Immunotherapy for Recurrent Solid Tumors||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:58:12.535518|2017-10-10 21:58:12.535518
NCT02843191|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-01-06|||December 2016||2016-12-01|January 2017|2017-01-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy|KCSP Trial of cONsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After neoadjUvant Concurrent chemoraDiothErapy: A Multicenter, Randomized Controlled Trial (KONCLUDE Trial)|Recruiting||Phase 3|358|Anticipated|Kyung Hee University Hospital at Gangdong||2|||f||||||||||||No||2017-10-10 21:58:12.661845|2017-10-10 21:58:12.661845
NCT02843178|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|CHIVES||Designing Food Voucher Programs to Reduce Disparities in Healthy Diets|Coupons for Healthy Intake Using Variable Economic Strategies (CHIVES)|Active, not recruiting||N/A|359|Actual|Stanford University||4|||f||||t||||||||||2017-10-10 21:58:12.826085|2017-10-10 21:58:12.826085
NCT02843165|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-20|||May 2016||2016-05-01|July 2016|2016-07-01|May 2021|Anticipated|2021-05-01|January 2021|Anticipated|2021-01-01||Interventional|||Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease|Randomized Phase II Study of Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation Therapy in Advanced Metastatic Disease|Recruiting||Phase 2|146|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 21:58:12.932068|2017-10-10 21:58:12.932068
NCT02843152|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2016-07-20|||May 2015||2015-05-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|1 Week|Observational [Patient Registry]|||Association Study Postoperative Cognitive Dysfunction Associated With Inflammation Polymorphism|Risk Factor Analysis of Postoperative Cognitive Dysfunction and Its Association With Inflammation Related Gene Polymorphism|Recruiting||N/A|330|Anticipated|Xuzhou Medical University|||1||f||||f||||||Samples With DNA|"     whole blood   "|Undecided||2017-10-10 21:58:13.05297|2017-10-10 21:58:13.05297
NCT02843139|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-22|||April 2014||2014-04-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Observational|||Circulating microRNAs for Discriminating Obese Preschoolers at Risk of Diabetes|Circulating microRNAs as Novel Prognostic Biomarkers in Obese Preschoolers at Risk for Type 2 Diabetes in Adulthood|Completed||N/A|535|Actual|Nanjing Medical University|||2||f||||f||||||Samples With DNA|"     Whole blood, Serum   "|Undecided||2017-10-10 21:58:13.12944|2017-10-10 21:58:13.12944
NCT02843126|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:58:13.195577|2017-10-10 21:58:13.195577
NCT02843113|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-08-03|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|4yourchild||Stepping Up 4 Your Child|Stepping Up 4 Your Child: The Impact of an Educational Program and Social Case Work Involvement on Single Fathers|Recruiting||N/A|1560|Anticipated|University of Louisville||3|||f||||f||||||||||2017-10-10 21:58:13.298764|2017-10-10 21:58:13.298764
NCT02843100|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-20|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|M-EEN||Diet for Induction and Maintenance of Remission and Re-biosis in Crohn's Disease|Modified Exclusive Enteral Nutrition With the Crohn's Disease Exclusion Diet for Induction and Maintenance of Remission and Re-biosis|Not yet recruiting||N/A|40|Anticipated|Wolfson Medical Center||2|||f||||f|f|f||||||||2017-10-10 21:58:13.406736|2017-10-10 21:58:13.406736
NCT02843087|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-06-02|||April 28, 2017|Actual|2017-04-28|June 2017|2017-06-01|August 2034|Anticipated|2034-08-01|August 2034|Anticipated|2034-08-01||Observational|BEACH||Pediatric Obesity and the Infant Microbiome (BEACH)|The Breastfeeding and Early Child Health (BEACH) Study|Recruiting||N/A|1800|Anticipated|University of Florida|||10||f||||f|f|f||||Samples With DNA|"     Non- invasive biospecimens include stool, saliva, blood, urine, human milk, and vaginal swab.   "|Yes|In accordance with the NIH Data Sharing Policy of award 1U24DK097193, all data generated by Southeast Center for Integrated Metabolomics (SECIM), along with the corresponding metadata, will be deposited into the NIH Metabolomics Data Repository and Coordinating Center (DRCC) as soon as all quality control steps are completed. Data will be embargoed for one year and, after the expiration of the embargo, made visible to the scientific community regardless of publication status for the data.|2017-10-10 21:58:13.52169|2017-10-10 21:58:13.52169
NCT02843074|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-16|||September 21, 2016|Actual|2016-09-21|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|July 2021|Anticipated|2021-07-01||Interventional|||Elotuzumab, Lenalidomide and Dexamethasone (ERd) in the Induction, Consolidation and Maintenance Treatment of Transplant-Eligible, Newly Diagnosed Multiple Myeloma Patients|Phase 2 Study to Assess the Feasibility and Tolerance of the Combination of Elotuzumab, Lenalidomide and Dexamethasone (ERd) in the Induction, Consolidation and Maintenance Treatment of Transplant-Eligible Patients Newly Diagnosed With Multiple Myeloma|Recruiting||Phase 2|53|Anticipated|SCRI Development Innovations, LLC||1|||||||f|t|f||||||||2017-10-10 21:58:13.635026|2017-10-10 21:58:13.635026
NCT02843061|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Rituximab and NK Immunotherapy for B Lymphoma||Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||||||||||||2017-10-10 21:58:13.757104|2017-10-10 21:58:13.757104
NCT02843048|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-20|||April 2016||2016-04-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|BaSEIB||Bariatric Surgery and Exercise Bone Trial|BaSEIB Clinical Trial - Bariatric Surgery and Exercise Intervention Bone Trial|Recruiting||N/A|120|Anticipated|Universidade do Porto||2|||f||||f||||||||No||2017-10-10 21:58:13.860134|2017-10-10 21:58:13.860134
NCT02843035|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-06-07|||January 4, 2017||2017-01-04|June 2017|2017-06-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|LEAP||GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3|A 52-week Two-part, Open-label, Multicenter, Multinational Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3|Recruiting||Phase 2|10|Anticipated|Sanofi||1|||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:58:13.959629|2017-10-10 21:58:13.959629
NCT02843022|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-10-04|||November 2015||2015-11-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effectiveness of a Web-based Nursing Intervention in the Reduction of Postpartum Depression and Parenting Stress.|Enhancing Follow-up Mechanisms for Women at Risk for Postpartum Depression|Active, not recruiting||N/A|683|Actual|Saint Anselm College||3|||f||||f||||||||||2017-10-10 21:58:14.049772|2017-10-10 21:58:14.049772
NCT02843009|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-20|||September 2012||2012-09-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Fish Oil and Adaptations to Resistance Exercise in Older People|Overcoming the Blunted Response to Resistance Exercise With Fish Oil to Maximise Musculoskeletal Properties and Functional Abilities in Older People|Completed||N/A|58|Actual|University of Glasgow||2|||f||||f||||||||||2017-10-10 21:58:14.150171|2017-10-10 21:58:14.150171
NCT02842996|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-07-22|||August 2016||2016-08-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Patient Reported Experience Measures Following Hip Fracture Surgery in the Elderly|A Qualitative Study to Ascertain Patient Reported Experience Measures Following Hip Fracture Surgery in the Elderly|Not yet recruiting||N/A|15|Anticipated|University of Birmingham|||1||f||||f||||||||No||2017-10-10 21:58:14.215774|2017-10-10 21:58:14.215774
NCT02842983|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-22|||December 2014||2014-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock Patients|Pilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock Patients|Recruiting||Phase 2/Phase 3|36|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||No|There is not a plan to share individual participant data.|2017-10-10 21:58:14.27628|2017-10-10 21:58:14.27628
NCT02842970|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-21|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:58:14.354226|2017-10-10 21:58:14.354226
NCT02842385|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-20|||October 2009||2009-10-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Soft Tissue Thickness on Submerged and Non Submerged Implants|The Influence of Soft Tissue Thickness On Crestal Bone Changes Around Submerged and Nonsubmerged Implants: A Randomized Prospective Clinical Study|Completed||N/A|35|Actual|Ege University||4|||f||||f||||||||Undecided||2017-10-10 21:58:21.019356|2017-10-10 21:58:21.019356
NCT02842944|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2016-12-02|||January 2017||2017-01-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|BEACON||Weaning From Mechanical Ventilation Comparison of Open-loop Decision Support System and Routine Care|Weaning From Mechanical Ventilation Comparison of Open-loop Decision Support System and Routine Care|Not yet recruiting||N/A|116|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 21:58:14.464761|2017-10-10 21:58:14.464761
NCT02842931|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-07-20|||February 2015||2015-02-01|July 2016|2016-07-01|February 2023|Anticipated|2023-02-01|February 2020|Anticipated|2020-02-01||Interventional|||R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis|Multicenter, Randomized, Controlled (Comparative), Open, Prospective Study Evaluating an Efficacy of R-DA-EPOCH-21, R-mNHL-BFM-90 and (Auto-SCT)in Patients With DLBCL|Recruiting||Phase 3|300|Anticipated|National Research Center for Hematology, Russia||4|||f||||f||||||||||2017-10-10 21:58:14.543936|2017-10-10 21:58:14.543936
NCT02842918|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of Thoracic Spine Manipulation on Peripheral Neurodynamic Mobility|The Immediate Effects of Thoracic Spine Manipulation Versus a Sham Comparator on the Upper Limb Provocation Test and Seated Slump Test|Completed||N/A|43|Actual|Shenandoah University||2|||f||||f||||||||Yes|Data will be available to analyze; Subject grouping will not be available to participants in attempt to control believability of the sham comparator|2017-10-10 21:58:14.633316|2017-10-10 21:58:14.633316
NCT02842905|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Examining the Impact of Physician Influence on Hearing Aid User Satisfaction and Retention|Examining the Impact of Physician Influence on Hearing Aid User Satisfaction and Retention|Not yet recruiting||N/A|100|Anticipated|University of British Columbia||2|||f||||||||||||Yes|We intend to publish the data once it has been compiled. We estimate that this will be July 2017|2017-10-10 21:58:14.715355|2017-10-10 21:58:14.715355
NCT02842892|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-04-11|||July 2016||2016-07-01|April 2017|2017-04-01||||April 2017|Anticipated|2017-04-01||Interventional|||Implication of Stiffness of the Hamstrings, Achilles Tendon and Calf Muscles for Jumping Performance||Recruiting||N/A|35|Anticipated|Goethe University||3|||f||||||||||||||2017-10-10 21:58:14.821488|2017-10-10 21:58:14.821488
NCT02842879|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-20|||January 2014||2014-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Outpatient Foley Cervix Priming|Outpatient Versus Inpatient Cervix Priming With Foley Catheter|Completed||N/A|120|Actual|Hospital de Santa Maria, Portugal||2|||f||||f||||||||Yes||2017-10-10 21:58:14.891828|2017-10-10 21:58:14.891828
NCT02842866|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-09-29|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older|Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older|Completed||Phase 3|882|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 21:58:14.953223|2017-10-10 21:58:14.953223
NCT02842853|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-06-28|||July 15, 2016|Actual|2016-07-15|June 2017|2017-06-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine|Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults Aged 10 to 55 Years|Completed||Phase 3|3344|Actual|Sanofi||4|||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available the company continue to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 21:58:15.107106|2017-10-10 21:58:15.107106
NCT02842840|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-07-23|||April 2016||2016-04-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effectiveness of Multimodal Educational Intervention to Improve Adherence to Treatment Regimens in Older Stroke Patients|The Effectiveness of Multimodal Educational Intervention to Improve Adherence to Treatment Regimens in Older Stroke Patients: A Randomised Trial|Recruiting||N/A|405|Anticipated|Qazvin University Of Medical Sciences||3|||f||||||||||||||2017-10-10 21:58:17.126884|2017-10-10 21:58:17.126884
NCT02842827|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-21|||October 2016||2016-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||IMG-7289, With and Without ATRA, in Patients With Advanced Myeloid Malignancies|A Multi-Center, Open Label Study to Assess the Safety, Steady-State Pharmacokinetics and Pharmacodynamics of IMG-7289 With and Without ATRA (Tretinoin) in Patients With Advanced Myeloid Malignancies|Recruiting||Phase 1|30|Anticipated|Imago BioSciences,Inc.||3|||f||||t||||||||||2017-10-10 21:58:17.223439|2017-10-10 21:58:17.223439
NCT02842814|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-09-09|||October 2016||2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRESS||Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus|Evaluation and Prediction of Relapse Risk After Glucocorticoid Withdrawal in Patients With Stable Systemic Lupus Erythematosus: An Open-labeled Multi-centric Randomized Controlled Study From China|Recruiting||N/A|350|Anticipated|Peking Union Medical College Hospital||3|||f||||t||||||||||2017-10-10 21:58:17.307272|2017-10-10 21:58:17.307272
NCT02842788|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-20|||April 2016||2016-04-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|APRONET||Prevalence of Prone Positioning Use in ARDS Patients|Prospective Study on the Prevalence on the Use of Prone Positioning in ARDS Patients|Recruiting||N/A|400|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:58:17.498161|2017-10-10 21:58:17.498161
NCT02842775|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-20|||January 2016||2016-01-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Clinical Evaluation and Rehabilitation System for Dynamic Balance Control in Cervical Myelopathy Patients|Clinical Evaluation and Rehabilitation System for Dynamic Balance Control in Cervical Myelopathy Patients|Recruiting||N/A|120|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 21:58:17.620217|2017-10-10 21:58:17.620217
NCT02842762|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-11|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||3D Echocardiographic Assessment of Epicardial Pacing After Cardiopulmonary Bypass.|The Hemodynamic Effect of Transient Epicardial Right Ventricular Pacing After Cardiopulmonary Bypass, Assessed by Real-time Three-dimensional Echocardiography.|Recruiting||N/A|40|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||No||2017-10-10 21:58:17.738634|2017-10-10 21:58:17.738634
NCT02842749|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-30|||March 15, 2016|Actual|2016-03-15|June 2017|2017-06-01|September 5, 2023|Anticipated|2023-09-05|September 5, 2023|Anticipated|2023-09-05||Interventional|||Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China|Phase IV, Open-label, Multi-center, Single-arm Study of the Safety and Efficacy of Everolimus (Afinitor) in Adult Patients With Local Advanced or Metastatic, Well Differentiated Progressive Pancreatic Neuroendocrine Tumors (pNET) in China.|Recruiting||Phase 4|61|Anticipated|Novartis||1|||f||||t|f|f||||||||2017-10-10 21:58:17.855057|2017-10-10 21:58:17.855057
NCT02842736|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-21|2017-03-07|||June 2016||2016-06-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|April 2018|Anticipated|2018-04-01||Interventional|CLARITY||A CLinical Study to Evaluate the Safety And Effectiveness of the CeRene DevIce to Treat HeavY Menstrual Bleeding||Active, not recruiting||N/A|242|Actual|Channel Medsystems||1|||f||||||||||||||2017-10-10 21:58:18.083064|2017-10-10 21:58:18.083064
NCT02842723|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-20|||March 2010||2010-03-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)|Phase II Study on the Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy|Active, not recruiting||Phase 2|33|Actual|Institut Curie||1|||f||||f||||||||No||2017-10-10 21:58:18.22665|2017-10-10 21:58:18.22665
NCT02842710|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-22|||October 2016||2016-10-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|TRAUMASARM||Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma|Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma|Not yet recruiting||Phase 1/Phase 2|500|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 21:58:18.34269|2017-10-10 21:58:18.34269
NCT02842697|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-10-03|||August 2016|Actual|2016-08-01|October 2017|2017-10-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|vHVPG||Virtual Imaging-based Hepatic Venous Pressure Gradient (vHVPG) (CHESS1601)|Virtual Imaging-based Hepatic Venous Pressure Gradient for Assessment of Clinically Significant Portal Hypertension|Completed||N/A|102|Actual|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||||2017-10-10 21:58:18.482307|2017-10-10 21:58:18.482307
NCT02842684|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-22|||October 2016||2016-10-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|ORTHOPLAN||Orthopedic Digital Planning for Total Hip Arthroplasties|Orthopedic Digital Planning for Total Hip Arthroplasties|Not yet recruiting||Phase 1/Phase 2|1000|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 21:58:18.639395|2017-10-10 21:58:18.639395
NCT02842671|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-31|||December 1, 2016|Actual|2016-12-01|August 2017|2017-08-01|April 1, 2019|Anticipated|2019-04-01|March 31, 2018|Anticipated|2018-03-31||Interventional|ASAP||Autism Spectrum Ambassador Program|The Implementation and Evaluation of the Autism Spectrum Ambassador Program|Recruiting||N/A|50|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 21:58:18.732254|2017-10-10 21:58:18.732254
NCT02842658|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-08-31|||April 2016||2016-04-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|EXACCT||Exercise Preconditioning and Breast Cancer Cardiotoxicity|Aerobic Interval Exercise Preconditioning to Prevent Cardiometabolic and Neuropsychological Complications of Anthracycline Based Breast Cancer Chemotherapy|Recruiting||N/A|34|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 21:58:18.877676|2017-10-10 21:58:18.877676
NCT02842645|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2016-08-16|||February 2011||2011-02-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Observational|||Growth-Health and Development in Children Exposed to Drugs During Pregnancy|Growth-Health and Development in Children Exposed to Drugs During Pregnancy.|Completed||N/A|170|Actual|Haukeland University Hospital|||2||f||||t||||||||No||2017-10-10 21:58:18.990571|2017-10-10 21:58:18.990571
NCT02842632|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-09|||April 2016||2016-04-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|TEESimulation||Evaluation of Simulator Training on TEE Performance in Residents|Evaluation of Simulator Training on Transesophageal Echocardiography (TEE) Performance in Anaesthesia Residents|Recruiting||N/A|54|Anticipated|Medical University of Vienna||3|||f||||t||||||||No||2017-10-10 21:58:19.081027|2017-10-10 21:58:19.081027
NCT02842619|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-01-03|||July 2016||2016-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Filling Bone Defects/Voids With Autologous BonoFill-II for Maxillofacial Bone Regeneration|Phase I/II Open Label First in Human Single Center Clinical Study Aimed to Evaluate the Safety and Efficacy of BonoFill-II in Reconstructing Maxillofacial Bone|Recruiting||Phase 1/Phase 2|20|Anticipated|BonusBio Group Ltd||1|||f||||f||||||||No||2017-10-10 21:58:19.180879|2017-10-10 21:58:19.180879
NCT02842606|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-09|||March 2015||2015-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|PROPASTA||Metabolic Response to the Acute Consumption of Fiber-enriched Pasta|Effects of the Consumption of Fiber-enriched Pasta on Glucose and Lipid Metabolism and Satiety|Completed||N/A|13|Actual|Federico II University||2|||f||||f||||||||||2017-10-10 21:58:19.275368|2017-10-10 21:58:19.275368
NCT02842593|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-01-13|||September 2014||2014-09-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Vascular Responses to High vs Low Repetition Resistance Exercise Training in Young Men|Vascular Responses to High vs Low Repetition Resistance Exercise Training in Young Men|Completed||N/A|60|Anticipated|McMaster University||2|||f||||||||||||||2017-10-10 21:58:19.337394|2017-10-10 21:58:19.337394
NCT02842580|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-12-27|||September 2016||2016-09-01|July 2016|2016-07-01|July 2021|Anticipated|2021-07-01|November 2018|Anticipated|2018-11-01||Interventional|HIGH-LIGHT||De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer|Randomized Phase II Study Assessing the Efficacy and Safety of 2 Therapeutic Strategies Combining Bevacizumab With Chemotherapy: De-escalation Versus Escalation in Patients With Non-pretreated Unresectable Metastatic Colorectal Cancer|Recruiting||Phase 2|168|Anticipated|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||Undecided||2017-10-10 21:58:19.413724|2017-10-10 21:58:19.413724
NCT02842567|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-07-14|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Hydroxytyrosol and Vitamin E in Pediatric NASH|Hydroxytyrosol and Vitamin E in the Treatment of Children With Biopsy-proven NASH|Recruiting||Phase 3|80|Anticipated|Bambino Gesù Hospital and Research Institute||2|||f|||||f|f||||||||2017-10-10 21:58:19.542921|2017-10-10 21:58:19.542921
NCT02842554|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-07-22|||August 2013||2013-08-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||"Training Pain Connoisseurs for Efficient Analgesic Proof-of-Concept Studies"|"Training Pain Connoisseurs for Efficient Analgesic Proof-of-Concept Studies"|Completed||Phase 4|98|Actual|Analgesic Solutions||3|||f||||f||||||||||2017-10-10 21:58:19.630152|2017-10-10 21:58:19.630152
NCT02842541|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema|An Open Label, Multi-Center, Safety Study of Intravitreal EBI-031, an Interleukin-6 (IL-6) Inhibitor, Administered as Single and Repeat Injections in Subjects With Diabetic Macular Edema (DME)|Withdrawn||Phase 1|0|Actual|Eleven Biotherapeutics||2||New study planned.|f||||||||||||||2017-10-10 21:58:19.721112|2017-10-10 21:58:19.721112
NCT02842528|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-20|||September 2007||2007-09-01|July 2016|2016-07-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|CoVAD||Cognitive Vulnerability Factors in Alcohol-dependence|Study of Mental Flexibility and Inhibition Processes as Cognitive Vulnerability Markers of Alcohol Dependence|Terminated||N/A|261|Actual|CHU de Reims||3|||f||||||||||||||2017-10-10 21:58:19.782143|2017-10-10 21:58:19.782143
NCT02842515|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-20|||January 2015||2015-01-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|Pulp'R||Feasibility of the Preparation of an Advanced Therapy Medicinal Product for Dental Pulp Regeneration|Study the Feasibility of Preparing an Autologous Advanced Therapy Medicinal Product for the Dental Pulp Regeneration in the Patient With Irreversible Pulp Inflammation or Dental Trauma|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||Samples Without DNA|"     Dental Pulp stem cells   "|||2017-10-10 21:58:19.881356|2017-10-10 21:58:19.881356
NCT02842502|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-22|||September 2014||2014-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|MecaSkin||Clinical Feasibility of an Advanced Therapy Medicinal Product (ATMP) Preparation for Autologous Skin Regeneration in Case of Chronic Leg Ulcers|Clinical Feasibility of an Advanced Therapy Medicinal Product (ATMP) Preparation for Autologous Skin Regeneration in Patients Carriers of Leg Ulcers|Recruiting||N/A|7|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||Yes||2017-10-10 21:58:19.9388|2017-10-10 21:58:19.9388
NCT02842489|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2017-09-17|||June 2016||2016-06-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Left Lateral Tilt-down Position During Colonoscopy Insertion|The Role of Left Lateral Tilt-down Position During Colonoscopy Insertion: a Randomized Controlled Trial|Completed||N/A|258|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-10-10 21:58:20.039458|2017-10-10 21:58:20.039458
NCT02842476|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-22|||June 2016||2016-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Accuracy Validation of the Cadwell Pulse Oximetry System|Accuracy Validation of the Cadwell Pulse Oximetry System|Completed||N/A|11|Actual|Cadwell Industries, Inc.|||3||f||||f||||||Samples With DNA|"     Arterial blood samples were drawn during simultaneous data collection from the test devices.     The blood was immediately analyzed by Reference CO-Oximetry providing functional SaO2 for the     basis of the SpO2 accuracy comparison.   "|No||2017-10-10 21:58:20.2627|2017-10-10 21:58:20.2627
NCT02842450|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-07|||June 30, 2016|Actual|2016-06-30|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|May 31, 2017|Actual|2017-05-31||Observational|PhotoCrohn||Study of Photographs of Interest in Training to Obtain Good Reproducibility of the Diagnosis of Perianal Lesions of Crohn's Disease Inspection in Internal Gastroenterology|Study of Photographs of Interest in Training to Obtain Good Reproducibility of the Diagnosis of Perianal Lesions of Crohn's Disease Inspection in Internal Gastroenterology|Completed||N/A|249|Actual|Groupe Hospitalier Paris Saint Joseph|||2||f||||t||||||||||2017-10-10 21:58:20.476651|2017-10-10 21:58:20.476651
NCT02842437|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Dexmedetomidine on Respiratory Function and Inflammatory Responses in Patient With Sepsis Undergoing Cleaning Focus of Infection|Effects of Dexmedetomidine on Respiratory Function and Inflammatory Responses in Patient With Sepsis Undergoing Cleaning Focus of Infection|Not yet recruiting||N/A|50|Anticipated|General Hospital of Ningxia Medical University||2|||f||||t||||||||No||2017-10-10 21:58:20.562225|2017-10-10 21:58:20.562225
NCT02842424|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-09-22|||October 2015||2015-10-01|September 2017|2017-09-01|March 31, 2020|Anticipated|2020-03-31|March 2020|Anticipated|2020-03-01||Interventional|||Ramipril Treatment of Claudication|Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis|Recruiting||Phase 4|70|Anticipated|University of Nebraska||1|||f||||f||||||||||2017-10-10 21:58:20.687903|2017-10-10 21:58:20.687903
NCT02842411|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2016-10-29|||August 2016||2016-08-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Risk Factors for Inadequate Bowel Preparation in Patients With Chronic Constipation||Recruiting||N/A|200|Anticipated|Fourth Military Medical University|||1||f||||t||||||||Undecided||2017-10-10 21:58:20.821081|2017-10-10 21:58:20.821081
NCT02842372|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-07-20|||December 2015||2015-12-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|||Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease|Non-interventional Study to Investigate Treatment Responses to Topical Application With Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin GvHD|Recruiting||N/A|20|Anticipated|Bitop AG|||1||f||||t||||||||Undecided||2017-10-10 21:58:21.134012|2017-10-10 21:58:21.134012
NCT02842359|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-05-04|||August 23, 2016|Actual|2016-08-23|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension|Efficacy Evaluation of Metabolic, Anti-inflammatory, and Antioxidative Factors of Irbesartan/Atorvastatin Fixed-dose Combination in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension, With Adequately Controlled Blood Glucose Levels|Recruiting||Phase 4|84|Anticipated|Sanofi||3|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:58:21.234263|2017-10-10 21:58:21.234263
NCT02842346|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-21|||November 2015||2015-11-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Correlation Between Umbilical Resistance Index and Fetal Growth|Correlation Between Umbilical Resistance Index and Fetal Growth: a Pilot Study|Completed||N/A|77|Actual|University Tunis El Manar|||1||f||||||||||||||2017-10-10 21:58:21.349956|2017-10-10 21:58:21.349956
NCT02842333|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-07-28|||May 2016||2016-05-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|PAMIR01||Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor|Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:58:21.414228|2017-10-10 21:58:21.414228
NCT02842320|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-20|||October 2015||2015-10-01|July 2016|2016-07-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|CAR-LMC||Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)|Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:58:21.528205|2017-10-10 21:58:21.528205
NCT02842307|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2016-07-20|||January 2010||2010-01-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Acupuncture for Chemical Therapy Induced Nausea and Vomiting|Impact of Acupuncturist Expertise on Clinical Effectiveness for Chemotherapy Induced Nausea and Vomiting in Cancer Patients: a Randomized Controlled Trial|Completed||N/A|102|Actual|Beijing University of Chinese Medicine||4|||f||||f||||||||||2017-10-10 21:58:21.6344|2017-10-10 21:58:21.6344
NCT02842294|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-21|||May 2013||2013-05-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Observational|COBEQOL||Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer|Etude de Cohorte évaluant l'Impact de l'Association chimiothérapie et Bevacizumab en 1ère Ligne du Cancer Colorectal métastatique Sur la qualité de Vie Relative Des Patients. Etude COBEQOL|Recruiting||N/A|320|Anticipated|Centre Hospitalier Universitaire de Besancon|||3||f||||t||||||||||2017-10-10 21:58:21.745504|2017-10-10 21:58:21.745504
NCT02842281|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-01|||September 2014||2014-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Microbiome Fructan Metabolism and Symptoms in Childhood IBS|Intestinal Microbiome Fructan Metabolism and Symptom Generation in Childhood IBS|Recruiting||N/A|80|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 21:58:21.853897|2017-10-10 21:58:21.853897
NCT02842268|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-06-20|||June 17, 2016|Actual|2016-06-17|June 2017|2017-06-01|June 22, 2016|Actual|2016-06-22|June 22, 2016|Actual|2016-06-22||Interventional|||Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating|Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating|Completed||N/A|15|Actual|Bayer||1|||f||||f||||||||||2017-10-10 21:58:21.981063|2017-10-10 21:58:21.981063
NCT02842255|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-20|||October 2015||2015-10-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PATCHSANTESpO2||Calibration of a New Reflectance Oximeter.|Calibration of a New Reflectance Oximeter.|Completed||N/A|10|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:22.057553|2017-10-10 21:58:22.057553
NCT02842242|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-28|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|PIONEER-HCM||A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction|A Phase 2 Open-label Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction|Active, not recruiting||Phase 2|21|Actual|MyoKardia, Inc.||1|||f||||||||||||||2017-10-10 21:58:22.142465|2017-10-10 21:58:22.142465
NCT02842229|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-24|||July 20, 2016|Actual|2016-07-20|July 2017|2017-07-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Observational|||A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms|Retrospective Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms|Completed||N/A|117|Actual|Celgene|||1||f||||f||||||||||2017-10-10 21:58:22.229124|2017-10-10 21:58:22.229124
NCT02842216|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-18|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Retrospective Analysis of Hospital Medical Records on Medication and Supplement Use in Pregnant Women|Retrospective Analysis of Hospital Medical Records on Medication and Supplement Use in Pregnant Women|Completed||N/A|1200|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-10 21:58:22.343966|2017-10-10 21:58:22.343966
NCT02842203|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-01-15|||September 2016||2016-09-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Use of ctDNA for Monitoring of Stage III Colorectal Cancer|Use of ctDNA for Monitoring of Stage III Colorectal Cancer|Recruiting||N/A|150|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     blood samples; formalin-fixed, paraffin-embedded tumor blocks   "|Yes|De-identified individual participant data will be made available according to NIH data sharing policies.|2017-10-10 21:58:22.405176|2017-10-10 21:58:22.405176
NCT02842190|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||NIPPV Versus Bi-level Nasal Continuous Positive Airway Pressure Following Extubation|Nasal Intermittent Positive Pressure Ventilation Versus Bi-level Nasal Continuous Positive Airway Pressure Following Extubation in Infants ≤ 1250 g Birthweight|Not yet recruiting||N/A|140|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-10 21:58:22.477904|2017-10-10 21:58:22.477904
NCT02842177|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-03-26|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of a Novel Technique for Intrauterine Contraceptive Devices Insertion|Classic vs. Uterine Sound-sparing Approach for Insertion of Copper T380A Intrauterine Device|Completed||N/A|92|Actual|Assiut University||2|||f||||f||||||||Yes||2017-10-10 21:58:22.54845|2017-10-10 21:58:22.54845
NCT02842164|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Foley's Catheter Balloon for Induction of Mid Trimester Abortion in Nulliparous Women With or Without Tension Applied||Recruiting||Phase 2|180|Anticipated|Assiut University||2|||f||||f||||||||Yes||2017-10-10 21:58:22.613537|2017-10-10 21:58:22.613537
NCT02842151|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-09-19|||September 21, 2016|Actual|2016-09-21|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Optimizing the Assessment of Refractive Outcomes After Cataract Surgery|Optimizing the Assessment of Refractive Outcomes After Cataract Surgery and Implantation of a Monofocal Intraocular Lens (IOL)|Active, not recruiting||N/A|163|Actual|Alcon Research||1|||f||||f||||||||||2017-10-10 21:58:22.681572|2017-10-10 21:58:22.681572
NCT02842138|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-02-23|||June 2016||2016-06-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma|A Safety and Efficacy Study of Autologous T Cells Engineered to Express Chimeric Antigen Receptor Targeting CD19 in Patients With Relapsed or Refractory B-cell Lymphoma|Recruiting||Phase 1|25|Anticipated|Peking University||1|||f||||t||||||||Yes||2017-10-10 21:58:22.757564|2017-10-10 21:58:22.757564
NCT02842125|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-03-31|||June 2016||2016-06-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Safety and Efficacy of Intra-Arterial Ad-p53 in Liver Metastases of Solid Tumors|Evaluation of Intra-Arterial Ad-p53 Combined With Capecitabine in Patients With Unresectable Liver Metastases of Colorectal Carcinoma and Other Solid Tumors as Well as Primary Hepatocellular Carcinoma (HCC)|Recruiting||Phase 1|24|Anticipated|MultiVir, Inc.||1|||f||||t||||||||No||2017-10-10 21:58:23.032005|2017-10-10 21:58:23.032005
NCT02842112|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-22|||January 2013||2013-01-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Observational|||Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia|Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia|Completed||N/A|123|Actual|Hospices Civils de Lyon|||3||f||||f||||||||||2017-10-10 21:58:23.140565|2017-10-10 21:58:23.140565
NCT02842099|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-21|||January 2014||2014-01-01|July 2016|2016-07-01||||January 2020|Anticipated|2020-01-01||Interventional|||Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer|A Randomized, Phase II Study Comparing Standard Chemotherapy (TA-Taxol+Epirubicin or TAC-Taxol+Epirubicin+Cyclophosphamide) With Standard Chemotherapy (TA or TAC) Followed by Capecitabine (X) as Prolonged Postoperative Adjuvant Treatment for Breast Cancer|Recruiting||Phase 2|500|Anticipated|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 21:58:23.239338|2017-10-10 21:58:23.239338
NCT02842086|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-07-11|||September 2, 2016|Actual|2016-09-02|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|February 2019|Anticipated|2019-02-01||Interventional|DISCOVER||Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection|A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection|Active, not recruiting||Phase 3|5400|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:58:23.344898|2017-10-10 21:58:23.344898
NCT02842073|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-05-07|||September 2016||2016-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Understanding of the Pathophysiology and Psychopharmacology of Binge Drinking|Assessing Changes in the Brain Melanocortin System and Sensory Processing in Response to Alcohol to Advance Our Understanding of the Pathophysiology and Psychopharmacology of Binge Drinking|Recruiting||Phase 2|12|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||Yes||2017-10-10 21:58:23.655195|2017-10-10 21:58:23.655195
NCT02842060|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2017-05-09|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|myDEx||Development of a Tailored HIV Prevention Intervention for Young Men|Development of a Tailored HIV Prevention Intervention for Young Men|Completed||N/A|180|Actual|University of Pennsylvania||2|||f||||f||||||||Yes|The investigators will assure the timely release and sharing of data two years after the publication of the main trial findings from the final dataset. Study variables will be available; however, the investigators will protect the rights and privacy of human subjects by redacting all identifiers from the dataset. The de-identified data from this project will be available through individual requests directed to the Principal Investigator.|2017-10-10 21:58:23.758094|2017-10-10 21:58:23.758094
NCT02842047|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-15|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Mediating Effects of Decentering on Self-Management of Stress and End of Life Planning|Self-Management of Stress in Caregivers of Cancer Patients|Active, not recruiting||N/A|20|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 21:58:23.847936|2017-10-10 21:58:23.847936
NCT02842034|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-07-19|||July 2016||2016-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients.|A Randomized Double-blind Controlled Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia Patients.|Not yet recruiting||N/A|60|Anticipated|Shanghai Mental Health Center||2|||f||||t||||||||||2017-10-10 21:58:23.949174|2017-10-10 21:58:23.949174
NCT02842021|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-10-03|||September 2016||2016-09-01|January 2017|2017-01-01|October 2017|Actual|2017-10-01|October 2017|Actual|2017-10-01||Interventional|||Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis|A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis|Completed||Phase 2|280|Actual|Sol-Gel Technologies, Ltd.||4|||f||||f||||||||||2017-10-10 21:58:24.055317|2017-10-10 21:58:24.055317
NCT02842008|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-08-06|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|July 2016|Actual|2016-07-01||Interventional|||Effects of a Therapeutic Exercise Program for Injuries Prevention in Wheelchair Basketball (WB) Players|Effects of a Therapeutic Exercise Program for Injuries Prevention in Wheelchair Basketball (WB) Players|Recruiting||N/A|36|Anticipated|Universidad Politecnica de Madrid||2|||f||||f||||||||Undecided||2017-10-10 21:58:24.184314|2017-10-10 21:58:24.184314
NCT02841995|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-02-07|||August 2016||2016-08-01|February 2017|2017-02-01||||August 2018|Anticipated|2018-08-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease|A Phase 2a, Dose-Escalation, Open-Label Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease|Recruiting||Phase 2|48|Anticipated|Kadmon Corporation, LLC||3|||f||||f||||||||No||2017-10-10 21:58:24.31168|2017-10-10 21:58:24.31168
NCT02841982|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery||Recruiting||N/A|31|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-10 21:58:24.440573|2017-10-10 21:58:24.440573
NCT02841969|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-13|||February 28, 2017|Actual|2017-02-28|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|NEWfeet||Management of the Diabetic Foot Using Electrolysed Water|Randomised Double Blind Controlled Trial of Neutral Electrolysed Water vs Conventional Management of Non-healing Diabetic Feet (NEWfeet)|Recruiting||N/A|200|Anticipated|NHS Lanarkshire||2|||f||||f|f|f||||||||2017-10-10 21:58:24.560824|2017-10-10 21:58:24.560824
NCT02841956|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-24|||September 2014||2014-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DUP||Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement|Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement|Recruiting||N/A|350|Anticipated|University of California, Davis||4|||f||||f||||||||No||2017-10-10 21:58:24.656149|2017-10-10 21:58:24.656149
NCT02841943|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-03-19|||March 2016||2016-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|FRACAS||Fluid Responsiveness After CArdiac Surgery Study|Fluid Responsiveness After Cardiac Surgery (FRACAS) Study|Completed||N/A|102|Actual|South West Sydney Local Health District|||1||f||||f||||||||No||2017-10-10 21:58:24.753628|2017-10-10 21:58:24.753628
NCT02841930|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-12|||June 2016||2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||ActionHealthNYC Research Study|ActionHealthNYC: A Health Care Access Program for the Uninsured|Active, not recruiting||N/A|2428|Actual|New York City Department of Health and Mental Hygiene||2|||f||||t||||||||||2017-10-10 21:58:24.826388|2017-10-10 21:58:24.826388
NCT02841917|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-05-16|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|ROS||Reactive Oxygen Species Following Aortic Valve Replacement|Oxidative Stress Response in Patients With Severe Aortic Stenosis Undergoing Transcatheter or Surgical Aortic Valve Replacement (ROS Study)|Recruiting||N/A|12|Anticipated|University Hospital Southampton NHS Foundation Trust|||2||f||||f||||||Samples Without DNA|"     Blood samples will be taken for measurement of reactive oxygen species   "|No||2017-10-10 21:58:24.904463|2017-10-10 21:58:24.904463
NCT02841904|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-19|||November 2016||2016-11-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|||The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder Neoplasia|The Accuracy of Probe-based Confocal Laser Endomicroscopy Versus Conventional Endoscopic Biopsies for the Diagnosis of Superficial Bladder Neoplasia.|Not yet recruiting||N/A|189|Anticipated|Herlev Hospital||2|||f||||t||||||||No||2017-10-10 21:58:24.985534|2017-10-10 21:58:24.985534
NCT02841891|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-10-03|||July 2016||2016-07-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys® Surgical Sealant|A Pilot, Prospective, Randomized, Controlled, Multicenter Technical Feasibility Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys® Surgical Sealant|Recruiting||N/A|80|Anticipated|Cohera Medical, Inc.||2|||f||||t||||||||||2017-10-10 21:58:25.071462|2017-10-10 21:58:25.071462
NCT02841878|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-07-19|||September 2016||2016-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PROTIBS||Genetic Determinism of Epithelial Barrier Defects in Irritable Bowel Syndrome|Genetic Determinism of Epithelial Barrier Defects Induced by Increase in Proteases Activity in Irritable Bowel Syndrome|Not yet recruiting||N/A|70|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 21:58:25.189658|2017-10-10 21:58:25.189658
NCT02841865|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-03-28|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|CRIPNET||Evaluation of Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria|Evaluation of Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria|Recruiting||N/A|64|Anticipated|Grupo Espanol de Tumores Neuroendocrinos|||1||f||||f||||||||No||2017-10-10 21:58:25.280209|2017-10-10 21:58:25.280209
NCT02841852|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-25|||January 2014||2014-01-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|IPP SA||Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients?|Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients Over 75 Years Old ?|Completed||N/A|280|Actual|Nantes University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:58:25.38875|2017-10-10 21:58:25.38875
NCT02841839|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-10-04|||June 2016||2016-06-01|October 2017|2017-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate Sampling Methods for Subgingival Plaque|A Pilot Study to Evaluate Sampling Methods for Subgingival Plaque|Completed||N/A|20|Actual|Procter and Gamble||1|||f|||||f|f||||||||2017-10-10 21:58:25.437323|2017-10-10 21:58:25.437323
NCT02841826|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-11-23|||January 2016||2016-01-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation of a Novel and Simplified Technique for Intrauterine Contraceptive Devices Insertion: a Prospective Cohort Study||Completed||Phase 2|90|Actual|Assiut University||2|||f||||f||||||||Yes||2017-10-10 21:58:25.491296|2017-10-10 21:58:25.491296
NCT02841813|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-26|||March 2016||2016-03-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Effects of Genomic and Metabolomic Variations of Choline on Risk of Preterm Birth and Clinical Outcomes in Preterms|Genomic and Metabolomic Differences of Choline on the Risk of Preterm Delivery and Their Effects on Clinical Outcomes in Preterms Receiving Total Parenteral Nutrition Therapy|Recruiting||N/A|400|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||4||f||||||||||Samples With DNA|"     Blood samples   "|||2017-10-10 21:58:25.562242|2017-10-10 21:58:25.562242
NCT02841800|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-02-21|||June 2016||2016-06-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis|Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis|Enrolling by invitation||N/A|20|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:58:25.648448|2017-10-10 21:58:25.648448
NCT02841774|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-21|||November 2016||2016-11-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|HILLCLIMBER||High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV|High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With Human Immunodeficiency Virus (HILLCLIMBER)|Not yet recruiting||Phase 2|30|Anticipated|Northwestern University||2|||f||||t||||||||No||2017-10-10 21:58:25.806979|2017-10-10 21:58:25.806979
NCT02841761|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-07-26|||July 1, 2016||2016-07-01|July 2017|2017-07-01|October 1, 2016|Actual|2016-10-01|September 1, 2016|Actual|2016-09-01||Interventional|||A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male Subjects|A Single-center, Open-label, Two-treatment Study to Investigate the Effect of ACT-132577 at Steady State on the Pharmacokinetics of Midazolam and Its Metabolite 1-hydroxy Midazolam in Healthy Male Subjects|Completed||Phase 1|20|Actual|Actelion||3|||f||||f||||||||||2017-10-10 21:58:25.882247|2017-10-10 21:58:25.882247
NCT02841748|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-21|||May 10, 2017|Actual|2017-05-10|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study|A Randomized, Double-blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence - the PATHWay Study.|Recruiting||Phase 2|100|Anticipated|University of Chicago||2|||f||||f|t|f||||||||2017-10-10 21:58:25.964415|2017-10-10 21:58:25.964415
NCT02841735|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-12-12|||July 2016||2016-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Young Adult Naturalistic Alcohol Study (YANAS) Using Smartphone Technology in a Simulated Laboratory Environment|Young Adult Naturalistic Alcohol Study (YANAS) Using Smartphone Technology in a Simulated Laboratory Environment|Recruiting||Phase 1/Phase 2|129|Anticipated|University of Florida|||3||f||||f||||||||No||2017-10-10 21:58:26.221028|2017-10-10 21:58:26.221028
NCT02841722|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-06-19|||December 3, 2015|Actual|2015-12-03|June 2017|2017-06-01|December 3, 2018|Anticipated|2018-12-03|June 3, 2018|Anticipated|2018-06-03||Interventional|EMEG-E-01||Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin|Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin|Recruiting||N/A|120|Anticipated|Centre Georges Francois Leclerc||1|||f||||f||||||||No||2017-10-10 21:58:26.327774|2017-10-10 21:58:26.327774
NCT02841709|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-13|||November 28, 2016|Actual|2016-11-28|September 2017|2017-09-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Efficacy and Safety of ACT-541468 in Elderly With Insomnia Disorder|Multi-center, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Polysomnography Dose-response Study to Assess the Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder|Completed||Phase 2|50|Actual|Actelion||5|||f||||t||||||||||2017-10-10 21:58:26.413659|2017-10-10 21:58:26.413659
NCT02841696|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-20|||September 2016||2016-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|GLOBAL-HTN||Predictive Factors of Systolic Dysfunction in Non-complicated Hypertensive Patients|Predictive Factors of Systolic Dysfunction in Non-complicated Hypertensive Patients (GLS OBservationAL Study in HyperTensioN - GLOBAL-HTN)|Not yet recruiting||N/A|400|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||No||2017-10-10 21:58:26.532826|2017-10-10 21:58:26.532826
NCT02841683|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-07-21|||January 2017||2017-01-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||"Pragmatic Randomised Controlled Trial Evaluating Effectiveness of a Smoking Cessation e- Intervention  Tabac Info Service "||Not yet recruiting||N/A|3000|Anticipated|Ecole des Hautes Etudes en Santé Publique||2|||f||||||||||||||2017-10-10 21:58:26.631034|2017-10-10 21:58:26.631034
NCT02841670|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-10-03|||August 2016|Actual|2016-08-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|INFOLO||Evaluation of Efficacy and Long-term Safety for the InFo - Instant Focus © Lens / PMCF|Evaluation of Efficacy and Long-term Safety for the InFo - Instant Focus © Lens / PMCF|Active, not recruiting||N/A|30|Actual|SAV-IOL SA|||1||f||||f||||||||||2017-10-10 21:58:26.718801|2017-10-10 21:58:26.718801
NCT02841657|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-04|||January 2016||2016-01-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|Lap3D||3D Laparoscopy Versus 2D Laparoscopy|3D vs 2D Colorectal Resections and Valuation of Visual Load of Surgeons|Recruiting||N/A|350|Anticipated|Casa di Cura Dott. Pederzoli|||1||f||||f||||||||||2017-10-10 21:58:26.789764|2017-10-10 21:58:26.789764
NCT02841644|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-08-09|||April 2015||2015-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|||Operative and Non-operative Treatment of Traumatic Arthrotomies|Operative and Non-operative Treatment of Traumatic Arthrotomies: A Prospective Observational Study|Recruiting||N/A|100|Anticipated|Carolinas Healthcare System|||1||f||||f||||||||||2017-10-10 21:58:26.873359|2017-10-10 21:58:26.873359
NCT02841631|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Observational|||Investigation Into the Infectivity Levels of Human Papilloma Virus (HPV) in Tonsillar Tissue|Investigation Into the Infectivity Levels of Human Papilloma Virus (HPV) in Tonsillar Tissue|Enrolling by invitation||N/A|300|Anticipated|University of Derby|||1||f||||t||||||Samples With DNA|"     Oral rinse and Tonsillectomy specimens   "|Undecided||2017-10-10 21:58:26.97695|2017-10-10 21:58:26.97695
NCT02841618|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-28|||January 2016||2016-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Healthy Cookie Study: Understanding How Healthy Cookies Affect Fat in the Blood,||Active, not recruiting||N/A|123|Actual|Ohio State University||2|||f||||f||||||||||2017-10-10 21:58:27.049087|2017-10-10 21:58:27.049087
NCT02841605|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-21|||October 2016||2016-10-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|ENTEROMA||Enteric Nervous System in Alzheimer Disease|Enteric Nervous System in Alzheimer Disease|Not yet recruiting||N/A|55|Anticipated|Nantes University Hospital||4|||f||||f||||||||No||2017-10-10 21:58:27.125528|2017-10-10 21:58:27.125528
NCT02841592|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-12-23|||July 2016||2016-07-01|December 2016|2016-12-01||||August 2016|Actual|2016-08-01||Interventional|||Non-rebreather at Flush Rate Compared to Bag Valve Mask With Assist||Recruiting||N/A|30|Anticipated|Minneapolis Medical Research Foundation||2|||f||||f||||||||||2017-10-10 21:58:27.204347|2017-10-10 21:58:27.204347
NCT02841579|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-01-03|||August 2016||2016-08-01|January 2017|2017-01-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|AZENT||Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M|A Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of Osimertinib (AZD9291) in First-line Patients With EGFR Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer and Concomitant EGFR T790M Mutation at Time of Diagnosis|Recruiting||Phase 2|73|Anticipated|MedSIR||1|||f||||f||||||||No||2017-10-10 21:58:27.283232|2017-10-10 21:58:27.283232
NCT02841566|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-19|||October 2015||2015-10-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|1 Day|Observational [Patient Registry]|GAMMA||Comparative Study of the Link Between the Practice of Gambling and Money and Materialism Among Problem Gamblers and Non-problem Gamblers|GAMbling and MAterialism|Completed||N/A|144|Actual|Nantes University Hospital|||2||f||||f||||||||||2017-10-10 21:58:27.38629|2017-10-10 21:58:27.38629
NCT02841553|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-10-05|||July 2011||2011-07-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|20 Years|Observational [Patient Registry]|||Wolfram Syndrome International Registry and Clinical Study|Wolfram Syndrome International Registry and Clinical Study|Recruiting||N/A|200|Anticipated|Washington University School of Medicine|||1||f||||f||||||Samples With DNA|"     DNA samples will be used to sequence the WFS1 gene. If no mutations are found in this gene     and the subject's doctor(s) are convinced he has Wolfram Syndrome, investigators may also     offer sequencing of the WFS2 (CISD2) gene or of autosomal dominant hearing loss genes.   "|Yes|Publications and through the NCATS GRDR Program.|2017-10-10 21:58:27.4551|2017-10-10 21:58:27.4551
NCT02841540|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-08-21|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia|An Open-label, Multicenter Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia|Recruiting||Phase 1|110|Anticipated|Eisai Inc.||4|||f||||f||||||||||2017-10-10 21:58:27.54345|2017-10-10 21:58:27.54345
NCT02841527|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-09-11|||April 2012||2012-04-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|December 2019|Anticipated|2019-12-01||Interventional|ByBandSleeve||Gastric Bypass, Gastric Band or Sleeve Gastrectomy to Treat Obesity|Gastric Bypass, Adjustable Gastric Banding or Sleeve Gastrectomy Surgery to Treat Severe and Complex Obesity: a Multi-centre Randomised Controlled Trial|Recruiting||N/A|1341|Anticipated|University of Bristol||3|||f||||t||||||||||2017-10-10 21:58:27.673372|2017-10-10 21:58:27.673372
NCT02841514|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-19|||September 2016||2016-09-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|||The Efficacy and Safety of Tooth Bleaching Procedure Using Y10 Whitening Toothpaste and RF Current||Not yet recruiting||N/A|60|Anticipated|Brighttonix Medical Ltd.||2|||f||||f||||||||||2017-10-10 21:58:27.848239|2017-10-10 21:58:27.848239
NCT02841501|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-01-17|||June 2013||2013-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Genetic Susceptibility Factors for Candidemia.|Genetic Susceptibility Factors Involved in Candidemia: Case-control Study.|Recruiting||N/A|750|Anticipated|University Hospital, Lille|||2||f||||f||||||Samples With DNA|"     20 mL of blood samples are collected at inclusion. 10 mL on EDTA tubes for the genetic     analysis, and 1 mL on dry tube for biomarkers development.      Paxgen tubes will be collected in a sample of patients for a transcriptomic study.   "|No||2017-10-10 21:58:27.920837|2017-10-10 21:58:27.920837
NCT02841358|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-01-12|||December 2013||2013-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|NPCPsy||Screening of Niemann-Pick Disease, Type C in a Psychiatric Population|Study Qbout the Screening of Niemann-Pick Disease, Type C in a Psychiatric Population|Terminated||N/A|22|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:29.15619|2017-10-10 21:58:29.15619
NCT02841488|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-21|||September 2016||2016-09-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|ISCHAEMIC||Ischemic Pain Control With Analgesic Methods Clinical Trial|Comparative Study Between Systemic Analgesia and Continuous Sciatic Nerve Block in Patients With Chronic Obstructive Arterial Disease and Ischemic Pain in Lower Limbs|Not yet recruiting||Phase 3|56|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:58:28.011191|2017-10-10 21:58:28.011191
NCT02841475|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-19|||September 2013||2013-09-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|AVKetcomorbid||Factors Associated to the Instability of the INR (International Normalized Ratio ) in the Prevention of Thromboembolism AVK (Anti Vitamin K) in Atrial Fibrillation in the Elderly: Instead of Comorbidities||Completed||N/A|2164|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:58:28.0941|2017-10-10 21:58:28.0941
NCT02841462|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-07-27|||May 2016||2016-05-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|VMT-001||Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis|Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis With the Ablaflex Device: An Open, Exploratory, 6-month Dose-tolerance and Dose Response Study|Recruiting||N/A|120|Anticipated|Vesalius Medical Technologies||1|||f||||f||||||||No||2017-10-10 21:58:28.149257|2017-10-10 21:58:28.149257
NCT02841449|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-05-08|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The Effect of Hydration Status on Glycemic Control and Appetite Regulation|The Effect of Hydration Status on Glycemic Control and Appetite Regulation|Completed||N/A|16|Actual|University of Bath||2|||f||||f||||||||Yes|Anonymised data will be shared|2017-10-10 21:58:28.239458|2017-10-10 21:58:28.239458
NCT02841436|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-02-21|||November 2012||2012-11-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer|A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer|Active, not recruiting||N/A|40|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||Undecided||2017-10-10 21:58:28.328994|2017-10-10 21:58:28.328994
NCT02841423|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2016-08-04|||February 2013||2013-02-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|POCD ELA||Postoperative Cognitive Dysfunction After Propofol Anesthesia for Noncardiac Surgery|Postoperative Cognitive Dysfunction After Intravenous Anesthesia or Closed-loop Coadministration of Propofol and Remifentanil Guided by Bispectral Index for Noncardiac Surgery : a Randomized Monocenter Study|Recruiting||N/A|204|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-10 21:58:28.393483|2017-10-10 21:58:28.393483
NCT02841410|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-19|||January 2015||2015-01-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|NeuroFood||Neuroeconomic Approach of Food Nutritionnal Assesment|Neural Networks of Decision Making Processes Triggered by Food Labels|Completed||N/A|35|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:58:28.478639|2017-10-10 21:58:28.478639
NCT02840292|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-19|||June 2014||2014-06-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Effect of Maternal Hemoglobin on Neurobehavioural Development of Late Preterm Neonates : A Cohort Study|Effect of Maternal Hemoglobin on Neurobehavioural Development of Late Preterm Neonates : A Cohort Study|Completed||N/A|100|Actual|Lady Hardinge Medical College|||2||f||||t||||||||Undecided||2017-10-10 21:58:28.579423|2017-10-10 21:58:28.579423
NCT02840279|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-01-17|||June 2016||2016-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects|A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Examine the Safety, Tolerability, Pharmacokinetic, and Preliminary Cognitive Profile of BPN14770 in Healthy Young and Elderly Male and Female Subjects|Completed||Phase 1|77|Actual|Tetra Discovery Partners||2|||f||||f||||||||No||2017-10-10 21:58:28.641506|2017-10-10 21:58:28.641506
NCT02840266|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-20|||August 2015||2015-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||The Accuracy of Automated Audiometry Application on Smart Phone to Screen Hearing Loss||Recruiting||N/A|555|Anticipated|Khon Kaen University|||1||f||||||||||||||2017-10-10 21:58:28.714679|2017-10-10 21:58:28.714679
NCT02840253|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-07-14|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Changes in Tissue and Cerebral Oxygenation Following Spinal Anesthesia in Neonates, Infants, and Children||Enrolling by invitation||N/A|50|Anticipated|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-10 21:58:28.779808|2017-10-10 21:58:28.779808
NCT02840240|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-03-14|||January 2016||2016-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores|A Randomized Controlled Trial to Determine the Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores in Patients Having Hip and Knee Arthroplasties With Spinal Anesthesia|Recruiting||N/A|100|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 21:58:28.838145|2017-10-10 21:58:28.838145
NCT02841397|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-27|||March 9, 2017||2017-03-09||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:58:28.918471|2017-10-10 21:58:28.918471
NCT02841384|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-09-29|||July 2016||2016-07-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||McConnell Patellar Taping in Static and Dynamic Postural Control of Women With Patellofemoral Pain Syndrome|McConnell Patellar Taping in Static and Dynamic Postural Control of Women With Patellofemoral Pain Syndrome: Randomized Clinical Trial and Blind|Recruiting||N/A|30|Anticipated|Universidade Estadual de Londrina||2|||f||||t||||||||No||2017-10-10 21:58:28.956968|2017-10-10 21:58:28.956968
NCT02841371|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-01-26|||August 1, 2009|Actual|2009-08-01|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Early Screening and Diagnosis of CKD|Early Screening and Diagnosis of Chronic Kidney Disease|Recruiting||N/A|1000|Anticipated|Nanjing First Hospital, Nanjing Medical University|||2||f||||t||||||||Undecided||2017-10-10 21:58:29.064268|2017-10-10 21:58:29.064268
NCT02841345|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-07-19|||December 2011||2011-12-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|March 2012|Actual|2012-03-01||Interventional|EMOBISCHI||Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic Patients|Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic Patients|Recruiting||N/A|75|Anticipated|University Hospital, Grenoble||3|||f||||t||||||||||2017-10-10 21:58:29.239786|2017-10-10 21:58:29.239786
NCT02841332|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-12-18|||May 2013||2013-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|IMAGLIO||Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma|Multimodal Imaging Analysis of Tissue Changes Occurring During Treatment With Antiangiogenic (Bevacizumab) in Patients With Recurrent Glioblastoma|Terminated||N/A|6|Actual|University Hospital, Toulouse||1||lack of recruitment|f||||f||||||||No||2017-10-10 21:58:29.325713|2017-10-10 21:58:29.325713
NCT02841319|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-21|2016-07-25|||May 2016||2016-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||The Effects of Virtual Reality on Upper Extremity Function in Hemiplegic Cerebral Palsy|The Effects of Virtual Reality Therapy Compared With Home Exercise Program on Upper Extremity Functions in Children With Hemiplegic Cerebral Palsy: a Randomized Controlled Trial|Recruiting||N/A|34|Anticipated|Istanbul University||2|||f||||f||||||||No|We have no permission to share individual participant data.|2017-10-10 21:58:29.435957|2017-10-10 21:58:29.435957
NCT02841306|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2017-05-15|||July 2016||2016-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|UDCA-RD||Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment|Ursodeoxycholic Acid (UDCA) as Adjuvant Treatment for Rhegmatogenous Retinal Detachment: a Phase I Pilot Study|Recruiting||Phase 1|20|Anticipated|University of Lausanne||5|||f||||t||||||||||2017-10-10 21:58:29.517175|2017-10-10 21:58:29.517175
NCT02841293|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-19|||March 2017||2017-03-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|GRECCAR-9||Cost-utility Evaluation of Two Strategies of Perineal Reconstruction After Abdominoperineal Resection for Anorectal Carcinoma|Cost-utility Evaluation of Two Strategies of Perineal Reconstruction After Abdominoperineal Resection for Anorectal Carcinoma: Perineal Filling With Biological Meshes vs. Primary Perineal Wound Closure|Not yet recruiting||N/A|140|Anticipated|University Hospital, Toulouse|||2||f||||f||||||||Undecided||2017-10-10 21:58:29.597663|2017-10-10 21:58:29.597663
NCT02841280|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-08-21|||July 2016||2016-07-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|CLICK||Chlorthalidone in Chronic Kidney Disease||Recruiting||Phase 2|160|Anticipated|Indiana University||2|||f||||t|t|f|||f|||||2017-10-10 21:58:29.723415|2017-10-10 21:58:29.723415
NCT02841267|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-22|||July 2016||2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||A Trial of PF-06252616 in Ambulatory Participants With LGMD2I|A Phase 1b/2, Open-Label, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Ambulatory Participants With LGMD2I|Active, not recruiting||Phase 1/Phase 2|19|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||3|||f||||f||||||||||2017-10-10 21:58:29.914587|2017-10-10 21:58:29.914587
NCT02841254|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-08-09|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|MEDWATCH||Diagnostic Performance of Clinical Signs Patients Suspected of Meningitis to Emergencies|Diagnostic Performance of Clinical Signs Patients Suspected of Meningitis to Emergencies. Prospective and Multicentric Study|Completed||N/A|579|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 21:58:30.016944|2017-10-10 21:58:30.016944
NCT02841241|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-06-19|||April 2016||2016-04-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|ECASSS-R||Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia|Esmolol to Control Adrenergic Storm in Septic Shock - Roll-in|Active, not recruiting||Phase 2|10|Anticipated|Intermountain Health Care, Inc.||1|||f||||t||||||||No||2017-10-10 21:58:30.120784|2017-10-10 21:58:30.120784
NCT02841228|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-19|||November 2015||2015-11-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer|Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) Dose Escalation to the Gross Tumor Volume (GTV) With Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|40|Anticipated|Hunan Province Tumor Hospital||1|||f||||f||||||||||2017-10-10 21:58:30.221533|2017-10-10 21:58:30.221533
NCT02841215|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-12-07|||March 2017||2017-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|GALECRUSTED||Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies|A Randomized Controlled Double-blind Trial Assessing the Efficacy of a 400 ug/kg Ivermectin Regime in Patients With Crusted Scabies as Compared to a 200 ug/kg|Not yet recruiting||Phase 3|130|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-10 21:58:30.307338|2017-10-10 21:58:30.307338
NCT02841202|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-16|||January 2014||2014-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Oral Contraceptive Pills On Eyes|The Effect of Oral Contraceptive Pills On Macula, Retinal Nerve Fiber Layer and Choroid Thickness|Completed||Phase 4|40|Actual|Kayseri Education and Research Hospital||2|||f||||||||||||||2017-10-10 21:58:30.433849|2017-10-10 21:58:30.433849
NCT02841189|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-03-10|||December 2014||2014-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||King Vision Video Laryngoscope Ambu (aBlade) System for Use in Children|King Vision Video Laryngoscope aBlade System for Use in Children|Enrolling by invitation||N/A|100|Anticipated|Indiana University||1|||f||||||||||||||2017-10-10 21:58:30.519244|2017-10-10 21:58:30.519244
NCT02841176|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-08-30|||July 2016||2016-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|Go-Thermal||Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis|A Pilot Study to Evaluate the Utility of Thermography in Assessing Response to Golimumab Treatment in Psoriatic Arthritis|Recruiting||N/A|10|Anticipated|Imperial College Healthcare NHS Trust||1|||f||||f||||||||Yes|De-identified data will be made available within 1 year of the end of the study|2017-10-10 21:58:30.601546|2017-10-10 21:58:30.601546
NCT02841163|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-24|||April 2016|Actual|2016-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Observational|||Disc Resorption in Lumbar and Cervical Disc Herniation Patients Receiving Integrative Korean Medicine Treatment|Evaluation of Disc Resorption in Lumbar and Cervical Intervertebral Disc Herniation Patients Receiving Integrative Korean Medicine Treatment|Completed||N/A|505|Actual|Jaseng Medical Foundation|||1||f||||f||||||||No||2017-10-10 21:58:30.700459|2017-10-10 21:58:30.700459
NCT02841150|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-12-02|||June 2016||2016-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules|A Single-Dose, Open-Label, Randomized, Replicate Crossover Study in Healthy Adult Subjects to Assess the Bioequivalence of an Ibrutinib 560-mg Tablet Compared to the Four IMBRUVICA 140 mg Capsules|Completed||Phase 1|102|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 21:58:30.820965|2017-10-10 21:58:30.820965
NCT02841137|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-18|||June 2016||2016-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2, 2017|Actual|2017-08-02||Interventional|||Efficacy Study of Progesterone Tablet in Post-menopausal Women|Effect of Progesterone 5, 10, and 20 mg Tablets Compared To Progesterone 100 mg Capsules on the Endometrial Thickness of Post-Menopausal Women Under Hormone Therapy - A Prospective, Open-Label, Randomized, Four-Arm, Parallel-Group, Phase II Clinical Trial|Active, not recruiting||Phase 2|80|Actual|IBSA Institut Biochimique SA||4|||f||||f||||||||||2017-10-10 21:58:30.919402|2017-10-10 21:58:30.919402
NCT02841124|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-26|||January 2011||2011-01-01|July 2016|2016-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|WHATELSE||Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies.|Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies : Physicians and Patients Points of View and Interactions.|Completed||N/A|21|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 21:58:31.005726|2017-10-10 21:58:31.005726
NCT02841111|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-19|||January 2002||2002-01-01|July 2016|2016-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|ORBIT||Old Red Blood Cell In Renal Transplantation|Impact of Early Transfusions of Packed Red Cells on the Evolution of Renal Transplantation|Completed||N/A|12000|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 21:58:31.093296|2017-10-10 21:58:31.093296
NCT02841098|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-09-27|||September 2016||2016-09-01|July 2016|2016-07-01|December 2022|Anticipated|2022-12-01|September 2022|Anticipated|2022-09-01||Interventional|ACTRIS||" Endarterectomy Combined With Optimal Medical Therapy (OMT) vs OMT Alone in Patients With Asymptomatic Severe Atherosclerotic Carotid Artery Stenosis at Higher-than-average Risk of Ipsilateral Stroke "|" Endarterectomy Combined With Optimal Medical Therapy Versus Optimal Medical Therapy Alone in Patients With Asymptomatic Severe Atherosclerotic Carotid Artery Stenosis at Higher-than-average Risk of Ipsilateral Stroke "|Not yet recruiting||Phase 3|700|Anticipated|Centre Hospitalier St Anne||2|||f||||f||||||||Undecided||2017-10-10 21:58:31.183387|2017-10-10 21:58:31.183387
NCT02841085|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-05-17|||May 2010||2010-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|Fit-Génétique||"New Genetic Mutations in Thromboembolic Venous Disease Idiopathic. Study FIT GENETIQUE."|"Search for New Mutations Genetic Predisposing to an Increased Risk Venous Thromboembolic Disease Idiopathic. Study FIT GENETIQUE."|Recruiting||N/A|450|Anticipated|University Hospital, Brest|||1||f||||t||||||Samples With DNA|"     Blood or saliva sample   "|||2017-10-10 21:58:31.37015|2017-10-10 21:58:31.37015
NCT02841072|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-20|||May 2015||2015-05-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Chart Review Study of Medical Abortion|Chart Review Study of Medical Abortion at 64-70 Days of Gestation|Completed||N/A|579|Actual|Gynuity Health Projects|||1||f||||f||||||||||2017-10-10 21:58:31.440836|2017-10-10 21:58:31.440836
NCT02841059|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-02-22|||May 2015||2015-05-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01|2 Years|Observational [Patient Registry]|HYS-PF-QOL||The Pelvic Floor Function and Sexual Life of the Women After Different Type of Hysterectomy|The Association of Total Hysterectomy and Disorders of Female Pelvic Floor or Sexual Function: a Survey on Pelvic Floor Function and Sexual Life for Women After Different Type of Hysterectomy|Enrolling by invitation||N/A|120|Anticipated|Buddhist Tzu Chi General Hospital|||3||f||||f||||||||Undecided||2017-10-10 21:58:31.498321|2017-10-10 21:58:31.498321
NCT02841046|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-12-13|||July 2016||2016-07-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||The Effect of Goal-directed Therapy Guided by Stroke Volume Variation and Cardiac Index in Non-severe Surgical Patients|The Application of Goal-directed Therapy With the Combination of Stroke Volume Variation and Cardiac Index as the Primary Judgment in Non-severe Patients Underwent Gastrointestinal Tumor Surgery|Active, not recruiting||N/A|50|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||Undecided|It should be discuss.|2017-10-10 21:58:31.597134|2017-10-10 21:58:31.597134
NCT02841033|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-03-28|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Daratumumab for the Treatment of Patients With AL Amyloidosis|A Phase I-II Trial of Daratumumab for the Treatment of Patients With AL Amyloidosis|Recruiting||Phase 1/Phase 2|25|Anticipated|Boston Medical Center||1|||f||||t|t|f|||f|||No||2017-10-10 21:58:31.693678|2017-10-10 21:58:31.693678
NCT02841020|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Pre-treatment Biopsy for Non-neoplastic Renal Disease vs no Biopsy on Estimated Glomerular Filtration Rate in Patients With Small Renal Mass: a Single-center, Single-blinded, Randomized, Parallel Group Clinical Trial||Enrolling by invitation||N/A|100|Anticipated|University of Virginia||2|||f||||||||||||||2017-10-10 21:58:31.783376|2017-10-10 21:58:31.783376
NCT02841007|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-04-12|||July 2016||2016-07-01|July 2016|2016-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Midds Ankle Fracture|gekoTM Neuromuscular Electrostimulation (NMES) Device, Pilot Feasibility Study Looking at Time to Surgery Study in Patients Requiring Ankle Fixation Following Fracture, Comparison to Matched Retrospective Controls|Completed||N/A|20|Actual|Firstkind Ltd||1|||f||||f||||||||No||2017-10-10 21:58:31.845232|2017-10-10 21:58:31.845232
NCT02840786|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-19|||January 2016||2016-01-01|April 2016|2016-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Study of Stent Versus Direct Atherectomy to Treat Arteriosclerosis Occlusive Disease of Lower Extremity|Occlusive Disease of Lower Extremity|Recruiting||N/A|120|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t||||||||Undecided||2017-10-10 21:58:33.24541|2017-10-10 21:58:33.24541
NCT02840994|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-09-21|||December 2016||2016-12-01|September 2017|2017-09-01||||December 2020|Anticipated|2020-12-01||Interventional|||A Trial of CV301 in Combination With Anti-PD-1 Therapy Versus Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer|A Phase 1/2 Trial of CV301 in Combination With Anti-PD-1 Therapy Versus Anti-PD-1 Therapy Alone in Subjects With Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|200|Anticipated|Bavarian Nordic, Inc.||2|||f||||f||||||||||2017-10-10 21:58:31.90615|2017-10-10 21:58:31.90615
NCT02840981|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-20|||December 2013||2013-12-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Subjects|Obese Patients Adhering to Mediterranean Diet Show Less Reduced Circulating Levels of Sirtuin 4|Completed||N/A|43|Actual|Federico II University|||1||f||||f||||||||||2017-10-10 21:58:31.997907|2017-10-10 21:58:31.997907
NCT02840968|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-20|||January 2010||2010-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|||Adherence to Mediterranean Diet and Phase Angle|Influence of Mediterranean Diet on Phase Angle in a Sample of Adult Population: Results of a Pilot Study|Completed||N/A|1464|Actual|Federico II University|||1||f||||f||||||||||2017-10-10 21:58:32.044729|2017-10-10 21:58:32.044729
NCT02840955|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-19|||June 2016||2016-06-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic Dermatitis|The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic Dermatitis|Recruiting||N/A|100|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-10-10 21:58:32.088135|2017-10-10 21:58:32.088135
NCT02840942|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-08-11|||September 2016||2016-09-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Robots to Reduce Pain During IV Placement|Socially Assistive Robots to Reduce Children's Pain During Peripheral IV Placement|Not yet recruiting||N/A|100|Anticipated|Children's Hospital Los Angeles||3|||f||||f||||||||Undecided||2017-10-10 21:58:32.180943|2017-10-10 21:58:32.180943
NCT02840929|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-23|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents|Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents|Recruiting||N/A|214|Anticipated|The University of Hong Kong||2|||f||||f||||||||No||2017-10-10 21:58:32.266655|2017-10-10 21:58:32.266655
NCT02840916|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-11-20|2016-07-23||January 2014||2014-01-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Laser Acupuncture for Postpartum Weight Retention|Laser Acupuncture Therapy in Patients With Postpartum Weight Retention: A Randomized Controlled Trial|Completed||Phase 3|66|Actual|Chang Gung Memorial Hospital|The postpartum weight trend cannot be assessed. The average duration of admission in our postpartum care center was 18.6 days. Some confounders should also be considered. The lack of follow-up for BFP and WBR after 1 and 3 months may be limitations.|2|||f||||f||||||||Undecided||2017-10-10 21:58:32.359605|2017-10-10 21:58:32.359605
NCT02840903|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-08-08|||July 26, 2016|Actual|2016-07-26|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|July 28, 2017|Actual|2017-07-28||Observational|RIGHT||A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting|A Study of the Image Quality in Coronary or Craniocervical CT Angiography With Different Iodine Delivery Rates Using Low Tube Voltage (80 or 100 kV) Imaging in MDCT|Active, not recruiting||N/A|1214|Actual|Bayer|||8||f||||t||||||||||2017-10-10 21:58:32.608809|2017-10-10 21:58:32.608809
NCT02840890|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-06-20|||November 2015|Actual|2015-11-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|PREDIGOSTEO||Osteopathy and Prevention of Gastrointestinal Side Effects in Women Treated for Breast Cancer|Osteopathy and Prevention of Gastrointestinal Side Effects of the Adjuvant Treatment FEC in Women Treated in Day Hospital for Breast Cancer|Recruiting||N/A|94|Anticipated|Centre Georges Francois Leclerc||2|||f||||f||||||||No||2017-10-10 21:58:32.726599|2017-10-10 21:58:32.726599
NCT02840877|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-06-01|||May 16, 2017|Actual|2017-05-16|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|October 2020|Anticipated|2020-10-01||Interventional|||The Impact of Alcohol Consumption on Tuberculosis Treatment Outcomes|The Impact of Alcohol Consumption on Tuberculosis Treatment Outcomes|Recruiting||N/A|438|Anticipated|Boston Medical Center||1|||f||||f|f|f||||||No||2017-10-10 21:58:32.792209|2017-10-10 21:58:32.792209
NCT02840864|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparison of Conventional With Sonography Assisted Breast Surgery|Comparison of Sonographically Assisted With Conventionally Breast Surgery - Prospective, Randomised, Multicenter, Parallel Group Study With Two Study Arms|Recruiting||N/A|374|Anticipated|University Women's Hospital Tübingen||2|||f||||f||||||||||2017-10-10 21:58:32.865461|2017-10-10 21:58:32.865461
NCT02840851|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-12-16|||August 2016||2016-08-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Brain Blood Flow: Age and Gender|Brain Blood Flow Response to Hypercapnia in Healthy Adults: The Effect of Age and Sex|Recruiting||N/A|48|Anticipated|University of Wisconsin, Madison|||4||f||||f||||||||No||2017-10-10 21:58:32.926437|2017-10-10 21:58:32.926437
NCT02840825|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-08-08|||March 8, 2016|Actual|2016-03-08|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Observational|VIRUMILK||Biochip for HCMV Detection in Breast Milk|Biochip for HCMV Detection in Breast Milk From Lactating Women of Preterm Infants Less Than 33 Weeks|Recruiting||N/A|33|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||Samples Without DNA|"     breastmilk   "|||2017-10-10 21:58:33.021565|2017-10-10 21:58:33.021565
NCT02840812|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-11-06|||September 2016||2016-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function||Not yet recruiting||Phase 1|24|Anticipated|Zhejiang Medicine Co., Ltd.||2|||f||||||||||||Yes||2017-10-10 21:58:33.076953|2017-10-10 21:58:33.076953
NCT02840799|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-06-08|||August 2016||2016-08-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)|Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)|Recruiting||Phase 2|76|Anticipated|University of Pennsylvania||2|||f||||t||||||||No||2017-10-10 21:58:33.150141|2017-10-10 21:58:33.150141
NCT02840773|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-07-20|||February 2010||2010-02-01|July 2016|2016-07-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||OPG-RANKL Levels Around Short Implants|Impact of Implant-abutment Connection on Osteoimmunological Parameters in Short Implants: a Randomised Controlled Clinical Trial|Completed||N/A|15|Actual|Adnan Menderes University||4|||f||||f||||||||Yes||2017-10-10 21:58:33.331734|2017-10-10 21:58:33.331734
NCT02840760|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-06-11|||September 2016||2016-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.|Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.|Recruiting||N/A|60|Anticipated|Shanghai Mental Health Center||2|||f||||t||||||||No||2017-10-10 21:58:35.201357|2017-10-10 21:58:35.201357
NCT02840747|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-02-06|||July 2016||2016-07-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Observational|||Tissue Repository: CTCL Collection Protocol|A Tissue Repository for the Collection of Samples From Patients With Cutaneous T Cell Lymphoma and Healthy Volunteers|Recruiting||N/A|400|Anticipated|Columbia University|||3||f||||f|f|f||||Samples With DNA|"     Skin biopsies, swabs (skin, cheek epithelium, nasal), samples of blood, fecal and urine.   "|Undecided||2017-10-10 21:58:35.276205|2017-10-10 21:58:35.276205
NCT02840734|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-07-18|||March 2015||2015-03-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Kinesio Taping on Performance|Kinesio Taping and Muscular Function in Obese Adults|Completed||N/A|13|Actual|Texas A&M University San Antonio||3|||f||||f||||||||Undecided||2017-10-10 21:58:35.375695|2017-10-10 21:58:35.375695
NCT02840721|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-10-02|||October 26, 2016|Actual|2016-10-26|October 2017|2017-10-01|November 27, 2018|Anticipated|2018-11-27|September 4, 2018|Anticipated|2018-09-04||Interventional|||Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.|A Phase 2a, Multicenter, Single Arm, Open Label, Two Stage, Study To Evaluate The Efficacy, Safety, Tolerability And Pharmacokinetics Of Pf 06480605 In Subjects With Moderate To Severe Ulcerative Colitis|Recruiting||Phase 2|40|Anticipated|Pfizer||1|||f||||f|t|f||||||||2017-10-10 21:58:35.480041|2017-10-10 21:58:35.480041
NCT02840708|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-12-27|||May 2016||2016-05-01|December 2016|2016-12-01||||December 2016|Actual|2016-12-01||Interventional|||SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study|SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study|Completed||Phase 1|14|Actual|Niigata University Medical & Dental Hospital||3|||f||||||||||||||2017-10-10 21:58:35.667794|2017-10-10 21:58:35.667794
NCT02840695|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-18|||January 2005||2005-01-01|July 2016|2016-07-01||||December 2015|Actual|2015-12-01|10 Years|Observational [Patient Registry]|||Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)|Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)|Active, not recruiting||N/A|9858|Actual|Uppsala University|||1||f||||f||||||||No||2017-10-10 21:58:35.743658|2017-10-10 21:58:35.743658
NCT02840682|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-10-05|||April 2016|Actual|2016-04-01|October 2017|2017-10-01|August 15, 2016|Actual|2016-08-15|August 15, 2016|Actual|2016-08-15||Observational|||Outcomes of Neonatal Resuscitation|Outcomes of Neonatal Resuscitation in a Resource Limited Setting on the Thailand-Myanmar Border|Completed||N/A|15073|Actual|University of Oxford|||1||f||||f||||||||||2017-10-10 21:58:35.812267|2017-10-10 21:58:35.812267
NCT02840669|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-07-07|||July 2016||2016-07-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)|A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)|Active, not recruiting||N/A|40|Anticipated|Adverum Biotechnologies, Inc.||2|||f||||||||||||||2017-10-10 21:58:36.011465|2017-10-10 21:58:36.011465
NCT02840656|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-05-22|||September 2016||2016-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|OroColi-HS||Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization|Comparative Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization of Healthy Adults Subjects|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||Undecided||2017-10-10 21:58:36.108601|2017-10-10 21:58:36.108601
NCT02840643|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-05-04|||July 2011||2011-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Combined Constraint Therapy and Bimanual Therapy for Children With Unilateral Brain Injury|Combined Constraint Therapy and Bimanual Therapy for Children With Unilateral Brain Injury|Recruiting||Phase 1/Phase 2|75|Anticipated|Blythedale Children's Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:58:36.201143|2017-10-10 21:58:36.201143
NCT02840630|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-07-18|||September 2016||2016-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FISHMEAL||Effect of FISH Intake on MEtabolic Health in a Diabetic South Asian popuLation (FISH MEAL)|Effect of FISH Intake on MEtabolic Health in a Diabetic South Asian popuLation (FISH MEAL)|Not yet recruiting||N/A|330|Anticipated|University of Aberdeen||3|||f||||f||||||||No||2017-10-10 21:58:36.304853|2017-10-10 21:58:36.304853
NCT02840617|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-18|||March 2016||2016-03-01|July 2016|2016-07-01||||December 2018|Anticipated|2018-12-01||Interventional|||ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes|A Pilot and Feasibility Study of Indocyanine Green-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes|Recruiting||Phase 1|50|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||1|||f||||||||||||Undecided||2017-10-10 21:58:36.396466|2017-10-10 21:58:36.396466
NCT02840604|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-06-20|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|EXOMA||What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors|What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors|Recruiting||N/A|528|Anticipated|Centre Georges Francois Leclerc|||1||f||||f||||||||||2017-10-10 21:58:36.499845|2017-10-10 21:58:36.499845
NCT02840591|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01||||June 2017|Anticipated|2017-06-01||Interventional|||Ramelteon and Citicoline for Delirium|A Feasibility Study of Ramelteon and Citicoline for Delirium in a General Inpatient Hospital Population|Not yet recruiting||Phase 4|160|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 21:58:36.576979|2017-10-10 21:58:36.576979
NCT02840578|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-18|||May 2016||2016-05-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|||NK Cell Activity in Smokers Screened for Lung Cancer|Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Lung Cancer|Recruiting||N/A|100|Anticipated|University of Southern California|||1||f||||f||||||Samples Without DNA|"     Blood sample (1 ml) will be collected following a set of established Standard Operating     Procedures (SOPs). Blood samples will be incubated for 20 hours after initial draw then     centrifuged. Serum will then be frozen and stored at USC until they are sent to Cynvenio's     CLIA and CAP certified laboratory in Thousand Oaks, CA for ELISA processing. All serum     samples will be picked up by a Cynvenio representative who will personally deliver the     specimens to the Cynvenio Labs.   "|Undecided||2017-10-10 21:58:36.680284|2017-10-10 21:58:36.680284
NCT02840565|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-20|||September 2007||2007-09-01|July 2016|2016-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453|A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453 in Healthy Male Volunteers|Completed||Phase 1|57|Actual|Bial - Portela C S.A.||6|||f||||f||||||||Undecided||2017-10-10 21:58:36.757264|2017-10-10 21:58:36.757264
NCT02840552|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-12-30|||September 2016||2016-09-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer||Enrolling by invitation||Phase 3|1500|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||1|||f||||f||||||||||2017-10-10 21:58:36.832089|2017-10-10 21:58:36.832089
NCT02840539|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-11-01|||October 2016||2016-10-01|November 2016|2016-11-01|June 2025|Anticipated|2025-06-01|February 2020|Anticipated|2020-02-01||Interventional|BATMAN||Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma|A Phase 2 Trial to Evaluate the Efficacy of Bortezomib, Cytarabine, and Dexamethasone in Patients With Relapsed or Refractory Mantle Cell Lymphoma|Recruiting||Phase 2|32|Anticipated|Seoul National University Hospital||1|||f||||t||||||||Yes|Demographics, baseline characteristics, response, survival data|2017-10-10 21:58:36.907243|2017-10-10 21:58:36.907243
NCT02840526|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-07-18|||May 2013||2013-05-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Thoracic Paravertebral Block in Pain Management After Renal Surgery|Thoracic Paravertebral Block in Postoperative Pain Management After Renal Surgery|Completed||N/A|58|Actual|Silesian University of Medicine||2|||f||||f||||||||No||2017-10-10 21:58:37.005632|2017-10-10 21:58:37.005632
NCT02840513|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-30|||November 2016||2016-11-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|SMART-CO||Smartphone App and CO Self-monitoring for Smoking Cessation|Support by Smartphone App and Carbon Monoxide Self-monitoring for Smoking Cessation: a Randomised Controlled Trial Nested Into the Swiss HIV Cohort Study|Not yet recruiting||Phase 4|510|Anticipated|Basel Institute for Clinical Epidemiology and Biostatistics||2|||f||||f||||||||No||2017-10-10 21:58:37.106793|2017-10-10 21:58:37.106793
NCT02840487|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-10-05|||July 11, 2016||2016-07-11|July 27, 2017|2017-07-27|December 28, 2018|Anticipated|2018-12-28|December 29, 2017|Anticipated|2017-12-29||Interventional|||Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults|VRC 319: A Phase I/Ib, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of A Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults|Active, not recruiting||Phase 1|39|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 21:58:37.282286|2017-10-10 21:58:37.282286
NCT02840474|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-07-13|||July 11, 2016||2016-07-11|July 12, 2017|2017-07-12|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Safety and Virologic Effect of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously to HIV-Infected Adults|VRC 607: A Phase 1, Single Dose Study of the Safety and Virologic Effect of a Human MonoclonalAntibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously to HIV-Infected Adults.|Recruiting||Phase 1|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 21:58:37.392641|2017-10-10 21:58:37.392641
NCT02840461|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-06-26|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Clinical Endpoint Study of Ivermectin 1% Cream|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Ivermectin Cream 1% (Actavis Laboratories UT, Inc.) to SoolantraTM (Ivermectin) Cream 1% (Galderma) in the Treatment of Moderate to Severe Papulopustular Rosacea|Completed||Phase 3|635|Actual|Actavis Inc.||3|||f||||f||||||||No||2017-10-10 21:58:37.484406|2017-10-10 21:58:37.484406
NCT02840448|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-10-03|||July 7, 2016||2016-07-07|October 2, 2017|2017-10-02|March 16, 2021|Anticipated|2021-03-16|March 16, 2021|Anticipated|2021-03-16||Observational|||Impact of Elastin Mediated Vascular Stiffness on End Organs|Impact of Elastin Mediated Vascular Stiffness on End Organs|Recruiting||N/A|110|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:58:37.561813|2017-10-10 21:58:37.561813
NCT02840435|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-05-11|||September 2016||2016-09-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Study on Sit to Quit Phone Intervention|Pilot Study on Mindfulness Training for Smokers Via Web-based Video and Telephone Counseling|Enrolling by invitation||N/A|60|Anticipated|Duke University||2|||f||||f||||||||No||2017-10-10 21:58:37.746477|2017-10-10 21:58:37.746477
NCT02840422|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-19|||January 2016||2016-01-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Observational|ART-QUALIVIE||Assessment of Patients Quality of Life Treated With Three ARTHRUM H 2% Joint Injections|Assessment of Patients Quality of Life Suffering From Knee Osteoarthritis Treated With Three Intra-articular Injections of ARTHRUM H 2% Over a Period of Six Months|Active, not recruiting||N/A|126|Anticipated|LCA Pharmaceutical|||1||f||||f||||||||No||2017-10-10 21:58:37.865821|2017-10-10 21:58:37.865821
NCT02840409|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|August 2026|Anticipated|2026-08-01|August 2026|Anticipated|2026-08-01||Interventional|||Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)|A Phase II, Open-Labeled, Multi-Center, Randomized Controlled Trial of Vinblastine +/- Bevacizumab for the Treatment of Chemotherapy-Naïve Children With Unresectable or Progressive Low Grade Glioma (LGG)|Recruiting||Phase 2|75|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-10 21:58:37.948224|2017-10-10 21:58:37.948224
NCT02840396|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-05-01|||March 2016||2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of rTMS of the Dorsolateral Prefrontal Cortex on Language Production in Healthy Participants|Role of Executive Function in Language: an Experimental and Clinical Approach With Application to Mother Language and Second Language|Recruiting||N/A|26|Anticipated|University of Fribourg||2|||f||||f||||||||No||2017-10-10 21:58:38.065657|2017-10-10 21:58:38.065657
NCT02840383|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-04-19|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|TRUST||Trial of a Health Promoting School Approach to Positive Youth Development and Wellness Promotion|Participatory Trial of a Health Promoting School Approach to Positive Youth Development and Wellness Promotion|Not yet recruiting||N/A|1900|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||Undecided||2017-10-10 21:58:38.175485|2017-10-10 21:58:38.175485
NCT02840370|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-07-20|||May 2016||2016-05-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Stimulation of the Prefrontal Cortex on Language Production in Aphasic Patients|Effect of Transcranial Direct Current Stimulation of the Prefrontal Cortex on Language Production in Aphasic Patients: a Multicentre Experimental Study With a Placebo-controlled and Double Blind Crossover Design|Recruiting||N/A|30|Anticipated|University of Fribourg||2|||f||||f||||||||No||2017-10-10 21:58:38.270976|2017-10-10 21:58:38.270976
NCT02840357|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-07-12|||July 2016||2016-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Impact of Purple Wheat Consumption on Markers of Inflammation and Oxidative Stress in Adults.|The Purple Wheat Intervention Study: Impact of Purple Wheat Consumption on Markers of Inflammation and Oxidative Stress in Adults.|Active, not recruiting||N/A|32|Actual|University of Guelph||2|||f||||f||||||||||2017-10-10 21:58:38.374005|2017-10-10 21:58:38.374005
NCT02840344|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-10-02|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|C-MBSR||Couples-Based Mindfulness for Young Breast Cancer Survivors|Couples-Based Mindfulness for Young Breast Cancer Survivors|Recruiting||N/A|150|Anticipated|University of Missouri-Columbia||2|||f||||f|f|f||||||||2017-10-10 21:58:38.465699|2017-10-10 21:58:38.465699
NCT02840331|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-18|||October 2016||2016-10-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|Hypericin-PDT||Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis|Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis|Not yet recruiting||Phase 3|50|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||No||2017-10-10 21:58:38.574565|2017-10-10 21:58:38.574565
NCT02840318|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-08-15|||February 2014||2014-02-01|February 2014|2014-02-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Compassion Pilot Intervention Study to Enhanced Integrated Care for People With Severe Memory Problems|The Compassion Intervention: A Pilot Study of Enhanced Integrated Care for People With Severe Memory Problems|Completed||N/A|41|Actual|University College, London||1|||f||||f||||||||No||2017-10-10 21:58:38.659739|2017-10-10 21:58:38.659739
NCT02840305|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-01-17|||April 2012||2012-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|SCENES||Brain Bases of Natural Scenes's Visual Perception of Natural Scenes|Brain Bases of Visual Perceptionnatural Scenes of Natural Scenes.|Completed||N/A|141|Actual|University Hospital, Grenoble||3|||f||||f||||||||||2017-10-10 21:58:38.761449|2017-10-10 21:58:38.761449
NCT02840227|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-10-03|||December 2013||2013-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections|The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections|Recruiting||N/A|2000|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-10 21:58:38.875655|2017-10-10 21:58:38.875655
NCT02840214|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-06-28||||||June 2017|2017-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Impact of Transcranial Direct Current Stimulation on Fatigability and Fatigue Induced by a Selective Attention Task||Withdrawn||Phase 1|0|Actual|University of Colorado, Denver||3||Study was never initiated.|f||||f||||||||Yes|Deidentified data may be released to other researchers upon request.|2017-10-10 21:58:38.977331|2017-10-10 21:58:38.977331
NCT02840201|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-06-26|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|SCAF-b||Sub-Clinical Atrial Fibrillation Biomarker Study|Sub-Clinical Atrial Fibrillation Biomarker (SCAF-b): A Sub-study of Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA)|Recruiting||N/A|700|Anticipated|Ottawa Heart Institute Research Corporation|||1||f||||f||||||Samples Without DNA|"     Blood samples will be collected for biomarker evaluation.   "|No||2017-10-10 21:58:39.081018|2017-10-10 21:58:39.081018
NCT02840188|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-13|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|September 13, 2017|Actual|2017-09-13||Observational|Goalkeeper||Young Goalkeeper's Fracture: Radiographic Findings|Young Goalkeeper's Fracture: Radiographic Findings, Risk Factors and Prevention Measures|Completed||N/A|179|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-10 21:58:39.1734|2017-10-10 21:58:39.1734
NCT02840175|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-05-22|||May 18, 2017|Actual|2017-05-18|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|November 2019|Anticipated|2019-11-01||Interventional|AJIBIOREM||Treatment Tapering in JIA With Inactive Disease|Treatment Tapering in Oligoarticular or Rheumatoid Factor Negative Polyarticular Juvenile Idiopathic Arthritis With Inactive Disease on Biologic Therapy|Recruiting||Phase 3|230|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 21:58:39.259961|2017-10-10 21:58:39.259961
NCT02840162|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-04-26|||May 2001||2001-05-01|April 2017|2017-04-01|May 2011|Actual|2011-05-01|January 2005|Actual|2005-01-01||Interventional|||Pre-Prostatectomy Celecoxib or Placebo|Randomized Study of Pre-Prostatectomy Celecoxib or Placebo|Terminated||Phase 2|34|Actual|OHSU Knight Cancer Institute||2||Drug safety concerns|f||||t||||||||||2017-10-10 21:58:39.371529|2017-10-10 21:58:39.371529
NCT02840149|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-09-05|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors|Correlation Between SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors|Enrolling by invitation||Phase 3|75|Anticipated|Jewish General Hospital||1|||f|||||f|f||||||||2017-10-10 21:58:39.461442|2017-10-10 21:58:39.461442
NCT02840136|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-05-08|||February 2016||2016-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients|Optimisation, Valorisation and Application of UPLC-MS/MS Based Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients - Part 3: Non-blank Sputum Samples for Method Optimisation and Validation|Enrolling by invitation||N/A|40|Anticipated|University Ghent||1|||f||||f||||||||Yes|The data generated in this trial will be published in a peer reviewed international journal. This way, concentration measurements in individual patients will be made available to the scientific community.|2017-10-10 21:58:39.526926|2017-10-10 21:58:39.526926
NCT02840123|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-08-02|||June 2016||2016-06-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines|Phase Ib Clinical Trial on the Safety of Immunotherapy With Autologous Dendritic Cells Primed With Lysate Allogeneic Tumor Lines in Patients With Diffuse Intrinsic Pontine Glioma (DIPG)|Recruiting||Phase 1|10|Anticipated|Fundació Sant Joan de Déu||1|||f||||||||||||||2017-10-10 21:58:39.610557|2017-10-10 21:58:39.610557
NCT02840110|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-21|||October 2016||2016-10-01|September 2017|2017-09-01|December 2035|Anticipated|2035-12-01|December 2035|Anticipated|2035-12-01||Observational|||Long-Term Follow-Up Study of Clinical Study Subjects Treated With ACTR087|Long-Term Follow-Up Study of Clinical Study Subjects Treated With ACTR087 Autologous T Cells Expressing Antibody-Coupled T-Cell Receptors|Enrolling by invitation||N/A|50|Anticipated|Unum Therapeutics Inc.|||1||f||||f||||||Samples With DNA|"     Blood for replication competent retrovirus (RCR) testing      Remaining biological samples from other protocol procedures (e.g., blood for presence of     ACTR+ T cells) may also be stored, at the discretion of the sponsor, for potential future     biomarker analyses of T cells, DNA, RNA, and other cells or molecules to study immunology or     gene therapy.      Optional blood, bone marrow, and tissue samples also may be collected in the event of a     subject's death if an autopsy is performed.   "|||2017-10-10 21:58:39.683253|2017-10-10 21:58:39.683253
NCT02840097|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|TIC-TOC||Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children|Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study|Not yet recruiting||Phase 2|40|Anticipated|University of California, Davis||3|||f||||t|t|f||||||||2017-10-10 21:58:39.7543|2017-10-10 21:58:39.7543
NCT02840084|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-18|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|September 1, 2018|Anticipated|2018-09-01|April 7, 2018|Anticipated|2018-04-07||Interventional|||Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture|A Study on the Safety and Effectiveness of the Aspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular Contracture Baker Grade III|Recruiting||N/A|60|Anticipated|Naidu, Nina S., M.D.||1|||f||||t|f|t|t|f||||No|Non-identified data may be made available to the FDA if requested.|2017-10-10 21:58:39.862475|2017-10-10 21:58:39.862475
NCT02840071|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-18|||October 2016||2016-10-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||ACT for Distress in Head and Neck Cancer Patients|Acceptance and Commitment Therapy for Individuals With Head and Neck Cancer Experiencing Psychological Distress: A Hermeneutic Single-Case Efficacy Design|Not yet recruiting||N/A|3|Anticipated|University of Nottingham||1|||f||||t||||||||No||2017-10-10 21:58:39.934355|2017-10-10 21:58:39.934355
NCT02840058|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-01-24|||July 2016|Actual|2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|ITHER||Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1|Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:58:40.038399|2017-10-10 21:58:40.038399
NCT02840045|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-08|||February 20, 2015|Actual|2015-02-20|August 2017|2017-08-01|August 20, 2018|Anticipated|2018-08-20|August 20, 2018|Anticipated|2018-08-20||Interventional|RIHANNA||Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients|Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Besancon||3|||f||||f||||||||||2017-10-10 21:58:40.104742|2017-10-10 21:58:40.104742
NCT02840032|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Determination of Pneumothorax Post Lung Biopsy|Role of Ultrasonography in the Diagnosis of Pneumothorax Following Transbronchial Biopsy in LungTransplant Patients.|Recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||Undecided||2017-10-10 21:58:40.306257|2017-10-10 21:58:40.306257
NCT02840019|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-21|||July 2016||2016-07-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Advanced Fetal Imaging - Phase II|Advanced Fetal Imaging - Phase II|Recruiting||N/A|300|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||No||2017-10-10 21:58:40.387606|2017-10-10 21:58:40.387606
NCT02840006|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-20|||September 2014||2014-09-01|July 2016|2016-07-01||||September 2015|Actual|2015-09-01||Interventional|||Spinal Anesthesia Associated With General Anesthesia in Coronary Artery Bypass||Completed||Phase 4|60|Actual|Universidade do Vale do Sapucai||2|||f||||f||||||||Yes||2017-10-10 21:58:40.480506|2017-10-10 21:58:40.480506
NCT02839993|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRAINSTIM2||tDCS Effects on Associative Learning in Older Adults of Retirement Age|Effects of Transcranial Direct Current Stimulation (tDCS) on Associative Learning in Older Adults|Recruiting||Phase 2|24|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 21:58:40.561335|2017-10-10 21:58:40.561335
NCT02839980|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-04-13|||September 2016||2016-09-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|OroColi||Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization|Comparative Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization of Hospital Subjects|Recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||||Undecided||2017-10-10 21:58:40.66115|2017-10-10 21:58:40.66115
NCT02839967|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-12-26|||July 2016||2016-07-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Influence of Intraoral Phototherapy in Individuals With Temporomandibular Joint Dysfunction|Influence of Intraoral Phototherapy on Pain, Joint Mobility, Functionality and Quality of Life in Individuals With Temporomandibular Joint Dysfunction|Recruiting||N/A|20|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 21:58:40.741296|2017-10-10 21:58:40.741296
NCT02839954|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-12-04|||July 2016||2016-07-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor|Study Evaluating the Efficacy and Safety of Chimeric Antigen Receptor-Modified pNK Cells in MUC1 Positive Advanced Refractory or Relapsed Solid Tumor|Recruiting||Phase 1/Phase 2|10|Anticipated|PersonGen BioTherapeutics (Suzhou) Co., Ltd.||1|||f||||t||||||||Yes||2017-10-10 21:58:40.825341|2017-10-10 21:58:40.825341
NCT02839941|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2016-11-30|||August 2016||2016-08-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Iguratimod in Kidney Transplant Recepients|An Open-label Study to Evaluate the Effect of Iguratimod Concomitant With Conventional Immunosuppressive Drugs on Preventing Antibody-induced Rejection in Human Leukocyte Antigen(HLA) Highly Mismatched Kidney Transplant Recipients|Recruiting||N/A|60|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||f||||||||No||2017-10-10 21:58:40.921575|2017-10-10 21:58:40.921575
NCT02839928|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Nasal Ketamine for Minor Procedures in Children|Nasal Ketamine: Mild Sedation and Analgesia for Minor Procedures in the Pediatric Emergency Department (ED)|Not yet recruiting||N/A|20|Anticipated|Kaplan Medical Center||1|||f||||f||||||||No||2017-10-10 21:58:41.022898|2017-10-10 21:58:41.022898
NCT02839915|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-09|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 1, 2023|Anticipated|2023-01-01|January 1, 2022|Anticipated|2022-01-01||Interventional|ASD||Folinic Acid and Language Impairment in Autism Spectrum Disorder|Efficacy of Folinic Acid in the Improvement of Language Impairment in Children With Autism Spectrum Disorder|Not yet recruiting||Phase 3|160|Anticipated|Emory University||2|||f||||t|t|f||||||||2017-10-10 21:58:41.10629|2017-10-10 21:58:41.10629
NCT02839889|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Interventional|||Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)|A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation|Recruiting||Phase 4|44|Anticipated|Hospice of Henderson County, Inc.||2|||f||||f||||||||No||2017-10-10 21:58:41.297535|2017-10-10 21:58:41.297535
NCT02839876|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-03-15|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty|Comparison of Multimodal Analgesic Regimen With Intravenous Acetaminophen to Standard Oral Multimodal Therapy in Primary Total Hip Arthroplasty: A Randomized Controlled Double Blind Trial|Recruiting||Phase 4|60|Anticipated|Duke University||2|||f||||t|t|f|||f|||No||2017-10-10 21:58:41.415591|2017-10-10 21:58:41.415591
NCT02839863|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-07-18|||October 2013||2013-10-01|July 2016|2016-07-01||||October 2053|Anticipated|2053-10-01|10 Years|Observational [Patient Registry]|UMBRELLA||Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA Cohort|Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA Cohort|Recruiting||N/A|10000|Anticipated|UMC Utrecht|||1||f||||f||||||||||2017-10-10 21:58:41.517983|2017-10-10 21:58:41.517983
NCT02839850|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-08-14|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|June 1, 2024|Anticipated|2024-06-01|June 1, 2024|Anticipated|2024-06-01||Interventional|||14022 ATTUNE Cementless RP Clinical Performance Evaluation|Multi-Center Clinical Evaluation of the ATTUNE Cementless Rotating Platform Total Knee Arthroplasty|Recruiting||N/A|500|Anticipated|DePuy Orthopaedics||1|||f||||f|f|t|f|f|f|||||2017-10-10 21:58:41.612444|2017-10-10 21:58:41.612444
NCT02839837|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-29|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acute Aerobic Exercise and Neuroplasticity in Depression|The Benefits of Acute Aerobic Exercise on Neuroplastic Potential in Depression|Recruiting||N/A|50|Anticipated|Medical University of South Carolina||1|||f||||f||||||||||2017-10-10 21:58:41.745118|2017-10-10 21:58:41.745118
NCT02839824|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-18|||August 2016||2016-08-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|CALICOL||Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting|Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting (CALICOL Study)|Not yet recruiting||N/A|406|Anticipated|Casen Recordati S.L.|||1||f||||f||||||||No||2017-10-10 21:58:41.852729|2017-10-10 21:58:41.852729
NCT02839811|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-18|||May 2016||2016-05-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|COBIOPHAD||Medical Device for Drug Allergy Diagnosis|Compact Biophotonic Platform for Drug Allergy Diagnosis|Recruiting||N/A|150|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 21:58:41.933547|2017-10-10 21:58:41.933547
NCT02839798|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-08|||May 2016||2016-05-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|NESTTBID||NeoSync TMS Treatment for Bipolar I Depression|Evaluation of NeoSync EEG Synchronized TMS For the Treatment of Major Depressive Episode in Bipolar Disorder and Associated Neural Response: An Open Label Trial|Recruiting||Phase 2|30|Anticipated|Butler Hospital||1|||f||||f||||||||||2017-10-10 21:58:42.022193|2017-10-10 21:58:42.022193
NCT02839785|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ANTALKINECP||Analgesia and Physiotherapy in Children With Cerebral Palsy (ANTALKINECP)|Analgesia and Physiotherapy in Children With Cerebral Palsy (ANTALKINECP): Double Blind Cross-over Placebo Controlled Study of Ibuprofen in Children With Cerebral Palsy Undergoing Physiotherapy|Active, not recruiting||Phase 3|180|Anticipated|University Hospital, Brest||2|||f||||f||||||||||2017-10-10 21:58:42.108605|2017-10-10 21:58:42.108605
NCT02839772|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-11-08|2016-08-06||January 2014||2014-01-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Clinic A. 47 with less severe/ moderate disease (stages 1,2,3) and 47 with severe disease (stages 4,5) Clinic B. 49 with less severe/ moderate disease and 50 with severe disease|An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis|A Randomised Controlled Trial to Evaluate the Effect of a New Skin Care Regimen on Skin Barrier Function in Those With Podoconiosis in Ethiopia|Completed||Phase 3|193|Actual|University of Hull|The study was not blinded which would have strengthened credibility and limited bias.The groups were matched but factors such as diet and co-morbidities particularly relating to blood flow in the legs/feet were not collected.|2|||f||||f||||||||No||2017-10-10 21:58:42.241181|2017-10-10 21:58:42.241181
NCT02839759|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-08|||October 16, 2017|Anticipated|2017-10-16|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|April 30, 2019|Anticipated|2019-04-30||Interventional|||Hearing Aid Education and Adaptation System|Interactive Technology for Hearing Aid Education and Acceptance|Not yet recruiting||N/A|80|Anticipated|Healthcare Technologies and Methods, LLC||2|||f||||t|f|f||||||||2017-10-10 21:58:43.027551|2017-10-10 21:58:43.027551
NCT02839746|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-29|||June 13, 2016|Actual|2016-06-13|September 2017|2017-09-01|June 18, 2018|Anticipated|2018-06-18|June 18, 2018|Anticipated|2018-06-18||Observational|||Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)|Non-interventional Study Describing Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)|Recruiting||N/A|1087|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 21:58:43.093784|2017-10-10 21:58:43.093784
NCT02839733|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-09-12|||July 12, 2016||2016-07-12|September 6, 2017|2017-09-06|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Dopamine and Motor Learning in Cerebral Palsy|Dopamine and Motor Learning in Cerebral Palsy|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 21:58:43.166227|2017-10-10 21:58:43.166227
NCT02839720|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-25|||April 11, 2017|Actual|2017-04-11|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma|Pilot Study of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) for Adults With Neurofibromatosis Type 1 (NF1) and Cutaneous Neurofibromas (CNF)|Recruiting||Phase 2|24|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-10 21:58:43.238707|2017-10-10 21:58:43.238707
NCT02839707|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-20|2017-09-11|||May 12, 2017|Actual|2017-05-12|September 2017|2017-09-01|June 30, 2023|Anticipated|2023-06-30|June 30, 2023|Anticipated|2023-06-30||Interventional|||Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer|Recruiting||Phase 2/Phase 3|488|Anticipated|National Cancer Institute (NCI)||3|||f||||f|t|f||||||||2017-10-10 21:58:43.340567|2017-10-10 21:58:43.340567
NCT02839694|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-19|2017-08-08|||July 7, 2016||2016-07-07|April 26, 2017|2017-04-26|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|||Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy|Phase I Evaluation of Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in Patients Undergoing Pulmonary Metastasectomy|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 21:58:43.671946|2017-10-10 21:58:43.671946
NCT02839668|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2017-08-21|||August 2016||2016-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|TIVA/TCI-BC||The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)|The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer|Recruiting||Phase 2|120|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy||4|||f||||f||||||||||2017-10-10 21:58:43.907305|2017-10-10 21:58:43.907305
NCT02839655|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-20|||May 2016||2016-05-01|July 2016|2016-07-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|EVATAR||Prospective Study Assessing Thyroidectomy Using Robot|Prospective Study Assessing Thyroidectomy Using Robot|Recruiting||Phase 2|288|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||No||2017-10-10 21:58:44.052532|2017-10-10 21:58:44.052532
NCT02839642|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-08-29|||May 2016||2016-05-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|RIVA-PSP||Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy|RIVA-PSP: Efficacy of Rivastigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy: A Randomised Double Blind Placebo-controlled Clinical Trial|Recruiting||Phase 3|106|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||Undecided||2017-10-10 21:58:44.139728|2017-10-10 21:58:44.139728
NCT02839629|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-07-26|||November 30, 2015|Actual|2015-11-30|July 2017|2017-07-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Observational|SCAN-LEAF||Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia|Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia|Active, not recruiting||N/A|1500|Anticipated|Bristol-Myers Squibb|||2||f||||t||||||||||2017-10-10 21:58:44.237503|2017-10-10 21:58:44.237503
NCT02839603|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-28|||September 2015||2015-09-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Asymptomatic Leishmania Infection in HIV Patients|Asymptomatic Leishmania Infection and Burden of Visceral Leishmaniasis in HIV-infected Individuals in North West Ethiopia: a Pilot Study|Terminated||N/A|540|Actual|Institute of Tropical Medicine, Belgium|||1|Aim to assess feasibility achieved, larger project starting earlier than anticipated|f||||f||||||Samples With DNA|"     Serum Plasma Whole blood Urine Stool   "|||2017-10-10 21:58:44.424852|2017-10-10 21:58:44.424852
NCT02839590|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Aqueous Dynamics and Glaucoma Surgeries|The Effect of Glaucoma Surgery on Aqueous Dynamics in Patients With Glaucoma or Ocular Hypertension: An Observational Study|Recruiting||N/A|100|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||7||f||||f||||||||No|There is no plan to share individual participant data (IPD)|2017-10-10 21:58:44.50769|2017-10-10 21:58:44.50769
NCT02839577|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-06-30|||December 2013||2013-12-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||The Effect of High Volume Injection With and Without Steroid in Chronic Achilles Tendinopathy|The Effect of High Volume Injection With and Without Steroid in Chronic Achilles Tendinopathy: A Randomized Double Blinded Prospective Trial|Completed||N/A|28|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-10 21:58:44.631017|2017-10-10 21:58:44.631017
NCT02839564|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-18|||August 1997||1997-08-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Benefit of Laparoscopic Adhesiolysis in Patients With Chronische Abdominal Pain|Benefit of Laparoscopic Adhesiolysis|Completed||Phase 4|100|Actual|Groene Hart Ziekenhuis||2|||f||||f||||||||No||2017-10-10 21:58:44.715173|2017-10-10 21:58:44.715173
NCT02839551|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-21|||May 2016||2016-05-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|NewBL||Optimal Doses for Drug Provocation Tests to Beta-lactams|Optimal Step Doses for Drug Provocation Tests to Prove Beta-lactam Hypersensitivity|Recruiting||N/A|45|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 21:58:44.813838|2017-10-10 21:58:44.813838
NCT02839538|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-18|||December 2014||2014-12-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Comparative Study of the Analgesic Effect of Spinal Anesthesia or Infiltration Anesthesia for Hemorrhoidectomy|A Comparative Randomised Study of the Analgesic Effect of Local Infiltration or Spinal Block for Haemorrhoidectomy|Completed||Phase 4|40|Actual|Federal University of São Paulo||2|||f||||t||||||||No||2017-10-10 21:58:44.899853|2017-10-10 21:58:44.899853
NCT02839525|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-03-08|||July 26, 2016|Actual|2016-07-26|March 2017|2017-03-01|February 9, 2017|Actual|2017-02-09|January 9, 2017|Actual|2017-01-09||Interventional|||The Effect of Nutritional Interventions on Exercise-induced Muscle Damage|The Effect of Nutritional Interventions on Exercise-induced Muscle Damage|Completed||N/A|2|Actual|Federal University of Health Science of Porto Alegre||3|||f||||t||||||||Yes||2017-10-10 21:58:44.979455|2017-10-10 21:58:44.979455
NCT02839512|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-07-28|||October 2014||2014-10-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2016|Actual|2016-04-01||Interventional|||A Trial of the Jejunal to Ileal Diversion Endoscopic Procedure (Side-to-Side Anastomosis)|A Trial of the Jejunal to Ileal Diversion Endoscopic Procedure (Side-to-Side Anastomosis)|Active, not recruiting||N/A|10|Actual|GI Windows, Inc.||1|||f||||f||||||||||2017-10-10 21:58:45.081349|2017-10-10 21:58:45.081349
NCT02839499|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-11-09|||July 2016||2016-07-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Screening of Obstructive Sleep Apnea Syndrome in Residents of a Unit of Long-term Care Under Mixed Food|Screening of Obstructive Sleep Apnea Syndrome in Residents of a Unit of Long-term Care Under Mixed Food|Recruiting||Phase 3|210|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 21:58:45.155166|2017-10-10 21:58:45.155166
NCT02839486|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-08-10|||September 2016||2016-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|VANCOCEF||Vancomycin and Cefoxitin During Pediatric Cardiopulmonary Bypass|Vancomycin and Cefoxitin Levels During Pediatric Cardiac Surgery With Cardiopulmonary Bypass|Not yet recruiting||Phase 2|40|Anticipated|Bambino Gesù Hospital and Research Institute||2|||f||||t||||||||No||2017-10-10 21:58:45.266919|2017-10-10 21:58:45.266919
NCT02839473|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-08-09|||March 2010||2010-03-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|HYDROSORB||Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial|Hydrosorb® Versus Control (Water Based Spray) in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial|Completed||Phase 3|278|Actual|Institut Curie||2|||f||||f||||||||No||2017-10-10 21:58:45.343515|2017-10-10 21:58:45.343515
NCT02839460|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-12-19|||November 2016||2016-11-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|TWEAK||A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy|A Single-Center, Prospective Study to Evaluate Biomarkers of Skeletal Muscle Atrophy in Sarcopenia|Recruiting||N/A|30|Anticipated|University of Florida|||2||f||||f||||||Samples Without DNA|"     Muscle biopsy samples may be retained for mRNA analysis   "|No||2017-10-10 21:58:45.431447|2017-10-10 21:58:45.431447
NCT02839447|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-18|||September 2016||2016-09-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Observational|||A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0|A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0|Not yet recruiting||N/A|330|Anticipated|Aytu BioScience, Inc.|||2||f||||f||||||Samples With DNA|"     human male semen containing sperm   "|Undecided||2017-10-10 21:58:45.519946|2017-10-10 21:58:45.519946
NCT02839434|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-04|||December 2015||2015-12-01|September 2017|2017-09-01|June 29, 2018|Anticipated|2018-06-29|June 29, 2018|Anticipated|2018-06-29||Observational|ACTARD||Evaluation of the Interference of Antithrombotic Agents With Laboratory Monitoring of Heparin Therapy||Recruiting||N/A|105|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 21:58:45.612779|2017-10-10 21:58:45.612779
NCT02839421|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-07-18|||December 2015||2015-12-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment|Efficacy of Moxifloxacin, Amoxicillin+Metronidazole for Aggressive Periodontitis Treatment|Recruiting||Phase 4|45|Anticipated|Facultad Nacional de Salud Publica||3|||f||||t||||||||Undecided||2017-10-10 21:58:45.68227|2017-10-10 21:58:45.68227
NCT02839408|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-09-25|||June 2015||2015-06-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Oral Probiotic and Antibiotic Administration in Patients With Chronic Periodontitis|Efficacy of Oral Probiotic and Antibiotic Administration in Clinical, Immunological and Microbiological Parameters of Patients With Chronic Periodontitis Treated With Non Surgical Periodontal Treatment|Active, not recruiting||Phase 2|54|Actual|University of Chile||3|||f||||t||||||||Undecided||2017-10-10 21:58:45.762256|2017-10-10 21:58:45.762256
NCT02839395|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||The Effects of Acute vs. Chronic of Screen Illumination on: Sleep Efficacy and Architecture, Physiology, Emotion and Behavior: Possible Effect on Human Health|The Effects of Acute vs. Chronic of Screen Illumination on: Sleep Efficacy and Architecture, Physiology, Emotion and Behavior: Possible Effect on Human Health|Active, not recruiting||N/A|20|Anticipated|Assuta Medical Center||3|||f||||f||||||||No||2017-10-10 21:58:45.843694|2017-10-10 21:58:45.843694
NCT02839369|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-28|2016-07-20|||April 2009||2009-04-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Walking Dynamic Among Children With Brain Damge|The Effect of Changing Walking Conditions on Walking Dynamic Characteristics Among Children Post a Severe Traumatic Brain Injury, Cerebral Palsy and Typically Developed (TD) Control.|Active, not recruiting||N/A|45|Actual|Alyn Pediatric & Adolecent Rehabilitation Center|||1||f||||f||||||||No||2017-10-10 21:58:46.006528|2017-10-10 21:58:46.006528
NCT02839356|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-03-02|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis||Recruiting||Phase 4|670|Anticipated|Anhui Provincial Hospital||2|||f||||t||||||||No||2017-10-10 21:58:46.080785|2017-10-10 21:58:46.080785
NCT02839343|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-09-29|||December 2016||2016-12-01|September 2017|2017-09-01||||March 2020|Anticipated|2020-03-01||Interventional|||Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer|Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas|Recruiting||Phase 2|134|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 21:58:46.181208|2017-10-10 21:58:46.181208
NCT02839330|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-10-26|||July 2016||2016-07-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age|A Phase 3 Randomized, Observer-Blind, Multi-center, Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age|Active, not recruiting||Phase 3|3192|Anticipated|Seqirus||4|||f||||f||||||||Undecided||2017-10-10 21:58:46.596329|2017-10-10 21:58:46.596329
NCT02839317|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-22|||May 2016||2016-05-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|COMeBACk||COmparison of MicroBiota AccordIng to Age in Crohn's Disease (COMeBACk)|Comparison of Fecal Microbiota Between Patients With Early and Late Crohn's Disease and Relationship With Different Genetic and Serological Profiles|Recruiting||N/A|300|Anticipated|University Hospital, Lille|||4||f||||f||||||Samples With DNA|"     Stool samples Blood samples (DNA extraction) and sera Salivary samples   "|||2017-10-10 21:58:46.731826|2017-10-10 21:58:46.731826
NCT02839304|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-05-08|||July 2016||2016-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|CryoCure2||Investigation of the Adagio PolarStar System in Patients With Atrial Fibrillation|A Prospective, Multicenter Investigation of the Adagio PolarStar System in Patients With Atrial Fibrillation|Recruiting||N/A|50|Anticipated|Adagio Medical||1|||f||||t||||||||No||2017-10-10 21:58:46.844353|2017-10-10 21:58:46.844353
NCT02839291|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-20|||May 2016||2016-05-01|July 2016|2016-07-01|May 2021|Anticipated|2021-05-01|November 2019|Anticipated|2019-11-01||Interventional|PRISM||Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life|Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life|Recruiting||N/A|154|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||||||||||||2017-10-10 21:58:46.918872|2017-10-10 21:58:46.918872
NCT02839278|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-20|||April 2015||2015-04-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|Super-Bio||Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases|Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases|Recruiting||N/A|135|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:58:47.006413|2017-10-10 21:58:47.006413
NCT02839265|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|FLT3||FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer|FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer|Recruiting||Phase 2|29|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||No||2017-10-10 21:58:47.075339|2017-10-10 21:58:47.075339
NCT02839252|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-01-11|||July 2016||2016-07-01|January 2017|2017-01-01||||September 2017|Anticipated|2017-09-01||Interventional|||Iggy and the Inhalers: A Study to Assess the Impact of an Asthma Education Program in School Age Children|Iggy and the Inhalers: A Pilot Study to Assess the Impact of an Asthma Education Program in School Age Children|Recruiting||N/A|200|Anticipated|Advocate Health Care||2|||f||||||||||||||2017-10-10 21:58:47.165905|2017-10-10 21:58:47.165905
NCT02839239|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-23|||July 2016||2016-07-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|LACONIC||Lactocare Baby Drops in Infants Colic|Role of Lactobacillus Rhamnosus (FloraActive™) 19070 and Lactobacillus Reuteri (FloraActive™) DSM 12246 in Infant Colic: a Controlled Dietary Study|Not yet recruiting||Phase 2|168|Anticipated|Biocare Copenhagen A/S||2|||f||||f||||||||Undecided||2017-10-10 21:58:47.385139|2017-10-10 21:58:47.385139
NCT02839226|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-19|||August 2016||2016-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds|Prospective, Placebo-controlled, Double-blind, Randomized Clinical Study to Assess the Safety and Efficacy of Topical Treatment of AR/101 Compared With for up to 28 Days, in Accelerating Granulation Tissue Formation in Chronic Wound Patients|Not yet recruiting||Phase 2|60|Anticipated|Arava Bio Tech Ltd.||2|||f||||t||||||||||2017-10-10 21:58:47.512879|2017-10-10 21:58:47.512879
NCT02839213|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-18|||October 2015||2015-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||The Effect of Hyoscine Butylbromide on Shortening of First and Second Stages of Labor||Completed||Phase 2|400|Actual|Woman's Health University Hospital, Egypt||2|||f||||f||||||||Yes||2017-10-10 21:58:47.655464|2017-10-10 21:58:47.655464
NCT02839200|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-16|||October 4, 2016|Actual|2016-10-04|August 2017|2017-08-01|June 20, 2017|Actual|2017-06-20|April 12, 2017|Actual|2017-04-12||Interventional|||Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder|Multi-center, Double-blind, Randomized, Placebo-controlled, Active-reference, Parallel-group, Polysomnography Dose-response Study to Assess the Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder|Completed||Phase 2|360|Actual|Actelion||6|||f||||t||||||||||2017-10-10 21:58:47.753013|2017-10-10 21:58:47.753013
NCT02839187|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-05-10|||June 2010|Actual|2010-06-01|May 2017|2017-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|NIMAD||Neuro Imaging and Multimodal Alzheimer's Disease|Neuro Imaging and Multimodal Alzheimer's Disease|Completed||N/A|59|Actual|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-10 21:58:47.991821|2017-10-10 21:58:47.991821
NCT02839174|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-06-07|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Observational|||Type One Diabetes and Low Carb Study|Investigation of Glycemic Control Among an International Community of People With Type 1 Diabetes Following a Low Carbohydrate Diet|Completed||N/A|340|Actual|Boston Children’s Hospital|||1||f||||f||||||||Yes|Deidentified data will be shared with external collaborators.|2017-10-10 21:58:48.099099|2017-10-10 21:58:48.099099
NCT02839161|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-05-18|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children|Randomized, Controlled, Phase 1 Study to Assess Safety and Immunogenicity of Co-administered Hookworm Vaccine Candidates Na-APR-1 (M74)/Alhydrogel® and Na-GST-1/ Alhydrogel® in Gabonese Children|Recruiting||Phase 1|60|Anticipated|Baylor College of Medicine||8|||f||||t||||||||||2017-10-10 21:58:48.208453|2017-10-10 21:58:48.208453
NCT02839148|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-23|||April 2016||2016-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Development of Appetite Measuring Tool and Appetite Status of Stunted Children|Assessment of Maternal Perception Regarding Childhood Stunting and Development of a Tool to Assess Appetite in Children|Recruiting||N/A|390|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 21:58:48.340712|2017-10-10 21:58:48.340712
NCT02839135|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-06-28|||May 1, 2016|Actual|2016-05-01|June 2017|2017-06-01|August 10, 2016|Actual|2016-08-10|August 1, 2016|Actual|2016-08-01||Interventional|||A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.|A Randomized, Single-center, Crossover, Comparative Bioavailability and Adhesion Performance Study, Comparing Single Administrations of a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.|Completed||Phase 1|128|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 21:58:48.471168|2017-10-10 21:58:48.471168
NCT02839122|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-02|||May 2016||2016-05-01|April 2017|2017-04-01|September 23, 2016|Actual|2016-09-23|September 2016|Actual|2016-09-01||Interventional|||A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects||Completed||Phase 1|28|Actual|Yuyu Pharma, Inc.||2|||f||||t||||||||Yes||2017-10-10 21:58:48.584869|2017-10-10 21:58:48.584869
NCT02839109|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-18|||February 2015||2015-02-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|PET/MRI-EC||PET-CT vs DWI-MRI in Response Evaluation in Esophageal Cancer|PET-CT and DWI-MRI in Evaluating and Predicting Response to Neo-adjuvant Chemoradiotherapy in Esophageal Cancer Patients|Completed||N/A|26|Actual|University Medical Center Groningen|||1||f||||t||||||||||2017-10-10 21:58:48.670364|2017-10-10 21:58:48.670364
NCT02839096|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-09-05|||June 2016||2016-06-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Once Versus Twice Daily Iron Supplementation in Pregnant Women|Once Daily Versus Twice Daily Iron Supplementation to Treat Anemia in Pregnancy: A Prospective, Randomized, Placebo Controlled, Double Blinded, Clinical Trial|Recruiting||N/A|50|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 21:58:48.750847|2017-10-10 21:58:48.750847
NCT02839083|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2016-07-16|||April 2015||2015-04-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Pecs II Block as Alternative for Paravertebral Block in Modified Radical Mastectomy|Thoracic Paravertebral Block Versus Pecs II Block for Perioperative Analgesia in Modified Radical Mastectomy|Enrolling by invitation||N/A|60|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 21:58:48.840565|2017-10-10 21:58:48.840565
NCT02839070|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-05-22|||November 2016||2016-11-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Influence of Sleep Regularity on Circadian Rhythms, Learning, Performance, and Mood|Influence of Sleep Regularity on Circadian Rhythms, Learning, Performance, and Mood|Recruiting||N/A|32|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:58:48.927365|2017-10-10 21:58:48.927365
NCT02839057|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-05-18|||October 2015||2015-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|20 Years|Observational [Patient Registry]|||Survival After Surgical Treatment of Axis Fractures in Elderly|Survival After Surgical Treatment of Axis Fractures in Elderly: A National Registry Based Cohort Study|Completed||N/A|6231|Actual|Uppsala University|||2||f||||f||||||||No||2017-10-10 21:58:49.018238|2017-10-10 21:58:49.018238
NCT02839044|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-18|||June 2016||2016-06-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|Vitacal||A Randomized, Placebo-controlled, Double Blind Trial to Investigate Whether Vitamin K2 Can Influence Arterial Calcification in Patients With Type 2 Diabetes||Recruiting||Phase 2|70|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-10 21:58:49.11377|2017-10-10 21:58:49.11377
NCT02839031|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-21|||March 2015||2015-03-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DI-CO||Cognitive-Behavioral Therapy (CBT) in Children With Diabetes|Assessment of a Cognitive-behavioral Group Intervention in Children With Diabetes Mellitus and Their Parents|Recruiting||N/A|80|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 21:58:49.213359|2017-10-10 21:58:49.213359
NCT02839018|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-22|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|NAChO||Nutrient Pattern Analysis in Critically Ill Patients (NAChO)|Nutrient Pattern Analysis in Critically Ill Patients Using Omics Technology (NAChO): A Prospective Single-center Observational Trial|Recruiting||N/A|100|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||Samples Without DNA|"     Blood, Urine, Muscle biopsy   "|||2017-10-10 21:58:49.303766|2017-10-10 21:58:49.303766
NCT02839005|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-18|||April 2015||2015-04-01|July 2016|2016-07-01||||January 2016|Actual|2016-01-01||Interventional|||Absorbable Suture Versus Nonabsorbable Suture Intradermal for the Skin Transverse Section in Cesarean||Completed||N/A|60|Actual|Universidade do Vale do Sapucai||2|||f||||f||||||||||2017-10-10 21:58:49.385366|2017-10-10 21:58:49.385366
NCT02838992|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-01-31|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia|Multi-center Clinical Study of Immunosuppressants, Cyclophosphamide, And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia|Not yet recruiting||Phase 4|130|Anticipated|Jinan Military General Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 21:58:49.457008|2017-10-10 21:58:49.457008
NCT02838979|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-15|||July 2015||2015-07-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Trial of Oral Glutamine on Mitochondrial Function in CKD|Randomized Cross-over Trial of Oral L-Glutamine vs Maltodextrin on Mitochondrial Function in Chronic Kidney Disease|Recruiting||Phase 2|20|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 21:58:49.590749|2017-10-10 21:58:49.590749
NCT02838966|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-05-01|||August 2014||2014-08-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Interventional|||Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)|Preoperative Nutritional Supplementation With Immunomodulators for Patients With Resectable Pancreatic Adenocarcinoma: Efficacy and Optimal Dose|Recruiting||N/A|20|Anticipated|University of Louisville||4|||f||||f||||||||||2017-10-10 21:58:49.700188|2017-10-10 21:58:49.700188
NCT02838953|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-09|||March 2016||2016-03-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Measurements of Diaphragmatic Mobility on COPD Patients|Diaphragmatic Mobility, Lung Hyperinflation and Effects of the Pulmonary Rehabilitation|Completed||N/A|56|Actual|Casa Di Cura Villa Serena SpA||2|||f||||t||||||||||2017-10-10 21:58:49.793355|2017-10-10 21:58:49.793355
NCT02838940|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-07-17|||August 2016||2016-08-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Preventive Antibiotic Serum Levels During Caesarean Section|Preventive Antibiotic Serum Levels During Caesarean Section|Not yet recruiting||Phase 3|250|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||No||2017-10-10 21:58:49.872899|2017-10-10 21:58:49.872899
NCT02838927|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-07-25|||July 2016||2016-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|2 Years|Observational [Patient Registry]|Epi-Hypo||Survey on Epidemiology of Hypoparathyroidism in France|Epi-Hypo: Survey on Epidemiology of Hypoparathyroidism in France|Recruiting||N/A|500|Anticipated|European Georges Pompidou Hospital|||1||f||||f||||||||||2017-10-10 21:58:49.935856|2017-10-10 21:58:49.935856
NCT02838914|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-07-17|||June 2015||2015-06-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Assessment of Reconstruction and Inverse Reconstruction in Right Atrium by Multimodal Echocardiographic Techniques|Assessment of Reconstruction and Inverse Reconstruction in Right Atrium by by Multimodal Echocardiographic Techniques for Atrial Fibrillation Patients Before and After Radiofrequency Ablation|Recruiting||Phase 4|80|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||No||2017-10-10 21:58:50.094455|2017-10-10 21:58:50.094455
NCT02838888|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-04-08|||July 2016||2016-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|December 2016|Actual|2016-12-01||Observational|KoloPol I||Computer-assisted Detection of Colonic Polyps||Recruiting||N/A|40|Anticipated|Technische Universität München|||1||f||||f||||||Samples Without DNA|"     Colon polyps   "|No||2017-10-10 21:58:50.285291|2017-10-10 21:58:50.285291
NCT02838875|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-18|||August 2016||2016-08-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||To Examine if the Mother's Glucose Levels and Glucose Levels in the Blood Can Predict Cord Hypoglycemia in Newborns at Risk.|To Examine if the Mother's Glucose Levels and Glucose Levels in the Blood Can Predict Cord Hypoglycemia in Newborns at Risk.|Not yet recruiting||Phase 3|1000|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||No||2017-10-10 21:58:50.396886|2017-10-10 21:58:50.396886
NCT02838862|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2016-07-19|||July 2016||2016-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Identification of Biomarker Profiles GEP-NEN Patients|Identification of Biomarker Profiles for Individualized Prognostic Stratification and Therapy in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia (GEP-NEN)|Recruiting||N/A|470|Anticipated|University of Schleswig-Holstein|||2||f||||f||||||Samples Without DNA|"     proteomic analysis (MALDI-MS) applied to existing pathology specimens of Neuroendocrine     tumors (paraffin-embedded specimens, FFPE).   "|No||2017-10-10 21:58:50.458762|2017-10-10 21:58:50.458762
NCT02838849|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-16|||August 2015||2015-08-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Fiber and Water Improve Bowel Habit in Humans|Fiber and Water Improve Bowel Habit and Stool Microbiota in Healthy Participants: a Randomized Clinical Trial|Completed||Phase 1/Phase 2|20|Actual|Universidade de Passo Fundo||2|||f||||f||||||||No||2017-10-10 21:58:50.537845|2017-10-10 21:58:50.537845
NCT02838836|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2016-10-03|||June 2016||2016-06-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Observational|||Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers|Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers|Recruiting||N/A|110|Anticipated|University of Missouri-Columbia|||1||f||||t||||||Samples With DNA|"     Blood, bone marrow, tissue, urine   "|No||2017-10-10 21:58:50.603327|2017-10-10 21:58:50.603327
NCT02838823|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-21|||July 2016||2016-07-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Patients With Advanced Breast Cancer|A Phase I,Open,Mono-center and Dose Escalation Study Investigating Tolerance and Pharmacokinetics of Single and Multiple Doses of Anti-PD-1 Monoclonal Antibody in Patients With Triple-negative Breast Cancer|Recruiting||Phase 1|27|Anticipated|Shanghai Junshi Bioscience Co.,Ltd.||1|||f||||t||||||||||2017-10-10 21:58:50.708754|2017-10-10 21:58:50.708754
NCT02838810|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2017-01-30|||June 2016||2016-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg|The Optimizing Treatment of PegIFN Alfa in HBeAg-negative Chronic Hepatitis B Patients With Low Level HBsAg|Recruiting||Phase 4|200|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||Undecided||2017-10-10 21:58:50.853494|2017-10-10 21:58:50.853494
NCT02838797|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-09-06|||June 2016||2016-06-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|RQ-10||RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease|RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease|Recruiting||Phase 1|75|Anticipated|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-10 21:58:50.972669|2017-10-10 21:58:50.972669
NCT02838771|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-09-07|||March 2011||2011-03-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Validation and Clinical Application of Dysphagia Screening Questionnaire|Validation and Clinical Application of Dysphagia Screening Questionnaire|Completed||N/A|293|Actual|Lithuanian University of Health Sciences||2|||f||||t||||||||Undecided||2017-10-10 21:58:51.196244|2017-10-10 21:58:51.196244
NCT02838758|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-19|||July 2016||2016-07-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Compare Ultrasound Assisted Cold Therapy and Lidocaine Injection to Treat Morton's Neuroma|A 3-arm Randomized Controlled Study Comparing Ultrasound-guided Cryoablation, Ultrasound-guided Perineural Lidocaine and Ultrasound-guided Perineural Saline to Treat Intermetatarsal Neuroma|Recruiting||Phase 1|66|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||No||2017-10-10 21:58:51.277816|2017-10-10 21:58:51.277816
NCT02838745|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2017-03-24|||September 2016||2016-09-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for Malignant Pleural Mesotheliomas|Phase I Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for Malignant Pleural Mesotheliomas|Recruiting||Phase 1|36|Anticipated|Baylor College of Medicine||1|||f||||||||||||||2017-10-10 21:58:53.158086|2017-10-10 21:58:53.158086
NCT02838732|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-17|||May 2016||2016-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Investigation on the Effect of Carnitine Supplement on Gut Microbiota and TMAO Plasma Concentration|Investigation on the Effect of Carnitine Supplement on Gut Microbiota and TMAO Plasma Concentration|Recruiting||N/A|30|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||No||2017-10-10 21:58:53.251391|2017-10-10 21:58:53.251391
NCT02838719|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-07-16|||December 2014||2014-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|AEDDATB||Analgesic Efficacy of Dexamethasone in Different Routes of Administration in Transverse Abdominis Plane Block|Effect of Perineural Versus Intravenous Dexamethasone On Analgesic Efficacy of Transverse Abdominis Plane Block With Levobupivacaine In Laparoscopic Gynaecological Procedures: A Randomized, Double-Blind Study|Completed||N/A|40|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||No||2017-10-10 21:58:53.326905|2017-10-10 21:58:53.326905
NCT02838706|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-04-25|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|December 1, 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Elderly With Hip Fracture and Perioperative Hemoglobin and Perfusion Index Levels|Contionuous Perioperative Hemoglobin and Perfusion Index Measurements in Elderly Patients With Hip Fracture and Post Operative Delirium|Completed||N/A|50|Anticipated|Hvidovre University Hospital|||1||f||||t||||||||||2017-10-10 21:58:53.405352|2017-10-10 21:58:53.405352
NCT02838693|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-21|||March 2016||2016-03-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Observational|APT-2D||Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)|Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)|Recruiting||N/A|2300|Anticipated|National University Hospital, Singapore|||2||f||||t||||||Samples Without DNA|"     Storage of plasma and serum   "|Yes||2017-10-10 21:58:53.490754|2017-10-10 21:58:53.490754
NCT02838680|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-05-25|||December 2016||2016-12-01|May 2017|2017-05-01|September 2022|Anticipated|2022-09-01|December 2017|Anticipated|2017-12-01||Interventional|RADIANT CANADA||Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA|Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA|Recruiting||N/A|20|Anticipated|HLT Inc.||1|||f||||t||||||||Undecided||2017-10-10 21:58:53.592215|2017-10-10 21:58:53.592215
NCT02838082|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-20|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|OSABI||Optimized Sleep After Brain Injury: Sleep Hygiene Intervention After Traumatic Brain Injury|Optimized Sleep After Brain Injury: A Pilot Study|Recruiting||N/A|20|Anticipated|Craig Hospital||2|||f||||||||||||||2017-10-10 21:59:00.169281|2017-10-10 21:59:00.169281
NCT02838667|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)|Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)|Recruiting||Early Phase 1|2300|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 21:58:53.685382|2017-10-10 21:58:53.685382
NCT02838654|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-03|||July 2016||2016-07-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Cervical Epidural Waveform Analysis Using Pressure Monitoring Kit|Reliability of Epidural Waveform Analysis for Cervical Epidural Blocks|Not yet recruiting||N/A|75|Anticipated|Keimyung University Dongsan Medical Center|||1||f||||f||||||||||2017-10-10 21:58:53.765395|2017-10-10 21:58:53.765395
NCT02838641|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-02-03|||November 2015||2015-11-01|February 2017|2017-02-01||||April 2017|Anticipated|2017-04-01||Observational|||Application of GeneXpert on Bronchoscopic Samples for Patients Suspicious of TB||Recruiting||N/A|219|Anticipated|Chinese University of Hong Kong|||1||f||||||||||||||2017-10-10 21:58:53.840748|2017-10-10 21:58:53.840748
NCT02838628|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-12-01|||April 2016||2016-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Ph2a, Open-Label, Multicenter, Activity&Safety Study of KX2-391 Oint in Subj. w Actinic Keratosis on the Face or Scalp|A Phase 2a, Open-Label, Multicenter, Activity and Safety Study of KX2-391 Ointment in Subjects With Actinic Keratosis on the Face or Scalp|Active, not recruiting||Phase 2|83|Actual|Kinex Pharmaceuticals Inc||1|||f||||f||||||||No||2017-10-10 21:58:53.910556|2017-10-10 21:58:53.910556
NCT02838615|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-07-19|||July 2016||2016-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of Transforaminal vs. Parasagittal Interlaminar Epidural Injection|Comparison of Lumbar Epidural Steroid Injection: Transforaminal vs. Parasagittal Interlaminar Approach|Not yet recruiting||N/A|56|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||f||||||||No||2017-10-10 21:58:54.885628|2017-10-10 21:58:54.885628
NCT02838602|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|May 2024|Anticipated|2024-05-01|November 2023|Anticipated|2023-11-01||Interventional|ETOILE||Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors|Transnational Randomized Study Comparing Carbon Ions Therapy Versus Conventional Radiotherapy - Including Protontherapy - for the Treatment of Radioresistant Tumors|Not yet recruiting||N/A|250|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 21:58:54.98186|2017-10-10 21:58:54.98186
NCT02838589|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-02-06|||August 2016||2016-08-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|EGRABINS1||The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers|The Effect of Glucagon-like Peptide 1 (GLP-1) Receptor Agonist on Cerebral Blood Flow Velocity in Non-Stroke Volunteers (EGRABINS1)|Completed||Phase 2|30|Actual|Herlev Hospital||2|||f||||t||||||||No||2017-10-10 21:58:55.088764|2017-10-10 21:58:55.088764
NCT02838576|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-07-15|||November 2016||2016-11-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women|Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women: a Randomized, Double-blind Controlled Trial|Not yet recruiting||Phase 2|72|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 21:58:55.188609|2017-10-10 21:58:55.188609
NCT02838563|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-07-11|||January 13, 2016|Actual|2016-01-13|February 2017|2017-02-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Observational|SIWA||Validation of a Scale of Well-Being Assessment (SIWA) in Patients With Alzheimer's Disease or a Related Disease.|Validation of a Scale of Well-Being Assessment (SIWA) in Patients With Alzheimer's Disease or a Related Disease.|Terminated||N/A|135|Actual|Hospices Civils de Lyon|||1|no new location to open|f||||f||||||||||2017-10-10 21:58:55.327184|2017-10-10 21:58:55.327184
NCT02838550|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-15|||January 2013||2013-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Increasing Physical Activity Through a Motivational Online Intervention Using Pedometers in Sedentary Students|Increasing Physical Activity Through a Motivational Online Intervention Using Pedometers in Sedentary Students|Completed||N/A|76|Actual|University of Valencia||3|||f||||f||||||||Undecided||2017-10-10 21:58:55.452959|2017-10-10 21:58:55.452959
NCT02838537|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-19|||November 2015||2015-11-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Observational|TRUE||TRiptan Use and Serious Vascular Events in Elderly Over 65 Years||Recruiting||N/A|25000|Anticipated|Assistance Publique Hopitaux De Marseille|||2||f||||f||||||||Undecided||2017-10-10 21:58:55.590943|2017-10-10 21:58:55.590943
NCT02838524|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-05-17|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|EFFORT||Acceptable Range of Inspiratory Effort During Mechanical Ventilation||Recruiting||N/A|30|Anticipated|St. Michael's Hospital, Toronto|||1||f||||||||||||||2017-10-10 21:58:55.715698|2017-10-10 21:58:55.715698
NCT02838511|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-03-07|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Measure of Frailty in Perioperative Setting|Which is a Better Measure of Frailty in Perioperative Setting: Deficit Accumulation Model or Phenotype Model?|Recruiting||N/A|1190|Anticipated|The Cleveland Clinic|||1||f||||f||||||||No||2017-10-10 21:58:55.827468|2017-10-10 21:58:55.827468
NCT02838498|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-09-30|||July 2016||2016-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Practice With Simulator Improves Basic ERCP Skills of Surgical Trainees|Practice With ERCP Mechanical Simulator (EMS) Improves Basic ERCP Skills of Novice Surgical Trainees|Recruiting||N/A|12|Anticipated|Hepatopancreatobiliary Surgery Institute of Gansu Province||2|||f||||t||||||||Undecided||2017-10-10 21:58:55.942952|2017-10-10 21:58:55.942952
NCT02838485|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-17|||August 2016||2016-08-01|July 2016|2016-07-01||||August 2017|Anticipated|2017-08-01||Interventional|||Cortical Activation in Individuals With Finger Amputation During Mirror Versus Imagery Treatment|Cortical Activation in Individuals With Finger Amputation During Mirror Versus Imagery Treatment|Not yet recruiting||N/A|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-10 21:58:56.096364|2017-10-10 21:58:56.096364
NCT02837718|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-07-15|||December 2014||2014-12-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|||Minimum Effective Volume Of Local Anesthetic İn USG Guided Axillary Approach Brachial Plexus Block|Minimum Effective Volume Of Local Anesthetic İn USG Guided Axillary Approach Brachial Plexus Block|Completed||Phase 4|55|Actual|Ankara Numune Training and Research Hospital||11|||f||||f||||||||Undecided||2017-10-10 21:59:03.33458|2017-10-10 21:59:03.33458
NCT02838472|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-19|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Ascorbic Acid Treatment in Congenital Glucocorticoids and Mineralocorticoids Deficiency Due to NNT Mutation|Ascorbic Acid Treatment for Patients With Combined Mineralocorticoid and Glucocorticoid Deficiency Secondary to Nicotinamide Nucleotide Transhydrogenase Mutation|Enrolling by invitation||N/A|3|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||No||2017-10-10 21:58:56.206028|2017-10-10 21:58:56.206028
NCT02838459|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-16|2017-02-26|||July 2016||2016-07-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Observational|||Can Prediction Models Triage Trauma Patients More Accurately Than Clinicians?|Can Prediction Models Triage Trauma Patients More Accurately Than Clinicians?|Recruiting||N/A|1350|Anticipated|Karolinska Institutet|||1||f||||||||||||||2017-10-10 21:58:56.316914|2017-10-10 21:58:56.316914
NCT02838446|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-15|||January 2014||2014-01-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effectiveness of Graded Motor Imagery to Improve Hand Function in Patients With Distal Radius Fracture|Cognitive Therapy Model: Graded Motor Imagery|Completed||Phase 2/Phase 3|36|Actual|Hacettepe University||2|||f||||||||||||||2017-10-10 21:58:56.392536|2017-10-10 21:58:56.392536
NCT02838433|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-19|||January 2012||2012-01-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|LyTéloMel||Study of Anti-telomerase T CD4 Immunity in Melanoma|Study of Anti-telomerase T CD4 Immunity in Melanoma: Predictive Biomarker and Implications for Immunotherapy|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:58:56.476832|2017-10-10 21:58:56.476832
NCT02838420|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-08-16|||August 3, 2016|Actual|2016-08-03|August 2017|2017-08-01|December 6, 2019|Anticipated|2019-12-06|December 6, 2019|Anticipated|2019-12-06||Interventional|||A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)|Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Crizotinib in Asian Patients With Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer|Active, not recruiting||Phase 3|187|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 21:58:56.568993|2017-10-10 21:58:56.568993
NCT02838407|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-01-16|||September 2013||2013-09-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.|Identification and Characterization of Bacteria in the Lower Airways of Children Aged ≥ 6 Months to < 6 Years With Suspected Lower Respiratory Tract Infections (LRTI) in Spain.|Completed||N/A|197|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 21:58:56.749592|2017-10-10 21:58:56.749592
NCT02838394|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-19|||July 2016||2016-07-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|DN||Dry Needling and Functional Improvement|Does Site-specific Trigger Point Dry Needling Evoke Segmental Neuromodulation in the Lower Extremity and if so, do These Changes Make an Impact on the Subject's Disability?|Not yet recruiting||N/A|40|Anticipated|Brigham Young University||2|||f||||f||||||||No|Data will not be shared with any other researcher|2017-10-10 21:58:56.983902|2017-10-10 21:58:56.983902
NCT02838381|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-20|||June 2012||2012-06-01|July 2016|2016-07-01|December 2022|Anticipated|2022-12-01|June 2022|Anticipated|2022-06-01||Interventional|Epitopes-CRC01||Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer|Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 21:58:57.122364|2017-10-10 21:58:57.122364
NCT02838368|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-04-13|||July 2015||2015-07-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|IPANEMA||Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices|Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices|Recruiting||N/A|1500|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-10 21:58:57.223687|2017-10-10 21:58:57.223687
NCT02838355|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-26|||October 2016||2016-10-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients|Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients|Suspended||N/A|60|Anticipated|Emory University||2||Funding not received|f||||f||||||||||2017-10-10 21:58:57.337277|2017-10-10 21:58:57.337277
NCT02838342|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2016-07-18|||May 2015||2015-05-01|July 2016|2016-07-01|November 2019|Anticipated|2019-11-01|August 2018|Anticipated|2018-08-01||Interventional|EPICentro||Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors|Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors|Recruiting||Phase 2|29|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||||||||||||2017-10-10 21:58:57.444952|2017-10-10 21:58:57.444952
NCT02838329|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-18|2017-02-24|||July 2016|Actual|2016-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LETWR||Labour Epidural Top-up With Warmed Ropivacaine|The Effect of the Body Temperature 0.75% Ropivacaine on the Time to Convert Labour Epidural Analgesia to Anaesthesia for Surgical Delivery|Recruiting||N/A|90|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 21:58:57.568034|2017-10-10 21:58:57.568034
NCT02838316|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-06-13|||May 24, 2017|Actual|2017-05-24|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|||Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia|Muscle Cell Mediated Therapy for Tongue Dysphagia: An Investigation of Cook MyoSite Autologous Muscle Derived Cells|Recruiting||Phase 1|20|Anticipated|University of California, Davis||2|||f||||t|t|f||||||Undecided||2017-10-10 21:58:57.669223|2017-10-10 21:58:57.669223
NCT02838303|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-17|||September 2014||2014-09-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers|The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study|Completed||N/A|42|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-10 21:58:58.207605|2017-10-10 21:58:58.207605
NCT02838277|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-14|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|INSIGHT||Insight Into Subcutaneous Adipose Tissue Disorders|Insight Into Subcutaneous Adipose Tissue Disorders As Part of The TREAT Program (Treatment, Research, Education, Adipose Tissue) at the University of Arizona|Recruiting||N/A|500|Anticipated|University of Arizona|||5||f||||f|f|f||||Samples With DNA|"     Blood, adipose tissue and DNA   "|||2017-10-10 21:58:58.451875|2017-10-10 21:58:58.451875
NCT02838264|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2017-05-12|||August 16, 2016|Actual|2016-08-16|May 2017|2017-05-01|May 3, 2017|Actual|2017-05-03|March 31, 2017|Actual|2017-03-31||Interventional|||A Study To Evaluate The Effect Of Itraconazole On Pharmacokinetics Of PF-06463922 In Healthy Volunteers|Phase 1, Open-label, Fixed Sequence, 2-period Study To Investigate The Effect Of Multiple Doses Of Itraconazole On The Pharmacokinetics Of Single Dose Pf-06463922 In Healthy Volunteers In The Fasted Condition|Completed||Phase 1|16|Actual|Pfizer||4|||f||||f||||||||||2017-10-10 21:58:58.57467|2017-10-10 21:58:58.57467
NCT02838251|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-26|||September 2015||2015-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|ULCEREMIXTE||Effects of Compression in Mixed Ulcers|Effects of Compression in Mixed Ulcers|Completed||N/A|25|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||Undecided||2017-10-10 21:58:58.714533|2017-10-10 21:58:58.714533
NCT02838238|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-17|||January 2014||2014-01-01|July 2016|2016-07-01||||January 2020|Anticipated|2020-01-01||Interventional|||X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer|A Randomized, Phase II Study Comparing Single X (Xeloda/Capetabine) With Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer|Recruiting||Phase 2|300|Anticipated|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 21:58:58.818196|2017-10-10 21:58:58.818196
NCT02838225|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-17|||January 2009||2009-01-01|July 2016|2016-07-01||||January 2016|Actual|2016-01-01||Interventional|||DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer|A Randomized, Phase II Study Comparing DA (Paclitaxel, Pirarubicin) With DAC ( Paclitaxel, Pirarubicin，Cyclophosphamide) as Postoperative Adjuvant Treatment for Early-stage Breast Cancer|Completed||Phase 2|300|Actual|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 21:58:58.914965|2017-10-10 21:58:58.914965
NCT02838212|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-15|||February 2016||2016-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|||Adverse Drug Reactions With Fatal Outcome|Adverse Drug Reactions With Fatal Outcome|Completed||N/A|1135|Actual|Germans Trias i Pujol Hospital|||2||f||||f||||||||No||2017-10-10 21:58:59.011502|2017-10-10 21:58:59.011502
NCT02838199|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-11-22|||December 2016||2016-12-01|November 2016|2016-11-01|December 2030|Anticipated|2030-12-01|June 2020|Anticipated|2020-06-01||Interventional|TRANSIT||TRANscatheter or SurgIcal Aortic Valve ReplacemenT in All-Comers With Severe Aortic Valve Stenosis|Prospective, Open Label, Multicenter, Dual Arm, Randomized Trial of TRANscatheter or SurgIcal Aortic Valve ReplacemenT in All-Comers With Severe Aortic Valve Stenosis|Withdrawn||Phase 4|0|Actual|Asan Medical Center||2|||f||||t||||||||Undecided||2017-10-10 21:58:59.124251|2017-10-10 21:58:59.124251
NCT02838186|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-07-16|||May 2013||2013-05-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Backwards Examination of the Right Colon: A Back-to-back Study|Diagnostic Yield of Scope Retroflexion in the Right Colon: A Prospective Cohort Study|Completed||N/A|674|Actual|Attikon Hospital||2|||f||||f||||||||||2017-10-10 21:58:59.278113|2017-10-10 21:58:59.278113
NCT02838173|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-19|||July 2016||2016-07-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery|Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery|Not yet recruiting||N/A|110|Anticipated|Erasme University Hospital||2|||f||||||||||||||2017-10-10 21:58:59.418923|2017-10-10 21:58:59.418923
NCT02838160|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-07-19|||October 2011||2011-10-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effectiveness of Different Educational Strategies on the KAP, Psychological and Clinical Outcomes|Effectiveness of Different Educational Strategies on the Knowledge, Attitude, and Practice ( KAP), Psychological and Clinical Outcomes in Intensive Care Unit: A Triple-blinded Randomized Controlled Follow-up Study|Completed||N/A|160|Actual|Baqiyatallah Medical Sciences University||3|||f||||t||||||||||2017-10-10 21:58:59.543547|2017-10-10 21:58:59.543547
NCT02838147|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-17|2016-08-08|||September 2016||2016-09-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Effect of a Continuous Glucose Monitoring on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus|Effect of a Continuous Glucose Monitoring on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus: A Randomized Controlled Trial|Not yet recruiting||Phase 3|200|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||t||||||||No||2017-10-10 21:58:59.638284|2017-10-10 21:58:59.638284
NCT02838134|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-17|||November 2016||2016-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RELAX||Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery|The Effectiveness of Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery|Recruiting||Phase 4|96|Anticipated|Radboud University||2|||f||||f||||||||No||2017-10-10 21:58:59.727821|2017-10-10 21:58:59.727821
NCT02838121|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-15|||December 2009||2009-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|January 2013|Actual|2013-01-01||Interventional|||Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy|Investigation on the Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy: A Prospective Randomized Clinical Trial|Completed||Phase 3|62|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||No||2017-10-10 21:58:59.850373|2017-10-10 21:58:59.850373
NCT02838108|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-07|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|April 2024|Anticipated|2024-04-01|July 2023|Anticipated|2023-07-01||Observational|||The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort|MURDOCK COPD Observational Study: The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort|Recruiting||N/A|850|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 21:58:59.977524|2017-10-10 21:58:59.977524
NCT02838095|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-15|||August 2015||2015-08-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Napping in Sleep-Restricted Adolescents|Effectiveness of a Daytime Nap on Alleviating Cognitive Impairment Due to Short Sleep in Adolescents|Completed||N/A|57|Actual|Duke-NUS Graduate Medical School||2|||f||||t||||||||No||2017-10-10 21:59:00.088099|2017-10-10 21:59:00.088099
NCT02838069|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-11-07|||September 2016||2016-09-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|ADIPOA-2||A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis|A Phase IIb, Prospective, Multicentre, Double-blind, Triple-arm, Randomized Versus Placebo Trial, to Assess the Efficacy of a Single Injection of Either 2 or 10 x 106 Autologous Adipose Derived Mesenchymal Stromal Cells (ASC) in the Treatment of Mild to Moderate Osteoarthritis (OA) of the Knee, Active and Unresponsive to Conservative Therapy for at Least 12 Months|Recruiting||Phase 2|153|Anticipated|University Hospital, Montpellier||3|||f||||f||||||||No||2017-10-10 21:59:00.258339|2017-10-10 21:59:00.258339
NCT02838056|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-02-24|||February 21, 2017|Actual|2017-02-21|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Early Detection of Epidural Onset by Temperature Change|Early Detection of the Effect of Epidural Local Anesthetic by Temperature Change on the Big Toe|Recruiting||N/A|40|Anticipated|Taipei Medical University WanFang Hospital||1|||f||||t|f|f||||||Undecided||2017-10-10 21:59:00.371703|2017-10-10 21:59:00.371703
NCT02838043|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-01|||August 2016||2016-08-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Efficacy, Safety, and Tolerability of Probiotics on the Mood and Cognition of Depressed Patients|The Efficacy, Safety, and Tolerability of Probiotics on the Mood and Cognition of Depressed Patients|Active, not recruiting||Phase 3|10|Anticipated|Queen's University||1|||f||||||||||||||2017-10-10 21:59:00.647637|2017-10-10 21:59:00.647637
NCT02838030|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy of Aspirin and L-arginine in High Risk Preeclamptic|Efficacy of the Combination of Acetylsalicylic Acid and L-arginine to Prevent Preeclampsia in Pregnant High Risk|Not yet recruiting||Phase 2|82|Anticipated|University of Guadalajara||2|||f||||t||||||||No||2017-10-10 21:59:00.772218|2017-10-10 21:59:00.772218
NCT02838017|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-15|||June 2016||2016-06-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Dermabond vs. Steri-Strips in Pfannenstiel Incisions|Dermabond Compared With Steri-Strips to Reduce Wound Complications in Pfannenstiel Incision Closure After Cesarean Delivery|Recruiting||N/A|900|Anticipated|NorthShore University HealthSystem||2|||f||||t||||||||||2017-10-10 21:59:00.942759|2017-10-10 21:59:00.942759
NCT02838004|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-21|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2016|Actual|2016-08-01||Interventional|PSM15||Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens|An Open Label, Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus|Completed||N/A|77|Actual|SIFI MedTech Srl||1|||f||||t||||||||||2017-10-10 21:59:01.074395|2017-10-10 21:59:01.074395
NCT02837991|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-08|||June 2016||2016-06-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|April 2019|Anticipated|2019-04-01||Interventional|||A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Advanced or Metastatic Renal Cell Carcinoma|A Phase l/ll Open-Label, Dose Escalation, Safety and Activity Study of the Antibody-Drug Conjugate CDX-014 in Advanced or Metastatic Renal Cell Carcinoma (RCC)|Recruiting||Phase 1/Phase 2|47|Anticipated|Celldex Therapeutics||1|||f||||f||||||||||2017-10-10 21:59:01.197085|2017-10-10 21:59:01.197085
NCT02837978|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-15|||January 2015||2015-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Clinical Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months Treatment|Prospective Clinical Study to Observe the Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months Treatment in China|Recruiting||Phase 4|100|Anticipated|Qilu Hospital of Shandong University||2|||f||||f||||||||Yes|De-identified individual participant data for all primary and secondary outcome measures will be made available within 12 months of study completion.|2017-10-10 21:59:01.331923|2017-10-10 21:59:01.331923
NCT02837965|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-15|||April 2013||2013-04-01|July 2016|2016-07-01||||October 2016|Anticipated|2016-10-01||Observational|EDP-PB||Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid|Multicenter Prospective Observational Study Assessing Outcomes, Adverse Events, Treatment Patterns and Related Costs in Patients Diagnosed With Bullous Pemphigoid|Recruiting||N/A|150|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 21:59:01.449083|2017-10-10 21:59:01.449083
NCT02837952|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-04-18|||August 31, 2016|Actual|2016-08-31|April 2017|2017-04-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain|A Phase 3, Double-Blind, Randomized Safety And Efficacy Study Comparing Multiple Administrations Of IBU 250 Mg/APAP 500 Mg (Administered As Two Tablets Of IBU/APAP 125 Mg/250 Mg) To Placebo In The Treatment Of Post Surgical Dental Pain In Adult Subjects|Completed||Phase 3|123|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 21:59:01.544596|2017-10-10 21:59:01.544596
NCT02837939|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-19|||July 2016||2016-07-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|IMUNO-HEGITO7||Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction|Prospective Randomized Single-blind Study on Transfer-factor in Acute Decompensation of Advanced Chronic Liver Disease and Acute-on-chronic Liver Failure.|Recruiting||Phase 2/Phase 3|124|Anticipated|Pavol Jozef Safarik University||2|||f||||t||||||||||2017-10-10 21:59:01.647385|2017-10-10 21:59:01.647385
NCT02837926|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-15|||May 2016||2016-05-01|July 2016|2016-07-01||||May 2018|Anticipated|2018-05-01||Interventional|CoheaHr-WP4||Comparing Health Services Interventions for the Prevention of HPV-related Cancer|Work Package 4: HPV Vaccination of Women in Screening Ages|Recruiting||Phase 4|300|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 21:59:01.757244|2017-10-10 21:59:01.757244
NCT02837913|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-07-19|||June 5, 2017|Actual|2017-06-05|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of a Warming Mattress on Perioperative Hypothermia Following Cesarean Delivery|Effect of a Warming Mattress on Perioperative Hypothermia Following Cesarean Delivery|Recruiting||N/A|200|Anticipated|Cedars-Sinai Medical Center||2|||f|||||f|t|f|f|f|||||2017-10-10 21:59:01.862585|2017-10-10 21:59:01.862585
NCT02837705|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-14|||September 2015||2015-09-01|July 2016|2016-07-01||||December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|PRNP||Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers|Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers|Recruiting||N/A|500|Anticipated|University of Zurich|||2||f||||||||||||Yes||2017-10-10 21:59:03.428109|2017-10-10 21:59:03.428109
NCT02837900|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-09-18|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Study Evaluating the Safety and Efficacy of a Second Course of TPX-100 in Subjects Who Previously Received TPX-100 for Patellar Osteoarthritis Involving Both Knees|A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Safety and Efficacy of a Second Course of Intra-articular Injections of TPX-100 in Subjects Who Previously Received TPX-100 for Patellar Osteoarthritis Involving Both Knees|Completed||Phase 2|14|Actual|OrthoTrophix, Inc||3|||f||||f||||||||||2017-10-10 21:59:01.987601|2017-10-10 21:59:01.987601
NCT02837887|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-14|||July 2016||2016-07-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer|A Computerized Cognitive Behavioral Therapy for Cancer Patients With Major Depressive Disorder|Recruiting||N/A|150|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 21:59:02.076038|2017-10-10 21:59:02.076038
NCT02837874|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-15|||March 2016||2016-03-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy|Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy, Randomized Prospective Pilot Study|Recruiting||N/A|80|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||f||||||||Yes||2017-10-10 21:59:02.183879|2017-10-10 21:59:02.183879
NCT02837861|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-03-22|||March 7, 2017|Actual|2017-03-07|March 2017|2017-03-01|January 31, 2020|Anticipated|2020-01-31|December 31, 2019|Anticipated|2019-12-31||Interventional|EMS||Early and Adequate Protein Feeding Post-Traumatic Injury|Early Metabolomic Support Study|Recruiting||Early Phase 1|40|Anticipated|Boston Medical Center||2|||f||||t|t|f||||||No|A Data and Safety Monitoring Safety plan has been created per Boston University Medical Campus (BUMC) guidelines. The Principal Investigator at Boston Medical Center (BMC) or Boston University Medical Campus will report all adverse events and Unanticipated Problems to the Institutional Review Board (IRB) in compliance with IRB policy, Federal/State regulations, and sponsor requirements.|2017-10-10 21:59:02.294673|2017-10-10 21:59:02.294673
NCT02837848|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-16|||July 2016||2016-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|coacticuff||Effect of Muscle Coactivation Strengthening for Rotator Cuff Tendinopathy|Effect of Adding Muscle Coactivation to Regular Shoulder Strengthening Exercises on Function and Pain With Patients Suffering of Rotator Cuff Tendinopathy: A Single-Blind Randomized Controlled Trial|Recruiting||N/A|42|Anticipated|Université de Sherbrooke||2|||f||||t||||||||Undecided||2017-10-10 21:59:02.405802|2017-10-10 21:59:02.405802
NCT02837835|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-15|||March 2005||2005-03-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|CEFTALC||Lung Concentrations of Ceftazidime in Patients With Ventilator-associated Pneumonia|Comparison of Lung Concentrations of Ceftazidime Administered by Continuous Versus Intermittent Infusion in Patients With Ventilator-associated Pneumonia|Completed||Phase 3|34|Actual|CHU de Reims||2|||f||||||||||||||2017-10-10 21:59:02.511018|2017-10-10 21:59:02.511018
NCT02837822|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-01-12|||October 2015||2015-10-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients|Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients|Recruiting||N/A|50|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f||||||||Undecided||2017-10-10 21:59:02.593301|2017-10-10 21:59:02.593301
NCT02837809|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-05-10|||September 2005||2005-09-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|January 2011|Actual|2011-01-01||Interventional|MILD||Early Lung Cancer Detection in High Risk Individuals|Early Lung Cancer Detection With Spiral Computed Tomography (CT), Positron Emission Tomography (PET) and Biomarkers: Randomized Trial in High Risk Individuals|Completed||N/A|4099|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||Undecided||2017-10-10 21:59:02.692319|2017-10-10 21:59:02.692319
NCT02837796|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-19|||September 2013||2013-09-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Trans-Obturator Tape outside-in Versus Inside-out Procedure for Stres Urinary Incontinence||Completed||N/A|101|Actual|Istanbul Bakirkoy Maternity and Children Diseases Hospital||2|||f||||||||||||||2017-10-10 21:59:02.797433|2017-10-10 21:59:02.797433
NCT02837783|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-15|||July 2016||2016-07-01|July 2016|2016-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C|A Phase 4, Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group, Fixed-dose Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation|Not yet recruiting||Phase 4|40|Anticipated|Ironwood Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-10 21:59:02.867162|2017-10-10 21:59:02.867162
NCT02837770|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-01-07|||July 2016||2016-07-01|October 2016|2016-10-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections|Analgesic Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections, a Randomized, Triple-arm, Double-blind, Placebo-controlled Study.|Completed||N/A|76|Actual|University Hospital of Patras||3|||f||||f||||||||Undecided||2017-10-10 21:59:02.953866|2017-10-10 21:59:02.953866
NCT02837757|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-15|||November 2015||2015-11-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|EMIR||Everolimus Modulation of Anti-tumor T CD4 Immune Responses|Everolimus Modulation of Anti-tumor T CD4 Immune Responses|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||||||||||||2017-10-10 21:59:03.051182|2017-10-10 21:59:03.051182
NCT02837731|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-10-17|||September 2016||2016-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|FRESH||Fluid Responsiveness Evaluation in Sepsis-associated Hypotension|Evaluation of Fluid Volume in Patients With Sepsis and Refractory Hypotension|Recruiting||Phase 4|210|Anticipated|Cheetah Medical Inc.||2|||f||||t||||||||Yes|Summary data will be reviewed periodically|2017-10-10 21:59:03.235459|2017-10-10 21:59:03.235459
NCT02837692|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-08-09|||June 8, 2016|Actual|2016-06-08|August 2017|2017-08-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Interventional|||A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy Adults|An Open-Label Single Dose Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy Adults|Recruiting||Phase 1|110|Anticipated|Janssen Research & Development, LLC||4|||f||||f||f||||||||2017-10-10 21:59:03.532874|2017-10-10 21:59:03.532874
NCT02837679|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-04-07|||January 2016||2016-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Oncogeriatric Intervention and Follow-up at Home|Oncogeriatric Intervention and Follow-up at Home to Improve Quality of Life and the Possibility to Accomplish Cancer Treatment in Multimorbid Elderly|Recruiting||N/A|350|Anticipated|University of Aarhus||2|||f||||f||||||||No||2017-10-10 21:59:03.625442|2017-10-10 21:59:03.625442
NCT02837666|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-05-16|||May 4, 2017|Actual|2017-05-04|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Hypolipidemic and Antioxidant Capacity of Spirulina and Exercise|Independent and Synergistic Effect of Spirulina Maxima With Exercise on General Fitness, Lipid Profile and Antioxidant Capacity in Overweight and Obese Subjects|Recruiting||N/A|80|Anticipated|Universidad Autonoma de Ciudad Juarez||2|||f||||t|f|f||||||Yes|Will be published in index journals|2017-10-10 21:59:03.763939|2017-10-10 21:59:03.763939
NCT02837653|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-15|||January 2016||2016-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy of a Physical Activity Counselling on the Severity of Chronic Low Back Pain in Patients With Cardiovascular Risk|Efficacy of a Physical Activity Counselling on the Severity of Chronic Low Back Pain in Patients With Cardiovascular Risk|Completed||N/A|64|Actual|Universidad Autonoma de Madrid||2|||f||||||||||||||2017-10-10 21:59:03.923062|2017-10-10 21:59:03.923062
NCT02837640|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-07-15|||June 2016||2016-06-01|July 2016|2016-07-01|June 2021|Anticipated|2021-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa|The Effect of L-Dopa on the Progression of Retinitis Pigmentosa|Recruiting||Phase 2|50|Anticipated|Beirut Eye Specialist Hospital||1|||f||||t||||||||No|Individual participant date will not be shared at the moment being, since it is not of value unless it is thoroughly analysed.|2017-10-10 21:59:04.02336|2017-10-10 21:59:04.02336
NCT02837627|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2017-04-01|||December 2015||2015-12-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|FT-GER-SO||Effect of Tube Feeding on Gastroesophageal Reflux in Preterm Infants|Effect of Different Modalities of Enteral Tube Feeding (ETF) on Gastroesophageal Reflux (GER) in Symptomatic Preterm Infants|Enrolling by invitation||N/A|30|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||f||||||||Yes||2017-10-10 21:59:04.108849|2017-10-10 21:59:04.108849
NCT02837614|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2016-07-18|||October 2015||2015-10-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of Preoperative Submucosal Dexamethasone in Third Molar Surgery||Completed||Early Phase 1|60|Actual|Sun Yat-sen University||3|||f||||f||||||||No||2017-10-10 21:59:04.200608|2017-10-10 21:59:04.200608
NCT02837601|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-07-18|||February 2017||2017-02-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|PRESSURE||Pneumoperitoneum Management With SurgiQuest AirSeal® at Low vs. Higher Pressure|A Single Center, Prospective, Randomized, Controlled Study To Evaluate Physician Preference Related To The Use Of The Surgiquest Airseal® Insufflation System (AIS) At Low Vs. Higher Pressure For The Management Of Pneumoperitoneum|Not yet recruiting||N/A|102|Anticipated|Akron Children's Hospital||2|||f||||f||||||||||2017-10-10 21:59:04.452299|2017-10-10 21:59:04.452299
NCT02837588|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-12-02|||August 2015||2015-08-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hyperthermy Endocavitary Treatment in Pelvic Pain|Endocavitary Radiofrequency Treatment in Patients Who Present With Chronic Pelvic Pain Compared to Usual Drug Therapy|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|Universidad Rey Juan Carlos||2|||f||||t||||||||Yes|It's approved from 2015 May to 2016 December, when the investigators have to report clinical trial conclusions|2017-10-10 21:59:04.575114|2017-10-10 21:59:04.575114
NCT02837575|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-04-27|||September 2016||2016-09-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|HSV-2||Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of Herpes Simplex Virus, Type 2 (HSV-2) Therapeutic DNA Vaccine in Adults With Symptomatic Genital HSV-2 Infection|Active, not recruiting||Phase 2|261|Actual|Vical||2|||f||||t||||||||Undecided||2017-10-10 21:59:04.67611|2017-10-10 21:59:04.67611
NCT02837562|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-14|||May 2016||2016-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|IC-CATARACT||Risk of Radiation-induced Cataracts Among Interventional Cardiology Staff|Risk of Radiation-induced Cataracts Among Interventional Cardiology Staff- CATaracts Attributed to Radiation in the CaTh Lab: The IC-CATARACT Study|Enrolling by invitation||N/A|2000|Anticipated|University of Texas Southwestern Medical Center|||2||f||||f||||||||No||2017-10-10 21:59:04.81757|2017-10-10 21:59:04.81757
NCT02837549|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-11-01|||July 2016||2016-07-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma|Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma|Recruiting||Phase 1|20|Anticipated|University of Michigan||1|||f||||f||||||||Undecided|upon written request|2017-10-10 21:59:04.897978|2017-10-10 21:59:04.897978
NCT02837536|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-03-06|||June 23, 2016|Actual|2016-06-23|March 2017|2017-03-01|December 23, 2016|Actual|2016-12-23|July 20, 2016|Actual|2016-07-20||Interventional|||Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings|Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings|Completed||N/A|107|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-10-10 21:59:05.006185|2017-10-10 21:59:05.006185
NCT02837341|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-12-01|||December 2015||2015-12-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Camera-based Measurement of Respiratory Rates|Camera-based Measurement of Respiratory Rates|Completed||N/A|30|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||No||2017-10-10 21:59:06.722547|2017-10-10 21:59:06.722547
NCT02837523|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-01-18|||July 2016||2016-07-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Observational|BioCystinosis||Biomarker for Patient With Cystinosis Disease or Highly Suspected for Cystinosis Disease|Biomarker for Cystinosis Disease: An International Epidemiological Protocol|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectrometry 7,5 ml     EDTA blood and a dry blood spot filter card are taken. To proof the correct Cystinosis     diagnosis in those patients where up to the enrollment in the study no genetic testing has     been done, sequencing of Cystinosis disease will be done.   "|Undecided||2017-10-10 21:59:05.108681|2017-10-10 21:59:05.108681
NCT02837510|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-03-28|||May 2016||2016-05-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|July 2020|Anticipated|2020-07-01||Interventional|||Neural Mechanisms Associated With Risk of Smoking Relapse|Neural Mechanisms Associated With Risk of Smoking Relapse|Recruiting||N/A|250|Anticipated|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 21:59:05.214562|2017-10-10 21:59:05.214562
NCT02837497|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-01-17|||October 2016||2016-10-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|ICU-RESUS||The ICU-Resuscitation Project (ICU-RESUS)|Improving Outcomes After Pediatric Cardiac Arrest|Recruiting||N/A|1540|Anticipated|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-10 21:59:05.333167|2017-10-10 21:59:05.333167
NCT02837484|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-07|||May 2016||2016-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||NuTech Affinity™ for the Treatment of Chondral Defects|The NuTech Affinity™ Membrane Product Evaluation for the Treatment of Chondral Defects|Recruiting||N/A|10|Anticipated|NuTech Medical, Inc||1|||f||||f||||||||||2017-10-10 21:59:05.486924|2017-10-10 21:59:05.486924
NCT02837471|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-04-12|||October 2016||2016-10-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|PiezoRx||Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking Canadians|Assessing the Feasibility and Usability of a Commercial Medical Grade Pedometer in a Case-managed Home-based Primary and Secondary Cardiovascular Disease Prevention Program for French-speaking Canadians (PiezoRx RCT Study)|Recruiting||N/A|120|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||Yes||2017-10-10 21:59:05.624407|2017-10-10 21:59:05.624407
NCT02837458|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-04-11|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of High Frequency Electrical Currents in Healthy Subjects.|Application of High Frequency Electrical Currents: Effects on Mechanical Threshold, Tactile Threshold and Evoked Potentials in Healthy Subjects.|Not yet recruiting||N/A|15|Anticipated|University of Castilla-La Mancha||2|||f||||f|f|f||||||Undecided||2017-10-10 21:59:05.76601|2017-10-10 21:59:05.76601
NCT02837445|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-09-04|||July 12, 2016|Actual|2016-07-12|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Moderato System: A Double-Blind Randomized Trial|Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial|Recruiting||N/A|190|Anticipated|BackBeat Medical Inc||2|||f||||t||||||||||2017-10-10 21:59:05.888683|2017-10-10 21:59:05.888683
NCT02837432|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-07-18|||July 2016||2016-07-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||The Effect of Cortisol Administration on Neural Correlates of Emotion in Depression||Recruiting||Early Phase 1|80|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 21:59:06.066569|2017-10-10 21:59:06.066569
NCT02837419|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-15|||October 2015||2015-10-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01|12 Months|Observational [Patient Registry]|||Cost-effectiveness of Extracorporeal Life Support Treatment|A Multicenter Prospective Observational Cohort Study Determining the Cost-effectiveness of Extracorporal Life Support (ECLS) Treatment|Recruiting||N/A|200|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 21:59:06.173344|2017-10-10 21:59:06.173344
NCT02837406|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-08-18|||June 2015||2015-06-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|EvaTSN||Evaluation of the Health Digital Territories Program in the Five Pilot Territories (EvaTSN Project )|Evaluation of the Implementation and Results of the Health Digital Territories Program in the Five Pilot Territories (EvaTSN Project )|Active, not recruiting||N/A|150|Anticipated|University Hospital, Bordeaux|||3||f||||f||||||||No||2017-10-10 21:59:06.264224|2017-10-10 21:59:06.264224
NCT02837393|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-15|||July 2016||2016-07-01|August 2017|2017-08-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Observational|||Understanding the Urine Electrolyte Profile of the Individual Renal Unit|Understanding the Urine Electrolyte Profile of the Individual Renal Unit|Terminated||N/A|13|Actual|Johns Hopkins University|||2|Low Recruitment and Enrollment|f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-10 21:59:06.350202|2017-10-10 21:59:06.350202
NCT02837380|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-01-23|||September 2016||2016-09-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects|An Open Label Study to Evaluate the Pharmacokinetics of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 mcg) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 21:59:06.435416|2017-10-10 21:59:06.435416
NCT02837367|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-01-24|||September 2016||2016-09-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|NutriGen||Use of Nutrigenomic Models for the Personalized Treatment With Medical Foods in Obese People|Use of Nutrigenomic Models for the Personalized Treatment With Medical Foods in Obese People|Recruiting||Phase 1/Phase 2|600|Anticipated|"University of Medicine and Pharmacy Victor Babes Timisoara"||6|||f||||f||||||||No||2017-10-10 21:59:06.53496|2017-10-10 21:59:06.53496
NCT02837354|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-18|||June 2014||2014-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|November 2015|Actual|2015-11-01||Observational|CAA||The Silent Cortical Infarcts in the Cerebral Amyloid Angiopathy: Is There a Link With Subarachnoid Hemorrhage?|The Silent Cortical Infarcts in the Cerebral Amyloid Angiopathy: Is There a Link With Subarachnoid Hemorrhage?|Completed||N/A|60|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||Undecided||2017-10-10 21:59:06.644229|2017-10-10 21:59:06.644229
NCT02837315|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-05-01|||October 23, 2014|Actual|2014-10-23|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|BLUE-J||Improving Brief Marijuana Interventions With a Behavioral Economic Supplement|Improving Brief Marijuana Interventions With a Behavioral Economic Supplement|Completed||N/A|133|Actual|University of Memphis||3|||f||||t||||||||Yes|Researchers will maintain a de-identified database and after publishing the primary outcomes, they will make individual level data available to researchers who are conducting integrated analyses.|2017-10-10 21:59:06.889583|2017-10-10 21:59:06.889583
NCT02837302|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-27|||November 2012||2012-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|BRAVE||Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease|Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease (BRAVE): Korean Nation-wide Multicenter Retrospective and Prospective Observational Cohort Study|Active, not recruiting||Phase 4|1470|Anticipated|Kyungpook National University||2|||f||||f||||||||||2017-10-10 21:59:06.986166|2017-10-10 21:59:06.986166
NCT02837289|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-14|||July 2016||2016-07-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Activation of Hip Muscles in Runners With Patellofemoral Syndrome|Activation of Hip Muscles in Runners With Patellofemoral Syndrome: Double-blind Randomized Clinical Trial|Not yet recruiting||N/A|15|Anticipated|Universidade Estadual de Londrina||2|||f||||t||||||||No||2017-10-10 21:59:07.078079|2017-10-10 21:59:07.078079
NCT02837276|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-04-17|||July 2016||2016-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|IHAKI||Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study)|Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study)|Recruiting||N/A|50|Anticipated|University of Kentucky|||1||f||||t||||||Samples Without DNA|"     Urine   "|No||2017-10-10 21:59:07.174227|2017-10-10 21:59:07.174227
NCT02837263|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-08-28|||August 2016||2016-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|March 2018|Anticipated|2018-03-01||Interventional|||PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer|Pembrolizumab in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer|Recruiting||Phase 1|15|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-10 21:59:07.251502|2017-10-10 21:59:07.251502
NCT02837250|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-12-07|||October 2016||2016-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Pilot RCT of Pos4Health for Nonadherent HIV+ Substance Users|Pilot RCT of Patient Centered eHealth Intervention for Nonadherent HIV+ Substance Users|Recruiting||Phase 1|75|Anticipated|University of Virginia||2|||f||||f||||||||No||2017-10-10 21:59:07.360457|2017-10-10 21:59:07.360457
NCT02837237|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-02-28|||June 2016||2016-06-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease|A Phase 1, Open-Label Study in Hemodialysis and Non-Hemodialysis Patients With Severe Chronic Kidney Disease to Evaluate the Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration|Active, not recruiting||Phase 1/Phase 2|12|Anticipated|KBP Biosciences||1|||f||||f||||||||No||2017-10-10 21:59:07.471408|2017-10-10 21:59:07.471408
NCT02837224|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-04-20|||August 2016|Actual|2016-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Effectiveness of a RF Sponge Detection|Effectiveness of a Radiofrequency Surgical Sponge Detection System for Preventing Retained Surgical Sponges|Active, not recruiting||N/A|27000|Anticipated|University of Iowa|||2||f||||f||||||||No||2017-10-10 21:59:07.549552|2017-10-10 21:59:07.549552
NCT02837211|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-10-31|||August 2016||2016-08-01|October 2016|2016-10-01||||August 2018|Anticipated|2018-08-01||Interventional|TREND||The TREND Study: Tapered Reduction in Energy Intake as a Novel Approach to Dieting||Recruiting||N/A|40|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-10 21:59:07.650106|2017-10-10 21:59:07.650106
NCT02837198|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-09-07|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)|Seven-day Repeated Dose Clinical Pharmacological Study of FYU-981 Administered to Hyperuricemia|Active, not recruiting||Phase 2|18|Anticipated|Fuji Yakuhin Co., Ltd.||3|||f||||f||||||||||2017-10-10 21:59:07.733791|2017-10-10 21:59:07.733791
NCT02837185|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-08-07|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effects of Botulinum Toxin on Muscle and Brain Activity|Physiological Effects of Botulinum Toxin Therapy in Primary Cervical Dystonia|Recruiting||N/A|60|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-10 21:59:07.809484|2017-10-10 21:59:07.809484
NCT02837172|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-04-10|||September 2014||2014-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|K23||Diagnosis of PD and PD Progression Using DWI|Diagnosis of Parkinson's Disease and Prediction of Progression Using Diffusion Weighted Imaging|Recruiting||N/A|310|Anticipated|University of Alabama at Birmingham|||3||f||||f||||||||Yes|progress report information to NIH|2017-10-10 21:59:07.902856|2017-10-10 21:59:07.902856
NCT02837159|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Mobile Aplication for the Promotion of Healthy Lifestyle Habits in Patients With Colorectal Cancer|Effectiveness of a Mobile Application for the Promotion of Healthy Lifestyle Habits in Patients With Colorectal Cancer: a Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|54|Anticipated|Universidad de Granada||2|||f||||||||||||||2017-10-10 21:59:07.99641|2017-10-10 21:59:07.99641
NCT02837146|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-28|||December 2015||2015-12-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|TOVERA||Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis|Ultrasound Scores as Imaging Biomarkers of Early Response to Subcutaneous Tocilizumab in Association With Methotrexate in Very Early Rheumatoid Arthritis (TOVERA)|Recruiting||Phase 3|45|Anticipated|Université Catholique de Louvain||1|||f||||t||||||||No||2017-10-10 21:59:08.103875|2017-10-10 21:59:08.103875
NCT02837120|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-22|||June 2016||2016-06-01|July 2016|2016-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|RESPECT||Retrospective Study of Acute Chest Pain in Extremely Critical Condition for More Than Ten Years|Retrospective Study of Acute Chest Pain in Extremely Critical Condition for More Than Ten Years|Recruiting||N/A|7000|Anticipated|Qilu Hospital of Shandong University|||1||f||||||||||||||2017-10-10 21:59:08.274462|2017-10-10 21:59:08.274462
NCT02837107|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-07-19|||September 2013||2013-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|October 2014|Actual|2014-10-01||Interventional|||Study of Supplement's Antioxidant Properties That Contains Natural Extracts||Active, not recruiting||N/A|62|Actual|Harokopio University||2|||f||||||||||||||2017-10-10 21:59:08.344262|2017-10-10 21:59:08.344262
NCT02837094|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-06-09|||September 29, 2016||2016-09-29|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|May 31, 2018|Anticipated|2018-05-31||Interventional|EE-ASI-1||Enhanced Epidermal Antigen Specific Immunotherapy Trial -1|Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 (EE-ASI-1): A Phase 1a Study of Gold Nanoparticles Administered Intradermally by Microneedles to Deliver Immunotherapy With a Proinsulin Derived Peptide in Type 1 Diabetes|Recruiting||Phase 1|8|Anticipated|Cardiff University||1|||f||||t||||||||Undecided||2017-10-10 21:59:08.435067|2017-10-10 21:59:08.435067
NCT02837081|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-07-14|||December 2015||2015-12-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Preauthorization Versus Prospective Audit in Antimicrobial Stewardship Program|The Impact of Preauthorization Compared to Prospective Audit on Outcome Indicators as Core Strategies of Antimicrobial Stewardship Program|Recruiting||N/A|1060|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||f||||||||Undecided||2017-10-10 21:59:08.513442|2017-10-10 21:59:08.513442
NCT02837068|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-14|||December 2012||2012-12-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|EHSP||Effect of Wheelchair Handrail Compensator and Rehabilitation Training for Patients With Hemiplegic Shoulder Pain|Effect and Evaluation: A Randomized Controlled Trial of Wheelchair Handrail Compensator and Rehabilitation Training for Stroke Patients With Shoulder Pain|Completed||N/A|120|Actual|Guangzhou University of Traditional Chinese Medicine||2|||f||||t||||||||No||2017-10-10 21:59:08.62504|2017-10-10 21:59:08.62504
NCT02837055|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|VivaITN||Conventional Intubation Versus VivaSight™-SL|Prospective, Randomized Study in Critically Ill Patients Receiving Endotracheal Intubation: Comparison Between a Conventional Approach and Video Assisted Intubation by the VivaSight™-SL Tube|Recruiting||N/A|54|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 21:59:08.708852|2017-10-10 21:59:08.708852
NCT02837042|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-06-22|||October 2016||2016-10-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma|Phase II Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma Following Previous Chemotherapy|Recruiting||Phase 2|35|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||No||2017-10-10 21:59:08.798758|2017-10-10 21:59:08.798758
NCT02837029|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-01-12|||July 2016||2016-07-01|January 2017|2017-01-01||||July 2019|Anticipated|2019-07-01||Interventional|||Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer|Phase I/Ib Study of Nivolumab in Combination With Therasphere (Yttrium-90) in Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 1|35|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 21:59:09.097145|2017-10-10 21:59:09.097145
NCT02837003|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-31|||July 2016||2016-07-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01|12 Months|Observational [Patient Registry]|MODEL U-SES||3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation|3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation|Recruiting||N/A|1500|Anticipated|Teikyo University|||2||f||||t||||||||||2017-10-10 21:59:09.389738|2017-10-10 21:59:09.389738
NCT02836990|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-10-03|||July 2016||2016-07-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery|Prevena™ Incision Management System Versus Dermabond in the Prevention of Groin Wound Infections in Patients Undergoing Vascular Surgery|Recruiting||N/A|140|Anticipated|State University of New York at Buffalo||2|||f||||f||||||||||2017-10-10 21:59:09.521413|2017-10-10 21:59:09.521413
NCT02836977|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2017-02-06|||March 2016||2016-03-01|June 2016|2016-06-01|February 29, 2024|Anticipated|2024-02-29|March 2017|Anticipated|2017-03-01||Interventional|||Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection||Active, not recruiting||N/A|400|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||Undecided||2017-10-10 21:59:09.656499|2017-10-10 21:59:09.656499
NCT02836964|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-06-14|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Early Loading of Dental Implants; A Prospective Study in the Mandibular First Molar Area.|Early Loading of Dental Implants; A Prospective Study in the Mandibular First|Recruiting||N/A|24|Anticipated|Loma Linda University||2|||f||||f|f|t|f|||||No||2017-10-10 21:59:09.76789|2017-10-10 21:59:09.76789
NCT02836951|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-02-02|||September 2016|Actual|2016-09-01|July 2016|2016-07-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Observational|||Rapid Diagnostics for Traumatic Brain Injury (TBI)|Rapid Chemical Diagnostics of Brain Injuries|Completed||N/A|24|Actual|Medicortex Finland Oy|||2||f||||f||||||Samples Without DNA|"     Blood, urine, saliva and cerebrospinal fluid (CSF).   "|||2017-10-10 21:59:09.865042|2017-10-10 21:59:09.865042
NCT02836938|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-02-13|||June 2016||2016-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Breath Volatile Organic Compounds Patterns of Lung Transplant Patients With Chronic Lung Allograft Dysfunction||Completed||N/A|75|Actual|Fraunhofer-Institute of Toxicology and Experimental Medicine|||3||f||||||||||||||2017-10-10 21:59:09.966491|2017-10-10 21:59:09.966491
NCT02836925|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-03-24|||March 2016||2016-03-01|September 2016|2016-09-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Sofosbuvir+Ledipasvir ±Ribavirin and Sofosbuvir+Ribavirin for Pts With Indolent Bcell Lymphoma Associated With HCV Infection Treatment With Sofosbuvir Plus Ledipasvir ± Ribavirin(G1, 3 and 4) and Sofosbuvir+Ribavirin(G2) for Pts With Hepatitis C Virus Associated Indolent B-cell Lymphomas|A Multicenter Study to Evaluate the Anti-viral Activity of an Interferonfree Treatment With Sofosbuvir Plus Ledipasvir ± Ribavirin(G1, 3 and 4)and Sofosbuvir+Ribavirin(G2)for Pts With Hepatitis C Virus Associated Indolent B-cell Lymphomas|Recruiting||Phase 2|50|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-10 21:59:10.068494|2017-10-10 21:59:10.068494
NCT02836912|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-09-07|||December 4, 2015|Actual|2015-12-04|September 2017|2017-09-01|September 26, 2016|Actual|2016-09-26|July 26, 2016|Actual|2016-07-26||Interventional|||The Efficacy of Pulmonary Rehabilitation Exercise in Home Care for the Non-invasive Ventilator-dependent Elderly With COPD|The Efficacy of Pulmonary Rehabilitation Exercise in Home Care for the Non-invasive Ventilator-dependent Elderly With Chronic Obstructive Pulmonary Disease|Completed||N/A|28|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-10 21:59:10.261504|2017-10-10 21:59:10.261504
NCT02836899|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-03-21|||February 8, 2017|Actual|2017-02-08|March 2017|2017-03-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|MGHK23||Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.|Prevention of Acute Kidney Injury by Nitric Oxide in Prolonged Cardiopulmonary Bypass. A Double Blind Controlled Randomized Trial in Cardiac Surgical Patients With Endothelial Dysfunction.|Recruiting||Phase 3|250|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f|||t|||No||2017-10-10 21:59:10.338774|2017-10-10 21:59:10.338774
NCT02836886|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-02-06|||June 2016||2016-06-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||VircapSeq Virus Detection in Sézary Syndrome|Searching for Oncogenic Viruses in Sézary Cells Using a Novel Viral Discovery Technique, VirCapSeq-VERT|Completed||N/A|6|Actual|Columbia University|||1||f||||f|f|f||||Samples With DNA|"     Blood sample: two tubes collected by standard blood draw (venipuncture) procedure. The total     amount of blood drawn will be about two teaspoons.   "|No||2017-10-10 21:59:10.461075|2017-10-10 21:59:10.461075
NCT02836873|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-06-15|||September 2016||2016-09-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment|A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment|Active, not recruiting||Phase 3|300|Anticipated|Theracos||2|||f||||t||||||||No||2017-10-10 21:59:10.548378|2017-10-10 21:59:10.548378
NCT02836847|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-11-01|||July 2016||2016-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma|A Multicentre, Open-label, Randomised, Controlled Study of Molecularly Precision Target Therapy Based on Tumor Molecular Profiling With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma|Recruiting||Phase 2|152|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||Undecided||2017-10-10 21:59:10.876778|2017-10-10 21:59:10.876778
NCT02836834|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-28|||August 2016||2016-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors|A Phase I Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Injection in Patients With Advanced Solid Tumors|Recruiting||Phase 1|90|Anticipated|Shanghai Junshi Bioscience Co.,Ltd.||3|||f||||t||||||||||2017-10-10 21:59:10.99293|2017-10-10 21:59:10.99293
NCT02836821|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-02-23|||May 2016||2016-05-01|June 2016|2016-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effect of Rifampicin on the Pharmacokinetics of Apatinib|Effect of Rifampicin on the Pharmacokinetics of Apatinib in Chinese Healthy Volunteers|Completed||Phase 1|20|Actual|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:59:11.093507|2017-10-10 21:59:11.093507
NCT02836808|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-27|||October 2013||2013-10-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|CAIPADI||Validation of an Integrated Attention Model for Patients With Type 2 Diabetes|Validation of an Integrated Attention Model for Patients With Type 2 Diabetes|Recruiting||N/A|1200|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-10 21:59:11.171915|2017-10-10 21:59:11.171915
NCT02836795|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-09-27|||April 2016||2016-04-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors|A Phase I, Open, Mono-center and Dose Escalation Study Investigating Tolerance and Pharmacokinetics of Single and Multiple Doses of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Injection in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|35|Actual|Shanghai Junshi Bioscience Co.,Ltd.||1|||f||||t||||||||||2017-10-10 21:59:11.283334|2017-10-10 21:59:11.283334
NCT02836782|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-07-14|||April 2016||2016-04-01|July 2016|2016-07-01|April 2025|Anticipated|2025-04-01|April 2020|Anticipated|2020-04-01|3 Years|Observational [Patient Registry]|ViDyMoCo||HIV-DNA Dynamics in HIV Monoinfected or HIV/HCV Coinfected Patients|Dynamics of Viral Reservoir in HIV-positive Patients With or Without HCV Coinfection in the Era of Direct-acting Antiviral and Antiretroviral Drugs|Recruiting||Phase 4|600|Anticipated|Catholic University of the Sacred Heart|||2||f||||f||||||Samples With DNA|"     whole blood   "|Undecided||2017-10-10 21:59:11.379396|2017-10-10 21:59:11.379396
NCT02835820|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-08-25|||April 2016||2016-04-01|August 2017|2017-08-01|December 10, 2017|Anticipated|2017-12-10|October 20, 2017|Anticipated|2017-10-20||Interventional|EDBP||Effects of Diet on Brain Processing|The Effect of a Ketogenic Diet on HIV-Associated Neurocognitive Impairment|Active, not recruiting||N/A|17|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 21:59:22.041367|2017-10-10 21:59:22.041367
NCT02836769|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-04-26|||January 2016||2016-01-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|HNC-RC||Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer|Development and Pilot Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer|Recruiting||N/A|35|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||No||2017-10-10 21:59:11.466782|2017-10-10 21:59:11.466782
NCT02836743|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-04-26|||January 2016||2016-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study|Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic REM Sleep Behavior Disorder: a Pilot Study|Recruiting||Phase 4|30|Anticipated|Seoul National University Hospital||3|||f||||f||||||||Undecided||2017-10-10 21:59:11.581734|2017-10-10 21:59:11.581734
NCT02836730|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2016-07-15|||November 2004||2004-11-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Long-term Outcomes of Surgical and Nonsurgical Management of Sciatica Secondary to a Lumbar Disc Herniation or Spinal Stenosis|Long-term Outcomes of Surgical and Nonsurgical Management of Sciatica Secondary to a Lumbar Disc Herniation or Spinal Stenosis|Completed||N/A|425|Actual|Back and Rehabilitation Center, Copenhagen|||3||f||||f||||||||||2017-10-10 21:59:11.683603|2017-10-10 21:59:11.683603
NCT02836717|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-01-30|||April 2016|Actual|2016-04-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence|Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence|Completed||N/A|101|Actual|Cantonal Hospital of St. Gallen|||1||f||||f||||||||No||2017-10-10 21:59:11.763121|2017-10-10 21:59:11.763121
NCT02836704|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-03-31|||September 2016||2016-09-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)|Comparison of Efficacy and Safety of Standard vs Higher Starting Dose of Insulin Glargine in Overweight and Obese Chinese Patients With Type 2 Diabetes|Recruiting||Phase 4|880|Anticipated|Sanofi||2|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 21:59:11.830131|2017-10-10 21:59:11.830131
NCT02836691|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-07-14|||May 2016||2016-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|ANASTHMA||Autonomic Nervous System Role in Uncontrolled ASTHMA and the Paucigranulocitic Phenotype|Autonomic Nervous System Role in Uncontrolled ASTHMA and the Paucigranulocitic Phenotype|Recruiting||N/A|40|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||4|||f||||f||||||||No||2017-10-10 21:59:11.985022|2017-10-10 21:59:11.985022
NCT02836678|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Bone Changes in Atrophic Maxilla Treated by Split-crest Technique|Bone Changes in Atrophic Maxilla Treated by Split-crest Technique and Dental Implants With Platelet Rich Fibrin and Nanobone® Versus Platelet Rich Fibrin Alone; Randomized Controlled Trial|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 21:59:12.187679|2017-10-10 21:59:12.187679
NCT02836665|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-04-07|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|Telederm||Application of Telemedicine for Dermatological Emergency Patients|Application of Telemedicine for Dermatological Emergency Patients|Recruiting||N/A|100|Anticipated|RWTH Aachen University||2|||f||||f||||||||Undecided||2017-10-10 21:59:12.292061|2017-10-10 21:59:12.292061
NCT02836652|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-03-21|||November 2016||2016-11-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|PREVENT II||Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy|Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy|Recruiting||Phase 4|350|Anticipated|St. Jude Medical||2|||f||||t|t|t|f|f|t|||Undecided||2017-10-10 21:59:12.407696|2017-10-10 21:59:12.407696
NCT02836639|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-14|||February 2016||2016-02-01|July 2016|2016-07-01||||December 2019|Anticipated|2019-12-01||Interventional|||BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma|Phase II Study for Safety and Efficacy of BEB (Bendamustine, Etoposide, Busulfan) Conditioning Regimen for ASCT in Non-Hodgkin's Lymphoma|Recruiting||Phase 2|20|Anticipated|Pusan National University Hospital||1|||f||||t||||||||No||2017-10-10 21:59:12.615383|2017-10-10 21:59:12.615383
NCT02836626|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-04-10|||June 2016||2016-06-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Fascial Scar Mobilization Techniques in Treating Chronic Caesarian Section Scar Pain|Fascial Scar Mobilization Techniques in Treating Chronic Caesarian Section Scar Pain: A Randomized Clinical Trial|Active, not recruiting||N/A|29|Anticipated|Rocky Mountain University of Health Professions||2|||f||||t||||||||||2017-10-10 21:59:12.729878|2017-10-10 21:59:12.729878
NCT02836613|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-03-23|||July 2016||2016-07-01|March 2017|2017-03-01|November 27, 2017|Anticipated|2017-11-27|February 27, 2017|Actual|2017-02-27||Interventional|||A Study of Galcanezumab in Healthy Participants.|Pharmacokinetics and Pharmacodynamics of LY2951742 (Galcanezumab) in Healthy Subjects Following Subcutaneous Administration of LY2951742 (Galcanezumab) Solution in a Prefilled Syringe or an Autoinjector|Active, not recruiting||Phase 1|160|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 21:59:12.840033|2017-10-10 21:59:12.840033
NCT02836600|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-15|2017-09-15|||September 2016||2016-09-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors|A Phase 1 Study of LY3039478 in Japanese Patients With Advanced Solid Tumors|Recruiting||Phase 1|12|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 21:59:12.937188|2017-10-10 21:59:12.937188
NCT02836587|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-09-19|||September 2016||2016-09-01|September 2017|2017-09-01|September 19, 2017|Actual|2017-09-19|July 16, 2017|Actual|2017-07-16||Interventional|||The Influence of Balance Training on Postural Control in Elderly|The Influence of Balance Training on Postural Control in Elderly|Completed||N/A|44|Actual|Palacky University||2|||f||||||||||||||2017-10-10 21:59:13.031572|2017-10-10 21:59:13.031572
NCT02836574|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-08|||September 2016||2016-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Autologous Neo-Kidney Augment™ (NKA) in Type 2 Diabetics With Chronic Kidney Disease|A Phase 2 Prospective, Randomized, Double-Arm, Deferred Treatment, Open Label, Repeat Dose, Safety and Efficacy Sudy of Autologous Neo-Kidney Augment™ (NKA) in Subjects With Type 2 Diabetes and Chronic Kidney Disease|Recruiting||Phase 2|50|Anticipated|inRegen||2|||f||||t||||||||||2017-10-10 21:59:13.122522|2017-10-10 21:59:13.122522
NCT02836561|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-04-17|||July 2016||2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Contraceptive Choice at the Time of Uterine Evacuation|Contraceptive Choice at the Time of Uterine Evacuation: A Randomized Controlled Pre-visit LARC Educational Intervention|Completed||N/A|234|Actual|Planned Parenthood League of Massachusetts||2|||f||||f||||||||Yes|Present at conferences and publish results in peer reviewed journal|2017-10-10 21:59:15.304033|2017-10-10 21:59:15.304033
NCT02836548|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-18|||June 2016||2016-06-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|June 2017|Anticipated|2017-06-01||Interventional|||HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma|HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma|Recruiting||Phase 1/Phase 2|21|Anticipated|The Netherlands Cancer Institute||1|||f||||t||||||||Undecided||2017-10-10 21:59:15.377663|2017-10-10 21:59:15.377663
NCT02836535|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-06-28|||July 2016||2016-07-01|August 2016|2016-08-01|June 28, 2017|Actual|2017-06-28|June 28, 2017|Actual|2017-06-28||Observational|||The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative Analysis|The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative Analysis|Completed||N/A|9|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-10 21:59:15.490389|2017-10-10 21:59:15.490389
NCT02836522|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-04-12|||April 25, 2016||2016-04-25|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)|Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)|Enrolling by invitation||N/A|100|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 21:59:15.567674|2017-10-10 21:59:15.567674
NCT02836509|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-18|||September 2016||2016-09-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Low Back Pain Presented to the Emergency Department|Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Low Back Pain Presented to the Emergency Department: A Randomized, Double-Blind, Controlled Trial|Not yet recruiting||Phase 4|200|Anticipated|Pamukkale University||2|||f||||t||||||||Undecided||2017-10-10 21:59:15.643319|2017-10-10 21:59:15.643319
NCT02836483|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-28|||December 10, 2016|Actual|2016-12-10|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK|A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial to Evaluate the EBA, Safety and PK of Orally Administered LCB01-0371 in Adult Patients With Smear-positive Pulmonary Tuberculosis|Recruiting||Phase 2|64|Anticipated|LegoChem Biosciences, Inc||5|||f||||f||||||||||2017-10-10 21:59:15.935706|2017-10-10 21:59:15.935706
NCT02836470|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-08-29|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|PROFILE||A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection|A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate LB1148 for Return of Gastrointestinal Function, Post-Operative Ileus and Intra-Abdominal Adhesions in Subjects Undergoing Elective Bowel Resection|Not yet recruiting||Phase 2|120|Anticipated|Leading BioSciences, Inc||2|||f||||t||||||||No||2017-10-10 21:59:16.151831|2017-10-10 21:59:16.151831
NCT02836457|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-26|||July 2016||2016-07-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE|ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE|Recruiting||N/A|1000|Anticipated|Bristol-Myers Squibb|||1||f||||||||||||||2017-10-10 21:59:16.269016|2017-10-10 21:59:16.269016
NCT02836444|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|STANDARDS-2||Stratification of the Acute Respiratory Distress Syndrome - A Second Phase Study|STratification AND Outcome of Patients With the Acute Respiratory Distress Syndrome - A Second Phase Study|Completed||N/A|410|Actual|Dr. Negrin University Hospital|||1||f||||f||||||||||2017-10-10 21:59:16.381643|2017-10-10 21:59:16.381643
NCT02836431|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-28|||January 2016||2016-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children|Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children|Recruiting||Phase 1|36|Anticipated|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-10-10 21:59:16.539357|2017-10-10 21:59:16.539357
NCT02836418|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-04-20|||July 12, 2016|Actual|2016-07-12|April 2017|2017-04-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|FSHD||Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy|An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy|Completed||Phase 1/Phase 2|8|Actual|aTyr Pharma, Inc.||1|||f||||t||||||||No||2017-10-10 21:59:16.689408|2017-10-10 21:59:16.689408
NCT02835248|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-13|||September 2015||2015-09-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||A Novel System to Detect Falls in Real-life Conditions||Recruiting||N/A|200|Anticipated|BioSensics|||1||f||||f||||||||No||2017-10-10 21:59:27.498791|2017-10-10 21:59:27.498791
NCT02836405|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-10-03|||May 2015||2015-05-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||TMS for the Investigation of Brain Plasticity in Autism Spectrum Disorders|Investigations of Neuroplasticity Mechanisms in Autism Spectrum Disorders|Recruiting||N/A|185|Anticipated|Boston Children’s Hospital|||3||f||||t||||||Samples With DNA|"     Saliva sample for genetic testing (optional)   "|||2017-10-10 21:59:16.825526|2017-10-10 21:59:16.825526
NCT02836392|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-08-09|||May 2016||2016-05-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||CRQ Survey Study: Clinical Research Questionnaire of Oncology Patients - A Nationwide Survey||Completed||N/A|1000|Actual|Cancer Trials Ireland|||1||f||||t||||||||||2017-10-10 21:59:16.981131|2017-10-10 21:59:16.981131
NCT02836366|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-07-18|||March 2016||2016-03-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|March 2018|Anticipated|2018-03-01||Observational|||Targon PH+ Follow-Up|Prospective Cohort Study of Proximal Humeral Fractures Treated With Targon® PH+|Recruiting||N/A|102|Anticipated|Aesculap AG|||1||f||||f||||||||No||2017-10-10 21:59:17.26546|2017-10-10 21:59:17.26546
NCT02836353|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01||||October 2021|Anticipated|2021-10-01||Interventional|MaS||Metabolic Consequences of Gastrointestinal Surgery|The Metabolic Consequences of Gastrointestinal Surgery|Recruiting||N/A|200|Anticipated|Cambridge University Hospitals NHS Foundation Trust||3|||f||||f||||||||No||2017-10-10 21:59:17.380599|2017-10-10 21:59:17.380599
NCT02836340|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-06-26|||May 2016||2016-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TIBOHCA||TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA|TIBOHCA: A Single-centre, Phase II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After Out of Hospital Cardiac Arrest|Recruiting||Phase 1/Phase 2|24|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||No||2017-10-10 21:59:17.513769|2017-10-10 21:59:17.513769
NCT02836327|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-07|||September 2014||2014-09-01|August 2016|2016-08-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Observational|||Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders|Multimodel MRI to Explore the Pathophysiology of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders|Recruiting||N/A|300|Anticipated|Chinese PLA General Hospital|||3||f||||t||||||||Undecided||2017-10-10 21:59:17.634363|2017-10-10 21:59:17.634363
NCT02836314|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-14|||January 2011||2011-01-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Clinical and Radiological Effect Of Platelet Rich Fibrin on the Healing of Periodontal Intrabony Periodontal Defects|Effect Of Platelet Rich Fibrin on the Healing of Periodontal Intrabony Defects Treated With Anorganic Bovine Bone Mineral: A Randomized Clinical and Radiological Study|Completed||N/A|15|Actual|Baskent University||2|||f||||f||||||||Yes||2017-10-10 21:59:17.755424|2017-10-10 21:59:17.755424
NCT02836301|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-10-05|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||RCT- Comparing Testimonial Versus Documentary Organ Donation Video Education|Optimizing Educational Video Designs to Improve Minority Organ Donor Registration - Aim 2 Randomized Trial Comparing Testimonials Versus Documentary Videos|Not yet recruiting||N/A|1716|Anticipated|New York University School of Medicine||6|||f||||f|f|f||||||||2017-10-10 21:59:17.873658|2017-10-10 21:59:17.873658
NCT02836288|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-16|||July 2016||2016-07-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer|A Randomized, Double Blind, Feasibility Study of Oral Ketamine Versus Placebo for Treating Depression in Patients With Cancer|Recruiting||Early Phase 1|20|Anticipated|Cedars-Sinai Medical Center||3|||f||||t|t|f||||||||2017-10-10 21:59:17.996809|2017-10-10 21:59:17.996809
NCT02836275|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-30|||October 2016||2016-10-01|August 2016|2016-08-01||||February 2019|Anticipated|2019-02-01||Interventional|IOTA-MRI||Value of MRI in the Characterization of Ovarian Masses Unable to Classify With Ultrasound Using the International Ovarian Tumor Analysis (IOTA) Simple Rules|Characterization of Ovarian Masses Unable to Classify With Ultrasound Using the International Ovarian Tumor Analysis (IOTA) Simple Rules: Value of Pelvic MRI With Perfusion- and Diffusion-weighted Imaging|Not yet recruiting||N/A|250|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-10 21:59:18.156302|2017-10-10 21:59:18.156302
NCT02836262|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-09-11|||August 25, 2017|Actual|2017-08-25|September 2017|2017-09-01|March 2024|Anticipated|2024-03-01|March 2024|Anticipated|2024-03-01||Interventional|(HRS-P)||Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty|A Multi-Center Prospective Study of the Hip Innovation Technology (HIT) Hip Replacement System in Primary Total Hip Arthroplasty|Recruiting||N/A|100|Anticipated|Hip Innovation Technology||1|||f||||t|f|f||||||||2017-10-10 21:59:18.394189|2017-10-10 21:59:18.394189
NCT02836249|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-03-02|||June 19, 2015|Actual|2015-06-19|March 2017|2017-03-01|November 2023|Anticipated|2023-11-01|December 15, 2016|Actual|2016-12-15||Interventional|||Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg Positive, Chronic Hepatitis B|Active, not recruiting||Phase 3|181|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:59:18.516332|2017-10-10 21:59:18.516332
NCT02836236|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-03-02|||June 19, 2015|Actual|2015-06-19|March 2017|2017-03-01|January 2024|Anticipated|2024-01-01|February 24, 2017|Actual|2017-02-24||Interventional|||Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B|Active, not recruiting||Phase 3|155|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 21:59:18.679558|2017-10-10 21:59:18.679558
NCT02836210|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-11-30|||May 2015||2015-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||27-gauge Vitrectomy Wound Integrity: a Prospective, Randomized Trial Comparing Angled Versus Straight Entry|27-gauge Vitrectomy Wound Integrity: a Prospective, Randomized Trial Comparing Angled Versus Straight Entry in Fluid-filled Vitrectomized Eyes|Completed||N/A|30|Actual|Wills Eye||2|||f||||f||||||||Undecided||2017-10-10 21:59:18.907226|2017-10-10 21:59:18.907226
NCT02836197|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-06-27|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2018|Anticipated|2018-09-01||Interventional|CERTAIN||Randomized Controlled Trial Assessing the Efficacy of a Communication Skills Training Program|Communication About Uncertainty and Hope: A Randomized Controlled Trial Assessing the Efficacy of a Communication Skills Training Program for Physicians Caring for Cancer Patients|Recruiting||N/A|72|Anticipated|Jules Bordet Institute||2|||f||||f|f|f||||||No||2017-10-10 21:59:19.00534|2017-10-10 21:59:19.00534
NCT02836184|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-08-29|||July 2016||2016-07-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|NAHPH||Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia|The Efficacy and Safety of Nicotinic Acid in the Hemodialysis Patients With Hyperphosphatemia|Recruiting||Phase 4|45|Anticipated|Jiujiang No.1 People's Hospital||2|||f||||f||||||||No||2017-10-10 21:59:19.160212|2017-10-10 21:59:19.160212
NCT02836171|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-02-23|||July 2016||2016-07-01|July 2016|2016-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effect of Itraconazole on the Pharmacokinetics of Apatinib|Effect of Itraconazole on the Pharmacokinetics of Apatinib in Chinese Healthy Volunteers|Completed||Phase 1|20|Actual|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 21:59:19.29106|2017-10-10 21:59:19.29106
NCT02836158|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-15|||September 2010||2010-09-01|July 2016|2016-07-01|December 2030|Anticipated|2030-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL|Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With Primary CNS Lymphoma|Recruiting||Phase 2/Phase 3|100|Anticipated|Navy General Hospital, Beijing||1|||f||||f||||||||Undecided||2017-10-10 21:59:19.384239|2017-10-10 21:59:19.384239
NCT02836145|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-14|||August 2016||2016-08-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Observational|||Biomolecular Messages Associated With the Differentiation of Human Induced Pluripotent Stem Cells to Skeletal Muscle Progenitor Cells||Not yet recruiting||N/A|6|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-10 21:59:19.467886|2017-10-10 21:59:19.467886
NCT02836132|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Experience Success: Virtual Reality Skills Training to Enhance e-Weight Loss||Recruiting||N/A|125|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-10-10 21:59:19.525495|2017-10-10 21:59:19.525495
NCT02836119|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-03-31|||July 2016||2016-07-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|SDEGU||Infant Sleep Behaviour and Gut Microbacteria|Sleep Behaviour and Gut Microbiota in Healthy Infants|Recruiting||N/A|128|Anticipated|University of Zurich|||1||f||||f|||||||"     Stool samples   "|No||2017-10-10 21:59:19.621058|2017-10-10 21:59:19.621058
NCT02836106|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-05-09|||June 2016||2016-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Postprandial Effects of High-fat Meals With Different Dairy Products on Lipid Metabolism and Inflammation|Postprandial Effects of High-fat Meals With Different Dairy Products on Lipid Metabolism and Inflammation in Healthy and Obese Subjects|Completed||N/A|59|Actual|University of Oslo||2|||f||||||||||||||2017-10-10 21:59:19.700432|2017-10-10 21:59:19.700432
NCT02836093|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-04-05|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment|Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue|Recruiting||N/A|35|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 21:59:19.809923|2017-10-10 21:59:19.809923
NCT02836080|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-06-06|||August 2016||2016-08-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)|Integrated Collaborative Care Teams to Enhance Service Delivery to Youth With Mental Health and Substance Use Challenges: Protocol for a Pragmatic Randomized-controlled Trial|Recruiting||N/A|500|Anticipated|Centre for Addiction and Mental Health||2|||f||||t||||||||Undecided||2017-10-10 21:59:19.925451|2017-10-10 21:59:19.925451
NCT02836067|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-07-10|||June 15, 2017|Actual|2017-06-15|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation|Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation|Recruiting||N/A|120|Anticipated|Boston Medical Center||2|||f||||t|f|f|||t|||||2017-10-10 21:59:20.052207|2017-10-10 21:59:20.052207
NCT02836054|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-05-31|||November 2013||2013-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|BPL-1318||Study of Degenerescence CSF Hallmarks in Older Bipolar Patients|Study of Degenerescence CSF Hallmarks in Older Bipolar Patients|Recruiting||N/A|30|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 21:59:20.146688|2017-10-10 21:59:20.146688
NCT02836041|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-06-26|||July 2016||2016-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Sleep in Hospitalized Children at MSKCC|A Pilot Study: Sleep in Hospitalized Children With Cancer and Related Diseases|Active, not recruiting||N/A|66|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 21:59:20.243359|2017-10-10 21:59:20.243359
NCT02836028|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-05-23|||October 2016||2016-10-01|December 2016|2016-12-01||||June 2020|Anticipated|2020-06-01||Interventional|||A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer|A Phase 2, Multiple-Cohort, Open-Label, International Study of Talazoparib Monotherapy and Talazoparib Plus Temozolomide in Women With Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer|Withdrawn||Phase 2|0|Actual|Medivation, Inc.||2|||f||||||||||||||2017-10-10 21:59:20.315739|2017-10-10 21:59:20.315739
NCT02836015|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-07-15|||May 2016||2016-05-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|SMV||Shared Medical Visits for Spanish-speaking Patients With Type 2 Diabetes|Shared Medical Visits for Spanish-speaking Patients With Type 2 Diabetes|Recruiting||N/A|16|Anticipated|University of Nebraska||1|||f||||f||||||||Undecided||2017-10-10 21:59:20.394066|2017-10-10 21:59:20.394066
NCT02836002|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-09-28|||June 2016||2016-06-01|September 2017|2017-09-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|CHMI-trans1||Controlled Human Malaria Infection Model for Evaluation of Transmission‐Blocking Interventions - Study 1|'Controlled Human Malaria Infection Study to Assess Gametocytaemia and Mosquito Transmissibility in Participants Challenged With Plasmodium Falciparum by Sporozoite Challenge to Establish a Model for the Evaluation of Transmission-blocking Interventions'|Completed||Phase 1/Phase 2|29|Actual|Radboud University||4|||f||||t||||||||||2017-10-10 21:59:20.496696|2017-10-10 21:59:20.496696
NCT02835989|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2017-08-30|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|CP@Home||Community Paramedicine at Home|Community Paramedicine at Home (CP @Home)|Not yet recruiting||N/A|1200|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 21:59:20.59443|2017-10-10 21:59:20.59443
NCT02835976|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-14|||July 2014||2014-07-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of the Excretion Balance of Radiocarbon and the Pharmacokinetics and Metabolic Profile of TRO19622 (Olesoxime)|A Single-Center, Open-Label, Single Oral Dose Phase I Study to Determine the Excretion Balance of Radiocarbon (i.e., the Sum of 14C-Labeled TRO19622 and Its 14C-Metabolites) and to Investigate the Pharmacokinetics and Metabolic Profile of TRO19622|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 21:59:20.66498|2017-10-10 21:59:20.66498
NCT02835963|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-06-30|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Observational|PREDICA||Acute Heart Failure Study in Patients Admitted to Emergency Department for Dyspnea|Predictive Criteria of Acute Heart Failure (AHF) in Patients Admitted to Emergency Department for Dyspnea.|Completed||N/A|342|Actual|University Hospital, Toulouse|||1||f||||f||||||||||2017-10-10 21:59:20.738687|2017-10-10 21:59:20.738687
NCT02835950|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2017-07-19|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|October 2022|Anticipated|2022-10-01|October 2018|Anticipated|2018-10-01||Interventional|TROPHY 1-US||TReatment Of Pulmonary HYpertension 1-US Study|Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Pulmonary Artery Denervation (PDN) in Patients With Pulmonary Hypertension - US|Recruiting||N/A|15|Anticipated|SoniVie Ltd.||1|||f||||t|f|t|t|f||||||2017-10-10 21:59:20.944269|2017-10-10 21:59:20.944269
NCT02835937|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-07-15|||August 2016||2016-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status|Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status|Not yet recruiting||N/A|30|Anticipated|Mayo Clinic||2|||f||||t||||||||Yes|Participants may obtain their data by request|2017-10-10 21:59:21.078451|2017-10-10 21:59:21.078451
NCT02835924|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-07-31|||July 2016||2016-07-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|RE-ARRANGE||Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC|A Randomized Phase 2 Study Comparing Different Dose Approaches of Induction Treatment (First Cycle) of Regorafenib in Metastatic Colorectal Cancer (mCRC) Patients|Recruiting||Phase 2|295|Anticipated|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||3|||f||||f||||||||||2017-10-10 21:59:21.181527|2017-10-10 21:59:21.181527
NCT02835911|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-02|||November 2012||2012-11-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||Clinical Cohort of Lymphoma Patients in Malawi|LCCC 1229: Developing a Prospective Lymphoma Clinical Cohort in Malawi|Recruiting||N/A|800|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||Samples Without DNA|"     Left-over blood and tissue to be stored for future research testing.   "|No||2017-10-10 21:59:21.287792|2017-10-10 21:59:21.287792
NCT02835898|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-15|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Epigenetics and Periodontal Treatment|The Effect of Periodontal Therapy on Epigenetic Changes: A Pilot Study|Completed||Phase 1|20|Actual|University of Milan|||2||f||||f||||||Samples With DNA|"     Gingival biopsies will be collected in tubes that contain Allprotect tissue reagent (100 ml,     Qiagen, USA), to immediately and effectively stabilize the DNA in tissues, based on the     manufacturer's instructions. Tubes containing the reagent will be stored at 2-8 C. Later     DNA/RNA will be purified using AllPrep DNA/RNA Mini Kit (50 ml, Qiagen, USA), following the     manufacturer's instructions. With this approach, quantitative gene expression of specific     cytokines is possible.   "|Undecided||2017-10-10 21:59:21.390319|2017-10-10 21:59:21.390319
NCT02835885|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-15|||November 2014||2014-11-01|June 2016|2016-06-01||||August 2015|Actual|2015-08-01||Interventional|||Parametric Testing of Direct Physiological Effects of Transcutaneous Vagus Nerve Stimulation (tVNS) in Healthy Controls||Completed||Phase 1|15|Actual|Medical University of South Carolina||2|||f||||t||||||||No||2017-10-10 21:59:21.470576|2017-10-10 21:59:21.470576
NCT02835872|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-09-26|||May 2016||2016-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study to Evaluate the Effects of Dietary Fiber on Blood Lipids in Men and Women|A Randomized, Double-Blind, Parallel Study to Evaluate the Effects of a Dietary Fiber Ingredient on Blood Lipids in Men and Women|Completed||N/A|90|Actual|Tate & Lyle||2|||f||||||||||||Undecided|No plan to share data at this time.|2017-10-10 21:59:21.568129|2017-10-10 21:59:21.568129
NCT02835846|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-11-10|||September 2016||2016-09-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|FUM||Investigation of the Effect of the Female Urinary Microbiome on Incontinence|Investigation of the Effect of the Female Urinary Microbiome on Incontinence|Recruiting||Phase 4|60|Anticipated|Loyola University||1|||f||||f||||||||No||2017-10-10 21:59:21.783366|2017-10-10 21:59:21.783366
NCT02835833|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-01-19|||June 2016||2016-06-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors|Phase I Dose Escalation Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors|Recruiting||Phase 1|8|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||No||2017-10-10 21:59:21.916084|2017-10-10 21:59:21.916084
NCT02835807|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-14|2016-11-02|||June 2015||2015-06-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|September 2019|Anticipated|2019-09-01||Interventional|||Engaging Moms on Teen Indoor Tanning Through Social Media|Likes Pins and Views: Engaging Moms on Teen Indoor Tanning Thru Social Media|Recruiting||N/A|4200|Anticipated|Klein Buendel, Inc.||2|||f||||f||||||||Yes||2017-10-10 21:59:22.158357|2017-10-10 21:59:22.158357
NCT02835794|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-05-01|||August 2016||2016-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)|A Phase I/II Clinical Trial of Omacetaxine, Azacitidine, and G-CSF for Relapsed and/or Refractory Myelodysplastic Syndromes|Withdrawn||Phase 1/Phase 2|0|Actual|University of Florida||1||Lack of funding to support clinical trial|f||||t|t|f||||||||2017-10-10 21:59:22.295779|2017-10-10 21:59:22.295779
NCT02835781|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-13|||January 2010||2010-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|January 2014|Actual|2014-01-01||Observational|Adermbrerec||Acellular Dermal Matrix in Breast Reconstruction|Allogenic Acellular Dermal Matrix Use in Patients With Breast Reconstruction|Completed||N/A|30|Actual|University Hospital Bratislava|||1||f||||f||||||Samples Without DNA|"     Acellular dermal tissue after primary reconstruction will be harvested prior to second     surgery with permanent implant.   "|No||2017-10-10 21:59:22.428942|2017-10-10 21:59:22.428942
NCT02835768|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-07-13|||July 2016||2016-07-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||Effectiveness of Internet-based Injury Prevention Program in Enhancing Mother's Knowledge on Child Safety||Not yet recruiting||N/A|934|Anticipated|The University of Hong Kong||2|||f||||||||||||||2017-10-10 21:59:22.533584|2017-10-10 21:59:22.533584
NCT02835755|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-01|||July 11, 2016|Actual|2016-07-11|August 2017|2017-08-01|April 16, 2017|Actual|2017-04-16|September 8, 2016|Actual|2016-09-08||Interventional|||Mobile Health Intervention in Increasing HPV Vaccine Coverage Among Young Adult Gay and Bisexual Men|Increasing HPV Vaccine Coverage Among Young Adult Gay and Bisexual Men|Completed||N/A|150|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 21:59:23.161641|2017-10-10 21:59:23.161641
NCT02835742|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-12|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|August 2017|Actual|2017-08-01||Interventional|||Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan|Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan|Active, not recruiting||Phase 2|80|Anticipated|Niigata University Medical & Dental Hospital||2|||f||||||||||||||2017-10-10 21:59:23.275986|2017-10-10 21:59:23.275986
NCT02835729|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-08-02|||July 2016||2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase 1b / Randomized Phase 2a Trial of Indoximod in Combination With Idarubicin and Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)|Recruiting||Phase 1/Phase 2|138|Anticipated|NewLink Genetics Corporation||3|||f||||t||||||||||2017-10-10 21:59:23.361656|2017-10-10 21:59:23.361656
NCT02835716|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-09-10|||September 2016||2016-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01|5 Years|Observational [Patient Registry]|PCD=OOALZ||Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO|Pre-Clinical Alzheimer's (ALZ) Diagnosis (PCD) = Optimum Outcomes (OO)|Recruiting||N/A|150|Anticipated|Millennium Magnetic Technologies, LLC|||1||f||||f||||||||Yes||2017-10-10 21:59:23.481605|2017-10-10 21:59:23.481605
NCT02835703|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-15|||July 2016||2016-07-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Clinical Assessment of Perfusion Techniques During Repair of Coarctation With Aortic Arch Hypoplasia in Infants|Clinical Assessment of Perfusion Techniques During Surgical Repair of Coarctation of Aorta With Aortic Arch Hypoplasia in Infants|Recruiting||N/A|45|Anticipated|Meshalkin Research Institute of Pathology of Circulation||3|||f||||t||||||||Undecided||2017-10-10 21:59:23.60539|2017-10-10 21:59:23.60539
NCT02835690|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-09-06|||August 4, 2016|Actual|2016-08-04|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)|An Open-label, Randomized Phase I Study Investigating Safety, Tolerability, Pharmacokinetics, and Efficacy of Pembrolizumab (MK-3475) in Chinese Subjects With Non-Small-Cell Lung Cancer|Active, not recruiting||Phase 1|42|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-10 21:59:23.740581|2017-10-10 21:59:23.740581
NCT02835677|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-06-12|||September 7, 2016|Actual|2016-09-07|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|MS Caregiver||Integrating Caregiver Support Into MS Care|Integrating Caregiver Support Into MS Care|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||No||2017-10-10 21:59:23.835444|2017-10-10 21:59:23.835444
NCT02835664|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-12-21|||December 2016||2016-12-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Nicotinamide Riboside and Metabolic Health|Effects of Nicotinamide Riboside on Metabolic Health in (Pre)Obese Humans|Recruiting||N/A|15|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 21:59:23.920567|2017-10-10 21:59:23.920567
NCT02835651|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-21|||April 14, 2016|Actual|2016-04-14|March 2017|2017-03-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|||Saturated Fatty Acids and HDL Metabolism|Effects of C16:0 Versus C18:0 on HDL Metabolism and Other Cardiometabolic Risk Markers: A Dietary Intervention Study in Healthy Normal-weight and Overweight Subjects|Completed||N/A|41|Actual|Maastricht University Medical Center||2|||f||||||||||||||2017-10-10 21:59:24.019464|2017-10-10 21:59:24.019464
NCT02835638|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-09-12|||June 26, 2017|Actual|2017-06-26|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|FACIL-VAA||Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASV|Observational Multicenter Cohort Study of French Patients With a Central or Combined Syndrome of Sleep Apnea With a Predominant Central SAS Treated by Adaptive Servo-Ventilation|Recruiting||N/A|520|Anticipated|Société Française de Recherche et de Médecine du Sommeil|||1||f||||t||||||||||2017-10-10 21:59:24.127654|2017-10-10 21:59:24.127654
NCT02835625|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-08-09|||January 2016||2016-01-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|TOBE||The Tomosynthesis Trial in Bergen|Digital Breast Tomosynthesis - The Future Screening Tool for Breast Cancer?|Recruiting||N/A|37000|Anticipated|Cancer Registry of Norway||2|||f||||f||||||||||2017-10-10 21:59:24.23594|2017-10-10 21:59:24.23594
NCT02835612|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-08-18|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Early Intervention Program for Preterm Infants and Their Parents: Establishing the Impact at 18 Months Corrected Age|Early Intervention Program for Preterm Infants and Their Parents: Establishing the Impact at 18 Months Corrected Age|Recruiting||N/A|88|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 21:59:24.36458|2017-10-10 21:59:24.36458
NCT02835599|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-08-17|||November 1, 2016|Actual|2016-11-01|August 2017|2017-08-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06|5 Years|Observational [Patient Registry]|REVOLUTION||Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now|Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now|Terminated||N/A|23|Actual|AstraZeneca|||1|"The study sponsor requested the study be terminated as the existing study design did not meet   their needs."|f||||f||||||Samples With DNA|"     Archived residual specimens will be requested from appropriate institution for each patient     at consent. One block or 20 slides (if block is not available) will be requested for each     patient for molecular testing and sent as directed by the Lab Manual. Specimens will be     banked at the Carolinas HealthCare Biospecimen Repository (CHS BSR) specifically for this     protocol in their Clinical Trials Management System Biospecimen Module (CTMS BSM).   "|||2017-10-10 21:59:24.45672|2017-10-10 21:59:24.45672
NCT02835586|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-13|||May 2013||2013-05-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|STREAMER||STREAMER : STent Restenosis And MEdicaments Release|STREAMER : Stent Restenosis and Medicaments Release : Does Local Delivery of Paclitaxel be Safe and Efficient in Stenting of TransAtlantic InterSociety Consensus (TASC) Class C and D Femoropopliteal Artery Lesions|Completed||Phase 3|15|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-10 21:59:24.567238|2017-10-10 21:59:24.567238
NCT02835573|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-13|||April 2016||2016-04-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Potential Diagnostic and Prognostic Value of microRNAs for the Patients of Sepsis-induced Myocardial Injury||Active, not recruiting||N/A|100|Actual|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||||Undecided||2017-10-10 21:59:24.649088|2017-10-10 21:59:24.649088
NCT02835560|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2016-07-15|||June 2013||2013-06-01|June 2012|2012-06-01||||July 2015|Actual|2015-07-01||Interventional|||Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection|Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection|Completed||Phase 4|100|Actual|Livzon Pharmaceutical Group Inc.||2|||f||||t||||||||||2017-10-10 21:59:24.712201|2017-10-10 21:59:24.712201
NCT02835547|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-15|||February 2009||2009-02-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|CARMIN||Evaluation and Management of Cardiovascular Risk Factors in Inflammatory and Acquired Dysimmune Diseases (CARMIN)|Evaluation and Management of Cardiovascular Risk Factors in Inflammatory and Acquired Dysimmune Diseases (CARMIN)|Completed||N/A|600|Actual|Hospices Civils de Lyon|||6||f||||f||||||||||2017-10-10 21:59:24.7727|2017-10-10 21:59:24.7727
NCT02835534|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-07-13|||May 2016||2016-05-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI|The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute ST Elevation Myocardial Infarction(STEMI): a Multi-center, Randomized, Open, Parallel, Non-inferiority, Active Controlled Trial|Active, not recruiting||Phase 4|6200|Anticipated|Guangzhou Recomgen Biotech Co., Ltd.||2|||f||||t||||||||Undecided||2017-10-10 21:59:24.833172|2017-10-10 21:59:24.833172
NCT02835521|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-13|||August 2016||2016-08-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|||Influence of Perception of Patients Suffering of Knee Osteoarthritis Regarding Effectiveness of Intra-articular Injection|Influence of Perception of Patients Suffering of Osteoarthritis of Knee Over the Effectiveness and Tolerance in Intra-articular Injection of Corticoids: a Prospective, Controlled and Randomized Study|Not yet recruiting||Phase 4|100|Anticipated|Federal University of São Paulo||2|||f||||f||||||||No||2017-10-10 21:59:24.975803|2017-10-10 21:59:24.975803
NCT02835508|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-01-10|||June 2016||2016-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants|A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Pharmacokinetic Profile of JNJ-56021927 When Administered as the Tablet Formulation in Healthy Male Japanese Subjects|Completed||Phase 1|18|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-10-10 21:59:25.189875|2017-10-10 21:59:25.189875
NCT02835495|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-07-14|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|HELP Vets||Healthy Living Partnerships to Prevent Diabetes in Veterans Pilot Study|The Healthy Living Partnerships to Prevent Diabetes in Veterans Pilot Study|Not yet recruiting||N/A|50|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-10 21:59:25.314806|2017-10-10 21:59:25.314806
NCT02835482|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-02-07|||April 14, 2016|Actual|2016-04-14|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|FEMTOHTO||Effect of Elevated Intraocular Pressure in Glaucoma Patients During Femtolaser Cataract Surgery||Recruiting||N/A|260|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f||||||||||2017-10-10 21:59:25.416806|2017-10-10 21:59:25.416806
NCT02835430|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2016-07-16|||November 2014||2014-11-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Coronally Advanced Flap and PRF With or Without Demineralized Freeze-dried Bone Allograft in Gingival Recession||Completed||Phase 4|10|Actual|Dr. D. Y. Patil Dental College & Hospital||2|||f||||t||||||||||2017-10-10 21:59:25.890974|2017-10-10 21:59:25.890974
NCT02835417|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-03-20|||January 2012||2012-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FETUSES||Fetal Evaluation at Term Using Statistical ECG Signal Processing (FETUSES)|Fetal Evaluation at Term Using Statistical ECG Signal Processing (FETUSES)|Suspended||N/A|4500|Anticipated|Hospices Civils de Lyon|||1|"The recruitement is suspended because of problems wtih the society responsible of the data   base."|f||||f||||||||||2017-10-10 21:59:26.005441|2017-10-10 21:59:26.005441
NCT02835404|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-13|||November 2012||2012-11-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|June 2017|Anticipated|2017-06-01||Interventional|||Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer|A Randomized, Open Label, Single Centre Clinical Trial of Pelvic External Radiotherapy Combined With 252-Cf Neutron Intracavitary Brachytherapy With or Without Platinum in Treatment of Local Advanced Cervical Cancer|Recruiting||Phase 2|200|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||||||||||||2017-10-10 21:59:26.098227|2017-10-10 21:59:26.098227
NCT02835391|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-08-31|||November 2015||2015-11-01|July 2016|2016-07-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||PerClot Compared to Usual Care in Gynaecology Procedures|A Prospective, Multi-Centre, Randomized, Safety and Effectiveness Study of PerClot Compared to Usual Care When Used During Gynaecology Procedures|Completed||N/A|90|Actual|CryoLife Europa||2|||f||||f||||||||||2017-10-10 21:59:26.241237|2017-10-10 21:59:26.241237
NCT02835378|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-15|||December 2015||2015-12-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|ARMOBS||Bilateral Upper Limb Amputation Observatory|Observational Study of Bilateral Upper Limb Amputees in France|Recruiting||N/A|40|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:59:26.359706|2017-10-10 21:59:26.359706
NCT02835365|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-07-31|||January 2015||2015-01-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|OBADE||Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in France|Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in French Gastro and Hepatology Departments|Active, not recruiting||N/A|200|Anticipated|Centre Hospitalier Intercommunal Creteil|||1||f||||f||||||Samples Without DNA|"     biologic sample to dose the blood baclofenemia   "|||2017-10-10 21:59:26.512064|2017-10-10 21:59:26.512064
NCT02835352|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-13|||June 2016||2016-06-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|RHECAP||Essential Oils on Anxiety of Patients Suffering From Cancer|Impact of Essential Oils on Anxiety of Patients Suffering From Metastasis Cancer - Feasibility Study|Recruiting||Early Phase 1|80|Anticipated|Center Eugene Marquis||2|||f||||f||||||||No|Not authorized by French law|2017-10-10 21:59:26.627044|2017-10-10 21:59:26.627044
NCT02835339|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-07-30|||July 2016||2016-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Magnesium Sulfate in Obese Preeclamptics|Randomized Trial of Magnesium Sulfate in Obese Preeclamptic Women|Enrolling by invitation||Phase 1/Phase 2|38|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 21:59:26.72189|2017-10-10 21:59:26.72189
NCT02835326|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|CLIP-OA||Collaborative Lifestyle Intervention Program in Knee Osteoarthritis Patients|The Collaborative Lifestyle Intervention Program in Knee Osteoarthritis Patients: CLIP-OA|Recruiting||N/A|224|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-10 21:59:26.826988|2017-10-10 21:59:26.826988
NCT02835313|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-05-16|||July 2016||2016-07-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|January 2021|Anticipated|2021-01-01||Interventional|PROWALKS||Promoting Recovery Optimization With WALKing Exercise After Stroke||Recruiting||Phase 2/Phase 3|258|Anticipated|University of Delaware||3|||f||||t||||||||Yes|De-identified data will be deposited in the National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH) repository.|2017-10-10 21:59:26.955712|2017-10-10 21:59:26.955712
NCT02835300|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-06-27|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|CampAirPilot||Mobile Technology and Online Tools to Improve Asthma Control in Adolescents|Mobile Technology and Online Tools to Improve Asthma Control in Adolescents|Completed||Phase 2|79|Actual|3-C Institute for Social Development||2|||f||||t||||||||Undecided||2017-10-10 21:59:27.066294|2017-10-10 21:59:27.066294
NCT02835287|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-11-30|||September 2016||2016-09-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|December 2018|Anticipated|2018-12-01||Interventional|D4C||Diabetes Complication Control in Community Clinics (D4C) Trial|Diabetes Complication Control in Community Clinics (D4C) Trial|Recruiting||N/A|12000|Anticipated|Tulane University||2|||f||||f||||||||No||2017-10-10 21:59:27.169834|2017-10-10 21:59:27.169834
NCT02835274|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-09-18|||July 2016||2016-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|DIRECT-DBS||Study to Characterize Acute and Chronic Directional Aspects of Deep Brain Stimulation|Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation|Recruiting||N/A|12|Anticipated|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-10 21:59:27.274469|2017-10-10 21:59:27.274469
NCT02835261|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-18|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Impact of Sleep Restriction in Women|Impact of Sleep Restriction on Cardiometabolic Risk Factors in Pre vs Postmenopausal Women|Recruiting||N/A|80|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-10 21:59:27.366579|2017-10-10 21:59:27.366579
NCT02835235|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-07-21|||July 26, 2016|Actual|2016-07-26|July 2017|2017-07-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|||A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity|A Double-blinded Placebo-controlled Multiple Dose Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects With Prediabetes and With Overweight or Obesity|Completed||Phase 1|48|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 21:59:27.579034|2017-10-10 21:59:27.579034
NCT02835222|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Selinexor With Induction, Consolidation, and Maintenance Therapy in Treating Older Patients With Acute Myeloid Leukemia|A Pilot Phase II Study of Selinexor in Combination With Induction/Consolidation/Maintenance Therapy in Older AML Patients|Not yet recruiting||Phase 2|50|Anticipated|Wake Forest University Health Sciences||1|||f||||t|t|f|||f|||||2017-10-10 21:59:27.670039|2017-10-10 21:59:27.670039
NCT02835209|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-09-22|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|||Positioning During SBT in NICU Infants|Effect of Position on the Spontaneous Breathing Trial|Not yet recruiting||N/A|30|Anticipated|Christiana Care Health Services|||1||f||||f||||||||||2017-10-10 21:59:27.792489|2017-10-10 21:59:27.792489
NCT02834104|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-12|||May 2012||2012-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Validation of Fibrosis Quantification Using T1 Mapping Against Histology as Reference and Comparison With Fibrosis Biomarkers|Validation of Fibrosis Quantification Using T1 Mapping Against Histology as Reference and Comparison With Fibrosis Biomarkers|Recruiting||N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 21:59:27.868861|2017-10-10 21:59:27.868861
NCT02834091|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-04|||January 22, 2016|Actual|2016-01-22|September 2017|2017-09-01|June 2017|Actual|2017-06-01|November 2, 2016|Actual|2016-11-02||Observational|SEDuCE||Satisfaction Survey of Patients Over Hypnoanalgesia or Hypnosedation at a Digestive Endoscopy or Surgery|Satisfaction Survey of Patients Over Hypnoanalgesia or Hypnosedation at a Digestive Endoscopy or Surgery|Completed||N/A|80|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 21:59:27.962214|2017-10-10 21:59:27.962214
NCT02835196|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-18|||September 2016||2016-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:59:28.025926|2017-10-10 21:59:28.025926
NCT02835183|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-07-14|||January 2017||2017-01-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of iDECIDE: A Smartphone App for Insulin Dosing Accounting for Alcohol and Exercise|Prospective Evaluation of iDECIDE: A Smartphone App for Insulin Bolus Dosing|Not yet recruiting||Phase 1|30|Anticipated|Arizona State University||2|||f||||t||||||||No||2017-10-10 21:59:28.066695|2017-10-10 21:59:28.066695
NCT02835170|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-06-28|||March 2015||2015-03-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Development of a Personalized Immune-modulating Therapy for Patients With Atopic Dermatitis|Evaluation of Clinical Efficacy of Autologous Immunoglobulin Therapy for Recalcitrant Atopic Dermatitis: A Randomized, Double-blind, Placebo-controlled Study|Recruiting||Phase 2/Phase 3|70|Anticipated|Ajou University School of Medicine||2|||f||||f||||||||Yes||2017-10-10 21:59:28.140753|2017-10-10 21:59:28.140753
NCT02835157|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-07-27|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Balanced Salt Solutions vs. Normal Saline in Children With Septic Shock|Balanced Salt Solutions Versus Normal Saline for Initial Fluid Resuscitation in Children With Septic Shock: A Randomized Controlled Trial|Recruiting||N/A|708|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t|f|f||||||||2017-10-10 21:59:28.233439|2017-10-10 21:59:28.233439
NCT02835144|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-14|||July 2016||2016-07-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Substance Use in Elderly Individuals: Brain and Cognitive Correlates and the Effect of Psychotherapy|Randomised Monocentric Clinical Study for the Identification of Cognitive and Neuroanatomical Alterations and for the Evaluation of the Efficacy of a Psychotherapeutic Intervention in Individuals With Risky Consumption of Alcohol and/or Sedative Drugs Aged ≥ 65 Years|Not yet recruiting||N/A|120|Anticipated|Psychiatric University Hospital, Zurich||2|||f||||f||||||||Undecided||2017-10-10 21:59:28.363061|2017-10-10 21:59:28.363061
NCT02835131|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-13||||||May 2016|2016-05-01||||||||Expanded Access|||Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia|Compassionate Use of SOM230 for Individual Patient (NS, 14-Jan-1986) With Hyperinsulinemic/Hypoglycemia|Available||N/A|||Montefiore Medical Center|||||||||||||||||||2017-10-10 21:59:28.432512|2017-10-10 21:59:28.432512
NCT02835118|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-21|||July 2009||2009-07-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)|A Randomized, Double-Blinded, Placebo-Controlled, Multiple-Dose, Safety and Pharmacokinetic Study of Ascending Doses of Oral CB-183,315 in Healthy Volunteers|Completed||Phase 1|30|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-10 21:59:28.519188|2017-10-10 21:59:28.519188
NCT02835105|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-21|||January 2009||2009-01-01|July 2016|2016-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)|A Randomized, Double-Blinded, Placebo-Controlled, Single-Dose, Safety and Pharmacokinetic Study of Ascending Doses of CB-183,315 in Healthy Volunteers|Completed||Phase 1|40|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-10 21:59:28.616192|2017-10-10 21:59:28.616192
NCT02835092|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-02-24|||July 2016|Actual|2016-07-01|July 2016|2016-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Weight Loss Using the Take Shape For Life Program or the Medifast Direct Program Versus a Self-Directed Diet|A Randomized, Controlled, 3-Arm Clinical Trial to Assess Weight Loss Using the Take Shape For Life Program or the Medifast Direct Program Versus a Self-Directed Diet|Completed||N/A|198|Actual|Medifast, Inc.||3|||f||||f||||||||Undecided||2017-10-10 21:59:28.714543|2017-10-10 21:59:28.714543
NCT02835079|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-07-13|||November 2016||2016-11-01|July 2016|2016-07-01||||November 2019|Anticipated|2019-11-01||Interventional|||Treatment Effect of Tamoxifen on Patients With DMD||Not yet recruiting||Phase 1|30|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-10-10 21:59:28.814891|2017-10-10 21:59:28.814891
NCT02835066|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-05-25|||July 2016||2016-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer|A Pilot Study Investigating Patient Function/Fitness and Psychosocial Health in Patients With Non-Small Cell Lung Cancer|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences|||1||f||||t|f|f||||||||2017-10-10 21:59:28.895564|2017-10-10 21:59:28.895564
NCT02835040|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2017-04-29|||August 2016||2016-08-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|IMPROVe-GAP||IMPROVinG Outcomes in Community Acquired Pneumonia|Evaluating the Impact of a New Model of Care Designed to Improve Evidence-based Management of Community-acquired Pneumonia|Recruiting||N/A|800|Anticipated|Western Health, Australia||2|||f||||f||||||||No||2017-10-10 21:59:29.108429|2017-10-10 21:59:29.108429
NCT02835027|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-18|||January 1994||1994-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2014|Actual|2014-12-01|22 Years|Observational [Patient Registry]|||Treatment of Acute Lower Limb Ischaemia in Sweden 1994-2014|Treatment of Acute Lower Limb Ischaemia in Sweden 1994-2014|Completed||N/A|16287|Actual|Uppsala University Hospital|||1||f||||f||||||||Undecided||2017-10-10 21:59:29.239488|2017-10-10 21:59:29.239488
NCT02835001|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-14|||January 2017||2017-01-01|July 2016|2016-07-01|June 2022|Anticipated|2022-06-01|January 2020|Anticipated|2020-01-01||Interventional|HEAT-LVRC||Hyperinflation Assessment After Treatment by Lung Volume Reduction Coil|Impact of Reduction Lung Volume Reduction by Coil on Hyperinflation in Severe Emphysema|Not yet recruiting||Phase 3|20|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||Undecided||2017-10-10 21:59:29.406039|2017-10-10 21:59:29.406039
NCT02834988|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-05-02|||July 28, 2016|Actual|2016-07-28|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer|The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)|Recruiting||N/A|1700|Anticipated|University of Miami||1|||f||||t||||||||No||2017-10-10 21:59:29.470387|2017-10-10 21:59:29.470387
NCT02834975|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-28|||December 22, 2016|Actual|2016-12-22|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).|Phase II Single Arm Study of Combination Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Ovarian, Fallopian Tube, or Peritoneal Carcinoma Receiving Neoadjuvant Chemotherapy|Recruiting||Phase 2|40|Anticipated|University of Miami||1|||f||||t|t|f||||||||2017-10-10 21:59:29.555251|2017-10-10 21:59:29.555251
NCT02834962|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-14|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of Single And Double Bundle Anterior Cruciate Ligament (ACL) Graft Cross-sectional Dimensions|Study of Single And Double Bundle ACL Graft Cross-sectional Dimensions Compared With Native ACL|Not yet recruiting||N/A|100|Anticipated|Peking University Third Hospital||2|||f||||t||||||||||2017-10-10 21:59:29.831408|2017-10-10 21:59:29.831408
NCT02834949|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-12|||July 2012||2012-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Improving Brief Alcohol Interventions With a Behavioral Economic Supplement|Improving Brief Alcohol Interventions With a Behavioral Economic Supplement|Active, not recruiting||N/A|393|Actual|University of Memphis||3|||f||||t||||||||Yes|The investigators will maintain a de-identified database and after they publish the primary outcomes, they will make an individual level data available to researchers who are conducting integrated analyses.|2017-10-10 21:59:29.977867|2017-10-10 21:59:29.977867
NCT02834936|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-03-27|||September 27, 2016||2016-09-27|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation|A Phase 2 Clinica Study: Efficacy and Safety of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation|Recruiting||Phase 2|55|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||Undecided|The plan havn't been decided|2017-10-10 21:59:30.143391|2017-10-10 21:59:30.143391
NCT02834923|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-15|||October 2016||2016-10-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|April 2019|Anticipated|2019-04-01||Interventional|EE-CTH||Enhancing Self-Management Support in Diabetes Through Patient Engagement|Enhancing Self-Management Support in Diabetes Through Patient Engagement|Not yet recruiting||N/A|744|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 21:59:30.323958|2017-10-10 21:59:30.323958
NCT02834910|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-26|||January 2009||2009-01-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Observational|||Qnr Genes in Enterobacteriaceae|Prevalence, Characterization and Risk Factors of Acquiring Qnr Genes in Extended Spectrum Beta-lactamase Producing Enterobacteriaceae Isolated in East Inter-region.|Completed||N/A|133|Actual|CHU de Reims|||2||f||||||||||||||2017-10-10 21:59:30.492463|2017-10-10 21:59:30.492463
NCT02834897|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-20|||May 2015||2015-05-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|May 2016|Actual|2016-05-01||Interventional|PELVI-EOS||Performance Evaluation of System EOS Imaging in Pelvimetry Versus Pelvi-scanner||Recruiting||N/A|35|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 21:59:30.591446|2017-10-10 21:59:30.591446
NCT02834884|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-05-30|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01|5 Years|Observational [Patient Registry]|SPECTArare||SPECTArare: Screening Patients With Rare Tumors for Efficient Clinical Trial Access|SPECTArare: Screening Patients With Rare Tumors for Efficient Clinical Trial Access|Recruiting||N/A|1000|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||t||||||Samples With DNA|"     FFPE tissue sample Blood sample   "|||2017-10-10 21:59:30.695442|2017-10-10 21:59:30.695442
NCT02834858|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-04-04|||January 2016||2016-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications|Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications|Recruiting||Phase 1|240|Anticipated|The Third Affiliated Hospital of Southern Medical University||2|||f||||t||||||||Undecided||2017-10-10 21:59:30.896566|2017-10-10 21:59:30.896566
NCT02834845|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-12|||June 2016||2016-06-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of Volatile Anesthetics on Cerebral Oxygenation During Controlled Hypotension|Comparison of Effects of Sevoflurane and Desflurane on Cerebral Oxygenation During Controlled Hypotension|Recruiting||Phase 4|60|Anticipated|Ufuk University||2|||f||||f||||||||||2017-10-10 21:59:31.027394|2017-10-10 21:59:31.027394
NCT02834819|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-07-14|||September 2013||2013-09-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis|A Randomized Controlled Trial of Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis|Terminated||N/A|29|Actual|University of Colorado, Denver||2||Lack of financial support|f||||f||||||||Undecided||2017-10-10 21:59:31.251057|2017-10-10 21:59:31.251057
NCT02834806|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-10-30|||September 2016||2016-09-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|December 2016|Anticipated|2016-12-01||Interventional|||BIONICS Israel Trial|BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial|Recruiting||N/A|60|Anticipated|Medinol Ltd.||1|||f||||t||||||||No||2017-10-10 21:59:31.400887|2017-10-10 21:59:31.400887
NCT02834793|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-18|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|September 2019|Anticipated|2019-09-01||Interventional|||Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome|Recruiting||Phase 3|142|Anticipated|Eisai Inc.||2|||f||||t||||||||||2017-10-10 21:59:31.528955|2017-10-10 21:59:31.528955
NCT02834780|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-15|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma|An Open-Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma|Recruiting||Phase 1|105|Anticipated|Eisai Inc.||1|||f||||f||||||||||2017-10-10 21:59:31.697016|2017-10-10 21:59:31.697016
NCT02834767|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-08|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Genioglossus Muscle Training for Snoring and Obstructive Sleep Apnea|Genioglossus Muscle Training for Snoring and Obstructive Sleep Apnea|Recruiting||N/A|100|Anticipated|University of Florida|||4||f||||f|f|f||||||||2017-10-10 21:59:31.811059|2017-10-10 21:59:31.811059
NCT02834754|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-15|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|Vedo Post-op||A Randomized, Double-blind, Placebo Controlled Study of Vedolizumab for the Prevention of Post-operative Crohn's Disease Recurrence|A Randomized, Double-blind, Placebo Controlled Study of Vedolizumab for the Prevention of Post-operative Crohn's Disease Recurrence|Not yet recruiting||Phase 2|24|Anticipated|University of Pittsburgh||2|||f||||t|t|f|||f|||||2017-10-10 21:59:31.912905|2017-10-10 21:59:31.912905
NCT02834741|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-04-04|||July 2016||2016-07-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Safety, Tolerability, PK of Oral NYX-2925 in Healthy Volunteers|A Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Daily Oral NYX2925 in Healthy Volunteers|Completed||Phase 1|84|Actual|Aptinyx||2|||f||||f||||||||Yes||2017-10-10 21:59:32.008869|2017-10-10 21:59:32.008869
NCT02834728|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-22|||March 2001||2001-03-01|July 2016|2016-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|SAFES Cohort||Frail Elderly Subjects - Evaluation and Follow-Up|Frail Elderly Subjects: Inhospital Pathways and Adverse Outcome After Hospitalisation Via Emergency Department|Completed||N/A|1306|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 21:59:32.10572|2017-10-10 21:59:32.10572
NCT02834715|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-01-23|||March 2016||2016-03-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|STEDIA1||Metabolic Effects of Stevia in Type 2 Diabetic Patients|Effects of Stevia on Glycaemic Profile and Insulin Secretion of Type 2 Diabetic Patients|Completed||N/A|22|Actual|Yaounde Central Hospital||2|||f||||t||||||||||2017-10-10 21:59:32.209139|2017-10-10 21:59:32.209139
NCT02834702|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-21|||January 2017||2017-01-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Sinew Acupuncture for Neck Pain: Randomized Controlled Trial|Sinew Acupuncture for Chronic Mechanical Neck Pain: a Randomized Assessor-blind Sham-controlled Trial|Not yet recruiting||N/A|130|Anticipated|The University of Hong Kong||2|||f||||f||||||||Undecided||2017-10-10 21:59:32.316148|2017-10-10 21:59:32.316148
NCT02834689|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-01|||July 2016||2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|E-PAraDiGM||The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol||Recruiting||N/A|80|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 21:59:32.419539|2017-10-10 21:59:32.419539
NCT02834676|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-12|||June 2016||2016-06-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|||Clinical Effects of Gelified Ethanol Application in Cervical Disc Hernia|Retrospective Evaluation of Treatment of Chronic Pain Related to Cervical Disc Hernia Using Chemonucleolysis Substance|Recruiting||N/A|35|Anticipated|Sakarya University|||1||f||||f||||||||No||2017-10-10 21:59:32.51893|2017-10-10 21:59:32.51893
NCT02834663|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2016-07-14|||July 2016||2016-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effects of Ranibizumab to Delay or Regression Non-proliferative Diabetic Retinopathy(NPDR) With DME Assessed by Microaneurysm Changes: A Pilot Study|Effects of Ranibizumab to Delay or Regression Non-proliferative Diabetic Retinopathy(NPDR) With DME Assessed by Microaneurysm Changes: A Pilot Study|Not yet recruiting||Phase 4|25|Anticipated|Wonkwang University Hospital||1|||f||||f||||||||No||2017-10-10 21:59:32.61946|2017-10-10 21:59:32.61946
NCT02834650|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-08-14|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|October 2022|Anticipated|2022-10-01|January 2021|Anticipated|2021-01-01||Interventional|||Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD|Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for Duchenne Muscular Dystrophy (DMD)|Recruiting||N/A|154|Anticipated|University of California, Los Angeles||4|||f||||t|f|f||||||||2017-10-10 21:59:32.7118|2017-10-10 21:59:32.7118
NCT02834637|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-06-19|||February 23, 2017|Actual|2017-02-23|August 2016|2016-08-01|March 2021|Anticipated|2021-03-01|November 2020|Anticipated|2020-11-01||Interventional|DoRIS||A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls|A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls|Recruiting||Phase 3|900|Anticipated|London School of Hygiene and Tropical Medicine||6|||f||||t|f|f|||f|||Undecided||2017-10-10 21:59:32.819969|2017-10-10 21:59:32.819969
NCT02834624|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-05-08|2016-11-02||July 2013||2013-07-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|NEOSURF|Preterm infants less than 35 weeks gestation who required intubation for RDS and surfactant administration|Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome|Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome|Completed||N/A|30|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-10-10 21:59:32.952677|2017-10-10 21:59:32.952677
NCT02834611|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-09-11|||March 15, 2017|Actual|2017-03-15|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Ceramide NanoLiposome in Patients With Advanced Solid Tumors|Phase I Study of C6 Ceramide NanoLiposome in Patients With Advanced Solid Tumors|Recruiting||Phase 1|24|Anticipated|Keystone Nano, Inc||1|||f||||t|t|f||||||||2017-10-10 21:59:33.245284|2017-10-10 21:59:33.245284
NCT02834598|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-13|||June 2014||2014-06-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|BAL-EASE||Towards an Objectivation of the Therapeutic Effect of a Rocking Movement|Objectivating the Therapeutic Effect of a Rocking Movement by High Density Electroencephalography|Completed||N/A|18|Actual|Centre Hospitalier Universitaire de Besancon||3|||f||||f||||||||||2017-10-10 21:59:33.333493|2017-10-10 21:59:33.333493
NCT02834585|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-13|||October 2014||2014-10-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Observational|MUSTT||Magnetic Resonance Imaging or Ultrasound in Soft Tissue Tumors (MUSTT)|Follow-up of Recurrences of Limb Soft Tissue Sarcomas in Patients With Localized Disease: Performance of Ultrasound|Recruiting||N/A|70|Anticipated|University of Genova|||2||f||||t||||||||||2017-10-10 21:59:33.450189|2017-10-10 21:59:33.450189
NCT02834572|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-04-24|||June 2016||2016-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options|Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options|Active, not recruiting||N/A|236|Actual|New York Blood Center||2|||f||||t||||||||Undecided||2017-10-10 21:59:33.532648|2017-10-10 21:59:33.532648
NCT02834559|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-11-29|||October 2016||2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|PRIVENT||Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.|Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.|Recruiting||Phase 3|560|Anticipated|Universitätsklinikum Köln||2|||f||||t||||||||||2017-10-10 21:59:33.61379|2017-10-10 21:59:33.61379
NCT02834546|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-11-03|||October 2016||2016-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|November 2017|Anticipated|2017-11-01||Observational|ACTES||Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma|Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 21:59:33.74491|2017-10-10 21:59:33.74491
NCT02834533|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-15|||January 2014||2014-01-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||Role of Virtual Reality in MS Rehabilitation|Robotic Gait Training in Multiple Sclerosis: a Randomized Clinical Trial Evaluating Virtual Reality Role|Completed||N/A|40|Actual|"IRCCS Centro Neurolesi Bonino-Pulejo"||2|||f||||t||||||||Undecided|We are planning this.|2017-10-10 21:59:33.837004|2017-10-10 21:59:33.837004
NCT02834520|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-14|||May 2015||2015-05-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|||Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus|Expression of miRNA-138 and Cyclin D1 in Oral Lichen Planus (A Study Utilizing Immunohistochemistry and Real-time Polymerase Chain Reaction)|Completed||N/A|60|Actual|Cairo University|||2||f||||f||||||Samples Without DNA|"     oral mucosa tissue specimen   "|||2017-10-10 21:59:33.900927|2017-10-10 21:59:33.900927
NCT02834507|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-13|||March 2005||2005-03-01|July 2016|2016-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients|A Double-blind, Randomised, Placebo- and Active-controlled, Cross-over Study to Investigate the Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients|Completed||Phase 2|19|Actual|Bial - Portela C S.A.||4|||f||||f||||||||Undecided||2017-10-10 21:59:33.963284|2017-10-10 21:59:33.963284
NCT02834494|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-07-10|||February 2016||2016-02-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|NEO-ELASTO||Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave),|3D Elastography (Shear Wave) : Assessment of Response to Neo-adjuvant Chemotherapy (NACT) : in Vivo Quantification, for Patients With a Locally Advanced Breast Cancer.|Recruiting||N/A|140|Anticipated|Institut Curie||1|||f||||f||||||||||2017-10-10 21:59:34.056228|2017-10-10 21:59:34.056228
NCT02834481|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-31|||September 2016||2016-09-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|ANI/NIPE||Assessment of Pain Monitoring With ANI/NIPE Monitor Program in Pediatric Cardiac Surgery Postoperative.|ANI/NIPE Assessment of Pain Monitoring With ANI (Analgesia Nociceptive Index)/NIPE (Newborn Infant Parasympathetic Evaluation) Monitor Program in Pediatric Cardiac Surgery Postoperative.|Not yet recruiting||Phase 4|20|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 21:59:34.132793|2017-10-10 21:59:34.132793
NCT02834468|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-07-13|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients|A Multicenter Randomized Study of Dexamethasone Combined With Rituximab, Cyclosporin and Intravenous Immunoglobulin in the Management of Newly Diagnosed ITP Patients|Recruiting||Phase 3|100|Anticipated|Shandong University||1|||f||||t||||||||No||2017-10-10 21:59:35.917905|2017-10-10 21:59:35.917905
NCT02834455|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-08-30|||May 2015||2015-05-01|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|REPEAT||Rational Approach to a Unilateral Pleural Effusion2|Rational Approach to Unilateral Pleural Effusion in Patients Suspected of Malignancy. Efficacy, Pain, Quality of Life, and Economy|Recruiting||N/A|200|Anticipated|Naestved Hospital||2|||f||||f||||||||||2017-10-10 21:59:36.027427|2017-10-10 21:59:36.027427
NCT02834442|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-07-24|||July 2016||2016-07-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects|A Randomised, Double Blind, Placebo Controlled Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of MT-7117 in Healthy Subjects|Completed||Phase 1|144|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||||||||||||2017-10-10 21:59:36.118454|2017-10-10 21:59:36.118454
NCT02834429|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2016-08-01|||February 2010||2010-02-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Pre-endoscopy Serological Testing for Coeliac Disease; a Novel Approach Using Rapid Antibody Testing|Pre-endoscopy Serological Testing for Coeliac Disease - a Novel Approach Using Rapid Antibody Testing.|Recruiting||N/A|1000|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 21:59:36.19696|2017-10-10 21:59:36.19696
NCT02834416|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-21|||August 2016||2016-08-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|ADTExRCT||ADT Exercise Trial and Economic Analysis|A Randomized Control Trial (RCT) and Economic Analysis of Two Exercise Delivery Methods in Men With Prostate Cancer on ADT|Recruiting||Phase 3|200|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 21:59:36.282919|2017-10-10 21:59:36.282919
NCT02834403|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-27|||July 2016||2016-07-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||L-NMMA Plus Docetaxel in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients|Clinical Phase Ib/II Trial of L-NMMA Plus Docetaxel in the Treatment of Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients|Recruiting||Phase 1/Phase 2|42|Anticipated|The Methodist Hospital System||1|||f||||f|t|f||||||||2017-10-10 21:59:36.408065|2017-10-10 21:59:36.408065
NCT02834390|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-13|2017-09-26|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)|Phase 1b, Open-label, Dose Escalation Study of Quizartinib in Combination With Induction and Consolidation Chemotherapy in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 1|18|Anticipated|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-10 21:59:36.510704|2017-10-10 21:59:36.510704
NCT02834377|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-08-03|||May 19, 2016|Actual|2016-05-19|August 2017|2017-08-01||||June 30, 2017|Actual|2017-06-30||Interventional|TAPIR||Personalized Hemodynamic Therapy in Patients Undergoing High-risk Surgery|Individualized Goal-directed Hemodynamic Therapy Targeting Preoperatively Assessed Personal Cardiac Output Values in Patients Undergoing High-risk Surgical Procedures: a Prospective and Randomized Clinical Trial|Completed||N/A|188|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 21:59:36.594255|2017-10-10 21:59:36.594255
NCT02834364|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-07-12|||June 2016||2016-06-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|March 2018|Anticipated|2018-03-01||Interventional|GMMG-BIRMA||BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA)|LGX818 in Combination With MEK162 in Refractory or Relapsed Multiple Myeloma Patients With BRAFV600E or BRAFV600K Mutation|Recruiting||Phase 2|15|Anticipated|University of Heidelberg Medical Center||1|||f||||f||||||||Undecided||2017-10-10 21:59:36.69793|2017-10-10 21:59:36.69793
NCT02834351|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-12-15|||July 2016||2016-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SARTORIUS||Tissue Lesions in Exercise Related Ischemia|Atteinte Tissulaire au Cours de l'ischémie Chronique d'Effort. Validation d'un modèle d'étude du Muscle Sartorius Humain|Completed||N/A|36|Actual|University Hospital, Angers||2|||f||||f||||||||No||2017-10-10 21:59:36.943709|2017-10-10 21:59:36.943709
NCT02834338|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-04-25|||July 2016||2016-07-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|EPMIII||Enhanced Perioperative Mobilization (EPM) Trial|Usage of Activity Tracking in Major Visceral Surgery - the Enhanced Perioperative Mobilization (EPM) Trial|Recruiting||N/A|120|Anticipated|Technische Universität Dresden||4|||f||||f||||||||No||2017-10-10 21:59:37.031301|2017-10-10 21:59:37.031301
NCT02834325|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-07-12|||January 2009||2009-01-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Predicting Success of HFNC: The Utility of the ROX Index|Predicting Failure of High Flow Nasal Cannula in Pneumonia Patients With Hypoxemic Respiratory Failure: The Utility of ROX Index|Completed||N/A|201|Actual|Hospital Universitari Vall d'Hebron Research Institute|||2||f||||f||||||||No||2017-10-10 21:59:37.14219|2017-10-10 21:59:37.14219
NCT02834299|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-09-08|||September 20, 2016||2016-09-20|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|DBT-GSH-BED||Dialectical Behavior Therapy Guided Self-Help for Binge Eating Disorder|A Randomized Controlled Study of a Dialectical Behavior Therapy Guided Self-Help Intervention for Binge Eating Disorder|Recruiting||N/A|75|Anticipated|Memorial University of Newfoundland||3|||f||||f||||||||||2017-10-10 21:59:37.376388|2017-10-10 21:59:37.376388
NCT02834286|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-12|||March 2015||2015-03-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia|Low-dose Rituximab in Combination With Eltrombopag and High-dose Dexamethasone as Frontline Treatment for Immune Thrombocytopenia|Recruiting||Phase 2|15|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||f||||||||Yes||2017-10-10 21:59:37.481096|2017-10-10 21:59:37.481096
NCT02834273|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-05-29|||June 2013||2013-06-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|EPIC||Patient Education Following a Stroke|Impact of Patient Education Following a Stroke on Knowledge of Risk Factors, Stroke Warning Signs and What to do in Cases of Stroke|Completed||N/A|199|Actual|Hopital Foch||2|||f||||f||||||||No||2017-10-10 21:59:37.605664|2017-10-10 21:59:37.605664
NCT02834260|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-05-22|||January 2017||2017-01-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|IDEXACOR||Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study|Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone: Tolerance and Safety Pilot Study|Recruiting||Phase 2|14|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||t||||||||No||2017-10-10 21:59:37.683736|2017-10-10 21:59:37.683736
NCT02834247|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-07-28|||July 30, 2016|Actual|2016-07-30|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors|A Phase 1b Study to Evaluate TAK-659 in Combination With Nivolumab in Patients With Advanced Solid Tumors|Recruiting||Phase 1|126|Anticipated|Takeda||5|||f||||f|t|f||||||||2017-10-10 21:59:37.797158|2017-10-10 21:59:37.797158
NCT02834234|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-07-25|||May 2013||2013-05-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays|Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays|Completed||N/A|33|Actual|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     mesothelioma tumor specimen and normal tissue specimen   "|||2017-10-10 21:59:37.95767|2017-10-10 21:59:37.95767
NCT02834221|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-06-06|||June 2016||2016-06-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ULTRA-FAST||Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment|Ultrasound-guided or Anatomical Femoral Venipuncture for Pulmonary Vein Isolation for Atrial Fibrillation Treatment|Completed||N/A|320|Actual|Institute for Clinical and Experimental Medicine||2|||f||||f||||||||No||2017-10-10 21:59:38.025325|2017-10-10 21:59:38.025325
NCT02834208|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-08-29|||December 2015||2015-12-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|SCHIZOIMAGEN||Emotion Endophenotypes in Schizophrenia|Neurofunctional Basis of Emotion Processing: Clinical, Genetic, Biological and Imaging Study in Patients With Schizophrenia and Healthy Relatives of Patients in Comparison With a Control Group|Recruiting||N/A|105|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||Undecided||2017-10-10 21:59:38.138189|2017-10-10 21:59:38.138189
NCT02834195|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-18|||June 2013||2013-06-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|CLASS-MS||Types of Upper Limb and Hand in Patients With Cerebral Palsy|Validation of a Classification of Types of Upper Limb and Hand in Patients With Cerebral Palsy|Completed||N/A|111|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:59:38.234173|2017-10-10 21:59:38.234173
NCT02834182|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-12|||July 2016||2016-07-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|TOM-i||fMRI of Theory of Mind in Schizophrenia and Bipolar Disorder|Functional Magnetic Resonance Imaging Study: Theory of Mind Deficits in Schizophrenia and Bipolar Disorder|Not yet recruiting||N/A|120|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 21:59:38.301797|2017-10-10 21:59:38.301797
NCT02834169|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-18|||October 2010||2010-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|8 Years|Observational [Patient Registry]|RENAPE||French National Registry of Rare Peritoneal Surface Malignancies|French National Registry of Rare Peritoneal Surface Malignancies (RENAPE Registry)|Active, not recruiting||N/A|2171|Actual|Hospices Civils de Lyon|||7||f||||f||||||||||2017-10-10 21:59:38.397018|2017-10-10 21:59:38.397018
NCT02834156|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-12|||September 2015||2015-09-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|PHIPA-PEPL||Impact of Child Positioning on Pain During a Lumbar Puncture|Impact Assessment of Positioning on Pain Sensitivity During a Lumbar Puncture in Children|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||No||2017-10-10 21:59:38.702033|2017-10-10 21:59:38.702033
NCT02834143|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-02-21|||June 13, 2014|Actual|2014-06-13|July 2016|2016-07-01|June 14, 2015|Actual|2015-06-14|January 14, 2015|Actual|2015-01-14||Observational|CRIMI||Evaluation of Diagnostic Criteria for Chronic Critical Limb Ischemia|Evaluation of Diagnostic Criteria for Chronic Critical Limb Ischemia|Completed||N/A|180|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||Undecided||2017-10-10 21:59:38.790107|2017-10-10 21:59:38.790107
NCT02834130|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-07-18|||April 2014||2014-04-01|July 2016|2016-07-01||||April 2016|Actual|2016-04-01||Interventional|ACADHEM||Input of a Multidisciplinary Device to Accompany the Announce of Diagnosis for Young Children With Serious Constitutional Hemorrhagic Disease and Their Families|Input of a Multidisciplinary Device Including a Psychological Approach, to Accompany the Announce of Diagnosis for Young Children With Serious Constitutional Hemorrhagic Disease and Their Families|Completed||N/A|30|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 21:59:38.874774|2017-10-10 21:59:38.874774
NCT02834117|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-08-02|||May 2015||2015-05-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|SONTEC||Natural Cycle Versus Stimulated Cycle Before Frozen Embryo Transfer|Comparison of the Number of Visits and the Quality of Life Versus Natural Cycle in Stimulated Cycle Before Frozen Embryo Transfer|Recruiting||Phase 4|124|Anticipated|Centre Hospitalier Intercommunal Creteil||2|||f||||f||||||||||2017-10-10 21:59:38.96161|2017-10-10 21:59:38.96161
NCT02834078|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-12|||September 2015||2015-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Glucogold||Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome|Effect of 'Berberine Glucogold' [BGG] on Glucose Metabolism in Individuals With Marginally Impaired Glucose Metabolism Along With Other Markers of Metabolic Syndrome|Completed||N/A|126|Actual|Vedic Lifesciences Pvt. Ltd.||2|||f||||f||||||||No||2017-10-10 21:59:39.081201|2017-10-10 21:59:39.081201
NCT02834065|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-20|||July 2016||2016-07-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest|Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest|Recruiting||N/A|273|Anticipated|Duke University||3|||f||||t|f|f||||||No||2017-10-10 21:59:39.173425|2017-10-10 21:59:39.173425
NCT02834052|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-12|||July 2016||2016-07-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pembrolizumab + Poly-ICLC in MRP Colon Cancer|A Phase I/II Trial of Pembrolizumab (MK-3475) and Poly-ICLC in Patients With Metastatic Mismatch Repair-proficient (MRP) Colon Cancer|Not yet recruiting||Phase 1/Phase 2|42|Anticipated|Augusta University||2|||f||||f||||||||No||2017-10-10 21:59:39.291935|2017-10-10 21:59:39.291935
NCT02834039|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-15|||May 2016||2016-05-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|February 28, 2017|Actual|2017-02-28||Interventional|||Comparison of Ventilation Distribution Between Tidal Volume 6ml/kgBW and 10ml/kgBW|Comparison of Ventilation Distribution Between Tidal Volume 6ml/kgBW and 10ml/kgBW in Laparoscopic Nephrectomy Patients|Completed||N/A|30|Actual|Indonesia University||2|||f||||||||||||||2017-10-10 21:59:39.412368|2017-10-10 21:59:39.412368
NCT02834026|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-04-06|||January 2016||2016-01-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||Impact of the Cycle Ergometer in Muscle Strength and Pulmonary Function in Patients in Hemodialysis|Impact of the Cycle Ergometer in Muscle Strength and Pulmonary Function in Patients in Hemodialysis|Recruiting||N/A|46|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t||||||||Yes||2017-10-10 21:59:39.511214|2017-10-10 21:59:39.511214
NCT02834000|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-07-12|||June 2014||2014-06-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|HRespToAS||Haemodynamic Response to General Anaesthesia in Healthy Orthopaedic Patients|Haemodynamic Response to General Anaesthesia Induction in Elective Orthopaedic Surgery Patients Using Non-invasive Cardiovascular Monitoring|Completed||N/A|40|Actual|Chelsea and Westminster NHS Foundation Trust||2|||f||||t||||||||Yes||2017-10-10 21:59:43.459689|2017-10-10 21:59:43.459689
NCT02833987|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-12|||March 2015||2015-03-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Direct Oral Anticoagulants and Venous Thromboembolism|The Comparative Safety of Direct Oral Anticoagulants Versus Warfarin for the Treatment of Venous Thromboembolism|Completed||N/A|148859|Anticipated|Canadian Network for Observational Drug Effect Studies, CNODES|||2||f||||f||||||||||2017-10-10 21:59:43.522835|2017-10-10 21:59:43.522835
NCT02833974|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-07-17|||December 5, 2016|Actual|2016-12-05|July 2017|2017-07-01|July 6, 2018|Anticipated|2018-07-06|July 6, 2018|Anticipated|2018-07-06||Interventional|||Effect of the GSK2245035 on the Allergen-induced Asthmatic Response|A Randomised, Double-blind, Placebo-controlled, Parallel Group, 8-week Treatment Study to Investigate the Safety, Pharmacodynamics, and Effect of the TLR7 Agonist, GSK2245035, on the Allergen-induced Asthmatic Response in Subjects With Mild Allergic Asthma|Recruiting||Phase 2|48|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 21:59:43.608741|2017-10-10 21:59:43.608741
NCT02833961|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-08-29|||July 28, 2016|Actual|2016-07-28|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|ISIS||Diffusion Spectroscopy in Stroke|DIFFUSION SPECTROSCOPY AND IMAGING IN ACUTE STROKE|Recruiting||N/A|24|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-10 21:59:43.720984|2017-10-10 21:59:43.720984
NCT02833948|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-08-10|||May 2016||2016-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|GALILEO-4D||Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)|Randomized Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) - Substudy of the GALILEO-trial|Recruiting||Phase 3|300|Anticipated|ECRI bv||2|||f||||t||||||||||2017-10-10 21:59:43.791024|2017-10-10 21:59:43.791024
NCT02833935|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-01-31|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Enhancing Quality of Life Through Exercise: A Tele-Rehabilitation Approach|Pilot Randomized Controlled Trial Evaluating a Self-Determination Theory Video-based Tele-rehabilitation Physical Activity Intervention Aimed to Enhance Motivation, Physical Activity, and Quality of Life-related Outcomes Among Adults With Spinal Cord Injury|Recruiting||N/A|24|Anticipated|The Craig H. Neilsen Foundation||2|||f||||f||||||||Undecided|Data will be shared among co-investigators. Currently, it is undecided if individual participant data will be available.|2017-10-10 21:59:44.110118|2017-10-10 21:59:44.110118
NCT02833922|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-13|||September 2016||2016-09-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Effectiveness and Efficacy of Dynamic Optimal Timing, a Smart Phone App for Avoiding Pregnancy: an Observational Study||Not yet recruiting||N/A|1200|Anticipated|Georgetown University|||1||f||||f||||||||No||2017-10-10 21:59:44.220141|2017-10-10 21:59:44.220141
NCT02833909|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-15|||March 2015||2015-03-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients|ex Vivo Study of the Inflammatory Response Associated With Hidradenitis Suppurativa|Completed||N/A|20||CHU de Reims||2|||f||||||||||||||2017-10-10 21:59:44.302903|2017-10-10 21:59:44.302903
NCT02833896|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-12|||November 2010||2010-11-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Endometrial Cancer and Array CGH|Endometrial Cancer: Evaluation of Genetic Imbalances in the Carcinogenesis Process|Completed||N/A|95|Actual|CHU de Reims|||2||f||||||||||||||2017-10-10 21:59:44.405139|2017-10-10 21:59:44.405139
NCT02833883|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-18|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer|A Phase 1b Study of Enzalutamide Plus CC-115 in Men With Castration-Resistant Prostate Cancer (CRPC)|Recruiting||Phase 1|46|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:59:44.479787|2017-10-10 21:59:44.479787
NCT02833870|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-12-30|||September 2013||2013-09-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MusicAlzheimer||Non-pharmacological Care of Alzheimer's Disease: Benefice of Musical Interventions|Non-drug Taken Charge of Alzheimer's Disease: Profit Musical Activities|Completed||N/A|150|Actual|CHU de Reims||3|||f||||||||||||||2017-10-10 21:59:44.590548|2017-10-10 21:59:44.590548
NCT02833857|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-10-04|||March 14, 2017|Actual|2017-03-14|October 2017|2017-10-01|January 29, 2018|Anticipated|2018-01-29|January 29, 2018|Anticipated|2018-01-29||Interventional|||A Single-dose Study in Paediatric Subjects Aged 2 to Less Than 18 Years With (sHPT) Receiving Haemodialysis|An Open-label, Single-dose Study to Evaluate Etelcalcetide (AMG 416) in Paediatric Subjects Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Maintenance Haemodialysis|Recruiting||Phase 1|1|Anticipated|Amgen||1|||f||||f|t|f||||||||2017-10-10 21:59:44.688888|2017-10-10 21:59:44.688888
NCT02833831|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-09-15|||June 2, 2016|Actual|2016-06-02|September 2017|2017-09-01|February 24, 2017|Actual|2017-02-24|February 17, 2017|Actual|2017-02-17||Interventional|||Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants|A Double-blind, Double-dummy, Randomized, 3-Period Cross-over, Placebo- and Positive Controlled Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Subjects|Completed||Phase 1|103|Actual|Janssen Research & Development, LLC||9|||f||||f||f||||||||2017-10-10 21:59:45.04894|2017-10-10 21:59:45.04894
NCT02833818|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-07-12|||November 2015||2015-11-01|July 2016|2016-07-01|November 2025|Anticipated|2025-11-01|November 2025|Anticipated|2025-11-01||Interventional|CAKE||Effect of Intensive Dietary Intervention in Children With Birth Weight Between 1500 and 2000 g|Growth and Development of Premature Babies|Enrolling by invitation||N/A|200|Anticipated|University Hospital, Akershus||2|||f||||f||||||||Undecided||2017-10-10 21:59:45.161717|2017-10-10 21:59:45.161717
NCT02833805|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-05-01|||August 2016||2016-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia|A Phase II Trial of Non-Myeloablative (NMA) Conditioning and Transplantation of Partially HLA-Mismatched/Haploidentical Related or Matched Unrelated Donor (MUD) Bone Marrow for Newly Diagnosed Patients With Severe Aplastic Anemia|Recruiting||Phase 2|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||No||2017-10-10 21:59:45.225987|2017-10-10 21:59:45.225987
NCT02833792|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-10-27|||June 2016||2016-06-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease|A Phase IIa Study of Allogeneic Human Mesenchymal Stem Cells in Subjects With Mild to Moderate Dementia Due to Alzheimer's Disease|Recruiting||Phase 2|40|Anticipated|Stemedica Cell Technologies, Inc.||2|||f||||t||||||||No||2017-10-10 21:59:45.339146|2017-10-10 21:59:45.339146
NCT02833779|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-14|||April 2010||2010-04-01|July 2016|2016-07-01||||October 2013|Actual|2013-10-01||Interventional|||Trial to Compare the Effectiveness of Group Versus Individual Therapy on Alternate Days in Patients With Subacromial Impingement Syndrome||Completed||N/A|89|Actual|Basque Health Service||2|||f||||||||||||||2017-10-10 21:59:45.433235|2017-10-10 21:59:45.433235
NCT02833766|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer|Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer - A Multicenter Single Arm Phase II Trial|Recruiting||Phase 2|49|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||No||2017-10-10 21:59:45.4917|2017-10-10 21:59:45.4917
NCT02833753|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-07-20|||July 2016||2016-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI|Phase I Trial of Intraperitoneal Oxaliplatin in Combination With Intravenous FOLFIRI (5-fluorouracil, Leucovorin and Irinotecan) for Peritoneal Carcinomatosis From Colorectal and Appendiceal Cancer|Recruiting||Phase 1|16|Anticipated|University of Massachusetts, Worcester||1|||f||||t||||||||||2017-10-10 21:59:45.771671|2017-10-10 21:59:45.771671
NCT02833740|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-27|||September 2016|Actual|2016-09-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||"Comparing Performance of Simplified Mid-Upper Arm Circumference Devices (Click-MUACs) to Detect Acute Malnutrition"|"Field Testing of a Set of Simplified Mid-upper Arm Circumference Classification Devices (Click-MUAC) for Use by Mothers and Caregivers to Screen for Acute Malnutrition in Young Children at Community Level, in Isiolo County, Kenya"|Recruiting||N/A|345|Anticipated|Action Contre la Faim||1|||f||||f||||||||No||2017-10-10 21:59:45.859411|2017-10-10 21:59:45.859411
NCT02833727|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-13|||September 2016||2016-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Airway Inflammation and Disease Burden in Asthmatic Smokers|Assessment of Airway Inflammation and Disease Burden in Moderate to Severe Asthmatic Smokers|Not yet recruiting||N/A|160|Anticipated|Université de Montréal|||2||f||||f||||||||No||2017-10-10 21:59:45.952557|2017-10-10 21:59:45.952557
NCT02833714|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-09-14|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Observational|||Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.|Characterization of Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.|Terminated||N/A|26|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 21:59:46.027228|2017-10-10 21:59:46.027228
NCT02833701|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-10-26|||March 2016||2016-03-01|October 2016|2016-10-01||||March 2019|Anticipated|2019-03-01||Interventional|||Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma|A Phase I Study of Bevacizumab and Intravenous Ascorbic Acid for Patients With Recurrent High Grade Glioma|Recruiting||Phase 1|21|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-10 21:59:46.101943|2017-10-10 21:59:46.101943
NCT02833688|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-01-25|||August 2, 2016|Actual|2016-08-02|January 2017|2017-01-01|January 26, 2017|Actual|2017-01-26|January 26, 2017|Actual|2017-01-26||Interventional|||Effects of Dexmedetomidine on the Liver Injury After Hepatectomy|the Ethnic Committee of the Chinese People's Liberation Army (PLA) General Hospital|Completed||Phase 4|70|Actual|Chinese PLA General Hospital||2|||f||||t||||||||Undecided||2017-10-10 21:59:46.211225|2017-10-10 21:59:46.211225
NCT02833675|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-27|||October 2012||2012-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Observational|BIOBRAD||Determination of Specific Biomarkers of Angioneurotic Crisis|Determination of Specific Biomarkers of Angioneurotic Crisis|Completed||N/A|120|Actual|University Hospital, Grenoble|||3||f||||f||||||||||2017-10-10 21:59:46.294169|2017-10-10 21:59:46.294169
NCT02833662|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-07-12|||June 2015||2015-06-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|Etude3A||Evaluation of Sleep Apnea and Cardiac Rhythm Abnormalities After Surgery Under General Anesthesia|Evolution of the Severity of Obstructive Sleep Apnea and Consequences on Cardiac Rhythm Abnormalities After Surgery Under General Anesthesia|Active, not recruiting||N/A|120|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 21:59:46.37456|2017-10-10 21:59:46.37456
NCT02833649|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-14|||December 2011||2011-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TICL||Comparative Analysis of the Visual Performance After TICL Implantation in Patients With Stable Keratoconus|Comparative Analysis of the Visual Performance in Patients With Stable Keratoconus After Implantation of the Toric Implantable Collamer Lens (TICL).|Recruiting||N/A|24|Anticipated|Shahid Beheshti University||1|||f||||t||||||||Undecided||2017-10-10 21:59:46.463758|2017-10-10 21:59:46.463758
NCT02833636|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-11|||January 2006||2006-01-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Prognostic Value of The Age, Creatinine, and Ejection Fraction Score for Non-infarct-related Chronic Total Occlusion Revascularization After Primary Percutaneous Intervention in Acute ST-elevation Myocardial Infarction Patients: A Retrospective Study||Completed||N/A|2952|Actual|Xibei Hospital|||2||f||||||||||||||2017-10-10 21:59:46.536289|2017-10-10 21:59:46.536289
NCT02833623|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication|Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication|Recruiting||Phase 4|310|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 21:59:46.67618|2017-10-10 21:59:46.67618
NCT02833610|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-31|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|October 2023|Anticipated|2023-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency|A Phase 2, Single-Arm Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency|Recruiting||Phase 2|55|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 21:59:46.773029|2017-10-10 21:59:46.773029
NCT02833597|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-12-15|||July 2016||2016-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|CERES||Claudication Evaluation During Rowing ExerciseS|Claudication Evaluation During Rowing ExerciseS. Rehabilitation Arteritis of Lower Limbs by Rowing|Completed||N/A|6|Actual|University Hospital, Angers|||1||f||||t||||||||No||2017-10-10 21:59:46.874873|2017-10-10 21:59:46.874873
NCT02833584|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-26|||September 2016||2016-09-01|August 2017|2017-08-01||||February 2018|Anticipated|2018-02-01||Interventional|||Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults||Recruiting||N/A|164|Anticipated|Phramongkutklao College of Medicine and Hospital||2|||f||||f||||||||||2017-10-10 21:59:46.948721|2017-10-10 21:59:46.948721
NCT02833571|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||September 2016||2016-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:59:47.072049|2017-10-10 21:59:47.072049
NCT02833558|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-01-24|||May 2016||2016-05-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Purastat® vs Standard Therapy for Haemostasis During Endoscopic Submucosal Dissection|Randomised Controlled Trial Comparing Purastat® to Standard Therapy for Haemostasis Control During Endoscopic Submucosal Dissection|Recruiting||N/A|90|Anticipated|Portsmouth Hospitals NHS Trust||2|||f||||t||||||||Yes||2017-10-10 21:59:47.118439|2017-10-10 21:59:47.118439
NCT02833545|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-07-12|||September 2016||2016-09-01|July 2016|2016-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis|Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis|Not yet recruiting||Phase 4|20|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-10 21:59:47.229686|2017-10-10 21:59:47.229686
NCT02833532|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-06|||June 2015||2015-06-01|July 2016|2016-07-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of Volus as Compared to PowerFill® for Temporary Penile Enhancement|A Multi-center, Randomized, Subject Blind, Active Controlled Design Clinical Study to Evaluate the Efficacy and Safety of Volus as Compared to PowerFill® for Temporary Penile Enhancement|Completed||Phase 3|68|Anticipated|Hugel||2|||f||||t||||||||||2017-10-10 21:59:47.30467|2017-10-10 21:59:47.30467
NCT02833519|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-07-14|||August 2016||2016-08-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|EWE||Exercise and Wellbeing: The Effect of Group Exercise on Mental Wellbeing Among Pregnant Women|Effect of Group Exercise on Mental Wellbeing Among Pregnant Women at Risk of Perinatal Depression: A Randomized Controlled Clinical Trial|Enrolling by invitation||N/A|300|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-10 21:59:47.396864|2017-10-10 21:59:47.396864
NCT02833324|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-01-05|||July 2016||2016-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Fitbit for Postoperative Ambulation|Can a Fitbit (a Mobile Tracking Device) Increase Ambulation of Colorectal Surgical Patients in the Postoperative Period?|Completed||N/A|48|Actual|Emory University||2|||f||||f||||||||No||2017-10-10 21:59:49.391044|2017-10-10 21:59:49.391044
NCT02833506|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-09-25|||October 15, 2017|Anticipated|2017-10-15|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 15, 2018|Anticipated|2018-08-15||Interventional|||Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase I Clinical Trial of mTOR Inhibition With Sirolimus for Enhancing NY-ESO-1 Protein With MIS416 Vaccine Induced Anti-Tumor Immunity in Ovarian, Fallopian Tube and Primary Peritoneal Cancer|Not yet recruiting||Phase 1|12|Anticipated|Roswell Park Cancer Institute||2|||f||||t|t|f||||||||2017-10-10 21:59:47.515481|2017-10-10 21:59:47.515481
NCT02833493|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-13|||September 2016||2016-09-01|July 2016|2016-07-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Observational|||Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload|Observational Study of MRI Monitoring in Patients With Aplastic Anemia (AA) and Low or Int-1 Risk of Myelodysplastic Syndromes(MDS) Complicated With Iron Overload|Not yet recruiting||N/A|80|Anticipated|Peking Union Medical College Hospital|||1||f||||||||||||Undecided||2017-10-10 21:59:47.640447|2017-10-10 21:59:47.640447
NCT02833480|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-07-11|||February 2015||2015-02-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|DISARM||A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota|A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota|Recruiting||Phase 2|69|Anticipated|University of British Columbia||3|||f||||f||||||||No||2017-10-10 21:59:47.70805|2017-10-10 21:59:47.70805
NCT02833467|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-09-18|||January 2015||2015-01-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2016|Actual|2016-06-01||Observational|||Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA|A Prospective Study of Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA|Active, not recruiting||N/A|45|Actual|Peking University People's Hospital|||1||f||||f||||||Samples With DNA|"     Fresh tumor tissue, peripheral blood cells, and plasma samples were collected from each     patient.   "|||2017-10-10 21:59:47.824377|2017-10-10 21:59:47.824377
NCT02833454|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-13|||July 2016||2016-07-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of the Anatomical Direct Insertion Anterior Cruciate Ligament Reconstruction|Anterior Cruciate Ligament Reconstruction (ACLR) Using Direct Insertion Technique or Traditional Technique With Single and Double Bundle Procedure.|Not yet recruiting||N/A|320|Anticipated|Peking University Third Hospital||4|||f||||t||||||||||2017-10-10 21:59:47.89886|2017-10-10 21:59:47.89886
NCT02833441|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-10-26|||July 2016||2016-07-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PESU||The Peer Support Intervention - Supporting HIV Positive Adolescents in Zimbabwe to Improve HIV Care Continuum Outcomes|The Peer Support Intervention - Supporting HIV Positive Adolescents in Zimbabwe to Improve HIV Care Continuum Outcomes|Recruiting||N/A|250|Anticipated|University of Zimbabwe||2|||f||||f||||||||No|Data is readily available and can be obtained following review by MRCZ as required in the consent forms.|2017-10-10 21:59:47.98571|2017-10-10 21:59:47.98571
NCT02833428|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-03-26|||November 17, 2016|Actual|2016-11-17|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|SKY||Spinal Cord and Artificial Intelligence|Acquisition and Analysis of Medullary Trauma Patients Signs, With an Expert Model|Recruiting||N/A|30|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||Undecided||2017-10-10 21:59:48.08849|2017-10-10 21:59:48.08849
NCT02833415|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-05-17|||March 2016||2016-03-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging|Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging|Recruiting||Phase 4|40|Anticipated|University of Texas Southwestern Medical Center||4|||f||||t||||||||Undecided||2017-10-10 21:59:48.197889|2017-10-10 21:59:48.197889
NCT02833402|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-29|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Sacral Neuromodulation and the Microbiome|The Association Between the Urinary Microbiome and Response to Sacral Neuromodulation in Women With Urgency Urinary Incontinence|Recruiting||N/A|50|Anticipated|Northwestern University|||1||f||||f|f|f||||Samples Without DNA|"     We will be obtaining urine specimens for microbial analysis.   "|||2017-10-10 21:59:48.324032|2017-10-10 21:59:48.324032
NCT02833389|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-07-26|||November 15, 2016|Actual|2016-11-15|July 2017|2017-07-01|May 21, 2018|Anticipated|2018-05-21|May 21, 2018|Anticipated|2018-05-21||Interventional|||The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers|A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers|Recruiting||Phase 1|72|Anticipated|Genentech, Inc.||5|||f||||||||||||||2017-10-10 21:59:48.418689|2017-10-10 21:59:48.418689
NCT02833376|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-13|||May 2016||2016-05-01|July 2016|2016-07-01||||March 2017|Anticipated|2017-03-01||Interventional|||Alcohol 70% Versus Chlorhexidine 0.5% in the Spinal Anesthesia Skin Antissepsis|Alcohol 70% Versus Chlorhexidine 0.5% in the Spinal Anesthesia Skin Antissepsis|Recruiting||N/A|70|Anticipated|Universidade do Vale do Sapucai||2|||f||||f||||||||No||2017-10-10 21:59:48.525003|2017-10-10 21:59:48.525003
NCT02833363|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-10-25|||July 2016||2016-07-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Observational|||Difference of Gastric Microbiota in the Process of Correa's Model.|Difference of Gastric Microbiota in the Process of Correa's Model.|Recruiting||Phase 4|50|Anticipated|Shandong University|||5||f||||t||||||Samples With DNA|"     gastric mucosal samples from antrum and corpus will be collected during gastroscopy,and used     for microbiota analysis by high-throughput sequencing.   "|||2017-10-10 21:59:48.610645|2017-10-10 21:59:48.610645
NCT02833350|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-22|||September 9, 2016|Actual|2016-09-09|September 2017|2017-09-01|June 26, 2018|Anticipated|2018-06-26|June 26, 2018|Anticipated|2018-06-26||Interventional|||Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)|A Two-Cohort Randomized Phase II, Double-Blind, Parallel Group Study in Patients With Active Rheumatoid Arthritis Evaluating the Efficacy and Safety of GDC-0853 Compared With Placebo and Adalimumab in Patients With an Inadequate Response to Previous Methotrexate Therapy (Cohort 1) and Compared With Placebo in Patients With an Inadequate Response or Intolerance to Previous TNF Therapy (Cohort 2)|Recruiting||Phase 2|600|Anticipated|Genentech, Inc.||7|||f||||||||||||||2017-10-10 21:59:48.738201|2017-10-10 21:59:48.738201
NCT02833311|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||November 2013||2013-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||e-Mobile Tablet for People With Chronic Conditions|Examining the Usability of Computer Tablets to Promote Symptom Self-management and Engagement in Healthy Behaviors in Adults With Chronic Conditions|Completed||N/A|46|Actual|Case Western Reserve University||3|||f||||f||||||||Yes||2017-10-10 21:59:49.470686|2017-10-10 21:59:49.470686
NCT02833298|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-11-04|||November 2016||2016-11-01|November 2016|2016-11-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Interventional|||Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening|Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening|Recruiting||Phase 1|100|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-10 21:59:49.632452|2017-10-10 21:59:49.632452
NCT02833285|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-01-31|||May 2015||2015-05-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|LBPARO||B Cell Functions in Periodontitis|Periodontitis and Inflammation : Biological and Clinical Approach of B Cell Role.|Recruiting||N/A|60|Anticipated|University Hospital, Brest|||1||f||||f||||||Samples With DNA|"     gingiva biopsy gingival fluid blood   "|No||2017-10-10 21:59:49.763959|2017-10-10 21:59:49.763959
NCT02833272|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-02-14|||July 2016||2016-07-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Understanding Benzodiazepine and Non-benzodiazepine Sedative Use|Deprescribing Sedative Hypnotics on the Clinical Teaching Unit Using a Patient Empowerment Tool|Recruiting||N/A|50|Anticipated|McGill University Health Center||1|||f||||t||||||||Yes||2017-10-10 21:59:49.861307|2017-10-10 21:59:49.861307
NCT02833259|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-08-18|||May 10, 2017|Actual|2017-05-10|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|R3P||Avoidable Readmissions For Patients Hospitalized With Community-Acquired Pneumonia|Development of a Risk Prediction Model for Identifying Potentially Avoidable Readmissions of Patients Hospitalized With Community-Acquired Pneumonia|Recruiting||N/A|1500|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 21:59:49.980745|2017-10-10 21:59:49.980745
NCT02833246|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-16|||June 28, 2016||2016-06-28|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications|Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications|Suspended||N/A|360|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 21:59:50.096347|2017-10-10 21:59:50.096347
NCT02833233|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-05-03|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer|A Pilot Study of Pre-Operative, Single-Dose Ipilimumab, Nivolumab and Cryoablation in Early Stage/Resectable Breast Cancer|Recruiting||N/A|6|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 21:59:50.182102|2017-10-10 21:59:50.182102
NCT02833220|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-04-26|||January 2017||2017-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||The Effects of Single-Pulse Transcranial Magnetic Stimulation on the Autonomic Nervous System in Healthy Adults|The Effects of Single-Pulse Transcranial Magnetic Stimulation on the Autonomic Nervous System in Healthy Adults|Recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|t|f|f|f|||No||2017-10-10 21:59:50.29112|2017-10-10 21:59:50.29112
NCT02833207|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-08-26|||July 2011||2011-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ObeseDilate||Peripheral Vasodilation in Obese Humans|Peripheral Vasodilation in Obese Humans|Active, not recruiting||Phase 1|360|Anticipated|University of Wisconsin, Madison||4|||f||||t||||||||No||2017-10-10 21:59:50.386042|2017-10-10 21:59:50.386042
NCT02833194|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||July 2005||2005-07-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|NOHA-PSY||Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome|Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome|Completed||N/A|1592|Actual|Centre Hospitalier Universitaire de Nīmes|||3||f||||f||||||||||2017-10-10 21:59:50.490853|2017-10-10 21:59:50.490853
NCT02833181|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-05-21|||July 2016||2016-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Observational|||Evaluation of Circadian Variation of EEG Using BIS Monitor in ICU Patients||Completed||N/A|30|Actual|Centro Hospitalar do Tâmega e Sousa|||3||f||||||||||||||2017-10-10 21:59:50.570004|2017-10-10 21:59:50.570004
NCT02833168|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-13|||April 2016||2016-04-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Screening Questionnaire for Respiratory Muscle Weakness and Sleep-disordered Breathing in Neuromuscular Disorders|Validation of a German Language Screening Questionnaire for Symptoms of Respiratory Muscle Weakness and Sleep-disordered Breathing in Patients With Neuromuscular Disorders|Recruiting||N/A|90|Anticipated|Westfälische Wilhelms-Universität Münster|||3||f||||f||||||||||2017-10-10 21:59:50.659118|2017-10-10 21:59:50.659118
NCT02833155|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-09-20|||July 2016||2016-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer|A Phase I and Pharmacokinetic Study to Evaluate Histone Deacetylase Inhibitor, Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer|Recruiting||Phase 1|18|Anticipated|EddingPharm Oncology Co., LTD.||1|||f||||f||||||||Undecided||2017-10-10 21:59:50.781687|2017-10-10 21:59:50.781687
NCT02833142|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-12-06|||July 2016||2016-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes|A Randomized, Blinded, Parallel-Group, Phase 1 Study of Pharmacokinetics, Safety and Tolerability of Single Intravenous Doses of BIIB033 (Opicinumab ) Produced by 2 Manufacturing Processes, in Healthy Volunteers|Completed||Phase 1|28|Actual|Biogen||2|||f||||f||||||||||2017-10-10 21:59:50.893796|2017-10-10 21:59:50.893796
NCT02833129|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-14|||January 1957||1957-01-01|July 2016|2016-07-01|December 2011|Actual|2011-12-01|December 2003|Actual|2003-12-01||Observational|||The Effects of Playing High School Football on Later Life Cognitive Functioning and Mental Health|The Effects of Playing High School Football on Later Life Cognitive Functioning and Mental Health: An Observational Study|Completed||N/A|3904|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 21:59:50.993771|2017-10-10 21:59:50.993771
NCT02833116|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-10-24|||June 2016||2016-06-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|BetaDexaCaudal||Epidural Dexamethasone Versus Betamethasone for Treatment of Lumbosacral Radiculalgia|Efficacy and Safety of Dexamethasone Versus Betamethasone Epidural Caudal Administration for Treatment of Lumbosacral Radiculalgia: Randomized Clinical Trial|Recruiting||Phase 4|320|Anticipated|Basque Health Service||2|||f||||f||||||||No||2017-10-10 21:59:51.080371|2017-10-10 21:59:51.080371
NCT02833103|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction|Application of Pinaverium Bromide in the Treatment of Patients With Post-cholecystectomy Sphincter of Oddi Dysfunction (SOD): A Randomized, Controlled and Multicenter Clinical Study|Recruiting||Phase 4|168|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||No||2017-10-10 21:59:51.178988|2017-10-10 21:59:51.178988
NCT02833090|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-05-10|||February 2010|Actual|2010-02-01|May 2017|2017-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|SERAOPI||The Plasma Serotonin and Aortic Stenosis: a Pilot Study.|The Plasma Serotonin and Aortic Stenosis: a Pilot Study.|Completed||N/A|52|Actual|University Hospital, Toulouse||4|||f||||f||||||||No||2017-10-10 21:59:51.320687|2017-10-10 21:59:51.320687
NCT02832154|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-26|||April 21, 2017|Actual|2017-04-21|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Internet-Delivered Positive Affect Program in Managing Emotion in Young Adult Cancer Survivors|Enhancing Management of Patient Reported Outcomes With Emotion Regulation (EMPOWER)|Recruiting||N/A|60|Anticipated|Wake Forest University Health Sciences||1|||f||||t|f|f||||||||2017-10-10 21:59:51.42635|2017-10-10 21:59:51.42635
NCT02832141|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2016-07-11|||May 2016||2016-05-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Effect of Thoracic Spine Mobilization on Sympathetic Nervous Systems|Effect of Thoracic Spine Mobilization on Skin-blood Flow, Erythema and Sympathetic Nervous Systems|Recruiting||Phase 1|10|Anticipated|Bern University of Applied Sciences|||2||f||||f||||||||No||2017-10-10 21:59:51.528114|2017-10-10 21:59:51.528114
NCT02832128|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-05-23|||May 2016||2016-05-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)|A Pilot Double Blind Placebo Controlled Crossover Study to Explore Possible Benefits of AUT00063, An Oral Modulator of Voltage - Gated Potassium Channels , In Adults Post-lingual Unilateral Cochlear Implant Recipients|Completed||Phase 2|15|Actual|Autifony Therapeutics Limited||2|||f||||f||||||||||2017-10-10 21:59:51.626252|2017-10-10 21:59:51.626252
NCT02832115|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2017-01-10|||September 2016||2016-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|TNT-RASP||Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention|Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention|Recruiting||Phase 4|300|Anticipated|Aultman Health Foundation||2|||f||||t||||||||Undecided||2017-10-10 21:59:51.714992|2017-10-10 21:59:51.714992
NCT02832102|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-07-11|||April 2016||2016-04-01|July 2016|2016-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|BD2Decide||Big Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)|Big Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)|Recruiting||N/A|1450|Anticipated|Azienda Ospedaliero-Universitaria di Parma|||2||f||||f||||||Samples With DNA|"     FFPE tumor specimens   "|Yes|Patients' data are pseudonymised and stored in a shared Case Report Form (CRF) for data analysis|2017-10-10 21:59:51.814163|2017-10-10 21:59:51.814163
NCT02832089|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-07-11|||December 2000||2000-12-01|July 2016|2016-07-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation|Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation|Completed||Phase 3|30|Actual|Andhra Medical College||1|||f||||f||||||||No||2017-10-10 21:59:51.928682|2017-10-10 21:59:51.928682
NCT02832076|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-07-30|||March 2016||2016-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Role of Subcutaneous Negative Pressure Suction Drain Placed for Ten Days on Wound Healing in Obese Patients Undergoing Midline Laparotomies||Completed||N/A|90|Actual|Ain Shams Maternity Hospital||2|||f||||||||||||||2017-10-10 21:59:51.995371|2017-10-10 21:59:51.995371
NCT02833077|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-08-17|||June 28, 2016||2016-06-28||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 21:59:52.057354|2017-10-10 21:59:52.057354
NCT02833064|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-08-29|||October 2016||2016-10-01|July 2016|2016-07-01|November 2026|Anticipated|2026-11-01|October 2026|Anticipated|2026-10-01||Observational|||Biomarkers in Liver Failure|Identification of Outcome Biomarkers in Patients With Liver Failure.|Not yet recruiting||N/A|200|Anticipated|University of Edinburgh|||5||f||||f||||||||Undecided||2017-10-10 21:59:52.095698|2017-10-10 21:59:52.095698
NCT02833051|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-07-11|||May 2015||2015-05-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||The Impact of an Acute Bout of Exercise on Children's Eating Behaviors||Completed||N/A|20|Actual|Penn State University|||1||f||||f||||||||No||2017-10-10 21:59:52.184762|2017-10-10 21:59:52.184762
NCT02833038|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||October 2016||2016-10-01|July 2016|2016-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Intravenous Magnesium During Robot Assisted Prostatectomy||Not yet recruiting||N/A|60|Anticipated|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 21:59:52.29748|2017-10-10 21:59:52.29748
NCT02833025|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-11|||August 2016||2016-08-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Point-of-care Assessment of Thrombin Generation and Platelet Function in Children Requiring Cardiopulmonary Bypass|Point-of-care Assessment of Thrombin Generation and Platelet Function in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Not yet recruiting||N/A|130|Anticipated|The Hospital for Sick Children|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|No||2017-10-10 21:59:52.390992|2017-10-10 21:59:52.390992
NCT02833012|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-04-10|||July 2016||2016-07-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production|A Phase 1, Pilot, Single-Dose, 4-Way Crossover Study to Compare the Pharmacokinetics of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production|Completed||Phase 1|20|Actual|Accera, Inc.||4|||f||||f||||||||||2017-10-10 21:59:52.498577|2017-10-10 21:59:52.498577
NCT02832999|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-17|||January 2016||2016-01-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|LIRAVIS||Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes|Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in a Sub Saharan African Population With Type 2 Diabetes|Recruiting||Phase 4|20|Anticipated|Yaounde Central Hospital||2|||f||||t||||||||||2017-10-10 21:59:52.651933|2017-10-10 21:59:52.651933
NCT02832986|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-11|||January 2015||2015-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Observational|||Herpes Zoster Prevalence in Frailty Consultations|Herpes Zoster Prevalence in Frailty Consultations in University Hospital of Toulouse|Completed||N/A|1245|Actual|University Hospital, Toulouse|||1||f||||f||||||||Undecided||2017-10-10 21:59:52.782324|2017-10-10 21:59:52.782324
NCT02832973|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-10-03|||September 2015||2015-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ResHypOT||Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension|Resistant Hypertension On Treatment - Sequential Nephron Blockade Compared to Dual Blockade of the Renin-angiotensin-aldosterone System Plus Bisoprolol in the Treatment of Resistant Arterial Hypertension: A Randomized Trial (ResHypOT)|Recruiting||Phase 4|80|Anticipated|Sao Jose do Rio Preto Medical School||2|||f||||f||||||||||2017-10-10 21:59:52.881352|2017-10-10 21:59:52.881352
NCT02832960|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-02-27|||June 2016||2016-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The TRUST Trial - CardioVascular Imaging ECHO|Impact of Thyroid Hormone Replacement on Cardiac Function: a Randomized Placebo-Controlled Trial in Older Adults With Subclinical Hypothyroidism|Completed||Phase 4|185|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 21:59:53.233969|2017-10-10 21:59:53.233969
NCT02832947|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-04-10|||February 2016||2016-02-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||PK of Rivaroxaban in Bariatric Patients - Extension|Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban in Obesity Patients Before and After Bariatric Surgery - The Extension Study|Completed||Phase 1|13|Actual|University Hospital Inselspital, Berne||1|||f||||t||||||||No||2017-10-10 21:59:53.359039|2017-10-10 21:59:53.359039
NCT02832934|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-02-27|||June 2016||2016-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The TRUST Study - CardioVascular Imaging IMT|Impact of Thyroid Hormone Replacement on Progression of Atherosclerosis : a Randomized Placebo-Controlled Trial in Older Adults With Subclinical Hypothyroidism.|Completed||Phase 4|184|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||Undecided||2017-10-10 21:59:53.461175|2017-10-10 21:59:53.461175
NCT02832921|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2017-07-12|||July 2016||2016-07-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Cognitive-motor Rehabilitation Program Using Virtual Reality for Middle-aged Individuals at High Dementia Risk|Cognitive-motor Rehabilitation Program Using Virtual Reality for Middle-aged Individuals at High Dementia Risk|Recruiting||N/A|200|Anticipated|Sheba Medical Center||4|||f||||f||||||||||2017-10-10 21:59:53.583903|2017-10-10 21:59:53.583903
NCT02832908|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||December 2014||2014-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PULSATILITY||Evaluation of the Physiopathological Phenomena and the Haemodynamic and Cerebral Metabolic Effects From Semi-seated Position to Lying Position in Patients With Brain Trauma||Recruiting||N/A|90|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-10 21:59:53.701742|2017-10-10 21:59:53.701742
NCT02832895|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||July 2015||2015-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|FBW-ICU||Frontal Bone Window in ICUF (FBW-ICU)|Assessment of Frontal Bone Window for Transcranial Doppler Among Acute Brain Injured Patients in Intensive Care Units: a Prospective Study.|Recruiting||N/A|220|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 21:59:53.791433|2017-10-10 21:59:53.791433
NCT02832882|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||RFA for Small HCC With No-touch Technique Using Octopus Electrode|Radiofrequency Ablation for Small Hepatocellular Carcinoma Using Octopus Electrode and No-touch Technique: Preliminary Study|Not yet recruiting||Phase 4|100|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 21:59:53.876946|2017-10-10 21:59:53.876946
NCT02832869|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-06-17|||August 2016||2016-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Impact of Reinforced Education by Wechat and Short Message Service on the Quality of Bowel Preparation|Impact of Reinforced Education by Wechat and Short Message Service on the Quality of Bowel Preparation|Not yet recruiting||Phase 4|450|Anticipated|Changhai Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:59:53.953403|2017-10-10 21:59:53.953403
NCT02832856|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-11-02|||August 2016||2016-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Testing the Effectiveness of the Full and Abridged Relationship Smarts Curriculum for 9th Grade Students|Testing the Effectiveness of the Full and Abridged Versions of the Relationship Smarts Curriculum for 9th Grade Students|Enrolling by invitation||N/A|1840|Anticipated|Mathematica Policy Research, Inc.||3|||f||||f||||||||No||2017-10-10 21:59:54.043166|2017-10-10 21:59:54.043166
NCT02832843|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Observational|||Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease|Elucidation of Genetic Susceptibility of Patients With Nontuberculous Mycobacterial Lung Disease Using Genome-Wide Association Study|Not yet recruiting||N/A|1200|Anticipated|Seoul National University Hospital|||2||f||||f||||||Samples With DNA|"     Extraction of DNA will be conducted from serum of patients with NTM lung disease. For     controls, preexisting dataset of GWAS will be used.   "|No||2017-10-10 21:59:54.116357|2017-10-10 21:59:54.116357
NCT02832830|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||August 2016||2016-08-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|IRON-1||Image-guided and Intensity-modulated Radiotherapy Versus External Beam Radiotherapy for Patients With Spine Metastases|Image-guided and Intensity-modulated Radiotherapy Versus External Beam Radiotherapy for Patients With Spine Metastases|Not yet recruiting||Phase 2|60|Anticipated|Heidelberg University||2|||f||||f||||||||No||2017-10-10 21:59:54.28612|2017-10-10 21:59:54.28612
NCT02832817|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-05-10|||February 20, 2016|Actual|2016-02-20|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PULSEREA||Accuracy and Precision of Different Devices for the Monitoring of Pulsed Oxygen Saturation|Accuracy and Precision of Different Devices for the Monitoring of Pulsed Oxygen Saturation|Recruiting||N/A|200|Anticipated|University Hospital, Angers|||1||f||||f||||||||||2017-10-10 21:59:54.406974|2017-10-10 21:59:54.406974
NCT02832804|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-07-14|||February 2016||2016-02-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients|Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients: A Pilot Study.Insomnia Patients|Recruiting||N/A|30|Anticipated|Seoul National University Hospital||3|||f||||t||||||||Undecided||2017-10-10 21:59:54.506457|2017-10-10 21:59:54.506457
NCT02832791|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-10-11|||July 2015||2015-07-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparative Study of Anterior Cruciate Ligament Reconstruction (Quadriceps Versus Hamstring Tendon)|Comparative Study of Anterior Cruciate Ligament Reconstruction Using Quadriceps Tendon Versus Hamstring Tendon in Postoperative Clinical and Functional State: a Prospective Randomized Controlled Study|Recruiting||N/A|55|Anticipated|Universidad de Granada||2|||f||||f||||||||||2017-10-10 21:59:54.635675|2017-10-10 21:59:54.635675
NCT02832778|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-06-20|||November 21, 2016|Actual|2016-11-21|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid|Steady-state Pharmacokinetics of Efavirenz (Sustiva/Stocrin) 400 mg Once Daily in the Presence of Rifampicin and Isoniazid (Rifinah or the Local Generics)|Recruiting||Phase 1|35|Anticipated|St Stephens Aids Trust||2|||f||||t||||||||No||2017-10-10 21:59:54.780759|2017-10-10 21:59:54.780759
NCT02832765|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||September 2016||2016-09-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|IRON-2||Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases|Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases|Not yet recruiting||Phase 2|120|Anticipated|Heidelberg University||4|||f||||f||||||||No||2017-10-10 21:59:54.972601|2017-10-10 21:59:54.972601
NCT02832752|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-15|||July 2016||2016-07-01|August 2016|2016-08-01|May 2023|Anticipated|2023-05-01|June 2018|Anticipated|2018-06-01||Interventional|||BC ECPR Trial for Out-of-Hospital Cardiac Arrest|The BC Extracorporeal Cardiopulmonary Resuscitation Trial for Refractory Out-of-Hospital Cardiac Arrest|Recruiting||Phase 2/Phase 3|420|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 21:59:55.581884|2017-10-10 21:59:55.581884
NCT02832739|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-07-06|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|USECARE||Exploring Acceptance and Outcomes of an Online-based Self-management Support System in Chronic Illness|Exploring Acceptance and Outcomes of an ICT-based Self-management Support System for Community-dwelling Older Adults With Chronic Diseases and Informal Caregivers: USECARE Study Protocol|Active, not recruiting||N/A|30|Actual|Assuta Medical Center||1|||f||||f||||||||||2017-10-10 21:59:55.783214|2017-10-10 21:59:55.783214
NCT02832726|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-11|||January 2014||2014-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||TRIM: Danish Form and Dose Study on Vitamin B12|TRIM: Danish Form and Dose Study in Vitamin B12|Completed||N/A|45|Actual|University of Aarhus||2|||f||||t||||||||No|No plan at this point|2017-10-10 21:59:55.905521|2017-10-10 21:59:55.905521
NCT02832713|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-09-21|||June 9, 2017|Actual|2017-06-09|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|GOTOX||Trial Comparing Botulin Toxin Versus Hyaluronic Acid by Intra-articular Injection for the Treatment of Painful Knee Osteoarthritis|Randomized Controlled Trial Comparing Botulin Toxin Versus Hyaluronic Acid by Intra-articular Injection for the Treatment of Painful Knee Osteoarthritis|Recruiting||Phase 2|50|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||||2017-10-10 21:59:55.989953|2017-10-10 21:59:55.989953
NCT02832700|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-05-18|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||Casein Glycomacropeptide in Healthy Subjects|Casein Glycomacropeptide in Healthy Subjects - Anti-inflammatory and Microbiome Modulating Effects|Recruiting||N/A|24|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 21:59:56.112083|2017-10-10 21:59:56.112083
NCT02832687|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-06-23|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Multi-dose Acetaminophen for Patients Undergoing General Anesthesia|A Multi-center, Randomized, Double-blind, Pilot Study on the Effect of Intravenous Multi-dose Acetaminophen on Readiness for Discharge in Patients Undergoing Surgery With General Anesthesia|Recruiting||Phase 4|90|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f|t|f||||||No||2017-10-10 21:59:56.233939|2017-10-10 21:59:56.233939
NCT02832674|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-04-26|||June 25, 2016|Actual|2016-06-25|July 2016|2016-07-01|April 8, 2017|Actual|2017-04-08|February 20, 2017|Actual|2017-02-20||Interventional|||Safety and Effectiveness Evaluation of the Device in Achieving Submental Lift|An Open-Label, Single-Center, Single-Treatment, Safety and Effectiveness Evaluation of Percutaneous Radiofrequency in Achieving Submental Lift|Completed||N/A|72|Actual|ThermiGen, LLC||1|||f||||f||||||||Yes|Individual participant data may be presented in a publication or professional meeting presentation. Subject identifiers will be not used, nor the full photo image of the participant. only the treated area with before and after images.|2017-10-10 21:59:56.369534|2017-10-10 21:59:56.369534
NCT02832661|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-07-13|||March 2015||2015-03-01|July 2016|2016-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|BECS||BIOMARGIN European, Ambispective Cohort of Adult and Paediatric Renal Transplant Patients|BIOMARGIN European, Ambispective Cohort of Adult and Paediatric Renal Transplant Patients for the Evaluation of the Diagnostic and Prognostic Performance of Biomarkers of Renal Graft Injuries|Recruiting||N/A|500|Anticipated|University Hospital, Limoges|||1||f||||f||||||Samples With DNA|"     Urine, plasma, whole blood, biopsy core (only in adults)   "|||2017-10-10 21:59:56.461716|2017-10-10 21:59:56.461716
NCT02832648|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-05-04|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Selenium for Musculoskeletal Health|The Effect of Selenium Supplementation on Musculoskeletal Health in Older Women Double-blind, Randomised, Placebo-controlled Trial|Recruiting||Phase 3|120|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||3|||f||||t|f|f||||||No||2017-10-10 21:59:56.575869|2017-10-10 21:59:56.575869
NCT02832635|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-07-11|||July 2016||2016-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases|Effectiveness and Safety of Whole-brain Radiotherapy With/Without TMZ Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases: a Multi-institutional, Randomized Controlled Clinical Trial|Not yet recruiting||Phase 2|256|Anticipated|Sun Yat-sen University||4|||f||||t||||||||||2017-10-10 21:59:56.685005|2017-10-10 21:59:56.685005
NCT02832622|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|November 2019|Anticipated|2019-11-01||Observational|MPP-PMS||MultiPoint Pacing™ Post Market Study|MultiPoint Pacing™ Post Market Study|Recruiting||Phase 4|2000|Anticipated|St. Jude Medical|||4||f||||f||||||||Undecided||2017-10-10 21:59:56.840341|2017-10-10 21:59:56.840341
NCT02832609|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-20|||March 2010||2010-03-01|July 2016|2016-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|OBAIRWAY||Mechanisms of Orthopnea in Stable Obese Patients|Mechanisms of Orthopnea in Stable Obese Patients|Completed||N/A|30|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 21:59:56.937866|2017-10-10 21:59:56.937866
NCT02832596|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-10-31|||October 2016||2016-10-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Changes in Measured Plasma Volume, Glycocalyx and Atrial Natriuretic Peptide During Anaesthesia|Changes in Measured Plasma Volume, Glycocalyx and Atrial Natriuretic Peptide During Anaesthesia, a Randomised Clinical Trial|Recruiting||N/A|24|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||Undecided||2017-10-10 21:59:57.007492|2017-10-10 21:59:57.007492
NCT02832583|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-09-30|||December 2014||2014-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Autologous Platelet Rich Plasma Combined to Hyaluronic Acid Obtained With Regen-Kit BCT-HA in Aesthetic Medicine|Efficacy of the Use of Autologous Platelet Rich Plasma Combined to Hyaluronic Acid Obtained With regenKit BCT-HA Cellular Matrix for Skin in Aesthetic Medicine|Completed||N/A|31|Actual|Regen Lab SA||1|||f||||f||||||||Yes||2017-10-10 21:59:57.095797|2017-10-10 21:59:57.095797
NCT02832570|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-18|||August 2016||2016-08-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ARTERIOFIL||Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication|Etude préliminaire Sur l'efficacité Aigue du Sildenafil Sur le Temps de Marche Chez Les Patients Atteints d'AOMI de Stade II présentant Une Claudication artérielle|Not yet recruiting||Phase 3|14|Anticipated|University Hospital, Angers||2|||f||||f||||||||No||2017-10-10 21:59:57.157831|2017-10-10 21:59:57.157831
NCT02832557|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-15|||November 2015||2015-11-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||A Salivary miRNA Diagnostic Test for Autism|Validation of a Salivary miRNA Diagnostic Test for Autism Spectrum Disorder|Recruiting||N/A|300|Anticipated|State University of New York - Upstate Medical University|||2||f||||t||||||Samples Without DNA|"     Salivary RNA   "|No||2017-10-10 21:59:57.242926|2017-10-10 21:59:57.242926
NCT02832544|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|October 2020|Anticipated|2020-10-01|July 2020|Anticipated|2020-07-01||Interventional|INVICTUS-VKA||INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority|INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies|Not yet recruiting||Phase 3|4500|Anticipated|Population Health Research Institute||2|||f||||t||||||||No|cumulative participant data only|2017-10-10 21:59:57.336367|2017-10-10 21:59:57.336367
NCT02832531|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-07-11|||December 2016||2016-12-01|July 2016|2016-07-01|October 2020|Anticipated|2020-10-01|July 2020|Anticipated|2020-07-01||Interventional|INVICTUS-ASA||INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority|INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies|Not yet recruiting||Phase 3|2000|Anticipated|Population Health Research Institute||2|||f||||t||||||||No|cumulative participant data only|2017-10-10 21:59:57.4236|2017-10-10 21:59:57.4236
NCT02832518|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2016-07-12|||March 2016||2016-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01|6 Months|Observational [Patient Registry]|||Analyse Cardio-respiratory Patterns in Order to Early Detect the Clinical Complications in the Hemodialysis Patients|Using Contact Free Sensor to Analyse Cardio-respiratory Patterns in Order to Early Detect the Clinical Complications in the Hemodialysis Patients.|Active, not recruiting||N/A|140|Actual|Taipei Medical University|||1||f||||f||||||||No||2017-10-10 21:59:57.52954|2017-10-10 21:59:57.52954
NCT02832505|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-11|||August 2016||2016-08-01|July 2016|2016-07-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Observational|||Applications of MRI in Kidney Disease|Applications of MRI in Kidney Disease|Not yet recruiting||N/A|72|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||3||f||||f||||||||No||2017-10-10 21:59:57.800085|2017-10-10 21:59:57.800085
NCT02832492|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-04-23|||October 29, 2015|Actual|2015-10-29|April 2017|2017-04-01|February 10, 2016|Actual|2016-02-10|February 10, 2016|Actual|2016-02-10||Observational|||Pupil Near Response in UWS Patients|Pupil Near Response - A Promising Prognostic Index in Patients With Unresponsive Wakefulness Syndrome|Completed||N/A|20|Actual|Hangzhou Normal University|||2||f||||f|f|f||||||||2017-10-10 21:59:57.893391|2017-10-10 21:59:57.893391
NCT02832479|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-08-09|||October 2014||2014-10-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|COMURA MUCOBS||Costs of Care and Adherence to Treatment for Cystic Fibrosis|Costs of Care and Adherence to Treatment for Cystic Fibrosis.|Completed||N/A|500|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 21:59:57.959698|2017-10-10 21:59:57.959698
NCT02832466|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-04-04|||September 2014||2014-09-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||Quantifying the Deterioration of Physical Function in Renal Patients|Quantifying the Deterioration of Physical Function Along 6 Months in Patients in End Stage Renal Disease|Completed||N/A|60|Actual|Cardenal Herrera University|||1||f||||||||||||||2017-10-10 21:59:58.017441|2017-10-10 21:59:58.017441
NCT02832453|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-07-01|||February 2016||2016-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|BELLUGAT||Metabolic Risk Management, Physical Exercise and Lifestyle Counselling in Low-active Adults; Controlled Randomized Trial|Supervised Physical Exercise and Lifestyle Counselling in the Management of Metabolic Risk in Low-active Adults; a Controlled Randomized Trial. Belluga't de CAP a Peus|Active, not recruiting||N/A|77|Actual|INEFC-Lleida||3|||f||||f||||||||||2017-10-10 21:59:58.084735|2017-10-10 21:59:58.084735
NCT02832440|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-04-04|||September 2014||2014-09-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of Two Exercise Programmes in Patients Undergoing Hemodialysis|Comparison of Intradialytic Versus Home-based Programmes on Adherence and Strength of Stage 5 Chronic Kidney Disease Patients|Completed||N/A|60|Actual|Cardenal Herrera University||2|||f||||||||||||||2017-10-10 21:59:58.186929|2017-10-10 21:59:58.186929
NCT02832427|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-07-11|||June 2016||2016-06-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|FORCAST6||Is Six Weeks Too Long for First Outpatient Review After Cardiac Surgery?|The First Planned Outpatient Review After Cardiac Surgery: Is Six Weeks Too Long?|Recruiting||N/A|200|Anticipated|Hull and East Yorkshire Hospitals NHS Trust|||1||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-10 21:59:58.261251|2017-10-10 21:59:58.261251
NCT02832414|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-06-28|||July 2016||2016-07-01|June 2017|2017-06-01||||October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness of an Intensive Weight Loss Program for Obstructive Sleep Apnea Syndrome (OSAS) Treatment.|Effectiveness of an Intensive Weight Loss Program for Obstructive Sleep Apnea Syndrome (OSAS) Treatment.|Recruiting||N/A|42|Anticipated|Hospital Universitari de Bellvitge||2|||f||||||||||||||2017-10-10 21:59:58.354772|2017-10-10 21:59:58.354772
NCT02832401|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-07-18|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||The Impact of Caffeine on Cognition in Schizophrenia|The Impact of Caffeine on Cognition in Schizophrenia|Recruiting||N/A|30|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-10 21:59:58.476058|2017-10-10 21:59:58.476058
NCT02832388|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-08-11|||June 2013||2013-06-01|August 2017|2017-08-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Observational|||Primary Aldosteronism in Western Norway|Primary Aldosteronism: a Study of Diagnostic Approach and Treatment Outcome in Western Norway|Recruiting||N/A|180|Anticipated|Haukeland University Hospital|||3||f||||f||||||Samples Without DNA|"     Blood and urine samples are collected from each study participants for routine biochemistry     including hormone values.   "|||2017-10-10 21:59:58.602368|2017-10-10 21:59:58.602368
NCT02832375|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-04-25|2017-01-09||March 1, 2016||2016-03-01|April 2017|2017-04-01|May 12, 2016|Actual|2016-05-12|May 1, 2016|Actual|2016-05-01||Interventional|||Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|Completed||Phase 3|242|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 21:59:58.683973|2017-10-10 21:59:58.683973
NCT02832362|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-06-28|||June 11, 2016|Actual|2016-06-11|June 2017|2017-06-01|July 18, 2016|Actual|2016-07-18|July 10, 2016|Actual|2016-07-10||Interventional|||Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants|A Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Local Nasal Tolerability and Safety of 1146A in Healthy Adult Subjects|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 21:59:59.141313|2017-10-10 21:59:59.141313
NCT02832349|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-16|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|EQOLE||Impact of Educational Actions on the Quality Of Life of Epileptic Patients|Impact of Educational Actions on the Quality Of Life of Epileptic Patients|Recruiting||N/A|80|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 21:59:59.238361|2017-10-10 21:59:59.238361
NCT02832336|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-08-15|||October 1, 2016||2016-10-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||The Effect of Caffeine on the Narcoleptic Patients|The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial|Recruiting||Phase 1/Phase 2|60|Anticipated|King Saud University||2|||f||||t||||||||||2017-10-10 21:59:59.307806|2017-10-10 21:59:59.307806
NCT02832323|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-06-22|||June 22, 2016|Actual|2016-06-22|June 2017|2017-06-01|December 22, 2019|Anticipated|2019-12-22|December 22, 2018|Anticipated|2018-12-22||Interventional|RETICERA||Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera Hemodialysis Population|Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera|Recruiting||N/A|150|Anticipated|University Hospital, Brest||1|||f||||t||||||||||2017-10-10 21:59:59.441338|2017-10-10 21:59:59.441338
NCT02832310|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-07-13|||April 2016||2016-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||The Effects of Valsalva Maneuver on Head, Neck and Upper Extremity Arterial Systems|The Effects of Valsalva Maneuver on Head, Neck and Upper Extremity Arterial Systems|Completed||N/A|70|Actual|Tokat Gaziosmanpasa University|||1||f||||t||||||||No||2017-10-10 21:59:59.549902|2017-10-10 21:59:59.549902
NCT02832297|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-07-03|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care|Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care|Recruiting||N/A|318|Anticipated|Crescendo Bioscience||2|||f||||f||||||||||2017-10-10 22:00:01.500429|2017-10-10 22:00:01.500429
NCT02832284|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-20|||January 18, 2017||2017-01-18||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:00:01.77763|2017-10-10 22:00:01.77763
NCT02832271|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-07-18|||December 8, 2016|Actual|2016-12-08|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Green Tea for Endometriosis|Randomised Double-blinded Placebo Controlled Trial of Green Tea Extract for Endometriosis|Recruiting||Phase 2|185|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:00:01.830013|2017-10-10 22:00:01.830013
NCT02832258|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-28|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|PYELOBLSE||Urinary Tract Infection Due to Beta-lactamase-producing Enterobacteriaceae in Children|Urinary Tract Infection Due to Extended-spectrum Beta-lactamase-producing Enterobacteriaceae in Children: an Observational French Study|Recruiting||N/A|800|Anticipated|Centre Hospitalier Intercommunal Creteil|||1||f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-10 22:00:02.003394|2017-10-10 22:00:02.003394
NCT02832245|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-09-28|||March 2001||2001-03-01|September 2017|2017-09-01|December 2027|Anticipated|2027-12-01|December 2026|Anticipated|2026-12-01|3 Years|Observational [Patient Registry]|RIETE||Computerized Registry of Patients With Venous Thromboembolism (RIETE)|Computerized Registry of Patients With Venous Thromboembolism (RIETE)|Recruiting||N/A|90000|Anticipated|Foundation for the study of VTE diseases. (FUENTE)|||1||f||||t||||||||||2017-10-10 22:00:02.330791|2017-10-10 22:00:02.330791
NCT02832232|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-08-30|||July 2016||2016-07-01|May 2016|2016-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Specific Manual Approach to the Suboccipital Area on Patients With Chronic Mechanical Neck Pain|Effectiveness of a Manual Specific Approach to the Suboccipital Area on Pain, Range of Motion, Disability and Clinical Significance of Changes on Patients With Chronic Mechanical Neck Pain and Rotation Deficit of the Upper Cervical Spine|Recruiting||Phase 2|78|Anticipated|Jordi Gol i Gurina Foundation||3|||f||||f||||||||||2017-10-10 22:00:02.420829|2017-10-10 22:00:02.420829
NCT02832219|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-11|||January 2016||2016-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Medium-term Effects of Molecular Hydrogen on Metabolic Fitness in Obesity|Medium-term Effects of Molecular Hydrogen on Metabolic Fitness in Obesity|Completed||Phase 3|12|Actual|Center for Health, Exercise and Sport Sciences, Serbia||2|||f||||f||||||||No||2017-10-10 22:00:02.572491|2017-10-10 22:00:02.572491
NCT02832206|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-27|||March 2016||2016-03-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Hybrid Ablation of Persistent and Long-standing Persistent Stand-alone Atrial Fibrillation|EndoMaze HYBRID project-a Detailed Assessment of Efficacy and Safety of Hybrid Ablation of Persistent and Long-standing Persistent Atrial Fibrillation|Recruiting||N/A|60|Anticipated|Charles University, Czech Republic|||1||f||||t||||||||Undecided||2017-10-10 22:00:02.715575|2017-10-10 22:00:02.715575
NCT02832193|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-14|||March 2009||2009-03-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|December 2020|Anticipated|2020-12-01||Observational|||Retrospective Evaluation of POCD Data of Studies From KAI, Charité - Universitätsmedizin Berlin|Retrospective Evaluation of POCD Data of Studies From the Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK) Charité - Universitätsmedizin Berlin|Recruiting||N/A|3000|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-10 22:00:02.864834|2017-10-10 22:00:02.864834
NCT02832180|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-12-23|||May 2016||2016-05-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects|The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone Acetate in Healthy Female Subjects|Completed||Phase 1|25|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:00:02.976104|2017-10-10 22:00:02.976104
NCT02832167|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-09-14|||September 13, 2016|Actual|2016-09-13|September 2017|2017-09-01|January 4, 2019|Anticipated|2019-01-04|January 21, 2018|Anticipated|2018-01-21||Interventional|CheckMate 627||An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread|An Open Label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies|Recruiting||Phase 2|150|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 22:00:03.114637|2017-10-10 22:00:03.114637
NCT02832063|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-07-20|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|||Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris|A Randomized, Double Blinded, Phase IIb/III, Decentralized Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Participants With Mild to Moderate Acne Vulgaris|Completed||Phase 2/Phase 3|372|Actual|AOBiome LLC||2|||f||||f||||||||||2017-10-10 22:00:03.384988|2017-10-10 22:00:03.384988
NCT02832050|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-05-25|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Interventional|PLAYTIME||PLAY Therapy Intervention: Re-Modelling Patient Experience (The PLAYTIME Study)|PLAY Therapy Intervention: Re-Modelling Patient Experience (The PLAYTIME Study)|Recruiting||N/A|60|Anticipated|Alder Hey Children's NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:00:03.478488|2017-10-10 22:00:03.478488
NCT02832037|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-02-22|||July 2016||2016-07-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia|A Phase II Randomised, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period in Patients With Schizophrenia|Suspended||Phase 2|504|Anticipated|Boehringer Ingelheim||5|||f||||||||||||||2017-10-10 22:00:03.570666|2017-10-10 22:00:03.570666
NCT02832024|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-07-11|||January 2014||2014-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Clinical Study of Stent Versus Direct Atherectomy Versus Angioplasty to Treat Lower Limb In-stent Restenosis||Recruiting||N/A|120|Anticipated|Xuanwu Hospital, Beijing||3|||f||||t||||||||Yes||2017-10-10 22:00:03.680296|2017-10-10 22:00:03.680296
NCT02832011|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-11|||January 2016||2016-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|RDS||How Effect Olive Oil and Eoprotin on Immunological Parameters and Growth|The Effect on Immunological Parameters and Growth of Olive Oil and Eoprotin Used as a Fortification Breast Milk at the VLBW Babies|Active, not recruiting||N/A|60|Anticipated|Yuzuncu Yıl University||2|||f||||t||||||||||2017-10-10 22:00:03.810239|2017-10-10 22:00:03.810239
NCT02831998|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-07-12|||July 27, 2016|Actual|2016-07-27|July 2017|2017-07-01|April 9, 2017|Actual|2017-04-09|April 9, 2017|Actual|2017-04-09||Interventional|||In-vivo Efficacy of Patient Preoperative Prep|Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZP|Completed||Phase 3|690|Actual|Zurex Pharma, Inc.||3|||f||||f||||||||||2017-10-10 22:00:03.91608|2017-10-10 22:00:03.91608
NCT02831985|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-09-08|||August 15, 2017|Actual|2017-08-15|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|ConVenTu||Follow up After Middle-ear Ventilation Tube Insertion: Who and Where?|Follow up After Middle-ear Ventilation Tube Insertion: a Randomised Controlled Study|Recruiting||N/A|400|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 22:00:04.022685|2017-10-10 22:00:04.022685
NCT02831972|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-06-26|||June 2016||2016-06-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Drug-Drug Interaction Study of AG120 in Healthy Subjects|An Open-Label, 2-Period, Fixed Sequence Study to Determine the Effect of Multiple Oral Doses of Itraconazole on the Single Dose Pharmacokinetics of AG 120 in Healthy Adult Subjects|Completed||Phase 1|22|Actual|Agios Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 22:00:04.245095|2017-10-10 22:00:04.245095
NCT02831400|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-06-07|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Changes in Circulatory I-FABP in Elderly Persons in Daily Life|Changes in Circulatory I-FABP in Elderly Persons in Daily Life: A Pilot Study|Completed||N/A|34|Actual|University Medical Center Groningen||1|||f||||f||||||||No||2017-10-10 22:00:10.371162|2017-10-10 22:00:10.371162
NCT02831946|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-07-11|||May 2016||2016-05-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|May 2017|Anticipated|2017-05-01||Interventional|SVGCS||Suture Versus Glue (Dermabond) Closure During Cesarean Delivery|Intracuticular Sutures Versus Glue (Dermabond) for Skin Closure After Cesarean Delivery|Recruiting||Phase 4|100|Anticipated|Meir Medical Center||2|||f||||t||||||||Yes|within 6 m of finishing the study|2017-10-10 22:00:04.698275|2017-10-10 22:00:04.698275
NCT02831933|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-08-08|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Interventional|ENSIGN||Trial of Stereotactic Body Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma|ENSIGN: Phase II Window of Opportunity Trial of Stereotactic Body Radiation Therapy and In Situ Gene Therapy Followed by Nivolumab in Metastatic Squamous or Non-Squamous Non-Small Cell Lung Carcinoma|Recruiting||Phase 2|29|Anticipated|The Methodist Hospital System||1|||f||||f|t|f||||||||2017-10-10 22:00:04.802822|2017-10-10 22:00:04.802822
NCT02831920|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-09-18|||December 7, 2015|Actual|2015-12-07|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer|CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer|Recruiting||N/A|299|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 22:00:04.926405|2017-10-10 22:00:04.926405
NCT02831907|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-28|||August 2016||2016-08-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|PP-AKI||Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery|Assessment of Portal Flow Using Bedside Doppler Ultrasonography for the Detection of Portal Pulsatility as a Risk Factor for Acute Kidney Injury in Cardiac Surgery Patients|Completed||N/A|146|Actual|Montreal Heart Institute|||1||f||||f||||||||||2017-10-10 22:00:05.061748|2017-10-10 22:00:05.061748
NCT02831894|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-09-07|||August 2015||2015-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation|The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation|Recruiting||Phase 2|75|Anticipated|National Jewish Health||3|||f||||t||||||||||2017-10-10 22:00:05.19114|2017-10-10 22:00:05.19114
NCT02831881|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-11|||November 2015||2015-11-01|July 2016|2016-07-01||||November 2020|Anticipated|2020-11-01||Observational|||Protected PCI Study|PROTECTED PCI STUDY: A Prospective Clinical Trial For Patients Undergoing Protected Percutaneous Coronary Intervention With IMPELLA® 2.5 System|Recruiting||N/A|369|Anticipated|Abiomed Inc.|||1||f||||t||||||||Undecided||2017-10-10 22:00:05.30471|2017-10-10 22:00:05.30471
NCT02831868|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-05-04|||December 2011||2011-12-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability and Efficacy of HAVAI, for Correction of Inter-metatarsal Angle|Multi Center, Open-label, Double Arm, Study Designed to Evaluate Safety, Tolerability and Efficacy of HAVAI, a Minimally Invasive Implant Composed of Spring, Double Anchor and Suture, Versus Standard of Care 1st Metatarsal Osteotomy,|Recruiting||N/A|30|Anticipated|Rabin Medical Center||1|||f||||f||||||||No||2017-10-10 22:00:05.383168|2017-10-10 22:00:05.383168
NCT02831855|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-09-25|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|March 20, 2019|Anticipated|2019-03-20|March 20, 2019|Anticipated|2019-03-20||Interventional|||Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis|A Phase 3b/4 Randomized Double Blind Placebo Controlled Study Of Methotrexate (MTX) Withdrawal In Subjects With Rheumatoid Arthritis (RA) Treated With Tofacitinib 11mg Modified Release (MR) Formulation|Recruiting||Phase 4|580|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 22:00:05.50668|2017-10-10 22:00:05.50668
NCT02831829|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-30|||May 2016||2016-05-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Influence of Different Forms of Exercise Training in Patients With Coronary Artery Disease|Comparative Effect of Water-based and Land-based Exercise Training on Exercise Capacity and Other Selected Cardiovascular Parameters in Patients With Coronary Artery Disease|Recruiting||N/A|90|Anticipated|University Medical Centre Ljubljana||3|||f||||t||||||||Yes||2017-10-10 22:00:06.004297|2017-10-10 22:00:06.004297
NCT02831816|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-07-12|||August 3, 2016|Actual|2016-08-03|July 2017|2017-07-01||||September 2017|Anticipated|2017-09-01||Interventional|||Clinical Evaluation of Patient Preoperative Prep|Clinical Evaluation of ZP, A Patient Preoperative Skin Preparation|Recruiting||Phase 3|352|Anticipated|Zurex Pharma, Inc.||3|||f||||f||||||||||2017-10-10 22:00:06.223879|2017-10-10 22:00:06.223879
NCT02831803|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-03-07|||October 2014||2014-10-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Interventional|||Nuts and Extra Virgin Olive Oil Pilot Study|A Pilot Study to Evaluate the Feasibility of Walnut and Extra Virgin Olive Oil Supplementation in Older Adults Being Treated for Hypertension|Completed||N/A|27|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||No||2017-10-10 22:00:06.326314|2017-10-10 22:00:06.326314
NCT02831790|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-13|||July 2016||2016-07-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|July 2018|Anticipated|2018-07-01||Interventional|||The Fontan Education Study: A Randomized Control Trial|The Fontan Education Study: A Randomized Control Trial|Recruiting||N/A|16|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 22:00:06.408134|2017-10-10 22:00:06.408134
NCT02831777|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-11|||March 2016||2016-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|Self_Cal||CareTaker Self-Calibration Validation|CareTaker Self-Calibration Validation|Completed||N/A|140|Actual|CareTaker Medical LLC|||1||f||||f||||||||Undecided||2017-10-10 22:00:06.512607|2017-10-10 22:00:06.512607
NCT02831751|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-08-30|||April 2016||2016-04-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults|A Randomized, Observer-Blind, Multicenter, Phase 2 Study to Assess the Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults of 65 Years of Age or Older|Active, not recruiting||Phase 2|1000|Anticipated|Medicago||4|||f||||f||||||||No||2017-10-10 22:00:06.944344|2017-10-10 22:00:06.944344
NCT02831738|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-02-03|||July 2016||2016-07-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PDX2||Fiber Effects on Glycemic Index|Verifying Fibers Meet Regulatory Definitions for Nutrition Facts Labeling: A Randomized, Controlled Trial Evaluating Polydextrose in Dry Form|Active, not recruiting||N/A|20|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||Undecided||2017-10-10 22:00:07.084051|2017-10-10 22:00:07.084051
NCT02831725|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||An Observational Cohort Study to Establish Accurate Nutrition Therapy for Critically Ill Patients||Not yet recruiting||N/A|120|Anticipated|Peking Union Medical College Hospital|||1||f||||||||||||||2017-10-10 22:00:07.190101|2017-10-10 22:00:07.190101
NCT02831712|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-15|||April 2013||2013-04-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load|Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load|Active, not recruiting||N/A|50|Anticipated|National University, Singapore||1|||f||||f||||||||||2017-10-10 22:00:07.271828|2017-10-10 22:00:07.271828
NCT02831699|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-07-14|||June 2016||2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|Zik01||The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico|The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico (Zik01)|Recruiting||N/A|600|Anticipated|Mexican Emerging Infectious Diseases Clinical Research Network|||4||f||||f||||||Samples Without DNA|"     Urine samples Blood samples   "|||2017-10-10 22:00:07.402402|2017-10-10 22:00:07.402402
NCT02831686|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-08-29|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma|An Investigator-Initiated Phase I Study of Selinexor (KPT-330), Ixazomib, and Low Dose Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:00:07.567175|2017-10-10 22:00:07.567175
NCT02831647|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Acceptability and Tolerance Study of New Oral Nutritional Supplement PRAGUE|Tolerance and Acceptability of AYMES PRAGUE|Not yet recruiting||N/A|20|Anticipated|Aymes International Limited||1|||f||||f||||||||No||2017-10-10 22:00:08.189363|2017-10-10 22:00:08.189363
NCT02831634|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-01-06|||June 2016||2016-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)|A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes|Recruiting||N/A|40|Anticipated|Institut Curie||1|||f||||f||||||||||2017-10-10 22:00:08.27237|2017-10-10 22:00:08.27237
NCT02831621|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-08|||June 2016||2016-06-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|ectofat||Exercise and Ectopic Fat Deposition|Effect of Diet Plus Exercise Versus Diet Alone on the Reduction of Ectopic Fat Deposition in Adults With Overweight|Recruiting||N/A|60|Anticipated|Universiteit Antwerpen||2|||f||||f||||||||||2017-10-10 22:00:08.380158|2017-10-10 22:00:08.380158
NCT02831608|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-10-04|||October 2016||2016-10-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|March 2019|Anticipated|2019-03-01||Interventional|IAMI||Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis|Influenza Vaccination After Myocardial Infarction (IAMI Trial): A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on the Swedish Angiography and Angioplasty Registry (SCAAR) Platform|Recruiting||Phase 4|4400|Anticipated|Region Örebro County||2|||f||||t||||||||||2017-10-10 22:00:08.495054|2017-10-10 22:00:08.495054
NCT02831595|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-08|||June 2016||2016-06-01|June 2016|2016-06-01||||October 2018|Anticipated|2018-10-01||Observational|||Effectiveness of Titanium Niobium Nitride Coating in Total Knee Arthroplasty||Active, not recruiting||N/A|80|Actual|Permedica Manufacturing|||1||f||||||||||||||2017-10-10 22:00:08.67685|2017-10-10 22:00:08.67685
NCT02831582|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-08-11|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer|Prevention of Aromatase Inhibitor-Induced Toxicity With Omega-3 Supplementation|Recruiting||N/A|200|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 22:00:08.865207|2017-10-10 22:00:08.865207
NCT02831556|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-03-21|||July 2016||2016-07-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Observational|||Point of Care 3D Ultrasound for Various Applications: A Pilot Study|A Pilot Study to Test Rapid Acquisition of Point of Care Ultrasound for Various Applications|Recruiting||N/A|300|Anticipated|Duke University|||2||f||||f||||||||No||2017-10-10 22:00:09.109538|2017-10-10 22:00:09.109538
NCT02831543|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-11|||April 2016||2016-04-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.||Recruiting||Phase 3|354|Anticipated|IlDong Pharmaceutical Co Ltd||3|||f||||||||||||||2017-10-10 22:00:09.220296|2017-10-10 22:00:09.220296
NCT02831530|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-08-07|||March 7, 2016|Actual|2016-03-07|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|ABC-POP||Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients|Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients|Recruiting||Phase 2|115|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-10 22:00:09.333037|2017-10-10 22:00:09.333037
NCT02831517|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-03-07|||August 2016||2016-08-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants|A Phase 1 Pharmacokinetics and Safety Study of BIIB074 in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|64|Actual|Biogen||2|||f||||f||||||||||2017-10-10 22:00:09.42493|2017-10-10 22:00:09.42493
NCT02831504|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-03-29|||August 2015|Actual|2015-08-01|March 2017|2017-03-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|PhenoDM1||PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)|Myotonic Dystrophy Type 1 (DM1) Deep Phenotyping to Improve Delivery of Personalized Medicine and Assist in the Planning, Design and Recruitment of Clinical Trials|Recruiting||N/A|400|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f||||||Samples With DNA|"     All blood and urine will be processed and stored in Newcastle Biobank for Research of     Neuromuscular Disorders (Newcastle and North Tyneside 1 -REF/08/H0906/28).   "|Yes||2017-10-10 22:00:09.543296|2017-10-10 22:00:09.543296
NCT02831491|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-12-09|||November 2016||2016-11-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer|A Single-Arm, Phase 2 Study of Ramucirumab in Combination With Weekly Docetaxel in Patients With Stage IV Non-Small Cell Lung Cancer Following Disease Progression After Prior Platinum-Based Chemotherapy|Withdrawn||Phase 2|0|Actual|Eli Lilly and Company||1||To pursue broader program objectives in oncology.|f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 22:00:09.664764|2017-10-10 22:00:09.664764
NCT02831478|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-06-21|||July 9, 2016|Actual|2016-07-09|June 2017|2017-06-01|July 10, 2016|Actual|2016-07-10|July 10, 2016|Actual|2016-07-10||Interventional|||Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old|Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old|Completed||N/A|98|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:00:09.752413|2017-10-10 22:00:09.752413
NCT02831465|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2017-02-01|||April 2015||2015-04-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Dynamic Hyperinflation During Maximal Voluntary Ventilation in Healthy Subjects|Dynamic Hyperinflation During Maximal Voluntary Ventilation in Healthy Subjects|Recruiting||N/A|45|Anticipated|Centre Hospitalier Universitaire Saint Pierre||1|||f||||f||||||||No||2017-10-10 22:00:09.840436|2017-10-10 22:00:09.840436
NCT02831452|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-07-12|||December 2014||2014-12-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01|1 Day|Observational [Patient Registry]|||Relationship Among Vaginal Palpation, Vaginal Squeeze Pressure and Dynamometry of Nulliparous Pelvic Floor Muscles|Relationship Among Vaginal Palpation, Vaginal Squeeze Pressure and Dynamometry of Nulliparous Pelvic Floor Muscles|Completed||N/A|141|Actual|Federal University of São Paulo|||4||f||||||||||||||2017-10-10 22:00:09.942931|2017-10-10 22:00:09.942931
NCT02831439|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-16|||September 2014||2014-09-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care|A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer Care|Enrolling by invitation||N/A|9000|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-10 22:00:10.039275|2017-10-10 22:00:10.039275
NCT02831426|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-09-30|||January 2017||2017-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Interventional|PreBRec||Pre-pectoral Breast Reconstruction PART 2|Prospective Multicentric Randomized Comparison of an Acellular Dermal Matrix Versus a Synthetic Mesh in Pre-pectoral Implant Based Breast Reconstruction|Not yet recruiting||Phase 3|86|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||||||||||||2017-10-10 22:00:10.173806|2017-10-10 22:00:10.173806
NCT02831413|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-11-02|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Testing the Effectiveness of Relationship Smarts and the Effects of Enhanced Facilitator Training|Testing the Effectiveness of Relationship Smarts Curriculum and the Effects of Enhanced Facilitator Training|Enrolling by invitation||N/A|1200|Anticipated|Mathematica Policy Research, Inc.||3|||f||||f||||||||No||2017-10-10 22:00:10.283712|2017-10-10 22:00:10.283712
NCT02831387|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-08-09|||July 2016||2016-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease|Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days|Terminated||Phase 2|60|Anticipated|Parion Sciences||2|||f||||f|t|f||||||||2017-10-10 22:00:10.440978|2017-10-10 22:00:10.440978
NCT02831374|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-10|||October 2015||2015-10-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effectiveness of Platelet Rich Plasma in Wound Healing|Assessment Effectiveness of Platelet Rich Plasma in Wound Healing After Surgical Removal of Mandibular Third Molars: A Clinical Study|Completed||Early Phase 1|40|Actual|Linyi People's Hospital||2|||f||||f||||||||No||2017-10-10 22:00:10.54683|2017-10-10 22:00:10.54683
NCT02831361|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-10|||October 2016||2016-10-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)|A Multinational, Multicenter, Randomized, Placebo-controlled, Parallel Group, Double-Blind, Phase 3 Trial to Evaluate the Efficacy and Safety of Gemigliptin 50 mg q.d Compared With Placebo Added to Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Insulin Alone or on Insulin in Combination With Metformin|Not yet recruiting||Phase 3|285|Anticipated|LG Life Sciences||2|||f||||f||||||||No||2017-10-10 22:00:10.656202|2017-10-10 22:00:10.656202
NCT02831348|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-11|2016-11-30|||October 2015||2015-10-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Observational|COOX||Association of Transcutaneous Pulse CO-oximetry With Inflammatory Lung Diseases|Association of Transcutaneous Pulse CO-oximetry With Inflammatory Lung Diseases|Recruiting||N/A|84|Anticipated|Boston Children’s Hospital|||8||f||||f||||||||No||2017-10-10 22:00:10.772936|2017-10-10 22:00:10.772936
NCT02831335|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-05-09|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|September 2022|Anticipated|2022-09-01|August 2020|Anticipated|2020-08-01||Observational|||Technical Development of Multi-Parametric Renocerebral MRI|Technical Development of Multi-Parametric Renocerebral MRI|Recruiting||N/A|120|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||4||f||||f|f|f||||||No||2017-10-10 22:00:10.858493|2017-10-10 22:00:10.858493
NCT02831322|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-03-17|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of Structure and Function of Radial Artery After Transradial Coronary Intervention||Recruiting||N/A|1000|Anticipated|The First Hospital of Qinhuangdao||2|||f||||f||||||||Yes||2017-10-10 22:00:10.943788|2017-10-10 22:00:10.943788
NCT02831309|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-12|||June 2014||2014-06-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|ACS||Active Class Space Metabolic Benefits Study|Active Class Space Metabolic Benefits Study|Completed||N/A|39|Actual|University of Michigan||4|||f||||f||||||||No||2017-10-10 22:00:11.037491|2017-10-10 22:00:11.037491
NCT02831296|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-04-18|||February 2016||2016-02-01|April 2017|2017-04-01||||March 2022|Anticipated|2022-03-01|10 Years|Observational [Patient Registry]|SPOTSMA||Prospective Evaluation of Infants With Spinal Muscular Atrophy:|Prospective Evaluation of Infants With Spinal Muscular Atrophy: SPOT SMA|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital|||4||f||||t||||||Samples With DNA|"     DNA, RNA and specific biomarker assessments for whole blood SMN protein levels, plasma and     serum for exploratory metabolomics profiling, skin biopsy for fibroblast cell line     establishment (iPS cell line studies)   "|Yes|"The National Institute of Child Health and Human Development has a contract with the American College of Medical Genomics and the Newborn Screening Translational Research Network (NBSTRN) in collaboration with the bioinformatics group at the Cincinnati Children's Hospital to develop a national database for data capture and management for all the follow-up data to be collected for those who agree to participate in the research study. The investigators will share deidentified data with the NBSTRN database.
The investigators will also submit large-scale human genomic data as well as relevant associated data (e.g., phenotype and exposure data) to an NIH-designated data repository in a timely manner, as indicated by the NIH Genomic Data Sharing policy.
Aggregate Data will be available for submission/general research use."|2017-10-10 22:00:11.135826|2017-10-10 22:00:11.135826
NCT02831283|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-12-07|||June 2016||2016-06-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Imaging Inflammation in Alzheimer's Disease|Imaging Inflammation in Elders With Different Clinical and Biomarker Profiles of Alzheimer's Disease|Recruiting||Phase 2|100|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-10 22:00:11.258541|2017-10-10 22:00:11.258541
NCT02831270|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-07-10|||December 2011||2011-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery|Does Acute Normovolemic Hemodilution Affect Intraoperative Value of Serum-creatinine Concentration in Patients Undergoing Cardiac Surgery?|Completed||N/A|32|Actual|Konkuk University Medical Center|||2||f||||t||||||||||2017-10-10 22:00:11.363737|2017-10-10 22:00:11.363737
NCT02831257|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-27|||August 31, 2016|Actual|2016-08-31|September 2017|2017-09-01|November 2024|Anticipated|2024-11-01|March 2020|Anticipated|2020-03-01||Interventional|||AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas|A Single Arm Phase 2 Study of the Dual mTORC1/mTORC2 Inhibitor AZD2014 Provided on an Intermittent Schedule for Neurofibromatosis 2 Patients With Progressive or Symptomatic Meningiomas|Active, not recruiting||Phase 2|18|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:00:11.44263|2017-10-10 22:00:11.44263
NCT02831244|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-08-14|||August 2016||2016-08-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Agili-CTM Implant Performance Evaluation in the Treatment of Osteoarthritis of the Great Toe|Agili-CTM Implant Performance Evaluation in the Treatment of Osteoarthritis of the Great Toe|Recruiting||Phase 4|20|Anticipated|Cartiheal (2009) Ltd||1|||f||||f||||||||Yes||2017-10-10 22:00:11.530085|2017-10-10 22:00:11.530085
NCT02831231|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-04-18|||September 7, 2016|Actual|2016-09-07|April 2017|2017-04-01|October 28, 2016|Actual|2016-10-28|October 28, 2016|Actual|2016-10-28||Interventional|||Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium|A Phase I, Double-Blind, Randomized, Multiple-Dose, Pilot Study Comparing Xanomeline Administered Alone to Xanomeline Administered in Combination With Trospium Chloride in Normal Healthy Volunteers|Completed||Phase 1|70|Actual|Karuna Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:00:11.612324|2017-10-10 22:00:11.612324
NCT02831218|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-12-21|||December 2016||2016-12-01|December 2016|2016-12-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|GUIDE-BVS||Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation||Recruiting||Phase 4|1528|Anticipated|Asan Medical Center||4|||f||||t||||||||No|This is not a publicly funded trial.|2017-10-10 22:00:11.695053|2017-10-10 22:00:11.695053
NCT02831205|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-12|||July 2016||2016-07-01|July 2016|2016-07-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Interventional|ABSORB-LONG||Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease|Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease|Not yet recruiting||Phase 4|800|Anticipated|Asan Medical Center||2|||f||||t||||||||No|This is not a publicly funded trial.|2017-10-10 22:00:11.780101|2017-10-10 22:00:11.780101
NCT02831192|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-07-12|||May 2006||2006-05-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Microtransplantation in Older Patients With Acute Myeloid Leukemia|International Multi-center Clinical Study on Microtransplantation for Treatment of Newly Diagnosed Elderly Acute Myeloid Leukemia (EAML)|Completed||Phase 2|150|Actual|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||1|||f||||t||||||||Undecided||2017-10-10 22:00:11.868239|2017-10-10 22:00:11.868239
NCT02831179|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2017-09-26|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor|A Phase 1 Study of Veliparib (ABT-888) in Combination With Capecitabine and Temozolomide in Advanced Well-Differentiated Neuroendocrine Tumors|Withdrawn||Phase 1|0|Actual|Vanderbilt-Ingram Cancer Center||1||Loss of funding support|f||||t|t|f||||||||2017-10-10 22:00:11.932533|2017-10-10 22:00:11.932533
NCT02831166|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2017-01-01|||January 2016||2016-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|ARISE-2||Vascular Closure Device Versus Transradial Approach in Primary Percutaneous Coronary Intervention|A Randomized Comparison Between Transfemoral Approach With Vascular Closure Device Versus Transradial Approach in Primary Percutaneous Coronary Intervention|Recruiting||Phase 4|300|Anticipated|Irmandade Santa Casa Misericórdia Marília||2|||f||||f||||||||No||2017-10-10 22:00:12.041514|2017-10-10 22:00:12.041514
NCT02831153|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-07-10|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|STRAIN-TIMI||Evaluation of Emotional Status and Coronary Flow Characteristics by TIMI Frame Count Method|Effects of Emotional Status on Coronary Flow in Patients Undergoing Coronary Angiography:Multicenter TIMI Frame Count Assessment Study (STRAIN-TIMI Study)|Recruiting||N/A|2000|Anticipated|Vascular and Molecular Cardiology Society||5|||f||||f||||||||Yes|The results will be made available within 6 months of study completion|2017-10-10 22:00:12.134753|2017-10-10 22:00:12.134753
NCT02831140|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-07-08|||January 2016||2016-01-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|FTR-TS||The Fast Track Rehabilitation in Thoracic Surgery|The Fast Track Rehabilitation in Thoracic Surgery - A Prospective Randomized Study|Recruiting||N/A|100|Anticipated|Habib Bourguiba University Hospital||3|||f||||f||||||||No||2017-10-10 22:00:12.241681|2017-10-10 22:00:12.241681
NCT02831127|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-07-10|||February 2012||2012-02-01|July 2016|2016-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Mobile Messages Affects Adherence of Stent Removal or Exchange in Patients With Benign Pancreaticobiliary Diseases|Mobile Phone Reminder Messages Improves the Adherence of Stent Removal or Exchange in Patients With Benign Pancreaticobiliary Diseases|Completed||N/A|48|Actual|Fourth Military Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:00:12.322314|2017-10-10 22:00:12.322314
NCT02831114|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-02-23|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluating the Effects of Acupuncture in the Treatment of Taxane Induces Peripheral Neuropathy|Evaluating the Effects of Acupuncture in the Treatment of Taxane Induces Peripheral Neuropathy (TIPN)|Recruiting||N/A|18|Anticipated|Greenville Health System||2|||f||||f||||||||No||2017-10-10 22:00:12.528873|2017-10-10 22:00:12.528873
NCT02831101|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-13|||February 2012||2012-02-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Sufentanil Bispectral Index Elderly|Impact of Sufentanil on the Depth of Sedation Measured by Bispectral Index During Induction of Anaesthesia With Propofol in the Elderly - a Randomised Trial|Completed||N/A|71|Actual|University Hospital, Geneva||3|||f||||f||||||||No||2017-10-10 22:00:12.661296|2017-10-10 22:00:12.661296
NCT02831088|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-07-11|||July 2016||2016-07-01|December 2016|2016-12-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|SONIC||Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC)|A Phase II, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Assess Efficacy and Safety of Neu2000KWL in Patients With Acute Ischemic Stroke Receiving Endovascular Therapy|Recruiting||Phase 2|210|Anticipated|GNT Pharma||3|||f||||t||||||||||2017-10-10 22:00:12.754313|2017-10-10 22:00:12.754313
NCT02831075|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-04-05|||January 2015||2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Study Using Adipose-derived Stem Cells for Diabetic Foot|A Clinical Study Using Adipose-derived Stem Cells for Diabetic Foot|Recruiting||Phase 1|240|Anticipated|The Third Affiliated Hospital of Southern Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:00:12.888046|2017-10-10 22:00:12.888046
NCT02831062|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-07-08|||August 2016||2016-08-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|NutriAKI||Nutritional Therapy to Prevent Progression of Acute Kidney Injury to Chronic Kidney Disease|Nutritional Therapy to Prevent Progression of Acute Kidney Injury to Chronic Kidney Disease|Not yet recruiting||Phase 4|50|Anticipated|University of California, San Diego||2|||f||||f||||||||No|individual data will not be shared|2017-10-10 22:00:13.007091|2017-10-10 22:00:13.007091
NCT02831049|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-09-12|||June 30, 2016||2016-06-30|August 22, 2017|2017-08-22|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Effects of a New Behavioral Intervention on Alcohol Craving and Drinking|Effects of a New Behavioral Intervention on Alcohol Craving and Drinking|Recruiting||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 22:00:13.099652|2017-10-10 22:00:13.099652
NCT02831036|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2016-07-10|||October 2016||2016-10-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||The Impact of Physical Exercise on Navigation Performance in Soldier|The Impact of Physical Exercise on Navigation Performance in Soldier|Not yet recruiting||N/A|20|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 22:00:13.194722|2017-10-10 22:00:13.194722
NCT02831023|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-01-09|||July 2016||2016-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Phase 2 Efficacy Study of Primaquine and Methylene Blue|Efficacy, Safety, and Pharmacokinetics of Sulphadoxine-pyrimethamine-amodiaquine (SP-AQ), SP-AQ Plus Primaquine, Dihydroartemisinin-piperaquine (DP), DP Plus Methylene Blue for Preventing Transmission of P. Falciparum Gametocytes in Mali|Completed||Phase 2|80|Actual|University of California, San Francisco||4|||f||||t||||||||Yes|Data can be shared on request|2017-10-10 22:00:13.294213|2017-10-10 22:00:13.294213
NCT02831010|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-10|2017-09-18|||April 2014||2014-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Multi-Center Cohort Study of Risk Factors and Outcomes of Encephalopathy of Prematurity in China|A Multi-Center Cohort Study of Risk Factors and Outcomes of Encephalopathy of Prematurity in China|Recruiting||N/A|1500|Anticipated|Children's Hospital of Fudan University|||2||f||||f||||||Samples Without DNA|"     serum, tissue   "|||2017-10-10 22:00:13.418465|2017-10-10 22:00:13.418465
NCT02830997|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2016-07-09|||July 2015||2015-07-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|July 2017|Anticipated|2017-07-01||Observational|||Total Knee Arthroplasty Guidance Systems Study|A Comparison of Surgical Technologies for Accuracy of Prosthesis Placement and Ease of Surgeon Use in Total Knee Arthroplasty|Enrolling by invitation||N/A|150|Anticipated|Athens Orthopedic Clinic, P.A.|||2||f||||f||||||||No||2017-10-10 22:00:13.57647|2017-10-10 22:00:13.57647
NCT02830984|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-03-05|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||ENBD After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing PEP|Nasobiliary Drainage After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing Postoperative Pancreatitis in Treating of Large Bile Duct Stones|Recruiting||N/A|160|Anticipated|Anhui Provincial Hospital||2|||f||||t||||||||No||2017-10-10 22:00:13.677658|2017-10-10 22:00:13.677658
NCT02830971|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-08|||July 2016||2016-07-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Developing a Standardized Learning Curve|Effect of Specific Training for Mastery in Doing Different Techniques in Intensive Care Unit: Developing a Standardized Learning Curve|Not yet recruiting||N/A|60|Anticipated|Baqiyatallah Medical Sciences University||1|||f||||t||||||||Yes|After the study termination, data will be entered.|2017-10-10 22:00:13.768213|2017-10-10 22:00:13.768213
NCT02830958|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-08-22|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|March 31, 2017|Actual|2017-03-31||Interventional|||Postoperative Kinesio Taping Effect on Pain and Edema in Patients Who Underwent Total Hip Arthroplasty||Recruiting||N/A|60|Anticipated|Groupe Hospitalier Paris Saint Joseph||2|||f||||f||||||||||2017-10-10 22:00:13.855383|2017-10-10 22:00:13.855383
NCT02830945|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-04-19|||July 1, 2015|Actual|2015-07-01|April 2017|2017-04-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|FITSMI||Innovative Multigenerational Household Intervention to Reduce Stroke and CVD|Innovative Multigenerational Household Intervention to Reduce Stroke and CVD|Active, not recruiting||N/A|458|Actual|Washington State University||2|||f||||t||||||||No||2017-10-10 22:00:13.941463|2017-10-10 22:00:13.941463
NCT02830932|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-05-08|||June 22, 2016|Actual|2016-06-22|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 9, 2017|Anticipated|2017-09-09||Interventional|||Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Determine the Safety and Immunogenicity of an Adenoviral-Vector Based Respiratory Syncytial Virus (RSV) F Protein Vaccine (VXA-RSV-f) Expressing Protein F and dsRNA Adjuvant Administered Orally to Healthy Volunteers|Recruiting||Phase 1|66|Anticipated|Vaxart||3|||f||||t||||||||Undecided|Data may be made available to subjects following the 1 year safety follow-up period.|2017-10-10 22:00:14.043911|2017-10-10 22:00:14.043911
NCT02830919|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-12-19|||November 2016||2016-11-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|GLACIAL||Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)|Phase III Clinical Study, Multicenter, Randomized, Single-blind, Parallel Groups for Safety Evaluation and Non-inferiority of Efficacy of Glucosamine Sulfate Plus Chondroitin Sulfate From Bovine Origin (Eurofarma Laboratorios S.A.) Versus Condroflex ® in the Treatment of Symptomatic Knee Primary Osteoarthritis|Recruiting||Phase 3|314|Anticipated|Eurofarma Laboratorios S.A.||2|||f||||f||||||||||2017-10-10 22:00:14.136717|2017-10-10 22:00:14.136717
NCT02830906|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-09|||April 2014||2014-04-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting|Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial|Completed||Phase 3|99|Actual|Thammasat University||2|||f||||t||||||||No||2017-10-10 22:00:14.231654|2017-10-10 22:00:14.231654
NCT02830893|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-05-02|||February 15, 2017|Actual|2017-02-15|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Efficacy Study of the LARA Wheelchair System for Subacute Stroke Patients|Lever Actuated Rehabilitation of the Arm Using Wheelchair Propulsion and Computer Gaming|Recruiting||N/A|44|Anticipated|University of California, Irvine||2|||f||||f|f|t|f||f|||No||2017-10-10 22:00:14.315551|2017-10-10 22:00:14.315551
NCT02830880|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-07-27|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||FACBC Prostate Therapy Response|Investigation of Therapy Response With Amino Acid Analogue Transport PET Imaging|Recruiting||Phase 2|30|Anticipated|Emory University||1|||f||||f|t|f||||||||2017-10-10 22:00:14.411692|2017-10-10 22:00:14.411692
NCT02830867|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-07-08|||July 2016||2016-07-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|||Review of French Cases of Glutathione Synthetase Deficiency||Not yet recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:00:14.52227|2017-10-10 22:00:14.52227
NCT02830854|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-10-27|||July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Molecular Hydrogen for Cognitive Function and Performance in Elderly||Completed||Phase 3|13|Actual|University of Novi Sad, Faculty of Sport and Physical Education||1|||f||||f||||||||Undecided||2017-10-10 22:00:14.595097|2017-10-10 22:00:14.595097
NCT02830841|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-09|||February 2016||2016-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIPC-PLDT||Liver Protection of RIPC in Pediatric Living Donor Liver Transplantation|Remote Ischemic Preconditioning Protects Against Hepatic Ischemic and Reperfusion Injury in Pediatric Living Donor Liver Transplantation|Recruiting||N/A|200|Anticipated|RenJi Hospital||4|||f||||||||||||||2017-10-10 22:00:14.679422|2017-10-10 22:00:14.679422
NCT02830828|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-06-04|||March 2015||2015-03-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Studying Finger-thumb Grip in Patients With Carpal Tunnel Syndrome|How Does Disease Severity, Object Weight, Object Friction, and Sudden Changes to Object Weight Affect Precision Pinch Grip Force in Carpal Tunnel Syndrome?|Recruiting||N/A|35|Anticipated|University Hospital Birmingham NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 22:00:14.783596|2017-10-10 22:00:14.783596
NCT02830815|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-05|||June 2016||2016-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Comparative Effects of Two Anesthetic Techniques on Auditory Brain Response in Children|Comparative Effects of Two Anesthetic Techniques on Auditory Brain Response in Children|Recruiting||N/A|80|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-10 22:00:14.864796|2017-10-10 22:00:14.864796
NCT02830802|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-05-09|||October 2016||2016-10-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Trial for Evaluating Sage-Based Mouthrinse|Randomized Controlled Clinical Trial for Evaluating a Sage-based Mouthrinse in Regard to Its Anti-inflammatory Potential in Elderly Patients Which Are Dependent in Their ADLs|Recruiting||N/A|48|Anticipated|University of Bern||2|||f||||f|f|f||||||No||2017-10-10 22:00:14.937495|2017-10-10 22:00:14.937495
NCT02830789|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-06-23|||December 2016||2016-12-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass|Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass in Order to Treat Secondary Hyperparathyroidism: A Clinical Randomized Trial|Completed||N/A|38|Actual|University of Aarhus||2|||f||||f||||||||No||2017-10-10 22:00:15.039364|2017-10-10 22:00:15.039364
NCT02830776|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-04-30|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|June 30, 2017|Anticipated|2017-06-30|April 30, 2017|Actual|2017-04-30||Interventional|||Topical Bimatoprost for Chemical Blepharoplasty|Topical Bimatoprost for Chemical Blepharoplasty|Active, not recruiting||Early Phase 1|14|Actual|Tulane University||1|||f||||f||||||||No||2017-10-10 22:00:15.123335|2017-10-10 22:00:15.123335
NCT02830763|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M|Clinical Study on the Safety and Efficacy of Medium-chain Fatty Acid Capsules (CNT-02) for Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Neutral Lipid Storage Disease With Myopathy (NLSD-M)|Recruiting||N/A|10|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||t||||||||||2017-10-10 22:00:15.200355|2017-10-10 22:00:15.200355
NCT02830750|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-10|||April 2016||2016-04-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01|1 Year|Observational [Patient Registry]|||Low Fluoroscopy Afib Ablation Registry|A Multi Center Registry of Low- Fluoroscopy Atrial Fibrillation Ablation Using Electroanatomic Mapping Carto|Recruiting||N/A|160|Anticipated|Stanford University|||1||f||||f||||||||No||2017-10-10 22:00:15.351865|2017-10-10 22:00:15.351865
NCT02830737|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-09-13|||January 2016||2016-01-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma|Prospective Randomized Comparative Study on No-touch Radiofrequency Ablation Treatment of Small Hepatocellular Carcinoma|Enrolling by invitation||N/A|178|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-10 22:00:15.427152|2017-10-10 22:00:15.427152
NCT02830724|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-12|2017-09-12|||June 16, 2016||2016-06-16|August 23, 2017|2017-08-23|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers|Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to Patients With CD70 Expressing Cancers|Recruiting||Phase 1/Phase 2|113|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:00:15.502469|2017-10-10 22:00:15.502469
NCT02830711|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-09|||May 2011||2011-05-01|July 2016|2016-07-01||||June 2011|Actual|2011-06-01||Observational|||The Impact of a 3-day High-altitude Mountain Trek on the Emotional States of Children|The Impact of a 3-day High-altitude Mountain Trek on the Emotional States of Children|Active, not recruiting||N/A|180|Anticipated|Chang Gung Memorial Hospital|||1||f||||||||||||||2017-10-10 22:00:15.599336|2017-10-10 22:00:15.599336
NCT02830698|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-17|||May 31, 2017|Actual|2017-05-31|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Irritable Bowel Syndrome in Children: Impact of Hypno-analgesia on the Autonomic Balance|Irritable Bowel Syndrome in Children: Impact of Hypno-analgesia on the Autonomic Balance. A Prospective Single-center Study|Recruiting||N/A|25|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f|f|f||||||||2017-10-10 22:00:15.658777|2017-10-10 22:00:15.658777
NCT02830685|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-09-30|||January 2017||2017-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|July 2019|Anticipated|2019-07-01||Interventional|PreBRec||Pre-pectoral Breast Reconstruction PART 1|Prospective Multicentric Randomized Comparison of an Acellular Dermal Matrix Versus a Synthetic Mesh in DIRECT-TO-IMPLANT (DTI) Pre-pectoral Implant Based Breast Reconstruction|Not yet recruiting||Phase 3|131|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||||||||||||2017-10-10 22:00:15.743414|2017-10-10 22:00:15.743414
NCT02830672|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-09|||November 2015||2015-11-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Ultrasound Guided A1 Pulley Release For The Treatment of Trigger Finger||Active, not recruiting||Phase 2/Phase 3|60|Anticipated|National and Kapodistrian University of Athens||2|||f||||f||||||||No||2017-10-10 22:00:15.829921|2017-10-10 22:00:15.829921
NCT02830659|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2016-07-09|||July 2016||2016-07-01|July 2016|2016-07-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|CIRT||Cochlear Implants Registry in Thailand Project|Cochlear Implants Registry in Thailand Project|Active, not recruiting||N/A|1500|Anticipated|Khon Kaen University|||1||f||||||||||||||2017-10-10 22:00:15.897136|2017-10-10 22:00:15.897136
NCT02830646|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-07-08|||May 2015||2015-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Kidney Function Indexed Extracellular Volume Before and After Obesity Surgery|Measurement of Kidney Function Indexed Extracellular Volume Before and After Obesity Surgery in Kidney Patients With Severe Obesity or Massive|Recruiting||N/A|14|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 22:00:15.971666|2017-10-10 22:00:15.971666
NCT02830633|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-07-09|||July 2016||2016-07-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Trial to Evaluate Laparoscopy-assisted Nerve-preserved Total Mesorectal Excision (LNTME) Versus Open TME for Rectal Cancer||Not yet recruiting||Phase 2|80|Anticipated|Anhui Medical University||2|||f||||||||||||||2017-10-10 22:00:16.048271|2017-10-10 22:00:16.048271
NCT02830620|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-07-08|||August 2012||2012-08-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|CHIMIOKINES||Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy|Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy.|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Nice||4|||f||||f||||||||||2017-10-10 22:00:16.115126|2017-10-10 22:00:16.115126
NCT02830607|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2017-09-11|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Wearable Devices to Monitor Efficacy of Epidural Steroid Injection in Patients With Low Back Pain|Using Wearable Monitoring Devices for Assessing Efficacy of Epidural Steroid Injection in Patients With Low Back Pain|Enrolling by invitation||N/A|40|Anticipated|Sheba Medical Center||1|||f||||f|f|f||||||||2017-10-10 22:00:16.187849|2017-10-10 22:00:16.187849
NCT02830594|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-03-31|||October 5, 2016|Actual|2016-10-05|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer|Combining Pembrolizumab and Palliative Radiotherapy in Gastroesophageal Cancer to Enhance Anti-Tumor T Cell Response and Augment the Abscopal Effect|Recruiting||Phase 2|14|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 22:00:16.26276|2017-10-10 22:00:16.26276
NCT02830568|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-07|2016-07-08|||June 2010||2010-06-01|May 2010|2010-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|DOVIREIN||Medical Economic Evaluation and of Quality of Life of the Kidney Living Donors.|"Medical Economic Evaluation and of Quality of Life of the Kidney Living Donors. Comparison of the Taking of Kidney by cœliosurgery (Pure or  Hand-assisted ), by cœliosurgery Assisted by Robot and by the Classic Technique of Open Donor Nephrectomy."|Completed||N/A|268|Actual|Central Hospital, Nancy, France|||1||f||||t||||||||||2017-10-10 22:00:16.371985|2017-10-10 22:00:16.371985
NCT02830542|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-01-23|||July 2016||2016-07-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence|A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence|Recruiting||Phase 1|60|Anticipated|Seres Therapeutics, Inc.||2|||f||||t||||||||No||2017-10-10 22:00:16.49154|2017-10-10 22:00:16.49154
NCT02830529|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-09-26|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|MADDASH||Mindfulness Attitude to Deliver Dietary Approach to Stop Hypertension|Mindfulness Attitude to Deliver Dietary Approach to Stop Hypertension|Completed||N/A|31|Actual|Case Western Reserve University||3|||f||||t||||||||||2017-10-10 22:00:16.843035|2017-10-10 22:00:16.843035
NCT02830516|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-05-02|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Actual|2017-05-01||Observational|Lungbaro||Intraoperative Measurement of Lung Elastance and Transpulmonary Pressure Using Two Different Methods.|Intraoperative Measurement of Lung Elastance and Transpulmonary Pressure Using Two Different Methods|Recruiting||N/A|25|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||Undecided||2017-10-10 22:00:16.953793|2017-10-10 22:00:16.953793
NCT02830503|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-03-28|||June 2016||2016-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Feeding Tube Practices and Colonization of the Preterm Stomach in the First Week of Life|Feeding Tube Practices and Colonization of the Preterm Stomach in the First Week of Life: A Randomized Controlled Trial|Recruiting||N/A|22|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||Undecided||2017-10-10 22:00:17.051463|2017-10-10 22:00:17.051463
NCT02830490|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-04-03|||September 2014||2014-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Observational|||Reliability of Functional Measures in Hemodialysis Patient.|Test-retest Reliability and Minimal Detectable Change Scores for the Short Physical Performance Battery (SPPB), One Leg Balance and Timed up and go.|Completed||N/A|66|Actual|Cardenal Herrera University|||1||f||||f||||||||||2017-10-10 22:00:17.153268|2017-10-10 22:00:17.153268
NCT02830477|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-09-26|||October 14, 2016|Actual|2016-10-14|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|January 31, 2020|Anticipated|2020-01-31||Observational|TAURUS||"Study Evaluating Real World Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis"|"A Multinational Phase IV Study Evaluating Real World Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis"|Recruiting||N/A|350|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 22:00:17.244529|2017-10-10 22:00:17.244529
NCT02830464|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-08-15|||August 2016||2016-08-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|IM19 Register||New Biomarkers in Heart- and Renal Failure|New Biomarkers in Heart- and Renal Failure: Cohort Study for Assessing Prognosis in Acute Coronary Syndrome and Acute/Chronic Cardiovascular and Renal Failure by Means of Fibroblast Growth Factor 23|Recruiting||N/A|500|Anticipated|RWTH Aachen University|||1||f||||f||||||||No||2017-10-10 22:00:17.433024|2017-10-10 22:00:17.433024
NCT02830451|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-08|||July 2016||2016-07-01|June 2016|2016-06-01||||September 2019|Anticipated|2019-09-01|5 Years|Observational [Patient Registry]|||Metastatic Tumor Research and Outcome Network|Metastatic Tumor Research and Outcome Network A Multicenter Prospective Registry for the Management of Metastatic Spine Tumors|Not yet recruiting||N/A|300|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f||||||||No||2017-10-10 22:00:17.547678|2017-10-10 22:00:17.547678
NCT02830438|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-08-11|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Shear Wave Elastography in Native Kidney Disease|Shear Wave Elastography in Native Kidney Disease: a Pilot Study|Recruiting||N/A|40|Anticipated|Albert Einstein Healthcare Network||1|||f||||f||t|f||f|||||2017-10-10 22:00:17.673451|2017-10-10 22:00:17.673451
NCT02830425|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-09-12|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|PIMyC||Potentially Inappropriate Prescription Associated to Multimorbidity|Potentially Inappropriate Prescription Associated to Multimorbidity, Using the Explicit STOPP-START (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions/Screening Tool to Alert Doctors to the Right Treatment) Criteria|Recruiting||N/A|800|Anticipated|Corporacion Parc Tauli|||1||f||||||||||||||2017-10-10 22:00:17.789109|2017-10-10 22:00:17.789109
NCT02830412|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-08-10|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Intraoperative Electronic Reminder Module to Enhance Postoperative Nausea and Vomiting Prophylaxis|A Prospective Randomized Evaluation of an Intraoperative Electronic Reminder Module to Enhance Postoperative Nausea and Vomiting Prophylaxis Guideline Adherence|Withdrawn||N/A|0|Actual|The Cleveland Clinic||2||No patients enrolled|f||||f||||||||||2017-10-10 22:00:17.882773|2017-10-10 22:00:17.882773
NCT02830399|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-11-28|||July 2016||2016-07-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|STIMAGNECT||Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant Depression|Clinical Trial on Efficacy of Repeated Transcranial Magnetic Stimulation (rTMS) to Improve Electroconvulsive Therapy (ECT) in Treatment-Resistant Depression (TRD): STIMAGNECT Study|Recruiting||N/A|84|Anticipated|Centre Hospitalier du Rouvray||2|||f||||f||||||||No||2017-10-10 22:00:17.966086|2017-10-10 22:00:17.966086
NCT02830386|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-08|||June 2016||2016-06-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Observational|CRANIAL-2||Chinese Registry of Assisted Embolization for Ruptured Wide Necked Intracranial Aneurysm Using LVIS Stent|Chinese Registry of Assisted Embolization for Unruptured Wide Necked Intracranial Aneurysm Using LVIS Stent|Recruiting||N/A|200|Anticipated|Changhai Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:00:18.071491|2017-10-10 22:00:18.071491
NCT02830373|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-08|||June 2016||2016-06-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Observational|CRANIAL-1||Chinese Registry of Assisted Embolization for Unruptured Wide Necked Intracranial Aneurysm Using LVIS Stent|Chinese Registry of Assisted Embolization for Unruptured Wide Necked Intracranial Aneurysm Using LVIS Stent|Recruiting||N/A|200|Anticipated|Changhai Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:00:18.174571|2017-10-10 22:00:18.174571
NCT02830360|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-01-19|||October 2016||2016-10-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|VANISH2Pilot||Antiarrhythmics or Ablation for Ventricular Tachycardia Pilot|Ventricular Tachycardia Antiarrhythmics or AblatioN In Structural Heart Disease 2 Pilot Study|Recruiting||Phase 4|75|Anticipated|Nova Scotia Health Authority||2|||f||||t||||||||No||2017-10-10 22:00:18.29389|2017-10-10 22:00:18.29389
NCT02830347|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-08|||June 2015||2015-06-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|||Changes in Resistome After Dental Extraction and Amoxicillin.|Evaluation of the Changes in Oral and Gut Bacterial Resistance Caused by Short Term Antibiotic Treatment Following a Surgical Dental Procedure - A Prospective Clinical Study.|Recruiting||N/A|16|Anticipated|The University of Hong Kong|||2||f||||t||||||Samples With DNA|"     Saliva      Toungue coatings      Stool samples   "|Yes|Deidentified patient data will be published within 6 months of the study completion.|2017-10-10 22:00:18.444145|2017-10-10 22:00:18.444145
NCT02830334|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-06-30|||June 14, 2016||2016-06-14|May 17, 2017|2017-05-17|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Use of the Ask Suicide-Screening Questions (ASQ) in Pediatric Outpatient Settings|Use of the Ask Suicide-Screening Questions (ASQ) in Pediatric Outpatient Settings|Enrolling by invitation||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:00:18.555334|2017-10-10 22:00:18.555334
NCT02830321|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-07-11|||March 2015||2015-03-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|AOHPIPOHGIPW||The Association of Helicobacter Pylori in the Pathogenesis of Hyperemesis Gravidarum in Pregnant Women|Study to Explore the Association Between Hyperemesis Gravidarum in Pregnant Women and Helicobacter Pylori Infection by Using H.P. Stool Antigen Test to Diagnose H Pylori Infection|Completed||N/A|90|Actual|Ain Shams University|||2||f||||f||||||||No||2017-10-10 22:00:18.634134|2017-10-10 22:00:18.634134
NCT02830308|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2017-09-21|||May 31, 2016||2016-05-31|September 18, 2017|2017-09-18|December 31, 2036|Anticipated|2036-12-31|December 31, 2036|Anticipated|2036-12-31||Observational|||Evaluation of Adults With Endocrine and Metabolic-Related Conditions|Evaluation of Adults With Endocrine-Related Conditions|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:00:18.720324|2017-10-10 22:00:18.720324
NCT02830295|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2017-05-08|||July 2016||2016-07-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|BBAT||Effectiveness of Basic Body Awareness Therapy (BBAT) in Patients Suffering From Fibromyalgia|Physiotherapy in Mental Health: A Clinical Trial of Basic Body Awareness Therapy in Patients Suffering From Fibromyalgia|Completed||N/A|40|Actual|Universitat de Lleida||2|||f||||t||||||||Undecided||2017-10-10 22:00:18.810705|2017-10-10 22:00:18.810705
NCT02830282|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-08|||July 2013||2013-07-01|July 2016|2016-07-01||||September 2016|Anticipated|2016-09-01||Observational|||Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer|Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer|Active, not recruiting||N/A|21|Actual|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:00:18.914523|2017-10-10 22:00:18.914523
NCT02830269|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-04-20|||August 18, 2016|Actual|2016-08-18|April 2017|2017-04-01|February 18, 2018|Anticipated|2018-02-18|February 18, 2018|Anticipated|2018-02-18||Observational|ECHO-V3||Third Ventricle Echographic Study for Neuro-intensive Care Unit Patients|Third Ventricle Echographic Study for Neuro-intensive Care Unit Patients|Recruiting||N/A|100|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||||2017-10-10 22:00:19.000308|2017-10-10 22:00:19.000308
NCT02830256|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-20|||November 3, 2016|Actual|2016-11-03|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Observational|D co réa||Psychometric Measurements of Three Nociception Assessments Methods in Intubated Brain Injured Critical Care Patients|Psychometric Measurements of Three Nociception Assessments Methods in Intubated Brain Injured Critical Care Patients|Recruiting||N/A|50|Anticipated|University Hospital, Montpellier|||1||f||||t||||||||Undecided||2017-10-10 22:00:19.087119|2017-10-10 22:00:19.087119
NCT02830243|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-09|2016-07-09|||July 2016||2016-07-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Analgesic Effect of Volatile Anesthetics|The Comparison of Analgesic Effect of Volatile Anesthetics Using Surgical Pleth Index|Recruiting||Phase 3|90|Anticipated|Kangbuk Samsung Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:00:19.171108|2017-10-10 22:00:19.171108
NCT02830230|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-08|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||"Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"|"Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"|Not yet recruiting||N/A|508|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||No||2017-10-10 22:00:19.252723|2017-10-10 22:00:19.252723
NCT02830217|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-18|||December 2015||2015-12-01|July 2016|2016-07-01||||December 2018|Anticipated|2018-12-01||Observational|||Evaluation of Soluble ST2 in Patients Receiving Primary PCI With ST-elevation Myocardial Infarction|Using Soluble ST2 to Predict Clinical Outcomes in Patients Receiving Primary Percutaneous Coronary Intervention With ST-elevation Myocardial Infarction|Recruiting||N/A|500|Anticipated|Wuhan Asia Heart Hospital|||1||f||||f||||||Samples Without DNA|"     peripheral blood   "|No||2017-10-10 22:00:19.337773|2017-10-10 22:00:19.337773
NCT02830204|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-11-15|||April 2016||2016-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SITRAL||Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification (SITRAL) Study|Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification (SITRAL) Study|Recruiting||Phase 1/Phase 2|30|Anticipated|Baylor Research Institute||1|||f||||t||||||||No|There is currently no plan to share individual participant data|2017-10-10 22:00:19.415136|2017-10-10 22:00:19.415136
NCT02830191|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-08|||November 2014||2014-11-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|CICLOSPOT||Therapeutic Drug Monitoring (TDM) of Cyclosporine in Kidney Transplant Patients by Dried Blood Spot Assay. Interest and Feasibility.|Therapeutic Drug Monitoring (TDM) of Cyclosporine in Kidney Transplant Patients by Dried Blood Spot Assay. Interest and Feasibility.|Completed||N/A|22|Actual|University Hospital, Caen|||1||f||||f||||||||Yes||2017-10-10 22:00:19.514279|2017-10-10 22:00:19.514279
NCT02830178|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-10-10|||January 2016||2016-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications|Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications|Completed||N/A|144337|Actual|Janssen Research & Development, LLC|||2||f||||f||||||||||2017-10-10 22:00:19.570649|2017-10-10 22:00:19.570649
NCT02830165|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-25|||March 10, 2016|Actual|2016-03-10|September 2017|2017-09-01|March 31, 2020|Anticipated|2020-03-31|March 10, 2019|Anticipated|2019-03-10||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery|Phase I Feasibility Trial of Preoperative Adjuvant Stereotactic Body Radiotherapy for Patients at High Risk of Local Failure After Prostatectomy|Recruiting||N/A|12|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:00:19.665152|2017-10-10 22:00:19.665152
NCT02830152|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-17|||May 3, 2017|Actual|2017-05-03|May 2017|2017-05-01|May 2030|Anticipated|2030-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage|Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage: A Multicenter Randomized Clinical Trial|Recruiting||N/A|750|Anticipated|Karolinska University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-10 22:00:19.798064|2017-10-10 22:00:19.798064
NCT02830139|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-07-31|||July 2016||2016-07-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer|A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Locally Advanced Colorectal Cancer During Radical Colorectal Resection|Not yet recruiting||Phase 2|100|Anticipated|Wuhan University||2|||f||||t||||||||||2017-10-10 22:00:19.933474|2017-10-10 22:00:19.933474
NCT02830126|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-06-01|||August 2016||2016-08-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|ACTFAST||Anesthesiology Control Tower|Anesthesiology Control Tower: Feedback Alerts to Supplement Treatments (ACTFAST)|Not yet recruiting||N/A|1200|Anticipated|Washington University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:00:20.07996|2017-10-10 22:00:20.07996
NCT02830113|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-08|||December 2014||2014-12-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|PARODIA2||Metabolic Effects of Treatment of Chronic Periodontitis in Non-diabetic Subjects|Effects of Non-surgical Treatment of Chronic Periodontitis on Insulin Resistance and Glucose Tolerance in Non-diabetic Subjects|Completed||N/A|20|Actual|Yaounde Central Hospital||1|||f||||t||||||||||2017-10-10 22:00:20.187656|2017-10-10 22:00:20.187656
NCT02830100|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-01-17|||July 2015||2015-07-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|INNERSPEECH||Neural Correlates of Intern Speech|Neural Correlates of Intern Speech|Recruiting||N/A|40|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 22:00:20.266178|2017-10-10 22:00:20.266178
NCT02830087|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-02-27|||June 2016||2016-06-01|February 2017|2017-02-01|July 1, 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Tourniquet Pressure in Primary Total Knee Arthroplasty|The Effect of Tourniquet Time and Pressure on Intraoperative and Postoperative Performance, Function, Pain, and Complications in Primary Total Knee Arthroplasty.|Recruiting||N/A|146|Anticipated|Wake Forest University Health Sciences||6|||f||||f||||||||No||2017-10-10 22:00:20.355872|2017-10-10 22:00:20.355872
NCT02830074|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-06-14|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|March 1, 2018|Anticipated|2018-03-01||Interventional|||Treatment of Sleep-disordered Breathing in Patients With SCI|Does Treatment of Sleep-Disordered Breathing Improve Functional Outcomes in SCI?|Recruiting||N/A|74|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:00:20.471452|2017-10-10 22:00:20.471452
NCT02830061|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Experience of TYAC Offered Ovarian Tissue Cryopreservation|An Interpretative Phenomenological Analysis Study Into the Experience of Teenagers and Young Adults Who Have Been Offered Ovarian Tissue Cryopreservation Prior to Cancer Treatment.|Not yet recruiting||N/A|10|Anticipated|University of Oxford|||1||f||||f||||||||||2017-10-10 22:00:20.564517|2017-10-10 22:00:20.564517
NCT02830048|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-05-30|||July 2016||2016-07-01|May 2017|2017-05-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|LEGEND-A||Low dosE GlibENclamide in Diabetes Part A|Low-dose Glibenclamide in Type 2 Diabetes Mellitus - Part A|Completed||Phase 2|16|Actual|University of Oxford||1|||f||||t||||||||Yes|The anonymised data (i.e. with studyID only) generated from this study will be deposited in the Oxford Research Archive (http://ora.ox.ac.uk/). This will provide a link between the results presented in publications and the underlying data. At the end of the retention period (currently 5 years), the data will be deleted from the archive.|2017-10-10 22:00:20.635035|2017-10-10 22:00:20.635035
NCT02830035|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-08-05|||June 2014||2014-06-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Real-Time Ultrasound-guidance Facilitates Paramedian Spinal Anaesthesia|Comparison Between Real-Time Ultrasound Guidance vs Anatomical Landmark Technique on the Efficacy of Paramedian Spinal Anaesthesia|Completed||N/A|60|Actual|University of Science Malaysia||2|||f||||f||||||||Undecided||2017-10-10 22:00:20.730468|2017-10-10 22:00:20.730468
NCT02830022|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-07-04|||December 11, 2013|Actual|2013-12-11|March 2017|2017-03-01|March 31, 2019|Anticipated|2019-03-31|June 11, 2017|Actual|2017-06-11||Interventional|APAUTRES||Sleep, Autonomic Nervous System and Cardiorespiratory Capacity in Autism Spectrum Disorders Children (APAUTRES)|Sleep, Autonomic Nervous System and Cardiorespiratory Capacity in Autism Spectrum Disorders Children|Active, not recruiting||N/A|140|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 22:00:20.840108|2017-10-10 22:00:20.840108
NCT02830009|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-12|||May 2013||2013-05-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|July 2013|Actual|2013-07-01||Interventional|PH1||IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA||Completed||N/A|5|Actual|Hospices Civils de Lyon||4|||f||||f||||||||No||2017-10-10 22:00:20.953409|2017-10-10 22:00:20.953409
NCT02829996|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-06-06|||August 19, 2016|Actual|2016-08-19|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 24, 2017|Actual|2017-05-24||Interventional|||Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma|Phase II, Randomized, Double-masked, Active-controlled Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Subjects With Ocular Hypertension or Primary Open-Angle Glaucoma|Completed||Phase 2|201|Actual|Inotek Pharmaceuticals Corporation||5|||f||||f||||||||No||2017-10-10 22:00:22.798556|2017-10-10 22:00:22.798556
NCT02829970|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-11|||September 2015||2015-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Helping College Students With ADHD Lead Healthier Lifestyles|Behavioral Activation To Reduce Problem Alcohol Use In College Students With ADHD|Recruiting||N/A|80|Anticipated|University of Maryland||2|||f||||f||||||||No||2017-10-10 22:00:22.97342|2017-10-10 22:00:22.97342
NCT02829957|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-10-07|||September 2016||2016-09-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|RAMBLE||RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding|Randomized Trial to Test the Effect of Rivaroxaban or Apixaban on Menstrual Blood Loss in Women|Recruiting||Phase 2/Phase 3|50|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 22:00:23.069813|2017-10-10 22:00:23.069813
NCT02829944|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-05-25|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery|Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery|Recruiting||Phase 4|100|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:00:23.157747|2017-10-10 22:00:23.157747
NCT02829931|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-07-05|||August 9, 2016|Actual|2016-08-09|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Hypofractionated Stereotactic Irradiation With Nivolumab in Patients With Recurrent High Grade Gliomas|Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) Combined With Nivolumab in Patients With Recurrent High Grade Gliomas|Recruiting||Phase 1|26|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 22:00:23.263505|2017-10-10 22:00:23.263505
NCT02829918|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-07-05|||September 19, 2016|Actual|2016-09-19|July 2017|2017-07-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers|A Phase II Investigator Sponsored Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers|Recruiting||Phase 2|32|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-10 22:00:23.367962|2017-10-10 22:00:23.367962
NCT02829905|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-05-01|||July 2016||2016-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|WEM-Quant||Women's Experiences of Mammography: Quantitative Evaluation|Women's Experiences of Mammography: Quantitative Evaluation|Recruiting||N/A|300|Anticipated|University of Dundee|||1||f||||f||||||||Undecided|Applications considered on case by case basis.|2017-10-10 22:00:23.464385|2017-10-10 22:00:23.464385
NCT02829892|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-08|||June 2015||2015-06-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SOLEIL SOMMEIL||Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia|Using Environmental Light Therapy to Improve Sleep and Neuropsychiatric Symptoms in Dementia|Completed||N/A|12|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||Undecided||2017-10-10 22:00:23.534393|2017-10-10 22:00:23.534393
NCT02829346|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-11|||October 2012||2012-10-01|July 2016|2016-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty|Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty: A Randomized Controlled Trial|Completed||Phase 2|60|Actual|Thammasat University||2|||f||||t||||||||No||2017-10-10 22:00:28.51777|2017-10-10 22:00:28.51777
NCT02829879|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-11|||December 2015||2015-12-01|July 2016|2016-07-01||||September 2016|Anticipated|2016-09-01||Interventional|||Effectiveness of Arginin and Potassium Nitrate Dentifrices in Dentin Hypersensitivity Therapy|Comparison of the Clinical Effectiveness of 8% Arginine/1450 Ppm Sodium Monofluorophosphate Versus 5% Potassium Nitrate/2500 Ppm Sodium Fluoride in Dentin Hypersensitivity Therapy: A Randomized Controlled Clinical Trial|Recruiting||Phase 3|50|Anticipated|University of Chile||2|||f||||||||||||||2017-10-10 22:00:23.706485|2017-10-10 22:00:23.706485
NCT02829866|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-07|||March 2016||2016-03-01|July 2016|2016-07-01||||December 2016|Anticipated|2016-12-01||Observational|||AMIStem-H Radiographic Analysis|THP AMIStem-H: Open, Retrospective and Prospective, Monocentric, Non Randomised Observational Study|Recruiting||N/A|456|Anticipated|Medacta International SA|||1||f||||||||||||||2017-10-10 22:00:23.795235|2017-10-10 22:00:23.795235
NCT02829853|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-08|||January 2008||2008-01-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|SARCFAM||Clinical and Genetic Study of Familial Sarcoidosis (SARCFAM)|Clinical and Genetic Study of Familial Sarcoidosis (SARCFAM)|Recruiting||N/A|800|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||Samples With DNA|"     For main index cases in familial forms of sarcoidosis, two 1 ml samples of frozen PBMC     (peripheral blood mononuclear cells) have been included in the bio bank of the diagnosis     laboratory (Molecular genetics - GH-HEH - LYON - F)   "|||2017-10-10 22:00:23.8631|2017-10-10 22:00:23.8631
NCT02829840|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-06-01|||September 2016||2016-09-01|June 2017|2017-06-01||||September 2021|Anticipated|2021-09-01||Interventional|||Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)|Phase I/II, Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 22:00:23.948662|2017-10-10 22:00:23.948662
NCT02829814|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-09-19|||July 2016||2016-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|RE-AFFIRM||Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia|A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study To Evaluate The EFFIcacy and Safety of TNX-102 SL Tablets Taken Daily At Bedtime In Patients With FibRoMyalgia|Terminated||Phase 3|51|Actual|Tonix Pharmaceuticals, Inc.||2||"For business reason unrelated to safety or tolerability,Tonix has discontinued the Fibromyalgia   development with TNX102 SL."|f||||f||||||||||2017-10-10 22:00:24.170582|2017-10-10 22:00:24.170582
NCT02829801|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-08-08|||March 2, 2016|Actual|2016-03-02|August 2017|2017-08-01|May 2, 2019|Anticipated|2019-05-02|May 2, 2019|Anticipated|2019-05-02||Interventional|ELIAUT||Evaluation of the Animal Intervention Used as Therapy|Evaluation of the Animal Intervention Used as Therapy. Impact of Animal-assisted Therapy on the Well-being in Patients With Alzheimer's Disease|Recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:00:24.343918|2017-10-10 22:00:24.343918
NCT02829788|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-11|||November 2015||2015-11-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|COELIOCHIP||Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic Approach|Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic Approach|Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:00:24.458828|2017-10-10 22:00:24.458828
NCT02829775|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-11-18|2016-09-28||January 2004||2004-01-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||All participants who were recruited in the study.|A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies|Extension Protocol for Patients With Chronic Myelogenous Leukemia, Malignant Melanoma or Renal Cell Carcinoma That Have Responded to Treatment With Pegylated-Interferon α-2a or Roferon-A® in Prior Clinical Studies|Completed||Phase 2/Phase 3|9|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:00:24.58168|2017-10-10 22:00:24.58168
NCT02829762|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-12|||May 2016||2016-05-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|PREDOMOS||Precarious Elderly Patient Supported For Cancer Impact on Quality Of Life of a Domotic And Remote Assistance Approach for Elderly Patients Supported For Locally Advanced or Metastatic Cancer, Socially Isolated|Precarious Elderly Patient Supported For Cancer Impact on Quality Of Life of a Domotic And Remote Assistance Approach for Elderly Patients Supported For Locally Advanced or Metastatic Cancer, Socially Isolated: Randomized, Comparative, Prospective Multi-Centre Study|Recruiting||N/A|320|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||Undecided||2017-10-10 22:00:24.800574|2017-10-10 22:00:24.800574
NCT02829749|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-08|||December 2016||2016-12-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|MITRACHORD||Effectiveness and Safety of Mitral Valve Repair With the NeoChord DS1000 Artificial Chordae Delivery System Versus Conventional Surgery in Patients With Severe Primary Mitral Regurgitation Due to Isolated Leaflet Prolapse|A European, Multicenter, Randomized Study Comparing the Effectiveness and Safety of Mitral Valve Repair With the NeoChord DS1000 Artificial Chordae Delivery System Versus Conventional Surgery in Patients With Severe Primary Mitral Regurgitation Due to Isolated Leaflet Prolapse|Not yet recruiting||N/A|194|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||No||2017-10-10 22:00:24.941393|2017-10-10 22:00:24.941393
NCT02829736|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-08-01|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|TOTTI||ThOracoscopic Wedge Resection Treated With Chest Tube Removal Intraoperatively|Pain and Reasons for Hospitalization in Patients Treated Without Post-operative Chest Tube After Thoracoscopic Wedge Resection - A Randomized Controlled Study|Terminated||N/A|25|Actual|Rigshospitalet, Denmark||2||Slow accrual|f||||t||||||||||2017-10-10 22:00:25.055897|2017-10-10 22:00:25.055897
NCT02829723|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-08-07|||October 21, 2016|Actual|2016-10-21|August 2017|2017-08-01|October 18, 2019|Anticipated|2019-10-18|October 18, 2019|Anticipated|2019-10-18||Interventional|||Phase I/II Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors|A Phase I/II, Open-label, Multi-center Study of the Safety and Efficacy of BLZ945 as Single Agent and in Combination With PDR001 in Adults Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|151|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 22:00:25.139591|2017-10-10 22:00:25.139591
NCT02829710|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-08|||January 2013||2013-01-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|SEDATIDE||Implementation and Evaluation of a Pediatric Nurse-driven Sedation Protocol in a PICU|Implementation and Evaluation of a Paediatric Nurse-driven Sedation Protocol in a Paediatric Intensive Care Unit|Completed||N/A|200|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:00:25.260835|2017-10-10 22:00:25.260835
NCT02829697|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-03-20|||July 2016||2016-07-01|March 2017|2017-03-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Interventional|||The Effect of Local Anaesthetic Volume on Nerve Block Duration and Nerve Block Duration Variability|The Effect of Local Anaesthetic Volume on Nerve Block Duration and Nerve Block Duration Variability. A Randomised, Blinded, Healthy Volunteer Study|Completed||Phase 4|120|Actual|Nordsjaellands Hospital||10|||f||||t||||||||Yes|We will attach relevant data sheets to all our scientific submissions.|2017-10-10 22:00:25.349359|2017-10-10 22:00:25.349359
NCT02829684|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-12|||March 2009||2009-03-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Register of Patients With Prader-Willi Syndrome|Implementation of a National Register of Children and Adults Presenting Prader-Willi Syndrome|Recruiting||N/A|500|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||No||2017-10-10 22:00:25.554254|2017-10-10 22:00:25.554254
NCT02829671|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-07|||July 2016||2016-07-01|July 2016|2016-07-01|January 2021|Anticipated|2021-01-01|July 2020|Anticipated|2020-07-01||Interventional|SOLSTIS||Loneliness and Occurrence of Suicide Attemps and Suicidal Ideas|Study of Loneliness as Predictive Factor for Suicidal Behavior|Not yet recruiting||N/A|600|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:00:25.630174|2017-10-10 22:00:25.630174
NCT02829658|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-05-10|||February 2009||2009-02-01|May 2017|2017-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|EpiB||Use of Care Services by Patients With Borderline Personality Disorder|Use of Care Services by Patients With Borderline Personality Disorder|Completed||N/A|98|Actual|University Hospital, Toulouse|||2||f||||f||||||||Undecided||2017-10-10 22:00:25.755166|2017-10-10 22:00:25.755166
NCT02829645|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-07|||February 2012||2012-02-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.|Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.|Active, not recruiting||N/A|370|Actual|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:00:25.841154|2017-10-10 22:00:25.841154
NCT02829632|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-12-02|||March 2015||2015-03-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|SMARTER||Feasibility Study of Receiving Feedback Messages Based on Self-monitored Dietary Intake|12 Weeks Weight Loss Study Using Feedback Messages Delivered Via Smartphone|Completed||N/A|39|Actual|University of Pittsburgh||3|||f||||f||||||||No|there is no plan to share the data. The data are being used for a grant application.|2017-10-10 22:00:25.905447|2017-10-10 22:00:25.905447
NCT02829619|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-05-18|||January 2008||2008-01-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|ONTIME||Meal Timing, Genetics and Weight Loss|Meal Timing, Genetics and Weight Loss in a Mediterranean Population|Recruiting||N/A|5000|Anticipated|Universidad de Murcia|||1||f||||t||||||Samples With DNA|"     whole blood, serum, saliva   "|No||2017-10-10 22:00:25.99207|2017-10-10 22:00:25.99207
NCT02829606|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-06|||April 2016||2016-04-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|HETALCEV||Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)|Head Mounted Eye Tracking Aide for Loss of Central Vision|Recruiting||N/A|70|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||No|participants will be de-identified|2017-10-10 22:00:26.100175|2017-10-10 22:00:26.100175
NCT02829593|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-02-21|||February 2016||2016-02-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|GABA||Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 7 Tesla: Effect of Recurrent Hypoglycemia on Hypothalamic GABA|Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 7 Tesla: Effect of Recurrent Hypoglycemia on Hypothalamic GABA|Recruiting||Phase 1|40|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:00:26.18495|2017-10-10 22:00:26.18495
NCT02829580|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-05-10|||September 2008||2008-09-01|May 2017|2017-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular Ultrasound|Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular Ultrasound|Completed||N/A|31|Actual|University Hospital, Toulouse||2|||f||||f||||||||Undecided||2017-10-10 22:00:26.268519|2017-10-10 22:00:26.268519
NCT02829567|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2016-07-07|||January 2016||2016-01-01|June 2016|2016-06-01||||January 2017|Anticipated|2017-01-01||Interventional|MIOrtho||Motivational Interviewing in Orthodontic Patients|Effectiveness of Motivational Interviewing in Improving Oral Hygiene in Orthodontic Patients|Active, not recruiting||N/A|80|Anticipated|University of Barcelona||2|||f||||||||||||||2017-10-10 22:00:26.341998|2017-10-10 22:00:26.341998
NCT02829554|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-09-12|||June 30, 2016||2016-06-30|August 21, 2017|2017-08-21|December 5, 2017|Anticipated|2017-12-05|December 5, 2017|Anticipated|2017-12-05||Observational|||Differential Influences of Integral and Incidental Emotion on Cancer-related Judgments and Decision Making|Differential Influences of Integral and Incidental Emotion on Cancer-Related Judgments and Decision Making|Recruiting||N/A|5768|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:00:26.409205|2017-10-10 22:00:26.409205
NCT02829541|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants|A Phase 1, Randomized, Blinded, Placebo-Controlled, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB068, a Bruton's Tyrosine Kinase Inhibitor, in Healthy Subjects|Completed||Phase 1|36|Actual|Biogen||6|||f||||f||||||||||2017-10-10 22:00:26.480209|2017-10-10 22:00:26.480209
NCT02829528|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-11|||September 2016||2016-09-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention|Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention|Not yet recruiting||N/A|30|Anticipated|New York University||1|||f||||f||||||||||2017-10-10 22:00:26.58166|2017-10-10 22:00:26.58166
NCT02829515|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-11|||May 2009||2009-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01|6 Months|Observational [Patient Registry]|NTSRS||Tonsil Surgery in Sweden: A National Quality Register|The National Tonsil Surgery Register in Sweden|Recruiting||N/A|11000|Anticipated|National Tonsil Surgery Register in Sweden|||1||f||||t||||||||Yes|All registered data i available online for registrating units.|2017-10-10 22:00:26.664571|2017-10-10 22:00:26.664571
NCT02829502|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-02-06|||August 2016||2016-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EGRABIS1||The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke|The Effect of Glucagon-like Peptide 1 (GLP-1) Receptor Agonist on Cerebral Blood Flow Velocity in Stroke Patients|Recruiting||Phase 2|30|Anticipated|Herlev Hospital||2|||f||||t||||||||No||2017-10-10 22:00:26.775651|2017-10-10 22:00:26.775651
NCT02829489|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|INFORM||International Nutrition Audit in FORegut TuMors|International Audit of Nutrition Care in Patients With FORegut TuMors|Recruiting||N/A|200|Anticipated|University of Alberta|||1||f||||f||||||||Yes|Only the aggregate of all anonymous participant data will be shared with the participating sites upon request. The site specific anonymous participant data will be shared with the site upon request. This is detailed in the Data Transfer Agreement with each site.|2017-10-10 22:00:26.881766|2017-10-10 22:00:26.881766
NCT02829476|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-05-10|||March 2010||2010-03-01|May 2017|2017-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Ghrelin Resistance in Adolescents With Idiopathic Scoliosis|Ghrelin Cellular Resistance Study in Adolescents With Idiopathic Scoliosis|Completed||N/A|45|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:00:27.032645|2017-10-10 22:00:27.032645
NCT02829463|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-05-07|2016-08-13||October 2015||2015-10-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|IPFP-MRI||MRI of Infrapatellar Fat Pad in Osteoarthritis|Magnetic Resonance Imaging of Infrapatellar Fat Pad in Osteoarthritis and Controls|Completed||N/A|121|Actual|The Third Xiangya Hospital of Central South University|||2||f||||f||||||||No||2017-10-10 22:00:27.128938|2017-10-10 22:00:27.128938
NCT02829450|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-07|||October 2015||2015-10-01|June 2016|2016-06-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Peritoneal Ultrafiltration to Treat Congestive Heart Failure|Home-based Ultrafiltration for Congestive Heart Failure: Impact on Survival, Hospitalizations Rate, Quality of Life, Peritoneal Membrane Characteristics and Residual Renal Function With Different Treatment Modes|Recruiting||Early Phase 1|40|Anticipated|Soroka University Medical Center|||2||f||||f||||||||No||2017-10-10 22:00:27.329484|2017-10-10 22:00:27.329484
NCT02829437|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-01-09|||October 2016||2016-10-01|January 2017|2017-01-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Observational|EST||Observational Study on Endometrial Stromal Tumors|Endometrial Stromal Tumors: an Observational Study|Recruiting||N/A|100|Anticipated|Italian Sarcoma Group|||2||f||||f||||||Samples With DNA|"     Paraffin-embedded pathologic tissue used for diagnostic confirmation purposes only   "|Yes|Aggregate anonymized results will be available upon request at the end of the study|2017-10-10 22:00:27.431086|2017-10-10 22:00:27.431086
NCT02829424|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-07|||April 2016||2016-04-01|July 2016|2016-07-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|METHOBIO||Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis|Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis|Recruiting||Phase 4|330|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||Undecided||2017-10-10 22:00:27.644284|2017-10-10 22:00:27.644284
NCT02829411|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-11-02|||August 2016||2016-08-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Testing the Effectiveness of Integrating Relationship Education Into an Existing Workforce Readiness Program|Testing the Effectiveness of Integrating Relationship Education Into an Existing Workforce Readiness Program|Enrolling by invitation||N/A|1000|Anticipated|Mathematica Policy Research, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:00:27.773713|2017-10-10 22:00:27.773713
NCT02829398|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-05-10|||March 2008||2008-03-01|May 2017|2017-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Determinants of Vasospasm and Delayed Ischemic Deficits in Aneurysmal Subarachnoid Hemorrhage|Hemodynamic and Biochemical Determinants of Vasospasm and Delayed Ischemic Deficits in Aneurysmal Subarachnoid Hemorrhage|Completed||N/A|41|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:00:27.86985|2017-10-10 22:00:27.86985
NCT02829385|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-11|||June 2016||2016-06-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients|A Phase II Clinical Trial Study on Apatinib and XELOX Combination Regimen in the First-line Treatment of End-stage Colorectal Cancer Patients|Recruiting||Phase 2|53|Anticipated|LanZhou University||1|||f||||t||||||||No||2017-10-10 22:00:27.969813|2017-10-10 22:00:27.969813
NCT02829372|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-04-28|||May 2016||2016-05-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|GBR 1302-101||Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers|A Phase 1, First-in-man, Multicenter, Open-label, Dose-escalation Study of Single-agent GBR 1302 in Subjects With HER2 Positive Cancers|Recruiting||Phase 1|60|Anticipated|Glenmark Pharmaceuticals S.A.||1|||f||||t||||||||||2017-10-10 22:00:28.10113|2017-10-10 22:00:28.10113
NCT02829359|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-06-08|||July 2012||2012-07-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HBV-DNA(-)||Effects of Antiviral Therapy on HBV Reactivation|Effects of Antiviral Therapy on HBV Reactivation and Liver Function After Hepatectomy for HBV-DNA Negative HBV-related Hepatocellular Carcinoma|Completed||Phase 2/Phase 3|200|Actual|Guangxi Medical University||2|||f||||t||||||||Yes||2017-10-10 22:00:28.399609|2017-10-10 22:00:28.399609
NCT02829333|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-11|||May 2015||2015-05-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Effect of Anesthetic Technique on VEGF-C and PGE2|Effect of Anesthetic Technique on Serum Vascular Endothelial Growth Factor C and Prostaglandin E2 in Women Undergoing Surgery for Uterine Leiomyomas|Completed||N/A|44|Actual|General Hospital of Ningxia Medical University||2|||f||||t||||||||No||2017-10-10 22:00:28.65542|2017-10-10 22:00:28.65542
NCT02829320|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-04-10|||August 1, 2016||2016-08-01|April 2017|2017-04-01|January 5, 2018|Anticipated|2018-01-05|January 1, 2018|Anticipated|2018-01-01||Interventional|||Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents|A 24-week, Phase III, Open-label, Non-comparative, Multi-center Study to Evaluate Efficacy and Safety of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents|Recruiting||Phase 3|22|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:00:28.7696|2017-10-10 22:00:28.7696
NCT02829307|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2017-02-02|||August 2016||2016-08-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects|An Open Label Positron Emission Tomography (PET) Imaging Study Using 89Zirconium Labeled GSK3128349 to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 Following Single Dose Intravenous Administration in Healthy Male Subjects|Completed||Phase 1|8|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:00:28.978767|2017-10-10 22:00:28.978767
NCT02829294|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-08|2016-07-18|||April 2016||2016-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)|Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)|Completed||N/A|30|Anticipated|Eosera Inc||1|||f||||f||||||||Undecided||2017-10-10 22:00:29.097004|2017-10-10 22:00:29.097004
NCT02829281|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-07|||July 2016||2016-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Intra-articular Botox Type A Versus Corticosteroids in Knee Osteoarthritis|Intra-articular Botulinum Toxin Type A Versus Corticosteroids: a Clinical Trial in Osteoarthritis of Knees|Recruiting||Phase 4|105|Anticipated|Federal University of São Paulo||3|||f||||f||||||||||2017-10-10 22:00:29.171019|2017-10-10 22:00:29.171019
NCT02829268|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-24|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome|A Phase 1b Safety Trial of Dantronele Sodium in Pediatric and Adult Patients With Wolfram Syndrome|Recruiting||Phase 1/Phase 2|50|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||Yes|publication|2017-10-10 22:00:29.285998|2017-10-10 22:00:29.285998
NCT02829255|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-05-23|||March 2016||2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of High Altitude Exposure, Acclimatization and Re-exposure on Cerebral Autoregulation in Lowlanders|Effect of High Altitude Exposure, Acclimatization and Re-exposure on Cerebral Autoregulation in Lowlanders|Active, not recruiting||N/A|18|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 22:00:29.412602|2017-10-10 22:00:29.412602
NCT02829242|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-29|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Near Infrared Spectroscopy in Patients Undergoing Robotic Assisted Laparoscopic Surgery in the Trendelenburg Position|Near Infrared Spectroscopy for Determination of Tissue Oxygenation in Patients Undergoing Robotic Assisted Laparoscopic Surgery in the Trendelenburg Position - A Feasibility Study|Recruiting||N/A|40|Anticipated|Medical University of Vienna|||2||f||||t||||||||No||2017-10-10 22:00:29.497638|2017-10-10 22:00:29.497638
NCT02829229|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-10-21|||September 2016||2016-09-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Community-based Obesity Treatment in African American Women After Childbirth|Community-based Obesity Treatment in African American Women After Childbirth: a Randomized Controlled Trial of Women Infant Children (WIC) Mothers|Recruiting||Phase 2|300|Anticipated|Temple University||2|||f||||f||||||||Yes|Dr. Herring (PI) will ensure that all publications that result from data collected as part of this project will comply with the NIH public access policy. Also, Dr. Herring agrees to develop a transportable de-identified database, codebook, and mechanism by which data can be shared with other investigators upon approval of the study's research team. The Resource Sharing Plan will be reviewed and approved by Temple University's Institutional Review Board.|2017-10-10 22:00:29.588596|2017-10-10 22:00:29.588596
NCT02829216|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-07-07|||April 2016||2016-04-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Observational|||Graft-versus-host Disease Associated Myelosuppression|Functional Profiling of the Hematopoietic Stem Cell Niche in Graft Versus Host Disease Mediated Bone Marrow Insufficiency|Recruiting||N/A|50|Anticipated|Technische Universität Dresden|||1||f||||f||||||||No||2017-10-10 22:00:29.689162|2017-10-10 22:00:29.689162
NCT02829203|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-07|||May 2015||2015-05-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Pre-Frailty Risk in Cardiovascular Surgery|Pre-Frailty Score as a Predictor Risk on Cardiovascular Surgery Outcome in Elderly|Completed||N/A|221|Actual|Instituto Dante Pazzanese de Cardiologia|||2||f||||f||||||||No||2017-10-10 22:00:29.761957|2017-10-10 22:00:29.761957
NCT02829190|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-07-07|||February 2014||2014-02-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|IRM-de-FLUX||Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries|Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries in Normal and Pathological Cases|Recruiting||Phase 3|80|Anticipated|Centre Hospitalier Universitaire, Amiens||4|||f||||f||||||||||2017-10-10 22:00:29.819155|2017-10-10 22:00:29.819155
NCT02829177|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-07-11|||September 2014||2014-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|August 2016|Anticipated|2016-08-01||Interventional|MIKAL||Microalbuminuria and Allopurinol in Type 1 Diabetes|A Double-blind, Randomized, Placebo Controlled Trial of Allopurinol in Patients With Type 1 Diabetes and Microalbuminuria|Active, not recruiting||Phase 4|30|Actual|Steno Diabetes Center||2|||f||||f||||||||No||2017-10-10 22:00:29.927666|2017-10-10 22:00:29.927666
NCT02828982|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-25|||July 2016||2016-07-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Determining the Potential Benefit of Powered Prostheses|Determining the Potential Benefit of Powered Prostheses|Recruiting||N/A|12|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 22:00:31.395871|2017-10-10 22:00:31.395871
NCT02829164|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-05-19|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East Region|Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East Region|Recruiting||N/A|20|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:00:30.004507|2017-10-10 22:00:30.004507
NCT02829151|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)||Not yet recruiting||Phase 4|390|Anticipated|Yonsei University||3|||f||||t||||||||Undecided||2017-10-10 22:00:30.117576|2017-10-10 22:00:30.117576
NCT02829138|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-11|||August 2015||2015-08-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Personalized Nutrition in Young Adults: The Ability of Genetic Information to Motivate Changes in Omega-3 Consumption|Personalized Nutrition in Young Adults: The Ability of Genetic Information to Motivate Changes in Omega-3 Consumption|Completed||N/A|60|Actual|University of Guelph||2|||f||||f||||||||No||2017-10-10 22:00:30.198047|2017-10-10 22:00:30.198047
NCT02829125|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-05-10|||January 1, 2015|Actual|2015-01-01|January 2015|2015-01-01|January 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Influence of Postoperative Rehabilitation and Pre- and Postoperative Physical Activity in Abdominal Surgery||Recruiting||N/A|400|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 22:00:30.272539|2017-10-10 22:00:30.272539
NCT02829112|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-04-25|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|SHULMAN||Shulman Fasciitis Prevalence Study in Alsace|Shulman Fasciitis Prevalence Study in Alsace|Recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:00:30.346884|2017-10-10 22:00:30.346884
NCT02829086|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-08-12|||July 2016||2016-07-01|August 2016|2016-08-01|October 2020|Anticipated|2020-10-01|September 2020|Anticipated|2020-09-01||Interventional|||Evaluation of the Refugee Family Strengthening (RFS) Program|Evaluation the of U.S. Committee for Refugees and Immigrants (USCRI): Refugee Family Strengthening (RFS) Program|Active, not recruiting||N/A|9350|Actual|US Committee for Refugees and Immigrants||3|||f||||f||||||||Undecided||2017-10-10 22:00:30.567659|2017-10-10 22:00:30.567659
NCT02829073|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study|Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study|Recruiting||N/A|120|Anticipated|United States Army Aeromedical Research Laboratory||2|||f||||f||||||||No||2017-10-10 22:00:30.644883|2017-10-10 22:00:30.644883
NCT02829060|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-08-09|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|PNLABXPART2||Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2|The Endourology Disease Group for Excellence (EDGE) Consortium: A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Percutaneous Nephrolithotomy in Patients With Moderate Risk of Postoperative Infection|Recruiting||N/A|330|Anticipated|University of California, San Diego||6|||f||||f||||||||||2017-10-10 22:00:30.774711|2017-10-10 22:00:30.774711
NCT02829047|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-03-12|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration|A Prospective, Multicenter, Open-label, Single-arm Study to Assess the Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration|Terminated||N/A|25|Actual|Vibrant Ltd.||1||"Study halted at interim analysis to allow the sponsor to focus on a new study with different   design."|f||||f||||||||Undecided||2017-10-10 22:00:30.907569|2017-10-10 22:00:30.907569
NCT02829034|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-06-22|||July 2016||2016-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Targeting Right Ventricle in Pulmonary Hypertension Gilead|A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Using Cardiovascular MRI|Recruiting||N/A|10|Anticipated|University of Pennsylvania||2|||f||||t||||||||Undecided||2017-10-10 22:00:30.990682|2017-10-10 22:00:30.990682
NCT02829021|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-07-07|||April 2009||2009-04-01|June 2016|2016-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Dynamic Infrared Thermography in Breast Cancer Diagnostics|Dynamic Infrared Thermography in Breast Cancer Diagnostics. A Diagnostic Accuracy Study Comparing Dynamic Infrared Thermography Against Mammography (Reference Standard)|Completed||N/A|168|Actual|University Hospital of North Norway||1|||f||||f||||||||Undecided|This is a small Diagnostic Accuracy Study, the investigators will decide upon data sharing when they have finished the statistical analysis. If someone is interested in the data, please contact the investigators.|2017-10-10 22:00:31.090804|2017-10-10 22:00:31.090804
NCT02829008|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-07-11|||April 2016||2016-04-01|July 2016|2016-07-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients|A Phase 2 Clinical Trial:Low -Dose-bevacizumab and Pemetrexed Versus Treatment of Physician's Choice in Metastatic HER2-negative Breast Cancer Patients After Failure of Taxanes and Anthracycline-containing Regimens|Active, not recruiting||Phase 2|120|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 22:00:31.168783|2017-10-10 22:00:31.168783
NCT02828995|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-07-28|||July 8, 2016|Actual|2016-07-08|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ENDSTIGMA||Evaluating the Influence of Diabetes Stigma on Medication Adherence|Evaluating the Influence of Diabetes Stigma on Medication Adherence|Recruiting||N/A|800|Anticipated|Vanderbilt University Medical Center||1|||f||||f||||||||||2017-10-10 22:00:31.27186|2017-10-10 22:00:31.27186
NCT02828969|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-07|||May 2014||2014-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TRAJECTORY||Clinical and Social Trajectory of Children and Adolescents With Disruptive Behavior|Clinical Trajectory of Children and Adolescents With Disruptive Behavior Admitted to Pediatric and Psychiatric Emergencies.|Recruiting||N/A|300|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 22:00:31.490242|2017-10-10 22:00:31.490242
NCT02828956|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-11|||January 2010||2010-01-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Motivation to Change, Coping, and Self-Esteem in Adolescent Anorexia Nervosa|Motivation to Change, Coping, and Self-Esteem in Adolescent Anorexia Nervosa|Completed||N/A|92|Actual|University of Zurich|||1||f||||f||||||||No||2017-10-10 22:00:31.582602|2017-10-10 22:00:31.582602
NCT02828943|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-09-11|||August 2016||2016-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Ventilatory Muscle Training in Stroke|Combined Inspiratory and Expiratory Muscle Training in Long-term Stroke|Recruiting||Phase 3|20|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-10 22:00:31.660661|2017-10-10 22:00:31.660661
NCT02828930|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-07-04|||September 8, 2016|Actual|2016-09-08|July 2017|2017-07-01|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Interventional|||A Study to Determine the Excretion Balance, Pharmacokinetics, Metabolism and Absolute Oral Bioavailability of a Single Oral Dose of [14C]-Labeled Idasanutlin and an Intravenous Tracer Dose of [13C]-Labeled Idasanutlin in a Single Cohort of Participants With Solid Tumors (Malignancies)||Completed||Phase 1|8|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:00:31.772279|2017-10-10 22:00:31.772279
NCT02828917|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-04-06|||January 16, 2017|Actual|2017-01-16|April 2017|2017-04-01|February 2022|Anticipated|2022-02-01|September 2021|Anticipated|2021-09-01||Interventional|JNIR||MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR)|Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial|Recruiting||N/A|86|Anticipated|Medinol Ltd.||1|||f||||t|f|t||f||||No||2017-10-10 22:00:32.079977|2017-10-10 22:00:32.079977
NCT02828904|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-03-13|||June 2016||2016-06-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|November 2019|Anticipated|2019-11-01||Observational|RIVET-CC||RIVET-Case Control Study|Risk of Venous Thromboembolism - The Role of Oral Contraceptives - a Case Control Study Comparing Levonorgestrel and Chlormadinone Acetate|Recruiting||N/A|27620|Anticipated|Center for Epidemiology and Health Research, Germany|||4||f||||t||||||||No||2017-10-10 22:00:32.227341|2017-10-10 22:00:32.227341
NCT02828891|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-06-12|||July 2016||2016-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Analysis of Translaminar Pressure Gradient Using Noninvasive Cerebrospinal Fluid Pressure Monitoring|Analysis of Translaminar Pressure Gradient Using Noninvasive Cerebrospinal Fluid Pressure Monitoring|Enrolling by invitation||N/A|200|Anticipated|University of Miami||1|||f||||f||||||||Undecided||2017-10-10 22:00:32.331073|2017-10-10 22:00:32.331073
NCT02828878|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-08-08|||January 2017||2017-01-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation|An Open-Label Phase I/II, Pilot, Staggered Four-Cohort Safety and Proof-of-Concept Study of ApoGraft in the Prevention of Acute Graft Versus Host Disease (aGvHD)|Recruiting||Phase 1/Phase 2|12|Anticipated|Cellect Biotechnology||1|||f||||t||||||||||2017-10-10 22:00:32.420117|2017-10-10 22:00:32.420117
NCT02828865|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-02-21|||November 2012||2012-11-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers|A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers|Enrolling by invitation||N/A|40|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:00:32.548817|2017-10-10 22:00:32.548817
NCT02828852|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-05-10|||May 2010||2010-05-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study of the Platelet Function During the Last Month of Pregnancy|Study of the Platelet Function During the Last Month of Pregnancy|Completed||N/A|60|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:00:32.695489|2017-10-10 22:00:32.695489
NCT02828839|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-19|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|December 31, 2017|Anticipated|2017-12-31||Interventional|STABLE||Prostate Biopsy Access Needle & Needle Guide Feasibility Study|Prostate Biopsy Access Needle & Needle Guide Feasibility Study|Active, not recruiting||N/A|500|Anticipated|Perineologic||1|||f||||f||||||||||2017-10-10 22:00:32.831496|2017-10-10 22:00:32.831496
NCT02828826|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-11|||October 2016||2016-10-01|July 2016|2016-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|STEP-PA||Impact of Telephone Coaching on Physical Performance in a Physical Exercise Maintenance Program for Fallers Elderly Patients Living at Home|Impact of Telephone Coaching on Physical Performance in a Physical Exercise Maintenance Program for Fallers Elderly Patients Living at Home|Not yet recruiting||N/A|180|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-10 22:00:32.979388|2017-10-10 22:00:32.979388
NCT02828813|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-07|||June 2016||2016-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Neural Mechanisms of Motor and Cognitive Networks|Neural Mechanisms of Motor and Cognitive Networks|Recruiting||N/A|120|Anticipated|National Research Center for Rehabilitation Technical Aids|||3||f||||f||||||||No|no plan to share data|2017-10-10 22:00:33.083771|2017-10-10 22:00:33.083771
NCT02828800|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|March 2018|Anticipated|2018-03-01||Observational|CARTODOL||Cartography of Allodynic and Hypoasthetic Territories Following TKA|Cartography of Allodynic and Hypoasthetic Territories Associated With Neuropathic Pain Following Total Knee Arthroplasty (TKA)|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||||||2017-10-10 22:00:33.188671|2017-10-10 22:00:33.188671
NCT02828787|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-01|||January 16, 2017|Actual|2017-01-16|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|PRURIM||Central Mechanisms of Chronic Pruritus: Functional and Structural Brain Imaging.|Central Mechanisms of Chronic Pruritus: Functional and Structural Brain Imaging.|Recruiting||N/A|45|Anticipated|University Hospital, Brest||3|||f||||f||||||||||2017-10-10 22:00:33.289709|2017-10-10 22:00:33.289709
NCT02828774|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-07-07|||August 2016||2016-08-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Observational|||Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia|Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia|Not yet recruiting||N/A|30|Anticipated|Assuta Medical Center|||1||f||||f||||||Samples Without DNA|"     RNA will be extracted from CLL cells in the blood.   "|Undecided||2017-10-10 22:00:33.421081|2017-10-10 22:00:33.421081
NCT02828761|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-07|||October 2016||2016-10-01|June 2016|2016-06-01|April 2021|Anticipated|2021-04-01|October 2020|Anticipated|2020-10-01||Interventional|||Coronary Calcium Scoring Versus Standard Care for Emergency Department Chest Pain Patients|A Randomized Controlled Trial of Early Coronary Calcium Scoring and Standard Care in Emergency Department Chest Pain Patients|Not yet recruiting||N/A|800|Anticipated|Montefiore Medical Center||2|||f||||t||||||||No||2017-10-10 22:00:33.523735|2017-10-10 22:00:33.523735
NCT02828748|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-10-23|||December 2016||2016-12-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Cytokine Production of Colonic Tissue From IBD Patients|The Effect of Cannabinoids on Cytokine Production of Colonic Tissue From IBD Patients|Not yet recruiting||N/A|50|Anticipated|Meir Medical Center||4|||f||||t||||||||No||2017-10-10 22:00:33.678226|2017-10-10 22:00:33.678226
NCT02828735|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-06-19|||January 30, 2017|Actual|2017-01-30|June 2017|2017-06-01|December 20, 2017|Anticipated|2017-12-20|September 20, 2017|Anticipated|2017-09-20||Interventional|EPIQ||Respiration Patterns With Impedance in LINQ|REspiration Patterns in REVEAL LINQ Insertable Cardiac Monitor|Active, not recruiting||N/A|20|Anticipated|Medtronic BRC||1|||f||||f|f|f||||||Undecided||2017-10-10 22:00:33.814847|2017-10-10 22:00:33.814847
NCT02828722|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-07|||November 2016||2016-11-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Proof of Concept Trial to Confirm That the Recovery of Patients Treated in the Intensive Care Unit Requiring Mechanical Ventilation is Beneficially Affected by the Environmental Simulation of Daytime and Night Time Alternation as Well as by the Nutrition Protocol Corresponding to the Daily Rhythm|Proof of Concept Trial to Confirm That the Recovery of Patients Treated in the Intensive Care Unit Requiring Mechanical Ventilation is Beneficially Affected by the Environmental Simulation of Daytime and Night Time Alternation as Well as by the Nutrition Protocol Corresponding to the Daily Rhythm|Not yet recruiting||N/A|45|Anticipated|Achros Health Technologies Corporation||3|||f||||f||||||||||2017-10-10 22:00:33.914872|2017-10-10 22:00:33.914872
NCT02828709|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-09-26|||July 2016||2016-07-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Safety and Feasibility of IRE for SRMs|The Safety and Feasibility of Irreversible Electroporation for the Ablation of Small Renal Masses|Recruiting||Phase 2|20|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||No||2017-10-10 22:00:34.02753|2017-10-10 22:00:34.02753
NCT02828696|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-06|||June 2016||2016-06-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Minimally Invasive Treatment of Worn Dentition With Innovative CAD-CAM Composites|Minimally Invasive Treatment of Worn Dentition With Innovative CAD-CAM Composites|Recruiting||N/A|14|Anticipated|University Hospital of Liege||1|||f||||f||||||||Undecided||2017-10-10 22:00:34.144157|2017-10-10 22:00:34.144157
NCT02828683|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-10-17|||July 2013||2013-07-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|July 2016|Actual|2016-07-01||Interventional|MASTER||Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study|Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in Management of Patients With Acute ST-Elevation Myocardial InfaRction - MASTER Study|Active, not recruiting||N/A|500|Anticipated|Terumo Europe N.V.||2|||f||||t||||||||||2017-10-10 22:00:34.262768|2017-10-10 22:00:34.262768
NCT02828657|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-27|||June 2016||2016-06-01|March 2017|2017-03-01||||June 2018|Anticipated|2018-06-01||Observational|OPAS-1||ORBERA™ Post-Approval Study|ORBERA™ Post-Approval Study|Recruiting||N/A|284|Anticipated|Apollo Endosurgery, Inc.|||1||f||||f||||||||||2017-10-10 22:00:34.48671|2017-10-10 22:00:34.48671
NCT02828644|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-05-18|||August 2016||2016-08-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|STARS-ADHD2||Software Treatment for Actively Reducing Severity of ADHD - Follow Up|An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)|Recruiting||N/A|330|Anticipated|Akili Interactive Labs, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:00:34.63559|2017-10-10 22:00:34.63559
NCT02828631|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-06-26|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparison of McGrath, Pentax and Macintosh Laryngoscopes for Nasotracheal Intubation in Pediatrics||Recruiting||N/A|108|Anticipated|Ajou University School of Medicine||3|||f||||||||||||||2017-10-10 22:00:34.78313|2017-10-10 22:00:34.78313
NCT02828605|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-08|||July 2016||2016-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Virtual Interactive Platform (VIP) Transplant Research Study|Virtual Interactive Platform (VIP) Transplant Research Study|Not yet recruiting||Early Phase 1|8|Anticipated|Yale University||2|||f||||||||||||||2017-10-10 22:00:34.971816|2017-10-10 22:00:34.971816
NCT02828592|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-06-08|||September 2016||2016-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia|A Study of T-Cell Replete, HLA-Mismatched Haploidentical Bone Marrow Transplantation With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia Lacking HLA-Matched Related Donor|Recruiting||Phase 2|20|Anticipated|Northside Hospital, Inc.||1|||f||||f||||||||No||2017-10-10 22:00:35.057324|2017-10-10 22:00:35.057324
NCT02828579|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-08|||February 2015||2015-02-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Observational|||The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease|The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease|Completed||N/A|20|Actual|Jagiellonian University|||1||f||||f||||||||No|data not entered|2017-10-10 22:00:35.176838|2017-10-10 22:00:35.176838
NCT02828566|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-25|||October 2017|Anticipated|2017-10-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|INK||Intranasal Ketamine for Procedural Sedation|Intranasal Ketamine Versus Intravenous Ketamine for Procedural Sedation in Children: a Multi-centre Randomized Controlled Non-inferiority Trial|Not yet recruiting||Phase 3|470|Anticipated|Lawson Health Research Institute||2|||f||||t|t|f|||t|||||2017-10-10 22:00:35.2502|2017-10-10 22:00:35.2502
NCT02828553|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-10-03|||October 2016||2016-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||CHF Inpatient Ambulation Trial|CHF Inpatient Ambulation Trial|Recruiting||N/A|352|Anticipated|Lancaster General Hospital|||2||f||||f||||||||||2017-10-10 22:00:35.340209|2017-10-10 22:00:35.340209
NCT02828540|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-03-21|||August 2016||2016-08-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke|A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke|Recruiting||Phase 2|141|Anticipated|Kyunghee University||3|||f||||t||||||||Undecided||2017-10-10 22:00:35.45175|2017-10-10 22:00:35.45175
NCT02828527|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-02-21|||September 12, 2014|Actual|2014-09-12|July 2016|2016-07-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Care Courses for Mild Head Injury Patients|Care Courses for Mild Head Injury Patients|Recruiting||N/A|50|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 22:00:35.560188|2017-10-10 22:00:35.560188
NCT02828514|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2017-02-02|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Nasal Resonance Change After Endoscopic Endonasal Transsphenoidal Skull Base Surgery: Analysis of Quality of Voice||Recruiting||N/A|46|Anticipated|Khon Kaen University|||1||f||||||||||||||2017-10-10 22:00:35.638876|2017-10-10 22:00:35.638876
NCT02828501|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-07-06|||March 2015||2015-03-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Additive Effects of Combined Spinal Manipulations on Pain Pressure Threshold|Additive Effects of Combined Cervical and Lumbar Manipulation on Pain Pressure Threshold in a Single Session|Completed||N/A|57|Actual|University of South Carolina||3|||f||||f||||||||No||2017-10-10 22:00:35.703721|2017-10-10 22:00:35.703721
NCT02828488|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-02-21|||June 13, 2014|Actual|2014-06-13|July 2016|2016-07-01|June 1, 2018|Anticipated|2018-06-01|January 1, 2018|Anticipated|2018-01-01||Observational|AIT70||Analysis of the Impact of the Fragility of the Over 70 Years of TIAprognosis|Analysis of the Impact of the Fragility of the Over 70 Years of TIA (Transient Ischemic Attack) Prognosis|Recruiting||N/A|50|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||t|f|f||||||No||2017-10-10 22:00:35.772097|2017-10-10 22:00:35.772097
NCT02828475|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-07-08|||June 2016||2016-06-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Observational|CALYPSO||CALYPSO Pilot Study: Machine Learning Based Predictions of Surgical Complications|Pilot Study for a Clinical Analytical Platform for Surgical Outcomes|Enrolling by invitation||N/A|200|Anticipated|Duke University|||2||f||||f||||||||No||2017-10-10 22:00:35.839497|2017-10-10 22:00:35.839497
NCT02828462|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-07|||October 2016||2016-10-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|CAPRI||Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics|Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics|Recruiting||N/A|1000|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||2||f||||f||||||||||2017-10-10 22:00:35.914975|2017-10-10 22:00:35.914975
NCT02828449|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-09-13|||November 2016|Actual|2016-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CHIMIO ORALE||Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy|Assessment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy|Recruiting||N/A|600|Anticipated|Institut de Cancérologie de la Loire||1|||f||||f||||||||||2017-10-10 22:00:36.007823|2017-10-10 22:00:36.007823
NCT02828436|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-04-18|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Spinal Cord Stimulation to Treat Hypertension|A Pilot Study to Assess Spinal Cord Stimulation To Inhibit Afferent Feedback During Exercise in Hypertension|Recruiting||Phase 1|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|t|f|f||||Undecided||2017-10-10 22:00:36.094843|2017-10-10 22:00:36.094843
NCT02828423|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-06|||September 2011||2011-09-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Regenerative Combined Therapy With Enamel Matrix Derivative and Biphasic Calcium Phosphate Graft|Treatment of Non-contained Infrabony Defects With Enamel Matrix Derivative Alone or in Combination With HA/β-TCP Graft: a 12-month Randomized Controlled Clinical Trial|Completed||Phase 4|52|Actual|Universitat Internacional de Catalunya||2|||f||||t||||||||Yes||2017-10-10 22:00:36.186916|2017-10-10 22:00:36.186916
NCT02828410|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2017-08-11|||July 2016||2016-07-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With IPAA|Evaluating the Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Ileal Pouch-Anal Anastomosis|Active, not recruiting||N/A|45|Anticipated|Boston Medical Center||1|||f||||f|f|f||||||||2017-10-10 22:00:36.258444|2017-10-10 22:00:36.258444
NCT02828397|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2016-11-03|||April 2016||2016-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study of the Blood Concentrations of Two Formulations of REGN2222 in Healthy Subjects|A Randomized, Open-Label, Parallel Group Study of the Pharmacokinetics, Safety, and Tolerability of a Single Intramuscular (IM) Injection of REGN2222 Produced by 2 Different Cell Lines in Healthy Adult Subjects|Completed||Phase 1|28|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:00:36.343995|2017-10-10 22:00:36.343995
NCT02828384|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-06-27|||September 2014||2014-09-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence|Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence: a Randomized, Controlled Trial.|Recruiting||Phase 2|40|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 22:00:36.406922|2017-10-10 22:00:36.406922
NCT02828371|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2016-07-06|||January 2015||2015-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Early Stepping Verticalization in ICU for ABI Patients|Effectiveness of a Very Early Stepping Verticalization Protocol in Severe Acquired Brain Injured Patients: a Randomized Pilot Study in ICU|Completed||N/A|40|Actual|Ospedale Generale Di Zona Moriggia-Pelascini||2|||f||||||||||||||2017-10-10 22:00:36.620398|2017-10-10 22:00:36.620398
NCT02828345|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-01-24|||December 2013||2013-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Observational|||Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma|Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma|Recruiting||N/A|100|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||f||||||||||2017-10-10 22:00:37.794796|2017-10-10 22:00:37.794796
NCT02828332|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-06|||October 2012||2012-10-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|EpiTED||Developmental Trajectories in ASD Until Adulthood: A 15 Years Follow-up Study|Study of Developmental Trajectories From Childhood to Adulthood Patients of the Cohort EpiTED: Research for Prognostic Factors Clinical and Biological|Completed||N/A|106|Actual|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:00:37.893638|2017-10-10 22:00:37.893638
NCT02828319|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-03-24|||July 2016||2016-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia||Active, not recruiting||Phase 3|30|Anticipated|Zeria Pharmaceutical||1|||f||||||||||||||2017-10-10 22:00:37.986997|2017-10-10 22:00:37.986997
NCT02828306|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|August 2019|Anticipated|2019-08-01||Observational|CAPSID||Computer Based Algorithm for Patient Specific Implants for Cranioplasty in Patients With Skull Defects|Computer Based Algorithm for Patient Specific Implants for Cranioplasty in Patients With Skull Defects: a Prospective Clinical Trial|Recruiting||N/A|15|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||Yes||2017-10-10 22:00:38.076919|2017-10-10 22:00:38.076919
NCT02828293|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-06|||September 2014||2014-09-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Observational|||Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy|Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy|Recruiting||N/A|30|Anticipated|Medacta International SA|||3||f||||||||||||||2017-10-10 22:00:38.211161|2017-10-10 22:00:38.211161
NCT02828280|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-05-06|||May 2011||2011-05-01|May 2017|2017-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||NuMask Versus Traditional Mask Ventilation During Routine Care|A Comparison of Controlled Ventilation With the NuMask vs. Traditional Mask Ventilation.|Completed||N/A|44|Actual|University of Utah|||2||f||||f|f|t|f|f||||||2017-10-10 22:00:38.307358|2017-10-10 22:00:38.307358
NCT02828267|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-01-31|||July 1, 2018|Anticipated|2018-07-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|BNI||Evaluating a Brief Negotiational Intervention for Alcohol Use Among Injury Patients in Tanzania|Developing a Brief Negotiational Intervention for Alcohol Use Among Injury Patients in Tanzania|Not yet recruiting||N/A|60|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 22:00:38.394696|2017-10-10 22:00:38.394696
NCT02828254|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-09-19|||December 2014||2014-12-01|September 2017|2017-09-01||||March 2018|Anticipated|2018-03-01|12 Months|Observational [Patient Registry]|||A Follow-up Evaluation Study of PRI-724-1101|A Follow-up Evaluation Study of the Safety and Efficacy of PRI-724 Administration in Patients With Cirrhosis Due to Hepatitis C|Active, not recruiting||N/A|18|Anticipated|Komagome Hospital|||1||f||||f||||||||||2017-10-10 22:00:38.521712|2017-10-10 22:00:38.521712
NCT02828241|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-07-20|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|January 2017|Actual|2017-01-01||Interventional|||A Study to Assess the Efficacy, Safety and Tolerability of DFD-04||Active, not recruiting||Phase 2|61|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-10 22:00:38.620313|2017-10-10 22:00:38.620313
NCT02828228|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-07-06|||February 2016||2016-02-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Vitamin D Supplementation in Vitamin D Deficient Obese Children During Weight-loss Program|Long-term Effects of Vitamin D Supplementation in Vitamin D Deficient Obese Children During Integrated Weight-loss Program - a Double Blind Placebo Controlled Study|Recruiting||N/A|200|Anticipated|University Clinical Centre, Gdansk||2|||f||||f||||||||Yes||2017-10-10 22:00:38.777883|2017-10-10 22:00:38.777883
NCT02828215|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-11-18|||July 2015||2015-07-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|ACAD||Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study)|A Prospective Study to Evaluate Swept-Source OCT and Adaptive Optics Imaging of Diseases of the Vitreous, Retina and Choroid|Recruiting||N/A|300|Anticipated|Moorfields Eye Hospital NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 22:00:38.910012|2017-10-10 22:00:38.910012
NCT02828033|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-09-12|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss|A Pilot Trial of Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss|Recruiting||Early Phase 1|10|Anticipated|Metroplex Clinical Research||1|||f||||f|t|f||||||||2017-10-10 22:00:40.740369|2017-10-10 22:00:40.740369
NCT02822313|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-05|||November 2015||2015-11-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:39.218041|2017-10-10 22:01:39.218041
NCT02828202|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-11-09|||February 2013||2013-02-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|MelBase||Follow-up of a National Cohort of Melanoma Stage IV and Unresectable Stage III Patients|Constitution of a National Cohort of Patients With Metastatic Melanoma Stage IV or Unresectable Stage III With the Objective of Setting up a Epidemiological Monitoring and a Clinico-biological Database, MELBASE|Recruiting||N/A|1000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"     Primary melanoma (mostly paraffin embedded), metastatic sample (s)(paraffin embedded and     frozen) from at least 1 site at inclusion and during evolution, particularly before treatment     modification if clinically required, DNA and RNA from peripheral blood mononuclear cells,     plasma sampled at inclusion and every 6 months during 3 years.   "|No||2017-10-10 22:00:39.035467|2017-10-10 22:00:39.035467
NCT02828189|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-06|||May 2015||2015-05-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Interventional|||Therapeutic Exercise in Cancer-Related Fatigue in Women After Breast Cancer Treatment|Efficacy of Therapeutic Exercise in Modulating Cancer-Related Fatigue in Women After Breast Cancer Treatment|Recruiting||N/A|90|Anticipated|University of Alcala||2|||f||||t||||||||No||2017-10-10 22:00:39.361741|2017-10-10 22:00:39.361741
NCT02828176|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-09|||January 2016||2016-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Left Uterine Displacement on Parturient Cardiovascular System|Hemodynamics Effects of Left Lateral Tilt on the Full Term Pregnant Females|Completed||N/A|75|Actual|Cairo University||1|||f||||f||||||||Undecided||2017-10-10 22:00:39.476327|2017-10-10 22:00:39.476327
NCT02828163|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-03-02|||January 2016||2016-01-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris|Comparative Study Between Intralesional Autologous Platelet Rich Plasma and Intralesional Triamcinolone Acetonide in the Oral Erosions of Pemphigus Vulgaris Patients|Completed||Phase 3|11|Actual|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 22:00:39.579528|2017-10-10 22:00:39.579528
NCT02828150|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-15|||July 2016||2016-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Integrative Parenteral Nutrition in Cancer Patients|Integrative Parenteral Nutrition in Hospitalized, Malnourished, Hypophagic Cancer Patients With Contraindication to Enteral Nutrition|Recruiting||N/A|110|Anticipated|IRCCS Policlinico S. Matteo||1|||f||||f||||||||||2017-10-10 22:00:39.71429|2017-10-10 22:00:39.71429
NCT02828137|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-09|2016-07-09||May 2009||2009-05-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|||Relation Between NLR and IMR in STEMI Patients|Relationships Between Neutrophil-to-Lymphocyte Ratio and Index of Microcirculatory Resistance in ST-segment Elevation Myocardial Infarction Patients Undergone Primary Percutaneous Coronary Intervention|Completed||N/A|123|Actual|Inha University Hospital|||3||f||||t||||||||Undecided|If it is feasible to upload the individual data, the investigator would consider it positively.|2017-10-10 22:00:39.843253|2017-10-10 22:00:39.843253
NCT02828124|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-15|||August 23, 2016|Actual|2016-08-23|September 2017|2017-09-01|October 22, 2020|Anticipated|2020-10-22|May 21, 2020|Anticipated|2020-05-21||Interventional|||A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer|A Phase 1/2 Study of BMS-986183 in Subjects With Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 1/Phase 2|25|Actual|Bristol-Myers Squibb||4|||f||||f|t|f||||||||2017-10-10 22:00:40.115004|2017-10-10 22:00:40.115004
NCT02828111|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-09-12|||October 2016||2016-10-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|BCC||Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas|Double-Blind, Dose Escalating, Randomized, Vehicle-Controlled Proof of Concept Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas|Active, not recruiting||Phase 2|36|Actual|PellePharm, Inc.||8|||f||||f||||||||||2017-10-10 22:00:40.253663|2017-10-10 22:00:40.253663
NCT02828098|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-07-11|||June 2016||2016-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Exploratory Study of BO-112 in Adult Patients With Aggressive Solid Tumors|An Exploratory First in Human Phase I Clinical and Pharmacokinetic Study of Intra-tumoral Administration of BO-112 in Adult Patients With Aggressive Solid Tumor|Recruiting||Phase 1|24|Anticipated|Bioncotech Therapeutics||1|||f||||||||||||||2017-10-10 22:00:40.373885|2017-10-10 22:00:40.373885
NCT02828085|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-06|||July 2013||2013-07-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|PERICARDITE||Improvement of the Etiological Diagnosis of the Pericarditis|Improvement of the Etiological Diagnosis of the Pericarditis|Recruiting||N/A|300|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-10 22:00:40.450731|2017-10-10 22:00:40.450731
NCT02828072|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-06|||March 2011||2011-03-01|July 2016|2016-07-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|||Sudarshan Kriya Yoga and Cardiac Autonomic Control in Patients With Anxiety-Depression Disorders|Effects of Sudarshan Kriya Yoga on Cardiac Autonomic Control and Anxiety/Depression Levels in Patients Affected by Anxiety-Depression Disorders|Completed||N/A|50|Actual|University of Milan||2|||f||||f||||||||No||2017-10-10 22:00:40.515817|2017-10-10 22:00:40.515817
NCT02828059|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-03-28|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|dip-Caesar||Continuous Wound Infiltration for Diminution of Post-surgery Pain After Caesarean Section|Continuous Wound Infiltration for Diminution of Post-surgery Pain After Caesarean Section (Dip-Caesar)|Withdrawn||N/A|0|Actual|Jena University Hospital|||1|changed drug approval|f||||f||||||||No|Dissemination of individual participant data is not planned|2017-10-10 22:00:40.576099|2017-10-10 22:00:40.576099
NCT02828046|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-02-16|||June 2016||2016-06-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)|A Phase 1, Single Center, Randomized, Double-Blind, Placebo-Controlled, Single (Part 1) and Multiple (Part 2) Ascending Dose Study to Evaluate the Safety, Tolerability, PK and PD of M281 Administered to Healthy Volunteers|Recruiting||Phase 1|72|Anticipated|Momenta Pharmaceuticals, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:00:40.642595|2017-10-10 22:00:40.642595
NCT02828020|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-07|2017-09-08|||July 22, 2016|Actual|2016-07-22|September 2017|2017-09-01|November 13, 2017|Anticipated|2017-11-13|November 13, 2017|Anticipated|2017-11-13||Interventional|||Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine|Recruiting||Phase 3|1650|Anticipated|Allergan||3|||f||||t|t|f||||||||2017-10-10 22:00:42.649858|2017-10-10 22:00:42.649858
NCT02828007|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-11-24|||April 2016||2016-04-01|July 2016|2016-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|EIT Step 1||EIT Study With Healthy Patients|Changes in Lung Ventilation With Different Modes of Non-invasive Ventilation in Healthy Subjects|Completed||Phase 1|12|Actual|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:00:42.915492|2017-10-10 22:00:42.915492
NCT02827994|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-06|||March 2015||2015-03-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Pain Neurophysiology Education and Exercise for Adolescents With Chronic Idiopathic Neck Pain|Pain Neurophysiology Education and Exercise for Adolescents With Chronic Idiopathic Neck Pain: a School-based Pilot, Randomised and Controlled Study|Completed||N/A|43|Actual|Aveiro University||2|||f||||f||||||||No||2017-10-10 22:00:42.995688|2017-10-10 22:00:42.995688
NCT02827981|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-16|||May 2015||2015-05-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|MODIC||Retrospective Study on the Evaluation of Intra-disc Infiltration in the Active Disc Disease|Retrospective Study on the Evaluation of Intra-disc Infiltration in the Active Disc Disease|Withdrawn||N/A|0|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||Undecided||2017-10-10 22:00:43.256169|2017-10-10 22:00:43.256169
NCT02827968|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-03-27|||January 13, 2017|Actual|2017-01-13|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors|A Phase I, Open Label, Dose Escalation Study of The Safety and Pharmacokinetics of Anti-PD-L1 Monoclonal Antibody KN035 Administered in Subcutaneous Injection as A Single Agent to Subjects With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|24|Anticipated|3D Medicines (Sichuan) Co., Ltd.||1|||f||||t|t|f||||||Undecided||2017-10-10 22:00:43.340339|2017-10-10 22:00:43.340339
NCT02827955|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-11|||April 2014||2014-04-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|VIMBIL||Evaluation of Bilateral Gamma Knife Thalamotomy in Patients Presenting With Severe Essential Tremor|Evaluation of Bilateral Gamma Knife Thalamotomy in Patients Presenting With Severe Essential Tremor|Recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||t||||||||No||2017-10-10 22:00:43.429818|2017-10-10 22:00:43.429818
NCT02827942|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-07-06|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication|Comparison of Dual Amoxicillin/Vonoprazan Therapy and Triple Vonoprazan/Amoxicillin/Clarithromycin or Metronidazole Therapy for H. Pylori Eradication|Not yet recruiting||Phase 3|100|Anticipated|Hamamatsu University||2|||f||||f||||||||No|The individual data cannot be taken out from the hospital without permission.|2017-10-10 22:00:43.526039|2017-10-10 22:00:43.526039
NCT02827929|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-10|||June 2014||2014-06-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy of Education Programs in Patients With Chronic Airway Diseases|Efficacy of Education Programs in Patients With Chronic Airway Diseases|Completed||N/A|285|Actual|Konkuk University Medical Center||1|||f||||t||||||||No||2017-10-10 22:00:43.637582|2017-10-10 22:00:43.637582
NCT02827916|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-09-04|||April 4, 2016|Actual|2016-04-04|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|April 13, 2016|Actual|2016-04-13||Interventional|CANALOXA||Exploration of Neuropathic Pain Induced by Oxaliplatin Electrophysiological Approach|Exploration of Neuropathic Pain Induced by Oxaliplatin Electrophysiological Approach: Interest Using the SUDOSCAN® Machine|Completed||N/A|36|Actual|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||||2017-10-10 22:00:43.731353|2017-10-10 22:00:43.731353
NCT02827903|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-06|||November 2015||2015-11-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia|A Multi-center, Randomized, Double-blind, Phase III Clinical Trial to Compare the Efficacy and Safety of Metformin/Rosuvastatin Combination Therapy With Metformin or Rosuvastatin Monotherapy in Patients With Type 2 Diabetes and Dyslipidemia|Recruiting||Phase 3|222|Anticipated|Jeil Pharmaceutical Co., Ltd.||3|||f||||f||||||||No||2017-10-10 22:00:43.81907|2017-10-10 22:00:43.81907
NCT02827890|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-08|||April 2016||2016-04-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)|A Randomized, Open-label, Multiple Dosing, 2-way Crossover Study to Evaluate the Effect of Lobeglitazoneon Pharmacokinetics of Sitagliptin in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:00:43.914052|2017-10-10 22:00:43.914052
NCT02827864|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-12-12|||August 2016||2016-08-01|June 2016|2016-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Efficacy and Time Dependent Effects of tDCS Combined With MT for Rehabilitation After Subacute and Chronic Stroke|Efficacy and Time Dependent Effects of Transcranial Direct Current Stimulation (tDCS) Combined With Mirror Therapy for Rehabilitation After Subacute and Chronic Stroke|Recruiting||N/A|99|Anticipated|Chang Gung Memorial Hospital||3|||f||||||||||||||2017-10-10 22:00:44.125027|2017-10-10 22:00:44.125027
NCT02827851|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-19|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy|Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy|Enrolling by invitation||Phase 2|200|Anticipated|Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation||1|||f||||f||||||||||2017-10-10 22:00:44.245743|2017-10-10 22:00:44.245743
NCT02827838|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-07-31|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer|Pilot Study to Evaluate the Anti-Tumor Effect of Durvalumab (Medi4736) in Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN), Human Papilloma Virus (HPV) Positive Versus Negative, When Treated Before Surgery|Recruiting||Phase 2|20|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-10 22:00:44.341131|2017-10-10 22:00:44.341131
NCT02827825|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-06|||September 2015||2015-09-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis|Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis|Completed||N/A|50|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 22:00:44.440709|2017-10-10 22:00:44.440709
NCT02827812|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-08|||June 2016||2016-06-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|TELEPARK||Telemedicine Program in Parkinson's Disease (TELEPARK)|Home-Based Telesurveillance and Rehabilitation Program in Parkinson's Disease: Pilot Randomized Trial|Active, not recruiting||N/A|30|Anticipated|Fondazione Salvatore Maugeri||2|||f||||f||||||||No||2017-10-10 22:00:44.504912|2017-10-10 22:00:44.504912
NCT02827799|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-19|||August 2009||2009-08-01|July 2016|2016-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|CBTI-HF||Cognitive Behavioral Therapy for Insomnia in Stable Heart Failure|Cognitive Behavioral Therapy for Insomnia in Stable Heart Failure|Completed||N/A|51|Actual|Yale University||2|||f||||f||||||||No||2017-10-10 22:00:44.580837|2017-10-10 22:00:44.580837
NCT02827786|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-07-08|||September 2016||2016-09-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours|Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours - A Pilot Study|Not yet recruiting||N/A|30|Anticipated|Enhanced Medical||1|||f||||f||||||||No||2017-10-10 22:00:44.666904|2017-10-10 22:00:44.666904
NCT02827773|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-05|||March 2009||2009-03-01|July 2016|2016-07-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|TPB||Improving Medication Adherence: A Study With Talking Pill Bottles|Improving Medication Adherence: A Pilot Study With Talking Pill Bottles|Completed||N/A|138|Actual|University of Washington||2|||f||||t||||||||No||2017-10-10 22:00:44.869421|2017-10-10 22:00:44.869421
NCT02827760|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-07-05|||May 2016||2016-05-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|ITF||The Effect of Prebiotic Synergy1 Supplementation on Microbiota, Protein Metabolism and Gastrointestinal (GI) Symptoms in People Consuming High Protein Diet|The Effect of Prebiotic Synergy1 Supplementation on Microbiota, Protein Metabolism and Gastrointestinal (GI) Symptoms in People Consuming High Protein Diet|Recruiting||Early Phase 1|50|Anticipated|University of Reading||2|||f||||||||||||||2017-10-10 22:00:44.950854|2017-10-10 22:00:44.950854
NCT02827747|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-07-13|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||The Role of Antioxidant Supplementation in Keratoconus Patients|The Role of Antioxidants in Keratoconus Patients—A Randomized Controlled Trial of Oral Supplementation of Glutathione, Vitamin A, Vitamin C and Vitamin E|Not yet recruiting||Phase 2|100|Anticipated|University of Miami||4|||f||||f|t|f||||||||2017-10-10 22:00:45.053157|2017-10-10 22:00:45.053157
NCT02827734|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-02-07|||October 2015||2015-10-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)|Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)|Recruiting||N/A|50|Anticipated|Universitätsmedizin Mannheim|||2||f||||t||||||||No||2017-10-10 22:00:45.167521|2017-10-10 22:00:45.167521
NCT02827721|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-02-07|||July 2015||2015-07-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|150|Anticipated|Universitätsmedizin Mannheim|||2||f||||t||||||||No||2017-10-10 22:00:45.266721|2017-10-10 22:00:45.266721
NCT02827695|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-05-26|||May 2016||2016-05-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Smart Phone Medication Adherence Saves Kidneys--SMASK|Smart Phone Medication Adherence Saves Kidneys--SMASK|Recruiting||N/A|160|Anticipated|Medical University of South Carolina||2|||f||||f||||||||No||2017-10-10 22:00:45.697452|2017-10-10 22:00:45.697452
NCT02827682|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2017-01-18|||July 2016||2016-07-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of IoC on Analgesia for Elderly Patients With Postoperative Effectiveness|The Effect of IoC on the Level of Intraoperative Analgesia for Elderly Patients With Postoperative Effectiveness|Recruiting||N/A|100|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||t||||||||No||2017-10-10 22:00:45.78775|2017-10-10 22:00:45.78775
NCT02827669|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-03-20|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||One Drop Experts Program for Type 2 Diabetes Self-Management: Impact on A1c|One Drop Experts Program for Type 2 Diabetes Self-Management: Impact on A1c|Completed||N/A|297|Actual|Evidation Health||2|||f||||||||||||||2017-10-10 22:00:45.893105|2017-10-10 22:00:45.893105
NCT02827656|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-10|||August 2016||2016-08-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS|Luteal Phase Support With Human Chorionic Gonadotropin (hCG) Versus Gonadotropin Releasing Hormone (GnRh) Agonist in IVF Patients Who Are Risk for Developing OHSS|Not yet recruiting||N/A|50|Anticipated|Meir Medical Center||2|||f||||t||||||||No||2017-10-10 22:00:45.967194|2017-10-10 22:00:45.967194
NCT02827643|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-07|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Vitamin D and Calcium Supplement Attenuate Bone Loss Among HIV- Infected Patients Receiving Tenofovir Disoproxil Fumarate, Lamivudine or Emtricitabine and Efavirenz|Vitamin D and Calcium Supplement Attenuate Bone Loss Among HIV- Infected Patients Receiving Tenofovir Disoproxil Fumarate, Lamivudine or Emtricitabine and Efavirenz: An Open-label, Randomized Controlled Trial|Recruiting||N/A|48|Anticipated|Mahidol University||2|||f||||f||||||||Yes||2017-10-10 22:00:46.056135|2017-10-10 22:00:46.056135
NCT02827630|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-05|||May 2015||2015-05-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes|Use of Proteus Discover to Enable Improved Clinical Outcomes in Subjects With Uncontrolled Hypertension and Type 2 Diabetes Mellitus: A Pilot Study|Completed||N/A|118|Actual|Proteus Digital Health, Inc.||3|||f||||f||||||||||2017-10-10 22:00:46.141939|2017-10-10 22:00:46.141939
NCT02827617|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-24|||June 2016||2016-06-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Observational|||Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia|Prospective, Observational, Multi-centred, Non-interventional Study on the Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia|Recruiting||N/A|32|Anticipated|Oncology Institute of Southern Switzerland|||1||f||||f||||||Samples With DNA|"     Tumor periphral blood cells, Plasma, Tumor genomic DNA, Plasma cell free DNA   "|||2017-10-10 22:00:46.253871|2017-10-10 22:00:46.253871
NCT02827604|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2017-01-04|||February 2015||2015-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|SALUTARY||Preoperative and Intraoperative Sonographic Assessment of Lower Uterine Segment Thickness at Term in Women With Previous Cesarean Delivery - a Ultrasound Method Comparison Study|Präoperative Und Intraoperative Sonografische Beurteilung Des Unteren Uterinsegmentes im Rahmen Der Re-Sectio Caesarea - Eine Ultraschall- Methoden-Vergleichsstudie|Completed||N/A|30|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||1||f||||f||||||||No||2017-10-10 22:00:46.371872|2017-10-10 22:00:46.371872
NCT02827591|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-01-04|||February 2015||2015-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|QUANTUSLUS||Assessing the Stability of Uterine Scar Tissue in Women With Previous History of Caesarean Section Using Multimodal Analyses of the Lower Uterine Segment Including Quantitative Sonography|Multimodale Beurteilung Der Stabilität Von Uterusnarbengewebe Bei Z.n. Sectio Caesarea|Completed||N/A|30|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||1||f||||f||||||Samples Without DNA|"     Scar tissue is placed in formalin and embedded in paraffin.   "|No||2017-10-10 22:00:46.43817|2017-10-10 22:00:46.43817
NCT02827578|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-11|||January 2016||2016-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia|Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia : a Randomized, Double Blinded, Parallel Design, Active Controlled, Multi-center, Phase 3 Clinical Trial|Recruiting||Phase 3|588|Anticipated|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||No||2017-10-10 22:00:46.501097|2017-10-10 22:00:46.501097
NCT02827565|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-04-27|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|CircuLOR-1||Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer|Prospective Study of Technical Optimization of the Detection of KRAS Mutations, BRAF and NRAS by Next Generation Sequencing on Tumor DNA Circulating in Metastatic Colorectal Cancer.|Recruiting||N/A|30|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 22:00:46.585072|2017-10-10 22:00:46.585072
NCT02827552|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-12-05|||January 2017||2017-01-01|December 2016|2016-12-01|January 2033|Anticipated|2033-01-01|January 2019|Anticipated|2019-01-01||Interventional|ARPEGE BioM||Description of Individual Radiosensitivity With Molecular Biomarkers in a Pediatric Oncology Population|Integrative Molecular Analysis of Individual Radiosensitivity Among a Population of Pediatric Patients Treated With Radiation in Eastern France.|Not yet recruiting||N/A|173|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 22:00:46.760937|2017-10-10 22:00:46.760937
NCT02827539|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-15|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Prospective Study of LessRay Enhanced Versus Standard Fluoroscopic Visualization in Surgical Placement of Spinal Cord Stimulator|A Prospective, Randomized Study of LessRay Enhanced Versus Standard Fluoroscopic Visualization in Surgical Placement of Spinal Cord Stimulator Epidural Array|Not yet recruiting||N/A|65|Anticipated|Duke University||2|||f||||f|f|t|f|f|f|||||2017-10-10 22:00:46.884909|2017-10-10 22:00:46.884909
NCT02827526|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-14|||July 2016||2016-07-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||Methadone and Ketamine for Spinal Surgery|Methadone and Ketamine for Spinal Surgery|Recruiting||Phase 4|140|Anticipated|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||No||2017-10-10 22:00:46.979475|2017-10-10 22:00:46.979475
NCT02827513|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-06|||December 2015||2015-12-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects|A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) (Formerly Called EB-1020) in Young Healthy Subjects|Terminated||Phase 1|16|Actual|Euthymics BioScience, Inc.||4|||f||||f||||||||||2017-10-10 22:00:47.077592|2017-10-10 22:00:47.077592
NCT02827500|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-08-31|||July 2016||2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|PRIME-HF||Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)|Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)|Recruiting||Phase 4|450|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 22:00:47.182077|2017-10-10 22:00:47.182077
NCT02827487|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-05-05|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|IUD||Tramadol Versus Celecoxib in Reducing Pain Associated With IUD Insertion|Tramadol Versus Celecoxib in Reducing Pain Associated With IUD Insertion: A Double Blind Placebo Controlled Trial|Recruiting||Phase 4|210|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 22:00:47.397828|2017-10-10 22:00:47.397828
NCT02827474|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-07-20|||July 2016||2016-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||We Experience: Perspectives on a Quality Abortion Care Experience: A Patient Centered Approach|Perspectives on a Quality Abortion Care Experience: A Patient Centered Approach|Active, not recruiting||N/A|35|Anticipated|University of New Mexico|||2||f||||||||||||||2017-10-10 22:00:47.514022|2017-10-10 22:00:47.514022
NCT02827461|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-07|||September 2003||2003-09-01|July 2016|2016-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Heritability of Sleep Homeostasis in Twins|Heritability of Sleep Homeostasis in Twins|Completed||N/A|240|Actual|University of Pennsylvania|||2||f||||t||||||Samples With DNA|"     Blood and DNA samples will be identified by a bar-coding system. This will only be able to be     matched to the subject ID using a secure computer database to which only the Principal     Investigator will have access.   "|||2017-10-10 22:00:47.589504|2017-10-10 22:00:47.589504
NCT02827448|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-06-09|||November 2015||2015-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies|Urinary Cell Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury Following Advanced Cardiac Replacement Therapies|Recruiting||N/A|300|Anticipated|Baylor Research Institute|||1||f||||f||||||||||2017-10-10 22:00:47.647725|2017-10-10 22:00:47.647725
NCT02827435|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-04-24|||July 2016||2016-07-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|May 28, 2017|Anticipated|2017-05-28||Interventional|||Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft|Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft During Kidney Transplantation|Recruiting||N/A|12|Anticipated|Seoul National University Hospital||1|||f||||f||||||||No||2017-10-10 22:00:47.755609|2017-10-10 22:00:47.755609
NCT02827422|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-10-19|||October 2015||2015-10-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|6 Months|Observational [Patient Registry]|||A Prospective, Multicenter Registry With Targeted Temperature Management After Out-of-hospital Cardiac Arrest in Korea|A Prospective, Multicenter Registry With Targeted Temperature Management After Out-of-hospital Cardiac Arrest in Korea|Recruiting||N/A|1800|Anticipated|Seoul St. Mary's Hospital|||1||f||||f||||||||No||2017-10-10 22:00:47.853201|2017-10-10 22:00:47.853201
NCT02827409|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-06-07|||July 2016||2016-07-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|Term-NRIC||Short-Delay Cord Clamping Compared to Extended- Delay Cord Clamping in Term Neonates That Require Resuscitation.|A Randomized Controlled Trial of Short-Delay Cord Clamping as Compared to Extended- Delayed Cord Clamping in Term Neonates That Require Resuscitation.|Completed||N/A|60|Actual|Sharp HealthCare||2|||f||||f||||||||No|small pilot study of term infants|2017-10-10 22:00:47.961791|2017-10-10 22:00:47.961791
NCT02827396|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-07-06|||December 2014||2014-12-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|July 2015|Actual|2015-07-01||Interventional|PSI||Effectiveness of a Training Intervention on Mental Health of Parents for Intellectually Disabled Children in Malawi|A Mixed Methods Study to Design and Test Effectiveness of a Psycho-social Training Intervention on Psychological Health of Parents for Intellectually Disabled Children in Malawi|Completed||N/A|170|Actual|St John of God, Malawi||2|||f||||t||||||||Yes|Yes|2017-10-10 22:00:48.056589|2017-10-10 22:00:48.056589
NCT02827383|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Pilot Stair Climbing Study|Pilot Study to Test the Effect of Fractionalized Vigorous-Intensity Activity on Acute Glucose in Adults at Risk for Type 2 Diabetes|Completed||N/A|10|Actual|University of Georgia||2|||f||||f||||||||Undecided|It is the investigator's intent to make data available after publication of the primary research questions. The method by which data will be made available is yet to be determined.|2017-10-10 22:00:48.134799|2017-10-10 22:00:48.134799
NCT02827370|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-05-17|||June 16, 2016|Actual|2016-06-16|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|November 2020|Anticipated|2020-11-01||Interventional|||CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer|CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer|Recruiting||N/A|45|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 22:00:48.210922|2017-10-10 22:00:48.210922
NCT02827357|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-07|||March 2013||2013-03-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation|Review of Responses to Systemic Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation|Completed||N/A|101|Actual|University Hospital, Toulouse|||1||f||||f||||||||No||2017-10-10 22:00:48.307454|2017-10-10 22:00:48.307454
NCT02827344|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-06|||October 2015||2015-10-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|IMMUNO-PREDICT||PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer|Feasibility Study of PD-L1 Expression Analysis on Circulating Tumor Cells by Immunocytochemistry and MDSCs Level Evolution Analysis in Non-small Cell Lung Cancer Treated With PD-L1 or PD1 Inhibitor|Recruiting||N/A|51|Anticipated|University Hospital, Toulouse|||1||f||||f||||||Samples With DNA|"     -  Peripheral blood sample        -  Circulating tumor cells isolated from peripheral blood sample        -  MDSCs : immature myeloid cells that inhibit T cell functions rate analysis from          peripheral blood sample        -  Tissue   "|No||2017-10-10 22:00:48.376087|2017-10-10 22:00:48.376087
NCT02827331|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-09-02|||September 2014||2014-09-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Taking Account of Inobservable Periods in Longitudinal Drug Treatment Follow-up|Taking Account of Inobservable Periods in Longitudinal Drug Treatment Follow-up|Completed||N/A|171861|Actual|University Hospital, Toulouse|||3||f||||t||||||||No||2017-10-10 22:00:48.468193|2017-10-10 22:00:48.468193
NCT02826941|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-07-05|||June 1999||1999-06-01|July 2016|2016-07-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Moderate Hypothermia in Neonatal Hypoxic Ischemic Encephalopathy|Moderate Hypothermia in Neonatal Hypoxic Ischemic Encephalopathy|Completed||Phase 2|65|Actual|Medical University of South Carolina||2|||f||||t||||||||Yes|upon request|2017-10-10 22:00:51.764815|2017-10-10 22:00:51.764815
NCT02827318|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-05|||September 2015||2015-09-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Eating Disinhibition and Vagal Tone and the Postprandial Response to Glycaemic Load|Eating Disinhibition and Vagal Tone Moderate the Postprandial Response to Glycaemic Load: A Randomised Controlled Trial|Completed||N/A|66|Actual|Swansea University||3|||f||||f||||||||||2017-10-10 22:00:48.549751|2017-10-10 22:00:48.549751
NCT02827305|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-07-07|||August 2015||2015-08-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Centella Asiatica (Gotukola) Mouthwash as an Adjunct to Mechanical Plaque Control|Clinical Evaluation of the Centella Asiatica (Gotukola) Mouthwash as an Adjunct to Mechanical Plaque Control: A RCT|Completed||Phase 1|36|Actual|Sri Hasanamba Dental College and Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:00:48.626439|2017-10-10 22:00:48.626439
NCT02827292|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-04-28|||March 2016||2016-03-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Music on Inflammatory Response During Laparoscopic Surgery|Effects of Peroperative Music on the Biomolecular Inflammatory Response In Laparoscopic Surgery: A Triple Blind Randomized Control Study|Recruiting||N/A|40|Anticipated|Sir Ganga Ram Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:00:48.706628|2017-10-10 22:00:48.706628
NCT02827279|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-30|||March 2013||2013-03-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|VisioTED||Study of the Visual Perception During Emotional States on Subjects With an Intrusive Disorder of the Development|Study of the Strategies of Visual Perception of Social Scenes During Emotional States Induced to Subjects With an Intrusive Disorder of the Development: Pilot Study|Recruiting||N/A|50|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 22:00:48.798672|2017-10-10 22:00:48.798672
NCT02827266|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-07-05|||October 2005||2005-10-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis|NADIR: Multicentre, Open-Label Trial Evaluating a Simple NeoRecormon Regimen in Anemic Patients With Diabetes and Chronic Kidney Disease (Stage 2 to 5) Who Are Not on Dialysis|Completed||Phase 3|122|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:00:48.879878|2017-10-10 22:00:48.879878
NCT02827253|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-09|||June 2016||2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|KIDBRAIN||Morphological Changes of the Brain by MRI in Chronic Kidney Disease|Cohort Study of Morphological Changes of the Brain by MRI in Chronic Kidney Disease Patients|Recruiting||N/A|100|Anticipated|Hospital General Universitario Gregorio Marañon|||2||f||||t||||||||||2017-10-10 22:00:49.064137|2017-10-10 22:00:49.064137
NCT02827240|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-12-20|||August 2016||2016-08-01|December 2016|2016-12-01||||February 2017|Anticipated|2017-02-01||Interventional|ZEST||Zambian Peer-Educators for HIV Self-Testing Study|A Peer Educator-delivered HIV Self-testing Intervention for Female Sex Workers in Zambian Border Towns|Active, not recruiting||N/A|965|Actual|Harvard School of Public Health||3|||f||||f||||||||Yes|De-identified data will be made available via International Initiative for Impact Evaluation's public access data repository.|2017-10-10 22:00:49.153275|2017-10-10 22:00:49.153275
NCT02827227|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-11|||January 2014||2014-01-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|PRIMIMMUNO||Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)|Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)|Completed||N/A|99|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:00:49.43249|2017-10-10 22:00:49.43249
NCT02827214|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-15|||October 2016||2016-10-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|||Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment|Thoracolumbar Burst Fractures (AOSpine A3, A4) in Neurologically Intact Patients: An Observational, Multicenter Cohort Study Comparing Surgical Versus Non-surgical Treatment|Recruiting||N/A|208|Anticipated|AO Clinical Investigation and Documentation|||2||f||||f||||||||||2017-10-10 22:00:49.531517|2017-10-10 22:00:49.531517
NCT02827201|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-02-20|||November 2015||2015-11-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|FIRGEMAX||FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine|Phase II Randomised Multicenter Trial Evaluating a Sequential Treatment With Nab-paclitaxel+Gemcitabine /FOLFIRI.3 vs Nab-paclitaxel + Gemcitabine in First Line Metastatic Pancreatic Cancer|Active, not recruiting||Phase 2|127|Actual|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||Undecided||2017-10-10 22:00:49.715246|2017-10-10 22:00:49.715246
NCT02827188|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-14|||June 2016||2016-06-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CRAFT||Cognitive Restructuring in ADHD: Functional Training|Cognitive Restructuring in ADHD: Functional Training|Recruiting||N/A|50|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||Yes|de-identified data will be shared with our sponsor/funders- Ontario Brain Institute and ehave.|2017-10-10 22:00:49.942388|2017-10-10 22:00:49.942388
NCT02827175|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-06|||January 2014||2014-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Evaluation of the Effectiveness of a Diagnostic Kit in the Etiological Diagnosis of Fevers of the Traveler|Evaluation of the Effectiveness of a Diagnostic Kit in the Etiological Diagnosis of Fevers of the Traveler|Recruiting||N/A|165|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 22:00:50.078045|2017-10-10 22:00:50.078045
NCT02827162|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-06-28|||March 29, 2016|Actual|2016-03-29|June 2017|2017-06-01|April 27, 2016|Actual|2016-04-27|April 27, 2016|Actual|2016-04-27||Observational|||Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine|Association of Host Genetics With Vaccine Efficacy, and Evaluation of Immune Correlates of Risk From the First Proof of Concept Efficacy Study With a Tetravalent Dengue Vaccine|Completed||N/A|364|Actual|Sanofi|||4||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available the investigators continue to protect the privacy of the participants in the clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 22:00:50.179788|2017-10-10 22:00:50.179788
NCT02827149|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01|2 Years|Observational [Patient Registry]|GITMO-HLA-HR||High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT|High Resolution Donor Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: the Italian Experience|Not yet recruiting||N/A|2000|Anticipated|Gruppo Italiano Trapianto di Midollo Osseo|||1||f||||t||||||||||2017-10-10 22:00:50.281531|2017-10-10 22:00:50.281531
NCT02827136|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-07|||October 2016||2016-10-01|July 2016|2016-07-01||||February 2018|Anticipated|2018-02-01||Interventional|||Effect of Lidocaine Patch for Shoulder Pain in Laparoscopic Cholecystectomy||Not yet recruiting||N/A|64|Anticipated|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 22:00:50.490728|2017-10-10 22:00:50.490728
NCT02827123|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-10-11|||July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Comparison of McGrath MAC Videolaryngoscopy and Macintosh Laryngoscopy for Orotracheal Intubation in Children||Completed||N/A|84|Actual|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 22:00:50.59718|2017-10-10 22:00:50.59718
NCT02827110|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-26|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Tracheal Intubation in Patient With Semi-rigid Collar Immobilization of the Cervical Spine: A Comparison of Fiberoptic Bronchoscope Assisted With Pentax-airway Scope and Fiberoptic Bronchoscope Alone||Completed||N/A|90|Actual|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 22:00:50.676603|2017-10-10 22:00:50.676603
NCT02827097|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-07|||October 2016||2016-10-01|July 2016|2016-07-01||||February 2018|Anticipated|2018-02-01||Interventional|||The Effect of Rectus Sheath Block on the Postoperative Analgesia in the Patients Undergoing Robotic Single Port Cholecystectomy||Not yet recruiting||N/A|62|Anticipated|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 22:00:50.760413|2017-10-10 22:00:50.760413
NCT02827084|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-14|||May 2016||2016-05-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effects of Kinesio Taping in Patellofemoral Pain|Effects of Kinesio Taping in Painful and Neuromuscular Performance of Patients With Patellofemoral Pain|Recruiting||N/A|54|Anticipated|Universidade Federal do Rio Grande do Norte||3|||f||||f||||||||||2017-10-10 22:00:50.833891|2017-10-10 22:00:50.833891
NCT02827071|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-07|||July 2016||2016-07-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Observational|||Ocular Imaging Study Using Advanced OCT|Ocular Imaging Study Using Advanced OCT|Recruiting||N/A|1000|Anticipated|University of California, Los Angeles|||1||f||||f||||||||No||2017-10-10 22:00:50.914883|2017-10-10 22:00:50.914883
NCT02827058|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-09-21|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||The Influence of Needle Diameter on Post Dural Puncture Headache|The Influence of Needle Diameter on Needle Failures and Post Dural Puncture Headache in Relation to Cesarean Section and Vaginal Delivery; a Prospective, Randomised Trial|Recruiting||N/A|900|Anticipated|Central Norway Regional Health Authority||2|||f||||f|f|f||||||||2017-10-10 22:00:50.991568|2017-10-10 22:00:50.991568
NCT02827045|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-07|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|BDmarker||Study of a Vestibular Biomarker of Phase in Bipolar Disorder|Exploratory Study of a Vestibular Biomarker of Phase in Bipolar Disorder|Enrolling by invitation||N/A|24|Anticipated|Vest Brain,Centro de Estudios Neurovestibulares|||4||f||||t||||||||No||2017-10-10 22:00:51.084251|2017-10-10 22:00:51.084251
NCT02827032|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-29|||June 2016||2016-06-01|March 2017|2017-03-01|June 2022|Anticipated|2022-06-01|December 2017|Anticipated|2017-12-01||Interventional|CALM-DIEM||Controlling and Lowering Blood Pressure With the MobiusHD™|Controlling and Lowering Blood Pressure With the MobiusHD™ - Defining Efficacy Markers|Recruiting||N/A|200|Anticipated|Vascular Dynamics, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:00:51.154286|2017-10-10 22:00:51.154286
NCT02827019|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-07|||January 2015||2015-01-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|EPAVM||NEWBORN IN HEALTHY BIRTH ROOM: ASSESSMENT OF PRACTICAL HOME AND MOTHER LIVED|NEWBORN IN HEALTHY BIRTH ROOM: ASSESSMENT OF PRACTICAL HOME AND MOTHER LIVED|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 22:00:51.295528|2017-10-10 22:00:51.295528
NCT02827006|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-05|||January 2007||2007-01-01|July 2016|2016-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||CaP Cement is Equivalent to Iliac Bone Graft in Filling of Large Metaphyseal Defects|CaP Cement is Equivalent to Iliac Bone Graft in Filling of Large Metaphyseal Defects: A 2 Year Prospective Randomised Study on Distal Radius Osteotomies|Completed||Phase 4|20|Actual|Oslo University Hospital||2|||f||||t||||||||Yes||2017-10-10 22:00:51.359744|2017-10-10 22:00:51.359744
NCT02826993|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-07-07|||June 2016||2016-06-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|CfC100||Patients With Incomplete Colonoscopy a Comparison of Colon Capsule Endoscopy and CT Colonography|Can Colon Capsule Endoscopy Substitute CT Colonography in the Large Bowel Examination of Persons Whose Colonoscopy Was Incomplete?|Recruiting||N/A|100|Anticipated|Odense University Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:00:51.428055|2017-10-10 22:00:51.428055
NCT02826980|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-07|||November 2015||2015-11-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|ENDOMETRIOS||Observational Study Rheumatological Manifestations Associated With Endometriosis|Observational Study Rheumatological Manifestations Associated With Endometriosis|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 22:00:51.507478|2017-10-10 22:00:51.507478
NCT02826967|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-03-10|||June 2016||2016-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Feasibility and Effectiveness of Colonic Irrigation|Feasibility and Effectiveness of Colonic Irrigation as a Non-oral, Same-day Bowel Preparation Option in Patients Undergoing Screening or Surveillance Colonoscopy|Active, not recruiting||N/A|50|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 22:00:51.589125|2017-10-10 22:00:51.589125
NCT02826954|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-01-09|||February 2016||2016-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|COPD||The Nasal Airway in Chronic Obstructive Pulmonary Disease|The Nasal Airway in Chronic Obstructive Pulmonary Disease|Recruiting||N/A|200|Anticipated|Norwegian University of Science and Technology|||2||f||||f||||||Samples With DNA|"     Nasal airway epithelial cells will be collected by the use of a nasal brush, and stored in a     biobank.   "|No|Biobank 1|2017-10-10 22:00:51.66844|2017-10-10 22:00:51.66844
NCT02826928|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-09-06|||September 2016||2016-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors|Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors|Not yet recruiting||N/A|120|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 22:00:51.850629|2017-10-10 22:00:51.850629
NCT02826915|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-12-02|||November 2009||2009-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|AEHCEE||Electro- Hemodynamic Activity in Children: Combined Analysis by Video -EEG Spectroscopy and Near-infrared (NIRS )|Electro- Hemodynamic Activity in Children: Combined Analysis by Video -EEG Spectroscopy and Near-infrared (NIRS )|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:00:51.93699|2017-10-10 22:00:51.93699
NCT02826902|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-12-07|||July 2016||2016-07-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Anesthesia on Quality of Recovery in Patients Undergoing Cosmetic Lower Limb Lengthening - A Randomized Controlled Trial||Recruiting||N/A|76|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:00:52.01158|2017-10-10 22:00:52.01158
NCT02826889|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2017-09-28|||May 24, 2016|Actual|2016-05-24|September 2017|2017-09-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Interventional|||Assessing the Diagnostic Accuracy of Corrected Flow Time (FTc) and Pleth Variability Index (PVI) as Predictors of Fluid Responsiveness in Patients in the Prone Position Using the Jackson Table||Completed||N/A|58|Actual|Yonsei University||1|||f||||f||||||||||2017-10-10 22:00:52.095452|2017-10-10 22:00:52.095452
NCT02826876|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-07-05|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Efficacy of Surgical Site Treatment With Ropivacaine in Laparoscopic Surgery|Local Analgesia in Laparoscopic Surgery|Not yet recruiting||N/A|100|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||f||||||||||2017-10-10 22:00:52.189096|2017-10-10 22:00:52.189096
NCT02826863|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-07-03|||June 2016||2016-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome|A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome|Recruiting||Phase 3|130|Anticipated|Zogenix, Inc.||3|||f||||t||||||||||2017-10-10 22:00:52.282517|2017-10-10 22:00:52.282517
NCT02826850|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-07|||September 2016||2016-09-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|SAPHENERO||Saphenous Nerve Radiofrequency for Knee Osteoarthritis Trial|Comparative Study of Neurotomy by Radiofrequency of Genicular Nerves, Guided by Fluoroscopy, and Neurotomy by Radiofrequency of Saphenous Nerve, Guided by Ultrasound, for the Treatment of Chronic Knee Pain in Patients With Osteoarthritis .|Not yet recruiting||Phase 3|20|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Yes||2017-10-10 22:00:52.413551|2017-10-10 22:00:52.413551
NCT02826837|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-24|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||LEAC-102 for Advanced Colorectal Cancer|A Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and Efficacy of LEAC-102 in Combination With FOLFOX + Bevacizumab/Cetuximab in Subjects With Advanced Colorectal Cancer|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Taiwan Leader Biotech Corp.||1|||f||||t|t|f||||||||2017-10-10 22:00:52.497004|2017-10-10 22:00:52.497004
NCT02826824|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-05-19|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||BECOME CHILDREN OF HOLDERS Corpus Callosum Agenesis Screened IN PERIOD Antenatal|BECOME CHILDREN OF HOLDERS Corpus Callosum Agenesis Screened IN PERIOD Antenatal|Recruiting||N/A|60|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:00:52.565771|2017-10-10 22:00:52.565771
NCT02826811|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-01-05|||July 2016||2016-07-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK|Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK|Recruiting||N/A|170|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:00:52.631607|2017-10-10 22:00:52.631607
NCT02826798|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-05|||June 2016||2016-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults|A Phase 1 Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Candidate Human Cytomegalovirus Vaccine (VBI-1501) in Healthy Adults|Recruiting||Phase 1|125|Anticipated|VBI Vaccines Inc.||5|||f||||t||||||||Yes||2017-10-10 22:00:52.704232|2017-10-10 22:00:52.704232
NCT02826785|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-11-03|||May 2014||2014-05-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|FOCI-PD||Feasibility and Optimization of a Cognitive Intervention for Parkinson Disease|Feasibility and Optimization of a Cognitive Intervention for Parkinson Disease|Completed||N/A|8|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 22:00:52.965789|2017-10-10 22:00:52.965789
NCT02826772|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-02-28|||February 2016||2016-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer|A Phase 1/2, Multi-Center, Open-Label, Two-Stage Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GT0918 in Subjects With Metastatic Castrate Resistant Prostate Cancer (mCRPC)|Recruiting||Phase 1/Phase 2|93|Anticipated|Suzhou Kintor Pharmaceutical Inc,||2|||f||||f||||||||No||2017-10-10 22:00:53.059998|2017-10-10 22:00:53.059998
NCT02826759|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-06|2016-07-07|||July 2016||2016-07-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Serum Sphingolipidomic Analyses in Healthy, Diabetic and Prediabetic Subjects|Comparison of Serum Sphingolipidomic Analyses in Healthy, Pre-diabetic and Diabetic Subjects|Not yet recruiting||N/A|200|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||5||f||||f||||||Samples Without DNA|"     serum samples are used to test the concentration of sphingolipid metabolites ( ceramide,     sphingosine, sphingosine-1-phosphate, sphinganine, sphinganine-1-phosphate) by mass     spectrometry   "|||2017-10-10 22:00:53.202753|2017-10-10 22:00:53.202753
NCT02826733|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-12-02|||September 2008||2008-09-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|HEMISPHERENOR||Evaluation of the Implementation of the Hemispheric Dominance During Development|Evaluation of the Implementation of the Hemispheric Dominance During Development : Electrometabolic and Hemodynamics Study in the Newborn Born Premature or Term|Active, not recruiting||N/A|40|Actual|Centre Hospitalier Universitaire, Amiens|||2||f||||||||||||||2017-10-10 22:00:53.424007|2017-10-10 22:00:53.424007
NCT02826720|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-05|||January 2014||2014-01-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Observational|||Is There a Relationship Between Hyperlipidemia and Periodontitis?|Is There a Relationship Between Hyperlipidemia and Periodontitis?|Completed||N/A|160|Actual|Marmara University|||4||f||||||||||||||2017-10-10 22:00:53.529829|2017-10-10 22:00:53.529829
NCT02826707|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-03-06|||October 2016||2016-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|SPPAC||Evaluation of a Smartphone-delivered Peer-led Physical Activity Counselling Program for Manual Wheelchair Users|Feasibility Evaluation of a Smartphone-delivered Peer-led Physical Activity Counselling Program for Improving Physical Activity in Manual Wheelchair Users|Recruiting||N/A|40|Anticipated|Laval University||2|||f||||f||||||||No||2017-10-10 22:00:53.634198|2017-10-10 22:00:53.634198
NCT02826694|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-09-13|||June 2016||2016-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|NC_NEXUS||North Carolina Newborn Exome Sequencing for Universal Screening|North Carolina Newborn Exome Sequencing for Universal Screening|Recruiting||N/A|400|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 22:00:53.751654|2017-10-10 22:00:53.751654
NCT02826681|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-07-05|||May 24, 2017|Actual|2017-05-24|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia|Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in Restless Legs Syndrome Patients With Iron-deficiency Anemia|Recruiting||Phase 2|70|Anticipated|Luitpold Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 22:00:53.867817|2017-10-10 22:00:53.867817
NCT02826668|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2016-07-07|||June 2014||2014-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Influence of Lumbar Ultrasound on Resident Learning Curve for Lateral Labor Epidural Placement|Pre-insertion Ultrasound Guidance for Labor Epidural Placement in the Lateral Position: A Randomized Controlled Trial of Image Reproducibility During Labor and Impact on Resident Learning Curve|Recruiting||N/A|64|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 22:00:53.989213|2017-10-10 22:00:53.989213
NCT02826655|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-07-25|||June 2016||2016-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Adaptive Optics for Ophthalmic Technologies|Adaptive Optics for Ophthalmic Technologies|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:00:54.128879|2017-10-10 22:00:54.128879
NCT02826642|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-11-29|||August 2016||2016-08-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia|A Phase I, Open Label, Multicenter, Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia|Suspended||Phase 1|88|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 22:00:54.237242|2017-10-10 22:00:54.237242
NCT02826629|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-07-05|||July 2016||2016-07-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|MADOCS||"Manual Dexterity and Oculomotor Control in Schizophrenia"|"MADOCS: Manual Dexterity and Oculomotor Control as Vulnerability Markers in Schizophrenia"|Not yet recruiting||N/A|105|Anticipated|Centre Hospitalier St Anne||4|||f||||f||||||||No||2017-10-10 22:00:54.337864|2017-10-10 22:00:54.337864
NCT02826616|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-05|||July 2016||2016-07-01|July 2016|2016-07-01||||August 2017|Anticipated|2017-08-01||Interventional|||Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial Infarction|Chinese People's Liberation Army General Hospital|Enrolling by invitation||N/A|240|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 22:00:54.490584|2017-10-10 22:00:54.490584
NCT02826590|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-10-02|||June 2016||2016-06-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||The Effects of Spinal Mobilizations on Symptoms, Neck 3D Movement, Neck Muscle Electromyography and Sympathetic Nervous System Activity in People With Neck Pain||Completed||N/A|40|Actual|King's College London||2|||f||||t||||||||||2017-10-10 22:00:54.989193|2017-10-10 22:00:54.989193
NCT02826577|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-05-10|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Effects of Pregnenolone on Perceived Social Isolation|Effects of Pregnenolone on Perceived Social Isolation: A Double-blind Randomized Electrical Neuroimaging Study|Recruiting||Phase 2|96|Anticipated|University of Chicago||4|||f||||f|t|f||||||No||2017-10-10 22:00:55.085676|2017-10-10 22:00:55.085676
NCT02826564|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-10-06|||June 2016||2016-06-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer|Phase I Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer|Recruiting||Phase 1|20|Anticipated|University Hospital, Ghent||2|||f||||||||||||||2017-10-10 22:00:55.176067|2017-10-10 22:00:55.176067
NCT02822300|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-05|||November 2015||2015-11-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:39.298196|2017-10-10 22:01:39.298196
NCT02826538|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-06-07|||June 30, 2017|Anticipated|2017-06-30|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||3D Geplante Osteosynthesen Mit Patientenspezifischen Zielvorrichtungen|Evaluation Der Intraoperativen Umsetzung Von 3D Geplanten Osteosynthesen Mit Patientenspezifischen Zielvorrichtungen Durch Eine Quantitative Postoperative Erfolgskontrolle|Not yet recruiting||N/A|320|Anticipated|Balgrist University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 22:00:56.074743|2017-10-10 22:00:56.074743
NCT02826525|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-23|||July 18, 2016|Actual|2016-07-18|August 2017|2017-08-01|December 12, 2017|Anticipated|2017-12-12|December 12, 2017|Anticipated|2017-12-12||Interventional|||AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.|Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4076 Following Multiple Ascending Dose Administration to T2DM Subjects With Non-Alcoholic Fatty Liver Disease|Active, not recruiting||Phase 1/Phase 2|14|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:00:56.151446|2017-10-10 22:00:56.151446
NCT02826512|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients|A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients: the ABC Study|Not yet recruiting||Phase 2|39|Anticipated|The Netherlands Cancer Institute||1|||f||||t|f|f||||||||2017-10-10 22:00:56.236019|2017-10-10 22:00:56.236019
NCT02826499|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-27|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Comparison of the Malposition Rates of the Vertebral Pedicle Screws Using the PediGuard Technique: PediGuard Technique Associated With Fluoroscopy and Fluoroscopy Alone|Comparison of the Malposition Rates of the Vertebral Pedicle Screws Using the PediGuard Technique: PediGuard Technique Associated With Fluoroscopy and Fluoroscopy Alone|Completed||N/A|20|Actual|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:00:56.318408|2017-10-10 22:00:56.318408
NCT02826486|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-05-29|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|COMBAT||Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202)|A Phase II, Multicenter, Open-label Single Arm Study to Assess the Safety and Efficacy of the Combination of BL-8040 and Pembrolizumab in Patients With Metastatic Pancreatic Cancer, the COMBAT Study|Recruiting||Phase 2|30|Anticipated|BioLineRx, Ltd.||1|||f||||t||||||||||2017-10-10 22:00:56.433169|2017-10-10 22:00:56.433169
NCT02826473|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-31|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|FCTI||Focused Cognitive Testing in Inpatients|Analysis of Clinical- and Cost-effectiveness of Focused Cognitive Testing in Elective Inpatients|Recruiting||N/A|500|Anticipated|Luzerner Kantonsspital||2|||f||||f|f|f||||||||2017-10-10 22:00:56.565266|2017-10-10 22:00:56.565266
NCT02826460|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-05|||November 2014||2014-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Psychosocial Risks in Liver Transplant Recipients|Psychosocial Predictors of Posttransplant Adherence and Outcomes|Completed||N/A|200|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||||No||2017-10-10 22:00:56.650579|2017-10-10 22:00:56.650579
NCT02826447|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-04-07|||February 21, 2017|Actual|2017-02-21|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|2 Weeks|Observational [Patient Registry]|IMMHoTHep||Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C|ANRS 12320 IMMHoTHep : Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C|Recruiting||N/A|550|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||2||f||||f||||||Samples With DNA|"     Blood sample (5mL)   "|||2017-10-10 22:00:56.720874|2017-10-10 22:00:56.720874
NCT02826434|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-09-28|||August 2016||2016-08-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer|A Phase 1b Study of Safety and Immune Response to PVX-410 Vaccine Alone and in Combination With Durvalumab in Human Leukocyte Antigen (HLA)-A2+ Subjects Following Standard Treatment of Stage II or III Triple Negative Breast Cancer|Recruiting||Phase 1|20|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:00:56.808103|2017-10-10 22:00:56.808103
NCT02826421|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-07-27|2017-06-30||July 4, 2016|Actual|2016-07-04|July 2017|2017-07-01|November 29, 2016|Actual|2016-11-29|November 29, 2016|Actual|2016-11-29||Interventional||This analysis population includes all randomized subjects whose cataract surgery procedure was completed (Full Analysis Set).|Clinical Investigation of Corneal Incision Size After Intraocular Lens (IOL) Implantation|Clinical Investigation of Corneal Incision Size After IOL Implantation With Preloaded Delivery Devices and a Manual Delivery Device|Completed||N/A|114|Actual|Alcon Research||4|||f||||f|f|t|f|f|t|||||2017-10-10 22:00:56.922969|2017-10-10 22:00:56.922969
NCT02826408|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-01-08|||October 2016||2016-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Proton Pump Inhibitors on Palpitations|A Randomized Placebo Controlled Trial on the Effect of Proton Pump Inhibitors on Palpitations With no Apparent Cause to Explain Such a Symptom|Recruiting||N/A|150|Anticipated|Jordan Collaborating Cardiology Group||2|||f||||f||||||||Undecided||2017-10-10 22:00:57.282261|2017-10-10 22:00:57.282261
NCT02826395|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-01-11||||||January 2017|2017-01-01||||||||Expanded Access|||C11 Sodium Acetate PET/CT Imaging of PCa|Carbon-11 Sodium Acetate PET/CT Imaging of Prostate Cancer|Available||N/A|||Jonsson Comprehensive Cancer Center|||||||||||||||||||2017-10-10 22:00:57.372575|2017-10-10 22:00:57.372575
NCT02826382|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-03|||September 20, 2016|Actual|2016-09-20|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041|A Preliminary Evaluation of Uptake in Bone Metastases, Biodistribution and Excretion of the Novel Radiotracer [68Ga]P15-041 by PET/CT|Recruiting||Early Phase 1|30|Anticipated|Five Eleven Pharma, Inc.||2|||f||||||||||||||2017-10-10 22:00:59.132233|2017-10-10 22:00:59.132233
NCT02826369|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-01-18|||March 2016||2016-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|COMPRIM||Use of Compressed Sensing in Breast MRI|Use of Compressed Sensing in Breast MRI|Completed||N/A|13|Actual|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 22:00:59.198888|2017-10-10 22:00:59.198888
NCT02826356|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-07|||February 2016||2016-02-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema|Efficient Treatments for ACE-I and ARB-induced Angioedema Exist and Should be Available to All Patients. Analysis of Their Availability and Influencing Factors in the Area Around Lyon, France|Completed||N/A|38|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:00:59.267575|2017-10-10 22:00:59.267575
NCT02826343|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-07-04|||May 2016||2016-05-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)|Xe129 Magnetic Resonance Imaging of the Lung: A New Technology to Assess Treatment for COPD|Recruiting||Early Phase 1|30|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-10 22:00:59.333372|2017-10-10 22:00:59.333372
NCT02826330|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-04|||March 2013||2013-03-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01|1 Year|Observational [Patient Registry]|MAGIC||Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease|Evidence of Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease: Family Studies and Relations With a Particular Genetic Profile and Serological. Comparison of Affected Individuals, Their Siblings and Healthy Controls.|Recruiting||N/A|240|Anticipated|University Hospital, Lille|||3||f||||f||||||Samples With DNA|"     Blood, saliva, stools   "|Undecided||2017-10-10 22:00:59.434014|2017-10-10 22:00:59.434014
NCT02826317|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-07|||January 2015||2015-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Observational|DN4-SFAR||Neuropathic Evaluation of Postoperative Pain|Evaluation du caractère Neuropathique Des Douleurs Post opératoires. Enquête 2 Jours : DN4-SFAR|Completed||N/A|800|Actual|Rennes University Hospital|||1||f||||f||||||||No||2017-10-10 22:00:59.565323|2017-10-10 22:00:59.565323
NCT02826304|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-07|||August 2014||2014-08-01|July 2016|2016-07-01|July 2016|Anticipated|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Vaginal Hysterectomy Versus Laparoscopically Assisted Vaginal Hysterectomy for Large Uteri|Vaginal Hysterectomy Versus Laparoscopically Assisted Hysterectomy for Large Uteri ( A Pilot Randomized Clinical Trial)|Active, not recruiting||N/A|50|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||No||2017-10-10 22:00:59.647797|2017-10-10 22:00:59.647797
NCT02826291|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-01-30|||March 2016||2016-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SLNM/OSNA||SLNM in Endometrial Cancer Combined With OSNA|Sentinel Lymph Node Mapping in Endometrial Cancer Patients Combined With One-step Nucleic Acid Amplification (OSNA)|Recruiting||N/A|31|Anticipated|Charles University, Czech Republic|||1||f||||f||||||Samples With DNA|"     Samples of the tissue homogenate will be retained and may be used for further testing.   "|No||2017-10-10 22:00:59.761707|2017-10-10 22:00:59.761707
NCT02826278|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-06|||October 2014||2014-10-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|VOGE||Genitalia and Androgen in New Born Girls|Study Protocol: Reference Values for External Genitalia and Androgen Blood Level in New Born Girls|Recruiting||N/A|180|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||No||2017-10-10 22:00:59.872663|2017-10-10 22:00:59.872663
NCT02826265|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-02-07|||January 2016||2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease|Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease|Recruiting||N/A|100|Anticipated|Universitätsmedizin Mannheim|||1||f||||t||||||||No||2017-10-10 22:01:00.076207|2017-10-10 22:01:00.076207
NCT02826252|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-03-14|||September 15, 2016|Actual|2016-09-15|March 2017|2017-03-01|January 24, 2017|Actual|2017-01-24|November 15, 2016|Actual|2016-11-15||Observational|VENTASWITCH||Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)|VENTASWITCH, Examination of Ventavis® (Iloprost) Inhalation Behavior Using the I-Neb® AAD® System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)|Completed||N/A|64|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:01:00.16902|2017-10-10 22:01:00.16902
NCT02826239|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-17|||February 2016||2016-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Evaluation of Postural Effects on Multiple-breath-washout Derived Lung Function Parameters|Evaluation of Postural Effects on Multiple-breath-washout Derived Lung Function Parameters|Recruiting||N/A|50|Anticipated|Universitätsmedizin Mannheim|||2||f||||t||||||||||2017-10-10 22:01:00.260292|2017-10-10 22:01:00.260292
NCT02826226|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-17|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Effect of Bronchodilatator Testing on Multiple-breath-washout (MBW) Derived Lung Function Parameters|Effect of Bronchodilatator Testing on Multiple-breath-washout (MBW) Derived Lung Function Parameters|Recruiting||N/A|50|Anticipated|Universitätsmedizin Mannheim|||1||f||||t||||||||||2017-10-10 22:01:00.344628|2017-10-10 22:01:00.344628
NCT02826213|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-05-23|||June 15, 2017|Anticipated|2017-06-15|January 2017|2017-01-01|May 15, 2020|Anticipated|2020-05-15|June 15, 2019|Anticipated|2019-06-15|1 Year|Observational [Patient Registry]|RENOMAP||Comparison of Two Techniques of Renal Pre-transplant Infusion on the Evolution of Renal Function in the Recipient|Comparison of Two Techniques of Renal Pre-transplant Infusion on the Evolution of Renal Function in the Recipient: Multicentre Randomized Trial|Not yet recruiting||N/A|280|Anticipated|University Hospital, Tours|||2||f||||f||||||||No||2017-10-10 22:01:00.436691|2017-10-10 22:01:00.436691
NCT02826200|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-01-16|||July 2016||2016-07-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|RETORIC||Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC)|Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography|Recruiting||Phase 4|200|Anticipated|Semmelweis University Heart and Vascular Center||2|||f||||t||||||||No||2017-10-10 22:01:00.564169|2017-10-10 22:01:00.564169
NCT02826187|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-05|||July 2014||2014-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||"Multicentric, Open Label With Retrospective Inclusion and Follow-up of Acetabular Prothetic Implant Polymax"|"Multicentric, Open Label With Retrospective Inclusion and 5 Years Prospective Follow-up of Acetabular Prothetic Implant Polymax"|Recruiting||N/A|180|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||Undecided||2017-10-10 22:01:00.668759|2017-10-10 22:01:00.668759
NCT02826161|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-07-07|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|CanStem43L||A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer|A Phase III Randomized, Open-Label Clinical Trial of BBI-608 Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer|Terminated||Phase 3|4|Actual|Boston Biomedical, Inc||2||Change of treatment landscape and evolving standard of care|f||||t||||||||||2017-10-10 22:01:00.884325|2017-10-10 22:01:00.884325
NCT02826148|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-05|||December 2011||2011-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|RAADS-R||Validation of the French Adaptation of the RAADS-R Scale : Scale of Asperger Syndrome Diagnosis|Validation of the French Adaptation of the Scale Aiding in the Diagnosis of the Autism Spectrum Disorders : Scale of Asperger Syndrome Diagnosis|Completed||N/A|324|Actual|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:01:00.983542|2017-10-10 22:01:00.983542
NCT02826135|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-06-15|||December 2, 2016|Actual|2016-12-02|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Prediction of Fluid Responsiveness in Children With Single Ventricle|Study on Prediction of Fluid Responsiveness Using an Abdominal Compression-Induced Change of Blood Pressure in Children With Bidirectional Cavopulmonary Shunt or Fontan Pathway|Recruiting||N/A|60|Anticipated|Seoul National University Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:01:01.048678|2017-10-10 22:01:01.048678
NCT02826122|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-12|||August 2016||2016-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Diastolic Dysfunction During Conservative Lifestyle Treatment|Prevalence of Diastolic Dysfunction and Effects of Conservative Lifestyle Treatment in Patients With Morbid Obesity|Recruiting||N/A|36|Anticipated|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 22:01:01.150389|2017-10-10 22:01:01.150389
NCT02826109|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-07-06|||June 2016||2016-06-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|May 2017|Anticipated|2017-05-01||Interventional|||The Efficacy of Cyanoacrylate Adhesive (PeriAcryl®90 HV) in Periodontal Wound Healing|The Efficacy of Cyanoacrylate (PeriAcryl®90 HV) in Its Adhesive Post-Operative Properties on Periodontal Wound Healing and Patient Discomfort After Non-Surgical Periodontal Treatment: A Pilot Randomized Clinical Trial|Not yet recruiting||Phase 4|20|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:01:01.338055|2017-10-10 22:01:01.338055
NCT02826096|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2016-07-07|||June 2016||2016-06-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Brief Version of Biofeedback Therapy for Panic Disorder|A Brief Version of Biofeedback Therapy for Panic Disorder|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:01:01.479896|2017-10-10 22:01:01.479896
NCT02826083|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-04|||November 2014||2014-11-01|June 2016|2016-06-01||||May 2018|Anticipated|2018-05-01||Interventional|XXS SYMPA||Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate Hyperlipidemia|Randomized, Double-blind Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate Hyperlipidemia and on Lipoprotein Kinetics|Recruiting||N/A|110|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:01:01.577806|2017-10-10 22:01:01.577806
NCT02826070|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-04|||April 2015||2015-04-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||EFFORT Further Extension Study|Efficacy of Long-term Telbivudine Treatment on Histological Improvements in Patients With Chronic Hepatitis B (EFFORT Further Extension Study)|Active, not recruiting||Phase 4|130|Actual|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:01:01.683095|2017-10-10 22:01:01.683095
NCT02826057|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-07-04|||February 2016||2016-02-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Complement Lectin Pathway After Cardiac Arrest|The Complement Lectin Pathway in Patients Resuscitated After Cardiac Arrest|Active, not recruiting||N/A|82|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-10 22:01:01.955897|2017-10-10 22:01:01.955897
NCT02826044|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-04|||July 2016||2016-07-01|April 2016|2016-04-01||||September 2016|Anticipated|2016-09-01||Interventional|||The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers|Pharmacokinetics,Safety and Tolerability Study Following Single and Multiple Dose of SP2086 in Healthy Volunteers|Not yet recruiting||Phase 1|30|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-10 22:01:02.102529|2017-10-10 22:01:02.102529
NCT02826031|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-05-03|||April 2016||2016-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|Artz||Clinical Study of Artz in the Treatment of Knee Osteoarthritis|A Multi-center, Randomized, Open-label, Parallel-arm Controlled Study Comparing Demand-based Monotherapy of Non-steroidal Anti-inflammatory Drug (NSAID) vs. Demand-based NSAID Combined With Sodium Hyaluronate Injection in the Treatment of Chinese Patients With Mild to Moderate Knee Osteoarthritis|Recruiting||Phase 4|300|Anticipated|Kunming Baker Norton Pharmaceutical Sales Co., Ltd.||2|||f||||||||||||||2017-10-10 22:01:02.235829|2017-10-10 22:01:02.235829
NCT02826018|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-08-04|||July 2016||2016-07-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection|A Phase 1/2, Randomized, Single-Blind, Placebo-Controlled, Single-Ascending and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetics, and Antiviral Efficacy Study of Subcutaneously Administered ALN-HBV in Healthy Adult Subjects and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection|Active, not recruiting||Phase 1/Phase 2|112|Anticipated|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:01:02.376443|2017-10-10 22:01:02.376443
NCT02826005|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.|Examination the Ability to Early Diagnose HCC|Enrolling by invitation||N/A|400|Anticipated|Ilex Medical||2|||f||||||||||||||2017-10-10 22:01:02.475516|2017-10-10 22:01:02.475516
NCT02825797|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-12-23|||June 2016||2016-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||3BNC117 and 10-1074 in HIV-infected Individuals|An Phase 1b Study of the Safety, Pharmacokinetics and Antiretroviral Activity of the Combination of 3BNC117 and 10-1074 in HIV-infected Individuals|Recruiting||Phase 1|37|Anticipated|Rockefeller University||5|||f||||t||||||||No||2017-10-10 22:01:04.061967|2017-10-10 22:01:04.061967
NCT02825979|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-06-09|||January 2017||2017-01-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|EARLY-AF||Early Aggressive Invasive Intervention for Atrial Fibrillation|Early Aggressive Invasive Intervention for Atrial Fibrillation|Recruiting||N/A|298|Anticipated|University of British Columbia||2|||f||||t||||||||Yes||2017-10-10 22:01:02.627014|2017-10-10 22:01:02.627014
NCT02825953|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-07-06|||January 2016||2016-01-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Does The Surfactant Administration by Aerosolization Effective?|Does The Surfactant Administration by Aerosolization of Respiratory Distress Syndrome Effective in Spontaneously Breathing Premature Infants ?|Active, not recruiting||N/A|75|Anticipated|Yuzuncu Yıl University||3|||f||||t||||||||||2017-10-10 22:01:02.824097|2017-10-10 22:01:02.824097
NCT02825940|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-05|2017-09-27|||August 4, 2016|Actual|2016-08-04|September 2017|2017-09-01|July 10, 2020|Anticipated|2020-07-10|May 28, 2018|Anticipated|2018-05-28||Interventional|IMYO29233||A Study to Assess Pharmacokinetics and Safety of Atezolizumab Administered Intravenously (IV) as a Single Agent or in Combination With Chemotherapy to Chinese Participants With Locally Advanced or Metastatic Solid Tumors|A Phase I, Open-Label Study to Assess the Pharmacokinetics and Safety of Atezolizumab Administered Intravenously as a Single Agent or in Combination With Chemotherapy to Chinese Patients With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|120|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:01:02.935939|2017-10-10 22:01:02.935939
NCT02825927|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-06|||October 2013||2013-10-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SOFIA||Swallowing Function, Oral Health, and Food Intake in Old Age|Swallowing Function, Oral Health, and Food Intake in Old Age|Recruiting||N/A|70|Anticipated|Umeå University||2|||f||||f||||||||No||2017-10-10 22:01:03.078511|2017-10-10 22:01:03.078511
NCT02825914|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-10-27|||September 2016||2016-09-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|August 2018|Anticipated|2018-08-01||Interventional|CAGLUCIM||CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)|CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM)|Recruiting||N/A|80|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 22:01:03.183689|2017-10-10 22:01:03.183689
NCT02825901|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-07-06|||July 2016||2016-07-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy Testing of Djulis-Buckwheat Drink on Cardiovascular Protection|Efficacy Testing of Djulis-Buckwheat Drink on Cardiovascular Protection|Not yet recruiting||N/A|90|Anticipated|Taipei Medical University Hospital||3|||f||||||||||||||2017-10-10 22:01:03.283758|2017-10-10 22:01:03.283758
NCT02825888|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-04|||August 2013||2013-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Perineural Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity on Block Performance Time, Failure Rate and Incidence of Acute Complications (Observational Study)||Recruiting||N/A|250|Anticipated|Western University, Canada|||2||f||||||||||||||2017-10-10 22:01:03.357903|2017-10-10 22:01:03.357903
NCT02825875|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-01|||June 2016||2016-06-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer|Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer|Recruiting||N/A|200|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-10 22:01:03.432433|2017-10-10 22:01:03.432433
NCT02825862|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-03-09|||February 2016||2016-02-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Investigating Affective Attitude Question-behaviour Effects on Intention to Become an Organ Donor|Circumventing the 'Ick' Factor: a Multi-site Randomised Trial of the Effects of Omitting Affective Attitudes to Increase Intention to Become an Organ Donor|Recruiting||N/A|750|Anticipated|Royal College of Surgeons, Ireland||3|||f||||f||||||||Undecided||2017-10-10 22:01:03.530399|2017-10-10 22:01:03.530399
NCT02825849|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|PRP-E||Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair|Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair: a Prospective Randomised Pilot Study|Recruiting||Phase 2|20|Anticipated|University of California, San Francisco||2|||f||||t||||||||Undecided||2017-10-10 22:01:03.623065|2017-10-10 22:01:03.623065
NCT02825810|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Cervical Motor Control in Long-term Breast Cancer Survivors|Effectiveness of a Physical Therapy Program for Improving Cervical Motor Control in Long-term Breast Cancer Survivors|Recruiting||Phase 2|52|Anticipated|Universidad de Granada||2|||f||||||||||||||2017-10-10 22:01:03.941749|2017-10-10 22:01:03.941749
NCT02825784|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-08-09|||January 6, 2017|Actual|2017-01-06|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Renastart||A Multicenter Study to Evaluate the Nutritional Suitability of Renastart|A Multicenter, Open Label, Uncontrolled Study to Evaluate the Acceptability, Tolerability and Nutritional Suitability of Renastart: Specially Formulated to Meet the Unique Nutritional Needs From Birth to 10 Years With Chronic Kidney Disease|Recruiting||N/A|15|Anticipated|Vitaflo International, Ltd||1|||f||||f||||||||||2017-10-10 22:01:04.204524|2017-10-10 22:01:04.204524
NCT02825771|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-07-20|||June 2017||2017-06-01|July 2016|2016-07-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|CARE||Caring Texts: A Strength-based, Suicide Prevention Trial in 4 Native Communities|Caring Texts: A Strength-based, Suicide Prevention Trial in 4 Native Communities|Not yet recruiting||N/A|1200|Anticipated|Washington State University||2|||f||||t||||||||Undecided|Collaborative decision with four tribal partners.|2017-10-10 22:01:04.345155|2017-10-10 22:01:04.345155
NCT02825758|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-09-11|||February 17, 2017|Actual|2017-02-17|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ZestiVits||Evaluation of ZestiVits in Children and Adults on a Ketogenic or Restricted Therapeutic Diet|A Study to Evaluate the Acceptability of ZestiVits; a New Vitamin, Mineral and Trace Element Supplement for Those Aged 11 and Over on a Ketogenic or Restricted Diet With Regard to Product Tolerance, Palatability and Compliance|Recruiting||N/A|15|Anticipated|Vitaflo International, Ltd||1|||f||||f|f|f||||||||2017-10-10 22:01:04.454048|2017-10-10 22:01:04.454048
NCT02825745|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-09-11|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of Betashot in Children and Adults With Epilepsy|A Feasibility Study of the Use of Betashot, a Medium Chain Triglyceride- Based (MCT) Food for Special Medical Purposes (FSMP) in Children and Adults With Epilepsy.|Recruiting||N/A|80|Anticipated|Vitaflo International, Ltd||1|||f||||f||||||||||2017-10-10 22:01:04.682288|2017-10-10 22:01:04.682288
NCT02825732|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-07|||November 2011||2011-11-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Observational|MEMORA||MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint|MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint|Completed||N/A|1300|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:01:04.806559|2017-10-10 22:01:04.806559
NCT02825719|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2017-01-30|||November 2015||2015-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ulipristal Use in Chinese Population|Pilot Study on the Pre-operative Use of Ulipristal on Fibroid in Chinese Population|Recruiting||Phase 4|40|Anticipated|Queen Mary Hospital, Hong Kong||2|||f||||f||||||||No|This is to protect the privacy of individual patients|2017-10-10 22:01:04.906451|2017-10-10 22:01:04.906451
NCT02825693|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-07-31|||August 2016||2016-08-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Femtosecond Laser Assisted Cataract Surgery in The NHS|The Development of Surgical Pathways Using Femto-second Laser Technology to Increase the Efficiency and Safety of Cataract Surgery Within a Public Health Sector Setting - A Randomised Controlled Trial|Active, not recruiting||N/A|400|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||||||||||||2017-10-10 22:01:05.192542|2017-10-10 22:01:05.192542
NCT02825680|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-07|||October 1, 2016|Actual|2016-10-01|June 2017|2017-06-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Learn, Engage, Act, Process (LEAP) for MOVE|Learn, Engage, Act, Process (LEAP) for Personalized Weight Management Support (QUE 15-286)|Enrolling by invitation||N/A|48|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:01:05.281731|2017-10-10 22:01:05.281731
NCT02825667|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-26|||September 12, 2016|Actual|2016-09-12|September 2017|2017-09-01|September 26, 2017|Actual|2017-09-26|September 8, 2017|Actual|2017-09-08||Interventional|||Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle|Randomized Clinical Study on the Effectiveness of the Myofascial Therapy in the Treatment of the Hemophilic Arthropathy of Ankle|Completed||N/A|65|Actual|Real Fundación Victoria Eugenia||2|||f||||f||||||||||2017-10-10 22:01:05.370908|2017-10-10 22:01:05.370908
NCT02825654|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-05-15|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|October 31, 2022|Anticipated|2022-10-31|April 30, 2021|Anticipated|2021-04-30|50 Years|Observational [Patient Registry]|SHADE||Service and Health Among Deployed Veterans|CSP #595 - Pulmonary Health and Deployment to Southwest Asia and Afghanistan|Not yet recruiting||N/A|6200|Anticipated|VA Office of Research and Development|||1||f||||t|f|f|||f|||Undecided||2017-10-10 22:01:05.469985|2017-10-10 22:01:05.469985
NCT02825641|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-03-29|||August 2016||2016-08-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Premature Rupture of Membranes With a Bishop Score<6: Comparison of Medical Induction/Expectant Management|Premature Rupture of Membranes at Term With an Unfavorable Cervix (Bishop Score<6): Comparison of Oxytocin, Dinoprostone Induction and Expectant Management|Recruiting||N/A|300|Anticipated|Rambam Health Care Campus||4|||f||||f||||||||No||2017-10-10 22:01:05.575628|2017-10-10 22:01:05.575628
NCT02825628|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-25|||May 2016||2016-05-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|CRPC||Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)|A Randomised, Double-blind, Dose Finding, Repeat Dose Phase II Multicentre Study of ODX for the Treatment of Patients With Castration Resistant Prostate Cancer (CRPC) and Skeletal Metastases|Recruiting||Phase 2|60|Anticipated|DexTech Medical AB||3|||f||||t||||||||||2017-10-10 22:01:05.679651|2017-10-10 22:01:05.679651
NCT02825615|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-07-07|||January 2015||2015-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|CCURDS||Better Arterial Cannulation Technique With Different Hemodynamics|Comparison of Conventional and Ultrasound Guided Techniques of Radial Artery Cannulation in Different Hemodynamic Subsets: a Randomized Controlled Study|Completed||N/A|100|Actual|Sultan Qaboos University||2|||f||||f||||||||No||2017-10-10 22:01:05.822276|2017-10-10 22:01:05.822276
NCT02825602|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-24|||July 2016||2016-07-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|March 31, 2017|Actual|2017-03-31||Observational|VE-HEROeS||Vietnam Era Health Retrospective Observational Study|Vietnam Era Health Retrospective Observational Study|Active, not recruiting||N/A|24306|Actual|Veteran Affairs Office of Patient Care Services|||4||f||||f||||||||Yes|Aggregate data will be available to investigators in accordance with VA access policy.|2017-10-10 22:01:05.895719|2017-10-10 22:01:05.895719
NCT02825589|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-08-31|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|BEDTIME||BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients|Effect of Bioelectrical Impedance Analysis-Guided Comparing With Standard Clinical-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients|Completed||N/A|19|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 22:01:05.98824|2017-10-10 22:01:05.98824
NCT02825576|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-04|||January 2017||2017-01-01|July 2016|2016-07-01||||January 2019|Anticipated|2019-01-01||Interventional|P-PERSON||Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine|Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine|Not yet recruiting||Phase 4|976|Anticipated|Northern Sydney Anaesthesia Research Institute||2|||f||||t||||||||Undecided||2017-10-10 22:01:06.078722|2017-10-10 22:01:06.078722
NCT02825563|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-06|||June 2016||2016-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients|Phase I Additional Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients|Recruiting||Phase 1|16|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||f||||||||Undecided||2017-10-10 22:01:06.18472|2017-10-10 22:01:06.18472
NCT02825537|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-08-23|||July 2016||2016-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study of the Effect of Elastic Compression (French Class III) on Water Balance Change in Healthy Subjects|Study of the Effect of Class III Elastic Venous Compression Focused on 33 mmHg on Water Balance Change in Healthy Subjects. Exploratory, Randomized, Open-label, Controlled and Crossover Study|Completed||N/A|23|Actual|Laboratoires Innothera||2|||f||||f||||||||||2017-10-10 22:01:06.424171|2017-10-10 22:01:06.424171
NCT02825524|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-08-25|||November 2012||2012-11-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|endoHPB||Destruction of Residual Endo-biliary Dysplastic Buds After Endoscopic Ampullectomy|Efficacy and Safety of Endobiliairy Radiofrequency (Probe Habib TM EndoHPB) for the Destruction of Residual Endo Biliairy Dysplastic Buds After Endoscopic Ampullectomy: Prospective Multicenter Study|Completed||N/A|20|Actual|Hôpital Cochin||1|||f||||f||||||||||2017-10-10 22:01:06.539653|2017-10-10 22:01:06.539653
NCT02825511|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-15|||March 2015||2015-03-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|CAC-CBC||Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma|Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma: Establishment of a Prospective Observational Cohort and Followed 3 Years|Active, not recruiting||N/A|2738|Actual|University Hospital, Bordeaux|||1||f||||f||||||||No||2017-10-10 22:01:06.662366|2017-10-10 22:01:06.662366
NCT02825498|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-05-08|||May 18, 2016|Actual|2016-05-18|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Randomised Prospective Trial Comparing Contact Force and Non-contact Force Guided Catheter Ablation for Cavotricuspid Isthmus Dependent Atrial Flutter|Randomised Prospective Trial Comparing Contact Force and Non-contact Force Guided Catheter Ablation for Cavotricuspid Isthmus Dependent Atrial Flutter|Enrolling by invitation||N/A|100|Anticipated|Victoria Cardiac Arrhythmia Trials||2|||f||||t||||||||Undecided|De-identified IPD may be shared with other researchers upon study completion. Data may be obtained by contacting Victoria Cardiac Arrhythmia Trials Inc. at 250-595-0400.|2017-10-10 22:01:06.779573|2017-10-10 22:01:06.779573
NCT02825485|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-01|||August 2016||2016-08-01|July 2016|2016-07-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Minimizing the Utilization of Voiding Cystourethrography for Patients With Antenatal Hydronephrosis|Minimizing the Utilization of Voiding Cystourethrography for Patients With Antenatal Hydronephrosis|Not yet recruiting||N/A|170|Anticipated|University of Virginia||2|||f||||||||||||||2017-10-10 22:01:06.859143|2017-10-10 22:01:06.859143
NCT02825472|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-06|||February 2016||2016-02-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ExTra-GUCH||Exercise Training in Grown-up Congenital Heart Disease|Exercise Training in Grown-up Congenital Heart Disease|Recruiting||N/A|100|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||No||2017-10-10 22:01:06.922311|2017-10-10 22:01:06.922311
NCT02825459|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-17|||July 2016||2016-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?|Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?|Recruiting||N/A|120|Anticipated|University of Vermont||2|||f||||f||||||||||2017-10-10 22:01:07.034178|2017-10-10 22:01:07.034178
NCT02825446|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-01-15|||May 2016||2016-05-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|ATRFPA||Angioplasty of the Tibial Arteries Augmented Radio Frequency Denervation of the Popliteal Artery|A Pilot Prospective Study of Two Methods of Revascularization of Tibial Arteries: Angioplasty Tibial Arteries, and Angioplasty Tibial Artery, Augmented by Radio Frequency Denervation Popliteal Artery in Patients With Steno-occlusive Lesion of the Tibial Arteries|Recruiting||N/A|40|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||||||||||||2017-10-10 22:01:07.147218|2017-10-10 22:01:07.147218
NCT02825433|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2016-07-01|||August 2013||2013-08-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Observing Changes in Ventilation Pattern During Procedural Sedation|Observing Changes in Ventilation Pattern During Procedural Sedation|Completed||N/A|160|Actual|University of Utah|||1||f||||f||||||||No||2017-10-10 22:01:07.235838|2017-10-10 22:01:07.235838
NCT02825420|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-10-04|||June 2015||2015-06-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|NIMES-ROC||Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients|NonInterventional, Multicenter, Prospective, European Study to Describe the Effectiveness of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients According to SmPC Regardless of Previous Use of an Antiangiogenic Drug|Recruiting||N/A|300|Anticipated|PharmaMar|||1||f||||||||||||||2017-10-10 22:01:07.296829|2017-10-10 22:01:07.296829
NCT02825407|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-06|||May 2015||2015-05-01|June 2016|2016-06-01||||May 2017|Anticipated|2017-05-01||Interventional|ALIMASSENS||Creation and Characterization of Two Groups of Subjects to Evaluate Sensitivity|Creation et Characterization of Two Groups of Elderly Subjects so as to Evaluate the Link Between the Characteristics of Oral Physiology, Sensory Sensitivity, the Release in Vivo Aromatic Compounds, and In-mouth Comfort During the Consumption of Foods|Recruiting||N/A|260|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 22:01:07.546014|2017-10-10 22:01:07.546014
NCT02825394|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-01|||September 2015||2015-09-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|SPOCT-NOAC 1||Specific PoC Testing of Coagulation in Patients Treated With NOAC 1|Specific Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants Part 1|Recruiting||N/A|120|Anticipated|University Hospital Tuebingen|||6||f||||f||||||Samples Without DNA|"     Whole blood samples, citrated blood samples and citrated plasma samples   "|Undecided||2017-10-10 22:01:07.621282|2017-10-10 22:01:07.621282
NCT02825381|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-07-01|||July 2016||2016-07-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||One-Stage Exchange for Chronically Infected Total Hip Arthroplasty|Evaluation of Routine One-Stage Exchange Procedure for Chronically Infected Total Hip Arthroplasty|Not yet recruiting||N/A|65|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 22:01:07.699695|2017-10-10 22:01:07.699695
NCT02825368|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-08-03|||September 2016||2016-09-01|August 2017|2017-08-01||||August 2017|Anticipated|2017-08-01||Interventional|HVT||Homeopathic Vaccine Trial|Homeopathic Vaccine Randomized Controlled Trial|Recruiting||Phase 4|||McMaster University||3|||f||||t||||||||||2017-10-10 22:01:07.751744|2017-10-10 22:01:07.751744
NCT02825355|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-03-20|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|SENTIREC I||Sentinel Node Mapping in Women With Cervical and Endometrial Cancer|Sentinel Node Mapping With Robotic Assisted Near Infra-red Fluorescent Imaging in Women With Cervical and Endometrial Cancer|Recruiting||N/A|380|Anticipated|University of Southern Denmark||2|||f||||t|f|f||||||||2017-10-10 22:01:07.841581|2017-10-10 22:01:07.841581
NCT02825342|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-08-16|||March 2014||2014-03-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|NCCP||PPI's and SSRI's Therapy for the Management of NCCP|Proton Pump Inhibitor (PPI's) and Selective Serotonin Reuptake Inhibitor Therapy (SSRI's) for the Management of Non Cardiac Chest Pain (NCCP)|Terminated||Phase 4|60|Actual|Evangelismos Hospital||3||Primary endpoint was reached.|f||||f||||||||||2017-10-10 22:01:08.123292|2017-10-10 22:01:08.123292
NCT02825329|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-04||||||July 2016|2016-07-01||||||||Expanded Access|EUPHORIA||Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock|Evaluating the Use of Polymyxin B Hemoperfusion in a Prospective Non-controlled Trial in Adults|Available||N/A|||Spectral Diagnostics (US) Inc.|||||||||||||||||||2017-10-10 22:01:08.207413|2017-10-10 22:01:08.207413
NCT02825316|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-04|||July 2016||2016-07-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease|Mediterranean Diet vs. Low Residue Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease|Not yet recruiting||N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 22:01:08.272757|2017-10-10 22:01:08.272757
NCT02825303|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-14|||January 2014||2014-01-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Mid-term Effect of a Novel Sit-to-stand Workplace (ACTIVE OFFICE) on Cognitive and Physiological Parameters|Mid-term Effect of a Novel Sit-to-stand Workplace (ACTIVE OFFICE) on Cognitive and Physiological Parameters|Completed||N/A|18|Actual|University of Applied Sciences Upper Austria||3|||f||||f||||||||Yes|Data resulting from this study will be analyzed and published in the PIs' PhD-thesis and journal articles.|2017-10-10 22:01:08.366013|2017-10-10 22:01:08.366013
NCT02825290|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2016-12-11|||July 2016||2016-07-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study|Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study|Recruiting||Phase 4|62|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 22:01:08.472591|2017-10-10 22:01:08.472591
NCT02825277|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-04|||December 2013||2013-12-01|July 2016|2016-07-01||||January 2017|Anticipated|2017-01-01||Interventional|EVUPA||Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies|Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies: Third Trimester Quantification Using 3D Power Doppler With Comparison to Placental Vascular Morphology|Recruiting||N/A|112|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 22:01:08.597106|2017-10-10 22:01:08.597106
NCT02825264|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-07-06|||July 2016||2016-07-01|July 2016|2016-07-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Observational|||STAR-LIFE Registry|STARflo Glaucoma Implant Clinical Experience Program in a Real-World Patient Population|Not yet recruiting||N/A|150|Anticipated|iSTAR Medical|||1||f||||f||||||||Undecided||2017-10-10 22:01:08.710368|2017-10-10 22:01:08.710368
NCT02825251|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-09-07|||July 6, 2016|Actual|2016-07-06|September 2017|2017-09-01|July 21, 2017|Actual|2017-07-21|June 20, 2017|Actual|2017-06-20||Interventional|Onset® 5||Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes|Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes|Completed||Phase 3|472|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 22:01:08.817277|2017-10-10 22:01:08.817277
NCT02824172|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-01|||September 2015||2015-09-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|OSGOOD||Treatment of the Osgood Schlatter|Treatment of the Osgood Schlatter Disease by Immobilization ( Ankle Cruro Resin ) Versus Sporting Rest ( Reference Treatment ) : Randomized Controlled Study|Recruiting||Phase 3|72|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:01:19.212649|2017-10-10 22:01:19.212649
NCT02825238|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-01|||October 2012||2012-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Hip and Core Muscle Strengthening for Patellofemoral Osteoarthritis: A Feasibility Study|The Effect of Hip and Core Muscle Strengthening on Pain, Function, Quality of Life and Movement Patterns in Persons With Patellofemoral Osteoarthritis: A Feasibility Study|Active, not recruiting||N/A|20|Actual|University of the Sciences in Philadelphia||2|||f||||f||||||||No||2017-10-10 22:01:09.127204|2017-10-10 22:01:09.127204
NCT02825225|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2016-07-03|||May 2012||2012-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes|A Randomized Controlled Trial To Assess and Compare the Outcomes of 20-core Versus 12-core Prostate Biopsy|Completed||N/A|750|Actual|University of Nove de Julho||2|||f||||f||||||||No|Secrecy will be maintained in observation of ethics committee opinion.|2017-10-10 22:01:09.275245|2017-10-10 22:01:09.275245
NCT02825212|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-03|2017-03-29|||February 2016||2016-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia|Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia|Recruiting||Phase 2/Phase 3|10|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||No||2017-10-10 22:01:09.419145|2017-10-10 22:01:09.419145
NCT02825199|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-07-04|||February 2016||2016-02-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Caffeine Intake in Vestibular Function|Effect of Caffeine Intake in Vestibular Function: A Randomized Triple-Blind Controlled Trial|Completed||Phase 4|32|Actual|Instituto Brasiliense de Otorrinolaringologia||2|||f||||f||||||||Yes|The data will be published in full on the master's dissertation|2017-10-10 22:01:09.547957|2017-10-10 22:01:09.547957
NCT02825186|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-07-03|||July 2016||2016-07-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Dexamethasone (Sterodex) Versus Loteprendol (Lotemax) Eye Drops Following Strabismus Surgery||Not yet recruiting||N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-10 22:01:09.668567|2017-10-10 22:01:09.668567
NCT02825173|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-04-26|||August 2016||2016-08-01|April 2017|2017-04-01|December 2, 2016|Actual|2016-12-02|November 2016|Actual|2016-11-01||Interventional|||Seal-G Safety Study|A Prospective, Multi-center, Open Label, Non-randomized Study, of Seal-G Surgical Sealant for the Reinforcement of Gastrointestinal Anastomosis|Completed||N/A|20|Actual|Sealantis Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:01:09.768936|2017-10-10 22:01:09.768936
NCT02825147|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-04-18|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|March 2016|Actual|2016-03-01||Interventional|||Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma|Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma|Active, not recruiting||Phase 2|40|Anticipated|Ruijin Hospital||1|||f||||f||||||||||2017-10-10 22:01:09.995423|2017-10-10 22:01:09.995423
NCT02825134|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-03|||June 2016||2016-06-01|July 2016|2016-07-01|June 2024|Anticipated|2024-06-01|June 2020|Anticipated|2020-06-01||Interventional|NOTION-2||Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in Younger Low Surgical Risk Patients With Severe Aortic Stenosis|Nordic Aortic Valve Intervention Trial 2 - A Randomized Multicenter Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in Younger Low Surgical Risk Patients With Severe Aortic Stenosis|Recruiting||N/A|992|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||No||2017-10-10 22:01:10.13242|2017-10-10 22:01:10.13242
NCT02825121|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-10-03|||February 2016||2016-02-01|October 2016|2016-10-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|CurHaTOF||Evaluation of Monitoring Neuromuscular Blockade the Flexor Hallucis Compared to the Adductor Pollicis||Completed||N/A|60|Actual|Poitiers University Hospital||1|||f||||||||||||||2017-10-10 22:01:10.332286|2017-10-10 22:01:10.332286
NCT02825108|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-04-26|||January 2015||2015-01-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Embryo Transfer on Pregnancy Outcomes in Frozen Embryo Transfer Cycles.|Evaluation the Effect of Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Implantation and Clinical Pregnancy Rates Per Cycle , Phase 3 Randomized Double Blinded Clinical Trial|Recruiting||Phase 3|150|Anticipated|Royan Institute||3|||f||||t||||||||No||2017-10-10 22:01:10.422908|2017-10-10 22:01:10.422908
NCT02825095|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-07-06|||August 2016||2016-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis|Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis ; a Prospective Randomized Controlled Study.|Not yet recruiting||Early Phase 1|120|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||Yes||2017-10-10 22:01:10.522385|2017-10-10 22:01:10.522385
NCT02825082|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-04-07|||January 2017||2017-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|FRAILESEL||Emergency Surgery in the Elderly: Comparison of Frailty Index and Surgical Risk Score|Risk Stratification Tools and Frailty Index for Predicting Perioperative Outcome in Elderly Patients Undergoing Abdominal Emergency Surgery|Recruiting||N/A|984|Anticipated|University of Roma La Sapienza|||1||f||||f||||||||Undecided||2017-10-10 22:01:10.626484|2017-10-10 22:01:10.626484
NCT02825069|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-01|||March 2014||2014-03-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|INTO||Study on the Induction of Food Tolerance in Babies|Randomized Controlled Study on the Induction of Food Tolerance in Babies|Recruiting||N/A|1380|Anticipated|University of Oulu||2|||f||||f||||||||No||2017-10-10 22:01:10.871914|2017-10-10 22:01:10.871914
NCT02825043|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-04-17|||February 2016||2016-02-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|COPD||HFNC Effect on BCSS in Patients With COPD|Effect of High-Flow Nasal Cannula (HFNC) on the Breathlessness, Cough, and Sputum Scale (BCSS), in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|30|Anticipated|University of Oklahoma||1|||f||||t||||||||No|Will share data as a cohort for other investigators, but will not share individual participant data.|2017-10-10 22:01:11.05069|2017-10-10 22:01:11.05069
NCT02825030|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-04|||December 2015||2015-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SPF Assay||Sun Protection Factor Assay (SPF Assay 18676)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment- Darkening Dose.|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:11.132942|2017-10-10 22:01:11.132942
NCT02825017|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2016-07-04|||December 2015||2015-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SPF Assay||Sun Protection Factor Assay (SPF Assay 18677)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose.|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:11.190938|2017-10-10 22:01:11.190938
NCT02825004|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-07-28|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Recognizing and Preventing Burnout|Recognizing and Preventing Burnout: A Pilot Randomized Controlled Trial|Recruiting||N/A|20|Anticipated|Fondazione Don Carlo Gnocchi Onlus||2|||f||||t||||||||||2017-10-10 22:01:11.255029|2017-10-10 22:01:11.255029
NCT02824991|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-10-03|||January 2016||2016-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|US-DN||Ultrasonography Detection of Local Twitch Response During Dry Needling|Semi-Automatic Ultrasonography Detection of Local Twitch Response Intensities During Dry Needling: Implications on Joint Range of Motion|Completed||Early Phase 1|7|Actual|University of Malaga||1|||f||||f||||||||||2017-10-10 22:01:11.323428|2017-10-10 22:01:11.323428
NCT02824978|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-04|2017-08-03|||October 7, 2016|Actual|2016-10-07|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|ALLIANCE||Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?||Recruiting||N/A|120|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 22:01:11.388569|2017-10-10 22:01:11.388569
NCT02824965|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-09-20|||August 9, 2017|Actual|2017-08-09|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pembrolizumab + CVA21 in Advanced NSCLC|A Phase I/II Open-label Trial of Intravenous CAVATAK^TM in Combination With Pembrolizumab for the Treatment of Patients With Advanced NSCLC|Recruiting||Phase 1|40|Anticipated|Olivia Newton-John Cancer Research Institute||3|||f||||t|f|f||||||||2017-10-10 22:01:11.526603|2017-10-10 22:01:11.526603
NCT02824952|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-11-17|||December 2016||2016-12-01|June 2016|2016-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC|Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC - a Phase 2 Open-label Study|Not yet recruiting||Phase 2|40|Anticipated|Rabin Medical Center||1|||f||||f||||||||No||2017-10-10 22:01:11.629136|2017-10-10 22:01:11.629136
NCT02824939|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-09-07|||September 2016||2016-09-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Quadratus Lumborum Block With TAP Block for Postoperative Analgesia After Laparoscopic Nephrectomy|Comparison of Ultrasound Guided Quadratus Lumborum Block With Ultrasound Guided TAP Block for Postoperative Analgesia After Laparoscopic Nephrectomy: a Prospective Randomized Controlled Trial|Recruiting||N/A|96|Anticipated|Postgraduate Institute of Medical Education and Research||3|||f||||f||||||||Undecided||2017-10-10 22:01:11.701852|2017-10-10 22:01:11.701852
NCT02824926|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-03|||July 2014||2014-07-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis|Non-inferiority Phase II Trial Comparing BL123 (Biolab Sanus Farmacêutica Ltda.) Versus Ketoconazole (Nizoral® Janssen-Cilag) in Patients With Tinea Pedis|Completed||Phase 2|60|Actual|Galeno Desenvolvimento de Pesquisas Clínicas||2|||f||||f||||||||Yes|No IPD available.|2017-10-10 22:01:11.842854|2017-10-10 22:01:11.842854
NCT02824913|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-06-02|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease|Randomized, Crossover Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Characterized by Low Tear Volume|Terminated||Phase 2|1|Actual|Parion Sciences||2|||f||||f||||||||No||2017-10-10 22:01:12.031599|2017-10-10 22:01:12.031599
NCT02824900|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-03|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Vibration Stimuli in Stroke Patients With Contraversive Pusher Syndrome|Vibration Stimuli in Stroke Patients With Contraversive Pusher Syndrome|Not yet recruiting||N/A|12|Anticipated|Loewenstein Hospital||2|||f||||||||||||||2017-10-10 22:01:12.145153|2017-10-10 22:01:12.145153
NCT02824887|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-07-06|||June 2016||2016-06-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01|1 Year|Observational [Patient Registry]|||Deep Needling Protrusion of Lumbar Intervertebral Disc the Five Acupoints|A Prospective Cohort Study of Electroacupuncture Deep Needling Protrusion of Lumbar Intervertebral Disc the Five Acupoints in the Treatment of Lumbar Disc Herniation|Not yet recruiting||N/A|175|Anticipated|The Third Affiliated Hospital of Beijing University of Chinese Medicine|||2||f||||t||||||||Undecided||2017-10-10 22:01:12.253955|2017-10-10 22:01:12.253955
NCT02824874|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-06|||April 2016||2016-04-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)|A Randomized, Open-label, Multiple Dosing, 2-way Crossover Study to Evaluate the Effect of Sitagliptin on Pharmacokinetics of Lobeglitazone in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||No||2017-10-10 22:01:12.359199|2017-10-10 22:01:12.359199
NCT02824861|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2016-07-06|||May 2015||2015-05-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Bemobile Intervention to Support Physical Activity in Cancer Survivors|Bemobile: A Text Intervention to Support Physical Activity in Cancer Survivors|Recruiting||N/A|50|Anticipated|University of Vermont||2|||f||||f||||||||No|No plan to make individual participant data available|2017-10-10 22:01:12.475965|2017-10-10 22:01:12.475965
NCT02824848|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2017-05-07|||July 2016||2016-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Perception-Action Approach vs. Passive Stretching for Infants With Congenital Muscular Torticollis|Comparison of Perception-Action Approach and Passive Stretching Interventions for Infants With Congenital Muscular Torticollis: A Single-Blind Randomized Clinical Trial|Recruiting||N/A|36|Anticipated|Rosalind Franklin University of Medicine and Science||2|||f||||f||||||||Undecided||2017-10-10 22:01:12.567419|2017-10-10 22:01:12.567419
NCT02824835|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-02|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Strigolactones and Dysplastic Colonic Lesions or Cancer|The Effect of the Plant Hormones Strigolactones on Cultures of Dysplastic Colonic Lesions and Cancer|Not yet recruiting||N/A|150|Anticipated|Meir Medical Center|||2||f||||f||||||||No||2017-10-10 22:01:12.689934|2017-10-10 22:01:12.689934
NCT02824822|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-04-15|||May 2016||2016-05-01|July 2016|2016-07-01|May 2022|Anticipated|2022-05-01|May 2020|Anticipated|2020-05-01||Observational|||Genetic Markers of Cardiovascular Disease in Epilepsy|Genetic Markers of Cardiovascular Diseases and the Potential Role in Sudden Unexpected Death in Epilepsy.|Recruiting||N/A|600|Anticipated|Mayo Clinic|||2||f||||f||||||Samples With DNA|"     50 mls of blood from a vein will be drawn at Mayo Clinic or another medical center and     returned through the mail. Buccal swabs will be collected using a swab and saliva based-kit.   "|||2017-10-10 22:01:12.781415|2017-10-10 22:01:12.781415
NCT02824809|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2016-07-02|||June 2016||2016-06-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|COPDTESTO||Association Between Testosterone Levels and COPD Severity|Association Between Testosterone Levels and COPD Severity Measured by BODE Index in Men|Recruiting||N/A|150|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f||||||||Undecided||2017-10-10 22:01:12.87458|2017-10-10 22:01:12.87458
NCT02824796|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|SPBT||Group Training for Parents Whose Children Suffer From ADHD and Comorbidity Using a Behavioral-Dynamic Approach|Group Training for Parents Whose Children Suffer From ADHD and Comorbidity Using a Behavioral-Dynamic Approach: A Randomized Controlled Trial|Recruiting||N/A|140|Anticipated|Assuta Hospital Systems||2|||f||||f||||||||No||2017-10-10 22:01:12.958421|2017-10-10 22:01:12.958421
NCT02824783|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2016-07-11|||January 2016||2016-01-01|July 2016|2016-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Quality of Life After Enhanced Recovery Protocol for Colorectal Surgery|Quality of Life and Satisfaction of Patients Discharged Home After Enhanced Recovery Protocol for Colorectal Surgery|Recruiting||N/A|41|Anticipated|University Hospital of Liege|||1||f||||f||||||||No||2017-10-10 22:01:13.043168|2017-10-10 22:01:13.043168
NCT02824757|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-07-07|||March 2016||2016-03-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||The Effects of Glucocorticoids on Glucose Metabolism in Patients With Interstitial Lung Disease|Explore the Effects of Glucocorticoids on Glucose Metabolism by Continuous Glucose Monitoring in Patients With Interstitial Lung Disease|Recruiting||N/A|40|Anticipated|Peking Union Medical College Hospital|||4||f||||t||||||Samples Without DNA|"     serum   "|Yes||2017-10-10 22:01:13.22059|2017-10-10 22:01:13.22059
NCT02824744|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-01|||October 2016||2016-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|TRAMONTANE2||Comparison Between 2l vs 3l in HFNC During the Initial Management of Severe Bronchiolitis in Infants|Comparison Between 2l/Min/kg vs 3l/Min/kg in High Flow Nasal Cannula (HFNC) During the Initial Management of Severe Bronchiolitis in Infants|Not yet recruiting||Phase 3|270|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||Yes|All data will be centralized at the sponsor office for the final analysis|2017-10-10 22:01:13.308602|2017-10-10 22:01:13.308602
NCT02824731|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-09-13|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2026|Anticipated|2026-07-01|July 2025|Anticipated|2025-07-01||Interventional|||Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)|Comparison of Proton and Photon Radiotherapy of Brain Tumors: Efficiency and Side Effects in Clinical Standard Doses|Recruiting||N/A|346|Anticipated|Technische Universität Dresden||8|||f||||f|f|f||||||||2017-10-10 22:01:13.392218|2017-10-10 22:01:13.392218
NCT02824718|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-06-19|||June 6, 2017|Actual|2017-06-06|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|ACTICAS||Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism|A Randomized Crossover TrIal to Compare Recombinant Human rhPTH(1-34) to the ASsociation Alfacalcidol/Hydrochlorothiazide in the Treatment of Severe Primary Hypoparathyroidism|Recruiting||Phase 2|12|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||||2017-10-10 22:01:13.504209|2017-10-10 22:01:13.504209
NCT02824705|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-01|||April 2016||2016-04-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Kids Intestinal Dysfunction in Congenital Heart Disease: the Kind Heart Study|Effects of Cardiac ICU Practice Variation on Intestinal Epithelial Barrier Function and Microbiome Diversity|Enrolling by invitation||N/A|80|Anticipated|University of Arizona|||1||f||||f||||||Samples With DNA|"     Stool samples, blood samples with permission of family   "|No||2017-10-10 22:01:13.64239|2017-10-10 22:01:13.64239
NCT02824692|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2016-07-02|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|||Preoperative Significant Clinical Findings Using Focused Ultrasound Examination|The Incidence of Significant Clinical Findings Using Focused Ultrasound Examination for the Heart, Lungs and Abdomen in Elderly Patients Before Emergent Surgery|Not yet recruiting||N/A|30|Anticipated|Rambam Health Care Campus|||1||f||||t||||||||Undecided||2017-10-10 22:01:13.712118|2017-10-10 22:01:13.712118
NCT02824679|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2017-03-19|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effect of Intravenous Hyoscine Butylbromide Injection on First Stage Labour in Primigavidae|Effect of Intravenous Hyoscine Butylbromide Injection on the Course and Duration of First Stage of Labour in Primigavidae|Completed||Phase 4|200|Actual|Cairo University||3|||f||||f||||||||Yes||2017-10-10 22:01:13.799642|2017-10-10 22:01:13.799642
NCT02824666|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-07-13|||June 20, 2016|Actual|2016-06-20|July 2017|2017-07-01|November 8, 2016|Actual|2016-11-08|September 6, 2016|Actual|2016-09-06||Interventional|||Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242|Phase 1, Open-Label Positron Emission Tomography (PET) Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242 in Adult Male Healthy Subjects|Completed||Phase 1|7|Actual|Braeburn Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:01:13.880004|2017-10-10 22:01:13.880004
NCT02824653|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-01-24|||January 2015||2015-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD|Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD- A Phase I/II Clinical Trial|Completed||Phase 1/Phase 2|10|Actual|Armed Forces Bone Marrow Transplant Center, Rawalpindi, Pakistan||1|||f||||t||||||||Undecided||2017-10-10 22:01:13.966463|2017-10-10 22:01:13.966463
NCT02824640|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-01|||August 2016||2016-08-01|July 2016|2016-07-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|HERO||Patient-Centered Models of HCV Care for People Who Inject Drugs|Patient-Centered Models of HCV Care for People Who Inject Drugs|Not yet recruiting||N/A|1000|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||Undecided||2017-10-10 22:01:14.077993|2017-10-10 22:01:14.077993
NCT02824627|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-04-24|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders|Investigating the Impact of Oxytocin on Irritability/Emotional Dysregulation in Children and Adolescents With Disruptive Behavior and Mood Disorders, and the Possible Mediating Role of Amygdala Activity|Recruiting||Phase 2|60|Anticipated|University of Nebraska||2|||f||||t||||||||No||2017-10-10 22:01:14.162217|2017-10-10 22:01:14.162217
NCT02824614|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-02|||June 2016||2016-06-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effect of the Natural Sweeteners Erythritol and Xylitol on Gut Microbiota and Glucose Metabolism in Obese Volunteers|Effect of the Natural Sweeteners Erythritol and Xylitol on Gut Microbiota and Glucose Metabolism in Obese Volunteers|Recruiting||N/A|60|Anticipated|University Hospital, Basel, Switzerland||3|||f||||f||||||||Undecided||2017-10-10 22:01:14.243302|2017-10-10 22:01:14.243302
NCT02824601|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-01|||February 2015||2015-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Photodynamic Therapy in Endodontic Treatment|Does Supplemental Photodynamic Therapy Optimize the Disinfection of Bacteria and Endotoxins in One-visit and Two-visit Root Canal Therapy? A Randomized Clinical Trial|Completed||Phase 2|24|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||Yes||2017-10-10 22:01:14.319484|2017-10-10 22:01:14.319484
NCT02824588|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-04-03|||September 2016||2016-09-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|NEPA||Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain|Executive Control, Processing Speed and Memory Function in Long- Term Peripheral Neuropathic Pain and Fibromyalgia|Recruiting||Early Phase 1|160|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 22:01:14.389496|2017-10-10 22:01:14.389496
NCT02824575|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-11|||July 2016||2016-07-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer|Phase Ib Study of Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Patients With Metastatic Breast Cancer|Recruiting||Phase 1|60|Anticipated|Montefiore Medical Center||2|||f||||t||||||||No||2017-10-10 22:01:14.467929|2017-10-10 22:01:14.467929
NCT02824549|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-27|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||An Evaluation of the FreeStyle Flash Glucose Monitoring System|An Evaluation of the Usability, Skin Reactions and Accuracy of the FreeStyle Libre Flash Glucose Monitoring System|Recruiting||N/A|50|Anticipated|Jessa Hospital|||1||f||||||||||||||2017-10-10 22:01:14.627716|2017-10-10 22:01:14.627716
NCT02824536|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-04-04|||June 2016||2016-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||3BNC117 and 10-1074 in HIV Uninfected Adults|A Phase 1 Study of the Safety and Pharmacokinetics of the Combination of 3BNC117 and 10-1074 in HIV-uninfected Adults|Active, not recruiting||Phase 1|24|Actual|Rockefeller University||3|||f||||t||||||||No||2017-10-10 22:01:14.689695|2017-10-10 22:01:14.689695
NCT02824523|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-18|||July 2016||2016-07-01|July 2017|2017-07-01||||July 2019|Anticipated|2019-07-01||Observational|||Role of Inflammatory Mediators in AERD|Role of PDG2 in the Aspirin-Induced Reactions and in the Treatment of Aspirin-Exacerbated Respiratory Disease|Recruiting||N/A|50|Anticipated|Brigham and Women's Hospital|||1||f||||t||||||||||2017-10-10 22:01:14.771709|2017-10-10 22:01:14.771709
NCT02824510|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-06|||August 2014||2014-08-01|July 2016|2016-07-01||||September 2016|Anticipated|2016-09-01||Interventional|TREAD-DIAB||Evaluation of Glycemic Changes During Exercise in Children With Type 1 Diabetes|Evaluation of Glycemic Changes and Optimization of Glycemic Control During Exercise in Children With Type 1 Diabetes Under Continuous Subcutaneous Insulin Infusion (CSII) or Multiple Daily Injection Regimen (MDI) (TREAD-DIAB Study)|Recruiting||N/A|40|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||Undecided||2017-10-10 22:01:14.880052|2017-10-10 22:01:14.880052
NCT02824497|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-21|||May 2015||2015-05-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|DROPE||Early Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year|Early Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 22:01:14.962275|2017-10-10 22:01:14.962275
NCT02824484|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-07-05|||November 2015||2015-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE|Promoting Post-traumatic Growth in Cancer Patients: a Study Protocol for a Randomized Controlled Trial of Guided Written Disclosure|Recruiting||N/A|250|Anticipated|Arcispedale Santa Maria Nuova-IRCCS||2|||f||||f||||||||Undecided||2017-10-10 22:01:15.034263|2017-10-10 22:01:15.034263
NCT02824471|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-07-06|||October 2014||2014-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)|Sickle Cell Disease (SCD) Biochip': Towards a Simple and Reliable Way to Monitor Sickle Cell Disease|Recruiting||N/A|100|Anticipated|University Hospitals Cleveland Medical Center|||2||f||||f||||||Samples Without DNA|"     This is a non-treatment study. The investigators will utilize the leftover blood or cast-off     collected from the same blood that will be drawn during participants standard-of-care     outpatient or hospital visit.   "|No||2017-10-10 22:01:15.149242|2017-10-10 22:01:15.149242
NCT02824458|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-06|||June 2016||2016-06-01|July 2016|2016-07-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations|A Multicenter, Randomized,Double-Blind Study of Gefitinib in Combination With Apatinib or Placebo in Previously Untreated Patients With EGFR Mutation-Positive Advanced Non-squamous Non-Small-Cell Lung Cancer|Recruiting||Phase 3|246|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 22:01:15.290398|2017-10-10 22:01:15.290398
NCT02824445|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-04-04|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder|A Pilot Study to Evaluate the Efficacy of EEG/ECG-guided Magnetic Resonant Therapy (MeRT) in War Veterans With Posttraumatic Stress Disorder (PTSD) at Tinker Air Force Base|Recruiting||N/A|50|Anticipated|72nd Medical Group, Tinker Air Force Base||2|||f||||t||||||||Yes||2017-10-10 22:01:15.383525|2017-10-10 22:01:15.383525
NCT02824432|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-13|||June 30, 2016|Actual|2016-06-30|September 2017|2017-09-01|August 19, 2017|Actual|2017-08-19|August 19, 2017|Actual|2017-08-19||Interventional|||Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation|Exploratory Study of the Effect of Omega-3-acid Ethyl Esters on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation|Completed||Phase 4|37|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 22:01:15.462107|2017-10-10 22:01:15.462107
NCT02824419|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-07-01|||May 2016||2016-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis|Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis|Recruiting||Phase 2/Phase 3|10|Anticipated|Turku University Hospital||2|||f||||f||||||||No||2017-10-10 22:01:15.532679|2017-10-10 22:01:15.532679
NCT02824406|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-07-05|||August 2014||2014-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|CRUISE||Cerebrovascular Reserve Measurements in Sickle Cell Disease|Cerebrovascular Reserve Measurements in Sickle Cell Disease: an MRI Study|Recruiting||N/A|60|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f||||||Samples Without DNA|"     The following outcomes will be assessed from veinous-drawn blood samples: Sodium, Potassium,     Creatinine, Bilirubin, ASAT(SGOT), ALAT (SGPT), LDH, Ferritin, Haptoglobin, Hemoglobin,     Erythrocytes, Leukocytes, Thrombocytes, MCV, MCH, MCHC, RDW, Hemoglobin, Hematocrit, Hb-F,     Hb-A2, Hb-S, Hb-A2, Reticulocytes, Lymphocytes, ADAMTS13, D-Dimer, von Willebrand activity /     antigen / multimer, hs-CRP, F1+2, PAI-1 antigen, t-PA-Ag antigen, NETs, Circulating histones,     Metalloproteinase, Interleukin 6,13 and 18, Free HB, ADMA asymmetric dimethylarginine, VCAM,     ICAM, AGEs:Pentosidine, CML - carboxyl methyl lysine, Thrombospondin, GFAP, L-selectin, VEGF,     Pentraxine-3   "|Yes||2017-10-10 22:01:17.167327|2017-10-10 22:01:17.167327
NCT02824393|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-06-06|||March 3, 2017|Actual|2017-03-03|June 2017|2017-06-01|June 15, 2019|Anticipated|2019-06-15|July 15, 2018|Anticipated|2018-07-15||Interventional|||Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria|Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria|Recruiting||Early Phase 1|20|Anticipated|Celal Bayar University||2|||f||||t|f|f||||||Yes||2017-10-10 22:01:17.317561|2017-10-10 22:01:17.317561
NCT02824380|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-06|||July 2016||2016-07-01|July 2016|2016-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia||Not yet recruiting||Phase 1|14|Anticipated|Dong-A ST Co., Ltd.||2|||f||||||||||||||2017-10-10 22:01:17.456837|2017-10-10 22:01:17.456837
NCT02824367|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-08-02|||October 2015||2015-10-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|EPMP-1||Evaluation of Clinical Perfectionism in Parkinson Disease|Evaluation of Clinical Perfectionism in Parkinson Disease|Active, not recruiting||N/A|60|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 22:01:17.542927|2017-10-10 22:01:17.542927
NCT02824354|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-01|||July 2016||2016-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|NalmeCir||Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.|Multicentre, Randomised, Double-blind, Placebo-controlled Trial of Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.|Not yet recruiting||Phase 3|250|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||t||||||||||2017-10-10 22:01:17.62719|2017-10-10 22:01:17.62719
NCT02824341|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-05|||October 2015||2015-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|MP-TCSP-IRMf||Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder|Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder|Recruiting||N/A|75|Anticipated|University Hospital, Clermont-Ferrand||3|||f||||||||||||||2017-10-10 22:01:17.725504|2017-10-10 22:01:17.725504
NCT02824159|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||April 2016||2016-04-01|June 2016|2016-06-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|PK-E3I||Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib|Real Life Assessment of the Association and Its Determinants Between Side Effects and Plasmatic Concentrations of Two Protein Kinase Inhibitors: Ibrutinib (IMBRUVICA®) and Idelalisib (ZYDELIG®) in Hematological Malignancies Treatment.|Recruiting||N/A|150|Anticipated|University Hospital, Toulouse|||1||f||||f||||||Samples With DNA|"     Samples to be collected are :        -  Blood samples for dosage of drug in plasma (No DNA)        -  Blood samples (genetic profile of drug elimination and presence of treatment resistance          mutation) and saliva samples (genetic profile drug elimination )   "|Undecided||2017-10-10 22:01:19.313808|2017-10-10 22:01:19.313808
NCT02824328|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-02|||June 2016||2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers|A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers|Recruiting||N/A|25|Anticipated|Duke University|||1||f||||f||||||Samples With DNA|"     1. Blood (30ml) on the day of biopsy        2. Additional tissue at time of clinical biopsy (if it is safe for additional tissue to be          collected during this time beyond what is clinically indicated, an effort will be made          to do so. All biopsy tissue collected will be sent to pathology, including any          additional tissue. Tissue remaining after pathology has performed their clinical care          requirements will be collected) OR Collection of excess tissue at time of clinical          biopsy (if it is unsafe for additional tissue to be collected, only tissue in excess of          what is what pathology uses will be collected)        3. Excess ascites at time of paracentesis (if performed for diagnostic/therapeutic          purposes)        4. Additional blood (30ml) within 3 days of surgery        5. Excess tumor tissue and ascites at the time of cytoreductive surgery        6. Blood (30ml) at the next scheduled visit after completion of post-surgical adjuvant          therapy.   "|Undecided||2017-10-10 22:01:17.836504|2017-10-10 22:01:17.836504
NCT02824315|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-11-30|||May 2016||2016-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese Participants|A Phase 1, Open-label, Fixed Sequence Study to Investigate the Pharmacokinetic Interaction Between 2 Direct Acting Antiviral Agents Odalasvir and AL-335 and Between 3 Direct Acting Antiviral Agents Simeprevir, Odalasvir and AL-335 at Steady State in Healthy Japanese Subjects|Completed||Phase 1|22|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 22:01:17.944488|2017-10-10 22:01:17.944488
NCT02824302|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-11-15|||July 2016||2016-07-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Observational|||3 Simple Questions to Predict Labor Pain and Epidural Analgesia Use in Parturients|A Prospective Observational Study to Evaluate Efficacy of Simple Questions to Predict Labor Pain and Epidural Analgesia Use in Parturients|Recruiting||N/A|50|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||Yes||2017-10-10 22:01:18.045968|2017-10-10 22:01:18.045968
NCT02824289|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-24|||July 1, 2009|Actual|2009-07-01|July 2017|2017-07-01|December 31, 2015|Actual|2015-12-31|April 30, 2015|Actual|2015-04-30||Interventional|SSW||Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers|Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers|Completed||N/A|1019|Actual|Klein Buendel, Inc.||2|||f||||f|f|f||||||||2017-10-10 22:01:18.149656|2017-10-10 22:01:18.149656
NCT02824276|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-05|||January 6, 2017|Actual|2017-01-06|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain|Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain|Recruiting||Phase 1|100|Anticipated|Brigham and Women's Hospital||2|||f||||t|t|f||||||||2017-10-10 22:01:18.373819|2017-10-10 22:01:18.373819
NCT02824263|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-11-02|||July 2013||2013-07-01|November 2016|2016-11-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|MIIC||Metabolic Impact of Intermittent CPAP|Metabolic Impact of Intermittent CPAP|Recruiting||N/A|144|Anticipated|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 22:01:18.465214|2017-10-10 22:01:18.465214
NCT02824250|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-26|||March 9, 2017|Actual|2017-03-09|April 2017|2017-04-01|May 31, 2019|Anticipated|2019-05-31|December 31, 2018|Anticipated|2018-12-31||Interventional|M&M||Mindfulness and Migraine Research Study|Mindfulness and Migraine: A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|California Pacific Medical Center Research Institute||2|||f||||t|f|f||||||Undecided||2017-10-10 22:01:18.575797|2017-10-10 22:01:18.575797
NCT02824237|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||GEOHealth Hub: Household Air Pollution and Cardio-pulmonary and Immune Function Outcomes|Bangladesh Center for Global Environmental and Occupational Health: A Study of Effects of Household Air Pollution on Cardio-pulmonary and Immune Function Outcomes Among Nonsmokers and Their Potential Prevention Avenues in Rural Bangladesh|Not yet recruiting||N/A|200|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||1|||f||||t|f|f||||||||2017-10-10 22:01:18.670835|2017-10-10 22:01:18.670835
NCT02824224|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-02|2017-02-03|||September 2016||2016-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)|Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)|Recruiting||Phase 4|42|Anticipated|Oregon Health and Science University||2|||f||||f||||||||No||2017-10-10 22:01:18.774834|2017-10-10 22:01:18.774834
NCT02824211|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-26|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Demonstrating the Feasibility of a Novel Oxygen Delivery Device|Demonstrating the Feasibility of a Novel Oxygen Delivery Device in Responding to Real Time Oxygen Needs (The Right Dose System, RDS)|Not yet recruiting||N/A|10|Anticipated|Loma Linda University||1|||f||||f|f|t|f|f|f|||||2017-10-10 22:01:18.876803|2017-10-10 22:01:18.876803
NCT02824198|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-08-21|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|February 21, 2019|Anticipated|2019-02-21|February 21, 2019|Anticipated|2019-02-21||Interventional|||Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule|Immunogenicity and Safety of a Tetravalent Dengue Vaccine Given as a Booster Injection in Adolescents and Adults Who Previously Completed the 3-dose Schedule in a Study Conducted in Singapore|Active, not recruiting||Phase 2|260|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:01:18.964154|2017-10-10 22:01:18.964154
NCT02824185|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-17|||June 14, 2017|Actual|2017-06-14|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|March 2020|Anticipated|2020-03-01||Interventional|TOMIC||Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) in Curative Treatment of a Hepatocellular Carcinoma|Potential Interest of Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) for the Selection of Patients Proposed for Curative Treatment of a Hepatocellular Carcinoma|Recruiting||N/A|70|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 22:01:19.079522|2017-10-10 22:01:19.079522
NCT02824146|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-01|||August 2014||2014-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Lung Recruitment Assessment With Lung Ultrasound In Pediatric Patient Scheduled For Laparoscopic Surgery|Lung Recruitment Assessment With Lung Ultrasound In Pediatric Patient Scheduled For Abdominal Laparoscopic Surgery|Completed||N/A|42|Actual|Hospital Privado de Comunidad de Mar del Plata||2|||f||||t||||||||Undecided||2017-10-10 22:01:19.426471|2017-10-10 22:01:19.426471
NCT02824133|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-08-11|||September 2015||2015-09-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|March 2017|Actual|2017-03-01||Interventional|TARGET||"Treatment With AZD4547 for Recurrent Malignant Glioma Expressing FGFR-TACC Gene Fusion"|A Phase I/II, Open-Label, Multicentre Study to Assess The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of AZD4547 in Patients With Relapsed/Refractory Glioma Positive for an FGFR Fusion|Suspended||Phase 1/Phase 2|38|Anticipated|Assistance Publique - Hôpitaux de Paris||1||Intermedary analysis of 12 first patients' data results|f||||t||||||||||2017-10-10 22:01:19.494258|2017-10-10 22:01:19.494258
NCT02824120|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-07|||June 2013|Actual|2013-06-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of Laugh Therapy Associated to Cardiopulmonary Rehab|Effects of Laugh Therapy Associated to Cardiopulmonary and Metabolic Rehabilitation in Ischemic Heart Disease: Randomized Clinical Trial|Recruiting||N/A|36|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:01:19.588294|2017-10-10 22:01:19.588294
NCT02824094|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-07-18||||||July 2017|2017-07-01||||||||Expanded Access|||Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC|Crizotinib (Xalkori (Registered)) Expanded Access Protocol For The Treatment Of Japanese Patients With Advanced Non-small Cell Lung Cancer (Nsclc) Harboring A Translocation Or Inversion Involving The Ros1 Oncogene|No longer available||N/A|||Pfizer|||||f||||||||||||||2017-10-10 22:01:19.761993|2017-10-10 22:01:19.761993
NCT02824081|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||November 2015||2015-11-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|NISIS||Neuroinflammation, Serotonin, Impulsivity and Suicide|Neuroinflammation, Serotonin, Impulsivity and Suicide|Recruiting||N/A|280|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:01:19.831507|2017-10-10 22:01:19.831507
NCT02824068|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-16|||June 2016||2016-06-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|ATBIG||Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (ATBIG-Pompe-Study)|Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months|Recruiting||N/A|100|Anticipated|Klinikum der Universitaet Muenchen|||1||f||||f||||||Samples With DNA|"     Blood and urine samples to be collected for exploratory research, Genetic/Genomic testing is     optional requiring specific consent   "|||2017-10-10 22:01:19.909909|2017-10-10 22:01:19.909909
NCT02824055|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-06-06|||June 27, 2016|Actual|2016-06-27|June 2017|2017-06-01|April 24, 2017|Actual|2017-04-24|April 24, 2017|Actual|2017-04-24||Interventional|||A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics||Completed||Phase 1|33|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-10 22:01:20.141906|2017-10-10 22:01:20.141906
NCT02824042|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-18|||September 12, 2016|Actual|2016-09-12|September 2017|2017-09-01|November 2, 2018|Anticipated|2018-11-02|October 31, 2018|Anticipated|2018-10-31||Interventional|||Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole|An Open Label, Phase I Study to Assess the Effect of Itraconazole (CYP3A4 and P-gp Inhibitor) on the Pharmacokinetics of Anetumab Ravtansine and to Assess the ECG Effects, Safety and Immunogenicity of Anetumab Ravtansine Given as a Single Agent and Together With Itraconazole in Subjects With Mesothelin-expressing Advanced Solid Cancers|Recruiting||Phase 1|61|Anticipated|Bayer||1|||f||||f|t|f||||||||2017-10-10 22:01:20.299155|2017-10-10 22:01:20.299155
NCT02824029|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-03-28|||June 2016||2016-06-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma|A Phase II Multicenter Single Arm Study to Evaluate the Efficacy and Safety of Single Agent Bruton's Tyrosine Kinase Inhibitor, Ibrutinib, in Patients With Relapsed Refractory Classical Hodgkin's Lymphoma|Recruiting||Phase 2|35|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-10 22:01:20.481297|2017-10-10 22:01:20.481297
NCT02824016|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-08-23|||February 2013||2013-02-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2015|Actual|2015-07-01||Interventional|EPITHERM||Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation|A Prospective Multicentric Evaluation of the Rate of Incidence of Hypothyroidism After Supraclavicular Irradiation for Breast Cancer|Active, not recruiting||N/A|500|Anticipated|Institut Jean-Godinot||2|||f||||t||||||||||2017-10-10 22:01:20.593716|2017-10-10 22:01:20.593716
NCT02824003|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-03-08|||April 2016||2016-04-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||Study to Evaluate the Effect of ISIS GCGRRx on Hepatic Lipid and Glycogen Content in Type 2 Diabetes|Double Blind, Randomized, Placebo-Controlled, Phase 2A Mechanistic Study to Evaluate the Effect of ISIS 449884 (ISIS-GCGRRx) on Hepatic Lipid and Glycogen Content in Patients With Type 2 Diabetes Being Treated With Metformin|Active, not recruiting||Phase 2|15|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:01:20.677822|2017-10-10 22:01:20.677822
NCT02823990|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-08-23|||December 2016||2016-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||TG4010 and Nivolumab in Patients With Lung Cancer|Phase II Trial of TG4010 Plus Nivolumab in Previously Treated Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|33|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 22:01:20.769505|2017-10-10 22:01:20.769505
NCT02823977|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-07-14|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal|A Randomized, Double-blind Study of Ketamine / Dexmedetomidine vs. Placebo / Dexmedetomidine as Adjunctive Therapies for Severe Alcohol Withdrawal|Not yet recruiting||Phase 4|20|Anticipated|University of Colorado, Denver||2|||f||||f|t|f||||||||2017-10-10 22:01:20.892474|2017-10-10 22:01:20.892474
NCT02823964|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-10-02|||September 2016||2016-09-01|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||EASY: Extended Access to Sollpura Over Years|An Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis|Recruiting||Phase 4|70|Anticipated|Anthera Pharmaceuticals||1|||f||||t||||||||||2017-10-10 22:01:20.995363|2017-10-10 22:01:20.995363
NCT02823951|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-06-14|||February 2016||2016-02-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|April 2017|Actual|2017-04-01||Observational|PROTRACT||Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®|Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study (PROTRACT)|Active, not recruiting||N/A|479|Actual|IMS HEALTH GmbH & Co. OHG|||10||f||||f||||||||No||2017-10-10 22:01:21.161154|2017-10-10 22:01:21.161154
NCT02823938|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||April 2016||2016-04-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|EXMEDEM||DRUG EXPOSURE AND RISK OF DEMENTIA|DRUG EXPOSURE AND RISK OF DEMENTIA: Sample Analysis Generalist Beneficiaries of Health Insurance From 2004 to 2014|Recruiting||N/A|120000|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||Yes|ND|2017-10-10 22:01:21.320115|2017-10-10 22:01:21.320115
NCT02823925|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-05|||February 2013||2013-02-01|July 2016|2016-07-01||||January 2015|Actual|2015-01-01||Observational|||Bisphosphonate Therapy in MONA Spectrum Disorder|Bisphosphonates in Multicentric Osteolysis, Nodulosis and Arthropathy (MONA) Spectrum Disorder - an Alternative Therapeutic Approach|Completed||N/A|3|Actual|Medical University Innsbruck|||1||f||||||||||||||2017-10-10 22:01:21.39375|2017-10-10 22:01:21.39375
NCT02823912|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-15|||October 2016||2016-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Capsaicin Effect on Cytokines Profile in Dyslipidemia|Effect of Administration of Capsaicin on Inflammatory Cytokines Profile(TNFα , IL - 1β , IL - 6, IL -8 , MIP - 1β) in Individuals With Dyslipidemia.|Not yet recruiting||Phase 2/Phase 3|17|Anticipated|University of Guadalajara||2|||f||||t||||||||No||2017-10-10 22:01:21.475744|2017-10-10 22:01:21.475744
NCT02823899|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-23|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine|A Phase I/II Dose-escalation Study to Evaluate Safety, Tolerability and Immunogenicity of '2-dose Primary Series' Single Strain (Hikojima Serotype) Inactivated Oral Cholera Vaccine Formulations (Two Formulations Based on Total O1 LPS Content), in Sequential Age Descending Population of Healthy Adults and Children|Active, not recruiting||Phase 1/Phase 2|840|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 22:01:21.581501|2017-10-10 22:01:21.581501
NCT02823886|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-25|||January 21, 2017|Actual|2017-01-21|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|RIFIFI||Inflammatory Response in Myocardial Infarction Evaluated by MRI and Biomarkers|Inflammatory Response in Myocardial Infarction Evaluated by MRI and Biomarkers of Inflammation|Completed||N/A|21|Actual|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 22:01:21.700775|2017-10-10 22:01:21.700775
NCT02823873|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Observational|||Validation of Pulsewave Blood Pressure Monitor in Hypertensive and Normotensive Pregnant and Postpartum Women|Validation of Pulsewave Oscillometric Wrist Cuff Blood Pressure Monitor in Hypertensive and Normotensive Pregnant and Postpartum Women|Withdrawn||N/A|0|Actual|University of Arkansas|||2|Study submitted in error|f||||f||||||||Undecided|Data will be de-identified. Data may be relevant to future studies regarding mobile health technology.|2017-10-10 22:01:21.828315|2017-10-10 22:01:21.828315
NCT02823860|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-04-25|||February 2016||2016-02-01|May 2016|2016-05-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|BIG-RENAPE||Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface Malignancies|Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface Malignancies|Recruiting||N/A|15000|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:01:21.900648|2017-10-10 22:01:21.900648
NCT02823847|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-01-03|||July 2016||2016-07-01|January 2017|2017-01-01||||July 2018|Anticipated|2018-07-01||Interventional|||Non Invasive Oral Cancer Screening Among HIV Infected Individuals|Non-invasive Oral Cancer Screening Among Individuals Who Have HIV Infection|Recruiting||Early Phase 1|80|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:01:21.992521|2017-10-10 22:01:21.992521
NCT02823834|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-06-19|||June 16, 2017|Actual|2017-06-16|June 2016|2016-06-01|June 2027|Anticipated|2027-06-01|June 2027|Anticipated|2027-06-01||Observational|||PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components|Post Market Clinical Follow-up Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components|Recruiting||N/A|143|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||No||2017-10-10 22:01:22.092693|2017-10-10 22:01:22.092693
NCT02823821|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-03-20|||June 2016||2016-06-01|July 2016|2016-07-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|RESOLVE||Randomised Evaluation of Sodium Dialysate Levels on Vascular Events|Randomised Evaluation of Sodium Dialysate Levels on Vascular Events|Recruiting||Phase 4|51520|Anticipated|The George Institute||2|||f||||t||||||||Undecided||2017-10-10 22:01:22.182295|2017-10-10 22:01:22.182295
NCT02823808|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-07-21|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|||Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function|Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function After Early Intensive Diabetes Treatment|Recruiting||Phase 4|96|Anticipated|Kyunghee University Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:01:22.275443|2017-10-10 22:01:22.275443
NCT02823795|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-12-10|||September 2016||2016-09-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|[sPATH]||The Supporting Patient Activation in Transition to Home Intervention|The Supporting Patient Activation in Transition to Home (sPATH) Intervention - a Study Protocol of Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 22:01:22.356983|2017-10-10 22:01:22.356983
NCT02817698|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-06-01|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Imaging the Neurochemistry of Drug Addiction With PET|Imaging the Neurochemistry of Drug Addiction With PET|Not yet recruiting||Early Phase 1|90|Anticipated|Yale University||1|||f||||f|t|f||||||No||2017-10-10 22:02:23.082496|2017-10-10 22:02:23.082496
NCT02823782|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-30|||May 2013||2013-05-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|HP||MRI Investigations in Attention Deficit Hyperactivity Disorder (ADHD) and High Potential (HP) Children for a Better Therapeutic Approach|MRI Investigations in Attention Deficit Hyperactivity Disorder (ADHD) and High Potential (HP) Children for a Better Therapeutic Approach|Completed||N/A|74|Actual|Hospices Civils de Lyon||4|||f||||f||||||||||2017-10-10 22:01:22.446216|2017-10-10 22:01:22.446216
NCT02823769|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-08-09|||January 2016||2016-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Evaluation of SI-R21204 Versus Nano-hybrid Resin Composite: A Prospective Controlled Clinical Trial|Clinical Evaluation of Restoration Made of SI-R21204 Resin Composite Based on S-PRG Filler Technology Versus Nano-hybrid Resin Composite: A Prospective Controlled Clinical Trial up to 3 Years|Recruiting||N/A|40|Anticipated|Istanbul Medipol University Hospital||2|||f||||f||||||||||2017-10-10 22:01:22.520607|2017-10-10 22:01:22.520607
NCT02823756|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-06-30|||March 2015||2015-03-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Short-Term Effects of PT on Physical Activity|The Short-Term Effects of Manipulation and Physical Therapy on Physical Activity Levels|Completed||N/A|27|Actual|Texas Woman's University||1|||f||||f||||||||No||2017-10-10 22:01:22.608142|2017-10-10 22:01:22.608142
NCT02823743|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-05|||March 2008||2008-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|RECAB-ASA||RECAB-ASA; Treatment of Recurrent Abortion With Aspirin|Treatment of Recurrent Abortion With Low Dose Aspirin - a Randomized Placebo Controlled Trial|Completed||N/A|400|Actual|Göteborg University||2|||f||||f||||||||Undecided||2017-10-10 22:01:22.798744|2017-10-10 22:01:22.798744
NCT02823730|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-05|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy|Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy (REWARDS-Synergy)|Not yet recruiting||N/A|500|Anticipated|Medstar Health Research Institute|||2||f||||f||||||||||2017-10-10 22:01:22.905169|2017-10-10 22:01:22.905169
NCT02823717|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-21|||January 31, 2015|Actual|2015-01-31|June 2016|2016-06-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01|3 Years|Observational [Patient Registry]|||Obstetric and Proctology Support of Patients With Perineums Suits|Obstetric and Proctology Support of Patients With Perineums Suits. Prospective Cohort|Recruiting||N/A|200|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 22:01:23.005644|2017-10-10 22:01:23.005644
NCT02823704|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-03-17|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|ADRISK||Proadrenomedullin for Early Risk Assessment in the Emergency Department|A Prospective Clinical Trial of the Efficacy of Mid-regional Proadrenomedullin in the Triage and Multi-dimensional Risk Assessment of Patients Admitted to the Emergency Department|Completed||N/A|300|Actual|University of Athens|||1||f||||f||||||Samples Without DNA|"     Plasma samples on study enrolment   "|No||2017-10-10 22:01:23.083524|2017-10-10 22:01:23.083524
NCT02823691|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-30|||April 2016||2016-04-01|June 2016|2016-06-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|MetNET-2||The MetNET-2 Trial|Safety of Lanreotide 120 mg ATG in Combination With Metformin in Patients With Progressive Advanced Well-differentiated Gastro-intestinal (GI) or Lung Carcinoids: A Pilot, One-arm, Open-label, Prospective Study: the MetNET-2 Trial|Recruiting||Early Phase 1|20|Anticipated|National Cancer Institute, Milan||1|||f||||f||||||||||2017-10-10 22:01:23.170634|2017-10-10 22:01:23.170634
NCT02823678|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-26|||October 2013||2013-10-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||Pancreas Volume and Diabetes Status Following Pancreatectomy|Using Pancreatic Volumetric to Determine the Onset of Diabetes Mellitus and Postoperative Outcomes After Pancreatectomy|Enrolling by invitation||N/A|100|Actual|Florida Hospital Tampa Bay Division|||1||f||||f||||||||||2017-10-10 22:01:23.28712|2017-10-10 22:01:23.28712
NCT02823652|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-10-04|||September 2016||2016-09-01|October 2016|2016-10-01||||September 2020|Anticipated|2020-09-01||Interventional|||Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer|COMET - Communication and Education in Tumor Profiling: A Randomized Study of Pre-Test Genetic Education v. Usual Care in Tumor Profiling for Advanced Cancer and a Pilot Study of Remote Genetic Counseling for Participants With Potential Germline Mutations Identified on Tumor Profiling|Recruiting||N/A|400|Anticipated|Eastern Cooperative Oncology Group||3|||f||||f||||||||||2017-10-10 22:01:23.503897|2017-10-10 22:01:23.503897
NCT02823639|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-30|||October 2015||2015-10-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Mechanisms of Transcranial Direct Current Stimulation (tDCS) - Effects on Working Memory in Schizophrenia|Efficacy and Mechanisms of Transcranial Direct Current Stimulation (tDCS) - Effects on Working Memory in Schizophrenia|Recruiting||N/A|128|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||Undecided||2017-10-10 22:01:23.66854|2017-10-10 22:01:23.66854
NCT02823626|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-04|||September 2016||2016-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure|High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure|Recruiting||N/A|20|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||Undecided||2017-10-10 22:01:23.813308|2017-10-10 22:01:23.813308
NCT02823613|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-30|||August 2016||2016-08-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|March 2017|Anticipated|2017-03-01||Interventional|||The Influence of High and Low Salt on Exosomes in the Urine|The Influence of High and Low Salt on Exosomes in the Urine|Not yet recruiting||N/A|10|Anticipated|University of Southern Denmark||2|||f||||t||||||||No||2017-10-10 22:01:23.950212|2017-10-10 22:01:23.950212
NCT02823600|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-06-19|||July 2016||2016-07-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers|A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers|Completed||N/A|68|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||No||2017-10-10 22:01:24.084265|2017-10-10 22:01:24.084265
NCT02823587|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-16|||July 2016|Actual|2016-07-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Pulmonary Rehabilitation in Non-Cystic Fibrosis Bronchiectasis|Effects of Pulmonary Rehabilitation on Secretion Transport, Inflammation and Respiratory System Strength and Quality of Life in Patients With Bronchiectasis|Recruiting||N/A|60|Anticipated|University of Sao Paulo||4|||f||||t||||||||||2017-10-10 22:01:24.196977|2017-10-10 22:01:24.196977
NCT02823574|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-09-28|||September 22, 2016|Actual|2016-09-22|September 2017|2017-09-01|October 17, 2020|Anticipated|2020-10-17|May 30, 2018|Anticipated|2018-05-30||Interventional|CheckMate 714||Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|A Double-Blind, Randomized, Two Arm Phase 2 Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 2|400|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:01:24.349869|2017-10-10 22:01:24.349869
NCT02823561|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-08-30|||November 2015||2015-11-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Garcinia Mangostana Extracts in the Management of Weight Loss|Efficacy and Tolerability of Garcinia Mangostana Extracts in the Management of Weight Loss in Severe Obese Patients|Completed||Phase 4|40|Actual|University of Roma La Sapienza||2|||f||||f||||||||No||2017-10-10 22:01:24.848234|2017-10-10 22:01:24.848234
NCT02823548|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-11-10|||August 2016||2016-08-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|PICASSO||Primary Care Study With Chondroitin Sulfate and Glucosamine Hydrochloride in Hand Osteoarhritis|Double-blind, Randomised, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of the Combination of Chondroitin Sulphate and Glucosamine Hydrochloride in Patients With Hand Osteoarthritis|Recruiting||Phase 4|330|Anticipated|Bioiberica||2|||f||||f||||||||No||2017-10-10 22:01:24.939924|2017-10-10 22:01:24.939924
NCT02823535|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-13|||June 16, 2017|Actual|2017-06-16|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Iwin: Individual Well-Being Navigator|iWin: Navigating Your Path to Well-Being|Recruiting||N/A|812|Anticipated|Pro-Change Behavior Systems||2|||f||||t|f|f||||||||2017-10-10 22:01:25.130999|2017-10-10 22:01:25.130999
NCT02823522|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-20|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Observational|||Non-Celiac Wheat Sensitivity: Permanent or Transient Condition?|Non-Celiac Wheat Sensitivity: Permanent or Transient Condition? A Follow-up Study|Completed||N/A|276|Actual|University of Palermo|||1||f||||f||||||||No||2017-10-10 22:01:25.291196|2017-10-10 22:01:25.291196
NCT02823509|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-01|||December 2015||2015-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SPF Assay||Sun Protection Factor Assay(SPF Assay18668)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose.|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:25.386698|2017-10-10 22:01:25.386698
NCT02823496|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-01|||November 2015||2015-11-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||18349-Human Photoallergy Test|Human Photoallergy Test|Completed||N/A|60|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:25.481366|2017-10-10 22:01:25.481366
NCT02823483|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-01|||November 2015||2015-11-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||18348-Human Phototoxicity Test|Human Phototoxicity Test|Completed||N/A|35|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:25.578062|2017-10-10 22:01:25.578062
NCT02823470|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-09-06|||June 2016||2016-06-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation|A Phase 4, Open-label Treatment, Randomized, Multicenter, 2-arm, Parallel-group, Pilot Study of Adherence to Lumacaftor/Ivacaftor in CF Subjects Homozygous for the F508del CFTR Mutation|Terminated||Phase 4|24|Actual|Vertex Pharmaceuticals Incorporated||2||Study terminated early due to slow recruitment of patients.|f||||f||||||||||2017-10-10 22:01:25.66407|2017-10-10 22:01:25.66407
NCT02823457|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-07-31|||April 5, 2017|Actual|2017-04-05|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|VBMI SUD/HCV||VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C|Evaluating Values-based Motivational Interviewing to Increase Treatment Completion With Fixed Dose Combination MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders and Treatment-naïve Genotype 1 Chronic Hepatitis C|Recruiting||N/A|30|Anticipated|G.V. (Sonny) Montgomery VA Medical Center||1|||f||||f|f|f||||||||2017-10-10 22:01:25.783265|2017-10-10 22:01:25.783265
NCT02823444|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2016-07-01|||April 2008||2008-04-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Non-Contrast Enhanced Peripheral Magnetic Resonance Angiography|Non-Contrast Enhanced Peripheral Magnetic Resonance Angiography|Enrolling by invitation||N/A|200|Anticipated|University of Utah|||2||f||||f||||||||No||2017-10-10 22:01:25.86783|2017-10-10 22:01:25.86783
NCT02823418|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-30|||July 2014||2014-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01|6 Weeks|Observational [Patient Registry]|||Neuraxial Labor Analgesia and the Incidence of Postpartum Depression|Impact of Neuraxial Labor Analgesia on the Incidence of Postpartum Depression: a Prospective, Observational, Multicenter Cohort Study|Completed||N/A|577|Actual|Peking University First Hospital|||2||f||||t||||||||Yes||2017-10-10 22:01:26.063332|2017-10-10 22:01:26.063332
NCT02823405|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-02-08|||June 2016||2016-06-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|X4P-001-MELA||X4P-001 and Pembrolizumab in Patients With Advanced Melanoma|A Phase 1b Trial of X4P-001 Alone and With Pembrolizumab in Patients With Advanced Melanoma|Recruiting||Phase 1|15|Anticipated|X4 Pharmaceuticals||1|||f||||f||||||||No||2017-10-10 22:01:26.168227|2017-10-10 22:01:26.168227
NCT02823392|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||September 2008||2008-09-01|June 2016|2016-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Difficult Bag Mask Ventilation in Children|Predictors of Unanticipated Difficult Bag Mask Ventilation in Children: A Prospective Cohort Study|Completed||N/A|765|Actual|Prince of Songkla University|||1||f||||t||||||||Yes|data was also sent to Anesthesia Department, McGill University, Canada|2017-10-10 22:01:26.436911|2017-10-10 22:01:26.436911
NCT02823379|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-07-05|||September 2015||2015-09-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Smart Walk: A Physical Activity Program for African American Women|Smart Walk: A Physical Activity Program for African American Women|Active, not recruiting||N/A|60|Anticipated|Arizona State University||2|||f||||f||||||||||2017-10-10 22:01:26.549207|2017-10-10 22:01:26.549207
NCT02823366|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-07-05|||January 2016||2016-01-01|June 2016|2016-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid||Recruiting||Phase 3|200|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||||||||||||2017-10-10 22:01:26.665143|2017-10-10 22:01:26.665143
NCT02823353|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-07-05|||January 2016||2016-01-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis|Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis: a Randomized Control Study|Recruiting||Phase 3|200|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||f||||||||||2017-10-10 22:01:26.849658|2017-10-10 22:01:26.849658
NCT02823340|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-07-06|||March 2016||2016-03-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis||Enrolling by invitation||N/A|20|Anticipated|Xijing Hospital||1|||f||||||||||||||2017-10-10 22:01:27.040369|2017-10-10 22:01:27.040369
NCT02823327|ClinicalTrials.gov processed this data on October 10, 2017|2016-07-01|2017-05-26|||March 2016||2016-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Clinical Factors and Gene Expression Analysis for Prognosis in Tissue Samples From Patients With AIDS-Related Primary Effusion Lymphoma|Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma|Recruiting||N/A|80|Anticipated|AIDS Malignancy Consortium|||1||f||||f||||||Samples With DNA|"     Tissues slides for verification of pathological diagnosis of primary effusion lymphoma.      Paraffin embedded tissues or cytology block or frozen tissue specimen for genomic analysis.   "|Undecided||2017-10-10 22:01:27.192514|2017-10-10 22:01:27.192514
NCT02823314|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-30|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Interventional|||Effectiveness of Medical Taping Concept in Cancer Patients|Effectiveness of Medical Taping Concept Applied in the T7-T8 Dermatome in Nausea and Vomiting After Chemotherapy in Cancer Patients|Recruiting||Early Phase 1|20|Anticipated|Universidad Miguel Hernandez de Elche||2|||f||||t||||||||No|Spanish law: 15/1999 Data Protection|2017-10-10 22:01:27.362961|2017-10-10 22:01:27.362961
NCT02823301|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-09-28|||July 2016||2016-07-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||VAMOS Program at Different Environments of Florianópolis|Implementation of VAMOS Program at Health Centers of Florianópolis: Analysis of Different Environments Settings|Active, not recruiting||N/A|120|Actual|Universidade Federal de Santa Catarina||2|||f||||t||||||||Undecided||2017-10-10 22:01:27.533559|2017-10-10 22:01:27.533559
NCT02823288|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-30|||February 2016||2016-02-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Sonke CHANGE||Multilevel Intervention for Preventing Men's Use of Violence in Urban South Africa (Sonke CHANGE Trial)|Refinement and Evaluation of a Multilevel Intervention for Preventing Men's Use of Violence in Urban South Africa (Sonke CHANGE Trial)|Recruiting||N/A|2880|Anticipated|University of Witwatersrand, South Africa||2|||f||||t||||||||Yes|Data will be available 5 years after the end of the research through an institutional repository managed by the South African MRC. Data sharing will be managed through an application process, whereby the original investigators will be invited to participate in future papers.|2017-10-10 22:01:27.649126|2017-10-10 22:01:27.649126
NCT02823275|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-05|||January 2012||2012-01-01|June 2016|2016-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Post Operative Quality of Life and Pain in Ankle Fractures: Cast Versus Functional Treatment|Post Operative Evaluation of Quality of Life and Pain in Ankle Fractures: Cast Immobilisation Versus Functional Treatment|Terminated||N/A|13|Actual|Rijnstate Hospital||2||Investigator changed jobs|f||||||||||||||2017-10-10 22:01:27.801173|2017-10-10 22:01:27.801173
NCT02823262|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-01-23|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|July 2024|Anticipated|2024-07-01|July 2022|Anticipated|2022-07-01||Interventional|||A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older|A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older|Recruiting||N/A|312|Anticipated|Dana-Farber Cancer Institute||2|||f||||f||||||||No||2017-10-10 22:01:27.943326|2017-10-10 22:01:27.943326
NCT02823249|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-02-26|||May 2014||2014-05-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Amino Acids and Sugar Alcohols on Satiation Peptides and Activation of Specific Brain Regions|Effect of Amino Acids and Sugar Alcohols on Release of Satiation Peptides and Activation of Specific Brain Regions in Normal Weight and Obese Subjects|Completed||N/A|20|Actual|University Hospital, Basel, Switzerland||6|||f||||f|f|f||||||Undecided||2017-10-10 22:01:28.112259|2017-10-10 22:01:28.112259
NCT02823236|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-12|||October 24, 2016|Actual|2016-10-24|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|December 31, 2019|Anticipated|2019-12-31||Interventional|LADISLAO||Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars|Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars: 3-arm Trial|Recruiting||Phase 3|102|Anticipated|Centro Dermatológico Dr. Ladislao de la Pascua||3|||f||||t||||||||||2017-10-10 22:01:28.27973|2017-10-10 22:01:28.27973
NCT02823223|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-06-30|||June 2016||2016-06-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Endobronchial Valve in Patients With Heterogeneous Emphysema|A Multi-center, Prospective, Randomized, Controlled Trial of Endobronchial Valve Therapy vs. Standard of Care in Heterogeneous Emphysema|Active, not recruiting||N/A|72|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||No|Because of personal privacy, the research-related individual participant data do not intend for public sharing.|2017-10-10 22:01:28.452034|2017-10-10 22:01:28.452034
NCT02823210|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|CTIM3||Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders|Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Neoplasms (CTIM3)|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Molecular markers include mutations in JAK2, MPL, TET2, LNK, CBL, IDH1/2, DNMT3A, EZH2,     ASXL1, SF3B1, SRSF2, NRAS/KRAS, and TP53   "|Undecided||2017-10-10 22:01:28.586215|2017-10-10 22:01:28.586215
NCT02823197|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-06-30|||September 2014||2014-09-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||An Intervention to Promote Active Transport for Short Distance Travel in Older Adolescents||Completed||N/A|860|Actual|University Ghent||3|||f||||||||||||||2017-10-10 22:01:28.685483|2017-10-10 22:01:28.685483
NCT02823184|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-25|||April 27, 2017|Actual|2017-04-27|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|PhiNESS||Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms|Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms|Recruiting||N/A|200|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 22:01:28.805749|2017-10-10 22:01:28.805749
NCT02823171|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-30|||August 2015||2015-08-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||To Assess the Bioequivalence of Two Pacritinib Drug Product Formulations and FMI Formulation Following Oral Administration in Healthy Subjects|A Phase 1, Open-Label, Single-Dose, Randomized, 2-Period Crossover Study to Assess the Bioequivalence of Two Pacritinib Drug Product Formulations (Phase 3 Clinical Trial [P3CT] Formulation [Reference] and Final Market Image [FMI] Formulation [Test]) Following Oral Administration in Healthy Subjects|Completed||Phase 1|28|Actual|CTI BioPharma||2|||f||||||||||||Yes||2017-10-10 22:01:28.982212|2017-10-10 22:01:28.982212
NCT02823158|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-05-08|||September 2016||2016-09-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|LATESTIM||Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM|A Prospective Randomized Controlled Trial of Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease With Motor Complications and Relative or Absolute Contraindications for Subthalamic Stimulation|Recruiting||N/A|55|Anticipated|University Hospital Inselspital, Berne||2|||f||||||||||||||2017-10-10 22:01:29.094801|2017-10-10 22:01:29.094801
NCT02823145|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-07-04|||June 2016||2016-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome|An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome|Enrolling by invitation||Phase 3|210|Anticipated|Zogenix, Inc.||1|||f||||t||||||||||2017-10-10 22:01:29.235336|2017-10-10 22:01:29.235336
NCT02823132|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-05||||||June 2016|2016-06-01||||June 2015|Actual|2015-06-01||Observational|MBL INFFONG||Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia|Study of the Level of Mannose Binding Lectin (MBL) as a Predictor of the Onset of a Invasive Fungal Infection (IFI) During Chemo-induced Aplasia in Patients With Acute Leukemia (AL)|Completed||N/A|134|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 22:01:29.417938|2017-10-10 22:01:29.417938
NCT02823119|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-30|||August 2016||2016-08-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Mini-hysteroscopy Versus Conventional Office Hysteroscopy in Nulliparous Patients Undergoing Office Hysteroscopy|Mini-hysteroscopy Versus Conventional Office Hysteroscopy in Nulliparous Patients Undergoing Diagnostic Office Hysteroscopy: A Randomized Controlled Trial|Not yet recruiting||Phase 2|100|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 22:01:29.5023|2017-10-10 22:01:29.5023
NCT02823106|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-09-21|||August 2016||2016-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|SCAVINGER||Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response|Superselective Citicoline And Verapamil for Ischemic Neuroprotection and Greater Effective Response (SCAVINGER) in the Kentucky Regional Population: A Clinical and Translational Study|Withdrawn||Phase 1|0|Actual|University of Kentucky||2||Study put on clinical hold by FDA. Sponsor decided to no pursue the study.|f||||t||||||||No||2017-10-10 22:01:29.584946|2017-10-10 22:01:29.584946
NCT02823093|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-30|||April 2016||2016-04-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|AVKAL||Aortic Calcification and Vitamin K Antagonists|Aortic Calcification and Vitamin K Antagonists|Recruiting||N/A|338|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||Samples With DNA|"     A tube of blood on EDTA tubes of 6 ml will be taken at the elbow to the Clinical Research     Center and then frozen at -80 ° . At the end of the study the tubes of all patients will be     routed to VetAgro Sup Lyon in dry ice.      DNA will be extracted from EDTA tubes . It will be stored frozen in the laboratory until     analysis of polymorphisms of interest, by PCR technique .      The promoter and the coding sequence of VKORC1 will be amplified by PCR and sequenced to     detect the possible presence of SNPs   "|||2017-10-10 22:01:29.670033|2017-10-10 22:01:29.670033
NCT02823080|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-03-01|2016-08-19||October 2014||2014-10-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome|Sequential E2 Levels Not Ovarian Maximal Diameter Estimates Were Correlated With Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome|Active, not recruiting||Phase 2/Phase 3|48|Actual|Benha University|no Limitations and Caveats|2|||f||||t||||||||No||2017-10-10 22:01:29.773265|2017-10-10 22:01:29.773265
NCT02823067|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-30|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SSENIOR||Pruritus and Pemphigoid in Nursing Home Patients|Pruritus and Pemphigoid in Nursing Home Patients|Recruiting||N/A|126|Anticipated|University Medical Center Groningen|||1||f||||t||||||Samples Without DNA|"     Serum   "|Undecided||2017-10-10 22:01:30.816137|2017-10-10 22:01:30.816137
NCT02823054|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-03|||June 2016||2016-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|VUPPAM||One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery|One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery|Recruiting||N/A|208|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 22:01:30.914717|2017-10-10 22:01:30.914717
NCT02823041|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|CT&E-RCT||Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode|Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode|Recruiting||N/A|100|Anticipated|University of California, Los Angeles||2|||f||||t||||||||Yes|After primary results have been published, de-identified data for primary outcome variables will be available for sharing.|2017-10-10 22:01:30.998401|2017-10-10 22:01:30.998401
NCT02823028|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-05|||October 2016||2016-10-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|March 2021|Anticipated|2021-03-01||Interventional|Tweet2Quit||Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)|Social Media Technology for Treating Tobacco Addiction|Recruiting||Phase 2|960|Anticipated|University of California, Irvine||3|||f||||f||||||||Yes|Drs. Pechmann, Prochaska, and Delucchi will be responsible for making the study data available to other researchers in compliance with the NIH requirement for sharing data. Study data will be made available after publication of the primary outcome papers. The availability of the data will be announced via websites of the Paul Merage School of Business, the Stanford Prevention Research Center, in publications resulting from the study, and as part of all conference presentations. To obtain a copy of the data, a researcher will have to submit a request in writing. In that request they will have to identify themselves and their affiliated institution, indicate what they plan to do with the data and include assurances that they will not share the data with others without the written permission of the contact PI. They also will have to agree to give proper credit to NIH and the study investigators in any publications resulting from the data.|2017-10-10 22:01:31.109455|2017-10-10 22:01:31.109455
NCT02823015|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-30|||October 2014||2014-10-01|June 2016|2016-06-01||||March 2015|Actual|2015-03-01||Observational|||Acute Pain Trajectories and Persistent Pain After Breast Cancer Surgery|Acute Pain Trajectories as a Predictive Factor for Persistent Pain After Breast Cancer Surgery|Completed||N/A|46|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||t||||||||Undecided||2017-10-10 22:01:31.238484|2017-10-10 22:01:31.238484
NCT02823002|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-05|||June 2016||2016-06-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pain Perception: Lidocaine Rate/Temp/Buffer|The Impact of Anesthetic Injection Rate, Temperature and Buffering on Pain Perception During Dermatologic Procedures: a Multicenter, Single-blinded Randomized Control Trial|Recruiting||N/A|302|Anticipated|Northwestern University||6|||f||||t||||||||Undecided||2017-10-10 22:01:31.303509|2017-10-10 22:01:31.303509
NCT02822976|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-10-10|||September 2011||2011-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|July 2015|Actual|2015-07-01||Observational|||HbA1c and Outcomes in the Critically Ill|The Association Between Glycosylated Hemoglobin A1c (HbA1c) and Outcomes in the Critically Ill|Completed||N/A|2500|Actual|McGill University Health Center|||2||f||||f||||||||Yes||2017-10-10 22:01:31.502916|2017-10-10 22:01:31.502916
NCT02822963|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-06-30|||March 2016||2016-03-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Observational|||Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate||Recruiting||N/A|20|Anticipated|National Cheng-Kung University Hospital|||3||f||||f||||||||||2017-10-10 22:01:31.715444|2017-10-10 22:01:31.715444
NCT02822950|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill Patients||Not yet recruiting||Phase 1|12|Anticipated|Michigan State University||1|||f||||t||||||||No||2017-10-10 22:01:31.838172|2017-10-10 22:01:31.838172
NCT02822937|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-11-03|||July 2016||2016-07-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents|A Study to Assess the Sensitivity of Project: EVO Monitor Cognitive Function Measurements to Methylphenidate and Triazolam in Adults 40-55 Years Old|Completed||N/A|18|Actual|Akili Interactive Labs, Inc.||6|||f||||f||||||||No||2017-10-10 22:01:31.96427|2017-10-10 22:01:31.96427
NCT02822924|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-18|||April 2015||2015-04-01|June 2017|2017-06-01||||April 2018|Anticipated|2018-04-01||Interventional|||Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia|Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia|Recruiting||Phase 1/Phase 2|80|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-10 22:01:32.119228|2017-10-10 22:01:32.119228
NCT02822911|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-11-23|||March 2016||2016-03-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|Caesar||Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly|Benefit of Carbohydrate Deficient Transferrin to Detect Chronic Alcohol Abuse in the Elderly. A French Multicentered Prospective Interventional Study.|Completed||N/A|194|Actual|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace||1|||f||||f||||||||No||2017-10-10 22:01:32.276226|2017-10-10 22:01:32.276226
NCT02822898|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-08-07|||June 2016||2016-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|MIHMoSA||Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults|Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults, a Single-Blind Randomized Crossover Trial|Completed||Phase 4|12|Actual|University Hospital, Antwerp||2|||f||||f||||||||Undecided||2017-10-10 22:01:32.452845|2017-10-10 22:01:32.452845
NCT02822885|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-24|2016-08-31||January 2014||2014-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|November 2016|Actual|2016-11-01||Interventional|||Uterine Artery and Spiral Artery Doppler Parameters in Patients With Postmenopausal Bleeding|Uterine Artery and Spiral Artery Doppler Parameters in Patients With Postmenopausal Bleeding|Active, not recruiting||N/A|70|Actual|Benha University||1|||f||||f||||||||No||2017-10-10 22:01:32.622643|2017-10-10 22:01:32.622643
NCT02822872|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-01|||July 2016||2016-07-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|SFT||Relation Between Emotional Stress and Infertility|Relation Between Emotional Stress and Infertility|Not yet recruiting||N/A|600|Anticipated|Bnai Zion Medical Center|||1||f||||f||||||Samples Without DNA|"     Scalp hair   "|No||2017-10-10 22:01:33.030173|2017-10-10 22:01:33.030173
NCT02822859|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-10-13|||June 2016||2016-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Comparison of Three Nebulizers for Standard Clinical and Research Use in Methacholine Challenge Testing|A Comparison of Three Nebulizers for Standard Clinical and Research Use in Methacholine Challenge Testing|Completed||N/A|60|Actual|University of Saskatchewan||3|||f||||f||||||||Yes|Journal Publication|2017-10-10 22:01:33.124547|2017-10-10 22:01:33.124547
NCT02822846|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||July 2016||2016-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|ECOVERA||Evaluation of the Ability to Diagnose the Position of the Intubation Probe Thanks to Lung Ultrasonography|Evaluation of Diagnostic Qualities of Lung Ultrasonography to Monitor the Position of the Intubation Probe|Not yet recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 22:01:33.231002|2017-10-10 22:01:33.231002
NCT02822833|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-09-11|||July 2016||2016-07-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer||Recruiting||N/A|100|Anticipated|Ankara University||1|||f||||t||||||||Undecided||2017-10-10 22:01:33.33731|2017-10-10 22:01:33.33731
NCT02822820|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-04-22|||July 2016||2016-07-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||The Comparison of Conventional and Advanced Bipolar Energy Modalities During Laparoscopic Staging Surgery of Gynecologic Cancers|The Impact of Bipolar Energy Modalities on Peri-operative Outcome During Laparoscopic Staging Surgery of Gynecologic Cancers: A Randomized Clinical Trial|Completed||N/A|68|Actual|Ankara University||2|||f||||||||||||||2017-10-10 22:01:33.42861|2017-10-10 22:01:33.42861
NCT02822807|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||July 2013||2013-07-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|Q Fever||Q Fever and Auto-immunity|Q Fever and Auto-immunity|Recruiting||N/A|300|Anticipated|Assistance Publique Hopitaux De Marseille||4|||f||||||||||||||2017-10-10 22:01:33.510052|2017-10-10 22:01:33.510052
NCT02822794|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-06|||July 25, 2016|Actual|2016-07-25|September 2017|2017-09-01|August 25, 2017|Actual|2017-08-25|June 2, 2017|Actual|2017-06-02||Interventional|||Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen|A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Subjects With Chronic Genotype 1 or 2 HCV Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen|Completed||Phase 3|117|Actual|Gilead Sciences||2|||f||||f|t|f|||t|||||2017-10-10 22:01:33.634274|2017-10-10 22:01:33.634274
NCT02822781|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-09-07|||November 1, 2015|Actual|2015-11-01|September 2017|2017-09-01|July 21, 2016|Actual|2016-07-21|April 30, 2016|Actual|2016-04-30||Observational|||Chronic Rhinosinusitis Classification Proposal|Chronic Rhinosinusitis Classification Proposal: Evaluation of the Severity and the Effectiveness of Medical and Surgical Treatments|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 22:01:33.787238|2017-10-10 22:01:33.787238
NCT02822768|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-09-29|||August 2016||2016-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Packing Versus no Packing for Cutaneous Abscess|Is Routine Packing of Cutaneous Abscesses Necessary?|Recruiting||N/A|196|Anticipated|University of California, San Francisco||2|||f||||t||||||||No||2017-10-10 22:01:33.866192|2017-10-10 22:01:33.866192
NCT02822755|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-05-09|||June 2016||2016-06-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Home Exercise Adherence in Physical Therapy|Effectiveness of Individualized Video Recordings Versus Conventional Printed Instructions on Home Exercise Program Adherence in Physical Therapy|Recruiting||N/A|110|Anticipated|University of the Incarnate Word||2|||f||||t||||||||No|All individual data will be reported as a group|2017-10-10 22:01:33.978424|2017-10-10 22:01:33.978424
NCT02822742|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-06|||July 2016||2016-07-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|||A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study|A Phase III, Open-label, Single-arm, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension Who Are Non-/Low-responders to Latanoprost Ophthalmic Solution: FUJI Study|Recruiting||Phase 3|30|Anticipated|Santen Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:01:34.074757|2017-10-10 22:01:34.074757
NCT02822729|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-03|||July 2016||2016-07-01|July 2016|2016-07-01||||October 2017|Anticipated|2017-10-01||Interventional|||A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study|A Long-term Open-label Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension : RENGE Study|Recruiting||Phase 3|120|Anticipated|Santen Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-10 22:01:34.150763|2017-10-10 22:01:34.150763
NCT02822716|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-18|||November 2013||2013-11-01|June 2017|2017-06-01||||June 2018|Anticipated|2018-06-01||Interventional|IRE||Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy|Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy|Recruiting||Phase 2|35|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-10 22:01:34.231189|2017-10-10 22:01:34.231189
NCT02822703|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-01|||January 2015||2015-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|rTMS||Enhancing Relapse Prevention for Smoking Cessation With Repetitive Transcranial Magnetic Stimulation|Enhancing Relapse Prevention for Smoking Cessation With Repetitive Transcranial Magnetic Stimulation (rTMS)|Completed||N/A|29|Actual|The City College of New York||2|||f||||f||||||||No||2017-10-10 22:01:34.317387|2017-10-10 22:01:34.317387
NCT02822690|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-04-20|||October 2016||2016-10-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Research Into the Quality of the Dying Phase|Research Into the Quality of the Dying Phase in Hospitals in the Province of Groningen|Recruiting||N/A|200|Anticipated|University Medical Center Groningen|||3||f||||f||||||||No||2017-10-10 22:01:34.406607|2017-10-10 22:01:34.406607
NCT02822521|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-12-21|||November 2016||2016-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||A Novel Mobile App & Population Management System to Manage Rheumatoid Arthritis Flares|A Novel Mobile App & Population Management System to Manage Rheumatoid Arthritis Flares|Recruiting||N/A|190|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 22:01:35.591835|2017-10-10 22:01:35.591835
NCT02822677|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-14|||July 7, 2016|Actual|2016-07-07|August 2017|2017-08-01|January 30, 2017|Actual|2017-01-30|January 16, 2017|Actual|2017-01-16|7 Days|Observational [Patient Registry]|||A Cross-sectional Study on IBS Subtypes, Chinese Medicine Pattern and Host-gut Microbiota Metabolic Interactions|The Distribution of Irritable Bowel Syndrome (IBS) Subtypes, Chinese Medicine Pattern and Host-gut Microbiota Metabolic Interactions Associated With IBS Subtypes|Completed||N/A|504|Actual|Hong Kong Baptist University|||1||f||||t||||||Samples With DNA|"     Serum: The participants will be instructed to meet fasting for the blood sample collection     and 15ml whole blood will be drawn from the participants.      Stool: Fecal samples should be naturally excreted from subjects (500ml at least) and should     be collected without mixing with urine, sanitizer and sewage.      Urine: Mid-stream morning urine will be collected.   "|||2017-10-10 22:01:34.500784|2017-10-10 22:01:34.500784
NCT02822664|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-01|||June 2011||2011-06-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PCNI||Analysis of Cerebral Correlates of Pedophilia With Neuroimaging Techniques|Analysis of Cerebral Correlates of Pedophilia With Neuroimaging Techniques|Completed||N/A|80|Actual|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 22:01:34.559341|2017-10-10 22:01:34.559341
NCT02822651|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-08-08|||September 19, 2016|Actual|2016-09-19|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SCOPYD||Hypovitaminosis D Prediction Score|SCOPYD Study: Development of a Predictive Clinical Score of Hypovitaminosis D|Recruiting||N/A|2500|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:01:34.6292|2017-10-10 22:01:34.6292
NCT02822638|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||August 2009||2009-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|STEMI||Cohort of STEMI Patients|CoHort of STEMI Patients|Completed||N/A|1204|Actual|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     In STEMI patient refered for PCI at Louis Pradel Hospital, blood samples were taken on     admission at (H0) and 4h after reperfusion.      To constitute the serum bank of our STEMI cohort, samples were collected the same time as the     blood tests done routinely.      These additional samples were be centrifuged and treated and stored in a collection of     biological samples of total serum and plasma and blood at the Biological Resource Center of     HCL Neurobiotec at -80 ° C (DC- 2008-72, AC-2013-1867 certified NFS96900 FR13-018140).   "|||2017-10-10 22:01:34.701765|2017-10-10 22:01:34.701765
NCT02822625|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-12-05|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|ENHYZA||Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch|Efficacity of a Standardized Hypnotic Message on Pain Experienced During the Application of a Qutenza (Capsaicin) 8% Patch in Patients With Peripheral Neuropathic Pain|Recruiting||Phase 3|69|Anticipated|Institut de Cancérologie de Lorraine||3|||f||||f||||||||No||2017-10-10 22:01:34.772212|2017-10-10 22:01:34.772212
NCT02822599|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-04-05|||January 2017||2017-01-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|RiaSTAP||Human Fibrinogen Concentrate in Pediatric Cardiac Surgery|The Role of Human Fibrinogen Concentrate (RiaSTAP) in Decreasing the Need for Component Blood Therapy in Infants Undergoing Cardiopulmonary Bypass.|Recruiting||Phase 4|30|Anticipated|Nicklaus Children's Hospital f/k/a Miami Children's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:01:34.990077|2017-10-10 22:01:34.990077
NCT02822586|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-10-03|||December 19, 2016|Actual|2016-12-19|October 2017|2017-10-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome|Phase 1B Trial: Evaluation of the Safety of Adding Brentuximab Vedotin to Low-Dose Total Skin Electron Beam (TSEB) for Treatment of Patients With Mycosis Fungoides and Sézary Syndrome|Recruiting||Phase 1|15|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f||||||||2017-10-10 22:01:35.099432|2017-10-10 22:01:35.099432
NCT02822573|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-07-11|||May 30, 2017|Actual|2017-05-30|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil - WF 97116|A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors With Cognitive Impairment|Recruiting||Phase 3|276|Anticipated|Wake Forest University Health Sciences||2|||f||||t|t|f||||||||2017-10-10 22:01:35.239984|2017-10-10 22:01:35.239984
NCT02822560|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-05-11|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|EVAccess||Economic Comparison of Percutaneous (pEVAR) vs. Open Access in EVAR.|Comparative Clinical and Economic Analysis of Percutaneous vs. Open Access for Endovascular Aortic Repair - a Prospective, Randomised Trial.|Completed||N/A|50|Actual|Wilhelminenspital Vienna||2|||f||||t|f|t|f||t|||Undecided|Patient characteristics (gender, age, body mass index, earlier operations, written wound documentation etc.), operation time, material and overall procedure costs.|2017-10-10 22:01:35.354138|2017-10-10 22:01:35.354138
NCT02822547|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||March 2015||2015-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults|Study to Identify Eligible Subjects Using Response Guided Therapy-Stopping Rule for Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults.|Recruiting||Phase 4|253|Anticipated|Yonsei University||1|||f||||f||||||||No||2017-10-10 22:01:35.428765|2017-10-10 22:01:35.428765
NCT02822534|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-06-30|||April 2016||2016-04-01|March 2016|2016-03-01||||July 2016|Anticipated|2016-07-01||Interventional|||The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients|the Pharmacokinetics,Pharmacodynamics,Safety and Tolerability Study Following Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients|Recruiting||Phase 1|24|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-10 22:01:35.514864|2017-10-10 22:01:35.514864
NCT02822508|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-07-25|||June 2016||2016-06-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation|A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation|Completed||Phase 2/Phase 3|435|Actual|Braintree Laboratories||4|||f||||f||||||||||2017-10-10 22:01:35.70175|2017-10-10 22:01:35.70175
NCT02822495|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-03-06||||||March 2017|2017-03-01||||||||Expanded Access|||Study of Allogeneic EBV-CTLs in EBV-Associated Viremia or Malignancies|Multicenter Expanded Access Protocol of Allogeneic Epstein-Barr Virus Cytotoxic T Lymphocytes (EBV-CTLs) for Patients With EBV-Associated Viremia or Malignancies for Whom There Are No Appropriate Alternative Therapies|Available||N/A|||Atara Biotherapeutics|||||||||||||||||||2017-10-10 22:01:37.611928|2017-10-10 22:01:37.611928
NCT02822482|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-03-29|||June 2016||2016-06-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|November 2017|Anticipated|2017-11-01||Interventional|COPAN-ORL06||Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss|Phase ib/II Trial of Copanlisib, a Selective PI3K Inhibitor, in Combination With Cetuximab in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss.|Recruiting||Phase 1/Phase 2|32|Anticipated|UNICANCER||1|||f||||t||||||||No|Individual Participant Data will not be shared at an individual level. Those data will be part of the study database including all enrolled patients.|2017-10-10 22:01:37.735804|2017-10-10 22:01:37.735804
NCT02822469|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-01|||July 2016||2016-07-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|TEMCMAPTTS||Thermograph Evaluation of Masticatory and Cervical Muscles After Physiotherapeutic Treatment in Tmd Subjects|Thermograph Evaluation of Masticatory Muscles Pre and Post Indirect Physiotherapeutic Treatment in TMD Subjects: A Randomized, Placebo-controlled Study|Not yet recruiting||N/A|32|Anticipated|University of Nove de Julho||2|||f||||f||||||||No||2017-10-10 22:01:37.854373|2017-10-10 22:01:37.854373
NCT02822456|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-01-13|||December 2015||2015-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intermittent Oro-Esophageal Tube Feeding Using Individually-Customized 3-Dimensional Printing|Intermittent Oro-Esophageal Tube Feeding Using Individually-Customized 3-Dimensional Printing: Prospective, Single Center, Observational Trial of Superiority|Recruiting||N/A|24|Anticipated|Ulsan University Hospital||3|||f||||t||||||||No||2017-10-10 22:01:37.936485|2017-10-10 22:01:37.936485
NCT02822443|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-07-01|||April 2015||2015-04-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|Improve||Improve: Integrating Emotion Focused Components Into Psychological Therapy|The Impact of Integrating Emotion Focused Components Into Psychological Therapy|Recruiting||Phase 2|130|Anticipated|University of Bern||2|||f||||t||||||||No||2017-10-10 22:01:38.067443|2017-10-10 22:01:38.067443
NCT02822430|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-29|||April 2014||2014-04-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|D-PSY||Pain in Psychiatry : Impact on Length of Hospital Stays|Pain in Psychiatry : Impact on Length of Hospital Stays|Completed||N/A|137|Actual|University Hospital, Toulouse|||1||f||||f||||||||No||2017-10-10 22:01:38.177572|2017-10-10 22:01:38.177572
NCT02822417|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-12-04|||June 2016||2016-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical and Genetic Factors on the Postoperative Recovery Time of General Anaesthesia|Clinical and Genetic Factors on the Postoperative Recovery Time of General Anaesthesia|Recruiting||N/A|2000|Anticipated|Central South University|||1||f||||t||||||Samples With DNA|"     Samples with DNA retain 1 year   "|Undecided|data not entered|2017-10-10 22:01:38.250698|2017-10-10 22:01:38.250698
NCT02822404|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-07-28|||February 2012||2012-02-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|CysPed||Description of the Cystatin C as an Early Nephrotoxic Bio-marker in Pediatric Oncology|Assessment of Cystatin C as a Tubular and Glomerular Marker of Nephrotoxicity in Pediatric Oncology|Recruiting||N/A|40|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 22:01:38.425951|2017-10-10 22:01:38.425951
NCT02822391|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-01|||February 2012||2012-02-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Oral Tactile Sensitivity in Stroke Patients|Tactile Sensitivity of the Oral Tissues and Chewing Efficiency Are Impaired in Stroke Patients|Completed||N/A|54|Actual|University of Bern|||2||f||||f||||||||No||2017-10-10 22:01:38.548047|2017-10-10 22:01:38.548047
NCT02822378|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-05-03|||June 2016||2016-06-01|May 2017|2017-05-01||||July 2020|Anticipated|2020-07-01||Interventional|||Dried Plums and Bone Health in Postmenopausal Women|Randomized Control Trial of Dietary Supplementation With Dried Plums on Bone Density, Geometry and Estimated Bone Strength in Postmenopausal Women|Recruiting||N/A|300|Anticipated|Penn State University||3|||f||||t||||||||||2017-10-10 22:01:38.673126|2017-10-10 22:01:38.673126
NCT02822365|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-23|||August 24, 2016|Actual|2016-08-24|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Pocket Phantom Tool in Improving Accuracy of Quantitative PET/CT Imaging of Patients With Solid Tumors|Calibrated Methods for Quantitative PET/CT Imaging Phase II|Recruiting||N/A|30|Anticipated|University of Washington|||1||f||||f||||||||||2017-10-10 22:01:38.807697|2017-10-10 22:01:38.807697
NCT02822352|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-08-18|||August 2016||2016-08-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|VIRTUOSO||RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding Colitis|A Comparison Of High Definition White Light And High Definition Virtual Chromoendoscopy For The Detection Of Intraepithelial Neoplasia In Longstanding Colitis: A Randomised Controlled Trial|Recruiting||N/A|204|Anticipated|Portsmouth Hospitals NHS Trust||2|||f||||f||||||||No||2017-10-10 22:01:38.935638|2017-10-10 22:01:38.935638
NCT02822339|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-06-12|||June 23, 2016|Actual|2016-06-23|June 2017|2017-06-01|June 29, 2016|Actual|2016-06-29|June 29, 2016|Actual|2016-06-29||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|5|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:39.038571|2017-10-10 22:01:39.038571
NCT02822326|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-08|||January 2016||2016-01-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia|CD19-CAR-T2 Cells for Relapse/Refractory CD19 Positive Acute Leukemia—a Phase I Trial|Recruiting||Phase 1|30|Anticipated|Guangdong General Hospital||1|||f||||t||||||||||2017-10-10 22:01:39.114999|2017-10-10 22:01:39.114999
NCT02822287|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-12-05|2016-09-08||February 2016||2016-02-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||The Safety Population was the primary population. The Safety Population was defined as all treated subjects, i.e., all subjects who received any dose of study drug.|Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough|An Open Label Study to Assess the Warming Sensation, Acceptability and Local Oral Tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, Given as a Single Dose in Subjects Suffering From Productive Cough Due to Upper Respiratory Tract Infection|Completed||Phase 3|58|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:01:39.417327|2017-10-10 22:01:39.417327
NCT02822274|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-05|||November 2015||2015-11-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:39.753699|2017-10-10 22:01:39.753699
NCT02822261|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-05|||November 2015||2015-11-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose|Completed||N/A|11|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:39.83244|2017-10-10 22:01:39.83244
NCT02822248|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2016-07-05|||November 2015||2015-11-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:01:39.912403|2017-10-10 22:01:39.912403
NCT02822235|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-03-09|||October 2016||2016-10-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil|Real-world Data of Moderate to Severe Inflammatory Bowel Disease in Brazil: a Non-interventional, Multicenter Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life (RISE BR)|Active, not recruiting||N/A|400|Anticipated|Takeda|||1||f||||f||||||||||2017-10-10 22:01:39.984998|2017-10-10 22:01:39.984998
NCT02822222|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-13|||June 2016||2016-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Safety Study of RMJH-111b to Treat Essential Hypertension|A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of RMJH-111b in Adult Subjects With Essential Hypertension|Completed||Phase 1/Phase 2|22|Actual|RMJ Holdings, LLC||2|||f||||f||||||||No||2017-10-10 22:01:40.143335|2017-10-10 22:01:40.143335
NCT02822209|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-31|||May 2016||2016-05-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|EVIDEC||Evaluation of the Impact of a Coordinating Nurse in a Personalized Care Program on Quality of Care, Coordination of the Actors and on Quality of Life for Patients With Lung Cancer|Evaluation of the Impact of a Coordinating Nurse in a Personalized Care Program on Quality of Care, Coordination of the Actors and on Quality of Life for Patients With Lung Cancer. A French Randomized Monocentric Prospective Study|Active, not recruiting||N/A|59|Actual|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace||2|||f||||f||||||||||2017-10-10 22:01:40.253356|2017-10-10 22:01:40.253356
NCT02822196|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-07-01|||July 2016||2016-07-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies|Effectiveness of Serratus Anterior Muscle Plane Block With Thoracic Paravertebral Block For Unilateral Mastectomies|Not yet recruiting||N/A|100|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||Undecided||2017-10-10 22:01:40.524732|2017-10-10 22:01:40.524732
NCT02822183|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2016-07-13|||August 2013||2013-08-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Online Survey of Clinicians to Learn About Their Interpretation of Capnography Waveforms||Completed||N/A|75|Actual|University of Utah|||1||f||||f||||||||No||2017-10-10 22:01:40.619802|2017-10-10 22:01:40.619802
NCT02822170|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2017-08-16|||June 2016||2016-06-01|August 2017|2017-08-01||||August 2017|Anticipated|2017-08-01||Interventional|||A Pilot Study of Combined Cycle Ergometry and Amino Acids in the ICU|A Pilot Study of Combined Cycle Ergometry and Amino Acids in the ICU|Active, not recruiting||N/A|10|Anticipated|University of Vermont||1|||f||||f||||||||||2017-10-10 22:01:40.683941|2017-10-10 22:01:40.683941
NCT02822157|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-04-06|||August 2016||2016-08-01|June 2016|2016-06-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|CLIO||Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer|Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian|Recruiting||Phase 2|160|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 22:01:40.791782|2017-10-10 22:01:40.791782
NCT02822144|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-02-03|||September 29, 2016|Actual|2016-09-29|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|GASS||General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke|General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke|Recruiting||Phase 3|350|Anticipated|Rennes University Hospital||2|||f||||t||||||||No||2017-10-10 22:01:40.888899|2017-10-10 22:01:40.888899
NCT02822131|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-06-29|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|Phos-RR||Phosphate in Blood Pressure Regulation|The Effect of Dietary Phosphate Intake on Blood Pressure Regulation and Renal Sodium Chloride Excretion in Healthy Male Volunteers|Completed||N/A|10|Actual|University of Zurich||2|||f||||t||||||||No||2017-10-10 22:01:41.008138|2017-10-10 22:01:41.008138
NCT02822118|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-09-02|||January 2013||2013-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea|Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial|Completed||Phase 1/Phase 2|216|Actual|Xiyuan Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 22:01:41.098861|2017-10-10 22:01:41.098861
NCT02822105|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-31|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers|Phase 1 Clinical Study To Investigate The Safety And Immunogenicity Of The H3N2 (A/Brisbane/10/2007) M2SR Monovalent Influenza Vaccine|Active, not recruiting||Phase 1|96|Actual|FluGen Inc||2|||f||||t||||||||||2017-10-10 22:01:41.194533|2017-10-10 22:01:41.194533
NCT02822092|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-03-10|||July 2016||2016-07-01|March 2017|2017-03-01|October 2022|Anticipated|2022-10-01|October 2021|Anticipated|2021-10-01||Observational|||Striatal Connectivity and Clinical Outcome in Psychosis|Striatal Connectivity and Clinical Outcome in Psychosis|Recruiting||N/A|170|Anticipated|Northwell Health|||2||f||||t||||||Samples Without DNA|"     Drug Levels   "|||2017-10-10 22:01:41.27358|2017-10-10 22:01:41.27358
NCT02822066|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-07-01|||April 2016||2016-04-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas||Recruiting||Phase 1/Phase 2|60|Anticipated|First Affiliated Hospital of Zhejiang University||1|||f||||||||||||||2017-10-10 22:01:41.36965|2017-10-10 22:01:41.36965
NCT02822053|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-07-01|||April 2016||2016-04-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effectivity and Safety of Ultrasound-guided Percutaneously Laser Ablation for Refractory Neoplasms||Recruiting||Phase 1/Phase 2|100|Anticipated|First Affiliated Hospital of Zhejiang University||1|||f||||||||||||||2017-10-10 22:01:41.478447|2017-10-10 22:01:41.478447
NCT02822040|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-09-19|||July 2016||2016-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||An Evaluation of Root Length Measurements Using Intraoral Scan and Panoramic Radiographs|An Evaluation of Root Length Measurements Using Intraoral Scan and Panoramic|Completed||N/A|21|Actual|Loma Linda University|||1||f||||f||||||||No||2017-10-10 22:01:41.573673|2017-10-10 22:01:41.573673
NCT02822027|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-29|||June 2016||2016-06-01|June 2016|2016-06-01||||July 2018|Anticipated|2018-07-01||Interventional|||Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity|Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity|Recruiting||N/A|20|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-10 22:01:41.648011|2017-10-10 22:01:41.648011
NCT02822014|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-29|||February 2010||2010-02-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|January 2013|Actual|2013-01-01||Interventional|||PET/CT in Extrapulmonary TB in HIV Patients: a Clinical Trial|FDG-PET/CT: a Tool in Diagnosis and Treatment Response Monitoring of Extrapulmonary Tuberculosis in HIV Patients|Completed||N/A|18|Actual|Centre Hospitalier Universitaire Saint Pierre||1|||f||||f||||||||No||2017-10-10 22:01:41.748042|2017-10-10 22:01:41.748042
NCT02822001|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-04-18|||February 16, 2017|Actual|2017-02-16|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|June 30, 2017|Anticipated|2017-06-30||Interventional|Sugammadex||Sugammadex vs. Placebo to Prevent Residual Neuromuscular Block in the Post--‐Anesthesia Care Unit|Randomized Double--‐Blinded, Controlled Trial to Compare the Effectiveness of Sugammadex vs. Placebo to Prevent Residual Neuromuscular Block in the Post--‐Anesthesia Care Unit as Evaluated With a Non--‐Invasive Respiratory Volume Monitor|Recruiting||Phase 4|300|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t|t|t|f||f|||Undecided||2017-10-10 22:01:41.837586|2017-10-10 22:01:41.837586
NCT02821988|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-29|||July 2016||2016-07-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|ATOWS||Antenatal Testing in Obese Woman, is it Really Necessary?|Antenatal Testing in Obese Woman, is it Really Necessary?|Not yet recruiting||N/A|100|Anticipated|University of Tennessee Health Science Center||3|||f||||f||||||||||2017-10-10 22:01:41.968228|2017-10-10 22:01:41.968228
NCT02821975|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-29|||December 2015||2015-12-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Cognitive Computer Training in Patients With Depression|Evaluating Cognitive Computer Training as a Tool for Returning Earlier to Work After Depression|Recruiting||N/A|20|Anticipated|University of Southern Denmark||2|||f||||t||||||||No||2017-10-10 22:01:42.049712|2017-10-10 22:01:42.049712
NCT02821962|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-09-26|||August 2016||2016-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|SIT-CR||Sedentary Intervention Trial in Cardiac Rehabilitation|Sedentary Intervention Trial in Cardiac Rehabilitation (SIT-CR): A Randomized Controlled Trial Using the activPAL3™ and activPAL3™ VT to Quantify Free-living Movement Patterns and Reducing Sedentary Time in Cardiac Rehabilitation Patients|Active, not recruiting||N/A|40|Actual|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-10 22:01:42.150114|2017-10-10 22:01:42.150114
NCT02821949|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-06-29|||December 2014||2014-12-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|KBPCT||Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy|Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||Samples Without DNA|"     blood   "|||2017-10-10 22:01:42.244594|2017-10-10 22:01:42.244594
NCT02821936|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-07-05|||May 2016||2016-05-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|PARAPET||Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer|Study of the Interest of the Parametric Imaging in Positron Emission Tomography on the Recurrence Prognosis at One Year in Patient With Non Small Cell Lung Cancer|Recruiting||N/A|30|Anticipated|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 22:01:42.32519|2017-10-10 22:01:42.32519
NCT02821923|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-15|||June 2016||2016-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of the Natural Sweeteners Erythritol and Xylitol on Vascular Function in Obese Volunteers|Effect of the Natural Sweeteners Erythritol and Xylitol on Vascular Function in Obese Volunteers: A Pilot Study|Recruiting||N/A|45|Anticipated|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-10 22:01:42.409539|2017-10-10 22:01:42.409539
NCT02821910|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-02-08|||July 2016||2016-07-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets|Relative Bioavailability of Two FDC Tablet Strengths of Empagliflozin/Linagliptin/Metformin Extended Release Compared to the Free Combination of Empagliflozin, Linagliptin and Metformin Extended Release Following Oral Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Study)|Completed||Phase 1|50|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 22:01:42.48244|2017-10-10 22:01:42.48244
NCT02820714|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-01-13|||February 2016||2016-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation|A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation|Completed||Phase 2|16|Actual|Braintree Laboratories||1|||f||||f||||||||No||2017-10-10 22:01:52.062288|2017-10-10 22:01:52.062288
NCT02821897|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-10-10|||March 2013||2013-03-01|June 2016|2016-06-01||||March 2018|Anticipated|2018-03-01||Interventional|AIVOC||Value of Target-controlled Intravenous Anaesthesia (TCIVA) in Spinal Cord Stimulation|Value of Target-controlled Intravenous Anaesthesia (TCIVA) to Optimize Coverage of the Low Back Pain Territory in Patients With Chronic Refractory Postoperative Multifocal Low Back and Legpain|Recruiting||N/A|60|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 22:01:42.56104|2017-10-10 22:01:42.56104
NCT02821884|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-08-15|||June 2016||2016-06-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Combine Transcranial Direct Current Stimulation and Neuromuscular Electrical Stimulation on Stroke Patients|Combine Transcranial Direct Current Stimulation and Neuromuscular Electrical Stimulation on Stroke Patients|Recruiting||N/A|90|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||f||||||||||2017-10-10 22:01:42.628477|2017-10-10 22:01:42.628477
NCT02821871|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2016-06-29|||March 2016||2016-03-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||the Food Effect Pharmacokinetic, Material Balance and Metabolite Identification of SP2086 in Healthy Volunteers||Recruiting||Phase 1|24|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:01:42.709583|2017-10-10 22:01:42.709583
NCT02821858|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-10-18|||June 2016||2016-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study to Investigate the Pharmacokinetics, Safety and Tolerability of Odalasvir and AL-335 in Healthy Japanese Participants|A Phase 1, Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Odalasvir and AL-335 in Healthy Japanese Subjects|Completed||Phase 1|40|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-10 22:01:42.791604|2017-10-10 22:01:42.791604
NCT02821845|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2016-07-05|||June 2015||2015-06-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Training of Eccentric Hip Function After SCI|Eccentric Motor Control Training to Improve Human Spinal Cord Injury: Hip Function During Walking|Recruiting||Phase 1/Phase 2|32|Anticipated|Ohio State University||3|||f||||f||||||||||2017-10-10 22:01:42.881973|2017-10-10 22:01:42.881973
NCT02821819|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-02-27|||January 10, 2017|Actual|2017-01-10|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|ROSE||Random-start Ovarian Stimulation in Egg-donors (ROSE)|Random-start Ovarian Stimulation in Egg-donors (ROSE) Trial: a Self-controlled Study|Recruiting||Phase 4|30|Anticipated|Instituto Bernabeu||1|||f||||f||||||||Yes||2017-10-10 22:01:43.209745|2017-10-10 22:01:43.209745
NCT02821806|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-30|2017-07-11|||June 24, 2016||2016-06-24|July 5, 2017|2017-07-05|March 1, 2026|Anticipated|2026-03-01|February 1, 2025|Anticipated|2025-02-01||Observational|||Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy|Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy Subjects for the Expansion of T Cells for Adoptive Cell Therapy|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:01:43.316368|2017-10-10 22:01:43.316368
NCT02821793|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-09-29|||January 2016||2016-01-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|May 2018|Anticipated|2018-05-01||Observational|PRIORITY||Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer|Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer : PRIORITY Study|Recruiting||N/A|500|Anticipated|Institut Bergonié|||2||f||||f||||||||||2017-10-10 22:01:43.402143|2017-10-10 22:01:43.402143
NCT02821767|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-10-03|||June 22, 2016||2016-06-22|September 22, 2017|2017-09-22|July 1, 2026|Anticipated|2026-07-01|July 1, 2026|Anticipated|2026-07-01||Observational|||Natural History, Pathogenesis, and Outcome of Ocular Disorders|Studies of the Natural History, Pathogenesis and Outcome of Ocular Disorders|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:01:43.613389|2017-10-10 22:01:43.613389
NCT02821754|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-26|||June 22, 2016||2016-06-22|July 17, 2017|2017-07-17|April 30, 2021|Anticipated|2021-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)|A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)|Recruiting||Phase 1/Phase 2|90|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:01:43.694749|2017-10-10 22:01:43.694749
NCT02821741|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-09-21|||June 22, 2016||2016-06-22|September 15, 2017|2017-09-15|March 30, 2019|Anticipated|2019-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|||Effects of External Ear Stimulation on Pain Perception and Mood|Effects of External Ear Stimulation on Pain Perception and Mood|Recruiting||N/A|76|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:01:43.810014|2017-10-10 22:01:43.810014
NCT02821728|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-06-01|||April 2016||2016-04-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|SAP||Sulphate Accumulation in Prostate|A Pre-Biopsy Window of Opportunity Trial to Measure Sulphate Levels in Human Prostate After Broccoli Consumption|Completed||N/A|18|Actual|Quadram Institute||2|||f||||f||||||||||2017-10-10 22:01:43.89009|2017-10-10 22:01:43.89009
NCT02821715|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-01-25|||September 2016||2016-09-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients|Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients|Recruiting||Phase 2|48|Anticipated|Theranexus||3|||f||||f||||||||Undecided||2017-10-10 22:01:43.98653|2017-10-10 22:01:43.98653
NCT02821702|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-07-02|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CSAC||Fertility Post Placenta Accrete|Fertility Post Preservative Cesarean Section and Uterine Artery Embolization|Not yet recruiting||N/A|300|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 22:01:44.106023|2017-10-10 22:01:44.106023
NCT02821689|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-30|||July 2016||2016-07-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis|Randomized Controlled Trial of Pirfenidone in Patients With Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis|Not yet recruiting||Phase 4|57|Anticipated|RenJi Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:01:44.192508|2017-10-10 22:01:44.192508
NCT02821676|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-29|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||PECI/SPB vs Intercostal Nerve Block for the Management of Postoperative Pain in Latissimus Dorsi Flap Reconstruction|A Randomized Controlled Comparison of PECI/SPB Versus Intercostal Nerve Block for the Management of Postoperative Pain in Latissimus Dorsi Flap Reconstruction|Not yet recruiting||N/A|42|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Yes|Individual participant data will not be made available. Anonymity will be maintained throughout the study.|2017-10-10 22:01:44.274542|2017-10-10 22:01:44.274542
NCT02821663|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-04-12|||November 2014||2014-11-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Vocal Intervention in Systemic Sclerosis|Rehabilitation in Patients Suffering From Systemic Sclerosis by Vocal Intervention: A Pilot Study|Recruiting||N/A|10|Anticipated|Medical University of Vienna||1|||f||||f||||||||Undecided||2017-10-10 22:01:44.37364|2017-10-10 22:01:44.37364
NCT02821650|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-04-30|||April 19, 2017|Actual|2017-04-19|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Test the Impact of an Improved Chulha on Respiratory Health of Women and Children in Indian Slums|Low-smoke Chulha in Indian Slums|Recruiting||N/A|250|Anticipated|Maastricht University||2|||f||||f|f|f||||||Undecided||2017-10-10 22:01:44.452492|2017-10-10 22:01:44.452492
NCT02821637|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-07-31|||January 2015||2015-01-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PRESEVAL||Impact of an Effort Rehabilitation Program for Overweight/Obese Children/Teens on Quality of Life and Wellbeing|Impact of an Effort Rehabilitation Program for Overweight or Obese Children and Teens on Quality of Life and Wellbeing: A French Monocentric Prospective Study|Active, not recruiting||N/A|47|Actual|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace||1|||f||||f||||||||||2017-10-10 22:01:44.543706|2017-10-10 22:01:44.543706
NCT02821624|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-06-13|||May 2016||2016-05-01|June 2017|2017-06-01|April 4, 2017|Actual|2017-04-04|December 15, 2016|Actual|2016-12-15||Interventional|||First-in-Human Safety, PK, and Food Effect Study of Single Ascending Doses of G1T38 in Healthy Volunteers|First-in-Human Phase 1 Safety, Pharmacokinetic, and Food Effect Study of Single Ascending Doses of G1T38 in Healthy Male and Female Subjects|Completed||Phase 1|76|Actual|G1 Therapeutics, Inc.||12|||f||||f||||||||Undecided||2017-10-10 22:01:44.631238|2017-10-10 22:01:44.631238
NCT02821611|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-06-30|||January 2015||2015-01-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Student Stress Levels and Management Through Meditation|Physical Therapist Doctoral Student Stress Levels and Management Through Meditation|Active, not recruiting||N/A|60|Anticipated|California State University, Northridge||2|||f||||t||||||||||2017-10-10 22:01:44.733993|2017-10-10 22:01:44.733993
NCT02821598|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-29|||June 2016||2016-06-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of the Proprioceptive Neuromuscular Facilitation for Promoting Muscular Irradiation||Recruiting||N/A|24|Anticipated|Federal University of Health Science of Porto Alegre||5|||f||||||||||||||2017-10-10 22:01:44.820072|2017-10-10 22:01:44.820072
NCT02821585|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-09-26|||January 2016||2016-01-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MEDIT||Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic Syndrome||Active, not recruiting||N/A|29|Actual|Institut de Recherches Cliniques de Montreal||2|||f||||||||||||||2017-10-10 22:01:44.908609|2017-10-10 22:01:44.908609
NCT02821559|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-06-29|||July 2012||2012-07-01|March 2016|2016-03-01||||August 2014|Actual|2014-08-01||Interventional|EROS||Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer||Completed||Phase 2|37|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||||||||||||2017-10-10 22:01:45.096341|2017-10-10 22:01:45.096341
NCT02821546|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-03-26|||August 2014||2014-08-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Aggressive Fluid Hydration for the Prevention of Post-ERCP Pancreatitis|Aggressive Fluid Hydration for the Prevention of Post-ERCP Pancreatitis|Completed||Phase 3|286|Actual|Mahidol University||2|||f||||f||||||||No||2017-10-10 22:01:45.201319|2017-10-10 22:01:45.201319
NCT02821533|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-18|||February 2012||2012-02-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Chemoembolization for Hepatocellular Carcinoma|Chemoembolization for Hepatocellular Carcinoma|Terminated||Phase 2|24|Actual|Chinese University of Hong Kong||1||Poor case accrual|f||||t||||||||||2017-10-10 22:01:45.281318|2017-10-10 22:01:45.281318
NCT02821520|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Initial Versus Delayed PDT Combination With Conbercept in PCV|Efficacy and Safety of Initial Versus Delayed Verteporfin Photodynamic Therapy in Combination With Conbercept in Patients With Symptomatic Polypoidal Choroidal Vasculopathy|Recruiting||Phase 4|80|Anticipated|The Eye Hospital of Wenzhou Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:01:45.356201|2017-10-10 22:01:45.356201
NCT02821507|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-09|2016-07-11|||June 2014||2014-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma|A Phase 2, Single Arm, Multi Center Trial Evaluating the Efficacy of the COmbination of Sirolimus and cYclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and chOndrosarcoma|Recruiting||Phase 2|105|Anticipated|Leiden University Medical Center||1|||f||||t||||||||||2017-10-10 22:01:45.476414|2017-10-10 22:01:45.476414
NCT02821494|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-12-09|||March 2015||2015-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hespecta Vaccination in HPV+ Tumors or Malignant Lesions|Phase I Study: to Determine the Biological Activity of Two HPV16 E6 Specific Peptides Coupled to Amplivant®, a Toll-like Receptor Ligand in Patients Treated for HPV16-positive Tumors or Premalignant Lesions|Recruiting||Phase 1|24|Anticipated|Leiden University Medical Center||1|||f||||t||||||||||2017-10-10 22:01:45.573453|2017-10-10 22:01:45.573453
NCT02821481|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-31|||June 2016||2016-06-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Beta-alanine and Elder Endurance|The Interactive Effects Of Beta-Alanine Supplementation and Resistance Training on Muscular Endurance in Older Adults|Completed||N/A|27|Actual|University of Miami||4|||f||||f||||||||||2017-10-10 22:01:45.66923|2017-10-10 22:01:45.66923
NCT02821468|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-30|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|DRIP||Evaluation of the Evolution of Imaging Markers of Cartilage Degradation in Patients With Knee Osteoarthritis Receiving DROGLICAN|Evaluation of the Evolution of Imaging Markers of Cartilage Degradation in Patients With Knee Osteoarthritis Receiving DROGLICAN: a Pilot Study|Recruiting||Phase 4|20|Anticipated|Bioiberica||2|||f||||f||||||||Yes||2017-10-10 22:01:45.749864|2017-10-10 22:01:45.749864
NCT02821442|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-06-29|||February 2016||2016-02-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||"Electro Acupuncture in the Treatment and Management of Chemotherapy Induced Peripheral Neuropathy"|"Electro Acupuncture in the Treatment and Management of Chemotherapy Induced Peripheral Neuropathy"|Recruiting||N/A|30|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-10 22:01:45.889546|2017-10-10 22:01:45.889546
NCT02821429|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-28|||January 2015||2015-01-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|ETCCCV||Respiratory Weaning Following Cardiac Surgery.|Respiratory Weaning Following Cardiac Surgery. Potential Interest of Combined Thoracic Echography in the Characterization of the Failure Causes.|Recruiting||N/A|100|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||Undecided||2017-10-10 22:01:45.980412|2017-10-10 22:01:45.980412
NCT02821403|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-02-23|2016-09-08||July 2014||2014-07-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Blue-light Blocking Lens on Visual Functions||Completed||N/A|80|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||Undecided||2017-10-10 22:01:46.171915|2017-10-10 22:01:46.171915
NCT02821390|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-05-04|||June 2016||2016-06-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections|Analgesic Effect Of Topical Nepafenac 0.1% On Pain Related To Intravitreal Injections: A Randomized Crossover Study|Completed||N/A|55|Actual|University Hospital of Patras||2|||f||||f||||||||Undecided||2017-10-10 22:01:46.48599|2017-10-10 22:01:46.48599
NCT02821377|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-30|||December 2013||2013-12-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Metabolic Effects of Furosemide +HSS in Refractory Ascites|Immune-inflammatory and Metabolic Effects of High Dose Furosemide Plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects With Refractory Ascite|Completed||Phase 2|40|Actual|University of Palermo||3|||f||||f||||||||No||2017-10-10 22:01:46.565653|2017-10-10 22:01:46.565653
NCT02821364|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-06-08|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 2025|Anticipated|2025-12-01|December 2023|Anticipated|2023-12-01||Interventional|PIPT||Philadelphia Immediate Transport in Penetrating Trauma Trial|Philadelphia Immediate Transport in Penetrating Trauma Trial|Not yet recruiting||N/A|1036|Anticipated|Temple University||2|||f||||t|f|f||||||No||2017-10-10 22:01:46.791097|2017-10-10 22:01:46.791097
NCT02821351|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-06|||January 2016||2016-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|TRAC-AF||ACT DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation|Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation|Active, not recruiting||N/A|75|Anticipated|Advanced Cardiac Therapeutics||1|||f||||f||||||||||2017-10-10 22:01:46.878656|2017-10-10 22:01:46.878656
NCT02821338|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-27|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects|A Randomized, 2-Sequence, 2-Treatment, 4-Period, Open-Label, Single Dose, Fully Replicated Comparative Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects Under Fed Conditions|Completed||Phase 4|30|Actual|Food and Drug Administration (FDA)||2|||f||||f||||||||Undecided||2017-10-10 22:01:46.964709|2017-10-10 22:01:46.964709
NCT02821325|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-03-08|||September 28, 2016|Actual|2016-09-28|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|TKA||Intra-articular Volumetric Assessment After Total Knee Arthroplasty|Intra-articular Volumetric Assessment After Total Knee Arthroplasty|Recruiting||N/A|10|Anticipated|Loma Linda University|||1||f||||f||||||||Yes|Sex and gender. The size of the implant placed during the TKA. Indication for operative procedure. Laterality of the procedure. Operative time. Blood Loss from surgery. Range of motion at week 2 post-operatively. Range of motion at week 6 post-operatively. Any complications that develop within 30 days of the surgery. There is no plan to make individual participant data available.|2017-10-10 22:01:47.068002|2017-10-10 22:01:47.068002
NCT02821312|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-06-29|||June 2016||2016-06-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects|A Phase I, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Oral Administration of DA-8010 in Healthy Subjects|Not yet recruiting||Phase 1|110|Anticipated|Dong-A ST Co., Ltd.||4|||f||||f||||||||No||2017-10-10 22:01:47.159035|2017-10-10 22:01:47.159035
NCT02821299|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-30|||January 2017||2017-01-01|June 2016|2016-06-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Interventional|ECLAT||Clinical Evaluation of Laryngeal Transplantation: Study of 3 Patients|Clinical Evaluation of Laryngeal Transplantation: Pilot Study of 3 Patients|Not yet recruiting||N/A|3|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-10 22:01:47.241412|2017-10-10 22:01:47.241412
NCT02821286|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-06-29|||June 2016||2016-06-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Identification of Anaphylactogenic Antibodies in Peanut Allergy|Identification of Anaphylactogenic Antibodies in the Blood of Peanut Allergic Patients|Enrolling by invitation||N/A|100|Anticipated|University of Zurich|||1||f||||f||||||Samples With DNA|"     Full blood   "|No||2017-10-10 22:01:47.313984|2017-10-10 22:01:47.313984
NCT02821273|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-12-19|||June 2016||2016-06-01|December 2016|2016-12-01||||July 2018|Anticipated|2018-07-01||Interventional|surfactant||Surfactant Administration in Preterm Infants|Modified INSURE vs INSURE in Preterm Infants With Respiratory Distress Syndrome: A Randomized Controlled Trials|Recruiting||N/A|200|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-10 22:01:47.383043|2017-10-10 22:01:47.383043
NCT02821260|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-09|||December 2015||2015-12-01|February 2017|2017-02-01|December 2025|Anticipated|2025-12-01|December 2023|Anticipated|2023-12-01||Observational|PEPSI||Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children|Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children|Recruiting||N/A|500|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 22:01:47.469764|2017-10-10 22:01:47.469764
NCT02821247|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-09-26|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|March 15, 2019|Anticipated|2019-03-15|March 15, 2019|Anticipated|2019-03-15||Observational|PERSEUS-GR||Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece|A Prospective obsERvational Study to asSEss the Effectiveness of Intravitreal Aflibercept Injection in roUtine Clinical Practice in Treatment Naive patientS With Wet Age-related Macular Degeneration in Greece|Recruiting||N/A|120|Anticipated|Bayer|||1||f||||t|t|f|||t|||||2017-10-10 22:01:47.535902|2017-10-10 22:01:47.535902
NCT02821234|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-08-22|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|April 3, 2017|Actual|2017-04-03|April 3, 2017|Actual|2017-04-03||Interventional|SOMNET||The Sleepless Brain: Neuroimaging Support for a Differential Diagnosis of Insomnia|The Sleepless Brain: Neuroimaging Support for a Differential Diagnosis of Insomnia|Completed||N/A|40|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 22:01:47.65142|2017-10-10 22:01:47.65142
NCT02821208|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-09-07|||August 2016||2016-08-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|PronoCNEP||Quality of Life and Psychogenic Nonepileptic Seizures.|Assessment and Prognostic Factors of Quality of Life in Patients With Psychogenic Nonepileptic Seizures|Recruiting||N/A|72|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||No||2017-10-10 22:01:47.743905|2017-10-10 22:01:47.743905
NCT02821182|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.|A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.|Recruiting||Phase 2|40|Anticipated|University Hospital, Ghent||1|||f||||||||||||||2017-10-10 22:01:47.844646|2017-10-10 22:01:47.844646
NCT02821169|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-03|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ROPI_POSTOP||Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain|Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.|Recruiting||Phase 3|150|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 22:01:47.930698|2017-10-10 22:01:47.930698
NCT02821156|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-06-29|||September 2014||2014-09-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|POSITIVE||Study on the Use of Inhaled NO (iNO)|Prospective Observational Study on the Use of Inhaled NO (iNO) Administered Through an Integrated deliVEry and Monitoring Device EZ-KINOX|Completed||N/A|239|Actual|Air Liquide Santé International|||1||f||||f||||||||||2017-10-10 22:01:48.044013|2017-10-10 22:01:48.044013
NCT02821130|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-01-16|||July 2016||2016-07-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|Orkambi||Orkambi Exercise Study|Effects of Orkambi on Exertional Dyspnea, Exercise Performance, and Ventilatory Responses in Adults With Cystic Fibrosis|Recruiting||N/A|16|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-10 22:01:48.251526|2017-10-10 22:01:48.251526
NCT02821117|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-04-20|||June 30, 2016|Actual|2016-06-30|April 2017|2017-04-01|February 22, 2017|Actual|2017-02-22|November 30, 2016|Actual|2016-11-30||Interventional|SELFY||FreeStyle Libre Glucose Monitoring System Paediatric Study|An Evaluation of Self-Management of Diabetes Using FreeStyle Libre Flash Glucose Monitoring System in Young People|Completed||N/A|76|Actual|Abbott Diabetes Care||1|||f||||f||||||||Undecided||2017-10-10 22:01:48.342169|2017-10-10 22:01:48.342169
NCT02821104|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-01-11|||June 2016||2016-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|CCRIA||Complement and Cardiovascular Risk in Adolescents|Complement and Cardiovascular Risk in Adolescents|Recruiting||N/A|100|Anticipated|Ohio State University|||1||f||||f||||||||Yes|Clinical Trials.gov|2017-10-10 22:01:48.454458|2017-10-10 22:01:48.454458
NCT02821091|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-04|||April 16, 2015|Actual|2015-04-16|June 2016|2016-06-01|January 24, 2017|Actual|2017-01-24|April 26, 2016|Actual|2016-04-26||Interventional|||Biomechanics Research in the Effects of Interactive Dynamic Balance Training on Postural and Gait Control in Older Adults|Biomechanics Research in the Effects of Interactive Dynamic Balance Training on Postural and Gait Control in Older Adults|Terminated||N/A|27|Actual|National Taiwan University Hospital||3||Limitaiotn of financial support|f||||f||||||||||2017-10-10 22:01:48.557938|2017-10-10 22:01:48.557938
NCT02821078|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-11-10|||December 2016||2016-12-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|HEPAFLUX||Evaluation of 4D Magnetic Resonance Flow Sequence at Hepatic Level|Evaluation of 4D Magnetic Resonance Flow Sequence at Hepatic Level|Not yet recruiting||N/A|45|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||No||2017-10-10 22:01:48.660346|2017-10-10 22:01:48.660346
NCT02821065|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-28|||September 2016||2016-09-01|June 2016|2016-06-01||||May 2017|Anticipated|2017-05-01||Interventional|TEC4Home||Telehealth for Emergency-Community Continuity of Care Connectivity Via Home-Telemonitoring|TEC4Home: Telehealth for Emergency-Community Continuity of Care Connectivity Via Home-Telemonitoring|Not yet recruiting||N/A|90|Anticipated|University of British Columbia||1|||f||||||||||||||2017-10-10 22:01:48.774586|2017-10-10 22:01:48.774586
NCT02821052|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-05-29|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®|Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®.|Enrolling by invitation||N/A|1250|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 22:01:48.845176|2017-10-10 22:01:48.845176
NCT02821039|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-04-15|||June 2016||2016-06-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01|3 Years|Observational [Patient Registry]|TURK-UIP||Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study|Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study|Recruiting||N/A|2000|Anticipated|Turkish Thoracic Society|||1||f||||t||||||||No||2017-10-10 22:01:48.924518|2017-10-10 22:01:48.924518
NCT02821026|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-28|||September 2015||2015-09-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Omental Islet Transplant|Allogeneic Islet Cells Transplanted Into the Omentum|Recruiting||Phase 1/Phase 2|6|Anticipated|University of Alberta||1|||f||||t||||||||Undecided||2017-10-10 22:01:49.237907|2017-10-10 22:01:49.237907
NCT02821013|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-10|||July 4, 2016||2016-07-04|April 2017|2017-04-01|December 2025|Anticipated|2025-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)|A Randomized Phase III Trial of the Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)|Recruiting||Phase 3|550|Anticipated|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-10 22:01:49.390398|2017-10-10 22:01:49.390398
NCT02821000|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-09-06|||July 8, 2016|Actual|2016-07-08|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)|A Phase Ib Study of Pembrolizumab (MK-3475) in Chinese Subjects With Locally Advanced or Metastatic Melanoma (Keynote-151)|Active, not recruiting||Phase 1|100|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f|t|f||||||||2017-10-10 22:01:49.518966|2017-10-10 22:01:49.518966
NCT02820987|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-01|||September 2016||2016-09-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|PAACS||PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock|Pharmacokinetics and Pharmacodynamic (PK/PD) of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock|Not yet recruiting||Phase 3|129|Anticipated|Centre Hospitalier Universitaire de Besancon||3|||f||||f||||||||Undecided||2017-10-10 22:01:49.590177|2017-10-10 22:01:49.590177
NCT02820974|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-28|||November 2016||2016-11-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|||The Functional Magnetic Resonance Imaging Study on the Processing of Acute Pain and Cognition Among Perimenopause Women|The Functional Magnetic Resonance Imaging Study on the Processing of Acute Pain and Cognition Among Perimenopause Women|Not yet recruiting||N/A|150|Anticipated|Tang-Du Hospital|||3||f||||t||||||||Yes||2017-10-10 22:01:49.664901|2017-10-10 22:01:49.664901
NCT02820961|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-02-22|||June 2016||2016-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer|A Phase 1, Two-Cohort, Open-Label, Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer|Recruiting||Phase 1|40|Anticipated|Syndax Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:01:49.721313|2017-10-10 22:01:49.721313
NCT02820948|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-06-30|||January 2015||2015-01-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Vitamin E Ointment on Incisional SSI in Colorectal Surgery|Effect of Subcutaneous Sterile Vitamin E Ointment on Incisional Surgical-site Infection Following Elective Laparoscopic Colorectal Cancer Surgery|Completed||Phase 3|108|Actual|Hospital General Universitario Elche||2|||f||||t||||||||Yes|Publication in scientific journal|2017-10-10 22:01:49.836093|2017-10-10 22:01:49.836093
NCT02820935|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-10-17|||July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects|A Phase 1, Open-label, Single-center Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects|Completed||Phase 1|36|Actual|Celgene Corporation||4|||f||||f||||||||||2017-10-10 22:01:49.90085|2017-10-10 22:01:49.90085
NCT02820922|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-28|||March 2016||2016-03-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Observational|||Anesthesia for Emergency Orthopedic Surgery|Anesthetic Techniques for Emergency Orthopedic Surgery|Recruiting||N/A|500|Anticipated|Sakarya University|||1||f||||f||||||||No||2017-10-10 22:01:49.978645|2017-10-10 22:01:49.978645
NCT02820909|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-03|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ECHOGUIDE||Interest of the Ultrasound Guidance for the Laying of Femoral Arterial and Venous Catheters in Intensive Care Unit|Interest of the Ultrasound Guidance for the Laying of Femoral Arterial and Venous Catheters in Intensive Care Unit: A Controlled, Randomized Trial: The ECHOGUIDE Study|Recruiting||N/A|92|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:01:50.083535|2017-10-10 22:01:50.083535
NCT02820896|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-19|||June 29, 2016|Actual|2016-06-29|July 2017|2017-07-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous and Subcutaneous RO7105705 Administered in Healthy Volunteers and Patients With Mild-to-Moderate Alzheimer's Disease|Completed||Phase 1|74|Actual|Genentech, Inc.||5|||f||||||||||||||2017-10-10 22:01:50.172126|2017-10-10 22:01:50.172126
NCT02820883|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-09-08|||June 2016||2016-06-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults|A Single-center, Dose-escalation, Open-label Pilot Study to Evaluate the Safety and Tolerability of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults Aged 18-65 Years in China|Completed||Early Phase 1|30|Actual|Jiangsu Province Centers for Disease Control and Prevention||3|||f||||t||||||||Yes||2017-10-10 22:01:50.245226|2017-10-10 22:01:50.245226
NCT02820870|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-06-12|||March 2016||2016-03-01|June 2017|2017-06-01|October 1, 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|QUIPS||Quality Improvement and Personalization for Statins|Quality Improvement and Personalization for Statins (QUIPS) (QUE 15-286)|Completed||N/A|15|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-10 22:01:50.322391|2017-10-10 22:01:50.322391
NCT02820857|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-07-12|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|March 2022|Anticipated|2022-03-01|September 2020|Anticipated|2020-09-01||Interventional|BEVANEC||Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer|Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment After the Failure of the Cisplatin (or Carboplatin)-Etoposide Combination in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer. A Phase 2 Non-comparative Randomized Study|Not yet recruiting||Phase 2|124|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 22:01:50.42316|2017-10-10 22:01:50.42316
NCT02820831|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-06-29|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|AGE-VASC||Anesthesia Geriatric Evaluation and Quality of Life After Peripheral Vascular Surgery|Anesthesia Geriatric Evaluation and the Prediction of Quality of Life in Elderly Peripheral Vascular Surgery Patients|Recruiting||N/A|440|Anticipated|St. Antonius Hospital|||1||f||||||||||Samples Without DNA|"     Blood samples are taken directly after induction of anesthaesia. Plasma is stored in frozen     aliquots at - 80 degrees Celcius.   "|||2017-10-10 22:01:51.136326|2017-10-10 22:01:51.136326
NCT02820818|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-07-05|||June 2016||2016-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Pulmonary Outcomes of Bronchopulmonary Dysplasia in Young Adulthood|Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD|Enrolling by invitation||N/A|50|Anticipated|St. Justine's Hospital|||1||f||||f||||||Samples With DNA|"     Nasal epithelial cells, whole blood   "|No||2017-10-10 22:01:51.232359|2017-10-10 22:01:51.232359
NCT02820805|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-08-07|||April 2016||2016-04-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Dietary Carbohydrate Consumption on Memory Performance and Mood in Children|The Effect of Dietary Carbohydrate Consumption on Memory Performance and Mood in Normal Weight and Overweight/Obese Children|Completed||N/A|22|Actual|Ryerson University||6|||f||||f||||||||||2017-10-10 22:01:51.311749|2017-10-10 22:01:51.311749
NCT02820792|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-01-25|||September 2016|Actual|2016-09-01|January 2017|2017-01-01|December 20, 2016|Actual|2016-12-20|December 2016|Actual|2016-12-01||Interventional|||Non-Crossover Study of the LMA Protector Versus Ambu AuraGain|A Randomized Non-Crossover Study of the LMA ProtectorTM Versus Ambu Aura GainTM in Adult Patients|Completed||N/A|96|Actual|Schulthess Klinik||2|||f||||f||||||||No||2017-10-10 22:01:51.427603|2017-10-10 22:01:51.427603
NCT02820779|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|COVER||New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry|New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry|Not yet recruiting||N/A|100|Anticipated|Xuanwu Hospital, Beijing||1|||f||||f||||||||Undecided||2017-10-10 22:01:51.526384|2017-10-10 22:01:51.526384
NCT02820766|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-08|||September 2016||2016-09-01|August 2017|2017-08-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Observational|||Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting|A Non-Randomized, Prospective Study of Short Term Outcomes Following Total Knee Replacement With JOURNEY™ II BCS Total Knee System Compared to Other Posterior Stabilized Total Knee Systems in a Physical Therapy Setting|Terminated||N/A|22|Actual|Smith & Nephew, Inc.|||2|Logistics of study did not allow for consistent data collection|f||||f||||||||||2017-10-10 22:01:51.678287|2017-10-10 22:01:51.678287
NCT02820753|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-07-27|||April 3, 2017|Actual|2017-04-03|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens|A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens|Recruiting||N/A|1505|Anticipated|Northwestern University||4|||f||||t|f|f||||||||2017-10-10 22:01:51.760919|2017-10-10 22:01:51.760919
NCT02820740|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-10-02|||April 21, 2017|Actual|2017-04-21|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Feasibility Study on LITT for Medical Refractory Epilepsy|Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)|Recruiting||N/A|45|Anticipated|Monteris Medical||1|||f||||t|f|t|f|f||||||2017-10-10 22:01:51.86008|2017-10-10 22:01:51.86008
NCT02820727|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-05-05|||October 2015||2015-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Observational|||Perioperative Three Dimensional Right Ventricular Function|Perioperative Three Dimensional Right Ventricular Function|Active, not recruiting||N/A|60|Actual|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-10 22:01:51.982049|2017-10-10 22:01:51.982049
NCT02820701|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-09-14|||July 2016||2016-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Ultrasound Evaluation of OMT for Sacral Base Asymmetry|Ultrasound Evaluation of the Effect of Osteopathic Manipulative Treatment on Sacral Base Asymmetry|Completed||N/A|40|Actual|A.T. Still University of Health Sciences||2|||f||||f||||||||No||2017-10-10 22:01:52.144268|2017-10-10 22:01:52.144268
NCT02820688|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-01-04|||June 2016||2016-06-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Concentration-Volume Relationship in Infraclavicular Block|Impact of Local Anesthetic Concentration-Volume Modifications on Ultrasound Guided Infraclavicular Nerve Block Effectiveness|Completed||Phase 4|81|Actual|Bozyaka Training and Research Hospital||3|||f||||f||||||||No||2017-10-10 22:01:52.225528|2017-10-10 22:01:52.225528
NCT02820675|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-06-30|||August 2015||2015-08-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|icosmos||Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions|Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions / Deutsches Qualitaetsbuendnis Sepsis (German Quality Network Sepsis)|Recruiting||N/A|70|Anticipated|Center for Sepsis Control and Care, Germany||1|||f||||t||||||||Yes|Our trial uses publicly accessible routine data and a risk adjustment algorithm being prepared for publication|2017-10-10 22:01:52.352984|2017-10-10 22:01:52.352984
NCT02820662|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2016-06-30|||July 2015||2015-07-01|June 2016|2016-06-01||||July 2017|Anticipated|2017-07-01||Interventional|OMEGAROP||Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants|Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in Newborns|Recruiting||N/A|55|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 22:01:52.495188|2017-10-10 22:01:52.495188
NCT02820649|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-28|||June 2015||2015-06-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|August 2015|Actual|2015-08-01||Interventional|SOMEX||Protective Effects of Exercise Training|Protective Effects of Exercise Training on Endothelial Dysfunction Induced by Total Sleep Deprivation in Healthy Subjects|Completed||N/A|16|Actual|Institut de Recherche Biomedicale des Armees||2|||f||||f||||||||No||2017-10-10 22:01:52.590232|2017-10-10 22:01:52.590232
NCT02820636|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-06-28|||August 2015||2015-08-01|June 2016|2016-06-01||||August 2017|Anticipated|2017-08-01||Interventional|||Treatment for Latino/a Adolescents With Suicidal Behavior||Recruiting||N/A|50|Anticipated|University of Puerto Rico||2|||f||||||||||||||2017-10-10 22:01:52.674919|2017-10-10 22:01:52.674919
NCT02820623|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-07-07|||November 2016||2016-11-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Project FACTS (Fidelity Accuracy: Comparing Three Strategies)|Increasing Accuracy and Efficiency of Fidelity Measurement in CBT|Enrolling by invitation||N/A|135|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-10-10 22:01:52.761987|2017-10-10 22:01:52.761987
NCT02820610|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-08-15|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Analgesia in Pediatric Laparoscopy|Dexmedetomidine Versus Magnesium Sulfate in Children Undergoing Laparoscopic Procedures|Recruiting||Phase 2|30|Anticipated|Assiut University||3|||f||||f||||||||||2017-10-10 22:01:52.835149|2017-10-10 22:01:52.835149
NCT02820597|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-29|2017-01-23|||June 15, 2015|Actual|2015-06-15|January 2017|2017-01-01|July 20, 2016|Actual|2016-07-20|February 5, 2016|Actual|2016-02-05||Interventional|||ClariFix Cryoablation Clinical Study|Clinical Evaluation of Cryotherapy in the Nasal Passageway Using the ClariFix Device|Completed||N/A|27|Actual|Arrinex, Inc.||1|||f||||f||||||||No||2017-10-10 22:01:52.930812|2017-10-10 22:01:52.930812
NCT02820584|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-06-28|||September 2016||2016-09-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|DENDR-STEM||A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma|A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma|Not yet recruiting||Phase 1|20|Anticipated|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta||1|||f||||t||||||||No||2017-10-10 22:01:53.002866|2017-10-10 22:01:53.002866
NCT02820571|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-28|||August 2016||2016-08-01|June 2016|2016-06-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|OPAL||The Oxford Pain, Activity and Lifestyle (OPAL) Cohort Study|The Oxford Pain, Activity and Lifestyle (OPAL) Cohort Study|Not yet recruiting||N/A|4000|Anticipated|University of Oxford|||1||f||||t||||||||||2017-10-10 22:01:53.074827|2017-10-10 22:01:53.074827
NCT02820558|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-28|||May 2016||2016-05-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Neuropeptide Therapy of Recent Onset Type 1 Diabetes|A Phase I Study of Safety and Pharmacological Activity of Substance P (sP) in the Reversal of Recent-Onset Type 1 Diabetes (T1D)|Recruiting||Phase 1|12|Anticipated|Vanilloid Genetics Inc.||4|||f||||t||||||||Yes||2017-10-10 22:01:53.148731|2017-10-10 22:01:53.148731
NCT02820545|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-08-08|||February 2016||2016-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|PERSEPOLIS||Patient's Perception of Hospital Safety|Patient's Perception of Hospital Safety: Measure of the Patients' Perception and Correlation With Patient Safety Strategies in the Surgical Care Units|Recruiting||N/A|1290|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:01:53.261375|2017-10-10 22:01:53.261375
NCT02820532|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-05-02|||July 2016||2016-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Influence of Couch Tracking Motion|Influence of Couch Tracking Motion on Physiological Parameters|Recruiting||N/A|100|Anticipated|University of Zurich||1|||f||||f||||||||Undecided||2017-10-10 22:01:53.356027|2017-10-10 22:01:53.356027
NCT02820519|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-08-25|||June 2016||2016-06-01|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|LOX2015PILOT||Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain|Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain|Terminated||Phase 2|4|Actual|University of Witten/Herdecke||1||Intolerable high amount of adverse events|f||||f||||||||||2017-10-10 22:01:53.444987|2017-10-10 22:01:53.444987
NCT02820506|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-03-20|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|SENTIREC II||Sentinel Node Mapping in Women With Endometrial and Cervical Cancer|Sentinel Node Mapping With Robotic Assisted Near Infra-red Fluorescent Imaging in Women With Cervical and Endometrial Cancer|Recruiting||N/A|400|Anticipated|University of Southern Denmark||2|||f||||t|f|f||||||||2017-10-10 22:01:53.538551|2017-10-10 22:01:53.538551
NCT02820493|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-28|||September 2016||2016-09-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNF|Effectiveness of Vedolizumab Therapy in Inducing Clinical Remission in CD Patients Naïve to Anti-TNF and Its Capability to Halt Disease Progression|Not yet recruiting||Phase 4|20|Anticipated|Universita degli Studi di Genova||1|||f||||t||||||||||2017-10-10 22:01:53.660352|2017-10-10 22:01:53.660352
NCT02820480|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-11|||November 2015||2015-11-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|June 2017|Actual|2017-06-01||Interventional|RehabCares||Design of an Affordable Gym for Post Stroke Rehabilitation|Design of an Affordable Gym for Post Stroke Rehabilitation|Active, not recruiting||N/A|20|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:01:53.821458|2017-10-10 22:01:53.821458
NCT02820467|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-03-16|||November 2015||2015-11-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|FLUORESCENCE||Use of Indocyanine Green Angiography in Critical Limb Ischemia|Study of Parameters of Infracyanine Angiography as Diagnostic Tool of Critical Limb Ischemia|Recruiting||Phase 3|30|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||Undecided||2017-10-10 22:01:53.88871|2017-10-10 22:01:53.88871
NCT02820454|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-10-04|||June 2016|Actual|2016-06-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|NANO-RAD||Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles|Etude Clinique de Phase I de Radiosensibilisation de métastases cérébrales Par Nanoparticules de Gadolinium|Recruiting||Phase 1|18|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-10 22:01:53.973126|2017-10-10 22:01:53.973126
NCT02820441|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-11-17|||May 2016||2016-05-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|ZODIAC||Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance|Adaptative Servoventilation Compliance in Left Ventricular Dysfunction Patients With Central Sleep Apnea: Benefit of One Month Hypnotic (Zopiclone) Versus Placebo|Recruiting||Phase 4|48|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||No||2017-10-10 22:01:54.063029|2017-10-10 22:01:54.063029
NCT02820428|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-28|||April 2009||2009-04-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ECMP||Evaluation of Behaviour in Parkinson's Disease. Normal Values in Healthy Subjects|Evaluation Comportementale Dans la Maladie de Parkinson. Normes Chez Des Sujets Sains|Completed||N/A|124|Actual|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 22:01:54.18578|2017-10-10 22:01:54.18578
NCT02820415|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-30|||June 2014||2014-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01|2 Years|Observational [Patient Registry]|PGSvitfreov||PGS on Blastocysts From Vitrified and Fresh Oocytes|Oocyte Accumulation by Vitrification is a Valid Strategy to Increase the Number of Euploid Available Embryos for Biopsy and Transfer After Preimplantation Genetic Testing|Completed||N/A|60|Actual|Unità di Medicina della Riproduzione, Italy|||1||f||||||||||Samples With DNA|"     DNA from trophectoderm cells   "|||2017-10-10 22:01:54.247525|2017-10-10 22:01:54.247525
NCT02820402|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-14|||January 1999||1999-01-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Project Viva: a Longitudinal Study of Health for the Next Generation|Project Viva: a Longitudinal Study of Health for the Next Generation|Active, not recruiting||N/A|2128|Actual|Harvard Pilgrim Health Care|||1||f||||f||||||Samples With DNA|"     Mom: 1st trimester - EDTA purple top (plasma, RBC, WBC-DNA), heparin green top (plasma); 2nd     trimester - EDTA purple top (plasma, RBC, WBC-DNA), heparin green top; birth - hair; age 3     (early childhood) - EDTA purple top (plasma, RBC, WBC-DNA), heparin green top (plasma)      Child: cord blood —heparin green top (cell pellets and supernatant), red top (serum), EDTA     purple top (plasma, WBC-DNA); age 3 (early childhood) - EDTA purple top (plasma, WBC-DNA),     heparin green top (plasma, RBC); age 3 (early childhood) Immune Substudy - EDTA purple top,     heparin green top (room temp - stimulation supernatants, plasma), and heparin green top (cold     - RBC, plasma); age 7 (mid childhood) - EDTA purple top (plasma, RBC, WBC-DNA), heparin green     top (plasma, RBC), grey top (plasma), urine, hair; early teen - EDTA purple top (plasma, RBC,     WBC-DNA), heparin green top (plasma, RBC), 2 ml grey top (plasma), urine, hair   "|||2017-10-10 22:01:54.325934|2017-10-10 22:01:54.325934
NCT02820389|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-07|||June 14, 2016|Actual|2016-06-14|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|CTCS||CT Colonography as the Initial Diagnostic Imaging Tool for Patients With Suspected Colorectal Cancer|Observational Study to Compare the Utilisation of CT Colonography With Optical Colonoscopy as the First Diagnostic Imaging Tool in Patients With Suspected Colorectal Cancer|Recruiting||N/A|246|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||2||f||||t||||||||||2017-10-10 22:01:54.3867|2017-10-10 22:01:54.3867
NCT02820376|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-07-20|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|DOVISCAN||Assessment of Differential Renal Function by CT in Living Donors|Assessment of Differential Renal Function by CT in Living Donors - The DOVISCAN Study|Recruiting||N/A|51|Anticipated|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-10 22:01:54.472722|2017-10-10 22:01:54.472722
NCT02820363|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-29|||February 14, 2017|Actual|2017-02-14|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||"Study Evaluating CERAMENT™|G in Open Diaphyseal Tibial Fractures"|"A Prospective, Randomized Multicenter Controlled Trial of CERAMENT™|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures"|Recruiting||N/A|230|Anticipated|BONESUPPORT AB||2|||f||||t|f|t|f|||||||2017-10-10 22:01:56.479591|2017-10-10 22:01:56.479591
NCT02820350|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-19|||October 2016||2016-10-01|April 2017|2017-04-01||||March 2018|Anticipated|2018-03-01||Interventional|SCD-PED-01||A Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).|A Multi-Center, Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI)|Recruiting||Phase 2|16|Anticipated|CytoPherx, Inc||1|||f||||t||||||||No||2017-10-10 22:01:56.675376|2017-10-10 22:01:56.675376
NCT02820337|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-17|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|ObéVIH||Pathophysiological Study of Adipose Tissue of Patients Infected With HIV|ObéVIH : Pathophysiology of Adipose Tissue of Obese HIV-infected Patients Undergoing a Sleeve Gastrectomy Using Single Port|Recruiting||N/A|20|Anticipated|Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida|||1||f||||t||||||||||2017-10-10 22:01:56.788522|2017-10-10 22:01:56.788522
NCT02820324|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-07-07||2017-07-07|May 2016||2016-05-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty|Completed||Phase 3|401|Actual|Trevena Inc.||5|||f||||f||||||||||2017-10-10 22:01:56.887037|2017-10-10 22:01:56.887037
NCT02820311|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-08-02|||May 2016||2016-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Thorough QT (TQT) Study of TD-4208 in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo- and Positive−Controlled, 4-Period Crossover Thorough QT Study to Evaluate the Effect of a Single Dose of TD-4208 on Cardiac Repolarization in Healthy Subjects|Completed||Phase 1|48|Actual|Theravance Biopharma R & D, Inc.||4|||f||||f||||||||No||2017-10-10 22:01:56.990603|2017-10-10 22:01:56.990603
NCT02820298|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-08-21|||June 2016||2016-06-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects|A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effect of A High-Fat Meal on the Pharmacokinetics of Bexagliflozin in Healthy Subjects|Completed||Phase 1|25|Actual|Theracos||2|||f||||t||||||||||2017-10-10 22:01:57.082987|2017-10-10 22:01:57.082987
NCT02820285|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-10-03|||March 2013||2013-03-01|June 2016|2016-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH|Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH|Completed||N/A|148|Actual|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-10 22:01:57.166526|2017-10-10 22:01:57.166526
NCT02820272|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-30|||October 2012||2012-10-01|June 2016|2016-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Water for Reducing Pain in Negative Pressure Wound Therapy|Cold Water for Reducing Pain in Negative Pressure Wound Therapy Dressing Change|Completed||Phase 2|27|Actual|Chulalongkorn University||3|||f||||f||||||||||2017-10-10 22:01:57.369203|2017-10-10 22:01:57.369203
NCT02820259|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-09-21|||May 1, 2016||2016-05-01|September 2017|2017-09-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Observational|STABILE||Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)|Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)|Completed||N/A|42|Actual|Rennes University Hospital|||1||f||||||||||||||2017-10-10 22:01:57.447081|2017-10-10 22:01:57.447081
NCT02820246|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-28|||January 2006||2006-01-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01|30 Days|Observational [Patient Registry]|nutritionday||NutritionDay in Worldwide Hospitals: An International Audit and Registry on Nutrition and Outcome|NutritionDay in Worldwide Hospitals: A Cross-sectional Registry|Recruiting||N/A|250000|Anticipated|Medical University of Vienna|||1||f||||t||||||||Yes|Upon submission of a research proposal data anonymised data are shared with researcher. Each proposal is submitted to the supervisory board for approval.|2017-10-10 22:01:57.544131|2017-10-10 22:01:57.544131
NCT02820233|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-29|||June 2015||2015-06-01|June 2016|2016-06-01||||June 2020|Anticipated|2020-06-01||Observational|||Studies of Neuregulin/ERBB Signaling in Human Heart||Recruiting||N/A|80|Anticipated|Maine Medical Center|||1||f||||t||||||Samples With DNA|"     Plasma, circulating monocytes, and cardiac tissue.   "|Yes||2017-10-10 22:01:57.680654|2017-10-10 22:01:57.680654
NCT02820220|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-29|||June 2015||2015-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Knowledge and Perceptions Regarding JSSK and RBSK in Patients and Nurses: A Comparative Study|Knowledge and Perceptions Regarding Janani Shishu Suraksha Karyakram (JSSK) and Rashtriya Bal Swasthya Karyakram (RBSK) Programs in the Patients/Patient Attendants,Nursing Students and in Service Nurses: A Comparative Study|Completed||N/A|293|Actual|Lady Hardinge Medical College|||3||f||||f||||||||Undecided||2017-10-10 22:01:57.757234|2017-10-10 22:01:57.757234
NCT02820207|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-07-19|||January 13, 2016|Actual|2016-01-13|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 30, 2017|Anticipated|2017-12-30|6 Months|Observational [Patient Registry]|||Identification of Carotid Plague Vulnerability by Contrast Enhanced Ultrasound: Correlation With Plague Histopathology|Vascular Surgery Department of Beijing Tsinghua Chang Gung Hospital|Active, not recruiting||N/A|50|Anticipated|Beijing Tsinghua Chang Gung Hospital|||1||f||||t||||||||||2017-10-10 22:01:57.835774|2017-10-10 22:01:57.835774
NCT02820194|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||A Trial on SBRT Versus MWA for Inoperable Colorectal Liver Metastases (CLM)|A Randomized Phase III Trial on Stereotactic Body Radiation Therapy (SBRT) Versus Microwave Ablation (MWA) for Inoperable Colorectal Liver Metastases (CLM)|Recruiting||Phase 3|250|Anticipated|Istituto Clinico Humanitas||2|||f||||t||||||||No||2017-10-10 22:01:57.913658|2017-10-10 22:01:57.913658
NCT02820181|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-12-02|||August 2016||2016-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|AONTT||Assessment of a Novel Tracheostomy Tie|Assessment of Functionality and Performance of a Novel Tracheostomy Tie|Recruiting||Phase 2|60|Anticipated|The First Affiliated Hospital of Shanxi Medical University||2|||f||||||||||||||2017-10-10 22:01:58.027658|2017-10-10 22:01:58.027658
NCT02820168|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-04-19|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|POP-PL||Designing a Programming Language for Patient-Oriented Prescriptions|Designing a Programming Language for Patient-Oriented Prescriptions|Recruiting||N/A|570|Anticipated|Northwestern University|||1||f||||f||||||||Undecided||2017-10-10 22:01:58.124258|2017-10-10 22:01:58.124258
NCT02820155|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-07-05|||June 2016||2016-06-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects|A Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating, Single Dose and Multiple Dose Study to Evaluate the Safety and Pharmacokinetics of RGN1016 in Healthy Male Subjects|Recruiting||Phase 1|80|Anticipated|National Taiwan University Hospital||6|||f||||t||||||||Undecided||2017-10-10 22:01:58.21229|2017-10-10 22:01:58.21229
NCT02819960|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-06-28|||March 2016||2016-03-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Prevention of Irinotecan Induced Diarrhea by Probiotics|Prevention of Irinotecan Induced Diarrhea by Probiotics: A Phase III Study|Recruiting||Phase 3|100|Anticipated|S&D Pharma SK s.r.o.||2|||f||||t||||||||Undecided||2017-10-10 22:01:59.848365|2017-10-10 22:01:59.848365
NCT02820142|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-28|||July 2016||2016-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Plasticity and Regeneration of Renal Epithelial Cells|Plasticity and Regeneration of Renal Epithelial Cells|Not yet recruiting||N/A|400|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     Serum sample will be collected for further protein, DNA, RNA analysis. Urine sample will also     be collected.   "|Undecided||2017-10-10 22:01:58.313478|2017-10-10 22:01:58.313478
NCT02820129|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-09-05|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of a Medication Wallet Card|Effectiveness of a Medication Wallet Card|Enrolling by invitation||Phase 1|100|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 22:01:58.389847|2017-10-10 22:01:58.389847
NCT02820116|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-29|||May 2016||2016-05-01|May 2016|2016-05-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|||The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation|An Open-label, Multicenter，Single-arm, Phase II Clinical Study of Icotinib for IIIA - IIIB NSCLC Patients With Epidermal Growth Factor Receptor Mutation|Recruiting||Phase 2|67|Anticipated|Beijing Haidian Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:01:58.471838|2017-10-10 22:01:58.471838
NCT02820103|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-14|||February 20, 2017|Actual|2017-02-20|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|RAPiD||Reducing Acute Coronary Syndrome Patient Delay|Reducing Patient Delay in Acute Coronary Syndrome (RAPiD): A Web-based Randomised Controlled Trial Examining the Effect of a Behaviour Change Intervention on Participants' Intentions to Seek Help|Recruiting||N/A|177|Anticipated|Edinburgh Napier University||3|||f||||f|f|f||||||||2017-10-10 22:01:58.558634|2017-10-10 22:01:58.558634
NCT02820090|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-29|||May 2014||2014-05-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||The Predictive Effect of the Inflammatory Response on the Evacuation of Mechanical Ventilation and the Mechanism|The Predictive Effect of the Inflammatory Response on the Evacuation of Mechanical Ventilation and the Mechanism|Active, not recruiting||N/A|300|Anticipated|Beijing Chao Yang Hospital|||4||f||||t||||||||Yes||2017-10-10 22:01:58.663455|2017-10-10 22:01:58.663455
NCT02820077|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-28|||August 2016||2016-08-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|February 2019|Anticipated|2019-02-01||Interventional|||Hemostatic Powder Versus Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions|Randomized Controlled Trial of Hemostatic Powder Versus Optimal Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions|Not yet recruiting||Phase 4|94|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||f||||||||No||2017-10-10 22:01:58.733716|2017-10-10 22:01:58.733716
NCT02820064|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-12-05|||January 2016||2016-01-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|HYPOCITRE||Effects of Hypoxia and Inflammation on Citrulline Synthesis by Ornithine Transcarbamylase in Human Enterocytes|Effects of Hypoxia and Inflammation on Citrulline Synthesis by Ornithine Transcarbamylase in Human Enterocytes|Recruiting||N/A|30|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 22:01:58.805727|2017-10-10 22:01:58.805727
NCT02820038|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-13|||September 2016||2016-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management|Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management|Recruiting||N/A|300|Anticipated|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-10-10 22:01:59.008452|2017-10-10 22:01:59.008452
NCT02820025|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-01-17|||October 2015||2015-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence|To Investigate the Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence From General Anesthesia Undergoing Elective Lumbar Surgery|Active, not recruiting||N/A|40|Actual|General Hospital of Ningxia Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:01:59.105781|2017-10-10 22:01:59.105781
NCT02820012|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-28|||May 2013||2013-05-01|June 2016|2016-06-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|ST2R||Scoliosis Surgery - ST2R (Simultaneous Translation on Two Rods)|Multicenter Study on the Contribution of Surgical Treatment by ST2R Technique (Simultaneous Translation on Two Rods) in Scoliosis of the Children and Adolescents|Active, not recruiting||N/A|164|Actual|Fondation Lenval||1|||f||||f||||||||No||2017-10-10 22:01:59.287114|2017-10-10 22:01:59.287114
NCT02819999|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-27|||October 2016||2016-10-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|||A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Delta-Like Protein 3-Expressing Extensive Stage Small Cell Lung Cancer|A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Delta-Like Protein 3-Expressing Extensive Stage Small Cell Lung Cancer|Recruiting||Phase 1|94|Anticipated|Stemcentrx||4|||f||||f||||||||||2017-10-10 22:01:59.401902|2017-10-10 22:01:59.401902
NCT02819986|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-28|||July 2016||2016-07-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PGAP||Effectiveness of Using the Progressive Goal Attainment Program in Anxiety and Mood Disorders|Effectiveness and Feasibility of Using the Progressive Goal Attainment Program in Anxiety and Mood Disorders|Not yet recruiting||N/A|44|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||Undecided||2017-10-10 22:01:59.57623|2017-10-10 22:01:59.57623
NCT02819973|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-03-21|||July 2016||2016-07-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|VIVID||Educational Videos to Address Racial Disparities in Implantable Cardioverter Defibrillator Therapy Via Innovative Designs|Educational Videos to Address Racial Disparities in Implantable Cardioverter Defibrillator Therapy Via Innovative Designs|Recruiting||N/A|480|Anticipated|Duke University||3|||f||||f||||||||No||2017-10-10 22:01:59.680722|2017-10-10 22:01:59.680722
NCT02819947|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-06-28|||March 2016||2016-03-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|3 Years|Observational [Patient Registry]|||Seoul National University Hospital Systemic Sclerosis Cohort|Systemic Sclerosis Cohort in Seoul National University Hospital Single Center Prospective Cohort, of Patients With Systemic Sclerosis in Korea|Enrolling by invitation||N/A|150|Anticipated|Seoul National University Hospital|||1||f||||f||||||||No||2017-10-10 22:01:59.974638|2017-10-10 22:01:59.974638
NCT02819934|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-09-21|||May 20, 2016|Actual|2016-05-20|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|June 6, 2016|Actual|2016-06-06||Interventional|||A Phase I Study to Investigate the ADME of KD101|A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of KD101 in Male Subjects|Enrolling by invitation||Phase 1|6|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 22:02:00.124545|2017-10-10 22:02:00.124545
NCT02819921|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-28|||July 2017|Anticipated|2017-07-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen|Desvenlafaxine for the Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen: a Randomized, Double-blind, Placebo-controlled Study|Not yet recruiting||Phase 4|200|Anticipated|Seoul National University Hospital||2|||f||||t|f|f|||f|||Undecided||2017-10-10 22:02:00.188655|2017-10-10 22:02:00.188655
NCT02819908|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-06-29|||September 2015||2015-09-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery|Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery|Completed||Phase 4|25|Actual|Eye Center of North Florida||2|||f||||f||||||||No||2017-10-10 22:02:00.315078|2017-10-10 22:02:00.315078
NCT02819895|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-05|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||PRIMM Trial (Phone Reminder for IMMunization)|PRIMM Trial (Phone Reminder for IMMunization) in Ondo State, Nigeria|Active, not recruiting||N/A|600|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||No||2017-10-10 22:02:00.424025|2017-10-10 22:02:00.424025
NCT02819882|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-06-19|||June 2016||2016-06-01|June 2017|2017-06-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01|5 Years|Observational [Patient Registry]|REGISTEM||A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)|A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)|Recruiting||N/A|1400|Anticipated|Spanish Breast Cancer Research Group|||5||f||||f||||||Samples With DNA|"     Blood samples Primary and metastatic lesion tissue samples   "|No||2017-10-10 22:02:00.521068|2017-10-10 22:02:00.521068
NCT02819869|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-04-18|||August 1, 2016|Actual|2016-08-01|October 2016|2016-10-01|December 14, 2016|Actual|2016-12-14|September 1, 2016|Actual|2016-09-01||Interventional|||The Combination Effect of Statin Plus Metformin on Relapse-free|The Combination Effect of Statin Plus Metformin on Relapse-free|Terminated||Phase 2|3|Actual|Taipei Medical University WanFang Hospital||2||insufficient for the fund|f||||f||||||||No||2017-10-10 22:02:00.724146|2017-10-10 22:02:00.724146
NCT02819856|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-09-21|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||SPI-1005 for Prevention and Treatment of Aminoglycoside Induced Ototoxicity|A PHASE 1b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS and PHARMACODYNAMICS OF SPI-1005 in CYSTIC FIBROSIS (CF) PATIENTS WITH ACTIVE PULMONARY EXACERBATION RECEIVING IV TOBRAMYCIN|Enrolling by invitation||Phase 1/Phase 2|100|Anticipated|Sound Pharmaceuticals, Incorporated||4|||f||||t|t|f||||||||2017-10-10 22:02:00.832422|2017-10-10 22:02:00.832422
NCT02819843|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-18|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors|A Phase II Randomized Trial of Intralesional Talimogene Laherparepvec (TALIMOGENE LAHERPAREPVEC) With or Without Radiotherapy for Cutaneous Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors|Recruiting||Phase 2|34|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 22:02:00.944506|2017-10-10 22:02:00.944506
NCT02819830|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2017-01-17|||May 2016||2016-05-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Effects of a Six-week Exercise Programme Undertaken by Women With Rheumatoid Arthritis|A Randomised Controlled Trial Assessing the Effects of a Six-week Exercise Programme on Fitness, Inflammation and Cardiovascular Risk in Women With Rheumatoid Arthritis|Completed||N/A|25|Actual|Belfast Health and Social Care Trust||2|||f||||f||||||||Yes||2017-10-10 22:02:01.044554|2017-10-10 22:02:01.044554
NCT02819817|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-02-15|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|ALOE||A Trial of Topical Aloe Vera Gel in Emergency Department Patients Presenting With Simple Traumatic Wounds|A Parallel Group Double Blind Placebo Randomised Controlled Trial (RCT) of Topical Aloe Vera Gel in Emergency Department (ED) Patients Presenting With Simple Traumatic Wounds|Withdrawn||Phase 1/Phase 2|0|Actual|NHS Lothian||3||MHRA CTA rejected due to no UK MHRA MA certificate or equivalent product info|f||||f|f|f||||||No||2017-10-10 22:02:01.136792|2017-10-10 22:02:01.136792
NCT02819804|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-06|||August 2016||2016-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Interventional|||Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|Phase Ib Study of Nivolumab and Dasatinib in Patients With Relapsed/Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)|Recruiting||Phase 1|22|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 22:02:01.243159|2017-10-10 22:02:01.243159
NCT02819791|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-01|||June 2014||2014-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|ETHEPAT||Impact of a Therapeutic Education Program of Patient on the Evolution of the Cardiovascular Chronic Disease||Active, not recruiting||N/A|200|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 22:02:01.386556|2017-10-10 22:02:01.386556
NCT02819778|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-30|||July 2016||2016-07-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|PROS100B||Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury|Interventional Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury|Not yet recruiting||Phase 3|4000|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:02:01.485659|2017-10-10 22:02:01.485659
NCT02819765|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-11|||February 7, 2017|Actual|2017-02-07|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Deep Phenotyping in Patients With ALS|Fluid Biomarkers With Deep Phenotyping in Patients With ALS|Recruiting||N/A|150|Anticipated|Barrow Neurological Institute|||1||f||||f|f|f||||Samples With DNA|"     Blood Serum Cerebrospinal fluid RNA DNA   "|||2017-10-10 22:02:01.63148|2017-10-10 22:02:01.63148
NCT02819752|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-27|||August 2016||2016-08-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|PEACH||PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck|Phase I Dose-escalation Study of PEmbrolizumab (MK3475) Anti-PD1 Immune Checkpoint Inhibitor Combined With Radical Chemoradiotherapy in Patients With Stage IV Squamous Cell Carcinoma of the Head and Neck|Not yet recruiting||Phase 1|36|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:02:01.944984|2017-10-10 22:02:01.944984
NCT02819739|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-06-30|||November 2014||2014-11-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|CARDIOX||Impact of Hyperoxia During Cardiopulmonary|Impact of Hyperoxia During Cardiopulmonary Bypass in the Occurrence of Cardiovascular Complications After Cardiac Surgery|Recruiting||Phase 3|330|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 22:02:02.063307|2017-10-10 22:02:02.063307
NCT02819726|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-09|||October 31, 2016|Actual|2016-10-31|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|RAMO-1||A Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis (RA)|A Randomized, Double-blind, Parallel Group, Multicenter Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis (RA)|Recruiting||Phase 1|282|Anticipated|Archigen Biotech Limited||4|||f||||t|t|f||||||||2017-10-10 22:02:02.156149|2017-10-10 22:02:02.156149
NCT02819713|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-06-30||||||June 2016|2016-06-01||||||||Interventional|||Difference in Pain Perception by Patients With Prostate Biopsy Using Instillagel Compared With Guided Ultrasound Gel|Difference in Pain Perception by Patients With Prostate Biopsy Using Instillagel Compared Guided Ultrasound Gel, a Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Rijnstate Hospital||2|||f||||t||||||||||2017-10-10 22:02:02.254595|2017-10-10 22:02:02.254595
NCT02819700|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-28|||January 2013||2013-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ISDC||Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)|Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)|Recruiting||N/A|285|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:02:02.355018|2017-10-10 22:02:02.355018
NCT02819687|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-29|||November 2010||2010-11-01|June 2016|2016-06-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RDX5791 in Healthy Volunteers|A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses of RDX5791 in Healthy Volunteers|Completed||Phase 1|80|Actual|Ardelyx||9|||f||||f||||||||||2017-10-10 22:02:02.44956|2017-10-10 22:02:02.44956
NCT02819674|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-06-29|||October 2012||2012-10-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|CEHS||The Chinese Early-onset Hypertension Study (CEHS)|The Chinese Early-onset Hypertension Study (CEHS)|Recruiting||N/A|5000|Anticipated|China National Center for Cardiovascular Diseases|||1||f||||t||||||Samples With DNA|"     Blood samples are collected after 12-hour overnight fast and biological variables are     determined. Genomic DNA is isolated from leukocytes according to a standard procedure.   "|Undecided||2017-10-10 22:02:02.545083|2017-10-10 22:02:02.545083
NCT02819661|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-12|||July 2016||2016-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Respiratory Depression in Women With BMI≥30 Underwent Spinal Anesthesia With Intrathecal Morphine in Elective C-section|Difference in the Frequency of Episodes of Respiratory Depression Between Obese (BMI≥30) and Women With Normal BMI Receiving Spinal Anesthesia Combined With Intrathecal Morphine During Elective Caesarean Section|Not yet recruiting||N/A|30|Anticipated|Rambam Health Care Campus||4|||f||||f||||||||No||2017-10-10 22:02:02.642661|2017-10-10 22:02:02.642661
NCT02819648|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-29|||June 2012||2012-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Oral Glucocorticoids Effect on Post Endodontic Pain|The Effect of Preoperative Oral Administration of Prednisolone on Postoperative Pain in Patients With Symptomatic Irreversible Pulpitis: A Single Center Randomized Controlled Trial|Completed||Phase 4|400|Actual|Cairo University||2|||f||||t||||||||Yes|Through journal publication|2017-10-10 22:02:02.745638|2017-10-10 22:02:02.745638
NCT02819635|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-15|||September 28, 2016||2016-09-28|August 2017|2017-08-01|July 30, 2021|Anticipated|2021-07-30|April 27, 2021|Anticipated|2021-04-27||Interventional|||A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis|Recruiting||Phase 2|1055|Anticipated|AbbVie||5|||f||||t||||||||||2017-10-10 22:02:02.875715|2017-10-10 22:02:02.875715
NCT02819622|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-27|||January 2015||2015-01-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|CSCR||Persona of Central Serous Chorioretinopathy|Persona of Central Serous Chorioretinopathy|Completed||N/A|83|Actual|Rafic Hariri University Hospital|||2||f||||f||||||||Yes|publication and excel sheet|2017-10-10 22:02:03.48772|2017-10-10 22:02:03.48772
NCT02819609|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-06-27|||November 2014||2014-11-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids|Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids|Completed||N/A|12234|Actual|Quintiles, Inc.|||4||f||||||||||||||2017-10-10 22:02:03.562456|2017-10-10 22:02:03.562456
NCT02819596|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-08-25|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|October 2018|Anticipated|2018-10-01||Interventional|CALYPSO||MEDI4736 Combinations in Metastatic Renal Cell Carcinoma|MEDI4736 Combinations in Metastatic Renal Cell Carcinoma|Recruiting||Phase 2|195|Anticipated|Queen Mary University of London||4|||f||||t||||||||||2017-10-10 22:02:03.638714|2017-10-10 22:02:03.638714
NCT02819583|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-10-23|||October 2016||2016-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma|Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma|Recruiting||Phase 1/Phase 2|10|Anticipated|PersonGen BioTherapeutics (Suzhou) Co., Ltd.||1|||f||||t||||||||Yes||2017-10-10 22:02:03.788024|2017-10-10 22:02:03.788024
NCT02819570|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-12-28|||November 2015||2015-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes|Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes. A Randomized Prospective, Open Trial|Recruiting||Phase 4|400|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||f||||||||No||2017-10-10 22:02:03.878457|2017-10-10 22:02:03.878457
NCT02819557|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-05-30|||June 2016||2016-06-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Ataluren in ≥2 to <5 Year-Old Males With Duchenne Muscular Dystrophy|A Phase 2 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Ataluren (PTC124®) in Patients Aged ≥2 to <5 Years Old With Nonsense Mutation Dystrophinopathy|Active, not recruiting||Phase 2|14|Actual|PTC Therapeutics||1|||f||||t||||||||Undecided||2017-10-10 22:02:03.98206|2017-10-10 22:02:03.98206
NCT02819544|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-28|||September 2016||2016-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VSD||Evaluation of the Interest of the Instillation of Saline Intraperitoneally (INSI ) Versus Instillation of Naropin the Surgical Site Versus Lung Recruitment Maneuvers ( PVM ) in the Management of Pain After Laparoscopic Cholecystectomy in Ambulatory Care|Prospective, Two-center , Randomized, ITT , Parallel Group Evaluating the Interest of the Instillation of Saline Intraperitoneally (INSI ) Versus Instillation of Naropin the Surgical Site Versus Lung Recruitment Maneuvers ( PVM ) in the Management of Pain After Laparoscopic Cholecystectomy in Ambulatory Care|Not yet recruiting||Phase 3|144|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 22:02:04.062918|2017-10-10 22:02:04.062918
NCT02819531|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-04-05|||June 2016||2016-06-01|April 2017|2017-04-01||||June 2018|Anticipated|2018-06-01||Interventional|ECSPAND||Efficacy CompariSon of Pre-stenting Atherectomy Versus Scoring ballooN for calcifieD Coronary Lesions Coronary Lesions|A Single Center, Randomized Trial of Treatment Strategies for Obstructive Calcified Coronary Lesions: Efficacy CompariSon of Pre-stenting Atherectomy Versus Scoring ballooN for calcifieD Coronary Lesions Coronary Lesions (ECSPAND)|Enrolling by invitation||N/A|30|Anticipated|North Texas Veterans Healthcare System||3|||f||||t||||||||No||2017-10-10 22:02:04.150493|2017-10-10 22:02:04.150493
NCT02819505|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-27|||December 2014||2014-12-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||β-alanine Supplementation on Knee Extensor Contractile and Force Properties|The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in Active Male Adults (18-30 Years).|Completed||Phase 4|23|Actual|Nottingham Trent University||2|||f||||f||||||||No||2017-10-10 22:02:05.462121|2017-10-10 22:02:05.462121
NCT02819492|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-04-08|||November 2014||2014-11-01|October 2016|2016-10-01|April 2017|Actual|2017-04-01|October 2016|Actual|2016-10-01||Observational|SNOWCAT||Side Specific Withdrawal Times for Colonoscopy: Impact on Adenoma Detection in the Proximal and Distal Colon||Completed||N/A|500|Actual|Technische Universität München|||1||f||||f||||||Samples Without DNA|"     Colon polyps   "|No||2017-10-10 22:02:05.560752|2017-10-10 22:02:05.560752
NCT02819466|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-28|||April 2013||2013-04-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|ECHO3DGASTRIQ||Visualization of the Stomach During Fasting and Measurement of Intragastric Volume After Ingestion of Fluid: Feasibility and Application of Three Dimensional Ultrasound in Healthy Subjects|Visualization of the Stomach During Fasting and Measurement of Intragastric Volume After Ingestion of Fluid: Feasibility and Application of Three Dimensional Ultrasound in Healthy Subjects. ECHO3DGASTRIQUE Study|Completed||N/A|6|Actual|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:02:05.837325|2017-10-10 22:02:05.837325
NCT02819453|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-29|||January 2015||2015-01-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Corticosteroid Mediates Acute Respiratory Distress Syndrome|Corticosteroid Mediates Acute Respiratory Distress Syndrome Via NLRP3 Inflammasome Signaling Pathway|Recruiting||Phase 4|20|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||1|||f||||t||||||||||2017-10-10 22:02:05.95131|2017-10-10 22:02:05.95131
NCT02819440|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-11-01|||July 2016||2016-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction|PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction|Recruiting||Phase 2|200|Anticipated|Vanderbilt University||2|||f||||t||||||||Yes||2017-10-10 22:02:06.057585|2017-10-10 22:02:06.057585
NCT02819427|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-29|||April 2013||2013-04-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|Absence||Concomitant High-resolution Recording of Haemodynamic and Electrical Activities of Children With Typical or Atypical Absence Seizures|Concomitant High-resolution Recording of Haemodynamic and Electrical Activities of Children With Typical or Atypical Absence Seizures: Near-infrared Spectroscopy (NIRS) Coupled to Electroencephalography (EEG)|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:02:06.163283|2017-10-10 22:02:06.163283
NCT02819414|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-07-02|||June 2016||2016-06-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Paracetamol Treatment of the Borderline Significant PDA|TIME TO RE-EVALUATE THE KINDER GENTLER APPROACH TO PATENT DUCTUS ARTERIOSUS (PDA) IN THE PRETERM NEONATE|Active, not recruiting||Phase 2|80|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||No||2017-10-10 22:02:06.243778|2017-10-10 22:02:06.243778
NCT02819401|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-06-28|||February 2013||2013-02-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||The Effects of a High-fiber Formula in Children With Failure to Thrive|A Prospective, Open-label, Post-marketing Observational Study to Evaluate the Effects of High-fiber Enteral Pediatric Formula in Children With Failure to Thrive Due to Malnutrition|Completed||N/A|345|Actual|Abbott Nutrition|||1||f||||f||||||||No||2017-10-10 22:02:06.352082|2017-10-10 22:02:06.352082
NCT02819388|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-30|||October 2011||2011-10-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SIRIAN||Evaluation of a Contraceptive Counseling Intervention in Deprived Neighborhoods: SIRIAN Randomized Controlled Trial|Evaluation of a Counseling Intervention to Improve Contraceptive Use in Deprived Neighborhoods: SIRIAN Randomized Controlled Trial.|Completed||N/A|500|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||Undecided||2017-10-10 22:02:06.458039|2017-10-10 22:02:06.458039
NCT02819375|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-01-24|||January 2017||2017-01-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison of Propofol, Propofol-remifentanil and Propofol-ketamine Anesthesia During Electroconvulsive Therapy|Inonu University Faculty of Medicine Department of Anesthesiology and Reanimation|Not yet recruiting||Phase 4|45|Anticipated|Inonu University||3|||f||||f||||||||No||2017-10-10 22:02:06.542558|2017-10-10 22:02:06.542558
NCT02819362|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-29|||April 2014||2014-04-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound|Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound.|Recruiting||N/A|106|Anticipated|Institut Bergonié|||1||f||||f||||||||No||2017-10-10 22:02:06.651491|2017-10-10 22:02:06.651491
NCT02819349|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|T4RP||Texting for Relapse Prevention|Texting for Relapse Prevention Among People Diagnosed With Schizophrenia or SAD|Not yet recruiting||N/A|40|Anticipated|Center for Innovative Public Health Research||2|||f||||f|f|f||||||||2017-10-10 22:02:06.736515|2017-10-10 22:02:06.736515
NCT02819336|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-06-25|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Effectiveness and Safety of Electroacupuncture on Poststroke Urinary Incontinence|Effectiveness and Safety of Electroacupuncture on Poststroke Urinary Incontinence: a Pilot Multicentered, Randomized, Parallel, Sham-controlled Trial|Completed||N/A|56|Actual|Kyunghee University||2|||f||||f||||||||No||2017-10-10 22:02:06.852352|2017-10-10 22:02:06.852352
NCT02819323|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-09|||June 2016||2016-06-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy|A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy|Recruiting||Phase 3|300|Anticipated|Braintree Laboratories||3|||f||||f||||||||||2017-10-10 22:02:06.964978|2017-10-10 22:02:06.964978
NCT02819310|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-09-09|||June 2016||2016-06-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults|An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults|Active, not recruiting||Phase 3|330|Actual|Braintree Laboratories||1|||f||||f||||||||No||2017-10-10 22:02:07.093379|2017-10-10 22:02:07.093379
NCT02819297|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-25|||June 2016||2016-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults||Completed||Phase 3|600|Actual|Braintree Laboratories||2|||f||||f||||||||||2017-10-10 22:02:07.197806|2017-10-10 22:02:07.197806
NCT02819284|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-04-12|||June 2016||2016-06-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease|A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease|Recruiting||Phase 3|900|Anticipated|Kala Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 22:02:07.472674|2017-10-10 22:02:07.472674
NCT02819271|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-01-19|||February 2014||2014-02-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers|A First-in-Human Study of the Safety of Single Continuous Intravenous Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers|Completed||Phase 1|80|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:02:07.982846|2017-10-10 22:02:07.982846
NCT02819258|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-27|||March 2009||2009-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Monocentric Study and Prognostic of Treatments Endodontics of Teeth With Periapical Pathology Realized CSERD (Nantes University Hospital)|Monocentric Study and Prognostic of Treatments Endodontics of Teeth With Periapical Pathology Realized CSERD (Nantes University Hospital)|Completed||N/A|100|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 22:02:08.088529|2017-10-10 22:02:08.088529
NCT02819245|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-27|||January 2003||2003-01-01|June 2016|2016-06-01||||December 2018|Anticipated|2018-12-01||Interventional|||Impact of Age on Surgical Outcome of Adolescent Idiopathic Scoliosis|Impact of Age on Surgical Outcome of Adolescent Idiopathic Scoliosis|Recruiting||N/A|300|Anticipated|Nanjing University School of Medicine||1|||f||||f||||||||No||2017-10-10 22:02:08.196472|2017-10-10 22:02:08.196472
NCT02819232|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-28|||March 2013||2013-03-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|Keratite||Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs|Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs|Recruiting||N/A|864|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 22:02:08.294749|2017-10-10 22:02:08.294749
NCT02819219|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-27|||August 2014||2014-08-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of ElevATP on Body Composition and Athletic Performance|Effects of ElevATP on Body Composition and Athletic Performance|Completed||N/A|51|Actual|MusclePharm Sports Science Institute||3|||f||||f||||||||Undecided|The decision is not for the researchers to make and must consult with the funding agencies|2017-10-10 22:02:08.412147|2017-10-10 22:02:08.412147
NCT02819206|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-28|||March 2013||2013-03-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs|Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs|Recruiting||N/A|810|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 22:02:08.565715|2017-10-10 22:02:08.565715
NCT02819193|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-29|||April 2012||2012-04-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|DOAL||Using Mother's Raw Milk Could Improve Breastfeeding in Hospitalized Neonates|Using Mother's Raw Milk Could Improve Breastfeeding in Hospitalized Neonates|Completed||N/A|665|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:02:08.663647|2017-10-10 22:02:08.663647
NCT02819180|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-29|||April 2014||2014-04-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|FLU-02-IB||Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB|Prospective Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal|Completed||N/A|120|Actual|Butantan Institute|||2||f||||f||||||||||2017-10-10 22:02:08.762331|2017-10-10 22:02:08.762331
NCT02819167|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-23|||May 26, 2016|Actual|2016-05-26|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|BCN||Brain and Cognitive Reserve|Neuro-anatomical Correlates on Volumetric MRI on the Impact of Brain Reserve and Cognitive Reserve on Ischemic Strokes in Elderly|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:02:08.846675|2017-10-10 22:02:08.846675
NCT02819154|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-09-04|||October 24, 2014|Actual|2014-10-24|June 2016|2016-06-01|June 2017|Actual|2017-06-01|May 30, 2016|Actual|2016-05-30||Observational|||Study of the Social and Psychological Consequences of ICU Hospitalization|Study of the Social and Psychological Consequences of ICU Hospitalization|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||t||||||||||2017-10-10 22:02:08.940853|2017-10-10 22:02:08.940853
NCT02819141|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-04-11|||November 2016||2016-11-01|April 2017|2017-04-01|November 2021|Anticipated|2021-11-01|April 2021|Anticipated|2021-04-01||Interventional|||Self-management of Sedative Therapy by Ventilated Patients|Efficacy of Self-management of Sedative Therapy by Ventilated ICU Patients|Recruiting||Phase 2/Phase 3|228|Anticipated|Mayo Clinic||2|||f||||t||||||||No||2017-10-10 22:02:09.023906|2017-10-10 22:02:09.023906
NCT02819128|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-28|||January 2014||2014-01-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|SDF||Investigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille.|Investigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille.|Recruiting||N/A|510|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 22:02:09.14369|2017-10-10 22:02:09.14369
NCT02819115|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-29|||June 2013||2013-06-01|June 2016|2016-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|FLU-01-IB||Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine|Prospective Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine|Completed||Phase 4|63|Actual|Butantan Institute|||2||f||||f||||||||||2017-10-10 22:02:09.244999|2017-10-10 22:02:09.244999
NCT02819102|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-01-30|||March 2016||2016-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates|A Single Sequence, Open-Label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 3A4, 2C9, 2C19 and 2D6 Enzyme Activity Using Probe Substrates in Healthy Subjects|Completed||Phase 1|20|Anticipated|BioCryst Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:02:09.335081|2017-10-10 22:02:09.335081
NCT02819089|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-27|||May 2016||2016-05-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Recovery Profiles After c Spine Surgery: With or Without Dexmedetomidine as an Anesthetic Adjuvant|Recovery Profiles After c Spine Surgery: With or Without Dexmedetomidine as an Anesthetic Adjuvant|Recruiting||N/A|100|Anticipated|Mahidol University||2|||f||||t||||||||No||2017-10-10 22:02:09.422315|2017-10-10 22:02:09.422315
NCT02819076|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-02-21|||June 13, 2014||2014-06-13|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 14, 2016|Actual|2016-11-14||Observational|||EVENDOL Scale Validation for at Term New-born|EVENDOL Scale Validation for at Term New-born|Active, not recruiting||N/A|100|Anticipated|Groupe Hospitalier Paris Saint Joseph|||2||f||||t||||||||||2017-10-10 22:02:09.52739|2017-10-10 22:02:09.52739
NCT02819037|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-22|||May 2016||2016-05-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01||Interventional|SIBOB||Small Intestinal Bacterial Overgrowth Obese|Modification of Digestive Flora After Gastric Bypass : Pilot Study on Microbial Overgrowth Using Gas Chromatography|Recruiting||N/A|62|Anticipated|Lille Catholic University||1|||f||||f||||||||||2017-10-10 22:02:09.68495|2017-10-10 22:02:09.68495
NCT02819024|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-03-29|||June 2016||2016-06-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography|Study of the Effects of Dexamethasone on Non-Small Cell Lung Cancer Using [F-18] FLT for Imaging With Positron Emission Tomography (PET)|Recruiting||N/A|10|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-10 22:02:09.797736|2017-10-10 22:02:09.797736
NCT02818452|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-12-05|||June 2016||2016-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Glycemic Impact of Oatmeal Plus OatWellXF28|Affecting the Glycemic Impact of Quaker Instant Oatmeal by Adding OatWell28XF: a Dose-Response Study|Completed||N/A|40|Actual|PepsiCo Global R&D||6|||f||||f||||||||No||2017-10-10 22:02:16.555954|2017-10-10 22:02:16.555954
NCT02819011|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-11|||May 2016||2016-05-01|July 2017|2017-07-01|December 15, 2018|Anticipated|2018-12-15|May 2018|Anticipated|2018-05-01||Interventional|||OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO|OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO|Recruiting||Phase 2|40|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 22:02:09.940884|2017-10-10 22:02:09.940884
NCT02818985|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-06-23|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Analgesia in Knee Arthroscopic Surgery|Intra-articular Dexamethasone vs Intra-articular Dexamedetomidine|Completed||Phase 2|60|Actual|Assiut University||3|||f||||t||||||||Yes||2017-10-10 22:02:10.292029|2017-10-10 22:02:10.292029
NCT02818972|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-29|||June 2016||2016-06-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Relay PRO Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers|A Prospective, Multicenter, Non-Blinded, Non-Randomized Study of the Relay PRO Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers|Not yet recruiting||N/A|110|Anticipated|Bolton Medical||1|||f||||t||||||||No||2017-10-10 22:02:10.359357|2017-10-10 22:02:10.359357
NCT02818959|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-27|||December 2013||2013-12-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|March 2014|Actual|2014-03-01||Interventional|CP-0001||First in Man Study of the JenaValve TAVI Plus System Transfemoral|First in Man Study of the JenaValve TAVI Plus System Transfemoral|Completed||N/A|7|Actual|JenaValve Technology, Inc.||1|||f||||f||||||||Yes||2017-10-10 22:02:10.426209|2017-10-10 22:02:10.426209
NCT02818946|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-05-23|||July 2016||2016-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective Trial|Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective Trial|Recruiting||N/A|150|Anticipated|Duke University||1|||f||||t||||||||No||2017-10-10 22:02:10.503381|2017-10-10 22:02:10.503381
NCT02818933|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-06-28|||November 2014||2014-11-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|DIETT||Diet Intake Estimation of Tweens and Teens: The DIETT Study|A Randomized Study of the Automated Self-Administered 24-hour Recall Compared to an Interviewer-administered 24-hour Diet Recall in Adolescents|Completed||N/A|30|Actual|Children's Hospital Medical Center, Cincinnati|||3||f||||f||||||||No|Not at this time.|2017-10-10 22:02:10.589269|2017-10-10 22:02:10.589269
NCT02818920|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-07-25|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2027|Anticipated|2027-01-01|January 2020|Anticipated|2020-01-01||Interventional|TOP 1501||Neoadjuvant Pembrolizumab|Pembrolizumab Prior to Surgery for Stage 1B, 2 or 3A Non-small Cell Lung Cancer (NSCLC): A Phase II Study|Recruiting||Phase 2|32|Anticipated|Duke University||1|||f||||t|t|f||||||||2017-10-10 22:02:10.642896|2017-10-10 22:02:10.642896
NCT02818907|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-08-02|||May 2016||2016-05-01|June 2016|2016-06-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|Pancreas-CGE||Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable|Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable : a Multicentre Prospective Cohort|Recruiting||N/A|350|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||||||||||||2017-10-10 22:02:12.675272|2017-10-10 22:02:12.675272
NCT02818894|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-01-21|||September 2016||2016-09-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Spinals in THA (Total Hip Arthroplasty)|Comparison of Lidocaine Versus Bupivacaine Spinal Anesthesia in Total Hip Arthroplasty: A Randomized, Double-Blind, Prospective Study|Recruiting||N/A|186|Anticipated|Emory University||2|||f||||f||||||||No||2017-10-10 22:02:12.791162|2017-10-10 22:02:12.791162
NCT02818881|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-08-31|||August 2015||2015-08-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Electromyography and Yoga|Differences in Energy Expenditure of Two Commonly Used Yoga Protocols|Completed||N/A|22|Actual|University of Miami||2|||f||||f||||||||||2017-10-10 22:02:12.887736|2017-10-10 22:02:12.887736
NCT02818868|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-27|||July 2016||2016-07-01|June 2016|2016-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|ALVO||Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial|Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial|Not yet recruiting||N/A|700|Anticipated|Hyogo College of Medicine|||1||f||||t||||||||No||2017-10-10 22:02:12.964076|2017-10-10 22:02:12.964076
NCT02818855|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-06-29|||March 2014||2014-03-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|3DMUCO||Treatment of Multiple Gingival Recessions|TREATMENT OF MULTIPLE RECESSION-TYPE DEFECTS WITH A PORCINE COLLAGEN 3D-MATRIX (MUCOGRAFT®) OR CONNECTIVE TISSUE GRAFTS: A RANDOMIZED, SINGLE BLIND, PARALLEL, NONINFERIORITY TRIAL.|Completed||Phase 4|15|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:02:13.051312|2017-10-10 22:02:13.051312
NCT02818842|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-27|||January 2016||2016-01-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2016|Actual|2016-06-01||Observational|||Evaluation of Drug's Risk in Pregnant Women|Evaluation of Drug's Risk in Pregnant Women|Recruiting||N/A|30000|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||Undecided||2017-10-10 22:02:13.136769|2017-10-10 22:02:13.136769
NCT02818829|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-27|||March 2014||2014-03-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|BACAP||Biological and Clinical Database for Pancreatic Adenocarcinoma|Biological and Clinical Database for Pancreatic Adenocarcinoma|Recruiting||N/A|1500|Anticipated|University Hospital, Toulouse|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, saliva, DNA and RNA from tumor cells, tissue from tumor biopsie,     tissue from tumor and adjacent tissue of pancreas   "|Undecided||2017-10-10 22:02:13.226068|2017-10-10 22:02:13.226068
NCT02818816|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-20|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|IOPsTBURG||Preoperative Brimonidine on IOP of Patients Undergoing RALP|A Prospective Study to Evaluate the Effect of Preoperative Topical Brimonidine Tartrate 0.2% (Allergan, Irvine, CA) on Intraocular Pressure (IOP) of Patients Undergoing Robot-assisted Laparoscopic Prostatectomy (RALP)|Recruiting||Phase 4|26|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:02:13.39294|2017-10-10 22:02:13.39294
NCT02818803|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-27|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic|Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic in Elderly People|Completed||Phase 3|40|Actual|University of Sao Paulo||2|||f||||t||||||||Undecided||2017-10-10 22:02:13.601194|2017-10-10 22:02:13.601194
NCT02818790|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-05-19|||May 2016||2016-05-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|PRECIOUS||PREventive Care Infrastructure Based On Ubiquitous Sensing (PRECIOUS). VHIR Pilot.|PREventive Care Infrastructure Based On Ubiquitous Sensing (PRECIOUS)|Completed||N/A|30|Actual|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||f||||||||||2017-10-10 22:02:13.708831|2017-10-10 22:02:13.708831
NCT02818777|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-04-26|||July 2016||2016-07-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease|A Randomized, Double Blind, Placebo-controlled Crossover Study of Tolerability and Efficacy of Cannabidiol (CBD) on Tremor in Parkinson's Disease|Recruiting||Phase 2|60|Anticipated|University of Colorado, Denver||2|||f||||t||||||||No||2017-10-10 22:02:13.832415|2017-10-10 22:02:13.832415
NCT02818764|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Delirium, Intraoperative Cerebral Perfusion and EEG Abnormalities After Total Hip Arthroplasty|Pathophysiology of Delirium in Patients Undergoing Total Hip Arthroplasty: Role of Intraoperative Cerebral Perfusion and EEG Abnormalities|Recruiting||N/A|110|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:02:13.972557|2017-10-10 22:02:13.972557
NCT02818751|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-29|||May 2015||2015-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|FiESTAA||Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety|Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety|Recruiting||N/A|84|Anticipated|University of Cincinnati||3|||f||||t||||||||No||2017-10-10 22:02:14.075802|2017-10-10 22:02:14.075802
NCT02818738|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-07-31|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|NEPHROVIR3||Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children|A Multicenter, Randomised, Double-blind Placebo-controlled Trial Assessing the Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children.|Not yet recruiting||Phase 3|156|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||||2017-10-10 22:02:14.235264|2017-10-10 22:02:14.235264
NCT02818725|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-06-29|||June 2010||2010-06-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|GETUG-AFU19||I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations|Intensified Methotrexate, Vinblastine, Doxorubicin and Cisplatin +/-Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma in Patients Without Harvey Nor Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations. Phase II Study|Active, not recruiting||Phase 3|93|Anticipated|UNICANCER||2|||f||||t||||||||Yes||2017-10-10 22:02:14.346057|2017-10-10 22:02:14.346057
NCT02818712|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-10-25|||August 2016||2016-08-01|October 2016|2016-10-01||||August 2018|Anticipated|2018-08-01||Observational|||Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up|Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up|Recruiting||N/A|150|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Serum and EDTA-plasma is collected from all patients at 0, 6 and 12 months.   "|Undecided||2017-10-10 22:02:14.463606|2017-10-10 22:02:14.463606
NCT02818699|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-27|||August 1, 2016|Actual|2016-08-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects|Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects|Recruiting||N/A|50|Anticipated|Tufts University||2|||f||||f||||||||No||2017-10-10 22:02:14.544094|2017-10-10 22:02:14.544094
NCT02818686|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-07-19|||August 2016||2016-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||TD-1473 for Active Ulcerative Colitis (UC)|A Phase 1b Multi-Center, Randomized, Double-Blind, Multi−Dose, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Plasma Exposure of TD−1473 in Subjects With Moderately-to-Severely Active Ulcerative Colitis|Recruiting||Phase 1|40|Anticipated|Theravance Biopharma R & D, Inc.||4|||f||||f|t|f||||||||2017-10-10 22:02:14.6444|2017-10-10 22:02:14.6444
NCT02818673|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-06-13|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|November 2019|Anticipated|2019-11-01||Interventional|ARAM||Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics|Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics Between Peritoneal and Vascular Compartments|Not yet recruiting||Phase 3|30|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||Undecided||2017-10-10 22:02:14.729197|2017-10-10 22:02:14.729197
NCT02818660|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-08-14|||May 2016||2016-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests|Mass Spectrometry Based Cutoffs for Cortisol and 17-hydroxy-progesterone (17-OH-progesterone) After Stimulation Tests for Primary and Secondary Adrenal Insufficiency.|Recruiting||N/A|200|Anticipated|Haukeland University Hospital||1|||f||||t||||||||||2017-10-10 22:02:14.825878|2017-10-10 22:02:14.825878
NCT02818647|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|TONSIL||Comparison of Cold Dissection Technique and Needle Monopolar Electrocautery Tonsillectomy|Comparison of Cold Dissection Technique and Needle Monopolar Electrocautery Tonsillectomy|Recruiting||N/A|40|Anticipated|Gaziosmanpasa Taksim Research and Education Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:02:14.915158|2017-10-10 22:02:14.915158
NCT02818634|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-27|||February 2016||2016-02-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|COSTA||Effect of Costal Harvesting Technique on Postoperative Donor-site Morbidity: Does Muscle Sparing Technique Cause Less Postoperative Pain ? A Clinical Trial|Effect of Costal Harvesting Technique on Postoperative Donor-site Morbidity: Does Muscle Sparing Technique Cause Less Postoperative Pain ? A Clinical Trial|Recruiting||N/A|20|Anticipated|Gaziosmanpasa Taksim Research and Education Hospital||2|||f||||f||||||||||2017-10-10 22:02:15.012672|2017-10-10 22:02:15.012672
NCT02818621|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-27|||October 2014||2014-10-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Administration of Dexmedetomidine Guided by Entropy/SPI Reduce|Does Administration of Dexmedetomidine Guided by Entropy/SPI Reduce the Requirement of Propofol and Remifentanil as Well as Increase the Quality of Recovery Profile?|Recruiting||N/A|64|Anticipated|Gangnam Severance Hospital||2|||f||||f||||||||No||2017-10-10 22:02:15.116378|2017-10-10 22:02:15.116378
NCT02818608|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Transcranial Direct Current Stimulation and Functional Electrical Stimulation for Rehabilitation After Stroke|Association Between the Transcranial Direct Current Stimulation (tDCS) and Functional Electrical Stimulation (FES) for Rehabilitation After Stroke - A Randomized Clinical Trial|Recruiting||N/A|51|Anticipated|Federal University of Health Science of Porto Alegre||3|||f||||f||||||||||2017-10-10 22:02:15.26499|2017-10-10 22:02:15.26499
NCT02818595|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-27|||March 2013||2013-03-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PREMAVOIX||Development of Maternal Voice Recognition in Preterm Neonates|Development of Maternal Voice Recognition in Preterm Neonates|Active, not recruiting||N/A|22|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 22:02:15.446451|2017-10-10 22:02:15.446451
NCT02818582|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-06-30|||June 24, 2016||2016-06-24|June 23, 2017|2017-06-23|January 26, 2018|Anticipated|2018-01-26|December 29, 2017|Anticipated|2017-12-29||Interventional|||GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen|PREVAIL IV: Double-Blind, Randomized, Two-Phase, Placebo-Controlled, Phase II Trial of GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen|Recruiting||Phase 2|120|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:02:15.52849|2017-10-10 22:02:15.52849
NCT02818569|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-07-21|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic|Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic|Recruiting||Phase 1/Phase 2|30|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 22:02:15.654109|2017-10-10 22:02:15.654109
NCT02818556|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01||||January 2017|Anticipated|2017-01-01||Interventional|||A Clinical Study Comparing Restylane® Silk and Belotero Balance® for the Treatment of Superficial, Vertical Perioral Lines||Recruiting||Phase 4|50|Anticipated|The Maas Clinic||2|||f||||||||||||||2017-10-10 22:02:15.781606|2017-10-10 22:02:15.781606
NCT02818543|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-12-13|||March 2016||2016-03-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis|An Open-Label, Single Ascending Dose Study To Evaluate The Pharmacokinetic Profile, Safety and Tolerability of Orally Administered LYC-30937 in Subjects With Active Ulcerative Colitis|Completed||Phase 1|6|Actual|Lycera Corp.||2|||f||||f||||||||No||2017-10-10 22:02:15.879338|2017-10-10 22:02:15.879338
NCT02818530|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2017-06-21|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Correlation Between Intraocular Pressure Measurement by Tomometer and Anterior Chamber Depth Measurement by Ultrasound|Correlation Between Intraocular Pressure Measurement by Tomometer and Anterior Chamber Depth Measurement by Ultrasound in Steep Trendelenberg Position During Robotic Assisted Surgery|Recruiting||N/A|50|Anticipated|Tata Memorial Centre||1|||f||||t|f|f||||||Undecided||2017-10-10 22:02:15.970518|2017-10-10 22:02:15.970518
NCT02818517|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-08-01|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01|2 Years|Observational [Patient Registry]|||Evaluation and Management of Cardio Toxicity in Oncologic Patients|Evaluation and Management of Cardio Toxicity in Oncologic Patients|Not yet recruiting||N/A|500|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||No||2017-10-10 22:02:16.072184|2017-10-10 22:02:16.072184
NCT02818504|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-11-03|||July 2016||2016-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|SEMEOTICONS||SEMEiotic Oriented Technology for Individual's CardiOmetabolic Risk Self- assessmeNt and Self-monitoring|SEMEiotic Oriented Technology for Individual's CardiOmetabolic Risk Self- assessmeNt and Self-monitoring|Completed||N/A|78|Actual|Istituto di Fisiologia Clinica CNR||2|||f||||f||||||||No||2017-10-10 22:02:16.159681|2017-10-10 22:02:16.159681
NCT02818491|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-07-18|||November 1, 2017|Anticipated|2017-11-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block: a Dose-finding|Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block: a Dose-finding|Not yet recruiting||Phase 4|75|Anticipated|Centre Hospitalier Universitaire Vaudois||5|||f||||f|f|f||||||||2017-10-10 22:02:16.269497|2017-10-10 22:02:16.269497
NCT02818478|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-02-07|||May 2016||2016-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PRO||Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis|Patient Reported Outcome Measures Reported Into the Danish Arthritis Registry (DANBIO) Via Computer or Tablet at Home Versus Touch Screen at the Outpatient Clinic Among Patients With Axial Spondyloarthritis or Rheumatoid Arthritis|Completed||N/A|42|Actual|Parker Research Institute||4|||f||||t||||||||No||2017-10-10 22:02:16.38648|2017-10-10 22:02:16.38648
NCT02818465|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-27|||March 2015||2015-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RAGE-VASCU||Role of the Interaction Between Advanced Glycation End Products and Their Receptor RAGE in the Development and the Progression of the Uremic Vasculopathy of Hemodialyzed Patients|Role of the Interaction Between AGEs and Their Receptor RAGE in the Development and the Progression of the Uremic Vasculopathy of Hemodialyzed Patients|Recruiting||N/A|100|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:02:16.475284|2017-10-10 22:02:16.475284
NCT02818426|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-10-05|||April 20, 2016|Actual|2016-04-20|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01||Interventional|UCPVax||Universal Cancer Peptide-based Vaccination in Metastatic NSCLC|Anticancer Therapeutic Vaccination Using Telomerase-derives Universal Cancer Peptides in Metastatic Non Small Cell Lung Cancer : A Phase I/II Study|Recruiting||Phase 1/Phase 2|54|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 22:02:16.738979|2017-10-10 22:02:16.738979
NCT02818413|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2017-08-28|||June 3, 2016|Actual|2016-06-03|August 2017|2017-08-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Observational|TRMC-Bio||Stool Microbiome, Pathogens, and Infectious Agents Among Olympic and Elite Athletes|"TRMC-Bio Molecular Profiling of Gut Microbiome, Microbiome Metabolome, Serum Chemistry, and Metabolism-Associated SNPs in Elite Athletes"|Completed||N/A|32|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Stool samples will be retained for future research   "|||2017-10-10 22:02:16.864331|2017-10-10 22:02:16.864331
NCT02818400|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-27|||November 2009||2009-11-01|June 2016|2016-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|AFTC||Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation|Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation|Recruiting||N/A|5|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-10 22:02:16.942924|2017-10-10 22:02:16.942924
NCT02818387|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-28|||October 2015||2015-10-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Remifentanil and Midazolam on Propofol for Loss of Consciousness in Elderly Patients|The Effect of Remifentanil and Midazolam on Propofol for Loss of Consciousness During Induction of Anesthesia in Elderly Patients|Recruiting||N/A|120|Anticipated|Gangnam Severance Hospital||3|||f||||t||||||||||2017-10-10 22:02:17.032259|2017-10-10 22:02:17.032259
NCT02818374|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-04-06|||March 2016||2016-03-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SAB||The Oral Accessibility Spatula (Spatule SAB)|Evaluation of the Efficacy and Safety of Use of an Innovative Medical Device for Improving Oral Accessibility in People With Disabilities, Presenting Behavioral Disorders: The Oral Accessibility Spatula (Spatule SAB)|Recruiting||N/A|200|Anticipated|Centre Hospitalier Régional Metz-Thionville||1|||f||||t||||||||No||2017-10-10 22:02:17.151284|2017-10-10 22:02:17.151284
NCT02818361|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-10-09|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Topical Tripterygium Wilfordii Gel for Moderate Activity Rheumatoid Arthritis|Topical Tripterygium Wilfordii Gel for Treatment in Patients With Moderate Activity Rheumatoid Arthritis|Recruiting||N/A|168|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||No||2017-10-10 22:02:17.244472|2017-10-10 22:02:17.244472
NCT02818348|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-12-05|||June 2016||2016-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients|Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients|Completed||Phase 1|30|Actual|Fundacio Lluita Contra la SIDA||2|||f||||f||||||||||2017-10-10 22:02:17.32351|2017-10-10 22:02:17.32351
NCT02818335|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-28|2016-11-03|||July 2016||2016-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study of LY3023414 Formulations and the Effect of Food|Relative Bioavailability and the Effect of Food on the Bioavailability of LY3023414 in Healthy Subjects|Completed||Phase 1|30|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:02:17.406228|2017-10-10 22:02:17.406228
NCT02818322|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-27|||April 2016||2016-04-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|A15-06||The Role of Telemedical Monitoring in Diabetic Foot Ulcer Care|The Role of Telemedical Monitoring in Diabetic Foot Ulcer Care|Recruiting||N/A|150|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 22:02:17.474791|2017-10-10 22:02:17.474791
NCT02818309|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-27|||January 2015||2015-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Lesogaberan in Chinese Patients With Refractory Reflux Symptoms|Efficacy and Safety of Lesogaberan (AZD3355) in Chinese Patients With Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy: a Randomized Placebo-controlled Trial|Active, not recruiting||Phase 2|72|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||No|The data will not open for public use.|2017-10-10 22:02:17.548327|2017-10-10 22:02:17.548327
NCT02818296|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-27|||August 2014||2014-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Computerized Cognitive Bias Intervention for Intolerance of Uncertainty|Computerized Cognitive Bias Intervention for Intolerance of Uncertainty|Completed||N/A|79|Actual|Florida State University||2|||f||||f||||||||||2017-10-10 22:02:17.633495|2017-10-10 22:02:17.633495
NCT02818283|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-09-18|||June 2016||2016-06-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|SMALL LIPIDS||Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention|Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention|Recruiting||Phase 1/Phase 2|100|Anticipated|Ohio State University||3|||f||||f||||||||||2017-10-10 22:02:17.694976|2017-10-10 22:02:17.694976
NCT02818270|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-01-30|||June 2016|Actual|2016-06-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|December 2016|Actual|2016-12-01||Interventional|||Evaluation of Aerosolized Drugs Deposition During Mechanical Ventilation|Evaluation of Aerosolized Drugs Deposition Delivered Through a Mechanical Ventilator|Completed||N/A|30|Actual|Chang Gung University||1|||f||||t||||||||No||2017-10-10 22:02:17.791019|2017-10-10 22:02:17.791019
NCT02818257|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-04|||June 2016||2016-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Investigation Exploring Adhesive Materials and Their Ability to Handle Moisture|An Investigation Exploring Adhesive Materials and Their Ability to Handle Moisture|Recruiting||N/A|18|Anticipated|Coloplast A/S||6|||f||||f||||||||||2017-10-10 22:02:17.937856|2017-10-10 22:02:17.937856
NCT02818244|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-06-01|2017-04-18||June 2016||2016-06-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Accuracy of Commercially Available Heart Rate Monitors II|Accuracy of Commercially Available Heart Rate Monitors II|Completed||N/A|50|Actual|The Cleveland Clinic||5|||f||||f||||||||Undecided||2017-10-10 22:02:18.140052|2017-10-10 22:02:18.140052
NCT02818231|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01|1 Month|Observational [Patient Registry]|ADK-FO||Mechanisms of Cancerogenesis of Woodworkers Adenocarcinomas|Mechanisms of Cancerogenesis for Woodworkers Adenocarcinomas: Transcriptional Study of Olfactory Cleft Cells of Patients Exposed or Not to Wood Dust|Recruiting||N/A|30|Anticipated|Central Hospital, Nancy, France|||2||f||||f||||||Samples With DNA|"     olfactory mucosae cells   "|No||2017-10-10 22:02:18.521423|2017-10-10 22:02:18.521423
NCT02818218|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-02-22|||July 2016||2016-07-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||SVC and Its Relationship to CVP Measurements in Liver Transplantation|SVC Diameter and Collapsibility Index and Its Relationship to Central Venous Pressure Measurements in Patients Undergoing Liver Transplantation|Recruiting||N/A|100|Anticipated|The Cleveland Clinic|||1||f||||f||||||||No||2017-10-10 22:02:18.606153|2017-10-10 22:02:18.606153
NCT02818205|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-27|||January 2013||2013-01-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||Electrodermal Patterns of Arousal in Children|Electrodermal Patterns of Arousal in Children With Autism Spectrum Disorder|Completed||N/A|32|Actual|Barpak Geriatric Health Services, Inc. d/b/a Barpak Occupational Therapy|||2||f||||f||||||||No||2017-10-10 22:02:18.692709|2017-10-10 22:02:18.692709
NCT02818192|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-03-31|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|March 2020|Anticipated|2020-03-01||Observational|iCARE||Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)|Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)|Recruiting||N/A|400|Anticipated|University of Manitoba|||1||f||||f||||||Samples With DNA|"     Serum, plasma, random urine and buffy coat for DNA extraction will be collected at the     baseline visit on all recruited patients that consent to biobanking such that future     ancillary studies can be performed. Samples will be processed and frozen at -80 °C, and will     be stored for up to 25 years with participant consent. Tests that may be run on stored     samples include metabolomics, peptidomics, proteomics, and podocyte microparticle analyses     should additional funding be obtained. Samples will be collected at each site and frozen.     Periodically samples will be sent to the Canadian Biosample Repository at the University of     Alberta for long term storage.   "|Undecided|This is a multi-site trial where the use and compilation of individual level data is being discussed amongst the various ethics boards across Canada.|2017-10-10 22:02:18.786589|2017-10-10 22:02:18.786589
NCT02818179|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-10-13|||December 2016||2016-12-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging|Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 22:02:18.885703|2017-10-10 22:02:18.885703
NCT02818166|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-08-02|||June 2014||2014-06-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|June 2016|Actual|2016-06-01||Interventional|||Magnetic Resonance Imaging for Cerebral Embolization During Minimal Invasive Mitral Valve Surgery|Magnetic Resonance Neurological Evaluation After Right Mini-thoracotomy Mitral Valve Surgery: Trans-thoracic Versus Endoaortic Clamp|Recruiting||N/A|80|Anticipated|University of Turin, Italy||2|||f||||t||||||||Yes||2017-10-10 22:02:18.965154|2017-10-10 22:02:18.965154
NCT02818153|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|September 2016|Anticipated|2016-09-01||Interventional|ARCTado||Validation of an Allergic Rhinitis Control Test in Teenagers|Validation of an Allergic Rhinitis Control Test in Teenagers|Not yet recruiting||N/A|200|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||No||2017-10-10 22:02:19.068193|2017-10-10 22:02:19.068193
NCT02818140|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-25|||July 2016||2016-07-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Ultrasound-guided Transmuscular Quadratus Lumborum Block for Percutaneous Nephrolithotomy|Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Percutaneous Nephrolithotomy|Not yet recruiting||Phase 4|60|Anticipated|Zealand University Hospital||2|||f||||t||||||||No||2017-10-10 22:02:19.153861|2017-10-10 22:02:19.153861
NCT02818127|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-10|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|TCCT-TIMI||Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method (TCCT-TIMI)|Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method In Patients Undergoing Coronary Angiography|Recruiting||N/A|2000|Anticipated|Vascular and Molecular Cardiology Society||5|||f||||f||||||||Yes||2017-10-10 22:02:19.25555|2017-10-10 22:02:19.25555
NCT02818114|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-05-16|||October 16, 2016|Actual|2016-10-16|May 2017|2017-05-01|August 30, 2018|Anticipated|2018-08-30|June 16, 2018|Anticipated|2018-06-16||Interventional|PEET||Peer Enhanced Prolonged Exposures|Peer Enhanced Exposure Therapy (PEET)|Enrolling by invitation||N/A|12|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||Undecided||2017-10-10 22:02:19.365709|2017-10-10 22:02:19.365709
NCT02818101|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-06-30|||March 2016||2016-03-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|HypCor||Hypnosis Efficacy for the Prevention of Anxiety During a Coronary Angiography||Recruiting||N/A|170|Anticipated|Centre Hospitalier Régional Metz-Thionville||2|||f||||f||||||||||2017-10-10 22:02:19.450999|2017-10-10 22:02:19.450999
NCT02818088|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-05-02|||February 2016||2016-02-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CTOCD||Cognitive Training in Obsessive Compulsive Disorder|Cognitive Training in Patients With Obsessive Compulsive Disorder|Recruiting||N/A|40|Anticipated|University of Stellenbosch||1|||f||||||||||||No||2017-10-10 22:02:19.556893|2017-10-10 22:02:19.556893
NCT02818075|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-24|||April 2016||2016-04-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Mobile Phone Based Peer Support to Prevent Postpartum Depression Among Adolescent Mothers|Mobile Phone Based Peer Support to Prevent Postpartum Depression Among Adolescent Mothers: A Pilot Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|University of Toronto||2|||f||||f||||||||Undecided||2017-10-10 22:02:19.643228|2017-10-10 22:02:19.643228
NCT02818062|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-24|||January 2008||2008-01-01|June 2016|2016-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Severe Intraocular Infection|Severe Intraocular Infection|Completed||N/A|263|Actual|University Hospital, Strasbourg, France|||2||f||||f||||||Samples Without DNA|"     Aqueous humor obtained by anterior chamber tap.   "|||2017-10-10 22:02:19.73955|2017-10-10 22:02:19.73955
NCT02818049|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-01-13|||February 2015||2015-02-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|FLOOD||Cardiopulmonary Effects of Bronchoalveolar Wash on Patients With Acute Respiratory Distress Syndrome|Cardiopulmonary Effects of Bronchoalveolar Wash on Patients With Acute Respiratory Distress Syndrome|Recruiting||N/A|50|Anticipated|University Hospital, Limoges||1|||f||||f||||||||No||2017-10-10 22:02:19.827479|2017-10-10 22:02:19.827479
NCT02818036|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-29|||August 2016||2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||An fMRI Study of Opioid-related Changes in Neural Activity||Recruiting||N/A|80|Anticipated|University of Pittsburgh||2|||f||||||||||||||2017-10-10 22:02:19.909808|2017-10-10 22:02:19.909808
NCT02818023|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-09-22|||July 2016||2016-07-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Dose-seeking and Efficacy Study of Pembrolizumab Plus Vemurafenib Advanced Melanoma|Dose-seeking and Efficacy Study of Pembrolizumab Plus Vemurafenib for Therapy of Advanced Melanoma|Recruiting||Phase 1|50|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 22:02:20.004152|2017-10-10 22:02:20.004152
NCT02818010|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-28|||May 2012||2012-05-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|PHYSALYS||Impact of Physical Activity on Patients With Chronic Kidney Disease Not Receiving Dialysis Followed in the TIRCEL Network. An Exposed / Unexposed Study (PHYSALYS)|Impact of Physical Activity on Patients With Chronic Kidney Disease Not Receiving Dialysis Followed in the TIRCEL Network. An Exposed / Unexposed Study (PHYSALYS)|Completed||N/A|259|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:02:20.100786|2017-10-10 22:02:20.100786
NCT02817997|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-07-12|||October 2016||2016-10-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01|5 Years|Observational [Patient Registry]|ACCELERATE||International Registry for Patients With Castleman Disease|ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease|Recruiting||N/A|500|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     Lymph node and/or bone marrow slides and/or tissue blocks may be sent to research team at the     University of Pennsylvania to be scanned and uploaded to assist with grading likelihood of     accurate diagnosis, if allowed by local regulations. Patients will be given the option to     consent for lymph node and bone marrow slides collected for the registry that are determined     to be unnecessary for the registry to be used for research studies, such as genomic     sequencing or immunohistochemistry.   "|||2017-10-10 22:02:20.16919|2017-10-10 22:02:20.16919
NCT02817971|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-20|||March 2016||2016-03-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Enhanced Feedback to Hospitals in an Emerging Clinical Information Network|Effect of Enhanced Feedback to Hospitals That Are Part of an Emerging Clinical Information Network on Uptake of Revised Childhood Pneumonia Treatment Policy: A Pragmatic Cluster Randomized Trial Protocol|Completed||N/A|900|Actual|KEMRI-Wellcome Trust Collaborative Research Program||2|||f||||f||||||||||2017-10-10 22:02:20.397383|2017-10-10 22:02:20.397383
NCT02817958|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-24|||April 2016||2016-04-01|June 2016|2016-06-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|MEGACEP||Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis|Prospective Phase II Study Evaluating a Multimodal Care of Inguinal Node Metastasis in Squamous Cell Carcinoma of the Penis by Bilateral Lymphadenectomy and Chemotherapy TIP|Active, not recruiting||Phase 2|37|Anticipated|UNICANCER||2|||f||||f||||||||No||2017-10-10 22:02:20.505601|2017-10-10 22:02:20.505601
NCT02817945|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01||||June 2018|Anticipated|2018-06-01||Interventional|||Dual Integrin αvβ3 and SSTR2 Targeting PET Imaging in Lung Cancer Patients|68Ga-NOTA-3PTATE-RGD PET/CT in Lung Cancer Patients|Recruiting||Phase 1|40|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||||2017-10-10 22:02:20.599361|2017-10-10 22:02:20.599361
NCT02817932|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-06-28|||March 2016||2016-03-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects|A Single-center, Open-label, Ascending Single- and Multiple-oral Dose Study to Evaluate the Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects|Recruiting||Phase 1|120|Anticipated|A.Menarini Asia-Pacific Holdings Pte Ltd||5|||f||||f||||||||No||2017-10-10 22:02:20.671741|2017-10-10 22:02:20.671741
NCT02817919|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-27|||May 2016||2016-05-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|CEMISA||Cohort Event Monitoring in Sub Saharan Africa|Modified Cohort Event Monitoring Of Injectable Artesunate, Artemether And Quinine In Ethiopia, Ghana, Malawi And Uganda|Recruiting||N/A|3000|Anticipated|African Collaborating Centre for Pharmacovigilance|||1||f||||f||||||||||2017-10-10 22:02:20.750556|2017-10-10 22:02:20.750556
NCT02817906|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-08-14|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 in the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease|Recruiting||Phase 3|360|Anticipated|Intra-Cellular Therapies, Inc.||2|||f|||||t|f||||||||2017-10-10 22:02:20.823844|2017-10-10 22:02:20.823844
NCT02817893|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-28|||October 2015||2015-10-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|April 2016|Actual|2016-04-01||Observational|PLETHYSMO||Comparison of Respiratory Variations of the Pulse Oximetry Plethysmographic Raw Signal and Pulse Pressure During Abdominal Surgery (PLETHYSMO)|Comparison of Respiratory Variations of the Pulse Oximetry Plethysmographic Raw Signal and Pulse Pressure During Abdominal Surgery (PLETHYSMO)|Active, not recruiting||N/A|20|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:02:20.926335|2017-10-10 22:02:20.926335
NCT02817880|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|ALGOSTIM||Comparison of the Analgesic Effect Between the Motor Cortex Stimulation and the Trans-spinal Stimulation in the Algoneurodystrophy.|Comparison of the Analgesic Effect Between the Motor Cortex Stimulation (tDCS and rTMS) and the Trans-spinal Stimulation (tsDCS ) in the Algoneurodystrophy of Members. A Randomised Clinical Trial. tDCS : Transcranial Direct-current Stimulation rTMS : Repetitive Transcranial Magnetic Stimulation tsDCS : Transcutaneous Spinal Direct Current Stimulation|Not yet recruiting||N/A|66|Anticipated|University Hospital, Grenoble||3|||f||||f||||||||No||2017-10-10 22:02:20.97246|2017-10-10 22:02:20.97246
NCT02817867|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Association Between Brain Stimulations for the Rehabilitation of Chronic Stroke Patients|Association Between Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation for Chronic Stroke Patients Rehabilitation: a Randomized Clinical Trial.|Recruiting||N/A|45|Anticipated|Federal University of Health Science of Porto Alegre||3|||f||||f||||||||||2017-10-10 22:02:21.091199|2017-10-10 22:02:21.091199
NCT02817854|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-29|||May 2016||2016-05-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|PREGRAD||PCT REveals Good Recovery After Acute Diverticulitis: the PREGRAD Study|Procalcitonin REveals Good Recovery After Acute Diverticulitis: the PREGRAD Study|Recruiting||N/A|500|Anticipated|University of Roma La Sapienza|||1||f||||f||||||||No||2017-10-10 22:02:21.303275|2017-10-10 22:02:21.303275
NCT02817841|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-11-03|||August 2016||2016-08-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - US/CA Study|A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15 mg Estetrol and 3 mg Drospirenone|Recruiting||Phase 3|2000|Anticipated|Estetra||1|||f||||f||||||||Undecided||2017-10-10 22:02:21.416185|2017-10-10 22:02:21.416185
NCT02817828|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-05-09|||June 2016||2016-06-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study|A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15 mg Estetrol and 3 mg Drospirenone|Active, not recruiting||Phase 3|1577|Actual|Estetra||1|||f||||f||||||||No||2017-10-10 22:02:21.530123|2017-10-10 22:02:21.530123
NCT02817815|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-24|||September 2016||2016-09-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|FAPS||Atrial Fibrillation and Characterization of Blood Platelet||Not yet recruiting||N/A|210|Anticipated|University Hospital, Bordeaux||5|||f||||f||||||||||2017-10-10 22:02:21.630659|2017-10-10 22:02:21.630659
NCT02817802|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-30|||August 2016|Actual|2016-08-01|June 2016|2016-06-01|October 2023|Anticipated|2023-10-01|October 2018|Anticipated|2018-10-01|5 Years|Observational [Patient Registry]|BIOSOLVE-IV||BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV|BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV|Recruiting||N/A|1065|Anticipated|Biotronik AG|||1||f||||t||||||||No|The primary outcome data will be shared after the publication of it.|2017-10-10 22:02:21.766257|2017-10-10 22:02:21.766257
NCT02817789|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-06-29|||May 2016||2016-05-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|TICTAVI||Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)||Recruiting||Phase 3|308|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 22:02:21.87249|2017-10-10 22:02:21.87249
NCT02817776|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-08-23|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|March 29, 2019|Anticipated|2019-03-29|March 30, 2018|Anticipated|2018-03-30||Interventional|PRECEPT||Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH® SF Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT)|Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH® SF Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT)|Recruiting||Phase 3|367|Anticipated|Biosense Webster, Inc.||1|||f|||||f|t|f|||||||2017-10-10 22:02:22.0373|2017-10-10 22:02:22.0373
NCT02817763|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-05-11|2017-05-11||February 2014||2014-02-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||A New Surgical-restorative Approach to Treat Gingival Recessions Associated With Non-carious Cervical Lesions (NCCL)|Evaluation of a New Surgical-restorative Approach for the Treatment of Gingival Recessions Associated With Non-carious Cervical Lesions: a Randomized Controlled Clinical Trial|Completed||N/A|40|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||Undecided||2017-10-10 22:02:22.301117|2017-10-10 22:02:22.301117
NCT02817750|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-13|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation|Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation, With Fasting and Postprandial Administration, in Male and Female Healthy Volunteers, Produced by Biolab Sanus Farmacêutica Ltda|Not yet recruiting||Phase 1|28|Anticipated|Biolab Sanus Farmaceutica||2|||f||||f|f|f||||||||2017-10-10 22:02:22.676548|2017-10-10 22:02:22.676548
NCT02817737|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-27|||April 2016||2016-04-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Observational|||Pre-operative Radiological Measurement to Assess Femur Rotational Alignment|Pre-operative Radiological Measurement of Proximal Tibia Angle to Assess Femur Rotational Alignment in Total Knee Arthroplasty|Recruiting||N/A|33|Anticipated|Xi'an Honghui Hospital|||2||f||||||||||||||2017-10-10 22:02:22.792248|2017-10-10 22:02:22.792248
NCT02817724|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-10-25|||July 2016||2016-07-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|August 2017|Anticipated|2017-08-01||Interventional|||Integral Strategy to Supportive Care in Breast Cancer Patients|Integral Strategy to Supportive Care in Breast Cancer Patients Through Occupational Therapy and a M-health System: a Randomized Controlled Trial.|Recruiting||Phase 2|80|Anticipated|Universidad de Granada||2|||f||||||||||||||2017-10-10 22:02:22.875426|2017-10-10 22:02:22.875426
NCT02817711|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-01-02|||July 2002||2002-07-01|January 2017|2017-01-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|||Lyon BJI Cohort Study|Lyon BJI Cohort Study|Recruiting||N/A|4000|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:02:22.993093|2017-10-10 22:02:22.993093
NCT02817685|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-27|||May 2016||2016-05-01|June 2016|2016-06-01||||May 2020|Anticipated|2020-05-01||Observational|||Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial|Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial|Recruiting||N/A|7660|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||6||f||||f||||||||No||2017-10-10 22:02:23.184106|2017-10-10 22:02:23.184106
NCT02817672|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-24|||July 2017||2017-07-01|June 2016|2016-06-01||||June 2018|Anticipated|2018-06-01||Interventional|PRIME-D||Evaluating the Feasibility of Disseminating a Novel Mobile Platform to Treat Depression|Scaling a Smarter and More Efficient Intervention: Evaluating the Feasibility of Disseminating a Novel Mobile App Platform to Treat Depression|Not yet recruiting||N/A|120|Anticipated|University of California, San Francisco||2|||f||||||||||||||2017-10-10 22:02:23.291553|2017-10-10 22:02:23.291553
NCT02817659|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-09-19|||June 2016||2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|GIO||To Determine Tolerability to Glucagon Infusion in Obese Subjects|A Pilot Study to Determine Tolerability to Glucagon Infusion in Obese Subjects|Active, not recruiting||Phase 1|20|Actual|Translational Research Institute for Metabolism and Diabetes, Florida||1|||f||||t||||||||||2017-10-10 22:02:23.373371|2017-10-10 22:02:23.373371
NCT02817646|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-03-08|||February 2012||2012-02-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|October 2016|Actual|2016-10-01||Observational|||Study in ICU Patients Regarding Protein Intake and CT-derived Body Composition|A Retrospective Investigator Initiated Trial Evaluating Protein Intake and CT Assessments of Muscle Mass of Critically Ill Patients in Relation to Outcome Parameters: the PROMUS-study|Active, not recruiting||N/A|800|Anticipated|VU University Medical Center|||1||f||||f||||||||No||2017-10-10 22:02:23.454311|2017-10-10 22:02:23.454311
NCT02817620|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-15|||August 24, 2016|Actual|2016-08-24|September 2017|2017-09-01|September 14, 2017|Actual|2017-09-14|September 14, 2017|Actual|2017-09-14||Interventional|SPIROX||Study to Assess Antioxidant Efficacy of Spirulina on oxLDL and Lipids Metabolism on Subjects With Metabolic Syndrome|Pilot Study to Assess Antioxidant Efficacy of a Spirulina Water Extract on Oxidized LDL Status and Lipids Metabolism on Subjects With Metabolic Syndrome|Completed||N/A|40|Actual|Algosource||2|||f||||f||||||||||2017-10-10 22:02:23.659831|2017-10-10 22:02:23.659831
NCT02817607|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-05-03|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Assess Breast Sensation Before and After Breast Cancer Treatment|Pilot Study to Assess Breast Sensation Before and After Breast Cancer Treatment|Recruiting||N/A|15|Anticipated|Duke University||1|||f||||||||||||||2017-10-10 22:02:23.783717|2017-10-10 22:02:23.783717
NCT02817594|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-07|||January 25, 2016||2016-01-25|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|May 31, 2018|Anticipated|2018-05-31||Observational|3DUTCH||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C (3DUTCH)|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in The Netherlands (3DUTCH)|Active, not recruiting||N/A|255|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:02:23.858023|2017-10-10 22:02:23.858023
NCT02817581|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-07-13|||July 2016||2016-07-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||NEWS and Rapid Lactate Testing for Early Identification of High Risk Patients in the Emergency Department|Validation of National Early Warning Score (NEWS) and Rapid Lactate Testing for Early Identification of High Risk Patients in the Emergency Department|Recruiting||N/A|1255|Anticipated|Chinese University of Hong Kong|||1||f||||f||||||||Yes||2017-10-10 22:02:23.950073|2017-10-10 22:02:23.950073
NCT02817568|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-29|||March 2011||2011-03-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|August 2012|Actual|2012-08-01||Observational|||Frequency Of MCP-1 And CCR2 Gene Polymorphisms And Its Effect On Gene Expression In Patients With AgP|The Evaluation of MCP-1 and CCR-2 Gene Polymorphisms Frequency and The Effects of This Polymorphism on Gene Expression in Patients With Aggressive Periodontitis|Completed||N/A|215|Actual|Abant Izzet Baysal University|||2||f||||f||||||Samples With DNA|"     Peripheral Blood of each subject is kept -80 celcius for further analysis.   "|No|Individual participant data is kept in private computer and all data can be shared if necessary|2017-10-10 22:02:24.032737|2017-10-10 22:02:24.032737
NCT02817555|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-27|||September 2010||2010-09-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients|A Randomized, Controlled Trial of Costs Associated With Anemia Therapy in Hemodialysis Patients Treated With Intravenous Darbepoetin Alfa Versus Epoetin Alfa|Completed||Phase 4|50|Actual|Eastern Health, Canada||2|||f||||f||||||||No||2017-10-10 22:02:24.127293|2017-10-10 22:02:24.127293
NCT02817542|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-02-14|||August 2010|Actual|2010-08-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Observational|TAHITI||Trhombus Aspiration in Hyperglycemic ST-elevation myocardiAl InfarcTIon|Trhombus Aspiration in Hyperglycemic ST-elevation myocardiAl InfarcTIon (STEMI) Patients: 1-year Follow-up of the Prospective Randomised TAHITI Study|Completed||N/A|990|Actual|"University of Campania Luigi Vanvitelli"|||2||f||||f|f|f||||||Yes|Monthly for 1 year|2017-10-10 22:02:24.229823|2017-10-10 22:02:24.229823
NCT02817529|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-06-25|||July 2016||2016-07-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison of Two Positive Expiratory Pressure Devices in Stable COPD Patients|Comparison of Two Positive Expiratory Pressure Devices in Stable COPD Patients|Not yet recruiting||N/A|40|Anticipated|Rush University Medical Center||2|||f||||f||||||||No||2017-10-10 22:02:24.33577|2017-10-10 22:02:24.33577
NCT02817347|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-08-22|||June 2016||2016-06-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea|A Randomized, Double-blind, Multicenter, Phase2 Trial to Evaluate the Safety and Efficacy of YH1177 or YH1177-D Otic Soultion in Patients With Otitis Media and Otorrhea|Active, not recruiting||Phase 1/Phase 2|300|Anticipated|Yuhan Corporation||5|||f||||f||||||||||2017-10-10 22:02:25.988101|2017-10-10 22:02:25.988101
NCT02817516|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-02-20|||July 2016||2016-07-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy Participants|A Randomized, Double-Blind (Sponsor-Open), Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Multiple Doses of TAK-828 in Healthy Subjects|Terminated||Phase 1|56|Anticipated|Takeda||8|||f||||f||||||||||2017-10-10 22:02:24.420793|2017-10-10 22:02:24.420793
NCT02817503|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2016-10-13|||December 2015||2015-12-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Feasibility Study of the Intensive Systolic Blood Pressure Control|Effects of Intensive Antihypertensive Therapies on the Risk of Stroke in Hypertensive Adults: A Prospective Randomized Open-Label Blinded-Endpoint Trial, a Feasibility Study|Enrolling by invitation||Phase 4|100|Anticipated|Second Affiliated Hospital of Nanchang University||3|||f||||f||||||||No||2017-10-10 22:02:24.519463|2017-10-10 22:02:24.519463
NCT02817490|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-28|||April 2013||2013-04-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|PREDUSED||Patient Education Program and Ehlers-Danlos Syndrome|Evaluation of an Education Program for Patients With Hypermobility Type Ehlers-Danlos Syndrome|Completed||N/A|28|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:02:24.628278|2017-10-10 22:02:24.628278
NCT02817477|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-29|||September 2012||2012-09-01|June 2016|2016-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Intranasal Ketamine for Acute Traumatic Pain|Intranasal Ketamine for Acute Traumatic Pain in the Emergency Department: A Prospective, Randomized Clinical Trial of Efficacy and Safety|Completed||Phase 4|90|Actual|Tel Aviv Medical Center||3|||f||||f||||||||No||2017-10-10 22:02:24.706183|2017-10-10 22:02:24.706183
NCT02817464|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-10-05|||October 7, 2016|Actual|2016-10-07|October 2017|2017-10-01|February 19, 2020|Anticipated|2020-02-19|January 8, 2020|Anticipated|2020-01-08||Interventional|||Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle|A Two-part, Phase 1, Exploratory and Dose-range Finding Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following a Single Subcutaneous Administration of TV-46046 in Women With Ovulatory Cycle|Recruiting||Phase 1|78|Anticipated|Teva Pharmaceutical Industries||3|||f||||t|t|f||||||||2017-10-10 22:02:24.785442|2017-10-10 22:02:24.785442
NCT02817451|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-06-28|||July 14, 2016|Actual|2016-07-14|June 2017|2017-06-01|September 11, 2018|Anticipated|2018-09-11|September 11, 2018|Anticipated|2018-09-11||Interventional|||DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected|Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-HB-PRP-T Combined Vaccine Given as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and in HIV-Exposed Uninfected Infants in Republic of South Africa|Active, not recruiting||Phase 3|100|Actual|Sanofi||2|||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 22:02:24.896715|2017-10-10 22:02:24.896715
NCT02817438|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-10-03|||June 2016||2016-06-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|RADCAT||Research on Anxiety and Depression: Computer-Assisted Therapy|Research on Anxiety and Depression: Computer-Assisted Therapy|Active, not recruiting||N/A|136|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 22:02:25.000425|2017-10-10 22:02:25.000425
NCT02817425|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-06-26|||May 2013||2013-05-01|June 2016|2016-06-01|May 2019|Anticipated|2019-05-01|April 2018|Anticipated|2018-04-01||Interventional|||A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer|A Efficacy and Tolerability Study of Uracil/Ftorafur/Leucovorin Combined With Oxaliplatin (TEGAFOX) Sequential S-1 or SOX Sequential S-1 and S-1 Monotherapy in the Treatment of Adjuvant Chemotherapy for Gastric Cancer|Recruiting||Phase 2/Phase 3|300|Anticipated|LanZhou University||3|||f||||t||||||||||2017-10-10 22:02:25.127536|2017-10-10 22:02:25.127536
NCT02817412|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-01-13|||June 2016||2016-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Food Response Training for Binge Eating|Food Response Training for Binge Eating|Recruiting||N/A|120|Anticipated|Loma Linda University||4|||f||||f||||||||No||2017-10-10 22:02:25.211892|2017-10-10 22:02:25.211892
NCT02817399|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-08-24|||January 2016||2016-01-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effect of Functional Electrical Stimulation|The Effect of Functional Electrical Stimulation on Gait Quality After Anterior Cruciate Ligament Reconstruction|Active, not recruiting||N/A|56|Anticipated|Medical Corps, Israel Defense Force||2|||f||||t||||||||No||2017-10-10 22:02:25.301419|2017-10-10 22:02:25.301419
NCT02817386|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-02-22|||March 2015||2015-03-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01|2 Days|Observational [Patient Registry]|||Study of Postoperative Delirium in Elderly People After Orthopedic Surgery|microRNA and Delirium After Hip and Knee Fracture|Completed||N/A|52|Actual|Zhongnan Hospital|||1||f||||f||||||||No||2017-10-10 22:02:25.515433|2017-10-10 22:02:25.515433
NCT02817373|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-12-29|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Implantation Prediction by Three Dimensional (3D) Ultrasound in Fresh Embryo Transfers|Implantation Prediction Model by the Use of Three Dimensional (3D) Ultrasound in Fresh Embryo Transfers Cycles|Recruiting||N/A|150|Anticipated|Meir Medical Center||1|||f||||t||||||||No||2017-10-10 22:02:25.617711|2017-10-10 22:02:25.617711
NCT02817360|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-08-30|||February 2016||2016-02-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients|NT-proBNP Selected PreventiOn of Cardiac eveNts in a populaTion of dIabetic Patients Without A History of Cardiac Disease: a Prospective Randomized Trial|Recruiting||Phase 4|2400|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-10 22:02:25.736467|2017-10-10 22:02:25.736467
NCT02817334|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-26|||March 2016||2016-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast Cancer|A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery|Recruiting||Phase 2|149|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-10 22:02:26.125534|2017-10-10 22:02:26.125534
NCT02817321|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-19|||May 2016||2016-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Thoracic Paravertebral Block : Effect on Acute Pain and Chronic Pain and Quality of Life After Hepatectomy With Right J-shape Subcostal Incision||Recruiting||N/A|72|Anticipated|Peking Union Medical College Hospital||3|||f||||f||||||||||2017-10-10 22:02:26.234844|2017-10-10 22:02:26.234844
NCT02817308|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-10-05|||July 2016||2016-07-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas|Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas|Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||No||2017-10-10 22:02:26.368362|2017-10-10 22:02:26.368362
NCT02817295|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-02-05|||January 2016||2016-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Bariatric Surgeries in Elderly|Bariatric Surgeries in Elderly|Completed||N/A|9000|Actual|Assuta Medical Center|||2||f||||f||||||||No||2017-10-10 22:02:26.490943|2017-10-10 22:02:26.490943
NCT02817282|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-06-24|||November 2015||2015-11-01|April 2016|2016-04-01|November 2019|Anticipated|2019-11-01|December 2018|Anticipated|2018-12-01||Interventional|CHANGE||Compliance With Hand Hygiene in Nursing Homes: Go for a Sustainable Effect (CHANGE)|Compliance With Hand Hygiene in Nursing Homes: Go for a Sustainable Effect (CHANGE)|Enrolling by invitation||N/A|20|Anticipated|Radboud University||1|||f||||t||||||||No||2017-10-10 22:02:26.586694|2017-10-10 22:02:26.586694
NCT02817269|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-10-27|||July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Referred Pain Patterns Infraspinatus Muscle|Referred Pain Patterns in Trigger Point 2 of the Infraspinatus Muscle in Patients With Shoulder Pain|Completed||N/A|96|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||Undecided||2017-10-10 22:02:26.679213|2017-10-10 22:02:26.679213
NCT02817256|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-06-26|||October 2016||2016-10-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|RCTVMSSG||Vitamin and Mineral Supplementation Post Bariatric Surgery|A Randomized Controlled Trial of Vitamin and Mineral Supplementation Post Bariatric Surgery: Sleeve Gastrectomy|Not yet recruiting||N/A|105|Anticipated|United Arab Emirates University||2|||f||||f||||||||No||2017-10-10 22:02:26.781282|2017-10-10 22:02:26.781282
NCT02817243|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-28|||March 2016||2016-03-01|March 2016|2016-03-01||||July 2016|Anticipated|2016-07-01||Interventional|||The DDI Study of SP2086 and Simvastatin|The Drug Interaction Study of SP2086 and Simvastatin in Healthy Subjects|Recruiting||Phase 1|24|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:02:26.902953|2017-10-10 22:02:26.902953
NCT02817230|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-24|||June 2015||2015-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Effect of Statins on Trained Immunity|Effect of Statins on Epigenetic Reprogramming of Monocytes in Patients With Elevated Levels of LDL|Recruiting||N/A|45|Anticipated|Radboud University|||2||f||||f||||||||||2017-10-10 22:02:26.995427|2017-10-10 22:02:26.995427
NCT02817217|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-28|||March 2016||2016-03-01|January 2016|2016-01-01||||July 2016|Anticipated|2016-07-01||Interventional|||The DDI Study of SP2086 and Valsartan|The Drug Interaction Study of SP2086 and Valsartan in Healthy Subjects|Recruiting||Phase 1|24|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:02:27.102565|2017-10-10 22:02:27.102565
NCT02817204|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-04-23|||May 2016||2016-05-01|April 2017|2017-04-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Interventional|||Effect of Aerobic EXercise on MiCroVAscular RarefacTION in Chinese Mild HyperteNsive Patients（EXCAVATION-CHN1）|Effect of Aerobic EXercise on MiCroVAscular RarefacTION in Chinese Mild HyperteNsive Patients（EXCAVATION-CHN1）|Recruiting||Phase 3|40|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||No||2017-10-10 22:02:27.189044|2017-10-10 22:02:27.189044
NCT02817191|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2016-11-24|||June 2016||2016-06-01|November 2016|2016-11-01|November 2016|Anticipated|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effects of Holy-Comod and Tears Naturale Forte in Patients After Phaco+IOL|Effects of Holy-Comod and Tears Naturale Forte on Ocular Surface and Tear Inflammatory Mediators in Patients After Phaco+IOL|Recruiting||N/A|80|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:02:27.309392|2017-10-10 22:02:27.309392
NCT02817178|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-10-05|||March 2013|Actual|2013-03-01|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|Epitopes-CRC02||Study for Validation of Immunological Biomarkers in Patients With Metastatic Colorectal Cancer|Prospective Study for Validation of Immunological Biomarkers in Patients With Metastatic Colorectal Cancer|Active, not recruiting||N/A|258|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||||||||||||2017-10-10 22:02:27.436511|2017-10-10 22:02:27.436511
NCT02817165|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|PAID||Probiotics for the Prevention of Antibiotic-Associated Diarrhea|Probiotics in the Prevention of Antibiotic-Associated Diarrhea in Hospitalized Children: a Randomized Trial|Recruiting||Phase 3|236|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||Undecided|To be determined.|2017-10-10 22:02:27.532849|2017-10-10 22:02:27.532849
NCT02817139|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-25|||June 2016||2016-06-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Transcranial Direct Current Simulation in Chronic Migraine|Transcranial Direct Current Simulation Over Primary Motor vs Prefrontal Cortex in Chronic Migraine: a Pilot Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|15|Anticipated|Federal University of Paraíba||3|||f||||||||||||||2017-10-10 22:02:27.753407|2017-10-10 22:02:27.753407
NCT02817126|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-06-25|||October 2015||2015-10-01|June 2016|2016-06-01|October 2023|Anticipated|2023-10-01|October 2021|Anticipated|2021-10-01||Interventional|REAL||Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer|Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer (REAL): A Multicenter Randomized Controlled Trial|Recruiting||Phase 3|680|Anticipated|Fudan University||2|||f||||||||||||||2017-10-10 22:02:27.862326|2017-10-10 22:02:27.862326
NCT02817113|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-24|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer|Phase I Study of NC-6004 in Combination With 5-FU and Cetuximab as First-line Treatment in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1|55|Anticipated|Orient Europharma Co., Ltd.||1|||f||||t||||||||No||2017-10-10 22:02:27.960194|2017-10-10 22:02:27.960194
NCT02817100|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-09-04|||July 22, 2016|Actual|2016-07-22|September 2017|2017-09-01|August 23, 2017|Actual|2017-08-23|May 11, 2017|Actual|2017-05-11||Interventional|||First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080|Randomized, Placebo-controlled, Double-blind, Parallel Group Study to Investigate the Safety, Tolerability and Pharmacokinetics of Increasing Single Oral Doses (10 - 1500 mg, Tablets) of BAY1817080 Including the Effect of Food and Itraconazole on the Relative Bioavailability of BAY1817080 in Healthy Men|Completed||Phase 1|88|Actual|Bayer||2|||f||||f|f|f||||||||2017-10-10 22:02:28.068279|2017-10-10 22:02:28.068279
NCT02817087|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-10-18|||April 2016||2016-04-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Multifocal Brain Magnetic Stimulation in Chronic Ischemic Stroke|An Innovative Approach to Restoration of Function in Chronic Ischemic Stroke Using a New Wearable Multifocal Brain Stimulator|Enrolling by invitation||N/A|30|Anticipated|The Methodist Hospital System||2|||f||||f||||||||No||2017-10-10 22:02:28.159922|2017-10-10 22:02:28.159922
NCT02817074|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|MIND||MIND Diet Intervention and Cognitive Decline|MIND Diet Intervention to Prevent Alzheimer's Disease|Recruiting||Phase 3|600|Anticipated|Rush University Medical Center||2|||f||||t||||||||Yes|Electronic data will be made available after trial completion|2017-10-10 22:02:28.272109|2017-10-10 22:02:28.272109
NCT02817061|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-10-03|||January 1, 2018|Anticipated|2018-01-01|October 2017|2017-10-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|ELECTRA||Effectiveness of Light for Enhancement of Cognition by Transcranial Repeated Application (ELECTRA)|Effectiveness of Light for Enhancement of Cognition by Transcranial Repeated Application (ELECTRA): a Placebo-Controlled Study of Efficacy, Tolerability and Acceptability in Healthy Adult Volunteers|Not yet recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||f|f|t|f|f|t|||||2017-10-10 22:02:28.381468|2017-10-10 22:02:28.381468
NCT02817048|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Tubeless VATS for Peripheral Lung Nodule|Thoracoscopic Surgery Without Chest Tube Placement in Patients With Peripheral Lung Nodules: A Prospective Randomized Trial|Not yet recruiting||N/A|100|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||Yes||2017-10-10 22:02:28.462424|2017-10-10 22:02:28.462424
NCT02817035|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-11-13|||June 2016||2016-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study of Neural Inspiratory Time and Expiratory Delay in Patient and Health During Spontaneous Breathing and Ventilation|Study of Neural Inspiratory Time and Expiratory Delay in Patients and Healthy Subjects During Unassisted Spontaneous Breathing and Mechanical Ventilation.|Completed||N/A|24|Actual|The First Affiliated Hospital of Guangzhou Medical University||1|||f||||t||||||||Undecided||2017-10-10 22:02:28.544446|2017-10-10 22:02:28.544446
NCT02817022|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-06-24|||January 2016||2016-01-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|DSC||Developmentally Supportive Care on Neurobehavioral Outcome of Preterm Very Low Birth Weight Neonates|Evaluation of the Effect of Application of Developmentally Supportive Care on Neurobehavioral Outcome of Preterm Very Low Birth Weight Neonates|Recruiting||N/A|120|Anticipated|Lady Hardinge Medical College||1|||f||||t||||||||Undecided||2017-10-10 22:02:28.640968|2017-10-10 22:02:28.640968
NCT02817009|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-09-20|||December 2015||2015-12-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Healthy Families: Transforming Care for Obese Children at NYU Lutheran Family Health Centers|Healthy Families: Transforming Care for Obese Children at NYU Lutheran Family Health Centers|Completed||N/A|53|Actual|New York University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:02:28.823112|2017-10-10 22:02:28.823112
NCT02816996|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-27|2017-07-10|||January 24, 2017|Actual|2017-01-24|July 2017|2017-07-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|||Patient Comfort During Dermatologic Procedures|Managing Patient Comfort During Dermatologic Procedures: A Randomized Controlled Trial|Completed||N/A|135|Actual|Northwestern University||3|||f||||t|f|f||||||||2017-10-10 22:02:28.916562|2017-10-10 22:02:28.916562
NCT02816983|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2017-10-05|||March 2016||2016-03-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|||SBRT for Oligometastatic Castration-Refractory Prostate Cancer|A Phase II Evaluation of SBRT in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SBRT|Recruiting||N/A|110|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 22:02:28.982341|2017-10-10 22:02:28.982341
NCT02816970|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-26|||February 2014||2014-02-01|June 2016|2016-06-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)|Open Label, Randomized, Single Dose, Two-way Crossover Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||Undecided||2017-10-10 22:02:29.05249|2017-10-10 22:02:29.05249
NCT02816957|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-04-24|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|Nigella||Benefits of Nigella Sativa in Children With Beta Thalassemia Major|Study of The Therapeutic Benefits of Nigella Sativa in Children With Beta Thalassemia Major|Recruiting||Early Phase 1|80|Anticipated|Tanta University||2|||f||||t||||||||Undecided||2017-10-10 22:02:29.13015|2017-10-10 22:02:29.13015
NCT02816944|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-29|||May 2016||2016-05-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms||Recruiting||Phase 1/Phase 2|80|Anticipated|First Affiliated Hospital of Zhejiang University||1|||f||||||||||||||2017-10-10 22:02:29.211803|2017-10-10 22:02:29.211803
NCT02816931|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-06-24|||March 2016||2016-03-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|TDM-MDR-TB||Drug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory Concentrations|Plasma Drug Concentrations in the Treatment of Multidrug-resistant Tuberculosis in Relation to Minimum Inhibitory Concentrations - a Prospective Observational Study|Recruiting||N/A|50|Anticipated|Karolinska Institutet|||1||f||||t||||||Samples With DNA|"     Mycobacterium tuberculosis isolates will be frozen and stored for whole genome sequencing in     order to compare with clinical and phenotypic characteristics. Blood samples will be frozen     and stored for drug concentration analysis.   "|No||2017-10-10 22:02:29.298646|2017-10-10 22:02:29.298646
NCT02816905|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-26|2016-06-26|||October 2015||2015-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery|Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery (Topical Rimexolone Versus Topical Dexamethasone and Topical Fluorometholone)|Completed||Phase 4|40|Actual|Cairo University||3|||f||||||||||||Undecided||2017-10-10 22:02:29.4696|2017-10-10 22:02:29.4696
NCT02816892|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-06-25|||June 2016||2016-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Significance of Serum Tenascin C in Patients With Acute Aortic Disease|Significance of Serum Tenascin C in Patients With Acute Aortic Disease|Recruiting||N/A|100|Anticipated|Central South University|||5||f||||t||||||||Yes||2017-10-10 22:02:29.559738|2017-10-10 22:02:29.559738
NCT02816879|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-12|||July 9, 2013||2013-07-09|January 2017|2017-01-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men|Improving Screening Tools to Better Predict High-Grade Anal Dysplasia for MSM|Recruiting||N/A|375|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 22:02:29.645075|2017-10-10 22:02:29.645075
NCT02816866|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-28|||July 2010||2010-07-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparing Two Modes of Survivorship Care|Comparing Two Modes of Survivorship Care: A Randomized Trial|Completed||N/A|106|Actual|Yale University||2|||f||||f||||||||No||2017-10-10 22:02:32.165089|2017-10-10 22:02:32.165089
NCT02816853|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-11-23|||May 2016||2016-05-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy Participants|A Randomized, Placebo- and Positive-Controlled, Multiple-Dose, 4-Way Crossover Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy Subjects|Completed||Phase 1|44|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-10 22:02:32.281875|2017-10-10 22:02:32.281875
NCT02816840|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-28|||September 2016||2016-09-01|June 2016|2016-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||PET-CT/MRI in the Radiotherapy for Prostate Cancer|Pilot Study of the Incorporation of PET-CT/MRI in the Radiotherapy for Prostate Cancer|Not yet recruiting||Phase 1/Phase 2|90|Anticipated|Xuzhou Medical University||3|||f||||t||||||||No||2017-10-10 22:02:32.420601|2017-10-10 22:02:32.420601
NCT02816827|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-09-08|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ALERMEN||A Study to Evaluate Efficacy of IP on Alertness and Mental Fatigue|A Randomized, Double Dummy, Double Blind, Placebo Controlled Cross Over Study to Evaluate Efficacy of Investigational Product E-AG-01/ E-AG02/ E-AG-03/ E-AG-04 on Alertness and Mental Fatigue|Completed||N/A|59|Actual|Vedic Lifesciences Pvt. Ltd.||4|||f||||f||||||||No||2017-10-10 22:02:32.539185|2017-10-10 22:02:32.539185
NCT02816814|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-29|||November 2016||2016-11-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal Women|Effects of a Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids on the Lipidomic Membrane Profile of Erythrocyte in Menopausal Women.|Enrolling by invitation||N/A|12|Anticipated|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis||2|||f||||||||||||||2017-10-10 22:02:32.730791|2017-10-10 22:02:32.730791
NCT02816801|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-05-09|||June 2016||2016-06-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||The Butler-Program 2.0: An Internet Platform for Elderly||Completed||N/A|27|Actual|University of Zurich||2|||f||||f||||||||No||2017-10-10 22:02:32.841749|2017-10-10 22:02:32.841749
NCT02816788|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-25|||June 20, 2017|Actual|2017-06-20|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|August 22, 2017|Anticipated|2017-08-22||Interventional|||Investigation of Equine Assisted Therapy for Post-Traumatic Stress Disorder|Investigation of Equine Assisted Therapy for Post-Traumatic Stress Disorder|Active, not recruiting||N/A|3|Actual|Western University, Canada||1|||f||||f|f|f||||||||2017-10-10 22:02:32.919563|2017-10-10 22:02:32.919563
NCT02816775|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-03-29|||June 2016|Actual|2016-06-01|June 2016|2016-06-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Hemodynamic Responses to Tracheal Intubation Direct Laryngoscope and Videolaryngoscope in Elderly Patients||Completed||Phase 4|90|Actual|Inonu University||2|||f||||f||||||||No||2017-10-10 22:02:33.013687|2017-10-10 22:02:33.013687
NCT02816762|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-10-02|||June 2016||2016-06-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|DIANA||CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea|Effect of Continuous Positive Airway Pressure on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea|Recruiting||Phase 4|180|Anticipated|Hospital Universitario La Paz||2|||f||||f||||||||No||2017-10-10 22:02:33.140152|2017-10-10 22:02:33.140152
NCT02816749|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-06-30|||June 2016||2016-06-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|MDTDF||Maggot Debridement Therapy Versus Conventional Dressing Therapy to Treat Diabetic Foot Ulcers|Maggot Debridement Therapy Versus Conventional Dressing Therapy to Treat Type 2 Diabetic Mellitus Foot Ulcers: A Prospective Randomized Controlled Study|Recruiting||Phase 4|138|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||f||||||||Undecided||2017-10-10 22:02:33.54289|2017-10-10 22:02:33.54289
NCT02816736|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-08-16|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|March 17, 2019|Anticipated|2019-03-17|March 3, 2019|Anticipated|2019-03-03||Interventional|HFN-LIFE||EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)|EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)|Recruiting||Phase 4|400|Anticipated|Duke University||2|||f||||t|t|f||||||||2017-10-10 22:02:33.728164|2017-10-10 22:02:33.728164
NCT02816723|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-10-04|||November 28, 2016|Actual|2016-11-28|October 2017|2017-10-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|MTGHOV||Mindfulness Training in Healthy Older Veterans|Improving Brain Health in Older Veterans: A Mindfulness Training Pilot Study|Recruiting||N/A|58|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:02:33.884695|2017-10-10 22:02:33.884695
NCT02816710|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-25|2016-06-25|||June 2016||2016-06-01|June 2016|2016-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Conbercept Injection in Treatment of Vitreous Hemorrhage|Different Conbercept Injection Methods in Treatment of Vitreous Hemorrhage|Recruiting||Phase 4|30|Anticipated|Ruijin Hospital||3|||f||||f||||||||Yes||2017-10-10 22:02:34.040795|2017-10-10 22:02:34.040795
NCT02816697|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-10-19|||June 2016||2016-06-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Implementation of a System-level Tobacco Treatment Intervention|Implementation of a System-level Tobacco Treatment Intervention in Thoracic Oncology|Recruiting||N/A|340|Anticipated|Dana-Farber Cancer Institute||5|||f||||t||||||||No||2017-10-10 22:02:34.179324|2017-10-10 22:02:34.179324
NCT02816684|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-24|||June 2016||2016-06-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety|Pegasys VR: Integrating Virtual Humans in the Treatment of Child Social Anxiety|Recruiting||Phase 2|50|Anticipated|University of Central Florida||2|||f||||t||||||||No||2017-10-10 22:02:35.118007|2017-10-10 22:02:35.118007
NCT02816671|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-07-25|||June 2016||2016-06-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01|1 Month|Observational [Patient Registry]|MATCH||MicroCutter Assisted Thoracic Surgery Hemostasis Registry|MicroCutter Assisted Thoracic Surgery Hemostasis Registry|Recruiting||N/A|80|Anticipated|Dextera Surgical Inc.|||1||f||||f||||||||||2017-10-10 22:02:35.241659|2017-10-10 22:02:35.241659
NCT02816658|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-05|||May 2016||2016-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||The Role of the Robotic Platform in Inguinal Hernia Repair Surgery|The Role of the Robotic Platform in Inguinal Hernia Repair Surgery|Recruiting||N/A|100|Anticipated|The Cleveland Clinic||2|||f||||t||||||||Yes|Data will be shared between the trial sites. Participants will be informed as to the procedure that was performed for their hernia repair at their 2 year follow-up appointment.|2017-10-10 22:02:35.343106|2017-10-10 22:02:35.343106
NCT02816645|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-28|||August 2015||2015-08-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Interventional|MPI-R2*||One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression?|One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression?|Recruiting||N/A|160|Anticipated|University Hospital, Clermont-Ferrand||4|||f||||||||||||||2017-10-10 22:02:35.475361|2017-10-10 22:02:35.475361
NCT02816632|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-06-01|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|March 30, 2023|Anticipated|2023-03-30|March 30, 2023|Anticipated|2023-03-30||Interventional|Feedbacks||Feedbacks' Influence on Decision Making Processes|Feedbacks' Influence on Decision Making Processes|Recruiting||N/A|150|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||No||2017-10-10 22:02:35.621472|2017-10-10 22:02:35.621472
NCT02816619|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-27|||March 2016||2016-03-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|APA-PARK||Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease|Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease|Recruiting||N/A|50|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:02:35.723075|2017-10-10 22:02:35.723075
NCT02816606|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-29|||June 2016||2016-06-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Anterior Cruciate Ligament Radiology Follow-up Study|Radiological Follow-up of Alternative ACL Reconstruction Technique|Not yet recruiting||N/A|50|Anticipated|Royal Devon and Exeter NHS Foundation Trust|||2||f||||f||||||||Yes|Dissemination in presentations at national meetings and publication in peer-reviewed journal|2017-10-10 22:02:35.839678|2017-10-10 22:02:35.839678
NCT02816593|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-30|||August 2015||2015-08-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Bleaching Tooth of Low Concentration Domestic and Office|Bleaching Tooth of Low Concentration Domestic and Office: Effectiveness, Security and Impact on Quality of Life Related to Oral Health|Active, not recruiting||N/A|90|Anticipated|Federal University of Minas Gerais||3|||f||||t||||||||||2017-10-10 22:02:35.955711|2017-10-10 22:02:35.955711
NCT02816580|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-24|||May 2014||2014-05-01|June 2016|2016-06-01||||May 2019|Anticipated|2019-05-01||Interventional|MAFRA||Biological MArkers of FRAilty in Elderly Subjects|PTMDP (Post-translational Modification Derived Products) as Markers of Frailty in Elderly Subjects|Recruiting||N/A|250|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:02:36.04851|2017-10-10 22:02:36.04851
NCT02816567|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-07-15|||January 2016||2016-01-01|July 2016|2016-07-01||||January 2018|Anticipated|2018-01-01||Interventional|COELIOCUR||Laparoscopic Surgery and Abdominal Compliance|Laparoscopic Surgery and Abdominal Compliance Factors Including Neuromuscular Blocking Agents|Recruiting||Phase 4|180|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 22:02:36.123894|2017-10-10 22:02:36.123894
NCT02816554|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-24|||April 2015||2015-04-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Immunogenicity of JECEVAX in Young Children|Safety and Immunogenicity of an Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Vietnamese Children|Completed||Phase 2|200|Actual|National Institute of Hygiene and Epidemiology, Vietnam||4|||f||||f||||||||No|"Individual data with identification removed are to be available for Ethical committee, Ministry of Health and National Foundation of Science and Technology Development to avoid misuse of data.
Public shared data will be in the form of summarised tables and figures."|2017-10-10 22:02:36.245662|2017-10-10 22:02:36.245662
NCT02816541|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of the Pelvic Position During Pilates-based Therapeutic Exercises on the Postural Control|Effects of the Pelvic Position During Pilates-based Therapeutic Exercises on the Postural Control|Recruiting||N/A|20|Anticipated|Federal University of Health Science of Porto Alegre||3|||f||||||||||||||2017-10-10 22:02:36.341162|2017-10-10 22:02:36.341162
NCT02816528|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-24|||February 2016||2016-02-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|SICAR-Amb||Efficacy of Information System Regarding the Consumption of Antibiotics and Bacterial Resistance in Primary Care|Efficacy of Information System Regarding the Consumption of Antibiotics and Bacterial Resistance on the Use of Antibiotics in Primary Care|Enrolling by invitation||N/A|472|Anticipated|Central Hospital, Nancy, France|||2||f||||f||||||||Undecided||2017-10-10 22:02:37.019784|2017-10-10 22:02:37.019784
NCT02816515|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-01-17|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Ectoin® Mouth Wash for the Prevention and Treatment of Chemotherapy-induced Oral Mucositis|Non Interventional Clinical Investigation of Ectoin® Mouth Wash for the Prevention and Treatment of Chemotherapy-induced Oral Mucositis|Recruiting||N/A|80|Anticipated|Bitop AG|||3||f||||t||||||||||2017-10-10 22:02:37.128287|2017-10-10 22:02:37.128287
NCT02816502|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-08-28|||June 15, 2017|Actual|2017-06-15|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|March 2021|Anticipated|2021-03-01||Interventional|||Hippocampal Plasticity of Young Adults With Childhood Adversity|Hippocampal Plasticity of Young Adults With Childhood Adversity|Recruiting||N/A|60|Anticipated|Mclean Hospital||2|||f||||t|f|f||||||||2017-10-10 22:02:37.265407|2017-10-10 22:02:37.265407
NCT02816489|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-27|||May 2016||2016-05-01|May 2016|2016-05-01||||January 2017|Anticipated|2017-01-01||Interventional|||Labial Alveolar Bone Thickness and Apical Root Resorption Changes Associated With Self-ligating Versus Conventional Brackets|A Randomized Clinical Trial to Evaluate Labial Alveolar Bone Thickness and Apical Root Resorption Between Two Kinds of Brackets Using CBCT|Recruiting||N/A|21|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 22:02:37.415523|2017-10-10 22:02:37.415523
NCT02816476|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-09-13|||September 2016||2016-09-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|AMYDARA||Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis|A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better|Recruiting||Phase 2|40|Anticipated|University Hospital, Limoges||1|||f||||t||||||||No||2017-10-10 22:02:37.536474|2017-10-10 22:02:37.536474
NCT02816463|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-06-05|||June 2016||2016-06-01|June 2017|2017-06-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|OLP-Aur/Sup||RCT:Oropharyngeal Leak Pressure (OLP) - Ambu AuraGain vs LMA Supreme|Comparison of Oropharyngeal Leak Pressure Between the Ambu AuraGain and the LMA Supreme - a Prospective Randomized Trial|Completed||N/A|170|Actual|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 22:02:37.675168|2017-10-10 22:02:37.675168
NCT02816450|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-24|||June 2014||2014-06-01|June 2016|2016-06-01||||October 2015|Actual|2015-10-01||Interventional|WITiKids||Water Intervention for Thinking in Kids (WITiKids ) Study|The Effects of Hydration on Brain, Cognition, Memory & Achievement in Childhood|Active, not recruiting||Early Phase 1|30|Actual|University of Illinois at Urbana-Champaign||2|||f||||||||||||||2017-10-10 22:02:37.758248|2017-10-10 22:02:37.758248
NCT02816437|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-07-14|||July 2016||2016-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|FMT||FMT for MDRO Colonization in Solid Organ Transplant|Fecal Microbiota Transplantation for the Treatment of Multidrug-Resistant Organism Colonization in Solid Organ Transplant Recipients|Recruiting||Phase 1|20|Anticipated|University of Miami||1|||f||||f||||||||||2017-10-10 22:02:37.835151|2017-10-10 22:02:37.835151
NCT02816424|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-24|||February 2016||2016-02-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|TEMPO||Brief Intervention for Teen Pregnancy Prevention|Prevention of Teen Pregnancy Through Screening and Brief Intervention in Primary Care|Recruiting||N/A|1350|Anticipated|University of New Mexico||2|||f||||f||||||||||2017-10-10 22:02:37.975071|2017-10-10 22:02:37.975071
NCT02816411|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-10-03|||May 2014||2014-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|||Protein Supplementation and Skeletal Muscle Healing Process|Effects of Protein Supplementation on Skeletal Muscle Regeneration and Healing Process Following Exercise-induced Aseptic Injury|Completed||N/A|14|Actual|University of Thessaly||2|||f||||f||||||||||2017-10-10 22:02:38.092589|2017-10-10 22:02:38.092589
NCT02816398|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-27|||January 2014||2014-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Catheter System Feasibility Clinical Trial|Vessel-Select Catheter System Feasibility Clinical Trial|Completed||Phase 1/Phase 2|27|Actual|Avenu Medical||1|||f||||f||||||||||2017-10-10 22:02:38.212558|2017-10-10 22:02:38.212558
NCT02816385|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-06-24|||September 2016||2016-09-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Myocardial Contractility After Cardiac Surgery Under an Anterograde or Retrograde Cardioplegia|Study of Myocardial Contractility After Cardiac Surgery Under an Anterograde or Retrograde Cardioplegia|Not yet recruiting||N/A|20|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:02:38.284539|2017-10-10 22:02:38.284539
NCT02816372|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-09-14|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|VT4ARDS||Ultra Protective Ventilation Without Extracorporeal Circulation in Severe ARDS Patients (VT4ARDS)|Ultra Protective Ventilation Without Extracorporeal Circulation in Severe ARDS Patients (VT4ARDS)|Recruiting||N/A|35|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:02:38.416384|2017-10-10 22:02:38.416384
NCT02816359|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-04|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|pEsition||Position and Esophageal Pressure|Impact of Patient Position on the Value of Esophageal Pressure. pEsition Study.|Recruiting||N/A|34|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:02:38.506894|2017-10-10 22:02:38.506894
NCT02816346|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-08-10|||September 12, 2016||2016-09-12|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Shigella Sonnei 53G Challenge|Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain|Active, not recruiting||Phase 1|45|Anticipated|PATH||4|||f||||t||||||||||2017-10-10 22:02:38.586961|2017-10-10 22:02:38.586961
NCT02816333|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-12-29|||June 2016||2016-06-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Korean Registry of Thoracic Endovascular Aortic Repair Timing for Type B Aortic Dissection (K-TEAM Study): A Prospective Multicenter Registry||Recruiting||N/A|50|Anticipated|Yonsei University|||1||f||||f||||||||No|no plan to share data|2017-10-10 22:02:38.664403|2017-10-10 22:02:38.664403
NCT02816320|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-24|||July 2014||2014-07-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|RNMH||Validity of Information Employed to Generate Standardized Mortality Ratios Using Hospital Administrative Databases (RNMH)|Validity of Information Employed to Generate Standardized Mortality Ratios Using Hospital Administrative Databases (RNMH)|Completed||N/A|715|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:02:38.736108|2017-10-10 22:02:38.736108
NCT02816307|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-24|||March 2013||2013-03-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|ENDOC||Etiology of Endocarditis in Negative Blood Cultures|Etiology of Endocarditis in Negative Blood Cultures|Recruiting||N/A|1830|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||No||2017-10-10 22:02:38.810739|2017-10-10 22:02:38.810739
NCT02816294|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-12-06|||October 2016||2016-10-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Housing Prescriptions as Health Care|Housing Prescriptions as Health Care|Recruiting||N/A|150|Anticipated|Boston Medical Center||2|||f||||f||||||||No||2017-10-10 22:02:38.906322|2017-10-10 22:02:38.906322
NCT02816281|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-04-05|||November 2016||2016-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Scheduled Elective Surgical Case Cancellation in Siriraj: Evaluation and Identification of the Reasons|Scheduled Elective Surgical Case Cancellation in Siriraj Hospital, a Thai University Hospital: Evaluation and Identification of the Reasons|Recruiting||N/A|3500|Anticipated|Siriraj Hospital|||1||f||||f||||||||No||2017-10-10 22:02:39.054111|2017-10-10 22:02:39.054111
NCT02816268|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-27|||September 2012||2012-09-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|May 2014|Actual|2014-05-01||Interventional|FULL CONTACT||Contact Force Guided Ablation Versus Conventional Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation|Contact Force Guided Ablation Versus Conventional Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation|Completed||N/A|120|Actual|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||Yes||2017-10-10 22:02:39.132717|2017-10-10 22:02:39.132717
NCT02816255|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Efficacy of a New Mathematical Formula to Predict Continuous Positive Air Pressure With an Oronasal Mask Interface.|The Efficacy of a New Mathematical Formula to Predict Continuous Positive Air Pressure With an Oronasal Mask Interface.|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||No||2017-10-10 22:02:39.206379|2017-10-10 22:02:39.206379
NCT02816242|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-10-21|||January 2014||2014-01-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Concept Mapping Teaching Method on Critical Thinking Skills of Medical Students|Effect of Concept Mapping Teaching Method on Critical Thinking Skills of Medical Students|Completed||N/A|100|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||No||2017-10-10 22:02:39.276887|2017-10-10 22:02:39.276887
NCT02816229|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-04|||August 2016||2016-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Endobronchial Valves in Inoperable Patients With Haemoptysis|Endobronchial Valves in Inoperable Patients With Life-threatening Haemoptysis Refractory to Bronchial Artery Embolisation|Not yet recruiting||N/A|20|Anticipated|University of Stellenbosch||2|||f||||f||||||||No||2017-10-10 22:02:39.350763|2017-10-10 22:02:39.350763
NCT02816216|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-01-27|||May 1, 2016|Actual|2016-05-01|January 2017|2017-01-01|October 5, 2016|Actual|2016-10-05|October 5, 2016|Actual|2016-10-05||Interventional|CampAir FEA||Mobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability|Mobile Technology and Online Tools to Improve Asthma Control in Adolescents|Completed||N/A|14|Actual|3-C Institute for Social Development||1|||f||||t||||||||||2017-10-10 22:02:39.429271|2017-10-10 22:02:39.429271
NCT02816203|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-09-14|||July 2016||2016-07-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|HEMOGYN2||Vacuum Device for Hemostasis in Obstetrics and Gynecology|Vacuum Device for Hemostasis in Obstetrics and Gynecology. Feasibility Study for Postpartum Hemorrhage|Enrolling by invitation||N/A|30|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||No||2017-10-10 22:02:39.491989|2017-10-10 22:02:39.491989
NCT02816190|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-03|||April 2016||2016-04-01|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|PROPOCAP||PROne POsition and Volumetric CAPnography|PROne POsition and Volumetric CAPnography|Recruiting||N/A|50|Anticipated|Hopital of Melun|||1||f||||f||||||||Undecided||2017-10-10 22:02:39.572183|2017-10-10 22:02:39.572183
NCT02816177|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-28|||July 2016||2016-07-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|July 2018|Anticipated|2018-07-01||Interventional|GERONTACCESS||Telemedicine and Nursing Home|Impact of Telemedicine on Avoiding Emergency Hospital Admissions and Hospitalization for Nursing Home Residents|Not yet recruiting||N/A|428|Anticipated|University Hospital, Limoges||2|||f||||f||||||||Undecided||2017-10-10 22:02:39.63628|2017-10-10 22:02:39.63628
NCT02816164|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|REaCT-G2||A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia|A Multi Centre Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (REaCT-G2)|Recruiting||Phase 4|176|Anticipated|Ottawa Hospital Research Institute||3|||f||||f||||||||No|There is no plan to make IPD available.|2017-10-10 22:02:39.709235|2017-10-10 22:02:39.709235
NCT02816151|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-27|||February 2011||2011-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|TBIDE||Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight's Doses|Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight's Doses|Completed||Phase 3|29|Actual|CHU de Reims||2|||f||||||||||||||2017-10-10 22:02:39.801275|2017-10-10 22:02:39.801275
NCT02816138|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)|Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)|Recruiting||Phase 4|15|Anticipated|Vanderbilt University||1|||f||||f||||||||Undecided||2017-10-10 22:02:39.981774|2017-10-10 22:02:39.981774
NCT02816125|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-10-24|||March 2004||2004-03-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women|Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal Women|Completed||Phase 3|56|Actual|University of Guelph||2|||f||||f||||||||No||2017-10-10 22:02:40.15078|2017-10-10 22:02:40.15078
NCT02816112|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|REaCT-TC2||Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia|A Multi-Centre Study to Compare Granulocyte-colony Stimulating Factors to Antibiotics for Primary Prophylaxis of Taxotere/Cyclophosphamide-Induced Febrile Neutropenia REaCT-TC2|Recruiting||Phase 4|176|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No|There is no plan to make IDP available.|2017-10-10 22:02:40.244861|2017-10-10 22:02:40.244861
NCT02816099|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-24|||November 2014||2014-11-01|June 2016|2016-06-01||||March 2017|Anticipated|2017-03-01||Interventional|ApoC1||Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients|Study of the Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesterol Ester Transfer Protein (CETP) in Type-1 Diabetes Patients|Recruiting||N/A|240|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:02:40.354031|2017-10-10 22:02:40.354031
NCT02816073|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-28|||December 2012||2012-12-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|November 2013|Actual|2013-11-01||Interventional|||Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy|Single-session Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy - a Randomized Study|Completed||N/A|17|Actual|United Christian Hospital||2|||f||||||||||||||2017-10-10 22:02:40.534112|2017-10-10 22:02:40.534112
NCT02816060|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-03-08|||May 2016||2016-05-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Neural Tensioner Exercise on Conditioned Pain Modulation|Effectiveness of Neural Tensioner Exercise on Conditioned Pain Modulation, Disability and Range of Motion in Patients With Chronic Neck Pain: A Randomized Clinical Trial|Completed||N/A|54|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||No||2017-10-10 22:02:40.614761|2017-10-10 22:02:40.614761
NCT02816047|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-23|||November 2014||2014-11-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|||Austrian Wearable Cardioverter Defibrillator Registry|Indications for and Experience With the Wearable Cardioverter Defibrillator (WCD) - Austrian WCD Registry|Recruiting||N/A|450|Anticipated|Medical University of Graz|||1||f||||t||||||||Undecided|possible|2017-10-10 22:02:40.695592|2017-10-10 22:02:40.695592
NCT02816034|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Cerebellar Alterations in Individuals With a Cannabis Use Disorder|Alterations in Cerebellar-dependent Adaptation Due to Cannabis Use Measured With an Explicit-implicit Visuo-motor Learning Paradigm|Not yet recruiting||N/A|32|Anticipated|Universitat Pompeu Fabra||4|||f||||f||||||||||2017-10-10 22:02:40.781476|2017-10-10 22:02:40.781476
NCT02816021|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-09-29|||February 14, 2017|Actual|2017-02-14|September 2017|2017-09-01|February 2025|Anticipated|2025-02-01|February 2025|Anticipated|2025-02-01||Interventional|||Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma|Phase II Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma|Recruiting||Phase 2|71|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 22:02:40.876167|2017-10-10 22:02:40.876167
NCT02816008|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-11-14|||July 2016||2016-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|SANaR||Smart Autonomous Neuro-Rehabilitation System||Enrolling by invitation||N/A|20|Anticipated|Universitat Pompeu Fabra||2|||f||||f||||||||Undecided||2017-10-10 22:02:41.004267|2017-10-10 22:02:41.004267
NCT02815995|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-08-23|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes|A Phase II Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes|Recruiting||Phase 2|150|Anticipated|M.D. Anderson Cancer Center||6|||f||||f|t|f||||||||2017-10-10 22:02:41.116532|2017-10-10 22:02:41.116532
NCT02815982|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-23|||January 2015||2015-01-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Interventional|NOURISH-T||Targeting Caregivers to Enhance Health Behaviors in Pediatric Cancer Survivors||Recruiting||N/A|66|Anticipated|University of South Florida||2|||f||||f||||||||No||2017-10-10 22:02:41.271704|2017-10-10 22:02:41.271704
NCT02815969|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-04-20|||September 2016||2016-09-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors|Exploring the Metabolic Profile of Neuroendocrine Tumors|Active, not recruiting||N/A|210|Anticipated|University Medical Center Groningen|||2||f||||f||||||||No||2017-10-10 22:02:41.412007|2017-10-10 22:02:41.412007
NCT02815956|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|pre-TAPIOCA||Tibial Nerve Stimulation and Postoperative Ileus|InteresT And Mechanisms of Percutaneous Posterior tIbial Nerve Stimulation to Prevent pOstoperative Ileus in ColorectAl Surgery: A Preliminary Study|Not yet recruiting||N/A|40|Anticipated|University Hospital, Angers||2|||f||||t||||||||No||2017-10-10 22:02:41.525857|2017-10-10 22:02:41.525857
NCT02815943|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-09-08|||August 2015||2015-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|CB4||Postprandial Metabolism After Bariatric Surgery in Type 2 Diabetes||Recruiting||N/A|44|Anticipated|Université de Sherbrooke||4|||f||||||||||||||2017-10-10 22:02:41.653661|2017-10-10 22:02:41.653661
NCT02815930|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-09-13|||April 2012||2012-04-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|March 2014|Actual|2014-03-01||Observational|||Characterizing the Senior High Cost User (HCU) in Ontario|Characterizing the Senior High Cost User in Ontario: A Population-Based Matched Cohort Study|Enrolling by invitation||N/A|700000|Anticipated|McMaster University|||2||f||||||||||||||2017-10-10 22:02:41.821451|2017-10-10 22:02:41.821451
NCT02815917|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT|Evaluation of D3 Receptor Occupancy Using [18F]FLUORTRIOPRIDE ([18F]FTP) PET/CT|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Pennsylvania||4|||f||||f||||||||No||2017-10-10 22:02:41.912363|2017-10-10 22:02:41.912363
NCT02815904|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-05-05|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|YTKS||Effects of Early Yakson Touch and Kinesthetic Stimulation on the Development of High Risk Neonates|Effects of Early Yakson Touch and Kinesthetic Stimulation on the Development of High Risk neonates-a Randomized Controlled Trial|Completed||N/A|28|Actual|Maharishi Markendeswar University||2|||f||||t||||||||Undecided|Not decided yet. Decision will be take after consulting with experts|2017-10-10 22:02:42.006791|2017-10-10 22:02:42.006791
NCT02815891|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-09-19|||July 2016||2016-07-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01|5 Years|Observational [Patient Registry]|||A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)|A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)|Recruiting||N/A|15000|Anticipated|Target PharmaSolutions, Inc.|||1||f||||f||||||Samples With DNA|"     Patients enrolled in TARGET-NASH will be invited to participate in the Biorepository Specimen     Bank (BSB). Blood samples for biomarker and DNA assays will be collected on a voluntary basis     and participation in this project will not affect participation in the main study. These     samples will be shipped to a central repository for storage to use in future studies. Samples     stored at the biorepository will be identified only with the patient's unique study ID number     and the date that the sample was obtained. This link between the patient's study ID number     and their name will be available only at the site where the samples were obtained.   "|||2017-10-10 22:02:42.120639|2017-10-10 22:02:42.120639
NCT02815878|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-10-03|||May 12, 2014|Actual|2014-05-12|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Enhance Wellness for Individuals With Long-Term Physical Disabilities|Project Enhance for Adults Aging With Long-Term Physical Disability|Active, not recruiting||N/A|240|Anticipated|University of Washington||3|||f||||f||||||||||2017-10-10 22:02:42.343076|2017-10-10 22:02:42.343076
NCT02815865|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-06-30|||August 2016||2016-08-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Induction||Comparing Cervical Foley Catheter, Dinoprostone and a Combination of the Two for Labor Induction|A Randomized Controlled Study Comparing Cervical Foley Catheter, Vaginal Dinoprostone and a Combination of the Two Methods for Induction of Labor|Not yet recruiting||N/A|360|Anticipated|Kaplan Medical Center||3|||f||||f||||||||Undecided||2017-10-10 22:02:42.416996|2017-10-10 22:02:42.416996
NCT02815852|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-27|||August 2016||2016-08-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|RAD2016||RETROSPECTIVE ANALYSIS OF BREAST BIOPSIES IN WOMEN YOUNGER THAN 40 YEARS OLD|RETROSPECTIVE ANALYSIS OF BREAST BIOPSIES IN WOMEN YOUNGER THAN 40 YEARS OLD|Not yet recruiting||N/A|210|Anticipated|Azienda U.S.L. 1 di Massa e Carrara|||1||f||||f||||||||||2017-10-10 22:02:42.496188|2017-10-10 22:02:42.496188
NCT02815839|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-02-26|||November 2015|Actual|2015-11-01|June 2016|2016-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Single Dose Study of SHR4640 in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Food Effect, Pharmacokinetics, and Pharmacodynamics of Single Doses of SHR4640 in Healthy Subjects|Completed||Phase 1|50|Actual|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||||||||||||2017-10-10 22:02:42.575878|2017-10-10 22:02:42.575878
NCT02815826|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-23|||September 2012||2012-09-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Observational|||16 Weeks of Progressive Barefoot Running Training Changes Impact Force and Muscle Activation in Habitual Shod Runners|16 Weeks of Progressive Barefoot Running Training Changes Impact Force and Muscle Activation in Habitual Shod Runners|Completed||N/A|6|Actual|University of Sao Paulo|||1||f||||||||||||||2017-10-10 22:02:42.676114|2017-10-10 22:02:42.676114
NCT02815813|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-27|||August 2016||2016-08-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|||Peer Support and mHealth Targeting Cardiometabolic Risk in Young Adults With Serious Mental Illness|Peer Support and Mobile Technology Targeting Cardiometabolic Risk Reduction in Young Adults With Serious Mental Illness|Not yet recruiting||N/A|144|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||Yes|"The proposed project involves human subject data, and all data collected on subjects (both positive and negative) will be submitted to the National Database for Clinical Trials Related to Mental Illness (NDCT). This will include individual level data from all subjects enrolled in both the active intervention and control conditions.
The NDCT is a secure data repository run by the National Institute of Mental Health (NIMH) that allows researchers to collect and share de-identified information with each other. This secure informatics platform facilitates scientific collaboration and data sharing, and enables effective communication of detailed research data, tools, and supporting documentation. The NDCT links data across research projects using Global Unique Identifiers (GUID) for each participant, and the NDCT Data Dictionary."|2017-10-10 22:02:42.738829|2017-10-10 22:02:42.738829
NCT02815800|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-09-29|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ETHNOPARK||Efficacy of Ethnodyne Visio in Parkinson's Disease||Recruiting||N/A|24|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||No||2017-10-10 22:02:42.834089|2017-10-10 22:02:42.834089
NCT02815787|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-06-23|||March 2014||2014-03-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Drug -Drug Interaction of SP2086 and Glyburide|A Single Randomized, Open, Cross-over, Phase Ie Study to Access the Drug-drug Interaction of SP2086 and Glyburide|Completed||Phase 1|16|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:02:42.908835|2017-10-10 22:02:42.908835
NCT02815774|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-06-23|||June 2014||2014-06-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||SP2086 Pharmacokinetic Study in Renal Insufficiency Patients|A Parallel, Open Phase Ih Study to Access the Pharmacokinetic of SP2086 in Renal Insufficiency Patients|Completed||Phase 1|30|Actual|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||f||||||||||2017-10-10 22:02:42.986373|2017-10-10 22:02:42.986373
NCT02815761|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-24|||January 2013||2013-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Prospective Study Readmission and Mortality of COPD Patients|A Prospective Study of Factors Related to Readmission and Mortality of COPD Patients in Hong Kong.|Recruiting||N/A|800|Anticipated|Chinese University of Hong Kong|||1||f||||f||||||Samples With DNA|"     Blood samples will be taken at first visit for assessment of inflammatory markers.   "|||2017-10-10 22:02:43.053792|2017-10-10 22:02:43.053792
NCT02815748|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-06-29|||August 2015||2015-08-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Metabolite Identification and Material Balance Study of SP2086|A Single-center, Randomized, Open, Single Dose Phase I Study to Access the Metabolite Identification and Material Balance in Health Volunteer|Completed||Phase 1|8|Actual|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:02:43.125352|2017-10-10 22:02:43.125352
NCT02815735|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-03-28|2017-03-28||August 2016||2016-08-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses|Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses|Completed||N/A|85|Actual|Coopervision, Inc.||2|||f||||f||||||||No||2017-10-10 22:02:43.190988|2017-10-10 22:02:43.190988
NCT02815722|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-06-23|||July 2013||2013-07-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Drug-drug Interaction of SP2086 and Simvastatin|A Single Randomized, Open,Cross-over, Phase Ig Study to Access the Drug-drug Interaction of SP2086 and Simvastatin|Completed||Phase 1|16|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:02:43.603116|2017-10-10 22:02:43.603116
NCT02815709|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-07-07||2017-07-07|May 2016||2016-05-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|APOLLO-1||Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy|A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active-controlled Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy|Completed||Phase 3|390|Actual|Trevena Inc.||5|||f||||||||||||||2017-10-10 22:02:43.699597|2017-10-10 22:02:43.699597
NCT02815696|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-07-27|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||MRI Analysis of Glycosaminoglycan Modifications Inside the Intervertebral Disk After Distraction and Posterior Fusion|MRI Analysis of Glycosaminoglycan Modifications Inside the Intervertebral Disk After Distraction and Posterior Fusion|Active, not recruiting||N/A|30|Anticipated|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 22:02:43.852875|2017-10-10 22:02:43.852875
NCT02815683|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-01-23|||September 2016|Actual|2016-09-01|January 2017|2017-01-01|September 2026|Anticipated|2026-09-01|September 2021|Anticipated|2021-09-01||Observational|BREATHE-NL||Bronchoscopic EmphysemA Treatment in THE NetherLands|Bronchoscopic Lung Volume Reduction Treatment in Clinical Practice: Introduction and Implementation in The Netherlands and Evaluation of a National Database|Recruiting||N/A|500|Anticipated|University Medical Center Groningen|||1||f||||f||||||||No||2017-10-10 22:02:43.943758|2017-10-10 22:02:43.943758
NCT02815670|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-10-02|||September 7, 2016|Actual|2016-09-07|October 2017|2017-10-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Reversal Dabigatran Anticoagulant Effect With Idarucizumab|Single Dose, Open Label, Uncontrolled, Safety Trial of Intravenous Administration of Idarucizumab to Paediatric Patients Enrolled From Ongoing Phase IIb/III Clinical Trials With Dabigatran Etexilate for the Treatment and Secondary Prevention of Venous Thromboembolism.|Recruiting||Phase 3|10|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:02:44.080602|2017-10-10 22:02:44.080602
NCT02815657|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-06-23|||April 2013||2013-04-01|June 2016|2016-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Drug-drug Interaction of SP2086 and Valsartan|A Single Randomized, Open,Cross-over, Phase I Study to Access the Drug-drug Interaction of SP2086 and Valsartan|Completed||Phase 1|16|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:02:44.239292|2017-10-10 22:02:44.239292
NCT02815631|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-06-23|||September 2015||2015-09-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|CARDIOFLOW||Assessing the Efficacy of CARDIOgoniometry (CGM) to Determine Physiologically Significant Stenosis in Patients With Stable Coronary Artery Disease in Comparison to Fractional FLOW Reserve - CARDIOFLOW|Assessing the Efficacy of CARDIOgoniometry (CGM) to Determine Physiologically Significant Stenosis in Patients With Stable Coronary Artery Disease in Comparison to Fractional FLOW Reserve - CARDIOFLOW|Recruiting||N/A|30|Anticipated|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 22:02:44.444207|2017-10-10 22:02:44.444207
NCT02815618|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-04-12|||June 2016||2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|BabyLux||An Optical Neuro-monitor of Cerebral Oxygen Metabolism and Blood Flow for Neonatology|An Optical Neuro-monitor of Cerebral Oxygen Metabolism and Blood Flow for Neonatology|Recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark|||3||f||||t||||||||Undecided||2017-10-10 22:02:44.579772|2017-10-10 22:02:44.579772
NCT02815605|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-06|||June 2016||2016-06-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Observational|PPH-REG||Risk Factors, Management and Complications of Severe Post-partum Hemorrhage|Risk Factors, Management and Complications of Severe Post-partum Hemorrhage: A Retrospective Analysis in a Single Tertiary Referral Center|Active, not recruiting||N/A|9000|Anticipated|Tampere University Hospital|||1||f||||f||||||||||2017-10-10 22:02:44.719045|2017-10-10 22:02:44.719045
NCT02815592|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-09-15|||October 11, 2016|Actual|2016-10-11|September 2017|2017-09-01|October 2, 2019|Anticipated|2019-10-02|August 4, 2019|Anticipated|2019-08-04||Interventional|||Trial of BMS-986012 in Combination With Platinum and Etoposide|A Phase 1/2 Randomized Trial of BMS-986012 in Combination With Platinum and Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer|Active, not recruiting||Phase 1/Phase 2|120|Anticipated|Bristol-Myers Squibb||4|||f||||f|t|f||||||||2017-10-10 22:02:44.828246|2017-10-10 22:02:44.828246
NCT02815579|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-03-14|||June 2016||2016-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Shamba R01||Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya|Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya|Recruiting||N/A|704|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 22:02:44.996174|2017-10-10 22:02:44.996174
NCT02815566|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-05-09|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|BEING||Bone Health in Aging HIV Infected Women|Bone Health in Aging HIV Infected Women: Improvement or Prevention of Changes in Bone Mineral Density by Switching Antiretroviral Agents. Is There an Optimal Time to Intervene?|Not yet recruiting||Phase 4|128|Anticipated|University Health Network, Toronto||2|||f||||t|t|f|||t|||Yes|Information on viral load, toxicity and bone scans will be available to treating physicians|2017-10-10 22:02:45.234699|2017-10-10 22:02:45.234699
NCT02815553|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-23|||April 2016||2016-04-01|May 2016|2016-05-01||||May 2018|Anticipated|2018-05-01||Interventional|CTIH||Cardiac Tumors Interventional （Radio Frequency/Laser Ablation）Therapy||Recruiting||N/A|10|Anticipated|Xijing Hospital||1|||f||||||||||||||2017-10-10 22:02:45.365101|2017-10-10 22:02:45.365101
NCT02815540|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|CBD1||The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy||Not yet recruiting||N/A|25|Anticipated|Gillette Children's Specialty Healthcare||1|||f||||t||||||||||2017-10-10 22:02:45.45828|2017-10-10 22:02:45.45828
NCT02815527|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-11-01|||March 2016||2016-03-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Observational|||Time to Protein Target Using a High Whey Protein Enteral Nutrition in Critically Ill Patients|Time to Protein Target, the 'HIGH WHEY' Study A Prospective Pilot Study|Recruiting||N/A|20|Anticipated|VU University Medical Center|||1||f||||f||||||||No||2017-10-10 22:02:45.564084|2017-10-10 22:02:45.564084
NCT02815514|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-22|2017-04-12|||January 2009||2009-01-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|November 2011|Actual|2011-11-01||Observational|TAVI||German TAVI-Register|Deutsches TAVI-Register|Completed||N/A|3000|Actual|Stiftung Institut fuer Herzinfarktforschung|||1||f||||f||||||||No||2017-10-10 22:02:45.669271|2017-10-10 22:02:45.669271
NCT02815501|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2016-06-27|||July 2016||2016-07-01|June 2016|2016-06-01||||December 2018|Anticipated|2018-12-01||Observational|TDOC||Thyroid Dysfunction and Obstetric Complications|Thyroid Dysfunction and Obstetric Complications|Not yet recruiting||N/A|940|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||Samples Without DNA|"     blood samples for a laboratory work-up and anti-thyroid antibodies.   "|||2017-10-10 22:02:45.760305|2017-10-10 22:02:45.760305
NCT02815488|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-31|||January 2016||2016-01-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CHF6297 FIH||A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD|A Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of CHF 6297 After Single and Repeated Ascending Doses in Healthy Male Subjects Followed by a Repeated Dose in COPD Patients and a 2-way, Crossover, Double-blind, Placebo-controlled, Repeated Dose Part to Investigate the Anti-inflammatory Effect of CHF 6297 After Lipopolysaccaride (LPS) Challenge in Healthy Male Subjects|Suspended||Phase 1/Phase 2|136|Anticipated|Chiesi Farmaceutici S.p.A.||2||Further ongoing animal safety investigations|f||||f||||||||||2017-10-10 22:02:45.855433|2017-10-10 22:02:45.855433
NCT02815475|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-09-08|||March 2016||2016-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|TACT||Turmeric Anti-Inflammatory and Cell-Damage Trial|Turmeric Anti-Inflammatory and Cell-Damage Trial|Completed||N/A|90|Actual|Newcastle University||3|||f||||f||||||||||2017-10-10 22:02:45.970335|2017-10-10 22:02:45.970335
NCT02815462|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-27|||August 2016||2016-08-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|FAMFACESGRCT||Impact of Implementing a Real Time Frequent Admitter Risk Score (FAM-FACE-SG) on Readmission Rates|Impact of Implementing a Real Time Frequent Admitter Risk Score (FAM-FACE-SG) on Readmission Rates: a Pragmatic Cluster Randomised Controlled Trial (RCT).|Not yet recruiting||N/A|3300|Anticipated|Singapore General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:02:46.046785|2017-10-10 22:02:46.046785
NCT02815449|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-07-31|||May 8, 2017|Actual|2017-05-08|July 2017|2017-07-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|||Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women|Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women|Completed||N/A|24|Actual|Unilever R&D||3|||f||||f|f|f||||||||2017-10-10 22:02:46.154305|2017-10-10 22:02:46.154305
NCT02815436|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-08-14|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Tel and SMS Reminder on Compliance With CRC Screening|The Effectiveness of Telephone Reminders and SMS Messages on Compliance With Colorectal Cancer Screening: An Open-label, Randomized Controlled Trial|Active, not recruiting||N/A|600|Anticipated|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-10 22:02:46.233234|2017-10-10 22:02:46.233234
NCT02815423|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-06-23|||January 2017||2017-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Exploratory Efficacy Study of UCMSCs in Patients With Fracture and Bone Nonunion||Not yet recruiting||Phase 1/Phase 2|40|Anticipated|South China Research Center for Stem Cell and Regenerative Medicine||2|||f||||t||||||||Yes||2017-10-10 22:02:46.30971|2017-10-10 22:02:46.30971
NCT02815410|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-23|||July 2016||2016-07-01|June 2016|2016-06-01|June 2022|Anticipated|2022-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients|The Prospective Trial for Validation of the Role of Levetiracetam as a Sensitizer of Temozolomide in the Treatment of Newly Diagnosed Glioblastoma Patients|Not yet recruiting||Phase 2|73|Anticipated|Seoul National University Hospital||1|||f||||t||||||||No||2017-10-10 22:02:46.392011|2017-10-10 22:02:46.392011
NCT02815384|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|MRIPACER||Assessment Of MRI In Patients With Implanted Cardiac Devices|Assessment Of MRI In Patients With Implanted Cardiac Devices|Not yet recruiting||N/A|600|Anticipated|University of Arizona|||1||f||||f||||||||No||2017-10-10 22:02:46.556742|2017-10-10 22:02:46.556742
NCT02815371|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-23|||June 2005||2005-06-01|June 2016|2016-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Laser Acupuncture Before and After Embryo Transfer Improves IVF Outcomes|Laser Acupuncture Before and After Embryo Transfer Improves in Vitro Fertilization Outcomes|Completed||N/A|803|Actual|Reproductive Medicine Associates of New Jersey||4|||f||||||||||||||2017-10-10 22:02:46.621817|2017-10-10 22:02:46.621817
NCT02815358|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of Segmental Stabilization on the Anticipatory Postural Adjustment of Subjects With Lumbar Pain||Recruiting||N/A|40|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||||||||||||2017-10-10 22:02:46.69464|2017-10-10 22:02:46.69464
NCT02815345|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-23|||March 2014||2014-03-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|MODERN||Objectives and Measures Dimensions Nasal Resistance of Preterm and Term (MODERN)|Determination by a Noninvasive Method of the Geometric Dimensions of the Nasal Cavities of the Premature Newborn|Recruiting||N/A|200|Anticipated|Centre Hospitalier Intercommunal Creteil||1|||f||||f||||||||No||2017-10-10 22:02:46.794451|2017-10-10 22:02:46.794451
NCT02815332|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-04-12|||August 2016||2016-08-01|April 2017|2017-04-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|OPAL||BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris|A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris|Completed||Phase 2|225|Actual|BioPharmX, Inc.||3|||f||||f||||||||Yes||2017-10-10 22:02:46.885701|2017-10-10 22:02:46.885701
NCT02815319|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-02-21|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Interventional|REaCT-dex||Schedules of Dexamethasone in Patients Incorrectly Taking Dexamethasone Premedication (REaCT-dexamethasone)|A Single Centre Randomised Study Comparing Standard of Care Schedules of Dexamethasone in Patients Incorrectly Taking Dexamethasone Premedication Prior to Docetaxel Chemotherapy (REaCT-dexamethasone)|Recruiting||Phase 4|80|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||Undecided||2017-10-10 22:02:46.99448|2017-10-10 22:02:46.99448
NCT02815306|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-06-23|||March 2011||2011-03-01|June 2016|2016-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Polyaxial Brace Fixing for the Treatment of Congenital Clubfoot|Polyaxial Brace Fixing for the Treatment of Congenital Clubfoot in Newborns and Infants|Completed||N/A|88|Actual|Children's Hospital of Chongqing Medical University||1|||f||||t||||||||Undecided||2017-10-10 22:02:47.090881|2017-10-10 22:02:47.090881
NCT02815293|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-28|||September 30, 2016|Actual|2016-09-30|June 2017|2017-06-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|||Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye|Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye|Terminated||Phase 3|18|Actual|Allergan||2|||f||||f||||||||||2017-10-10 22:02:47.158323|2017-10-10 22:02:47.158323
NCT02815280|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-22|||May 2016||2016-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne|A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-05|Active, not recruiting||Phase 3|450|Actual|Foamix Ltd.||2|||f||||f||||||||||2017-10-10 22:02:47.282138|2017-10-10 22:02:47.282138
NCT02815267|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-22|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne|A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04|Active, not recruiting||Phase 3|450|Actual|Foamix Ltd.||2|||f||||f||||||||||2017-10-10 22:02:47.434113|2017-10-10 22:02:47.434113
NCT02815254|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-06-27|||November 2015||2015-11-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Better Hips- Better Function|The Effect of Exercise in Elderly Hip Fracture Patients: a Clinical Randomised Trial|Recruiting||N/A|130|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-10 22:02:47.588001|2017-10-10 22:02:47.588001
NCT02815241|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-12|||June 29, 2016|Actual|2016-06-29|June 2017|2017-06-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|5|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:02:47.85428|2017-10-10 22:02:47.85428
NCT02815228|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-12|||June 28, 2016|Actual|2016-06-28|June 2017|2017-06-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Sun Protection Factor Assay (SPF Assay 19009)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|5|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:02:47.947577|2017-10-10 22:02:47.947577
NCT02815215|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy Analysis of Minimally Invasive Carroll's Technique in Treatment of Congenital Idiopathic Clubfoot|A Retrospective Multicenter Analysis on Treatment of Congenital Idiopathic Clubfoot With Minimally Invasive Carroll's Technique|Recruiting||Early Phase 1|80|Anticipated|Children's Hospital of Chongqing Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:02:48.030298|2017-10-10 22:02:48.030298
NCT02815202|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-24|2017-06-12|||June 28, 2016|Actual|2016-06-28|June 2017|2017-06-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Sun Protection Factor Assay (SPF Assay 19008)|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose.|Completed||N/A|5|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:02:48.152163|2017-10-10 22:02:48.152163
NCT02815189|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-05-01|||February 2014||2014-02-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|FlareUp||Incidence of Flare-ups and Apical Healing After Single-visit or Two-visits Treatment.|Incidence of Flare-ups and Apical Healing After Single-visit or Two-visits Treatment of Teeth With Necrotic Pulp and Apical Periodontitis After a Two-year Control Period. A Randomised Clinical Trial.|Completed||Phase 2|110|Actual|Universidad Autonoma de Baja California||2|||f||||t||||||||Yes|Each participant will be evaluated a week after the treatment.|2017-10-10 22:02:48.234789|2017-10-10 22:02:48.234789
NCT02815176|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers|Analysis of Plasminogen Activator Inhibitor-1 Level in Chronic Serous Chorioretinopathy and Polypoidal Choroidal Vasculopathy|Recruiting||N/A|100|Anticipated|Samsung Medical Center|||3||f||||f||||||Samples With DNA|"     Blood samples including DNA will be retained to perform the genotyping analysis of PAI-1 SNP.   "|No||2017-10-10 22:02:48.32496|2017-10-10 22:02:48.32496
NCT02815163|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-27|||September 2013||2013-09-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effects of Using the Empowerment Model Intervention in Primary Total Hip Replacement Surgery Elders|The Effects of Using the Empowerment Model Intervention in Primary Total Hip|Completed||N/A|108|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-10 22:02:48.442768|2017-10-10 22:02:48.442768
NCT02815150|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2017-08-08|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety of 250ml Preoperative Carbohydrate Drink in Gastric Cancer Patients|Safety and Effectiveness of Oral Administration of 5% Glucose Solution 250ml 2-3 Hours Before Surgery in Gastric Cancer Patients for Elective Radical Resection|Recruiting||N/A|88|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 22:02:48.535718|2017-10-10 22:02:48.535718
NCT02815137|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-07-19|||June 1, 2016|Actual|2016-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|December 2018|Anticipated|2018-12-01||Interventional|XPO1||Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma|Prevalence, Kinetic and Prognostic Value of XPO1 E571K Mutation Detection in Plasma Cell-free DNA From Patients Xith Classical Hodgkin Lymphoma|Recruiting||N/A|130|Anticipated|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 22:02:48.698429|2017-10-10 22:02:48.698429
NCT02815124|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-30|||October 2018|Anticipated|2018-10-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|IGCIP vs SOC||Trial of Image-Guided Cochlear Implant Programming Versus Standard of Care|Randomized Controlled Trial of Image-Guided Cochlear Implant Programming Versus Standard of Care|Not yet recruiting||N/A|120|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:02:48.841572|2017-10-10 22:02:48.841572
NCT02815111|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-09-14|||July 2016||2016-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||Evaluation of Ketamine and Multi-modal Analgesics|Evaluation of Ketamine and Multi-modal Analgesics for Postoperative Analgesia, Opioid Sparing, and Early Extubation in ICU Compared With Conventional Analgesia|Withdrawn||N/A|0|Actual|University of Florida|||2|Not IRB approved|f||||f||||||||||2017-10-10 22:02:49.012276|2017-10-10 22:02:49.012276
NCT02815085|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-27|||February 2016||2016-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||RecoverLINK Technology Pilot for HF Patients|Pilot to Assess Feasibility of Using RecoverLINK Technology to Supplement Outpatient Care for Heart Failure Patients|Recruiting||N/A|63|Anticipated|RecoverLINK||1|||f||||||||||||||2017-10-10 22:02:49.111082|2017-10-10 22:02:49.111082
NCT02815072|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-23|||October 2013||2013-10-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Generation of Marfan Syndrome and Fontan Cardiovascular Models Using Patient-specific Induced Pluripotent Stem Cells|Generation of Marfan Syndrome and Fontan Cardiovascular Models Using Patient-specific Induced Pluripotent Stem Cells|Recruiting||N/A|30|Anticipated|National Heart Centre Singapore|||1||f||||f||||||Samples With DNA|"     2 tablespoons of blood (20ml) will be taken for pre screening   "|No||2017-10-10 22:02:49.222958|2017-10-10 22:02:49.222958
NCT02815059|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-09-28|||September 2016||2016-09-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone|A Phase 1 Study of Combining Ibrutinib, Dasatinib and Prednisone in Patients 60 Years or Older With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia|Recruiting||Phase 1|24|Anticipated|University of Utah||1|||f||||t||||||||||2017-10-10 22:02:49.324655|2017-10-10 22:02:49.324655
NCT02815046|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Mixed Urinary Incontinence Symptoms Before and After Treatment With Botox and Bulkamid|Prospective, Non-randomized, Single-center Observational Study of Outcome Measures of Patients Suffering From Mixed Urinary Incontinence Before and After Surgical Procedure With Botulinum Toxin and Polyacrylamide Hydrogel (PAHG)|Recruiting||N/A|50|Anticipated|Cantonal Hospital, Frauenfeld|||1||f||||f||||||||Yes|Publication in peer-reviewed journal|2017-10-10 22:02:49.416326|2017-10-10 22:02:49.416326
NCT02815033|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2017-07-27|||July 2015||2015-07-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||11C or 18F-Choline PET/CT and Whole Body MRI for Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide|An Exploratory Phase 2, Open-label, Single-arm, Efficacy and Imaging Study of Oral Enzalutamide (XTANDI) Androgen Receptor (AR)-Directed Therapy in Hormono-Sensitive Patients With Metastatic Prostate Cancer (Hormono-sensitive Patients)|Recruiting||Phase 2|60|Anticipated|The European Uro-Oncology Group||1|||f||||||||||||||2017-10-10 22:02:49.510652|2017-10-10 22:02:49.510652
NCT02815020|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-27|||February 2014||2014-02-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|INSTTEPP||Implementing Networks Self-management Tools Through Engaging Patients and Practices|Implementing Networks Self-management Tools Through Engaging Patients and Practices|Completed||N/A|467|Actual|Oregon Health and Science University||1|||f||||f||||||||No||2017-10-10 22:02:49.639283|2017-10-10 22:02:49.639283
NCT02814487|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-09-09|||December 2015||2015-12-01|June 2016|2016-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|DAM||MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment.|"A Pilot Validation Study Comparing DAM a Smartphone Application With the Composite MSFC Score Intra-individually Among Multiple Sclerosis Patients"|Completed||N/A|30|Actual|Ad scientiam|||1||f||||f||||||||No||2017-10-10 22:02:57.612803|2017-10-10 22:02:57.612803
NCT02815007|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer|Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer: An Open-label, Single-armed Phase II Trial|Not yet recruiting||Phase 2|20|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||1|||f||||t||||||||Undecided||2017-10-10 22:02:49.720203|2017-10-10 22:02:49.720203
NCT02814994|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-27|||September 2012||2012-09-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients|Respiratory System Compliance Guided Tidal Volume in Moderate to Severe ARDS Patients: A Multicenter Randomized Controlled Study|Completed||N/A|242|Actual|Southeast University, China||2|||f||||f||||||||Undecided||2017-10-10 22:02:49.803979|2017-10-10 22:02:49.803979
NCT02814981|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-23|||November 2015||2015-11-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|HYDROXYZINE-QT||Hydroxyzine and Risk of Prolongation of QT Interval|Hydroxyzine and Risk of Prolongation of QT Interval|Recruiting||N/A|130|Anticipated|University Hospital, Caen|||1||f||||t||||||||Yes||2017-10-10 22:02:49.901879|2017-10-10 22:02:49.901879
NCT02814968|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2017-07-27|||February 2015||2015-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||18F-FDG PET/CT and Whole Body MRI for Staging and Response Prediction in Castration-resistant Prostate Cancer Patients Receiving Enzalutamide|An Exploratory Phase 2, Open-label, Single-arm, Efficacy and Imaging Study of Oral Enzalutamide (XTANDI) Androgen Receptor-Directed Therapy in Chemo-Naïve Patients With Progressive Prostate Cancer Who Have Failed Androgen Deprivation Therapy (Castration-resistant Prostate Cancer Patients)|Recruiting||Phase 2|60|Anticipated|The European Uro-Oncology Group||1|||f||||||||||||||2017-10-10 22:02:49.972113|2017-10-10 22:02:49.972113
NCT02814955|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-23|||June 2015||2015-06-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01|6 Months|Observational [Patient Registry]|NACO-VP||Electrophysiological Effects of NACOS and AVK on Pulmonary Veins and Left Atrium in Paroxysmal AF Catheter Ablation|Study of Electrophysiological Effects of NACOS and AVK on the Pulmonary Veins and the Left Atrium of Patients Referred for Paroxysmal AF Catheter Ablation|Recruiting||N/A|90|Anticipated|University Hospital, Caen|||5||f||||t||||||Samples Without DNA|"     cordarone   "|Yes||2017-10-10 22:02:50.138217|2017-10-10 22:02:50.138217
NCT02814942|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-27|||January 2011||2011-01-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|8 Years|Observational [Patient Registry]|PEACH||Prospective Evaluation of Asians With CRT for Heart Failure|Prospective Evaluation of Asians With CRT for Heart Failure|Recruiting||N/A|500|Anticipated|National University Heart Centre, Singapore|||1||f||||f||||||Samples Without DNA|"     Serum saved for biomarking   "|Yes||2017-10-10 22:02:50.246041|2017-10-10 22:02:50.246041
NCT02814929|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-05-08|||April 2016||2016-04-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|TR-ROP||Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey|Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey: A Prospective Multicenter Study Including 69 NICUs|Recruiting||N/A|5000|Anticipated|Etlik Zubeyde Hanim Womens' Health and Teaching Hospital|||3||f||||t||||||||No||2017-10-10 22:02:50.354381|2017-10-10 22:02:50.354381
NCT02814916|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-06-06|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|January 25, 2019|Anticipated|2019-01-25|January 25, 2019|Anticipated|2019-01-25||Interventional|||Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA|A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections|Recruiting||Phase 3|300|Anticipated|Durata Therapeutics Inc., an affiliate of Allergan plc||3|||f||||t|t|f||||||||2017-10-10 22:02:50.518389|2017-10-10 22:02:50.518389
NCT02814903|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-27|||January 2014||2014-01-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01|2 Years|Observational [Patient Registry]|ALDO-POAF||ALDOsterone for Prediction of Post-Operative Atrial Fibrillation|ALDOsterone for Prediction of Post-Operative Atrial Fibrillation|Recruiting||N/A|500|Anticipated|University Hospital, Caen|||1||f||||t||||||Samples Without DNA|"     -  aldosterone        -  galectin 3        -  ngal        -  mitochondria        -  right atrial sample   "|Yes||2017-10-10 22:02:50.688289|2017-10-10 22:02:50.688289
NCT02814877|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-03|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|CEFECA||Efficacy and Cost-effectiveness of Hospital Antimicrobial Stewardship Programs|Efficacy and Cost-effectiveness of Hospital Antimicrobial Stewardship Programs|Recruiting||N/A|30|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 22:02:50.88006|2017-10-10 22:02:50.88006
NCT02814864|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-03-21|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|May 2017|Anticipated|2017-05-01||Interventional|PRISME||Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy|Clinical Phase II Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy|Not yet recruiting||Phase 2|12|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t|f|f||||||Undecided||2017-10-10 22:02:51.009158|2017-10-10 22:02:51.009158
NCT02814851|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-06-23|||August 2016||2016-08-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluation of Cardiac Hemodynamic Modifications During Temporary Left Atrial Appendage Occlusion|Evaluation of Cardiac Hemodynamic Modifications During Temporary Left Atrial Appendage Occlusion|Not yet recruiting||N/A|20|Anticipated|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 22:02:51.110591|2017-10-10 22:02:51.110591
NCT02814838|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-01-26|||August 2016||2016-08-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes|A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 400 mg Twice a Day Oral Ladarixin in Patients With New-onset Type 1 Diabetes|Recruiting||Phase 2|72|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||f||||||||Undecided||2017-10-10 22:02:51.238147|2017-10-10 22:02:51.238147
NCT02814825|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-14|||June 2016||2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix|A Multi-Center, Prospective, Single-Arm Study of Patients Undergoing a Two or Three Level ACDF Using ViviGen Cellular Bone Matrix in Conjunction With Cervical Allograft Spacers and DePuy Synthes Spine Anterior Cervical Plate Systems|Enrolling by invitation||N/A|100|Anticipated|DePuy Spine|||1||f||||f||||||||||2017-10-10 22:02:51.395236|2017-10-10 22:02:51.395236
NCT02814812|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-12-27|||January 2014||2014-01-01|December 2016|2016-12-01||||May 2018|Anticipated|2018-05-01||Interventional|||Postoperative Comput Tomography as a Predictor of Postoperative Complications After Pancreatic Surgery|Postoperative Comput Tomography as a Predictor of Postoperative Complications After Pancreatic Surgery|Recruiting||N/A|80|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:02:51.489709|2017-10-10 22:02:51.489709
NCT02814799|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-23|||May 2013||2013-05-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Observational|||Effects of the Bone Tissue on the Haemostasis|Study of the Effects of the Bone Tissue on the Generation of Thrombine|Recruiting||N/A|30|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 22:02:51.574786|2017-10-10 22:02:51.574786
NCT02814786|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-10|||September 8, 2016|Actual|2016-09-08|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|September 2019|Anticipated|2019-09-01||Interventional|EQUINUS||Dynamic Evaluation of Ankle Joint and Muscle Mechanics in Children With Spastic Equinus Deformity Due to Cerebral Palsy|In Vivo Dynamic Evaluation of Ankle Joint and Muscle Mechanics in Children With Spastic Equinus Deformity Due to Cerebral Palsy: Implications for Recurrent Equinus.|Recruiting||N/A|30|Anticipated|University Hospital, Brest||2|||f||||f||||||||||2017-10-10 22:02:51.680727|2017-10-10 22:02:51.680727
NCT02814773|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-09-22|||May 2006||2006-05-01|September 2016|2016-09-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Observational|||Evaluation of the Quality of Life in the Elderly With Dementia : Validation of a Specific Instrument|Evaluation of the Quality of Life in the Elderly With Dementia : Validation of a Specific Instrument|Completed||N/A|310|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 22:02:51.815456|2017-10-10 22:02:51.815456
NCT02814760|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-27|||July 2010||2010-07-01|June 2016|2016-06-01||||July 2012|Actual|2012-07-01||Observational|AVC-II||Impact Of A Training Program And Organization On The Management Of Stroke In The Acute Phase (AVC-II)|Impact Of A Training Program And Organization On The Management Of Stroke In The Acute Phase (AVC-II)|Completed||N/A|3238|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:02:51.909434|2017-10-10 22:02:51.909434
NCT02814747|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-23||||||August 2014|2014-08-01||||February 2016|Actual|2016-02-01||Interventional|||Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes|Preferences and Representations Concerning High-throughput Sequencing Technologies in Medical Genetics. The Case of Development Anomalies.|Completed||N/A|530|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:02:53.896455|2017-10-10 22:02:53.896455
NCT02814734|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|SCANAPIV||Abdominal Compartment Syndrome : Diagnostic and Prognostic Value of CT Findings - a Prospective Study|Abdominal Compartment Syndrome : Diagnostic and Prognostic Value of CT Findings - a Prospective Study|Not yet recruiting||N/A|140|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||No||2017-10-10 22:02:53.974596|2017-10-10 22:02:53.974596
NCT02814721|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-23|||March 2015||2015-03-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique|Coronal Mode Ultrasound Guided Hemodialysis Cannulation: A Pilot Randomized Comparison With Standard Cannulation Technique|Completed||N/A|10|Actual|Henry Ford Health System||2|||f||||f||||||||No||2017-10-10 22:02:54.064161|2017-10-10 22:02:54.064161
NCT02814708|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-11|||May 2016||2016-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Trial of the BioMed rTSST‐1 Variant Vaccine in Healthy Adults|Phase 2 Clinical Trial of the BioMed rTSST‐1 Variant Vaccine in Healthy Adults|Recruiting||Phase 2|140|Anticipated|Biomedizinische Forschungs gmbH||7|||f||||t||||||||||2017-10-10 22:02:54.153902|2017-10-10 22:02:54.153902
NCT02814695|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-12-31|||August 2015||2015-08-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|Probiotics||Yeast Cells as Antioxidant-Producing Probiotics|Can Yeast Cells Emulate Vitamin E on In-vitro Protection of Human Spermatozoa Against Oxidative Stress?|Completed||Early Phase 1|40|Actual|Benha University||4|||f||||f||||||||||2017-10-10 22:02:54.286046|2017-10-10 22:02:54.286046
NCT02814682|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-06-23|||December 2012||2012-12-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|QUALI-PALLI||Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care|Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care|Completed||N/A|560|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 22:02:54.449098|2017-10-10 22:02:54.449098
NCT02814474|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-01|||October 2014||2014-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effects of Experimental Hyperketonemia on Myocardial Metabolism|Impact of Ketone Bodies on Myocardial Glucose and Fatty Acid Metabolism in Healthy Volunteers: A Positron Emission Tomography Study|Completed||Early Phase 1|10|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-10 22:02:57.678945|2017-10-10 22:02:57.678945
NCT02814656|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-12-01|||June 2016||2016-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects|A Phase I, Single Centre, Randomised, Single Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Inhaled AZD8871 in Healthy Male Subjects|Completed||Phase 1|70|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 22:02:54.745003|2017-10-10 22:02:54.745003
NCT02814643|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-02-03|||July 2016||2016-07-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ALIZE||Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma|A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma|Completed||Phase 3|133|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:02:55.0562|2017-10-10 22:02:55.0562
NCT02814630|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-06-27|||September 2016||2016-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria|Three-month, Single-center Study to Identify Biomarkers (Plasma Exosomal miRNAs) and Mechanism of Response (Basophil Transcriptome Analysis) to Xolair® (Omalizumab) in Patients With Chronic Idiopathic Urticaria|Recruiting||N/A|20|Anticipated|Asthma Inc Clinical Research Center||1|||f||||f||||||||Undecided|A paper may be written but individual participant data will not be made available|2017-10-10 22:02:55.219802|2017-10-10 22:02:55.219802
NCT02814617|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-23|||September 2015||2015-09-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity||Completed||Phase 2/Phase 3|80|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-10 22:02:55.350789|2017-10-10 22:02:55.350789
NCT02814604|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-05-15|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||FoodFLIP: Testing the Effectiveness of a Food Information App to Promote the Selection of Healthier Foods|FoodFLIP: Testing the Effectiveness of a Food Information App to Promote the Selection of Healthier Foods|Not yet recruiting||N/A|1020|Anticipated|University of Toronto||3|||f||||f|f|f||||||No||2017-10-10 22:02:55.45968|2017-10-10 22:02:55.45968
NCT02814591|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-06-22|||October 2011||2011-10-01|May 2016|2016-05-01||||June 2017|Anticipated|2017-06-01|1 Year|Observational [Patient Registry]|||Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy|Development of a Novel, Safe Method for the Non-invasive Assessment of Human Bone Quality, In Vivo, Using Spatially Offset Raman Spectroscopy|Enrolling by invitation||N/A|245|Anticipated|University College, London|||7||f||||f||||||||Undecided||2017-10-10 22:02:55.591829|2017-10-10 22:02:55.591829
NCT02814578|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-18|||September 2016||2016-09-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Interventional|ACTIV-BVS||Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation|Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation|Recruiting||N/A|200|Anticipated|Asan Medical Center||2|||f||||t||||||||No|This is not a publicly funded trial.|2017-10-10 22:02:55.714886|2017-10-10 22:02:55.714886
NCT02814565|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-04-20|||October 12, 2016|Actual|2016-10-12|April 2017|2017-04-01|March 14, 2017|Actual|2017-03-14|March 14, 2017|Actual|2017-03-14||Interventional|||Cyclobenzaprine HCl Extended Release 15mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local Origin|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Trial to Study the Efficacy and Safety of Cyclobenzaprine HCl Extended Release (CER) 15 mg in Subjects With Cervical and/or Lower Back Pain Due to Muscle Spasms of Local Origin|Completed||Phase 3|180|Anticipated|Takeda||2|||f||||f|f|f||||||||2017-10-10 22:02:55.865921|2017-10-10 22:02:55.865921
NCT02814552|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-08-07|||June 18, 2016|Actual|2016-06-18|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)|OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)|Active, not recruiting||N/A|46|Actual|University of Florida||2|||f||||f||||||||||2017-10-10 22:02:56.068879|2017-10-10 22:02:56.068879
NCT02814539|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-30|||March 2016||2016-03-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Brain Function in Children With Congenital Heart Disease (CHD)|Brain Network Function in School-age Children With Congenital Heart Disease and Its Relation to Higher Order Cognitive Functions|Enrolling by invitation||N/A|80|Anticipated|University Children's Hospital, Zurich|||2||f||||f||||||||Undecided||2017-10-10 22:02:57.054922|2017-10-10 22:02:57.054922
NCT02814526|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-20|||September 13, 2016|Actual|2016-09-13|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|EXERT||Exercise in Adults With Mild Memory Problems|Therapeutic Effects of Exercise in Adults With Amnestic Mild Cognitive Impairment|Recruiting||N/A|300|Anticipated|Alzheimer's Disease Cooperative Study (ADCS)||2|||f||||t||||||||||2017-10-10 22:02:57.139689|2017-10-10 22:02:57.139689
NCT02814513|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-05-03|||June 2016||2016-06-01|May 2017|2017-05-01|September 27, 2016|Actual|2016-09-27|September 27, 2016|Actual|2016-09-27||Interventional|||Feasibility of the ANDAGO System in Pediatric Neurorehabilitation|Feasibility of the ANDAGO System in Pediatric Neurorehabilitation: Bridging the Gap From Treadmill-based to Over-ground Walking|Completed||N/A|60|Anticipated|University Children's Hospital, Zurich||1|||f||||f||||||||Undecided||2017-10-10 22:02:57.360598|2017-10-10 22:02:57.360598
NCT02814500|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-23|||July 2016||2016-07-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||DP-R212 Pharmacokinetic Study Phase I|DP-R212 Pharmacokinetic Study Pharmacokinetic Characteristics of DP-R212 in Comparison to Each Component Coadministered in Healthy Volunteers|Not yet recruiting||Phase 1|36|Anticipated|Alvogen Korea||2|||f||||f||||||||Undecided||2017-10-10 22:02:57.506327|2017-10-10 22:02:57.506327
NCT02813863|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-24|||December 2015||2015-12-01|December 2015|2015-12-01||||March 2016|Actual|2016-03-01||Interventional|||The Drug-drug Interaction of SP2086 and Metformin||Completed||Phase 1|24|Actual|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:03:03.227693|2017-10-10 22:03:03.227693
NCT02814461|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-06-27|||November 2015||2015-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC|A Phase I Clinical Trial Evaluating the Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for Advanced Hepatocellular Carcinoma (HCC)|Recruiting||Phase 1|18|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:02:57.771939|2017-10-10 22:02:57.771939
NCT02814448|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-01-30|||February 2016||2016-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CryoPen||An Innovative Treatment for Cervical Pre Cancer|CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Settings|Completed||N/A|125|Anticipated|The Cleveland Clinic||5|||f||||f||||||||No||2017-10-10 22:02:57.872878|2017-10-10 22:02:57.872878
NCT02814435|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-12|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Quality of Life Measures in Patients With Retinal Degeneration|Quality of Life Measures in Patients With Retinal Degeneration|Recruiting||N/A|90|Anticipated|University of Oxford|||2||f||||f||||||||Undecided||2017-10-10 22:02:58.100778|2017-10-10 22:02:58.100778
NCT02814422|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-01-16|||July 2014||2014-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Triglyceride-rich Lipoprotein and Development of Dementia|Triglyceride-rich Lipoprotein and the Development of Dementia|Recruiting||N/A|1000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||Yes||2017-10-10 22:02:58.211983|2017-10-10 22:02:58.211983
NCT02814409|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-09-21|||October 2016||2016-10-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|ATTEST2||Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis|Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)|Not yet recruiting||Phase 3|1870|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||t||||||||No||2017-10-10 22:02:58.315606|2017-10-10 22:02:58.315606
NCT02814396|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-01-16|||January 2013||2013-01-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||The Application of Multichannel ECG Analytic System in Cardiovascular Diseases|The Application of Multichannel ECG Analytic System in Cardiovascular Diseases|Recruiting||N/A|5000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||Yes||2017-10-10 22:02:58.422109|2017-10-10 22:02:58.422109
NCT02814383|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-03-21|||May 2016||2016-05-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Observational|||Prediction of Brain Injury in Premature Infants|Diastolic Closing Margin Predicts Brain Injury in Premature Infants|Recruiting||N/A|310|Anticipated|Baylor College of Medicine|||1||f||||f||||||||No||2017-10-10 22:02:58.531904|2017-10-10 22:02:58.531904
NCT02814357|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-07-18|||July 2011||2011-07-01|July 2016|2016-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||To Test the Effect of Selected Fibres and Flours in Flat Bread on Post-Prandial Blood Glucose and Insulin Responses in Healthy Indian Population|To Evaluate the Effect of 4 Different Flour Compositions of Selected Fibres and Flours, on Post-prandial Plasma Glucose (PPG) and Serum Insulin Levels in Normal Indian Healthy Subjects|Completed||N/A|50|Actual|Unilever R&D||4|||f||||f||||||||||2017-10-10 22:02:58.682718|2017-10-10 22:02:58.682718
NCT02814344|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-23|||August 2011||2011-08-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|PropEHG||Comparative Study of the Propagation of Uterine Electrical Activity (EHG) in Pregnant Women During Pregnancy and During Labour|Comparative Study of the Propagation of Uterine Electrical Activity (EHG) in Pregnant Women During Pregnancy and During Labour|Recruiting||N/A|38|Anticipated|Centre Hospitalier Universitaire, Amiens|||2||f||||||||||||||2017-10-10 22:02:58.782982|2017-10-10 22:02:58.782982
NCT02814331|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-23|||October 2011||2011-10-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|NIRS Epilepsie||Electrohaemodynamic Activity in Epileptic Children : Combined Video-EEG and Near-infrared Spectroscopy (NIRS) Analysis|Electrohaemodynamic Activity in Epileptic Children: Combined Video-EEG and Near-infrared Spectroscopy (NIRS) Analysis|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire, Amiens|||2||f||||||||||||||2017-10-10 22:02:58.902065|2017-10-10 22:02:58.902065
NCT02814305|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-22|||March 2015||2015-03-01|June 2016|2016-06-01||||September 2015|Actual|2015-09-01||Interventional|||Opioid Analgesic Use and Disposal Following Outpatient Dental Surgery|Opioid Analgesic Use and Disposal Following Outpatient Dental Surgery|Completed||N/A|79|Actual|University of Pennsylvania||4|||f||||||||||||||2017-10-10 22:02:59.111584|2017-10-10 22:02:59.111584
NCT02814292|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-22|||June 2014||2014-06-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||A Cost-Effective Handheld Breast Scanner for Use in Low Resource Environments: A Validation Study|A Cost-Effective Handheld Breast Scanner for Use in Low Resource Environments: A Validation Study|Completed||N/A|89|Actual|University of Pennsylvania|||1||f||||f||||||||Yes||2017-10-10 22:02:59.187238|2017-10-10 22:02:59.187238
NCT02814279|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-05-11|2017-05-11||February 2014||2014-02-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Comparison of Two Flaps for Root Coverage|Evaluation of Two Different Flaps Associated With Connective Tissue Graft in the Treatment of Gingival Recession: A Randomized Clinical Trial|Completed||N/A|42|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||Undecided||2017-10-10 22:02:59.258835|2017-10-10 22:02:59.258835
NCT02814266|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-22|||November 2015||2015-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Difficult Intubation and Anthropometric Measurement|Trakya University, Faculty of Medicine, Department of Anatomy, Edirne, Turkey|Completed||N/A|170|Actual|Trakya University||2|||f||||f||||||||No||2017-10-10 22:02:59.750276|2017-10-10 22:02:59.750276
NCT02814253|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-01-30|||February 17, 2016|Actual|2016-02-17|January 2017|2017-01-01|December 2016|Actual|2016-12-01|July 6, 2016|Actual|2016-07-06||Observational|CBRS||Chronic Obstructive Pulmonary Disease (COPD) Breathing Record Study|An Exploratory, Observational Clinical Evaluation of the CRiL N-Tidal C Data-collector Capnometer to Collect Breathing Records in Patients With COPD|Completed||N/A|30|Actual|Cambridge Respiratory Innovations Limited|||2||f||||f||||||||Undecided|To be decided|2017-10-10 22:02:59.825646|2017-10-10 22:02:59.825646
NCT02814240|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-24|||March 2015||2015-03-01|June 2016|2016-06-01||||March 2018|Anticipated|2018-03-01||Interventional|SHAH||Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging|Hepatic Steatosis and Pituitary Gland Failure, Evaluation by NMR Imaging|Recruiting||N/A|166|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 22:02:59.915931|2017-10-10 22:02:59.915931
NCT02814227|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2017-06-27|2017-06-27||September 2014||2014-09-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Validation of Sleep Apnea Screening Device|Wireless Sensor Patch for Reducing Barriers to In-home Sleep Apnea Screening|Completed||N/A|52|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 22:03:00.017933|2017-10-10 22:03:00.017933
NCT02814214|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-07|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Observational|||Device-based QRS Evaluation|Device-based QRS Evaluation|Completed||N/A|103|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-10 22:03:00.211544|2017-10-10 22:03:00.211544
NCT02814201|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-12-02|||July 2011||2011-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|ERAMPPCI||Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm|Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm|Completed||N/A|55|Actual|Centre Hospitalier Universitaire, Amiens|||4||f||||||||||||||2017-10-10 22:03:00.268804|2017-10-10 22:03:00.268804
NCT02814188|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-09-18|||June 2016||2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Pre-Exercise Nutrition Strategies on Body Temperature and Thermoregulatory Responses|Effects of Pre-Exercise Nutrition Strategies on Body Temperature and Thermoregulatory Responses|Recruiting||N/A|60|Anticipated|Old Dominion University||2|||f||||f||||||||||2017-10-10 22:03:00.348012|2017-10-10 22:03:00.348012
NCT02814175|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-15|||August 5, 2016||2016-08-05|August 2017|2017-08-01|August 5, 2019|Anticipated|2019-08-05|July 12, 2018|Anticipated|2018-07-12||Interventional|CONTROL||A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation|A Phase 4 Open-label Randomized Controlled Study COmparing the Effectiveness of Adalimumab iNTROduction and Methotrexate Dose escaLation in Subjects With Psoriatic Arthritis (CONTROL)|Recruiting||Phase 4|240|Anticipated|AbbVie||7|||f||||f||||||||||2017-10-10 22:03:00.432754|2017-10-10 22:03:00.432754
NCT02814162|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-03-29|||April 2016||2016-04-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|||Predictive Values of Serum Adiponectin Levels in Aneurysmal Subarachnoid Hemorrhage.|Predictive Values of Serum Adiponectin Levels in Aneurysmal Subarachnoid Hemorrhage.|Recruiting||N/A|100|Anticipated|Tang-Du Hospital|||1||f||||f||||||Samples Without DNA|"     blood   "|No||2017-10-10 22:03:00.611757|2017-10-10 22:03:00.611757
NCT02814149|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-09-11|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|June 2027|Anticipated|2027-06-01|December 2026|Anticipated|2026-12-01||Interventional|||Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement|Esthetic, Clinical and Radiographic Outcomes of Immediate Implant Placement and Delayed Implant Placement in the Anterior Region of the Maxilla|Recruiting||N/A|40|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 22:03:00.685937|2017-10-10 22:03:00.685937
NCT02814136|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-12|||July 2016||2016-07-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|WACAvsEWACA||Wide Area Circular Ablation Versus Extra-wide Area Circular Ablation in Persistent Atrial Fibrillation|Comparison of Wide Area Circular Ablation With Extra-wide Area Circular Ablation in Subjects With Persistent Atrial Fibrillation, a Randomized Study|Recruiting||N/A|146|Anticipated|Mosaic Life Care||2|||f||||f||||||||||2017-10-10 22:03:00.909349|2017-10-10 22:03:00.909349
NCT02814123|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-06-28|||January 13, 2017|Actual|2017-01-13|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes|A Randomized, Three-way, Crossover Study to Assess the Efficacy of Fast-acting Insulin-plus-pramlintide Closed-loop Co-administration, Regular Insulin-plus-pramlintide Closed-loop Co-administration, and Fast-acting Insulin-alone Closed-loop Infusion in Regulating Glucose Levels Over a 24-hour Period in Adults With Type 1 Diabetes in Inpatient Settings.|Recruiting||Phase 2|28|Anticipated|McGill University||3|||f||||f||||||||No||2017-10-10 22:03:01.021781|2017-10-10 22:03:01.021781
NCT02814110|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-09-13|||March 1, 2013|Actual|2013-03-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy|Efficacy and the Safety of Granulocyte Colony-stimulating Factor Treatment in Children and Adolescents With Muscular Dystrophy: An Open Study|Recruiting||Phase 1|27|Anticipated|Medical University of Bialystok||1|||f||||t||||||||||2017-10-10 22:03:01.156055|2017-10-10 22:03:01.156055
NCT02814097|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-09-06|||September 2, 2016|Actual|2016-09-02|September 2017|2017-09-01|June 2, 2017|Actual|2017-06-02|May 4, 2017|Actual|2017-05-04||Interventional|||A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction|A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction|Completed||Phase 2|46|Actual|Stealth BioTherapeutics Inc.||2|||f||||f||||||||||2017-10-10 22:03:01.261994|2017-10-10 22:03:01.261994
NCT02814084|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-10-13|||August 2016||2016-08-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Interventional|Prevena||Prevena Incision Management|Effect of the Prevena Incision Management System on Sternal Wound Edge Perfusion in Patients Undergoing CABG With Bilateral Mammary Artery Grafts|Recruiting||N/A|80|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:03:01.36596|2017-10-10 22:03:01.36596
NCT02813109|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-04-27|||June 2016||2016-06-01|April 2017|2017-04-01|March 2, 2017|Actual|2017-03-02|February 15, 2017|Actual|2017-02-15||Observational|||Urine Biomarkers for Renal Function Monitoring in Preterm Infants||Completed||N/A|83|Actual|Inha University Hospital|||1||f||||||||||Samples Without DNA|"     urine   "|||2017-10-10 22:03:10.812078|2017-10-10 22:03:10.812078
NCT02814058|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-07-13|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation|Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation, With Fasting and Postprandial Administration, in Male and Female Healthy Volunteers, Produced by Biolab Sanus Farmacêutica Ltda|Not yet recruiting||Phase 1|28|Anticipated|Biolab Sanus Farmaceutica||2|||f||||f|f|f||||||||2017-10-10 22:03:01.571735|2017-10-10 22:03:01.571735
NCT02814045|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-06-22|||November 2015||2015-11-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation.|Impact of Obstructive Sleep Apnea in the Evolution of Alzheimer Disease. Role of Hypoxia and Sleep Fragmentation|Recruiting||N/A|144|Anticipated|Sociedad Española de Neumología y Cirugía Torácica|||2||f||||f||||||Samples With DNA|"     APoE4   "|Undecided||2017-10-10 22:03:01.689302|2017-10-10 22:03:01.689302
NCT02814032|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-06-24|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Proteomics of Papillary Thyroid Carcinoma|Differences Protein Expression in Papillary Thyroid Carcinoma|Recruiting||N/A|32|Anticipated|The Affiliated Hospital of Inner Mongolia Medical University|||4||f||||f||||||||Undecided||2017-10-10 22:03:01.801843|2017-10-10 22:03:01.801843
NCT02814019|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-08-14|||September 2016||2016-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Interventional|SIDEROS||A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids|A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids|Recruiting||Phase 3|266|Anticipated|Santhera Pharmaceuticals||2|||f||||||||||||||2017-10-10 22:03:01.947245|2017-10-10 22:03:01.947245
NCT02814006|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-10-24|||October 2016||2016-10-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SEXTACTIC||Sexual Timing in Couples Actively Trying to Conceive|What is the Best Sexual Intercourse Strategy for Couples Actively Trying to Conceive?|Recruiting||N/A|400|Anticipated|Universidade do Porto||3|||f||||f||||||||Undecided||2017-10-10 22:03:02.250222|2017-10-10 22:03:02.250222
NCT02813993|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-10-24|||October 2016||2016-10-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|CFPA||Couples Fertility and Pregnancy Awareness|Couples Fertility and Pregnancy Awareness|Recruiting||N/A|600|Anticipated|Universidade do Porto||2|||f||||f||||||||Undecided||2017-10-10 22:03:02.349526|2017-10-10 22:03:02.349526
NCT02813980|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-04-15|||June 2016||2016-06-01|September 2016|2016-09-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Observational|NC-SUDEP||Neural Circulatory Control and SUDEP Risk.|Neural Circulatory and Respiratory Control in Patients With Epilepsy and the Risk of Sudden Unexpected Death.|Recruiting||N/A|100|Anticipated|Mayo Clinic|||2||f||||f||||||Samples Without DNA|"     Serum and plasma to be stored for future biomarker based studies.   "|||2017-10-10 22:03:02.440422|2017-10-10 22:03:02.440422
NCT02813967|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer|S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus: A Prospective, Randomized, Multi-center Phase-III Study|Recruiting||Phase 3|196|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||No||2017-10-10 22:03:02.528933|2017-10-10 22:03:02.528933
NCT02813954|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-22|||August 2015||2015-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Predictive Value of Amniotic Fluid pH and Electrolytes on Neonatal Respiratory Disorders|The Predictive Value of Amniotic Fluid pH and Electrolytes on Neonatal Respiratory Disorders|Completed||N/A|184|Actual|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||t||||||||No||2017-10-10 22:03:02.624712|2017-10-10 22:03:02.624712
NCT02813941|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-04-03|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Comparison of Three Summary of Finding Tables to Improve Understanding in the Presentation of Systematic Review Results: A Three-arm, Randomized, Controlled, Noninferiority Trial|Two Alternatives Versus Usual GRADE-SoF Tables to Improve Understanding in the Presentation of Systematic Review Results: A Three-arm, Randomized, Controlled, Noninferiority Trial|Not yet recruiting||N/A|702|Anticipated|McMaster University||3|||f||||t|f|f||||||Yes|Yes|2017-10-10 22:03:02.69938|2017-10-10 22:03:02.69938
NCT02813928|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2016-08-12|||July 2016||2016-07-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|ADNCirc||Diagnostic and Prognosis Value of Circulating DNA for CRC Patients' Surveillance After Curative Treatment|Diagnostic and Prognosis Value of Circulating DNA for CRC Patients' Surveillance After Curative Treatment|Recruiting||N/A|300|Anticipated|University Hospital, Limoges||1|||f||||f||||||||No|the data are anonymized|2017-10-10 22:03:02.797095|2017-10-10 22:03:02.797095
NCT02813915|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-08-12|||June 2016||2016-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|NICOM||Non-invasive Cardiac Output Monitor in Young Adults|A Trial of a Non-Invasive Cardiac Output in Young Adults|Recruiting||N/A|50|Anticipated|Indiana University|||1||f||||f||||||||No||2017-10-10 22:03:02.877076|2017-10-10 22:03:02.877076
NCT02813902|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-24|||July 2016||2016-07-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors|A Pilot Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors|Not yet recruiting||Phase 1|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 22:03:02.972173|2017-10-10 22:03:02.972173
NCT02813889|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-11|||May 2015||2015-05-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants|SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants|Recruiting||N/A|30|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:03:03.056966|2017-10-10 22:03:03.056966
NCT02813876|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-05-24|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|ASERT||Enhanced Recovery in Acute Pancreatitis|Application of Surgical Enhanced Recovery Techniques in Acute Pancreatitis|Completed||Phase 2|46|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-10 22:03:03.163124|2017-10-10 22:03:03.163124
NCT02813850|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-06-13|||October 5, 2016|Actual|2016-10-05|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|February 2021|Anticipated|2021-02-01||Interventional|DRO2G||Oxygen Therapy and Pregnancy in Sickle Cell Disease|Impact of Home-based Oxygen Therapy on Maternal and Fetal Complications, in Pregnant Women With Sickle Cell Disease. A Randomized Multi-center Trial.|Recruiting||Phase 3|200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f|f|f||||||No||2017-10-10 22:03:03.290941|2017-10-10 22:03:03.290941
NCT02813837|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-06-26|||June 2015||2015-06-01|June 2016|2016-06-01|July 2021|Anticipated|2021-07-01|January 2021|Anticipated|2021-01-01||Interventional|||Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies|A Multicenter Efficacy and Safety Study of Cluster of Differentiation 19 (CD19)-Targeted CART (CD19CART) Therapy for CD19 Positive Relapsed or Refractory B-cell Hematologic Malignancies (SCT019-01）|Recruiting||N/A|30|Anticipated|Innovative Cellular Therapeutics Co., Ltd.||1|||f||||t||||||||Undecided||2017-10-10 22:03:03.394328|2017-10-10 22:03:03.394328
NCT02813811|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-07-26|||May 2016||2016-05-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|LASER-48||Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up.|A Prospective, Single Arm, Cohort Study of Nocturnal Temperature-controlled Laminar Airflow (TLA) Treatment (Airsonett®) in Patients With Allergic Asthma to Determine the Effect of Long-term Treatment on Exacerbation Frequency.|Recruiting||N/A|200|Anticipated|Portsmouth Hospitals NHS Trust|||1||f||||f||||||||Undecided||2017-10-10 22:03:03.573499|2017-10-10 22:03:03.573499
NCT02813785|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-08-01|||July 31, 2016|Actual|2016-07-31|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|IMpower210||A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy|A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Docetaxel in Patients With Non-Small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy|Active, not recruiting||Phase 3|563|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:03:03.771743|2017-10-10 22:03:03.771743
NCT02813772|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-09-07|||November 2015||2015-11-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy of a Partially Hydrolyzed Formula, Containing Lactobacillus Reuteri, for Infant Colic|Efficacy of a Partially Hydrolyzed Formula, Containing Lactobacillus Reuteri, for Infant Colic: a Double Blind, Randomized-controlled Trial|Recruiting||N/A|250|Anticipated|Federico II University||2|||f||||f||||||||Yes|December 2016|2017-10-10 22:03:04.054928|2017-10-10 22:03:04.054928
NCT02813759|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-22|||July 2015||2015-07-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|SDMIR||Sucralose in Subjects With Diabetes Mellitus Insulin Requesting|Effect of a Sucralose Preload on Postprandial Metabolic Parameters and Satiety in Subjects With Type 2 Diabetes Mellitus Under Intensive Insulin Therapy - Controlled Clinical Trial|Completed||N/A|10|Actual|Universidad de Valparaiso||2|||f||||t||||||||No||2017-10-10 22:03:04.16673|2017-10-10 22:03:04.16673
NCT02813746|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-27|||April 2016||2016-04-01|June 2016|2016-06-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Observational|||Maternal Transcriptomic Regulation of the Preimplantation Embryo|Maternal Transcriptomic Regulation of the Preimplantation Embryo|Recruiting||N/A|90|Anticipated|Igenomix|||2||f||||f||||||Samples With DNA|"     DNA will be analyzed in the endometrial fluid. These samples will be completely exhausted     during the analysis.   "|No||2017-10-10 22:03:04.251867|2017-10-10 22:03:04.251867
NCT02813733|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-24|||April 2008||2008-04-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|December 2009|Actual|2009-12-01||Observational|CATHY||Determinants of Thyroid Surgery Outcomes|Influence of Factors Specific to Patient, Procedure or Surgeon on Thyroid Surgery Outcomes|Completed||N/A|3500|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:03:04.366826|2017-10-10 22:03:04.366826
NCT02813720|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-24|||November 2013||2013-11-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Observational|PSUPSO||Distal Erosions and Nail Psoriasis|Distal Phalangeal Bone Involvement Observed by High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) in Patients With Nail Psoriasis|Recruiting||N/A|104|Anticipated|Hospices Civils de Lyon|||4||f||||f||||||Samples With DNA|"     Urine Serum and plasma Whole blood   "|||2017-10-10 22:03:04.450108|2017-10-10 22:03:04.450108
NCT02813707|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-26|||April 2016||2016-04-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|BS-PART2||Prospective Study to Determine Long Term Impact of Bariatric Surgery|A Prospective Study to Determine Long Term Impact of Bariatric Surgery on Metabolic, Nutritional and Quality of Life Status: PART 2|Recruiting||N/A|150|Anticipated|United Arab Emirates University|||1||f||||f||||||||||2017-10-10 22:03:04.549944|2017-10-10 22:03:04.549944
NCT02813694|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-24|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|LEAP2||Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia|A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia|Recruiting||Phase 3|738|Anticipated|Nabriva Therapeutics AG||2|||f||||t||||||||||2017-10-10 22:03:04.667505|2017-10-10 22:03:04.667505
NCT02813681|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-24|||May 2014||2014-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Ultrasound-Guided Landmark and Epidural Site Pain|A Prospective Randomized Clinical Trial to Study the Effect of Pre-Epidural Ultrasound Examination on Epidural Insertion Site Pressure Sensitivity in Parturient|Completed||N/A|80|Actual|The University of Texas Medical Branch, Galveston||6|||f||||f||||||||No||2017-10-10 22:03:05.54241|2017-10-10 22:03:05.54241
NCT02813668|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-05-04|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Worksite Lifestyle Program for Reducing Diabetes and Cardiovascular Risk in India|Worksite Lifestyle Program for Reducing Diabetes and Cardiovascular Risk in India|Recruiting||N/A|2000|Anticipated|Emory University||1|||f||||f|f|f||||||No||2017-10-10 22:03:05.659647|2017-10-10 22:03:05.659647
NCT02813655|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-03-01|||October 2016||2016-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|ESYBRECHE||Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)|Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)|Recruiting||Phase 2|88|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:03:05.773135|2017-10-10 22:03:05.773135
NCT02813642|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-01-17|||December 2011||2011-12-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients|Evaluation of Non Traditional Cardiovascular Risk Factors in Chronic Kidney Disease Patients Starting Dialysis|Recruiting||N/A|400|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:03:05.89105|2017-10-10 22:03:05.89105
NCT02813629|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-06-21|||March 2016||2016-03-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|tDCS/PES_SCD||tDCS Associated With Peripheral Electrical Stimulation for Pain Control in Individuals With Sickle Cell Disease|Transcranial Direct Current Stimulation Associated With Peripheral Electrical Stimulation for Pain Control in Individuals With Sickle Cell Disease|Recruiting||Phase 2|120|Anticipated|Faculdade Adventista da Bahia||8|||f||||t||||||||Undecided||2017-10-10 22:03:06.005966|2017-10-10 22:03:06.005966
NCT02813616|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-21|||February 2016||2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Observational|||Factors Affecting Dissatisfaction to Treatments in Patients With Chronic Constipation and IBS With Constipation|Factors Affecting Dissatisfaction to Treatments in Patients With Chronic Constipation and Irritable Bowel Syndrome With Constipation. Pooled Analysis of Multiple Prospective N-of-1 Treatment Optimization Trials|Recruiting||N/A|90|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||1||f||||f||||||||||2017-10-10 22:03:06.142676|2017-10-10 22:03:06.142676
NCT02813603|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-22|||May 2016||2016-05-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|July 2016|Anticipated|2016-07-01||Observational|||Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA|Comparison of the Diagnostic Yield Between Various Endobronchial Ultrasound-guided-transbronchial Needles (EBUS-TBN) to Evaluate Suspect Mediastinal and Hilar Lymph Nodes|Recruiting||N/A|100|Anticipated|University Hospital, Essen|||2||f||||f||||||||No||2017-10-10 22:03:06.26391|2017-10-10 22:03:06.26391
NCT02813590|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01||||September 2017|Anticipated|2017-09-01||Observational|||Ascitic Fluid Microbiome in Liver Cirrhosis||Recruiting||N/A|30|Anticipated|Medical University of Graz|||2||f||||||||||||||2017-10-10 22:03:06.416859|2017-10-10 22:03:06.416859
NCT02813577|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-02-23|||May 2016||2016-05-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|CONFIRM||Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM)|A Prospective, Multicenter, Single Arm, Post-Approval Study of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females|Active, not recruiting||N/A|160|Anticipated|C. R. Bard||1|||f||||f||||||||No||2017-10-10 22:03:06.521277|2017-10-10 22:03:06.521277
NCT02813564|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-30|||September 18, 2017|Anticipated|2017-09-18|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Cognitive Training in Children With ASD|Targeted Cognitive Training: Assessment and Plasticity in Autism Spectrum Disorder (ASD)|Not yet recruiting||N/A|50|Anticipated|McMaster University||4|||f||||f|f|f||||||||2017-10-10 22:03:06.637676|2017-10-10 22:03:06.637676
NCT02813551|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TROPHY||ToRsemide for pOstpartum HYpertension|Torsemide for the Prevention of Persistent Postpartum Hypertension in Preeclamptic Women: A Randomized, Placebo-Control Trial|Recruiting||Phase 2|118|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Undecided||2017-10-10 22:03:06.779166|2017-10-10 22:03:06.779166
NCT02813538|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-07-16|||February 2016||2016-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01|2 Years|Observational [Patient Registry]|||Major Liver Resection: Early Clotting Disorders and Functional Impairment.|Hypercoagulability and Liver Function After Major Liver Resection|Recruiting||N/A|60|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||f||||||Samples Without DNA|"     Blood samples for anticoagulant proteins levels analysis and thromboelastometry   "|Yes|Publishing results|2017-10-10 22:03:06.88608|2017-10-10 22:03:06.88608
NCT02813525|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-22|||September 2016||2016-09-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|f-ISI-RCIU||Ultrasound Monitoring of Fetuses With Vascular Intra-uterine Growth Restriction (IUGR) Using the Isthmus Systolic Index (ISI): Feasibility, Comparison to Normal Fetuses and Association With Perinatal Mortality|Ultrasound Monitoring of Fetuses With Vascular Intra-uterine Growth Restriction (IUGR) Using the Isthmus Systolic Index (ISI): Feasibility, Comparison to Normal Fetuses and Association With Perinatal Mortality|Not yet recruiting||N/A|320|Anticipated|University Hospital, Bordeaux|||2||f||||f||||||||||2017-10-10 22:03:06.983082|2017-10-10 22:03:06.983082
NCT02813512|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-07-04|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke|Adipose-Derived Stem Cells (ADSCs) Injections for Stroke|Not yet recruiting||Phase 1|3|Anticipated|Gwo Xi Stem Cell Applied Technology Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 22:03:07.072497|2017-10-10 22:03:07.072497
NCT02813499|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-06-23|||November 2016||2016-11-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Observational|ICARE||Interest of CARE Rule to Exclude the Hypothesis of an Acute Coronary Syndrome Without Bioassay - ICARE|Intérêt de la règle CARE Pour Exclure l'hypothèse d'un Syndrome Coronarien Aigu Sans Dosage Biologique - ICARE|Recruiting||N/A|1650|Anticipated|University Hospital, Angers|||1||f|||||f|f||||||||2017-10-10 22:03:07.143968|2017-10-10 22:03:07.143968
NCT02813486|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-11-04|||June 2016||2016-06-01|November 2016|2016-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine|Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine|Active, not recruiting||Phase 1/Phase 2|220|Anticipated|Green Cross Corporation||2|||f||||t||||||||No||2017-10-10 22:03:07.243296|2017-10-10 22:03:07.243296
NCT02813473|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-07-25|||June 2016||2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Observational|SYNTAX III||SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease|SYNTAX III REVOLUTION Trial: A Randomized Study to Evaluate the Feasibility of Heart-Team Clinical Decision Making Regarding the Optimal (Surgical or Percutaneous Based) Revascularization Strategy in Patients With Complex Coronary Artery Disease, Based on Non-invasive Coronary CT Angiography (CTA) Imaging Utilising High-definition GE RevolutionTM Multi-slice CT and HeartFlow FFRCT Compared to the Current Standard of Care With Conventional Invasive Coronary Angiography (CA)|Recruiting||N/A|223|Anticipated|ECRI bv|||1||f||||f||||||||||2017-10-10 22:03:07.325092|2017-10-10 22:03:07.325092
NCT02813460|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-09-14|||June 2016||2016-06-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants|A Phase 1, Double-blind, Randomized Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Subjects|Completed||Phase 1|11|Actual|Janssen Research & Development, LLC||12|||f||||f||||||||||2017-10-10 22:03:07.424349|2017-10-10 22:03:07.424349
NCT02813447|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-03-09|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|SAD-COPD||Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)|Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease|Recruiting||N/A|30|Anticipated|Duke University||2|||f||||||||||||||2017-10-10 22:03:07.554055|2017-10-10 22:03:07.554055
NCT02813434|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-22|||September 2014||2014-09-01|June 2016|2016-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|IDEA3||Cerebral Amyloid Imaging Using Florbetapir (AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia|Cerebral Amyloid Imaging Using Florbetapir (18F-AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia|Recruiting||Phase 3|100|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-10 22:03:07.63761|2017-10-10 22:03:07.63761
NCT02813421|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-05-08|||March 2016||2016-03-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Continue Glucose Monitoring Before Insulin Pump|Professional Continuous Glucose Monitoring Before Starting Insulin Pump Therapy|Completed||N/A|11|Actual|Children's Hospital Los Angeles||2|||f||||f||||||||No||2017-10-10 22:03:07.897491|2017-10-10 22:03:07.897491
NCT02813408|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-06-29|||May 3, 2016|Actual|2016-05-03|June 2017|2017-06-01|March 21, 2018|Anticipated|2018-03-21|October 31, 2017|Anticipated|2017-10-31||Observational|AQUARiUS||A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants|Prospective Multi-country Observational Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Patient-reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Patients|Active, not recruiting||N/A|187|Actual|Janssen Pharmaceutica N.V., Belgium|||2||f||||f||f||||||||2017-10-10 22:03:08.018469|2017-10-10 22:03:08.018469
NCT02813395|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-24|||April 2014||2014-04-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Laser Therapy on Neuromuscular Performance|Immediate Effects of Low-level Laser Therapy (808nm) on Neuromuscular Performance After Muscle Fatigue: Randomized-blinded Clinical Trial|Completed||N/A|80|Actual|Universidade Federal do Rio Grande do Norte||4|||f||||||||||||||2017-10-10 22:03:08.169509|2017-10-10 22:03:08.169509
NCT02813382|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-06-27|||August 2015||2015-08-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|spinal||Spinal Anesthesia for Outpatient Abdominal Wall Surgery: Comparison of Bupivacaine, 2-chloroprocaine and Prilocaine|Intrathecal 60mg Prilocaine, Hyperbaric 40mg 9-chloroprocaine and 10.5mg Bupivacaine Each With Added Sufentanil (2µg) for Elective Ambulatory Umbilical and Unilateral Inguinal Herniorrhaphy|Completed||N/A|101|Actual|AZ St.-Dimpna Geel|||3||f||||t||||||||Undecided||2017-10-10 22:03:08.278765|2017-10-10 22:03:08.278765
NCT02813369|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-03-01|||July 2016||2016-07-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Naloxegol Health Outcomes PASS|An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Among Patients Aged 18 Years and Older Diagnosed With Non-Cancer Pain and Treated With Opioids Chronically|Recruiting||N/A|10000|Anticipated|Kyowa Kirin Pharmaceutical Development Ltd|||2||f||||f||||||||||2017-10-10 22:03:08.419076|2017-10-10 22:03:08.419076
NCT02813356|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-09-29|||June 24, 2016|Actual|2016-06-24|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Naloxegol US PMR CV Safety|United States Post-Marketing Observational Cardiovascular Safety Study in Patients Taking Naloxegol.|Recruiting||N/A|8800|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-10-10 22:03:08.539088|2017-10-10 22:03:08.539088
NCT02813343|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-09-12|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Evaluate the Value of Telehomecare for Diabetes|Evaluate the Value of Telehomecare for Diabetes|Completed||N/A|221|Actual|Women's College Hospital||2|||f||||f||||||||||2017-10-10 22:03:08.638721|2017-10-10 22:03:08.638721
NCT02813330|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2016-06-21|||February 2015||2015-02-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Subcutaneous Sterile Water Injection for Relief of Low Back Pain|Subcutaneous Sterile Water Injection for Relief of Low Back Pain During Normal Labor: Randomized Controlled Study|Active, not recruiting||Phase 1/Phase 2|336|Actual|Woman's Health University Hospital, Egypt||2|||f||||t||||||||Yes|Protocol or seminar discussion|2017-10-10 22:03:08.75127|2017-10-10 22:03:08.75127
NCT02813317|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-04-12|||December 2014|Actual|2014-12-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Observational|OPTIsoins01||Optimizing the Care Pathways of Patients Treated for Operable Breast.|Optimizing the Care Pathways of Patients Treated for Operable Breast Cancer|Completed||N/A|617|Actual|Institut Curie|||1||f||||f||||||||No||2017-10-10 22:03:08.849425|2017-10-10 22:03:08.849425
NCT02813304|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-10-24|||June 2016||2016-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Two Treatments for Acute Rotator Cuff Tendinopathy|Rest or Gradual Reloading in Acute Presentations of Rotator Cuff Tendinopathy - A Randomised Control Trial|Recruiting||N/A|44|Anticipated|Laval University||2|||f||||f||||||||No||2017-10-10 22:03:08.977395|2017-10-10 22:03:08.977395
NCT02813291|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-07|||April 26, 2017|Actual|2017-04-26|August 2017|2017-08-01|May 26, 2018|Anticipated|2018-05-26|May 26, 2018|Anticipated|2018-05-26||Interventional|MISt||MI Practice and tDCS With Aging|Effects of Motor Imagery Practice Combined With Transcranial Direct Current Stimulation in the Learning of a Complex Motor Sequence in Young and Elderly Subjects|Recruiting||N/A|64|Anticipated|Hospices Civils de Lyon||4|||f||||f|f|f||||||||2017-10-10 22:03:09.099096|2017-10-10 22:03:09.099096
NCT02813278|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-23|||February 2014||2014-02-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|SMD/POI||Simo Decoction and Acupuncture on POI in Colorectal Cancer|Efficacy of Simo Decoction and Acupuncture or Chewing Gum Alone on Postoperative Ileus in Colorectal Cancer Resection: a Randomized Clinical Trial|Completed||Phase 3|600|Actual|Guangxi Medical University||3|||f||||t||||||||No||2017-10-10 22:03:09.20442|2017-10-10 22:03:09.20442
NCT02813265|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-04-12|||June 2016||2016-06-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease|A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease|Recruiting||Phase 3|900|Anticipated|Kala Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:03:09.338603|2017-10-10 22:03:09.338603
NCT02813239|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-23|||November 2014||2014-11-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2014|Actual|2014-11-01||Observational|||Dual Triggering in Patients With a High Immature Oocyte Rate|Dual Triggering With Gonadotropin-releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate|Completed||N/A|81|Actual|IVI Madrid|||2||f||||f||||||||No||2017-10-10 22:03:09.819038|2017-10-10 22:03:09.819038
NCT02813226|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-07-14|||December 2016||2016-12-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|MISTER||Assessment of New Molecular Imaging Strategies for Prostate Cancer|Assessment of New Molecular Imaging Strategies for Prostate Cancer: Predictive Value of Established and Novel Positron Emission Tomography (PET) Radiotracers in Castration-Resistant Prostate Cancer|Recruiting||N/A|30|Anticipated|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-10-10 22:03:09.908981|2017-10-10 22:03:09.908981
NCT02813213|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Effectiveness Comparison of Skin Micro-grafts vs Meshed Split Thickness Skin Grafts|Effectiveness Comparison Between the Use of Skin Micro-grafts vs Meshed Split Thickness Skin Grafts in Cutaneous Defects: A Randomized Controlled Clinical Trial|Recruiting||Phase 4|30|Anticipated|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||Yes|Only some data will be shared (age, gender, diagnosis, area defect and epithelialization ratio). Photos will be shared only if the patients give their consent.|2017-10-10 22:03:10.002738|2017-10-10 22:03:10.002738
NCT02813200|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-22|||September 2016||2016-09-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|INTUITIVE||Description of the Ability to Learn How to Handle Inhaler Devices in COPD||Not yet recruiting||Phase 4|30|Anticipated|University Hospital, Bordeaux||3|||f||||f||||||||||2017-10-10 22:03:10.125522|2017-10-10 22:03:10.125522
NCT02813187|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-23|||May 2016||2016-05-01|June 2016|2016-06-01|June 2025|Anticipated|2025-06-01|May 2025|Anticipated|2025-05-01|1 Month|Observational [Patient Registry]|VLUR||Venous Leg Ulcer Registry|A Real World, Observational Registry of Venous Leg Ulcers and Quality of Care in Clinical Practice|Enrolling by invitation||N/A|10000|Anticipated|U.S. Wound Registry|||1||f||||t||||||||||2017-10-10 22:03:10.235951|2017-10-10 22:03:10.235951
NCT02813174|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-08-16|||June 2016||2016-06-01|August 2017|2017-08-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Personality Style and Self Compassion in Postpartum Depression: An Online Prevention Study||Completed||N/A|228|Anticipated|i4Health||1|||f||||||||||||||2017-10-10 22:03:10.31722|2017-10-10 22:03:10.31722
NCT02813161|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-21|||February 2015||2015-02-01|June 2016|2016-06-01|February 2025|Anticipated|2025-02-01|January 2025|Anticipated|2025-01-01|1 Month|Observational [Patient Registry]|DFUR||The Diabetic Foot Ulcer Registry|A Real World, Observational Registry of Diabetic Foot Ulcers and Quality of Care in Clinical Practice|Recruiting||N/A|10000|Anticipated|U.S. Wound Registry|||1||f||||t||||||||||2017-10-10 22:03:10.393199|2017-10-10 22:03:10.393199
NCT02813148|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-03-01|||July 2016||2016-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Naloxegol Drug Utilization PASS|An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Drug Utilization in Selected European Populations|Recruiting||N/A|3000|Anticipated|Kyowa Kirin Pharmaceutical Development Ltd|||1||f||||f||||||||||2017-10-10 22:03:10.484069|2017-10-10 22:03:10.484069
NCT02813135|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-08-22|||June 2016||2016-06-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|ESMART||European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors|European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors|Recruiting||Phase 1/Phase 2|285|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||7|||f||||t||||||||No||2017-10-10 22:03:10.550571|2017-10-10 22:03:10.550571
NCT02813122|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-02-05|||June 2016||2016-06-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||The Use of X-ray in Bariatric Surgeries|The Use of X-ray in Bariatric Surgeries|Completed||N/A|8000|Actual|Assuta Medical Center|||2||f||||f||||||||No||2017-10-10 22:03:10.682407|2017-10-10 22:03:10.682407
NCT02813096|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-10-21|||October 2016||2016-10-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients|Efficacy and Safety Study of Folfox4 Chemotherapy Regimen to Prevent Early Recurrence of Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus Following Curative Resection|Not yet recruiting||N/A|500|Anticipated|Guangxi Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:03:10.869266|2017-10-10 22:03:10.869266
NCT02813083|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-27|||August 2011||2011-08-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|6 Months|Observational [Patient Registry]|||Detection of Pathological Lymphocytes in Patients With Autoimmune Disease|Detection of Pathological Lymphocytes in Patients With Autoimmune Disease|Recruiting||N/A|155|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples With DNA|"     Serum, peripheral blood mononuclear cells   "|No||2017-10-10 22:03:10.95259|2017-10-10 22:03:10.95259
NCT02813070|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-05-03|2017-02-08||October 2012||2012-10-01|May 2017|2017-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Baseline population included all randomized participants.|Comparison of PET Amyloid Imaging in Japanese and Western Subjects|An Open-label Study to Assess Brain Uptake and Safety of Flutemetamol F 18 Injection in Japanese Subjects With Probable Alzheimer's Disease, Subjects With Amnestic Mild Cognitive Impairment and Healthy Volunteers|Completed||Phase 2|70|Actual|GE Healthcare||3|||f||||f||||||||No||2017-10-10 22:03:11.031657|2017-10-10 22:03:11.031657
NCT02813057|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-22|||March 2012||2012-03-01|June 2016|2016-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Impacts of Stoppa and Total Extraperitoneal Inguinal Hernia Repair on the Lower Extremity Muscular Functions|Quantitative Assessment of the Impacts of Stoppa Repair and Total Extraperitoneal Repair on the Lower Extremity Muscular Functions in Cases of Unilateral Inguinal Hernia; a Randomized Controlled Study|Completed||N/A|50|Actual|Akdeniz University||2|||f||||t||||||||No||2017-10-10 22:03:11.331578|2017-10-10 22:03:11.331578
NCT02813044|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-12-29|||June 2016||2016-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor||Recruiting||N/A|82|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:03:11.415106|2017-10-10 22:03:11.415106
NCT02813031|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-21|||April 2015||2015-04-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Human Study of Functional Meat Products|Nutritional Intervention Study to Evaluate the Effect of an Olive Oil Lipid Rich in Diglycerides as a Fat Replacement in Different Meat Products, in a Healthy Population|Completed||N/A|78|Actual|IMDEA Food||2|||f||||||||||||||2017-10-10 22:03:11.515554|2017-10-10 22:03:11.515554
NCT02813018|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-12-29|||June 2016||2016-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||The Impact of Preemptive Epidural Analgesia on Acute Postoperative Pain in Pediatric Orthopedic Surgery||Recruiting||N/A|50|Anticipated|Yonsei University||2|||f||||f||||||||Undecided||2017-10-10 22:03:11.609315|2017-10-10 22:03:11.609315
NCT02813005|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-02-17|||July 2016||2016-07-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||High Frequency Jet Ventilation for Percutaneous Interventional Radiology|High Frequency Jet Ventilation for Percutaneous Interventional Radiology|Recruiting||Phase 3|108|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 22:03:11.729222|2017-10-10 22:03:11.729222
NCT02812992|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-14|||June 2016||2016-06-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|GrantPax||Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients|A Multicenter Phase 4 Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients|Recruiting||Phase 4|135|Anticipated|AIO-Studien-gGmbH||3|||f||||f||||||||||2017-10-10 22:03:13.853743|2017-10-10 22:03:13.853743
NCT02812979|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-10-24|||June 2016||2016-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|AirvoNEB||Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified|Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified Compared to a Usual Method|Recruiting||Phase 3|25|Anticipated|University Hospital, Tours||3|||f||||f||||||||No||2017-10-10 22:03:13.986155|2017-10-10 22:03:13.986155
NCT02812966|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-03-22|||April 2016||2016-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|HEROES-DCB||Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - DCB|Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - DCB|Recruiting||N/A|250|Anticipated|Advocate Health Care||2|||f||||f||||||||No||2017-10-10 22:03:14.119897|2017-10-10 22:03:14.119897
NCT02812953|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-24|||May 2016||2016-05-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01|12 Months|Observational [Patient Registry]|BIO TAVI||Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention||Recruiting||N/A|500|Anticipated|Action, France|||1||f||||f||||||Samples Without DNA|"     platelet poor plasma for von Willebrandt Factor further evaluation   "|Undecided||2017-10-10 22:03:14.22749|2017-10-10 22:03:14.22749
NCT02812940|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-06-24|||April 2016||2016-04-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|OCTET-Ever||Single-centre Study of Everolimus as GvHD Prophylaxis After Post-Transplantation Cyclophosphamide After Allogeneic SCT|A Single-centre Study of Certican (Everolimus) as Prophylaxis for Graft-versus-Host Disease Following Post-Transplantation Cyclophosphamide After Allogeneic Stem Cell Transplantation|Recruiting||Phase 2|20|Anticipated|University of Cologne||1|||f||||f||||||||No||2017-10-10 22:03:14.294042|2017-10-10 22:03:14.294042
NCT02812927|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-27|||September 2012||2012-09-01|June 2016|2016-06-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|GLAIVE||Evaluation of Glycemic Variability (GLAIVE)|Study of Glycemic Variability in Post-operative Intensive Care Unit Patients According to Two Insulin Infusion Techniques|Completed||N/A|172|Actual|University Hospital, Lille||2|||f||||t||||||||Undecided||2017-10-10 22:03:14.40166|2017-10-10 22:03:14.40166
NCT02812732|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-06-27|||April 2016||2016-04-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||DOSE HPV: Development of Systems and Education to Improve HPV Vaccination Rates|DOSE HPV: Development of Systems and Education to Improve HPV Vaccination Rates|Enrolling by invitation||N/A|11000|Anticipated|Boston Medical Center||1|||f||||f|f|f||||||No||2017-10-10 22:03:16.058814|2017-10-10 22:03:16.058814
NCT02812914|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-21|||April 2016||2016-04-01|June 2016|2016-06-01||||August 2017|Anticipated|2017-08-01||Interventional|||NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health|NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health|Recruiting||N/A|50|Anticipated|University of California, San Francisco||2|||f||||||||||||||2017-10-10 22:03:14.476175|2017-10-10 22:03:14.476175
NCT02812901|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-08-29|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|TOMIS||Tolerance of Myocardium to Ischemia Injury|Morning / Afternoon Variation in Myocardial Ischemia Tolerance|Completed||N/A|88|Actual|University Hospital, Lille||2|||f||||f|f|f||||||||2017-10-10 22:03:14.58714|2017-10-10 22:03:14.58714
NCT02812888|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-07-05|||July 2016||2016-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01|3 Months|Observational [Patient Registry]|||Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism|Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism|Recruiting||N/A|240|Anticipated|The First People's Hospital of Xuzhou|||2||f||||t||||||Samples Without DNA|"     Plasma samples   "|Yes|The investigators are committed to the open and timely dissemination of the research outcomes. Plans for sharing resources with the scientific community include presentations and publications in peer-reviewed journals. The final data set will be made available to the public upon completion of the study.|2017-10-10 22:03:14.710012|2017-10-10 22:03:14.710012
NCT02812875|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-19|||May 2016||2016-05-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas|A Phase 1, Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered CA-170 in Patients With Advanced Tumors and Lymphomas|Recruiting||Phase 1|300|Anticipated|Curis, Inc.||1|||f||||t||||||||||2017-10-10 22:03:14.958098|2017-10-10 22:03:14.958098
NCT02812862|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-08-08|||August 2016||2016-08-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|CREATES||Cardiac Effects of Fixed-dose Dual Bronchodilator in Patients With Heart Insufficiency and COPD|Cardiac Effects of Fixed-dose Dual Bronchodilator in Patients With Heart Insufficiency and COPD|Recruiting||N/A|100|Anticipated|RWTH Aachen University|||2||f||||f||||||||No||2017-10-10 22:03:15.109197|2017-10-10 22:03:15.109197
NCT02812849|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-26|||June 2016||2016-06-01|September 2017|2017-09-01||||November 2019|Anticipated|2019-11-01||Observational|||Somatostatin Receptor Imaging in Cardiac Sarcoidosis|Somatostatin Receptor Imaging in Cardiac Sarcoidosis|Recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark|||3||f||||f||||||||||2017-10-10 22:03:15.223574|2017-10-10 22:03:15.223574
NCT02812836|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-22|||September 2016||2016-09-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||3D High Resolution Manometry and Balloon Expulsion Test in Diagnosis of Dyssynergic Defecation in Children|3D High Resolution Manometry and Balloon Expulsion Test in Diagnosis of Dyssynergic Defecation in Children|Not yet recruiting||N/A|100|Anticipated|Medical University of Warsaw||1|||f||||f||||||||No||2017-10-10 22:03:15.317722|2017-10-10 22:03:15.317722
NCT02812823|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-06-23|||September 2016||2016-09-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Anorectal Manometry and 3D Manometry in Diagnosis of Functional Disorders in Children|Comparison of High-resolution Anorectal Manometry and 3D High-definition Anorectal Manometry in Diagnosis of Functional Disorders in Children|Not yet recruiting||N/A|100|Anticipated|Medical University of Warsaw||1|||f||||f||||||||No||2017-10-10 22:03:15.424851|2017-10-10 22:03:15.424851
NCT02812810|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-22|||September 2011||2011-09-01|June 2016|2016-06-01||||February 2015|Actual|2015-02-01||Interventional|rTMS TABAC||Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Low-frequency on Craving in Smoking Dependence|Evaluation of the Efficacy of Low-frequency rTMS on Craving in Smoking Dependence: Single-centre Randomized, Controlled Blinded Pilot Study|Completed||N/A|39|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:03:15.515808|2017-10-10 22:03:15.515808
NCT02812797|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01|1 Year|Observational [Patient Registry]|||Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure|Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure|Recruiting||N/A|70|Anticipated|Chongqing Medical University|||1||f||||t||||||||Undecided||2017-10-10 22:03:15.594835|2017-10-10 22:03:15.594835
NCT02812784|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-22|||July 2016||2016-07-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|AKI-CHECK||Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?|Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?|Not yet recruiting||N/A|190|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||Samples Without DNA|"     urine blood   "|||2017-10-10 22:03:15.68859|2017-10-10 22:03:15.68859
NCT02812771|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-04-05|||June 2016||2016-06-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis|A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails|Recruiting||Phase 4|60|Anticipated|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||Yes||2017-10-10 22:03:15.818839|2017-10-10 22:03:15.818839
NCT02812758|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-11-30|||December 2015||2015-12-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|BIS2||Does Sedation Depth (as Evaluated by the Bispectral Index) Influence Dynamic Indices of Preload Dependence?|Does Sedation Depth (as Evaluated by the Bispectral Index) Influence Dynamic Indices of Preload Dependence? An Observational, Single-centre Pilot Study|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire, Amiens|||1|no patients|f||||||||||||||2017-10-10 22:03:15.90982|2017-10-10 22:03:15.90982
NCT02812745|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-11-30|||October 2015||2015-10-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|BIS1||Is the Decrease in the Bispectral Index Correlated With a Decrease in Cardiac Output During the Induction of Anaesthesia?|Is the Decrease in the Bispectral Index Correlated With a Decrease in Cardiac Output During the Induction of Anaesthesia? A Observational, Single-centre Study|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire, Amiens|||1|no patients|f||||||||||||||2017-10-10 22:03:15.976058|2017-10-10 22:03:15.976058
NCT02812719|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-04-26|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel|Comparing the Efficacy and Safety of Combined Glycolic Acid and Salicylic Acid Peel Versus Glycolic Acid Peel Alone in the Treatment of Melasma: A Split Face Study|Not yet recruiting||Early Phase 1|30|Anticipated|Boston Medical Center||2|||f||||f|t|f|||t|||No||2017-10-10 22:03:16.135513|2017-10-10 22:03:16.135513
NCT02812693|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-13|||November 4, 2016|Actual|2016-11-04|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification|A Phase 1/2 Trial of Pembrolizumab in Combination With Imatinib in Patients With Locally Advanced or Metastatic Melanoma With c-KIT Mutation or Amplification|Recruiting||Phase 1/Phase 2|50|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:03:16.337416|2017-10-10 22:03:16.337416
NCT02812680|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-11-08|||June 2016||2016-06-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma|The Utility of Circulating Tumour Cells and Plasma microRNA Detection to Predict the Response to Treatment in Patients With Esophageal Adenocarcinoma|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 22:03:16.450287|2017-10-10 22:03:16.450287
NCT02812667|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-05-03|||August 2016||2016-08-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)|A Phase I Study of Nivolumab in Combination With Escalating Doses of Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|38|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-10 22:03:16.549779|2017-10-10 22:03:16.549779
NCT02812654|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-06-22|||March 2015||2015-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment|The Use of Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Treatment of High-grade Extremity Soft Tissue and Non-metastatic Sarcomas|Recruiting||Phase 2|70|Anticipated|AC Camargo Cancer Center||1|||f||||t||||||||Undecided||2017-10-10 22:03:16.777956|2017-10-10 22:03:16.777956
NCT02812641|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC|A Randomized Trial of Adding Bevacizumab to Neoadjuvant Platinum-Fluorouracil Concurrent Chemoradiation in Locally Advanced Esophageal Squamous Cell Carcinoma|Recruiting||Phase 2|50|Anticipated|National Taiwan University Hospital||3|||f||||t||||||||No||2017-10-10 22:03:16.923822|2017-10-10 22:03:16.923822
NCT02812628|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-21|||December 2012||2012-12-01|June 2016|2016-06-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Conventional Laparoscopic APR Versus Laparoscopic APR With Transabdominal Individualized Levator Transection|Randomized Clinical Trial of Conventional Laparoscopic Abdominoperineal Resection (APR) Versus Laparoscopic APR With Transabdominal Individualized Levator Transection for Low Rectal Cancer|Recruiting||N/A|528|Anticipated|Ruijin Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:03:17.053408|2017-10-10 22:03:17.053408
NCT02812615|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-08-15|||March 7, 2016|Actual|2016-03-07|August 2016|2016-08-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|BEED||The Bangladesh Environmental Enteric Dysfunction Study|Stunting and Bangladesh Environmental Enteric Dysfunction Study|Recruiting||N/A|1575|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||1|||f||||f||||||||||2017-10-10 22:03:17.155751|2017-10-10 22:03:17.155751
NCT02812602|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-06-21|||April 2016||2016-04-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Topical Anesthesia for Removal of Stitches After Total Knee Arthroplasty|Topical Anesthesia With Lidocaine Patch for Removal of Metal Staples After Total Knee Arthroplasty: A Prospective Randomized Trial|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:03:17.290892|2017-10-10 22:03:17.290892
NCT02812589|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-06-23|||April 2016||2016-04-01|June 2016|2016-06-01||||April 2019|Anticipated|2019-04-01||Interventional|||Diffusion Tensor Breast MRI (DTI)|Improving the Specificity of Breast MRI Through Diffusion Tensor Breast MRI (DTI)|Recruiting||N/A|300|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:03:17.388553|2017-10-10 22:03:17.388553
NCT02812576|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-21|||May 2016||2016-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China|Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China---A National, Multi-center, Prospective Observational Study|Recruiting||N/A|150|Anticipated|Health Science Center of Xi’an Jiaotong University|||1||f||||f||||||||Undecided||2017-10-10 22:03:17.486141|2017-10-10 22:03:17.486141
NCT02812563|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-06-23|||November 2014||2014-11-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|AFRIK||Familial Analysis of Keratoconus Risk|Familial Analysis of Keratoconus Risk|Recruiting||N/A|600|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||No||2017-10-10 22:03:17.592566|2017-10-10 22:03:17.592566
NCT02812550|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-21|||May 2015||2015-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Full-spectrum Endoscopy in Colorectal Cancer Screening|Impact of Full-spectrum Endoscopy in Colorectal Cancer Screening: Randomized Controlled Trial|Completed||N/A|249|Actual|Hospital del Río Hortega||2|||f||||f||||||||No||2017-10-10 22:03:17.712799|2017-10-10 22:03:17.712799
NCT02812355|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-05-11|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|RATIO||Randomized Anticoagulation Trial in Opcab (RATIO)|High Dose Versus Low Dose Heparinization in Patients Undergoing Offpump Coronary Artery Bypass|Recruiting||Phase 4|900|Anticipated|Azienda Ospedaliera di Lecco||2|||f||||f||||||||No||2017-10-10 22:03:19.124598|2017-10-10 22:03:19.124598
NCT02812537|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-21|||September 2016||2016-09-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|February 2019|Anticipated|2019-02-01||Observational|TRAJECTORIES||Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior|Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior: Multidisciplinary Approach of Pediatric and Psychiatric Emergencies in the Rhône-Alpes Auvergne Region|Not yet recruiting||N/A|500|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||No||2017-10-10 22:03:17.815386|2017-10-10 22:03:17.815386
NCT02812524|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-06-13|||July 2016||2016-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Ipilimumab for Head and Neck Cancer Patients|Intratumoral Ipilimumab in Head and Neck Cancer|Recruiting||Phase 1|18|Anticipated|Providence Health & Services||1|||f||||f||||||||No||2017-10-10 22:03:17.922503|2017-10-10 22:03:17.922503
NCT02812511|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-21|||June 2015||2015-06-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|COSTELLO||"Pathophysiology Analysis of Costello Syndrome on Cellular Models"|"Pathophysiology Analysis of Costello Syndrome on Cellular Models"|Completed||N/A|9|Actual|University Hospital, Bordeaux||1|||f||||f||||||||No||2017-10-10 22:03:18.042561|2017-10-10 22:03:18.042561
NCT02812498|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-23|||January 2015||2015-01-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|TELEDIAB||Teleconsultation in Type 1 Diabetes Mellitus|Teleconsultation in Type 1 Diabetes Mellitus|Recruiting||N/A|150|Anticipated|Niguarda Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:03:18.126293|2017-10-10 22:03:18.126293
NCT02812472|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-21|||August 2008||2008-08-01|June 2016|2016-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Treadmill Training With Functional Electric Stimulation After Stroke|Treadmill Training With Functional Electric Stimulation in Patients With Chronic Stroke|Completed||N/A|18|Actual|National Yang Ming University||2|||f||||||||||||||2017-10-10 22:03:18.240537|2017-10-10 22:03:18.240537
NCT02812459|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-24|||June 2016||2016-06-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|ELECBACK||Effectiveness of Electrical Stimulation or Kinesio Taping on Recovery Disability in Low Back Pain|Short-term Effectiveness of Additional Electrical Stimulation to Exercise Versus Kinesio Taping in Patients With Chronic Low Back Pain: A Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|62|Anticipated|Universidad de Granada||2|||f||||f||||||||||2017-10-10 22:03:18.33612|2017-10-10 22:03:18.33612
NCT02812446|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-23|||February 2012||2012-02-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|September 2012|Actual|2012-09-01||Observational|||Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development|Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development|Completed||N/A|88|Actual|Nantes University Hospital|||2||f||||f||||||Samples With DNA|"     A total of 57 nonduplicate S. aureus clinical isolates collected from implant-associated     infections (IAI) between January 2007 and December 2010 at Nantes University Hospital     (France) were analyzed. IAI were confirmed using Infectious Diseases Society of America     criteria for bone and joint infections. Thirty-five isolates came from hip arthroplasty, 18     from knee replacement and four from osteosynthesis. Thirty-one S. aureus isolates were     collected from 100 noninfected patients screened for S. aureus nasal colonization from     December 2011 to February 2012 at the orthopedic consultation ward.   "|No||2017-10-10 22:03:18.519595|2017-10-10 22:03:18.519595
NCT02812433|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-08-28|||July 2016||2016-07-01|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|SANE||Sildenafil Administration to Treat Neonatal Encephalopathy|Sildenafil Administration to Treat Neonatal Encephalopathy (SANE) and Repair Brain Injury Secondary to Birth Asphyxia: A Randomized, Double-blind, Placebo-controlled Pilot Phase Ib Study|Recruiting||Phase 1|80|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-10 22:03:18.627416|2017-10-10 22:03:18.627416
NCT02812420|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-10-02|||March 7, 2017|Actual|2017-03-07|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Pre-Surgical Study Evaluating Anti-PD-L1 Antibody (Durvalumab) Plus Anti-CTLA-4 (Tremelimumab) in Patients With Muscle-Invasive, High-Risk Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Neoadjuvant Chemotherapy|A Pilot Pre-Surgical Study Evaluating Anti-PD-L1 Antibody (Durvalumab) Plus Anti-CTLA-4 (Tremelimumab) in Patients With Muscle-Invasive, High-Risk Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Neoadjuvant Chemotherapy|Recruiting||Early Phase 1|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:03:18.719841|2017-10-10 22:03:18.719841
NCT02812407|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-21|||June 2016||2016-06-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||HRIM vs Mucosal Impedance in GERD Participants|Baseline Impedance Measured on High Resolution Esophageal Impedance Manometry to Discriminate GERD From Non GERD Patients|Enrolling by invitation||N/A|40|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 22:03:18.813787|2017-10-10 22:03:18.813787
NCT02812394|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2016-10-24|||June 2016||2016-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets|A Phase 1 Single Dose Pharmacokinetic Bridging Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets|Completed||Phase 1|24|Actual|Acorda Therapeutics||1|||f||||f||||||||||2017-10-10 22:03:18.884083|2017-10-10 22:03:18.884083
NCT02812381|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-08-30|||July 2016||2016-07-01|March 2016|2016-03-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy of Neuromuscular Bandage Technique Against Jones Technique After the Supraespinatus Muscle Tendon Suture|Efficacy of Neuromuscular Bandage Technique Against Jones Technique After the Supraespinatus Muscle Tendon Suture: a Prospective Randomized Clinical Trial|Completed||N/A|36|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||f||||||||Yes|"The investigators would like to share in the magazine Manual Therapy"|2017-10-10 22:03:18.961546|2017-10-10 22:03:18.961546
NCT02812368|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-01-31|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder||Withdrawn||Phase 2|0|Actual|Ohio State University||2||Failure to recruit|f||||f||||||||||2017-10-10 22:03:19.051245|2017-10-10 22:03:19.051245
NCT02812160|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-23|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:03:20.77955|2017-10-10 22:03:20.77955
NCT02812342|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-12-15|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants|Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants|Active, not recruiting||Phase 2|10|Actual|Yale University||1|||f||||t||||||||Undecided||2017-10-10 22:03:19.22975|2017-10-10 22:03:19.22975
NCT02812329|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-02-10|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Intervention to Encourage HIV Testing and Counseling Among Adolescents|Intervention to Encourage HIV Testing and Counseling Among Adolescents|Completed||Phase 1|26|Actual|Yale University||1|||f||||||||||||||2017-10-10 22:03:19.303918|2017-10-10 22:03:19.303918
NCT02812316|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-04-25|||August 2014||2014-08-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|February 2017|Actual|2017-02-01||Interventional|||Study to Evaluate the Safety and Efficacy of HI-BRITE Large Diameter Rigid Gas Permeable Contact Lens|Study to Evaluate the Safety and Efficacy of HI-BRITE Large Diameter Rigid Gas Permeable Contact Lens (Hexafocon b) Test When Worn on a Daily Wear Basis in the Correction of Myopia/Hyperopia/Astigmatism/Presbyopia/ and Irregular Cornea.|Active, not recruiting||N/A|136|Actual|Taipei Medical University Hospital||1|||f||||f||||||||No||2017-10-10 22:03:19.36823|2017-10-10 22:03:19.36823
NCT02812303|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-21|||July 2014||2014-07-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Implementation of a Population Health Chronic Disease Management Program|Implementation of a Population Health Chronic Disease Management Program in a Primary Care Network|Completed||N/A|108000|Actual|Massachusetts General Hospital|||2||f||||f||||||||No||2017-10-10 22:03:19.445354|2017-10-10 22:03:19.445354
NCT02812290|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-07-06|||May 2016||2016-05-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|INTERLUNG||Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation, a Multicenter Study|Multi-Centric Observational Study to Analyze the Diagnostic Molecular Features in the Clinical Setting of Lung Allograft Biopsies.|Recruiting||N/A|350|Anticipated|University of Alberta|||1||f||||f||||||Samples Without DNA|"     Lung transplant biopsies taken as per local standard of care.   "|||2017-10-10 22:03:19.662567|2017-10-10 22:03:19.662567
NCT02812277|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-06-21|||July 2016||2016-07-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Observational|||Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in HR+ Breast Cancer Patients|Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in Adjuvant Treatment of HR+ Early Breast Cancer Patients|Not yet recruiting||N/A|1000|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||2||f||||t||||||||No||2017-10-10 22:03:19.806015|2017-10-10 22:03:19.806015
NCT02812264|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-07-18|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Using an API to Commercialize an Evidence-Based Weight Loss Intervention|Using an API to Commercialize an Evidence-Based Weight Loss Intervention|Recruiting||N/A|206|Anticipated|Coeus Health, LLC||2|||f||||t|f|f||||||||2017-10-10 22:03:19.887508|2017-10-10 22:03:19.887508
NCT02812251|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-12-23|||July 2016||2016-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy Participants|A Randomized, Placebo-controlled, Double-blind, Single Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy Subjects|Completed||Phase 1|80|Actual|Janssen-Cilag International NV||10|||f||||f||||||||||2017-10-10 22:03:20.02659|2017-10-10 22:03:20.02659
NCT02812238|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-23|2017-10-03|||June 10, 2016||2016-06-10|September 20, 2017|2017-09-20|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Study to Evaluate the Effect of Nicotinamide Riboside on Immunity|Study to Evaluate the Effect of Nicotinamide Riboside on Immunity|Recruiting||Phase 2|58|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:03:20.151084|2017-10-10 22:03:20.151084
NCT02812225|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-10-04|||June 2016||2016-06-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Non-blinded Data Collection Study of Concussion Using the BrainPulse(TM)|Non-blinded Data Collection Study of Concussion Using the BrainPulse(TM)|Recruiting||N/A|500|Anticipated|Jan Medical, Inc.||1|||f||||t||||||||No|All primary and secondary outcome measures will be made available within 6 months of study completion.|2017-10-10 22:03:20.258111|2017-10-10 22:03:20.258111
NCT02812212|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-01-17|||June 2017||2017-06-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|JUMP||CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome|Cortical Transit Time on Diuretic Renogram as an Early Marker of Significant Obstruction in Antenatally Detected Uretero-pelvic Junction Syndrome|Not yet recruiting||N/A|75|Anticipated|Centre Hospitalier Universitaire de la Réunion||1|||f||||f||||||||No||2017-10-10 22:03:20.36208|2017-10-10 22:03:20.36208
NCT02812199|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-04-30|||August 2016||2016-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Post-FESS Implantation of Composite Removable Sinus Stent to Prevent Post-Operative Complications|Efficacy of Post-FESS Implantation of Composite Removable Sinus Stent System to Prevent Post-Operative Complications and Revision Surgery|Recruiting||N/A|30|Anticipated|STS Medical||3|||f||||f|f|f|||f|||Undecided||2017-10-10 22:03:20.453325|2017-10-10 22:03:20.453325
NCT02812186|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-04-06|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery|Effect of Deep Versus Moderate Neuromuscular Blockade on Peak Airway Pressures During Elective Laparoscopic Surgery|Recruiting||Phase 4|60|Anticipated|Stony Brook University||2|||f||||f||||||||Undecided|Fully analyzed results may be shared with Merck Investigator Studies Program personnel after the study has completed|2017-10-10 22:03:20.586284|2017-10-10 22:03:20.586284
NCT02812173|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-07-21|||May 2016||2016-05-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|MPH||Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP|Prospective, Randomized, Three-arm, Open Controlled Trial Comparing the Quality of Micturition and the Patient Comfort by Various Urinary Drainage After Robot-assisted Radical Prostatectomy (RARP)|Recruiting||N/A|201|Anticipated|St. Antonius Hospital Gronau||3|||f||||f||||||||No||2017-10-10 22:03:20.68766|2017-10-10 22:03:20.68766
NCT02812147|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-06-19|||May 2016||2016-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease|Effect of L-Dihydoxyphenylserine (L-DOPS, Northera) a Central and Peripheral Norepinephrine Agent on Locomotion, Postural Stability (Balance), and Fall Risk Reduction in Parkinson Disease (PD)|Recruiting||Phase 2|20|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||f||||||||No||2017-10-10 22:03:20.820263|2017-10-10 22:03:20.820263
NCT02812134|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-21|||June 2015||2015-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|IPSAASU||Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition.|Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition.|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:03:20.922309|2017-10-10 22:03:20.922309
NCT02812121|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-21|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure|Umbilical Cord Blood Derived Mesenchymal Stem Cells Infusion for HBV-Related Acute-on-Chronic Liver Failure: A Randomized Controlled Trial|Not yet recruiting||Phase 2|261|Anticipated|Sun Yat-sen University||3|||f||||t||||||||Undecided||2017-10-10 22:03:21.001601|2017-10-10 22:03:21.001601
NCT02812108|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-04-27|||August 2016||2016-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|HARET||Hemodynamic Analysis for Intracranial Aneurysms Recanalization After Endovascular Treatment|Investigation of Clinical and Hemodynamic Factors Affecting the Outcome of Intracranial Aneurysm Embolization|Recruiting||N/A|200|Anticipated|Beijing Neurosurgical Institute|||1||f||||||||||Samples With DNA|"     whole blood   "|||2017-10-10 22:03:21.083787|2017-10-10 22:03:21.083787
NCT02812082|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-09-13|||June 2016||2016-06-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|||Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant|Developing and Assessing the Feasibility of Implementing a Video Web-based Patient Education Application|Withdrawn||N/A|0|Actual|Memorial Sloan Kettering Cancer Center||1||The PI is leaving MSK.|f||||||||||||||2017-10-10 22:03:21.262985|2017-10-10 22:03:21.262985
NCT02812069|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-12-12|||September 2015||2015-09-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||WarmSmart Warming Protocol|WarmSmart Warming Protocol|Completed||N/A|10|Actual|The Cleveland Clinic||1|||f||||f||||||||No||2017-10-10 22:03:21.358647|2017-10-10 22:03:21.358647
NCT02812056|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-03-24|||September 2016||2016-09-01|March 2017|2017-03-01||||September 2021|Anticipated|2021-09-01||Interventional|||Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies|A Phase I Study of Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:03:21.480375|2017-10-10 22:03:21.480375
NCT02812043|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-03|||August 2016||2016-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis|Comparison of the Efficacy and Safety Between Long-pulsed Nd:YAG, Amorolfine and Combination of Long-pulsed Nd:YAG and Amorolfine in Treating Non-dermatophyte and Mixed-infection Onychomycosis|Recruiting||Phase 4|60|Anticipated|Mahidol University||3|||f||||t||||||||||2017-10-10 22:03:21.577029|2017-10-10 22:03:21.577029
NCT02812030|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-05-02|||September 2016||2016-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|ARRoW||Aflibercept for Retinopathy in the Real World|Aflibercept for Retinopathy in the Real World (ARRoW) Study: Evaluation of Anti-VEGF Treatment for Diabetic Macular Oedema|Withdrawn||N/A|0|Actual|University of Bristol|||1|Superceded by a larger trial by the pharmaceutical company|f||||f||||||||No||2017-10-10 22:03:21.675045|2017-10-10 22:03:21.675045
NCT02812017|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-06-22|||June 2016||2016-06-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|TMW-WB||Thirty Million Words- Well Baby Initiative|Randomized Controlled Trial of a Novel Pediatric Educational Video Intervention: Thirty Million Words-Well Baby|Recruiting||N/A|1000|Anticipated|University of Chicago||3|||f||||f||||||||||2017-10-10 22:03:21.753604|2017-10-10 22:03:21.753604
NCT02812004|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|Ellex||New Horizons in the Treatment of Vitreous Floaters|New Horizons in the Treatment of Vitreous Floaters: Efficacy and Safety of Vitreolysis With the Ultra Q Reflex YAG Laser (Ellex)|Not yet recruiting||Phase 4|30|Anticipated|Augenabteilung Allgemeines Krankenhaus Linz||2|||f||||f||||||||Yes||2017-10-10 22:03:21.849598|2017-10-10 22:03:21.849598
NCT02811991|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia|A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia—Multicentered, Randomized, Double-blind, Placebo-controlled Clinical Trial|Recruiting||Phase 2/Phase 3|348|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 22:03:21.931474|2017-10-10 22:03:21.931474
NCT02811978|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-21|||September 27, 2016|Actual|2016-09-27|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma|A Phase 3, Randomized, Open-label Study of Subcutaneous and Intravenous VELCADE in Combination With Dexamethasone in Chinese Subjects With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 3|120|Anticipated|Janssen Research & Development, LLC||2|||f||||f||f||||||||2017-10-10 22:03:22.070048|2017-10-10 22:03:22.070048
NCT02811965|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-02-06|||June 2016||2016-06-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of Heel Offloading Devices for Reducing Heel Contact Pressures in Healthy Volunteers|Evaluation of Heel Offloading Devices for Reducing Heel Contact Pressures in Healthy Volunteers|Completed||N/A|21|Actual|DeRoyal Industries, Inc.||1|||f||||f||||||||No||2017-10-10 22:03:22.199494|2017-10-10 22:03:22.199494
NCT02811952|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-23|||July 2016||2016-07-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients|Measuring Urinary Nano Particles and Arsenic and Comparing Them to Cystoscopic Findings and Urinary Cytology in Patients Suspected With Urinary Bladder Malignancy|Not yet recruiting||N/A|600|Anticipated|Carmel Medical Center|||2||f||||f||||||Samples Without DNA|"     A urine sample   "|Undecided||2017-10-10 22:03:22.277944|2017-10-10 22:03:22.277944
NCT02811939|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-21|||March 2016||2016-03-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|THC-PREG-I||Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I|Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I|Recruiting||Phase 1|19|Anticipated|Yale University||4|||f||||f||||||||||2017-10-10 22:03:22.337973|2017-10-10 22:03:22.337973
NCT02811926|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-10-04|||July 2016||2016-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Incidence and Risk Factors of Parastomal Bulging in Patients With Ileostomy or Colostomy|Incidence and Risk Factors of Parastomal Bulging in Patients With Ileostomy or Colostomy: a Register-based Study|Completed||N/A|5019|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||No||2017-10-10 22:03:22.439482|2017-10-10 22:03:22.439482
NCT02811913|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-05-23|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Can rTMS Enhance Somatosensory Recovery After Stroke?|Can rTMS Enhance Somatosensory Recovery After Stroke?|Recruiting||N/A|30|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||Undecided||2017-10-10 22:03:22.499977|2017-10-10 22:03:22.499977
NCT02811900|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-10-26|||January 1996||1996-01-01|October 2016|2016-10-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01|30 Years|Observational [Patient Registry]|ChirBar||An Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study|An Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study Internal Hernia After Laparoscopic Roux-en-Y Gastric Bypass: an Evaluation of the Impact on the Postoperative Course and a Quality of Life Case-control Study|Recruiting||N/A|10000|Anticipated|IHU Strasbourg|||1||f||||f||||||||No||2017-10-10 22:03:22.585764|2017-10-10 22:03:22.585764
NCT02811887|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-11-29|||August 2016||2016-08-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SMILE||SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy|A Randomized, Pragmatic, Outcome-assessor-blinded Study of an SMS-message-based Lifestyle Intervention in Patients With Decompensated Liver Cirrhosis|Recruiting||N/A|40|Anticipated|Frederiksberg University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:03:22.679882|2017-10-10 22:03:22.679882
NCT02811874|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-06-22|||February 2009||2009-02-01|June 2016|2016-06-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Community Health Workers and Diabetes Education|Efficacy of Community Health Workers Education in Diabetes Control: A Randomized Clinical Trial|Completed||N/A|118|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:03:22.789023|2017-10-10 22:03:22.789023
NCT02811861|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-24|||October 13, 2016|Actual|2016-10-13|July 2017|2017-07-01|January 15, 2020|Anticipated|2020-01-15|October 15, 2019|Anticipated|2019-10-15||Interventional|||Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma|A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma.|Recruiting||Phase 3|735|Anticipated|Eisai Inc.||3|||f||||t||||||||||2017-10-10 22:03:23.008086|2017-10-10 22:03:23.008086
NCT02811848|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-05-03|||May 9, 2016|Actual|2016-05-09|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Recruiting African American Fathers/ Sons|Pilot Feasibility Study: Recruiting African American Fathers and Their Adolescent Sons for Qualitative, Sexual Health Research|Completed||N/A|28|Actual|Duke University|||1||f||||f||||||||Undecided||2017-10-10 22:03:23.159263|2017-10-10 22:03:23.159263
NCT02811835|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-17|||November 2008|Actual|2008-11-01|August 2017|2017-08-01|November 2028|Anticipated|2028-11-01|May 2011|Actual|2011-05-01|20 Years|Observational [Patient Registry]|TxL-FN||TransplantLines Food and Nutrition Biobank and Cohort Study (TxL-FN)|Renal Sensing of the Acidifying Effect of Sulphur-containing Amino Acids: Consequences for the Relation Between Protein Intake and Blood Pressure in Renal Transplant Recipients|Active, not recruiting||N/A|1007|Actual|University Medical Center Groningen|||2||f||||f||||||Samples Without DNA|"     Serum and EDTA plasma stored at -80 degrees Centigrade Vials from 24h urine samples stored at     -80 degrees Centigrade   "|||2017-10-10 22:03:23.252181|2017-10-10 22:03:23.252181
NCT02811822|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-02-08|||June 2016|Actual|2016-06-01|February 2017|2017-02-01||||July 2018|Anticipated|2018-07-01||Interventional|||A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma|A Phase I Open-Label Dose Escalation Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care Chemotherapy for the Treatment of Multiple Myeloma|Recruiting||Phase 1|48|Anticipated|GlycoMimetics Incorporated||4|||f||||t||||||||No||2017-10-10 22:03:23.33058|2017-10-10 22:03:23.33058
NCT02811809|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-02|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer|Apalutamide Plus Intermittent Hormone Therapy (IHT) Versus IHT Alone in Prostate Cancer Patients With Biochemical Recurrence|Not yet recruiting||Phase 2|66|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t|t|f||||||||2017-10-10 22:03:23.470986|2017-10-10 22:03:23.470986
NCT02811796|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-03|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|July 2022|Anticipated|2022-07-01|July 2018|Anticipated|2018-07-01||Observational|HAWKEYE||Angio-based Flow Fractional Reserve to Predict Adverse Events After Stent Implantation|Prospective Validation of the Angio-based Flow Fractional Reserve (QFR) System to Discriminate Patients at Risk of Adverse Events After Stent Implantation.|Active, not recruiting||N/A|602|Actual|University Hospital of Ferrara|||1||f||||t|f|f||||||||2017-10-10 22:03:23.590079|2017-10-10 22:03:23.590079
NCT02811783|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-10-04|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|||Naloxone Hydrochloride Study for Relief of Pruritus in Patients With Mycosis Fungoides (MF) Form of CTCL|A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF Form of Cutaneous T-Cell Lymphoma (CTCL)|Recruiting||Phase 3|160|Anticipated|Elorac, Inc.||2|||f||||f||||||||||2017-10-10 22:03:23.679173|2017-10-10 22:03:23.679173
NCT02811770|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-07-15|||June 2016||2016-06-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Observational|||Interest to Perform a Renal Biopsy Early in the Course of the Henoch-Schoenlein Nephritis|Interest to Perform a Renal Biopsy Early in the Course of the Henoch-Schoenlein Nephritis|Recruiting||N/A|300|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 22:03:23.87068|2017-10-10 22:03:23.87068
NCT02811757|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-23|||December 2013||2013-12-01|June 2016|2016-06-01||||December 2019|Anticipated|2019-12-01||Interventional|||Clinical Outcomes After Arthroscopic Tenotomy or Tenodesis of the Long Head of the Biceps|Clinical Outcomes After Arthroscopic Tenotomy or Tenodesis of the Long Head of the Biceps|Recruiting||N/A|100|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 22:03:23.957815|2017-10-10 22:03:23.957815
NCT02811744|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-06-19|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|June 2024|Anticipated|2024-06-01|June 2021|Anticipated|2021-06-01||Interventional|||11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation|11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation|Recruiting||Phase 2|20|Anticipated|University of Pennsylvania||2|||f||||f||||||||Undecided||2017-10-10 22:03:24.057658|2017-10-10 22:03:24.057658
NCT02811731|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-21|||April 2015||2015-04-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B|A Randomized, Open-label, Single-dosing, 2x2 Crossover Study to Compare the Safety and Pharmacokinetics of CKD-330(Fixed-dose Combination of Candesartan 16 mg and Amlodipine 5 mg) With Coadministration of the Two Separate Drugs in Healthy Male Volunteers (B)|Completed||Phase 1|32|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:03:24.156878|2017-10-10 22:03:24.156878
NCT02811718|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-04-02|||July 2016||2016-07-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Resiliency Training for Patients With NF2 Via Videoconferencing With Skype|Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype|Recruiting||N/A|100|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:03:24.245984|2017-10-10 22:03:24.245984
NCT02811705|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-22|||July 2015||2015-07-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|PFAPA||Life Quality Study for PFAPA Patient||Recruiting||N/A|100|Anticipated|Versailles Hospital|||2||f||||f||||||||||2017-10-10 22:03:24.357959|2017-10-10 22:03:24.357959
NCT02811692|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-20|||September 30, 2016|Actual|2016-09-30|July 2017|2017-07-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Observational|CODEX||Study for Collection of Aflibercept Data in Routine Practice|CODEX:Collection of Aflibercept Data in Routine Practice|Active, not recruiting||N/A|2000|Anticipated|Bayer|||1||f||||f|t|f|||f|||||2017-10-10 22:03:24.442093|2017-10-10 22:03:24.442093
NCT02811679|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-25|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma|A Phase II Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma|Recruiting||Phase 2|28|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:03:24.561703|2017-10-10 22:03:24.561703
NCT02811666|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-21|||November 2016||2016-11-01|June 2016|2016-06-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|A15-10||Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers|Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers|Not yet recruiting||N/A|200|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:03:24.702793|2017-10-10 22:03:24.702793
NCT02811653|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-22|||December 2015||2015-12-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TAMA||Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease|Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease|Recruiting||N/A|155|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 22:03:24.803193|2017-10-10 22:03:24.803193
NCT02811640|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-17|||June 30, 2016|Actual|2016-06-30|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Intra-abdominal Pressure in Peritoneal Dialysis Patients|Development of a Simplified Method to Measure Intra-abdominal Pressure in Peritoneal Dialysis Patients|Recruiting||N/A|10|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-10 22:03:24.900709|2017-10-10 22:03:24.900709
NCT02811627|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-10-02|||June 2016||2016-06-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy|Predicting Treatment Response to Memantine in Autism Spectrum Disorder Using MR Spectroscopy|Recruiting||Early Phase 1|25|Anticipated|University of Missouri-Columbia||1|||f||||||||||||||2017-10-10 22:03:24.98595|2017-10-10 22:03:24.98595
NCT02811614|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-08-11|||August 2016||2016-08-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|MISICH||Minimally-invasive Surgery Versus Craniotomy in Patients With Supratentorial Hypertensive Intracerebral Hemorrhage|Minimally-invasive Surgery Versus Craniotomy in Patients With Supratentorial Hypertensive Intracerebral Hemorrhage: A Multi-center Randomized Controlled Trial|Recruiting||N/A|900|Anticipated|Chinese PLA General Hospital||3|||f||||t||||||||Yes||2017-10-10 22:03:25.127878|2017-10-10 22:03:25.127878
NCT02811601|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-12-15|||June 2016||2016-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Percutaneous Externally-Assembled Laparoscopic Urologic Surgery|A Prospective Study of Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Urologic Surgery|Recruiting||N/A|100|Anticipated|Loma Linda University||1|||f||||f||||||||Undecided||2017-10-10 22:03:25.243995|2017-10-10 22:03:25.243995
NCT02811016|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-10-13|||June 2016||2016-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Inhaled Budesonide and Acute Mountain Sickness|Effect of Inhaled Budesonide on the Incidence and Severity of Acute Mountain Sickness at 4559 m|Completed||Phase 1|51|Actual|Salzburger Landeskliniken||3|||f||||f||||||||No||2017-10-10 22:03:29.846771|2017-10-10 22:03:29.846771
NCT02811588|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-02-17|||July 2016||2016-07-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01|6 Months|Observational [Patient Registry]|HOmeVent||Registry of Stable Hypercapnic Chronic Obstructive Pulmonary Disease Treated With Non-Invasive Ventilation|Registry of Stable Hypercapnic Chronic Obstructive Pulmonary Disease Treated With Non-Invasive Ventilation - HOmeVent Registry|Recruiting||N/A|200|Anticipated|ResMed|||4||f||||f||||||||No||2017-10-10 22:03:25.340016|2017-10-10 22:03:25.340016
NCT02811575|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-04-14|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|SIMMUNIDIA||Type 2 Diabetes and Alteration of Immune System of Intestinal Mucosa : Proof of Concept|Type 2 Diabetes and Alteration of Immune System of Intestinal Mucosa : Proof of Concept|Recruiting||N/A|135|Anticipated|University Hospital, Toulouse|||2||f||||f||||||Samples Without DNA|"     Ileon and colon biopsy   "|No||2017-10-10 22:03:25.437825|2017-10-10 22:03:25.437825
NCT02811562|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-26|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Learning Curves of Intubation for Simulated Difficult Airway Scenarios by Manikin: Comparison of Combined Pentax Airwayscope-fiberoptic Bronchoscope and Fiberoptic Bronchoscope Alone||Recruiting||N/A|20|Anticipated|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 22:03:25.531945|2017-10-10 22:03:25.531945
NCT02811549|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss|Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss|Recruiting||N/A|10|Anticipated|Advanced Bionics||1|||f||||f||||||||||2017-10-10 22:03:25.619218|2017-10-10 22:03:25.619218
NCT02811536|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-05-01|||February 13, 2017|Actual|2017-02-13|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)|Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)|Recruiting||N/A|550|Anticipated|University Hospital Inselspital, Berne|||8||f||||f||||||||No||2017-10-10 22:03:25.733763|2017-10-10 22:03:25.733763
NCT02811523|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-05-04|||February 2016||2016-02-01|May 2017|2017-05-01|February 2024|Anticipated|2024-02-01|February 2024|Anticipated|2024-02-01||Interventional|||In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma|In Vivo Lung Perfusion (IVLP) as an Adjuvant Treatment for Patients Undergoing Surgical Resection of Pulmonary Metastases of Bone and Soft Tissues Sarcomas|Recruiting||Phase 1|11|Anticipated|University Health Network, Toronto||8|||f||||f|f|f|||f|||No||2017-10-10 22:03:25.8384|2017-10-10 22:03:25.8384
NCT02811510|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-02-22|||June 2016||2016-06-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|THC-Gender-I||Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I|Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I|Recruiting||Phase 1|40|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 22:03:25.935596|2017-10-10 22:03:25.935596
NCT02811497|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-09-19|||September 2016||2016-09-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|July 2021|Anticipated|2021-07-01||Interventional|METADUR||Study of Azacitidine and Durvalumab in Advanced Solid Tumors|An Open-label, Phase II Basket Study of a hypoMEThylating Agent Oral Azacitidine and DURvalumab (MEDI4736) (Anti-PDL1) in Advanced Solid Tumors (METADUR)|Recruiting||Phase 2|60|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 22:03:26.041593|2017-10-10 22:03:26.041593
NCT02811484|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-03-01|||June 2016||2016-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|Dexlar||Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes|Efficacy of Exenatide-LAR Alone and in Combination With Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Uncontrolled Type 2 Diabetes|Withdrawn||Phase 4|0|Actual|Weill Medical College of Cornell University||3||"Inability to enroll due to the widespread use of both classes of drugs in patients with T2DM,   including those on concomitant insulin therapy."|f||||f||||||||No||2017-10-10 22:03:26.13642|2017-10-10 22:03:26.13642
NCT02811458|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-05-08|||September 12, 2016|Actual|2016-09-12|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|T-CBT||Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders|A Pragmatic Randomized Controlled Trial of Group Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders in Primary Care|Recruiting||N/A|211|Anticipated|Université de Sherbrooke||2|||f||||t||||||||No||2017-10-10 22:03:26.229216|2017-10-10 22:03:26.229216
NCT02811432|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-21|||January 2017||2017-01-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|OMWaNA||Kangaroo Mother Care Among Unstable Low Birth Weight Neonates in Africa|The OMWaNA Study: Operationalizing Kangaroo Mother Care Among Unstable Low Birth Weight Neonates in Africa: a Randomized Controlled Trial to Examine Impact on Mortality in Uganda|Not yet recruiting||N/A|460|Anticipated|University of California, San Francisco||2|||f||||t||||||||Yes|LSHTM Data Compass|2017-10-10 22:03:26.398108|2017-10-10 22:03:26.398108
NCT02811419|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-01-27|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||I-scan for Adenoma Detection|I-scan Versus Standard High-Definition White Light for the Detection of Adenomatous Polyps|Recruiting||N/A|1000|Anticipated|University of California, San Francisco||2|||f||||f|f|t|f|f||||No||2017-10-10 22:03:26.468685|2017-10-10 22:03:26.468685
NCT02811406|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-21|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites|The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites|Recruiting||N/A|100|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||No||2017-10-10 22:03:26.545073|2017-10-10 22:03:26.545073
NCT02811393|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-21|||June 2016||2016-06-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|FUBA||Muscle Assessment in Women Who Have Undergone Roux-en-Y Gastric Bypass Surgery|Assessment of the Muscle Function Test in Women Who Have Undergone Roux-en-Y Gastric Bypass Surgery|Recruiting||N/A|26|Anticipated|University of Chile|||2||f||||f||||||Samples Without DNA|"     serum, urine.   "|No||2017-10-10 22:03:26.629982|2017-10-10 22:03:26.629982
NCT02811380|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-06-21|||September 2013||2013-09-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||BIP CVC Clinical Safety and Performance Study|Evaluation of Safety and Performance of the BIP Central Venous Catheter With Anti-infective Coating|Completed||Phase 4|36|Actual|Bactiguard AB||2|||f||||t||||||||No||2017-10-10 22:03:26.733038|2017-10-10 22:03:26.733038
NCT02811367|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-10-14|||June 2016||2016-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The HPV Self-test as a Test of Cure in Madagascar|The HPV Self-test as a Test of Cure in the Follow-up of HPV-positive Women in Madagascar|Completed||N/A|117|Actual|University Hospital, Geneva||1|||f||||f||||||||Undecided||2017-10-10 22:03:26.809693|2017-10-10 22:03:26.809693
NCT02811354|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-21|||February 24, 2017|Actual|2017-02-24|July 2017|2017-07-01|February 24, 2020|Anticipated|2020-02-24|February 24, 2019|Anticipated|2019-02-24||Interventional|PLASMA||Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA|Phase II Study of AZD9291 in Patients With Advanced Stage Non-small Cell Lung Cancer Following Prior EGFR TKI Therapy With EGFR and T790M Mutations Detected in Plasma Circulating Tumor DNA (PLASMA)|Recruiting||Phase 2|108|Anticipated|National University Hospital, Singapore||1|||f||||t|f|f||||||||2017-10-10 22:03:26.881062|2017-10-10 22:03:26.881062
NCT02811341|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-21|||August 2014||2014-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||The Application of Spasmolytic in PCLE Examination of Superior Gastrointestinal Endoscope|A Clinical Analysis of Scopolamine Hydrobromide in Probe-based Confocal Laser Endomicroscopy for Gastroendoscopy Examination|Completed||Phase 1|122|Actual|Shandong University||2|||f||||t||||||||No||2017-10-10 22:03:26.967484|2017-10-10 22:03:26.967484
NCT02811328|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-08-29|||May 2016||2016-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:03:27.035194|2017-10-10 22:03:27.035194
NCT02811315|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-21|||July 2016||2016-07-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Observational|||Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.|Flutiform Treatment in Patients With Asthma in Daily Clinical Practice; a Prospective Observational Non-interventional Study Assessing the Effect of Space Use and Adherence on Fluticasone/Formoterol FDC Efficacy Measured With the Asthma Control Questionnaire (ACQ-6).|Not yet recruiting||N/A|250|Anticipated|Mundipharma Pharmaceuticals B.V.|||1||f||||f||||||||Undecided||2017-10-10 22:03:27.07924|2017-10-10 22:03:27.07924
NCT02811302|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-10-02|||April 7, 2017|Actual|2017-04-07|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|PRODIGY||PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphY|PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphY (PRODIGY)|Recruiting||N/A|1650|Anticipated|Medtronic - MITG||1|||f||||f|f|t|f|f|f|||||2017-10-10 22:03:27.139426|2017-10-10 22:03:27.139426
NCT02811289|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-05-30|||August 5, 2016|Actual|2016-08-05|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GB6||Pharmacological Activation of Brown Adipose Tissue Metabolism|Pharmacological or Cold-induced Activation of Brown Adipose Tissue Metabolism|Recruiting||N/A|10|Anticipated|Université de Sherbrooke||2|||f||||||||||||||2017-10-10 22:03:27.425709|2017-10-10 22:03:27.425709
NCT02811276|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-08-09|||October 2016||2016-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Impact of a High Protein Diet on Substrate Oxidation and Energy Metabolism|A Randomized, Controlled, Cross-over Trial Investigating the Impact of a High Protein Diet on Substrate Oxidation and Energy Metabolism in Healthy Women|Recruiting||N/A|24|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 22:03:27.581383|2017-10-10 22:03:27.581383
NCT02811263|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-09-13|||January 2017||2017-01-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|June 2022|Anticipated|2022-06-01||Interventional|HEAL||High-dose Erythropoietin for Asphyxia and Encephalopathy|High-dose Erythropoietin for Asphyxia and Encephalopathy|Recruiting||Phase 3|500|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:03:27.694818|2017-10-10 22:03:27.694818
NCT02811250|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-05-29|||May 2010||2010-05-01|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|September 2017|Anticipated|2017-09-01||Interventional|RSR-1||Stereotactic Radiotherapy for Renal Cancers|Stereotactic Radiotherapy for Renal Cancers: Phase I Study|Recruiting||Phase 1|24|Anticipated|Hospices Civils de Lyon||4|||f||||t||||||||||2017-10-10 22:03:28.023133|2017-10-10 22:03:28.023133
NCT02811237|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-06-23|||January 2017||2017-01-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|HOME-PE||Hospitalization or Out-treatment ManagEment of Patients With Pulmonary Embolism: a Randomized Controlled Trial|Criteria for Hospitalization or Outpatient Management of Patients With Pulmonary Embolism, Hestia Rule Versus Simplified PESI Score : an Open-label Controlled Randomized International Trial (HOME-PE)|Recruiting||N/A|1975|Anticipated|University Hospital, Angers||2|||f||||t||||||||||2017-10-10 22:03:28.144765|2017-10-10 22:03:28.144765
NCT02811224|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-09-05|||May 2016||2016-05-01|September 2017|2017-09-01||||June 2018|Anticipated|2018-06-01||Observational|||Ovarian Cancer Hemoscope Trial||Enrolling by invitation||N/A|50|Anticipated|Scripps Translational Science Institute|||2||f||||f||||||||||2017-10-10 22:03:28.391955|2017-10-10 22:03:28.391955
NCT02811211|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-03-03|||February 2016||2016-02-01|February 2017|2017-02-01|January 6, 2017|Actual|2017-01-06|January 6, 2017|Actual|2017-01-06||Observational|||A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD|A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|1894|Actual|Aevi Genomic Medicine|||1||f||||f||||||Samples With DNA|"     Saliva   "|Undecided||2017-10-10 22:03:28.450697|2017-10-10 22:03:28.450697
NCT02811198|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-10-04|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Pain, Reward, Attention and Neurocircuitry: Biomarkers of Suicidality|Pain, Reward, Attention and Neurocircuitry: Biomarkers of Suicidality|Recruiting||N/A|120|Anticipated|St. Michael's Hospital, Toronto|||4||f||||||||||Samples With DNA|"     Blood samples will be collected for genetic and proteomic analysis. Saliva samples will be     collected to measure cortisol levels.   "|||2017-10-10 22:03:28.533457|2017-10-10 22:03:28.533457
NCT02811185|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-05-01|||June 2016||2016-06-01|May 2017|2017-05-01|January 30, 2017|Actual|2017-01-30|January 2017|Actual|2017-01-01||Interventional|||Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose|An Open-label, Non-randomized Study to Monitor for Adverse Drug Reactions Among Patients Administered Fedoruk-manufactured [F-18]-FDG Injection|Completed||Phase 4|1012|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-10 22:03:28.639809|2017-10-10 22:03:28.639809
NCT02811172|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-20|||May 2016||2016-05-01|June 2016|2016-06-01||||August 2017|Anticipated|2017-08-01||Observational|BECOME||BEhavior of Biomarkers During pregnanCy and lactatiOn Through a Biological Multi-paradigm modEl. BECOME Study Protocol|BEhavior of Biomarkers During pregnanCy and lactatiOn Through a Biological Multi-paradigm modEl. BECOME Study Protocol|Recruiting||N/A|224|Anticipated|Universidad de Granada|||2||f||||t||||||Samples Without DNA|"     Triglycerides; Cholesterol; Prolactin; Glucose; Human Milk.   "|||2017-10-10 22:03:28.739586|2017-10-10 22:03:28.739586
NCT02811159|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2017-07-25|||June 2016||2016-06-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids|An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids|Terminated||Phase 2|26|Actual|Repros Therapeutics Inc.||1||Business decision|f||||||||||||||2017-10-10 22:03:28.847069|2017-10-10 22:03:28.847069
NCT02811146|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-08-23|||July 2016||2016-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Cardiac Rehabilitation and Noninvasive Ventilation in Heart Failure||Recruiting||N/A|30|Anticipated|Universidade Federal de Pernambuco||6|||f||||t||||||||||2017-10-10 22:03:28.932759|2017-10-10 22:03:28.932759
NCT02811133|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-08-22|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder|Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|University of Pittsburgh||1|||f||||t|t|f||||||||2017-10-10 22:03:29.054685|2017-10-10 22:03:29.054685
NCT02811107|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-22|||March 2016||2016-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|April 2016|Actual|2016-04-01||Observational|ASDT||Evaluation of Anxiety in Surgery Preoperative Area (ASDT)|Evaluation of Anxiety in Surgery Preoperative Area (ASDT)|Active, not recruiting||N/A|1000|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:03:29.255725|2017-10-10 22:03:29.255725
NCT02811094|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-02|||November 9, 2016|Actual|2016-11-09|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Interventional|LUMIER²||LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse|LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse|Recruiting||N/A|300|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:03:29.331399|2017-10-10 22:03:29.331399
NCT02811081|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effective Maneuver for Post-laparoscopic Shoulder Pain|The Effective Maneuver to Reduce Shoulder Pain After Laparoscopic Gynecologic Surgery: Randomized Controlled Trial|Recruiting||Phase 3|144|Anticipated|Kangbuk Samsung Hospital||3|||f||||f||||||||Undecided||2017-10-10 22:03:29.42781|2017-10-10 22:03:29.42781
NCT02811055|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-21|||July 13, 2017|Actual|2017-07-13|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|APHOS-02||Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin|Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin|Recruiting||Phase 2|20|Anticipated|University Hospital, Rouen||2|||f||||f|f|f||||||||2017-10-10 22:03:29.607102|2017-10-10 22:03:29.607102
NCT02811042|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-20|||July 2016||2016-07-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Ambu AuraOnce Versus Ambu AuraGain LM in Children|Laryngeal Mask Ambu AuraOnce Versus Laryngeal Mask Ambu AuraGain in Non-paralysed, Anesthetized Children: A Randomized, Crossover Study Assessing Oropharyngeal Leak Pressure and Fiberoptic Position|Not yet recruiting||N/A|60|Anticipated|Schulthess Klinik||2|||f||||f||||||||No||2017-10-10 22:03:29.702054|2017-10-10 22:03:29.702054
NCT02811029|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-08-29|||July 2016||2016-07-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|LAMOPRESCO2||Language and Motricity in Preterm School Age Children|Language and Motricity in Preterm School Age Children|Recruiting||N/A|165|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 22:03:29.770958|2017-10-10 22:03:29.770958
NCT02810990|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-08-31|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|BEST||Bosutinib in Elderly Chronic Myeloid Leukemia|Bosutinib Efficacy, Safety, Tolerability (BEST) Study in Elderly Chronic Myeloid Leukemia Patients Failing Front-line Treatment With Other Tyrosine Kinase Inhibitors|Recruiting||Phase 2|65|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||t||||||||||2017-10-10 22:03:30.029876|2017-10-10 22:03:30.029876
NCT02810977|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-03-21|||June 2016||2016-06-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||Ultrasound Assessment of Gastric Content and Volume|Ultrasound Assessment of Gastric Content and Volume After Complete Fasting in Patients Undergoing Surgery at Two University Hospitals: A Multicentric Study|Completed||N/A|1000|Actual|Fundación Santa Fe de Bogota|||1||f||||t||||||||Yes||2017-10-10 22:03:30.322386|2017-10-10 22:03:30.322386
NCT02810964|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-09-07|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Sulforaphane to Reduce Symptoms of Schizophrenia|A Double-Blind Placebo-Controlled Trial of a Sulforaphane Nutraceutical to Reduce the Symptoms of Schizophrenia|Enrolling by invitation||Phase 2|64|Anticipated|Sheppard Pratt Health System||2|||f||||t|t|f||||||||2017-10-10 22:03:30.479257|2017-10-10 22:03:30.479257
NCT02810951|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-06-19|||July 1, 2016|Actual|2016-07-01|June 2017|2017-06-01|August 2033|Anticipated|2033-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)|A Phase I/II Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa (RDEB)|Recruiting||Phase 1/Phase 2|12|Anticipated|Fibrocell Technologies, Inc.||1|||f||||t||||||||No||2017-10-10 22:03:30.600837|2017-10-10 22:03:30.600837
NCT02810938|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-23|||October 2016||2016-10-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01|6 Months|Observational [Patient Registry]|MIFI||MIFI Flutter Registry - Ablation of Atrial Flutter With IntellaTip Sensor Technology|Prospective Atrial Flutter Ablation Registry Investigating IntellaTip Mifi XP 8 mm Technology and Maximum Voltage-guided (MVG) Isthmus Ablation Approach|Not yet recruiting||N/A|120|Anticipated|Stiftung Institut fuer Herzinfarktforschung|||1||f||||t||||||||Yes|Plan to publish data in scientific journal|2017-10-10 22:03:30.702557|2017-10-10 22:03:30.702557
NCT02810925|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-21|2016-06-21|||July 2015||2015-07-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Weight Loss and Appetite Reduction After Percutaneous Electrical Stimulation Dermatome T6|Weight Loss and Appetite Reduction and Their Correlation With Plasmatic Ghrelin Levels After Percutaneous Electrical Stimulation Dermatome T6 Associated With a Hypocaloric Diet|Completed||Phase 3|200|Actual|Hospital General Universitario Elche||4|||f||||t||||||||Yes|Data might be published in a journal, always preserving patients´ confidentiality.|2017-10-10 22:03:30.768494|2017-10-10 22:03:30.768494
NCT02810912|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-20|||June 2016||2016-06-01|June 2016|2016-06-01||||December 2021|Anticipated|2021-12-01||Observational|||Gastroesophageal Regurgitation Under General Anesthesia|Gastroesophageal Regurgitation During Perioperative Period Under General Anesthesia: a Pilot Study With Multichannel Intraluminal Impedance-pH Monitoring|Not yet recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No|We did not plan to share our data, because it involved the patients' privacy.|2017-10-10 22:03:30.832226|2017-10-10 22:03:30.832226
NCT02810899|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-09-28|||September 2015||2015-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy|The Effect of Dexmedetomidine as an Adjuvant to General Anesthesia on Intelligence Development in Pediatric Patients Undergoing Craniotomy: a Randomized, Double-blind and Placebo-controlled Pilot Trial|Completed||Phase 4|60|Actual|Peking University First Hospital||2|||f||||t||||||||Yes||2017-10-10 22:03:30.898957|2017-10-10 22:03:30.898957
NCT02810886|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-21|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|ProsPERo||Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management|Prospective Evaluation of 68Ga-PSMA-ligand PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management|Withdrawn||Phase 2|0|Actual|Jules Bordet Institute||1||"Recent publications demonstrating the clinical interest in performing 68Ga-PSMA for recurrence   detection of prostate cancer patients with biochemical relapse"|f||||f||||||||||2017-10-10 22:03:30.999711|2017-10-10 22:03:30.999711
NCT02810860|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-12-29|||May 2016||2016-05-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|EPICS||Multimedia Informed Consent & PROMs in Laparoscopic Cholecystectomy|A Study to Pilot the Use of a Multimedia Application to Collect the Largest PROMs (Patient Reported Outcome Measures) Dataset in Adult Patients Undergoing Elective Laparoscopic Cholecystectomy for Symptomatic Gallstones and to Aid the Informed Consent Process|Recruiting||N/A|1000|Anticipated|Nottingham University Hospitals NHS Trust||1|||f||||f||||||||No||2017-10-10 22:03:31.146935|2017-10-10 22:03:31.146935
NCT02810847|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-06-20|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|I-BiT Plus||The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years|The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years|Not yet recruiting||N/A|182|Anticipated|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||Undecided||2017-10-10 22:03:31.218898|2017-10-10 22:03:31.218898
NCT02810834|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-08-31|||September 2014||2014-09-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|June 23, 2017|Actual|2017-06-23||Interventional|||Understanding the Impact of School-Based Physical Activity Programs|Understanding the Impact of School-Based Physical Activity Programs|Completed||N/A|1182|Actual|Tufts University||3|||f||||||||||||||2017-10-10 22:03:31.293288|2017-10-10 22:03:31.293288
NCT02805673|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-06-15|||October 2014||2014-10-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|FMostéo||Osteopathic Support Evaluation of Fibromyalgia Patients|Osteopathic Support Evaluation of Fibromyalgia Patients|Recruiting||N/A|44|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 22:04:36.477385|2017-10-10 22:04:36.477385
NCT02810821|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-06-20|||July 2011||2011-07-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||Gonadal Hormone, Gonadotropin and Cardiovascular Events|Association Between Serum Gonadal Hormone, Gonadotropin and Cardiovascular Events|Recruiting||N/A|8000|Anticipated|Shandong Provincial Hospital|||4||f||||t||||||Samples With DNA|"     Serum，Plasma and Whole blood   "|||2017-10-10 22:03:33.291737|2017-10-10 22:03:33.291737
NCT02810808|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2016-11-03|||December 2013||2013-12-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|September 2016|Actual|2016-09-01||Interventional|ARTIS||Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD|Random, Open-label Multicenter, Phase IV Study Assessing the Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD|Recruiting||Phase 4|115|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||No||2017-10-10 22:03:33.415899|2017-10-10 22:03:33.415899
NCT02810795|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-10-04|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|SPECIFIC||Dynamic Stress Perfusion CT for Detection of Inducible Myocardial Ischemia|Dynamic Stress Perfusion ct for Detection of Inducible Myocardial Ischemia|Recruiting||N/A|180|Anticipated|Erasmus Medical Center|||1||f||||t||||||||No||2017-10-10 22:03:33.597497|2017-10-10 22:03:33.597497
NCT02810782|ClinicalTrials.gov processed this data on October 10, 2017|2009-06-02|2016-06-28|||June 2001||2001-06-01|June 2016|2016-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||How to Treat Opiate Withdrawal in Neonates|Pharmacological Treatment of Narcotic Neonatal Withdrawal|Completed||Phase 3|120|Actual|University of Zurich||3|||f||||f||||||||No||2017-10-10 22:03:33.724844|2017-10-10 22:03:33.724844
NCT02810769|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-06-20|||November 2012||2012-11-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Acute Effect of Two Berry Extracts on Cognition and Mood in Adults Aged 40 to 60|The Acute Effect of Two Berry Extracts on Cognition and Mood in Adults Aged 40 to 60|Completed||N/A|36|Actual|Northumbria University||3|||f||||t||||||||||2017-10-10 22:03:33.849714|2017-10-10 22:03:33.849714
NCT02810756|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-09-08|||September 15, 2016|Actual|2016-09-15|September 2017|2017-09-01|August 28, 2017|Actual|2017-08-28|August 28, 2017|Actual|2017-08-28||Interventional|||Study With Improved Solubility Pazopanib|Proof of Principle and Pharmacological Phase 0 Study With Improved Solubility Pazopanib|Completed||Early Phase 1|12|Actual|The Netherlands Cancer Institute||1|||f||||t||||||||||2017-10-10 22:03:33.932809|2017-10-10 22:03:33.932809
NCT02810743|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-09-13|||August 2016||2016-08-01|September 2017|2017-09-01|August 2029|Anticipated|2029-08-01|August 2019|Anticipated|2019-08-01||Interventional|Subito||Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer|Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer Patients With Personalized Therapy (SUBITO) - an International Randomized Phase III Trial|Recruiting||Phase 3|174|Anticipated|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-10-10 22:03:34.014065|2017-10-10 22:03:34.014065
NCT02810730|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-06-20|||June 2015||2015-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PAPAFA||Prevalence of Pancreatic Anomalies of Patients With a 1st Degree Familial History of Pancreatic Adenocarcinoma|Prevalence, With Medical Imaging, of the Parenchymatous and/or Ductal Pancreatic Anomalies of Patients With a 1st Degree Familial History of Pancreatic Adenocarcinoma|Recruiting||N/A|200|Anticipated|Centre Hospitalier Saint Joseph Saint Luc de Lyon||1|||f||||t||||||||||2017-10-10 22:03:34.149823|2017-10-10 22:03:34.149823
NCT02810717|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-06-18|||December 2016||2016-12-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Effects of TBS on 5-HT1A Receptor Binding|Effects of Theta-burst Transcranial Magnetic Stimulation on Serotonin-1A Receptor Binding in Treatment Resistant Depression|Recruiting||N/A|80|Anticipated|Medical University of Vienna||2|||f||||f||||||||Yes|A database that also includes data from this study will be created|2017-10-10 22:03:34.456183|2017-10-10 22:03:34.456183
NCT02810704|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-04-07|||December 2016|Actual|2016-12-01|April 2016|2016-04-01|February 2021|Anticipated|2021-02-01|August 2020|Anticipated|2020-08-01||Interventional|PEPPER||Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement|Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement: Balancing Safety and Effectiveness|Recruiting||Phase 4|25000|Anticipated|Medical University of South Carolina||3|||f||||t||||||||Yes|"Data Sharing Plan: The participating institutions will follow NIH guidelines concerning the sharing of research data. As outlined by the NIH and PCORI, the participating institutions will make available to the public the results of this collaboration and any accompanying data that were supported by PCORI. There are no specimens or biological resources for sharing as a result of this planned project.
In the course of this research project, we anticipate generating ranges of estimated complications and adverse events as they relate to the use of VTE prophylaxis in the context of hip and knee replacement. Access to these data and associated recommendations generated under the project will be available for educational, research and non-profit purposes. Such access will be provided using web-based applications, as appropriate and consistent with the data distribution policies of the Medical University of South Carolina and the University of Maryland."|2017-10-10 22:03:34.637238|2017-10-10 22:03:34.637238
NCT02810691|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-18|||July 2016||2016-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SOFI||The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis|The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis|Recruiting||N/A|22|Anticipated|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-10 22:03:34.93816|2017-10-10 22:03:34.93816
NCT02810678|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-08-28|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|ACT4||Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment|Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment: A Pragmatic Cluster Randomized Trial|Active, not recruiting||N/A|36|Anticipated|McGill University||2|||f||||f||||||||||2017-10-10 22:03:35.089875|2017-10-10 22:03:35.089875
NCT02810665|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-20|||July 2015||2015-07-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01|1 Day|Observational [Patient Registry]|||Repeatability and Concordance of VA Measured With ETDRS Numeric , Landolt C, and Letter Charts in Thai Individuals|Repeatability and Concordance of Visual Acuity Level Measured With ETDRS Numeric Charts, ETDRS Landolt C Charts, and Original ETDRS Letter Visual Acuity Charts in Thai Individuals|Recruiting||N/A|180|Anticipated|Chiang Mai University|||2||f||||f||||||||No||2017-10-10 22:03:35.255985|2017-10-10 22:03:35.255985
NCT02810652|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-04-20|||September 2016||2016-09-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection|Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection|Recruiting||N/A|160|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 22:03:35.422091|2017-10-10 22:03:35.422091
NCT02810639|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-22|||March 2013||2013-03-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Pain Prevalence After Cesarean Section in Siriraj Hospital|Pain Prevalence After Cesarean Section in Siriraj Hospital|Completed||N/A|297|Actual|Mahidol University|||1||f||||f||||||||No||2017-10-10 22:03:35.553695|2017-10-10 22:03:35.553695
NCT02810626|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-06-20|||July 2016||2016-07-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||DTI & Tractography in Pediatric Tumor Surgery|Application of Diffusion Tensor Imaging and Tractography in Pediatric Tumor Surgery|Not yet recruiting||N/A|24|Anticipated|London Health Sciences Centre||2|||f||||f||||||||||2017-10-10 22:03:35.624924|2017-10-10 22:03:35.624924
NCT02810613|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-08-28|||May 31, 2016|Actual|2016-05-31|August 2017|2017-08-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Observational|||Leiden University Medical Center Mini Donor Bank||Withdrawn||N/A|0|Actual|Leiden University Medical Center|||1|Study never started.|f||||f||||||Samples With DNA|"     Blood and urine   "|||2017-10-10 22:03:35.72363|2017-10-10 22:03:35.72363
NCT02810600|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-20|||June 2016||2016-06-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01|2 Days|Observational [Patient Registry]|PET/Ga68||Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors|Phase II Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors|Recruiting||N/A|120|Anticipated|Centre de recherche du Centre hospitalier universitaire de Sherbrooke|||1||f||||f||||||||||2017-10-10 22:03:35.772991|2017-10-10 22:03:35.772991
NCT02810587|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-20|||May 2015||2015-05-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics|Incidence of Endophthalmitis After Intravitreous Anti-vascular Endothelial Growth Factor Injections Comparison Between Patients Receiving Versus Not Receiving Topical Antibiotics Following the Injections|Recruiting||N/A|5000|Anticipated|Chiang Mai University|||2||f||||f||||||||No||2017-10-10 22:03:35.845788|2017-10-10 22:03:35.845788
NCT02810574|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-20|||March 2016||2016-03-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Combining Noninvasive Brain Stimulation and Cognitive Training on Tobacco Craving||Recruiting||N/A|24|Anticipated|Laval University||2|||f||||||||||||||2017-10-10 22:03:35.965819|2017-10-10 22:03:35.965819
NCT02810561|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-04-05|||January 2012||2012-01-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Troponin Leaks in Emergency Department Patients Presenting With Supraventricular Tachycardia (SVT)|Time Course and the Significance of Troponin Leaks in Emergency Department Patients Presenting With Supraventricular Tachycardia (SVT)|Completed||N/A|63|Actual|Lakeland Health|||1||f||||f||||||||Undecided||2017-10-10 22:03:36.06559|2017-10-10 22:03:36.06559
NCT02810548|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-20|||August 2016||2016-08-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of Platelets Rich Fibrin and Nanohydroxyapatite in the Treatment of Intrabony Defects|Clinical and Biochemical Evaluation of Platelets Rich Fibrin (PRF) and Nanohydroxyapatite in the Treatment of Intrabony Defects|Not yet recruiting||Early Phase 1|60|Anticipated|King Abdulaziz University||4|||f||||f||||||||No||2017-10-10 22:03:36.137353|2017-10-10 22:03:36.137353
NCT02810535|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-20|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|LISA||Local IgE in Subjects With Allergic or Non-allergic Rhinitis|Local IgE in Subjects With Allergic or Non-allergic Rhinitis|Recruiting||N/A|300|Anticipated|Johann Wolfgang Goethe University Hospital||3|||f||||f||||||||No||2017-10-10 22:03:36.253689|2017-10-10 22:03:36.253689
NCT02810522|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-20|||August 2016||2016-08-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||OneTouch Select® [Brand Name]Plus Blood Glucose Monitoring System(BGMS) Registration Study|A Registration Study to Assess User Performance of OneTouch Select® Plus Blood Glucose Monitoring System|Not yet recruiting||N/A|240|Anticipated|Johnson & Johnson Medical, China|||||f||||||||||||||2017-10-10 22:03:36.418497|2017-10-10 22:03:36.418497
NCT02810496|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-20|||April 2012||2012-04-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Interventional|MUTA-GR||Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia|Prevalence of Mutations of Glucocorticoid Receptors in Bilateral Adrenal Hyperplasia|Recruiting||N/A|150|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:03:36.852404|2017-10-10 22:03:36.852404
NCT02810483|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-22|||December 2012||2012-12-01|April 2016|2016-04-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|TOPRADER||Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks|Randomized, Placebo Controlled Double-blind Study of the Efficacy of Topiramate on the Symptoms of Irritability - Impulsivity, Overeating and Self-harm in a Population of Patients Suffering From Prader Willi Syndrome Over 8 Weeks|Completed||Phase 3|69|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 22:03:36.97593|2017-10-10 22:03:36.97593
NCT02810470|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-20|||June 2015||2015-06-01|May 2015|2015-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CNO Evaluation||Acceptability Study of Nutritional Supplements in Hospitalized Elderly Patients|Acceptability Study of Nutritional Supplements in Hospitalized Elderly Patients Aged for More Than 65 Years|Completed||N/A|107|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:03:37.116388|2017-10-10 22:03:37.116388
NCT02810275|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-11-29|||October 2012||2012-10-01|September 2016|2016-09-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|FAST||Folinic Acid: Supplementation and Therapy|Effect of Folic Acid on Homocysteine Levels and Flow-mediated Dilation in HIV and HIV-HCV Coinfected Patients: a Randomized Controlled Trial|Completed||Phase 3|69|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||No||2017-10-10 22:03:39.252926|2017-10-10 22:03:39.252926
NCT02810457|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-07-21|||June 2016||2016-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|AVANA||Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer|A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to Avastin® In 1st Line Treatment for Patients With Advanced/Recurrent Non Squamous NSCLC in Combination of Paclitaxel and Carboplatin|Recruiting||Phase 3|730|Anticipated|Centus Biotherapeutics Limited||2|||f||||t||||||||||2017-10-10 22:03:37.227597|2017-10-10 22:03:37.227597
NCT02810444|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-08-11|||October 2016||2016-10-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID|An Open-label, Prospective, Multicenter Study Investigating Clinical Efficacy, Safety, and Pharmacokinetic Properties of the Human Normal Immunoglobulin for Intravenous Administration BT595 as Replacement Therapy in Patients With Primary Immunodeficiency Disease (PID)|Recruiting||Phase 3|60|Anticipated|Biotest||1|||f||||t||||||||||2017-10-10 22:03:37.796389|2017-10-10 22:03:37.796389
NCT02810431|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-10-05|||December 22, 2011||2011-12-22|May 25, 2017|2017-05-25|October 4, 2030||2030-10-04|October 3, 2030|Anticipated|2030-10-03||Observational|||Long Term Retention of Protspectively Obtained Biospecimens|Long-Term Retention of Prospectively Obtained Biospecimens|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:03:37.954274|2017-10-10 22:03:37.954274
NCT02810405|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-22|2017-09-12|||June 10, 2011||2011-06-10|August 31, 2017|2017-08-31|January 1, 2019||2019-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Collection of Tissue Blocks or Slides From Patients With Cancer|Collection of Tissue Blocks or Slides From Patients With Cancer|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:03:38.184033|2017-10-10 22:03:38.184033
NCT02810392|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-07-19|||April 2016||2016-04-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intranasal Insulin and Post-stroke Cognition: A Pilot Study|Intranasal Insulin and Post-stroke Cognition: A Pilot Study|Recruiting||N/A|40|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-10 22:03:38.264981|2017-10-10 22:03:38.264981
NCT02810379|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-06-19|||January 2016||2016-01-01|June 2016|2016-06-01||||January 2017|Anticipated|2017-01-01||Interventional|||Video Consent Form Versus Written Consent Form for ERCP|Combination of Video and Written Information Provides the Patient With a More Comprehensive Level of Knowledge About Endoscopic Retrograde Cholangiopancreatography: Study Protocol for Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-10-10 22:03:38.36378|2017-10-10 22:03:38.36378
NCT02810366|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-06-19|||September 2015||2015-09-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Physician Versus Computer Coding of Verbal Autopsies|Physician Versus Computer Coding of Verbal Autopsies, a Randomised Control Trial|Recruiting||N/A|12500|Anticipated|Centre for Global Health Research, Toronto||2|||f||||f||||||||Yes|Personal identifiers within each collected verbal autopsy will be anonymized. This anonymized dataset will be made publically available.|2017-10-10 22:03:38.453748|2017-10-10 22:03:38.453748
NCT02810353|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2016-06-18|||May 2015||2015-05-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Analysis of the Dentoskeletal Effects of the Expander With Differential Opening|Analysis of the Dentoskeletal Effects of the Expander With Differential Opening: a Randomized Clinical Trial|Recruiting||N/A|50|Anticipated|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 22:03:38.552053|2017-10-10 22:03:38.552053
NCT02810340|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-03-17|||August 2016||2016-08-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults|A Phase 1, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of a New Meningococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X in Healthy Adults|Active, not recruiting||Phase 1|60|Actual|PATH||3|||f||||f||||||||||2017-10-10 22:03:38.638308|2017-10-10 22:03:38.638308
NCT02810327|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-05-04|||February 2015|Actual|2015-02-01|October 2016|2016-10-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Alpha-1 Carrier Genomics Study|Alpha-1 Carrier Genomics Study|Completed||N/A|117|Actual|Medical University of South Carolina|||2||f||||f||||||Samples With DNA|"     Bloodspot collections for DNA and limited protein analysis   "|||2017-10-10 22:03:38.727338|2017-10-10 22:03:38.727338
NCT02810314|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-09-18|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CONNECT-15||Default Mode Network in Multiple Sclerosis|Study of Default Mode Network (DMN) on Patients With Multiple Sclerosis (MS)|Recruiting||N/A|64|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||f|f|f||||||||2017-10-10 22:03:38.931265|2017-10-10 22:03:38.931265
NCT02810301|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-10-06|||April 2016||2016-04-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity|A Randomized, Double-Blind, Placebo-Controlled Study on the Efficacy of Bifidobacterium Longum Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity|Recruiting||Phase 2|60|Anticipated|Exzell Pharma Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:03:39.043959|2017-10-10 22:03:39.043959
NCT02810288|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-22|||January 2016||2016-01-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|SUR-AMPA||Airway Management Practice Patterns in Paediatric Anaesthesia: A Survey|A Survey of Airway Management Practice Patterns in Paediatric Anaesthesia by Anaesthesiologists in Different European Hospitals|Recruiting||N/A|200|Anticipated|IRCCS Policlinico S. Matteo|||2||f||||f||||||||No||2017-10-10 22:03:39.156522|2017-10-10 22:03:39.156522
NCT02810262|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-22|||June 2011||2011-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|POUMOS||Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS)|Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS)|Recruiting||N/A|200|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     Urine Serum and plasma Bone biopsy Whole blood   "|||2017-10-10 22:03:39.344345|2017-10-10 22:03:39.344345
NCT02810249|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-04-12|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|December 29, 2016|Actual|2016-12-29|December 29, 2016|Actual|2016-12-29||Observational|||Likely Use of PrEP for African American YMSM|Factors Affecting the Likely Use of PrEP for African American Young Men Who Have Sex With Men|Completed||N/A|25|Actual|Duke University|||1||f||||f||||||||No||2017-10-10 22:03:39.445368|2017-10-10 22:03:39.445368
NCT02810236|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-10-03|||November 2017|Anticipated|2017-11-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Focal Breast Pain: Does a Normal Ultrasound Provide Reassurance?|Focal Breast Pain: Does a Normal Ultrasound Provide Reassurance?|Not yet recruiting||N/A|160|Anticipated|Duke University||2|||f||||t|f|f||||||||2017-10-10 22:03:39.520856|2017-10-10 22:03:39.520856
NCT02810223|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-10-13|||May 2016||2016-05-01|June 2016|2016-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia||Recruiting||Phase 1|20|Anticipated|Beijing Sanwater Biological Technology Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:03:39.635007|2017-10-10 22:03:39.635007
NCT02810210|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-08-29|||June 2016||2016-06-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|ZIKA-DFA-BB||Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America|Études Observationnelles Des conséquences néonatales et pédiatriques de l'Infection à Virus Zika au Cours de la Grossesse Pendant l'épidémie Des départements français d'Amérique de l'année 2016|Recruiting||N/A|2220|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||3||f||||f||||||||No||2017-10-10 22:03:39.719937|2017-10-10 22:03:39.719937
NCT02810197|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-09-27|||June 2016||2016-06-01|December 2016|2016-12-01|April 30, 2023||2023-04-30|April 2022|Anticipated|2022-04-01||Interventional|REMEMBER||Resilience and Modification of Brain Control Network Following November 13|Etude Longitudinale en Imagerie cérébrale, en Neuropsychologie, et en Psychopathologie, Des conséquences d'un événement Traumatique|Recruiting||N/A|180|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||||||||||||2017-10-10 22:03:39.8438|2017-10-10 22:03:39.8438
NCT02810184|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-21|||June 2016||2016-06-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|VOLCRAN||Determination of Bone Volume Changes of the Cranial Bone-augmented Jaw: A Feasibility Study|Determination of Bone Volume Changes of the Cranial Bone-augmented Jaw: A Feasibility Study|Recruiting||N/A|16|Anticipated|AZ Sint-Jan AV||1|||f||||f||||||||No||2017-10-10 22:03:39.942249|2017-10-10 22:03:39.942249
NCT02810171|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-01-30|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|Anxiety-CBT||Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety|Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety|Recruiting||N/A|280|Anticipated|University of Michigan||3|||f||||t|f|f||||||Yes|Anonymized data will be shared with the National Database for Autism Research (NDAR) and the Research Domain Criteria Database (RDoCdb).|2017-10-10 22:03:40.041176|2017-10-10 22:03:40.041176
NCT02810158|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-09|||June 2016||2016-06-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Mass Spectral Fingerprinting in Obstructive Sleep Apnoea|Diagnosis of Obstructive Sleep Apnoea by Selective Secondary Electrospray Ionization - Mass Spectrometry (SESIMS)|Recruiting||N/A|150|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 22:03:40.14707|2017-10-10 22:03:40.14707
NCT02810145|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-10-11|||July 2016||2016-07-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Observational|||Cerebral Desaturation in Traumatic Brain Injury|The Incidence and Magnitude of Cerebral Desaturation in Traumatic Brain Injury (TBI) Patients|Recruiting||N/A|30|Anticipated|University of Manitoba|||1||f||||f||||||||No||2017-10-10 22:03:40.231814|2017-10-10 22:03:40.231814
NCT02810132|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-03-23|||January 20, 2017|Actual|2017-01-20|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|METRONOME||Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure|Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure: A Randomized, Double-blind, Placebo-controlled Study|Recruiting||Phase 2|36|Anticipated|Aarhus University Hospital||2|||f||||||||||||||2017-10-10 22:03:40.354261|2017-10-10 22:03:40.354261
NCT02810119|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-06-22|||August 2016||2016-08-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis|A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis|Not yet recruiting||Phase 2|21|Anticipated|Ocuwize LTD||2|||f||||||||||||Undecided|Final Data report will be publish when the study will be finalized|2017-10-10 22:03:40.559964|2017-10-10 22:03:40.559964
NCT02810106|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-10-27|||July 2016||2016-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|Perfusão||Assessment of Myocardial Perfusion by Tomography and Scintigraphy in Patients With Cardiac Stress Test With Ischemia|Assessment of Myocardial Perfusion by Tomography and Scintigraphy in Patients With Cardiac Stress Test With Ischemia|Not yet recruiting||N/A|50|Anticipated|University of Sao Paulo General Hospital|||1||f||||t||||||||No||2017-10-10 22:03:40.654215|2017-10-10 22:03:40.654215
NCT02810093|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-20|||May 2016||2016-05-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|SENOMETRY||Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis|SENOMETRY : Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis|Recruiting||N/A|10000|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:03:40.724126|2017-10-10 22:03:40.724126
NCT02810080|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-06-26|||December 2016||2016-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:03:40.812674|2017-10-10 22:03:40.812674
NCT02810067|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-21|||July 2016||2016-07-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Root Coverage Comparing an Allograft to a Bovine Xenograft|Root Coverage With Acellular Dermal Matrix Using the Coronally Positioned Tunnel Technique Comparing Two Different Donor Materials|Not yet recruiting||Phase 4|30|Anticipated|University of Louisville||2|||f||||t||||||||No|No plan to share data|2017-10-10 22:03:40.86043|2017-10-10 22:03:40.86043
NCT02810054|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-27|||September 2016||2016-09-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Using MIST With or Without EMD in Treatment of Intrabony Periodontal Defects.|Periodontal Minimally Invasive Surgical Techniques With or Without Enamel Matrix Derivative Gel for Treatment of Intrabony Periodontal Osseous Defects in Humans.|Not yet recruiting||N/A|30|Anticipated|University of Manchester||2|||f||||f||||||||No|Individual Participant data will not be shared however once anonymised the results may be published.|2017-10-10 22:03:40.959093|2017-10-10 22:03:40.959093
NCT02810041|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-30|||November 2014||2014-11-01|June 2016|2016-06-01||||May 2015|Actual|2015-05-01||Interventional|VITALIM Senior||Effect of Yoghurts Enriched With XXS (Mixture of Natural Polyphenolic Compounds and Plant Extracts) on the Evolution of Weight in Overweight Subjects|Randomized Controlled Double-blind Clinical Trial for the Effect of Yoghurts Enriched in XXS vs Without XXS on the Evolution of Weight in Overweight Subjects Aged 50 to 65 Years.|Completed||N/A|93|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:03:41.060042|2017-10-10 22:03:41.060042
NCT02810015|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-20|||July 2016||2016-07-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study|Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study|Not yet recruiting||Phase 2|40|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-10-10 22:03:41.302332|2017-10-10 22:03:41.302332
NCT02810002|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-19|||August 2014||2014-08-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Assessing Foot Injuries in Infantry Recruits Wearing Different Boots|Assessing Foot Injuries in Infantry Recruits Wearing Different Boots, a Prospective Randomized Study|Completed||Phase 1/Phase 2|98|Actual|Medical Corps, Israel Defense Force||2|||f||||f||||||||Yes|Raw unidentified data available by contacting the PI|2017-10-10 22:03:41.410744|2017-10-10 22:03:41.410744
NCT02809976|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-01|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Topical Ruxolitinib for the Treatment of Vitiligo|Open Label Phase 2 Proof-of-concept Pilot Trial of Topical Ruxolitinib in Repigmenting Adult Patients With Vitiligo|Completed||Phase 2|12|Actual|Tufts Medical Center||1|||f||||f||||||||||2017-10-10 22:03:41.616835|2017-10-10 22:03:41.616835
NCT02809963|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-05-11|||November 2015||2015-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Mineralocorticoid Receptor Antagonists in Type 2 Diabetes|A Randomized, Double-blind, Placebo-controlled Study of the Effect of Mineralocorticoid Receptor Antagonists in Type 2 Diabetes Patients on Myocardial Function, Glucose and Fat Metabolism (The MIRAD-study)|Active, not recruiting||Phase 4|140|Actual|Herlev Hospital||2|||f||||t||||||||No||2017-10-10 22:03:41.705418|2017-10-10 22:03:41.705418
NCT02809950|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-12-29|||June 2016||2016-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Preoperative Oral Carbohydrates Loading in Patients at High Risk of Postoperative Nausea and Vomiting Undergoing Spinal Surgery||Recruiting||Phase 4|288|Anticipated|Yonsei University||2|||f||||f||||||||Undecided||2017-10-10 22:03:41.783143|2017-10-10 22:03:41.783143
NCT02809937|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-06-15|||May 2011|Actual|2011-05-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Dexmedetomidine and Long-term Outcome in Elderly Patients After Surgery|Impact of Dexmedetomidine on Long-term Outcome in Elderly Patients After Noncardiac Surgery: 3-year Follow-up of a Randomized Controlled Trial|Completed||Phase 4|700|Actual|Peking University First Hospital||2|||f||||t||||||||Yes||2017-10-10 22:03:41.866141|2017-10-10 22:03:41.866141
NCT02809924|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-10-03|||July 1, 2017|Actual|2017-07-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Just-in-time Training for Teaching Neonatal Endotracheal Intubation|Simulation-based Just-in-time Training for Teaching Neonatal Endotracheal Intubation: A Randomized Controlled Trial|Recruiting||N/A|180|Anticipated|St. Justine's Hospital||2|||f||||f|f|f||||||||2017-10-10 22:03:42.095087|2017-10-10 22:03:42.095087
NCT02809911|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-03-01|2016-10-26||June 2016||2016-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate PEMF Therapy on Experimentally Inducted Pain in Subjects With Painful Peripheral Diabetic Neuropathy|A Randomized, Sham-Controlled, Double-Blind, Crossover Study to Evaluate PEMF Therapy on Pain Sensitivity to Different Qualities of Experimentally Induced Pain in Subjects With Painful Peripheral Diabetic Neuropathy|Completed||N/A|41|Actual|Regenesis Biomedical, Inc.||2|||f||||f||||||||No||2017-10-10 22:03:42.200212|2017-10-10 22:03:42.200212
NCT02809898|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-08-25|||July 2016||2016-07-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer|The Role of ctDNA and PBMC as Biomarkers in Diagnostic, Efficacy Monitoring and Prognostic Evaluation of Biliary Tract Cancer|Recruiting||N/A|30|Anticipated|RenJi Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:03:42.620065|2017-10-10 22:03:42.620065
NCT02804451|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-06-14|||December 2015||2015-12-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Intubation During Cardiopulmonary Resuscitation||Completed||N/A|47|Actual|Medical University of Warsaw||2|||f||||t||||||||||2017-10-10 22:04:44.3348|2017-10-10 22:04:44.3348
NCT02809885|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-08|||December 19, 2013|Actual|2013-12-19|August 2017|2017-08-01|December 19, 2017|Anticipated|2017-12-19|December 19, 2017|Anticipated|2017-12-19||Interventional|HEV||Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study|Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study|Recruiting||N/A|226|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:03:42.721273|2017-10-10 22:03:42.721273
NCT02809872|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-01-30|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Observational|||Ultrasound Estimation of Pleural Effusion in the Sitting Patients|Ultrasound Estimation of Pleural Effusion in the Sitting Patients|Active, not recruiting||N/A|50|Actual|Scarlata, Simone, M.D.|||1||f||||f||||||||Yes||2017-10-10 22:03:42.808054|2017-10-10 22:03:42.808054
NCT02808754|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-10-03|||December 2016||2016-12-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|RIP-CEA||Remote Ischemic Preconditioning for Carotid Endarterectomy|Remote Ischemic Preconditioning for Carotid Endarterectomy|Recruiting||N/A|86|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||||2017-10-10 22:03:42.900411|2017-10-10 22:03:42.900411
NCT02808741|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-11-25|||July 2016||2016-07-01|June 2016|2016-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of Immediate Release Tablet|F901318 - A Two Part Study Designed to Evaluate the Single and Multiple Dose Pharmacokinetics of an Immediate Release Tablet Formulation of F901318|Completed||Phase 1|20|Actual|F2G Ltd.||4|||f||||f||||||||No||2017-10-10 22:03:43.01761|2017-10-10 22:03:43.01761
NCT02808728|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-17|||May 2014||2014-05-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|March 2015|Actual|2015-03-01||Interventional|||Effectiveness of Intraoperative Exparel for Postoperative Pain Control in Total Knee Arthroplasty|Effectiveness of Intraoperative Exparel, a Bupivacaine Liposome Injectable Suspension, for Postoperative Pain Control in Total Knee Arthroplasty: A Prospective, Randomized, Double Blind, Controlled Study|Active, not recruiting||Phase 4|100|Actual|DeClaire LaMacchia Orthopaedic Institute||2|||f||||||||||||||2017-10-10 22:03:43.105682|2017-10-10 22:03:43.105682
NCT02808715|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-21|||May 2014||2014-05-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Identification and Metabolic Characterization of a Cohort of Human Subjects With Mutations in PRDM-16|Identification and Metabolic Characterization of a Cohort of Human Subjects With Mutations in PRDM-16|Completed||N/A|247|Actual|National Heart Centre Singapore|||1||f||||f||||||Samples With DNA|"     A blood sample will be obtained and processed to isolate genomic DNA. A PCR-based strategy     will be employed to sequence the entire PRDM-16 locus to identify variants. Variant alleles     of PRDM-16 will be classified as having benign or deleterious mutations. Subjects who harbor     deleterious mutations in both alleles of PRDM-16 will be identified for further study.      For subjects who withdraw from the study, no further testing of the blood samples will occur.     The blood will be stored at the NHRIS biobank. After the study is complete the samples will     remain in storage at the NHRIS biobank.   "|No||2017-10-10 22:03:43.1974|2017-10-10 22:03:43.1974
NCT02808702|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-04-21|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Brain Correlates of Self-Focused Processing|Brain Correlates of Self-Focused Processing as a Biomarker of Treatment Response|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||1|||f||||t|f|f||||||No||2017-10-10 22:03:43.265781|2017-10-10 22:03:43.265781
NCT02808689|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-09-09|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|FAst||Functional Medicine in Asthma (FAst) Study|Functional Medicine in Asthma (FAst) Study|Recruiting||N/A|60|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No||2017-10-10 22:03:43.370817|2017-10-10 22:03:43.370817
NCT02808676|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-06-01|||July 2016||2016-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|SYNERGIC||SYNchronizing Exercises, Remedies in GaIt and Cognition|SYNchronizing Exercises, Remedies in GaIt and Cognition (SYNERGIC): A Randomized Controlled Double Blind Trial|Recruiting||N/A|200|Anticipated|Lawson Health Research Institute||5|||f||||f||||||||No||2017-10-10 22:03:43.481014|2017-10-10 22:03:43.481014
NCT02808663|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-21|||May 2015||2015-05-01|June 2016|2016-06-01||||May 2017|Anticipated|2017-05-01||Interventional|CALPRO-HAA||Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis|Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis|Recruiting||N/A|40|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:03:43.641742|2017-10-10 22:03:43.641742
NCT02808650|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-06-20|||February 27, 2017|Actual|2017-02-27|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors|A Phase 1 Study of LY2606368, a CHK1/2 Inhibitor, in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors|Recruiting||Phase 1|65|Anticipated|Children's Oncology Group||1|||f||||f|t|f||||||||2017-10-10 22:03:43.727022|2017-10-10 22:03:43.727022
NCT02809859|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-06-14|||July 2016||2016-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:03:43.92068|2017-10-10 22:03:43.92068
NCT02809846|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-09-06|||July 2016||2016-07-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|August 2017|Actual|2017-08-01||Interventional|||Quell Opioid Reduction and Pain Relief in Patients With Cancer|Quell Opioid Reduction and Pain Relief in Patients With Cancer|Enrolling by invitation||Phase 3|40|Anticipated|Scripps Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:03:43.965145|2017-10-10 22:03:43.965145
NCT02809833|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-08-30|2016-08-30||January 2009||2009-01-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational||All Enrolled Population: All participants enrolled into the study.|Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine|Tocilizumab for the Treatment of Rheumatoid Arthritis: Findings on The Use of Tocilizumab in Daily Clinical Routine|Completed||N/A|850|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:03:44.149272|2017-10-10 22:03:44.149272
NCT02809820|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-09-10|||May 2016||2016-05-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|PLATE-BLOCK||Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome|Effects of Selective and Nonselective Beta-blockade on Platelet Aggregation in Patients With Acute Coronary Syndrome|Recruiting||Phase 4|100|Anticipated|Federico II University||2|||f||||f||||||||Undecided||2017-10-10 22:03:47.612304|2017-10-10 22:03:47.612304
NCT02809807|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-09-27|||June 2016||2016-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|COPD||Gas Mask and Chronic Obstructive Pulmonary Disease (COPD): New Understanding on the Respiratory Index Impact?|The Impact of the Work of Breathing and Gas Exchange for COPD Patient Using a Gas Mask.|Completed||N/A|9|Actual|Laval University||3|||f||||t||||||||Undecided||2017-10-10 22:03:47.729339|2017-10-10 22:03:47.729339
NCT02809794|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-06-26|||July 2016||2016-07-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||CPAP In-home Assessment Australia|CPAP In-home Assessment Australia|Completed||N/A|50|Actual|Fisher and Paykel Healthcare||1|||f||||t||||||||||2017-10-10 22:03:47.841051|2017-10-10 22:03:47.841051
NCT02809781|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis|Phase III Study of Human Bone Marrow-Derived Mesenchymal Stem Cells to Treat AS|Recruiting||Phase 2/Phase 3|250|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||Undecided|It all depends on the whole process of the study.|2017-10-10 22:03:47.960254|2017-10-10 22:03:47.960254
NCT02809768|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-03-07|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects|A 3-Part, Open-Label Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole (Moderate Inhibitor of CYP2C9 and CYP3A), Itraconazole (Strong CYP3A Inhibitor), or Rifampin (Strong CYP3A and Moderate CYP2C9 Inducer) in Healthy Subjects|Completed||Phase 1|48|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-10 22:03:48.065966|2017-10-10 22:03:48.065966
NCT02809755|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-07-12|||May 2016||2016-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|July 2017|Actual|2017-07-01||Interventional|||Sphenopalatine Ganglion Block to Prevent Shoulder Pain After Laparoscopic Bariatric Surgery|Sphenopalatine Ganglion Block to Prevent Shoulder Pain After Laparoscopic Bariatric Surgery|Active, not recruiting||N/A|88|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:03:48.155146|2017-10-10 22:03:48.155146
NCT02809742|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-18|||May 2016||2016-05-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Observational|OptimEpi||Intermittent Ropivacaine Bolus for Epidural Labor Analgesia|Intermittent Bolus Administration of Ropivacaine for Epidural Labor Analgesia : an Observational Study|Recruiting||N/A|500|Anticipated|Pierre and Marie Curie University|||1||f||||t||||||||No||2017-10-10 22:03:48.228877|2017-10-10 22:03:48.228877
NCT02809729|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Antibiotic Prophylaxis in Oncological Surgery of Breast|Antibiotic Prophylaxis in Oncological Surgery of Breast: Randomized Clinical Trial|Recruiting||N/A|124|Anticipated|Universidade do Vale do Sapucai||2|||f||||t||||||||No||2017-10-10 22:03:48.338502|2017-10-10 22:03:48.338502
NCT02809716|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-06-23|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|February 1, 2019|Anticipated|2019-02-01|August 1, 2018|Anticipated|2018-08-01||Observational|||High Definition Single Cell Analysis in Colorectal Cancer|High Definition Single Cell Analysis in Colorectal Cancer|Recruiting||N/A|45|Anticipated|University of Southern California|||1||f||||f||||||Samples With DNA|"     Blood, tissue   "|||2017-10-10 22:03:50.254594|2017-10-10 22:03:50.254594
NCT02809690|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-19|2017-08-01|||September 12, 2016|Actual|2016-09-12|September 2016|2016-09-01|September 12, 2019|Anticipated|2019-09-12|September 12, 2018|Anticipated|2018-09-12||Interventional|||18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer|Pilot Feasibility Study of 18F-FMAU PET for Diagnosing and Characterizing Prostate Cancer|Recruiting||Phase 1|40|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 22:03:50.435416|2017-10-10 22:03:50.435416
NCT02809677|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-03-23|||December 2015||2015-12-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators|Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators|Recruiting||Phase 4|196|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 22:03:50.552062|2017-10-10 22:03:50.552062
NCT02809664|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-05-15|||October 14, 2015|Actual|2015-10-14|May 2017|2017-05-01|November 14, 2017|Anticipated|2017-11-14|October 14, 2017|Anticipated|2017-10-14||Observational|||Feasibility and Safety of Ultrasound Guided Installation Central Subclavian Catheter Through Supraclavicular Way|Feasibility and Safety of Ultrasound Guided Installation Central Subclavian Catheter Through Supraclavicular Way|Recruiting||N/A|20|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 22:03:50.668404|2017-10-10 22:03:50.668404
NCT02809651|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner|A Prospective Study to Determine Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner|Completed||N/A|89|Actual|Ziekenhuis Oost-Limburg||6|||f||||f||||||||No||2017-10-10 22:03:50.73475|2017-10-10 22:03:50.73475
NCT02809638|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-06-26|||August 2015||2015-08-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|||A New Technique to Diagnose Acute and Chronic Deep Vein Thrombosis|Ultrasound Elastography: a New Technique to Diagnose Acute and Chronic Deep Vein Thrombosis|Recruiting||N/A|150|Anticipated|Azienda Sanitaria Locale ASL 6, Livorno|||1||f||||f||||||||||2017-10-10 22:03:50.831019|2017-10-10 22:03:50.831019
NCT02809625|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-18|||March 2016||2016-03-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Application of DCE-MRI in the Diagnosis of Brucellar Spondylitis|Application of Dynamic Contrast Enhanced MRI in Clinical and Early Diagnosis of Brucellar Spondylitis|Recruiting||N/A|100|Anticipated|The Affiliated Hospital of Inner Mongolia Medical University|||1||f||||t||||||||Undecided||2017-10-10 22:03:50.914301|2017-10-10 22:03:50.914301
NCT02809612|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-02-22|||March 2016||2016-03-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|EMBLA||An Internet-based Information Platform for Vulvodynia Patients|The EMBLA Project - An Internet-based Intervention as a Supplement to Clinical Management for Vulvodynia Patients|Recruiting||N/A|52|Anticipated|Uppsala University||2|||f||||f||||||||No||2017-10-10 22:03:50.990895|2017-10-10 22:03:50.990895
NCT02809599|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-13|||October 13, 2016|Actual|2016-10-13|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evidence Based Best Care Practice for Benign Paroxysmal Positional Vertigo|Partnered Implementation of Evidence Based Best Care Practice for Benign Paroxysmal Positional Vertigo: A Stepped Wedge, Randomized Controlled Clinical Trial|Enrolling by invitation||N/A|3960|Anticipated|University of Michigan||2|||f||||f||||||||No||2017-10-10 22:03:51.220127|2017-10-10 22:03:51.220127
NCT02809586|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-05-25|||January 2017||2017-01-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Social Media Alcohol Intervention|Social Media Interventions to Reduce Alcohol Use Among Youth|Recruiting||N/A|900|Anticipated|University of Michigan||3|||f||||t||||||||No||2017-10-10 22:03:51.302655|2017-10-10 22:03:51.302655
NCT02809573|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-07-20|||August 11, 2016|Actual|2016-08-11|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients|An Open-label, Multi-center, Phase Ib Clinical Trial of Chidamide Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphoma Patients|Recruiting||Phase 1|30|Anticipated|Chipscreen Biosciences, Ltd.||1|||f||||f||||||||||2017-10-10 22:03:51.419834|2017-10-10 22:03:51.419834
NCT02809560|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-17|||March 2013||2013-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CAVASTHME||Detection of Cav1 Calcium Channels in Inflammatory Cells of Asthmatic Children|Detection of Cav1 Calcium Channels in Inflammatory Cells of Asthmatic Children|Completed||N/A|60|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:03:51.540055|2017-10-10 22:03:51.540055
NCT02809547|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-11-08|||November 2016||2016-11-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|RADAR||RADAR1- Trial of a New Blood Sample Method (Remote Arthritis Disease Activity MonitoR)|Remote Arthritis Disease Activity MonitoR (RADAR 1) - a Feasibility Study of Home-based Dried Blood Spot Use to Monitor an Inflammatory Marker in Rheumatoid Arthritis Patients.|Recruiting||N/A|100|Anticipated|University of Ulster||2|||f||||||||||||||2017-10-10 22:03:51.618843|2017-10-10 22:03:51.618843
NCT02809534|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-09-04|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALTER0802||A Study of Anlotinib in Patients With Hepatocellular Carcinoma|A Single Group, Open Label, Single-center Clinical Trial to Assess the Efficacy and Safety of Anlotinib in Patients With Hepatocellular Carcinoma (ALTER0802)|Recruiting||Phase 2|60|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f||||||||Undecided||2017-10-10 22:03:51.718693|2017-10-10 22:03:51.718693
NCT02809521|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-09-20|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Increasing Spontaneous Non-exercise Activity (The Sitting Study)|Increasing Spontaneous Non-exercise Activity (The Sitting Study)|Completed||N/A|13|Actual|USDA Grand Forks Human Nutrition Research Center||1|||f||||f||||||||||2017-10-10 22:03:51.81972|2017-10-10 22:03:51.81972
NCT02809508|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-06-26|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Interventional|FiSK Junior||The Effect of Oily Fish and Poultry on Children's Cardiometabolic Health and Cognitive Function|The Effect of Oily Fish and Poultry on Children's Cardiometabolic Health and Cognitive Function|Completed||N/A|199|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-10 22:03:51.907746|2017-10-10 22:03:51.907746
NCT02809495|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-17|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Digital Application Usage for Adherence of Patients Undergoing Robotic Assisted Radical Prostatectomy Following Oncological and Postoperative Functional Outcomes|Digital Application Usage for Adherence of Patients Undergoing Robotic Assisted Radical Prostatectomy Following Oncological and Postoperative Functional Outcomes|Not yet recruiting||N/A|100|Anticipated|University of Sao Paulo General Hospital|||2||f||||f||||||||Undecided||2017-10-10 22:03:52.033868|2017-10-10 22:03:52.033868
NCT02809482|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-08-29|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||White Adipose Tissue Clocks and High Calorie Feeding|Pilot Study to Examine the Impact of Overfeeding on Peripheral Clock Gene Expression in Humans|Recruiting||N/A|10|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 22:03:52.112352|2017-10-10 22:03:52.112352
NCT02809469|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-21|||August 2016||2016-08-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ADREL||Apixaban Dose Reduction in Patients With Elevated Drug Levels|Optimal Dosing of Apixaban in Patients at Risk of Elevated Drug Levels: A Study Evaluating a Strategy of Apixaban Drug Level Measurement and Dose Reduction in Patients With Atrial Fibrillation Who Are at Risk of Elevated Drug Levels|Not yet recruiting||Phase 2|120|Anticipated|Hamilton Health Sciences Corporation||1|||f||||f||||||||No||2017-10-10 22:03:52.218169|2017-10-10 22:03:52.218169
NCT02809456|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-22|||July 2016||2016-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients|Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients|Enrolling by invitation||Phase 2|50|Anticipated|Taipei Medical University WanFang Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:03:52.306596|2017-10-10 22:03:52.306596
NCT02809443|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-03-07|||July 2016||2016-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of GLS-5700 in Healthy Volunteers|Phase I, Open-label, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of GLS-5700 Administered ID Followed by EP in Dengue Virus-Naïve Adults|Active, not recruiting||Phase 1|40|Actual|GeneOne Life Science, Inc.||2|||f||||t||||||||No||2017-10-10 22:03:52.386257|2017-10-10 22:03:52.386257
NCT02809430|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-18|||June 2016||2016-06-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|SCOUTS2||Stroke and CPAP Outcome Study 2|Maximizing Use of Continuous Positive Airway Pressure in Stroke Rehabilitation Patients With Obstructive Sleep Apnea|Recruiting||Phase 2|100|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 22:03:52.484678|2017-10-10 22:03:52.484678
NCT02809417|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-09-22|||January 28, 2016|Actual|2016-01-28|September 2017|2017-09-01|January 5, 2017|Actual|2017-01-05|January 5, 2017|Actual|2017-01-05||Observational|LICORNE||Interest of the Use of the Web Platform LICORNE (LIaison and COoRdination With a NumériquE Health Reseau) Concerning Coordination of Care for Dependant Elderly Patients|Interest of the Use of the Web Platform LICORNE (LIaison and COoRdination With a NumériquE Health Reseau) Concerning Coordination of Care for Dependant Elderly Patients|Completed||N/A|57|Actual|Centre Hospitalier Universitaire de Nice|||2||f||||||||||||||2017-10-10 22:03:52.580122|2017-10-10 22:03:52.580122
NCT02809391|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-18|||July 2016||2016-07-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Interventional|||Orthotics and Parkinson's Disease: The Acute and Long-term Effects of Increased Somatosensory Feedback|Orthotics and Parkinson's Disease: The Acute and Long-term Effects of Increased Somatosensory Feedback|Not yet recruiting||N/A|20|Anticipated|Wilfrid Laurier University||2|||f||||t||||||||No||2017-10-10 22:03:52.73426|2017-10-10 22:03:52.73426
NCT02809378|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|||The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV|The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of Postoperative Nausea and Vomiting in the Women Patients Undergoing Thyroidectomy|Completed||Phase 4|150|Actual|Ajou University School of Medicine||3|||f||||f||||||||||2017-10-10 22:03:52.838957|2017-10-10 22:03:52.838957
NCT02809365|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-08-24|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||FreeStyle Libre- Effect on QOL in Type 2 Diabetes Patients|The Impact on Quality of Life of Novel Glucose -Sensing Technology Used by Individuals With Type 2 Diabetes on Intensive-insulin Therapy|Not yet recruiting||N/A|100|Anticipated|Wolfson Medical Center||2|||f||||f||||||||No||2017-10-10 22:03:52.941168|2017-10-10 22:03:52.941168
NCT02809352|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-22|||July 2012||2012-07-01|June 2016|2016-06-01||||December 2014|Actual|2014-12-01||Observational|Epi-START||Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer|Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program Entitled START-HPV (STudy of Primary Screening in the ARdennes Department by Testing for HPV Infection)|Completed||N/A|348|Actual|CHU de Reims|||1||f||||||||||Samples With DNA|"     DNA extraction from cervical smears (DNAPap Cervical Sampler device, Qiagen) or from     self-collected vaginal lavages (Delphi-screener device, DelphiBioscience) and HPV genotyping     with the Multiplex HPV Genotyping kit© (Multimetrix, Progen) based on a Luminex technology.   "|||2017-10-10 22:03:53.047443|2017-10-10 22:03:53.047443
NCT02809339|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-06-18|||July 2016||2016-07-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|24 Months|Observational [Patient Registry]|||Improving Quality of Care for Patients With Recurrent Ovarian Cancer|Improving Quality of Care for Patients With Recurrent Ovarian Cancer|Not yet recruiting||N/A|360|Anticipated|Radboud University|||1||f||||f||||||||Undecided||2017-10-10 22:03:53.297681|2017-10-10 22:03:53.297681
NCT02809326|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-10-30|||November 2015||2015-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|TMT||Trauma Management Therapy for OEF and OIF Combat Veterans|Trauma Management Therapy for OEF and OIF Combat Veterans|Active, not recruiting||Phase 2|180|Actual|University of Central Florida||3|||f||||f||||||||||2017-10-10 22:03:53.434459|2017-10-10 22:03:53.434459
NCT02809313|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-10-24|||March 2016||2016-03-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Clinical and Microbiological Effects of Lactobacillus Rhamnosus in Treatment of Gingivitis|Clinical and Microbiological Effects of Lactobacillus Rhamnosus in Treatment of Gingivitis: a Randomized Placebo-controlled Trials With 3-month Follow-up|Recruiting||Phase 2|36|Anticipated|University of Chile||2|||f||||t||||||||No||2017-10-10 22:03:53.599273|2017-10-10 22:03:53.599273
NCT02809300|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-06-22|||November 2015||2015-11-01|June 2016|2016-06-01||||March 2017|Anticipated|2017-03-01||Interventional|ASAA||Ankylosing Spondylitis and Antiphospholipid Antibodies|Prevalence of Antiphospholipid Antibodies in Ankylosing Spondylitis: A Study of 80 Patients|Recruiting||N/A|80|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:03:53.758865|2017-10-10 22:03:53.758865
NCT02809287|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-21|||January 2015||2015-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife Position|A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife|Completed||N/A|10|Actual|Sun Yat-sen University|||1||f||||f||||||||No||2017-10-10 22:03:53.913805|2017-10-10 22:03:53.913805
NCT02809274|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-18|2016-06-21|||July 2016||2016-07-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Observational|||Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features|Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features|Not yet recruiting||N/A|200|Anticipated|Rambam Health Care Campus|||2||f||||t||||||Samples Without DNA|"     Serum blood sample for hepcidin   "|No||2017-10-10 22:03:54.027142|2017-10-10 22:03:54.027142
NCT02809261|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-12-04|||May 2016||2016-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Perineural Injection Therapy in Patients With Carpal Tunnel Syndrome|The Long-term Effect of Perineural Injection Therapy in Patients With Carpal Tunnel|Recruiting||N/A|60|Anticipated|Tri-Service General Hospital||2|||f||||t||||||||Yes||2017-10-10 22:03:54.275114|2017-10-10 22:03:54.275114
NCT02809248|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-07-07|||July 2016||2016-07-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|July 2016|Anticipated|2016-07-01||Interventional|||The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)|The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX-Stent Study)|Not yet recruiting||N/A|30|Anticipated|RWTH Aachen University||2|||f||||f||||||||No||2017-10-10 22:03:54.389219|2017-10-10 22:03:54.389219
NCT02809235|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-01-06|||October 2017||2017-10-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Fatty Acids in Airway Smooth Muscle of Asthmatics|The Role of Cholecystokinin and the Cholecystokinin Receptor in the Airway Smooth Muscle of Asthmatics|Not yet recruiting||N/A|20|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:03:54.480474|2017-10-10 22:03:54.480474
NCT02809222|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-21|||September 2016||2016-09-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PLASMYC||Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls|Kinetics of the Plasmatic Concentration of L-Ascorbic Acid in Patient With Myelodysplastic Syndromes and Control Subjects|Not yet recruiting||Phase 4|180|Anticipated|University Hospital, Tours||3|||f||||f||||||||No||2017-10-10 22:03:54.586318|2017-10-10 22:03:54.586318
NCT02809196|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2016-11-14|||June 2016||2016-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|T4HT||Texts For Healthy Teens: A Health Education Program for Adolescents|A Digital Messaging Education Program for Dietary Behavior Modification Towards Healthier Lifestyle Among Danish Adolescents|Recruiting||N/A|8000|Anticipated|Centre for Fetal Programming, Denmark||9|||f||||f||||||||Undecided||2017-10-10 22:03:54.73599|2017-10-10 22:03:54.73599
NCT02809183|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-12-05|||March 2016||2016-03-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of TRC101 in Subjects With Chronic Kidney Disease and Low Serum Bicarbonate Levels|Completed||Phase 1/Phase 2|135|Actual|Tricida, Inc.||6|||f||||f||||||||No||2017-10-10 22:03:54.869423|2017-10-10 22:03:54.869423
NCT02809157|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-21|||October 2014||2014-10-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Non-invasive Fractional Flow Reserve CT (FFRCT)Scan for the Study of Coronary Vaso-motion|Non-invasive Fractional Flow Reserve CT (FFRCT) Scan for the Study of Coronary Vaso-motion|Active, not recruiting||N/A|10|Anticipated|National Heart Centre Singapore|||1||f||||f||||||||No||2017-10-10 22:03:55.174178|2017-10-10 22:03:55.174178
NCT02809144|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-12-05|||April 2016||2016-04-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery|A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery|Completed||N/A|20|Actual|University Hospital of North Norway||1|||f||||f||||||||No||2017-10-10 22:03:55.248821|2017-10-10 22:03:55.248821
NCT02809131|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-03-23|||April 2016||2016-04-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ENVELOPE||Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.|Randomized Noninferiority Study of an Antibacterial Envelope Alone Versus Envelope Plus Intraoperative Antibacterial Irrigant and Postoperative Antibiotics to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Patients|Recruiting||Phase 3|1492|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 22:03:55.325651|2017-10-10 22:03:55.325651
NCT02809118|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-09-07|||June 2016||2016-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ASSENT||Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment|Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment|Recruiting||Phase 3|300|Anticipated|Auris Medical, Inc.||3|||f||||f||||||||||2017-10-10 22:03:55.453933|2017-10-10 22:03:55.453933
NCT02809092|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-29|||September 2016||2016-09-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia|A Phase I/II Clinical Trial Testing the Safety and Feasibility of IL-21- Expanded Natural Killer Cells for the Induction of Relapsed/Refractory Acute Myeloid Leukemia|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||f||||||||Undecided||2017-10-10 22:03:55.857799|2017-10-10 22:03:55.857799
NCT02809079|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-19|||January 2016||2016-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MONICA||Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients|Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients|Enrolling by invitation||Phase 4|100|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||Yes|share by publications and meetings|2017-10-10 22:03:55.93055|2017-10-10 22:03:55.93055
NCT02809066|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-21|||January 2015||2015-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Dietary Calcium Intake in Premenstrual Syndrome|Effect of Sufficient Dietary Calcium Intake in Women With Premenstrual Syndrome|Completed||N/A|31|Actual|Eastern Mediterranean University||2|||f||||f||||||||Undecided||2017-10-10 22:03:56.011873|2017-10-10 22:03:56.011873
NCT02809053|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-08-09|||January 18, 2017|Actual|2017-01-18|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|RAMO-2||A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma|A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma|Recruiting||Phase 3|308|Anticipated|Archigen Biotech Limited||2|||f||||t|t|f||||||||2017-10-10 22:03:56.257772|2017-10-10 22:03:56.257772
NCT02809040|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-07-11|||February 2015||2015-02-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||E_Stethoscope: Portable Digital Auscultation Study on Hypertensive/Hypertensive Heart Disease Patients|E_Stethoscope : Portable Digital Auscultation Based on Wireless Sensor Node to Diagnose Diastolic Dysfunction in Hypertensive Heart Disease|Active, not recruiting||N/A|60|Anticipated|National Heart Centre Singapore|||3||f||||f||||||||||2017-10-10 22:03:56.439814|2017-10-10 22:03:56.439814
NCT02809027|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-19|||June 1, 2016||2016-06-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Efficacy of Ginger in the Prevention of Abdominal Distention in Post Cesarean Section Patient|A Randomized Double-blind Placebo-controlled Trial on the Efficacy of Ginger in the Prevention of Abdominal Distention in Post Cesarean Section Patient|Completed||Phase 4|178|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 22:03:56.547775|2017-10-10 22:03:56.547775
NCT02809014|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-12-06|||February 2016||2016-02-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|December 2016|Actual|2016-12-01||Interventional|FdentifriceT||In Vivo Evaluation of an Experimental Fluoride-containing Dentifrice With Hydrocolloid|In Vivo Evaluation of an Experimental Fluoride-containing Dentifrice With Hydrocolloid|Active, not recruiting||Phase 1/Phase 2|24|Actual|Federal University of Paraíba||5|||f||||t||||||||Undecided||2017-10-10 22:03:56.644377|2017-10-10 22:03:56.644377
NCT02809001|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-17|||January 2011||2011-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||The Effects of Autologous Fat Transfer on Preventing Expanded Skin From Expansion Failure||Completed||Phase 1/Phase 2|80|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-10 22:03:57.342672|2017-10-10 22:03:57.342672
NCT02808988|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-19|||October 2013||2013-10-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis|Effect of Periodontal Therapy and Bisphosphonates on Gingival Crevicular Fluid Levels of Nuclear Factor- κb Ligand (RANKL) and Osteoprotegerin in Postmenopausal Osteoporosis: Results of a 12-Month Study|Completed||Phase 4|47|Actual|Ondokuz Mayıs University||4|||f||||f||||||||Yes||2017-10-10 22:03:57.88708|2017-10-10 22:03:57.88708
NCT02808975|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-20|2017-07-19|||July 18, 2016||2016-07-18|July 2017|2017-07-01|January 19, 2020|Anticipated|2020-01-19|October 2, 2019|Anticipated|2019-10-02||Interventional|SHARPS||Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study)|A Phase 4, Double-blind, Randomised, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Adalimumab Used in Conjunction With Surgery in Subjects With Moderate to Severe Hidradenitis Suppurativa|Recruiting||Phase 4|200|Anticipated|AbbVie||2|||f||||f||||||||||2017-10-10 22:03:58.010554|2017-10-10 22:03:58.010554
NCT02808962|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-01-17|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Optimal Performance of RFA of the Nerves Supplying the Posterior Sacroiliac Joint Complex.|In Pursuit of the Optimal Performance of Radiofrequency Ablation of the Nerves Supplying the Posterior Sacroiliac Joint Complex.|Recruiting||N/A|60|Anticipated|Milton S. Hershey Medical Center||1|||f||||f||||||||No||2017-10-10 22:03:58.211339|2017-10-10 22:03:58.211339
NCT02808949|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-29|||February 2015||2015-02-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women|Phase 1 Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women|Active, not recruiting||Phase 1|16|Anticipated|International Partnership for Microbicides, Inc.||1|||f||||t||||||||||2017-10-10 22:03:58.336763|2017-10-10 22:03:58.336763
NCT02808936|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-09-03|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|RIPC-Angina||The Effect of Remote Ischemic Preconditioning on Major Organ Function in Patients With Coronary Artery Disease Undergoing Orthopedic Surgery|The Effect of Remote Ischemic Preconditioning on Major Organ Function in Patients With Coronary Artery Disease Undergoing Orthopedic Surgery - a Randomized Controlled Trial|Completed||N/A|60|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:03:58.453834|2017-10-10 22:03:58.453834
NCT02808923|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-18|||June 2016||2016-06-01|June 2016|2016-06-01||||August 2016|Anticipated|2016-08-01||Interventional|||Effects of Long-term Foam Rolling Compared to Static Stretching on Hamstring Muscle Flexibility||Not yet recruiting||N/A|45|Anticipated|Creighton University||3|||f||||f||||||||Yes|Non-identifying participant demographics and data on outcome measures (range of motion) for the study may be made available through publication or presentation on the study.|2017-10-10 22:03:58.57679|2017-10-10 22:03:58.57679
NCT02808910|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-17|||April 2016||2016-04-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Small Nudge for Better Health Through Reduced Salt Intake, Increased Vegetable Intake, and Smaller Portion Size|Nudging: How Small Changes in the Cafeteria of the Feiring Heart Clinic Can Result in a Healthier Food Choice.|Enrolling by invitation||N/A|144|Anticipated|LHL Helse||5|||f||||f||||||||No||2017-10-10 22:03:58.692709|2017-10-10 22:03:58.692709
NCT02808897|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-17|||November 2015||2015-11-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|ACT-POAF||The Effect of Chest Tubes Using Active Clearance Technology® on the Incidence of Postoperative Atrial Fibrillation|Atrial Fibrillation and Pericardial Drainage: Incidence of Postoperative Atrial Fibrillation According to the Type of Mediastinal Drainage Catheters|Recruiting||Phase 4|508|Anticipated|Montreal Heart Institute||2|||f||||||||||||Undecided||2017-10-10 22:03:58.834076|2017-10-10 22:03:58.834076
NCT02808884|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-19|||September 2016||2016-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CANDACE||Cancer DNA Screening Pilot Study (CANDACE)|Cancer DNA Screening Pilot Study (CANDACE)|Active, not recruiting||Phase 1|1000|Anticipated|British Columbia Cancer Agency||3|||f||||t||||||||No|Only participants have the option of receiving their own personal data.|2017-10-10 22:03:59.019934|2017-10-10 22:03:59.019934
NCT02808871|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-06-13|||April 7, 2017|Actual|2017-04-07|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Phase ll Study of Pirfenidone in Patients With RAILD|Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients With Rheumatoid Arthritis Interstitial Lung Disease|Recruiting||Phase 2|270|Anticipated|Brigham and Women's Hospital||2|||f||||t|t|f|||t|||No||2017-10-10 22:03:59.170599|2017-10-10 22:03:59.170599
NCT02808858|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-10|||September 2013||2013-09-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|June 2016|Actual|2016-06-01|2 Years|Observational [Patient Registry]|FISM_registry||Italian Network MDS Registry|Rete Italiana Dei Registri Regionali Delle Sindromi Mielodisplastiche (MDS)|Recruiting||N/A|1000|Anticipated|Fondazione Italiana Sindromi Mielodisplastiche Onlus|||1||f||||f||||||||||2017-10-10 22:03:59.334483|2017-10-10 22:03:59.334483
NCT02807285|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-09-04||||||September 2017|2017-09-01||||||||Expanded Access|||Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis|An Open Label, MultiCenter, Expanded-Access Program for Ocrelizumab in Patients With Primary Progressive Multiple Sclerosis|No longer available||N/A|||Genentech, Inc.|||||||||||||||||||2017-10-10 22:04:17.140039|2017-10-10 22:04:17.140039
NCT02808845|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-21|||December 2016||2016-12-01|June 2016|2016-06-01||||December 2020|Anticipated|2020-12-01||Observational|MPCC||Microalbuminuria Predicting CIAKI After CAG|Pre-existing Microalbuminuria Predicting Contrast-induced Acute Kidney Injury (CIAKI) Following Coronary Angiography (CAG)|Not yet recruiting||N/A|800|Anticipated|The First Affiliated Hospital with Nanjing Medical University|||4||f||||||||||||||2017-10-10 22:03:59.495496|2017-10-10 22:03:59.495496
NCT02808832|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-09-12|||September 2010||2010-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||An HPV Vaccine Provider Intervention in Safety Net Clinics|Development of an HPV Vaccine and Cervical Cancer Screening Provider Intervention|Completed||N/A|806|Actual|Meharry Medical College||2|||f||||f||||||||No||2017-10-10 22:03:59.645889|2017-10-10 22:03:59.645889
NCT02808819|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-07|||June 30, 2016|Actual|2016-06-30|August 2017|2017-08-01|March 6, 2019|Anticipated|2019-03-06|March 6, 2019|Anticipated|2019-03-06||Interventional|MELTEMI||A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist|A Multicenter, Open-label, Safety Extension Study With Benralizumab (MEDI-563) for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist (MELTEMI)|Active, not recruiting||Phase 3|446|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:03:59.760121|2017-10-10 22:03:59.760121
NCT02808806|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-20|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|ARTEMIS||A Reduction in Time With Electronic Monitoring In Stroke|A Reduction in Time With Electronic Monitoring In Stroke (ARTEMIS) Trial|Not yet recruiting||N/A|500|Anticipated|Leiden University Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:04:00.202145|2017-10-10 22:04:00.202145
NCT02808793|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-12-21|||June 2016||2016-06-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002|A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Patients With Indolent Systemic Mastocytosis (ISM)|Recruiting||Phase 1|30|Anticipated|Allakos, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:04:00.446283|2017-10-10 22:04:00.446283
NCT02808780|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-10-03|||December 16, 2016|Actual|2016-12-16|October 2017|2017-10-01|July 30, 2031|Anticipated|2031-07-30|July 25, 2031|Anticipated|2031-07-25||Observational|OPAL||An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis|Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis|Recruiting||N/A|6000|Anticipated|Janssen Biotech, Inc.|||2||f||||f||f||||||||2017-10-10 22:04:00.555139|2017-10-10 22:04:00.555139
NCT02808767|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-08-10|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2016|Actual|2016-05-01||Interventional|PRAGUE-18||Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction|Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction|Completed||Phase 4|1226|Actual|Faculty Hospital Kralovske Vinohrady||2|||f||||t||||||||||2017-10-10 22:04:00.7993|2017-10-10 22:04:00.7993
NCT02808637|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-17|||April 2015||2015-04-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||Vaccine‐Related Pain in Infants||Completed||N/A|128|Actual|Çankırı Karatekin University||4|||f||||t||||||||||2017-10-10 22:04:00.905267|2017-10-10 22:04:00.905267
NCT02808624|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-04-20|||June 2015||2015-06-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients|The Potential Prophylactic Effect of Exogenous Antioxidant ''L-CARNOSINE'' on Oxaliplatin-induced Peripheral Neuropathy in Cancer Patients|Completed||Phase 1/Phase 2|65|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 22:04:00.988233|2017-10-10 22:04:00.988233
NCT02808611|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-06-27|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Influence of Propranolol on Conditioned Pain Modulation|Konditionerende Smertestimuli - Sammenligning af Forskellige Test og Konditioneringsmodaliteter|Completed||N/A|25|Actual|Aalborg University||2|||f||||f||||||||||2017-10-10 22:04:01.072354|2017-10-10 22:04:01.072354
NCT02808598|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-06-16|||May 2007||2007-05-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|January 2012|Actual|2012-01-01||Interventional|||Breast Cancer Trials Education Program|Scientific Literacy and Breast Cancer Clinical Trials Education Program for Hispanic American and African American Women|Completed||N/A|1065|Actual|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 22:04:01.147423|2017-10-10 22:04:01.147423
NCT02808585|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-09-26|||June 2016||2016-06-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)|Phase 2a, Randomized, Double-blind, Placebo-controlled, Multiple-dose, 2-Part Study to Assess the Safety, Tolerability and Pharmacokinetic Response and Explore the Pharmacodynamic Response Following 4 Weeks of Once Weekly Subcutaneous Injections of PB1046 in Adult Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF) (Part 1) and in Subjects With Cardiac Dysfunction Secondary to Duchenne Muscular Dystrophy (Part 2)|Recruiting||Phase 2|28|Anticipated|PhaseBio Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-10 22:04:01.256935|2017-10-10 22:04:01.256935
NCT02808572|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-01-17|||March 2013||2013-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients|New Biomarkers of Bone and Mineral Metabolism as Risk Factors for Morbidity/Mortality in Chronic Kidney Disease Patients Not Requiring Dialysis|Recruiting||N/A|250|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:04:01.383164|2017-10-10 22:04:01.383164
NCT02808559|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-17|||November 2014||2014-11-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PASIMAT||PASIMAT: Automatic Measure of PASI|PASIMAT: Automatic Measure of PASI by Skin Imaging|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||t||||||||Undecided||2017-10-10 22:04:01.509774|2017-10-10 22:04:01.509774
NCT02808546|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-17|||January 2009||2009-01-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Observational|||The Risk Factors of Symptomatic Gallbladder Stone: Age-Sex Matched Case-control Study Performed in Single Institute|The Risk Factors of Symptomatic Gallbladder Stone: Age-Sex Matched Case-control Study Performed in Single Institute|Completed||N/A|342|Actual|Cheju Halla General Hospital|||2||f||||t||||||||Undecided||2017-10-10 22:04:01.575961|2017-10-10 22:04:01.575961
NCT02808533|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-06-12|||April 2016||2016-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Topiramate and Schizophrenia: Effects on Weight and Psychopathology|Topiramate in Treatment Refractory Psychotic Illness: Effects on Weight Gain and Psychopathology|Recruiting||N/A|50|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 22:04:01.661033|2017-10-10 22:04:01.661033
NCT02808520|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-20|||March 2016||2016-03-01|June 2016|2016-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma|Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma. A Prospective Multicenter Cohort Study of Social and Personal Influencing Factors|Not yet recruiting||N/A|700|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||1||f||||||||||||||2017-10-10 22:04:01.779011|2017-10-10 22:04:01.779011
NCT02808507|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-10-12|||July 2016||2016-07-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Interventional|Kharitode TB||Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa|Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa|Recruiting||N/A|128171|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-10 22:04:01.866456|2017-10-10 22:04:01.866456
NCT02808494|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-02-28|||March 2016||2016-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers|Prospective Collection of Whole Blood Specimens of Subjects Diagnosed With Preeclampsia With Severe Features and/or Fetal Growth Restriction in Support of a Molecular Assay Development|Recruiting||N/A|240|Anticipated|Illumina, Inc.|||2||f||||f||||||Samples With DNA|"     Stored for future assay development use.   "|No||2017-10-10 22:04:01.969774|2017-10-10 22:04:01.969774
NCT02808481|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-20|||June 2016||2016-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC||Not yet recruiting||N/A|9|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:04:02.097009|2017-10-10 22:04:02.097009
NCT02808468|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-09-25|||March 2015||2015-03-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|BRITE||Brief Restructuring Intervention Following Trauma Exposure|Developing a Brief Early Cognitive Intervention for PTSD and Alcohol Misuse|Recruiting||N/A|82|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 22:04:02.155651|2017-10-10 22:04:02.155651
NCT02808455|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-16|||January 2015||2015-01-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects|A Phase 1, Open-Label, Single-Dose, Randomized, 2-Period, 2-Treatment-Sequence Crossover Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects|Completed||Phase 1|12|Actual|CTI BioPharma||2|||f||||f||||||||Yes||2017-10-10 22:04:02.243417|2017-10-10 22:04:02.243417
NCT02808442|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-05-11|||June 3, 2016|Actual|2016-06-03|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|PALL||Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia|A Phase 1, Open Label, Non-comparative Study to Evaluate the Safety and the Ability of UCART19 to Induce Molecular Remission in Paediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukaemia|Recruiting||Phase 1|10|Anticipated|Servier||1|||f||||t|f|f|||f|||Yes|The datasets generated and/or analysed during the current study will be available upon request from www.servier.com after the Marketing Authorisation has been granted.|2017-10-10 22:04:02.338702|2017-10-10 22:04:02.338702
NCT02808429|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-10-04|||January 31, 2017|Actual|2017-01-31|October 2017|2017-10-01|January 17, 2020|Anticipated|2020-01-17|November 4, 2018|Anticipated|2018-11-04||Interventional|||Efficacy and Safety of Atacicept in IgA Nephropathy|A Phase II Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in IgA Nephropathy|Recruiting||Phase 2|30|Anticipated|EMD Serono||7|||f||||t|t|f||||||||2017-10-10 22:04:02.439433|2017-10-10 22:04:02.439433
NCT02808416|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-20|||June 2016||2016-06-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|June 2018|Anticipated|2018-06-01||Interventional|PerCellVac3||Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)|Personalized Cellular Vaccine Therapy in Treating Patients With Brain Metastases From Solid Tumors|Recruiting||Phase 1/Phase 2|30|Anticipated|Guangdong 999 Brain Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:04:02.655468|2017-10-10 22:04:02.655468
NCT02808403|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-06-06|||June 24, 2016|Actual|2016-06-24|June 2017|2017-06-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2022|Anticipated|2022-04-30||Observational|||Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan|Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab (AMG 145) in Japan|Recruiting||N/A|6000|Anticipated|Amgen|||1||f||||f||||||||||2017-10-10 22:04:02.808361|2017-10-10 22:04:02.808361
NCT02808390|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-08-22|||November 28, 2016|Actual|2016-11-28|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|SEGMENT||Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC|A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of GED-0507-34-Levo (GED0507) for Treatment of Subjects With Active Ulcerative Colitis|Terminated||Phase 2|19|Actual|PPM Services S.A.||3||Sponsor decision|f||||f||||||||||2017-10-10 22:04:03.283935|2017-10-10 22:04:03.283935
NCT02808377|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|NTRSPOP||Native Tissue Repair With Surgical Pelvic Organ Pessary - an RCT|VAGINAL NATIVE TISSUE REPAIR AUGMENTATION WITH POST OPERATIVE PLACEMENT OF SURGICAL PELVIC ORGAN PESSARY (SPOP). A MULTICENTRE SINGLE BLINDED RANDOMISED CONTROLLED STUDY|Not yet recruiting||N/A|120|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:04:03.486342|2017-10-10 22:04:03.486342
NCT02808364|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-20|||June 2016||2016-06-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|June 2018|Anticipated|2018-06-01||Interventional|PerCellVac2||Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)|Personalized Cellular Vaccine Therapy in Treating Patients With Recurrent Glioblastoma (PerCellVac2)|Recruiting||Phase 1/Phase 2|30|Anticipated|Guangdong 999 Brain Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:04:03.721206|2017-10-10 22:04:03.721206
NCT02808351|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-02-09|||July 2016||2016-07-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes|Multicenter Randomized Controlled Study of Berberine for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Renal Insufficient|Recruiting||Phase 4|800|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t||||||||No||2017-10-10 22:04:03.891385|2017-10-10 22:04:03.891385
NCT02808338|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-16|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:04:04.030372|2017-10-10 22:04:04.030372
NCT02808325|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-08-10|||June 2016||2016-06-01|April 2017|2017-04-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Study on the Efficacy and Safety of Gelaspan|Prospective Controlled Randomized Double-blind Multicentre Study in Parallel Groups on the Efficacy and Safety of Gelaspan in Combination With Sterofundin ISO in Comparison With Gelofusine in Combination With Sodium Chloride Braun in Patients Scheduled for Abdominal or Pelvic Surgery|Completed||Phase 3|72|Actual|B. Braun Melsungen AG||2|||f||||f||||||||||2017-10-10 22:04:04.086915|2017-10-10 22:04:04.086915
NCT02808312|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-09-26|||July 13, 2016|Actual|2016-07-13|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pharmacokinetics and Pharmacodynamics of GS-9674 in Adults With Normal and Impaired Hepatic Function|A Phase 1 Open-Label, Parallel-Group, Adaptive, Single-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of GS-9674 in Subjects With Normal and Impaired Hepatic Function|Recruiting||Phase 1|60|Anticipated|Gilead Sciences||3|||f||||f||||||||||2017-10-10 22:04:04.236549|2017-10-10 22:04:04.236549
NCT02808299|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-17|||December 2016||2016-12-01|June 2016|2016-06-01||||December 2020|Anticipated|2020-12-01||Observational|LISHBV||Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection|Liver Injury by Statins in Coronary Heart Disease (CHD) Patients With History of Hepatitis B Virus (HBV) Infection|Not yet recruiting||N/A|600|Anticipated|The First Affiliated Hospital with Nanjing Medical University|||3||f||||||||||||||2017-10-10 22:04:04.406971|2017-10-10 22:04:04.406971
NCT02808286|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-10-17|||January 2016||2016-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Hybrid Emotion-focused Treatment for Chronic Pain Patients With Emotional Problems|An Randomized Controlled Trial (RCT) Testing the Effectiveness of a Hybrid Emotion-focused Treatment for Chronic Pain Patients With Co-occurring Emotional Problems|Recruiting||N/A|84|Anticipated|Örebro University, Sweden||2|||f||||f||||||||No||2017-10-10 22:04:04.585859|2017-10-10 22:04:04.585859
NCT02808273|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-06-28|||February 2016||2016-02-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2016|Actual|2016-02-01||Observational|||Use of Bemiparine as a Prophylactic Antithrombotic Agent, in Patients Undergoing Microsurgery for Head and Neck Reconstruction|Use of Bemiparine as a Prophylactic Antitrombotic Agent, in Patients Undergoing Microsurgery for Head and Neck Reconstruction|Recruiting||N/A|67|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal|||2||f||||f||||||||No||2017-10-10 22:04:04.740172|2017-10-10 22:04:04.740172
NCT02808260|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-24|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|July 2029|Anticipated|2029-07-01|July 2029|Anticipated|2029-07-01||Observational|||Predicting Development of SCAF in Device Patients|Predicting Development of Sub-Clinical Atrial Fibrillation in Device Patients|Not yet recruiting||N/A|500|Anticipated|Ottawa Heart Institute Research Corporation|||1||f||||f||||||Samples Without DNA|"     Blood samples will be collected for the measurement of biomarkers   "|No||2017-10-10 22:04:04.911761|2017-10-10 22:04:04.911761
NCT02808247|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-09-13|||July 7, 2017|Actual|2017-07-07|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|ANITA||Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma|"A Phase II Multicenter Study Comparing the Efficacy of the Oral Angiogenesis Inhibitor Nintedanib With the Intravenous Cytotoxic Compound Ifosfamide for Treatment of Patients With Advanced Metastatic Soft Tissue Sarcoma After Failure of Systemic Non-oxazaphosporine-based First Line Chemotherapy for Inoperable Disease ANITA"|Recruiting||Phase 2|185|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t|f|f||||||||2017-10-10 22:04:05.055569|2017-10-10 22:04:05.055569
NCT02808234|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-07|||December 2015||2015-12-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Study of Nucel for One and Two Level Lumbar Interbody Fusion|A Single-arm, Prospective, Multi-center Study of Nucel® in Patients Receiving Interbody Fusion for One and Two Level Degenerative Disease of the Lumbar Spine|Recruiting||N/A|200|Anticipated|NuTech Medical, Inc||1|||f||||f||||||||||2017-10-10 22:04:05.362843|2017-10-10 22:04:05.362843
NCT02808221|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-06-14|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|PRADO-IC||Readmission in the Case of Patients With Heart Failure||Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 22:04:05.536185|2017-10-10 22:04:05.536185
NCT02808208|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-08-16|||June 7, 2017|Actual|2017-06-07|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure|A Phase I, Open Label, Randomized Study of Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure|Recruiting||Phase 1|44|Anticipated|Mayo Clinic||2|||f||||f|t|f||||||||2017-10-10 22:04:05.640312|2017-10-10 22:04:05.640312
NCT02808195|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-04-18|||August 2016||2016-08-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparative Effectiveness of a Kinect-based Unilateral Arm Training System vs Constraint-Induced Therapy for Children With Cerebral Palsy|Comparative Effectiveness of a Kinect-based Unilateral Arm Training System vs Constraint-Induced Therapy for Children With Cerebral Palsy|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 22:04:05.764437|2017-10-10 22:04:05.764437
NCT02808182|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-02-06|||January 17, 2017|Actual|2017-01-17|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|May 2018|Anticipated|2018-05-01||Interventional|AGL11||Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)|Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D): Relative Contribution of Dietary vs Systemic Fatty Acids to Lean Tissue Fatty Acid Fluxes and Oxidative vs Non-oxidative Pathways|Recruiting||N/A|40|Anticipated|Université de Sherbrooke||4|||f||||||||||||||2017-10-10 22:04:05.934932|2017-10-10 22:04:05.934932
NCT02808169|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-07-20|||November 20, 2015|Actual|2015-11-20|July 2017|2017-07-01|August 8, 2016|Actual|2016-08-08|August 8, 2016|Actual|2016-08-08||Observational|||Radlink GPS Provide a Valid Intra-operative Assessment of Acetabular Inclination and Anteversion|Radlinik GPS Provide a Valid Intra-operative Assessment of Acetabular Inclination and Anteversion|Completed||N/A|200|Actual|Barrett, William, M.D.|||1||f||||f||||||||||2017-10-10 22:04:06.078415|2017-10-10 22:04:06.078415
NCT02808156|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-04-18|||June 2016||2016-06-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effectiveness of Unilateral Versus Bilateral Intensive Training in Children With Cerebral Palsy|Effectiveness of Unilateral Versus Bilateral Intensive Training in Children With Cerebral Palsy|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 22:04:06.155332|2017-10-10 22:04:06.155332
NCT02808143|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-02-20|||February 10, 2017|Actual|2017-02-10|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer|A Phase 1 Dose-Escalation Study of Intravesical MK-3475 and Bacillus Calmette-Guerin (BCG) in Subjects With High Risk and BCG-Refractory Non-Muscle-Invasive Bladder Cancer|Recruiting||Phase 1|27|Anticipated|Northwestern University||1|||f||||t|t|f||||||||2017-10-10 22:04:06.267779|2017-10-10 22:04:06.267779
NCT02808130|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-08-01|2016-06-20||January 2013||2013-01-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||PERIODONTAL DISEASE AND HYPERLIPIDEMIA|A CASE CONTROL STUDY TO DETERMINE THE GINGIVAL CREVICULAR FLUID MALONDIALDEHYDE, PROTEIN CARBONYL AND TOTAL ANTIOXIDANT CAPACITY IN PATIENTS WITH PERIODONTAL DISEASE AND HYPERLIPIDEMIA|Completed||N/A|90|Actual|Ondokuz Mayıs University|||6||f||||||||||Samples Without DNA|"     gingival crevicular fluid   "|||2017-10-10 22:04:06.417024|2017-10-10 22:04:06.417024
NCT02808117|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-11-29|||May 2015||2015-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Observational|||Microfinance Institutions as a Platform for Global Health|Microfinance Institutions as a Platform for Global Health Delivery: Evidence From a Pilot Program|Completed||N/A|526|Actual|Columbia University|||2||f||||f||||||||Undecided||2017-10-10 22:04:06.88594|2017-10-10 22:04:06.88594
NCT02808104|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-04-04|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|||Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2|84|Actual|NLS-1 Pharma Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:04:06.991891|2017-10-10 22:04:06.991891
NCT02808091|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-09-02|||March 2011||2011-03-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|Gifox-B||Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma|Phase II Trial of Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin (GIFOX-B)in Untreated NK/T Cell Lymphoma|Terminated||Phase 2|7|Actual|National Cancer Centre, Singapore||2||Slow recruitment|f||||f||||||||||2017-10-10 22:04:07.073991|2017-10-10 22:04:07.073991
NCT02808078|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|GASPAR||Gait Adaptation for Stroke Patients With Augmented Reality|Visually-guided Gait Training in Paretic Patients During First Rehabilitation: a Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|Clinique Romande de Readaptation||2|||f||||f||||||||Yes|At the end of the study, final anonymized database will be made available through a specialized online repository|2017-10-10 22:04:07.166565|2017-10-10 22:04:07.166565
NCT02808065|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-17|||May 2016||2016-05-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients|Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients|Recruiting||N/A|40|Anticipated|Seoul National University Hospital|||1||f||||||||||||||2017-10-10 22:04:07.278391|2017-10-10 22:04:07.278391
NCT02808052|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-07-12|||May 29, 2017|Actual|2017-05-29|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency|A Phase I, Open-Label, Single-Dose Trial To Determine The Safety And Pharmacokinetics Of Minocin (Minocycline) For Injection In Subjects With Renal Insufficiency|Recruiting||Phase 1|40|Anticipated|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||1|||f||||t|t|f||||||||2017-10-10 22:04:07.384044|2017-10-10 22:04:07.384044
NCT02808039|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-17|||September 2016||2016-09-01|June 2016|2016-06-01||||April 2017|Anticipated|2017-04-01||Observational|||Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy With Ticagrelor - a Single Center Prospective Observational Trial|Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy With Ticagrelor - a Single Center Prospective Observational Trial|Not yet recruiting||N/A|60|Anticipated|Rabin Medical Center|||1||f||||||||||||Yes||2017-10-10 22:04:07.583745|2017-10-10 22:04:07.583745
NCT02808026|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-03-31|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study of CS-3150 in Patients With Severe Hypertension|A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Patients With Severe Hypertension (Grade III)|Completed||Phase 3|20|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:04:07.685699|2017-10-10 22:04:07.685699
NCT02808013|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01||||September 2017|Anticipated|2017-09-01||Interventional|||Study to Evaluate Efficacy and Safety of NDS-446 in Men With Lower Urinary Tract Symptoms (LUTS)|Prospective Randomized, Double-Blind, Placebo Controlled Study of NDS-446 (500 mg/Cap) in Men 45 Years of Age or Older With Moderate to Severe Lower Urinary Tract Symptoms (LUTS)|Not yet recruiting||Phase 2|116|Anticipated|Naturex-Dbs||2|||f||||||||||||||2017-10-10 22:04:07.786012|2017-10-10 22:04:07.786012
NCT02808000|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-17|||April 2016||2016-04-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CDOC||BIP Foley in Prevention of CAUTI at Rehab Station|Evaluation of Suprapubic Noble Metal Alloy BIP Foley Catheter in the Prevention of Catheter-associated Urinary Tract Infections in Spinal Cord Injured Patients|Recruiting||Phase 4|20|Anticipated|Bactiguard AB||2|||f||||f||||||||No||2017-10-10 22:04:07.879998|2017-10-10 22:04:07.879998
NCT02807987|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-08-10|||June 2016||2016-06-01|August 2017|2017-08-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment|A Study of CS-3150 to Evaluate Efficacy and Safety in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment|Completed||Phase 3|58|Actual|Daiichi Sankyo, Inc.||1|||f||||f|f|f||||||||2017-10-10 22:04:08.006257|2017-10-10 22:04:08.006257
NCT02807974|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-03-31|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria|A Study of CS-3150 to Evaluate Efficacy and Safety in Hypertensive Patients With Type 2 Diabetes and Albuminuria.|Completed||Phase 3|51|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:04:08.097451|2017-10-10 22:04:08.097451
NCT02807961|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-30|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|||Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers|Phase 1a, Randomized, Double-blinded, Placebo-controlled, Single-dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ELX-02 in Healthy Adult Volunteers|Terminated||Phase 1|42|Actual|Eloxx Pharmaceuticals, Inc.||2||Transferred study to Antwerp, Belgium|f||||t||||||||||2017-10-10 22:04:08.178198|2017-10-10 22:04:08.178198
NCT02807948|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-05-22|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||SJM MRI Diagnostic Imaging Registry (IDE)|A Clinical Evaluation of the Diagnostic Utility of MRI Scans in Patients Implanted With St. Jude Medical Pacemakers, Implantable Cardioverter Defibrillator, and Cardiac Resynchronization Therapy Devices.|Recruiting||N/A|150|Anticipated|St. Jude Medical||1|||f||||f||||||||No||2017-10-10 22:04:08.276766|2017-10-10 22:04:08.276766
NCT02807935|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-22|||July 2016||2016-07-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal Micro-structure|The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal|Not yet recruiting||N/A|440|Anticipated|Sheba Medical Center||1|||f||||f||||||||Undecided||2017-10-10 22:04:10.402046|2017-10-10 22:04:10.402046
NCT02807922|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-02-06|||November 15, 2016|Actual|2016-11-15|February 2017|2017-02-01|December 15, 2020|Anticipated|2020-12-15|December 15, 2020|Anticipated|2020-12-15||Interventional|||Pharmacological Treatment of Insomnia in Palliative Care|Pharmacological Treatment of Insomnia in Palliative Care: A Randomized, Double-blind, Placebo Controlled, Parallel-group, Multicenter Trial Investigating the Short Time Effect of Zopiclone on Self-reported Sleep Quality in Patients With Advanced Cancer Who Use Opioids and Who Report Insomnia|Recruiting||Phase 4|100|Anticipated|St. Olavs Hospital||2|||f||||f|f|f||||||No||2017-10-10 22:04:10.491215|2017-10-10 22:04:10.491215
NCT02807909|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-09-09|||July 2016||2016-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects|An Open-Label Single-Sequence Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-Dose Pharmacokinetics of BMS-986177 in Healthy Subjects|Completed||Phase 1|28|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:04:10.619239|2017-10-10 22:04:10.619239
NCT02807896|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-09-13|||June 2016||2016-06-01|September 2016|2016-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|miRNA_Chip||Validation of Useful Markers Generated by Next Generation Bio-data Based Genome Research and Cohort Study|Multiple Biomarker Development Through Validation of Useful Markers Generated by Next Generation Bio-data Based Genome Research and Cohort Study|Recruiting||N/A|232|Anticipated|LG Electronics Inc.|||5||f||||t||||||Samples With DNA|"     Among patients with pancreatic cancer or bile duct cancer without previous chemotherapy or     radiation therapy, the subjects are divided into operable patients and inoperable patients.      For operable patients, about 10cc (paxgene tube) of blood sample is collected before     operation. After operation, 400mg of cancerous tissue and 400mg of normal tissue are     requested and received from the gene bank of Severance Hospital where the tissues are stored.   "|No||2017-10-10 22:04:10.694713|2017-10-10 22:04:10.694713
NCT02807883|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-05-02|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia|Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia|Recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:04:10.778791|2017-10-10 22:04:10.778791
NCT02807870|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-05-18|||June 2016||2016-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Interventions in Children With Attention Deficit/Hyperactivity Disorder|Early Interventions in Children With Attention Deficit/Hyperactivity Disorder: Randomized Controlled Trial Comparing Methylphenidate Parental Training in Treating Preschool Children With Attention Deficit / Hyperactivity Disorder|Recruiting||Phase 4|150|Anticipated|University of Sao Paulo||3|||f||||f||||||||No||2017-10-10 22:04:10.871555|2017-10-10 22:04:10.871555
NCT02807857|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-07-31|||July 7, 2016|Actual|2016-07-07|July 2017|2017-07-01|June 26, 2019|Anticipated|2019-06-26|June 26, 2019|Anticipated|2019-06-26||Interventional|PREFER||A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care|A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care|Recruiting||Phase 4|4000|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 22:04:11.01237|2017-10-10 22:04:11.01237
NCT02807844|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-06-26|||June 29, 2016|Actual|2016-06-29|June 2017|2017-06-01|June 17, 2019|Anticipated|2019-06-17|July 29, 2018|Anticipated|2018-07-29||Interventional|||Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies|A Phase Ib/II, Open Label, Multicenter Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies|Recruiting||Phase 1/Phase 2|196|Anticipated|Novartis||4|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:04:11.651587|2017-10-10 22:04:11.651587
NCT02807831|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-16|||February 2014||2014-02-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Randomized Clinical Trial Comparing Executive Function and Language Skills Training on School Readiness in Preschool Children|A Randomized Clinical Trial Comparing Executive Function and Language Skills Training on School Readiness in Preschool Children|Completed||N/A|582|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-10 22:04:11.775846|2017-10-10 22:04:11.775846
NCT02807805|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-09-27|||September 2016||2016-09-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer|A Phase II Study With a Lead-in Safety Phase of Abiraterone in Combination With PDMX1001/Niclosamide in Castration-Resistant Prostate Cancer (CRPC)|Recruiting||Phase 2|40|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 22:04:11.913354|2017-10-10 22:04:11.913354
NCT02807792|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-04-25|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Perianal Operating Scope Feasibliity|Perianal Operating Scope Feasibility|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||1||No funding|f||||f|f|t|f|f|f|||Undecided||2017-10-10 22:04:12.024873|2017-10-10 22:04:12.024873
NCT02807779|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-06-16|||August 2015||2015-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|INVADER MRI||Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging|Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging|Recruiting||Phase 4|80|Anticipated|University of California, San Francisco||2|||f||||t||||||||No||2017-10-10 22:04:12.097972|2017-10-10 22:04:12.097972
NCT02807766|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-11-09|||May 2016||2016-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brain Plasticity of Autism in Response to Early Behavioral Intervention: A Multimodal MRI Study|Brain Plasticity of Autism in Response to Early Behavioral Intervention: A Multimodal MRI Study|Recruiting||N/A|150|Anticipated|University of Electronic Science and Technology of China||5|||f||||t||||||||Undecided||2017-10-10 22:04:12.208547|2017-10-10 22:04:12.208547
NCT02807753|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-07-11|||July 2016||2016-07-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|HUP||The Hemophilia Ultrasound Project|Evaluation of Joint Arthropathy Using Ultrasound Technique in Children With Severe Hemophilia Undergoing Prophylaxis Regimen|Recruiting||N/A|60|Anticipated|University of Miami|||2||f||||||||||||||2017-10-10 22:04:12.444534|2017-10-10 22:04:12.444534
NCT02807740|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-02-11|||May 2016||2016-05-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|VRPark||Virtual Reality in Parkinson Disease|To Rehabilitate With Virtual Reality: To Evaluate the Effect of Virtual Reality on Cardiocirculatory System and on Balance in a Sample of Healthy Subject and Patients Affected by Parkinson Disease|Completed||N/A|30|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||No||2017-10-10 22:04:12.590319|2017-10-10 22:04:12.590319
NCT02807727|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-16|||July 2016||2016-07-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CREW-I||Cardiac REperfusion With Intralipid® at Reperfusion|Randomised Control Study on Cardiac Protection With Intralipid® in Patients Undergoing Coronary Artery Bypass Grafting on Cardiopulmonary Bypass|Not yet recruiting||Phase 2/Phase 3|30|Anticipated|University of Cape Town||2|||f||||t||||||||No|The individual participant data will not be shared|2017-10-10 22:04:12.688118|2017-10-10 22:04:12.688118
NCT02807714|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-04-10|||June 2016||2016-06-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Observational|||Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease|Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease|Recruiting||N/A|900|Anticipated|Bassett Healthcare|||4||f||||f||||||||Undecided||2017-10-10 22:04:12.777958|2017-10-10 22:04:12.777958
NCT02807701|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-20|||May 2016||2016-05-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|LPD||Minimally Invasive Pancreatico-duodenectomy|Comparative Study Between Minimally Invasive Pancreatico-duodenectomy and Open Pancreatico-duodenectomy for Periampullary Tumors|Active, not recruiting||N/A|40|Anticipated|Mansoura University||2|||f||||t||||||||Yes||2017-10-10 22:04:12.876012|2017-10-10 22:04:12.876012
NCT02807688|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-22|||March 2012||2012-03-01|June 2016|2016-06-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|PHYSICO-DSM-VR||Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses|PHYSICO-DSM-VR - Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses: a Prevalence Study and a Randomised Controlled Study|Completed||N/A|325|Actual|Azienda ULSS di Verona e Provincia||2|||f||||f||||||||Undecided||2017-10-10 22:04:12.958498|2017-10-10 22:04:12.958498
NCT02807675|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-01-27|||June 2016||2016-06-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)|A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease|Completed||Phase 1|36|Actual|Acorda Therapeutics||2|||f||||f||||||||||2017-10-10 22:04:13.057143|2017-10-10 22:04:13.057143
NCT02807662|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||February 2012||2012-02-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Meeting the Needs of Pregnant Women With PTSD in Prenatal Care|Meeting the Needs of Pregnant Women With PTSD in Prenatal Care|Completed||N/A|149|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||No||2017-10-10 22:04:13.170274|2017-10-10 22:04:13.170274
NCT02807649|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-06-20|||May 2015||2015-05-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|GkoCist||Effect of Ginko and Cistanche Against Fatigue Symptoms|A 60-Day Clinical Study to Evaluate Nutrilite Ginko Biloba Cistanche Tablets in Relieving the Symptoms of Chronic Fatigue Syndromes Compared to Negative Control|Completed||N/A|159|Actual|Access Business Group||3|||f||||t||||||||Undecided||2017-10-10 22:04:13.247088|2017-10-10 22:04:13.247088
NCT02807636|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-08-01|||June 30, 2016|Actual|2016-06-30|August 2017|2017-08-01|July 30, 2020|Anticipated|2020-07-30|December 31, 2018|Anticipated|2018-12-31||Interventional|IMvigor130||Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma|A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab (Anti−PD-L1 Antibody) as Monotherapy and in Combination With Platinum-Based Chemotherapy in Patients With Untreated Locally Advanced or Metastatic Urothelial Carcinoma|Recruiting||Phase 3|1200|Anticipated|Hoffmann-La Roche||3|||f||||t||||||||||2017-10-10 22:04:13.384844|2017-10-10 22:04:13.384844
NCT02807623|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-02|||September 2016||2016-09-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|NLP||Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation|"Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation: the NEED LESS PAIN Study"|Recruiting||N/A|300|Anticipated|Womack Army Medical Center||3|||f||||f||||||||||2017-10-10 22:04:14.14715|2017-10-10 22:04:14.14715
NCT02807610|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-20|||March 2011||2011-03-01|June 2016|2016-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|Induction||Etomidate vs Propofol-Induction Characteristics|Comparison of Induction Characteristics of Two Anaesthetic Agents-Etomidate Lipuro and Propofol|Completed||Phase 4|100|Actual|Maharashtra University of Health Sciences||2|||f||||t||||||||Yes|Data will be made available.|2017-10-10 22:04:14.279982|2017-10-10 22:04:14.279982
NCT02807597|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-07-17|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2020|Anticipated|2020-02-28||Interventional|||LS301 Uptake in Tumors of Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy for Breast Cancer|Evaluation of LS301 Uptake in Tumors of Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy for Breast Cancer|Not yet recruiting||Phase 1|22|Anticipated|Washington University School of Medicine||2|||f||||t|f|t|f|f|f|||||2017-10-10 22:04:14.375354|2017-10-10 22:04:14.375354
NCT02807584|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-10-13|||March 2016||2016-03-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Treatment of Wounds With a New Adhesive Foam Dressing|A Prospective, Open Study to Evaluate the Clinical Performance of a New Adhesive Foam Dressing in the Treatment of Partial Thickness Burns, Acute and Chronic Wounds.|Completed||Phase 4|25|Actual|Smith & Nephew, Inc.||1|||f||||f||||||||||2017-10-10 22:04:14.482816|2017-10-10 22:04:14.482816
NCT02807571|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-10-03|||February 10, 2017|Actual|2017-02-10|October 2017|2017-10-01|October 3, 2017|Actual|2017-10-03|October 3, 2017|Actual|2017-10-03||Observational|WALANT||Office Based Hand Surgery Using WALANT (Wide Awake Local Anesthesia No Tourniquet): Outcomes and Cost Savings Analysis|Office Based Hand Surgery Using WALANT (Wide Awake Local Anesthesia No Tourniquet): Outcomes and Cost Savings Analysis|Withdrawn||N/A|0|Actual|Spectrum Health Hospitals|||1|Study underwent major protocol changes prior to planned enrollment|f||||f||||||||||2017-10-10 22:04:14.588869|2017-10-10 22:04:14.588869
NCT02807545|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-11-15|||June 2016||2016-06-01|June 2016|2016-06-01||||July 2018|Anticipated|2018-07-01||Interventional|EX||Scoliosis-Specific Exercises for At-Risk AIS Curves|Scoliosis-Specific Exercises for At-Risk Mild Adolescent Idiopathic Scoliosis Curves: A Multi-Site Preliminary Randomized Trial|Enrolling by invitation||N/A|90|Anticipated|Texas Scottish Rite Hospital for Children||2|||f||||t||||||||Yes|Data will be shared in a de-identified fashion with the lead institution using generated study numbers|2017-10-10 22:04:14.811553|2017-10-10 22:04:14.811553
NCT02807532|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-16|||March 2015||2015-03-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Observational|||Relationship Between Apelin and New-onset Atrial Fibrillation After Coronary Artery Bypass Grafting|Relationship Between Apelin and New-onset Atrial Fibrillation After Coronary Artery Bypass Grafting: a Prospective Cohort Study and Retrospective Case-Control Clinical Trial|Completed||N/A|120|Actual|General Hospital of Shenyang Military Region|||2||f||||t||||||||Undecided||2017-10-10 22:04:14.913879|2017-10-10 22:04:14.913879
NCT02807519|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|October 2018|Anticipated|2018-10-01||Observational|Cytosal||Salivary Cytokines as Biomarker for Oral Health|Salivary Cytokines in Paediatric Oncology Patients and Healthy Persons - A Pilot Study to Investigation of Biomarkers for Oral Health|Recruiting||N/A|125|Anticipated|University Hospital, Basel, Switzerland|||2||f||||f||||||Samples With DNA|"     Saliva sample collection. Cytokines analysis in the saliva   "|Undecided||2017-10-10 22:04:15.001475|2017-10-10 22:04:15.001475
NCT02807506|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-06-20|||July 2014||2014-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Affordable Mobile Robots for the Elderly|PFI: BIC Affordable and Mobile Assistive Robots for Elderly Care|Recruiting||N/A|155|Anticipated|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 22:04:15.111056|2017-10-10 22:04:15.111056
NCT02807493|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-16|||July 2016||2016-07-01|June 2016|2016-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Use of an Occlusal Support Device During the Second Stage of Labor|Use of an Occlusal Support Device During the Second Stage of Labor|Not yet recruiting||Phase 2|500|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||No||2017-10-10 22:04:15.193879|2017-10-10 22:04:15.193879
NCT02807480|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-27|||June 2016||2016-06-01|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Approach-Avoidance Conflict-a Multi-level Predictor for Therapy Response|Approach-Avoidance Conflict-a Multi-level Predictor for Therapy Response|Recruiting||N/A|100|Anticipated|Laureate Institute for Brain Research, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:04:15.269651|2017-10-10 22:04:15.269651
NCT02807467|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Influence of Dexmedetomidine or Propofol on ICU Delirium|Comparison of Propofol and Dexmedetomidine to Treat Hyperactive and Mixed ICU Delirium - the Basel ProDex Randomized Trial|Recruiting||Phase 4|318|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||No|anonymized data will be analyzed and published|2017-10-10 22:04:15.381304|2017-10-10 22:04:15.381304
NCT02807454|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-09-27|||July 7, 2016|Actual|2016-07-07|September 2017|2017-09-01|November 1, 2019|Anticipated|2019-11-01|June 20, 2019|Anticipated|2019-06-20||Interventional|FUSIONMM-003||A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple Myeloma|A Phase 2, Multicenter, Open-label, Study to Determine the Safety and Efficacy for the Combination of Durvalumab (DURVA) and Daratumumab (DARA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)|Active, not recruiting||Phase 2|144|Anticipated|Celgene||2|||f||||f||||||||||2017-10-10 22:04:15.494187|2017-10-10 22:04:15.494187
NCT02807441|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-20|||July 2016||2016-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|ASA||Perioperative Bleeding and Aspirin Use in Spine Surgery|Association Between Perioperative Bleeding and Aspirin Use in Spine Surgery: A Randomized, Controlled Trial|Not yet recruiting||Phase 3|600|Anticipated|University Hospitals Cleveland Medical Center||3|||f||||f||||||||No|Data will be collected on a computer database containing unique identifiers, without names, social security numbers, medical record numbers, or other information that could be used to identify individuals. University Hospitals Research Electronic Data Capture will be used as a means of secure data storage. At no time will this data spreadsheet be printed or otherwise distributed, and no Protected Health Information will be transferred to investigators at other sites of this multi-center study.|2017-10-10 22:04:15.646691|2017-10-10 22:04:15.646691
NCT02807428|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2017-10-04|||February 20, 2017|Actual|2017-02-20|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery|A Phase 2 Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Intrathecal Preoperative Administration of AYX1 Injection in Patients Undergoing Unilateral Total Knee Arthroplasty|Active, not recruiting||Phase 2|210|Actual|Adynxx, Inc.||2|||f||||f|t|f||||||||2017-10-10 22:04:15.736344|2017-10-10 22:04:15.736344
NCT02807415|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|OrkambiFacts||ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor|Intestinal Current Measurements (ICM) to Evaluate the Activation of Mutant CFTR in Subjects With Cystic Fibrosis Aged 12 Years and Older, Homozygous for the p.Phe508del-CFTR Mutation, Treated With Lumacaftor in Combination With Ivacaftor|Recruiting||N/A|125|Anticipated|Hannover Medical School|||1||f||||t||||||Samples Without DNA|"     plasma samples   "|Yes|Individual participant data will be made available to study participant and parental guide and the physician treating the study participant|2017-10-10 22:04:15.935268|2017-10-10 22:04:15.935268
NCT02807402|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-08-14|||July 14, 2016||2016-07-14|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|August 3, 2017|Actual|2017-08-03||Observational|||Effectiveness of Paritaprevir/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Romania|Completed||N/A|522|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 22:04:16.058489|2017-10-10 22:04:16.058489
NCT02807389|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-07-03|||January 2017||2017-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Stem Cell Fistula Plug in Post Surgical Leak Fistulas|A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Complicated Post-surgical Fistulas|Recruiting||Phase 1|15|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:04:16.175417|2017-10-10 22:04:16.175417
NCT02807376|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-06-27|||July 2016||2016-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Evaluation of a Powered Vascular Stapler in Laparoscopic Nephrectomies and Nephroureterectomies|A Prospective, Randomized, Controlled, Multi-Center Evaluation of a Powered Vascular Stapler in Laparoscopic Nephrectomies and Nephroureterectomies|Recruiting||N/A|250|Anticipated|Ethicon Endo-Surgery||2|||f||||f||||||||Undecided||2017-10-10 22:04:16.252934|2017-10-10 22:04:16.252934
NCT02807363|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-18|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers|A Randomized, Open-label, Parallel-group, Active-control PK/PD Study of Two Doses of Leuprolide Oral Tablets in Comparison to an IM Dose of Leuprolide in Healthy Female Volunteers|Recruiting||Phase 2|32|Anticipated|Enteris BioPharma Inc.||3|||f||||t|t|f||||||||2017-10-10 22:04:16.327519|2017-10-10 22:04:16.327519
NCT02807350|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-08-15|||January 16, 2017|Actual|2017-01-16|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|IXT5||Trial of Overminus Spectacle Therapy for Intermittent Exotropia|A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia|Recruiting||N/A|384|Anticipated|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-10 22:04:16.463698|2017-10-10 22:04:16.463698
NCT02807337|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-03-09|||August 1, 2016||2016-08-01|June 2016|2016-06-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Supersaturated Calcium Phosphate Oral Rinse (Caphosol®) For the Prevention of Oral Mucositis in Children Undergoing Chemotherapeutic Treatments|Supersaturated Calcium Phosphate Oral Rinse (Caphosol®) For the Prevention of Oral Mucositis in Children Undergoing Chemotherapeutic Treatments|Recruiting||Phase 2|75|Anticipated|Tampere University Hospital||2|||f||||||||||||||2017-10-10 22:04:16.748114|2017-10-10 22:04:16.748114
NCT02807324|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-12-23|||June 2016||2016-06-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|WeCare||Women Specific Cardiac Recovery After Preeclampsia|Women Specific Cardiac Recovery After Preeclampsia|Recruiting||N/A|290|Anticipated|Maastricht University Medical Center|||6||f||||t||||||Samples With DNA|"     Blood samples for microRNA analyses   "|No||2017-10-10 22:04:16.850268|2017-10-10 22:04:16.850268
NCT02807311|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-05-12|||August 17, 2016|Actual|2016-08-17|May 2016|2016-05-01|August 17, 2017|Anticipated|2017-08-17|August 17, 2017|Anticipated|2017-08-17||Observational|||OPTIMIZATION OF NUTRITIONAL MANAGEMENT OF PATIENTS WAITING FOR LUNG TRANSPLANT INTO Strasbourg University Hospitals||Recruiting||N/A|62|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:04:16.974237|2017-10-10 22:04:16.974237
NCT02807298|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-20|||June 2014||2014-06-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||4% Articaine and 2% Lidocaine by Intraligamentary Technique in Irreversible Pulpitis||Completed||Phase 3|25|Actual|Dr. D. Y. Patil Dental College & Hospital||2|||f||||||||||||||2017-10-10 22:04:17.056566|2017-10-10 22:04:17.056566
NCT02807259|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-31|||January 2015||2015-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|SamPlus||Reducing Vulnerability in the Intimate Partnerships of Female Sex Workers Sex Workers|Evaluation of Samvedana Plus: An Intervention With Female Sex Workers (FSWs) and Their Intimate Partners to Reduce Partner Violence and Increase Consistent Condom Use Within Intimate Relationships|Recruiting||N/A|800|Anticipated|Karnataka Health Promotion Trust||1|||f||||f||||||||||2017-10-10 22:04:17.420796|2017-10-10 22:04:17.420796
NCT02807246|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-16|||December 2014||2014-12-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Probiotics on Neonatal Hyperbilirubinemia|Effects of Probiotics on Neonatal Hyperbilirubinemia|Completed||N/A|150|Actual|Karadeniz Technical University||2|||f||||f||||||||Undecided||2017-10-10 22:04:17.513656|2017-10-10 22:04:17.513656
NCT02807233|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-07-25|||July 2016||2016-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|SOMACROL||Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects|A Spanish Multicenter, Cross-sectional, Observational Study to Evaluate the Effectiveness of Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects in Daily Clinical Practice (SOMACROL).|Recruiting||N/A|100|Anticipated|Ipsen|||1||f||||f||||||||||2017-10-10 22:04:17.591492|2017-10-10 22:04:17.591492
NCT02807220|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-05-02|||February 27, 2017|Actual|2017-02-27|May 2017|2017-05-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|||Efficacy and Safety of Imuneks 10 mg Capsules in the Prophylaxis of Cold|A Phase 4, Single Arm Trial Assessing the Efficacy and Safety of Imuneks 10 mg Capsules in the Prophylaxis of Cold and the Maintenance of the Good Health State in Healthy Subjects|Completed||Phase 4|70|Actual|Imuneks Farma ilac San. Tic. A.S.||1|||f||||f|f|f||||||No|According to Turkish laws it is forbidden to share personal data|2017-10-10 22:04:17.734335|2017-10-10 22:04:17.734335
NCT02807207|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-16|||October 2014||2014-10-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects|A Phase 1, Single-Center, Pacritinib- Versus Placebo-Blinded, Active- and Placebo-Controlled, Randomized, 3-Way Crossover Study to Evaluate the Cardiac Safety and Pharmacokinetics Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects|Completed||Phase 1|42|Actual|CTI BioPharma||6|||f||||||||||||Yes||2017-10-10 22:04:17.805734|2017-10-10 22:04:17.805734
NCT02807194|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-21|||March 2014||2014-03-01|June 2016|2016-06-01||||January 2015|Actual|2015-01-01||Interventional|||Ambulatory Lumbar Disk Surgery|Epidural Anesthesia Versus General Anesthesia for Elective Lumbar Disk Surgery in a Outpatient Basis|Completed||N/A|51|Actual|CHU de Reims||2|||f||||||||||||||2017-10-10 22:04:17.892486|2017-10-10 22:04:17.892486
NCT02807181|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-10-04|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|SIRCCA||SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma|Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma|Recruiting||Phase 3|180|Anticipated|Sirtex Medical||2|||f||||t||t|f|f||||||2017-10-10 22:04:17.959777|2017-10-10 22:04:17.959777
NCT02807168|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-09|||June 2015||2015-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||NT-proBNP in the Management of Discharged Patients With Acutely Decompensated Heart Failure and Preserved Ejection Fraction|NT-proBNP in the Management of Discharged Patients With Acutely Decompensated Heart Failure and Preserved Ejection Fraction|Recruiting||N/A|420|Anticipated|Hospital Universitario Virgen de la Arrixaca||2|||f||||f||||||||||2017-10-10 22:04:18.433053|2017-10-10 22:04:18.433053
NCT02807155|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-15|||October 2009||2009-10-01|June 2016|2016-06-01||||July 2013|Actual|2013-07-01||Interventional|LEAP||Let's Empower and Prepare Young Adults With Type 1 Diabetes|Helmsley Type 1 Diabetes Youth Transitional Program|Completed||N/A|104|Actual|University of Southern California||3|||f||||f||||||||No||2017-10-10 22:04:18.50957|2017-10-10 22:04:18.50957
NCT02807142|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-25|||March 2016||2016-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CME-LEM4||Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia|Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia|Active, not recruiting||Phase 2|6|Actual|Puerta de Hierro University Hospital||1|||f||||f||||||||||2017-10-10 22:04:18.612839|2017-10-10 22:04:18.612839
NCT02807129|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-05-16|||January 2014||2014-01-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|AgElOn||Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer|Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer|Recruiting||N/A|300|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:04:18.692169|2017-10-10 22:04:18.692169
NCT02807116|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-20|||January 2015||2015-01-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects|A Phase 1, Open-Label, Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects|Completed||Phase 1|18|Actual|CTI BioPharma||1|||f||||||||||||Yes||2017-10-10 22:04:18.765516|2017-10-10 22:04:18.765516
NCT02807103|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|REOVAS||Rituximab in Eosinophilic Granulomatosis With Polyangiitis|Evaluation of Rituximab-based Regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Newly-Diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis. Prospective, Randomized, Controlled, Double-blind Study|Recruiting||Phase 3|108|Anticipated|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||No||2017-10-10 22:04:18.85707|2017-10-10 22:04:18.85707
NCT02807090|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-09-15|||July 2016||2016-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Lumbar Stabilization Exercises and Circular Dances in Chronic Non Specific Low Back Pain|Effect of Lumbar Stabilization Exercises and Circular Dances in Chronic Non Specific Low Back Pain in Middle-aged Women: Single-blind Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 22:04:18.974895|2017-10-10 22:04:18.974895
NCT02807077|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-20|||November 2014||2014-11-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||To Determine PK of Pacritinib in Patients With Mild, Moderate, and Severe Renal Impairment and ESRD Compared to Healthy Subjects|A Phase 1 Open-Label, Single-Dose, Parallel-Group Study to Determine the Pharmacokinetics of Pacritinib in Patients With Mild, Moderate, and Severe Renal Impairment and End-Stage Renal Disease (ESRD) Compared to Healthy Subjects|Completed||Phase 1|40|Actual|CTI BioPharma||5|||f||||||||||||Yes||2017-10-10 22:04:19.09461|2017-10-10 22:04:19.09461
NCT02807064|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-20|||February 2015||2015-02-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis|Evaluation of the Effectiveness of Treatment With Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis|Recruiting||Phase 3|40|Anticipated|"University of Campania Luigi Vanvitelli"||2|||f||||f||||||||No||2017-10-10 22:04:19.21121|2017-10-10 22:04:19.21121
NCT02807051|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-20|||September 2014||2014-09-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects|A Phase 1, Open-Label, Drug-Interaction Study to Evaluate the Effect of Clarithromycin, a Potent CYP3A4 Inhibitor, on the Systemic Exposure of Pacritinib in Healthy Subjects|Completed||Phase 1|20|Actual|CTI BioPharma||1|||f||||||||||||Yes||2017-10-10 22:04:19.293598|2017-10-10 22:04:19.293598
NCT02807038|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-15|||August 2011||2011-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|May 2013|Actual|2013-05-01||Interventional|||Assessment of Exposures of the Mother-infant Pair to the Air Pollution of São Paulo|Longitudinal Study of the Pulmonary Function Testing of Pregnant Women Exposed to Air Pollution in São Paulo|Completed||N/A|120|Actual|University of Sao Paulo General Hospital||1|||f||||f||||||||No||2017-10-10 22:04:19.387278|2017-10-10 22:04:19.387278
NCT02807025|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-03-03|||September 2015||2015-09-01|April 2016|2016-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|RESPI-SAM||Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases|Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases|Recruiting||N/A|72|Anticipated|Imperial College Healthcare NHS Trust|||6||f||||f||||||||No||2017-10-10 22:04:19.463891|2017-10-10 22:04:19.463891
NCT02807012|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-14|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2017|Anticipated|2017-12-01||Interventional|SHARE||Nursing Home Care Intervention Post Stroke|Nursing Home Care Educational Intervention for Family Caregivers of Older Adults Post Stroke|Active, not recruiting||N/A|82|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:04:19.569163|2017-10-10 22:04:19.569163
NCT02806999|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-16|||July 2016||2016-07-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||The Therapeutic Effects of Insulin and Berberine on Stress Hyperglycemia|The Therapeutic Effects of Combination of Insulin With Berberine on the Patients With Stess Hyperlipemia:a Prospective, Double Blind, Randomized, Placebo-controlled, Single-center Clinical Trial|Not yet recruiting||Phase 4|200|Anticipated|Guangdong General Hospital||2|||f||||t||||||||Undecided|Whether individual participant collected in this study data can be available depends on the participant's permission.|2017-10-10 22:04:19.67394|2017-10-10 22:04:19.67394
NCT02806986|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-07-10|||June 2016||2016-06-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy, Pharmacokinetics, Safety, and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency|A Multi-Center, Open-Label, Single-Arm Trial to Evaluate Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency|Recruiting||Phase 3|60|Anticipated|Grifols Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 22:04:19.801047|2017-10-10 22:04:19.801047
NCT02806973|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-17|2016-06-17|||January 2015||2015-01-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes|A Single Center, Randomized, 4-Period Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Single or Repeated 3 mg Doses of Intranasally Administered Glucagon in Adults With Type 1 or Type 2 Diabetes|Completed||Phase 1|32|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:04:19.945232|2017-10-10 22:04:19.945232
NCT02806960|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-10-17|||June 2014||2014-06-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes|A Single Center, Randomized, 4-Period Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Single or Repeated 3 mg Doses of Intranasally Administered Glucagon in Adults With Type 1 or Type 2 Diabetes|Terminated||Phase 1|12|Actual|Eli Lilly and Company||4||Drug delivery was below target dose due to partial obstruction by aggregated particles.|f||||f||||||||||2017-10-10 22:04:20.054975|2017-10-10 22:04:20.054975
NCT02806947|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-08-29|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)|A Randomized, Phase II, Multicenter, Open Label, Study Evaluating Sirolimus and Prednisone in Patients With Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease (BMT CTN #1501)|Recruiting||Phase 2|150|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-10 22:04:20.149726|2017-10-10 22:04:20.149726
NCT02806934|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-20|||June 2009||2009-06-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||TNF Polymorphism and Implantation Rate|Tumor Necrosis Factor-308 Polymorphism a Embryo Implantation Rate in Women Undergoing in Vitro Fertilization|Completed||N/A|120|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||||2017-10-10 22:04:20.311201|2017-10-10 22:04:20.311201
NCT02806921|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-16|||August 2016||2016-08-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|||Changes in the Tear Film With Scleral Contact Lens Wear for Keratoconic Eyes|Protease and Cytokine Composition in Post Lens Tear Reservoir of Scleral Lenses for Keratoconic Eyes|Not yet recruiting||N/A|15|Anticipated|University of Waterloo||2|||f||||f||||||||No||2017-10-10 22:04:20.374532|2017-10-10 22:04:20.374532
NCT02806908|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-21|||June 2016||2016-06-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Interventional|||Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy|A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Narcolepsy|Recruiting||Phase 2|33|Anticipated|Jazz Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:04:20.444653|2017-10-10 22:04:20.444653
NCT02806895|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-21|||June 2016||2016-06-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Interventional|||Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA|A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Obstructive Sleep Apnea|Recruiting||Phase 2|40|Anticipated|Jazz Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:04:20.528887|2017-10-10 22:04:20.528887
NCT02806882|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||April 2015||2015-04-01|June 2016|2016-06-01||||April 2017|Anticipated|2017-04-01||Interventional|Ceftaroline||Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF)|Open and Exploratory Trial to Investigate the Pharmacokinetic of Ceftaroline in Patients With CSF Device|Recruiting||Phase 1|10|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||t||||||||||2017-10-10 22:04:20.607088|2017-10-10 22:04:20.607088
NCT02806856|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-06-23|||July 2016||2016-07-01|June 2016|2016-06-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|tDCS||tDCS in Acute Stroke Patients|Transcranial Direct Current Stimulation (tDCS) in Acute Stroke Patients|Not yet recruiting||N/A|50|Anticipated|Centre Hospitalier St Anne||2|||f||||t||||||||No||2017-10-10 22:04:20.744605|2017-10-10 22:04:20.744605
NCT02806843|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-11|||May 2014||2014-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Baxter||Robot-Assisted Stroke Rehabilitation Based on Patient-Therapist Interactions|Robot-Assisted Stroke Rehabilitation Based on Patient-Therapist Interactions|Recruiting||N/A|65|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:04:20.825496|2017-10-10 22:04:20.825496
NCT02806830|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-27|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|January 2017|Actual|2017-01-01||Interventional|EVAGO||Ocular Discomfort Assessment After Intravitreal Injections|Evaluation de la gêne Oculaire après Injections intravitréennes|Completed||N/A|45|Actual|Centre Hospitalier Intercommunal Creteil||1|||f||||f||||||||||2017-10-10 22:04:20.892078|2017-10-10 22:04:20.892078
NCT02806817|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-13|||July 2016||2016-07-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism|ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism: a Phase 0 Trial|Recruiting||Early Phase 1|40|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III||2|||f||||f||||||||||2017-10-10 22:04:20.964607|2017-10-10 22:04:20.964607
NCT02806804|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-16|||May 2016||2016-05-01|June 2016|2016-06-01||||June 2016|Actual|2016-06-01||Interventional|||Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60||Enrolling by invitation||Phase 3|2400|Anticipated|Beijing Chaoyang District Centre for Disease Control and Prevention||3|||f||||||||||||||2017-10-10 22:04:21.082432|2017-10-10 22:04:21.082432
NCT02806791|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-20|||May 2016||2016-05-01|June 2016|2016-06-01||||May 2016|Actual|2016-05-01||Observational|||Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment|Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment After Autologous Transplant in Patients With Blood Cancers|Active, not recruiting||N/A|300|Actual|Azienda Ospedaliera San Giovanni Battista|||1||f||||||||||||||2017-10-10 22:04:21.140935|2017-10-10 22:04:21.140935
NCT02806778|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Observational|||Monitoring of Cerebral Oxygenation Using Jugular Oximetry in Comatose Patients After Cardiac Arrest|Monitoring of Cerebral Oxygenation Using Jugular Oximetry in Comatose Patients After Cardiac Arrest|Recruiting||N/A|60|Anticipated|University Hospital Ostrava|||1||f||||f||||||||No|Individual participant data will not be made available. The results of the study will be published in an impact factor journal.|2017-10-10 22:04:21.208195|2017-10-10 22:04:21.208195
NCT02806765|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-26|||April 2016||2016-04-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Dietary Supplementation on Dynamic Stability|Effects of a Single Nutrient Supplementation on Dynamic Stability in Community Dwelling Older Adults|Recruiting||N/A|70|Anticipated|Arizona State University||2|||f||||f||||||||Yes|The data will be shared with Abbott Nutrition and DSM Nutritional Products, Inc.|2017-10-10 22:04:21.439067|2017-10-10 22:04:21.439067
NCT02806752|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2017-01-23|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|RANTA||Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy|Multicenter Randomized Controlled Study of Intravitreal Ranibizumab and Triamcinolone Acetonide Combination Therapy Versus Ranibizumab Monotherapy in Patients With Polypoidal Choroidal Vasculopathy|Recruiting||Phase 4|120|Anticipated|Aier School of Ophthalmology, Central South University||2|||f||||t||||||||No||2017-10-10 22:04:21.562917|2017-10-10 22:04:21.562917
NCT02806739|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-10-26|||January 2013||2013-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Soy Supplementation and Gestational Diabetes|A Pilot Study of Soy Protein and Isoflavone Supplementation for Improved Glucose Metabolism and Lipid Profiles in Pregnant Women at High Risk for Gestational Diabetes Mellitus (GDM)|Completed||Early Phase 1|40|Actual|University of Massachusetts, Boston||2|||f||||t||||||||Yes|Individual participant data (IPD) will be not shared. Data will be shared in aggregated way in publications and national conferences.|2017-10-10 22:04:21.710712|2017-10-10 22:04:21.710712
NCT02806713|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-02-21|||February 2016||2016-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|EPIPhANy||The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)|The Effect of Oral phenazopyrIdine on Perioperative Voiding After Mid-urethral Sling|Recruiting||Phase 3|90|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||No||2017-10-10 22:04:21.859136|2017-10-10 22:04:21.859136
NCT02806700|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-09-27|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Twitter and Diabetes|Twitter and Diabetes|Enrolling by invitation||N/A|200|Anticipated|University of Pennsylvania||2|||f||||f|f|f||||||||2017-10-10 22:04:21.979854|2017-10-10 22:04:21.979854
NCT02806687|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-02-13|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|THERGAP-02||Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer|Phase 2 Gene Therapy Trial of Locally Advanced Pancreatic Adenocarcinoma Using Intratumoral Injection of CYL-02 in Combination With Gemcitabine|Recruiting||Phase 2|100|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||No||2017-10-10 22:04:22.06793|2017-10-10 22:04:22.06793
NCT02806674|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-07-26|||July 2016||2016-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection|A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection|Recruiting||N/A|1845|Anticipated|The University of Hong Kong-Shenzhen Hospital||2|||f||||||||||||||2017-10-10 22:04:22.201931|2017-10-10 22:04:22.201931
NCT02806661|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-06-17|||July 2016||2016-07-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Vagus Nerve-preserving RADG and Conventional RADG for AGC|Comparison of Vagus Nerve-preserving Robot-assisted Distal Gastrectomy (RADG) and Conventional Robot-assisted Distal Gastrectomy for Advanced Gastric Cancer (AGC)|Not yet recruiting||N/A|24|Anticipated|Southwest Hospital, China||2|||f||||t||||||||Yes|Yes, the investigators can share the data with other.|2017-10-10 22:04:22.311233|2017-10-10 22:04:22.311233
NCT02806648|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-06-21|||May 2015||2015-05-01|June 2016|2016-06-01||||December 2018|Anticipated|2018-12-01||Interventional|PALBONET||A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)|A Phase II Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)|Active, not recruiting||Phase 2|21|Actual|Grupo Espanol de Tumores Neuroendocrinos||1|||f||||t||||||||||2017-10-10 22:04:22.397396|2017-10-10 22:04:22.397396
NCT02806635|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-01-06|||October 2016||2016-10-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Web-based Programs to Improve and Strengthen Romantic Relationships|Web-based Marriage Preparation/Enrichment and Divorce Prevention for Low-Income Couples|Recruiting||N/A|850|Anticipated|University of Miami||3|||f||||f||||||||Yes|De-identified data will be provided to Administration for Children and Families to facilitate secondary data analyses.|2017-10-10 22:04:22.50522|2017-10-10 22:04:22.50522
NCT02806622|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-17|||July 2016||2016-07-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Comparison of Hip Range of Motion Values Among NCAA Division II Collegiate Athletes|Comparison of Hip Range of Motion Values Among NCAA Division II Collegiate Athletes|Not yet recruiting||N/A|100|Anticipated|California State University, Dominguez Hills|||1||f||||f||||||||Undecided||2017-10-10 22:04:22.634502|2017-10-10 22:04:22.634502
NCT02806609|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Muscle Pain in Late Cold Water Immersion, Muscular Recruitment, Postural Control Dynamic and Sleep Quality|Effect of Muscle Pain in Late Cold Water Immersion, Muscular Recruitment, Postural Control Dynamic and Sleep Quality in Soccer Athletes: Randomized Study and Blind|Not yet recruiting||N/A|28|Anticipated|Universidade Estadual de Londrina||4|||f||||t||||||||No||2017-10-10 22:04:23.311524|2017-10-10 22:04:23.311524
NCT02806596|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-28|||January 2010||2010-01-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Bispectral Index to Guide Intubation in Pediatric Anesthesia|Use of Bispectral Index to Guide Intubation During Sevoflurane Anesthesia in Children|Completed||N/A|60|Actual|University Hospital of Liege||1|||f||||t||||||||No|data will not been shared|2017-10-10 22:04:23.409584|2017-10-10 22:04:23.409584
NCT02804841|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-11-21|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Vitamin D3 Supplementation on Cognitive Function in Community Dwelling Older Adults|D-activating Decline- Exploring the Effects of Vitamin D3 Supplementation on Cognitive Function in Community Dwelling Healthy Older Adults- A Pilot Study|Completed||N/A|60|Actual|University of Dublin, Trinity College||2|||f||||t||||||||No||2017-10-10 22:04:23.5648|2017-10-10 22:04:23.5648
NCT02804828|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-06-14||||||June 2016|2016-06-01||||September 2018|Anticipated|2018-09-01||Interventional|||Mitochondrial Cocktail for Gulf War Illness||Not yet recruiting||N/A|||University of California, San Diego||2|||f||||||||||||||2017-10-10 22:04:23.659533|2017-10-10 22:04:23.659533
NCT02804815|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-06-14|||October 2015||2015-10-01|June 2016|2016-06-01|October 2026|Anticipated|2026-10-01|October 2026|Anticipated|2026-10-01||Interventional|||Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours|A Phase III, Double-blind, Placebo-controlled, Randomised Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours|Recruiting||Phase 3|11000|Anticipated|University College, London||4|||f||||t||||||||||2017-10-10 22:04:23.737219|2017-10-10 22:04:23.737219
NCT02803359|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-05|||June 2016||2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigation of Human Laryngeal Evoked Brainstem Potentials|Investigation of Human Laryngeal Evoked Brainstem Potentials|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 22:04:55.31672|2017-10-10 22:04:55.31672
NCT02804802|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-23|||February 2013||2013-02-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Observational|IDYLIC||Impact of DietarY and LIfestyle Risk Factors on Colorectal Cancer Screening|Impact of DietarY and LIfestyle Risk Factors on Colorectal Cancer Screening (IDYLIC Study). Is it Possible to Target Risk Subjects by Using a Predictive Score?|Recruiting||N/A|49000|Anticipated|University Hospital, Angers|||1||f||||t||||||||No||2017-10-10 22:04:23.96809|2017-10-10 22:04:23.96809
NCT02804789|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-08-07|||May 2016||2016-05-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|44 Months|Observational [Patient Registry]|EPAD LCS||European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)|European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)|Recruiting||N/A|6000|Anticipated|University of Edinburgh|||1||f||||t||||||Samples With DNA|"     -  Urine        -  Saliva        -  CSF        -  Blood (Serum, Plasma, Whole Blood, RNA, DNA)   "|||2017-10-10 22:04:24.054994|2017-10-10 22:04:24.054994
NCT02804776|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-31|||February 2015||2015-02-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PROGRESS||PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery|PROGRESS: PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery|Recruiting||Phase 2|20|Anticipated|National Cancer Centre, Singapore||1|||f||||f||||||||||2017-10-10 22:04:24.221248|2017-10-10 22:04:24.221248
NCT02804750|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-06-15|||June 2016||2016-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate CORT125134 in Patients With Cushing's Syndrome|Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome|Recruiting||Phase 2|30|Anticipated|Corcept Therapeutics||1|||f||||t||||||||Undecided||2017-10-10 22:04:24.536566|2017-10-10 22:04:24.536566
NCT02804737|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-06-14|||July 2014||2014-07-01|June 2016|2016-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Impact of Patient Education Website on the Quality of Outpatient Bowel Preparation for Colonoscopy|Impact of Patient Education Website on the Quality of Outpatient Bowel Preparation for Colonoscopy|Completed||N/A|160|Actual|University of British Columbia|||2||f||||f||||||||||2017-10-10 22:04:24.660525|2017-10-10 22:04:24.660525
NCT02806570|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-03-08|||August 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:04:24.736175|2017-10-10 22:04:24.736175
NCT02806557|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-07-29|||September 2016||2016-09-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Profiling Neutrophil Counts in Patients on Chemotherapy|Profiling Neutrophil Counts in Patients With Cancer During Cycle One of Chemotherapy|Not yet recruiting||N/A|200|Anticipated|University of Leeds|||3||f||||f||||||||No||2017-10-10 22:04:24.774521|2017-10-10 22:04:24.774521
NCT02806544|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-12-01|2016-07-22||January 2013||2013-01-01|December 2016|2016-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country|Neoadjuvant Endocrine Therapy in Locally Advanced Hormone Receptor Positive Breast Cancer in a Low-Resource, Middle-Income Setting (Guatemala)|Completed||Phase 2|35|Actual|Vanderbilt University||1|||f||||f||||||||No||2017-10-10 22:04:24.864295|2017-10-10 22:04:24.864295
NCT02806531|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-17|||July 2016||2016-07-01|June 2016|2016-06-01||||July 2018|Anticipated|2018-07-01||Interventional|||Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old||Not yet recruiting||Phase 4|20000|Anticipated|Beijing Chaoyang District Centre for Disease Control and Prevention||1|||f||||||||||||||2017-10-10 22:04:25.072804|2017-10-10 22:04:25.072804
NCT02806518|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-17|||April 2009||2009-04-01|June 2016|2016-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|DIRT||Dynamic Infrared Thermography as an Alternative to CT Angiography|Evaluation of Dynamic Infrared Thermography as an Alternative to CT Angiography for Perforator Mapping in Breast Reconstruction|Completed||N/A|25|Actual|University Hospital of North Norway|||1||f||||f||||||||No||2017-10-10 22:04:25.129693|2017-10-10 22:04:25.129693
NCT02806505|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-09-09|2016-09-09||June 2004||2004-06-01|September 2016|2016-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional||The intent-to-treat (ITT) analysis population included all the randomized participants who received at least one dose of study treatment.|HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)|A Randomized, Open-Label, Multicenter, Parallel Group Study Evaluating the Efficacy and Safety of 135 μg and 90 μg of PEGASYS® Given as Monotherapy to Patients With Chronic Hepatitis C and End-Stage Renal Disease Undergoing Hemodialysis|Completed||Phase 3|81|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:04:25.209224|2017-10-10 22:04:25.209224
NCT02806492|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-06-07|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|March 17, 2017|Actual|2017-03-17|March 17, 2017|Actual|2017-03-17||Interventional|||Parameters of Cerebral Perfusion|Blood Pressure or Cardiac Output - the Influence on Cerebral Perfusion During Cardiopulmonary Bypass|Completed||N/A|15|Actual|UMC Utrecht||1|||f||||f||||||||||2017-10-10 22:04:26.056518|2017-10-10 22:04:26.056518
NCT02806479|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-05-12|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Hypertrophic Cardiomyopathy Pilot Study|Pilot Observational Case-control Study of the Electrical Heterogeneity in Patients With Hypertrophic Cardiomyopathy and High Arrhythmic Risk|Enrolling by invitation||N/A|40|Anticipated|Oregon Health and Science University|||4||f||||f||||||||No||2017-10-10 22:04:26.145728|2017-10-10 22:04:26.145728
NCT02806466|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-15|||March 2012||2012-03-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|P'tit-ASTHME||Risk Factors for Early Remodelling in Severe Asthma in Children|Risk Factors for Early Remodelling in Severe Asthma in Children|Completed||N/A|67|Actual|University Hospital, Bordeaux||2|||f||||f||||||||No||2017-10-10 22:04:26.235395|2017-10-10 22:04:26.235395
NCT02806440|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-08-22|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|LDN-in-FM||Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?|Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? A Randomized, Double-blinded, Placebo-controlled, Crossover Study.|Recruiting||Phase 4|140|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||Yes|Anonymized IPD will be made available in a public research database as part of the final publication.|2017-10-10 22:04:26.412723|2017-10-10 22:04:26.412723
NCT02806427|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-29|||June 30, 2016|Actual|2016-06-30|June 2017|2017-06-01|March 11, 2017|Actual|2017-03-11|March 11, 2017|Actual|2017-03-11||Observational|||Tolerance of a Calorically Dense Enteral Nutrition Formula|Tolerance of a Calorically Dense Enteral Nutrition Formula|Completed||N/A|29|Actual|Nestlé|||1||f||||f||||||||No||2017-10-10 22:04:26.541724|2017-10-10 22:04:26.541724
NCT02806414|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-17|||July 2016||2016-07-01|June 2016|2016-06-01||||July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.|A Single Site Evaluation of the Inhibitory Effects of Topical Ivermectin on Serine Protease Activity and Production of LL-37 Cathelicidin Peptide, Biochemical Markers of Rosacea-specific Inflammation.|Not yet recruiting||Phase 1/Phase 2|15|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-10-10 22:04:26.62443|2017-10-10 22:04:26.62443
NCT02806401|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-09-03|||June 2016||2016-06-01|September 2016|2016-09-01||||May 2017|Anticipated|2017-05-01||Interventional|||Ultrasound Guided Axillary Venous Cannulation in Pediatrics|Real-time Ultrasound-guided Axillary Venous Catheterization in Pediatric Patients: Comparison With the Landmark Technique Subclavian Vein Catheterization|Recruiting||N/A|132|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 22:04:26.715807|2017-10-10 22:04:26.715807
NCT02806388|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-07-31|||October 2011||2011-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|IMPACT||Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project|Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project|Recruiting||N/A|1500|Anticipated|National Cancer Centre, Singapore|||1||f||||f||||||Samples With DNA|"     Remaining tumor and/or blood and/or saliva   "|||2017-10-10 22:04:26.814422|2017-10-10 22:04:26.814422
NCT02806375|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-08-22|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis|Graft-versus-host Disease Prophylaxis With Post-transplantation Cyclophosphamide and Ruxolitinib in Patients With Myelofibrosis|Recruiting||Phase 1/Phase 2|20|Anticipated|St. Petersburg State Pavlov Medical University||1|||f||||f||||||||||2017-10-10 22:04:26.889852|2017-10-10 22:04:26.889852
NCT02806362|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-12-02|||September 2016||2016-09-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|GIFT-R||Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)|An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease on Hemodialysis (GIFT-R)|Withdrawn||Phase 3|0|Actual|AbbVie||1||Study halted prematurely, prior to enrollment of first participant|f||||f||||||||||2017-10-10 22:04:27.035964|2017-10-10 22:04:27.035964
NCT02806349|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-06-15|||March 2002||2002-03-01|June 2016|2016-06-01|March 2005|Actual|2005-03-01|November 2004|Actual|2004-11-01||Interventional|||Konjac-Glucomannan Fibre Blend and American Ginseng in Type 2 Diabetes|Effect of Co-administration of a Konjac-Glucomannan Fibre Blend and American Ginseng (Panax Quinquefolius L.) on Glycemia and Serum Lipids in Well-controlled Type 2 Diabetes: A Randomized Controlled, Clinical Trial|Completed||Phase 2|39|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-10-10 22:04:27.133886|2017-10-10 22:04:27.133886
NCT02806336|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-08-01|||October 3, 2016|Actual|2016-10-03|August 2017|2017-08-01|October 3, 2020|Anticipated|2020-10-03|October 3, 2020|Anticipated|2020-10-03||Interventional|RISE||Multimodel Exercise and Weight Loss in Older Obese Veterans With Dysmobility|Multimodel Exercise and Weight Loss in Older Obese Veterans With Dysmobility|Recruiting||Phase 2/Phase 3|120|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:04:27.243835|2017-10-10 22:04:27.243835
NCT02806323|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-01-25|||July 1, 2016|Actual|2016-07-01|January 2017|2017-01-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Individually Tailored Yoga Program for the Treatment of Chronic Neck and Back Pain|An Individually Tailored Yoga Program for the Treatment of Chronic Neck and Back Pain in a Low-income Population: A Feasibility Study|Completed||N/A|10|Actual|University of Wisconsin, Madison||1|||f||||f||||||||Undecided||2017-10-10 22:04:27.3783|2017-10-10 22:04:27.3783
NCT02806310|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-02-01|||June 2016||2016-06-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01|24 Months|Observational [Patient Registry]|||Podocan and Wnt Pathway in the Development of Aortopathy in Bicuspid Valve Disease|Clinical Predictive Value of Podocan and Wnt Regulatory Molecules in Development of Aortopathy in Bicuspid Aortic Valve Disease|Recruiting||N/A|100|Anticipated|Bassett Healthcare|||2||f||||f||||||Samples With DNA|"     All patients who do undergo valve replacement or aortic graft surgery within the 24 month     follow up period, will have their valve tissue samples analyzed for podocan levels. These     tissues are removed as a routine part of the surgery and sent to the clinical laboratory at     Bassett. The Bassett Clinical Lab will prepare additional paraffin blocks and slides of the     tissue for the research study. Specifically, aortic aneurysm and aortic root tissue will be     analyzed. The relationship between cell density (mm2) and Podocan, in addition to the six Wnt     molecule levels, will be analyzed.   "|No||2017-10-10 22:04:27.473095|2017-10-10 22:04:27.473095
NCT02806297|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of the Effect of Timing of Cholecystectomy During Initial Admission for Mild Gallstone Pancreatitis|A Randomized Trial of the Effect of Timing of Cholecystectomy During Initial Admission for Mild Gallstone Pancreatitis|Recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Yes||2017-10-10 22:04:27.581714|2017-10-10 22:04:27.581714
NCT02806284|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-19|||January 2001||2001-01-01|June 2016|2016-06-01|January 2010|Actual|2010-01-01|January 2008|Actual|2008-01-01||Interventional|||Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery|Pneumococci and Hib Vaccination Early and Late After Neurotrauma or Neurosurgery|Completed||Phase 2|85|Actual|Uppsala University||3|||f||||f||||||||Undecided||2017-10-10 22:04:27.675013|2017-10-10 22:04:27.675013
NCT02806271|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-01-26|||June 2016||2016-06-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Short-Term Efficacy and Mechanisms of Change of a Worry Postponement Intervention for Generalized Anxiety Disorder|Short-Term Efficacy and Mechanisms of Change of a Worry Postponement Intervention for Generalized Anxiety Disorder|Recruiting||N/A|90|Anticipated|Ryerson University||3|||f||||f||||||||Yes|Results of the study will be disseminated via conference presentations, journal publications, and through our lab website. Upon request anonymized individual participant data may be made available to a publishing journal or individual research group. Individual research groups interested in accessing anonymized data will be required to submit a proposal detailing their intended use of the data. Their qualifications will be reviewed based on their proposal and CVs. Individual research groups approved for access will be required to agree to not attempt to re-identify participants, not further distribute data, and not use the data for purposes other than specified in their original proposal.|2017-10-10 22:04:27.756925|2017-10-10 22:04:27.756925
NCT02806258|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-10-04|||March 2016|Actual|2016-03-01|October 2017|2017-10-01|March 2025|Anticipated|2025-03-01|March 2018|Anticipated|2018-03-01||Interventional|Néo-APBI-01||Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone|Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone, for Triple Negative Locally Advanced Breast Cancers and Luminal B Proliferating, Inaccessible to a Conservative Surgery the Outset|Recruiting||Phase 1/Phase 2|362|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 22:04:27.867032|2017-10-10 22:04:27.867032
NCT02806232|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-09-27|||June 30, 2016|Actual|2016-06-30|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)|Open-label, Dose-finding, 2-parts, Efficacy Phase II Study With Three Formulations (Racemate Raziquantel Commercial Oral Tablets, New Oral Disintegrating Tablets of Racemate Praziquantel and L-praziquantel) in Schistosomiasis (S. Mansoni) Infected Children Aged 2-6 Years (Part 1), Followed by an Assessment of Efficacy and Safety With the Selected Formulation and Dosage in S. Mansoni Infected Infants Aged 3-24 Months (Part 2)|Recruiting||Phase 2|520|Anticipated|Merck KGaA||9|||f||||t||||||||||2017-10-10 22:04:28.042123|2017-10-10 22:04:28.042123
NCT02806219|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-11-16|||March 2016||2016-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Open-label, Bioequivalence Study of Certolizumab Pegol 200 mg Solution Injected Either by a Prefilled Syringe (Reference) or by an E-Device (Test) in Healthy Subjects|Open-label, Single-center, Randomized, Parallel Group, Single-dose, Bioequivalence Study of Certolizumab Pegol 200 mg Solution Injected Either by a Prefilled Syringe (Reference) or by an E-Device (Test) in Healthy Subjects|Completed||Phase 1|100|Actual|UCB Pharma||2|||f||||t||||||||||2017-10-10 22:04:28.137138|2017-10-10 22:04:28.137138
NCT02806206|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-07-13|||July 2016||2016-07-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Prucalopride Prior to Small Bowel Capsule Endoscopy|The Effect of Prucalopride on Small Bowel Transit Time in Patients Undergoing Capsule Endoscopy: A Randomized Controlled Trial|Not yet recruiting||Phase 4|122|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:04:28.212428|2017-10-10 22:04:28.212428
NCT02806193|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-17|||January 2014||2014-01-01|June 2016|2016-06-01||||December 2020|Anticipated|2020-12-01||Observational|GCMR||Global CMR Registry|Global Cardiovascular Magnetic Resonance Registry|Active, not recruiting||N/A|80000|Anticipated|Society for Cardiovascular Magnetic Resonance|||1||f||||f||||||||Yes|"Participating sites will send relevant de-identified to the data management team for harmonization. The aggregate data will be used for retrospective analyses and research. Researchers requesting data access for either grant proposals or sub-studies will be required to submit a proposal to the GCMR steering committee (composed of various experts in the CMR community) for approval.
If approved, data access will be given to the researchers for a specific time period determined by the magnitude of the work involved, and only for the purposes of the grant proposal or sub-study."|2017-10-10 22:04:28.303195|2017-10-10 22:04:28.303195
NCT02806180|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-15|||July 2016||2016-07-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Single v Dual-Operator Ultrasound Technique for Peripheral Vascular Access in the Emergency Department|Single v Dual-Operator Ultrasound Technique for Peripheral Vascular Access in the Emergency Department|Not yet recruiting||N/A|128|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||No||2017-10-10 22:04:28.376249|2017-10-10 22:04:28.376249
NCT02806167|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-15|||September 2016||2016-09-01|May 2016|2016-05-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Interventional|||Post-void Bladder Scanning in Acute Cauda Equina Syndrome|A Study Into the Use of Post-Void Bladder Scanning as Part of a Clinical Algorithm for the Assessment of Patients With Suspected Acute Cauda Equina Syndrome|Not yet recruiting||N/A|100|Anticipated|Royal Devon and Exeter NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:04:28.453313|2017-10-10 22:04:28.453313
NCT02806154|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-08-16|||November 2016||2016-11-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|FRACTION||Frailty and Body Composition in the Elderly Cancer Patients Treated With Chemotherapy|Frailty and Body Composition in the Elderly Cancer Patients Treated With Chemotherapy|Not yet recruiting||N/A|160|Anticipated|University Hospital, Toulouse|||1||f||||f||||||||No||2017-10-10 22:04:28.575219|2017-10-10 22:04:28.575219
NCT02806141|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates|Aerosolized Plus Intravenous Colistin Compared With Intravenous Colistin for Adjunctive Treatment of Ventilator-associated Pneumonia Due to Pandrugs-resistant Acinetobacter Baumannii in the Neonates: Randomized Controlled Trial|Recruiting||Phase 3|204|Anticipated|Hat Yai Medical Education Center||2|||f||||t||||||||No||2017-10-10 22:04:28.682071|2017-10-10 22:04:28.682071
NCT02806128|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-01-05|||November 2016||2016-11-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|MAISKFE||The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship|The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship|Recruiting||N/A|100|Anticipated|General Hospital of Shenyang Military Region||2|||f||||t||||||||Yes|After the completion of clinical trials ，Through the article published and upload data 。|2017-10-10 22:04:28.807755|2017-10-10 22:04:28.807755
NCT02806115|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01||||August 2016|Anticipated|2016-08-01||Interventional|||The Efficacy of Severe Whitening and Delayed Fading in Acetic Acid-enhanced Endoscopy for Diagnosing Gastric Intestinal Metaplasia||Recruiting||Phase 1|100|Anticipated|Shandong University||1|||f||||||||||||||2017-10-10 22:04:28.907991|2017-10-10 22:04:28.907991
NCT02806102|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-07-03|||January 2004||2004-01-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01|5 Years|Observational [Patient Registry]|||CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)|Cardiovascular Risk and Identification of Potential High-risk Population in Korean Patients With Acute Myocardial Infarction II (COREA-AMI II)|Recruiting||N/A|13000|Anticipated|Seoul St. Mary's Hospital|||2||f||||||||||||||2017-10-10 22:04:28.983929|2017-10-10 22:04:28.983929
NCT02806089|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-01-17|||January 2016||2016-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Determinants of Muscle Strength in Chronic Kidney Disease|Determinants of Muscle Strength in Chronic Kidney Disease|Recruiting||N/A|110|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:04:29.088545|2017-10-10 22:04:29.088545
NCT02806076|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-07-31|||July 2016||2016-07-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||RFA for Small HCC With No-touch Technique and Dual Cooled-Wet Electrode|Radiofrequency Ablation Using Dual Cooled-Wet Electrode for Small Hepatocellular Carcinoma With No-touch Technique: Preliminary Study|Recruiting||Phase 4|100|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 22:04:29.18604|2017-10-10 22:04:29.18604
NCT02806063|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-01|||April 2016||2016-04-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|Bac-UP||Bacteriological Setting Before Prosthesis Implantation With One Stage Surgery in Prosthetic Joint Infection|Bacteriological Setting Before Prosthesis Implantation With One Stage Surgery in Prosthetic Joint Infection|Recruiting||N/A|100|Anticipated|Groupe Hospitalier Diaconesses Croix Saint-Simon||1|||f||||t||||||||||2017-10-10 22:04:29.268934|2017-10-10 22:04:29.268934
NCT02806050|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-02-14|||September 2016||2016-09-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Palbociclib and FES PET|Early Identification of Patients Who Benefit From Palbociclib in Addition to Letrozole|Active, not recruiting||Phase 2|15|Actual|University Medical Center Groningen||1|||f||||t||||||||Undecided||2017-10-10 22:04:29.353433|2017-10-10 22:04:29.353433
NCT02806037|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-06-19|||November 2015|Actual|2015-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Utility of Intra-operative Image Guidance System for Missing Metastases|Utility of Intra-operative Image Guidance System for Missing Metastases|Enrolling by invitation||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:04:31.498899|2017-10-10 22:04:31.498899
NCT02806024|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-10-12|||October 2016||2016-10-01|June 2016|2016-06-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|TAPPAS||Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study|Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS): A Randomized, Placebo-controlled Double Blind Trial|Recruiting||Phase 4|40|Anticipated|University of California, San Francisco||2|||f||||t||||||||No||2017-10-10 22:04:31.582223|2017-10-10 22:04:31.582223
NCT02806011|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-09-18|||May 2016||2016-05-01|January 2016|2016-01-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Long-term Follow-up Study of Livercellgram in Alcoholic Liver Cirrhosis Patients Who Completed Livercellgram Phase 2 Study|Long-term Follow-up Study of Livercellgram in Alcoholic Liver Cirrhosis Patients Who Completed Livercellgram Phase 2 Study|Enrolling by invitation||Phase 2|50|Anticipated|Pharmicell Co., Ltd.||3|||f||||f||||||||||2017-10-10 22:04:31.680101|2017-10-10 22:04:31.680101
NCT02805998|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-14|||October 2016||2016-10-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|REST||Research on Expecting Moms and Sleep Therapy|Research on Expecting Moms and Sleep Therapy|Recruiting||N/A|208|Anticipated|University of California, San Francisco||2|||f||||||||||||||2017-10-10 22:04:31.742553|2017-10-10 22:04:31.742553
NCT02805985|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-01-23|||October 2016||2016-10-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|FLXFit||Post-market Surveillance Study of FLXfit™ TLIF Interbody Fusion Device|Post-market Surveillance Study of FLXfit™ TLIF Interbody Fusion Device|Not yet recruiting||N/A|30|Anticipated|Expanding Orthopedics Ltd.||1|||f||||t||||||||Yes||2017-10-10 22:04:31.826107|2017-10-10 22:04:31.826107
NCT02805972|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-05-05|||May 20, 2017|Anticipated|2017-05-20|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|BEE||Biology and Experience of Eating|Biology and Experience of Eating|Recruiting||Phase 2|32|Anticipated|University of California, San Francisco||2|||f||||f|t|f||||||Undecided|The researchers may share deidentified individual-level data through an open repository, but are not fully decided yet.|2017-10-10 22:04:31.928127|2017-10-10 22:04:31.928127
NCT02805959|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-06-19|||June 2016||2016-06-01|April 2016|2016-04-01||||April 2017|Anticipated|2017-04-01|1 Week|Observational [Patient Registry]|||Colonic Motility in Constipation and Aging: A Study With a New 3D Transit System|Colonic Motility in Constipation and Aging: A Pilot Study With a New 3D Transit System|Not yet recruiting||N/A|20|Anticipated|University of Aarhus|||4||f||||t||||||||No||2017-10-10 22:04:32.051394|2017-10-10 22:04:32.051394
NCT02805946|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-05-10|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PIRAÑA||Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections|Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections|Recruiting||Phase 4|20|Anticipated|Radboud University||2|||f||||f|f|f||||||No||2017-10-10 22:04:32.148372|2017-10-10 22:04:32.148372
NCT02805933|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-09-30|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:04:32.284343|2017-10-10 22:04:32.284343
NCT02805920|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-15|||August 2016||2016-08-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison Between 3 Solutions of Bupivacaine of Adductor Canal Block for Anterior Cruciate Ligament Reconstruction|Adductor Canal Block for Postoperative Analgesia After Anterior Cruciate Ligament Reconstruction: Comparison Between 3 Bupivacaine Volumes and Doses|Not yet recruiting||N/A|90|Anticipated|Procare Riaya Hospital||3|||f||||t||||||||No||2017-10-10 22:04:32.332009|2017-10-10 22:04:32.332009
NCT02805907|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-03|2017-02-14||June 2016||2016-06-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ACViD||Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)|Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)|Completed||Phase 4|112|Actual|MurciaSalud||2|||f||||f||||||||No||2017-10-10 22:04:32.439539|2017-10-10 22:04:32.439539
NCT02805894|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-09-12|||November 2016||2016-11-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma|A Phase I-II Dose-escalation Study of NBTXR3 Activated by EBRT or EBRT With Brachytherapy in Patients With Newly Diagnosed Unfavorable Intermediate or High Risk Prostate Adenocarcinoma Treated With Androgen Deprivation|Recruiting||Phase 1/Phase 2|96|Anticipated|Nanobiotix||2|||f||||t||||||||||2017-10-10 22:04:33.222961|2017-10-10 22:04:33.222961
NCT02805881|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-15|||May 2016||2016-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|CTO-TNS||Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)|Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)|Recruiting||N/A|40|Anticipated|Neurolief Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:04:33.38836|2017-10-10 22:04:33.38836
NCT02805868|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-10-21|||June 2016||2016-06-01|October 2016|2016-10-01||||February 2019|Anticipated|2019-02-01||Interventional|||Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis|A Single-arm, Single Center, Pilot Study of Siltuximab, an Anti-IL6 Therapy, for Patients With Myelofibrosis|Withdrawn||Early Phase 1|0|Actual|Northwestern University||1||Funding|f||||t||||||||||2017-10-10 22:04:33.525761|2017-10-10 22:04:33.525761
NCT02805855|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis|Safety and Feasibility of Autologous Culture Expanded Adipose Derived Mesenchymal Stromal Cells in the Treatment of Painful Knee Osteoarthritis|Recruiting||Phase 1|24|Anticipated|Mayo Clinic||4|||f||||f||||||||No||2017-10-10 22:04:33.665562|2017-10-10 22:04:33.665562
NCT02805842|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-07-10|||August 2016||2016-08-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Advagraf||Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus|Evaluation of Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus (ADVAGRAF) in Kidney Transplant Recipients|Not yet recruiting||Phase 3|60|Anticipated|Rabin Medical Center||2|||f||||f||||||||No||2017-10-10 22:04:33.793818|2017-10-10 22:04:33.793818
NCT02805829|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-20|||January 2017||2017-01-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer|Combination Trastuzumab With Expanded NK Cells for Treating HER2-positive Gastric Cancer|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Xuzhou Medical University||1|||f||||t||||||||No||2017-10-10 22:04:33.898086|2017-10-10 22:04:33.898086
NCT02805816|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease|Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease|Not yet recruiting||N/A|200|Anticipated|Rabin Medical Center|||2||f||||t||||||Samples Without DNA|"     10 cc of blood samples (for celiac serology kits assessment)   "|Undecided||2017-10-10 22:04:33.991897|2017-10-10 22:04:33.991897
NCT02805803|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-01-25|||November 9, 2016|Actual|2016-11-09|January 2017|2017-01-01|September 2022|Anticipated|2022-09-01|September 2020|Anticipated|2020-09-01||Observational|PSA-QOL||Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection.|Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection.|Recruiting||N/A|60|Anticipated|Groupe Hospitalier Diaconesses Croix Saint-Simon|||1||f||||t||||||||Yes||2017-10-10 22:04:34.089915|2017-10-10 22:04:34.089915
NCT02805790|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-01-23|||July 2016||2016-07-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|MMPOWER-2||A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study|Active, not recruiting||Phase 2|30|Actual|Stealth BioTherapeutics Inc.||2|||f||||f||||||||||2017-10-10 22:04:34.196193|2017-10-10 22:04:34.196193
NCT02804724|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-06-14|||June 2015||2015-06-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological Study|Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological Study|Completed||N/A|124|Actual|University of Aberdeen|||1||f||||f||||||||No||2017-10-10 22:04:34.322977|2017-10-10 22:04:34.322977
NCT02804711|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2017-07-21|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|July 2017|Actual|2017-07-01||Interventional|||A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults|A Phase Ia Single-center, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults Aged 18-65 Years in China|Active, not recruiting||Phase 1|144|Actual|Jiangsu Province Centers for Disease Control and Prevention||7|||f||||t||||||||||2017-10-10 22:04:34.433236|2017-10-10 22:04:34.433236
NCT02804698|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||August 2016||2016-08-01|June 2016|2016-06-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Tools And Practices To Decrease CVD And Complications In The Diabetic Population Of Mexico|Tools And Practices To Decrease CVD And Complications In The Diabetic Population Of Mexico|Not yet recruiting||N/A|400|Anticipated|University of Arizona||2|||f||||f||||||||No||2017-10-10 22:04:34.553314|2017-10-10 22:04:34.553314
NCT02804685|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effectiveness of an Exercise Protocol on Alteration of Knee Joint Position Sense in Futsal Players|Effectiveness of an Exercise Protocol on Alteration of Knee Joint Position Sense in Futsal Players|Completed||N/A|34|Actual|University of Alcala||2|||f||||||||||||||2017-10-10 22:04:34.652932|2017-10-10 22:04:34.652932
NCT02804672|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-20|||March 2008||2008-03-01|June 2016|2016-06-01||||October 2010|Actual|2010-10-01||Observational|Seniors-ENRICA||Study on Cardiovascular Health, Nutrition and Frailty in Older Adults in Spain|Study on Cardiovascular Health, Nutrition and Frailty in Older Adults in Spain|Enrolling by invitation||N/A|2500|Anticipated|Universidad Autonoma de Madrid|||1||f||||||||||||||2017-10-10 22:04:34.737289|2017-10-10 22:04:34.737289
NCT02804659|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-16|||July 2013||2013-07-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|CAMIA2||Physiopathological and Therapeutic Value of microRNA in the Progression of Carotid Artery Plaques: Carotid Protocol and microRNA|Physiopathological and Therapeutic Value of microRNA in the Progression of Carotid Artery Plaques: Carotid Protocol and microRNA|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||Samples Without DNA|"     carotid artery plaques blood   "|||2017-10-10 22:04:35.021963|2017-10-10 22:04:35.021963
NCT02804646|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-19|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma|Recombinant Human Endostatin Durative Transfusion Combined With Pemetrexed Plus Cisplatin or Carboplatin in the First-line Treatment of Advanced Lung Adenocarcinoma With Wild-type EGFR or ALK-negative|Recruiting||Phase 4|100|Anticipated|Anhui Provincial Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:04:35.119258|2017-10-10 22:04:35.119258
NCT02804633|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-14|||August 2013||2013-08-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|DOCIVA||Decrease Opioid Consumption With Intra-Venous (IV) Acetaminophen After Colorectal Surgery (DOCIVA)|Decreased Opioid Consumption and Enhance Recovery With the Addition of IV-Acetaminophen in Colorectal Patients: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Study|Completed||N/A|105|Actual|Jewish Hospital, Cincinnati, Ohio||2|||f||||t||||||||Yes||2017-10-10 22:04:35.221512|2017-10-10 22:04:35.221512
NCT02804620|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-06-14|||October 2014||2014-10-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|C2C||From Clinic to Community Study|From Clinic to Community: Using Peer Support as a Transition Model for Improving Long-term Diabetes-related Health Outcomes|Recruiting||Early Phase 1|228|Anticipated|University of British Columbia||2|||f||||t||||||||No||2017-10-10 22:04:35.306688|2017-10-10 22:04:35.306688
NCT02804607|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-16|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Children Severe Traumatic Skin Lesions and Functional Outcome|Children Severe Traumatic Skin Lesions and Functional Outcome|Completed||N/A|30|Actual|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:04:35.454342|2017-10-10 22:04:35.454342
NCT02805777|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-03-13|||May 1, 2017||2017-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:04:35.537259|2017-10-10 22:04:35.537259
NCT02805764|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-15|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:04:35.581948|2017-10-10 22:04:35.581948
NCT02805751|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-15|||October 2015||2015-10-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Early Controlled Loading on Conservative Treated Achilles Tendon Ruptures|Mechanical Properties in Conservative Treated Achilles Tendon Ruptures With or Without Early Controlled Loading|Recruiting||N/A|40|Anticipated|Linkoeping University||2|||f||||f||||||||No||2017-10-10 22:04:35.6394|2017-10-10 22:04:35.6394
NCT02805738|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-06-19|||April 2016||2016-04-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet|A Multicenter, Randomized, Double-blind, Parallel Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet and Viread® Tablet in Chronic Hepatitis B Patients|Recruiting||Phase 3|158|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||No||2017-10-10 22:04:35.775431|2017-10-10 22:04:35.775431
NCT02805725|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-29|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|TARMIC||Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide|Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide (CP) in Patients With Advanced Pretreated Soft-tissue Sarcomas. A Phase I/II Study From the French Sarcoma Group.|Recruiting||Phase 1/Phase 2|71|Anticipated|Institut Bergonié||2|||f||||t||||||||||2017-10-10 22:04:35.988336|2017-10-10 22:04:35.988336
NCT02805712|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-07-19|||September 2014||2014-09-01|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Focused Palliative Care Intervention in Advanced Heart Failure|Pilot Study of a Focused Palliative Care Intervention for Recently Hospitalized High-Risk Patients With Heart Failure|Completed||N/A|50|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 22:04:36.139517|2017-10-10 22:04:36.139517
NCT02805699|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-08-29|||June 2016||2016-06-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema Treatment|Beijing Municipal Science and Technology Commission|Recruiting||Phase 2|120|Anticipated|Beijing Municipal Science & Technology Commission||2|||f||||f||||||||||2017-10-10 22:04:36.233308|2017-10-10 22:04:36.233308
NCT02805686|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-24|||June 2014||2014-06-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|OCTAPS||" En Face  OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials"||Completed||N/A|45|Actual|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 22:04:36.387925|2017-10-10 22:04:36.387925
NCT02805660|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-29|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC|A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|119|Anticipated|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 22:04:36.579263|2017-10-10 22:04:36.579263
NCT02805647|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-17|||January 2011||2011-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|December 2013|Actual|2013-12-01||Observational|||Association Between Vitamin D Receptor Polymorphism and Serum Vitamin D Levels in Children With Low-Energy Fractures|Association Between Vitamin D Receptor Polymorphism and Serum Vitamin D Levels in Children With Low-Energy Fractures|Completed||N/A|222|Actual|Medical University of Bialystok|||2||f||||f||||||Samples With DNA|"     Whole blood samples   "|Undecided||2017-10-10 22:04:36.728095|2017-10-10 22:04:36.728095
NCT02805634|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-07-25|||June 2016||2016-06-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Correlation Between the 'Nine Holes Peg Test' Performance and the Triple Stimulation Technique Within a Group a Patients With Multiple Sclerosis|Correlation Between the 'Nine Holes Peg Test' Performance and the Triple Stimulation Technique Within a Group a Patients With Multiple Sclerosis|Recruiting||N/A|30|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:04:36.856706|2017-10-10 22:04:36.856706
NCT02805621|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-01-03|||April 2016||2016-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|Machine||Machine leArning Based CT angiograpHy derIved FFR: a Multi-ceNtEr, Registry|Machine leArning Based CT angiograpHy derIved FFR a Multi-ceNtEr, Registry|Completed||N/A|352|Actual|Erasmus Medical Center|||1||f||||f||||||||No||2017-10-10 22:04:36.96413|2017-10-10 22:04:36.96413
NCT02805608|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-10-24|||September 2016||2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer|Phase II Trial: uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer|Recruiting||Phase 2|40|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||No||2017-10-10 22:04:37.054936|2017-10-10 22:04:37.054936
NCT02805595|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-03-22|||August 2016||2016-08-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa|A Single Center Clinical Trial to Evaluate the Effect of Sclerotherapy on Fistulas and Sinus Tracts in Adult Patients With Hidradenitis Suppurativa|Recruiting||Phase 3|20|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 22:04:37.148575|2017-10-10 22:04:37.148575
NCT02805582|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|||Ultrasound Guided Intercostobrachial Nerve Block|Area of Sensory Loss, Onset Time and Duration of Two Different Ultrasound Guided Intercostobrachial Nerve Blocks for Vascular Access Surgery of the Upper Arm|Active, not recruiting||N/A|30|Anticipated|Marienhospital Stuttgart||2|||f||||f||||||||No||2017-10-10 22:04:37.265685|2017-10-10 22:04:37.265685
NCT02805569|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-07-04|||June 2016||2016-06-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Intubation Conditions of the Articulating Stylet and Intubating Stylet Guided Videolaryngoscopy|Comparison of Intubation Conditions of the Articulating Stylet and Intubating Stylet Guided Videolaryngoscopy in Patients With Difficult Airway|Recruiting||N/A|60|Anticipated|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-10 22:04:37.353765|2017-10-10 22:04:37.353765
NCT02805556|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-07-18|||March 15, 2016|Actual|2016-03-15|July 2017|2017-07-01|May 5, 2016|Actual|2016-05-05|May 5, 2016|Actual|2016-05-05||Interventional|||Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing|Study of the Absolute Bioavailability of BMS-626529 in Healthy Subjects Following Oral Dosing of BMS-663068 and Intravenous Dosing of BMS-626529|Completed||Phase 1|36|Actual|ViiV Healthcare||1|||f||||||||||||||2017-10-10 22:04:37.46579|2017-10-10 22:04:37.46579
NCT02805543|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-17|||February 2016||2016-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||The Correlation Between the Retrobulbar Hemodynamics and Intrarenal Hemodynamics in T2DM Patients During the Early Period||Completed||N/A|66|Actual|Fourth People's Hospital of Shenyang|||2||f||||||||||||||2017-10-10 22:04:37.709759|2017-10-10 22:04:37.709759
NCT02805530|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-03-01|||June 2015||2015-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma|Radical Treatment of Synchronous Oligometastatic Disease and Primary Tumor in Advanced Non-small Cell Lung Carcinoma (NSCLC)|Recruiting||N/A|25|Anticipated|Instituto Nacional de Cancerologia de Mexico||1|||f||||t||||||||No||2017-10-10 22:04:37.813825|2017-10-10 22:04:37.813825
NCT02805517|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-12-15|||August 2016||2016-08-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Donor Nephrectomy|A Prospective Study of Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Donor Nephrectomy|Recruiting||N/A|100|Anticipated|Loma Linda University||1|||f||||f||||||||Undecided||2017-10-10 22:04:37.963728|2017-10-10 22:04:37.963728
NCT02805504|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-12-15|||June 2016||2016-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures|Efficacy of the Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures|Recruiting||Phase 4|50|Anticipated|Loma Linda University||2|||f||||f||||||||No||2017-10-10 22:04:38.074518|2017-10-10 22:04:38.074518
NCT02805491|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-15|||March 2011||2011-03-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|HYPOMECO||Influence of Pesticide Exposure on the Occurrence of Hypospadias in Newborns in Picardie|Case-control Study of the Influence of Pesticide Exposure on the Occurrence of Hypospadias in Newborns in Picardie|Completed||N/A|219|Actual|Centre Hospitalier Universitaire, Amiens|||2||f||||f||||||Samples Without DNA|"     meconium   "|No||2017-10-10 22:04:38.186063|2017-10-10 22:04:38.186063
NCT02805478|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-17|||September 2009||2009-09-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|FATCOR||Fat-Associated Cardiovascular Organ Dysfunction|Fat-Associated Cardiovascular Organ Dysfunction|Recruiting||N/A|600|Anticipated|Haukeland University Hospital|||1||f||||f||||||Samples With DNA|"     The FATCOR Research biobank has been approved by Health authorities and includes samples from     serum, whole blood, urine   "|Undecided||2017-10-10 22:04:38.32819|2017-10-10 22:04:38.32819
NCT02805465|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-15|||January 2016||2016-01-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparison of His Bundle Pacing and Bi-Ventricular Pacing in Heart Failure With Atrial Fibrillation|Comparison of His Bundle Pacing (HBP) and Bi-Ventricular Pacing(BiVP) in Heart Failure (HF) Patients With Atrial Fibrillation (AF) Who Need Atrial-Ventricular Node (AVN) Ablation|Recruiting||N/A|50|Anticipated|First Affiliated Hospital of Wenzhou Medical Univeristy||2|||f||||t||||||||Undecided||2017-10-10 22:04:38.444254|2017-10-10 22:04:38.444254
NCT02805452|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-12-01|||July 2016||2016-07-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|VesiCaP||Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer|Impact of Solifenacin Succinate for Treatment of Acute Irritative Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer|Recruiting||Phase 3|70|Anticipated|Center Eugene Marquis||2|||f||||f||||||||No||2017-10-10 22:04:38.587735|2017-10-10 22:04:38.587735
NCT02805439|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-03-22|||March 2016||2016-03-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment|Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment of Major Depressive Disorder in Patients With an Inadequate Response to Antidepressant Therapy: A Randomised, Double-blind, Placebo Controlled International, Multicentre Study|Active, not recruiting||Phase 2|400|Actual|Servier||3|||f||||f||||||||||2017-10-10 22:04:38.747865|2017-10-10 22:04:38.747865
NCT02805426|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-09-15|||October 2016||2016-10-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage|Double-blind, Randomized Controlled Trial to Assess the Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage|Recruiting||Phase 4|250|Anticipated|Gynuity Health Projects||2|||f||||t||||||||||2017-10-10 22:04:39.003431|2017-10-10 22:04:39.003431
NCT02805413|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-06-15|||April 2015||2015-04-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CeCi||Simultaneous Determination of Blood Pressure by Oscillometry and Photoplethysmography Compared to the Standard Inert Gas Rebreathing Technique|Simultaneous Determination of Blood Pressure by Oscillometry and Photoplethysmography Compared to the Standard Inert Gas Rebreathing Technique|Recruiting||N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||No||2017-10-10 22:04:39.137246|2017-10-10 22:04:39.137246
NCT02805400|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-06-15|||April 2015||2015-04-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|NeuroCog||Neurocognitive Performance During Space Flight. Validation of a Test Battery|Neurocognitive Performance During Space Flight. Validation of a Test Battery|Recruiting||N/A|24|Anticipated|University Hospital, Caen||1|||f||||f||||||||No||2017-10-10 22:04:39.245286|2017-10-10 22:04:39.245286
NCT02805387|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-17|||January 2013||2013-01-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Bicarbonate Given During Dystocic Labor|Bicarbonate, a New Treatment of Labour Dystocia|Completed||N/A|200|Actual|Karolinska Institutet||2|||f||||f||||||||No||2017-10-10 22:04:39.332127|2017-10-10 22:04:39.332127
NCT02805374|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2016-08-22|||July 2016||2016-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Food Effect Study to Evaluate the Pharmacokinetics of ASP1517|ASP1517 Pharmacokinetic Study - Evaluation of Food Effect on the Pharmacokinetics of ASP1517|Completed||Phase 1|16|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 22:04:39.412772|2017-10-10 22:04:39.412772
NCT02805361|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-09-05|||August 21, 2016|Actual|2016-08-21|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|REWARD||Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus|Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan- for Dapagliflozin in Management of Type 2 Diabetes Mellitus|Active, not recruiting||N/A|511|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 22:04:39.538547|2017-10-10 22:04:39.538547
NCT02805348|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-16|2017-08-21|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease|Long-Term Specified Drug Use-Results Survey in Patients With Pre-dialysis Chronic Kidney Disease|Active, not recruiting||N/A|144|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 22:04:39.633479|2017-10-10 22:04:39.633479
NCT02805335|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-01-31|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KTFIXPICC||Comparison Between Sutureless Devices for PICC and a New System KT FIX PLUS|Comparison Between Actually Sutureless Devices for PICC to a New Device KT FIX PLUS|Recruiting||N/A|500|Anticipated|University Hospital, Caen||2|||f||||t||||||||Yes||2017-10-10 22:04:39.762939|2017-10-10 22:04:39.762939
NCT02805322|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-15|||April 2016||2016-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of a Novel Non-Invasive, Non-Touch Infrared Thermometer With Routine Thermometry in Routine Clinical Practice|Comparison of a Novel Non-Invasive, Non-Touch Infrared Thermometer With Routine Thermometry in Routine Clinical Practice|Completed||Phase 4|138|Actual|ARC Devices||2|||f||||f||||||||No||2017-10-10 22:04:39.863095|2017-10-10 22:04:39.863095
NCT02805309|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2017-08-16|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|August 31, 2018|Anticipated|2018-08-31||Interventional|REHAB-TAVR||Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement|Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement: A Pilot Study|Recruiting||N/A|60|Anticipated|Brigham and Women's Hospital||3|||f||||f|f|f||||||||2017-10-10 22:04:39.969056|2017-10-10 22:04:39.969056
NCT02805296|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-15|||June 2014||2014-06-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||High Intensity Phototherapy: Double vs. Single|Intensive Phototherapy, Double vs. Single, in Treatment of Neonatal Hyperbilirubinemia Using LED|Completed||N/A|83|Actual|Aalborg Universitetshospital||2|||f||||f||||||||No||2017-10-10 22:04:40.083732|2017-10-10 22:04:40.083732
NCT02805283|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-28|||June 22, 2016|Actual|2016-06-22|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Dapagliflozin Patient Satisfaction Survey|Direct to Patient Survey to Examine Treatment Satisfaction and Experience With Dapagliflozin Compared to Sulfonylureas|Recruiting||N/A|932|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-10-10 22:04:40.15941|2017-10-10 22:04:40.15941
NCT02805270|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-20|||January 2014||2014-01-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization|Implementation of a Medication Reconciliation Intervention and Its Impact on the Rate of ADEs and Healthcare Utilization 30 Days Following Discharge From the Hospital. A Randomized Controlled Trial.|Completed||N/A|587|Actual|Sultan Qaboos University||2|||f||||f||||||||No||2017-10-10 22:04:40.246658|2017-10-10 22:04:40.246658
NCT02805257|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|AMCT||Ahmed Glaucoma Valve Surgery With Mitomycin-C|Ahmed Glaucoma Valve Surgery With Mitomycin-C|Not yet recruiting||Phase 2|100|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:04:40.328268|2017-10-10 22:04:40.328268
NCT02805244|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-11-28|||June 2016||2016-06-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis|A Phase 1, Open-label, Single Dose, Mass Balance Study to Evaluate the Pharmacokinetics, Biotransformation and Excretion of 14C-JTZ-951 in Male Subjects With End-stage Renal Disease Receiving Hemodialysis|Completed||Phase 1|6|Actual|Akros Pharma Inc.||1|||f||||f||||||||||2017-10-10 22:04:40.432729|2017-10-10 22:04:40.432729
NCT02805231|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-01-08|||July 2013||2013-07-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|||Associations of Vitamin D Receptor ApaI and Tru9I Polymorphisms With the Risk of Primary Open-angle Glaucoma|Associations of Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma|Completed||N/A|300|Actual|Tianjin Medical University Eye Hospital|||2||f||||||||||Samples With DNA|"     ApaI and Tru9I Polymorphisms   "|||2017-10-10 22:04:40.515267|2017-10-10 22:04:40.515267
NCT02805218|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-16|||September 2013||2013-09-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy|The Multi-center,Open-label,Single Arm Clinical Trial of Efficacy and Safety of PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy|Completed||Phase 4|410|Actual|CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-10 22:04:40.590787|2017-10-10 22:04:40.590787
NCT02805205|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-17|||April 2013||2013-04-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia|A Multi-center, Open-label,Single Arm Phase IV Clinical Trial of Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia in Patients With Breast Cancer Receiving Chemotherapy|Completed||Phase 4|484|Actual|CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-10 22:04:40.656895|2017-10-10 22:04:40.656895
NCT02805192|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-05-02|||January 30, 2016||2016-01-30|May 2017|2017-05-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Validation of a Smart Phone App to Non-invasively Measure the Size of Children|Validation of a Smart Phone App to Non-invasively Measure the Size of Children|Completed||N/A|627|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 22:04:40.727701|2017-10-10 22:04:40.727701
NCT02805179|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-07|||August 26, 2016|Actual|2016-08-26|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma|Phase II Study of High Dose Radiotherapy and Concurrent Temozolomide Using Biologically-Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 2|30|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 22:04:40.80682|2017-10-10 22:04:40.80682
NCT02805166|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-16|||April 2013||2013-04-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy|The Multi-center,Open-label,Single Arm Phase IV Clinical Trial of Efficacy and Safety of PEG-rhG-CSF in Patients With Lung Cancer,Head and Neck Cancer,Colorectal Cancer,Ovarian Cancer and the Other Cancer Receiving Chemotherapy|Completed||Phase 4|420|Actual|CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-10 22:04:40.883243|2017-10-10 22:04:40.883243
NCT02805153|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-17|||April 2013||2013-04-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy|The Multi-center, Open-label,Randomized Comparison Phase IV Clinical Trial of Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia in Patients With Breast Cancer Receiving Chemotherapy|Completed||Phase 4|215|Actual|CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:04:40.956389|2017-10-10 22:04:40.956389
NCT02805140|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-02-24|||August 2016||2016-08-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|MOVE||The Moms Online Video Exercise Study|The Moms Online Video Exercise Study|Completed||N/A|64|Actual|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 22:04:41.045957|2017-10-10 22:04:41.045957
NCT02805127|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-11-16|||November 2016||2016-11-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Obstructive Airways Diseases in Emergency Department (OADED) Study|Obstructive Airways Diseases in Emergency Department (OADED) Study|Not yet recruiting||N/A|30|Anticipated|Medtronic - MITG|||1||f||||f||||||||No||2017-10-10 22:04:41.270754|2017-10-10 22:04:41.270754
NCT02805114|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-11-16|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Obstructive Airways Diseases in Pulmonary Clinic (OADPC) Study|Obstructive Airways Diseases in Pulmonary Clinic (OADPC) Study|Recruiting||N/A|70|Anticipated|Medtronic - MITG|||1||f||||f||||||||No|Study publication will not contain any identifying data of individuals.|2017-10-10 22:04:41.34824|2017-10-10 22:04:41.34824
NCT02805101|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-07-26|||January 2015||2015-01-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|June 20, 2017|Actual|2017-06-20||Interventional|||Comparative Study Between Biodentine and Mineral Trioxide Aggregate in Sealing Root Perforations|A Comparative Study of the Performance of Biodentine and Mineral Trioxide Aggregate (MTA) in Sealing Root Perforations.|Recruiting||N/A|30|Anticipated|Damascus University||2|||f||||t||||||||||2017-10-10 22:04:41.448927|2017-10-10 22:04:41.448927
NCT02805088|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-20|||February 2014||2014-02-01|June 2016|2016-06-01||||August 2016|Anticipated|2016-08-01||Interventional|ELISE||Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability?|Interaction Emotion-cognition in the Study of Literal and Figurative Language in Schizophrenia and Bipolar Disorders: Behavioral and Electrophysiological Studies|Recruiting||N/A|240|Anticipated|CHU de Reims||3|||f||||||||||||||2017-10-10 22:04:41.562222|2017-10-10 22:04:41.562222
NCT02805075|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-07-11|||June 2016||2016-06-01|July 2017|2017-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant|Single Arm Dose-Escalation Trial of Fructo-Oligosaccharides in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|Recruiting||Phase 1|15|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:04:41.666747|2017-10-10 22:04:41.666747
NCT02805062|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-20|||June 2016||2016-06-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|MASCOT||Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy|Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy|Not yet recruiting||N/A|65|Anticipated|NHS Greater Glasgow and Clyde|||1||f||||f||||||||No|Published results will not personally identify study subjects.|2017-10-10 22:04:41.767123|2017-10-10 22:04:41.767123
NCT02805049|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-12-01|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis|Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis|Not yet recruiting||Phase 4|24|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 22:04:41.853348|2017-10-10 22:04:41.853348
NCT02805036|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-02-22|||November 2015||2015-11-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|RHERA1||Comparison of the Hemodynamic Safety of Two Common Alveolar Recruitment Manoeuvres With Regard to Cardiac Output in a Surgical Intensive Care Unit|Comparison of the Hemodynamic Safety of Two Common Alveolar Recruitment Manoeuvres With Regard to Cardiac Output in a Surgical Intensive Care Unit: a Randomized Study|Completed||N/A|30|Actual|Centre Hospitalier Universitaire, Amiens|||2||f||||f||||||||||2017-10-10 22:04:41.984183|2017-10-10 22:04:41.984183
NCT02805023|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-01-31|||June 2016||2016-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EnEPC-CLI||Assessing the Feasibility of BGC101 in the Treatment of PAD & CLI|Phase 1/2, Open Label & Randomized Placebo Controlled Study to Assess the Feasibility of BGC101 (EnEPC) in the Treatment of Peripheral Arterial Disease (PAD) With Critical Limb Ischemia (CLI)|Recruiting||Phase 1/Phase 2|30|Anticipated|BioGenCell Ltd.||2|||f||||t||||||||Undecided||2017-10-10 22:04:42.066809|2017-10-10 22:04:42.066809
NCT02805010|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-12-03|||October 2016||2016-10-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously|A Randomized, Double-blind, Placebo-controlled Study to Assess the Pharmacokinetics, Safety and Tolerability of Single Dose of Abatacept 125mg Administered Subcutaneously in Chinese Healthy Subjects|Active, not recruiting||Phase 1|22|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||No||2017-10-10 22:04:42.171654|2017-10-10 22:04:42.171654
NCT02804997|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-15|||May 2015||2015-05-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|ARCTICS||Evaluation of the Alveolar Recruitment Obtained During Non-invasive Ventilation After Cardiac Surgery|Evaluation of the Alveolar Recruitment Obtained During Non-invasive Ventilation After Cardiac Surgery|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:04:42.26817|2017-10-10 22:04:42.26817
NCT02804984|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-15|||July 2015||2015-07-01|June 2016|2016-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|AMICUS||Identification of Molecular Defects in Idiopathic Cytopenia of Undetermined Significance|Identification of Molecular Defects in Idiopathic Cytopenia of Undetermined Significance|Recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||Samples With DNA|"     -  blood        -  bone marrow   "|||2017-10-10 22:04:42.333678|2017-10-10 22:04:42.333678
NCT02804971|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-07-31|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Observational|BRONCOCA||Cardiovascular Comorbidities and Bronchiectasis|Cardiovascular Comorbidities, Inflammation, Aging and Bronchiectasis|Recruiting||N/A|200|Anticipated|Centre Hospitalier Intercommunal Creteil|||1||f||||f||||||||||2017-10-10 22:04:42.423346|2017-10-10 22:04:42.423346
NCT02804958|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-15|||December 2014||2014-12-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Incheon-Bucheon Cohort of Patients Undergoing Primary PCI for Acute STEMI|Incheon-Bucheon Cohort of Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-segment Elevation Myocardial Infarction|Completed||N/A|1537|Actual|Gachon University Gil Medical Center|||1||f||||f||||||||No||2017-10-10 22:04:42.496603|2017-10-10 22:04:42.496603
NCT02804945|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-09-11|||February 24, 2017|Actual|2017-02-24|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies|A Phase II Trial of Mesenchymal Stem Cells for Treatment of Acute Respiratory Distress Syndrome in Patients With Malignancies|Recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 22:04:42.593909|2017-10-10 22:04:42.593909
NCT02804932|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-03-30|||June 2016||2016-06-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Nitrate Supplementation and Exercise Tolerance in Patients With Type 2 Diabetes|Nitrate Supplementation and Exercise Tolerance in Patients With Type 2 Diabetes|Recruiting||N/A|65|Anticipated|University of Iowa||2|||f||||t||||||||||2017-10-10 22:04:42.70057|2017-10-10 22:04:42.70057
NCT02804919|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-06-16|||July 2016||2016-07-01|June 2017|2017-06-01|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Interventional|||CPAP In-home Assessment NZ|CPAP In-home Assessment NZ|Completed||N/A|30|Actual|Fisher and Paykel Healthcare||1|||f||||t||||||||||2017-10-10 22:04:42.786889|2017-10-10 22:04:42.786889
NCT02804906|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-09-27|||June 2016||2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RESILIENT||Rehabilitation in the Home Setting for Older Adults In the Early Period After Myocardial Infarction|Rehabilitation in the Home Setting for Older Adults In the Early Period After Myocardial Infarction|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:04:42.863978|2017-10-10 22:04:42.863978
NCT02800928|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-06-20|||June 2016||2016-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Does CERC-501 Attenuate Stress-precipitated Smoking Lapse?|Does CERC-501 Attenuate Stress-precipitated Smoking Lapse?|Recruiting||Phase 2|20|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 22:05:19.721797|2017-10-10 22:05:19.721797
NCT02804893|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-17|||June 2016||2016-06-01|June 2016|2016-06-01||||June 2016|Actual|2016-06-01||Interventional|ROMAN||Videothoracoscopic (VATS) vs. Robotic Approach for Lobectomy or Anatomical Segmentectomy|Prospective, Randomized, Multicentric Study On Videothoracoscopic (Vats) Vs Robotic Approach For Lobectomy Or Anatomical Segmentectomy In Patients Affected By Early Lung Cancer (ROMAN)|Not yet recruiting||N/A|300|Anticipated|Istituto Clinico Humanitas||2|||f||||f||||||||Undecided||2017-10-10 22:04:42.981717|2017-10-10 22:04:42.981717
NCT02804880|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-10-24|||June 2016||2016-06-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||"Building Capacity and Promoting Smoking Cessation in the Community Via Quit to Win Contest 2016"|"Building Capacity and Promoting Smoking Cessation in the Community Via Quit to Win Contest 2016: a Single-blind Cluster Randomized Controlled Trial on High Intensity Active Referral and Simple Text Messaging to Achieve Abstinence"|Active, not recruiting||N/A|1200|Anticipated|The University of Hong Kong||3|||f||||t||||||||Undecided||2017-10-10 22:04:43.08737|2017-10-10 22:04:43.08737
NCT02804867|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-02-19|||March 2016||2016-03-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Spot Depression Study|A Blood Test to Identify Persons at Risk of Developing Depression or Bipolar Disorder|Completed||N/A|1000|Anticipated|University of Cambridge|||3||f||||f||||||||No||2017-10-10 22:04:43.203894|2017-10-10 22:04:43.203894
NCT02804854|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-05-02|||December 2016||2016-12-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|SNAP-IT||Sensing Using Neutrophil Activation Probe on the Intensive Therapy Unit|Sensing Using Neutrophil Activation Probe on the Intensive Therapy Unit|Recruiting||Phase 2|75|Anticipated|University of Edinburgh||1|||f||||t||||||||||2017-10-10 22:04:43.281713|2017-10-10 22:04:43.281713
NCT02804594|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-09-27|||August 2016||2016-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of Oxidative Pathways in MS Fatigue|A Phase 2 Randomized, Placebo- Controlled, Parallel Group, Double Blinded Single Center Study on Effect of N-acetyl Cysteine Compared to Placebo on Fatigue in Patients With Progressive Multiple Sclerosis|Recruiting||Phase 2|20|Anticipated|University of California, San Francisco||2|||f||||t||||||||Yes|De-identified data will be made available for the primary and secondary outcome measures within six months of study completion.|2017-10-10 22:04:43.371162|2017-10-10 22:04:43.371162
NCT02804581|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-19|||June 2016||2016-06-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Gum Arabic as Immunomodulator In Rheumatoid Arthritis Patients|Potential Role of Gum Arabic as Immunomodulator In Sudanese Rheumatoid Arthritis Patients|Recruiting||Phase 2|45|Anticipated|Al-Neelain University||1|||f||||f||||||||No||2017-10-10 22:04:43.473455|2017-10-10 22:04:43.473455
NCT02804568|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-09-21|||June 2016||2016-06-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Phase 1 Safety Study in Adults With Schizophrenia|A Multiple-dose, Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALKS 3831 in Adult Subjects With Schizophrenia|Completed||Phase 1|42|Actual|Alkermes, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:04:43.574932|2017-10-10 22:04:43.574932
NCT02804555|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-04-26|||June 2013||2013-06-01|November 2016|2016-11-01|November 30, 2016|Actual|2016-11-30|June 2016|Actual|2016-06-01||Interventional|||Effects of Intraoperative Oxygen Therapy on Oxygenation of Newborns Born Via Elective Cesarian Section|Effects of Intraoperative Oxygen Therapy on Oxygenation and Reactive Oxygen Species Levels of Newborns Born Via Elective Cesarian Section|Completed||N/A|107|Actual|Szeged University||2|||f||||t||||||||Undecided||2017-10-10 22:04:43.671092|2017-10-10 22:04:43.671092
NCT02804542|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-08-02|||August 11, 2016|Actual|2016-08-11|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Fascia Iliaca Blocks and Pre-operative Opioid Requirements in Hip Fracture Patients|Pre-operative Fascia Iliaca Blocks and Opioid Requirements in Hip Fracture Patients|Enrolling by invitation||N/A|60|Anticipated|Spectrum Health Hospitals|||2||f||||f||||||||||2017-10-10 22:04:43.753322|2017-10-10 22:04:43.753322
NCT02804529|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||A Comparison of Three Different Entry Points to Establish the Pneumoperitoneum|A Comparison of Three Different Puncture Points to Establish the Pneumoperitoneum in Laparoscopic Gastrointestinal Surgery: A Randomized Prospective Trial|Not yet recruiting||N/A|90|Anticipated|China-Japan Friendship Hospital||3|||f||||t||||||||Yes||2017-10-10 22:04:43.822111|2017-10-10 22:04:43.822111
NCT02804516|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-14|||July 2016||2016-07-01|June 2016|2016-06-01||||August 2016|Anticipated|2016-08-01||Interventional|||Recognition and Management of Early Mobilization in ICUs : Practice Patterns in China|Recognition and Management of Early Mobilization in ICUs : Practice Patterns in China|Not yet recruiting||N/A|1000|Anticipated|Southeast University, China||2|||f||||t||||||||Undecided||2017-10-10 22:04:43.91466|2017-10-10 22:04:43.91466
NCT02804503|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||November 2014||2014-11-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Menu Labels on Calories Ordered in Hispanics|The Effect of Menu Labels on Food Choices in Hispanics|Completed||N/A|372|Actual|Texas Christian University||3|||f||||f||||||||No||2017-10-10 22:04:44.010655|2017-10-10 22:04:44.010655
NCT02804490|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2017-08-16|||March 2016||2016-03-01|August 2017|2017-08-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|||Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status|Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status|Completed||Phase 3|255|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-10-10 22:04:44.111878|2017-10-10 22:04:44.111878
NCT02804477|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-25|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Observational|||Validation and Assessment of Patient Adherence to Opioids for Cancer Pain Using MMAS 8 Pain Clinic|Validation and Assessment of Patient Adherence to Opioids for Cancer Pain Using MMAS 8 Questionnaire in Pain Clinic|Completed||N/A|330|Actual|Tata Memorial Centre|||1||f||||t||||||||Undecided||2017-10-10 22:04:44.20035|2017-10-10 22:04:44.20035
NCT02804464|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-09-16|||July 2016||2016-07-01|September 2016|2016-09-01||||May 2018|Anticipated|2018-05-01||Observational|DISCOVER||The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)|The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)|Recruiting||N/A|100|Anticipated|Karius, Inc.|||1||f||||f||||||Samples With DNA|"     Plasma   "|Undecided||2017-10-10 22:04:44.276601|2017-10-10 22:04:44.276601
NCT02804438|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-14|||July 2015||2015-07-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|6 Months|Observational [Patient Registry]|ENDPANIC||Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care|Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care|Recruiting||N/A|1000|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||No||2017-10-10 22:04:44.425522|2017-10-10 22:04:44.425522
NCT02804425|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Comparison of Learning Outcomes Between the Roles of Learner During an Immersive Simulation|Comparison of Learning Outcomes Between the Roles of Learner (Actor-spectator and Spectator-only) During an Immersive Simulation|Not yet recruiting||N/A|100|Anticipated|Université Paris-Sud||2|||f||||f||||||||Yes|De-identified individual participant data for all participants for all primary and secondary outcomes will be available within 6 months of study completion|2017-10-10 22:04:44.509873|2017-10-10 22:04:44.509873
NCT02804412|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-14|||March 2005||2005-03-01|June 2016|2016-06-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Aphasia Therapy: Factors of Efficacy|Constraint Induced Aphasia Therapy in Stroke Patients in Acute Stage.|Completed||N/A|60|Actual|University of Leipzig||3|||f||||f||||||||No||2017-10-10 22:04:44.599932|2017-10-10 22:04:44.599932
NCT02804386|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-07-25|||June 2016||2016-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|HEATS||Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon|Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon (Hepatitis Eradication Accuracy Trial of Sofosbuvir): An Observational Non-interventional Real Life Trial|Recruiting||Phase 4|5000|Anticipated|PharmEvo Pvt Ltd||1|||f||||t||||||||Undecided||2017-10-10 22:04:44.791183|2017-10-10 22:04:44.791183
NCT02804373|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-06-14|||June 2014||2014-06-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|PRADOTIM||Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome|Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome|Recruiting||Phase 2/Phase 3|39|Anticipated|University Hospital, Toulouse||3|||f||||f||||||||No||2017-10-10 22:04:44.888245|2017-10-10 22:04:44.888245
NCT02804360|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-17|||January 2015||2015-01-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study|Dexamethasone in Retinitis Pigmentosa Cystoid Macular Edema|Enrolling by invitation||Phase 2|50|Anticipated|Rafic Hariri University Hospital||1|||f||||t||||||||Yes|we can share data through excel sheet|2017-10-10 22:04:45.005998|2017-10-10 22:04:45.005998
NCT02804347|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-01|||March 2016||2016-03-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||The Effects of ECT and/or iTBS on Olfaction and Cognition in Patients With Depression|The Effects of Electroconvulsive Therapy (ECT) and/or Intermittent Theta Burst Stimulation (iTBS) on Olfaction and Cognition in Patients With Depression|Completed||N/A|30|Actual|Queen's University|||2||f||||f||||||||||2017-10-10 22:04:45.076439|2017-10-10 22:04:45.076439
NCT02804334|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders|The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders|Recruiting||N/A|70|Anticipated|University Hospitals Cleveland Medical Center|||2||f||||t||||||||||2017-10-10 22:04:45.197646|2017-10-10 22:04:45.197646
NCT02804321|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-15|2016-06-16|||September 2013||2013-09-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01|6 Months|Observational [Patient Registry]|ALDO-AF||Plasma Aldosterone Levels and Atrial Fibrillation Reduction (ALDO-AF Study)|Plasma Aldosterone Levels and Atrial Fibrillation Reduction (ALDO-AF Study)|Recruiting||N/A|170|Anticipated|University Hospital, Caen|||1||f||||t||||||Samples Without DNA|"     aldosterone galectine 3 ngal   "|Yes||2017-10-10 22:04:45.27858|2017-10-10 22:04:45.27858
NCT02804308|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-16|||August 2015||2015-08-01|March 2015|2015-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Combined Training on Body Composition of Postmenopausal Women Undergoing Treatment for Breast Cancer|Effectiveness of Physical Training on Body Composition, Physical Activity Level and Quality of Life of Postmenopausal Women Undergoing Treatment for Breast Cancer With Aromatase Inhibitors: The Randomized Clinical Trial.|Completed||N/A|83|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||||2017-10-10 22:04:45.617274|2017-10-10 22:04:45.617274
NCT02804295|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-16|||January 2015||2015-01-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Collaborative Care From the ED for Trauma Patients With Prescription Drug Misuse|Collaborative Care From the Emergency Department for Trauma Patients With Prescription Drug Misuse: A Feasibility Study|Completed||N/A|30|Actual|University of Washington||1|||f||||f||||||||No||2017-10-10 22:04:45.771686|2017-10-10 22:04:45.771686
NCT02804269|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-14|||July 2013||2013-07-01|July 2013|2013-07-01|July 2033|Anticipated|2033-07-01|July 2033|Anticipated|2033-07-01||Observational|Biobank||Molecular and Imaging Studies of Cardiovascular Health and Disease|Molecular and Imaging Studies of Cardiovascular Health and Disease|Recruiting||N/A|5000|Anticipated|National Heart Centre Singapore|||5||f||||f||||||Samples With DNA|"     whole blood and serum.   "|No||2017-10-10 22:04:45.995161|2017-10-10 22:04:45.995161
NCT02800720|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-09|||November 2012||2012-11-01|June 2016|2016-06-01||||September 2014|Actual|2014-09-01||Interventional|||Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome|Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome: A Randomised Controlled Trial|Completed||N/A|148|Actual|Nottingham Trent University||2|||f||||||||||||||2017-10-10 22:05:21.24254|2017-10-10 22:05:21.24254
NCT02804256|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-14|||January 2014||2014-01-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Biomarkers of Inherited Cardiovascular Conditions|Biomarkers of Inherited Cardiovascular Conditions|Recruiting||N/A|10|Anticipated|National Heart Centre Singapore|||1||f||||f||||||Samples With DNA|"     For antibody studies, the investigators will invite 10 patients with phenotypes of interest     (e.g. myocardial fibrosis or previous myocardial infarction) whom have consented to the     biorepository to provide an additional 20mls (2 tablespoons).   "|No||2017-10-10 22:04:46.150943|2017-10-10 22:04:46.150943
NCT02804243|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-09-12|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Efficacy of Nasal High Flow Oxygen Therapy With Rehabilitation in the Patients With Chronic Respiratory Failure|The Efficacy of Nasal High Flow Oxygen Therapy With Rehabilitation in the Patients With Chronic Respiratory Failure|Recruiting||N/A|32|Anticipated|National Hospital Organization Minami Kyoto Hospital||2|||f||||f||||||||||2017-10-10 22:04:46.25569|2017-10-10 22:04:46.25569
NCT02804230|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-08-15|||June 2016||2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|EP001||MR-Guided Focused Ultrasound in the Treatment of Subcortical Lesional Epilepsy|A Feasibility Study to Evaluate Safety and Initial Effectiveness of MR-Guided Focused Ultrasound Ablation Therapy in the Treatment of Subcortical Lesional Epilepsy|Recruiting||N/A|10|Anticipated|InSightec||1|||f||||t||||||||||2017-10-10 22:04:46.379183|2017-10-10 22:04:46.379183
NCT02804217|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-18|||June 2016||2016-06-01|June 2016|2016-06-01||||June 2017|Anticipated|2017-06-01||Observational|||Acquired Resistant Mechanism of the First-generation EGFR TKIs|Identification of Genomic Mutation Profile Using Next Generation Sequencing for Non-small-cell Lung Cancer Patients With Activating EGFR Mutations Harboring Acquired Resistance to the First-generation EGFR TKIs.|Recruiting||N/A|60|Anticipated|Zhejiang Cancer Hospital|||1||f||||t||||||||||2017-10-10 22:04:46.492283|2017-10-10 22:04:46.492283
NCT02804204|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|AROMA||Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF|Analysis of Circulant Rheumatoid Factor, Cyclic Citrullinated Anti-peptide Anti-bodies and Albumin as a Potential Predictor in the Response to the Treatment With Anti-TNF in Patients With Rheumatoid Arthritis|Recruiting||N/A|200|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||1||f||||f||||||||||2017-10-10 22:04:46.596053|2017-10-10 22:04:46.596053
NCT02804191|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-25|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis|Recruiting||Phase 2|62|Anticipated|Ocuwize LTD||2|||f||||f||||||||||2017-10-10 22:04:46.797237|2017-10-10 22:04:46.797237
NCT02804178|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-06-21|||May 2016||2016-05-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia|A Phase 2, Multicenter Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia|Active, not recruiting||Phase 2|15|Actual|Millendo Therapeutics, Inc.||1|||f||||f||||||||No||2017-10-10 22:04:46.939987|2017-10-10 22:04:46.939987
NCT02804165|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-05-24|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|GENEVIR||Gene-virus Interactions Implicated in Type 1 Diabetes|Gene-virus Interactions Implicated in Type 1 Diabetes|Not yet recruiting||N/A|1100|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 22:04:47.047502|2017-10-10 22:04:47.047502
NCT02804152|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-29|||April 2016||2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Program for Pain & Prescription Opioid Use in Pregnancy|A Novel Approach to Reduce Pain, Prescription Opioid Use & Misuse in Pregnancy|Recruiting||N/A|200|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-10-10 22:04:47.161786|2017-10-10 22:04:47.161786
NCT02804139|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-19|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Physical Therapy in Addition to Standard Care Following C-Section|Physical Therapy in Addition to Standard Care Following C-Section|Active, not recruiting||N/A|125|Actual|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 22:04:47.276449|2017-10-10 22:04:47.276449
NCT02804126|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-05-01|||June 2016||2016-06-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Two Pain-treatment Techniques After Cesarean Section|Effectiveness of Transversus Abdominis Plane Block Versus Quadratus Lumborum Technique in Patients After Cesarean Section|Recruiting||Phase 4|200|Anticipated|Medical University of Lublin||2|||f||||f||||||||||2017-10-10 22:04:47.376398|2017-10-10 22:04:47.376398
NCT02804113|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-09-15|||April 2016||2016-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|VMI-CFA||Clinical Trial Investigating the Efficacy of the Supera Peripheral Stent System for the Treatment of the Common Femoral Artery|VMI-CFA Study: Physician-initiated Trial Investigating the Efficacy of the Vascular Mimetic Implant Supera Peripheral Stent System for the Treatment of the Common Femoral Artery|Active, not recruiting||N/A|100|Anticipated|ID3 Medical||1|||f||||||||||||||2017-10-10 22:04:47.528144|2017-10-10 22:04:47.528144
NCT02804100|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-10-31|||May 2016||2016-05-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients|A Multi-centre Observational Study on Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients Under Gefitinib Treatment|Recruiting||N/A|200|Anticipated|Wenzhou Medical University|||1||f||||f||||||||Undecided||2017-10-10 22:04:47.630937|2017-10-10 22:04:47.630937
NCT02804087|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-03-29|||December 2016||2016-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|CALM-START||Controlling And Lowering Blood Pressure With the MobiusHDTM Device|CALM-START - Controlling And Lowering Blood Pressure With the MobiusHDTM Device: STudying Effects in A Randomized Trial|Recruiting||N/A|110|Anticipated|Vascular Dynamics, Inc.||2|||f||||t||||||||Undecided||2017-10-10 22:04:47.716044|2017-10-10 22:04:47.716044
NCT02800148|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-06-06|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face||Active, not recruiting||Phase 3|665|Actual|Perrigo Company||3|||f||||f||||||||No||2017-10-10 22:05:26.081041|2017-10-10 22:05:26.081041
NCT02804074|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-06-30|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01||Interventional|MASTER||MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement|MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement (MASTER Study)|Not yet recruiting||N/A|1240|Anticipated|Istituto Auxologico Italiano||2|||f||||t|f|f||||||||2017-10-10 22:04:47.80904|2017-10-10 22:04:47.80904
NCT02804061|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-07-26|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|NELIP||Early Prevention of Excessive Gestational Weight Gain Using Lifestyle Change|Strategizing the Best Approach to Prevent Early Excessive Gestational Weight Gain Using a Nutrition and Exercise Lifestyle Intervention Program (NELIP)|Recruiting||N/A|81|Anticipated|University of Western Ontario, Canada||3|||f||||f||||||||No||2017-10-10 22:04:47.888127|2017-10-10 22:04:47.888127
NCT02804048|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-10-04|||December 2012||2012-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Physiotherapy Intervention in Climacteric Women With Dyspareunia|Physiotherapy Intervention in Climacteric Women With Dyspareunia: A Randomized Controlled Trial|Completed||N/A|42|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:04:47.998514|2017-10-10 22:04:47.998514
NCT02804022|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2017-02-05|||June 2016||2016-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|VPIAmorphine||Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia|Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia for Postsurgical Pain: A Novel Modality to Improve Patient Safety by Detecting and Preventing Respiratory Depression|Recruiting||Phase 2|20|Anticipated|KK Women's and Children's Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:04:48.143012|2017-10-10 22:04:48.143012
NCT02804009|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-08-08|||November 2015||2015-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ANGST||Elective Coronary Angiography and Anxiety Study|Evaluating and Predicting Anxiety in Patients Undergoing Elective Coronary Angiography|Recruiting||N/A|350|Anticipated|General and Teaching Hospital Celje|||1||f||||f||||||||No||2017-10-10 22:04:48.226135|2017-10-10 22:04:48.226135
NCT02803996|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-12-20|||May 2016||2016-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers|Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers|Completed||Phase 1|64|Actual|Galmed Pharmaceuticals Ltd||6|||f||||f||||||||||2017-10-10 22:04:48.305488|2017-10-10 22:04:48.305488
NCT02803983|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|PFNF||Pediatric Hip Plate Versus Cannulated Screw in Pediatric Femoral Neck Fracture|An Multicenter Prospective Observational Study to Pediatric Hip Plate Versus Cannulated Screw in Pediatric Femoral Neck Fracture (Delbet Type II and III)|Completed||N/A|30|Actual|The Fuzhou No 2 Hospital|||2||f||||t||||||||No||2017-10-10 22:04:48.391181|2017-10-10 22:04:48.391181
NCT02803970|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-09-27|||December 1994||1994-12-01|September 2016|2016-09-01|December 2040|Anticipated|2040-12-01|December 2040|Anticipated|2040-12-01|10 Years|Observational [Patient Registry]|KOBOT||KOrean Borderline Ovarian Tumor (KOBOT) Registry|Establishing the Registry of Korean Patients With Borderline Ovarian Tumors|Recruiting||N/A|3000|Anticipated|Kangbuk Samsung Hospital|||1||f||||f||||||||No||2017-10-10 22:04:48.459662|2017-10-10 22:04:48.459662
NCT02803957|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-08-16|||November 2016|Actual|2016-11-01|October 2016|2016-10-01|July 2023|Anticipated|2023-07-01|July 2019|Anticipated|2019-07-01||Interventional|ReChord||Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair|Randomized Trial of the NeoChord™ DS1000™ System Versus Open Surgical Repair|Recruiting||N/A|585|Anticipated|NeoChord||2|||f||||t||||||||||2017-10-10 22:04:48.545205|2017-10-10 22:04:48.545205
NCT02803944|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||September 2014||2014-09-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|AZITHRO||Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years|Long Term Effects of Azithromycin in Patients With Cystic Fibrosis Using the National Database|Completed||N/A|2055|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:04:48.635135|2017-10-10 22:04:48.635135
NCT02803931|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-06-14|||December 2015||2015-12-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|COGNITION||Assessing the Efficacy of CardiOGoniometry (CGM) to Localise the Culprit Vessel in Mixed Vessel Disease Non-ST elevatIon Myocardial infarcTION (NSTEMI)|Assessing the Efficacy of CardiOGoniometry (CGM) to Localise the Culprit Vessel in Mixed Vessel Disease Non-ST elevatIon Myocardial infarcTION (NSTEMI)|Recruiting||N/A|30|Anticipated|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 22:04:48.740692|2017-10-10 22:04:48.740692
NCT02803905|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-14|||April 2016||2016-04-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|ITA-OMEN||Islet Transplant Alone in OMENtum|A Monocentric, Open-label, Double-arm, Phase II Trial to Assess the Safety and Efficacy of Allogeneic Islet Cells Transplanted Into the Omentum|Recruiting||Phase 2|12|Anticipated|Ospedale San Raffaele||2|||f||||||||||||||2017-10-10 22:04:48.95175|2017-10-10 22:04:48.95175
NCT02799758|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-10|||February 2016||2016-02-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia||Terminated||Phase 3|2|Actual|Kowa Research Institute, Inc.||2|||f||||f||||||||||2017-10-10 22:05:29.337146|2017-10-10 22:05:29.337146
NCT02803892|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-14|||May 2016||2016-05-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|MONORAPA||Monotherapy With Rapamycin in Long-standing Type 1 Diabetes|Evaluation of the Efficacy of Rapamycin and a Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) in Improving Beta Cell Function in Type 1 Diabetes of Long Duration, a Perspective Randomized Study|Recruiting||Phase 2|60|Anticipated|Ospedale San Raffaele||3|||f||||||||||||Undecided||2017-10-10 22:04:49.035296|2017-10-10 22:04:49.035296
NCT02803879|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-06-16|||August 2015||2015-08-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|HF-CGM||Assessing the Capability of Cardiogoniometry (CGM) to Detect Changes in Cardiac Resynchronisation Therapy Device Settings|Assessing the Capability of Cardiogoniometry (CGM) to Detect Changes in Cardiac Resynchronisation Therapy Device Settings|Recruiting||N/A|10|Anticipated|Hull and East Yorkshire Hospitals NHS Trust||1|||f||||f||||||||Undecided||2017-10-10 22:04:49.147186|2017-10-10 22:04:49.147186
NCT02803866|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||June 2015||2015-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01|2 Months|Observational [Patient Registry]|CAP-PREM||Training Parenting Self-efficacy in Parents of Hospitalized Preterm Neonates|Assessing Parenting Self-efficacy Before and After Applying a Specific Training Program for Parents (CAP-PREM: Preterm Capacitation) During Hospitalization of Preterm Neonates|Recruiting||N/A|16|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||t||||||||No||2017-10-10 22:04:49.226085|2017-10-10 22:04:49.226085
NCT02803853|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-16|||April 2015||2015-04-01|June 2016|2016-06-01|August 2020|Anticipated|2020-08-01|April 2020|Anticipated|2020-04-01||Interventional|OPREVENT2||Engaging Tribal Policy Makers to Improve the Food and Physical Activity Environments in American Indian Communities|Engaging Tribal Policy Makers to Sustain Improvements to the Food and Physical Activity Environments in American Indian Communities (OPREVENT2)|Recruiting||N/A|876|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||Yes|The proposed data sharing plan is intended to make study data as widely and freely available as possible, while safeguarding the privacy of participants, and protecting confidentiality. The data sharing plan includes additional stages of review and approval by the Navajo and Indian Health Services (IHS) Institutional Review Boards (IRBs). The investigators will strip the final dataset of personal identifiers prior to release for sharing. As even aggregated data may be perceived as stigmatizing, the investigators will make the data available to users under a data-sharing agreement that provides for: 1 initial approval of the data sharing request by the investigator, Navajo/IHS IRBs; 2 a commitment to not identifying participating communities without the express permission of that tribe's authorities; 3 a commitment to destroying or returning the data after analyses are completed; and 4 a commitment to having all manuscripts/documents approved by the Navajo/IHS IRBs prior to publication.|2017-10-10 22:04:49.337912|2017-10-10 22:04:49.337912
NCT02803840|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-16|||July 2011||2011-07-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Low-dose Radiotherapy for Diffuse Large B-cell Lymphoma|A Phase II Trial of Low-Dose Radiotherapy for the Palliation of Patients With Diffuse Large B-cell Lymphoma|Recruiting||Phase 2|25|Anticipated|Centro di Riferimento Oncologico - Aviano||1|||f||||f||||||||No||2017-10-10 22:04:49.426549|2017-10-10 22:04:49.426549
NCT02803827|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-12-05|||June 2016||2016-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Optimizing the Management of Acute Diarrhoeal Disease|Optimizing the Management of Pediatric Acute Diarrhoeal Disease in Botswana|Recruiting||Phase 3|400|Anticipated|Hamilton Health Sciences Corporation||4|||f||||f||||||||||2017-10-10 22:04:49.500084|2017-10-10 22:04:49.500084
NCT02803814|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-14|||February 2016||2016-02-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DUOPAN-EPAM||Pancreatoduodenectomy in Pancreatic and Periampullary Tumors|Pancreatoduodenectomy in Pancreatic and Periampullary Tumors: Initial Approach of the Superior Mesenteric Artery Versus Classical Approach: A Prospective, Randomized, Multicenter Study|Recruiting||N/A|116|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||No||2017-10-10 22:04:51.48961|2017-10-10 22:04:51.48961
NCT02803775|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-03-28|||February 2, 2017|Actual|2017-02-02|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PASED||Paced And Sensed Electrical Delay in CRT Therapy (PASED CRT)|Paced And Sensed Electrical Delay in CRT Therapy (PASED CRT)|Recruiting||N/A|72|Anticipated|Deborah Heart and Lung Center||2|||f||||f||||||||No||2017-10-10 22:04:51.802808|2017-10-10 22:04:51.802808
NCT02803762|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-14|||July 2014||2014-07-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Investigate Absorption, Metabolism, Excretion, and Mass Balance of Pacritinib|A Phase 1, Open-Label Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of [14C] Pacritinib Following a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|6|Actual|CTI BioPharma||1|||f||||f||||||||||2017-10-10 22:04:51.905825|2017-10-10 22:04:51.905825
NCT02803749|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Buspirone in Parkinson's Disease|The Tolerability of Buspirone for the Treatment of Anxiety in Parkinson's Disease|Recruiting||Phase 2|27|Anticipated|University of Rochester||2|||f||||f||||||||No||2017-10-10 22:04:51.998829|2017-10-10 22:04:51.998829
NCT02803736|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|Acupuncture||Effectiveness of Acupuncture for Breast Cancer Related Lymphedema|Effectiveness of Acupuncture for Breast Cancer Related Lymphedema|Not yet recruiting||N/A|150|Anticipated|Fourth Affiliated Hospital of Guangxi Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:04:52.094974|2017-10-10 22:04:52.094974
NCT02803723|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-17|||June 2016||2016-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Casa||"Holding-cuddling Plus Oral Sucrose Versus Oral Sucrose for Reducing Venipuncture Pain in Newborns and Infants"|"Holding-cuddling Plus Oral Sucrose Versus Oral Sucrose for Reducing Venipuncture Pain in Newborns and Infants"|Not yet recruiting||N/A|68|Anticipated|Centre Hospitalier Universitaire de la Réunion||2|||f||||f||||||||No||2017-10-10 22:04:52.185605|2017-10-10 22:04:52.185605
NCT02803710|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-17|||January 2012||2012-01-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2012|Actual|2012-12-01||Observational|CARBAFREST||Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region|Prevalence of Enterobacteriaceae With Decreased Susceptibility to Carbapenems in Eastern Inter- Region|Active, not recruiting||N/A|315|Actual|CHU de Reims|||2||f||||||||||||||2017-10-10 22:04:52.262991|2017-10-10 22:04:52.262991
NCT02803697|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-12-27|||November 2015||2015-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|March 2017|Anticipated|2017-03-01||Observational|||Predictive Factors of Recurrence of Non Functioning Pituitary Adenomas : a Retrospective Study of 220 Patients in the Reims University Hospital, France|Predictive Factors of Recurrence of Non Functioning Pituitary Adenomas : a Retrospective Study of 220 Patients in the Reims University Hospital, France|Recruiting||N/A|220|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 22:04:52.340111|2017-10-10 22:04:52.340111
NCT02803684|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-14|||April 2014||2014-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Contribution of Diffusion MRI in Renal Graft Transplantation|Diagnostic Ability of Diffusion MRI and Diffusion Tensor in Renal Graft Biopsies: Pilot Study|Recruiting||N/A|50|Anticipated|CHU de Reims||1|||f||||f||||||||||2017-10-10 22:04:52.441468|2017-10-10 22:04:52.441468
NCT02803671|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-12-02|||August 2009||2009-08-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|NNP-MULTIMODAL||Analysis of the Impact of Patent Ductus Arteriosus on Brain Function in Preterm Neonates: Multimodal Approach Integrating EEG-NIRS, Ultrasound and Clinical Data|Analysis of the Impact of Patent Ductus Arteriosus on Brain Function in Preterm Neonates: Multimodal Approach Integrating EEG-NIRS, Ultrasound and Clinical Data|Recruiting||N/A|56|Anticipated|Centre Hospitalier Universitaire, Amiens||3|||f||||||||||||||2017-10-10 22:04:52.687154|2017-10-10 22:04:52.687154
NCT02803658|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-16|||December 2012||2012-12-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TABAFERTIMASC||Impact of Male Smoking on the Couple's Infertility|Impact of Male Smoking on the Couple's Infertility: Two-centre Case-control Study|Active, not recruiting||N/A|154|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 22:04:52.787662|2017-10-10 22:04:52.787662
NCT02803645|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-14|||July 2007||2007-07-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SAPL||Clinical Significance of Antiphospholipid Antibodies in Healthy Subjects|Clinical Significance of Antiphospholipid Antibodies in Healthy Subjects: Study of Their Association With Cardiovascular Risk Factors, Markers of Arterial Inflammation and Markers of Oxidative Stress|Completed||N/A|1282|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-10 22:04:52.889201|2017-10-10 22:04:52.889201
NCT02803632|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-14|||November 2012||2012-11-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|ACTIHUMEUR||Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide|Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide: Investigation of Disruptive Mood Dysregulation Disorder|Recruiting||N/A|140|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-10 22:04:52.977285|2017-10-10 22:04:52.977285
NCT02803619|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||November 2013||2013-11-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Observational|||A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis||Recruiting||N/A|60|Anticipated|Peking Union Medical College Hospital|||1||f||||||||||||||2017-10-10 22:04:53.087434|2017-10-10 22:04:53.087434
NCT02803606|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-16|||June 2009||2009-06-01|June 2016|2016-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|PREMARISQ||Evaluation of Risk Factors Predictive of Hypothermia in Preterm Neonates in Incubators During the First Week of Life|Evaluation of Risk Factors Predictive of Hypothermia in Preterm Neonates in Incubators During the First Week of Life|Completed||N/A|30|Actual|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||||||2017-10-10 22:04:53.17664|2017-10-10 22:04:53.17664
NCT02803593|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-04-17|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|TICAA||To Enhance Breast Cancer Survivorship of Asian Americans|To Enhance Breast Cancer Survivorship of Asian Americans|Recruiting||N/A|330|Anticipated|Duke University||2|||f||||t||||||||Undecided||2017-10-10 22:04:53.276028|2017-10-10 22:04:53.276028
NCT02803580|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-08-25|||November 17, 2015|Actual|2015-11-17|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|||IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis|IPF Italian Observational Study (FIBRONET)|Active, not recruiting||N/A|210|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 22:04:53.387877|2017-10-10 22:04:53.387877
NCT02803567|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-18|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Trial of a Novel Brief Intervention on Health Behaviors for Youth With Chronic Medical Conditions|Trial of a Novel Brief Intervention on Health Behaviors for Youth With Chronic Medical|Recruiting||N/A|450|Anticipated|Boston Children’s Hospital||2|||f||||t|f|f||||||||2017-10-10 22:04:53.524861|2017-10-10 22:04:53.524861
NCT02803554|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-10-31|||June 2016||2016-06-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Young Donor Plasma Transfusion and Age-Related Biomarkers|Young Donor Plasma Transfusion and Age-Related Biomarkers|Recruiting||N/A|600|Anticipated|Ambrosia LLC||1|||f||||f||||||||No||2017-10-10 22:04:53.636167|2017-10-10 22:04:53.636167
NCT02803541|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Does a Mainstream Summer Camp Experience Improve Pediatric Kidney Patients' Physical Fitness and Self Concept?|Does a Mainstream Summer Camp Experience Improve Pediatric Kidney Patients' Physical Fitness and Self Concept?|Enrolling by invitation||N/A|100|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||No||2017-10-10 22:04:53.718917|2017-10-10 22:04:53.718917
NCT02803528|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-26|||January 2015||2015-01-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|January 2017|Actual|2017-01-01||Interventional|||Comparative Study Between Biodentine and Mineral Trioxide Aggregate in Direct Pulp Capping|A Comparative Study of the Performance of Biodentine and Mineral Trioxide Aggregate (MTA) in Direct Pulp Capping of Deeply Carious Teeth.|Recruiting||N/A|30|Anticipated|Damascus University||2|||f||||t||||||||||2017-10-10 22:04:53.810116|2017-10-10 22:04:53.810116
NCT02803515|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||August 2016||2016-08-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Hyperthermic Intraperitoneal Chemotherapy (HIPEC) : Predictive Marker and Mechanism|HSP90 as a Predictive Marker of the Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Carcinomatosis From Ovarian Origin.|Not yet recruiting||N/A|44|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||Undecided||2017-10-10 22:04:53.900282|2017-10-10 22:04:53.900282
NCT02803502|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||July 2016||2016-07-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?|Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?|Not yet recruiting||N/A|50|Anticipated|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 22:04:53.986793|2017-10-10 22:04:53.986793
NCT02803489|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-05-11|||April 8, 2016|Actual|2016-04-08|April 2017|2017-04-01|May 9, 2017|Actual|2017-05-09|March 23, 2017|Actual|2017-03-23||Interventional|||Evaluation of the Performance of an e-Health System|Evaluation of the Performance of an e-Health System Comprising Tele-monitoring / Tele-notification and Tele-coaching in Ambulatory Multi-morbid Adult Patients|Terminated||N/A|23|Actual|Air Liquide Santé International||1||inclusion rate too low & investigators enable to recruit new patients rapidly|f||||t||||||||No||2017-10-10 22:04:54.126121|2017-10-10 22:04:54.126121
NCT02803476|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-16|||March 2016||2016-03-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Observational|||Is There Association Between Vitamin D Levels And Insulin Resistance In Polycystic Ovary Syndrome?|Is There An Association Between Vitamin D Levels And Insulin Resistance In Polycystic Ovary Syndrome?|Recruiting||N/A|166|Anticipated|Ain Shams Maternity Hospital|||2||f||||t||||||Samples Without DNA|"     Overnight fasting venous blood samples will be withdrawn between the 2nd and 3rd day of     menstruation, and withdrawal bleeding following progesterone therapy for 5 days in amenorheic     women, centrifuged and frozen to -80 C until analyzed for the assessment of vitamin D levels,     Androgen levels, plasma Glucose and plasma Insulin, FSH and LH analogues.   "|Yes||2017-10-10 22:04:54.262308|2017-10-10 22:04:54.262308
NCT02803463|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-12-15|||June 2016||2016-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Peritoneal Closure Versus Non Closure During Open Appendectomy|Peritoneal Closure Versus Non Closure During Open Appendectomy: a Randomized Trial|Completed||N/A|112|Actual|Bezmialem Vakif University||2|||f||||t||||||||Undecided||2017-10-10 22:04:54.488769|2017-10-10 22:04:54.488769
NCT02803450|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-02-10|||February 2016||2016-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Epidural Loading: High Volume, Low Concentration|Epidural Loading With High Volume, Low Concentration Prior to Catheter Insertion: is How You Administer the Volume Important?|Recruiting||N/A|105|Anticipated|Ohio State University||3|||f||||f||||||||No||2017-10-10 22:04:54.59921|2017-10-10 22:04:54.59921
NCT02803424|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-12-25|||June 2016||2016-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of Volume Controlled Ventilation and Autoflow-volume Controlled Ventilation in Robot-assisted Laparoscopic Radical Prostatectomy With Steep Trendelenburg Position and Pneumoperitoneum||Completed||N/A|80|Actual|Yonsei University||2|||f||||t||||||||No|no plan to share data|2017-10-10 22:04:54.800334|2017-10-10 22:04:54.800334
NCT02803411|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-05-18|||March 2003||2003-03-01|May 2017|2017-05-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01|12 Months|Observational [Patient Registry]|PARADIGM||Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)|Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)|Active, not recruiting||N/A|2000|Anticipated|Yonsei University|||1||f||||f|f|f||||||Undecided||2017-10-10 22:04:54.899706|2017-10-10 22:04:54.899706
NCT02803398|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-12-28|||February 2016||2016-02-01|December 2016|2016-12-01||||December 2016|Actual|2016-12-01||Interventional|||Modelling Interface Pressure Applied by Superimposed Compression Bandages|Modelling Interface Pressure Applied by Superimposed Compression Bandages|Completed||N/A|26|Actual|Thuasne||1|||f||||f||||||||Undecided||2017-10-10 22:04:54.991541|2017-10-10 22:04:54.991541
NCT02803385|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-04-25|||July 2016||2016-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Patient Controlled & Continuous Epidural Analgesia in Thoraco-abdominal Surgeries in Cancer Patients|Comparison of Efficacy of Patient Controlled Epidural Analgesia Versus Continuous Epidural Infusion Following Thoraco-abdominal Surgeries in Cancer Patients|Recruiting||N/A|70|Anticipated|Tata Memorial Centre||2|||f||||t||||||||No||2017-10-10 22:04:55.081453|2017-10-10 22:04:55.081453
NCT02803372|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-05-30|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|December 2016|Actual|2016-12-01||Interventional|||Circulatory Management and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy|Impact of Circulatory Management Based on LiDCOrapid Hemodynamic Monitoring on the Incidence of Acute Kidney Injury in Patients Undergoing Partial Nephrectomy: A Randomized Controlled Trial|Active, not recruiting||N/A|144|Actual|Peking University First Hospital||2|||f||||t||||||||Yes|Data of individual participants for all primary and secondary outcome measures will be made available within 6 months of study completion.|2017-10-10 22:04:55.200833|2017-10-10 22:04:55.200833
NCT02803346|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-15|||January 2009||2009-01-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|IMMUNOSEPSIS||Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)|Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)|Recruiting||N/A|160|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples Without DNA|"     plasma   "|||2017-10-10 22:04:55.413569|2017-10-10 22:04:55.413569
NCT02803333|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-28|||June 14, 2016|Actual|2016-06-14|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|ORIEN||Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study|Symptoms, Toxicity Prevalence and Quality of Life Benefit of Targeted Therapies and Immunotherapies in Lung Cancer Patients: An Observational Prospective Cohort Study Within the Total Cancer Care Population|Recruiting||N/A|400|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||1||f||||f|f|f||||||||2017-10-10 22:04:55.502627|2017-10-10 22:04:55.502627
NCT02803320|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||May 2015||2015-05-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||To Assess the Safety of a Sunscreen Product|Supervised Outdoor -Use Test to Assess the Safety of a Sunscreen Lotion on Sports Users|Completed||N/A|107|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:04:55.620519|2017-10-10 22:04:55.620519
NCT02803307|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-12-16|||June 2015||2015-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee|A Randomized, Open-label, Parallel, Phase I/II Single-Dose Administration Trial of TLC599 in Subjects With Osteoarthritis of the Knee|Completed||Phase 1/Phase 2|40|Actual|Taiwan Liposome Company||2|||f||||t||||||||No||2017-10-10 22:04:55.712973|2017-10-10 22:04:55.712973
NCT02803294|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01||||July 2026|Anticipated|2026-07-01||Interventional|TORCH||Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population|THE TORCH TRIAL：Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population|Not yet recruiting||Phase 3|2000|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||1|||f||||t||||||||||2017-10-10 22:04:55.824454|2017-10-10 22:04:55.824454
NCT02803281|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-11-08|||August 2015||2015-08-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Assessment of Patient Frailty Prior to Thoracic Surgery|Assessment of Patient Frailty Prior to Thoracic Surgery: A Feasibility Study|Recruiting||N/A|40|Anticipated|University Health Network, Toronto|||2||f||||f||||||||||2017-10-10 22:04:55.936568|2017-10-10 22:04:55.936568
NCT02803268|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-02-09|||June 2016||2016-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms||Completed||Phase 1|24|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-10-10 22:04:56.052579|2017-10-10 22:04:56.052579
NCT02803255|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-13|||May 2014||2014-05-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||AAN Robotic Therapy in SCI|Effect of Assist-as-needed Robot Aided Rehabilitation Strategies in Subjects With Incomplete Spinal Cord Injury|Completed||Phase 1|14|Actual|William Marsh Rice University||2|||f||||||||||||||2017-10-10 22:04:56.158553|2017-10-10 22:04:56.158553
NCT02803242|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||August 2014||2014-08-01|June 2016|2016-06-01|January 2030|Anticipated|2030-01-01|January 2025|Anticipated|2025-01-01|15 Years|Observational [Patient Registry]|COPD PPRN||COPD Patient-Powered Research Network|COPD Patient-Powered Research Network|Recruiting||N/A|75000|Anticipated|COPD Foundation|||1||f||||f||||||||||2017-10-10 22:04:56.252575|2017-10-10 22:04:56.252575
NCT02803229|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-04-03|||July 2016||2016-07-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|MJ-ADHD||Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder|Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder|Recruiting||Phase 2/Phase 3|50|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-10 22:04:56.362933|2017-10-10 22:04:56.362933
NCT02803216|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-09-02|||January 2013||2013-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori|Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori: a Prospective, Double-blinded, Randomized Trial|Completed||Phase 1/Phase 2|576|Actual|Xiyuan Hospital of China Academy of Chinese Medical Sciences||3|||f||||t||||||||Yes||2017-10-10 22:04:56.484002|2017-10-10 22:04:56.484002
NCT02803203|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-09-07|||June 29, 2016|Actual|2016-06-29|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers|A Phase 1/2 Study of Combination Osimertinib and Bevacizumab as Treatment for Patients With EGFR-mutant Lung Cancers|Recruiting||Phase 1/Phase 2|58|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:04:56.558245|2017-10-10 22:04:56.558245
NCT02803190|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-02-01|||June 2016||2016-06-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Osteoporosis and Fall Prevention and Posture Correction Interventions in the Metropolitan Area|Osteoporosis and Fall Prevention and Posture Correction Interventions in the Metropolitan Area|Enrolling by invitation||N/A|100|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 22:04:56.678301|2017-10-10 22:04:56.678301
NCT02803177|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-17|||July 2, 2016|Actual|2016-07-02|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BMC2012||Cell Therapy by Autologous BMC for Large Bone Defect Repair|BMC2012, Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures - a Randomized, Open, Multicentric Study - Phase IIa|Recruiting||Phase 2|94|Anticipated|Goethe University||2|||f||||t||||||||||2017-10-10 22:04:56.76302|2017-10-10 22:04:56.76302
NCT02803164|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-05-09|||February 10, 2017|Actual|2017-02-10|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds|A Pilot Study to Evaluate the Efficacy of Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds|Recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||f|f|t|f|f||||||2017-10-10 22:04:56.868866|2017-10-10 22:04:56.868866
NCT02803151|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-03-07|||May 2016||2016-05-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy|A Prospective Phase II Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy|Recruiting||N/A|59|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||No||2017-10-10 22:04:56.946291|2017-10-10 22:04:56.946291
NCT02803138|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-08-15|||July 18, 2016||2016-07-18|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|CITRINE||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C - An Observational Study in Israel (CITRINE STUDY)|Recruiting||N/A|250|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:04:57.525558|2017-10-10 22:04:57.525558
NCT02803125|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-06-05|||November 30, 2017|Anticipated|2017-11-30|June 2017|2017-06-01|November 30, 2021|Anticipated|2021-11-30|November 30, 2020|Anticipated|2020-11-30||Interventional|||Improving Psychosocial Functioning in Older Veterans With PTSD|Improving Psychosocial Functioning in Older Veterans With PTSD|Not yet recruiting||Early Phase 1|124|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 22:04:57.641251|2017-10-10 22:04:57.641251
NCT02803112|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-13|||February 2010||2010-02-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|January 2016|Actual|2016-01-01||Observational|||Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy|Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy. A 6-year Retrospective Analysis in a Level 1 Trauma Center|Active, not recruiting||N/A|67|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||No||2017-10-10 22:04:57.854136|2017-10-10 22:04:57.854136
NCT02803099|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-03-03|||November 2015||2015-11-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay ,UVA Protection Factor Assay (UVAPF), Minimal Persistent Pigment-Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:04:57.932069|2017-10-10 22:04:57.932069
NCT02803086|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-22|||February 2014||2014-02-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Observational|IHU-WPRT-TOX||Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer|Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer|Recruiting||N/A|400|Anticipated|IRCCS San Raffaele|||1||f||||f||||||||No||2017-10-10 22:04:58.047484|2017-10-10 22:04:58.047484
NCT02803073|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-09-05|||August 2016||2016-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction|Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After A Recent Myocardial Infarction.|Recruiting||Phase 2/Phase 3|60|Anticipated|Texas Tech University Health Sciences Center||2|||f||||t||||||||||2017-10-10 22:04:58.150808|2017-10-10 22:04:58.150808
NCT02803060|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||November 2015||2015-11-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay ,UVA Protection Factor Assay (UVAPF), Minimal Persistent Pigment-Darkening Dose (MPPD)|Completed||N/A|15|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:04:58.270563|2017-10-10 22:04:58.270563
NCT02803047|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||November 2015||2015-11-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment - Darkening Dose (MPPD)|Completed||N/A|11|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:04:58.367441|2017-10-10 22:04:58.367441
NCT02803034|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||November 2015||2015-11-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment - Darkening Dose (MPPD)|Completed||N/A|15|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:04:58.457657|2017-10-10 22:04:58.457657
NCT02803021|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||October 2015||2015-10-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay, UVA Protection Factor Assay (UVAPF), Minimal Persistent Pigment- Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:04:58.547735|2017-10-10 22:04:58.547735
NCT02803008|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||October 2015||2015-10-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay (UVAPF), Minimal Persistent Pigment-Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:04:58.654033|2017-10-10 22:04:58.654033
NCT02802995|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-13|||May 2016||2016-05-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety And Efficacy Of Topical Platelet Rich Plasma And Thrombin Coagulum|Safety And Efficacy Of Topical Platelet Rich Plasma And Thrombin Coagulum In The Treatment Of Recalcitrant Venous Stasis Ulcers|Recruiting||Phase 3|100|Anticipated|University of Witwatersrand, South Africa||2|||f||||f||||||||Yes||2017-10-10 22:04:58.755082|2017-10-10 22:04:58.755082
NCT02802982|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-07-18|||April 2013||2013-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates|Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates|Active, not recruiting||N/A|28|Actual|Boston Children’s Hospital|||1||f||||f||||||Samples Without DNA|"     A single blood sample drawn (approx. 800 mcL total) for a complete blood count with IPF and     for determination of a panel of factors important in the regulation of thrombopoiesis     (including TPO, IL-6, IL-11, IL-3, PF-4, VEGF, IGF-1, IGF-II, TGF-ß, HGF, PDGF, and Epo).      In addition, left-over blood from clinically indicated studies will be collected from the     clinical laboratory, processed and stored at -80C for future cytokine studies. Samples will     continue to be collected and serial platelet counts with IPF followed until resolution of the     thrombocytopenia, defined as a platelet count >60,000/uL for five days without platelet     transfusions.   "|||2017-10-10 22:04:58.90186|2017-10-10 22:04:58.90186
NCT02802969|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-06-13|||July 22, 2016|Actual|2016-07-22|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|PROTONCHORDE01||Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers|Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers|Recruiting||Phase 2|64|Anticipated|Institut Curie||1|||f||||t||||||||||2017-10-10 22:04:58.985159|2017-10-10 22:04:58.985159
NCT02802956|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Preliminary Feasibility Efficacy of Participation in Daily Life Promotion Program|National Taiwan University Hospital, Taiwan|Not yet recruiting||N/A|30|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 22:04:59.094249|2017-10-10 22:04:59.094249
NCT02802943|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-03-17|||October 2016||2016-10-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Patient-individualized Peptide Vaccination in Combination With Lenalidomide After First Line Therapy of CLL|iVAC-L-CLL01: Patient-individualized Peptide Vaccination in Combination With Lenalidomide After First Line Therapy of CLL|Recruiting||Phase 2|56|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-10 22:04:59.196449|2017-10-10 22:04:59.196449
NCT02802930|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||April 2015||2015-04-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Test the Phototoxicity of Sunscreen Products|A Randomized Study to Assess the Potential for Phototoxicity of SPF 50 Y65 110, SPF 50 Y51 002 and SPF 15 V27-104 in Human Subjects|Completed||N/A|32|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:04:59.338431|2017-10-10 22:04:59.338431
NCT02802917|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||May 2015||2015-05-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||To Evaluate Eye Installation-Tear Free|Evaluation of the Stinging Potential of Products in Human Eyes|Completed||N/A|83|Actual|Bayer||4|||f||||f||||||||||2017-10-10 22:04:59.447161|2017-10-10 22:04:59.447161
NCT02802904|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-15|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MC1||Multicountry Studies on the Effect of Positional Distribution of Fatty Acids at Triglyceride Backbone on Serum Lipids, Lipoprotein(a) and LDL-subclasses in Healthy Malaysian Volunteers|Multicountry Studies on the Effect of Positional Distribution of Fatty Acids at Triglyceride Backbone on Serum Lipids, Lipoprotein(a) and LDL-subclasses in Healthy Malaysian Volunteers|Completed||N/A|42|Actual|Malaysia Palm Oil Board||3|||f||||t||||||||Undecided||2017-10-10 22:04:59.576291|2017-10-10 22:04:59.576291
NCT02802891|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-05-02|||December 2015||2015-12-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|October 2017|Anticipated|2017-10-01||Observational|JOIN||The JOIN Project: The Air in Diagnosis and Prevention of Asthma and Allergy|Projeto JOIN - o ar Como Meio de prevenção e a diagnóstico da Asma e Alergia|Recruiting||N/A|75|Anticipated|Universidade do Porto|||5||f||||t||||||Samples With DNA|"     Exhaled breath condensate (no DNA)      Urine (DNA)   "|||2017-10-10 22:04:59.69878|2017-10-10 22:04:59.69878
NCT02802878|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-02-02|||June 2016||2016-06-01|February 2017|2017-02-01|December 14, 2016|Actual|2016-12-14|December 14, 2016|Actual|2016-12-14||Interventional|||Combined Application of Electrical Stimulation and Volitional Contractions for Muscle Strengthening and Knee Pain Inhibition (Seated Study)|Determining Efficacy of the Combined Application of Electrical Stimulation and Volitional Contractions for Muscle Strengthening and Knee Pain Inhibition in Women With or at Risk for Knee Osteoarthritis|Completed||N/A|42|Actual|University of Kansas Medical Center||2|||f||||f||||||||No||2017-10-10 22:04:59.806379|2017-10-10 22:04:59.806379
NCT02802865|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-12-12|||August 2016||2016-08-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||Combined Letrozole and Clomid in Women With Infertility and PCOS|Combined Letrozole and Clomid in Polycystic Ovary Syndrome: a Randomized Control Trial of Combination of Letrozole and Clomiphene Citrate or Letrozole Alone for the Treatment of Infertility in Women With Polycystic Ovary Syndrome|Recruiting||Phase 4|70|Anticipated|University of Iowa||2|||f||||t||||||||||2017-10-10 22:04:59.922201|2017-10-10 22:04:59.922201
NCT02802852|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Proteomics and Stem Cell Therapy as a New Vascularization Strategy|Proteomics and Stem Cell Therapy as a New Vascularization Strategy|Not yet recruiting||N/A|25|Anticipated|University of Illinois at Chicago||1|||f||||t||||||||No||2017-10-10 22:05:00.034147|2017-10-10 22:05:00.034147
NCT02802839|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|VRAP||Virtual Reality for the Reduction of Pain During Venipuncture in Children With CF|The Use of Virtual Reality in the Reduction of Pain and Anxiety During Venipuncture in Children With Cystic Fibrosis: a Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|University of Florence||2|||f||||f||||||||No||2017-10-10 22:05:00.154595|2017-10-10 22:05:00.154595
NCT02802826|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-15|||July 2016||2016-07-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|STEPS||Studying Tailored Exercise Prescriptions in Breast Cancer Patients|The Effects of a Tailored, Home-based Exercise Prescription to Increase Physical Activity in Breast Cancer Patients Undergoing Systemic Chemotherapy|Not yet recruiting||Phase 3|100|Anticipated|Loughborough University||2|||f||||f||||||||No||2017-10-10 22:05:00.284389|2017-10-10 22:05:00.284389
NCT02802813|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-08-22|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|Lao Pv||P.Vivax Treatment Trial|A Nested, Randomised Single-blind Treatment Trial of Subclinical Vivax Infections With Primaquine|Recruiting||Phase 1/Phase 2|60|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-10 22:05:00.406013|2017-10-10 22:05:00.406013
NCT02802800|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||A Comparison of Land Based and Water Based Plyometric Training Effects on the Physical Fitness of Field Hockey Players in Jamaica|A Comparison of Land Based and Water Based Plyometric Training Effects on the Physical Fitness of Field Hockey Players in Jamaica|Recruiting||N/A|54|Anticipated|The University of The West Indies||2|||f||||f||||||||Yes|At the end of the study each individual participant will be taken through the results of their data and recommendations made to them regarding the type of training programme they would want to use. Individual data will not be shared with anyone else.|2017-10-10 22:05:00.525978|2017-10-10 22:05:00.525978
NCT02802787|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Implementation and Evaluation of an Activity Program to Improve Quality of Life Outcomes in Women Diagnosed With Cancer|Implementation and Evaluation of an Activity Based Program to Improve Quality of Life Outcomes in Women Diagnosed With Cancer|Not yet recruiting||N/A|57|Anticipated|Temple University||1|||f||||f||||||||No||2017-10-10 22:05:00.617288|2017-10-10 22:05:00.617288
NCT02802774|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-09-07|||July 2016||2016-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immobilization of Postoperative Distal Radius Fractures|Immobilization of Postoperative Distal Radius Fractures|Enrolling by invitation||N/A|120|Anticipated|University of California, San Francisco||3|||f||||f||||||||No|We will not share any individual participant data.|2017-10-10 22:05:00.687205|2017-10-10 22:05:00.687205
NCT02802761|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-12-17|||January 2016||2016-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Nutritional Assessment Tool in Childhood Chronic Liver Disease|Nutritional Assessment Tool in Childhood Chronic Liver Disease|Recruiting||N/A|110|Anticipated|Institute of Liver and Biliary Sciences, India|||1||f||||f||||||||Undecided||2017-10-10 22:05:00.799711|2017-10-10 22:05:00.799711
NCT02802748|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-02-15|||July 2016||2016-07-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)|Randomized, Open-label, Three-arm, Parallel, Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole Versus Letrozole or Vinorelbine Alone in Post-menopausal Women With Hormone Receptor-positive HER2-negative Early Breast Cancer|Recruiting||Early Phase 1|60|Anticipated|SOLTI Breast Cancer Research Group||3|||f||||f||||||||No||2017-10-10 22:05:00.860488|2017-10-10 22:05:00.860488
NCT02802735|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-12-02|||June 2016||2016-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects|A Phase 1, Open-label, Two Part Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects|Completed||Phase 1|27|Actual|Celgene Corporation||4|||f||||f||||||||||2017-10-10 22:05:00.99725|2017-10-10 22:05:00.99725
NCT02802722|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-03-31|||February 24, 2017|Actual|2017-02-24|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ResolveD-CAP||Does Vitamin D Supplementation Enhance Resolution of Inflammation After Community-acquired Pneumonia?|A Prospective Randomised Placebo-controlled Study of the Influence of Vitamin D Supplementation on Resolution of Inflammation Following Community-acquired Pneumonia|Recruiting||N/A|50|Anticipated|Queen Mary University of London||2|||f||||f|f|f|||f|||No||2017-10-10 22:05:01.106422|2017-10-10 22:05:01.106422
NCT02802709|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-07-18|||May 2016||2016-05-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|February 2017|Actual|2017-02-01||Interventional|MODIFY-OA||A Trial of SB-061 in Osteoarthritis of the Knee|A Placebo-controlled, Double-blind, Randomized Trial of an Intra-articular Device, SB-061, in Symptomatic Osteoarthritis of the Knee|Completed||Phase 1/Phase 2|90|Anticipated|Symic OA Co.||2|||f||||f||||||||||2017-10-10 22:05:01.226026|2017-10-10 22:05:01.226026
NCT02802696|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-06-23|||June 2016||2016-06-01|October 2016|2016-10-01|April 15, 2017|Actual|2017-04-15|March 17, 2017|Actual|2017-03-17||Interventional|||Transfusion-Associated Circulatory Overload Best Eliminated With Lasix|Pre-transfusion Furosemide in Patients at High Risk of Transfusion-associated Circulatory Overload - The Transfusion-Associated Circulatory Overload Best Eliminated With Lasix (TACO-BEL) Study: A Pilot Randomized Controlled Trial|Completed||Early Phase 1|80|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||Undecided||2017-10-10 22:05:01.322285|2017-10-10 22:05:01.322285
NCT02802683|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-07-04|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Hemodynamic Impact of Hyperbaric Versus Isobaric for Spinal Anesthesia During Cesarean Delivery||Completed||Phase 4|72|Actual|Seoul National University Hospital||4|||f||||||||||||||2017-10-10 22:05:01.420895|2017-10-10 22:05:01.420895
NCT02802670|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-15|||May 2016||2016-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants||Completed||Phase 1|7|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-10 22:05:01.510913|2017-10-10 22:05:01.510913
NCT02802657|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-15|||July 2016||2016-07-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||"A Study Comparing Efficacy and Safety of Treat-and-Extend Regimen Versus PRN of Conbercept in AMD"|"A Multicenter Study Comparing Efficacy and Safety of  Treat-and-Extend Regimen Versus PRN Regimen of Conbercept in Neovascular Age-related Macular Degeneration"|Not yet recruiting||Phase 4|120|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 22:05:01.722541|2017-10-10 22:05:01.722541
NCT02802644|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01||||June 2019|Anticipated|2019-06-01||Interventional|||The Effect of DPP4 Inhibitor on Vasclular Healing|A Prospective, Multi-center, Randomized, Controlled Study to Evaluate the Effect of DiPeptidyl-Peptidase 4 Inhibitor on Vascular Healing After Biodegradable Polymer Based Sirolimus Eluting Stent Implantation in Diabetic Patients: OCT Study (DIAMOND-OCT)|Recruiting||Phase 4|66|Anticipated|Chung-Ang University||2|||f||||t||||||||||2017-10-10 22:05:01.862964|2017-10-10 22:05:01.862964
NCT02802618|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-03-01|||October 2013||2013-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Interactive 3D Visualization Technique Used in Pulmonary Rehabilitation Programme in COPD|Interactive 3D Visualization Technique Used in Pulmonary Rehabilitation Programme in Chronic Obstructive Pulmonary Disease (COPD)|Active, not recruiting||N/A|40|Anticipated|Karolinska University Hospital||2|||f||||f||||||||No||2017-10-10 22:05:02.092332|2017-10-10 22:05:02.092332
NCT02802605|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-13|||May 2016||2016-05-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|BEMI-2015||Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients|Randomized and Controlled Trial on the Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients|Active, not recruiting||Phase 3|225|Anticipated|Instituto de Investigación Marqués de Valdecilla||2|||f||||f||||||||No||2017-10-10 22:05:02.202223|2017-10-10 22:05:02.202223
NCT02802592|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-17|2017-08-17||May 2015||2015-05-01|August 2017|2017-08-01|February 27, 2017|Actual|2017-02-27|June 15, 2016|Actual|2016-06-15||Interventional|EPORT|This study was terminated due to loss of funding and those participants enrolled were not un-blinded to the study team members.|EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)|EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)|Terminated||Phase 1/Phase 2|4|Actual|Johns Hopkins University||2||Loss of funding|f||||f||||||||||2017-10-10 22:05:02.283264|2017-10-10 22:05:02.283264
NCT02802579|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-16|||December 2007||2007-12-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||ECG Triggered Dual Source CT for Non-invasive Pre-operative Cardiac Imaging in Morbid Obese Patients|ECG Triggered Dual Source CT for Non-invasive Pre-operative Cardiac Imaging in Morbid Obese Patients|Completed||N/A|70|Actual|Cantonal Hospital of St. Gallen||3|||f||||f||||||||No||2017-10-10 22:05:02.556816|2017-10-10 22:05:02.556816
NCT02802566|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-13|||December 2014||2014-12-01|June 2016|2016-06-01||||July 2017|Anticipated|2017-07-01||Interventional|||BMI-based Vitamins in Obese Pregnant Women|BMI-Based Prenatal Vitamins to Ameliorate Oxidative Stress in Obese Pregnancy|Recruiting||N/A|170|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:05:02.666543|2017-10-10 22:05:02.666543
NCT02802553|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-08-09|||March 2018|Anticipated|2018-03-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions|Evaluation of an Integrated Imaging System (Smartgoggles) For In Vivo Detection of Fluorescently Labeled Lesions: A Pilot Study To Visualize Sentinel Lymph Nodes After Peritumoral Injection of Indocyanine Green|Not yet recruiting||N/A|10|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f|f|||||2017-10-10 22:05:02.790244|2017-10-10 22:05:02.790244
NCT02802540|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-08-29|||December 2014||2014-12-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients|Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Patients With Anorexia Associated With Advanced Lung Cancer: Randomized Double Blind Clinical Trial|Recruiting||Phase 2/Phase 3|78|Anticipated|Instituto Nacional de Cancerologia de Mexico||2|||f||||t||||||||Yes|publishing the results|2017-10-10 22:05:02.903749|2017-10-10 22:05:02.903749
NCT02802527|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-06-13|||July 2016||2016-07-01|April 2016|2016-04-01||||May 2019|Anticipated|2019-05-01||Interventional|||Percutaneous Tracheostomy - Systematic Comparison Among Two Methods|Percutaneous Tracheostomy - Systematic Comparison Among Two Methods: Bronchoscopy Guided Tracheostomy, and Direct Laryngoscopy Tracheostomy|Not yet recruiting||N/A|300|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-10 22:05:03.068591|2017-10-10 22:05:03.068591
NCT02802501|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-04-27|||January 15, 2018|Anticipated|2018-01-15|April 2017|2017-04-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria|Study 200894: A Double-blind, Double-dummy, Randomized, Parallel Group, Placebo-controlled Superiority Study to Evaluate the Efficacy and Safety of Tafenoquine (SB-252263, WR238605) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax Malaria|Not yet recruiting||Phase 3|150|Anticipated|GlaxoSmithKline||3|||f||||f|f|f||||||||2017-10-10 22:05:03.27058|2017-10-10 22:05:03.27058
NCT02802488|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-07-25|||July 2016||2016-07-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Age Related D-dimer Evaluation for the Exclusion of a Left Atrium Thrombus in Patients With Atrial Fibrillation (ADDIT-AF)|Age Related D-dimer Evaluation for the Exclusion of a Left Atrium Thrombus in Patients With Atrial Fibrillation (ADDIT-AF)|Not yet recruiting||N/A|200|Anticipated|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 22:05:03.389558|2017-10-10 22:05:03.389558
NCT02802475|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-25|||December 2014||2014-12-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Observational|ACES||Antibodies Causing Epilepsy Syndromes: The ACES Study.|Antibodies Causing Epilepsy Syndromes: The ACES Study.|Recruiting||N/A|1000|Anticipated|Erasmus Medical Center|||2||f||||||||||Samples Without DNA|"     serum and (if available) CSF   "|||2017-10-10 22:05:03.477012|2017-10-10 22:05:03.477012
NCT02802462|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-13|||December 2012||2012-12-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||High-intensity Interval Training Enhances Mobilization/Functionality of Endothelial Progenitor Cells and Depressed Shedding of Vascular Endothelial Cells Undergoing Hypoxia||Completed||N/A|60|Actual|Chang Gung Memorial Hospital||3|||f||||||||||||||2017-10-10 22:05:03.621223|2017-10-10 22:05:03.621223
NCT02802449|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-04-18|||September 2013|Actual|2013-09-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|March 2016|Actual|2016-03-01||Interventional|||To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans|An Eight Week Double Blinded Randomized, Placebo-controlled Trial to Assess the Effect of Two Doses of 100,000 IU Vitamin D3 by Mouth on Select Genetic Responses in Overweight, Hypertensive African-Americans With Hypovitaminosis D|Active, not recruiting||N/A|330|Anticipated|Charles Drew University of Medicine and Science||2|||f||||t||||||||No||2017-10-10 22:05:03.726128|2017-10-10 22:05:03.726128
NCT02799199|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-13|||September 2014||2014-09-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|Gilenya||Fingolimod Real World Experience: the French Grand-Est Cohort|Fingolimod Real World Experience: the French Grand-Est Cohort|Completed||N/A|1014|Actual|CHU de Reims|||1||f||||||||||||||2017-10-10 22:05:36.72945|2017-10-10 22:05:36.72945
NCT02802436|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-21|||October 3, 2016|Actual|2016-10-03|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||The Impact of a Known Bioactive Agent on the Resolution of Alveolar Socket Preservation|The Impact of a Known Bioactive Agent on the Resolution of Alveolar Socket Preservation|Recruiting||N/A|25|Anticipated|Boston University||2|||f||||f|f|f|||t|||Yes||2017-10-10 22:05:03.863754|2017-10-10 22:05:03.863754
NCT02802423|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-13|||August 2016||2016-08-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase I/II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Docetaxel Monotherapy in Patients With Advanced/Metastatic Triple Negative Breast Cancer (TNBC).||Not yet recruiting||Phase 1/Phase 2|44|Anticipated|BioLite, Inc.||1|||f||||t||||||||||2017-10-10 22:05:03.984421|2017-10-10 22:05:03.984421
NCT02802410|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-07-11|||September 2015||2015-09-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Cross Sectional Study to Evaluate Effects of Kinesiotaping on Muscle Activity During Climbing Stairs and Sport Activity|Cross Sectional Study to Evaluate the Effects of Kinesio IQ-Tape, Kinesiotaping and no Taping on Muscle Activation and Reflex Activity During Climbing Stairs, Drop Jump and Running With 10, 12 and 15km/h|Recruiting||N/A|30|Anticipated|Bern University of Applied Sciences||3|||f||||f||||||||||2017-10-10 22:05:04.074577|2017-10-10 22:05:04.074577
NCT02802397|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-01-16|||December 2016||2016-12-01|January 2017|2017-01-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|AROPE||AROPE : Early Ovarian Reserve Decreased : Impact of Exposure to Persistent Endocrine Disruptors and Organic Solvents|AROPE : Early Ovarian Reserve Decreased : Impact of Exposure to Persistent Endocrine Disruptors and Organic Solvents|Recruiting||N/A|504|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-10 22:05:04.160867|2017-10-10 22:05:04.160867
NCT02802384|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-08-15|||April 2016||2016-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|||Pathophysiology of Paget's Disease of Bone|Investigation of Pathophysiology of Angiogenesis and Osteogenesis in Paget's Disease of Bone|Recruiting||N/A|20|Anticipated|Johns Hopkins University|||2||f||||f||||||Samples With DNA|"     Human blood samples with be collected. One tube of blood will be utilized to measure specific     serum chemokine concentrations. One tube will be utilized to extract DNA for potential future     studies if permission is provided. The remainder of the blood sample will be utilized to     count the number of stem cells.   "|||2017-10-10 22:05:04.306241|2017-10-10 22:05:04.306241
NCT02802371|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-02-17|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|PHARMAID||Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program|Evaluation of the Impact of Personalized Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program on the Burden Felt by Caregivers of Elderly Patients With Alzheimer's Disease and Related Disorders and Evaluated at 18-month Follow-up|Recruiting||N/A|240|Anticipated|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-10 22:05:04.387368|2017-10-10 22:05:04.387368
NCT02802358|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-13|||June 2009||2009-06-01|June 2016|2016-06-01||||September 2010|Actual|2010-09-01||Observational|||Evaluation of Health and Social Interventions Aimed to Old People Discharged From Hospital After a Hip or Wrist Fracture Due to a Fall||Completed||N/A|1824|Actual|Hospital Galdakao-Usansolo|||2||f||||f||||||||||2017-10-10 22:05:04.500085|2017-10-10 22:05:04.500085
NCT02802345|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-10-03|||June 30, 2016|Actual|2016-06-30|October 2017|2017-10-01|May 14, 2018|Anticipated|2018-05-14|January 11, 2018|Anticipated|2018-01-11||Interventional|||Efficacy and Safety of Nintedanib When Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment|INSTAGE: A 24-week, Double-blind, Randomized, Parallel-group Study Evaluating the Efficacy and Safety of Oral Nintedanib Co-administered With Oral Sildenafil, Compared to Treatment With Nintedanib Alone, in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Advanced Lung Function Impairment|Recruiting||Phase 3|250|Anticipated|Boehringer Ingelheim||2|||t||||||||||||||2017-10-10 22:05:04.57619|2017-10-10 22:05:04.57619
NCT02802332|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-08-24|||July 2016||2016-07-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Use of a Foot Length Card to Improve Careseeking Practices of Vulnerable Newborns in Sarlahi District, Nepal|Use of a Foot Length Card to Improve Careseeking Practices of Vulnerable Newborns in Sarlahi District, Nepal|Recruiting||N/A|4000|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||No|There is currently no plan to share individual participant data|2017-10-10 22:05:04.801384|2017-10-10 22:05:04.801384
NCT02802319|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-01-09|||July 2016||2016-07-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Ridge Preservation Following Tooth Extraction Using Porcine and Bovine Xenograft Materials|Ridge Preservation Following Tooth Extraction Using Porcine and Bovine Xenograft Materials|Recruiting||N/A|44|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||No||2017-10-10 22:05:04.909025|2017-10-10 22:05:04.909025
NCT02802306|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-05-09|||June 2016||2016-06-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|November 2017|Anticipated|2017-11-01||Interventional|TOBA III||Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries|Tack Optimized Drug Coated Balloon Angioplasty in the Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System™|Recruiting||N/A|200|Anticipated|Intact Vascular||1|||f||||f||||||||No||2017-10-10 22:05:04.987794|2017-10-10 22:05:04.987794
NCT02802280|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-15|||October 2015||2015-10-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|C-Endys||Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents.|Personalized Medicine in HCV Chronic Infection. Endothelial Dysfunction and Subclinical Atheromatosis in Patients With HCV Infection. Characterization and Potential Reversibility With Direct Antiviral Agents.|Recruiting||Phase 4|80|Anticipated|Instituto de Investigación Marqués de Valdecilla||1|||f||||f||||||||No||2017-10-10 22:05:05.264701|2017-10-10 22:05:05.264701
NCT02802267|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-06-30|||June 2016||2016-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy|Efficacy Study of Inecalcitol in Combination With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy|Recruiting||Phase 2|110|Anticipated|Hybrigenics Corporation||2|||f||||f||||||||||2017-10-10 22:05:05.354554|2017-10-10 22:05:05.354554
NCT02802254|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-06-09|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|RiskAct||Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback.|Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback: Randomized Controlled Trial.|Completed||Phase 2/Phase 3|121|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||No||2017-10-10 22:05:05.488925|2017-10-10 22:05:05.488925
NCT02802241|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2017-03-02|||June 2016||2016-06-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|June 2020|Anticipated|2020-06-01||Interventional|||Effects of Open-label vs Double-blind Treatment in IBS|Effects of Open-label vs Double-blind Treatment in IBS|Recruiting||N/A|307|Anticipated|Beth Israel Deaconess Medical Center||4|||f||||||||||||||2017-10-10 22:05:05.571689|2017-10-10 22:05:05.571689
NCT02802228|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-04-05|||March 6, 2017|Actual|2017-03-06|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients|A Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Safety and Efficacy of Ifetroban for the Treatment of Portal Hypertension in Cirrhotic Patients|Recruiting||Phase 2|30|Anticipated|Cumberland Pharmaceuticals||2|||f||||f|t|f||||||No||2017-10-10 22:05:05.64876|2017-10-10 22:05:05.64876
NCT02802215|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-06-15|||January 2016||2016-01-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|MGDPCOS||Metformin for Prevention Gestational Diabetes in Pregnant Women With Polycystic Ovarian Syndrome|Metformin for Prevention of Gestational Diabetes in Pregnant Women With Polycystic Ovarian Syndrome: Randomized Controlled Trial (RCT )|Recruiting||Phase 2/Phase 3|80|Anticipated|Ain Shams University||2|||f||||t||||||||Yes||2017-10-10 22:05:05.934139|2017-10-10 22:05:05.934139
NCT02802202|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-15|||January 2015||2015-01-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Validation of a Pressure Pain Threshold Scale in Patients Diagnosed With Myofascial Pain Syndrome and Fibromyalgia|Validation of a Pressure Pain Threshold Scale in Patients Diagnosed With Myofascial Pain Syndrome and Fibromyalgia|Completed||N/A|84|Actual|California State University, Dominguez Hills|||3||f||||f||||||||No||2017-10-10 22:05:06.083572|2017-10-10 22:05:06.083572
NCT02802189|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-06-27|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||The Effect of Integrated Neuromuscular Inhibition Technique in Combination With Therapeutic Exercise on Patients With Chronic Mechanical Neck Pain|The Effect of Integrated Neuromuscular Inhibition Technique in Combination With Therapeutic Exercise on Patients With Chronic Mechanical Neck Pain|Completed||N/A|40|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-10 22:05:06.213769|2017-10-10 22:05:06.213769
NCT02802176|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-08-23|||July 2016||2016-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation|Randomized Controlled Trial Comparing Intra-vaginal Culture of Embryos Using INVOcell Device to In-vitro Culture of Embryos Using Minimal Stimulation Protocols|Recruiting||Phase 4|40|Anticipated|University of California, San Francisco||2|||f||||t||||||||Undecided||2017-10-10 22:05:06.336704|2017-10-10 22:05:06.336704
NCT02802163|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-04-24|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat|Phase I-II Study of Carfilzomib, Lenalidomide, Dexamethasone, and Panobinostat, Ca-R-Pa-Diem, as Induction Therapy for Newly Diagnosed, Untreated, Transplant-Eligible, Multiple Myeloma Patients|Withdrawn||Phase 1/Phase 2|0|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||study drug unavailable|f||||f|t|f||||||||2017-10-10 22:05:06.472393|2017-10-10 22:05:06.472393
NCT02802150|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-06-13|||February 2015||2015-02-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Oral Zanthoxylum Schinifolium Seed Oil in Individuals With Dry Eye Disease||Completed||N/A|20|Actual|Chonbuk National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:05:06.602138|2017-10-10 22:05:06.602138
NCT02802137|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-13|||March 2015||2015-03-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy|24-hour Efficacy and Ocular Surface Health With PF Tafluprost and Combined Therapy With PF Tafluprost and Dorzolamide/Timolol Fixed Combination in Open-angle Glaucoma Subjects Insufficiently Controlled With Latanoprost|Completed||Phase 4|43|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||Undecided||2017-10-10 22:05:06.741862|2017-10-10 22:05:06.741862
NCT02802124|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-18|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma|Phase I Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma|Recruiting||Phase 1|48|Anticipated|Shanghai Proton and Heavy Ion Center||2|||f||||t||||||||No||2017-10-10 22:05:06.858819|2017-10-10 22:05:06.858819
NCT02802111|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-12-25|||June 2015||2015-06-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults|Change in Oxygen Consumption Following Inhalation of Albuterol in Comparison With Levalbuterol in Healthy Adult Volunteers|Enrolling by invitation||N/A|60|Anticipated|Children's Hospital Los Angeles||2|||f||||f||||||||No||2017-10-10 22:05:06.994538|2017-10-10 22:05:06.994538
NCT02802098|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-13|||May 2016||2016-05-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer|Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB (MEDI4736) in Advanced HER-2 Negative Breast Cancer: a Pilot Proof-of-concept Trial|Recruiting||Early Phase 1|25|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III||1|||f||||t||||||||||2017-10-10 22:05:07.113782|2017-10-10 22:05:07.113782
NCT02802085|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-06-27|||May 2016||2016-05-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||VEGA Prospective Kiel|A Prospective Observational 5 Year Follow-up on a Historical Consecutive Cohort of 100 Primary Total Knee Arthroplasty (TKA) Cases Treated With the Posterior-stabilized VEGA System® PS|Recruiting||N/A|100|Anticipated|Aesculap AG|||1||f||||f||||||||No||2017-10-10 22:05:07.296436|2017-10-10 22:05:07.296436
NCT02802072|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||January 2013||2013-01-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|||Enterprise Stent Implantation in the Treatment of Carotid Artery Stenosis With Ischemic Stroke|Long-term Effects of Enterprise Self-expanding Intracranial Stent Implantation in the Treatment of Carotid Artery Stenosis in Patients With Ischemic Stroke: Study Protocol for a Randomized Controlled Trial|Completed||N/A|100|Actual|Beijing Chao Yang Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:05:07.428959|2017-10-10 22:05:07.428959
NCT02802059|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-05-30|||October 2015||2015-10-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|RONi||E. Coli Nissle 1917 - Suspension for Infection Prophylaxis|E. Coli Nissle 1917 - Suspension for Infection Prophylaxis|Recruiting||Phase 3|558|Anticipated|Ardeypharm GmbH||2|||f||||f||||||||No||2017-10-10 22:05:07.531404|2017-10-10 22:05:07.531404
NCT02802046|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-16|||January 2017||2017-01-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||Evaluation of the Correlation Between the Coronary Stenosis Degree With FFRCT and the Grade of Stable Angina Pectoris||Not yet recruiting||N/A|20|Anticipated|Guiyang No.4 People's Hospital|||2||f||||f||||||||No||2017-10-10 22:05:07.71077|2017-10-10 22:05:07.71077
NCT02802033|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-13|||July 2016||2016-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01|3 Years|Observational [Patient Registry]|||A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders|DegenPRO: A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders|Not yet recruiting||N/A|250|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f||||||||No||2017-10-10 22:05:07.817574|2017-10-10 22:05:07.817574
NCT02802020|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-05-04|||January 25, 2017|Actual|2017-01-25|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||WallFlex Pancreatic Metal Stent for Pancreatic Duct Strictures|Fully Covered Self Expanding Metal Stents (FCSEMS) for Pancreatic Duct Strictures in Patients With Chronic Pancreatitis|Recruiting||N/A|92|Anticipated|Boston Scientific Corporation||1|||f||||f|f|t|t|f||||No||2017-10-10 22:05:07.941287|2017-10-10 22:05:07.941287
NCT02801994|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-02-15|||February 2016||2016-02-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|DYS-PAV||Impact of Proportional Assisted Ventilation on Dyspnea and Asynchrony in Mechanically Ventilated Patients|Impact of Proportional Assisted Ventilation on Dyspnea and Asynchrony in Mechanically Ventilated Patients|Recruiting||N/A|30|Anticipated|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil||1|||f||||f||||||||No||2017-10-10 22:05:08.172413|2017-10-10 22:05:08.172413
NCT02801981|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-11-08|||June 2016||2016-06-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers|A Double-blind, Randomized, Placebo Controlled, Dose Escalating Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Parameters of Single Doses of GSK2330672 in Japanese Healthy Male Volunteers|Completed||Phase 1|16|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-10 22:05:08.305716|2017-10-10 22:05:08.305716
NCT02801968|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2016-06-12|||April 2016||2016-04-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|TAPFANS||Tap Block and Cesarean Delivery: Efficacy and Consumption of Postoperative Drugs||Recruiting||N/A|62|Anticipated|S. Anna Hospital||2|||f||||f||||||||No||2017-10-10 22:05:08.398378|2017-10-10 22:05:08.398378
NCT02801955|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-06-13|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma|Predictive Value of Serum and Peritoneal CEA and CA 19-9 for TNM Stage and Peritoneal Dissemination of Gastric Adenocarcinoma|Completed||N/A|67|Actual|Bezmialem Vakif University|||1||f||||f||||||||No||2017-10-10 22:05:08.482086|2017-10-10 22:05:08.482086
NCT02801929|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-14|2016-06-14|||November 2015||2015-11-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SPF Assay||18670 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay ,UVA Protection Factor Assay (UVAPF), Minimal Persistent Pigment-Darkening Dose (MPPD).|Completed||N/A|15|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:05:08.681069|2017-10-10 22:05:08.681069
NCT02801916|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-15|||April 2015||2015-04-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Consuming Oat Bran Mixed in Water Before a Meal on Glycemic Responses in Healthy Humans - a Pilot Study|Effect of Consuming Oat Bran Mixed in Water Before a Meal on Glycemic Responses in Healthy Humans - a Pilot Study|Completed||N/A|10|Actual|Glycemic Index Laboratories, Inc||1|||f||||f||||||||No||2017-10-10 22:05:08.752117|2017-10-10 22:05:08.752117
NCT02801903|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-01-03|||June 2016||2016-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris|A Phase 1, Single-center, Open-label Pharmacokinetic, Safety and Tolerability Study of SB204 in Adolescents With Moderate to Severe Acne Vulgaris|Active, not recruiting||Phase 1|18|Actual|Novan, Inc.||1|||f||||f||||||||No||2017-10-10 22:05:08.827782|2017-10-10 22:05:08.827782
NCT02793362|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-07|||May 2016||2016-05-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|||Measurement of Sarcopenia at Post-stroke Rehabilitation Outcome|Measurement of Sarcopenia at Post-stroke Rehabilitation Outcome|Recruiting||N/A|70|Anticipated|Bucheon St. Mary's Hospital|||3||f||||t||||||||Undecided||2017-10-10 22:06:41.548223|2017-10-10 22:06:41.548223
NCT02801890|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-04-26|||August 2015|Actual|2015-08-01|December 2016|2016-12-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF)|Autologous AD-MSC Transplantation in Peritoneal Dialysis Patients With Ultra Filtration Failure and Evaluation of Cellular and Molecular Effects of Mesenchymal Stem Cell Infusion on Peritoneal Fibrosis|Completed||Phase 1/Phase 2|10|Actual|Royan Institute||2|||f||||t||||||||No||2017-10-10 22:05:08.916675|2017-10-10 22:05:08.916675
NCT02801877|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-09-14|||July 2016||2016-07-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|AIM||IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression|Artificial Intelligence in a Mobile (AIM) Intervention for Depression|Active, not recruiting||N/A|301|Actual|Northwestern University||4|||f||||t||||||||||2017-10-10 22:05:09.00177|2017-10-10 22:05:09.00177
NCT02801864|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-06-29|||January 2016||2016-01-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||tDCS as an Adjuvant to Intensive Speech Therapy for Chronic Post Stroke Aphasia|Transcranial Direct Current Stimulation (tDCS) an Adjuvant to Intensive Speech Therapy in Chronic Post Stroke Aphasia|Enrolling by invitation||N/A|6|Anticipated|Austin Speech Labs||2|||f||||f||||||||||2017-10-10 22:05:09.129959|2017-10-10 22:05:09.129959
NCT02801851|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-07-18|||July 2015||2015-07-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|SCREEN-ED||Delirium Screening of the Elderly in the Emergency Department|Delirium Screening of the Elderly in the Emergency Department|Recruiting||N/A|150|Anticipated|Northeastern University||1|||f||||f||||||||Undecided||2017-10-10 22:05:09.251716|2017-10-10 22:05:09.251716
NCT02801838|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-07-28|||February 23, 2016|Actual|2016-02-23|July 2017|2017-07-01|July 28, 2017|Actual|2017-07-28|February 23, 2017|Actual|2017-02-23||Interventional|DYS-NOC||Validation of an Observational Scale of Dyspnea in Non-communicating Patients in the ICU|Feasibility and Validity of an Observational Scale as a Surrogate of Dyspnea in Non-communicating Patients in the Intensive Care Unit (ICU): DYS-NOC|Completed||N/A|50|Actual|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil||1|||f||||f||||||||||2017-10-10 22:05:09.45985|2017-10-10 22:05:09.45985
NCT02801825|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-08-18|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Ultrasound-guided Axillary Artery Vs Femoral Artery Cannulation.|A Randomized Study of Ultrasound-guided Axillary and Femoral Artery Cannulation in Mechanically Ventilated Critically Ill Patients.|Recruiting||N/A|40|Anticipated|Publiczny Samodzielny Zaklad Opieki Zdrowotnej Wojewodzkie Centrum Medyczne||2|||f||||f||||||||No||2017-10-10 22:05:09.600571|2017-10-10 22:05:09.600571
NCT02801812|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-08-08|||January 2016||2016-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus|An Observational Multicenter International Case-control Study for the Assessment of Nailfold Capillary Abnormalities in Patients With Systemic Lupus Erythematosus|Enrolling by invitation||N/A|364|Anticipated|ASST Gaetano Pini-CTO|||2||f||||f||||||||||2017-10-10 22:05:09.692666|2017-10-10 22:05:09.692666
NCT02801799|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-03-28|||October 10, 2016|Actual|2016-10-10|June 2016|2016-06-01|December 9, 2016|Actual|2016-12-09|November 23, 2016|Actual|2016-11-23||Interventional|||Effects of Local Anaesthetic Infusion Rates on Nerve Block Duration|Effects of Local Anaesthetic Infusion Rates on Nerve Block Duration. A Randomised, Blinded, Healthy Volunteer Study|Terminated||Phase 1|60|Actual|Nordsjaellands Hospital||5||"The trial was comprised of two parts. After the first part we could repudiate our hypothesis.   Thus, no reason to carry on with the second part of the trial."|f||||t||||||||Yes|No matter the outcome of this trial tre results will be available at ClinicalTrials.gov, EudraCT.ema.europa.eu and will as far as possible, be published in a scientific paper of relevance for regional anesthesia.|2017-10-10 22:05:09.770065|2017-10-10 22:05:09.770065
NCT02801786|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-15|||July 2016||2016-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|TALI||TAmoxifen Versus LIdocaine Cream. A Randomized Clinical Trial for Reducing Pain and Discomfort During Mammography|Randomized Study of the Use of Tamoxifen Versus Ointment Lidocaine for Reducing the Pain and Discomfort in Mammography|Not yet recruiting||Phase 2/Phase 3|450|Anticipated|Universidade Federal de Goias||3|||f||||f||||||||||2017-10-10 22:05:09.864396|2017-10-10 22:05:09.864396
NCT02801773|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-18|||June 2016||2016-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Clinical Effect of Lactobacillus Reuteri in Treatment of Gingivitis|Clinical Effect of Lactobacillus Reuteri in Treatment of Gingivitis. Randomized Clinical Trials|Recruiting||Phase 2|20|Anticipated|University of Chile||2|||f||||t||||||||No||2017-10-10 22:05:09.978409|2017-10-10 22:05:09.978409
NCT02801760|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-02-27|||November 2015||2015-11-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Self-Consent for PrEP Perspectives|Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men|Completed||N/A|58|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||No||2017-10-10 22:05:10.109144|2017-10-10 22:05:10.109144
NCT02801747|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-04-19|||March 20, 2017|Actual|2017-03-20|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|HTH2-MOST||Using MOST to Optimize an HIV Care Continuum Intervention for Vulnerable Populations|Using MOST to Optimize an HIV Care Continuum Intervention for Vulnerable Populations|Recruiting||N/A|512|Anticipated|New York University||16|||f||||t|f|f||||||||2017-10-10 22:05:10.22964|2017-10-10 22:05:10.22964
NCT02801734|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-09-12|||August 1, 2016|Actual|2016-08-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|January 20, 2017|Actual|2017-01-20||Interventional|EQUIP||Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer|Pilot Trial of the Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer|Active, not recruiting||N/A|69|Actual|National Cancer Centre, Singapore||2|||f||||f||||||||||2017-10-10 22:05:10.338548|2017-10-10 22:05:10.338548
NCT02801721|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-29|||July 2015||2015-07-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Long Term Effect of Early Iron Supplementation and Psychosocial Stimulation on Growth and Development of Iron-deficient Anaemic Infants||Completed||N/A|349|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||Yes|if required we will share data with our expert|2017-10-10 22:05:12.516801|2017-10-10 22:05:12.516801
NCT02801708|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2016-12-01|||August 2014||2014-08-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|EDUCATE-ESUS||Enhanced Detection of Underlying, Covert ATrial Fibrillation Using 7-day Holter Electrocardiogram in Patients With Embolic Stroke of Undetermined Source||Recruiting||N/A|200|Anticipated|National Cerebral and Cardiovascular Center|||1||f||||f||||||||||2017-10-10 22:05:12.635755|2017-10-10 22:05:12.635755
NCT02801695|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-06-01|||February 20, 2017|Actual|2017-02-20|June 2017|2017-06-01|October 20, 2018|Anticipated|2018-10-20|October 20, 2018|Anticipated|2018-10-20||Interventional|CITRUPE||Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)|Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)|Recruiting||Phase 2/Phase 3|116|Anticipated|Nantes University Hospital||2|||f|||||f|f||||||||2017-10-10 22:05:12.728916|2017-10-10 22:05:12.728916
NCT02801682|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-08-01|||June 2016||2016-06-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|NOBICS||NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis|NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis|Active, not recruiting||N/A|240|Anticipated|Medical University of Graz|||4||f||||f||||||||||2017-10-10 22:05:12.878671|2017-10-10 22:05:12.878671
NCT02801656|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea|Fecal Microbiota Transplantation for Primary Therapy in Clostridium Difficile Diarrhea - A Placebo-blinded Randomized Clinical Trial|Not yet recruiting||Phase 3|130|Anticipated|Memorial University of Newfoundland||2|||f||||f|f|f||||||||2017-10-10 22:05:13.056427|2017-10-10 22:05:13.056427
NCT02801643|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-06-09|||June 2016||2016-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study|The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study|Recruiting||N/A|20|Anticipated|Stony Brook University|||1||f||||f||||||||No||2017-10-10 22:05:13.215858|2017-10-10 22:05:13.215858
NCT02801630|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia|An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia|Recruiting||N/A|60|Anticipated|Rosenblum, Jonathan I., DPM||2|||f||||t||||||||No||2017-10-10 22:05:13.317207|2017-10-10 22:05:13.317207
NCT02801617|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-15|||September 2015||2015-09-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|COMPLIANCE||Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension|A Multicentric, Prospective, Crossover, Double Blind Clinical Study to Evaluate the Non-inferiority of PRO-067 an Ophthlamic Solution Manufactured by Laboratorios Sophia S.A.de C.V., Previous Treatment With GAAP Ofteno ®, in Subjects With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT): COMPLIANCE Study|Recruiting||Phase 3|100|Anticipated|Laboratorios Sophia S.A de C.V.||2|||f||||t||||||||Yes|Electronic Case Report Format (eCRF). The on line registry in a digital plataform will help to verification process.|2017-10-10 22:05:13.413384|2017-10-10 22:05:13.413384
NCT02801604|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Observational|Attention||Attentin® in Children and Adolescents With ADHD - A Non-interventional Study|Attentin® in Children and Adolescents With ADHD - A Non-interventional Study|Recruiting||N/A|500|Anticipated|Medice Arzneimittel Pütter GmbH & Co KG|||1||f||||f||||||||No||2017-10-10 22:05:13.539247|2017-10-10 22:05:13.539247
NCT02801591|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-12|||February 2016||2016-02-01|June 2016|2016-06-01||||February 2017|Anticipated|2017-02-01||Observational|||Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET|Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of Poor Ovarian Response (POR) Clinical Outcome in Patients Undergoing in Vitro Fertilization / Embryo Transfer (IVF/ET)|Recruiting||N/A|240|Anticipated|GeneScience Pharmaceuticals Co., Ltd.|||1||f||||t||||||||||2017-10-10 22:05:13.843958|2017-10-10 22:05:13.843958
NCT02801578|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-06-21|||July 6, 2016|Actual|2016-07-06|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)|A Pilot Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||N/A|14|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:05:13.950416|2017-10-10 22:05:13.950416
NCT02801565|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-11-24|||February 2016||2016-02-01|June 2016|2016-06-01||||February 2017|Anticipated|2017-02-01||Interventional|||Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS|Clinical Observation of Recombinant Human Growth Hormone Injection Assisted in Vitro Fertilization and Embryo Transfer (IVF-ET) in the Treatment of Polycystic Ovary Syndrome (PCOS)|Recruiting||N/A|208|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:05:14.044703|2017-10-10 22:05:14.044703
NCT02801552|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-16|||May 2013||2013-05-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|||Regenerative Endodontic Procedure of Immature Permanent Teeth With Apical Periodontitis Using PRF|Regenerative Endodontic Procedure of Immature Permanent Teeth With Apical Periodontitis Using Platelet-rich Fibrin : A Pilot Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Fujian Medical University||2|||f||||t||||||||No||2017-10-10 22:05:14.14516|2017-10-10 22:05:14.14516
NCT02801539|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-05-18|||February 2, 2017|Actual|2017-02-02|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Respiratory Muscle Training in L-Onset Pompe Disease (LOPD)|Respiratory Muscle Training in Late-Onset Pompe Disease|Recruiting||N/A|28|Anticipated|Duke University||2|||f||||f|f|f||||||No||2017-10-10 22:05:14.243031|2017-10-10 22:05:14.243031
NCT02801526|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-12|||April 2015||2015-04-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A|A Randomized, Open-label, Single-dosing, 2x2 Crossover Study to Compare the Safety and Pharmacokinetics of CKD-330 (Fixed-dose Combination of Candesartan 16 mg and Amlodipine 5 mg) With Coadministration of the Two Separate Drugs in Healthy Male Volunteers (A)|Completed||Phase 1|32|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:05:14.333405|2017-10-10 22:05:14.333405
NCT02801513|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-06-15|||September 2013||2013-09-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|GetWell||Maintaining Mechanisms of Chronic Depression and Their Changeability|Maintaining Mechanisms of Chronic Depression and Their Changeability: the Role of Discrepancy-based Processing|Completed||N/A|74|Actual|Freie Universität Berlin||2|||f||||f||||||||No||2017-10-10 22:05:14.416869|2017-10-10 22:05:14.416869
NCT02801500|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2017-09-19|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|CTREG||Superior Bilioenteric Anastomosis by Magnetic Compressive Technique|Superior Bilioenteric Anastomosis by Magnetic Compressive Technique: A Multicenter, Prospective, Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f|f|f||||||||2017-10-10 22:05:14.510654|2017-10-10 22:05:14.510654
NCT02801487|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-06-14|||September 2015||2015-09-01|June 2016|2016-06-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma|Phase I/II Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma|Recruiting||Phase 1/Phase 2|62|Anticipated|Shanghai Proton and Heavy Ion Center||1|||f||||t||||||||||2017-10-10 22:05:14.665173|2017-10-10 22:05:14.665173
NCT02801474|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-15|||January 2012||2012-01-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Surgical Management of Posterior Malleolar Fractures Using the Direct or Indirect Reduction Techniques|Surgical Management of Posterior Malleolar Fractures Using the Direct or Indirect Reduction Techniques|Completed||N/A|148|Actual|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||No||2017-10-10 22:05:14.768445|2017-10-10 22:05:14.768445
NCT02801448|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-08-14|||September 2015||2015-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes|Randomized Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes|Active, not recruiting||Phase 2|103|Actual|Region Skane||2|||f||||f||||||||||2017-10-10 22:05:14.981954|2017-10-10 22:05:14.981954
NCT02801435|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2017-07-12|||September 17, 2016|Actual|2016-09-17|July 2017|2017-07-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|||Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis|A Single-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis|Completed||Phase 1|41|Actual|Betta Pharmaceuticals Co.,Ltd.||8|||f||||f||||||||||2017-10-10 22:05:15.090168|2017-10-10 22:05:15.090168
NCT02801422|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-06-11|||February 2016||2016-02-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|March 2017|Anticipated|2017-03-01||Observational|||Neural Indices Associated With Relapse in Cannabis Dependence|Altered Neural Activation Patterns of Emotional Processing in Dependent Cannabis Users Associated With Relapse|Recruiting||N/A|75|Anticipated|University of Electronic Science and Technology of China|||2||f||||f||||||||||2017-10-10 22:05:15.21401|2017-10-10 22:05:15.21401
NCT02801409|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2017-08-31|||January 2014||2014-01-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Epidural Anesthesia/Analgesia and Outcome of Patients After Lung Cancer Surgery|Effects of Epidural Anesthesia/Analgesia on Recurrence and Metastasis in Patients After Lung Cancer Surgery: A Randomized Controlled Trial|Recruiting||N/A|396|Anticipated|Peking University First Hospital||2|||f||||t||||||||||2017-10-10 22:05:15.310715|2017-10-10 22:05:15.310715
NCT02801396|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-06-14|2017-05-05||April 24, 2016|Actual|2016-04-24|June 2017|2017-06-01|May 22, 2016|Actual|2016-05-22|May 22, 2016|Actual|2016-05-22||Interventional||All subjects that were dispensed at least one study lens.|Clinical Evaluation of Investigational Contact Lenses||Completed||N/A|116|Actual|Johnson & Johnson Vision Care, Inc.||6|||f||||f|f|t|f|f|t|||||2017-10-10 22:05:15.479164|2017-10-10 22:05:15.479164
NCT02801383|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-14|||September 2015||2015-09-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Recombinant Human Interferon a-2b Gel for HPV-16 and/ or HPV-18 Gynecological Infections|Randomized, Double-blind, Parallel, Controlled Clinical Study to Evaluated the Efficacy and Safety of Recombinant Human Interferon Alpha-2b Gel (Yallaferon®) in HPV-16 and/or HPV-18 Infection|Recruiting||Phase 2/Phase 3|100|Anticipated|Lee's Pharmaceutical Limited||2|||f||||||||||||||2017-10-10 22:05:15.967994|2017-10-10 22:05:15.967994
NCT02801370|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2017-05-23||2017-05-23|June 2016|Actual|2016-06-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Phase 3 Study of OTO-201 in Acute Otitis Externa|A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Phase 3 Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Externa|Completed||Phase 3|262|Actual|Otonomy, Inc.||2|||f||||f||||||||No||2017-10-10 22:05:16.067456|2017-10-10 22:05:16.067456
NCT02801357|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-05-01|||June 2016||2016-06-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction|A Phase 1 Study to Evaluate the Relative Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction|Completed||Phase 1|10|Actual|US WorldMeds LLC||1|||f||||f||||||||No||2017-10-10 22:05:16.15831|2017-10-10 22:05:16.15831
NCT02801344|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-24|||May 2016||2016-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Impact of Protein Intake on Protein Metabolism During Intensified Training|The Impact of Protein Intake on Amino Acid and Protein Metabolism, and Performance During Intensified Training|Active, not recruiting||N/A|9|Actual|University of Toronto||3|||f||||f||||||||No||2017-10-10 22:05:16.26485|2017-10-10 22:05:16.26485
NCT02801331|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-03-12|||March 9, 2017|Actual|2017-03-09|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence Syndrome|A Randomized Controlled Study of Stochastic Vibrotactile Stimulation for Neonatal Abstinence Syndrome: Therapeutic Efficacy and Neurobehavioral Outcomes|Enrolling by invitation||N/A|230|Anticipated|University of Massachusetts, Worcester||2|||f||||t|f|f||||||No||2017-10-10 22:05:16.373141|2017-10-10 22:05:16.373141
NCT02801318|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-10-10||||||October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Role of REM Sleep Alterations in Post Operative Delirium After Cardiac Surgery||Not yet recruiting||N/A|60|Anticipated|Poitiers University Hospital||1|||f||||||||||||||2017-10-10 22:05:16.505808|2017-10-10 22:05:16.505808
NCT02801305|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-03-03|||June 2016||2016-06-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers|Assessing and Comparing the Effect of Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers.|Completed||Phase 2|90|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||No|The individual characteristic and information of the patients will be preserved by the researches and won't be released.|2017-10-10 22:05:16.600863|2017-10-10 22:05:16.600863
NCT02801292|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-10|||July 2016||2016-07-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|KSickle||Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease|Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease, a Pilot Study|Not yet recruiting||Phase 3|20|Anticipated|Augusta University||1|||f||||f||||||||No|IPD will not be shared|2017-10-10 22:05:16.760916|2017-10-10 22:05:16.760916
NCT02801279|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-08-31|||August 2016||2016-08-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Development of Kinect-assisted Home-based Bilateral Arm Training Program for Cerebral Palsy|Development of Kinect-assisted Home-based Bilateral Arm Training Program for Cerebral Palsy|Not yet recruiting||N/A|130|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 22:05:16.866732|2017-10-10 22:05:16.866732
NCT02801266|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-11|||October 2012||2012-10-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|ICC||Improving Contraceptive Counseling in the United States|Improving Contraceptive Counseling in the United States|Completed||N/A|1418|Actual|New York University||2|||f||||f||||||||No||2017-10-10 22:05:17.03237|2017-10-10 22:05:17.03237
NCT02801253|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-08-25|||September 2015||2015-09-01|August 2017|2017-08-01|September 2025|Anticipated|2025-09-01|September 2019|Anticipated|2019-09-01||Observational|COPINS||Cohort of Prosthetic Joint Infections|Prospective Cohort of Patients With Prosthetic Joint Infection|Recruiting||N/A|400|Anticipated|Groupe Hospitalier Diaconesses Croix Saint-Simon|||1||f||||t||||||||||2017-10-10 22:05:17.162904|2017-10-10 22:05:17.162904
NCT02801240|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-02-23|||June 2016||2016-06-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease|Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease|Active, not recruiting||N/A|10|Actual|National University of Natural Medicine||1|||f||||f||||||||No||2017-10-10 22:05:17.284829|2017-10-10 22:05:17.284829
NCT02801227|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-09|||September 2016||2016-09-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Oxytocin vs. Prostaglandin for Induction of Labor in Primiparas With Prelabor Rupture of Membrane and Low Bishop|Oxytocin vs. Prostaglandin for Induction of Labor in Primiparas With Prelabor Rupture of Membrane and Low Bishop Score: Randomized Control Study|Not yet recruiting||Phase 4|68|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||Yes||2017-10-10 22:05:17.414355|2017-10-10 22:05:17.414355
NCT02801214|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2017-02-01|||May 2015||2015-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Observational|||Emotional Brain Processes in Recreational Cannabis Users|Effects of Recreational Cannabis Use on Brain Activation Patterns Associated With Emotional Processes|Completed||N/A|50|Anticipated|University of Electronic Science and Technology of China|||2||f||||f||||||||||2017-10-10 22:05:17.547362|2017-10-10 22:05:17.547362
NCT02801201|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-10|||June 2016||2016-06-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|RaVem||Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation|Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation; Prospective, Controlled, Randomized Study|Not yet recruiting||Phase 3|200|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 22:05:17.6462|2017-10-10 22:05:17.6462
NCT02801188|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-06-14|||October 2014||2014-10-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of Dexmedetomidine and Bupivacaine for Paravertebral Block|Evaluation Effect of Adding Dexmedetomidine to Bupivacaine for Paravertebral Block in Femoral Fractures|Recruiting||N/A|88|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:05:17.754866|2017-10-10 22:05:17.754866
NCT02801175|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-13|||May 2016||2016-05-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|ABLAA-FV||Effect of Left Atrial Ablation on Left Atrial Appendage Emptying Flow Velocity|Differential Effect of Radiofrequency and Cryoballoon Ablation on Left Atrial Appendage Emptying Flow Velocity|Recruiting||N/A|40|Anticipated|National and Kapodistrian University of Athens|||2||f||||||||||||||2017-10-10 22:05:17.85737|2017-10-10 22:05:17.85737
NCT02801162|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-12-07|||September 2016||2016-09-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard|Evaluation of Accuracy and Precision of the Proxima 3® (Sphere Medical) Arterial Blood Gas Analysis System in Comparison With the Reference Standard Hospital ABG in a Rapidly Changing Clinical Context|Recruiting||N/A|20|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||Yes||2017-10-10 22:05:17.945191|2017-10-10 22:05:17.945191
NCT02800941|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-06-26|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|HEMA-HTP||Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension|Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension : HEMA-HTP Multicentric Study.|Not yet recruiting||N/A|203|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||t||||||||No||2017-10-10 22:05:19.607219|2017-10-10 22:05:19.607219
NCT02801149|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-07|||June 6, 2016|Actual|2016-06-06|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|SMRI||The Use of MRI in the Assessment of Suspected Scaphoid Fracture With Negative Findings on the Initial Plain Radiography|A Single Centre Randomised, Non-blinded, Prospective Study to Evaluate the Use of MRI for Patients Presenting With Suspected Scaphoid Fracture With Negative Findings on the Initial Conventional Radiography|Recruiting||N/A|136|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:05:18.055524|2017-10-10 22:05:18.055524
NCT02801136|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2017-06-07|||June 2016||2016-06-01|June 2017|2017-06-01||||June 2018|Anticipated|2018-06-01||Interventional|||Treatment Outcomes of CBT for PNES|Treatment Outcomes of Cognitive-behavioral Therapy for Psychogenic Non-epileptic Seizures (PNES)|Recruiting||N/A|50|Anticipated|University of Alabama at Birmingham||3|||f||||f||||||||||2017-10-10 22:05:18.156497|2017-10-10 22:05:18.156497
NCT02801123|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-10|||July 2016||2016-07-01|June 2016|2016-06-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|MATCH||The MATCH Study: Mindfulness And Tai Chi for Cancer Health|The MATCH Study: Mindfulness And Tai Chi for Cancer Health A Preference-Based Multi-Site Randomized Comparative Effectiveness Trial (CET) of Mindfulness-Based Cancer Recovery (MBCR) vs. Tai Chi/Qigong (TCQ) in Cancer Survivors|Not yet recruiting||N/A|600|Anticipated|University of Calgary||8|||f||||f||||||||No||2017-10-10 22:05:18.24825|2017-10-10 22:05:18.24825
NCT02801110|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-13|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease|Comparison of [18F] FDOPA PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease: Pilot Study|Not yet recruiting||N/A|40|Anticipated|Assuta Medical Center|||1||f||||f||||||||No||2017-10-10 22:05:18.377576|2017-10-10 22:05:18.377576
NCT02801097|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-09-06|||August 30, 2016|Actual|2016-08-30|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PAYLOAD||A Phase I, Multiple Ascending Dose Study to Assess the Safety and Tolerability of RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)|A Phase I, Open-Label, Multiple Ascending Dose Study to Assess the Safety and Tolerability of RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer Patients Without Life-Prolonging Therapies of Demonstrated Clinical Benefit (PAYLOAD)|Recruiting||Phase 1|24|Anticipated|EpicentRx, Inc.||1|||f||||f||||||||||2017-10-10 22:05:18.448061|2017-10-10 22:05:18.448061
NCT02801084|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-22|||April 2016||2016-04-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Reduced Environmental Stimulation on Eating Disorders|Examining the Effects of Reduced Environmental Stimulation on Eating Disorders|Recruiting||N/A|20|Anticipated|Laureate Institute for Brain Research, Inc.||1|||f||||f||||||||||2017-10-10 22:05:18.541425|2017-10-10 22:05:18.541425
NCT02801071|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-02-13|||June 2016||2016-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||L-Citrulline in Patients With Post-Polio Syndrome|"Treatment With L-citrulline in Patients With Post-polio Syndrome - a Randomized Double Blind Placebo Controlled Study"|Active, not recruiting||Phase 3|30|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 22:05:18.645398|2017-10-10 22:05:18.645398
NCT02801058|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-16|||September 2015||2015-09-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Ultrasound Evaluation of Changes in Diaphragm Induced by Osteopathic Manipulative Techniques|Ultrasound Evaluation of Changes in Diaphragmatic Motion and Contractility Induced by Osteopathic Manipulative Techniques: a Prospective, Randomized, Double Blinded, Case vs Sham vs Control Clinical Trial.|Completed||N/A|66|Actual|Scarlata, Simone, M.D.||3|||f||||f||||||||Undecided||2017-10-10 22:05:18.72017|2017-10-10 22:05:18.72017
NCT02801045|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-03-21|||September 2016||2016-09-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient|Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient|Recruiting||N/A|80|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||f||||||||No||2017-10-10 22:05:18.79459|2017-10-10 22:05:18.79459
NCT02801032|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-20|||November 29, 2016|Actual|2016-11-29|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|ETLAS||Effect of Tadalafil on Cerebral Large Arteries in Stroke|The Effect of Tadalafil on Cerebral Large Arteries in Stroke Patients|Completed||Phase 2|20|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-10 22:05:18.870709|2017-10-10 22:05:18.870709
NCT02801019|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-06-09|||June 2008||2008-06-01|June 2016|2016-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Vitamin E-Diffused Highly Cross-Linked Polyethylene Liner|Wear and Creep of Vitamin E-Diffused Highly Cross-Linked Polyethylene Liners Randomized Radiostereometric Study of 70 Hips Followed for 2 Years|Completed||N/A|70|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-10 22:05:18.961671|2017-10-10 22:05:18.961671
NCT02800980|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-08|||June 2016||2016-06-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Management of Symptomatic Post-operative Lymphocele|Management of Symptomatic Post-operative Lymphocele With an Patient-controlled, Vascular Catheter: A Validation Study|Recruiting||N/A|100|Anticipated|Gdynia Oncology Center|||2||f||||f||||||||||2017-10-10 22:05:19.228868|2017-10-10 22:05:19.228868
NCT02800967|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Interventional|AMARCord||The Effects of Aronia Juice Polyphenols on Cardiovascular Disease Risk|Investigation of Beneficial Effects of Aronia Juice (Aronia Melanocarpa) and Dietary Polyphenols on the Activity of Thrombocytes as Well as Other Risk Factors Causing Cardio-vascular Diseases|Active, not recruiting||N/A|84|Anticipated|University of Belgrade||3|||f||||t||||||||No||2017-10-10 22:05:19.349846|2017-10-10 22:05:19.349846
NCT02800954|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-01-30|||February 2009||2009-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MCSF-MYELOME||Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma|Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire, Amiens||3|||f||||f||||||||||2017-10-10 22:05:19.483754|2017-10-10 22:05:19.483754
NCT02800902|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-14|||May 2015||2015-05-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Locally Delivered Atorvastatin & Rosuvastatin for Treatment of Furcation Defects in Chronic Periodontitis|Comparative Evaluation of Locally Delivered 1.2% Atorvastatin and 1.2% Rosuvastatin Gel in Treatment of Mandibular Degree ii Furcation Defects in Chronic Periodontitis Subjects: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|90|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||||||||||||2017-10-10 22:05:19.917115|2017-10-10 22:05:19.917115
NCT02800889|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-01-17|||October 2016||2016-10-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer|A Phase 1, Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer|Recruiting||Phase 1|35|Anticipated|CTI BioPharma||1|||f||||t||||||||||2017-10-10 22:05:20.012179|2017-10-10 22:05:20.012179
NCT02800876|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-10|||January 2016||2016-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Evaluation of Aortic Aneurysms With Focus on Wall Stress and Wall Rupture Risk|Evaluation of Aortic Aneurysms With Focus on Wall Stress and Wall Rupture Risk by Computational Finite Element Analysis With Dedicated Software|Recruiting||N/A|150|Anticipated|University of Zurich|||4||f||||f||||||||||2017-10-10 22:05:20.099173|2017-10-10 22:05:20.099173
NCT02800863|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-20|||July 2016||2016-07-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Observational|TARGET PAS||TARGET Post-Approval Study|TARGET: A Post-Approval Study to Evaluate Targeted SCS Spinal Cord Stimulation (SCS) Dorsal Root Ganglion (DRG) Stimulation for the Management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs Due to CRPS Types I and II|Recruiting||N/A|376|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-10 22:05:20.18499|2017-10-10 22:05:20.18499
NCT02800850|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-16|||July 2013||2013-07-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Bright Light Therapy for Individuals With Dementia|Bright Light Therapy for Individuals With Dementia|Completed||N/A|71|Actual|Radford University||2|||f||||f||||||||No||2017-10-10 22:05:20.420323|2017-10-10 22:05:20.420323
NCT02800837|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-06-10|||May 2016||2016-05-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|TRUNC||Clinical Study to Evaluate the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease|Multicenter Prospective Clinical Study of the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease|Recruiting||N/A|200|Anticipated|Stentys|||1||f||||||||||||||2017-10-10 22:05:20.491143|2017-10-10 22:05:20.491143
NCT02800824|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-09||||||June 2016|2016-06-01||||June 2016|Actual|2016-06-01||Interventional|||Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam||Completed||Phase 1|||Perrigo Company||2|||f||||f||||||||No||2017-10-10 22:05:20.586604|2017-10-10 22:05:20.586604
NCT02800811|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-07-20|||April 2015||2015-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104|Randomized, Double-blind, Placebo-controlled, Dose-escalation Study for the Assessment of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Single and Multiple Intravenous Doses of FR104 in Healthy Subjects|Completed||Phase 1|64|Actual|OSE Immunotherapeutics||13|||f||||t||||||||Undecided||2017-10-10 22:05:20.649873|2017-10-10 22:05:20.649873
NCT02800798|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Correlation Between Preeclampsia and Positive for Obstructive Sleep Apnea Screening Test: STOPBANG Questionnaire||Not yet recruiting||N/A|1100|Anticipated|Ramathibodi Hospital|||2||f||||f||||||||No||2017-10-10 22:05:20.753179|2017-10-10 22:05:20.753179
NCT02800785|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-06-09|||May 2016||2016-05-01|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|CODA||The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial|The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial|Recruiting||N/A|1552|Anticipated|University of Washington||2|||f||||t||||||||Yes|De-identified datasets, analytic datasets, and codebook will be shared back to study sponsor, PCORI.|2017-10-10 22:05:20.832679|2017-10-10 22:05:20.832679
NCT02800772|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2017-06-09|||June 2016||2016-06-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Impact of Intraduodenal Acetic Acid Infusion on Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography: a Double-blind, Randomized Controlled Trial||Recruiting||N/A|200|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-10-10 22:05:20.959928|2017-10-10 22:05:20.959928
NCT02800759|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-10|||September 2013||2013-09-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Cis-9-cetylmyristoleate in Sub-healthy Subjects Presenting With Knee Joint Pain|The Minimal Effective Dose of Cis-9-cetylmyristoleate (CMO) in Persons Presenting With Knee Joint Pain|Completed||N/A|28|Actual|Seoul National University||4|||f||||t||||||||Yes||2017-10-10 22:05:21.034637|2017-10-10 22:05:21.034637
NCT02800746|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravenous Iron Pre-treatment in Prognathic Surgery|Preoperative Intravenous Iron Supplementation on Postoperative Hematocrit and Intraoperative Transfusion Amount in Prognathic Surgery|Not yet recruiting||N/A|48|Anticipated|Konkuk University Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:05:21.110226|2017-10-10 22:05:21.110226
NCT02800733|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-11|2016-06-11|||June 2016||2016-06-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Effects of Saffron on Mild to Moderate Generalized Anxiety Disorder (GAD)|The Effect of Saffron (Crocus Satious L.) in the Treatment of Mild to Moderate Generalized Anxiety Disorder: a Double Blind Randomized Controlled Trial|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|National Nutrition and Food Technology Institute||2|||f||||t||||||||Undecided||2017-10-10 22:05:21.18481|2017-10-10 22:05:21.18481
NCT02800707|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-09-14|||January 3, 2017|Actual|2017-01-03|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Sucralose, Stevia, Gut Microbiome and Glucose Metabolism|Sucralose, Stevia, Gut Microbiome and Glucose Metabolism|Recruiting||N/A|40|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|f||||||||2017-10-10 22:05:21.319008|2017-10-10 22:05:21.319008
NCT02800694|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-09|||July 2016||2016-07-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Role of the Single-shot Spinal Analgesia to Control Labour Pain|Role of the Single-shot Spinal Analgesia to Control Labour Pain in Appropriately-selected Primiparous Parturients: A Prospective Study|Not yet recruiting||N/A|100|Anticipated|Minia University||1|||f||||f||||||||No||2017-10-10 22:05:21.399944|2017-10-10 22:05:21.399944
NCT02800681|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-17|||June 2016||2016-06-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Observational|||Psychopathological Differences Between Asperger Syndrome and Schizotypal Disorder in an Adult Sample|Psychopathological Differences Between Asperger Syndrome/Normal IQ, no Language Impairment Autism Spectrum Disorder and Schizotypal Disorder in an Adult Sample|Recruiting||N/A|100|Anticipated|Mental Health Services in the Capital Region, Denmark|||2||f||||f||||||||No||2017-10-10 22:05:21.479609|2017-10-10 22:05:21.479609
NCT02800668|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-10|||October 2011||2011-10-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|DJBL-T2DM||Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus|Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients With Type 2 Diabetes Mellitus|Completed||N/A|19|Actual|Ruhr University of Bochum|||1||f||||f||||||Samples Without DNA|"     Blood sampling during study, analysis via ELISA for special markers at study end in one     batch, active medical control parameters like HbA1c, cholesterol, hemogram etc. at visits   "|Yes|after publication of results|2017-10-10 22:05:21.600594|2017-10-10 22:05:21.600594
NCT02800655|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-06-09|||June 2016||2016-06-01|June 2016|2016-06-01|October 2019|Anticipated|2019-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Initial ARV Therapy|A Prospective Single Arm Open Label Intervention Study Using the Digital Health Feedback System (DHFS) With Antiretroviral(ARV)-Naive Subjects Initiating HIV Treatment|Not yet recruiting||Phase 4|100|Anticipated|mHealth UCSD||1|||f||||f||||||||Yes||2017-10-10 22:05:21.676484|2017-10-10 22:05:21.676484
NCT02800629|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-09-19|||July 2016||2016-07-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Blocking Extracellular Galectin-3 in Patients With Osteoarthritis|Blocking Extracellular Galectin-3 in Patients With Osteoarthritis|Recruiting||Phase 3|50|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:05:21.910995|2017-10-10 22:05:21.910995
NCT02800616|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-06-09|||September 2015||2015-09-01|March 2016|2016-03-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|THESF||The Healthy Elementary School of the Future|The Healthy Elementary School of the Future|Enrolling by invitation||N/A|1800|Anticipated|Maastricht University||3|||f||||f||||||||No||2017-10-10 22:05:21.999797|2017-10-10 22:05:21.999797
NCT02800603|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Targeted Prevention Approach to Reducing Child Emotional and Behaviour Problems|"Making the Race Fair for Young Children at Risk: A Targeted Prevention Approach to Reducing Child Emotional and Behaviour Problems"|Not yet recruiting||N/A|280|Anticipated|McMaster University||2|||f||||t||||||||No||2017-10-10 22:05:22.123655|2017-10-10 22:05:22.123655
NCT02800590|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-02-27|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|ABP-700||Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy|A Phase II, Two-part, Multiple-dose, Dose-finding, Single-blind Study to Investigate the Safety and Efficacy of ABP-700 for Procedural Sedation in Adult Patients Undergoing Colonoscopy|Recruiting||Phase 2|150|Anticipated|The Medicines Company||3|||f||||f|f|f||||||No||2017-10-10 22:05:22.634138|2017-10-10 22:05:22.634138
NCT02800577|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-06-10|||June 2014||2014-06-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Using Computer Tasks to Predict Response to Antidepressants|An Exploratory Investigation in Depressed Patients Initiating Treatment With Citalopram, to Determine the Sensitivity and Specificity of the P1vital® Oxford GP-Emotional Test Battery in Predicting Drug Response and Non-response|Completed||Phase 1|80|Actual|P1vital Products Limited||1|||f||||f||||||||No||2017-10-10 22:05:22.760485|2017-10-10 22:05:22.760485
NCT02800564|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-08-28|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Change in Child-feeding Knowledge, Attitudes, and Practices With Nutrition Education Mass Media in Ghana|Assessing Change in Knowledge, Attitudes, and Practices of Mothers With Infants and Young Children Receiving a District-wide Interactive Nutrition Education Mass Media Programme in the Upper Manya Krobo District|Active, not recruiting||N/A|1258|Anticipated|McGill University||2|||f||||f|f|f||||||||2017-10-10 22:05:22.874917|2017-10-10 22:05:22.874917
NCT02800551|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-10-28|||July 2016||2016-07-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|December 2017|Anticipated|2017-12-01||Interventional|DOSIS RCT||Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy for Spinal Metastases|Dose-intensified Image-guided Fractionated Stereotactic Body Radiation Therapy for Painful Spinal Metastases (DOSIS) Versus Conventional Radiation Therapy: a Phase II Randomised Controlled Trial|Recruiting||Phase 2|146|Anticipated|University of Zurich||2|||f||||f||||||||No||2017-10-10 22:05:22.96984|2017-10-10 22:05:22.96984
NCT02800538|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-07|||May 25, 2015|Actual|2015-05-25|November 2016|2016-11-01|June 27, 2017|Actual|2017-06-27|June 27, 2017|Actual|2017-06-27||Interventional|||The Effects of Intragastric Administration of Nutrients on Executive Control in Healthy Subjects.|The Effects of Intragastric Administration of Nutrients on Executive Control in Healthy Subjects.|Completed||N/A|26|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||||2017-10-10 22:05:23.068881|2017-10-10 22:05:23.068881
NCT02800525|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-09-19|||June 2016||2016-06-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Comparison of Picosecond and Q-switched Laser for Benign Pigmented Lesions Treatment|The Comparison of Picosecond 532 and 1,064 Nanometers Laser and Q-switched Nd:YAG 532 and 1,064 Nanometers Laser in the Treatment of Benign Pigmented Lesions: A Randomized Controlled Trial|Recruiting||Phase 4|20|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-10 22:05:23.151121|2017-10-10 22:05:23.151121
NCT02800512|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-08-22|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||SCP vs HUSLS for Pelvic Organ Prolapse Repair|Robotic Sacrocolpopexy Versus High Uterosacral Ligament Suspension: A Randomized Trial|Recruiting||N/A|112|Anticipated|Loma Linda University||2|||f||||f||||||||||2017-10-10 22:05:23.254478|2017-10-10 22:05:23.254478
NCT02800499|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2016-06-14|||January 2012||2012-01-01|June 2016|2016-06-01|January 2022|Anticipated|2022-01-01|November 2016|Anticipated|2016-11-01|10 Years|Observational [Patient Registry]|KOCOSS||KOrea COpd Subgroup Registry and Subtype Research|Domestic COPD Patients Registry Business and COPD Phenotype Research Based by Registry Data - Multi-centered Trial|Recruiting||N/A|2000|Anticipated|Konkuk University Medical Center|||1||f||||f||||||||Undecided||2017-10-10 22:05:23.369368|2017-10-10 22:05:23.369368
NCT02800486|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-01-27|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA|Phase II Trial of Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory Glioblastoma Multiforme, Anaplastic Astrocytoma, and Anaplastic Oligoastrocytoma|Recruiting||Phase 2|37|Anticipated|Northwell Health||1|||f||||f||||||||||2017-10-10 22:05:23.464185|2017-10-10 22:05:23.464185
NCT02800473|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-01-17|||July 2016||2016-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CyPaM2||Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection|Evaluation of an Innovative Medical Device Made of a Bimodal Endoscopic Imager and of a Software for Panoramic Images Building of the Bladder Inner Wall (French National Research Agency, CyPaM2 Project, ANR-11-TECS-001) (CyPaM2)|Recruiting||N/A|10|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 22:05:23.575725|2017-10-10 22:05:23.575725
NCT02800460|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-09|||June 2016||2016-06-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|Optimise_3T||New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients|Development of New Multi-contrasts Approaches by Magnetic Resonance Imaging at 3 Tesla Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients.|Not yet recruiting||N/A|35|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||No||2017-10-10 22:05:23.697548|2017-10-10 22:05:23.697548
NCT02800447|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-10|||June 2016||2016-06-01|May 2016|2016-05-01||||February 2020|Anticipated|2020-02-01||Interventional|||Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol||Not yet recruiting||N/A|184|Anticipated|Lee's Pharmaceutical Limited||2|||f||||||||||||||2017-10-10 22:05:23.815421|2017-10-10 22:05:23.815421
NCT02800434|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-08|||January 2000|Actual|2000-01-01|August 2017|2017-08-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Clinical Evaluation of Bilateral Hand Allograft: Pilot Study of 7 Cases|Clinical Evaluation of Bilateral Hand Allograft: Pilot Study of 7 Cases|Active, not recruiting||N/A|7|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:05:23.890975|2017-10-10 22:05:23.890975
NCT02800421|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-09|||January 2007||2007-01-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01|2 Years|Observational [Patient Registry]|||Prognostic Impact of Organ Damage in STEMI Patients|Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Completed||N/A|668|Actual|Inha University Hospital|||4||f||||t||||||||Undecided|Sharing individual participant data is available, since I have full data encoded. However, if it is feasible uploading the individual data, I would consider it positively.|2017-10-10 22:05:23.979513|2017-10-10 22:05:23.979513
NCT02800408|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-11-29|||July 2016||2016-07-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans|Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans|Active, not recruiting||N/A|10|Actual|University of Wisconsin, Madison||3|||f||||f||||||||No||2017-10-10 22:05:24.074697|2017-10-10 22:05:24.074697
NCT02800395|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-18|||December 2014||2014-12-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|GERIOX||Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease|Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease|Recruiting||N/A|350|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:05:24.187075|2017-10-10 22:05:24.187075
NCT02800382|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-09|||January 2012||2012-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2013|Actual|2013-12-01||Interventional|||Paraoxanase Enzyme Activity in Patients With Pulmonary Diseases|Bronchoalveolar Lavage Liq To Distinguish Benign and Malignant Pulmonary Diseases|Completed||N/A|44|Actual|Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital||2|||f||||f||||||||No|It can be shared, after being published in scientific journals.|2017-10-10 22:05:24.292193|2017-10-10 22:05:24.292193
NCT02800369|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-07-09|||December 10, 2016|Actual|2016-12-10|July 2017|2017-07-01|July 10, 2017|Anticipated|2017-07-10|June 10, 2017|Actual|2017-06-10||Interventional|||Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions|Safety Study of Zinc Finger Nucleases ZFN-602 and ZFN-758 in HPV-infected Subjects|Active, not recruiting||Phase 1|20|Anticipated|Huazhong University of Science and Technology||1|||f||||t||||||||||2017-10-10 22:05:24.378226|2017-10-10 22:05:24.378226
NCT02800343|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-10|||July 2016||2016-07-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Intraoperative Cell Salvage and Postoperative Acidosis|The Contribution of Intraoperative Mechanical Red Cell Salvage to Acidosis in the Immediate Postoperative Period After Cardiac Surgery|Not yet recruiting||N/A|60|Anticipated|University of Edinburgh|||1||f||||f||||||||Yes|"The findings of the study will be written up as a scientific report, which will be submitted for publication in a peer-reviewed scientific journal and presented at a conference.
At the time of publication/dissemination, individual participant data will be reported as an aggregate."|2017-10-10 22:05:24.591536|2017-10-10 22:05:24.591536
NCT02800330|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-27|||May 2016||2016-05-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|REGORA||The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib|The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC) or Gastrointestinal Stromal Tumour (GIST)|Recruiting||Phase 4|14|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 22:05:24.687927|2017-10-10 22:05:24.687927
NCT02800317|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-21|||October 2016||2016-10-01|April 2017|2017-04-01||||October 2018|Anticipated|2018-10-01||Interventional|||RISAS Procedure in Node Positive Breast Cancer Following NAC|Primary Radioactive Iodine Seed Localisation in the Axilla in Axillary Node Positive Breast Cancer Combined With Sentinel Node Procedure (RISAS) Following Neoadjuvant Chemotherapy|Recruiting||N/A|200|Anticipated|Erasmus Medical Center||1|||f||||f||||||||||2017-10-10 22:05:24.786003|2017-10-10 22:05:24.786003
NCT02800304|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-18|||September 1, 2015||2015-09-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|m2E||More-2-Eat; Implementation of INPAC||Completed||N/A|5995|Actual|University of Waterloo|||1||f||||f||||||||No||2017-10-10 22:05:24.880368|2017-10-10 22:05:24.880368
NCT02800291|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-14|||January 2015||2015-01-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|M3||Making the Most of Mealtimes Determinants of Food Intake|Making the Most of Mealtimes (M3): Determinants of Food Intake in Long Term Care|Completed||N/A|640|Actual|University of Waterloo|||1||f||||f||||||||No||2017-10-10 22:05:24.949488|2017-10-10 22:05:24.949488
NCT02800278|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-10|||January 2016||2016-01-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|FOOP||Characteristics and Outcomes of Odontoid Fragility Fractures in Elderly|Characteristics and Outcomes of Odontoid Fragility Fractures in Elderly|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 22:05:25.02303|2017-10-10 22:05:25.02303
NCT02800265|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Bioavailability and Mucosal Bioactivity of Avmacol® in Healthy Volunteers|A Pilot Study Evaluating the Bioavailability and Mucosal Bioactivity of the Dietary Supplement, Avmacol®, in Healthy Volunteers With Optimization of Buccal Cell Biomarkers|Not yet recruiting||N/A|10|Anticipated|University of Pittsburgh||1|||f||||t||||||||No||2017-10-10 22:05:25.104463|2017-10-10 22:05:25.104463
NCT02800252|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-11-22|||June 2016||2016-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Omega-3 Plus Low-dose Aspirin as Adjunct to Periodontal Debridement for Chronic Periodontitis in Diabetics|Effects of Omega-3 Polyunsaturated Fatty Acids Daily Supplementation Plus Low-dose Aspirin as Adjunct to Full-mouth Periodontal Ultrasonic Debridement for the Treatment of Chronic Periodontitis in Type 2 Diabetics: Randomized Clinical Trial|Recruiting||N/A|75|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||f||||||||Undecided||2017-10-10 22:05:25.178038|2017-10-10 22:05:25.178038
NCT02800239|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-05-01|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|IAAO-AF||Protein Requirements for Active Adolescent Females|Evaluation of Protein Requirements in Active Adolescent Females|Recruiting||N/A|7|Anticipated|University of Toronto||1|||f||||f||||||||No||2017-10-10 22:05:25.293443|2017-10-10 22:05:25.293443
NCT02800226|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-14|||March 2014||2014-03-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pilot Study Comparing 10hz vs Theta Burst Stimulation|Pilot Study Comparing 10Hz Repetitive Transcranial Magnetic Stimulation (rTMS) vs. Intermittent Theta Burst Stimulation (iTBS) for Treatment Resistant Depression|Completed||Phase 3|20|Actual|University of British Columbia||2|||f||||f||||||||Undecided||2017-10-10 22:05:25.373951|2017-10-10 22:05:25.373951
NCT02800200|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-10-03|||April 2016||2016-04-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effect of Combined PRP and ESWT for Carpal Tunnel Syndrome|The Long-term Effect of Combined Platelet Rich Plasma With Extracorporeal Shock Wave Therapy in Patients With Carpal Tunnel Syndrome|Recruiting||N/A|60|Anticipated|Tri-Service General Hospital||3|||f||||t||||||||||2017-10-10 22:05:25.721582|2017-10-10 22:05:25.721582
NCT02800174|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-12|2016-06-12|||June 2006||2006-06-01|June 2016|2016-06-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis|Use of the Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis: Study Protocol for a Retrospective, Non-randomized, Long-term Parallel Controlled Trial|Completed||N/A|103|Actual|Beijing Jishuitan Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:05:25.91782|2017-10-10 22:05:25.91782
NCT02800161|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-21|||June 2016||2016-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Trehalose as add-on Therapy in Bipolar Depression|Trehalose as add-on Therapy in Bipolar Depression|Recruiting||Phase 3|60|Anticipated|Centro de Investigación Biomédica en Red||2|||f||||f||||||||Yes||2017-10-10 22:05:25.995905|2017-10-10 22:05:25.995905
NCT02800135|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-01-20|||April 2016||2016-04-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Performance of Diuretic Stress Test in Predicting Short Term Renal Recovery in Oliguric Critically-ill Patients Recovery in the Short Term|Performance of Diuretic Stress Test in Predicting Short Term Renal Recovery in Oliguric Critically-ill Patients|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 22:05:26.160391|2017-10-10 22:05:26.160391
NCT02800122|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-07-25|||March 2016||2016-03-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|PArADIsE||PAthwAy of Dyspneic patIent in Emergency (PArADIsE)|PAthwAy of Dyspneic patIent in Emergency|Enrolling by invitation||N/A|4000|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 22:05:26.244422|2017-10-10 22:05:26.244422
NCT02800109|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-05-23|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Child Follow-up Until 2 Years|Impact of Malaria Infection in Pregnancy on Fetal and Newborn Growth - Child Follow-up Until 2 Years of Age, in Relation to the Fetal Growth|Recruiting||N/A|1680|Anticipated|University of Oxford|||1||f||||f||||||Samples With DNA|"     Biological samples will consist of a 50 uL of finger prick blood sample at month 3,6,9,12,18     and 24, and a stool sample.      A buccal swab will be collected at 1 and 2 years.   "|Yes||2017-10-10 22:05:26.325044|2017-10-10 22:05:26.325044
NCT02800096|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-02-07|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Online Interventions for Gamblers With and Without Co-occurring Mental Health Concerns|Online Interventions for Problem Gamblers With and Without Co-occurring Mental Health Concerns: Randomized Controlled Trial|Active, not recruiting||N/A|284|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 22:05:26.398747|2017-10-10 22:05:26.398747
NCT02800083|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-01-11|||October 2016||2016-10-01|June 2016|2016-06-01||||December 2019|Anticipated|2019-12-01||Interventional|PoC Alcohol||A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment|A Multisite Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Pitolisant (BF2.649) For Alcohol Use Disorder Treatment|Withdrawn||Phase 2|0|Actual|Bioprojet||2||Sponsor decision|f||||t||||||||||2017-10-10 22:05:26.478275|2017-10-10 22:05:26.478275
NCT02800070|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-08-08|||July 2016||2016-07-01|August 2017|2017-08-01|June 2024|Anticipated|2024-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease|Clinical Pilot Study of Autologous Stem Cell Transplantation of Cluster of Differentiation 34 Positive (CD34+) Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease|Recruiting||Phase 1|6|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 22:05:26.550077|2017-10-10 22:05:26.550077
NCT02800057|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-09|||August 2010||2010-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:05:26.63308|2017-10-10 22:05:26.63308
NCT02800044|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-11-01|||November 2016||2016-11-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|SENSOR||Studying the Effectiveness of Non-Invasive Glucose Sensors in Patients With Diabetes: The SENSOR Study|Studying the Effectiveness of Non-Invasive Glucose Sensors in Patients With Diabetes: The SENSOR Study|Recruiting||N/A|20|Anticipated|University of California, San Diego||1|||f||||f||||||||Yes||2017-10-10 22:05:26.672067|2017-10-10 22:05:26.672067
NCT02800031|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-06-17|||April 2016||2016-04-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||IOTA Versus Pattern Recognition Method in Diagnosis of Ovarian Masses|The Diagnostic Value Of International Ovarian Tumour Analysis (IOTA) Simple Rules Versus the Pattern Recognition Method In Differentiating Between Malignant And Benign Adnexal Masses|Recruiting||N/A|70|Anticipated|Woman's Health University Hospital, Egypt||1|||f||||t||||||||Undecided||2017-10-10 22:05:26.762513|2017-10-10 22:05:26.762513
NCT02800018|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-02-06|||June 2016||2016-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy|Evaluation of Perinatal Risk Factors for Hypoxic-ischaemic Encephalopathy (HIE) and Their Influence on Severity of Encephalopathy During and After Hypothermia Therapy|Recruiting||N/A|160|Anticipated|University Children's Hospital, Zurich|||1||f||||f||||||||No||2017-10-10 22:05:27.035686|2017-10-10 22:05:27.035686
NCT02800005|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-06-11|||July 2015||2015-07-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Obesity on Surgical Outcomes and Survival for Gastric Cancer|Effect of Obesity on Surgical Outcomes and Survival for Gastric Cancer Patients: a Single Center Prospective Cohort Study|Recruiting||N/A|600|Anticipated|West China Hospital||2|||f||||t||||||||No||2017-10-10 22:05:27.150253|2017-10-10 22:05:27.150253
NCT02799992|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-09|||June 2016||2016-06-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Pseudo-PDT in Central Serous Chorioretinopathy||Not yet recruiting||N/A|22|Anticipated|Università degli Studi di Brescia||2|||f||||||||||||||2017-10-10 22:05:27.277134|2017-10-10 22:05:27.277134
NCT02799979|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-10-03|||October 2014||2014-10-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Observational|HTP3S||3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension|3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire de Nice|||2||f||||f||||||||||2017-10-10 22:05:27.379751|2017-10-10 22:05:27.379751
NCT02799966|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MyndMove||Recovery of Upper Limb Function in Persons With Spinal Cord Injury: Lead-In Study|Recovery of Upper Limb Function in Persons With Spinal Cord Injury: Lead-In Study|Not yet recruiting||N/A|40|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:05:27.482211|2017-10-10 22:05:27.482211
NCT02799953|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-19|||March 2016||2016-03-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Technology-augmented Self-monitoring Model Among Patients With Type 2 Diabetes and Hypertension|Evaluating a Technology-augmented Self-monitoring Model for Glycemic and Blood Pressure Control and Medication Adherence in Type 2 Diabetes and Hypertension Patients: a Randomized Controlled Trial|Recruiting||N/A|296|Anticipated|The University of Hong Kong||2|||f||||f||||||||No||2017-10-10 22:05:27.591027|2017-10-10 22:05:27.591027
NCT02799940|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-09-01|||August 2016||2016-08-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|August 2018|Anticipated|2018-08-01|60 Days|Observational [Patient Registry]|||Abnormalities in Lung Computed Tomography and Physiological Alterations in Patients With Acute Respiratory Distress Syndrome|Abnormalities in Lung Computed Tomography and Physiological Alterations in Patients With Acute Respiratory Distress Syndrome|Recruiting||N/A|29|Anticipated|Hospital Regional Rio Gallegos|||1||f||||f||||||||No||2017-10-10 22:05:27.703786|2017-10-10 22:05:27.703786
NCT02799927|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-14|||November 2014||2014-11-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|April 2016|Actual|2016-04-01||Interventional|IPT||Comparison Between Biodentine and Calcium Hydroxide in the Indirect Pulp Treatment on Primary Teeth|A Split-mouth Trial Comparing Biodentine and Calcium Hydroxide in the Indirect Pulp Treatment on Primary Teeth|Active, not recruiting||Phase 2/Phase 3|80|Anticipated|Universidad Autonoma de San Luis Potosí||2|||f||||t||||||||Undecided|Yes. Only in case of future systematic reviews with meta-analysis.|2017-10-10 22:05:27.817167|2017-10-10 22:05:27.817167
NCT02799914|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Evaluation of the Sinus-Venous Stent for the Treatment of Iliofemoral Venous Occlusive Disease|Evaluation of the Sinus-Venous Stent for the Treatment of Iliofemoral Venous Occlusive Disease: A Monocenter Post Market Clinical Follow-up Study|Not yet recruiting||N/A|50|Anticipated|be Medical|||1||f||||f||||||||No||2017-10-10 22:05:27.928646|2017-10-10 22:05:27.928646
NCT02799901|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-22|||March 3, 2017|Actual|2017-03-03|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|March 3, 2019|Anticipated|2019-03-03||Interventional|NIRVANA||Nivolumab Plus Radiotherapy in Advanced Melanoma|Nivolumab in Combination With High Dose Radiotherapy at Varied Tumor Sites in Advanced Melanoma and no Prior Antitumoral Treatment|Recruiting||Phase 2|72|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f|f|f||||||||2017-10-10 22:05:28.025417|2017-10-10 22:05:28.025417
NCT02799888|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-09|||April 2014||2014-04-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation|Safety and Efficacy of Maraviroc-Based Graft-Versus-Host-Disease Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Donor Transplantation|Recruiting||Phase 2|40|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-10 22:05:28.207839|2017-10-10 22:05:28.207839
NCT02799875|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-01-12|||December 2015||2015-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HYFIVE||Late Permissive Hypercapnia for Intubated and Ventilated Preterm Infants|A Randomized Controlled Trial of pH-Controlled Late Permissive Hypercapnia for Intubated and Ventilated Preterm Infants|Recruiting||N/A|130|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||No||2017-10-10 22:05:28.332634|2017-10-10 22:05:28.332634
NCT02799862|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-10-20|||August 2016||2016-08-01|October 2016|2016-10-01|November 2020|Anticipated|2020-11-01|May 2018|Anticipated|2018-05-01||Observational|NEPTUN||Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC|A Non-interventional Study of Nab-paclitaxel (Abraxane®) in Combination With Carboplatin as First Line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NEPTUN)|Recruiting||N/A|500|Anticipated|iOMEDICO AG|||1||f||||f||||||||No||2017-10-10 22:05:28.460213|2017-10-10 22:05:28.460213
NCT02799849|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-14|||December 2013||2013-12-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|Narcolepsy||Metabolism Characteristics in the Children With Narcolepsy|Is There a Change in the Total Metabolism Over 24 Hours for Narcoleptic Children That Could Explain Their Tendency to Obesity?|Recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 22:05:28.584947|2017-10-10 22:05:28.584947
NCT02799836|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-06-14|||July 2016||2016-07-01|June 2016|2016-06-01||||October 2016|Anticipated|2016-10-01||Interventional|||The Effect of Light Deprivation on Visual Functions in Adult Amblyopes||Not yet recruiting||N/A|12|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||Yes|Study subject's visual acuity before and after the intervention will be given to the study subject.|2017-10-10 22:05:28.69676|2017-10-10 22:05:28.69676
NCT02799823|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-05-01|||April 27, 2017|Actual|2017-04-27|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|October 30, 2017|Anticipated|2017-10-30||Interventional|RADIANT||Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial|Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial|Recruiting||N/A|20|Anticipated|HLT Inc.||1|||f||||t|f|t|t|f||||Undecided||2017-10-10 22:05:28.772508|2017-10-10 22:05:28.772508
NCT02799810|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-06-09|||January 2016||2016-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|EVALUT||Psychosocial Evaluation Prior to Lung Transplantation|Standardized Evaluation of Psychosocial Functioning in Patients Awaiting Lung Transplantation|Enrolling by invitation||N/A|200|Anticipated|Hannover Medical School|||1||f||||f||||||||No||2017-10-10 22:05:28.871163|2017-10-10 22:05:28.871163
NCT02799797|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-09-19|||January 2016||2016-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Ultrasound-guided Continuous Adductor Canal Block for Analgesia After Total Knee Replacement: Comparison of Short-axis and Long-axis Techniques||Recruiting||N/A|50|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-10 22:05:28.96039|2017-10-10 22:05:28.96039
NCT02799784|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-08-25|||July 14, 2016|Actual|2016-07-14|August 2017|2017-08-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|||An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients|A Randomized, Open-Label, 8-Week Cross-Over Study to Compare Umeclidinium/Vilanterol With Tiotropium/Olodaterol Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|242|Actual|GlaxoSmithKline||2|||f||||f|t|f||||||||2017-10-10 22:05:29.072122|2017-10-10 22:05:29.072122
NCT02799771|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-02-22|||February 2013||2013-02-01|February 2017|2017-02-01|February 2022|Anticipated|2022-02-01|February 2018|Anticipated|2018-02-01||Observational|HYPID-2||HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION|Observational Study of Incident Patients With Pre Capillary Pulmonary Hypertension and Interstitial Lung Disease|Recruiting||N/A|250|Anticipated|Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:05:29.24885|2017-10-10 22:05:29.24885
NCT02792777|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-08|||January 2016||2016-01-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|VOICe||Concept Mapping as a Scalable Method for Identifying Patient-Important Outcomes||Recruiting||N/A|195|Anticipated|Thomas Jefferson University|||2||f||||f||||||||No||2017-10-10 22:06:47.314428|2017-10-10 22:06:47.314428
NCT02799745|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-10-05|||May 24, 2016|Actual|2016-05-24|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|ENACT||A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance|A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT)|Recruiting||Phase 2|222|Anticipated|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 22:05:29.526821|2017-10-10 22:05:29.526821
NCT02799732|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-09|||May 2016||2016-05-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Observational|FS-ESCUDDO||A Feasibility Study for the One-dose Clinical Trial (1DT)|"A Feasibility Study for the Clinical Trial: A Scientific Evaluation of One and Two Doses of the Bivalent and Nonavalent Prophylactic HPV Vaccines (1DT)"|Enrolling by invitation||N/A|130|Anticipated|Fundación Inciensa|||1||f||||f||||||Samples Without DNA|"     De-identified samples will be retained to be used as controls in the main trial.   "|No||2017-10-10 22:05:29.741457|2017-10-10 22:05:29.741457
NCT02799719|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-02-17|||March 2014|Actual|2014-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Body Fat Mass Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines|Body Fat Mass as Predictors of Survival in Hemodialysis Patients and Its Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines in Chronic Hemodialysis Patients: a Prospective Study.|Completed||N/A|65|Actual|Tungs’ Taichung Metroharbour Hospital|||1||f||||t||||||||Yes||2017-10-10 22:05:29.787405|2017-10-10 22:05:29.787405
NCT02799706|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-27|||September 25, 2017|Actual|2017-09-25|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Interventional|PEGASUS||Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer|Phase IIIb Randomized Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer. A Joint Study of the EORTC ROG and GUCG|Recruiting||Phase 3|885|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t|f|f||||||||2017-10-10 22:05:29.843504|2017-10-10 22:05:29.843504
NCT02799693|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-01-23|||July 2016||2016-07-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Intramural Needle Ablation for Ventricular Tachycardia|Outcomes of Intramural Needle Ablation for Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation|Recruiting||N/A|20|Anticipated|Nova Scotia Health Authority|||1||f||||f||||||||No||2017-10-10 22:05:29.945145|2017-10-10 22:05:29.945145
NCT02799680|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-10|||October 2015||2015-10-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Allogeneic CART-33 for Relapsed/Refractory CD33+ AML|Treatment of Relapsed and/or Refractory CD33-positive Acute Myeloid Leukemia by Infusions of Allogeneic CART-33|Recruiting||Phase 1|12|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||1|||f||||t||||||||Undecided||2017-10-10 22:05:30.043489|2017-10-10 22:05:30.043489
NCT02799667|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-10|||May 2016||2016-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Do Single Use Negative Pressure Dressings Reduce Wound Complications in Obese Women After Cesarean Delivery|Randomized Controlled Trial: Do Single Use Negative Pressure Dressings Reduce Wound Complications in Women With a BMI >40 kg/m2 Undergoing Cesarean Delivery at a Tertiary Medical Center?|Recruiting||N/A|242|Anticipated|Tufts Medical Center||2|||f||||f||||||||No||2017-10-10 22:05:30.12598|2017-10-10 22:05:30.12598
NCT02799654|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-04|||August 2017|Anticipated|2017-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||Excia T Cementless EBRA Study|Non-Interventional Post Market Clinical Follow-up Study Excia T® Cementless EBRA Study|Withdrawn||N/A|0|Actual|Aesculap AG|||1|Change of organizational circumstances.|f||||f||||||||||2017-10-10 22:05:30.210828|2017-10-10 22:05:30.210828
NCT02799628|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-07-08|||July 2016||2016-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Positive Appraisal Improve Trust Between Patients and Therapists, and Change Treatment Effects|Positive Appraisal Improve Trust Between Patients and Therapists, and Change Treatment Effects|Recruiting||N/A|168|Anticipated|Taoyuan General Hospital||2|||f||||f||||||||No||2017-10-10 22:05:30.38035|2017-10-10 22:05:30.38035
NCT02799615|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-04-04|||May 2016||2016-05-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Observational|ARCH||Anti-TNF Therapy for Refractory Colitis in Hospitalized Children|Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children|Recruiting||N/A|36|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     Blood, blood DNA, serum, plasma, colon endoscopic biopsy tissue (RNA/DNA/Formalin-fixed),     stool (DNA and supernatant)   "|No||2017-10-10 22:05:30.46213|2017-10-10 22:05:30.46213
NCT02799602|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-21|||November 30, 2016|Actual|2016-11-30|September 2017|2017-09-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2022|Anticipated|2022-08-01||Interventional|ARASENS||ODM-201 in Addition to Standard ADT and Docetaxel in Metastatic Castration Sensitive Prostate Cancer|A Randomized, Double-blind, Placebo Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients With Metastatic Hormone Sensitive Prostate Cancer|Recruiting||Phase 3|1300|Anticipated|Bayer||2|||f||||t|t|f|||f|||||2017-10-10 22:05:32.598604|2017-10-10 22:05:32.598604
NCT02799589|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-02-06|||July 2016||2016-07-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|Remi-dex||Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex)|Remifentanil-dexmedetomidine Anesthesia as an Alternative Anesthetic for Elective Pediatric Surgery: a Pilot Study.|Active, not recruiting||Phase 4|30|Anticipated|Children's Research Institute||1|||f||||f||||||||No||2017-10-10 22:05:33.549273|2017-10-10 22:05:33.549273
NCT02799576|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-09|||July 2016||2016-07-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Curved Block Needle for the Infraclavicular Brachial Plexus Block|A Curved Block Needle for the Infraclavicular Brachial Plexus Block in Patients Undergoing Surgery Distal to the Elbow|Not yet recruiting||Phase 4|70|Anticipated|Suez Canal University||2|||f||||f||||||||Undecided||2017-10-10 22:05:33.629461|2017-10-10 22:05:33.629461
NCT02799563|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-09|||July 2014||2014-07-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|DKA||A Computer‐Based Simulation of DKA Management|Integration of a Computer‐Based Simulation of DKA Management Into Medical Education: A 2 by 2 Factorial Cluster Randomized Controlled Trial|Completed||N/A|124|Actual|St. Michael's Hospital, Toronto||4|||f||||f||||||||No||2017-10-10 22:05:33.707804|2017-10-10 22:05:33.707804
NCT02799550|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-14|||October 2015||2015-10-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL|Treatment of Elderly Relapsed and/or Refractory CD19-positive Acute Lymphoblastic Leukemia by Infusions of Allogeneic CART-19|Recruiting||Phase 1|10|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||1|||f||||t||||||||Undecided||2017-10-10 22:05:33.783673|2017-10-10 22:05:33.783673
NCT02799537|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-01-10|||February 2016||2016-02-01|January 2017|2017-01-01|December 2026|Anticipated|2026-12-01|August 2026|Anticipated|2026-08-01||Interventional|SLP||Comparing the Stanford Letter Project Form to Traditional Advance Directives|Comparing the Stanford Letter Project Form to Traditional Advance Directives|Recruiting||N/A|1000|Anticipated|Stanford University||2|||f||||t||||||||Undecided||2017-10-10 22:05:33.872531|2017-10-10 22:05:33.872531
NCT02799524|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-08-16|||December 2015||2015-12-01|January 2017|2017-01-01|July 2017|Actual|2017-07-01|December 2016|Actual|2016-12-01||Observational|Thymog||Comparison of Mood Disorders Screening Scales in Geriatric Oncology|Comparison of Mood Disorders Screening Scales in Geriatric Oncology|Completed||N/A|93|Actual|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 22:05:33.957222|2017-10-10 22:05:33.957222
NCT02799511|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-09|||March 2015||2015-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|MAESTRO||Biomarkers for the Diagnosis of Transient Ischemic Attack|Biomarkers for the Diagnosis of Transient Ischemic Attack|Recruiting||N/A|25|Anticipated|University Hospital, Caen||1|||f||||t||||||||Undecided||2017-10-10 22:05:34.021164|2017-10-10 22:05:34.021164
NCT02799498|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-06-09|||October 2003||2003-10-01|June 2016|2016-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection|An Open-label, Randomized, 2-period Crossover Study to Compare the Pharmacokinetics of a 50-mg Dose of Liquid Etanercept Administered to Healthy Subjects by Subcutaneous Injection Using an Auto-Injector Device and Manual Injection|Completed||Phase 1|36|Actual|Amgen||2|||f||||f||||||||||2017-10-10 22:05:34.214301|2017-10-10 22:05:34.214301
NCT02799472|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-12|||June 15, 2016|Actual|2016-06-15|July 2017|2017-07-01|October 19, 2017|Anticipated|2017-10-19|October 19, 2017|Anticipated|2017-10-19||Interventional|||Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis|A Phase IIa, Double-Blind, Mechanistic Study of GSK3196165 in Combination With Methotrexate Therapy in Subjects With Active Rheumatoid Arthritis Despite Treatment With DMARDs|Active, not recruiting||Phase 2|40|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:05:34.46507|2017-10-10 22:05:34.46507
NCT02799459|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-03-24|||January 2016||2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|HYPNONISAT°||Evaluation of Medical and Economic Incidence of Hypnosis|Evaluation of Medical and Economic Incidence of Hypnosis in Conization|Recruiting||N/A|150|Anticipated|Groupe Hospitalier Mutualiste de Grenoble|||2||f||||t||||||||Undecided||2017-10-10 22:05:34.617692|2017-10-10 22:05:34.617692
NCT02799446|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-03-10|||June 2016||2016-06-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Reslizumab in Chronic Rhinosinusitis|Efficacy of Reslizumab for the Treatment of Chronic Rhinosinusitis A Double Blind, Randomized, Placebo-controlled, Phase III Trial|Recruiting||Phase 3|30|Anticipated|Allergy and Asthma Clinical Research Inc.||2|||f||||||||||||||2017-10-10 22:05:34.735544|2017-10-10 22:05:34.735544
NCT02799433|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-10|||September 2011||2011-09-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Evaluation of the Healthy Apple Program in San Francisco|Evaluation of the Healthy Apple Program to Improve Nutrition and Physical Activity Practices and Child Weight Change in Child Care Centers in San Francisco|Completed||N/A|3493|Actual|San Francisco Department of Public Health||2|||f||||f||||||||No|The data used for this analysis are public health program screening data.|2017-10-10 22:05:34.828805|2017-10-10 22:05:34.828805
NCT02799420|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Role of Probe-based Confocal Laser Endomicroscopy Targeted Biopsy in the Molecular Study of Undifferentiated Gastric Cancer||Not yet recruiting||N/A|64|Anticipated|Yonsei University||2|||f||||f||||||||No|no plan to share data|2017-10-10 22:05:34.910902|2017-10-10 22:05:34.910902
NCT02799407|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-07-27|||September 1, 2017|Anticipated|2017-09-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|ECONSENT||Electronic Consent of Numerous Subjects Employing Novel Techniques Trial|Electronic Consent of Numerous Subjects Employing Novel Techniques Trial|Not yet recruiting||N/A|120|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 22:05:34.988222|2017-10-10 22:05:34.988222
NCT02799394|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-01-26|||June 2016|Actual|2016-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Activity Modification and Exercises in Young Adolescents With Osgood Schlatter Disease.|Effect of Activity Modification and Exercises in Young Adolescents With Osgood Schlatter Disease.|Recruiting||N/A|50|Anticipated|Aalborg University||1|||f||||f||||||||Yes|Data will be made publicly available no later than six months after the final publication.|2017-10-10 22:05:35.08736|2017-10-10 22:05:35.08736
NCT02799381|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-09-29|||February 9, 2017|Actual|2017-02-09|September 2017|2017-09-01|January 18, 2021|Anticipated|2021-01-18|May 4, 2018|Anticipated|2018-05-04||Interventional|DYSCOVER||An Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease|An Open-label, Randomized 12 Week Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease DYSCOVER (DYSkinesia COmparative Interventional Trial on Duodopa VERsus Oral Medication)|Recruiting||Phase 3|60|Anticipated|AbbVie||2|||f||||f|t|f||||||||2017-10-10 22:05:35.185748|2017-10-10 22:05:35.185748
NCT02799355|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-09-24|||May 2016||2016-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|GCNI-CHC||Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium|Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium|Completed||N/A|1203|Actual|Dayanand Medical College and Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:05:35.458235|2017-10-10 22:05:35.458235
NCT02799342|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-31|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:05:35.551006|2017-10-10 22:05:35.551006
NCT02799329|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-08-31|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:05:35.592937|2017-10-10 22:05:35.592937
NCT02799316|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-06-17|||June 2016||2016-06-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?|Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test for Hepatitis B Virus Infection in Rheumatic Disease Patients Before Starting Immunosuppressive Therapies??|Recruiting||N/A|100|Anticipated|Tanta University||1|||f||||t||||||||Undecided||2017-10-10 22:05:35.634883|2017-10-10 22:05:35.634883
NCT02799303|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-11-15|||June 2016||2016-06-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|MVP||MRI Versus PSA in Prostate Cancer Screening|A Randomized Clinical Trial Comparing the Efficacy of MRI Versus PSA for Prostate Cancer Screening: The MVP Study (MRI vs PSA)|Recruiting||Phase 3|1010|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||Undecided||2017-10-10 22:05:35.725584|2017-10-10 22:05:35.725584
NCT02799277|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-13|||August 2016||2016-08-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PSY||A Multinomial Process Model of Moral Judgment|A Multinomial Process Model of Moral Judgment|Not yet recruiting||Phase 4|120|Anticipated|University of Texas at Austin||2|||f||||f||||||||No||2017-10-10 22:05:35.909218|2017-10-10 22:05:35.909218
NCT02799264|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-01-12|||June 2016||2016-06-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate the Effect of High Fat Meal on Cabotegravir|A Phase I Study Evaluating the Effect of a High Fat Meal on the Pharmacokinetics of Cabotegravir in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-10 22:05:35.988531|2017-10-10 22:05:35.988531
NCT02799251|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|EVALYMPH||Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections|Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections: EVALYMPH Study|Not yet recruiting||N/A|1125|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 22:05:36.087381|2017-10-10 22:05:36.087381
NCT02799238|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-08-29|||March 2016||2016-03-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|ALECSAT||Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma|An Open Label, Randomised, Phase II Study to Investigate the Efficacy and Safety of ALECSAT Treatment as an add-on Therapy to Radiotherapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 2|87|Anticipated|CytoVac A/S||2|||f||||t||||||||||2017-10-10 22:05:36.417149|2017-10-10 22:05:36.417149
NCT02799225|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-01-30|||June 2012||2012-06-01|January 2017|2017-01-01|February 2, 2014|Actual|2014-02-02|February 2, 2014|Actual|2014-02-02||Observational|ERC||Prevalence of Clinical Strains of Enterobacteria With Reduced Susceptibility to Carbapenems in the North-West Region of France|Prevalence of Clinical Strains of Enterobacteria With Reduced Susceptibility to Carbapenems in the North-West Region of France|Completed||N/A|287|Actual|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:05:36.542989|2017-10-10 22:05:36.542989
NCT02799212|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-09-19|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|April 15, 2020|Anticipated|2020-04-15|April 15, 2020|Anticipated|2020-04-15||Interventional|SOMAPROTECT01||Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma by Laparotomy|Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma by Laparotomy: Multicenter Randomized Double-blind Placebo Controlled Trial (SOMAPROTECT01)|Not yet recruiting||Phase 3|152|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 22:05:36.631132|2017-10-10 22:05:36.631132
NCT02799186|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-09|||May 2016||2016-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|DISCO||The Study of the Prevalence Fibromuscular Dysplasia in Patient With Haematoma or Spontaneous Coronary Artery Dissection.|PREVALENCE STUDY OF FIBROMUSCULAR DYSPLASIA IN PATIENTS WITH HAEMATOMA OR SPONTANEOUS CORONARY ARTERY DISSECTION|Recruiting||N/A|200|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 22:05:36.78805|2017-10-10 22:05:36.78805
NCT02799173|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2016-06-15|||April 2011||2011-04-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|CALCILUP||Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification|Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification|Active, not recruiting||N/A|74|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-10 22:05:36.88427|2017-10-10 22:05:36.88427
NCT02799160|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-07-19|||October 2016||2016-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|Paracentesis||Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations|Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations|Recruiting||N/A|50|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples Without DNA|"     Ascites fluid, serum and plasma probes   "|||2017-10-10 22:05:36.986422|2017-10-10 22:05:36.986422
NCT02799147|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-08-22|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia|Dose-escalation Study of Graft-versus-host Disease Prophylaxis With High-dose Post-transplantation Bendamustine in Patients With Refractory Acute Leukemia|Recruiting||Phase 1/Phase 2|30|Anticipated|St. Petersburg State Pavlov Medical University||3|||f||||f||||||||||2017-10-10 22:05:37.072704|2017-10-10 22:05:37.072704
NCT02799134|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-02-12|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|NMCARSEHHSC||Neural Mechanism of Cortisol Awakening Response Suppression Effect on Human High-order and Social Cognitions|Neural Mechanism of Cortisol Awakening Response Suppression Effect on Human High-order and Social Cognitions|Recruiting||Early Phase 1|90|Anticipated|Beijing Normal University||3|||f||||f||||||||Undecided||2017-10-10 22:05:37.211015|2017-10-10 22:05:37.211015
NCT02799121|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-12-09|||May 2016||2016-05-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers|A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers|Recruiting||Phase 4|24|Anticipated|Avita Medical||1|||f||||f||||||||||2017-10-10 22:05:37.303265|2017-10-10 22:05:37.303265
NCT02799108|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-09|||May 2012||2012-05-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|LANGLAT||Analysis of Lateralization of Language in Epileptic Children by Near-infrared Spectroscopy (NIRS)|Analysis of Lateralization of Language in Epileptic Children by Near-infrared Spectroscopy (NIRS)|Terminated||N/A|4|Actual|Centre Hospitalier Universitaire, Amiens||1||inclusion difficulty|f||||f||||||||||2017-10-10 22:05:37.402475|2017-10-10 22:05:37.402475
NCT02799095|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-07-21|||July 2016||2016-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of the Effects of ALKS 4230 on Subjects With Solid Tumors|A Phase I Study of ALKS 4230 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|120|Anticipated|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 22:05:37.492709|2017-10-10 22:05:37.492709
NCT02799082|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-04-04|2016-08-01||December 2007||2007-12-01|April 2017|2017-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Baseline description is given for the FAS (Full Analysis Set). One patient each in the vehicle/placebo groupd and in the BF-200 ALA group dropped out without a post-treatment assessment of the target lesions and thus were not considered for the FAS.|Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.|A Randomized, Double-Blind, Phase III Multi-Center Study Evaluating the Safety and Efficacy of BF-200 ALA Versus Placebo in the Treatment of Actinic Keratosis (AK) When Using PDT|Completed||Phase 3|122|Actual|Biofrontera Bioscience GmbH||2|||f||||f||||||||No||2017-10-10 22:05:37.621051|2017-10-10 22:05:37.621051
NCT02799069|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-03-28|2016-09-07||April 2008||2008-04-01|March 2017|2017-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Intended-to-treat (ITT)|Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy|A Randomized, Observer Blind, Multinational Phase III Study to Evaluate the Safety and Efficacy of a Nanoemulsion Gel Formulation BF-200 ALA, in Comparison With Metvix® and Placebo, for the Treatment of Actinic Keratosis With PDT|Completed||Phase 3|571|Actual|Biofrontera Bioscience GmbH||3|||f||||f||||||||No||2017-10-10 22:05:38.438534|2017-10-10 22:05:38.438534
NCT02799056|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-13|||May 2016||2016-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Diaphragmatic and Pulmonary US for Extubation Success Prediction|Diaphragmatic Shortening Fraction and Pulmonary Ultrasound Combined Analysis for Extubation Success Prediction in Critical Care Patients|Recruiting||N/A|70|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez|||1||f||||f||||||||||2017-10-10 22:05:40.18406|2017-10-10 22:05:40.18406
NCT02799043|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-26|||June 2016||2016-06-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|REDO-FIRM||Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With Focal Impulse and Rotor Modulation Guided Procedures|Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With Focal Impulse and Rotor Modulation Guided Procedures (REDO-FIRM)|Recruiting||N/A|268|Anticipated|Abbott Electrophysiology||2|||f||||t||||||||||2017-10-10 22:05:40.282056|2017-10-10 22:05:40.282056
NCT02799030|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-07-18|||October 2006||2006-10-01|June 2016|2016-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis|A Randomized Placebo-controlled Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis|Completed||Phase 2|105|Actual|Biofrontera Bioscience GmbH||4|||f||||f||||||||No||2017-10-10 22:05:40.432505|2017-10-10 22:05:40.432505
NCT02799017|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-06-29|||June 2015||2015-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Phonological Treatment Paired With Intensive Speech Therapy Promotes Reading Recovery in Chronic Aphasia|Phonological Treatment Paired With Intensive Speech Therapy Promotes Reading Recovery in Chronic Aphasia|Active, not recruiting||N/A|20|Anticipated|Austin Speech Labs||2|||f||||f||||||||||2017-10-10 22:05:40.515848|2017-10-10 22:05:40.515848
NCT02799004|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||How Much Opioids Do You Need After Your Emergency Department Visit|Opioid Prescription for Patient With Acute Pain After Discharge From Emergency Department: Ideal Duration for Adequate Relief, Adverse Events, and Addiction|Recruiting||N/A|1200|Anticipated|Hopital du Sacre-Coeur de Montreal|||1||f||||f||||||||No||2017-10-10 22:05:40.607839|2017-10-10 22:05:40.607839
NCT02798991|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-01-16|||June 2016||2016-06-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects|A Phase I, 14 Day, Randomized, Double-Blind (Sponsor Unblinded), Placebo-Controlled, Repeat Dose, Ascending Cohort Study to Evaluate the Safety, Tolerability Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers|Completed||Phase 1|46|Actual|GlaxoSmithKline||8|||f||||f||||||||||2017-10-10 22:05:40.688475|2017-10-10 22:05:40.688475
NCT02798978|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-08-03|||January 10, 2017|Actual|2017-01-10|August 2017|2017-08-01|September 19, 2017|Anticipated|2017-09-19|September 19, 2017|Anticipated|2017-09-19||Interventional|||A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects|A 2-part Randomized, Double-blind (Sponsor-unblinded), Placebo-controlled, Ascending Dose and Parallel Group Study of TLR4 Agonist (GSK1795091) Administered to Healthy Subjects|Recruiting||Phase 1|76|Anticipated|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:05:40.784952|2017-10-10 22:05:40.784952
NCT02798965|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-15|||December 2010||2010-12-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|GPCBasedow||Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study|Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study|Completed||N/A|52|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 22:05:40.906391|2017-10-10 22:05:40.906391
NCT02798952|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-09-07|||August 23, 2016|Actual|2016-08-23|September 2017|2017-09-01|July 5, 2017|Actual|2017-07-05|July 5, 2017|Actual|2017-07-05||Interventional|||A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy|Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine, Engerix™-B Kinder (SKF103860) Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa (SB217744) During Infancy|Completed||Phase 4|302|Actual|GlaxoSmithKline||1|||f|||||f|f||||||||2017-10-10 22:05:40.987153|2017-10-10 22:05:40.987153
NCT02798939|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-09|||March 2010||2010-03-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Evaluation of Lactoferrin, Procalcitonin and Aution® Urine Dipsticks for the Diagnosis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients|Evaluation of Lactoferrin, Procalcitonin and Aution® Urine Dipsticks for the Diagnosis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||Samples Without DNA|"     ascitic fluid   "|||2017-10-10 22:05:41.103199|2017-10-10 22:05:41.103199
NCT02798926|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-09|||June 2014||2014-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|PSac||Polyethylene Bag: a Way of Preventing Hypothermia During Central Venous Catheter Placement in Preterm Neonates?|Polyethylene Bag: a Way of Preventing Hypothermia During Central Venous Catheter Placement in Preterm Neonates?|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire, Amiens|||2||f||||||||||||||2017-10-10 22:05:41.18761|2017-10-10 22:05:41.18761
NCT02798913|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-08-11|||January 2016||2016-01-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|LONGDAPTPAD||Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD|Effects of Prolonged Dual Antiplatelet Therapy With Clopidogrel Plus Acetylsalicylic Acid (ASA) After Percutaneous Lower Extremity Revascularization in Patients With Peripheral Arterial Disease|Recruiting||Phase 3|300|Anticipated|Federico II University||2|||f||||f||||||||Undecided||2017-10-10 22:05:41.267967|2017-10-10 22:05:41.267967
NCT02798900|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-07-08|||January 2017||2017-01-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Functional Task Training Combined With Therapeutic Ultrasound on Adults With Hip Osteoarthritis|The Effect of a Functional Task-training Program Combined With Therapeutic Ultrasound on Pain, Strength, Gait Biomechanics and Functionality in Adults With Hip Osteoarthritis|Not yet recruiting||N/A|50|Anticipated|Universidad del Rosario||2|||f||||t||||||||Undecided||2017-10-10 22:05:41.360816|2017-10-10 22:05:41.360816
NCT02798887|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-09|||July 2016||2016-07-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Ridge Preservation Comparing the Healing With or Without a Barrier Membrane|Ridge Preservation Comparing the Clinical and Histologic Healing of Membrane vs. no Membrane Approach to Grafting.|Not yet recruiting||N/A|30|Anticipated|University of Louisville||2|||f||||f||||||||||2017-10-10 22:05:41.467216|2017-10-10 22:05:41.467216
NCT02798874|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-13|||May 2016||2016-05-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial Infarction|Chinese People's Liberation Army General Hospital|Enrolling by invitation||N/A|240|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 22:05:41.551941|2017-10-10 22:05:41.551941
NCT02798861|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-06-13|||June 2016||2016-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Controlled Attenuation Parameter (CAP) in Liver Allografts|Usefulness of Controlled Attenuation Parameter (CAP) for the Assessment of Liver Steatosis in Liver Donors|Enrolling by invitation||N/A|100|Anticipated|University of Arkansas||1|||f||||f||||||||No||2017-10-10 22:05:41.644324|2017-10-10 22:05:41.644324
NCT02798848|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-06-08|||March 2016||2016-03-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|CREATE||CREATE - Children Reading With Electronic Assistance To Educate|Tablet Computers Versus Optical Aids to Support Education and Learning in Children and Young People With Low Vision: a Pilot Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|University College, London||2|||f||||f||||||||No||2017-10-10 22:05:41.719346|2017-10-10 22:05:41.719346
NCT02798835|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-06-14|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Single Injection Adductor Canal Block vs Catheter for Total Knee Arthroplasty|Adductor Canal Block: Single Injection vs Catheter for Pain Management of Total Knee Arthroplasty - A Randomized, Unblinded, Non-Inferiority Trial|Completed||Phase 4|180|Actual|University of British Columbia||3|||f||||f||||||||No||2017-10-10 22:05:41.800034|2017-10-10 22:05:41.800034
NCT02798822|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-06-08|||June 2013||2013-06-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|6vsE||Maxillary and Mandibular Arch Response to RME: a Multicentric Randomized Controlled Trial|Dental Arches Response to Haas-type RME Anchored to Deciduous vs Permanent Molars in Children With Unilateral Posterior Crossbite|Completed||N/A|88|Actual|University of Genova||2|||f||||f||||||||Undecided||2017-10-10 22:05:41.895634|2017-10-10 22:05:41.895634
NCT02798809|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-08|||April 2012||2012-04-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|GeOrGS||GENOA ORAL GROWTH LONGITUDINAL STUDY (GeOrGS)|GENOA ORAL GROWTH STUDY: Longitudinal Investigation of Preschool and Primary School Children|Recruiting||N/A|270|Anticipated|University of Genova|||1||f||||f||||||||Undecided||2017-10-10 22:05:41.981556|2017-10-10 22:05:41.981556
NCT02798796|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-06-08|||November 2014||2014-11-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|BREAST-MRI||Brazilian Randomized Study - Impact of MRI for Breast Cancer|Brazilian Randomized Study - Impact of Preoperative Magnetic Resonance in the Evaluation for Breast Cancer Conservative Surgery|Recruiting||N/A|372|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:05:42.046116|2017-10-10 22:05:42.046116
NCT02798783|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|June 2023|Anticipated|2023-06-01|June 2020|Anticipated|2020-06-01|1 Year|Observational [Patient Registry]|EVAR||Enlarged Vestibular Aqueduct Registry|Enlarged Vestibular Aqueduct Patient Registry at University Hospitals Rainbow Babies and Children's Hospital|Recruiting||N/A|300|Anticipated|University Hospitals Cleveland Medical Center|||1||f||||t||||||||Yes|A limited data set will be available to researchers who demonstrate IRB approval for a study that would require the use of data points collected by the Enlarged Vestibular Aqueduct Registry. This dataset will include information only in accordance with HIPAA definitions of a limited dataset, for example, excluding names and addresses. Data will be available one year after enrollment is to start, on June 2, 2017. The data may be obtained by submission of a request along with proof of investigator institutional review board approval, forms for which will be available through the registry web site.|2017-10-10 22:05:42.117114|2017-10-10 22:05:42.117114
NCT02798770|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-13|||August 2015||2015-08-01|June 2016|2016-06-01||||April 2017|Anticipated|2017-04-01|5 Days|Observational [Patient Registry]|||Reasons for Prehospital Delay in Patients With Acute Ischemic Stroke|Reasons for Prehospital Delay in Patients With Acute Ischemic Stroke: a Prospective Cohort Study|Recruiting||N/A|300|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||||Yes|Ready to share/pool data. The plan to make individual participant data has to be elaborated with the interested Party.|2017-10-10 22:05:42.185885|2017-10-10 22:05:42.185885
NCT02798757|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-08-29|||June 2016||2016-06-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy|Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy|Active, not recruiting||Phase 4|50|Anticipated|University of Ioannina||1|||f||||f||||||||No||2017-10-10 22:05:42.374425|2017-10-10 22:05:42.374425
NCT02798744|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-08-04|||September 2016||2016-09-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SEESAW||SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.|SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation: A Randomised Double-blind Placebo-controlled Trial (The SEESAW Study)|Not yet recruiting||Phase 4|76|Anticipated|University of Leicester||4|||f||||t||||||||No||2017-10-10 22:05:42.445267|2017-10-10 22:05:42.445267
NCT02798731|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-14|||May 2016||2016-05-01|June 2016|2016-06-01|December 2025|Anticipated|2025-12-01|June 2025|Anticipated|2025-06-01|6 Years|Observational [Patient Registry]|||Physiologic Assessment of Microvascular Function in Heart Transplant Patients|Physiologic Assessment of Microvascular Function and Its Impact on Cardiac Allograft Vasculopathy in Heart Transplant Patients: Prospective Registry and Pilot Study|Recruiting||N/A|30|Anticipated|Samsung Medical Center|||1||f||||t||||||||Yes|After publication of first manuscript and trial results, the de-identified data will be shared by permission of principle investigator, when asked|2017-10-10 22:05:42.557487|2017-10-10 22:05:42.557487
NCT02798718|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-24|||May 2016||2016-05-01|June 2016|2016-06-01||||August 2016|Anticipated|2016-08-01||Interventional|||Whole Milk Intake and Cardio-metabolic Risk Factors|Effect of Whole Milk Intake on the Cardio-metabolic Risk Factors of Healthy Person With or Without Lactose Maldigestion|Recruiting||N/A|60|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 22:05:42.639967|2017-10-10 22:05:42.639967
NCT02798705|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-14|||May 2016||2016-05-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01|2 Years|Observational [Patient Registry]|||Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis|Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis: Prospective Registry and Pilot Study|Recruiting||N/A|30|Anticipated|Samsung Medical Center|||1||f||||t||||||||Yes|After publication of first manuscript and trial results, the de-identified data will be shared by permission of principle investigator, when asked|2017-10-10 22:05:42.73958|2017-10-10 22:05:42.73958
NCT02798692|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-01-24|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV|Randomized, Placebo-controlled, Double-blind Phase I Dose-escalating Trial to Evaluate the Safety and Immunogenicity of a Vaccine Against Human Cytomegalovirus|Active, not recruiting||Phase 1|54|Actual|Hookipa Biotech||4|||f||||t||||||||No||2017-10-10 22:05:42.823441|2017-10-10 22:05:42.823441
NCT02798679|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Observational|||Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity|Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity|Recruiting||N/A|158|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||No||2017-10-10 22:05:42.916359|2017-10-10 22:05:42.916359
NCT02798666|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-13|||June 2015||2015-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CALIN||Effect of High-intensity Interval Training on Metabolic Fitness in Overweight Males.|High-intensity Interval Training is Associated With Greater Impact on Physical Fitness, Insulin Sensitivity and Muscle Mitochondrial Content in Overweight Males, as Opposed to Continuous Endurance Training: a Randomized Controlled Trial.|Completed||N/A|16|Actual|University Ghent||2|||f||||f||||||||No||2017-10-10 22:05:42.991205|2017-10-10 22:05:42.991205
NCT02798653|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-04-26|||November 2015||2015-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of Different Luteal Phase Support Methods in Patients With Poor Ovarian Response|Comparison of Different Methods for Luteal Phase Support in IVF / ICSI Cycles With Antagonist Protocol in Women With Poor Ovarian Response|Recruiting||Phase 3|210|Anticipated|Royan Institute||3|||f||||t||||||||||2017-10-10 22:05:43.084895|2017-10-10 22:05:43.084895
NCT02798640|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-13|||September 2013||2013-09-01|June 2016|2016-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Comparative Study Evaluating Performance of Celliant Fibers on Tissue Oxygenation|A Single Center Prospective Comparative Study to Evaluate the Performance of a Upper Torso Garment Containing 100% Celliant Fibers That Emits Far Infrared (FIR) From Ceramic Particles Contained Within the Fibers in Healthy Subjects|Completed||N/A|153|Actual|Hologenix, LLC||2|||f||||f||||||||No||2017-10-10 22:05:43.206526|2017-10-10 22:05:43.206526
NCT02798627|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-06-21|||May 2016||2016-05-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial Of NS2359 For The Treatment of Cocaine Dependence|A Phase II, Double-Blind, Placebo-Controlled, Trial Of NS2359 For The Treatment of Cocaine Dependence|Recruiting||Phase 2|80|Anticipated|University of Pennsylvania||2|||f||||t||||||||No||2017-10-10 22:05:43.286333|2017-10-10 22:05:43.286333
NCT02798614|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-14|||September 2002||2002-09-01|June 2016|2016-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|GitRa||Short Versus Conventional Plaster Cast Fixation Time in Reduced Distal Radius Fractures|A Comparison of Radiographic and Clinical Results After Short Versus Conventional Plaster Cast Fixation Time in Reduced Distal Radius Fractures|Completed||N/A|109|Actual|Uppsala University Hospital||2|||f||||f||||||||No||2017-10-10 22:05:43.374686|2017-10-10 22:05:43.374686
NCT02798601|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-21|2017-08-09|||October 2018|Anticipated|2018-10-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|August 2022|Anticipated|2022-08-01||Interventional|EHIBE||Early Induced Hypernatremia for the Prevention and Management of Brain Edema|Early Induced Hypernatremia for the Prevention and Management of Brain Edema in Patients With Severe Traumatic Brain Injury in a University Hospital|Not yet recruiting||N/A|278|Anticipated|Hospital Pablo Tobón Uribe||2|||f||||t|f|f||||||||2017-10-10 22:05:43.466106|2017-10-10 22:05:43.466106
NCT02798588|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-08-08|||February 16, 2017|Actual|2017-02-16|August 2017|2017-08-01|June 16, 2019|Anticipated|2019-06-16|June 16, 2019|Anticipated|2019-06-16||Interventional|ETIC||Improving Awakening Prognostication After Non Anoxic Coma Using PET-MRI in Intensive Care Unit|Improving Awakening Prognostication After Non Anoxic Coma Using PET-MRI in Intensive Care Unit|Recruiting||N/A|20|Anticipated|Hospices Civils de Lyon||1|||f||||f|f|f||||||||2017-10-10 22:05:43.570278|2017-10-10 22:05:43.570278
NCT02798575|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-07-07|||June 2016||2016-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||COPD Exacerbations|Detecting Chronic Obstructive Pulmonary Disease (COPD) Exacerbations and Need for Hospitalization With Software Analysis of Ventilators for Invasive Mechanical Ventilation|Recruiting||N/A|10|Anticipated|RWTH Aachen University|||1||f||||f||||||Samples Without DNA|"     Samples for arterial blood gas analyses   "|Yes||2017-10-10 22:05:43.682416|2017-10-10 22:05:43.682416
NCT02798562|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-14|||January 2017||2017-01-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Evaluation of the High-resolution, Contrast Enhanced Low-dose Breast-CT|Evaluation of the High-resolution, Contrast Enhanced Low-dose Breast-CT|Not yet recruiting||N/A|400|Anticipated|RWTH Aachen University||1|||f||||f||||||||No||2017-10-10 22:05:43.785045|2017-10-10 22:05:43.785045
NCT02798549|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-17|||January 12, 2015|Actual|2015-01-12|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||HBV Virions Bound Proteins|Hepatitis B Virus Particles-bound Human Proteins : Identification in Clinical Samples and Implication in the Viral Life Cycle|Recruiting||N/A|16|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:05:43.875368|2017-10-10 22:05:43.875368
NCT02798523|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-10-03|||June 7, 2016||2016-06-07|October 2, 2017|2017-10-02|October 2, 2017|Actual|2017-10-02|October 2, 2017|Actual|2017-10-02||Interventional|||Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids|Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids|Completed||Phase 1|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:05:44.097502|2017-10-10 22:05:44.097502
NCT02798510|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-21|||April 2016||2016-04-01|June 2016|2016-06-01||||April 2019|Anticipated|2019-04-01||Interventional|||Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma||Recruiting||Phase 3|140|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 22:05:44.19938|2017-10-10 22:05:44.19938
NCT02798497|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-06-16|||May 2011|Actual|2011-05-01|June 2017|2017-06-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|PVL||Panton Valentine Leucocidin|Panton Valentine Leucocidin : Independent Severity Factor of Staphylococcus Aureus Pneumonias|Completed||N/A|250|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:05:44.299729|2017-10-10 22:05:44.299729
NCT02798484|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-07-25|||June 2016||2016-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging|Pilot Study: Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging|Recruiting||N/A|50|Anticipated|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 22:05:44.384577|2017-10-10 22:05:44.384577
NCT02798471|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-10-04|||March 27, 2017|Actual|2017-03-27|October 2017|2017-10-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)|A Phase 3, Open-label, Randomized, Multi-center, Controlled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Edoxaban and to Compare the Efficacy and Safety of Edoxaban With Standard of Care Anticoagulant Therapy in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed Venous Thromboembolism (VTE)|Recruiting||Phase 3|274|Anticipated|Daiichi Sankyo, Inc.||2|||f||||t|t|f||||||||2017-10-10 22:05:44.513015|2017-10-10 22:05:44.513015
NCT02798458|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-04-19|||May 2016||2016-05-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of the Gastrointestinal Manifestation of Fabry's Disease|Evaluation of the Gastrointestinal Manifestation of Fabry's Disease|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 22:05:45.247497|2017-10-10 22:05:45.247497
NCT02798445|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-08-19|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|TAPIRS||TAPIRS Technique Plus Adjustable Compression System in Treatment of Venous Leg Ulcers|Clinical Trial : Terminal Axial Perforator Interruption Reflux Source (TAPIRS ) Plus Adjustable Compression System in Treatment of Venous Leg Ulcers Versus Multilayer Bandage Treatment|Not yet recruiting||N/A|26|Anticipated|Hospital Occidente de Kennedy||2|||f||||t||||||||No||2017-10-10 22:05:45.322272|2017-10-10 22:05:45.322272
NCT02798432|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Hybrid Versus Cemented TKA Using the NexGen LPS Prosthesis|Comparing Hybrid and Cemented TKA Using the NexGen LPS Prosthesis|Recruiting||N/A|154|Anticipated|Hospital Galdakao-Usansolo||2|||f||||t||||||||||2017-10-10 22:05:45.397418|2017-10-10 22:05:45.397418
NCT02798419|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-08-15|||January 2016||2016-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts||Completed||Phase 2|50|Actual|Dr. Reddys Laboratories, SA||2|||f||||f||||||||||2017-10-10 22:05:45.491364|2017-10-10 22:05:45.491364
NCT02798406|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-08-28|||June 2016||2016-06-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|CAPTIVE||Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects|A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)|Recruiting||Phase 2|48|Anticipated|DNAtrix, Inc.||1|||f||||t||||||||||2017-10-10 22:05:45.586514|2017-10-10 22:05:45.586514
NCT02798393|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2017-02-27|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ResearchNIR||Efficacy of Near Infrared Phototherapy in Type 2 Diabetic Neuropathy|Randomized Double-Blind Study of the Efficacy of Near Infrared Phototherapy on Sensation and Pain in Type 2 Diabetic Neuropathy|Terminated||N/A|22|Actual|Healthlight, LLC||2||Study blind compromised.|f||||f||||||||No||2017-10-10 22:05:45.85231|2017-10-10 22:05:45.85231
NCT02798380|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2017-08-08|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Mild to Moderate Toenail Fungus of the Big Toenail|An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail|Recruiting||Phase 2|30|Anticipated|Hallux, Inc.||1|||f||||f||||||||||2017-10-10 22:05:45.966224|2017-10-10 22:05:45.966224
NCT02798367|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-02-14|||August 2017|Anticipated|2017-08-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|Morfeu||Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia|National, Phase II/III, Multicenter, Randomized, Double-blind, Controlled, Parallel,Effect of Melatonin 3mg and 5mg Plus Cognitive Behavioral Therapy for Insomnia (CBT-I) Compared to the CBT-I Alone in the Treatment of Insomnia Disorder|Not yet recruiting||Phase 2/Phase 3|256|Anticipated|Ache Laboratorios Farmaceuticos S.A.||3|||f||||f|f|f||||||||2017-10-10 22:05:46.074112|2017-10-10 22:05:46.074112
NCT02798354|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-29|||June 2015||2015-06-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Reducing Diagnostic Errors in Primary Care Pediatrics (Project RedDE)|Reducing Diagnostic Errors in Primary Care Pediatrics|Active, not recruiting||N/A|42|Actual|Montefiore Medical Center||3|||f||||f||||||||||2017-10-10 22:05:46.199564|2017-10-10 22:05:46.199564
NCT02798341|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-06-13|||July 2012||2012-07-01|June 2016|2016-06-01||||July 2027|Anticipated|2027-07-01||Observational|||The Breast Program - Translational Cancer Resource|The Breast Program - Translational Cancer Resource|Recruiting||N/A|800|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:05:46.310465|2017-10-10 22:05:46.310465
NCT02798328|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-03-07|||August 2016||2016-08-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System|Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System|Recruiting||N/A|395|Anticipated|Haemonetics Corporation|||2||f||||f||||||Samples Without DNA|"     Whole blood sample   "|Undecided||2017-10-10 22:05:46.40371|2017-10-10 22:05:46.40371
NCT02798315|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-06-19|||May 25, 2016|Actual|2016-05-25|June 2017|2017-06-01|June 12, 2017|Actual|2017-06-12|June 12, 2017|Actual|2017-06-12||Observational|||Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Kuwait, United Arab Emirates and Qatar|Completed||N/A|40|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 22:05:46.551307|2017-10-10 22:05:46.551307
NCT02798302|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-12-23|||June 2016||2016-06-01|December 2016|2016-12-01||||September 2016|Actual|2016-09-01||Interventional|||Bag Valve Mask vs Non-rebreather at Flush Rate|Preoxygenation With a Bag Valve Mask vs Non-rebreather at Flush Rate|Completed||N/A|30|Actual|Minneapolis Medical Research Foundation||3|||f||||f||||||||||2017-10-10 22:05:46.661366|2017-10-10 22:05:46.661366
NCT02798276|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-08-29|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|AGTP II||Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar: The AGTP II Trial|Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar: The AGTP II Trial|Recruiting||N/A|108|Anticipated|Germans Trias i Pujol Hospital||2|||f|||||f|f||||||||2017-10-10 22:05:46.88179|2017-10-10 22:05:46.88179
NCT02798263|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-06-08|||May 2016||2016-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Breast Cancer Rehabilitation With Acupuncture and Physical Therapy Protocol|Randomized Clinical Trials of Acupuncture Effectiveness in the Rehabilitation of Women Under the Physical and Functional Dysfunction to Surgical Treatment of Breast Cancer|Recruiting||Phase 2/Phase 3|78|Anticipated|Federal University of São Paulo||3|||f||||t||||||||No||2017-10-10 22:05:47.115531|2017-10-10 22:05:47.115531
NCT02798250|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-04-25|||June 2016||2016-06-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2||Completed||Phase 2|11|Actual|Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||||2017-10-10 22:05:47.257067|2017-10-10 22:05:47.257067
NCT02798237|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-05|||August 2, 2017|Actual|2017-08-02|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Aerobic Training Post-stroke|Effects of Aerobic Training on Physical Activity Levels and Sedentary Behavior in Subjects Post-stroke: a Randomized Controlled Trial|Recruiting||Phase 4|22|Anticipated|Federal University of Minas Gerais||2|||f||||f|f|f||||||||2017-10-10 22:05:47.403819|2017-10-10 22:05:47.403819
NCT02798224|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-06-13|||June 14, 2017|Actual|2017-06-14|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|January 2019|Anticipated|2019-01-01||Interventional|||A Patient Portal Tool, E-assist, for Supporting CRC Screening|A Post-Visit Patient Portal Tool to Promote Colorectal Cancer Screening|Enrolling by invitation||N/A|2700|Anticipated|UNC Lineberger Comprehensive Cancer Center||3|||f||||t|f|f||||||Undecided||2017-10-10 22:05:47.523919|2017-10-10 22:05:47.523919
NCT02798211|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-08-31|||June 27, 2016|Actual|2016-06-27|August 2017|2017-08-01|November 12, 2018|Anticipated|2018-11-12|November 12, 2018|Anticipated|2018-11-12||Interventional|||Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis After 16 Weeks of Treatment Compared to Placebo and to Assess the Safety, Tolerability and Efficacy up to 52 Weeks|Recruiting||Phase 4|250|Anticipated|Novartis||3|||f||||f||||||||||2017-10-10 22:05:47.636296|2017-10-10 22:05:47.636296
NCT02798198|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-08|||September 2015||2015-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||The Correlation Between the Pulmonary Function and Intrarenal Hemodynamics in 37 T2DM Patients in Early Period||Completed||N/A|70|Actual|Fourth People's Hospital of Shenyang|||2||f||||||||||||||2017-10-10 22:05:47.839593|2017-10-10 22:05:47.839593
NCT02798185|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-03|||August 2016||2016-08-01|August 2017|2017-08-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Observational|DIAGNOSE-CTE||The DIAGNOSE-CTE Research Project|Diagnostics, Imaging And Genetics Network for the Objective Study and Evaluation of Chronic Traumatic Encephalopathy (DIAGNOSE CTE) Research Project|Recruiting||N/A|240|Anticipated|Boston University|||3||f||||f|f|f||||Samples With DNA|"     Biospecimen samples to be collected include: saliva, blood and cerebral spinal fluid (CSF)   "|||2017-10-10 22:05:47.909449|2017-10-10 22:05:47.909449
NCT02798172|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-08|||May 2014||2014-05-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy||Completed||N/A|81|Actual|Fourth People's Hospital of Shenyang||2|||f||||||||||||||2017-10-10 22:05:47.991545|2017-10-10 22:05:47.991545
NCT02798159|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2016-06-08|||May 2016||2016-05-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|TD0025||Safety and Efficacy of TD0025 (Rocket1h) for Treatment of Erectile Dysfunction|A Randomized, Placebo Control, Double-blinded, Double-dummy, Phase 2/3 Combination Study to Evaluate the Safety and Efficacy of TD0025 (Rocket1h) Compared With Sildenafil Citrate for Treatment of Erectile Dysfunction|Recruiting||Phase 2/Phase 3|168|Anticipated|Vietstar Biomedical Research||6|||f||||f||||||||Undecided||2017-10-10 22:05:48.063659|2017-10-10 22:05:48.063659
NCT02798146|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2017-04-17|||June 2016||2016-06-01|April 2017|2017-04-01|April 11, 2017|Actual|2017-04-11|August 2016|Actual|2016-08-01||Interventional|||Early Luteal Progesterone Profile After hCG Triggering|The Early Luteal Progesterone Profile in IVF Patients Triggered With hCG - a Pilot Study|Completed||N/A|20|Actual|Vietnam National University||1|||f||||f||||||||No||2017-10-10 22:05:48.264915|2017-10-10 22:05:48.264915
NCT02798133|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2017-04-25|||July 2014||2014-07-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Open Lung Approach Versus Standard Protective Strategies|Open Lung Approach Versus Standard Protective Strategies: Effects on Driving Pressure and Ventilatory Efficiency During Anesthesia|Completed||N/A|36|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||Yes||2017-10-10 22:05:48.356897|2017-10-10 22:05:48.356897
NCT02798120|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-08-02|||May 2016||2016-05-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||P3 Long Term Safety Study of Once Daily SB204 in Acne|A Phase 3 Multi-Center, Open Label Study Evaluating the Long Term Safety of SB204 Once Daily in the Treatment of Acne Vulgaris|Active, not recruiting||Phase 3|605|Actual|Novan, Inc.||1|||f||||f||||||||No||2017-10-10 22:05:48.461679|2017-10-10 22:05:48.461679
NCT02798107|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-10|2017-07-11|||July 31, 2017|Anticipated|2017-07-31|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|||Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients|Safety of Potential Paediatric Patients Treated With Idarucizumab: a Non-internventional Chart Review Study|Not yet recruiting||N/A|10|Anticipated|Boehringer Ingelheim|||1||f|||||t|f|||f|||||2017-10-10 22:05:48.676746|2017-10-10 22:05:48.676746
NCT02798094|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-09-18|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|CAN-BIND-04||Stress Sensitivity and Reward Responsivity in Depression|Stress Sensitivity and Reward Responsivity: An Integration of Two Endophenotypes in Major Depression|Recruiting||N/A|200|Anticipated|Queen's University|||2||f||||f||||||Samples Without DNA|"     Saliva is collected at eight points across the second session in 5mL vials. Saliva samples     are assayed for neuroendocrine hormones (e.g., cortisol). Whole blood is collected in EDTA     tubes at the first session. Whole blood is currently being banked. No assays are being     conducted at this time.   "|||2017-10-10 22:05:48.759659|2017-10-10 22:05:48.759659
NCT02798081|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-08-17|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Virtual Reality Games for Elderly Socialization|Virtual Reality Games for Elderly Socialization|Recruiting||N/A|46|Anticipated|Faculdade de Medicina do ABC||1|||f||||f||||||||No||2017-10-10 22:05:48.859493|2017-10-10 22:05:48.859493
NCT02798068|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-07|||May 2016||2016-05-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SICS||Steroids and Microcirculation In Cardiac Surgery|Evaluation of High-dose Corticosteroids on Microcirculation Alterations in Cardiac Surgery, by FMD (Flow Mediated vasoDilation), Near Infrared Spectrophotometry (NIRS) and Biological Analysis (Syndecan-1)|Recruiting||Phase 4|60|Anticipated|Erasme University Hospital||2|||f||||t||||||||||2017-10-10 22:05:48.955023|2017-10-10 22:05:48.955023
NCT02798055|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-09-28|||September 30, 2016|Actual|2016-09-30|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|4 Months|Observational [Patient Registry]|GRegistry SCDU||Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis|A National, Observational, Multi-center Registry to Examine the Characteristics of Patients With Systematic Sclerosis Digital Ulcers and Assess Bosentan Treatment.|Recruiting||N/A|100|Anticipated|Elpen Pharmaceutical Co. Inc.|||1||f||||t||||||||||2017-10-10 22:05:49.081235|2017-10-10 22:05:49.081235
NCT02798042|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-12-28|||June 2016||2016-06-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Observational|||Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery?|Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery?|Recruiting||N/A|1800|Anticipated|New York University School of Medicine|||1||f||||f||||||||No||2017-10-10 22:05:49.152467|2017-10-10 22:05:49.152467
NCT02798029|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-02-17|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Frameless Fractionated Stereotactic Radiation Therapy (FSRT) for Brain Mets Study|A Phase II Study of the Efficacy, Safety, and Cost of Frameless Fractionated Stereotactic Radiation for Parenchymal Brain Metastases|Recruiting||Phase 2|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:05:49.26311|2017-10-10 22:05:49.26311
NCT02798016|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-07-26|||October 2015||2015-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|June 23, 2017|Actual|2017-06-23||Interventional|||Treatment of Atrophic Acne Scars With Platelet-Rich Plasma and Skin Needling|Treatment of Atrophic Acne Scars With Platelet-Rich Plasma Alone or in Combination With Skin Needling: A Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Damascus University||2|||f||||t||||||||||2017-10-10 22:05:49.360445|2017-10-10 22:05:49.360445
NCT02798003|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-12-22|||November 2016||2016-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||Food Reward in Cachexia Induced by Acute or Chronic Disease|Analysis of Food Reward System in Cachexia Induced by Acute or Chronic Disease|Recruiting||N/A|44|Anticipated|Maastricht University Medical Center|||4||f||||t||||||Samples Without DNA|"     Blood serum   "|Undecided||2017-10-10 22:05:49.45224|2017-10-10 22:05:49.45224
NCT02797990|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2016-09-07|||May 2016||2016-05-01|May 2016|2016-05-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|||Conflict Between Maternal Autonomy and Child Health in Substance-use|Mother vs. Child? Healthcare Worker Perceptions of Conflict Between Maternal Autonomy and Child Health When Providing Care for Pregnant Women Engaging in Problematic Substance Use|Completed||N/A|6|Actual|London School of Hygiene and Tropical Medicine|||1||f||||f||||||||No||2017-10-10 22:05:49.561266|2017-10-10 22:05:49.561266
NCT02797977|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-05-05|||July 2016|Actual|2016-07-01|May 2017|2017-05-01||||April 2019|Anticipated|2019-04-01||Interventional|||A Phase 1 Trial of SRA737 in Combination With Gemcitabine Plus Cisplatin or Gemcitabine Alone in Subjects With Advanced Cancer|A Phase 1 Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination With Gemcitabine Plus Cisplatin or Gemcitabine Alone in Subjects With Advanced Cancer|Recruiting||Phase 1|65|Anticipated|Sierra Oncology, Inc.||2|||f||||f||||||||No||2017-10-10 22:05:49.647365|2017-10-10 22:05:49.647365
NCT02797951|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-06-25|||July 2016||2016-07-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|July 2020|Anticipated|2020-07-01||Interventional|||A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache|A Phase 3b Multicenter, Single-Arm, Open-Label Safety Study of LY2951742 (Galcanezumab) in Patients With Episodic or Chronic Cluster Headache|Enrolling by invitation||Phase 3|300|Anticipated|Eli Lilly and Company||1|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 22:05:51.890459|2017-10-10 22:05:51.890459
NCT02797938|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-01-29|||June 2016||2016-06-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Comparison of the Cuff Pressure Between a Taper-guard Cuffed Tube and a Cylindrical-shaped Cuffed Tube|Comparison of the Endotracheal Tube Cuff Pressure Between a Taper-guard Cuffed Tube and a Cylindrical-shaped Cuffed Tube After Changing in Position During Middle Ear Surgery|Completed||N/A|52|Actual|Kyungpook National University||2|||f||||f||||||||Yes||2017-10-10 22:05:52.080121|2017-10-10 22:05:52.080121
NCT02797925|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-11-01|||June 2016||2016-06-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Observational|TESINaC||Mechanisms Behind Development of Tendinopathy|Mechanisms Behind Development of Tendinopathy: Early Structural, Inflammatory, Nociceptive and Clinical Changes in Recreational Runners|Recruiting||N/A|400|Anticipated|Bispebjerg Hospital|||2||f||||t||||||Samples With DNA|"     Whole blood, serum, plasma and tissue.   "|No||2017-10-10 22:05:52.159191|2017-10-10 22:05:52.159191
NCT02797912|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01||||September 2016|Anticipated|2016-09-01||Observational|||LBM & Lung Function in Adolescents With CF|Nutritional Status and Pulmonary and Respiratory Muscle Function in Children and Young People With Cystic Fibrosis|Recruiting||N/A|62|Anticipated|King's College Hospital NHS Trust|||1||f||||f||||||||||2017-10-10 22:05:52.281778|2017-10-10 22:05:52.281778
NCT02797899|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-13|||September 2013||2013-09-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Effect of PRF Palatal Bandage on Pain Scores and Wound Healing After Free Gingival Graft|Effect of Platelet Rich Fibrin Palatal Bandage on Pain Scores and Wound Healing After Free Gingival Graft|Completed||Phase 2/Phase 3|24|Actual|King Abdulaziz University||2|||f||||f||||||||No||2017-10-10 22:05:52.420179|2017-10-10 22:05:52.420179
NCT02797886|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-08|||June 2016||2016-06-01|June 2016|2016-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Pairing Functional Electrical Stimulation (FES) and Volitional Effort Training Promotes Neuroplasticity and Motor Gain||Not yet recruiting||N/A|45|Anticipated|Kessler Foundation||3|||f||||||||||||||2017-10-10 22:05:52.518966|2017-10-10 22:05:52.518966
NCT02797873|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-06-08|||August 2016||2016-08-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Emotional and Non-emotional Regulation in Patients With Emotional Instability and ADHD|Emotional and Non-emotional Regulation in Patients With Emotional Instability Personality Disorder (EIP) and Attention Deficit Hyperactivity Disorder (ADHD) Symptoms|Not yet recruiting||N/A|60|Anticipated|Karolinska Institutet||2|||f||||f||||||||Yes||2017-10-10 22:05:52.823462|2017-10-10 22:05:52.823462
NCT02797860|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-09|||June 2016||2016-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Comparison of Onset and Duration of Rocuronium Between 2nd Trimester Pregnant and Non-pregnant Women|Comparison of Onset and Duration of Rocuronium Induced Neuromuscular Block Between 2nd Trimester Pregnant and Non-pregnant Women|Recruiting||N/A|90|Anticipated|Hallym University Kangnam Sacred Heart Hospital|||2||f||||f||||||||||2017-10-10 22:05:53.137359|2017-10-10 22:05:53.137359
NCT02797847|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-06-02|||May 2016||2016-05-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|April 2017|Actual|2017-04-01||Interventional|||A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects|A Phase 1, Randomized, Single-Blind, Placebo Controlled, Single-Ascending Dose, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Subcutaneously Administered ALN-TTRSC02 in Healthy Subjects|Active, not recruiting||Phase 1|110|Anticipated|Alnylam Pharmaceuticals||2|||f||||f||||||||Undecided||2017-10-10 22:05:53.314893|2017-10-10 22:05:53.314893
NCT02797834|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-20|||April 2016||2016-04-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|March 2017|Anticipated|2017-03-01||Observational|||Isolation and Characterization of the Extracellular Vesicles Secreted by the Human Endometrium|Isolation and Characterization of the Extracellular Vesicles Secreted by the Human Endometrium to the Endometrial Fluid|Recruiting||N/A|300|Anticipated|Igenomix|||1||f||||f||||||Samples With DNA|"     DNA, RNA, proteins, lipids and other metabolits will be analyzed in the different samples of     the endometrial fluid.      These samples will be completely exhausted during the analysis.   "|No||2017-10-10 22:05:53.466508|2017-10-10 22:05:53.466508
NCT02797821|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-11|||June 2016|Actual|2016-06-01|September 2017|2017-09-01||||June 2017|Actual|2017-06-01||Interventional|||Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)|A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia|Completed||Phase 2|27|Actual|Alexion Pharmaceuticals||3|||f||||f||||||||||2017-10-10 22:05:53.600812|2017-10-10 22:05:53.600812
NCT02797808|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-10-04|||August 2013||2013-08-01|October 2017|2017-10-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Effects of Sertraline on Brain Connectivity in Adolescents With OCD|Effects of Sertraline on Brain Connectivity in Adolescents With OCD (Obsessive-Compulsive Disorder)|Completed||Phase 1/Phase 2|41|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 22:05:53.724266|2017-10-10 22:05:53.724266
NCT02797795|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-03-02|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers|A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered NEV801 in Subjects With Advanced Malignancies|Recruiting||Phase 1|78|Anticipated|Neovia Oncology Ltd.||1|||f||||t|t|||||||No||2017-10-10 22:05:53.858994|2017-10-10 22:05:53.858994
NCT02797782|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-06-17|||June 2016||2016-06-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Study of the Long Term Efficacy of Recombinant Hepatitis B Vaccine in Nile Delta of Egypt|Study of the Long Term Efficacy of Recombinant Hepatitis B Vaccine in Young Adults 20-22 Years After the Primary Vaccination in Nile Delta of Egypt|Recruiting||N/A|200|Anticipated|Tanta University|||1||f||||t||||||||Undecided||2017-10-10 22:05:53.97364|2017-10-10 22:05:53.97364
NCT02797769|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-07-01|||August 2015||2015-08-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||A Time to Cardiovascular Event Analysis Comparing Tocilizumab to Other Biologics in Patients With Rheumatoid Arthritis (RA)|Risk of Cardiovascular Events in Patients Using Tocilizumab as Compared With Other Biologics in Multiple Large Healthcare Databases|Not yet recruiting||N/A|75000|Anticipated|Hoffmann-La Roche|||3||f||||||||||||||2017-10-10 22:05:54.089029|2017-10-10 22:05:54.089029
NCT02797561|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-23|||July 2016||2016-07-01|June 2016|2016-06-01|June 2023|Anticipated|2023-06-01|June 2020|Anticipated|2020-06-01||Observational|IRISFFRTandem||Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions|A Multicenter, Prospective Cohort to Evaluate the Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions|Not yet recruiting||N/A|1000|Anticipated|Asan Medical Center|||1||f||||f||||||||No|This is not a publicly funded trial.|2017-10-10 22:05:55.745794|2017-10-10 22:05:55.745794
NCT02797756|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-03-17|||June 2014||2014-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough|Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough|Recruiting||N/A|120|Anticipated|New York University School of Medicine|||2||f||||f||||||Samples Without DNA|"     Case: CC/GER+ presence of chronic cough and presence of GER evidenced by     esophago-gastro-duodenoscopy (EGD) with biopsy and Esophageal Impedance Monitoring (EIM)     Control: CC/GER- presence of chronic cough and absence of GER by esophago-gastro-duodenoscopy     (EGD) with biopsy and Esophageal Impedance Monitoring (EIM)   "|||2017-10-10 22:05:54.174058|2017-10-10 22:05:54.174058
NCT02797743|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-15|||July 2015||2015-07-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|||Whole Blood Specimen Collection From Healthy Subjects|Whole Blood Specimen Collection From Healthy Subjects|Recruiting||N/A|750|Anticipated|Progenity, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood samples   "|No||2017-10-10 22:05:54.274564|2017-10-10 22:05:54.274564
NCT02797730|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-10-10|||May 2016||2016-05-01|June 2016|2016-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|EDUCARTPED||Study of Impact of Art Therapy Sessions Given to Family Caregivers of Children With Type 1 Diabetes||Completed||N/A|40|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 22:05:54.371637|2017-10-10 22:05:54.371637
NCT02797717|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-06-13|||November 2015||2015-11-01|June 2016|2016-06-01|December 2027|Anticipated|2027-12-01|December 2022|Anticipated|2022-12-01||Interventional|EuroNet-PHL-C2||Treatment for Classical Hodgkin Lymphoma in Children and Adolescents|An International, Multicentre, Randomised Controlled Trial. Treatment for Classical Hodgkin Lymphoma in Children and Adolescents Standard Treatment (Chemotherapy and RT) Compared With Experimental Treatment (Chemotherapy Without RT or Restricted to RT)|Recruiting||N/A|2200|Anticipated|Rabin Medical Center||2|||f||||t||||||||No||2017-10-10 22:05:54.471372|2017-10-10 22:05:54.471372
NCT02797704|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-07-17|||September 2016||2016-09-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization||Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-10 22:05:54.582248|2017-10-10 22:05:54.582248
NCT02797691|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-08-15|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Developing and Testing of Culturally Adapted Cognitive Behavior Therapy (CaCBT) for Pashto Speaking Pakistanis and Afghans|Developing and Testing of Culturally Adapted Cognitive Behavior Therapy (CaCBT) for Pashto Speaking Pakistanis and Afghans|Completed||N/A|40|Actual|Peshawar Medical College||2|||f||||f||||||||No||2017-10-10 22:05:54.662706|2017-10-10 22:05:54.662706
NCT02797678|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-18|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:05:54.740892|2017-10-10 22:05:54.740892
NCT02797665|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-08|||May 2016||2016-05-01|June 2016|2016-06-01||||April 2019|Anticipated|2019-04-01||Interventional|||Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids||Recruiting||N/A|40|Anticipated|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 22:05:54.779769|2017-10-10 22:05:54.779769
NCT02797652|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-11|||May 2016||2016-05-01|June 2016|2016-06-01||||April 2018|Anticipated|2018-04-01||Observational|||Clinical Application of CTDNA in Operable Breast Cancer Patients|Clinical Application of CTDNA in Operable Breast Cancer Patients|Recruiting||N/A|60|Anticipated|Peking Union Medical College Hospital|||2||f||||||||||||||2017-10-10 22:05:55.016472|2017-10-10 22:05:55.016472
NCT02797639|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2016-06-10|||September 2014||2014-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Interventional|||Collaborative Consultation for Participation Among Students With IDD|The Effectiveness of Collaborative Consultation for Participation Among Students With Moderate Intellectual Disability (Co-PID)|Completed||N/A|60|Actual|Ono Academic College||2|||f||||f||||||||No||2017-10-10 22:05:55.127398|2017-10-10 22:05:55.127398
NCT02797626|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-10|||June 2016||2016-06-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)|Phase II Single-arm Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)|Recruiting||Phase 2|30|Anticipated|Heinrich-Heine University, Duesseldorf||1|||f||||t||||||||Undecided||2017-10-10 22:05:55.23025|2017-10-10 22:05:55.23025
NCT02797613|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-05-18|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Restricted Reporting for Positive Urine Cultures|Restricted Reporting for Positive Urine Cultures Randomized Controlled Trial|Completed||N/A|110|Actual|Memorial University of Newfoundland||2|||f||||f|f|f||||||No||2017-10-10 22:05:55.330331|2017-10-10 22:05:55.330331
NCT02797600|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-06-07|||June 2011||2011-06-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Community Awareness, Resources and Education (CARE II) Project: Project 1|Community Awareness, Resources and Education (CARE II) Project: Project 1|Completed||N/A|285|Actual|Ohio State University Comprehensive Cancer Center|||3||f||||f||||||Samples With DNA|"     Plasma, serum, saliva samples, buccal scrapes, oral rinse, tissue.   "|||2017-10-10 22:05:55.42097|2017-10-10 22:05:55.42097
NCT02797587|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-07-19|||July 19, 2017|Actual|2017-07-19|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|St PETER HIV||Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)|URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities With Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected Russians|Recruiting||Phase 2/Phase 3|400|Anticipated|Boston Medical Center||4|||f||||t|f|f||||||||2017-10-10 22:05:55.518565|2017-10-10 22:05:55.518565
NCT02797574|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-12-16|||October 2015||2015-10-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Stress Response Pathways in Vitiligo|Stress Response Pathways in Vitiligo: A Prospective, Investigator Initiated, Interventional Study With Two Arms|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:05:55.650256|2017-10-10 22:05:55.650256
NCT02797548|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-06-14|||March 16, 2017|Actual|2017-03-16|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|June 30, 2020|Anticipated|2020-06-30||Interventional|ASSURE-DES||Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery|Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery|Recruiting||Phase 4|2000|Anticipated|Asan Medical Center||2|||f||||t|f|f||||||Undecided||2017-10-10 22:05:55.855957|2017-10-10 22:05:55.855957
NCT02797535|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-09-17|||July 2016||2016-07-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|CLARINET||GI Fluids Collection for an Ex-Vivo Development of Ingestible Capsule Devices With Real Time Biosensors|GI Fluids Collection for an Ex-Vivo Development of Ingestible Capsule Devices With Real Time Biosensors|Recruiting||N/A|500|Anticipated|Medtronic - MITG||1|||f||||f||||||||||2017-10-10 22:05:55.979267|2017-10-10 22:05:55.979267
NCT02797522|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-01-04|||June 2016||2016-06-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B|A Sequential Phase 1a/1b Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ARC-521 in Normal Adult Volunteers and Patients With Chronic Hepatitis B|Terminated||Phase 1|47|Actual|Arrowhead Pharmaceuticals||3||Company decision to discontinue trial|f||||f||||||||No||2017-10-10 22:05:56.085877|2017-10-10 22:05:56.085877
NCT02797509|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-07|||July 2016||2016-07-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Preventing Chronic Depression and PTSD in Stroke Patients Admitted to the Neuroscience Intensive Care Unit (NICU) and Their Family Caregivers|Preventing Chronic Depression and PTSD in Patients With Stroke Admitted to the Neuroscience ICU and Their Family Caregivers|Not yet recruiting||N/A|200|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:05:56.190492|2017-10-10 22:05:56.190492
NCT02797496|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-08|||December 2010||2010-12-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|ASYMOT||Comparison of Two Rehabilitation Programs in Patients With Mild to Moderate Parkinson's Disease.|Comparison of Two Rehabilitation Programs in Patients With Mild to Moderate Parkinson's Disease. A Randomized, Controlled Study.|Completed||N/A|39|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-10 22:05:56.295589|2017-10-10 22:05:56.295589
NCT02797483|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-10|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Multi-country Study- Effect of Dietary Fats on Fat Deposition|Multi-country Studies on the Effect of Positional Distribution of Fatty Acids at the Triglyceride Backbone of Vegetable Oils on Fat Deposition and Selected Health Outcome Measures - Malaysia|Completed||N/A|102|Actual|Malaysia Palm Oil Board||3|||f||||f||||||||Undecided||2017-10-10 22:05:56.419439|2017-10-10 22:05:56.419439
NCT02797470|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-07-14|||May 2016||2016-05-01|December 2016|2016-12-01||||September 2019|Anticipated|2019-09-01||Interventional|||Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant|Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells|Suspended||Phase 1/Phase 2|18|Anticipated|AIDS Malignancy Consortium||1||Temporarily suspended due to manufacturing issues|f||||t||||||||||2017-10-10 22:05:56.555454|2017-10-10 22:05:56.555454
NCT02797457|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2025|Anticipated|2025-09-01|September 2020|Anticipated|2020-09-01||Interventional|ARMEDIC||Medical Economic Evaluation of Bilateral Allograft of Hands and Forearms|Medical Economic Evaluation of Bilateral Allograft of Hands and Forearms|Not yet recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||2|||f||||t|f|f||||||||2017-10-10 22:05:56.792938|2017-10-10 22:05:56.792938
NCT02797444|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-27|||September 2015|Actual|2015-09-01|February 2016|2016-02-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Advance Care Planning for Critical Care - A Prelude to Breaking Barriers|Advance Care Planning for Critical Care - A Prelude to Breaking Barriers|Completed||N/A|30|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-10 22:05:56.879178|2017-10-10 22:05:56.879178
NCT02797431|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-02|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|IRIS-7a||Immune Reconstitution of Immunosuppressed Sepsis Patients|A Multicenter, Randomized, Double-blinded, Placebo-controlled Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients|Recruiting||Phase 2|15|Anticipated|University Hospital, Limoges||3|||f||||t||||||||No||2017-10-10 22:05:56.975121|2017-10-10 22:05:56.975121
NCT02797418|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|COGNITUS||"Cognitus & Moi: a New Cognitive Remediation Tool"|"Cognitus & Moi: a New Cognitive Remediation Tool for Children With Intellectual Deficiency With Behavioral Disorders"|Recruiting||N/A|72|Anticipated|Hôpital le Vinatier||2|||f||||f||||||||No||2017-10-10 22:05:57.11012|2017-10-10 22:05:57.11012
NCT02797405|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-01-17|||October 2016||2016-10-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|THEODORA||Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay|Evaluation of Individual Radiosensitivity of Cancer Patients to be Treated by Radiotherapy or Radiochemotherapy Per-operative|Recruiting||N/A|100|Anticipated|Centre Leon Berard||1|||f||||f||||||||No||2017-10-10 22:05:57.224977|2017-10-10 22:05:57.224977
NCT02797392|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-05-05|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|February 28, 2017|Actual|2017-02-28||Interventional|||Feasibility of a Preventive Program Against Lifestyle Related Diseases|Early Detection and Prevention of Lifestyle Related Diseases - a Pilot Study|Active, not recruiting||N/A|9400|Actual|University of Southern Denmark||1|||f||||t||||||||No||2017-10-10 22:05:57.950553|2017-10-10 22:05:57.950553
NCT02797379|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-07-12|||September 2016|Actual|2016-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|MANAGE||The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders|The Development of a Psychoeducation Tool to Manage Anxiety in People With Autism Spectrum Disorders: the Managing Anxiety iN Autism GuidE (MANAGE)|Recruiting||N/A|35|Anticipated|King's College London||2|||f||||f|f|f||||||||2017-10-10 22:05:58.103286|2017-10-10 22:05:58.103286
NCT02797366|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-07|||August 2015||2015-08-01|June 2016|2016-06-01|July 2030|Anticipated|2030-07-01|July 2020|Anticipated|2020-07-01||Interventional|PRO-CNS||Proton Radiotherapy for Primary Central Nervous System Tumours in Adults|Proton Radiotherapy for Primary Central Nervous System Tumours in Adults - a Prospective Swedish Multicentre Study|Recruiting||Phase 2|500|Anticipated|Uppsala University||1|||f||||f||||||||||2017-10-10 22:05:58.241873|2017-10-10 22:05:58.241873
NCT02797353|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-02-02|||January 2013||2013-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|SRC||Strengthening Maternal Neonatal and Child Health Services in a Rural District of Pakistan|Strengthening Maternal Neonatal and Child Health Services in a Rural District of Pakistan|Completed||N/A|15000|Actual|Aga Khan University||2|||f||||t||||||||Yes||2017-10-10 22:05:58.528076|2017-10-10 22:05:58.528076
NCT02797340|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|MetKin||Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure|Metformin in Patients With Chronic and Acute Heart Failure: Pharmacokinetics and Polymorphisms in Genes Encoding Membrane Metformin Transporter Proteins|Recruiting||Phase 4|162|Anticipated|Aarhus University Hospital||1|||f||||||||||||||2017-10-10 22:05:58.632936|2017-10-10 22:05:58.632936
NCT02797327|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-06-07|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|March 2017|Actual|2017-03-01||Observational|MSP||Molecular Signature Pregnancy|Molecular Signature of Karen and Burmese Pregnant Women on the Thailand-Myanmar Border|Recruiting||N/A|400|Anticipated|University of Oxford|||1||f||||f||||||Samples With DNA|"     Blood sample, vaginal swab and stool specimen will be collected.   "|Yes||2017-10-10 22:05:58.724899|2017-10-10 22:05:58.724899
NCT02797314|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-05-30|||March 28, 2017|Actual|2017-03-28|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|DIABONE||Comparison of Bone Quality in Type 2 Diabetic Patients With a Non-diabetic Control Population|Comparison of Bone Quality in Type 2 Diabetic Patients With a Non-diabetic Control Population|Recruiting||N/A|184|Anticipated|Hospices Civils de Lyon||2|||f||||f|f|f||||||||2017-10-10 22:05:58.812779|2017-10-10 22:05:58.812779
NCT02797301|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-07|||September 2010||2010-09-01|June 2016|2016-06-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|||A Computerised Test for Assessing the Early Reading Skills|A Computerised Test for Assessing the Early Reading Skills of Children With Mobility Limitations|Completed||N/A|40|Actual|University of Mogi das Cruzes||3|||f||||t||||||||No||2017-10-10 22:05:58.908321|2017-10-10 22:05:58.908321
NCT02797288|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-02-12|||July 2016||2016-07-01|February 2017|2017-02-01|March 2021|Anticipated|2021-03-01|May 2018|Anticipated|2018-05-01||Observational|||Immune Response to FMT for C.Difficile|Role of Eosinophils in Innate Protection From C. Difficile|Recruiting||N/A|10|Anticipated|University of Virginia|||1||f||||f||||||Samples With DNA|"     Colon biopsies   "|No||2017-10-10 22:05:58.997678|2017-10-10 22:05:58.997678
NCT02797275|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-07-01|||March 2013||2013-03-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||Secondhand Smoke Respiratory Health Study|Lung Anatomic, Physiologic, and Inflammatory Changes With Chronic Exposure to Secondhand Tobacco Smoke|Recruiting||Phase 4|225|Anticipated|University of California, San Francisco||2|||f||||f||||||||Undecided||2017-10-10 22:05:59.097764|2017-10-10 22:05:59.097764
NCT02797262|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-07|||September 2015||2015-09-01|June 2016|2016-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System|Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System|Recruiting||N/A|165|Anticipated|University of California, Los Angeles||2|||f||||t||||||||Yes|De-identified individual participant data for all primary and secondary outcome measures will be made available within 6 months of study completion.|2017-10-10 22:05:59.234188|2017-10-10 22:05:59.234188
NCT02797249|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|APPEC||Low Dose Aspirin in the Prevention of Preeclampsia in China|Low Dose Aspirin in the Prevention of Preeclampsia in Chinese Pregnant Women.|Recruiting||Phase 3|1000|Anticipated|Peking University First Hospital||2|||f||||t||||||||No||2017-10-10 22:05:59.348072|2017-10-10 22:05:59.348072
NCT02797236|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers|A Phase I Dose Escalation Study to Assess the Safety and Immunogenicity of the SF2a-TT15 Conjugate Vaccine Against S. Flexneri 2a in Healthy Adult Volunteers|Not yet recruiting||Phase 1|64|Anticipated|Institut Pasteur||6|||f||||t||||||||||2017-10-10 22:05:59.502272|2017-10-10 22:05:59.502272
NCT02797223|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-10|||June 2016||2016-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||"Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"|"Impacto de la Alopecia Inducida Por Quimioterapia en la Calidad de Vida de Mujeres Con cáncer de Mama"|Recruiting||N/A|15|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||Undecided||2017-10-10 22:05:59.639977|2017-10-10 22:05:59.639977
NCT02797210|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01||||May 2017|Anticipated|2017-05-01||Interventional|OFC-rTMS||Examining the Efficacy of Orbitofrontal Cortex rTMS for Depression|Efficacy of Orbital Frontal Cortex Repetitive Transcranial Magnetic Stimulation Magnetic Stimulation in the Treatment of Refractory Depression|Recruiting||N/A|50|Anticipated|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 22:05:59.754501|2017-10-10 22:05:59.754501
NCT02797197|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-26|||May 18, 2016|Actual|2016-05-18|September 2017|2017-09-01|February 15, 2017|Actual|2017-02-15|September 1, 2016|Actual|2016-09-01||Interventional|FIGHTDIGO||Feasibility of Systematic Handgrip Strength (HGS) Testing and Short-term Changes in Muscle Strength in Digestive Cancer Patients Treated by Chemotherapy|Feasibility of Systematic Handgrip Strength (HGS) Testing and Short-term Changes in Muscle Strength in Digestive Cancer Patients Treated by Chemotherapy|Completed||N/A|201|Actual|CHU de Reims||1|||f||||f||||||||||2017-10-10 22:05:59.876788|2017-10-10 22:05:59.876788
NCT02797184|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-05-10|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2025|Anticipated|2025-12-01|December 2023|Anticipated|2023-12-01||Interventional|iNIX-HF||Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF)|Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF)|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|Washington University School of Medicine||7|||f||||t|t|f||||||Yes|HIPPA-related data will not be available for publishing. Study results will be published in accordance with journal, institution, and HIPPA guidelines.|2017-10-10 22:05:59.986109|2017-10-10 22:05:59.986109
NCT02796989|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-10|||March 2016||2016-03-01|June 2016|2016-06-01||||September 2018|Anticipated|2018-09-01||Interventional|||The Impact of Modified Wheat Bran on Carbohydrate Fermentation in the Colon in Healthy and Obese Subjects||Recruiting||Phase 1/Phase 2|100|Anticipated|Katholieke Universiteit Leuven||4|||f||||f||||||||||2017-10-10 22:06:01.716445|2017-10-10 22:06:01.716445
NCT02797171|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-04-12|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults|A Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Viral Activity of VRCHIVMAB060-00-AB (VRC01) and VRC-HIVMAB080-00-AB (VRC01LS) in the Serum and Mucosa of Healthy, HIV-Uninfected Adult Participants|Recruiting||Phase 1|101|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t|t|f||||||||2017-10-10 22:06:00.140826|2017-10-10 22:06:00.140826
NCT02797158|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|REVASC-TAVI||Post TAVI Coronary REVASCularisation Guided by Myocardial Perfusion Imaging: a Prospective Open Label Pilot Study: The REVASC-TAVI Study||Not yet recruiting||Phase 2|71|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-10 22:06:00.303631|2017-10-10 22:06:00.303631
NCT02797145|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-10|||May 2016||2016-05-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|ICHF||Intensive Versus Conventional Digoxin Use in Patients With Heart Failure|Intensive Versus Conventional Digoxin Use in Patients With Heart Failure: a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|200|Anticipated|Hospital Ana Nery||2|||f||||t||||||||Undecided||2017-10-10 22:06:00.44439|2017-10-10 22:06:00.44439
NCT02797132|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-12|||May 2016||2016-05-01|August 2017|2017-08-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del|A Phase 3, 2-Part, Open-label Study to Evaluate the Safety and Pharmacokinetics of Lumacaftor/Ivacaftor Combination Therapy in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation|Completed||Phase 3|60|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||t||||||||||2017-10-10 22:06:00.577452|2017-10-10 22:06:00.577452
NCT02797119|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-30|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|TRACES||Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery|Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery: a Multicenter Randomized Double Blind Placebo Controlled Therapeutic and Pharmaco-biological Dose Ranging Study (TRACES) for Its Optimal Benefit/Risk|Recruiting||Phase 4|390|Anticipated|University Hospital, Lille||4|||f||||f|f|f||||||Undecided||2017-10-10 22:06:00.744424|2017-10-10 22:06:00.744424
NCT02797106|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-10|||April 2013||2013-04-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|TOXSIALO||Management of Drooling in Children With Cerebral Palsy in France|Management of Drooling in Children With Cerebral Palsy: A French Survey of the Practices and Opinions of Health Professionals|Completed||N/A|400|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:06:00.891663|2017-10-10 22:06:00.891663
NCT02797093|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01|6 Months|Observational [Patient Registry]|||Impact of ART Adherence on HIV Persistence and Inflammation|Impact of ART Adherence on HIV Persistence and Inflammation|Recruiting||N/A|100|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     The aim of the study is to quantify levels of CA-RNA, CA-DNA, and plasma residual viremia in     suppressed, HIV infected individuals and correlate them with levels of TFV-DP in DBS as a     measure of cumulate drug exposure (adherence). Second, the investigators will evaluate the     changes in the HIV reservoir in relation to changes in ART adherence over time.   "|No||2017-10-10 22:06:00.955258|2017-10-10 22:06:00.955258
NCT02797080|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-04-19|||June 2016||2016-06-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||STEADFAST Long-Term Safety Extension|Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia|Completed||Phase 3|38|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||1|||f||||f||||||||||2017-10-10 22:06:01.030715|2017-10-10 22:06:01.030715
NCT02797067|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-11-15|||September 2016||2016-09-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Rectal Indomethacin to Prevent Post ESWL-pancreatitis||Recruiting||Phase 4|1116|Anticipated|Changhai Hospital||2|||f||||f||||||||No||2017-10-10 22:06:01.136027|2017-10-10 22:06:01.136027
NCT02797054|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-06-26|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Educational Intervention to Improve HPV Vaccination Decision Quality|Culturally Tailored Educational Intervention to Improve Decision Quality Around Humanpapillomavirus (HPV) Vaccination|Completed||N/A|1205|Actual|University of Colorado, Denver||3|||f||||f||||||||No||2017-10-10 22:06:01.226293|2017-10-10 22:06:01.226293
NCT02797041|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-13|||August 2015||2015-08-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|March 2016|Actual|2016-03-01||Observational|REBOUND||Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.|REal Life, Retrospective Study of BOrtezomib Use as secoND Treatment for Myeloma Patients Previously Exposed to Bortezomib-based Therapies as First Line|Active, not recruiting||N/A|100|Anticipated|IRCCS Centro di Riferimento Oncologico della Basilicata|||1||f||||t||||||||Yes|Central database of single patients|2017-10-10 22:06:01.320973|2017-10-10 22:06:01.320973
NCT02797028|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-07|||January 2015||2015-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines||Recruiting||Phase 4|320|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||3|||f||||t||||||||||2017-10-10 22:06:01.386064|2017-10-10 22:06:01.386064
NCT02797015|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-13|||June 23, 2016|Actual|2016-06-23|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS|A Phase I, Multicenter, Randomized, 12-Week, Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics and Pharmacodynamics of RPC 1063 in Patients With Relapsing Multiple Sclerosis|Active, not recruiting||Phase 1|24|Anticipated|Celgene||2|||f||||f||||||||||2017-10-10 22:06:01.486071|2017-10-10 22:06:01.486071
NCT02797002|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Observational|||Validity of Neck Extensor Muscles Endurance Test in Non-specific Chronic Neck Pain and Asymptomatic Subjects||Recruiting||N/A|60|Anticipated|University of Social Welfare and Rehabilitation Science|||2||f||||||||||||||2017-10-10 22:06:01.583885|2017-10-10 22:06:01.583885
NCT02796976|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-05-02|||March 2016||2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ExAMIN AGE||Exercise, Arterial Cross-Talk Modulation and Inflammation in an Ageing Population|Exercise, Arterial Cross-Talk Modulation and Inflammation in an Ageing Population (ExAMIN AGE)|Recruiting||N/A|180|Anticipated|University of Basel||3|||f||||t||||||||No||2017-10-10 22:06:01.854207|2017-10-10 22:06:01.854207
NCT02796963|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-13|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||Crowdsourcing A Public Health Campaign|IGHID 11604 - Crowdsourcing to Promote HIV Testing: A Stepped Wedge Randomized Controlled Trial to Evaluate Promoting HIV Testing in China|Active, not recruiting||N/A|1381|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 22:06:02.011189|2017-10-10 22:06:02.011189
NCT02796950|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-07|||June 2016||2016-06-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion|The Effect of Acipimox on GLP-1 Secretion in Healthy Subjects: a Pilot Study|Not yet recruiting||N/A|8|Anticipated|University of Aarhus||2|||f||||f||||||||No||2017-10-10 22:06:02.143542|2017-10-10 22:06:02.143542
NCT02796937|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-12-01|||July 2016||2016-07-01|December 2016|2016-12-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|SPARTA-OLE||Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency|An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency|Enrolling by invitation||Phase 3|250|Anticipated|Grifols Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 22:06:02.255105|2017-10-10 22:06:02.255105
NCT02796924|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-07|||June 2016||2016-06-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Treating Non-epileptic Seizures Using Magnetic Brain Stimulation|The Efficacy of Transcranial Magnetic Stimulation in the Treatment of Non-epileptic Seizures|Not yet recruiting||N/A|15|Anticipated|University of Manitoba||1|||f||||f||||||||No||2017-10-10 22:06:02.571002|2017-10-10 22:06:02.571002
NCT02796911|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-10|||September 2015||2015-09-01|June 2016|2016-06-01||||August 2016|Anticipated|2016-08-01||Interventional|||Comparative Study of Different Bone Grafts in Accelerating Tooth Movement|Effectiveness of Bovine Derived Xenograft Versus Bioactive Glass With Periodontally Accelerated Osteogenic Orthodontics in Adults|Recruiting||N/A|30|Anticipated|King Abdulaziz University||3|||f||||t||||||||Undecided||2017-10-10 22:06:02.650735|2017-10-10 22:06:02.650735
NCT02796898|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-09-09|||June 2016||2016-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer|A Phase 1b/2, Open-Label, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of SM88 in Patients With Prostate Cancer|Recruiting||Phase 1/Phase 2|42|Anticipated|Tyme, Inc||1|||f||||t||||||||||2017-10-10 22:06:02.761445|2017-10-10 22:06:02.761445
NCT02796885|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Characterisation of Adult-Onset Hypophosphatasia|Characterisation of Adult-Onset Hypophosphatasia|Not yet recruiting||N/A|250|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||3||f||||f||||||Samples With DNA|"     Serum, plasma, urine, whole blood for DNA   "|||2017-10-10 22:06:02.918434|2017-10-10 22:06:02.918434
NCT02796872|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-07-17|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of Feeding Infant Formula With Bimuno Galactooligosaccharide (GOS)|The Effect of Feeding Infant Formula With Bimuno Galactooligosaccharide (GOS)|Completed||N/A|392|Actual|Clasado||4|||f||||t||||||||||2017-10-10 22:06:03.024686|2017-10-10 22:06:03.024686
NCT02796859|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-26|||May 2016||2016-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Siltuximab in Schizophrenia|A Randomized Controlled Trial of Adjunctive Siltuximab in Schizophrenia|Recruiting||Phase 1/Phase 2|30|Anticipated|Augusta University||2|||f||||t||||||||Yes||2017-10-10 22:06:03.114589|2017-10-10 22:06:03.114589
NCT02796846|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-10|||June 2015||2015-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||The Association of CPAP Compliance Study|The Association of CPAP Compliance and Nocturnal Hypoxemia in the Perioperative Period|Recruiting||N/A|108|Anticipated|University Health Network, Toronto|||2||f||||f||||||||No||2017-10-10 22:06:03.262732|2017-10-10 22:06:03.262732
NCT02796833|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-10|||April 2016||2016-04-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of Two Intravenous Lipid Emulsions in Home Parenteral Nutrition Patients|A Randomized Controlled Trial Comparing Two Commercially Available Lipid Emulsions in Patients Receiving Home Parenteral Nutrition - SMOF Versus Intralipid|Not yet recruiting||Phase 4|50|Anticipated|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 22:06:03.40022|2017-10-10 22:06:03.40022
NCT02796820|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery|Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery|Recruiting||Phase 3|230|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||Yes|The investigators would like to share the data to the Participating units.|2017-10-10 22:06:03.51051|2017-10-10 22:06:03.51051
NCT02796807|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-04-24|||May 2016||2016-05-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer|Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer|Enrolling by invitation||Phase 2|150|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||1|||f||||f||||||||No||2017-10-10 22:06:03.608184|2017-10-10 22:06:03.608184
NCT02796794|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-06-07|||June 2015||2015-06-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of Enteral Genistein Supplementation in Sepsis|Effect of Enteral Genistein Supplementation on Inflammatory Cytokines, Morbidity and Mortality in Patients With Sepsis|Recruiting||Phase 4|30|Anticipated|TC Erciyes University||2|||f||||f||||||||Undecided||2017-10-10 22:06:03.681539|2017-10-10 22:06:03.681539
NCT02796768|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-07|||December 2014||2014-12-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Automatic Characterization of the Neonatal Hip Using Ultrasound Imaging|Automatic Characterization of the Neonatal Hip Using Ultrasound Imaging|Recruiting||N/A|75|Anticipated|British Columbia Children's Hospital|||1||f||||f||||||||No||2017-10-10 22:06:03.890585|2017-10-10 22:06:03.890585
NCT02796755|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-04-19|||April 2016||2016-04-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation|Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation|Recruiting||Phase 4|40|Anticipated|Emory University||2|||f||||t||||||||No||2017-10-10 22:06:04.008928|2017-10-10 22:06:04.008928
NCT02796742|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-28|||June 2015||2015-06-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|SSTIs||S. Aureus, Skin and Soft Tissue Infections|Prevalence of S. Aureus Among Patients Presenting With Skin and Soft Tissue Infections: a Multi-centre Pilot Study in Europe|Completed||N/A|249|Actual|Hospices Civils de Lyon|||4||f||||f||||||||||2017-10-10 22:06:04.165369|2017-10-10 22:06:04.165369
NCT02796729|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-01-30|||October 2016||2016-10-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||CEST- Glucose Enhanced MRI for Metastatic Brain Tumours|Detection of Metastatic Brain Tumours Using Dynamic Glucose Enhanced MRI After D-glucose Injection|Recruiting||Phase 2|20|Anticipated|British Columbia Cancer Agency||1|||f||||t||||||||No|Only participants (and their most responsible physician with permission) have the option of receiving their own personal data.|2017-10-10 22:06:04.27834|2017-10-10 22:06:04.27834
NCT02796716|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-02-01|||July 2015||2015-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections|Rapid Microbiological Diagnostics for MDRO Quantitative Identification and Resistance Phenotyping to Guide Antibiotic Selection in Wounded Warriors and Veterans - Task 3|Completed||N/A|2102|Actual|Denver Health and Hospital Authority|||1||f||||f||||||||No||2017-10-10 22:06:04.386006|2017-10-10 22:06:04.386006
NCT02796703|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|July 2020|Anticipated|2020-07-01||Interventional|||Heat Killed Probiotics in the Prevention of Necrotizing Enterocolitis|Heat Killed Probiotics in the Prevention of Necrotizing Enterocolitis (NEC) in Premature Neonates|Not yet recruiting||Phase 2|450|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||No||2017-10-10 22:06:04.48218|2017-10-10 22:06:04.48218
NCT02796690|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-07|||April 2014||2014-04-01|June 2016|2016-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|SANAC||Staphylococcus Aureus Nasal Carriage|Staphylococcus Aureus Nasal Carriage Among Technical Staff of a Teaching Hospital: An Unexpected Group at Risk of Colonization|Completed||N/A|310|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:06:04.575826|2017-10-10 22:06:04.575826
NCT02796677|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-07-04|||July 5, 2016|Actual|2016-07-05|July 2017|2017-07-01|June 9, 2017|Actual|2017-06-09|June 9, 2017|Actual|2017-06-09||Interventional|||AMPLIFY - D6571C00001 Duaklir USA Phase III Study|A 24 Week Treatment, Multicenter, Randomized, Double Blinded, Double Dummy, Parallel-group, Clinical Trial Evaluating the Efficacy and Safety of Aclidinium Bromide 400 μg/Formoterol Fumarate 12 μg Fixed-dose Combination BID Compared With Each Monotherapy (Aclidinium Bromide 400 μg BID and Formoterol Fumarate 12 μg BID) and Tiotropium 18 μg QD When Administered to Patients With Stable Chronic Obstructive Pulmonary Disease.|Completed||Phase 3|1595|Actual|AstraZeneca||4|||||||f||||||||||2017-10-10 22:06:04.683374|2017-10-10 22:06:04.683374
NCT02796664|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-07-06|||June 2016||2016-06-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||Preventive Effects of Ginseng Against Atherosclerosis|Preventive Effects of Ginseng Against Atherosclerosis and Subsequent Ischemic Stroke: A Randomized Controlled Trial|Recruiting||Phase 4|58|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-10 22:06:05.129131|2017-10-10 22:06:05.129131
NCT02796651|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-04|||June 30, 2016|Actual|2016-06-30|July 2017|2017-07-01|December 7, 2016|Actual|2016-12-07|December 7, 2016|Actual|2016-12-07||Interventional|||Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb).|A Randomized, Double-blind, Placebo-controlled, Incomplete Unbalanced, Crossover Study to Assess the Efficacy and Safety of Three Doses of Formoterol Fumarate in Pressair® Compared With Perforomist® Inhalation Solution (20 and 40 μg Open-label) in Moderate to Severe COPD Patients With Reversible Airway Disease.|Completed||Phase 2|132|Actual|AstraZeneca||6|||f||||f||||||||||2017-10-10 22:06:05.227941|2017-10-10 22:06:05.227941
NCT02796638|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-06|||October 2015||2015-10-01|June 2016|2016-06-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|ASLEEP PK||Adaptive Servo-Ventilation In Acute Heart Failure Patients Protecting the Heart and Kidneys|Adaptive Servo-Ventilation In Acute Heart Failure Patients Protecting the Heart|Recruiting||N/A|66|Anticipated|Veterans Medical Research Foundation||2|||f||||t||||||||No|All data will be de-identified and used only within our local research group.|2017-10-10 22:06:05.3693|2017-10-10 22:06:05.3693
NCT02796625|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-07-19|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|APB||Alpha as a Predictive Biomarker|Development of a Reliable Neurophysiological Pain Assessment Tool: Alpha as a Predictive Biomarker|Recruiting||N/A|120|Anticipated|University of Maryland Baltimore Dental School||1|||f||||f||||||||No||2017-10-10 22:06:05.466401|2017-10-10 22:06:05.466401
NCT02796612|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-02-13|||April 2014||2014-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Empathy and Standard Diagnostic Procedures in an Outpatient Breast Clinic Might Not be Enough|Empathy and Standard Diagnostic Procedures in an Outpatient Breast Clinic Might Not be Enough|Recruiting||N/A|334|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||Yes||2017-10-10 22:06:05.545344|2017-10-10 22:06:05.545344
NCT02792244|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-20|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Observational|FiTMAI6||First Time Mothers and Anal Incontinence Six Years Postpartum|First Time Mothers and Anal Incontinence Six Years Postpartum|Completed||N/A|800|Actual|Ostfold Hospital Trust|||1||f||||f||||||||||2017-10-10 22:06:53.949775|2017-10-10 22:06:53.949775
NCT02796586|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-05-16|||July 2015||2015-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women|Salt Lake Refugee Women's Health Project-Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women|Completed||N/A|17|Actual|University of Utah||2|||f||||f||||||||No||2017-10-10 22:06:05.716789|2017-10-10 22:06:05.716789
NCT02796573|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-05-01|||March 2016||2016-03-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Blended Cognitive Behavioural Therapy Versus Face-to-face Cognitive Behavioural Therapy|Blended Cognitive Behavioural Therapy Versus Face-to-face Cognitive Behavioural Therapy: A Randomised Non-inferiority Trial|Recruiting||N/A|130|Anticipated|University of Southern Denmark||2|||f||||||||||||||2017-10-10 22:06:05.794165|2017-10-10 22:06:05.794165
NCT02796560|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-06|||July 2016||2016-07-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension|Randomized Crossover Trial Comparing the Hypotensive Effect of Generic Travoprost With That of the Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension|Not yet recruiting||Phase 4|76|Anticipated|Université de Sherbrooke||2|||f||||t||||||||Undecided||2017-10-10 22:06:05.867488|2017-10-10 22:06:05.867488
NCT02796547|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-04-11|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of Levobupivacaine Infiltration on the Post Partum Perineal Pain in Episiotomy, in Primiparous Women After Instrumental Delivery|Randomized Double Blind Clinical Trial on the Effect of Levobupivacaine Infiltration Versus Placebo on the Post Partum Perineal Pain in Episiotomy in Primiparous Women After Instrumental Delivery|Not yet recruiting||Phase 2|330|Anticipated|Brugmann University Hospital||2|||f||||f|f|f||||||||2017-10-10 22:06:05.970201|2017-10-10 22:06:05.970201
NCT02796534|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-07-08|||September 2014||2014-09-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|AT1Home||Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home)|Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home)|Recruiting||N/A|1025|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||No||2017-10-10 22:06:06.090983|2017-10-10 22:06:06.090983
NCT02796521|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-06|||March 2015||2015-03-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|NutriPratiC||Evaluation of Effectiveness of Nutritional Practical Counseling for Elderly Patients at Risk of Malnutrition on Nutritional Status at Home|Evaluation of the Effectiveness of Nutritional Practical Counseling for Elderly Patients at Risk of Malnutrition (and Their Caregivers) on Nutritional Status at Home|Enrolling by invitation||N/A|120|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||No||2017-10-10 22:06:06.185776|2017-10-10 22:06:06.185776
NCT02796508|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-10|||September 2015||2015-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Interventional|AGEGAME||Attention and Memory Training With Video Games in Old Age|Age-related Cognitive Decline: Effects of Video Game Training on Behavioral and Neuroimaging Measures of Attention and Memory|Active, not recruiting||N/A|75|Actual|Universidad Nacional de Educación a Distancia||2|||f||||t||||||||Undecided||2017-10-10 22:06:06.444122|2017-10-10 22:06:06.444122
NCT02796495|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-10|||May 2016||2016-05-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|EPIONE||Use of Hand Prosthesis With Direct Nerve Stimulation for Treatment of Phantom Limb Pain|Natural Sensory Feedback for Phantom Limb Modulation and Therapy|Recruiting||N/A|2|Anticipated|University of Lausanne Hospitals||1|||f||||f||||||||Yes|The laws on protection and data sharing is currently being analysed by one of the consortium partners|2017-10-10 22:06:06.575145|2017-10-10 22:06:06.575145
NCT02796482|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-09|||July 2016||2016-07-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||EnergieShake 1.5kcal Complete Acceptability and Tolerance Study|Open Label Study of Acceptability, Tolerance, and Compliance Using EnergieShake 1.5kcal Complete Nutritional Drink|Not yet recruiting||N/A|18|Anticipated|Anaiah Healthcare Pvt Ltd||1|||f||||f||||||||Yes||2017-10-10 22:06:06.706019|2017-10-10 22:06:06.706019
NCT02796469|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-06|||May 2015||2015-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis|Statistical Analysis Plan for an Individual Patient Data Meta-analysis of Ten Clinical Trials Comparing Drug Therapy in Patients With Severe Alcoholic Hepatitis|Completed||N/A|1974|Actual|University Hospital, Lille|||4||f||||f||||||||Undecided||2017-10-10 22:06:06.833698|2017-10-10 22:06:06.833698
NCT02796456|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-05-30|||April 2016||2016-04-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|OB-APE||Determination of Maternal and Neonatal Apelinemia in Obese Women During Pregnancy|Determination of Maternal and Neonatal Apelinemia in Obese Women During Pregnancy|Recruiting||N/A|120|Anticipated|University Hospital, Lille|||3||f||||f|f|f||||Samples With DNA|"     Placenta samples will be collected and RT-qPCR will be done to analyze RNA in each group.   "|Undecided||2017-10-10 22:06:06.95493|2017-10-10 22:06:06.95493
NCT02796443|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-14|||January 2006||2006-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|September 2015|Actual|2015-09-01||Observational|REWO||The Real World of Acute Cholecystitis|When Results of Randomised Controlled Trials and Population Based Studies do Not Reflect the Real World: A Cohort Study in Acute Cholecystitis|Completed||N/A|1729|Actual|Asklepios Klinik Langen|||4||f||||f||||||||Yes|Individual participant data (IPD) will be published on www.dkmic.de|2017-10-10 22:06:07.151575|2017-10-10 22:06:07.151575
NCT02796430|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-09-09|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|March 31, 2018|Anticipated|2018-03-31||Observational|ICALIC||The ICALIC International Multicentric Study|Clinical Evaluation of the Ease of Use of a New Indirect Calorimeter for Energy Expenditure Measurement in ICU Patients: The ICALIC International Multicentric Study|Recruiting||N/A|343|Anticipated|University Hospital, Geneva|||1||f||||t|f|f||||||||2017-10-10 22:06:07.280273|2017-10-10 22:06:07.280273
NCT02796417|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-06-06|||March 2012||2012-03-01|June 2016|2016-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CSrehacopSZ||The Efficacy of REHACOP Program in Schizophrenia|Implementation of REHACOP Cognitive Training Program in Schizophrenia|Completed||N/A|111|Actual|University of Deusto||2|||f||||t||||||||||2017-10-10 22:06:07.465281|2017-10-10 22:06:07.465281
NCT02796404|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-06|||August 2015||2015-08-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|NUUBO||Homebased Monitoring Cardiac Rehabilitation Program|Effectiveness of a Homebased Cardiac Rehabilitation Program of Mixed Surveillance Using NUUBO Monitoring Vest in Patients With Ischemic Heart Disease at Moderate Cardiovascular Risk|Recruiting||N/A|148|Anticipated|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||2|||f||||f||||||||No||2017-10-10 22:06:07.593409|2017-10-10 22:06:07.593409
NCT02796391|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-29|||August 29, 2017|Actual|2017-08-29|August 2017|2017-08-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Facilitating Smoking Cessation With Reduced Nicotine Cigarettes|Facilitating Smoking Cessation With Reduced Nicotine Cigarettes|Recruiting||Phase 2|220|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|t|f||||||||2017-10-10 22:06:07.769319|2017-10-10 22:06:07.769319
NCT02796378|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-01-03|||June 2016||2016-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LIFESTAT||Living With Statins - Interventional Exercise Study|Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being|Recruiting||Phase 4|30|Anticipated|University of Copenhagen||3|||f||||f||||||||No||2017-10-10 22:06:07.905338|2017-10-10 22:06:07.905338
NCT02796365|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-06-09|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|HF-PROACTIVE||Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy|Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy|Recruiting||N/A|30|Anticipated|Henry Ford Health System||2|||f||||f||||||||No||2017-10-10 22:06:08.071794|2017-10-10 22:06:08.071794
NCT02796352|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-08-16|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|February 16, 2017|Actual|2017-02-16||Interventional|||A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker Study|A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker Study|Terminated||Phase 2|1|Actual|University of Pittsburgh||1||Slow accrual.|f||||t||||||||||2017-10-10 22:06:08.194688|2017-10-10 22:06:08.194688
NCT02796339|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-08-30|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study on the Effectiveness of a Nutritional Supplement With Natural Mastiha in Inflammatory Bowel Diseases.|A Phase-II Clinical Trial on the Effectiveness of a Nutritional Supplement With Natural Mastiha in Inflammatory Bowel Diseases Patients.|Active, not recruiting||Phase 2|100|Anticipated|Harokopio University||2|||f||||f||||||||||2017-10-10 22:06:08.308576|2017-10-10 22:06:08.308576
NCT02796326|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-03-10|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Modified Endotracheal Balloon Dilator to Improve Patient Oxygenation and Allow Ventilation During Airway Procedures|Modified Endotracheal Balloon Dilator to Improve Patient Oxygenation and Allow Ventilation During Airway Procedures|Recruiting||N/A|20|Anticipated|University of Cape Town||1|||f||||f|f|f||||||Yes||2017-10-10 22:06:08.447112|2017-10-10 22:06:08.447112
NCT02796313|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-05-04|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|NOSH||Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities|Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities|Not yet recruiting||N/A|400|Anticipated|Washington State University||2|||f||||t|f|f||||||No||2017-10-10 22:06:08.563724|2017-10-10 22:06:08.563724
NCT02796300|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-09|||July 2016||2016-07-01|June 2016|2016-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters|Comparison of the Palindrome vs. BioFlo DuraMax Hemodialysis Catheters: A Prospective Randomized Trial|Not yet recruiting||Phase 4|60|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 22:06:08.676808|2017-10-10 22:06:08.676808
NCT02796287|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-07|||July 6, 2015|Actual|2015-07-06|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|September 1, 2017|Actual|2017-09-01||Interventional|||Longitudinal Monitoring of Cerebral Connectivity 3T MRI in Patients With a Transcient Global Amnesia|Longitudinal Monitoring of Cerebral Connectivity 3T MRI in Patients With a Transcient Global Amnesia|Active, not recruiting||N/A|45|Actual|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||||2017-10-10 22:06:08.782176|2017-10-10 22:06:08.782176
NCT02796274|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-03-01|||May 2016||2016-05-01|March 2017|2017-03-01||||April 2017|Anticipated|2017-04-01||Observational|||Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)|Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)|Recruiting||N/A|100|Anticipated|Santhera Pharmaceuticals|||1||f||||||||||||||2017-10-10 22:06:08.876741|2017-10-10 22:06:08.876741
NCT02796261|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-21|||July 2016||2016-07-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|STELLAR||Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients|A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy|Recruiting||Phase 3|280|Anticipated|Orbus Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 22:06:09.030214|2017-10-10 22:06:09.030214
NCT02796248|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-03-23|||May 2016||2016-05-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|STIGMA||STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide Study|STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide Study|Completed||N/A|380|Actual|McGill University Health Center|||1||f||||f||||||||No||2017-10-10 22:06:09.475927|2017-10-10 22:06:09.475927
NCT02796235|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-07|||November 2012||2012-11-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|November 2016|Anticipated|2016-11-01||Interventional|IMATEM||Prospective and Monocentric Study of the Incidence of Venous Thromboembolic Disease (VTE) in Spinal Cord Injury (SCI) Patient Between 3 and 12 Months After SCI|Prospective and Monocentric Study of the Incidence of Venous Thromboembolic Disease (VTE) in Spinal Cord Injury (SCI) Patient Between 3 and 12 Months After SCI|Recruiting||N/A|100|Anticipated|Nantes University Hospital||1|||f||||f||||||||No||2017-10-10 22:06:09.583738|2017-10-10 22:06:09.583738
NCT02796222|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-06|||April 2016||2016-04-01|June 2016|2016-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Factor Product Utilization and Health Outcomes in Patients With Hemophilia|Factor Product Utilization and Health Outcomes in Patients With Hemophilia A and B in Canada: An Observational Study of Real-world Outcomes|Recruiting||N/A|120|Anticipated|University of British Columbia|||4||f||||f||||||||No||2017-10-10 22:06:09.668373|2017-10-10 22:06:09.668373
NCT02796209|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-10-05|||May 2016||2016-05-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||Norepinephrine Transporter Blockade, Autonomic Failure|Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure|Recruiting||Phase 2|40|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 22:06:09.805823|2017-10-10 22:06:09.805823
NCT02796196|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-03-07|||May 2016||2016-05-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|April 30, 2017|Anticipated|2017-04-30||Observational|||Prescribed Physical Activity in Improving Sleep and Physical Performance in Patients Undergoing Stem Cell Transplant|Effects of Prescribed Physical Activity on Sleep and Performance in Hematopoietic Cell Transplantation Patients|Active, not recruiting||N/A|75|Actual|Stanford University|||1||f||||t||||||||||2017-10-10 22:06:09.895905|2017-10-10 22:06:09.895905
NCT02796183|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-09|||January 2015||2015-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema|The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema|Completed||N/A|20|Actual|Neon Hospital||1|||f||||f||||||||No||2017-10-10 22:06:10.00027|2017-10-10 22:06:10.00027
NCT02796170|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-04-27|||March 2016||2016-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes|Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes|Recruiting||Phase 4|40|Anticipated|Tulane University||2|||f||||f||||||||No||2017-10-10 22:06:10.071664|2017-10-10 22:06:10.071664
NCT02796157|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-05-11|||June 2016||2016-06-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions||Recruiting||N/A|950|Anticipated|Yonsei University||2|||f||||t||||||||Undecided||2017-10-10 22:06:10.158425|2017-10-10 22:06:10.158425
NCT02796144|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-08-08|||September 2016||2016-09-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|MELT||MEtformin and Lorcaserin for WeighT Loss in Schizophrenia|Metformin and Lorcaserin for Weight Loss in Schizophrenia|Recruiting||Phase 4|110|Anticipated|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-10 22:06:10.232856|2017-10-10 22:06:10.232856
NCT02796131|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-07|||July 2011||2011-07-01|June 2016|2016-06-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|||Safety, Tolerability, and Pharmacodynamics of RDX5791 in Healthy Volunteers|A Phase I, Single-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Different Multiple Dose Regimens of RDX5791 in Healthy Volunteers|Completed||Phase 1|105|Actual|Ardelyx||7|||f||||f||||||||||2017-10-10 22:06:10.353372|2017-10-10 22:06:10.353372
NCT02796118|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-08-25|||July 2006||2006-07-01|August 2016|2016-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly Subjects|ASP2151 Phase 1 Study - Multiple Oral Dosing Study in Healthy Non-elderly Male and Elderly Male Japanese Subjects-|Completed||Phase 1|36|Actual|Astellas Pharma Inc||6|||f||||f||||||||Undecided||2017-10-10 22:06:12.562988|2017-10-10 22:06:12.562988
NCT02796105|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-09-12|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|July 10, 2017|Actual|2017-07-10|July 2017|Actual|2017-07-01||Interventional|||Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors|Evaluation of Efficacy and Safety of Medroxiprogesterone Acetate (Progevera 10 mg®) Versus GnRh Antagonist (Orgalutran®) in Ovarian Stimulation Cycles of Oocyte Donors|Completed||Phase 4|232|Actual|Fundació Privada Eugin||2|||f||||||||||||||2017-10-10 22:06:12.682555|2017-10-10 22:06:12.682555
NCT02796092|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-02-28|2016-07-21||February 2014||2014-02-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Interventional||All the patients were women referred from a vascular surgeon, diagnosed of pelvic congestion syndrome and pelvic varices by transvaginal ultrasound Doppler aged over 18.|Fibered Platinum Coils vs Vascular Plugs in Pelvic Varices Embolization for the Treatment of Pelvic Congestion Syndrome|Fibered Platinum Coils vs Vascular Plugs in Pelvic Varices Embolization for the Treatment of Pelvic Congestion Syndrome|Completed||N/A|100|Actual|Group of Research in Minimally Invasive Techniques|"Analysis of cost dependent on the hospital/region/country. It cannot be extrapolated.
Small number of subjects to compare complication rate of both techniques."|2|||f||||t||||||||No||2017-10-10 22:06:12.792525|2017-10-10 22:06:12.792525
NCT02796079|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-04-04|||January 2015||2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications|A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications|Recruiting||Phase 1|240|Anticipated|The Third Affiliated Hospital of Southern Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:06:13.868685|2017-10-10 22:06:13.868685
NCT02796066|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-04-24|||June 2016||2016-06-01|April 2017|2017-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris|A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of TSN2898 Topical Gel for the Treatment of Acne Vulgaris|Withdrawn||Phase 2|0|Actual|Thesan Pharmaceuticals, Inc.||4||Protocol not approved|f||||f||||||||No||2017-10-10 22:06:13.980104|2017-10-10 22:06:13.980104
NCT02796053|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-02-14|||April 2016||2016-04-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment|Study to Assess Pharmacodynamics, Clinical Effects, Safety and Pharmacokinetics of TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Concomitant Therapy|Completed||Phase 1/Phase 2|9|Actual|Theramab LLC||2|||f||||f||||||||Undecided||2017-10-10 22:06:14.105728|2017-10-10 22:06:14.105728
NCT02796040|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-06-10|||February 2016||2016-02-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|TCI-IRMdiff||Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.|Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.|Recruiting||N/A|75|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:06:14.192486|2017-10-10 22:06:14.192486
NCT02796027|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-18|||February 1, 2017|Actual|2017-02-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|March 2020|Anticipated|2020-03-01||Interventional|||BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs|BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs|Recruiting||N/A|600|Anticipated|Columbia University||2|||f||||t|f|f||||||||2017-10-10 22:06:14.289019|2017-10-10 22:06:14.289019
NCT02796014|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-16|||May 2016||2016-05-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis|Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis, and Comparison of This Scale With the Children's Dermatology Life Quality Index and Disease Severity|Completed||N/A|129|Actual|Istanbul Medeniyet University|||1||f||||f||||||||||2017-10-10 22:06:14.374818|2017-10-10 22:06:14.374818
NCT02796001|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-05-01|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in Humans|Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in Humans|Not yet recruiting||Phase 1/Phase 2|150|Anticipated|University of Virginia||2|||f||||f|t|f||||||Undecided||2017-10-10 22:06:14.463738|2017-10-10 22:06:14.463738
NCT02795988|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-08-31|||August 30, 2017|Actual|2017-08-30|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of IMU-131 Plus Standard of Care Chemotherapy in Patients With HER2/Neu Overexpressing Advanced Cancer of the Stomach|A Phase 1b/2 Open-label Study of IMU-131 HER2/Neu Peptide Vaccine Plus Cisplatin and Either 5-Fluorouracil or Capecitabine Chemotherapy in Patients With HER2/Neu Overexpressing Metastatic or Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction|Recruiting||Phase 1/Phase 2|18|Anticipated|Imugene Limited||3|||f||||t|f|f||||||||2017-10-10 22:06:14.528122|2017-10-10 22:06:14.528122
NCT02795975|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-03-22|||June 30, 2016|Actual|2016-06-30|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|||Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples|Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples|Terminated||N/A|1766|Actual|Hologic, Inc.|||1|Sponsor business decision|f||||f||||||||No||2017-10-10 22:06:14.675871|2017-10-10 22:06:14.675871
NCT02795962|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-03-02|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01||||March 2020|Anticipated|2020-03-01||Interventional|RACECAT||Direct Transfer to an Endovascular Center Compared to Transfer to the Closest Stroke Center in Acute Stroke Patients With Suspected Large Vessel Occlusion|A Trial Comparing Transfer to the Closest Local Stroke Center vs. Direct Transfer to Endovascular Stroke Center of Acute Stroke Patients With Suspected Large Vessel Occlusion in the Catalan Territory.|Recruiting||N/A|1754|Anticipated|Fundacio Ictus Malaltia Vascular||2|||f||||t|f|f||||||Undecided||2017-10-10 22:06:14.798248|2017-10-10 22:06:14.798248
NCT02795949|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-12-09|||October 2016||2016-10-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|October 2018|Anticipated|2018-10-01||Interventional|SIMPLIFY||Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae|Randomized, Multicenter, Phase III, Controlled Clinical Trial, to Demonstrate the no Inferiority of Reduced Antibiotic Treatment vs a Broad Spectrum Betalactam Antipseudomonal Treatment in Patients With Bacteremia by Enterobacteriaceae|Recruiting||Phase 3|344|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f||||||||||2017-10-10 22:06:14.966994|2017-10-10 22:06:14.966994
NCT02795936|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-10-02|||July 2016||2016-07-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FCR-HF||Feasibility of Cardiac Rehabilitation in Patients With Heart Failure at the Moi Teaching and Referral Hospital|Feasibility of Cardiac Rehabilitation in Patients With Heart Failure at the Moi Teaching and Referral Hospital|Recruiting||N/A|101|Anticipated|Duke University||3|||f||||t||||||||||2017-10-10 22:06:15.14728|2017-10-10 22:06:15.14728
NCT02795910|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-05-15|||April 1, 2017|Actual|2017-04-01|January 2017|2017-01-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|PACKBrazDCVD||Integrated Primary Care for Diabetes and Cardiovascular Disease|Integrated Primary Care for Diabetes and Cardiovascular Disease in Less Developed Countries: Pragmatic Trial of the Practical Approach to Care Kit|Recruiting||N/A|35000|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||No||2017-10-10 22:06:15.259781|2017-10-10 22:06:15.259781
NCT02795897|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-19|||November 2016||2016-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|June 2019|Anticipated|2019-06-01||Observational|GTAC||Genomic Translation for ALS Care|Genomic Translation for Amyotrophic Lateral Sclerosis Care|Recruiting||N/A|1500|Anticipated|Columbia University|||1||f||||f|f|f||||Samples With DNA|"     DNA, RNA and Peripheral blood mononuclear cells (PBMCs)   "|||2017-10-10 22:06:15.39673|2017-10-10 22:06:15.39673
NCT02795884|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-12-29|||June 2016||2016-06-01|December 2016|2016-12-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation||Withdrawn||Phase 3|0|Actual|Yonsei University||2||Because of reconsideration of using erlotinib(EGFR Tyrosine kinase inhibitor) as adjuvant aim|f||||f||||||||No|no plan to share data|2017-10-10 22:06:15.674787|2017-10-10 22:06:15.674787
NCT02795871|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-02-21|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Prenatal Dex||Prenatal Dex Study|Multicentric Evaluation of in Utero Dexamethasone (DEX) on the Cognitive Development of Children at Risk of Congenital Adrenal Hyperplasia|Recruiting||N/A|500|Anticipated|Hospices Civils de Lyon||5|||f||||f||||||||||2017-10-10 22:06:15.769207|2017-10-10 22:06:15.769207
NCT02795858|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-08-03|||June 2016||2016-06-01|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors|A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors|Recruiting||Phase 2|43|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 22:06:15.883966|2017-10-10 22:06:15.883966
NCT02795845|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2016-11-13|||November 2016||2016-11-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study|Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study|Recruiting||N/A|506|Anticipated|HaEmek Medical Center, Israel||8|||f||||t||||||||No||2017-10-10 22:06:16.002556|2017-10-10 22:06:16.002556
NCT02795832|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-07-14|||June 2016|Actual|2016-06-01|June 2016|2016-06-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis|A Randomised, Double-blind, Placebo Controlled Study to Determine the Safety, Pharmacokinetics and Efficacy of Topical ZPL-5212372 Ointment Administered BID for up to 2 Weeks in Healthy Subjects and Subjects With Atopic Dermatitis.|Completed||Phase 1/Phase 2|53|Actual|Ziarco Pharma Ltd||6|||f||||f||||||||||2017-10-10 22:06:16.122873|2017-10-10 22:06:16.122873
NCT02795819|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-05-03|||July 8, 2016||2016-07-08|May 2017|2017-05-01|June 30, 2025|Anticipated|2025-06-30|March 30, 2019|Anticipated|2019-03-30||Interventional|||Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer|Phase 1 Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Soft Tissue Sarcoma and Renal Cell Carcinoma|Suspended||Phase 1|51|Anticipated|Virginia Commonwealth University||1||Protocol revisions|f||||t|t|f||||||||2017-10-10 22:06:16.234287|2017-10-10 22:06:16.234287
NCT02795806|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-09|2017-06-30|||May 25, 2016||2016-05-25|May 4, 2017|2017-05-04|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|||NLM Scrubber: NLM s Software Application to De-identify Clinical Text Documents|NLM Scrubber: NLM's Software Application to De-identify Clinical Text Documents|Enrolling by invitation||N/A|1|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:06:16.327399|2017-10-10 22:06:16.327399
NCT02795793|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-06-06|||May 2016||2016-05-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|APRES||Non-operative Management for Appendicitis in Children|A Prospective Randomised Controlled Non-inferiority Study to Evaluate the Effectiveness and Safety (APRES) of Non-operative Management in Children With Acute Uncomplicated Appendicitis|Recruiting||N/A|226|Anticipated|Sydney Children's Hospitals Network||2|||f||||t||||||||||2017-10-10 22:06:16.398577|2017-10-10 22:06:16.398577
NCT02795767|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-07|2017-07-26|||July 22, 2016|Actual|2016-07-22|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|April 28, 2018|Anticipated|2018-04-28||Interventional|HAVEN 2||A Study of Once-Weekly Emicizumab in Children and Adolescents With Hemophilia A and Factor VIII (FVIII) Inhibitors|A Single-Arm, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once Weekly Subcutaneous Administration of Emicizumab in Hemophilia A Pediatric Patients With Inhibitors|Enrolling by invitation||Phase 3|60|Actual|Hoffmann-La Roche||1|||t||||t|t|f||||||||2017-10-10 22:06:16.678248|2017-10-10 22:06:16.678248
NCT02795754|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-01-16|||March 2016||2016-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Single and Repeated Dose Escalation Study of GSK2838232|A Double-Blind (Sponsor Unblinded), Randomized, Placebo-Controlled, Continuation Single and Repeated Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 With Ritonavir, in Healthy Subjects|Completed||Phase 1|62|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:06:16.865116|2017-10-10 22:06:16.865116
NCT02795741|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-07-31|||July 2016||2016-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Study to Evaluate the Effects of the Cooling Bolero in Women With Common Menopause Symptoms|Pilot Study to Evaluate the Effects of the Nanohealth, Inc. Cooling Bolero in Women With Common Menopause Symptoms|Enrolling by invitation||N/A|20|Anticipated|Englewood Hospital and Medical Center||1|||f||||f||||||||||2017-10-10 22:06:17.022728|2017-10-10 22:06:17.022728
NCT02795728|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2016-06-09|||February 2010||2010-02-01|May 2016|2016-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Fuji Type VII Sealant Versus Resin Based Sealant. A Clinical Trial|Fuji Type VII Sealants Versus Resin Based Sealants. A Clinical Trial|Completed||Phase 4|120|Actual|Kamineni Institute of Dental Sciences||2|||f||||t||||||||Yes||2017-10-10 22:06:17.099019|2017-10-10 22:06:17.099019
NCT02795715|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRAINSTIM2||tDCS Effects on Associative Learning in Younger Adults|Effects of Transcranial Direct Current Stimulation (tDCS) on Associative Learning in Young Adults|Recruiting||Phase 2|24|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 22:06:17.185809|2017-10-10 22:06:17.185809
NCT02795702|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRAINSTIM2||tDCS Effects on Associative Learning in Older Adults of Working Age|Effects of Transcranial Direct Current Stimulation (tDCS) on Associative Learning in Older Adults|Recruiting||Phase 2|24|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 22:06:17.289858|2017-10-10 22:06:17.289858
NCT02795689|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-05-17|||December 2014||2014-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:06:17.379248|2017-10-10 22:06:17.379248
NCT02795676|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-28|||June 2016||2016-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|BALANCE||Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function|A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta|Recruiting||Phase 3|78|Anticipated|Protalix||2|||f||||f||||||||||2017-10-10 22:06:17.425|2017-10-10 22:06:17.425
NCT02789111|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-27|||June 2016||2016-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Alvimopan in Major Spine Surgery|Randomized, Double-Blind, Placebo-Controlled Trial of Alvimopan in Major Spine Surgery|Not yet recruiting||Phase 4|50|Anticipated|University of Virginia||2|||f||||f||||||||No||2017-10-10 22:07:28.604762|2017-10-10 22:07:28.604762
NCT02795663|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-12-02|||September 2014||2014-09-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|SCP TCI NIRS||Deep Brain Stimulation and Parkinson's Disease|Deep Brain Stimulation and Parkinson's Disease: Analysis of the Modifications of the Cortical Activation During Driving Tasks and During Tasks Involving the Control of the Impulses by Means of the Optical Imaging and of the Technique of Delay Discounting Task|Recruiting||Early Phase 1|40|Anticipated|Centre Hospitalier Universitaire, Amiens||3|||f||||||||||||||2017-10-10 22:06:17.712781|2017-10-10 22:06:17.712781
NCT02795650|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-06|||May 2016||2016-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|AVATAR||Personalised Therapy for Patients With Metastatic Adenocarcinoma of the Pancreas Determined by Genetic Testing and Avatar Model Generation|Personalised Therapy for Patients With Metastatic Adenocarcinoma of the Pancreas Determined by Genetic Testing and Avatar Model Generation|Recruiting||Phase 2|146|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III||2|||f||||t||||||||||2017-10-10 22:06:17.808553|2017-10-10 22:06:17.808553
NCT02795637|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-12-01|||May 2016||2016-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction|Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction|Completed||Phase 1|44|Actual|Sunovion||1|||f||||f||||||||||2017-10-10 22:06:17.898484|2017-10-10 22:06:17.898484
NCT02795624|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-03-24|||February 2016||2016-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Vascular Aging in Flight Attendants With Occupational Secondhand Smoke Exposure|Vascular Aging in Flight Attendants With Occupational Secondhand Smoke Exposure|Suspended||N/A|300|Anticipated|Cedars-Sinai Medical Center|||1|The study sponsor stopped the funding.|f||||f||||||||Yes||2017-10-10 22:06:18.142725|2017-10-10 22:06:18.142725
NCT02795611|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-06-06|||May 2016||2016-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Family Centered Occupational Therapy on Play Skills and Participation of Children With ASD|Effectiveness of Family Centered Occupational Therapy on Play Skills and Participation of Children With Autism Spectrum Disorder|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||3|||f||||f||||||||No||2017-10-10 22:06:18.245265|2017-10-10 22:06:18.245265
NCT02795598|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-07-07|||August 2016||2016-08-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Diaphragmatic Dysfunction After Ultrasound-guided Supraclavicular Block With Single or Double Injection Technique|Diaphragmatic Dysfunction After Ultrasound-guided Supraclavicular Brachial Plexus Block With Single or Double Injection Technique|Not yet recruiting||N/A|48|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||Undecided||2017-10-10 22:06:18.353238|2017-10-10 22:06:18.353238
NCT02795585|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-09-22|||January 2016||2016-01-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|June 2016|Actual|2016-06-01||Observational|WIFI||The Wire-free Invasive Functional Imaging (WIFI) Study|Feasibility of On-line Computed Fractional Flow Reserve: The Wire-free Invasive Functional Imaging (WIFI) Study|Recruiting||N/A|100|Anticipated|Aarhus University Hospital Skejby|||1||f||||f||||||||Undecided||2017-10-10 22:06:18.437278|2017-10-10 22:06:18.437278
NCT02795572|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-14|||June 27, 2017|Actual|2017-06-27|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|CIPN||Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy|Protocol Comparing a Nutraceutical Formulation Consisting of Omega-3 Fatty Acids, Vitamin D, and Vitamins B6 Plus B12 Versus No Treatment in the Prevention or Reduction of Chemotherapy Induced Peripheral Neuropathy (CIPN) in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy|Recruiting||Phase 2|106|Anticipated|AHS Cancer Control Alberta||2|||f||||f|f|f||||||||2017-10-10 22:06:18.554857|2017-10-10 22:06:18.554857
NCT02795559|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-09|||March 2012||2012-03-01|June 2016|2016-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Acute Effects of Dietary Fiber on Postprandial Responses in Lean and Overweight Subjects|Role of Colonic Short Chain Fatty Acids in Obesity: Acute Effects of Inulin and Resistant Starch on Postprandial Short Chain Fatty Acid, Glucose, Insulin, Free-fatty Acid and Gut Hormone Responses|Completed||N/A|25|Actual|University of Toronto||2|||f||||f||||||||No||2017-10-10 22:06:18.683459|2017-10-10 22:06:18.683459
NCT02795546|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-06|||January 2015||2015-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects.|Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects: A Randomized, Controlled Clinical Trial.|Completed||Phase 4|32|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||t||||||||No|statistical data will be provided.|2017-10-10 22:06:18.814948|2017-10-10 22:06:18.814948
NCT02795533|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-09-19|||June 2016||2016-06-01|September 2017|2017-09-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Observational|||Changes in Physical, Cognitive and Emotional Function 5 and 10 Years After Aneurysmal Subarachnoid Hemorrhage (aSAH)|Changes in Physical, Cognitive and Emotional Function 5 and 10 Years After Aneurysmal Subarachnoid Hemorrhage (aSAH)|Enrolling by invitation||N/A|157|Anticipated|Oslo University Hospital|||1||f||||f||||||||||2017-10-10 22:06:18.916921|2017-10-10 22:06:18.916921
NCT02795520|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-09-12|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia|Phase I/II and Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia|Recruiting||Phase 1/Phase 2|60|Anticipated|OncoTherapy Science, Inc.||1|||f||||f||||||||||2017-10-10 22:06:19.026591|2017-10-10 22:06:19.026591
NCT02795507|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-08-30|||July 2016||2016-07-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Cross Education in Patients With Sensorimotor Impairment|Cross Education in Patients With Sensorimotor Impairment|Recruiting||N/A|40|Anticipated|Loewenstein Hospital||2|||f||||||||||||||2017-10-10 22:06:19.139567|2017-10-10 22:06:19.139567
NCT02795494|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-06|||May 2007||2007-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|WOMAC||WOMAC Hip Score in Children and Adolescents With Perthes Disease|Validation and Reliability Testing of the Western Ontario and McMaster Osteoarthritis Scale (WOMAC) Hip Score in Children and Adolescents With Perthes Disease|Recruiting||N/A|200|Anticipated|British Columbia Children's Hospital|||2||f||||f||||||||No||2017-10-10 22:06:19.257299|2017-10-10 22:06:19.257299
NCT02795481|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-07-04|||July 2016||2016-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||The SMARTChip Stroke Study|SMARTChip: A Field Deployable Blood Test for Stroke, Capable of Detecting Brain Ischaemia From the Earliest Stages of Pathology|Active, not recruiting||N/A|375|Actual|University Hospitals Coventry and Warwickshire NHS Trust|||4||f||||f||||||||||2017-10-10 22:06:19.37436|2017-10-10 22:06:19.37436
NCT02795468|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-11-22|||June 2016||2016-06-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||The Usefulness of Ultrasound Guided Technique Insertion of Radial Artery Catheter in Neonates and Infants|The Usefulness of Ultrasound Guided Technique Insertion of Radial Artery Catheter in Neonates and Infants|Recruiting||N/A|80|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 22:06:19.446317|2017-10-10 22:06:19.446317
NCT02795455|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Reward Systems and Food Avoidance in Eating Disorders|Reward Systems and Food Avoidance in Adolescents With Low Weight Eating Disorders|Recruiting||Phase 1|90|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||f||||||||No||2017-10-10 22:06:19.548059|2017-10-10 22:06:19.548059
NCT02795442|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-20|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Daily Protein Intake Patterns on Energy Metabolism and the Motivation to Snack|Daily Protein Intake Patterns on Energy Metabolism and the Motivation to Snack|Recruiting||N/A|40|Anticipated|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 22:06:19.664027|2017-10-10 22:06:19.664027
NCT02795429|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-13|||June 15, 2016|Actual|2016-06-15|September 2017|2017-09-01|December 24, 2018|Anticipated|2018-12-24|December 24, 2018|Anticipated|2018-12-24||Interventional|||Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC|A Phase Ib/II, Open-label, Multi-center Study of INC280 in Combination With PDR001 or PDR001 Single Agent in Advanced Hepatocellular Carcinoma.|Recruiting||Phase 1/Phase 2|108|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 22:06:19.773605|2017-10-10 22:06:19.773605
NCT02795416|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-04-19|||June 2016||2016-06-01|April 2017|2017-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population|A 16-week, Single Arm, Multicenter Study for the Assessment of Efficacy and Safety of Secukinumab in aduLt Patients With Moderate to Severe plaquE Psoriasis in Turkish Population|Withdrawn||Phase 3|0|Actual|Novartis||1|||f||||f||||||||||2017-10-10 22:06:19.915003|2017-10-10 22:06:19.915003
NCT02795403|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-06|||January 2011||2011-01-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||HCV Virions Bound Proteins|Hepatitis C Virus Particles-bound Human Proteins : Identification in Clinical Samples and Implication in the Viral Life Cycle|Completed||N/A|10|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:06:20.01725|2017-10-10 22:06:20.01725
NCT02795390|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-08|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Clinical Trial on Palliative Cancer Patients With Constipation|Chinese and Western Medicine Collaborative Studies on Palliative Cancer Patients With Constipation|Recruiting||Phase 2|60|Anticipated|Hong Kong Baptist University||2|||f||||t||||||||||2017-10-10 22:06:20.103182|2017-10-10 22:06:20.103182
NCT02795377|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-08-08|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Hypertension and Injury|Hypertension, Endothelial Microparticle Release, and Endothelial Function: Role of Pressure, Shear, and Stretch|Active, not recruiting||N/A|80|Anticipated|Heinrich-Heine University, Duesseldorf|||4||f||||f||||||||||2017-10-10 22:06:20.219801|2017-10-10 22:06:20.219801
NCT02795364|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-06|||June 2016||2016-06-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas|A Prospective Study About the Validity of MRS-guided Resection on Prognosis High-grade Gliomas|Not yet recruiting||N/A|50|Anticipated|Huashan Hospital||2|||f||||t||||||||Yes||2017-10-10 22:06:20.308528|2017-10-10 22:06:20.308528
NCT02795351|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2016-06-06|||June 2015||2015-06-01|June 2016|2016-06-01||||September 2016|Anticipated|2016-09-01||Interventional|||Induction of Migraine Aura With Sildenafil|The Effect of the Selective PDE5 Inhibitor, Sildenafil, on Aura and Migraine Headache Induction.|Recruiting||Early Phase 1|16|Anticipated|Herlev Hospital||2|||f||||f||||||||No||2017-10-10 22:06:20.39023|2017-10-10 22:06:20.39023
NCT02795338|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-15|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01|6 Months|Observational [Patient Registry]|||Multi-modality Localization of Eloquent Brain Function|Multi-modality Localization of Eloquent Brain Function-A Comparison of Technologies for Improved Applicability|Not yet recruiting||N/A|80|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-10-10 22:06:20.462242|2017-10-10 22:06:20.462242
NCT02795325|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-10-11|||May 2016||2016-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)|A Phase 1 Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)|Active, not recruiting||Phase 1|30|Anticipated|Dicerna Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-10 22:06:20.518181|2017-10-10 22:06:20.518181
NCT02795312|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-12-15|||July 2016||2016-07-01|December 2016|2016-12-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Mindfulness Based Smoking Cessation Program|Feasibility, Acceptability and Effectiveness of Modified Mindfulness Based Stress Reduction (MBSR) for Smoking Cessation in Cancer Patients|Recruiting||N/A|30|Anticipated|Boston Medical Center||1|||f||||f||||||||No|Individual patient data will not be included in any publications|2017-10-10 22:06:20.600599|2017-10-10 22:06:20.600599
NCT02795104|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-10-04|||October 2016||2016-10-01|October 2017|2017-10-01|September 2020|Anticipated|2020-09-01|July 2019|Anticipated|2019-07-01||Interventional|RISE||Rural Interventions for Screening Effectiveness|Comparative Effectiveness of Interventions to Improve Screening Among Rural Women|Recruiting||N/A|1058|Anticipated|Ohio State University Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-10 22:06:21.989393|2017-10-10 22:06:21.989393
NCT02795299|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-06-15|||November 2016||2016-11-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis|Phase 2, Rand, Placebo-Controlled, Double-Blind, Dose Ranging Study to Evaluating Safety/Efficacy of Gerilimzumab in Patients With Moderately to Severely Active Rheumatoid Arthritis Inadequately Treated With Methotrexate or TNFα Antagonist|Not yet recruiting||Phase 2|200|Anticipated|Bird Rock Bio, Inc.||4|||f||||t||||||||||2017-10-10 22:06:20.671887|2017-10-10 22:06:20.671887
NCT02795286|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-04-19|||March 2016||2016-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ASIST||Automated Setting of Individualized Sodium Technology|Automated Setting of Individualized Sodium Technology (ASIST) - Proof of Principle Study|Completed||N/A|18|Actual|Baxter Healthcare Corporation||3|||f||||f||||||||No||2017-10-10 22:06:20.763017|2017-10-10 22:06:20.763017
NCT02795273|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-06-21|||May 2016||2016-05-01|June 2016|2016-06-01||||October 2018|Anticipated|2018-10-01||Interventional|||Efficacy and Safety of Grass-SPIRE Registration Study|A Combined Phase 2b/3, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Centre Study to Assess the Efficacy and Safety of Grass-SPIRE in Subjects With Grass Pollen-Induced Allergic Rhinitis, With or Without Conjunctivitis|Withdrawn||Phase 2/Phase 3|0|Actual|Circassia Limited||2||Decision made to stop study following availability of results from another study|f||||t||||||||Undecided||2017-10-10 22:06:20.83123|2017-10-10 22:06:20.83123
NCT02795260|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-01-05|||May 2016||2016-05-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy)|Phase III Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65,Adopting Randomized Blinded and Parallel Controlled Method|Completed||Phase 3|1802|Actual|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.||2|||f||||f||||||||No||2017-10-10 22:06:20.897204|2017-10-10 22:06:20.897204
NCT02795247|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-11|||August 26, 2016|Actual|2016-08-26|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of 3 Techniques for Recreation of Anterior Cruciate Ligament Anatomic Footprint|Three Dimensional Computed Tomography Comparison of the Transtibial, Modified Transtibial and Anteromedial Portal Technique for Recreation of the Anterior Cruciate Ligament Anatomic Footprint|Recruiting||N/A|30|Anticipated|OrthoCarolina Research Institute, Inc.||3|||f||||t||||||||||2017-10-10 22:06:20.977863|2017-10-10 22:06:20.977863
NCT02795234|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-09|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Empirical Comperative Study Of Variation Blood Level Antibody Vitamin D at Different Groups Of Patients Compared Healthy Peoples|Empirical Comperative Study Of Variation Blood Level Antibody Vitamin D at Different Groups Of Patients Compared Healthy Peoples And The Correlation Between Vitamin D Level|Not yet recruiting||N/A|64|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-10 22:06:21.060837|2017-10-10 22:06:21.060837
NCT02795221|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-08|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SSc NVC||NVC Test in Order to Assess Pathological Changes in Family Members of Patient Diagnosed With SSc|Observative and Community Study, Using Nailfold Video-capillaroscopy in Order to Assess the Prevalence of Pathological Changes in the Capillaries in First Grade Family Members of Patient Diagnosed With Systemic Sclerosis|Not yet recruiting||N/A|400|Anticipated|Meir Medical Center|||1||f||||t||||||||No|Principal investigator initiates|2017-10-10 22:06:21.129035|2017-10-10 22:06:21.129035
NCT02795208|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-12|||March 2015||2015-03-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Lung Recruitment Improves Right Ventricle Performance|Lung Recruitment Improves Right Ventricle Performance After Cardio-Pulmonary Bypass|Completed||N/A|40|Actual|Hospital Privado de Cordoba, Argentina||2|||f||||f||||||||Undecided||2017-10-10 22:06:21.187724|2017-10-10 22:06:21.187724
NCT02795195|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-06|||January 2016||2016-01-01|June 2016|2016-06-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma|Phase I/II Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma|Recruiting||Phase 1/Phase 2|58|Anticipated|Shanghai Proton and Heavy Ion Center||1|||f||||t||||||||||2017-10-10 22:06:21.257859|2017-10-10 22:06:21.257859
NCT02795182|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2016-08-30|||February 2016||2016-02-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||BGB-3111 in Combination With BGB-A317 in Subjects With B-cell Malignancies|A Phase 1b, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Assess Safety, Tolerability and Antitumor Activities of the Combination of BGB-3111 With BGB-A317 in Subjects With B-Cell Lymphoid Malignancies|Recruiting||Phase 1|25|Anticipated|BeiGene||1|||f||||t||||||||||2017-10-10 22:06:21.384557|2017-10-10 22:06:21.384557
NCT02795156|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-03-08|||September 28, 2016|Actual|2016-09-28|March 2017|2017-03-01|December 30, 2018|Anticipated|2018-12-30|December 1, 2018|Anticipated|2018-12-01||Interventional|||Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations|Phase II Study to Evaluate the Activity of Commercially Available Molecularly Matched Targeted Therapies in Selected Tumor Types Based on Genomic Alterations|Recruiting||Phase 2|160|Anticipated|SCRI Development Innovations, LLC||2|||f||||f|t|f|||f|||||2017-10-10 22:06:21.618258|2017-10-10 22:06:21.618258
NCT02795143|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-12-05|||November 2016||2016-11-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study|Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 22:06:21.730923|2017-10-10 22:06:21.730923
NCT02795130|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-06|||June 2016||2016-06-01|June 2016|2016-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Short-Term Outcomes of Different Suture Materials for Sclerotomy Closure||Not yet recruiting||N/A|40|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||Yes||2017-10-10 22:06:21.831033|2017-10-10 22:06:21.831033
NCT02795117|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-03-20|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea||Completed||Phase 3|485|Actual|Perrigo Company||3|||f||||f||||||||No||2017-10-10 22:06:21.905651|2017-10-10 22:06:21.905651
NCT02795091|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-06-10|||December 2016||2016-12-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparision of Different Methods of Enviromennt Disinfection|Comparision of Different Methods of Enviromennt Disinfection|Not yet recruiting||Phase 2/Phase 3|480|Anticipated|Southeast University, China||2|||f||||t||||||||Undecided||2017-10-10 22:06:22.119569|2017-10-10 22:06:22.119569
NCT02795078|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2016-10-09|||October 2015||2015-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Observational|CAIASA||The Coexistence of Atherosclerotic Intracranial Arterial Stenosis With Intracranial Aneurysms|To Investigate the Coexistence of Atherosclerotic Intracranial Arterial Stenosis With Intracranial Aneurysms|Recruiting||N/A|700|Anticipated|Ministry of Science and Technology of the People´s Republic of China|||1||f||||t||||||||||2017-10-10 22:06:22.19783|2017-10-10 22:06:22.19783
NCT02795065|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-08|||March 2014||2014-03-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients|Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients|Completed||N/A|100|Actual|Al Mouwasat Hospital||2|||f||||f||||||||Yes||2017-10-10 22:06:22.291601|2017-10-10 22:06:22.291601
NCT02795052|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-04-10|||June 2016||2016-06-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|NEST||Neurologic Stem Cell Treatment Study|Neurologic Bone Marrow Derived Stem Cell Treatment Study|Recruiting||N/A|300|Anticipated|MD Stem Cells||2|||f||||t||||||||Undecided||2017-10-10 22:06:22.36413|2017-10-10 22:06:22.36413
NCT02795039|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-03-08|||June 2016||2016-06-01|July 2016|2016-07-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects|Open-label, Two-treatment, Single Period, Parallel, Single-dose, Randomized, Fasting, Lab-blinded Bioequivalence Study of Fulvestrant 50 mg/mL Versus Faslodex®, 50 mg/mL, in Healthy, Post-menopausal Female Subjects|Completed||Phase 1|266|Actual|Fresenius Kabi||2|||f||||f||||||||No||2017-10-10 22:06:22.485668|2017-10-10 22:06:22.485668
NCT02795026|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2017-03-25|||April 2016||2016-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Trans-perineal Trigger Point Dry Needling for Chronic Pelvic Pain|To Investigate the Use of Trans-perineal Trigger Point Dry Needling With Manual Therapy and to Compare the Outcome With Manual Therapy Treatment for Chronic Pelvic Pain With Dyspareunia. A Randomized Clinical Trial.|Recruiting||N/A|72|Anticipated|Cork University Hospital||2|||f||||t||||||||Yes||2017-10-10 22:06:22.592889|2017-10-10 22:06:22.592889
NCT02795013|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-03-31|||August 17, 2016|Actual|2016-08-17|January 2017|2017-01-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Observational|||Genetic Study of Families With High Frequency of Hodgkin Lymphoma|Genetic Study of Families With High Frequency of Hodgkin Lymphoma|Recruiting||N/A|50|Anticipated|St. Jude Children's Research Hospital|||2||f||||f|f|f||||Samples With DNA|"     Saliva, minimal blood, or tumor will be retained for whole exome sequencing.   "|||2017-10-10 22:06:22.713302|2017-10-10 22:06:22.713302
NCT02795000|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-06-08|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Development a Predictive Nomogram for Primary Ovarian Insufficiency|Development a Predictive Nomogram for Primary Ovarian Insufficiency|Not yet recruiting||N/A|200|Anticipated|Guangzhou University of Traditional Chinese Medicine|||2||f||||t||||||Samples With DNA|"     Whole blood to be retained   "|Undecided||2017-10-10 22:06:22.799644|2017-10-10 22:06:22.799644
NCT02794987|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-12-20|||December 2015||2015-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Cholangioscopic Classification of Bile Duct Lesions|Proposal of a Macroscopic Classification for Tissular Lesions of the Bile Duct Detected During Per Oral Cholangioscopy (POCS)|Completed||N/A|130|Actual|Instituto Ecuatoriano de Enfermedades Digestivas|||2||f||||t||||||Samples Without DNA|"     Histological biopsies of tissular lesions of bile duct   "|Yes||2017-10-10 22:06:22.88769|2017-10-10 22:06:22.88769
NCT02794974|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-08-16|||May 2016||2016-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Ultrasound-guided Intermediate Cervical Plexus Block|Ultrasound-guided Intermediate Cervical Plexus Block for Carotid Endarterectomies|Completed||N/A|30|Actual|Helios Research Center||2|||f||||f||||||||||2017-10-10 22:06:22.979992|2017-10-10 22:06:22.979992
NCT02794961|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-06|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies|Application of Humanized Anti-CD22 Antibody in CAR-T Therapy of B Cell Hematological Malignancies|Recruiting||Phase 1/Phase 2|10|Anticipated|Xuzhou Medical University||1|||f||||f||||||||Yes||2017-10-10 22:06:23.11211|2017-10-10 22:06:23.11211
NCT02794948|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-06-08|||April 2016||2016-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency|Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency:Randomized, Double-blind, DHEA-controlled Trial|Recruiting||Early Phase 1|60|Anticipated|Guangzhou University of Traditional Chinese Medicine||2|||f||||t||||||||Undecided||2017-10-10 22:06:23.246431|2017-10-10 22:06:23.246431
NCT02794935|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-08-07|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Inspiratory Muscle Training in Patients With Heart Failure and Obstructive Sleep Apnea Syndrome|The Effects of Inspiratory Muscle Training in Patients With Heart Failure and Obstructive Sleep Apnea Syndrome|Recruiting||N/A|30|Anticipated|University of Cruz Alta||2|||f||||t||||||||Yes|The volunteers will receive the results of the evaluations pre and post-intervention by the of the study.|2017-10-10 22:06:23.347757|2017-10-10 22:06:23.347757
NCT02794922|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-05|||November 2015||2015-11-01|June 2016|2016-06-01||||May 2017|Anticipated|2017-05-01||Interventional|||Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain|Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain|Recruiting||N/A|40|Anticipated|The University of Hong Kong||2|||f||||||||||||||2017-10-10 22:06:23.452843|2017-10-10 22:06:23.452843
NCT02794909|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-02-22|||July 2016||2016-07-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|AFRICA||AFrican Resuscitation Ultrasound In Critically-ill Adults|Pilot Study- Ultrasound-guided Resuscitation of Patients Presenting With Shock or Dyspnea to the Emergency Department in a Resource-limited Setting|Completed||N/A|180|Actual|University of Michigan||2|||f||||f||||||||No||2017-10-10 22:06:23.583026|2017-10-10 22:06:23.583026
NCT02794896|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-10-26|||March 2009||2009-03-01|October 2016|2016-10-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|BIS-MA||Anesthetic Depth Effects Upon Immune Competent Cells|Hypnotic Depth Reduces Lymphocyte Proliferation to Natural Killer Cells, B-cells, Memory T-cells, Depresses Intracellular Oxidative Burst and Changes Protein Expression Pattern of Monocytes|Completed||N/A|16|Actual|Universitätsmedizin Mannheim||2|||f||||f||||||||Yes|per request|2017-10-10 22:06:23.699891|2017-10-10 22:06:23.699891
NCT02794883|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-09-22|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma|A Phase II, Open Label, Clinical Trial Of Pre-Surgical and Adjuvant Treatment of Recurrent Malignant Glioma With Tremelimumab and Durvalumab (MEDI4736) Alone and in Combination to Determine Immunologic Changes From Treatment|Recruiting||Phase 2|36|Anticipated|Northwestern University||3|||f||||t||||||||||2017-10-10 22:06:23.805768|2017-10-10 22:06:23.805768
NCT02794870|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-07-17|||June 2016||2016-06-01|July 2017|2017-07-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|||Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age|Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID ΔM2-2 1030s, Lot RSV#010A, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age|Completed||Phase 1|33|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:06:23.968905|2017-10-10 22:06:23.968905
NCT02794857|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-07-10|||August 2016||2016-08-01|July 2017|2017-07-01||||September 2017|Anticipated|2017-09-01||Interventional|||Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation|A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation|Active, not recruiting||Phase 2|138|Actual|Neuraltus Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:06:24.099555|2017-10-10 22:06:24.099555
NCT02794844|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-06-06|||March 2016||2016-03-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PGX||Implementation of PPI Medication PGX Testing|Implementation of Pharmacogenomic Testing in Nemours Children's Health System|Recruiting||Phase 4|120|Anticipated|Nemours Children's Clinic||1|||f||||f||||||||||2017-10-10 22:06:24.234574|2017-10-10 22:06:24.234574
NCT02794831|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-06-06|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|ANAIG||Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections|Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections|Not yet recruiting||N/A|300|Anticipated|Nantes University Hospital|||2||f||||t||||||||No||2017-10-10 22:06:24.327517|2017-10-10 22:06:24.327517
NCT02794818|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-02-17|||August 2016||2016-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Penn State ProduceRx Feasibility Study|"Penn State ProduceRx Feasibility Study: Developing a Prescription Produce Model That Can Impact Long-term Health Outcomes for Patients"|Completed||N/A|32|Actual|Milton S. Hershey Medical Center|||2||f||||f||||||||Undecided||2017-10-10 22:06:24.416813|2017-10-10 22:06:24.416813
NCT02794805|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-05|2017-08-15|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis|Evaluation of the Capability of the ¹³C-Octanoate Breath Test (OBT) Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI in Patients With Chronic Liver Disease|Completed||Phase 2|100|Anticipated|Exalenz Bioscience LTD.||2|||f||||f||||||||||2017-10-10 22:06:24.490643|2017-10-10 22:06:24.490643
NCT02794792|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-08-31|||May 16, 2016|Actual|2016-05-16|August 2017|2017-08-01|June 20, 2017|Actual|2017-06-20|March 2, 2017|Actual|2017-03-02||Interventional|IMPRESSION||A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin|A Phase 3, Double-blind, Randomized Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Metformin Compared to Metformin Plus Placebo in Subjects in Russia With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin|Completed||Phase 3|268|Actual|Astellas Pharma Inc||3|||f||||f|f|f||||||||2017-10-10 22:06:24.579973|2017-10-10 22:06:24.579973
NCT02794779|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2017-01-30|||July 2016||2016-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MODCL||Minimum Oxytocin Dose for Cesarean During Labor: Adaptative Clinical Trial|Minimum Oxytocin Dose for Cesarean During Labor: Adaptative Clinical Trial|Recruiting||Phase 3|64|Anticipated|Brasilia University Hospital||2|||f||||f||||||||||2017-10-10 22:06:24.734084|2017-10-10 22:06:24.734084
NCT02794766|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-06-05|||March 2014||2014-03-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|||Inulin and S. Salivarius Reduce Halitosis|Inulin and Streptococcus Salivarius Reduce Halitosis Associated With Tongue Coating: A Randomized Clinical Trial|Completed||Phase 2|45|Actual|Universidade de Passo Fundo||3|||f||||f||||||||No||2017-10-10 22:06:24.817605|2017-10-10 22:06:24.817605
NCT02794753|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-08|||February 2016||2016-02-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CTTTM||Cognitive Training in Patients With Trichotillomania (Hair-pulling Disorder)|Cognitive Training in Patients With Trichotillomania (Hair-pulling Disorder)|Recruiting||N/A|40|Anticipated|University of Stellenbosch||2|||f||||t||||||||Yes|Findings will be made available in dissertation, as well as published in articles.|2017-10-10 22:06:24.899714|2017-10-10 22:06:24.899714
NCT02794740|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-09-14|||June 2016||2016-06-01|June 2016|2016-06-01||||May 2017|Anticipated|2017-05-01||Interventional|||Study of Ibuprofenamine Hydrochloride Spray Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers||Recruiting||Phase 1|34|Anticipated|Tianjin XinChen-Techfields Pharma Co., LTD.||7|||f||||f||||||||||2017-10-10 22:06:25.004397|2017-10-10 22:06:25.004397
NCT02794727|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-08-08|||June 2016||2016-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|OPA||Physical Activity in the Medical Workplace|Physical Activity in the Medical Workplace- a Way to Improve Physical and Mental Well-being?|Recruiting||N/A|135|Anticipated|Mayo Clinic||3|||f||||f|f|f||||||||2017-10-10 22:06:25.096255|2017-10-10 22:06:25.096255
NCT02794714|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-06|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction|Comparing Deep Neuromuscular Block and Moderate Neuromuscular Block in Patients Undergoing Laparoscopic Gynaecological Surgeries: Impact on Surgical Satisfaction of Operating Conditions and Patient Satisfaction|Not yet recruiting||Phase 4|82|Anticipated|Kuala Lumpur General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:06:25.191519|2017-10-10 22:06:25.191519
NCT02794701|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-05|||January 2016||2016-01-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Comprehensive Risk Assessment of People With Silicosis: A Population-based Study|Comprehensive Risk Assessment of People With Silicosis: A Population-based Study|Recruiting||N/A|320|Anticipated|Chinese University of Hong Kong|||1||f||||||||||||No||2017-10-10 22:06:25.298163|2017-10-10 22:06:25.298163
NCT02794688|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-06-06|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Ductal Lavage in Non-lactating Female Women With Mastitis|Ductal Lavage in Non-lactating Female Women With Mastitis: A Single Arm, Observational Study|Active, not recruiting||N/A|27|Actual|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|||1||f||||f||||||Samples With DNA|"     All patients are required to have biopsy to exclude breast carcinoma. The storage of the     biospecimen will follow the standard of practices of Sun Yat-sen Memorial Hospital.   "|Yes|Individual patient data (de-identified) is available upon request.|2017-10-10 22:06:25.404538|2017-10-10 22:06:25.404538
NCT02794675|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-01-05|||December 2016||2016-12-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer|A Pilot Study Using Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Resectable High Risk Recurrent Head and Neck Cancer|Recruiting||Early Phase 1|43|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:06:25.503655|2017-10-10 22:06:25.503655
NCT02794662|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-11-30|||April 2016||2016-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ECO||Environmental or Nasal Cannula Oxygen for Preterm Infants Receiving Oxygen Therapy: a Randomized Cross-over Pilot Study|Environmental or Nasal Cannula Oxygen for Preterm Infants Receiving Oxygen Therapy: a Randomized Cross-over Pilot Study|Completed||N/A|25|Actual|University of Alabama at Birmingham||2|||f||||t||||||||No||2017-10-10 22:06:25.601037|2017-10-10 22:06:25.601037
NCT02794649|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-23|||June 2016||2016-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients|Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients|Recruiting||N/A|60|Anticipated|VA New York Harbor Healthcare System|||4||f||||t||||||Samples Without DNA|"     fecal samples   "|||2017-10-10 22:06:25.713722|2017-10-10 22:06:25.713722
NCT02794636|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-06-06|||May 2014||2014-05-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|ITMT||Interferon Toxicities in Melanoma Treatment|Analysis of the Clinical and Economic Impact of Adverse Events and Medication-related Toxicities Associated With Interferon (IFN) Treatment for Patients With Stage III Melanoma|Completed||N/A|436|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:06:25.817383|2017-10-10 22:06:25.817383
NCT02794623|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2016-08-16|||October 2014||2014-10-01|May 2016|2016-05-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Tinnitus Suppression for Cochlear Implant Recipients|Evaluation of Tinnitus Suppression for Cochlear Implant Recipients|Recruiting||N/A|14|Anticipated|The Hearing Cooperative Research Centre||1|||f||||f||||||||No||2017-10-10 22:06:26.117642|2017-10-10 22:06:26.117642
NCT02794610|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-08|||May 2016||2016-05-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Ocular Penetration of Topical Tacrolimus Eye Drops||Recruiting||N/A|10|Anticipated|The Eye Center and The Eye Foundation for Research in Ophthalmology||1|||f||||t||||||||No||2017-10-10 22:06:26.265586|2017-10-10 22:06:26.265586
NCT02794597|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-10-03|||August 2016||2016-08-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)|Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)|Recruiting||N/A|200|Anticipated|Denver Health and Hospital Authority||2|||f||||f||||||||||2017-10-10 22:06:26.40176|2017-10-10 22:06:26.40176
NCT02794584|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-06-25|||January 2011|Actual|2011-01-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Hybrid Closure of Congenital Heart Disease|Precision Assessment of Perioperative Effectiveness and Safety of Transthoracic Minimally Invasive Hybrid Closure for Pediatric Ventricular Septal Defects|Completed||N/A|200|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-10-10 22:06:26.562528|2017-10-10 22:06:26.562528
NCT02794571|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-20|||May 23, 2016|Actual|2016-05-23|September 2017|2017-09-01|September 28, 2019|Anticipated|2019-09-28|September 28, 2019|Anticipated|2019-09-28||Interventional|||Safety and Pharmacokinetics (PK) of Escalating Doses of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Locally Advanced or Metastatic Tumors|A Phase Ia/Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors|Recruiting||Phase 1|300|Anticipated|Genentech, Inc.||4|||f||||||||||||||2017-10-10 22:06:26.715479|2017-10-10 22:06:26.715479
NCT02794558|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-05|||June 2005||2005-06-01|June 2016|2016-06-01|April 2021|Anticipated|2021-04-01|December 2020|Anticipated|2020-12-01||Interventional|||Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas|A Clinical Study To Evaluate the Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas|Active, not recruiting||Phase 2|100|Actual|InSightec||1|||f||||t||||||||Undecided||2017-10-10 22:06:26.979338|2017-10-10 22:06:26.979338
NCT02794545|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2016-12-11|||October 2014||2014-10-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Functional Cure Study of HIV-infected Patients||Recruiting||N/A|20|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:06:27.077309|2017-10-10 22:06:27.077309
NCT02793973|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-06-02|||May 2016||2016-05-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||The Development and Clinical Verification of Intelligent Rehabilitation System for Leg Length Discrepancy Patients||Not yet recruiting||N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||Undecided||2017-10-10 22:06:35.357349|2017-10-10 22:06:35.357349
NCT02794532|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-04-16|||June 2016||2016-06-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Interventional|PRIOR||PreOxygenation In RSI Anesthesia|Pre-oxygenation With High-flow Nasal Cannula in Comparison to Standard in Adults During Rapid Sequence Induction Anesthesia- a Prospective Randomized Non-blinded Clinical Trial|Enrolling by invitation||N/A|200|Anticipated|Karolinska University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:06:27.197824|2017-10-10 22:06:27.197824
NCT02794519|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-10-02|||September 23, 2016|Actual|2016-09-23|October 2017|2017-10-01|August 13, 2018|Anticipated|2018-08-13|August 13, 2018|Anticipated|2018-08-13||Interventional|||A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma|205076: A Phase II, Multicenter, Randomized, Double-blind (Sponsor-unblind), Placebo- Controlled, Parallel Group Trial to Evaluate the Efficacy and Safety of Sirukumab in Subjects With Severe, Poorly Controlled Asthma|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||2||This study has suspended participant recruitment.|f||||f||||||||||2017-10-10 22:06:27.320261|2017-10-10 22:06:27.320261
NCT02794506|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-06-08|||June 2014||2014-06-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Propolis Improves Glycemic Control in Subjects With Type 2 Diabetes and Chronic Periodontitis|Propolis Improves Periodontal Status and Glycemic Control in Subjects With Type 2 Diabetes Mellitus and Chronic Periodontitis: a Randomized Clinical Trial|Completed||Phase 4|52|Actual|Mansoura University||2|||f||||t||||||||Yes||2017-10-10 22:06:27.498885|2017-10-10 22:06:27.498885
NCT02794493|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-04|||June 2016||2016-06-01|January 2016|2016-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer|A Phase III Randomized, Placebo-controlled, Double-blind Trial to Determine the Effectiveness of Traditional Chinese Medicine Formula LC09 for Treatment of Capecitabine-Induced Hand and Foot Syndrome|Not yet recruiting||Phase 3|156|Anticipated|China-Japan Friendship Hospital||2|||f||||||||||||||2017-10-10 22:06:27.67802|2017-10-10 22:06:27.67802
NCT02794467|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-01-16|||July 2016||2016-07-01|January 2017|2017-01-01|October 2016|Anticipated|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis|A Phase II, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Proof of Concept Study With an Interim Futility Analysis of Epelsiban in Patients With Adenomyosis|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||3||"Study was prematurely discontinued due to GSK's change in prioritization for the portfolio and   is not due to any safety concerns or regulatory interaction."|f||||f||||||||||2017-10-10 22:06:28.010924|2017-10-10 22:06:28.010924
NCT02794454|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-01-27|||May 2016||2016-05-01|June 2016|2016-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|HeezOn-Ultra||A Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health|A Randomized, Placebo-controlled, Double-blind Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health|Completed||N/A|15|Actual|Vedic Lifesciences Pvt. Ltd.||3|||f||||f||||||||No||2017-10-10 22:06:28.186049|2017-10-10 22:06:28.186049
NCT02794441|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-18|||December 2016||2016-12-01|July 2017|2017-07-01|June 28, 2017|Actual|2017-06-28|June 2017|Actual|2017-06-01||Interventional|||Oral Dexamethasone for the Treatment of Acute Migraine Recurrence in the Pediatric Emergency Department|Oral Dexamethasone for the Treatment of Acute Migraine Recurrence in Pediatric Patients Presenting to the Emergency Department With Migraine: A Pilot Randomized Controlled Trial|Completed||Phase 3|12|Actual|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-10 22:06:28.310857|2017-10-10 22:06:28.310857
NCT02794428|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-15|||September 19, 2016|Actual|2016-09-19|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Chemoprevention of Gastric Carcinogenesis|Targeted Chemoprevention of Gastric Carcinogenesis in High Risk Populations|Recruiting||Phase 2|300|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||No||2017-10-10 22:06:28.440355|2017-10-10 22:06:28.440355
NCT02794415|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-08|||June 2016||2016-06-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Evaluating a Community-Based Exercise Intervention With Adults Living With HIV: An Interrupted Time Series Study|Translating Exercise Into the HIV Community: Evaluating a Community-based Exercise Intervention to Improve the Health of Adults Living With HIV|Recruiting||N/A|120|Anticipated|University of Toronto||1|||f||||f||||||||Undecided||2017-10-10 22:06:28.589078|2017-10-10 22:06:28.589078
NCT02794402|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-08|||September 2015||2015-09-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|Combat-JUDO||Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI|A Parallel, Double-blinded, Randomized, 6 Months, Two Arms Study With Lifestyle Intervention and Bydureon® or Lifestyle Intervention and Placebo in Adolescents With Obesity to Explore Differences With Regard to Change in BMI SDS|Active, not recruiting||Phase 2|44|Actual|Uppsala University||2|||f||||t||||||||||2017-10-10 22:06:28.715206|2017-10-10 22:06:28.715206
NCT02794389|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-03|||March 2016||2016-03-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Glutathione Levels and Compulsivity|How do Glutathione Levels Affect Compulsivity? A Double-blind, Placebo-controlled Study|Recruiting||N/A|24|Anticipated|University of Oxford||2|||f||||f||||||||Undecided||2017-10-10 22:06:28.802853|2017-10-10 22:06:28.802853
NCT02794376|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-03|||February 2016||2016-02-01|June 2016|2016-06-01||||May 2018|Anticipated|2018-05-01||Interventional|MIBS||Mindfulness for Irritable Bowel Syndrome|Mindfulness for Irritable Bowel Syndrome|Active, not recruiting||N/A|30|Actual|University of Oxford||2|||f||||||||||||||2017-10-10 22:06:28.936959|2017-10-10 22:06:28.936959
NCT02794363|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-04|||May 2014||2014-05-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||Platelet Rich Plasma Injections for Vulvar Lichen Sclerosus|Autologous Platelet Rich Plasma Intradermal Injections for Vulvar Lichen Sclerosus|Completed||N/A|15|Actual|Center for Vulvovaginal Disorders||1|||f||||f||||||||No||2017-10-10 22:06:29.028538|2017-10-10 22:06:29.028538
NCT02794350|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-09|||July 2015||2015-07-01|June 2016|2016-06-01|December 2025|Anticipated|2025-12-01|September 2017|Anticipated|2017-09-01||Observational|RBANS-H-CI-A||RBANS-H in Older Patients Before and After Cochlear Implantation: A Protocol for a Prospective Study|Repeatable Battery for the Assessment of Neuropsychological Status for Hearing Impaired Subjects (RBANS-H) in Older Patients Before and After Cochlear Implantation: A Protocol for a Prospective, Longitudinal Cohort Study|Recruiting||N/A|20|Anticipated|University Hospital, Antwerp|||1||f||||||||||||||2017-10-10 22:06:29.105038|2017-10-10 22:06:29.105038
NCT02794337|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-06-08|||December 2014||2014-12-01|June 2016|2016-06-01|January 2022|Anticipated|2022-01-01|January 2019|Anticipated|2019-01-01||Interventional|TACE-SBRT||TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer|Integrated Phase II/III Randomized Control Trial of Transarterial Chemoembolisation Alone or in Combination With Stereotactic Body Radiation in Patients With Unresectable Hepatocellular Cancer|Recruiting||Phase 2/Phase 3|386|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:06:29.209245|2017-10-10 22:06:29.209245
NCT02794324|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-06-08|||February 2012||2012-02-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The HeartSpare Study (Stage I)|Optimisation and Individualisation of Heart-Sparing Breast Radiotherapy Techniques (The HeartSpare Study)|Completed||Phase 2/Phase 3|57|Actual|Royal Marsden NHS Foundation Trust||3|||f||||f||||||||||2017-10-10 22:06:29.332283|2017-10-10 22:06:29.332283
NCT02794311|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-03|||February 2015||2015-02-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|AlcoolPredict||Risk Factors Associated With Binge Drinking Behaviors Among College Students|AlcoholPredict: Neuropsychology, Brain Imaging and Genetic Polymorphisms in Binge Drinking|Recruiting||N/A|300|Anticipated|CHU de Reims||1|||f||||f||||||||||2017-10-10 22:06:29.434123|2017-10-10 22:06:29.434123
NCT02794298|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TRAINSTIM1||tDCS Effects on GABA Concentration and Brain Functional Connectivity in Young Adults|Effects of Transcranial Direct Current Stimulation (tDCS) on GABA Concentration and Brain Functional Connectivity in Young Adults.|Completed||N/A|32|Actual|Charite University, Berlin, Germany||3|||f||||||||||||||2017-10-10 22:06:29.517157|2017-10-10 22:06:29.517157
NCT02794285|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-09-28|||June 30, 2016|Actual|2016-06-30|September 2017|2017-09-01|June 14, 2021|Anticipated|2021-06-14|June 14, 2021|Anticipated|2021-06-14||Interventional|TULIP SLE LTE||Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus|A Multicentre, Randomised, Double-blind, Placebo-Controlled Phase 3 Extension Study to Characterise the Long-term Safety and Tolerability of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus|Recruiting||Phase 3|575|Anticipated|AstraZeneca||2|||f||||t||||||||||2017-10-10 22:06:29.632985|2017-10-10 22:06:29.632985
NCT02794272|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|TRAINSTIM1||tDCS Effects on GABA Concentration and Brain Functional Connectivity in Older Adults Of Working Age|Effects of Transcranial Direct Current Stimulation (tDCS) on GABA Concentration and Brain Functional Connectivity in Older Adults.|Completed||N/A|24|Actual|Charite University, Berlin, Germany||3|||f||||||||||||||2017-10-10 22:06:32.407911|2017-10-10 22:06:32.407911
NCT02794259|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|TRAINSTIM1||tDCS Effects on GABA Concentration and Brain Functional Connectivity in Older Adults of Retirement Age|Effects of Transcranial Direct Current Stimulation (tDCS) on GABA Concentration and Brain Functional Connectivity in Older Adults|Completed||N/A|24|Actual|Charite University, Berlin, Germany||3|||f||||||||||||||2017-10-10 22:06:32.496329|2017-10-10 22:06:32.496329
NCT02794246|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-06|2017-07-07|||June 2016||2016-06-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Interventional|||CART-19 Post-ASCT for Multiple Myeloma|Phase 2 Study Of Autologous T Cells Engineered To Express an Anti-CD19 Chimeric Antigen Receptor (CART-19) Following First-line Autologous Stem Cell Transplantation for High-risk Multiple Myeloma|Active, not recruiting||Phase 2|25|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:06:32.604119|2017-10-10 22:06:32.604119
NCT02794233|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-07-03|||July 2016||2016-07-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Identification of Clinically Relevant Markers of Deep Brain Stimulation Electrode Impedance|Identification of Clinically Relevant Markers of Deep Brain Stimulation Electrode Impedance|Completed||N/A|6|Actual|University of Florida||1|||f||||f||||||||||2017-10-10 22:06:32.693352|2017-10-10 22:06:32.693352
NCT02794207|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-02-16|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Home or Away From Home - Descriptive Interviews (Aim 2)|Home or Away From Home: Patient-Centered Outcomes Related to the Management of Neutropenia Which Are Most Important to Children With AML and Their Caregivers|Enrolling by invitation||N/A|132|Anticipated|Children's Hospital of Philadelphia|||2||f||||f||||||||No|Only aggregate level data will be shared with the study sponsor Patient-Centered Outcomes Research Institute (PCORI).|2017-10-10 22:06:33.075339|2017-10-10 22:06:33.075339
NCT02794194|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-08|||December 2015||2015-12-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Whole Body Vibration Training on Unstable Surface|Effects of a Whole Body Vibration Training on Unstable Surface in Recreational Athletes With Chronic Ankle Instability|Completed||N/A|50|Actual|University of Castilla-La Mancha||3|||f||||||||||||||2017-10-10 22:06:33.205252|2017-10-10 22:06:33.205252
NCT02794181|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-08|2017-06-30|||May 31, 2016||2016-05-31|May 16, 2017|2017-05-16|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)|Study of Zika Virus and Related Arbovirus Infections in Deferred Blood Donors|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:06:33.306814|2017-10-10 22:06:33.306814
NCT02794168|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-07-12|||June 2016||2016-06-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|NOSTRA-III||Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury|Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury - (NOSTRA Phase III Trial): A Confirmatory, Placebo-controlled, Randomised, Double Blind, Multi-centre Study|Recruiting||Phase 3|220|Anticipated|Vasopharm GmbH||2|||f||||t||||||||||2017-10-10 22:06:33.426958|2017-10-10 22:06:33.426958
NCT02794142|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-03|||May 2015||2015-05-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|POPEYE||Oxidative Stress on Muscle Dysfunction in Hemodialysis Patient|Impact of the Oxidative Stress on the Skeletal Muscle Dysfunction in Hemodialysis Patient|Recruiting||N/A|22|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 22:06:33.869259|2017-10-10 22:06:33.869259
NCT02794129|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-07|||August 2013||2013-08-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|i-TCP||fMRI of Flight of Ideas in Bipolar Disorder|Functional Magnetic Resonance Imaging of Formal Thought Disorders in Bipolar Disorder|Recruiting||N/A|80|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 22:06:33.956457|2017-10-10 22:06:33.956457
NCT02794116|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-06-07|||January 2012||2012-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2013|Actual|2013-01-01||Interventional|||Sealants in Molars Affected by Molar-Incisor Hypomineralization|Survival of Sealants in Molars Affected by Molar-Incisor Hypomineralization|Completed||N/A|21|Actual|Universidade Federal do Paraná||2|||f||||t||||||||Yes||2017-10-10 22:06:34.056025|2017-10-10 22:06:34.056025
NCT02794103|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-04-24|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Virtual Reality Distraction for Procedural Pain Management and Anxiety in Children With Burn Injuries : A Pilot Study|A Pilot Study to Assess the Feasibility and the Preliminary Efficacy of a Virtual Reality Distraction Intervention for Pain Management and Anxiety in Children With Burn Injuries During Hydrotherapy|Completed||N/A|18|Actual|St. Justine's Hospital||1|||f||||f||||||||||2017-10-10 22:06:34.138185|2017-10-10 22:06:34.138185
NCT02794090|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-08|||May 2007||2007-05-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Childhood Obesity Treatment - Telephone Coaching vc Usual Care|Exclusive Telephone Coaching in Maintaining Weight Loss - An Randomized Controlled Trial of Childhood Obesity Treatment|Completed||N/A|37|Actual|Sodertalje Hospital||2|||f||||f||||||||No||2017-10-10 22:06:34.246628|2017-10-10 22:06:34.246628
NCT02794077|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-02|||January 2008||2008-01-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Cyclophosphamide for Nasopharyngeal Carcinoma|Metronomic Oral Cyclosphosphamide as Third-line Systemic Treatment or Beyond in Patients With Inoperable Locoregionally Advanced Recurrent or Metastatic Nasopharyngeal Carcinoma|Active, not recruiting||Phase 2|50|Anticipated|The University of Hong Kong||1|||f||||f||||||||No|There is no plan for to make individual participant data available.|2017-10-10 22:06:34.325254|2017-10-10 22:06:34.325254
NCT02794064|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-02|||May 2016||2016-05-01|June 2016|2016-06-01||||May 2017|Anticipated|2017-05-01||Interventional|||A Prototype Tri-modal Imaging Device for Breast Cancer|Clinical Evaluation of a Prototype Tri-modal Imaging Instrument for Guiding Breast Cancer Surgery|Recruiting||Phase 1|10|Anticipated|University Health Network, Toronto||1|||f||||f||||||||Yes||2017-10-10 22:06:34.402491|2017-10-10 22:06:34.402491
NCT02794051|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-09-28|||May 2016||2016-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Transdiagnostic Group Intervention for Children With Behavior Problems|Implementation of a Transdiagnostic Group Intervention for Children With Behavior Problems Within a Pediatric Outpatient Setting|Completed||N/A|8|Actual|University of Colorado, Denver||1|||f||||f||||||||Yes|Single subject design data|2017-10-10 22:06:34.490482|2017-10-10 22:06:34.490482
NCT02794025|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2016-06-07|||January 2010||2010-01-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Effect of Esmolol on Clinical Prognosis of Patients With Severe Sepsis|The Effect of Esmolol on Tissue Perfusion and Clinical Prognosis of Patients With Severe Sepsis: a Prospective Cohort Study .|Completed||N/A|151|Actual|Fujian Provincial Hospital||2|||f||||t||||||||Yes|151 patients with severe sepsis were selected and divided into the esmolol group (n = 75) or the control group (n = 76)|2017-10-10 22:06:34.866436|2017-10-10 22:06:34.866436
NCT02794012|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-08-29|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis|Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis|Recruiting||N/A|180|Anticipated|University of Colorado, Denver|||4||f||||f||||||||||2017-10-10 22:06:34.990464|2017-10-10 22:06:34.990464
NCT02793999|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-12-06|||May 2015||2015-05-01|December 2016|2016-12-01|May 2022|Anticipated|2022-05-01|May 2020|Anticipated|2020-05-01||Observational|||Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia|Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia|Recruiting||N/A|125|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||No||2017-10-10 22:06:35.108728|2017-10-10 22:06:35.108728
NCT02793986|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-04|2017-06-28|||August 2015||2015-08-01|June 2016|2016-06-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Dexmedetomidine vs Propofol Sedation Reduces Postoperative Delirium in Patients Receiving Hip Arthroplasty.|Dexmedetomidine vs Propofol Sedation Reduces Postoperative Delirium in Patients Receiving Hip Arthroplasty.|Completed||N/A|296|Actual|The First Affiliated Hospital of Anhui Medical University||2|||f||||t||||||||No||2017-10-10 22:06:35.228953|2017-10-10 22:06:35.228953
NCT02793960|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-09|||July 2016||2016-07-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Interventional|||Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa|A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Therapeutic Effect of Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa|Recruiting||Phase 1|10|Anticipated|University of Miami||1|||f||||t||||||||No||2017-10-10 22:06:35.488349|2017-10-10 22:06:35.488349
NCT02793947|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures|Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures: A Randomized Controlled Trial|Completed||Phase 4|102|Actual|University of Iowa||2|||f||||f||||||||No||2017-10-10 22:06:35.595789|2017-10-10 22:06:35.595789
NCT02793934|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-06-02|||September 2015||2015-09-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|||The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation|The Development Of MEdical Rehabilitation inRussia Pilot Project|Recruiting||N/A|2000|Anticipated|St. Petersburg State Pavlov Medical University|||2||f||||f||||||||No||2017-10-10 22:06:35.727882|2017-10-10 22:06:35.727882
NCT02793921|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-10-03|||April 2016||2016-04-01|October 2017|2017-10-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|EPICC||Exercise Program in Cancer and Cognition|Influence of Exercise on Neurocognitive Function in Breast Cancer|Recruiting||N/A|254|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 22:06:35.915382|2017-10-10 22:06:35.915382
NCT02793908|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-11-17|||June 2016||2016-06-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|PleyrisEndom||Subcutaneous Progesterone Supplementation in Patients With Endometriosis|The Role of the Subcutaneous Progesterone in Luteal Phase Supplementation in Patients With Endometriosis|Recruiting||Phase 3|52|Anticipated|University Magna Graecia||2|||f||||f||||||||Yes|Data will be published at the end of the study.|2017-10-10 22:06:36.054545|2017-10-10 22:06:36.054545
NCT02793895|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-05-15|||February 24, 2017|Actual|2017-02-24|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|December 2019|Anticipated|2019-12-01||Interventional|SEARCH-AF||Detection of Atrial Fibrillation After Cardiac Surgery|Post-Surgical Enhanced Monitoring for Cardiac Arrhythmias and Atrial Fibrillation (SEARCH-AF): A Randomized Controlled Trial|Recruiting||N/A|396|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||Undecided||2017-10-10 22:06:36.183184|2017-10-10 22:06:36.183184
NCT02793882|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-04-24|||September 2013||2013-09-01|April 2017|2017-04-01|April 24, 2017|Actual|2017-04-24|March 25, 2017|Actual|2017-03-25||Observational|||Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer|Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer|Completed||N/A|218|Actual|Sir Mortimer B. Davis - Jewish General Hospital|||1||f||||||||||||||2017-10-10 22:06:36.371809|2017-10-10 22:06:36.371809
NCT02793869|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-03|||February 2011||2011-02-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||A Novel Congenital Cataract Category System|A Novel Congenital Cataract Category System Based on Lens Opacity Positions and Their Relevant Anterior Segment Characteristics|Completed||N/A|428|Actual|Sun Yat-sen University|||4||f||||t||||||||||2017-10-10 22:06:36.443719|2017-10-10 22:06:36.443719
NCT02793856|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-11-21|||August 2016||2016-08-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer|A Dose-escalation Phase I Trial of PD-1 Knockout Engineered T Cells for the Treatment of Metastatic Non-small Cell Lung Cancer|Recruiting||Phase 1|15|Anticipated|Sichuan University||3|||f||||t||||||||Undecided||2017-10-10 22:06:36.570036|2017-10-10 22:06:36.570036
NCT02793843|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-01-07|||June 2016||2016-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Ondansetron vs Ondansetron Plus Dexamethasone for Relieving Intrathecal Morphine Side Effects After C-section|A Randomized Study Evaluating Preventive Role of Ondansetron Versus Ondansetron Plus Dexamethasone for Postoperative Side Effects of Intrathecal Morphine Injection in Patients Undergoing Elective C-section|Recruiting||N/A|200|Anticipated|Makassed General Hospital||2|||f||||f||||||||No||2017-10-10 22:06:36.785445|2017-10-10 22:06:36.785445
NCT02793830|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-01-27|||July 11, 2016||2016-07-11|January 2017|2017-01-01|November 12, 2016|Actual|2016-11-12|September 19, 2016|Actual|2016-09-19||Interventional|||A Mobile Phone Based Medication Reminder Program|A Mobile Phone Based Medication Reminder Program for Patients in China With Coronary Heart Disease: A Pilot Study|Completed||N/A|49|Actual|Duke University||2|||f||||t||||||||No||2017-10-10 22:06:36.897237|2017-10-10 22:06:36.897237
NCT02793817|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-08-15|||June 2016||2016-06-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain|A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain|Completed||Phase 3|520|Anticipated|Kala Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:06:36.982218|2017-10-10 22:06:36.982218
NCT02793804|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-09-20|||June 2016||2016-06-01|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|January 31, 2018|Anticipated|2018-01-31||Interventional|STAR Zambia||HIV Self-Testing Africa Zambia|Self-testing for HIV (HIVST) Amongst Urban, Peri-urban and Rural Communities in Zambia, Including a Cluster-randomised Trial of Community-based HIVST Distribution|Recruiting||N/A|4800|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-10 22:06:37.228027|2017-10-10 22:06:37.228027
NCT02793791|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-02|||September 2016||2016-09-01|June 2016|2016-06-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients|Prophylactic Minimally-invasive Local Ablation Therapies for the Hepatic Dysplastic Nodules in Patients With Positive Hepatitis B Surface Antigen (HBsAg).|Not yet recruiting||N/A|30|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||||||||||Undecided||2017-10-10 22:06:37.316974|2017-10-10 22:06:37.316974
NCT02793778|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-04-26|||July 2016||2016-07-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PIONEER-CD||Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effectiveness of a Nutritional Intervention in Improving the Intestinal Mucosal Health Status in Subjects With Crohn's Disease (CD) Receiving Anti-TNF Therapy|Recruiting||Phase 2|240|Anticipated|Prometheus Laboratories||2|||f||||t||||||||No||2017-10-10 22:06:37.428023|2017-10-10 22:06:37.428023
NCT02793765|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-10-10|||December 2016||2016-12-01|October 2016|2016-10-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Docetaxel Followed by Provenge in Metastatic Prostate Cancer|Docetaxel Followed by Provenge in Castration-Resistant Prostate Cancer|Not yet recruiting||Phase 2|32|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||No||2017-10-10 22:06:37.728677|2017-10-10 22:06:37.728677
NCT02793752|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-03|||March 2016||2016-03-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Observational|||Mitochondrial Activity of Cumulus Cells From the Cumulus-oocyte Complex and Oocyte Competence|A Prospective Study to Determine if Mitochondrial Activity of Cumulus Cells From the Cumulus-oocyte Complex is Associated With Maternal Age and Oocyte Competence to Blastocyst|Recruiting||N/A|100|Anticipated|Main Line Fertility Center|||2||f||||f||||||Samples Without DNA|"     Cumulus Cells   "|No||2017-10-10 22:06:37.865227|2017-10-10 22:06:37.865227
NCT02793739|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-28|||September 2016||2016-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Hyaluronic Acid Filler for Dorsal Finger Volume Loss|A Pilot Study Examining the Efficacy of Hyaluronic Acid Filler to Correct Volume Loss in the Dorsal Fingers|Recruiting||N/A|20|Anticipated|Marmur Medical||1|||f||||f||||||||||2017-10-10 22:06:37.984947|2017-10-10 22:06:37.984947
NCT02793726|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-02-01|||June 2016||2016-06-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|MoM_&_3Tesla||The Effects of Large Head MoM Hip Prosthesis on Soft Tissue: Study With 3 Tesla NMR|The Effects of Large Head Metal on Metal (MOM) Hip Prosthesis on Soft Tissue: Study With 3 Tesla Nuclear Magnetic Resonance (NMR)|Recruiting||N/A|30|Anticipated|Istituto Ortopedico Rizzoli|||2||f||||f|f|t|f|f||||Yes||2017-10-10 22:06:38.083681|2017-10-10 22:06:38.083681
NCT02793713|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-07|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Observational|||EBUS Score Validation for Malignancy|Prospective Validation of a Malignancy Scoring System During Endoscopic Evaluation of Mediastinal Lymph Nodes for Lung Cancer|Not yet recruiting||N/A|300|Anticipated|McMaster University|||1||f||||f||||||||No||2017-10-10 22:06:38.175056|2017-10-10 22:06:38.175056
NCT02793700|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-08-21|||July 2016||2016-07-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|||Pharmacokinetics (PK) and Modeling of Betamethasone Therapy in Threatened Preterm Birth|Pharmacokinetics and Modeling of Betamethasone Therapy in Threatened Preterm Birth|Recruiting||N/A|200|Anticipated|Indiana University|||1||f||||f||||||Samples With DNA|"     Maternal whole blood Cord blood Placenta   "|||2017-10-10 22:06:38.278982|2017-10-10 22:06:38.278982
NCT02793687|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-03|||October 2014||2014-10-01|June 2016|2016-06-01||||May 2016|Actual|2016-05-01||Interventional|||Study of Efficacy and Safety of MEXIDOL®|Multicenter, Randomized, Double Blind, Placebo-controlled, Parallel-group Study of Efficacy and Safety of the Drug MEXIDOL® for a Long Sequence of Therapy in Patients With Hemispheric Ischemic Stroke in the Acute and Early Recovery Period|Completed||Phase 3|150|Actual|Pharmasoft||2|||f||||f||||||||||2017-10-10 22:06:38.370556|2017-10-10 22:06:38.370556
NCT02793674|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-08-04|||September 2014||2014-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|HFNCandEOB||HFNC Flow Titration and Effort of Breathing in the PICU|High-Flow Nasal Cannula Flow Titration and Effort of Breathing in the Pediatric Intensive Care Unit|Completed||N/A|21|Actual|Children's Hospital Los Angeles||1|||f||||||||||||||2017-10-10 22:06:38.447344|2017-10-10 22:06:38.447344
NCT02793661|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-09-02|||May 2016||2016-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|STRENGTH||Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI|Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI (STRENGTH)|Recruiting||N/A|300|Anticipated|European Cardiovascular Research Center||2|||f||||f||||||||||2017-10-10 22:06:38.546172|2017-10-10 22:06:38.546172
NCT02793648|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-06-03|||October 2014||2014-10-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effectiveness of Ascorbic Acid and Tocopherol for Depression in Elderly.|Phase II, Double-blind, Randomized, 1-way Cross-over, to Investigate the Effectiveness of the Combination of Ascorbic Acid (Vitamin C) and Tocopherol (Vitamin E) Versus Placebo for the Treatment of Depressive Disorders in Elderly|Recruiting||Phase 2|50|Anticipated|The Mediterranean Institute for the Advance of Biotechnology and Health Research||2|||f||||t||||||||No||2017-10-10 22:06:38.716242|2017-10-10 22:06:38.716242
NCT02793635|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-07-27|||June 2016||2016-06-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Indego Exoskeleton After SCI|Impact of Gait Training With an Exoskeleton on Walking Function After Spinal Cord Injury (SCI)|Recruiting||N/A|10|Anticipated|Parker Hannifin Corporation||1|||f||||f|f|t|f|f|f|||||2017-10-10 22:06:38.852085|2017-10-10 22:06:38.852085
NCT02793622|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-09-08|||September 2016||2016-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PROMOTE-BC3||Prevention of Malaria in HIV-uninfected Pregnant Women and Infants|Prevention of Malaria in HIV-uninfected Pregnant Women and Infants|Recruiting||Phase 3|782|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:06:38.973004|2017-10-10 22:06:38.973004
NCT02793609|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Outpatient Versus Inpatient Balloon Catheter Induction of Labor|Outpatient Versus Inpatient Double Balloon Catheter for Induction of Labor: a Randomised Trial|Not yet recruiting||N/A|200|Anticipated|Turku University Hospital||2|||f||||f||||||||Undecided|Letter to patients.|2017-10-10 22:06:39.100652|2017-10-10 22:06:39.100652
NCT02793596|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-03-17|||August 2016||2016-08-01|March 2017|2017-03-01||||November 2016|Actual|2016-11-01||Interventional|||Reliability of Waveform Analysis as an Adjunct to Loss of Resistance for Obstetrical Epidural Blocks|Reliability of Waveform Analysis as an Adjunct to Loss of Resistance for Obstetrical Epidural Blocks|Completed||N/A|100|Actual|McGill University Health Center||1|||f||||f||||||||No||2017-10-10 22:06:39.206673|2017-10-10 22:06:39.206673
NCT02793583|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-07-03|||June 2016||2016-06-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|UNITY-NHL||Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma|A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkin's Lymphoma|Recruiting||Phase 2/Phase 3|500|Anticipated|TG Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 22:06:39.303925|2017-10-10 22:06:39.303925
NCT02793570|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-11-08|||January 2015||2015-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Non-contrast 3D MR Angiography for Assessment of the Thoracic Aorta in Pregnancy|Native High-resolution 3D SSFP MR Angiography for Assessment of the Thoracic Aorta in Pregnant Subjects With Familial Aortopathies|Completed||N/A|15|Actual|University Hospital Birmingham NHS Foundation Trust|||1||f||||f||||||||Undecided||2017-10-10 22:06:39.554968|2017-10-10 22:06:39.554968
NCT02793557|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-07-29|||January 2016||2016-01-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth|A Randomised, Double-blind, Placebo-controlled Trial of FOL-005 to Investigate Clinical Safety and Effect on Hair Growth in Healthy Volunteers|Completed||Phase 1/Phase 2|44|Actual|Follicum AB||5|||f||||f||||||||||2017-10-10 22:06:39.645576|2017-10-10 22:06:39.645576
NCT02793544|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-10-02|||December 2016|Actual|2016-12-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide|A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide for Patients With Hematologic Malignancies|Recruiting||Phase 2|80|Anticipated|Center for International Blood and Marrow Transplant Research||4|||f||||t||||||||||2017-10-10 22:06:39.778441|2017-10-10 22:06:39.778441
NCT02793531|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-07|||May 2016||2016-05-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Anabolic Response Cancer|Assessment of Anabolic Responsiveness to Protein Intake in Advanced Cancer|Recruiting||N/A|60|Anticipated|Texas A&M University||2|||f||||f||||||||||2017-10-10 22:06:40.05428|2017-10-10 22:06:40.05428
NCT02793518|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-07|||May 2013||2013-05-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Mental Time Travel and Identity in Bipolar Disorder Patients|Self-defining Memories and Future Projections in Bipolar Disorder Patients|Recruiting||N/A|60|Anticipated|CHU de Reims||2|||f||||f||||||||||2017-10-10 22:06:40.175889|2017-10-10 22:06:40.175889
NCT02793505|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-02|||January 2014||2014-01-01|June 2016|2016-06-01||||November 2015|Actual|2015-11-01||Observational|||Safety of Metformin in Pregnancy|Pregnancy Outcome Following Maternal Exposure to Metformin: a Collaborative ENTIS Study|Completed||N/A|950|Actual|Centre Hospitalier Universitaire Vaudois|||2||f||||||||||||||2017-10-10 22:06:40.294177|2017-10-10 22:06:40.294177
NCT02793492|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-07-25|||August 2016||2016-08-01|July 2016|2016-07-01||||August 2018|Anticipated|2018-08-01||Interventional|OSPREY ILIAC||Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery|OSPREY ILIAC: Occlusive/Stenotic Peripheral Artery REvascularization StudY for Common and/or External ILIAC Artery Using the Misago® RX Self-expanding Peripheral Stent|Not yet recruiting||Phase 3|101|Anticipated|Terumo Medical Corporation||1|||f||||t||||||||||2017-10-10 22:06:40.377861|2017-10-10 22:06:40.377861
NCT02793479|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-06-20|||March 1, 2017|Actual|2017-03-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|RABE||Radiofrequency Ablation in Patients With Barrett's Esophagus|National Registry for Radiofrequency Ablation in Patients With Barrett's Esophagus|Recruiting||N/A|500|Anticipated|Austrian Society Of Surgical Oncology|||1||f||||||||||||||2017-10-10 22:06:40.475591|2017-10-10 22:06:40.475591
NCT02793466|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-01-30|||July 2016||2016-07-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Durvalumab in Pediatric and Adolescent Patients|A Phase I, Open-Label, Single Institution Study to Assess the Safety, Tolerability, and Pharmacokinetics of Durvalumab in Pediatric Patients With Relapsed or Refractory Solid Tumors, Lymphoma, and Central Nervous System Tumors|Recruiting||Phase 1|36|Anticipated|Children's Hospital Los Angeles||1|||f||||t||||||||Undecided||2017-10-10 22:06:40.549057|2017-10-10 22:06:40.549057
NCT02793453|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-03-29|||January 19, 2016|Actual|2016-01-19|March 2017|2017-03-01|April 2016|Actual|2016-04-01|March 23, 2016|Actual|2016-03-23||Interventional|PAROPAM||Antimicrobial Peptides in Periodontitis|Antimicrobial Peptides in Periodontitis : a Pilot Study|Completed||N/A|29|Actual|CHU de Reims||2|||f||||f||||||||||2017-10-10 22:06:40.643215|2017-10-10 22:06:40.643215
NCT02793440|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-05-15|||December 2013||2013-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effectiveness of Lumbar Traction in Lumbar Disk Herniation|Clinical Results After Medical Therapy Alone or Medical Therapy Associated With Lumbar Traction in the Treatment of Nerve Root Pain of Lumbar Disc Herniation With Disco-radicular Conflict|Recruiting||N/A|310|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 22:06:40.728556|2017-10-10 22:06:40.728556
NCT02793427|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-08|||February 2011||2011-02-01|June 2016|2016-06-01||||June 2019|Anticipated|2019-06-01||Interventional|AGEDIA||Patient With Any Pathology (According to the Appreciation of the Investigator) Which Could Disturb the Participation in the Study|Evaluation of Advanced Glycation End Products of Proteins as a Long-term Retrospective Markers of Glycemic Control in a Population of Non-complicated Type 1 Diabetic Children.|Active, not recruiting||N/A|160|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 22:06:40.819841|2017-10-10 22:06:40.819841
NCT02793414|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-01-31|||September 2016||2016-09-01|January 2017|2017-01-01||||April 2017|Anticipated|2017-04-01||Observational|||Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia||Withdrawn||N/A|0|Actual|Menzies School of Health Research|||2||f||||f||||||||||2017-10-10 22:06:40.92326|2017-10-10 22:06:40.92326
NCT02793401|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-06-03|||May 2015||2015-05-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Chronic Shoulder Pain Treatment: High Intensity Laser or Ultrasound|A Comparison of the Efficacy of High Intensity Laser and Ultrasound Therapies in Patients With Chronic Shoulder Pain: A Randomized Controlled Single Blind Study|Completed||Phase 4|141|Actual|Bursa Yüksek İhtisas Education and Research Hospital||2|||f||||f||||||||||2017-10-10 22:06:40.990754|2017-10-10 22:06:40.990754
NCT02793388|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-02-07|||September 2016||2016-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SPRUE||A Trial on Supervised Primaquine Use in Ethiopia|A Randomized Controlled Trial on Supervised Primaquine Use in Ethiopia|Withdrawn||Phase 4|0|Actual|Menzies School of Health Research||2|||f||||f||||||||||2017-10-10 22:06:41.305375|2017-10-10 22:06:41.305375
NCT02793375|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-07|||July 2016||2016-07-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|Montelukast||Does Montelukast Decrease Post Adenotonsillectomy Pain in Children|Does Montelukast Decrease Post Adenotonsillectomy Pain in Children? A Randomized Controlled Trial|Not yet recruiting||Phase 3|120|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No||2017-10-10 22:06:41.444126|2017-10-10 22:06:41.444126
NCT02793349|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-03|||June 2015||2015-06-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The ABSORB Bioresorbable Scaffold Below the Knee Study|ABSORB BTK Study: A Prospective, Multi-center, Controlled Clinical Evaluation of the Use of a Bioresorbable Drug Eluting Stent (Absorb, Abbott Vascular) in the Arterial Vasculature Below the Knee|Recruiting||N/A|60|Anticipated|The University of New South Wales||1|||f||||t||||||||Undecided||2017-10-10 22:06:41.665105|2017-10-10 22:06:41.665105
NCT02793336|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-14|||August 3, 2016|Actual|2016-08-03|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|ELIPI||Early Life Cohort in Papua Indonesia (ELIPI Study)||Recruiting||N/A|500|Anticipated|Menzies School of Health Research|||1||f||||f||||||||||2017-10-10 22:06:41.814828|2017-10-10 22:06:41.814828
NCT02793323|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-01-07|||June 2016||2016-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Superficial Cervical Nerve Block vs NSAIDs for the Relief of Shoulder Pain After Laparoscopic Surgeries|Superficial Cervical Nerve Block Versus NSAIDs for the Relief of Shoulder Tip Pain After Laparoscopic Surgeries|Recruiting||N/A|60|Anticipated|Makassed General Hospital||2|||f||||f||||||||||2017-10-10 22:06:41.939807|2017-10-10 22:06:41.939807
NCT02793310|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-29|||October 2016|Actual|2016-10-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|DMEK||DMEK Versus DSAEK Study|Corneal Transplantation by DMEK - is it Really Better Than DSAEK?|Recruiting||N/A|56|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 22:06:42.082551|2017-10-10 22:06:42.082551
NCT02793297|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-06-08|||January 2015||2015-01-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Sourdough Fermented Rye Crisp Bread on Appetite and Postprandial Metabolic Responses|Effects of Sourdough Fermented Rye Crisp Bread on Appetite and Postprandial Metabolic Responses: A Randomized Cross-over Trial|Completed||N/A|24|Actual|Swedish University of Agricultural Sciences||3|||f||||f||||||||Undecided||2017-10-10 22:06:42.219873|2017-10-10 22:06:42.219873
NCT02793284|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-12|||January 9, 2017|Actual|2017-01-09|July 2017|2017-07-01|October 2023|Anticipated|2023-10-01|October 2020|Anticipated|2020-10-01||Interventional|PICs||Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy|Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy|Recruiting||N/A|80|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-10 22:06:42.327659|2017-10-10 22:06:42.327659
NCT02793271|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-07-24|||February 1, 2016|Actual|2016-02-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|RESHAPE-mh||Reducing Stigma Among Healthcare Providers to Improve Mental Health Services|Reducing Stigma Among Healthcare Providers to Improve Mental Health Services: RESHAPE-mh Protocol for a Feasibility and Acceptability Pilot Cluster Randomized Control Trial|Recruiting||N/A|300|Anticipated|George Washington University||2|||f||||t||||||||||2017-10-10 22:06:42.460929|2017-10-10 22:06:42.460929
NCT02793258|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-07-07|||July 22, 2016|Actual|2016-07-22|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|EmoStim||Impact of tDCS on Emotional Processing in Major Depression|Impact of Transcranial Direct Current Stimulation on Emotional Processing in Major Depression|Recruiting||Phase 3|60|Anticipated|Hôpital le Vinatier||2|||f||||t||||||||||2017-10-10 22:06:42.626569|2017-10-10 22:06:42.626569
NCT02793245|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-11|||June 2015||2015-06-01|July 2017|2017-07-01|November 21, 2016|Actual|2016-11-21|November 21, 2016|Actual|2016-11-21||Interventional|Scan-Bronchi||Patient Characteristics and Tracheobronchial Anatomy|Influence of Patient Characteristics on the Tracheobronchial Anatomy Evaluated by a CT Examination|Completed||N/A|240|Actual|Hopital Foch||1|||f||||f||||||||||2017-10-10 22:06:42.796298|2017-10-10 22:06:42.796298
NCT02793232|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-02-14|||June 2016||2016-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.|A 3-part Phase 1, Randomized, Double-blind, Sponsor-open, Placebo Controlled Trial To Evaluate The Safety, Tolerability, Food Effect, Pharmacokinetics And Pharmacodynamics Of Pf-06751979 After Oral Administration: Part A - Single Ascending Doses In Healthy Adults; Part B - Multiple Ascending Doses In Healthy Adults; And Part C - Multiple Doses To Older Subjects|Completed||Phase 1|46|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 22:06:42.912652|2017-10-10 22:06:42.912652
NCT02793219|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-10-10|||December 2016||2016-12-01|October 2016|2016-10-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer|Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer|Not yet recruiting||Phase 2|32|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||No||2017-10-10 22:06:43.074917|2017-10-10 22:06:43.074917
NCT02793206|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-02|||August 2011||2011-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|TODS||Spectral Domain OCT Imaging in Patients With Optic Nerve Head Drusen (Tuebingen SD-OCT IN OPTIC NERVE HEAD DRUSEN STUDY)|Spectral Domain Optic Cohaerence Tomography Imaging in Patients With Optic Nerve Head Drusen|Active, not recruiting||N/A|35|Actual|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-10 22:06:43.211199|2017-10-10 22:06:43.211199
NCT02793193|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-02|||July 2016||2016-07-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Probiotics on Central Nervous System Functions in Humans|Effect of Probiotics on Central Nervous System Functions in Humans|Not yet recruiting||Phase 2/Phase 3|170|Anticipated|University Hospital Tuebingen||5|||f||||t||||||||Yes||2017-10-10 22:06:43.318387|2017-10-10 22:06:43.318387
NCT02793180|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-11-14|||November 2016||2016-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01|1 Day|Observational [Patient Registry]|DYSPNEA||Documentation of Heart Failure in a Gulf Registry|Gulf Documentation of Ambulatory Sick Patients With Heart Failure Registry|Recruiting||N/A|4000|Anticipated|Gulf Heart Association|||1||f||||f||||||||||2017-10-10 22:06:43.46234|2017-10-10 22:06:43.46234
NCT02793167|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-02-06|||March 2016||2016-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Clinical Values of Automated Electronic Alert for Acute Kidney Injury|Clinical Values of Automated Electronic Alert for Acute Kidney injury-a Prospective ,Randomly Controlled Cohort Study|Recruiting||N/A|2000|Anticipated|Guangdong General Hospital||2|||f||||||||||||||2017-10-10 22:06:43.576335|2017-10-10 22:06:43.576335
NCT02793154|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-07-12|||September 26, 2016|Actual|2016-09-26|July 2017|2017-07-01|March 16, 2017|Actual|2017-03-16|March 16, 2017|Actual|2017-03-16||Interventional|||An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects|A Randomized, Open-label, Active-Controlled, Parallel-Group, Exploratory Study on the Effects of Repeated Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 4|4|Actual|GlaxoSmithKline||3||Early termination due to insufficient enrollment.|f||||f||||||||||2017-10-10 22:06:43.700406|2017-10-10 22:06:43.700406
NCT02793128|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2017-09-27|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Interventional|Olympus||The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study|A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma|Recruiting||Phase 3|74|Anticipated|UroGen Pharma Ltd.||1|||f||||t|t|f||||||||2017-10-10 22:06:43.976476|2017-10-10 22:06:43.976476
NCT02793115|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-07-27|||November 2014||2014-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Physician Disclosures in the Real World of Conflicting Interests|Physician Disclosures in the Real World of Conflicting Interests|Completed||N/A|895|Actual|The Cleveland Clinic||5|||f||||f||||||||||2017-10-10 22:06:44.205106|2017-10-10 22:06:44.205106
NCT02793102|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2016-06-03|||September 2012||2012-09-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Sensory Workshops and Anorexia Nervosa|Prospective Evaluation of a Year of Therapeutic Impact Sensory Workshops on Body Mass Index in Anorexia Adolescent Mental|Withdrawn||N/A|0|Actual|Fondation Lenval||2||Lack of patient responding to criteria|f||||f||||||||No||2017-10-10 22:06:44.313591|2017-10-10 22:06:44.313591
NCT02793089|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-02|||January 2005||2005-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF|Retrospective Cohort Study of Increased Risk of Ectopic Pregnancy Associated With Marked Variation of Estradiol During the Early Luteal Phase and High Progesterone on hCG Day in IVF|Completed||N/A|578|Actual|IVI Vigo|||4||f||||f||||||||No||2017-10-10 22:06:44.411792|2017-10-10 22:06:44.411792
NCT02793076|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-02|||February 2016||2016-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Physical and Emotional Benefits of Group Dance Intervention for Breast Cancer Survivors|Physical and Emotional Benefits of Group Dance Intervention for Breast Cancer Survivors|Completed||N/A|12|Actual|University of the Sciences in Philadelphia||1|||f||||f||||||||No||2017-10-10 22:06:44.50925|2017-10-10 22:06:44.50925
NCT02793063|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-03-01|||June 2016||2016-06-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2|Rare Diseases Clinical Research Network Brittle Bone Disorders Consortium Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2|Completed||N/A|300|Actual|University of South Florida|||1||f||||f||||||||No||2017-10-10 22:06:44.598108|2017-10-10 22:06:44.598108
NCT02793050|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-03-17|||June 2016||2016-06-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|TrObs||Retrospective Study of Trabectedin in Soft Tissue Sarcomas|Trabectedin in Soft Tissue Sarcomas. A Retrospective Observational Analysis (TrObs)|Recruiting||N/A|900|Anticipated|Italian Sarcoma Group|||1||f||||f||||||||Yes|Aggregate anonymized results will be available upon request at the end of the study|2017-10-10 22:06:44.685483|2017-10-10 22:06:44.685483
NCT02793037|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-06-02|||January 2016||2016-01-01|June 2016|2016-06-01||||December 2019|Anticipated|2019-12-01||Interventional|||A Proof of Concept for All-ceramic Zirconia Resin Bonded Bridges for Canine, Premolar and Short Span Posterior Teeth|A Proof of Concept for All-ceramic Zirconia Resin Bonded Bridges for Canine, Premolar and Short Span Posterior Teeth Official Title:|Enrolling by invitation||N/A|84|Anticipated|The University of Hong Kong||1|||f||||||||||||||2017-10-10 22:06:44.890416|2017-10-10 22:06:44.890416
NCT02793024|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-03-07|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01||Interventional|||Shopping Smart - Adolescent Intervention to Improve Shopping Practices Where You Live and Learn|Shopping Smart - Adolescent Intervention to Improve Shopping Practices Where You Live and Learn|Not yet recruiting||N/A|400|Anticipated|University of Kentucky||2|||f||||t|f|f||||||No||2017-10-10 22:06:44.954608|2017-10-10 22:06:44.954608
NCT02793011|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-06-14|||June 2016||2016-06-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Dexamethasone and Post-tonsillectomy Pain in Children|Does Dexamethasone Reduce Postoperative Pain in Pediatric Tonsillectomy Patients?|Recruiting||Phase 4|150|Anticipated|University of Michigan||2|||f||||f||||||||No||2017-10-10 22:06:45.031221|2017-10-10 22:06:45.031221
NCT02792998|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-12-20|||May 2016||2016-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects|A 2-Stage Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IW-1701 Tablets in Healthy Subjects in a Double-blind, Placebo-controlled, Multiple-ascending-dose Stage and an Open-label, Single-dose, Crossover Food-effect Stage|Completed||Phase 1|67|Actual|Ironwood Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-10 22:06:45.123343|2017-10-10 22:06:45.123343
NCT02792985|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-06-02|||August 2015||2015-08-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|||Multisensory Stimulation and Enriched Environments During Post-traumatic Amnesia|The Effects of Multisensory Stimulation and Enriched Environments During Post-traumatic Amnesia Following a Traumatic Brain Injury|Recruiting||N/A|20|Anticipated|Institut Guttmann||2|||f||||f||||||||No||2017-10-10 22:06:45.206815|2017-10-10 22:06:45.206815
NCT02792972|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-07|||September 2015||2015-09-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Antiseptic and Analgesic Action Acmella Oleracea Skin: Randomized Clinical Trial|Antiseptic and Analgesic Action Acmella Oleracea Skin: Randomized Clinical Trial|Completed||N/A|60|Actual|Universidade do Vale do Sapucai||2|||f||||||||||||Undecided||2017-10-10 22:06:45.30178|2017-10-10 22:06:45.30178
NCT02792959|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-28|||August 2014||2014-08-01|November 2016|2016-11-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|IMOVA||Evaluation of Response to the Neoadjuvante Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging|Evaluation of Response to the Neoadjuvante Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging (Fusion MRI and FDG-PET-CT)|Completed||N/A|10|Actual|Institut Bergonié||1|||f||||f||||||||||2017-10-10 22:06:45.385816|2017-10-10 22:06:45.385816
NCT02792946|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-06-15|||November 2015|Actual|2015-11-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis||Completed||Phase 3|244|Actual|Hyundai Pharmaceutical Co., LTD.||2|||f||||f||||||||No||2017-10-10 22:06:45.485513|2017-10-10 22:06:45.485513
NCT02792933|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-06-14|||July 2009||2009-07-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||Air Versus Saline Solution for the Localization of the Epidural Space in Labour Analgesia|Localization of the Epidural Space Using the Loss of Resistance Technique for Labour Analgesia: A Randomized Controlled Trial Comparing Air Versus Saline Solution|Completed||N/A|400|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||Yes||2017-10-10 22:06:45.546586|2017-10-10 22:06:45.546586
NCT02792920|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-06-07|||March 2016||2016-03-01|June 2016|2016-06-01||||April 2017|Anticipated|2017-04-01||Interventional|XIENCE STEMI||Multicenter Registry of Very Early and Late Clinical Outcomes to Everolimus-eluting Cobalt-Chromium Stent In Patients With ST Elevation Myocardial Infarction|Multicenter Registry of Very Early and Late Clinical Outcomes to Everolimus-eluting Cobalt-Chromium Stent In Patients With ST Elevation Myocardial Infarction|Recruiting||N/A|400|Anticipated|Hyogo Brain and Heart Center||1|||f||||||||||||||2017-10-10 22:06:45.88748|2017-10-10 22:06:45.88748
NCT02792907|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-02-13|||July 2016||2016-07-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SENSCOMP||Sensor Controlled Compliance Evaluation of Compressive Elastic Stockings|"Sensor Controlled Compliance Evaluation of Compressive Elastic Stockings Treatment in Patients After Elective Foot and Ankle Surgery A Prospective, Randomized and Controlled Cohort Study"|Completed||N/A|100|Actual|Balgrist University Hospital||2|||f||||t||||||||No||2017-10-10 22:06:46.015537|2017-10-10 22:06:46.015537
NCT02792894|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-02-23|||April 2016|Actual|2016-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|FaNs||Family Networks (FaNs) for Children With Developmental Disorders and Delays|Evaluation of Family Networks (FaNs) for Children With Developmental Disorders and Delays Program: A Cluster Randomized Control Trial|Recruiting||N/A|540|Anticipated|Human Development Research Foundation, Pakistan||2|||f||||t||||||||No||2017-10-10 22:06:46.127506|2017-10-10 22:06:46.127506
NCT02792881|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-02|||June 2016||2016-06-01|June 2016|2016-06-01|June 2022|Anticipated|2022-06-01|June 2019|Anticipated|2019-06-01||Interventional|||The Safety and Feasibility of Laparoscopic Total Gastrectomy for Remnant Gastric Cancer||Enrolling by invitation||Phase 2|50|Anticipated|Fujian Medical University||1|||f||||t||||||||||2017-10-10 22:06:46.26199|2017-10-10 22:06:46.26199
NCT02792868|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-04-06|||April 2016||2016-04-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|BIOCAC||Biological Phosphocalcic Metabolism and Coronary Artery Calcifications|Biological Phosphocalcic Metabolism and Coronary Artery Calcifications|Completed||N/A|83|Actual|French Cardiology Society|||1||f||||f||||||Samples Without DNA|"     Blood 24h urines   "|||2017-10-10 22:06:46.393497|2017-10-10 22:06:46.393497
NCT02792855|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-09-23|||January 2017||2017-01-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||"Comparing the snifﬁng Position With Simple Head Extension"|"Randomized Study Comparing the snifﬁng Position With Simple Head Extension for Awake Orotracheal Intubation With Fiberoptic in Obesity Patients"|Recruiting||N/A|60|Anticipated|The First Hospital of Qinhuangdao||2|||f||||t||||||||||2017-10-10 22:06:46.495772|2017-10-10 22:06:46.495772
NCT02792842|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2017-04-24|||July 2016||2016-07-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer|Phase 2 Clinical Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer: a Multicenter Randomized Placebo-controlled Double-blind Study to Investigate the Efficacy and Safety of ART-123|Active, not recruiting||Phase 2|75|Anticipated|Asahi Kasei Pharma Corporation||3|||f||||||||||||||2017-10-10 22:06:46.627548|2017-10-10 22:06:46.627548
NCT02792829|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-06-02|||August 2014||2014-08-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Crossover Study to Evaluate the Relative Bioavailability and Palatability of a Lenvatinib Suspension Compared to the Capsule Formulation in Adult Healthy Volunteers|A Randomized Three-Arm, Single-dose, Two-period Crossover Study to Evaluate the Relative Bioavailability and Palatability of a Lenvatinib Suspension Compared to the Capsule Formulation in Adult Healthy Volunteers|Completed||Phase 1|60|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-10 22:06:46.74223|2017-10-10 22:06:46.74223
NCT02792816|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-07|||June 2009||2009-06-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|December 2013|Actual|2013-12-01||Observational|||Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar|A Multi-site Cohort Observational Study for Molecular Assessment of Artemisinin Resistance Falciparum Malaria in Myanmar|Completed||N/A|550|Actual|Department of Medical Research, Lower Myanmar|||6||f||||t||||||Samples With DNA|"     Finger prick blood samples were taken onto filter paper and Keep dry until DNA extraction.   "|Undecided|We may share the data on request after publication.|2017-10-10 22:06:46.869322|2017-10-10 22:06:46.869322
NCT02792803|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|April 2017|Actual|2017-04-01||Interventional|||A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma|An 8 Week Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Open Angle Glaucoma|Recruiting||Phase 4|60|Anticipated|DBYAN Medicine Professional Corporation||2|||f||||f||||||||||2017-10-10 22:06:47.017081|2017-10-10 22:06:47.017081
NCT02792790|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-06|||March 2016||2016-03-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Carpal Tunnel Syndrome and Amyloid Cardiomyopathy|Carpal Tunnel Syndrome and Amyloid Cardiomyopathy|Active, not recruiting||N/A|96|Actual|The Cleveland Clinic|||1||f||||f||||||Samples Without DNA|"     Blood will be stored in Cleveland Clinic to be used for the future studies.   "|||2017-10-10 22:06:47.202698|2017-10-10 22:06:47.202698
NCT02792764|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-06-06|||February 2014||2014-02-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|VEINSFORLIFE||Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs|A Prospective, Multi-centered Study to Assess the Complication Rates of Oncology Patients Accessed With Peripheral Intravenous Lines Versus Implantable Ports for Chemotherapy Administration|Completed||N/A|300|Actual|C. R. Bard|||2||f||||f||||||||No||2017-10-10 22:06:47.447843|2017-10-10 22:06:47.447843
NCT02792751|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-01-23|||May 2014||2014-05-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Does the Use of Bispectral Index Reduce the Oxidative Stress in Endoscopic Retrograde Cholangiopancreatography?|Effects of Bispectral Index on Oxidative Stress|Completed||N/A|50|Actual|Antalya Training and Research Hospital||2|||f||||f||||||||No|There is no plan to share data|2017-10-10 22:06:47.535445|2017-10-10 22:06:47.535445
NCT02792738|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-02-24|||May 2016||2016-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Hypnopnee||Effect of Hypnosis on Dyspnea|Effect of Hypnosis on Dyspnea|Recruiting||N/A|20|Anticipated|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil||1|||f||||f||||||||No||2017-10-10 22:06:47.636492|2017-10-10 22:06:47.636492
NCT02792725|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-07-13||||||July 2017|2017-07-01||||||||Expanded Access|||Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer|An Open-Label, Multi-Center Expanded Access Program of Abemaciclib for the Treatment of Hormone Receptor Positive, HER2 Negative Advanced or Metastatic Breast Cancer in Patients With Disease Progression on Prior Therapies|Available||N/A|||Eli Lilly and Company|||||||||||||||||||2017-10-10 22:06:47.740553|2017-10-10 22:06:47.740553
NCT02792712|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-01|||January 2016||2016-01-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI|Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With ST-elevation Myocardial Infarction (STEMI) Undergoing Primary Percutaneous Coronary Intervention: A Magnetic Resonance Imaging Study (TIGER Study)|Recruiting||Phase 4|200|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||No||2017-10-10 22:06:47.918719|2017-10-10 22:06:47.918719
NCT02792686|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-02|||March 2014||2014-03-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||ABX464 First in Man Study|ABX464 First in Man, Open Label, Parallel Group, Single Ascending Dose Study|Completed||Phase 1|24|Actual|Abivax S.A.||1|||f||||f||||||||No||2017-10-10 22:06:48.386764|2017-10-10 22:06:48.386764
NCT02792673|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-06|||May 2016||2016-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparative Study of Three Different Embryo Transfer Media in ICSI Cycles|"Comparative Study Between Three Different Embryo Transfer Media: Hyaluronan-enriched Medium Embryo Glue®, 30% Protein-supplemented Culture Medium Global Total® and Autologous Follicular Fluid Concerning Chemical and Clinical Pregnancy Rate and Ongoing Pregnancy and Miscarriage Rates in ICSI Cycles"|Active, not recruiting||N/A|150|Anticipated|South Valley University||3|||f||||t||||||||Undecided||2017-10-10 22:06:48.473536|2017-10-10 22:06:48.473536
NCT02792660|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-06-05|||July 2016||2016-07-01|June 2017|2017-06-01||||June 2018|Anticipated|2018-06-01||Interventional|||Identification of Cerebrospinal Fluid With Injeq IQ-Needle During Paediatric Lumbar Puncture|Identification of Cerebrospinal Fluid With Injeq IQ-Needle During Paediatric Lumbar Puncture|Recruiting||N/A|40|Anticipated|Injeq Ltd||1|||f||||f||||||||No||2017-10-10 22:06:48.557944|2017-10-10 22:06:48.557944
NCT02792647|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-11-09|||May 2016||2016-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects|A Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose Escalation Study to Investigate the Safety, Toleration, and Pharmacokinetics of Multiple Oral Doses of IX-01 in Healthy Male Subjects|Completed||Phase 1|24|Actual|Ixchelsis Limited||2|||f||||f||||||||No||2017-10-10 22:06:48.660003|2017-10-10 22:06:48.660003
NCT02792634|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-10-24|||June 2016||2016-06-01|May 2016|2016-05-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Observational|NALKOSTEP||Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery|Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery / Untersuchung Der Pathogenese Der Nicht-alkoholischen Steatohepatitis Und Der Leberregeneration Nach Bariatrischer Chirurgie|Recruiting||N/A|200|Anticipated|RWTH Aachen University|||1||f||||f||||||||||2017-10-10 22:06:48.75884|2017-10-10 22:06:48.75884
NCT02792621|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-02-20|||November 8, 2016|Actual|2016-11-08|December 2016|2016-12-01|December 8, 2017|Anticipated|2017-12-08|June 8, 2017|Anticipated|2017-06-08||Interventional|Rejuvenate||Increasing Mitochondrial Function on Skeletal Muscle Performance in Older Men|Assessing the Effects of Increased Mitochondrial Function on Skeletal Muscle Performance in Older Men; a Pilot Study|Recruiting||N/A|20|Anticipated|Royal Devon and Exeter NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:06:48.842257|2017-10-10 22:06:48.842257
NCT02792608|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-08-28|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Mindfulness-Based Therapy for Brain Tumour Survivors|A Mindfulness-Based Intervention to Improve Quality of Life Among Brain Tumour Survivors|Recruiting||N/A|15|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 22:06:48.940526|2017-10-10 22:06:48.940526
NCT02792595|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-06-16|||June 2015||2015-06-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||In Vivo Sun Protection Factor Determination|Sun Protection Factor Determination (In Vivo Determination of the Sun Protection Factor ISO 24444) (61-SPF-iM)|Completed||N/A|28|Actual|GlaxoSmithKline||10|||f||||f||||||||||2017-10-10 22:06:49.058335|2017-10-10 22:06:49.058335
NCT02791347|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-05-09|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Nutrition Intervention Among Stem Cell Recipients: Post Hospital Discharge|Nutrition Intervention Among Stem Cell Recipients: a Randomized Controlled Trial Post Hospital Discharge|Recruiting||N/A|52|Anticipated|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-10 22:07:04.201708|2017-10-10 22:07:04.201708
NCT02792582|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-09-26|||June 22, 2016|Actual|2016-06-22|September 2017|2017-09-01|June 2027|Anticipated|2027-06-01|June 2025|Anticipated|2025-06-01||Interventional|||A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection|A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection|Recruiting||Phase 2|140|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|f|f||||||||2017-10-10 22:06:49.177739|2017-10-10 22:06:49.177739
NCT02792569|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-07|||April 2016||2016-04-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|||Follicle Activation by Inhibition of the Hippo Pathway|Auto-transplantation of Fragmented Ovarian Cortical Tissue in Infertile Patients With Premature Ovarian Oocyte Depletion - a Study to Promote Follicular Activation and Subsequent Fertility|Recruiting||N/A|20|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||Undecided||2017-10-10 22:06:49.34507|2017-10-10 22:06:49.34507
NCT02792556|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-12-19|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CHECK-TOP||Urine Pregnancy Test Compared to Transvaginal Ultrasound (CHECK-TOP).|Evaluation of Urine Pregnancy Test, CHECK TOP Test, Compared to Transvaginal Ultrasound During Control Visit Post Drug Abortion (CHECK-TOP).|Recruiting||N/A|300|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:06:49.530138|2017-10-10 22:06:49.530138
NCT02792543|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-07|||January 2017||2017-01-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|FRY||Impact of Chyme Reinfusion Compared to Parenteral Nutrition on the Incidence of Complications in Patients With a Temporary High-output Double Enterostomy: a Multicentre Randomized Controlled Trial - FRY: efFiciency of Reinfusion of chYme - (FRY)|Impact of Chyme Reinfusion Compared to Parenteral Nutrition on the Incidence of Complications in Patients With a Temporary High-output Double Enterostomy: a Multicentre Randomized Controlled Trial - FRY: efFiciency of Reinfusion of chYme - (FRY)|Not yet recruiting||N/A|268|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:06:49.603475|2017-10-10 22:06:49.603475
NCT02792530|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-06-09|||August 2016||2016-08-01|April 2016|2016-04-01||||May 2017|Anticipated|2017-05-01||Interventional|||Daily Sodium Intake in Anuric Hemodialysis Patients and Interdialytic Weight Gain|Daily Sodium Intake in Anuric Hemodialysis Patients and Interdialytic Weight Gain|Not yet recruiting||N/A|20|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-10 22:06:49.682974|2017-10-10 22:06:49.682974
NCT02792517|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-05-11|||February 12, 2016|Actual|2016-02-12|May 2017|2017-05-01|September 9, 2016|Actual|2016-09-09|September 9, 2016|Actual|2016-09-09||Interventional|||AMG 334 Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females|A Multi-Center, Open-label, Pharmacokinetic Drug Interaction Study of AMG 334 and a Combined Oral Contraceptive in Healthy Female Subjects|Completed||Phase 1|41|Actual|Amgen||1|||f||||f||||||||||2017-10-10 22:06:49.752545|2017-10-10 22:06:49.752545
NCT02792504|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-10-02|||January 23, 2016|Actual|2016-01-23|October 2017|2017-10-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive|Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive|Recruiting||N/A|600|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 22:06:49.834223|2017-10-10 22:06:49.834223
NCT02792491|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-07|||August 2012||2012-08-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over|Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over|Active, not recruiting||Phase 2|57|Actual|Pusan National University Hospital||1|||f||||f||||||||Yes|We will share collected data with principal investigators in Korea.|2017-10-10 22:06:49.916786|2017-10-10 22:06:49.916786
NCT02792478|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-08-25|||May 6, 2016|Actual|2016-05-06|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Observational|PERSEIDA||Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study|Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type Colorectal Cancer in First-line Treatment: a Prospective, Observational Multi-centre Study in Spain. PERSEIDA Study|Recruiting||N/A|119|Anticipated|Amgen|||1||f||||f||||||Samples With DNA|"     The blood samples will be collected according to the site's routine clinical practice usually     prior to each treatment cycle and at the follow-up visits. Analysis of the RAS mutation     status will be carried out on blood samples taken at baseline, on those carried out at 20     +/-2 weeks after the start of treatment (in any case, prior to the second tumour assessment)     and on the sample obtained upon progression, coinciding with routine clinical practices for     collecting blood.   "|||2017-10-10 22:06:49.988949|2017-10-10 22:06:49.988949
NCT02792465|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-06-16|||November 11, 2016|Actual|2016-11-11|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors|An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-402257 Administered Orally to Patients With Advanced Solid Tumors|Recruiting||Phase 1|48|Anticipated|University Health Network, Toronto||1|||f||||t||||||||No||2017-10-10 22:06:50.087655|2017-10-10 22:06:50.087655
NCT02792452|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-04-12|||September 2016||2016-09-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Clinical Value of Stress Echocardiography in Moderate Aortic Stenosis|Clinical Value of Stress Echocardiography in Moderate Aortic Stenosis|Recruiting||N/A|100|Anticipated|London North West Healthcare NHS Trust|||1||f||||f||||||||Yes|Patient scan results will be shared with their referring physician|2017-10-10 22:06:52.187901|2017-10-10 22:06:52.187901
NCT02792439|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-01-12|||February 2016||2016-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|AMWALKS||America Walks: An Observational Study of Walking Behavior Based on Passive Step Tracking|America Walks: An Observational Study of Walking Behavior Based on Passive Step Tracking Using a Mobile Phone Application|Completed||N/A|200|Actual|TrialX Inc|||1||f||||f||||||||Yes|All study data will be released on http://trialx.com/americawalksstudy in aggregate manner and findings will submitted for publication in academic journals such as the Journal of American Medical Informatics. Any identifiable participant information will not be revealed publicly in any manner whatsoever.|2017-10-10 22:06:52.28491|2017-10-10 22:06:52.28491
NCT02792426|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-06|||July 2016||2016-07-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users|A Study to Evaluate the Comparative Pharmacokinetics of Nicotine After Administration Via Research Electronic Nicotine Delivery System S-TA-U001 in Healthy Volunteer Smokers and Current E-Cigarette Users|Not yet recruiting||Phase 1|34|Anticipated|NJOY, Inc.||3|||f||||f||||||||Undecided||2017-10-10 22:06:52.388601|2017-10-10 22:06:52.388601
NCT02792413|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-28|||September 2016||2016-09-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|HDENO||Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease|Randomized Controlled Study Evaluating the Effect of a Biotherapy Treatment (Anti-RANKL Ligand Antibody: Denosumab) on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease|Not yet recruiting||Phase 4|30|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||No||2017-10-10 22:06:52.509341|2017-10-10 22:06:52.509341
NCT02792400|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-10-24|||May 2016||2016-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|August 2016|Actual|2016-08-01||Interventional|||The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors|The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors|Active, not recruiting||N/A|24|Actual|University Hospital, Gentofte, Copenhagen||8|||f||||f||||||||Undecided||2017-10-10 22:06:52.662302|2017-10-10 22:06:52.662302
NCT02792374|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-06|||January 2012||2012-01-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|||Psychological Profile of Dental Patients|Psychological Profile of Dental Patients. A Case Control Study|Completed||N/A|97|Actual|Talebian, Alireza, M.D.|||2||f||||f||||||||No||2017-10-10 22:06:52.854886|2017-10-10 22:06:52.854886
NCT02792361|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-06|||June 2016||2016-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|EPOP||A Clinical Effectiveness Trial in Post-Operative Pterional Craniotomy Drain Placement|A Randomized, Non-Blind, Clinical Effectiveness Trial in Post-Operative Pterional Craniotomy Drain Placement|Not yet recruiting||N/A|90|Anticipated|University of Arizona||2|||f||||f||||||||No|Individual participant data will not be made available. However, findings may be published in a peer-reviewed academic journal.|2017-10-10 22:06:52.924972|2017-10-10 22:06:52.924972
NCT02792348|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-06|||February 2011||2011-02-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|January 2015|Actual|2015-01-01||Observational|ACEU||Change of Urinary Metabolic Profile Secondary to a Congenital Urine Flow Impairment (UFI) by Nuclear Magnetic Resonance (NMR) and Metabolomics Analysis|Change of Urinary Metabolic Profile Secondary to a Congenital Urine Flow Impairment (UFI) by Nuclear Magnetic Resonance (NMR) and Metabolomics Analysis|Active, not recruiting||N/A|200|Actual|Hospices Civils de Lyon|||2||f||||f||||||Samples Without DNA|"     De-identified and study coded urine samples.   "|||2017-10-10 22:06:52.99492|2017-10-10 22:06:52.99492
NCT02792335|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-06|||January 2012||2012-01-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients|Oral Anticoagulant Bleeding Rate and Discontinuation and Adherence Patterns in Non-Valvular Atrial Fibrillation (NVAF) Patients|Completed||N/A|28000|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 22:06:53.187844|2017-10-10 22:06:53.187844
NCT02792322|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-18|||May 2016||2016-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Pilot Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck|A Pilot Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck Using the da Vinci&#174; Robotic Surgical Systems|Recruiting||N/A|50|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:06:53.293492|2017-10-10 22:06:53.293492
NCT02792309|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-28|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Impact Evaluation of MotherWise Program|Strengthening Relationship Education and Marriage Services - Impact Evaluation of MotherWise Program|Recruiting||N/A|1000|Anticipated|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-10 22:06:53.404781|2017-10-10 22:06:53.404781
NCT02792296|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-11-03|||June 2016||2016-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Feasibility & Characterization of Project: EVO Monitor Cognitive Measurements|A Study to Assess the Feasibility of and to Characterize Project: EVO Monitor Cognitive Function Measurements When Played Daily, Weekly, or Multiple Times Per Day in Adults 40-55 Years Old|Completed||N/A|71|Actual|Akili Interactive Labs, Inc.||3|||f||||f||||||||No||2017-10-10 22:06:53.510605|2017-10-10 22:06:53.510605
NCT02792283|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-12-27|||January 2016||2016-01-01|December 2016|2016-12-01||||July 2018|Anticipated|2018-07-01||Interventional|||Platelet Function in Hemodialysis Patient|Evaluation of the Bleeding Risk in Patient Undergoing Hemodialysis by the Analysis of Platelet Function by PFA-100®|Recruiting||N/A|100|Anticipated|CHU de Reims||1|||f||||||||||||||2017-10-10 22:06:53.58965|2017-10-10 22:06:53.58965
NCT02792270|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-06-01|||June 2016||2016-06-01|June 2016|2016-06-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects Of Caloric Restriction On Post-Operative Complications In Sarcoma Patients Treated With Pre-Operative Radiation Therapy|Effects Of Caloric Restriction On Post-Operative Complications In Sarcoma Patients Treated With Pre-Operative Radiation Therapy|Not yet recruiting||N/A|30|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 22:06:53.698832|2017-10-10 22:06:53.698832
NCT02792257|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-03-02|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|THC-AD||Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (AD) (THC-AD)|Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (AD) (THC-AD)|Recruiting||Phase 2|160|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||Undecided||2017-10-10 22:06:53.827877|2017-10-10 22:06:53.827877
NCT02792205|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-11-23|||January 2017||2017-01-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|PERICOLL||Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding|Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding|Not yet recruiting||N/A|200|Anticipated|Nantes University Hospital|||1||f||||f||||||||No||2017-10-10 22:06:55.304023|2017-10-10 22:06:55.304023
NCT02792192|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-28|||June 13, 2016|Actual|2016-06-13|September 2017|2017-09-01|November 27, 2021|Anticipated|2021-11-27|March 7, 2019|Anticipated|2019-03-07||Interventional|||Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants|A Phase Ib/II, Open-Label Study of the Safety and Pharmacology of Atezolizumab Administered With or Without Bacille Calmette-Guérin in Patients With High-Risk Non−Muscle-Invasive Bladder Cancer|Recruiting||Phase 1/Phase 2|70|Anticipated|Hoffmann-La Roche||4|||f||||t||||||||||2017-10-10 22:06:55.386539|2017-10-10 22:06:55.386539
NCT02792179|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-07-20|||July 19, 2016|Actual|2016-07-19|July 2017|2017-07-01|September 28, 2016|Actual|2016-09-28|September 28, 2016|Actual|2016-09-28||Interventional|||Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants|A Pilot Longitudinal Follow-Up Study of Tau Burden in The Brain of Subjects With Alzheimer's Disease Who Previously Participated in Study BP29409 Using [18F]RO6958948 Positron Emission Tomography|Completed||Phase 1|4|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:06:55.508425|2017-10-10 22:06:55.508425
NCT02792166|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-30|||June 2016||2016-06-01|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Single Anastomosis Duodeno-ileal Bypass With Sleeve Gastrectomy (SADI-S): A Prospective Cohort Study|Single Anastomosis Duodeno-ileal Bypass With Sleeve Gastrectomy (SADI-S): A Prospective Cohort Study|Recruiting||N/A|40|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 22:06:55.584371|2017-10-10 22:06:55.584371
NCT02792153|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Estradiol and Fear Extinction in Anorexia Nervosa (AN)|Estradiol and Fear Extinction for Calorie-Dense Foods in Weight Restored Adult Women With Anorexia Nervosa (AN)|Recruiting||Phase 1|40|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 22:06:55.6813|2017-10-10 22:06:55.6813
NCT02792140|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-04-04|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams|The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams|Completed||Phase 4|32|Actual|University of Bern||3|||f||||t||||||||Undecided||2017-10-10 22:06:55.754201|2017-10-10 22:06:55.754201
NCT02792127|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-06-06|||July 2016||2016-07-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Online Program for Social Anxiety|Online Cognitive Behavioural Therapy Program for Social Anxiety|Not yet recruiting||N/A|400|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:06:55.825858|2017-10-10 22:06:55.825858
NCT02792114|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-04-19|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||T-Cell Therapy for Advanced Breast Cancer|A Phase I Clinical Trial to Evaluate the Safety and Tolerability of Mesothelin-Specific Chimeric Antigen Receptor-Positive T Cells in Patients With Metastatic Mesothelin-Expressing Breast Cancer|Recruiting||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:06:55.893062|2017-10-10 22:06:55.893062
NCT02792088|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-07|||July 2015||2015-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HBV||Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues|A Phase III, Multi-center, Randomized, Double-blinded, Parallel Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues|Recruiting||Phase 3|244|Anticipated|IlDong Pharmaceutical Co Ltd||2|||f||||t||||||||Undecided||2017-10-10 22:06:55.989246|2017-10-10 22:06:55.989246
NCT02792075|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-01-01|||July 2016||2016-07-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|July 2020|Anticipated|2020-07-01||Observational|IRIS imaging||Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study|Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study|Recruiting||N/A|4000|Anticipated|Asan Medical Center|||4||f||||f||||||||No|This is not a publicly funded trial.|2017-10-10 22:06:56.08293|2017-10-10 22:06:56.08293
NCT02790398|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-11-29|||January 2014||2014-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Up-regulating Positive Affect in Emotional Disorders|Transdiagnostic Up-regulation of Positive Affect in Emotional Disorders: A Randomized Pilot Study|Completed||N/A|24|Actual|Universitat Jaume I||2|||f||||f||||||||No||2017-10-10 22:07:16.020681|2017-10-10 22:07:16.020681
NCT02792049|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-09-16|2016-06-12||July 2015||2015-07-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ventilation Using a Bag Valve Mask With Integrated Internal Handle|Single Rescuer Ventilation Using a Bag Valve Mask With Integrated Internal Handle Versus Standard Bag Valve Mask in a Manikin Model: A Randomized Crossover Trial|Completed||N/A|70|Actual|Brooke Army Medical Center||2|||f||||f||||||||No||2017-10-10 22:06:56.451233|2017-10-10 22:06:56.451233
NCT02792036|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-03-31|||November 1, 2016|Actual|2016-11-01|December 2016|2016-12-01|December 31, 2024|Anticipated|2024-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma|Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma|Recruiting||Phase 1|18|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-10 22:06:56.801458|2017-10-10 22:06:56.801458
NCT02792023|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-16|||June 30, 2016|Actual|2016-06-30|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|IDAFIT||Usefulness of Fecal Immunochemical Test in Iron Deficiency Anemia (IDAFIT)|Usefulness of Fecal Immunochemical Test in the Diagnosis Algorithm of Iron Deficiency Anemia.|Recruiting||N/A|550|Anticipated|Hospital Universitario de Canarias||2|||f||||t||||||||||2017-10-10 22:06:56.919746|2017-10-10 22:06:56.919746
NCT02792010|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-01-11|||May 2015||2015-05-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CARHAT02||Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage|Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage|Completed||N/A|31|Actual|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 22:06:57.043262|2017-10-10 22:06:57.043262
NCT02791997|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-01-06|||February 2015||2015-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Audition After a Lesion and in Migraine. (AuditionPostLesion)|Consequences of a Brain Lesion or of Migraine on Auditory Processing: Attention, Memory and Emotion|Recruiting||N/A|335|Anticipated|Hospices Civils de Lyon||3|||f||||f||||||||No||2017-10-10 22:06:57.129702|2017-10-10 22:06:57.129702
NCT02791984|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-01|||April 2015||2015-04-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SUPRA-PAM||Respiratory Variability in Aortic Blood Velocity Measured by Suprasternal View as an Indicator of Fluid Responsiveness|Respiratory Variability in Aortic Blood Velocity Measured by Suprasternal View as an Indicator of Fluid Responsiveness|Completed||N/A|62|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:06:57.243077|2017-10-10 22:06:57.243077
NCT02791971|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-03-10|||November 2016||2016-11-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Share Health Study: Teen Social Connections and Health|SpeakOut: Empowering Teen to Teen Social Communication About Highly Effective Contraception (Also Known As: The Share Health Study: Teen Social Connections and Health)|Recruiting||N/A|2500|Anticipated|University of California, San Francisco||2|||f||||f||||||||Undecided||2017-10-10 22:06:57.329563|2017-10-10 22:06:57.329563
NCT02791958|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-04-07|||March 2016||2016-03-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy|Pharmacodynamic Equivalence Study of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular Fixed Dose Combination Pill AAR as Compared to Monotherapy With the Reference Products Altace® 10 mg and Lipitor® 40 mg|Active, not recruiting||Phase 2|528|Anticipated|Ferrer Internacional S.A.||3|||f||||f||||||||No||2017-10-10 22:06:57.47192|2017-10-10 22:06:57.47192
NCT02791945|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-09-30|||August 2016||2016-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|NAC||N-acetylcysteine Treatment of Hazardous or Harmful Alcohol Use In Veterans With TBI|N-acetylcysteine Treatment of Hazardous or Harmful Alcohol Use In Veterans With TBI|Recruiting||Phase 2|30|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:06:58.323181|2017-10-10 22:06:58.323181
NCT02791932|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-07-28|||July 2016||2016-07-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of Exercise on Perinatal Depression|Exercise Intervention for Preventing Perinatal Depression|Not yet recruiting||N/A|200|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:06:58.460325|2017-10-10 22:06:58.460325
NCT02791919|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-03|2017-05-01|||May 25, 2017|Anticipated|2017-05-25|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 1 Trial of the Wee1 Kinase Inhibitor AZD1775 in Combination With Flag Chemotherapy in Children, Adolescents, and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia|Withdrawn||Phase 1|0|Actual|National Cancer Institute (NCI)||1||Other - Protocol moved to Disapproved|f||||t|t|f||||||||2017-10-10 22:06:58.541319|2017-10-10 22:06:58.541319
NCT02791906|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-14|||May 2016||2016-05-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|||Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease|Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease|Recruiting||Phase 2|20|Anticipated|University of Pennsylvania||2|||f||||||||||||||2017-10-10 22:06:58.698271|2017-10-10 22:06:58.698271
NCT02791893|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-04-28|||March 21, 2017|Actual|2017-03-21|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|||Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness|Vagus Nerve Stimulation: A Non-invasive Treatment to Improve the Health of Gulf Veterans With Gulf War Illness|Recruiting||N/A|40|Anticipated|Beth Israel Medical Center||2|||f||||f|f|t|f|||||No||2017-10-10 22:06:58.820234|2017-10-10 22:06:58.820234
NCT02791711|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-06|||December 2013||2013-12-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|HFNC||Using Nasal Broadband Glasses in the Initial Management of Severe Bronchiolitis in Infants Admitted in ICU|Using Nasal Broadband Glasses HFNC (High Flow Nasal Cannula) in the Initial Management of Severe Bronchiolitis in Infants Admitted in ICU: Bicentric Observational Study on the 2013-2014 Epidemic|Completed||N/A|33|Actual|Fondation Lenval||1|||f||||f||||||||No||2017-10-10 22:07:00.740022|2017-10-10 22:07:00.740022
NCT02791880|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-06-21|||October 25, 2016|Actual|2016-10-25|June 2017|2017-06-01|March 2031|Anticipated|2031-03-01|March 2031|Anticipated|2031-03-01||Observational|||Acute Kidney Injury Genomics and Biomarkers in TAVR Study|Genomic and Biomarker Predictors of Acute Kidney Injury and Other Post-Procedural Outcomes Following Transcatheter Aortic Valve Replacement|Recruiting||N/A|3000|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples With DNA|"     DNA collected before procedure. Paired urine, serum, and plasma samples collected before     valve replacement, six hours after valve replacement, and post-procedure days 1 and 2.     Additional samples are collected on post-procedure days 3, 4 and 5 if the patient develops     acute kidney injury after the procedure.   "|Yes|There is a possibility that individual participant data and samples will be de-identified and shared with other cohort study investigators for purposes of replicating biomarker and genetic associations with adverse outcomes.|2017-10-10 22:06:58.953059|2017-10-10 22:06:58.953059
NCT02791867|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-01|||December 2014||2014-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake||Terminated||Phase 1/Phase 2|48|Actual|Dasman Diabetes Institute||2||The study drug was not provided resulting in termination for unacceptable delays|f||||||||||||||2017-10-10 22:06:59.103279|2017-10-10 22:06:59.103279
NCT02791854|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-12-13|||February 2016||2016-02-01|December 2016|2016-12-01||||December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|IBD:QUORUS||Improving the Quality of Care for Adults With Inflammatory Bowel Disease|Improving the Quality of Care for Adults With Inflammatory Bowel Disease|Enrolling by invitation||N/A|5000|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||f||||||||Undecided||2017-10-10 22:06:59.183696|2017-10-10 22:06:59.183696
NCT02791841|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-04-11|||January 2016||2016-01-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Interventions for Developmental Dyslexia|The Effectiveness of Intervention for Developmental Dyslexia: The Rhythmic Reading Training Compared With Hemisphere-Specific Stimulation and Action Video Games|Recruiting||N/A|33|Anticipated|Catholic University of the Sacred Heart||3|||f||||||||||||Undecided||2017-10-10 22:06:59.290711|2017-10-10 22:06:59.290711
NCT02791828|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-01|||March 2016||2016-03-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Observational|VecuHD||Creation and Validation of a Questionnaire to Measure the Feelings of a Chronic Renal Insufficiency Person During His Hemodialysis|Creation and Validation of an Instrument for Measuring the Quality of Experience of a Hemodialysis of Chronic Renal Insufficiency Subject|Recruiting||N/A|320||CHU de Reims|||1||f||||||||||||||2017-10-10 22:06:59.390423|2017-10-10 22:06:59.390423
NCT02791815|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-10-12|||July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects|A Single-center, Open-label, Randomized, Two-treatment Crossover Study to Investigate the Effect of Selexipag on the Pharmacokinetics of Midazolam and Its Metabolite 1-hydroxymidazolam in Healthy Male Subjects|Completed||Phase 1|20|Actual|Actelion||2|||f||||f||||||||||2017-10-10 22:06:59.460595|2017-10-10 22:06:59.460595
NCT02791802|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-11-23|||August 2016||2016-08-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|June 2020|Anticipated|2020-06-01||Observational|MultiSELECt||Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes|A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes|Recruiting||N/A|1000|Anticipated|Technische Universität Dresden|||2||f||||t||||||Samples With DNA|"     For biosampling one additional serum (9 ml), one EDTA vaccutainer (2.7 ml) and two PAXgene™     Blood RNA Tubes will be provided for each subject.   "|Undecided||2017-10-10 22:06:59.566691|2017-10-10 22:06:59.566691
NCT02791789|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-01|||October 2013||2013-10-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|sematic||SEMATIC Pilot Study in Children With Autism Spectrum Disorder Using an Innovative Edutainment Software|Multicenter Pilot Study: Measuring the Evolution of Learning Words and Phrases in Children With Autism Spectrum Disorder Using an Innovative Edutainment Software (SEMATIC)|Completed||N/A|17|Actual|Fondation Lenval||1|||f||||f||||||||No||2017-10-10 22:06:59.658703|2017-10-10 22:06:59.658703
NCT02791776|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-01|||November 2014||2014-11-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|VD-SIA||Impact of the Choice of the Distal Vertebral in the Surgery of the Thoracic Adolescent Idiopathic Scoliosis|Impact of the Choice of the Distal Vertebral When Posterior Instrumentation in the Surgery of the Thoracic Adolescent Idiopathic Scoliosis|Active, not recruiting||N/A|200|Anticipated|Fondation Lenval||1|||f||||f||||||||No||2017-10-10 22:06:59.915917|2017-10-10 22:06:59.915917
NCT02791763|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-01-16|||June 2016||2016-06-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase III Study of GSK1278863 in Japanese Non-dialysis and Peritoneal Dialysis Subjects With Renal Anemia|A 52-week, Phase III, Open-label, Multi-center Study to Evaluate Efficacy and Safety of GSK1278863 in Japanese Non-dialysis and Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease|Recruiting||Phase 3|320|Anticipated|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:07:00.08136|2017-10-10 22:07:00.08136
NCT02791750|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-01-17|||June 2016||2016-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|HACAMI||5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma|5 Years Follow-up in the Lorraine Institute of Oncology With Adjuvant Therapy for Women With Breast Invasive Carcinoma|Recruiting||N/A|150|Anticipated|Institut de Cancérologie de Lorraine|||1||f||||f||||||||No||2017-10-10 22:07:00.412091|2017-10-10 22:07:00.412091
NCT02791737|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-09-21|||July 2016||2016-07-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Exercise Prehab in Older Adults With Hematologic Malignancies|Maintaining Fitness: Exercise in Patients With Hematologic Malignancy|Recruiting||N/A|30|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:07:00.500194|2017-10-10 22:07:00.500194
NCT02791724|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-03|||June 2016||2016-06-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|ENCODE||Evaluating a Novel Internet Intervention for Persons With Epilepsy and Depression|Evaluating a Novel Cognitive-Behavioral Online Depression Intervention for Persons With Epilepsy (Desiconnect): Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Gaia AG||2|||f||||f||||||||Yes|Anonymized individual participant data shall be made available upon request for projects such as meta-analyses after completion of the study|2017-10-10 22:07:00.632364|2017-10-10 22:07:00.632364
NCT02791698|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-10-26|||June 2016||2016-06-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Observational|||The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis|The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis|Recruiting||N/A|80|Anticipated|Bnai Zion Medical Center|||1||f||||f||||||Samples Without DNA|"     urine and hair   "|No||2017-10-10 22:07:00.824294|2017-10-10 22:07:00.824294
NCT02791685|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-12-28|||May 2016||2016-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Smartphone Delivered In-home Cardiopulmonary Rehabilitation|Smartphone Delivered In-home Cardiopulmonary Rehabilitation|Recruiting||N/A|100|Anticipated|Emory University||3|||f||||f||||||||||2017-10-10 22:07:00.911341|2017-10-10 22:07:00.911341
NCT02791672|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-02|||June 2016||2016-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Perioperative Care of Breast Reconstruction With Latissimus Dorsi Flap and Tissue Expander: Early Discharge Protocol in a Day Surgery Setting|Perioperative Care of Breast Reconstruction With Latissimus Dorsi Flap and Tissue Expander: Early Discharge Protocol in a Day Surgery Setting|Not yet recruiting||N/A|40|Anticipated|Ottawa Hospital Research Institute|||1||f||||t||||||||Yes|Individual participant data will not be made available. Anonymity will be maintained for all published data.|2017-10-10 22:07:01.026472|2017-10-10 22:07:01.026472
NCT02791659|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-04-25|2017-02-01||July 2016|Actual|2016-07-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Radiation Exposure of ERCP Personnel at Different Standing Locations and Different Patient Positions.|Radiation Exposure of ERCP Personnel at Different Standing Locations and Different Patient Positions (Prone and Left Lateral Decubitus)|Completed||N/A|55|Actual|Chulalongkorn University||2|||f||||t||||||||No||2017-10-10 22:07:01.147457|2017-10-10 22:07:01.147457
NCT02791646|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|SMART||Optimizing Delivery of a Behavioral Cancer Pain Intervention Using a SMART|Optimizing Delivery of a Behavioral Cancer Pain Intervention Using a SMART|Recruiting||N/A|350|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:07:01.511081|2017-10-10 22:07:01.511081
NCT02791633|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-02-06|||January 2017||2017-01-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|REmLap||Recovery After Emergency Laparotomy|Recovery After Emergency Laparotomy: a Prospective Observational Feasibility Study|Not yet recruiting||N/A|75|Anticipated|Dudley Group NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 22:07:01.613404|2017-10-10 22:07:01.613404
NCT02791620|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-01|||June 2016||2016-06-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||The Efficacy of Nanofractional Radiofrequency Device in Arm Rejuvenation and Tightening : a Pilot Study|The Efficacy of Nanofractional Radiofrequency Device in Arm Rejuvenation and Tightening : a Pilot Study|Recruiting||N/A|20|Anticipated|Chulalongkorn University||1|||f||||f||||||||No||2017-10-10 22:07:01.702302|2017-10-10 22:07:01.702302
NCT02791607|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-08-09|||July 2015||2015-07-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01|12 Months|Observational [Patient Registry]|||The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.|Technical Development of P16-INk4A-expressing Circulating Tumor Cells Detection Comparing With Human Papillomavirus Infection in Cancer Tissue in Patients With Head and Neck Cancer and Its Clinical Relevance.|Recruiting||N/A|150|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||None Retained|"     Blood samples were drawn by standard procedure, stored in EDTA-coating tubes in 4 degree     temperature, then sent for CTCs counting and analysis.   "|||2017-10-10 22:07:01.795938|2017-10-10 22:07:01.795938
NCT02791594|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-09-23|||June 2016||2016-06-01|September 2016|2016-09-01||||June 2018|Anticipated|2018-06-01||Observational|||Imaging FDG Flare in Melanoma|Imaging the Flare Response With FDG PET/CT in Patients With Advanced Metastatic Melanoma on Pembrolizumab.|Recruiting||N/A|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:07:01.903943|2017-10-10 22:07:01.903943
NCT02791581|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-28|||July 28, 2017|Actual|2017-07-28|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|UPBEAT||Understanding and Predicting Breast Cancer Events After Treatment|Understanding and Predicting Breast Cancer Events After Treatment (UPBEAT)|Recruiting||N/A|1000|Anticipated|Wake Forest University Health Sciences|||3||f||||t|f|f||||Samples With DNA|"     A blood sample of approximately 2 tablespoons drawn from a vein in the arm or central line.   "|||2017-10-10 22:07:02.004406|2017-10-10 22:07:02.004406
NCT02791568|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-03-07|||January 31, 2017|Actual|2017-01-31|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Observational|||Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation|Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation|Recruiting||N/A|200|Anticipated|University of Wisconsin, Madison|||3||f||||t||||||||Yes||2017-10-10 22:07:02.152737|2017-10-10 22:07:02.152737
NCT02791555|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-04-10|||June 2016||2016-06-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers|Comparison of the Effects of the Direct Thrombin Inhibitor, Pradaxa, to That of Warfarin on Bone Mass and Bone Turnover Markers|Terminated||N/A|2|Actual|UConn Health|||2|Study was terminated early due to low enrollment numbers.|f||||f||||||Samples Without DNA|"     samples w/o DNA   "|Undecided||2017-10-10 22:07:02.254647|2017-10-10 22:07:02.254647
NCT02791542|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-03-01|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Observational|SEARCH||Sorting and Expression Profiling of Airway Cells From Humans (The SEARCH Study)|The Regulation of RhoA Activation in Airway Smooth Muscle|Recruiting||N/A|40|Anticipated|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     Bronchial biopsies, brushes and lavage Whole blood Urine Serum Plasma   "|No||2017-10-10 22:07:02.36149|2017-10-10 22:07:02.36149
NCT02791529|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-01|||September 2016||2016-09-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|OCTR-Electro||Scalpel Versus Electrocautery for Surgical Skin Incision in Open Carpal Tunnel Release|Scalpel Versus Electrocautery for Surgical Skin Incision in Open Carpal Tunnel Release - Randomized, Controlled Open-Label Trial|Not yet recruiting||Phase 1|200|Anticipated|Turku University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:07:02.47228|2017-10-10 22:07:02.47228
NCT02791516|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-02|2017-09-01|||January 16, 2017|Actual|2017-01-16|August 2017|2017-08-01|May 14, 2018|Anticipated|2018-05-14|February 13, 2018|Anticipated|2018-02-13||Interventional|||A Safety and Efficacy Study to Evaluate AMG 785 in South Korean Women With Osteoporosis.|A Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Compare the Efficacy and Safety of Romosozumab With Placebo in Postmenopausal South Korean Women With Osteoporosis|Active, not recruiting||Phase 3|67|Actual|Amgen||2|||f||||f|f|f||||||||2017-10-10 22:07:02.542283|2017-10-10 22:07:02.542283
NCT02791503|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-08|||May 2016||2016-05-01|June 2016|2016-06-01||||May 2019|Anticipated|2019-05-01||Interventional|CROSSFIRE||CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy|CROSSFIRE Trial: Crossatlantic Randomized Controlled Trial Comparing Outcome in Survival After Systemic Plus Focal Therapy for Inoperable Pancreatic Carcinoma: Radiotherapy Versus Irreversible Electroporation|Recruiting||Phase 2/Phase 3|138|Anticipated|VU University Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:07:02.670076|2017-10-10 22:07:02.670076
NCT02791490|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-06-08|||June 16, 2016|Actual|2016-06-16|June 2017|2017-06-01|February 8, 2018|Anticipated|2018-02-08|February 8, 2018|Anticipated|2018-02-08||Interventional|||A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin During Metformin Up-titration Compared With Metformin Up-titration Alone in Subjects With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 3|380|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:07:02.794332|2017-10-10 22:07:02.794332
NCT02791477|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-06-01|||May 2016||2016-05-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Functional Results With Attune Fixed Bearing Posterior Stabilized Knee Arthroplasty (A-16)|Functional Results With Attune Fixed Bearing Posterior Stabilized Knee Arthroplasty|Recruiting||N/A|65|Anticipated|Vestre Viken Hospital Trust||1|||f||||f||||||||Undecided||2017-10-10 22:07:02.945666|2017-10-10 22:07:02.945666
NCT02791464|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-03|||March 2014||2014-03-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Transcendental Meditation and Reduced Trauma Symptoms in Women Inmates|Transcendental Meditation and Reduced Trauma Symptoms in Women Inmates: A Randomized Controlled Pilot Study|Completed||N/A|22|Actual|Maharishi University of Management||2|||f||||f||||||||Yes|inquiring investigators may contact the principal investigator, Dr Sanford Nidich, for data share plans. Database resides with the PI and the biostatistician|2017-10-10 22:07:03.040561|2017-10-10 22:07:03.040561
NCT02791451|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-08-10|||October 2016||2016-10-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Predicting Exacerbation of COPD With Wireless Telemonitoring|Open-Label Prospective Study of Predicting Exacerbation of COPD With Wireless Telemonitoring of Respiratory Rate, Heart Rate and Sleep|Not yet recruiting||N/A|40|Anticipated|Turku University Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:07:03.114045|2017-10-10 22:07:03.114045
NCT02791438|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-09-28|||August 31, 2016|Actual|2016-08-31|September 2017|2017-09-01|June 5, 2019|Anticipated|2019-06-05|June 5, 2019|Anticipated|2019-06-05||Interventional|||A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension|A Phase 3, Open-label, Multicenter, Long-term Study to Evaluate the Safety, Efficacy and Pharmacokinetics of TAK-536 in Pediatric Patients 6 to Less Than 16 Years of Age With Hypertension|Recruiting||Phase 3|50|Anticipated|Takeda||2|||f||||f|f|f||||||||2017-10-10 22:07:03.172657|2017-10-10 22:07:03.172657
NCT02791425|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-03-11|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Brain Computer Interface for Communication in Ventilated Patients|Wearable Brain Computer Interface (BCI) to Assist Communication in Mechanically Ventilated Patients the Intensive Care Unit (ICU)|Recruiting||N/A|30|Anticipated|University of Michigan||1|||f||||f|f|f||||||No||2017-10-10 22:07:03.292821|2017-10-10 22:07:03.292821
NCT02791412|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-06-15|||January 13, 2017|Actual|2017-01-13|June 2017|2017-06-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Observational|MAIN COMPARE||Ten-Year Outcomes of Stents Versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease|Ten-Year Outcomes of Stents Versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease in Korea : Multicenter, Long-term, Observational Trial|Recruiting||N/A|2000|Anticipated|Asan Medical Center|||1||f||||f|f|f||||||No|This is not a publicly funded trial.|2017-10-10 22:07:03.578742|2017-10-10 22:07:03.578742
NCT02791399|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-09-07|||March 23, 2016|Actual|2016-03-23|September 2017|2017-09-01|October 15, 2019|Anticipated|2019-10-15|April 1, 2018|Anticipated|2018-04-01||Interventional|ISOP||A Patient-Centered Intervention to Improve Opioid Safety|A Patient-Centered Intervention to Improve Opioid Safety|Recruiting||N/A|300|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:07:03.718439|2017-10-10 22:07:03.718439
NCT02791386|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-09-26|||November 22, 2016|Actual|2016-11-22|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Observational|NAs resistance||Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy|Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Monotherapy: A Retrospective Cohort Study|Active, not recruiting||N/A|343|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:07:03.850725|2017-10-10 22:07:03.850725
NCT02791373|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-07-13|||March 2014||2014-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ViGeM||Vinorelbine and Gemcitabine in Myeloma|A Randomized Evaluation of Vinorelbine Versus Gemcitabine for Mobilization of Peripheral Stem Cells in Myeloma Patients Undergoing Autologous Stem Cell Transplantation.|Active, not recruiting||Phase 2|136|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 22:07:03.969527|2017-10-10 22:07:03.969527
NCT02791360|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-08-11|||January 2016||2016-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|TCSEQ||Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor|Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor|Recruiting||N/A|30|Anticipated|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-10 22:07:04.101731|2017-10-10 22:07:04.101731
NCT02791334|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-10-05|||June 29, 2016|Actual|2016-06-29|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|PACT||A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors|A Phase 1a/1b Study of a Novel Anti-PD-L1 Checkpoint Antibody (LY3300054) Administered Alone or in Combination With Other Agents in Advanced Refractory Solid Tumors (Phase 1a/1b Anti-PD-L1 Combinations in Tumors-PACT)|Recruiting||Phase 1|100|Anticipated|Eli Lilly and Company||7|||f||||f||||||||||2017-10-10 22:07:04.317396|2017-10-10 22:07:04.317396
NCT02791321|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-06|||July 2016||2016-07-01|April 2016|2016-04-01|February 2026|Anticipated|2026-02-01|February 2024|Anticipated|2024-02-01||Interventional|EFAAR||Fragility Assessment in Adults With ADHD and Mental Retardation|Fragility Assessment in Adults With ADHD and Mental Retardation, Advancing Age|Not yet recruiting||N/A|60|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||No||2017-10-10 22:07:04.519047|2017-10-10 22:07:04.519047
NCT02791308|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-06-26|||February 2015||2015-02-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis|Double-Blind Randomized Vehicle Controlled Study Evaluating Safety and Bioequivalence of Generic Pimecrolimus Cream 1% and Elidel® Comparing Both Active Treatments to a Vehicle Control in Treatment of Mild to Moderate Atopic Dermatitis|Completed||Phase 3|587|Actual|Actavis Inc.||3|||f||||f|t|f|||f|||No||2017-10-10 22:07:04.618915|2017-10-10 22:07:04.618915
NCT02791295|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-12-30|||July 2016||2016-07-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|WeightPump||Lifestyle Intervention in Type 2 Diabetes|Diet and Physical Activity Lifestyle Intervention to Prevent Body Weight Gain in Patients With Type 2 Diabetes Starting Insulin Pump Treatment: a Randomized Controlled Trial|Recruiting||N/A|54|Anticipated|Icadom||2|||f||||t||||||||No||2017-10-10 22:07:04.842499|2017-10-10 22:07:04.842499
NCT02791282|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2016-06-01|||May 2016||2016-05-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|||CTEPH DIAGNOSIS Europe - MRI|CHANGE-MRI (CTEPH DIAGNOSIS Europe - MRI)|Recruiting||Phase 3|1080|Anticipated|Hannover Medical School||1|||f||||t||||||||No||2017-10-10 22:07:04.955312|2017-10-10 22:07:04.955312
NCT02791269|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-12-13|2016-08-26||January 2006||2006-01-01|December 2016|2016-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||Safety analysis population included participants who received at least one dose of study medication and had one subsequent post baseline safety assessment.|A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program|Expanded Access Program of PEGASYS® (Peg Interferon Alpha-2a 40 KD) in Patients With HBeAg-Positive And HBeAg-Negative Chronic Hepatitis B|Completed||Phase 4|24|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:07:05.064362|2017-10-10 22:07:05.064362
NCT02791256|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-06|||June 2005||2005-06-01|June 2016|2016-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6|An Open-label Pilot Study of Dose Escalation of PEGASYS on Virological Response in Patients With Chronic Hepatitis C Viral Infection Showing an Early Non-response to a Standard Course of PEGASYS Plus Ribavirin|Terminated||Phase 3|23|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:07:05.430693|2017-10-10 22:07:05.430693
NCT02791243|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-05-17|||May 9, 2016|Actual|2016-05-09|May 2017|2017-05-01|June 27, 2016|Actual|2016-06-27|June 2016|Actual|2016-06-01||Interventional|||Photosensitization Study in Androgenetic Alopecia|A Within-subject, Randomized, Evaluator-blinded, Vehicle-controlled Study to Assess the Photosensitization Potential of Finasteride Cutaneous Solution(P-3074) in Human Subjects|Completed||Phase 1|58|Actual|Polichem S.A.||3|||f||||f||||||||No||2017-10-10 22:07:05.538478|2017-10-10 22:07:05.538478
NCT02791230|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-09-29|||June 13, 2016|Actual|2016-06-13|September 2017|2017-09-01|December 31, 2021|Anticipated|2021-12-31|December 23, 2021|Anticipated|2021-12-23||Interventional|||Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy|A Phase 3 Multicenter, Randomized, Double-blind, Extension Study To Evaluate The Safety Of Daily Oral Dosing Of Tafamidis Meglumine (Pf-06291826) 20 Mg Or 80 Mg In Subjects Diagnosed With Transthyretin Cardiomyopathy (ttr-cm)|Recruiting||Phase 3|330|Anticipated|Pfizer||3|||f||||t|t|f||||||||2017-10-10 22:07:05.63395|2017-10-10 22:07:05.63395
NCT02791217|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-03|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Observational|||Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool|Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool|Not yet recruiting||N/A|100|Anticipated|Assuta Medical Center|||5||f||||f||||||||Undecided||2017-10-10 22:07:05.810838|2017-10-10 22:07:05.810838
NCT02791204|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-09|||May 2016||2016-05-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||SPECT/CT Imaging of Skeletal Muscle Perfusion|SPECT/CT Imaging of Skeletal Muscle Perfusion in Healthy Control Subjects and Patients With Peripheral Arterial Disease: Pilot Clinical Study|Recruiting||N/A|50|Anticipated|Yale University||2|||f||||||||||||||2017-10-10 22:07:05.947455|2017-10-10 22:07:05.947455
NCT02791191|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-09-02|||June 2016||2016-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|NAVIGATE-AD||A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia|Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia|Recruiting||Phase 2|380|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:07:06.037161|2017-10-10 22:07:06.037161
NCT02791178|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-05-31|||February 2016||2016-02-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Optical Coherence Tomography in STEMI|Plaque Evaluation by Optical Coherence Tomography and Its Association With Microvascular Obstruction in Reperfused STEMI Patients - The POMS Study|Recruiting||N/A|35|Anticipated|National Heart Centre Singapore|||1||f||||f||||||Samples With DNA|"     Blood samples will be collected from all participants.   "|No||2017-10-10 22:07:06.407018|2017-10-10 22:07:06.407018
NCT02791165|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-05-31|||December 2015||2015-12-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Using Cardiac MRI to Characterise the Dynamic Changes Which Occur in the Acutely Reperfused STEMI Patient|Using Cardiac MRI to Characterise the Dynamic Changes Which Occur in the Acutely Reperfused STEMI Patient|Recruiting||N/A|20|Anticipated|National Heart Centre Singapore|||1||f||||f||||||Samples With DNA|"     Blood samples will be collected from all participants.   "|No||2017-10-10 22:07:08.470141|2017-10-10 22:07:08.470141
NCT02791152|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-05-31|||October 2015||2015-10-01|September 2015|2015-09-01|December 2036|Anticipated|2036-12-01|December 2036|Anticipated|2036-12-01||Observational|SingHEART||Effects of Physical Activity, Ambulatory Blood Pressure and Calcium Score on Cardiovascular Health in Normal People|SingHEART: Effects of Physical Activity, Ambulatory Blood Pressure and Calcium Score on Cardiovascular Health in Normal People|Recruiting||N/A|1000|Anticipated|National Heart Centre Singapore|||1||f||||t||||||||Yes||2017-10-10 22:07:08.546723|2017-10-10 22:07:08.546723
NCT02791139|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-14|||July 2014||2014-07-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|CardiacAging||Association of Midlife Dietary and Lifestyle Factors on Cardiac Functional Changes in the Elderly|Association of Midlife Dietary and Lifestyle Factors on Cardiac Functional Changes in the Elderly|Recruiting||N/A|800|Anticipated|National Heart Centre Singapore|||2||f||||f||||||Samples With DNA|"     The blood will be stored for genetic tests and development of cell lines to study genetic     risks for aging related diseases and cardiovascular disease.   "|No||2017-10-10 22:07:08.622386|2017-10-10 22:07:08.622386
NCT02791126|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-04-05|||November 2013||2013-11-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||A Novel Automated & Comprehensive Approach for Ventricular Function Assessment in Heart Failure|Curvedness-based Imaging: A Novel Automated & Comprehensive Approach for Ventricular Function Assessment in Heart Failure|Recruiting||N/A|120|Anticipated|National Heart Centre Singapore|||1||f||||f||||||||No||2017-10-10 22:07:08.717226|2017-10-10 22:07:08.717226
NCT02791113|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-14|||March 2014||2014-03-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|CTAAnalyzer||Analysis of Coronary CT Angiography to Identify Patients With Significant Coronary Artery Stenosis|Automatic Analysis of Coronary CT Angiography to Identify Patients With Significant Coronary Artery Stenosis for Clinical Decision-making.|Recruiting||N/A|50|Anticipated|National Heart Centre Singapore|||1||f||||f||||||||No||2017-10-10 22:07:08.805471|2017-10-10 22:07:08.805471
NCT02791100|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-03-08|||May 25, 2016|Actual|2016-05-25|March 2017|2017-03-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Interventional|||Promotion of Egg and Eggshell Powder Consumption Improve Nutritional Status of Children in Halaba Ethiopia|Promotion of Egg and Eggshell Powder Consumption Improve Nutritional Status of Children of Under Two Years of Age: A Cluster Randomized Controlled Community Trial in Halaba Sp. Woreda, Southern Nations and Nationalities Peoples Region (SNNPR), Ethiopia|Completed||N/A|287|Actual|University of Saskatchewan||2|||f||||f||||||||No|Only group data, means, median|2017-10-10 22:07:08.880014|2017-10-10 22:07:08.880014
NCT02791087|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-17|||June 2013||2013-06-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Investigation of the Role of Hemodynamics in Re-stenosis of CABG Patients|Investigation of the Role of Hemodynamics in Re-stenosis of CABG Patients|Active, not recruiting||N/A|54|Actual|National Heart Centre Singapore|||2||f||||f||||||||No||2017-10-10 22:07:08.979722|2017-10-10 22:07:08.979722
NCT02791074|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-03-30|||May 2013||2013-05-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Observational|HF-VFM||Heart Failure Ventricular Pressure Time Profile|Non-invasive Determination of Intra-left Ventricular Pressure-time Profile for Diagnosis of Heart Failure With Normal and Reduced Ejection Fraction.|Completed||N/A|75|Actual|National Heart Centre Singapore|||2||f||||f||||||||No||2017-10-10 22:07:09.077879|2017-10-10 22:07:09.077879
NCT02791061|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-03-30|||January 2013||2013-01-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|RVShape||Study of RV Remodeling in Congenital Heart Disease|Segmentation, Structural Reconstruction and Quantification of Right Ventricular Remodeling in Congenital Heart Disease for Clinical Decision-making and Treatment Planning.|Active, not recruiting||N/A|54|Actual|National Heart Centre Singapore|||2||f||||f||||||||No||2017-10-10 22:07:09.168741|2017-10-10 22:07:09.168741
NCT02791048|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-31|||April 2016||2016-04-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Music Therapy for Palliative Care Patients|Evaluation of the Effectiveness of Music Therapy in Improving the Quality of Life of Palliative Care Patients: a Randomised Controlled Pilot and Feasibility Study|Recruiting||N/A|52|Anticipated|Queen's University, Belfast||2|||f||||t||||||||No||2017-10-10 22:07:09.25543|2017-10-10 22:07:09.25543
NCT02791035|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-07-03|||June 2016||2016-06-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin||Completed||Phase 4|100|Actual|Asan Medical Center||1|||f||||||||||||||2017-10-10 22:07:09.342149|2017-10-10 22:07:09.342149
NCT02791022|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-02|||March 2016||2016-03-01|May 2016|2016-05-01||||March 2019|Anticipated|2019-03-01||Observational|SAFS||Singapore Atrial Fibrillation Study|A Multi-centre Population-based Study on the Incidence of Paroxysmal Atrial Fibrillation in Inpatient and Outpatient Cohorts in Singapore|Recruiting||N/A|2500|Anticipated|National Heart Centre Singapore|||1||f||||f||||||||No||2017-10-10 22:07:09.569276|2017-10-10 22:07:09.569276
NCT02791009|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-02|||August 2015||2015-08-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||"Asian neTwork for Translational Research and Cardiovascular Trials (ATTRaCT)"|"Asian neTwork for Translational Research and Cardiovascular Trials (ATTRaCT)"|Recruiting||N/A|1600|Anticipated|National Heart Centre Singapore|||4||f||||f||||||Samples With DNA|"     Specific biomarker profiles   "|No||2017-10-10 22:07:09.665488|2017-10-10 22:07:09.665488
NCT02790996|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-03-21|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|February 1, 2019|Anticipated|2019-02-01|December 1, 2018|Anticipated|2018-12-01||Interventional|NeoVanc||Neonatal Vancomycin Trial|Multi-centre, Randomised, Open Label, Phase IIb Study to Compare the Efficacy, Safety and Pharmacokinetics (PK) of an Optimised Dosing to a Standard Dosing Regimen of Vancomycin in Neonates and Infants Aged ≤ 90 Days With Late Onset Bacterial Sepsis Known or Suspected to be Caused by Gram-positive Microorganisms|Recruiting||Phase 2|300|Anticipated|PENTA Foundation||2|||f||||t||||||||||2017-10-10 22:07:09.800401|2017-10-10 22:07:09.800401
NCT02790983|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-09-20|||October 2016||2016-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|3 Years|Observational [Patient Registry]|PTRON||Primary Tumor Research and Outcome Network|Primary Tumor Research and Outcome Network (PTRON) A Multicenter Prospective Registry for the Management of Primary Tumors of the Spine|Recruiting||N/A|300|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f||||||Samples Without DNA|"     Tumor tissue and adjacent normal tissue Blood   "|||2017-10-10 22:07:10.024937|2017-10-10 22:07:10.024937
NCT02790970|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-17|||May 2016||2016-05-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Predicting Response to Depression Treatment (PReDicT)|Interventional, Randomised, Open Label, Multi-centre, Parallel-group, Controlled Study Investigating the Effects of Using the PReDicT Test to Guide the Antidepressant Treatment of Depressed Patients|Recruiting||N/A|1200|Anticipated|P1vital Products Limited||2|||f||||t||||||||||2017-10-10 22:07:10.212204|2017-10-10 22:07:10.212204
NCT02790957|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-08|||June 2016||2016-06-01|June 2016|2016-06-01|February 2020|Anticipated|2020-02-01|January 2020|Anticipated|2020-01-01||Interventional|MOZOBL07740||Plerixafor in Diabetic Wound Healing|Effect of a Single Plerixafor Injection on Diabetic Wound Healing. A Pilot, Single-blind, Placebo-controlled, Randomized Trial|Recruiting||Phase 2|46|Anticipated|University of Padova||2|||f||||f||||||||||2017-10-10 22:07:10.630874|2017-10-10 22:07:10.630874
NCT02790944|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-06-14|||May 4, 2016|Actual|2016-05-04|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|October 2017|Anticipated|2017-10-01||Observational|||Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer|Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer in Consecutive Cases Unselected for Family History|Active, not recruiting||N/A|300|Actual|Ambry Genetics|||1||f||||f||||||Samples With DNA|"     Blood, saliva or DNA   "|Undecided||2017-10-10 22:07:10.722474|2017-10-10 22:07:10.722474
NCT02790931|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-28|||August 2016||2016-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effects of Foot Muscle Strengthening in Daily Activity in Diabetic Neuropathic Patients|Effects of Foot Muscle Strengthening in Daily Activity, Biomechanics and Functionality of Foot and Ankle in Diabetic Polyneuropathy Patients : a Randomized Controlled Trial|Recruiting||N/A|77|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 22:07:10.816692|2017-10-10 22:07:10.816692
NCT02790918|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-04-05|||May 2013||2013-05-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Diagnosis of Pulmonary Hypertension Using Cardiac Magnetic Resonance Images|Noninvasive Diagnosis of Pulmonary Hypertension Using Three-dimensional Interventricular Septal Curvedness From Cardiac Magnetic Resonance Images|Recruiting||N/A|60|Anticipated|National Heart Centre Singapore|||2||f||||f||||||||No||2017-10-10 22:07:10.900406|2017-10-10 22:07:10.900406
NCT02790905|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-10-05|||September 2015||2015-09-01|October 2017|2017-10-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Observational|||Validating the Patient Health Questionnaire in Pregnant and Post-partum Migrant Women|Validating the Patient Health Questionnaire-9 (PHQ-9) and Refugee Health Screener-15(RHS-15) Questionnaires to Screen for Depression in Pregnant and Post-partum Migrant Women on the Thai-Myanmar Border|Completed||N/A|370|Actual|University of Oxford|||1||f||||f||||||||||2017-10-10 22:07:11.129044|2017-10-10 22:07:11.129044
NCT02790892|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-06|||April 2016||2016-04-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|CADI||Creative Arts Diabetes Initiative for Youth/Young Adults Transitioning to Adult Care|Creative Arts Diabetes Initiative: Group Art Therapy and Peer Support for Youth and Young Adults Transitioning From Pediatric to Adult Diabetes Care|Recruiting||N/A|20|Anticipated|University of Manitoba||1|||f||||f||||||||Undecided||2017-10-10 22:07:11.224968|2017-10-10 22:07:11.224968
NCT02790879|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-03|||October 2015||2015-10-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01|2 Years|Observational [Patient Registry]|SAFETIM RNM||Transition From Pediatric to Adult Cystic Fibrosis Care Center|Clinical Impact of the Transition From Pediatric to Adult Cystic Fibrosis Care Center|Recruiting||N/A|300|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:07:11.336797|2017-10-10 22:07:11.336797
NCT02790866|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-01-20|||March 2016||2016-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|LuCaS-DA||Development and Feasibility Testing of a Lung Cancer Screening Decision Aid|Development and Feasibility Testing of a Lung Cancer Screening Decision Aid|Completed||N/A|50|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 22:07:11.453846|2017-10-10 22:07:11.453846
NCT02790853|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-05-08|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|May 2026|Anticipated|2026-05-01|May 2026|Anticipated|2026-05-01||Interventional|||Multimodal Imaging for Surveillance of Patients With Oral Potentially Malignant Disorders|Multimodal Imaging for Surveillance of Patients With Oral Potentially Malignant Disorders|Recruiting||N/A|600|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||t|f|||||||2017-10-10 22:07:11.577312|2017-10-10 22:07:11.577312
NCT02790840|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-04-17|||May 16, 2016|Actual|2016-05-16|April 2017|2017-04-01|June 21, 2016|Actual|2016-06-21|June 15, 2016|Actual|2016-06-15||Interventional|||A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations|A Study in Healthy Subjects to Assess the Multiple- Dose Pharmacokinetics of Three AF-219 Formulations|Completed||Phase 1|32|Actual|Afferent Pharmaceuticals, Inc.||1|||f||||f||||||||No||2017-10-10 22:07:11.710389|2017-10-10 22:07:11.710389
NCT02790827|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-03-08|||May 2016||2016-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trial of a Multi-pronged Intervention to Address Prevention of Violence in Zambia|Randomized Controlled Trial of a Multi-pronged Intervention to Address Prevention of Violence in Zambia|Recruiting||N/A|625|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||Undecided||2017-10-10 22:07:11.817509|2017-10-10 22:07:11.817509
NCT02790814|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-05-19|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Moyo; strap-on Fetal Heart Rate Monitoring in a Rural Setting|Evaluation of an Innovative Fetal Heart Rate Monitoring Device (Named Moyo) to Improve Perinatal Outcome at Haydom Hospital, Tanzania|Completed||N/A|2652|Actual|Helse Stavanger HF||2|||f||||t||||||||No||2017-10-10 22:07:11.950078|2017-10-10 22:07:11.950078
NCT02790801|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-08-01|||February 2015||2015-02-01|August 2017|2017-08-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31|1 Year|Observational [Patient Registry]|RIF-CHF||The First Russian Observational Survey of Heart Failure Patients With Atrial Fibrillation|The First Russian Observational Survey of Heart Failure Patients With Atrial Fibrillation|Completed||N/A|1000|Actual|Federal State Budgetary Scientific Institution, Research Institute of Cardiology|||1||f||||t||||||||||2017-10-10 22:07:12.067|2017-10-10 22:07:12.067
NCT02790788|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-03-27|||November 2016||2016-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|CORTICA||Physiologic Effects of Steroids in Cardiac Arrest|Physiologic Effects of Stress Dose Corticosteroids in the Management of Inhospital Cardiac Arrest - CORTICA|Recruiting||Phase 1/Phase 2|100|Anticipated|University of Athens||2|||f||||t||||||||No||2017-10-10 22:07:12.220713|2017-10-10 22:07:12.220713
NCT02790775|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-08-29|||December 2015||2015-12-01|September 2015|2015-09-01|August 30, 2016||2016-08-30|May 30, 2016|Actual|2016-05-30||Interventional|pain & visual||Pain and Visual Outcome in Intravitreal Bevacizumab Injection|Evaluation of the Pain and Visual Outcome Associated With Location of Intravitreal Bevacizumab Injection|Completed||Phase 2|1004|Actual|Shahid Beheshti University of Medical Sciences||4|||f||||t||||||||||2017-10-10 22:07:12.433511|2017-10-10 22:07:12.433511
NCT02790762|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-31|||June 2016||2016-06-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis|A Phase I Study of Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis|Not yet recruiting||Phase 1|10|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||1|||f||||t||||||||Undecided||2017-10-10 22:07:12.559977|2017-10-10 22:07:12.559977
NCT02790749|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-03|||August 2016||2016-08-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRSPAO||Periacetabular Osteotomy With Versus Without Adjunctive Hip Arthroscopy|Periacetabular Osteotomy With Versus Without Adjunctive Hip Arthroscopy for Intra-Articular Pathology in Hip Dysplasia: a Prospective Randomized Trial|Not yet recruiting||N/A|44|Anticipated|Sharp HealthCare||2|||f||||f||||||||Undecided||2017-10-10 22:07:12.705038|2017-10-10 22:07:12.705038
NCT02790736|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-12-22|||June 2016||2016-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Brief Intervention to Reduce Fear of Public Speaking|Brief Intervention to Reduce Fear of Public Speaking|Recruiting||Phase 4|20|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-10-10 22:07:12.855728|2017-10-10 22:07:12.855728
NCT02790723|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-31|||January 2017||2017-01-01|May 2016|2016-05-01|February 2021|Anticipated|2021-02-01|April 2020|Anticipated|2020-04-01||Interventional|AAVIL-1Ra||Safety of Intra-Articular Sc-rAAV2.5IL-1Ra in Subjects With Moderate Knee OA|A Phase I Study Evaluating the Safety of Intra-Articular Sc-rAAV2.5IL-1Ra in Subjects With Moderate Osteoarthritis of the Knee|Not yet recruiting||Phase 1|9|Anticipated|Mayo Clinic||3|||f||||f||||||||No||2017-10-10 22:07:12.965831|2017-10-10 22:07:12.965831
NCT02790710|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-01-03|||June 2016||2016-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Brief Intervention for OCD Fears|Brief Intervention for OCD Fears|Recruiting||Phase 4|20|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-10-10 22:07:13.071296|2017-10-10 22:07:13.071296
NCT02790697|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-09-09|||September 10, 2017|Actual|2017-09-10|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|ICALIC||The ICALIC Accuracy Validation in Geneva Study|Clinical Evaluation of the Ease of Use of a New Indirect Calorimeter for Energy Expenditure Measurement in ICU Patients: The ICALIC International Multicentric Study|Recruiting||N/A|30|Anticipated|University Hospital, Geneva|||1||f||||t|f|f||||||||2017-10-10 22:07:13.172243|2017-10-10 22:07:13.172243
NCT02790684|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-09-26|||May 2016||2016-05-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy Subjects||Completed||Phase 1|12|Actual|Daiichi Sankyo, Inc.||1|||f||||t||||||||||2017-10-10 22:07:13.262552|2017-10-10 22:07:13.262552
NCT02790671|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-08-02|||May 2016||2016-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy Subjects|An Open-Label, One-Sequence, Two-Period Study to Evaluate the Effects of Itraconazole on the Pharmacokinetics of DS-8500a in Healthy Subjects|Completed||Phase 1|26|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:07:13.336148|2017-10-10 22:07:13.336148
NCT02790658|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-06-13|||March 2014||2014-03-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|August 2014|Actual|2014-08-01||Interventional|||Metabolomics Approach After Acute Intake of Grumixama Juice|Metabolomics Approach After Acute Intake of Grumixama Juice (Eugenia Brasiliensis Lam)|Completed||N/A|15|Actual|University of Sao Paulo||1|||f||||f||||||||No||2017-10-10 22:07:13.422554|2017-10-10 22:07:13.422554
NCT02790645|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-07-12|||September 2012||2012-09-01|February 2016|2016-02-01|September 19, 2016|Actual|2016-09-19|April 2016|Actual|2016-04-01||Interventional|||Telemedicine Program in Type 1 Diabetes and CSII|Randomized Crossover Clinical Trial in Patients With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion to Assess the Impact of Telemedicine vs. Conventional Medical Care. Integral Clinical Impact and Cost|Completed||N/A|51|Actual|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||4|||f||||f||||||||||2017-10-10 22:07:13.525399|2017-10-10 22:07:13.525399
NCT02790632|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-28|||July 2016||2016-07-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|NEWTON2||Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage|Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage|Recruiting||Phase 3|374|Anticipated|Edge Therapeutics Inc||2|||f||||t||||||||||2017-10-10 22:07:13.650924|2017-10-10 22:07:13.650924
NCT02790619|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-03-22|||April 2015||2015-04-01|March 2017|2017-03-01|March 21, 2017|Actual|2017-03-21|August 2015|Actual|2015-08-01||Interventional|||A Pilot Study Investigating Transcranial Direct Current Stimulation (tDCS) to Enhance Mindfulness Meditation|A Pilot Study Investigating Transcranial Direct Current Stimulation (tDCS) to Enhance Mindfulness Meditation|Completed||N/A|15|Actual|Medical University of South Carolina||3|||f||||f||||||||||2017-10-10 22:07:14.17215|2017-10-10 22:07:14.17215
NCT02790606|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-10-02|||July 2016||2016-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:07:14.260342|2017-10-10 22:07:14.260342
NCT02790593|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-03-13|||January 12, 2017|Actual|2017-01-12|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|Juxta-Cures||Juxta-CuresTM Versus Bandaging for Venous Ulcers|A Randomised Controlled Clinical Trial Comparing the Effectiveness of Bandaging Compared to the Juxta-CuresTM Device in the Management of People With Venous Ulceration: Feasibility Study|Recruiting||Phase 4|50|Anticipated|Colchester Hospital University NHS Foundation Trust||2|||f||||f|f|f||||||No||2017-10-10 22:07:14.317805|2017-10-10 22:07:14.317805
NCT02790203|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-05-29|||June 2016||2016-06-01|May 2016|2016-05-01||||December 2018|Anticipated|2018-12-01||Interventional|||Perioperative Use of a Selective COX2 Inhibitor in Patients Undergoing Elective Colorectal Surgery: the Effect on Post-operative Bowel Motility and Post-operative Pain||Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:07:17.514166|2017-10-10 22:07:17.514166
NCT02790580|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-05-30|||May 2016||2016-05-01|May 2016|2016-05-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01||Interventional|||Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients|Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib as Neoadjuvant or First-line Palliative Treatment of Newly Diagnosed HER2 Negative Breast Cancer Patients With Measurable Primary Breast Tumor|Recruiting||Phase 2|98|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||No||2017-10-10 22:07:14.4624|2017-10-10 22:07:14.4624
NCT02790567|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-06-29|||October 2012||2012-10-01|May 2013|2013-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|TIH||Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients|Evaluation of Automated Immunoassay, Particle Gel Immunoassay and Pretest Scoring Systems (4Ts and HEP Scores) in the Diagnosis of Heparin-induced Thrombocytopenia in Surgical Critically Ill Patients|Completed||N/A|120|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 22:07:14.574605|2017-10-10 22:07:14.574605
NCT02790554|ClinicalTrials.gov processed this data on October 10, 2017|2016-06-01|2017-05-18|||March 2016||2016-03-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Moyo; strap-on Fetal Heart Rate Monitoring in an Urban Setting|Evaluation of an Innovative Fetal Heart Rate Monitoring Device (Named Moyo) to Improve Perinatal Outcome in Dar es Salaam, Tanzania|Recruiting||N/A|3000|Anticipated|Helse Stavanger HF||2|||f||||t||||||||No||2017-10-10 22:07:14.730972|2017-10-10 22:07:14.730972
NCT02790541|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-03|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ANGIOHBOT||Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy|Changes in Blood Flow and Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy|Not yet recruiting||N/A|25|Anticipated|Assaf-Harofeh Medical Center||1|||f||||f||||||||Undecided||2017-10-10 22:07:14.849152|2017-10-10 22:07:14.849152
NCT02790528|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-14|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|June 2023|Anticipated|2023-06-01||Interventional|STAVA||Statin Therapy In Patients With Vasospastic Angina|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Statin Therapy In Patients With Vasospastic Angina|Withdrawn||Phase 4|0|Actual|Asan Medical Center||2||Funding issue|f||||t|f|f||||||No|This is not a publicly funded trial.|2017-10-10 22:07:14.954688|2017-10-10 22:07:14.954688
NCT02790515|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-09-28|||June 14, 2016|Actual|2016-06-14|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation|Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation|Recruiting||Phase 2|18|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|t|t|f||||||2017-10-10 22:07:15.074018|2017-10-10 22:07:15.074018
NCT02790502|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-05-02|||June 15, 2017|Anticipated|2017-06-15|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||OSU Plate Waste Study|InFACT Seed Proposal: Ohio State University Food Waste Collaborative|Not yet recruiting||N/A|18|Anticipated|Pennington Biomedical Research Center||1|||f||||f|f|f||||||No||2017-10-10 22:07:15.284481|2017-10-10 22:07:15.284481
NCT02790489|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-08-08|||May 2016||2016-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ECPH1-01||Tolerance Study of the Dietary Supplement Valedia|Valedia Dietary Supplement Tolerance Study Based on Blood, Urinary and Hemodynamic Biological Parameters|Completed||Phase 1|14|Actual|Valbiotis||1|||f||||t||||||||Yes||2017-10-10 22:07:15.356908|2017-10-10 22:07:15.356908
NCT02790476|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-04-24|||January 27, 2017|Actual|2017-01-27|April 2017|2017-04-01|September 27, 2017|Anticipated|2017-09-27|September 27, 2017|Anticipated|2017-09-27||Interventional|||Behavioral Insights to Encourage Judicious Prescribing of Opioids|Use of Behavioral Insights to Encourage Judicious Prescribing of Opioids|Recruiting||N/A|600|Anticipated|University of Southern California||2|||f||||f|f|f||||||No||2017-10-10 22:07:15.457819|2017-10-10 22:07:15.457819
NCT02790450|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-12-22|||October 2015||2015-10-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Acute Effects of Benzbromaron on the Pulmonary Circulation|Acute Effects of Benzbromaron on the Pulmonary Circulation|Completed||Phase 2|10|Actual|Medical University of Graz||1|||f||||t||||||||Yes||2017-10-10 22:07:15.639106|2017-10-10 22:07:15.639106
NCT02790437|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-22|||June 2016||2016-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|HighIdeS||A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test|A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test|Recruiting||Phase 2|15|Anticipated|Hansa Medical AB||1|||f||||t||||||||||2017-10-10 22:07:15.724027|2017-10-10 22:07:15.724027
NCT02790424|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-17|||May 2013||2013-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MAP-EFNI PV||Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Patient Volunteers|Adjustment Exploratory Protocols (MagnetoEncephaloGraphy Study : MEG, ElectroEncephaloGram : EEG, Magnetic Resonance Imaging : MRI, Functional MRI : MRIf, Motor Platform) and Functional Evaluation of New Non Invasive Devices (REX BIONICS Exoskeleton) in Patient Volunteers|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 22:07:15.84141|2017-10-10 22:07:15.84141
NCT02790411|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-17|||May 2013||2013-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MAP-EFNI||Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Healthy Volunteers|Adjustment Exploratory Protocols (MagnetoEncephaloGraphy Study : MEG, ElectroEncephaloGram : EEG, Magnetic Resonance Imaging : MRI, Functional MRI : MRIf, Motor Platform) and Functional Evaluation of New Non Invasive Devices (REX BIONICS Exoskeleton) in Healthy Volunteers|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 22:07:15.935678|2017-10-10 22:07:15.935678
NCT02790385|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-05-30|||July 2014||2014-07-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|NPWT||Negative Pressure Wound Therapy - A Multi-Centered Randomized Control Trial|Use of Incisional Negative Pressure Wound Dressing Versus Standard Dry Gauze Dressing for Wound Closure in Patients Undergoing Spinal Surgery - A Multicentre Randomized Control Trial|Recruiting||Early Phase 1|870|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 22:07:16.097806|2017-10-10 22:07:16.097806
NCT02790372|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-04-05|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|||The Effect of Case Conferencing in Nursing Homes|The Effect of Comprehensive Geriatric Assessment and Case Conferencing on Neuropsychiatric Symptoms Among Patients in Norwegian Nursing Homes|Completed||N/A|309|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||Yes||2017-10-10 22:07:16.17877|2017-10-10 22:07:16.17877
NCT02790359|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-03-02|||March 2015||2015-03-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Carbon Dioxide Insufflation Versus Conventional Air Insufflation|Carbon Dioxide Insufflation Versus Air Insufflation for Colonoscopy in Deeply Sedated Pediatric Patients: a Prospective, Randomized, Double Blind, Controlled Trial|Recruiting||N/A|200|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||No||2017-10-10 22:07:16.266707|2017-10-10 22:07:16.266707
NCT02790346|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-31|||December 2015||2015-12-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|talobot||Talonavicular Arthrodesis and Surgical Treatment of Ankle and Varus Foot|Interest of Talonavicular Arthrodesis on Walking Speed at Brain Lesion Patients Who Benefit of a Surgical Treatment of Ankle and Varus Foot : Randomized Study|Recruiting||N/A|32|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||No||2017-10-10 22:07:16.34189|2017-10-10 22:07:16.34189
NCT02790333|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-02|||May 2016||2016-05-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Different Stapler Cartridge For Pancreatic Stump Texture To Prevent Pancreatic Fistula|A Randomized Trail Of Different Stapler Cartridge For Pancreatic Stump Texture To Prevent Pancreatic Fistula After Laparoscopic Distal Pancreatectomy|Recruiting||N/A|94|Anticipated|Zhejiang Provincial People’s Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:07:16.418018|2017-10-10 22:07:16.418018
NCT02790320|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-02|||June 2012||2012-06-01|April 2016|2016-04-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Observational|EUFORIA-1||Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer|Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer: Observational Retrospective Analysis|Completed||N/A|112|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-10 22:07:16.493359|2017-10-10 22:07:16.493359
NCT02790307|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-05-31|||January 2013||2013-01-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome|Single Centre Randomised Pilot Study of Two Regimens (30mins Daily or Weekly for 12 Weeks) of Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome|Completed||Phase 2|48|Actual|University College, London||2|||f||||f||||||||No||2017-10-10 22:07:16.584951|2017-10-10 22:07:16.584951
NCT02790294|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-01-05|||January 2016||2016-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal|Optimal Timing of Postoperative Magnetic Resonance Imaging (MRI) in Patients With Extradural Spinal Tumors - a Pilot Study|Recruiting||Early Phase 1|8|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:07:16.661891|2017-10-10 22:07:16.661891
NCT02790281|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-01-13|2016-11-02||December 2014||2014-12-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational||Full Analysis Set, consisted of all eligible subjects with CRP >5 mg/L.|A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease||Completed||N/A|33|Actual|Ferring Pharmaceuticals|||1||f||||||||||||||2017-10-10 22:07:16.75132|2017-10-10 22:07:16.75132
NCT02790268|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-02|||January 2014||2014-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Ultrasound Biomicroscopic Analysis of Cionni Ring and In-the-bag IOL Implantation for Subluxated Lenses|Ultrasound Biomicroscopic Analysis of Cionni Ring and In-the-bag IOL Implantation for Subluxated Lenses|Completed||N/A|17|Actual|Iladevi Cataract and IOL Research Center|||1||f||||f||||||||No||2017-10-10 22:07:16.922422|2017-10-10 22:07:16.922422
NCT02790255|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-07-20|||November 2014||2014-11-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|BRIGHT||BRown Fat Activity Measurement With Infrared imaginG tHermography andThermogenesis - the BRIGHT Study|BRown Fat Activity Measurement With Infrared imaginG tHermography and Thermogenesis - the BRIGHT Study|Active, not recruiting||N/A|20|Actual|Clinical Nutrition Research Centre, Singapore||2|||f||||f||||||||||2017-10-10 22:07:16.985871|2017-10-10 22:07:16.985871
NCT02790242|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-02|||November 2013||2013-11-01|May 2016|2016-05-01||||August 2018|Anticipated|2018-08-01|12 Months|Observational [Patient Registry]|RESCUE||Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy|Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy|Recruiting||N/A|200000|Anticipated|Columbia University|||1||f||||t||||||||No||2017-10-10 22:07:17.184835|2017-10-10 22:07:17.184835
NCT02790229|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Postoperatively Treated Patients With Lower Limb Fracture With or Without an Anti-gravity Treadmill|Outcome of Patients After Lower Limb Fracture With Partial Weight Bearing Postoperatively Treated With or Without Anti-gravity Treadmill (Alter G®) During Six Weeks of Rehabilitation - a Bicentric Prospective Randomized Trial|Recruiting||N/A|120|Anticipated|University of Leipzig||2|||f||||t||||||||Yes||2017-10-10 22:07:17.314509|2017-10-10 22:07:17.314509
NCT02790216|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-29|||June 2016||2016-06-01|May 2016|2016-05-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|||Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy|Phase II Study of Focused Dose Painted I-125 Brachytherapy for Low to Intermediate Risk Prostate Cancer Using Deformable Registration of Multi-parametric MRI (Magnetic Resonance Imaging) to Intra-operative TRUS (Trans Rectal Ultrasound)|Not yet recruiting||N/A|24|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples Without DNA|"     Biopsies will be obtained using a transperineal approach   "|Undecided||2017-10-10 22:07:17.422811|2017-10-10 22:07:17.422811
NCT02790190|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-05-29|||May 2015||2015-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Phase III Study of Individualized Adaptive Radiotherapy Based on PET/CT and 3DCRT/IMRT in Combination With Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 3|400|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||||||||||||2017-10-10 22:07:17.593846|2017-10-10 22:07:17.593846
NCT02790177|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-29|||June 2016||2016-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|HiB||Role of Hyaluronic Acid in the Prevention of Post-operative Adhesions: a RCT|Is Hyaluronic Acid Effective in the Prevention of Post-operative Adhesion?|Not yet recruiting||Phase 3|150|Anticipated|Services Institute of Medical Sciences, Pakistan||2|||f||||t||||||||No||2017-10-10 22:07:17.7962|2017-10-10 22:07:17.7962
NCT02790164|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-12-05|||May 2016||2016-05-01|December 2016|2016-12-01||||November 2016|Actual|2016-11-01||Interventional|||Continuous NMB in PCAS|Continuous Neuromuscular Blocking Agent for out-of Hospital Cardiac Arrest; Multicenter Randomized Controlled Trial|Completed||Phase 2|81|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-10 22:07:17.886401|2017-10-10 22:07:17.886401
NCT02790151|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-10-17|||November 2014||2014-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Memory Rehabilitation by Means of Working Memory Training in Combination With a Recollection Training|Memory Rehabilitation by Means of Working Memory Training in Combination|Completed||N/A|36|Actual|University of Oldenburg||2|||f||||f||||||||||2017-10-10 22:07:17.988072|2017-10-10 22:07:17.988072
NCT02790138|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-08|||October 12, 2016|Actual|2016-10-12|September 2017|2017-09-01|March 9, 2019|Anticipated|2019-03-09|March 9, 2019|Anticipated|2019-03-09||Interventional|EARNEST||Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis|A Randomized, Double-Blind, Placebo-Controlled Phase 4 Study to Evaluate the Efficacy and Safety of Entyvio (Vedolizumab IV) in the Treatment of Chronic Pouchitis (EARNEST)|Recruiting||Phase 4|110|Anticipated|Takeda||2|||f||||f|t|f||||||||2017-10-10 22:07:18.100285|2017-10-10 22:07:18.100285
NCT02790125|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-08-31|||July 28, 2016|Actual|2016-07-28|August 2017|2017-08-01|October 27, 2017|Anticipated|2017-10-27|October 26, 2017|Anticipated|2017-10-26||Interventional|||A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects|A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects|Recruiting||Phase 1|66|Anticipated|Bristol-Myers Squibb||5|||f||||f|t|f||||||||2017-10-10 22:07:18.311943|2017-10-10 22:07:18.311943
NCT02790112|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-30|||April 2016||2016-04-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|April 2016|Actual|2016-04-01||Interventional|||Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty|Influence of Early Adiposity Rebound, Genetic Polymorphisms and GnRHa Treatment on Long-term Outcome of Girls With Idiopathic Central Precocious Puberty.|Enrolling by invitation||N/A|418|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f||||t||||||||Yes|De-identified individual participant data for some outcome measures will be made available within 6 months of study recruitment for the Belgian Study Group for Pediatric Endocrinology.|2017-10-10 22:07:18.428443|2017-10-10 22:07:18.428443
NCT02790099|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-21|2016-10-02|||September 2014||2014-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Comparison of Surgical Rectus Sheath Block and Intrathecal Morphine|Double-blinded Randomized Controlled Study for Comparison of Surgical Rectus Sheath and Intrathecal Morphine for Postoperative Pain Control After Caesarean Section|Completed||Phase 4|144|Actual|Queen Mary Hospital, Hong Kong||3|||f||||f||||||||No|That's for patient privacy that individual participant data will not be available.|2017-10-10 22:07:18.586897|2017-10-10 22:07:18.586897
NCT02790086|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-06-02|||October 2014||2014-10-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Observational|HYPOTHERMIE||Prevalence Survey in France of Unintentional Perioperative Hypothermia and Its Impact on Two Outcomes|Prevalence Survey in France of Unintentional Perioperative Hypothermia and Its Impact on Two Outcomes: Blood Loss, Myocardial Injury After Non Cardiac Surgery|Recruiting||N/A|2000|Anticipated|Société Française d'Anesthésie et de Réanimation|||1||f||||f||||||Samples Without DNA|"     2 tubes of 5 ml of blood   "|No||2017-10-10 22:07:18.705443|2017-10-10 22:07:18.705443
NCT02790073|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-11|||May 2016||2016-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase 2 Study With SNF472 in Calciphylaxis Patients|Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients|Recruiting||Phase 2|15|Anticipated|Laboratoris Sanifit||1|||f||||||||||||||2017-10-10 22:07:18.795549|2017-10-10 22:07:18.795549
NCT02790060|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-10|||June 2015||2015-06-01|May 2016|2016-05-01||||June 2016|Actual|2016-06-01||Observational|VARDIA||Fear of Hypoglycemia and Glycemic Variability|Peur De l'Hypoglycémie et Variabilité Glycémique Chez Les Sujets Diabétiques de Type 1|Completed||N/A|600|Anticipated|Poitiers University Hospital|||1||f||||f||||||Samples Without DNA|"     -  blood (whole blood + plasma + serum)        -  urines   "|||2017-10-10 22:07:18.921918|2017-10-10 22:07:18.921918
NCT02790047|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|HBEcPEP||Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD|Effect of Home-base Exercise Program With a Conical Positive Expiratory Pressure Device on Physical Performance and Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|50|Anticipated|Khon Kaen University||2|||f||||f||||||||Undecided||2017-10-10 22:07:19.014343|2017-10-10 22:07:19.014343
NCT02790021|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-08-28|||July 2018|Anticipated|2018-07-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|||Lymphaticovenous Anastomosis for Breast Cancer-related Lymphedema|Improving Quality of Survivorship for Breast Cancer-related Lymphedema by Lymphaticovenous Anastomosis: A Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Maastricht University Medical Center||2|||f||||t|f|f||||||||2017-10-10 22:07:19.383479|2017-10-10 22:07:19.383479
NCT02790008|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-06-02|||June 2015||2015-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Observational|MRF||Magnetic Resonance Imaging and Fibrosis|Magnetic Resonance Imaging and Fibrosis: Histological and Functional Changes in Left Ventricular Function Caused by Aortic Valve Disease|Recruiting||N/A|60|Anticipated|Linkoeping University|||1||f||||f||||||Samples Without DNA|"     Endomyocardial biopsy   "|||2017-10-10 22:07:19.468512|2017-10-10 22:07:19.468512
NCT02789995|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-01|||June 2016||2016-06-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|DISCUSS||Dysfunctions of Human Muscle Stem Cells in Sepsis|Dysfunctions of Human Muscle Stem Cells in Sepsis|Recruiting||N/A|96|Anticipated|Institut Pasteur||1|||f||||f||||||||||2017-10-10 22:07:19.550285|2017-10-10 22:07:19.550285
NCT02789982|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-28|||May 2016||2016-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|PARIS-MEM||Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study|Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study|Recruiting||Phase 3|400|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:07:19.68274|2017-10-10 22:07:19.68274
NCT02789969|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-02|||April 2016||2016-04-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Pain Medications in Children Undergoing Strabismus Surgery|A Randomized Controlled Trial to Compare Pain Medications in Children Undergoing Strabismus Surgery|Recruiting||N/A|128|Anticipated|St. Louis Children's Hospital||2|||f||||f||||||||No||2017-10-10 22:07:19.773012|2017-10-10 22:07:19.773012
NCT02789956|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2017-08-21|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Internal vs. External Connection in Screw-retained Multi-units Bridges With Cad/Cam Milled Co/Cr Framework (ISUS-Atlantis)||Recruiting||Phase 2|40|Anticipated|Institute Franci||2|||f||||f||||||||||2017-10-10 22:07:19.875973|2017-10-10 22:07:19.875973
NCT02789943|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-04-05|||May 2013||2013-05-01|May 2016|2016-05-01|April 2021|Anticipated|2021-04-01|July 2017|Anticipated|2017-07-01|5 Years|Observational [Patient Registry]|STaR-CABG||Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction|The National Heart Centre Singapore Prospective CABG Cohort: Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction|Recruiting||N/A|750|Anticipated|National Heart Centre Singapore|||1||f||||f||||||Samples With DNA|"     Tissue samples ( Atrial Appendage Tissue/ Aortic Button ) Blood Serum   "|No||2017-10-10 22:07:19.963196|2017-10-10 22:07:19.963196
NCT02789930|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-05-30|||February 2016|Actual|2016-02-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|March 2017|Actual|2017-03-01||Observational|||Evaluation of Program for Length Based Weight Estimation|"Evaluation of a Program for Length Based Weight Estimation in Comparison to the Anesthesia Tape (Anästhesie-Lineal)"|Active, not recruiting||N/A|500|Actual|University Children's Hospital, Zurich|||1||f||||t||||||||Undecided||2017-10-10 22:07:20.056265|2017-10-10 22:07:20.056265
NCT02789917|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-09-08|||June 2016||2016-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|APPROACH||APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF|APixaban Versus PhenpRocoumon: Oral AntiCoagulation Plus Antiplatelet tHerapy in Patients With Acute Coronary Syndrome and Atrial Fibrillation|Recruiting||Phase 4|400|Anticipated|Klinikum der Universitaet Muenchen||2|||f||||t||||||||Yes|Inclusion in central DZHK Database (German Centre for Cardiovascular Research)|2017-10-10 22:07:20.132528|2017-10-10 22:07:20.132528
NCT02789904|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-14|||May 2016||2016-05-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|hsTnI||Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emergency Department|Evaluation of High Sensitivity Troponin I (hsTnI) in the Management of Patients With Chest Pain in the Emergency Department|Recruiting||N/A|4000|Anticipated|National Heart Centre Singapore|||1||f||||f||||||Samples With DNA|"     Blood samples will be collected   "|No||2017-10-10 22:07:20.231511|2017-10-10 22:07:20.231511
NCT02789891|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|January 2021|Anticipated|2021-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized Controlled Trials on Laparoscopic No. 14v LNS Dissection|Randomized Controlled Trials on Laparoscopic No. 14v Lymph Node Dissection for Advanced Lower Third Gastric Cancer|Enrolling by invitation||Phase 2|326|Anticipated|Fujian Medical University||2|||f||||||||||||||2017-10-10 22:07:20.30759|2017-10-10 22:07:20.30759
NCT02789878|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-03-04|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer|Phase II Study of Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for Patients With High-Risk Localized Prostate Cancer Prior to Radical Prostatectomy|Not yet recruiting||Phase 2|64|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||t|f|f||||||No||2017-10-10 22:07:20.39017|2017-10-10 22:07:20.39017
NCT02789865|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-05-29|||May 2016||2016-05-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis|Multicenter Prospective Randomized Clinical Trial Comparing Endoscopic Retrograde Appendicitis Therapy (ERAT) vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis|Not yet recruiting||Phase 2|240|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||3|||f||||f||||||||Undecided||2017-10-10 22:07:20.487145|2017-10-10 22:07:20.487145
NCT02789852|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-04-10|||May 30, 2016|Actual|2016-05-30|April 2017|2017-04-01|April 2017|Actual|2017-04-01|January 30, 2017|Actual|2017-01-30||Interventional|||Evaluation of the Effectiveness of Night Orthosis in Treating Women With Symptomatic Osteoarthritis in the Interphalangeal Joint of the Dominant Hand|Evaluation of the Effectiveness of Night Orthosis in Treating Women With Symptomatic Osteoarthritis in the Interphalangeal Joint of the Dominant Hand|Completed||N/A|52|Actual|Federal University of São Paulo||2|||f||||||||||||||2017-10-10 22:07:20.591701|2017-10-10 22:07:20.591701
NCT02789839|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-18|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|HEALTHOX||Analyses of Bone Marrow and Blood Samples From Healthy Volunteers: Focus on the redOx Metabolism|Analyses of Bone Marrow and Blood Samples From Healthy Volunteers: Focus on the redOx Metabolism - HEALTHOX|Completed||N/A|102|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 22:07:20.659469|2017-10-10 22:07:20.659469
NCT02789826|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2017-06-30|||June 2016||2016-06-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Laparoscopic Versus Open Resection of Cancer Stomach|Laparoscopic Versus Open Resection of Cancer Stomach Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 22:07:20.888779|2017-10-10 22:07:20.888779
NCT02789813|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-07-26|||July 2016||2016-07-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|VALPRO||Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.|Randomized Placebo-controlled Phase II Study on the Influence of Valproic Acid in Combination With Reactivation of Fear Memory on the Outcome of Extinction-based Therapy in Patients With Fear of Spiders.|Recruiting||Phase 2|100|Anticipated|University of Basel||4|||f||||t||||||||No||2017-10-10 22:07:21.024333|2017-10-10 22:07:21.024333
NCT02789800|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-05-27|||January 2016||2016-01-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|PACEinMM-QC||Patient-Centred Innovations for Persons With Multimorbidity - Quebec|Patient-Centred Innovations for Persons With Multimorbidity - Quebec|Recruiting||N/A|1956|Anticipated|Université de Sherbrooke||3|||f||||f||||||||No||2017-10-10 22:07:21.174474|2017-10-10 22:07:21.174474
NCT02789787|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-27|||March 2015||2015-03-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|PROTRACTSURG||Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate|Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate|Recruiting||N/A|100|Anticipated|University of Southern California|||2||f||||t||||||||Undecided||2017-10-10 22:07:21.360003|2017-10-10 22:07:21.360003
NCT02789774|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-06-07|||February 2012||2012-02-01|June 2016|2016-06-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|USOFT||Uppsala Study on Odontoid Fracture Treatment in the Elderly|Randomised Controlled Trial on Surgical vs Non-surgical Treatment of Type II Odontoid Fracture Treatment in the Elderly|Recruiting||N/A|50|Anticipated|Uppsala University||2|||f||||f||||||||No||2017-10-10 22:07:21.506742|2017-10-10 22:07:21.506742
NCT02789761|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-27|||January 2016||2016-01-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||The Vascular and Cognitive Effects of Chronic High-flavanol Intake in Healthy Males|The Vascular and Cognitive Effects of Chronic High-flavanol Intake in Healthy Males|Active, not recruiting||N/A|34|Actual|University of Reading||2|||f||||f||||||||No||2017-10-10 22:07:21.627678|2017-10-10 22:07:21.627678
NCT02789748|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-10-03|||June 1, 2016|Actual|2016-06-01|October 2017|2017-10-01|October 2, 2017|Actual|2017-10-02|October 2, 2017|Actual|2017-10-02||Interventional|EKINOx||PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-respiratory Holter moNitoring, for Sleep Apnea syndrOmes||Completed||N/A|42|Actual|LivaNova||2|||f||||f||||||||||2017-10-10 22:07:21.729462|2017-10-10 22:07:21.729462
NCT02789735|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-02-21|||March 2016||2016-03-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Low Level Laser Therapy in Persistent Pelvic Girdle Pain|Effectiveness of Low Level Laser Therapy in Persistent Pregnancy-related Pelvic Girdle Pain After Childbirth|Recruiting||N/A|60|Anticipated|Uppsala University||2|||f||||f||||||||No||2017-10-10 22:07:21.842745|2017-10-10 22:07:21.842745
NCT02789722|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-05-27|||June 2016||2016-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|YMCH-2015||Yerba Mate (Ilex Paraguariensis A.St.-Hil.): Assessment of Cardiovascular Health|Application of Yerba Mate (Ilex Paraguariensis A.St.-Hil.) Products on the Promotion of Health: Assessment of Cardiovascular Health|Enrolling by invitation||N/A|36|Anticipated|Universidade Paranaense||2|||f||||t||||||||Undecided||2017-10-10 22:07:21.968058|2017-10-10 22:07:21.968058
NCT02789709|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-05-30|||January 2016||2016-01-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Metabolomic Phenotyping After Surgery for Colon Cancer: Study of Novel Predictive Biomarkers|Metabolomic Phenotyping After Surgery for Colon Cancer: Study of Novel Predictive Biomarkers|Recruiting||N/A|130|Anticipated|Parc de Salut Mar|||1||f||||f||||||Samples Without DNA|"     Plasma   "|Undecided||2017-10-10 22:07:22.093207|2017-10-10 22:07:22.093207
NCT02789696|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-06-02|||November 2013||2013-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|October 2014|Actual|2014-10-01||Interventional|ACROSAS||Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome|Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome: A Prospective, National and Multicentric Study|Completed||N/A|880|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-10 22:07:22.203174|2017-10-10 22:07:22.203174
NCT02789683|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-11-04|||July 2015||2015-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effects of Emulsification and Lipid Droplet Size on Postprandial Metabolic Responses|Effects of Emulsification and Lipid Droplet Size on Postprandial Metabolic Responses|Completed||N/A|20|Anticipated|Clinical Nutrition Research Centre, Singapore||3|||f||||f||||||||||2017-10-10 22:07:22.295846|2017-10-10 22:07:22.295846
NCT02789670|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-05-30|||July 2014|Actual|2014-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|B-MS||Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients|Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients|Recruiting||N/A|160|Anticipated|University Hospital, Lille|||2||f||||f||||||Samples Without DNA|"     Blood samples to collect peripheral blood mononuclear cells Phenotypic and functional studies     using flow cytometric approaches   "|No||2017-10-10 22:07:22.389573|2017-10-10 22:07:22.389573
NCT02789657|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-01|||November 2016||2016-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||BrUOG 308: Efficacy of wPCbTP and Switching to an AC in Non-responding Patients as Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.|BrUOG 308: Efficacy of Weekly Carboplatin and Paclitaxel With Trastuzumab and Pertuzumab (wPCbTP) and Switching to an Anthracycline-based Regimen (AC) in Non-responding Patients as Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.|Recruiting||Phase 2|30|Anticipated|Brown University||4|||f||||t||||||||||2017-10-10 22:07:22.486553|2017-10-10 22:07:22.486553
NCT02789644|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-05-31|||May 2016||2016-05-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Clinical Trial to Investigate Pharmacokinetics, Metabolomics and Biomarker in Elderly After UDCA Administration|A Randomized, Open-label Clinical Trial to Investigate Pharmacokinetics, Metabolomics and Biomarker in Healthy Elderly Subjects After Ursodeoxycholic Acid Administration|Recruiting||Phase 1|16|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:07:22.619129|2017-10-10 22:07:22.619129
NCT02789631|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-05-05|||October 2015||2015-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Relationship Between Musculoskeletal, Sensorimotor and Functional Factors and Nonspecific Chronic Neck Pain||Completed||N/A|232|Actual|University of Social Welfare and Rehabilitation Science|||2||f||||||||||||||2017-10-10 22:07:22.720054|2017-10-10 22:07:22.720054
NCT02789618|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-27|||June 2016||2016-06-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||A Pilot Study to Substantiate the Use of the Jay Sensitivity Sensor Probe|A Pilot Study to Substantiate the Use of the Jay Sensitivity Sensor Probe by Correlating the Results With the Those of Yeaple Probe, Schiff Air Blast, Visual Analogue Scale (VAS) and Oral Health Impact Profile Questionnaire (OHIP)|Not yet recruiting||N/A|220|Anticipated|Unilever R&D||3|||f||||f||||||||Undecided||2017-10-10 22:07:22.828068|2017-10-10 22:07:22.828068
NCT02789605|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-05-30|||June 2016||2016-06-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|Aphtose||Effectiveness and Safety of Lactobacillus Rhamnosus Lcr35® in the Treatment of Recurrent Aphthous Stomatitis|Treatment of Idiopathic and Recurrent Aphthous Stomatitis by a Probiotic, the Lactobacillus Rhamnosus Lcr35® : a Randomized, Double Blind and Placebo-controlled Trial|Not yet recruiting||Phase 2|40|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||No||2017-10-10 22:07:22.911045|2017-10-10 22:07:22.911045
NCT02789592|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2016-06-02|||July 2016||2016-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease|A Randomized Double-Blind, Double-Dummy, Crossover Study to Evaluate the Efficacy and Safety of Prolonged-Release Melatonin and Clonazepam in Patients With Rapid Eye Movement (REM) Sleep Behavior Disorder in Parkinson Disease|Not yet recruiting||Phase 2|30|Anticipated|Seoul National University Hospital||6|||f||||f||||||||Undecided||2017-10-10 22:07:23.002672|2017-10-10 22:07:23.002672
NCT02789579|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-07-27|||June 2016||2016-06-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract Lithotomy|The Preventive Urinary Tract Infection Role of One Week Solutions of Antimicrobial Application Before Minimally Invasive Upper Tract Lithotomy|Not yet recruiting||Early Phase 1|150|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||Undecided||2017-10-10 22:07:23.129118|2017-10-10 22:07:23.129118
NCT02789566|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-01|||August 2011||2011-08-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|November 2011|Actual|2011-11-01||Interventional|PQ in Obese||Pharmacokinetic Study of Primaquine in Healthy Obese Thai Adult Subjects|Phase 1, Open-Label Study to Evaluate Potential Pharmacokinetic of Orally Administered Primaquine in Healthy Obese Thai Adult Subjects|Completed||Phase 1|10|Actual|University of Oxford||1|||f||||t||||||||Yes||2017-10-10 22:07:23.236838|2017-10-10 22:07:23.236838
NCT02789553|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-05-27|||November 2015||2015-11-01|May 2016|2016-05-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|GLUBYPASS||Starches Digestion After Obesity Surgery.|Starches Digestion After Obesity Surgery. A Comparative Study.|Recruiting||N/A|14|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:07:23.311648|2017-10-10 22:07:23.311648
NCT02789540|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-12-01|||June 2016||2016-06-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|LASSYC||Latin American Study of 24-hs Symptoms in Chronic Obstructive Pulmonary Disease (COPD) Patients; LASSYC Study|An Observational, Multinational, Cross Sectional Primary Data Collection Study to Describe Symptoms Around 24-hs and Their Relationship With Adherence to Respiratory Treatment, Direct Costs and Patient Reported Outcomes (PRO) in Stable COPD Patients in Latin America.|Completed||N/A|900|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-10 22:07:23.399984|2017-10-10 22:07:23.399984
NCT02789527|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-05-09|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Human Genomic Population Structure and Phenotype-genotype Variation in ADME Genes in Four Populations|"Exploratory Study of the Variability, in Five Human Populations, of ADME (Administration, Distribution, Metabolism, Excretion) Genotypes and Phenotypes After the Intake of the Geneva Micrococktail"|Completed||N/A|367|Actual|University Hospital, Geneva||4|||f||||f||||||||Undecided||2017-10-10 22:07:23.468145|2017-10-10 22:07:23.468145
NCT02789514|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-02-02|||July 2016|Actual|2016-07-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Observational|||A Survey of the Indications for Esophagogastroduodenoscopy (EGD) in Children's Hospital of Fudan University|A Survey of the Indications for Esophagogastroduodenoscopy (EGD) in Children's Hospital of Fudan University|Completed||N/A|1303|Actual|Children's Hospital of Fudan University|||1||f||||f||||||||Undecided||2017-10-10 22:07:23.55887|2017-10-10 22:07:23.55887
NCT02789501|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-12-02|||January 2012||2012-01-01|December 2016|2016-12-01||||August 2016|Actual|2016-08-01||Interventional|||Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction|Prospective Trial for Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction|Completed||Phase 4|106|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-10 22:07:23.617763|2017-10-10 22:07:23.617763
NCT02789488|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-05-30|||September 2013||2013-09-01|September 2013|2013-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome|Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome|Completed||Phase 4|50|Actual|Chemical Resources||1|||f||||f||||||||No||2017-10-10 22:07:23.699942|2017-10-10 22:07:23.699942
NCT02789475|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-02|||May 2016||2016-05-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||DP-R212 Pharmacokinetic Study||Recruiting||Phase 1|38|Anticipated|Alvogen Korea||2|||f||||f||||||||No||2017-10-10 22:07:23.763068|2017-10-10 22:07:23.763068
NCT02789462|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-12|||January 2015||2015-01-01|September 2017|2017-09-01||||March 2017|Actual|2017-03-01|15 Years|Observational [Patient Registry]|LAVA||Multicenter LAser VA Registry of Percutaneous Coronary Interventions (LAVA)|Multicenter LAser VA Registry of Percutaneous Coronary Interventions (LAVA)|Active, not recruiting||N/A|200|Anticipated|North Texas Veterans Healthcare System|||1||f||||f||||||||||2017-10-10 22:07:23.903261|2017-10-10 22:07:23.903261
NCT02789449|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-12-22|||November 2015||2015-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Estimation of Pulmonary Capillary Blood Volume in Pre- and Postcapillary Pulmonary Hypertension|Non-invasive Estimation of Pulmonary Capillary Blood Volume in Pre- and Postcapillary Pulmonary Hypertension - a Pilot Study|Recruiting||N/A|20|Anticipated|Medical University of Graz|||2||f||||f||||||||No||2017-10-10 22:07:23.986746|2017-10-10 22:07:23.986746
NCT02789436|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-05-29|||June 2016||2016-06-01|May 2016|2016-05-01||||September 2016|Anticipated|2016-09-01||Interventional|||Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis|Effect of Probiotic Lactobacillus Reuteri-containing Lozenges (Prodentis) on Halitosis in Patients With Chronic Periodontitis|Not yet recruiting||Phase 4|30|Anticipated|University of Zagreb||2|||f||||f||||||||Undecided||2017-10-10 22:07:24.06699|2017-10-10 22:07:24.06699
NCT02789423|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-02-27|||June 2014||2014-06-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth|Clinical and Radiographical Evaluation of the Effect of Calcium Hydroxide Cement (Dycal) and Calcium Silicate Cement (Biodentine) in Direct Pulp Capping in Primary Teeth: a Randomized Clinical Trial|Completed||N/A|60|Actual|Modern Dental College and Research Centre, Indore||2|||f||||f||||||||No||2017-10-10 22:07:24.15791|2017-10-10 22:07:24.15791
NCT02789410|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-08-28|||May 2016||2016-05-01|August 2017|2017-08-01||||September 2017|Anticipated|2017-09-01||Interventional|||Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery|Intrathecal Morphine Versus Intrathecal Hydromorphone for Analgesia Following Cesarean Delivery|Recruiting||N/A|130|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:07:24.227837|2017-10-10 22:07:24.227837
NCT02789397|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-05-09|||July 2016||2016-07-01|May 2017|2017-05-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Clinical Trial to Assess the Efficacy of Rituximab and Azathioprine in the Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in Adult Patients With Common Variable Immunodeficiency (CVID)|Clinical Trial to Assess the Efficacy of Rituximab and Azathioprine in the Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in Adult Patients With Common Variable Immunodeficiency (CVID)|Withdrawn||Phase 2|0|Actual|Medical College of Wisconsin||2||Co-investigator left MCW.|f||||t||||||||Undecided||2017-10-10 22:07:24.312414|2017-10-10 22:07:24.312414
NCT02789384|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-09-29|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|NEOSarcomics||CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.|Prognostic Value of the CINSARC (Complexity Index in Sarcoma) Signature and Correlation With Chemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study. (NEOSarcomics )|Recruiting||N/A|205|Anticipated|Institut Bergonié||1|||f||||f||||||||||2017-10-10 22:07:24.398848|2017-10-10 22:07:24.398848
NCT02789371|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-21|2016-06-06|||May 2016||2016-05-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions|Comparing of Modified Wet Suction Technique and Dry Suction Technique for Endoscopic Ultrasound -Guided Fine Needle Aspiration (EUS-FNA) of Solid Occupying Lesions: a Prospective Multi-center,Randomized,and Controlled Trial|Recruiting||N/A|296|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||Undecided||2017-10-10 22:07:24.504174|2017-10-10 22:07:24.504174
NCT02789358|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-08-08|||December 2015||2015-12-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|plusONE||A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation|A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation. Results of the the plusONE Randomized Multicenter Trial|Recruiting||N/A|120|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||No||2017-10-10 22:07:24.600308|2017-10-10 22:07:24.600308
NCT02789345|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-31|2017-10-03|||October 24, 2016|Actual|2016-10-24|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer|An Open-Label, Multicenter, Phase 1 Study With Expansion Cohorts of Ramucirumab or Necitumumab in Combination With Osimertinib in Patients With Advanced T790M-Positive EGFR-Mutant Non-Small Cell Lung Cancer After Progression on First-Line EGFR TKI Therapy|Recruiting||Phase 1|74|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:07:26.580345|2017-10-10 22:07:26.580345
NCT02789332|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-06-26|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|GeparOla||Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency|A Randomized Phase II Trial to Assess the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency (HRD Patients With Deleterious BRCA1/2 Tumor or Germline Mutation and/or HRD Score High)|Recruiting||Phase 2|102|Anticipated|German Breast Group||2|||f||||t||||||||||2017-10-10 22:07:26.75902|2017-10-10 22:07:26.75902
NCT02789319|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-08-01|||June 2016||2016-06-01|August 2016|2016-08-01||||August 2016|Anticipated|2016-08-01||Interventional|||DTS Blood Glucose Monitor System Surveillance Program SubStudy 1|DTS Blood Glucose Monitor System Surveillance Program SubStudy 1|Active, not recruiting||Phase 4|1125|Anticipated|Diabetes Technology Society||18|||f||||f||||||||No||2017-10-10 22:07:26.915252|2017-10-10 22:07:26.915252
NCT02789306|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-04-24|||May 2016||2016-05-01|April 2017|2017-04-01|March 1, 2017|Actual|2017-03-01|January 1, 2017|Actual|2017-01-01||Observational|PIMT||Preventive Maintenance Therapy on Peri-implant Diseases|Influence of Maintenance Therapy on Peri-implant Disease|Completed||N/A|115|Actual|Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain|||2||f||||t||||||||Undecided||2017-10-10 22:07:27.034985|2017-10-10 22:07:27.034985
NCT02789293|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-01|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients|Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients|Not yet recruiting||Phase 4|80|Anticipated|EyeTechCare||1|||f||||f||||||||No||2017-10-10 22:07:27.120652|2017-10-10 22:07:27.120652
NCT02789280|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-11-21|||May 2016||2016-05-01|April 2016|2016-04-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Mood Management Effects of Brief Unsupported Internet Interventions II|Mood Management Effects of Brief Unsupported Internet Interventions|Completed||N/A|300|Actual|i4Health||2|||f||||f||||||||No||2017-10-10 22:07:27.210753|2017-10-10 22:07:27.210753
NCT02789267|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-20|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|NUQUE3||Nutrition and Quality of Life of Patients With Head and Neck Carcinoma After Radiotherapy|Nutrition and Quality of Life of Patients With Head and Neck Carcinoma After Radiotherapy|Recruiting||N/A|224|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 22:07:27.292809|2017-10-10 22:07:27.292809
NCT02789254|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-09-28|||February 7, 2017|Actual|2017-02-07|July 2017|2017-07-01|October 31, 2019|Anticipated|2019-10-31|July 31, 2019|Anticipated|2019-07-31||Interventional|FLYSYN-101||FLYSYN in MRD Positive AML|First in Man Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of the Fc-optimized FLT3 Antibody FLYSYN for the Treatment of Acute Myeloid Leukemia Patients With Minimal Residual Disease|Recruiting||Phase 1/Phase 2|28|Anticipated|University Hospital Tuebingen||1|||f||||t|f|f||||||||2017-10-10 22:07:27.501203|2017-10-10 22:07:27.501203
NCT02789241|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-04-08|||August 2016||2016-08-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans|Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans: An Evaluation of a New Clinical Lot of Escherichia Coli (E. Coli Group O 113:H10:K Negative) Endotoxin in Healthy Volunteers|Completed||Phase 1|23|Actual|Duke University||2|||f||||f||||||||Yes|The bio-marker specimens collected will be shipped to the NIH for analysis and reviewed by the investigator and Dr. Anthony Suffredini who is a collaborator on the trial and is the Deputy Chief & Senior Investigator in the Department of Critical Care Medicine at the National Institutes of Health|2017-10-10 22:07:27.646384|2017-10-10 22:07:27.646384
NCT02789228|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|May 2019|Anticipated|2019-05-01||Interventional|REST||Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors||Recruiting||Phase 1|32|Anticipated|Children's Research Institute||1|||f||||t||||||||No||2017-10-10 22:07:27.775151|2017-10-10 22:07:27.775151
NCT02789215|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-11|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2017|Actual|2017-05-01||Interventional|||Proposed Meal Changes for CACFP: Impact on Child Food Intake and Costs|Proposed Meal Changes for CACFP: Impact on Child Food Intake and Costs|Active, not recruiting||N/A|32|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 22:07:27.860888|2017-10-10 22:07:27.860888
NCT02789202|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-01|||October 2014||2014-10-01|May 2016|2016-05-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Diammine Silver Fluoride in Arresting Enamel Caries Lesions on Babies' Occlusal Surfaces|Efficacy, Cost-efficacy and Parental Acceptability of Using Diammine Silver Fluoride in Arresting Enamel Caries Lesions on Babies' Occlusal Surfaces|Recruiting||N/A|100|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:07:27.945343|2017-10-10 22:07:27.945343
NCT02789189|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-29|2016-05-29|||June 2016||2016-06-01|May 2016|2016-05-01||||June 2022|Anticipated|2022-06-01||Interventional|||Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail||Not yet recruiting||Phase 2|60|Anticipated|Sun Yat-sen University||1|||f||||||||||||||2017-10-10 22:07:28.04923|2017-10-10 22:07:28.04923
NCT02789176|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-07|||October 2016||2016-10-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study|Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study|Enrolling by invitation||N/A|300|Anticipated|University of Michigan|||2||f||||f||||||||||2017-10-10 22:07:28.134135|2017-10-10 22:07:28.134135
NCT02789163|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-27|||July 2013||2013-07-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Comparison of Diagnostic Accuracy of Automated Volume Breast Scanner to Hand Held Ultrasound for Diagnostic Breast Exam|Comparison of Diagnostic Accuracy of Automated Volume Breast Scanner to Hand Held Ultrasound for Diagnostic Breast Exam|Completed||N/A|90|Actual|Northeastern Ohio Radiology Research and Education Fund|||1||f||||t||||||||No||2017-10-10 22:07:28.262398|2017-10-10 22:07:28.262398
NCT02789150|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-01-26|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg|Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg|Recruiting||Early Phase 1|18|Anticipated|University of Louisville||2|||f||||f||||||||||2017-10-10 22:07:28.341334|2017-10-10 22:07:28.341334
NCT02789137|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-28|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30|9 Months|Observational [Patient Registry]|TROYA||Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment|Estudio Observacional, Prospectivo Y Multicéntrico De Calidad De Vida En Relación Con La Fatiga Y El Síndrome Mano-pie De Los Pacientes Con Carcinoma Renal Metastásico Tratados Con Un Inhibidor De La Tirosina Quinasa En Primera Línea (Estudio Troya)|Recruiting||N/A|100|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 22:07:28.433097|2017-10-10 22:07:28.433097
NCT02789124|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-06-07|||June 2014||2014-06-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Diagnostic Value of Passive Leg Raise Induced Changes in Carotid Artery Flow Time to Predict Fluid Responsiveness in Critically Ill Patients|Diagnostic Value of Passive Leg Raise Induced Changes in Carotid Artery Flow Time to Predict Fluid Responsiveness in Critically Ill Patients|Completed||N/A|22|Actual|University of Louisville||1|||f||||t||||||||||2017-10-10 22:07:28.531249|2017-10-10 22:07:28.531249
NCT02789098|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-01-31|||June 2016||2016-06-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|August 2018|Anticipated|2018-08-01||Interventional|REMOD-TEP||Relationship Between Left Ventricular Remodeling, Coronary Endothelial Function and Myocardial Fibrosis Using Positron Emission Tomography in Patients With ST-elevation Myocardial Infarction|Assessment of Coronary Endothelial Function and Myocardial Fibrosis in Positron Emission Tomography With the Waning of Acute Coronary Syndrome With Elevated ST Segment : Relationship With Left Ventricular Remodeling|Recruiting||N/A|30|Anticipated|University Hospital, Caen||1|||f||||f||||||||No||2017-10-10 22:07:28.707117|2017-10-10 22:07:28.707117
NCT02789085|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-06-02|||November 2013||2013-11-01|June 2016|2016-06-01||||December 2015|Actual|2015-12-01||Interventional|||ANS Effects of ULF-TENS Stimulation in Patients With and Without TMD||Enrolling by invitation||Early Phase 1|200|Anticipated|University of L'Aquila||2|||f||||f||||||||||2017-10-10 22:07:28.79756|2017-10-10 22:07:28.79756
NCT02789072|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-05-27|||September 2015||2015-09-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CapFlight||Effects of Microgravity on Central Aortic Pressure During Parabolic Flights|Effects of Microgravity on Central Aortic Pressure During Parabolic Flights|Recruiting||N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||No||2017-10-10 22:07:28.898893|2017-10-10 22:07:28.898893
NCT02789059|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-05-18|||July 2, 2015|Actual|2015-07-02|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|OXYNEMU||Muscle Oxygenation in Effort in Neuromuscular Diseases|Muscle Oxygenation Modification During Effort in 4 Groups of Neuromuscular Diseases Compared to Healthy Controls, and Mitochondrial Function and Phenotype Assessment|Recruiting||N/A|170|Anticipated|University Hospital, Lille||1|||f||||f||||||||Undecided||2017-10-10 22:07:28.976865|2017-10-10 22:07:28.976865
NCT02789046|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-04-10|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|VENSCORE||DIFFICULT INTRAVENOUS ACCESS IN ADULTS (VENSCORE)|DIFFICULT PERIPHERAL INTRAVENOUS ACCESS IN ADULT DURING THE PREOPERATIVE PERIOD|Recruiting||N/A|3500|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 22:07:29.10493|2017-10-10 22:07:29.10493
NCT02789033|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-05-26|||June 2015||2015-06-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabetic Foot Ulcers|Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabetic Foot Ulcers|Completed||Phase 3|60|Actual|University of Guadalajara||3|||f||||t||||||||No||2017-10-10 22:07:29.359938|2017-10-10 22:07:29.359938
NCT02789020|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-06-19|||December 2016||2016-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Image Parkinson's Disease Progression Study|Image Parkinson's Disease Progression Study|Recruiting||N/A|116|Anticipated|University of Florida|||2||f||||t|f|f||||||Yes|Individual participant data will be available without any personal identifiers included.|2017-10-10 22:07:29.48469|2017-10-10 22:07:29.48469
NCT02789007|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-11-25|||March 2016||2016-03-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|HypoCampus||Effects of Parabolic Flight on Spatial Cognition and Hippocampal Plasticity|Effects of Parabolic Flight on Spatial Cognition and Hippocampal Plasticity|Recruiting||N/A|24|Anticipated|University Hospital, Caen||1|||f||||f||||||||No||2017-10-10 22:07:29.598377|2017-10-10 22:07:29.598377
NCT02788994|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-03-20|||June 2016||2016-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|PET||Stabilization of Fresh Unilateral Unstable Pertrochanteric Hip Fracture|Outcome Following Stabilization of Fresh Unilateral Unstable Pertrochanteric Hip Fracture With Either the Endovis BA2 Cephalomedullary Nail or the Dynamic Hip Screw: A Single Centre, Feasibility Study|Recruiting||N/A|60|Anticipated|University of Leeds||2|||f||||f||||||||No||2017-10-10 22:07:29.682917|2017-10-10 22:07:29.682917
NCT02788981|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-25|||March 28, 2017|Actual|2017-03-28|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Trial of Nanoparticle Albumin-Bound Paclitaxel (Nab-Paclitaxel, Abraxane®) With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer|A Randomized, Placebo-Controlled, Double-Blind, Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel (Nab-Paclitaxel, Abraxane®) With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer|Recruiting||Phase 2|64|Anticipated|University of Chicago||2|||f||||f|t|f||||||||2017-10-10 22:07:29.784695|2017-10-10 22:07:29.784695
NCT02788968|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-06-01|||September 2014||2014-09-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|DéCoR||Conflict Detection Development During the Reasoning|Conflict Detection Development During the Reasoning|Recruiting||N/A|44|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 22:07:29.91402|2017-10-10 22:07:29.91402
NCT02788955|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-04-08|||April 2016||2016-04-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|PRIMe||Protein Recommendation to Increase Muscle|Decreasing the Burden of Sarcopenia in Cancer Through Targeted Nutrition Intervention: A Feasibility Study|Recruiting||N/A|36|Anticipated|University of Alberta||2|||f||||f||||||||Undecided||2017-10-10 22:07:30.022156|2017-10-10 22:07:30.022156
NCT02788942|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-12-14|||March 2016||2016-03-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||The Removing Port of the Laparoscopic Cholecystectomy Material|The Relationship Between the Removing Port of the Laparoscopic Cholecystectomy Material and the Port Site Infections|Active, not recruiting||N/A|120|Anticipated|Sisli Etfal Training & Research Hospital||2|||f||||f||||||||Yes|Once a three months time|2017-10-10 22:07:30.125962|2017-10-10 22:07:30.125962
NCT02788929|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-27|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2017|Anticipated|2017-05-01||Interventional|INCENTIVE||Increasing Exercise Adherence After Percutaneous Coronary Intervention With the Fitbit Charge HR Device|INCreasing Exercise adhereNce After percuTaneous Coronary InterVEntion With the Fitbit Charge HR Device: the INCENTIVE Trial|Enrolling by invitation||N/A|40|Anticipated|North Texas Veterans Healthcare System||2|||f||||f||||||||||2017-10-10 22:07:30.209545|2017-10-10 22:07:30.209545
NCT02788916|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-03-17|||September 25, 2015|Actual|2015-09-25|March 2017|2017-03-01|January 12, 2017|Actual|2017-01-12|November 10, 2016|Actual|2016-11-10||Observational|||A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas|A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas in the Spanish Population|Completed||N/A|198|Actual|Takeda|||1||f||||f||||||Samples With DNA|"     Initial tumor biopsies and histological preparations, filed and previously anonymized, will     be assessed.   "|||2017-10-10 22:07:30.312039|2017-10-10 22:07:30.312039
NCT02788903|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-01|||March 2016||2016-03-01|May 2016|2016-05-01||||February 2021|Anticipated|2021-02-01||Observational|||A Patient-Centered PaTH to Addressing Diabetes|A Patient-Centered PaTH to Addressing Diabetes: Impact of State Health Policies on Diabetes Outcomes and Disparities|Active, not recruiting||N/A|2000000|Anticipated|Milton S. Hershey Medical Center|||2||f||||f||||||||||2017-10-10 22:07:30.42244|2017-10-10 22:07:30.42244
NCT02788890|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-27|||February 10, 2017|Actual|2017-02-10|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|October 25, 2017|Anticipated|2017-10-25||Interventional|||Vital Signs Changes During Dental Procedures|Vital Signs Changes During Different Dental Procedures in Otherwise Healthy Adult Patients.|Recruiting||N/A|50|Anticipated|Riyadh Colleges of Dentistry and Pharmacy||3|||f||||f|f|f||||||||2017-10-10 22:07:30.499861|2017-10-10 22:07:30.499861
NCT02788877|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-11-22|||April 2016||2016-04-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|VIBIM||Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)|Single Arm, Single Dose Clinical Study to Investigate Efficacy of Treat-and-Extend Regimen of Intravitreal Aflibercept Injection in Diabetic Macular Edema|Recruiting||Phase 4|48|Anticipated|Pusan National University Hospital||1|||f||||f||||||||No||2017-10-10 22:07:30.609172|2017-10-10 22:07:30.609172
NCT02788864|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-03-06|||May 20, 2016|Actual|2016-05-20|March 2017|2017-03-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|PREMAL||Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers|A Randomized, Placebo-controlled, Double-blind Trial Using Dihydroartemisinine+Piperaquine (DP) to Protect Forest Workers From Malaria in Bu Gia Map National Park|Completed||Phase 4|150|Actual|Oxford University Clinical Research Unit, Vietnam||2|||f||||t||||||||Yes|Anonymized individual participant data will be made available to researcher and public as a supporting material via open access journal and/or upon request by qualified research groups.|2017-10-10 22:07:30.753948|2017-10-10 22:07:30.753948
NCT02788851|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-29|||April 2016||2016-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)|The Relative Efficacy of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD) Versus Medication Only and the Combination of the Two: A Pilot Study|Recruiting||N/A|70|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-10-10 22:07:30.864403|2017-10-10 22:07:30.864403
NCT02788838|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-27|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Observational|||The Impact of Food Advertisements on Brain Response and Eating Behavior in Children||Recruiting||N/A|40|Anticipated|Penn State University|||1||f||||f||||||||||2017-10-10 22:07:30.995898|2017-10-10 22:07:30.995898
NCT02788825|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-08-17|||April 2016||2016-04-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies||Completed||N/A|687|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 22:07:31.070576|2017-10-10 22:07:31.070576
NCT02788812|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-21|2016-05-28|||June 2016||2016-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||QOL in Incarcerated Inguinal Hernias: TAPP Vs Open Repair|The Comparison of the Quality of Life and Outcomes in Patient's With Incarcerated Inguinal Hernias: Laparoscopic Transabdominal Pre-peritoneal (TAPP) Versus Modified Lichtenstein Hernioplasty|Not yet recruiting||N/A|100|Anticipated|Sarawak General Hospital||2|||f||||f||||||||No||2017-10-10 22:07:31.130713|2017-10-10 22:07:31.130713
NCT02788799|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-26|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|August 31, 2018|Anticipated|2018-08-31||Observational|FLAWLESs||Finding LCX AMI With Posterior ECG LeadS|Clinical Impact of Pre-hospital Posterior ECG Leads Implementation for Identifying Occlusion of Left Circumflex Coronary Artery in ST Segment Elevation Myocardial Infarction|Recruiting||N/A|1200|Anticipated|Rigshospitalet, Denmark|||2||f||||||||||||||2017-10-10 22:07:31.201149|2017-10-10 22:07:31.201149
NCT02788786|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-02-20|||June 27, 2016|Actual|2016-06-27|January 2017|2017-01-01|November 15, 2016|Actual|2016-11-15|November 15, 2016|Actual|2016-11-15||Interventional|||Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal|Feasibility and Acceptability of Daily Oral Rinse in Pregnant Women and Impact on Oral Inflammatory Biomarkers in Rural Nepal|Completed||Phase 2|175|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||No||2017-10-10 22:07:31.282949|2017-10-10 22:07:31.282949
NCT02788773|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-08-14|||August 18, 2016||2016-08-18|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer|A Phase II Study of Durvalumab (MEDI4736) With or Without Tremelimumab in Patients With Metastatic Castration Resistant Prostate Cancer|Recruiting||Phase 2|74|Anticipated|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-10 22:07:31.364707|2017-10-10 22:07:31.364707
NCT02788760|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-11-15|||June 2016||2016-06-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|October 2017|Anticipated|2017-10-01||Interventional|||"The Length of Cervical Collar Treatment for Traumatic Sub-axial Fractures"|"The Length of Cervical Collar Treatment for Traumatic Sub-axial Fractures: Is Six Weeks as Safe as 12 Weeks? (A Randomized, Clinical Trial.)"|Recruiting||N/A|150|Anticipated|Oslo University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:07:31.479501|2017-10-10 22:07:31.479501
NCT02788747|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-09-06|||June 2016||2016-06-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Effect of Multiple Injections of Elamipretide on Various Measures of Heart Function in Patients With Chronic Heart Failure With a Reduced Ejection Fraction|A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of Multiple Subcutaneous Injections of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction|Active, not recruiting||Phase 2|66|Anticipated|Stealth BioTherapeutics Inc.||3|||f||||f||||||||||2017-10-10 22:07:31.558606|2017-10-10 22:07:31.558606
NCT02788734|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-03-01|||June 2016||2016-06-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies|Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies|Completed||N/A|333|Actual|University of South Florida|||1||f||||f||||||||No||2017-10-10 22:07:31.84175|2017-10-10 22:07:31.84175
NCT02788721|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-07-10|||April 14, 2016|Actual|2016-04-14|July 2017|2017-07-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|||A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Female Subjects|Assessment of Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of GLPG2451 and of the Combination of GLPG2451 and GLPG2222 in Healthy Female Subjects|Completed||Phase 1|31|Actual|Galapagos NV||2|||f||||f||||||||||2017-10-10 22:07:31.997529|2017-10-10 22:07:31.997529
NCT02788708|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-02-12|||May 27, 2016|Actual|2016-05-27|February 2017|2017-02-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer|Phase I Evaluation of Lenvatinib and Weekly Paclitaxel in Patients With Recurrent Endometrial, Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 1|30|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:07:32.105153|2017-10-10 22:07:32.105153
NCT02788695|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-31|||November 2014||2014-11-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Observational|NISA||The Northern Ireland Sensory Ageing Study|The Northern Ireland Sensory Ageing Study|Recruiting||N/A|450|Anticipated|Queen's University, Belfast|||2||f||||f||||||Samples With DNA|"     Blood sample.   "|No||2017-10-10 22:07:32.248848|2017-10-10 22:07:32.248848
NCT02788682|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-07-25|||September 2013||2013-09-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Association of Vitamin D Binding Protein Polymorphisms With Response to HCV Therapy|Association of Vitamin D Binding Protein Polymorphisms With Response to Therapy in Chronic Hepatitis C Egyptian Patients|Completed||N/A|162|Actual|Cairo University|||2||f||||f||||||Samples With DNA|"     EDTA blood   "|No||2017-10-10 22:07:32.357869|2017-10-10 22:07:32.357869
NCT02788669|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-06-01|||November 2015||2015-11-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||LRP1 and Colon Cancer|Prognostic Impact of Immunohistochemical and Molecular Expression of the Endocytosis Receptor LRP1 in Colonic Adenocarcinomas|Recruiting||N/A|100|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 22:07:32.455233|2017-10-10 22:07:32.455233
NCT02788656|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-01-30|||September 2016||2016-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|PARENT||Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)|PARENT Trial Pilot Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)|Recruiting||N/A|20|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 22:07:32.55545|2017-10-10 22:07:32.55545
NCT02788643|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-07-19|||May 2014||2014-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BRONCOLL||Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies|Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies|Recruiting||N/A|51|Anticipated|CHU de Reims|||1||f||||||||||||||2017-10-10 22:07:32.733935|2017-10-10 22:07:32.733935
NCT02788630|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-14|||October 2015||2015-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Infant Sleep Hygiene Counseling Trial|Infant Sleep Hygiene Counseling: A Randomized Controlled Trial|Completed||N/A|552|Actual|Federal University of Pelotas||2|||f||||f||||||||Undecided||2017-10-10 22:07:32.83839|2017-10-10 22:07:32.83839
NCT02788617|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-07-28|||June 24, 2016|Actual|2016-06-24|July 2017|2017-07-01|April 4, 2017|Actual|2017-04-04|January 30, 2017|Actual|2017-01-30||Observational|||Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage|A Prospective, Non-interventional, Multicenter, Clinical Study to Evaluate the Efficacy of the Diafert G-CSF ELISA as an Adjunct to Morphological Assessment in Predicting Embryos' Potential to Develop to the Blastocyst Stage|Completed||N/A|100|Actual|Forest Laboratories|||1||f||||f||||||Samples Without DNA|"     Human follicular fluid   "|||2017-10-10 22:07:32.938527|2017-10-10 22:07:32.938527
NCT02788604|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-01|||June 2015||2015-06-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Improving Quality of Life of Children With Cancer Through Psychosocial Screening|Improving Quality of Life of Children With Cancer Through Psychosocial Screening and Improved Communication in Health Care Providers|Recruiting||N/A|160|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||No||2017-10-10 22:07:33.05496|2017-10-10 22:07:33.05496
NCT02788591|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-07-28|||August 2015||2015-08-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CENERDD||Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection|Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection (CENERDD)|Recruiting||N/A|140|Anticipated|Ochsner Health System||2|||f||||f||||||||Undecided||2017-10-10 22:07:33.219268|2017-10-10 22:07:33.219268
NCT02788578|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-05-29|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|PRELUDE||A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours|Peptide Receptor Radionuclide Therapy (PRRT) in Combination With Lanreotide Autogel: A Retrospective Study in Progressive Digestive and Bronchopulmonary Neuroendocrine Neuroendocrine Tumours|Recruiting||N/A|150|Anticipated|Ipsen|||1||f||||f||||||||||2017-10-10 22:07:33.34889|2017-10-10 22:07:33.34889
NCT02788565|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-05-03|||March 2016||2016-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|STREET||Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours|STREET- SOMATOSTATIN TREATMENT EXPERIENCE TRIAL An Observational Cross Sectional International Trial Investigating Quality of Life, Treatment Experience and Direct Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS)|Completed||N/A|156|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 22:07:33.474071|2017-10-10 22:07:33.474071
NCT02788552|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-05-26|||September 2014||2014-09-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OpTIn||Optimum Thiamine Intervention (OpTIn) Trial|Optimum Thiamine Intervention (OpT In) for Treatment and Prevention of Wernicke-Korsakoff Syndrome (WKS): A Randomised Controlled Trial|Recruiting||Phase 4|450|Anticipated|Menzies School of Health Research||6|||f||||f||||||||No||2017-10-10 22:07:33.572234|2017-10-10 22:07:33.572234
NCT02788539|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-09-25|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Interventional|OWL||Our Whole Lives: Online Chronic Pain Management|Reducing Disparities in the Treatment of Chronic Pain Using an Innovative mHealth Tool|Recruiting||N/A|70|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:07:33.713272|2017-10-10 22:07:33.713272
NCT02788526|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-06-16|||June 2009||2009-06-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2012|Actual|2012-06-01||Interventional|||Adjuvant TACE to Reduce the HCC Recurrence After Resection|The Clinical Randomized Trial of Adjuvant Transarterial Chemo Embolization (TACE) to Reduce the Recurrence in Hepatocellular Carcinoma (HCC) Patients at High Risk After Resection|Completed||Phase 3|180|Actual|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 22:07:33.854111|2017-10-10 22:07:33.854111
NCT02788513|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-02-22|||August 2016||2016-08-01|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|August 2020|Anticipated|2020-08-01||Interventional|||BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.|A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy and Safety of Orally Administered BI 425809 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease.|Suspended||Phase 2|585|Anticipated|Boehringer Ingelheim||5|||f||||||||||||||2017-10-10 22:07:33.953076|2017-10-10 22:07:33.953076
NCT02788500|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||The Sports-Related Injuries and Illnesses in Para-sport Study (SRIIPS)|The Sports-Related Injuries and Illnesses in Para-sport Study (SRIIPS): A Prospective Longitudinal Study|Recruiting||N/A|100|Anticipated|Lund University|||1||f||||t||||||||No||2017-10-10 22:07:34.15698|2017-10-10 22:07:34.15698
NCT02788474|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-09-11|||June 9, 2016|Actual|2016-06-09|September 2017|2017-09-01|June 11, 2018|Anticipated|2018-06-11|August 4, 2017|Actual|2017-08-04||Interventional|||Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment|A 12-week, Double Blind, Randomised, Placebo Controlled, Parallel Group Trial Followed by a Single Active Arm Phase of 40 Weeks Evaluating the Effect of Oral Nintedanib 150 mg Twice Daily on Change in Biomarkers of Extracellular Matrix (ECM) Turnover in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Limited Forced Vital Capacity (FVC) Impairment.|Active, not recruiting||Phase 4|347|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:07:34.348722|2017-10-10 22:07:34.348722
NCT02788461|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-01-26|||May 2016||2016-05-01|January 2017|2017-01-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01||Interventional|PET-BOOST||Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy|A Randomized Phase II Trial to Assess the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy|Recruiting||N/A|78|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||No||2017-10-10 22:07:35.246979|2017-10-10 22:07:35.246979
NCT02788448|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-27|||January 2016||2016-01-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|March 2017|Anticipated|2017-03-01||Interventional|Frontier III||Safety and Performance Study of Large Hole Vascular Closure Device|Clinical Investigation Plan (CIP) for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER III Study|Recruiting||N/A|51|Anticipated|Vivasure Medical Limited||1|||f||||t||||||||||2017-10-10 22:07:35.352896|2017-10-10 22:07:35.352896
NCT02788435|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-26|||July 2016||2016-07-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||The Role of Voice Rest on Voice Outcomes Following Phonosurgery|The Role of Voice Rest on Voice Outcomes Following Phonosurgery: A Randomized-Controlled Trial|Not yet recruiting||N/A|50|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||No||2017-10-10 22:07:35.447943|2017-10-10 22:07:35.447943
NCT02788422|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-05-08|||March 20, 2017|Actual|2017-03-20|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Video Discharge Instructions for Acute Otitis Media|The Effectiveness of Video Discharge Instructions for Acute Otitis Media on Knowledge Acquisition and Clinical Outcomes: a Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||No||2017-10-10 22:07:35.524805|2017-10-10 22:07:35.524805
NCT02788409|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-06-16|||May 15, 2016|Actual|2016-05-15|June 2017|2017-06-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Observational|||Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US|Incidence of Second Primary Malignancies in Patients With Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US|Completed||N/A|15750|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:07:35.61007|2017-10-10 22:07:35.61007
NCT02788396|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-08-08|||May 2016||2016-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|POSTDILSTEMI||The Impact of Post Stenting Balloon Dilatation on Coronary Microcirculation in STEMI Patients Undergoing PPCI|The Impact of Post Stenting Balloon Dilatation on Coronary Microcirculation in ST Segment Elevation Myocardial Infarction (STEMI) Patients Undergoing Primary Percutaneous Coronary Intervention (PPCI)|Recruiting||N/A|30|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 22:07:35.701282|2017-10-10 22:07:35.701282
NCT02788383|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-06-20|||June 2016||2016-06-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Observational|||Fetal RhD Genotye Non Invasive Prenatal Determination|Aplicación en la práctica clínica de la determinación Prenatal no Invasiva en el Genotipo RhD Fetal Durante el Primer Trimestre de la gestación en Gestantes RhD Negativas|Recruiting||N/A|200|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||Undecided||2017-10-10 22:07:35.961434|2017-10-10 22:07:35.961434
NCT02788370|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-08-17|||July 2016||2016-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|CPEPolder||Cardiopulmonary Response to Conical-PEP Breathing During Exercise in Older People.|Cardiopulmonary Response to Conical Positive Expiratory Breathing During Exercise in Older People.|Active, not recruiting||N/A|12|Actual|Khon Kaen University||2|||f||||f||||||||||2017-10-10 22:07:36.040826|2017-10-10 22:07:36.040826
NCT02788357|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-07-13|2017-06-15||November 2006||2006-11-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Interventional|||Post-stroke Neural Plasticity With Atomoxetine|Enhancement of Post-stroke Neural Plasticity With Atomoxetine: a Pilot Study|Completed||Phase 2|12|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 22:07:36.148154|2017-10-10 22:07:36.148154
NCT02788344|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-16|||May 15, 2017|Actual|2017-05-15|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|STEMI-Qual||Quality and Safety of Initial Management for ST-segment Elevation Myocardial Infarction|Baseline Characteristics, Processes of Care, System-related Factors, and Clinical Outcomes Associated With the Quality and Safety of Initial Management for ST-segment Elevation Myocardial Infarction: A Multicenter Cohort Study|Recruiting||N/A|7435|Anticipated|Centre Hospitalier de la Région d'Annecy|||1||f||||t||||||||Undecided||2017-10-10 22:07:37.012963|2017-10-10 22:07:37.012963
NCT02788331|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-06-16|||April 2016||2016-04-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|TREVORS||Trends in Volume-Outcome Relationship in Surgery|Revisiting the Volume-outcome Relationship in Surgery: Trends Analysis in French Hospitals|Completed||N/A|759518|Actual|Hospices Civils de Lyon|||3||f||||f||||||||No||2017-10-10 22:07:37.144115|2017-10-10 22:07:37.144115
NCT02788318|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-05-27|||January 2014||2014-01-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|SUDEP||Serotoninergic Pathways in Sudden and Unexpted Death in Epilepsy (SUDEP)|Serotoninergic Pathways in Sudden and Unexpted Death in Epilepsy (SUDEP)|Recruiting||N/A|45|Anticipated|Hospices Civils de Lyon|||3||f||||f||||||Samples Without DNA|"     Brain tissue (brainstem, hippocampus and insula) and fibroblasts culture   "|||2017-10-10 22:07:37.266312|2017-10-10 22:07:37.266312
NCT02788292|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-05-27|||July 2016||2016-07-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of N-Acetylcysteine on Autologous Fat Graft Survival|Effect of N-Acetylcysteine on Autologous Fat Graft Survival|Not yet recruiting||Phase 4|14|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||No|IPD will not be available, but will be published as an average of outcomes.|2017-10-10 22:07:37.515088|2017-10-10 22:07:37.515088
NCT02788279|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-09-26|||July 5, 2016|Actual|2016-07-05|September 2017|2017-09-01|February 7, 2019|Anticipated|2019-02-07|February 7, 2019|Anticipated|2019-02-07||Interventional|||A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)|A Phase III, Open-Label, Multicenter, Three-Arm, Randomized Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy vs. Regorafenib in Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Adenocarcinoma|Active, not recruiting||Phase 3|360|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:07:37.640581|2017-10-10 22:07:37.640581
NCT02788266|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2016-05-27|||December 2013||2013-12-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Treatment of Gingival Recession-type Defects Using Different Restorative Materials|Clinical Evaluation of Combined Surgical/ Restorative Treatment of Gingival Recession-type Defects Using Different Restorative Materials|Completed||N/A|18|Actual|Gazi University||3|||f||||f||||||||No||2017-10-10 22:07:37.986002|2017-10-10 22:07:37.986002
NCT02788253|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-03-31|||June 2015||2015-06-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Mallampati Score in Sitting or Supine Position With or Without Phonation|Comparison of the Mallampati Score in Supine or Sitting Position With and Without Phonation to Predict Difficult Airway Management|Recruiting||N/A|2000|Anticipated|University Hospital, Caen|||1||f||||f||||||||No||2017-10-10 22:07:38.108004|2017-10-10 22:07:38.108004
NCT02788240|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-11-28|||May 2016||2016-05-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase|To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase - A Randomized Controlled Study|Recruiting||N/A|80|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||No||2017-10-10 22:07:38.239527|2017-10-10 22:07:38.239527
NCT02788227|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2017-07-13|||January 12, 2016||2016-01-12|July 12, 2017|2017-07-12|October 31, 2022|Anticipated|2022-10-31|October 31, 2021|Anticipated|2021-10-31||Interventional|||Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure|A Multicenter Study of the Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSVdeltaG-ZEBOV GP) for Pre-Exposure Prophylaxis in Individuals at Potential Occupational Risk for Ebola Virus Exposure (PREPARE)|Enrolling by invitation||Phase 2|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:07:38.364282|2017-10-10 22:07:38.364282
NCT02788214|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2017-06-30|||May 23, 2016||2016-05-23|May 3, 2017|2017-05-03|September 30, 2020|Anticipated|2020-09-30|December 31, 2017|Anticipated|2017-12-31||Observational|||Helicobacter Pylori Genome Project|Helicobacter Pylori Genome Project|Not yet recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:07:38.469367|2017-10-10 22:07:38.469367
NCT02788201|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2017-07-04|||May 20, 2016||2016-05-20|May 2, 2017|2017-05-02|June 29, 2019|Anticipated|2019-06-29|June 29, 2018|Anticipated|2018-06-29||Interventional|||Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma|A Pilot Clinical Trial of Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma|Recruiting||Phase 2|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:07:38.574205|2017-10-10 22:07:38.574205
NCT02788188|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2017-10-05|||May 18, 2016||2016-05-18|July 12, 2017|2017-07-12|April 30, 2018|Anticipated|2018-04-30|April 10, 2018|Anticipated|2018-04-10||Interventional|||Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults|A Phase 1, Randomized Double-Blind, Placebo-Controlled, Single Ascending Dose Safety, Tolerability, and Pharmacokinetics Study of SAB-301 in Healthy Adults|Active, not recruiting||Phase 1|43|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:07:38.693823|2017-10-10 22:07:38.693823
NCT02788175|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-28|2017-07-13|||May 18, 2016||2016-05-18|July 12, 2017|2017-07-12|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption|An Exploratory, Open-Label Study of Vedolizumab (Anti-alpha4beta7 Antibody) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption|Recruiting||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:07:38.801721|2017-10-10 22:07:38.801721
NCT02788162|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-05-30|||October 2015||2015-10-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SPF Assay||18616 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose.|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:07:38.907148|2017-10-10 22:07:38.907148
NCT02788149|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-05-26|||June 2016||2016-06-01|May 2016|2016-05-01||||May 2017|Anticipated|2017-05-01||Interventional|||Ultrasound Against Obstructive Sleep Apnea|Ultrasound Against Obstructive Sleep Apnea|Not yet recruiting||N/A|200|Anticipated|Henry Ford Health System||2|||f||||t||||||||Yes||2017-10-10 22:07:38.988972|2017-10-10 22:07:38.988972
NCT02788136|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2016-06-06|||February 2012||2012-02-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Human Chorionic Gonadotropin Stimulation Effects on Steroidogenesis in Men With Klinefelter Syndrome|Analisi Del Profilo Sierico Steroideo Basale e Dopo Stimolo Con Gonadotropina Corionica Umana (HCG) Nei Soggetti Affetti da Sindrome di Klinefelter (SK).|Completed||N/A|25|Actual|Azienda USL Modena||2|||f||||f||||||||Undecided||2017-10-10 22:07:39.085867|2017-10-10 22:07:39.085867
NCT02788123|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-09-19|||March 3, 2017|Actual|2017-03-03|September 2017|2017-09-01|June 13, 2017|Actual|2017-06-13|May 29, 2017|Actual|2017-05-29||Interventional|BiGARD||A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy|Phase IV, Multicenter, Open Label, Randomized Study in Parallel Groups To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol®) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Patients With NSAID Induced Gastropathy|Terminated||Phase 4|9|Actual|Astellas Pharma Inc||2||Internal reassessment of the medicinal product development strategy by Sponsor|f||||f|f|f||||||||2017-10-10 22:07:39.189184|2017-10-10 22:07:39.189184
NCT02788110|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-11|||August 2016||2016-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Work of Breathing During Non-invasive Ventilation in Premature Neonates|Prospective Crossover Comparison of Work of Breathing During Non-invasive Ventilation: Neurally Adjusted Ventilatory Assist (NAVA) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) in Premature Neonates|Recruiting||N/A|15|Anticipated|Arkansas Children's Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:07:39.309777|2017-10-10 22:07:39.309777
NCT02788097|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-12-09|2016-10-17||May 2016||2016-05-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Comparison of Day 19 and Day 20 Artificial FET|Assessment of Artificial FET Reproductive Outcomes: Transfer of Blastocysts on Progesterone + 4 Versus Progesterone + 5|Terminated||N/A|130|Actual|Antalya IVF||2||Large and sustained difference in pregnancy rate|f||||f||||||||Yes|data to be entered|2017-10-10 22:07:39.420476|2017-10-10 22:07:39.420476
NCT02788084|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-06-26|||October 2016||2016-10-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow|Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow|Recruiting||N/A|80|Anticipated|Alberta Health Services, Calgary|||1||f||||f||||||Samples With DNA|"     DNA library, RNA and formalin fixed paraffin embedded (FFPE) specimens will be banked with     participants' prior permission.   "|No||2017-10-10 22:07:39.658428|2017-10-10 22:07:39.658428
NCT02788071|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-30|2017-08-01|||October 2016||2016-10-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome|Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome (IBS) - a Randomized, Double-blind Placebo Controlled Pilot Study|Completed||Phase 2/Phase 3|52|Actual|Aleris-Hamlet Hospitaler København||2|||f||||t||||||||||2017-10-10 22:07:39.738728|2017-10-10 22:07:39.738728
NCT02788058|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-26|||May 2016||2016-05-01|May 2016|2016-05-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|||A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy|A Phase II Trial of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy|Not yet recruiting||Phase 2|76|Anticipated|First People's Hospital of Hangzhou||2|||f||||t||||||||||2017-10-10 22:07:39.825816|2017-10-10 22:07:39.825816
NCT02788045|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-27|2017-07-18|||July 8, 2016|Actual|2016-07-08|July 2017|2017-07-01|September 14, 2018|Anticipated|2018-09-14|December 15, 2017|Anticipated|2017-12-15||Interventional|||Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults|A Randomized, Parallel-Group, Placebo-Controlled, Double-Blind Phase 1/2a Study in Healthy HIV Uninfected Adults to Assess the Safety/Tolerability and Immunogenicity of 2 Different Prime/Boost Regimens; Priming With Trivalent Ad26.Mos.HIV and Boosting With Trivalent Ad26.Mos.HIV And Clade C Gp140 Plus Adjuvant or Priming With Tetravalent Ad26.Mos4.HIV and Boosting With Tetravalent Ad26.Mos4.HIV and Clade C Gp140 Plus Adjuvant|Recruiting||Phase 2|198|Anticipated|Janssen Vaccines & Prevention B.V.||4|||f||||f||f||||||||2017-10-10 22:07:39.903725|2017-10-10 22:07:39.903725
NCT02788032|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-01|||July 2016||2016-07-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||EnergieShake® Acceptability and Tolerance Study|Open Label Study of Acceptability, Tolerance, and Compliance Using EnergieShake® Dietary Powdered Supplement|Not yet recruiting||N/A|18|Anticipated|Anaiah Healthcare Pvt Ltd||1|||f||||f||||||||No||2017-10-10 22:07:40.02073|2017-10-10 22:07:40.02073
NCT02788019|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-07|||May 2018|Anticipated|2018-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Adductor Canal Mid-thigh and Adductor Canal Distal Thigh: Is Cutaneous Sensory Blockade Similar Among Block Techniques?|Adductor Canal Mid-thigh and Adductor Canal Distal Thigh: Is Cutaneous Sensory Blockade Similar Among Block Techniques?|Recruiting||Phase 4|68|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|t|f||||||||2017-10-10 22:07:40.097792|2017-10-10 22:07:40.097792
NCT02788006|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-08-10|||January 2016||2016-01-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|REGOLD||Phase II Study Evaluating the Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .|Phase II Study Evaluating the Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years Old With a Metastatic Colorectal Adenocarcinoma .|Recruiting||Phase 2|42|Anticipated|Federation Francophone de Cancerologie Digestive||1|||f||||t||||||||||2017-10-10 22:07:40.201877|2017-10-10 22:07:40.201877
NCT02787993|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||ICAN Symptoms Duke-NUS|Feasibility and Acceptability of a Behavioral Symptom Management Program for Patients With Advanced Breast Cancer in Singapore and the US|Recruiting||N/A|40|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 22:07:40.661719|2017-10-10 22:07:40.661719
NCT02787980|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-12-27|||October 2015||2015-10-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Dosage of Serum Tryptase Levels in a Population of Premature Newborns to Evaluate Mast Cell Activity|Dosage of Serum Tryptase Levels in a Population of Premature Newborns to Evaluate Mast Cell Activity|Recruiting||N/A|140|Anticipated|CHU de Reims||2|||f||||f||||||||||2017-10-10 22:07:40.780998|2017-10-10 22:07:40.780998
NCT02787967|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-22|||August 2016||2016-08-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old|A Single-dose, Open-label, Randomized, 2-way Cross-over Study of CHF 1535 35/4 NEXThaler® (Fixed Combination of Beclometasone Dipropionate (BDP) 35 μg Plus Formoterol Fumarate (FF) 4 μg Versus the Free Combination of Licensed BDP DPI (Dry Powder Inhaler) and FF DPI in Asthmatic Children|Completed||Phase 2|26|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||No||2017-10-10 22:07:40.884318|2017-10-10 22:07:40.884318
NCT02787954|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-05-26|||January 2016||2016-01-01|May 2016|2016-05-01|January 2026|Anticipated|2026-01-01|January 2021|Anticipated|2021-01-01|5 Years|Observational [Patient Registry]|Liver||Prospective Tumor Response Evaluation|Prospective Evaluation of Tumor Response to Cancer Treatment Therapies|Recruiting||N/A|250|Anticipated|The University of Texas Health Science Center, Houston|||4||f||||f||||||Samples With DNA|"     Biopsy liver tumor samples and blood tumor samples   "|No||2017-10-10 22:07:41.013865|2017-10-10 22:07:41.013865
NCT02787941|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-31|||November 2015||2015-11-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Pharmacist-led Intervention to Enhance Medication Adherence in Post-acute Coronary Syndrome Patients in Vietnam|Pharmacist-delivered Multifaceted Intervention to Enhance Medication Adherence Among Post-acute Coronary Syndrome Patients in Vietnam: A Randomised Controlled Trial|Recruiting||N/A|140|Anticipated|University of Groningen||2|||f||||f||||||||Undecided||2017-10-10 22:07:41.174799|2017-10-10 22:07:41.174799
NCT02787928|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-12-07|||April 2016||2016-04-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System|Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System|Recruiting||Phase 1|50|Anticipated|Virginia Commonwealth University||1|||f||||f||||||||No||2017-10-10 22:07:41.300176|2017-10-10 22:07:41.300176
NCT02787915|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-05-31|||September 2016||2016-09-01|May 2016|2016-05-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||DC1s-CTL Cellular Therapy for Renal Cell Carcinoma|DC1s-CTL Cell Therapy to Treat Patients With Renal Cell Carcinoma After Radical Resection|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Xuzhou Medical University||1|||f||||t||||||||No||2017-10-10 22:07:41.430013|2017-10-10 22:07:41.430013
NCT02787902|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-05-31|||June 2016||2016-06-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Weight Management in Mothers and Adult Daughters|Improving Communication and Collaboration for Weight Management in Mother-daughter|Not yet recruiting||N/A|168|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 22:07:41.536213|2017-10-10 22:07:41.536213
NCT02787889|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-26|||January 2014||2014-01-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Dietary Protein Intake Distribution on Protein Metabolism and Skeletal Muscle|Effect of Dietary Protein Intake Distribution on Protein Metabolism and Skeletal Muscle|Completed||N/A|19|Actual|University of Arkansas||2|||f||||f||||||||||2017-10-10 22:07:41.635117|2017-10-10 22:07:41.635117
NCT02787876|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-06-05|||October 4, 2016|Actual|2016-10-04|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Pegteograstim in Children With Solid Tumors|Efficacy and Safety of Pegteograstim on Chemotherapy-induced Neutropenia in Children With Solid Tumors|Recruiting||Phase 2|34|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:07:41.721876|2017-10-10 22:07:41.721876
NCT02787863|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-04|||September 2012|Actual|2012-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|January 2017|Actual|2017-01-01||Interventional|||Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology|Pathogenetic Justification and Clinical and Immunological Efficiency of Application Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology|Recruiting||Phase 4|520|Anticipated|Russian Academy of Medical Sciences||16|||f||||f||||||||No||2017-10-10 22:07:41.838074|2017-10-10 22:07:41.838074
NCT02787850|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-20|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|CMI||Treatment of Abdomen Study|CoolSculpting the Abdomen Using an Applicator With a Crown Cooling Insert|Completed||N/A|20|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-10 22:07:42.029206|2017-10-10 22:07:42.029206
NCT02787837|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-03-26|||May 2014||2014-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|PROSABI||PROSABI: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Abiraterone|Prospective Multi-centre Studies of Prognostic Factors in Castration Resistant PROState Cancer Treated With Abiraterone|Recruiting||N/A|208|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III|||2||f||||f||||||Samples With DNA|"     PAXgene and TEMPUS tubes at baseline, precycle 3 and progression   "|||2017-10-10 22:07:42.119083|2017-10-10 22:07:42.119083
NCT02787824|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-19|||May 2016||2016-05-01|May 2016|2016-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Periodic Versus Continuous IV Iron Supplementation in HD Patients|Periodic Versus Continuous (at Every Session of Hemodialysis) iv Iron Supplementation in Chronic HD Patients|Completed||Phase 4|27|Actual|Papageorgiou General Hospital||2|||f||||||||||||||2017-10-10 22:07:42.378307|2017-10-10 22:07:42.378307
NCT02787811|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-03-18|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Predictors of Success of IUI in Unexplained Infertility|Factors Affecting Success of IUI in Women With Unexplained Infertility|Completed||N/A|100|Actual|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 22:07:42.467201|2017-10-10 22:07:42.467201
NCT02787798|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-05-17|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|B2AN-SNS||Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure|Evaluation of the Effect of Double Inhibition of Angiotensin II AT1 Receptor and Neprilysin Activity on Sympathic Nervous System Activity in Patient With Heart Failure|Recruiting||Phase 4|50|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||Undecided||2017-10-10 22:07:42.55725|2017-10-10 22:07:42.55725
NCT02787772|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-08|||January 2009||2009-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|November 2014|Actual|2014-11-01||Interventional|||Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment?|Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment?|Completed||N/A|246|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 22:07:42.828163|2017-10-10 22:07:42.828163
NCT02787759|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-12-27|||June 2012||2012-06-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|FBT||Falls-based Training for Walking Post-Stroke|Falls-based Training to Improve Balance and Mobility Post-Stroke|Completed||Phase 2|54|Actual|University of Alabama at Birmingham||2|||f||||f||||||||No||2017-10-10 22:07:42.93799|2017-10-10 22:07:42.93799
NCT02787746|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-08-15|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|STDMMAD||Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease|Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease: A Multi-center Single-arm Study in China|Recruiting||Phase 4|554|Anticipated|Beijing Friendship Hospital||1|||f||||t||||||||||2017-10-10 22:07:43.015134|2017-10-10 22:07:43.015134
NCT02787733|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-01|||July 2014||2014-07-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of an Orange Peel Extract on Exercise Performance|Establishing the Effect of Long-term Orange Peel Extract Supplementation on Exercise Performance and Recovery|Completed||N/A|39|Actual|Maastricht University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:07:43.107053|2017-10-10 22:07:43.107053
NCT02787720|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-31|||December 2009||2009-12-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Rehabilitation Techniques on Survivors of Acute Respiratory Distress Syndrome|Effects of Varied Rehabilitation Techniques on Survivors of Acute Respiratory Distress Syndrome: A Randomized Controlled Trial|Completed||N/A|140|Actual|Baqiyatallah Medical Sciences University||2|||f||||t||||||||No||2017-10-10 22:07:43.17336|2017-10-10 22:07:43.17336
NCT02787694|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-12-16|||June 2013||2013-06-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|MARS||Machines Assisting Recovery From Stroke|Machines Assisting Recovery From Stroke: Robotic Activity Mobility Center in a Fitness Center for People With Neurologic Disability|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Alabama at Birmingham||1|||f||||f||||||||Undecided||2017-10-10 22:07:43.333368|2017-10-10 22:07:43.333368
NCT02787681|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-08-23|||August 15, 2016|Actual|2016-08-15|August 2017|2017-08-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Interventional|||Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube|Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube After Intubation of Critically Ill Patients|Completed||N/A|69|Actual|Loma Linda University||1|||f||||f|f|t|f|f|f|||||2017-10-10 22:07:43.416519|2017-10-10 22:07:43.416519
NCT02787668|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-19|||May 2016||2016-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity|A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity|Recruiting||N/A|36|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||Undecided||2017-10-10 22:07:43.484817|2017-10-10 22:07:43.484817
NCT02787655|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-05-26|||February 1, 2013|Actual|2013-02-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Aerobic Exercise and Cognitive Training in Older Adults|Aerobic Exercise and Cognitive Training in Older Adults|Recruiting||N/A|80|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||No||2017-10-10 22:07:43.570031|2017-10-10 22:07:43.570031
NCT02787642|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-30|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|RADIOSARP||A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma|A Phase Ib Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma|Recruiting||Phase 1|41|Anticipated|Institut Bergonié||1|||f||||t||||||||||2017-10-10 22:07:43.651819|2017-10-10 22:07:43.651819
NCT02787629|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-07|||July 2016||2016-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Simultaneous Endotracheal Tube Insertion With GlideScope Use|Comparison of Simultaneous Endotracheal Tube Insertion With GlideScope Use: a Pilot Study|Not yet recruiting||N/A|50|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 22:07:43.748417|2017-10-10 22:07:43.748417
NCT02787616|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-04-24|||May 2015||2015-05-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Genetic Basis of Rosacea|Validation of Candidate Rosacea Genes By Targeted Interrogation of Alleles and Assessment of Rosacea Co-morbidities|Recruiting||N/A|300|Anticipated|Stanford University|||2||f||||||||||||||2017-10-10 22:07:43.923641|2017-10-10 22:07:43.923641
NCT02787603|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-06-05|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|EPICAD||Procalcitonin in Early Antibiotic Interruption in Patient With Bacterial Pulmonary infeCtion and Acute Heart Failure|Evaluation of Procalcitonin in the Early Antibiotic Therapy Interruption in Patient With Bacterial Pulmonary infeCtion and Decompensated Acute Heart Failure|Completed||N/A|46|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:07:43.995351|2017-10-10 22:07:43.995351
NCT02787590|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-04-12|||September 2015||2015-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|PD STAT||Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease|Simvastatin as a Neuroprotective Treatment for Parkinson's Disease: a Double-blind, Randomised, Placebo Controlled Futility Study in Patients of Moderate Severity.|Recruiting||Phase 2|198|Anticipated|Plymouth Hospitals NHS Trust||2|||f||||t||||||||No||2017-10-10 22:07:44.080271|2017-10-10 22:07:44.080271
NCT02787577|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-12-08|||April 2016||2016-04-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SLuMBER||The Sleep Lengthening and Metabolic Health, Body Composition, Energy Balance and Cardiovascular Risk Study|The SLuMBER Study: The Sleep Lengthening and Metabolic Health, Body Composition, Energy Balance and Cardiovascular Risk Study|Completed||N/A|43|Actual|King's College London||2|||f||||f||||||||No||2017-10-10 22:07:44.206327|2017-10-10 22:07:44.206327
NCT02787538|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-05-31|||January 2016||2016-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SuPER-US||Supporting Patient Care With Electronic Resources in the United States|Supporting Patient Care With Electronic Resources in the United States (SuPER-US): Effectiveness of an Online Decision Aid for Patients Considering Biologic Therapy for Rheumatoid Arthritis|Recruiting||N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:07:46.881356|2017-10-10 22:07:46.881356
NCT02787525|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-01-02|||July 2016||2016-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Comparison of Outcomes After Left Atrial Appendage Closure or Oral Anticoagulation in Patients With Atrial Fibrillation|Comparison of Clinical Outcomes After Left Atrial Appendage Closure or Oral Anticoagulation in Patients With Atrial Fibrillation: A Retrospective Propensity Matched Study|Completed||N/A|1000|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||No||2017-10-10 22:07:46.973431|2017-10-10 22:07:46.973431
NCT02787512|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-28|||June 2016||2016-06-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Preoperative Biliary Drainage With Metal Versus Plastic Stents in Periampullary Cancer|A Randomized Controlled Trial for Preoperative Biliary Drainage With Metal Versus Plastic Stents in Patients With Periampullary Cancer|Recruiting||N/A|60|Anticipated|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 22:07:47.042439|2017-10-10 22:07:47.042439
NCT02787499|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-11-11|||November 2016||2016-11-01|November 2016|2016-11-01||||June 2021|Anticipated|2021-06-01||Interventional|REVAMP||Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa|Resistance Testing Versus Adherence Support for Management of Patients With Virologic Failure on First-Line Antiretroviral Therapy in Sub-Saharan Africa|Recruiting||N/A|840|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Yes|Data will be made public and accessible through request after completion of primary analysis.|2017-10-10 22:07:47.293365|2017-10-10 22:07:47.293365
NCT02787486|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-05-31|||October 2015||2015-10-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Expanded Noninvasive Genomic Medical Assessment: The Enigma Study|A Clinical Study to Evaluate the Relative Clinical Sensitivity, Specificity, and Performance of the a Laboratory Developed Test as a Screening Test for Fetal Chromosomal Aneuploidy, Infectious and Other Diseases, and RhD Genotyping in the General Population of Pregnant Women|Recruiting||N/A|2500|Anticipated|Progenity, Inc.|||2||f||||f||||||Samples With DNA|"     Whole blood   "|Undecided||2017-10-10 22:07:47.418023|2017-10-10 22:07:47.418023
NCT02787473|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-11-23|||October 2016||2016-10-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|October 2019|Anticipated|2019-10-01||Interventional|||A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer|A Phase II Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Every-21-Day Docetaxel Consolidation in Patients With Inoperable Stage IIIA/B Squamous Cell Lung Cancer|Recruiting||Phase 2|54|Anticipated|First People's Hospital of Hangzhou||1|||f||||t||||||||||2017-10-10 22:07:47.570103|2017-10-10 22:07:47.570103
NCT02787460|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-08-28|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Testing the Effectiveness of Behavioral Text Messages to Promote Attendance at HMRE Sessions|Testing the Effectiveness of Behavioral Text Messages to Promote Attendance at HMRE Sessions|Recruiting||N/A|1500|Anticipated|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-10 22:07:47.67582|2017-10-10 22:07:47.67582
NCT02787447|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-11-23|||May 2016||2016-05-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy|A Phase II Trial of Hypofractionated Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy|Recruiting||Phase 2|46|Anticipated|First People's Hospital of Hangzhou||1|||f||||t||||||||||2017-10-10 22:07:47.772812|2017-10-10 22:07:47.772812
NCT02787434|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-12-21|||August 2014||2014-08-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|PCSPrep||Addressing Prostate Cancer Information Disparities With eHealth Technology|Addressing Prostate Cancer Information Disparities With eHealth Technology|Completed||N/A|125|Actual|Tufts University||1|||f||||t||||||||Yes|Data Sharing Plan agreement between Tufts University, Emory University, and Dana-Farber Cancer Institute|2017-10-10 22:07:47.886061|2017-10-10 22:07:47.886061
NCT02787421|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-06-13|||April 2016||2016-04-01|June 2017|2017-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Nasal Dilator Strips for Rhinoplasty|Predictive Value of Nasal Dilator Strips for Evaluating Nasal Valve Obstruction as Measured by Post-Operative Rhinoplasty Outcomes|Withdrawn||N/A|0|Actual|Emory University||1||Study withdrawn - changing study design.|f||||f||||||||||2017-10-10 22:07:47.992231|2017-10-10 22:07:47.992231
NCT02787408|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-06|||September 2016||2016-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|March 2018|Anticipated|2018-03-01||Interventional|SPACER||The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System|The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System|Recruiting||N/A|78|Anticipated|Edwards Lifesciences||1|||f||||t||||||||||2017-10-10 22:07:48.068139|2017-10-10 22:07:48.068139
NCT02787395|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-06-01|||June 2016||2016-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|SR-SD||Self Reduction of Shoulder Dislocation|Patients Education of a Self-reduction Technique for Anterior Dislocation of Shoulder|Not yet recruiting||N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||No||2017-10-10 22:07:48.242764|2017-10-10 22:07:48.242764
NCT02787382|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-05-25|||June 2016||2016-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection|Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection|Not yet recruiting||Phase 3|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||No||2017-10-10 22:07:48.304261|2017-10-10 22:07:48.304261
NCT02787369|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-25|||May 2016||2016-05-01|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01||Interventional|||ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL|A Phase Ib Study of ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|3|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 22:07:48.376677|2017-10-10 22:07:48.376677
NCT02787343|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-08-31|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:07:48.596737|2017-10-10 22:07:48.596737
NCT02787330|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-25|||January 2011||2011-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Assessing the Efficacy of a Psychosocial Intervention Program for Siblings of Children With Cancer|Assessing the Efficacy of a Psychosocial Intervention Program for Siblings of Children With Cancer|Active, not recruiting||N/A|184|Actual|The Hospital for Sick Children||2|||f||||t||||||||No||2017-10-10 22:07:48.64474|2017-10-10 22:07:48.64474
NCT02787317|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-31|||May 2016||2016-05-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI|Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI|Not yet recruiting||Phase 4|1770|Anticipated|Chinese PLA General Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:07:48.759064|2017-10-10 22:07:48.759064
NCT02787304|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-07-05|||July 1, 2016|Actual|2016-07-01|July 2017|2017-07-01|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)|A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)|Recruiting||Phase 2|266|Anticipated|Shire||4|||f||||t||||||||||2017-10-10 22:07:49.037475|2017-10-10 22:07:49.037475
NCT02787291|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-10|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|January 12, 2017|Actual|2017-01-12||Interventional|MRI Ready IDE||A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an IDE Study|A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing Magnetic Resonance Imaging, an Investigational Device Exemption (IDE) Study|Active, not recruiting||N/A|228|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-10 22:07:49.497013|2017-10-10 22:07:49.497013
NCT02787278|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-09|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|SP-8203-2001||Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA|A Prospective, Randomized, Double-blinded Phase IIa Clinical Trial to Investigate the Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA Standard of Care|Active, not recruiting||Phase 2|80|Actual|Shin Poong Pharmaceutical Co. Ltd.||3|||f||||f||||||||||2017-10-10 22:07:49.653374|2017-10-10 22:07:49.653374
NCT02787265|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-05-26|||June 2016||2016-06-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01|1 Year|Observational [Patient Registry]|Discover||High-density in Spinal Cord Stimulation: Virtual Expert Registry|High-density in Spinal Cord Stimulation: Virtual Expert Registry|Not yet recruiting||N/A|400|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||||||||||||2017-10-10 22:07:49.792393|2017-10-10 22:07:49.792393
NCT02787252|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-06-07|||June 2016||2016-06-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|HFSCS||Stimwave HF SCS Pilot Study|Prospective, Clinical Pilot Study of High Frequency Wireless Spinal Cord Stimulation (SCS) in the Treatment of Chronic Pain With The Freedom Spinal Cord Stimulatory|Completed||N/A|6|Actual|Stimwave Technologies||1|||f||||f||||||||||2017-10-10 22:07:49.895412|2017-10-10 22:07:49.895412
NCT02787239|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-25|||October 2015||2015-10-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL||Recruiting||Phase 3|400|Anticipated|Shanghai Henlius Biotech||2|||f||||||||||||||2017-10-10 22:07:49.995424|2017-10-10 22:07:49.995424
NCT02787226|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-05-31|||August 2014||2014-08-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Liposomal Bupivacaine Infiltration vs Continuous Perineural Ropivacaine Infusion for Post-operative Pain After Total Shoulder Arthroplasty|Bupivacaine 1.3% Liposomal Suspension (Exparel) vs Continuous Perineural Ropivacaine Infusion in the Management of Post-operative Pain Following Total Shoulder Arthroplasty; An Open-label, Randomized, Controlled Study|Active, not recruiting||Phase 4|100|Anticipated|University of Maryland||4|||f||||t||||||||||2017-10-10 22:07:50.146405|2017-10-10 22:07:50.146405
NCT02787213|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-28|||August 2016||2016-08-01|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|January 2018|Anticipated|2018-01-01||Observational|TREETOP||A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor|A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor|Recruiting||N/A|4000|Anticipated|Sera Prognostics, Inc.|||2||f||||t||||||||||2017-10-10 22:07:50.289774|2017-10-10 22:07:50.289774
NCT02787200|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-06|||May 2016||2016-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Identification of Time-invariant EEG Signals for Brain-Computer Interface|Identification of Time-invariant EEG Signals for Brain-Computer Interface|Recruiting||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:07:50.456363|2017-10-10 22:07:50.456363
NCT02787174|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-11-08|||February 2016||2016-02-01|November 2016|2016-11-01||||September 2018|Anticipated|2018-09-01||Interventional|ED-AMAP||A Computer-Based ED Intervention to Improve Pediatric Asthma Medicine Adherence|A Computer-Based ED Intervention to Improve Pediatric Asthma Medicine Adherence|Recruiting||N/A|120|Anticipated|Rhode Island Hospital||2|||f||||||||||||Undecided||2017-10-10 22:07:50.648444|2017-10-10 22:07:50.648444
NCT02787161|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-19|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|September 2017|Actual|2017-09-01||Interventional|HDFIT||Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes|Impact of HemoDiaFIltration on Physical Activity and Self-reported Outcomes: a Randomized Controlled Trial (HD-FIT Trial)|Recruiting||N/A|110|Anticipated|Pontifícia Universidade Católica do Paraná||2|||f||||t||||||||||2017-10-10 22:07:50.739781|2017-10-10 22:07:50.739781
NCT02787148|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-07-04|||October 2015||2015-10-01|June 2016|2016-06-01||||June 2018|Anticipated|2018-06-01||Interventional|||Psychotherapy and Cardiovascular Risk Factors in Depression|The Impact of Psychotherapy on Hemodynamic and Inflammatory Risk Factors for Cardiovascular Disease in Major Depression|Recruiting||N/A|80|Anticipated|Philipps University Marburg Medical Center||2|||f||||f||||||||No||2017-10-10 22:07:50.851254|2017-10-10 22:07:50.851254
NCT02787135|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-11-24|||May 2016||2016-05-01|November 2016|2016-11-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|CBTd-E||Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis|Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis (CBTp-E) in Reducing Delusions. A Randomized-controlled Treatment Study (CBTd-E)|Recruiting||Phase 2|102|Anticipated|Philipps University Marburg Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:07:50.941442|2017-10-10 22:07:50.941442
NCT02787122|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-11-24|||January 2014||2014-01-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|CBT-E||Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia|Comparison of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia With Standard Treatment: Effects on Psychological Parameters and Rehospitalisation|Active, not recruiting||Phase 2|80|Anticipated|Philipps University Marburg Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:07:51.047812|2017-10-10 22:07:51.047812
NCT02787109|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-08-08|||July 2016||2016-07-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years|A Phase I First in Human, Double-blind, Parallel, Randomised and Placebo Controlled Clinical Trial of the Safety of SSI's Adjuvanted Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years|Completed||Phase 1|35|Actual|Statens Serum Institut||3|||f||||t||||||||||2017-10-10 22:07:51.305839|2017-10-10 22:07:51.305839
NCT02787096|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-08-08|||May 9, 2012|Actual|2012-05-09|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|LaxIRM||Dynamic Knee Laxity Measurement Coupled to MRI in Cases of Suspected Partial Anterior Cruciate Ligament Tear|Dynamic Knee Laxity Measurement Coupled to MRI in Cases of Suspected Partial Anterior Cruciate Ligament Tear|Active, not recruiting||N/A|200|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:07:51.423233|2017-10-10 22:07:51.423233
NCT02787083|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|MirabegronIC||A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis|A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis|Recruiting||Phase 3|60|Anticipated|Philadelphia Urosurgical Associates||2|||f||||f||||||||Undecided||2017-10-10 22:07:51.520585|2017-10-10 22:07:51.520585
NCT02787070|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-14|||September 14, 2016|Actual|2016-09-14|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|TRIPI||A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)|A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)|Recruiting||Phase 4|420|Anticipated|Menzies School of Health Research||2|||f||||t||||||||||2017-10-10 22:07:51.636891|2017-10-10 22:07:51.636891
NCT02787057|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-25|||November 2012||2012-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PD||Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dislysis (PD)-Related Peritonitis|Intraperitoneal (IP) Vancomycin Plus Oral Moxifloxacin Versus IP Vancomycin Plus IP Ceftazidime for the Treatment of Peritoneal Dialysis-related Peritonitis: a Pilot Randomized Controlled Study|Completed||N/A|80|Actual|Peking University First Hospital||2|||f||||f||||||||No||2017-10-10 22:07:51.763813|2017-10-10 22:07:51.763813
NCT02787044|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-08|||August 2016||2016-08-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|August 2020|Anticipated|2020-08-01||Interventional|INVESTED||INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure|INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure|Recruiting||Phase 4|9300|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 22:07:51.860366|2017-10-10 22:07:51.860366
NCT02787031|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-31|||April 2002||2002-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|March 2013|Actual|2013-03-01||Observational|||Variations in Anesthesia Care for Hip Fracture Surgery|Sources of Variation in Anesthesia Care for Hip Fracture Surgery and the Association With Outcomes|Completed||N/A|100000|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||||Undecided||2017-10-10 22:07:52.001267|2017-10-10 22:07:52.001267
NCT02787018|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2017-08-20|||June 2016||2016-06-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block|Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block|Recruiting||Phase 3|120|Anticipated|B.P. Koirala Institute of Health Sciences||3|||f||||f||||||||||2017-10-10 22:07:52.103357|2017-10-10 22:07:52.103357
NCT02787005|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-21|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|March 16, 2020|Anticipated|2020-03-16|December 3, 2018|Anticipated|2018-12-03||Interventional|||Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)|Phase II Trial of Pembrolizumab (MK-3475) in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-199)|Recruiting||Phase 2|370|Anticipated|Merck Sharp & Dohme Corp.||5|||f||||f|t|f||||||||2017-10-10 22:07:52.233039|2017-10-10 22:07:52.233039
NCT02786992|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-01-25|||May 2016||2016-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|CS||Misoprostol+Oxytocin vs. Carbetocin in CS|Adjuvant Use of Misoprostol and Oxytocin vs. Carbetocin for the Prevention of Post-partum Hemorrhage in Elective Cesarian Section|Completed||Phase 2/Phase 3|600|Actual|Ain Shams University||2|||f||||||||||||||2017-10-10 22:07:52.460485|2017-10-10 22:07:52.460485
NCT02786979|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-17|||July 2010||2010-07-01|May 2016|2016-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients|Combination of Beraprost Sodium Tablets (Dorner) and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients|Terminated||Phase 4|190|Actual|Astellas Pharma Inc||2||Upon interim analysis, sponsor's decision due to absence of demonstration of efficacy.|f||||f||||||||Undecided||2017-10-10 22:07:52.575404|2017-10-10 22:07:52.575404
NCT02786966|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-03-13|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Pragmatic Evaluation of the Canadian C-Spine Rule by Paramedics|A Pragmatic Strategy Empowering Paramedics to Assess Low-Risk Trauma Patients With the Canadian C-Spine Rule and Selectively Transport Them Without Immobilization|Recruiting||N/A|8200|Anticipated|Ottawa Hospital Research Institute||1|||f||||t|f|f||||||Undecided||2017-10-10 22:07:52.711229|2017-10-10 22:07:52.711229
NCT02786940|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-26|||October 24, 2016|Actual|2016-10-24|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|REMOSYNC||Remote Cardiac Monitoring of Higher-Risk Emergency Department Syncope Patients After Discharge|Remote Cardiac Monitoring of Higher-Risk Emergency Department Syncope Patients After Discharge|Recruiting||N/A|600|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-10 22:07:52.9555|2017-10-10 22:07:52.9555
NCT02786914|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-31|||April 2016||2016-04-01|May 2016|2016-05-01||||April 2020|Anticipated|2020-04-01||Observational|||Predictors of Positive Food Challenge|Identification of Risk for Anaphylactic Reactions Using Basophil Activation Test|Recruiting||N/A|250|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 22:07:53.433392|2017-10-10 22:07:53.433392
NCT02786901|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-08-29|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|June 13, 2017|Actual|2017-06-13||Interventional|||LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery|A Phase 3, Multi-Center, Double-Masked, Vehicle-Controlled, Randomized, Parallel-Group Study to Assess Loteprednol Etabonate Ophthalmic Gel, (BID and TID) Versus Vehicle Gel|Completed||Phase 3|600|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-10-10 22:07:53.534958|2017-10-10 22:07:53.534958
NCT02786888|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-31|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle|Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle|Recruiting||N/A|40|Anticipated|University of Utah|||2||f||||f||||||||No||2017-10-10 22:07:53.637431|2017-10-10 22:07:53.637431
NCT02786862|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-05-25|||March 2009||2009-03-01|May 2016|2016-05-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional|||A Unique Device for Independent Lung Ventilation|1:1 Proportion Ventilation With a Unique Device for Independent Lung Ventilation Using a Double-Lumen Tube in the Supine and Lateral Decubitus Positions. A Pilot Study|Completed||N/A|69|Actual|Medical University of Lublin||1|||f||||f||||||||Yes||2017-10-10 22:07:53.858451|2017-10-10 22:07:53.858451
NCT02786849|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-09-21|||June 2015||2015-06-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|July 2016|Actual|2016-07-01||Interventional|||Neuromuscular Electrical Stimulation During Hemodialysis in Peripheral Muscle Strength and Exercise Capacity||Recruiting||N/A|52|Anticipated|University of the State of Santa Catarina||2|||f||||||||||||||2017-10-10 22:07:53.946044|2017-10-10 22:07:53.946044
NCT02786836|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-06-15|||June 2016||2016-06-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|ALF-MBT||13C-Methacetin Breath Test for the Prediction of Outcome in ALF|13C-Methacetin Breath Test for the Prediction of Outcome in Acute Liver Failure|Recruiting||Phase 2/Phase 3|200|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||Yes|De-identified data for the overall study will be shared once the study is completed.|2017-10-10 22:07:54.05751|2017-10-10 22:07:54.05751
NCT02786823|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-18|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|August 15, 2017|Actual|2017-08-15||Interventional|||Effect of Folic Acid and Vitamin B12 Supplementation in Subjects With Type 2 Diabetes|Effect of Folic Acid and Vitamin B12 Supplementation on Biochemical Parameters in Subjects With Type-2 Diabetes|Completed||Phase 2/Phase 3|80|Actual|All India Institute of Medical Sciences, Bhubaneswar||4|||f||||f|f|f||||||||2017-10-10 22:07:54.199208|2017-10-10 22:07:54.199208
NCT02786810|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-25|||March 2016||2016-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy|Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy|Recruiting||Phase 2|12|Anticipated|University of Tennessee||1|||f||||f||||||||||2017-10-10 22:07:54.299005|2017-10-10 22:07:54.299005
NCT02786797|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-25|||July 2015||2015-07-01|May 2016|2016-05-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors|Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors|Recruiting||N/A|330|Anticipated|University of South Florida||3|||f||||t||||||||No||2017-10-10 22:07:54.631542|2017-10-10 22:07:54.631542
NCT02786784|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-09-22|||June 2016||2016-06-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|PFP-Inhibit||The Role of Arthrogenic Muscular Inhibition in Patellofemoral Pain and the Response to an Exercise Programme|The Role of Arthrogenic Muscular Inhibition in Patellofemoral Pain and the Response to an Exercise Programme|Recruiting||N/A|40|Anticipated|University of Salford||1|||f||||t||||||||Undecided||2017-10-10 22:07:54.771704|2017-10-10 22:07:54.771704
NCT02786771|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-01-04|||July 2016||2016-07-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|Stressless||Exploring the Effects of Muse and Spire on Stress Management|Exploring the Effects of Muse and Spire on Stress Management|Active, not recruiting||N/A|126|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 22:07:54.905048|2017-10-10 22:07:54.905048
NCT02786758|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-20|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|co-EC||Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals|Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals: The Co-EC Study|Recruiting||N/A|500|Anticipated|Macfarlane Burnet Institute for Medical Research and Public Health Ltd|||1||f||||t||||||Samples With DNA|"     Standard of care blood tests (whole blood) will be obtained at screening and subsequent     visits, depending on HCV medication regimen and health status, in order to assess: HCV     genotype, HCV RNA viral load, host IL28B genotype, liver function, full blood examinations,     iron studies, vitamin D, lipid profile, clotting profile, alpha-feto protein, HIV RNA viral     load and hepatitis B virus serology. In addition, a study specimen for HCV NS3/NS5 sequencing     will be collected at screening and stored. Specimens for pregnancy tests will be collected     where applicable. Biospecimens from this study will be frozen and stored in secure     laboratories at the Burnet and Victorian Infectious Diseases Reference Laboratory, for a     minimum of 15 years in a biobank, under custody of the principal investigator.   "|||2017-10-10 22:07:55.010117|2017-10-10 22:07:55.010117
NCT02786745|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-05-25|||November 2013||2013-11-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris|A Safety and Efficacy Study to Compare Dapsone Dermal Gel With Vehicle Control in Patients With Acne Vulgaris|Completed||Phase 3|17|Actual|MedDerm Associates||2|||f||||t||||||||No||2017-10-10 22:07:55.121402|2017-10-10 22:07:55.121402
NCT02786732|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-05-25|||August 2012||2012-08-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|AMAGINE-3||Study to Evaluate Broadlumab vs Placebo and Ustekinumab|Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis|Terminated||Phase 3|15|Actual|MedDerm Associates||4||Sponsor|f||||f||||||||No||2017-10-10 22:07:55.213491|2017-10-10 22:07:55.213491
NCT02786719|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-02|||June 2016||2016-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|SPRING||A Study of High Risk Induction Chemotherapy for Neuroblastoma Without Prophylactic Administration of Myeloid Growth Factors|A Safety Pilot Study of High Risk Induction Chemotherapy for Neuroblastoma Without Prophylactic Administration of Myeloid Growth Factors|Recruiting||N/A|21|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 22:07:55.326095|2017-10-10 22:07:55.326095
NCT02786706|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-06-02|||July 2015||2015-07-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 2019|Anticipated|2019-12-01||Interventional|||Automated Measurement of Optic Nerve Sheath Diameter|Accuracy of Optic Nerve Sheath Diameter Measurement From Ultrasound Videos Using an Image Analysis Algorithm Compared to Expert Measurement in Patients With Acute Brain Injury|Recruiting||N/A|50|Anticipated|University of Michigan||1|||f||||f||||||||Undecided||2017-10-10 22:07:55.451312|2017-10-10 22:07:55.451312
NCT02786693|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-01-12|||December 2015||2015-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|FUO||Evaluation of Diagnosis of Fever and Biologic Inflammatory Syndrome of Unknown Origin|Evaluation of Diagnosis of Fever and Biologic Inflammatory Syndrome of Unknown Origin|Recruiting||N/A|40|Anticipated|University Hospital, Grenoble|||1||f||||t||||||||No||2017-10-10 22:07:55.572016|2017-10-10 22:07:55.572016
NCT02786680|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-05-25|||December 2014||2014-12-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|DBS-EMOTION||How Does STN-DBS Influence Emotional Conflict Decision in Parkinson's Disease: a EEG Study|How Does STN-DBS Influence Emotional Conflict Decision in Parkinson's Disease: a EEG Study|Completed||N/A|16|Actual|University Hospital, Grenoble||2|||f||||f||||||||No||2017-10-10 22:07:55.679494|2017-10-10 22:07:55.679494
NCT02786667|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-25|||June 2012||2012-06-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|Honeymoon||Non Motors Aspects in De Novo Parkinson's Disease|Non Motors Aspects in De Novo Parkinson's Disease: Clinical and Physiopathological Description; Dopamine Agonist Treatment Effects.|Recruiting||Phase 3|52|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||No||2017-10-10 22:07:55.754589|2017-10-10 22:07:55.754589
NCT02786654|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-03|||January 2007||2007-01-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01|6 Years|Observational [Patient Registry]|||β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure|β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure|Completed||N/A|179810|Actual|University of Leeds|||1||f||||||||||||No||2017-10-10 22:07:55.845409|2017-10-10 22:07:55.845409
NCT02786641|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-05-26|||August 2016||2016-08-01|May 2016|2016-05-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma|Induction Chemotherapy of Docetaxel, Cisplatin and Xeloda in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma|Not yet recruiting||Phase 3|235|Anticipated|Sun Yat-sen University||3|||f||||f||||||||Undecided||2017-10-10 22:07:55.929347|2017-10-10 22:07:55.929347
NCT02786628|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-04-25|||February 2016||2016-02-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Observational|||Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation|Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation|Recruiting||N/A|45|Anticipated|UNC Lineberger Comprehensive Cancer Center|||3||f||||t||||||||Undecided||2017-10-10 22:07:56.040184|2017-10-10 22:07:56.040184
NCT02786615|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-02-03|||October 1, 2017|Anticipated|2017-10-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|December 2020|Anticipated|2020-12-01||Interventional|||Increasing MSM in the Continuum of Care in Kazakhstan|Increasing Involvement of MSM in the Continuum of Care in Kazakhstan|Not yet recruiting||N/A|1000|Anticipated|Columbia University||2|||f||||t|f|f||||||Undecided||2017-10-10 22:07:56.142343|2017-10-10 22:07:56.142343
NCT02786602|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-03-02|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|November 2016|Actual|2016-11-01||Observational|||LRP1 Methylation and Colon Cancer|Prognostic Impact of the Endocytic Receptor LRP-1 Gene Promoter Methylation in a Retrospective Study of Colonic Adenocarcinomas|Completed||N/A|345|Actual|CHU de Reims|||1||f||||||||||Samples With DNA|"     Biobank   "|||2017-10-10 22:07:56.243239|2017-10-10 22:07:56.243239
NCT02786589|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-02|||May 2016||2016-05-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||Plasmodium Immunotherapy for Lung Cancer|Clinical Study of Plasmodium Immunotherapy for Advanced Non-small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|80|Anticipated|State Key Laboratory of Respiratory Disease||1|||f||||f||||||||No||2017-10-10 22:07:56.308876|2017-10-10 22:07:56.308876
NCT02786576|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-08-15|||July 10, 2016||2016-07-10|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|HARMONY||Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting|Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study|Recruiting||N/A|200|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:07:56.421316|2017-10-10 22:07:56.421316
NCT02786563|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-07|||October 31, 2017|Anticipated|2017-10-31|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Observational|||Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate|Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate|Not yet recruiting||N/A|60|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:07:56.703674|2017-10-10 22:07:56.703674
NCT02786550|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-06-22|||June 2016||2016-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Botulinum Toxin to Improve Lower Blepharoplasty Scar|Botulinum Toxin to Improve Lower Blepharoplasty Scar|Recruiting||Phase 4|40|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-10 22:07:56.799607|2017-10-10 22:07:56.799607
NCT02786537|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-08-10|||June 2016||2016-06-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|August 2020|Anticipated|2020-08-01||Interventional|PRIORITIZE||Study of Oral Treatments for Hepatitis C|THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders|Recruiting||Phase 4|2670|Anticipated|University of Florida||3|||f||||f|t|f|||f|||||2017-10-10 22:07:56.928673|2017-10-10 22:07:56.928673
NCT02786524|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-06-02|||February 2016||2016-02-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy|A Randomized Study to Evaluate the Effect of Outpatient Symptom Management on Symptom Burden in Advanced Stage or Recurrent Gynecologic Oncology Patients Receiving Chemotherapy|Recruiting||N/A|180|Anticipated|University of Michigan||2|||f||||t||||||||No||2017-10-10 22:07:57.207668|2017-10-10 22:07:57.207668
NCT02786511|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-09-12|||April 2016||2016-04-01|September 2017|2017-09-01|April 2035|Anticipated|2035-04-01|April 2035|Anticipated|2035-04-01||Observational|||Longterm Follow-up of Subjects Treated With bb2121|Longterm Follow-up of Subjects Treated With bb2121|Enrolling by invitation||N/A|50|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 22:07:57.304594|2017-10-10 22:07:57.304594
NCT02786498|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-05-01|||December 2016||2016-12-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|Vita-Shock||Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing|A Blinded Exploratory Randomized Controlled Trial to Determine Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing|Recruiting||Phase 2|96|Anticipated|University of Maryland||4|||f||||t||||||||||2017-10-10 22:07:57.38902|2017-10-10 22:07:57.38902
NCT02786485|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-11|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT|A Phase I Study of Matched Unrelated Donor BPX-501 T Cell Infusion for Adults With Recurrent or Minimal Residual Disease Hematologic Malignancies Post-Allogeneic Transplant|Not yet recruiting||Phase 1|24|Anticipated|Bellicum Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 22:07:57.51809|2017-10-10 22:07:57.51809
NCT02786472|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-01-25|||May 2016||2016-05-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ConnectEd||ConnectEd: A Randomized Controlled Trial Connecting Through Educational Training|ConnectEd: A Randomized Controlled Trial Connecting Through Educational Training|Enrolling by invitation||N/A|4000|Anticipated|University of Kentucky||4|||f||||f||||||||No||2017-10-10 22:07:57.596051|2017-10-10 22:07:57.596051
NCT02786459|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-20|||April 2016||2016-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|ProxiScan||Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study|Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study|Recruiting||N/A|60|Anticipated|University Health Network, Toronto||3|||f||||f||||||||||2017-10-10 22:07:57.692137|2017-10-10 22:07:57.692137
NCT02786446|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2016-05-26|||July 2015||2015-07-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Comparison of Different Analgesia Drug Regimens for Pain Control During ESWL for Renal Stones|Comparison of Different Analgesia Drug Regimens for Pain Control During ESWL for Renal Stones: A Randomized Control Study|Completed||N/A|135|Actual|Shifa International Hospital||3|||f||||f||||||||No||2017-10-10 22:07:57.778957|2017-10-10 22:07:57.778957
NCT02786433|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-31|||February 2014||2014-02-01|May 2016|2016-05-01||||April 2014|Actual|2014-04-01||Interventional|||Virtual Reality Effects on Functional Capacity and Quality of Life of People With Parkinson's Disease||Completed||N/A|20|Actual|Universidade Federal de Pernambuco||2|||f||||||||||||||2017-10-10 22:07:57.872507|2017-10-10 22:07:57.872507
NCT02786420|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-05-25|||October 2015||2015-10-01|May 2016|2016-05-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|PARENTs||Imaging Innovations for Placental Assessment in Response to Environmental Pollution (PARENTs)|Imaging Innovations for Placental Assessment in Response to Environmental Pollution (PARENTs)|Recruiting||N/A|320|Anticipated|University of California, Los Angeles|||1||f||||f||||||Samples With DNA|"     Frozen samples of blood and urine will be kept for further study related to this project     involving markers relevant to placental insufficiency that may be discovered in the future. A     gross assessment of the placenta will be performed by weighing the disc with cord and     membranes removed. Cord insertion, length, diameter, coiling, number of vessels, focal     lesions, membrane color, thickness, translucency, attachment, disc dimensions, range of     thickness, fetal surface vascular distribution, pigmentation and site of rupture will be     recorded. Microscopic assessment of H&E stained sections will be performed to detect any     inflammatory/infectious processes, villous development/maturity, decidual vasculopathy,     infarct/fibrin deposition, or other processes that may be associated with placental     insufficiency and fetal development.   "|No||2017-10-10 22:07:58.587446|2017-10-10 22:07:58.587446
NCT02786407|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-09-23|||March 2016||2016-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection in Chinese Subjects With Overactive Bladder (OAB)|Enrolling by invitation||Phase 3|216|Anticipated|Lanzhou Institute of Biological Products Co., Ltd||2|||f||||t||||||||No||2017-10-10 22:07:58.949369|2017-10-10 22:07:58.949369
NCT02786394|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-13|||May 2016||2016-05-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|REACH||Return to Everyday Activities in the Community and Home|REACH Lifestyle Program for Older Adults|Completed||N/A|11|Actual|University of British Columbia||1|||f||||f||||||||No||2017-10-10 22:07:59.053877|2017-10-10 22:07:59.053877
NCT02786381|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-11-21|||November 2015||2015-11-01|September 2016|2016-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|RP1||Idylla IFV-RSV Panel Clinical Testing|Idylla Respiratory (IFV-RSV) Panel Clinical Testing and Sample Collection Protocol in Support of 510(k) Premarket Submission|Completed||N/A|213|Actual|Janssen Pharmaceutica N.V., Belgium|||1||f||||f||||||Samples Without DNA|"     Nasal swabs (NS); Nasopharyngeal swabs (NP) in viral transport medium (VTM)   "|||2017-10-10 22:07:59.151138|2017-10-10 22:07:59.151138
NCT02786368|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-09|||April 2016||2016-04-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Scale up of Enhanced Homestead Food Production in Cambodia|Scale up of Enhanced Homestead Food Production for Improved Household Food Security and Nutrition in Cambodia|Active, not recruiting||N/A|1318|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:07:59.236731|2017-10-10 22:07:59.236731
NCT02786342|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-07-19|||February 2016||2016-02-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|INNOVATE||Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib|Italian Multicentric Prospective Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib|Recruiting||N/A|160|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori|||1||f||||f||||||Samples With DNA|"     Whole Blood, plasma and serum samples.   "|||2017-10-10 22:07:59.439736|2017-10-10 22:07:59.439736
NCT02786329|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-25|||June 2016||2016-06-01|May 2016|2016-05-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Anesthesia and Postoperative Outcome in Colorectal Cancer Patients|The Influence of Anesthesia on Postoperative Outcome and Complications in Colorectal Cancer Patients|Not yet recruiting||Early Phase 1|450|Anticipated|Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor||4|||f||||t||||||||Yes|Regular meeting for sharing data.|2017-10-10 22:07:59.564679|2017-10-10 22:07:59.564679
NCT02786316|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-09-16|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|LBP-HIT||High Intensity Training With Non-specific Chronic Low Back Pain|High Intensity Training in Patients With Non-Specific Chronic Low Back Pain: A Clinical Pilot Trial|Completed||N/A|20|Actual|Hasselt University||2|||f||||f||||||||No||2017-10-10 22:07:59.715377|2017-10-10 22:07:59.715377
NCT02786303|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-25|||April 2014||2014-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2016|Actual|2016-04-01||Interventional|LAB-2013-01||Interest of Whole-body MRI Correlated to Spreading Sequences for Staging Neuroendocrine Tumors|Interest of Whole-body MRI Correlated to Spreading Sequences for Staging|Active, not recruiting||N/A|100|Anticipated|CHU de Reims||1|||f||||f||||||||||2017-10-10 22:07:59.830106|2017-10-10 22:07:59.830106
NCT02786290|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-25|||April 2016||2016-04-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|October 2016|Anticipated|2016-10-01||Interventional|ZEST||The Zenflow Spring System Feasibility and Safety Study|The Zenflow Spring System Feasibility and Safety Study (ZEST)|Recruiting||N/A|30|Anticipated|Zenflow, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:07:59.918436|2017-10-10 22:07:59.918436
NCT02786277|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-04-24|||January 2018|Anticipated|2018-01-01|December 2016|2016-12-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Learning Alerts for Acute Kidney Injury|Uplift Modeling to More Narrowly Target Alerts for Acute Kidney Injury|Not yet recruiting||N/A|4400|Anticipated|Yale University||2|||f||||t|f|f||||||||2017-10-10 22:08:00.077483|2017-10-10 22:08:00.077483
NCT02786264|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-10-24|||May 2016||2016-05-01|October 2016|2016-10-01|May 2021|Anticipated|2021-05-01|September 2017|Anticipated|2017-09-01||Observational|||Association of Type of Anesthetic and Outcomes in Transfemoral Aortic Valve Replacement|Pilot Analysis of the Association Between Types of Anesthetic and Outcomes in Transfemoral Aortic Valve Replacement|Active, not recruiting||N/A|186|Actual|Yale University|||3||f||||f||||||||No||2017-10-10 22:08:00.162056|2017-10-10 22:08:00.162056
NCT02786251|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-01-11|||May 2016||2016-05-01|January 2017|2017-01-01||||August 2018|Anticipated|2018-08-01||Interventional|BAT-TG||The Role of Brown Adipose Tissue in Triglyceride Clearance in People|The Role of Brown Adipose Tissue in Triglyceride Clearance in People|Recruiting||N/A|40|Anticipated|Washington University School of Medicine||2|||f||||f||||||||Undecided||2017-10-10 22:08:00.269341|2017-10-10 22:08:00.269341
NCT02786238|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-02-02|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|COSMOS||Cognitive and Self-regulatory Mechanisms Of Obesity Study|Cognitive and Self-regulatory Mechanisms Of Obesity Study|Enrolling by invitation||N/A|58|Actual|Oklahoma State University||2|||f||||f||||||||Undecided||2017-10-10 22:08:00.360103|2017-10-10 22:08:00.360103
NCT02786225|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-04-05|||July 2016||2016-07-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|CARE||Collaboration for Antepartum Risk Evaluation|Interprofessional Perinatal Consults to Improve Communication Quality, Satisfaction, and Team Cohesion: A Randomized Trial of the Collaboration for Antepartum Risk Evaluation (CARE) Model|Enrolling by invitation||N/A|236|Anticipated|Vanderbilt University||2|||f||||t||||||||Yes||2017-10-10 22:08:00.450883|2017-10-10 22:08:00.450883
NCT02786212|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-11-03|||September 2016||2016-09-01|November 2016|2016-11-01||||May 2017|Anticipated|2017-05-01||Interventional|||The Effects of Dexmedetomidine on Intestine and Other Organ Damages After Cardiac Surgeries|The Effects of Dexmedetomidine on Intestine and Other Organ Damages After Cardiac Surgeries|Recruiting||N/A|70|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 22:08:00.552279|2017-10-10 22:08:00.552279
NCT02786199|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-05-25|||June 2015||2015-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Histological Differentiation Grade Predicted by Ultrasound Backscatterer Imaging|Histological Differentiation Grade Predicted by Ultrasound Backscatterer Imaging|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 22:08:00.661295|2017-10-10 22:08:00.661295
NCT02786186|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-09-01|||December 2015||2015-12-01|May 2016|2016-05-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01|60 Months|Observational [Patient Registry]|PURE||A Registry of Patients With Moderate to Severe Plaque Psoriasis|A Registry of Patients With Moderate to Severe Chronic Plaque Psoriasis in Canada and Latin AmErica (LACan)|Recruiting||N/A|2500|Anticipated|Novartis|||2||f||||f||||||||||2017-10-10 22:08:00.736555|2017-10-10 22:08:00.736555
NCT02786173|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-02-09|||December 2012||2012-12-01|April 2016|2016-04-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01|3 Years|Observational [Patient Registry]|PRIME||"Peripheral Registry of Endovascular Clinical Outcomes The PRIME Registry"|Peripheral Registry of Endovascular Clinical Outcomes|Recruiting||N/A|5000|Anticipated|Metro Health, Michigan|||1||f||||f||||||||Undecided||2017-10-10 22:08:00.820053|2017-10-10 22:08:00.820053
NCT02786160|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-06-20|||May 2016||2016-05-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of HMOs on the Faecal Microbiota and on Host Metabolism in Obese Children|The Effects of Human Milk Oligosaccharides (HMO) on the Faecal Microbiota and on Host Metabolism in Obese Children: A Parallel, Double-blind, Randomized, Placebo-controlled Study|Recruiting||Phase 1/Phase 2|75|Anticipated|Glycom A/S||3|||f||||f||||||||No||2017-10-10 22:08:00.912396|2017-10-10 22:08:00.912396
NCT02786134|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|CIRT-CFR||Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)|Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)|Recruiting||Phase 3|150|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 22:08:01.0864|2017-10-10 22:08:01.0864
NCT02786121|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-08-04|||April 2016||2016-04-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Observational|kinesiofob||The Role of Kinesiophobia in the Functional Recovery After Hip Replacement|Is Kinesiophobia a Predictive Factor of the Early Functional Recovery After Total Hip Replacement? - An Observational Study|Completed||N/A|200|Actual|Istituto Ortopedico Rizzoli|||1||f||||f||||||||||2017-10-10 22:08:01.171279|2017-10-10 22:08:01.171279
NCT02786108|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-05|||May 2016||2016-05-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|BAEMO||Bariatric Arterial Embolization for Morbid Obesity|Bariatric Arterial Embolization for Morbid Obesity|Recruiting||Phase 3|50|Anticipated|Zhongda Hospital||2|||f||||f||||||||||2017-10-10 22:08:01.236055|2017-10-10 22:08:01.236055
NCT02786095|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-12-29|||May 2016||2016-05-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation (AF) (Code-AF Trial)||Recruiting||N/A|24000|Anticipated|Yonsei University|||1||f||||f||||||||No||2017-10-10 22:08:01.324398|2017-10-10 22:08:01.324398
NCT02786082|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-25|||June 2016||2016-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers|Single Center, Randomized, Open Labeled Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers|Not yet recruiting||Phase 1|24|Anticipated|Lee's Pharmaceutical Limited||2|||f||||||||||||||2017-10-10 22:08:01.386087|2017-10-10 22:08:01.386087
NCT02786069|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-25|||June 2015||2015-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese|A Single-arm, Self-controlled, Three-period Dynamics Single-dose Escalation Safety and Pharmacokinetics Study for Propionyl L-carnitine Hydrochloride Tablets of Healthy Subjects in China|Completed||Phase 1|16|Actual|Lee's Pharmaceutical Limited||1|||f||||||||||||||2017-10-10 22:08:01.446473|2017-10-10 22:08:01.446473
NCT02786056|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-08-02|||July 2015||2015-07-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PULMOREM||Feasibility of Regional Lung Ventilation Imaging Using 3T MR Imaging With Ultrashort Echo Time (UTE) Pulse Sequences|Feasibility of Regional Lung Ventilation Imaging Using 3T MR Imaging With Ultrashort Echo Time (UTE) Pulse Sequences (PULMOREM Study)|Recruiting||Early Phase 1|40|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-10 22:08:01.502741|2017-10-10 22:08:01.502741
NCT02786043|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-25|||June 2015||2015-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses|An Open-label, Single Arm, Self-controlled Safety and Pharmacokinetics Study to Evaluate the Effect of Propionyl L-carnitine Hydrochloride on Healthy Chinese Subjects by Diet and Multiple-doses|Completed||Phase 1|12|Actual|Lee's Pharmaceutical Limited||1|||f||||||||||||||2017-10-10 22:08:01.623394|2017-10-10 22:08:01.623394
NCT02786030|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-05-15|||April 1, 2017|Actual|2017-04-01|May 2016|2016-05-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|PACKBrazilR||Integrated Primary Care for Chronic Lung Disease: PACK Brazil|Integrated Primary Care for Chronic Lung Diseases in Less Developed Countries: Pragmatic Trial of the Practical Approach to Care Kit in Brazil (PACK Brazil)|Recruiting||N/A|1950|Anticipated|University of Sao Paulo General Hospital||2|||f||||f|f|f||||||No||2017-10-10 22:08:01.692301|2017-10-10 22:08:01.692301
NCT02786017|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-25|||May 2016||2016-05-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis|The Safety and Efficacy Assessment of Injectable Collagen Scaffold™ Combined With Human Umbilical Cord-derived Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Decompensated Cirrhosis|Recruiting||Phase 1/Phase 2|40|Anticipated|Chinese Academy of Sciences||2|||f||||t||||||||||2017-10-10 22:08:01.788598|2017-10-10 22:08:01.788598
NCT02786004|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-06-19|2017-06-19||February 2016||2016-02-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Image Quality Assessment for Screening and Diagnostic Mammography|Mammography Image Quality Assessment Reading NextGen Images for Screening and Diagnostic Use (MAGNIFI)|Completed||N/A|24|Actual|GE Healthcare||2|||f||||f||||||||No||2017-10-10 22:08:01.872786|2017-10-10 22:08:01.872786
NCT02785991|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-03|||July 2016||2016-07-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|July 2019|Anticipated|2019-07-01||Observational|RECABA||Spanish Registry of Cryoballoon Ablation|Prospective Observational Study of Pulmonary Vein Cryoablation in Subjects With Atrial Fibrillation (AF) in Spain|Recruiting||N/A|1000|Anticipated|Medtronic Bakken Research Center|||1||f||||t||||||||||2017-10-10 22:08:02.076015|2017-10-10 22:08:02.076015
NCT02785965|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-11|||July 2016||2016-07-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Interventional|||Acupuncture in the Regulation of Dai Meridian for Polycystic Ovarian Syndrome Patients With Abdominal Obesity|Acupuncture in the Regulation of Dai Meridian for Polycystic Ovarian Syndrome Patients With Abdominal Obesity|Active, not recruiting||N/A|84|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||2|||f||||t||||||||||2017-10-10 22:08:02.260149|2017-10-10 22:08:02.260149
NCT02785952|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-12|||December 2015||2015-12-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||S1400I Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers|A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-Map Sub-Study)|Recruiting||Phase 3|350|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-10 22:08:04.933448|2017-10-10 22:08:04.933448
NCT02785757|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-08-08|||July 12, 2014|Actual|2014-07-12|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|PROSPECT||Cancer-related Thromboembolic Disease|The Challenge of Cancer-related Thromboembolic Disease: Can we Better Predict the Risk?|Recruiting||N/A|18|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:08:19.564778|2017-10-10 22:08:19.564778
NCT02785939|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-17|||June 2014||2014-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2017|Actual|2017-06-01||Interventional|||S1400C Lung-MAP: Palbociclib as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches|A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)|Active, not recruiting||Phase 2/Phase 3|42|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-10 22:08:11.031812|2017-10-10 22:08:11.031812
NCT02785926|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-08-02|||December 2014||2014-12-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|PHYSIOMECO||Impact of Antenatal Exposure to Pesticides on Neurophysiological Functions (Sleep, Respiration) of Preterm Neonates|Impact of Antenatal Exposure to Pesticides on Neurophysiological Functions (Sleep, Respiration) of Preterm Neonates|Recruiting||N/A|63|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||||||||||||2017-10-10 22:08:13.326846|2017-10-10 22:08:13.326846
NCT02785913|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-17|||June 2014||2014-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2017|Actual|2017-06-01||Interventional|||S1400B Lung-MAP: Taselisib as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches|A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K Positive Patients With Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)|Active, not recruiting||Phase 2|59|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-10 22:08:13.490212|2017-10-10 22:08:13.490212
NCT02785900|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-07|||May 2016||2016-05-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|CASCADE||Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia|A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)|Terminated||Phase 3|240|Actual|Seattle Genetics, Inc.||2|||f||||t||||||||||2017-10-10 22:08:17.818499|2017-10-10 22:08:17.818499
NCT02785887|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-07-31|||August 2014||2014-08-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|GIVE||Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients|Impact of Geriatrician-implemented Interventions on Chemotherapy Delivery in Vulnerable Elderly Patients With Early or Metastatic Solid Malignancies: the GIVE Trial|Recruiting||N/A|231|Anticipated|Azienda USL 4 Prato||2|||f||||f||||||||||2017-10-10 22:08:18.277052|2017-10-10 22:08:18.277052
NCT02785874|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-04-18|||September 1, 2016|Actual|2016-09-01|May 2016|2016-05-01|November 1, 2016|Actual|2016-11-01|October 1, 2016|Actual|2016-10-01||Interventional|||Statin With Palliative Therapy for HCC|Statin With Palliative Therapy for HCC|Terminated||N/A|4|Actual|Taipei Medical University WanFang Hospital||2||insufficient for the fund|f||||f||||||||No||2017-10-10 22:08:18.390136|2017-10-10 22:08:18.390136
NCT02785861|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-30|||December 2014||2014-12-01|May 2016|2016-05-01|November 2025|Anticipated|2025-11-01|November 2025|Anticipated|2025-11-01||Interventional|SBSAC||Step by Step After Cancer|Evaluating the Effectiveness of Supervised Practice or Distance Supervised Physical Activity (Walking) in the Overall Management of Fatigue in Breast Cancer Patients During Hormonal Therapy: Pilot Study|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||||||||||||2017-10-10 22:08:18.47269|2017-10-10 22:08:18.47269
NCT02785848|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-06-01|||May 2016||2016-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging|Identifying Patient-centered Barriers and Preferred Strategies to Support Self-efficacy for Medication Adherence With Two-way Text Messaging|Recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||||||2017-10-10 22:08:18.563174|2017-10-10 22:08:18.563174
NCT02785835|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-12-07|||May 2014||2014-05-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2016|Actual|2016-12-01||Observational|GEHEP-002||Hepatocellular Carcinoma in HIV-infected Patients|Hepatocellular Carcinoma in HIV-infected Patients|Recruiting||N/A|302|Anticipated|Hospital Universitario de Valme|||1||f||||f||||||||No||2017-10-10 22:08:18.655532|2017-10-10 22:08:18.655532
NCT02785822|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-27|||June 2016||2016-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.|Randomized, Single Blind, Prospective Clinical Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.|Not yet recruiting||Phase 4|164|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 22:08:18.901197|2017-10-10 22:08:18.901197
NCT02785809|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-27|||April 2016||2016-04-01|May 2016|2016-05-01|March 2020|Anticipated|2020-03-01|May 2019|Anticipated|2019-05-01||Observational|||Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception|Recovery of Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception: Is the Recovery Period Related to AMH?|Recruiting||N/A|50|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples Without DNA|"     Withdrawal of bloodsamples (6 within a three months period) for analyses of reproductive     hormones.   "|Undecided||2017-10-10 22:08:19.015176|2017-10-10 22:08:19.015176
NCT02785796|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-01-25|||May 2016||2016-05-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Cranial Manipulation on ANS Activity|Effects of Cranial Manipulation in Healthy Patients Revealed by Salivary Alpha Amylase Activity|Completed||N/A|90|Actual|Accademia Italiana Medicina Osteopatica||3|||f||||f||||||||No||2017-10-10 22:08:19.107951|2017-10-10 22:08:19.107951
NCT02785783|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-12-05|||May 2016||2016-05-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|Erings™||Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection|Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection in Symptomatic and Asymptomatic Patients: A Randomised Controlled Trial|Recruiting||N/A|554|Anticipated|Portsmouth Hospitals NHS Trust||2|||f||||t||||||||No||2017-10-10 22:08:19.198124|2017-10-10 22:08:19.198124
NCT02785744|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-07-05|||April 2016||2016-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Genzyme Osteopenia/Osteoporosis Study|Prevalence of Gaucher Among Patients With Osteopenia/Osteoporosis|Recruiting||N/A|200|Anticipated|New York University School of Medicine|||1||f||||f||||||||||2017-10-10 22:08:19.664334|2017-10-10 22:08:19.664334
NCT02785731|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-05-17|||July 2016||2016-07-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Observational|||Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.|ANG-001 Pelvic Mass Training Study: Evaluation of Multiple Circulating Tumor Cell-derived RNA Markers to Estimate Risk of Ovarian Cancer in Patients Presenting With a Pelvic Mass.|Active, not recruiting||N/A|200|Anticipated|Angle plc|||1||f||||f||||||Samples With DNA|"     All excess components (i.e. serum, plasma, RNA, DNA, cells, etc.) generated from the     peripheral blood samples collected for research testing under this study be stored frozen at     the Medical University of Vienna for up to 10 years for possible use in future research,     including but not limited to, serum biomarker analyses, genomic evaluations and genetic     studies pertaining to cancer and other disease processes.   "|No||2017-10-10 22:08:19.753361|2017-10-10 22:08:19.753361
NCT02785718|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-30|||June 2015||2015-06-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|CONTACT||The Proteins of the Contact Activation System|The Influence of the Proteins of the Contact Activation System on Thrombus Formation in Human Blood|Recruiting||N/A|18|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:08:19.860993|2017-10-10 22:08:19.860993
NCT02785705|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-25|||April 2015||2015-04-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|TTbOPV||Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine|Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine by Comparing Different Poliomyelitis Vaccination Schedules in Chinese Infant: a Randomized Controlled Non-Inferiority Clinical Trial|Completed||Phase 3|600|Actual|Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control||6|||f||||f||||||||No||2017-10-10 22:08:19.953357|2017-10-10 22:08:19.953357
NCT02785692|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-25|||January 2016||2016-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Preoperative IMRT for Soft Tissue Sarcoma of the Extremities and Trunk: Low Rate of Wound Complications|Preoperative IMRT for Soft Tissue Sarcoma of the Extremities and Trunk: Low Rate of Wound Complications|Completed||N/A|67|Actual|Balgrist University Hospital|||1||f||||f||||||||No||2017-10-10 22:08:20.055265|2017-10-10 22:08:20.055265
NCT02785679|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-31|||July 2016||2016-07-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy|The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy|Not yet recruiting||N/A|2500|Anticipated|Meir Medical Center||4|||f||||f||||||||||2017-10-10 22:08:20.15585|2017-10-10 22:08:20.15585
NCT02785653|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-07|||April 2004||2004-04-01|June 2016|2016-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|SRI||Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium|Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium Under Routine Clinical Practice|Completed||Phase 4|60|Actual|Maharashtra University of Health Sciences||2|||f||||t||||||||No||2017-10-10 22:08:20.33197|2017-10-10 22:08:20.33197
NCT02785640|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-02-24|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|PAWS||Prompting Activity in a Workplace Setting|A Study to Assess the Impact of a Multicomponent Intervention to Reduce Prolonged Sitting in the Workplace|Completed||N/A|30|Actual|Glasgow Caledonian University||2|||f||||f||||||||No||2017-10-10 22:08:20.521908|2017-10-10 22:08:20.521908
NCT02785627|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-24|||September 2016||2016-09-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Observational|ANTELOPE||Assessment of Bone Loss in Men Receiving Treatment for Prostate Cancer|Assessment of Bone Loss in Men Receiving Treatment for Prostate Cancer|Not yet recruiting||N/A|90|Anticipated|University of Sheffield|||3||f||||f||||||Samples Without DNA|"     Serum samples   "|||2017-10-10 22:08:20.625026|2017-10-10 22:08:20.625026
NCT02785614|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-27|||May 2016||2016-05-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese|Pharmacokinetics Study of Trazodone Hydrochloride Prolonged-Released Tablets in Chinese Healthy Volunteers|Not yet recruiting||Phase 1|12|Anticipated|Lee's Pharmaceutical Limited||2|||f||||||||||||||2017-10-10 22:08:20.724928|2017-10-10 22:08:20.724928
NCT02785601|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-27|||May 2016||2016-05-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||PK Study of Diet Effect of Trazodone Hydrochloride Prolonged-Released Tablets in Healthy Chinese|Pharmacokinetics Study of Trazodone Hydrochloride Prolonged -Released Tablets in Chinese Healthy Volunteers|Not yet recruiting||Phase 1|16|Anticipated|Lee's Pharmaceutical Limited||4|||f||||||||||||||2017-10-10 22:08:20.806154|2017-10-10 22:08:20.806154
NCT02785588|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-31|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit (Firefly Sheffield)|Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit|Recruiting||N/A|60|Anticipated|GE Healthcare||1|||f||||f||||||||||2017-10-10 22:08:20.899426|2017-10-10 22:08:20.899426
NCT02785575|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-10-05|||April 2016|Actual|2016-04-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|December 2016|Actual|2016-12-01||Interventional|||Adjusted Calculation of Heparin and Protamin Dosing and Correlation With Postoperative Bleeding and Transfusions|The Impact of an Adjusted Calculation Model Regarding Heparin and Protamine Dosing on Bleeding and Transfusions After Cardiac Surgery Compared With Standard Dosing: A Randomized Single Blind Trial|Active, not recruiting||Phase 4|200|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-10 22:08:20.999544|2017-10-10 22:08:20.999544
NCT02785562|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-05-27|||June 2016||2016-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|EXPLORE-PDL1||Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.|Epidemiologic Multicenter Prospective Study in Advanced NSCLC Patients With PDL1 Expression : Evaluation of Clinical and Pathological Characteristics of PDL1 High Expression Patients Compared to Patients With a Weak or no Expression of PDL1.|Not yet recruiting||N/A|200|Anticipated|Groupe Francais De Pneumo-Cancerologie||1|||f||||f||||||||No||2017-10-10 22:08:21.093435|2017-10-10 22:08:21.093435
NCT02785549|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-01-09|||November 2016||2016-11-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Randomized Clinical Trial to Compare the Treatment of Mild Acute Diverticulitis With or Without Antibiotics|Multicentre Controlled, Randomized Clinical Trial to Compare the Efficacy and Safety of Ambulatory Treatment of Mild Acute Diverticulitis Without Antibiotics With the Standard Treatment With Antibiotics|Recruiting||Phase 4|460|Anticipated|Corporacion Parc Tauli||2|||f||||||||||||Undecided||2017-10-10 22:08:21.215209|2017-10-10 22:08:21.215209
NCT02785536|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-30|||July 2013||2013-07-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|RITCh||RITCH: Reducing Disparities in Tobacco Cessation Outcomes|RITCH: Reducing Disparities in Tobacco Cessation Outcomes|Completed||N/A|256|Actual|The City College of New York||2|||f||||f||||||||No||2017-10-10 22:08:21.368189|2017-10-10 22:08:21.368189
NCT02785523|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2017|Anticipated|2017-05-01||Interventional|||Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers||Recruiting||Phase 3|60|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||||||||||Undecided||2017-10-10 22:08:21.469638|2017-10-10 22:08:21.469638
NCT02785497|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-05-26|||January 2010||2010-01-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Electrical Stimulation of Cutaneous Lesions|Electrical Stimulation of Cutaneous Lesions|Completed||N/A|60|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:08:21.720145|2017-10-10 22:08:21.720145
NCT02785484|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-06-06|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Impact of Cigarette Pack Constituent Disclosures|Randomized Controlled Trial Evaluating the Impact of Cigarette Pack Constituent Disclosures|Completed||N/A|784|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-10 22:08:21.842082|2017-10-10 22:08:21.842082
NCT02785471|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-07-07|||September 2016||2016-09-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Assessing Online Interventions for Men's' Mental Health and Wellbeing|Assessing Online Interventions for Men's' Mental Health and Wellbeing|Recruiting||N/A|300|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-10 22:08:21.957317|2017-10-10 22:08:21.957317
NCT02785458|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-15|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial|Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial|Recruiting||N/A|1200|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 22:08:22.07895|2017-10-10 22:08:22.07895
NCT02785445|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-07|||October 2015||2015-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|June 2017|Actual|2017-06-01||Interventional|||Healthy.io Method Comparison & User Performance Study|A Comparative, Controlled Study to Evaluate the Clinical Accuracy and User Performance of the Dip Home-Based Dipstick Analyzer|Completed||N/A|425|Actual|Healthy.io Ltd.||1|||f||||f||||||||||2017-10-10 22:08:22.169828|2017-10-10 22:08:22.169828
NCT02785432|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-26|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Low Level Laser Therapy With Physical Therapy for Chronic Musculoskeletal Pain|The Use of Low Level Laser Therapy With Physical Therapy for Pain and Improved Function in Individuals With Chronic Musculoskeletal Pain|Enrolling by invitation||N/A|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 22:08:22.261348|2017-10-10 22:08:22.261348
NCT02785419|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-01-17|||January 2016||2016-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Action Selection and Arm Rehabilitation After Stroke|Targeted Engagement of the Motor Action Selection Network During Arm Rehabilitation After Stroke|Recruiting||N/A|38|Anticipated|University of South Carolina||1|||f||||||||||||||2017-10-10 22:08:22.354003|2017-10-10 22:08:22.354003
NCT02785406|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use|Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use|Recruiting||Phase 2|30|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||No||2017-10-10 22:08:22.458608|2017-10-10 22:08:22.458608
NCT02785393|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-09-28|||March 2011||2011-03-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|DOX-Meth||DOX as a Potential Treatment for Methamphetamine Dependence|Doxazosin as a Potential Treatment for Methamphetamine Dependence|Completed||Phase 1|11|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 22:08:22.630861|2017-10-10 22:08:22.630861
NCT02785380|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-01|||December 2016||2016-12-01|June 2016|2016-06-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Interventional|||Laparoscopic Surgery VS RFA for Recurrent HCC|Laparoscopic Surgery Versus Radiofrequency Ablation for the Treatment of Recurrent Hepatocellular Carcinoma|Not yet recruiting||Phase 4|340|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:08:22.900833|2017-10-10 22:08:22.900833
NCT02785367|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-05-25|||June 2016||2016-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Changes of Gas Values in Cord Blood Versus Time and Temperature|Changes of Gas Values in Cord Blood Versus Time and Temperature|Not yet recruiting||Phase 4|1000|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||No||2017-10-10 22:08:23.00152|2017-10-10 22:08:23.00152
NCT02785341|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-24|||May 2015||2015-05-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|APA2||Adaptated Physical Activity During Chemotherapy: Evaluation of the Psychological, Physiological and Biological Impact|Adaptated Physical Activity During Chemotherapy: Evaluation of the Psychological, Physiological and Biological Impact|Terminated||N/A|5|Actual|Institut Paoli-Calmettes||2||Insufficient recruitment|f||||t||||||||||2017-10-10 22:08:23.138741|2017-10-10 22:08:23.138741
NCT02785328|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-24|||February 2015||2015-02-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|EnSOM||Sleep and Memory in Children|Sleep-dependent Memory Consolidation in Children With Sleep Diseases|Recruiting||N/A|120|Anticipated|Hospices Civils de Lyon||5|||f||||f||||||||||2017-10-10 22:08:23.218301|2017-10-10 22:08:23.218301
NCT02785315|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-24|||June 2016||2016-06-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment|Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment: The Efficacy in Enhancement of Cognition and Complex Activities of Daily Living Function|Not yet recruiting||N/A|250|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 22:08:23.352397|2017-10-10 22:08:23.352397
NCT02785302|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-02-27|||August 2015||2015-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Transitioning HIV+ Adolescents to Adult Care: Exploring Adolescent and Adult Medicine Clinics Role in the Process|CATCH: Comprehensive Assessment of Transition and Coordination for HIV-Positive Youth as They Move From Adolescent to Adult Care|Completed||N/A|136|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-10 22:08:23.449174|2017-10-10 22:08:23.449174
NCT02785289|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-09-12|||June 2016||2016-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection|A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection|Completed||N/A|120|Actual|University Hospital, Geneva||2|||f||||f||||||||Undecided||2017-10-10 22:10:01.968596|2017-10-10 22:10:01.968596
NCT02785276|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-31|||August 2016||2016-08-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Improving Pain Relief Following Laparoscopic Ventral Hernia Repair|Intra-abdominal Infusions of Ropivacaine Following Laparoscopic Ventral Hernia Repair: a Randomised Double-blind Controlled Trial.|Not yet recruiting||N/A|96|Anticipated|University of Auckland, New Zealand||2|||f||||f||||||||No||2017-10-10 22:10:02.08477|2017-10-10 22:10:02.08477
NCT02785263|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-12-14|||April 2016||2016-04-01|December 2016|2016-12-01|September 2023|Anticipated|2023-09-01|March 2019|Anticipated|2019-03-01||Interventional|PC-Anal-01||Shared Decision Making With Anal Cancer Patients on Radiation Dose|Patient Centered Radiation Treatment of Anal Cancer Using Shared Decision Making as to Dose Level|Recruiting||N/A|30|Anticipated|Vejle Hospital||3|||f||||f||||||||||2017-10-10 22:10:02.226275|2017-10-10 22:10:02.226275
NCT02785250|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-06-12|||April 2016||2016-04-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of DPX-Survivac Vaccine Therapy and Epacadostat in Patients With Recurrent Ovarian Cancer|A Phase 1b Study of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide and Epacadostat (INCB024360) in Patients With Recurrent Ovarian Cancer|Recruiting||Phase 1|40|Anticipated|ImmunoVaccine Technologies, Inc.||1|||f||||t||||||||||2017-10-10 22:10:02.36855|2017-10-10 22:10:02.36855
NCT02785237|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-13|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up|Intra-patient Randomized Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT Follow up|Recruiting||N/A|70|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||4|||f||||t||||||||||2017-10-10 22:10:02.68509|2017-10-10 22:10:02.68509
NCT02785224|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2017-08-14|||May 2018|Anticipated|2018-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Arterial Pressure and Stress-Dose Steroids in Cardiac Arrest.|Arterial Pressure and Stress-Dose Steroids in In-hospital Cardiac Arrest: a Mediation Analysis of Prior Randomized Clinical Trial Data.|Not yet recruiting||N/A|191|Anticipated|University of Athens|||2||f||||f||||||||||2017-10-10 22:10:02.883911|2017-10-10 22:10:02.883911
NCT02785211|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-05-24|||April 2014||2014-04-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Modified Behavioral Activation Treatment for Geriatric Depressive Symptoms in Left-behind Elderly in Rural China||Completed||N/A|80|Actual|The Third Xiangya Hospital of Central South University||2|||f||||||||||||||2017-10-10 22:10:03.033429|2017-10-10 22:10:03.033429
NCT02785198|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-06-15|||April 2016||2016-04-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|||Passive Training as a Treatment for Diabetic Foot Ulcers|Passive Training as a Treatment for Diabetic Foot Ulcers: A Randomized, Single-blinded Clinical Trial of Wound Healing|Recruiting||N/A|44|Anticipated|Herlev Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:10:03.130215|2017-10-10 22:10:03.130215
NCT02785185|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-04-25|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2, 2016|Actual|2016-12-02||Interventional|||Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis|A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion to Ultravate® (Halobetasol Propionate) Cream, in the Treatment of Plaque Psoriasis|Completed||Phase 2|150|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||t||||||||Yes||2017-10-10 22:10:03.283299|2017-10-10 22:10:03.283299
NCT02785172|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-04-17|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis|A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis|Completed||Phase 2|154|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||t||||||||Yes||2017-10-10 22:10:03.480313|2017-10-10 22:10:03.480313
NCT02785159|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-04-25|||February 2016||2016-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|November 20, 2016|Actual|2016-11-20||Interventional|||Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis|A Phase 2, Multicenter, Double Blinded, Randomized, Vehicle Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis|Completed||Phase 2|152|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||t||||||||Yes||2017-10-10 22:10:03.6025|2017-10-10 22:10:03.6025
NCT02785146|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-07|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer|Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer|Recruiting||Phase 3|230|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||Yes|The investigators would like to share the data to the Participating units.|2017-10-10 22:10:03.726498|2017-10-10 22:10:03.726498
NCT02785133|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-25|||December 2014||2014-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Feasibility of Polychromatic Light Emitting Diode for Peripheral Catheter Illumination During Peripheral Intravenous Delivery of Normal Saline|A Polychromatic Light Emitting Diode System to Deliver Low Dose Light Directly Into a Peripheral Intravascular Catheter: A Safety and Feasibility Study|Completed||N/A|3063|Actual|UVLrx Therapeutics||1|||f||||f||||||||Undecided|At this juncture, there is no specific plan to share data with any regulatory agency for the purposes of 510k market clearance or there is no determination at this juncture to present data to the medical community (i.e. peer-reviewed publication of medical conference)|2017-10-10 22:10:03.83271|2017-10-10 22:10:03.83271
NCT02785120|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-03-12|||September 2016||2016-09-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|TF0023||A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Study to Evaluate the Efficacy and Safety of TF0023 Spray Versus Placebo in Functional Improvement of Patients With Ischemic Strokes|Recruiting||Phase 2|225|Anticipated|Techfields Inc||3|||f||||t||||||||No||2017-10-10 22:10:03.914252|2017-10-10 22:10:03.914252
NCT02785107|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-29|||January 2015||2015-01-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Exercise Habit and M-PAC|Facilitating an Exercise Habit Via the Multi-Process Action Control Model: A Randomized-Controlled Trial|Completed||Phase 2/Phase 3|94|Actual|University of Victoria||2|||f||||f||||||||No||2017-10-10 22:10:04.103525|2017-10-10 22:10:04.103525
NCT02785094|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-09-02|||June 2016||2016-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Education and Social Media Versus Non-Indicated Caesarean Section Rate in Egypt|Education and Social Media Versus Non-Indicated Caesarean Section Rate in Egypt|Completed||N/A|1400|Actual|Talkha Central Hospital|||4||f||||f||||||||Undecided||2017-10-10 22:10:04.329817|2017-10-10 22:10:04.329817
NCT02785081|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-13|||May 2016||2016-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Thoracic Epidural Depth in Children Using Magnetic Resonance Imaging.Magnetic Resonance Imaging|Thoracic Epidural Depth in Children Using Magnetic Resonance Imaging|Completed||N/A|109|Actual|King Fahad Medical City|||1||f||||t||||||||||2017-10-10 22:10:04.472023|2017-10-10 22:10:04.472023
NCT02785068|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-01-10|||July 2016||2016-07-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer|A Phase 1 Study Combining MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|Merrimack Pharmaceuticals||1|||f||||f||||||||No||2017-10-10 22:10:04.580078|2017-10-10 22:10:04.580078
NCT02785042|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-27|||June 2016||2016-06-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)||Recruiting||N/A|249|Anticipated|Heidelberg Engineering GmbH||1|||f||||f||||||||No||2017-10-10 22:10:04.827972|2017-10-10 22:10:04.827972
NCT02785029|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-27|||June 2016||2016-06-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)||Recruiting||N/A|249|Anticipated|Heidelberg Engineering GmbH||1|||f||||f||||||||No||2017-10-10 22:10:04.975633|2017-10-10 22:10:04.975633
NCT02785016|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-18|||May 2013||2013-05-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Surgical Management for Suburethral Slings|Prospective, Non-Randomized, Observational Trial of the Surgical Management for Suburethral Slings in Women With Stress Urinary Incontinence|Active, not recruiting||N/A|100|Anticipated|Cantonal Hospital, Frauenfeld|||1||f||||t||||||||||2017-10-10 22:10:05.118201|2017-10-10 22:10:05.118201
NCT02785003|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-27|||July 2016||2016-07-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|KCRS||Ketamine in Colorectal Surgery|Continuous Ketamine Infusion Versus Placebo in the Treatment of Acute Post-Surgical Pain: A Randomized Trial Evaluating the Efficacy of Ketamine in Colorectal Surgery|Not yet recruiting||Phase 4|60|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||Undecided||2017-10-10 22:10:05.21174|2017-10-10 22:10:05.21174
NCT02784990|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-26||||||May 2016|2016-05-01||||August 2019|Anticipated|2019-08-01||Interventional|LIPA-DRAIN||Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions|Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions|Not yet recruiting||N/A|670|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 22:10:05.335163|2017-10-10 22:10:05.335163
NCT02784418|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01||||December 2018|Anticipated|2018-12-01||Interventional|SHINE-CTO||The SHINE-CTO Trial|SHam-controlled INtErvention to Improve QOL in CTOs: the SHINE CTO Trial|Enrolling by invitation||N/A|142|Anticipated|North Texas Veterans Healthcare System||2|||f||||t||||||||No||2017-10-10 22:10:14.116861|2017-10-10 22:10:14.116861
NCT02784977|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-10-02|||October 3, 2017|Actual|2017-10-03|October 2017|2017-10-01|December 31, 2027|Anticipated|2027-12-31|December 31, 2020|Anticipated|2020-12-31|10 Years|Observational [Patient Registry]|TURKAPNE||TURKAPNE - The Turkish Sleep Apnea Database: A National, Multicenter, Observational, Prospective Cohort Study|TURKAPNE - The Turkish Sleep Apnea Database: A National, Multicenter, Observational, Prospective Cohort Study|Recruiting||N/A|10000|Anticipated|Marmara University|||2||f||||t||||||||||2017-10-10 22:10:05.426253|2017-10-10 22:10:05.426253
NCT02784964|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-26|||March 2016||2016-03-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis|A Phase I/II Study to Evaluate the Safety and Efficacy of the Allogeneic Injection of Expanded Adipose-derived Stem Cells to Patients With Knee Osteoarthritis|Recruiting||Phase 1/Phase 2|24|Anticipated|UnicoCell Biomed CO. LTD||2|||f||||t||||||||Undecided||2017-10-10 22:10:05.540944|2017-10-10 22:10:05.540944
NCT02784951|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|ProHEMS||Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical Systems|Use of Blood and Plasma in Prehospital Haemorrhagic Shock - a Prospective, Multicenter, Observational Trial of Advanced Deployment of Blood Products in Norwegian Physician-staffed Helicopter Emergency Medical Systems|Recruiting||N/A|400|Anticipated|Haukeland University Hospital|||1||f||||t||||||||No||2017-10-10 22:10:05.633941|2017-10-10 22:10:05.633941
NCT02784938|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-22|||November 11, 2015|Actual|2015-11-11|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|VEP||Vocational Empowerment Photovoice (VEP)|Randomized Clinical Trial Evaluating the Efficacy of the Peer-run Vocational Empowerment Photovoice (VEP) to Increase the Capacity of Individuals With Psychiatric Disabilities to Pursue Employment|Recruiting||N/A|160|Anticipated|Boston University Charles River Campus||2|||f||||f||||||||||2017-10-10 22:10:05.785905|2017-10-10 22:10:05.785905
NCT02784925|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-06-20|2016-09-18||June 2016||2016-06-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement|Evaluate Patients With Chronic Hepatitis Before and After Treatment of Body Index by Three-dimensional Force-controlled Ultrasound Measurement of Subcutaneous Fat|Completed||N/A|30|Actual|Taipei Medical University WanFang Hospital||1|||f||||f||||||||No||2017-10-10 22:10:05.886876|2017-10-10 22:10:05.886876
NCT02784912|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-21|2017-06-07|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01|12 Months|Observational [Patient Registry]|STORM||Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation|Biomarkers-related riSk sTratification of Arrhythmia Recurrence in Patients undergOing Ablation of Sustained ventRicular Tachycardia or Electrical storM - STORM Study|Not yet recruiting||N/A|50|Anticipated|Medical University of Warsaw|||1||f||||f||||||Samples Without DNA|"     From each patient will be collected 10 ml of venous blood which will be centrifurgated to     obtain serum.   "|Yes|The investigators will be able to share data for meta-analyses|2017-10-10 22:10:06.103907|2017-10-10 22:10:06.103907
NCT02784899|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-12-29|||October 2015||2015-10-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of Iloprost on Pulmonary Oxygenation in Patients With Low Diffusing Capacity During One-lung Ventilation||Recruiting||N/A|40|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:10:06.198337|2017-10-10 22:10:06.198337
NCT02784886|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-24|||November 2013||2013-11-01|May 2016|2016-05-01|November 2016|Anticipated|2016-11-01|November 2015|Actual|2015-11-01||Observational|DNA-Accreta||Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta|Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta in a High Risk Population|Active, not recruiting||N/A|63|Actual|University Hospital, Angers|||1||f||||f||||||||No||2017-10-10 22:10:06.274964|2017-10-10 22:10:06.274964
NCT02784873|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-08-16|||July 2016||2016-07-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|HIIT-or-MISS||High Intensity Interval Training in UK Cardiac Rehabilitation Programmes|High Intensity Interval Training (HIIT) Versus Moderate Intensity Steady State Training (MISS) in UK Cardiac Rehabilitation Programmes: a Multi-centre Randomised Controlled Trial and Economic Evaluation|Recruiting||N/A|510|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust||2|||f||||f||||||||No||2017-10-10 22:10:06.374893|2017-10-10 22:10:06.374893
NCT02784860|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-06-25|||March 2016||2016-03-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of Intravenous Lidocaine During Sedation for Colonoscopy.|Investigation of the Effects of Intravenous Lidocaine Infusion During Sedation for Colonoscopy|Recruiting||Phase 4|40|Anticipated|University Hospital of Liege||2|||f||||f||||||||No||2017-10-10 22:10:06.490106|2017-10-10 22:10:06.490106
NCT02784847|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-05-24|||June 2016||2016-06-01|May 2016|2016-05-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|TRIMI||A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine|A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine|Not yet recruiting||Early Phase 1|10|Anticipated|University Hospital of Liege||1|||f||||f||||||||No||2017-10-10 22:10:06.594076|2017-10-10 22:10:06.594076
NCT02784834|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-03-13|||June 2016||2016-06-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL|Phase I Clinical Trial to Evaluate Dimethylfumarate (DMF) in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.|Recruiting||Phase 1|15|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-10 22:10:06.674251|2017-10-10 22:10:06.674251
NCT02784821|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-26|||January 2017||2017-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||"Antibiotic Dysbiosis in Preterm Infants"|Antibiotic Effects on the Developing Microbiome, Metabolome and Morbidities in Preterm Neonates|Recruiting||Phase 2|420|Anticipated|University of Florida||4|||f||||t|t|f||||||||2017-10-10 22:10:06.778747|2017-10-10 22:10:06.778747
NCT02784808|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2016-06-06|||January 2000||2000-01-01|June 2016|2016-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)||Completed||N/A|4557|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-10 22:10:06.932394|2017-10-10 22:10:06.932394
NCT02784795|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-15|||November 2016||2016-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors|A Phase 1b Study of LY3039478 in Combination With Other Anticancer Agents in Patients With Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|163|Anticipated|Eli Lilly and Company||5|||f||||f||||||||||2017-10-10 22:10:09.803328|2017-10-10 22:10:09.803328
NCT02784782|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-05-26|||March 2016||2016-03-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Interventional|BONO||Thoracolumbar Burstfractures, Orthesis or No Orthesis|Thoracolumbar Burstfractures, Orthesis or no Orthesis|Recruiting||Phase 4|122|Anticipated|Elisabeth-TweeSteden Ziekenhuis||2|||f||||f||||||||Yes|"In this research project the investigators aim for multiple publications in scientific journals and a promotion of a PhD student.
The investigators want to develop a treating protocol with better functional outcome and less costs."|2017-10-10 22:10:10.027142|2017-10-10 22:10:10.027142
NCT02784769|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-12-27|||February 2015||2015-02-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|VIMANE||Matrix Aging and Aneurysm|Role of Molecular Aging of Matrix Proteins of the Vessel Wall in the Aneurysm Pathology|Recruiting||N/A|40|Anticipated|CHU de Reims||2|||f||||||||||||||2017-10-10 22:10:10.147093|2017-10-10 22:10:10.147093
NCT02784756|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-05-24|||June 2016||2016-06-01|February 2016|2016-02-01||||January 2018|Anticipated|2018-01-01||Interventional|QFT-CMV||Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients|Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multi-Center Study|Not yet recruiting||Phase 3|200|Anticipated|University Health Network, Toronto||1|||f||||f||||||||No||2017-10-10 22:10:10.255492|2017-10-10 22:10:10.255492
NCT02784743|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-05-24|||May 2001||2001-05-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|December 2008|Actual|2008-12-01||Interventional|||Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali|Impact of Albendazole -Ivermectin Combination Treatment on Wuchereria Bancrofti Infection and Transmission in Mali|Completed||Phase 4|1139|Actual|Centre d'Appui à la lutte contre la Maladie||1|||f||||f||||||||||2017-10-10 22:10:10.339521|2017-10-10 22:10:10.339521
NCT02784730|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|PICC One Day||Iterative PICC Placement Versus Long Term Device|A Randomized, Multicentre, Comparative Phase III Study of Catheter-related Complications of an Iterative PICC Placement vs a Long-term PAC in Patients With Breast Cancer|Not yet recruiting||Phase 3|408|Anticipated|Centre Leon Berard||2|||f||||f|f|f||||||||2017-10-10 22:10:10.424552|2017-10-10 22:10:10.424552
NCT02784704|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-05-30|||October 13, 2016|Actual|2016-10-13|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|IGNITE4||Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections|A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections|Active, not recruiting||Phase 3|400|Anticipated|Tetraphase Pharmaceuticals, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:10:10.598993|2017-10-10 22:10:10.598993
NCT02784691|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-07-29|||October 2016||2016-10-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficiency and Usability of the Iontophoretic Patch Feeligreen Diclofenac in Treating Acute Osteoarthritic Knee Pain||Not yet recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||No||2017-10-10 22:10:12.031111|2017-10-10 22:10:12.031111
NCT02784678|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-24|||June 2016||2016-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Minimally Invasive Closed Reduction and Internal Fixation With Screws for Distal Radius Fracture|Minimally Invasive Closed Reduction and Internal Fixation With Fully Threaded Headless Cannulated Compression Screws for Repair of Distal Radius Fracture: Study Protocol for a Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Shenyang Medical College||2|||f||||t||||||||Undecided||2017-10-10 22:10:12.106518|2017-10-10 22:10:12.106518
NCT02784665|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-04-19|||April 2016||2016-04-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment Trial for Acute Central Serous Chorioretinopathy|Randomized Controlled Clinical Trial to Evaluate the Effects of 577nm Micropulse Laser vs Traditional Laser Therapy on Acute Central Serous Chorioretinopathy|Enrolling by invitation||N/A|110|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 22:10:12.185226|2017-10-10 22:10:12.185226
NCT02784652|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-03-27|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors|Phase II Study of Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients With Gastrointestinal Tumors|Completed||Phase 2|60|Actual|Severance Hospital||1|||f||||||||||||||2017-10-10 22:10:12.272188|2017-10-10 22:10:12.272188
NCT02784639|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-08-02|||October 2013||2013-10-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|KPLEX2||Comparison of KRAS/BRAF Mutational Status With Conventional Techniques and Plasma Samples Analysis|Comparison of KRAS/BRAF Mutational Status Between Tumor Tissue Section Analysis With Conventional Techniques and Plasma Samples Analysis (KPLEX2)|Completed||N/A|115|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||No||2017-10-10 22:10:12.349046|2017-10-10 22:10:12.349046
NCT02784626|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-10-25|||May 2016||2016-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Intraoperative Sedatives and Postoperative Pain|The Influence of Intraoperative Sedative on Postoperative Pain in Total Knee Arthroplasty Under Spinal Anesthesia: Comparison Between Dexmedetomidine and Propofol|Completed||Phase 4|48|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||No||2017-10-10 22:10:12.415815|2017-10-10 22:10:12.415815
NCT02784613|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-04-17|||July 2015||2015-07-01|September 2016|2016-09-01|April 17, 2017|Actual|2017-04-17|February 7, 2017|Actual|2017-02-07||Interventional|||Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA|An Open-Label Pilot Prospective Vulvoscopy With Photography Study of the Visible Changes in the Vulva, Vestibule and Vagina Pre- and Post- Twenty Weeks of Daily Administration of 60 Mg Ospemifene in Post-Menopausal Women With Dyspareunia From Vulvar Vaginal Atrophy|Completed||Phase 4|10|Actual|San Diego Sexual Medicine||1|||f||||f||||||||No|Information will be combined and not reported as IPD.|2017-10-10 22:10:12.51069|2017-10-10 22:10:12.51069
NCT02784600|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-07-10|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|REBUILD||Rotation Medical Bioinductive Implant Database Registry||Recruiting||N/A|500|Anticipated|Rotation Medical, Inc.|||1||f||||f||||||||||2017-10-10 22:10:12.599792|2017-10-10 22:10:12.599792
NCT02784587|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-06-19|||May 31, 2016|Actual|2016-05-31|June 2017|2017-06-01|December 7, 2016|Actual|2016-12-07|December 6, 2016|Actual|2016-12-06||Interventional|||Feasibility of Perioperative Stellate Ganglion Blocks in Cardiac Surgery|Feasibility of Perioperative Stellate Ganglion Blocks in Cardiac Surgery|Completed||N/A|25|Actual|Maine Medical Center||1|||f||||t||||||||||2017-10-10 22:10:12.857701|2017-10-10 22:10:12.857701
NCT02784574|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-08-30|||May 2016||2016-05-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|August 2016|Actual|2016-08-01||Observational|||Post ICU Follow up: A Questionnaire Survey of Aftercare in Denmark|Post ICU Follow up: A Questionnaire Survey of Aftercare in Denmark|Active, not recruiting||N/A|31|Actual|Zealand University Hospital|||1||f||||t||||||||No||2017-10-10 22:10:12.947857|2017-10-10 22:10:12.947857
NCT02784561|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-24|||July 2016||2016-07-01|May 2016|2016-05-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation|Safety and Efficacy Study of Busulfan/FLAG Conditioning Regimen in Patients With Relapsed/Refractory Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation|Not yet recruiting||Phase 4|80|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||No||2017-10-10 22:10:13.053697|2017-10-10 22:10:13.053697
NCT02784548|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-28|||October 2, 2017|Anticipated|2017-10-02|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Virtual Reality for Phantom Limb Pain|Adapting Virtual Reality Technology for the Treatment of Phantom Limb Pain|Not yet recruiting||N/A|20|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:10:13.171602|2017-10-10 22:10:13.171602
NCT02784535|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-24|||August 29, 2016|Actual|2016-08-29|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|NETAF||Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)|Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure IND117394 12/28/12|Recruiting||Phase 2|40|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 22:10:13.269444|2017-10-10 22:10:13.269444
NCT02784522|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-24|||May 2014||2014-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Minimally Invasive of Proximal Humerus Fractures With Internal Fixation Improves Shoulder Function in Older Patients|Minimally Invasive Treatment of Proximal Humerus Fractures With Locking Compression Plate Improves Shoulder Function in Older Patients: Study Protocol for a Prospective Randomized Controlled Trial|Completed||N/A|82|Actual|Qinghai University||2|||f||||f||||||||Undecided||2017-10-10 22:10:13.379355|2017-10-10 22:10:13.379355
NCT02784509|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-09-26|||May 2016||2016-05-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|TIGER Kids||Translational Investigation of Growth and Everyday Routines in Kids|Translational Investigation of Growth and Everyday Routines in Kids (TIGER Kids)|Recruiting||N/A|340|Anticipated|Pennington Biomedical Research Center|||1||f||||f||||||Samples Without DNA|"     An aliquot of sample will be stored in case further tests are needed and if further consent     is obtained from the subject.   "|||2017-10-10 22:10:13.472307|2017-10-10 22:10:13.472307
NCT02784496|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-03-28|||September 29, 2016|Actual|2016-09-29|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Study of Ruxolitinib for Patients With Myelofibrosis (MF)|Open-label Roll-Over Study to Assess the Long-term Safety and Efficacy of Ruxolitinib in Subjects With Myelofibrosis|Active, not recruiting||Phase 2|8|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:10:13.561232|2017-10-10 22:10:13.561232
NCT02784483|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-12-01|||December 2016||2016-12-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma|Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma|Recruiting||Phase 1|20|Anticipated|Yale University||1|||f||||t||||||||No||2017-10-10 22:10:13.663662|2017-10-10 22:10:13.663662
NCT02784470|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-24|||October 2015||2015-10-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Gastroduodenal Metallic Stent vs Gastrojejunostomy||Recruiting||Phase 3|92|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-10 22:10:13.729037|2017-10-10 22:10:13.729037
NCT02784457|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-24|||June 2014||2014-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome|Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome - a Randomized Controlled Trial|Completed||Phase 2|84|Actual|Ain Shams University||2|||f||||f||||||||Undecided||2017-10-10 22:10:13.802107|2017-10-10 22:10:13.802107
NCT02784444|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-06-20|||July 2016||2016-07-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|EMMINENCE||A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC 0602K in Patients With NASH|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC 0602K in Patients With NASH (EMMINENCE™)|Recruiting||Phase 2|200|Anticipated|Cirius Therapeutics, Inc.||4|||f||||f||||||||No||2017-10-10 22:10:13.879444|2017-10-10 22:10:13.879444
NCT02784431|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-24|||July 2016||2016-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:10:14.079988|2017-10-10 22:10:14.079988
NCT02784405|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|SPARTA||Self-apposing Stentys Stents Registry|Safety and Effectiveness of the Self-aPposing, bAlloon-delivered, dRug-eluting Stent for the Treatment of the Coronary Artery Disease: A multiCenter Registry|Recruiting||N/A|100|Anticipated|Azienda Ospedaliera Città della Salute e della Scienza di Torino|||1||f||||f||||||||No||2017-10-10 22:10:14.295702|2017-10-10 22:10:14.295702
NCT02784392|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-03-10|||July 2016||2016-07-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|PROMOTE||Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial|A Phase 2, Multicenter, Randomized, Double-Blind, Comparator-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of Intravenous Ulimorelin (LP101) in Patients With Enteral Feeding Intolerance (EFI)|Recruiting||Phase 2|120|Anticipated|Lyric Pharmaceuticals||2|||f||||t||||||||Undecided||2017-10-10 22:10:14.451114|2017-10-10 22:10:14.451114
NCT02784379|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-11-26|||March 2016||2016-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|||Electromyography of the Pectoral Muscle in Mastalgia Patients|The Comparison Both of the Electromyography Results of the Pectoral Muscle in Unilateral Mastalgia Patients|Completed||N/A|31|Actual|Sisli Etfal Training & Research Hospital|||2||f||||f||||||||Undecided||2017-10-10 22:10:14.550946|2017-10-10 22:10:14.550946
NCT02784366|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-04-21|||August 2015||2015-08-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||GI Complications in Cancer Immunotherapy Patients|GI Complications in Cancer Immunotherapy Patients|Recruiting||N/A|100|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples With DNA|"     Blood and stool samples will be collected.   "|Yes||2017-10-10 22:10:14.627523|2017-10-10 22:10:14.627523
NCT02784353|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-07-07|||October 4, 2016|Actual|2016-10-04|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|June 30, 2018|Anticipated|2018-06-30||Interventional|PReHeBP||Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy|Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP(Hepatobiliary and Pancreatic) Malignancy|Recruiting||N/A|158|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-10 22:10:14.717262|2017-10-10 22:10:14.717262
NCT02784340|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-26|||May 2014||2014-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Local and Intravenous Dexamethasone on Post Operative Pain a After CS|Comparison of Local and Intra Venous Dexamethasone on Post Operative Pain and Recovery After Caeseream Section|Completed||Phase 4|120|Actual|Cairo University||3|||f||||f||||||||No||2017-10-10 22:10:14.83491|2017-10-10 22:10:14.83491
NCT02784327|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-24|||August 2016||2016-08-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of PRF110 in Bunionectomy Surgery|A Single-Dose, Open-Label, Multi-Center Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of PRF110 in Bunionectomy Surgery|Not yet recruiting||Phase 2|15|Anticipated|PainReform LTD||1|||f||||f||||||||||2017-10-10 22:10:14.936749|2017-10-10 22:10:14.936749
NCT02784314|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-06-02|||May 2010||2010-05-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|May 2013|Actual|2013-05-01||Interventional|ROBOTCAP||Cost Efficacy Evaluation of Robot Assisted Radical Prostatectomy|Medico-economic Evaluation of Robotic-assisted Radical Prostatectomy Versus Laparoscopic Radical Prostatectomy|Completed||N/A|25|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:10:15.047824|2017-10-10 22:10:15.047824
NCT02784301|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of a Biofeedback Tool to Minimize Procedural Pain and Anxiety in Children|Evaluation of a Biofeedback Tool to Minimize Procedural Pain and Anxiety in Children|Not yet recruiting||N/A|300|Anticipated|British Columbia Children's Hospital||4|||f||||f||||||||No||2017-10-10 22:10:15.156787|2017-10-10 22:10:15.156787
NCT02784288|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-06|||October 3, 2016|Actual|2016-10-03|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer|Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer|Recruiting||Phase 2|100|Anticipated|University of Michigan Cancer Center||3|||f||||t||||||||||2017-10-10 22:10:15.276137|2017-10-10 22:10:15.276137
NCT02784275|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-28|||June 9, 2016|Actual|2016-06-09|August 2017|2017-08-01|May 17, 2017|Actual|2017-05-17|May 3, 2017|Actual|2017-05-03||Interventional|||A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes|Completed||Phase 2|64|Actual|NovMetaPharma Co., Ltd.||4|||f||||f||||||||||2017-10-10 22:10:15.383382|2017-10-10 22:10:15.383382
NCT02784262|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-02-20|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis|Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis|Recruiting||Phase 2|10|Anticipated|Norwegian University of Science and Technology||1|||f||||f||||||||Undecided||2017-10-10 22:10:15.491421|2017-10-10 22:10:15.491421
NCT02784249|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-03-27|||June 2016||2016-06-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Comparison of Two Ab Interno Procedures in the Treatment of Glaucoma in Patients Undergoing Cataract Extraction|A Prospective, Randomized, Multi-Center, Open-Label Trial Comparing a Novel Goniotomy Procedure and an Ab Interno Trabecular Bypass Device in the Treatment of Mild to Moderate Glaucoma in Patients Undergoing Cataract Extraction|Recruiting||N/A|150|Anticipated|New World Medical, Inc.||2|||f||||f||||||||No||2017-10-10 22:10:15.610194|2017-10-10 22:10:15.610194
NCT02784236|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-02-03|||April 2014|Actual|2014-04-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||INTEGRATED IMPACT ASSESSMENT a Telemedicine Program in the Care of Patients With Diabetes Mellitus Type 1 Intensive Treatment With Multiple Daily Injections.|INTEGRATED IMPACT ASSESSMENT a Telemedicine Program in the Care of Patients With Diabetes Mellitus Type 1 Intensive Treatment With Multiple Daily Injections.|Completed||N/A|121|Actual|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||1|||f||||f||||||||No||2017-10-10 22:10:15.70929|2017-10-10 22:10:15.70929
NCT02784223|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-07-27|||May 2016||2016-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|CHOCOLATE||Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study|Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study|Recruiting||N/A|135|Anticipated|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-10 22:10:15.777204|2017-10-10 22:10:15.777204
NCT02784210|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-26|2017-07-06|||May 12, 2016||2016-05-12|May 31, 2017|2017-05-31|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques|The Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques: An Investigator-Blinded Study|Enrolling by invitation||Phase 2|1|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 22:10:15.857576|2017-10-10 22:10:15.857576
NCT02784197|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-07-07|||May 2016||2016-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:10:15.955207|2017-10-10 22:10:15.955207
NCT02784184|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-26|||August 2016||2016-08-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|CPHMINIPUB||COPENHAGEN Minipuberty Study|COPENHAGEN Minipuberty Study|Recruiting||N/A|200|Anticipated|Rigshospitalet, Denmark|||2||f||||f||||||Samples With DNA|"     DNA EDTA-Blood Serum   "|||2017-10-10 22:10:15.994599|2017-10-10 22:10:15.994599
NCT02784158|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-05-31||||||May 2017|2017-05-01||||||||Expanded Access|||An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer||No longer available||N/A|||Ariad Pharmaceuticals|||||||||||||||||||2017-10-10 22:10:16.257885|2017-10-10 22:10:16.257885
NCT02784145|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-08-22|||May 2016||2016-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|RESISTA-PD||Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson Disease|Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson Disease|Recruiting||N/A|90|Anticipated|Saarland University||2|||f||||f||||||||||2017-10-10 22:10:16.321415|2017-10-10 22:10:16.321415
NCT02784132|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-24|||June 2012||2012-06-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Video Diversion Improves Success Rate of Fundoscopic Examination in Children|Video Diversion Improves the Success Rate of Fundoscopic Examination in Children: a Prospective Multi-clinic, Multi-practitioner, Randomized Controlled Trial|Completed||N/A|101|Actual|University of British Columbia||4|||f||||f||||||||No||2017-10-10 22:10:16.405862|2017-10-10 22:10:16.405862
NCT02784119|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-12-06|||January 2017||2017-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|February 2019|Anticipated|2019-02-01||Interventional|APCext||APCext : Effect of Temporary Porto-caval Shunt During Liver Transplantation on Function of Liver Graft From Extended Criteria Donor|APCext : Effect of Temporary Porto-caval Shunt During Liver Transplantation on Function of Liver Graft From Extended Criteria Donor|Not yet recruiting||N/A|214|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-10 22:10:16.487927|2017-10-10 22:10:16.487927
NCT02784106|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-25|||July 31, 2016|Actual|2016-07-31|September 2017|2017-09-01|November 14, 2017|Anticipated|2017-11-14|April 30, 2017|Actual|2017-04-30||Interventional|||Safety and Efficacy Study of M2951 in Subjects With Rheumatoid Arthritis|Phase IIa Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of M2951 in Subjects With Rheumatoid Arthritis on Stable Methotrexate Therapy|Active, not recruiting||Phase 2|65|Actual|EMD Serono||3|||f||||t||||||||||2017-10-10 22:10:16.742952|2017-10-10 22:10:16.742952
NCT02784093|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-08|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Interventional|||Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation|Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation: A Double-blinded Randomized Controlled Trial|Active, not recruiting||Phase 2|83|Actual|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 22:10:16.861392|2017-10-10 22:10:16.861392
NCT02784080|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-06-01|||August 2015||2015-08-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Donor Specific HLA Alloantibodies in Liver Transplantation|Donor Specific HLA Alloantibodies in Liver Transplantation: a Prospective Blinded Multicenter Prognostic Study|Recruiting||N/A|1162|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     Recipient samples, pre-transplant, at discharge or day 14 (±4 days), 3 months (±3 weeks), 1     year (±1 month, and at liver biopsy        -  1 Plasma, EDTA-glass (9 ml), redistributed 4 aliquots        -  2 Serum, clot activator (9 ml + 4 ml), redistributed 8 aliquots        -  Liver biopsy sample: Formalin fixed paraffin-embeded   "|Undecided||2017-10-10 22:10:16.963058|2017-10-10 22:10:16.963058
NCT02784067|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-09-20|||May 2016||2016-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GSID-E||A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency|A Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency|Withdrawn||Phase 4|0|Actual|QOL Medical, LLC||2||Clinical Trial Material|f||||f||||||||||2017-10-10 22:10:17.126026|2017-10-10 22:10:17.126026
NCT02784054|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-24|||April 2014||2014-04-01|May 2016|2016-05-01||||March 2018|Anticipated|2018-03-01||Interventional|||Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor|Reduced-dose Radiotherapy Following High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Central Nervous System Non-germinomatous Germ Cell Tumors|Recruiting||Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:10:17.232592|2017-10-10 22:10:17.232592
NCT02784041|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-04-04|||September 2016||2016-09-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty|Comparison of the Effect of Single Adductor-canal-block and Peri-articular Infiltration on the Outcome After Unilateral Total Knee Arthroplasty|Enrolling by invitation||N/A|200|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||Yes||2017-10-10 22:10:17.354694|2017-10-10 22:10:17.354694
NCT02784028|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-10|||December 2014|Actual|2014-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|FLUOCAR-1||Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer|Phase I Study Assessing Safety of SGM-101, a Fluorochrome-labeled Anti-carcinoembryonic Antigen Monoclonal Antibody for the Detection of Neoplastic Lesions in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer|Recruiting||Phase 1|36|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-10 22:10:17.46231|2017-10-10 22:10:17.46231
NCT02784015|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2020|Anticipated|2020-05-01||Interventional|||Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma|Response-based Treatment for Children With Unresectable Localized Soft Tissue Sarcomas|Recruiting||Phase 2|41|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:10:17.565591|2017-10-10 22:10:17.565591
NCT02783989|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-02-09|||January 20, 2016|Actual|2016-01-20|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|DOPET3||Effects on Cardiovascular Risk Factors of the Endogenous Hydroxytyrosol Generation After the Combined Intake of Wine and Tyrosol in Humans|A Single-center, Crossover, Randomized and Controlled Nutritional Intervention Clinical Trial. A Nutritional Intervention Study|Recruiting||N/A|60|Anticipated|Parc de Salut Mar||3|||f||||f||||||||||2017-10-10 22:10:17.804248|2017-10-10 22:10:17.804248
NCT02783963|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-23|||April 2015||2015-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|SOFT-MI||Optical Coherence Tomography in Patients With Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease|Optical Coherence Tomography in Patients With Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease: OCT and CMR Study (SOFT-MI)|Recruiting||N/A|35|Anticipated|Institute of Cardiology, Warsaw, Poland||1|||f||||t||||||||||2017-10-10 22:10:18.027304|2017-10-10 22:10:18.027304
NCT02783950|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-01-23|||August 2016||2016-08-01|January 2017|2017-01-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|G-MINOR||Genomics in Michigan Impacting Observation or Radiation|Genomics in Michigan Impacting Observation or Radiation (G-MINOR)|Recruiting||N/A|350|Anticipated|GenomeDx Biosciences Corp||2|||f||||f||||||||No||2017-10-10 22:10:18.117608|2017-10-10 22:10:18.117608
NCT02783937|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-11-28|||November 2016||2016-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|FIL-POI||Filgrastim for Premature Ovarian Insufficiency|Filgrastim for Treatment of Premature Ovarian Insufficiency: Randomized Clinical Trial|Active, not recruiting||Phase 4|10|Actual|South Valley University||2|||f||||f||||||||No||2017-10-10 22:10:18.22771|2017-10-10 22:10:18.22771
NCT02783924|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-11-14|||October 2014||2014-10-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The GLOBAL Vitamin D Study. A Genomic, Transcriptomic, Proteomic and Metabolomic Approach|The GLOBAL Vitamin D Study. A Genomic, Transcriptomic, Proteomic and Metabolomic Approach to the Effects of Vitamin D in Adipose Tissue and Peripheral Blood|Recruiting||Phase 2|50|Anticipated|University of Tromso||2|||f||||f||||||||No|not planned|2017-10-10 22:10:18.322987|2017-10-10 22:10:18.322987
NCT02783911|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-06-30|||April 2016||2016-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies|Comparison of Clinical and Radiographic Success Between Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies for Primary Molars|Enrolling by invitation||N/A|60|Anticipated|Loma Linda University||2|||f||||f||||||||||2017-10-10 22:10:18.430925|2017-10-10 22:10:18.430925
NCT02783885|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-23|||May 2016||2016-05-01|May 2016|2016-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Clinical Utilization of Newly Approved Oncology Medications|Clinical Utilization of Newly Approved Oncology Medications in Middle Eastern Population|Recruiting||N/A|100|Anticipated|National Guard Health Affairs|||1||f||||f||||||||No||2017-10-10 22:10:18.643078|2017-10-10 22:10:18.643078
NCT02783872|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-23|||June 2016||2016-06-01|May 2016|2016-05-01||||June 2019|Anticipated|2019-06-01||Observational|||Emotion Regulation and Binge Eating in Youth With Obesity|Neurodevelopmental Substrates of Emotion Regulation in Overweight, Binge Eating Youth|Not yet recruiting||N/A|75|Anticipated|The Miriam Hospital|||3||f||||t||||||||Undecided||2017-10-10 22:10:18.719369|2017-10-10 22:10:18.719369
NCT02783859|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-07-02|||June 2016||2016-06-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|HOPE||Hospitalised Pneumonia With Extended Treatment (HOPE) Study|A Multi-centre Double-blind Randomised Controlled Trial to Determine if a Longer Duration of Amoxicillin-clavulanic Acid (Compared to Shorter Duration) Improves Clinical Outcomes of Children Hospitalised With Community-acquired Pneumonia|Recruiting||Phase 4|314|Anticipated|Menzies School of Health Research||2|||f||||t||||||||||2017-10-10 22:10:18.783134|2017-10-10 22:10:18.783134
NCT02783846|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-11-06|||June 2016||2016-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial|The Effects of Different Dexmedetomidine on the Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index|Completed||N/A|73|Actual|General Hospital of Ningxia Medical University||3|||f||||t||||||||No|safety|2017-10-10 22:10:18.912993|2017-10-10 22:10:18.912993
NCT02783833|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-02-07|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|January 16, 2017|Actual|2017-01-16|January 16, 2017|Actual|2017-01-16||Interventional|||MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B|A Single Centre, Two-part, Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects|Completed||Phase 1/Phase 2|15|Actual|Medicines for Malaria Venture||2|||f||||t||||||||Yes|clinical safety data (physical exam, ECG, vital signs, clinical score, AEs), lab safety data, PK data, PCR data, subject withdrawals, significant protocol deviations, SAEs.|2017-10-10 22:10:18.98323|2017-10-10 22:10:18.98323
NCT02783820|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-01-12|||May 2016||2016-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A|A Single Centre, Two-part, Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Medicines for Malaria Venture||6|||f||||t||||||||Yes|Clinical safety data (physical exam, ECG, vital signs, clinical score, AEs) lab safety data PK data PCR data Dosing completed, subject withdrawals,significant protocol deviations. Serious Adverse Event Reports|2017-10-10 22:10:19.06665|2017-10-10 22:10:19.06665
NCT02783794|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-27|||December 2012||2012-12-01|May 2016|2016-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||BP-C1 Monotherapy in Patients With Metastatic Breast Cancer|A Randomized, Double Blind and Placebo Controlled Multicenter Study Comparing BP-C1 and Equal Looking Placebo in Metastatic Breast Cancer Patients. A Phase IIB Study|Completed||Phase 2|36|Actual|Meabco A/S||2|||f||||f||||||||||2017-10-10 22:10:19.239084|2017-10-10 22:10:19.239084
NCT02783781|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2016-11-14|||September 2016||2016-09-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|EuroSCOREbio||Contribution of Preoperative Biological Data in Risk Assessment in Cardiac Surgery in Addition to the EuroSCORE (EuroSCOREbio)|Contribution of Preoperative Biological Data in Risk Assessment in Cardiac Surgery in Addition to the EuroSCORE|Recruiting||N/A|9500|Anticipated|University Hospital Center of Martinique|||1||f||||f||||||||No||2017-10-10 22:10:19.345958|2017-10-10 22:10:19.345958
NCT02783768|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-03-24|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|VaPE-Tox||Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study|Ventilation and Pulmonary Endothelium Toxicities (VaPE-Tox) of E-cigarettes: A Randomized Crossover Pilot Study|Recruiting||Phase 1|10|Anticipated|Columbia University||2|||f||||t|t|t|t|f||||No||2017-10-10 22:10:19.473936|2017-10-10 22:10:19.473936
NCT02783755|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-01|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|June 30, 2017|Actual|2017-06-30|June 2017|Actual|2017-06-01||Interventional|||A mHealth Behavioral Cancer Pain Protocol for Medically Underserved Communities|A mHealth Behavioral Cancer Pain Protocol for Medically Underserved Communities.|Completed||N/A|20|Actual|Duke University||1|||f||||f||||||||||2017-10-10 22:10:19.573457|2017-10-10 22:10:19.573457
NCT02783742|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-03-23|||May 2016||2016-05-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Provider-Patient Communication Coaching|Teaching Provider Communication Via Coaching to Reduce Burnout|Recruiting||N/A|2400|Anticipated|Duke University||2|||f||||f||||||||No||2017-10-10 22:10:19.663384|2017-10-10 22:10:19.663384
NCT02783729|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-19|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Parallel-Group Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder|Recruiting||Phase 3|950|Anticipated|Eisai Inc.||4|||f||||f||||||||||2017-10-10 22:10:19.757424|2017-10-10 22:10:19.757424
NCT02783716|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-23|||May 2016||2016-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure|Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure|Recruiting||N/A|75|Anticipated|Mayo Clinic||2|||f||||f|f|t|f|f||||||2017-10-10 22:10:20.205053|2017-10-10 22:10:20.205053
NCT02783703|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-05-30|||April 28, 2017|Actual|2017-04-28|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of MCT in a Mixed Racial Population of Patients With Metabolic Syndrome: a Feasibility Study|Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients With Metabolic Syndrome: a Feasibility Study|Recruiting||N/A|12|Anticipated|Boston Medical Center||1|||f||||f|f|f||||||No|Patient data is protected by HIPAA. Results will be published in a peer-reviewed journal.|2017-10-10 22:10:20.288164|2017-10-10 22:10:20.288164
NCT02783690|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-27|||May 18, 2016|Actual|2016-05-18|July 2017|2017-07-01|September 2025|Anticipated|2025-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation|MC1631: A Randomized Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation|Recruiting||Phase 2|82|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 22:10:20.383824|2017-10-10 22:10:20.383824
NCT02783677|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-02-02|||January 2013||2013-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Application of Digital Infrared Thermal Imaging in Peripheral Artery Disease of the Lower Extremities|The Application of Digital Infrared Thermal Imaging in Peripheral Artery Disease|Recruiting||N/A|230|Anticipated|National Taiwan University Hospital|||4||f||||f||||||||No||2017-10-10 22:10:20.481799|2017-10-10 22:10:20.481799
NCT02783664|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-09-14|||July 2016||2016-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Evaluating the Effects of Genetic Testing on Patients' Stress Levels|Evaluating the Effects of Genetic Testing on Patients' Stress Levels|Recruiting||N/A|164|Anticipated|Medical College of Wisconsin|||1||f||||t||||||||||2017-10-10 22:10:20.566043|2017-10-10 22:10:20.566043
NCT02783651|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-08-16|||June 30, 2016|Actual|2016-06-30|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|||An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US|An Observational Study of Patients With Philadelphia Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US|Recruiting||N/A|300|Anticipated|Amgen|||2||f||||f||||||||||2017-10-10 22:10:20.675671|2017-10-10 22:10:20.675671
NCT02783638|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-11-07|||January 2016||2016-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||PK and Food Effect of Pregabalin Study After Dosing in Healthy Male Volunteers|A Open-label, Randomized, Crossover Clinical Trial to Assess the PK of Pregabalin CR After Multiple Dosing as Compared to Pregabalin IR and the Food Effect of High Fat Diet After Single Dosing in Healthy Male Volunteers|Completed||Phase 1|64|Actual|Yuhan Corporation||2|||f||||t||||||||No||2017-10-10 22:10:20.788455|2017-10-10 22:10:20.788455
NCT02783625|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-08-18|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas|A Phase I Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas|Recruiting||Phase 1|88|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 22:10:20.888645|2017-10-10 22:10:20.888645
NCT02783612|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-05-25|||March 2016||2016-03-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Digital Glucose Monitoring in Gestational Diabetes|Improvement of Compliance by Digital Blood Glucose Monitoring of Women With Gestational Diabetes|Recruiting||N/A|100|Anticipated|Wolfson Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:10:21.029519|2017-10-10 22:10:21.029519
NCT02783599|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-07-21|||October 2016||2016-10-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma|A Phase 1b Trial to Assess the Modulation of Biological Markers in Patients With Potentially Resectable Soft Tissue Sarcoma Treated With Olaratumab Monotherapy Followed by Olaratumab Plus Doxorubicin Combination Therapy|Recruiting||Phase 1|40|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 22:10:21.127063|2017-10-10 22:10:21.127063
NCT02783586|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-10|||April 2016||2016-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||TAPB vs QLBII for Kidney Transplantation Procedure|Ultrasound Guided Transversus Abdominalis Plane Block ( TAPB) Versus Quadratus Lumborum Type II Block (QLBII) in Perioperative Analgesia for Kidney Transplantation Procedure: Clinical Randomized Multicenter Study|Recruiting||Phase 4|104|Anticipated|Medical University of Warsaw||2|||f||||f||||||||No||2017-10-10 22:10:21.278728|2017-10-10 22:10:21.278728
NCT02783573|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-24|2017-10-03|||July 2016||2016-07-01|October 2017|2017-10-01|March 2021|Anticipated|2021-03-01|September 2019|Anticipated|2019-09-01||Interventional|DAYBREAK-ALZ||A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia|A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia|Recruiting||Phase 3|1899|Anticipated|Eli Lilly and Company||4|||f||||t||||||||||2017-10-10 22:10:21.437372|2017-10-10 22:10:21.437372
NCT02783560|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-03-20|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Behavioral Sleep Intervention in Children With Disruptive Behaviors|The Role of Sleep in Addressing Disruptive Behavior in Children|Enrolling by invitation||N/A|24|Anticipated|Indiana University||2|||f||||f||||||||No||2017-10-10 22:10:22.777399|2017-10-10 22:10:22.777399
NCT02783547|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-05-23|||December 2015||2015-12-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome|A Phase 1, Open Label, Multicentre Clinical Trial of SyB C-1101 in Combination With Azacytidine in Patients With Myelodysplastic Syndrome|Active, not recruiting||Phase 1|12|Anticipated|SymBio Pharmaceuticals||1|||f||||||||||||||2017-10-10 22:10:22.896176|2017-10-10 22:10:22.896176
NCT02783534|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-23|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy Study of Acupuncture in the Prevention of Primary Dysmenorrhea|Clinical Efficacy of Acupuncture in the Prevention of Primary Dysmenorrhea: A Randomized Sham-controlled Trial|Not yet recruiting||N/A|300|Anticipated|Huazhong University of Science and Technology||3|||f||||t||||||||Undecided||2017-10-10 22:10:23.022466|2017-10-10 22:10:23.022466
NCT02783521|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-25|||May 2016||2016-05-01|May 2016|2016-05-01||||June 2017|Anticipated|2017-06-01||Interventional|||Gender- and Culturally-Sensitive Weight Loss Intervention for Hispanic Males|Feasibility of a Gender- and Culturally-Sensitive Weight Loss Intervention for Hispanic Males|Recruiting||Phase 1|48|Anticipated|University of Arizona||2|||f||||f||||||||No||2017-10-10 22:10:23.174229|2017-10-10 22:10:23.174229
NCT02783508|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-09|||August 2016||2016-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Pethidine Versus Nitrous Oxide for Pain Relief During Labor|Pethidine Versus Nitrous Oxide for Pain Relief During Labor Among Multiparous. A Randomized Controlled Trial|Recruiting||N/A|214|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-10 22:10:23.322498|2017-10-10 22:10:23.322498
NCT02783495|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2017-06-26|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients|Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients|Recruiting||N/A|20|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 22:10:23.485|2017-10-10 22:10:23.485
NCT02783482|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-12-13|||June 2016||2016-06-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Interventional|||Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency|An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency|Recruiting||Phase 3|50|Anticipated|Green Cross Corporation||1|||f||||t||||||||No||2017-10-10 22:10:23.598676|2017-10-10 22:10:23.598676
NCT02783469|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-05-01|||May 2016||2016-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|April 2018|Anticipated|2018-04-01||Observational|GoDARTS||Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)|Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)|Recruiting||N/A|2000|Anticipated|University of Dundee|||2||f||||f||||||Samples With DNA|"     Whole blood for DNA/RNA Serum for biomarkers Urine for microalbumin, metabolites and proteins   "|Yes||2017-10-10 22:10:23.75841|2017-10-10 22:10:23.75841
NCT02783456|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-03-27|||March 2016||2016-03-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|LÄRM||The Influence of Aircraft Noise Exposure on Renal Hemodynamic in Healthy Individuals|The Influence of Aircraft Noise Exposure on Renal Hemodynamic in Healthy Individuals|Recruiting||N/A|88|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||No||2017-10-10 22:10:23.895368|2017-10-10 22:10:23.895368
NCT02783443|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-23|||June 2016||2016-06-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Observational|||Effect General and Regional Anesthesia on Glycocalyx|Effect General and Regional Anesthesia on Glycocalyx|Enrolling by invitation||N/A|60|Anticipated|University Hospital Hradec Kralove|||2||f||||f||||||||Yes|On request if privacy guaranteed|2017-10-10 22:10:23.997042|2017-10-10 22:10:23.997042
NCT02783430|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-05-18|||September 8, 2016|Actual|2016-09-08|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|KETAPAL||Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care|Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care|Recruiting||Phase 2/Phase 3|80|Anticipated|University Hospital, Lille||2|||f||||t||||||||Undecided|Undecided yet|2017-10-10 22:10:24.090711|2017-10-10 22:10:24.090711
NCT02783417|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-23|||August 2015||2015-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Strength Training With Vascular Occlusion in Patients Harboring With HIV/Aids|Impact of Strength Training With Vascular Occlusion on the Syndrome Lipodystrophy in Patients Harboring With HIV/Aids|Recruiting||Phase 1|36|Anticipated|University of Sao Paulo||3|||f||||t||||||||Undecided||2017-10-10 22:10:24.270778|2017-10-10 22:10:24.270778
NCT02783404|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2017-03-15|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures|An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following|Recruiting||Phase 4|150|Anticipated|University of Santiago de Compostela||3|||f||||f|t|f|||f|||Undecided||2017-10-10 22:10:24.358245|2017-10-10 22:10:24.358245
NCT02783391|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-17|||September 2015||2015-09-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|June 2021|Anticipated|2021-06-01||Interventional|BRAINSPEAK||Pre and Per-operative Electrophysiological Cartography of Speech Area With Cortical Electrode Matrices||Recruiting||N/A|15|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 22:10:24.471803|2017-10-10 22:10:24.471803
NCT02783378|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-25|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||48 Hours Esophagal pH-monitoring With and Without Gaviscon|48 Hoursesophagal pH-monitoring With and Without Gaviscon|Not yet recruiting||N/A|25|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f||||||||Undecided||2017-10-10 22:10:24.548249|2017-10-10 22:10:24.548249
NCT02783365|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-06-08|||July 2016||2016-07-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Improving the Management of Chronic Pain in Primary Care|Improving the Management of Chronic Pain in Primary Care|Recruiting||N/A|270|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||Yes|We will post de-identified data on an open-access website when the study is completed.|2017-10-10 22:10:24.629491|2017-10-10 22:10:24.629491
NCT02783352|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-10|||February 2016||2016-02-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Microfragmented Lipoaspirate Tissue in Arthroscopic Rotator Cuff Repair|Efficacy of Microfragmented Lipoaspirate Tissue in Arthroscopic Rotator Cuff Repairs: a Randomized Controlled Study|Recruiting||N/A|52|Anticipated|University of Milan||2|||f||||f||||||||No||2017-10-10 22:10:24.711342|2017-10-10 22:10:24.711342
NCT02783339|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-10-04|||September 2016||2016-09-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01|16 Months|Observational [Patient Registry]|ATLAS EU PMCF||Neuroform Atlas Stent for Intracranial Aneurysm Treatment|Evaluation of Safety and Performance of the Neuroform AtlasTM Stent System for Intracranial Aneurysm Treatment - Post Market Clinical Follow-up|Recruiting||N/A|105|Anticipated|Stryker Neurovascular|||1||f||||f||||||||||2017-10-10 22:10:24.798423|2017-10-10 22:10:24.798423
NCT02783326|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-05-23|||July 2015||2015-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Rehabilitation Cardiorrespiratory Improvement in Patients With Chronic Disease Obstructive Pulmonary|Effects of a Protocol Of Rehabilitation in Patients With Chronic Disease Obstructive Pulmonary (COPD) Improvement Modulation Autonomic Heart Rate, Oxidative Stress, Quality of Life and Function|Recruiting||N/A|26|Anticipated|Universidade Metodista de Piracicaba||2|||f||||t||||||||No||2017-10-10 22:10:25.017963|2017-10-10 22:10:25.017963
NCT02783313|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-01-10|||November 2010||2010-11-01|January 2017|2017-01-01||||November 2016|Actual|2016-11-01||Interventional|PREPAReS||Pathogen Reduction Evaluation & Predictive Analytical Rating Score|Clinical Effectiveness of Standard Versus Pathogen-reduced Buffy Coat-derived Platelet Concentrates in Plasma in Hemato-oncological Patients.|Completed||N/A|567|Actual|Sanquin Research & Blood Bank Divisions||2|||f||||t||||||||Undecided||2017-10-10 22:10:25.132479|2017-10-10 22:10:25.132479
NCT02783300|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-07|||August 30, 2016|Actual|2016-08-30|September 2017|2017-09-01|September 12, 2019|Anticipated|2019-09-12|September 12, 2019|Anticipated|2019-09-12||Interventional|||Dose Escalation Study of GSK3326595 in Subjects With Solid Tumors and Non-Hodgkin's Lymphoma|A Phase I, Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Subjects With Solid Tumors and Non-Hodgkin's Lymphoma|Recruiting||Phase 1|208|Anticipated|GlaxoSmithKline||6|||f||||f||||||||||2017-10-10 22:10:25.246506|2017-10-10 22:10:25.246506
NCT02783287|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-05-23|||January 2012||2012-01-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Impact of Text Messaging on Medication Adherence and Exercise Regimen Among Post-myocardial Infarction Patients|The Impact of Text Messaging on Medication Adherence and Exercise Regimen Among Post-myocardial Infarction Patients|Completed||N/A|84|Actual|Brigham and Women's Hospital||4|||f||||f||||||||No||2017-10-10 22:10:25.402965|2017-10-10 22:10:25.402965
NCT02783274|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-08-14|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|Actis14014||Actis Total Hip System 2 Year Follow-up|Actis Total Hip System 2 Year Follow-up|Recruiting||N/A|255|Anticipated|DePuy Orthopaedics||1|||f||||f||||||||||2017-10-10 22:10:25.478569|2017-10-10 22:10:25.478569
NCT02783261|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-02-12|||June 2014||2014-06-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Prospective Post Y90 Liver Hypertrophy|Prospective Study of Early Contra-lateral Liver Lobar Hypertrophy After Unilobar Y-90 Selective Internal Radiation Therapy (SIRT) in Patients With Hepatocellular Carcinoma (HCC)|Active, not recruiting||N/A|25|Actual|Singapore General Hospital|||1||f||||f||||||||||2017-10-10 22:10:25.586067|2017-10-10 22:10:25.586067
NCT02783248|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-25|||June 2016||2016-06-01|May 2016|2016-05-01|December 2022|Anticipated|2022-12-01|June 2022|Anticipated|2022-06-01||Observational|CALCIMIT||French National Observatory of Percutaneous Mitral Commissurotomy|French National Observatory of Percutaneous Mitral Commissurotomy (PMC) Immediate Score, Scanner, Late Results|Not yet recruiting||N/A|500|Anticipated|French Cardiology Society|||1||f||||f||||||||No||2017-10-10 22:10:25.659329|2017-10-10 22:10:25.659329
NCT02783235|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-25|||February 2017||2017-02-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Cervical Cancer Screening : Video Based Tutorials for ANMs/ASHAs/PHWs|Cervical Cancer Screening: Video-based Tutorials for Skills Development of ANMs/ASHAs/PHWs|Not yet recruiting||N/A|50|Anticipated|Tata Memorial Hospital||1|||f||||t||||||||Yes|Data entry will be done in IIT Bombay and in the Department of Preventive Oncology, Tata Memorial Hospital, using SPSS version 18.|2017-10-10 22:10:25.73134|2017-10-10 22:10:25.73134
NCT02783222|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-07-31|||November 2012||2012-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|EFFECT||EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer|EFFECT: A Randomized Phase II Study to Evaluate the EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly Patients With advanCed breasT Cancer|Active, not recruiting||Phase 2|160|Actual|Fondazione Sandro Pitigliani||2|||f||||f||||||||||2017-10-10 22:10:25.806162|2017-10-10 22:10:25.806162
NCT02783209|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-02-06|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|VITRECAT||Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient|Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient|Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 22:10:25.915964|2017-10-10 22:10:25.915964
NCT02783196|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-25|||July 2016||2016-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|LIR-CG||Effect of Liraglutide on Clock Genes|Advantages of Liraglutide Mediated Through Its Effect on Clock Gene mRNA Expression|Not yet recruiting||N/A|14|Anticipated|Tel Aviv University||2|||f||||f||||||||No||2017-10-10 22:10:25.996171|2017-10-10 22:10:25.996171
NCT02783183|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-11-08|||June 2016||2016-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin|A Open-label, Radomized, Crossover Clinical Trial to Assess the Pharmacokinetics of Pregabalin CR After Multiple Dosing as Compared to Pregabalin IR in Healthy Male Volunteers|Completed||Phase 1|32|Actual|Yuhan Corporation||2|||f||||f||||||||No||2017-10-10 22:10:26.089074|2017-10-10 22:10:26.089074
NCT02783170|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-12-09|||September 2016||2016-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|Tdap/IIV||Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women|A Prospective, Randomized, Open-label Clinical Trial to Assess the Safety and Immunogenicity of Simultaneous vs Sequential Administration of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and Inactivated Influenza Vaccine in Pregnant Women - Pilot|Recruiting||Phase 4|50|Anticipated|Duke University||2|||f||||f||||||||Undecided||2017-10-10 22:10:26.171385|2017-10-10 22:10:26.171385
NCT02783157|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-03-30|||May 2016||2016-05-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|TON-POINTS||Transcutaneous Autonomic Modulation in Thoracic Surgery|Transcutaneous Autonomic Modulation to Prevent Organ Injury After Thoracic Surgery|Recruiting||N/A|200|Anticipated|Duke University||2|||f||||t|f|f||||||Undecided||2017-10-10 22:10:26.288245|2017-10-10 22:10:26.288245
NCT02783144|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-08-04|||May 2015||2015-05-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Dexamethasone Added in Ultrasound-guided Transversus Abdominis Plain Block for Postoperative Analgesia|Dexamethasone Added to Levobupivacaine in Ultrasound-guided Tranversus Abdominis Plain Block Increased the Duration of Postoperative Analgesia After Laparoscopic Cholecystectomy|Completed||Phase 3|120|Actual|San Salvatore Hospital of L'Aquila||3|||f||||t||||||||No||2017-10-10 22:10:27.994594|2017-10-10 22:10:27.994594
NCT02783131|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-25|||August 2014||2014-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Does Mednav, a Medical Navigation System, Aid Non-technical and Technical Skills in the Simulated Obstetric Emergency?||Completed||N/A|266|Actual|Chelsea and Westminster NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:10:28.074273|2017-10-10 22:10:28.074273
NCT02782715|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||PII SBRT + Microwave Ablation in Renal Cell Carcinoma|Phase IA/IB Trial of Real-Time MRI-Guided Stereotactic Body Radiation Therapy and Microwave Ablation for Non-Operable Renal Cell Carcinoma|Recruiting||Phase 1/Phase 2|28|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-10 22:10:31.307761|2017-10-10 22:10:31.307761
NCT02783118|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-07-12|||May 2016||2016-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Using a Smartphone App to Reduce Cognitive Vulnerability and Mild Depressive Symptoms|Using a Smartphone App to Reduce Cognitive Vulnerability and Mild Depressive Symptoms: An Exploratory Study Protocol for a Randomized Controlled Trial|Active, not recruiting||N/A|255|Actual|Babes-Bolyai University||4|||f||||f||||||||||2017-10-10 22:10:28.169096|2017-10-10 22:10:28.169096
NCT02783105|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|June 2020|Anticipated|2020-06-01||Interventional|MUSIC-TCNV||Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury|Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury: the Prospective Randomized MUSIC-TCNV Trial.|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||No||2017-10-10 22:10:28.257565|2017-10-10 22:10:28.257565
NCT02783092|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-09-09|||November 2016||2016-11-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||A Double Blind, Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epileptic Crisis in Children and Adolescents||Not yet recruiting||Phase 3|126|Anticipated|University of Sao Paulo||2|||f||||||||||||||2017-10-10 22:10:28.371112|2017-10-10 22:10:28.371112
NCT02783079|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-05-25|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2018|Anticipated|2018-05-01||Interventional|||Insomnia Interventions in Cancer Survivors|Insomnia Interventions in Cancer Survivors|Not yet recruiting||N/A|210|Anticipated|The Cooper Health System||2|||f||||f||||||||||2017-10-10 22:10:28.457277|2017-10-10 22:10:28.457277
NCT02783066|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-11|||January 2016||2016-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Novel Offloading for Diabetic Foot Ulcers With PulseFlow: A Prospective Study||Recruiting||Phase 2|15|Anticipated|Baylor College of Medicine||1|||f||||f||||||||||2017-10-10 22:10:28.544599|2017-10-10 22:10:28.544599
NCT02783053|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-10-07|||October 2015||2015-10-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|McTOM||Metformin and Core Temperature in Obese and Lean Males|Metformin and Core Temperature in Obese and Lean Males|Completed||N/A|18|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 22:10:28.630469|2017-10-10 22:10:28.630469
NCT02783040|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-05-23|||September 2015||2015-09-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin|A Study to Investigate the Effects of Multiple Doses of BI 425809 on the Single Dose Pharmacokinetics of Cytochrome P450 Substrates (Midazolam, Warfarin and Omeprazole) and a P Glycoprotein Substrate (Digoxin) Administered Orally in an Open-label, One-sequence Trial in Healthy Male Subjects|Completed||Phase 1|13|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 22:10:28.700989|2017-10-10 22:10:28.700989
NCT02783027|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-08-04|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|August 2017|Actual|2017-08-01||Interventional|SleepTrackTXT2||Air-Medical Sleep Study|Air-Medical Sleep Study: Phase 2|Active, not recruiting||N/A|100|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 22:10:28.867763|2017-10-10 22:10:28.867763
NCT02783014|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-07-25|||June 2016||2016-06-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|May 2017|Actual|2017-05-01||Observational|||Investigating Central Mechanisms of Overactive Bladder in Adults With Parkinson's Disease|Case-control Study Investigating Central Mechanisms of Overactive Bladder in Adults With Parkinson's Disease and Overactive Bladder and Adults With Parkinson's Disease Only|Active, not recruiting||N/A|20|Anticipated|EvergreenHealth|||1||f||||f||||||||||2017-10-10 22:10:28.955836|2017-10-10 22:10:28.955836
NCT02782988|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-09-06|||May 2016||2016-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|INFECSMELL||Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV|Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital Cytomegalovirus Infection|Recruiting||N/A|120|Anticipated|Institut Pasteur|||3||f||||f||||||||||2017-10-10 22:10:29.044746|2017-10-10 22:10:29.044746
NCT02782975|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-01-12|||May 2016||2016-05-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants|A Randomized, Open-Label, Parallel-Arm Study to Assess the Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab (BIIB037) in Healthy Subjects Compared to a Single, Weight-Based Intravenous Dose|Completed||Phase 1|28|Actual|Biogen||2|||f||||f||||||||||2017-10-10 22:10:29.134412|2017-10-10 22:10:29.134412
NCT02782962|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-06-06|||December 2014||2014-12-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Observational|STANDING||Accuracy of a Diagnostic Algorithm for the Differential Diagnosis of Vertigo in the ED: the STANDING.|Accuracy of a Diagnostic Algorithm for the Differential Diagnosis of Vertigo in the Emergency Department: the STANDING.|Completed||N/A|350|Actual|Azienda Ospedaliero-Universitaria Careggi|||1||f||||f||||||||No||2017-10-10 22:10:29.236701|2017-10-10 22:10:29.236701
NCT02782949|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-25|2017-09-06|||April 4, 2017|Actual|2017-04-04|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia|Randomized, Double-blind, Placebo-Controlled Trial of Meriva® (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis|Recruiting||Phase 2|60|Anticipated|National Cancer Institute (NCI)||2|||f||||t|t|f||||||||2017-10-10 22:10:29.319556|2017-10-10 22:10:29.319556
NCT02782936|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-09-27|||June 2015||2015-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Gas Mask: the Effects on Respiration!|Impact of Gas Masks on Index of Efforts and Breathing Pattern|Completed||N/A|15|Actual|Laval University||3|||f||||f||||||||Undecided||2017-10-10 22:10:29.441635|2017-10-10 22:10:29.441635
NCT02782923|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-01-06|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Driving After Cervical Spine Surgery|Driving After Cervical Spine Surgery|Recruiting||N/A|150|Anticipated|New York University School of Medicine||6|||f||||f||||||||||2017-10-10 22:10:29.546183|2017-10-10 22:10:29.546183
NCT02782910|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-05-20|||August 2016||2016-08-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|BipoLife_A3||Smartphone-based Ambulatory Assessment of Early Warning Signs|Smartphone-based Ambulatory Assessment of Early Warning Signs, Including Personalized Real-time Data-driven Therapeutic Interventions, in the Long-term Treatment of Bipolar Disorders.|Not yet recruiting||N/A|180|Anticipated|Technische Universität Dresden||2|||f||||f||||||||||2017-10-10 22:10:29.669939|2017-10-10 22:10:29.669939
NCT02782897|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-24|||June 2016||2016-06-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravenous Immunoglobulin for Acute Intracranial Hemorrhage|A Pilot Study of Safety and Efficacy of Intravenous Immunoglobulin Therapy in Patients With Acute Intracranial Hemorrhage|Not yet recruiting||Phase 2|60|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||Undecided||2017-10-10 22:10:29.767694|2017-10-10 22:10:29.767694
NCT02782884|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-05-26|||June 2016||2016-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|GSopioids||A Prospective Study of Post-operative Opioid Use in General Surgery Patients|A Prospective Study of Post-operative Opioid Use in General Surgical Patients|Not yet recruiting||N/A|500|Anticipated|Dartmouth-Hitchcock Medical Center|||2||f||||t||||||||No||2017-10-10 22:10:29.874502|2017-10-10 22:10:29.874502
NCT02782871|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-05-24|||June 2016||2016-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A RCT to Compare the Pneupac VR1 Portable Ventilator and Manual Ventilation Via a Mapleson C- Circuit During the Intra-hospital Transfers of Intubated Patients|A Randomised Control Trial to Compare the Pneupac VR1 Portable Ventilator and Manual Ven-tilation Via a Mapleson C- Circuit During the Intra-hospital Transfers of Intubated Patients|Not yet recruiting||N/A|63|Anticipated|Brighton and Sussex University Hospitals NHS Trust||2|||f||||f||||||||No||2017-10-10 22:10:29.949905|2017-10-10 22:10:29.949905
NCT02782858|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-06-06|||April 2016||2016-04-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|CHANGE-MS||Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS|An International, Double-blind, Randomised, Placebo-controlled Phase IIb Trial to Assess the Efficacy, Safety, and Pharmacokinetics of GNbAC1 in Patients With Relapsing Remitting Multiple Sclerosis|Active, not recruiting||Phase 2|260|Anticipated|GeNeuro SA||4|||f||||t||||||||||2017-10-10 22:10:30.025721|2017-10-10 22:10:30.025721
NCT02782845|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-11-18|||June 2006||2006-06-01|September 2016|2016-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)|Expanded Access Program of Pegfilgrastim in Patients With Non-Hodgkin Lymphoma (NHL)|Completed||Phase 4|53|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:10:30.133647|2017-10-10 22:10:30.133647
NCT02782832|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Observational|||No Need for Neuromuscular Blockade in Daycase Laparoscopic Surgery|No Need for Neuromuscular Blockade in Day Case Standardised Laparoscopic Surgery. A Consecutive Retrospective Study|Not yet recruiting||N/A|1245|Anticipated|Hvidovre University Hospital|||1||f||||t||||||||No||2017-10-10 22:10:30.243088|2017-10-10 22:10:30.243088
NCT02782819|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-24|||September 2014||2014-09-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation|A Randomized Controlled Trial of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation|Recruiting||N/A|320|Anticipated|Mahidol University||2|||f||||t||||||||No||2017-10-10 22:10:30.316106|2017-10-10 22:10:30.316106
NCT02782806|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-19|||April 11, 2016||2016-04-11||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:10:30.430075|2017-10-10 22:10:30.430075
NCT02782793|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-15|||August 2014||2014-08-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|5 Years|Observational [Patient Registry]|||Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps|"Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: You Can Look But You Can't Touch"|Completed||N/A|500|Actual|Northwestern University|||1||f||||f||||||||No||2017-10-10 22:10:30.467203|2017-10-10 22:10:30.467203
NCT02782780|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-05-16|||October 24, 2016|Actual|2016-10-24|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|January 30, 2019|Anticipated|2019-01-30||Interventional|CBTi GWI||Cognitive Behavioral Therapy for Insomnia for Gulf War Illness|Pilot Test of Telephone-Delivered Cognitive Behavioral Therapy for Insomnia for Veterans With Gulf War Illness|Recruiting||Phase 2|80|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Undecided||2017-10-10 22:10:30.605596|2017-10-10 22:10:30.605596
NCT02782767|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-02-05|||May 2016||2016-05-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Comparison of Continuous Wound Catheter Infusion Versus Continuous Epidural Infusion in Abdominal Surgery|Comparison of Continuous Wound Catheter Infusion Versus Continuous Epidural Infusion in Abdominal Surgery|Completed||N/A|40|Actual|Postgraduate Institute of Medical Education and Research, Chandigarh||2|||f||||f||||||||Undecided||2017-10-10 22:10:30.784852|2017-10-10 22:10:30.784852
NCT02782754|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-23|||January 2013||2013-01-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma|Treatment of Intracranial Germinoma With Chemotherapy Prior to Reduced Dose and Volume of Radiotherapy|Recruiting||Phase 2|40|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:10:30.869985|2017-10-10 22:10:30.869985
NCT02782728|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-22|||June 2016||2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Interventional|TIPS||Trauma-informed Personalized Scripts (TIPS) for Relationship Abuse|Trauma-informed Personalized Scripts (TIPS) to Address Relationship Abuse and Reproductive Coercion in Family Planning Clinics|Active, not recruiting||N/A|240|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:10:31.20347|2017-10-10 22:10:31.20347
NCT02782702|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-20|||September 2015||2015-09-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|ToxHD||Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds.|Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds. Toxin Hailey Darier|Active, not recruiting||Phase 1|30|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||Undecided||2017-10-10 22:10:31.414803|2017-10-10 22:10:31.414803
NCT02782689|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-12-28|||June 2014||2014-06-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|December 2016|Actual|2016-12-01||Interventional|COMPULCE||Clinical Study to Assess Efficacy and Safety of a New Compression System in the Management of Venous Leg Ulcers|Evaluation of Efficacy and Safety of the 2-layer Compression System Kit Biflex® Versus the 4-layer Compression System PROFORE® in the Management of Venous Leg Ulcers (Stage C6).|Terminated||N/A|92|Actual|Thuasne||2||difficulties in enrolling patients|f||||f||||||||||2017-10-10 22:10:31.511357|2017-10-10 22:10:31.511357
NCT02782676|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-05-23|||June 21, 2016||2016-06-21||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:10:31.592677|2017-10-10 22:10:31.592677
NCT02782663|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2017-08-15|||May 18, 2016||2016-05-18|August 2017|2017-08-01|December 28, 2022|Anticipated|2022-12-28|December 28, 2022|Anticipated|2022-12-28||Interventional|||A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT-494 in Subjects With Crohn's Disease|A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT-494 in Subjects With Crohn's Disease|Enrolling by invitation||Phase 2|210|Anticipated|AbbVie||2|||f||||t||||||||||2017-10-10 22:10:31.644546|2017-10-10 22:10:31.644546
NCT02782650|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-24|||July 2012||2012-07-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|PreCo-profs||Prenatal Counseling in Extreme Prematurity: Professionals' View|Prenatal Counseling in Extreme Prematurity: Professionals' View|Completed||N/A|122|Actual|Radboud University|||1||f||||f||||||||Undecided|available upon request|2017-10-10 22:10:31.878097|2017-10-10 22:10:31.878097
NCT02782637|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-24|||March 2015||2015-03-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|PreCo-parents||Prenatal Counseling in Extreme Prematurity: Parents' View|Prenatal Counseling in Extreme Prematurity: Parents' View|Completed||N/A|63|Actual|Radboud University|||1||f||||t||||||||||2017-10-10 22:10:31.968996|2017-10-10 22:10:31.968996
NCT02782624|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-23|2016-05-23|||September 2009||2009-09-01|May 2016|2016-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Relative Bioavailability of BI 10773 Administered Twice Daily Compared BI 10773 Given Once Daily After Multiple Oral Doses in Healthy Male and Female Volunteers|Relative Bioavailability of 5 mg BI 10773 Administered Twice Daily Compared to 10 mg BI 10773 Given Once Daily After Multiple Oral Doses in Healthy Male and Female Volunteers (an Open-label, Randomised, Crossover, Clinical Phase I Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:10:32.050053|2017-10-10 22:10:32.050053
NCT02782611|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-12-12|||April 2016||2016-04-01|December 2016|2016-12-01||||June 2017|Anticipated|2017-06-01||Interventional|ENHANCE||Enduring Happiness and Continued Self-Enhancement|Enduring Happiness and Continued Self-Enhancement|Active, not recruiting||N/A|154|Actual|University of Virginia||2|||f||||f||||||||Yes||2017-10-10 22:10:32.134012|2017-10-10 22:10:32.134012
NCT02782598|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-13|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy With MultiPoint Pacing|The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy With MultiPoint Pacing|Enrolling by invitation||N/A|20|Anticipated|St. Jude Medical||1|||f||||f|f|f||||||||2017-10-10 22:10:32.224843|2017-10-10 22:10:32.224843
NCT02782585|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-20|||July 2010||2010-07-01|May 2016|2016-05-01|June 2011|Actual|2011-06-01|October 2010|Actual|2010-10-01||Interventional|||Manual Therapy Techniques on Cervical Spine and Psychological Interaction|Hypoalgesic Effects of Three Different Manual Therapy Techniques on Cervical Spine and Psychological Interaction: Randomized Clinical Trial|Completed||N/A|75|Actual|Fondazione Don Carlo Gnocchi Onlus||3|||f||||f||||||||No||2017-10-10 22:10:32.291376|2017-10-10 22:10:32.291376
NCT02782572|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-20|||July 2010||2010-07-01|July 2011|2011-07-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Safety of Aerobic Exercise in Acute Heart Failure|Safety and Efficacy of Exercise Training in Patients With Acute Heart Failure: a Pilot Study|Completed||N/A|29|Actual|Instituto Dante Pazzanese de Cardiologia||3|||f||||f||||||||No||2017-10-10 22:10:32.370438|2017-10-10 22:10:32.370438
NCT02782559|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-05-24|||July 2016||2016-07-01|May 2016|2016-05-01||||July 2017|Anticipated|2017-07-01||Interventional|SIL||Efficacy of Sildenafil in Preterm Preeclampsia|Randomized Double-Blind, Placebo Controlled Evaluation of the Efficacy of Sildenafil Versus Placebo in Preterm Preeclampsia|Not yet recruiting||Phase 2/Phase 3|44|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Yes||2017-10-10 22:10:32.437219|2017-10-10 22:10:32.437219
NCT02782546|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2017-10-03|||January 30, 2017|Actual|2017-01-30|October 2017|2017-10-01|February 28, 2022|Anticipated|2022-02-28|November 30, 2020|Anticipated|2020-11-30||Interventional|||Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation|A Phase II Study of Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation|Recruiting||Phase 2|60|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 22:10:32.504287|2017-10-10 22:10:32.504287
NCT02782533|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-17|||November 2008||2008-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|DBS V3||DBS of the Third Ventricle for Cluster Headache and Obesity||Recruiting||N/A|15|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 22:10:32.641851|2017-10-10 22:10:32.641851
NCT02782520|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-10-06|||June 2016||2016-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SUCCESS||Comparison of the Effects of an Hypertonic Solution With Ringer Lactate on Right Ventricular Function Following Cardiac Surgery|Comparison of the Effects of an Hypertonic Solution With Ringer Lactate on Right Ventricular Function Following Cardiac Surgery|Recruiting||Phase 3|30|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||No||2017-10-10 22:10:32.720823|2017-10-10 22:10:32.720823
NCT02782507|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-05-24|||January 2012||2012-01-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Cognitive Therapy for Distressing Visual Hallucinations: A Pilot Study|Cognitive Therapy for Distressing Visual Hallucinations: A Pilot Study|Completed||N/A|7|Actual|Newcastle University|||1||f||||f||||||||Yes|The findings are shared with the individual participants and an anonymised version of the material is to be submitted for publication. The participants have consented to the sharing of anonymised material in this format.|2017-10-10 22:10:32.834427|2017-10-10 22:10:32.834427
NCT02782494|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-12-13|||May 2016||2016-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Comparing Consistency of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold for Latent Tuberculosis in Dialysis Population|Comparing Consistency of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold for Latent Tuberculosis in Dialysis Population|Recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     blood   "|Undecided||2017-10-10 22:10:33.016285|2017-10-10 22:10:33.016285
NCT02782481|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-22|2016-09-21|||August 2016||2016-08-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations|A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel Group Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations|Recruiting||Phase 3|150|Anticipated|NeuroDerm Ltd.||2|||f||||t||||||||||2017-10-10 22:10:33.099795|2017-10-10 22:10:33.099795
NCT02782468|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-21|||May 30, 2016|Actual|2016-05-30|September 2017|2017-09-01|September 20, 2019|Anticipated|2019-09-20|September 20, 2019|Anticipated|2019-09-20||Interventional|||A Study of Pevonedistat in Adult East Asian Participants|A Phase 1/1b, Open-label Study of Pevonedistat (MLN4924, TAK-924) as Single Agent and in Combination With Azacitidine in Adult East Asian Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)|Recruiting||Phase 1|37|Anticipated|Takeda||4|||f||||t||||||||||2017-10-10 22:10:33.211513|2017-10-10 22:10:33.211513
NCT02782455|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-01-26|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease|Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease a Randomised Triple Blind Controlled Trial|Recruiting||Phase 4|100|Anticipated|Services Hospital, Lahore||2|||f||||t|f|f||||||Undecided||2017-10-10 22:10:33.340399|2017-10-10 22:10:33.340399
NCT02782442|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-01-30|||September 2016||2016-09-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|ROAM||"Cognitive Training Delivered Remotely to Individuals With Psychosis"|"Cognitive Training Delivered Remotely to Individuals With Psychosis"|Recruiting||N/A|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||Yes||2017-10-10 22:10:33.439544|2017-10-10 22:10:33.439544
NCT02782429|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-24|||April 2016||2016-04-01|May 2016|2016-05-01||||May 2017|Anticipated|2017-05-01||Interventional|KeCoDy||The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery|The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery|Recruiting||Phase 4|50|Anticipated|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||||||||||||2017-10-10 22:10:33.538354|2017-10-10 22:10:33.538354
NCT02782416|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-12-13|||January 2014||2014-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation|A Randomized Study for Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Patients Preparing for Kidney Transplantation|Recruiting||N/A|800|Anticipated|National Taiwan University Hospital||4|||f||||f||||||||No||2017-10-10 22:10:33.658585|2017-10-10 22:10:33.658585
NCT02782403|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-15|||March 20, 2017|Actual|2017-03-20|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Axitinib and Bosutinib for Patients With Chronic Myeloid Leukemia in Chronic, Accelerated or Blastic Phases|Alternating or Combined Therapy With Axitinib and Bosutinib for Patients With Chronic Myeloid Leukemia in Chronic, Accelerated or Blastic Phases|Recruiting||Phase 1/Phase 2|52|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 22:10:33.74934|2017-10-10 22:10:33.74934
NCT02782390|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-10-04|||June 2016|Actual|2016-06-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|SLM2078||Efficacy of Hall Technique in Atypical Lesions on Primary Teeth|Efficacy of Hall Technique in Atypical Lesions on Primary Teeth: Randomized Clinical Trial|Recruiting||N/A|464|Anticipated|Faculty Sao Leopoldo Mandic Campinas||2|||f||||f||||||||||2017-10-10 22:10:33.868282|2017-10-10 22:10:33.868282
NCT02782377|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-05-20|||February 2016||2016-02-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Evaluation of the Rectal Reflex Using Anal Acoustic Reflectometry|Evaluation of the Rectal Reflex Using Anal Acoustic Reflectometry|Recruiting||N/A|19|Anticipated|University Hospital of South Manchester NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 22:10:33.989627|2017-10-10 22:10:33.989627
NCT02782364|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-20|||November 2015||2015-11-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Evaluation of the Fast Fill Technique for Anal Acoustic Reflectometry (AAR) in the Incontinent Anal Sphincter|Evaluation of the Fast Fill Technique for Anal Acoustic Reflectometry (AAR) in the Incontinent Anal Sphincter|Recruiting||N/A|32|Anticipated|University Hospital of South Manchester NHS Foundation Trust|||1||f||||f||||||||No|individual patient data will not add any further information to the overall data|2017-10-10 22:10:34.08228|2017-10-10 22:10:34.08228
NCT02782351|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-08-03|||May 2016||2016-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Humanized CAR-T Therapy for Treatment of B Cell Malignancy|Humanized CAR-T Therapy for Treatment of Recurrent or Refractory B Cell Malignancy by Targeting CD19|Recruiting||Phase 1/Phase 2|50|Anticipated|Xuzhou Medical University||1|||f||||f||||||||||2017-10-10 22:10:34.187366|2017-10-10 22:10:34.187366
NCT02781779|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-01-05|||December 2015||2015-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant|Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant|Recruiting||Phase 4|200|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 22:10:39.733245|2017-10-10 22:10:39.733245
NCT02782338|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-29|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin|The Effect of Voltaren-ophtha 0.1% (Diclofenac Sodium 0.1%) Eye Drops After Cataract Surgery on INR Levels (International Normalized Ratio) in Patients Taking Warfarin|Not yet recruiting||N/A|100|Anticipated|Wolfson Medical Center|||1||f||||f||||||||Undecided||2017-10-10 22:10:34.277944|2017-10-10 22:10:34.277944
NCT02782325|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-01|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|January 1, 2020|Anticipated|2020-01-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)|Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)|Recruiting||Phase 1/Phase 2|20|Anticipated|University of North Carolina, Chapel Hill||3|||f||||t|t|f||||||No|The final results of the trial will be posted on clinical trials.gov. No individual patient data will be posted.|2017-10-10 22:10:34.351943|2017-10-10 22:10:34.351943
NCT02782312|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-25|||June 2011||2011-06-01|May 2016|2016-05-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Interventional|||Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis|Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis With Airway Limitation: a Prospective Study|Completed||Phase 4|120|Actual|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||||||||||||2017-10-10 22:10:34.456853|2017-10-10 22:10:34.456853
NCT02782299|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-05-24|||December 2015||2015-12-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Shared Decision Making in Older Adults With Distal Radius Fractures|Shared Decision Making in Older Adults With Distal Radius Fractures|Recruiting||N/A|88|Anticipated|Washington University School of Medicine||2|||f||||t||||||||No||2017-10-10 22:10:34.549788|2017-10-10 22:10:34.549788
NCT02782286|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-22|||May 2016||2016-05-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Morphine Versus Ketorolac in Low Back Pain|The Analgesic Effects of Morphine Versus Ketorolac in Low Back Pain|Not yet recruiting||Phase 4|100|Anticipated|Bucharest Emergency Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:10:34.643537|2017-10-10 22:10:34.643537
NCT02782273|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Morphine Versus Ketorolac in Renal Colic|The Analgesic Effects of Morphine Versus Ketorolac in Renal Colic|Not yet recruiting||Phase 4|100|Anticipated|Bucharest Emergency Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:10:34.724738|2017-10-10 22:10:34.724738
NCT02782260|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-24|||July 2016||2016-07-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium||Not yet recruiting||Phase 2|40|Anticipated|Ariel University||2|||f||||f||||||||Undecided||2017-10-10 22:10:34.819397|2017-10-10 22:10:34.819397
NCT02782247|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-09-29|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Dynamic Liver Tests in Liver Disease|Changes in Dynamic Liver Function Tests in Patients With Chronic Viral Hepatitis Undergoing Antiviral Therapy|Recruiting||N/A|180|Anticipated|Queen Mary University of London||3|||f||||f|f|f||||||||2017-10-10 22:10:34.893521|2017-10-10 22:10:34.893521
NCT02782234|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-05-24|||June 2016||2016-06-01|May 2016|2016-05-01||||June 2019|Anticipated|2019-06-01||Interventional|ACMMPDFB||Application Contract Management Mode in Maintaining PD Fluid Balance|Application of Contract Management Mode in Maintaining Body Fluid Balance of Peritoneal Dialysis Patients|Not yet recruiting||N/A|72|Anticipated|The Second Affiliated Hospital of Harbin Medical University||2|||f||||f||||||||No||2017-10-10 22:10:35.023295|2017-10-10 22:10:35.023295
NCT02782221|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-20|||May 2016||2016-05-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Lipolytic Effects of GH in Human Subjects in Vivo|Lipolytic Effects of GH in Human Subjects in Vivo: Molecular Mechanisms and Temporal Patterns|Recruiting||N/A|8|Anticipated|University of Aarhus||2|||f||||f||||||||No||2017-10-10 22:10:35.086055|2017-10-10 22:10:35.086055
NCT02782208|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-20|||May 2016||2016-05-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|March 2017|Anticipated|2017-03-01||Interventional|||Lipolytic Effects of GH in Hypopituitary Patients in Vivo|Lipolytic Effects of GH in Hypopituitary Patients in Vivo: Molecular Mechanisms and Temporal Patterns.|Recruiting||N/A|8|Anticipated|University of Aarhus||4|||f||||f||||||||No||2017-10-10 22:10:35.181418|2017-10-10 22:10:35.181418
NCT02782195|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-05-20|||November 2008||2008-11-01|May 2016|2016-05-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Observational|||Evaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 Diabetes|Validation of the Gut Absorption Rate of Glucose During a Large, Slowly and Rapidly-absorbed Evening Meal in Subjects With Type 1 Diabetes|Completed||N/A|16|Actual|University of Cambridge|||1||f||||f||||||||||2017-10-10 22:10:35.310077|2017-10-10 22:10:35.310077
NCT02782182|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-08-22|||June 28, 2016|Actual|2016-06-28|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study|Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study|Recruiting||N/A|28|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 22:10:35.374679|2017-10-10 22:10:35.374679
NCT02782169|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-01-19|||June 2015||2015-06-01|January 2017|2017-01-01||||March 2017|Anticipated|2017-03-01||Interventional|||Prophylactic Pregabalin to Decrease Pain During Medical Abortion|Prophylactic Pregabalin to Decrease Pain During Medical Abortion: a Randomized Controlled Trial|Active, not recruiting||Phase 4|110|Actual|University of Hawaii||2|||f||||t||||||||||2017-10-10 22:10:35.459138|2017-10-10 22:10:35.459138
NCT02782156|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-07-11|||November 2014||2014-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Observational|||Process Evaluation Standardised Nurse-led Approach for Risk Screening and Decrease of Alcohol Withdrawal in ENT|Evaluation of the Standardised Nurse-led Approach for Risk Screening and Decrease of Alcohol Withdrawal Among Adult Inpatients With Alcohol Dependence in an Ear, Nose, Throat and Jaw Surgery Department|Completed||N/A|89|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-10 22:10:35.535369|2017-10-10 22:10:35.535369
NCT02782143|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-09-12|||November 2015||2015-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Observational|Val_mCAM-ED||"Testing the Validity of the Modified Confusion Assessment Method for the Emergency Department (mCAM-ED)"|"Testing the Validity of the Modified Confusion Assessment Method for the Emergency Department (mCAM-ED) for the Recognition of Delirium in Elderly Patient Admitted to the Emergency Department"|Completed||N/A|289|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-10 22:10:35.610746|2017-10-10 22:10:35.610746
NCT02782130|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-03-14|||June 2015||2015-06-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Epic Allies HIV ART Adherence Intervention|Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men|Active, not recruiting||N/A|146|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 22:10:35.681282|2017-10-10 22:10:35.681282
NCT02782117|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-06-07|||December 5, 2016||2016-12-05||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:10:35.784826|2017-10-10 22:10:35.784826
NCT02782104|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-09-22|||June 9, 2016|Actual|2016-06-09|September 2017|2017-09-01|May 30, 2025|Anticipated|2025-05-30|August 6, 2021|Anticipated|2021-08-06||Interventional|SUSTAIN-3||A Long-term Safety Study of Intranasal Esketamine in Treatment-resistant Depression|An Open-label Long-term Extension Safety Study of Intranasal Esketamine in Treatment-resistant Depression|Recruiting||Phase 3|330|Anticipated|Janssen Research & Development, LLC||1|||f||||t||f||||||||2017-10-10 22:10:35.87725|2017-10-10 22:10:35.87725
NCT02782091|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-20|||May 2016||2016-05-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|VALITEM||Discriminant Validity of the Multiple Errands Test in Schizophrenia|Validation of an Ecological Assessment of Executive Function (Multiple Errands Test) in Patients With Schizophrenia : Study of Discriminant Validity|Not yet recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 22:10:37.096092|2017-10-10 22:10:37.096092
NCT02782078|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-24|||March 6, 2017|Actual|2017-03-06|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|DALARI||Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections|Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections|Recruiting||N/A|30|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t|f|f||||||||2017-10-10 22:10:37.173215|2017-10-10 22:10:37.173215
NCT02782065|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-02|||September 29, 2016|Actual|2016-09-29|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|HASS||Validation of the Hospital Asthma Severity Score (HASS)|Validation Of The Hospital Asthma Severity Score (HASS) In Children Ages 2-18 Years Old|Recruiting||N/A|195|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||No|To ensure anonymity and confidentiality of participants, the investigators will not be sharing individual data. A summary report will be provided to participants upon request.|2017-10-10 22:10:37.259882|2017-10-10 22:10:37.259882
NCT02782052|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-01-03|||July 2016||2016-07-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|BD-HTAP||Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension|Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension|Active, not recruiting||Phase 3|18|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||No||2017-10-10 22:10:37.344533|2017-10-10 22:10:37.344533
NCT02782039|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-06-13|||May 17, 2017|Actual|2017-05-17|June 2017|2017-06-01|May 2022|Anticipated|2022-05-01|November 2021|Anticipated|2021-11-01||Observational|SAPL-LUPUS||Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)|Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 22:10:37.426993|2017-10-10 22:10:37.426993
NCT02782026|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-09-29|||March 2016||2016-03-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|SNOOPY2||Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension|Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension Detected by an Artificial Nose: A Clinical Validation Study|Recruiting||N/A|350|Anticipated|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||||2017-10-10 22:10:37.496156|2017-10-10 22:10:37.496156
NCT02782013|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-09-21|||September 2009|Actual|2009-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|PROGRESS||Study of Progression of Community Acquired Pneumonia in the Hospital|Study of Progression of Hospitalized Community Acquired Pneumonia - Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis|Recruiting||N/A|3000|Anticipated|Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps|||1||f||||f||||||Samples With DNA|"     DNA from EDTA whole blood, RNA from stabilized whole blood, serum, citrate plasma, stabilized     EDTA plasma, urin   "|||2017-10-10 22:10:37.585136|2017-10-10 22:10:37.585136
NCT02782000|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-20|||June 2016||2016-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Model and Effect Assessment of Training General Practitioner for Dementia Early Recognition|The Model and Effect Assessment of Training General Practitioner for Dementia Early Recognition|Not yet recruiting||N/A|152|Anticipated|Peking University Sixth Hospital||2|||f||||||||||||||2017-10-10 22:10:37.83567|2017-10-10 22:10:37.83567
NCT02781987|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-01-12|||January 2011||2011-01-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic Pancreatitis|Changhai Hospital, the Second Military Medical University|Completed||N/A|2028|Actual|Changhai Hospital|||2||f||||f||||||||No||2017-10-10 22:10:37.929721|2017-10-10 22:10:37.929721
NCT02781974|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-09-22|||January 2016||2016-01-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effect of Exercise on Physical Function in Older Women With Osteoporosis and a History of Vertebral Fracture|The Effect of Exercise on Physical Function in Older Women With Osteoporosis and a History of Vertebral Fracture: A Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-10 22:10:38.007889|2017-10-10 22:10:38.007889
NCT02781961|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-20|||June 2016||2016-06-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Identification of In-vivo Probe Based Confocal Laser Endomicroscopy Cellular Characteristics in Obese Women|Identification of In-vivo Probe Based Confocal Laser Endomicroscopy (pCLE) Gastric & Duodenal Cellular Characteristics in Obese Women Before & After Weight Reduction|Not yet recruiting||N/A|10|Anticipated|Sheba Medical Center|||1||f||||t||||||||No||2017-10-10 22:10:38.103792|2017-10-10 22:10:38.103792
NCT02781948|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-09-23|||May 2016||2016-05-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With iVue SD-OCT|Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With iVue SD-OCT|Completed||N/A|60|Actual|Optovue|||2||f||||f||||||||||2017-10-10 22:10:38.17741|2017-10-10 22:10:38.17741
NCT02781935|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-08-08|||November 2016||2016-11-01|August 2017|2017-08-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Observational|DREAM||Diffusion-Weighted MRI for Liver Metastasis|Diffusion-Weighted Magnetic Resonance Imaging Assessment of Liver Metastasis to Improve Surgical Planning|Recruiting||N/A|400|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||t||||||||||2017-10-10 22:10:38.264736|2017-10-10 22:10:38.264736
NCT02781922|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-09-10|||June 2016||2016-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|APOLLON||Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)|Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease: A Multicenter Randomized Single-blind Parallel-group Study|Recruiting||Phase 3|40|Anticipated|Japan Regenerative Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:10:38.429795|2017-10-10 22:10:38.429795
NCT02781909|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-09-05|||September 2016||2016-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|NSAIDS-XDRTB||Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis|Pilot Study to Estimate the Potential Efficacy and Safety of Using Adjunctive Ibuprofen for the Treatment of XDR Tuberculosis|Enrolling by invitation||Phase 2|24|Anticipated|Fundació Institut Germans Trias i Pujol||2|||f||||t||||||||||2017-10-10 22:10:38.53703|2017-10-10 22:10:38.53703
NCT02781896|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-03-24|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EASY TAVI||Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI|Direct Left Ventricular Rapid Pacing Via the Valve Delivery Guide-wire in TAVI: a Randomized Study|Not yet recruiting||N/A|300|Anticipated|Groupe Hospitalier Mutualiste de Grenoble||2|||f||||t||||||||No||2017-10-10 22:10:38.624534|2017-10-10 22:10:38.624534
NCT02781883|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-04-21|||May 2016||2016-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With LDAC in Patients With Previously Untreated AML|A Phase IIa Single-arm, Open-label, Two-stage Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of BP1001 (a Liposomal Grb2 Antisense Oligonucleotide) in Combination With Low-dose Cytarabine (LDAC) in Patients With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Induction Therapy|Recruiting||Phase 2|54|Anticipated|Bio-Path Holdings, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:10:38.732883|2017-10-10 22:10:38.732883
NCT02781870|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-11-23|||May 2016||2016-05-01|November 2016|2016-11-01|May 2023|Anticipated|2023-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Laparoscopic Groin Hernia Repair by a 3D ENDOLAP Visible Mesh With or Without LiquiBand Fix 8 Mesh Fixation|Randomized Single-center Study on Laparoscopic Groin Hernia Repair by a 3D ENDOLAP Visible With and Without LiquiBand Fix 8 Mesh Fixation|Recruiting||N/A|100|Anticipated|Algemeen Ziekenhuis Maria Middelares||2|||f||||f||||||||No||2017-10-10 22:10:38.860312|2017-10-10 22:10:38.860312
NCT02781857|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-08-09|||May 2016||2016-05-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Mass Spectral Fingerprinting in Lung Cancer|Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS) in Patients With Lung Cancer|Recruiting||N/A|120|Anticipated|University of Zurich|||2||f||||f||||||||||2017-10-10 22:10:38.94822|2017-10-10 22:10:38.94822
NCT02781844|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-19|||March 11, 2017|Actual|2017-03-11|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|PARALLAX||Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism|An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism|Recruiting||Phase 1|32|Anticipated|Shire||4|||f||||f|t|f||||||||2017-10-10 22:10:39.048586|2017-10-10 22:10:39.048586
NCT02781831|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-07-26|||May 2016||2016-05-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Robot-assisted Gait Training for Patients With Stroke|Clinical Feasibility and Efficacy of Robot-assisted Gait Training for Improving Motor Functions in Patients With Stroke|Recruiting||N/A|60|Anticipated|China Medical University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:10:39.176021|2017-10-10 22:10:39.176021
NCT02781818|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-02|||June 2016||2016-06-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.|A Randomized, Controlled, Double-blind Study to Evaluate the Efficacy of Intralesional Triamcinolone in the Treatment of Hidradenitis Suppurativa.|Recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f||||||||No||2017-10-10 22:10:39.267338|2017-10-10 22:10:39.267338
NCT02781805|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-01|||August 2016||2016-08-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Pilot Study of Bisphosphonates for Breast Cancer|Pilot Clinical Trial of Short-Term Bisphosphonate Administration as Chemoprevention for Breast Cancer Via Engagement of γδ T Cells|Recruiting||Phase 1|20|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-10 22:10:39.551098|2017-10-10 22:10:39.551098
NCT02781792|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-27|||August 11, 2016|Actual|2016-08-11|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Temozolomide Chronotherapy for High Grade Glioma|A Randomized Feasibility Study Evaluating Temozolomide Chronotherapy for High Grade Glioma|Recruiting||Phase 1|30|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 22:10:39.634247|2017-10-10 22:10:39.634247
NCT02781766|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-02-17|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|HOPE||TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia|Thrombin Generation Capacity of Patients With Severe Haemophilia Receiving Prophylaxis|Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:10:39.83416|2017-10-10 22:10:39.83416
NCT02781753|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-04|||April 7, 2016|Actual|2016-04-07|April 2017|2017-04-01|April 12, 2017|Actual|2017-04-12|August 2, 2016|Actual|2016-08-02||Interventional|||Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers|A Phase 1 Study to Evaluate the Pharmacokinetic and Pharmacodynamic Profile, Safety, and Tolerability of Escalating Single Dose Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Healthy Chinese Volunteers|Completed||Phase 1|34|Actual|Tianjin SinoBiotech Ltd.||2|||f||||f||||||||No||2017-10-10 22:10:39.917475|2017-10-10 22:10:39.917475
NCT02781740|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-23|||April 2016||2016-04-01|May 2016|2016-05-01||||December 2019|Anticipated|2019-12-01||Interventional|||Effects of Suboptimal CPAP Therapy on Symptoms of Obstructive Sleep Apnoea|Effects of Suboptimal Use of CPAP Therapy on Symptoms of Obstructive Sleep Apnoea|Recruiting||N/A|56|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-10 22:10:40.007419|2017-10-10 22:10:40.007419
NCT02781727|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-11-30|||August 2016||2016-08-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)|A Multicenter, Phase 3, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children With Growth Hormone Deficiency (GHD)|Recruiting||Phase 3|150|Anticipated|Ascendis Pharma A/S||2|||f||||t||||||||||2017-10-10 22:10:40.122877|2017-10-10 22:10:40.122877
NCT02781714|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2017-04-06|||July 2016||2016-07-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Mobile WACh XY||Evaluation of an mHealth SMS Dialogue Strategy to Meet Women's and Couples' Postpartum Contraceptive Needs in Kenya|Evaluation of an mHealth SMS Dialogue Strategy to Meet Women's and Couples' Postpartum Contraceptive Needs in Kenya|Recruiting||N/A|220|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 22:10:40.227343|2017-10-10 22:10:40.227343
NCT02781701|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Tongue Protrusion Force: A Pilot Study|Tongue Protrusion Force: A Pilot Study|Recruiting||Phase 1|25|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||No|There is no plan to make IPD available.|2017-10-10 22:10:40.309096|2017-10-10 22:10:40.309096
NCT02781688|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-23|||December 2015||2015-12-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Increasing Physical Activity in Persons With Depression|Increasing Physical Activity in Persons With Depression - Pilot|Recruiting||N/A|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||No||2017-10-10 22:10:40.490967|2017-10-10 22:10:40.490967
NCT02781675|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-26|||April 2016||2016-04-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|MFFD||The Mediterranean Full-Fat Dairy Study|Effects of a Modified High-fat Mediterranean Dietary Pattern on Lipoprotein and Inflammatory Markers of CVD Risk in Adults|Recruiting||N/A|40|Anticipated|Children's Hospital & Research Center Oakland||3|||f||||f||||||||No||2017-10-10 22:10:40.574373|2017-10-10 22:10:40.574373
NCT02781662|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-04-10|||July 2016||2016-07-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Improving Safety After Hospitalization in Older Persons on High-Risk Medications|Improving Safety After Hospitalization in Older Persons on High-Risk Medications|Enrolling by invitation||N/A|500|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||No||2017-10-10 22:10:40.676355|2017-10-10 22:10:40.676355
NCT02781649|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-24|||September 2016||2016-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EXPANDER-1||Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients|An Open-label Pilot Study to Determine the Tolerability and Efficacy of Fixed-dose Grazoprevir/Elbasvir Treatment in Hepatitis C Uninfected Recipients of Renal Transplants From Hepatitis C Infected Deceased Donors|Active, not recruiting||Phase 4|10|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-10-10 22:10:40.751708|2017-10-10 22:10:40.751708
NCT02781636|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-12-23|||April 2016||2016-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Protect Chronic Tibial Nerve Stimulator (CTNS) System|A European Trial to Assess the Efficacy of an Implantable Wireless Neuromodulation Device at the Tibial Nerve to Treat Urinary Urgency Incontinence|Enrolling by invitation||Phase 2|10|Anticipated|StimGuard, LLC.||1|||f||||f||||||||Yes|Upon Study Completion|2017-10-10 22:10:40.857336|2017-10-10 22:10:40.857336
NCT02781623|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-07-06|||October 2015||2015-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture|Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture|Enrolling by invitation||N/A|10|Anticipated|New York University School of Medicine|||1||f||||||||||||||2017-10-10 22:10:40.946208|2017-10-10 22:10:40.946208
NCT02781610|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-28|||June 2016||2016-06-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|STOP2||Standardized Treatment of Pulmonary Exacerbations II|Standardized Treatment of Pulmonary Exacerbations II (STOP2)|Recruiting||Phase 4|880|Anticipated|Seattle Children's Hospital||4|||f||||t||||||||||2017-10-10 22:10:41.035164|2017-10-10 22:10:41.035164
NCT02781597|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-05-20|||January 2011||2011-01-01|May 2016|2016-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy of Tranexamic Acid in Hemoptysis|Efficacy of Tranexamic Acid in Controlling Hemoptysis, A Randomized Control Trial|Completed||Phase 3|66|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||No|Not required at present|2017-10-10 22:10:41.34081|2017-10-10 22:10:41.34081
NCT02781584|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-01|||July 13, 2016|Actual|2016-07-13|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety, Tolerability, and Efficacy of Selonsertib, GS-0976, and GS-9674 in Adults With Nonalcoholic Steatohepatitis (NASH)|A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)|Recruiting||Phase 2|110|Anticipated|Gilead Sciences||8|||f||||t|t|f||||||||2017-10-10 22:10:41.421263|2017-10-10 22:10:41.421263
NCT02781571|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-03|||July 27, 2016|Actual|2016-07-27|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|||Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant|A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination in Subjects With Chronic HCV Infection Who Have Received a Liver Transplant|Completed||Phase 2|79|Actual|Gilead Sciences||1|||f||||f|t|f|||t|||||2017-10-10 22:10:41.534666|2017-10-10 22:10:41.534666
NCT02781558|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-02|||July 29, 2016|Actual|2016-07-29|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis|A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Subjects With Chronic Genotype 3 HCV Infection and Cirrhosis|Active, not recruiting||Phase 2|204|Actual|Gilead Sciences||2|||f||||f|t|f|||t|||||2017-10-10 22:10:41.647985|2017-10-10 22:10:41.647985
NCT02781545|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-31|||May 2015||2015-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Motor Development of Children That Have Surgery as Newborns for Complex Congenital Heart Disease|Predicting and Monitoring Motor Development of Children Requiring Surgery as Neonates for Complex Congenital Heart Disease|Recruiting||N/A|100|Anticipated|Advocate Health Care|||1||f||||t||||||||Yes|Manuscript, Poster presentation, Conference presentation|2017-10-10 22:10:41.803278|2017-10-10 22:10:41.803278
NCT02781532|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-05-23|||April 2014||2014-04-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestive Cancer||Completed||N/A|100|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 22:10:41.886605|2017-10-10 22:10:41.886605
NCT02781519|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-02-22|||June 2015||2015-06-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|THC-Gender||Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans|Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans|Recruiting||Phase 1|100|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 22:10:41.938258|2017-10-10 22:10:41.938258
NCT02781506|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-06-21|||June 20, 2016|Actual|2016-06-20|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma|Phase II Trial of Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC)|Recruiting||Phase 2|35|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 22:10:42.013763|2017-10-10 22:10:42.013763
NCT02781493|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-21|2016-05-25|||June 2016||2016-06-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy||Not yet recruiting||Phase 4|600|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 22:10:42.119069|2017-10-10 22:10:42.119069
NCT02781480|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-07|||April 2016||2016-04-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|OPTIRPE65||Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)|An Open-label, Multi-centre, Phase I/II Dose Escalation Trial of an Adeno Associated Virus Vector for Gene Therapy of Adults And Children With Retinal Dystrophy Associated With Defects in RPE65 (LCA)|Recruiting||Phase 1/Phase 2|27|Anticipated|MeiraGTx UK II Ltd||3|||f||||t|f|f||||||||2017-10-10 22:10:42.205225|2017-10-10 22:10:42.205225
NCT02781467|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-09-28|||July 25, 2016|Actual|2016-07-25|September 2017|2017-09-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30||Interventional|||A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)|A Phase 1, Multicenter, Open-Label, Dose Escalating Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (RHIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML).|Recruiting||Phase 1|28|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 22:10:42.290474|2017-10-10 22:10:42.290474
NCT02781454|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-22|||October 2016||2016-10-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Mexiletine-2||Mexiletine in Sporadic Amyotrophic Lateral Sclerosis|Effect of Mexiletine on Cortical Hyperexcitability in Sporadic Amyotrophic Lateral Sclerosis (SALS)|Recruiting||Phase 2|60|Anticipated|University of Washington||3|||f||||f||||||||||2017-10-10 22:10:42.397169|2017-10-10 22:10:42.397169
NCT02781441|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-09-01|||April 2016||2016-04-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|QPL-MDS||Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)|Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)|Recruiting||N/A|140|Anticipated|Institut Paoli-Calmettes||3|||f||||t||||||||||2017-10-10 22:10:42.705973|2017-10-10 22:10:42.705973
NCT02781428|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-11-03|||September 2016||2016-09-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|DETECT II||To Detect the Sensitivity of the UroMark Assay|A Multicentre Observational Study Design to Determine the Sensitivity of the UroMark Assay, a Urine Test, to Detect New and Recurrent Low, Intermediate and High Grade Bladder Cancer|Recruiting||N/A|400|Anticipated|University College, London|||1||f||||f||||||Samples With DNA|"     Urine samples   "|Yes|Papers will be prepared for publication in general and urological peer-reviewed journals. The findings will also be presented at national and international conferences. The results of the study will be disseminated regardless of the direction of effect. Authorship will be determined according to an agreed Publication Policy.|2017-10-10 22:10:42.79865|2017-10-10 22:10:42.79865
NCT02781415|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-06-18|||July 2014||2014-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|July 2015|Actual|2015-07-01||Interventional|AcuRC||Acupuncture Versus Titrated Morphine in Patients With Renal Colic|Comparison of Acupuncture and Titrated (TM) Morphine in Patients Presenting to the Emergency Room (ER) With Acute Renal Colic (RC)|Completed||Phase 3|200|Actual|University of Monastir||2|||f||||t||||||||Yes||2017-10-10 22:10:42.868578|2017-10-10 22:10:42.868578
NCT02781402|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-23|||September 2015||2015-09-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Relationship Between BMI & HRR After 4 Weeks of Aerobic Training|Relationship Between Body Mass Index and Heart Rate Recovery Following 4 Weeks of Aerobic Training Among Sedentary Adults|Completed||N/A|25|Actual|Universiti Tunku Abdul Rahman||1|||f||||t||||||||No|Confidentiality of participants.|2017-10-10 22:10:42.948029|2017-10-10 22:10:42.948029
NCT02781389|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2017-04-01|||April 29, 2016|Actual|2016-04-29|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|JONAS||Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions|Non-interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions|Recruiting||N/A|53|Anticipated|University Hospital, Essen|||1||f||||t||||||||No||2017-10-10 22:10:43.021461|2017-10-10 22:10:43.021461
NCT02781376|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-03-03|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Evidence-based Diagnosis and Management of Pediatric Obstructive Sleep Apnea in Primary Care|Evidence-based Diagnosis and Management of Pediatric Obstructive Sleep Apnea in Primary Care|Enrolling by invitation||N/A|1500|Anticipated|Indiana University||2|||f||||f||||||||No||2017-10-10 22:10:43.115164|2017-10-10 22:10:43.115164
NCT02781363|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-23|||January 2016||2016-01-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Can the Thoracic Replace the Conventional Radiography for the Diagnosis of Acute Pneumonia in Children?|Can the Thoracic Replace the Conventional Radiography for the Diagnosis of Acute Pneumonia in Children?|Recruiting||N/A|45|Anticipated|Hospital Universitari General de Catalunya||2|||f||||f||||||||No||2017-10-10 22:10:43.19809|2017-10-10 22:10:43.19809
NCT02781350|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-23|||November 2010||2010-11-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Anti-inflammatory Effects of Fiber|To Study the Effect of High Fat High Carbohydrate Meal on Oxidative Load, Inflammatory Mediators and Insulin Resistance in Normal and Obese Subjects|Completed||N/A|20|Actual|University at Buffalo||2|||f||||f||||||||||2017-10-10 22:10:43.285457|2017-10-10 22:10:43.285457
NCT02781337|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-19|||May 2012||2012-05-01|May 2016|2016-05-01||||December 2020|Anticipated|2020-12-01|10 Years|Observational [Patient Registry]|EMR-CRC||Epidemiological and Molecular Colorectal Cancer Registry|Epidemiological and Molecular Colorectal Cancer Registry|Recruiting||N/A|600|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f||||||Samples With DNA|"     Tissue samples and blood specimens are frozen and store at -80ºC.   "|Undecided||2017-10-10 22:10:43.364704|2017-10-10 22:10:43.364704
NCT02781324|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-06-14|||June 2016||2016-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis|Use of Ultrasonic Bone Scalpel in Adolescent Idiopathic Scoliosis - Randomized Clinical Trial|Enrolling by invitation||N/A|72|Anticipated|University of Colorado, Denver||2|||f||||t||||||||No||2017-10-10 22:10:43.466085|2017-10-10 22:10:43.466085
NCT02781311|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-07-18|||June 29, 2016|Actual|2016-06-29|July 2017|2017-07-01|August 30, 2018|Anticipated|2018-08-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males|Recruiting||Phase 2|163|Anticipated|Allergan||2|||f||||f|t|f||||||||2017-10-10 22:10:43.655157|2017-10-10 22:10:43.655157
NCT02781298|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-22|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|ACER||Acceptability, Tolerance, Satiety and Prebiotic Effect of a New Infant Cereal|Acceptability, Tolerance, Satiety and Prebiotic Effect of a New Infant Cereal in Infant Between 5 and 8 Months of Age, at the Beginning of Complementary Feeding|Completed||N/A|46|Actual|Hero Institute for Infant Nutrition||2|||f||||f||||||||No||2017-10-10 22:10:43.785327|2017-10-10 22:10:43.785327
NCT02781272|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-05-17|||June 2016||2016-06-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2017|Anticipated|2017-06-01||Observational|EMBER||Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.|ANG-003 EMBER Study: Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.|Active, not recruiting||N/A|200|Anticipated|Angle plc|||1||f||||f||||||Samples With DNA|"     All excess components (i.e. serum, RNA, DNA, cells, etc.) generated from the whole blood and     tissue samples collected for research testing, as well as any remaining tissue samples     collected under this study, will be stored frozen at the Targeted Therapeutics Laboratory at     the Wilmot Cancer Institute indefinitely for possible use in future research, including but     not limited to, biomarker analyses, genomic evaluations and genetic studies pertaining to     cancer and other disease processes.   "|No||2017-10-10 22:10:43.978443|2017-10-10 22:10:43.978443
NCT02781259|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-09-18|||May 2016||2016-05-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer|Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer|Recruiting||Phase 4|150|Anticipated|Samsung Medical Center||1|||f||||f||||||||No||2017-10-10 22:10:44.094978|2017-10-10 22:10:44.094978
NCT02781246|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-19|||September 2016||2016-09-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Perineural Dexmedetomidine on the ED50 Ropivacaine for Brachial Plexus Blocks in Pediatric Patients: a Randomized Trial||Not yet recruiting||Phase 4|160|Anticipated|Guangzhou Women and Children's Medical Center||5|||f||||||||||||||2017-10-10 22:10:44.188641|2017-10-10 22:10:44.188641
NCT02781233|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-10-25|||January 2017||2017-01-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||A Progressive Resistance Training Program in Patients With Haemophilia|The Impact of Progressive Resistance Training on Quality of Life in Patients With Haemophilia|Not yet recruiting||N/A|35|Anticipated|University of Valencia||2|||f||||f||||||||No||2017-10-10 22:10:44.272596|2017-10-10 22:10:44.272596
NCT02781220|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-07-05|||July 2016||2016-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|IMPACT2||Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial|Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial|Recruiting||N/A|100|Anticipated|University of Utah|||1||f||||t||||||||||2017-10-10 22:10:44.384945|2017-10-10 22:10:44.384945
NCT02781207|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-20|||February 2016||2016-02-01|May 2016|2016-05-01||||March 2017|Anticipated|2017-03-01||Observational|||Comparison Between Standard and Ultrasound Integrated Approach for Risk Stratification of Syncope in the Emergency Department|Comparison Between Standard and Bedside Ultrasound Integrated Approach for Risk Stratification of Patients Presenting With Syncope in the Emergency Department|Recruiting||N/A|130|Anticipated|University of Turin, Italy|||1||f||||f||||||||Yes|The study collect only clinical data, also reported in the Emergency Department chart. The chart is always given to the patient at the discharge.|2017-10-10 22:10:44.536562|2017-10-10 22:10:44.536562
NCT02781194|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-08|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|TePaLa||Temperature and Pain in Laparoscopy|A Prospective, Randomized, Controlled, Study Investigating Intraoperative Temperature and Postoperative Pain Course Following Gynaecological Laparoscopy|Recruiting||N/A|150|Anticipated|RWTH Aachen University||3|||f||||t||||||||||2017-10-10 22:10:44.650098|2017-10-10 22:10:44.650098
NCT02781181|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-06-28|||May 2016||2016-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Carotid Artery Stenting Without Protection|Carotid Artery Stenting Without Embolic Protection: A Randomized Multicenter Trial (the CASWEP Trial)|Recruiting||N/A|200|Anticipated|Acibadem University||2|||f||||f||||||||Yes||2017-10-10 22:10:44.743525|2017-10-10 22:10:44.743525
NCT02781168|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-19|||June 2013||2013-06-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Influence of the Use of Hearing Protection in the Salivary Cortisol Level and in the Sleep of Premature Infants|Influence of the Use of Hearing Protection in the Salivary Cortisol Level and in the Sleep of Premature Infants: Clinical, Randomized, Controlled, Crossover|Active, not recruiting||N/A|12|Actual|Federal University of São Paulo||2|||f||||t||||||||No||2017-10-10 22:10:44.854389|2017-10-10 22:10:44.854389
NCT02781155|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-19|||February 2016||2016-02-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|||Limiting Chemotherapy Side Effects by Using Moxa|Using Daily Self-administered Indirect Moxibustion to Zusanli St-36 to Reduce Chemotherapy Induced Pancytopenia: a Feasibility Study|Recruiting||Phase 1/Phase 2|25|Anticipated|East and North Hertfordshire NHS Trust||1|||f||||f||||||||No||2017-10-10 22:10:44.955695|2017-10-10 22:10:44.955695
NCT02781142|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-09-22|||May 2016||2016-05-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Motor Imagery Training in Persons With Multiple Sclerosis|The Effect of Telerehabilitation Based Motor Imagery Training on Gait and Balance Performance of the Persons With Multiple Sclerosis: A Randomized Controlled Trial|Recruiting||N/A|75|Anticipated|Dokuz Eylul University||3|||f||||f||||||||Undecided||2017-10-10 22:10:45.062037|2017-10-10 22:10:45.062037
NCT02781129|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2021|Anticipated|2021-05-01||Interventional|||Navigation and Free Recall in Chronically Implanted Humans|Memory, Epilepsy and Brain Stimulation: Oscillatory Patterns During Real-world Navigation and Free Recall in Chronically Implanted Humans|Recruiting||N/A|24|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||No||2017-10-10 22:10:45.16614|2017-10-10 22:10:45.16614
NCT02781116|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-05-19|||March 2016||2016-03-01|May 2016|2016-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Risk Assessment Tool in Saudi Arabia|Risk Assessment Tool for Breast Cancer in Saudi Arabia|Recruiting||N/A|2000|Anticipated|National Guard Health Affairs|||1||f||||f||||||||||2017-10-10 22:10:45.258879|2017-10-10 22:10:45.258879
NCT02781103|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-15|||September 2016||2016-09-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain|A Randomized Control, Single Blind, Pilot Study of Electroencephalogram (EEG) and Symptoms After Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain|Recruiting||N/A|20|Anticipated|William Beaumont Hospitals||2|||f||||f||||||||||2017-10-10 22:10:45.336786|2017-10-10 22:10:45.336786
NCT02781090|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-19|||June 2016||2016-06-01|May 2016|2016-05-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|PSFW+||RCT of an Internet Cessation Program Plus Online Social Network for HIV+ Smokers|RCT of an Internet Cessation Program Plus Online Social Network for HIV+ Smokers|Not yet recruiting||N/A|550|Anticipated|Montefiore Medical Center||2|||f||||t||||||||No|No plan to share IPD at this time.|2017-10-10 22:10:45.421506|2017-10-10 22:10:45.421506
NCT02781077|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-06-23|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|August 30, 2016|Actual|2016-08-30|August 30, 2016|Actual|2016-08-30|7 Days|Observational [Patient Registry]|TOE||Intensity of Task-Oriented Exercises|Intensity of a Task-Oriented Exercise Program for Optimizing Walking Competency in Stroke Survivors|Completed||N/A|10|Actual|Mahidol University|||1||f||||f||||||||Undecided||2017-10-10 22:10:45.526462|2017-10-10 22:10:45.526462
NCT02781051|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-23|||May 2016||2016-05-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Increasing Physical Activity Among Breast Cancer Survivors With Depression|Increasing Physical Activity Among Breast Cancer Survivors With Depression|Not yet recruiting||N/A|50|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-10 22:10:45.699414|2017-10-10 22:10:45.699414
NCT02781038|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-19|||February 2014||2014-02-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Smoking Cessation and a Teachable Moment in Patients With Acute Fractures|Smoking Cessation and a Teachable Moment in Patients With Acute Fractures|Completed||N/A|40|Actual|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 22:10:45.785278|2017-10-10 22:10:45.785278
NCT02781025|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-01-13|||April 2016||2016-04-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease|Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease|Recruiting||N/A|30|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-10 22:10:45.870041|2017-10-10 22:10:45.870041
NCT02781012|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-05-23|||March 2016||2016-03-01|December 2016|2016-12-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01|5 Years|Observational [Patient Registry]|||Project Survival-Prospective Biomarker Discovery|Project Survival-Prospective Biomarker Discovery to Transform Diagnosis and Treatment for Patients With Pancreatic Diseases and Cancer|Recruiting||N/A|600|Anticipated|Pancreatic Cancer Research Team|||5||f||||f||||||Samples With DNA|"     Blood (serum, plasma, buffy coat), saliva, urine, and pancreatic tissue designated as     surgical waste by site's treating pathologist.   "|No||2017-10-10 22:10:45.95132|2017-10-10 22:10:45.95132
NCT02780999|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-23|||June 2013||2013-06-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Immobilization of the Metacarpophalangeal Joint in Thumb Osteoarthritis|Effect of Immobilization of the Metacarpophalangeal Joint in Thumb Osteoarthritis on Pain and Function Three Months Follow up: Randomized Clinical Trial|Completed||N/A|84|Actual|University of Malaga||2|||f||||f||||||||No||2017-10-10 22:10:46.057082|2017-10-10 22:10:46.057082
NCT02780986|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-23|||March 2015||2015-03-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||STI Prevention Program for Entertainment Establishments in Singapore|Efficacy of a Health Promotion and STI Prevention Program for Entertainment Establishments in Singapore|Recruiting||N/A|1440|Anticipated|National University, Singapore||4|||f||||t||||||||||2017-10-10 22:10:46.143029|2017-10-10 22:10:46.143029
NCT02780973|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-08|||February 7, 2017|Actual|2017-02-07|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Influence of Gender Specific Differences of Saliva Composition on the Development of Dental Erosion - an In-situ Study|Influence of Gender Specific Differences of Saliva Composition on the Development of Dental Erosion - an In-situ Study|Recruiting||N/A|50|Anticipated|University of Göttingen|||2||f||||f|f|f||||Samples With DNA|"     Saliva samples are obtained and retained for 10 years.   "|No||2017-10-10 22:10:46.250087|2017-10-10 22:10:46.250087
NCT02780960|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-08-11|||May 2016||2016-05-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Human Papillomavirus (HPV) Self-sampling as a Test of Cure After Treatment of Cervical Intra-epithelial Neoplasia|HPV Self-sampling as a Test of Cure After Treatment of Cervical Intra-epithelial Neoplasia|Recruiting||N/A|168|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-10-10 22:10:46.357815|2017-10-10 22:10:46.357815
NCT02780947|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-19|||June 2016||2016-06-01|May 2016|2016-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Prophylactic Substrate Ablation in Post-myocardial Patients Undergoing Defibrillator Implantation.|Prophylactic Substrate Ablation in Post-myocardial Patients Undergoing Defibrillator Implantation.|Not yet recruiting||N/A|40|Anticipated|National and Kapodistrian University of Athens||2|||f||||f||||||||Undecided||2017-10-10 22:10:46.430013|2017-10-10 22:10:46.430013
NCT02780934|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-08-18|||October 2015||2015-10-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction|Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction|Completed||N/A|81|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||||||||||||2017-10-10 22:10:46.517015|2017-10-10 22:10:46.517015
NCT02780921|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-01-24|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PREHAB||Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial|Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial|Recruiting||Phase 3|120|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:10:46.610633|2017-10-10 22:10:46.610633
NCT02780908|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-08-29|||April 2016||2016-04-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|October 2016|Anticipated|2016-10-01||Interventional|PreTerm||Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely|Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely|Recruiting||N/A|37|Anticipated|Jozef Stefan Institute||2|||f||||f||||||||No||2017-10-10 22:10:46.710977|2017-10-10 22:10:46.710977
NCT02780895|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-09|||May 2014||2014-05-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|HSCfPD||Parkinsonian Brain Repair Using Human Stem Cells|Human OK99 Allogeneic Stem Cell Transplantation for Patients With Severe Parkinson's Disease|Active, not recruiting||Phase 1|8|Actual|Celavie Bioscences, LLC||1|||f||||f||||||||Yes||2017-10-10 22:10:47.121068|2017-10-10 22:10:47.121068
NCT02780882|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-06-21|||December 2015||2015-12-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||SOM230 Ectopic ACTH-producing Tumors|A Proof of Concept and Open-label Study to Test the Efficacy and Safety of Pasireotide in Patients With Ectopic ACTH-producing Tumors|Recruiting||Phase 2|16|Anticipated|Cedars-Sinai Medical Center||1|||f||||t||||||||No||2017-10-10 22:10:47.250049|2017-10-10 22:10:47.250049
NCT02780869|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-03-07|||July 18, 2016|Actual|2016-07-18|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|February 1, 2017|Actual|2017-02-01||Interventional|||HEMOBLAST Pivotal Clinical Investigation|Prospective, Randomized, Controlled, Multicenter, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of HEMOBLAST Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries|Active, not recruiting||N/A|412|Actual|Biom'Up SA||2|||f||||t||||||||No||2017-10-10 22:10:47.34888|2017-10-10 22:10:47.34888
NCT02780856|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-22|||January 14, 2017|Actual|2017-01-14|May 2017|2017-05-01|June 21, 2017|Actual|2017-06-21|May 4, 2017|Actual|2017-05-04||Interventional|||Safety and Performance Evaluation of the Calcivis System|Clinical Study to Evaluate the Safety and Performance of the Calcivis System for Identifying Active Demineralization on Tooth Surfaces|Completed||N/A|111|Actual|Calcivis Ltd||1|||f||||f||||||||Yes|A Final Clinical Study report will be issued|2017-10-10 22:10:47.457495|2017-10-10 22:10:47.457495
NCT02780843|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-05-23|||December 2013||2013-12-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||CT or MRI in Work up for i.v. Thrombolysis: a Single-centre Study|Computerized Tomography (CT) or Magnetic Resonance Imaging (MRI) in Work up for i.v. Thrombolysis: a Single-centre Study|Completed||N/A|499|Actual|Bispebjerg Hospital||2|||f||||f||||||||No||2017-10-10 22:10:47.545049|2017-10-10 22:10:47.545049
NCT02780830|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-09-14|||June 2016||2016-06-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|INHIBITOR||AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma|A Modular Phase I/IIa, Open-Label, Multicentre Study to Assess AZD2014 in Combination With Novel Anti-Cancer Agents in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma (INHIBITOR Study)|Withdrawn||Phase 1|0|Actual|AstraZeneca||1||"Study D2276C00001 was not started. No patients were enrolled. The sponsor decided to pursue an   alternate design."|f||||f||||||||||2017-10-10 22:10:47.633692|2017-10-10 22:10:47.633692
NCT02780817|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-05-18|||December 2015||2015-12-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Motor Adaptation by Error Augmentation Force Field in Healthy Peoples` Upper Extremity|Motor Adaptation by Error Augmentation Force Field in Healthy Peoples` Upper Extremity, a Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|University of Haifa||2|||f||||t||||||||Yes|Journal article|2017-10-10 22:10:47.712486|2017-10-10 22:10:47.712486
NCT02780791|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-11-24|||December 2016||2016-12-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|Ovartrans||Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary|Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary After Cryopreservation of Ovarian Tissue Before Cytotoxic Therapies - Where do More Follicles Grow?|Enrolling by invitation||Early Phase 1|25|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||Yes|"The Source data will include:
All documents required in the Trial master file
Visit dates and participation in the study along with consent forms
Completed CRFs and patient medical charts
All documentation related to SAEs and AEs
All documentation related to concomitant medication and results of study relevant examinations
Direct access to source documents will be permitted for purposes of monitoring, audits and inspections. Access to protocol, dataset, statistical code during and after the study will be given to the PI, the other defined investigators, the persons who perform the monitoring and the statistician.
The key to decode the health related data will be stored at the Universitätsfrauenklinik, Abteilung Gynäkologische Endokrinologie und Reproduktionsmedizin, Effingerstrasse 102, 3010 Bern. The access to the key will only be given to persons, who need it to fulfill their tasks in the sense of the study."|2017-10-10 22:10:48.125426|2017-10-10 22:10:48.125426
NCT02780778|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-19|||May 2016||2016-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer|Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer|Recruiting||Phase 2/Phase 3|20|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t||||||||||2017-10-10 22:10:48.239881|2017-10-10 22:10:48.239881
NCT02780765|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-04-25|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Study to Compare the Effect of Two Different Types of Humidifier on the Endotracheal Tube Patency|Study to Compare the Effect of Two Different Types of Humidifier on the Endotracheal Tube Patency|Completed||N/A|60|Actual|Tata Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:10:48.352403|2017-10-10 22:10:48.352403
NCT02780752|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-20|||July 2016||2016-07-01|May 2016|2016-05-01||||June 2018|Anticipated|2018-06-01||Interventional|||A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis|A Pilot Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-10 22:10:48.43005|2017-10-10 22:10:48.43005
NCT02780739|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-19|||March 2014||2014-03-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|INSIGHT||INSIGHT, A Comprehensive, Multidisciplinary Brain Training System|An Integrative System for Enhancing Fluid Intelligence (Gf) Through Human Cognitive Activity, Fitness, High-definition Transcranial Direct-current Brain Stimulation (HD-tDCS), and Nutritional Intervention|Completed||N/A|521|Actual|University of Illinois at Urbana-Champaign||5|||f||||f||||||||Undecided|Aggregate data will be shared. Details of individual participant data to be shared are still under discussion.|2017-10-10 22:10:48.533155|2017-10-10 22:10:48.533155
NCT02780726|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-08-09|||June 22, 2016|Actual|2016-06-22|August 2017|2017-08-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Interventional|||A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia|ASP1517 Phase 3 Clinical Trial -A Multi-center, Open-label Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia|Completed||Phase 3|56|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-10 22:10:48.754057|2017-10-10 22:10:48.754057
NCT02780700|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-06-21|||July 5, 2016||2016-07-05|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|||Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]|LUME-Colon 2: An Open-label Randomized Phase II Study to Assess the Efficacy and Safety of Nintedanib Alone or in Combination With Capecitabine for Patients With Refractory Metastatic Colorectal Cancer|Terminated||Phase 2|1|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:10:49.035103|2017-10-10 22:10:49.035103
NCT02780167|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-23|||April 15, 2016|Actual|2016-04-15|June 2017|2017-06-01|April 4, 2017|Actual|2017-04-04|March 9, 2017|Actual|2017-03-09||Interventional|||Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis|A Phase 2b Randomized, Double‑Blind, Placebo-controlled, Parallel, Multicenter, Dose-ranging, Study To Evaluate The Efficacy And Safety Profile Of Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis|Completed||Phase 2|268|Actual|Pfizer||5|||f||||f||||||||||2017-10-10 22:10:55.994708|2017-10-10 22:10:55.994708
NCT02780687|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-10-03|||June 9, 2016|Actual|2016-06-09|October 2017|2017-10-01|March 29, 2019|Anticipated|2019-03-29|February 28, 2019|Anticipated|2019-02-28||Interventional|LUX-Bladder 1||Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy|LUX-Bladder 1: Phase II Open Label Single Arm Exploratory Trial of Oral Afatinib Monotherapy Following Platinum Failure for Patients With Advanced/Metastatic Urothelial Tract Carcinoma With Genetic Alterations in ERBB Receptors.|Recruiting||Phase 2|80|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:10:49.137821|2017-10-10 22:10:49.137821
NCT02780674|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-14|||August 26, 2016|Actual|2016-08-26|September 2017|2017-09-01|July 3, 2018|Anticipated|2018-07-03|October 23, 2017|Anticipated|2017-10-23||Interventional|||A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases|A Phase 1, Randomized, Blinded, Single-Dose, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases|Active, not recruiting||Phase 1|36|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-10 22:10:49.256971|2017-10-10 22:10:49.256971
NCT02780661|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-07-31|||June 20, 2016|Actual|2016-06-20|July 2017|2017-07-01|November 15, 2016|Actual|2016-11-15|September 1, 2016|Actual|2016-09-01||Interventional|||Frequency of Denture Cleanser Use and Denture Cleanliness|A Method Development Clinical Study to Investigate the Efficacy of the Different Frequencies of Use of a Denture Cleanser|Completed||N/A|19|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 22:10:49.363813|2017-10-10 22:10:49.363813
NCT02780648|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-12-06|||May 2016||2016-05-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Interventional|||Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region|Pilot Study of Respiratory-gated Stereotactic Body Radiation Therapy for Borderline Resectable, Unresectable, or Recurrent/Residual Adenocarcinoma of the Pancreas or Periampullary Region|Recruiting||Early Phase 1|30|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 22:10:49.453154|2017-10-10 22:10:49.453154
NCT02780635|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-06-22|||December 2015||2015-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of Mobile Apps for Those With PTSD and Their Partners|Use of Mobile Apps for Those With PTSD and Their Partners|Recruiting||N/A|200|Anticipated|VA Palo Alto Health Care System||2|||f||||f||||||||||2017-10-10 22:10:49.56678|2017-10-10 22:10:49.56678
NCT02780622|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2016-09-19|2016-07-25||February 2008||2008-02-01|June 2016|2016-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||Analysis was performed on all enrolled participants.|A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)|An Open-label, Randomized 2-period Crossover Study to Investigate the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Warfarin in Combination With Oseltamivir in Volunteers Stabilized on Warfarin Therapy|Completed||Phase 4|20|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:10:49.68191|2017-10-10 22:10:49.68191
NCT02780609|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-20|2017-06-26|||June 26, 2017|Actual|2017-06-26|June 2017|2017-06-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma|Phase 1/2 Investigator Sponsored Study of Selinexor in Combination With High-Dose Melphalan Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma|Recruiting||Phase 1/Phase 2|46|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 22:10:50.255346|2017-10-10 22:10:50.255346
NCT02780596|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-03-03|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Infant Night Wakings in Pediatric Primary Care|Management of Infant Night Wakings in Pediatric Primary Care|Enrolling by invitation||N/A|1000|Anticipated|Indiana University||8|||f||||f||||||||No||2017-10-10 22:10:50.506389|2017-10-10 22:10:50.506389
NCT02780583|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-12-28|||May 2016||2016-05-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|MAS||Treatment of Macrophage Activation Syndrome (MAS) With Anakinra|Randomized Placebo Controlled Trial of Subcutaneous rhIL-1A (Anakinra) in the Management of Hospitalized Pediatric and Adult Patients With Macrophage Activation Syndrome|Recruiting||Phase 1|40|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||Undecided|Nurse Study Coordinators will gather and enter data|2017-10-10 22:10:50.609531|2017-10-10 22:10:50.609531
NCT02780570|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-07-26|||January 1, 2016||2016-01-01|July 2017|2017-07-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients|Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome Patients in Bangladesh: A Safety and Feasibility Study|Completed||Phase 2|20|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 22:10:50.709465|2017-10-10 22:10:50.709465
NCT02780557|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||How Parents Can Help Babies Learn to Talk With Picture Books.|A Randomised Control Trial to Test the Effect of Parent Contingent Talk During Shared Book Reading on Infant Language Learning.|Recruiting||N/A|140|Anticipated|University of Sheffield||2|||f||||f||||||||Yes|With participants' permission, IPD will be archived in accordance with the guidelines of the University of Sheffield, the UK Data Archive and the ESRC's Research Data Policy.|2017-10-10 22:10:50.805644|2017-10-10 22:10:50.805644
NCT02780544|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-07-15|||January 2014||2014-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Infant-parent Skin-to-skin Contact During Screening for Retinopathy|Is There a Difference in Pain Score, Stress Response and Motor Repertoire in Infants Given Skin-to-skin Contact With the Mother/Father or Standard Care During Screening for Retinopathy?|Completed||N/A|34|Actual|St. Olavs Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:10:50.886272|2017-10-10 22:10:50.886272
NCT02780375|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-03-01|||October 2016||2016-10-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|RTGene||Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects|Feasibility Study Testing Multi-panel Coding and Non-coding Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects in Radiation Therapy Patients|Recruiting||N/A|20|Anticipated|Institute of Cancer Research, United Kingdom|||1||f||||f||||||Samples With DNA|"     Blood samples   "|Undecided||2017-10-10 22:10:51.90909|2017-10-10 22:10:51.90909
NCT02780531|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-12-07|||December 2015||2015-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|Neurogenetic||Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases|Genetic and Blood Biomarkers in Subjects With Neurological and Neuromuscular Diseases|Recruiting||N/A|350|Anticipated|St. Louis University|||1||f||||f||||||Samples With DNA|"     Whole blood: Blood is the preferred sample to be collected as it yields the broadest number     of components to be studied, including deoxyribonucleic acid (DNA), ribonucleic acid     (RNA), protein & lymphocytes (approximately 10 milliliters). These may be immediately     utilized or frozen -80C for future esearch.      Other tissues: In some circumstances, a subject may have undergone or will undergo a clinical     procedure yielding bodily tissues or fluids (e.g. a muscle, tumor biopsy, spinal tap). If     this is the case, nucleic acids (DNA & RNA) and proteins can be extracted for study.     Furthermore, there may be rare cases where comparisons between blood DNA & tissue DNA/RNA is     needed (e.g. a mutation identified is predicted to affected splicing which can only be     verified by studying the RNA from tissues).   "|No||2017-10-10 22:10:50.961197|2017-10-10 22:10:50.961197
NCT02780518|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-04-27|||June 2016||2016-06-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Airvo/Optiflow High Flow Nasal Oxygenation During Microlaryngeal Surgery|Airvo/Optiflow High Flow Nasal Oxygenation During Microlaryngeal Surgery - Assessing Effectiveness of Oxygenation and Carbon Dioxide Clearance|Withdrawn||N/A|0|Actual|Singapore General Hospital||1||Airvo 2 not suitable for CO2 clearance, awaiting Optiflow THRIVE machine|f||||f||||||||No||2017-10-10 22:10:51.029556|2017-10-10 22:10:51.029556
NCT02780505|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-19|||November 2011||2011-11-01|May 2016|2016-05-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Assessment of the Effect of Vitamin C on Anemia in Patients With Continuous Ambulatory Peritoneal Dialysis|Assessment of the Effect of Vitamin C on Anemia in Patients With Continuous Ambulatory Peritoneal Dialysi|Completed||Phase 4|66|Actual|Shiraz University of Medical Sciences||2|||f||||f||||||||Undecided||2017-10-10 22:10:51.098441|2017-10-10 22:10:51.098441
NCT02780492|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-23|||June 2012||2012-06-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study|Developing Tools for Assessing the Natural History of Ambulant and Non-ambulant DMD Individuals to Assist in Antisense-oligomer Clinical Trials|Recruiting||N/A|80|Anticipated|University College, London|||3||f||||f||||||||Yes||2017-10-10 22:10:51.169315|2017-10-10 22:10:51.169315
NCT02780479|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-29|||March 20, 2017|Actual|2017-03-20|August 2017|2017-08-01|August 29, 2017|Actual|2017-08-29|August 29, 2017|Actual|2017-08-29||Interventional|||Steroids in Children Hospitalized With Asthma|Oral Dexamethasone Versus Oral Prednisone in Children Hospitalized With Asthma: A Randomized Control Study|Terminated||Phase 4|6|Actual|University of Florida||2||insufficient number of participants met the enrollment criteria.|f||||f|f|f||||||||2017-10-10 22:10:51.266253|2017-10-10 22:10:51.266253
NCT02780466|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-25|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2017|Anticipated|2017-05-01||Observational|INTUBATIC||Observational Study on Intubation in Septic Shock||Not yet recruiting||N/A|600|Anticipated|University Hospital, Angers|||1||f||||||||||||||2017-10-10 22:10:51.352341|2017-10-10 22:10:51.352341
NCT02780453|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-11-26|||January 2013||2013-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Prophylactic Negative Pressure Dressings for Closed Laparotomy Wounds - A Randomised, Controlled, Open Label Trial|Prophylactic Negative Pressure Dressings for Closed Laparotomy Wounds - A Randomised, Controlled, Open Label Trial|Completed||Phase 2|50|Actual|University Hospital of Limerick||2|||f||||f||||||||Undecided||2017-10-10 22:10:51.403443|2017-10-10 22:10:51.403443
NCT02780440|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-11-30|||November 2014||2014-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Comparing Unimanual and Bimanual Mirror Therapy for Upper Limb Recovery Post Stroke|Home Mirror Therapy: A Randomized Control Study Comparing Unimanual and Bimanual Mirror Therapy for Improved Hand Function Post-stroke|Recruiting||N/A|45|Anticipated|New York University School of Medicine|||3||f||||f||||||||||2017-10-10 22:10:51.459962|2017-10-10 22:10:51.459962
NCT02780427|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-23|||June 2016||2016-06-01|June 2016|2016-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||ED50 and ED95 of Intranasal Dexmedetomidine in Pediatric Patients Undergoing Transthoracic Echocardiography Study||Recruiting||Phase 4|320|Anticipated|Guangzhou Women and Children's Medical Center||4|||f||||t||||||||||2017-10-10 22:10:51.532718|2017-10-10 22:10:51.532718
NCT02780414|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-19|||January 2016||2016-01-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers|Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers|Recruiting||N/A|1791|Anticipated|Progenity, Inc.|||2||f||||f||||||Samples Without DNA|"     This research study will collect 20 mL of whole blood and a 5 mL urine sample at one or more     clinic visits from pregnant women carrying a single fetus with no known fetal abnormalities.   "|No||2017-10-10 22:10:51.606316|2017-10-10 22:10:51.606316
NCT02780401|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-06-06|||September 2, 2016|Actual|2016-09-02|June 2017|2017-06-01|September 2, 2024|Anticipated|2024-09-02|September 2, 2024|Anticipated|2024-09-02||Interventional|WOKVAC||Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission|A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived From Three Breast Cancer Antigens (IGFBP-2, HER2, and IGF-1R) in Patients With Breast Cancer|Recruiting||Phase 1|30|Anticipated|University of Washington||1|||f||||t|t|f||||||||2017-10-10 22:10:51.693283|2017-10-10 22:10:51.693283
NCT02780388|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-08-28|||May 12, 2016|Actual|2016-05-12|August 2017|2017-08-01|September 6, 2017|Anticipated|2017-09-06|June 12, 2017|Actual|2017-06-12||Interventional|MEDI4920 in RA||A Phase 1b Study of MEDI4920 in Subjects With Adult-onset Rheumatoid Arthritis|A Phase 1b Randomized, Double-blind, Placebo-controlled Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics, and Clinical Response of MEDI4920 in Subjects With Adult-onset Rheumatoid Arthritis|Active, not recruiting||Phase 1|41|Actual|MedImmune LLC||4|||f||||f|t|f||||||||2017-10-10 22:10:51.802368|2017-10-10 22:10:51.802368
NCT02779998|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|VNI-RYTHMO||Prophylactic Non-invasive Ventilation During Surgical Procedure in Rhythmology|Prophylactic Non-invasive Ventilation During Surgical Procedure in Rhythmology|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 22:10:58.137582|2017-10-10 22:10:58.137582
NCT02780362|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-20|||April 2016||2016-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)|Open Label, Randomized, Single Dose, Two-way Crossover Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||Undecided||2017-10-10 22:10:53.895844|2017-10-10 22:10:53.895844
NCT02780349|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-06-29|||May 2016||2016-05-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|August 30, 2017|Anticipated|2017-08-30||Interventional|WISE LE||Evaluation of WIRION™ EPS in Lower Extremities Arteries|Evaluation of WIRION™ EPS in Lower Extremities Arteries|Recruiting||N/A|153|Anticipated|Gardia Medical||1|||f||||t||||||||No||2017-10-10 22:10:54.043241|2017-10-10 22:10:54.043241
NCT02780336|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-01|||August 2016||2016-08-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Blepharospasm Tools|Diagnostic and Rating Tools for Blepharospasm|Recruiting||N/A|400|Anticipated|Emory University|||3||f||||f||||||||||2017-10-10 22:10:54.17544|2017-10-10 22:10:54.17544
NCT02780323|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-24|||October 2015||2015-10-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis|A Multi-center, Double-blind, Active-controlled, Randomized, Parallel-group Clinical Trial to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis|Recruiting||Phase 4|158|Anticipated|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:10:54.352496|2017-10-10 22:10:54.352496
NCT02780310|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-21|||May 19, 2016||2016-05-19|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma|A Phase II Study of Lenvatinib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma|Active, not recruiting||Phase 2|33|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:10:54.461248|2017-10-10 22:10:54.461248
NCT02780284|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-20|||March 2015||2015-03-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Microbiome, Exercise Tracking Study (METS)|Physical Activity and the Microbiome Among Individuals at High Risk of Colorectal Cancer|Recruiting||N/A|20|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-10 22:10:54.726859|2017-10-10 22:10:54.726859
NCT02780271|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-19|||February 2016||2016-02-01|May 2016|2016-05-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Diet and Physical Activity Changes Among Latina Breast Cancer Survivors|Mi Vida Saludable: Maintaining Diet and Physical Activity Changes Among Latina Breast Cancer Survivors|Recruiting||N/A|250|Anticipated|Columbia University||4|||f||||t||||||||Undecided||2017-10-10 22:10:54.946835|2017-10-10 22:10:54.946835
NCT02780258|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-20|||November 2015||2015-11-01|May 2016|2016-05-01||||July 2016|Anticipated|2016-07-01||Interventional|||Restylane Silk for Photoaged Thinned Hands|Restylane Silk for Photoaged Thinned Hands|Active, not recruiting||N/A|25|Actual|Skin Laser & Surgery Specialists||2|||f||||||||||||||2017-10-10 22:10:55.066673|2017-10-10 22:10:55.066673
NCT02780245|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-09-01|||June 2016||2016-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section|Tranexamic Acid Versus Novel Uterine Cooling Technique in Reducing Blood Loss and Incidence of Postpartum Hemorrhage at Caesarean Section|Completed||Phase 4|100|Actual|Talkha Central Hospital||2|||f||||t||||||||No||2017-10-10 22:10:55.152565|2017-10-10 22:10:55.152565
NCT02780232|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-21|||February 2018||2018-02-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|||An Internet-based Program for Prevention and Early Intervention of Adolescent Depression|A Randomized Controlled Trial of an Internet-based Program for Prevention and Early Intervention of Adolescent Depression|Not yet recruiting||N/A|600|Anticipated|CES University||2|||f||||f||||||||Undecided||2017-10-10 22:10:55.312093|2017-10-10 22:10:55.312093
NCT02780219|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-02-28|||February 2016||2016-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Chronic Obstructive Pulmonary Disorder and Acute Exercise|The Effects of Acute Resistance Exercise on Protein and Amino Acid Metabolism in Chronic Obstructive Pulmonary Disease|Recruiting||N/A|90|Anticipated|Texas A&M University||2|||f||||f||||||||No||2017-10-10 22:10:55.440075|2017-10-10 22:10:55.440075
NCT02780206|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-11-28|||May 2016||2016-05-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Very Low Calorie Diet Weight Loss|Omics Profiling of the Response to Food and Variability of Weight Loss in Medically Supervised Very Low Calorie Diet|Recruiting||N/A|100|Anticipated|Texas A&M University||1|||f||||f||||||||No||2017-10-10 22:10:55.574094|2017-10-10 22:10:55.574094
NCT02780193|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-09-29||||||September 2017|2017-09-01||||||||Expanded Access|||Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury|Open Protocol for the Use of an Intravenous Fat Emulsion Comprised of Fish Oils (Omegaven) in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury|Available||N/A|||Rush University Medical Center|||||||||||||||||||2017-10-10 22:10:55.719584|2017-10-10 22:10:55.719584
NCT02780180|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-08-11|||June 2016||2016-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|QUID-HF||QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF|A Phase II Randomized, Placebo Controlled, Double-blind, Multi-centre Study to Assess Safety and Efficacy of Incremental Doses of QGC001 in Patients Upon Discharge or Following Hospitalization for Worsening Chronic Heart Failure With Left Ventricular Systolic Dysfunction|Recruiting||Phase 2|75|Anticipated|Quantum Genomics SA||2|||f||||t||||||||||2017-10-10 22:10:55.815179|2017-10-10 22:10:55.815179
NCT02779985|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-01-31|||April 2016|Actual|2016-04-01|April 2016|2016-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Goji Berries and Energy Expenditure|The Effect of a Single Dose of Lycium Barbarum on Postprandial Energy Expenditure in Healthy Overweight Men|Completed||N/A|18|Actual|Maastricht University Medical Center||2|||f||||||||||||||2017-10-10 22:10:58.231186|2017-10-10 22:10:58.231186
NCT02780154|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-05-04|||August 25, 2016|Actual|2016-08-25|April 5, 2017|2017-04-05|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||PfSPZ Challenge in Non-immune Adults in Baltimore, USA|A Phase 1 Trial to Evaluate the Safety and Infectivity of Direct Venous Inoculation of Aseptic, Purified, Cryopreserved Plasmodium Falciparum (7G8 and NF54) Sporozoites in Non-immune Adults in Baltimore, USA|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f|||||t|f|||f|||||2017-10-10 22:10:56.266333|2017-10-10 22:10:56.266333
NCT02780128|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-01-04|||July 2016||2016-07-01|January 2017|2017-01-01|May 2026|Anticipated|2026-05-01|May 2018|Anticipated|2018-05-01||Interventional|NEPENTHE||Next Generation Personalized Neuroblastoma Therapy|Next Generation Personalized Neuroblastoma Therapy (The NEPENTHE Trial)|Recruiting||Phase 1|83|Anticipated|Children's Hospital of Philadelphia||4|||f||||t||||||||||2017-10-10 22:10:56.799122|2017-10-10 22:10:56.799122
NCT02780115|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-10-04|||May 26, 2016|Actual|2016-05-26|October 2017|2017-10-01|October 27, 2017|Anticipated|2017-10-27|October 27, 2017|Anticipated|2017-10-27||Interventional|||A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia|A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia|Active, not recruiting||Phase 2|151|Actual|Allergan||5|||f||||f|t|f||||||||2017-10-10 22:10:57.00401|2017-10-10 22:10:57.00401
NCT02780102|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-20|||September 2015||2015-09-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|March 2016|Actual|2016-03-01||Interventional|ADHD||Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD|Comparison of the Effects of Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control on Executive Functions and Clinical Symptoms of Attention Deficit/ Hyperactivity Disorder|Active, not recruiting||N/A|48|Actual|Allameh Tabatabai University||3|||f||||t||||||||No||2017-10-10 22:10:57.188196|2017-10-10 22:10:57.188196
NCT02780089|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-10-05|||July 2015||2015-07-01|October 2017|2017-10-01|September 2021|Anticipated|2021-09-01|October 2020|Anticipated|2020-10-01||Observational|||Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study|A US Multi-Site Observational Study in Patients With Unresectable And Metastatic Melanoma: The OPTIMIzE Study|Recruiting||N/A|2200|Anticipated|Bristol-Myers Squibb|||8||f||||t||||||||||2017-10-10 22:10:57.302764|2017-10-10 22:10:57.302764
NCT02780076|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-18|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|HIPFRAC||Recovery of Physical Functioning After Hip Fracture|Recovery of Physical Functioning, Activity Level, and Quality of Life After Hip Fracture in the Fragile Elderly|Not yet recruiting||Phase 1|160|Anticipated|Vestre Viken Hospital Trust||2|||f||||f||||||||Undecided||2017-10-10 22:10:57.501261|2017-10-10 22:10:57.501261
NCT02780063|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-12-16|||September 2015||2015-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Medications Effect on Lenstar Measurements|The Effects of Dilation Medication on Lenstar Measurements for Cataract Surgery|Recruiting||N/A|50|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:10:57.601411|2017-10-10 22:10:57.601411
NCT02780050|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-06-10|||May 2016||2016-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Influence of Core Muscles Activation Using Physical Fitness on the Performance of Chest Compression|Influence of Core Muscles Activation Using Physical Fitness on the Performance of Chest Compression|Completed||N/A|25|Actual|Hallym University Kangnam Sacred Heart Hospital||2|||f||||f||||||||||2017-10-10 22:10:57.694498|2017-10-10 22:10:57.694498
NCT02780037|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-05-18|||February 2016||2016-02-01|February 2016|2016-02-01||||December 2016|Anticipated|2016-12-01||Interventional|||To Motivate Elderly to Move|To Motivate Elderly to Move: Focus on Prevention or Promotion?|Recruiting||N/A|80|Anticipated|Universitaire Ziekenhuizen Leuven||3|||f||||||||||||No||2017-10-10 22:10:57.779841|2017-10-10 22:10:57.779841
NCT02780024|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-11-01|||March 2015||2015-03-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM|Metformin and Neo-adjuvant Temozolomide and Hypofractionated Accelerated Limited-margin Radiotherapy Followed by Adjuvant Temozolomide in Patients With Glioblastoma Multiforme (M-HARTT STUDY)|Recruiting||Phase 2|50|Anticipated|McGill University Health Center||1|||f||||t||||||||No||2017-10-10 22:10:57.884531|2017-10-10 22:10:57.884531
NCT02780011|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-06-30|||September 2016||2016-09-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|AD3LE||Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies|A Phase I Study of the Combination of Alsertib (MLN8237) and Brentuximab Vedotin in Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies|Not yet recruiting||Phase 1|24|Anticipated|The Methodist Hospital System||1|||f||||t||||||||Yes|Data and materials on human subjects will be shared with other eligible investigators through appropriate means in accordance with the NIH policy on Sharing Research Data (NIH Guide, February 26, 2003). Data will be also shared with the funding agency and regulatory agencies as required. Data will be shared with other investigators within the limits of HIPAA and other patient confidentiality requirements. This will generally require removal of all patient identifiers for all source documents and the use of arbitrarily assigned one-way identifiers. In some cases, requestors will be asked to sign a formal data sharing agreement that will provide for a commitment to use data only for research purposes and not to identify individuals, keep the data secure, and destroy or return data after analyses are complete. Prior approval will be obtained from collaborating investigators, research sponsors, and/or other stake-holders before sharing if proprietary information or products are involved.|2017-10-10 22:10:58.01427|2017-10-10 22:10:58.01427
NCT02779972|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-19|||March 2016||2016-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|||Age Related Changes in Cardiac Physiology as a Predictor of Exercise Tolerance|Age Related Changes in Cardiac Physiology as a Predictor of Exercise Tolerance|Completed||N/A|574|Actual|Tel-Aviv Sourasky Medical Center|||3||f||||f||||||||No||2017-10-10 22:10:58.305239|2017-10-10 22:10:58.305239
NCT02779959|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-06-07|||April 2016||2016-04-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT|Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT|Recruiting||Phase 3|80|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||f||||||||No||2017-10-10 22:10:58.376848|2017-10-10 22:10:58.376848
NCT02779946|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-06-15|||October 2015||2015-10-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Observational|NILS-R-CHD||Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease|Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease|Completed||N/A|216|Actual|University of Leipzig|||2||f||||f||||||||||2017-10-10 22:10:58.456598|2017-10-10 22:10:58.456598
NCT02779933|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-18|||January 2011||2011-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Observational|||Epidemiology of Risk Factors for Hospital-acquired Pneumonia (HAP) in Intensive Care Unit (ICU) Patients|Epidemiology of Risk Factors for Hospital-acquired Pneumonia in ICU Patients|Completed||N/A|310|Actual|University Hospital Olomouc|||1||f||||f||||||Samples Without DNA|"     endotracheal aspirate   "|Yes|Collecting data from individual patients medical documentation|2017-10-10 22:10:58.53759|2017-10-10 22:10:58.53759
NCT02779920|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-17|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|GASTROPOP||Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study.|Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study.|Completed||N/A|20|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-10-10 22:10:58.620839|2017-10-10 22:10:58.620839
NCT02779907|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-06-03|||May 2016||2016-05-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Observational|||Prevalence and Associations of Paediatric Chronic Suppurative Otitis Media and Hearing Impairment in Rural Malawi|Prevalence and Associations of Paediatric Chronic Suppurative Otitis Media and Hearing Impairment in a Rural District of Malawi: A Cross-sectional Survey|Recruiting||N/A|270|Anticipated|Liverpool School of Tropical Medicine|||1||f||||f||||||||Yes|Participants will be consented for anonymised data storage for further research up to a period of 5 years following completion of the study. These data will be held on a secure server at LSTM by the principal investigator. Data may be shared with any interested parties following successful ethical review from COMREC and LSTM.|2017-10-10 22:10:58.698763|2017-10-10 22:10:58.698763
NCT02779894|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-28|||November 2015||2015-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|July 2017|Actual|2017-07-01||Interventional|||Sleep Apnoea Management by a Communication Based Technology (ICT)|Applicability, Efficacy and Cost Effectiveness of Sleep Apnoea Hypopnea Syndrome (SAHS) Management by an Information and Communication Based Technology (ICT)|Active, not recruiting||N/A|186|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-10 22:10:58.784055|2017-10-10 22:10:58.784055
NCT02779881|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-19|||December 2012||2012-12-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Epigenetic Features of FoxP3 in Children With Cow's Milk Allergy||Completed||N/A|40|Actual|Federico II University|||4||f||||f||||||||No||2017-10-10 22:10:58.856655|2017-10-10 22:10:58.856655
NCT02779868|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-07-24|||May 2016||2016-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy|Effect of Omega-3 Supplementation on Body Composition, Functional Capacity, Inflammatory Profile and Quality of Life in Cervix Cancer Patients Undergoing Chemoradiotherapy|Completed||N/A|40|Actual|Brazilian National Cancer Institute||2|||f||||t||||||||||2017-10-10 22:10:59.032404|2017-10-10 22:10:59.032404
NCT02779855|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-08-18|||March 22, 2017|Actual|2017-03-22|August 2017|2017-08-01|August 31, 2021|Anticipated|2021-08-31|August 31, 2021|Anticipated|2021-08-31||Interventional|||Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer|A Phase 1/2 Study of Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer|Recruiting||Phase 1/Phase 2|46|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 22:10:59.133139|2017-10-10 22:10:59.133139
NCT02779842|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-19|||July 2015||2015-07-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SPF Assay||18431-Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose(MPPD).|Completed||N/A|6|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:10:59.234781|2017-10-10 22:10:59.234781
NCT02779829|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-05-19|||July 2015||2015-07-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SPF Assay||18432-Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose(MPPD).|Completed||N/A|13|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:10:59.313703|2017-10-10 22:10:59.313703
NCT02779816|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-08-22|||May 1, 2017||2017-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:10:59.390724|2017-10-10 22:10:59.390724
NCT02779803|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-03-07|||September 2016||2016-09-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01|24 Months|Observational [Patient Registry]|||STAMCAR: A Prospective EC-IC Bypass Registry|STAMCAR: A Prospective EC-IC Bypass Registry|Recruiting||N/A|80|Anticipated|Lahey Clinic|||1||f||||f||||||||Undecided||2017-10-10 22:10:59.435196|2017-10-10 22:10:59.435196
NCT02779790|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-18|||April 2016||2016-04-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Meta-analyses of the Effect of Liquid Meal Replacements on Cardiometabolic Risk|Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors: A Series of Systematic Reviews and Meta-analyses of Randomized Controlled Trials|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:10:59.531|2017-10-10 22:10:59.531
NCT02779426|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-21|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|TADPOLES||Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores|Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores|Completed||N/A|84|Actual|Columbia University||2|||f||||t||||||||||2017-10-10 22:11:03.140807|2017-10-10 22:11:03.140807
NCT02779751|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2017-10-02|||November 14, 2016|Actual|2016-11-14|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer|A Phase 1b Study of Abemaciclib in Combination With Pembrolizumab for Patients With Stage IV Non-Small Cell Lung Cancer or Hormone Receptor Positive, HER2 Negative Breast Cancer|Recruiting||Phase 1|75|Anticipated|Eli Lilly and Company||3|||f||||f|t|f||||||||2017-10-10 22:10:59.884655|2017-10-10 22:10:59.884655
NCT02779738|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-19|2016-08-25|||May 2016||2016-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study of Merestinib (LY2801653) in Healthy Participants|The Effect of Food on the Bioavailability of Merestinib in Healthy Subjects|Completed||Phase 1|24|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:11:00.114568|2017-10-10 22:11:00.114568
NCT02779725|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-15|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|June 2020|Anticipated|2020-06-01||Interventional|SCH||SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention|SymptomCare@Home (SCH): Deconstructing an Effective, Technology-assisted, Symptom Management Intervention|Not yet recruiting||N/A|750|Anticipated|University of Utah||5|||f||||t|f|f||||||Yes|We will present our findings at conferences and publish the findings. We welcome analysis and use by other investigators once our primary aims have been analyzed and disseminated. The PI will share de-identified data to other investigators for study, including demographics, diagnosis, chemotherapy treatment, symptom patterns, work attendance, overall health function and health care utilization. Data will be shared with investigators working under an institution with a Federal Wide Assurance (FWA) and can be used for secondary study purposes. The PI agrees to make available data within one year of the completion of the funded project period and manuscripts pertaining to the aims. De-identified data will be available directly from the PI. The PI agrees to share data in a manner that is fully consistent with NIH data sharing policies and applicable laws and regulations.|2017-10-10 22:11:00.206299|2017-10-10 22:11:00.206299
NCT02779712|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-07-06|||August 2016||2016-08-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ReCAST-2||Remote Ischaemic Conditioning After Stroke Trial (ReCAST-2)|Remote Ischaemic Conditioning After Stroke Trial (ReCAST-2): A Pilot Randomised Controlled Phase II Trial Evaluating Remote Ischaemic Conditioning (RIC) After Hyperacute Stroke 2|Recruiting||Phase 2|60|Anticipated|University of Nottingham||2|||f||||t||||||||||2017-10-10 22:11:00.326112|2017-10-10 22:11:00.326112
NCT02779699|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-09-15|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of AL2846 on Tolerance and Pharmacokinetics|Phase I Study of Tolerance and Pharmacokinetics of AL2846 in Patients With Advanced Cancer|Recruiting||Phase 1|20|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f||||||||||2017-10-10 22:11:00.416854|2017-10-10 22:11:00.416854
NCT02779686|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-10-03|||January 2012||2012-01-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|PIIR||PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration|PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration|Terminated||N/A|32|Actual|University of Missouri-Columbia|||2|Investigator left institution|f||||f||||||||No||2017-10-10 22:11:00.492805|2017-10-10 22:11:00.492805
NCT02779673|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-19|||July 2014||2014-07-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effectiveness of Plant Stanols as Ester on Change in Blood Cholesterol Level|Investigation of the Effectiveness of Plant Stanols as Ester on Change in Blood Cholesterol Level in Korean Adult|Completed||N/A|69|Actual|Yonsei University||2|||f||||||||||||||2017-10-10 22:11:00.585335|2017-10-10 22:11:00.585335
NCT02779660|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-17|||May 2016||2016-05-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|RIPPAF||Effect of Remote Ischemic Preconditioning on Electrophysiological and Biomolecular Parameters in Non-valvular Paroxysmal Atrial Fibrillation: RIPPAF Study|Effect of Remote Ischemic Preconditioning on Electrophysiological and Biomolecular Parameters in Non-valvular Paroxysmal Atrial Fibrillation: RIPPAF Study|Recruiting||N/A|146|Anticipated|Heartcenter Leipzig GmbH||2|||f||||f||||||||||2017-10-10 22:11:00.674644|2017-10-10 22:11:00.674644
NCT02779647|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-03-14|||June 1, 2016|Actual|2016-06-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|January 1, 2017|Actual|2017-01-01||Interventional|Kids-Play||Play as a Method to Reduce Overweight and Obesity in Children.|Play as a Method to Reduce Overweight and Obesity in Children. Kids-Play Study.|Completed||N/A|54|Actual|Universidad de Granada||2|||f||||t||||||||||2017-10-10 22:11:01.458602|2017-10-10 22:11:01.458602
NCT02779634|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-05-18|||July 2016||2016-07-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction|The Effect of Ubiquinol Treatment on Cardiac Function in Patients With Heart Failure With Preserved Ejection Fraction|Not yet recruiting||Phase 2|60|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||Undecided||2017-10-10 22:11:01.527104|2017-10-10 22:11:01.527104
NCT02779621|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-02-22|||January 2016|Anticipated|2016-01-01|February 2017|2017-02-01|January 25, 2017|Actual|2017-01-25|January 2017|Anticipated|2017-01-01||Interventional|PROMOTER||The Potential for HPV Self-testing to Promote Participation in Cervical Screening|A Pragmatic Randomized Control Trial Which Evaluates the Potential for HPV Self-testing to Promote Participation in Cervical Screening (PROMOTER) Trial|Withdrawn||N/A|0|Actual|University Hospitals Coventry and Warwickshire NHS Trust||2||Due to Chief Investigator relocating out of the United Kingdom.|f||||f||||||||No||2017-10-10 22:11:01.617552|2017-10-10 22:11:01.617552
NCT02779608|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-01-23|||January 20, 2017|Actual|2017-01-20|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites|The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites Due to Far Advanced Gastric Cancer|Recruiting||Phase 2|50|Anticipated|Fudan University||1|||f||||t|f|f||||||Yes||2017-10-10 22:11:01.699998|2017-10-10 22:11:01.699998
NCT02779595|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-23|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery|Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery|Recruiting||N/A|44|Anticipated|Wuerzburg University Hospital|||2||f||||f||||||||No||2017-10-10 22:11:01.7832|2017-10-10 22:11:01.7832
NCT02779582|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-05-09|||June 2015||2015-06-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow|Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow: A Randomized, Double-masked, Placebo-controlled Trial|Active, not recruiting||Phase 3|59|Actual|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:11:01.893455|2017-10-10 22:11:01.893455
NCT02779569|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-06-26|||March 2016||2016-03-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|March 2017|Anticipated|2017-03-01||Interventional|||A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)|Prospective, Open, Multi-center, Double Arm Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)|Recruiting||N/A|80|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||f||||||||Undecided||2017-10-10 22:11:01.985553|2017-10-10 22:11:01.985553
NCT02779556|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-07-18|||September 2016||2016-09-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients|Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients|Recruiting||N/A|900|Anticipated|University of Arkansas||2|||f||||t||||||||||2017-10-10 22:11:02.132438|2017-10-10 22:11:02.132438
NCT02779543|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-08|||July 31, 2017|Anticipated|2017-07-31|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Clinical Validation of New Commercial Sleep Monitoring Devices|Clinical Validation of New Commercial Sleep Monitoring Devices|Not yet recruiting||N/A|300|Anticipated|Weill Medical College of Cornell University||3|||f||||f|f|t|f|f||||No||2017-10-10 22:11:02.240186|2017-10-10 22:11:02.240186
NCT02779530|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-17|||October 2011||2011-10-01|May 2016|2016-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs|Evaluation of CYP4A11 and CYP4F2 Gene Variants as Makers in Edema and Elevated Blood Pressure Occurrence After Nonsteroidal Anti-inflammatory (NSAID) Use|Completed||Phase 4|20|Actual|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 22:11:02.332898|2017-10-10 22:11:02.332898
NCT02779517|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-18|||February 2014||2014-02-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations|Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations|Completed||N/A|62|Actual|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 22:11:02.400929|2017-10-10 22:11:02.400929
NCT02779504|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-10-13|||May 2016||2016-05-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Post Market Clinical Follow Up Study for Evaluation of Agluna® METS|Post Market Clinical Follow Up for the Evaluation of Reducing the Risk of Infection Using the Agluna® Treated METS Modular System|Recruiting||N/A|106|Anticipated|Stanmore Implants Ltd.|||2||f||||f||||||||No|Individual patient data will not be made available as all patient data is anonymised and therefore can not be traced back to individual patients|2017-10-10 22:11:02.483203|2017-10-10 22:11:02.483203
NCT02779491|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-07-11|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Evaluation of a 5-a-day Fruit and Vegetable Mobile Phone Application|Evaluation of a 5-a-day Fruit and Vegetable Mobile Phone Application|Enrolling by invitation||N/A|100|Anticipated|Bournemouth University||2|||f||||f||||||||||2017-10-10 22:11:02.563316|2017-10-10 22:11:02.563316
NCT02779478|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-12-28|||April 2016||2016-04-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Evaluation Of The Lung Microbiome In NTM Bronchiectasis|Evaluation Of The Lung Microbiome In NTM Bronchiectasis|Recruiting||N/A|200|Anticipated|New York University School of Medicine|||2||f||||t||||||Samples With DNA|"     Airway microbiome using an aliquot of the induced sputum and upper airway samples. Since     induced sputum may reflect different regions of the upper/lower airways, investigators will     evaluate the upper and lower airway microbiome in a subgroup (case-control group) of patients     using samples obtained through upper airway sampling and bronchoscopy, respectively.   "|||2017-10-10 22:11:02.631083|2017-10-10 22:11:02.631083
NCT02779465|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-19|||June 2016||2016-06-01|May 2016|2016-05-01|December 2026|Anticipated|2026-12-01|June 2016|Anticipated|2016-06-01||Interventional|VDHCC||Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma|Study of Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B|Not yet recruiting||Phase 4|1500|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||Yes||2017-10-10 22:11:02.719486|2017-10-10 22:11:02.719486
NCT02779452|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-18|||December 2013||2013-12-01|May 2016|2016-05-01||||November 2014|Actual|2014-11-01||Observational|||Gestational Diabetes Mellitus and Neurodevelopment in Newborns|Does Brain Functions Depend on Omega 3 Transferred to the Fetus During the Intra Uterine Life ?|Completed||N/A|46|Actual|Université de Sherbrooke|||2||f||||f||||||Samples Without DNA|"     cord blood plasma   "|No||2017-10-10 22:11:02.980422|2017-10-10 22:11:02.980422
NCT02779439|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-07-20|||January 2013||2013-01-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|R3ACT||Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation|Therapeutic Infusion of Partially HLA-matched Third Party Donor-derived Virus- and Fungus Specific T-lymphocytes in Patients With Active Viral or Fungal Infection Post-allogeneic Stem Cell or Solid Organ Transplantation|Recruiting||Phase 1|25|Anticipated|University of Sydney||1|||f||||f||||||||No||2017-10-10 22:11:03.05165|2017-10-10 22:11:03.05165
NCT02779413|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-09-20|||June 4, 2016|Actual|2016-06-04|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Observational|||A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea|A Multi-centre, Prospective, Open-label, Single-arm, Non-interventional, Regulatory Post Marketing Surveillance (rPMS) Study of Tresiba® FlexTouch® (Insulin Degludec) to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea|Enrolling by invitation||N/A|3750|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 22:11:03.225109|2017-10-10 22:11:03.225109
NCT02779400|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-05-17|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|HEMOPTICS2||Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement|Conformity Measurement Assessment of a Diagnostic Medical Device Used for the Measurement of the INR (International Normalized Ratio)|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 22:11:03.340125|2017-10-10 22:11:03.340125
NCT02779387|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-19|||May 2016||2016-05-01|May 2016|2016-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy|Efficacy of Laparoscopic Surgery Combined With GnRH-a in the Treatment of Endometriosis Associated Infertility: A Multicenter, Prospective, Randomized-control-trial|Not yet recruiting||N/A|1184|Anticipated|Peking University People's Hospital||2|||f||||f||||||||Yes|Willing to share IPD|2017-10-10 22:11:03.433011|2017-10-10 22:11:03.433011
NCT02779374|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-10-20|||July 2016||2016-07-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|BMT-POI||Autologous Bone Marrow Transplantation for Premature Ovarian Insufficiency|Autologous Bone Marrow Transplantation for Treatment of Premature Ovarian Insufficiency|Active, not recruiting||N/A|10|Anticipated|South Valley University||1|||f||||t||||||||No||2017-10-10 22:11:03.505902|2017-10-10 22:11:03.505902
NCT02779361|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-07-26|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|February 14, 2017|Actual|2017-02-14|February 14, 2017|Actual|2017-02-14||Interventional|||Effect of Tea Consumption on Steroid Profile in Healthy Volunteers|Effect of Tea Consumption on Steroid Profile in Healthy Volunteers. Pilot Study|Completed||Phase 1|29|Actual|Parc de Salut Mar||1|||f||||f||||||||||2017-10-10 22:11:03.61137|2017-10-10 22:11:03.61137
NCT02779348|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-23|||September 2006||2006-09-01|August 2017|2017-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin|Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers|Completed||Phase 1|16|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 22:11:03.691784|2017-10-10 22:11:03.691784
NCT02779335|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-10-20|||May 2016||2016-05-01|March 2016|2016-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Enteral Formula Tolerance in Pediatric Patients|Enteral Formula Tolerance in Pediatric Patients|Completed||N/A|22|Actual|Nestlé||1|||f||||f||||||||No||2017-10-10 22:11:03.798115|2017-10-10 22:11:03.798115
NCT02779322|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-10-04|||June 2015||2015-06-01|October 2017|2017-10-01|June 2025|Anticipated|2025-06-01|June 2019|Anticipated|2019-06-01||Interventional|MGB-vs-LGBP||Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Single Anastomosis Gastric Bypass|Prospective Randomized Controlled Clinical Trial: Laparoscopic Gastric Bypass vs. Single Anastomosis Laparoscopic Gastric Bypass|Recruiting||N/A|20|Anticipated|Puerta de Hierro University Hospital||2|||f||||t||||||||||2017-10-10 22:11:03.887724|2017-10-10 22:11:03.887724
NCT02779309|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-04-26|||January 2007||2007-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2013|Actual|2013-12-01||Observational|RESPECT||Risk Evaluation for Support: Predicting Elder Life in the Community Tool (RESPECT)|An Algorithm for Predicting Death Among Older Adults in the Home Care Setting: Study Protocol for the Risk Evaluation for Support: Predicting Elder Life in the Community Tool (RESPECT)|Active, not recruiting||N/A|486000|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||||No||2017-10-10 22:11:04.021567|2017-10-10 22:11:04.021567
NCT02779296|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-18|||June 2016||2016-06-01|May 2016|2016-05-01||||March 2017|Anticipated|2017-03-01||Interventional|||Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery|Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery|Not yet recruiting||Phase 4|30|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-10 22:11:04.095446|2017-10-10 22:11:04.095446
NCT02779283|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-18|||December 2015||2015-12-01|May 2017|2017-05-01||||December 2018|Anticipated|2018-12-01||Interventional|||Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase Ib Feasibility Study of Personalized Kinase Inhibitor Therapy Combined With Induction Chemotherapy in Acute Myeloid Leukemia in Patients Who Exhibit In Vitro Kinase Inhibitor Sensitivity|Recruiting||Phase 1|24|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 22:11:04.188909|2017-10-10 22:11:04.188909
NCT02779270|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-18|||September 2015||2015-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Test the Outdoor Usage for Sunscreen Products in Female Adults|Supervised Outdoor -Use Test for Sunscreen Products in Female Adults|Completed||N/A|105|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:11:04.338235|2017-10-10 22:11:04.338235
NCT02779257|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-06-06|||April 2016||2016-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pasireotide Treatment for Neuroendocrine Tumor|Pasireotide Treatment for Insulin Producing Pancreatic Neuro-endocrine Tumor|Withdrawn||Phase 4|0|Actual|University of Maryland||1||Subject passed away prior to enrollment|f||||f||||||||||2017-10-10 22:11:04.414778|2017-10-10 22:11:04.414778
NCT02779231|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-19|||September 2015||2015-09-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Text Messages and Blood Pressure Control|Hypertension Control Using Bi-directional Texting for Home Blood Pressure Monitoring|Recruiting||N/A|430|Anticipated|University of Iowa||2|||f||||f||||||||||2017-10-10 22:11:04.578792|2017-10-10 22:11:04.578792
NCT02779218|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-05-17|||January 2013||2013-01-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MIPAS||Combination of Motor Imagery Exercises and Brain Stimulation TMS Type PAS in Patients After Hemiplegic Stroke|Study of the Effects of the Combination of Motor Imagery Exercises and Transcranial Magnetic Stimulation (TMS) Type PAS in Patients After Hemiplegic Stroke|Recruiting||N/A|24|Anticipated|University Hospital, Toulouse||3|||f||||f||||||||No||2017-10-10 22:11:04.663828|2017-10-10 22:11:04.663828
NCT02779205|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-05-10|||January 2012||2012-01-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|cicASChild||Child's Adipose Cells: Capacity of Tissue Regeneration|Evaluation of Tissue Regeneration Potential (in the Skin) of Child's Adipose Cells During the Development.|Completed||N/A|38|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:11:04.795036|2017-10-10 22:11:04.795036
NCT02779192|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-09-21|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|NIHL||A Phase 2b Study of SPI-1005 to Reduce the Incidence, Severity, and Duration of Acute Noise Induced Hearing Loss|A Phase 2b, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety and Efficacy of SPI-1005 to Reduce the Incidence, Severity and Duration of Acute Noise Induced Hearing Loss (NIHL)|Not yet recruiting||Phase 2|180|Anticipated|Sound Pharmaceuticals, Incorporated||3|||||||t|t|f||||||||2017-10-10 22:11:04.878883|2017-10-10 22:11:04.878883
NCT02779179|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-02-21|||November 2010||2010-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ESPERA||Therapeutic Management of Periodontitis and Clinical Manifestations of Rheumatoid Arthritis|Efficacy of Therapeutic Management of Periodontitis on the Clinical Manifestations of Rheumatoid Arthritis: the Randomized, Controlled ESPERA Trial.|Recruiting||N/A|40|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:11:05.001918|2017-10-10 22:11:05.001918
NCT02779153|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-12-07|||October 2016||2016-10-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|Acthar SLE||Acthar SLE (Systemic Lupus Erythematosus)|Efficacy, Safety, and Steroid Sparing Effect of Acthar in Patients With Hematologic Manifestations of Systemic Lupus Erythematosus|Recruiting||Phase 4|25|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:11:05.18422|2017-10-10 22:11:05.18422
NCT02779140|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-04-13|||August 1, 2016|Actual|2016-08-01|April 5, 2017|2017-04-05|May 27, 2017|Anticipated|2017-05-27|May 27, 2017|Anticipated|2017-05-27||Interventional|||Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632|A Phase I, Double-Blind, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632 vs Placebo Administered Intravenously in Healthy Adults|Active, not recruiting||Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f|||||t|f|||f|||||2017-10-10 22:11:05.306697|2017-10-10 22:11:05.306697
NCT02779127|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-04-14|||December 2007||2007-12-01|April 2017|2017-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|DILATER||Impact of Ban on Smoking in Pubs, Restaurants and Nightclubs on Endothelial Function in Workers|Impact of Ban on Smoking in Pubs, Restaurants and Nightclubs on Endothelial Function in Workers : Evaluation of Endothelial Vasomotoricity Before and After Cessation of Exposure to Passive Smoking : DILATER Study|Completed||N/A|49|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:11:05.415927|2017-10-10 22:11:05.415927
NCT02779114|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-20|||January 2009||2009-01-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|RETRO||RETRO (REduction of Therapy in RA Patients in Ongoing Remission)|A Phase 3, Multicenter, Randomized, Open, Prospective, Controlled, Parallel Group Study of Reduction of Therapy in Patients With Rheumatoid Arthritis in Ongoing Remission.|Recruiting||Phase 3|318|Anticipated|University of Erlangen-Nürnberg Medical School||3|||f||||t||||||||Yes||2017-10-10 22:11:05.509145|2017-10-10 22:11:05.509145
NCT02779101|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-21|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)|Open-label Single Arm Phase II Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)|Recruiting||Phase 2|21|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 22:11:05.683587|2017-10-10 22:11:05.683587
NCT02779088|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-26|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Physical Fitness Cohort Study in the Community-dwelling Elderly in the WanHwa Area|The Physical Fitness Cohort Study in the Community-dwelling Elderly in the WanHwa Area|Recruiting||N/A|1200|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 22:11:05.781372|2017-10-10 22:11:05.781372
NCT02779075|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-07-16|||June 2016||2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Exendin-9,39 and Satiety After Bariatric Surgery|Exendin-9,39 and Satiety After Bariatric Surgery|Recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 22:11:05.867479|2017-10-10 22:11:05.867479
NCT02779062|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-05|||March 2015||2015-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Apparent Life Threatening Events in Infants|ALTE Study: Interviews With Parents of Infants Seen in an Emergency Department|Completed||N/A|22|Actual|Winthrop University Hospital|||1||f||||f||||||||||2017-10-10 22:11:05.961233|2017-10-10 22:11:05.961233
NCT02779049|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-12-13|||January 2015||2015-01-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Program Cell Death Receptor 1 in Mycobacterium Avium Complex Lung Disease|The Pathogenic Role and Diagnostic Implication of Program Cell Death Receptor 1 Expressed on T Cells in Mycobacterium Avium Complex Lung Disease|Completed||N/A|112|Actual|National Taiwan University Hospital|||4||f||||f||||||Samples With DNA|"     blood   "|Undecided||2017-10-10 22:11:06.027892|2017-10-10 22:11:06.027892
NCT02779036|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-06-07|||June 2016||2016-06-01|October 2016|2016-10-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|TOHE||Optimizing Walking Function of Stroke Survivors by a Task-Oriented Home Exercise Program|The Effects of a Structured, Progressive, Task-oriented Home Exercise Program on Walking Competency in Individual Post Stroke|Completed||N/A|63|Actual|Mahidol University||2|||f||||f||||||||Undecided||2017-10-10 22:11:06.115854|2017-10-10 22:11:06.115854
NCT02779023|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-05-23|||September 2015||2015-09-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|ICHP CBT-I||Integrative Cardiac Health Project Cognitive-Behavior Therapy for Insomnia|Integrative Cardiac Health Project Cognitive-Behavior Therapy for Insomnia|Enrolling by invitation||N/A|64|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||No||2017-10-10 22:11:06.208874|2017-10-10 22:11:06.208874
NCT02779010|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-18|||February 2015||2015-02-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|WASH||Impact of Hand Washing and WASH Educational Intervention on Under-five Diarrheal Diseases|Hand Washing and WASH Educational Intervention in Reducing Incidence of Diarrhea Among Under-five Children in Eastern Ethiopia: A Community-based Cluster Randomized Controlled Trial|Completed||N/A|1190|Actual|Ethiopian Institute of Water Resources||2|||f||||f||||||||Yes||2017-10-10 22:11:06.280281|2017-10-10 22:11:06.280281
NCT02778997|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-17|||April 2016||2016-04-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|ShuCS||Prospective Shunt Complication Study|Prospective Shunt Complication Study (Pro-ShuCS)|Recruiting||N/A|150|Anticipated|University of Zurich|||1||f||||f||||||||No||2017-10-10 22:11:06.342737|2017-10-10 22:11:06.342737
NCT02778984|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-08-12|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|EMAF||Facial Mask Tightness: A Comparative Study|Facial Mask Tightness: A Comparative Study|Recruiting||N/A|70|Anticipated|University Hospital, Limoges||2|||f||||f||||||||No||2017-10-10 22:11:06.422665|2017-10-10 22:11:06.422665
NCT02778971|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-07-05|||June 2016||2016-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|IMPACT||Implications for Management of PET Amyloid Classification Technology|Implications for Management of PET Amyloid Classification Technology|Recruiting||N/A|50|Anticipated|University of Utah|||1||f||||t||||||||||2017-10-10 22:11:06.492891|2017-10-10 22:11:06.492891
NCT02778958|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-30|||January 2016||2016-01-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Comparisons of iv Ibuprofen and iv Paracetamol During Bariatric Surgery|Comparisons of iv Ibuprofen and iv Paracetamol for Postoperative Pain Levels and Opioid Consumption During Bariatric Surgery|Completed||Phase 4|32|Actual|Inonu University||2|||f||||f||||||||No||2017-10-10 22:11:06.624864|2017-10-10 22:11:06.624864
NCT02778945|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-08-10|||September 2016||2016-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Neuromuscular Blockade for Optimising Surgical Conditions During Spinal Surgery|Deep Versus Moderate Neuromuscular Blockade for Optimising Surgical Conditions Include Patient Benefits During Spinal Surgery: A Randomized Controlled Double Blinded Clinical Study|Not yet recruiting||N/A|66|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-10-10 22:11:06.703575|2017-10-10 22:11:06.703575
NCT02778932|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-11-24|||May 2016||2016-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|ITNLMAPPV||Comparison of Intubation and Laryngeal Mask for Pars Plana Vitrectomy|Comparison of Immobilization Quality During General Anesthesia for Pars Plana-vitrectomy With and Without Neuromuscular Blockade and Endotracheal Intubation Measured by a Questionnaire|Completed||N/A|160|Actual|University of Schleswig-Holstein|||2||f||||f||||||||||2017-10-10 22:11:06.90811|2017-10-10 22:11:06.90811
NCT02778919|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-20||||||May 2016|2016-05-01||||March 2019|Anticipated|2019-03-01||Interventional|||Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis||Recruiting||Phase 2|||Kissei Pharmaceutical Co., Ltd.||6|||f||||||||||||||2017-10-10 22:11:07.000127|2017-10-10 22:11:07.000127
NCT02778906|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-05-20|||November 2014||2014-11-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ARIAA||Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia|Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia (ARIAA)|Recruiting||Phase 3|98|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||No||2017-10-10 22:11:07.09723|2017-10-10 22:11:07.09723
NCT02778893|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-18|||March 2016||2016-03-01|May 2016|2016-05-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Conmana Combined With Thalidomide to Treat NSCLC|A Phase Ⅳ,Open,Multicenter,Single Arm Study to Evaluate the Efficacy of the Combination Conmana With Thalidomide in Patients With NSCLC(Non-Small-Cell-Lung-Cancer)|Recruiting||Phase 4|67|Anticipated|Henan Provincial Hospital||1|||f||||t||||||||Yes||2017-10-10 22:11:07.306854|2017-10-10 22:11:07.306854
NCT02778880|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-04-17|||March 2016||2016-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIME||Pain Reduction With Intranasal Medications for Extremity Injuries|A Randomized Controlled Trial of Intranasal Sub-dissociative Dosing of Ketamine Compared to Intranasal Fentanyl for Treatment of Pain Associated With Acute Extremity Injuries in Children|Active, not recruiting||Phase 3|90|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||No||2017-10-10 22:11:07.426015|2017-10-10 22:11:07.426015
NCT02778867|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-20|||November 2015||2015-11-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|SOFEED||SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study|Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) Followed by Swallowed Glucocorticoid Trial|Recruiting||Phase 2/Phase 3|136|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-10 22:11:07.543297|2017-10-10 22:11:07.543297
NCT02778854|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-02-05|||November 2015||2015-11-01|February 2017|2017-02-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01|5 Years|Observational [Patient Registry]|||Liquid Biopsy for Detection of Driver Mutation in NSCLC|Liquid Biopsy for Detection of Driver Mutation in Diagnostic and Prognostic of NSCLC|Recruiting||N/A|200|Anticipated|Chinese PLA General Hospital|||2||f||||t||||||Samples With DNA|"     body fluid   "|No|considering of personal privacy, the research-related individual participant data do not intend for public sharing.|2017-10-10 22:11:07.735669|2017-10-10 22:11:07.735669
NCT02778841|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-05-17|||November 2014||2014-11-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|FITT||Effects of Exergame, Conventional Exercise, and Mixed Exercise On Proprioception, Balance, & Mobility on Males Elderly|Comparative Effects of Kinect Game ™ Exercise, Conventional Balance Exercise, and Concurrent Exercise On Knee Proprioception, Balance, And Functional Mobility on Males Elderly|Completed||Phase 2|80|Actual|Universiti Putra Malaysia||4|||f||||t||||||||No|I am not prefer to share data now|2017-10-10 22:11:07.85346|2017-10-10 22:11:07.85346
NCT02778828|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-06|||December 10, 2015|Actual|2015-12-10|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LINEZOLIDE||Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis|Determination of Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis MDR-TB|Recruiting||N/A|40|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||||2017-10-10 22:11:07.962747|2017-10-10 22:11:07.962747
NCT02778815|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-07-27|||September 2016||2016-09-01|July 2017|2017-07-01|May 11, 2017|Actual|2017-05-11|May 11, 2017|Actual|2017-05-11||Interventional|||The Development and Initial Evaluation of a Web-based, Compassion-focussed Course for New Mothers|The Development and Initial Evaluation of a Web-based, Compassion-focussed Course for New Mothers|Completed||N/A|272|Actual|Canterbury Christ Church University||2|||f||||f||||||||||2017-10-10 22:11:08.084234|2017-10-10 22:11:08.084234
NCT02778802|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2017-01-01|||June 2016||2016-06-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR|Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post Bronchoscopic Volume Reduction by Histoacryl or Silver Nitrate (Single Center Experince )|Recruiting||N/A|20|Anticipated|Cairo University|||1||f||||f||||||||Yes|Publication in peer reviewed Journal|2017-10-10 22:11:08.168063|2017-10-10 22:11:08.168063
NCT02778789|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-27|||October 2015||2015-10-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|Re-Bone||Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers|Non Randomized Parallel-group Clinical Study to Compare the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers.|Recruiting||N/A|66|Anticipated|University of Erlangen-Nürnberg Medical School|||2||f||||f||||||||||2017-10-10 22:11:08.266692|2017-10-10 22:11:08.266692
NCT02778776|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-19|||January 2013||2013-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome|Effect of Administration of Combination Metformine/Inulin Versus Metformine on Patients With Prostate Benign Hyperplasia and Metabolic Syndrome Syndrome|Completed||Phase 3|40|Actual|Centro Universitario de Ciencias de la Salud, Mexico||4|||f||||f||||||||No||2017-10-10 22:11:08.392851|2017-10-10 22:11:08.392851
NCT02778763|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-07-19|||December 2015||2015-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis|Double Blind, Randomized, Placebo-controlled, Multicenter Pilot Study on Efficacy and Safety of CBLB612 Following Single Administration for Neutropenia Prophylaxis in Breast Cancer Patients Receiving Doxorubicin and Cyclophosphamide Myelosuppressive Chemotherapy|Completed||Phase 2|23|Actual|BioLab 612 LLC||3|||f||||f||||||||||2017-10-10 22:11:08.520105|2017-10-10 22:11:08.520105
NCT02778750|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-12-30|||December 2014||2014-12-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Evaluation Of The Pan-microbiome and Host Immune Response in CF|Evaluation Of The Pan-microbiome and Host Immune Response in Cystic Fibrosis (CF)|Recruiting||N/A|70|Anticipated|New York University School of Medicine|||2||f||||f||||||||||2017-10-10 22:11:08.634355|2017-10-10 22:11:08.634355
NCT02778737|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-20|||September 2013||2013-09-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|ALGEA||Acceptance and Commitment Therapy and Cognitive Behavioral Therapy for Chronic Pain|An Innovative Psychosocial Intervention for the Treatment of Chronic Pain Patients and Their Families|Active, not recruiting||N/A|200|Anticipated|University of Cyprus||2|||f||||f||||||||Yes|Data will be available upon request and after the sponsor's permission.|2017-10-10 22:11:08.741418|2017-10-10 22:11:08.741418
NCT02778724|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-02-20|||January 2014||2014-01-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Observational|||CRAC Observational Study|Observational Study of Interventional Cardiology in Centre Region|Recruiting||N/A|40000|Anticipated|Club Régional des Angioplasticiens de la région Centre|||1||f||||||||||||||2017-10-10 22:11:08.852745|2017-10-10 22:11:08.852745
NCT02778711|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-17|||January 2016||2016-01-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Anti-IL-17 a New Treatment for Contact Dermatititis|Anti-IL-17 a New Treatment for Contact Dermatititis|Recruiting||Phase 3|20|Anticipated|University of Copenhagen||1|||f||||t||||||||||2017-10-10 22:11:08.935935|2017-10-10 22:11:08.935935
NCT02778698|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-08-01||||||August 2017|2017-08-01||||||||Expanded Access|||Compassionate Use of Omegaven|Compassionate Use of an Intravenous Fat Emulsion Comprised of Fish Oil in The Treatment of Parenteral Nutrition Induced Liver Injury in Children|Available||N/A|||Geisinger Clinic|||||||||||||||||||2017-10-10 22:11:09.034438|2017-10-10 22:11:09.034438
NCT02778685|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-09-01|||September 30, 2016|Actual|2016-09-30|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Pembrolizumab, Letrozole, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Stage IV Estrogen Receptor Positive Breast Cancer With Stable Disease That Has Not Responded to Letrozole and Palbociclib|Phase II Study of the Combination of Pembrolizumab, Letrozole and Palbociclib in Postmenopausal Patients With Newly Diagnosed Metastatic Estrogen Receptor Positive Breast Cancer|Recruiting||Phase 2|22|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-10 22:11:09.109846|2017-10-10 22:11:09.109846
NCT02778672|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-09-05|||May 2016||2016-05-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Thermal Imaging of the Lung on a Smartphone to Differentiate Bacterial From Non Bacterial Causes of Pneumonia|Thermal Imaging of the Lung on a Smartphone to Differentiate Bacterial From Non Bacterial Causes of Pneumonia|Completed||N/A|273|Actual|Boston University|||1||f||||f|f|f||||||||2017-10-10 22:11:09.267606|2017-10-10 22:11:09.267606
NCT02778659|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-19|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|CHAM||Hypnotic Intake and Motor and Cognitive Performances at High Altitude|The Effect of Acute Hypnotic Intake Before a Night at High Altitude on Cognitive and Motor Performances|Recruiting||N/A|24|Anticipated|Centre d’Expertise sur l’Altitude EXALT||4|||f||||f||||||||No||2017-10-10 22:11:09.343734|2017-10-10 22:11:09.343734
NCT02778126|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-18|||September 22, 2016|Actual|2016-09-22|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 29, 2017|Actual|2017-04-29||Interventional|||A Study of LY2606368 in Participants With Advanced Cancer|Disposition of [¹⁴C]LY2606368 Following Intravenous Administration in Patients With Advanced and/or Metastatic Solid Tumours|Active, not recruiting||Phase 1|10|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:11:15.703848|2017-10-10 22:11:15.703848
NCT02778646|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-17|||January 2003||2003-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|10 Years|Observational [Patient Registry]|||Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry|Detection of Familial Hypercholesterolaemia Within United Kingdom Based National Disease Registries: A National Institute for Cardiovascular Outcomes Research (NICOR) Study|Completed||N/A|1622948|Actual|University College, London|||2||f||||||||||||||2017-10-10 22:11:09.427556|2017-10-10 22:11:09.427556
NCT02778633|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-19|||August 2013||2013-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Mean Systemic Filling Pressure and Heart Performance Predicting Fluid Responsiveness in Sepsis|Mean Systemic Filling Pressure and Heart Performance as Predictors of Successful Fluid Responsiveness in Patients With Sepsis|Recruiting||N/A|20|Anticipated|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||No|No, data remain anonymized within hospital and property of PI.|2017-10-10 22:11:09.531148|2017-10-10 22:11:09.531148
NCT02778620|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-19|||August 2013||2013-08-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Mean Systemic Filling Pressure and Heart Performance Predicting Fluid Responsiveness in Aortic Valve Replacement|Mean Systemic Filling Pressure and Heart Performance as Predictors of Successful Fluid Responsiveness in Patients With Aortic Valve Replacement|Completed||N/A|27|Actual|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||No|No, data remain anonymized within hospital and property of PI.|2017-10-10 22:11:09.632049|2017-10-10 22:11:09.632049
NCT02778607|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-17|||October 2014||2014-10-01|April 2016|2016-04-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01|5 Years|Observational [Patient Registry]|PROSPECT-M||PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK|PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK|Recruiting||N/A|392|Anticipated|University College, London|||5||f||||f||||||Samples With DNA|"     1. Blood sample collection for: DNA extraction, Peripheral blood lymphocyte storage,          plasma, serum and RNA storage.        2. Brain MRI scan        3. Skin biopsy        4. Cerebro-spinal fluid   "|Yes|Following the first 2 years of the study a data and samples access committee will be established comprised of a representative of each study site together with representatives of the PSP Association and MSA trust, and will be chaired by an independent member who is experienced in the review of sample and tissue requests. The availability of tissue and samples will be publicized by the PSP Association and MSA trust.|2017-10-10 22:11:09.731713|2017-10-10 22:11:09.731713
NCT02778594|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-06-13|||September 2005||2005-09-01|June 2016|2016-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide|Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 3-202 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide (Madopar® HBS 125): a Double-blind, Randomised, Four-way Crossover, Placebo-controlled Study in Healthy Volunteers|Completed||Phase 1|17|Actual|Bial - Portela C S.A.||4|||f||||f||||||||Undecided||2017-10-10 22:11:09.87793|2017-10-10 22:11:09.87793
NCT02778581|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-06-01|||March 2016||2016-03-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment|Randomized, Double Blind, Placebo Controlled Prospective Study, to Evaluate the Effect of a Vegetal Oil in the Disease's Natural Evolution in Patients Diagnosed With Cognitive Impairment or Mild to Moderate Alzheimer Disease.|Recruiting||N/A|110|Anticipated|Team Foods Colombia S.A.||3|||f||||f||||||||No||2017-10-10 22:11:09.990789|2017-10-10 22:11:09.990789
NCT02778568|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-05-23|||January 2010||2010-01-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||Acute Cardiovascular Responses and Chronic Adaptations of Strength Exercise in Intermittent Claudication Patients|Acute Cardiovascular Responses and Chronic Adaptations of Strength Exercise in Intermittent Claudication Patients|Completed||N/A|30|Actual|University of Pernambuco||2|||f||||f||||||||No||2017-10-10 22:11:10.107336|2017-10-10 22:11:10.107336
NCT02778542|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-07-17|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|July 2017|Actual|2017-07-01||Interventional|Way2Text||Bidirectional Text Messaging for Measurement and Motivation of Medication Adherence in Hypertension, a Pilot Study|Bidirectional Text Messaging for Measurement and Motivation of Medication Adherence in Hypertension, a Pilot Study|Active, not recruiting||N/A|150|Anticipated|University of Pennsylvania||3|||f||||||||||||||2017-10-10 22:11:10.298795|2017-10-10 22:11:10.298795
NCT02778529|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-07-11|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|BiAs||Arm Motor Control on Bi and Uni ADLs|Insights Into Impaired Arm Motor Control on Bilateral and Unilateral Functional Activities After Injury: A Kinematic Study|Recruiting||N/A|30|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:11:10.364825|2017-10-10 22:11:10.364825
NCT02778516|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-06-13|||August 2014|Actual|2014-08-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT|Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT|Completed||N/A|42|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-10-10 22:11:10.462135|2017-10-10 22:11:10.462135
NCT02778503|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-10-04|||April 2016||2016-04-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|SLM1797||Effectiveness of Atraumatic Restorative Treatment Using Glass Ionomer Cement of Different Costs|Effectiveness of Atraumatic Restorative Treatment Using Glass Ionomer Cement of Different Costs: a Randomized Controlled Trial|Recruiting||N/A|574|Anticipated|Faculty Sao Leopoldo Mandic Campinas||2|||f||||f||||||||||2017-10-10 22:11:10.540752|2017-10-10 22:11:10.540752
NCT02778490|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-02-03|||June 15, 2016|Actual|2016-06-15|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Observational|||Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton|Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton|Recruiting||N/A|50|Anticipated|San Francisco Veterans Affairs Medical Center|||1||f||||f||||||Samples Without DNA|"     serum, urine   "|No||2017-10-10 22:11:10.639789|2017-10-10 22:11:10.639789
NCT02778477|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-06-20|||May 23, 2016|Actual|2016-05-23|June 2017|2017-06-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|||Topical Multiple Ascending Dose Study for PF-06423264|A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess The Safety, Tolerability And Pharmacokinetics Of Multiple Ascending Doses Of Pf-06423264 Administered Topically To Sequential Cohorts Of Healthy Subjects With And Without Oily Skin|Terminated||Phase 1|65|Actual|Pfizer||18||"Preliminary analysis of accrued data failed to indicate any meaningful pharmacodynamic   response."|f||||f||||||||||2017-10-10 22:11:10.727514|2017-10-10 22:11:10.727514
NCT02778464|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-06-20|||November 8, 2016|Actual|2016-11-08|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|PREGCAL||Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease|PREGCAL: Pilot Study to Assess Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease|Recruiting||N/A|42|Anticipated|The Royal Wolverhampton Hospitals NHS Trust|||4||f||||f||||||Samples Without DNA|"     Faecal calprotectin, faecal S100A12, serum S100 and serum calprotectin   "|No||2017-10-10 22:11:10.834102|2017-10-10 22:11:10.834102
NCT02778451|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-05-18|||May 2013||2013-05-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Certification Standards and Diagnostic Accuracy for Surgeon-performed Ultrasonography|Certification Standards and Diagnostic Accuracy for Surgeon-performed Ultrasonography|Completed||N/A|17|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||No||2017-10-10 22:11:10.918033|2017-10-10 22:11:10.918033
NCT02778438|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-09-26|||February 2016||2016-02-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|REINVENT||A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits|REINVENT:A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits|Completed||N/A|30|Actual|Quintiles, Inc.|||1||f||||f||||||||No||2017-10-10 22:11:10.977101|2017-10-10 22:11:10.977101
NCT02778425|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2017-09-13|||February 2016||2016-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||The Treatment of Hepatocirrhosis and Portal Hypertension|The Treatment of Gastroesophageal Varices Accompanied With Splenomegaly or Hypersplenism of Hepatocirrhosis and Portal Hypertension|Recruiting||N/A|404|Anticipated|Qilu Hospital of Shandong University||7|||f||||t||||||||||2017-10-10 22:11:12.738264|2017-10-10 22:11:12.738264
NCT02778412|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-08-16|||May 2016||2016-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||ctDNA in Patients With Thyroid Nodules|Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for Detection of Thyroid Cancer in Patients Undergoing Diagnostic Fine Needle Aspirations of the Thyroid|Terminated||N/A|66|Actual|Pathway Genomics|||1|Preliminary results indicated that this test had a number of false-negative results.|f||||f||||||Samples With DNA|"     Blood is drawn and DNA is purified from the plasma. The DNA is analyzed for circulating tumor     DNA. The DNA will be stored for up to 10 years with the patient's permission.   "|||2017-10-10 22:11:12.823371|2017-10-10 22:11:12.823371
NCT02778399|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-03-02|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|February 2018|Anticipated|2018-02-01||Interventional|EDELWEISS||A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis|A Randomized, Double-blind, Placebo-controlled, Phase 2b Dose-ranging Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis Associated Pain|Recruiting||Phase 2|330|Anticipated|ObsEva SA||6|||f||||t||||||||||2017-10-10 22:11:12.902399|2017-10-10 22:11:12.902399
NCT02778386|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-09-21|||April 2016||2016-04-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal Patients|Phase I Trial to Assess the Safety and Pharmacokinetics of a Single Ascending Dose (SAD) of N-Methanocarbathymidine (N-MCT) in Normal Volunteers|Active, not recruiting||Phase 1|28|Anticipated|N&N Pharmaceuticals Inc.||4|||f||||t||||||||Undecided||2017-10-10 22:11:13.223656|2017-10-10 22:11:13.223656
NCT02778373|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-17|||September 2014||2014-09-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Comparative Effects of Post-exercise Ingestion of a High or Low Molecular Weight Solution on Resistance Exercise Performance|Comparative Effects of Post-exercise Ingestion of a High or Low Molecular Weight Solution on Resistance Exercise Performance|Completed||N/A|30|Actual|Texas Christian University||3|||f||||f||||||||Yes||2017-10-10 22:11:13.472934|2017-10-10 22:11:13.472934
NCT02778360|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-04-03|||August 2016||2016-08-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Newrofeed||Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder|Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) as Compared With Methylphenidate in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Multicentre Randomized Clinical Study|Recruiting||Phase 1/Phase 2|179|Anticipated|Mensia Technologies SA||2|||f||||f||||||||Undecided||2017-10-10 22:11:13.58238|2017-10-10 22:11:13.58238
NCT02778347|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-05-17|||September 2013||2013-09-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|September 2016|Anticipated|2016-09-01||Observational|ACTI-PALLI||Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs|Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs|Recruiting||N/A|480|Anticipated|Maison Médicale Jeanne Garnier|||1||f||||t||||||||||2017-10-10 22:11:13.816257|2017-10-10 22:11:13.816257
NCT02778334|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-02-19|||April 13, 2015|Actual|2015-04-13|May 2016|2016-05-01|November 11, 2017|Anticipated|2017-11-11|November 11, 2017|Anticipated|2017-11-11||Interventional|COPING||Links Between Depression, Anxiety, Coping and Quality of Life After a Stroke|Links Between Depression, Anxiety, Coping and Quality of Life After a Stroke: Depressive and Anxiety Symptoms and Individual Coping Strategies of the Acute Phase in the Fourth Month as a Factor Influencing Mental Health and Quality of Life|Recruiting||N/A|75|Anticipated|Groupe Hospitalier Paris Saint Joseph||2|||f||||t||||||||||2017-10-10 22:11:13.922509|2017-10-10 22:11:13.922509
NCT02778321|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-04|||November 17, 2014|Actual|2014-11-17|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|January 14, 2017|Actual|2017-01-14||Interventional|SPIDERFLASH||Prospective Study Evaluating the Interest of Long-term Cardiac Recording in Cerebral Infarction|Prospective Study Evaluating the Interest of Long-term Cardiac Recording in Cerebral Infarction|Active, not recruiting||N/A|108|Actual|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||||2017-10-10 22:11:14.076831|2017-10-10 22:11:14.076831
NCT02778308|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-05-18|||January 2012||2012-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma|Randomized Controlled Trial Comparing Adjuvant Chemotherapy Vs. no Chemotherapy for Patients With Carcinoma of Gallbladder Undergoing Curative Resection.|Recruiting||N/A|100|Anticipated|Govind Ballabh Pant Institute of Postgraduate Medical Education and Research||2|||f||||t||||||||No||2017-10-10 22:11:14.163047|2017-10-10 22:11:14.163047
NCT02778295|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-04-25|||May 2016||2016-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Observational|BioFabry||Biomarker for Patients With Fabry Disease|Biomarker for Patients With Fabry Disease - AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectrometry 7,5 ml     EDTA blood or a dry blood spot filter card are taken. To proof the correct diagnosis of a     Fabry disease in those patients where up to the enrollment in the study no genetic testing     has been done, sequencing of a Fabry disease will be done.      The analyses are done in the Centogene AG Schillingallee 68 D-18057 Rostock Germany   "|Undecided||2017-10-10 22:11:14.29735|2017-10-10 22:11:14.29735
NCT02778282|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-01-26|||January 2017|Anticipated|2017-01-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|MySafeRx||MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence|MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence|Not yet recruiting||N/A|70|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||Yes||2017-10-10 22:11:14.403369|2017-10-10 22:11:14.403369
NCT02778269|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-04-06|||June 2016|Actual|2016-06-01|August 2016|2016-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|HypoArrhythmia||Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study|Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease - Validation Study|Completed||N/A|7|Actual|RWTH Aachen University||1|||f||||f||||||||No||2017-10-10 22:11:14.501501|2017-10-10 22:11:14.501501
NCT02778256|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-07-06|||June 2016||2016-06-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of the Effectiveness of Vestibular Stimulation Treatment in the Depressive Phase of Bipolar Disorder|Study of the Effectiveness of Vestibular Stimulation as a Coadjuvant Treatment in the Depressive Phase of Bipolar Disorder|Recruiting||N/A|120|Anticipated|Vest Brain,Centro de Estudios Neurovestibulares||2|||f||||f||||||||Undecided||2017-10-10 22:11:14.607242|2017-10-10 22:11:14.607242
NCT02778243|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-13|||September 2014|Actual|2014-09-01|November 2016|2016-11-01|November 12, 2016|Actual|2016-11-12|November 12, 2016|Actual|2016-11-12||Interventional|STERPROSER||Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level||Completed||N/A|107|Actual|Hopital Foch||2|||f||||f||||||||No||2017-10-10 22:11:14.705489|2017-10-10 22:11:14.705489
NCT02778230|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-16|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|||Efficacy of Pea Hull Fibre Supplementation|Efficacy of Pea Hull Fibre Supplementation on Gastrointestinal Transit Time-induced Reduction in Proteolytic Fermentation and Enhancement of Wellness in Older Adults.|Active, not recruiting||N/A|32|Actual|University of Florida||2|||f||||f|f|f||||||||2017-10-10 22:11:14.812667|2017-10-10 22:11:14.812667
NCT02778217|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-06-10|||May 2016||2016-05-01|June 2016|2016-06-01||||January 2017|Anticipated|2017-01-01||Interventional|||Blastocyst Culture in a Time-lapse Incubator|The Blastocyst Development and Clinical Outcome in Single Step Medium With or Without Renewal on Day 3 in a Time-lapse Incubator|Recruiting||N/A|200|Anticipated|Dar AlMaraa Center||2|||f||||t||||||||Undecided||2017-10-10 22:11:14.912376|2017-10-10 22:11:14.912376
NCT02778204|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-07-11|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection|Phase I Safety and Pharmacokinetic Study of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection|Recruiting||Phase 1|72|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 22:11:15.004699|2017-10-10 22:11:15.004699
NCT02778191|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-16|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma|Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma|Completed||N/A|413|Actual|University Medical Center Groningen|||2||f||||f||||||||||2017-10-10 22:11:15.252771|2017-10-10 22:11:15.252771
NCT02778178|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-05-18|||May 2, 2016|Actual|2016-05-02|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|TAP-LIF||TAP Block Efficacy After Lumbar Spine Surgery Through Anterior Approach: a Randomized, Placebo-controlled Study|Analgesic Efficacy of Transversus Abdominis Plane (TAP) Block After Lumbar Spine Surgery Through Anterior Approach (Anterior Lumbar or Direct Lateral Interbody Fusion): a Prospective, Randomized, Double-blind Placebo-controlled Study|Completed||Phase 4|40|Actual|University Hospital, Lille||2|||f||||t|f|f||||||No||2017-10-10 22:11:15.360377|2017-10-10 22:11:15.360377
NCT02778165|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-18|||July 2016||2016-07-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|MyCaRe||My Cardiac Recovery (MyCaRe): A Pilot RCT.|My Cardiac Recovery (MyCaRe): A Pilot RCT to Examine the Effect of MyCaRe Android Application on Recovery Outcomes and Enrolment in Cardiac Rehab Post Cardiac Surgery.|Not yet recruiting||N/A|40|Anticipated|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 22:11:15.491075|2017-10-10 22:11:15.491075
NCT02778152|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-08|||April 2016||2016-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Pilot Study of Laser Hair Depilation for Pilonidal Disease|Pilonidal Disease Laser Depilation Pilot Study|Enrolling by invitation||Phase 1|10|Anticipated|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-10 22:11:15.558773|2017-10-10 22:11:15.558773
NCT02778139|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2017-04-03|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Observational|||An Exploratory Study on the Risk Behaviours and Its Associated Psychosocial Factors in Hong Kong Chinese Youth Smokers|An Exploratory Study on the Risk Behaviours and Its Associated Psychosocial Factors in Hong Kong Chinese Youth Smokers|Completed||N/A|224|Actual|The University of Hong Kong|||2||f||||f||||||||No||2017-10-10 22:11:15.631589|2017-10-10 22:11:15.631589
NCT02778113|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-18|||October 2011||2011-10-01|May 2016|2016-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults|A Single Site, Randomized, Four-Way, Four-Period PK/PD Crossover Phase 1 Clinical Study in 16 Fasted Healthy Adult Volunteers Receiving 3 Dose Levels of Intranasally Administered Glucagon and One Dose Level of Glucagon Administered by Subcutaneous Injection|Completed||Phase 1|16|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:11:15.792263|2017-10-10 22:11:15.792263
NCT02778100|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-18|||March 2013||2013-03-01|May 2016|2016-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study of LY900018 in Participants With a Common Cold|A Phase 1 Study to Evaluate the Effects of Common Cold and of Concomitant Administration of Nasal Decongestant on the Pharmacokinetics and Pharmacodynamics of a Novel Glucagon Formulation in Otherwise Healthy Subjects|Completed||Phase 1|36|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:11:15.88491|2017-10-10 22:11:15.88491
NCT02778087|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-01-09|||January 2017||2017-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mirror Therapy After Stroke: A Dosing Study|Self-directed Box (Mirror) Therapy After Stroke: A Dosing Study|Recruiting||Phase 2/Phase 3|45|Anticipated|Columbia University||3|||f||||f||||||||No||2017-10-10 22:11:15.987096|2017-10-10 22:11:15.987096
NCT02778074|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-02-06|||February 6, 2017|Actual|2017-02-06|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Internet-guided Cognitive Behavioural Therapy to Improve Depression Patients With Cardiovascular Disease|Internet-guided Cognitive Behavioural Therapy to Improve Depression in Patients With Cardiovascular Disease|Recruiting||N/A|140|Anticipated|University Hospital, Linkoeping||2|||f||||f|f|f||||||||2017-10-10 22:11:16.090597|2017-10-10 22:11:16.090597
NCT02778061|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-18|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||IUB(TM) SCu300B - Post Marketing Performance Study in Austria|A Retrospective, Post-marketing Study of the Expulsion Rate, Efficacy and Satisfaction From Use of the IUB(TM) SCu300B MIDI Spherical Copper Intrauterine Device in Austria|Not yet recruiting||N/A|200|Anticipated|Ocon Medical Ltd.|||1||f||||f||||||||No||2017-10-10 22:11:16.185196|2017-10-10 22:11:16.185196
NCT02778048|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-07-19|||April 2016||2016-04-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||BAFIARS - Biomedical Assessment of Function and Imaging of the Ano-rectal Sphincter|Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor - An Observational Single Center Study on Patients Suffering From Fecal Incontinence.|Suspended||N/A|50|Anticipated|University Hospital Inselspital, Berne|||1||f||||t||||||||||2017-10-10 22:11:16.25024|2017-10-10 22:11:16.25024
NCT02778035|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-18|||April 2016||2016-04-01|May 2016|2016-05-01||||October 2018|Anticipated|2018-10-01||Interventional|||Comparing Different Patterns of rTMS in Major Depression|A Randomized Controlled Trial Comparing Different Patterns of Repetitive Transcranial Magnetic Stimulation in the Treatment of Refractory Depression|Recruiting||N/A|180|Anticipated|University Health Network, Toronto||3|||f||||||||||||||2017-10-10 22:11:16.357957|2017-10-10 22:11:16.357957
NCT02778022|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-11-18|||May 2016||2016-05-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PriCARE||Child Adult Relationship Enhancement in Pediatric Primary Care Parenting Group to Reduce Child Behavior Problems|Child Adult Relationship Enhancement in Pediatric Primary Care Parenting Group to Reduce Child Behavior Problems|Recruiting||N/A|360|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||No||2017-10-10 22:11:16.455846|2017-10-10 22:11:16.455846
NCT02778009|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-08-16|||July 7, 2016|Actual|2016-07-07|July 2017|2017-07-01|June 3, 2017|Actual|2017-06-03|June 3, 2017|Actual|2017-06-03||Interventional|FitPhysician||Fit Physicians: Use of Activity Monitors and Activity Integration Program in First Year Medical Students|Fit Physicians: A Novel Physical Activity Integration Program to Improve Fitness and Activity in Medical Students: A Randomized Pilot Study|Completed||N/A|124|Actual|New York Institute of Technology||3|||f||||f||||||||||2017-10-10 22:11:16.572007|2017-10-10 22:11:16.572007
NCT02777996|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-19|||September 2003||2003-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ITALUNG||Italian Lung Cancer Screening Trial (ITALUNG)|An Italian Randomized Trial for the Evaluation of the Efficacy of Lung Cancer Screening With Low Dose Computed Tomography. The ITALUNG Study.|Completed||N/A|3106|Actual|Cancer Prevention and Research Institute, Italy||2|||f||||f||||||||Yes|European Collaboration of Randomized Controlled Trial (RCT) in lung cancer screening|2017-10-10 22:11:16.6649|2017-10-10 22:11:16.6649
NCT02777983|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-12-06|||March 2016||2016-03-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|MOBIL||MOBile Instruction for Low Back Pain (MOBIL)|Brief Mobile Education at the Point of Care to Influence Healthcare Decisions Related Low Back Pain Management in Primary Care|Active, not recruiting||N/A|220|Actual|Brooke Army Medical Center||2|||f||||f||||||||Yes|Requests for data must go through a Data Sharing Agreement Application submitted and approved through the Defense Health Agency|2017-10-10 22:11:16.748863|2017-10-10 22:11:16.748863
NCT02777970|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-02-09|||April 2016||2016-04-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|DAVID||Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar|Analgesic Efficacy of Oral Dexketoprofen Trometamol/Tramadol Hydrochloride Versus Tramadol Hydrochloride/Paracetamol: a Randomised, Double-blind, Placebo and Active-controlled, Parallel Group Study in Moderate to Severe Acute Pain After Removal of Impacted Lower Third Molar (Dexketoprofen Analgesic eVolution wIth tramaDol- DAVID Study)|Active, not recruiting||Phase 4|640|Anticipated|Menarini Group||3|||f||||f||||||||||2017-10-10 22:11:16.83428|2017-10-10 22:11:16.83428
NCT02777957|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-18|2016-05-18|||December 2008||2008-12-01|May 2016|2016-05-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01|3 Years|Observational [Patient Registry]|||Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases|Predictors and Survival in Pulmonary Hypertension Associated With Severe Lung Disease|Recruiting||N/A|200|Anticipated|Silesian Centre for Heart Diseases|||2||f||||f||||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 22:11:16.954885|2017-10-10 22:11:16.954885
NCT02777944|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-02-03|||October 2016||2016-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|||Motivate: A Web-based Intervention|Motivate: A Web Based Intervention to Increase Attendance at an Eating Disorder Service|Enrolling by invitation||N/A|180|Anticipated|Bournemouth University||2|||f||||f||||||||No|Group data will be publicly available on completion|2017-10-10 22:11:17.025014|2017-10-10 22:11:17.025014
NCT02777931|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-03-06|||June 2016||2016-06-01|January 2017|2017-01-01|February 17, 2017|Actual|2017-02-17|February 10, 2017|Actual|2017-02-10||Interventional|||Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD|A Multicenter, 6-week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of NFC-1 in Adolescents (Ages 12-17) With Genetic Disorders Impacting Metabotropic Glutamate Receptors and ADHD|Completed||Phase 2/Phase 3|90|Anticipated|Aevi Genomic Medicine||2|||f||||f||||||||Undecided||2017-10-10 22:11:17.106037|2017-10-10 22:11:17.106037
NCT02777918|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-02-03|||June 2016|Actual|2016-06-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Changing Habits and Lifestyles in Older Individuals|Changing Habits and Lifestyles in Older Individuals|Enrolling by invitation||N/A|100|Anticipated|Bournemouth University||2|||f||||f||||||||No|Group data will be made available on publication of the study|2017-10-10 22:11:17.178277|2017-10-10 22:11:17.178277
NCT02777905|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-11-01|||September 2016||2016-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Mindfulness-Based Cognitive Therapy for Depression and Anxiety|Group Mindfulness-Based Cognitive Therapy for the Treatment of Late-Life Depression and Anxiety Symptoms in Primary Care: A Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Lady Davis Institute||2|||f||||f||||||||||2017-10-10 22:11:17.245333|2017-10-10 22:11:17.245333
NCT02777892|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-15|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|PulmonicS3||Pulmonic SAPIEN S3™ THV Registry|Pulmonic SAPIEN S3™ THV Registry A Multi-center, Observational Registry With Retrospective Enrollment of Patients That Underwent Transcatheter Pulmonic Valve Implantation and a Retrospective or Prospective Follow-up|Recruiting||N/A|50|Anticipated|Institut für Pharmakologie und Präventive Medizin|||1||f||||f||||||||||2017-10-10 22:11:17.332913|2017-10-10 22:11:17.332913
NCT02777879|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-12-30|||May 2014||2014-05-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Lung Microbiome and Inflammation in Early COPD|Lung Microbiome and Inflammation in Early Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|116|Anticipated|New York University School of Medicine|||2||f||||f||||||Samples With DNA|"     Microbial DNA will be extracted from sputum and BAL fluid. Variable 16S rRNA gene regions     will be amplified by PCR using bar-coded primers flanking a portion of marker gene. PCR     products will be sequenced in the NYU Genome Technology Center using MiSeq platform     (Illumina).   "|||2017-10-10 22:11:17.430114|2017-10-10 22:11:17.430114
NCT02777866|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-18|||May 2016||2016-05-01|April 2016|2016-04-01||||January 2017|Anticipated|2017-01-01||Interventional|LAW||LAW Trial -The Impact of Local Anesthetics Infiltration in Surgical Wound of Gastrointestinal Procedures|LAW Trial -The Impact of Local Anesthetics Infiltration in Surgical Wound of Gastrointestinal Procedures: A Blind Prospective Randomized Trial|Recruiting||N/A|570|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-10 22:11:17.65146|2017-10-10 22:11:17.65146
NCT02777853|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-08-23|||May 2016||2016-05-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||The Effect of Tea on Vascular Function and Insulin Sensitivity|Can Tea Prevent Impairments in Vascular Function and Insulin Sensitivity Induced by 7-days Physical Inactivity and Overfeeding in Healthy Men|Completed||N/A|12|Actual|Liverpool John Moores University||2|||f||||f||||||||||2017-10-10 22:11:17.745193|2017-10-10 22:11:17.745193
NCT02777840|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-10-03|||March 2015|Actual|2015-03-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|THRIVE/RSI 1||High Flow Oxygen With THRIVE Gives Better Oxygenation in Rapid Sequence Induction Patients|High Flow Oxygen With THRIVE Gives Better Oxygenation in Rapid Sequence Induction Patients|Recruiting||N/A|80|Anticipated|St George's, University of London||2|||f||||t||||||||||2017-10-10 22:11:17.841185|2017-10-10 22:11:17.841185
NCT02777827|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-12-19|||June 2016||2016-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma|A Randomised, Double-Blinded, Double-Dummy, Placebo-Controlled, MultiCentre-, Six-Way, Crossover Study to Assess the Pharmacodynamics, Pharmacokinetics, and Safety of Abediterol Single Dose, Given by Dry Powder Inhaler (DPI) or Pressurised Metered-Dose Inhaler (pMDI), in Patients With Asthma on Inhaled Corticosteroids|Completed||Phase 1|42|Actual|AstraZeneca||6|||f||||f||||||||||2017-10-10 22:11:17.936704|2017-10-10 22:11:17.936704
NCT02777775|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-05-17|||May 2016||2016-05-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.|Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.|Recruiting||N/A|74|Anticipated|Spectrum Health Hospitals|||1||f||||t||||||Samples With DNA|"     Harvesting CNFs from 3 groups of subjects in order to obtain a minimum of 18 tumors in three     size categories: <5mm, 5-10mm, and >1cm   "|No||2017-10-10 22:11:18.357266|2017-10-10 22:11:18.357266
NCT02777749|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-07-19|||July 19, 2016|Actual|2016-07-19|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|September 19, 2017|Anticipated|2017-09-19||Interventional|||Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty|Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty|Recruiting||Phase 4|250|Anticipated|Columbia University||5|||f||||t|t|f|||f|||||2017-10-10 22:11:18.540806|2017-10-10 22:11:18.540806
NCT02777736|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-06-03|||July 2015||2015-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CLSG-CNS-001||CNS Prophylaxis in Diffuse Large B-cell Lymphoma|Study Evaluating Relapses in Central Nervous System in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemotherapy With or Without CNS Prophylaxis. Multicentric, Prospective, Randomized Phase III Study|Recruiting||Phase 3|500|Anticipated|Czech Lymphoma Study Group||3|||f||||f||||||||No||2017-10-10 22:11:18.66786|2017-10-10 22:11:18.66786
NCT02777723|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-05-17|||May 2016||2016-05-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Study to Evaluate the Efficacy and Safety of CKD-350|Active Controlled, Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-350 Eye Drops in Patients With Dry Eye Syndrome|Recruiting||Phase 3|138|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||No||2017-10-10 22:11:18.790253|2017-10-10 22:11:18.790253
NCT02777710|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-13|||June 2016||2016-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|MEDIPLEX||Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers|A Dose Escalation Phase I Study With an Extension Part Evaluating the Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With a Small Molecule CSF-1R Tyrosine Kinase Inhibitor (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers|Recruiting||Phase 1|58|Anticipated|Centre Leon Berard||1|||f||||t||||||||||2017-10-10 22:11:18.945347|2017-10-10 22:11:18.945347
NCT02777697|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-20|||March 2016||2016-03-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Observational|CanoPEe||Cancer Chronic Pain Predicted by Emotional and Cognitive Status|Cancer Chronic Pain Predicted by Emotional and Cognitive Status|Recruiting||N/A|360|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 22:11:19.061963|2017-10-10 22:11:19.061963
NCT02777684|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-17|||June 2014||2014-06-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Motivators and Barriers to Physical Activity in Knee Osteoarthritis Patients: a Qualitative Study|Motivators and Barriers to Physical Activity in Knee Osteoarthritis Patients: a Qualitative Study|Completed||N/A|27|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 22:11:19.170713|2017-10-10 22:11:19.170713
NCT02777671|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-17|||October 2007||2007-10-01|May 2016|2016-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers|Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers|Completed||Phase 1|20|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 22:11:19.250185|2017-10-10 22:11:19.250185
NCT02777658|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-22|||May 26, 2016|Actual|2016-05-26|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30|36 Months|Observational [Patient Registry]|PANORAMA||PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC|PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes in Patients With EGFR Mutation-Positive Locally Advanced or Advanced NSCLC|Recruiting||N/A|800|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-10-10 22:11:19.336045|2017-10-10 22:11:19.336045
NCT02777645|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-18|||March 2016||2016-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Growth, Dietary Intakes and Feeding Behaviors of Children With Cerebral Palsy Who Have Chewing Disorders|Growth, Dietary Intakes and Feeding Behaviors of Children With Cerebral Palsy Who Have Chewing Disorders|Completed||N/A|85|Actual|Hacettepe University|||2||f||||f||||||||Undecided||2017-10-10 22:11:19.578519|2017-10-10 22:11:19.578519
NCT02777632|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-02-02|||January 2014||2014-01-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Resistant Bacterial Infections in the Early Post LDLT Period|Resistant Bacterial Infections in the Early Post LDLT Period|Completed||N/A|45|Actual|Ain Shams University|||2||f||||||||||||||2017-10-10 22:11:19.661008|2017-10-10 22:11:19.661008
NCT02777619|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-07-27|||January 2016||2016-01-01|May 2016|2016-05-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|PIPDIA||Pharmacodynamic Interactions of Propofol and Dexmedetomidine on Intravenous Anesthesia|Pharmacodynamic Interactions of Propofol and Dexmedetomidine on Target-controlled Infusion Intravenous Anesthesia During the Induction|Completed||Phase 4|64|Actual|Guangzhou General Hospital of Guangzhou Military Command||4|||f||||f||||||||No||2017-10-10 22:11:19.727039|2017-10-10 22:11:19.727039
NCT02777606|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2017-07-29|||June 2016||2016-06-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||The Efficacy of Si-Ni-Tang (a Chinese Herbal Formula) for Severe Sepsis||Recruiting||N/A|100|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||||||||||||2017-10-10 22:11:19.82843|2017-10-10 22:11:19.82843
NCT02777593|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-29|||August 2016||2016-08-01|September 2017|2017-09-01|July 2023|Anticipated|2023-07-01|July 2019|Anticipated|2019-07-01||Interventional|SSB 11-02||Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)|Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta|Recruiting||N/A|285|Anticipated|W.L.Gore & Associates||2|||f||||t||||||||||2017-10-10 22:11:19.919803|2017-10-10 22:11:19.919803
NCT02777580|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-08-14|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|STREAM-2||STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction|STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction|Recruiting||Phase 4|600|Anticipated|Katholieke Universiteit Leuven||2|||f||||t|f|f||||||||2017-10-10 22:11:20.12754|2017-10-10 22:11:20.12754
NCT02777203|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-01-17|||May 2016||2016-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy|Safety and Efficacy of Contained Electromechanical Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy|Recruiting||N/A|60|Anticipated|Advocate Health Care||2|||f||||t||||||||No||2017-10-10 22:11:23.679276|2017-10-10 22:11:23.679276
NCT02777567|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-09-18|||September 29, 2016|Actual|2016-09-29|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|KOREA||KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)|Open Label, Multicenter, Real World Treatment Study of Single Agent Tagrisso for Patients With Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR) T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC), Who Have Progressed on or After EGFR Tyrosine Kinase Receptor (TKI) Therapy|Recruiting||N/A|300|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-10 22:11:20.247567|2017-10-10 22:11:20.247567
NCT02777554|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-03-02|||August 17, 2016|Actual|2016-08-17|March 2017|2017-03-01|November 22, 2016|Actual|2016-11-22|November 22, 2016|Actual|2016-11-22||Interventional|||An Open Label Study to Evaluate the Pharmacokinetic Exposure of Apremilast in Healthy Subjects|A Phase 1, Open Label, Randomized, Two Part Study to Evaluate the Pharmacokinetic Exposure of a Once-Daily (QD) Apremilast Formulation Relative to the Twice-Daily (BID) Reference Immediate Release (IR) Tablet and the Effect of Food on the QD Apremilast Formulation in Healthy Subjects.|Completed||Phase 1|164|Actual|Celgene||6|||f||||||||||||||2017-10-10 22:11:20.307545|2017-10-10 22:11:20.307545
NCT02777541|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-18|||January 2015||2015-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Evaluation of Tolerance and Safety of Early Enteral Nutrition in Children After Percutaneous Endoscopic Gastrostomy Placement|Evaluation of Tolerance and Safety of Early Enteral Nutrition in Children After Percutaneous Endoscopic Gastrostomy Placement|Recruiting||N/A|100|Anticipated|Children's Memorial Health Institute, Poland||2|||f||||t||||||||||2017-10-10 22:11:20.407198|2017-10-10 22:11:20.407198
NCT02777528|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-29|||August 2016||2016-08-01|September 2017|2017-09-01|July 2024|Anticipated|2024-07-01|July 2020|Anticipated|2020-07-01||Interventional|SSB 11-02||Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)|Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta|Recruiting||N/A|150|Anticipated|W.L.Gore & Associates||2|||f||||t||||||||||2017-10-10 22:11:20.658856|2017-10-10 22:11:20.658856
NCT02777515|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-04|||May 4, 2015|Actual|2015-05-04|February 2017|2017-02-01|December 31, 2015|Actual|2015-12-31|December 5, 2015|Actual|2015-12-05||Interventional|ECLOP||Study of the Immediate Cardiovascular Effects of Electronic Cigarette in Subjects With Cardiovascular Disease|Pilot Study of the Immediate Cardiovascular Effects of Electronic Cigarette in Subjects With Cardiovascular Disease|Terminated||N/A|5|Actual|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||||2017-10-10 22:11:20.889189|2017-10-10 22:11:20.889189
NCT02777502|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-04-20|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Effects of Cannabidiol on Marijuana-seeking in Humans|Effects of Cannabidiol on Marijuana-seeking in Humans|Recruiting||N/A|25|Anticipated|Wayne State University|||1||f||||t||||||||No||2017-10-10 22:11:20.989996|2017-10-10 22:11:20.989996
NCT02777489|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-02|||February 18, 2016||2016-02-18|August 2017|2017-08-01|April 27, 2017|Actual|2017-04-27|January 18, 2017|Actual|2017-01-18||Interventional|GPD-01-01||Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects|Influence of Single Nucleotide Polymorphisms of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects: A Phase II, Multicenter, Double-blind Study|Terminated||Phase 2|140|Actual|Gene PreDiT||1||Unproven hypothesis|f||||f||||||||||2017-10-10 22:11:21.080765|2017-10-10 22:11:21.080765
NCT02777476|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-03-06|||October 2016||2016-10-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Clinical Performance of B-Lite® Light Weight Breast Implant||Recruiting||N/A|120|Anticipated|G&G Biotechnology Ltd.||1|||f||||f||||||||No||2017-10-10 22:11:21.20699|2017-10-10 22:11:21.20699
NCT02777463|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-25|||July 2016||2016-07-01|May 2016|2016-05-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01|2 Years|Observational [Patient Registry]|DIFFERENT||The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.|The Prediction Using Diffusion-weighted MRI of the Response Evaluation in Borderline Resectable Pancreatic Cancer.|Not yet recruiting||N/A|28|Anticipated|Wakayama Medical University|||1||f||||t||||||||||2017-10-10 22:11:21.280538|2017-10-10 22:11:21.280538
NCT02777450|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-05-10|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|September 2016|Actual|2016-09-01||Observational|||Validity and Predictive Value of Manual Clinical Test to Identify Symptomatic Segments in Lumbar Chronic Patients|Validity and Predictive Value of Manual Clinical Test to Identify Symptomatic Segments in Lumbar Chronic Patients|Completed||N/A|93|Actual|Universidad de Zaragoza|||1||f||||t||||||||No|Yes to the pain clinic service|2017-10-10 22:11:21.367204|2017-10-10 22:11:21.367204
NCT02777437|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-17|||October 2016||2016-10-01|May 2016|2016-05-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer|Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer: A Prospective, Multi-Center, Randomized, Open-Label, Parallel Group Clinical Trial|Not yet recruiting||Phase 2/Phase 3|1960|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 22:11:21.478668|2017-10-10 22:11:21.478668
NCT02777424|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-02-03|||January 2016||2016-01-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CLOT-CRANE||Prothrombin Complex Concentrate Versus Fresh Frozen Plasma to Correct Coagulation Disorders in Adult Neurosurgical Patients||Recruiting||Phase 4|46|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 22:11:21.565731|2017-10-10 22:11:21.565731
NCT02777411|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-11-28|||December 2014||2014-12-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 6 to 35 Months Old|An Open-label, Dose-finding, Phase II Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 6 to 35 Months Old|Completed||Phase 2|122|Actual|Enimmune Corporation||7|||f||||t||||||||No||2017-10-10 22:11:21.656794|2017-10-10 22:11:21.656794
NCT02777398|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2017-09-28|||May 2016||2016-05-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|STRICT-TAQ||Surgical Treatment of Intra-spinal Canal Tumors Via Trans-Quadrant Channel|The Prospcetive Randomized Controlled Trial of the Surgical Treatment of Intra-spinal Canal Tumors Using Microsurgical Technique Through Trans-Quadrant Channel Pathway|Enrolling by invitation||N/A|58|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||||2017-10-10 22:11:21.784599|2017-10-10 22:11:21.784599
NCT02777385|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-04|||June 2016||2016-06-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer|Randomized, Phase II Study Evaluating Concurrent or Sequential Fixed-Dose Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy in Intermediate or High Risk, Previously Untreated, Locally Advanced Head and Neck Cancer|Recruiting||Phase 2|44|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 22:11:21.901792|2017-10-10 22:11:21.901792
NCT02777372|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-14|||January 2016||2016-01-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Stress & Premenstrual Symptoms Study|Acoustic Startle Response in Women With Premenstrual Mood Disorders|Recruiting||Phase 4|60|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:11:22.053351|2017-10-10 22:11:22.053351
NCT02777359|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-07-18|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches|Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches:A Prospective,Multicenter,Randomized,Controlled Trial|Recruiting||Phase 2|100|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||f||||||||||2017-10-10 22:11:22.190739|2017-10-10 22:11:22.190739
NCT02777346|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-03-17|||May 2016||2016-05-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Evaluation of Emergency Suturing With Absorbable Versus Non-absorbable Suture Material in a Pediatric Population|Evaluation of Emergency Suturing With Absorbable Versus Non-absorbable Suture Material in a Pediatric Population|Recruiting||N/A|500|Anticipated|Pediatric Clinical Research Platform||2|||f||||f||||||||No||2017-10-10 22:11:22.298126|2017-10-10 22:11:22.298126
NCT02777333|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-16|||January 2016||2016-01-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Simulation-based Arthroscopic Surgery Study|Simulation-based Arthroscopic Surgery Study|Enrolling by invitation||N/A|30|Anticipated|University of Oxford||2|||f||||f||||||||No||2017-10-10 22:11:22.394061|2017-10-10 22:11:22.394061
NCT02777320|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-07-14|||March 2016||2016-03-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department|Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department: A Randomized, Double-Blind, Controlled Trial.|Recruiting||Phase 4|120|Anticipated|Pamukkale University||2|||f||||t||||||||Undecided||2017-10-10 22:11:22.483642|2017-10-10 22:11:22.483642
NCT02777307|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-18|||June 2016||2016-06-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Demonstrate the Effectiveness to Hemopatch in Controlling Postoperative Bleeding After Laparoscopic Cholecistectomy and in Reducing of Morbidity and Postoperative Hospital Stay|Efficacy of Hemopatch in Reducing of Postoperative Bleeding After Laparoscopic Cholecystectomy: Prosective and Multicenter Study|Not yet recruiting||N/A|150|Anticipated|Ospedale Regina Apostolorum||2|||f||||f||||||||||2017-10-10 22:11:22.609119|2017-10-10 22:11:22.609119
NCT02777294|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-17|||May 2012||2012-05-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of Web-Based CBT for Rape Victims|Evaluation of Web-Based CBT for Rape Victims|Completed||N/A|87|Actual|East Carolina University||2|||f||||t||||||||||2017-10-10 22:11:22.70414|2017-10-10 22:11:22.70414
NCT02777281|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-05-16|||September 2015||2015-09-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Safe and Effective Shoulder Exercise Training in Manual Wheelchair Users With SCI|Safe and Effective Shoulder Exercise Training in Manual Wheelchair Users With SCI|Recruiting||Phase 1/Phase 2|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:11:22.767927|2017-10-10 22:11:22.767927
NCT02777268|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-08|2017-02-09||July 2013||2013-07-01|August 2017|2017-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone|A Single Centre, Open Label, Randomised, Crossover Study in Dexamethasone-suppressed Healthy Adult Male Volunteers to Compare the Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone Tablets at a Single Dose of 10 mg and to Evaluate the Dose Proportionality of Infacort® at Doses of 0.5 mg, 2 mg, 5 mg and 10 mg|Completed||Phase 1|16|Actual|Diurnal Limited||5|||f||||f||||||||||2017-10-10 22:11:22.873461|2017-10-10 22:11:22.873461
NCT02777255|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-05-16|||May 2012||2012-05-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|||Severe CAV MRI in Heart Transplant Recipient|Evaluation of Genomic, Structural and Molecular Changes Associated With Severe Cardiac Allograft Vasculopathy in Heart Transplant Recipients|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute|||1|PI left University|f||||f||||||Samples Without DNA|"     Blood samples will be saved in paxgene tubes for RNA sequencing   "|||2017-10-10 22:11:23.307346|2017-10-10 22:11:23.307346
NCT02777242|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-26||2017-09-26|June 2016||2016-06-01|September 2017|2017-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism|An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot® Testosterone 50 mg, 75 mg, or 100 mg by Intended Users and QuickShot™ Summative Usability Study|Completed||Phase 2|66|Actual|Antares Pharma Inc.||1|||f||||f||||||||||2017-10-10 22:11:23.371181|2017-10-10 22:11:23.371181
NCT02777229|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-09-28|||July 2016||2016-07-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|NAMSAL||Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings|A Phase III Randomized, Open Label Trial to Evaluate Dolutegravir Versus Efavirenz 400 mg, Both Combined With Tenofovir Disoproxil Fumarate + Lamivudine for the Initial Management of HIV Infected Adults in Resource-limited Settings|Recruiting||Phase 3|606|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-10 22:11:23.472688|2017-10-10 22:11:23.472688
NCT02777216|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-08-20|||October 2016||2016-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|RDN||ConfidenHT System for Diagnostic Electrical Mapping of Renal Nerves|ConfidenHTTM System Safety and Performance of Diagnostic Electrical Mapping of Renal Nerves in Hypertensive Patients and/or Potential Candidates for a Renal Sympathetic Denervation (RDN) Procedure|Active, not recruiting||N/A|20|Anticipated|Rainbow Medical||1|||f||||f||||||||||2017-10-10 22:11:23.594158|2017-10-10 22:11:23.594158
NCT02777190|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-06-08|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor|A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor|Recruiting||Phase 4|110|Anticipated|Milton S. Hershey Medical Center||2|||f||||t|t|f||||||No||2017-10-10 22:11:23.766798|2017-10-10 22:11:23.766798
NCT02777177|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-05-26|||May 2016||2016-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Ecological Momentary Assessment of Behavioral and Psychosocial Predictors of Weight Loss Following Bariatric Surgery|Ecological Momentary Assessment of Behavioral and Psychosocial Predictors of Weight Loss Following Bariatric Surgery|Recruiting||N/A|100|Anticipated|The Miriam Hospital|||1||f||||f||||||||No||2017-10-10 22:11:23.885762|2017-10-10 22:11:23.885762
NCT02777164|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-18|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer|Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer|Recruiting||N/A|800|Anticipated|Real Imaging Ltd.||1|||f||||t||||||||||2017-10-10 22:11:23.96449|2017-10-10 22:11:23.96449
NCT02777151|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-12-15|||May 2016||2016-05-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Study of Safety, Tolerability, and Pharmacokinetics of REGN3470-3471-3479 in Healthy Adult Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenously Administered REGN3470-3471-3479 in Healthy Adult Subjects|Active, not recruiting||Phase 1|24|Actual|Regeneron Pharmaceuticals||4|||f||||f||||||||No||2017-10-10 22:11:24.063327|2017-10-10 22:11:24.063327
NCT02777138|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-16|||May 2016||2016-05-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Impact of Ageing on Adipose, Muscle and Systemic Inflammation|Impact of Ageing on Adipose, Muscle and Systemic Inflammation|Recruiting||N/A|24|Anticipated|University of Bath|||2||f||||f||||||Samples With DNA|"     muscle and adipose biopsies blood plasma blood serum peripheral blood mononuclear cells   "|Yes||2017-10-10 22:11:24.145188|2017-10-10 22:11:24.145188
NCT02777125|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-08-14|2017-05-20||October 2014||2014-10-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers|A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers|Completed||N/A|980|Actual|Le Bonheur Children's Hospital|Unblinded study, eligible subjects may have been overlooked for fear of treatment failure. Recheck times were not standardized possibly affecting EDLOS and tachycardia. Baseline acuity differences between cohorts.|2|||f||||f||||||||||2017-10-10 22:11:24.258497|2017-10-10 22:11:24.258497
NCT02777112|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-10-17|||September 2016||2016-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||The Effects of E-mental Health Program and Job Coaching on the Risk of Major Depression in Canadian Working Men|The Effects of E-mental Health Program and Job Coaching on the Risk of Major Depression and Productivity in Canadian Male Workers|Recruiting||N/A|1200|Anticipated|University of Calgary||3|||f||||t||||||||Undecided|Need to discuss with the ethics review board regarding the format of data sharing.|2017-10-10 22:11:24.788659|2017-10-10 22:11:24.788659
NCT02777099|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-27|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|IRAS||Impact of Remote Ischemic Postconditioning on Autonomic Function in Stroke Patients|Impact of Remote Ischemic Postconditioning on Autonomic Function and Prognosis in Clients With Acute Ischemic Stroke|Recruiting||N/A|150|Anticipated|Guangzhou University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 22:11:24.937221|2017-10-10 22:11:24.937221
NCT02777086|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-05-16|||September 2015||2015-09-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|DRR2||Sustainable HIV Risk Reduction Strategies for Probationers|Sustainable HIV Risk Reduction Strategies for Criminal Justice (CJ) Systems|Recruiting||N/A|1200|Anticipated|Texas Christian University||2|||f||||f||||||||Yes|De-identified data files will be prepared at the conclusion of the study to be embargoed for two years after the end of grant funding for archiving in the National Addiction and HIV Data Archives (NAHDAP) funded by the National Institute on Drug Abuse (NIDA) and hosted by the Inter-university Consortium for Political and Social Research, which is part of the University of Michigan's Institute for Social Research. NAHDAP archives and preserves data produced by research grants to support secondary data analysis by other researchers.|2017-10-10 22:11:25.08954|2017-10-10 22:11:25.08954
NCT02777073|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-02-08|||March 2016||2016-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|1974||Effects of Single Doses of Liraglutide and Dapagliflozin on Hyperglycemia and Ketogenesis in Type 1 Diabetes|Effects of Single Doses of Liraglutide and Dapagliflozin on Hyperglycemia and Ketogenesis in Type 1 Diabetes|Completed||Phase 3|2|Actual|University at Buffalo||3|||f||||t||||||||No||2017-10-10 22:11:25.21128|2017-10-10 22:11:25.21128
NCT02777060|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-05-16|||September 2014||2014-09-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures|Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures|Recruiting||N/A|200|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-10 22:11:25.331505|2017-10-10 22:11:25.331505
NCT02777047|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-18|||April 2017||2017-04-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Anticoagulant Safety at Hospital Discharge|Improving Anticoagulant Safety at Hospital Discharge: A Randomized Trial|Not yet recruiting||N/A|150|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||t||||||||Undecided||2017-10-10 22:11:25.452901|2017-10-10 22:11:25.452901
NCT02777034|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-18|||May 2016||2016-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Laparoscopy Combined With Enhanced Recovery Pathway|Short-Term Outcomes of Laparoscopy Combined With Enhanced Recovery Pathway After Ileocolon Resection for Crohn's Disease|Recruiting||N/A|30|Anticipated|Sir Run Run Shaw Hospital||2|||f||||t||||||||Yes||2017-10-10 22:11:25.55481|2017-10-10 22:11:25.55481
NCT02777021|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-01-13|||September 2016||2016-09-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|Aim 3||Home Away From Home - Quality of Life Surveys|Home or Away From Home: Comparing Patient and Caregiver Reported Quality of Life (QoL) and Other Patient-centered Outcomes for Inpatient Versus Outpatient Management of Neutropenia in Children With AML|Recruiting||N/A|118|Anticipated|Children's Hospital of Philadelphia|||2||f||||f||||||||No|only aggregate and de-identified data will be shared upon appropriate request.|2017-10-10 22:11:25.679121|2017-10-10 22:11:25.679121
NCT02777008|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-03-10|||May 2016||2016-05-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects|A Two-Part Single Center, Randomized, Sequential, Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTP-543 in Healthy Volunteers|Completed||Phase 1|77|Actual|Concert Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:11:25.831474|2017-10-10 22:11:25.831474
NCT02776995|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-19|||November 2014||2014-11-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Tumor Monitoring Using Thermography During Radiation Therapy|Tumor Monitoring Using Thermography During Radiation Therapy|Recruiting||N/A|80|Anticipated|Sheba Medical Center||1|||f||||f||||||||No||2017-10-10 22:11:25.917031|2017-10-10 22:11:25.917031
NCT02776982|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-08-01|||November 2016||2016-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Influence of Central Obesity on the Esophageal Epithelial Barrier|Influence of Central Obesity on the Esophageal Epithelial Barrier|Recruiting||N/A|40|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:11:26.007299|2017-10-10 22:11:26.007299
NCT02776969|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-12-14|||July 1998||1998-07-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Gene Hunting Study for Familial Papillary Thyroid Cancer|A Strategy to Search for Genes Predisposing to Papillary Carcinoma of the Thyroid When Mutated|Recruiting||N/A|1200|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||f||||||Samples With DNA|"     DNA, RNA, and (in some cases) lymphoblastoid cell lines will be maintained in the OSU     Division of Human Genetics Sample Bank for the duration of the study.   "|No||2017-10-10 22:11:26.109919|2017-10-10 22:11:26.109919
NCT02776956|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-18|||April 2016||2016-04-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy|Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy|Recruiting||N/A|180|Anticipated|The Second Hospital of Hebei Medical University||2|||f||||||||||||||2017-10-10 22:11:26.189121|2017-10-10 22:11:26.189121
NCT02776943|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-05-16|||June 2016||2016-06-01|January 2016|2016-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||UCMSC Transplantation in the Treatment of Cartilage Damage|Phase I/II Study of Umbilical Cord Mesenchymal Stem Cell Implantation in the Treatment of Articular Cartilage Defect of Knee and Knee Osteoarthritis|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|South China Research Center for Stem Cell and Regenerative Medicine||2|||f||||t||||||||No||2017-10-10 22:11:26.276899|2017-10-10 22:11:26.276899
NCT02776930|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-12-06|||January 2016||2016-01-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Observational|MP3-RD||Predictive Models for Spine and Lower Extremity Injury After Discharge From Rehab|Development of Predictive Models for Lower Extremity, Lumbar, and Thoracic Injury After Discharge From Physical Rehabilitation|Recruiting||N/A|480|Anticipated|Brooke Army Medical Center|||1||f||||f||||||||Undecided|Data sharing must be requested and approved through the Defense Health Agency via a Data Sharing Agreement Application|2017-10-10 22:11:26.370821|2017-10-10 22:11:26.370821
NCT02776917|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-05-10|||January 2018|Anticipated|2018-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer|A Phase 1 Clinical Trial to Determine the Safety and Tolerability of Cirmtuzumab, an Anti-ROR1 Monoclonal Antibody, in Combination With Paclitaxel for the Treatment of Patients With Metastatic or Locally Advanced Unresectable Breast Cancer|Not yet recruiting||Phase 1|12|Anticipated|University of California, San Diego||1|||f||||t|t|f||||||No||2017-10-10 22:11:26.49845|2017-10-10 22:11:26.49845
NCT02776904|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-29|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Movement Assessment for Concussion Management|Comprehensive Dynamic Movement Assessment for Concussion Management|Enrolling by invitation||N/A|270|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-10-10 22:11:26.595721|2017-10-10 22:11:26.595721
NCT02776891|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-06-07|||May 2016||2016-05-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Protein Expression in Diffuse Large B-Cell Lymphoma|A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Protein Expression in Diffuse Large B-Cell Lymphoma|Recruiting||N/A|20|Anticipated|University of California, San Francisco||1|||f||||t||||||||No||2017-10-10 22:11:26.688843|2017-10-10 22:11:26.688843
NCT02776878|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-17|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|||A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST|A Prospective, Single-arm, Multi-center Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in RefrActory MetAstatic Gastrointestinal Stromal Tumor|Recruiting||N/A|57|Anticipated|Beijing Cancer Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:11:26.794954|2017-10-10 22:11:26.794954
NCT02776865|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-17|||October 2015||2015-10-01|March 2016|2016-03-01||||October 2016|Anticipated|2016-10-01||Interventional|2015/8/1||Does Ultrasound-guided Suprascapular Nerve Block Provide Additional Benefit Over Traditional Rehabilitation Program for Patients With Chronic Shoulder Pain|Does Ultrasound-guided Suprascapular Nerve Block Provide Additional Benefit|Recruiting||N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-10 22:11:26.920223|2017-10-10 22:11:26.920223
NCT02776852|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2016-05-19|||August 2015||2015-08-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SPF Assay||18519 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment - Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:11:27.001803|2017-10-10 22:11:27.001803
NCT02776839|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-06-01|||March 2015||2015-03-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MOSS||Mobile Sensing and Support for Depression|Monocentric Study for Development of a Smartphone Application for Patients With Depressive|Completed||N/A|126|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 22:11:27.069004|2017-10-10 22:11:27.069004
NCT02776826|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-06-06|||July 2016||2016-07-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|5 Months|Observational [Patient Registry]|WBDR||World Bleeding Disorders Registry|World Bleeding Disorders Registry Pilot Phase|Not yet recruiting||N/A|300|Anticipated|World Federation of Hemophilia|||1||f||||t||||||||||2017-10-10 22:11:27.137293|2017-10-10 22:11:27.137293
NCT02776813|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-21|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma|Phase 1 Study of ACTR087, Autologous T Lymphocytes Expressing Antibody Coupled T-cell Receptors (CD16V-41BB-CD3ζ), in Combination With Rituximab, in Subjects With Relapsed or Refractory CD20-Positive B-Cell Lymphoma|Recruiting||Phase 1|54|Anticipated|Unum Therapeutics Inc.||1|||f||||t||||||||||2017-10-10 22:11:27.203783|2017-10-10 22:11:27.203783
NCT02776800|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-02-08|||August 2016|Anticipated|2016-08-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Managing Wounds With Allevyn Life in a Home Health Care Environment|A Randomized, Controlled Study of Allevyn Life in the Management of Wounds in Home Health Care|Withdrawn||N/A|0|Actual|Smith & Nephew, Inc.||2||Business Decision|f||||f||||||||No||2017-10-10 22:11:27.335527|2017-10-10 22:11:27.335527
NCT02776787|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-05-16|||March 2016||2016-03-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Observational|DEBUT||DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory|DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory|Recruiting||N/A|750|Anticipated|University of Washington|||2||f||||f||||||||No||2017-10-10 22:11:27.464046|2017-10-10 22:11:27.464046
NCT02776774|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-16|||July 2015||2015-07-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Topical Antibiotic Treatment for Spine Surgical Site Infection|Topical Antibiotic Treatment for Spine Surgical Site Infection|Recruiting||N/A|250|Anticipated|University of Washington|||1||f||||f||||||||No||2017-10-10 22:11:27.604381|2017-10-10 22:11:27.604381
NCT02776748|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-05-17|||January 2015||2015-01-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||PrEP in Breastfeeding Study|An Open-label, Short-duration, Repeat-dose Study of Breastmilk Excretion and Infant Absorption of Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine When Used by HIV-uninfected Lactating Women|Completed||Phase 2/Phase 3|50|Actual|University of Washington||1|||f||||f||||||||Yes|Data from the PrEP in Breastfeeding Study are available by contacting the International Clinical Research Center at the University of Washington (icrc@uw.edu).|2017-10-10 22:11:27.821021|2017-10-10 22:11:27.821021
NCT02776735|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-08-02|||September 6, 2016||2016-09-06|August 2017|2017-08-01|December 20, 2021|Anticipated|2021-12-20|September 1, 2017|Anticipated|2017-09-01||Interventional|||An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)|An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered With Subcutaneous (SC) Injection, in Children and Adolescents, Aged 2 to 17 Years, With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) Followed by an Extension Phase|Recruiting||Phase 2|36|Anticipated|Sanofi||1|||f||||t||||||||||2017-10-10 22:11:27.977572|2017-10-10 22:11:27.977572
NCT02776722|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2017-04-13|||January 2016||2016-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Meta-analyses of the Effect of 'Catalytic' Doses of Fructose and Its Epimers on Carbohydrate Metabolism|The Effect of 'Catalytic' Doses of Fructose and Its Epimers on Acute Postprandial Carbohydrate Metabolism and Longterm Glycemic Control: A Series of Systematic Reviews and Meta-analyses of Controlled Feeding Trials|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:11:28.16284|2017-10-10 22:11:28.16284
NCT02776709|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-15|||July 2015||2015-07-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01|6 Months|Observational [Patient Registry]|||Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass)|Clinical Feasibility and Efficacy of a New Digital Single-operator Peroral Cholangiopancreatioscopy System: a Multicenter Registry|Recruiting||N/A|200|Anticipated|Northwestern University|||2||f||||f||||||||||2017-10-10 22:11:28.256734|2017-10-10 22:11:28.256734
NCT02776696|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-07-09|||June 2016||2016-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2|Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2|Recruiting||N/A|134|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 22:11:28.357526|2017-10-10 22:11:28.357526
NCT02776683|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-05|||June 8, 2016|Actual|2016-06-08|September 2017|2017-09-01|January 7, 2019|Anticipated|2019-01-07|January 7, 2019|Anticipated|2019-01-07||Interventional|||Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer|A Single Arm, Open-label, Multicenter, Multinational, Safety and Efficacy Phase IIIb Trial of BI 695502 Plus mFOLFOX6 in Patients With Previously Untreated Metastatic Colorectal Cancer|Active, not recruiting||Phase 3|120|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:11:28.486674|2017-10-10 22:11:28.486674
NCT02776670|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-17|2017-09-12|||July 29, 2016|Actual|2016-07-29|September 2017|2017-09-01|December 7, 2017|Anticipated|2017-12-07|December 7, 2017|Anticipated|2017-12-07||Interventional|||Clinical Outcomes Following Treatment With SYSTANE® BALANCE|Clinical Evaluation Following Use of SYSTANE® BALANCE in Subjects With Lipid-Deficient Dry Eye|Recruiting||N/A|242|Anticipated|Alcon Research||2|||f||||f||||||||||2017-10-10 22:11:30.444507|2017-10-10 22:11:30.444507
NCT02776657|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-05-05|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Intracoronary Thrombus Detection by Magnetic Resonance Imaging|Non-Invasive Assessment of Intracoronary Thrombosis in Patients With Acute Coronary Syndrome and Chronic Stable Angina Using Magnetic Resonance Imaging.|Suspended||N/A|40|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-10-10 22:11:30.524954|2017-10-10 22:11:30.524954
NCT02776644|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-09-11|||October 2016|Actual|2016-10-01|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|December 31, 2017|Anticipated|2017-12-31||Observational|||Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan|Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan, A Retrospective Nhia Database Analysis|Active, not recruiting||N/A|1|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 22:11:30.600465|2017-10-10 22:11:30.600465
NCT02776631|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-19|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Pinloc Versus Hansson Pins in the Treatment of Femoral Neck Fractures.|Pinloc Versus Hansson Pins in the Treatment of Femoral Neck Fractures: A Prospective Randomized Study of 500 Patients|Active, not recruiting||N/A|537|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-10 22:11:30.661187|2017-10-10 22:11:30.661187
NCT02776618|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-05-15|||May 15, 2016|Actual|2016-05-15|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||Polyglactin 910 vs Poligelecaprone 25 Running Subcuticular Closure of Elliptical Excision Wounds|Aesthetic and Functional Efficacy of Poliglecaprone 25 vs Polyglactin 910 in Running Subcuticular Closures: a Split-scar, Rater-blinded Randomized Controlled Trial|Withdrawn||N/A|0|Actual|University of California, Los Angeles||2||could not and did not recruit any participants|f||||f||||||||No||2017-10-10 22:11:30.751738|2017-10-10 22:11:30.751738
NCT02776605|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-12-08|||June 2016||2016-06-01|December 2016|2016-12-01|December 2024|Anticipated|2024-12-01|January 2018|Anticipated|2018-01-01||Interventional|PONALFIL||Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia|Concurrent Ponatinib With Chemotherapy for Young Adults With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|Recruiting||Phase 2|30|Anticipated|PETHEMA Foundation||1|||f||||t||||||||Undecided||2017-10-10 22:11:30.822445|2017-10-10 22:11:30.822445
NCT02776592|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-03-14|||July 20, 2016|Actual|2016-07-20|March 2017|2017-03-01|December 23, 2016|Actual|2016-12-23|December 23, 2016|Actual|2016-12-23||Interventional|||Nutritive Effects of a Cow's Milk Based Formula Fed to Young Children|Nutritive Effects of a Cow's Milk Based Formula Fed to Young Children|Completed||N/A|199|Actual|Mead Johnson Nutrition||2|||f||||f||||||||No||2017-10-10 22:11:31.051277|2017-10-10 22:11:31.051277
NCT02776579|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-07-17|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of a Female Strength & Conditioning Specialist on High School Girls' Health|Girls in the Weight Room: Assessing the Influence of a Female School-based Strength & Conditioning Specialist on the Health of High School Girls|Recruiting||N/A|30|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-10 22:11:31.172409|2017-10-10 22:11:31.172409
NCT02776566|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-05-16|||January 2016||2016-01-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Patient-Centered Anticoagulation Self-Monitoring in Minority Patients|Patient-Centered Anticoagulation Self-Monitoring in Minority Patients|Recruiting||N/A|80|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||Undecided||2017-10-10 22:11:31.285828|2017-10-10 22:11:31.285828
NCT02776553|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-05-03|||June 2016||2016-06-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Physical Activity Program in End-state Liver Disease|A Physical Activity Program in End-stage Liver Disease: Pilot Study Assessing Changes in Physical Fitness, Sarcopenia, and the Metabolic Profile|Enrolling by invitation||N/A|50|Anticipated|University of Arkansas||2|||f||||f||||||||No||2017-10-10 22:11:31.389282|2017-10-10 22:11:31.389282
NCT02776540|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-06-24|||May 2016||2016-05-01|May 2016|2016-05-01||||March 2018|Anticipated|2018-03-01||Interventional|CAIRO||Clopidogrel for Acute Ischaemia of Recent Onset|Clopidogrel Loading for Acute Ischaemia of Recent Onset (CAIRO)|Recruiting||Phase 4|201|Anticipated|Ain Shams University||3|||f||||t||||||||||2017-10-10 22:11:31.478527|2017-10-10 22:11:31.478527
NCT02776527|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-05-19|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy|A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy|Recruiting||Phase 4|40|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-10 22:11:31.576402|2017-10-10 22:11:31.576402
NCT02776514|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-05-17|||February 2016||2016-02-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|KIT||Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis|Intraarticular Injections of Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis|Recruiting||Phase 2|240|Anticipated|Balgrist University Hospital||4|||f||||t||||||||No||2017-10-10 22:11:31.669105|2017-10-10 22:11:31.669105
NCT02776501|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-16|||September 2015||2015-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SPF Assay||18572 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose.|Completed||N/A|10|Actual|Bayer||1|||f||||||||||||||2017-10-10 22:11:31.779683|2017-10-10 22:11:31.779683
NCT02776488|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-06-22|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|MT-TBI||Metabolic Therapy for Traumatic Brain Injury|Metabolic Therapy for Traumatic Brain Injury|Not yet recruiting||Phase 1/Phase 2|170|Anticipated|University of California, Los Angeles||4|||f||||f|t|f|||f|||No|All PHI will be expunged from records before any sharing occurs|2017-10-10 22:11:31.844125|2017-10-10 22:11:31.844125
NCT02776475|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-10-02|||August 4, 2016|Actual|2016-08-04|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Sacral Neuromodulation for Urinary Urgency, Frequency, and Urge Incontinence|Are the Effects of Sacral Neuromodulation for Urinary Urgency, Frequency, and Urge Incontinence Maintained With the Device Temporarily Turned Off?|Recruiting||N/A|20|Anticipated|TriHealth Inc.||1|||f||||f||||||||||2017-10-10 22:11:31.942329|2017-10-10 22:11:31.942329
NCT02776462|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-17|||June 2016||2016-06-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Observational|DETECT||Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients|Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients|Not yet recruiting||N/A|400|Anticipated|Oculogica, Inc.|||2||f||||t||||||||No||2017-10-10 22:11:32.021918|2017-10-10 22:11:32.021918
NCT02776449|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-05-02|||February 2016||2016-02-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Pressure Difference Between Brain and Eye: a Possible Cause to Normal Tension Glaucoma.|Pathological Cerebral Venous Drainage System Giving Large Pressure Difference Between Brain and Eye at Upright Posture: a Possible Cause to Normal Tension Glaucoma.|Completed||N/A|17|Actual|Umeå University|||1||f||||f||||||||Undecided||2017-10-10 22:11:32.09946|2017-10-10 22:11:32.09946
NCT02776436|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-08-26|||January 2016||2016-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|REDEX||Reducing Dexamethasone Around Docetaxel Infusion|Phase 1 Study to Evaluate the Safety of REducing the Prophylactic Dose of DEXamethasone Around Docetaxel Infusion in Patients With Early or Advanced Breast Cancer and Prostate Cancer|Recruiting||Phase 1|60|Anticipated|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 22:11:32.165858|2017-10-10 22:11:32.165858
NCT02776423|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2016-05-17|||January 2014||2014-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Polyacrylamide Injection in Patients Ineligible for Surgery|Transurethral Polyacrylamide Hydrogel Injection in Patients Ineligible for Midurethral Sling Surgery|Completed||N/A|81|Actual|Karolinska Institutet|||1||f||||f||||||||No||2017-10-10 22:11:32.264058|2017-10-10 22:11:32.264058
NCT02776410|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-08-29|||May 2016||2016-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Young Consumers' Attitudes and Behaviour Towards Sustainable and Healthy Eating|Young Consumers' Attitudes and Behaviour Towards Sustainable and Healthy Eating|Completed||N/A|201|Actual|Consumer and Sensory Research Institute Ltd, Poland||2|||f||||f||||||||No||2017-10-10 22:11:32.322748|2017-10-10 22:11:32.322748
NCT02776397|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-18|||June 2015||2015-06-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|EVAS||Relationship of Haptoglobin Phenotype to Vascular Function and Response to Vitamin E Supplementation in Patients With Diabetes Mellitus Type 2: The EVAS Trial|Relationship of Haptoglobin Phenotype to Vascular Function and Response to Vitamin E Supplementation in Patients With Diabetes Mellitus Type 2: The EVAS Trial|Recruiting||N/A|300|Anticipated|Tan Tock Seng Hospital||4|||f||||f||||||||||2017-10-10 22:11:32.393399|2017-10-10 22:11:32.393399
NCT02776384|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-05-15|||December 2015||2015-12-01|May 2016|2016-05-01||||December 2025|Anticipated|2025-12-01|10 Years|Observational [Patient Registry]|||Prognostic and Diagnostic Value of Biomarkers and Cardiac Functional Parameters in Patients With Chronic Heart Failure|Prognostic and Diagnostic Value of Serial Biomarker Measurements, Echocardiographic Techniques and Cardiopulmonary Function Tests in Patients With Chronic Heart Failure.|Recruiting||N/A|1000|Anticipated|Shanghai Jiao Tong University School of Medicine|||1||f||||t||||||||Undecided||2017-10-10 22:11:32.497548|2017-10-10 22:11:32.497548
NCT02776371|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-11-09|||May 2013||2013-05-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori||Completed||Phase 4|301|Actual|Shandong University||2|||f||||t||||||||||2017-10-10 22:11:32.675796|2017-10-10 22:11:32.675796
NCT02776358|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-15|||September 2014||2014-09-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SimAG||HFS in the Assessement and Management of Severe Asthma Attack Among Fifth Year Medical School Students|High Fidelity Simulation (HFS) Versus Video-case(VC) Trainings in the Assessement and Management of Severe Asthma Attack Among Medical School Students: a Randomized Controlled Study|Completed||Phase 1|33|Actual|University of Monastir||2|||f||||f||||||||Undecided||2017-10-10 22:11:32.765462|2017-10-10 22:11:32.765462
NCT02776345|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-09-09|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SUCTION||Ultrasound Guided Interventions of Calcific Tendonitis of Rotator Cuff (SUCTION)|Study to Evaluate Ultrasound Guided Interventions of Calcific Tendonitis of Rotator Cuff- International CollabratioN (SUCTION)|Not yet recruiting||N/A|160|Anticipated|Hamilton Health Sciences Corporation||3|||f||||f|f|f||||||||2017-10-10 22:11:32.846463|2017-10-10 22:11:32.846463
NCT02776332|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-17|||May 2016||2016-05-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|MERIT||The Merit Study (Manual Expression pRemature InfanTs)|A Randomized Controlled Trial Comparing The Effect Of Duration Of Manual Expression And Breastfeeding Self-efficacy On Milk Volumes In Mothers Of Premature Infants|Not yet recruiting||N/A|108|Anticipated|St. Louis Children's Hospital||2|||f||||f||||||||No||2017-10-10 22:11:32.957855|2017-10-10 22:11:32.957855
NCT02776319|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-17|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of Non-invasive Brain Stimulation in Tobacco Use Disorder||Recruiting||N/A|15|Anticipated|Laval University||2|||f||||||||||||||2017-10-10 22:11:33.048479|2017-10-10 22:11:33.048479
NCT02776306|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-12-13|||April 2016||2016-04-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Mirror Box Imaging Study|Effects of Mirror Box Therapy on Neuroplasticity and Functional Outcome in Hemiparetic Upper Limb Post Stroke|Recruiting||N/A|40|Anticipated|Southend University Hospital Foundation NHS Trust||2|||f||||f||||||||||2017-10-10 22:11:33.12605|2017-10-10 22:11:33.12605
NCT02776293|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-05-02|||January 2014||2014-01-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Prenatal Listening to Songs Composed for Pregnancy and Symptoms of Anxiety and Depression: a Pilot Study|Prenatal Listening to Songs Composed for Pregnancy and Symptoms of Anxiety and Depression: a Pilot Study|Completed||N/A|223|Actual|Goldsmiths, University of London||2|||f||||f||||||||No||2017-10-10 22:11:33.211743|2017-10-10 22:11:33.211743
NCT02776280|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-05-07|||July 2015||2015-07-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Oral Fluoride Bioavailability by the Consumption of Meals Prepared With Fluoridated Water or Salt||Completed||Phase 4|12|Actual|University of Campinas, Brazil||3|||f||||f||||||||No||2017-10-10 22:11:33.278988|2017-10-10 22:11:33.278988
NCT02776267|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2017-05-09|||May 2015||2015-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Percutaneous Coronary Intervention With the Angiolite Drug-eluting Stent: an Optical Cohenrece Tomography Study|Percutaneous Coronary Intervention With the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study|Active, not recruiting||N/A|100|Anticipated|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec||2|||f||||t||||||||Undecided||2017-10-10 22:11:33.347474|2017-10-10 22:11:33.347474
NCT02776254|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-06-17|||March 2016||2016-03-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CommART||Differentiated Care for Improved Health Systems Efficiency and Health Outcomes in Zambia|Community ART for Retention in Zambia: Evaluating the Feasibility, Effectiveness, and Efficiency of Decentralized and Streamlined Antiretroviral Therapy Care Models|Recruiting||N/A|3600|Anticipated|Centre for Infectious Disease Research in Zambia||6|||f||||f||||||||No||2017-10-10 22:11:33.477588|2017-10-10 22:11:33.477588
NCT02776241|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-28|||September 2015||2015-09-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease|Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney: The HYDRA Study|Completed||N/A|40|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 22:11:33.616065|2017-10-10 22:11:33.616065
NCT02776228|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-11-09|||December 2016||2016-12-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Treatment With Benzodiazepine After Cardiac Surgery|The Influence of Short Term Treatment With Benzodiazepine After Cardiac Surgery|Not yet recruiting||Phase 3|200|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||Yes||2017-10-10 22:11:33.692114|2017-10-10 22:11:33.692114
NCT02776215|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-02-27|||September 2016||2016-09-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Interventional|||Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents|Open-label Study to Investigate the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents|Recruiting||Phase 1|24|Anticipated|Vanda Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:11:33.771413|2017-10-10 22:11:33.771413
NCT02776202|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-05-18|||May 2016||2016-05-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen|HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen|Recruiting||Phase 2|15|Anticipated|National Guard Health Affairs||1|||f||||f||||||||Undecided||2017-10-10 22:11:33.860919|2017-10-10 22:11:33.860919
NCT02776189|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-07-17|||October 2012||2012-10-01|July 2016|2016-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|DPMP||Dexmedetomidine Verses Propofol for Paediatric MRI Brain|Comparative Study of Dexmedetomidine-midazolam Combination and Propofol-midazolam Combination for MRI Brain in Paediatric Patient|Completed||Phase 4|70|Actual|Maharashtra University of Health Sciences||2|||f||||t||||||||Yes||2017-10-10 22:11:33.96619|2017-10-10 22:11:33.96619
NCT02776176|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2016-05-18|||January 2016||2016-01-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ERASIHD||Enhanced Recovery After Surgery In Hirschsprung Disease|A Prospective Multi-center Randomized Controlled Clinical Trials of Enhanced Recovery After Surgery in Hirschsprung Disease.|Recruiting||N/A|200|Anticipated|Nanjing Children's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:11:34.06675|2017-10-10 22:11:34.06675
NCT02776163|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-09-30|||June 2016||2016-06-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors|Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors of Head and Neck, A Non-Randomized, Phase II Trial|Recruiting||Phase 2|53|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||2|||f||||t||||||||No||2017-10-10 22:11:34.175162|2017-10-10 22:11:34.175162
NCT02776150|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-16|||May 2016||2016-05-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|PMTforDR-TB||Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis|Multi Center Clinical Research and Evaluation of Melting Technology for Rapid Detection of Drug Resistant Tuberculosis|Not yet recruiting||N/A|3100|Anticipated|Beijing Hospital|||3||f||||t||||||||Yes||2017-10-10 22:11:34.271583|2017-10-10 22:11:34.271583
NCT02776137|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-09-30|||June 2016||2016-06-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck|Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck，A Non-Randomized Phase II Trial|Recruiting||Phase 2|90|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||1|||f||||t||||||||Undecided||2017-10-10 22:11:34.353495|2017-10-10 22:11:34.353495
NCT02776124|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-10-17|||March 2014||2014-03-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients|A Randomized Phase II Trial to Assess the Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients During Concurrent Chemotherapy|Recruiting||Phase 2|60|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||2|||f||||t||||||||Undecided||2017-10-10 22:11:34.455463|2017-10-10 22:11:34.455463
NCT02776111|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-09-20|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients|The Use of Microfluidics and Transcriptomics to Implement Precision Medicine in Post Solid Organ Transplant Patients|Recruiting||N/A|50|Anticipated|University of Florida|||2||f||||t|f|f||||Samples With DNA|"     400 microliters of blood   "|||2017-10-10 22:11:34.55355|2017-10-10 22:11:34.55355
NCT02776098|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-11-17|||May 2016||2016-05-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance|Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance|Recruiting||N/A|62|Anticipated|Children's Hospital of Philadelphia|||3||f||||f||||||||No||2017-10-10 22:11:34.66668|2017-10-10 22:11:34.66668
NCT02776085|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-18|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|||Bedside Ultrasound to Measure Optic Nerve Sheath Diameter in Pediatric CSF Shunts|Using Bedside Ultrasound to Measure the Optic Nerve Sheath Diameter in the Evaluation of Pediatric Patients With CSF Shunts|Recruiting||N/A|87|Anticipated|Carolinas Medical Center|||3||f||||t||||||||No||2017-10-10 22:11:34.757275|2017-10-10 22:11:34.757275
NCT02776072|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-03-21|||May 2016||2016-05-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|EFFECT||Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)|A Multicenter, Global, Retrospective, Observational Study to Characterize Real-world Clinical Outcomes in Patients With Relapsing-remitting Multiple Sclerosis Treated With Disease-modifying Therapies (Tecfidera®, Copaxone®, Aubagio®, or Gilenya®)|Completed||N/A|2978|Actual|Biogen|||4||f||||f||||||||||2017-10-10 22:11:34.852356|2017-10-10 22:11:34.852356
NCT02776059|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-18|||June 2016||2016-06-01|May 2016|2016-05-01|December 2033|Anticipated|2033-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Pegfilgrastim in Patients With Alcoholic Hepatitis|A Phase II, Multicenter, Randomized, Open-label Study to Investigate the Safety and Efficacy of Pegfilgrastim (Neulasta®) in Patients With Alcoholic Hepatitis|Not yet recruiting||Phase 2|78|Anticipated|Southern California Institute for Research and Education||2|||f||||t||||||||Yes|Patients' coded data will be shared .|2017-10-10 22:11:35.370015|2017-10-10 22:11:35.370015
NCT02776046|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-06-07|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|iPROVE-O2||Individualized Perioperative Open-lung Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction (iPROVE-O2).|Individualized Perioperative Open-luna Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction (iPROVE-O2). A Comparative, Prospective, Multicenter, Randomized Controlled Trial|Recruiting||N/A|756|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||t|f|f||||||||2017-10-10 22:11:35.504672|2017-10-10 22:11:35.504672
NCT02776033|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-10-02|||August 30, 2016|Actual|2016-08-30|October 2017|2017-10-01|January 30, 2018|Anticipated|2018-01-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis|A Multicentre, Randomised, Double-blind (Sponsor-unblinded), Placebo-controlled, Repeat Dose Study to Investigate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2982772 in Subjects With Active Plaque-type Psoriasis|Recruiting||Phase 2|54|Anticipated|GlaxoSmithKline||4|||f||||t||||||||||2017-10-10 22:11:35.639602|2017-10-10 22:11:35.639602
NCT02776020|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-15|||June 2016||2016-06-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Observational|ADM||Non-invasive, Real-time Anesthetic Drug-monitoring System||Not yet recruiting||N/A|30|Anticipated|Rambam Health Care Campus|||1||f||||t||||||||No||2017-10-10 22:11:35.781771|2017-10-10 22:11:35.781771
NCT02776007|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-01-10|||July 2016||2016-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||"Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial"|Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial|Recruiting||N/A|60|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 22:11:35.85639|2017-10-10 22:11:35.85639
NCT02775994|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-19|||June 2016||2016-06-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)|Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)|Not yet recruiting||Phase 1|10|Anticipated|Rabin Medical Center||1|||f||||f||||||||Undecided||2017-10-10 22:11:35.971179|2017-10-10 22:11:35.971179
NCT02775981|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-05-15|||February 2016||2016-02-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function|A Phase-1 Study Comparing the Pharmacokinetics of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function|Recruiting||Phase 1|24|Anticipated|Pharmaceutical Project Solutions, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:11:36.052582|2017-10-10 22:11:36.052582
NCT02775968|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-06-23|||June 21, 2017|Actual|2017-06-21|June 2017|2017-06-01|October 2022|Anticipated|2022-10-01|August 2022|Anticipated|2022-08-01||Observational|||Population Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired Pneumonia|Population Pharmacokinetics of Cephalosporins and Macrolides in Children With Community Acquired Pneumonia|Recruiting||N/A|750|Anticipated|Beijing Children's Hospital|||1||f||||f||||||Samples With DNA|"     whole blood   "|Yes||2017-10-10 22:11:36.138488|2017-10-10 22:11:36.138488
NCT02775955|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-05-17|||February 2016||2016-02-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||Pharmacokinetic Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal Function|A Phase-1 Study Comparing the Pharmacokinetics of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal Function|Recruiting||Phase 1|16|Anticipated|Pharmaceutical Project Solutions, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:11:36.246096|2017-10-10 22:11:36.246096
NCT02775942|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-06-28|||November 2015||2015-11-01|May 2016|2016-05-01|October 31, 2016|Actual|2016-10-31|July 25, 2016|Actual|2016-07-25||Interventional|||Safety and Immunogenicity of IPOVAC in Young Children|Safety and Immunogenicity of an Inactivated Poliomyelitis Vaccine (IPOVAC) in Vietnamese Children|Completed||Phase 2|240|Actual|National Institute of Hygiene and Epidemiology, Vietnam||4|||f||||t||||||||No|"Individual data with identification removed are to be available for Ethical committee, Ministry of Health and National Foundation of Science and Technology Development to avoid misuse of data.
Public shared data will be in the form of summarised tables and figures."|2017-10-10 22:11:36.33573|2017-10-10 22:11:36.33573
NCT02775929|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-04-07|||November 2012||2012-11-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Partners Demonstration Project of PrEP and ART|An Open Label, Pilot Demonstration and Evaluation Project of Antiretroviral-based HIV-1 Prevention Among High-risk Serodiscordant African Couples|Completed||Phase 4|1013|Actual|University of Washington||1|||f||||t||||||||Yes|Data from the Partners Demonstration Project are available by contacting the International Clinical Research Center at the University of Washington (icrc@uw.edu).|2017-10-10 22:11:36.436161|2017-10-10 22:11:36.436161
NCT02775916|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-06-08|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|||Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CDZ173 in Patients With Primary Sjögren's Syndrome|Completed||Phase 2|30|Actual|Novartis||2|||f||||f|f|f||||||No|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:11:36.559091|2017-10-10 22:11:36.559091
NCT02775903|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-06-21|||June 3, 2016|Actual|2016-06-03|June 2017|2017-06-01|April 16, 2019|Anticipated|2019-04-16|February 11, 2018|Anticipated|2018-02-11||Interventional|||An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML)|A Randomized, Multicenter, Open-label, Phase 2 Study Evaluating the Efficacy and Safety of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly (>= 65 Years) Acute Myeloid Leukemia (AML) Subjects Not Eligible for Hematopoietic Stem Cell Transplantation (HSCT)|Recruiting||Phase 2|182|Anticipated|Celgene||2|||f||||t||||||||||2017-10-10 22:11:36.655689|2017-10-10 22:11:36.655689
NCT02775890|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-14|||February 1, 2019|Anticipated|2019-02-01|September 2017|2017-09-01|April 1, 2021|Anticipated|2021-04-01|February 1, 2021|Anticipated|2021-02-01||Observational|||Potential Lead Exposure Through Eating Self-harvested Wild Game|A Prospective Observational Cohort Study Assessing the Feasibility of Measuring Serum Lead Levels in New Zealand Hunters Using Lead Projectiles|Not yet recruiting||N/A|68|Anticipated|Nelson Marlborough Institute of Technology|||2||f||||f|f|f||||||||2017-10-10 22:11:36.986863|2017-10-10 22:11:36.986863
NCT02775877|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-06-21|||May 2016||2016-05-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Interventional|||Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer|Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer in Polycystic Ovary Syndrome (PCOS) Patients|Recruiting||N/A|100|Anticipated|Navy General Hospital, Beijing||2|||f||||t||||||||Yes||2017-10-10 22:11:37.059922|2017-10-10 22:11:37.059922
NCT02775864|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-06-27|||July 2015||2015-07-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Observational|||Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia|Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia|Active, not recruiting||N/A|25000|Anticipated|New York State Psychiatric Institute|||4||f||||f||||||||No||2017-10-10 22:11:37.163707|2017-10-10 22:11:37.163707
NCT02775851|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-10-05|||October 20, 2016|Actual|2016-10-20|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery|A Phase II and Pilot Trial of PD-1 Blockade With MK-3475 (Pembrolizumab) in Patients With Resectable or Unresectable Desmoplastic Melanoma (DM)|Recruiting||Phase 2|67|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 22:11:37.279953|2017-10-10 22:11:37.279953
NCT02775838|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-30|||April 2016||2016-04-01|May 2016|2016-05-01||||April 2018|Anticipated|2018-04-01||Interventional|||Measurements of Kidney Perfusion After Transplantation by Intraoperative Fluorescence Angiography||Recruiting||Phase 2|200|Anticipated|University Hospital Erlangen||1|||f||||||||||||||2017-10-10 22:11:38.065122|2017-10-10 22:11:38.065122
NCT02775825|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-18|||October 2015||2015-10-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Quality of the End of Life Care|Quality of the End of Life Care for Adult Patients With Advanced Cancer in Saudi Arabia|Completed||N/A|180|Actual|National Guard Health Affairs|||1||f||||f||||||||No||2017-10-10 22:11:38.159909|2017-10-10 22:11:38.159909
NCT02775799|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2016-05-25|||April 2015||2015-04-01|May 2016|2016-05-01|March 2040|Anticipated|2040-03-01|March 2035|Anticipated|2035-03-01|20 Years|Observational [Patient Registry]|SwissSARCOS||National Swiss Sarcoma Cohort Study|Prospective Multi-center National Swiss Sarcoma Cohort Study|Recruiting||N/A|5000|Anticipated|Balgrist University Hospital|||1||f||||f||||||||Yes|Assessed data shall be shared with the National Institute for Cancer Epidemiology an Registration and the cantonal cancer registers|2017-10-10 22:11:38.417415|2017-10-10 22:11:38.417415
NCT02775786|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-06-08|||June 2013||2013-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma|Assessing the Utility of Macromolecular Dynamic Contrast Enhanced MRI and Diffusion Weighted Imaging as Biomarkers for Vascular Permeability and Fibrosis in Pancreatic Cancer|Recruiting||N/A|70|Anticipated|Columbia University||2|||f||||f||||||||Undecided||2017-10-10 22:11:38.494556|2017-10-10 22:11:38.494556
NCT02775773|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-01-20|||January 1, 2017|Actual|2017-01-01|May 2016|2016-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|TRANOXY2016||Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH|Longitudinal Clinical, Controlled, Randomized, Open-label, Phase III Study to Assess the Equivalence of Tranexamic Acid (TXA) vs Oxytocin (OXY) in Reducing Post Partum Haemorrhage (PPH) in Patients at the End of Pregnancy (37-42 w), at Low Risk of PPH|Active, not recruiting||Phase 3|256|Anticipated|Azienda U.S.L. 1 di Massa e Carrara||2|||f||||t||||||||Undecided||2017-10-10 22:11:38.581954|2017-10-10 22:11:38.581954
NCT02775760|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-09-24|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|ECE||The Entorhinal Cortex and Aerobic Exercise in Aging|The Entorhinal Cortex and Aerobic Exercise in Aging|Not yet recruiting||N/A|42|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 22:11:38.668291|2017-10-10 22:11:38.668291
NCT02775734|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-16|2017-04-28|||May 2016||2016-05-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|NAC||NAC in CC Resistant PCOS After LOD|N-acetyl-cysteine in Clomiphene Citrate Resistant Polycystic Ovary Syndrome After Laparoscopic Ovarian Drilling: A Randomized Controlled Trial|Completed||Phase 2/Phase 3|144|Actual|Ain Shams University||2|||f||||t||||||||Undecided||2017-10-10 22:11:38.864513|2017-10-10 22:11:38.864513
NCT02775721|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-10-03|||July 2015||2015-07-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|G-Tube||Weight Loss and Gastrostomy Tube Care Outcomes in Head and Neck Cancer Patients With Gastrostomy Tube Placement|Weight Loss and Gastrostomy Tube Care Outcomes in Head and Neck Cancer Patients With Gastrostomy Tube Placement|Active, not recruiting||N/A|100|Anticipated|St. John Health System, Oklahoma||3|||f||||f||||||||||2017-10-10 22:11:38.954694|2017-10-10 22:11:38.954694
NCT02775708|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-17|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|NOISE||Development of Applications of the ® PillCam Endoscopy System and Evaluation of Their Performance|Development of Applications of the ® PillCam Endoscopy System and Evaluation of Their Performance|Active, not recruiting||N/A|53|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-10 22:11:39.080225|2017-10-10 22:11:39.080225
NCT02775695|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-04-17|||April 3, 2017|Actual|2017-04-03|April 2017|2017-04-01|July 2023|Anticipated|2023-07-01|April 2020|Anticipated|2020-04-01||Interventional|||Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer|Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer|Recruiting||Phase 2|12|Anticipated|Medical College of Wisconsin||1|||f||||t|t|f|||f|||Undecided||2017-10-10 22:11:39.149305|2017-10-10 22:11:39.149305
NCT02775682|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-03-20|||April 2016||2016-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|CAPE||Cerebral Autoregulation in Patients With Epilepsy|Cerebral Autoregulation in Patients With Epilepsy|Recruiting||N/A|100|Anticipated|First Hospital of Jilin University|||2||f||||t||||||||||2017-10-10 22:11:39.235176|2017-10-10 22:11:39.235176
NCT02775669|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-17|||January 2015||2015-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||Non-invasive Epicutaneous Transfontanel Intracranial Pressure Monitoring in Children Under the Age of One: a Novel Technique|Non-invasive Epicutaneous Transfontanel Intracranial Pressure Monitoring in Children Under the Age of One: a Novel Technique|Enrolling by invitation||N/A|10|Anticipated|University Clinic Frankfurt|||2||f||||f||||||||||2017-10-10 22:11:39.307595|2017-10-10 22:11:39.307595
NCT02775656|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-06-29|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|May 2027|Anticipated|2027-05-01|May 2027|Anticipated|2027-05-01||Observational|||UCB Cimzia Pregnancy Follow-up Study|An Observational Follow-up Study of Women Who Become Pregnant While Participating in a Certolizumab Pegol (CZP) Clinical Study or Whose Pregnancies Have Otherwise Been Reported to UCB Due to Potential CZP Exposure During Pregnancy|Recruiting||N/A|360|Anticipated|UCB Pharma|||2||f||||t||||||||||2017-10-10 22:11:39.363996|2017-10-10 22:11:39.363996
NCT02775630|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-04|||July 4, 2014|Actual|2014-07-04|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|May 29, 2015|Actual|2015-05-29||Interventional|FIBROHYPNOSE||Assessment of the Contribution of Hypnosis in the Tolerance of the Bronchoscopy|Assessment of the Contribution of Hypnosis in the Tolerance of the Bronchoscopy|Recruiting||N/A|126|Anticipated|Groupe Hospitalier Paris Saint Joseph||2|||f||||t||||||||||2017-10-10 22:11:39.552859|2017-10-10 22:11:39.552859
NCT02775604|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Home-based Video, Print Checklist and Professional Home Assessment in Detection of Fall Hazards at Home|Comparison of Home-based Video, Print Checklist and Professional Home Assessment in Detection of Fall Hazards for Older Adults Living at Home: A Pilot Randomized Crossover Trial|Not yet recruiting||N/A|40|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 22:11:39.732975|2017-10-10 22:11:39.732975
NCT02775591|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-21|||April 2016||2016-04-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PASS-GI||Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms|Effect of Short-term Motilitone Therapy on Health-related Quality of Life in Parkinson's Disease Patients With Gastrointestinal Symptoms: a Multicenter, Double-blind Randomized, Placebo-controlled Trial|Recruiting||Phase 4|150|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:11:39.814092|2017-10-10 22:11:39.814092
NCT02775578|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-17|||April 2016||2016-04-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|OSCRM-HF||Optimizing Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart Failure|Study of Serum Level of Heart Failure Related Biomarkers and Optimization Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart Failure|Recruiting||N/A|525|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||t||||||||Undecided||2017-10-10 22:11:39.934692|2017-10-10 22:11:39.934692
NCT02775565|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-11-07|||February 2016||2016-02-01|November 2016|2016-11-01||||September 2016|Actual|2016-09-01||Observational|||Initial Experience With the AngioVac Venous Drainage Cannula|Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review|Enrolling by invitation||N/A|100|Anticipated|Angiodynamics, Inc.|||1||f||||f||||||||||2017-10-10 22:11:40.031289|2017-10-10 22:11:40.031289
NCT02775552|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-05|||March 2015||2015-03-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|A&T-2 Ethiopia||Impact Evaluation of a Multi-Sectoral Community-Based Approach to Improving Infant and Young Child Feeding in Amhara, Ethiopia|Impact Evaluation of Alive & Thrive's Multi-Sectoral Community-Based Approach to Improving Infant and Young Child Feeding in Amhara, Ethiopia|Completed||N/A|3100|Anticipated|International Food Policy Research Institute||2|||f||||f||||||||||2017-10-10 22:11:40.093758|2017-10-10 22:11:40.093758
NCT02775539|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2016-05-16|||June 2016||2016-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|January 2017|Anticipated|2017-01-01||Interventional|SPHERE-HF||Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure|Beta3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure|Not yet recruiting||Phase 2|80|Anticipated|Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III||2|||f||||t||||||||Undecided||2017-10-10 22:11:40.174078|2017-10-10 22:11:40.174078
NCT02775526|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-04-28|||May 2016||2016-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||TOT, TVT And Burch Colpo-Suspension for Treatment of Female Mixed Urinary Incontinence|Trans-Obturator Tape, Tension-Free Vaginal Tape and Burch Colposuspension for Treatment of Female Mixed Urinary Incontinence: A Randomized Clinical Trial|Recruiting||Phase 3|210|Anticipated|Ain Shams University||3|||f||||||||||||||2017-10-10 22:11:40.254295|2017-10-10 22:11:40.254295
NCT02775513|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-05-13|||September 2010||2010-09-01|May 2016|2016-05-01||||May 2016|Anticipated|2016-05-01||Observational|||Metabolism of Patients With Genetically Caused Cardiac Arrhythmia|Metabolism of Patients With Genetically Caused Cardiac Arrhythmia|Active, not recruiting||N/A|50|Anticipated|University of Copenhagen|||2||f||||t||||||||Undecided||2017-10-10 22:11:40.337655|2017-10-10 22:11:40.337655
NCT02775500|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-03-22|||November 2014||2014-11-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|February 2021|Anticipated|2021-02-01|2 Years|Observational [Patient Registry]|||Apremilast Pregnancy Exposure Registry|Apremilast Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project|Recruiting||N/A|300|Anticipated|University of California, San Diego|||4||f||||f||||||||No||2017-10-10 22:11:40.396515|2017-10-10 22:11:40.396515
NCT02775487|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-09-29|||January 2013||2013-01-01|September 2016|2016-09-01|January 2013|Actual|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Smog Induced Indoor Air Pollution in Homes of Chronic Obstructive Pulmonary Disease Patients.|Smog Induced Indoor Air Pollution in Homes of Chronic Obstructive Pulmonary Disease Patients: Effectiveness of Controls|Withdrawn||N/A|0|Actual|University of Missouri-Columbia|||1|Withdrawn before IRB review. Investigator no longer working at facility.|f||||f||||||||No||2017-10-10 22:11:40.498369|2017-10-10 22:11:40.498369
NCT02775474|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-25|||June 2016||2016-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Does Intraoperative Methadone Prevent Postoperative Pain in Bariatric Surgery?|Does Intraoperative Methadone Prevent Postoperative Pain in Bariatric Surgery?|Completed||Phase 4|32|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:11:40.566895|2017-10-10 22:11:40.566895
NCT02775461|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-08-04|||March 2013||2013-03-01|August 2017|2017-08-01|March 2026|Anticipated|2026-03-01|March 2021|Anticipated|2021-03-01|10 Years|Observational [Patient Registry]|||Pancreas Registry and High Risk Registry|Pancreas Disease and High Risk Registry|Recruiting||N/A|500|Anticipated|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||Samples With DNA|"     Whole Blood samples for DNA, serum and plasma extraction.   "|||2017-10-10 22:11:40.787043|2017-10-10 22:11:40.787043
NCT02775448|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-26|||February 2016||2016-02-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Dose-response Study of Carduus Marianus in Centesimal Scale for Dyslipidemia in Climacteric Overweighed or Obese Women.|Dose-response Study of the Efficacy and Safety of Carduus Marianus in Centesimal Scale for Dyslipidemia in Overweighed or Obese Women in Peri- and Postmenopause: a Randomized Controlled Trial|Recruiting||Phase 2|140|Anticipated|Hospital Nacional Homeopático, Mexico||4|||f||||t||||||||No||2017-10-10 22:11:40.91202|2017-10-10 22:11:40.91202
NCT02775435|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-15|2017-09-28|||June 9, 2016|Actual|2016-06-09|September 2017|2017-09-01|August 15, 2019|Anticipated|2019-08-15|March 15, 2018|Anticipated|2018-03-15||Interventional|||A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)|A Randomized, Double-Blind, Phase III Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in First Line Metastatic Squamous Non-small Cell Lung Cancer Subjects (KEYNOTE-407)|Recruiting||Phase 3|560|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:11:41.055599|2017-10-10 22:11:41.055599
NCT02775422|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-31|||March 2015||2015-03-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|VARI-IMM||Comparison of Serological Test s for the Virus Chicken Pox Virus (VZV) and Correlation With the Patient's Memory of the Infection or Vaccination|Comparison of Serological Tests for the Varicella-zoster Virus and Correlation With the Memory of the Infection or Vaccination|Recruiting||N/A|400|Anticipated|Hopital Foch||1|||f||||f||||||||No||2017-10-10 22:11:41.308722|2017-10-10 22:11:41.308722
NCT02775409|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-03-29|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Prospective Trial of Subcutaneous Versus Subpectoral 2-Staged Implant-Based Breast Reconstruction|Prospective Trial of Subcutaneous Versus Subpectoral 2-Staged Implant-Based Breast Reconstruction|Recruiting||N/A|190|Anticipated|Mayo Clinic||2|||f||||t|f|f||||||Yes|Present/publish results at professional meetings/journals|2017-10-10 22:11:41.41956|2017-10-10 22:11:41.41956
NCT02775396|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-16|||September 2014||2014-09-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Wearing Progressive Addition Lens on Working Distance and Refractive Status in Adult Computer Users|Effects of Wearing a New Progressive Addition Lens on Working Distance and Refractive Status in Adult Chinese Computer Users|Completed||N/A|64|Actual|The Hong Kong Polytechnic University||1|||f||||f||||||||||2017-10-10 22:11:41.520775|2017-10-10 22:11:41.520775
NCT02775383|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-01-09|||April 2016||2016-04-01|December 2016|2016-12-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|MDS||The National Myelodysplastic Syndromes (MDS) Study|The National Myelodysplastic Syndromes Natural History Study|Recruiting||N/A|3500|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||2||f||||t||||||Samples With DNA|"     bone marrow, peripheral blood, serum, plasma, eyebrow hairs with attached follicles, buccal     cells, skin biopsy   "|||2017-10-10 22:11:41.636834|2017-10-10 22:11:41.636834
NCT02775370|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-27|||June 2016||2016-06-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck|Phase II Study of Apatinib Mesylate Administered as a Daily Oral Treatment in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck|Recruiting||Phase 2|60|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||1|||f||||t||||||||||2017-10-10 22:11:42.464603|2017-10-10 22:11:42.464603
NCT02775357|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-05-12|||November 2014||2014-11-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Measurement of HIV Risk to Create Demand for Safe Male Circumcision|Using the Rakai HIV Risk Index to Measure and Communicate HIV Risk to Create Demand for Safe Male Circumcision: A Randomized Controlled Trial|Active, not recruiting||N/A|968|Actual|Rakai Health Sciences Program||2|||f||||f||||||||No|Data will be published in peer-reviewed journals and at scientific conferences.|2017-10-10 22:11:42.552117|2017-10-10 22:11:42.552117
NCT02775344|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-10-02|||May 2014||2014-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||3D Versus 2D Laparoscopic Ovarian Cystectomy|Comparison of Three-dimension Versus Two-dimension Laparoscopic Ovarian Cystectomy|Completed||N/A|83|Actual|Queen Mary Hospital, Hong Kong||2|||f||||t||||||||No||2017-10-10 22:11:42.641472|2017-10-10 22:11:42.641472
NCT02775331|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-02-14|||January 2016||2016-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PLANTOOLS||The Use of Worktime Planning Tools in the Finnish Public Sector. A Quasi-experimental Study (PLANTOOLS)|The Use of Worktime Planning Tools in the Finnish Public Sector. A Quasi-experimental Study (PLANTOOLS)|Enrolling by invitation||N/A|6000|Anticipated|Finnish Institute of Occupational Health||3|||f||||f||||||||No||2017-10-10 22:11:42.73974|2017-10-10 22:11:42.73974
NCT02775318|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-12|||September 2014||2014-09-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm|Efficacy Of Ultrasound Guided Stellate Ganglion Block To Relieve Vasospasm Following Clipping Of Cerebral Aneurysm|Completed||Phase 1|20|Actual|Postgraduate Institute of Medical Education and Research||1|||f||||t||||||||Undecided||2017-10-10 22:11:42.859309|2017-10-10 22:11:42.859309
NCT02775305|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-05-16|||October 2013||2013-10-01|May 2016|2016-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||The Effects of Frailty on Chronic Kidney Disease|The Effects of Frailty on Chronic Kidney Disease|Active, not recruiting||N/A|50|Anticipated|San Francisco Veterans Affairs Medical Center||2|||f||||f||||||||No|There is no plan to make IPD available.|2017-10-10 22:11:42.963501|2017-10-10 22:11:42.963501
NCT02775292|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-04-25|||January 3, 2017||2017-01-03|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|NYM||Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1|NY-ESO-1 TCR Engineered Adoptive Cell Transfer Therapy With Nivolumab PD-1 Blockade|Recruiting||Phase 1|12|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:11:43.040152|2017-10-10 22:11:43.040152
NCT02775279|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2016-05-14|||January 2016||2016-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Association Between Telomere Length and Risk of Acute Coronary Syndrome|Short Telomere Length in Peripheral Blood Leukocyte Predicts the Risk of Acute Coronary Syndrome|Completed||N/A|400|Actual|Fourth Military Medical University|||2||f||||f||||||Samples With DNA|"     Telomeres consist of a tandem TTAGG repeat located at ends of linear chromosomes of eukaryote     cells that often decrease in length over time (largely due to oxidative damage and the end     replication problem during cell division) and may trigger cellular senescence once telomere     become critically short   "|No||2017-10-10 22:11:43.202283|2017-10-10 22:11:43.202283
NCT02775266|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-03-10|||February 2016||2016-02-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|EARGD||Effect of Antioxidant Intake on Resistin Levels In Patients With Gum Disease and Diabetes|Effect of Systemic Administration of ALA (Alpha Lipoic Acid) as an Adjunct to Scaling and Rootplaning on Serum Resistin Levels in Patients With Chronic Periodontitis and Type 2 Diabetes Mellitus|Completed||N/A|40|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||t||||||||No||2017-10-10 22:11:43.262108|2017-10-10 22:11:43.262108
NCT02775253|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-06-22|||May 2016||2016-05-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Chronic Cold Acclimation Stimulates the Browning of Subcutaneous White Adipose in Patients With Type 2 Diabetes Mellitus|Chronic Cold Acclimation Stimulates the Browning of Subcutaneous White Adipose in Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 4|11|Anticipated|Wuhan General Hospital of Guangzhou Military Command||1|||f||||t||||||||No||2017-10-10 22:11:43.346489|2017-10-10 22:11:43.346489
NCT02775227|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2016-12-04|||May 2016||2016-05-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Hydrocortisone vs. Pasireotide in Preventing Pancreatic Surgery Complications|Hydrocortisone vs Pasireotide in Preventing Pancreatic Fistula and Other Complications After Pancreatic Resection - a Prospective, Randomized, Controlled Trial|Recruiting||Phase 4|124|Anticipated|Helsinki University Central Hospital||2|||f||||||||||||||2017-10-10 22:11:43.546725|2017-10-10 22:11:43.546725
NCT02775214|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-03-10|||September 2013||2013-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Conventional Direct Laryngoscopy Vs. Video Laryngoscopy With The C-MAC For Pyloromyotomy|Conventional Direct Laryngoscopy Vs. Video Laryngoscopy With The C-MAC For Pyloromyotomy|Enrolling by invitation||N/A|72|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 22:11:43.633111|2017-10-10 22:11:43.633111
NCT02775201|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-31|||May 2016||2016-05-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Plantaris Release for Non-insertional Achilles Tendinopathy|A Comparison of Intra-operative and Ultrasound Guided Plantaris Release for the Treatment of Non-insertional Achilles Tendinopathy|Not yet recruiting||N/A|26|Anticipated|Fortius Clinic||2|||f||||f||||||||Undecided||2017-10-10 22:11:43.714273|2017-10-10 22:11:43.714273
NCT02775188|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2017-08-13|||July 2016||2016-07-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||interACTION: A Portable Joint Function Monitoring and Training System to Supplement Home Exercise Programs Following Anterior Cruciate Ligament Reconstruction|interACTION: A Portable Joint Function Monitoring and Training System to Supplement Home Exercise Programs Following Anterior Cruciate Ligament Reconstruction|Recruiting||N/A|40|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:11:43.801646|2017-10-10 22:11:43.801646
NCT02775175|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-14|2016-10-28|||May 2016||2016-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|Ramadan_16||Influence of a Modified Ramadan Fasting on Health and Well-being in Healthy Muslims - a Randomised Controlled Trial|The Influence of a Modified Ramadan Fasting Regimen on Health and Well-being in Healthy Muslims - a Randomised Controlled Trial|Completed||N/A|114|Actual|Universität Duisburg-Essen||2|||f||||f||||||||Undecided||2017-10-10 22:11:43.8698|2017-10-10 22:11:43.8698
NCT02775162|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-10|||June 2016||2016-06-01|July 2017|2017-07-01||||March 2018|Anticipated|2018-03-01||Interventional|||WP01 - Normothermic Liver Preservation|A Multicenter Randomized Controlled Trial to Compare the Efficacy of Ex-vivo Normothermic Machine Perfusion With Static Cold Storage in Human Liver Transplantation|Recruiting||Phase 3|266|Anticipated|OrganOx Ltd.||2|||f||||t||||||||||2017-10-10 22:11:43.965254|2017-10-10 22:11:43.965254
NCT02775149|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-08|||November 1, 2016|Actual|2016-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Dental Erosion in Patients With Gastro-oesophageal Reflux|Dental Erosion in Patients With Gastro-oesophageal Reflux|Enrolling by invitation||N/A|30|Anticipated|University of Göttingen|||1||f||||f|f|f||||Samples With DNA|"     Saliva samples are obtained and retained for 10 years.   "|No||2017-10-10 22:11:44.073022|2017-10-10 22:11:44.073022
NCT02775136|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-12-21|||October 2014||2014-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||An Evaluation of a Non-invasive Brain Monitor|An Open-Label, Non-Randomized, Comparative Study Designed to Evaluate the Accuracy and Safety of HS-1000 Device, a Non-Invasive Brain Monitor|Recruiting||N/A|160|Anticipated|HeadSense Medical||1|||f||||f||||||||No||2017-10-10 22:11:45.848779|2017-10-10 22:11:45.848779
NCT02775123|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-12-06|||May 2016||2016-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|CCCC||Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass|Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass: a Pilot Study|Recruiting||Phase 1/Phase 2|30|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||No||2017-10-10 22:11:45.951159|2017-10-10 22:11:45.951159
NCT02775110|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-05-13|||November 2012||2012-11-01|May 2016|2016-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|NaTDS||Natalizumab Temporary Discontinuation Study|Natalizumab Temporary Discontinuation Study|Completed||Phase 4|50|Actual|University at Buffalo||2|||f||||f||||||||No||2017-10-10 22:11:46.033899|2017-10-10 22:11:46.033899
NCT02775097|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-09-23|||April 2016||2016-04-01|May 2016|2016-05-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|||Evaluation of the Accuracy of Corneal Epithelial Thickness Mapping With SD-OCT|Evaluation of the Accuracy of Corneal Epithelial Thickness Mapping With SD-OCT|Completed||N/A|89|Actual|Optovue|||2||f||||f||||||||||2017-10-10 22:11:46.115301|2017-10-10 22:11:46.115301
NCT02775084|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-07|||January 2016||2016-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2016|Actual|2016-06-01||Interventional|||Fish Oil T Cell Function|Nutritional Intervention to Test Effect on Healthy Human T Cell Function|Active, not recruiting||N/A|13|Actual|Texas A&M University||2|||f||||f||||||||||2017-10-10 22:11:46.175582|2017-10-10 22:11:46.175582
NCT02775071|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-02|||December 2015||2015-12-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|SIDE-BAR||Psychopathology, Disordered Eating, and Impulsivity as Predictors of Outcomes of Bariatric Surgery|Psychopathology, Disordered Eating, and Impulsivity as Predictors of Outcomes of Bariatric Surgery|Enrolling by invitation||N/A|300|Anticipated|University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:11:46.258994|2017-10-10 22:11:46.258994
NCT02775058|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Observational|||CP009 SYNERGOSS PXX Observational|Clinical Evaluation Protocol Post Market Follow Up Pavia CP009 SYNERGOSS PXX Observational|Recruiting||N/A|22|Anticipated|Nobil Bio Ricerche srl|||1||f||||t||||||Samples With DNA|"     vital bone specimen sampled during surgery for dental implant placement   "|||2017-10-10 22:11:46.320556|2017-10-10 22:11:46.320556
NCT02775045|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-06-28|||August 30, 2016|Actual|2016-08-30|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|EoE||Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis|Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis|Recruiting||N/A|50|Anticipated|University of Wisconsin, Madison|||1||f||||t||||||Samples With DNA|"     55 mL of blood will be drawn during V1 and V2. The blood will be drawn to save serum, for     flow cytometry to answer the research questions, to isolate plasma and purify eosinophils for     banking of whole cell protein and RNA, and to allow for genetic analysis of DNA. DNA will be     isolated for directed genetic analysis of genes related to eosinophil biology and     inflammation associated with EoE. Currently, these include ORMDL3, eotaxin-3, and IL-13 and     may include others upon identification in the literature. This limited analysis is not     expected to be sufficient for subject identification nor is it expected that the genes will     be predictive of any other disease process. The genetic portion of the blood draw will not be     optional.   "|Yes||2017-10-10 22:11:46.393782|2017-10-10 22:11:46.393782
NCT02775032|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-16|||October 2016||2016-10-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Initiating ACP in General Practice. A Phase II Study|Evaluation of a Complex Intervention to Initiate Advance Care Planning in General Practice for the Improvement of End-of-life Care|Not yet recruiting||Phase 2|||Vrije Universiteit Brussel|||||f||||||||||||||2017-10-10 22:11:46.470592|2017-10-10 22:11:46.470592
NCT02775019|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-05-08|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|NAVLAC16||Health Impact of L.Reuteri Consumption in Crew Members of a Naval Ship at Sea|Impact of the Daily Consumption of L.Reuteri-containing Lozenges on Oral and General Health in Crew Members of a Naval Ship at Sea|Completed||N/A|72|Actual|Wuerzburg University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:11:46.531929|2017-10-10 22:11:46.531929
NCT02775006|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-14|||May 2016||2016-05-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma|A Randomized Phase III Study of Docetaxel Versus Intercalated Erlotinib Docetaxel Combination Therapy in Patients With Relapsed EGFR (Epidermal Growth Factor Receptor) Wild Type, ALK(Anaplastic Lymphoma Kinase) Negative Non Squamous Cell Carcinoma. (NVALT 18 Study)|Recruiting||Phase 3|230|Anticipated|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-10 22:11:46.723298|2017-10-10 22:11:46.723298
NCT02774993|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-05-12|||September 2015||2015-09-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|Doxy-TB||Doxycycline in Human Pulmonary Tuberculosis|Doxycycline and the Modulation of Host Immunopathology in Human Pulmonary Tuberculosis: A Pilot Study|Recruiting||Phase 2|40|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-10 22:11:46.909407|2017-10-10 22:11:46.909407
NCT02774980|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-13|||January 2015||2015-01-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|DEP-ICOR||Cognitive Markers of Response to Treatment in Resistant Depression|Cognitive Markers of Response to Treatment in Resistant Depression|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 22:11:47.000478|2017-10-10 22:11:47.000478
NCT02774967|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-19|||March 2014||2014-03-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Comparation Between Two Surgical Techniques With Acellular Dermal Matrix in Treatment of Gingival Recessions|Comparation Between Two Surgical Techniques With Acellular Dermal Matrix in Treatment of Gingival Recessions|Completed||N/A|20|Actual|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 22:11:47.083795|2017-10-10 22:11:47.083795
NCT02774954|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-05-21|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|CTC||Change the Cycle: An RCT to Prevent Injection Initiation|Preventing Injection Initiation: The Change the Cycle Randomized Controlled Trial.|Recruiting||Phase 3|1110|Anticipated|University of Southern California||2|||f||||t||||||||Yes|Using the National Addiction and HIV Data Archive program (NAHDAP), we will provide our datasets and codebooks to researchers in a format that facilitates data-sharing. After the completion of the study, the dataset will be de-identified and made available for secondary analysis on the NAHDAP website (http://www.icpsr.umich.edu/icpsrweb/NAHDAP/). Researchers who request access will be given a password to access the data, documentation, and surveys. As part of the registration process, researchers will sign an agreement to adhere to the data coding guidelines that were developed for the project, will state their intentions for use, and will agree to inform the original investigators of their findings and publications for tracking purposes with acknowledgments to the granting agency. Because the respondents will be identified only by ID codes in the datasets, it will be impossible to identify individuals from the datasets.|2017-10-10 22:11:47.172078|2017-10-10 22:11:47.172078
NCT02774941|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-09-02|||August 2016||2016-08-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient a Randomized Controlled Trial|Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-10 22:11:47.2827|2017-10-10 22:11:47.2827
NCT02774928|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-07-11|||June 2016||2016-06-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01|1 Year|Observational [Patient Registry]|||Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)|Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)|Recruiting||N/A|150|Anticipated|Cairo University|||3||f||||f||||||||Yes|publication at international journal|2017-10-10 22:11:47.355192|2017-10-10 22:11:47.355192
NCT02774915|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-05-12|||November 2014||2014-11-01|May 2016|2016-05-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|Pregnancy||Outcome of Pregnancy and Breast Cancer|Outcome of Pregnancy Associated Breast Cancer (PABC) in Saudi Arabia ; Prospective Cohort Study.|Recruiting||N/A|20|Anticipated|National Guard Health Affairs|||1||f||||f||||||||No||2017-10-10 22:11:47.450674|2017-10-10 22:11:47.450674
NCT02774902|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-13|||August 2010||2010-08-01|May 2016|2016-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor Clarithromycin|A Phase 1, Open-Label, Sequential Design Study to Evaluate the Effect of Multiple Oral Doses of Clarithromycin on the Pharmacokinetics of a Single Oral Dose of TAK-438|Completed||Phase 1|16|Actual|Takeda||1|||f||||f||||||||||2017-10-10 22:11:47.538787|2017-10-10 22:11:47.538787
NCT02774889|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-16|||July 2016||2016-07-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||KOSO (Keep On Stepping On)/ Stepping Online|Once 'Stepping On' Ends: Continuing a Group Falls Prevention Program Via the Internet|Enrolling by invitation||N/A|112|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||No||2017-10-10 22:11:47.61924|2017-10-10 22:11:47.61924
NCT02774876|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-07-03|||June 2016||2016-06-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes|An Open-label, Randomized, Four-way, Cross-over Study to Examine the Efficacy of Single-hormone Closed-loop System in Regulating Glucose Levels in Adults With Type 1 Diabetes Following Meals of Various Macronutrient Contents: a Pilot Study|Recruiting||Phase 2|15|Anticipated|Institut de Recherches Cliniques de Montreal||4|||f||||f||||||||||2017-10-10 22:11:47.70238|2017-10-10 22:11:47.70238
NCT02774863|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-08-08|||November 23, 2016|Actual|2016-11-23|August 2017|2017-08-01|July 5, 2017|Actual|2017-07-05|July 5, 2017|Actual|2017-07-05||Observational|RESOPSYBB||How to Collect the Expression of Psychological Suffering of Children Under Two Years?|Regional Prospective Multicenter Pilot Study: How to Collect the Expression of Psychological Suffering of Children Under Two Years ?|Terminated||N/A|6|Actual|Nantes University Hospital|||2|Not enough inclusion|f||||f||||||||||2017-10-10 22:11:47.815565|2017-10-10 22:11:47.815565
NCT02774850|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-01-13|||June 2015||2015-06-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|Aim 1||Home Away From Home - Medical Outcomes|Home or Away From Home: Comparing Clinical Outcomes Relevant to the Care of Pediatric Acute Myeloid Leukemia During Periods of Neutropenia|Recruiting||N/A|480|Anticipated|Children's Hospital of Philadelphia|||2||f||||f||||||||No|Coded, limited data sets will be shared with participating sites upon approved request. Only aggregate level data will be shared with the study sponsor Patient-Centered Outcomes Research Institute (PCORI).|2017-10-10 22:11:47.886692|2017-10-10 22:11:47.886692
NCT02774837|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-16|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|DUAL||Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B|Open Label Study of Nucleus(t)Ide Treated Patients Randomised to Tenofovir, or Tenofovir + Telbivudine|Recruiting||Phase 4|146|Anticipated|National University Health System, Singapore||2|||f||||f||||||||Undecided||2017-10-10 22:11:48.021903|2017-10-10 22:11:48.021903
NCT02774824|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-05-29|||October 1, 2015|Actual|2015-10-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||9 Months Extension Study of SOMVC001 Study (GALA) Vascular Conduit Preservation Solution|A 9-month Extension Study to: A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing Coronary Artery Bypass Grafting (CABG)|Active, not recruiting||N/A|53|Actual|Montreal Heart Institute|||1||f||||f||||||||No||2017-10-10 22:11:48.14625|2017-10-10 22:11:48.14625
NCT02774811|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-16|||February 2014||2014-02-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|SLT/med||Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication|Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication|Recruiting||N/A|400|Anticipated|University College, London||2|||f||||f||||||||Yes|Once publication accepted data to be shared in normal fashion with publication|2017-10-10 22:11:48.216832|2017-10-10 22:11:48.216832
NCT02774798|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-12|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Correlation of Anal Acoustic Reflectometry Parameters With Degree of Rectal Intussusception and Prolapse|Correlation of Anal Acoustic Reflectometry Parameters With Degree of Rectal Intussusception and Prolapse|Recruiting||N/A|99|Anticipated|University Hospital of South Manchester NHS Foundation Trust|||1||f||||f||||||||No|Individual data will not be shared. The correlations will be made with grade of oxford prolapse and then be grouped|2017-10-10 22:11:48.438462|2017-10-10 22:11:48.438462
NCT02774785|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-12|||March 2016||2016-03-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|MarginProbe||Does Intra-operative MarginProbe Use Reduce Re-excision Rates?|Reducing Re-excisions After Breast Conserving Surgery: A Randomized Controlled Trial Comparing the MarginProbe Device in Addition to Standard Operating Procedure Versus Standard Operating Procedure Alone in Preventing Re-excision|Not yet recruiting||N/A|460|Anticipated|University Hospital of South Manchester NHS Foundation Trust||2|||f||||t||||||||Yes|Peer Reviewed Scientific Journals Conference Presentation Publication on Website Access to raw data by Independent Steering Committee|2017-10-10 22:11:48.524879|2017-10-10 22:11:48.524879
NCT02774772|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-05-12|||April 2016||2016-04-01|January 2016|2016-01-01||||December 2017|Anticipated|2017-12-01||Observational|||The Use of Home-monitoring and mHealth Systems to Predict Asthma Control and the Occurrence of Asthma Exacerbations|The Use of Home-monitoring and mHealth Systems to Predict Asthma Control and the Occurrence of Asthma Exacerbations|Not yet recruiting||N/A|150|Anticipated|University Hospital of South Manchester NHS Foundation Trust|||1||f||||f||||||||Yes||2017-10-10 22:11:48.610382|2017-10-10 22:11:48.610382
NCT02774759|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-02-28|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers|Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers|Recruiting||N/A|75|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 22:11:48.68952|2017-10-10 22:11:48.68952
NCT02774746|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-08-28|||August 9, 2017|Actual|2017-08-09|August 2017|2017-08-01|May 2038|Anticipated|2038-05-01|May 2028|Anticipated|2028-05-01||Interventional|||Gastroschisis Outcomes of Delivery (GOOD) Study|Gastroschisis Outcomes of Delivery (GOOD) Study|Recruiting||N/A|800|Anticipated|Medical College of Wisconsin||2|||f||||t|f|f||||||||2017-10-10 22:11:48.812698|2017-10-10 22:11:48.812698
NCT02774733|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-05-16|||August 2015||2015-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Observational|CPCT2DM||Correlation Between the Pulmonary Function Parameters and the Circulatory Parameters (PSV, EDV, RI) of Retrobulbar Blood Vessels (CRA, PCA, and OA) in 48 T2DM Patients Did Not Combinate With DR|Correlation Between the Pulmonary Function Parameters and the Circulatory Parameters of Retrobulbar Blood Vessels in Patients With Type 2 Diabetes|Completed||N/A|48|Actual|Fourth People's Hospital of Shenyang|||1||f||||||||||||||2017-10-10 22:11:48.914242|2017-10-10 22:11:48.914242
NCT02774720|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-06-06|||September 2016||2016-09-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|CHIME||Centre- Versus Home-based Exercise for MCI and Early Dementia|How do we Get People With MCI and Dementia to be Physically Active?|Recruiting||N/A|60|Anticipated|University of Waterloo||2|||f||||f||||||||Undecided||2017-10-10 22:11:48.973215|2017-10-10 22:11:48.973215
NCT02774707|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-12-06|||January 2016||2016-01-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome|Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome|Enrolling by invitation||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:11:49.088287|2017-10-10 22:11:49.088287
NCT02774694|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-12-01|||January 2017||2017-01-01|December 2016|2016-12-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Observational|POINTPM||Prediction of Outcome of Interventional Pain Management|Observational Study of the Nociceptive Flexion Reflex Threshold to Predict Outcome After Interventional Pain Management Procedures in Patients With Chronic Back and Neck Pain. A Study of Diagnostic Accuracy|Not yet recruiting||N/A|350|Anticipated|University Hospital, Geneva|||1||f||||f||||||Samples With DNA|"     blood sample   "|Undecided||2017-10-10 22:11:49.159893|2017-10-10 22:11:49.159893
NCT02774681|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-06-14|||May 2016||2016-05-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|November 2019|Anticipated|2019-11-01||Interventional|||Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis|A Phase II Single Arm Study of Palbociclib in Patients With Metastatic HER2-positive Breast Cancer With Brain Metastasis|Recruiting||Phase 2|33|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 22:11:49.254901|2017-10-10 22:11:49.254901
NCT02774668|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-05-09|||May 2016||2016-05-01|August 2016|2016-08-01|December 31, 2017|Anticipated|2017-12-31|March 2017|Actual|2017-03-01||Interventional|||A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults|A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults|Active, not recruiting||N/A|20|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||Yes|After the study results are published we will share data with researchers who request this in writing.|2017-10-10 22:11:49.403714|2017-10-10 22:11:49.403714
NCT02774655|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-09-21|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|June 2017|Actual|2017-06-01||Interventional|||New Health Devices to Improve Adherence to Physical Activity in Overweight Inactive Adults|New Health Devices to Improve Adherence to Physical Activity in Overweight Inactive Adults|Completed||N/A|60|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 22:11:49.499533|2017-10-10 22:11:49.499533
NCT02774642|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-22|||October 1, 2016|Actual|2016-10-01|August 2017|2017-08-01|September 30, 2021|Anticipated|2021-09-30|March 31, 2021|Anticipated|2021-03-31||Interventional|||Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)|The Impact of Integrated CBT-I and PE on Sleep and PTSD Outcomes|Recruiting||N/A|90|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:11:49.623218|2017-10-10 22:11:49.623218
NCT02774629|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-12|||July 2014||2014-07-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Observational|||Efficacy of Local Food Extracts at Different Storage Times|Efficacy of Local Lyophilized Food Extracts for Skin Prick Tests and Atopy Patch Test at Different Storage Times (0, 3 and 6 Months)|Recruiting||N/A|60|Anticipated|Mahidol University|||1||f||||f||||||||No||2017-10-10 22:11:49.73124|2017-10-10 22:11:49.73124
NCT02774616|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-07-31|||June 2016||2016-06-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Master Study of the Ilivia ICD Family and the Plexa ICD Lead|"BIO|MASTER.Ilivia Family / Plexa"|Active, not recruiting||N/A|292|Actual|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-10-10 22:11:49.816723|2017-10-10 22:11:49.816723
NCT02774603|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-12-02|||June 2015||2015-06-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|ALT||Aquatic vs. Land Locomotor Training Overground Locomotor Training in Improving Ambulatory Function and Health-Related Quality of Life|The Efficacy of Aquatic Locomotor Training Compared to Overground Locomotor Training in Improving Ambulatory Function and Health-Related Quality of Life|Recruiting||N/A|10|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||||||||||||2017-10-10 22:11:49.94972|2017-10-10 22:11:49.94972
NCT02774590|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-12|||March 2016||2016-03-01|May 2016|2016-05-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Timolol for the Treatment of Acne and Rosacea|Timolol for the Treatment of Acne and Rosacea|Recruiting||Phase 1|24|Anticipated|Johns Hopkins University||1|||f||||f||||||||Yes|Following publication the investigators will honor all requests for original data|2017-10-10 22:11:50.035477|2017-10-10 22:11:50.035477
NCT02774577|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Interventional|||Oxygen Consumption After Acute Whole Body Vibration Session|Acute Effects on Oxygen Consumption and Blood Flow After a Single Session of Whole Body Vibration|Recruiting||N/A|30|Anticipated|Universidade Federal de Pernambuco||1|||f||||||||||||||2017-10-10 22:11:50.1211|2017-10-10 22:11:50.1211
NCT02774564|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-18|||September 2005||2005-09-01|May 2016|2016-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa|Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 3-202 and a Single Dose of Controlled-release 200/50 mg Levodopa/Carbidopa (Sinemet® cr 200/50): a Double-blind, Randomised, Four-way Crossover, Placebo-controlled Study in Healthy Volunteers|Completed||Phase 1|16|Actual|Bial - Portela C S.A.||4|||f||||f||||||||Undecided||2017-10-10 22:11:50.204385|2017-10-10 22:11:50.204385
NCT02774551|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-15|||January 2016||2016-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Physical Activity Intervention Trial to Mitigate Muscle Loss and Increase Muscle Strength|Physical Activity Intervention Trial to Mitigate Muscle Loss and Increase Muscle Strength in Esophageal Cancer Survivors|Enrolling by invitation||N/A|160|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:11:50.285805|2017-10-10 22:11:50.285805
NCT02774538|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-12-05|||May 2016||2016-05-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|PAPILLOR||Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort|Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort of Women Infected With Cervical HPV|Recruiting||N/A|165|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||f||||||||No||2017-10-10 22:11:50.353098|2017-10-10 22:11:50.353098
NCT02774525|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-04-04|||April 2013||2013-04-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Concurrent Treatment of Substance Abuse and Child Maltreatment|Concurrent Treatment of Substance Abuse and Child Maltreatment|Active, not recruiting||N/A|200|Anticipated|University of South Carolina||4|||f||||f||||||||Undecided||2017-10-10 22:11:50.435708|2017-10-10 22:11:50.435708
NCT02774512|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-10-04|||May 2016||2016-05-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ZAK-0||Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer|Phase 0 Study Aiming at Identifying Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer|Withdrawn||Early Phase 1|0|Actual|Institut Bergonié||1||"none participant has been enrolled and recruited during the first year after competent autority   autorisation."|f||||f||||||||||2017-10-10 22:11:50.525674|2017-10-10 22:11:50.525674
NCT02774499|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-10-27|||April 2016||2016-04-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Preoperative Oral Methadone for Patients Undergoing Cardiac Surgery: Reduction of Postoperative Pain|Preoperative Oral Methadone for Patients Undergoing Cardiac Surgery: Reduction of Postoperative Pain|Active, not recruiting||Phase 2|40|Anticipated|University of Saskatchewan||2|||f||||f||||||||Yes||2017-10-10 22:11:50.599202|2017-10-10 22:11:50.599202
NCT02774486|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficacy and Safety of IQP-AK-102 in Reducing Appetite|Open-Label Clinical Investigation to Evaluate Efficacy and Safety of IQP-AK-102 on Appetite Reduction in Healthy Over- Weight Subjects|Recruiting||N/A|36|Anticipated|InQpharm Group||1|||f||||f||||||||No||2017-10-10 22:11:50.674118|2017-10-10 22:11:50.674118
NCT02774473|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-07-28|||February 2016||2016-02-01|July 2017|2017-07-01||||February 2020|Anticipated|2020-02-01||Interventional|||[18F]Fluorothymidine (FLT) PET/CT Imaging In Rb+ Metastatic Breast Cancer Patients Undergoing LEE011 And Weekly Paclitaxel Therapy|[18F]Fluorothymidine (FLT) PET/CT Imaging In Rb+ Metastatic Breast Cancer Patients Undergoing LEE011 And Weekly Paclitaxel Therapy|Recruiting||N/A|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:11:50.867985|2017-10-10 22:11:50.867985
NCT02774460|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-09-09|||November 2016||2016-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|PHYSIC||The Precision Hypertension Care Study|The Precision Hypertension Care Study|Not yet recruiting||Phase 4|300|Anticipated|Uppsala University||7|||f||||||||||||||2017-10-10 22:11:50.954996|2017-10-10 22:11:50.954996
NCT02774447|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-05-12|||August 2015||2015-08-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Day-Case Closure of Loop Ileostomy in Rectal Cancer|Day-Case Closure of Ileostomy: A Pilot Study|Recruiting||N/A|30|Anticipated|Uppsala University|||1||f||||f||||||||||2017-10-10 22:11:51.070901|2017-10-10 22:11:51.070901
NCT02774434|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-06-23|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age|Efficacy Study of the Draeger Jaundice Meter (JM-105) in Providing TcB Measurements to Estimate TSB in Neonates of ≥ 24 Weeks of Gestational Age Who Have and Have Not Undergone Phototherapy|Recruiting||N/A|400|Anticipated|Draeger Medical Systems, Inc.||1|||f||||f|f|||||||||2017-10-10 22:11:51.177475|2017-10-10 22:11:51.177475
NCT02774421|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-09-15|||December 2016||2016-12-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|November 2021|Anticipated|2021-11-01||Interventional|||Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma|Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma|Recruiting||Phase 1|33|Anticipated|University of Colorado, Denver||2|||f||||||||||||||2017-10-10 22:11:51.279489|2017-10-10 22:11:51.279489
NCT02774408|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-05-16|||June 2016||2016-06-01|May 2016|2016-05-01||||July 2016|Anticipated|2016-07-01||Interventional|||Effects of Automated Adjustment of Inspired Oxygen With Combined Adaptive Mechanical Backup Ventilation as Compared to Automated Oxygen Adjustment Alone in Preterm Infants With Intermittent Hypoxemic Events During Non-invasive Ventilatory Support|Effects of Automated Adjustment of Inspired Oxygen With Combined Adaptive Mechanical Backup Ventilation as Compared to Automated Oxygen Adjustment Alone in Preterm Infants With Intermittent Hypoxemic Events During Non-invasive Ventilatory Support|Not yet recruiting||N/A|37|Anticipated|University of Ulm||2|||f||||f||||||||||2017-10-10 22:11:51.384468|2017-10-10 22:11:51.384468
NCT02774395|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-13|||May 2016||2016-05-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Observational|||Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine|Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine|Not yet recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Nice|||4||f||||f||||||Samples Without DNA|"     endometrioid adenocarcinoma and healthy endometrioid (obtain after hysterectomia)   "|No||2017-10-10 22:11:51.485595|2017-10-10 22:11:51.485595
NCT02774382|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-09-26|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections|Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections|Recruiting||Phase 3|450|Anticipated|Hvidovre University Hospital||3|||f||||t|f|f||||||||2017-10-10 22:11:51.584946|2017-10-10 22:11:51.584946
NCT02774369|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-13|||June 2012||2012-06-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Improving Sleep Among Cancer Patients: Comparison Between Physical Activity and Self-administered Cognitive-behavioral Therapy (CBT)|Improving Sleep Among Cancer Patients: Comparison Between Physical Activity and Self-administered Cognitive-behavioral Therapy (CBT)|Completed||N/A|41|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||No||2017-10-10 22:11:51.759705|2017-10-10 22:11:51.759705
NCT02774356|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-01-17|||July 2015||2015-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Testing Native Language Neural Commitment at the Subcortical Level|Testing Native Language Neural Commitment at the Subcortical Level: Links Between Brainstem Frequency Following Responses and Behavioral Perception for Lexical Tones|Completed||N/A|36|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||No||2017-10-10 22:11:51.86703|2017-10-10 22:11:51.86703
NCT02774343|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-16|||August 2012||2012-08-01|May 2016|2016-05-01||||June 2015|Actual|2015-06-01||Interventional|||PPARγ Agonist Treatment for Cocaine Dependence|PPARγ Agonist Treatment for Cocaine Dependence|Completed||Phase 1/Phase 2|30|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||No||2017-10-10 22:11:51.963126|2017-10-10 22:11:51.963126
NCT02774330|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-06-08|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|STORE||Impact of the Minneapolis Staple Foods Ordinance|Impact of a Local Staple Foods Ordinance on Food Choice and Calories Purchased|Recruiting||N/A|3500|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||No||2017-10-10 22:11:52.076181|2017-10-10 22:11:52.076181
NCT02774317|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-05-12|||October 2016||2016-10-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months|A Pilot Study to Compare the Use of Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months|Not yet recruiting||N/A|50|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-10 22:11:52.20378|2017-10-10 22:11:52.20378
NCT02774122|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2017-07-01|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Cochleural Alternating Acoustic Beam Therapy (CAABT) Versus Masking Intervention for Tinnitus|Cochleural Alternating Acoustic Beam Therapy Versus Masking Intervention for Tinnitus: A Randomised Controlled Trial|Active, not recruiting||N/A|60|Actual|Beijing Friendship Hospital||2|||f||||t||||||||||2017-10-10 22:11:54.118372|2017-10-10 22:11:54.118372
NCT02774304|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-12-05|||June 2016||2016-06-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|Eadyn||Assessment of Arterial Dynamic Elastance as a Function Variable of Arterial Load|Assessment of Arterial Dynamic Elastance as a Function Variable of Arterial Load, Derived From Both Non-invasive and Invasive Haemodynamic Variables.|Recruiting||N/A|15|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||No||2017-10-10 22:11:52.303115|2017-10-10 22:11:52.303115
NCT02774291|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Anti-ESO (Cancer/Test Antigen) mTCR-transduced Autologous Peripheral Blood Lymphocytes and Combination Chemotherapy in Treating Patients With Metastatic Cancer That Expresses NY-ESO-1|Pilot Study of Adoptive Cell Transfer for the Treatment of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 Murine TCR-Gene Engineered Lymphocytes|Not yet recruiting||N/A|10|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-10 22:11:52.428583|2017-10-10 22:11:52.428583
NCT02774278|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-08-05|2016-06-22||July 2005||2005-07-01|August 2016|2016-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|MERIT|Analysis population included all enrolled participants.|A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC)|MERIT - A Phase II Marker Identification Trial for Tarceva in Second Line NSCLC Patients|Completed||Phase 2|264|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:11:52.608704|2017-10-10 22:11:52.608704
NCT02774252|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-16|||August 2015||2015-08-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SPF Assay||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|13|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:11:53.190898|2017-10-10 22:11:53.190898
NCT02774239|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-08-24|||October 2014||2014-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SCIG-MG||A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)|A Pilot Trial To Assess The Feasibility And Efficacy Of Subcutaneous Immunoglobulin In Patients With Myasthenia Gravis Exacerbation|Recruiting||Phase 3|30|Anticipated|University of Alberta||1|||f||||f||||||||||2017-10-10 22:11:53.270831|2017-10-10 22:11:53.270831
NCT02774226|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-02-24|||September 2015||2015-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|COPD-LT||Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease|Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease|Recruiting||Phase 2|12|Anticipated|Augusta University||2|||f||||t||||||||Yes||2017-10-10 22:11:53.385542|2017-10-10 22:11:53.385542
NCT02774213|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-26|||July 2014||2014-07-01|September 2017|2017-09-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Observational|||A Study to Collect Data About Analgesia in Patients With Bone Metastasis|An Observational Study to Collect Data Characterizing Analgesia in Patients Suffering From Bone Metastasis Induced Pain|Completed||N/A|74|Actual|Tools4Patient|||1||f||||f||||||Samples With DNA|"     Use of potentially available archived tumor tissue block and/or aliquot of standard safety     laboratory blood sample for genotyping purposes are optional in this study for patients     recruited in Belgium.      This optional research is not proposed to any patient recruited in France   "|||2017-10-10 22:11:53.498139|2017-10-10 22:11:53.498139
NCT02774200|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-12|||May 2016||2016-05-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.|A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients|Not yet recruiting||Phase 2|20|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||f||||||||No||2017-10-10 22:11:53.585947|2017-10-10 22:11:53.585947
NCT02774187|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-12-27|||May 2016||2016-05-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC|Sorafenib Alone Versus Sorafenib Combined With Hepatic Arterial Chemoinfusion for Advanced HCC With Major Portal Vein Tumor Thrombosis: a Multicentre Randomised Controlled Trial|Recruiting||Phase 3|162|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:11:53.66099|2017-10-10 22:11:53.66099
NCT02774174|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-10-13|||May 2016||2016-05-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Evaluation of the METS™ Proximal Humeral System|Post Marketing Clinical Follow Up for the Evaluation of the METS™ Proximal Humeral System Using Retrospective Data|Recruiting||N/A|100|Anticipated|Stanmore Implants Ltd.|||1||f||||f||||||||No|This is a retrospective safety evaluation study. Data will already be deidentified before the clinical research team receive it.|2017-10-10 22:11:53.788138|2017-10-10 22:11:53.788138
NCT02774148|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-06-27|||December 2016||2016-12-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Pain Control in Elderly Hip Fracture Patients: Is Intravenous Acetaminophen Superior to Oral Administration?|Pain Control in Elderly Hip Fracture Patients: Is Intravenous Acetaminophen Superior to Oral Administration?|Terminated||Phase 4|1|Actual|Spectrum Health Hospitals||2||Proved difficult to consent patient population due to comorbidities|f||||f||||||||No||2017-10-10 22:11:53.953423|2017-10-10 22:11:53.953423
NCT02774135|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-06-13|||May 1, 2017|Actual|2017-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||Improvement in Preschoolers' Participation as a Result of Occupational Therapy Intervention|A Prospective Cohort Study to Examine the Improvement in Preschoolers' Participation as a Result of Occupational Therapy Intervention|Recruiting||N/A|90|Anticipated|Clalit Health Services|||1||f||||f||||||||No||2017-10-10 22:11:54.036328|2017-10-10 22:11:54.036328
NCT02774109|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-13|||April 2016||2016-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effects of Fish Oil on Patients With Chronic Nonspecific Low Back Pain|The Effects of Fish Oil on Patients With Chronic Nonspecific Low Back Pain|Recruiting||N/A|52|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-10 22:11:54.196727|2017-10-10 22:11:54.196727
NCT02774096|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-12|||February 2016||2016-02-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Cerebral and Spinal Protection of Xenon Post-conditioning in Patients Undergoing Aortic Dissection Repair|Cerebral and Spinal Protection of Xenon Post-conditioning in Patients Undergoing Aortic Dissection Repair|Active, not recruiting||N/A|120|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:11:54.304129|2017-10-10 22:11:54.304129
NCT02774083|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-17|||October 2015||2015-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Feuerstein||Cognitive Training Using Feuerstein Instrumental Enrichment|An Evaluation of the Feuerstein Instrumental Enrichment Program for the Cognitive Enhancement of Older People With Mild Cognitive Impairment (MCI) Living in the Community|Recruiting||N/A|150|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-10 22:11:54.587766|2017-10-10 22:11:54.587766
NCT02774070|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-12|||June 2016||2016-06-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|MRI||Characteristics of Rheumatoid Arthritis Patients With Atlantoaxial Synovitis Detected by Plain X-ray and MRI|Characteristics of Rheumatoid Arthritis Patients With Asymptomatic Versus Symptomatic Atlantoaxial Joint Affection Detected by Plain X-ray and Magnetic Resonance Imaging|Not yet recruiting||N/A|200|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:11:54.70958|2017-10-10 22:11:54.70958
NCT02774057|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-01-24|||March 2016||2016-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD|Randomized Cross-Over Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With Inflammatory Bowel Disease|Recruiting||Phase 4|20|Anticipated|American University of Beirut Medical Center||2|||f||||t||||||||No||2017-10-10 22:11:54.7956|2017-10-10 22:11:54.7956
NCT02774044|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-16|||June 2016||2016-06-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates|Evaluating the Efficacy and Safety of an Innovative and Affordable Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates: a Multi-site Randomized Clinical Trial|Not yet recruiting||Phase 2/Phase 3|900|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||Undecided||2017-10-10 22:11:54.902813|2017-10-10 22:11:54.902813
NCT02774031|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-12-01|||May 2016||2016-05-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of Gas Consumption From Two Different Anesthesia Machines|Comparing Gas Consumption With Conventional Low Flow Ventilation and Gas Control Systems From Two Different Anesthesia Machines: Flow-i and Aisys|Recruiting||N/A|160|Anticipated|St. Olavs Hospital||4|||f||||f||||||||Undecided||2017-10-10 22:11:55.023852|2017-10-10 22:11:55.023852
NCT02774018|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-05-12|||June 2015||2015-06-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Life Satisfaction and Psychopathology in Institutionalized Elderly People|Life Satisfaction and Psychopathology in Institutionalized Elderly People: The Results of an Adapted Mindfulness-Based Stress Reduction Program|Completed||N/A|12|Actual|Irmandade da Misericórdia de Albergaria-a-Velha||1|||f||||||||||||||2017-10-10 22:11:55.117811|2017-10-10 22:11:55.117811
NCT02774005|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-21|||May 2016||2016-05-01|September 2017|2017-09-01||||April 2020|Anticipated|2020-04-01||Interventional|LEROS||Study to Assess the Efficacy and Safety of Raxone in LHON Patients|External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)|Recruiting||Phase 4|250|Anticipated|Santhera Pharmaceuticals||1|||f||||||||||||||2017-10-10 22:11:55.186206|2017-10-10 22:11:55.186206
NCT02773992|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-13|||August 2015||2015-08-01|May 2016|2016-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Clinical Study of Three Plus Two Type Early Diagnosis of Pulmonary Nodules in Medical Internet of Things|Multi Center Clinical Study of Three Plus Two Type Early Diagnosis of Pulmonary Nodules in Medical Internet of Things|Recruiting||N/A|600|Anticipated|Henan Provincial Hospital|||2||f||||f||||||||No||2017-10-10 22:11:55.346748|2017-10-10 22:11:55.346748
NCT02773979|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-15|||September 12, 2016|Actual|2016-09-12|April 5, 2017|2017-04-05|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States|A Phase 1, Blinded, Randomized, Dose Escalation Trial to Assess the Safety and Efficacy of Infectious (Replication-intact), Cryopreserved Plasmodium Falciparum Sporozoites (PfSPZ Challenge) Administered by Direct Venous Inoculation Under Chloroquine Cover (PfSPZ-CVac) in Healthy Malaria-Naïve Adults in the United States|Recruiting||Phase 1|36|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f|||||t|f|||f|||||2017-10-10 22:11:55.432511|2017-10-10 22:11:55.432511
NCT02773966|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-07-14|||July 2016||2016-07-01|July 2016|2016-07-01|November 2023|Anticipated|2023-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Kypho-IORT vs. EBRT in Spinal Metastases|Intraoperative Radiotherapy During Kyphoplasty/Vertebroplasty (Kypho-IORT) Versus EBRT in the Treatment of Painful Vertebral Metastases - a Randomized Prospective Phase III Study -|Recruiting||Phase 3|54|Anticipated|Universitätsmedizin Mannheim||2|||f||||t||||||||No||2017-10-10 22:11:55.530922|2017-10-10 22:11:55.530922
NCT02773953|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-04-25|||April 2016||2016-04-01|October 2016|2016-10-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Impact of Telemonitoring to Improve Adherence in Continuous Positive Airway Pressure (CPAP)-Treated Patients|Impact of Telemonitoring on Delay of Intervention to Improve Precocious Adherence in CPAP-treated Sleep Apnea Patients|Completed||N/A|46|Actual|Centre Hospitalier Universitaire Saint Pierre||2|||f||||f||||||||No||2017-10-10 22:11:55.627117|2017-10-10 22:11:55.627117
NCT02773940|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-11-03|||May 2016||2016-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy|Prospective, Multi-Center Study of the ClariCore™ Optical Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy For Prostate Tissue Classification Algorithm Development|Recruiting||N/A|100|Anticipated|Precision Biopsy, Inc.||1|||f||||f||||||||No||2017-10-10 22:11:55.712781|2017-10-10 22:11:55.712781
NCT02773927|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-17|||January 2013||2013-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|January 2014|Actual|2014-01-01||Interventional|||Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome|Effect of the Combination Metformin/Inulin vs Inulin on Adiponectin in Patients With Metabolic Syndrome|Completed||Phase 3|40|Actual|Centro Universitario de Ciencias de la Salud, Mexico||4|||f||||f||||||||No||2017-10-10 22:11:55.799264|2017-10-10 22:11:55.799264
NCT02773914|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-08-21|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||Comprehensive Geriatric Assessment for Frail Older People|Comprehensive Geriatric Assessment for Frail Older People in Swedish Acute Care Settings: A Randomized Controlled Study|Recruiting||N/A|156|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 22:11:55.91475|2017-10-10 22:11:55.91475
NCT02773901|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-12-21|||November 2015||2015-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of the Non-invasive ICP HeadSense Monitor vs Lumbar CSF Pressure Measurement|Comparison of the Non-invasive ICP HeadSense Monitor vs Lumbar CSF Pressure Measurement|Recruiting||N/A|60|Anticipated|HeadSense Medical||1|||f||||f||||||||No||2017-10-10 22:11:56.005889|2017-10-10 22:11:56.005889
NCT02773888|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-02-23|||December 2015||2015-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device|An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device|Suspended||N/A|80|Anticipated|HeadSense Medical||1||Recruitment temporarily held for site retraining|f||||f||||||||No||2017-10-10 22:11:56.103121|2017-10-10 22:11:56.103121
NCT02773875|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-13|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|ZoneMPC||Fault Detection, Zone MPC and DiAs System in T1D|A Randomized Crossover Study to Evaluate the Efficacy of Fault Detection Algorithms Using the ZoneMPC Algorithm and DiAs System in Adult Subjects With Type 1 Diabetes in the Outpatient Setting|Not yet recruiting||N/A|20|Anticipated|Rensselaer Polytechnic Institute||2|||f||||f||||||||No||2017-10-10 22:11:56.19384|2017-10-10 22:11:56.19384
NCT02773862|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-13|||June 2014||2014-06-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Prospective Evaluation of the Non-invasive ICP HeadSense Monitor in TBI Patients Undergoing Invasive ICP Monitoring|Prospective Evaluation of the Non-invasive ICP HeadSense Monitor in TBI Patients Undergoing Invasive ICP Monitoring|Completed||N/A|12|Actual|HeadSense Medical||1|||f||||f||||||||No||2017-10-10 22:11:56.270803|2017-10-10 22:11:56.270803
NCT02773849|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-10-05|||September 2016||2016-09-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study to Evaluate INSTILADRIN® in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive NMIBC|A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN® (rAd-IFN)/Syn3) Administered Intravesically to Patients With High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)|Recruiting||Phase 3|135|Anticipated|FKD Therapies Oy||1|||f||||t||||||||||2017-10-10 22:11:56.357173|2017-10-10 22:11:56.357173
NCT02773823|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-05-13|||November 2015||2015-11-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A Behavior Intervention Study on Cardiovascular Health Among Chinese Obese Schoolchildren|A Comprehensive Intervention Study on Klotho Gene Methylation and Cardiovascular Risk Factors|Recruiting||N/A|200|Anticipated|Wuhan University||2|||f||||f||||||||Undecided||2017-10-10 22:11:56.664448|2017-10-10 22:11:56.664448
NCT02773810|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-07-26|||April 2014||2014-04-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Interventional|||Integration of Family Planning Services Into Anticoagulation Monitoring Services|Can Integration of Family Planning Services Into Anticoagulation Monitoring Services Improve Uptake of Long-Acting Reversible Contraception?|Active, not recruiting||N/A|218|Actual|Indiana University||1|||f||||f||||||||||2017-10-10 22:11:56.761806|2017-10-10 22:11:56.761806
NCT02773797|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-13|||August 2016||2016-08-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Interventional|||Placebo Controlled Evaluation of Sedation and Physiological Response to Intranasal Dexmedetomidine in Severe COPD|Sedation and Physiologic Response to Intranasal Dexmedetomidine in Severe Chronic Obstructive Pulmonary Disease (COPD): A Randomized, Blinded, Placebo Controlled Crossover Trial|Not yet recruiting||Phase 4|50|Anticipated|Dayton VA Medical Center||3|||f||||t||||||||||2017-10-10 22:11:56.824421|2017-10-10 22:11:56.824421
NCT02773784|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-08-24|||September 2014|Actual|2014-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Observational|||Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.|Comparison of Core Needle Biopsy (CNB) and Surgical Specimens for Estrogen Receptor (ER), Progesterone Receptor (PgR), Human Epidermal Growth Factor Receptor 2 (HER2) Status and Ki67 Index in Invasive Breast Cancer.|Recruiting||N/A|310|Anticipated|Peking University|||1||f||||f||||||Samples Without DNA|"     ER, PgR, Her-2 and Ki67 are determined by immunohistochemistry (IHC) in CNB and surgical     specimen. FISH analysis will be carried out in all HER2 2+ samples.   "|||2017-10-10 22:11:56.917099|2017-10-10 22:11:56.917099
NCT02773771|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-11-21|||January 2017||2017-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|STROMA-ICU||Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit|Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit (STROMA-ICU)|Not yet recruiting||Phase 2/Phase 3|60|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 22:11:57.000312|2017-10-10 22:11:57.000312
NCT02773576|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-10-07|||April 2016||2016-04-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Tolerability of Risperidone Implants|A One Year, Open-label, Study to Evaluate the Safety and Tolerability of Risperidone Implants as a Maintenance Treatment in Patients With Schizophrenia|Active, not recruiting||Phase 3|145|Anticipated|Braeburn Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:11:58.947886|2017-10-10 22:11:58.947886
NCT02773758|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-31|2016-10-17||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|March 11, 2016|Actual|2016-03-11|March 11, 2016|Actual|2016-03-11||Interventional||One participant was randomized to sodium monofluorophosphate dentifrice but received stannous fluoride dentifrice, therefore, treatment arm “stannous fluoride dentifrice” included 72 participants & treatment arm “sodium monofluorophosphate dentifrice” included 69 participants.|Study to Investigate the Efficacy of an Occluding Dentifrice in Providing Relief From Dentine Hypersensitivity|Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|Completed||Phase 4|143|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:11:57.138443|2017-10-10 22:11:57.138443
NCT02773745|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-07-17|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Prehabilitation Using Aquatic Exercise|The Effects of Aquatic Prehabilitation in Knee OA Patients on Knee Arthroplasty Outcomes|Recruiting||N/A|45|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-10 22:11:57.43274|2017-10-10 22:11:57.43274
NCT02773732|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-21|||December 16, 2016|Actual|2016-12-16|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)|A Phase Ib/II Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)|Recruiting||Phase 1/Phase 2|68|Anticipated|University of Florida||1|||f||||t|t|f||||||No||2017-10-10 22:11:57.546328|2017-10-10 22:11:57.546328
NCT02773719|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-13|||April 2016||2016-04-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|MAGNETIK||Biofields Therapy on Warts|Effect of the Intervention of Biofields Therapy on Warts of the Hands and Feet in Adults: a Prospective, Randomized, Double-blind Trial|Recruiting||Phase 2|62|Anticipated|University Hospital, Caen||2|||f||||f||||||||No||2017-10-10 22:11:57.66289|2017-10-10 22:11:57.66289
NCT02773706|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-05-12|||September 2016||2016-09-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|DECADES||Detecting and Evaluating Childhood and Anxiety and Depression Effectively in Subspecialties|Detecting and Evaluating Childhood and Anxiety and Depression Effectively in Subspecialties|Not yet recruiting||N/A|100|Anticipated|Indiana University||2|||f||||t||||||||No||2017-10-10 22:11:57.766126|2017-10-10 22:11:57.766126
NCT02773693|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-10-24|||August 2016||2016-08-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Treatment of Comorbid Sleep Disorders and Post Traumatic Stress Disorder (PTSD)|Treatment of Comorbid Sleep Disorders and Post Traumatic Stress Disorder (PTSD)|Recruiting||Phase 3|222|Anticipated|University of North Texas, Denton, TX||3|||f||||t||||||||No||2017-10-10 22:11:57.858441|2017-10-10 22:11:57.858441
NCT02773680|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|||Human Electrical-Impedance-Tomography Reconstruction Models|Assessment of CT-derived Thoracic Electrical-Impedance-Tomography Finite Element Models|Not yet recruiting||Phase 3|160|Anticipated|Medical University of Vienna||1|||f||||f||||||||No||2017-10-10 22:11:57.957086|2017-10-10 22:11:57.957086
NCT02773667|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-06-19|||January 2016||2016-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|RETENTION||Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine|Relationship Between Estimated Glomerular Filtration Rate and Biological Half-life of 131I. Prospective Analysis in Patients With Differentiated Thyroid Carcinoma.|Recruiting||N/A|110|Anticipated|Jena University Hospital|||1||f||||f||||||||No||2017-10-10 22:11:58.039157|2017-10-10 22:11:58.039157
NCT02773654|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-27|||June 2016||2016-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Observational|MnMotion||Mobile Application Utilization for Measurement of Scapular Position|1) Mobile Application Utilization for Measurement of Scapular Position 2) 3D Shoulder Motion Measurement Device (The MnMotion System)|Active, not recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-10 22:11:58.117967|2017-10-10 22:11:58.117967
NCT02773641|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Botulinum Toxin A as a Treatment for Provoked Vestibulodynia|Double Blind Placebo-controlled RCT of the Efficacy and Safety of Intramuscular Injections of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia|Not yet recruiting||Phase 3|90|Anticipated|Karolinska Institutet||2|||f||||f||||||||No||2017-10-10 22:11:58.199521|2017-10-10 22:11:58.199521
NCT02773628|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-11-15|||May 2016||2016-05-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Impact of Reduction of Dust Mite Allergenic Load on Step Down of Inhaled Corticosteroids in Stable Asthma|Impact of Reduction of Dust Mite Allergenic Load on Step Down of Inhaled Corticosteroids in Stable Asthma|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire Saint Pierre||2|||f||||f||||||||No||2017-10-10 22:11:58.35034|2017-10-10 22:11:58.35034
NCT02773615|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-12-19|||June 2016||2016-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|2 Years|Observational [Patient Registry]|PERFeCT||CT Perfusion Added to CT Angiography|CT Perfusion Added to CT Angiography for Unstable Angina or Nonanginal Chest Pain in the Emergency Department (PERFeCT) : a Feasibility and Safety Pilot Study.|Not yet recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||Undecided||2017-10-10 22:11:58.517013|2017-10-10 22:11:58.517013
NCT02773589|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-06-30|||March 2014||2014-03-01|May 2016|2016-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Prospective Evaluation of a New Approach to Perform an Esophageal Myotomy: the Transesophageal Submucosa Approach|Prospective Evaluation of a New Approach to Perform an Esophageal Myotomy: the Transesophageal Submucosa Approach|Completed||N/A|10|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 22:11:58.857739|2017-10-10 22:11:58.857739
NCT02773563|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-04-07|||April 2016||2016-04-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Observational|||CO2 vs. Air Insufflation for Endoscopic Ultrasound|Role of CO2 Insufflation vs. Air Insufflation for Endoscopic Ultrasound: a Prospective Observational Study|Completed||N/A|200|Actual|University of Bologna|||2||f||||f||||||||No||2017-10-10 22:11:59.047044|2017-10-10 22:11:59.047044
NCT02773550|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-05-13|||January 2014||2014-01-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|Velcadito||Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma|Clinical, Multicenter, Single-arm, Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma (MM) Newly Diagnosed Symptomatic ≥75 Years|Recruiting||Phase 4|44|Anticipated|Basque Health Service||1|||f||||t||||||||No||2017-10-10 22:11:59.140721|2017-10-10 22:11:59.140721
NCT02773537|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-31|||April 2015||2015-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||RCT of Anesthesia/Analgesia for Total Knee Arthroplasty|Randomized Comparative Effectiveness Trial of Anesthesia/Analgesia Techniques for Primary Total Knee Arthroplasty|Enrolling by invitation||N/A|75|Anticipated|Medical University of South Carolina||3|||f||||f||||||||||2017-10-10 22:11:59.264119|2017-10-10 22:11:59.264119
NCT02773524|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-12|||June 2016||2016-06-01|May 2016|2016-05-01||||April 2019|Anticipated|2019-04-01||Interventional|INTEGRATEII||A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer|A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)|Not yet recruiting||Phase 3|350|Anticipated|Australasian Gastro-Intestinal Trials Group||2|||f||||t||||||||||2017-10-10 22:11:59.357641|2017-10-10 22:11:59.357641
NCT02773511|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-13|||July 2016||2016-07-01|May 2016|2016-05-01||||July 2019|Anticipated|2019-07-01||Interventional|||Multi-center Study on Surgical or Non-surgical Treatment for Children Type 1 Humeral Condyle Fracture||Not yet recruiting||N/A|240|Anticipated|Wuhan Union Hospital, China||2|||f||||f||||||||||2017-10-10 22:11:59.446151|2017-10-10 22:11:59.446151
NCT02773498|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-04-28|||April 26, 2017|Actual|2017-04-26|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Interventional|Microsperm||Comparison of Medical Results of Testicular Sperm Extraction by Conventional Surgery and Microsurgical Track|Comparison of Medical Results of Testicular Sperm Extraction by Conventional Surgery and Microsurgical Track|Active, not recruiting||N/A|220|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||Undecided||2017-10-10 22:11:59.52632|2017-10-10 22:11:59.52632
NCT02773485|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-05-17|||May 2015||2015-05-01|May 2016|2016-05-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma|Phase III Randomized Trial of High Dose Chemoradiation and Systemic Chemotherapy vs Systemic Chemotherapy Alone in Patients With Unresectable Nonmetastatic Cholangiocarcinoma|Recruiting||Phase 3|155|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:11:59.643657|2017-10-10 22:11:59.643657
NCT02773472|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-08-08|||August 2015||2015-08-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Electroacupuncture for Laparoscopic/ Robotic Colorectal Surgery|Post-operative Electroacupuncture as Part of the Multimodal Analgesic Regimen for Laparoscopic or Robotic Colorectal Surgery|Recruiting||N/A|70|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 22:11:59.756555|2017-10-10 22:11:59.756555
NCT02773459|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2016-05-15|||April 2016||2016-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer|Phase Ib Study of MEK162 in Combination With Capecitabine in Gemcitabine-pretreated Advanced Biliary Tract Cancer|Recruiting||Phase 1/Phase 2|35|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 22:11:59.861752|2017-10-10 22:11:59.861752
NCT02773446|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-03-08|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A|Human Challenge Model Refinement for B7A, An Enterotoxigenic Escherichia Coli (ETEC) Challenge Strain That Expresses CS6|Completed||N/A|47|Actual|Johns Hopkins Bloomberg School of Public Health||6|||f||||f||||||||Yes|Data will be published in Peer reviewed journal|2017-10-10 22:11:59.967404|2017-10-10 22:11:59.967404
NCT02773433|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-12-05|||January 2016||2016-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||PAV vs Assist Control After Failed SBT|Proportional Assist Ventilation Versus Volume-Assist-Control After a Failed Spontaneous Breathing Trial: a Randomized Controlled Trial|Completed||N/A|20|Actual|University of Louisville||2|||f||||t||||||||||2017-10-10 22:12:00.090377|2017-10-10 22:12:00.090377
NCT02773420|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-30|||August 2015||2015-08-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|HET||HET Bipolar System: Validation of Outpatient Hemorrhoid Treatment|HET Bipolar System: Validation of a New Minimally Invasive Outpatient Treatment for Symptomatic Hemorrhoids|Active, not recruiting||N/A|30|Anticipated|University of Illinois at Chicago||1|||f||||f||||||||||2017-10-10 22:12:00.196936|2017-10-10 22:12:00.196936
NCT02773407|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-12-14|||June 2016||2016-06-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|NUFIT||Nepal Undifferentiated Febrile Illness Trial|Parallel Group, Double Blinded, 1:1, Randomized Controlled Phase III Trial of Co-trimoxazole Versus Azithromycin for the Treatment of Undifferentiated Fever In Nepal|Recruiting||Phase 3|330|Anticipated|Oxford University Clinical Research Unit, Vietnam||2|||f||||t||||||||Yes|Anonymised individual participant data will be made available to researcher and public as a supporting material via open access journal and/or upon request by qualified research groups|2017-10-10 22:12:00.30026|2017-10-10 22:12:00.30026
NCT02773394|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-05|||April 12, 2016|Actual|2016-04-12|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Observational|PICTURE||Study to Describe the Actual Situation of Hepatitis C Treatment in Brazil|Protocol to Describe the Actual Situation of Hepatitis C Treatment in Brazil|Completed||N/A|1649|Actual|Janssen-Cilag Ltd.|||1||f||||f||f||||||||2017-10-10 22:12:00.432798|2017-10-10 22:12:00.432798
NCT02773199|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-10-17|||May 2016||2016-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Effects of Preoperative Fasting on ECG and Vital Parameters|Effects of Preoperative Fasting on ECG and Vital Parameters in Patients Undergoing Orthopedic and Urologic Surgery|Completed||N/A|100|Actual|Bozyaka Training and Research Hospital|||2||f||||f||||||||No||2017-10-10 22:12:02.710464|2017-10-10 22:12:02.710464
NCT02773368|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-09-28|||May 23, 2016|Actual|2016-05-23|September 2017|2017-09-01|October 23, 2017|Anticipated|2017-10-23|October 23, 2017|Anticipated|2017-10-23||Interventional|DUALTM IX||A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus|A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus. DUALTM IX - Add-on to SGLT2i|Recruiting||Phase 3|416|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 22:12:00.642904|2017-10-10 22:12:00.642904
NCT02773355|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-13|2017-07-21|||May 16, 2016|Actual|2016-05-16|July 2017|2017-07-01|May 16, 2019|Anticipated|2019-05-16|May 16, 2019|Anticipated|2019-05-16||Observational|||Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients|Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients|Enrolling by invitation||N/A|100|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 22:12:00.952302|2017-10-10 22:12:00.952302
NCT02773342|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-05-13|||June 2013||2013-06-01|May 2016|2016-05-01||||April 2016|Actual|2016-04-01||Observational|||An Evaluation of Sequential Computed Tomography of the Chest in Management of Invasive Pulmonal Aspergillosis in Neutropenic Patients With Haematological Malignancies||Not yet recruiting||N/A|40|Anticipated|University Hospital of Cologne|||1||f||||||||||||||2017-10-10 22:12:01.533296|2017-10-10 22:12:01.533296
NCT02773329|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-12-16|||May 2016||2016-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Using Game-based Exercise to Improve Balance in Cancer Patients|Managing Chemotherapy Induced Neuropathy in Cancer Patients Using Game-based Exercise|Recruiting||Phase 2|66|Anticipated|Baylor College of Medicine||2|||f||||f||||||||Undecided|Only de-identified data and associated results will be published in peer-review papers or scientific abstracts.|2017-10-10 22:12:01.619711|2017-10-10 22:12:01.619711
NCT02773316|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-13|||September 2015||2015-09-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution|2-cohort, 3-part, Open-label, Randomised, Single Dose, Crossover Study in Healthy Subjects to Compare PK & Bioavailability of a Single Dose, in Fed and Fasted State, of MR902 Prolonged Release (PR) Tablets With Immediate Release (IR) Morphine Sulfate Oral Solution|Completed||Phase 1|84|Actual|Mundipharma Research Limited||3|||f||||f||||||||No||2017-10-10 22:12:01.703272|2017-10-10 22:12:01.703272
NCT02773290|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-05-16|||May 2016||2016-05-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia|Phase 2/3 Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia Refractory to or Ineligible for Immunosuppressive Therapy|Active, not recruiting||Phase 2/Phase 3|46|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||No||2017-10-10 22:12:01.880606|2017-10-10 22:12:01.880606
NCT02773277|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-13|||June 2016||2016-06-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||Prospective Assessment of Peripheral-vestibular Function After Skull Base Surgery||Not yet recruiting||N/A|50|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 22:12:01.982931|2017-10-10 22:12:01.982931
NCT02773264|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-05-03|||March 2016||2016-03-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Observational|USE||Validation of Ultra Sound (US) Elastography|Validation of Ultra Sound (US) Elastography for the Evaluation of Soft Tissue and Organ Lesions|Recruiting||N/A|70|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 22:12:02.099545|2017-10-10 22:12:02.099545
NCT02773251|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-14|||November 2011||2011-11-01|May 2016|2016-05-01||||June 2014|Actual|2014-06-01||Interventional|||The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery|Hyaluronic Acid-Carboxymethylcellulose Reduced Postoperative Bowel Adhesions Following Laparoscopic Urologic Pelvic Surgery: a Prospective, Randomized, Controlled, Single-Blind Study|Completed||Phase 4|60|Actual|Bucheon St. Mary's Hospital||2|||f||||t||||||||||2017-10-10 22:12:02.196392|2017-10-10 22:12:02.196392
NCT02773238|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-03-23|||May 2016||2016-05-01|March 2017|2017-03-01||||December 2021|Anticipated|2021-12-01||Interventional|||FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging|Personalized Radiation Therapy Through Functional Lung Avoidance and Response-Adaptive Dose Escalation: Utilizing Multimodal Molecular Imaging to Improve the Therapeutic Ratio (FLARE RT)|Recruiting||Phase 2|50|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-10 22:12:02.279055|2017-10-10 22:12:02.279055
NCT02773225|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-05-11|||March 2015||2015-03-01|February 2016|2016-02-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|EMAA||Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)|Efficacy and Safety of Thrombopoetin-Receptor Agonist Eltrombopag in in Combination With Ciclosporin A in Moderate Aplastic Anemia (EMAA): Prospective Randomized Multicenter Study|Recruiting||Phase 2/Phase 3|116|Anticipated|University of Ulm||2|||f||||t||||||||Yes||2017-10-10 22:12:02.488006|2017-10-10 22:12:02.488006
NCT02773212|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Targeting Anhedonia in Cocaine Use Disorder|Targeting Anhedonia in Cocaine Use Disorder - Treatment Study|Not yet recruiting||N/A|80|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||t||||||||Yes||2017-10-10 22:12:02.59927|2017-10-10 22:12:02.59927
NCT02773186|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-05-14|||December 2012||2012-12-01|May 2016|2016-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Cerebral Oximetry With Near-infrared Spectroscopy and Negative Postoperative Behavioral Changes in Pediatric Surgery|Cerebral Oximetry With Near-infrared Spectroscopy and Negative Postoperative Behavioral Changes in Pediatric Surgery|Completed||N/A|198|Actual|Hospital Clínico Universitario de Valladolid|||1||f||||f||||||||Undecided|there is not plan by the moment|2017-10-10 22:12:02.799843|2017-10-10 22:12:02.799843
NCT02773173|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-04-20|||January 25, 2017|Actual|2017-01-25|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse-II)|Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse II)|Recruiting||Phase 4|190|Anticipated|Instituto de Investigacion Sanitaria La Fe||2|||f||||f|f|f||||||Undecided||2017-10-10 22:12:02.866785|2017-10-10 22:12:02.866785
NCT02773160|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-05-13|||April 2015||2015-04-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Motor Learning for the Lumbar Spine Using Sensor-based Postural Feedback: a Randomized Controlled Trial|Motor Learning for the Lumbar Spine Using Sensor-based Postural Feedback: a Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Hasselt University||3|||f||||f||||||||Undecided||2017-10-10 22:12:02.978804|2017-10-10 22:12:02.978804
NCT02773147|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-11-14|||April 2016||2016-04-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Vitamin B on Plasma Neurofilament Light Protein (NFL) in HIV-infected Individuals With Increased Plasma Homocysteine|Effect of Vitamin B Substitution on Plasma NFL and Neurocognitive Performance in HIV-infected Individuals With Increased Plasma Homocysteine|Recruiting||Phase 2|60|Anticipated|Göteborg University||2|||f||||||||||||||2017-10-10 22:12:03.076684|2017-10-10 22:12:03.076684
NCT02773134|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-13|||March 2009||2009-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Early Impact of Postoperative Bracing on Pain and Quality of Life Following Posterior Instrumented Fusion for Lumbar Degenerative Conditions|The Early Impact of Postoperative Bracing on Pain and Quality of Life Following Posterior Instrumented Fusion for Lumbar Degenerative Conditions: A Randomized Trial|Completed||N/A|43|Actual|Hopital du Sacre-Coeur de Montreal||2|||f||||f||||||||Undecided||2017-10-10 22:12:03.151553|2017-10-10 22:12:03.151553
NCT02773121|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-09-26|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|CTSI||Physical Activity and Cognition Study|Feasibility of Using Physical Activity Monitoring for Enhancing Cognition in Healthy Seniors|Recruiting||N/A|80|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 22:12:03.227464|2017-10-10 22:12:03.227464
NCT02773095|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-11-14|||June 2016||2016-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative|Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative|Active, not recruiting||N/A|887|Actual|Boston University||2|||f||||f||||||||Yes||2017-10-10 22:12:05.170857|2017-10-10 22:12:05.170857
NCT02773082|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-05-11|||January 2015||2015-01-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|DBS||Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)|Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)|Recruiting||Phase 2|50|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 22:12:05.250964|2017-10-10 22:12:05.250964
NCT02773069|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||June 2016||2016-06-01|May 2016|2016-05-01||||July 2017|Anticipated|2017-07-01||Interventional|||The Church as a Bridge to Deliver Health Resources Via Telehealth|The Church as a Bridge to Deliver Health Resources Via Telehealth to Alleviate Obesity and Chronic Disease Disparities in Rural African Americans of Mississippi|Not yet recruiting||N/A|50|Anticipated|University of Southern Mississippi||1|||f||||||||||||||2017-10-10 22:12:05.330524|2017-10-10 22:12:05.330524
NCT02773056|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-03-22|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Prosthetic Socket Interface Design on Socket Comfort, Residual Limb Health, and Function for the Transfemoral Amputee|Prosthetic Socket Interface Design on Socket Comfort, Residual Limb Health, and Function for the Transfemoral Amputee|Recruiting||N/A|5|Anticipated|University of South Florida||3|||f||||t||||||||Yes||2017-10-10 22:12:05.390034|2017-10-10 22:12:05.390034
NCT02773043|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-10-04|||December 2015|Actual|2015-12-01|October 2017|2017-10-01||||September 2019|Anticipated|2019-09-01||Interventional|EVARESERVE||Evaluation of Myocardial Perfusion Reserve||Recruiting||N/A|33|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-10 22:12:05.471325|2017-10-10 22:12:05.471325
NCT02773030|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-29|||October 14, 2016|Actual|2016-10-14|June 2017|2017-06-01|May 14, 2020|Anticipated|2020-05-14|April 16, 2020|Anticipated|2020-04-16||Interventional|||A Safety Study to Determine Dose and Tolerability of CC-220 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma|A Multicenter, Open-label Study to Determine the Maximum Tolerated Dose, Assess the Safety and Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-220 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|106|Anticipated|Celgene||4|||f||||t||||||||||2017-10-10 22:12:05.555335|2017-10-10 22:12:05.555335
NCT02773017|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||The ED50 of DEX for Providing Sedation in Different Female Age Group||Not yet recruiting||Phase 4|90|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||3|||f||||f||||||||||2017-10-10 22:12:05.68838|2017-10-10 22:12:05.68838
NCT02772640|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-05-24|||March 2016||2016-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ROSEZE||Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe|The Impact of the Time of Drug Administration on the Effectiveness of Combined Treatment of Hypercholesterolemia With ROSuvastatin and EZEtimibe (ROSEZE) - A Single-center, Crossover, Open-label Study|Recruiting||Phase 4|200|Anticipated|Collegium Medicum w Bydgoszczy||2|||f||||f||||||||Undecided||2017-10-10 22:12:09.279971|2017-10-10 22:12:09.279971
NCT02773004|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-05-03|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ADENDOM||Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer|Prospective Multicenter Study Assessing EndoPredict® (EP) Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer With Uncertainty on the Indication of Chemotherapy Using Standard Assessments|Active, not recruiting||N/A|203|Actual|UNICANCER||1|||f||||t|f|f||||||Undecided||2017-10-10 22:12:05.775133|2017-10-10 22:12:05.775133
NCT02772991|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-27|||March 2016||2016-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CONECTTIN||Analysis Between Coronary Angiotomography and Sensitive Troponin in Intermediate Risk of Acute Coronary Syndrome|COmparative Prospective aNalysis betweEn Coronary angioTomography and Sensitive Troponin in Patients With Chest Pain and INtermediate Risk of Acute Coronary Syndrome in the Emergency Room - CONECTTIN Trial|Recruiting||N/A|200|Anticipated|University of Sao Paulo General Hospital||1|||f||||f||||||||||2017-10-10 22:12:05.891365|2017-10-10 22:12:05.891365
NCT02772965|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-28|||October 2016||2016-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|COMBINE||Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy|Recruiting||Phase 3|425|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|t|f||||||||2017-10-10 22:12:06.14281|2017-10-10 22:12:06.14281
NCT02772952|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-05-14|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|PowerA-01||Effectiveness of a Multi-component Physical Training in Hyper-fragile Elders: A Randomized Clinical Trial|Effectiveness of a Multi-componentphysical Training Integrated Into a Multimodal Program Based on the Evidence in Hiper-fragile Elders: A Randomized Clinical Trial STUDY POWER_AGING|Recruiting||N/A|200|Anticipated|University of Malaga||2|||f||||||||||||||2017-10-10 22:12:06.466787|2017-10-10 22:12:06.466787
NCT02772939|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-05-07|||August 2015||2015-08-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|EFFECTIVENES||Arterial Stiffness as a Predictor of Response to Renal Sympathetic Denervation|Evaluation of Arterial Stiffness as a Predictor of Response to Renal Sympathetic Denervation|Recruiting||N/A|100|Anticipated|University of Leipzig||1|||f||||f||||||||No||2017-10-10 22:12:06.579343|2017-10-10 22:12:06.579343
NCT02772926|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-06-05|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Benfotiamine Effect on Advanced Glycation End Products(AGEs) and Soluble Receptor for AGEs(sRAGE) in Diabetes Mellitus.|Benfotiamine Effect on Advanced Glycation End Products(AGEs) and Soluble Receptors for AGEs(sRAGE) in Type 2 Diabetes Mellitus.|Completed||N/A|41|Actual|Universidad de Guanajuato||2|||f||||t||||||||No||2017-10-10 22:12:06.672058|2017-10-10 22:12:06.672058
NCT02772913|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-02|||August 2016||2016-08-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Observational|||Mesenteric Ischemia in the Emergency Department: a Retrospective Multicenter Study|Acute Mesenteric Ischemia in the Emergency Department: Incidence, Early Recognition and Risk Stratification From an Observational Multicenter Study|Recruiting||N/A|500|Anticipated|University of Genova|||2||f||||t||||||||Yes||2017-10-10 22:12:06.779404|2017-10-10 22:12:06.779404
NCT02772900|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-15|||May 2015||2015-05-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Aging, Nitrate, Endothelial Function and Muscle Oxygenation|Effect of a Beetroot-based Nutritional Gel on Vascular Function and Forearm Muscle Oxygenation Responses in the Elderly at Cardiometabolic Risk|Completed||N/A|25|Actual|Universidade Federal do Rio de Janeiro||2|||f||||||||||||||2017-10-10 22:12:06.866029|2017-10-10 22:12:06.866029
NCT02772887|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-22|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Nutraceutical Citrulline in Pregnancy|Phase 1 Trial Citrulline and Type 2 Diabetes in Pregnancy|Recruiting||N/A|40|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||No||2017-10-10 22:12:06.937687|2017-10-10 22:12:06.937687
NCT02772874|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-14|||June 2014||2014-06-01|August 2017|2017-08-01|July 1, 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|FIST||Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders|Clinical, Anatomic, and Physiologic Characteristics of Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders|Completed||N/A|21|Actual|University of Pennsylvania|||2||f||||f||||||||||2017-10-10 22:12:07.020669|2017-10-10 22:12:07.020669
NCT02772861|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-05-11|||August 2011||2011-08-01|May 2016|2016-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|CHS-UK||Citrulline Challenge Study for Healthy Subjects in the United Kingdom|Randomised Cross-over Single-site Study on the Bioavailability of Citrulline After an Oral Bolus of Citrulline, Glutamine, Arginine, 3-Methylhistidine or Placebo in Healthy Subjects|Completed||N/A|20|Actual|University College, London||5|||f||||f||||||||No||2017-10-10 22:12:07.116097|2017-10-10 22:12:07.116097
NCT02772848|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-08-09|||April 2016||2016-04-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Fertility in Healthy Premenopausal Women|A Prospective Collection of Peripheral Blood Specimens to Study Fertility in Healthy, Premenopausal Women|Completed||N/A|60|Actual|Fujirebio Diagnostics, Inc.|||1||f||||f||||||Samples Without DNA|"     Serum   "|No||2017-10-10 22:12:07.192933|2017-10-10 22:12:07.192933
NCT02772835|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-03-08|||January 2016||2016-01-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||nHFOV vs nCPAP: Effects on Gas Exchange for the Treatment of Neonates Recovering From RDS|Nasal HFOV vs Nasal CPAP: Effects on Gas Exchange for the Treatment of Neonates Recovering From Respiratory Distress Syndrome. A Multicenter Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|Fondazione Poliambulanza Istituto Ospedaliero||2|||f||||f||||||||Undecided||2017-10-10 22:12:07.258968|2017-10-10 22:12:07.258968
NCT02772822|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-11|||June 2016||2016-06-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients|A Phase Ⅲ, Multi-center, Randomized, Controlled Study to Compare the Efficiency and Safety of SCT400(Recombinant Chimeric Anti-CD20 Monoclonal Antibody, Experimental Drug) Plus CHOP Versus Rituximab Plus CHOP in Untreated CD20-positive DLBCL Patients|Not yet recruiting||Phase 3|330|Anticipated|Sinocelltech Ltd.||2|||f||||f||||||||No||2017-10-10 22:12:07.431508|2017-10-10 22:12:07.431508
NCT02772809|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-07-11|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Actual|2017-07-01||Interventional|Theradrive||Usability Testing of Affordable Haptic Robots for Stroke Therapy|Usability Testing of Affordable Haptic Robots for Stroke Therapy|Active, not recruiting||N/A|56|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:12:07.507932|2017-10-10 22:12:07.507932
NCT02772796|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-11|||February 2016||2016-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Single Dose PK Study of SENS-218 in Healthy Volunteers|An Open-label, Single-dose, Pharmacokinetic Study of SENS-218 in Healthy Adult, Caucasian Subjects.|Completed||Phase 1|24|Actual|Simbec Research||1|||f||||f||||||||Undecided||2017-10-10 22:12:07.589004|2017-10-10 22:12:07.589004
NCT02772783|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes Mellitus|Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes Mellitus|Recruiting||N/A|15|Anticipated|Boston Children’s Hospital||3|||f||||f||||||||No||2017-10-10 22:12:07.83243|2017-10-10 22:12:07.83243
NCT02772770|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-03-29|||September 2016|Actual|2016-09-01|March 2017|2017-03-01|December 2026|Anticipated|2026-12-01|May 2026|Anticipated|2026-05-01||Observational|PLUTO||Pediatric ACL: Understanding Treatment Options|Pediatric ACL: Understanding Treatment Options (PLUTO)|Recruiting||N/A|405|Anticipated|Boston Children’s Hospital|||5||f||||f||||||||No||2017-10-10 22:12:07.974116|2017-10-10 22:12:07.974116
NCT02772757|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-05-01|||January 4, 2016|Actual|2016-01-04|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|May 1, 2017|Actual|2017-05-01||Interventional|||Coupler-Based Hearing-Aid Fitting Approach for Experienced Users|Efficacy of a Coupler-Based Hearing-Aid Fitting Approach for Experienced Users|Recruiting||N/A|63|Anticipated|VA Office of Research and Development||3|||f||||f||||||||Undecided||2017-10-10 22:12:08.147061|2017-10-10 22:12:08.147061
NCT02772718|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-02-02|||April 2016||2016-04-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|XOMA 358||An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery|An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery|Recruiting||Phase 2|20|Anticipated|XOMA (US) LLC||2|||f||||f||||||||||2017-10-10 22:12:08.518944|2017-10-10 22:12:08.518944
NCT02772705|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|August 2016|Anticipated|2016-08-01||Observational|||Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans|Comparison of Standardized Update Value Using Single-photo Emission Computed Tomography and Computed Tomography Between Grave's Disease (Hyperthyroidism) Patients and Normal Humans|Recruiting||N/A|100|Anticipated|West China Hospital|||2||f||||t||||||||Yes|"The data of the subjects will be shared including gender, age, values of SUV, TSH, FT3, FT4 and other relative records.
The information will not be shared until the study is completed and the article is published.
Anyone who wants to get the data should send an e-mail to Li, with reasons for needing these data.
E-mail address: 617381606@qq.com"|2017-10-10 22:12:08.622023|2017-10-10 22:12:08.622023
NCT02772692|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Defecation Postures for Functional Consumption|Influence of Defecation Postures on Functional Consumption in Humans|Not yet recruiting||N/A|600|Anticipated|Fourth Military Medical University||2|||f||||t||||||||Yes||2017-10-10 22:12:08.770926|2017-10-10 22:12:08.770926
NCT02772679|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-05-15|||August 2016||2016-08-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|TILT||T1DM Immunotherapy Using Polyclonal Tregs + IL-2|A Phase 1 Trial of CD4+CD127lo/-CD25+ Polyclonal Treg Adoptive Immunotherapy With Interleukin-2 for the Treatment of Type 1 Diabetes|Recruiting||Phase 1|16|Anticipated|University of California, San Francisco||1|||f||||t|t|||||||No||2017-10-10 22:12:08.873359|2017-10-10 22:12:08.873359
NCT02772666|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-11-02|2016-07-14||December 2015||2015-12-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary Defect|New Automatic Portable Ophthalmology Device|Completed||N/A|44|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||Undecided|I have not decided about it.|2017-10-10 22:12:09.000659|2017-10-10 22:12:09.000659
NCT02772653|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-05-13|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Evaluation of Resuscitation Markers in Trauma Patients|Evaluation of Resuscitation Markers in Trauma Patients|Recruiting||N/A|50|Anticipated|Corporacion Parc Tauli|||1||f||||f||||||Samples Without DNA|"     Blood samples for Natriuretic Peptide analysis. Retained just for one month, until samples     are analyzed at an external laboratory.   "|||2017-10-10 22:12:09.159022|2017-10-10 22:12:09.159022
NCT02772237|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-09|||August 2016||2016-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Impact of Riboflavin on Sports-related Concussion|The Impact of Riboflavin on Sports-related Concussion: A Randomized Control Trial|Recruiting||Phase 2|500|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-10 22:12:12.829468|2017-10-10 22:12:12.829468
NCT02772627|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-12|||September 2001||2001-09-01|May 2016|2016-05-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202|A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202 in Healthy Volunteers.|Completed||Phase 1|22|Actual|Bial - Portela C S.A.||3|||f||||f||||||||No||2017-10-10 22:12:09.413519|2017-10-10 22:12:09.413519
NCT02772614|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-12|||January 2006||2006-01-01|May 2016|2016-05-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites|An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites Following a Single-dose Oral Administration|Completed||Phase 1|4|Actual|Bial - Portela C S.A.||1|||f||||f||||||||No||2017-10-10 22:12:09.516197|2017-10-10 22:12:09.516197
NCT02772601|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-22|||September 15, 2016|Actual|2016-09-15|September 2017|2017-09-01|September 22, 2017|Actual|2017-09-22|June 15, 2017|Actual|2017-06-15||Interventional|||This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis|The Effect of Multiple Subcutaneous Doses of Risankizumab on the Single Dose Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) Administered Orally in an Open-label, One-sequence Trial in Patients With Plaque Psoriasis With or Without Concomitant Psoriatic Arthritis|Completed||Phase 1|21|Actual|AbbVie||1|||f||||||||||||||2017-10-10 22:12:09.61219|2017-10-10 22:12:09.61219
NCT02772588|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-17|||May 2016||2016-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||AASUR in High Risk Prostate Cancer|ARN-509+Abiraterone Acetate+Leuprolide With Stereotactic, Ultra-Hypofractionated Radiation (AASUR) in Very High Risk Prostate Cancer: A Single Arm, Phase II Study|Recruiting||Phase 2|58|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:12:09.753952|2017-10-10 22:12:09.753952
NCT02772575|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-01-30|||April 2016||2016-04-01|January 2017|2017-01-01||||January 2017|Anticipated|2017-01-01||Observational|||A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)|A PILOT STUDY TO IDENTIFY MOLECULAR PREDICTORS OF SENSITIVITY AND RESISTANCE TO TRANS-ARTERIAL EMBOLIZATION OF PRIMARY LIVER TUMORS AND LIVER METASTASES|Withdrawn||N/A|0|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     tissue blood   "|||2017-10-10 22:12:09.871653|2017-10-10 22:12:09.871653
NCT02772549|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-08-01|||March 2016||2016-03-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|||Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay|Early Diagnosis of Pulmonary Fibrosis|Recruiting||N/A|100|Anticipated|University Hospital, Gentofte, Copenhagen|||1||f||||f||||||||Undecided||2017-10-10 22:12:10.050751|2017-10-10 22:12:10.050751
NCT02772536|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-05-03|||March 2015||2015-03-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Clinical Trial Investigating Effect of Tinted Light on Perception of Tinnitus|An Open Design Clinical Trial Investigating the Effect of Tinted Light on Perception of Tinnitus to Establish Its Efficacy|Recruiting||N/A|32|Anticipated|University of Leicester||1|||f||||f||||||||No||2017-10-10 22:12:10.143459|2017-10-10 22:12:10.143459
NCT02772523|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-03-01|||May 2016||2016-05-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|ALFAlife||Control and Intervention Programme on Alzheimer's Disease Risk Factors|Control and Intervention Programme on Alzheimer's Disease Risk Factors|Active, not recruiting||N/A|409|Actual|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation||1|||f||||f||||||||||2017-10-10 22:12:10.243917|2017-10-10 22:12:10.243917
NCT02772510|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-10-23|||February 2015||2015-02-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Upper Extremity Rehabilitation Using Game Rehabilitation System With Functional Electrical Stimulation for Stroke Patients|Upper Extremity Rehabilitation Using Game-based Virtual Reality Rehabilitation System (Smart Glove System) With Functional Electrical Stimulation for Stroke Patients : Randomized Controlled Trial|Recruiting||N/A|54|Anticipated|National Rehabilitation Center, Seoul, Korea||2|||f||||f||||||||No||2017-10-10 22:12:10.325725|2017-10-10 22:12:10.325725
NCT02772497|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-07-03|||January 2016||2016-01-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||3 Month Outcome of Ziv-aflibercept for DME|Three-month Outcome of Ziv-aflibercept for Diabetic Macular Edema|Completed||Phase 2/Phase 3|10|Actual|Marashi Eye Clinic||1|||f||||t||||||||||2017-10-10 22:12:10.557872|2017-10-10 22:12:10.557872
NCT02772484|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-12-28|||April 2016||2016-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Routine Care|An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Routine Care|Completed||N/A|24|Actual|HeadSense Medical||1|||f||||f||||||||No||2017-10-10 22:12:10.649141|2017-10-10 22:12:10.649141
NCT02772471|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-12|||March 2014||2014-03-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Development and Evaluation of the ICP Waveform Tracing Capabilities and Safety of HS-1000 Device|Development and Evaluation of the ICP Waveform Tracing Capabilities and Safety of HS-1000 Device|Completed||N/A|40|Actual|HeadSense Medical||1|||f||||f||||||||No||2017-10-10 22:12:10.741997|2017-10-10 22:12:10.741997
NCT02772445|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-06-02|||April 2016||2016-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|STROKE-CARE||Stroke Caregiver Empowerment|Stroke Caregiver Empowerment|Recruiting||N/A|25|Anticipated|University of Pittsburgh||1|||f||||f||||||||No||2017-10-10 22:12:10.943895|2017-10-10 22:12:10.943895
NCT02772432|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-13|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|January 18, 2018|Anticipated|2018-01-18|January 18, 2018|Anticipated|2018-01-18||Interventional|SPLD||Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities|Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities|Active, not recruiting||N/A|58|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 22:12:11.059264|2017-10-10 22:12:11.059264
NCT02772406|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-12|||April 2016||2016-04-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative Colitis|Linked Color Imaging (LCI) Versus White Light for the Detection of Colorectal Dysplasia in Ulcerative Colitis|Recruiting||N/A|60|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 22:12:11.292966|2017-10-10 22:12:11.292966
NCT02772380|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-05|||May 2016||2016-05-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Acute Study to Collect Electrical Signals From the Heart Using a Special Lead|Acute Extravascular Defibrillation Study|Completed||Phase 1|120|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-10-10 22:12:11.424487|2017-10-10 22:12:11.424487
NCT02772367|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-10-03|||May 2016||2016-05-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Generation of Heart Muscle Cells From Skin Cells of Breast Cancer Patients|Generation of Induced Pluripotent Stem Cell Derived Cardiomyocytes From Patients Exposed to Anthracycline-Trastuzumab for Breast Cancer|Recruiting||N/A|6|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"     skin tissue   "|||2017-10-10 22:12:11.611337|2017-10-10 22:12:11.611337
NCT02772354|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-09-08|||April 2016||2016-04-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|RAS||Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population|Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes as a First-line Therapy in Pediatric Population Without Structural Heart Disease|Recruiting||Phase 2/Phase 3|124|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||||||||||||2017-10-10 22:12:11.722818|2017-10-10 22:12:11.722818
NCT02772341|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-05-10|||August 2012||2012-08-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of Halotherapy as Asthma Treatment in Children|Evaluation of Halotherapy as Asthma Treatment in Children: a Randomized, Controlled, Double-blind Prospective Pilot Study|Completed||N/A|60|Actual|Rambam Health Care Campus||2|||f||||||||||||||2017-10-10 22:12:11.861105|2017-10-10 22:12:11.861105
NCT02772328|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-03-08|||December 19, 2016|Actual|2016-12-19|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|HCV-TTP||A Peer-based Mobile-health Intervention to Increase Access & Adherence to Hepatitis C Treatment & HIV Viral Suppression|Randomized Controlled Trial of a Social-network Oriented Mobile Health Based Intervention to Increase Access and Adherence to Hepatitis C Treatment and HIV Viral Suppression|Recruiting||N/A|300|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||Undecided|Will work with NIH to determine sharing plan|2017-10-10 22:12:11.95333|2017-10-10 22:12:11.95333
NCT02772315|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-01-25|||August 2016||2016-08-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|ENSAT-HT||Omics Signature in the Diagnosis of Hypertension|Performance of an Omics-signature in the Diagnosis and Prognosis of Endocrine and Primary Hypertension|Recruiting||N/A|4000|Anticipated|Radboud University|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-10 22:12:12.073557|2017-10-10 22:12:12.073557
NCT02772302|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-05-11|||March 2016||2016-03-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Feasibility of mindBEAGLE in Disorders of Consciousness or Locked-In Syndrome|Feasibility Study of the mindBEAGLE Device in Patients With Disorders of Consciousness or Locked-In Syndrome|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 22:12:12.235126|2017-10-10 22:12:12.235126
NCT02772289|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars|Recruiting||Phase 2|90|Anticipated|Maternal and Child Health Hospital of Foshan||3|||f||||t||||||||Undecided||2017-10-10 22:12:12.341368|2017-10-10 22:12:12.341368
NCT02772276|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-29|||July 2016||2016-07-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types|A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types|Recruiting||Phase 2|132|Anticipated|MediBeacon||5|||f||||f||||||||||2017-10-10 22:12:12.468284|2017-10-10 22:12:12.468284
NCT02772263|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-11|||November 2013||2013-11-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CHAP-EMS||Pilot Project: Community Health Assessment Program Through Emergency Medical Services|Pilot Project: Community Health Assessment Program Through Emergency Medical Services|Completed||N/A|79|Actual|McMaster University||1|||f||||f||||||||No||2017-10-10 22:12:12.619532|2017-10-10 22:12:12.619532
NCT02772250|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2017-04-07|||May 2016||2016-05-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|FFRE||Bowel Preparation by Face-to-face Re-education on the Day of Colonoscopy for Outpatient: a RCT|Effecacy of Face-to-face Bowel Preparation for Afternoon Colonoscopy: a Randomised Clinical Trial|Completed||Phase 4|658|Actual|Shandong University||2|||f||||t||||||||||2017-10-10 22:12:12.723267|2017-10-10 22:12:12.723267
NCT02772224|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-11|||June 2016||2016-06-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Efficacy and Safety of Paclitaxel-eluting Balloons for Below the Knee Peripheral Arterial Disease|The Efficacy and Safety of Paclitaxel-eluting Balloons for the Treatment of Below the Knee Peripheral Arterial Disease as Compared to Conventional Balloon Angioplasty: a Randomized Controlled Clinical Trial.|Not yet recruiting||Phase 1|180|Anticipated|Shanghai 10th People's Hospital||2|||f||||f||||||||No||2017-10-10 22:12:12.92004|2017-10-10 22:12:12.92004
NCT02772211|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||June 2016||2016-06-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression|D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression|Not yet recruiting||Phase 4|60|Anticipated|Sheba Medical Center||2|||f||||t||||||||No||2017-10-10 22:12:13.004694|2017-10-10 22:12:13.004694
NCT02772198|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-11-02|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies|A Phase 1 / 2 Single Arm Study of T-cells Expressing Anti-CD19 Chimeric Antigen Receptor in Pediatric and Young Adult Patients With B-cell Malignancies|Recruiting||Phase 1/Phase 2|40|Anticipated|Sheba Medical Center||1|||f||||f||||||||Undecided||2017-10-10 22:12:13.09841|2017-10-10 22:12:13.09841
NCT02772185|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|NeuroAD||Neurostimulation and Cognitive Intervention in Alzheimer's Disease|Neurostimulation and Cognitive Intervention in Alzheimer's Disease|Recruiting||Phase 2/Phase 3|60|Anticipated|Federal University of Paraíba||4|||f||||||||||||||2017-10-10 22:12:13.182181|2017-10-10 22:12:13.182181
NCT02772172|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-08-15|||August 2016||2016-08-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Accuracy of Dental Implant Placement Using Two Different CBCT-derived Templates|Accuracy of Dental Implant Placement Using Two Different CBCT-derived Templates: a Randomized Controlled Clinical Trial|Recruiting||N/A|30|Anticipated|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 22:12:13.279841|2017-10-10 22:12:13.279841
NCT02772159|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-07-29|||June 2015||2015-06-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects|A Single−Dose, Fixed-Sequence, Two-Period Study to Evaluate the Absorption, Distribution, Metabolism, Excretion of TD-4208 Following an IV Infusion and an Oral Dose of [14C]−Labeled TD−4208 in Healthy Male Subjects|Completed||Phase 1|9|Actual|Theravance Biopharma R & D, Inc.||1|||f||||f||||||||No||2017-10-10 22:12:13.372252|2017-10-10 22:12:13.372252
NCT02772146|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-03-13|||May 11, 2016|Actual|2016-05-11|February 2017|2017-02-01|January 23, 2017|Actual|2017-01-23|January 23, 2017|Actual|2017-01-23||Interventional|||A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure|A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure|Terminated||N/A|2|Actual|Triomed AB||1||"After 2 patients it was concluded that a large change in exclusion criteria and study design   was needed to obtain the ojective for the study"|f||||f||||||||Undecided|The Sponsor may choose to publish or present data from this clinical investigation.|2017-10-10 22:12:13.448833|2017-10-10 22:12:13.448833
NCT02772133|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-07-16|||May 2016||2016-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Circulating PRCP in STEMI Patients Undergoing Primary PCI||Completed||N/A|220|Actual|Qilu Hospital of Shandong University|||2||f||||||||||||||2017-10-10 22:12:13.52675|2017-10-10 22:12:13.52675
NCT02772120|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2018|Anticipated|2018-05-01||Interventional|||Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles|Comparison of Vaginal Progesterone Gel (Crinone 8%®) and Intramuscular Progesterone in Vitrified-Warmed Blastocyst Transfer Cycles|Not yet recruiting||Phase 4|610|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||No||2017-10-10 22:12:13.602017|2017-10-10 22:12:13.602017
NCT02772107|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-05-15|||December 2015||2015-12-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer||Recruiting||Phase 2/Phase 3|132|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:12:13.698108|2017-10-10 22:12:13.698108
NCT02772094|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-05-12|||May 2005||2005-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)|Autologous Dendritic Cell-Based Adjuvant Immunotherapy of Malignant Gliomas (WHO Grade IV Glioblastoma Multiforme) - Phase II Clinical Trial|Active, not recruiting||Phase 2|50|Anticipated|China Medical University Hospital||1|||f||||f||||||||Yes||2017-10-10 22:12:13.780992|2017-10-10 22:12:13.780992
NCT02772081|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-01-12|||June 2018||2018-06-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|October 2019|Anticipated|2019-10-01||Interventional|LISPAP||A Study in Preterm Neonates With RDS to Compare CUROSURF® Administration Through LISA and Conventional Administration|A Randomized, Controlled Study in Preterm Neonates With RDS to Compare Two Procedures for Porcine Surfactant (Poractant Alfa, CUROSURF®) Administration: a Less Invasive Method (LISA) and the Conventional Administration|Not yet recruiting||Phase 3|300|Anticipated|Chiesi Farmaceutici S.p.A.||2|||f||||t||||||||No||2017-10-10 22:12:13.878262|2017-10-10 22:12:13.878262
NCT02772068|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-12|||September 2015||2015-09-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a|Hemodynamic Response to Exercise in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients After Upregulation of SERCA2a|Recruiting||Early Phase 1|30|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 22:12:13.966469|2017-10-10 22:12:13.966469
NCT02771678|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-12-08|||May 2016||2016-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Estimating Quality of Life in People With Asthma|Estimating the Loss in Quality of Life Associated With an Asthma Related Crisis Event (ESQUARE)|Recruiting||N/A|100|Anticipated|University of East Anglia|||1||f||||f||||||||||2017-10-10 22:12:17.140975|2017-10-10 22:12:17.140975
NCT02772055|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy of Moxibustion Therapy With or Without Smoke for Knee Osteoarthritis|A Multicentre, Randomised, Single Blinded, Parallel-group Study of Moxa Smoke Effect in Moxibustion Treating Knee Osteoarthritis|Recruiting||Phase 2/Phase 3|138|Anticipated|Chengdu University of Traditional Chinese Medicine||2|||f||||f||||||||No||2017-10-10 22:12:14.062194|2017-10-10 22:12:14.062194
NCT02772042|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-08-03|||October 2015||2015-10-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|November 2015|Actual|2015-11-01||Interventional|||Traction Manipulation of Upper Cervical Spine on Cervicogenic Dizziness|Effectiveness of Traction Manipulation of Upper Cervical Spine on Cervicogenic Dizziness|Recruiting||Phase 1/Phase 2|10|Anticipated|Universidad de Zaragoza||2|||f||||f||||||||No||2017-10-10 22:12:14.157914|2017-10-10 22:12:14.157914
NCT02772029|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure|A Pilot Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|The First Affiliated Hospital of Zhengzhou University||1|||f||||f||||||||No||2017-10-10 22:12:14.36474|2017-10-10 22:12:14.36474
NCT02772003|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-08-15|||July 2016||2016-07-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection|Phase I Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection|Recruiting||Phase 1|32|Anticipated|Inovio Pharmaceuticals||4|||f||||t||||||||No||2017-10-10 22:12:14.540687|2017-10-10 22:12:14.540687
NCT02771990|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-10-05|||October 2013||2013-10-01|October 2017|2017-10-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||tDCS for Chronic Low Back Pain|tDCS for Chronic Low Back Pain: A Study Examining the Effect of Transcranial Direct Current Stimulation on the Emotional Response to Chronic Low Back Pain|Completed||N/A|17|Actual|Providence VA Medical Center||2|||f||||f||||||||||2017-10-10 22:12:14.662443|2017-10-10 22:12:14.662443
NCT02771977|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-04-24|||December 1, 2017|Anticipated|2017-12-01|December 2016|2016-12-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Drug-Targeted Alerts for Acute Kidney Injury|Drug-Targeted Alerts for Acute Kidney Injury|Not yet recruiting||N/A|5000|Anticipated|Yale University||3|||f||||t|f|f||||||||2017-10-10 22:12:14.745675|2017-10-10 22:12:14.745675
NCT02771964|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-06-01|||January 2014||2014-01-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|October 2015|Actual|2015-10-01||Observational|||Assessing Change in Patient-reported Quality of Life After Elective Surgery: an Observational Comparison Study|Assessing Preoperative Falls as a Predictor for Postoperative Surgical Outcomes|Completed||N/A|17850|Actual|Washington University School of Medicine|||1||f||||f||||||||Yes|De-identified data can be provided upon email request.|2017-10-10 22:12:14.830411|2017-10-10 22:12:14.830411
NCT02771951|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-12|||April 2010||2010-04-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Luces||Clinical/Behavioral Approach to Overweight in Latino Youth|Clinical/Behavioral Approach to Overweight in Latino Youth: Luces de Cambio|Completed||N/A|297|Actual|San Diego State University||2|||f||||f||||||||No||2017-10-10 22:12:14.924932|2017-10-10 22:12:14.924932
NCT02771938|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-08-15|||January 2016||2016-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRADA||Primary Radiotherapy And DIEP flAp Reconstruction Trial|Primary Radiotherapy And DIEP flAp Reconstruction Trial|Recruiting||N/A|30|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 22:12:15.01604|2017-10-10 22:12:15.01604
NCT02771925|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-06-09|||June 2016||2016-06-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|TAG||Treatment for Alcohol Dependence With Gabapentin|Treatment for Alcohol Dependence With Gabapentin: A Double Blind Placebo Controlled Randomized Clinical Trial|Recruiting||Phase 4|200|Anticipated|Dayanand Medical College and Hospital||2|||f||||t||||||||||2017-10-10 22:12:15.115802|2017-10-10 22:12:15.115802
NCT02771912|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-07-26|||July 2016||2016-07-01|July 2017|2017-07-01|February 21, 2017|Actual|2017-02-21|February 21, 2017|Actual|2017-02-21||Interventional|CATARSIS||Patient-controlled Sedation With Propofol During Cataract Surgery Under Topical Anesthesia|Randomised Study of Propofol Versus Placebo for Sedation During Cataract Surgery Under Topical Anesthesia|Completed||Phase 4|60|Actual|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 22:12:15.248388|2017-10-10 22:12:15.248388
NCT02771899|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-05-12|||April 2016||2016-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Value of 3D Modeling in Spine Surgery|Value of 3D Modeling in Spine Surgery|Recruiting||Phase 2|80|Anticipated|Columbia University||4|||f||||f||||||||||2017-10-10 22:12:15.336546|2017-10-10 22:12:15.336546
NCT02771886|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-04-01|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|SUBMI||Evaluation of a Brief Surf the Urge Intervention|"Evaluation of a Brief Surf the Urge Intervention"|Completed||N/A|36|Actual|University of Nevada, Las Vegas||2|||f||||f||||||||Undecided|If individual participant data is disseminated, it will include only data that has been de-identified. Specifically, only information regarding the effectiveness of the intervention will likely be reported. This could include statistics on urge-related behavior engagement, urge intensity, mental health symptoms, and personality factors.|2017-10-10 22:12:15.465409|2017-10-10 22:12:15.465409
NCT02771873|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-06-15|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|PROLIFIC||Programme of Lifestyle Intervention in Families for Cardiovascular Risk Reduction|A Family Based Randomized Controlled Trial of Cardiovascular Risk Reduction in Individuals With Family History of Premature Coronary Heart Disease in India|Active, not recruiting||N/A|1678|Actual|Public Health Foundation of India||2|||f||||t||||||||No||2017-10-10 22:12:15.577728|2017-10-10 22:12:15.577728
NCT02771860|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|January 2018|Anticipated|2018-01-01||Interventional|||RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints|Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Denosumab 60mg sc Every 3 Months in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints|Recruiting||Phase 2|100|Anticipated|University Hospital, Ghent||2|||f||||f||||||||No||2017-10-10 22:12:15.669359|2017-10-10 22:12:15.669359
NCT02771847|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-12|||February 2015||2015-02-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Impact of Comorbidities Among Adolescents Infected Pain Associated With Disorders of the Masticatory System|Impact of Comorbidities Among Adolescents Infected Pain Associated With Disorders of the Masticatory System|Completed||N/A|566|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||No||2017-10-10 22:12:15.82366|2017-10-10 22:12:15.82366
NCT02771834|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-10|||July 2009||2009-07-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Observational|||Evaluation of the Association Between Osteoporosis and Postural Balance in Postmenopausal Women|Evaluation of the Association Between Osteoporosis and Postural Balance in Postmenopausal Women|Completed||N/A|126|Actual|University of Sao Paulo|||2||f||||f||||||||No||2017-10-10 22:12:15.912944|2017-10-10 22:12:15.912944
NCT02771821|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Interventional|||Promoting Healthy Habits With Elderlies Diabetics|Promoting Healthy Habits With Elderlies Diabetics: Evaluation of Operative Groups as Therapeutic Intervention|Completed||N/A|202|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||Undecided||2017-10-10 22:12:16.038033|2017-10-10 22:12:16.038033
NCT02771808|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-17|2016-05-12|||September 2010||2010-09-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients|Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients|Completed||Early Phase 1|83|Actual|University of Virginia|||1||f||||f||||||||No||2017-10-10 22:12:16.125511|2017-10-10 22:12:16.125511
NCT02771795|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-08-31|||April 2016||2016-04-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC|A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 Positive Early or Locally Advanced Breast Cancer Who Have Completed the SB3-G31-BC|Active, not recruiting||Phase 3|367|Actual|Samsung Bioepis Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:12:16.22182|2017-10-10 22:12:16.22182
NCT02771782|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-10-12|||January 2015||2015-01-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|July 2016|Actual|2016-07-01||Interventional|||Influence of BCG on TDaP-IPV Vaccination|The Influence of BCG Vaccine as a Booster TDaP-IPV Vaccination: an Explorative Study|Active, not recruiting||Phase 4|75|Anticipated|Radboud University||3|||f||||f||||||||Undecided||2017-10-10 22:12:16.299815|2017-10-10 22:12:16.299815
NCT02771769|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||January 2016||2016-01-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Observational|||Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels|A Multi-center Prospective Study to Analyze Cancer-derived Cell-free DNA (cfDNA) in Men With Elevated PSA Levels|Recruiting||N/A|1500|Anticipated|Chronix Biomedical Corporation|||1||f||||f||||||Samples With DNA|"     Cell-free and cell-associated DNA will be obtained from plasma and peripheral blood     mononuclear cells, respectively. DNA will be stored until study is completed and data are     published.   "|Yes|Participants may request data upon writing to their physician. Data will not be available until after publication of data.|2017-10-10 22:12:16.424144|2017-10-10 22:12:16.424144
NCT02771756|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-05-12|||May 2015||2015-05-01|May 2016|2016-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy|Randomized, Self Controlled Study on the Effect of Oral Supplement of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy|Recruiting||N/A|300|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 22:12:16.53142|2017-10-10 22:12:16.53142
NCT02771743|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2016-05-23|||April 2015||2015-04-01|May 2016|2016-05-01|March 2023|Anticipated|2023-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Response-based Treatment of High-risk Neuroblastoma|Response-based Treatment of High-risk Neuroblastoma|Recruiting||Phase 2|54|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:12:16.640733|2017-10-10 22:12:16.640733
NCT02771730|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-10|||March 2015||2015-03-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Interventional|||Study to Evaluate the Safety and Immunogenicity of Orally-administered HIV Vaccine in Healthy, HIV-uninfected Adult Participants|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Orally-administered Replication-competent Adenovirus Type-4 HIV Vaccine Regimens in Combination With an AIDSVAX® B/E Boost in Healthy, HIV-uninfected Adult Participants|Active, not recruiting||Phase 1|60|Anticipated|PaxVax, Inc.||5|||f||||t||||||||No||2017-10-10 22:12:16.751855|2017-10-10 22:12:16.751855
NCT02771717|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|LowNO||Low Exhaled NO and ICS in Suspected Asthma|Does a Low Exhaled Nitric Oxide Level Exclude a Clinical Benefit From Inhaled Corticosteroids in Suspected Asthma: A Randomised, Placebo Controlled Trial|Not yet recruiting||Phase 4|165|Anticipated|University of Nottingham||2|||f||||f||||||||No||2017-10-10 22:12:16.84493|2017-10-10 22:12:16.84493
NCT02771704|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-06-08|||October 2015||2015-10-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Diamine Silver Fluoride and Potassium Iodide|In Vivo Evaluation of the Antimicrobial Activity of Diamine Silver Fluoride and Potassium Iodide on Dentin Carious Lesions in Kuwaiti Subjects.|Completed||N/A|5|Actual|Kuwait University||5|||f||||f||||||||||2017-10-10 22:12:16.946837|2017-10-10 22:12:16.946837
NCT02771691|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-09-12|||February 2016||2016-02-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Mentalization-Based Group Therapy for Adolescents|Efficacy of Mentalization-Based Group Therapy for Adolescents: A Pilot Randomised Controlled Trial|Active, not recruiting||N/A|53|Actual|University of Edinburgh||2|||f||||f||||||||||2017-10-10 22:12:17.041721|2017-10-10 22:12:17.041721
NCT02771665|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-11|||March 2014||2014-03-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Mammographic Density and the Risk of Tumor Recurrence in Asian Women: a Case-control Study|Mammographic Density and the Risk of Tumor Recurrence in Asian Women: a Case-control Study|Completed||N/A|300|Actual|National Taiwan University Hospital|||2||f||||f||||||||No||2017-10-10 22:12:17.248469|2017-10-10 22:12:17.248469
NCT02771652|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-06-23|||February 2010||2010-02-01|June 2016|2016-06-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|ms-intakt||Effect of an Internet-based At-home Physical Training Protocol on Quality of Life, Fatigue, Functional Performance, Aerobic Capacity and Muscle Strength in Multiple Sclerosis Patients||Completed||N/A|126|Actual|University of Erlangen-Nürnberg||2|||f||||f||||||||Undecided||2017-10-10 22:12:17.320423|2017-10-10 22:12:17.320423
NCT02771639|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-12|||January 2016||2016-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|DAIR||Early Periprosthetic Joint Infection and Outcome Debridement, Antibiotics and Implant Retention|Early Periprosthetic Joint Infection and Debridement, Antibiotics and Implant Retention in Arthroplasty for Femoral Neck Fracture|Completed||N/A|736|Actual|Sundsvall Hospital|||1||f||||f||||||||Undecided|No individual data|2017-10-10 22:12:17.419804|2017-10-10 22:12:17.419804
NCT02771626|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-09-18|||August 2016||2016-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Study CB-839 in Combination With Nivolumab in Patients With ccRCC and Other Solid Tumors|A Phase 1/2 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Glutaminase Inhibitor CB-839 in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma and Other Solid Tumors|Recruiting||Phase 1/Phase 2|242|Anticipated|Calithera Biosciences, Inc||6|||f||||f||||||||||2017-10-10 22:12:17.506938|2017-10-10 22:12:17.506938
NCT02771613|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-08-08|||April 2016||2016-04-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|RMM Simulation||Impact on the Adverse Event (AE) Incidence of Two Types of Experience Feedback on AE Analyzed During Local Morbidity Mortality Reviews|Impact on Adverse Events (AE) Occurrence of Two Types of Experience Feedback on AE Analysed During Local Morbidity Mortality Reviews (MMR), (by Multi Professional Simulation Education Versus Simple Diffusion of MMR Decisions)|Recruiting||N/A|144000|Anticipated|Hospices Civils de Lyon|||3||f||||f||||||||||2017-10-10 22:12:17.666866|2017-10-10 22:12:17.666866
NCT02771600|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Pilot Study of a New Device (Buzzy®) for Procedural Pain Relief During Needle-Related Procedures in Paediatric Patients|Feasibility, Acceptability and Satisfaction of a New Device (Buzzy®) for Pediatric Procedural Pain and Anxiety Management During Needle-Related Procedures: A Pilot Study.|Recruiting||N/A|100|Anticipated|St. Justine's Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:12:17.784061|2017-10-10 22:12:17.784061
NCT02771587|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-10-18|||June 2016||2016-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|AEDED||Interaction of Alcohol With Energy Drinks|Effects of Alcohol and Energy Drinks on Driving Performance and Bleeding Risk|Completed||Phase 1|16|Actual|Parc de Salut Mar||4|||f||||f||||||||No||2017-10-10 22:12:17.920593|2017-10-10 22:12:17.920593
NCT02771574|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia|A Phase 2 Multi-Ascending Dose Trial to Assess the Efficacy, Tolerability and Pharmacokinetic Profile of Exendin (9-39) in Patients With Post-bariatric Hyperinsulinemic Hypoglycemia|Recruiting||Phase 2|16|Anticipated|Stanford University||4|||f||||t||||||||No||2017-10-10 22:12:18.059456|2017-10-10 22:12:18.059456
NCT02771561|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-10|||April 2013||2013-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|PCOSA-1||PFO Closure for Obstructive Sleep Apnoea|PFO Closure for Obstructive Sleep Apnoea-1 Study|Recruiting||N/A|30|Anticipated|Papworth Hospital NHS Foundation Trust||1|||f||||t||||||||No|We do not plan to make individual participant data available.|2017-10-10 22:12:18.182641|2017-10-10 22:12:18.182641
NCT02771548|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-05-10|||January 2014||2014-01-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|||Biomechanical Analysis of Dynamic Tasks and Muscular Strength Following Anterior Cruciate Ligament Reconstruction|Biomechanical Analysis of Dynamic Tasks and Muscular Strength Following Anterior Cruciate Ligament Reconstruction|Recruiting||N/A|1000|Anticipated|Sports Surgery Clinic, Santry, Dublin|||2||f||||||||||||||2017-10-10 22:12:18.297982|2017-10-10 22:12:18.297982
NCT02771535|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-02|||March 2016||2016-03-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Long-term Efficacy of Metacognitive Training for Depression (D-MCT)|Long-term Efficacy of Metacognitive Training for Depression (D-MCT): a 3-year Follow up|Completed||N/A|84|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 22:12:18.403101|2017-10-10 22:12:18.403101
NCT02771522|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-22|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Caries Lesion Activity in Orthodontic Patients - Calcivis System|Monitoring of Caries Lesion Activity in Orthodontic Patients With the Calcivis System|Recruiting||N/A|45|Anticipated|Calcivis Ltd||1|||f||||f|f|f||||||Yes|Final Clinical Study report to be issued|2017-10-10 22:12:18.490593|2017-10-10 22:12:18.490593
NCT02771509|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-08|||December 2016||2016-12-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass|A Multicenter, Prospective, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of BB3 to Assess the Safety and Efficacy of BB3 in Patients Developing Acute Kidney Injury After Cardiac Surgery|Recruiting||Phase 2|100|Anticipated|Angion Biomedica Corp||2|||f||||t||||||||||2017-10-10 22:12:18.579733|2017-10-10 22:12:18.579733
NCT02771496|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-06-26|||May 2014||2014-05-01|June 2017|2017-06-01|December 2064|Anticipated|2064-12-01|May 2064|Anticipated|2064-05-01||Observational|||Osteochondritis Dissecans of Knee Prospective Cohort|ROCK Comprehensive Prospective Cohort for Osteochondritis Dissecans of the Knee|Recruiting||N/A|3000|Anticipated|University of Pennsylvania|||1||f||||f||||||||Undecided||2017-10-10 22:12:18.685542|2017-10-10 22:12:18.685542
NCT02770924|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-13|||May 2016||2016-05-01|August 2017|2017-08-01|September 13, 2017|Actual|2017-09-13|July 2017|Actual|2017-07-01||Interventional|||Clinical Outcomes After Bilateral Implantation of ZEISS AT LISA TRI AND TRI TORIC IOL|Clinical Outcomes After Bilateral Implantation of ZEISS AT LISA TRI AND TRI TORIC IOL|Completed||Phase 4|20|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 22:12:25.27968|2017-10-10 22:12:25.27968
NCT02771483|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-08-19|||May 2016||2016-05-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Giant Cell Arteritis and PET Scan (GAPS) Study|Giant Cell Arteritis and PET Scan (GAPS) Study - Improving the Diagnosis and Prognostication of Giant Cell Arteritis Through the Novel Use of Positron Emission Tomography and Immune Biomarkers|Recruiting||N/A|50|Anticipated|Royal North Shore Hospital|||2||f||||f||||||Samples With DNA|"     Temporal artery specimens Serology   "|||2017-10-10 22:12:19.073585|2017-10-10 22:12:19.073585
NCT02771470|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-05-21|||September 2014||2014-09-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Intestinal Microflora in Lung Cancer After Chemotherapy|Intestinal Microflora in Lung Cancer After Chemotherapy|Completed||Phase 1|41|Actual|Shandong University||2|||f||||t||||||||Undecided||2017-10-10 22:12:19.210733|2017-10-10 22:12:19.210733
NCT02771457|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-06-29|||July 2016||2016-07-01|June 2016|2016-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Managing Infliximab Reinduction After Temporary Discontinuation of Drug|Managing Infliximab Reinduction After Temporary Discontinuation of Drug|Withdrawn||Phase 3|0|Actual|New York University School of Medicine||3|||f||||f||||||||||2017-10-10 22:12:19.33146|2017-10-10 22:12:19.33146
NCT02771444|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-04-03|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Low Dose Tomosynthesis Compared to Traditional Tomosynthesis|Low Dose Tomosynthesis Compared to Traditional Tomosynthesis|Recruiting||N/A|60|Anticipated|Philips Digital Mammography Sweden AB||1|||f||||f||||||||No||2017-10-10 22:12:19.440854|2017-10-10 22:12:19.440854
NCT02771431|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-11-21|||February 2015||2015-02-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||The Use of Videoconferencing for Monitoring of Patients Post Urologic Surgery|The Use of Videoconferencing for Monitoring of Patients Post Urologic Surgery|Recruiting||N/A|500|Anticipated|Northwell Health||2|||f||||f||||||||||2017-10-10 22:12:19.545268|2017-10-10 22:12:19.545268
NCT02771418|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-09-21|||February 2015||2015-02-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CEE-VIMA||The Effects of Anaesthesia on Cerebral Oxygenation and Cognitive Function in Carotid Endarterectomy|The Effects of Anaesthesia on Cerebral Oxygenation and Cognitive Function in Carotid Endarterectomy|Completed||N/A|40|Actual|Northern State Medical University||2|||f||||f||||||||Yes|Will be published in the peer-reviewed journal|2017-10-10 22:12:19.661349|2017-10-10 22:12:19.661349
NCT02771405|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-11|||March 2016||2016-03-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|FRI-STC||Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC|Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC|Recruiting||Phase 3|150|Anticipated|National Hepatology & Tropical Medicine Research Institute||4|||f||||t||||||||No||2017-10-10 22:12:19.777192|2017-10-10 22:12:19.777192
NCT02771392|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-10|||June 2016||2016-06-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Corneal Abrasions With Topical Tetracaine|Treatment of Corneal Abrasions With Topical Tetracaine: an Evaluation of Safety and Efficacy|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|New York Methodist Hospital||2|||f||||f||||||||Yes|Plan to share data of pain perception and complications of patients|2017-10-10 22:12:19.930391|2017-10-10 22:12:19.930391
NCT02771379|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-07-06|||September 2016||2016-09-01|July 2017|2017-07-01||||February 2021|Anticipated|2021-02-01||Observational|PAROS||Post Authorisation Safety Study With Raxone in LHON Patients|A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)|Recruiting||N/A|250|Anticipated|Santhera Pharmaceuticals|||1||f||||||||||||||2017-10-10 22:12:20.068164|2017-10-10 22:12:20.068164
NCT02771366|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-12-08|||November 2016||2016-11-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Efficient Brain Study|The Influence of Fermented Papaya Preparation (FPP) on Cerebral Energy Metabolism, Neuroinflammation, and Cognition in Older Adults|Recruiting||Phase 2|30|Anticipated|University of Florida||2|||f||||t||||||||No||2017-10-10 22:12:20.25461|2017-10-10 22:12:20.25461
NCT02771353|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-12|||June 2016||2016-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The HeartSpare Plus 1B Trial|The HeartSpare Plus 1B Trial: A Randomised Phase II Trial Comparing the Resource Impact, Acute Toxicity and Feasibility of Different Pan-lymph Node Radiotherapy Techniques for Breast Cancer Patients|Not yet recruiting||Phase 2|43|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||Yes||2017-10-10 22:12:20.402538|2017-10-10 22:12:20.402538
NCT02771340|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-08-11|||May 2016||2016-05-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma|A Phase 1, Open-label, Multicenter Study Evaluating the Safety and Tolerability, Biologic Activity, Pharmacodynamics, and Pharmacokinetics of Single and Repeated Escalating Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma Who Are Planned to Undergo Enucleation or Brachytherapy|Recruiting||Phase 1|10|Anticipated|Iconic Therapeutics, Inc.||3|||f||||||||||||||2017-10-10 22:12:20.510971|2017-10-10 22:12:20.510971
NCT02771327|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-11-17|||February 2014||2014-02-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Use of a Pressurized Face Mask for Preventing Respiratory Complications After Chest Surgery|Phase 4, Randomized, Controlled Trial on the Efficacy as Prophylaxis of Postoperative Respiratory Complications and Safety of Continuous Positive Airways Pressure (CPAP) Applied Throughout Boussignac Mask During the Immediate Postoperative Period of Patients Undergoing Lung Resection|Completed||Phase 4|258|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-10 22:12:20.636666|2017-10-10 22:12:20.636666
NCT02771314|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-10-03|||June 2016||2016-06-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC|"A Longitudinal Study Evaluating Molecular Changes Associated With Resistance to First and Third (AZD9291) Generation EGFR TKIs in Patients With EGFR Mutant NSCLC Using Liquid Biopsy"|Recruiting||Phase 2|48|Anticipated|Hellenic Oncology Research Group||1|||f||||f||||||||Undecided||2017-10-10 22:12:20.739933|2017-10-10 22:12:20.739933
NCT02771301|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||February 2016||2016-02-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas|Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas|Recruiting||N/A|30|Anticipated|Hebei Yanda Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:12:20.921079|2017-10-10 22:12:20.921079
NCT02771288|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-23|||February 2016||2016-02-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Safety and Vascular Remodelling After BVS Implantation for Stenotic or Occluded Lesions in Children and Young Adults With KD.|Safety and Vascular Remodelling After Bioresorbable Vascular Scaffold Implantation for Stenotic or Occluded Lesions in Children and Young Adults With Kawasaki Disease|Recruiting||N/A|10|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||No||2017-10-10 22:12:21.040966|2017-10-10 22:12:21.040966
NCT02771275|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-11|||February 2016||2016-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||CE Mark Study for the Harpoon Medical Device in Poland|Safety and Qualitative Parameters of the Harpoon Medical Transapical Surgical Device (TSD-5) in Subjects With Degenerative Mitral Valve Regurgitation|Recruiting||N/A|50|Anticipated|Harpoon Medical||1|||f||||t|f|t|f|f|t|||||2017-10-10 22:12:21.133477|2017-10-10 22:12:21.133477
NCT02771262|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-10|||October 2014||2014-10-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|SODA||Making Sense of Dyspnea Assessment|Interpreting COPD Dyspnea Change: Sensitivity, Responsiveness, and Predictive Validity of the Dyspnea Management Questionnaire Computer Adaptive Test (DMQ-CAT)|Enrolling by invitation||N/A|144|Anticipated|Shirley Ryan AbilityLab|||1||f||||f||||||||No||2017-10-10 22:12:21.234486|2017-10-10 22:12:21.234486
NCT02771249|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-09-14|||May 5, 2016||2016-05-05|August 4, 2017|2017-08-04|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy Volunteers|Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy Volunteers|Recruiting||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:12:21.307578|2017-10-10 22:12:21.307578
NCT02771236|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-12|2017-06-30|||May 2, 2016||2016-05-02|April 10, 2017|2017-04-10|February 1, 2026|Anticipated|2026-02-01|February 1, 2026|Anticipated|2026-02-01||Observational|||Clinical and Molecular Studies in Families With Inherited Eye Disease|Clinical and Molecular Studies in Families With Inherited Eye Disease|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:12:21.413077|2017-10-10 22:12:21.413077
NCT02771223|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-13|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|CPB-PLT-FNCT||Quantification of Thrombocytes Number and Function in Patients Undergoing Prolonged Extracorporeal Circulation|Quantification of Thrombocytes Number and Function in Patients Undergoing Prolonged Extracorporeal Circulation for Cardiac Surgery|Not yet recruiting||N/A|20|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||No||2017-10-10 22:12:21.499939|2017-10-10 22:12:21.499939
NCT02771210|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-06-27|||August 31, 2016|Actual|2016-08-31|June 2017|2017-06-01|March 30, 2019|Anticipated|2019-03-30|March 30, 2019|Anticipated|2019-03-30||Interventional|ACHILLES||Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site|A Randomized, Double-blind, Placebo-controlled Multicenter Study of Subcutaneous Secukinumab to Demonstrate Efficacy in the Treatment of Enthesitis at the Achilles Tendon up to 1 Year in Adult Patients With Active Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA) (ACHILLES)|Recruiting||Phase 3|200|Anticipated|Novartis||2|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:12:21.569593|2017-10-10 22:12:21.569593
NCT02771197|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-06-08|||November 2016||2016-11-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant|Phase II Trial of Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in High Risk AML Patients Who Are Not Eligible for Allogeneic Stem Cell Transplantation|Recruiting||Phase 2|20|Anticipated|Northside Hospital, Inc.||1|||f||||f||||||||No||2017-10-10 22:12:21.770004|2017-10-10 22:12:21.770004
NCT02771184|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-07-11|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CLSA||Computerized Lung Sound Analysis|Computerized Lung Sound Analysis|Recruiting||N/A|56|Anticipated|Medical University of Graz||3|||f||||t||||||||||2017-10-10 22:12:21.894989|2017-10-10 22:12:21.894989
NCT02771158|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-06-13|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Midodrine During Recovery From Septic Shock|A Randomized Controlled Trial of Midodrine During Recovery Phase From Septic Shock|Not yet recruiting||Phase 4|180|Anticipated|Northwell Health||2|||f||||f|t|f|||f|||No||2017-10-10 22:12:22.042197|2017-10-10 22:12:22.042197
NCT02771145|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-01-26|||May 20, 2016|Actual|2016-05-20|January 2017|2017-01-01|January 10, 2017|Actual|2017-01-10|January 10, 2017|Actual|2017-01-10||Interventional|||Clinical Evaluation of the Safety and Efficacy of FID 120947A||Completed||N/A|91|Actual|Alcon Research||1|||f||||f||||||||||2017-10-10 22:12:22.149377|2017-10-10 22:12:22.149377
NCT02771132|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-11|||September 2015||2015-09-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||A Cluster-randomized Trial to Assess a Sexual Assault Prevention Intervention in Adolescents in Nairobi, Kenya|A Cluster-randomized Trial to Assess a Sexual Assault Prevention Intervention in Upper Primary School Adolescents in Nairobi, Kenya|Enrolling by invitation||N/A|3500|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 22:12:22.2337|2017-10-10 22:12:22.2337
NCT02771119|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-09-20|||October 2015||2015-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:12:22.306911|2017-10-10 22:12:22.306911
NCT02771106|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-28|||June 2016||2016-06-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Observational|||Neuroimaging and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury|Neuroimaging and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury|Recruiting||N/A|30|Anticipated|Minneapolis Medical Research Foundation|||2||f||||f||||||||||2017-10-10 22:12:22.344951|2017-10-10 22:12:22.344951
NCT02771093|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-05-09|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|TRACK||An Exploratory Study to Evaluate the Effects of Trelagliptin and Alogliptin by CGM on Glucose Variability for One Week With Type 2 Diabetes Mellitus|An Exploratory Study to Evaluate the Effects of Trelagliptin and Alogliptin by CGM on Glucose Variability for One Week With Type 2 Diabetes Mellitus|Completed||Phase 4|27|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 22:12:22.426662|2017-10-10 22:12:22.426662
NCT02771080|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-11-22|||June 2016||2016-06-01|June 2016|2016-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Peak Systolic Global Longitudinal Strain and Low Cardiac Output Syndrome After Cardiac Surgery||Completed||N/A|275|Actual|University Hospital of Liege|||1||f||||f||||||||||2017-10-10 22:12:22.517866|2017-10-10 22:12:22.517866
NCT02771067|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Utility of Pulse Pressure Variation to Predict the Fluid Responsiveness During Pneumoperitoneum and Reverse-Trendelenburg Position||Not yet recruiting||N/A|62|Anticipated|Yonsei University||1|||f||||f||||||||No|The purpose of this study is to investigate the validity of pulse pressure variation to predict fluid responsiveness in patients undergoing robotic or laparoscopic gastrectomy.|2017-10-10 22:12:22.572949|2017-10-10 22:12:22.572949
NCT02771054|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-11-14|||May 2016||2016-05-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation|Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation|Enrolling by invitation||Phase 4|20|Anticipated|Göteborg University||1|||f||||f||||||||Yes||2017-10-10 22:12:22.62811|2017-10-10 22:12:22.62811
NCT02771041|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-21|||September 23, 2015|Actual|2015-09-23|May 2016|2016-05-01|May 1, 2016|Actual|2016-05-01|May 1, 2016|Actual|2016-05-01||Interventional|PTHJ-8||Assessment of the Influence of Early Preoperative Consultation on Satisfaction and the Average Length of Stay of Patients Who Underwent Total Hip Arthroplasty|Prospective Randomized Assessment of the Influence of Early Preoperative Consultation on Satisfaction and the Average Length of Stay of Patients Who Underwent Total Hip Arthroplasty|Withdrawn||N/A|0|Actual|Groupe Hospitalier Paris Saint Joseph||2|||f||||t||||||||||2017-10-10 22:12:22.6907|2017-10-10 22:12:22.6907
NCT02771028|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-09-11|||October 2016||2016-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|EMOTICON||Emotional Freedom Techniques as an Intervention Strategy to Reduce Patient Reported Cognitive Complaints in Cancer Survivors|A Randomized Wait-list Controlled Trial on the Use of Emotional Freedom Techniques as an Intervention Strategy to Reduce Patient Reported Cognitive Complaints in Cancer Survivors on Behalf of the Belgian Society for Medical Oncology (BSMO)-Cancer Survivorship Taskforce|Recruiting||N/A|140|Anticipated|General Hospital Groeninge||2|||f||||||||||||||2017-10-10 22:12:22.754016|2017-10-10 22:12:22.754016
NCT02771015|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|wounddressing||Performance of Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip -,Knee- Arthroplasty,Primary Spine Surgery in Comparison to a Standard Wound Dressing|A Mono-centre, Post CE-mark, Prospective-randomized Clinical Trial to Evaluate the Performance of a Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip or Knee Arthroplasty or Primary Spine Surgery in Comparison to a Standard Wound Dressing (Cosmopor E®Steril, Fa. Hartmann)|Completed||N/A|200|Actual|University of Cologne||2|||f||||f||||||||||2017-10-10 22:12:24.666986|2017-10-10 22:12:24.666986
NCT02771002|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-06-21|||July 13, 2016|Actual|2016-07-13|June 2017|2017-06-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Observational|CRTPPI||Assessment of Peripheral Perfusion in the Critically Ill Patient|Evaluation of the Clinical Assessment of Peripheral Perfusion by Capillary Refill Time and Peripheral Perfusion Index|Completed||N/A|100|Actual|University Hospital Inselspital, Berne|||3||f||||f||||||None Retained|"     blood samples for detecting lactate   "|No||2017-10-10 22:12:24.765831|2017-10-10 22:12:24.765831
NCT02770989|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-12-07|||March 2016||2016-03-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|CAI||Vimecon CAI Trial for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF)|A Clinical Trial for the Assessment of the Safety and Performance of the Vimecon Laser Cardiac Ablation Instrument (CAI) for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF)|Recruiting||N/A|66|Anticipated|Vimecon GmbH||1|||f||||f||||||||No||2017-10-10 22:12:24.838385|2017-10-10 22:12:24.838385
NCT02770976|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-15|||May 2016||2016-05-01|August 2017|2017-08-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||Respiratory Pattern During Neurally Adjusted Ventilator Assist (NAVA) in Preterm Infants||Completed||N/A|12|Actual|Inha University Hospital||1|||f||||||||||||||2017-10-10 22:12:24.917854|2017-10-10 22:12:24.917854
NCT02770963|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Acupuncture for Discogenic Sciatica|Efficacy of Acupuncture for Discogenic Sciatica: a Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 22:12:24.984828|2017-10-10 22:12:24.984828
NCT02770950|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-10-09|||May 2016||2016-05-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Zushima Plaster for Treating Knee Osteoarthritis|Zushima Plaster for Patients in Knee Osteoarthritis: a Random, Positive Drug Controlled, Multi-center Clinical Research|Recruiting||Phase 4|396|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||3|||f||||t||||||||Undecided||2017-10-10 22:12:25.107412|2017-10-10 22:12:25.107412
NCT02770937|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-11|||February 2015||2015-02-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Simulator Versus Box Trainer on Laparoscopic Suturing|A Prospective Randomized Controlled Trial Comparing Virtual Reality Simulation Training and Box Trainer on the Acquisition of Laparoscopic Suturing Skills|Completed||N/A|36|Actual|The University of Hong Kong||3|||f||||f||||||||No||2017-10-10 22:12:25.204101|2017-10-10 22:12:25.204101
NCT02770911|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-11|||June 2016||2016-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||"Laparoscopic Anterior Resection With or Without Dog Ear Double-stapled Anastomosis for Rectal Cancer"|"Anastomotic Leakage in Laparoscopic Anterior Resection With or Without Dog Ear Double-stapled Anastomosis for Rectal Cancer : A Prospective, Randomized, Controlled Study"|Not yet recruiting||Phase 3|250|Anticipated|Fujian Medical University||2|||f||||t||||||||||2017-10-10 22:12:25.360437|2017-10-10 22:12:25.360437
NCT02770898|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-05-10|||July 2015||2015-07-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Improving Family Holistic Health in Probationers|Improving Family Holistic Health in Probationers- a Mixed Methods Evaluation|Recruiting||N/A|300|Anticipated|The University of Hong Kong||3|||f||||t||||||||Undecided||2017-10-10 22:12:25.458298|2017-10-10 22:12:25.458298
NCT02770885|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-11-17|||March 2016||2016-03-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|GOLD||Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)|"Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia: The GOLD-Study"|Recruiting||Phase 2|35|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||No||2017-10-10 22:12:25.661851|2017-10-10 22:12:25.661851
NCT02770872|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-04-10|||February 2014||2014-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk|The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk|Recruiting||N/A|75|Anticipated|University of Kentucky|||3||f||||f||||||Samples With DNA|"     Whole blood will be collected, which will contain DNA   "|No||2017-10-10 22:12:25.762911|2017-10-10 22:12:25.762911
NCT02770859|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-07-02|||October 2014|Actual|2014-10-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01|3 Months|Observational [Patient Registry]|POEM||Per-Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia, Database Repository|Per-Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia, Database Repository|Enrolling by invitation||N/A|50|Anticipated|Indiana University|||1||f||||f||||||||||2017-10-10 22:12:25.886703|2017-10-10 22:12:25.886703
NCT02770846|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-11|||April 2011||2011-04-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2015|Actual|2015-12-01||Interventional|||Immediate Loading Versus Delayed Loading in Single-implant|Evaluation of Immediate Loading Versus Delayed Loading in Single-implant Restorations|Active, not recruiting||N/A|50|Actual|Fölktandvården Skåne AB||2|||f||||f||||||||No||2017-10-10 22:12:25.968874|2017-10-10 22:12:25.968874
NCT02770833|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-05-17|||August 2014||2014-08-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|FINS||Acute Effects of Different Protein Sources and Different Glycemic Index on Energy Balance, Glucose Allostasis and Amino Acid Metabolism: a Randomized, 4-condition, Two Cross-over Study in Adults.|Acute Effects of Different Protein Sources and Different Glycemic Index on Energy Balance, Glucose Allostasis and Amino Acid Metabolism.|Completed||N/A|48|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 22:12:26.058951|2017-10-10 22:12:26.058951
NCT02770820|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-07-17|||January 1, 2018|Anticipated|2018-01-01|July 2017|2017-07-01|January 1, 2033|Anticipated|2033-01-01|January 1, 2022|Anticipated|2022-01-01||Interventional|||Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia|Phase I/II Study of Autologous (Central Memory/Naive) CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor for Treatment of AML|Not yet recruiting||Phase 1/Phase 2|35|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f||||||||2017-10-10 22:12:26.152686|2017-10-10 22:12:26.152686
NCT02770807|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-03-28|||March 2, 2017|Actual|2017-03-02|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Interventional|ATTeST||EDS in Ataxia Telangiectasia Patients|Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia|Recruiting||Phase 3|180|Anticipated|Erydel||3|||f||||t|t|f||||||Undecided||2017-10-10 22:12:26.290272|2017-10-10 22:12:26.290272
NCT02770794|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|OPTIWIT||Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis|Multicenter Prospective Trial to Investigate Accuracy of Ultrasound to Predict Relapse After Discontinuation of Infliximab and Efficacy/Safety of Readministration of Infliximab in Patients With Rheumatoid Arthritis in Low Disease Activity|Not yet recruiting||Phase 4|200|Anticipated|Chiba University||1|||f||||t||||||||No||2017-10-10 22:12:26.463505|2017-10-10 22:12:26.463505
NCT02770781|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-11-11|||October 2015||2015-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility Study of the Addition of a Personal Trainer to the Post-Treatment Regimen of Breast Cancer Survivors|Feasibility Study of the Addition of a Personal Trainer to the Post-Treatment Regimen of Breast Cancer Survivors|Recruiting||N/A|80|Anticipated|University of Pittsburgh||1|||f||||f||||||||Undecided||2017-10-10 22:12:26.546045|2017-10-10 22:12:26.546045
NCT02770768|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-03-30|||October 2016||2016-10-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Flibanserin on the Pre- and Post-menopausal Female Brain|Flibanserin and Women With Hypoactive Sexual Desire Disorder: A Double-Blind, Randomized, Electrical Neuroimaging Study|Recruiting||N/A|60|Anticipated|University of Chicago||2|||f||||t||||||||No||2017-10-10 22:12:26.642649|2017-10-10 22:12:26.642649
NCT02770755|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-05-11|||September 2014||2014-09-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|June 2016|Anticipated|2016-06-01|1 Year|Observational [Patient Registry]|ACHILLES||Registry of Celution Device for Processing ADRCs and Healing in Muscle and Ligament Sports Injuries|Registry of Celution Device for the Processing of Adipose Derived Regenerative Cells (ADRCs) and Healing in Muscle and Ligament Sports Injuries (ACHILLES)|Withdrawn||N/A|0|Actual|Cytori Therapeutics|||1|Corporate decision|f||||||||||||||2017-10-10 22:12:26.747432|2017-10-10 22:12:26.747432
NCT02770742|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Patient Satisfaction With Sedated vs. Unsedated Colonoscopy|Patient Satisfaction With Sedated vs. Unsedated Colonoscopy - Which Factors Affect Satisfaction and Pain in Routine Care?|Recruiting||N/A|1070|Anticipated|Helios Research Center|||1||f||||f||||||||No||2017-10-10 22:12:26.81851|2017-10-10 22:12:26.81851
NCT02770729|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-03-15|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.|Use of Intracameral Moxifloxacin for the Prevention of Acute Endophthalmitis Following Cataract Surgery: a Controlled and Randomized Clinical Trial|Recruiting||Phase 3|6000|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||Undecided||2017-10-10 22:12:26.888675|2017-10-10 22:12:26.888675
NCT02770716|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-22|||July 13, 2016||2016-07-13|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||A Study To Confirm Efficacy and Safety of Terlipressin in HRS Type 1|A Multi-Center, Randomized, Placebo Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 (The CONFIRM Study)|Recruiting||Phase 3|300|Anticipated|Mallinckrodt||2|||f||||t||||||||||2017-10-10 22:12:27.004895|2017-10-10 22:12:27.004895
NCT02770703|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Mesh Position and Outcomes Following Inguinal Hernia Repair Using an MRI Visible Hernia Mesh|Mesh Position and Outcomes Following Open (Lichtenstein), Endoscopic (TEP) and Laparoscopic (TAPP) Inguinal Hernia Repair Using a MRI Visible Hernia Mesh|Recruiting||N/A|60|Anticipated|University Hospital, Basel, Switzerland||3|||f||||f||||||||No||2017-10-10 22:12:27.286183|2017-10-10 22:12:27.286183
NCT02770690|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-12-05|||April 2016||2016-04-01|April 2016|2016-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||the Effect of Spray on Propofol Injection Pain|the Effect of Ethyl Chloride Spray on Propofol Injection Pain|Completed||Phase 4|90|Actual|The Catholic University of Korea||3|||f||||t||||||||No||2017-10-10 22:12:27.380156|2017-10-10 22:12:27.380156
NCT02770677|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-05-10|||April 2016||2016-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Modified Dantien Salee Yoga Training Program in Chronic Obstructive Pulmonary Disease Rehabilitation|Modified Dantien Salee Yoga Training Program in Chronic Obstructive Pulmonary Disease Rehabilitation|Recruiting||N/A|40|Anticipated|Mahidol University||2|||f||||t||||||||No||2017-10-10 22:12:27.467222|2017-10-10 22:12:27.467222
NCT02770664|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-10|||April 2016||2016-04-01|May 2016|2016-05-01||||August 2018|Anticipated|2018-08-01||Interventional|||Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients||Recruiting||Phase 2|100|Anticipated|LG Life Sciences||4|||f||||f||||||||Undecided||2017-10-10 22:12:27.56942|2017-10-10 22:12:27.56942
NCT02770651|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-08-15|||May 2016||2016-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI|LAte Stent Strut APPosition and COverage After Drug-Eluting Stent ImplantaTIOn by Optical Coherence Tomography in PatieNts With Acute Myocardial Infarction II(APPOSITION-AMI II)|Enrolling by invitation||N/A|69|Anticipated|Keimyung University Dongsan Medical Center|||1||f||||f||||||||||2017-10-10 22:12:27.658312|2017-10-10 22:12:27.658312
NCT02770638|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-11|||April 2016||2016-04-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|October 2016|Anticipated|2016-10-01||Interventional|||Tissue Interface Pressures in Athlete Medical Extraction|A Comparison of Tissue Interface Pressures and Comfort Ratings of the Scoop Stretcher and Traditional Long Back Board in Rugby and University Athletes|Recruiting||N/A|54|Anticipated|University of Nottingham||2|||f||||f||||||||No||2017-10-10 22:12:27.758901|2017-10-10 22:12:27.758901
NCT02770625|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2017-06-13|2017-02-10||September 2011||2011-09-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|March 2013|Actual|2013-03-01||Interventional|||Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease|A Multicenter, Open-Label Phase III Study to Evaluate the Safety and Efficacy of ISU302 (Imiglucerase for Injection) in Patients With Type 1 Gaucher Disease|Completed||Phase 3|8|Actual|ISU Abxis Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:12:27.88851|2017-10-10 22:12:27.88851
NCT02770599|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-06-20|||May 15, 2016|Actual|2016-05-15|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|June 30, 2017|Anticipated|2017-06-30||Observational|||Improving the Health Care in Inflammatory Bowel Disease.|IMPROVING THE HEALTH CARE IN INFLAMMATORY BOWEL DISEASE. A Clinical Study Comparing Two Different Outpatient Follow-up Models by Measuring Patient Reported Health Related Quality of Life, Quality of Care, Adherence and Clinical Outcomes.|Recruiting||N/A|300|Anticipated|University Hospital of North Norway|||2||f||||f||||||||No||2017-10-10 22:12:28.311929|2017-10-10 22:12:28.311929
NCT02770586|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-26|||August 2015||2015-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|PEM/MRI||Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI|Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI in Women With a High Suspicion of Breast Cancer|Enrolling by invitation||N/A|150|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:12:28.408641|2017-10-10 22:12:28.408641
NCT02770573|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-04-19|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Use of Biomaterials as Desensitizer Agents|Long-term Response of Three Biomaterials Used as Desensitizer Agents Under Oral Environmental Exposure.|Active, not recruiting||N/A|90|Anticipated|Università degli Studi di Sassari||1|||f||||t||||||||No|Not a plan for data sharing has been established. But, for anyone researcher would like to have this information, simply they may request them to us directly.|2017-10-10 22:12:28.490713|2017-10-10 22:12:28.490713
NCT02770560|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-05-11|||May 2010||2010-05-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|||Efficacy of Urokinase Containing Locking Solutions for Thrombotic Dysfunction of Tunneled Hemodialysis Catheters|Efficacy of Urokinase Containing Locking Solutions for Thrombotic Dysfunction of Tunneled Cuffed Catheters : a Single-center Retrospective Study|Completed||N/A|148|Actual|Universitair Ziekenhuis Brussel|||1||f||||f||||||||No||2017-10-10 22:12:28.585884|2017-10-10 22:12:28.585884
NCT02770547|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-03-28|||June 2016||2016-06-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Leg Thermotherapy for Intermittent Claudication|Leg Thermotherapy for Intermittent Claudication|Recruiting||N/A|32|Anticipated|Indiana University||2|||f||||t||||||||No||2017-10-10 22:12:28.664092|2017-10-10 22:12:28.664092
NCT02770521|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-07-29|||May 2016||2016-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants|A Study to Evaluate the Safety and Tolerability of Subcutaneous Treprostinil and Pharmacokinetics of a Novel LY900014 Formulation in Healthy Japanese Subjects|Completed||Phase 1|23|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:12:28.832433|2017-10-10 22:12:28.832433
NCT02770508|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-08-10|||November 2015||2015-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|ANDES||Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects|A Phase 4, Randomized, Open Label, Controlled Study of Boosted Darunavir and Lamivudine Versus Boosted Darunavir and Emtricitabine/Tenofovir or Lamivudine/Tenofovir in Naïve HIV-1 Infected Subjects|Active, not recruiting||Phase 4|145|Actual|The Huesped Foundation||2|||f||||f||||||||||2017-10-10 22:12:28.917672|2017-10-10 22:12:28.917672
NCT02770495|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-10|||January 2011||2011-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PREDICT||Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease|Dynamics of Regulatory and Effector T Lymphocyte Subsets in Patients With Crohn's Disease During Postoperative Recurrence : Implications for Identifying Patients at High Risk of Relapse.|Completed||Phase 3|59|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:12:29.013538|2017-10-10 22:12:29.013538
NCT02770482|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-05-26|||June 2014||2014-06-01|May 2016|2016-05-01||||June 2016|Anticipated|2016-06-01||Interventional|ADAB40||Amyloid Beta-peptide 1-40 and Alzheimer's Disease|Utility of Amyloid Beta-peptide 1-40 Measurement in the Diagnosis of Alzheimer's Disease|Recruiting||N/A|200|Anticipated|CHU de Reims||1|||f||||f||||||||||2017-10-10 22:12:29.081133|2017-10-10 22:12:29.081133
NCT02770469|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-07-07|||February 2014||2014-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TOGETHER||Culturally Tailored Educational and Support Program to Increase Quality of Life Among Korean Breast Cancer Survivors|Behavioral Intervention to Reduce Breast Cancer Disparity Among Underserved Koreans|Completed||N/A|86|Actual|University of Maryland||2|||f||||||||||||||2017-10-10 22:12:29.150936|2017-10-10 22:12:29.150936
NCT02770456|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-11|||March 2008||2008-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|FOPCHIN||Fish Oil Supplementation to Pregnant Women in China|Fish Oil Supplementation to Prevent Preterm Delivery in China: A Randomized Controlled Trial|Completed||N/A|5531|Actual|Centre for Fetal Programming, Denmark||3|||f||||f||||||||Yes||2017-10-10 22:12:29.239365|2017-10-10 22:12:29.239365
NCT02770443|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-11|||February 2016||2016-02-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|WrecEF||Withdrawal of Medication in Recovered DCM|Withdrawal of Beta- Blockers and ACE Inhibitors After Left Ventricular Systolic Function Recovery in Patient With Dilated Cardiomyopathy: A Randomized Control Trial.|Recruiting||N/A|100|Anticipated|McGill University||2|||f||||f||||||||No||2017-10-10 22:12:29.316262|2017-10-10 22:12:29.316262
NCT02770430|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-05-10|||September 2015||2015-09-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease|A Phase II, Randomized Study to Evaluate the Human Mesenchymal Stem Cells as a First-line Treatment for aGVHD in Patients Steroids Resistant.|Recruiting||Phase 2|90|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:12:29.43567|2017-10-10 22:12:29.43567
NCT02770417|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-06|||May 2016||2016-05-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|BACOPD||Oral β-Alanine Supplementation in Patients With COPD|Oral β-Alanine Supplementation in Patients With COPD: Structural, Metabolic and Functional Adaptations|Recruiting||N/A|50|Anticipated|Hasselt University||3|||f||||f||||||||Undecided||2017-10-10 22:12:29.617206|2017-10-10 22:12:29.617206
NCT02770404|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-08-03|||April 2016||2016-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects|Recruiting||Phase 1|60|Anticipated|Wockhardt||2|||f||||f||||||||||2017-10-10 22:12:29.72069|2017-10-10 22:12:29.72069
NCT02770391|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-12-12|||October 2016||2016-10-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Interventional|||ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer|The Association Between HSD3B1 Genotype and Steroid Metabolism in Normal and Prostate Cancer Tissue of Men With Intermediate and High-risk Prostate Cancer Undergoing Radical Prostatectomy After Treatment With ARN-509 and Leuprolide|Recruiting||Phase 2|57|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:12:29.820851|2017-10-10 22:12:29.820851
NCT02770378|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-12-05|||November 2016||2016-11-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|||A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma|A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma|Recruiting||Phase 1|10|Anticipated|University of Ulm||1|||f||||f||||||||No||2017-10-10 22:12:29.926769|2017-10-10 22:12:29.926769
NCT02770365|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-12-15||2016-12-15|May 2016||2016-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy||Completed||Phase 3|695|Actual|Perrigo Company||3|||f||||f||||||||No||2017-10-10 22:12:30.058859|2017-10-10 22:12:30.058859
NCT02770352|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-11-16|||October 2012||2012-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Fistula Formation and Successful Repair|Assessment of Factors Surrounding Fistula Formation and Successful Repair at Bwaila Hospital, Lilongwe|Recruiting||N/A|1250|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||No||2017-10-10 22:12:30.145467|2017-10-10 22:12:30.145467
NCT02770339|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-10-15|||June 2016||2016-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Pharmacogenomic Profiling of Pediatric Patients|Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department|Recruiting||N/A|100|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"     Blood samples will be collected to store DNA for potential Genomic Data Sharing (GDS)(     studies if further study is prompted by the results of this study.   "|Yes|Based on the initial results with the GeneSight data, the researchers will decide if further analysis (genotype) of the DNA will be undertaken. The informed consent allows the participant to agree or disagree to having their blood stored for this additional analysis. Their decision does not affect their ability to participate in the research study. No personal identifiers will be associated with this analysis. If further analysis is done, the plan is to share through the NIH Genome Data Sharing program, according to its process.|2017-10-10 22:12:30.235835|2017-10-10 22:12:30.235835
NCT02770326|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-05-16|||May 10, 2016|Actual|2016-05-10|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection|Safety of Fecal Microbiota Transplantation (FMT) for Recurrent or Refractory C. Difficile Infection in Patients With Solid Tumors|Recruiting||N/A|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:12:30.350984|2017-10-10 22:12:30.350984
NCT02770313|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-05-25|||October 2016||2016-10-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|WONDERFUL||Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction|Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction|Enrolling by invitation||N/A|128|Anticipated|Intermountain Health Care, Inc.||2|||f||||f||||||||No||2017-10-10 22:12:30.461169|2017-10-10 22:12:30.461169
NCT02770300|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-09-22|||May 2016||2016-05-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effect of Personalized Robotic Therapy|Effect of an Automatic Personalized Robot-assisted Rehabilitation on Cortical Organization and Clinical Recovery After Stroke|Recruiting||N/A|48|Anticipated|Wearable Robotics srl.||3|||f||||t||||||||||2017-10-10 22:12:30.546101|2017-10-10 22:12:30.546101
NCT02770287|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-08-01|||March 8, 2016|Actual|2016-03-08|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Radiofrequency and Pulsed Electromagnetic Field Treatment of Skin Laxity of the Mon Pubis, Labia and Vaginal Introitus|Clinical Evaluation of the Safety and Efficacy of Using Multi-Polar Radio Frequency and Pulsed Electromagnetic Field Therapy Technologies for the Treatment of the Mon Pubis, Vaginal Introitus and Labia Skin Laxity|Active, not recruiting||N/A|10|Actual|Venus Concept||1|||f||||f||||||||||2017-10-10 22:12:30.711754|2017-10-10 22:12:30.711754
NCT02770274|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CILO-PER||Cilostazol Following Peripheral Endovascular Procedures|Multi-center, Randomized Trial Comparing Dual Antiplatelet Therapy With CILOstazol Plus Aspirin Versus Aspirin Alone Following PERipheral Endovascular Procedures|Recruiting||Phase 3|200|Anticipated|Attikon Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:12:30.802869|2017-10-10 22:12:30.802869
NCT02770261|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-12-23|||December 2015||2015-12-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy|A Multi-center, Randomized, Double-blind, Parellel Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy in Patients With Hypertension and Primary Hypercholesterolemia.|Completed||Phase 3|219|Actual|Alvogen Korea||3|||f||||f||||||||No||2017-10-10 22:12:30.935967|2017-10-10 22:12:30.935967
NCT02770248|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-01-18|||May 2016||2016-05-01|January 2017|2017-01-01|January 14, 2017|Actual|2017-01-14|January 14, 2017|Actual|2017-01-14||Interventional|||24-hr Intraocular Pressure Control With SIMBRINZA ®|24-hr Intraocular Pressure Control With Brinzolamide 1% / Brimonidine 0.2% Ophthalmic Suspension vs Vehicle|Completed||Phase 4|163|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 22:12:31.037457|2017-10-10 22:12:31.037457
NCT02770235|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-08-02|||March 2014||2014-03-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|APGADEPD||Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients|Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-10 22:12:31.122184|2017-10-10 22:12:31.122184
NCT02770222|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-07-20|||June 2016||2016-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects|A Single-center, Open-label, Randomized, Two-part, Two-treatment, Two-period Crossover Study to Investigate the Effect of Gemfibrozil or Rifampicin on the Pharmacokinetics of Selexipag and Its Metabolite ACT-333679 in Healthy Male Subjects.|Completed||Phase 1|40|Actual|Actelion||4|||f||||f||||||||||2017-10-10 22:12:31.215739|2017-10-10 22:12:31.215739
NCT02770209|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-05-11|||February 2012||2012-02-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|August 2013|Actual|2013-08-01||Interventional|||Autologous Cell-derived Tissue Engineered Cartilage for Repairing Articular Cartilage Lesions|Autologous Cell-derived Tissue Engineered Cartilage for Repairing Articular Cartilage Lesions: a Protocol for a Prospective, Randomized, Controlled Clinical Trial|Active, not recruiting||N/A|100|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:12:31.314297|2017-10-10 22:12:31.314297
NCT02770196|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-03-22|||April 2015||2015-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Intervention Study of Cost-Offset Community Supported Agriculture (CO-CSA)|Farm Fresh Foods for Healthy Kids: Innovative Community Supported Agriculture Cost-Offset Intervention to Prevent Childhood Obesity and Strengthen Local Agricultural Economies|Recruiting||N/A|240|Anticipated|Cornell University||4|||f||||f||||||||No||2017-10-10 22:12:31.415958|2017-10-10 22:12:31.415958
NCT02770183|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-05-02|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|Imacor-1||Rate of Left Ventricular Systolic Function's Recuperation After Cardiac Surgery With Extracorporeal Circulation.|Rate of Left Ventricular Systolic Function's Recuperation After Cardiac Surgery With Extracorporeal Circulation.|Not yet recruiting||N/A|40|Anticipated|University Hospital, Geneva|||1||f||||f||||||||No||2017-10-10 22:12:31.581476|2017-10-10 22:12:31.581476
NCT02770170|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-10-03|||May 16, 2016|Actual|2016-05-16|October 2017|2017-10-01|October 22, 2019|Anticipated|2019-10-22|August 28, 2019|Anticipated|2019-08-28||Interventional|||Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis|A Double-blind, Randomised, Placebo-controlled Trial Evaluating the Effect of BI 655064 Administered as Sub-cutaneous Injections, on Renal Response After One Year of Treatment, in Patients With Active Lupus Nephritis|Recruiting||Phase 2|120|Anticipated|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 22:12:31.685893|2017-10-10 22:12:31.685893
NCT02770157|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-18|||February 2016||2016-02-01|September 2017|2017-09-01||||April 2019|Anticipated|2019-04-01||Interventional|SGA||Efficacy and Safety of DA-3002 in Short Children Borns SGA.|Phase III Clinical Trial for Assessment of Efficacy and Safety of DA-3002 (Recombinant Human Growth Hormone) in Short Children Born Small for Gestational Age.|Recruiting||Phase 3|75|Anticipated|Dong-A ST Co., Ltd.||3|||f||||||||||||||2017-10-10 22:12:31.925724|2017-10-10 22:12:31.925724
NCT02770144|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Impact of Family Financial Support on Child Health||Recruiting||N/A|150|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No|Participant consent does not include data sharing beyond the study and there is no appropriate repository for such data.|2017-10-10 22:12:32.017722|2017-10-10 22:12:32.017722
NCT02770131|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-10-04|||May 4, 2016|Actual|2016-05-04|October 2017|2017-10-01|June 24, 2021|Anticipated|2021-06-24|June 24, 2021|Anticipated|2021-06-24||Observational|||Chart Review of Repatha® in Subjects With Hyperlipidaemia|Observational Serial Chart Review of Repatha® Use in European Subjects With Hyperlipidaemia|Recruiting||N/A|2000|Anticipated|Amgen|||1||f||||f||||||||||2017-10-10 22:12:32.120151|2017-10-10 22:12:32.120151
NCT02770118|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-17|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|BAT||Effects of Sleep Restriction on BAT Activation in Humans|Effects of Sleep Restriction on BAT Activation in Humans|Completed||N/A|4|Actual|Columbia University||2|||f||||t||||||||||2017-10-10 22:12:32.551107|2017-10-10 22:12:32.551107
NCT02770105|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-08-31|||May 2016||2016-05-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|THECNA||Theanine and Caffeine on Neurophysiology of Attention|Neurophysiological Correlates of L-theanine, Caffeine and Their Combination on Improving Selective Attention in a Visual Reaction Time Task: A Functional Magnetic Resonance Imaging (fMRI) Study|Completed||N/A|9|Actual|Texas Tech University||1|||f||||f||||||||No||2017-10-10 22:12:32.652962|2017-10-10 22:12:32.652962
NCT02770092|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-11-28|||February 2016||2016-02-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||CHF COPD Sip Feed Anabolic Response|Anabolic Responsiveness to Protein Intake in Chronic Heart Failure and Chronic Obstructive Pulmonary Disorder|Recruiting||N/A|150|Anticipated|Texas A&M University||3|||f||||f||||||||No||2017-10-10 22:12:32.734214|2017-10-10 22:12:32.734214
NCT02770079|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-10-13|||May 2016||2016-05-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.|Botnia Clamp in Women Before, Immediately After Delivery and 6 Months Post Partum.|Recruiting||N/A|40|Anticipated|University of Aarhus|||2||f||||t||||||Samples With DNA|"     Whole blood approximately 10 mL.   "|||2017-10-10 22:12:32.837868|2017-10-10 22:12:32.837868
NCT02770066|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|January 2030|Anticipated|2030-01-01|January 2025|Anticipated|2025-01-01||Observational|DAN-PTRA||A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension|A Prospective Danish National Registry of Percutaneous Transluminal Renal Angioplasty in Patients With Renovascular Hypertension|Recruiting||N/A|30|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-10 22:12:32.924172|2017-10-10 22:12:32.924172
NCT02770053|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2016-10-28|||January 2016||2016-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Foraminal Enlargement and Postoperative Pain.|Influence of Foraminal Enlargement on Postoperative Pain in Teeth With Necrotic Pulp and Apical Periodontitis: A Randomized Controlled Trial.|Completed||Phase 1|80|Actual|Isparta Military Hospital||2|||f||||f||||||||Yes||2017-10-10 22:12:33.046839|2017-10-10 22:12:33.046839
NCT02770040|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-07-02|||July 2016||2016-07-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|PREDICT-UC||Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis|PREDICT UC: Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis - A Randomised Controlled Trial|Recruiting||Phase 4|138|Anticipated|Austin Health||3|||f||||t||||||||No||2017-10-10 22:12:33.142328|2017-10-10 22:12:33.142328
NCT02770027|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for Colon Surgery|Impact of Intravascular Fluid Resuscitation on Whole Blood Viscosity During Colon Surgery|Not yet recruiting||N/A|30|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:12:33.282682|2017-10-10 22:12:33.282682
NCT02770014|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-01-19|||June 2016||2016-06-01|January 2017|2017-01-01|November 2023|Anticipated|2023-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer|Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer|Recruiting||Phase 2|100|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 22:12:33.399714|2017-10-10 22:12:33.399714
NCT02770001|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-10-05|||May 5, 2016||2016-05-05|May 15, 2017|2017-05-15|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Observational|||Suitability of Some Data Quality Controls Thresholds for Genetic Association Studies of Admixed Population|Investigating the Suitability of Some Data Quality Controls Thresholds for Genetic Association Studies of Admixed Population|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:12:33.551952|2017-10-10 22:12:33.551952
NCT02769988|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-06-30|||April 19, 2016||2016-04-19|March 24, 2017|2017-03-24|September 30, 2019|Anticipated|2019-09-30|October 5, 2016|Actual|2016-10-05||Observational|||Educational Impact of the NLM/National Area Health Education Center Organization (NAO) Project-SHARE Based Teen Health Information Literacy Curriculum|Focus Group Evaluation of Educational Impact of the NLM / National Area Health Education Center Organization (NAO) Project-SHARE Based Teen Health Information Literacy Curriculum|Enrolling by invitation||N/A|175|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f||||||||||||||2017-10-10 22:12:33.63796|2017-10-10 22:12:33.63796
NCT02769975|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-06-30|||May 6, 2016||2016-05-06|April 14, 2017|2017-04-14|December 31, 2036|Anticipated|2036-12-31|December 31, 2030|Anticipated|2030-12-31||Observational|||Evaluation of Children With Endocrine and Metabolic-Related Conditions|Evaluation of Children With Endocrine and Metabolic-Related Conditions|Recruiting||N/A|15000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:12:33.753362|2017-10-10 22:12:33.753362
NCT02769962|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-11|2017-09-21|||May 3, 2016||2016-05-03|September 11, 2017|2017-09-11|December 31, 2026|Anticipated|2026-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer|A Phase I/II Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in Patients With Relapsed/Refractory Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|138|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 22:12:33.887354|2017-10-10 22:12:33.887354
NCT02769936|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||November 2013||2013-11-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Glutamate, Learning, and Working Memory|The Effects of D-cycloserine on Neuroplasticity and Working Memory in Healthy Adults and Patients With Schizophrenia|Completed||Phase 1|110|Actual|University of California, Los Angeles||4|||f||||f||||||||Undecided||2017-10-10 22:12:34.160383|2017-10-10 22:12:34.160383
NCT02769923|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-09-12|||September 2015||2015-09-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|ID-ADAP||ID Administration of fIPV Using Intradermal Adapters vs. BCG Syringe|Intradermal Administration of Fractional Dose of Inactivated Poliovirus Vaccine Using Intradermal Adapters vs. BCG Syringe: Community Based Randomized Control Trial in Pakistan|Completed||N/A|450|Actual|Aga Khan University||3|||f||||t||||||||||2017-10-10 22:12:34.264086|2017-10-10 22:12:34.264086
NCT02769910|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-11-19|||May 2016||2016-05-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch|The Role of Pre-established Skin Inflammation on the Susceptibility to Histamine and Cowhage-induced Itch in Healthy Humans|Completed||Phase 1/Phase 2|16|Actual|Aalborg University||2|||f||||f||||||||No||2017-10-10 22:12:36.717278|2017-10-10 22:12:36.717278
NCT02769897|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-08-18|||May 2016||2016-05-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Obesity in Schoolchildren of Basic Education - Phase III|Obesity in Schoolchildren of Basic Education: a Study of Interdisciplinary Intervention - Phase III|Completed||N/A|50|Actual|University of Santa Cruz do Sul||2|||f||||t||||||||||2017-10-10 22:12:36.851305|2017-10-10 22:12:36.851305
NCT02769884|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-03-28|||July 2016||2016-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|MMPPC||MMPPC Outpatient Clinical Protocol 2016|Multiple Model Probabilistic Predictive Control (MMPPC) Outpatient Clinical Protocol|Completed||Phase 2|10|Actual|Rensselaer Polytechnic Institute||1|||f||||f||||||||No||2017-10-10 22:12:36.938595|2017-10-10 22:12:36.938595
NCT02769871|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-06-20|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||NICE: NeuroImaging in Cessation Education|Effect of Showing Stroke Neuroimaging to Patients in Setting of Smoking Cessation Education on Smoking Cessation Rates in Patients With New Stroke.|Enrolling by invitation||N/A|350|Anticipated|Yale University||2|||f||||||||||||||2017-10-10 22:12:37.498889|2017-10-10 22:12:37.498889
NCT02769858|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-12-19|||June 2015||2015-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression|The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression|Completed||Phase 1/Phase 2|10|Actual|University of Michigan||1|||f||||f||||||||No||2017-10-10 22:12:37.58755|2017-10-10 22:12:37.58755
NCT02769845|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-29|||May 2016||2016-05-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|November 2019|Anticipated|2019-11-01||Interventional|SACRED||SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia|Stroke Avoidance for Children in REpublica Dominicana (SACRED): A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia|Recruiting||N/A|500|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 22:12:37.671254|2017-10-10 22:12:37.671254
NCT02769832|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-02-07|||August 2016||2016-08-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Lung Cancer|Phase II Study of Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Lung Cancer or Those With Progression on First Line Therapy|Recruiting||Phase 2|32|Anticipated|University of Iowa||1|||f||||t||||||||||2017-10-10 22:12:37.771405|2017-10-10 22:12:37.771405
NCT02769806|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-06-26|||March 2016||2016-03-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|April 2018|Anticipated|2018-04-01||Observational|||Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma|Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma|Recruiting||N/A|25|Anticipated|University of Wisconsin, Madison|||1||f||||t||||||||No|Currently, there is no plan to share data.|2017-10-10 22:12:37.952693|2017-10-10 22:12:37.952693
NCT02769793|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-21|||June 2015||2015-06-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON|Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in Parkinson's Disease Patients With Delayed ON: a Multicenter Randomized Open-label Cross-over Trial|Recruiting||Phase 4|40|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:12:38.061778|2017-10-10 22:12:38.061778
NCT02769780|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-05-11|||June 2015||2015-06-01|May 2016|2016-05-01||||June 2020|Anticipated|2020-06-01|6 Months|Observational [Patient Registry]|||A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy|A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy|Recruiting||N/A|1500|Anticipated|Jazz Pharmaceuticals|||1||f||||f||||||||Yes||2017-10-10 22:12:38.181879|2017-10-10 22:12:38.181879
NCT02769767|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-10|||August 2012||2012-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|WESTEMDRB1||Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.|Association of Polymorphisms of the Interleukin-7 Receptor-α (IL-7R), Glypican 5 (GPC5), Interleukin-2 Receptor-α (IL2-RA) , Human Leukocyte Antigen Class II Beta Chain (HLA-DRB1) Genes and Treatment Response in Multiple Sclerosis (MS).|Recruiting||N/A|500|Anticipated|Instituto Jalisciense de Cancerologia|||4||f||||f||||||Samples With DNA|"     Total blood for posterior extraction of DNA.   "|Undecided||2017-10-10 22:12:38.260206|2017-10-10 22:12:38.260206
NCT02769754|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-09-05|||May 2016||2016-05-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|HEMOPATCH||Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection|Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection|Recruiting||Phase 3|250|Anticipated|Instituto de Investigacion Sanitaria La Fe||2|||f||||f||||||||Undecided||2017-10-10 22:12:38.356496|2017-10-10 22:12:38.356496
NCT02769741|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-10-28|||January 2016||2016-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Controlled-Feeding Study to Assess the Effect of Cashews on Fasting Lipoprotein Levels|A Randomized, Controlled-Feeding, Crossover Study to Assess the Effect of Cashews on Fasting Lipoprotein Levels|Completed||N/A|51|Actual|Kraft Heinz Company||2|||f||||t||||||||Undecided||2017-10-10 22:12:38.476284|2017-10-10 22:12:38.476284
NCT02769728|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-08-02|||February 2016||2016-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus|EndoBarrierTM in Obese Subjects With Type 2 Diabetes: Impact on Pancreatic Function, Insulin Resistance, Gut Peptides and Gut Permeability - a Pilot Study|Active, not recruiting||N/A|10|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-10 22:12:38.558541|2017-10-10 22:12:38.558541
NCT02769715|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-10|||January 2014||2014-01-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|||A Study About Patient Satisfaction With Laser-sintered Removable Partial Dentures|Laser-sintered Removable Partial Dentures: a Crossover Pilot Clinical Trial|Completed||N/A|12|Actual|McGill University Health Center||2|||f||||t||||||||Yes|The patients' demographic data including (age, sex, the number of missing anterior and posterior teeth, previous denture experience, denture arch, opposing arch and Kennedy classification of the denture, first denture received and preferred denture) will be published in a scientific journal without any indication of personal identity of the patients.|2017-10-10 22:12:38.641257|2017-10-10 22:12:38.641257
NCT02769702|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-10|||June 2016||2016-06-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis|Prospective Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Who Are Not Well Controlled With, or Intolerant of, Topical or Systemic Corticosteroids|Not yet recruiting||Phase 4|10|Anticipated|Washington University School of Medicine||1|||f||||t||||||||No||2017-10-10 22:12:38.731686|2017-10-10 22:12:38.731686
NCT02769689|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-05-09|||April 2016||2016-04-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|NTZ2TTY||Methylprednisolone During the Switch Between Natalizumab and Fingolimod|Once a Month High-dose Methylprednisolone During Wash-out Period Between Natalizumab and Fingolimod Treatments in Patients With Multiple Sclerosis: a Randomised, Controlled, Double-blind Trial (NTZ2FTY)|Recruiting||Phase 4|56|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:12:38.804329|2017-10-10 22:12:38.804329
NCT02769676|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-09|||May 2016||2016-05-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|December 2016|Anticipated|2016-12-01||Interventional|||A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation|A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation|Recruiting||N/A|200|Anticipated|Washington University School of Medicine||2|||f||||t||||||||No||2017-10-10 22:12:38.897671|2017-10-10 22:12:38.897671
NCT02769663|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-09|||June 2012||2012-06-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Observational|||Cognitive Complaints in Obstructive Sleep Apnea|Cognitive Complaints in Obstructive Sleep Apnea|Recruiting||N/A|180|Anticipated|VieCuri Medical Centre|||2||f||||f||||||||No||2017-10-10 22:12:38.978144|2017-10-10 22:12:38.978144
NCT02769650|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-15|||October 2010||2010-10-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Stress-MRI Assessment After Right Coronary Artery CTO Recanalization|Clinical Significance of Stress-MRI Evaluation of Right Coronary Artery Chronic Total Occlusion Recanalization Efficacy in Patients With Coronary Artery Disease.|Completed||N/A|72|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||No||2017-10-10 22:12:39.094671|2017-10-10 22:12:39.094671
NCT02769637|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-21|||September 7, 2017|Actual|2017-09-07|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Observational|||Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)|Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)|Recruiting||N/A|23|Anticipated|University of Colorado, Denver|||2||f||||t||||||Samples With DNA|"     DNA for 16S amplification   "|||2017-10-10 22:12:39.183323|2017-10-10 22:12:39.183323
NCT02769624|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-04-26|||February 21, 2017|Actual|2017-02-21|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Acute Effects of Inhaled Treprostinil in Fontan Patients|A Randomized, Placebo-Controlled Pilot Study to Determine the Acute Effects of Inhaled Treprostinil on Exercise, Vascular Function, and Exercise Induced Liver Stiffness in Fontan Patients|Recruiting||Phase 2|26|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t|t|f||||||||2017-10-10 22:12:39.47081|2017-10-10 22:12:39.47081
NCT02769234|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-05-25|||May 2016||2016-05-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|||EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)|ERP and qEEG Measures Collected in Outpatient Settings as Indices of Disease Progression in Alzheimer's Disease (AD)|Enrolling by invitation||N/A|75|Anticipated|Neuronetrix, Inc.|||1||f||||f|f|f||||||||2017-10-10 22:12:43.239545|2017-10-10 22:12:43.239545
NCT02769611|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-07-28|||June 28, 2017|Actual|2017-06-28|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ruboxistaurin in New York Heart Failure Classification III-IV Patients|A Prospective Phase I/II Dose Escalation Pilot Analysis of Ruboxistaurin (LY333531) for Safety in New York Heart Failure Classification III-IV Patients, As Well As For Efficacy in Acutely Augmenting Cardiac Function.|Recruiting||Phase 1/Phase 2|30|Anticipated|Children's Hospital Medical Center, Cincinnati||3|||f||||t|t|f||||||||2017-10-10 22:12:39.610194|2017-10-10 22:12:39.610194
NCT02769598|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-01-26|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|ANI-DOL||Pain Management in Pediatric Intensive Care by Studying the Autonomic Balance|Pain Management in Pediatric Intensive Care by Studying the Autonomic Balance: Interest of Pain Hetero-assessment by Coupling ANI-HRV-scales : ANI-DOL Study|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f|f|f||||||No||2017-10-10 22:12:39.770661|2017-10-10 22:12:39.770661
NCT02769585|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-12|||July 2013||2013-07-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy of Self-hypnosis for Weight Loss in Type 2 Diabetics|Efficacy of Self-hypnosis for Weight Loss in Type 2 Diabetics|Completed||N/A|74|Actual|Levenson, David I., M.D.||2|||f||||f||||||||Undecided|If the need arises we are happy to share data (blinded)|2017-10-10 22:12:39.922668|2017-10-10 22:12:39.922668
NCT02769572|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Moxibustion in Osteoarthritis of the Knee|The Effectiveness of Moxibustion Treatment for Osteoarthritis of the Knee : a Double-blinded, Double-dummy, Randomized Controlled Trial|Recruiting||Phase 3|144|Anticipated|Chengdu University of Traditional Chinese Medicine||2|||f||||f||||||||Yes||2017-10-10 22:12:40.080731|2017-10-10 22:12:40.080731
NCT02769559|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||January 2000||2000-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2014|Actual|2014-12-01||Observational|MammaRed||Reduction Mammaplasty and Improved Quality of Life|Reduction Mammaplasty Safely Increases the Quality of Life in Patients With Mammary Hypetrophy.|Completed||N/A|52|Actual|University Hospital Bratislava|||1||f||||f||||||||No||2017-10-10 22:12:40.219546|2017-10-10 22:12:40.219546
NCT02769546|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-10|||January 2016||2016-01-01|May 2016|2016-05-01||||January 2017|Anticipated|2017-01-01||Observational|||Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis|Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis|Recruiting||N/A|50||Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:12:40.313482|2017-10-10 22:12:40.313482
NCT02769533|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-07-28|||September 2015||2015-09-01|July 2017|2017-07-01||||September 2020|Anticipated|2020-09-01||Interventional|||A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma|A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma|Recruiting||Phase 1|50|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:12:40.401517|2017-10-10 22:12:40.401517
NCT02769520|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-12-12|||June 2016||2016-06-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck|An Open-Label, Phase 2 Efficacy Study With Window of Opportunity Immune Assessment of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 2|45|Anticipated|University of California, San Diego||2|||f||||t||||||||No||2017-10-10 22:12:40.51028|2017-10-10 22:12:40.51028
NCT02769507|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations|Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations|Recruiting||N/A|60|Anticipated|University of Bergen||2|||f||||t||||||||Yes|"Data will be shared with the ERC Advanced Projects Advanced Grant #249516 VOICE and #693124 ONOFF."|2017-10-10 22:12:40.646667|2017-10-10 22:12:40.646667
NCT02769494|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-05-10|||March 2016||2016-03-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer|The Efficacy of Topically Applied Mesalazine Sustained-Release Tablets in Oral Lesions of Crohn's Disease|Recruiting||Phase 3|40|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||t||||||||No||2017-10-10 22:12:40.778926|2017-10-10 22:12:40.778926
NCT02769481|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-01|||August 2016||2016-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects|A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of Bexagliflozin Versus Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin|Active, not recruiting||Phase 3|429|Actual|Theracos||2|||f||||t|t|f||||||||2017-10-10 22:12:40.920789|2017-10-10 22:12:40.920789
NCT02769468|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-10|||November 2015||2015-11-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Probe Placement in Delivery Room on Temperature at the Admission of Premature Infants?|Effect of Temperature Probe Placement in Delivery Room on Temperature at the Admission in the Neonatal Intensive Care Unit (NICU) of Premature Infants?|Recruiting||N/A|121|Anticipated|Maisonneuve-Rosemont Hospital||3|||f||||t||||||||No||2017-10-10 22:12:41.156058|2017-10-10 22:12:41.156058
NCT02769455|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-29|||August 2016||2016-08-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Interventional|SUPERNET||Online Experimental Supermarket|Impact of front-of Pack Nutrition Labels on Purchase Intentions in an Online Supermarket-A Series of Randomized Trials|Completed||N/A|6000|Anticipated|University of Paris 13||3|||f||||f||||||||||2017-10-10 22:12:41.255532|2017-10-10 22:12:41.255532
NCT02769442|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-10-24|||June 2016||2016-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED|Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED|Completed||N/A|600|Actual|University of Maryland||2|||f||||f||||||||No||2017-10-10 22:12:41.359836|2017-10-10 22:12:41.359836
NCT02769429|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-08-31|||October 2016||2016-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Continuous Blockade of the Brachial Plexus|Is There a Difference Between Posterior Approach Ultrasound-guided Continuous Interscalene Block (Upper Trunk Block) and Stimulator Guided Continuous Cervical Paravertebral Block (C6 Root Block)?|Recruiting||N/A|100|Anticipated|University of Florida|||2||f||||f|f|f||||||||2017-10-10 22:12:41.463553|2017-10-10 22:12:41.463553
NCT02769416|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-01-16|||December 2015||2015-12-01|January 2017|2017-01-01|December 2035|Anticipated|2035-12-01|December 2035|Anticipated|2035-12-01|5 Years|Observational [Patient Registry]|NCTT||The National Center for Testing Treatments in Chronic Spinal Cord and Traumatic Brain Injury|The National Center for Testing Treatments in Chronic Spinal Cord and Traumatic Brain Injury|Recruiting||N/A|5000|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||f||||||Samples With DNA|"     Blood, urine, and saliva   "|No|IPD data will not be freely available. Participating centers will share data.|2017-10-10 22:12:41.585372|2017-10-10 22:12:41.585372
NCT02769403|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-05-16|||June 2016||2016-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Mindfulness With Biofeedback|Using a Daily Mindfulness Practice With Biofeedback to Improve Job Satisfaction and Performance in a Primary Care Outpatient Clinic|Completed||N/A|18|Actual|University of Florida||2|||f||||f||||||||Undecided||2017-10-10 22:12:41.686249|2017-10-10 22:12:41.686249
NCT02769390|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-05-12|||July 2015||2015-07-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|clonidine||Association of Different Doses of Clonidine in Caudal Epidural Anesthesia for Hypospadias Surgery|Association of Different Doses of Clonidine in Caudal Epidural Anesthesia for Hypospadias Surgery|Completed||Phase 2|80|Actual|Federal University of Minas Gerais||4|||f||||t||||||||Undecided||2017-10-10 22:12:41.784661|2017-10-10 22:12:41.784661
NCT02769377|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-12|||September 2014||2014-09-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Glucometer and Mobile-phone Based Data Transfer System in Diabetes|Efficacy of Combination of Glucometer and Mobile-phone Based Data Transfer System on Glycemic Control in Patients With Diabetes|Recruiting||Phase 4|300|Anticipated|Taichung Veterans General Hospital||3|||f||||f||||||||No||2017-10-10 22:12:41.883717|2017-10-10 22:12:41.883717
NCT02769364|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-10|||November 2013||2013-11-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|EXTER||Extended Treatment in Metastatic Breast Cancer With Eribulin|Long-term Eribulin Treatment in Metastatic Breast Cancer: A Multicenter, Case-study Analysis|Completed||N/A|45|Actual|Eisai Inc.|||1||f||||||||||||||2017-10-10 22:12:41.984745|2017-10-10 22:12:41.984745
NCT02769351|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-08-15|||December 2015||2015-12-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|GENTLE-UF||Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration|A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload|Recruiting||N/A|500|Anticipated|Fresenius Medical Care Deutschland GmbH|||1||f||||f||||||||No|Overall results will be published. Individual participant data will not be made available.|2017-10-10 22:12:42.123383|2017-10-10 22:12:42.123383
NCT02769338|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-05-15|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|September 30, 2020|Anticipated|2020-09-30|June 1, 2020|Anticipated|2020-06-01||Interventional|PREVENT||Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms|Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms (PREVENT) (QUE 15-280)|Recruiting||N/A|6|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:12:42.288228|2017-10-10 22:12:42.288228
NCT02769325|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|ALGOS||Atropine in Laparoscopic Gynaecological Surgery|Atropine in Laparoscopic Gynaecological Surgery (The ALGOS Trial) A Randomised, Double Blind, Controlled Trial|Not yet recruiting||Phase 4|150|Anticipated|Clinica Santa Maria||2|||f||||t||||||||No||2017-10-10 22:12:42.413449|2017-10-10 22:12:42.413449
NCT02769312|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-30|||April 1, 2016|Actual|2016-04-01|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2018|Anticipated|2018-01-31||Interventional|TBS||Theta-Burst Neuromodulation for PTSD|Pilot Testing of Theta-Burst Neuromodulation for Chronic PTSD|Recruiting||Phase 1/Phase 2|50|Anticipated|VA Office of Research and Development||2|||f||||f|f|t|f|f|f|||||2017-10-10 22:12:42.577527|2017-10-10 22:12:42.577527
NCT02769299|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-09-06|||April 2015||2015-04-01|September 2016|2016-09-01||||April 2017|Anticipated|2017-04-01||Observational|||Cardiotoxicity of Radiation Therapy (CTRT)|Cardiotoxicity of Radiation Therapy (CTRT)|Recruiting||N/A|100|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:12:42.677509|2017-10-10 22:12:42.677509
NCT02769286|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-08-02|||August 2016||2016-08-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|LiquidLung-O||Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA|Phase II Trial of AZD9291 in First Line Treatment of Lung Cancer Harboring Activating EGFR Mutation From Circulating Tumor DNA and Second Line Treatment After Acquired Resistance With T790M Mutation Detected From Circulating Tumor DNA|Recruiting||Phase 2|38|Anticipated|Chonnam National University Hospital||2|||f||||f||||||||No||2017-10-10 22:12:42.749279|2017-10-10 22:12:42.749279
NCT02769273|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-09-01|||June 2016||2016-06-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01|3 Years|Observational [Patient Registry]|SAVER||Stellarex Vascular E-Registry|Stellarex Vascular E-Registry|Recruiting||N/A|10000|Anticipated|Spectranetics Corporation|||1||f||||f||||||||||2017-10-10 22:12:42.858361|2017-10-10 22:12:42.858361
NCT02769260|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-05-08|||September 2015||2015-09-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Biofilm Characteristics Between an in Situ Biofilm Model of Supragingival Plaque and Natural Teeth|Comparison of Biofilm Characteristics Between an in Situ Biofilm Model of Supragingival Plaque and Natural Teeth|Recruiting||Early Phase 1|15|Anticipated|University of Santiago de Compostela||3|||f||||f||||||||Yes|Data will shared in a supplementary file in the published paper|2017-10-10 22:12:43.053073|2017-10-10 22:12:43.053073
NCT02769247|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-10|||February 2014|Actual|2014-02-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion|Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion|Completed||N/A|159|Actual|Walter Reed National Military Medical Center||4|||f||||f||||||||||2017-10-10 22:12:43.144765|2017-10-10 22:12:43.144765
NCT02769221|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||June 2016||2016-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Intubation Success Rate_Rigid Video Stylet Vs Video Laryngoscope|Comparison of the Initial Intubation Success Rate Between Video Laryngoscope and Rigid Video Stylet in Patients Undergoing Cervical Spine Surgery|Not yet recruiting||N/A|370|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 22:12:44.974231|2017-10-10 22:12:44.974231
NCT02769208|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-31|||November 2014||2014-11-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Influence of Indoor Air Filtration Strategies on Occupant Health Indicators|Influence of Indoor Air Filtration Strategies on Occupant Health Indicators|Completed||N/A|89|Actual|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:12:45.072948|2017-10-10 22:12:45.072948
NCT02769195|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-06-27|||April 2016||2016-04-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLE|Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLE: Pooled Analysis of the HGS1006-C1056 (BLISS-76) and HGS1006-C1057 (BLISS-52) Trials|Active, not recruiting||N/A|1684|Actual|Monash University|||1||f||||f||||||||No|This study is a secondary analysis of two existing clinical trial datasets. Anyone who wants to use the data should contact the primary study sponsor (GSK) via their data sharing website: https://clinicalstudydatarequest.com/|2017-10-10 22:12:45.181949|2017-10-10 22:12:45.181949
NCT02769182|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-08|||May 2016||2016-05-01|May 2016|2016-05-01||||May 2019|Anticipated|2019-05-01||Interventional|||Development and Validation of a Smart Phone Based System to Enhance Gait, Cognition and Socialization in Elderly Fallers|Development and Validation of a Smart Phone Based System to Enhance Gait, Cognition and Socialization in Elderly Fallers|Not yet recruiting||N/A|80|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 22:12:45.24152|2017-10-10 22:12:45.24152
NCT02769169|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-07-10|||August 2016||2016-08-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy|Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy: A Prospective Randomized Multicenter Study|Not yet recruiting||Phase 2/Phase 3|110|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 22:12:45.329324|2017-10-10 22:12:45.329324
NCT02769156|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-07-31|||June 2015||2015-06-01|July 2017|2017-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||A Pilot & Feasibility Study of Intraoperative Imaging With OTL38 In Patients With Lung and Pleural Nodules|A Pilot & Feasibility Study of Intraoperative Imaging With OTL38 In Patients With Lung and Pleural Nodules|Recruiting||Phase 1|50|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:12:45.440371|2017-10-10 22:12:45.440371
NCT02769143|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-12-10|||May 2016||2016-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Effects of Whole Body Vibration and Pilates on Bone Mineral Density in Postmenopausal Women|Effects of Whole Body Vibration and Pilates Method on Bone Mineral Density in Postmenopausal Women: a Randomized, Controlled, Clinical Trial|Completed||Early Phase 1|51|Actual|Universidade Norte do Paraná||3|||f||||t||||||||No||2017-10-10 22:12:45.512054|2017-10-10 22:12:45.512054
NCT02769130|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-09|||May 2016||2016-05-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis|Pilot Trial: the Safety and Feasibility of Losartan Therapy for Treatment of Pulmonary Vein Stenosis in Pediatric Patients|Recruiting||Phase 1/Phase 2|40|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||No||2017-10-10 22:12:45.601993|2017-10-10 22:12:45.601993
NCT02769117|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-07-31|||May 2016||2016-05-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Bone Ultrasound to Access Forearm Fracture Healing|Utilizing Bone Ultrasound to Access Forearm Fracture Healing|Enrolling by invitation||N/A|60|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:12:45.687324|2017-10-10 22:12:45.687324
NCT02769104|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2017-09-09|||May 2016||2016-05-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|ACCN||Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer|Aromatase Inhibitors (AI) Plus Chemotherapy Versus Chemotherapy as Neoadjuvant Treatment in Postmenopausal Hormone Receptor-positive Breast Cancer|Recruiting||Phase 3|120|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-10 22:12:45.777365|2017-10-10 22:12:45.777365
NCT02769091|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-11-16|||September 2016||2016-09-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|NASH||A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes|A 24-Week, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of 80 mg TEV-45478 Once Daily as Treatment in Adult Patients With Nonalcoholic Steatohepatitis (NASH) Who Also Have Type 2 Diabetes Mellitus|Suspended||Phase 2|80|Anticipated|Teva Pharmaceutical Industries||2||Business decision|f||||t||||||||||2017-10-10 22:12:46.079309|2017-10-10 22:12:46.079309
NCT02769078|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-10|||November 2014||2014-11-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S|Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S|Completed||N/A|14201|Actual|Bristol-Myers Squibb|||4||f||||f||||||||Undecided||2017-10-10 22:12:46.200973|2017-10-10 22:12:46.200973
NCT02769065|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-08-02|||May 5, 2016|Actual|2016-05-05|August 2017|2017-08-01|March 13, 2018|Anticipated|2018-03-13|March 13, 2018|Anticipated|2018-03-13||Interventional|||Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants|A Phase 1 Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Oral Doses of TAK-071 in Healthy Subjects and Subjects With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability and Food Effect of TAK-071 in Healthy Subjects|Recruiting||Phase 1|186|Anticipated|Takeda||22|||f||||f|t|f||||||||2017-10-10 22:12:46.328032|2017-10-10 22:12:46.328032
NCT02768870|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-11|||April 2016||2016-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|TRACER||CE Mark Study for the Harpoon Medical Device|Mitral TRans-Apical neoChordal Echo-guided Repair (TRACER) Trial|Recruiting||N/A|30|Anticipated|Harpoon Medical||1|||f||||t|f|t|f|f|t|||||2017-10-10 22:12:48.086061|2017-10-10 22:12:48.086061
NCT02769052|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-04|||March 2016||2016-03-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|tici_mira||TENS Self-applied in the Complementary Treatment of Deep Endometriosis|Transcutaneous Electrical Nerve Stimulation (TENS) Self-applied as Complementary Treatment for Pain and Its Impact on Biomechanics, Quality of Life and Sexuality of Women With Deep Endometriosis: Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|University of Campinas, Brazil||2|||f||||f||||||||No||2017-10-10 22:12:46.538166|2017-10-10 22:12:46.538166
NCT02769039|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-06-13|||October 2015||2015-10-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Predictors of Motor Progression in Parkinson's Disease|Predictors of Progression to Freezing of Gait in Parkinson's Disease|Recruiting||N/A|72|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||||Undecided||2017-10-10 22:12:46.654318|2017-10-10 22:12:46.654318
NCT02769026|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-09-05|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|||Prognostication Biomarkers in Pediatric Cardiac Arrest|Development of Serum, Imaging, and Clinical Biomarker Driven Models to Direct Clinical Management After Pediatric Cardiac Arrest|Recruiting||N/A|164|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 22:12:46.739534|2017-10-10 22:12:46.739534
NCT02769013|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-05-13|||April 2016||2016-04-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|July 2017|Anticipated|2017-07-01||Observational|TRANSMAL||Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicity|Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicity|Recruiting||N/A|395|Anticipated|University Hospital Tuebingen|||4||f||||t||||||Samples With DNA|"     Blood sample and urine collection potentially containing genetic material of Plasmodium     falciparum and Schistosoma haematobium   "|No||2017-10-10 22:12:46.812466|2017-10-10 22:12:46.812466
NCT02769000|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-03-23|||May 2016||2016-05-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's|Phase IIa Trial of Low Dose Radiation THerapy to Reduce Cerebral Amyloidosis in Early Alzheimer's Dementia|Recruiting||N/A|30|Anticipated|Virginia Commonwealth University||1|||f||||f||||||||Yes||2017-10-10 22:12:46.945253|2017-10-10 22:12:46.945253
NCT02768987|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-07-29|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|B1B||Bright 1 Bodies Weight Management Program|Bright 1 Bodies: Extending the Bright Bodies Weight Management Program to Adolescents With Type 1 Diabetes|Recruiting||N/A|50|Anticipated|Yale University||2|||f||||t||||||||Undecided||2017-10-10 22:12:47.028023|2017-10-10 22:12:47.028023
NCT02768974|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-09-26|||September 2016||2016-09-01|May 2016|2016-05-01||||February 2017|Anticipated|2017-02-01||Interventional|||Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis|An Open Label, Proof of Concept Study to Assess the Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis|Recruiting||Phase 2|20|Anticipated|Protalix||2|||f||||f||||||||Undecided||2017-10-10 22:12:47.134845|2017-10-10 22:12:47.134845
NCT02768961|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-05-17|||May 10, 2016|Actual|2016-05-10|May 2017|2017-05-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|JAILFREE-C||Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C)|Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria. JAILFREE-C|Completed||Phase 4|64|Actual|Instituto de Investigación Marqués de Valdecilla||1|||f||||f||||||||No||2017-10-10 22:12:47.256077|2017-10-10 22:12:47.256077
NCT02768948|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-11|||July 2016||2016-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?|Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?|Not yet recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||No||2017-10-10 22:12:47.365158|2017-10-10 22:12:47.365158
NCT02768935|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-10|||July 2016||2016-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Macrophage Phenotype in Type 2 Diabetics After Myocardial Infarction and the Potential Role of miRNAs Secreted|Macrophage Phenotype in Type 2 Diabetics After Myocardial Infarction and the Potential Role of miRNAs Secreted|Not yet recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||No||2017-10-10 22:12:47.448856|2017-10-10 22:12:47.448856
NCT02768922|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-09|||April 2016||2016-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|AT||Aphasia Telerehabilitation|Aphasia Telerehabilitation Early Post Stroke|Recruiting||N/A|80|Anticipated|Sunnaas Rehabilitation Hospital||2|||f||||t||||||||Yes|The project will result in a Doctor of Philosophy (PhD) -thesis based on articles in international peer-reviewed scientific journals. In addition, the results of the project will be disseminated through national and international conference contributions as well as Norwegian publications in scientific journals, journals of user organizations and media contributions.|2017-10-10 22:12:47.522779|2017-10-10 22:12:47.522779
NCT02768909|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-05-09|||January 2015||2015-01-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB|Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB|Active, not recruiting||N/A|250|Anticipated|Universidad Central de Venezuela||3|||f||||t||||||||No||2017-10-10 22:12:47.645572|2017-10-10 22:12:47.645572
NCT02768896|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-06-06|||June 2016||2016-06-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients|Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients|Not yet recruiting||N/A|100|Anticipated|Rambam Health Care Campus||4|||f||||f||||||||No||2017-10-10 22:12:47.746425|2017-10-10 22:12:47.746425
NCT02768883|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-07-12|||February 2014||2014-02-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|Respira Sano||Imperial County Asthma CER Project: Respira Sano|PCORI - The Imperial County CER Asthma Project|Active, not recruiting||N/A|400|Anticipated|San Diego State University||4|||f||||t||||||||||2017-10-10 22:12:47.989163|2017-10-10 22:12:47.989163
NCT02768857|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-12|||December 2014||2014-12-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effects of Early Sensory Reeducation Programs Using Mirror Therapy for Patients With Peripheral Nerve Injuries|A Touch-Observation and Task-based Mirror Therapy Protocol (MTPTOT) to Improve Sensorimotor Control and Functional Capability of Hands for Patients With Peripheral Nerve Injury|Completed||N/A|12|Actual|National Cheng-Kung University Hospital||2|||f||||||||||||||2017-10-10 22:12:48.222002|2017-10-10 22:12:48.222002
NCT02768844|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-20|||April 2011||2011-04-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Physiology and Therapeutic Management of Neonatal Abstinence Syndrome|Physiology and Therapeutic Management of Neonatal Abstinence Syndrome|Enrolling by invitation||N/A|40|Anticipated|University of Massachusetts, Worcester|||1||f||||f||||||||||2017-10-10 22:12:48.308849|2017-10-10 22:12:48.308849
NCT02768831|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-07-14|||May 2016||2016-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Minimal Occlusive Pressure With Cuffed ETTs: A Comparison of Two Different Techniques to Ensure a Tracheal Seal||Enrolling by invitation||N/A|100|Anticipated|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-10 22:12:48.391081|2017-10-10 22:12:48.391081
NCT02768818|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-05-09|||January 2016||2016-01-01|January 2016|2016-01-01|December 2016||2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Modulation of the Intestinal Flora With the Probiotic VIVOMIXX™ in Pregnant Women at Risk of Metabolic Complications|Modulation of the Intestinal Flora With the Probiotic VIVOMIXX™ in Pregnant Women at Risk of Metabolic Complications|Recruiting||Phase 3|205|Anticipated|University of Modena and Reggio Emilia||2|||f||||||||||||||2017-10-10 22:12:48.495558|2017-10-10 22:12:48.495558
NCT02768805|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-08-30|||March 2016||2016-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults|Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Adults 18-64 Years of Age|Active, not recruiting||Phase 2|900|Anticipated|Medicago||3|||f||||f||||||||No||2017-10-10 22:12:48.631101|2017-10-10 22:12:48.631101
NCT02768792|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-09-28|||August 22, 2016|Actual|2016-08-22|September 2017|2017-09-01|September 2025|Anticipated|2025-09-01|September 2020|Anticipated|2020-09-01||Interventional|||High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML|LCCC 1522: Phase 2 Study of High Dose Cytarabine Followed by Pembrolizumab in Relapsed and Refractory Acute Myeloid Leukemia|Recruiting||Phase 2|37|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:12:48.786586|2017-10-10 22:12:48.786586
NCT02768779|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-08-22|||April 1, 2016|Actual|2016-04-01|August 2017|2017-08-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Observational|||ARV Concentrations in Hair|IGHID 11601 - Measuring Antiretroviral Concentrations in Hair|Completed||N/A|84|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 22:12:48.915079|2017-10-10 22:12:48.915079
NCT02768766|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-12-15|||September 2016||2016-09-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Intermittent Selumetinib for Uveal Melanoma|Multi-Center Phase Ib Study of Intermittent Dosing of the MEK Inhibitor, Selumetinib, in Patients With Advanced Uveal Melanoma Not Previously Treated With a MEK Inhibitor|Recruiting||Phase 1|28|Anticipated|Columbia University||1|||f||||t||||||||No||2017-10-10 22:12:49.023691|2017-10-10 22:12:49.023691
NCT02768753|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-09|||May 2016||2016-05-01|May 2016|2016-05-01||||June 2017|Anticipated|2017-06-01||Observational|||Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic Thyroidectomy|Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic Thyroidectomy|Recruiting||Phase 1/Phase 2|60|Anticipated|Jinan Military General Hospital|||2||f||||t||||||||||2017-10-10 22:12:49.143881|2017-10-10 22:12:49.143881
NCT02768740|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2016-05-20|||April 2008||2008-04-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|May 2010|Actual|2010-05-01||Interventional|HSHC00582434||Hydrocortisone 50 mg Every 6 Hours Compared to Hydrocortisone 300 mg Per Day in Treatment of Septic Shock.|Double Blinded, Randomized Trial, Comparing Intravenous Bolus of 50 mg of Hydrocortisone Every 6 Hours for 7 Days With a Continuous Infusion of 300 mg Per Day of Hydrocortisone 300-mg Group During 5 Days in the Treatment of Septic Shock.|Completed||Phase 4|120|Actual|Association Niçoise de Réanimation Médicale||2|||f||||f||||||||Undecided|The data are available for additional analysis|2017-10-10 22:12:49.290692|2017-10-10 22:12:49.290692
NCT02768727|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-09-01|||April 2016||2016-04-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||A Test of Neural Inertia in Humans With Xenon|A Test of Neural Inertia in Humans With Xenon|Recruiting||Phase 2|12|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:12:49.423444|2017-10-10 22:12:49.423444
NCT02768714|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-14|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy|A Randomized, Assessor-blind, Parallel Group, Multicentre Phase III Trial to Compare the Efficacy and Safety of Eurofarma's Pegfilgrastim to Neulastim® in Subjects With High Risk Stage II or Stage III / IV Breast Cancer Receiving Chemotherapy.|Withdrawn||Phase 3|0|Actual|Eurofarma Laboratorios S.A.||2||Strategic changes regarding the product development|f||||t|f|f||||||||2017-10-10 22:12:49.562521|2017-10-10 22:12:49.562521
NCT02768701|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-07-31|||October 2016||2016-10-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer|Phase II Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer|Recruiting||Phase 2|36|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:12:49.684295|2017-10-10 22:12:49.684295
NCT02768688|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-05-01|||July 2014||2014-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|February 9, 2017|Actual|2017-02-09||Interventional|||MRI of Glymphatic Clearance During Anesthetic Sedation|Glymphatic Clearance During Anesthesia and Sleep: A Diffusion Tensor Imaging (DTI) Study in Humans|Active, not recruiting||Early Phase 1|25|Anticipated|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 22:12:49.84636|2017-10-10 22:12:49.84636
NCT02768493|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-09-07|||May 2016||2016-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Ultrasonographic Assessment of Optic Nerve Sheath Diameter in Children Receiving Caudal Block||Completed||N/A|80|Actual|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:12:51.561764|2017-10-10 22:12:51.561764
NCT02768675|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-08-18|||May 2016||2016-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|LOADPRO||Intra-operative Assessment of the Intellirod LOADPRO Spinal Rod Strain Sensor for Use During Kyphotic Corrective Surgery|Intra-Operative Assessment of the Intellirod LOADPRO Disposable Spinal Rod Strain Sensor for Use During Kyphotic Corrective Surgery|Recruiting||N/A|12|Anticipated|Intellirod Spine||1|||f||||f||||||||||2017-10-10 22:12:49.961104|2017-10-10 22:12:49.961104
NCT02768662|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-14|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A 6-Month Extension Study of OTO-104 in Meniere's Disease|A 6-Month, Multicenter, Phase 3, Open-Label Extension Safety Study of OTO-104 Given At 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease|Terminated||Phase 3|141|Actual|Otonomy, Inc.||1||Negative Efficacy Results from the recently completed Phase 3 study 104-201506|f||||f||||||||||2017-10-10 22:12:50.089212|2017-10-10 22:12:50.089212
NCT02768649|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-09|||April 2011||2011-04-01|May 2016|2016-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Single Ascending Dose Study of RBP-7000|A Phase I, Open Label, Single Center, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetic Profile of RBP-7000 at Low, Medium, and High Doses|Completed||Phase 1|45|Actual|Indivior Inc.||3|||f||||f||||||||||2017-10-10 22:12:50.173595|2017-10-10 22:12:50.173595
NCT02768636|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-10-31|||April 2016||2016-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|HRV||Can Omega-3 Improve Heart Rate Variability Measurement?|Can Omega-3 Improve Heart Rate Variability Measurement?|Completed||Phase 4|100|Actual|Vachira Phuket Hospital||1|||f||||f||||||||No||2017-10-10 22:12:50.284219|2017-10-10 22:12:50.284219
NCT02768623|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-09-26|||May 27, 2016|Actual|2016-05-27|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of a Community Pharmacist Managed Asthma Consultation Service|Evaluation of a Community Pharmacist Managed Asthma Consultation Service|Active, not recruiting||N/A|105|Anticipated|Ryerson University||2|||f||||f||||||||||2017-10-10 22:12:50.368558|2017-10-10 22:12:50.368558
NCT02768610|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-09|||March 2016||2016-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Use of Preanesthetic Dexmedetomidine in Elderly, Treated-hypertensive Patients|Effects of Preanesthetic Dexmedetomidine on Hemodynamic Responses to Endotracheal Intubation in Elderly Patients Being Treated for Hypertension: A Randomized Trial|Completed||Phase 4|2|Actual|DongGuk University||2|||f||||||||||||||2017-10-10 22:12:50.46021|2017-10-10 22:12:50.46021
NCT02768597|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-18|||April 2016||2016-04-01|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||Comparing The Outcome of Large-Diameter vs Small-Diameter Glenospheres in Primary Reverse Shoulder Arthroplasty|A Prospective, Randomized Study Comparing The Outcome of Large-Diameter vs Small-Diameter Glenospheres in Primary Reverse Shoulder Arthroplasty Using the ReUnion System|Recruiting||N/A|220|Anticipated|Mayo Clinic||4|||f||||t||||||||||2017-10-10 22:12:50.536555|2017-10-10 22:12:50.536555
NCT02768571|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-05-10|||January 2016||2016-01-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke|Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Patients With Severe Motor Involvement at Subacute Phase of Stroke|Recruiting||Phase 4|80|Anticipated|Samsung Medical Center||2|||f||||t||||||||No||2017-10-10 22:12:50.729943|2017-10-10 22:12:50.729943
NCT02768558|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-10-05|||October 2016||2016-10-01|October 2017|2017-10-01|October 2024|Anticipated|2024-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC|Randomized, Double Blinded Phase III Trial of Cisplatin and Etoposide Plus Thoracic Radiation Therapy Followed By Nivolumab/Placebo For Locally Advanced Non-Small Cell Lung Cancer|Recruiting||Phase 3|660|Anticipated|RTOG Foundation, Inc.||2|||f||||t||||||||||2017-10-10 22:12:50.838401|2017-10-10 22:12:50.838401
NCT02768545|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-10|||June 2013||2013-06-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|May 2016|Actual|2016-05-01||Interventional|EZE-2||Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)|Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)|Recruiting||Phase 4|12|Anticipated|Pontificia Universidad Catolica de Chile||1|||f||||f||||||||No||2017-10-10 22:12:51.146233|2017-10-10 22:12:51.146233
NCT02768532|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-21|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|VEDO-PREDIRESP||Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease|VEDO-PREDIRESP Project: Value of Pharmacokinetic Assays (Vedolizumab and Anti-vedolizumab Antibody) in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease|Recruiting||Phase 4|93|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 22:12:51.254248|2017-10-10 22:12:51.254248
NCT02768519|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-05-31|||January 2016||2016-01-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study to Evaluate Systemic Bioavailability of Oral OTS167 in Healthy Adult Subjects|A Phase 1, Randomised, Placebo-controlled, Double-blind, Cross-over Study to Evaluate Systemic Bioavailability of Oral OTS167 Under Fed and Fasting Conditions in Healthy Adult Subjects|Completed||Phase 1|11|Actual|OncoTherapy Science, Inc.||2|||f||||||||||||Undecided||2017-10-10 22:12:51.40304|2017-10-10 22:12:51.40304
NCT02768506|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-08|||September 2009||2009-09-01|May 2016|2016-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|SADI-S-GB||Prospective Comparison Between SADI-S and Gastric Bypass|Non-randomized Prospective Comparison Between SADI-S and Gastric Bypass for the Treatment of Morbid Obesity and Its Associated Co-morbidities|Completed||N/A|50|Actual|Hospital San Carlos, Madrid|||2||f||||f||||||Samples With DNA|"     Liver biopsy   "|||2017-10-10 22:12:51.488841|2017-10-10 22:12:51.488841
NCT02768480|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-28|||June 2015||2015-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of Phone Calls Intervention on Diabetic Patients After Ambulatory Discharge of a Tertiary Care Center|Evaluation of the Effectiveness of Phone Calls Intervention (TelessaúdeRS) on Diabetic Patients After Ambulatory Discharge of a Tertiary Care Center: A Randomized Clinical Trial|Active, not recruiting||N/A|150|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:12:51.652913|2017-10-10 22:12:51.652913
NCT02768467|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-12-16|||May 2016||2016-05-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Buccal Mucosa Healing Trial With Tissue Matrix Placement|A Prospective Randomized Controlled Trial of Buccal Mucosa Donor Site Healing With Tissue Matrix Placement|Recruiting||Phase 3|50|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:12:51.753727|2017-10-10 22:12:51.753727
NCT02768454|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-05-11|||September 2015||2015-09-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Antimicrobials Stewardship by Pharmacist|Appropriate Use of Controlled Broad-spectrum Antimicrobials by Establish Stewardship and Execute by Antibiotic Pharmacist|Active, not recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:12:51.850475|2017-10-10 22:12:51.850475
NCT02768441|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-06-01|||November 1, 2016|Actual|2016-11-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots|Pharmacokinetics of New Dexamphetamine Sustained Release Tablets and the Clinical Validation of Measuring Dexamphetamine in Dried Blood Spots|Completed||Early Phase 1|12|Actual|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-10 22:12:51.93794|2017-10-10 22:12:51.93794
NCT02768428|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness of Knowledge by Video and Handbook of Liver Cancer Patients With First Trans-arterial Chemoembolization|Effectiveness of Knowledge by Video and Handbook to Measure Knowledge of Liver Cancer Patients With First Trans-arterial Chemoembolization (TACE)|Recruiting||N/A|80|Anticipated|Chulabhorn Hospital||2|||f||||t||||||||Yes||2017-10-10 22:12:52.024941|2017-10-10 22:12:52.024941
NCT02768415|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-04-15|||June 2016||2016-06-01|April 2017|2017-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer|Phase II Study of Apatinib Combined With Oral Vinorelbine in Pretreated Metastatic HER2 Negative Breast Cancer|Recruiting||Phase 2|40|Anticipated|Chinese Academy of Medical Sciences||1|||f||||||||||||||2017-10-10 22:12:52.135087|2017-10-10 22:12:52.135087
NCT02768402|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-11-15|||June 2016||2016-06-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|PRELUDE||Caisson Transcatheter Mitral Valve Replacement (TMVR) System Early Feasibility Study|Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)|Recruiting||Phase 1|20|Anticipated|Caisson Interventional LLC||1|||f||||f||||||||Undecided||2017-10-10 22:12:52.23644|2017-10-10 22:12:52.23644
NCT02768389|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-06-09|||September 6, 2016|Actual|2016-09-06|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma|A Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma|Recruiting||Early Phase 1|15|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 22:12:52.340769|2017-10-10 22:12:52.340769
NCT02768376|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-07-16|||March 2016||2016-03-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|Sp-Lap||Spinal for Laparoscopic Cholecystectomy||Recruiting||N/A|60|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:12:52.443167|2017-10-10 22:12:52.443167
NCT02768363|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-10-04|||May 2016||2016-05-01|October 2017|2017-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)|A Randomized Controlled Trial Of AdV-tk + Valacyclovir Administered During Active Surveillance For Newly Diagnosed Prostate Cancer|Recruiting||Phase 2/Phase 3|156|Anticipated|Advantagene, Inc.||2|||f||||f||||||||||2017-10-10 22:12:52.534879|2017-10-10 22:12:52.534879
NCT02768350|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-06-02|||May 2016||2016-05-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Ventilatory Responses to VHI in Atelectasis Patients|Efficacy and Ventilatory Responsiveness of Ventilator Hyperinflation Technique to Re-expand Lung Atelectasis and Improved Airway Clearance on Patients With Critical Trauma Who Are Intubated and Mechanically Ventilated|Recruiting||N/A|36|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-10-10 22:12:52.722318|2017-10-10 22:12:52.722318
NCT02768337|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-02-21|||February 2015||2015-02-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|CamBMT1||Cambridge Brain Mets Trial 1|Cambridge Brain Mets Trial 1: A Proof-of-principle Phase 1b/Randomised Phase 2 Study of Afatinib Penetration Into Cerebral Metastases for Patients Undergoing Neurosurgical Resection, Both With and Without Prior Low-dose, Targeted Radiotherapy|Recruiting||Phase 1/Phase 2|70|Anticipated|Cambridge University Hospitals NHS Foundation Trust||3|||f||||t||||||||||2017-10-10 22:12:52.816965|2017-10-10 22:12:52.816965
NCT02768324|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-03-07|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|September 1, 2019|Anticipated|2019-09-01|December 1, 2018|Anticipated|2018-12-01||Observational|||the Effect of Gut Microbiota on the Prognosis of Sepsis|the Effect of Gut Microbiota on the Prognosis of Sepsis|Not yet recruiting||N/A|30|Anticipated|Jinan University Guangzhou|||2||f||||||||||||||2017-10-10 22:12:52.926337|2017-10-10 22:12:52.926337
NCT02768311|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-10|||May 2016||2016-05-01|April 2016|2016-04-01||||May 2017|Anticipated|2017-05-01||Interventional|||Comparative Evaluation of Post Endodontic Pain Following Root Canal Treatment With Two Rotary System: Neolix & Waveone|Comparative Evaluation of Post Endodontic Pain Following Root Canal Treatment With Two Rotary System: Neolix & Waveone|Active, not recruiting||N/A|150|Anticipated|Zahedan University of Medical Sciences||3|||f||||t||||||||Yes||2017-10-10 22:12:52.99179|2017-10-10 22:12:52.99179
NCT02768298|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-07-08|||July 12, 2016|Actual|2016-07-12|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.|A Randomized, Double-blind, Active-controlled Study to Assess the Effect of LCZ696 Compared With Enalapril to Improve Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF).|Recruiting||Phase 4|200|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 22:12:53.070283|2017-10-10 22:12:53.070283
NCT02768285|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-08-09|||January 1, 2016|Actual|2016-01-01|January 2016|2016-01-01|August 7, 2017|Actual|2017-08-07|July 17, 2017|Actual|2017-07-17||Interventional|||Apical Patency and Postoperative Pain.|Influence of Maintaining Apical Patency on Postoperative Pain in Posterior Teeth With Necrotic Pulp and Apical Periodontitis: A Randomized Controlled Trial.|Completed||Phase 1|320|Actual|Isparta Military Hospital||2|||f||||f||||||||||2017-10-10 22:12:53.238098|2017-10-10 22:12:53.238098
NCT02768272|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-08-09|||March 1, 2016|Actual|2016-03-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|PIEB-CT||PIEB vs PCEA With Epidural or CSE Technique. A Randomized Double Blind Clinical Trial|A Randomized Double Blind Clinical Trial Comparing Programed Intermittent Epidural Boluses (PIEB) Versus Patient Controlled Epidural Analgesia (PCEA) With Epidural or Combined Spinal-epidural (CSE) Technique|Completed||Phase 4|240|Actual|Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-10 22:12:53.338935|2017-10-10 22:12:53.338935
NCT02768259|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-07-11|||June 2016||2016-06-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01|1 Year|Observational [Patient Registry]|||Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients|Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue in Egyptian Patients ( Single Center Study)|Recruiting||N/A|100|Anticipated|Cairo University|||1||f||||f||||||||Undecided||2017-10-10 22:12:53.425877|2017-10-10 22:12:53.425877
NCT02768246|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-02-28|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|BVGA01||Comparison of Bag-Valve-Guedel Adaptor to Common Face Mask for the Ventilation of Bearded Men|Comparison of the Efficacy of a Bag-Valve-Guedel Adaptor to the Commonly Used Face Mask in Healthy Bearded Volunteers|Completed||N/A|25|Actual|Hebrew University of Jerusalem||2|||f||||f||||||||No||2017-10-10 22:12:53.514874|2017-10-10 22:12:53.514874
NCT02768233|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-02-24|||October 2015||2015-10-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment|Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment|Enrolling by invitation||N/A|124|Anticipated|Hospital of South West Denmark||2|||f||||t||||||||No||2017-10-10 22:12:53.625825|2017-10-10 22:12:53.625825
NCT02768220|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-05-15|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products|The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products|Not yet recruiting||Phase 4|30|Anticipated|Northwell Health||2|||f||||f|f|f|||f|||No||2017-10-10 22:12:53.712304|2017-10-10 22:12:53.712304
NCT02768207|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-27|||May 23, 2016|Actual|2016-05-23|September 2017|2017-09-01|July 28, 2021|Anticipated|2021-07-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma|A Single Arm, Open Label, Phase II, Multicenter Study to Assess The Detection of The BRAF V600 Mutation on cfDNA From Plasma in Patients With Advanced Melanoma|Recruiting||Phase 2|52|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:12:53.789484|2017-10-10 22:12:53.789484
NCT02768181|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-12-11|||November 2015||2015-11-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluate Bundling of Nutrition Interventions|A Community-based Cluster Randomized Controlled Trial to Evaluate the Effectiveness of Different Bundles of Nutrition-specific Interventions in Improving Mean Length-for-age Z Score Among Children at 24 Months of Age in Rural Bangladesh|Enrolling by invitation||N/A|2550|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||5|||f||||f||||||||||2017-10-10 22:12:53.994032|2017-10-10 22:12:53.994032
NCT02768155|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-01-27|||April 2016||2016-04-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Evaluation of Amniotic Fluid Product in Knee Osteoarthritis|Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis|Active, not recruiting||N/A|60|Actual|MiMedx Group, Inc.||3|||f||||t||||||||No||2017-10-10 22:12:54.185669|2017-10-10 22:12:54.185669
NCT02768142|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2017-08-13|||August 2016||2016-08-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||"The Impact of Natural Cesarean Delivery on Peripartum Maternal Blood Loss."|"The Impact of Natural Cesarean Delivery on Peripartum Maternal Blood Loss. A Randomized Controlled Trial."|Recruiting||N/A|214|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-10 22:12:54.26927|2017-10-10 22:12:54.26927
NCT02768129|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-12-14|||November 2014||2014-11-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Interventional|||Transcranial Direct Current Stimulation for Chronic Low Back Pain|tDCS for Chronic Low Back Pain: A Study Examining the Effect of Transcranial Direct Current Stimulation on the Emotional Response to Chronic Low Back Pain|Active, not recruiting||N/A|60|Anticipated|Butler Hospital||2|||f||||||||||||||2017-10-10 22:12:54.473381|2017-10-10 22:12:54.473381
NCT02768116|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-10|||June 2016||2016-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Study of Active Transfer of Plaque Technique for Non-Left Main Coronary Bifurcation Lesions|A Prospective Multicenter Randomized Trial Comparing Active Transfer of Plaque vs. Provisional T Stenting for the Treatment of Non-Left-Main Coronary Bifurcation Lesions|Not yet recruiting||N/A|316|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||||2017-10-10 22:12:54.541054|2017-10-10 22:12:54.541054
NCT02768090|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Proteomic Analysis of Sweat in Cutaneous Conditions|Proteomic Analysis of Sweat in Cutaneous Inflammatory and Neoplastic Conditions|Recruiting||N/A|20|Anticipated|Larkin Community Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:12:54.72208|2017-10-10 22:12:54.72208
NCT02768077|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-05-16|||January 2016||2016-01-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease|Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease: Double Blind, Randomized, Placebo Controlled Trial|Enrolling by invitation||Phase 4|100|Anticipated|Kuhnil Pharmaceutical Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 22:12:54.80393|2017-10-10 22:12:54.80393
NCT02768064|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-05-10|||June 2016||2016-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|PAMIT||Temporary Pacemaker in Transcatheter Aortic Valve Implantation Patients|Temporary Pacemaker in Transcatheter Aortic Valve Implantation Patients|Not yet recruiting||N/A|120|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||No||2017-10-10 22:12:54.907237|2017-10-10 22:12:54.907237
NCT02768051|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluation of the Safety, Feasibility and Usability of the EPD D700 System in Atrial Flutter Ablation Procedures|EP Dynamics (EPD) Research First In Man Clinical Study|Not yet recruiting||N/A|10|Anticipated|EP Dynamics Research Ltd||1|||f||||f||||||||Undecided||2017-10-10 22:12:54.996348|2017-10-10 22:12:54.996348
NCT02768038|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Intestinal Microbiome and Chronic Inflammatory Bowel Disease|The Role of Intestinal Microbiome ih the Pathogenesis and Course of Chronic Inflammatory Bowel Diseases|Not yet recruiting||N/A|120|Anticipated|Turku University Hospital|||1||f||||f||||||Samples Without DNA|"     Blood nad stool specimens. Biopsy specimens from large intestine ja ileum.   "|No||2017-10-10 22:12:55.080243|2017-10-10 22:12:55.080243
NCT02768025|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-02-26|||July 2016||2016-07-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Trial of Treatment Protocol for Smoking Cessation|Trial of Treatment Protocol for Smoking Cessation: A Pragmatic Randomized Controlled Pilot Study|Recruiting||N/A|40|Anticipated|Daejeon University||2|||f||||t||||||||No|This is confidential.|2017-10-10 22:12:55.150163|2017-10-10 22:12:55.150163
NCT02768012|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-10|||July 2016||2016-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|MASS||Mindfulness for Antidepressant-induced Sexual Symptoms||Not yet recruiting||N/A|30|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:12:55.253972|2017-10-10 22:12:55.253972
NCT02767999|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-25|||January 2016||2016-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|RECONISE||Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke|Resting State MRI Connectivity in Acute Ischemic Stroke: Serotonin Selective Reuptake Inhibitor (SSRI) in Enhancing Motor Recovery: a Placebo Controlled Study|Recruiting||Phase 4|60|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:12:55.318043|2017-10-10 22:12:55.318043
NCT02767986|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-10|2017-06-30|||May 4, 2016||2016-05-04|February 23, 2017|2017-02-23|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Observational|||Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance|Where Culture Meets Genetics: Exploring Latinas' Causal Attributions of Breast and Colon Cancer and Mental Models of Disease Inheritance|Completed||N/A|22|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:12:55.428872|2017-10-10 22:12:55.428872
NCT02767973|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-01-11|||May 2016||2016-05-01|December 2016|2016-12-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|SmokeScreen||To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Factors in This Susceptibility|To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Factors in This Susceptibility|Recruiting||Early Phase 1|80|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||No||2017-10-10 22:12:55.499251|2017-10-10 22:12:55.499251
NCT02767960|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-07-29|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|January 2017|Actual|2017-01-01|12 Months|Observational [Patient Registry]|||Serum Tenascin-C Concentration in Patients With Acute Coronary Syndrome|Change of Serum Tenascin-C Concentration and the Relationship With Hs-CRP，cTnI and Prognosis in Patients With Acute Coronary Syndrome|Completed||N/A|183|Actual|The First Affiliated Hospital of Dalian Medical University|||4||f||||t||||||||||2017-10-10 22:12:55.582386|2017-10-10 22:12:55.582386
NCT02767947|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-04-26|||February 8, 2016|Actual|2016-02-08|April 2017|2017-04-01|September 22, 2016|Actual|2016-09-22|June 29, 2016|Actual|2016-06-29||Interventional|||Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis|A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis|Completed||Phase 4|75|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 22:12:55.665963|2017-10-10 22:12:55.665963
NCT02767934|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-19|||January 2017||2017-01-01|May 2017|2017-05-01||||January 2019|Anticipated|2019-01-01||Interventional|||Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia|A Phase II Study of Anti-PD-1 Antibody (MK-3475; Pembrolizumab) for the Treatment of Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia|Recruiting||Phase 2|21|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 22:12:55.764718|2017-10-10 22:12:55.764718
NCT02767921|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-06-02|||August 2, 2016|Actual|2016-08-02|June 2017|2017-06-01|August 2, 2019|Anticipated|2019-08-02|August 2, 2018|Anticipated|2018-08-02||Interventional|||sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer|A Pilot Study of Neoadjuvant sEphB4-HSA in Patients With Genitourinary Cancers|Recruiting||Phase 1|30|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 22:12:55.916476|2017-10-10 22:12:55.916476
NCT02767908|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-08-11|||June 28, 2016|Actual|2016-06-28|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|October 30, 2017|Anticipated|2017-10-30||Interventional|HTH||Hospital to Home, Smoker Support Trial|Randomised Controlled Trial to Test the Effectiveness of an Intensive Home Support Intervention for Newly Abstinent Smokers Leaving Hospital|Active, not recruiting||N/A|404|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-10 22:12:56.037128|2017-10-10 22:12:56.037128
NCT02767895|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-08-01|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prehabilitation for PAD Revascularization Patients|A Pilot Trial of Prehabilitation Among Patients Undergoing PAD Revascularization|Recruiting||N/A|40|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 22:12:56.119672|2017-10-10 22:12:56.119672
NCT02767882|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-20|||May 2016||2016-05-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Dexamethasone in Pain Control After Total Knee Replacement|Effects of Preoperative Dexamethasone in Post-operative Pain Control After Total Knee Replacement|Recruiting||Phase 4|135|Anticipated|The University of Hong Kong||3|||f||||t||||||||No||2017-10-10 22:12:56.209899|2017-10-10 22:12:56.209899
NCT02767869|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-02|||January 2015||2015-01-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity|Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity|Completed||Phase 2|24|Anticipated|University of Guadalajara||2|||f||||f||||||||||2017-10-10 22:12:56.306135|2017-10-10 22:12:56.306135
NCT02767856|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-10-12|||May 2016||2016-05-01|October 2016|2016-10-01||||May 2018|Anticipated|2018-05-01||Interventional|||Regimens of Intermittent Occlusion Therapy for Amblyopia in Children|Intense vs Standard Regimens of Intermittent Occlusion Therapy for Unilateral Moderate Amblyopia in Children|Recruiting||N/A|56|Anticipated|Salus University||2|||f||||f||||||||No||2017-10-10 22:12:56.439099|2017-10-10 22:12:56.439099
NCT02767843|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-03-20|2017-01-09||May 2016||2016-05-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional||all subjects who underwent cNEP usage|Pilot Study of cNEP for the Treatment of Snoring|Pilot Study to Assess the Effectiveness and Safety of Continuous Negative External Pressure (cNEP) in Reducing Respiratory Sounds in Individuals With Chronic Snoring|Terminated||N/A|4|Actual|Sommetrics, Inc.|Early termination due to difficulty of recruitment. Technical problems with measurements, so data were uninterpretable.|1||Recruiting sufficient number of qualified subjects proved impossible.|f||||f||||||||Undecided||2017-10-10 22:12:56.519078|2017-10-10 22:12:56.519078
NCT02767830|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-08|2016-05-08|||September 2016||2016-09-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Cleveland Kids Run|Adherence to a Running and Nutrition Program in Children Aged 8-12 Years: A Pilot Study|Not yet recruiting||N/A|30|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||||||||||||2017-10-10 22:12:56.782803|2017-10-10 22:12:56.782803
NCT02767817|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-09|||March 2016||2016-03-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Injectable Collagen Scaffold™ Combined With MSCs Transplantation for Brain Injury|The Safety and Efficacy Assessment of Injectable Collagen Scaffold™ Combined With Mesenchymal Stem Cells Transplantation in Patients With Brain Injury|Recruiting||Phase 1|30|Anticipated|Chinese Academy of Sciences||3|||f||||t||||||||||2017-10-10 22:12:56.866934|2017-10-10 22:12:56.866934
NCT02767804|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2017-05-19|||June 2016||2016-06-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients|Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients|Recruiting||Phase 3|402|Anticipated|Xcovery Holding Company, LLC||2|||f||||t||||||||||2017-10-10 22:12:57.009925|2017-10-10 22:12:57.009925
NCT02767791|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-11-02|||April 2016||2016-04-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|NVCI||Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)|Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)|Recruiting||N/A|144|Anticipated|Hopital Foch||4|||f||||f||||||||No||2017-10-10 22:12:57.517958|2017-10-10 22:12:57.517958
NCT02767778|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-09-16|||April 2016||2016-04-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|I-NIC||Low-frequency Pulsed Electromagnetic Fields (ELF-MF) as Treatment for Acute Ischemic Stroke|A Multicentric, Prospective, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Effectiveness of Low-frequency Pulsed Electromagnetic Fields (ELF-MF) in Acute Ischemic Stroke|Recruiting||N/A|124|Anticipated|Campus Bio-Medico University||2|||f||||t||||||||Undecided||2017-10-10 22:12:57.625753|2017-10-10 22:12:57.625753
NCT02767765|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-02-16|2017-02-16||June 2003||2003-06-01|February 2017|2017-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional||The safety population included all enrolled participants who received at least one dose of study medication.|A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy|Pilot Study for Evaluating the Efficacy and Tolerability of Induction Therapy With Recombinant Human Erythropoietin Beta (rHuEPO) NeoRecormon® - at High Dose in Anemic Cancer Patients Treated With Chemotherapy|Completed||Phase 3|61|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:12:57.729325|2017-10-10 22:12:57.729325
NCT02767752|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-11-10|||November 2016||2016-11-01|November 2016|2016-11-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|CHIPAC||Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer|A Single Center, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Gemcitabine (GEM) and Capecitabine (CAP) With or Without T-ChOS as Adjuvant Therapy in Patients With Surgically Resected Pancreatic Cancer.|Recruiting||Phase 2|180|Anticipated|Herlev Hospital||2|||f||||t||||||||Yes||2017-10-10 22:12:57.991228|2017-10-10 22:12:57.991228
NCT02767739|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-05|||September 2011||2011-09-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Physical Activity on Cardiovascular Risk and Quality of Life|A Randomized Community Trial of Physical Activity Intervention in Primary Healthcare to Improve Cardiovascular Risk Factors and Health-Related Quality of Life in Older Adults|Completed||N/A|419|Actual|University Rovira i Virgili||2|||f||||f||||||||No||2017-10-10 22:12:58.089952|2017-10-10 22:12:58.089952
NCT02767726|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-07-28|||January 2016||2016-01-01|July 2017|2017-07-01||||January 2019|Anticipated|2019-01-01||Interventional|||A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study|A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study|Terminated||N/A|4|Actual|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:12:58.156253|2017-10-10 22:12:58.156253
NCT02767713|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-07|||March 2015||2015-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Interventional|CDCS||Cognitive Dysfunction Following Cardiac Surgery|The Role of Inflammatory and Stress Response in the Pathogenesis of Cognitive Dysfunction After Cardiac Surgery|Active, not recruiting||Phase 4|171|Actual|Clinical Hospital Center, Split||2|||f||||t||||||||No||2017-10-10 22:12:58.222339|2017-10-10 22:12:58.222339
NCT02767700|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-08-24|||April 2016||2016-04-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|PePaCaKa-01||NGS and TME for Evidence-based Treatment of Pancreatic Cancer|Evaluation of NGS in Combination With an Oncology Treatment Decision Support Software for Evidence-based Priorization of Individualised Treatment in Patients With Pancreatic Cancer|Enrolling by invitation||N/A|100|Anticipated|Karolinska University Hospital|||1||f||||t||||||Samples With DNA|"     The study will make use of routinely taken samples (surgical resection, biopsy)   "|||2017-10-10 22:12:58.323692|2017-10-10 22:12:58.323692
NCT02767687|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-05-07|||September 2013||2013-09-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Influence of Non Invasive Mechanical Ventilation on Tissue Perfusion in Patients After Cardiac Surgery|Influence of Non Invasive Mechanical Ventilation on Tissue Perfusion in Patients After Cardiac Surgery|Completed||N/A|80|Actual|Federal University of São Paulo||1|||f||||f||||||||No|No participant data will be made available, however every subject was provided the investigator's e-mail address as well a phone number and was encouraged to call or send an e-mail in case of doubt or to receive information regarding the research.|2017-10-10 22:12:58.38549|2017-10-10 22:12:58.38549
NCT02767674|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-05-07|||May 2016||2016-05-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma|Phase III,Randomized Controlled Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma|Recruiting||Phase 3|614|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||Yes||2017-10-10 22:12:58.463844|2017-10-10 22:12:58.463844
NCT02767661|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2017-06-01|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|May 2023|Anticipated|2023-05-01|May 2021|Anticipated|2021-05-01||Interventional|MECCA||Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer|A Phase 3 Randomized Controlled Study of Metronomic Capecitabine Combined With Aromatase Inhibitor Versus Aromatase Inhibitor Alone for First Line Treatment in Hormone Receptor-positive, Her2-negative Metastatic Breast Cancer|Not yet recruiting||Phase 3|240|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||Undecided||2017-10-10 22:12:58.792943|2017-10-10 22:12:58.792943
NCT02767648|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-05-09|||May 2010||2010-05-01|May 2016|2016-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|CHOLESTASE||Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest Region|Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest Region|Terminated||N/A|57|Actual|University Hospital, Toulouse|||1|recruitment difficulties|f||||f||||||Samples With DNA|"     proteomic urine analysis   "|||2017-10-10 22:12:58.915542|2017-10-10 22:12:58.915542
NCT02767635|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-09|||January 2012||2012-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison Between Steroid and Different Sites of Botulinum Toxin Injection in the Treatment of Lateral Epicondylalgia|Comparison Between Steroid and Two Different Sites of Botulinum Toxin Injection in the Treatment of Lateral Epicondylalgia: A Randomized Double-blind Active Drug-controlled Pilot Study|Recruiting||Phase 3|90|Anticipated|National Cheng-Kung University Hospital||3|||f||||f||||||||No||2017-10-10 22:12:59.031996|2017-10-10 22:12:59.031996
NCT02767622|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-07|2016-05-09|||June 2014||2014-06-01|May 2016|2016-05-01||||April 2015|Actual|2015-04-01||Observational|||Reversibility of Minimal Hepatic Encephalopathy Following Liver Transplantation||Completed||N/A|40|Actual|Ain Shams University|||2||f||||||||||||||2017-10-10 22:12:59.155895|2017-10-10 22:12:59.155895
NCT02767609|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-06-13|||May 2014||2014-05-01|June 2017|2017-06-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging|Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging|Completed||N/A|1|Actual|Loma Linda University||1|||f||||f||||||||No||2017-10-10 22:12:59.239882|2017-10-10 22:12:59.239882
NCT02767596|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-04-06|||July 12, 2016|Actual|2016-07-12|April 2017|2017-04-01|February 21, 2017|Actual|2017-02-21|February 2017|Actual|2017-02-01||Interventional|||Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog|A Pilot Single-Arm Open-Label Study to Evaluate the Efficacy of Treatment With Lixisenatide in Diabetes Mellitus Type 2 Patients With Failure of Other GLP-1 Analog|Terminated||Phase 4|2|Actual|Laniado Hospital||1||Insufficient recruitment rate|f||||f||||||||No||2017-10-10 22:12:59.320959|2017-10-10 22:12:59.320959
NCT02767583|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-02-19|||March 2, 2015|Actual|2015-03-02|May 2016|2016-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|NEUROBISITE||Assessment of the Prevalence of Small Fiber Peripheral Neuropathy Among Non-diabetic Obese Patients|Assessment of the Prevalence of Small Fiber Peripheral Neuropathy Among Non-diabetic Obese Patients|Recruiting||N/A|100|Anticipated|Groupe Hospitalier Paris Saint Joseph||1|||f||||f||||||||||2017-10-10 22:12:59.413894|2017-10-10 22:12:59.413894
NCT02767570|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-05-11|||November 1, 2016|Actual|2016-11-01|May 2017|2017-05-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||Long-Term Effectiveness of Walking Training in Patients With Knee Osteoarthritis|Personalized Gait Training With Feedback to Reduce Knee Pain From Osteoarthritis|Recruiting||N/A|104|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-10 22:12:59.522174|2017-10-10 22:12:59.522174
NCT02767557|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-01-27|||January 26, 2017|Actual|2017-01-26|January 2017|2017-01-01|January 26, 2020|Anticipated|2020-01-26|January 26, 2019|Anticipated|2019-01-26||Interventional|PACTO||Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients|A Single Center, Randomized, Phase II Study of the Combination of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab, an IL-6R Inhibitor, as First-line Treatment in Patients With Locally Advanced or Metastatic Pancreatic Cancer.|Recruiting||Phase 2|140|Anticipated|Herlev Hospital||2|||f||||t|f|f||||||Yes||2017-10-10 22:12:59.647057|2017-10-10 22:12:59.647057
NCT02766972|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-05|||July 2013||2013-07-01|May 2016|2016-05-01||||December 2020|Anticipated|2020-12-01||Interventional|||Rapid Ventricular Pacing in Surgical Treatment of Intracranial Aneurysms|Rapid Ventricular Pacing in Surgical Treatment of Intracranial Aneurysms|Recruiting||N/A|100|Anticipated|University Clinic Frankfurt||1|||f||||f||||||||||2017-10-10 22:13:07.814325|2017-10-10 22:13:07.814325
NCT02767544|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-09|||November 2014||2014-11-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Vaginal Wound Infiltration Analgesia for Postoperative Pain After Laparoscopic Hysterectomy: a Randomized Trial|Vaginal Wound Infiltration Analgesia for Postoperative Pain After Laparoscopic Hysterectomy: a Randomized Trial|Active, not recruiting||N/A|81|Actual|Helsinki University Central Hospital||2|||f||||f||||||||No||2017-10-10 22:12:59.776043|2017-10-10 22:12:59.776043
NCT02767531|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-06-16|||December 2015||2015-12-01|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|T1HLP||Orlistat for the Treatment of Type I Hyperlipoproteinemia|Orlistat for the Treatment of Type I Hyperlipoproteinemia|Recruiting||Phase 2|20|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 22:12:59.891165|2017-10-10 22:12:59.891165
NCT02767518|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-08-01|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PREPARE||Prehabilitation for Aortic Repair Patients|Does Prehabilitation Prior to Thoracic Aortic Repair Improve Quality of Care?|Recruiting||N/A|100|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 22:13:00.038486|2017-10-10 22:13:00.038486
NCT02767505|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-07-04|||September 2015||2015-09-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|BEST||Bypass Equipoise Sleeve Trial (BEST)|Bypass Equipoise Sleeve Trial, Gastric Bypass or Sleeve Gastrectomy: A Randomized Controlled National Multicenter Study (BEST)|Recruiting||N/A|4000|Anticipated|Göteborg University||2|||f||||t||||||||||2017-10-10 22:13:00.18258|2017-10-10 22:13:00.18258
NCT02767492|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Steroid Injection vs. BioDRestore for Patients With Knee OA|A Double-blind, Randomized Study Comparing Steroid Injection and BioDRestore for Patients With Knee Osteoarthritis|Recruiting||N/A|84|Anticipated|The Hawkins Foundation||2|||f||||f||||||||No||2017-10-10 22:13:00.378497|2017-10-10 22:13:00.378497
NCT02767479|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-06-20|||July 2012||2012-07-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori|Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori (CREATION Study)|Completed||Phase 3|200|Actual|Hamamatsu University||2|||f||||f||||||||||2017-10-10 22:13:00.486089|2017-10-10 22:13:00.486089
NCT02767466|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-09|||December 2012||2012-12-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Affective Responses in Neurological Rehabilitation|A Preliminary Study on Acute Affective Responses Focussing on Differences Between Physical Therapy and Robotic Assisted Gait Training|Completed||N/A|16|Actual|Universitaet Innsbruck|||1||f||||||||||||||2017-10-10 22:13:00.580188|2017-10-10 22:13:00.580188
NCT02767453|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-06|||January 2015||2015-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Closed Suction Drainage in Shoulder Arthroplasty|The Utility of Closed Suction Drainage in Total Shoulder Arthroplasty: A Prospective Analysis.|Recruiting||N/A|100|Anticipated|Columbia University||2|||f||||f||||||||No||2017-10-10 22:13:00.667454|2017-10-10 22:13:00.667454
NCT02767440|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-10-02|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|June 29, 2017|Actual|2017-06-29|June 2017|Actual|2017-06-01||Interventional|||Families on Track: A Digital Health Behavioral Intervention for Parents Seeking Treatment for Their Child With Obesity|Families on Track: A Digital Health Behavioral Intervention for Parents Seeking Treatment for Their Child With Obesity|Completed||N/A|50|Actual|Duke University||1|||f||||t||||||||||2017-10-10 22:13:00.787847|2017-10-10 22:13:00.787847
NCT02767427|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2017-02-07|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery|The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery|Recruiting||N/A|225|Anticipated|Columbia University||2|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 22:13:00.897687|2017-10-10 22:13:00.897687
NCT02767414|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-12-04|||July 2016||2016-07-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Validation of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test for the Rapid Identification of Influenza A/B|A Prospective Multi-centre Study of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test Performance Versus Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for the Rapid Detection of Influenza A/B|Completed||N/A|1500|Actual|Ellume Pty Ltd||1|||f||||f||||||||No||2017-10-10 22:13:01.015076|2017-10-10 22:13:01.015076
NCT02767401|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-09-05|||September 2015||2015-09-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)|The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)|Enrolling by invitation||Phase 4|200|Anticipated|The First Affiliated Hospital of Dalian Medical University||2|||f||||t||||||||||2017-10-10 22:13:01.156838|2017-10-10 22:13:01.156838
NCT02767388|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-05-01|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|Chemobrain||Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery||Recruiting||N/A|45|Anticipated|University of Nebraska|||3||f||||f||||||Samples Without DNA|"     Blood serum   "|Undecided||2017-10-10 22:13:01.264726|2017-10-10 22:13:01.264726
NCT02767375|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-08-09|||February 2015||2015-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|HAICAT||Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection|Hepatic Arterial Infusion Chemotherapy as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma(HCC): A Prospective Randomized Controlled Clinical Trial|Recruiting||Phase 2/Phase 3|192|Anticipated|Beijing Cancer Hospital||2|||f||||t||||||||||2017-10-10 22:13:02.40605|2017-10-10 22:13:02.40605
NCT02767362|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-09-12|||November 2015||2015-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium|Evaluating the Anti-Proliferative Effects of Atorvastatin on the Endometrium of Endometrial Cancer Patients: A Pre-Operative Window Study|Recruiting||Early Phase 1|24|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:13:02.52739|2017-10-10 22:13:02.52739
NCT02767349|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-04-04|||January 2016||2016-01-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain||Withdrawn||Phase 1|0|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-10 22:13:02.635963|2017-10-10 22:13:02.635963
NCT02767336|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-09-12|||April 2016||2016-04-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Project BLOOM Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation|Project Bloom Regulatory Clinical Evaluation - System Accuracy, User Performance, System Use, Instructions for Use and Marketing Claims Evaluation|Completed||N/A|174|Actual|LifeScan||1|||f||||f||||||||No||2017-10-10 22:13:02.733944|2017-10-10 22:13:02.733944
NCT02767323|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-03-23|||January 2016||2016-01-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|WMTMS||Using TMS to Increase Executive Function in Older Adults|Using fMRI-guided TMS to Increase Central Executive Function in Older Adults|Recruiting||N/A|60|Anticipated|Duke University||2|||f||||t||||||||Undecided||2017-10-10 22:13:02.845543|2017-10-10 22:13:02.845543
NCT02767310|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-07-04|||May 2016||2016-05-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)|A Pivotal, Open-label, Balanced, Randomised, Two-treatment, Two-sequence, Two-period, Two-way Crossover, Single Oral Dose Bioequivalence Study of Rosuvastatin/ Verisfield 20 mg Film-coated Tablets Versus Crestor/ AstraZeneca 20 mg Film-coated Tablets in Healthy Adults Under Fasting Conditions|Completed||Phase 1|49|Actual|Verisfield UK Ltd. Greek Branch||2|||f||||f||||||||||2017-10-10 22:13:02.946181|2017-10-10 22:13:02.946181
NCT02767297|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-10-21|||April 2016||2016-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis|A Three-Part Phase 1b Bioavailability and Pharmacokinetics Study of Two Formulations of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis|Completed||Phase 1/Phase 2|46|Actual|Flatley Discovery Lab LLC||5|||f||||f||||||||Undecided||2017-10-10 22:13:03.023413|2017-10-10 22:13:03.023413
NCT02767284|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||A Comparative Study of Six Methods to Measure Human Contrast Vision|UCST Studie 1 - Jämförande Studie Mellan några Befintliga Och Nyutvecklade Metoder för Att mäta Den Spektrala kontrastkänslighetsfunktionen Hos människa|Recruiting||N/A|40|Anticipated|Uppsala University||6|||f||||f||||||||Yes|Anonymous or pseudo-anonymous data will be available on request or in a repository.|2017-10-10 22:13:03.156659|2017-10-10 22:13:03.156659
NCT02767271|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-04-26|||December 14, 2015|Actual|2015-12-14|April 2017|2017-04-01|September 21, 2016|Actual|2016-09-21|April 27, 2016|Actual|2016-04-27||Interventional|||Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris|An Open-Label Study to Assess the Pharmacokinetics With Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris|Completed||Phase 4|30|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||Yes||2017-10-10 22:13:03.24846|2017-10-10 22:13:03.24846
NCT02767258|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-02-13|||May 1, 2016|Actual|2016-05-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Nursing Care on Prevention of Dry Eye|Randomized Clinical Trial: Effect of Nursing Interventions on Prevention of Dry Eye in Critically Ill Patients|Recruiting||N/A|300|Anticipated|Federal University of Minas Gerais||2|||f||||f||||||||No|The study and the information provided will be confidential and used only for purposes of this research. Disclosure of information will be anonymous and in conjunction with the responses of a group of people, never individually.|2017-10-10 22:13:03.327603|2017-10-10 22:13:03.327603
NCT02767245|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-10-03|||January 2014||2014-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Thiamine Supplement in Patients With Severe Hyperthyroidism|Efficacy of Thiamine Supplement for Improve Cardiovascular Function in Patients With Severe Hyperthyroidism|Completed||N/A|12|Actual|Ramathibodi Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:13:03.420665|2017-10-10 22:13:03.420665
NCT02767232|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-18|||July 2018|Anticipated|2018-07-01|September 2017|2017-09-01|June 2023|Anticipated|2023-06-01|April 2023|Anticipated|2023-04-01||Interventional|PHLO||Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial|Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial|Not yet recruiting||Phase 3|270|Anticipated|University of Colorado, Denver||2|||f||||t|t|f||||||||2017-10-10 22:13:03.502325|2017-10-10 22:13:03.502325
NCT02767219|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|RAFTS||The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery|The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery: A Single Centre Randomised Controlled Phase III Pilot Study|Not yet recruiting||Phase 3|30|Anticipated|Moorfields Eye Hospital NHS Foundation Trust||2|||f||||t||||||||No|Individual patient data will not be disclosed publically, all the data will be anonymised and analysed in accordance with the Data Protection Act|2017-10-10 22:13:03.615552|2017-10-10 22:13:03.615552
NCT02767206|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-02-19|||March 2016||2016-03-01|February 2017|2017-02-01||||March 2016|Actual|2016-03-01||Observational|||Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.|Evaluation of Gastroesophageal Varices in Cirrhotic and Non-cirrhotic Patients With Portal Hypertension by Transnasal Endoscopy.|Enrolling by invitation||N/A|50|Actual|Federal University of Minas Gerais|||1||f||||||||||||||2017-10-10 22:13:03.710666|2017-10-10 22:13:03.710666
NCT02767193|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-04-05|||May 2016||2016-05-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected Patients|Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated HIV in HIV-1 Infected Patients. Prospective, Randomized, Partially Blinded Study|Recruiting||Phase 1|32|Anticipated|Fundacion Clinic per a la Recerca Biomédica||4|||f||||f||||||||||2017-10-10 22:13:03.792915|2017-10-10 22:13:03.792915
NCT02767180|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Evaluation of an ICU-specific Questionnaire for Patient-reported Outcome Measures|Evaluation of an Intensive Care Specific Questionnaire for Patient-reported Outcome|Recruiting||N/A|800|Anticipated|Sahlgrenska University Hospital, Sweden|||2||f||||f||||||||Undecided||2017-10-10 22:13:03.881302|2017-10-10 22:13:03.881302
NCT02767167|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-06|||September 2015||2015-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SIMI||Contribution of Cow's Milk to Iodine and Selenium Status in Women of Child-bearing Age||Completed||N/A|78|Actual|University of Ulster||2|||f||||f||||||||No||2017-10-10 22:13:05.930647|2017-10-10 22:13:05.930647
NCT02767141|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-05-09|||May 2012||2012-05-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Coping Strategies Used by Food Insecure Households|Understanding the Interdependencies Among Three Types of Coping Strategies Used by Very Low Food Security Households With Children|Completed||N/A|320|Actual|RTI International|||1||f||||f||||||||||2017-10-10 22:13:06.149443|2017-10-10 22:13:06.149443
NCT02767115|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-09|||February 2015||2015-02-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Grape Seeds Extract Gel as an Adjunct for the Treatment of Chronic Periodontitis|Grape Seeds Extract Gel as an Adjunct to Scaling and Root Planing for the Treatment of Chronic Periodontitis: A Pilot Clinical Study|Completed||Phase 2|24|Actual|Riyadh Colleges of Dentistry and Pharmacy||2|||f||||f||||||||Undecided||2017-10-10 22:13:06.385908|2017-10-10 22:13:06.385908
NCT02767102|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2016-05-05|||July 2014||2014-07-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|Wine-MLT||Bioavailability and Bioactivity of Red Wine Melatonin in Humans|Serum and Salivary Melatonin Levels and Antioxidant Power of Melatonin-rich Red Wine|Completed||N/A|12|Actual|University of Milan||2|||f||||f||||||||No||2017-10-10 22:13:06.47544|2017-10-10 22:13:06.47544
NCT02767089|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-05-06|||October 2005||2005-10-01|May 2016|2016-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers|A Randomized, Single-blind, Placebo-controlled, Crossover Studyto Assess The Dose Response Of Prednisone On Biochemical Andclinical Markers Of Efficacy And Safety In Adult Healthyvolunteers|Completed||Phase 1|37|Actual|Pfizer||7|||f||||f||||||||||2017-10-10 22:13:06.57433|2017-10-10 22:13:06.57433
NCT02767076|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-06|||April 2016||2016-04-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Paramedian Spinal Anaesthesia : Comparison Between Land-mark Guided Technique and Real-time Ultrasound Guided Technique.|Paramedian Spinal Anaesthesia for Orthopaedic Knee Surgery: Comparison Between Conventional Blind Land-mark Guided Technique and Real-time Ultrasound Guided Technique: a Randomized Controlled Trial.|Recruiting||N/A|110|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-10 22:13:06.692331|2017-10-10 22:13:06.692331
NCT02767063|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-08-19|||July 2016||2016-07-01|August 2016|2016-08-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|ACTIW||Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)|Candidate Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors in Chronic Phase-chronic Myelogenous Leukemia Patients in CCR Without Achieving a Deep Molecular Response: an Adaptative Trial Based on a Drop Loser Design|Recruiting||Phase 1/Phase 2|100|Anticipated|Versailles Hospital||2|||f||||t||||||||||2017-10-10 22:13:06.930256|2017-10-10 22:13:06.930256
NCT02767050|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-05-10|||December 2015||2015-12-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|ICSSLT||Incidence of Caries in Smoking and Smokeless Tobacco|Incidence of Caries in Smoking and Smokeless Tobacco-An Observation Study|Completed||N/A|613|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||3||f||||f||||||||No||2017-10-10 22:13:07.160949|2017-10-10 22:13:07.160949
NCT02767037|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-09-26|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SudoScan as a Biomarker of Parkinson's Disease|SudoScan as a Biomarker of Parkinson's Disease|Active, not recruiting||N/A|140|Anticipated|McGill University Health Center||4|||f||||f||||||||||2017-10-10 22:13:07.260786|2017-10-10 22:13:07.260786
NCT02767024|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-06|||May 2016||2016-05-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|PRIORITY-ADHF||Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure Reduced Ejection Fraction and Acute Decompensation With Low Cardiac Output (PRIORITY-ADHF Study)|Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure Reduced Ejection Fraction and Acute Decompensation With Low Cardiac Output: A Single Center, Randomized, Non-Blinded, and Parallel Study (PRIORITY-ADHF Study)|Not yet recruiting||Phase 4|148|Anticipated|Montefiore Medical Center||2|||f||||t||||||||Undecided|Plan to share data is undecided, pending Data Monitoring Committee (DMC) recommendations.|2017-10-10 22:13:07.362864|2017-10-10 22:13:07.362864
NCT02767011|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-08-23|||July 2016||2016-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|THEM||Tele-Health Electronic Monitoring to Reduce Post Discharge Complications and Surgical Site Infections|Tele-Health Electronic Monitoring to Reduce Post Discharge Complications and Surgical Site Infections Following Arterial Revascularization With Groin Incision|Completed||N/A|30|Actual|CAMC Health System||2|||f||||f||||||||||2017-10-10 22:13:07.521455|2017-10-10 22:13:07.521455
NCT02766998|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-12-01|||December 2016||2016-12-01|December 2016|2016-12-01||||January 2019|Anticipated|2019-01-01||Interventional|||Preserved Umbilical Vein Use as Autologous Shunt Conduits in Neonatal Cardiac Surgery|Preserved Umbilical Vein Use as Autologous Shunt Conduits in Neonatal Cardiac Surgery|Recruiting||N/A|6|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-10 22:13:07.604787|2017-10-10 22:13:07.604787
NCT02766985|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-12-08|||March 2016||2016-03-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|ROC-FSHD||Rasch-analysis of Clinical Severity in FSHD|Rasch-analysis of Clinical Severity in FSHD|Active, not recruiting||N/A|100|Anticipated|University of Kansas Medical Center|||1||f||||f||||||Samples With DNA|"     Whole blood samples will be collected and stored for genetic testing. Muscle biopsies are     also being collected for future functional assays to verify identified genetic modifiers.   "|||2017-10-10 22:13:07.705116|2017-10-10 22:13:07.705116
NCT02766959|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-12-06|||January 2016||2016-01-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Observational|||Allele-specific Expression of a Bitter Taste Receptor|Bitter Taste and Allele-specific Expression of the Human TAS2R38 Gene|Recruiting||N/A|100|Anticipated|Monell Chemical Senses Center|||3||f||||f||||||Samples With DNA|"     In part one of the study, each subject will provide a saliva sample. DNA will be isolated,     purified, and quantitated for alleles of TAS2R38, a bitter taste receptor gene. Based on the     results of the genetic screen, 25 individuals with the heterozygous genotype will be invited     to return for part two of the study. In part two of the study, subject will provide nasal     epithelium and taste tissue in the form of fungiform papillae. One half of each set of tissue     will be placed in saline on ice in preparation for cell culture and assessment of AHL-induced     defensive responses, while the second half will be placed in RNA preservative for mRNA     isolation.   "|No||2017-10-10 22:13:07.930384|2017-10-10 22:13:07.930384
NCT02766946|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-09|||June 2013||2013-06-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|ECHODIAPH||Diaphragmatic Atrophy Related to Mechanical Ventilation|Ultrasound Observation of Diaphragmatic Atrophy Related to Mechanical Ventilation A Prospective Monocentric Study in Intensive Care Unit|Completed||N/A|105|Actual|Centre Hospitalier Saint Joseph Saint Luc de Lyon||3|||f||||f||||||||||2017-10-10 22:13:08.0909|2017-10-10 22:13:08.0909
NCT02766933|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-11-07|||May 2016||2016-05-01|November 2016|2016-11-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01|5 Years|Observational [Patient Registry]|||Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study|Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study|Recruiting||N/A|500|Anticipated|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"     Serum and urine at enrollment and follow-up visits   "|No||2017-10-10 22:13:08.207757|2017-10-10 22:13:08.207757
NCT02766907|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-27|||March 2016||2016-03-01|January 2017|2017-01-01|January 27, 2017|Actual|2017-01-27|January 2017|Actual|2017-01-01||Interventional|||Optimizing the Ocular Surface Prior to Cataract Surgery|Optimizing the Ocular Surface Prior to Cataract Surgery|Completed||N/A|20|Actual|Tissue Tech Inc.||2|||f||||f||||||||No||2017-10-10 22:13:08.315606|2017-10-10 22:13:08.315606
NCT02766894|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-08-17|||May 2016||2016-05-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Adequate Depth of Anesthesia: the Anesthesiologist`s Assessment and the EEG Processed Monitoring|Adequate Depth of Anesthesia: the Anesthesiologist`s Assessment and the EEG Processed Monitoring|Completed||N/A|600|Actual|Kepler University Hospital|||1||f||||f||||||||||2017-10-10 22:13:08.417092|2017-10-10 22:13:08.417092
NCT02766881|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-08-04|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|DUCHESS||Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS|Evaluation of the Ductal Carcinoma In Situ Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS|Recruiting||N/A|200|Anticipated|Ontario Clinical Oncology Group (OCOG)|||1||f||||f||||||Samples Without DNA|"     patient's tumour sample   "|||2017-10-10 22:13:08.515731|2017-10-10 22:13:08.515731
NCT02766868|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-07-28|||January 2016||2016-01-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL|Sequential Intensive Chemotherapy With Reduced Intensity Conditioning Regimen in Adult Patients With Refractory and Relapse Acute Lymphoblastic Leukemia|Recruiting||Phase 2|20|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||No||2017-10-10 22:13:08.70725|2017-10-10 22:13:08.70725
NCT02766842|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-11|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)|Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore): A Prospective Randomized, Controlled Multicenter Study|Withdrawn||Phase 2|0|Actual|Johns Hopkins University||2||The reason was the fact that the ProCore needle was removed from clinical use|f||||t||||||||Undecided||2017-10-10 22:13:08.997902|2017-10-10 22:13:08.997902
NCT02766829|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-09|||March 2015||2015-03-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Comparison of Successful Spinal Needle Placement Between Crossed Leg Sitting Position and Traditional Sitting Position|Comparison of Successful Spinal Needle Placement Between Crossed Leg Sitting Position and Traditional Sitting Position in Patients Underwent Urology Surgery|Completed||N/A|211|Actual|Indonesia University||2|||f||||||||||||||2017-10-10 22:13:09.099984|2017-10-10 22:13:09.099984
NCT02766816|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-07-11|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven Biologicals|A Phase III, Observer Blind, Active Controlled, Randomized, Clinical Study Comparing Safety and Immunogenicity of BBio Bivalent Oral Polio Vaccine With a Licensed Bivalent Oral Polio Vaccine|Recruiting||Phase 3|1120|Anticipated|Bilthoven Biologicals||6|||f||||t||||||||||2017-10-10 22:13:09.204912|2017-10-10 22:13:09.204912
NCT02766803|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2016-09-06|||May 2016||2016-05-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients|Prospective, Randomized, Double - Blind Placebo Controlled Trial of Simvastatin and Resveratrol Therapy on Clinical, Endocrinological, Biochemical and Endothelial Dysfunction Parameters in Women With Polycystic Ovary Syndrome.|Recruiting||Phase 4|60|Anticipated|Poznan University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:13:09.327837|2017-10-10 22:13:09.327837
NCT02766790|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-06-02|||May 2016||2016-05-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|TA-65MD||Effect of TA-65MD on Healthy Volunteers|A Randomized, Double Blind, Placebo Controlled, Parallel Study of TA-65MD in Healthy Volunteers Evaluating Immunosenescence and Telomere Length Over a Nine Month Period|Recruiting||N/A|500|Anticipated|Telomerase Activation Sciences, Inc||5|||f||||f||||||||Undecided||2017-10-10 22:13:09.448665|2017-10-10 22:13:09.448665
NCT02766777|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-12-23|||April 2016||2016-04-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of the Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation|A Multicenter, 6-month, Open-label Safety Study of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation|Completed||Phase 3|87|Actual|Sucampo Pharma Americas, LLC||1|||f||||f||||||||||2017-10-10 22:13:09.560609|2017-10-10 22:13:09.560609
NCT02766764|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-07-03|||June 2016||2016-06-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI|Evaluation of the Role of Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI: A Double Blind Placebo Controlled Study.|Recruiting||Phase 4|230|Anticipated|Cairo University||2|||f||||f||||||||No||2017-10-10 22:13:09.68796|2017-10-10 22:13:09.68796
NCT02766751|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-07-17|||November 15, 2016|Actual|2016-11-15|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|HIVPass||Treating Comorbid Pain and Depression in HIV+ Individuals|Treating Comorbid Pain and Depression in HIV+ Individuals|Recruiting||N/A|236|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-10 22:13:09.819693|2017-10-10 22:13:09.819693
NCT02766738|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-04|||May 2016||2016-05-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Improving Mobility in Residential Aged Care|Improving Mobility in Residential Aged Care: Comparing the Benefits of Two Resistance Exercise Programs|Completed||N/A|84|Actual|Bond University||3|||f||||f||||||||No||2017-10-10 22:13:09.934029|2017-10-10 22:13:09.934029
NCT02766725|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-06|||January 2015||2015-01-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|ss||Thermosensitive Gels for the Vaginal Delivery of Sildenafil Citrate|Development and Clinical Evaluation of Thermosensitive Gels for the Vaginal Delivery of Sildenafil Citrate on the Endometrium of Women Use Clomiphene Citrate for Induction of Ovulation|Completed||Phase 2/Phase 3|90|Actual|Assiut University||3|||f||||t||||||||Undecided||2017-10-10 22:13:10.098558|2017-10-10 22:13:10.098558
NCT02766712|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-12-01|||April 2016||2016-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|PEP AF||The Physiological Effects of Pacing on Catheter Ablation Procedures to Treat Atrial Fibrillation|The Physiological Effects of Pacing on Catheter Ablation Procedures to Treat Atrial Fibrillation|Recruiting||N/A|68|Anticipated|New York University School of Medicine||2|||f||||t||||||||No||2017-10-10 22:13:10.178586|2017-10-10 22:13:10.178586
NCT02766699|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-07-23|||October 25, 2016|Actual|2016-10-25|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|CerebralEDV||A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM)|A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of EGFR (Vectibix® Sequence)-Targeted EnGeneIC Dream Vectors Containing Doxorubicin (EGFR(V)-EDV-Dox) in Subjects With Recurrent Glioblastoma Multiforme (GBM)|Recruiting||Phase 1|20|Anticipated|Engeneic Pty Limited||1|||f||||f|t|f||||||||2017-10-10 22:13:10.284691|2017-10-10 22:13:10.284691
NCT02766686|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-04-03|||September 2016||2016-09-01|April 2017|2017-04-01|August 2023|Anticipated|2023-08-01|August 2022|Anticipated|2022-08-01||Interventional|ProtoChoice-P||Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons|Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons in Standard Fractionation and Standard Dosage|Recruiting||N/A|146|Anticipated|Technische Universität Dresden||3|||f||||f||||||||No||2017-10-10 22:13:10.412663|2017-10-10 22:13:10.412663
NCT02766673|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-09|2017-09-22|||August 2016||2016-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Aerosolized Albuterol Use in Severe BPD|Safety and Efficacy of Aerosolized Albuterol in Mechanically Ventilated Infants With Bronchopulmonary Dysplasia (BDP)|Recruiting||N/A|25|Anticipated|Children's Hospital of Philadelphia||3|||f||||f||||||||||2017-10-10 22:13:10.546698|2017-10-10 22:13:10.546698
NCT02766660|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-05-09|||January 2012||2012-01-01|April 2016|2016-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy|Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy|Completed||N/A|102|Actual|Neon Hospital||2|||f||||f||||||||No||2017-10-10 22:13:10.674512|2017-10-10 22:13:10.674512
NCT02766647|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-06|||December 2015||2015-12-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)|A Randomized Open-Label, Single-Dose, Crossover Study Evaluating The Pharmacokinetics And Pharmacodynamics Of Filgrastim Hospira Compared To U.S.-Approved Neupogen® (Amgen) Following Subcutaneous Administration To Healthy Volunteers|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 22:13:10.770631|2017-10-10 22:13:10.770631
NCT02766634|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-07-20|||March 2016||2016-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)|A Randomized Open-label, Multiple-dose, Crossover Study Evaluatig The Pharmacodynamics And Pharmacokinetics Of Filgrastim Hospira Compared To Us-approved Neupogen (Registered) Following Subcutaneous Administration To Healthy Volunteers|Completed||Phase 1|60|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 22:13:10.930991|2017-10-10 22:13:10.930991
NCT02766621|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-08-15|||May 27, 2016|Actual|2016-05-27|August 2017|2017-08-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859|Phase 1, Randomized, Double-blind, Third-party Open Placebo-controlled, Dose Escalating Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single And Multiple Intravenous And Subcutaneous Doses Of Pf-06823859 In Healthy Subjects|Active, not recruiting||Phase 1|62|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 22:13:11.052923|2017-10-10 22:13:11.052923
NCT02766426|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-05-06|||January 2015||2015-01-01|April 2016|2016-04-01|May 2016||2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Cytokine and Body Composition's Changes in Overweight/Obese Women|Cytokine and Body Composition's Changes Throughout Pregnancy in Overweight/Obese Women Undergoing an Early Lifestyle Change Program|Active, not recruiting||N/A|59|Anticipated|University of Modena and Reggio Emilia||1|||f||||f||||||||No||2017-10-10 22:13:13.286725|2017-10-10 22:13:13.286725
NCT02766608|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-05-24|||May 31, 2016|Actual|2016-05-31|May 2017|2017-05-01|November 28, 2017|Anticipated|2017-11-28|November 28, 2017|Anticipated|2017-11-28||Interventional|telos||Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD|A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort® Turbuhaler®, as an Active Control, on Lung Function Over a 24-Week Treatment Period in Subjects With Moderate to Very Severe COPD|Active, not recruiting||Phase 3|2420|Anticipated|Pearl Therapeutics, Inc.||5|||f||||t||||||||||2017-10-10 22:13:11.224056|2017-10-10 22:13:11.224056
NCT02766595|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-05-05|||June 2016||2016-06-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Does Body Positioning Affect the Yield of Hyperventilation in Routine Pediatric Electroencephalography - EEG Studies?|Hyperventilation During Routine EEG in Children: the Impact of Body Position - Sitting vs Supine- on the Yield of the Procedure in Provoking Absence Seizures|Not yet recruiting||N/A|50|Anticipated|Meir Medical Center||1|||f||||f||||||||No||2017-10-10 22:13:11.512849|2017-10-10 22:13:11.512849
NCT02766582|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-11-17|||October 2016||2016-10-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer|Phase II Open Label Nonrandomized Trial of the Anti PD 1 Therapy Pembrolizumab With First Line Platinum Based Chemotherapy Followed by 12 Months Pembrolizumab Monotherapy for Patients With Stage III/IV Epithelial Ovarian Cancer|Recruiting||Phase 2|30|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||Undecided||2017-10-10 22:13:11.767737|2017-10-10 22:13:11.767737
NCT02766569|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-09-08|||July 2016||2016-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01|1 Year|Observational [Patient Registry]|IRFACODE-II||International Registry for ASD Closure by Using the Occlutech®Flex II Device in More Than 2000 Patients|International Registry for Secundum Atrial Septal Defects Closure by Using the Occlutech®Flex II Device in More Than 2000 Patients|Enrolling by invitation||N/A|2000|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||No||2017-10-10 22:13:11.966009|2017-10-10 22:13:11.966009
NCT02766556|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-05|||August 2014||2014-08-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Dexamedetomidine for Interscalene Brachial Plexus Block on Plasma Biomarkers After Rotator Cuff Repair|The Effect of Dexamedetomidine for Interscalene Brachial Plexus Block on Plasma Cortisol and IL-6 After Rotator Cuff Repair: a Prospective Randomized Study|Completed||N/A|50|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||Yes||2017-10-10 22:13:12.054691|2017-10-10 22:13:12.054691
NCT02766543|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-08-16|||September 21, 2016|Actual|2016-09-21|August 2017|2017-08-01|November 2022|Anticipated|2022-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer|Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study|Recruiting||Phase 2|110|Anticipated|Profound Medical Inc.||1|||f||||t||||||||||2017-10-10 22:13:12.191188|2017-10-10 22:13:12.191188
NCT02766530|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-05-06|||July 2014||2014-07-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast Cancer|Use of Integrated PET/MR to Evaluate Clinical Staging and Monitor Treatment Response of Neoadjuvant Chemotherapy for Breast Cancer Patients: A Pilot Study|Recruiting||Phase 4|40|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||Undecided|undecided yet|2017-10-10 22:13:12.365835|2017-10-10 22:13:12.365835
NCT02766517|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-02-01|||September 28, 2016|Actual|2016-09-28|February 2017|2017-02-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Biomarker Study in Participants With Migraine|LY2951742 Biomarker Study in Patients With Migraine|Completed||Early Phase 1|100|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 22:13:12.469338|2017-10-10 22:13:12.469338
NCT02766504|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2016-05-05|||October 2015||2015-10-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Observational|AiUs||Ultrasound in Airway Assessment of Morbidly Obese Patients||Recruiting||N/A|100|Anticipated|Mansoura University|||1||f||||t||||||||||2017-10-10 22:13:12.59203|2017-10-10 22:13:12.59203
NCT02766491|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-05|||June 2016||2016-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Improving Stretching Interventions for Children With Cerebral Palsy|Improving Stretching Interventions for Children With Cerebral Palsy|Not yet recruiting||N/A|30|Anticipated|Liverpool John Moores University||2|||f||||f||||||||No||2017-10-10 22:13:12.669248|2017-10-10 22:13:12.669248
NCT02766465|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-08-29|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|March 2023|Anticipated|2023-03-01|March 2022|Anticipated|2022-03-01||Interventional|STRIDE2||Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)|A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults With Severe Sickle Cell Disease (BMT CTN #1503)|Recruiting||Phase 2|200|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-10 22:13:12.876638|2017-10-10 22:13:12.876638
NCT02766452|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-05|||September 2011||2011-09-01|May 2016|2016-05-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Preparing Parents To Participate In Their Child's Care In The Recovery Room|The Effects of a Preoperative Educational DVD on Parents' Participation in Their Child's Care in the Recovery Room at the Time of a Same-day Surgery: A Randomized Controlled Trial|Completed||N/A|105|Actual|University of Ottawa||2|||f||||f||||||||No||2017-10-10 22:13:13.132711|2017-10-10 22:13:13.132711
NCT02766439|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2016-05-06|||March 2013||2013-03-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Observational|||Rhupus Syndrome and Efficacy of Etanercept Treatment|the First People's Hospital of Chenzhou|Completed||N/A|6|Actual|First People's Hospital of Chenzhou|||1||f||||t||||||||Undecided||2017-10-10 22:13:13.215746|2017-10-10 22:13:13.215746
NCT02766400|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-08-27|2016-07-08||August 2012||2012-08-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|GUIDE||Examining Rehabilitation Training Methods|Guided Versus Directed Training in Acute Stroke Rehabilitation|Completed||N/A|77|Actual|University of Pittsburgh|Both interventions were offered in addition to usual care (comprised mostly of direct skill training). This may have minimized the overall effect of guided training.|2|||f||||t||||||||No|At present, there is no plan to share data.|2017-10-10 22:13:13.374293|2017-10-10 22:13:13.374293
NCT02766387|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-06|||May 2016||2016-05-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||Evaluation of Correlations Between Different Walk Tests in Patients With Transfemoral Amputees|Evaluation of Correlations Between the 2 Minutes, 6 Minutes and 2 Kilometers Walk Tests in Patients With Transfemoral Amputees With a Microprocessor-controlled Prosthetic Knees|Enrolling by invitation||N/A|||University Hospital, Angers||2|||f||||||||||||||2017-10-10 22:13:13.758906|2017-10-10 22:13:13.758906
NCT02766374|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-05-07|||December 2009||2009-12-01|May 2016|2016-05-01||||October 2015|Actual|2015-10-01||Interventional|BioAce||Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics|Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics|Active, not recruiting||N/A|120|Anticipated|National Jewish Health||2|||f||||t||||||||||2017-10-10 22:13:13.8274|2017-10-10 22:13:13.8274
NCT02766361|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-10-04|||March 2016||2016-03-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|REHABBipolar||Cognitive-Behavioral Rehabilitation for Bipolar Disorder|Cognitive-Behavioral Rehabilitation Versus Treatment as Usual for Bipolar Patients|Enrolling by invitation||Early Phase 1|92|Anticipated|University of Sao Paulo||2|||f||||f||||||||Yes||2017-10-10 22:13:13.928419|2017-10-10 22:13:13.928419
NCT02766348|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-06|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients|Randomized, Controlled Study of the Safety and Efficacy of DC-CTL Immune Cell for Non-Small Cell Lung Cancer|Not yet recruiting||Phase 2|60|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||2|||f||||f||||||||No||2017-10-10 22:13:14.048133|2017-10-10 22:13:14.048133
NCT02766335|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-06|2017-07-12|||June 2014||2014-06-01|July 2017|2017-07-01|April 2027|Anticipated|2027-04-01|April 2022|Anticipated|2022-04-01||Interventional|||S1400A Lung-Map: MEDI4736 as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers|A Phase II Study of MEDI4736 for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (Lung-Map Sub-Study)|Active, not recruiting||Phase 2|100|Anticipated|Southwest Oncology Group||3|||f||||t||||||||||2017-10-10 22:13:14.339574|2017-10-10 22:13:14.339574
NCT02766322|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-19|||March 2016||2016-03-01|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|March 2021|Anticipated|2021-03-01||Observational|ABS||Alcohol and Bariatric Surgery|Pharmacokinetics and Subjective Responses to Alcohol After Bariatric Surgery|Recruiting||N/A|112|Anticipated|University of Illinois at Urbana-Champaign|||6||f||||t||||||Samples With DNA|"     Blood and Plasma   "|||2017-10-10 22:13:17.080598|2017-10-10 22:13:17.080598
NCT02766309|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-05|||September 2014||2014-09-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Observational|||The Correlation Between Health Status and Self-Assessment of Health Condition, and the Relation to Health Services Utilization|The Correlation Between Health Status and Self-Assessment of Health Condition, and the Relation to Health Services Utilization|Completed||N/A|250|Actual|Western Galilee Hospital-Nahariya|||1||f||||f||||||||No||2017-10-10 22:13:17.344417|2017-10-10 22:13:17.344417
NCT02766296|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-08|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Emotional Working Memory Training for Veterans With PTSD Symptoms|Emotional Working Memory Training for Veterans With Elevated Trauma-related Symptoms|Recruiting||N/A|60|Anticipated|Milwaukee VA Medical Center||2|||f||||f||||||||||2017-10-10 22:13:17.4081|2017-10-10 22:13:17.4081
NCT02766270|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-01-18|||September 26, 2016|Actual|2016-09-26|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III Gliomas|A Prospective Study of Concurrent Chemoradiotherapy With Temozolomide Versus Radiation Therapy Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III Gliomas|Recruiting||Early Phase 1|30|Anticipated|Beijing Tiantan Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:13:17.633829|2017-10-10 22:13:17.633829
NCT02766257|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-05|||June 2014||2014-06-01|May 2016|2016-05-01||||November 2014|Actual|2014-11-01||Interventional|||Anesthesia for Ambulatory Pediatric Surgery in Sub-Saharan Africa (SSA)|Anesthesia for Ambulatory Pediatric Surgery in Sub-Saharan Africa (SSA): a Pilot Study in Burkina Faso|Completed||N/A|103|Actual|Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle||1|||f||||||||||||||2017-10-10 22:13:17.757919|2017-10-10 22:13:17.757919
NCT02766244|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-06-16|2016-06-16||January 2014||2014-01-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing|Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing|Completed||N/A|3|Actual|Texas Tech University Health Sciences Center||1|||f||||f||||||||No||2017-10-10 22:13:17.847692|2017-10-10 22:13:17.847692
NCT02766231|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-05|||February 2016||2016-02-01|May 2016|2016-05-01||||March 2023|Anticipated|2023-03-01||Observational|||Physica CR and PS Clinical Trial|A Multicentre, Prospective Study Evaluating Clinical, Radiographic and Patient-reported Outcomes of Total Knee Arthroplasty With Physica CR or Physica PS Prosthesis|Recruiting||N/A|164|Anticipated|Limacorporate S.p.a|||2||f||||f||||||||||2017-10-10 22:13:18.12068|2017-10-10 22:13:18.12068
NCT02766205|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-05|||June 2016||2016-06-01|May 2016|2016-05-01||||June 2018|Anticipated|2018-06-01|12 Months|Observational [Patient Registry]|AF-ESUS||Prediction of AF in ESUS|Prediction of Atrial Fibrillation in Patients With Embolic Stroke of Undetermined Source (AF-ESUS)|Not yet recruiting||N/A|500|Anticipated|University of Thessaly|||1||f||||t||||||||Undecided||2017-10-10 22:13:18.280126|2017-10-10 22:13:18.280126
NCT02766192|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-05-05|||August 2013||2013-08-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSD|Ketamine and Mindfulness Based Cognitive Therapy (MBCT) in Treatment of Post-Traumatic Stress Disorder (PTSD): Comparison of Treatment Efficacy and Metabolomic Profiles|Recruiting||N/A|50|Anticipated|The Cooper Health System||2|||f||||t||||||||Undecided||2017-10-10 22:13:18.490374|2017-10-10 22:13:18.490374
NCT02766166|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-07|||May 2016||2016-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|CHAOS||Critical Health Assessment and Outcomes Score/Study|Critical Health Assessment and Outcomes Score/Study|Enrolling by invitation||N/A|6000|Anticipated|Johns Hopkins University|||2||f||||||||||||||2017-10-10 22:13:18.830188|2017-10-10 22:13:18.830188
NCT02766153|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-05-06|||May 2016||2016-05-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Observational|||Exploring the Mechanisms of Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine Kinase Inhibitors in 3d Model Niche Endosteal||Not yet recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Nice|||2||f||||f||||||Samples Without DNA|"     bone marrow   "|||2017-10-10 22:13:18.923082|2017-10-10 22:13:18.923082
NCT02766140|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-02-28|||June 2016|Actual|2016-06-01|April 2016|2016-04-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|||SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer|Multicentre, Randomised, Double-blind, Phase III Trial to Investigate the Efficacy and Safety of Oral SHR1020 Plus Docetaxel Therapy Compared to Placebo Plus Docetaxel Therapy in Patients With Local Advanced or Metastatic or Recurrent Non Squamous Non Small Cell Lung Cancer After Failure of First Line Chemotherapy.|Terminated||Phase 3|15|Actual|Jiangsu HengRui Medicine Co., Ltd.||2||difficulty in recruitment|f||||t||||||||||2017-10-10 22:13:19.037007|2017-10-10 22:13:19.037007
NCT02766127|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-03-21|||March 2012||2012-03-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|June 2014|Actual|2014-06-01||Interventional|||Effect of a Self-adhering Material in Dental Hypersensitivity|A Comparative Study of a Self-adhering Material in Dental Hypersensitivity in Xerostomic Patients Due to Radiotherapy|Completed||N/A|17|Actual|Università degli Studi di Sassari||1|||f||||t||||||||No|Not a plan for data sharing has been established. But, for anyone researcher would like to have this information, simply they may request them to us directly.|2017-10-10 22:13:19.172373|2017-10-10 22:13:19.172373
NCT02766114|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-06|||February 2013||2013-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CTRMTA||Carpal Tunnel Release Through Mini Transverse Approach|Carpal Tunnel Release Through Mini Transverse Approach|Completed||N/A|43|Actual|Issa, Abdulhamid Sayed, M.D.||1|||f||||t||||||||Yes||2017-10-10 22:13:19.339528|2017-10-10 22:13:19.339528
NCT02766101|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-05|||October 2014||2014-10-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|MM||Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges|Can a Physical Activity Program Implemented at a Therapeutic School Promote Emotional Regulation and School Success in Socially and Emotionally Vulnerable Children?|Completed||N/A|103|Actual|Harvard School of Public Health||2|||f||||||||||||||2017-10-10 22:13:19.487421|2017-10-10 22:13:19.487421
NCT02766088|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-09-14|||July 14, 2016||2016-07-14|September 2017|2017-09-01|March 23, 2020|Anticipated|2020-03-23|March 23, 2020|Anticipated|2020-03-23||Interventional|||This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia|A Cohort Study to Assess the Burden of Dengue Illness in Household Members From Selected Communities in Southeast Asia and Latin America|Recruiting||N/A|3000|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 22:13:19.61834|2017-10-10 22:13:19.61834
NCT02766075|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-04-17|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|STEP||A STEP for Patients Prior to Undergoing TAVR: A Pilot Study|A Supervised TAVR Exercise Program (STEP) for Patients Prior to Undergoing Transcatheter Aortic Valve Replacement (TAVR): A Pilot Study|Recruiting||N/A|24|Anticipated|OSF Healthcare System||2|||f||||f|f|f||||||No||2017-10-10 22:13:19.791452|2017-10-10 22:13:19.791452
NCT02766049|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-07-19|||February 2010||2010-02-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus|Phase I/II Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus|Completed||Phase 1/Phase 2|19|Actual|University of Sao Paulo General Hospital||3|||f||||||||||||No||2017-10-10 22:13:20.070139|2017-10-10 22:13:20.070139
NCT02766036|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-12-14|||May 2016||2016-05-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Propolis Effects in Patients With Chronic Kidney Disease|Propolis Effects on Proteinuria and Kidney Function in Patients With Chronic Kidney Disease|Active, not recruiting||Phase 2|37|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Yes|The data will be evaluated monthly by researchers at the scientific meetings of the department. Data from this study will be considered joint property of the parties involved. Researchers are, however, responsible for committing to make public the results.|2017-10-10 22:13:20.191419|2017-10-10 22:13:20.191419
NCT02766010|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-05-06|||May 2016||2016-05-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||A Comparative Clinical Study to Assess the Accuracy of TensorTip MTX, a Non Invasive Device|A Comparative Clinical Study to Assess the Accuracy of TensorTip MTX, a Non Invasive Device for the Measurement of Physiological and Hematological Parameters|Not yet recruiting||N/A|50|Anticipated|Cnoga Medical Ltd.||1|||f||||t||||||||Undecided||2017-10-10 22:13:20.540034|2017-10-10 22:13:20.540034
NCT02765997|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-06-08|||April 2017|Anticipated|2017-04-01|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|||StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies|Single-Center, Open Label, Randomized Trial Comparing StemRegenin-1 Expanded Versus Unmanipulated Umbilical Cord Blood Transplantation In Patients With High-Risk Malignancy|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||2||IRB Disapproval|f|||||t|f|||f|||||2017-10-10 22:13:20.654542|2017-10-10 22:13:20.654542
NCT02765984|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2016-05-05|||May 2016||2016-05-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Relation of Implantation Site to Placental Site|Relation of Implantation Site to Placental Site With or Without Cesarean Section Scar|Not yet recruiting||N/A|200|Anticipated|Cairo University|||2||f||||t||||||||Undecided||2017-10-10 22:13:20.794872|2017-10-10 22:13:20.794872
NCT02765971|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2016-05-06|||May 2016||2016-05-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Efficacy of Chewing Gums Versus Laxative in Early Return of Bowel Function After CS|The Efficacy of Chewing Gums Versus Laxatives in Early Return of Bowel Function After Cesarean Section|Not yet recruiting||Phase 4|540|Anticipated|Cairo University||3|||f||||t||||||||No||2017-10-10 22:13:20.937212|2017-10-10 22:13:20.937212
NCT02765958|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-05|||May 2016||2016-05-01|May 2016|2016-05-01||||November 2016|Anticipated|2016-11-01||Observational|||Analyze Sleep Stages by Portable ECG Device|Analyze Sleep Stages by Portable ECG Device|Not yet recruiting||N/A|35|Anticipated|Far Eastern Memorial Hospital|||2||f||||t||||||||Yes||2017-10-10 22:13:21.063003|2017-10-10 22:13:21.063003
NCT02765945|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-06|||December 1996||1996-12-01|May 2016|2016-05-01|April 1998|Actual|1998-04-01|April 1998|Actual|1998-04-01||Interventional|||Exercise as an Modulator of Immunological Risk Factors for Osteoporosis|The Effect of Long-term Exercise on the Production of Osteoclastogenic and Anti-osteoclastogenic Cytokines by Peripheral Blood Mononuclear Cells and on Serum Markers of Bone Metabolism|Completed||N/A|43|Actual|East Tennessee State University||1|||f||||f||||||||No||2017-10-10 22:13:21.163854|2017-10-10 22:13:21.163854
NCT02765932|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-10-03|||June 2016||2016-06-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of a Psychosensory Therapy|The Effect of a Psychosensory Therapy on Post-Op Pain in Hip and Knee Surgery: A Randomized Study|Recruiting||N/A|50|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:13:21.279188|2017-10-10 22:13:21.279188
NCT02765919|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-12-06|||July 2015||2015-07-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine Cervix|Study of Two Fractions Versus Three Fractions High Dose Rate Brachytherapy in Locally Advanced Carcinoma of Uterine Cervix After Pelvic Concurrent Chemoradiotherapy - a Randomized Controlled Trial|Recruiting||Phase 3|30|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||t||||||||No||2017-10-10 22:13:21.419723|2017-10-10 22:13:21.419723
NCT02765906|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-09-24|||May 2016||2016-05-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|July 30, 2017|Actual|2017-07-30||Interventional|||Comparing Different Methods of Patient Education on Preeclampsia|Comparing Different Methods of Patient Education on Preeclampsia: A Randomized Controlled Trial|Active, not recruiting||N/A|150|Actual|Geisinger Clinic||3|||f||||f||||||||||2017-10-10 22:13:21.568803|2017-10-10 22:13:21.568803
NCT02765893|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-07-05|||December 2015||2015-12-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Indwelling vs Immediate Removal of Foley Catheter After Robotic Assisted Laparoscopic Sacrocolpopexy: a Prospective Study|Indwelling vs Immediate Removal of Foley Catheter After Robotic Assisted Laparoscopic Sacrocolpopexy: a Prospective Study|Active, not recruiting||N/A|88|Actual|Atlantic Health System||2|||f||||f||||||||||2017-10-10 22:13:21.753836|2017-10-10 22:13:21.753836
NCT02765880|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-05-11|||June 2016||2016-06-01|May 2016|2016-05-01||||September 2020|Anticipated|2020-09-01||Interventional|Self and Time||Time,Self and Spontaneous Mental Activities in Patients With Psychotic Disorders|Time,Self and Spontaneous Mental Activities in Patients With Psychotic Disorders|Not yet recruiting||N/A|161|Anticipated|University Hospital, Strasbourg, France||3|||f||||||||||||||2017-10-10 22:13:21.877647|2017-10-10 22:13:21.877647
NCT02765867|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-06|||November 2010||2010-11-01|May 2016|2016-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Single-dose, Study of RBP-6000 in Opioid Dependent Individuals|A Single-Dose, Open-Label Study of Depot Buprenorphine (RBP-6000) in Opioid-Dependent Individuals|Completed||Phase 1|18|Actual|Indivior Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:13:21.970156|2017-10-10 22:13:21.970156
NCT02765854|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-08-17|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement|Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR)|Recruiting||Phase 2|90|Anticipated|Emory University||3|||f||||t|||||t|||||2017-10-10 22:13:22.348603|2017-10-10 22:13:22.348603
NCT02765841|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-09-01|||May 2016||2016-05-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy|A Phase 3, Single-arm, Open-label, International, Multi-center Study to Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy|Withdrawn||Phase 3|0|Actual|Aegerion Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-10 22:13:22.524212|2017-10-10 22:13:22.524212
NCT02765828|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-03-29|||May 2016||2016-05-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Identification of Tongue Involvement in Late-Onset Pompe Disease|Determining the Diagnostic Utility of the Identification of Tongue Involvement in Late-Onset Pompe Disease (LOPD)|Recruiting||N/A|70|Anticipated|Duke University|||3||f||||f|f|f||||||No||2017-10-10 22:13:22.650468|2017-10-10 22:13:22.650468
NCT02765815|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-08-08|||February 2016|Anticipated|2016-02-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients|A Prospective Randomized Case Series Comparison on the Clinical Efficacy of Exparel Local Anesthetic in Total Knee Arthroplasty Patients|Withdrawn||Phase 4|0|Actual|Holy Cross Hospital, Florida||2||competing protocol|f||||f||||||||||2017-10-10 22:13:22.794642|2017-10-10 22:13:22.794642
NCT02765802|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-07-27|||October 19, 2016|Actual|2016-10-19|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|LIMT||A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection|A Phase 2 Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection (LIMT)|Active, not recruiting||Phase 2|33|Actual|Eiger BioPharmaceuticals||2|||f|||||t|f||||||||2017-10-10 22:13:22.9283|2017-10-10 22:13:22.9283
NCT02765789|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-06|||June 2016||2016-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Immunoadsorption in Anti-GBM Glomerulonephritis.|Immunoadsorption in Anti-glomerular Basement Membrane Glomerulonephritis; a Pilot Study|Not yet recruiting||Phase 4|8|Anticipated|University Medical Center Groningen||1|||f||||f||||||||No||2017-10-10 22:13:23.040082|2017-10-10 22:13:23.040082
NCT02765776|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-05|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|RalAge||An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens in Aged HIV Patients (RalAge)|An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients (RalAge)|Not yet recruiting||N/A|90|Anticipated|Azienda Policlinico Umberto I|||1||f||||f||||||||Undecided||2017-10-10 22:13:23.136095|2017-10-10 22:13:23.136095
NCT02765763|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-01-31|||May 2016|Actual|2016-05-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules|Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules|Active, not recruiting||Phase 4|45|Anticipated|Advanced Dermatology||2|||f||||f||||||||No||2017-10-10 22:13:23.273978|2017-10-10 22:13:23.273978
NCT02765750|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-06-28|||March 2016||2016-03-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Postoperative Outcomes After Positive Intraoperative Messages|Study of the Effect of Intraoperative Positive Messages on Postoperative Outcomes|Recruiting||N/A|120|Anticipated|424 General Military Hospital||3|||f||||f||||||||No||2017-10-10 22:13:23.423758|2017-10-10 22:13:23.423758
NCT02765737|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-03-02|||April 2016||2016-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.|Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.|Recruiting||N/A|60|Anticipated|MiMedx Group, Inc.||2|||f||||f||||||||No||2017-10-10 22:13:23.763781|2017-10-10 22:13:23.763781
NCT02765724|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-04|||January 2015||2015-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Determine Pacritinib Pharmacokinetics in Impaired Hepatic Patients and Healthy Subjects|A Phase 1 Open Label, Single Dose, Parallel-Group Study to Determine the Pharmacokinetics of Pacritinib in Patients With Impaired Hepatic Function in Comparison With Healthy Subjects|Completed||Phase 1|28|Actual|CTI BioPharma||4|||f||||||||||||Yes||2017-10-10 22:13:23.897441|2017-10-10 22:13:23.897441
NCT02765711|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-07-31|||May 2016||2016-05-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|TIFU||Ticagrelor in Fuwai Hospital|TIFU: A Non-Interventional, Descriptive Cohort Study to Describe the Use of Ticagrelor in Patients With Acute Coronary Syndrome (TIFU: Ticagrelor in Fuwai Hospital)|Recruiting||N/A|1200|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||||||||||||2017-10-10 22:13:24.016754|2017-10-10 22:13:24.016754
NCT02765698|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer|Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer|Recruiting||N/A|10|Anticipated|Mayo Clinic|||1||f||||f||||||||No||2017-10-10 22:13:24.155674|2017-10-10 22:13:24.155674
NCT02765685|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-06|||February 2015||2015-02-01|April 2016|2016-04-01||||August 2017|Anticipated|2017-08-01||Interventional|ERGONOMIE||Internal Compartment Knee Osteoarthritis: ODRA (Orthosis Distraction and Rotation for osteoArthritis) Made-to-measure Hinged Knee Brace Versus Usual Care.|Randomized Controlled Trial in Internal Compartment Knee Osteoarthritis: ODRA Made-to-measure Hinged Knee Brace Versus Usual Care.|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:13:24.297378|2017-10-10 22:13:24.297378
NCT02765672|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Effectiveness of a Driving Intervention on Safe Community Mobility for Returning Combat Veterans|Effectiveness of a Driving Intervention on Safe Community Mobility for Returning Combat Veterans|Recruiting||N/A|550|Anticipated|University of Florida||6|||f||||f||||||||No||2017-10-10 22:13:24.42684|2017-10-10 22:13:24.42684
NCT02765659|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2017-08-14|||June 2016||2016-06-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||A Community-based Implementation Model for HIV Prevention and Testing in Malawi|A Community-based Implementation Model for HIV Prevention and Testing in Malawi|Recruiting||N/A|1011|Anticipated|University of Illinois at Chicago||3|||f||||t||||||||||2017-10-10 22:13:24.633833|2017-10-10 22:13:24.633833
NCT02765464|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-06-28|||July 2016||2016-07-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Acute Kidney Injury in Critically Ill Patients|Predicting Acute Kidney Injury in Critically Ill Trauma Patients Using Metalloproteinase 2 (TIMP2) and Insulin-like Growth Factor Binding Protein7 (IGFBP 7)|Recruiting||N/A|100|Anticipated|Loma Linda University|||1||f||||f||||||||No||2017-10-10 22:13:26.738726|2017-10-10 22:13:26.738726
NCT02765646|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-10-05|||May 2016||2016-05-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|May 2017|Anticipated|2017-05-01|9 Months|Observational [Patient Registry]|eTRYTONLM||eTryton Left Main Registry Tryton Side Branch Stent® Tmt of Denovo CAD in LM and CFX Arteries|eTryton Left Main Multi-center, Prospective, Non-randomized Single Arm Registry Evaluating the Tryton Side Branch Stent® for Treatment of de Novo CAD in Both LM and Circumflex (LCX) Coronary Arteries|Recruiting||N/A|100|Anticipated|Tryton Medical, Inc.|||1||f||||f||||||||Undecided||2017-10-10 22:13:24.829876|2017-10-10 22:13:24.829876
NCT02765633|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-04-10|||January 3, 2017|Actual|2017-01-03|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Cangrelor Neonatal PK/PD and Safety Study|A Prospective, Open-Label, Single-Arm, Single-Center Study To Assess The Pharmacokinetics/Pharmacodynamics (PK/PD) And Safety Of Different Cangrelor Doses In Neonatal Subjects At Risk Of Thrombosis|Recruiting||Phase 1|20|Anticipated|Chiesi USA||1|||f||||t|t|f||||||||2017-10-10 22:13:24.995167|2017-10-10 22:13:24.995167
NCT02765620|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-05-04|||April 2016||2016-04-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||PERCIST Criteria for Response Evaluation With Solid Tumors|PERCIST Criteria for Response Evaluation of Non-surgical Therapy in Patients With Solid Tumors:Prospective Multicenter Study|Recruiting||N/A|150|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||2||f||||t||||||||Yes||2017-10-10 22:13:25.17319|2017-10-10 22:13:25.17319
NCT02765607|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-12-12|||March 2016||2016-03-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Circulatory Oscillations in Post Cardiac Surgery Patients|Circulatory Oscillations in Post Cardiac Surgery Patients|Recruiting||N/A|20|Anticipated|St. Olavs Hospital|||1||f||||f||||||||No||2017-10-10 22:13:25.293282|2017-10-10 22:13:25.293282
NCT02765594|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2017-09-19|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|HCQIgAN||Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy|Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy:a Single Center Prospective Randomized Controlled Study|Recruiting||Phase 4|98|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 22:13:25.387102|2017-10-10 22:13:25.387102
NCT02765581|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-05-28|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura|Clinical Efficacy of Acupuncture in the Prevention of Migraine Without Aura: a Randomized Sham-controlled Trial|Not yet recruiting||N/A|150|Anticipated|Huazhong University of Science and Technology||3|||f||||t||||||||Undecided||2017-10-10 22:13:25.546628|2017-10-10 22:13:25.546628
NCT02765568|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-09-20|||June 2016||2016-06-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|CRX-Modalities||Investigating the Effects of Cardiac Rehabilitation eXercise Modalities on Physical and Mental Health Outcomes|Investigating the Effects of Cardiac Rehabilitation eXercise Modalities on Physical and Mental Health Outcomes|Recruiting||N/A|135|Anticipated|Ottawa Heart Institute Research Corporation||3|||f||||f||||||||||2017-10-10 22:13:25.692211|2017-10-10 22:13:25.692211
NCT02765555|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-05|||March 2010||2010-03-01|May 2016|2016-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||First in Man Study of Safety, Tolerability and PK Profile of RBP-7000|An Open Label, Single Center, Single Dose, Phase 1, First in Man Study of the Safety, Tolerability and Pharmacokinetic Profile of RBP-7000|Completed||Phase 1|12|Actual|Indivior Inc.||1|||f||||f||||||||||2017-10-10 22:13:25.802182|2017-10-10 22:13:25.802182
NCT02765542|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-05-04|||July 2014||2014-07-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Developing Accessible mHealth Programs for Depression Management in Bolivia|Developing Accessible mHealth Programs for Depression Management in Bolivia|Completed||N/A|32|Actual|University of Michigan||1|||f||||f||||||||No||2017-10-10 22:13:25.900993|2017-10-10 22:13:25.900993
NCT02765529|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-06|||November 2015||2015-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|AEROTOX-2||Biomarkers of Exposure to Air Pollutants (AEROTOX-2)|Research of Biomarkers of Air Pollutants Exposure|Completed||N/A|101|Actual|Lille Catholic University||4|||f||||f||||||||No||2017-10-10 22:13:26.011314|2017-10-10 22:13:26.011314
NCT02765516|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-03-21|||June 2016||2016-06-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|GenePredict-PS||Genetic Basis for Prediction of Non-responders to Dietary Plant Sterol Intervention|Genetic Basis for Prediction of Non-responders to Dietary Plant Sterol Intervention|Recruiting||N/A|64|Anticipated|University of Manitoba||2|||f||||f||||||||Undecided||2017-10-10 22:13:26.114787|2017-10-10 22:13:26.114787
NCT02765503|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-03-29|||March 2014||2014-03-01|March 2017|2017-03-01|November 2021|Anticipated|2021-11-01|November 2018|Anticipated|2018-11-01||Interventional|HYPNO||Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial|A Randomized Multicenter Trial of Accelerated Hypo - vs. Normo-fractionated Radiotherapy for Head and Neck Squamous Cell Carcinoma (IAEA-HYPNO Trial)|Recruiting||Phase 3|836|Anticipated|International Atomic Energy Agency||2|||f||||t||||||||No||2017-10-10 22:13:26.2358|2017-10-10 22:13:26.2358
NCT02765490|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-08-17|||November 9, 2016|Actual|2016-11-09|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|August 9, 2017|Actual|2017-08-09||Interventional|||Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection|A Phase 2b, Multicenter, Randomized, Open-label Study to Investigate the Efficacy, Safety and Pharmacokinetics of Different Treatment Regimens of AL-335, Odalasvir, and Simeprevir in Treatment-naive and Treatment-experienced Subjects With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5, and 6 Infection Without Cirrhosis|Active, not recruiting||Phase 2|365|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 22:13:26.473676|2017-10-10 22:13:26.473676
NCT02765477|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-11-29|||June 2016||2016-06-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Observational|PERFECT||Paced Electrocardiogram Requiring Fast Emergent Coronary Therapy (PERFECT) Study|Paced Electrocardiogram Requiring Fast Emergent Coronary Therapy (PERFECT) Study|Recruiting||N/A|1500|Anticipated|Hennepin County Medical Center, Minneapolis|||4||f||||f||||||||Undecided||2017-10-10 22:13:26.642277|2017-10-10 22:13:26.642277
NCT02764866|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-03-01|||February 2016||2016-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|SAIL||Sleep Apnea in Lung Cancer: A Prospective Study|Prevalence of Sleep Apnea in Lung Cancer|Recruiting||N/A|100|Anticipated|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz||1|||f||||f||||||||Undecided||2017-10-10 22:13:32.111566|2017-10-10 22:13:32.111566
NCT02765451|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-06-08|||September 2015||2015-09-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|ERNU||Study Evaluating Intervention in the Development of Clinical Research in Non-Academic Health Institution (ERNU)|Randomized Trial Evaluating Intervention of the Cancéropôle Nord-Ouest in the Development of Clinical Research in Non-Academic Health Institutions (ERNU)|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||t||||||||||2017-10-10 22:13:26.804938|2017-10-10 22:13:26.804938
NCT02765438|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-05-24|||June 2016||2016-06-01|May 2017|2017-05-01||||August 2017|Anticipated|2017-08-01||Interventional|||"Lower Limb Muscle Activity With BOBO"|"Lower Limb Muscle Activity During Task-specific Exercises With BOBO"|Not yet recruiting||N/A|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||Undecided||2017-10-10 22:13:27.012174|2017-10-10 22:13:27.012174
NCT02765425|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-12-14|||January 2017||2017-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Training the Brain With a Robotic Device for Balance Recovery|Training the Brain With a Robotic Device for Balance Recovery in Near-frail Older Adults|Not yet recruiting||Phase 1|40|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-10-10 22:13:27.069636|2017-10-10 22:13:27.069636
NCT02765412|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-06-19|||November 15, 2016|Actual|2016-11-15|June 2017|2017-06-01|September 30, 2019|Anticipated|2019-09-30|August 31, 2019|Anticipated|2019-08-31||Observational|||PrOVE QUERI Project #1|Implementing Guidelines for Shared Decision Making in Lung Cancer Screening (QUE 15-286)|Enrolling by invitation||N/A|60000|Anticipated|VA Office of Research and Development|||2||f||||f|f|f|||f|||No||2017-10-10 22:13:27.368719|2017-10-10 22:13:27.368719
NCT02765399|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-02-28|||February 1, 2015|Actual|2015-02-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis|The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis - a Single-center Randomized Controlled Study|Recruiting||Phase 4|26|Anticipated|Helsinki University Central Hospital||2|||f||||||||||||No||2017-10-10 22:13:27.475709|2017-10-10 22:13:27.475709
NCT02765386|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-05-10|||October 2015||2015-10-01|April 2016|2016-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Optimisation of Hybrid Fittings for Cochlear Implant Recipients|Optimisation of Hybrid Fittings for Newly Implanted Cochlear Implant Recipients|Recruiting||N/A|30|Anticipated|The Hearing Cooperative Research Centre||1|||f||||f||||||||No||2017-10-10 22:13:27.564244|2017-10-10 22:13:27.564244
NCT02765373|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-05-05|||January 2015||2015-01-01|May 2016|2016-05-01||||November 2017|Anticipated|2017-11-01||Observational|||Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients||Enrolling by invitation||N/A|500|Anticipated|Chinese Academy of Medical Sciences|||2||f||||||||||||Undecided||2017-10-10 22:13:27.646263|2017-10-10 22:13:27.646263
NCT02765360|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-05-02|||May 2016||2016-05-01|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|EIT & NIV Step||EIT Study With COPD and OHS Patients (EIT Step 2)|Changes in Lung Ventilation With Different Modes of Non-invasive Ventilation in COPD and OHS Patients|Completed||N/A|22|Actual|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:13:27.725288|2017-10-10 22:13:27.725288
NCT02765347|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-05-07|||January 2016||2016-01-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effects of Metformin on Glycemic Control and Insulin Sensitivity in Adolescents With T1DM|The Effects of Metformin on Glycemic Control and Insulin Sensitivity in Adolescents With T1DM: A Randomized, Cross-over, Prospective Study|Recruiting||Phase 4|30|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||Undecided||2017-10-10 22:13:27.795452|2017-10-10 22:13:27.795452
NCT02765334|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-05-04|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|nBETTER||A Study of Neurostyle Brain Exercise Therapy Towards Enhanced Recovery (nBETTER) for Stroke|A Pilot Feasibility Clinical Trial of Neurostyle Brain Exercise Therapy Towards Enhanced Recovery (nBETTER) for postStroke Arm Paresis|Recruiting||N/A|13|Anticipated|Tan Tock Seng Hospital||1|||f||||f||||||||No||2017-10-10 22:13:27.883924|2017-10-10 22:13:27.883924
NCT02765321|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-05|||April 2016||2016-04-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Interventional|Life of Health||"Populational Program of Physical Activity and Healthy Eating Promotion: the Life of Health Study"||Recruiting||N/A|10000|Anticipated|University of Sao Paulo||1|||f||||f||||||||No||2017-10-10 22:13:27.985946|2017-10-10 22:13:27.985946
NCT02765308|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-07-31|||August 2013||2013-08-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Aqueous Humor Dynamics and Hypertensive Uveitis|The Contribution of Altered Aqueous Dynamics in the Development of Raised Intraocular Pressure in Patients With Uveitis|Completed||N/A|94|Actual|Guy's and St Thomas' NHS Foundation Trust|||3||f||||f||||||||||2017-10-10 22:13:28.080865|2017-10-10 22:13:28.080865
NCT02765295|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-09-07|||September 2016||2016-09-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|HYBRID||Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis: A Randomized, Multi-center, Double-blind Study|Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis (HYBRID): A Randomized, Multi-center, Double-blind, Parallel-group Study|Not yet recruiting||N/A|120|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||t||||||||Undecided||2017-10-10 22:13:28.171838|2017-10-10 22:13:28.171838
NCT02765282|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-04|||July 2016||2016-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|DBS-Expert||Automated Deep Brain Stimulation Programming Using Functional Mapping|Automated Deep Brain Stimulation Programming Using Functional Mapping|Not yet recruiting||N/A|40|Anticipated|Great Lakes NeuroTechnologies Inc.||2|||f||||f||||||||||2017-10-10 22:13:28.458573|2017-10-10 22:13:28.458573
NCT02765269|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-10-23|2016-07-13||May 2016||2016-05-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Intelligent Pain Management System for Assessing Pain in Cancer Patients|Development and Testing of an Intelligent Pain Management System (IPMS) for Chinese Patients With Cancer|Completed||N/A|46|Actual|Xinhua Translational Institute for Cancer Pain, Shanghai||2|||f||||f||||||||Undecided||2017-10-10 22:13:28.59525|2017-10-10 22:13:28.59525
NCT02764853|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-03-31|||December 2015||2015-12-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|STEP-AD||Striving Towards EmPowerment and Medication Adherence (STEP-AD)|Striving Towards EmPowerment and Medication Adherence (STEP-AD)|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 22:13:32.186182|2017-10-10 22:13:32.186182
NCT02765256|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-05|||August 2016||2016-08-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|Holiday||Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease|Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease|Recruiting||Phase 2|30|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:13:29.05676|2017-10-10 22:13:29.05676
NCT02765243|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-03-09|||May 2016||2016-05-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|4SCAR-GD2||Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma|Anti-GD2 4th Generation Chimeric Antigen Receptor-modified T Cells (4SCAR-GD2) Targeting Refractory and/or Recurrent Neuroblastoma|Recruiting||Phase 2|30|Anticipated|Zhujiang Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:13:29.202742|2017-10-10 22:13:29.202742
NCT02765230|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-05|||January 2014||2014-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||An Interocular Comparative Study of Unilateral Cataract|Interocular Anatomical and Visual Functional Differences in Pediatric Patients With Unilateral Cataracts at 3 Months Post-surgery: A Cross-sectional Study|Completed||N/A|53|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 22:13:29.314288|2017-10-10 22:13:29.314288
NCT02765217|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-25|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|July 1, 2018|Anticipated|2018-07-01||Interventional|PEARL||Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children|Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children: Prospective, Multi-center, Randomize, Parallel Group Placebo Controlled Clinical Trial|Recruiting||Phase 4|1440|Anticipated|Eskisehir Osmangazi University||4|||f||||f|f|f||||||||2017-10-10 22:13:29.399409|2017-10-10 22:13:29.399409
NCT02765204|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-12-09|||March 2016||2016-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Single-dose Cross-over Study to Assess Direct and Indirect Effects of Dapagliflozin on Pancreatic Alpha and Beta Cells in Patients With Type 2 Diabetes|A Single-dose Cross-over Study to Assess Direct and Indirect Effects of Dapagliflozin on Pancreatic Alpha and Beta Cells in Patients With Type 2 Diabetes|Completed||Phase 4|15|Actual|Uppsala University||6|||f||||f||||||||||2017-10-10 22:13:29.538728|2017-10-10 22:13:29.538728
NCT02765191|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-04|||April 2016||2016-04-01|May 2016|2016-05-01||||April 2018|Anticipated|2018-04-01||Interventional|MERSEP||MR-Evaluation of Renal Function In Septic Patients|MR-Evaluation of Renal Function In Septic Patients|Recruiting||N/A|20|Anticipated|Uppsala University||1|||f||||f||||||||No||2017-10-10 22:13:29.655984|2017-10-10 22:13:29.655984
NCT02765178|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-07-03|||April 2016||2016-04-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Observational|||Apathy in Tourette Syndrome and Changes in Quality of Life|Apathy in Tourette Syndrome and Changes in Quality of Life - Effect of Medications|Completed||N/A|38|Actual|University of Florida|||2||f||||f||||||||||2017-10-10 22:13:29.779876|2017-10-10 22:13:29.779876
NCT02765165|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-08|||April 2016||2016-04-01|September 2017|2017-09-01||||December 2019|Anticipated|2019-12-01||Interventional|||Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)|A Phase 1/2 Dose-escalation of USL311 as Single Agent and in Combination With Lomustine (CCNU) in Subjects With Advanced Solid Tumors, With Subsequent Single Agent and Combination Phase 2 Cohorts for Subjects With Relapsed/Recurrent Glioblastoma Multiforme (GBM)|Active, not recruiting||Phase 1/Phase 2|120|Anticipated|Proximagen, LLC||4|||f||||||||||||||2017-10-10 22:13:29.885814|2017-10-10 22:13:29.885814
NCT02765152|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-01-27|||June 2016||2016-06-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Training Rhythmic and Discrete Aiming Movements on Arm Control and Functionality After Stroke|Effects of Training Rhythmic and Discrete Aiming Movements on the Upper Limb Control and Functionality After Stroke: Randomized Controlled Trial|Recruiting||N/A|75|Anticipated|Universidade Cidade de Sao Paulo||3|||f||||t||||||||No||2017-10-10 22:13:30.016262|2017-10-10 22:13:30.016262
NCT02765139|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-05-23|||February 2016||2016-02-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Preventing Intimate-partner Violence: Impact Evaluation of Engaging Men Through Accountable Practice in Eastern DRC|Preventing Intimate-partner Violence: Impact Evaluation of Engaging Men Through Accountable Practice in Eastern DRC|Active, not recruiting||N/A|1500|Anticipated|World Bank||2|||f||||f|f|f||||||Yes|The World Bank has an open data policy, and the de-identified, anonymized data will be published online after the study is completed.|2017-10-10 22:13:30.154891|2017-10-10 22:13:30.154891
NCT02765126|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-07-25|||May 2016||2016-05-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly|Clifford Craig Vaccine Trial Centre: Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Vaccine Challenge in the Elderly|Recruiting||N/A|450|Anticipated|Clifford Craig Medical Research Trust||3|||f||||f||||||||||2017-10-10 22:13:30.245476|2017-10-10 22:13:30.245476
NCT02765113|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-05-04|||May 2016||2016-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Two Different Surgical Methods of Blepharospasm|Effect of Two Different Surgical Methods on the Prognosis of Patients With Blepharospasm|Not yet recruiting||Early Phase 1|40|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Yes||2017-10-10 22:13:30.360699|2017-10-10 22:13:30.360699
NCT02765100|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-11-22|||October 2014||2014-10-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Depression, Obesity and Inflammatory Markers|Depression, Obesity and Inflammatory Markers|Recruiting||N/A|180|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||No|Individual Participant Data will not be shared.|2017-10-10 22:13:30.424592|2017-10-10 22:13:30.424592
NCT02765087|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-05|||January 2015||2015-01-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||E-Nose: Diagnostic Tool for Pleural TB|Diagnostic Utility of the E-Nose for Pleural TB|Active, not recruiting||N/A|100|Actual|Universidad Central de Venezuela||2|||f||||t||||||||No||2017-10-10 22:13:30.503496|2017-10-10 22:13:30.503496
NCT02764879|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-05|||July 2014||2014-07-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Omega 3 on Periodontitis in Postmenopausal Women|Effect of Omega 3 Fatty Acids on Chronic Periodontitis Patients in Postmenopausal Women: A Randomized Controlled Clinical Study|Completed||Phase 2|50|Actual|October 6 University||2|||f||||f||||||||No||2017-10-10 22:13:32.042052|2017-10-10 22:13:32.042052
NCT02765074|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-03-24|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|REPAIR||Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis|Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of 12 Months Subcutaneous Tocilizumab in Rheumatoid Arthritis Phase IV Prospective Multicentrique Study|Recruiting||Phase 4|60|Anticipated|Centre Hospitalier Régional d'Orléans||1|||f||||f||||||||No||2017-10-10 22:13:30.577867|2017-10-10 22:13:30.577867
NCT02765061|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-06|||May 2013||2013-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Hyponatremia and Hypoalbuminemia is Morbimortality Predictors in Coronary Artery Bypass Graft Surgery|Hyponatremia and Hypoalbuminemia is Morbimortality Predictors in Coronary Artery Bypass|Completed||N/A|1157|Actual|Ankara University|||1||f||||f||||||||Undecided||2017-10-10 22:13:30.668636|2017-10-10 22:13:30.668636
NCT02765048|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-04|||August 2010||2010-08-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|GAIN||Violence Prevention for Adolescent Girls With Prior Maltreatment|Violence Prevention for Adolescent Girls With Prior Maltreatment|Completed||N/A|312|Actual|Washington University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:13:30.71637|2017-10-10 22:13:30.71637
NCT02765035|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-12-13|||April 2016||2016-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||C-Leg 3 and C-Leg 4 Study in Transfemoral Amputees|A Randomized, Blinded, Cross-over Trial to Evaluate the Safety, Functional Mobility and Satisfaction of the Microprocessor Controlled Prosthetic Knee Component C-Leg 4 in Transfemoral Amputees|Recruiting||Phase 4|20|Anticipated|Otto Bock Healthcare Products GmbH||2|||f||||t||||||||Yes|Data for primary and secondary outcome measures will be made available within one year of study completion.|2017-10-10 22:13:30.811457|2017-10-10 22:13:30.811457
NCT02765022|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-02|||June 2016||2016-06-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Clip Closure of Mucosal Defects After Endoscopic Mucosal Resection.|Clip Closure of Mucosal Defects After Endoscopic Mucosal Resection of Large Colorectal Lesions as Prophylaxis of Delayed Haemorrhage.|Recruiting||Phase 4|332|Anticipated|Fundacion Miguel Servet||2|||f||||||||||||||2017-10-10 22:13:31.073529|2017-10-10 22:13:31.073529
NCT02765009|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-07-26|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|POINCARE||Effects of Fluid Balance Control in Critically Ill Patients|Effects of Fluid Balance Control in Critically Ill Patients: A Multicenter Randomized Study|Recruiting||N/A|1716|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 22:13:31.162465|2017-10-10 22:13:31.162465
NCT02764996|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-09|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||An Exploratory Prospective Trial of Rescue Acupuncture for the Treatment of Acute Migraine|An Exploratory Prospective Trial of Rescue Acupuncture for the Treatment of Acute Migraine|Completed||N/A|26|Actual|Mike O'Callaghan Federal Hospital||1|||f||||f||||||||||2017-10-10 22:13:31.302603|2017-10-10 22:13:31.302603
NCT02764983|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-14|||January 2013||2013-01-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|September 2015|Actual|2015-09-01||Interventional|||Occupational Therapy Driving Intervention for Returning Combat Veterans.|Efficacy of a Driving Program on Safe Community Mobility for Combat Veterans|Active, not recruiting||N/A|66|Actual|University of Florida||5|||f||||f|f|f||||||||2017-10-10 22:13:31.386502|2017-10-10 22:13:31.386502
NCT02764957|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-08-25|||December 1, 2016|Actual|2016-12-01|August 2017|2017-08-01|April 21, 2017|Actual|2017-04-21|March 21, 2017|Actual|2017-03-21||Interventional|||Green Coffee Extract and Metabolic Syndrome|Effects of Green Coffee Extract Supplementation on Anthropometric Measurements, Glycemic Control, Blood Pressure, Lipid Profile|Completed||Phase 2/Phase 3|43|Actual|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-10 22:13:31.55482|2017-10-10 22:13:31.55482
NCT02764944|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-05-04|||August 2015||2015-08-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Endoscopic Full Thickness Resection Without Exposure to Peritoneum|Endoscopic Full Thickness Resection Without Exposure to Peritoneum: Single Center Single Arm Study|Recruiting||Phase 1|12|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||No||2017-10-10 22:13:31.63431|2017-10-10 22:13:31.63431
NCT02764931|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-05-29|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 1|Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 1|Not yet recruiting||N/A|15|Anticipated|University of Turku||3|||f||||f|f|f||||||Undecided||2017-10-10 22:13:31.718527|2017-10-10 22:13:31.718527
NCT02764918|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-04|||January 2014||2014-01-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Cryptosporidiosis and Enteropathogens in Bangladesh|Field Studies of Cryptosporidiosis and Enteropathogens in Bangladesh|Recruiting||N/A|500|Anticipated|University of Virginia|||2||f||||f||||||||No||2017-10-10 22:13:31.808556|2017-10-10 22:13:31.808556
NCT02764905|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-05-03|||November 2016||2016-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|||Intensive Cognitive and Physical Rehabilitation Program|A Comprehensive Intervention for Promoting Successful Aging Amongst Below the Cognitive Norm Older People With Diabetes- a Feasibility Study|Enrolling by invitation||N/A|60|Anticipated|Sheba Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:13:31.887349|2017-10-10 22:13:31.887349
NCT02764892|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-05-04|||August 2012||2012-08-01|May 2016|2016-05-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease|An Open Label Study of V81444 Using Positron Emission Tomography to Assess Occupancy of Brain Adenosine A2A Receptors & Functional & Perfusion MRI to Explore Effects on Regional Brain Activity & Perfusion in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Vernalis (R&D) Ltd||1|||f||||f||||||||||2017-10-10 22:13:31.970269|2017-10-10 22:13:31.970269
NCT02764840|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-04-24|||February 2015||2015-02-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Muscular Resistance Test in the Elastic Tube: Reliability and Training of the Proposed Method|Muscular Resistance Test in the Elastic Tube: Reliability and Training of the Proposed Method|Completed||N/A|230|Actual|São Paulo State University||2|||f||||t||||||||Yes||2017-10-10 22:13:32.273346|2017-10-10 22:13:32.273346
NCT02764827|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-06|||November 2014||2014-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Comparison of Skin Prick Testing Results of Local and Imported Pollen Allergen Extracts and Specific IgE|Comparison of Skin Prick Testing Results of Local and Imported Pollen Allergen Extracts (Bermuda ,Johnson Grasses and Careless Weed) With Specific IgE Levels.|Completed||N/A|68|Actual|Mahidol University|||1||f||||f||||||||No||2017-10-10 22:13:32.344949|2017-10-10 22:13:32.344949
NCT02764814|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-11-21|||July 2015||2015-07-01|August 2016|2016-08-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye|In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye|Completed||N/A|20|Actual|Tissue Tech Inc.||2|||f||||f||||||||No||2017-10-10 22:13:32.412047|2017-10-10 22:13:32.412047
NCT02764788|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-11-02|||April 2016||2016-04-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|Fib-Auric||Auriculotherapy Treatment in Fibromyalgia||Recruiting||N/A|100|Anticipated|Hopital Foch||3|||f||||f||||||||No||2017-10-10 22:13:32.603828|2017-10-10 22:13:32.603828
NCT02764775|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-04-25|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|headpod||Measuring Head Control Change With 2D Video Analysis After Utilization of Headpod in Children With Poor Head Control|Measuring Head Control Changes With 2d Video Analysis After Utilization of the Headpod in Children With Cerebral Palsy and Poor Head Control|Completed||N/A|14|Actual|Texas Woman's University||1|||f||||t||||||||No||2017-10-10 22:13:32.691921|2017-10-10 22:13:32.691921
NCT02764762|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2017-04-06|||April 5, 2017|Actual|2017-04-05|April 2017|2017-04-01|April 23, 2021|Anticipated|2021-04-23|April 23, 2021|Anticipated|2021-04-23||Interventional|||Triple Combination Therapy in High Risk Crohn's Disease|An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Triple Combination Therapy With Vedolizumab IV, Adalimumab SC, and Oral Methotrexate in Early Treatment of Subjects With Crohn's Disease Stratified at Higher Risk for Developing Complications|Recruiting||Phase 4|60|Anticipated|Takeda||1|||f||||f|t|f||||||||2017-10-10 22:13:34.40204|2017-10-10 22:13:34.40204
NCT02764749|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-11-24|||June 2016||2016-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Cranberry (Poly)Phenol Consumption on Vascular Function|Sustained Effects of Cranberry (Poly)Phenol Consumption on Vascular Function in Healthy Individuals|Completed||N/A|40|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||No||2017-10-10 22:13:34.566405|2017-10-10 22:13:34.566405
NCT02764736|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-05-16|||March 4, 2016|Actual|2016-03-04|May 2017|2017-05-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|ARChIVED||Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)|Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)|Withdrawn||N/A|0|Actual|Albert Einstein Healthcare Network||1||Enrollment did not progress as anticipated. No participants enrolled.|f||||t|f|f||||||No||2017-10-10 22:13:34.658065|2017-10-10 22:13:34.658065
NCT02764723|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-06-06|||January 2013||2013-01-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Isobaric Spinal Ropivacaine Versus Hyperbaric Spinal Bupivacaine in Total Knee Arthroplasty in Geriatric Patients|Isobaric Ropivacaine 15 mg Versus Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Geriatric Patients Undergoing Total Knee Arthroplasty|Completed||N/A|52|Actual|Al Mouwasat Hospital||2|||f||||f||||||||Yes||2017-10-10 22:13:34.748924|2017-10-10 22:13:34.748924
NCT02764710|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-08|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Randomized Controlled Trial Comparing Long and Short Duration of Antibiotic Prophylaxis for Patients Undergoing Sinus Lift Surgery|Randomized Controlled Trial Comparing Long and Short Duration of Antibiotic Prophylaxis for Patients Undergoing Sinus Lift Surgery|Not yet recruiting||Phase 3|250|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-10 22:13:34.825996|2017-10-10 22:13:34.825996
NCT02764697|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-07|||July 2016||2016-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients|Prospective Open Label Study of H.P. Acthar Gel Injection in Patients With Active Non-Infectious Uveitis With Associated Glaucoma Thus High Frequency Regional Corticosteroid and Oral Corticosteroids Cause Intolerable Side-Effects|Completed||Phase 4|6|Actual|Tampa Bay Uveitis Center, LLC||1|||f||||f||||||||No||2017-10-10 22:13:34.9233|2017-10-10 22:13:34.9233
NCT02764684|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-10-09|||January 2015||2015-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||The Effect of Probiotics on Microbial Translocation and Inflammation in HIV-infected Patients|The Effect of Probiotics on Microbial Translocation and Inflammation in HIV-infected Patients|Completed||N/A|45|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||Yes|The investigator plan to publish data in an article when the study is completed|2017-10-10 22:13:35.052121|2017-10-10 22:13:35.052121
NCT02764671|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-05|||May 2015||2015-05-01|May 2016|2016-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates|The Safety and Immunogenicity of 10μg/0.5ml Recombinant Hepatitis B Vaccines(Saccharomyces Cerevisiae) in the Healthy Neonates|Recruiting||Phase 4|5000|Anticipated|Shenzhen Kangtai Biological Products Co., LTD||1|||f||||t||||||||||2017-10-10 22:13:35.136653|2017-10-10 22:13:35.136653
NCT02764658|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-05-05|||May 2016||2016-05-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Proteoglycan 4 Mechanism the Effectiveness of Pulmaonry Recovery in COPD Patients|Studies in Pulmonary Inflammation and the Effectiveness of Pulmonary Recovery in COPD Patients：the Mechanism of Proteoglycan 4|Enrolling by invitation||N/A|90|Anticipated|Taipei Medical University||3|||f||||t||||||||No||2017-10-10 22:13:35.328648|2017-10-10 22:13:35.328648
NCT02764645|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-05|||May 2016||2016-05-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Interventional|GECG||Performance of the CARDIOGARD Cannula|A Study to Collect Additional Information Related to the Performance of the CARDIOGARD Cannula|Not yet recruiting||N/A|400|Anticipated|Rambam Health Care Campus||2|||f||||t||||||||Yes|The data of this research would be published as an article and will include all the relevant clinical outcomes related to the effect of gaseous emboli.|2017-10-10 22:13:35.442651|2017-10-10 22:13:35.442651
NCT02764632|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-05|2016-05-08|||August 2015||2015-08-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|NGT||Facilitation of NGT Insertion|Digital Facilitation of Nasogastric Tube Insertion Under General Anethesia|Completed||N/A|150|Actual|Mansoura University||2|||f||||t||||||||Yes||2017-10-10 22:13:35.530326|2017-10-10 22:13:35.530326
NCT02764619|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-05-16|||December 2013||2013-12-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|INSPIRE-AF||Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation|Phase 3, Prospective, Randomized, Double-blinded, Placebo-controlled Study to Evaluate Efficacy of add-on Therapy With Spironolactone to Reduce Diffuse Myocardial Fibrosis Thus Preventing Recurrent Episodes of Atrial Fibrillation in Patients With Paroxysmal or Persistent Atrial Fibrillation and Preserved Ejection Fraction Compared to Usual Care.|Active, not recruiting||Phase 3|125|Actual|Svendborg Hospital||2|||f||||t||||||||||2017-10-10 22:13:35.602849|2017-10-10 22:13:35.602849
NCT02764606|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-05|||November 2013||2013-11-01|May 2016|2016-05-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Observational|CANPOS||CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer|CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer|Recruiting||N/A|250|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     Serum and plasma   "|||2017-10-10 22:13:35.720724|2017-10-10 22:13:35.720724
NCT02764593|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-07-11|||June 2016||2016-06-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer|Safety Evaluations of Nivolumab (Anti-PD-1) Added To Chemotherapy (CRT) Platforms In Patients With Intermediate And High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1|120|Anticipated|RTOG Foundation, Inc.||4|||f||||t||||||||||2017-10-10 22:13:35.814374|2017-10-10 22:13:35.814374
NCT02764580|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-05|||May 2016||2016-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:13:35.96933|2017-10-10 22:13:35.96933
NCT02764567|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-06-01|||May 2016||2016-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Essential Oil Aromatherapy Intervention|Essential Oil Aromatherapy Intervention: Easing the Discomforts of Phlebotomy With Essential Oil Aromatherapy|Recruiting||N/A|40|Anticipated|HealthEast Care System||2|||f||||f||||||||No|Study results will be shared with the organization and submitted for publication. Individual participant data will not be shared.|2017-10-10 22:13:36.01902|2017-10-10 22:13:36.01902
NCT02764554|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-06-01|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|||Post-Marketing Surveillance of Lenvima in Korean Patients|Post-Marketing Surveillance of Lenvima in Korean Patients|Recruiting||N/A|3000|Anticipated|Eisai Inc.|||1||f||||f||||||||||2017-10-10 22:13:36.110725|2017-10-10 22:13:36.110725
NCT02764541|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-07-25|||May 2016||2016-05-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)|Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS): A Randomized Phase II Study of Palbociclib With Letrozole Versus Letrozole Alone for Invasive Lobular Carcinoma and Invasive Ductal Carcinoma|Recruiting||Phase 2|180|Anticipated|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-10-10 22:13:36.17928|2017-10-10 22:13:36.17928
NCT02764528|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-10-04|||February 1, 2016|Anticipated|2016-02-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|December 1, 2016|Anticipated|2016-12-01||Interventional|||Intervention Study to Improve Maternal Handwashing|Effects of Promoting Handwashing With Soap to Improve Maternal Handwashing Behavior During the Neonatal Period|Withdrawn||N/A|0|Actual|State University of New York at Buffalo||4||Donor altered priorities for available funding and eliminated the project|f||||f|f|f||||||||2017-10-10 22:13:36.28658|2017-10-10 22:13:36.28658
NCT02764515|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-03-08|||September 2015||2015-09-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Kunxian for the Treatment of Rheumatoid Arthritis|Comparison of the Efficacy and Safety of Kunxian Capsule and Methotrexate for the Treatment of Rheumatoid Arthritis|Recruiting||Phase 4|428|Anticipated|Chinese SLE Treatment And Research Group||2|||f||||t||||||||No||2017-10-10 22:13:36.375657|2017-10-10 22:13:36.375657
NCT02764502|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-05-05|||March 2012||2012-03-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Identification of Epidural Space Description of New Technique|Identification of Epidural Space Description of New Technique|Completed||N/A|60|Actual|Assiut University||1|||f||||t||||||||Yes||2017-10-10 22:13:36.552591|2017-10-10 22:13:36.552591
NCT02764489|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||FEIBA Reconstitution Volume Reduction and Faster Infusion Study|A Two-part, Phase 3b, Prospective, Multicenter, Open-label, Randomized, Crossover Study of the PK and Safety of FEIBA Reconstituted in Regular or 50% Reduced Volume and the Safety of Faster Infusion Rates in Patients With Hemophilia A or B With Inhibitors|Not yet recruiting||Phase 3|32|Anticipated|Baxalta US Inc.||2|||f||||||||||||||2017-10-10 22:13:36.630002|2017-10-10 22:13:36.630002
NCT02764476|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-02-19|||May 2016||2016-05-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|December 2018|Anticipated|2018-12-01||Interventional|VR4FND||Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder|Safety and Feasibility of Virtual Reality Therapy for Functional Neurological Symptom/Conversion Disorder|Recruiting||N/A|30|Anticipated|Stanford University||2|||f||||t||||||||No||2017-10-10 22:13:36.724288|2017-10-10 22:13:36.724288
NCT02764463|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-07-25|||June 1999||1999-06-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|September 2016|Anticipated|2016-09-01||Interventional|FRCPDs||15 Years Control of Fiber Reenforced Composite Fixed Partial Dentures|Clinical Survival of Indirect, Lateral-posterior 3-unit Occlusal-retained Fiber-reinforced Composite Fixed Dental Prosthesis: 15-years Follow-up|Enrolling by invitation||N/A|58|Actual|BNM Clinic and Research||1|||f||||f||||||||Undecided||2017-10-10 22:13:36.820297|2017-10-10 22:13:36.820297
NCT02764424|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-12-07|||August 2016||2016-08-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|NIPE-DOL||Pain Management in Neonatal Intensive Care Units by Studying the Autonomic Balance|Pain Management in Neonatal Intensive Care Units by Studying the Autonomic Balance : Interest of the Co-evaluation of NIPE and Hetero-assessment Scale : the NIPE-DOL Study|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 22:13:37.189921|2017-10-10 22:13:37.189921
NCT02764411|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-03|||June 2016||2016-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations|Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations: A Prospective, Open-label, Cohort Study|Not yet recruiting||Phase 3|20|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||No||2017-10-10 22:13:37.325496|2017-10-10 22:13:37.325496
NCT02764398|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-05-09|||December 2013||2013-12-01|May 2016|2016-05-01||||November 2015|Actual|2015-11-01||Observational|||Cardio-respiratory Events During Ophthalmic Artery Chemotherapy for Retinoblastoma Under a Deep Anesthesia|Prospective Analysis of Serious Cardio-respiratory Events During Ophthalmic Artery Chemotherapy for Retinoblastoma Under a Deep and Standardized Anesthesia|Completed||N/A|32|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 22:13:37.470827|2017-10-10 22:13:37.470827
NCT02764385|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-05-05|||June 2016||2016-06-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||Using a Teachable Moment Communication Process to Improve Outcomes of Quitline Referrals|Using a Teachable Moment Communication Process to Improve Outcomes of Quitline Referrals|Not yet recruiting||N/A|20000|Anticipated|Case Western Reserve University||2|||f||||f||||||||Undecided||2017-10-10 22:13:37.525269|2017-10-10 22:13:37.525269
NCT02764372|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-05|||July 2015||2015-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|Telerehab||Telerehabilitation Upper Extremity for Neurological Disorders|Serious Games for Upper Extremity Rehabilitation for Patients With Neurological Disorders: A Pilot Study|Completed||Phase 1|20|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||Undecided||2017-10-10 22:13:37.600577|2017-10-10 22:13:37.600577
NCT02764359|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-14|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of Obese Patients Comparing Two Vancomycin Loading Dose Regimens|Single-Center Prospective Study of Obese Patients Comparing Two Vancomycin Loading Dose Regimens|Recruiting||N/A|128|Anticipated|CAMC Health System||2|||f||||f||||||||||2017-10-10 22:13:37.678727|2017-10-10 22:13:37.678727
NCT02764346|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-20|||July 2016||2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||iCanCope With Pain: Usability and Feasibility Testing of a Smartphone Application to Manage Pain in Youth With Arthritis|iCanCope With Pain: Usability and Feasibility Testing of a Smartphone Application to Manage Pain in Youth With Arthritis|Recruiting||N/A|60|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 22:13:37.767264|2017-10-10 22:13:37.767264
NCT02764333|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-06-02|||May 6, 2016||2016-05-06|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer|A Phase II Trial of TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer|Recruiting||Phase 2|40|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:13:37.873223|2017-10-10 22:13:37.873223
NCT02764320|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-08-31|||January 9, 2017|Actual|2017-01-09|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|MOTS||The MOTS (Medication Overuse Treatment Strategy) Trial|Determining the Optimal Treatment Strategy for Patients Who Have Chronic Migraine With Medication Overuse|Enrolling by invitation||N/A|1280|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 22:13:38.002059|2017-10-10 22:13:38.002059
NCT02764307|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-30|||October 2015|Actual|2015-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Aerosol Delivery in Different Types of Nebulizers|Evaluation of Aerosol Delivery in Different Types of Nebulizers|Completed||N/A|10|Actual|Chang Gung University||1|||f||||t||||||||Undecided||2017-10-10 22:13:38.127858|2017-10-10 22:13:38.127858
NCT02764294|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-05|||March 2016||2016-03-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effectiveness of the Distraction Methods During Cystoscopy|Effectiveness of the Distraction Methods on Pain, Anxiety and Satisfaction During Cystoscopy|Active, not recruiting||N/A|112|Anticipated|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||4|||f||||t||||||||No||2017-10-10 22:13:38.211681|2017-10-10 22:13:38.211681
NCT02764281|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-09-02|||April 2015||2015-04-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma|The Efficacy and Safety of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Chemotherapy (MEDA) With Autologous HSCT in the Treatment of Stage IV Natural Killer/T-Cell Lymphoma: A Multicenter, Prospective Study|Recruiting||Phase 3|37|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||||2017-10-10 22:13:38.300877|2017-10-10 22:13:38.300877
NCT02764268|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-08|||June 2016||2016-06-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer|Apatinib Dose Titration: Analyses of Exposure, Safety and Efficacy in Advanced or Metastatic Gastric Cancer|Not yet recruiting||N/A|60|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||No||2017-10-10 22:13:38.433719|2017-10-10 22:13:38.433719
NCT02764255|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-07-24|||May 2016|Actual|2016-05-01|May 2016|2016-05-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||Embryoscope and Reproductive Outcome|Does Embryoscope Improve Reproductive Outcome in ICSI Patients|Completed||N/A|770|Actual|Cairo University|||2||f||||t||||||||||2017-10-10 22:13:38.507786|2017-10-10 22:13:38.507786
NCT02764242|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-04|||February 2015||2015-02-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||The Causative Insects in Severe Insect Sting Allergy|Evaluating the Causative Insects in the Cases With Severe Insect Sting Allergy|Completed||N/A|20|Actual|Mahidol University||1|||f||||f||||||||No||2017-10-10 22:13:38.565875|2017-10-10 22:13:38.565875
NCT02764229|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-08|||September 2016||2016-09-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis|A Multicenter Open-label Extension Study to Assess the Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis|Recruiting||Phase 2|120|Anticipated|Lycera Corp.||1|||f||||f||||||||||2017-10-10 22:13:38.634185|2017-10-10 22:13:38.634185
NCT02764216|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-10-13|||January 2015||2015-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary|Elective Mucosal Irradiation in Head-and Neck Cancer of Unknown Primary, A Single Arm Phase II Trial|Recruiting||Phase 2|40|Anticipated|Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University||1|||f||||t||||||||Undecided||2017-10-10 22:13:38.745439|2017-10-10 22:13:38.745439
NCT02764203|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-10-01|||September 16, 2016|Actual|2016-09-16|October 2017|2017-10-01|September 12, 2017|Actual|2017-09-12|September 12, 2017|Actual|2017-09-12||Interventional|COCOA-BP||ChOcolate COnsumption And Blood Pressure (COCOA-BP): A Wearable Devices Pilot Trial|ChOcolate COnsumption And Blood Pressure (COCOA-BP): A Wearable Devices Pilot Trial|Completed||N/A|67|Actual|Boston Scientific Corporation||1|||f||||f|f|f||||||||2017-10-10 22:13:38.828888|2017-10-10 22:13:38.828888
NCT02764190|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-10-26|||October 2016||2016-10-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||I-ACT With Check Yourself|Delivering Patient-Centered Adolescent Preventative Care With Training and Technology|Recruiting||N/A|300|Anticipated|Seattle Children's Hospital||2|||f||||||||||||||2017-10-10 22:13:38.910933|2017-10-10 22:13:38.910933
NCT02764177|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-05|||October 2014||2014-10-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Resistance Exercise, Recovery Drinks and Appetite|Effect of Recovery Drink Composition Consumed After Resistance Exercise on Subsequent Appetite and Energy Intake|Completed||N/A|15|Actual|Loughborough University||2|||f||||f||||||||||2017-10-10 22:13:39.037755|2017-10-10 22:13:39.037755
NCT02764164|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-09-02|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Transcranial Direct Current Stimulation (TDCS) for Auditory Hallucinations in Early Onset Schizophrenia (EOS)|Transcranial Direct Current Stimulation for Auditory Hallucinations in Early Onset Schizophrenia|Completed||N/A|1|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||Undecided||2017-10-10 22:13:39.113902|2017-10-10 22:13:39.113902
NCT02764151|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-28|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||First in Patient Study for PF-06840003 in Malignant Gliomas|A Phase 1 Dose Escalation Study Evaluating The Safety And Tolerability Of Pf-06840003 In Patients With Malignant Gliomas|Recruiting||Phase 1|97|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 22:13:39.195163|2017-10-10 22:13:39.195163
NCT02764138|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-04-03|||April 2016||2016-04-01|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Preventing Internalizing in Preadolescents Exposed to Chronic Stress|Preventing Internalizing Psychopathology in Preadolescents Exposed to Chronic Stress|Recruiting||N/A|150|Anticipated|Penn State University||2|||f||||t||||||||Yes|National Data Archives, DataBrary|2017-10-10 22:13:39.312838|2017-10-10 22:13:39.312838
NCT02764112|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-12-30|||October 2015||2015-10-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Assessing the Ability of Warfarin Treated Patients to Predict Their INR|Assessing the Ability of Warfarin Treated Patients to Predict Their INR|Completed||N/A|87|Actual|Northeast Iowa Medical Education Foundation|||1||f||||f||||||||No||2017-10-10 22:13:39.68385|2017-10-10 22:13:39.68385
NCT02764099|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-05-05|||May 2016||2016-05-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||Testing a Multilevel Preventive Intervention in Youth Courts|Testing a Multilevel Preventive Intervention in Youth Courts|Not yet recruiting||N/A|560|Anticipated|National Health Promotion Associates, Inc.||2|||f||||t||||||||No||2017-10-10 22:13:39.755236|2017-10-10 22:13:39.755236
NCT02764086|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-02|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|September 2041|Anticipated|2041-09-01|September 2021|Anticipated|2021-09-01||Interventional|||INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer|INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer|Recruiting||Phase 1/Phase 2|104|Anticipated|Cancer Trials Ireland||1|||f||||t|f|f||||||Undecided||2017-10-10 22:13:39.843104|2017-10-10 22:13:39.843104
NCT02764073|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-05-03|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|BIS-HF||Bioimpedance Spectroscopy for the Evaluation of Heart Failure|Bioimpedance Spectroscopy for the Evaluation of Heart Failure - a Comparison With Clinical Assessment, Lung Ultrasonography, Cardiac Biomarkers and Echocardiography|Not yet recruiting||N/A|150|Anticipated|Grigore T. Popa University of Medicine and Pharmacy|||1||f||||f||||||Samples Without DNA|"     Serum   "|Yes||2017-10-10 22:13:39.937546|2017-10-10 22:13:39.937546
NCT02764060|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-03|||January 2011||2011-01-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of Tongue Cleaning in Periodontitis Patients|The Effect of Tongue Scraping Compared to Tongue Cleaning on the Tongue Coating of Periodontitis Patients|Completed||Early Phase 1|18|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 22:13:40.029269|2017-10-10 22:13:40.029269
NCT02764047|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-10-05|||January 2015||2015-01-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Probiotics in the Treatment of NAFLD|Effect of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease|Recruiting||N/A|58|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||||2017-10-10 22:13:40.131271|2017-10-10 22:13:40.131271
NCT02764034|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-07-22||||||July 2017|2017-07-01||||||||Expanded Access|LLLT||Effect of Low Level Laser Therapy on Endometrial Cells: An In Vitro Study|Low Level Laser Therapy to Endometrial Cells: A Novel Approach to Increase Endometrial Proliferation and Enhance Endometrial Receptivity|Available||N/A|||Cairo University|||||f||||||||||||||2017-10-10 22:13:40.25109|2017-10-10 22:13:40.25109
NCT02764021|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-07-11|||April 2016||2016-04-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CutDM-iso||Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes|Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes; Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients. The Isoenergetic Study.|Active, not recruiting||N/A|32|Actual|Bispebjerg Hospital||1|||f||||t||||||||||2017-10-10 22:13:40.346287|2017-10-10 22:13:40.346287
NCT02764008|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-10-10|||May 2016||2016-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||The Comparison of Low Thoracic Paravertebral Block Versus Peritubal Infiltration|The Comparison of Low Thoracic Paravertebral Block Versus Peritubal Infiltration in Patients Undergoing Percutaneous Nephrolithotomy|Completed||Phase 4|60|Actual|Ataturk University||3|||f||||f||||||||Undecided||2017-10-10 22:13:40.462138|2017-10-10 22:13:40.462138
NCT02763995|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-08|||April 2013||2013-04-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Pharmacotherapy Follow-up in Older HIV-infected Patients|Pharmacotherapy Follow-up in Older HIV-infected Patients: Impact on Cardiovascular Risk and Quality of Life|Completed||N/A|42|Actual|Universidad de Granada||1|||f||||f||||||||Undecided||2017-10-10 22:13:40.56441|2017-10-10 22:13:40.56441
NCT02763982|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-04|||May 2016||2016-05-01|May 2016|2016-05-01|May 2016|Anticipated|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Cardiac Function and Inspiratory Muscles Performance|Correlation Between Cardiac Function and Inspiratory Muscles Performance, Chest Wall Volumes and Quality of Life in Individuals With Heart Failure|Not yet recruiting||N/A|24|Anticipated|Universidade Federal de Pernambuco|||3||f||||||||||||||2017-10-10 22:13:40.65679|2017-10-10 22:13:40.65679
NCT02763969|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-08-02|||May 18, 2016|Actual|2016-05-18|July 2017|2017-07-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis|Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986202 in Healthy Subjects and to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of BMS-986202 in Subjects With Moderate to Severe Psoriasis|Completed||Phase 1|357|Actual|Bristol-Myers Squibb||5|||f||||t||||||||||2017-10-10 22:13:40.740359|2017-10-10 22:13:40.740359
NCT02763956|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-03|||April 2016||2016-04-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparative Evaluation of Clinical Outcome of Degenerative Disc Disease Treated With the GelStix GelStix Study|Comparative Evaluation of Clinical Outcome of Degenerative Disc Disease Treated With the GelStix™ Nucleus Augmentation Device A Randomized, Placebo-Controlled, Outcome Study|Recruiting||Phase 3|72|Anticipated|Ospedale Regionale di Lugano||2|||f||||t||||||||||2017-10-10 22:13:40.859352|2017-10-10 22:13:40.859352
NCT02763930|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-03|||February 2016||2016-02-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|GABA2||Study of the Impact of Low Fat Dairy and High Fat Dairy Consumption on Daytime Ambulatory Blood Pressure|Study of the Impact of Low Fat Dairy (Milk) and High Fat Dairy (Cheese) Consumption on Daytime Ambulatory Blood Pressure and Other Cardiometabolic Risk Factors|Recruiting||N/A|60|Anticipated|Laval University||3|||f||||f||||||||No||2017-10-10 22:13:41.053633|2017-10-10 22:13:41.053633
NCT02763917|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-09-30|||August 2016||2016-08-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma|AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma|Recruiting||N/A|200|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-10 22:13:41.167076|2017-10-10 22:13:41.167076
NCT02763904|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-15|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Systematic Oral Nutritional Support in Hospitalized, Moderately Hypophagic Patients at Nutritional Risk|Systematic Oral Nutritional Support in Hospitalized, Moderately Hypophagic Patients at Nutritional Risk Receiving Dietary Counseling: a Randomized, Controlled Trial|Recruiting||N/A|286|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||f||||||||||2017-10-10 22:13:41.260435|2017-10-10 22:13:41.260435
NCT02763891|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-11-24|||September 2015||2015-09-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Body Suspension and Tilting Exercises in Parkinson's Disease|Effect of Body Suspension and Tilting Exercises in Parkinson's Disease|Completed||N/A|40|Actual|Pontificia Universidade Católica do Rio Grande do Sul||2|||f||||f||||||||Undecided||2017-10-10 22:13:41.357532|2017-10-10 22:13:41.357532
NCT02763878|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-07-18|||September 2016||2016-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy|Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy|Recruiting||Phase 3|832|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:13:41.450405|2017-10-10 22:13:41.450405
NCT02763865|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-05-11|||July 2014||2014-07-01|April 2016|2016-04-01||||December 2015|Actual|2015-12-01||Interventional|||A Pilot Study to Assess the Effects of Pre-SMA LF-rTMS for the Treatment of Essential Tremor|A Pilot Study to Assess the Effects of Pre-SMA LF-rTMS for the Treatment of Essential|Completed||N/A|10|Actual|Medical University of South Carolina||2|||f||||t||||||||No||2017-10-10 22:13:41.549332|2017-10-10 22:13:41.549332
NCT02763852|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-04|||April 2001||2001-04-01|May 2016|2016-05-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)|Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg): a Double-blind, Randomised, Crossover, Placebo Controlled Study in Healthy Volunteers|Completed||Phase 1|18|Actual|Bial - Portela C S.A.||5|||f||||f||||||||No||2017-10-10 22:13:41.641472|2017-10-10 22:13:41.641472
NCT02763839|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-04|||April 2001||2001-04-01|May 2016|2016-05-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)|Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg): a Double-blind, Randomised, Crossover, Placebo Controlled Study in Healthy Volunteers|Completed||Phase 1|19|Actual|Bial - Portela C S.A.||5|||f||||f||||||||No||2017-10-10 22:13:41.745997|2017-10-10 22:13:41.745997
NCT02763826|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-03-22|||December 2014||2014-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|COBRE_JIpro3||Optimizing Current and Electrode Montage for Transcranial Direct Current Stimulation in Stroke Patients|Optimizing Current and Electrode Montage for Transcranial Direct Current Stimulation in Stroke Patients|Recruiting||N/A|36|Anticipated|Medical University of South Carolina||1|||f||||f||||||||Undecided||2017-10-10 22:13:41.846264|2017-10-10 22:13:41.846264
NCT02763813|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-10-13|||May 2010||2010-05-01|October 2016|2016-10-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Two Oral Appliances in the Treatment of Sleep Apnea Syndrome|Comparison of a Retention Type and Propulsion Type Oral Appliance in the Treatment of Obstructive Sleep Apnea|Terminated||N/A|4|Actual|Hopital Foch||2||recruitment difficulties|f||||f||||||||||2017-10-10 22:13:41.950928|2017-10-10 22:13:41.950928
NCT02763800|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-04|||September 2000||2000-09-01|May 2016|2016-05-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202|Double-Blind, Randomised, Placebo-Controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202, in Young Healthy Volunteers|Completed||Phase 1|33|Actual|Bial - Portela C S.A.||4|||f||||f||||||||No||2017-10-10 22:13:42.027508|2017-10-10 22:13:42.027508
NCT02763787|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-05-13|||April 2000||2000-04-01|May 2016|2016-05-01|June 2000||2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-202|A Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of Single Doses of BIA 3-202 in Healthy Volunteers.|Completed||Phase 1|71|Actual|Bial - Portela C S.A.||9|||f||||f||||||||No||2017-10-10 22:13:42.119405|2017-10-10 22:13:42.119405
NCT02763774|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-03|||June 2014||2014-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Effects a Rehabilitation Program in Patients With Left Ventricular Dysfunction After Coronary Artery Bypass Grafting|Effects of Exercise Rehabilitation Program at Hospitalar Fase on Inflammatory Markers, Functional Capacity and Clinical Outcomes in Patients With Left Ventricular Dysfunction After Coronary Artery Bypass Grafting|Recruiting||N/A|45|Anticipated|Federal University of São Paulo||3|||f||||t||||||||Yes||2017-10-10 22:13:42.199738|2017-10-10 22:13:42.199738
NCT02763761|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-08-25|||August 16, 2016|Actual|2016-08-16|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo|A Phase 2, Randomized, Open-Label Study of Infliximab and Lower Exposure Corticosteroids vs Methylprednisolone and Higher Exposure Oral Corticosteroids for the Management of Immune-Related Severe or Persistent Diarrhea in Patients Treated With Yervoy (Ipilimumab) and/or Opdivo (Nivolumab)|Withdrawn||Phase 2|0|Actual|Bristol-Myers Squibb||2||Insufficient enrollment|f||||t|t|f||||||||2017-10-10 22:13:42.286906|2017-10-10 22:13:42.286906
NCT02763748|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-04|||June 2016||2016-06-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor|the Prospective, Randomized and Comparative Clinical Study of Laparoscopic and Endoscopic Cooperative Surgery in the Treatment of Gastrointestinal Stromal Tumor|Not yet recruiting||N/A|120|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||3|||f||||f||||||||Yes||2017-10-10 22:13:42.390884|2017-10-10 22:13:42.390884
NCT02763735|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-02|||June 2014||2014-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Right Ventricular Metabolism in Pulmonary Arterial Hypertension|Metabolic Intervention in the Right Ventricle in Pulmonary Arterial Hypertension|Recruiting||N/A|34|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 22:13:42.471153|2017-10-10 22:13:42.471153
NCT02763722|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-06-13|||May 2016||2016-05-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy|Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy|Recruiting||N/A|35|Anticipated|Medical University of Warsaw||1|||f||||f||||||||No||2017-10-10 22:13:42.571329|2017-10-10 22:13:42.571329
NCT02763709|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-04|||March 2016||2016-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Evaluation of Pediatric Critical Illness Neuropathy/Myopathy in Pediatric Intensive Care Unit|Evaluation of Pediatric Critical Illness Neuropathy/Myopathy in Pediatric Intensive Care Unit|Recruiting||N/A|97|Anticipated|Postgraduate Institute of Medical Education and Research|||1||f||||f||||||||No||2017-10-10 22:13:42.674786|2017-10-10 22:13:42.674786
NCT02755519|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-11-10|||May 2014||2014-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|ODPA||Optimizing Diagnosis Of Primary Aldosteronism|Case Detection and Confirmation, Subtype Classification of Patients With Primary Aldosteronism|Completed||N/A|300|Actual|Chongqing Medical University|||2||f||||t||||||||||2017-10-10 22:15:23.301816|2017-10-10 22:15:23.301816
NCT02763696|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-03-23|||May 10, 2016|Actual|2016-05-10|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|1 Month|Observational [Patient Registry]|ESSACWVM||Establishment of a Sensitive System for Analysis of Child-bearing Women Vaginal Microbiota|Establishment of a Sensitive System for Analysis of Child-bearing Women Vaginal Microbiota Which Overall Evaluation of Microscopic Precision Reference Standards|Recruiting||N/A|50|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||f||||||Samples With DNA|"     Vaginal secretions from Child-bearing Women   "|Undecided||2017-10-10 22:13:42.740085|2017-10-10 22:13:42.740085
NCT02763683|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-09|||June 2016||2016-06-01|May 2016|2016-05-01|March 2030|Anticipated|2030-03-01|March 2030|Anticipated|2030-03-01||Observational|PIB||Dementia in Parkinson Disease|Investigations of Dementia in Parkinson Disease|Not yet recruiting||N/A|320|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples With DNA|"     whole blood   "|Undecided||2017-10-10 22:13:42.816444|2017-10-10 22:13:42.816444
NCT02763670|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-02-24|||September 2015||2015-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|EFFICARD||Patient Care Management Strategies for Severe Heart Failure in Rhône-Alpes, France.|Comparison of Patient Care Management Strategies of Heart Failure in the Rhône-Alpes Region. A Clinical and Economic Study.|Recruiting||N/A|720|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 22:13:43.011716|2017-10-10 22:13:43.011716
NCT02763657|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-03|||October 2013||2013-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NEUREAS||Neural Development of Deductive Reasoning|Neural Development of Deductive Reasoning: an fMRI Study of Relational and Categorical Reasoning in Children|Recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 22:13:43.105521|2017-10-10 22:13:43.105521
NCT02763644|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-09-28|||April 22, 2016|Actual|2016-04-22|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|February 10, 2017|Actual|2017-02-10||Interventional|||Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients|A Randomized, Open Label, Controlled, Multiple Dose Study to Evaluate the Clinical Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LFG316 in Patients With Transplant Associated Microangiopathy After Hematopoietic Precursor Cell Transplantation|Terminated||Phase 2|7|Actual|Novartis||2|||f||||t|t|f||||||||2017-10-10 22:13:43.18703|2017-10-10 22:13:43.18703
NCT02763631|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-02-20|||September 2016||2016-09-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|EPOC||Symptomatic Treatment of Excessive Dynamic Airway Collapse Using Daytime Portable Continuous Positive Airway Pressure|Symptomatic Treatment of Excessive Dynamic Airway Collapse Using Daytime Portable Continuous Positive Airway Pressure|Recruiting||N/A|14|Anticipated|Guy's and St Thomas' NHS Foundation Trust||3|||f||||f||||||||No||2017-10-10 22:13:43.292247|2017-10-10 22:13:43.292247
NCT02763618|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-09-09|||February 2016||2016-02-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TBR-NFT||EEG Theta-Beta Ratio Neurofeedback-training|EEG Theta-Beta Ratio Neurofeedback-training Using a Multiple Baseline Design|Completed||N/A|12|Actual|Leiden University Medical Center||3|||f||||f||||||||Undecided||2017-10-10 22:13:43.406689|2017-10-10 22:13:43.406689
NCT02763605|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-05-05|||January 2014||2014-01-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|||Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years|Retrospective Study of the in Vivo Confocal Microscopic Findings and the Treatment Outcome of Acanthamoebic Keratitis|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-10 22:13:43.513001|2017-10-10 22:13:43.513001
NCT02763592|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-03-31|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|LiNe||Impact of 5% Lidocaine Medicated Plaster on Allodynic Symptoms of Localized Neuropathic Pain After Knee Surgery|Impact of 5% Lidocaine Medicated Plaster on Allodynic Symptoms of Localized Neuropathic Pain After Knee Surgery|Completed||Phase 2|37|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:13:43.641257|2017-10-10 22:13:43.641257
NCT02763579|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-08-01|||June 7, 2016|Actual|2016-06-07|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|IMpower133||A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)|A Phase I/III, Randomized, Double-Blind, Placebo-Controlled Study of Carboplatin Plus Etoposide With or Without Atezolizumab (Anti-PD-L1 Antibody) in Patients With Untreated Extensive-Stage Small Cell Lung Cancer|Recruiting||Phase 3|500|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:13:43.767489|2017-10-10 22:13:43.767489
NCT02763566|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2017-09-20|||December 2016||2016-12-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|MONARCH plus||A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare NSAI (Anastrozole or Letrozole) Plus Abemaciclib, a CDK4 and CDK6 Inhibitor, or Plus Placebo, and to Compare Fulvestrant Plus Abemaciclib or Plus Placebo in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer|Recruiting||Phase 3|450|Anticipated|Eli Lilly and Company||4|||f||||t||||||||||2017-10-10 22:13:44.169367|2017-10-10 22:13:44.169367
NCT02763553|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-11-08|||December 2016||2016-12-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Does a Ketogenic Diet Causes Ketosis in Patients on Intensive Care?|Does a Ketogenic Diet Reduce Delirium in Intensive Care? Part 1: - A Feasibility Study to Test if a Ketogenic Diet Causes Ketosis in Patients on Intensive Care|Not yet recruiting||Phase 2|10|Anticipated|University Hospitals Bristol NHS Foundation Trust||2|||f||||f||||||||Yes|No, anonymised data only|2017-10-10 22:13:44.457561|2017-10-10 22:13:44.457561
NCT02763527|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-03|||May 2016||2016-05-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effectiveness of Negotiating Self-determination to Reduce Cigarette Consumption|The Effectiveness of Negotiating Self-Determination to Reduce Cigarette Consumption (NSD-RCC) Among Smokers Attending Outpatient Clinics: A Cluster Randomized Controlled Trial|Not yet recruiting||N/A|1566|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 22:13:44.631057|2017-10-10 22:13:44.631057
NCT02763514|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-06-26|||September 2016||2016-09-01|June 2017|2017-06-01||||July 2018|Anticipated|2018-07-01||Interventional|||The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood|Efficacy Evaluation of 26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cognitive Function and Mood in Healthy Adults|Recruiting||N/A|336|Anticipated|Northumbria University||3|||f||||f||||||||No||2017-10-10 22:13:44.715825|2017-10-10 22:13:44.715825
NCT02763488|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Blood Flow Restriction Training Following Total Knee Arthroplasty|Blood Flow Restriction Training Following Primary Total Knee Arthroplasty|Enrolling by invitation||N/A|100|Anticipated|San Antonio Military Medical Center||2|||f||||f||||||||No||2017-10-10 22:13:44.899921|2017-10-10 22:13:44.899921
NCT02763475|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-11-08|||May 2016||2016-05-01|November 2016|2016-11-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents|NK Cells Infusion as Consolidation Treatment of Acute Myeloid Leukemia in Children and Adolescents|Recruiting||Phase 2|35|Anticipated|Instituto de Investigación Hospital Universitario La Paz||1|||f||||f||||||||No||2017-10-10 22:13:44.98907|2017-10-10 22:13:44.98907
NCT02763462|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-08-27|||July 2013||2013-07-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|October 2016|Actual|2016-10-01||Observational|AFIRE||The Etiology of Acute Febrile Illness Requiring Hospitalization|The Etiology of Acute Febrile Illness Requiring Hospitalization (AFIRE). A Multicenter Study of the Indonesia Research Partnership on Infectious Disease (INA-RESPOND)|Completed||N/A|1492|Actual|Ina-Respond|||1||f||||f||||||Samples With DNA|"     Plasma, buffy coat, urine, throat swab, nasal swab.   "|||2017-10-10 22:13:45.153998|2017-10-10 22:13:45.153998
NCT02763449|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-05-03|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|AAA||Appetite and Adiposity Across a Continuum of Activity|Appetite and Adiposity Across a Continuum of Activity|Not yet recruiting||N/A|40|Anticipated|Iowa State University||2|||f||||f||||||||Undecided||2017-10-10 22:13:45.255225|2017-10-10 22:13:45.255225
NCT02763436|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-01-24|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||"Improves Physiological Based Cord Clamping (PBCC) the Systemic and Cerebral Oxygenation in Term Infants?"|"Improves Physiological Based Cord Clamping (PBCC) the Systemic and Cerebral Oxygenation in Term Infants?"|Recruiting||N/A|78|Anticipated|Medical University of Graz||2|||f||||f||||||||Undecided||2017-10-10 22:13:45.316097|2017-10-10 22:13:45.316097
NCT02763423|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-04|||January 2009||2009-01-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|UCMSCDKA||Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis|The Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation to Treat New-onset Type 1 Diabetes With Diabetic Ketoacidosis|Recruiting||Phase 2|30|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||t||||||||No||2017-10-10 22:13:45.425897|2017-10-10 22:13:45.425897
NCT02763410|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-03-27|||September 8, 2016|Actual|2016-09-08|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|TRANSNEPHRON||Impact of the Composition of Packed Red Blood Cell Supernatant on Renal Dysfunction and Posttransfusion Immunomodulation|Impact of the Composition of the Packed Red Blood Cell Supernatant on Renal Dysfunction and Post-transfusion Immunomodulation|Recruiting||N/A|200|Anticipated|Nantes University Hospital|||2||f||||t||||||Samples With DNA|"     urine samples and PRBC tubing   "|||2017-10-10 22:13:45.50942|2017-10-10 22:13:45.50942
NCT02763397|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-04|||May 2016||2016-05-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (NbM) in Patients With Parkinson's Disease|Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (NbM) in Patients With Parkinson's Disease: A Pilot Study|Not yet recruiting||N/A|13|Anticipated|University Medical Center Groningen||2|||f||||||||||||Undecided||2017-10-10 22:13:45.599086|2017-10-10 22:13:45.599086
NCT02763384|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-14|||December 2, 2016|Actual|2016-12-02|September 2017|2017-09-01|April 30, 2021|Anticipated|2021-04-30|May 31, 2019|Anticipated|2019-05-31||Interventional|||BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma|A Phase IIa Study of BL-8040 in Combination With Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma|Recruiting||Phase 2|20|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 22:13:45.684994|2017-10-10 22:13:45.684994
NCT02763371|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-03|||April 2016||2016-04-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|CogniDo-GI||Cognition Intervention Study Dortmund- Glycemic Index (CogniDo GI)|Cognition Intervention Study Dortmund- Glycemic Index (CogniDo GI)|Recruiting||N/A|200|Anticipated|Research Institute of Child Nutrition, Dortmund||2|||f||||t||||||||No||2017-10-10 22:13:45.856207|2017-10-10 22:13:45.856207
NCT02763358|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-05-04|||March 2016||2016-03-01|March 2016|2016-03-01||||March 2017|Anticipated|2017-03-01||Interventional|||Assessing the Bite Counter|Assessing the Bite Counter as a Tool for Food Intake Monitoring: Phase II|Recruiting||N/A|42|Anticipated|Medical University of South Carolina||1|||f||||f||||||||No||2017-10-10 22:13:45.943511|2017-10-10 22:13:45.943511
NCT02763345|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-05-02|||October 2016||2016-10-01|May 2017|2017-05-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||The Added Value of a Mobile Application of Community Case Management on Pediatric Referral Rates in Malawi|The Added Value of a Mobile Application of Community Case Management on Under-5 Referral, Re-consultation and Hospitalization Rates in Malawi: a Pragmatic Stepped-wedge Cluster Randomized Trial|Completed||N/A|6995|Actual|University of Washington||2|||f||||t||||||||||2017-10-10 22:13:46.020732|2017-10-10 22:13:46.020732
NCT02763332|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-24|||April 2016||2016-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|EffKtFbm||Effect of the Kinesio Taping in Fibromyalgia.|Effect of the Kinesio Taping in Patients With Fibromyalgia.|Completed||N/A|35|Actual|University of Valencia||2|||f||||f||||||||||2017-10-10 22:13:46.1026|2017-10-10 22:13:46.1026
NCT02763319|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2017-08-28|||June 2016||2016-06-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|B-MIND||A Trial to Evaluate the Efficacy and Safety of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)|A Phase 2/3, Randomised, Multicentre Study of MOR208 With Bendamustine Versus Rituximab With Bendamustine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL) Who Are Not Eligible for High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT)|Recruiting||Phase 2/Phase 3|330|Anticipated|MorphoSys AG||2|||f||||t||||||||||2017-10-10 22:13:46.208787|2017-10-10 22:13:46.208787
NCT02763306|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-05-03|||June 2015||2015-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:13:46.738789|2017-10-10 22:13:46.738789
NCT02763293|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-07-22|||May 2016||2016-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|ONManCD||Osteopathy Non-manipulative in Patients With Crohn's Disease.|Soft Ostheopathic Techniques Improve the Quality of Life in Patients With Crohn's Disease. A Randomized Controlled Trial.|Completed||N/A|33|Actual|University of Valencia||2|||f||||f||||||||||2017-10-10 22:13:46.792669|2017-10-10 22:13:46.792669
NCT02763280|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-05-13|||June 2015||2015-06-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy and Safety of Ginseng Extract on Improvement of Bone Metabolism in Menopausal Women|A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Ginseng Extract on Improvement of Bone Metabolism in Menopausal Women|Recruiting||Phase 2/Phase 3|90|Anticipated|Chonbuk National University Hospital||3|||f||||t||||||||||2017-10-10 22:13:46.90684|2017-10-10 22:13:46.90684
NCT02763267|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-11-09|||February 2016||2016-02-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|February 2021|Anticipated|2021-02-01||Observational|SPRING||Study of Pregnancy Regulation of Insulin and Glucose|Study of Pregnancy Regulation of Insulin and Glucose|Recruiting||N/A|350|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples With DNA|"     Blood, urine, DNA, plasma, serum. With subject consent: maternal cord blood, urine, DNA,     fetal cord blood, neonatal DNA, placental tissue, RNA   "|Undecided||2017-10-10 22:13:47.009453|2017-10-10 22:13:47.009453
NCT02763254|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-12|||November 2016||2016-11-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01||Interventional|CIVIC||Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas|A Phase 2 Open Label Study to Investigate the Safety and Clinical Activity of Autologous EBV-specific T Cells (CMD-003) for the Treatment of Patients With EBV Positive Lymphomas|Recruiting||Phase 2|70|Anticipated|Cell Medica Ltd||1|||f||||t||||||||||2017-10-10 22:13:47.145037|2017-10-10 22:13:47.145037
NCT02763241|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-15|||January 2016||2016-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis|Phase III Randomized Open-label Clinical Trial Comparing Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis|Recruiting||Phase 3|142|Anticipated|Khon Kaen University||2|||f||||f||||||||||2017-10-10 22:13:47.297002|2017-10-10 22:13:47.297002
NCT02763228|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-09-29|||March 2016||2016-03-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer Survivors|A Physical Activity Intervention to Reduce Functional Health Disparities Among Older Breast Cancer Survivors|Recruiting||N/A|320|Anticipated|Case Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 22:13:47.39887|2017-10-10 22:13:47.39887
NCT02763215|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-01-19|||May 2016||2016-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment|Multi-Center Study for the Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment|Active, not recruiting||N/A|60|Anticipated|Wilson Therapeutics AB|||1||f||||f||||||||||2017-10-10 22:13:47.544423|2017-10-10 22:13:47.544423
NCT02763202|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-05-04|||February 2016||2016-02-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|AIRTIGHT||Aiming to Improve Readmissions Through InteGrated Hospital Transitions|Aiming to Improve Readmissions Through InteGrated Hospital Transitions|Recruiting||N/A|1520|Anticipated|Carolinas Healthcare System||2|||f||||t||||||||No||2017-10-10 22:13:47.667311|2017-10-10 22:13:47.667311
NCT02763189|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-03-29|2017-02-08||June 2016||2016-06-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|FACETTE2||Effect of Mentoring on Endotracheal Tube Exchange Using a New Device|The Effects of Mentoring on Apnea Time While Using a Novel Fiber-optic Assisted Coaxial Endotracheal Tube Exchange Device|Terminated||N/A|8|Actual|Wake Forest University Health Sciences|Early termination leading to small numbers of subjects analyzed. Technical problems with the device used in the study.|2||The device did not work well enough in its current form to continue the study.|f||||f||||||||Yes|Apnea times will be shared at the conclusion of the study|2017-10-10 22:13:47.786148|2017-10-10 22:13:47.786148
NCT02763176|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-07-13|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||Measuring hCG Levels in Pregnant Women|Measuring hCG Levels in Pregnant Women: a Prenatal Study of hCG Using MLPT and Serum Testing|Not yet recruiting||N/A|150|Anticipated|Gynuity Health Projects|||1||f||||f||||||Samples Without DNA|"     Blood and urine for hCG measurement   "|No||2017-10-10 22:13:48.174436|2017-10-10 22:13:48.174436
NCT02763163|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-05|||May 2016||2016-05-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Observational|||Examination of the Link Between Sun Exposure Routine and Bacteria Population of the Skin|Examination of the Link Between Sun Exposure Routine and Bacteria Population of the Skin|Not yet recruiting||N/A|100|Anticipated|Institute for Skin Research, Israel|||2||f||||f||||||||No||2017-10-10 22:13:48.232987|2017-10-10 22:13:48.232987
NCT02763150|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-02-13|||August 2016||2016-08-01|February 2017|2017-02-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Pre-pregnancy Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes in Overweight and Obese Women|Gestational Diabetes Prevention Program|Recruiting||N/A|252|Anticipated|California Polytechnic State University-San Luis Obispo||2|||f||||t||||||||Yes|A de-identified dataset will be made available to outside investigators after the primary and secondary analyses are completed and in accordance with local institutional review board and NIH policies.|2017-10-10 22:13:48.301126|2017-10-10 22:13:48.301126
NCT02763137|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-04|||January 2015||2015-01-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients|A Phase IIa Study to Assess the Safety, Tolerability, Plasma Pharmacokinetics and Efficacy of Intermittent Oral Administration of Standard Levodopa/Carbidopa vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Patients With Advanced Parkinson's Disease Who Suffer Motor Fluctuations|Completed||Phase 2|18|Actual|IRCCS San Raffaele||2|||f||||t||||||||Yes|Publication on peer-reviewed journal|2017-10-10 22:13:48.394048|2017-10-10 22:13:48.394048
NCT02763124|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-08-10|||May 2016||2016-05-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions|Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions|Completed||N/A|30|Actual|Gainesville Eye Associates||1|||f||||f||||||||||2017-10-10 22:13:48.473295|2017-10-10 22:13:48.473295
NCT02763111|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-03-24|||September 2016||2016-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis|International Multi-center Comparative Randomized Double-blind Placebo-controlled Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Active Ankylosing Spondylitis|Active, not recruiting||Phase 2|88|Anticipated|Biocad||4|||f||||f||||||||No||2017-10-10 22:13:48.547989|2017-10-10 22:13:48.547989
NCT02763098|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-04|||January 2012||2012-01-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Remifentanil on Hemodynamic Response to Anesthesia Induction|Effects of Different Doses of Remifentanil on Hemodynamic Response to Anesthesia Induction in Elderly Patients|Completed||Phase 4|90|Actual|Dokuz Eylul University||3|||f||||t||||||||Yes||2017-10-10 22:13:48.643903|2017-10-10 22:13:48.643903
NCT02763085|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2017-01-26|||July 2015||2015-07-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Evaluation of Basic Filling Material in Class I and II Posterior Restorations|"Clinical Evaluation of Basic Filling Material in Class I and II Cavities: A Prospective Controlled Clinical Trial up to 3 Years"|Recruiting||N/A|80|Anticipated|Istanbul Medipol University Hospital||1|||f||||t||||||||No||2017-10-10 22:13:48.721628|2017-10-10 22:13:48.721628
NCT02763072|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-04|||April 2016||2016-04-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||A Single-Center 2-Arm Study for Lentigines on the Hands|A Single-Center 2-Arm Study of the Enlighten and Excel V Laser for Lentigines on the Hands|Enrolling by invitation||N/A|24|Anticipated|Cutera Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:13:48.805208|2017-10-10 22:13:48.805208
NCT02763059|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-05-04|||September 2013||2013-09-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|May 2015|Actual|2015-05-01||Interventional|CBDIPPCFSIP||Comparison Between Dexamethasone and Ibuprofen on Pain Prevention and Control Following Surgical Implant Placement|Comparison Between Dexamethasone and Ibuprofen on Postoperative Pain Prevention and Control Following Surgical Implant Placement: a Double-Blind, Parallel-Group, Placebo-Controlled Randomized Clinical Trial|Completed||Phase 4|132|Actual|King Abdulaziz University||3|||f||||t||||||||||2017-10-10 22:13:48.901063|2017-10-10 22:13:48.901063
NCT02763046|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-21|||May 2016||2016-05-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ASTRUM||A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis|A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the NSAID-sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis (ASTRUM)|Recruiting||Phase 4|204|Anticipated|Novartis||3|||f||||f||||||||||2017-10-10 22:13:48.988986|2017-10-10 22:13:48.988986
NCT02763033|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-11-01|||December 2016||2016-12-01|November 2016|2016-11-01||||December 2019|Anticipated|2019-12-01||Interventional|||Modification of the Intestinal Microbiome by Diet Intervention to Mitigate Acute Graft-Versus-Host Disease|Modification of the Intestinal Microbiome by Diet Intervention to Mitigate Acute Graft-Versus-Host Disease|Not yet recruiting||Phase 2|70|Anticipated|University of Michigan Cancer Center||2|||f||||t||||||||Undecided||2017-10-10 22:13:49.165954|2017-10-10 22:13:49.165954
NCT02763020|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-12-08|||March 2016||2016-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Postprandial Glycemic Response to Polyphenol-fortified Snack Bars|Postprandial Glycemic Response to Polyphenol-fortified Snack Bars|Recruiting||N/A|20|Anticipated|United States Army Research Institute of Environmental Medicine||5|||f||||f||||||||No||2017-10-10 22:13:49.236009|2017-10-10 22:13:49.236009
NCT02763007|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-07-12|||May 18, 2016|Actual|2016-05-18|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|May 2020|Anticipated|2020-05-01||Interventional|PEAK-E||An Extension Study of PEAK Trial|An Extension Study of Protocol ALO-IIT(PEAK Study) to Examine the Long-term Efficacy and Safety of Metformin + Alogliptin + Pioglitazone Triple Combination Therapy in the Korean Type 2 Diabetes Patients|Recruiting||Phase 4|300|Anticipated|The Catholic University of Korea||3|||f||||f||||||||||2017-10-10 22:13:49.321704|2017-10-10 22:13:49.321704
NCT02762994|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-07-14|||June 2016||2016-06-01|April 2017|2017-04-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis|International Multi-center Comparative Randomized Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis|Completed||Phase 2|120|Actual|Biocad||4|||f||||f|f|f||||||||2017-10-10 22:13:49.428423|2017-10-10 22:13:49.428423
NCT02762981|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-02-23|||March 2016||2016-03-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study to Evaluate CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors|Phase 1/2 Study of CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors|Recruiting||Phase 1/Phase 2|82|Anticipated|Corcept Therapeutics||1|||f||||f||||||||Undecided||2017-10-10 22:13:49.521512|2017-10-10 22:13:49.521512
NCT02755129|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-06-19|||September 20, 2016|Actual|2016-09-20|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|April 20, 2017|Actual|2017-04-20||Interventional|FRAP||FRailty WAlking Patterns (FRAP) Study|FRailty WAlking Patterns (FRAP) Study|Active, not recruiting||N/A|15|Actual|Medtronic BRC||1|||f||||f||||||||No||2017-10-10 22:15:26.174557|2017-10-10 22:15:26.174557
NCT02762968|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-01-27|||April 2016||2016-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||The Effects of Probiotic and HMB Supplementation on Immune and Digestive Function in Special Operations Soldiers|The Effects of 8-weeks of Probiotic and HMB Supplementation on Immune and Digestive Function in Special Operations Soldiers|Completed||N/A|26|Actual|Metabolic Technologies Inc.||3|||f||||f||||||||No||2017-10-10 22:13:49.61575|2017-10-10 22:13:49.61575
NCT02762955|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-06|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CALYPSO||Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis|International Multi-center Comparative Randomized Double-blind Clinical Trial of Efficacy and Safety of BCD-057 (Adalimumab Produced by BIOCAD, Russia) and Humira® (Adalimumab Produced by Vetter Pharma-Fertigung Gmbh & Co KG, Germany) in Patients With Moderate to Severe Plaque Psoriasis|Recruiting||Phase 3|344|Anticipated|Biocad||2|||f||||f|f|f||||||No||2017-10-10 22:13:49.694821|2017-10-10 22:13:49.694821
NCT02762942|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of Vaginal Misoprostol Plus Supracervical Balloon Versus Vaginal Misoprostol Alone for Induction of Labor|Prospective Randomized Clinical Trial Comparing the Effect of Vaginal Misoprostol Synchronously With Supracervical Balloon Versus Vaginal Misoprostol Alone for Induction of Labor|Recruiting||Phase 4|80|Anticipated|Consorci Sanitari de Terrassa||2|||f||||f||||||||No||2017-10-10 22:13:49.823993|2017-10-10 22:13:49.823993
NCT02762929|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-09-26|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy|A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011, HTX-002, or HTX-009 for Postoperative Analgesia Following Bunionectomy|Completed||Phase 2|430|Actual|Heron Therapeutics||27|||f||||||||||||||2017-10-10 22:13:51.447374|2017-10-10 22:13:51.447374
NCT02762916|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-03|||May 2014||2014-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||CONTECI Program: A New Way to Control Peripheral Arterial Disease Using New Technologies|Randomized Trial of CONTECI Program: Pilot Study|Completed||N/A|150|Actual|Consorci Sanitari del Maresme||2|||f||||t||||||||No||2017-10-10 22:13:51.571104|2017-10-10 22:13:51.571104
NCT02762903|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-03|||August 2009||2009-08-01|May 2016|2016-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Lesser Tuberosity Osteotomy for Subscapularis Repair|Lesser Tuberosity Osteotomy Versus Tenotomy for Subscapularis Repair During Total Shoulder Arthroplasty|Completed||N/A|59|Actual|Columbia University||2|||f||||f||||||||No||2017-10-10 22:13:51.644593|2017-10-10 22:13:51.644593
NCT02762890|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-04|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of Deep Neuromuscular Block and Moderate Neuromuscular Block on Quality of Recovery in Patients Undergoing Robotic Gastrectomy||Not yet recruiting||N/A|72|Anticipated|Yonsei University||2|||f||||f||||||||No|no plan to share data|2017-10-10 22:13:51.72586|2017-10-10 22:13:51.72586
NCT02762877|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-11-14|||April 2016||2016-04-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer|A Study to Determine the Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma From Patients With Non Small Cell Lung Carcinoma (NSCLC)|Recruiting||N/A|200|Anticipated|Genomic Health®, Inc.|||1||f||||||||||Samples Without DNA|"     Blood and tissue   "|||2017-10-10 22:13:51.801235|2017-10-10 22:13:51.801235
NCT02762864|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-03|||May 2016||2016-05-01|May 2016|2016-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity Unit|Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity Unit|Enrolling by invitation||N/A|200|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:13:51.886357|2017-10-10 22:13:51.886357
NCT02762851|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-08-03|||June 2016||2016-06-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|RCT-IVVE||Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)|A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events|Recruiting||Phase 4|3500|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 22:13:51.981587|2017-10-10 22:13:51.981587
NCT02762838|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-05-06|||January 2016||2016-01-01|May 2016|2016-05-01||||May 2018|Anticipated|2018-05-01||Interventional|||Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis|"International Multi-center Comparative Double-blind Randomized Clinical Trial of Efficacy and Safety of BCD-055 (JSC BIOCAD, Russia) and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis"|Recruiting||Phase 3|426|Anticipated|Biocad||2|||f||||f||||||||Undecided||2017-10-10 22:13:52.161432|2017-10-10 22:13:52.161432
NCT02762825|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-04|||March 2016||2016-03-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|CRpEF||Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction|Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction|Recruiting||Phase 3|66|Anticipated|Henry Ford Health System||2|||f||||||||||||||2017-10-10 22:13:52.365104|2017-10-10 22:13:52.365104
NCT02762812|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-03-27|||January 2016||2016-01-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis|"International Multi-center Comparative Double-blind Randomized Clinical Trial to Evaluate Efficacy and Safety of BCD-055 (JSC BIOCAD, Russia) and Remicade® in Patients With Ankylosing Spondylitis"|Active, not recruiting||Phase 3|198|Anticipated|Biocad||2|||f||||f||||||||Undecided||2017-10-10 22:13:52.448174|2017-10-10 22:13:52.448174
NCT02762799|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-05-05|||August 2016||2016-08-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®|"Single-center Open Randomized Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® (JSC BIOCAD, Russia) Compared to Neupogen® (F. Hoffman-La Roche Ltd., Switzerland)"|Not yet recruiting||Phase 1|60|Anticipated|Biocad||4|||f||||f||||||||Undecided||2017-10-10 22:13:52.541797|2017-10-10 22:13:52.541797
NCT02762786|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-03|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effectiveness of Musical Training in Children From Low Income Families|Effectiveness of Musical Training in the Improvement of Psychological Well-being and Quality of Life of Children From Low Income Families|Not yet recruiting||N/A|960|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 22:13:52.65192|2017-10-10 22:13:52.65192
NCT02762773|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-04|||September 2016||2016-09-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Non-Dissection of the Inferior Rectus Sheath on Intraoperative Blood Loss|Does Avoiding Inferior Rectus Sheath Dissection Lead to Decreased Operative Blood Loss and Operating Time Without Increasing Delivery of Fetus in Primary Cesarean Delivery|Not yet recruiting||N/A|120|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 22:13:52.75423|2017-10-10 22:13:52.75423
NCT02762760|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-11-11|||May 2016||2016-05-01|October 2016|2016-10-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint|A Prospective Phase I Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ as a Treatment for Arthritis of the Basal Thumb Joint|Completed||Phase 1|15|Actual|Ampio Pharmaceuticals. Inc.||2|||f||||t||||||||Undecided||2017-10-10 22:13:52.846825|2017-10-10 22:13:52.846825
NCT02762747|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-08|||May 2016||2016-05-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Randomised Controlled Trial on Pre-peritoneal Drainage After Totally Extra-peritoneal Hernioplasty for Inguinal Hernia|Pre-peritoneal Drainage Versus No Drainage After Totally Extra-peritoneal Hernioplasty for Inguinal Hernia - a Randomised Controlled Study|Recruiting||N/A|200|Anticipated|The University of Hong Kong||2|||f||||f||||||||Undecided||2017-10-10 22:13:52.939645|2017-10-10 22:13:52.939645
NCT02762734|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-07-27|||February 16, 2017|Actual|2017-02-16|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|MEDIACONNEX||Prevention of Recurrence of Suicide Attempt by Adolescent by Sending SMS (MEDIACONNEX)|Multicenter Randomized Prevention Trial of Recurrence of Suicide Attempt by Adolescent by Sending SMS (MEDIACONNEX)|Recruiting||N/A|225|Anticipated|Central Hospital, Nancy, France||2|||f||||t|f|f||||||||2017-10-10 22:13:53.073072|2017-10-10 22:13:53.073072
NCT02762721|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-06-07|||June 6, 2016|Actual|2016-06-06|June 2017|2017-06-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Observational|||Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples|Molecular Analysis of Oncogenes in Tumor Samples From Adult Patients With Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma|Completed||N/A|131|Actual|ArQule|||1||f||||f||||||Samples With DNA|"     A minimum of 1 cubic mm of tumor tissue (archival) with at least 50% nucleated tumor cell     content is required.   "|||2017-10-10 22:13:53.22947|2017-10-10 22:13:53.22947
NCT02762708|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-11-08|||March 2016||2016-03-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Microbiome||The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes|The Effect of Bariatric Surgery on Metabolism, the Metabolome and the Microbiome in Patients With Type 2 Diabetes|Recruiting||N/A|30|Anticipated|Mayo Clinic||4|||f||||t||||||||No||2017-10-10 22:13:53.31654|2017-10-10 22:13:53.31654
NCT02762695|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-26|||May 4, 2016|Actual|2016-05-04|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effectiveness of a Case Management Model for Patients With Hypertension and Type II Diabetes in Chile|Evaluation of a Model of Care for People With Hypertension and Type II Diabetes Based on Case Management and Risk Adjustment|Active, not recruiting||N/A|616|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-10 22:13:53.418309|2017-10-10 22:13:53.418309
NCT02762682|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-12-27|||July 2015||2015-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||A Study of Vitamin B12 Status in Children With Infantile Tremor Syndrome and Pre Infantile Tremor Syndrome|A Study of Vitamin B12 Status in Children With Infantile Tremor Syndrome and Pre Infantile Tremor Syndrome|Completed||N/A|93|Actual|Postgraduate Institute of Medical Education and Research|||2||f||||f||||||Samples Without DNA|"     serum samples   "|Undecided||2017-10-10 22:13:53.493192|2017-10-10 22:13:53.493192
NCT02762669|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-07-12|||May 2016||2016-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization: an In-vitro Analysis of Oxytocin Receptor Expression and Signaling|Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization: an In-vitro Analysis of Oxytocin Receptor Expression and Signaling|Recruiting||N/A|16|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||8|||f||||f||||||||||2017-10-10 22:13:53.574085|2017-10-10 22:13:53.574085
NCT02762656|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-03|||June 2016||2016-06-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Perioperative Lidocaine Intravenous Infusion on Postoperative Recovery After Spine Surgery.|The Effect of Perioperative Lidocaine Intravenous Infusion on Postoperative Recovery After Spine Surgery.|Not yet recruiting||Phase 4|60|Anticipated|Sheba Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:13:53.744425|2017-10-10 22:13:53.744425
NCT02762643|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-10-31|||May 2016||2016-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||DP-R213 Pharmacokinetics Study|An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetics and Safety of a Fixed Dose Combination of Raloxifen/Cholecalciferol Compared With Coadministration of Raloxifen and Cholecalciferol in Healthy Male Subjects|Completed||Phase 1|61|Actual|Alvogen Korea||2|||f||||f||||||||No||2017-10-10 22:13:53.89608|2017-10-10 22:13:53.89608
NCT02762630|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-04-26|||July 2016||2016-07-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|NPF||Use of a Novel Weight Bearing Cone Beam Computed Tomography (CBCT) Scanner for Imaging of the Patellofemoral Joint|Use of a Novel Weight Bearing Cone Beam Computed Tomography (CBCT) Scanner for Imaging of the Patellofemoral Joint|Completed||N/A|20|Actual|State University of New York at Buffalo|||1||f||||f||||||||||2017-10-10 22:13:53.974647|2017-10-10 22:13:53.974647
NCT02753985|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-29|||July 2014||2014-07-01|July 2017|2017-07-01||||April 2016|Actual|2016-04-01||Observational|||Adherence to Aromatase Inhibitors: The Role of Partners|Adherence to Aromatase Inhibitors: The Role of Partners|Active, not recruiting||N/A|40|Actual|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:15:36.894145|2017-10-10 22:15:36.894145
NCT02762617|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-09-05|||February 24, 2017|Actual|2017-02-24|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002)|Phase 1 Safety and Pharmacokinetic Study of a Polyurethane Tenofovir Disoproxil Fumarate Vaginal Ring in Sexually Active Women (TDF IVR-002)|Active, not recruiting||Phase 1|17|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t|t|f||||||||2017-10-10 22:13:54.034564|2017-10-10 22:13:54.034564
NCT02762604|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-07|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|||Motor Imagery Intervention for Improving Gait and Cognition in the Elderly|Motor Imagery Intervention for Improving Gait and Cognition in the Elderly|Recruiting||N/A|48|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t|f|f||||||||2017-10-10 22:13:54.141389|2017-10-10 22:13:54.141389
NCT02762591|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-04-17||||||April 2017|2017-04-01||||||||Expanded Access|||Expanded Access of Pimavanserin for Patients With PD Psychosis|Expanded Access Program of Pimavanserin in Patients With Parkinson's Disease Psychosis|Approved for marketing||N/A|||ACADIA Pharmaceuticals Inc.|||||||||||||||||||2017-10-10 22:13:54.405643|2017-10-10 22:13:54.405643
NCT02762578|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-07-20|||May 3, 2016|Actual|2016-05-03|July 2017|2017-07-01|June 19, 2017|Actual|2017-06-19|May 19, 2017|Actual|2017-05-19||Interventional|BOOST||Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes|A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes BOOST: INTENSIFY PREMIX/ALL 2|Completed||Phase 3|543|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 22:13:54.494177|2017-10-10 22:13:54.494177
NCT02762565|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-12|||February 2015||2015-02-01|January 2017|2017-01-01||||February 2017|Anticipated|2017-02-01||Interventional|||Clinical Utility of a Low-Cost Hand-Held Breast Scanner|Clinical Utility of a Low-Cost Hand-Held Breast Scanner|Recruiting||Phase 2|1000|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:13:54.718333|2017-10-10 22:13:54.718333
NCT02762552|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-08-03|||September 14, 2015|Actual|2015-09-14|August 2017|2017-08-01|September 14, 2018|Anticipated|2018-09-14|September 14, 2017|Anticipated|2017-09-14||Interventional|HOLISTER||Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke|Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STroke: Yield in the Etiologic woR-kup|Recruiting||N/A|200|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 22:13:54.823986|2017-10-10 22:13:54.823986
NCT02762539|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-05|||June 2016||2016-06-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|SMOFbrain||Omega3 PUFA in Head Trauam||Not yet recruiting||N/A|70|Anticipated|Mansoura University||2|||f||||t||||||||Yes||2017-10-10 22:13:54.96477|2017-10-10 22:13:54.96477
NCT02762526|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-02|||May 2016||2016-05-01|May 2016|2016-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||Lipoabdominoplasty and Diaphragmatic Mobility|Repercussions of Lipoabdominoplasty Surgery on Diaphragmatic Mobility, Regional Distribution Ventilation of Thoracoabdominal System and Lung Function in Women Healthy.|Not yet recruiting||N/A|15|Anticipated|Universidade Federal de Pernambuco|||1||f||||t||||||||Undecided||2017-10-10 22:13:55.075851|2017-10-10 22:13:55.075851
NCT02762513|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-06|||August 2016||2016-08-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Expansion Trial for Axitinib In Head And Neck Cancer|Phase II Expansion Trial for Axitinib In Head And Neck Cancer|Recruiting||Phase 2|37|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 22:13:55.205574|2017-10-10 22:13:55.205574
NCT02762500|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-09-11|||July 2016||2016-07-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis|A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis|Recruiting||Phase 2|120|Anticipated|Lycera Corp.||2|||f||||t||||||||||2017-10-10 22:13:55.355504|2017-10-10 22:13:55.355504
NCT02762474|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-02-06|||July 2014||2014-07-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer|A Phase I/II Trial of Weekly Regimens of Nab-paclitaxel Plus Cispaltin Combined With Concurrent IMRT for Inoperable,Locally Advanced Esophageal Carcinoma|Recruiting||Phase 1/Phase 2|30|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:13:55.908466|2017-10-10 22:13:55.908466
NCT02762461|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-02|||February 2016||2016-02-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01|4 Weeks|Observational [Patient Registry]|||Artificial Reproductive Techniques (ART) and Progression of Endometriosis Symptoms|Artificial Reproductive Techniques (ART) and Progression of Endometriosis Symptoms|Recruiting||N/A|144|Anticipated|University of Aarhus|||3||f||||f||||||||No||2017-10-10 22:13:56.056881|2017-10-10 22:13:56.056881
NCT02762448|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-01|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|May 2018|Anticipated|2018-05-01||Observational|||Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas|Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas Patients Using Daclatasvir and Asunaprevir: A Pilot Study|Active, not recruiting||N/A|10|Anticipated|Tainan Municipal Hospital|||1||f||||f||||||||||2017-10-10 22:13:56.18947|2017-10-10 22:13:56.18947
NCT02762435|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-04-24|||March 2016||2016-03-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Acupressure in Hospitalized Patients|Randomized Controlled Trial of Acupressure to Improve Patient Satisfaction and Quality of Recovery in Hospitalized Patients|Completed||N/A|200|Actual|Stony Brook University||3|||f||||f||||||||No||2017-10-10 22:13:56.270061|2017-10-10 22:13:56.270061
NCT02762422|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-04|||June 2009||2009-06-01|May 2016|2016-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Serial Phlebotomy in Voluntary Blood Donors|Serial Phlebotomy in Voluntary Blood Donors|Completed||N/A|84|Actual|New York University School of Medicine||3|||f||||f||||||||Yes|PI will make de-identified dataset available upon request in accord with institutional data use agreement policy|2017-10-10 22:13:56.376912|2017-10-10 22:13:56.376912
NCT02762409|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-07-20|||October 1, 2015|Actual|2015-10-01|August 2016|2016-08-01|December 31, 2016|Actual|2016-12-31|October 31, 2016|Actual|2016-10-31|1 Year|Observational [Patient Registry]|AQVAR||Improve the Quality of Life After a Hospitalization in Critical Care|Improve the Quality of Life After a Hospitalization in Critical Care Thanks to a Program of Prevention of Discomforts Perceived by the Patients of Critical Care Base on Targeted Measures|Completed||N/A|1006|Actual|Centre Hospitalier of Chartres|||2||f||||t||||||None Retained|"     The calculation of the number of necessary subjects is realized from the main criterion and     bases on the proportion of presenting subjects of the clinically significant depressive     symptoms in 1 year of their hospitalization in intensive care, estimated from it under scale     D of the score HAD-S.The proposal of the subject waited for the patient presenting this     profile was on the works available in particular on the general review of DAVYDOW and AL   "|||2017-10-10 22:13:56.533588|2017-10-10 22:13:56.533588
NCT02762396|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-05-02|||March 2016||2016-03-01|May 2016|2016-05-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01|1 Year|Observational [Patient Registry]|NOR-SYSII||The Norwegian Stroke in the Young Study II|The Norwegian Stroke in the Young Study II|Recruiting||N/A|600|Anticipated|Haukeland University Hospital|||1||f||||f||||||Samples With DNA|"     EDTA-blood and serum will be collected for future analysis   "|Yes|Contribution to the SECRETO study|2017-10-10 22:13:56.713481|2017-10-10 22:13:56.713481
NCT02762383|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-09-06|||March 2005||2005-03-01|May 2016|2016-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)|A Pilot, Open-Label, Multicentre Study Evaluating the Long-Term Safety and Tolerability of a Low-Dose Peginterferon Alfa-2a Maintenance Monotherapy in Chronic Hepatitis C Patients Co-Infected With Human Immunodeficiency Virus and Who Do Not Respond to a Standard Regimen of Peginterferon Alfa-2a Plus Ribavirin|Terminated||Phase 3|19|Actual|Hoffmann-La Roche||1||Low recruitment|f||||||||||||||2017-10-10 22:13:56.816802|2017-10-10 22:13:56.816802
NCT02762370|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-08-08|||April 2016||2016-04-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes|A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus|Completed||Phase 2|33|Actual|Flexion Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:13:56.926149|2017-10-10 22:13:56.926149
NCT02762357|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-01-25|||September 2016||2016-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Observational|EPINOQ||PMCF-study Using Novosyn® Quick Suture Material for Perineal Repair After Episiotomy|Post-Marketing Clinical Follow-up (PMCF) Study to Evaluate the Safety and Efficacy of Novosyn® Quick Suture Material for Episiotomy . A Monocenter, Prospective, Observational Study.|Recruiting||N/A|100|Anticipated|Aesculap AG|||1||f||||f||||||||No||2017-10-10 22:13:57.581115|2017-10-10 22:13:57.581115
NCT02762344|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-05|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01|12 Months|Observational [Patient Registry]|||Radial Artery Occlusion After Endovascular Procedure|Relationship Between Activated Clotting Time and Occlusion of Radial Artery When Used as Vascular Access for Percutaneous Endovascular Procedures.|Recruiting||N/A|2168|Anticipated|Azienda Sanitaria ULSS 13 Dolo, Mirano|||3||f||||f||||||||Undecided||2017-10-10 22:13:57.695051|2017-10-10 22:13:57.695051
NCT02762331|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-07-06|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||High Dose Vitamin C in Cardiac Surgery Patients|Pilot Study to Assess Effect of High Dose Ascorbic Acid (Vitamin C) on Inflammation Reduction in Cardiac Surgery Patients.|Recruiting||Phase 1|24|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f||||||||2017-10-10 22:13:57.807574|2017-10-10 22:13:57.807574
NCT02762318|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-05-23|||December 2015||2015-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Identification and Characterization of Bone-related Genetic Variants in Families|Identification and Characterization of Bone-related Genetic Variants in Families|Enrolling by invitation||N/A|400|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||Samples With DNA|"     Blood, Cheek swab (optional)      [If for any reason, the blood sample cannot be obtained, a swab will be applied to the inside     of the cheek to obtain saliva]   "|Yes|To facilitate future genetic diagnostics related to skeletal dysplasias, the variants identified and their classifications will be shared in Gulf-based health forums and the international online databases of clinically significant genetic variation in humans (ie Clinvar, dbSNP). The data gathered regarding the spectrum of disorders identified will be similarly disseminated. HMC-affiliated investigators will use the data generated for poster and oral presentations at international meetings. Similarly, the genetic data will be likewise shared at the relevant local and international meetings. Most importantly, we are committed to publishing the results in a timely fashion in the biomedical literature, aiming for publications in high quality, high impact, peer reviewed journals. All original data and reagents generated will be made available to other investigators according to the conventions of biomedical science.|2017-10-10 22:13:57.963995|2017-10-10 22:13:57.963995
NCT02762305|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-07-27|||April 2016||2016-04-01|May 2016|2016-05-01||||August 2016|Anticipated|2016-08-01||Interventional|||The Effects of the RSVP Bone Builders Program on Strength, Balance, Fall Risk and Life Satisfaction||Recruiting||N/A|40|Anticipated|California State University, Northridge||1|||f||||||||||||||2017-10-10 22:13:58.161724|2017-10-10 22:13:58.161724
NCT02762292|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-04-27|||June 7, 2016|Actual|2016-06-07|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|WOAW||Work of Breathing Assessment During Weaning From Mechanical Ventilation|Work of Breathing Assessment During Weaning From Mechanical Ventilation|Recruiting||N/A|20|Anticipated|St. Justine's Hospital||1|||f||||t||||||||||2017-10-10 22:13:58.272801|2017-10-10 22:13:58.272801
NCT02756923|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-01-13|||April 2012||2012-04-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Regulation of Stem Spermatogonia in the Mature Testis|Regulation of Stem Spermatogonia in the Mature Testis|Recruiting||N/A|1000|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||Samples With DNA|"     Testicular tissue   "|No||2017-10-10 22:15:07.89705|2017-10-10 22:15:07.89705
NCT02762279|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-04-27|||June 28, 2016|Actual|2016-06-28|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|APPLE||Assessment of Esophageal Pressure Reliability to Estimate Pleural Pressure in Critically Ill Children|Assessment of Esophageal Pressure Reliability to Estimate Pleural Pressure in Critically Ill Children|Recruiting||N/A|20|Anticipated|St. Justine's Hospital||1|||f||||t||||||||||2017-10-10 22:13:58.395766|2017-10-10 22:13:58.395766
NCT02762266|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-03-01|||February 27, 2016|Actual|2016-02-27|March 2017|2017-03-01|February 27, 2021|Anticipated|2021-02-27|February 27, 2019|Anticipated|2019-02-27||Interventional|||Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization|International Randomized Study of Transarterial Chemoembolization (TACE) Versus Stereotactic Body Radiotherapy (SBRT) / Stereotactic Ablative Radiotherapy (SABR) for Residual or Recurrent Hepatocellular Carcinoma After Initial TACE|Recruiting||Phase 3|160|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:13:58.515982|2017-10-10 22:13:58.515982
NCT02762253|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-04|||September 2012||2012-09-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.|Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.|Terminated||Phase 2|320|Actual|Nvision Laser Eye Centers||1||No IND submitted to the FDA|f||||f||||||||Undecided||2017-10-10 22:13:58.726892|2017-10-10 22:13:58.726892
NCT02762240|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-05-24|||June 2014||2014-06-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|July 2017|Anticipated|2017-07-01||Interventional|ACIAP||The Effectiveness of a Nationwide Mandatory Accreditation in General Practice in Denmark|The Effectiveness of a Nationwide Mandatory Accreditation in General Practice in Denmark: A Randomized Controlled Trial|Active, not recruiting||N/A|1900|Anticipated|University of Southern Denmark||2|||f||||f||||||||No||2017-10-10 22:13:58.895816|2017-10-10 22:13:58.895816
NCT02762227|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Role of Different Imaging Methods in the Diagnosis of Gallbladder Polyps|The Role of Different Imaging Methods in the Diagnosis of Gallbladder Polyps|Recruiting||N/A|60|Anticipated|RenJi Hospital||1|||f||||t||||||||No||2017-10-10 22:13:59.025875|2017-10-10 22:13:59.025875
NCT02762214|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-05-02|||October 2015||2015-10-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|RoManHy||Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY|Role Of Uterine Manipulator in Hysterectomy for Early Stage Endometrial Cancer|Recruiting||Phase 3|154|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||Undecided||2017-10-10 22:13:59.170983|2017-10-10 22:13:59.170983
NCT02762201|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-08-08|||May 16, 2014|Actual|2014-05-16|August 2017|2017-08-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Interventional|PASI-PAC||Clinical Evaluation of Implant-secured Removable Partial Denture|Clinical Evaluation of Therapeutic Efficiency of Implant-secured Removable Partial Denture: A Randomized, Controlled, Prospective Multicentric Study.|Recruiting||N/A|190|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:13:59.314232|2017-10-10 22:13:59.314232
NCT02762188|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-11-15|||August 2013||2013-08-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)|Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)|Active, not recruiting||N/A|501|Actual|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 22:13:59.451155|2017-10-10 22:13:59.451155
NCT02762175|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|June 2030|Anticipated|2030-06-01|January 2030|Anticipated|2030-01-01|6 Months|Observational [Patient Registry]|MMA-OSAS||3D Volumetric Changes in the Upper Airway After MMA in OSAS Patients and the Implication on QOL: A Prospective Registry|3D Volumetric Changes in the Upper Airway After Maxillomandibular Advancement in Obstructive Sleep Apnea Syndrome Patients and the Implication on Quality of Life: A Prospective Registry|Recruiting||N/A|150|Anticipated|AZ Sint-Jan AV|||1||f||||f||||||||No||2017-10-10 22:13:59.582239|2017-10-10 22:13:59.582239
NCT02762162|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-30|||January 2007||2007-01-01|May 2016|2016-05-01|January 2037|Anticipated|2037-01-01|January 2027|Anticipated|2027-01-01|10 Years|Observational [Patient Registry]|ONASSIST||Registry of Coronary Artery Ill Patients With Platelet Test Results|Online Assistance for Stent Thrombosis|Recruiting||N/A|5000|Anticipated|Action, France|||1||f||||f||||||||Yes||2017-10-10 22:13:59.692288|2017-10-10 22:13:59.692288
NCT02762149|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-31|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Response Patterns to the Electrical Stimulation of Epidural Catheters With Varying Pulse Widths in Term Pregnant Women|The Response Patterns to the Electrical Stimulation of Epidural Catheters With Varying Pulse Widths in Term Pregnant Women|Terminated||N/A|20|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2||"Analysis after 20 patients was convincing for a negative result for the primary outcome, so the   study was stopped."|f||||f||||||||||2017-10-10 22:13:59.80533|2017-10-10 22:13:59.80533
NCT02762136|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-04|||August 2015||2015-08-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS)|Xiang-sha-liu-jun Granules as an Herbal Formula for the Treatment of Postprandial Distress Syndrome(PDS): a Prospective, Double-blinded, Randomized and Placebo-controlled,Three-center Trial|Recruiting||Phase 1/Phase 2|216|Anticipated|Xiyuan Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 22:13:59.953535|2017-10-10 22:13:59.953535
NCT02762123|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-09-15|||May 2016||2016-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates|Effects of Concomitant Administration of BMS-986142 on the Single-dose Pharmacokinetics of Probe Substrates for CYP2C8, CYP2C9, CYP2C19, CYP3A4, and P-gp in Healthy Subjects|Completed||Phase 1|28|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:14:00.095697|2017-10-10 22:14:00.095697
NCT02756910|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-05-09|||May 2016||2016-05-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|||Perioperative Accuracy of the Raiing Wireless Axillary Thermometer|Perioperative Accuracy of the Raiing Wireless Axillary Thermometer|Recruiting||N/A|80|Anticipated|Peking Union Medical College Hospital|||1||f||||f||||||||No||2017-10-10 22:15:07.985958|2017-10-10 22:15:07.985958
NCT02762110|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-09|||October 2014||2014-10-01|May 2016|2016-05-01||||October 2017|Anticipated|2017-10-01||Interventional|||Imaging of In Vivo Sigma-2 Receptor Expression With [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer|Imaging of In Vivo Sigma-2 Receptor Expression With [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer|Recruiting||Phase 1|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:14:00.215357|2017-10-10 22:14:00.215357
NCT02762097|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2017-08-15|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Clinical Pregnancy Rate After Removal of Unsuspected Polyps|Clinical Pregnancy Rate in Women With Unexplained Infertility After Removal of Unsuspected Intrauterine Pathology|Not yet recruiting||Phase 3|200|Anticipated|Karachi Medical and Dental College||2|||f||||f|f|f||||||||2017-10-10 22:14:00.330873|2017-10-10 22:14:00.330873
NCT02762084|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-07-06|||June 6, 2016|Actual|2016-06-06|July 2017|2017-07-01|April 24, 2017|Actual|2017-04-24|April 24, 2017|Actual|2017-04-24||Interventional|BCC||Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients|Double-Blind, Randomized, Vehicle-Controlled Proof of Concept Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal (SEB) Cell Carcinomas in Gorlin Syndrome Patients|Completed||Phase 2|17|Actual|PellePharm, Inc.||3|||f||||t||||||||||2017-10-10 22:14:00.44899|2017-10-10 22:14:00.44899
NCT02762071|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-02|||April 2016||2016-04-01|May 2016|2016-05-01||||August 2017|Anticipated|2017-08-01||Interventional|||Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty|Liposomal Bupivacaine vs. Interscalene Nerve Block for Pain Control After Total Shoulder Arthroplasty: A Randomized Clinical Trial|Recruiting||N/A|120|Anticipated|Johns Hopkins University||2|||f||||f||||||||Undecided||2017-10-10 22:14:00.605683|2017-10-10 22:14:00.605683
NCT02762058|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-03|||June 2016||2016-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Virtual Reality Mirror Therapy for Those With Acquired Brain Injury: A Clinical Pilot Study|Virtual Reality Mirror Therapy for Those With Acquired Brain Injury: A Clinical Pilot Study|Not yet recruiting||N/A|30|Anticipated|University of Guelph||2|||f||||f||||||||Undecided||2017-10-10 22:14:00.74434|2017-10-10 22:14:00.74434
NCT02762045|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-02|||April 2016||2016-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine|Phase I Clinical Trial of Recombinant Adenovirus Type 5 Therapeutic AIDS Vaccine Expressing Gag|Recruiting||Phase 1|36|Anticipated|Centers for Disease Control and Prevention, China||3|||f||||f||||||||Undecided||2017-10-10 22:14:00.842911|2017-10-10 22:14:00.842911
NCT02762032|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-07-20|||February 2016||2016-02-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Natreon Healthy Skin Study - PrimaVie Supplement|The Ability of an Oral Supplement to Improve Skin Microperfusion, Hydration, Elasticity, and Barrier Function|Recruiting||Phase 1|45|Anticipated|Ohio State University||3|||f||||f||||||||||2017-10-10 22:14:00.961441|2017-10-10 22:14:00.961441
NCT02762019|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-02|||September 2013||2013-09-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|LAMPO||Laser for Oral Mucositis in Pediatric Onco-hematology|LAMPO: Multicenter Randomized Double-blind Controlled Trial to Evaluate the Efficacy of Laser Therapy for Treatment of Oral Mucositis Induced by Chemotherapy in Children|Completed||Phase 3|101|Actual|IRCCS Burlo Garofolo||2|||f||||f||||||||Undecided||2017-10-10 22:14:01.090423|2017-10-10 22:14:01.090423
NCT02762006|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-01-05|||December 2016||2016-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma|A Phase Ib Trial of Neoadjuvant Durvalumab (MEDI4736) +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma|Recruiting||Phase 1|54|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:14:01.204179|2017-10-10 22:14:01.204179
NCT02761993|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-12-13|||April 2016||2016-04-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy, and Treatment Regimen of ST266 in Subjects With Moderate to Severe Periodontitis|Active, not recruiting||Phase 2|151|Actual|Noveome Biotherapeutics, formerly Stemnion||3|||f||||f||||||||Undecided||2017-10-10 22:14:01.334409|2017-10-10 22:14:01.334409
NCT02761967|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-11-10|||June 2016||2016-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|October 2016|Actual|2016-10-01||Interventional|||Physical Activity in Pregnancy and Postpartum Period, Effects on Women|Physical Training in Water (SWEP Method) During Pregnancy and Low Pressure Fitness (LPF) in Postpartum Period, Effects on Women|Active, not recruiting||N/A|140|Actual|Universidad de Granada||2|||f||||f||||||||Undecided||2017-10-10 22:14:01.529656|2017-10-10 22:14:01.529656
NCT02761954|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-01-30|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Variation of Cerebral Blood Flow in Anterior Cerebral and Basilar Artery in Neonates and Infants in Genreal Anesthesia With Caudal Block|Variation of Cerebral Blood Flow in Anterior Cerebral and Basilar Artery in Neonates and Infants - a Prospective Study During Planed Surgery of the Infra Umbilical Region in Combined Anaesthesia|Enrolling by invitation||N/A|50|Anticipated|Bürgerhospital Frankfurt|||1||f||||f||||||||No||2017-10-10 22:14:01.620724|2017-10-10 22:14:01.620724
NCT02761941|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-04|||May 2016||2016-05-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|90 Days|Observational [Patient Registry]|EWA||Excessive Warfarin Anticoagulation - Causes and Consequences|Excessive Warfarin Anticoagulation - Causes and Consequences|Recruiting||N/A|25000|Anticipated|University of Turku|||1||f||||f||||||||Undecided||2017-10-10 22:14:01.676862|2017-10-10 22:14:01.676862
NCT02761928|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2017-05-04|||January 2016||2016-01-01|May 2017|2017-05-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|Hypermoble||Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients|Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients|Active, not recruiting||N/A|2000|Anticipated|The University of Texas Health Science Center, Houston|||10||f||||f||||||Samples With DNA|"     Blood, urine, saliva   "|||2017-10-10 22:14:01.758417|2017-10-10 22:14:01.758417
NCT02761915|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-17|||February 2016||2016-02-01|March 2017|2017-03-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Interventional|||A Cancer Research UK Trial of Anti-GD2 T-cells (1RG-CART)|A Cancer Research UK Phase I Trial of Anti-GD2 Chimeric Antigen Receptor (CAR) Transduced T-cells (1RG-CART) in Patients With Relapsed or Refractory Neuroblastoma|Recruiting||Phase 1|27|Anticipated|Cancer Research UK||5|||f||||f||||||||||2017-10-10 22:14:01.914508|2017-10-10 22:14:01.914508
NCT02761902|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-02|||February 2015||2015-02-01|May 2016|2016-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01|3 Months|Observational [Patient Registry]|PSGNV||Normal Polysomnography Values in Healthy Children and Adolescents in China|Research to Characterize Normal Polysomnography Values in Healthy Children and Adolescents in China|Recruiting||N/A|180|Anticipated|Beijing Children's Hospital|||3||f||||f||||||||No||2017-10-10 22:14:02.04896|2017-10-10 22:14:02.04896
NCT02761889|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-02|||February 2016||2016-02-01|May 2016|2016-05-01|February 2022|Anticipated|2022-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer|Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer|Recruiting||N/A|200|Anticipated|Fundacao Champalimaud||1|||f||||t||||||||No||2017-10-10 22:14:02.634375|2017-10-10 22:14:02.634375
NCT02761876|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-05-03|||February 2016||2016-02-01|May 2016|2016-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|SNAP||Singida Nutrition and Agroecology Project|Singida Nutrition and Agroecology Project|Enrolling by invitation||N/A|700|Actual|Cornell University||2|||f||||f||||||||Undecided||2017-10-10 22:14:02.890216|2017-10-10 22:14:02.890216
NCT02761863|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-03-23|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Observational|||Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma|Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma Receiving Pemetrexed/Platinum Protocol|Not yet recruiting||N/A|100|Anticipated|Ain Shams University|||1||f||||t||||||Samples Without DNA|"     Paraffin Blocks   "|No||2017-10-10 22:14:02.990848|2017-10-10 22:14:02.990848
NCT02761850|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-04|||January 2010||2010-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Developmental Profile of Ocular Refraction in Patients With Congenital Cataract|Developmental Profile of Ocular Refraction in Patients With Congenital Cataract: A Prospective Cohort Study|Completed||N/A|1164|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 22:14:03.110024|2017-10-10 22:14:03.110024
NCT02761837|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-03-29|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|April 2020|Anticipated|2020-04-01||Interventional|||The Breathe Well Program for Adults With Asthma|The Breathe Well Program to Improve Asthma Outcomes|Active, not recruiting||N/A|14978|Actual|National Jewish Health||2|||f||||f|f|f||||||Undecided||2017-10-10 22:14:03.228322|2017-10-10 22:14:03.228322
NCT02761824|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-03|||June 2012||2012-06-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Activity Based Program to Improve Quality of Life Outcomes in Women Diagnosed With Cancer|Implementation and Evaluation of an Activity Based Program to Improve Quality of Life Outcomes in Women Diagnosed With Cancer|Completed||N/A|71|Actual|University of the Sciences in Philadelphia||1|||f||||f||||||||No||2017-10-10 22:14:03.343846|2017-10-10 22:14:03.343846
NCT02761811|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-08-02|||June 2016||2016-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SMART||Sympathetic Mapping/ Ablation of Renal Nerves Trial|A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I™ Catheter and SYMPIONEER S1™ Stimulator/Generator for the Treatment of Hypertension (SMART Trial)|Recruiting||N/A|212|Anticipated|SyMap Medical (Suzhou), Ltd.||2|||f||||t||||||||||2017-10-10 22:14:03.459793|2017-10-10 22:14:03.459793
NCT02761798|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-21|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Automated Mobile Interactive Audiometer - Validation in Adults|The Automated Mobile Interactive Audiometer - Validation in Adults|Suspended||N/A|160|Anticipated|Ottawa Hospital Research Institute|||1|Pending revisions to protocol/consent as requested by the REB.|f||||f||||||||||2017-10-10 22:14:03.65217|2017-10-10 22:14:03.65217
NCT02761785|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-05-29|||May 29, 2017|Actual|2017-05-29|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 2|Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 2|Recruiting||N/A|60|Anticipated|University of Turku|||4||f||||f||||||Samples With DNA|"     Fecal samples, urine samples and blood serum samples   "|Undecided||2017-10-10 22:14:03.772901|2017-10-10 22:14:03.772901
NCT02761772|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-11-09|||April 2016||2016-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01|1 Year|Observational [Patient Registry]|PEP-cohort||Early Pregnancy Cohort and Preimplantation Factor|Prospective Early Pregnancy Cohort and Preimplantation Factor: Factors Related to Successful Implantation, Risk of Miscarriage and Recurrent Pregnancy Loss in the First Trimester|Enrolling by invitation||N/A|250|Anticipated|Nordsjaellands Hospital|||2||f||||t||||||||Yes|Following collection, data are planned to be shared within a global archive.|2017-10-10 22:14:03.888365|2017-10-10 22:14:03.888365
NCT02761759|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-03|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:14:03.997037|2017-10-10 22:14:03.997037
NCT02761746|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-05-09|||August 2015||2015-08-01|May 2016|2016-05-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|MESA||Motivational Enhancement System for Adherence (MESA) for Youth Starting ART|Motivational Enhancement System for Adherence (MESA) for Youth Starting Antiretroviral Therapy (ART)|Recruiting||N/A|300|Anticipated|Wayne State University||2|||f||||t||||||||No||2017-10-10 22:14:04.064636|2017-10-10 22:14:04.064636
NCT02761733|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-16|2016-10-31||September 2013||2013-09-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Effectiveness of a Decision-Support Tool for Adult Consumers With Mental Health Needs and Their Care Managers|Researching the Effectiveness of a Decision-Support Tool for Adult Consumers With Mental Health Needs and Their Care Managers|Completed||N/A|240|Actual|Felton Institute|Missing responses at baseline and 24 month followups were handled using full-information ML as part of a 2(Tx)x2(Location)x5(Time) mixed-effects ANOVA estimated using SAS PROC MIXED 9.4.|2|||f||||f||||||||No||2017-10-10 22:14:04.288375|2017-10-10 22:14:04.288375
NCT02761720|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-05-03|||February 2015||2015-02-01|May 2016|2016-05-01||||November 2015|Actual|2015-11-01||Observational|||Mobile App for Mood in Pregnancy (Ginger iO)||Completed||N/A|72|Actual|University of Pennsylvania|||3||f||||||||||||||2017-10-10 22:14:05.69243|2017-10-10 22:14:05.69243
NCT02761707|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-07|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Observational|||Biomarkers in Neural Disorders|Biomarkers in Neural Disorders|Recruiting||N/A|440|Anticipated|University of Pennsylvania|||11||f||||f|f|f||||||||2017-10-10 22:14:05.789164|2017-10-10 22:14:05.789164
NCT02761681|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-07-26|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help (Phase II)|Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help|Enrolling by invitation||N/A|469|Anticipated|Contextual Change LLC||2|||f||||t||||||||||2017-10-10 22:14:06.142601|2017-10-10 22:14:06.142601
NCT02761668|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2016-11-01|||October 2016||2016-10-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Timing of Orthodontic Therapy and Regenerative Periodontal Surgery in Advanced Periodontitis Patients With Pathologic Tooth Migration|The Effect of Timing of Orthodontic Therapy on the Outcomes of Regenerative Periodontal Surgery in Patients With Advanced Periodontitis and Pathologic Tooth Migration. A Multi Centre Randomized Clinical Trial.|Recruiting||N/A|46|Anticipated|University of Bonn||2|||f||||f||||||||Undecided||2017-10-10 22:14:06.289318|2017-10-10 22:14:06.289318
NCT02761655|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-08|||August 2015||2015-08-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Study of a Memory Intervention to Improve MA in PWMCI & FCG MA|A Study of a Memory Intervention to Improve Medicine Adherence in Patients With Mild Cognitive Impairments and Family Caregiver Medication Administration|Recruiting||N/A|200|Anticipated|Chang Gung University||2|||f||||f||||||||Undecided||2017-10-10 22:14:06.484291|2017-10-10 22:14:06.484291
NCT02761629|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-07-05|2016-07-05||April 2005||2005-04-01|July 2016|2016-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Intent-to-treat (ITT) analysis population included all randomized participants who receive at least one dose of any study medication and have at least one post-baseline efficacy assessment.|Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus|Randomized, Multi-Center, Phase IV, Comparative Study to Assess the Efficacy and Safety of Combined Peg-Interferon Alpha-2a (40 kD) With Ribavirin Combined Therapy for 48 or 72 Weeks of Treatment and 24 Weeks of Follow-Up in Patients With Chronic Hepatitis C, Genotype 1, Co-Infected With Human Immunodeficiency Virus|Completed||Phase 4|180|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:14:06.847981|2017-10-10 22:14:06.847981
NCT02761616|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2017-01-30|||June 2016||2016-06-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer||Completed||N/A|76|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:14:07.692278|2017-10-10 22:14:07.692278
NCT02761603|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-03|||April 2015||2015-04-01|May 2016|2016-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|HAPI-CHI||Healthy Aging Practice-centered Instruction Cardiovascular Health Investigation (HAPI-CHI)|Autonomic and Immuno-Vascular Mechanisms of Antihypertensive Effects of Tai Chi|Enrolling by invitation||N/A|250|Anticipated|University of California, San Diego||2|||f||||t||||||||No||2017-10-10 22:14:07.800954|2017-10-10 22:14:07.800954
NCT02761590|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-01|||March 2015||2015-03-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Circuit Training on Knee Osteoarthritis Patients|Influence of a Circuit Trining Protocol on Intermuscular Adipose Tissue of Knee Osteoarthritis Patients: a Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Universidade Federal de Sao Carlos||2|||f||||t||||||||Yes||2017-10-10 22:14:07.901555|2017-10-10 22:14:07.901555
NCT02761577|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-02|||June 2012||2012-06-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|July 2013|Actual|2013-07-01||Interventional|||A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia|A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia With the Use of Standard Laboratory Measures and Novel Biomarkers|Completed||Phase 4|90|Actual|Clinical Hospital Centre Zagreb||3|||f||||f||||||||Undecided||2017-10-10 22:14:08.037074|2017-10-10 22:14:08.037074
NCT02761564|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-18|||September 2016||2016-09-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|ReTSEACS||SvO2 Trigger in Transfusion Strategy After Cardiac Surgery|Restrictive Transfusion Strategy Early After Cardiac Surgery|Not yet recruiting||N/A|100|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||Undecided||2017-10-10 22:14:08.396371|2017-10-10 22:14:08.396371
NCT02761551|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-03-22|||September 2016||2016-09-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates|Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates: Colorado|Enrolling by invitation||N/A|100000|Anticipated|University of Colorado, Denver||4|||f||||f||||||||||2017-10-10 22:14:08.569375|2017-10-10 22:14:08.569375
NCT02761538|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-05-06|||September 2015||2015-09-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Medico-economic Evaluation of Obesity|Medico-economic Evaluation of Complicated Obesity in Primary Care|Recruiting||N/A|300|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||No||2017-10-10 22:14:08.713835|2017-10-10 22:14:08.713835
NCT02761525|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-05-02|||October 2014||2014-10-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Topical Application of Silver Nanoparticles and Oral Pathogens in Ill Patients|Topical Application of Silver Nanoparticles Reduced Oral Pathogens in Mechanically Ventilated Patients: A Randomized Controlled Clinical Trial|Completed||N/A|50|Actual|Universidad Autonoma de San Luis Potosí||2|||f||||f||||||||No|in process|2017-10-10 22:14:08.883863|2017-10-10 22:14:08.883863
NCT02761512|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-12-28|||May 2016||2016-05-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer|A Double Blind, Randomized, Active-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer|Recruiting||Phase 3|306|Anticipated|CJ HealthCare Corporation||3|||f||||f||||||||No||2017-10-10 22:14:09.008713|2017-10-10 22:14:09.008713
NCT02761499|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-02-10|||January 2016||2016-01-01|February 2017|2017-02-01|January 2024|Anticipated|2024-01-01|January 2019|Anticipated|2019-01-01||Observational|UMove||Post Approval Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem|Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem|Recruiting||N/A|200|Anticipated|United Orthopedic Corporation|||1||f||||f||||||||Undecided||2017-10-10 22:14:09.195167|2017-10-10 22:14:09.195167
NCT02761486|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-30|||August 2016||2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2017|Actual|2017-08-01||Interventional|ASMIC||Effect of Aspirin on Gut Microbiome|Pilot Trial to Examine the Effect of Aspirin on the Gut Microbiome|Recruiting||Phase 1|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||||2017-10-10 22:14:09.364071|2017-10-10 22:14:09.364071
NCT02761473|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-03-13|||November 2016||2016-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations|Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations|Recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||Samples With DNA|"     Buccal swabs, skin biopsy and blood   "|No||2017-10-10 22:14:09.5299|2017-10-10 22:14:09.5299
NCT02761460|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-05-30|||May 4, 2016|Actual|2016-05-04|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia|The Study of Evaluating the Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia|Recruiting||Phase 3|338|Anticipated|Sun Yat-sen University||1|||f||||t||||||||Undecided||2017-10-10 22:14:09.710434|2017-10-10 22:14:09.710434
NCT02761447|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-07-21|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectivity of Motor Imagery and MirrorTherapy in Amputees|Effectivity of Differences Therapies on Central Nerve System for Pain, Phantom, Disability and Quality of Life in Amputees|Active, not recruiting||N/A|40|Anticipated|Universidad de Almeria||2|||f||||f||||||||||2017-10-10 22:14:09.878014|2017-10-10 22:14:09.878014
NCT02761434|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-05-27|||April 13, 2016|Actual|2016-04-13|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|HYPERGlu||The Effect of Vasopressin on Glucose Regulation|The Effect of Osmotically Stimulated Vasopressin on Glucose Regulation|Completed||N/A|60|Actual|University of Arkansas, Fayetteville||2|||f||||f||||||||||2017-10-10 22:14:10.098296|2017-10-10 22:14:10.098296
NCT02761421|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-02|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT|Effect of Motor Development, Motor Function and Electrodiagnostic Characteristic of IOPD Under ERT|Recruiting||N/A|15|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||t||||||||Yes|publication in journal|2017-10-10 22:14:10.247197|2017-10-10 22:14:10.247197
NCT02761408|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-02|||April 2016||2016-04-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Observational|||ALDH2 Mutation in Taiwanese Head and Neck Cancer|Correlation Between Radiation Dermatitis/Mucositis and ALDH2 Mutation in Taiwanese Head and Neck Cancer|Recruiting||N/A|120|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||f||||||Samples With DNA|"     Residual whole blood   "|No||2017-10-10 22:14:10.33935|2017-10-10 22:14:10.33935
NCT02761395|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2017-04-24|||November 2015||2015-11-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|Al-hijamah||Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major|Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major|Recruiting||N/A|60|Anticipated|Tanta University||3|||f||||t||||||||Undecided||2017-10-10 22:14:10.422879|2017-10-10 22:14:10.422879
NCT02761382|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-06-19|||March 2016||2016-03-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Psychological Pain Treatment in Endometriosis|Mindfulness-based Psychological Pain Treatment in Endometriosis|Recruiting||N/A|100|Anticipated|University of Aarhus||3|||f||||||||||||||2017-10-10 22:14:10.532286|2017-10-10 22:14:10.532286
NCT02761369|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-05-01|||May 2016||2016-05-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|FAOB||Deep TMS With Paired Associative Stimulation (PAS) for the Treatment of Food Addiction in Obesity|Comparison of Two Deep TMS Protocols With Paired Associative Stimulation (PAS) for the Treatment of Food Addiction in Severe Obesity|Not yet recruiting||N/A|60|Anticipated|Soroka University Medical Center||3|||f||||t||||||||||2017-10-10 22:14:10.665788|2017-10-10 22:14:10.665788
NCT02756338|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-15|||June 2016||2016-06-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|BioInsight||BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment||Completed||N/A|77|Actual|Biotronik, Inc.|||1||f||||f||||||||||2017-10-10 22:15:14.259073|2017-10-10 22:15:14.259073
NCT02761356|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-05-02|||January 2010||2010-01-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||The Added Value of Hybrid Functional Anatomical Imaging PET-CT and SPECT-CT in Patients Treated With Y-90 SIRT for Liver Malignancies|The Added Value of Hybrid Functional Anatomical Imaging PET-CT and SPECT-CT in Patients Treated With Yttrium-90 SIRT for Liver|Completed||N/A|50|Actual|Tel-Aviv Sourasky Medical Center|||2||f||||f||||||||No||2017-10-10 22:14:10.764681|2017-10-10 22:14:10.764681
NCT02761343|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-30|||April 2014||2014-04-01|January 2017|2017-01-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01||Interventional|||MRI Assessment of Arrythmia Ablation Lesions|MRI Assessment of Arrythmia Ablation Lesions|Recruiting||N/A|100|Anticipated|Children's Research Institute||1|||f||||f||||||||No||2017-10-10 22:14:10.847967|2017-10-10 22:14:10.847967
NCT02761330|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2017-06-20|||April 2016||2016-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|RCC2||Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia|Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia Reconstitution of Consciousness and Cognition (Phase 2)|Recruiting||N/A|20|Anticipated|Washington University School of Medicine||3|||f||||f||||||||No||2017-10-10 22:14:10.959678|2017-10-10 22:14:10.959678
NCT02761317|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-31|||May 2016||2016-05-01|May 2016|2016-05-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Optimal Bowel Preparation Regimen in Patients With Colorectal Surgery|Optimal Bowel Preparation Regimen for Patients With With a History of Colorectal Resection Before Colonoscopy|Recruiting||Phase 4|300|Anticipated|Shandong University||3|||f||||t||||||||||2017-10-10 22:14:11.088065|2017-10-10 22:14:11.088065
NCT02761304|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-02|||June 2013||2013-06-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|eng - echo||"Assessment of the Interests of Mesure of Ultrasound  Angle of Progression  on the Cesarean Rate :a Randomized Comparative Prospective Study Multicenter Center Open"|Assessment of the Interests of Mesure of Ultrasound Engagement on the Cesarean Rate :Study Eng - Echo Randomized Comparative Prospective Study Multicenter Center Open|Recruiting||N/A|80|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 22:14:11.20474|2017-10-10 22:14:11.20474
NCT02761291|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-05-12|||May 2016||2016-05-01|March 2016|2016-03-01||||June 2017|Anticipated|2017-06-01||Interventional|||Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma|Phase I Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma|Recruiting||Phase 1|18|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:14:11.303922|2017-10-10 22:14:11.303922
NCT02761278|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-11|||July 2016||2016-07-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Expression of HOXA10 and HOXA11 in the Endometrium of Infertility Patients With an Endometrial Polyp Before and After Polypectomy||Not yet recruiting||N/A|20|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||No||2017-10-10 22:14:11.411106|2017-10-10 22:14:11.411106
NCT02761265|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-02|||March 2016||2016-03-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Gait and Balance in Thoracolumbar Spinal Deformity|The Effect of Thoracolumbar Spinal Deformity and Its Surgical Correction on Gait and Balance in Adults|Recruiting||N/A|100|Anticipated|Texas Back Institute||2|||f||||f||||||||No||2017-10-10 22:14:11.474354|2017-10-10 22:14:11.474354
NCT02761252|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-01|||April 2016||2016-04-01|September 2017|2017-09-01|November 24, 2016|Actual|2016-11-24|November 24, 2016|Actual|2016-11-24||Interventional|SKY||Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma|Bilastine and Montelukast in Patients With Seasonal Allergic Rhinoconjunctivitis and Asthma: Efficacy of Concomitant Administration - the SKY Study|Completed||Phase 4|453|Actual|Menarini International Operations Luxembourg SA||3|||f||||f||||||||||2017-10-10 22:14:11.607027|2017-10-10 22:14:11.607027
NCT02761239|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-05-01|||February 2015||2015-02-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve|Descriptive In Vivo Study of Evaluating the Innervation of The Human Cricopharyngeal Muscle By The Recurrent Laryngeal Nerve and External Branch of The Superior Laryngeal Nerve|Completed||N/A|100|Actual|Sisli Etfal Training & Research Hospital||1|||f||||f||||||||No||2017-10-10 22:14:11.778646|2017-10-10 22:14:11.778646
NCT02761226|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-05-06|||March 2015||2015-03-01|April 2016|2016-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PS||Clinical and Radiographic Evaluation of Crestal Bone Loss Around Implant With or Without Platform Switching Design|Clinical and Radiographic Evaluation of Crestal Bone Loss Around Implant With or Without Platform Switching Design (Randomized Clinical Trial, Split Mouth Design)|Completed||Phase 2|10|Actual|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 22:14:11.859061|2017-10-10 22:14:11.859061
NCT02761200|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-04-24|||March 2016||2016-03-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Observational|||Post Analytic Treatment Interruption Study|Safety and Virologic Outcomes After Analytic Treatment Interruption in Thai Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection|Recruiting||N/A|25|Anticipated|South East Asia Research Collaboration with Hawaii|||1||f||||f||||||Samples With DNA|"     Total blood HIV DNA at initiation of therapy predicted reservoir size after 24 weeks of     aggressive ART, underscoring the importance of early initiation of ART.   "|Undecided||2017-10-10 22:14:12.113336|2017-10-10 22:14:12.113336
NCT02761187|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-28|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|July 31, 2024|Anticipated|2024-07-31|July 31, 2024|Anticipated|2024-07-31||Observational|||An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants|A Global, Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients - the INSIGHT-MM Study|Recruiting||N/A|5000|Anticipated|Takeda|||2||f||||f||||||||||2017-10-10 22:14:12.21466|2017-10-10 22:14:12.21466
NCT02761174|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-05-02|||March 2016||2016-03-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias|Topical Brimonidine to Reduce Post-inflammatory Response After IPL-treatment and Effect on IPL-efficacy in Patients With Facial Telangiectasias|Recruiting||Phase 4|20|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||Yes|Sponsor and investigator allow access to registries, CRF and trial master files in case of audit or quality inspection from relevant authorities such as GCP-unit, Danish Health and Medicine Authority or The Regional Committee on Health Research Ethics|2017-10-10 22:14:14.235216|2017-10-10 22:14:14.235216
NCT02761161|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-29|||March 2016||2016-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|PTF5||Treatment of Sleep Disturbances in Trauma-affected Refugees|Treatment of Sleep Disturbances in Trauma-affected Refugees: A Randomised Controlled Trial|Recruiting||Phase 4|230|Anticipated|Mental Health Services in the Capital Region, Denmark||4|||f||||t||||||||||2017-10-10 22:14:14.349667|2017-10-10 22:14:14.349667
NCT02761148|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-06-10|||January 2014||2014-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||The Relationship Between White Matter Hyperintensity With Cognition and Emotion|The Relationship Between White Matter Hyperintensity With Cognition and Emotion|Recruiting||N/A|200|Anticipated|Zhejiang University|||2||f||||t||||||||||2017-10-10 22:14:14.466377|2017-10-10 22:14:14.466377
NCT02761135|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-05-02|||January 2011||2011-01-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|August 2016|Anticipated|2016-08-01||Observational|||Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?|Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique, in Investigating a Raised Prostatic Specific Antigen (PSA)?|Recruiting||Early Phase 1|400|Anticipated|Kronoberg County Council|||2||f||||t||||||Samples With DNA|"     Biopsy cores from prostate.   "|Yes||2017-10-10 22:14:14.563694|2017-10-10 22:14:14.563694
NCT02761122|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-08-01|||May 2016||2016-05-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|HPVLichen||Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)|Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human|Recruiting||N/A|30|Anticipated|Institut Pasteur||1|||f||||f||||||||||2017-10-10 22:14:14.636886|2017-10-10 22:14:14.636886
NCT02761109|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-01-29|||January 2011||2011-01-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|3 Years|Observational [Patient Registry]|||Postoperative Complications After Liver Transplantation|Postoperative Renal, Pulmonary, Cardiovascular Complications and Use of Blood Components in Patients Undergoing Liver Transplantation|Recruiting||N/A|1600|Anticipated|Azienda Ospedaliera S. Maria della Misericordia|||1||f||||f||||||||No||2017-10-10 22:14:14.733458|2017-10-10 22:14:14.733458
NCT02761096|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-02|||April 2016||2016-04-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of Acupuncture on Inflammation and Immune Function After Craniotomy|Effect of Acupuncture on Inflammation and Immune Function After Craniotomy|Recruiting||N/A|40|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||No||2017-10-10 22:14:14.819852|2017-10-10 22:14:14.819852
NCT02761083|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-03|2016-06-09|||May 2016||2016-05-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|OPHTHALNOQ||PMCF-study Using Novosyn® Quick Suture Material in Ophthalmic Surgery|Post-Marketing Clinical Follow-up (PMCF) Study in Ophthalmic Surgery to Evaluate the Safety and Efficacy of Novosyn® Quick Suture Material. A Multicenter Randomized, Active-controlled, Double-blinded, Prospective, Observational Study.|Withdrawn||Phase 4|0|Actual|Aesculap AG||2||Comparator was not available in the planned setting|f||||f||||||||No||2017-10-10 22:14:14.902861|2017-10-10 22:14:14.902861
NCT02761070|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-17|||July 2016||2016-07-01|August 2017|2017-08-01|July 2023|Anticipated|2023-07-01|July 2022|Anticipated|2022-07-01||Interventional|RE-GEND||Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III|A Multicenter Randomized Phase III Study for Recurrent Glioblastoma Comparing Bevacizumab Alone With Dose-dense Temozolomide Followed by Bevacizumab (JCOG1308C, RE-GEND-pIII)|Recruiting||Phase 3|210|Anticipated|Kyorin University||2|||f||||t||||||||||2017-10-10 22:14:15.015044|2017-10-10 22:14:15.015044
NCT02761031|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-03|||April 2016||2016-04-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Observational|PHERVR||Perioperative Heart Rate Variability Analysis in Realtime|Perioperative Heart Rate Variability Analysis in Realtime: Detection of Cardiovascular and Autonomic Dysfunction|Enrolling by invitation||N/A|200|Anticipated|Medical University of Vienna|||1||f||||||||||||||2017-10-10 22:14:18.206863|2017-10-10 22:14:18.206863
NCT02761018|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-07|||November 2016||2016-11-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes|Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes|Recruiting||N/A|150|Anticipated|Mike O'Callaghan Federal Hospital||2|||f||||f|f|f||||||||2017-10-10 22:14:18.280261|2017-10-10 22:14:18.280261
NCT02761005|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-01|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|EHR||Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori|Eradication of H. Pylori With the Regimen Individualized Susceptibility of H. Pylori to Clarithromycin Determined by the Mutation of 23S rRNA of H. Pylori|Not yet recruiting||Phase 2|100|Anticipated|Hamamatsu University||2|||f||||f||||||||No|The data obtained with this study are restricted in our hospital.|2017-10-10 22:14:18.371501|2017-10-10 22:14:18.371501
NCT02760992|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-11-28|||May 2017||2017-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Repeated Dose IV Baclofen Safety/Bioequivalence Study|Steady-State Bioequivalence Study of Multiple Doses of Oral Versus Intravenous Baclofen in Healthy Adult Volunteers|Not yet recruiting||Phase 1/Phase 2|42|Anticipated|Allaysis, LLC||2|||f||||t||||||||Undecided|Undecided|2017-10-10 22:14:18.454252|2017-10-10 22:14:18.454252
NCT02760979|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-10|||January 2013||2013-01-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|January 2014|Actual|2014-01-01||Interventional|||The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty|The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty: A Randomised, Double Blind, Placebo Controlled Clinical Trial|Completed||Phase 4|60|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-10 22:14:18.52331|2017-10-10 22:14:18.52331
NCT02760966|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-05-02|||October 2015||2015-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effectiveness of Alcohol 70º vs Soap on Cord Separation Time and the Complication in the Newborn|Effectiveness of Alcohol 70º Compared With Soap on Cord Separation Time and the Complication Rate in the Newborn|Recruiting||N/A|34|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 22:14:18.613632|2017-10-10 22:14:18.613632
NCT02760953|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-03|||June 2016||2016-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||TURBt With Adjuvant Cryoablation to Treat Bladder Cancer|A Multi Center, Randomized, Parallel Controlled Study of Applying Transurethral Resection of Bladder Tumor With Adjuvant Cryoablation to Treat Bladder Cancer|Not yet recruiting||Phase 2|150|Anticipated|Huashan Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:14:18.700867|2017-10-10 22:14:18.700867
NCT02760940|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-08-07|||August 2016||2016-08-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|IBD||Anemia in Inflammatory Bowel Disease|Anemia Treatment in Inflammatory Bowel Disease: Predictive Factors of Response to Oral Iron Treatment|Not yet recruiting||Phase 4|200|Anticipated|Federal University of Juiz de Fora||1|||f||||t||||||||Yes|data will be published every 6 months until the end of the study|2017-10-10 22:14:18.77769|2017-10-10 22:14:18.77769
NCT02760927|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-09-30|||March 2016||2016-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Assessment of a Oral Endotracheal Tube Fastener on Patients Intubated With Oral Endotracheal Tubes|Assessment of AnchorFast Guard Oral Endotracheal Tube Fastener on Patients Intubated With Oral Endotracheal Tubes With Subglottic Suction|Terminated||N/A|4|Actual|Hollister Incorporated||1||Study product will not be commercialized.|f||||f||||||||No||2017-10-10 22:14:18.863506|2017-10-10 22:14:18.863506
NCT02760914|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-03|||June 2016||2016-06-01|May 2016|2016-05-01|December 2029|Anticipated|2029-12-01|December 2029|Anticipated|2029-12-01||Observational|ATICH||Adipose Tissue and Inflammation in Coronary Heart Disease|Inflammatory Activity in Various Compartments of Adipose Tissue in Patients With Coronary Heart Disease|Not yet recruiting||N/A|50|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     adipose tissue, whole blood   "|||2017-10-10 22:14:18.987817|2017-10-10 22:14:18.987817
NCT02760901|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-01-23|||November 2013||2013-11-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity|Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity|Completed||Phase 2|52|Actual|Ain Shams University||3|||f||||f||||||||||2017-10-10 22:14:19.22481|2017-10-10 22:14:19.22481
NCT02760888|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2016-05-03|||May 2016||2016-05-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|OPH||Oral Tramadol Versus Diclofenac For Pain Relief Before Outpatient Hysteroscopy:|Oral Tramadol Versus Diclofenac For Pain Relief Before Outpatient Hysteroscopy: A Randomized Controlled Trial|Not yet recruiting||Phase 3|102|Anticipated|Ain Shams University||3|||f||||||||||||||2017-10-10 22:14:19.343137|2017-10-10 22:14:19.343137
NCT02760875|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-01|||January 2016||2016-01-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|||Foot Pressure Mapping and Tendon Length After Nonoperative Treatment of Acute Achilles Tendon Rupture|Foot Pressure Mapping and Ultrasound Achilles Tendon Length, in Medium Term Acute Achilles Tendon Rupture Patients Using Nonoperative Treatment.|Enrolling by invitation||N/A|41|Anticipated|Copenhagen University Hospital, Hvidovre|||2||f||||t||||||||No||2017-10-10 22:14:19.466739|2017-10-10 22:14:19.466739
NCT02760862|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-03|||October 2014||2014-10-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Comparative Study Between Hydrocortisone and Mannitol in Treatment of Postdural Puncture Headache|Comparative Study Between Hydrocortisone and Mannitol in Treatment of Postdural Puncture Headache: a Randomized Double-blind Study|Completed||Phase 4|50|Actual|Ain Shams University||2|||f||||||||||||||2017-10-10 22:14:19.588067|2017-10-10 22:14:19.588067
NCT02760849|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-09-19|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|May 2041|Anticipated|2041-05-01|May 2041|Anticipated|2041-05-01||Interventional|||The Women Choosing Surgical Prevention (WISP) Trial|WISP (Women Choosing Surgical Prevention)|Recruiting||Phase 2|300|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|f|f||||||||2017-10-10 22:14:19.700958|2017-10-10 22:14:19.700958
NCT02760836|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-12-26|||April 2016||2016-04-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|PICASSO||Predictive Model of Clinical Outcomes Using Web-based Self-reporting Symptom Diary for Crohn's Disease|Development and Validation of Predictive Model of Clinical Outcomes Using Pattern Analysis of Web-based Self-reporting Symptom Diary for Crohn's Disease|Recruiting||N/A|250|Anticipated|Kyungpook National University|||1||f||||f||||||||No||2017-10-10 22:14:19.83788|2017-10-10 22:14:19.83788
NCT02760823|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-07|||May 2016||2016-05-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ALA||Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning|Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning: A Randomized Clinical Trial|Not yet recruiting||Phase 2|50|Anticipated|Kafrelsheikh University||2|||f||||f||||||||||2017-10-10 22:14:19.968578|2017-10-10 22:14:19.968578
NCT02760810|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-06-12|2017-05-01||April 12, 2016|Actual|2016-04-12|June 2017|2017-06-01|April 26, 2016|Actual|2016-04-26|April 26, 2016|Actual|2016-04-26||Interventional||All subjects that were dispensed a study lens.|Clinical Evaluation of An Approved Contact Lens||Completed||N/A|31|Actual|Johnson & Johnson Vision Care, Inc.||1|||f||||f|f|t|f|f|t|||No||2017-10-10 22:14:20.144784|2017-10-10 22:14:20.144784
NCT02760446|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-11-17|||November 2015||2015-11-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CAM-ICU||Translation and Validation of the French Version of Confusion Assessment Method for the Intensive Care Unit|Validation of the French Confusion Assessment Method for the Intensive Care Unit Among Adult ICU Patient|Completed||N/A|115|Actual|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 22:14:25.965063|2017-10-10 22:14:25.965063
NCT02760784|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-08-09|||January 2016||2016-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2016|Actual|2016-06-01||Observational|||Medium Term Outcome of Nonoperative Treatment After Achilles Tendon Rupture.|Medium Term Outcome of Nonoperative Dynamic Treatment of Acute Achilles Tendon Rupture: the Influence of Early Weight-bearing on Clinical Outcome: a Blinded, Randomized Controlled Trial.|Completed||N/A|37|Actual|Copenhagen University Hospital, Hvidovre|||2||f||||t||||||||||2017-10-10 22:14:20.54526|2017-10-10 22:14:20.54526
NCT02760771|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-08-15|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01|6 Months|Observational [Patient Registry]|EASE-IT-TF||Transfemoral Transcatheter Aortic Valve Implantation With or Without Predilation of the Aortic Valve (EASE-IT TF)|Transfemoral Transcatheter Aortic Valve Implantation With or Without Predilation of the Aortic Valve (EASE-IT TF)|Recruiting||N/A|200|Anticipated|Institut für Pharmakologie und Präventive Medizin|||2||f||||f||||||||||2017-10-10 22:14:20.629921|2017-10-10 22:14:20.629921
NCT02760758|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-07-18|||April 2016||2016-04-01|August 2016|2016-08-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects|A Phase Ia/Ib Study Assessing Single and Multiple Doses of CDI-31244: A Non-Nucleoside Inhibitor in Healthy and Hepatitis C Virus-Infected Subjects|Completed||Phase 1|76|Actual|Cocrystal Pharma, Inc.||11|||f||||f||||||||||2017-10-10 22:14:20.928994|2017-10-10 22:14:20.928994
NCT02760745|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-11-13|||January 2016||2016-01-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Fever and Shivering: Frequency and Role in Predicting Serious Bacterial Infection|Fever and Shivering: Frequency Among Children Visiting the Emergency Department and Its Role in Predicting Serious Bacterial Infection|Recruiting||N/A|200|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||Samples Without DNA|"     blood, urine, stool, csf, throat culture, joint fluid   "|Undecided||2017-10-10 22:14:21.067427|2017-10-10 22:14:21.067427
NCT02760732|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-03-25|||November 2015||2015-11-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Drug Eluting Balloon for Treatment of Unstable Angina|Drug Eluting Balloon Combined With Cutting Balloon for Treatment of Unstable Angina|Recruiting||N/A|60|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:14:21.219959|2017-10-10 22:14:21.219959
NCT02760719|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-05-17|||December 2015||2015-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NHSAB||The Effectiveness of Nebulized Hypertonic Saline Solution for Acute Bronchiolitis|The Effectiveness of Nebulized 3% Hypertonic Saline With Salbutamol in Acute Bronchiolitis in Hospitalised Children- a Randomized Clinical Trial|Recruiting||Phase 2|100|Anticipated|University Medical Centre Ljubljana||2|||f||||f||||||||No||2017-10-10 22:14:21.328749|2017-10-10 22:14:21.328749
NCT02760706|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2017-05-18|||October 2013||2013-10-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Preliminary Assessment of Added Diagnostic Value of Dual Energy CT Images Using Data Acquired on a Spectral Detector CT|Preliminary Assessment of the Added Diagnostic Value of Dual Energy Computed Tomography (DECT) Images Using Data Acquired on a Spectral Detector Computed Tomography (SDCT)|Completed||N/A|303|Actual|Philips Healthcare|||1||f||||f||||||||||2017-10-10 22:14:21.445185|2017-10-10 22:14:21.445185
NCT02760693|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-29|||May 2000||2000-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Bipolar Cohort Neunkirchen, Final Statement|SPICS (Secure Platform for Integrating Clinical Studies) for Recurrent (Bipolar) Affective Disorders for Long Term Follow up Treatment Regiments and Outcome in a Natural Setting|Completed||N/A|515|Actual|Österreichische Gesellschaft für Bipolare Erkrankungen|||1||f||||t||||||||No||2017-10-10 22:14:21.518047|2017-10-10 22:14:21.518047
NCT02760680|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-03-15|||March 2015||2015-03-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|June 2015|Actual|2015-06-01||Interventional|||Validation of the Peripheral Arterial Tone to Detect Sleep-disordered Breathing in Patients With Chronic Heart Failure|Validierung Der Peripher Arteriellen Tonometrie Zur Diagnostik Schlafbezogener Atmungsstörungen Bei Patienten Mit Systolischer Herzinsuffizienz|Completed||N/A|30|Actual|Heart and Diabetes Center North-Rhine Westfalia||2|||f||||f||||||||No||2017-10-10 22:14:21.604465|2017-10-10 22:14:21.604465
NCT02760667|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-27|||June 2015||2015-06-01|April 2016|2016-04-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer|A Phase II Study of Induction Chemotherapy Followed by Surgical Treatment in Locally Advanced Oropharyngeal And Supraglotic Cell Carcinoma|Recruiting||Phase 2|20|Anticipated|George Washington University||1|||f||||f||||||||No||2017-10-10 22:14:21.768706|2017-10-10 22:14:21.768706
NCT02760654|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-04-26|2017-03-04||April 2016||2016-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SONICS||Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy|Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy|Completed||N/A|60|Actual|University of Michigan|Small sample size, high drop out, lack of active monitoring of intervention usage, lack of generalizability to any specific type of chronic painful neuropathy, and changes in pain medications during the trial may have confounded the primary analysis.|2|||f||||t||||||||No||2017-10-10 22:14:21.915273|2017-10-10 22:14:21.915273
NCT02760641|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-16|||January 2015||2015-01-01|October 2016|2016-10-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Egg Diet to Improve Metabolic Health and Function|Does an Egg-Rich Diet Improve Metabolic Health and Function in Obese Older Adults|Completed||N/A|34|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 22:14:23.738515|2017-10-10 22:14:23.738515
NCT02760628|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-09-20|||August 2016||2016-08-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The First Twenty (TF20) for Volunteer Firefighters in a Clinic Based Setting|A Clinic and Tech-Based Diet and Fitness Intervention for Volunteer Firefighters|Not yet recruiting||N/A|128|Anticipated|National Development and Research Institutes, Inc.||2|||f||||t||||||||Undecided||2017-10-10 22:14:23.857051|2017-10-10 22:14:23.857051
NCT02760615|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-06-23|||November 1, 2016|Actual|2016-11-01|June 2017|2017-06-01|July 29, 2019|Anticipated|2019-07-29|July 1, 2019|Anticipated|2019-07-01||Interventional|||Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study|An Open-Label, 2-Part, Multicenter, Post-marketing Study to Evaluate the Effect of Moderately or Severely Active Ulcerative Colitis or Crohn's Disease on Cytochrome P-450 Enzyme Substrates Compared to Healthy Subjects and the Effect of Vedolizumab Treatment on Cytochrome P-450 Enzyme Substrates in Subjects With Ulcerative Colitis or Crohn's Disease|Recruiting||Phase 4|60|Anticipated|Takeda||3|||f||||f|t|f||||||||2017-10-10 22:14:23.945378|2017-10-10 22:14:23.945378
NCT02760602|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-06-15|||June 2016||2016-06-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|ExpeditionPRO||A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease|A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease|Terminated||Phase 3|26|Actual|Eli Lilly and Company||2||"Insufficient scientific evidence that solanezumab would likely demonstrate a meaningful benefit   to patients with prodromal AD as defined by the study protocol."|f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 22:14:24.114088|2017-10-10 22:14:24.114088
NCT02760589|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-06-26|||November 2015||2015-11-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Magnetic Resonance Imaging and Functional Performance Outcome After ACL Repair With Internal Brace Technique|Clinical Evaluation After Anterior Cruciate Ligament Tears (Internal Brace Technique vs. ACL Reconstruction vs. Conservative Treatment) With Special Regard to Magnetic Resonance Imaging and Functional Performance|Active, not recruiting||N/A|92|Actual|AUVA|||4||f||||f||||||||Undecided|Individual data may be allocated confidentially to each individual at the end of the investigation.|2017-10-10 22:14:24.745781|2017-10-10 22:14:24.745781
NCT02760576|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-03|||October 2015||2015-10-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:14:24.835895|2017-10-10 22:14:24.835895
NCT02760563|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2016-05-03|||October 2015||2015-10-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:14:24.967578|2017-10-10 22:14:24.967578
NCT02760550|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-29|||January 2015||2015-01-01|April 2016|2016-04-01||||July 2015|Actual|2015-07-01||Observational|||Policy-Related Survey - Territory-wide Telephone Survey on Tobacco Control|Policy-Related Survey - Territory-wide Telephone Survey on Tobacco Control|Completed||N/A|5252|Actual|The University of Hong Kong|||3||f||||f||||||||No||2017-10-10 22:14:25.053078|2017-10-10 22:14:25.053078
NCT02760537|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-03|||April 2013||2013-04-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|LHWAA||Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans|Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans|Completed||N/A|232|Actual|Thomas Jefferson University||2|||f||||f||||||||No||2017-10-10 22:14:25.143903|2017-10-10 22:14:25.143903
NCT02760524|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-01-19|||April 2009||2009-04-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|NET||Desensitizing Distressing Recollections in Cancer Patients|Desensitizing Distressing Recollections in Cancer Patients|Active, not recruiting||N/A|45|Actual|Thomas Jefferson University||2|||f||||t||||||||No||2017-10-10 22:14:25.229465|2017-10-10 22:14:25.229465
NCT02760511|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-02|||February 2016||2016-02-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Anthocyanin Dose-escalation Study in Healthy Young Adults|Anthocyanin Dose-escalation Study in Healthy Young Adults: A CONSORT-compliant, Randomized, Controlled Trial|Recruiting||N/A|120|Anticipated|Shaoguan University||6|||f||||t||||||||Undecided||2017-10-10 22:14:25.32477|2017-10-10 22:14:25.32477
NCT02760498|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-10-02|||March 2016||2016-03-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma|A Phase 2 Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients With Advanced Cutaneous Squamous Cell Carcinoma|Recruiting||Phase 2|182|Anticipated|Regeneron Pharmaceuticals||3|||f||||t||||||||||2017-10-10 22:14:25.418951|2017-10-10 22:14:25.418951
NCT02760485|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-02|2017-07-17|||December 2016||2016-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|An Open-Label Phase 1/2 Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Recruiting||Phase 1/Phase 2|78|Anticipated|Incyte Corporation||1|||f||||f||||||||||2017-10-10 22:14:25.590268|2017-10-10 22:14:25.590268
NCT02760472|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-29|||March 2013||2013-03-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|DonnaMega||A Fatty Acids Study in Preventing Retinopathy of Prematurity|A Randomised Intervention Single Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity|Completed||Phase 3|90|Actual|Queen Silvia Children's Hospital, Gothenburg, Sweden||2|||f||||t||||||||Yes||2017-10-10 22:14:25.763113|2017-10-10 22:14:25.763113
NCT02760459|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|||Effects of Perioperative Intravenous Dexamethasone on the Severity of Persistent Postsurgical Pain After Total Knee Arthroplasty : A Prospective, Randomized, Double-blind, Placebo-controlled Trial|Effects of Perioperative Intravenous Dexamethasone on the Severity of Persistent Postsurgical Pain After Total Knee Arthroplasty : A Prospective, Randomized, Double-blind, Placebo-controlled Trial|Recruiting||Phase 4|70|Anticipated|Chiang Mai University||2|||f||||||||||||||2017-10-10 22:14:25.857476|2017-10-10 22:14:25.857476
NCT02760433|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-17|||December 2016||2016-12-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|CREDO 3||Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Have Active Disease|A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy|Recruiting||Phase 3|350|Anticipated|R-Pharm||3|||f||||t||||||||||2017-10-10 22:14:26.102231|2017-10-10 22:14:26.102231
NCT02760420|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-09-26|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi|Double-blind Randomized Controlled Clinical Trial of 3 Days of Amoxicillin Disperable Tablet (DT) Versus Placebo for Fast Breathing Childhood Pneumonia Among Children 2-59 Months of Age Presenting to Kamuzu Central Hospital in Lilongwe, Malawi|Active, not recruiting||Phase 4|1126|Actual|Save the Children||2|||f||||t||||||||||2017-10-10 22:14:27.185974|2017-10-10 22:14:27.185974
NCT02760407|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-17|||May 2016||2016-05-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|CREDO 2||Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease|A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy|Recruiting||Phase 3|1575|Anticipated|R-Pharm||4|||f||||t||||||||||2017-10-10 22:14:27.44108|2017-10-10 22:14:27.44108
NCT02760394|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-11-18|||July 2014||2014-07-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Hyperbaric Oxygen Therapy in Patients With Chronic Stable Ischemic Heart Disease: An Option for Therapeutic Angiogenesis?|Hyperbaric Oxygen Therapy in Patients With Chronic Stable Ischemic Heart Disease: An Option for Therapeutic Angiogenesis?|Recruiting||N/A|20|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||No||2017-10-10 22:14:29.075237|2017-10-10 22:14:29.075237
NCT02760381|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2017-04-08|||May 2016||2016-05-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|November 2016|Actual|2016-11-01||Interventional|ATOMIC I||Acetic Acid for Optical Characterization of Colonic Polyps|Acetic Acid for Optical Characterization of Colonic Polyps: A Feasibility Study|Recruiting||N/A|55|Anticipated|Technische Universität München||1|||f||||f||||||||No||2017-10-10 22:14:29.180133|2017-10-10 22:14:29.180133
NCT02760368|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-17|||May 2016||2016-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|CREDO 1||Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease|A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy|Recruiting||Phase 3|420|Anticipated|R-Pharm||3|||f||||t||||||||||2017-10-10 22:14:29.280269|2017-10-10 22:14:29.280269
NCT02760355|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2016-05-02|||March 2016||2016-03-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Extrahepatic Insulin Resistance in Chronic Hepatitis C|Hepatitis C Virus Infection Induced Insulin Resistance: Different Contribution From Liver and Extrahepatic Sites as Inferred by Treating Chronic Hepatitis C Patients With an Interferon-free Antiviral Combination|Recruiting||N/A|20|Anticipated|University Hospital, Geneva||1|||f||||t||||||||Yes|Scientific publication in a peer-reviewed journal|2017-10-10 22:14:29.535047|2017-10-10 22:14:29.535047
NCT02760342|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-07-18|||May 2016||2016-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Metformin|ASP015K Pharmacokinetic Study - Evaluation of Drug-Drug Interaction Between ASP015K and Metformin-|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-10 22:14:29.624694|2017-10-10 22:14:29.624694
NCT02760316|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-08-25|||May 2, 2016|Actual|2016-05-02|August 2017|2017-08-01|October 16, 2017|Anticipated|2017-10-16|October 16, 2017|Anticipated|2017-10-16||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.|A Phase I, Randomised, Single-blind Study to Asses the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567 in Healthy Volunteers Using Prednisolone as Positive Control|Recruiting||Phase 1|64|Anticipated|AstraZeneca||9|||f||||f|f|f||||||||2017-10-10 22:14:30.873165|2017-10-10 22:14:30.873165
NCT02760303|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-05-31|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|October 2016|Actual|2016-10-01||Interventional|T1D||Reducing Stress in Adolescents and Young Adults With Type 1 Diabetes to Improve Diabetes Care|Reducing Stress in Adolescents and Young Adults With T1D to Improve Diabetes Care|Completed||N/A|60|Actual|Wayne State University||3|||f||||t||||||||No||2017-10-10 22:14:31.003724|2017-10-10 22:14:31.003724
NCT02760290|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-06-08|||March 2016||2016-03-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparison of Extraperitoneal and Intraperitoneal Cesarean Technique|Comparison of Extraperitoneal and Intraperitoneal Cesarean Technique: Double Blind Controlled Study|Recruiting||N/A|50|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||||||||||||2017-10-10 22:14:31.095454|2017-10-10 22:14:31.095454
NCT02760277|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-26|||August 2016||2016-08-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)|A Phase II Open-label, Multicenter Extension Study to Assess the Long-term Safety and Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)|Recruiting||Phase 2|48|Anticipated|ReveraGen BioPharma, Inc.||4|||f||||t||||||||||2017-10-10 22:14:31.187174|2017-10-10 22:14:31.187174
NCT02760264|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-26|||June 2016||2016-06-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)|A Phase IIa Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)|Recruiting||Phase 2|48|Anticipated|ReveraGen BioPharma, Inc.||4|||f||||t||||||||||2017-10-10 22:14:31.340794|2017-10-10 22:14:31.340794
NCT02760251|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-11-02|||April 2016||2016-04-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|iROM||Immunomodulation With Romiplostim in Young Adults With ITP|Thrombopoietin-receptor Agonist-immunomodulation in Young Adult Primary Immune Thrombocytopenia (ITP): A Multi-center Open Label Trial With Romiplostim|Recruiting||Phase 4|14|Anticipated|University Hospital, Basel, Switzerland||1|||f||||f||||||||No||2017-10-10 22:14:31.638563|2017-10-10 22:14:31.638563
NCT02760238|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-28|||April 2016||2016-04-01|April 2016|2016-04-01|October 2025|Anticipated|2025-10-01|October 2025|Anticipated|2025-10-01|10 Years|Observational [Patient Registry]|||Myeloproliferative Neoplasms (MPNs) Patient Registry|Clinical and Molecular Epidemiology of Myeloproliferative Neoplasms (MPNs)|Recruiting||N/A|5000|Anticipated|University Health Network, Toronto|||1||f||||f||||||||Yes|De-identified participant data may be shared for REB approved research studies. Only the data necessary to achieve the study's aims will be shared and all data will be de-identified prior to sharing.|2017-10-10 22:14:31.754721|2017-10-10 22:14:31.754721
NCT02760225|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-01-17|||September 2016||2016-09-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pembrolizumab-PET Imaging|89Zr-pembrolizumab-PET Imaging in Patients With Locally Advanced or Metastatic Melanoma or Non-small Cell Lung Cancer|Recruiting||N/A|21|Anticipated|University Medical Center Groningen||1|||f||||f||||||||||2017-10-10 22:14:31.86149|2017-10-10 22:14:31.86149
NCT02760212|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-22|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Treatment and Assessment of Fibromyalgia|Physical Approaches to the Management of Fibromyalgia - A Multidisciplinary Approach|Recruiting||N/A|50|Anticipated|Lakehead University||2|||f||||f|f|f||||||||2017-10-10 22:14:31.959384|2017-10-10 22:14:31.959384
NCT02760199|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-01|||August 2016||2016-08-01|June 2017|2017-06-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Interventional|||89Zr-AMG211 PET Imaging Study|89Zr-AMG211 PET Imaging in Patients With Relapsed/Refractory Gastrointestinal Adenocarcinoma Before and During Treatment With AMG 211|Completed||Phase 1|9|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-10 22:14:32.063699|2017-10-10 22:14:32.063699
NCT02760186|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-05-04|||March 2016||2016-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of High Altitude Exposure, Acclimatization and Re-exposure on Lung Water Content by Ultrasound|Effect of High Altitude Exposure, Acclimatization and Re-exposure on Lung Water Content by Ultrasound|Completed||N/A|21|Actual|University of Zurich||1|||f||||f||||||||Undecided||2017-10-10 22:14:32.147963|2017-10-10 22:14:32.147963
NCT02760173|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-09|||June 2016||2016-06-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Verticality Perception - Effects of Prolonged Roll-tilt in Healthy Human Subjects|Verticality Perception - Effects of Prolonged Roll-tilt in Healthy Human Subjects|Not yet recruiting||N/A|20|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 22:14:32.322136|2017-10-10 22:14:32.322136
NCT02760160|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-01-19|||October 2015||2015-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Dietary Prevention of Photodamage in Skin With Grapes|Dietary Prevention of Photodamage in Skin With Grapes: A Human Clinical Study|Recruiting||N/A|20|Anticipated|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-10 22:14:32.414646|2017-10-10 22:14:32.414646
NCT02760147|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|BEACON3||BEACON Care ® System Assisting Ventilation in Pressure Support Ventilation (PSV) Patient|Evaluation of Beacon Care System Advice in Pressure Support: Does the System Maintain Patients Within Appropriate Levels of Support?|Recruiting||N/A|20|Anticipated|Università degli Studi di Ferrara||4|||f||||f||||||||No||2017-10-10 22:14:32.538172|2017-10-10 22:14:32.538172
NCT02760134|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-30|2017-02-10|||April 2016||2016-04-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Influence of SMP on Renal Pelvic Pressure In Vivo|The Influence of Super-Mini Percutaneous Nephrolithotomy on Renal Pelvic Pressure In Vivo|Recruiting||N/A|100|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||f||||||||||2017-10-10 22:14:32.661913|2017-10-10 22:14:32.661913
NCT02760121|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-10-18|||May 2016||2016-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||AZ, MZ, and the Pulmonary System Response to Hypoxia|The Effect of Carbonic Anhydrase Inhibitors on the Pulmonary System Response to Hypoxia|Completed||Phase 4|14|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-10 22:14:32.778884|2017-10-10 22:14:32.778884
NCT02760108|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-29|||April 2015||2015-04-01|April 2016|2016-04-01|January 2027|Anticipated|2027-01-01|January 2027|Anticipated|2027-01-01|1 Month|Observational [Patient Registry]|PFP||Parkinson's Families Project|Parkinson's Families Project|Recruiting||N/A|2000|Anticipated|University College, London|||3||f||||f||||||Samples With DNA|"     DNA will be extracted from whole blood.   "|Yes|Anonymous study information may made available to collaborators at other sites in the UK and overseas and may be made publicly available to bona fide researchers to enable the combined analysis of samples from different, large patient series around the world. This may include commercial companies. These are rare conditions and it is likely that sharing and collaboration between research groups and companies in different countries will be needed to make the best use of the study. Transfer of study data will be managed in a highly secure and anonymised format.|2017-10-10 22:14:32.91681|2017-10-10 22:14:32.91681
NCT02760095|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-05-08|||November 2015||2015-11-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|ZEED1||Effects of EED on Zn Absorption and Retention in Children From a Standard Dose|Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 1 - Absorption of Zn and Vitamin A From a Standard Dose|Recruiting||N/A|40|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     Spot urine samples x 4 days; complete fecal collections x 4 days; blood sample   "|No||2017-10-10 22:14:33.05237|2017-10-10 22:14:33.05237
NCT02760082|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-29|||February 2016||2016-02-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Motivation of Patients Diagnosed With Multiple Sclerosis to Become Citizen Researchers|Identifying Motivational Factors for Registering Nutrition and Lifestyle Factors Among Patients With Multiple Sclerosis|Recruiting||N/A|500|Anticipated|University of Copenhagen|||3||f||||t||||||||No||2017-10-10 22:14:33.197091|2017-10-10 22:14:33.197091
NCT02760069|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-01-30|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department|Nasally Inhaled Isopropyl Alcohol Versus Oral Ondansetron for the Treatment of Nausea in the Emergency Department: A Double-Blind Randomized Controlled Trial|Recruiting||Phase 4|180|Anticipated|Brooke Army Medical Center||3|||f||||t||||||||No||2017-10-10 22:14:33.289761|2017-10-10 22:14:33.289761
NCT02760043|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-08-16|||April 2016||2016-04-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Dexamethasone in Total Knee and Total Hip Arthroplasty|Does the Addition of Dexamethasone to a Local Infiltration Analgesia Mixture Improve Functional Outcomes Following Total Joint Arthroplasty?|Recruiting||Phase 2/Phase 3|314|Anticipated|University Health Network, Toronto||2|||f||||f||||||||Undecided|Undecided at this moment.|2017-10-10 22:14:33.517226|2017-10-10 22:14:33.517226
NCT02760030|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-09-21|||May 2016||2016-05-01|September 2016|2016-09-01||||July 2020|Anticipated|2020-07-01||Interventional|||Fulvestrant and Palbociclib in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery|Phase II Trial of Primary Endocrine Therapy With Combination of Fulvestrant and Palbociclib in Elderly Patients With Hormone Responsive Breast Cancer Who Have Inoperable Tumor Or Operable Tumor But Cannot Undergo Surgery Due to Frailty Or Who Refuse Surgery|Recruiting||Phase 2|37|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:14:33.633063|2017-10-10 22:14:33.633063
NCT02760017|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-05-24|||April 2016||2016-04-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Bauhinia Forficata in Diabetic Patients|Evaluation of Clinical Efficacy Capsules Containing Standardized Extract of Bauhinia Forficata (Pata- De-vaca) in Diabetic Patients|Recruiting||N/A|80|Anticipated|Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude||2|||f||||f||||||||||2017-10-10 22:14:33.749464|2017-10-10 22:14:33.749464
NCT02760004|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-11-16|||April 2016||2016-04-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PRISM||PRogram In Support of Moms: An Innovative Stepped-Care Approach for Obstetrics and Gynecology Clinics|PRogram In Support of Moms: An Innovative Stepped-Care Approach for Obstetrics and Gynecology Clinics|Recruiting||N/A|300|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||Undecided||2017-10-10 22:14:33.832912|2017-10-10 22:14:33.832912
NCT02759991|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-09-08|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Interventional|||Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.|An Effectiveness Trial (Phase IV) to Evaluate Protection of Pregnant Women by Hepatitis E Virus (HEV) Vaccine in Bangladesh and Risk Factors for Severe HEV Infection.|Recruiting||Phase 4|20745|Anticipated|Norwegian Institute of Public Health||2|||f||||t|f|f||||||||2017-10-10 22:14:33.938594|2017-10-10 22:14:33.938594
NCT02759978|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-14|||May 2016||2016-05-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|May 2018|Anticipated|2018-05-01|1 Year|Observational [Patient Registry]|IDENTICAL||Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL|Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL|Recruiting||N/A|300|Anticipated|University Medical Center Groningen|||3||f||||f||||||||No|Currently single center study|2017-10-10 22:14:34.04819|2017-10-10 22:14:34.04819
NCT02759965|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-01-10|||November 2014||2014-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Neuroinflammation and Cognitive Dysfunction After Orthopedic Surgery|Neuroinflammation and Cognitive Dysfunction After Orthopedic Surgery|Enrolling by invitation||N/A|40|Anticipated|Karolinska University Hospital|||1||f||||f||||||Samples Without DNA|"     CSF and blood   "|Undecided||2017-10-10 22:14:34.157214|2017-10-10 22:14:34.157214
NCT02759952|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-28|||February 2013||2013-02-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial|Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial: An Observational Study|Recruiting||N/A|50|Anticipated|STZ eyetrial|||1||f||||f||||||Samples With DNA|"     Blood samples (DNA) for genetic validation of genotype   "|No||2017-10-10 22:14:34.219986|2017-10-10 22:14:34.219986
NCT02759939|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-05-04|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|December 30, 2016|Actual|2016-12-30||Interventional|||Right For Me: Birth Control Decisions Made Easier|Right For Me: Birth Control Decisions Made Easier|Active, not recruiting||N/A|4160|Anticipated|Dartmouth-Hitchcock Medical Center||4|||f||||f||||||||Yes|The investigators will make an anonymized copy of the final participant-level data set and essential analysis syntax available to others for research purposes, either via data sharing on request or via digital repository deposition, before October 2018.|2017-10-10 22:14:34.303185|2017-10-10 22:14:34.303185
NCT02758795|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-07-31|||February 2016||2016-02-01|July 2017|2017-07-01|April 8, 2017|Actual|2017-04-08|April 8, 2017|Actual|2017-04-08||Interventional|AEDP||Antiinflammatory Effect of Dietary Protein Intake in Elderly People|Antiinflammatory Effect of Dietary Protein Intake in Elderly People|Completed||N/A|16|Actual|University of Limerick||2|||f||||t||||||||||2017-10-10 22:14:47.309809|2017-10-10 22:14:47.309809
NCT02759926|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-29|||August 2011||2011-08-01|April 2016|2016-04-01||||November 2015|Actual|2015-11-01||Interventional|||The Effect of Bitter Taste Receptor Agonists on The Gastrointestinal Tract, Hunger and Food Intake|The Role of Bitter Taste Receptors Expressed in the Gastrointestinal Tract in Altering Food Intake and Gastrointestinal Motility|Active, not recruiting||N/A|98|Anticipated|Universitaire Ziekenhuizen Leuven||6|||f||||f||||||||||2017-10-10 22:14:34.410912|2017-10-10 22:14:34.410912
NCT02759913|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-29|||January 2015||2015-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||A Study to Evaluate the Performance of a Diagnostic Test in ALS|A Study to Evaluate the Sensitivity, Specificity, and Overall Accuracy of an Amyotrophic Lateral Sclerosis Diagnostic Test Developed by Iron Horse Diagnostics|Recruiting||N/A|300|Anticipated|Iron Horse Diagnostics, Inc.|||2||f||||f||||||Samples With DNA|"     Cerebrospinal fluid, EDTA plasma, serum, whole blood (optional) and PAX gene tubes will be     collected   "|No||2017-10-10 22:14:34.644924|2017-10-10 22:14:34.644924
NCT02759900|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-04-27|||January 2016||2016-01-01|April 2017|2017-04-01||||March 2019|Anticipated|2019-03-01||Interventional|||Using a Cold Atmospheric Plasma Device to Treat Skin Disorders|Using a Cold Atmospheric Plasma Device to Treat Skin Disorders|Recruiting||N/A|50|Anticipated|The Skin Center Dermatology Group||1|||f||||||||||||||2017-10-10 22:14:34.7457|2017-10-10 22:14:34.7457
NCT02759887|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-11-01|||November 2016||2016-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)|Longitudinal Assessment of Amyloid Positron Emission Tomography (PET), Fludeoxyglucose F18 (FDG) PET, Tau PET, Magnetic Resonance Imaging (MRI), and Blood Spot Ribonucleic Acid (RNA) in Down Syndrome Individuals With and Without Alzheimer's Dementia and Normal Controls|Recruiting||N/A|40|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||3|||f||||f||||||||No||2017-10-10 22:14:34.828246|2017-10-10 22:14:34.828246
NCT02759874|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-21|||November 2015||2015-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of Technology|Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of Technology|Enrolling by invitation||N/A|110|Anticipated|Institute of Health Economics, Canada||2|||f||||f||||||||||2017-10-10 22:14:34.959916|2017-10-10 22:14:34.959916
NCT02759861|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-21|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics|A Phase IV, Single Arm, Open-Label Study to Determine the Efficacy and Safety of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Naive Alcoholic Subjects With Chronic Genotype 1 Hepatitis C Infection|Recruiting||Phase 4|30|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-10 22:14:35.047526|2017-10-10 22:14:35.047526
NCT02759848|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2016-05-01|||January 2012||2012-01-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|TROTIC||The Role of Tuberculosis in Chronic Obstructive Lung Disease|The Role of Tuberculosis in Chronic Obstructive Lung Disease|Completed||N/A|598|Actual|Istanbul Medeniyet University|||2||f||||t||||||||Undecided||2017-10-10 22:14:35.131664|2017-10-10 22:14:35.131664
NCT02759835|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-09-21|||April 4, 2016||2016-04-04|September 18, 2017|2017-09-18|September 1, 2022|Anticipated|2022-09-01|February 1, 2021|Anticipated|2021-02-01||Interventional|||Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib|A Pilot Study of Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-mutated, Non-Small Cell Lung Cancer (NSCLC) After Treatment With Osimertinib (AZD9291, Tagrisso)|Recruiting||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 22:14:35.19603|2017-10-10 22:14:35.19603
NCT02759822|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-29|||April 2016||2016-04-01|April 2016|2016-04-01||||April 2021|Anticipated|2021-04-01||Observational|||Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias|Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias|Recruiting||N/A|30|Anticipated|Instituto Nacional de Cancer, Brazil|||2||f||||f||||||||No||2017-10-10 22:14:35.30336|2017-10-10 22:14:35.30336
NCT02759809|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-10-03|||June 2016|Actual|2016-06-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||OptiMoM Kindergarten Study|Optimizing Mothers' Milk for Preterm Infants (OptiMoM) Program of Research: Study 1-Impact of Donor Milk at Kindergarten|Recruiting||N/A|246|Anticipated|The Hospital for Sick Children|||2||f||||||||||||||2017-10-10 22:14:35.387591|2017-10-10 22:14:35.387591
NCT02759796|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-04-21|||November 2015||2015-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Fluorescence Angiography in the Assessment of DIEP Flap Perfusion|Indocyanine Green Fluorescence Angiography in the Assessment of Deep Inferior Epigastric Perforator (DIEP) Flap Perfusion|Completed||N/A|60|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||No||2017-10-10 22:14:35.482062|2017-10-10 22:14:35.482062
NCT02759783|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-11-03|||October 2016||2016-10-01|November 2016|2016-11-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|CORE||Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases|A Randomised Trial of Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases|Recruiting||Phase 2/Phase 3|206|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:14:35.596378|2017-10-10 22:14:35.596378
NCT02759770|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-05|||June 2016||2016-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Risk Factors and Prediction Score of ARDS After Cardiac Surgery|Risk Factors and Prediction Score of ARDS After Cardiac Surgery|Not yet recruiting||N/A|3000|Anticipated|Beijing Anzhen Hospital|||3||f||||||||||||||2017-10-10 22:14:35.736697|2017-10-10 22:14:35.736697
NCT02759757|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-29|||May 2016||2016-05-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Interventional|||Is Kinesio Taping Able to Influence the Electrical Activity of Muscles in Patients With Low Back Pain?|Is Kinesio Taping Able to Influence the Electrical Activity of Muscles in Patients With Low Back Pain? A Controlled Randomized Trial|Not yet recruiting||N/A|63|Anticipated|Universidade Cidade de Sao Paulo||3|||f||||f||||||||Undecided||2017-10-10 22:14:35.844676|2017-10-10 22:14:35.844676
NCT02759744|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-06-30|||April 15, 2016||2016-04-15|June 28, 2017|2017-06-28|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Fusion Guided Focal Laser Ablation of Prostate Cancer|Pilot Study of Ultrasound Guided Focal Thermal Ablation of Prostate Cancer|Enrolling by invitation||Phase 3|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:14:35.935762|2017-10-10 22:14:35.935762
NCT02759731|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-07-18|||April 8, 2016||2016-04-08|July 12, 2017|2017-07-12|June 1, 2020|Anticipated|2020-06-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation|A Phase 1/2 Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (SCT)|Recruiting||Phase 1/Phase 2|31|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:14:36.008522|2017-10-10 22:14:36.008522
NCT02759718|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-29|||June 2012||2012-06-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|CgA||Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors|Clinical Effectiveness of Serum Chromogranin A (CgA) Levels on Diagnostic Relevance, Response After Surgical Resection and Recurrence of Pancreatic Endocrine Tumors (PET)|Active, not recruiting||Phase 4|111|Actual|Asan Medical Center||1|||f||||t||||||||Undecided||2017-10-10 22:14:36.103059|2017-10-10 22:14:36.103059
NCT02759705|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-18|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|FIVES||Bladder Exstrophy (FIVES FertIlity Vesical Exstrophy Sexuality)|Male Bladder Exstrophy in Adulthood : What Sexuality and Fertility Prospects ?|Not yet recruiting||N/A|73|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:14:36.179165|2017-10-10 22:14:36.179165
NCT02759692|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-07-20|2017-06-13||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||Clinical Evaluation of Two Approved Contact Lenses||Completed||N/A|283|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f|f|t|f|f|t|||||2017-10-10 22:14:36.252771|2017-10-10 22:14:36.252771
NCT02759679|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-05-09|||May 2016||2016-05-01|May 2016|2016-05-01||||December 2019|Anticipated|2019-12-01||Interventional|||Canine-Assisted Profiling of Lung Cancer From Human Breath|Canine-Assisted Profiling of Lung Cancer From Human Breath|Not yet recruiting||N/A|1000|Anticipated|Haukeland University Hospital||2|||f||||f||||||||No||2017-10-10 22:14:38.615336|2017-10-10 22:14:38.615336
NCT02759666|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-06-07|||June 2016|Actual|2016-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors|A Multicenter, Open-Label, Phase 1 Trial of SHR3162 Given Orally to Subjects With Advanced Solid Tumors|Recruiting||Phase 1|30|Anticipated|Atridia Pty Ltd.||1|||f||||f||||||||No||2017-10-10 22:14:38.751544|2017-10-10 22:14:38.751544
NCT02759653|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-08-30|||May 2016||2016-05-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Observational|NOR-PLAQ||Norwegian Carotid Plaque Study|Norwegian Carotid Plaque Study (NOR-PLAQ). Advanced Neurosonology in Acute Ischemic Stroke|Recruiting||N/A|100|Anticipated|Haukeland University Hospital|||2||f||||f||||||||||2017-10-10 22:14:38.857945|2017-10-10 22:14:38.857945
NCT02759640|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-16|||September 2016||2016-09-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|August 2018|Anticipated|2018-08-01||Interventional|||A Phase I Trial of HS-10241 in Solid Tumors|First-in-Human, Dose-Escalation Trial of C-Met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|36|Anticipated|Atridia Pty Ltd.||1|||f||||f||||||||||2017-10-10 22:14:38.942959|2017-10-10 22:14:38.942959
NCT02759627|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-06|||November 2014||2014-11-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Does Isolated Robotic-Assisted Gait Training Improve Functional Status, Daily Living And Quality Of Life In Stroke?|Does Isolated Robotic-Assisted Gait Training Improve Functional Status, Daily Living And Quality Of Life In Stroke Patients?: A Single-Blinded Randomized Controlled Study|Completed||N/A|51|Actual|Istanbul University||3|||f||||f||||||||No||2017-10-10 22:14:39.031514|2017-10-10 22:14:39.031514
NCT02759614|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-06-05|||April 1, 2016|Actual|2016-04-01|June 2017|2017-06-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in NSCLC Patients Activating EGFR Mutations|Randomized, Open-label, Controlled Multicenter Study to Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in Chinese NSCLC Patients Harbouring Activating EGFR Mutations(Artemis)|Recruiting||Phase 3|310|Anticipated|Guangdong Association of Clinical Trials||2|||f||||t||||||||Yes|DSMB|2017-10-10 22:14:39.141547|2017-10-10 22:14:39.141547
NCT02759601|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-09-18|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CHR-2845||Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)|A Phase I/II Dose Escalation Trial of HDAC Inhibitor Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma|Active, not recruiting||Phase 1/Phase 2|69|Anticipated|Queen Mary University of London||1|||f||||t||||||||||2017-10-10 22:14:39.262563|2017-10-10 22:14:39.262563
NCT02759588|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-08-04|||May 2016||2016-05-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|April 2018|Anticipated|2018-04-01||Interventional|||GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer|Phase 1b/2 Study With GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer (VIRO-15)|Recruiting||Phase 1/Phase 2|52|Anticipated|Genelux Corporation||1|||f||||f||||||||||2017-10-10 22:14:39.496399|2017-10-10 22:14:39.496399
NCT02759575|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-29|||April 2016||2016-04-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma|A Phase I/II Study of Chemo Radiation Plus the Anti-Programmed Death-1 (Anti-PD-1) Antibody, Pembrolizumab (MK-3475) for Locally Advanced Laryngeal Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|47|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-10 22:14:39.642441|2017-10-10 22:14:39.642441
NCT02759562|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-15|||November 4, 2016|Actual|2016-11-04|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 6, 2017|Actual|2017-07-06||Interventional|||Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis|A Phase 2b, Dose-Ranging Study of the Effect of GS-5745 on FEV1 in Adult Subjects With Cystic Fibrosis|Terminated||Phase 2|6|Actual|Gilead Sciences||6||Discontinuation of development for this indication|f||||t|t|f||||||||2017-10-10 22:14:39.760404|2017-10-10 22:14:39.760404
NCT02759549|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-11-11|||September 2015||2015-09-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH|Fatigue in Breast Cancer Patients Undergoing Radiotherapy-Electronic Self-Management Resource Training for Mental Health (eSMART-MH)|Withdrawn||N/A|0|Actual|Emory University||2|||f||||t||||||||||2017-10-10 22:14:39.89458|2017-10-10 22:14:39.89458
NCT02759536|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-06-06|||July 2013||2013-07-01|April 2016|2016-04-01||||December 2018|Anticipated|2018-12-01||Interventional|||In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma|In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma: A Feasibility Study|Recruiting||Phase 1/Phase 2|30|Anticipated|The Third Xiangya Hospital of Central South University||1|||f||||t||||||||Yes||2017-10-10 22:14:40.049433|2017-10-10 22:14:40.049433
NCT02759523|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-02|||July 2013||2013-07-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Observational|||Neural Mechanisms Underlying Children's Responses to Food Portion Size and Energy Density|Neural Mechanisms Underlying Children's Responses to Food Portion Size and Energy Density|Completed||N/A|54|Actual|Penn State University|||1||f||||f||||||||Undecided||2017-10-10 22:14:40.187414|2017-10-10 22:14:40.187414
NCT02759510|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-02|||June 2016||2016-06-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Cardiac Output Changes in Cesarean Section|Comparison of Norepinephrine and Phenylephrine in Cesarean Section by Transesophageal Ultrasound|Not yet recruiting||Early Phase 1|106|Anticipated|RenJi Hospital||2|||f||||f||||||||No||2017-10-10 22:14:40.281216|2017-10-10 22:14:40.281216
NCT02759497|ClinicalTrials.gov processed this data on October 10, 2017|2016-05-01|2017-06-17|||March 2016||2016-03-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|October 2020|Anticipated|2020-10-01||Observational|||Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis|Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis|Recruiting||N/A|100|Anticipated|Tanta University|||2||f||||t||||||||Undecided||2017-10-10 22:14:40.396685|2017-10-10 22:14:40.396685
NCT02759484|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-05-05|||March 2015||2015-03-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|MATCH2||Multi-clinic Action Trial to Control Hyperglycemia and Hypertension|MATCH2: The Multi-clinic Action Trial to Control Hyperglycemia and Hypertension|Recruiting||N/A|240|Anticipated|Rush University Medical Center||2|||f||||t||||||||Yes|Deidentified data from the trial will be made available to qualified investigators following completion of the trial and all major data analyses.|2017-10-10 22:14:40.50786|2017-10-10 22:14:40.50786
NCT02759471|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-01-03|2017-01-03||April 2016||2016-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||One Month Dispensing Study Comparing the Clinical Performance of the Comfilcon A Sphere Lenses Compared to Comfilcon A Asphere Lenses.|One Month Dispensing Study Comparing the Clinical Performance of the Comfilcon A Sphere Lenses Compared to Comfilcon A Asphere Lenses.|Completed||N/A|54|Actual|Coopervision, Inc.||1|||f||||f||||||||||2017-10-10 22:14:40.679072|2017-10-10 22:14:40.679072
NCT02759458|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-12|||November 2013||2013-11-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluation of the Healicoil Suture Anchor for Rotator Cuff Repair|Evaluation of the Healicoil Suture Anchor for Rotator Cuff Repair|Enrolling by invitation||N/A|38|Actual|Rush University Medical Center||2|||f||||||||||||||2017-10-10 22:14:40.98561|2017-10-10 22:14:40.98561
NCT02759445|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-04-29|||April 2016||2016-04-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Observational|C2||Myocardial Deformation Imaging After Acute Alcohol Excess|Detection of Early Changes in Left Ventricular Function by Myocardial Deformation Imaging After Acute Excessive Alcohol Ingestion|Not yet recruiting||N/A|200|Anticipated|RWTH Aachen University|||1||f||||t||||||||||2017-10-10 22:14:41.05386|2017-10-10 22:14:41.05386
NCT02759406|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-28|||September 2013||2013-09-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study|Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study|Completed||N/A|48|Actual|Palmaz Scientific||2|||f||||||||||||||2017-10-10 22:14:41.390155|2017-10-10 22:14:41.390155
NCT02759393|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-05-02|||October 2015||2015-10-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis|Comparing Dexlansoprazole With Double-dose Lansoprazole to Achieve Sustained Symptomatic Response in Overweight and Obesity Patients With Reflux Esophagitis in Los Angeles Grades A & B|Enrolling by invitation||Phase 4|200|Anticipated|National Cheng-Kung University Hospital||2|||f||||t||||||||||2017-10-10 22:14:41.461449|2017-10-10 22:14:41.461449
NCT02759367|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-05-23|||March 2008||2008-03-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Increasing Potassium Intake in Hypertensive Individuals|Adequate Intake of Potassium Does Not Cause Hyperkalemia in Hypertensive Individuals on Medications That Antagonize the Renin Angiotensin Aldosterone System|Completed||N/A|20|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||No||2017-10-10 22:14:41.793383|2017-10-10 22:14:41.793383
NCT02759354|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-03-06|||April 2016||2016-04-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4- to 5 Year Old Children Previously Vaccinated With VAXELIS or INFANRIX Hexa|Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4- to 5 Year Old Children Previously Vaccinated With a 2-dose or 3-dose Infants Series and Toddler Dose With VAXELIS or INFANRIX Hexa|Completed||Phase 4|756|Actual|MCM Vaccines B.V.||4|||f||||f||||||||Undecided||2017-10-10 22:14:41.887768|2017-10-10 22:14:41.887768
NCT02759341|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-04-04|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|BRAINHEART||Brain-heart Interactions in Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X:|Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: a Study on the Brain-heart Interactions in Two Orphan Cardiac Diseases.|Recruiting||N/A|45|Anticipated|Ospedale San Giovanni Bellinzona||3|||f||||f||||||||||2017-10-10 22:14:42.013998|2017-10-10 22:14:42.013998
NCT02759328|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-29|||December 2012||2012-12-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Xbox Kinect™ Training for Stroke Rehabilitation|Clinical Feasibility of the Xbox Kinect™ Training for Stroke Rehabilitation: a Single Blind Randomized Controlled Pilot Study|Completed||N/A|20|Actual|Ankara University||2|||f||||f||||||||No||2017-10-10 22:14:42.155974|2017-10-10 22:14:42.155974
NCT02759315|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-08-22|||May 3, 2016|Actual|2016-05-03|August 2017|2017-08-01|April 7, 2020|Anticipated|2020-04-07|July 27, 2017|Actual|2017-07-27||Interventional|||Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)|A Phase II, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682 + MK-8408 in Subjects With Chronic HCV Genotype 1, 2, 3, 4, 5 or 6 Infection|Active, not recruiting||Phase 2|160|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-10 22:14:42.301372|2017-10-10 22:14:42.301372
NCT02759302|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-04-10|||April 2016||2016-04-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||MRI on Persons With Mutations in POMT2 Gene (LGMD2N)|MRI on Persons With Mutations in POMT2 Gene (LGMD2N)|Completed||N/A|12|Actual|Rigshospitalet, Denmark|||1||f||||||||||||||2017-10-10 22:14:42.408506|2017-10-10 22:14:42.408506
NCT02759289|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-12-28|||November 2015||2015-11-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|EMERALD-D||Arsenic, Disordered Glucose Homeostasis and Atherosclerosis|Arsenic Exposure, Disordered Glucose Homeostasis and Atherosclerosis Protocol|Recruiting||N/A|250|Anticipated|New York University School of Medicine|||3||f||||f||||||||||2017-10-10 22:14:42.499876|2017-10-10 22:14:42.499876
NCT02759276|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-29|||May 2015||2015-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|MICRORAH||Microcirculation and Inflammatory Markers in Patients With Resistant, Stages 1/2 Hypertension and Normal Blood Pressure|Inflammatory Biomarkers and Endothelial Function Assessed by Venous Occlusion Plethysmography and Nailfold Videocapillaroscopy in Patients With Resistant Hypertension, Stages 1 and 2 and Normotensive|Completed||N/A|75|Actual|Rio de Janeiro State University|||3||f||||f||||||||No||2017-10-10 22:14:42.594349|2017-10-10 22:14:42.594349
NCT02759263|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-02-24|||June 2016||2016-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Improving Neurodevelopment in Adolescents With Congenital Heart Disease|Pilot Study of Executive Function Intervention to Improve Neurodevelopmental Outcomes in Adolescents With CHD|Recruiting||N/A|60|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||Yes||2017-10-10 22:14:42.702807|2017-10-10 22:14:42.702807
NCT02759250|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-04-20|||February 2015||2015-02-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|April 2017|Actual|2017-04-01||Interventional|||A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)|A Pilot, Phase Ib Feasibility Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)|Active, not recruiting||Phase 1|15|Anticipated|arGEN-X BVBA||3|||f||||f||||||||Undecided||2017-10-10 22:14:42.791231|2017-10-10 22:14:42.791231
NCT02759237|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-06-12|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|CoreValveIndia||The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS)|The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS)|Terminated||N/A|3|Actual|Medtronic Cardiovascular|||1||f||||f||||||||No||2017-10-10 22:14:42.87905|2017-10-10 22:14:42.87905
NCT02759224|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-02-06|||April 15, 2016|Actual|2016-04-15|February 2017|2017-02-01|December 29, 2016|Actual|2016-12-29|July 1, 2016|Actual|2016-07-01||Interventional|||A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet||Completed||Phase 1|34|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-10 22:14:42.968674|2017-10-10 22:14:42.968674
NCT02759211|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis|Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis|Recruiting||N/A|16|Anticipated|Mount Sinai Rehabilitation Hospital||2|||f||||f||||||||||2017-10-10 22:14:43.047924|2017-10-10 22:14:43.047924
NCT02759198|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-10-05|||April 2016||2016-04-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis|A Randomized, Double-blind, Placebo- and Active-Controlled, Multicenter, Phase 2 Trial to Evaluate the Efficacy and Safety of YH23537 in Patients With Osteoarthritis of the Knee|Recruiting||Phase 2|435|Anticipated|Yuhan Corporation||3|||f||||f||||||||No||2017-10-10 22:14:43.12219|2017-10-10 22:14:43.12219
NCT02759185|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-09-21|||January 2, 2017|Actual|2017-01-02|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of Four Different Potencies of Smoked Marijuana in 76 Veterans With Chronic, Treatment-Resistant PTSD|Placebo-Controlled, Triple-Blind, Randomized Crossover Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)|Recruiting||Phase 2|76|Anticipated|Multidisciplinary Association for Psychedelic Studies||4|||f||||f||||||||||2017-10-10 22:14:43.225205|2017-10-10 22:14:43.225205
NCT02757690|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-29|||January 2015||2015-01-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and Splenectomy|Validation and Verification of 3 Dimensional Laparoscopic System in Laparoscopic Distal Pancreatectomy & Splenectomy|Completed||Phase 4|60|Actual|Asan Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:14:59.860335|2017-10-10 22:14:59.860335
NCT02759172|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-28|||April 2016||2016-04-01|April 2016|2016-04-01||||June 2019|Anticipated|2019-06-01||Interventional|SPIRIT||Suicide Prevention Intervention for At-Risk Individuals in Transition|Suicide Risk Reduction in the Year Following Jail Release: the SPIRIT Trial (Suicide Prevention Intervention for At-Risk Individuals in Transition)|Recruiting||N/A|800|Anticipated|Michigan State University||2|||f||||t||||||||Yes|De-identified data will be made available through relevant NIH and NIJ repositories after the trial has ended.|2017-10-10 22:14:43.329928|2017-10-10 22:14:43.329928
NCT02759159|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-10-04|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRI|"The Study of Brain Functional Network Modulatory Mechanism of Alzheimer's Disease Using Acupuncture at the Four-gate Acupoints"|Recruiting||N/A|120|Anticipated|Xuanwu Hospital, Beijing||4|||f||||t||||||||||2017-10-10 22:14:43.439576|2017-10-10 22:14:43.439576
NCT02759146|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-02-01|||May 2016||2016-05-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients|Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients|Recruiting||N/A|363|Anticipated|Michigan State University||3|||f||||t||||||||Yes|Findings from this study will be available to other researchers under the following conditions: 1) appropriate human subjects protection is in place; 2) data have been de-identified; and 3) study investigators have publicly presented and published key findings.|2017-10-10 22:14:43.544103|2017-10-10 22:14:43.544103
NCT02759133|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-04-12|||June 2016||2016-06-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|IodineBreast||Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire|Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire: A Randomized Prospective Trial|Recruiting||N/A|350|Anticipated|Centre Antoine Lacassagne||2|||f||||t||||||||No||2017-10-10 22:14:43.646255|2017-10-10 22:14:43.646255
NCT02759120|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-14|||March 22, 2017|Actual|2017-03-22|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|CleanUp-IPF||CleanUP IPF for the Pulmonary Trials Cooperative|Study of Clinical Efficacy of Antimicrobial Therapy Strategy Using Pragmatic Design in Idiopathic Pulmonary Fibrosis|Recruiting||Phase 3|500|Anticipated|Weill Medical College of Cornell University||2|||f||||t|t|f|||f|||||2017-10-10 22:14:43.743996|2017-10-10 22:14:43.743996
NCT02759107|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-06-28|||May 11, 2016|Actual|2016-05-11|June 2017|2017-06-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||A Study of LY3298176 in Healthy Participants and Participants With Type 2 Diabetes (T2DM)|A Single- and Multiple-Ascending Dose Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176 and Multiple Doses in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|198|Actual|Eli Lilly and Company||7|||f||||f||||||||||2017-10-10 22:14:43.899312|2017-10-10 22:14:43.899312
NCT02759094|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-06-09|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Safety and Effectiveness of the RefluxStop Device in the Management of GERD|Evaluation of Safety and Effectiveness of the RefluxStop Device in the Management of Gastroesophageal Reflux Disease (GERD)|Recruiting||N/A|50|Anticipated|Implantica CE & Production Ltd||1|||f||||t||||||||||2017-10-10 22:14:43.989808|2017-10-10 22:14:43.989808
NCT02759081|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-29|||January 2015||2015-01-01|April 2016|2016-04-01||||December 2015|Actual|2015-12-01||Interventional|||Comparing Cap-assisted Water Exchange and Water Exchange in Colonoscopy|A Randomized, Controlled Trial Comparing Cap-assisted Water Exchange and Water Exchange in Colonoscopy|Completed||N/A|120|Actual|Dalin Tzu Chi General Hospital||2|||f||||t||||||||No||2017-10-10 22:14:44.078821|2017-10-10 22:14:44.078821
NCT02759068|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-18|||November 2014||2014-11-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|COGNICOMA||Beneficial Effects of Preference on Behavior in DOC Patients (COGNICOMA)|Beneficial Effects of Preference on Behavior|Recruiting||N/A|70|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:14:44.151995|2017-10-10 22:14:44.151995
NCT02759055|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-05-15|||October 2016||2016-10-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pre-Diabetes Cardiovascular Care (Pre-Diabetes Wizard)|Improving Prediabetes Cardiovascular Care With EHR-Based Decision Support|Enrolling by invitation||N/A|6600|Anticipated|HealthPartners Institute||2|||f||||t||||||||No||2017-10-10 22:14:44.229102|2017-10-10 22:14:44.229102
NCT02759042|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-30||||||August 2017|2017-08-01||||||||Expanded Access|CD02_EA||An Expanded Access Protocol for a Single Subject Who Has Completed 24-Weeks of Treatment in PR0140_CD02 Study|An Expanded Compassionate Access Protocol for a Single Subject Who Has Completed 24-Weeks of Treatment in PRO140_CD02 Study|No longer available||N/A|||CytoDyn, Inc.|||||||||||||||||||2017-10-10 22:14:44.303478|2017-10-10 22:14:44.303478
NCT02759029|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-28|||March 2016||2016-03-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test|Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test|Recruiting||N/A|123|Anticipated|Gangnam Severance Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:14:44.496704|2017-10-10 22:14:44.496704
NCT02759016|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-10-03|||June 23, 2016|Actual|2016-06-23|October 2017|2017-10-01|November 11, 2022|Anticipated|2022-11-11|August 11, 2020|Anticipated|2020-08-11||Interventional|||Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients Who Have Received at Least One Prior Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib|A Phase Ib/II, Open Label, Single Arm, Multi-center, Dose Escalation Trial of Intravenous BI 836826 in Combination With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia|Recruiting||Phase 1|60|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:14:44.58387|2017-10-10 22:14:44.58387
NCT02759003|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-03|||March 2011||2011-03-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|||Nightime NIV Initiation in Amyotrophic Lateral Sclerosis in an Outpatient Setting|Nightime Noninvasive Mechanical Ventilation Initiation in Amyotrophic Lateral Sclerosis in an Outpatient Setting. A Non-inferiority Study.|Completed||N/A|50|Actual|Fondazione Salvatore Maugeri||2|||f||||f||||||||No||2017-10-10 22:14:44.684477|2017-10-10 22:14:44.684477
NCT02758990|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-27|||March 2016||2016-03-01|October 2016|2016-10-01|November 23, 2016|Actual|2016-11-23|November 23, 2016|Actual|2016-11-23||Interventional|||Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application|Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application|Terminated||N/A|16|Actual|Verifomics LLC||24||Recruiting and financial constraints|f||||f||||||||||2017-10-10 22:14:44.803968|2017-10-10 22:14:44.803968
NCT02758977|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-28|||May 2016||2016-05-01|April 2016|2016-04-01||||April 2019|Anticipated|2019-04-01||Interventional|ALPPSforCRLM||Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)|Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Conventional Two-Stage Hepatectomy (TSH) for Surgical Treatment of Marginally Resectable Colorectal Liver Metastases (CRLM) - A Multicentric, Randomized Controlled Trial|Not yet recruiting||N/A|214|Anticipated|University of Zurich||2|||f||||t||||||||No||2017-10-10 22:14:45.015314|2017-10-10 22:14:45.015314
NCT02758964|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2017-01-25|||September 2016||2016-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|EARTH - TAVR||Evaluation of Cerebral Thrombembolism After TAVR|Evaluation of Cerebral Thrombembolism After TAVR|Recruiting||N/A|230|Anticipated|Charite University, Berlin, Germany|||1||f||||t||||||||||2017-10-10 22:14:45.164313|2017-10-10 22:14:45.164313
NCT02758951|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-05-05|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|August 1, 2026|Anticipated|2026-08-01|August 1, 2024|Anticipated|2024-08-01||Interventional|CAIRO6||Perioperative Systemic Therapy and Surgery Versus Surgery Alone for Resectable Colorectal Peritoneal Metastases.|Perioperative Systemic Therapy and Surgery Versus Surgery Alone for Resectable Colorectal Peritoneal Metastases: the Multicentre, Phase II-III, Randomised CAIRO6 Study.|Recruiting||Phase 2/Phase 3|358|Anticipated|Catharina Ziekenhuis Eindhoven||2|||f||||t|f|f||||||Undecided||2017-10-10 22:14:45.315148|2017-10-10 22:14:45.315148
NCT02758938|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-05-08|||June 2016||2016-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Urological Biofeedback Game Software|End User Assessment of Urological Biofeedback Game Software|Recruiting||N/A|40|Anticipated|University of Wisconsin, Madison||4|||f||||f||||||||||2017-10-10 22:14:45.563794|2017-10-10 22:14:45.563794
NCT02758925|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-05-03|||June 2016||2016-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|CyBeR-Lymph||CyBeR Association in Relapsed/Refractory DLBCL|Phase 2 Study of Cytarabine in Association With Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma|Not yet recruiting||Phase 2|78|Anticipated|University Hospital, Caen||1|||f||||t||||||||No||2017-10-10 22:14:45.706341|2017-10-10 22:14:45.706341
NCT02758912|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-02-06|||April 2016||2016-04-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers|Open-label Clinical Pharmacokinetic Study of Cardionat®, Capsules 250 mg (JSC Nizhpharm, Russia) Using in Health Athlete Volunteers|Active, not recruiting||Phase 4|32|Actual|Burnasyan Federal Medical Biophysical Center||2|||f||||t||||||||||2017-10-10 22:14:45.824656|2017-10-10 22:14:45.824656
NCT02758899|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-27|||March 2014||2014-03-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Observational|||Diabetes and Glycosylation in Cervical Spondylosis|The Effects of Diabetes and Glycosylation Profile on Outcomes in the Surgical Treatment of Cervical Spondylosis|Recruiting||N/A|20|Anticipated|Washington University School of Medicine|||2||f||||t||||||||||2017-10-10 22:14:45.935001|2017-10-10 22:14:45.935001
NCT02758886|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-27|||April 2014||2014-04-01|April 2016|2016-04-01||||May 2015|Actual|2015-05-01||Interventional|PYSA||Pet Your Stress Away Study||Completed||N/A|247|Actual|Washington State University||3|||f||||f||||||||No||2017-10-10 22:14:46.063297|2017-10-10 22:14:46.063297
NCT02758873|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-05-02|||February 2016||2016-02-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|PACT||Prescribing Asthma Controller Medication According to Gene Status to Improve Quality of Life in Young People With Asthma|Prescribing Asthma Controller Medication According to Gene Status to Improve Quality of Life in Young People With Asthma|Recruiting||N/A|240|Anticipated|University of Sussex||2|||f||||t||||||||Undecided||2017-10-10 22:14:46.143164|2017-10-10 22:14:46.143164
NCT02758860|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2017-03-06|||June 2016||2016-06-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01|3 Years|Observational [Patient Registry]|||Predictive Value of DICA in the Diverticular Disease of the Colon|Predictive Value of the Diverticular Inflammation and Complication Assessment (DICA) Endoscopic Classification on the Outcome of the Diverticular Disease of the Colon: a Prospective, Multicenter, International Study.|Recruiting||N/A|281|Anticipated|University of Roma La Sapienza|||1||f||||f||||||||No||2017-10-10 22:14:46.343705|2017-10-10 22:14:46.343705
NCT02758847|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-10-04|||September 2016|Actual|2016-09-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Evaluation of Paclitaxel in Patients With CLI and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty|Evaluation of Paclitaxel in Patients With CLI (Critical Limb Ischemia) and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty|Recruiting||N/A|50|Anticipated|University of Pittsburgh||1|||f||||t|f|t|f|f|t|||||2017-10-10 22:14:46.854932|2017-10-10 22:14:46.854932
NCT02758834|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-28|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition|Half-life of Plasma Phytosterols in Very Low-birth-weight Preterm Infants on Routine Parenteral Nutrition With Soy-bean Oil Based Lipid Emulsions|Completed||N/A|45|Actual|Università Politecnica delle Marche|||1||f||||f||||||Samples Without DNA|"     Plasma.   "|Undecided||2017-10-10 22:14:47.002084|2017-10-10 22:14:47.002084
NCT02758821|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-05-08|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Impact of C-reactive Protein Testing|The Impact of C-reactive Protein Testing on Antibiotic Prescription in Febrile Patients Attending Primary Care in Low-resource Settings|Recruiting||N/A|2400|Anticipated|University of Oxford||3|||f||||f||||||||No||2017-10-10 22:14:47.096553|2017-10-10 22:14:47.096553
NCT02758808|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-27|||March 2016||2016-03-01|April 2016|2016-04-01|October 2021|Anticipated|2021-10-01|March 2021|Anticipated|2021-03-01|5 Years|Observational [Patient Registry]|PFFR||Pulmonary Fibrosis Foundation Patient Registry|Pulmonary Fibrosis Foundation Patient Registry|Recruiting||N/A|2000|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"     whole blood, plasma, PAXgene   "|No||2017-10-10 22:14:47.217222|2017-10-10 22:14:47.217222
NCT02758782|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-16|||September 2016||2016-09-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|CONSUL||NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis|COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of StrUctural Damage in the Spine Over Two Years in Patients With ankyLosing Spondylitis: a Randomized Controlled Multicentre Trial|Recruiting||Phase 4|170|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 22:14:47.412299|2017-10-10 22:14:47.412299
NCT02758769|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-09-26|||November 30, 2015|Actual|2015-11-30|September 2017|2017-09-01|September 30, 2023|Anticipated|2023-09-30|September 30, 2023|Anticipated|2023-09-30||Observational|||Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings|Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings|Recruiting||N/A|300|Anticipated|Bristol-Myers Squibb|||1||f||||||||||Samples Without DNA|"     Whole Blood   "|||2017-10-10 22:14:47.622593|2017-10-10 22:14:47.622593
NCT02758756|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-11-10|||March 2016||2016-03-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Pilot Study on Energy Therapy or Massage to Reduce Fatigue|Pilot Study on Energy Therapy or Massage to Reduce Fatigue in Breast and Prostate Cancer Patients on Hormone Therapy|Recruiting||Phase 1/Phase 2|99|Anticipated|University of Rochester||3|||f||||t||||||||No||2017-10-10 22:14:47.736208|2017-10-10 22:14:47.736208
NCT02758743|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-06-22|||April 2016||2016-04-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||The Efficacy of Acetium Lozenges in Intervention for Smoking Cessation|The Efficacy of Acetium Lozenges in Intervention for Smoking Cessation: A Double-blind, Placebo-controlled Trial|Completed||N/A|1998|Actual|Biohit Oyj||2|||f||||f||||||||No|individual participants data not public.|2017-10-10 22:14:47.843334|2017-10-10 22:14:47.843334
NCT02758730|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-08-04||||||August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Interventional|||Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients|A Randomized, Placebo-controlled, Parallel Group, Patient-blind, Single-center Phase I Pilot Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A, a New Vaccine Against Alpha-synuclein, in Patients With PD-GBA|Withdrawn||Phase 1|0|Actual|Affiris AG||2|||f||||t||||||||||2017-10-10 22:14:47.933487|2017-10-10 22:14:47.933487
NCT02758704|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-05-01|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Stress on Performance of Neonatal Endotracheal Intubation|Impact of Stress on the Performance of Neonatal Endotracheal Intubation: A Randomized Controlled Trial on Manikins|Recruiting||N/A|65|Anticipated|St. Justine's Hospital||2|||f||||f||||||||Yes||2017-10-10 22:14:48.179598|2017-10-10 22:14:48.179598
NCT02758691|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-27|||December 2015||2015-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||fMRI Study of Effects of Nasal Insulin on Memory|Examining the Neural Correlates of Memory in Response to Intranasal Insulin Through fMRI & Device Testing|Active, not recruiting||Phase 1|45|Actual|Virginia Polytechnic Institute and State University||2|||f||||f||||||||||2017-10-10 22:14:48.401302|2017-10-10 22:14:48.401302
NCT02758678|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-10-17|||November 2015||2015-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients|Analysis of P-selectin Expression on Platelets of Blood Between Serum Samples From Lung Cancer and Healthy Individuals by Using Raman Spectroscopy|Completed||N/A|40|Actual|Science and Technology Park, Center of Innovation Technologies for Human Health|||3||f||||f||||||Samples Without DNA|"     A single 2 ml heparinised peripheral blood sample was centrifuges to get serum   "|Yes|2016 - as a manuscript|2017-10-10 22:14:48.482219|2017-10-10 22:14:48.482219
NCT02758665|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-01-11|||September 2016||2016-09-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|CLL2-GiVe||Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL|A Prospective, Open-label, Multicentre Phase-II Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Physically Fit or Unfit Patients With Previously Untreated Chronic Lymphocytic Leukemia (Cll) With tp53 Deletion (17p-) and/or Mutation|Recruiting||Phase 2|40|Anticipated|University of Ulm||1|||f||||f||||||||Yes||2017-10-10 22:14:48.581196|2017-10-10 22:14:48.581196
NCT02758652|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-05-06|||May 2016||2016-05-01|May 2016|2016-05-01|May 2026|Anticipated|2026-05-01|April 2026|Anticipated|2026-04-01||Observational|CHEMOVA||Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer|Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer|Recruiting||N/A|100|Anticipated|Tampere University Hospital|||1||f||||f||||||Samples With DNA|"     Plasma, urine and tissue samples   "|No||2017-10-10 22:14:48.72435|2017-10-10 22:14:48.72435
NCT02758639|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-05-01|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Wonders & Worries: A Clinical Trial of a Psychosocial Intervention for Children Who Have a Parent With Cancer||Recruiting||N/A|60|Anticipated|University of Texas at Austin||2|||f||||f||||||||No||2017-10-10 22:14:48.803817|2017-10-10 22:14:48.803817
NCT02758626|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome|A Phase 2 Randomized, Double-Masked Placebo-Controlled Crossover Safety and Tolerability Study of Ataluren for Drug Resistant Epilepsy in Patients With Nonsense Mutation CDKL5 or Dravet Syndrome|Recruiting||Phase 2|16|Anticipated|New York University School of Medicine||2|||f||||t||||||||No||2017-10-10 22:14:48.9163|2017-10-10 22:14:48.9163
NCT02758600|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-08-15|||March 2016||2016-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Cardiopulmonary and Metabolic Responses to Early Exercise in Patients After Coronary Arterial Bypass Grafting|Cardiopulmonary and Metabolic Responses in Early Exercise-based Rehabilitation in Patients With or Without Left Ventricular Dysfunction After Coronary Arterial Bypass Grafting|Recruiting||N/A|30|Anticipated|Federal University of São Paulo||2|||f||||f||||||||No||2017-10-10 22:14:49.153164|2017-10-10 22:14:49.153164
NCT02758587|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-08|||July 4, 2017|Actual|2017-07-04|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|May 2019|Anticipated|2019-05-01||Interventional|||Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)|A Phase I/IIA Study to Assess Safety, Tolerability and Preliminary Activity of the Combination of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Patients With Advanced Solid Malignancies (FAK-PD1)|Recruiting||Phase 1/Phase 2|59|Anticipated|NHS Greater Glasgow and Clyde||4|||f||||t|f|f||||||||2017-10-10 22:14:49.263225|2017-10-10 22:14:49.263225
NCT02758574|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-06|||May 2016||2016-05-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|SUNSET sPE||Standard vs. Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism|Comparison of Standard Catheter Directed Thrombolysis vs. Ultrasound Assisted Thrombolysis for Patients With Acute Submassive Pulmonary Embolism|Recruiting||N/A|80|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 22:14:49.418243|2017-10-10 22:14:49.418243
NCT02758561|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-05-17|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Motivational Interviewing in Women`s Pelvic Wellness Education|2015 Motivational Interviewing in Women`s Pelvic Wellness Education Project|Not yet recruiting||N/A|80|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No||2017-10-10 22:14:49.573416|2017-10-10 22:14:49.573416
NCT02758548|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-11-13|||March 2016||2016-03-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects|A Multicenter Clinical Evaluation Study to Determine the External Site Accuracy of Total Immunoglobulin E Measurement Using a Novel Point of Care Test Device Compared to a Reference Method in Atopic Subjects|Completed||Phase 2|193|Actual|Novartis||1|||f||||f||||||||||2017-10-10 22:14:49.672829|2017-10-10 22:14:49.672829
NCT02758535|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-04-29|||March 2015||2015-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Interventional|||Renal Parenchymal Core Needle Biopsy||Completed||N/A|166|Actual|Modarres Hospital||2|||f||||f||||||||No||2017-10-10 22:14:49.778362|2017-10-10 22:14:49.778362
NCT02758522|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-28|||October 2013||2013-10-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||NPH and Regular Insulin in the Treatment of Inpatient Hyperglycemia: Comparison of 3 Basal-bolus Regimens|NPH and Regular Insulin in the Treatment of Inpatient Hyperglycemia: Comparison of 3 Basal-bolus Regimens|Completed||Phase 4|105|Actual|Hospital Universitario Dr. Jose E. Gonzalez||3|||f||||t||||||||No||2017-10-10 22:14:49.869859|2017-10-10 22:14:49.869859
NCT02758509|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-03-29|||January 1, 2010||2010-01-01|March 2017|2017-03-01|October 15, 2017|Anticipated|2017-10-15|June 15, 2017|Anticipated|2017-06-15||Observational|||Impact of Antiviral Therapy on Gastroesophageal Varices.|Efficacy and Safety of Interferon Based Therapy and Interferon-free Direct-acting Antivirals in Cirrhotic Patients With Hepatitis C. Impact of Antiviral Therapy on Gastroesophageal Varices.|Active, not recruiting||N/A|374|Anticipated|Parc de Salut Mar|||3||f||||f||||||||No||2017-10-10 22:14:50.00734|2017-10-10 22:14:50.00734
NCT02758496|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-05-05|||April 2016||2016-04-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD|A Chart Review to Evaluate the Safety and Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on Subjects With Autism Spectrum Disorder (ASD)|Completed||N/A|141|Actual|Newport Brain Research Laboratory|||2||f||||f||||||||No||2017-10-10 22:14:50.12871|2017-10-10 22:14:50.12871
NCT02758483|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-02-23|||February 23, 2017|Actual|2017-02-23|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Glucose Variability in Patients With Type 1 Diabetes With a Sucrose-added Diet|Influence of Sucrose-free Diet or Sucrose-added Diet on Glucose Variability in Patients With Type 1 Diabetes|Recruiting||N/A|30|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t|f|f||||||Undecided|The study was approved by Ethical Committee (Institutional Review Board)|2017-10-10 22:14:50.290961|2017-10-10 22:14:50.290961
NCT02758470|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-07-07|||November 2016||2016-11-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Muscle Fatigue and Carbonic Anhydrase Inhibitors|The Effect of Carbonic Anhydrase Inhibitors on the Pulmonary System Response to Muscle Fatigue.|Completed||Phase 4|15|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-10-10 22:14:50.427737|2017-10-10 22:14:50.427737
NCT02758457|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-04-28|||January 2008||2008-01-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|January 2013|Actual|2013-01-01||Interventional|||Zirconia and Metal-based Single Crown Posterior Restorations.|Zirconia-based and Metal-based Single Crown Posterior Restorations: 5-year Results of a Randomized Controlled Clinical Study.|Completed||Phase 4|72|Actual|University of Bologna||2|||f||||f||||||||Undecided||2017-10-10 22:14:50.531252|2017-10-10 22:14:50.531252
NCT02758444|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-21|||November 2015||2015-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|ZEED2||Effects of EED on Zn Absorption and Retention in Children From a MNP|Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 2 - Absorption of Zn From a Multi-micronutrient Powder (MNP)|Recruiting||N/A|80|Anticipated|University of Colorado, Denver||4|||f||||f||||||||||2017-10-10 22:14:50.610258|2017-10-10 22:14:50.610258
NCT02758431|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-07-10|||February 2016||2016-02-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|CardioVOLT||Cardiovascular Outcomes of Low Testosterone|Cardiovascular Consequences of Hypogonadism in Men|Recruiting||N/A|379|Anticipated|University of Colorado, Denver||3|||f||||f||||||||||2017-10-10 22:14:50.757962|2017-10-10 22:14:50.757962
NCT02758418|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|TAO||Development and Validation of an Online Treatment Program for Adjustment Disorders|Efficacy of an Internet-based CBT Program for Adjustment Disorders: A Randomized Controlled Trial|Recruiting||N/A|141|Anticipated|Universitat Jaume I||3|||f||||t||||||||No||2017-10-10 22:14:50.909662|2017-10-10 22:14:50.909662
NCT02758405|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-05-23|||May 2016||2016-05-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor 2|Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 5 of Bupivacaine 0.125% Plus Fentanyl 2 mcg/ml.|Completed||N/A|40|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||4|||f||||f||||||||No||2017-10-10 22:14:51.048095|2017-10-10 22:14:51.048095
NCT02758392|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-01-20|||April 2016||2016-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Study to Evaluate Safety and Tolerability of JNJ-61178104 in Healthy Participants|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose, Interventional Study of JNJ-61178104 in Healthy Subjects|Completed||Phase 1|54|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-10 22:14:51.166235|2017-10-10 22:14:51.166235
NCT02758379|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-07-19|||July 2014||2014-07-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Shockwave Coronary Lithoplasty Study|Early Safety and Feasibility Study of the Shockwave Coronary Lithoplasty™ System in Coronary Arteries|Completed||N/A|12|Actual|Shockwave Medical, Inc.||1|||f||||f||||||||||2017-10-10 22:14:51.306174|2017-10-10 22:14:51.306174
NCT02758366|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-28|||February 2016||2016-02-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma|An Open-label, Single-arm, Phase II Study to Evaluate Safety and Efficacy of Doxorubicin in Combination With Radiotherapy, Temozolomide and Valproic Acid in Patients With Glioblastoma Multiforme (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG)|Recruiting||Phase 2|20|Anticipated|Meyer Children's Hospital||1|||f||||f||||||||||2017-10-10 22:14:51.406171|2017-10-10 22:14:51.406171
NCT02758353|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-28|||April 2015||2015-04-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|MIPP-NG||The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria|Scaling up the Use of Sulphadoxine-Pyrimethamine for the Preventive Treatment of Malaria in Pregnancy: Results and Lessons on Scalability, Costs and Program From Three Local Government Areas in Sokoto State, Nigeria|Completed||N/A|31493|Actual|JSI Research & Training Institute, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:14:51.519846|2017-10-10 22:14:51.519846
NCT02758340|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-11-28|||April 2016||2016-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Failure of Vaginal Delivery After Induction|Comparison of Maternal Outcome Between Patients Undergoing Induction of Labor With Oral Misoprostol Alone and Oral Misoprostol and Foley's Catheter Both at a Tertiary Care Hospital|Completed||Phase 3|335|Actual|Karachi Medical and Dental College||2|||f||||t||||||||No|not available|2017-10-10 22:14:51.63011|2017-10-10 22:14:51.63011
NCT02758327|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-15|||October 2015||2015-10-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|AKORN||Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops|Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating|Completed||Phase 4|14|Actual|Koffler Vision Group||1|||f||||t||||||||||2017-10-10 22:14:51.747128|2017-10-10 22:14:51.747128
NCT02758314|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-11-23|||March 2017||2017-03-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients|Clinical Pathological Features Associated With the Expression of PD1 / PD-L1 in Subpopulations of Peripheral Blood and Tumor Tissue in Patients With Advanced Non-small Cell Lung Cancer, Their Role as Prognostic and Therapeutic Targets|Not yet recruiting||N/A|150|Anticipated|Instituto Nacional de Cancerologia de Mexico|||2||f||||f||||||Samples With DNA|"     Whole blood cells, serum and plasma, tumor tissue   "|Yes||2017-10-10 22:14:51.835511|2017-10-10 22:14:51.835511
NCT02758301|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-05-22|||June 8, 2016|Actual|2016-06-08|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|LINQ HF||Reveal LINQ™ Heart Failure|Reveal LINQ™ Heart Failure|Active, not recruiting||N/A|99|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f|f|t|f|||||No||2017-10-10 22:14:51.942187|2017-10-10 22:14:51.942187
NCT02758288|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-10-26|||September 2015||2015-09-01|October 2016|2016-10-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Observational|||BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach|BK Viremia and BK Virus Nephropathy Post Kidney Transplant Comparison of New Practices With Traditional Approach: A Combined Retrospective Chart Review and Prospective Observational Study|Recruiting||N/A|170|Anticipated|Loma Linda University|||2||f||||f||||||||No||2017-10-10 22:14:52.071773|2017-10-10 22:14:52.071773
NCT02758275|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-03-18|||April 28, 2016|Actual|2016-04-28|March 2017|2017-03-01|July 14, 2017|Anticipated|2017-07-14|July 21, 2016|Actual|2016-07-21||Interventional|ENURSIN||Teaching: Individual to Increase Adherence to Therapeutic Regimen in Hypertension Arterial and/or Diabetes Type 2|"Efficacy of Nursing Intervention Teaching: Individual to Increase Adherence to Therapeutic Regimen in People With Hypertension Arterial and/or Diabetes Mellitus Type 2"|Active, not recruiting||N/A|200|Actual|Universidad Industrial de Santander||2|||f||||t||||||||No||2017-10-10 22:14:52.184835|2017-10-10 22:14:52.184835
NCT02758262|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-03-31|||April 2016||2016-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of Noninvasive Brain Stimulation on Brain Activity and Appetite||Recruiting||N/A|60|Anticipated|Laval University||2|||f||||f||||||||Undecided||2017-10-10 22:14:52.277388|2017-10-10 22:14:52.277388
NCT02758249|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-05-02|||January 2016||2016-01-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Anesthetic Effect on Immune Cell in Patients With Cancer|Anesthetic Effect on Immune Cell in Patients With Cancer|Recruiting||N/A|80|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:14:52.365098|2017-10-10 22:14:52.365098
NCT02758067|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-07-29|||June 2016||2016-06-01|July 2016|2016-07-01||||June 2016|Actual|2016-06-01||Interventional|TAILWIND||Comparison of the Effectiveness of Brexpiprazole With That of Risperidone|Interventional, Randomised, Double-blind, Parallel-group, Active-comparator, Flexible-dose Study to Compare the Effectiveness of Brexpiprazole to That of Risperidone in Adult Patients With Schizophrenia|Withdrawn||Phase 3|0|Actual|H. Lundbeck A/S||2||This study was withdrawn for administrative reasons. There were no safety concerns.|f||||f||||||||||2017-10-10 22:14:54.67131|2017-10-10 22:14:54.67131
NCT02758236|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-08-27|||February 7, 2017|Actual|2017-02-07|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|TRIPOD||Tuberculosis Research of INA-RESPOND On Drug Resistance|Tuberculosis Research of INA-RESPOND On Drug Resistance|Recruiting||N/A|1357|Anticipated|Ina-Respond|||1||f||||f||||||Samples With DNA|"     Subjects must be willing to allow storage of sputum, Mtb isolate, whole blood (PAXgene blood     , plasma, PBMC), and urine on baseline, month 1, month 2, and end of treatment visit, saliva     on baseline and end of treatment visit for use in future studies (for example, host response,     spoligotyping, and genetic tests). Serum and whole blood for DNA are collected on baseline     visit only.      All samples will be stored at the NIHRD, Mtb isolate, plasma, saliva and urine will also be     stored at each site   "|||2017-10-10 22:14:52.473009|2017-10-10 22:14:52.473009
NCT02758223|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-11-07|||April 2016||2016-04-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PACT||Prophylactic Application of Donor-derived TCM After Allogeneic HSCT|Prophylactic Application of Donor-derived Central Memory T Lymphocytes (TCM) After Allogeneic HSCT to Prevent Infectious Complications|Recruiting||Phase 1/Phase 2|30|Anticipated|Wuerzburg University Hospital||1|||f||||t||||||||No||2017-10-10 22:14:52.603122|2017-10-10 22:14:52.603122
NCT02758210|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-08|2017-09-08||April 2016||2016-04-01|September 2017|2017-09-01|October 24, 2016|Actual|2016-10-24|October 24, 2016|Actual|2016-10-24||Interventional|MICRA|Patients who were eligible to participate and were randomized to a study arm|Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)|Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)|Completed||N/A|20|Actual|Emory University||1|||f||||f||||||||||2017-10-10 22:14:52.715468|2017-10-10 22:14:52.715468
NCT02758197|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-12-06|||July 2016||2016-07-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|COMPASSION||Online MBSR Program for Cancer Survivors With Chronic Neuropathic Pain|The Effects of an Online Mindfulness-Based Stress Reduction (MBSR) Program on Quality of Life and Immune Function Among Cancer Survivors With Chronic Neuropathic Pain|Recruiting||N/A|100|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No||2017-10-10 22:14:53.32715|2017-10-10 22:14:53.32715
NCT02758184|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-02-20|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of ROTEM-based Coagulation Surveillance on Reducing Blood Product Utilization During Complex Spine Surgery|Effectiveness of ROTEM-based Coagulation Surveillance on Reducing Blood Product Utilization During Complex Spine Surgery: A Prospective Randomized Study|Recruiting||N/A|40|Anticipated|Duke University||2|||f||||||||||||||2017-10-10 22:14:53.499905|2017-10-10 22:14:53.499905
NCT02758158|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-08-08|||January 2016||2016-01-01|August 2016|2016-08-01||||June 2017|Anticipated|2017-06-01||Interventional|||Tri-modal Imaging Instrument for Thyroid Cancer|Clinical Evaluation of a Prototype Tri-modal Imaging Instrument for Thyroid Cancer|Enrolling by invitation||N/A|10|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:14:53.719819|2017-10-10 22:14:53.719819
NCT02758145|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-29|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit|Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit|Active, not recruiting||N/A|400|Anticipated|Service de Médecine Préventive Hospitalière||2|||f||||f||||||||No||2017-10-10 22:14:53.808975|2017-10-10 22:14:53.808975
NCT02758132|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-07-18|||July 2015||2015-07-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases|Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases: Clinical Testing and Feasibility of a Serum-based Metabolomics Profile|Terminated||N/A|1|Actual|University of Hawaii||2||Low accruals|f||||t||||||||||2017-10-10 22:14:53.914925|2017-10-10 22:14:53.914925
NCT02758119|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2017-02-18|||June 2016|Actual|2016-06-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Serious Game Versus Online Course to Pre-train Medical Students on the Management of an Adult Cardiac Arrest.|Conciliating Mastery Learning and Time Constraints on High-fidelity Simulators: Serious Game Versus Online Course to Pre-train Medical Students on the Management of an Adult Cardiac Arrest.|Completed||N/A|82|Actual|Departement de simulation en Santé de l'Université Paris Descartes||2|||f||||f||||||||No||2017-10-10 22:14:54.075207|2017-10-10 22:14:54.075207
NCT02758106|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-29|||February 2014||2014-02-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|HFCWOonAFR||HFCWO on Pneumonic Respiratory Failure|The Instantaneous Effects of High-Frequency Chest Wall Oscillation on Patients With Acute Pneumonic Respiratory Failure Receiving Mechanical Ventilation|Completed||N/A|73|Actual|Chung Shan Medical University||2|||f||||t||||||||No||2017-10-10 22:14:54.225982|2017-10-10 22:14:54.225982
NCT02758093|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-11|||April 2016||2016-04-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|September 2020|Anticipated|2020-09-01||Interventional|SOP||Speed of Processing Training in Adults With HIV|An RCT of Speed of Processing Training in Middle-Aged and Older Adults With HIV|Recruiting||N/A|264|Anticipated|University of Alabama at Birmingham||3|||f||||t||||||||Yes|We will make the cleaned electronic database available to NIMH after the study is complete.|2017-10-10 22:14:54.387151|2017-10-10 22:14:54.387151
NCT02758080|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-06-21|||January 2016||2016-01-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Matching Patients With Hematologic Malignancy to Adequate Clinical Trials|Pragmatic Clinical Trial of Matching Malignant Hematologic Cancer Patients With Adequate Early Phase Clinical Trials by Next-generation Sequencing|Recruiting||N/A|90|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 22:14:54.533817|2017-10-10 22:14:54.533817
NCT02758054|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-07-17|||June 16, 2017|Actual|2017-06-16|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System|A Randomized Controlled Trial (RCT) of Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System|Recruiting||N/A|340|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:14:54.780905|2017-10-10 22:14:54.780905
NCT02758041|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-05|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris|A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris|Completed||N/A|85|Actual|Sebacia, Inc.||1|||f||||f||||||||||2017-10-10 22:14:54.904124|2017-10-10 22:14:54.904124
NCT02758028|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-01-06|||August 2005||2005-08-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Helping Youth Smokers Stop Smoking Through the Youth Quitline Programme|Helping Youth Smokers Stop Smoking Through the Youth Quitline Programme|Recruiting||N/A|300|Anticipated|The University of Hong Kong||1|||f||||f||||||||No||2017-10-10 22:14:55.009216|2017-10-10 22:14:55.009216
NCT02758015|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-07-28|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|||Effect of Betaine and Food on Gastric pH|Countering the Gastric ph Effect of a Standardized Meal in Healthy Volunteers Using Clinical Doses of Betaine Hydrochloride|Active, not recruiting||N/A|10|Anticipated|University of California, San Francisco||4|||f||||t||||||||||2017-10-10 22:14:55.13104|2017-10-10 22:14:55.13104
NCT02758002|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-29|||June 2016||2016-06-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|TRANS AF||Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms|Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms|Not yet recruiting||N/A|20|Anticipated|University of California, San Diego||1|||f||||f||||||||No||2017-10-10 22:14:55.246969|2017-10-10 22:14:55.246969
NCT02757989|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-11|||May 31, 2016|Actual|2016-05-31|July 2017|2017-07-01|April 2021|Anticipated|2021-04-01|May 2019|Anticipated|2019-05-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk|Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Low or Intermediate-1 Myelodysplastic Syndrome: A Prospective Multicenter Phase II Study Based on Donor Availability on Behalf of the GFM & SFGM-TC|Recruiting||N/A|105|Anticipated|Groupe Francophone des Myelodysplasies||2|||f||||t||||||||||2017-10-10 22:14:55.394454|2017-10-10 22:14:55.394454
NCT02757976|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-28|||June 2016||2016-06-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|RAFT-LVendo||Resynchronization for Ambulatory Heart Failure Trial - LV Endocardial Acute Hemodynamic Study|Resynchronization for Ambulatory Heart Failure Trial - LV Endocardial Acute Hemodynamic Study (RAFT-LVendo AHS)|Not yet recruiting||Phase 3|100|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||Yes||2017-10-10 22:14:55.65696|2017-10-10 22:14:55.65696
NCT02757963|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-28|||May 12, 2016|Actual|2016-05-12|August 2017|2017-08-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years|Implementation of a Screening Tool for Subjects With Benign Prostatic Enlargement/Obstruction to Identify Men >=50 Years Presenting in General Practice With Other Co-morbidities Who Should be Assessed for BPH|Completed||Phase 4|1701|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:14:55.762443|2017-10-10 22:14:55.762443
NCT02757950|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-06-14|||July 14, 2016|Actual|2016-07-14|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|||A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.|A Post-marketing, Observational, Retrospective, Cohort Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.|Completed||N/A|2400|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-10-10 22:14:55.928104|2017-10-10 22:14:55.928104
NCT02757937|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-08-31|||May 2016||2016-05-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|REACH||Reaching Better Health Study: A Website to Improve Type 2 Diabetes Self-Management|Study to Measure Merck Engage Usability and Conduct Outcomes Testing|Active, not recruiting||N/A|513|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 22:14:56.014249|2017-10-10 22:14:56.014249
NCT02757924|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-06-16|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|||Behavior of Infants Fed Formula Supplemented With Prebiotics|Behavior of Infants Fed a Partially Hydrolyzed Formula Supplemented With Prebiotics|Completed||N/A|59|Actual|Abbott Nutrition||1|||f||||f||||||||Undecided||2017-10-10 22:14:56.090363|2017-10-10 22:14:56.090363
NCT02757911|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-27|||March 2016||2016-03-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Gene Therapy for X-linked Chronic Granulomatous Disease|A Phase I/II, Non Randomized, Monocentric Open-label Study of Autologous CD34+ Cells Transduced With the G1XCGD Lentiviral Vector in Patients With X-Linked Chronic Granulomatous Disease|Recruiting||Phase 1/Phase 2|5|Anticipated|Genethon||1|||f||||||||||||||2017-10-10 22:14:56.17126|2017-10-10 22:14:56.17126
NCT02757898|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-04-12|||April 2016||2016-04-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|b-RBCs||Transfusion of Biotinylated Red Blood Cells|RBC Survival Validation in Adult Humans Under Condition of Normal RBC Survival|Recruiting||Phase 1|8|Anticipated|Emory University||1|||f||||f||||||||||2017-10-10 22:14:56.289997|2017-10-10 22:14:56.289997
NCT02757885|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TRANSFORM||Transplantation Using Reduced Intensity Approach for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow|Transplantation Using Reduced Intensity Approach for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow|Recruiting||Phase 2|15|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 22:14:56.379823|2017-10-10 22:14:56.379823
NCT02757872|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-28|||April 2016||2016-04-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives|Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives|Enrolling by invitation||Phase 3|2250|Anticipated|Albert Einstein College of Medicine, Inc.||4|||f||||t||||||||||2017-10-10 22:14:56.482044|2017-10-10 22:14:56.482044
NCT02757859|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-29|2016-10-18|||February 2016||2016-02-01|October 2016|2016-10-01||||August 2020|Anticipated|2020-08-01||Interventional|||High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery|The WASH (Water or Saline at High Volumes) Trial: A Randomized Trial to Assess the Survival Impact of Extensive Peritoneal Lavage Using Distilled WAter or Saline at High Volumes After Pancreatic Resection for Pancreatic Ductal Adenocarcinoma|Recruiting||N/A|667|Anticipated|Thomas Jefferson University||3|||f||||t||||||||||2017-10-10 22:14:56.567108|2017-10-10 22:14:56.567108
NCT02757846|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-28|||April 2017||2017-04-01|April 2016|2016-04-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||Radiomics of Hepatocellular Carcinoma|Quantitative Imaging for Evaluation of Response to Cancer Therapies|Enrolling by invitation||N/A|1200|Anticipated|Chinese Academy of Sciences|||1||f||||f||||||||Undecided||2017-10-10 22:14:56.651762|2017-10-10 22:14:56.651762
NCT02757833|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Central Glutathione Levels in Women With Late Life Depression: a Cross Sectional Pilot Feasibility Study|Central Glutathione Levels in Women With Late Life Depression: a Cross Sectional Pilot Feasibility Study|Not yet recruiting||Early Phase 1|26|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 22:14:56.717401|2017-10-10 22:14:56.717401
NCT02757820|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-11-24|||April 2016||2016-04-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|I-gelvsAir-q||A Randomized Comparison of Pediatric I-gel, Air-Q With Classic Laryngeal Mask Airway|A Randomized Comparison of Pediatric I-gel, Air-Q With Classic Laryngeal Mask Airway in Terms of Clinical Performance and Fiber Optic Glottic View|Recruiting||Phase 2/Phase 3|120|Anticipated|Assiut University||3|||f||||t||||||||No||2017-10-10 22:14:56.787797|2017-10-10 22:14:56.787797
NCT02757807|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-07-19|||July 2016||2016-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Stress Management Using an App to Improve Response With PDE5 Inhibitors in Men With Erectile Dysfunction.|Stress Management Using an App to Improve Response With PDE5 Inhibitors in Men With Erectile Dysfunction.|Recruiting||N/A|100|Anticipated|Eco Fusion||1|||f||||f||||||||Undecided||2017-10-10 22:14:56.861662|2017-10-10 22:14:56.861662
NCT02757794|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-05-12|||November 29, 2016|Actual|2016-11-29|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|EPIREMED||Long-term Effects of Visual Spatial Working Memory Training Program Performed at Preschool Age in Very Preterm Infants With Visual Spatial Working Memory Deficit. A Randomized Controlled Trial|Long-term Effects of Visual Spatial Working Memory Training Program Performed at Preschool Age in Very Preterm Infants With Visual Spatial Working Memory Deficit. A Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||Undecided||2017-10-10 22:14:56.936348|2017-10-10 22:14:56.936348
NCT02757781|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-05-10|||July 2016||2016-07-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|eMPODERA||Effectiveness of a Virtual Intervention for Professionals to Improve Their Attitudes Towards Patient Empowerment.|Effectiveness of a Virtual Intervention (CoP) for Professionals to Improve Their Attitude Towards the Empowerment of Patients With Chronic Disease: Cluster Randomised Controlled Trial (eMPODERA Project)|Not yet recruiting||N/A|272|Anticipated|Avedis Donabedian Research Institute||2|||f||||f||||||||No|There is not plan to make individual participant data available|2017-10-10 22:14:58.714338|2017-10-10 22:14:58.714338
NCT02757768|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-08-15|||April 30, 2016|Actual|2016-04-30|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)|A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With Overactive Bladder (OAB) Symptoms While Taking the Alpha Blocker Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)|Recruiting||Phase 4|856|Anticipated|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 22:14:58.861439|2017-10-10 22:14:58.861439
NCT02757755|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-08-29|||May 2016||2016-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults|Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults|Completed||Phase 1|12|Actual|AmpliPhi Biosciences Corporation||2|||f||||f||||||||Undecided||2017-10-10 22:14:59.207776|2017-10-10 22:14:59.207776
NCT02757742|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-08-09|||December 2010||2010-12-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Quantitive LGE Mass in Prediction of SCD in NICM Patients With Severe Cardiac Dysfunction|A Quantitive Late Gadolinium Enhancement(LGE) Mass Based Tool for Risk Prediction of Sudden Cardiac Death(SCD) in Non-ischemic Cardiomyopathy(NICM) Patients With Severe Cardiac Dysfunction|Completed||N/A|356|Actual|Fu Wai Hospital, Beijing, China|||1||f||||t||||||||||2017-10-10 22:14:59.440017|2017-10-10 22:14:59.440017
NCT02757729|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-09-19|||October 2015||2015-10-01|September 2016|2016-09-01||||August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis|Multi Center, Randomized, Double-blind, Placebo-controlled Parallel-group, Phase II Clinical Trial to Evaluate the Safety and Efficacy of PAC-14028 Cream in Mild to Moderate Atopic Dermatitis Patients|Completed||Phase 2|192|Actual|Amorepacific Corporation||4|||f||||t||||||||No||2017-10-10 22:14:59.528416|2017-10-10 22:14:59.528416
NCT02757716|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-10-29|||April 2016||2016-04-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Addiction Remission and Addiction Transfer After Bariatric Surgery|Addiction Remission and Addiction Transfer After Bariatric Surgery|Recruiting||N/A|100|Anticipated|Sana Klinikum Offenbach||3|||f||||f||||||||No||2017-10-10 22:14:59.625083|2017-10-10 22:14:59.625083
NCT02757703|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-04-29|||May 2010||2010-05-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Vasoactive Drugs in Real World Practice|Short-course Somatostatin Versus Terlipressin Infusion in Combination With Endoscopic Variceal Ligation for the Prevention of Early Esophageal Variceal Rebleeding|Completed||Phase 4|150|Actual|Kaohsiung Veterans General Hospital.||2|||f||||f||||||||No||2017-10-10 22:14:59.73872|2017-10-10 22:14:59.73872
NCT02757677|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-27|||December 2015||2015-12-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Evaluation of Blood Flow Characteristics in Glaucoma Using Optical Coherence Tomography Angiography (OCT-A).|A Cross-sectional, Prospective, Observational Study to Evaluate Blood Flow Characteristics in Glaucoma Patients Using Optical Coherence Tomography Based Angiography (OCT-A).|Recruiting||N/A|500|Anticipated|Swiss Vision Network|||3||f||||f||||||||||2017-10-10 22:14:59.937152|2017-10-10 22:14:59.937152
NCT02757664|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-07-28|||June 2016||2016-06-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Trial to Evaluate the Adjuvant Effect of Shock Wave Therapy in the Insertional Achilles Tendinopathy|Shock Wave Therapy, Associated to Eccentric Strengthening Versus Isolated Eccentric Strengthening for Treating Insertional Achilles Tendinopathy: Double Blinded Randomized Clinical Trial|Recruiting||N/A|93|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-10 22:15:00.038998|2017-10-10 22:15:00.038998
NCT02757651|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-15|||January 2017||2017-01-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response|Phase I 'Run in' Study Followed by Randomised Phase II Trial Testing Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Women With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response|Recruiting||Phase 1/Phase 2|96|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:15:00.175453|2017-10-10 22:15:00.175453
NCT02757638|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-17|||October 2015||2015-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|Bariatric||Omics Profiling of Weight Loss With Bariatric Surgery|Omics Profiling of the Response to Food and Variability of Weight Loss With Bariatric Surgery|Recruiting||N/A|50|Anticipated|Texas A&M University||2|||f||||f||||||||No||2017-10-10 22:15:00.261423|2017-10-10 22:15:00.261423
NCT02757625|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-08|||July 20, 2016|Actual|2016-07-20|June 2017|2017-06-01|May 24, 2017|Actual|2017-05-24|May 24, 2017|Actual|2017-05-24||Interventional|||Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit|Phase 3, Multi-center, Single-arm, Open-label Study Evaluating The Efficacy, Safety, And Pharmacokinetics Of Da-9501 (Dexmedetomidine Hydrochloride) In Pediatric Subjects In The Intensive Care Unit|Completed||Phase 3|63|Actual|Pfizer||1|||f||||t||||||||||2017-10-10 22:15:00.360009|2017-10-10 22:15:00.360009
NCT02757612|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-05-01|||June 2015||2015-06-01|May 2017|2017-05-01|July 30, 2016|Actual|2016-07-30|October 2015|Actual|2015-10-01||Interventional|laser||Study Evaluating the Laser Diode Effect Burning Mouth Syndrome|Study Evaluating the Laser Diode Effect on Burning Mouth Syndrome|Completed||N/A|30|Actual|Universidad de Murcia||2|||f||||f||||||||No||2017-10-10 22:15:00.470663|2017-10-10 22:15:00.470663
NCT02757599|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-19|||August 2016||2016-08-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Top-down Versus Bottom-up Transvaginal Ultrasound Scan|Impact of Image Orientation During Transvaginal Ultrasound on Learning: A Randomized Trial|Completed||N/A|59|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||Yes||2017-10-10 22:15:00.55933|2017-10-10 22:15:00.55933
NCT02757586|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-05-11|||December 2016||2016-12-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Treatment of Chronic Lymphocytic Leukemia|Resistances of CLL and Treatment of CLL|Not yet recruiting||N/A|70|Anticipated|Peking University People's Hospital|||1||f||||t||||||Samples With DNA|"     PB   "|Undecided||2017-10-10 22:15:00.625019|2017-10-10 22:15:00.625019
NCT02757573|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-05-20|||April 2016||2016-04-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||The Right Ventricular Responses to Mild Hypercarbia After Mitral Valve Repair Surgery|The Right Ventricular Responses to Mild Hypercarbia After Mitral Valve Repair Surgery - Assessment With Pulmonary Arterial Catheter and Transesophageal Echocardiography Measurements|Recruiting||N/A|20|Anticipated|Tampere University Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:15:00.699072|2017-10-10 22:15:00.699072
NCT02757560|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-01-31|||February 2012||2012-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|January 2017|Actual|2017-01-01||Interventional|||Dietary Lipid Induced Insulin Resistance|Mechanisms of Dietary Lipid Induced Insulin Resistance|Recruiting||N/A|300|Anticipated|Phoenix VA Health Care System||3|||f||||f||||||||No|Subject to VA regulation.|2017-10-10 22:15:00.784044|2017-10-10 22:15:00.784044
NCT02757547|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-02-06|||September 2015||2015-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|RESET||RESET Treatment of Epilepsy|Registered Electrical Sources for Effective TMS Treatment of Epilepsy|Enrolling by invitation||Phase 1|10|Anticipated|Electrical Geodesics, Inc.||2|||f||||t||||||||No||2017-10-10 22:15:01.00354|2017-10-10 22:15:01.00354
NCT02757534|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-11-10|||May 2015||2015-05-01|November 2016|2016-11-01||||May 2018|Anticipated|2018-05-01||Interventional|||Domperidone for Chronic Nausea and Vomiting|Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis|Recruiting||Phase 2|50|Anticipated|University of Iowa||1|||f||||||||||||||2017-10-10 22:15:01.0954|2017-10-10 22:15:01.0954
NCT02757521|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-09-12|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|||Nitrous TRD Bipolar Depression|Nitrous Oxide - A Novel Therapy for Treatment-Resistant Bipolar Depression|Recruiting||Early Phase 1|64|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 22:15:01.189802|2017-10-10 22:15:01.189802
NCT02757508|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-11-09|||March 2016||2016-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Healthy and Affordable Protein Rich Foods for African Market|Healthy and Affordable Protein Rich Foods for African Market School Feeding Programs|Recruiting||N/A|1200|Anticipated|Washington University School of Medicine||4|||f||||f||||||||No|There is no plan to make individual data available|2017-10-10 22:15:01.289969|2017-10-10 22:15:01.289969
NCT02757495|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-03|||April 2016||2016-04-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Can Caudal Dexmedetomidine Prevents Sevoflurane Induced Emergence Agitation in Children|Can Caudal Dexmedetomidine Prevents Sevoflurane Induced Emergence Agitation in Children|Recruiting||Phase 4|48|Anticipated|Suez Canal University||2|||f||||f||||||||Undecided||2017-10-10 22:15:01.371494|2017-10-10 22:15:01.371494
NCT02756117|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-02-03|||May 2016||2016-05-01|February 2017|2017-02-01|October 1, 2016|Actual|2016-10-01|October 1, 2016|Actual|2016-10-01||Interventional|||The Effect of Acute Lysine Administration on α-aminoadipic Acid|The Effect of Acute Lysine Administration on α-aminoadipic Acid|Completed||Phase 1|13|Actual|Vanderbilt University Medical Center||1|||f||||f||||||||Yes||2017-10-10 22:15:15.943435|2017-10-10 22:15:15.943435
NCT02757482|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-28|||September 2014||2014-09-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Patient Training About the Safety of Warfarin Therapy|Effects of Patient Training About the Safety of Warfarin Therapy on the Patients' Warfarin Knowledge Level and International Normalized Ratio Control (INR)|Completed||N/A|63|Actual|Celal Bayar University||2|||f||||f||||||||Undecided||2017-10-10 22:15:01.481449|2017-10-10 22:15:01.481449
NCT02757469|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-27|||May 2016||2016-05-01|April 2016|2016-04-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure|Drospirenone and Ethinyl Estradiol Combinations (Yasmin) as Infertility Treatments for Premature Ovarian Failure: a Perspective Follow-up Study.|Not yet recruiting||N/A|20|Anticipated|Navy General Hospital, Beijing||1|||f||||t||||||||Yes||2017-10-10 22:15:01.567652|2017-10-10 22:15:01.567652
NCT02757456|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-04-04|||February 2015||2015-02-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Exercise and Vascular Parameters in Hemodialysis|Aerobic Exercise and Vascular Hemodynamic Parameters Among Prevalent Hemodialysis Population|Completed||N/A|21|Actual|McGill University Health Center||2|||f||||f||||||||No||2017-10-10 22:15:01.676173|2017-10-10 22:15:01.676173
NCT02757443|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-09-20|||June 2016||2016-06-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|PRISE||Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients|Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients: a Single-center Randomised Double-blind Placebo-controlled Exploratory Pilot Clinical Trial|Recruiting||Phase 3|||Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 22:15:01.77295|2017-10-10 22:15:01.77295
NCT02757430|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-08-23|||August 30, 2016|Actual|2016-08-30|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01|7 Days|Observational [Patient Registry]|||EnSite Precision™ 2.0 Registry|EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0 Observational Registry|Active, not recruiting||N/A|512|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-10 22:15:01.952025|2017-10-10 22:15:01.952025
NCT02757417|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-05-05|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency|A Randomized Trial Comparing Intaoperative Intravenous Sodium Fluorescein to Pre-Operative Oral Phenazopyridine For Evaluation of Ureteral Patency|Recruiting||N/A|88|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:15:02.042942|2017-10-10 22:15:02.042942
NCT02757404|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-29|||May 2016||2016-05-01|April 2016|2016-04-01||||November 2016|Anticipated|2016-11-01||Interventional|||Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity|Impact of Injection Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity|Not yet recruiting||Phase 4|60|Anticipated|Medy-Tox||3|||f||||f||||||||Undecided||2017-10-10 22:15:02.19302|2017-10-10 22:15:02.19302
NCT02757391|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-05|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||T Cell Immunotherapy Plus Anti-PD1 Antibody in Advanced Solid Malignancies|Pilot Study of Feasibility and Safety of Personalized Autologous Cluster of Differentiation 8 (CD8+) T Cell Therapy Plus Anti-PD1Antibody in Advanced Solid Malignancies|Not yet recruiting||Phase 1|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:15:02.352951|2017-10-10 22:15:02.352951
NCT02757378|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-27|||May 2015||2015-05-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Manual Therapy as a Form of Sensory Discrimination in Chronic Low Back Pain|A Randomized Controlled Trial of Manual Therapy as a Form of Sensory Discrimination in Chronic Low Back Pain|Completed||N/A|62|Actual|St. Ambrose University||2|||f||||f||||||||No||2017-10-10 22:15:03.207076|2017-10-10 22:15:03.207076
NCT02757365|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-27|||April 2014||2014-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer||Recruiting||Phase 4|100|Anticipated|West China Hospital||4|||f||||||||||||||2017-10-10 22:15:03.369183|2017-10-10 22:15:03.369183
NCT02757352|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-10-02|||August 2016||2016-08-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|June 2018|Anticipated|2018-06-01||Interventional|COAST-X||A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis|A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis|Recruiting||Phase 3|305|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:15:03.516253|2017-10-10 22:15:03.516253
NCT02757339|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-31|||June 2015||2015-06-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and Neglect|Evaluating the Neurobiological Basis of Traumatic Dissociation in a Cross-Diagnostic Sample of Women With Histories of Childhood Abuse and Neglect|Enrolling by invitation||N/A|150|Anticipated|Mclean Hospital|||2||f||||f||||||Samples With DNA|"     Study participatants will provide a 2mm saliva sample.   "|||2017-10-10 22:15:04.183136|2017-10-10 22:15:04.183136
NCT02757326|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-02-21|||December 13, 2016|Actual|2016-12-13|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|ABC-103||ABC294640 in Refractory / Relapsed Multiple Myeloma|A Phase Ib/II Safety and Efficacy Study of ABC294640 in Patients With Refractory or Relapsed Multiple Myeloma Who Have Previously Been Treated With Proteasome Inhibitors and Immunomodulatory Drugs|Recruiting||Phase 1/Phase 2|74|Anticipated|RedHill Biopharma Limited||1|||f||||t||||||||No||2017-10-10 22:15:04.315429|2017-10-10 22:15:04.315429
NCT02757313|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-15|||October 2016||2016-10-01|June 2017|2017-06-01||||May 2020|Anticipated|2020-05-01||Interventional|MJDriving||Neuroscience of Marijuana Impaired Driving|Neuroscience of Marijuana Impaired Driving|Recruiting||N/A|96|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 22:15:04.459155|2017-10-10 22:15:04.459155
NCT02757300|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-02|||May 2016||2016-05-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Mucosal Injury Using Pharyngeal Packing|Incidence of Mucosal Injury Using Pharyngeal Packing in Surgery of the Nasal Sinuses|Not yet recruiting||N/A|2|Anticipated|Marienhospital Osnabrück||2|||f||||f||||||||Undecided||2017-10-10 22:15:04.645657|2017-10-10 22:15:04.645657
NCT02757287|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-09-28|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors|Desogestrel and Corifollitropin Treatment for Ovarian Stimulation in Donors|Suspended||Phase 4|35|Anticipated|Institut Universitari Dexeus||1||Lack of financial support|f||||f||||||||||2017-10-10 22:15:04.748456|2017-10-10 22:15:04.748456
NCT02757274|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-07-25|||February 22, 2017|Actual|2017-02-22|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|July 2022|Anticipated|2022-07-01|5 Years|Observational [Patient Registry]|||Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence|Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence in Multiple European Centres|Recruiting||N/A|500|Anticipated|European Association of Urology Research Foundation|||1||f||||f||||||||||2017-10-10 22:15:04.862676|2017-10-10 22:15:04.862676
NCT02757261|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-27|||June 2016||2016-06-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|Bruxism||Evaluation of Muscle Activity, Bite Force and Salivary Cortisol in Children With Bruxism|Evaluation of Muscle Activity, Bite Force and Salivary Cortisol in Children With Bruxism Before and After Laser Use of Low Power in Acupoints- Controlled Clinical Trial|Not yet recruiting||Early Phase 1|76|Anticipated|University of Nove de Julho||4|||f||||t||||||||No||2017-10-10 22:15:05.018957|2017-10-10 22:15:05.018957
NCT02757248|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-11-29|||November 2016||2016-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL|A Phase I Trial of Volasertib Plus Romidepsin in Patients With Relapsed/Refractory Peripheral T Cell and Cutaneous T Cell Lymphoma|Withdrawn||Phase 1|0|Actual|Duke University||5||Boehringer Ingelheim is discontinuing their volasertib development program|f||||t||||||||No||2017-10-10 22:15:05.147109|2017-10-10 22:15:05.147109
NCT02757235|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-10-04|||March 2016||2016-03-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SIC!||The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural Hematoma|The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural Hematoma - A Multicenter Randomised Controlled Trial|Recruiting||N/A|600|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-10 22:15:05.252637|2017-10-10 22:15:05.252637
NCT02757222|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-02|||January 2016||2016-01-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|INTELHOPE||Dose Escalation Versus Standard in Laryngopharyngeal Cancers|Intensifying Radiation Treatment in Advanced/ Poor Prognosis Laryngeal, Hypopharyngeal (LH) and Oropharyngeal Cancers (OPC) Using PET -CT Based Dose Escalation Strategies ( INTELHOPE)|Recruiting||Phase 1/Phase 2|100|Anticipated|Tata Medical Center||2|||f||||t||||||||Undecided|Once appropriate authorities approach and once clearance of local authorities is received, data could be shared|2017-10-10 22:15:05.427088|2017-10-10 22:15:05.427088
NCT02757209|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-01-31|||April 2016||2016-04-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PMC-101-APT||Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD|STUDY NUMBER: PMC-101-APT Usability and Adherence of Spiromax® Inhaler Device, Turbohaler® and Diskus® Inhaler Devices for Fixed Combination of Corticosteroid/Long-acting beta2- Agonist, in Adults With Asthma or COPD|Recruiting||N/A|84|Anticipated|Consorzio Futuro in Ricerca||3|||f||||f||||||||Undecided||2017-10-10 22:15:05.572074|2017-10-10 22:15:05.572074
NCT02757196|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of ITP With Rituximab and / or Accutane|Rituximab Plus Short-term Methylprednisolone Versus Standard Dose Methylprednisolone in Newly Diagnosed Participants With Immune Thrombocytopenia (ITP): A Multicenter, Randomized Phase II Study in China|Not yet recruiting||Phase 2|112|Anticipated|Peking University People's Hospital||2|||f||||t||||||||No||2017-10-10 22:15:05.705271|2017-10-10 22:15:05.705271
NCT02757183|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-05-11|||April 2016||2016-04-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Observational|||Do Patient-Centric mHealth Programs Improve Patient Engagement and Health Outcomes.|Do Patient-Centric mHealth Programs Improve Patient Engagement and Health Outcomes.|Recruiting||N/A|20|Anticipated|AnalyticsPlus, Inc.|||1||f||||f||||||||Undecided||2017-10-10 22:15:05.821296|2017-10-10 22:15:05.821296
NCT02757170|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-27|||July 2015||2015-07-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using Thromboelastography|Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using Thromboelastography|Recruiting||Phase 4|180|Anticipated|All India Institute of Medical Sciences, New Delhi||4|||f||||t||||||||Undecided||2017-10-10 22:15:05.905168|2017-10-10 22:15:05.905168
NCT02757157|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-02-06|||October 2016||2016-10-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD)|Determining the Metabolic Load of Walking in Water Compared to Walking on Land in People With COPD, Who Are Normal Weight and Obese, Compared to Peak Exercise Metabolic Response: a Prospective, Randomised Cross-over Pilot Trial|Recruiting||N/A|20|Anticipated|European Respiratory Society||2|||f||||t||||||||No||2017-10-10 22:15:06.004689|2017-10-10 22:15:06.004689
NCT02757144|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-23|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers|A Dose Block-randomized, Double-blind, Placebo- and Active-controlled, Single and Multiple Dosing, Dose-escalation Clinical Phase 1 Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|120|Anticipated|Daewoong Pharmaceutical Co. LTD.||14|||f||||f||||||||||2017-10-10 22:15:06.112908|2017-10-10 22:15:06.112908
NCT02757131|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-09|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Dedicated Ambulator-assisted Physical Activity to Improve Hospital Outcome Measures in Elderly Patients|Dedicated Ambulator-assisted Physical Activity to Improve Hospital Outcome Measures in Elderly Patients: A Randomized, Controlled Trial|Completed||N/A|102|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 22:15:06.224299|2017-10-10 22:15:06.224299
NCT02757118|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-27|||May 2016||2016-05-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for Cardiac Surgery|Impact of Intravascular Fluid Resuscitation on Whole Blood Viscosity During Cardiac Surgery|Not yet recruiting||N/A|30|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:15:06.313255|2017-10-10 22:15:06.313255
NCT02757105|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-06-10|||April 2016||2016-04-01|November 2016|2016-11-01||||July 2017|Anticipated|2017-07-01||Interventional|||Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)|Randomized, Double-blind, Placebo-controlled, Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)|Active, not recruiting||Phase 2|120|Anticipated|RedHill Biopharma Limited||2|||f||||f||||||||No||2017-10-10 22:15:06.385144|2017-10-10 22:15:06.385144
NCT02757092|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-08-16|||April 2016||2016-04-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|PR||The Impacts of Pulmonary Rehabilitation Therapy on Patients After Thoracic Surgery||Recruiting||N/A|120|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:15:06.502739|2017-10-10 22:15:06.502739
NCT02757079|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|NPC-15-6||Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders|Phase III Clinical Trial of NPC-15 - Study of the Efficacy and Safety for Sleep Disorders of Children With Neurodevelopmental Disorders -|Not yet recruiting||Phase 3|100|Anticipated|Nobelpharma||1|||f||||f||||||||Undecided||2017-10-10 22:15:06.605263|2017-10-10 22:15:06.605263
NCT02757066|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|NPC-15-5||Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders|Phase II/III Clinical Trial of NPC-15 - Verification of the Efficacy for Sleep Disorders of Children With Autism Spectrum Disorders -|Not yet recruiting||Phase 2/Phase 3|180|Anticipated|Nobelpharma||3|||f||||f||||||||Undecided||2017-10-10 22:15:06.694664|2017-10-10 22:15:06.694664
NCT02757053|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-08-08|||April 2016||2016-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Screening Brain MRI in High School Football: Does the Guardian Cap Reduce the Risk of Traumatic Brain Injury|Screening Brain MRI in High School Football: What is the Risk of Traumatic Brain Injury and Does the Guardian Cap Reduce the Incidence of Injury as Determined by Fluid-attenuated Inversion Recovery (FLAIR) and Susceptibility Weighted Imaging (SWI) Magnetic Resonance Imaging (MRI) Sequences|Completed||N/A|8|Actual|Mosaic Life Care||2|||f||||t||||||||Yes|Plan to share data with MRI results of individual exams with the patient and plan to publish in peer reviewed journal|2017-10-10 22:15:06.795231|2017-10-10 22:15:06.795231
NCT02757040|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-27|||December 2016||2016-12-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination of Ibrutinib and As2O3 in the Treatment of CLL|Combination of Ibrutinib and As2O3 in the Treatment of CLL|Not yet recruiting||Phase 3|70|Anticipated|Peking University People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:15:06.887408|2017-10-10 22:15:06.887408
NCT02757027|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-28|||May 2016||2016-05-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity for CABG Surgery|Impact of Intravascular Fluid Resuscitation on Whole Blood Viscosity During CABG Surgery|Not yet recruiting||N/A|30|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:15:07.067049|2017-10-10 22:15:07.067049
NCT02757014|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-28|||October 2015||2015-10-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SPF Assay||18613 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment - Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:15:07.141959|2017-10-10 22:15:07.141959
NCT02757001|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-05-12|||June 2016||2016-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01|12 Months|Observational [Patient Registry]|REFiVeC||Inferior Vena Cava Retrievable Filters: Spanish Register|Inferior Vena Cava Retrievable Filters: Spanish Register (REFiVeC)|Not yet recruiting||N/A|200|Anticipated|Group of Research in Minimally Invasive Techniques|||1||f||||t||||||||||2017-10-10 22:15:07.229775|2017-10-10 22:15:07.229775
NCT02756988|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-28|||October 2015||2015-10-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SPF Assay||18615 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment - Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:15:07.302333|2017-10-10 22:15:07.302333
NCT02756975|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-27|||December 2014||2014-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|Prostate||Prostate Core Needle Biopsy||Completed||N/A|240|Actual|Modarres Hospital||2|||f||||f||||||||No||2017-10-10 22:15:07.385737|2017-10-10 22:15:07.385737
NCT02756962|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-14|||July 6, 2016|Actual|2016-07-06|September 2017|2017-09-01|July 31, 2024|Anticipated|2024-07-31|July 31, 2024|Anticipated|2024-07-31||Interventional|||Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance|Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance|Recruiting||Phase 2|43|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 22:15:07.49995|2017-10-10 22:15:07.49995
NCT02756949|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-28|||October 2015||2015-10-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|SmartLtC||Smart Linkage-to-HIV Care Via a Smartphone App|Do Smartphones Increase Linkage to and Retention in Care in Newly Diagnosed HIV-positive Patients in Johannesburg, South Africa: A Multisite Randomised Controlled Trial|Recruiting||N/A|350|Anticipated|World Bank||2|||f||||f||||||||No||2017-10-10 22:15:07.689112|2017-10-10 22:15:07.689112
NCT02756936|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-02-27|||February 2016||2016-02-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Bioequivalence Study of Daclatasvir From Daclatasvir Zeta 60 mg Film Coated Tablets (Zeta Pharm Pharmaceutical Industries, Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)|Open Label, Randomized, Single Dose, Two-way Crossover Bioequivalence Study of Daclatasvir From Daclatasvir Zeta 60 mg Film Coated Tablets (Zeta Pharm Pharmaceutical Industries, Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK) in Healthy Human Volunteers Under Fasting Condition.|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||Undecided||2017-10-10 22:15:07.803199|2017-10-10 22:15:07.803199
NCT02756884|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-12-12|||April 2016||2016-04-01|December 2016|2016-12-01||||April 2018|Anticipated|2018-04-01||Interventional|||Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in Peripheral Arterial Disease|Phase I/Phase II Safety and Preliminary Efficacy Study Using Low Frequency Ultrasound in Addition to Adipose Derived Stem Cells (ADSCs) in Patients With Moderate to Severe Lower Extremity Peripheral Arterial Disease (PAD)|Recruiting||Phase 1|10|Anticipated|Arkansas Heart Hospital||2|||f||||f||||||||No||2017-10-10 22:15:08.251277|2017-10-10 22:15:08.251277
NCT02756871|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-27|||July 2015||2015-07-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Overcoming Perfectionism: A Randomised Controlled Trial of an Online CBT Based Guided Self-help Intervention|Overcoming Perfectionism: A Randomised Controlled Trial of an Online CBT Based Guided Self-help Intervention|Recruiting||N/A|173|Anticipated|Institute of Child Health||2|||f||||f||||||||Undecided||2017-10-10 22:15:08.394376|2017-10-10 22:15:08.394376
NCT02756858|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-04-27|||March 2016||2016-03-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease|An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease|Enrolling by invitation||Phase 2|32|Anticipated|Anavex Life Sciences Corp.||1|||f||||t||||||||Yes|Study results will be presented at a scientific conference and/or published.|2017-10-10 22:15:08.545786|2017-10-10 22:15:08.545786
NCT02756845|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-20|||August 16, 2017|Actual|2017-08-16|September 2017|2017-09-01|December 20, 2021|Anticipated|2021-12-20|February 4, 2020|Anticipated|2020-02-04||Interventional|||Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors|A Phase 1, Multi-center, Open-label, Dose De-escalation Study to Evaluate the Safety and Efficacy of Talimogene Laherparepvec in Pediatric Subjects With Advanced Non Central Nervous System Tumors That Are Amenable to Direct Injection|Recruiting||Phase 1|18|Anticipated|Amgen||1|||f||||t|t|f||||||||2017-10-10 22:15:08.641525|2017-10-10 22:15:08.641525
NCT02756832|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-11|||September 20, 2016|Actual|2016-09-20|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Local, Multicenter, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2|Local, Multicentre, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Patients With Diabetes Mellitus Type 2|Recruiting||N/A|1403|Anticipated|Takeda|||1||f||||f||||||||||2017-10-10 22:15:08.767257|2017-10-10 22:15:08.767257
NCT02756806|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-09|||April 2016||2016-04-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Evaluation for Tattoo Removal|A Clinical Evaluation of a Novel Multi-Wavelength Laser for Tattoo Removal|Terminated||N/A|7|Actual|Cutera Inc.||1||Change protocol to include multiple sites.|f||||f||||||||Undecided||2017-10-10 22:15:09.001565|2017-10-10 22:15:09.001565
NCT02756793|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-07-06|||October 2016||2016-10-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Stereotactic Radiotherapy for Oligo-Progressive Non-Small Cell Lung Cancer (STOP-NSCLC)|Stereotactic Radiotherapy for Oligo-Progressive Non-Small Cell Lung Cancer (STOP-NSCLC): A Randomized Phase II Trial|Recruiting||N/A|54|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-10 22:15:09.10597|2017-10-10 22:15:09.10597
NCT02756780|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-28|||April 2016||2016-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer|Tenovus Cancer Choirs: the Effect of Choir Singing on Psychological and Immune Responses of Cancer Patients, Staff and Carers|Recruiting||N/A|420|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:15:09.254825|2017-10-10 22:15:09.254825
NCT02756767|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-12-06|||April 2016||2016-04-01|December 2016|2016-12-01||||April 2021|Anticipated|2021-04-01||Observational|||Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology|Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology|Recruiting||N/A|200|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-10 22:15:09.403046|2017-10-10 22:15:09.403046
NCT02756754|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-08-16|||September 2016||2016-09-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ADERADHTA||Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism|Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism: Evaluation of the Blood Pressure Control and of Its Safety.|Not yet recruiting||N/A|25|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||No||2017-10-10 22:15:09.527207|2017-10-10 22:15:09.527207
NCT02756741|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-27|||April 2014||2014-04-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Standard Dose Versus Once a Day Intravenous Albumin in Spontaneous Bacterial Peritonitis|Assessment of Cytokine Profile in an Open Labeled Randomized Controlled Trial of Standard Dose vs. Once a Day Intravenous Albumin in Patients With Spontaneous Bacterial Peritonitis|Completed||N/A|40|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||Yes||2017-10-10 22:15:09.657453|2017-10-10 22:15:09.657453
NCT02756728|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-12-12|||May 2016||2016-05-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma|A Randomized Phase I/II Study of BI-505 in Conjunction With High-dose Melphalan and Autologous Stem Cell Transplantation for Multiple Myeloma|Terminated||Phase 1/Phase 2|5|Actual|BioInvent International AB||2||Full clinical hold from FDA|f||||f||||||||No||2017-10-10 22:15:09.750924|2017-10-10 22:15:09.750924
NCT02756715|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-02|||February 2016||2016-02-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effect of Anesthetics Agents on Vascular Injury and Level of Syndecan-1 During Knee Surgery|The Effect of Anesthetics Agents on Vascular Injury and Level of Syndecan-1 During Knee Surgery|Recruiting||N/A|100|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:15:09.875183|2017-10-10 22:15:09.875183
NCT02756702|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-12-06|||March 2016||2016-03-01|December 2016|2016-12-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|APT-VEGA_KI||All Polyethylene Tibia-VEGA Kiel|Prospective Observational 5 Year Follow-up on a Consecutive Cohort of 70 Primary Total Knee Arthroplasty (TKA) Cases Treated With All-polyethylene Tibia (APT) Components of the Posterior-stabilized VEGA System PS|Recruiting||N/A|70|Anticipated|Aesculap AG|||1||f||||f||||||||No||2017-10-10 22:15:09.984435|2017-10-10 22:15:09.984435
NCT02756689|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-19|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|OFFSITE||Outpatient Foley For Starting Induction of Labor at TErm|Outpatient Foley for Starting Induction of Labor at Term|Recruiting||N/A|128|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 22:15:10.169088|2017-10-10 22:15:10.169088
NCT02756676|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-04-03|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Impact of Rehabilitation in Quality of Life in PD|Impact of an Intensive Multi-Disciplinary Rehabilitation Treatment on Quality Of Life in Subjects With Parkinson's Disease|Completed||N/A|250|Actual|Ospedale Generale Di Zona Moriggia-Pelascini||1|||f||||f||||||||No||2017-10-10 22:15:10.31859|2017-10-10 22:15:10.31859
NCT02756663|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-11-07|||December 2016||2016-12-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|PANORAMA-5||Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma|A Randomized, Triple-arm, Controlled, Open-label, Multicenter Phase II Study Assessing Two Different Doses of Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma|Withdrawn||Phase 2|0|Actual|Novartis||3|||f||||t||||||||||2017-10-10 22:15:10.437442|2017-10-10 22:15:10.437442
NCT02756650|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-07-11|||June 2016||2016-06-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|Behcet||1 Year Canakinumab Treatment in Behcet's Disease Patients With Neurologic or Vascular Involvement|An Open Label, Exploratory Study to Establish the Efficacy and Safety of 1 Year Canakinumab Treatment in Behcet's Disease Patients With Neurologic or Vascular Involvement|Recruiting||Phase 2|10|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 22:15:10.564172|2017-10-10 22:15:10.564172
NCT02756637|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-02-27|2016-12-02||April 2016||2016-04-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational||Prognostic Cohort: Eligible for SWOG 8710, had NLR and completed curative treatment Predicitive Cohort: Eligible for SWOG 8710, had NLR and were assigned to a trial arm.|Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710|Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710|Completed||N/A|634|Actual|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-10 22:15:10.686197|2017-10-10 22:15:10.686197
NCT02756624|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-05|2017-06-27||April 2016||2016-04-01|September 2017|2017-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution|A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution|Completed||Phase 3|516|Actual|Nicox Ophthalmics, Inc||2|||f||||f||||||||||2017-10-10 22:15:11.041491|2017-10-10 22:15:11.041491
NCT02756598|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-01-24|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01||Interventional|SATA-1||Stress, Anxiety and Type A Personality and Analgesics|Stress, Anxiety and Type A Personality and Analgesics. Impact on Induction Time and Consumption of Analgesics During Cardiac Surgery|Enrolling by invitation||Phase 4|60|Actual|Aarhus University Hospital||2|||f||||f||||||||No||2017-10-10 22:15:11.992662|2017-10-10 22:15:11.992662
NCT02756585|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-28|||September 2016||2016-09-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Computed Tomography Perfusion in Patients With Severe Head Injury|Computed Tomography Perfusion in Patients With Severe Head Injury|Not yet recruiting||N/A|50|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||No||2017-10-10 22:15:12.083929|2017-10-10 22:15:12.083929
NCT02756572|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-07-26|||September 22, 2016|Actual|2016-09-22|July 2017|2017-07-01||||May 1, 2018|Anticipated|2018-05-01||Interventional|||Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms|A Feasibility Study of ?Early? Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory High-Grade Myeloid Neoplasms|Recruiting||N/A|30|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-10 22:15:12.185895|2017-10-10 22:15:12.185895
NCT02756559|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-29|||January 2014||2014-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||MiRNAs Evaluating Lymphocyte Proliferation and Apoptosis as Well as Prognosis of Sepsis||Recruiting||N/A|100|Anticipated|Chinese PLA General Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:15:12.419552|2017-10-10 22:15:12.419552
NCT02756546|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-27|||September 2014||2014-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis|Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis|Completed||Phase 1/Phase 2|100|Actual|Cairo University||2|||f||||f||||||||Yes|Publication|2017-10-10 22:15:12.50537|2017-10-10 22:15:12.50537
NCT02756533|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-02-01|||August 2016||2016-08-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|EXA-VNI2||Impact of a Telemonitoring Program on the Rate of Hospitalizations for Worsening of Cardio-respiratory Symptoms in COPD Patients Treated at Home by Long-term Non-invasive Ventilation (NIV)|Impact of a Telemonitoring Program on the Rate of Hospitalizations for Worsening of Cardio-respiratory Symptoms in COPD Patients Treated at Home by Long-term Non-invasive Ventilation (NIV): a Randomized Controlled Trial|Recruiting||N/A|140|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||No||2017-10-10 22:15:12.58024|2017-10-10 22:15:12.58024
NCT02756520|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-10-10|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)|Characterisation of Patient Profile and Contemporary Treatment of Pre-dialytic Chronic Kidney Disease (CKD) in Patients Receiving a Restricted Protein Diet Supplemented With Ketosteril® - a Drug Utilisation Study (DUS)|Recruiting||N/A|180|Anticipated|Fresenius Kabi|||1||f||||f||||||||||2017-10-10 22:15:12.686451|2017-10-10 22:15:12.686451
NCT02756507|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-07-24|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Transdiagnostic REBT Prevention Program for Adolescents|The Efficacy of a Video-based Transdiagnostic REBT Universal Prevention Program Delivered in a School Context for Internalizing Problems in Adolescents|Recruiting||N/A|338|Anticipated|Babes-Bolyai University||2|||f||||t||||||||||2017-10-10 22:15:12.81581|2017-10-10 22:15:12.81581
NCT02756494|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||Ischemic Stroke in Chinese Young Adults|Some Biomarkers Underlying in Ischemic Stroke in Chinese Young Adults: a Protocol for a Case-control Clinical Trial|Not yet recruiting||N/A|200|Anticipated|Beijing Chao Yang Hospital|||2||f||||t||||||||Undecided||2017-10-10 22:15:12.924692|2017-10-10 22:15:12.924692
NCT02756481|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-04-27|||October 2013||2013-10-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela|Treatment Patterns of Care for Patients With Atrial Fibrillation In Venezuela|Completed||N/A|80|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:15:12.994984|2017-10-10 22:15:12.994984
NCT02756468|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-28|||January 2015||2015-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01|2 Years|Observational [Patient Registry]|PREDIPS||Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study|Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study|Recruiting||N/A|100|Anticipated|University of Roma La Sapienza|||1||f||||t||||||||No||2017-10-10 22:15:13.072353|2017-10-10 22:15:13.072353
NCT02756455|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-28|||January 2015||2015-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01|2 Years|Observational [Patient Registry]|||Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS Study|Procalcitonin Reveals Early Dehiscence In Gastric Surgery: the PREDIGS Study|Recruiting||N/A|100|Anticipated|University of Roma La Sapienza|||1||f||||t||||||||No||2017-10-10 22:15:13.156159|2017-10-10 22:15:13.156159
NCT02756442|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Respiratory Disorder During Sleep in the Pregnancy : A Risk Factor in Gestational Diabetese||Active, not recruiting||N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 22:15:13.245251|2017-10-10 22:15:13.245251
NCT02756429|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-05-04|||February 2014||2014-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|REMI-2||Quantification of Endothelial Thrombogenicity in Patients With Atrial Fibrillation||Recruiting||N/A|200|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 22:15:13.32827|2017-10-10 22:15:13.32827
NCT02756416|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-07-25|||July 2016||2016-07-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome|Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome|Not yet recruiting||N/A|10|Anticipated|University of Nottingham||1|||f||||f||||||||Undecided||2017-10-10 22:15:13.415279|2017-10-10 22:15:13.415279
NCT02756403|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions|A Randomized Controlled Trial of Three Prophylactic Antibiotic Regimens for First Trimester Surgical Abortion|Completed||N/A|180|Actual|Medstar Health Research Institute||4|||f||||f||||||||||2017-10-10 22:15:13.524512|2017-10-10 22:15:13.524512
NCT02756390|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-08-31|||December 2015||2015-12-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors|CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors|Recruiting||N/A|60|Anticipated|Dana-Farber Cancer Institute||2|||f||||f||||||||No||2017-10-10 22:15:13.621193|2017-10-10 22:15:13.621193
NCT02756377|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-29|||May 2014||2014-05-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||A Comparison of Mouth Rinse Containing Alcohol-free Chlorhexidine With a Cetylpyridinium Chloride in Periodontal Diseases|A Comparison of Mouth Rinse Containing Alcohol-free Chlorhexidine With a Cetylpyridinium Chloride in Periodontal Diseases (A Randomized, Double-blind Clinical Trials)|Completed||Phase 2/Phase 3|34|Actual|Islamic Azad University, Tehran||2|||f||||t||||||||No||2017-10-10 22:15:13.720789|2017-10-10 22:15:13.720789
NCT02756364|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-06-05|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||MLN0128 in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy|An Open-Label Phase 2 Study of MLN0128 (A TORC1/2 Inhibitor) in Combination With Fulvestrant in Women With ER-Positive/HER2-Negative Advanced or Metastatic Breast Cancer That Has Progressed During or After Aromatase Inhibitor Therapy|Recruiting||Phase 2|153|Anticipated|Takeda||3|||f||||f|t|f||||||||2017-10-10 22:15:13.802923|2017-10-10 22:15:13.802923
NCT02756351|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-12-08|2016-12-08||April 2016||2016-04-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||A Efficacy and Safety Study of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization|A Double-blinded Randomized Clinical Pilot Trial of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization|Completed||N/A|48|Actual|CytaCoat AB||2|||f||||||||||||||2017-10-10 22:15:13.962495|2017-10-10 22:15:13.962495
NCT02756325|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-01-17|||June 2016||2016-06-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Quantitative MRI for Functional Imaging of the Testis: A New Methodology for Evaluation of the Infertile Male|Quantitative MRI for Functional Imaging of the Testis: A New Methodology for Evaluation of the Infertile Male|Enrolling by invitation||N/A|20|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 22:15:14.325688|2017-10-10 22:15:14.325688
NCT02756312|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-07-14|||July 15, 2017|Actual|2017-07-15|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||The Perioperative Anesthetic Management and the Prognosis of Patients Undergoing Brain Malignant Glioma Resection|The Effect of Anesthetic Management on the Outcome of Patients With Brain Tumors.|Recruiting||N/A|500|Anticipated|Beijing Tiantan Hospital||2|||f||||t|f|f||||||||2017-10-10 22:15:14.393021|2017-10-10 22:15:14.393021
NCT02756299|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-28|||June 2014||2014-06-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Patient Education and PAP Compliance in OSA|Patient Education and PAP Compliance in OSA|Completed||N/A|115|Actual|Marmara University||2|||f||||f||||||||No||2017-10-10 22:15:14.481135|2017-10-10 22:15:14.481135
NCT02756286|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-05-12|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|NAT-II||Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD|Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD|Recruiting||N/A|240|Anticipated|Think Now Incorporated|||2||f||||f||||||||||2017-10-10 22:15:14.555175|2017-10-10 22:15:14.555175
NCT02756273|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-08-03|||May 2016||2016-05-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|July 2018|Anticipated|2018-07-01||Interventional|IBIP||Impact of a Bridge Device on the Loop Ileostomy|Impact of a Bridge Device on the Loop Ileostomy|Recruiting||Phase 2|134|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||No||2017-10-10 22:15:14.646727|2017-10-10 22:15:14.646727
NCT02756260|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-06-21|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:15:14.747991|2017-10-10 22:15:14.747991
NCT02756247|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-31|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma|Phase Ib Clinical Trial of Buparlisib and Ibrutinib in Mantle Cell Lymphoma, Follicular Lymphoma and Diffuse Large B Cell Lymphoma|Recruiting||Phase 1|60|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:15:14.793328|2017-10-10 22:15:14.793328
NCT02756234|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-10-03|||May 1, 2016|Actual|2016-05-01|October 2017|2017-10-01|April 30, 2018|Anticipated|2018-04-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting|Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting|Recruiting||N/A|19|Anticipated|Lancaster General Hospital|||1||f||||t||||||||||2017-10-10 22:15:14.912356|2017-10-10 22:15:14.912356
NCT02756221|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-26|||March 2016||2016-03-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Probiotic Supplementation and Endurance Performance in Cyclists and Masters Runners|The Effect of Probiotic Supplementation on the Incidence of Gastrointestinal (GI) Tract and Upper Respiratory System Symptoms and the Endurance Exercise Performance in Masters Runners and Elite Cyclists|Recruiting||N/A|90|Anticipated|Tel Hai College||2|||f||||t||||||||Yes|Anonymous individual subjects data for all outcome measures will be made available within 12 months of study completion|2017-10-10 22:15:14.989005|2017-10-10 22:15:14.989005
NCT02756208|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2017-08-02|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FLSC-001||A Safety and Immunogenicity Trial of IHV01|A Phase I Safety and Immunogenicity Trial of IHV01 in HIV-1 Uninfected Volunteers|Active, not recruiting||Phase 1|60|Anticipated|University of Maryland||6|||f||||t|t|||||||||2017-10-10 22:15:15.093147|2017-10-10 22:15:15.093147
NCT02756195|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-07|||November 2016||2016-11-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|1 Month|Observational [Patient Registry]|||The Impact of Non-Routine Events on Neonatal Safety|The Impact of Non-Routine Events on Neonatal Safety in the Perioperative Environment|Recruiting||N/A|500|Anticipated|Vanderbilt University Medical Center|||1||f||||t||||||||No|Individual participant data will not be shared. Only aggregate de-identified data will be disseminated.|2017-10-10 22:15:15.206564|2017-10-10 22:15:15.206564
NCT02756182|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-09-06|||April 2016||2016-04-01|September 2016|2016-09-01||||November 2016|Anticipated|2016-11-01||Interventional|AvW (Bonn)||Air vs Water Catheters|Comparison of Air-Charged and Water-Perfused Catheters for Use in Urodynamic|Enrolling by invitation||N/A|25|Anticipated|Laborie Medical Technologies Inc.||1|||f||||f||||||||No||2017-10-10 22:15:15.294442|2017-10-10 22:15:15.294442
NCT02756156|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-26|||April 2016||2016-04-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Low Dose Interscalene and Infraclavicular Block for Humerus Surgery|Low Dose Interscalene and Infraclavicular Block for Humerus Surgery|Not yet recruiting||N/A|30|Anticipated|Kahramanmaras Sutcu Imam University|||1||f||||f||||||||No||2017-10-10 22:15:15.62559|2017-10-10 22:15:15.62559
NCT02756143|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-28|||November 2014||2014-11-01|April 2016|2016-04-01||||November 2016|Anticipated|2016-11-01||Interventional|||Exercise During Pregnancy and Perinatal Outcome|Exercise During Pregnancy and Perinatal Outcome. Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|University Hospital of Torrejon||2|||f||||f||||||||No||2017-10-10 22:15:15.710451|2017-10-10 22:15:15.710451
NCT02756130|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-01-20|||January 2017||2017-01-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|July 2019|Anticipated|2019-07-01||Interventional|||Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas|A Phase II, Single Center, Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Participants With Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas|Not yet recruiting||Phase 2|34|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-10 22:15:15.842104|2017-10-10 22:15:15.842104
NCT02756104|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-29|||May 2016||2016-05-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|VITALS||T Cell Phenotypes in Amyotropic Lateral Sclerosis (ALS), Influence of Vitamin D|T Cell Phenotypes in ALS, Influence of Vitamin D|Not yet recruiting||N/A|97|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||Yes|The investigator communicate the global results on demand|2017-10-10 22:15:16.030347|2017-10-10 22:15:16.030347
NCT02756091|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-05-08|||August 2016||2016-08-01|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|November 2021|Anticipated|2021-11-01|12 Months|Observational [Patient Registry]|I-IDIS||International Intracranial Dissection Study|International Intracranial Artery Dissection Study|Recruiting||N/A|500|Anticipated|University Hospital Inselspital, Berne|||1||f||||||||||||||2017-10-10 22:15:16.117723|2017-10-10 22:15:16.117723
NCT02756078|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-08-15|||April 1, 2016|Actual|2016-04-01|August 2017|2017-08-01|October 3, 2017|Anticipated|2017-10-03|October 3, 2017|Anticipated|2017-10-03||Interventional|||Clinical Performance Evaluation of Two Silicone Hydrogel Lenses||Active, not recruiting||N/A|140|Anticipated|Johnson & Johnson Vision Care, Inc.||2|||f|||||f|t|f|f|t|||||2017-10-10 22:15:16.257192|2017-10-10 22:15:16.257192
NCT02756065|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-08-16|||September 2014||2014-09-01|August 2016|2016-08-01|September 2023|Anticipated|2023-09-01|June 2019|Anticipated|2019-06-01||Observational|||Connectomics in Psychiatric Classification of Bipolar Disorder and Schizophrenia|Connectomics in Psychiatric Classification|Recruiting||N/A|220|Anticipated|Washington University Early Recognition Center|||3||f||||f||||||Samples With DNA|"     saliva   "|No||2017-10-10 22:15:16.35581|2017-10-10 22:15:16.35581
NCT02756052|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-08-22|||January 2016||2016-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Enhancing Laparoscopic Skill Acquisition and Retention With Transcranial Direct-current Stimulation|Enhancing Laparoscopic Skill Acquisition and Retention With Transcranial Direct-current Stimulation|Active, not recruiting||N/A|48|Anticipated|University of Calgary||4|||f||||f||||||||No||2017-10-10 22:15:16.475273|2017-10-10 22:15:16.475273
NCT02756039|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-09-22|||May 25, 2016|Actual|2016-05-25|September 2017|2017-09-01|June 25, 2019|Anticipated|2019-06-25|February 28, 2019|Anticipated|2019-02-28||Observational|||Tagrisso Tablets Clinical Experience Investigation (All Case Investigation)|Tagrisso Tablets Clinical Experience Investigation (All Case Investigation)|Active, not recruiting||N/A|3494|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 22:15:16.59406|2017-10-10 22:15:16.59406
NCT02756026|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-26|||September 2013||2013-09-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Assessing the Quality of Breast Milk|Assessing the Quality of Breast Milk|Completed||N/A|19|Actual|USDA, Western Human Nutrition Research Center||1|||f||||f||||||||Undecided||2017-10-10 22:15:16.790983|2017-10-10 22:15:16.790983
NCT02756013|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-09-09|||April 2016||2016-04-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ BSA > 2.0|A Phase II Trial of Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients With a BSA > 2.0|Recruiting||Phase 2|34|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:15:16.909698|2017-10-10 22:15:16.909698
NCT02756000|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-04-28|||January 2016||2016-01-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|MVD||Timing of Complete Revascularization for Multivessel Coronary Artery Disease in STEMI|Appropriate Timing of Complete Revascularization for Multivessel Coronary Artery Disease After Culprit Only Primary Percutaneous Coronary Intervention (PCI) for ST Elevation Myocardial Infarction|Recruiting||N/A|616|Anticipated|Clinical Hospital Center Zemun||3|||f||||t||||||||Undecided||2017-10-10 22:15:17.048515|2017-10-10 22:15:17.048515
NCT02755987|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-06-03||||||June 2016|2016-06-01||||||||Expanded Access|||Expanded Access to ANG1005 for Individual Patients|Expanded Access to ANG1005 for an Individual Patient With Recurrent WHO Grade III Anaplastic Astrocytoma; Expanded Access to ANG1005 for an Individual Patient With Recurrent WHO Grade III Anaplastic Oligodendroglioma; Expanded Access to ANG1005 for an Individual Breast Cancer Patient With Recurrent Brain Metastases and Leptomeningeal Carcinomatosis.|No longer available||N/A|||Angiochem Inc|||||||||||||||||||2017-10-10 22:15:17.209262|2017-10-10 22:15:17.209262
NCT02755974|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-03-08|||January 2009||2009-01-01|March 2016|2016-03-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Observational|EXCEL_Cohort||The London COPD Exacerbation Cohort|Relationship Between Patient Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.|Recruiting||N/A|300|Anticipated|Imperial College London|||1||f||||f||||||Samples With DNA|"     Blood, Sputum, Urine, Bronchoscopy brushing and Lavage fluid, DNA   "|No||2017-10-10 22:15:17.277377|2017-10-10 22:15:17.277377
NCT02755961|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-28|||July 2015||2015-07-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients|A Randomized Controlled Trial to Evaluate the Efficacy of Reducing High-Phosphate Containing Diet Education and Proper Phosphate Binder Intake Education to Serum Phosphate Level Among Maintenance Hemodialysis Patients|Completed||N/A|70|Actual|Ajou University School of Medicine||2|||f||||f||||||||||2017-10-10 22:15:17.357677|2017-10-10 22:15:17.357677
NCT02755948|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-30|||April 2012||2012-04-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers|Cell Mediated Immunity Against RSV and Influenza in a Human Experimental Challenge|Active, not recruiting||N/A|57|Actual|Imperial College London||2|||f||||t||||||||||2017-10-10 22:15:17.443298|2017-10-10 22:15:17.443298
NCT02755935|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-28|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|June 2017|Actual|2017-06-01||Interventional|||CI532 - Early Experience Study|Implantation With the Cochlear Nucleus® CI532 Implant - Early Experience Study|Completed||N/A|24|Actual|Cochlear||1|||f||||f||||||||||2017-10-10 22:15:17.546344|2017-10-10 22:15:17.546344
NCT02755922|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-26|||April 2010||2010-04-01|April 2016|2016-04-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Bone Regeneration With Mesenchymal Stem Cells|Bone Regeneration in Mandibular Fractures After the Application of Autologous Mesenchymal Stem Cells. Randomized Clinical Trial.|Completed||Phase 3|20|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||Yes||2017-10-10 22:15:17.655841|2017-10-10 22:15:17.655841
NCT02755909|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-05-01|||December 2015||2015-12-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Pre-anesthetic Education on Cardiac Surgery Patients' Anxiety Level|The Effect of Pre-anesthetic Education on Patients' Anxiety Level Undergoing Cardiac Surgery|Completed||N/A|36|Actual|Indonesia University||1|||f||||||||||||||2017-10-10 22:15:17.776885|2017-10-10 22:15:17.776885
NCT02755896|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-18|||July 2015||2015-07-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Trial to Compare Radiation Fibrosis With Five Versus Three Fractions|Prone Partial Breast Irradiation (PBI): Prospective Randomized Controlled Non-inferiority Trial to Compare Radiation Fibrosis With Five Versus Three Fractions|Recruiting||N/A|284|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-10 22:15:17.899454|2017-10-10 22:15:17.899454
NCT02755883|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-26|||April 2016||2016-04-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients|Strides For Life I: A Randomized Controlled Trial of Induction of Positive Affect to Increase Physical Activity in Early Stage Lung Cancer Survivors|Enrolling by invitation||N/A|54|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||Undecided||2017-10-10 22:15:18.031449|2017-10-10 22:15:18.031449
NCT02755870|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-04-28|||April 2015||2015-04-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers|A Phase 1 Single-Ascending Dose (SAD) and Multiple- Ascending Dose (MAD) Study of CNM-Au8 in Healthy Male and Female Volunteers|Recruiting||Phase 1|80|Anticipated|Clene Nanomedicine||2|||f||||t||||||||Undecided||2017-10-10 22:15:18.148041|2017-10-10 22:15:18.148041
NCT02755857|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2016-07-19|||July 2016||2016-07-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis|A Single-arm, Multiple-Dose, Steady-State, Bioavailability Study With Twice Daily Dosing of Lozanoc™ (65 mg Itraconazole Capsules, Mayne) Taken Regardless of Food|Not yet recruiting||Phase 2|20|Anticipated|Mayne Pharma International Pty Ltd||1|||f||||f||||||||No|Individual patient data will not be made available|2017-10-10 22:15:18.263305|2017-10-10 22:15:18.263305
NCT02755844|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-26|||April 2016||2016-04-01|April 2016|2016-04-01|November 2019|Anticipated|2019-11-01|April 2018|Anticipated|2018-04-01||Interventional|ENDOLA||Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients|A Phase I/II Trial to Assess the Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Recurrent Advanced/Metastatic Endometrial Cancer Patients|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-10 22:15:18.340272|2017-10-10 22:15:18.340272
NCT02755831|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-09-19|||February 20, 2017|Actual|2017-02-20|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|February 2020|Anticipated|2020-02-01||Interventional|||Targeted CPAP Therapy for OSA in Pregnancy|Randomized Controlled Trial for a Sleep Study and Targeted CPAP Therapy for Obstructive Sleep Apnea to Reduce the Incidence Adverse Pregnancy Related Outcomes|Recruiting||N/A|360|Anticipated|United States Naval Medical Center, San Diego||2|||f||||f|f|t|f|f||||||2017-10-10 22:15:18.451227|2017-10-10 22:15:18.451227
NCT02755818|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-10-28|||October 2008||2008-10-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Study of the Relationship Between Body Composition, Insulin Resistance and HDL Levels|The Independent Effect of Level of Kidney Function and Body Composition On Establishing HDL Cholesterol Levels|Enrolling by invitation||N/A|90|Anticipated|University of California, Davis|||2||f||||f||||||Samples Without DNA|"     whole blood taken separated into plasma, serum, and red cells   "|Yes|once published data will be shared|2017-10-10 22:15:18.569593|2017-10-10 22:15:18.569593
NCT02755805|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-10-20|2016-07-08||July 2009||2009-07-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CO-OP||CO-OPerative Training for Stroke Rehabilitation|CO-OPerative Training For Stroke Rehabilitation: A Phase II Trial Examining Meta-Cognitive Strategy Training in Acute Stroke Rehabilitation|Completed||N/A|30|Actual|University of Pittsburgh||2|||f||||t||||||||No|There is no current plan to share individual participant data at this time.|2017-10-10 22:15:18.673607|2017-10-10 22:15:18.673607
NCT02755792|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-26|||July 2012||2012-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|CALLI-MCI||Calligraphy Writing for Cognitive and Emotional Enhancement Among Older MCI People|Can Chinese Calligraphy Writing Enhance Cognitive Performance and Emotional Calmness in Older Adults With Mild Cognitive Impairment? A RCT Study|Completed||N/A|99|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-10 22:15:19.239711|2017-10-10 22:15:19.239711
NCT02755779|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2016-04-28|||June 2016||2016-06-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Characterization of Breast Masses Incidentally Detected on Chest CT|Characterization of Breast Masses Incidentally Detected on Chest CT - a Prospective Study|Not yet recruiting||N/A|100|Anticipated|Tel Aviv Medical Center|||1||f||||t||||||||No||2017-10-10 22:15:19.328098|2017-10-10 22:15:19.328098
NCT02755766|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-05-02|||May 6, 2015|Actual|2015-05-06|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Observational|||Bracing Compliance and Personality Traits: A Compliance Assessment Program for Scoliosis and Clubfeet|Bracing Compliance and Personality Traits: A Compliance Assessment Program for Scoliosis and Clubfeet|Recruiting||N/A|105|Anticipated|Shriners Hospitals for Children|||3||f||||t||||||||No||2017-10-10 22:15:19.378518|2017-10-10 22:15:19.378518
NCT02755753|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-04-26|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|REPAIR||A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis|A Multicenter, Randomized, Double-blinded, Placebo-controlled Pilot Study to Evaluate the Efficacy and Safety of Rebamipide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis (REPAIR)|Completed||Phase 4|143|Actual|Severance Hospital||2|||f||||f||||||||No||2017-10-10 22:15:19.462396|2017-10-10 22:15:19.462396
NCT02755740|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2017-08-17|||July 2015||2015-07-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|May 2017|Actual|2017-05-01||Interventional|||Promoting Smoking Cessation for Female Smokers in Hong Kong Through Training Female Youth SCRA|Promoting Smoking Cessation for Female Smokers in Hong Kong Through Training Female Youth Smoking Cessation and Reduction Ambassadors (SCRA)|Recruiting||N/A|100|Anticipated|The University of Hong Kong||1|||f||||f||||||||||2017-10-10 22:15:19.575916|2017-10-10 22:15:19.575916
NCT02755727|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-05-08|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|April 2017|Actual|2017-04-01||Interventional|||Platelet Rich Plasma vs Open Surgery in the Treatment of Tennis Elbow|Platelet Rich Plasma vs Open Surgery in the Treatment of Chronic Lateral Epicondylar Tendinopathy (Tennis Elbow) A Pilot Randomized Control Trial|Active, not recruiting||N/A|12|Actual|Royal Devon and Exeter NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:15:19.647197|2017-10-10 22:15:19.647197
NCT02755714|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Atrovent in Exercise Induced Laryngeal Obstruction (EILO)|Ipratropium Bromide (Atrovent®) Used to Treat Exercise Induced Laryngeal Obstruction (EILO). An Open Label Pilot Study|Not yet recruiting||Phase 2|20|Anticipated|Haukeland University Hospital||2|||f||||t||||||||Yes||2017-10-10 22:15:19.728665|2017-10-10 22:15:19.728665
NCT02755701|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-08-31|||July 2016||2016-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites|The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites: A Multi-center, Randomized, Double-blind, Placebo-controlled, Investigator Initiated Clinical Trial|Recruiting||Phase 4|188|Anticipated|Soonchunhyang University Hospital||2|||f||||f||||||||No||2017-10-10 22:15:19.818556|2017-10-10 22:15:19.818556
NCT02755688|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-26|||June 2015||2015-06-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CASA-AF||Catheter Ablation Versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF)|Catheter Ablation Versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF)|Recruiting||N/A|120|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||No||2017-10-10 22:15:21.481567|2017-10-10 22:15:21.481567
NCT02755675|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-11-18|||April 2016||2016-04-01|November 2016|2016-11-01|October 2023|Anticipated|2023-10-01|April 2023|Anticipated|2023-04-01||Interventional|||uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung||Recruiting||Phase 2|120|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||No||2017-10-10 22:15:21.63016|2017-10-10 22:15:21.63016
NCT02755662|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-09-27|||May 2016||2016-05-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|ESTAMPS||Clinical Impact of 2 Types of Mandibular Retention Devices - Narval O.R.M CadCam Design vs Narval O.R.M Traditional Design - on Obstructive Sleep Apnea (OSA) Therapy: ESTAMPS Study|Clinical Impact of 2 Types of Mandibular Retention Devices - Narval O.R.M Cad Cam Design vs Narval O.R.M Traditional Design - on Obstructive Sleep Apnea Syndrome (OSA) Therapy: ESTAMPS Study|Completed||N/A|12|Actual|ResMed||2|||f||||f||||||||||2017-10-10 22:15:21.739932|2017-10-10 22:15:21.739932
NCT02755649|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-05-10|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||A Study to Assess the Efficacy and Safety of Dupilumab in Patients With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable|A Phase 3 Study Investigating the Efficacy, Safety, and Tolerability of Dupilumab Administered to Adult Patients With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Are Intolerant to Oral Cyclosporine A, or When This Treatment is Not Medically Advisable|Completed||Phase 3|325|Actual|Regeneron Pharmaceuticals||3|||f||||t||||||||||2017-10-10 22:15:21.848586|2017-10-10 22:15:21.848586
NCT02755636|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-05-31|||May 2016||2016-05-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PCPHS||Pro-Change Population Health Solution|Integrative Platform for Primary Care Delivery of Evidence-Based Cancer Risk Behavior Interventions|Recruiting||Phase 2|780|Anticipated|Pro-Change Behavior Systems||2|||f||||t||||||||No||2017-10-10 22:15:22.119224|2017-10-10 22:15:22.119224
NCT02755623|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-29|||May 2015||2015-05-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|TMSCCS||Structural and Functional Correlates of Clinical Response to rTMS Treatment in Schizophrenia Patients With Resistant Auditory Hallucinations|Structural and Functional Correlates of Clinical Response to Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Schizophrenia Patients With Resistant Auditory Hallucinations|Recruiting||N/A|45|Anticipated|Centre hospitalier de Ville-Evrard, France||2|||f||||f||||||||No||2017-10-10 22:15:22.363666|2017-10-10 22:15:22.363666
NCT02755610|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-04-26|||May 2016||2016-05-01|April 2016|2016-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|CLIP-SP||Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis|Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis|Not yet recruiting||N/A|880|Anticipated|Chulalongkorn University||2|||f||||f||||||||No||2017-10-10 22:15:22.469895|2017-10-10 22:15:22.469895
NCT02755597|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-31|||July 11, 2016||2016-07-11|August 2017|2017-08-01|September 2, 2019|Anticipated|2019-09-02|September 2, 2019|Anticipated|2019-09-02||Interventional|||A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy|A Phase 3, Multicenter, Randomized, Double Blind Study of Bortezomib and Dexamethasone in Combination With Either Venetoclax or Placebo in Subjects With Relapsed or Refractory Multiple Myeloma Who Are Sensitive or Naïve to Proteasome Inhibitors|Recruiting||Phase 3|240|Anticipated|AbbVie||2|||f||||t||||||||||2017-10-10 22:15:22.599192|2017-10-10 22:15:22.599192
NCT02755584|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-28|2017-06-30|||April 22, 2016||2016-04-22|June 9, 2017|2017-06-09|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Study of Skin Cells That Stop Replicating (Senescent) During Wound Healing|A Pilot Study of Skin Cells That Stop Replicating (Senescent) During Wound Healing|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:15:22.985858|2017-10-10 22:15:22.985858
NCT02755558|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-03-17|||September 2014||2014-09-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Energy Density and Portion Size of Milk in Preschool Children|Effects of Energy Density and Portion Size of Milk in Preschool Children|Completed||N/A|143|Actual|Penn State University||4|||f||||f||||||||Undecided||2017-10-10 22:15:23.065115|2017-10-10 22:15:23.065115
NCT02755545|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-07-31|||May 1, 2016|Actual|2016-05-01|July 2017|2017-07-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Interventional|||A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments|A Multi-Center Clinical Trial to Evaluate the Efficacy of Two Acne Treatments|Completed||Phase 4|127|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||||2017-10-10 22:15:23.146371|2017-10-10 22:15:23.146371
NCT02755532|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-26|||January 2014||2014-01-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Bupivacaine Pharmacokinetics in Ultrasound-guided Axillary Brachial Plexus Block.|A Clinical and Pharmacokinetic Study to Evaluate the Influence of Two Bupivacaine Concentrations on Peak Plasma After Ultrasound-guided Axillary Brachial Plexus Block|Completed||N/A|30|Actual|Federal University of São Paulo||2|||f||||t||||||||No||2017-10-10 22:15:23.228465|2017-10-10 22:15:23.228465
NCT02755506|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-26|||October 2015||2015-10-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|March 2016|Actual|2016-03-01||Interventional|||Study on The Value of Endobronchial Ultrasound Elastography in The Diagnosis of Thoracic Lesions|Study on The Value of Endobronchial Ultrasound Elastography in The Diagnosis of Thoracic Lesions|Active, not recruiting||N/A|100|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||No|Because of personal privacy, the research-related individual participant data do not intend for public sharing.|2017-10-10 22:15:23.37676|2017-10-10 22:15:23.37676
NCT02755493|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-27|||April 2016||2016-04-01|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control|"Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control"|Active, not recruiting||N/A|22|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 22:15:23.447116|2017-10-10 22:15:23.447116
NCT02755480|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-04-25|||February 2015||2015-02-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|ULDCT-IC||Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients|Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients|Recruiting||N/A|250|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:15:23.513788|2017-10-10 22:15:23.513788
NCT02755467|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-09-12|||May 26, 2016|Actual|2016-05-26|April 2016|2016-04-01|April 4, 2017|Actual|2017-04-04|January 13, 2017|Actual|2017-01-13||Interventional|||Clinical Evaluation of the Treatment of Spider Angioma|A Clinical Evaluation of the Treatment of Spider Angioma Using a Dual Wavelength Laser Emitting 532 nm Laser Energy|Completed||N/A|21|Actual|Cutera Inc.||1|||f||||f||||||||||2017-10-10 22:15:23.600901|2017-10-10 22:15:23.600901
NCT02755454|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-05-04|||October 2013||2013-10-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Perfusion CT Imaging in Lung Cancer With SBRT|Perfusion CT Imaging in Patients With Lung Malignancies Receiving Stereotactic Body Radiation Therapy (SBRT)|Recruiting||N/A|126|Anticipated|University Health Network, Toronto||1|||f||||f||||||||No||2017-10-10 22:15:23.769515|2017-10-10 22:15:23.769515
NCT02755441|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-08-01|||April 2016||2016-04-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Observational|||Early Diagnosis of Pulmonary Fibrosis - Use of Biomarkers in Idiopathic Pulmonary Fibrosis|Early Diagnosis of Pulmonary Fibrosis|Recruiting||N/A|100|Anticipated|University Hospital, Gentofte, Copenhagen|||1||f||||f||||||Samples With DNA|"     Serum and EDTA-plasma is collected from all patients at 0, 6 and 12 months. Blood DNA and RNA     tubes are collected for all patients at one site (Gentofte hospital)   "|Undecided||2017-10-10 22:15:23.85538|2017-10-10 22:15:23.85538
NCT02755428|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-04-06|||April 2017|Anticipated|2017-04-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases|Safety and Efficacy of Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases|Recruiting||Early Phase 1|10|Anticipated|Chinese Academy of Sciences||1|||f||||t|f|f||||||Undecided||2017-10-10 22:15:23.948147|2017-10-10 22:15:23.948147
NCT02755415|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-07-26|||May 2016||2016-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Clinical Applicability of Robot-assisted Gait Training System in Acute Stroke Patients|Clinical Applicability of Robot-assisted Gait Training System in Acute Stroke Patients|Recruiting||N/A|60|Anticipated|China Medical University Hospital||2|||f||||t||||||||No|Individual participant data will remain confidential and accessible to only the approved researchers|2017-10-10 22:15:24.045544|2017-10-10 22:15:24.045544
NCT02755402|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-01-19|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Impact of an Accelerated Pre-treatment Evaluation on Linkage-to-care and Linkage-to-treatment for HCV Infected Persons Who Inject Drugs||Recruiting||N/A|200|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||||||||||||2017-10-10 22:15:24.149927|2017-10-10 22:15:24.149927
NCT02755389|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-06-06|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow|Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow|Recruiting||Phase 4|45|Anticipated|Nova Scotia Health Authority||3|||f||||f||||||||No||2017-10-10 22:15:24.247212|2017-10-10 22:15:24.247212
NCT02755376|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-04-25|||January 2014||2014-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|January 2014|Actual|2014-01-01||Interventional|||Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell|A Randomized, Single Center, Investigator Initiated Clinical Trial to Evaluate Enhancement of Healing Between Bone Tunnel and Graft in Anterior Cruciate Ligament (ACL) Injury Using Human Umbilical Cord Blood Derived Mesenchymal Stem Cell|Active, not recruiting||N/A|30|Actual|Samsung Medical Center||3|||f||||f||||||||Undecided|age, physical exam, lab, etc will be shared|2017-10-10 22:15:24.368171|2017-10-10 22:15:24.368171
NCT02755363|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-28|||April 2016||2016-04-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease|Evaluation of the Immediate Effects of Osteopathic Techniques on Plethysmographic Measurement of Residual Volume in Patients With Severe Chronic Obstructive Pulmonary Disease|Recruiting||N/A|20|Anticipated|Medical University of Warsaw||2|||f||||f||||||||Yes||2017-10-10 22:15:24.466142|2017-10-10 22:15:24.466142
NCT02755350|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-04-27|||August 2015||2015-08-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|IPCP-Kenya||Introducing PrEP Into HIV Combination Prevention - Kenya|Demonstrating Effective Delivery of Daily Oral HIV Pre-Exposure Prophylaxis as Part of HIV Combination Prevention Intervention Among Young Women at High HIV Risk, Female Sex Workers and Men Who Have Sex With Men in Kenya (IPCP-KENYA)|Recruiting||N/A|2100|Anticipated|LVCT Health||1|||f||||t||||||||Undecided||2017-10-10 22:15:24.56591|2017-10-10 22:15:24.56591
NCT02755337|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-27|||January 2016||2016-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Observational|EVALUATE||The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase|The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase|Recruiting||N/A|70|Anticipated|Dr. Soetomo General Hospital|||1||f||||f||||||||No||2017-10-10 22:15:24.688717|2017-10-10 22:15:24.688717
NCT02755324|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-06-29|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding|Establishing a Single-sex Controlled Human Schistosomiasis Infection Model: Safety and Dose Finding|Recruiting||N/A|40|Anticipated|Leiden University Medical Center||1|||f||||f|f|f||||||||2017-10-10 22:15:24.778211|2017-10-10 22:15:24.778211
NCT02755311|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-27|||March 2014||2014-03-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma|Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma: a Prospective Non-randomized Trial|Recruiting||Phase 3|198|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-10-10 22:15:24.869053|2017-10-10 22:15:24.869053
NCT02755298|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-04|||October 2016||2016-10-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ChronicAZA||Chronic Clinical Effect of Acetazolamide|Chronic Clinical Effect of Acetazolamide in Pulmonary Hypertension|Recruiting||Phase 2/Phase 3|24|Anticipated|University of Zurich||2|||f||||t||||||||Undecided||2017-10-10 22:15:24.982768|2017-10-10 22:15:24.982768
NCT02755285|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-11-17|||August 2016||2016-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:15:25.08787|2017-10-10 22:15:25.08787
NCT02755272|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-25|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|April 2023|Anticipated|2023-04-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer|A Randomized Phase II Clinical Trial Assessing the Efficacy and Safety of MK-3475 (Pembrolizumab) in Combination With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer|Recruiting||Phase 2|87|Anticipated|Fox Chase Cancer Center||2|||f||||t||||||||||2017-10-10 22:15:25.133018|2017-10-10 22:15:25.133018
NCT02755259|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-04|||October 2016||2016-10-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|AcuteAZA||Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension|Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension|Recruiting||Phase 2/Phase 3|42|Anticipated|University of Zurich||2|||f||||t||||||||Undecided||2017-10-10 22:15:25.251587|2017-10-10 22:15:25.251587
NCT02755246|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-12-21|||April 2016||2016-04-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|preSmartAge||Polyamine-enriched Diet in Healthy Older Adults With Subjective Cognitive Decline|Effect of Polyamine-enriched Dietary Supplementation on Cognitive Function in Healthy Older Adults With Subjective Cognitive Decline|Completed||Phase 2|30|Actual|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 22:15:25.399541|2017-10-10 22:15:25.399541
NCT02755233|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-25|||January 2014||2014-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|Ipi-Lu-Tox||Ipilimumab-induced Lung Toxicity: Observational Study|Ipilimumab-induced Lung Toxicity: A Prospective Observational Study on Pulmonary Function Changes in Patients With Metastatic Melanoma|Completed||N/A|71|Actual|University of Zurich|||1||f||||f||||||||Yes|Additional supporting file|2017-10-10 22:15:25.50643|2017-10-10 22:15:25.50643
NCT02755220|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-26|||January 2016||2016-01-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cingularbio® Heart Valve Clincial Study|A Prospective, Mutli-center, Open Lable, Single Arm Study to Evaluate the Safety and Effectiveness of Cingularbio® Heart Valve in Aortic/Mitral Valve Replacement Patients|Recruiting||Phase 3|180|Anticipated|Shanghai Cingularbio Co. Ltd||1|||f||||t||||||||Yes|the publication will be started after study close out|2017-10-10 22:15:25.598374|2017-10-10 22:15:25.598374
NCT02755207|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-12-28|||April 2016||2016-04-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Potential Diagnostic and Prognostic Value of microRNAs for the Patients of Acute Coronary Syndrome|Potential Diagnostic and Prognostic Value of microRNAs for the Patients of Acute Coronary Syndrome|Active, not recruiting||N/A|100|Actual|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||||Undecided||2017-10-10 22:15:25.694118|2017-10-10 22:15:25.694118
NCT02755194|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-24|||September 2014||2014-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|DLAC||"Drugs in Lactation Analysis Consortium"|"Drugs in Lactation Analysis Consortium (DLAC)"|Recruiting||N/A|300|Anticipated|The Hospital for Sick Children|||1||f||||f||||||Samples Without DNA|"     Breast milk samples are collected at different time-points before and after taking the     medication.   "|No||2017-10-10 22:15:25.764347|2017-10-10 22:15:25.764347
NCT02755181|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-10-03|||July 22, 2016|Actual|2016-07-22|October 2017|2017-10-01|July 13, 2018|Anticipated|2018-07-13|July 13, 2018|Anticipated|2018-07-13||Observational|||fMRI in Impulsivity|Assessment of Longitudinal Functional Magnetic Resonance Imaging (fMRI) as a Brain Measure for Impulsivity in a Borderline Personality Disorder (BPD) Model|Recruiting||N/A|60|Anticipated|Boehringer Ingelheim|||2||f||||||||||||||2017-10-10 22:15:25.857496|2017-10-10 22:15:25.857496
NCT02755168|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2017-07-29|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||External Pop-Out Technique Versus Classic Head Extraction During Cesarean Section|Feasibility and Outcomes of External Pop-out Versus Classic Fetal Head Extract During Cesarean Section|Recruiting||N/A|500|Anticipated|Assiut University||2|||f||||f|f|f||||||||2017-10-10 22:15:25.937754|2017-10-10 22:15:25.937754
NCT02755155|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-09-07|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|AlbAlsace||Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients|Comparison of 2 Strategies of Therapeutic Human Serum Albumin Infusion in Critically Ill Patients With Severe Systemic Inflammatory Response Syndrome and Low Plasma Albumin: Continuous Low Versus Intermittent High Doses|Recruiting||Phase 4|550|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 22:15:26.022809|2017-10-10 22:15:26.022809
NCT02755142|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-20|||February 2000||2000-02-01|April 2016|2016-04-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas|Clinical Phase I/II Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas|Completed||Phase 1/Phase 2|21|Actual|medac GmbH||3|||f||||f||||||||No||2017-10-10 22:15:26.107684|2017-10-10 22:15:26.107684
NCT02755116|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-03-07|||January 2016||2016-01-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Olanzapine for Nausea After Surgery|Olanzapine for the Treatment of Post-Discharge Nausea and Vomiting After Ambulatory Surgery|Recruiting||Phase 2|140|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||No||2017-10-10 22:15:26.371994|2017-10-10 22:15:26.371994
NCT02755103|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-11|||June 2016||2016-06-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD|Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD|Recruiting||N/A|80|Anticipated|Medical University of South Carolina||2|||f||||t||||||||No||2017-10-10 22:15:26.488817|2017-10-10 22:15:26.488817
NCT02755090|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-17|2017-06-15||July 2016||2016-07-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|NOVIA||Nitrous Oxide Versus Intravenous Sedation for Anesthesia|Nitrous Oxide Versus Intravenous Sedation for Anesthesia|Completed||N/A|39|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-10 22:15:26.603457|2017-10-10 22:15:26.603457
NCT02755077|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-26|||July 2014||2014-07-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Head Rotation on Efficiency of Face Mask Ventilation in Anesthetized Apneic Adults|Effect of Head Rotation on Efficiency of Face Mask Ventilation in Anesthetized Apneic Adults: A Prospective Randomized Crossover Study|Completed||N/A|40|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:15:27.025482|2017-10-10 22:15:27.025482
NCT02755064|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-27|||June 2010||2010-06-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus|Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus|Completed||Phase 1|30|Actual|Mayo Clinic||5|||f||||f||||||||No||2017-10-10 22:15:27.105572|2017-10-10 22:15:27.105572
NCT02755051|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-04-28|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Targeting Sleep in Kids With Autism Spectrum Disorder|Targeting Sleep in Kids With Autism Spectrum Disorder|Recruiting||N/A|30|Anticipated|University of Missouri-Columbia||1|||f||||f||||||||No||2017-10-10 22:15:27.221871|2017-10-10 22:15:27.221871
NCT02755038|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-26|||March 2016||2016-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|||Scalp Hair Estradiol and Progesterone Level Determination in Women (Proof of Concept Study)|Scalp Hair Estradiol and Progesterone Level Determination in Pre-menopausal and Post-menopausal Women (Proof of Concept Study)|Recruiting||N/A|40|Anticipated|Bnai Zion Medical Center|||1||f||||f||||||Samples Without DNA|"     Scalp Hair   "|No||2017-10-10 22:15:27.336724|2017-10-10 22:15:27.336724
NCT02755025|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-03-27|||July 1, 2016|Actual|2016-07-01|March 2017|2017-03-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Observational|ScoreInt||Clinical Score Usefulness and EHR Integration|Evaluation of Clinical Score Usefulness and Feasibility of Integration Into Electronic Health Record Interfaces|Completed||N/A|215|Actual|Mayo Clinic|||1||f||||f||||||||No||2017-10-10 22:15:27.442074|2017-10-10 22:15:27.442074
NCT02755012|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-26|||June 2012||2012-06-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Impact of Maternal Stress on Infant Stunting|Reducing Maternal Stress Due to Infection, Malnutrition and Psychosocial Conditions of Poverty: A New Paradigm for Tackling Infant Stunting|Completed||N/A|271|Actual|McGill University|||3||f||||f||||||Samples Without DNA|"     Stool sample (mother and infant) Urine sample (mother) Saliva sample (mother) Breast milk     sample (mother)   "|Undecided||2017-10-10 22:15:27.534144|2017-10-10 22:15:27.534144
NCT02754999|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-06-26|||March 2016||2016-03-01|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|||A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia.|An Open-label Phase 1 Safety Study of SANGUINATE™ Infusion in Patients With Acute Severe Anemia Who Are Unable to Receive Red Blood Cell Transfusion|Completed||Phase 1|103|Actual|Prolong Pharmaceuticals||1|||f||||f||||||||No||2017-10-10 22:15:27.646508|2017-10-10 22:15:27.646508
NCT02754986|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-04-25|||March 2015||2015-03-01|March 2016|2016-03-01||||August 2015|Actual|2015-08-01||Interventional|||Quantification of Autonomic Nervous Activity During Hemodialysis|Quantification of Autonomic Nervous Activity by Heart Rate Variability and Approximate Entropy in High Ultrafiltration Rate During Hemodialysis|Completed||N/A|35|Actual|University of Hyogo||1|||f||||t||||||||Yes||2017-10-10 22:15:27.809793|2017-10-10 22:15:27.809793
NCT02754973|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-03-28|||May 2015||2015-05-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Integrated Experiential Training Program With Coaching by Healthcare Professionals in Childhood Cancer Patients|Effectiveness of an Integrated Experiential Training Program With Coaching by Healthcare Professionals in Promoting Regular Physical Activity Among Childhood Cancer Patients|Recruiting||N/A|70|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 22:15:27.90359|2017-10-10 22:15:27.90359
NCT02754960|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-26|||March 2010||2010-03-01|April 2016|2016-04-01|September 2014|Anticipated|2014-09-01|March 2014|Anticipated|2014-03-01||Interventional|||Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding|A Randomised, Double-blind, Placebo-controlled Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding|Withdrawn||Phase 2|0|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 22:15:28.045296|2017-10-10 22:15:28.045296
NCT02754947|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-04-05|||February 2015||2015-02-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|||Need for the Assessment and Consultation Team (ACT) Following Anesthetic Care|Etiology of Post-anesthetic and Post-sedation Events on the Inpatient Ward: Data From a Rapid Response Team at a Tertiary Care Children's Hospital|Completed||N/A|100|Actual|Nationwide Children's Hospital|||1||f||||f||||||||No||2017-10-10 22:15:28.171681|2017-10-10 22:15:28.171681
NCT02754934|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-11-03|||November 2014||2014-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Observational|||Development of a Self-administered Neck Mobility Assessment Tool in Chronic Neck Pain Patients.|Development of a Self-administered Neck Mobility Assessment Tool in Chronic Neck Pain Patients.|Completed||N/A|50|Actual|Balgrist University Hospital|||1||f||||f||||||||No||2017-10-10 22:15:28.261056|2017-10-10 22:15:28.261056
NCT02750943|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-09-23|2016-09-23||November 2015||2015-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease|A Clinical Study Investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice|Completed||N/A|253|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:16:10.872042|2017-10-10 22:16:10.872042
NCT02754921|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-27|||January 2013||2013-01-01|April 2016|2016-04-01||||December 2015|Actual|2015-12-01||Interventional|||Percutaneous Dilatational Tracheostomy: Ultra-perc Versus Ciaglia Blue Dolphin|Percutaneous Dilatational Tracheostomy: Ultra-perc Single Stage Dilator Technique Versus Ciaglia Blue Dolphin Ballon Dilatation Technique for Intubated Unweanable ICU Patients|Completed||N/A|60|Actual|Al Mouwasat Hospital||2|||f||||f||||||||Yes||2017-10-10 22:15:28.334413|2017-10-10 22:15:28.334413
NCT02754908|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-05-03|||January 2016||2016-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Musical Training in Children Surviving Brain Tumours|Effectiveness of Musical Training in the Improvement of the Neurocognitive Function and Psychological Well-being of Children Surviving Brain Tumours|Recruiting||N/A|60|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 22:15:28.412069|2017-10-10 22:15:28.412069
NCT02754895|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-05-30|||October 2014||2014-10-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|PEACEIII||Positive Psychology for ACS Patients: a Factorial Design Study|Positive Psychology for Acute Coronary Syndrome Patients: a Factorial Design Study|Completed||N/A|128|Actual|Massachusetts General Hospital||8|||f||||f||||||||Undecided||2017-10-10 22:15:28.498892|2017-10-10 22:15:28.498892
NCT02754882|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-09-18|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer|A Phase 3, Randomised, Double-blind Study to Compare the Efficacy, Safety, PK and Immunogenicity Between SB8 (Proposed Bevacizumab Biosimilar) and Avastin® in Subjects With Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer|Active, not recruiting||Phase 3|678|Anticipated|Samsung Bioepis Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:15:28.613245|2017-10-10 22:15:28.613245
NCT02754869|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-04-25|||February 2011||2011-02-01|November 2015|2015-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Magnetic Resonance Imaging Assessment of Small Bowel Motility|Post-Hoc Analysis of Dynamic Magnetic Resonance Sequences to Establish Descriptive Metrics for Small Bowel Motility in Vivo|Recruiting||N/A|172|Anticipated|University College, London|||4||f||||t||||||||Yes||2017-10-10 22:15:28.914531|2017-10-10 22:15:28.914531
NCT02754856|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-11|||July 28, 2016|Actual|2016-07-28|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Tremelimumab (Anti-CTLA-4) Plus Durvalumab (MEDI4736) (Anti-PD-L1) in the Treatment of Resectable Colorectal Cancer Liver Metastases|Pilot Study Assessing the Safety and Tolerability of the Neoadjuvant Use of Tremelimumab (Anti-CTLA-4) Plus Durvalumab (MEDI4736) (Anti-PD-L1) in the Treatment of Resectable Colorectal Cancer Liver Metastases|Recruiting||Phase 1|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:15:28.986911|2017-10-10 22:15:28.986911
NCT02754843|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-04-25|||October 2015||2015-10-01|April 2016|2016-04-01||||January 2016|Actual|2016-01-01||Interventional|||Quality Control of CE-Labelled Phonak Hearing Systems (Study Part: Sonova2015-00)||Completed||N/A|27|Actual|Sonova AG||2|||f||||||||||||||2017-10-10 22:15:29.097598|2017-10-10 22:15:29.097598
NCT02754830|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-08-31|||April 25, 2016|Actual|2016-04-25|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)|Single-Dose, Dose-Escalation Study With LY3303560 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease|Recruiting||Phase 1|110|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:15:29.183985|2017-10-10 22:15:29.183985
NCT02754817|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-09-07|||April 26, 2016|Actual|2016-04-26|September 2017|2017-09-01|October 20, 2016|Actual|2016-10-20|October 20, 2016|Actual|2016-10-20||Observational|||A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus|A European Multi-centre, Retrospective, Non-interventional Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus|Completed||N/A|611|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 22:15:29.400553|2017-10-10 22:15:29.400553
NCT02754804|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2017-08-28|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|CLAUSEL||Claudication, Systematic Evaluation of Limp on Treadmill|Claudication et Fatigue Musculaire de l'artériopathe|Enrolling by invitation||N/A|100|Anticipated|University Hospital, Angers|||1||f||||f||||||||||2017-10-10 22:15:29.496851|2017-10-10 22:15:29.496851
NCT02754791|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-02|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Reducing Blood Culture Contamination:|Reducing Blood Culture Contamination: a Prospective Crossover Study|Not yet recruiting||N/A|1500|Anticipated|Shaare Zedek Medical Center||3|||f||||f||||||||Undecided||2017-10-10 22:15:29.578216|2017-10-10 22:15:29.578216
NCT02754778|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-01-04|||April 2016||2016-04-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|RedCarRisk||Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome|Evaluation of Practicability in Survey and Test Procedures and of Successful Implementation of Complex Interventions - Feasibility Analysis Based on a Pilot Study: Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome|Recruiting||N/A|40|Anticipated|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||No||2017-10-10 22:15:29.65691|2017-10-10 22:15:29.65691
NCT02754765|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-08-31|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|September 2020|Anticipated|2020-09-01||Interventional|endTB||Evaluating Newly Approved Drugs for Multidrug-resistant TB|Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial|Recruiting||Phase 3|750|Anticipated|Médecins Sans Frontières France||6|||f||||f||||||||||2017-10-10 22:15:29.762539|2017-10-10 22:15:29.762539
NCT02754752|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-07-20|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Trial of Acupuncture for Chronic Pain After Breast Cancer Treatment|Randomized-Controlled Trial of Acupuncture for Chronic Pain After Breast Cancer Treatment|Recruiting||Phase 2|109|Anticipated|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-10-10 22:15:29.915755|2017-10-10 22:15:29.915755
NCT02754739|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2017-06-17|||April 15, 2014|Actual|2014-04-15|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes|Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes|Recruiting||Phase 4|46|Anticipated|Samsung Medical Center||3|||f||||f||||||||||2017-10-10 22:15:30.013798|2017-10-10 22:15:30.013798
NCT02754726|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma|A Phase II Pilot Trial of Nivolumab + Albumin-Bound Paclitaxel + Paricalcitol + Cisplatin + Gemcitabine (NAPPCG) In Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma|Recruiting||Phase 2|10|Anticipated|HonorHealth Research Institute||1|||f||||t||||||||||2017-10-10 22:15:30.136238|2017-10-10 22:15:30.136238
NCT02754713|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-25|||September 2009||2009-09-01|April 2016|2016-04-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||Prognostic Biomarkers in Patients With Acute Pericarditis|Prognostic Biomarkers in Patients With Acute Pericarditis|Recruiting||N/A|300|Anticipated|Hippocration General Hospital|||1||f||||f||||||Samples Without DNA|"     Blood samples will be collected for plasma biomarkers (e.g. circulating pro-inflammatory     cytokines, miRNAs etc)      Image datasets from available imaging tests will be also analysed to quantify imaging     biomarkers (e.g. epicardial fat volume from computerised tomography, speckle-tracking     analysis for cardiac ultrasound etc.).   "|Undecided||2017-10-10 22:15:30.256518|2017-10-10 22:15:30.256518
NCT02754700|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-17|||April 2016||2016-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|ROBUST||Real-time Optimized Biofeedback Utilizing Sport Techniques|Effects of Real-time Optimized Biofeedback Utilizing Sport Techniques (ROBUST) Training on Risk of Anterior Cruciate Ligament Injury|Enrolling by invitation||Phase 2|150|Anticipated|High Point University||3|||f||||t||||||||||2017-10-10 22:15:30.340183|2017-10-10 22:15:30.340183
NCT02754687|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-08-08|||April 2016||2016-04-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CCN014||Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men|Single Dose, Dose-Ranging Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men|Active, not recruiting||Phase 1|12|Actual|Health Decisions||2|||f||||t||||||||||2017-10-10 22:15:30.460843|2017-10-10 22:15:30.460843
NCT02754674|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-05-09|||May 2014||2014-05-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Femoral Tunnel and Clinical Outcome Using Two Anterior Cruciate Ligament Reconstruction Techniques|Comparison of Femoral Tunnel Placement, Geometry and Clinical Outcome Using Two Anterior Cruciate Ligament Reconstruction Technique; Transportal Technique and Outside in Technique With Remnant Preservation. Prospective Randomized Trial|Active, not recruiting||N/A|66|Anticipated|Samsung Medical Center||2|||f||||t||||||||Undecided|if yes, age, sex, physical examination, trauma date, MRI.|2017-10-10 22:15:30.640905|2017-10-10 22:15:30.640905
NCT02754661|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-07-24|||September 2016||2016-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|TOPAZ||Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.|Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population|Recruiting||N/A|320|Anticipated|Medtronic - MITG||2|||f||||f||||||||||2017-10-10 22:15:30.745867|2017-10-10 22:15:30.745867
NCT02754648|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-04-26|||September 2015||2015-09-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve|Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve|Active, not recruiting||N/A|90|Anticipated|Ain Shams University||3|||f||||t||||||||No||2017-10-10 22:15:30.923272|2017-10-10 22:15:30.923272
NCT02754635|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-08-13|||March 2016||2016-03-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Induction Versus Expectant Management With Abnormal Maternal Biochemical Markers|Induction of Labor at Term Versus Expectant Management Among Women With Abnormal Maternal Serum Biochemical Markers: A Randomized Controlled Trial|Recruiting||N/A|320|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-10 22:15:31.003844|2017-10-10 22:15:31.003844
NCT02754622|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-02-20|||July 2016||2016-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|ENERGY-ICU||The Feasibility of Measuring Energy Expenditure During Physical Rehabilitation In Critically Ill Patients|A Pilot Observational Cohort Study Examining the Feasibility of Measuring Energy Expenditure During Physical Rehabilitation In Critically Ill Patients|Completed||N/A|4|Actual|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 22:15:31.107956|2017-10-10 22:15:31.107956
NCT02754609|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-08-22|||September 2016||2016-09-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|NainCeD-3||Hookworm Therapy for Coeliac Disease|Hookworm Therapy for Coeliac Disease: A Phase 1B Safety and Dose-ranging Clinical Trial Examining Sustained Gluten Consumption in Hookworm-naive and Hookworm-infection People With Coeliac Disease|Not yet recruiting||Phase 1|60|Anticipated|James Cook University, Queensland, Australia||3|||f||||t||||||||No||2017-10-10 22:15:31.19335|2017-10-10 22:15:31.19335
NCT02754596|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-27|||March 2016||2016-03-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Interventional|||Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution|Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants to Timolol Maleate Ophthalmic Solution, USP, 0.5%|Recruiting||Phase 2|300|Anticipated|Glaukos Corporation||3|||f||||f||||||||Undecided||2017-10-10 22:15:31.35237|2017-10-10 22:15:31.35237
NCT02754583|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-02-13|||November 2015||2015-11-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|SWIFT||Sanitation, Water, and Instruction in Face-washing for Trachoma|Sanitation, Water, and Instruction in Face-washing for Trachoma|Recruiting||Phase 4|220000|Anticipated|Francis I. Proctor Foundation||6|||f||||t||||||||||2017-10-10 22:15:31.441424|2017-10-10 22:15:31.441424
NCT02750020|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-22|||February 2016||2016-02-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|July 2016|Anticipated|2016-07-01||Observational|||Policy-related Survey on Tobacco Control|Policy-Related Survey - Territory-wide Telephone Survey on Tobacco Control|Recruiting||N/A|5000|Anticipated|The University of Hong Kong|||3||f||||f||||||||No||2017-10-10 22:16:29.819821|2017-10-10 22:16:29.819821
NCT02754570|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-07-17|||July 2016||2016-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure|The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure|Recruiting||N/A|30|Anticipated|University of Colorado, Denver||1|||f||||f||||||||||2017-10-10 22:15:31.586839|2017-10-10 22:15:31.586839
NCT02754557|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-10-27|||March 2016||2016-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PAMM||Physiological Augmentation of Mindfulness Meditation|Physiological Augmentation of Mindfulness Meditation|Recruiting||N/A|60|Anticipated|Emory University||2|||f||||f||||||||Undecided||2017-10-10 22:15:31.68617|2017-10-10 22:15:31.68617
NCT02754544|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-02-09|||July 2016|Actual|2016-07-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Using Electrocorticogram (ECoG) in Predicting Eloquent Cortex and Post-Op Functional Outcomes in Patients With Brain Tumors|Pilot Investigation of Using Electrocorticogram (ECoG) in Predicting Eloquent Cortex and Post-Operative Functional Outcomes in Patients With Brain Tumors|Recruiting||N/A|20|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 22:15:31.80519|2017-10-10 22:15:31.80519
NCT02754531|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-03-01|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Ultrasonography vs Cole Formula to Predict Endotracheal Tube Diameter|Comparison Between Ultrasonography and Cole Formula in Predicting Uncuffed Endotracheal Tube Diameter|Completed||N/A|60|Actual|Indonesia University||1|||f||||||||||||Undecided||2017-10-10 22:15:31.920858|2017-10-10 22:15:31.920858
NCT02754518|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Demonstration of Reverse Remodeling Effects of Entresto (Valsartan/Sacubitril) Using Echocardiography Endocardial Surface Analysis|Demonstration of Reverse Remodeling Effects of Entresto (Valsartan/Sacubitril) Using Echocardiography Endocardial Surface Analysis|Recruiting||Phase 4|40|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 22:15:32.009829|2017-10-10 22:15:32.009829
NCT02754505|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-25|||February 2008||2008-02-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|ER||Early Rehabilitation in Critical Illness Survivors|Can Early Rehabilitation on the General Ward Following an Intensive Care Unit Stay Reduce Hospital Length of Stay in Critical-illness-survivors? A Randomised Controlled Trial|Completed||N/A|53|Actual|Danube Hospital||2|||f||||f||||||||||2017-10-10 22:15:32.105666|2017-10-10 22:15:32.105666
NCT02754492|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-04-21|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Evaluation of Trima Version 7.0 Platelets in 100% Plasma|Evaluation of the Performance of Trima Accel® Version 7.0 Software Enhancements for the Collection of Platelets Stored in 100% Plasma|Completed||N/A|333|Actual|Terumo BCT||3|||f||||f||||||||No||2017-10-10 22:15:32.187596|2017-10-10 22:15:32.187596
NCT02754479|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-28|||April 2016||2016-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||A Clinical Evaluation of the Treatment of Spider Veins on the Ankles|A Clinical Evaluation of the Treatment of Spider Veins on the Ankles Using a Dual Wavelength Laser Emitting 532 nm and 1064 nm Laser Energy|Enrolling by invitation||N/A|10|Anticipated|Cutera Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:15:32.275104|2017-10-10 22:15:32.275104
NCT02754466|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-05-01|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|May 2, 2020|Anticipated|2020-05-02|May 2, 2018|Anticipated|2018-05-02||Interventional|||Oral Health and Its Relation to Development and Well-being of Schoolchildren Before and After Restorative Treatments|Oral Health and Its Relation to Growth, Development and Well-being of Schoolchildren Before and After Restorative Treatments|Recruiting||N/A|200|Anticipated|University of Brasilia||2|||f||||f|f|f||||||No||2017-10-10 22:15:32.348127|2017-10-10 22:15:32.348127
NCT02754453|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-04-25|||July 2013||2013-07-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Weight Regain Study After Bariatric Surgery-A Pilot Project|An Evaluation of the Efficacy of a Group Treatment Intervention for Weight Regain After Bariatric Surgery-A Pilot Project|Withdrawn||N/A|0|Actual|The Cleveland Clinic||1||No funding|f||||f||||||||||2017-10-10 22:15:32.43685|2017-10-10 22:15:32.43685
NCT02754427|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-16|||February 2013||2013-02-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Pilot Study for a Prospective Surveillance Program for Rehabilitation Following Surgery for Breast Cancer||Completed||N/A|41|Actual|University of British Columbia||2|||f||||f||||||||Undecided||2017-10-10 22:15:32.588467|2017-10-10 22:15:32.588467
NCT02754414|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-07-31|||April 2016||2016-04-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|CAPP||Cold Apheresis Platelets in Plasma|Cold Apheresis Platelets in Plasma|Recruiting||Phase 1|80|Anticipated|Bloodworks (Puget Sound Blood Center)||1|||f||||f||||||||||2017-10-10 22:15:32.664874|2017-10-10 22:15:32.664874
NCT02754401|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-27|||January 2014||2014-01-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of a New Self-reported Tool for Periodontitis Screening|Evaluation of a New Self-reported Tool for Periodontitis Screening.|Completed||N/A|200|Actual|Renatus, Antonio Renatus, Dent., M.Sc||2|||f||||t||||||||No||2017-10-10 22:15:32.776691|2017-10-10 22:15:32.776691
NCT02754388|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-04-25|||February 2016||2016-02-01|April 2016|2016-04-01||||December 2018|Anticipated|2018-12-01|98 Weeks|Observational [Patient Registry]|||Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography|Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography (LDCT)- a Screening Program|Enrolling by invitation||N/A|5000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 22:15:32.897276|2017-10-10 22:15:32.897276
NCT02754375|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-05-30|||May 2016||2016-05-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|January 2017|Anticipated|2017-01-01||Interventional|SMTr-METAB||SMTr-METAB : FDG-PET Assessment of Cerebral Metabolism in Resistant Depression Treated With rTMS|Cerebral Functional Modifications After Low Frequency Repetitive Transcranial Magnetic Stimulation in Refractory Depression. Assessment With 18F-FDG-PET Imaging.|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||No||2017-10-10 22:15:32.99573|2017-10-10 22:15:32.99573
NCT02754362|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-29|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma|A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma|Enrolling by invitation||Phase 2|30|Anticipated|New York University School of Medicine||3|||f||||t|t|f||||||||2017-10-10 22:15:33.122109|2017-10-10 22:15:33.122109
NCT02754349|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-09-06|||February 2015||2015-02-01|April 2016|2016-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Validation Study of Pulse Wave Velocity and Augmentation Index in Atrial Fibrillation|Assessment of Pulse Wave Velocity and Augmentation Index in Patients With Atrial Fibrillation Before and After Electrical Cardioversion: a Validation Study.|Completed||N/A|40|Actual|Onze Lieve Vrouw Hospital||1|||f||||f||||||||No||2017-10-10 22:15:33.230095|2017-10-10 22:15:33.230095
NCT02754336|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2016-04-25|||October 2014||2014-10-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study|Working Memory Training and Neurofeedback for Children With ADHD, a Pilot Study|Completed||N/A|6|Actual|Helse Stavanger HF||2|||f||||f||||||||No||2017-10-10 22:15:33.453436|2017-10-10 22:15:33.453436
NCT02754323|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-25|||May 2016||2016-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|codesna||Feasibility Study and Validation of Measuring Apparatus Codesna Stress at Work||Not yet recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 22:15:33.541969|2017-10-10 22:15:33.541969
NCT02754310|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-10-29|||May 2016||2016-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|REVAR||Repeated Versus Varied Simulation Scenarios to Teach Medical Students the Management of a Pediatric Asthma Exacerbation|Repeated Versus Varied Simulation Scenarios to Teach Medical Students the Management of a Pediatric Asthma Exacerbation: A Randomized Controlled Study|Completed||N/A|85|Actual|Departement de simulation en Santé de l'Université Paris Descartes||2|||f||||f||||||||||2017-10-10 22:15:33.619749|2017-10-10 22:15:33.619749
NCT02754297|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-02-01|||April 2016||2016-04-01|February 2016|2016-02-01|December 2026|Anticipated|2026-12-01|April 2021|Anticipated|2021-04-01||Interventional|P-PRRT||Personalized PRRT of Neuroendocrine Tumors|Personalized Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Phase 2 Study|Recruiting||Phase 2|85|Anticipated|CHU de Quebec-Universite Laval||1|||f||||t||||||||No||2017-10-10 22:15:33.725061|2017-10-10 22:15:33.725061
NCT02754284|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-23|||December 2015||2015-12-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Study of Regeneration on Larynx Soft Tissue Guided by Functional Collagen Scaffold|The Safety and Efficacy Assessment of Functional Collagen Scaffold Transplantation for Larynx Soft Tissue Regeneration|Active, not recruiting||Phase 1|10|Anticipated|Chinese Academy of Sciences||2|||f||||f||||||||||2017-10-10 22:15:33.864801|2017-10-10 22:15:33.864801
NCT02754271|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-25|||April 2014||2014-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|||Fit for Dialysis: Research-based Film as a Knowledge Translation Strategy|Fit for Dialysis: Research-based Film as a Knowledge Translation Strategy|Recruiting||Phase 2|60|Anticipated|Toronto Rehabilitation Institute||2|||f||||f||||||||No||2017-10-10 22:15:33.968787|2017-10-10 22:15:33.968787
NCT02754258|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-02|||January 2017||2017-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|MPH||The Effects of Methylphenidate on Energy Intake and Energy Expenditure|The Effects of Methylphenidate on the Reduction of Food Energy Intake and on the Augmentation of Energy Expenditure|Recruiting||Phase 3|40|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-10 22:15:34.123196|2017-10-10 22:15:34.123196
NCT02754245|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-06-06|||November 14, 2016|Actual|2016-11-14|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|January 31, 2017|Actual|2017-01-31||Observational|EDOVS||ED Overcrowding Validation Study|A Validation Study of Emergency Department Crowding Estimation|Active, not recruiting||N/A|55000|Anticipated|Baylor Research Institute|||6||f||||f||||||||No||2017-10-10 22:15:34.287429|2017-10-10 22:15:34.287429
NCT02754232|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Telemedical Training for Chronically Ill COPD Patients: a Cross Sectoral Study|Telemedical Training in a Daily Perspective for Chronically Ill COPD Patients: a Cross Sectoral Study|Withdrawn||N/A|0|Actual|Odense University Hospital||2||Due to resource problems in the clinic at University Hospital Odense|f||||t||||||||||2017-10-10 22:15:34.431852|2017-10-10 22:15:34.431852
NCT02754219|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-27|2017-08-20|||September 22, 2016|Actual|2016-09-22|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction|A Study to Evaluate Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction and Control Healthy Volunteers|Recruiting||Phase 1|24|Anticipated|Dong-A ST Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:15:34.556641|2017-10-10 22:15:34.556641
NCT02754206|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-25|||January 2016||2016-01-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Cerebral Blood Flow Regulation and Concussions|Association Between Brain Blood Flow Regulation, Cognition, and Balance in Sports-Related Concussion|Recruiting||N/A|200|Anticipated|Southern Methodist University|||2||f||||f||||||||Undecided||2017-10-10 22:15:34.662337|2017-10-10 22:15:34.662337
NCT02754193|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-07-07|||July 2016||2016-07-01|April 2016|2016-04-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|HYPO-ECMO||Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)|Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)|Recruiting||N/A|334|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||No||2017-10-10 22:15:34.792526|2017-10-10 22:15:34.792526
NCT02754180|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-27|||March 2016||2016-03-01|April 2016|2016-04-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes|Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes|Recruiting||Phase 2|110|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||No||2017-10-10 22:15:35.054165|2017-10-10 22:15:35.054165
NCT02754167|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-04-03|||April 2016||2016-04-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients|Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Hepcidin Antagonist PRS-080#022-DP in Anemic Chronic Kidney Disease Patients Undergoing Hemodialysis|Active, not recruiting||Phase 1/Phase 2|24|Actual|Pieris Pharmaceuticals GmbH||2|||f||||t||||||||No||2017-10-10 22:15:35.19553|2017-10-10 22:15:35.19553
NCT02754154|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-09-01|||December 31, 2014|Actual|2014-12-31|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|||Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants|Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants|Active, not recruiting||N/A|88983|Anticipated|Bristol-Myers Squibb|||4||f||||f||||||||||2017-10-10 22:15:35.356213|2017-10-10 22:15:35.356213
NCT02754141|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-09-15|||June 20, 2016|Actual|2016-06-20|September 2017|2017-09-01|May 21, 2020|Anticipated|2020-05-21|March 11, 2019|Anticipated|2019-03-11||Interventional|||An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread|A Phase 1/2a Study of BMS-986179 Administered in Combination With Nivolumab (BMS-936558) in Subjects With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|216|Anticipated|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 22:15:35.507652|2017-10-10 22:15:35.507652
NCT02754128|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-07-12|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||BeFAST or BeSTRONG: Brain Change After Fun Athletic Sports-skill Training or Brain Change After Strength TRaining Focusing ON Gait|Linking Neuroplasticity With the Outcomes of Walking-based Interventions: A Feasibility Trial Comparing a Motor Learning Versus a Strength-based Program in Children With Cerebral Palsy|Active, not recruiting||N/A|20|Actual|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||f||||||||||2017-10-10 22:15:35.726285|2017-10-10 22:15:35.726285
NCT02754115|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-06-21|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|April 2021|Anticipated|2021-04-01||Observational|||An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy|A Prospective Audit of Perioperative Parameters of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)|Recruiting||N/A|150|Anticipated|Tata Memorial Centre|||1||f||||t||||||||Yes||2017-10-10 22:15:35.855362|2017-10-10 22:15:35.855362
NCT02754102|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-04-28|||May 3, 2016|Actual|2016-05-03|April 2017|2017-04-01|May 6, 2016|Actual|2016-05-06|May 6, 2016|Actual|2016-05-06||Interventional|||Human Phototoxicity Test|Human Phototoxicity Test|Completed||N/A|35|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:15:35.942696|2017-10-10 22:15:35.942696
NCT02754089|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-09-01|||May 2016||2016-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|SomaghWeight||The Effects of Rhus Coriaria L. on Body Weight|The Effects of Rhus Coriaria L. (Rhus or Somagh) on Body Weight|Completed||N/A|70|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 22:15:36.04|2017-10-10 22:15:36.04
NCT02754076|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2017-08-30|||April 2016||2016-04-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|MPS IIIB||A Treatment Study of Mucopolysaccharidosis Type IIIB|A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Intracerebroventricular BMN 250 in Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)|Recruiting||Phase 1/Phase 2|33|Anticipated|BioMarin Pharmaceutical||1|||f||||f||||||||||2017-10-10 22:15:36.127698|2017-10-10 22:15:36.127698
NCT02754063|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-03-28|||June 2016||2016-06-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|OXY-TC||Impact of Early Optimization of Brain Oxygenation on the Volume of Cerebral Lesions After Severe Traumatic Brain Injury|Impact of Early Optimization of Brain Oxygenation on the Volume of Cerebral Lesions After Severe Traumatic Brain Injury|Recruiting||N/A|300|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 22:15:36.221745|2017-10-10 22:15:36.221745
NCT02754050|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-25|||September 2016||2016-09-01|April 2016|2016-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety and Feasibility of the Tandem Snare Device|Safety and Feasibility of the Tandem Snare Device|Not yet recruiting||N/A|12|Anticipated|Tandem Technologies LTD||1|||f||||||||||||||2017-10-10 22:15:36.39115|2017-10-10 22:15:36.39115
NCT02754037|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-08-17|||April 2016||2016-04-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Non-Invasive Evaluation of Liver Steatosis, Inflammation and Fibrosis|Non-Invasive Evaluation of Liver Steatosis, Inflammation and Fibrosis|Recruiting||N/A|25|Anticipated|University of California, Davis|||1||f||||f||||||Samples With DNA|"     Blood plasma/serum will be banked at the UC Davis GI Biobank for future liver-related study     use in -80°C freezer. Samples will be used for liver related studies. Potential future     analyses of plasma samples could include fatty liver metabolomics analyses. All future Sample     specimens will be stored for as long as they are viable (for up to 20 years). Dr. Sarkar and     his study staff will maintain records of the storage location and have access to them.   "|||2017-10-10 22:15:36.45093|2017-10-10 22:15:36.45093
NCT02754024|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-27|||September 2005||2005-09-01|April 2016|2016-04-01|September 2025|Anticipated|2025-09-01|March 2016|Actual|2016-03-01||Observational|||Humeral Head Implants: Radiological and Clinical Evaluation||Active, not recruiting||N/A|100|Anticipated|Austrian Research Group for Regenerative and Orthopedic Medicine|||2||f||||f||||||||||2017-10-10 22:15:36.53122|2017-10-10 22:15:36.53122
NCT02754011|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-02-09|||January 2017||2017-01-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|GEP14-LEECAP||Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative|Dose-escalation, Phase I Multicentric Trial, Evaluating the Combination of Ribociclib and Capecitabine in Locally Advanced or Metastatic Breast Cancer HER2 Negative in Patients Previously Treated With Anthracyclines and Taxanes|Recruiting||Phase 1|52|Anticipated|UNICANCER||1|||f||||t||||||||Undecided||2017-10-10 22:15:36.613727|2017-10-10 22:15:36.613727
NCT02753972|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-26|||August 2006||2006-08-01|April 2016|2016-04-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|MEAL||Mindful Eating and Living for Obese Women|Mindful Eating and Living: A Controlled Study Investigating the Effects of Mindfulness on Weight Loss, Habits, Mood and Biological Markers of Inflammation and Metabolism in Obese Post-Menopausal Women|Completed||N/A|36|Actual|University of New Mexico||2|||f||||f||||||||No||2017-10-10 22:15:36.960724|2017-10-10 22:15:36.960724
NCT02753959|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-02-20|||August 2016||2016-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MIE and EIT||Changes in Regional Lung Ventilation Following Mechanical Insufflation-Exsufflation|Changes in Regional Lung Ventilation Following Mechanical Insufflation-Exsufflation|Recruiting||N/A|20|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:15:37.045372|2017-10-10 22:15:37.045372
NCT02753946|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-06-26|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|January 12, 2017|Actual|2017-01-12||Interventional|ZEUS||Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections|Randomized, Double-Blind, Comparative Study to Evaluate the Safety and Efficacy of ZTI-01 vs Piperacillin/Tazobactam in the Treatment of cUTI/AP Infection in Hospitalized Adults|Completed||Phase 2/Phase 3|465|Actual|Zavante Therapeutics||2|||f||||t||||||||Yes|Individual IPD data will be shared in listings with FDA, other Competent Authorities, IRB/ECs, Data Monitoring Committee|2017-10-10 22:15:37.151316|2017-10-10 22:15:37.151316
NCT02753933|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-08-07|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Direct Access to MRI and Neurology Referrals for the Management of Patients With Chronic Headache.|An Observational Study to Evaluate Referral From General Practitioners (GPs) to: 1) Direct Access to Magnetic Resonance Imaging (MRI); and 2) the Neurology Department for the Management of Patients With Chronic Headache.|Recruiting||N/A|296|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||2||f||||t||||||||||2017-10-10 22:15:38.987701|2017-10-10 22:15:38.987701
NCT02753920|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-23|||March 2016||2016-03-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|June 2017|Actual|2017-06-01||Interventional|||Comparing Force of Stream to Retrograde Fill Voiding Trial After Vaginal Apex Suspension|A Randomized, Controlled Trial After Vaginal Apex Suspension Comparing Force of Stream to Traditional Retrograde Fill Voiding Trial|Active, not recruiting||N/A|154|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-10 22:15:39.084938|2017-10-10 22:15:39.084938
NCT02753907|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-25|||June 2015||2015-06-01|April 2016|2016-04-01||||September 2015|Actual|2015-09-01||Interventional|||Impact of an 8-week Linoleic Acid Intake in Soy Oil on Lp-PLA2 Activity in Healthy Adults||Completed||Phase 3|150|Actual|Yonsei University||3|||f||||||||||||||2017-10-10 22:15:39.192004|2017-10-10 22:15:39.192004
NCT02753894|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-06-17|||January 2008||2008-01-01|April 2016|2016-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia|Phase II Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia|Completed||Phase 2|73|Actual|Astellas Pharma Inc||3|||f||||f||||||||Undecided||2017-10-10 22:15:39.266062|2017-10-10 22:15:39.266062
NCT02753881|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-12-01|||November 2015||2015-11-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer|Pharmacokinetics of Doxorubicin in Conventional Transarterial Chemoembolization (cTACE) of Primary and Secondary Liver Cancer|Recruiting||Phase 1|30|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 22:15:39.403109|2017-10-10 22:15:39.403109
NCT02753868|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2017-03-05|||February 2016||2016-02-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|ACE-HD||Acute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis Patients|Acute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis Patients|Completed||N/A|12|Actual|University of Illinois at Urbana-Champaign||3|||f||||f||||||||No||2017-10-10 22:15:39.502575|2017-10-10 22:15:39.502575
NCT02753855|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-11-01|||April 2016||2016-04-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Pharmacokinetics of Telavancin in Normal and Obese Subjects|Pharmacokinetics of Telavancin in Normal and Obese Subjects|Completed||Phase 1|32|Actual|University of Illinois at Chicago||1|||f||||f||||||||No||2017-10-10 22:15:39.585935|2017-10-10 22:15:39.585935
NCT02753842|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-09-20|||May 2016||2016-05-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|C-PLEASURE||Condom Performance in a Longitudinal Enhanced Assessment of User Experiences|A Double-Blind, Single Center, Randomized 3-way Crossover Trial to Determine Pleasure for Fitted, Thin and Standard Condoms, and to Assess Clinical Failure for Vaginal and Anal Sex|Completed||N/A|504|Actual|Emory University||3|||f||||f||||||||||2017-10-10 22:15:39.663895|2017-10-10 22:15:39.663895
NCT02753829|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-27|||September 2013||2013-09-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Home-based Cardiovascular Rehabilitation, Maintenance Phase, in Subjects With Coronary Artery Disease|Home-based Cardiovascular Rehabilitation, Maintenance Phase, in Subjects With Coronary Artery Disease|Completed||N/A|33|Actual|Universidade do Porto||3|||f||||f||||||||No||2017-10-10 22:15:39.757889|2017-10-10 22:15:39.757889
NCT02753816|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||TXA Study in Major Burn Surgery|The Effect of Tranexamic Acid (TXA) on Blood Loss and Transfusion Rates in Burn Wound Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial|Recruiting||N/A|53|Anticipated|Spectrum Health Hospitals||2|||f||||t||||||||No||2017-10-10 22:15:40.020343|2017-10-10 22:15:40.020343
NCT02753803|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-09-15|||July 27, 2016|Actual|2016-07-27|September 2017|2017-09-01|March 10, 2017|Actual|2017-03-10|October 19, 2016|Actual|2016-10-19||Interventional|||Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg|A Randomized, Open-label, Multiple Dosing, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg|Completed||Phase 1|36|Actual|Dong-A ST Co., Ltd.||6|||f||||f||||||||||2017-10-10 22:15:40.192597|2017-10-10 22:15:40.192597
NCT02753790|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-15|||February 2016||2016-02-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|December 2020|Anticipated|2020-12-01||Interventional|||Whole Brain Radiation Using IMRT for Patients With Brain Metastases|Single Center, Phase II Study of Whole Brain Radiation Using IMRT to Spare the Hippocampus While Delivering Differential Doses to Subclinical Sites Versus Gross Disease for Treatment of Patients With Brain Metastases|Recruiting||Phase 2|35|Anticipated|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-10 22:15:40.390663|2017-10-10 22:15:40.390663
NCT02753777|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-11-10|||April 2016||2016-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|AIBD||Autoimmune Blistering Diseases Study|Prevalence and Clinical Severity of Autoimmune Blistering Diseases|Recruiting||N/A|150|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Blood specimens will be collected during regularly scheduled clinic visits. The specimens     will be processed and stored at the research labs belonging to the principal investigator at     the University of Pennsylvania and the Philadelphia VA Medical Center. The specimens will not     be publicly available and will be coded and stored in a locked facility equipped with a     freezer.   "|No||2017-10-10 22:15:40.528346|2017-10-10 22:15:40.528346
NCT02753764|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma|Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma|Recruiting||Phase 2|30|Anticipated|National Jewish Health||4|||f||||f||||||||Undecided||2017-10-10 22:15:40.642837|2017-10-10 22:15:40.642837
NCT02753751|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-04-24|||July 1, 2017|Anticipated|2017-07-01|December 2016|2016-12-01|December 1, 2022|Anticipated|2022-12-01|April 1, 2022|Anticipated|2022-04-01||Interventional|||Optimizing Electronic Alerts for Acute Kidney Injury|Optimizing Electronic Alerts for Acute Kidney Injury|Not yet recruiting||N/A|6030|Anticipated|Yale University||2|||f||||t|f|f||||||Yes||2017-10-10 22:15:40.763537|2017-10-10 22:15:40.763537
NCT02753738|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-25|||August 2016||2016-08-01|April 2016|2016-04-01||||August 2019|Anticipated|2019-08-01||Interventional|||Enhancement of Learning Associated Neural Plasticity by Selective Serotonin Reuptake Inhibitors|Enhancement of Learning Associated Neural Plasticity by Selective Serotonin Reuptake Inhibitors|Not yet recruiting||Phase 4|80|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 22:15:40.84932|2017-10-10 22:15:40.84932
NCT02753725|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-07-15|||April 2016||2016-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Fentanyl on Emergence Delirium (ED) on Children Undergoing Adeno-tonsilectomy at Kenyatta National Hospital (KNH)|Effect of Fentanyl Given Approximately Ten Minutes to the End of Surgery on Emergence Delirium in Children Undergoing Adeno-tonsilectomy at Kenyatta National Hospital: A Randomized Placebo Controlled Clinical Trial|Completed||N/A|110|Actual|University of Nairobi||2|||f||||t||||||||Yes|conferences, report writing|2017-10-10 22:15:40.952846|2017-10-10 22:15:40.952846
NCT02753712|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-18|||June 15, 2016|Actual|2016-06-15|December 2016|2016-12-01|August 14, 2017|Actual|2017-08-14|August 14, 2017|Actual|2017-08-14||Interventional|||A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma|A Two-arm, Randomised, Assessor-blind, Parallel Group Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) and Relvar® Ellipta® DPI on Ventilation Heterogeneity in Subjects With Partially Controlled or Uncontrolled Asthma|Completed||Phase 3|105|Actual|Mundipharma Research Limited||2|||f||||f||||||||||2017-10-10 22:15:41.035681|2017-10-10 22:15:41.035681
NCT02753699|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-07-14|2016-05-19||December 2011||2011-12-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||The Safety Set, defined as including all patients who had at least one safety observation (adverse event (AE), vital sign and/or laboratory assessment), unless excluded due to protocol deviations.|Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients|A Multi-centre Long Term Follow-up Study to Assess the Durability of Sustained Virologic Response in Alisporivir-treated Chronic Hepatitis C Patients|Completed||Phase 3|723|Actual|Debiopharm International SA||3|||f||||f||||||||||2017-10-10 22:15:41.140697|2017-10-10 22:15:41.140697
NCT02753686|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-01-06|||March 2016||2016-03-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|2 Years|Observational [Patient Registry]|Treat ER+ight||Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy|Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy|Recruiting||N/A|320|Anticipated|Novartis|||2||f||||f||||||||||2017-10-10 22:15:42.112111|2017-10-10 22:15:42.112111
NCT02753673|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-05-15|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Developing a New Questionnaire About Patient Expectations of Breast Conserving Therapy|Patient Expectations of Breast Conserving Therapy: Broadening a Patient Reported Outcomes Instrument|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:15:42.26939|2017-10-10 22:15:42.26939
NCT02753660|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-28|||August 2014||2014-08-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pendant Position and Traditional Sitting Position for Successful Spinal Puncture in Spinal Anaesthesia|Comparison Between Pendant Position and Traditional Sitting Position for Successful Spinal Puncture in Spinal Anaesthesia for Cesarean Section|Completed||N/A|308|Actual|Indonesia University||2|||f||||||||||||||2017-10-10 22:15:42.39346|2017-10-10 22:15:42.39346
NCT02753647|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-10-08|||April 2016||2016-04-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Chidamide Plus R-CHOP in Elderly DLBCL|A Prospective, Single Arm, Open-label, Phase II Study of Chidamide in Combination With R-CHOP in the Treatment of de Novo, Elderly, High-risk Diffuse Large B-cell Lymphoma|Recruiting||Phase 2|49|Anticipated|Ruijin Hospital||1|||f||||t||||||||No||2017-10-10 22:15:42.516033|2017-10-10 22:15:42.516033
NCT02753634|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-11-25|||April 2015||2015-04-01|March 2016|2016-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||An Innovative Mind-motor Exercise Approach to Osteoarthritis Treatment|An Innovative Mind-motor Exercise Approach to Osteoarthritis Treatment|Completed||N/A|22|Actual|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 22:15:42.642797|2017-10-10 22:15:42.642797
NCT02753621|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-02-28|||December 1, 2015|Actual|2015-12-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|October 1, 2016|Actual|2016-10-01||Interventional|Parkinsonics||Parkinsonics: A Controlled Study of Group Singing in Parkinson Disease|Parkinsonics: A Controlled Study of Group Singing for Quality of Life and Voice Outcomes in Parkinson Disease|Completed||Phase 2|32|Actual|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 22:15:42.763123|2017-10-10 22:15:42.763123
NCT02753608|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-08-15|||June 28, 2016|Actual|2016-06-28|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|cheqVAP||Early Detection of Ventilator-associated Pneumonia (VAP)|Exhalate Sample Collection for Raman Spectroscopy-based Early Detection of Ventilator-associated Pneumonia (VAP)|Recruiting||N/A|100|Anticipated|Jena University Hospital||2|||f||||f||||||||||2017-10-10 22:15:42.864246|2017-10-10 22:15:42.864246
NCT02753595|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-08-15|||July 13, 2016|Actual|2016-07-13|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)|A Randomized, Open-label, Multicenter, Phase 1b/2 Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)|Recruiting||Phase 1/Phase 2|114|Anticipated|Eisai Inc.||3|||f||||f||||||||||2017-10-10 22:15:42.980104|2017-10-10 22:15:42.980104
NCT02753582|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-05-27|||April 2016||2016-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||The Effect of SOD Enzyme on Frailty and HRQOL Among Indonesian Pre-frail Elderly: A Double Blind Randomized Controlled Trial|The Effect of Superoxide Dismutase (SOD) Enzyme on Frailty and Health Related Quality of Life Among Indonesian Pre-frail Elderly: A Double Blind Randomized Controlled Trial|Recruiting||Phase 4|150|Anticipated|Indonesia University||2|||f||||t||||||||No||2017-10-10 22:15:43.141795|2017-10-10 22:15:43.141795
NCT02753569|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-14|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Imaging NSCLC Treatment Response to Immunotherapy|Imaging NSCLC Treatment Response to Immunotherapy: Relating Inflammatory Activity on 18FDG PET to Tumour Specific Measures From DW-MRI|Recruiting||N/A|30|Anticipated|Institute of Cancer Research, United Kingdom|||1||f||||||||||||||2017-10-10 22:15:43.268039|2017-10-10 22:15:43.268039
NCT02753556|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-25|||April 2016||2016-04-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||ScreenFlow: Strategy for Finding Cases of Moderate-to-Severe COPD||Not yet recruiting||N/A|360|Anticipated|Dimagi Inc.|||1||f||||f||||||||No||2017-10-10 22:15:43.373518|2017-10-10 22:15:43.373518
NCT02753543|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-10-30|||November 2015||2015-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma|A Multi-center, Prospective, Single-arm, Open Label Phase II Study of Chidamide Combined With Chemotherapy in the Treatment of Peripheral T Cell Lymphoma|Recruiting||Phase 2|33|Anticipated|Ruijin Hospital||1|||f||||t||||||||No||2017-10-10 22:15:43.434592|2017-10-10 22:15:43.434592
NCT02753530|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-08-30|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Study of Arimoclomol in Inclusion Body Myositis (IBM)|Phase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM)|Recruiting||Phase 2|150|Anticipated|University of Kansas Medical Center||2|||f||||t|t|f||||||||2017-10-10 22:15:43.508459|2017-10-10 22:15:43.508459
NCT02753517|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-05-18|||December 8, 2015|Actual|2015-12-08|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|November 2018|Anticipated|2018-11-01||Interventional|SCINTIVOL||Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies|Predictive Value of Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies Stretches of 4 or More Segments on Non-cirrhotic Liver|Recruiting||N/A|400|Anticipated|University Hospital, Lille||1|||f||||t||||||||Undecided||2017-10-10 22:15:43.602599|2017-10-10 22:15:43.602599
NCT02753504|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-07-11|||April 2016||2016-04-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519|A Dose-block Randomized, Double-blind, Placebo-controlled, Multiple Dosing, Dose-escalation Phase I Clinical Trial to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 After Oral Administration in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Chong Kun Dang Pharmaceutical||3|||f||||f||||||||||2017-10-10 22:15:43.711239|2017-10-10 22:15:43.711239
NCT02753491|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-24|||October 2015||2015-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Motivational Short Interview Model in Type 2 Diabetic Patient in Primary Care in TURKEY|The Effect of Motivational Short Interview Model in Type 2 Diabetic Paitent in Primary Care in TURKEY|Completed||N/A|163|Actual|Marmara University||2|||f||||f||||||||No||2017-10-10 22:15:43.807741|2017-10-10 22:15:43.807741
NCT02753478|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-11-19|||June 2016||2016-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SINTAMI||Safety and Feasibility of Intracoronary Hypothermia in Acute Myocardial Infarction|Safety and Feasibility of Intracoronary Hypothermia in Acute Myocardial Infarction|Completed||Phase 1/Phase 2|10|Actual|Catharina Ziekenhuis Eindhoven||1|||f||||t||||||||Yes|by publishing the results in a peer reviewed journal|2017-10-10 22:15:43.878214|2017-10-10 22:15:43.878214
NCT02753465|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-05-10|||April 2016||2016-04-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Prospective Clinical Study for Laparoscopic D3 Dissection With Preservation of Left Colic Artery in Rectal Cancer|A Prospective Randomized Clinical Study for Laparoscopic D3 Lymph Node Dissection With Preservation of Left Colic Artery in Rectal Cancer Surgery|Recruiting||N/A|200|Anticipated|Fudan University||2|||f||||f||||||||Undecided||2017-10-10 22:15:43.952304|2017-10-10 22:15:43.952304
NCT02753452|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-26|||May 2015||2015-05-01|April 2016|2016-04-01||||July 2018|Anticipated|2018-07-01||Interventional|||Optimizing Life Success Through Residential Immersive Life Skills (RILS) Programs for Youth With Disabilities|Optimizing Life Success Through Residential Immersive Life Skills Programs for Youth With Disabilities|Recruiting||N/A|370|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||4|||f||||f||||||||No||2017-10-10 22:15:44.164451|2017-10-10 22:15:44.164451
NCT02753439|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-04-25|||February 2017||2017-02-01|March 2016|2016-03-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Extraction of Impacted 3rd Molars, Can Bone Support of the Second Molar be Promoted by a Bio-Oss Graft?|Extraction of Impacted 3rd Molars, Can Bone Support of the Second Molar be Promoted by a Bio-Oss Graft?|Not yet recruiting||N/A|40|Anticipated|The Baruch Padeh Medical Center, Poriya||1|||f||||t||||||||No||2017-10-10 22:15:44.295913|2017-10-10 22:15:44.295913
NCT02753413|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-06-13|2017-06-13||April 1, 2016||2016-04-01|July 2016|2016-07-01|June 28, 2016|Actual|2016-06-28|June 28, 2016|Actual|2016-06-28||Interventional|||Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women|An Observer-blind Safety and Reactogenicity Study to Assess GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women|Completed||Phase 2|102|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 22:15:44.517708|2017-10-10 22:15:44.517708
NCT02753400|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-03-20|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy|A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Pilot Study to Evaluate Effects of Emixustat Hydrochloride on Aqueous Humor Biomarkers Associated With Proliferative Diabetic Retinopathy|Recruiting||Phase 2|20|Anticipated|Acucela Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:15:46.115168|2017-10-10 22:15:46.115168
NCT02753387|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-05-29|||May 23, 2016|Actual|2016-05-23|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|ORAL-ISO||Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer|Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer|Recruiting||Phase 3|80|Anticipated|Rennes University Hospital||2|||f||||f||||||||No||2017-10-10 22:15:46.208184|2017-10-10 22:15:46.208184
NCT02753374|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-04-27|||May 2016||2016-05-01|April 2016|2016-04-01|July 2030|Anticipated|2030-07-01|May 2030|Anticipated|2030-05-01||Observational|||Registry Study on Cystic Fibrosis in Chinese Children|Registry Study on Cystic Fibrosis in Chinese Children-a Multicenter, Prospective Cohort Study|Not yet recruiting||N/A|100|Anticipated|Beijing Children's Hospital|||1||f||||t||||||||||2017-10-10 22:15:46.305408|2017-10-10 22:15:46.305408
NCT02753361|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-26|||May 2016||2016-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Ultra-sounded Guided Regional Blockade for Lipoma Excision|Ultrasound‐Guided Regional Blockade for Lipoma Excision: a New Approach to an Old Technique|Not yet recruiting||Phase 4|50|Anticipated|Suez Canal University||2|||f||||f||||||||Undecided||2017-10-10 22:15:46.378438|2017-10-10 22:15:46.378438
NCT02753348|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-26|||April 2016||2016-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Copenhagen Baby Heart|Copenhagen Baby Heart|Enrolling by invitation||N/A|30000|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     Blood sample from umbilical cord for DNA extraction and analysis of biomarkers.   "|||2017-10-10 22:15:46.464404|2017-10-10 22:15:46.464404
NCT02753335|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Comparison of Two Treatments for CRPS and Changes in Resting-State Connectivity of Cerebral Networks.|A Randomized Trial of Patients With Complex Regional Pain Syndrome Comparing Graded Motor Imagery and Desensitization Versus Simple Desensitization and Changes in Resting-State Connectivity of Cerebral Networks Before and After Treatment.|Recruiting||N/A|42|Anticipated|University of Tromso||2|||f||||f||||||||No||2017-10-10 22:15:46.536594|2017-10-10 22:15:46.536594
NCT02753322|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-26|||April 2016||2016-04-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Training Dual-task Balance and Walking in People With Stroke|Training Dual-task Balance and Walking in People With Stroke: a Randomized Controlled Trial|Recruiting||N/A|84|Anticipated|The Queen Elizabeth Hospital||3|||f||||t||||||||No||2017-10-10 22:15:46.631491|2017-10-10 22:15:46.631491
NCT02753309|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-28|||June 2016||2016-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer|A Randomized Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer|Recruiting||Early Phase 1|30|Anticipated|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-10-10 22:15:46.73034|2017-10-10 22:15:46.73034
NCT02753296|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-04-22|||May 2016||2016-05-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Development and Evaluation of a Fertility Preservation Patient Decision Aid for Women With Cancer.|Development and Evaluation of a Patient Fertility Preservation Decision Aid for Women With Cancer: The Cancer, Fertility and Me Research Study|Not yet recruiting||N/A|98|Anticipated|University of Sheffield|||1||f||||f||||||||No||2017-10-10 22:15:46.841998|2017-10-10 22:15:46.841998
NCT02753283|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-05-23|||June 2016||2016-06-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|PROUD||Preventing Osteoporosis Using Denosumab|Sustaining Skeletal Health in Frail Elderly|Recruiting||Phase 4|212|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-10 22:15:46.936401|2017-10-10 22:15:46.936401
NCT02753270|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-05-01|||December 2014||2014-12-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Ultrasound Guided Foam Sclerotherapy Transcatheter in Great Saphenous Vein, Preceded of Tumescence.|Ultrasound Guided Foam Sclerotherapy Transcatheter in Great Saphenous Vein, Preceded of Tumescence. Randomized Controlled Trial.|Active, not recruiting||N/A|50|Actual|University of Sao Paulo||2|||f||||f||||||||Yes||2017-10-10 22:15:47.024413|2017-10-10 22:15:47.024413
NCT02753257|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-04-26|||September 2016||2016-09-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|VALISS||Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation|Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation (VALISS)|Active, not recruiting||N/A|250|Anticipated|Valtari Bio|||1||f||||t||||||Samples With DNA|"     Venous blood samples will be collected from all patients at baseline resulting in two 2.5 ml     Paxgene RNA tubes, two 8 ml EDTA tube, and one 7 ml serum tube. Approximately 28 ml of blood     will be collected.   "|Yes||2017-10-10 22:15:47.274002|2017-10-10 22:15:47.274002
NCT02753244|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-03-01|||April 2015||2015-04-01|March 2017|2017-03-01||||September 2017|Anticipated|2017-09-01||Interventional|||Cognitive Motion-Based Videogames Exploratory Study in Acquired Brain Injury|A Study to Assess the Feasibility of Intendu Cognitive Motion-Based Videogames in Acquired Brain Injury Patients and to Evaluate the Effects of Training on Their Cognitive Performance|Recruiting||N/A|50|Anticipated|Intendu Ltd.||3|||f||||f||||||||No||2017-10-10 22:15:47.363345|2017-10-10 22:15:47.363345
NCT02753231|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-05-03|||January 2017||2017-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HEPAFIT||Exercise Training and Hepatic Metabolism in Overweight/Obese Adolescent|Effects of an Exercise Program on Hepatic Metabolism and Cardiovascular Health in Overweight/Obese Adolescent From Bogota, Colombia (HEPAFIT Study)|Not yet recruiting||N/A|120|Anticipated|Universidad Santo Tomas||4|||f||||t||||||||No||2017-10-10 22:15:47.483473|2017-10-10 22:15:47.483473
NCT02753218|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects|LEO 32731 - A Phase I Drug-Drug Interaction Study With LEO 32731 and Midazolam in Healthy Male Subjects|Terminated||Phase 1|12|Actual|LEO Pharma||1||"Due to tolerability issues related to the dose titration, unexpected withdrawals were observed   and it was unlikely for the trial to meet its objectives"|f||||f||||||||||2017-10-10 22:15:47.602388|2017-10-10 22:15:47.602388
NCT02753205|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-11-08|||April 2016||2016-04-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Dexmedetomidine on Optic Nerve Sheath Diameter|Effect of Dexmedetomidine on Optic Nerve Sheath Diameter During Laparoscopic Anterior Resection|Withdrawn||N/A|0|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||No||2017-10-10 22:15:47.680964|2017-10-10 22:15:47.680964
NCT02753192|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-25|||January 2014||2014-01-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|FraLusoPark||Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison|Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison|Recruiting||N/A|120|Anticipated|Centre National de la Recherche Scientifique, France||1|||f||||f||||||||Undecided|Undecided|2017-10-10 22:15:47.770406|2017-10-10 22:15:47.770406
NCT02753179|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-13|||May 2016||2016-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|COSQOL||Covert-saccades, Dynamic Visual Acuity and Quality of Life|Quality of Life and Dynamic Visual Acuity in Patients With Bilateral Vestibulopathy: the Impact of Covert-saccades|Completed||N/A|20|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:15:47.878867|2017-10-10 22:15:47.878867
NCT02753166|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-01-31|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Dexamethasone as an Immediate Intervention|Dexamethasone as an Immediate Intervention to Reduce Long-Term Stress Responses|Recruiting||Phase 1|100|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:15:47.973774|2017-10-10 22:15:47.973774
NCT02753153|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-22|||May 2011||2011-05-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Extraction Socket Management Using Connective Tissue Graft Versus Mucograft®|Extraction Socket Management Using Connective Tissue Graft Versus Mucograft®: A Randomized Controlled Trial|Completed||Phase 4|14|Actual|University Hospital of Liege||2|||f||||f||||||||No||2017-10-10 22:15:48.068542|2017-10-10 22:15:48.068542
NCT02753140|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-24|||April 2016||2016-04-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy|Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Versus Concomitant Cetuximab With Radiotherapy After Neoadjuvant Chemotherapy: a Randomized, Opened, Multicenter Phase II Trial|Not yet recruiting||Phase 2|60|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||||||||||||2017-10-10 22:15:48.146826|2017-10-10 22:15:48.146826
NCT02753114|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2017-04-16|||May 1, 2017|Anticipated|2017-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PAIN-K||Prehospital Analgesia With Intra-Nasal Ketamine|Prehospital Analgesia With Intra-Nasal Ketamine|Not yet recruiting||Phase 4|40|Anticipated|University of British Columbia||2|||f||||t|f|f||||||Undecided||2017-10-10 22:15:48.758758|2017-10-10 22:15:48.758758
NCT02753101|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-26|||February 2016||2016-02-01|April 2016|2016-04-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||[18F]FTC-146 PET/MRI in Healthy Volunteers and in CRPS and Sciatica|Biodistribution and Pharmacokinetic Determination of the PET Radiopharmaceutical [18F]FTC-146 Using PET/MRI in Healthy (Asymptomatic) Volunteers and in Patients With CRPS and Sciatica|Recruiting||Early Phase 1|30|Anticipated|Stanford University||1|||f||||f||||||||No||2017-10-10 22:15:48.880783|2017-10-10 22:15:48.880783
NCT02753088|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-10-31|||October 2013||2013-10-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis|"International, Multicentre, Double-blind, Placebo-controlled, Comparative, Randomized Study to Compare Efficacy and Safety of the Generic Drug BCD-063 (CJSC BIOCAD, Russia) and Copaxone®-Teva (Teva Pharmaceutical Industries Limited, Israel) in Patients With Relapsing-remitting Multiple Sclerosis"|Completed||Phase 3|158|Actual|Biocad||3|||f||||||||||||||2017-10-10 22:15:49.154717|2017-10-10 22:15:49.154717
NCT02753075|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-01-16|2016-08-05||September 2015||2015-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.|A Clinical Study Investigating the Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity|Completed||N/A|240|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-10 22:15:49.25953|2017-10-10 22:15:49.25953
NCT02753062|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-24|||August 2015||2015-08-01|April 2016|2016-04-01|August 2023|Anticipated|2023-08-01|August 2018|Anticipated|2018-08-01||Interventional|PTLD||Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma|Multicenter Phase II Study of Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma (DLBCL) Type Monomorphic Post-transplant Lymphoproliferative Disorder|Recruiting||Phase 2|22|Anticipated|Asan Medical Center||1|||f||||t||||||||Yes|we will share collected data with principal investigators in Korea|2017-10-10 22:15:49.787356|2017-10-10 22:15:49.787356
NCT02753049|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-04-10|||November 23, 2016|Actual|2016-11-23|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|ACCESS||Adherence Connection for Counseling, Education, and Support|Adherence Connection for Counseling, Education, and Support (ACCESS): A Proof of Concept Study|Recruiting||N/A|50|Anticipated|New York University||1|||f||||t|f|f||||||Undecided||2017-10-10 22:15:49.889387|2017-10-10 22:15:49.889387
NCT02753036|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-07-18|||January 2016||2016-01-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Observational|CICARO||Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer|Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer (CICARO)|Recruiting||N/A|160|Anticipated|Charite University, Berlin, Germany|||4||f||||t||||||Samples Without DNA|"     serum samples   "|||2017-10-10 22:15:49.969039|2017-10-10 22:15:49.969039
NCT02753023|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-06-05|||May 2015|Actual|2015-05-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|January 2019|Anticipated|2019-01-01|5 Years|Observational [Patient Registry]|ROAD-Brazil||Registry Of Acute meDical Emergencies in Brazil|Registry Of Acute meDical Emergencies in Brazil - ROAD-Brazil|Recruiting||N/A|1650|Anticipated|University of Sao Paulo General Hospital|||8||f||||f||||||||No||2017-10-10 22:15:50.133319|2017-10-10 22:15:50.133319
NCT02753010|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-26|||March 2011||2011-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|GASEMPHIP||Gastric Emptying in Elderly With Hip Fracture|Gastric Emptying Time of a Carbohydrate-rich Drink in Elderly Patients With Acute Hip Fracture: a Pilot Study|Completed||Phase 2|30|Actual|Uppsala University|||3||f||||f||||||||No||2017-10-10 22:15:50.247924|2017-10-10 22:15:50.247924
NCT02752997|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-23|||December 2015||2015-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services|Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services|Completed||N/A|24|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:15:50.344665|2017-10-10 22:15:50.344665
NCT02752984|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-26|||April 2016||2016-04-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|DVT-PICC||Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion|Prospective Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion|Recruiting||N/A|400|Anticipated|IRCCS Policlinico S. Matteo|||1||f||||f||||||||No||2017-10-10 22:15:50.450733|2017-10-10 22:15:50.450733
NCT02752971|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-04-26|||February 2015||2015-02-01|April 2016|2016-04-01||||February 2016|Actual|2016-02-01||Interventional|diclofenac||Wound Infiltration With Sodium Diclofenac vs Bupivacaine for Postoperative Pain Following Appendectomy|Surgical Wound Infiltration With Sodium Diclofenac Versus Bupivacaine in the Treatment of Acute Postoperative Pain Following Appendectomy|Completed||Phase 3|43|Actual|Hospital Central Dr. Luis Ortega||3|||f||||||||||||||2017-10-10 22:15:50.533687|2017-10-10 22:15:50.533687
NCT02752958|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-03-03|||May 2016||2016-05-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health|Study to Investigate the Impact on Oral Health Related Quality of Life of Managing Dentine Hypersensitivity With a Daily Use Anti-Sensitivity Toothpaste|Completed||N/A|63|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:15:50.614968|2017-10-10 22:15:50.614968
NCT02752945|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-03|||April 2016|Actual|2016-04-01|April 2016|2016-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||"Feasibility Trial of a One-day CBT Workshop (DISCOVER) for 15-18 Year Olds With Anxiety and/or Depression in Clinics"|"Feasibility Randomised Controlled Trial of a One-day CBT Workshop (DISCOVER) for 15-18 Year Olds With Anxiety and/or Depression in Clinic Settings"|Completed||N/A|28|Actual|King's College London||2|||f||||f||||||||No||2017-10-10 22:15:50.701314|2017-10-10 22:15:50.701314
NCT02752932|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-22|||November 2015||2015-11-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Xenograft||TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study|TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study|Recruiting||N/A|60|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 22:15:50.799448|2017-10-10 22:15:50.799448
NCT02752919|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2016-06-30|||April 2016||2016-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of Galunisertib in Healthy Participants|A Single Dose Study to Evaluate the Exposure-Response Relationship Between Galunisertib (LY2157299) and QT Interval in Healthy Japanese and Non-Japanese Subjects|Completed||Phase 1|40|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:15:50.907991|2017-10-10 22:15:50.907991
NCT02752906|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-09-29|||December 20, 2016|Actual|2016-12-20|September 2017|2017-09-01|December 20, 2016|Actual|2016-12-20|December 20, 2016|Actual|2016-12-20||Interventional|||Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine|Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults|Completed||Phase 3|810|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:15:50.99908|2017-10-10 22:15:50.99908
NCT02752893|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-05-12|||January 30, 2017|Actual|2017-01-30|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Observational|||Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts|Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts|Recruiting||N/A|100|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||No||2017-10-10 22:15:51.176541|2017-10-10 22:15:51.176541
NCT02752880|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-26|2017-02-14|||June 2016||2016-06-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||The Efficacy and Safety of Chinese Herbal Medicine YH1 as Add-On Medication in Poorly Controlled Type 2 Diabetes Patients||Recruiting||Phase 2/Phase 3|80|Anticipated|Chang Gung Memorial Hospital||2|||f||||||||||||||2017-10-10 22:15:51.288076|2017-10-10 22:15:51.288076
NCT02752867|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-07-27|||December 2016||2016-12-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||An fMRI Study of Jianpi Yishen Huatan Granules for Cognitive Impairment After Acute Cerebral Infarction|Functional Magnetic Resonance Imaging Study to Explore the Mechanism and the Efficacy and Safety of Jianpi Yishen Huatan Granule for Cognitive Impairment After Acute Cerebral Infarction|Recruiting||N/A|40|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||2|||f||||t||||||||||2017-10-10 22:15:51.391868|2017-10-10 22:15:51.391868
NCT02752854|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-26|||April 2015||2015-04-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||Pain Threshold Measurements in High and Low Altitude Among Healthy Volunteer Adults: A Comparative Study|Pain Threshold Measurements in High and Low Altitude Among Healthy Volunteer Adults: A Comparative Study|Enrolling by invitation||N/A|484|Anticipated|Taif University|||2||f||||f||||||||No||2017-10-10 22:15:51.520548|2017-10-10 22:15:51.520548
NCT02752841|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-26|||May 2016||2016-05-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effect of Vitamin D Repletion on Kidney Stone Risk|The Effect of Vitamin D Repletion on Urinary Calcium Excretion in Kidney Stone Formers With Vitamin D Deficiency and High Urinary Calcium|Not yet recruiting||N/A|50|Anticipated|Brown University||1|||f||||f||||||||Undecided||2017-10-10 22:15:51.605255|2017-10-10 22:15:51.605255
NCT02752815|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-10-30|||April 2016||2016-04-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Reduced Chemotherapy in Low Risk DLBCL|Four Cycles of R-CHOP Followed by Four Cycles of Rituximab Versus Six Cycles of R-CHOP Followed by Two Cycles of Rituximab in the Treatment of de Novo, Low-risk, Non-bulky Diffuse Large B-cell Lymphoma.|Recruiting||Phase 4|290|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-10 22:15:52.018819|2017-10-10 22:15:52.018819
NCT02752802|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-01-09|2016-11-04||April 2016||2016-04-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||DyeVert System RCT|Single Site Randomized Control Trial Evaluating the DyeVert System|Completed||N/A|96|Actual|Osprey Medical, Inc||2|||f||||f||||||||No||2017-10-10 22:15:52.109316|2017-10-10 22:15:52.109316
NCT02752789|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-11-30|||July 2014||2014-07-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function|An Observational Cohort Study to Determine the Impact of Alloantibodies and Antibodies to Self Antigens on Chronic Graft Function up to 5 Years After Pediatric Heart Transplantation (CTOTC-09)|Active, not recruiting||N/A|404|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     Whole blood, plasma, PBMC and tissue   "|||2017-10-10 22:15:52.341514|2017-10-10 22:15:52.341514
NCT02752776|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-16|||March 17, 2016|Actual|2016-03-17|August 2017|2017-08-01|March 26, 2018|Anticipated|2018-03-26|August 18, 2017|Anticipated|2017-08-18||Interventional|PROSE||A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.|An Open-label, Prospective, Non-randomized, Multicenter Study to Evaluate Clear Skin Effect on Health Related Quality of Life Outcomes at 16 and 52 Weeks in Patients With Moderate to Severe Plaque Psoriasis Treated With Secukinumab 300 mg s.c. With or Without Previous Exposure to Systemic Therapy.|Active, not recruiting||Phase 4|1661|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-10 22:15:52.66231|2017-10-10 22:15:52.66231
NCT02752763|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-26|||October 2015||2015-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of Autologous Serum Versus Preservative Free Artificial Tear|Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients With Dry Eye Due to Systemic Isotretinoin Therapy|Completed||Phase 4|24|Actual|Niğde State Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:15:53.248168|2017-10-10 22:15:53.248168
NCT02752750|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-28|||May 2016||2016-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease|Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease|Enrolling by invitation||N/A|50|Anticipated|Medical University of Graz|||2||f||||f||||||||||2017-10-10 22:15:53.366591|2017-10-10 22:15:53.366591
NCT02752737|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-06-02|||May 2016||2016-05-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01|12 Months|Observational [Patient Registry]|||Cryo AF Global Registry|Cryo AF Global Registry|Recruiting||N/A|1000|Anticipated|Medtronic Atrial Fibrillation Solutions|||1||f||||f||||||||||2017-10-10 22:15:53.45441|2017-10-10 22:15:53.45441
NCT02752724|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|KAID||Ketamine Anesthesia for Improvement of Depression in ECT|Ketamine vs. Methohexital Anesthesia for Improvement of Major Depressive Disorder in Electroconvulsive Therapy|Recruiting||N/A|50|Anticipated|VA Puget Sound Health Care System||2|||f||||t||||||||No||2017-10-10 22:15:53.569558|2017-10-10 22:15:53.569558
NCT02752711|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-28|||May 2013||2013-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|||Validation of the PECARN Clinical Decision Rule for Children With Minor Head Trauma|Validation of the PECARN Clinical Decision Rule for Children With Minor Head Trauma: a French Multicenter Prospective Study|Completed||N/A|1499|Actual|Nantes University Hospital|||1||f||||f||||||||No||2017-10-10 22:15:53.697644|2017-10-10 22:15:53.697644
NCT02752698|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-08-10|||January 1, 2015||2015-01-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Observational|||Domestic Surgical Robot Clinical Study|Safty and Feasible Study of Domestic Surgical Robot That Had Been Authorized to Enter the Clinical Trial Stage|Recruiting||N/A|30|Anticipated|The Third Xiangya Hospital of Central South University|||3||f||||t||||||||||2017-10-10 22:15:53.783845|2017-10-10 22:15:53.783845
NCT02752685|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-03-15|||June 2016||2016-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer|Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer|Recruiting||N/A|50|Anticipated|New York University School of Medicine|||1||||||t|t|f||||||||2017-10-10 22:15:53.88531|2017-10-10 22:15:53.88531
NCT02752672|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-01-11|||March 2016||2016-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|||Study on the Therapeutic Mechanisms of Dithranol Treatment in Patients With Chronic Plaque Psoriasis|Study on the Therapeutic Mechanisms of Dithranol Treatment With Regard to Pro- and Contra-inflammatory Factors, microRNA as Well as Lymph and Blood Vessels in Patients With Chronic Plaque Psoriasis|Recruiting||N/A|15|Anticipated|Medical University of Graz|||1||f||||f||||||Samples With DNA|"     Skin Biopsies   "|||2017-10-10 22:15:53.991065|2017-10-10 22:15:53.991065
NCT02752659|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-01-09|||June 2016||2016-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Reliability and Validity of Self-measured Arm Circumference in Women With Breast Cancer|Reliability and Validity of Self-measured Arm Circumference in Women With Breast Cancer|Recruiting||N/A|40|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:15:54.080877|2017-10-10 22:15:54.080877
NCT02752646|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-03-03|||April 2016||2016-04-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%|Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%|Completed||N/A|200|Actual|MDbackline, LLC||2|||f||||f||||||||No|There is not a plan to make individual patient data available.|2017-10-10 22:15:54.173214|2017-10-10 22:15:54.173214
NCT02752620|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-10-11|||May 2016||2016-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Osteopathic Manipulative Treatment Versus Therapeutic Exercises in Subjects With Chronic Non-specific Low Back Pain|Osteopathic Manipulative Treatment Versus Therapeutic Exercises in Subjects With Chronic Non-specific Low Back Pain: a Randomized Controlled and Double-blind Trial|Completed||N/A|38|Actual|Rio de Janeiro State University||2|||f||||t||||||||No||2017-10-10 22:15:54.35294|2017-10-10 22:15:54.35294
NCT02752607|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-26|||May 2016||2016-05-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|STEP-CAT||Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots|The STEP-CAT Cohort Management Study: Step-down to Prophylactic Doses of Enoxaparin After a Minimum of 3-6 Months of Anticoagulation for the Treatment of Cancer-associated Thrombosis.|Not yet recruiting||N/A|150|Anticipated|Lady Davis Institute|||1||f||||||||||||No||2017-10-10 22:15:54.430403|2017-10-10 22:15:54.430403
NCT02752581|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-26|||January 2009||2009-01-01|April 2016|2016-04-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of Peroperative Suction Drain Usage in Arthroscopic Knee Surgery|Efficacy of Peroperative Suction Drain Usage in Arthroscopic Knee Surgery|Completed||N/A|110|Actual|Trakya University||2|||f||||f||||||||No||2017-10-10 22:15:54.563213|2017-10-10 22:15:54.563213
NCT02752568|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2016-04-26|||May 2016||2016-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure|Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure.A Comparative Study|Not yet recruiting||N/A|300|Anticipated|Kasr El Aini Hospital||3|||f||||f||||||||No||2017-10-10 22:15:54.645786|2017-10-10 22:15:54.645786
NCT02752555|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-11-25|||April 2016||2016-04-01|November 2016|2016-11-01||||December 2016|Anticipated|2016-12-01||Interventional|OAT||Severe Male Factor Infertility Management|Investigating the Effect of Modifiable Lifestyle Factors in Severe Oligoasthenotertozoospermic Men Combined With Antioxidant Treatment Prior ICSI|Recruiting||N/A|60|Anticipated|Benha University||2|||f||||t||||||||Yes|Publishing a manuscript|2017-10-10 22:15:54.727972|2017-10-10 22:15:54.727972
NCT02752542|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-04-25|||October 31, 2016|Actual|2016-10-31|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|CANBIND6||Personalized Indications for CBT and Antidepressants in Treating Depression|Personalized Indications for Cognitive Behavioural Therapy and Antidepressants in the Treatment of Major Depressive Disorder and Persistent Depressive Disorder|Recruiting||Phase 4|360|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||Yes|The investigators will not share any identifiable or anonymized data with parties other than the participating established academic institutions, which will sign a data transfer agreement (DTA) which will be created in collaboration with NSHA Research Services and subscribe to the code of ethics and confidential to rules commensurate with the TCPS2.|2017-10-10 22:15:54.841129|2017-10-10 22:15:54.841129
NCT02752529|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-28|||March 2016||2016-03-01|March 2016|2016-03-01||||December 2019|Anticipated|2019-12-01||Interventional|||The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter||Recruiting||N/A|415|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-10 22:15:54.940367|2017-10-10 22:15:54.940367
NCT02752516|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-09-15|||April 27, 2016|Actual|2016-04-27|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics|Phase I Additional Study of Tolerance and Pharmacokinetics of Anlotinib in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|16|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f||||||||||2017-10-10 22:15:55.132211|2017-10-10 22:15:55.132211
NCT02752503|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-22|||March 2015||2015-03-01|April 2016|2016-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||Nalmefene in Alcohol Dependence and Borderline Personality Disorder|Open-label Trial on Therapeutic Effect and Tolerability of Nalmefene in Subjects With Alcohol Use Disorder and Comorbid Borderline Personality Disorder|Recruiting||N/A|30|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||||||||||||2017-10-10 22:15:55.205443|2017-10-10 22:15:55.205443
NCT02752477|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-03-20|||August 2, 2016|Actual|2016-08-02|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Opioid-free Anesthesia in Reducing Postoperative Pain in Chronic Pain Patients Undergoing Spinal Surgery|Efficacy of Opioid-free Anesthesia in Reducing Postoperative Pain in Chronic Pain Patients Undergoing Spinal Surgery: A Pilot Study|Recruiting||Phase 3|30|Anticipated|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 22:15:55.390119|2017-10-10 22:15:55.390119
NCT02752464|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Behavioral CVD Prevention Using Informatics|Behavioral Cardiovascular Disease Prevention Using Informatics|Recruiting||N/A|148|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:15:55.49095|2017-10-10 22:15:55.49095
NCT02752451|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-06-02|||March 2015||2015-03-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|CBA||Cigar Box Arthroscopy: A Study of Non-Anatomic Arthroscopy Training|Cigar Box Arthroscopy: A Randomized Controlled Trial Validates Non-Anatomic Simulation Training of Novice Arthroscopy Skills|Completed||N/A|24|Actual|University of Arizona||3|||f||||f||||||||Undecided||2017-10-10 22:15:55.576866|2017-10-10 22:15:55.576866
NCT02752438|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-23|2016-09-12|||May 2016||2016-05-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01|3 Months|Observational [Patient Registry]|RescueHFO||Rescue High Frequency Oscillatory Ventilation in Newborns Who Do Not Respond to Conventional Ventilation|Rescue High Frequency Oscillatory Ventilation in Newborns Who Do Not Respond to Conventional Ventilation|Recruiting||N/A|400|Anticipated|Ankara University|||2||f||||t||||||||No|No individual data will be shared.|2017-10-10 22:15:55.640357|2017-10-10 22:15:55.640357
NCT02752425|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-30|||May 2016||2016-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|REVISON||Visual Feedback of Tongue by Ultrasound Echography for Speech Trouble Rehabilitation|Visual Feedback of Tongue by Ultrasound Echography for Speech Trouble Rehabilitation|Recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:15:55.742822|2017-10-10 22:15:55.742822
NCT02752399|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-22|||April 2016||2016-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Six Minutes Walk Test and Shuttle Walk Test in Eisenmenger Syndrome|Applicability of the Six Minutes Walk Test and Shuttle Walk Test and Evaluation of Peripheral and Respiratory Muscle Function, Autonomic Control, Quality of Life and Sleep, Inflammatory Markers and Tissue Perfusion in Eisenmenger Syndrome|Recruiting||N/A|60|Anticipated|Federal University of São Paulo|||1||f||||f||||||||No||2017-10-10 22:15:56.133551|2017-10-10 22:15:56.133551
NCT02752386|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-05-15|||February 2016||2016-02-01|May 2017|2017-05-01|January 2023|Anticipated|2023-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Biofeedback Training to Control Pain Processing|Biofeedback Training to Control Pain Processing|Recruiting||N/A|105|Anticipated|University of Tulsa||3|||f||||f||||||||No||2017-10-10 22:15:56.203843|2017-10-10 22:15:56.203843
NCT02752373|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-03-16|||May 2016||2016-05-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Observational|||A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization|A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization|Terminated||N/A|5|Actual|Brain Sentinel|||1|This study was terminated due to low enrollment|f||||f||||||||No||2017-10-10 22:15:56.28254|2017-10-10 22:15:56.28254
NCT02752360|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-06-18|||April 2016||2016-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis|Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Surgery of Intestinal Anastomosis: A Multicenter, Prospective Cohort Study|Recruiting||Phase 1|288|Anticipated|Beijing Friendship Hospital||2|||f||||t||||||||||2017-10-10 22:15:58.11682|2017-10-10 22:15:58.11682
NCT02752334|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-04-21|||September 2015||2015-09-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|Mg||Magnesium Sulphate in the Ultrasound-guided Supraclavicular Brachial Plexus Block|The Effect on Outcome of Adding Magnesium Sulphate to Bupivacaine in the Ultrasound-guided Supraclavicular Brachial Plexus Block Anesthesia|Recruiting||Phase 2|60|Anticipated|Magrabi Eye & Ear Hospital||2|||f||||t||||||||Undecided|yes|2017-10-10 22:15:58.303332|2017-10-10 22:15:58.303332
NCT02752321|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-07-25|||August 2016||2016-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Electronic Multimedia Discharge Application|Video Assisted Transitions of Care: The Power of Video for Hospital Discharge Process|Recruiting||N/A|192|Anticipated|Northwell Health||2|||f||||f||||||||||2017-10-10 22:15:58.412417|2017-10-10 22:15:58.412417
NCT02752308|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-25|||September 2014||2014-09-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effectiveness of Caudal Epidural Block on Intraoperative Blood Loss During Hypospadias Repair|Effectiveness of Caudal Epidural Block on Intraoperative Blood Loss During Hypospadias Repair; A Randomized Clinical Trial|Completed||Phase 2/Phase 3|60|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||No||2017-10-10 22:15:58.499874|2017-10-10 22:15:58.499874
NCT02752295|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-09-15|||May 2015||2015-05-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|ISCIW||Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients|Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients|Completed||N/A|43|Actual|Medical University of Vienna||3|||f||||f||||||||No||2017-10-10 22:15:58.585753|2017-10-10 22:15:58.585753
NCT02752282|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-04-14|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|ACCCUSS||Anticipatory Counseling on LNG-IUS Continuation, Utilization and Satisfaction: A Pilot Study|Anticipatory Counseling on LNG-IUS Continuation, Utilization and Satisfaction: A Pilot Study|Completed||N/A|30|Actual|University of Washington||2|||f||||f||||||||||2017-10-10 22:15:58.676189|2017-10-10 22:15:58.676189
NCT02752269|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-11-29|||October 2014||2014-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome|Early Detection of Pulmonary- and Pulmonary Vascular Disease in Patients Suffering From Sjögren Syndrome|Recruiting||N/A|100|Anticipated|Medical University of Graz|||1||f||||f||||||||No||2017-10-10 22:15:58.763778|2017-10-10 22:15:58.763778
NCT02752256|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-04-13|||October 2015||2015-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Thrombolytic Care During Inter-hospital Transfer|"Quality and Effectiveness of Thrombolytic Care During Inter-hospital Transfer (Drip-Ship) With Air Ambulance Services"|Recruiting||N/A|70|Anticipated|University of Iowa|||2||f||||f||||||||||2017-10-10 22:15:58.847451|2017-10-10 22:15:58.847451
NCT02752243|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-01-31|||March 2016||2016-03-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.|A Prospective Phase I/II Study to Investigate the Feasibility, Safety and Efficacy of IL-15 Activated Cytokine Induced Killer (CIK) Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After Allogeneic SCT|Recruiting||Phase 1/Phase 2|40|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||No||2017-10-10 22:15:58.923832|2017-10-10 22:15:58.923832
NCT02752230|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-08-12|||April 2016||2016-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison of Exparel to Marcaine in Post-Surgical Analgesia in Bariatrics|Comparison of Exparel (Bupivacaine Liposome) to Marcaine (Bupivacaine) in Post-Surgical Analgesia for Laparoscopic Trocar Site Incisions in Bariatric Surgery|Not yet recruiting||Phase 4|142|Anticipated|Kettering Health Network||2|||f||||f||||||||||2017-10-10 22:15:59.146999|2017-10-10 22:15:59.146999
NCT02752204|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-05-02|||October 2015||2015-10-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Interventional|TORCH||An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma|Torch: A Phase II Study to Determine the Safety and Efficacy of the Dual mTORC Inhibitor AZD2014 and to Investigate Additional Toxicities in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)|Active, not recruiting||Phase 2|36|Actual|University of Birmingham||2|||f||||t||||||||Undecided||2017-10-10 22:15:59.341549|2017-10-10 22:15:59.341549
NCT02752191|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease||Recruiting||Phase 4|120|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 22:15:59.476816|2017-10-10 22:15:59.476816
NCT02752178|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-11-11|||June 2015||2015-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|BIODEP||Peripheral Immunomarker Validation in Treatment-resistant Depression|A Clinical Biomarker Study of Immunological Phenotypes Associated With Monoaminergic Anti-depressant Response, and the Brain and Cognitive Phenotypes Associated With Variation in Peripheral C-reactive Protein (CRP) Levels, in Patients With Major Depressive Disorder (MDD).|Recruiting||N/A|250|Anticipated|University of Cambridge|||4||f||||f||||||Samples With DNA|"     Blood and saliva samples will be stored in a linked anonymised form for immunophenotyping and     DNA analysis   "|Yes|All publications resulting from this study will be made available Open Access. Additionally, supporting research data will be also made available. This page will be updated with information about research outputs as soon as they become available.|2017-10-10 22:15:59.574401|2017-10-10 22:15:59.574401
NCT02752165|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-10-05|||August 2016||2016-08-01|October 2017|2017-10-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Interventional|TEAM-ED||Telemedicine Enhanced Asthma Management Through the Emergency Department|Telemedicine Enhanced Asthma Management Through the Emergency Department|Recruiting||N/A|430|Anticipated|University of Rochester||2|||f||||||||||||||2017-10-10 22:15:59.717515|2017-10-10 22:15:59.717515
NCT02752152|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-11-01|||December 2015||2015-12-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|Lightning||Counseling for HIV and STIs Screening|A Randomized Study to Compare Three Counseling Strategies for HIV, Hepatitis B and C, and Syphilis Testing|Recruiting||N/A|1600|Anticipated|Institut de Recherche pour le Developpement||3|||f||||f||||||||Undecided|To be discussed with the steering committee|2017-10-10 22:15:59.838076|2017-10-10 22:15:59.838076
NCT02752139|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-07-28|||May 2016||2016-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|6 Months|Observational [Patient Registry]|||Cerebral Hemodynamics in Sleep Disorders|Cerebral Hemodynamics in Sleep Disorders|Recruiting||N/A|300|Anticipated|First Hospital of Jilin University|||2||f||||t||||||||||2017-10-10 22:15:59.946106|2017-10-10 22:15:59.946106
NCT02752126|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-08-22|||June 2016||2016-06-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|PROACTIVE||A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus|A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus|Recruiting||N/A|90|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-10 22:16:00.036252|2017-10-10 22:16:00.036252
NCT02752113|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-28|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|ELMI||Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes|ELMI - Prospective, Randomized, Controlled, Parallel-arm Study to Assess the Effects of the Combined Therapy of Empagliflozin and Linagliptin Compared to Metformin and Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes|Recruiting||Phase 3|100|Anticipated|Institut für Pharmakologie und Präventive Medizin||2|||f||||f||||||||||2017-10-10 22:16:00.144024|2017-10-10 22:16:00.144024
NCT02752100|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-04-21|||March 2016||2016-03-01|April 2016|2016-04-01|May 2020|Anticipated|2020-05-01|February 2020|Anticipated|2020-02-01||Interventional|||A Study on the Effects of Interventional Therapy in Patients With Lower Extremity Arterial Occlusive Disease and Its Risk Factors(EILRF)|Long-term Prognosis of Interventional Therapy in Patients With Lower Extremity Arterial Occlusive Disease and Its Risk Factors|Recruiting||N/A|200|Anticipated|Third Military Medical University||2|||f||||t||||||||No||2017-10-10 22:16:00.251504|2017-10-10 22:16:00.251504
NCT02752087|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-06-02|||April 2016||2016-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants|A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY900014 Test Versus Reference Formulations in Healthy Subjects|Completed||Phase 1|32|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:16:00.34151|2017-10-10 22:16:00.34151
NCT02752074|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-09-05|||June 2016||2016-06-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)|Active, not recruiting||Phase 3|706|Actual|Incyte Corporation||2|||f||||t||||||||||2017-10-10 22:16:00.418171|2017-10-10 22:16:00.418171
NCT02752061|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-08-27|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care|Potlako: A Programmatic Multi-facility Level Intervention to Improve Access to Timely Oncology Care in Botswana|Recruiting||N/A|2600|Anticipated|Harvard School of Public Health||2|||f||||f||||||||||2017-10-10 22:16:00.84217|2017-10-10 22:16:00.84217
NCT02752048|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-02-05|||May 2016||2016-05-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy|A Randomized Phase IIa Study of TAS-205 in Patients With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 2|33|Anticipated|Taiho Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-10 22:16:00.936231|2017-10-10 22:16:00.936231
NCT02752035|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-10-02|||August 1, 2016|Actual|2016-08-01|October 2017|2017-10-01|October 2020|Anticipated|2020-10-01|May 2020|Anticipated|2020-05-01||Interventional|||A Study of ASP2215 (Gilteritinib), Combination of ASP2215 Plus Azacitidine and Azacitidine Alone in the Treatment of Newly Diagnosed Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation in Patients Not Eligible for Intensive Induction Chemotherapy|A Phase 2/3 Multicenter, Open-label, 3-arm, 2-Stage Randomized Study of ASP2215 (Gilteritinib), Combination of ASP2215 Plus Azacitidine and Azacitidine Alone in the Treatment of Newly Diagnosed Acute Myeloid Leukemia With FLT3 Mutation in Patients Not Eligible for Intensive Induction Chemotherapy|Recruiting||Phase 2/Phase 3|540|Anticipated|Astellas Pharma Inc||4|||t||||t||||||||||2017-10-10 22:16:01.074586|2017-10-10 22:16:01.074586
NCT02752022|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-09-28|||September 2016||2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Observational|||Monitoring the Transition From Smoking to E-cigarettes|Monitoring Levels of Tobacco-specific Nitrosamines, DNA Adducts, Stress Hormones and DNA Methylation During the Transition From Cigarette Smoking to Electronic Cigarette Use: a Prospective Observational Study|Recruiting||N/A|50|Anticipated|St George's, University of London|||1||f||||f||||||Samples With DNA|"     Saliva, blood, bucal swab, urine   "|No||2017-10-10 22:16:01.392264|2017-10-10 22:16:01.392264
NCT02752009|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-04-22|||June 2016||2016-06-01|April 2016|2016-04-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy|Evaluation Of Axillary Lymph Node Metastases With Sentinel Lymph Node Biopsy After Neoadjuvant Therapy In Breast Cancer Patients|Not yet recruiting||N/A|75|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 22:16:01.484443|2017-10-10 22:16:01.484443
NCT02751996|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-05-05|||May 2016||2016-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ACHIEVE||A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV|A Phase 2, Open-Label, Randomized Two-part, Multiple Dose Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic Hepatitis B Virus|Recruiting||Phase 2|300|Anticipated|Spring Bank Pharmaceuticals, Inc.||13|||f||||t||||||||No|No plan to share data at this stage|2017-10-10 22:16:01.593773|2017-10-10 22:16:01.593773
NCT02751983|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-24|||November 15, 2016|Actual|2016-11-15|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|April 15, 2017|Actual|2017-04-15||Interventional|||ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises|ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises|Enrolling by invitation||N/A|70|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 22:16:01.780278|2017-10-10 22:16:01.780278
NCT02751970|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-25|||April 2014||2014-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|May 2016|Anticipated|2016-05-01||Interventional|||Clinical Trial of the Effect of Different Categories of Adhesive System|Randomized Clinical Trial of the Effect of Different Categories of Adhesive System|Active, not recruiting||Phase 2|185|Anticipated|Universidad de Valparaiso||4|||f||||t||||||||No||2017-10-10 22:16:01.891543|2017-10-10 22:16:01.891543
NCT02751957|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-03-02|||July 1, 2016|Actual|2016-07-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Pilot Study to Improve Access to Early Intervention for Autism in Africa|Pilot Study to Improve Access to Early Intervention for Autism in Africa|Recruiting||N/A|46|Anticipated|Duke University||2|||f||||||||||||||2017-10-10 22:16:02.005987|2017-10-10 22:16:02.005987
NCT02751554|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-14|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||PET Imaging of Patients Using 124I-PU-AD|PET Imaging of Patients Using 124I-PU-AD: A Pilot Study|Recruiting||N/A|10|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:16:05.698368|2017-10-10 22:16:05.698368
NCT02751944|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-02-06|||December 2015||2015-12-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||NEM® Brand Eggshell Membrane Versus Placebo on Exercise-induced Joint Pain, Stiffness, & Cartilage Turnover|Evaluation of the Effects of NEM® Brand Eggshell Membrane Versus Placebo on Exercise-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy, Post-menopausal Women|Completed||N/A|60|Actual|ESM Technologies, LLC||2|||f||||f||||||||No||2017-10-10 22:16:02.085981|2017-10-10 22:16:02.085981
NCT02751931|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-08-17|||June 17, 2016|Actual|2016-06-17|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|Crocodile||Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity|An Open-label, Baseline-controlled, Multicenter, Phase 3 Dose-titration Study Followed by a Fixed-dose Observation Period to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Children and Adolescents From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)|Recruiting||Phase 3|63|Anticipated|Astellas Pharma Inc||1|||f||||t||||||||||2017-10-10 22:16:02.175525|2017-10-10 22:16:02.175525
NCT02751918|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-09-01|||June 8, 2016|Actual|2016-06-08|September 2017|2017-09-01|May 7, 2019|Anticipated|2019-05-07|February 25, 2019|Anticipated|2019-02-25||Interventional|||Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer|An Open-label Phase Ib Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Maximum Tolerated Dose of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin 30 mg/m2 Given Every 3 Weeks in Subjects With Mesothelin-expressing Platinum-resistant Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Recruiting||Phase 1|40|Anticipated|Bayer||1|||f||||f|t|f||||||||2017-10-10 22:16:02.336912|2017-10-10 22:16:02.336912
NCT02751905|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-06-15|||April 2016||2016-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Absorption, Metabolism, and Excretion Study of BIIB074|A Phase 1, Open-Label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-BIIB074 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Biogen||1|||f||||f||||||||||2017-10-10 22:16:02.425994|2017-10-10 22:16:02.425994
NCT02751892|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-21|||October 2013||2013-10-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MOVE||The Feasibility of an Active Lifestyle Programme in Patients Recovering From Colorectal Cancer|Feasibility of a Physical Activity Intervention Informed by Self-Determination Theory With Patients Recovering From Colorectal Cancer|Completed||N/A|28|Actual|University of East Anglia||2|||f||||f||||||||No||2017-10-10 22:16:02.511207|2017-10-10 22:16:02.511207
NCT02751879|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-09-19|||November 24, 2016|Actual|2016-11-24|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Real World Data on Gi(l)Otrif® Dose Adjustment|Real-world Data on Gi(l)Otrif® Dose Adjustment in First-line Treatment, TKI-naïve, Advanced Non-small Cell Lung Cancer Patients With EGFR Activating Mutations|Recruiting||N/A|215|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 22:16:02.635943|2017-10-10 22:16:02.635943
NCT02751866|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-02|||January 2016||2016-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Early Intervention in Cognitive Aging|Early Intervention in Cognitive Aging|Recruiting||N/A|100|Anticipated|University of Cincinnati||2|||f||||f||||||||Undecided||2017-10-10 22:16:02.862341|2017-10-10 22:16:02.862341
NCT02751853|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-10-24|||December 2016||2016-12-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|May 2018|Anticipated|2018-05-01||Interventional|ANREP-EF||Effects of Acutely Elevated Afterload on Left Ventricular Contractility and Relaxation|Effects of Acutely Elevated Afterload oN Left VentRicular Contractility and RElaxation in Heart Failure With Preserved and Reduced Ejection Fraction|Not yet recruiting||Phase 4|60|Anticipated|University of Luebeck||3|||f||||f||||||||Undecided||2017-10-10 22:16:02.950492|2017-10-10 22:16:02.950492
NCT02751840|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-26|||October 2014||2014-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|August 2015|Actual|2015-08-01||Interventional|RMR||Effects of Caffeine and Coffee on Resting Metabolic Rate, Comparing Normal Weight Men to Obese Men|Effects of Caffeine and Coffee on Resting Metabolic Rate, Comparing Normal Weight Men to Obese Men|Completed||Phase 3|33|Actual|Tel Hai College||4|||f||||f||||||||No||2017-10-10 22:16:03.48113|2017-10-10 22:16:03.48113
NCT02751827|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-25|2017-06-23|||February 2016||2016-02-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|PreToxE||Predicting Severe Toxicity of Targeted Therapies in Elderly Patients With Cancer|Predicting Severe Toxicity of Targeted Therapies in Elderly Patients With Cancer|Recruiting||N/A|250|Anticipated|Institut Bergonié|||1||f||||f||||||Samples With DNA|"     One blood sample before treatment initiation (Cycle 1 Day predose) for pharmacogenomics.      One blood sample at the end of the firth month of treatment (postdose) for pharmacokinetic   "|No||2017-10-10 22:16:03.616519|2017-10-10 22:16:03.616519
NCT02751814|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-26|||April 2016||2016-04-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|Pause and Play||Physical Activity and Screen-Time Regulations in Childcare Centers - Aim 2|Physical Activity and Screen-Time Regulations in Childcare Centers: Influence on Young Children's Health Behaviors (Pause & Play) - Aim 2|Enrolling by invitation||N/A|266|Anticipated|Pennington Biomedical Research Center|||1||f||||f||||||||||2017-10-10 22:16:03.74078|2017-10-10 22:16:03.74078
NCT02751801|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Health Burden of Hypophosphatasia|Health Burden of Hypophosphatasia|Not yet recruiting||N/A|17|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 22:16:03.828283|2017-10-10 22:16:03.828283
NCT02751788|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-26|||April 2016||2016-04-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|Pause and Play||Physical Activity and Screen-Time Regulations in Childcare Centers - Aim 1|Physical Activity and Screen-Time Regulations in Childcare Centers: Influence on Young Children's Health Behaviors (Pause & Play) - Aim 1|Active, not recruiting||N/A|10|Anticipated|Pennington Biomedical Research Center|||1||f||||f||||||||||2017-10-10 22:16:03.918946|2017-10-10 22:16:03.918946
NCT02751775|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-26|||June 2016||2016-06-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|Pause and Play||Physical Activity and Screen-Time Regulations in Childcare Centers - Aim 3|Physical Activity and Screen-Time Regulations in Childcare Centers: Influence on Young Children's Health Behaviors (Pause & Play) - Aim 3|Completed||N/A|28|Actual|Pennington Biomedical Research Center|||1||f||||f||||||||||2017-10-10 22:16:04.01147|2017-10-10 22:16:04.01147
NCT02751762|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-05-05|||January 2017||2017-01-01|May 2016|2016-05-01||||October 2019|Anticipated|2019-10-01||Observational|||A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Extended-release/Long Acting (ER/LA) Opioids for the Treatment of Chronic Pain||Not yet recruiting||N/A|2530|Anticipated|Member Companies of the Opioid PMR Consortium|||2||f||||||||||||||2017-10-10 22:16:04.096646|2017-10-10 22:16:04.096646
NCT02751749|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-09-26|||December 2015||2015-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||A Transdiagnostic Treatment for Comorbid Chronic Pain and Emotional Problems|Chronic Pain and Emotional Problems: a Single Case Study of an Internet Based Self-help Treatment Based on CBT Principles and the Unified Protocol for Transdiagnostic Treatments|Completed||N/A|12|Actual|Örebro University, Sweden||1|||f||||f||||||||Undecided||2017-10-10 22:16:04.210694|2017-10-10 22:16:04.210694
NCT02751736|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-04-24|||April 2016||2016-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect Of Probiotics On Bowel Function Restoration After Ileostomy Closure In Patients With Rectal Cancer|The Effect Of Probiotics From Kimchi (CJLP243) On Bowel Function Restoration After Ileostomy Closure In Patients With Rectal Cancer: A Pilot Randomized Controlled Trial|Enrolling by invitation||N/A|40|Anticipated|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 22:16:04.293102|2017-10-10 22:16:04.293102
NCT02751723|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-06|||September 2014||2014-09-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|APM-Project||Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease|Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease|Active, not recruiting||N/A|500|Anticipated|University of Leipzig|||10||f||||f||||||||No||2017-10-10 22:16:04.381015|2017-10-10 22:16:04.381015
NCT02751710|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-07-13|||December 2016||2016-12-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|PET ABC||Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer|Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer|Recruiting||N/A|370|Anticipated|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-10-10 22:16:04.54747|2017-10-10 22:16:04.54747
NCT02751684|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-04-12|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Observational|EUROpE-RSI||EUROpE-RSI (EURopean Online Evaluation RSI Study)|EUROpE RSI-Study (EURopean Online Evaluation) - Pan-european Online-survey About Rapid Sequence Induction (RSI) by Anesthetists|Recruiting||N/A|1000|Anticipated|Universitätsklinikum Köln|||1||f||||f||||||||||2017-10-10 22:16:04.684058|2017-10-10 22:16:04.684058
NCT02751671|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-08-01|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Point-of-care Ultrasound for Clean-Catch Urine Collection in Young Children|Are Stimulated Clean-Catch Urine Collection Techniques More Successful When Combined With Prior Emergency Point-of-care Ultrasound in Paediatric Patients?|Completed||N/A|201|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-10 22:16:04.77354|2017-10-10 22:16:04.77354
NCT02751658|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-04-21|||April 2016||2016-04-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|April 2016|Anticipated|2016-04-01||Interventional|TapPAS||"Tap to Tap, Pathobiome Associates Health Care"|Pathobiomes Training in the Care of Water Sources and Dynamics of Water-borne Pathogens Involved in Healthcare Associated Infections|Not yet recruiting||N/A|500|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 22:16:04.868466|2017-10-10 22:16:04.868466
NCT02751645|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-06-08|||June 2016||2016-06-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety and Efficacy of Acute Normovolemic Hemodilution in Pediatric Cardiac Surgery Patients|The Efficacy and Safety of Acute Normovolemic Hemodilution in Pediatric Cardiac Surgery Patients|Recruiting||N/A|24|Anticipated|Oregon Health and Science University||2|||f||||t||||||||No|There are no plans to share the data collected during this study.|2017-10-10 22:16:04.953527|2017-10-10 22:16:04.953527
NCT02751632|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-19|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|STEP||The Staged Treatment in Early Psychosis Study|Staged Treatment in Early Psychosis (STEP): A Sequential Multistage Randomized Clinical Trial (SMART) of Interventions for Ultra High Risk (UHR) of Psychosis Patients.|Recruiting||Phase 3|500|Anticipated|Orygen Youth Health Research Centre||7|||f||||t||||||||||2017-10-10 22:16:05.054827|2017-10-10 22:16:05.054827
NCT02751619|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-25|||January 2013||2013-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Preventive Skin Analgesia With Lidocaine Patch 5% for Controlling Post-thoracotomy Pain|Preventive Application Of Lidocaine Patch In Adjunction To Intravenous Morphine Analgesia For Management Of Post-Thoracotomy Pain: Results Of A Randomized, Double Blind, Placebo Controlled Study|Completed||N/A|90|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||t||||||||Yes||2017-10-10 22:16:05.185056|2017-10-10 22:16:05.185056
NCT02751606|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-09-28|||June 2015||2015-06-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|June 2018|Anticipated|2018-06-01||Interventional|||Nano MRI on 7 Tesla in Rectal and Breast Cancer|Nano MRI on 7 Tesla: a Technical Validation Study in Rectal and Breast Cancer|Recruiting||Phase 3|30|Anticipated|Radboud University||1|||f||||f||||||||||2017-10-10 22:16:05.284591|2017-10-10 22:16:05.284591
NCT02751593|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-21|||January 2016||2016-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Thrombocytopenia in Gestational Period|Thrombocytopenia in Gestational Period|Active, not recruiting||Phase 2/Phase 3|70|Anticipated|Peking University People's Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:16:05.428955|2017-10-10 22:16:05.428955
NCT02751580|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-05|||March 23, 2016|Actual|2016-03-23|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits|TELEPORT STUDY: A Pilot Feasibility Trial Examining The Use of Telehealth in Post Radiation Therapy Visits|Recruiting||N/A|65|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 22:16:05.50593|2017-10-10 22:16:05.50593
NCT02751567|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-05-20|||May 2016||2016-05-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||18776 - Human Photoallergy Test|Human Photoallergy Test|Withdrawn||N/A|0|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:16:05.624404|2017-10-10 22:16:05.624404
NCT02751528|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-22|||December 2016||2016-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer|Phase I Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Low-Expressing (IHC 1+/2+) Breast Cancer|Recruiting||Phase 1|30|Anticipated|NantBioScience, Inc.||1|||f||||f||||||||||2017-10-10 22:16:05.872984|2017-10-10 22:16:05.872984
NCT02751515|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-07-25|||May 2016||2016-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Human Photoallergy Test|Human Photoallergy Test|Completed||N/A|54|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:16:05.976775|2017-10-10 22:16:05.976775
NCT02751502|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-11-23|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Home Based Adaptive Arm Training for Children|Home Based Adaptive Arm Training for Children With Hemiplegia|Not yet recruiting||Phase 3|20|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:16:06.058839|2017-10-10 22:16:06.058839
NCT02751489|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-06-16|||May 2016||2016-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Human Phototoxicity Test|Human Phototoxicity Test|Completed||N/A|35|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:16:06.141688|2017-10-10 22:16:06.141688
NCT02751476|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-01-27|||April 2016|Actual|2016-04-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|October 2016|Actual|2016-10-01||Interventional|||Effectiveness of Safe Drinking Water in Treatment of Severe Acute Malnutrition (Pakistan)|Effectiveness of Safe Drinking Water in Community Based Treatment of Severe Acute Malnutrition|Active, not recruiting||N/A|820|Anticipated|Action Contre la Faim||4|||f||||f||||||||Undecided||2017-10-10 22:16:06.203601|2017-10-10 22:16:06.203601
NCT02751463|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-06-20|||May 9, 2016|Actual|2016-05-09|June 2017|2017-06-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|||18850 - Human Photoallergy Test|Human Photoallergy Test|Completed||N/A|54|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:16:06.275831|2017-10-10 22:16:06.275831
NCT02751450|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-12|2017-01-17||February 1, 2016||2016-02-01|April 2017|2017-04-01|June 17, 2016|Actual|2016-06-17|May 1, 2016|Actual|2016-05-01||Interventional|||The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity(DH)|A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|Completed||N/A|263|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:16:06.361395|2017-10-10 22:16:06.361395
NCT02751437|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-10-02|||August 5, 2016|Actual|2016-08-05|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|July 31, 2017|Actual|2017-07-31||Interventional|PAINT||Preterm Arginine INTake Study|Effect of Preterm Arginine INTake on Biological Pathways Affecting Immune Function in Infants Requiring Early Parenteral Nutrition|Active, not recruiting||N/A|12|Anticipated|Liverpool Women's NHS Foundation Trust||3|||f||||f||||||||||2017-10-10 22:16:06.956914|2017-10-10 22:16:06.956914
NCT02751424|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-03-15|||June 2016||2016-06-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830|A Phase I, Randomized, Double-Blind (Sponsor Unblinded), Single-Center, Placebo-Controlled, Two-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Single and Repeat Intravenous Doses of GSK3342830 in Healthy Adult Subjects|Suspended||Phase 1|78|Anticipated|GlaxoSmithKline||4||Study data is currently under review.|f||||f||||||||||2017-10-10 22:16:07.065783|2017-10-10 22:16:07.065783
NCT02751411|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-08-02|||April 18, 2016|Actual|2016-04-18|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months|Multicenter, Prospective, Comparative, Randomized Controlled Clinical Trial to Evaluate the Performance and the Safety of Promelaxin® Micro-enemas Vs. Macrogol 4000 Per os in the Treatment of Functional Chronic Constipation in Children Aged Between 6 and 48 Months.|Recruiting||Phase 4|120|Anticipated|Aboca Spa Societa' Agricola||2|||f||||f|f|f||||||||2017-10-10 22:16:07.19722|2017-10-10 22:16:07.19722
NCT02751398|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-08-25|||May 2016||2016-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients||Recruiting||Phase 4|60|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:16:07.30607|2017-10-10 22:16:07.30607
NCT02751385|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-10-03|||May 20, 2016|Actual|2016-05-20|October 2017|2017-10-01|September 28, 2018|Anticipated|2018-09-28|September 28, 2018|Anticipated|2018-09-28||Interventional|||Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer|A Phase I Trial to Investigate the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer|Recruiting||Phase 1|14|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:16:07.397278|2017-10-10 22:16:07.397278
NCT02751372|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2017-05-03|||May 2, 2016|Actual|2016-05-02|May 2017|2017-05-01|May 6, 2016|Actual|2016-05-06|May 6, 2016|Actual|2016-05-06||Interventional|||18794 - Human Photo Toxicity Test|Human Phototoxicity Test|Completed||N/A|35|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:16:07.51559|2017-10-10 22:16:07.51559
NCT02751359|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-10|||June 2016||2016-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers|Characterization of the Analgesic Effects of Oral CBD in Healthy, Normal Volunteers|Active, not recruiting||Phase 1/Phase 2|18|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-10 22:16:07.607638|2017-10-10 22:16:07.607638
NCT02751346|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-04-04|||January 2016||2016-01-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Observational|||Persistent Pain After Cystectomy for Bladder Cancer|Persistent Postsurgical Pain (PPSP) Following Cystectomy: A Survey and Sensory Examination|Completed||N/A|383|Actual|Washington University School of Medicine|||2||f||||f||||||||No||2017-10-10 22:16:07.708485|2017-10-10 22:16:07.708485
NCT02751333|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-05-11|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Esophageal Stent Migration With Endoscopic Suture Fixation Compared to Standard Deployment|Esophageal Stent Migration With Endoscopic Suture Fixation Compared to Standard Deployment in the Management of Benign Esophageal Pathology: A Randomized Controlled Trial|Withdrawn||Phase 2|0|Actual|Johns Hopkins University||2||The reason was the fact that the study was not clinically feasible.|f||||t||||||||||2017-10-10 22:16:07.822656|2017-10-10 22:16:07.822656
NCT02751307|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-26|||May 2013||2013-05-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities|Treatment of Metabolic Abnormalities in Patients With Schizophrenia: Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities|Completed||Phase 4|55|Actual|Taipei Medical University WanFang Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:16:08.086653|2017-10-10 22:16:08.086653
NCT02751294|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-01-19|||May 2016||2016-05-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution|A Randomized, Open-label, Single-period, Parallel-group Study in Healthy Subjects to Determine the Effects of Dissolution Profile on the Pharmacokinetics (Via Both Venous and Peripheral Micro-samples) of Single Oral 300 mg Doses of Tafenoquine (SB-252263) Tablets + 30 mg Tafenoquine Stable Isotope Labelled (SIL) Solution|Completed||Phase 1|14|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:16:08.19913|2017-10-10 22:16:08.19913
NCT02751281|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-21|||December 2014||2014-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Comparing Pneumatic Versus Ultra-sonic Percutaneous Nephrolithotomy in Large Kidney Stones|Comparing Pneumatic Versus Ultra-sonic Percutaneous Nephrolithotomy in Large Kidney Stones|Completed||Phase 2|180|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 22:16:08.30242|2017-10-10 22:16:08.30242
NCT02751268|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-24|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect of Infraorbital and Infratrochlear Nerve Block on Emergence Agitation in Patients Undergoing Septorhinoplasty|Effect of Infraorbital and Infratrochlear Nerve Block on Emergence Agitation in Patients Undergoing Septorhinoplasty: A Randomized Controlled Trial|Enrolling by invitation||Phase 4|66|Actual|Armed Forces Hampyeong Hospital||2|||f||||f||||||||No||2017-10-10 22:16:08.388562|2017-10-10 22:16:08.388562
NCT02751255|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-10-31|||August 2016||2016-08-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|DARA/ATRA||Daratumumab in Combination With ATRA|A Phase 1 and Phase 2 Study of Daratumumab in Combination With All-trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|58|Anticipated|VU University Medical Center||1|||f||||t||||||||Undecided||2017-10-10 22:16:08.507797|2017-10-10 22:16:08.507797
NCT02751242|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-08-08|||August 2016||2016-08-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Identifying Diuretic Resistance in Patients With Acute Heart Failure|Identifying Diuretic Resistance in Patients With Acute Heart Failure|Recruiting||N/A|60|Anticipated|Vanderbilt University|||1||f||||f||||||Samples Without DNA|"     Serial urine at 1, 2, 4, and 6 hours   "|No||2017-10-10 22:16:08.623244|2017-10-10 22:16:08.623244
NCT02751229|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-08|||May 2016||2016-05-01|March 2017|2017-03-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Honest Open Proud for Adolescents With Mental Illness|Adaptation and Evaluation of the Honest Open Proud Program for Adolescents With Mental Illness|Completed||Phase 2|100|Anticipated|University of Ulm||2|||f||||||||||||||2017-10-10 22:16:08.755032|2017-10-10 22:16:08.755032
NCT02751216|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-05-01|||May 2016||2016-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|EEGInspiration||EEG Mapping During High Frequency/High Density Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome|EEG Mapping During High Frequency/High Density Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome|Recruiting||N/A|6|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-10 22:16:08.876981|2017-10-10 22:16:08.876981
NCT02751203|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-01-31|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Make Safe Happen App Evaluation Study|Make Safe Happen App Evaluation Study|Active, not recruiting||N/A|2100|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||No||2017-10-10 22:16:08.986746|2017-10-10 22:16:08.986746
NCT02751190|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-02-22|||September 1, 2013|Actual|2013-09-01|April 2016|2016-04-01|February 1, 2017|Actual|2017-02-01|March 1, 2016|Actual|2016-03-01|1 Year|Observational [Patient Registry]|||Chronic Pain After Groin Hernia Repair|Chronic Pain After Groin Hernia Repair, Impact of Method of Surgery|Completed||N/A|24607|Actual|Umeå University|||1||f||||f||||||||Undecided||2017-10-10 22:16:09.055345|2017-10-10 22:16:09.055345
NCT02751177|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-04-27|||March 2016||2016-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ColoBEAM||Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer|Multicenter Prospective Study Comparing KRAS, NRAS and BRAF Mutation Testing Using OncoBEAM Technique in Plasma vs Conventional Techniques in Formalin Fixed Paraffin Embedded Tissues|Recruiting||N/A|236|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||t||||||||Yes||2017-10-10 22:16:09.148509|2017-10-10 22:16:09.148509
NCT02751164|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-09-05|||April 2013||2013-04-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Evaluation of the Association Between Day and Time of Admission to Critical Care and Acute Hospital Outcome|Evaluation of the Association Between Day and Time of Admission to Critical Care and Acute Hospital Outcome for Unplanned Admissions to Adult, General Critical Care Units in the United Kingdom|Completed||N/A|195428|Actual|Intensive Care National Audit & Research Centre|||4||f||||f||||||||No||2017-10-10 22:16:09.281294|2017-10-10 22:16:09.281294
NCT02751151|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-07-26|||February 2016||2016-02-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|February 2020|Anticipated|2020-02-01||Interventional|PDT||Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients|Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients|Recruiting||Phase 2|20|Anticipated|Inova Health Care Services||1|||f||||f||||||||||2017-10-10 22:16:09.364011|2017-10-10 22:16:09.364011
NCT02751138|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-25|||March 2016||2016-03-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01|5 Years|Observational [Patient Registry]|||Determination of Immune Phenotype in Glioblastoma Patients|Determination of Immune Phenotype in Glioblastoma Patients|Recruiting||N/A|250|Anticipated|University of Ulm|||2||f||||t||||||Samples With DNA|"     Peripheral Blood Mononuclear Cell (PBMC), Plasma, Tumor tissue, DNA, RNA, miRNA   "|Yes|Immune phenotypes of glioma patients included and clinical follow-up|2017-10-10 22:16:09.453573|2017-10-10 22:16:09.453573
NCT02751125|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-06|||June 2014||2014-06-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reconstruction of Jaw Bone Using Mesenchymal Stem Cells|Jaw Bone Reconstruction Using a Combination of Autologous Mesenchymal Stem Cells and Biomaterial Prior to Dental Implant Placement|Recruiting||Phase 1|13|Anticipated|University of Bergen||1|||f||||t||||||||Undecided||2017-10-10 22:16:09.546165|2017-10-10 22:16:09.546165
NCT02751112|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-24|||November 2015||2015-11-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|Predictor007||Evaluation of a Kit for the Prediction of the Risk of Graft Versus Host Disease|Evaluation of a Kit for the Prediction of the Risk of Graft Versus Host Disease|Terminated||N/A|34|Actual|Imagine Institute||1||Slow recruitment and preliminary observations leading to early termination|f||||f||||||||||2017-10-10 22:16:09.640851|2017-10-10 22:16:09.640851
NCT02751099|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-07-11|||November 2015||2015-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Bone and Cardiovascular Disease After Kidney Transplant|Bone Metabolism and Cardiovascular Risk After Kidney Transplant in Adult Patients|Recruiting||N/A|80|Anticipated|Centro Hospitalar de Lisboa Central|||1||f||||t||||||Samples Without DNA|"     serum and bone biopsy   "|||2017-10-10 22:16:09.730994|2017-10-10 22:16:09.730994
NCT02751086|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-08-15|||April 2016||2016-04-01|August 2017|2017-08-01|December 2024|Anticipated|2024-12-01|May 2019|Anticipated|2019-05-01||Observational|IMIGASTRICII||Robotic, Laparoscopic and Open Gastrectomy Compared on Short and Long Term Outcomes|Prospective, Observational, Multicenter Study on Minimally Invasive Gastrectomy for Gastric Cancer: Robotic, Laparoscopic and Open Surgery Compared on Operative and Follow-up Outcomes|Recruiting||N/A|5000|Anticipated|International Study Group on Minimally Invasive Surgery for Gastric Cancer|||3||f||||t||||||||||2017-10-10 22:16:09.834973|2017-10-10 22:16:09.834973
NCT02751073|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-18|||February 2016||2016-02-01|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|May 31, 2017|Actual|2017-05-31||Observational|||Evaluation of the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After Hysterectomy|Evaluation of Vaginal and Urinary Microbiome Markers as Predictors of Post-Surgical Urinary Tract Infection|Active, not recruiting||N/A|25|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Vaginal swabs and urine samples (catheterized and clean-catch) collected longitudinally     throughout the perioperative period.   "|||2017-10-10 22:16:09.95292|2017-10-10 22:16:09.95292
NCT02751060|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-05-17|||April 2016||2016-04-01|May 2017|2017-05-01||||April 2018|Anticipated|2018-04-01|2 Years|Observational [Patient Registry]|||Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease|Evaluation of Plasma Non-coding RNAs (miRNA-320a) as Biomarkers of Diagnosis, Prognosis and Treatment Effects in Coronary Heart Disease|Enrolling by invitation||N/A|4000|Anticipated|Tongji Hospital|||1||f||||||||||||||2017-10-10 22:16:10.05543|2017-10-10 22:16:10.05543
NCT02751047|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-22|2016-06-16|||May 2016||2016-05-01|June 2016|2016-06-01||||October 2017|Anticipated|2017-10-01||Interventional|||Manual Ventilation Versus Pressure Controlled Mechanical Ventilation in Children|Comparison Between Pressure Controlled Mechanical Ventilation and Manual Ventilation During Mask Ventilation for Induction of Anesthesia in Children|Recruiting||N/A|154|Anticipated|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:16:10.142109|2017-10-10 22:16:10.142109
NCT02751034|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-04-21|||June 2013||2013-06-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy and Safety Evaluation Study of Neuramis® Deep Lidocaine in Correction of Nasolabial Fold|A Randomized, Multi-center, Double Blind, Intra-Individual Controlled, Active-controlled Clinical Trial to Evaluate the Efficacy and Safety of Injection With Neuramis® Deep Lidocaine as Compared to Restylane® PERLANE-L in Correction of Nasolabial Fold|Completed||Phase 3|60|Actual|Medy-Tox||2|||f||||f||||||||No||2017-10-10 22:16:10.23366|2017-10-10 22:16:10.23366
NCT02751021|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-16|||June 22, 2016|Actual|2016-06-22|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|SAPAAD||Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction|Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction: SAPAAD Study|Recruiting||N/A|60|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 22:16:10.317285|2017-10-10 22:16:10.317285
NCT02751008|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-21|||April 2016||2016-04-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|April 2016|Actual|2016-04-01||Observational|||Bone Fragility Study in Pediatric Population With Risk Factors|Bone Fragility Study in Pediatric Population With Risk Factors|Not yet recruiting||N/A|100|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||Undecided||2017-10-10 22:16:10.400255|2017-10-10 22:16:10.400255
NCT02750995|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-08-31|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|April 2020|Anticipated|2020-04-01||Interventional|AZACTA||Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML|Peptide Vaccination in Combination With Azacitidine for Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia - A Phase I Study|Recruiting||Phase 1|15|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-10-10 22:16:10.451602|2017-10-10 22:16:10.451602
NCT02750982|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-01-31|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.|A Single-Arm Prospective Investigation of the Effects of Laughter Therapy on Mood, Stress, and Self-Efficacy in People With Central Nervous System Disorders.|Recruiting||N/A|24|Anticipated|Brown, Theodore R., M.D., MPH||1|||f||||f||||||||No||2017-10-10 22:16:10.571949|2017-10-10 22:16:10.571949
NCT02750969|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-04-21|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Lidoderm Patch (Lidocaine 5%) for Tinnitus Treatment|Lidocaine Patch (Lidocaine 5%) as a Treatment for Tinnitus and Its Accompanied Symptoms|Not yet recruiting||Phase 4|58|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||No||2017-10-10 22:16:10.68815|2017-10-10 22:16:10.68815
NCT02750956|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-21|||June 2015||2015-06-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|||Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment|Effect of Non-surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Endocan, Vascular Endothelial Growth Factor-A and Tumor Necrosis Factor Alpha Levels|Completed||N/A|40|Actual|Bulent Ecevit University|||3||f||||f||||||Samples Without DNA|"     Gingival crevicular fluid and Serum   "|No||2017-10-10 22:16:10.785894|2017-10-10 22:16:10.785894
NCT02750930|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-06-12|||October 7, 2016||2016-10-07|June 2017|2017-06-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|||Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects|An Open-label Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|8|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:16:11.332908|2017-10-10 22:16:11.332908
NCT02750904|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-06-07|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Interventional|WebQuit Plus||Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder|Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder|Recruiting||N/A|72|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t|f|f||||||Yes|Investigators will publish results of the study in peer reviewed, scientific journals.|2017-10-10 22:16:11.600659|2017-10-10 22:16:11.600659
NCT02750891|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-06-12|||April 2016||2016-04-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas|A Phase 1/2 Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Sumitomo Dainippon Pharma Co., Ltd.||1|||f||||||||||||||2017-10-10 22:16:11.749276|2017-10-10 22:16:11.749276
NCT02750878|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-21|||November 2015||2015-11-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Surgical Consent Process for Trans-obturator Tape Slings.|A Randomized Controlled Trial of the Consent Process for Patients Undergoing Trans-obturator Tape Slings.|Recruiting||N/A|120|Anticipated|Boston Urogynecology Associates||2|||f||||f||||||||No||2017-10-10 22:16:11.851664|2017-10-10 22:16:11.851664
NCT02750865|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-02|||August 2, 2017|Actual|2017-08-02|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|ECA-PAL||Conversational Agents to Improve Quality of Life in Palliative Care|Conversational Agents to Improve Quality of Life in Palliative Care|Enrolling by invitation||N/A|823|Anticipated|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-10 22:16:11.95882|2017-10-10 22:16:11.95882
NCT02750852|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-21|||April 2016||2016-04-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|April 2016|Actual|2016-04-01||Observational|||An Algorithm for Predicting Blood Loss and Transfusion Risk in Fast Track Total Hip Arthroplasty|An Algorithm for Predicting Blood Loss and Transfusion Risk in Fast Track Total Hip Arthroplasty|Active, not recruiting||N/A|124|Actual|Azienda Ospedaliera Bolognini di Seriate Bergamo|||2||f||||t||||||||No||2017-10-10 22:16:12.059247|2017-10-10 22:16:12.059247
NCT02750839|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-21|||April 2016||2016-04-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Influence of Osteoporosis on Clinical Outcomes of Mini-invasive Surgical Treatment of Proximal Humerus Fractures|Influence of Osteoporosis on Clinical Outcomes of Mini-invasive Surgical Treatment of Proximal Humerus Fractures|Enrolling by invitation||N/A|65|Actual|Azienda Ospedaliera Bolognini di Seriate Bergamo|||1||f||||t||||||||Undecided||2017-10-10 22:16:12.146717|2017-10-10 22:16:12.146717
NCT02750826|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-29|||August 2016||2016-08-01|September 2017|2017-09-01||||May 2030|Anticipated|2030-05-01||Interventional|||Breast Cancer WEight Loss Study (BWEL Study)|Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer|Recruiting||Phase 3|3136|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-10 22:16:12.734783|2017-10-10 22:16:12.734783
NCT02750813|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-08-28|2017-07-25||April 27, 2016|Actual|2016-04-27|August 2017|2017-08-01|August 17, 2016|Actual|2016-08-17|August 17, 2016|Actual|2016-08-17||Interventional||This analysis population includes all randomized subjects who were exposed to any study lens, except for lenses used at Visit 1 for parameter optimization and fitting (Full Analysis Set).|ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®|ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®: Clinical Comparison in a Symptomatic Population|Completed||N/A|252|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 22:16:21.631962|2017-10-10 22:16:21.631962
NCT02750800|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-16|||April 7, 2016||2016-04-07|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|VALUE||Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary|Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary|Active, not recruiting||N/A|387|Anticipated|AbbVie|||6||f||||f||||||||||2017-10-10 22:16:21.850359|2017-10-10 22:16:21.850359
NCT02750787|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-07-21|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Use of a Peptide-based Formula in an Adult Population|An Evaluation of the Use of a Peptide-based Formula in an Adult Population|Completed||N/A|37|Actual|Abbott Nutrition||1|||f||||f||||||||||2017-10-10 22:16:21.9801|2017-10-10 22:16:21.9801
NCT02750774|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-20|||December 2015||2015-12-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||An Early-customized Low Glycaemic-index (GI) Diet Prevents LGA Babies in Overweight/Obese Pregnant Women|A Customized Low Glycaemic-index (GI) Diet, Introduced at First Trimester of Pregnancy by Both Gynecologist and Dietitian, Prevents Large for Gestational Age (LGA) Newborns in Overweight/Obese Pregnant Women|Recruiting||N/A|100|Anticipated|University of Modena and Reggio Emilia||2|||f||||f||||||||Yes||2017-10-10 22:16:22.048779|2017-10-10 22:16:22.048779
NCT02750761|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-09-21|||May 2, 2016|Actual|2016-05-02|September 2017|2017-09-01|March 23, 2019|Anticipated|2019-03-23|March 23, 2019|Anticipated|2019-03-23||Interventional|||A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)|A Phase 1, Single-Administration Pharmacokinetic and Safety Study of Oral and IV Tedizolid Phosphate in Hospitalized Subjects 2 to <12 Years Old|Recruiting||Phase 1|32|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||f|t|f||||||||2017-10-10 22:16:22.129157|2017-10-10 22:16:22.129157
NCT02750748|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-01-11|||July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers|Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers|Completed||Phase 1|14|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||t||||||||||2017-10-10 22:16:22.236818|2017-10-10 22:16:22.236818
NCT02750735|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-20|||January 2001||2001-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|June 2011|Actual|2011-06-01||Observational|||Nickel Allergy and Systemic Nickel Allergy Syndrome in Non Celiac Wheat Sensitivity|Nickel Allergy and Systemic Nickel Allergy Syndrome in Non Celiac Wheat Sensitivity|Completed||N/A|200|Actual|University of Palermo|||4||f||||f||||||||No||2017-10-10 22:16:22.421631|2017-10-10 22:16:22.421631
NCT02750722|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-01-24|||May 2016||2016-05-01|January 2017|2017-01-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|||Exercise and Oscillatory Positive Expiratory Pressure Therapy in Cystic Fibrosis|Acute Effects of Combined Exercise and Oscillatory Positive Expiratory Pressure Therapy on Sputum Properties and Lung Diffusion Capacity in Cystic Fibrosis: a Randomized Crossover Trial|Completed||N/A|16|Anticipated|University of Zurich||2|||f||||f||||||||Undecided||2017-10-10 22:16:22.513848|2017-10-10 22:16:22.513848
NCT02750709|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-02-06|2016-10-19||October 2015||2015-10-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin|A Single Center, Single-Dose, Open-Label, Laboratory-Blind, Randomized, Three-Period Crossover Study to Determine the Bioequivalence of Two Oral Formulations Containing of Nitisinone 10 mg Compared to the Reference Formulation Orfadin 10 mg in at Least 18 Healthy Male and Female Subjects Under Fasting Conditions|Completed||Phase 1|24|Actual|Cycle Pharmaceuticals Ltd.||6|||f||||f||||||||||2017-10-10 22:16:22.631056|2017-10-10 22:16:22.631056
NCT02750696|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-20|||April 2013||2013-04-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Two Combinations of Opioid and Non-opioid Analgesics for Acute Periradicular Abscess|Comparison of Two Combinations of Opioid and Non-opioid Analgesics for Acute Periradicular Abscess: A Randomized Clinical Trial|Completed||N/A|27|Actual|Federal University of Rio Grande do Sul||2|||f||||||||||||||2017-10-10 22:16:23.078702|2017-10-10 22:16:23.078702
NCT02750683|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-25|||October 2014||2014-10-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Norepinephrine Exerts an Inotropic Effect at the Early Phase of Human Septic Shock|Norepinephrine Exerts an Inotropic Effect at the Early Phase of Human Septic|Completed||N/A|38|Actual|Hopital Antoine Beclere|||1||f||||f||||||||No||2017-10-10 22:16:23.16601|2017-10-10 22:16:23.16601
NCT02750670|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-05-04|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma|Pilot Study of Obinutuzumab in Combination With GDP Chemotherapy for the Treatment of Relapsed or Refractory CD20+ Aggressive Non-Hodgkin Lymphoma|Recruiting||Phase 2|30|Anticipated|University Health Network, Toronto||1|||f||||t|f|f||||||||2017-10-10 22:16:23.227426|2017-10-10 22:16:23.227426
NCT02750657|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-04-20|||February 2016||2016-02-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|February 2021|Anticipated|2021-02-01||Observational|COMPASS||Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection|Comprehensive Molecular Characterization of Advanced Pancreatic Ductal Adenocarcinomas (PDAC) for Better Treatment Selection: A Prospective Study|Recruiting||N/A|180|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     -  Fresh tumor tissue biopsy samples        -  Archival tumor tissue samples        -  Whole blood samples        -  Plasma samples        -  Serum samples   "|||2017-10-10 22:16:23.332049|2017-10-10 22:16:23.332049
NCT02750644|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-21|||January 2005||2005-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|REAL||Postapproval Trial On Carotid Stenting in Patients With High Risk Vs Standard Risk for Open Carotid Endarterectomy(REAL)|Post Approval Non-randomized Double-arm Prospective Open Label Follow-up Trial on Carotid Stenting Using MOMA Proximal Embolic Cerebral Protection Device in Patients With High Risk vs Standard Risk for Open Carotid Endarterectomy(REALTrial)|Completed||N/A|125|Actual|Hospital Universitario Getafe|||2||f||||f||||||||Undecided||2017-10-10 22:16:23.419258|2017-10-10 22:16:23.419258
NCT02750631|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-28|||April 2014||2014-04-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|WakeTherapy||Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression|Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression|Completed||N/A|30|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-10 22:16:23.47953|2017-10-10 22:16:23.47953
NCT02750618|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-05-02|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 30, 2017|Anticipated|2017-10-30||Interventional|||Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)|An Open-Label, Phase 2 Study to Assess the Safety, Pharmacodynamics, and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)|Active, not recruiting||Phase 2|13|Actual|Ultragenyx Pharmaceutical Inc||1|||f||||t||||||||||2017-10-10 22:16:23.567177|2017-10-10 22:16:23.567177
NCT02750605|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-28|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||DEB ( Drug Eluting Balloon) in Crural Arteries and Critical Limb Ischemia|Randomized Trial Comparing Drug Coated Balloon vs Plain Balloon Angioplasty in Critical Limb Ischemia and Treatment of Long Lesions in Crural Arteries|Recruiting||N/A|70|Anticipated|Skane University Hospital||2|||f||||f||||||||No||2017-10-10 22:16:23.834788|2017-10-10 22:16:23.834788
NCT02750592|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-04-20|||March 22, 2016|Actual|2016-03-22|April 2017|2017-04-01|May 8, 2018|Anticipated|2018-05-08|July 3, 2017|Anticipated|2017-07-03||Interventional|||Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis|An Open-label, Phase III, Study of Subcutaneous Secukinumab to Assess Efficacy, Safety and Tolerability at up to 52 Weeks in Japanese Patients With Active Ankylosing Spondylitis|Active, not recruiting||Phase 3|29|Actual|Novartis||1|||f||||f|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:16:23.914953|2017-10-10 22:16:23.914953
NCT02750579|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-06-30|||September 5, 2016|Actual|2016-09-05|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?|Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?|Recruiting||N/A|740|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f|f|f||||||||2017-10-10 22:16:24.008299|2017-10-10 22:16:24.008299
NCT02750566|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-22|||November 15, 2015|Actual|2015-11-15|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparing the Effect of Osteopathic Manipulative Medicine (OMM) Versus Counseling in the Treatment of Concussion|Comparing the Effect of Osteopathic Manipulative Medicine (OMM) Versus Counseling in the Treatment of Concussion|Recruiting||N/A|40|Anticipated|New York Institute of Technology||2|||f||||f|f|f||||||||2017-10-10 22:16:24.091252|2017-10-10 22:16:24.091252
NCT02750553|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-24|||January 2015||2015-01-01|April 2016|2016-04-01||||January 2016|Actual|2016-01-01||Interventional|||A Phase 1, Randomized, Placebo-controlled, Single & Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Healthy Chinese Volunteers||Completed||Phase 1|51|Actual|Jiangsu HengRui Medicine Co., Ltd.||6|||f||||f||||||||No||2017-10-10 22:16:24.185916|2017-10-10 22:16:24.185916
NCT02750540|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-11-04|||October 2016||2016-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|DREAM-01||Optimization of a Tenofovir Enema for HIV Prevention|DREAM-01: Optimization of a Tenofovir Enema for HIV Prevention|Recruiting||Phase 1|18|Anticipated|Johns Hopkins University||5|||f||||t||||||||No||2017-10-10 22:16:24.263886|2017-10-10 22:16:24.263886
NCT02750527|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-20|||September 2016||2016-09-01|April 2017|2017-04-01|December 2028|Anticipated|2028-12-01|April 2018|Anticipated|2018-04-01||Observational|Fr1dolin||Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany|Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany|Enrolling by invitation||N/A|150000|Anticipated|Kinderkrankenhaus auf der Bult|||1||f||||f||||||||No||2017-10-10 22:16:24.365895|2017-10-10 22:16:24.365895
NCT02750501|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-04-10|||June 10, 2016|Actual|2016-06-10|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|ASSURE||Absorption and Safety With Sustained Use of Relizorb Evaluation (ASSURE) Study|Absorption and Safety With Sustained Use of Relizorb Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding|Completed||N/A|44|Actual|Alcresta Therapeutics, Inc.||1|||f||||t||||||||Yes|Individual data will be provided for specific data fields required by the Data Monitoring Committee.|2017-10-10 22:16:24.807567|2017-10-10 22:16:24.807567
NCT02750488|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-06-20|||May 9, 2016|Actual|2016-05-09|June 2017|2017-06-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|||18793 - Human Photoallergy Test|Human Photoallergy Test|Completed||N/A|54|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:16:24.904841|2017-10-10 22:16:24.904841
NCT02750475|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-03|||May 2, 2016|Actual|2016-05-02|May 2017|2017-05-01|May 6, 2016|Actual|2016-05-06|May 6, 2016|Actual|2016-05-06||Interventional|||Human Phototoxicity Test|Human Phototoxicity Test|Completed||N/A|35|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:16:24.977601|2017-10-10 22:16:24.977601
NCT02750462|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-11-29|||August 2016||2016-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|TOMAHAWK||Immediate Unselected Coronary Angiography Versus Delayed Triage in Survivors of Out-of-hospital Cardiac Arrest Without ST-segment Elevation|Immediate Unselected Coronary Angiography Versus Delayed Triage in Survivors of Out-of-hospital Cardiac Arrest Without ST-segment Elevation|Recruiting||Phase 4|558|Anticipated|University of Schleswig-Holstein||2|||f||||t||||||||Undecided||2017-10-10 22:16:25.06676|2017-10-10 22:16:25.06676
NCT02750449|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-06-20|||May 9, 2016|Actual|2016-05-09|June 2017|2017-06-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|||Human Photoallergy Test|Human Photoallergy Test|Completed||N/A|54|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:16:25.149601|2017-10-10 22:16:25.149601
NCT02750436|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2017-03-24|||April 25, 2016|Actual|2016-04-25|March 2017|2017-03-01|July 30, 2016|Actual|2016-07-30|July 30, 2016|Actual|2016-07-30||Interventional|USGSLBB||A Comparison of Ultrasound Versus Fluoroscopic Guidance for Sacral Lateral Branch Blocks|A Prospective Randomized Comparison of Ultrasound Versus Fluoroscopic Guidance for Sacral Lateral Branch Blocks|Completed||N/A|40|Actual|Montreal General Hospital||2|||f||||f||||||||No||2017-10-10 22:16:25.234271|2017-10-10 22:16:25.234271
NCT02750423|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-07-10|||April 2016||2016-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neurologic Injury Following Aortic Arch Replacement|Neurologic Injury AAR: Neurologic Injury Following Aortic Arch Replacement: A Comparison of Two Different Cerebral Protection Strategies (A Pilot Study)|Active, not recruiting||N/A|20|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 22:16:25.320461|2017-10-10 22:16:25.320461
NCT02750410|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-25|||August 2016||2016-08-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes|A Phase 4 Study of Efficacy and Safety of Dulaglutide When Added to Insulin Treatment With or Without Oral Antidiabetic Medication in Patients With Type 2 Diabetes|Active, not recruiting||Phase 4|160|Anticipated|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 22:16:25.436071|2017-10-10 22:16:25.436071
NCT02750397|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-04-19|||August 2016||2016-08-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|May 2019|Anticipated|2019-05-01||Observational|||HIV-to-HIV Transplant at MGH|Prospective Study of HIV+ Deceased Donor Transplant for HIV+ Recipients|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital|||2||f||||||||||||||2017-10-10 22:16:25.570327|2017-10-10 22:16:25.570327
NCT02750384|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-09-13|||May 2016||2016-05-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects|An Assessment of the Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects|Terminated||Phase 1|11|Actual|Medicines for Malaria Venture||3||Sponsor strategic decision based on preliminary results|f||||f||||||||No||2017-10-10 22:16:25.654199|2017-10-10 22:16:25.654199
NCT02750371|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-22|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|ISOMAB||Effect of Irradiation of the Cavernous Sinus and the Sellar Region on Autobiographical Memory|Effect of Irradiation of the Cavernous Sinus and the Sellar Region on Autobiographical Memory|Recruiting||N/A|30|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 22:16:25.738086|2017-10-10 22:16:25.738086
NCT02750358|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-09-15|||May 19, 2016||2016-05-19|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer|Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR(+) Triple Negative Breast Cancer|Recruiting||Phase 2|200|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:16:25.859048|2017-10-10 22:16:25.859048
NCT02750345|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-22|2016-10-14||March 2016||2016-03-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)|A Three-Period Crossover Study to Determine the Bioequivalence of Two Oral Formulations Containing Nitisinone 10 mg Compared to Reference Formulation Orfadin In Healthy Subjects Under Fasting Conditions|Completed||Phase 1|24|Actual|Cycle Pharmaceuticals Ltd.||6|||f||||f||||||||Undecided||2017-10-10 22:16:26.031575|2017-10-10 22:16:26.031575
NCT02750332|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-02-06|2016-10-19||November 2015||2015-11-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)|A Single Center, Single-Dose, Open-Label, Randomized Study to Compare the Bioavailability of an Oral Test Formulation Containing Nitisinone 10 mg in at Least 16 Healthy Male and Female Subjects Under Fasting and Fed Conditions|Completed||Phase 1|20|Actual|Cycle Pharmaceuticals Ltd.||2|||f||||f||||||||Undecided||2017-10-10 22:16:26.671337|2017-10-10 22:16:26.671337
NCT02750319|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-06-20|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery|A Randomized, Double-Blind, Controlled Trial of Combined Amiodarone and N-Acetylcysteine Versus Amiodarone Plus Placebo for the Prevention of Atrial Fibrillation in High Risk Patients Undergoing Thoracic Surgery|Recruiting||Phase 3|244|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||t||||||||||2017-10-10 22:16:27.03548|2017-10-10 22:16:27.03548
NCT02750293|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-11-10|||June 2015||2015-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|D-COR||The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors|The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors in Subjects With Low Serum 25-hydroxyvitamin D Levels|Recruiting||Phase 3|600|Anticipated|University of Tromso||2|||f||||f||||||||No|not planned|2017-10-10 22:16:27.381951|2017-10-10 22:16:27.381951
NCT02750280|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-04-22|||June 2015||2015-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|M-S-DFU-RCT||A Longitudinal Study to Evaluate an Extracellular Matrix (MatriStem®) for the Treatment of Diabetic Foot Ulcers|A Prospective, Randomized, Controlled, Longitudinal Study Using Repeated Measures Design to Evaluate a Porcine Urinary Bladder-Derived Extracellular Matrix (MatriStem®) in the Management of Diabetic Foot Ulcers|Completed||N/A|17|Actual|Calvary Hospital, Bronx, NY||2|||f||||f||||||||No||2017-10-10 22:16:27.590318|2017-10-10 22:16:27.590318
NCT02750267|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-06-22|2017-05-30||May 2016||2016-05-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform|Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform|Completed||N/A|12|Actual|University of Virginia||2|||f||||t||||||||Yes|Not yet determined|2017-10-10 22:16:27.699665|2017-10-10 22:16:27.699665
NCT02750254|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-10-03|||June 27, 2016|Actual|2016-06-27|October 2017|2017-10-01|October 14, 2020|Anticipated|2020-10-14|May 24, 2017|Actual|2017-05-24||Interventional|||Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation|A Phase I/II Study of Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation|Active, not recruiting||Phase 1/Phase 2|5|Actual|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 22:16:28.247284|2017-10-10 22:16:28.247284
NCT02750241|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-11-17|||April 2016||2016-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Pink Warrior—Support Group Toolkit for Breast Cancer Survivors|Pink Warrior—Support Group Toolkit for Breast Cancer Survivors|Recruiting||N/A|60|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||No||2017-10-10 22:16:28.396451|2017-10-10 22:16:28.396451
NCT02750228|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-03-31|||May 2016||2016-05-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Observational|PDA||PDA Post NICU Discharge|Patent Ductus Arteriosus Post NICU Discharge in Premature Infants: A Prospective Registry|Recruiting||N/A|200|Anticipated|Mednax Center for Research, Education and Quality|||1||f||||f||||||||||2017-10-10 22:16:28.52063|2017-10-10 22:16:28.52063
NCT02750215|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-22|||May 2016||2016-05-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor|A Phase 2 Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor|Active, not recruiting||Phase 2|20|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:16:28.651168|2017-10-10 22:16:28.651168
NCT02750202|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-22|||July 2016||2016-07-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|TheraVACCS||Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts|Prophylactic Vaccines as Therapy: Prevention of Recurrence of Extensive Genital Warts|Not yet recruiting||Phase 3|75|Anticipated|University of Pretoria||2|||f||||f||||||||No||2017-10-10 22:16:28.746053|2017-10-10 22:16:28.746053
NCT02750189|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-07-18|||September 2015||2015-09-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|BOC||The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea|The Economic Burden of Patients With COPD in South Korea|Completed||N/A|390|Actual|Konkuk University Medical Center|||4||f||||f||||||||||2017-10-10 22:16:28.864075|2017-10-10 22:16:28.864075
NCT02750176|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CERCT||Rehabilitation: Closed-Chain Exercises for Rotator Cuff Tears|Rehabilitation of Patients With Full-thickness Rotator Cuff Tears: Planning and Pilot Study for Feasibility and Efficacy|Recruiting||Early Phase 1|30|Anticipated|University of Southern California||1|||f||||f||||||||Undecided||2017-10-10 22:16:28.956815|2017-10-10 22:16:28.956815
NCT02750163|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-07-15|||September 2016||2016-09-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Circulating Free Hemoglobin and Microcirculation After Administration of Paracetamol in Febrile Septic Patient|Circulating Free Hemoglobin and Microcirculation After Administration of Paracetamol in Febrile Septic Patient|Not yet recruiting||N/A|50|Anticipated|Università Politecnica delle Marche|||1||f||||f||||||Samples Without DNA|"     Dosage of free hemoglobin; dosage of oxidative markers as F2-isoprostane F2 and-isoflurane,     sindecan-1, heparasulfate and hyaluronic acid, endothelin-1, plasma assay of NO, reduced     glutathione, haptoglobin and hemopexin.   "|||2017-10-10 22:16:29.060399|2017-10-10 22:16:29.060399
NCT02750150|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-20|||July 2013||2013-07-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|TrauCC||Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients|A Randomized Trial to Evaluate Freezed-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients|Completed||Phase 3|42|Actual|University Hospital, Lille||2|||f||||t||||||||Undecided||2017-10-10 22:16:29.122815|2017-10-10 22:16:29.122815
NCT02750137|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-22|||August 2014||2014-08-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Ametop - Friend and Foe A Prospective Study of the Incidence of Adverse Reactions With Ametop|Ametop - Friend or Foe A Prospective Observational Study of the Incidence of Adverse Reactions With Ametop|Completed||N/A|192|Actual|KK Women's and Children's Hospital|||1||f||||f||||||||No|Data will be protected and not shared.|2017-10-10 22:16:29.194899|2017-10-10 22:16:29.194899
NCT02750124|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-04-22|||March 2016||2016-03-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||IT-system Development for Reaching Cervix Cancer Screening Non-attenders|IT-system Development for Individualization of Cervix Cancer Screening and Implementation of New Strategies to Reach Non-attenders|Enrolling by invitation||Phase 2/Phase 3|8000|Anticipated|Karolinska Institutet||4|||f||||f||||||||Undecided|Our intention is to share data, but a plan for how this will be done in practise has not been written.|2017-10-10 22:16:29.273835|2017-10-10 22:16:29.273835
NCT02750111|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-20|||May 2016||2016-05-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|||Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes|Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes|Not yet recruiting||N/A|50|Anticipated|Sheba Medical Center|||1||f||||f||||||||Yes||2017-10-10 22:16:29.341148|2017-10-10 22:16:29.341148
NCT02750098|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-20|||May 2016||2016-05-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Aqueous and Plasma Glucose Level in Diabetic Patients|Comparison of Aqueous and Plasma Glucose Level in Diabetic Patients|Not yet recruiting||N/A|25|Anticipated|Sheba Medical Center||1|||f||||||||||||||2017-10-10 22:16:29.388546|2017-10-10 22:16:29.388546
NCT02750085|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-06-02|||April 2016||2016-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 31, 2017|Anticipated|2017-12-31||Observational|||Evaluation of a Simple Pharmacokinetic Tool (myPKFiT™) to Guide Personalized Factor VIII Dosing in Patients With Hemophilia|Evaluation of a Simple Pharmacokinetic Tool (myPKFiT™) to Guide Personalized Factor VIII Dosing in Patients With Hemophilia|Enrolling by invitation||N/A|50|Anticipated|The Hospital for Sick Children|||1||f||||f||||||Samples Without DNA|"     Plasma collected from PK blood sampling   "|No||2017-10-10 22:16:29.446394|2017-10-10 22:16:29.446394
NCT02750072|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|INSURT||INfrapatellar Versus SUprapatellar Reamed Intramedullary Nailing for Fractures of the Tibia|INfrapatellar Versus SUprapatellar Reamed Intramedullary Nailing for Fractures of the Tibia|Recruiting||N/A|202|Anticipated|Simon Fraser Orthopaedic Fund||2|||f||||t||||||||No||2017-10-10 22:16:29.516868|2017-10-10 22:16:29.516868
NCT02750059|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2017-04-24|||January 2015||2015-01-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis|Adjunctive Therapy With Telmisartan Instituted With ART During Acute HIV Infection to Reduce the Establishment of CNS Reservoirs of HIV and Lymph Node Fibrosis|Active, not recruiting||Phase 2|21|Actual|South East Asia Research Collaboration with Hawaii||2|||f||||t||||||||Undecided||2017-10-10 22:16:29.610933|2017-10-10 22:16:29.610933
NCT02750046|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-20|||March 2016||2016-03-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of A Special Vessel Subtype in Bone Samples From Patients With Osteoporotic and Nonosteoporotic Fracture|Collection of Bone Specimens for Testing of A Special Vessel Subtype|Active, not recruiting||N/A|30|Anticipated|Second Affiliated Hospital of Soochow University||2|||f||||t||||||||Undecided||2017-10-10 22:16:29.688415|2017-10-10 22:16:29.688415
NCT02750033|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-02-08|||October 2016|Anticipated|2016-10-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Intraoperative Margin Assessment During Mohs Surgery|Intraoperative Margin Assessment During Mohs Surgery|Withdrawn||N/A|0|Actual|Seton Healthcare Family|||2|Protocol changed to meet IRB requirements for patient safety|f||||f|f|f||||||Undecided||2017-10-10 22:16:29.757275|2017-10-10 22:16:29.757275
NCT02750007|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-22|||December 2015||2015-12-01|April 2016|2016-04-01||||January 2017|Anticipated|2017-01-01||Interventional|||Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients|Open-label, Non-randomized, Weekly-dose Titration Study to Assess the Tolerability to HS-20004 in Type 2 (Diabetes Mellitus) Diabetic Patients|Recruiting||Phase 1|12|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||1|||f||||f||||||||No||2017-10-10 22:16:29.893949|2017-10-10 22:16:29.893949
NCT02749994|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-03-12|||April 2016||2016-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|I-ROSETTE||A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)||Completed||Phase 3|396|Actual|IlDong Pharmaceutical Co Ltd||6|||f||||f||||||||No||2017-10-10 22:16:29.981943|2017-10-10 22:16:29.981943
NCT02749981|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-05-02|||December 2012||2012-12-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Observational|CEFA||Cefazolin Dosing in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Cefazolin Dosing in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Completed||N/A|56|Actual|University Hospital, Ghent|||1||f||||f||||||Samples Without DNA|"     blood and tissue samples   "|||2017-10-10 22:16:30.101326|2017-10-10 22:16:30.101326
NCT02749968|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-09-23|||December 2016||2016-12-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma||Not yet recruiting||Phase 2|100|Anticipated|University of Cincinnati||2|||f||||f||||||||No||2017-10-10 22:16:30.411934|2017-10-10 22:16:30.411934
NCT02749955|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-06-08|||November 2015||2015-11-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|PS-PrEP||Partner Services Pre-exposure Prophylaxis (PS-PrEP)|Partner Services Pre-exposure Prophylaxis (PS-PrEP)|Recruiting||N/A|120|Anticipated|University of Chicago||3|||f||||f||||||||||2017-10-10 22:16:30.515926|2017-10-10 22:16:30.515926
NCT02749942|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-22|||April 2016||2016-04-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|RISCAID||RISCAID Study: Remote ISchemic Conditioning for Angiopathy In Diabetes|The RISCAID Study: Remote ISchemic Conditioning for Angiopathy In Diabetes|Not yet recruiting||N/A|40|Anticipated|Steno Diabetes Center||2|||f||||t||||||||No|To ensure data security no data will be shared outside the study group|2017-10-10 22:16:30.6174|2017-10-10 22:16:30.6174
NCT02749929|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-05-10|||April 2016||2016-04-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Low-level Laser Therapy on Wrist Fractures|A Double-blind Placebo-controlled Study of Low-level Laser Therapy on Wrist Fractures|Recruiting||N/A|40|Anticipated|University of Bergen||2|||f||||f||||||||No||2017-10-10 22:16:30.731224|2017-10-10 22:16:30.731224
NCT02749916|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-05-22|||August 2016||2016-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Week|Observational [Patient Registry]|||Contrast Enhanced SWI for Carotid Plaque Imaging|Contrast Enhanced Susceptibility Weighted Imaging (SWI) for Characterization of Carotid Plaque|Recruiting||N/A|68|Anticipated|Seoul St. Mary's Hospital|||1||f||||f||||||||||2017-10-10 22:16:30.816406|2017-10-10 22:16:30.816406
NCT02749903|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2017-09-29|||June 2016||2016-06-01|September 2017|2017-09-01||||April 2018|Anticipated|2018-04-01||Interventional|||Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers|A Phase II Study of Enzalutamide (NSC# 766085) for Patients With Androgen Receptor Positive Salivary Cancers|Recruiting||Phase 2|45|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-10 22:16:30.980645|2017-10-10 22:16:30.980645
NCT02749877|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Efficacy of Cognitive and Physical Trainings in Pediatric Cancer Survivors|Efficacy of Cognitive and Physical Trainings in Pediatric Cancer Survivors|Recruiting||N/A|190|Anticipated|University Hospital Inselspital, Berne||3|||f||||f||||||||Undecided||2017-10-10 22:16:32.55313|2017-10-10 22:16:32.55313
NCT02749864|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-04-26|||June 2015||2015-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|PREVHEP||Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP)|Personalized Medicine in HCV Infection. A Prospective, Multicenter, Epidemiological Study to Evaluate the Prevalence of Hepatitis C Infection in Spain in 2015 (PREVHEP)|Recruiting||N/A|16000|Anticipated|Instituto de Investigación Marqués de Valdecilla|||3||f||||f||||||Samples With DNA|"     Samples of whole blood, plasma and serum will be collected to analyse different markers     related to the virus and the medical status of the patients.      DNA samples will be transferred to the Biobank Valdecilla (Node DNA and fluids) according to     Spanish law. Law 14/2007 of 3 July, on biomedical research and the Biobank law:      Royal Decree 1716/2011, establishing the basic requirements for authorization and operation     of biobanks are established for biomedical research and treatment of biological samples of     human origin   "|No||2017-10-10 22:16:32.629844|2017-10-10 22:16:32.629844
NCT02749851|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-04-07|||March 2016||2016-03-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PIP||Placenta Imaging Project|Functional Imaging of Human Placenta by MRI|Recruiting||Phase 1/Phase 2|300|Anticipated|Oregon Health and Science University||3|||f||||t||||||||No||2017-10-10 22:16:32.739018|2017-10-10 22:16:32.739018
NCT02749838|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-04-20|||May 2014||2014-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|||Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens|Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens|Active, not recruiting||N/A|183|Actual|Pharmatech|||1||f||||f||||||||No||2017-10-10 22:16:32.949109|2017-10-10 22:16:32.949109
NCT02749825|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-04-20|||September 2002||2002-09-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer|A Multicenter, Randomized Clinical Investigation of Trelstar Versus Continued Therapy in Patients Receiving Lupron or Zoladex for Advanced Prostate Cancer|Terminated||Phase 4|41|Actual|Pharmatech||3||Withdrawal of funding support|f||||f||||||||No||2017-10-10 22:16:33.011359|2017-10-10 22:16:33.011359
NCT02749812|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-20|||January 2013||2013-01-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PREDIVARIUS||Interest of Treatment of Obstructive Sleep Apnea Syndrome by Constant CPAP and Auto CPAP|Beneficial Effects of Obstructive Sleep Apnea Syndrome (OSAS) Treatment by Automatic Continuous Positive Airway Pressure (APAP) vs Constant Continuous Positive Airway Pressure (Constant CPAP) According to the Level of the Efficient Pressure and Its Variability. A Multicentric Randomized Trial|Completed||N/A|800|Actual|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 22:16:33.118422|2017-10-10 22:16:33.118422
NCT02749799|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-11-18|||February 2016||2016-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis||Completed||Phase 3|44|Actual|Promius Pharma, LLC||1|||f||||f||||||||No||2017-10-10 22:16:33.180946|2017-10-10 22:16:33.180946
NCT02749786|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-11-21|||October 2015||2015-10-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Genetic Basis of Rosacea Study (Control)|Expansion Arm of Papulopustular Rosacea Gene Expression Profiling to Include Normal Individuals as Anatomic Site Specific Controls|Recruiting||N/A|10|Anticipated|Stanford University||1|||f||||f||||||||Undecided||2017-10-10 22:16:33.254445|2017-10-10 22:16:33.254445
NCT02749773|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-05-01|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Is There a Difference in Oocyte Quality? A Comparison of Two Aspiration Needle Gauges||Not yet recruiting||N/A|100|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||No||2017-10-10 22:16:33.330066|2017-10-10 22:16:33.330066
NCT02749760|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-05-05|||February 2014||2014-02-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Prevention of Ulnar Collateral Ligament (UCL) Injuries in Minor League Pitchers|The Effect of Dynamic Stabilizers for Valgus Stability of the Elbow in Professional Baseball Players|Enrolling by invitation||N/A|175|Anticipated|University of Kansas Medical Center||1|||f||||t||||||||No||2017-10-10 22:16:33.398717|2017-10-10 22:16:33.398717
NCT02749747|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-22|||June 2014||2014-06-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Interventional|||Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric|Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric: a Double-blind Randomized Clinical Trial|Recruiting||Phase 3|2|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:16:33.486818|2017-10-10 22:16:33.486818
NCT02749734|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-04-20|||May 2015||2015-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases|Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases|Recruiting||Phase 1|15|Anticipated|Southwest Hospital, China||1|||f||||f||||||||||2017-10-10 22:16:33.575084|2017-10-10 22:16:33.575084
NCT02749721|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-04-10|||December 2016||2016-12-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder|Relationship Among Changes in Brain Network Activation, Changes in Core Depressive and Cognitive Symptoms and Safety and Tolerability in Adults With Major Depressive Disorder Treated With Open-Label, Flexible-Dose Vortioxetine|Recruiting||Phase 4|50|Anticipated|Rush University Medical Center||1|||f||||f||||||||No||2017-10-10 22:16:33.651887|2017-10-10 22:16:33.651887
NCT02749708|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-07-12|||April 2016||2016-04-01|July 2017|2017-07-01||||December 2020|Anticipated|2020-12-01||Interventional|||Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome|Phase I/II Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1/Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:16:33.739746|2017-10-10 22:16:33.739746
NCT02749695|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-20|||October 2013||2013-10-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Efficiency of Placental Drug Melsmon® in Correction of Climacteric Symptoms in Premenopausal Women|The Prospective, Blind, Randomized, Placebo-controlled, 4 Months Study of Efficacy of Melsmon® for Correction of Insomnia and Other Climacteric Symptoms in Premenopausal Women|Completed||Phase 2/Phase 3|40|Actual|Scientific Center for Family Health and Human Reproduction Problems, Russia||2|||f||||f||||||||Yes|"We plan to share all available IPD: age, body mass, character of menstrual disorder and climacteric syndromes, treatment regimen (for both experimental and placebo groups), Kupperman index, results of overall-health and sleep evaluation.
Until the publications are available, any concerned party can contact the researcher Inna I. Kovalenko (innakov2010@yandex.ru)."|2017-10-10 22:16:33.827127|2017-10-10 22:16:33.827127
NCT02749682|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-04-22|||January 2015||2015-01-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01|12 Months|Observational [Patient Registry]|||Relationship Between Constipation and Inguinal Hernia|Impact of Chronic Constipation on the Development Inguinal Hernia|Completed||N/A|200|Actual|Siverek Devlet Hastanesi|||2||f||||t||||||||No||2017-10-10 22:16:33.898818|2017-10-10 22:16:33.898818
NCT02749669|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-01-31|||March 2016||2016-03-01|April 2016|2016-04-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Interventional|PAGE||Health Care Courses of Elderly Hospitalized Patients for Inappropriate Reasons: Qualitative and Economic Analyzes|Health Care Courses of Elderly Hospitalized Patients for Inappropriate Reasons: Qualitative and Economic Analyzes|Completed||N/A|22|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-10 22:16:33.957135|2017-10-10 22:16:33.957135
NCT02749656|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-04-28|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis|A Randomized Control Trial of Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) Compared With 0.25% Desoximetasone Cream (Topicorte®) in the Treatment of Scalp Psoriasis|Recruiting||Phase 3|105|Anticipated|Siriraj Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:16:34.045073|2017-10-10 22:16:34.045073
NCT02749643|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-22|||April 2016||2016-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Functional Outcome Measures With Vibrotactile Feedback to Prostheses|The Effects of Adding Vibrotactile Feedback to Prostheses on Functional Outcome Measures of Transradial Amputation Prosthetic Users|Recruiting||N/A|15|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||Undecided||2017-10-10 22:16:34.140871|2017-10-10 22:16:34.140871
NCT02749617|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-02-22|||May 2016||2016-05-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ADAM||A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma|A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma|Recruiting||Phase 2|24|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-10 22:16:34.331479|2017-10-10 22:16:34.331479
NCT02749604|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-20|||March 2016||2016-03-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the Prostate|Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLightTM Laser Photoselective Vaporization of the Prostate (PVP): A Randomized Double Blind Sexual and Urodynamic Assessment|Recruiting||Phase 4|40|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 22:16:34.407963|2017-10-10 22:16:34.407963
NCT02749591|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-08-22|||May 2, 2016|Actual|2016-05-02|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparative Hybrid Effects of Combining BoNT-A With Robot-assisted or Mirror Therapy for U/E Spasticity Stroke Patients|Comparative Hybrid Effects of Combining Botulinum Toxin Type A With Robot-assisted Training v.s. With Mirror Therapy for Stroke Patients With Upper Extremity Spasticity: A Randomized Controlled Study|Recruiting||Phase 3|60|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-10 22:16:36.162399|2017-10-10 22:16:36.162399
NCT02749578|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-08-29|||April 2016||2016-04-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Drug Interaction Study of MGL-3196 With Atorvastatin|A Single Center, Open-label, Drug Interaction Study of MGL-3196 With Atorvastatin in Healthy Subjects|Completed||Phase 1|14|Actual|Madrigal Pharmaceuticals, Inc.||1|||f||||f||||||||No||2017-10-10 22:16:36.268365|2017-10-10 22:16:36.268365
NCT02749565|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-11-20|||January 2015||2015-01-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Observational|||The Role of Endothelium A and EGFR Receptor in Fibrocytes From Asthma With Obstructive Sleep Apnea|he Role of Endothelium A and EGFR Receptor in Fibrocytes From Asthma With Obstructive Sleep Apnea|Recruiting||N/A|60|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||Samples With DNA|"     circulating fibrocytes purified from PBMC   "|No||2017-10-10 22:16:36.33745|2017-10-10 22:16:36.33745
NCT02749552|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-20|||May 2016||2016-05-01|April 2016|2016-04-01|June 2021|Anticipated|2021-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Role of Values, Acceptance, and Mindfulness Strategies in Long Term Weight Management|The Role of Values, Acceptance, and Mindfulness Strategies in Long Term Weight Management|Not yet recruiting||N/A|200|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||No||2017-10-10 22:16:36.417453|2017-10-10 22:16:36.417453
NCT02749539|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-22|||February 2015||2015-02-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Post Mastectomy Shoulder Problems and Kinesio Taping|Investigating the Effect of Kinesio Tape Over the Conventional Physical Therapy Management of Shoulder Related Complications in Post-mastectomy Peri-menopausal Females: A Randomized Control Trial|Completed||N/A|70|Actual|Cairo University||2|||f||||t||||||||Yes|publication in a refereed journal|2017-10-10 22:16:36.495271|2017-10-10 22:16:36.495271
NCT02749526|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-04-22|||April 2016||2016-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial||Recruiting||Phase 2|70|Anticipated|The First Affiliated Hospital with Nanjing Medical University||1|||f||||t||||||||No||2017-10-10 22:16:36.560274|2017-10-10 22:16:36.560274
NCT02749513|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-07-25|||January 2016||2016-01-01|July 2017|2017-07-01||||December 2018|Anticipated|2018-12-01||Interventional|||Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients|Feasibility of Itraconazole as a Targeted Therapy for Inhibition of Hedgehog Pathway Signaling in Patients With Esophageal Cancer|Recruiting||Early Phase 1|10|Anticipated|Dallas VA Medical Center||1|||f||||f||||||||||2017-10-10 22:16:36.642019|2017-10-10 22:16:36.642019
NCT02749500|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-07-06|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Independent Adaptive Arm and Hand Rehab|Early Independent Adaptive Arm and Hand Rehabilitation Post Stroke|Recruiting||N/A|120|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:16:36.719278|2017-10-10 22:16:36.719278
NCT02749487|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-21|2016-12-15|||June 2015||2015-06-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Observational|||Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients|Neutrophil Lymphocyte and Platelet Lymphocyte Ratios as Predictors of Outcome in Traumatic Critically Ill Patients|Completed||N/A|80|Actual|Assiut University|||2||f||||t||||||||No||2017-10-10 22:16:36.805787|2017-10-10 22:16:36.805787
NCT02749474|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-07-20|||July 2003||2003-07-01|July 2017|2017-07-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01|20 Years|Observational [Patient Registry]|CANCRPREGREG||Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes|Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being|Recruiting||N/A|400|Anticipated|The Cooper Health System|||1||f||||f||||||||||2017-10-10 22:16:36.875804|2017-10-10 22:16:36.875804
NCT02749461|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-02|||November 2015||2015-11-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|BERN-PAIN||Validation of the Bernese Pain Scale for Neonates|Validation of the Bernese Pain Scale for Neonates With Consideration for Contextual Factors|Completed||N/A|156|Actual|Bern University of Applied Sciences|||1||f||||f||||||||||2017-10-10 22:16:38.166131|2017-10-10 22:16:38.166131
NCT02749448|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2016-07-22|||February 2015||2015-02-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|||Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients|The Effect of Autologous Adipose Mesenchymal Stem Cells in Treatment of Airway Injury in Patients Exposed to Sulfur Mustard|Active, not recruiting||Phase 1|10|Anticipated|Baqiyatallah Medical Sciences University||1|||f||||f||||||||No|there is no individual participant data|2017-10-10 22:16:38.245981|2017-10-10 22:16:38.245981
NCT02749422|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-02-27|||October 2016||2016-10-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||fMRI Guided TMS Enhancement of Associative Memory Networks|A Randomized Controlled Pilot Study of TMS Enhancement of Associative Memory Networks in Healthy Subjects and Epilepsy Patients|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||||||t|f|t|f|f||||||2017-10-10 22:16:38.432107|2017-10-10 22:16:38.432107
NCT02749409|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture|Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture|Not yet recruiting||Phase 3|204|Anticipated|Chang Gung Memorial Hospital||2|||f||||||||||||||2017-10-10 22:16:38.535437|2017-10-10 22:16:38.535437
NCT02749383|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-04-20|||February 2014||2014-02-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis|A Randomized, Double-blind, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Seborrheic Dermatitis of the Face|Completed||Phase 2|75|Actual|Amorepacific Corporation||3|||f||||t||||||||||2017-10-10 22:16:38.74661|2017-10-10 22:16:38.74661
NCT02749370|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-08-24|||May 18, 2016|Actual|2016-05-18|August 2017|2017-08-01|November 19, 2017|Anticipated|2017-11-19|August 15, 2017|Actual|2017-08-15||Interventional|||Study Will Evaluate the Efficacy of Etanercept Treatment in Subjects Who Have Failed Therapy With Apremilast|Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast|Active, not recruiting||Phase 4|80|Actual|Amgen||1|||f||||f||||||||||2017-10-10 22:16:38.834063|2017-10-10 22:16:38.834063
NCT02749357|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-15|||May 2016||2016-05-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Robotic Gait Training in Spinal Cord Injury|Effect of Different Programs of Robotic Assisted Gait Training in Individuals With Chronic Motor Incomplete Spinal Cord Injury.|Recruiting||N/A|10|Anticipated|Instituto Nacional de Rehabilitacion||2|||f||||t||||||||||2017-10-10 22:16:39.10104|2017-10-10 22:16:39.10104
NCT02749344|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-01-08|||May 2016||2016-05-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Natural Cycle/Progesterone Fortified Protocol for Endometrial Preparation for Frozen/Thawed Embryo Transfer|Natural Cycle/Progesterone Fortified Protocol for Endometrial Preparation for Frozen/Thawed Embryo Transfer|Recruiting||N/A|40|Anticipated|HaEmek Medical Center, Israel||1|||f||||f||||||||Undecided||2017-10-10 22:16:39.367577|2017-10-10 22:16:39.367577
NCT02749331|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-05-18|||March 2016||2016-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|RADNET||Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy|Study of Recombinant Adenovirus (AdVince) in Patients With Neuroendocrine Tumors; Safety and Efficacy|Recruiting||Phase 1/Phase 2|35|Anticipated|Uppsala University||1|||f||||t||||||||No||2017-10-10 22:16:39.470567|2017-10-10 22:16:39.470567
NCT02749318|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-09-12|||July 2017|Anticipated|2017-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Dental Engagement Study Behavior Modification|Engagement Study: (Multi-site, Practice-Based Research Network (PBRN) Prospective Clinical Trial to Assess if Knowledge of Genetic Risk Changes Behavior)|Withdrawn||N/A|0|Actual|Interleukin Genetics, Inc.||2||Company Assets Being Sold|f||||t|f|f||||||||2017-10-10 22:16:39.590423|2017-10-10 22:16:39.590423
NCT02749305|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-09-19|||March 2016||2016-03-01|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|June 2019|Anticipated|2019-06-01||Interventional|LOBSTER PROMs||Comparative Effectiveness of Bariatric Surgery With PROMs|Comparative Effectiveness of Metabolic and Bariatric Surgical Procedures Using Patient Reported Outcome Measures (PROMs)|Recruiting||N/A|200000|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:16:39.679739|2017-10-10 22:16:39.679739
NCT02749292|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-09-21|||June 2016||2016-06-01|September 2016|2016-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|MAINTANCAVAS||Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing|Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing Based on B-cell Reconstitution vs a Serologic ANCA Flare|Recruiting||Phase 4|200|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:16:39.790182|2017-10-10 22:16:39.790182
NCT02749279|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-28|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01|12 Months|Observational [Patient Registry]|LLT-R-Registry||Lipid Lowering Therapy After Cardiac Rehabilitation LLT-R-Registry|Adherence to Lipid Lowering Therapy After Cardiac Rehabilitation (LLT-Rehabilitation-Registry)|Recruiting||N/A|1100|Anticipated|Paracelsus Harz Clinic Bad Suderode.|||1||f||||f||||||||||2017-10-10 22:16:39.90574|2017-10-10 22:16:39.90574
NCT02749266|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-04-19|||June 2014||2014-06-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Impact of Chiropractic Activator Adjustments on Mental Rotation and Line Judgment Reaction Time|The Impact of Chiropractic Activator Adjustments on Mental Rotation and Line Judgment Reaction Time: A Pilot Study|Completed||N/A|16|Actual|Life University||2|||f||||f||||||||||2017-10-10 22:16:39.968481|2017-10-10 22:16:39.968481
NCT02749253|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-08-22|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Sudarshan Kriya Yoga (SKY) in Post Traumatic Stress Disorder: a Feasibility Study|Sudarshan Kriya Yoga (SKY) in Post Traumatic Stress Disorder: a Feasibility Study|Completed||N/A|33|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-10 22:16:40.073789|2017-10-10 22:16:40.073789
NCT02749240|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-22|||June 2016||2016-06-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Feasibility (Pilot) Study of an Innovative Non-pharmacological Intervention Program in at Risk Youth|A Feasibility (Pilot) Study of an Innovative Non-pharmacological Intervention Program in at Risk Youth|Recruiting||Early Phase 1|30|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-10 22:16:40.159058|2017-10-10 22:16:40.159058
NCT02749227|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-01-30|||January 2017|Anticipated|2017-01-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PASSILCORT||Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors|Pilot Study of Pasireotide LAR Treatment of Silent Corticotrophin Pituitary Tumors and Effects on Plasma Levels of POMC|Recruiting||Phase 2|10|Anticipated|Columbia University||1|||f||||f||||||||No||2017-10-10 22:16:40.249109|2017-10-10 22:16:40.249109
NCT02749214|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-10-21|||February 2016||2016-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes|Defining a Parkinson's Disease (PD) -Specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes|Recruiting||N/A|100|Anticipated|Emory University|||2||f||||f||||||Samples Without DNA|"     Breath samples will be collected to analyze for breath volatile organic compounds (BVOC).     Peripheral blood samples will also be collected and analyzed for inflammatory proteins.   "|||2017-10-10 22:16:40.333|2017-10-10 22:16:40.333
NCT02749201|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-09-20|||April 2016||2016-04-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|TiLLT||Transmitted Light Tissue Thickness Analysis (TiLTT)|Transmitted Light Tissue Thickness Analysis (TiLTT)|Completed||N/A|10|Actual|Maimonides Medical Center||1|||f||||f||||||||||2017-10-10 22:16:40.413332|2017-10-10 22:16:40.413332
NCT02749188|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-20|||October 2014||2014-10-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|StiVeN||Evaluation of Bladder Stimulation as a Noninvasive Technique of Urine Collection in Infant Who Have Not Acquired Walking|Evaluation of Bladder Stimulation as a Noninvasive Technique of Urine Collection in Infants Who Have Not Acquired Walking|Recruiting||Phase 3|300|Anticipated|Fondation Lenval||1|||f||||f||||||||No||2017-10-10 22:16:40.478239|2017-10-10 22:16:40.478239
NCT02749175|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-09-05|||May 2016||2016-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||SMART Study (Sellick's Maneuver Assisted Real Time) to Deliver Target Cricoid Pressure in Simulated Environment|Novel Ultrathin Miniature Force Sensor to Deliver Optimal Cricoid Pressure for Airway Protection in Patients at High Risk of Gastric Aspiration - a Verification of Design|Recruiting||N/A|21|Anticipated|KK Women's and Children's Hospital||3|||f||||t||||||||Yes||2017-10-10 22:16:40.558001|2017-10-10 22:16:40.558001
NCT02749162|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-08-01|||November 2015||2015-11-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Perineural Dexamethasone in Femural Nerve Block After Ligament Reconstruction|Perineural Dexamethasone Administered in Femural Nerve Block After Anterior Cruciate Ligament Reconstruction|Completed||Phase 3|90|Actual|Foisor Orthopedics Clinical Hospital||3|||f||||t||||||||||2017-10-10 22:16:40.728873|2017-10-10 22:16:40.728873
NCT02749149|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-19|||January 2016||2016-01-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|FOCuS||Does Frailty Help Predict Postoperative Outcomes in Cardiac Surgery?|Assessment of the Frailty Score in Cardiac Surgery and Its Correlation to Cardiac Postoperative Morbidity and Disability - a Prospective Observational Study|Enrolling by invitation||N/A|120|Anticipated|King's College Hospital NHS Trust|||1||f||||t||||||||No|Contact research lead.|2017-10-10 22:16:40.864233|2017-10-10 22:16:40.864233
NCT02749136|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-03-08|||May 2016||2016-05-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Interventional|||Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer|Phase 2 Study of Neoadjuvant Modified FOLFIRINOX in Patients With Borderline Resectable Pancreas Adenocarcinoma|Recruiting||Phase 2|44|Anticipated|Asan Medical Center||1|||f||||f||||||||No||2017-10-10 22:16:40.967184|2017-10-10 22:16:40.967184
NCT02749123|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-19|||April 2016||2016-04-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Prescription Lidocaine Patch to Over the Counter Lidocaine Patch and Placebo for Back Pain and Arthritis|Comparison of Prescription Lidocaine Patch to Over the Counter Lidocaine Patch and Placebo for Back Pain and Arthritis|Recruiting||N/A|100|Anticipated|J.A.R. Laboratories||2|||f||||t||||||||No|Investigators plan to share the study results as a whole but no plans to share individual results.|2017-10-10 22:16:41.073862|2017-10-10 22:16:41.073862
NCT02749110|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-09-22|||August 2016||2016-08-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|PaCUDAHL-Gé||Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner|Participation in Screening for Cervical Cancer: Interest of a Human Papillomavirus (HPV) Self-sampling Device Provided by the General Practitioner; a Cluster Randomized Clinical Trial|Recruiting||N/A|2000|Anticipated|University Hospital, Lille||2|||f||||f||||||||Undecided||2017-10-10 22:16:41.165947|2017-10-10 22:16:41.165947
NCT02749097|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-20|||October 2013||2013-10-01|April 2016|2016-04-01||||December 2013|Actual|2013-12-01||Interventional|||A PHASE I, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SHR0534 IN HEALTHY VOLUNTEERS||Completed||Phase 1|40|Actual|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||||||||||||2017-10-10 22:16:41.283786|2017-10-10 22:16:41.283786
NCT02749084|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-02-01|||August 3, 2016|Actual|2016-08-03|February 2017|2017-02-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|TREG2015001||Multiple Donor Treg DLI for Severe Refractory Chronic GVHD|Multiple Donor Regulatory T Cell (Treg) Infusions (T Reg DLI) for Severe Refractory Chronic Graft Versus Host Disease (GVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|Recruiting||Phase 1/Phase 2|20|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||f||||||||Undecided||2017-10-10 22:16:41.37892|2017-10-10 22:16:41.37892
NCT02749071|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-09-11|||May 2016||2016-05-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|March 2018|Anticipated|2018-03-01||Interventional|||An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux|A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD)|Recruiting||N/A|110|Anticipated|EndoStim Inc.||2|||f||||t||||||||||2017-10-10 22:16:41.473286|2017-10-10 22:16:41.473286
NCT02749058|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-08-22|||April 2016||2016-04-01|August 2017|2017-08-01||||October 2018|Anticipated|2018-10-01||Interventional|||Capsulectomy vs Capsulotomy in Total Hip Arthroplasty. Clinical Outcomes and Proprioception Evaluation|Capsulectomy vs Capsulotomy in Total Hip Arthroplasty. Clinical Outcomes and Proprioception Evaluation|Enrolling by invitation||N/A|94|Anticipated|IRCCS San Raffaele||2|||f||||t||||||||||2017-10-10 22:16:41.711156|2017-10-10 22:16:41.711156
NCT02749045|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Simultaneous Assessment of FFR and SPECT|The Simultaneous Assessment of Invasive Fractional Flow Reserve and SPECT Myocardial Ischemia Using Regadenoson in the Catheterization Laboratory|Recruiting||N/A|50|Anticipated|University of Pittsburgh||1|||f||||t||||||||No||2017-10-10 22:16:41.823596|2017-10-10 22:16:41.823596
NCT02749032|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-20|||November 2011||2011-11-01|April 2016|2016-04-01||||March 2014|Actual|2014-03-01||Interventional|||Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion|Feed-Back Suppression of Meal-Induced GLP-1 Secretion Mediated Through Elevations in Intact GLP-1 Caused by Dipeptidyl Peptidase 4 (DPP-4) Inhibition: A Randomized, Prospective Comparison of Sitagliptin and Vildagliptin Treatment|Completed||Phase 1|24|Actual|Diabeteszentrum Bad Lauterberg im Harz||6|||f||||f||||||||Undecided||2017-10-10 22:16:41.932073|2017-10-10 22:16:41.932073
NCT02749019|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-21|||July 2015||2015-07-01|April 2016|2016-04-01||||July 2018|Anticipated|2018-07-01||Interventional|||Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients|68Ga-NOTA-BBN-RGD PET/CT in Breast Cancer Patients|Recruiting||Phase 1|40|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||||2017-10-10 22:16:42.035222|2017-10-10 22:16:42.035222
NCT02749006|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-11-18|||April 2016||2016-04-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|rTMS-BD||Efficacy of rTMS in Bipolar I Depression|A Randomized Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in Acute Bipolar-I Depression|Recruiting||Phase 4|100|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:16:42.119329|2017-10-10 22:16:42.119329
NCT02748993|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-08-27|||March 2016||2016-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis|A Randomized, Double-blind, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Systemic Exposure and Efficacy of PAC-14028 in Children With Mild to Moderate Pediatric Atopic Dermatitis|Recruiting||Phase 1/Phase 2|56|Anticipated|Amorepacific Corporation||4|||f||||t||||||||||2017-10-10 22:16:42.23307|2017-10-10 22:16:42.23307
NCT02748980|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-21|||March 2016||2016-03-01|April 2016|2016-04-01||||March 2019|Anticipated|2019-03-01||Observational|||Clinical Observation of Coronary Arterial Microcirculation Dysfunction in Diabetic Patients With Non- Obstructive Coronary Artery Disease||Recruiting||N/A|200|Anticipated|Shaanxi Provincial People's Hospital|||2||f||||||||||||||2017-10-10 22:16:42.347707|2017-10-10 22:16:42.347707
NCT02748967|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-10-03|||April 2016||2016-04-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of Different Doses of ExPEC4V (JNJ-63871860) in Healthy Japanese Adult Participants|Randomized, Double-Blind, Placebo-controlled Phase 1 Study in Healthy Japanese Adult Subjects to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860|Completed||Phase 1|48|Actual|Janssen Pharmaceutical K.K.||6|||f||||f||||||||||2017-10-10 22:16:42.422605|2017-10-10 22:16:42.422605
NCT02748954|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-19|||May 2014||2014-05-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Mood Management Effects of Brief Unsupported Internet Interventions|Mood Management Effects of Brief Unsupported Internet Interventions|Completed||N/A|765|Actual|i4Health||5|||f||||f||||||||No||2017-10-10 22:16:42.509995|2017-10-10 22:16:42.509995
NCT02748941|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-08|||January 12, 2017|Actual|2017-01-12|August 2017|2017-08-01|February 12, 2019|Anticipated|2019-02-12|February 12, 2019|Anticipated|2019-02-12||Interventional|ACABII||Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control||Recruiting||N/A|150|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:16:42.586267|2017-10-10 22:16:42.586267
NCT02748928|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-01-04|||June 2016||2016-06-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|||UltraShape Power for Abdominal Fat and Circumference Reduction|Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Power Device Using the U-Sculpt Power Transducer for Abdominal Fat and Circumference Reduction|Active, not recruiting||N/A|62|Actual|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 22:16:42.68579|2017-10-10 22:16:42.68579
NCT02748915|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-08-08|||January 2016||2016-01-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|ENPICME||Electrophysiological-based Estimation of Cochlear Implant Fitting|Estimation of Perceptual Levels Used in Cochlear Implant Fitting Based on Electrophysiological Measures|Recruiting||N/A|120|Anticipated|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-10 22:16:42.784496|2017-10-10 22:16:42.784496
NCT02748902|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-07-12|||April 27, 2016|Actual|2016-04-27|July 2017|2017-07-01|March 30, 2017|Actual|2017-03-30|January 27, 2017|Actual|2017-01-27||Interventional|||Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.|An Open Label Exploratory Study Evaluating the Efficacy and Safety of Ingenol Mebutate 0.05% Gel for the Treatment of Verruca Vulgaris.|Completed||Phase 1|16|Actual|TCR Medical Corporation||1|||f||||f||||||||||2017-10-10 22:16:42.88778|2017-10-10 22:16:42.88778
NCT02748889|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-07-10|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer|An Open Label, Randomized Phase I/II Trial of Carboplatin Plus Etoposide With ot Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|1|Actual|Georgetown University||2||Difficulties with recruitment|f||||t||||||||||2017-10-10 22:16:42.976538|2017-10-10 22:16:42.976538
NCT02748876|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-25|||August 2016||2016-08-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of His-Ventricular (HV) Interval Optimisation in Cardiac Resynchronisation Therapy|A Randomised Cross-over Pilot Study of the Effect of His-Ventricular (HV) Interval Optimisation in Cardiac Resynchronisation Therapy|Not yet recruiting||N/A|40|Anticipated|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||f||||||||No||2017-10-10 22:16:43.086671|2017-10-10 22:16:43.086671
NCT02748850|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-19|||April 2016||2016-04-01|April 2016|2016-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|DIMATE||Evaluation of the Effectiveness of an Aldehyde Inhibitor Dehydrogenases (DIMATE) on the Cell Population Leukemic or Normal Stem|Evaluation of the Effectiveness of an Aldehyde Inhibitor Dehydrogenases (DIMATE) on the Cell Population Leukemic or Normal Stem|Recruiting||N/A|20|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 22:16:43.479683|2017-10-10 22:16:43.479683
NCT02748837|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-01-26|||August 2016||2016-08-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of ERY974 in Patient With Advanced Solid Tumors|A Phase 1 Dose Escalation and Cohort Expansion Study of ERY974, An Anti-Glypican3 (GPC3)/CD3 Bispecific Antibody, in Patients With Advanced Solid Tumors|Recruiting||Phase 1|125|Anticipated|Chugai Pharmaceutical||4|||f||||||||||||||2017-10-10 22:16:43.569539|2017-10-10 22:16:43.569539
NCT02748824|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-06-07|||July 2016||2016-07-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|AMDIncidencePT||Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal|Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal|Recruiting||N/A|5996|Anticipated|Association for Innovation and Biomedical Research on Light and Image|||1||f||||||||||||||2017-10-10 22:16:43.698977|2017-10-10 22:16:43.698977
NCT02748811|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-01|||May 2015||2015-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|GERICO||Effect of Geriatric Intervention in Frail Elderly Patients Receiving Chemotherapy for Colorectal Cancer|Effect of Geriatric Intervention in Frail Elderly Patients Receiving Chemotherapy for Colorectal Cancer|Recruiting||N/A|140|Anticipated|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 22:16:43.81374|2017-10-10 22:16:43.81374
NCT02748798|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-19|||June 2016||2016-06-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders|Developing Optimal Parameters for Hyperpolarized Noble Gas (3He and 129Xe) and Inert Fluorinated Gas Magnetic Resonance Imaging of Lung Disorders|Not yet recruiting||Early Phase 1|160|Anticipated|Thunder Bay Regional Research Institute||2|||f||||f||||||||||2017-10-10 22:16:43.972169|2017-10-10 22:16:43.972169
NCT02748772|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-04-21|||January 2016||2016-01-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical||Recruiting||Phase 3|148|Anticipated|The First People's Hospital of Hefei||2|||f||||t||||||||Undecided||2017-10-10 22:16:44.302881|2017-10-10 22:16:44.302881
NCT02748759|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-20|||May 2014||2014-05-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Early Mobilization of Knee Joint After ACL Surgery. Continuous Passive Motion Versus Manual Passive Mobilization|Early Mobilization of Knee Joint After ACL Reconstructive Surgery Comparing Continuous Passive Motion Versus Manual Passive Mobilization|Completed||N/A|15|Actual|Althaia Xarxa Assistencial Universitària de Manresa||2|||f||||f||||||||Undecided||2017-10-10 22:16:44.470893|2017-10-10 22:16:44.470893
NCT02748746|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-06-23|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|BIA||Early Detection of Lymphedema With Bio-Electrical Impedance Analysis in Patients After Breast Cancer Surgery|Early Detection of Lymphedema With Bio-Electrical Impedance Analysis in Patients After Breast Cancer Surgery|Not yet recruiting||N/A|60|Anticipated|Abant Izzet Baysal University||3|||f||||t|f|f||||||Yes||2017-10-10 22:16:44.557318|2017-10-10 22:16:44.557318
NCT02748733|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-06-01|||April 2016||2016-04-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|PC-AAPD||Proof of Concept of Adapted PD in Children (PC-AAPD)|Randomized Cross-over Comparison of Double Mini PET With Standard vs. Adapted Dwell Volume and Dwell Time - Proof of Concept of Adapted PD|Recruiting||N/A|15|Anticipated|Heidelberg University||2|||f||||f||||||||No||2017-10-10 22:16:44.678459|2017-10-10 22:16:44.678459
NCT02748720|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-21|||October 2014||2014-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Respiratory Dynamics During Birth Stabilization in Preterm Infants Less Than 32+6/7 Weeks Gestation|Impact of Measurement of Respiratory Dynamics During Birth Stabilization in Preterm Infants Less Than 32+6/7 Weeks Gestation|Completed||N/A|126|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||t||||||||No||2017-10-10 22:16:44.799688|2017-10-10 22:16:44.799688
NCT02748707|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-11-08|||August 2015||2015-08-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|ERLO-XIB||Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study|Effect of COX-2 (Cyclooxygenase-2) and EGFR (Epidermal Growth Factor Receptor) Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study.|Recruiting||Phase 2|64|Anticipated|Tata Memorial Hospital||4|||f||||t||||||||No||2017-10-10 22:16:44.899532|2017-10-10 22:16:44.899532
NCT02748694|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-05-25|||June 27, 2016|Actual|2016-06-27|May 2017|2017-05-01|February 4, 2018|Anticipated|2018-02-04|February 4, 2018|Anticipated|2018-02-04||Interventional|||Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study|A Randomized, Double-Blind, Placebo-Controlled, Phase 1, Ascending Oral Single and Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-041 in Healthy Subjects|Recruiting||Phase 1|40|Anticipated|Takeda||5|||f||||f||||||||||2017-10-10 22:16:45.052654|2017-10-10 22:16:45.052654
NCT02748681|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-07-17|||April 2016||2016-04-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|HOPES||Telemedicine Monitoring of Sleep Apnea in Stroke|Home Polygraphic Recording With Telemedicine Monitoring for Diagnosis and Treatment of Sleep Apnea in Stroke (HOPES)|Active, not recruiting||N/A|34|Actual|Neurologisches Rehabiliationszentrum Rosenhügel||2|||f||||f||||||||||2017-10-10 22:16:45.177412|2017-10-10 22:16:45.177412
NCT02748668|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-05-12|||March 2015||2015-03-01|May 2017|2017-05-01|March 2025|Anticipated|2025-03-01|March 2024|Anticipated|2024-03-01|8 Days|Observational [Patient Registry]|||Extracorporeal Membrane Oxygenation: Blood Cells|Extracorporeal Membrane Oxygenation: Blood Cells|Recruiting||N/A|600|Anticipated|Spectrum Health Hospitals|||2||f||||||||||Samples Without DNA|"     Blood is collected for analysis of cytokines and inflammatory cell patterns, and will be     stored for future research.   "|||2017-10-10 22:16:45.283371|2017-10-10 22:16:45.283371
NCT02748655|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-10-31|||March 2016||2016-03-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Alkaline Ionized Water: Sports Recovery and Inflammation Management|Alkaline Ionized Water: Sports Recovery and Inflammation Management|Completed||Phase 1/Phase 2|12|Actual|Natural Immune Systems Inc||2|||f||||f||||||||No||2017-10-10 22:16:45.361732|2017-10-10 22:16:45.361732
NCT02748642|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-06-15|||April 7, 2016|Actual|2016-04-07|June 2017|2017-06-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|||A Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers and Participants With Mild Atopic Asthma|A Phase I, Randomized, Observer-Blinded, Placebo-Controlled, Single and Multiple Ascending-Dose Study to Investigate the Safety, Pharmacokinetics, and Immunogenecity of BITS7201A in Healthy Volunteers and Patients With Mild Atopic Asthma|Completed||Phase 1|67|Actual|Genentech, Inc.||11|||f||||||||||||||2017-10-10 22:16:45.445408|2017-10-10 22:16:45.445408
NCT02748629|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-10-04|||March 2015||2015-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||ProGrip Mesh Repair vs Lichtenstein Operation|Randomized Controlled Single-Center Trial: Self-Gripping ProGrip Mesh Repair vs Lichtenstein Operation of Inguinal Hernia|Completed||N/A|143|Actual|Regional Health Center in Kartuzy, Poland||2|||f||||f||||||||Undecided||2017-10-10 22:16:45.567142|2017-10-10 22:16:45.567142
NCT02748616|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-04-25|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||C. Difficile and Ursodiol|A Clinical Trial for the Off Label Use of Ursodiol for the Prevention of Recurrent C. Difficile Colitis and Diarrhea|Recruiting||Phase 4|32|Anticipated|New York University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 22:16:45.673886|2017-10-10 22:16:45.673886
NCT02748603|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-26|||October 2014||2014-10-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Observational|APACHE||Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease|Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease|Recruiting||N/A|400|Anticipated|Italian Society of Invasive Cardiology|||2||f||||f||||||||||2017-10-10 22:16:45.774032|2017-10-10 22:16:45.774032
NCT02748590|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-12-14|||June 2016||2016-06-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PRIMICISTIM||Evaluation of Sacral Neuromodulation (SNM) in the Treatment of Active Ulcerative Colitis (PRIMICISTIM)|Evaluation of Sacral Neuromodulation (SNM) in the Treatment of Active Ulcerative Colitis|Recruiting||N/A|12|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 22:16:45.873868|2017-10-10 22:16:45.873868
NCT02748577|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-09-12|||January 2016||2016-01-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Pain Processing in Adults With Migraines|Pain Processing in Adults With Migraines|Recruiting||N/A|98|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||Yes||2017-10-10 22:16:45.967674|2017-10-10 22:16:45.967674
NCT02748564|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-05-08|||March 21, 2017|Actual|2017-03-21|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma|A Phase 1b/II Trial of Interleukin-2 in Combination With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma|Recruiting||Phase 2|65|Anticipated|Rutgers, The State University of New Jersey||1|||f||||t|t|f||||||||2017-10-10 22:16:46.075068|2017-10-10 22:16:46.075068
NCT02748551|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-12-11|||April 2016||2016-04-01|December 2016|2016-12-01|April 2022|Anticipated|2022-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer|Prospective Multicenter Study on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery for Locally Advanced Gastric Cancer|Recruiting||Phase 3|800|Anticipated|Moscow Clinical Scientific Center||2|||f||||||||||||||2017-10-10 22:16:46.19403|2017-10-10 22:16:46.19403
NCT02748538|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-21|||April 2016||2016-04-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||The Posturing After Retinal Detachment (Post RD) Trial|A Randomised Controlled Trial to Evaluate the Effect of Face-down Posturing on Retinal Displacement and Distortion Following Retinal Detachment Repair|Not yet recruiting||N/A|368|Anticipated|Moorfields Eye Hospital NHS Foundation Trust|||2||f||||f||||||||No||2017-10-10 22:16:46.336242|2017-10-10 22:16:46.336242
NCT02748161|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-07-10|||August 2015||2015-08-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|QED||DEB-TACE for Hepatocellular Carcinoma|Surefire vs. Endhole for DEB-TACE: Quantifying Hepatic Artery Embolization to Improve Outcomes by Comparing Two Different Catheter Systems for DEB-TACE (QED Study)|Recruiting||N/A|170|Anticipated|Surefire Medical, Inc.||2|||f||||f||||||||||2017-10-10 22:16:50.352107|2017-10-10 22:16:50.352107
NCT02748525|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-05-05|||April 2016||2016-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|Milk||Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively|Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively|Recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f||||||||No|Patient data will be collected, deidentified, and collated into aggregate. Descriptive statistics will be used to describe outcome.|2017-10-10 22:16:46.402548|2017-10-10 22:16:46.402548
NCT02748512|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-12-22|||February 2016||2016-02-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye||Active, not recruiting||Phase 3|38|Actual|pSivida Corp.||1|||f||||||||||||||2017-10-10 22:16:46.505927|2017-10-10 22:16:46.505927
NCT02748499|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-05-10|||July 12, 2014|Actual|2014-07-12|May 2017|2017-05-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||Healthy Beat Accupunch (HBA) Exercise Program for Community Older Adults|Evaluation of the Healthy Beat Accupunch (HBA) Exercise Program for the Community Older Adults|Completed||N/A|232|Actual|Kaohsiung Medical University||2|||f||||f||||||||No||2017-10-10 22:16:46.574742|2017-10-10 22:16:46.574742
NCT02748486|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-19|||May 2014||2014-05-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize...|Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... Among Patients of Psychiatric Rehabilitation Ward With Diagnosis of Schizophrenia.|Completed||N/A|38|Actual|University of Warsaw||3|||f||||f||||||||No||2017-10-10 22:16:46.655678|2017-10-10 22:16:46.655678
NCT02748473|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-22|||May 2012||2012-05-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|June 2013|Actual|2013-06-01||Interventional|||Effectiveness of Adding Voluntary Pelvic Floor Muscle Contraction to a Pilates Exercises Program|Effectiveness of Adding Voluntary Pelvic Floor Muscle Contraction to a Pilates Exercises Program: An Assessor-masked Randomized Controlled Trial|Completed||N/A|57|Actual|Federal University of São Paulo||2|||f||||f||||||||Undecided||2017-10-10 22:16:46.735253|2017-10-10 22:16:46.735253
NCT02748460|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-12-07|||December 2015||2015-12-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|Premium||Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting|Prospective, Multi-national, Multicentre, Non-interventional Study to Evaluate the Long Term Safety of Esmya, in Particular Endometrial Safety, and the Current Prescription and Management Patterns of Esmya in a Long Term Treatment Setting.|Recruiting||N/A|1500|Anticipated|PregLem SA|||1||f||||f||||||||||2017-10-10 22:16:46.994046|2017-10-10 22:16:46.994046
NCT02748447|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-04-14|||April 2016||2016-04-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Automated Adjustment of Inspired Oxygen to Maintaining Regional Cerebral Oxygenation in Preterm Infants on Respiratory Support|Effects of Automated Adjustment of the Inspired Oxygen in Reducing the Risk of Regional Cerebral (rSO2) Hypo-oxygenation in Preterm Infants on Non Invasive or Invasive Respiratory Support|Recruiting||N/A|60|Anticipated|ASST Fatebenefratelli Sacco||2|||f||||||||||||||2017-10-10 22:16:47.310375|2017-10-10 22:16:47.310375
NCT02748434|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-04-12|||October 2016|Actual|2016-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Glucose Variability in Subclinical Hypertrophy|Glucose Variability in Subclinical Hypertrophy|Recruiting||N/A|20|Anticipated|University of British Columbia||2|||f||||f|f|f||||||No||2017-10-10 22:16:47.413569|2017-10-10 22:16:47.413569
NCT02748421|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-19|||May 2016||2016-05-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Optical Coherence Tomography - Rescan During Dissection of Macular Membranes|Evaluation Use Optical Coherence Tomography - Rescan During Dissection of Macular Membranes : Pre and Post Operative Aspects|Not yet recruiting||N/A|30|Anticipated|Federal University of São Paulo||2|||f||||f||||||||Yes|scientific publication|2017-10-10 22:16:47.536503|2017-10-10 22:16:47.536503
NCT02748408|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-14|||July 2015||2015-07-01|September 2017|2017-09-01|July 2028|Anticipated|2028-07-01|July 2028|Anticipated|2028-07-01||Observational|||The Medacta International SMS Post-Marketing Surveillance Study|The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study|Recruiting||N/A|550|Anticipated|Medacta International SA|||1||f||||||||||||||2017-10-10 22:16:47.63857|2017-10-10 22:16:47.63857
NCT02748395|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-12-02|||May 2016||2016-05-01|December 2016|2016-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain|Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain|Withdrawn||Phase 4|0|Actual|Temple University||2||No IRB approval|f||||f||||||||Undecided||2017-10-10 22:16:47.720518|2017-10-10 22:16:47.720518
NCT02748382|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-04-18|||August 2016||2016-08-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|FISSH||Fluids in Sepsis and Septic Shock|Fluids in Sepsis and Septic Shock: A Pilot Randomized Controlled Trial|Recruiting||Early Phase 1|50|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 22:16:47.799357|2017-10-10 22:16:47.799357
NCT02748369|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-31|||July 2016||2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||In Vivo Assessment of Cellular Metabolism in Humans|In Vivo Assessment of the Tricarboxylic Acid Cycle Flux in the Muscle and Splanchnic Bed of Humans: A Pilot Study|Recruiting||N/A|20|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 22:16:47.92078|2017-10-10 22:16:47.92078
NCT02748356|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-06-14|||January 2016||2016-01-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|May 31, 2017|Actual|2017-05-31||Interventional|||Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB|The Impact of Self-Management With Probiotics on Urinary Symptoms and the Urine Microbiome in Individuals With Spinal Cord Injury (SCI) and Spina Bifida (SB)|Active, not recruiting||Phase 2|7|Actual|Medstar Health Research Institute||1|||f||||t||||||||Undecided||2017-10-10 22:16:48.023493|2017-10-10 22:16:48.023493
NCT02748343|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-04-19|||November 2014||2014-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||The Clinical Therapeutic Effects and Safety of Tissue-engineered Bone|The Clinical Therapeutic Effects and Safety of Tissue-engineered Bone|Recruiting||Phase 1/Phase 2|20|Anticipated|Xijing Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:16:48.113634|2017-10-10 22:16:48.113634
NCT02748330|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-11|||June 2016||2016-06-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|PLATIDE-PCI||Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention|A Randomized, Open-label, Active-controlled, Parallel-group Study to Investigate the Platelet Inhibition of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease and Type 2 Diabetes Mellitus After Recent Elective Percutaneous Coronary Intervention|Recruiting||Phase 4|40|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-10 22:16:48.209379|2017-10-10 22:16:48.209379
NCT02748317|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-06-14|||January 2016||2016-01-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|May 31, 2017|Actual|2017-05-31||Interventional|||Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB|"The Impact of Self-Management With Probiotics on Urinary Symptoms and the Urine Microbiome in Individuals With Spinal Cord Injury (SCI) and Spina Bifida (SB)"|Active, not recruiting||Phase 2|96|Actual|Medstar Health Research Institute||1|||f||||t||||||||Undecided||2017-10-10 22:16:48.365308|2017-10-10 22:16:48.365308
NCT02748304|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-10-09|||April 2016||2016-04-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma|A Prospective Randomized Control Trial of the Effect of Sorafenib Combined With Aspirin in Preventing the Recurrence in High-risk Patients With Hepatocellular Carcinoma|Recruiting||N/A|150|Anticipated|Fudan University||3|||f||||f||||||||Undecided||2017-10-10 22:16:48.46178|2017-10-10 22:16:48.46178
NCT02748291|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-19|||January 2015||2015-01-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2016|Actual|2016-04-01||Interventional|WalkOut||An Investigation Into the Role of Walking in Treating the Symptoms of Knee Osteoarthritis: The WalkOut Study|An Investigation Into the Role of Walking in Treating the Symptoms of Knee Osteoarthritis: The WalkOut Study|Active, not recruiting||N/A|50|Anticipated|University of Nottingham||2|||f||||t||||||||No||2017-10-10 22:16:48.575527|2017-10-10 22:16:48.575527
NCT02748278|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-11-01|||May 2016||2016-05-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|||Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment|Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women Undergoing in Vitro Fertilization Treatment With a Standard Ovarian Stimulation Regimen|Recruiting||N/A|192|Anticipated|The University of Hong Kong|||1||f||||t||||||Samples With DNA|"     Blood will be saved for genetic study if there is significant difference in the number of     oocytes obtained between Chinese and Caucasian women.   "|Undecided||2017-10-10 22:16:48.686261|2017-10-10 22:16:48.686261
NCT02748265|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-07|||March 2016||2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FLOLAN||Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV)|A Pilot Study of the Effects of Nebulized Epoprostenol (Flolan) and Systemic Phenylephrine on Arterial Oxygenation During One Lung Ventilation|Recruiting||Phase 4|10|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:16:48.782299|2017-10-10 22:16:48.782299
NCT02748252|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-05|||December 2015||2015-12-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Observational|PROFES||Prognosis of a First-Ever Stroke in Persons Living With HIV||Recruiting||N/A|180|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||f||||||||||2017-10-10 22:16:48.876259|2017-10-10 22:16:48.876259
NCT02748239|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-08-08|||February 2013||2013-02-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|MEDIAS-2-CT||Evaluation of a Diabetes Self-Management Education Program for Non-Intensified Insulin Therapy in Type 2 Diabetes|Evaluation of a Self-management Oriented Diabetes Education Program for the Initiation of Non-Intensive Insulin Therapy in Type 2 Diabetic Patients|Completed||N/A|182|Actual|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||f||||||||No||2017-10-10 22:16:48.957941|2017-10-10 22:16:48.957941
NCT02748226|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-12-29|||August 2013||2013-08-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb Artery Diseases: (A Retrospective & Prospective Observational Study)||Recruiting||N/A|7000|Anticipated|Yonsei University|||2||f||||f||||||||No||2017-10-10 22:16:49.051634|2017-10-10 22:16:49.051634
NCT02748213|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-09-30|2016-06-15||February 2002||2002-02-01|September 2016|2016-09-01|January 2008|Actual|2008-01-01|March 2006|Actual|2006-03-01||Interventional||Full Analysis Set (FAS) Population: All participants, according to randomization scheme, who received at least one dose of study medication.|A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer|An Open-Label, Randomized Phase II Study of Herceptin (Trastuzumab), Taxotere (Docetaxel), and Xeloda (Capecitabine) in Combination, Versus Herceptin (Trastuzumab) Plus Taxotere (Docetaxel), in Patients With Advanced and/or Metastatic Breast Cancers That Overexpress HER2|Completed||Phase 2|225|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:16:49.170222|2017-10-10 22:16:49.170222
NCT02748200|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-04-19|||March 2015||2015-03-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||External Beam Radiotherapy for Muscle Invasive Bladder Cancer|Muscle Invasive Bladder Cancer: External Beam Radiotherapy as an Alternative for Cystectomy|Recruiting||Phase 1|9|Anticipated|University Hospital, Ghent||3|||f||||f||||||||Undecided||2017-10-10 22:16:50.07166|2017-10-10 22:16:50.07166
NCT02748187|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2017-03-28|||January 2016||2016-01-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Attachment Style and Reflective Functioning in CBASP|Are Therapist and Client Attachment Style and Reflective Functioning Associated With Outcomes in Cognitive Behavioural Analysis System of Psychotherapy (CBASP): A Longitudinal Proof of Concept Study|Enrolling by invitation||N/A|20|Anticipated|University of Edinburgh||1|||f||||f||||||||Yes|via peer review journal|2017-10-10 22:16:50.179802|2017-10-10 22:16:50.179802
NCT02748148|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-10-14|||April 2016||2016-04-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|EMTM||Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice|Implementing an Enhanced Standardized Medication Therapy Management Approach Within a Primary Care Setting|Completed||N/A|50|Actual|Tabula Rasa HealthCare||1|||f||||f||||||||No||2017-10-10 22:16:50.471067|2017-10-10 22:16:50.471067
NCT02748135|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-04|||May 2016||2016-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Two-Part Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma|A Two-Part Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma|Recruiting||Phase 1/Phase 2|36|Anticipated|Oncurious NV||5|||f||||||||||||||2017-10-10 22:16:50.548281|2017-10-10 22:16:50.548281
NCT02748096|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-21|||March 2012||2012-03-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|February 2013|Actual|2013-02-01||Interventional|||The Assessment of Patient Specific Instrumentation for Unicompartmental Knee Replacement|The Assessment of Patient Specific Instrumentation for Unicompartmental Knee Replacement|Completed||Phase 4|43|Actual|Oxford University Hospitals NHS Trust||2|||f||||t||||||||Yes|Plan to publish in high impact peer reviewed orthopaedic journal|2017-10-10 22:16:51.013774|2017-10-10 22:16:51.013774
NCT02748083|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-12-21|||December 2015||2015-12-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic|Research on Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic|Recruiting||N/A|40|Anticipated|Shanghai Mental Health Center||2|||f||||t||||||||No|No plan to share IPD data|2017-10-10 22:16:51.119961|2017-10-10 22:16:51.119961
NCT02748070|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-19|||August 2015||2015-08-01|April 2016|2016-04-01||||August 2017|Anticipated|2017-08-01||Interventional|||Perioperative Oral Steroids for Chronic Rhinosinusitis Without Polyps (CRSsNP)|The Role of Perioperative Systemic Steroids in Patients With Chronic Rhinosinusitis Without Polyps (CRSsNP)|Recruiting||N/A|76|Anticipated|Stanford University||2|||f||||||||||||||2017-10-10 22:16:51.238185|2017-10-10 22:16:51.238185
NCT02748057|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-07-27|||May 18, 2016|Actual|2016-05-18|July 2017|2017-07-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)|A Phase III, Open-label, Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Patients With Hypercholesterolemia Who Have Inadequate LDL-C Control on Ezetimibe or Rosuvastatin Monotherapy|Active, not recruiting||Phase 3|134|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:16:51.351272|2017-10-10 22:16:51.351272
NCT02748044|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-21|||January 2012||2012-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Validation of the Utility of Rare Disease Intelligence Platform|Validation of the Utility of Rare Disease Intelligence Platform: A Multicenter Cluster Clinical Trial|Completed||N/A|53|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 22:16:51.462227|2017-10-10 22:16:51.462227
NCT02748031|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-21|||January 2014||2014-01-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Congenital Cataract Morphological Classifications|Congenital Cataract Morphological Classifications and Monitoring Using Slit-Lamp-Adapted Photography in CCPMOH|Completed||N/A|1050|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 22:16:51.604333|2017-10-10 22:16:51.604333
NCT02748018|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-09-14|||May 25, 2017|Actual|2017-05-25|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|August 2021|Anticipated|2021-08-01||Interventional|||Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home|Multi-center, Randomized, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home|Recruiting||N/A|1500|Anticipated|Medtronic Diabetes||2|||f||||t|f|t|f|f||||||2017-10-10 22:16:51.743423|2017-10-10 22:16:51.743423
NCT02748005|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2016-06-29|||August 2014||2014-08-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Furosap in Human Volunteers|Asses the Efficacy of Furosap: A Testosterone Booster Supplement in Human Volunteers|Completed||N/A|50|Actual|Chemical Resources||1|||f||||f||||||||No||2017-10-10 22:16:51.990736|2017-10-10 22:16:51.990736
NCT02747992|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-19|||October 2015||2015-10-01|April 2016|2016-04-01||||February 2016|Actual|2016-02-01||Observational|||Paravertebral Block (PVB) Combined Pectoral Musculature Blocks for Modified Radical Mastectomy (MRM)|Comparisons the Analgesia of Paravertebral Block Combined With Thoracic Wall Block Versus Paravertebral Block Alone for Modified Radical Mastectomy in Breast Cancer|Completed||N/A|100|Actual|Sun Yat-sen University|||2||f||||||||||||||2017-10-10 22:16:52.097759|2017-10-10 22:16:52.097759
NCT02747979|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-04-25|||April 2009||2009-04-01|April 2016|2016-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia Patients|The Effect and Safety of Combination Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia Patients|Completed||Phase 2/Phase 3|20|Actual|Sun Yat-sen University||3|||f||||t||||||||||2017-10-10 22:16:52.169184|2017-10-10 22:16:52.169184
NCT02747966|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-04-25|||April 2009||2009-04-01|April 2016|2016-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||The Relationship Between the Flow of Arteriovenous Fistula and Cardiac Function in Haemodialysis Patients|Study of Access Flow ,Access Recirculation of Arteriovenous Fistula and the Relationship With Cardiac Function|Completed||N/A|100|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 22:16:52.277934|2017-10-10 22:16:52.277934
NCT02747953|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-04-19|||July 2011||2011-07-01|April 2016|2016-04-01||||December 2014|Actual|2014-12-01||Interventional|||Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib|An Open Label Compassionate Use Programme of Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib|Completed||Phase 2|50|Actual|Samsung Medical Center||1|||f||||||||||||||2017-10-10 22:16:52.352537|2017-10-10 22:16:52.352537
NCT02747940|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-19|||December 2015||2015-12-01|March 2016|2016-03-01||||December 2019|Anticipated|2019-12-01||Interventional|||Neurologic Signatures of Chronic Pain Disorders|Neurologic Signatures of Chronic Pain Disorders|Recruiting||Phase 4|200|Anticipated|Taipei Veterans General Hospital, Taiwan||3|||f||||f||||||||No||2017-10-10 22:16:52.441906|2017-10-10 22:16:52.441906
NCT02747927|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-07-20|||September 7, 2016||2016-09-07|July 2017|2017-07-01|December 27, 2021|Anticipated|2021-12-27|June 29, 2018|Anticipated|2018-06-29||Interventional|TIDES||Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children|Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Investigate the Efficacy, Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TDV) Administered Subcutaneously in Healthy Children Aged 4 - 16 Years Old|Active, not recruiting||Phase 3|20100|Actual|Takeda||2|||f||||t||||||||||2017-10-10 22:16:52.562409|2017-10-10 22:16:52.562409
NCT02747914|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-04-25|||January 2015||2015-01-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|January 2017|Actual|2017-01-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis Patients|Repetitive Transcranial Magnetic Stimulation Boosted Exercise Therapy for Lower Limb Spasticity in Multiple Sclerosis Patients|Active, not recruiting||Phase 1/Phase 2|40|Actual|University of Belgrade||2|||f||||t||||||||||2017-10-10 22:16:52.743973|2017-10-10 22:16:52.743973
NCT02747901|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-19|||January 2015||2015-01-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparison Between Kinesiotaping and Cold Therapy After Total Knee Arthroplasty|Comparison Between Kinesiotaping and Cold Therapy on Muscle Strength and Functional Performance Outcomes After Total Knee Arthroplasty: a Randomized Controlled Trial|Recruiting||N/A|111|Anticipated|Dokuz Eylul University||3|||f||||t||||||||No|Individual participant data (IPD) are going to be kept.|2017-10-10 22:16:52.827087|2017-10-10 22:16:52.827087
NCT02747888|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-31|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|March 1, 2021|Anticipated|2021-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Hereditary Risk Factors for Thyroid Cancer|Hereditary Risk Factors for Thyroid Cancer|Recruiting||N/A|165|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 22:16:52.929583|2017-10-10 22:16:52.929583
NCT02747875|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-12-16|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|CV_RCT_M_F||Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery|The Effect of Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery: A Randomized, Double-Blinded Controlled Trial|Recruiting||N/A|104|Anticipated|Children's Research Institute||2|||f||||f||||||||No||2017-10-10 22:16:53.010445|2017-10-10 22:16:53.010445
NCT02747862|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-10-26|||February 2008||2008-02-01|October 2016|2016-10-01||||February 2020|Anticipated|2020-02-01||Observational|||Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program|Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program|Recruiting||N/A|1500|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-10-10 22:16:53.144791|2017-10-10 22:16:53.144791
NCT02747849|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-08-30|||April 2016||2016-04-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Hand & Foot TENS Study|Pilot Study: Hand & Foot Neuromodulation for Nocturnal Enuresis in Children|Recruiting||N/A|60|Anticipated|Children's Hospital of Pittsburgh||2|||f||||f||||||||No||2017-10-10 22:16:53.238569|2017-10-10 22:16:53.238569
NCT02747836|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-02|||May 2006||2006-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Ultrasound Analysis of Human Carpal Tunnel System|Ultrasound Analysis of Human Carpal Tunnel Synovium|Enrolling by invitation||N/A|240|Anticipated|Mayo Clinic|||2||f||||f||||||||||2017-10-10 22:16:53.328981|2017-10-10 22:16:53.328981
NCT02747823|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-09-16|||June 2016||2016-06-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|CBT124NHV001||PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US)|A Randomized, Double-blind, Single-dose, 3-way, Parallel Group, Comparator-controlled, Adaptive Design, Pharmacokinetic, Safety, and Tolerability Study in Healthy Male Volunteers to Evaluate Bioequivalence of CBT124 to Avastin® (EU and US)|Recruiting||Phase 1|150|Anticipated|Cipla BioTec Pvt. Ltd.||3|||f||||t||||||||No|As sponsors, we would be protecting the confidentiality of the subjects and would be unaware of the IPD ourselves.|2017-10-10 22:16:53.401986|2017-10-10 22:16:53.401986
NCT02747810|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-08-30|||March 2016||2016-03-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Pilot Study: Foot Neuromodulation for Nocturnal Enuresis in Children||Enrolling by invitation||N/A|10|Anticipated|Children's Hospital of Pittsburgh||1|||f||||f||||||||No||2017-10-10 22:16:53.497828|2017-10-10 22:16:53.497828
NCT02747797|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-11-01|||April 2017||2017-04-01|October 2016|2016-10-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations|Histology-Independent Study of the Multikinase Inhibitor Lucitanib (E3810) in Patients With Advanced Cancer and Fibroblast Growth Factor Receptor (FGFR), Vascular Endothelial Growth Factor Receptors (VEGFR), or Platelet Derived Growth Factor Receptor (PDGFR) Pathway Aberrations|Withdrawn||Phase 2|0|Actual|University of California, San Diego||1||Drug Supply No Longer Available|f||||t||||||||||2017-10-10 22:16:53.56137|2017-10-10 22:16:53.56137
NCT02747784|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-07-25|||July 25, 2017|Actual|2017-07-25|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluation to Assess Cognitive Training for the Prevention of Post-operative Cognitive Decline|Randomized Evaluation to Assess Cognitive Training for the Prevention of Post-operative Cognitive Decline (REACT) - a Pilot Study|Recruiting||N/A|72|Anticipated|Charite University, Berlin, Germany||3|||f||||f|f|f||||||||2017-10-10 22:16:53.669255|2017-10-10 22:16:53.669255
NCT02747771|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-21|||January 2013||2013-01-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Observational|NorTriP||Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder)|The Norwegian Trichotillomania Project|Active, not recruiting||N/A|75|Actual|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Saliva or blood   "|Undecided||2017-10-10 22:16:53.793154|2017-10-10 22:16:53.793154
NCT02747758|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-04-05|||September 19, 2016|Actual|2016-09-19|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|Neuro-tDCS||Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy|Randomized Controlled Clinical Trial Evaluating Transcranial Direct Current Stimulation (tDCS) in Chronic Pain Patients With Neuropathy|Recruiting||N/A|24|Anticipated|Charite University, Berlin, Germany||3|||f||||t||||||||No||2017-10-10 22:16:53.868776|2017-10-10 22:16:53.868776
NCT02747745|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-04-19|||January 2016||2016-01-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Theoretical Based Case Management Intervention for Dementia Family Caregivers|Theoretical Based Case Management Intervention for Dementia Family Caregivers|Recruiting||N/A|152|Anticipated|Chang Gung University||2|||f||||f||||||||Undecided||2017-10-10 22:16:53.963718|2017-10-10 22:16:53.963718
NCT02747732|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-20|2017-03-07|||December 2016||2016-12-01|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL|A Phase II Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Bendamustine and Rituximab (BR) for Patients With Relapsed/Refractory Aggressive B Cell Lymphomas|Recruiting||Phase 2|72|Anticipated|Sheba Medical Center||1|||f||||f||||||||No||2017-10-10 22:16:54.064237|2017-10-10 22:16:54.064237
NCT02747719|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-27|||April 2016||2016-04-01|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Effects of Light and Exercise on Human Circadian Rhythms and Performance|Effects of Light and Exercise on Human Circadian Rhythms and Performance|Active, not recruiting||N/A|8|Actual|Brigham and Women's Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:16:54.177602|2017-10-10 22:16:54.177602
NCT02747706|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-19|||April 2016||2016-04-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|CAMPP||Childhood Asthma Mentoring Program for Parents|Peer Mentor Training to Reduce Hospitalizations for Children With Asthma|Recruiting||N/A|240|Anticipated|InquisitHealth, Inc.||2|||f||||||||||||||2017-10-10 22:16:54.253709|2017-10-10 22:16:54.253709
NCT02747680|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-10-25|||January 2003||2003-01-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|1018||Cerebral Responses to Insulin Induced Hypoglycemia|Cerebral Responses to Insulin Induced Hypoglycemia|Recruiting||N/A|80|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||No||2017-10-10 22:16:54.39173|2017-10-10 22:16:54.39173
NCT02747667|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-21|||June 2014||2014-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Observational|||Characteristics and Risk Ratios of Late Intraocular Lens (IOL) Complication|Late Dislocation and Haptic Deformation of a Hydrophilic Intraocular Lens: Characteristics, Incidence Rates and Predisposing Factors|Completed||N/A|10125|Actual|Medical University of Graz|||2||f||||f||||||||No||2017-10-10 22:16:54.487933|2017-10-10 22:16:54.487933
NCT02747654|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-21|||June 2014||2014-06-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Isoniazid Dosage Prediction Model Development|Development of a Dosing Model Based on Anti-tuberculosis Drug Monitoring NAT2 Genotypes in Tuberculosis Patients.|Recruiting||N/A|200|Anticipated|Samsung Medical Center||2|||f||||f||||||||No||2017-10-10 22:16:54.573942|2017-10-10 22:16:54.573942
NCT02747641|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-10-13|||May 2016||2016-05-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|November 2016|Anticipated|2016-11-01||Interventional|||Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects|Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects|Active, not recruiting||Early Phase 1|15|Actual|Alma Lasers Inc.||1|||f||||||||||||||2017-10-10 22:16:54.643198|2017-10-10 22:16:54.643198
NCT02747628|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-19|||April 2013||2013-04-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Transdermal Nicotine and Melatonin Patches for Postoperative Pain Relief|Comparative Study Between Transdermal Nicotine and Melatonin Patches on Postoperative Pain Relief After Laparoscopic Cholecystectomy, a Double-blind, Placebo-controlled Trial|Completed||Phase 4|60|Actual|Ain Shams University||3|||f||||||||||||||2017-10-10 22:16:54.705398|2017-10-10 22:16:54.705398
NCT02747615|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-19|||August 2010||2010-08-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty|Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty: a Randomized Controlled Trial|Completed||Phase 4|60|Actual|Ain Shams University||2|||f||||||||||||||2017-10-10 22:16:54.777312|2017-10-10 22:16:54.777312
NCT02747602|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-10-26|||April 2016||2016-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production|A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Evaluate the Pharmacokinetic of AC-1204 Versus Caprylic Triglyceride Oil Including the Effect of Food on Ketone Body Production|Completed||Phase 1|16|Actual|Accera, Inc.||3|||f||||f||||||||No||2017-10-10 22:16:54.841325|2017-10-10 22:16:54.841325
NCT02747589|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-18|||April 2016||2016-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Feasibility of Stimulating the Visual Cortex in Blind|Study to Assess the Feasibility of Stimulating the Visual Cortex in Blind Volunteers|Recruiting||N/A|5|Anticipated|University of California, Los Angeles||1|||f||||f||||||||No||2017-10-10 22:16:54.937329|2017-10-10 22:16:54.937329
NCT02747576|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-07-12|||July 13, 2016|Actual|2016-07-13|July 2017|2017-07-01|February 28, 2019|Anticipated|2019-02-28|August 31, 2018|Anticipated|2018-08-31||Observational|||Social Cognition and Brain Integrity in Survivors of Pediatric Medulloblastoma|Social Cognition and Brain Integrity in Survivors of Pediatric Medulloblastoma|Recruiting||N/A|120|Anticipated|St. Jude Children's Research Hospital|||2||f||||f|f|f||||||||2017-10-10 22:16:55.004968|2017-10-10 22:16:55.004968
NCT02747563|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-20|||May 2016||2016-05-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination|Evaluation of PSA Blood Levels in Men on Active Surveillance and Men With Benign Prostatic Hyperplasia Prior to and After Digital Rectal Examination|Not yet recruiting||Phase 1|60|Anticipated|Kaplan Medical Center||2|||f||||t||||||||No||2017-10-10 22:16:55.091201|2017-10-10 22:16:55.091201
NCT02747550|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|TESTO||Temporary Simultaneous Two-arterial Occlusions During Laparoscopic Myomectomy|Temporary Simultaneous Two-arterial Occlusions to Reduce Operative Blood Loss During Laparoscopic Myomectomy: a Randomized Controlled Trial|Recruiting||Phase 3|80|Anticipated|Kangbuk Samsung Hospital||2|||f||||f||||||||No||2017-10-10 22:16:55.166933|2017-10-10 22:16:55.166933
NCT02747537|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-02-14|||June 24, 2016|Actual|2016-06-24|February 2017|2017-02-01|February 29, 2020|Anticipated|2020-02-29|January 31, 2020|Anticipated|2020-01-31||Interventional|||Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan|Phase 2 Clinical Trial Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With the Genomically-Targeted Agent Sorafenib in Combination With Irinotecan|Recruiting||Phase 2|30|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||No||2017-10-10 22:16:56.951271|2017-10-10 22:16:56.951271
NCT02747511|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-02-07|||October 2015||2015-10-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||IV Haloperidol for the Treatment of Headache in the ED|Intravenous Haloperidol for the Treatment of Headache in the Emergency Department|Active, not recruiting||Phase 4|159|Anticipated|Western Michigan University School of Medicine||2|||f||||||||||||||2017-10-10 22:16:57.118826|2017-10-10 22:16:57.118826
NCT02747498|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-12-29|||January 2016||2016-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparison of Circumferential Pulmonary Vein Isolation and Complex Pulmonary Vein Isolation Additional Linear Ablation for Recurred Atrial Fibrillation After Previous Catheter Ablation: Prospective Randomized Trial (CALRA-AF)||Recruiting||N/A|100|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:16:57.210888|2017-10-10 22:16:57.210888
NCT02747485|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-07-26|||May 2016||2016-05-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|August 2016|Anticipated|2016-08-01||Interventional|DIFFUsE||Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases ( The DIFFUsE Study)|"Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases  The DIFFUsE Study "|Not yet recruiting||N/A|316|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||Undecided||2017-10-10 22:16:57.310809|2017-10-10 22:16:57.310809
NCT02747472|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-04-25|||April 2016||2016-04-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|GA-1||GIP Receptor Antagonist Studies in Humans|Involvement of Glucose-dependent Insulinotropic Polypeptide (GIP) in Human Physiology and Pathophysiology - Receptor Antagonist Studies in Humans|Completed||N/A|10|Actual|University Hospital, Gentofte, Copenhagen||4|||f||||t||||||||||2017-10-10 22:16:57.401388|2017-10-10 22:16:57.401388
NCT02747459|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-05-15|||March 2012||2012-03-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|SSS||Sensory Supported Swimming for Children With ASD|Sensory Supported Swimming-Swimming and Water Safety for Children With Autism Spectrum Disorder|Enrolling by invitation||N/A|500|Anticipated|University of Kansas Medical Center||1|||f||||t||||||||No|Data is only used my KUMC study team|2017-10-10 22:16:57.492266|2017-10-10 22:16:57.492266
NCT02747446|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-22|||January 2013||2013-01-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|HONEY||Metabolic Effects of Honey or Fructose:Glucose Mixtures|Effects of a Dietary Honey or Isomolar Fructose:Glucose Mixture on Glucose Tolerance and Blood Lipid Profile in Healthy Male Volunteers|Completed||N/A|8|Actual|University of Lausanne||3|||f||||f||||||||Undecided||2017-10-10 22:16:57.570987|2017-10-10 22:16:57.570987
NCT02747433|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-10-04|||July 2016|Actual|2016-07-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|ALPS||Robot-Assisted Therapy and Motor Learning: An Active Learning Program for Stroke|Infusing Robot-Assisted Therapy With Motor Learning Principles: An Active Learning Program for Stroke|Recruiting||N/A|20|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||f||||||||||2017-10-10 22:16:57.664842|2017-10-10 22:16:57.664842
NCT02747420|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-02-27|||June 2016||2016-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||PTNS Versus Sham Efficacy in Treatment of BPS|Randomized Controlled Trial of PTNS Versus Sham Efficacy in Treatment of Bladder Pain Syndrome|Recruiting||N/A|100|Anticipated|New York University School of Medicine||2|||f||||f|f|t|f|f||||||2017-10-10 22:16:57.81252|2017-10-10 22:16:57.81252
NCT02747407|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-14|||May 2016||2016-05-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors|Determining the Competence of the Immune System Over the First Year of Therapy in Patients With Glioma: A Battery of Quantitative, Qualitative and Functional Measures of Immune Readiness|Recruiting||N/A|50|Anticipated|Wake Forest University Health Sciences|||2||f||||t|f|f||||Samples With DNA|"     peripheral blood   "|||2017-10-10 22:16:58.07389|2017-10-10 22:16:58.07389
NCT02747394|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-06-19|||January 2013|Actual|2013-01-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Cognitive Training for Fragile X Syndrome|Cognitive Training for Fragile X Syndrome|Recruiting||N/A|100|Anticipated|University of California, Davis||2|||f||||f||||||||Undecided||2017-10-10 22:16:58.216722|2017-10-10 22:16:58.216722
NCT02747381|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-20|||August 2014||2014-08-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of Vitamin D Supplementation on the Pulmonary Functions of Adult Asthmatic Egyptian Patients|The Effect of Vitamin D Supplementation on the Pulmonary Functions of Adult Asthmatic Egyptian Patients|Completed||Phase 4|82|Actual|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 22:16:58.314124|2017-10-10 22:16:58.314124
NCT02747368|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-04-25|||April 2016||2016-04-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration|Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration|Enrolling by invitation||N/A|600|Anticipated|Turku University Hospital||1|||f||||f||||||||No||2017-10-10 22:16:58.412279|2017-10-10 22:16:58.412279
NCT02747355|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-21|||August 18, 2016|Actual|2016-08-18|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 1, 2017|Actual|2017-07-01||Observational|||Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors|Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors|Active, not recruiting||N/A|70|Anticipated|Bnai Zion Medical Center|||1||f||||f||||||Samples Without DNA|"     adrenal tissue   "|||2017-10-10 22:16:58.499383|2017-10-10 22:16:58.499383
NCT02747342|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-06-07|||September 2016|Actual|2016-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 1 Trial of SHR3680 in Prostate Cancer as Monotherapy|A Phase 1 Trial of SHR3680 in Subjects With Metastatic Castration-Resistant Prostate Cancer as Monotherapy|Recruiting||Phase 1|42|Anticipated|Atridia Pty Ltd.||1|||f||||f||||||||No||2017-10-10 22:16:58.574062|2017-10-10 22:16:58.574062
NCT02747329|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-08-12|||June 2016||2016-06-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|September 2016|Anticipated|2016-09-01||Interventional|||A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT|A Prospective, Multicenter, Randomized Comparative Evaluation of BuMA Supreme Stent and of Xience Stent in Terms of the Extent of Neointimal Formation at 1 Month and 2 Months Via OCT After Implantation in High Bleeding Risk CAD Patients（PIONEER-II OCT Study）|Recruiting||N/A|80|Anticipated|Sino Medical Sciences Technology Inc.||4|||f||||t||||||||||2017-10-10 22:16:58.697908|2017-10-10 22:16:58.697908
NCT02747316|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PIANO||Iron Absorption and Transfer to the Fetus During Pregnancy in Normal Weight and Overweight/Obese Women and the Effects on Infants Iron Status|Maternal Iron Absorption and Utilization and Iron Transfer to the Fetus During Pregnancy in Normal Weight and Overweight/Obese Women and the Effects on Infant Iron Status|Recruiting||N/A|70|Anticipated|Swiss Federal Institute of Technology||2|||f||||f||||||||||2017-10-10 22:16:58.836446|2017-10-10 22:16:58.836446
NCT02747303|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-01-17|||June 2016||2016-06-01|January 2017|2017-01-01||||May 2018|Anticipated|2018-05-01||Interventional|||The Clinical Relevance of Margins in Frameless Stereotactic Radiosurgery for Intact Brain Metastases: a Randomized Trial of 0 vs 2 mm Margins|The Clinical Relevance of Margins in Frameless Stereotactic Radiosurgery for Intact Brain Metastases: a Randomized Trial of 0 vs 2 mm Margins|Recruiting||Phase 2|166|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 22:16:58.953441|2017-10-10 22:16:58.953441
NCT02747290|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-19|||July 2014||2014-07-01|March 2016|2016-03-01||||July 2017|Anticipated|2017-07-01||Interventional|||68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients|Safety and Diagnostic Performance of 68Gallium-labeled NOTA-BBN-RGD PET/CT in Prostate Cancer Patients|Recruiting||Early Phase 1|30|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||||2017-10-10 22:16:59.07829|2017-10-10 22:16:59.07829
NCT02747277|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-06-14|||May 2016||2016-05-01|June 2017|2017-06-01|May 2026|Anticipated|2026-05-01|May 2024|Anticipated|2024-05-01||Observational|||Analysis of B Cells From Autoimmune Individuals|Analysis of B Cells From Autoimmune Individuals|Recruiting||N/A|200|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     whole blood, umbilical cord blood   "|Undecided|De-identified individual participant data will be presented at conferences and eventually published in peer-reviewed publication.|2017-10-10 22:16:59.168828|2017-10-10 22:16:59.168828
NCT02747264|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-02-24|||December 1, 2016|Actual|2016-12-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|eRAPID-RT||eRAPID Feasibility Pilot Study in Pelvic Radiotherapy|eRAPID Electronic Patient Self-Reporting of Adverse-events: Patient Information and aDvice: Feasibility Pilot Study in Radiotherapy|Recruiting||N/A|168|Anticipated|University of Leeds||2|||f||||t||||||||No||2017-10-10 22:16:59.235752|2017-10-10 22:16:59.235752
NCT02747251|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-05-18|||May 13, 2016|Actual|2016-05-13|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|June 2018|Anticipated|2018-06-01||Interventional|||Strengthening Exercises in Shoulder Impingement (SExSI) Trial|The Effects of Additional Home-based Strengthening Exercises in Shoulder Impingement Rehabilitation (The SEXSI-Trial): A Pragmatic Randomized Controlled Trial.|Recruiting||N/A|200|Anticipated|Copenhagen University Hospital, Hvidovre||2|||f||||f||||||||Undecided||2017-10-10 22:16:59.340434|2017-10-10 22:16:59.340434
NCT02747238|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-04-08|||June 1, 2017|Anticipated|2017-06-01|April 2017|2017-04-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Does Ultrasound Help Junior Anesthesia Residents With Placement of Labor Analgesia in Pregnant Patients|Does Ultrasound-guided CSE Technique Improve Midline Placement of Epidural Needle Thereby Helping Junior Residents With Correct Placement of the Catheter Compared to the Placement Using With Anatomical Landmarks?|Not yet recruiting||N/A|288|Anticipated|St. Luke's-Roosevelt Hospital Center||2|||f||||f|f|f||||||No||2017-10-10 22:16:59.455635|2017-10-10 22:16:59.455635
NCT02747225|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-25|||October 2016||2016-10-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|||Measuring the Electrical Properties of Malignant Tissues In Vivo|Measuring the Electrical Properties of the Malignant Tissues During Cancer Surgeries|Not yet recruiting||N/A|50|Anticipated|Southern Medical University, China|||1||f||||t||||||||Undecided||2017-10-10 22:16:59.561729|2017-10-10 22:16:59.561729
NCT02747212|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-25|||January 2015||2015-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|August 2017|Anticipated|2017-08-01||Observational|||Measuring the Electrical Properties of Malignant Tissues Ex Vivo|Measuring the Electrical Properties of the Excised Malignant Tissues Obtained From Cancer Surgeries|Active, not recruiting||N/A|200|Anticipated|Southern Medical University, China|||1||f||||t||||||||Undecided||2017-10-10 22:16:59.650945|2017-10-10 22:16:59.650945
NCT02747199|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-05-01|||August 2015||2015-08-01|May 2017|2017-05-01|April 12, 2017|Actual|2017-04-12|July 2016|Actual|2016-07-01||Interventional|ENHANCE||ENdothelial Healing Assessment With Novel Coronary tEchnology|Comparison Between SYNERGY™ vs. Bioresorbable Vascular Scaffold (BVS) ABSORB Neointimal Formation Assessed by (Optical Coherence Tomography) OCT and Coronary Angioscopy (CAS) Evaluation (The ENHANCE Study - ENdothelial Healing Assessment With Novel Coronary tEchnology)|Completed||N/A|13|Actual|University of Malaya||2|||f||||t||||||||||2017-10-10 22:16:59.737141|2017-10-10 22:16:59.737141
NCT02747186|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-04-20|||May 2016||2016-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Outcomes Maxilla: Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine|Pilot Study: Comparison of Buffered 1% vs. Non-Buffered 2% Lidocaine Used in Dental and Oral Surgical Procedures: Clinical Outcomes Maxilla|Active, not recruiting||N/A|24|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No|No Plans|2017-10-10 22:16:59.829411|2017-10-10 22:16:59.829411
NCT02747173|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-04-18|||October 2015||2015-10-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|METHEOS||Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques|Study to Assess Bone Biomarkers for TKI Response in RCC Patients With Bone Metastasis and HRQoL in These Patients as Well as Comparing Whole Body MRI vs. Bone Scintigraphy and vs. CT in the Assessment of Metastatic Lesions|Recruiting||N/A|60|Anticipated|Spanish Oncology Genito-Urinary Group|||1||f||||t||||||Samples Without DNA|"     Blood plasma samples   "|||2017-10-10 22:16:59.920504|2017-10-10 22:16:59.920504
NCT02747160|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-11-29|||April 2016||2016-04-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention|Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention|Recruiting||N/A|30|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-10-10 22:17:00.214083|2017-10-10 22:17:00.214083
NCT02747147|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-08|||April 12, 2016|Actual|2016-04-12|May 2017|2017-05-01|December 7, 2016|Actual|2016-12-07|November 21, 2016|Actual|2016-11-21||Interventional|||Multi-Day Evaluation of the TIVA Device|Multi-Day Evaluation of the TIVA Device|Completed||N/A|160|Actual|Velano Vascular, Inc.||2|||f||||f||||||||||2017-10-10 22:17:00.337418|2017-10-10 22:17:00.337418
NCT02747134|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-20|||September 2008||2008-09-01|April 2016|2016-04-01||||September 2011|Actual|2011-09-01||Interventional|||Combining Emotion Regulation and Mindfulness Skills for Preventing Depression Relapse||Completed||N/A|75|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||||||||||||2017-10-10 22:17:00.463911|2017-10-10 22:17:00.463911
NCT02747121|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-04-05|||April 2016||2016-04-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of External Inspection on Sepsis Detection and Treatment|Effects of External Inspection on Sepsis Detection and Treatment|Recruiting||N/A|2376|Anticipated|Norwegian Board of Health Supervision||2|||f||||f||||||||No|In line with the ethical approval data is not to be shared outside the research group|2017-10-10 22:17:00.547213|2017-10-10 22:17:00.547213
NCT02747108|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-26|||December 2, 2015|Actual|2015-12-02|September 2017|2017-09-01|March 30, 2020|Anticipated|2020-03-30|June 1, 2017|Actual|2017-06-01||Interventional|FINDIT||ForgIng New Paths to Prevent DIabeTes (FINDIT)|Improving Veteran Engagement in Diabetes Prevention (CDA 13-267-1)|Active, not recruiting||N/A|315|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:17:00.674262|2017-10-10 22:17:00.674262
NCT02747095|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-07-30|||January 2016||2016-01-01|July 2017|2017-07-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|||Clinical Investigation Plan for IQon Spectral CT at Utrecht Medical Center (UMC)|Clinical Investigation Plan for IQon Spectral CT at Utrecht Medical Center (UMC)|Completed||N/A|980|Actual|Philips Healthcare||1|||f||||f||||||||||2017-10-10 22:17:00.795392|2017-10-10 22:17:00.795392
NCT02747082|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-04-18|||January 2012||2012-01-01|April 2016|2016-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Antibacterial Effectiveness of Two Root Canal Irrigants|Antibacterial Effectiveness of Two Root Canal Irrigants in Root-filled Teeth With Infection: A Randomized Clinical Trial|Completed||Phase 2|49|Actual|University of Oslo||2|||f||||t||||||||Yes||2017-10-10 22:17:00.925726|2017-10-10 22:17:00.925726
NCT02747069|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-01-04|||May 2016||2016-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|HLPulseS||HeartLight Pulse Study: Evaluation of Heart Rate Using an Electronic Stethoscope and Pre Placed ECG in the Delivery Room|Determination of Heart Rate in Neonates on the NICU and Delivery Suite Using ECG and Electronic Stethoscope, a Feasibility Study|Recruiting||N/A|50|Anticipated|University of Nottingham|||2||f||||f||||||||Yes||2017-10-10 22:17:01.050512|2017-10-10 22:17:01.050512
NCT02747056|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-09-07|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|TSASDI||Study of the Personal Identity in Adults With Autism Spectrum Disorder Without Intellectual Deficiency|Study of the Personal Identity in Adults With Autism Spectrum Disorder Without Intellectual Deficiency|Recruiting||N/A|104|Anticipated|University Hospital, Strasbourg, France||8|||f||||f||||||||||2017-10-10 22:17:01.169405|2017-10-10 22:17:01.169405
NCT02747030|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-01-04|||December 2016||2016-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|RVC_CRVO||Phase I RVC With Ocriplasmin for CRVO|Phase I Study on the Feasibility and Safety of Surgical Stabilizer Assisted Retinal Vein Cannulation With Ocriplasmin Infusion for Central Retinal Vein Occlusion.|Recruiting||Phase 1|6|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||No||2017-10-10 22:17:01.727164|2017-10-10 22:17:01.727164
NCT02747017|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-15|||June 2016||2016-06-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|CDIFF||Observational Study of C. Diff in Post-Transplant Patients|An International Prospective Observational Study to Assess the Characteristics and Outcomes of Post-transplant Patients Treatment for C. Difficile Infections|Recruiting||N/A|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     serum, stool   "|||2017-10-10 22:17:01.856483|2017-10-10 22:17:01.856483
NCT02747004|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-10-03|||September 2016|Actual|2016-09-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|February 2018|Anticipated|2018-02-01||Interventional|nextMONARCH 1||A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer|A Randomized, Open-Label, Phase 2 Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone, in Women With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer|Recruiting||Phase 2|225|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:17:02.029504|2017-10-10 22:17:02.029504
NCT02746991|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2017-08-02|||June 2015||2015-06-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|April 2017|Actual|2017-04-01||Interventional|||Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Posterior Uveitis|A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye|Active, not recruiting||Phase 3|153|Actual|pSivida Corp.||2|||f||||f||||||||||2017-10-10 22:17:02.279879|2017-10-10 22:17:02.279879
NCT02746978|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-04-18|||August 2013||2013-08-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Patient-centered Approach to Successful Community Transition After Catastrophic Injury|A Patient-centered Approach to Successful Community Transition After Catastrophic Injury|Enrolling by invitation||N/A|800|Anticipated|Shepherd Center, Atlanta GA||2|||f||||f||||||||No||2017-10-10 22:17:02.390408|2017-10-10 22:17:02.390408
NCT02746965|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-05-03|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Magnetic Seizure Therapy for Schizophrenia|Magnetic Seizure Therapy for Schizophrenia|Recruiting||N/A|180|Anticipated|Shanghai Mental Health Center||2|||f||||t|f|f||||||No|No plan to share IPD data|2017-10-10 22:17:02.589562|2017-10-10 22:17:02.589562
NCT02746952|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-05-19|||August 1, 2016|Actual|2016-08-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CALM||Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia|Phase I, Open Label, Dose-escalation Study to Evaluate the Safety, Expansion and Persistence of a Single Dose of UCART19 (Allogeneic Engineered T-cells Expressing Anti-CD19 Chimeric Antigen Receptor), Administered Intravenously in Patients With Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukaemia (B-ALL)|Recruiting||Phase 1|40|Anticipated|Servier||1|||f||||t|t|f||||||Yes|The datasets generated and/or analysed during the current study will be available upon request from www.servier.com after the Marketing Authorisation has been granted.|2017-10-10 22:17:02.707931|2017-10-10 22:17:02.707931
NCT02746939|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-20|||April 2016||2016-04-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Student Outcomes in Fitness and Nutrition ISEO|Student Behavior Outcomes in Fitness and Nutrition Integrated Science Education Outreach (InSciEd Out, ISEO)|Not yet recruiting||N/A|250|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:17:02.809797|2017-10-10 22:17:02.809797
NCT02746926|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-26|||April 29, 2016|Actual|2016-04-29|September 2017|2017-09-01|July 15, 2016|Actual|2016-07-15|July 15, 2016|Actual|2016-07-15||Interventional|||A Study Comparing Amounts of Tafamidis (PF‑06291826) in the Blood Without Food in Healthy Volunteers|A Phase 1, Open‑Label, Three‑Period Randomized, Single Dose Study To Estimate The Relative Bioavailability Of Pf‑06291826 (Tafamidis) Free Acid Capsule Formulation Versus Commercial Capsule In Healthy Subjects Under Fasted Conditions|Completed||Phase 1|12|Actual|Pfizer||3|||f||||f|t|f||||||||2017-10-10 22:17:02.896224|2017-10-10 22:17:02.896224
NCT02746913|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-07|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ambulatory Pessary Trial|Ambulatory Pessary Trial as a Preoperative Method for Diagnosing Occult Stress Urinary Incontinence|Withdrawn||N/A|0|Actual|New York University School of Medicine||2||Lack of funding|f||||f|f|t|f|f||||||2017-10-10 22:17:02.984973|2017-10-10 22:17:02.984973
NCT02746900|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-18|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length|Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length|Recruiting||Phase 4|587|Anticipated|Federico II University||2|||f||||t||||||||||2017-10-10 22:17:03.072875|2017-10-10 22:17:03.072875
NCT02746887|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-04-18|||December 2015||2015-12-01|April 2016|2016-04-01||||November 2016|Anticipated|2016-11-01||Observational|||Risk Factors Related to Metabolic Syndrome in School-aged Children Who Were Born Preterm|Risk Factors Related to Metabolic Syndrome in School-aged Children Who Were Born Preterm|Recruiting||N/A|120|Anticipated|Seoul National University Hospital|||2||f||||t||||||||||2017-10-10 22:17:03.166965|2017-10-10 22:17:03.166965
NCT02746874|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-19|||December 2015||2015-12-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|July 2017|Anticipated|2017-07-01||Interventional|||Does Radiofrequency Ablation of the Articular Nerves of the Knee Prior to Total Knee Replacement Improve Pain Outcomes|Does Radiofrequency Ablation of the Articular Nerves of the Knee Prior to Total Knee Replacement Improve Pain Outcomes? A Prospective Randomized Sham-Control Trial With 6 Month Follow Up|Recruiting||Phase 4|70|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 22:17:03.96026|2017-10-10 22:17:03.96026
NCT02746861|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-04-19|||April 2016||2016-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|DSMS||Peer-Supported Diabetes Self-Management Support|Web-based Training of Peers to Deliver Diabetes Self-Management Support|Recruiting||N/A|96|Anticipated|InquisitHealth, Inc.||2|||f||||||||||||||2017-10-10 22:17:04.056921|2017-10-10 22:17:04.056921
NCT02746848|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-04-18|||June 2014||2014-06-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|||Utilization of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Healing|Evaluation the Effect of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Epithelium Healing (Phase I and II Clinical Trial)|Completed||Phase 1/Phase 2|20|Actual|Royan Institute||1|||f||||t||||||||No||2017-10-10 22:17:04.171514|2017-10-10 22:17:04.171514
NCT02746835|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-19|||September 2015||2015-09-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|Fall Risk||Physical Condition and Self-efficacy in People With Fall Risk|Physical Condition and Self-efficacy in People With Fall Risk - a Preliminary Study|Completed||N/A|7|Actual|Aveiro University||1|||f||||f||||||||||2017-10-10 22:17:04.2698|2017-10-10 22:17:04.2698
NCT02746822|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-18|||April 2015||2015-04-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|TASTI||Thrombus Aspiration in Acute ST-elevation Myocardial Infarction||Recruiting||N/A|30|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     thrombus material and blood   "|||2017-10-10 22:17:04.379051|2017-10-10 22:17:04.379051
NCT02746809|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01|November 2021|Anticipated|2021-11-01|January 2017|Anticipated|2017-01-01||Interventional|||Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)|Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)|Active, not recruiting||N/A|60|Actual|Medtronic Cardiovascular||1|||f||||t||||||||||2017-10-10 22:17:04.49527|2017-10-10 22:17:04.49527
NCT02746796|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-09-21|||March 2016||2016-03-01|August 2016|2016-08-01||||August 2020|Anticipated|2020-08-01||Interventional|||Study of ONO-4538 in Gastric Cancer|ONO-4538 Phase II/III Study A Multicenter, Randomized Study in Patients With Unresectable Advanced or Recurrent Gastric Cancer|Recruiting||Phase 2/Phase 3|680|Anticipated|Ono Pharmaceutical Co. Ltd||4|||f||||t||||||||||2017-10-10 22:17:04.650246|2017-10-10 22:17:04.650246
NCT02746783|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-04-18|||October 2013||2013-10-01|April 2016|2016-04-01||||July 2014|Actual|2014-07-01||Interventional|||Immunogenicity (Humoral and Cellular Immune Responses) and Safety of the 2013-2014 Seasonal Flu Vaccine in Elderly|Immunogenicity (Humoral and Cellular Immune Responses) and Safety of the Northern Hemisphere 2013-2014 Seasonal Flu Vaccine in Patients >65 Year Old|Completed||Phase 1/Phase 2|39|Actual|University of Lausanne Hospitals||2|||f||||t||||||||||2017-10-10 22:17:05.059686|2017-10-10 22:17:05.059686
NCT02746770|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-04-20|||February 2016||2016-02-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Physiotherapy in Vestibular Disorders|Physiotherapy in Vestibular Disorders|Active, not recruiting||N/A|80|Actual|University of Jaén||2|||f||||f||||||||||2017-10-10 22:17:05.165427|2017-10-10 22:17:05.165427
NCT02746757|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-03-01|||May 2015||2015-05-01|March 2017|2017-03-01||||April 2017|Anticipated|2017-04-01||Interventional|||Glucagon Like Peptide-1 in Remote Ischemic Conditioning|The Role of Glucagon Like Peptide-1 in the Protective Effect of Remote Ischemic Conditioning During Ischemia-reperfusion|Recruiting||N/A|12|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-10 22:17:05.253397|2017-10-10 22:17:05.253397
NCT02746744|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-09-01|||May 2016||2016-05-01|September 2016|2016-09-01|August 2021|Anticipated|2021-08-01|May 2021|Anticipated|2021-05-01||Interventional|RIFUND-MS||RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.|RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis. A Randomized Phase 3 Study Comparing Rituximab With Dimethyl Fumarate in Early Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome.|Recruiting||Phase 3|200|Anticipated|Karolinska Institutet||3|||f||||t||||||||No||2017-10-10 22:17:05.356317|2017-10-10 22:17:05.356317
NCT02746731|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-08-24|||June 2016||2016-06-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|pERACS||Prehabilitation - Enhanced Recovery After Colorectal Surgery|Randomized Controlled Trial Assessing the Value of Prehabilitation in Patients Undergoing Colorectal Surgery According to the ERAS Protocol for the Improvement of Postoperative Outcomes|Recruiting||N/A|112|Anticipated|Kantonsspital Winterthur KSW||2|||f||||f||||||||||2017-10-10 22:17:05.476299|2017-10-10 22:17:05.476299
NCT02746718|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-22|||December 11, 2015|Actual|2015-12-11|September 2017|2017-09-01|December 11, 2017|Anticipated|2017-12-11|December 11, 2017|Anticipated|2017-12-11||Interventional|POPS3||Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness|Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness|Recruiting||N/A|500|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 22:17:05.592002|2017-10-10 22:17:05.592002
NCT02746705|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-08-24|||April 2016||2016-04-01|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Pilot Study of Transcranial Direct Current Stimulation (tDCS)|Pilot Study of Transcranial Direct Current Stimulation (tDCS)|Recruiting||Phase 3|115|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:17:05.770699|2017-10-10 22:17:05.770699
NCT02746692|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-04-11|||July 2016||2016-07-01|April 2017|2017-04-01||||April 2017|Anticipated|2017-04-01||Interventional|Fit15||Faster Back Home: Efficacy of a High-intensity Endurance Training|Faster Back Home: a Randomized Controlled Equivalence Study on the Efficacy of a High-intensity 15 Minute Aerobic Endurance Training|Recruiting||N/A|30|Anticipated|Goethe University||2|||f||||||||||||||2017-10-10 22:17:05.862261|2017-10-10 22:17:05.862261
NCT02746679|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-19|2016-07-16|2016-05-25||January 2015||2015-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|IMBSRADQWIUA||Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and QOL in Women With Intrauterine Adhesion.|Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and Quality of Life in Women With Intrauterine Adhesion:a Randomized Controlled Trial.|Completed||N/A|226|Actual|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||Yes||2017-10-10 22:17:05.952971|2017-10-10 22:17:05.952971
NCT02746666|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2016-10-26|||April 2016||2016-04-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PIBC||Pharmacist's Influence on Breast Cancer Patient Quality of Life|Influence of a Clinical Pharmacist's Intervention on Quality of Life of a Breast Cancer Patient Under Adjuvant Chemotherapy|Completed||N/A|70|Actual|"University Hospital Sestre Milosrdnice"||2|||f||||f||||||||||2017-10-10 22:17:06.764892|2017-10-10 22:17:06.764892
NCT02746653|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-20|||April 2016||2016-04-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2016|Anticipated|2016-08-01||Interventional|GOR-CLN-01||Effectiveness and Safety of Gordian Surgical's TroClose1200™|Effectiveness and Safety of Gordian Surgical's TroClose1200™, a Trocar With built-in Closure Device Capability, in Subjects Undergoing Laparoscopic Surgery|Recruiting||N/A|50|Anticipated|Gordian Surgical||1|||f||||f||||||||||2017-10-10 22:17:06.832877|2017-10-10 22:17:06.832877
NCT02746640|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-20|||June 2015||2015-06-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Prospective Assessment Project About Cardiac Arrest Resuscitation|Prospective Assessment Project About Cardiac Arrest Resuscitation|Completed||N/A|148|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||No||2017-10-10 22:17:06.929157|2017-10-10 22:17:06.929157
NCT02746627|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-24|||January 2014||2014-01-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D|Positive Psychology to Improve Adherence in Adolescents With Type 1 Diabetes|Completed||N/A|120|Actual|Vanderbilt University Medical Center||3|||f||||t||||||||||2017-10-10 22:17:07.00887|2017-10-10 22:17:07.00887
NCT02744027|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-07-13|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Imaging of Lymphatic Anomalies|Dynamic Contrast Enhanced MR Lymphangiogram Imaging of Lymphatic Anomalies (LA)|Enrolling by invitation||N/A|10|Anticipated|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-10 22:17:31.497127|2017-10-10 22:17:31.497127
NCT02746614|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-18|||September 2014||2014-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|||Psychomotor Therapy Effects in Adaptive Behavior and Motor Proficiency in Intellectual Disability|Psychomotor Therapy Effects Adaptive Behavior and Motor Proficiency of Adults With Intellectual Disability|Completed||N/A|15|Actual|Faculdade de Motricidade Humana||2|||f||||f||||||||Yes|All individual data were provided to institutions where the individuals were, helping in Individual Program' planning|2017-10-10 22:17:07.094111|2017-10-10 22:17:07.094111
NCT02746601|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-11-10|||February 2016||2016-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||My Health eSnapshot - A Preconception Health Research Study|My Health eSnapshot - A Preconception Health Research Study|Recruiting||N/A|720|Anticipated|Wellington-Dufferin-Guelph Public Health||1|||f||||f||||||||Yes|Non-identifying, client level data will be shared with Boston Medical Centre via encrypted means.|2017-10-10 22:17:07.170189|2017-10-10 22:17:07.170189
NCT02746588|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-21|||February 2016||2016-02-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Description of the Uterine Cavity in Patients With Recurrent Miscarriages||Recruiting||N/A|200|Anticipated|Hvidovre University Hospital|||1||f||||f||||||Samples With DNA|"     Two endometrial biopsies   "|No||2017-10-10 22:17:07.281824|2017-10-10 22:17:07.281824
NCT02746575|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-04-27|||November 2015||2015-11-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Pilot - Peri-operative Beta Blockade|Novel Strategy For Perioperative Beta-Blocker Therapy - Pilot Study|Active, not recruiting||Phase 4|70|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 22:17:07.363507|2017-10-10 22:17:07.363507
NCT02746562|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-27|||May 2016||2016-05-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|March 2019|Anticipated|2019-03-01||Interventional|||"Study Comparing Outcomes Between Conventional IVF and a Freeze-all-Strategy in Assisted Reproductive Technology"|"A Multicentre Randomized Controlled Trial of a Freeze All and Transfer Later Versus a Conventional Fresh Embryo Transfer Strategy for Assisted Reproductive Technology (ART) in Women With a Regular Menstrual Cycle"|Recruiting||N/A|424|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-10 22:17:07.452658|2017-10-10 22:17:07.452658
NCT02746549|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-03-27|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Accuracy of 1.5 T Versus 3 T Magnetic Resonance Arterial Spin Labeling to Measure Renal Blood Flow|Randomized, Clinical Study to Compare Accuracy of 1.5 T Versus 3 T Magnetic Resonance Arterial Spin Labeling to Measure Renal Blood Flow and the Changes of Renal Perfusion Caused by Physiological Stress (Cold Pressor Test).|Recruiting||N/A|20|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-10 22:17:07.563295|2017-10-10 22:17:07.563295
NCT02746536|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-28|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Slow Chest Compression on Dynamic Hyperinflation, Dyspnea and Peripheral Muscle Deoxygenation in Patients With COPD|Effects of Slow Chest Compression on Dynamic Hyperinflation, Dyspnea and Peripheral Muscle Deoxygenation Induced by Exercise in Patients With COPD|Recruiting||N/A|30|Anticipated|University of the State of Santa Catarina||2|||f||||f||||||||||2017-10-10 22:17:07.656734|2017-10-10 22:17:07.656734
NCT02746523|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-25|||March 2016||2016-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|NHL||Effects of Multiple Concussions in Retired NHL Players|Later Life Cognitive Impairment, Proprioception, and Biomarkers in Former NHL Players Who Suffered Multiple Concussions|Terminated||N/A|6|Actual|New York Institute of Technology|||2|Could not recruit enough subjects|f||||f||||||Samples With DNA|"     Blood, urine, saliva, nasal swab, mouth swab   "|||2017-10-10 22:17:07.761165|2017-10-10 22:17:07.761165
NCT02746510|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-12|||July 2016||2016-07-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|Schizo-CGH||Validation of a Clinical Screening Grid for Syndromic Schizophrenia|Validation of a Clinical Screening Grid for Syndromic Schizophrenia|Recruiting||N/A|150|Anticipated|Hôpital le Vinatier||1|||f||||t||||||||||2017-10-10 22:17:07.88264|2017-10-10 22:17:07.88264
NCT02746497|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-01-26|||October 2016||2016-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|ACOM||The Efficacy of ACupuncture On Menopausal Symptoms (ACOM)|The Efficacy of ACupuncture On Menopausal Symptoms (ACOM): A Randomized Controlled Trial|Active, not recruiting||N/A|70|Actual|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 22:17:07.983192|2017-10-10 22:17:07.983192
NCT02746484|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-01-16|||April 2015||2015-04-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program|ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.|Completed||N/A|30|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||||||||||||2017-10-10 22:17:08.097441|2017-10-10 22:17:08.097441
NCT02746471|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-03-30|||April 2014|Actual|2014-04-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|||Reveal LINQ Registry|Medtronic Reveal LINQ Insertable Cardiac Monitor Registry|Recruiting||N/A|1500|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f|f|f||||||Undecided||2017-10-10 22:17:08.202692|2017-10-10 22:17:08.202692
NCT02746458|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-08-22|||April 2016||2016-04-01|April 2016|2016-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|REPAIR||Rehabilitation Enhanced by Partial Arterial Inflow Restrictions|REPAIR: Rehabilitation Enhanced by Partial Arterial Inflow Restrictions|Recruiting||Phase 3|250|Anticipated|Major Extremity Trauma Research Consortium||2|||f||||t||||||||||2017-10-10 22:17:08.396973|2017-10-10 22:17:08.396973
NCT02746445|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-05-05|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT|A Longitudinal Study on the Safety and Efficacy for Subjects With Autism Spectrum Disorder (ASD) Who Received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT)|Completed||N/A|11|Actual|Newport Brain Research Laboratory|||1||f||||f||||||||No||2017-10-10 22:17:08.523235|2017-10-10 22:17:08.523235
NCT02746432|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-08-20|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial|Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial|Not yet recruiting||Phase 4|144|Anticipated|King Saud University||2|||f||||t|f|f|||f|||||2017-10-10 22:17:08.639511|2017-10-10 22:17:08.639511
NCT02746419|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain|The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain|Not yet recruiting||N/A|20|Anticipated|University of Chicago||2|||f||||t||||||||No||2017-10-10 22:17:08.744673|2017-10-10 22:17:08.744673
NCT02746406|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-11-15|2016-08-02||February 2016||2016-02-01|September 2016|2016-09-01||||July 2016|Actual|2016-07-01||Interventional|||A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use||Completed||N/A|5|Actual|Laborie Medical Technologies Inc.||1|||f||||f||||||||||2017-10-10 22:17:08.822529|2017-10-10 22:17:08.822529
NCT02746393|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-07-03|||July 2016||2016-07-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||SFGH Health Advocates Stage II Study|San Francisco General Hospital (SFGH) Health Advocates Phase II Study|Recruiting||N/A|1448|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 22:17:08.966372|2017-10-10 22:17:08.966372
NCT02746380|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-02-06|||April 2016||2016-04-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Multi-center (in Korea and Japan), Double-blind, Randomized, Parallel-group Study to Evaluate the Similarity of Efficacy and Safety of LBAL 40mg Subcutaneous Biweekly Injection to Humira® 40mg Subcutaneous Biweekly Injection, as Adjunctive Therapy to Methotrexate (MTX), in Patients With Active Rheumatoid Arthritis Who Had an Inadequate Response to MTX|Active, not recruiting||Phase 3|380|Anticipated|LG Life Sciences||2|||f||||||||||||||2017-10-10 22:17:09.077881|2017-10-10 22:17:09.077881
NCT02746367|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-14|||March 2016||2016-03-01|January 2017|2017-01-01||||April 2018|Anticipated|2018-04-01||Observational|||Bipolar Proteomic Assay Validation Study|A Validation Study to Measure the Impact of a Proteomic Assay in Distinguishing Bipolar I Disorder, Bipolar II Disorder, and Major Depressive Disorder in People Presenting With a Major Depressive Episode|Recruiting||N/A|261|Anticipated|Myriad Genetic Laboratories, Inc.|||3||f||||||||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:17:09.150636|2017-10-10 22:17:09.150636
NCT02746354|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-20|||October 2012||2012-10-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|PDAP||Effects of a Patient Driven Assessment Process With Complex Pain Patients|Effects of a Patient Driven Assessment Process With Complex Pain Patients (PDAP)|Completed||N/A|100|Actual|Kaiser Permanente||2|||f||||f||||||||No||2017-10-10 22:17:09.266634|2017-10-10 22:17:09.266634
NCT02746341|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-06-19|||April 2016||2016-04-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Natural History Study of Patients With MPS IIIA|An Observational, Prospective, Multi-center, Natural History Study of Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)|Recruiting||N/A|25|Anticipated|LYSOGENE|||1||f||||f||||||Samples With DNA|"     Cerebral Spinal Fluid   "|Undecided||2017-10-10 22:17:09.351163|2017-10-10 22:17:09.351163
NCT02746328|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-07-31|||April 2016||2016-04-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass|Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass|Active, not recruiting||Phase 2|12|Anticipated|GTx||1|||f||||f||||||||||2017-10-10 22:17:09.435185|2017-10-10 22:17:09.435185
NCT02746315|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-18|||October 2014||2014-10-01|April 2016|2016-04-01||||February 2015|Actual|2015-02-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Volunteers|A Randomised, Double-blind, Single-centre, Placebo-controlled, Dose Escalation, Multiple s.c. DoseStudy to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Subjects|Completed||Phase 1|40|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||4|||f||||f||||||||No||2017-10-10 22:17:09.507467|2017-10-10 22:17:09.507467
NCT02746302|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-20|||December 2012||2012-12-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers|A Randomised, Double-blind, Single-centre, Placebo-controlled, Ascending Single s.c. Dose, Sequential Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Subjects|Completed||Phase 1|62|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||2|||f||||f||||||||No||2017-10-10 22:17:09.580183|2017-10-10 22:17:09.580183
NCT02746289|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-10-20|||January 2016||2016-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:17:09.644795|2017-10-10 22:17:09.644795
NCT02746276|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-06-30|||April 1, 2016|Actual|2016-04-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2016|Actual|2016-09-30||Interventional|FLACSAM-PK||Optimising Antibiotic Treatment for Sick Malnourished Children|Pharmacokinetics of Antimicrobials and Carriage of Antimicrobial Resistance Amongst Hospitalised Children With Severe Acute Malnutrition|Active, not recruiting||Phase 2|81|Actual|University of Oxford||1|||f||||f||||||||||2017-10-10 22:17:09.684338|2017-10-10 22:17:09.684338
NCT02746263|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-11-02|||February 2016||2016-02-01|November 2016|2016-11-01||||October 2016|Actual|2016-10-01||Interventional|||Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain|A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Repeated Dose, Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain in Combination With Patient-Controlled Analgesia With Morphine in Adults Following Elective Total Knee Arthroplasty|Terminated||Phase 4|1|Actual|Mallinckrodt||2|||f||||f||||||||No||2017-10-10 22:17:09.792924|2017-10-10 22:17:09.792924
NCT02746250|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-18|||March 2016||2016-03-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||Muscle Soreness and Stiffness in Patients With Chronic or Frequent Episodic Tension Type Headache.|Muscle Soreness and Stiffness in Patients With Chronic or Frequent Episodic Tension Type Headache.|Recruiting||N/A|90|Anticipated|Danish Headache Center||2|||f||||t||||||||No||2017-10-10 22:17:09.882651|2017-10-10 22:17:09.882651
NCT02746237|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-08-29|||November 2015||2015-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585|A Randomized, Double-blind, Placebo-controlled, Phase 1, First-in-human, Single-center, Safety, Tolerability, Ventricular Repolarization and Pharmacokinetic Study of Single and Multiple Ascending Doses of KAR5585 in Healthy Subjects|Completed||Phase 1|120|Actual|Karos Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:17:10.132103|2017-10-10 22:17:10.132103
NCT02746224|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-24|||April 2016||2016-04-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|TAHR||Reconstruction Techniques and Vascular Approach After Laparoscopic Left Hemicolectomy and Rectum Low Anterior Resection|Reconstruction Techniques and Vascular Approach After Laparoscopic Left Hemicolectomy and Laparoscopic Low Anterior Resection for Rectal Cancer: a Randomized Clinical Trial|Recruiting||N/A|64|Anticipated|Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta||4|||f||||f||||||||||2017-10-10 22:17:10.266789|2017-10-10 22:17:10.266789
NCT02746211|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-04-18|||January 2008||2008-01-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Influenza Challenge Study in Healthy Volunteers|An Open Label Dose-Ranging Influenza Challenge Study in Healthy Volunteers|Completed||Phase 1/Phase 2|24|Actual|Hvivo||4|||f||||f||||||||Yes|Only in anonymised form|2017-10-10 22:17:10.422115|2017-10-10 22:17:10.422115
NCT02746198|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-11-16|||January 2016||2016-01-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Pilot Trial on the Effect of a Probiotic Fermented Drink on Antibiotic-associated Diarrhea (AAD)|A Randomized Double-blind Placebo-controlled Clinical Pilot Trial on the Effect of a Probiotic Fermented Drink on Antibiotic-associated Diarrhea (AAD) in Patients With Helicobacter Pylori Eradication Therapy|Active, not recruiting||N/A|125|Actual|Clinical Research Center Kiel GmbH||2|||f||||t||||||||No||2017-10-10 22:17:10.552918|2017-10-10 22:17:10.552918
NCT02746185|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-08-28|||September 2016||2016-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CASTA-DIVA||Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban|Efficacy and Safety of Oral Rivaroxaban for the Treatment of Venous Thromboembolism in Patients With Active Cancer. A Pilot Study.|Recruiting||Phase 3|200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:17:10.702817|2017-10-10 22:17:10.702817
NCT02746172|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-18|||November 2015||2015-11-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Clinical Metrics for Assessing Cochlear Implant Recipient MAPs|Clinical Metrics for Assessing Audibility, Comfort and Performance of Cochlear Implant Recipient MAPs|Recruiting||N/A|40|Anticipated|The Hearing Cooperative Research Centre||2|||f||||f||||||||No||2017-10-10 22:17:10.937657|2017-10-10 22:17:10.937657
NCT02746146|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-06-16|||April 5, 2017|Actual|2017-04-05|September 2016|2016-09-01|April 5, 2018|Anticipated|2018-04-05|April 5, 2018|Anticipated|2018-04-05||Interventional|KITE||A Simple Clinical Tool for Increasing Enrollment on a Kidney Transplant Waiting List for Patients Aged Over 70 and Initiating Dialysis|Impact of a Simple Clinical Tool for Increasing Enrollment on a Kidney Transplant Waiting List for Patients Aged Over 70 and Initiating Dialysis|Recruiting||N/A|180|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||f|f|f||||||||2017-10-10 22:17:11.290143|2017-10-10 22:17:11.290143
NCT02746133|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-01-25|||July 2016|Actual|2016-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-027-CNI)|Characterisation of Patient Profile and Contemporary Treatment of Pre-dialytic Chronic Kidney Disease (CKD) in Patients Receiving a Restricted Protein Diet Supplemented With Ketosteril® - a Drug Utilisation Study (DUS)|Recruiting||N/A|60|Anticipated|Fresenius Kabi|||1||f||||f||||||||||2017-10-10 22:17:11.519303|2017-10-10 22:17:11.519303
NCT02746120|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-11-01|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:17:11.659797|2017-10-10 22:17:11.659797
NCT02746107|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-09-13|2016-06-09||March 2016||2016-03-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional||age: median (min, max): 39 (25, 83)|Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk.|RCT Concerning the Intention to Prescribe/Take Oral Anticoagulants for Atrial Fibrillation Depending on the Number of Risk Diagrams (w Treatment +/- w/Out Treatment), and Number of Years (1 or 5) for the Estimation of the Risk of Stroke.|Completed||N/A|968|Actual|Carol Davila University of Medicine and Pharmacy|"prescription was only simulated - not real patients, physicians had to imagine they had atrial fibrillation
results could be different on patients
participants had to decide prescription/not after seeing the risk diagram for only 5 minutes"|11|||f||||t||||||||Undecided|At the end, when published|2017-10-10 22:17:11.719003|2017-10-10 22:17:11.719003
NCT02746094|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-06-16|||April 2017|Anticipated|2017-04-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|ProstaChoc 1||Low Frequency Shock Wave Therapy for Improving Post-prostatectomy Erectile Dysfunction: a Prospective Pilot Study|Low Frequency Shock Wave Therapy for Improving Post-prostatectomy Erectile Dysfunction: a Prospective Pilot Study|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes||1||Change strategy|f||||f|f|f||||||||2017-10-10 22:17:12.11836|2017-10-10 22:17:12.11836
NCT02746081|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-09-22|||May 26, 2016|Actual|2016-05-26|September 2017|2017-09-01|February 2, 2019|Anticipated|2019-02-02|December 2, 2018|Anticipated|2018-12-02||Interventional|||Phase I Study of BAY1436032 in Isocitrate Dehydrogenase-1 (IDH1)-Mutant Advanced Solid Tumors|An Open-label, Non-randomized, Multicenter Phase I Study to Determine the Maximum Tolerated or Recommended Phase II Dose of Oral Mutant IDH1 Inhibitor BAY1436032 and to Characterize Its Safety, Tolerability, Pharmacokinetics and Preliminary Pharmacodynamic and Anti-tumor Activity in Patients With IDH1-R132X-mutant Advanced Solid Tumors|Recruiting||Phase 1|100|Anticipated|Bayer||1|||f||||f||||||||||2017-10-10 22:17:12.22656|2017-10-10 22:17:12.22656
NCT02746068|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-08-24|||March 2016||2016-03-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|COAST-1||A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions|COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.|Recruiting||Phase 3|346|Anticipated|Axsome Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 22:17:12.347807|2017-10-10 22:17:12.347807
NCT02746055|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-21|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|||Study of the Prevalence of TGFBI Corneal Dystrophies|Cross-Sectional Study of the Prevalence of TGFBI Corneal Dystrophies|Enrolling by invitation||N/A|20000|Anticipated|Avellino Labs USA, Inc.|||1||f||||f||||||Samples With DNA|"     buccal epithelial swabs   "|No||2017-10-10 22:17:12.537695|2017-10-10 22:17:12.537695
NCT02746042|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-07-26|||April 2016||2016-04-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Sinupret Extract Coated Tablets in Chronic Rhinosinusitis|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Trial to Assess Efficacy and Safety of the Herbal Medicinal Product Sinupret Extract Coated Tablets in Patients With Chronic Rhinosinusitis|Active, not recruiting||Phase 3|572|Actual|Bionorica SE||2|||f||||f||||||||||2017-10-10 22:17:12.599819|2017-10-10 22:17:12.599819
NCT02746029|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-06-27|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|CAMUS||Cardiac Murmurs in Children: Predictive Value of Cardiac Markers|Cardiac Murmurs in Children: Predictive Value of Cardiac Markers|Recruiting||N/A|500|Anticipated|University Hospital, Akershus|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma   "|||2017-10-10 22:17:12.819903|2017-10-10 22:17:12.819903
NCT02746016|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-03-28|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Formula on Infant Behavior|Effect of Formula Supplemented With Oligosaccharides on Infant Behavior|Completed||N/A|69|Actual|Abbott Nutrition||1|||f||||f||||||||Undecided||2017-10-10 22:17:12.900908|2017-10-10 22:17:12.900908
NCT02746003|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-09-21|||April 2016||2016-04-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Health Impacts of a Climate Change Adaptation Strategy to Address Drinking-water Salinity in Coastal Bangladesh|Health Impacts of a Climate Change Adaptation Strategy to Address Drinking-water Salinity in Coastal Bangladesh|Recruiting||N/A|1200|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 22:17:12.982194|2017-10-10 22:17:12.982194
NCT02745990|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-25|||May 2016||2016-05-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|EPO||Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants||Enrolling by invitation||N/A|440|Anticipated|Zhengzhou Children's Hospital, China||1|||f||||t||||||||No||2017-10-10 22:17:13.055709|2017-10-10 22:17:13.055709
NCT02745977|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-05-08|||June 2014||2014-06-01|May 2017|2017-05-01|April 24, 2017|Actual|2017-04-24|April 24, 2017|Actual|2017-04-24||Interventional|||Recruiting All Strictly Breast-fed Babies With Blood In Stool|Breast Milk Protein Intolerance and Maternal Dairy Consumption|Completed||N/A|25|Actual|Winthrop University Hospital||2|||f||||f||||||||No||2017-10-10 22:17:13.131382|2017-10-10 22:17:13.131382
NCT02745964|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-10-30|||April 2016||2016-04-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Comparison of LMA-Supreme and I-gel for the Incidence of Postoperative Sore Throat||Recruiting||N/A|406|Anticipated|Yonsei University||2|||f||||f||||||||No|no plan to share data|2017-10-10 22:17:13.190347|2017-10-10 22:17:13.190347
NCT02745951|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-05-02|||April 2016||2016-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|HELICOPTER-1||HELIox CardiOPlegia Trial During Cardiac surgERy|HELIox CardiOPlegia Trial During Cardiac surgERy|Recruiting||N/A|24|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||Undecided||2017-10-10 22:17:13.25629|2017-10-10 22:17:13.25629
NCT02745938|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-14|||June 2016||2016-06-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|GDF-15||GDF-15 as a Biomarker for Mitochondrial Disease|GDF-15 as a Biomarker for Mitochondrial Disease|Completed||N/A|97|Actual|Rigshospitalet, Denmark|||4||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-10 22:17:13.328517|2017-10-10 22:17:13.328517
NCT02745925|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-01-27|||April 2016|Actual|2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mechanism of Decreased Iron Absorption in Obesity: Controlling Adiposity-related Inflammation|Mechanism of Decreased Iron Absorption in Obesity: Controlling Adiposity-related Inflammation|Completed||N/A|40|Actual|Swiss Federal Institute of Technology||2|||f||||f||||||||||2017-10-10 22:17:15.179182|2017-10-10 22:17:15.179182
NCT02745912|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-09-27|||April 2016||2016-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants|A Phase 1, Open-Label, Sequential Design Study to Evaluate the Potential Effect of Multiple Oral Doses of Extended-Release Combination of Naltrexone and Bupropion on the Pharmacokinetics of a Single Oral Dose of Metformin in Healthy Subjects|Completed||Phase 1|30|Actual|Orexigen Therapeutics, Inc||1|||f||||f||||||||||2017-10-10 22:17:15.288147|2017-10-10 22:17:15.288147
NCT02745899|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-05-01|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of Cow Milk Consumption on Respiratory Symptoms and Pulmonary Functions in Asthmatic and Non Asthmatic Children|The Effect of Cow-milk Consumption on Respiratory Symptoms and Pulmonary Functions in Asthmatic and Non-asthmatic Children|Not yet recruiting||N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||4|||f||||f||||||||No||2017-10-10 22:17:15.378247|2017-10-10 22:17:15.378247
NCT02745886|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-22|||April 2016||2016-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Metformin Induces a Dietary Restriction-like State in Human|Chronic Metformin Treatment Induces a Dietary Restriction-like State in Overweight Human|Recruiting||Phase 4|60|Anticipated|Wuhan General Hospital of Guangzhou Military Command||3|||f||||t||||||||Yes||2017-10-10 22:17:15.483415|2017-10-10 22:17:15.483415
NCT02745873|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-23|||May 2012||2012-05-01|April 2016|2016-04-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|LDVC||Lead Detoxifying Effects of Ascorbic Acid Among School Going Adolescents of Karachi- A Cluster Randomized Control Trial|Lead Detoxifying Effects of Ascorbic Acid Among School Going Adolescents of Karachi- A Cluster Randomized Control Trial|Completed||Phase 2/Phase 3|144|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-10 22:17:15.583395|2017-10-10 22:17:15.583395
NCT02745860|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-07-01|||June 2016||2016-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of Two Dose Strengths of Selexipag in Healthy Adults|Single-center, Open-label, Randomized, Two-way Crossover Study in Healthy Adult Male Subjects to Compare the Pharmacokinetics of Selexipag (ACT-293987) Following Single Oral Administration of 4 Film-coated Pediatric Tablets of 50 µg vs One Film-coated Tablet of 200 µg Selexipag|Completed||Phase 1|20|Actual|Actelion||2|||f||||f||||||||No||2017-10-10 22:17:15.658433|2017-10-10 22:17:15.658433
NCT02745847|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-18|||May 2016||2016-05-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer|The Safety and Efficacy of Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer|Not yet recruiting||Phase 2|30|Anticipated|Changhai Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:17:15.758699|2017-10-10 22:17:15.758699
NCT02745834|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-19|||October 2015||2015-10-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|May 2016|Anticipated|2016-05-01||Interventional|||The Influence of Dual Task and Gait Speed on Gait Variability in Patients With Chronic Ankle Instability|The Influence of Dual Task and Gait Speed on Gait Variability in Patients With Chronic Ankle Instability - a Case-control Study|Recruiting||N/A|40|Anticipated|Medical Corps, Israel Defense Force||2|||f||||f||||||||No|Data will be published after statistical analysis only.|2017-10-10 22:17:15.85543|2017-10-10 22:17:15.85543
NCT02745821|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-04-24|||June 2016||2016-06-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus|Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus|Recruiting||N/A|50|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-10 22:17:15.941583|2017-10-10 22:17:15.941583
NCT02745808|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-06-01|||September 2015||2015-09-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes|Injectable Collagen Scaffold™ Combined With Human Umbilical Cord-derived Mesenchymal Stem Cells (HUC-MSCs) for the Improvement of Erectile Function in Men With Diabetes|Recruiting||Phase 1|30|Anticipated|Chinese Academy of Sciences||2|||f||||t||||||||||2017-10-10 22:17:16.027338|2017-10-10 22:17:16.027338
NCT02745795|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-17|||October 2015||2015-10-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|IMAGINE||Efficacy of Motivational Interview in the Treatment of Obesity and Overweight in Adolescents|Motivational Intervention Through the Generation of an Interpersonal Plan About Nutrition and Physical Exercise Study (IMAGINE Study), a Randomized Controlled Trial With Obese and Overweight Adolescents in Portuguese High Schools|Active, not recruiting||N/A|83|Actual|Centro Hospitalar Lisboa Norte||2|||f||||t||||||||No||2017-10-10 22:17:16.25472|2017-10-10 22:17:16.25472
NCT02745782|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2016-04-19|||October 2014||2014-10-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||A Study of the Trigeminal Cardio-Reflex in Endodontic and Other Dental Treatment|A Study of the Trigeminal Cardio-Reflex in Endodontic and Other Dental Treatment|Recruiting||N/A|500|Anticipated|Chung Shan Medical University|||1||f||||f||||||||No||2017-10-10 22:17:16.3929|2017-10-10 22:17:16.3929
NCT02745769|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-10-03|||October 21, 2016|Actual|2016-10-21|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents|An Open-Label, Phase 1a/1b Study of Ramucirumab in Combination With Other Targeted Agents in Advanced Cancers|Recruiting||Phase 1|45|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:17:16.480479|2017-10-10 22:17:16.480479
NCT02745756|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-08-29|||April 14, 2016|Actual|2016-04-14|August 2017|2017-08-01|August 21, 2017|Actual|2017-08-21|August 21, 2017|Actual|2017-08-21||Interventional|||A Combined Cell Therapy Approach to the Treatment of Neuroblastoma|A Combined Cell Therapy Approach to the Treatment of Neuroblastoma|Withdrawn||Phase 1|0|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||no enrollment|f||||f||||||||||2017-10-10 22:17:16.60087|2017-10-10 22:17:16.60087
NCT02745743|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-19|||June 17, 2016|Actual|2016-06-17|September 2017|2017-09-01|February 14, 2019|Anticipated|2019-02-14|February 14, 2019|Anticipated|2019-02-14||Interventional|||Phase I Trial of BAY1251152 for Advanced Blood Cancers|An Open-label, Multicenter Phase I Study to Characterize the Safety, Tolerability, Preliminary Anti-tumor Activity, Pharmacokinetics and Maximum Tolerated Dose of BAY1251152 in Patients With Advanced Hematological Malignancies|Recruiting||Phase 1|74|Anticipated|Bayer||2|||f||||f|t|f||||||||2017-10-10 22:17:16.69352|2017-10-10 22:17:16.69352
NCT02745730|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-11-18|||March 2016||2016-03-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||RS-fMRI to Nutrient Shakes|Resting State Functional Magnetic Resonance Imaging of Human Brain Responses to Nutrient Shake|Completed||N/A|20|Actual|Unilever R&D||4|||f||||f||||||||No||2017-10-10 22:17:16.793085|2017-10-10 22:17:16.793085
NCT02745717|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-12-23|||January 2016||2016-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia|The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia|Recruiting||Phase 4|120|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 22:17:16.898485|2017-10-10 22:17:16.898485
NCT02745704|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-05-04|||April 2016||2016-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg|The Optimizing Treatment of PegIFN Alfa in HBeAg-negative Chronic Hepatitis B Patients With Low Level HBsAg|Recruiting||Phase 4|200|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||Undecided||2017-10-10 22:17:17.013404|2017-10-10 22:17:17.013404
NCT02745691|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-09-29|||April 1, 2016|Actual|2016-04-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|May 31, 2018|Anticipated|2018-05-31||Observational|LC29_Phase4||Phase 4 Field Study for Analyzing the Psychometric Properties of the EORTC Quality of Life Questionnaire (QLQ) LC29|An International Phase 4 Field Study for Analyzing the Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Lung Cancer (EORTC QLQ-LC29)|Recruiting||N/A|450|Anticipated|University Hospital Regensburg|||4||f||||f||||||||||2017-10-10 22:17:17.111357|2017-10-10 22:17:17.111357
NCT02745678|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-15|||January 2016||2016-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Localized Therapeutics for the Treatment of Gastrointestinal Disorders II|Localized Therapeutics for the Treatment of Gastrointestinal Disorders II|Recruiting||Phase 1|10|Anticipated|Stanford University||1|||f||||f||||||||No||2017-10-10 22:17:17.205123|2017-10-10 22:17:17.205123
NCT02745665|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-15|||June 2016||2016-06-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Observational|||A Pilot Case Control Study of Vascular Function in Cyclists|A Pilot Case Control Study of Endothelial Function and Arterial Stiffness in Male Cyclists and Healthy Subjects|Not yet recruiting||N/A|30|Anticipated|St George's, University of London|||3||f||||f||||||||No||2017-10-10 22:17:17.288497|2017-10-10 22:17:17.288497
NCT02745652|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-20|||May 2014||2014-05-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Carpel Tunnel Syndrome and Physical Therapy Modalities|Pulsed Magnetic Field Versus Ultrasound in Treatment of Postnatal Carpal Tunnel Syndrome: Randomized Control Trial on Female Egyptian Population|Completed||N/A|55|Actual|Cairo University||2|||f||||t||||||||Yes|publication in a refereed journal|2017-10-10 22:17:17.387411|2017-10-10 22:17:17.387411
NCT02745639|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-17|||February 2010||2010-02-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2013|Actual|2013-11-01||Interventional|GRACE||Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer|Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: a Phase II Study.|Completed||Phase 2|18|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||f||||||||Yes|International Journals|2017-10-10 22:17:17.477845|2017-10-10 22:17:17.477845
NCT02745626|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-01-20|2016-09-21||December 2011||2011-12-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|RCT||Comparison of Oral Hygiene & Root Resorption During Orthodontic Treatment|Comparison of Root Resorption, Microbial Colonization & Gingival Health Between Clear Aligners, Self-Ligating Brackets & Conventional Brackets- A Randomized Controlled Clinical Trial|Completed||N/A|68|Actual|UConn Health|There was no protocol in place to monitor the compliance of the patient with clear aligners.|3|||f||||f||||||||Yes||2017-10-10 22:17:17.56674|2017-10-10 22:17:17.56674
NCT02745613|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|HIT||Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity|Does a Family History of Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity in a Hispanic Population?|Recruiting||N/A|24|Anticipated|University of Texas, El Paso||2|||f||||t||||||||||2017-10-10 22:17:18.023762|2017-10-10 22:17:18.023762
NCT02745600|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-21|||February 2016||2016-02-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|ClinicIMPPACT||Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment|Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment (ClinicIMPPACT)|Recruiting||N/A|60|Anticipated|University of Leipzig||1|||f||||t||||||||Undecided||2017-10-10 22:17:18.141148|2017-10-10 22:17:18.141148
NCT02745587|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-20|||April 2016||2016-04-01|April 2016|2016-04-01|April 2024|Anticipated|2024-04-01|April 2021|Anticipated|2021-04-01||Interventional|PROPER||Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer.|The N+-PROPER Trial: Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer.|Recruiting||Phase 3|330|Anticipated|University Hospital, Ghent||2|||f||||f||||||||Undecided||2017-10-10 22:17:18.301587|2017-10-10 22:17:18.301587
NCT02745574|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2016-04-16|||April 2013||2013-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Randomized Controlled Trail for Post Laparoscopic Pain|Prevention of Post-laparoscopic Shoulder and Upper Abdominal Pain: A Randomized Controlled Trial.|Recruiting||N/A|360|Anticipated|Taipei Veterans General Hospital, Taiwan||3|||f||||t||||||||Undecided||2017-10-10 22:17:18.399898|2017-10-10 22:17:18.399898
NCT02745561|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-19|||January 2016||2016-01-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.|A Phase II Study of Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.|Recruiting||Phase 2|22|Anticipated|Hangzhou Cancer Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:17:18.506374|2017-10-10 22:17:18.506374
NCT02745548|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-06-05|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|December 2025|Anticipated|2025-12-01|December 2019|Anticipated|2019-12-01||Observational|||Bronchial Mapping (GCC 1635)|Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)|Recruiting||N/A|40|Anticipated|University of Maryland|||1||f||||t||||||||No||2017-10-10 22:17:18.60107|2017-10-10 22:17:18.60107
NCT02745535|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-18|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|RESOLVE||Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience|Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience|Recruiting||Phase 2|120|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-10 22:17:18.684956|2017-10-10 22:17:18.684956
NCT02745522|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-07-29|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|March 2017|Actual|2017-03-01||Interventional|||Can Oxytocin Enhance the Placebo Effect?|Can Oxytocin Enhance the Placebo Effect?|Recruiting||Phase 1|240|Anticipated|University of Electronic Science and Technology of China||2|||f||||||||||||||2017-10-10 22:17:18.80023|2017-10-10 22:17:18.80023
NCT02745509|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-04-19|||March 2016||2016-03-01|April 2016|2016-04-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Interventional|EIPL||Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (EIPL)|A Prospective, Multicentral, Open-label, Randomized, Controlled, Phase III Clinical Trial to Investigation the Value of Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer|Recruiting||Phase 3|530|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 22:17:18.899189|2017-10-10 22:17:18.899189
NCT02745496|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-04-15|||December 2014||2014-12-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|MULTIPROS||Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer|Multiparametric Magnetic Resonance Imaging Characterization and Guided Biopsy of the Prostate in Men Suspected of Having Prostate Cancer|Recruiting||N/A|600|Anticipated|University of Dundee||2|||f||||t||||||||No||2017-10-10 22:17:19.07172|2017-10-10 22:17:19.07172
NCT02745483|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-16|||November 2011||2011-11-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study|Prospective, Single-center, Single-arm, Clinical Trial Evaluating the Clinical Efficacy and Safety of a Novel Separable Cluster Electrode in Patients With Focal Liver Malignancies|Completed||Phase 2|153|Actual|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 22:17:19.171998|2017-10-10 22:17:19.171998
NCT02745470|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-17|2016-04-20|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain|Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain Measured by Functional MRI|Recruiting||N/A|30|Anticipated|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:17:19.252034|2017-10-10 22:17:19.252034
NCT02745457|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-12-06|||April 2016||2016-04-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Body Composition in Children With Inflammatory Bowel Disease|The Natural Course and the Effect of Treatment on Body Composition in Children With Inflammatory Bowel Disease|Recruiting||N/A|75|Anticipated|Schneider Children's Medical Center, Israel|||1||f||||f||||||||Undecided||2017-10-10 22:17:19.36071|2017-10-10 22:17:19.36071
NCT02745444|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-02|||April 2015||2015-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CR_LSP||Prevention of Acute Kidney Injury - Molecular Mechanisms of Dietary Pre-conditioning in Human|Prevention of Acute Kidney Injury - Molecular Mechanisms of Dietary Pre-conditioning in Human|Recruiting||N/A|20|Anticipated|University of Cologne||4|||f||||f||||||||Undecided||2017-10-10 22:17:19.455431|2017-10-10 22:17:19.455431
NCT02745431|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-07-29|||June 2015||2015-06-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Oxytocin Effects on Likeability After Being Liked or Disliked||Completed||N/A|86|Actual|University of Electronic Science and Technology of China||2|||f||||||||||||||2017-10-10 22:17:19.577883|2017-10-10 22:17:19.577883
NCT02745418|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-09-13|||March 2016||2016-03-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|||The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy|Deconstructing the Atopic March - the Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy|Recruiting||N/A|100|Anticipated|Queen's University|||1||f||||f||||||Samples With DNA|"     Blood samples will be collected and DNA will be isolated for genotyping of filaggrin     mutations.   "|||2017-10-10 22:17:19.683583|2017-10-10 22:17:19.683583
NCT02745405|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-15|||April 2014||2014-04-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Implications of Wearing a Fat Suit|Implications of Wearing a Fat Suit for Eating, Physiological Stress, and Psychological Well-Being|Completed||N/A|109|Actual|University of California, Los Angeles||2|||f||||f||||||||Undecided|Interested individuals should contact the PI, who will consult with the UCLA IRB regarding the request.|2017-10-10 22:17:19.759205|2017-10-10 22:17:19.759205
NCT02745392|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-08-09|||June 2016||2016-06-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|Zotrip||Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine|Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine|Completed||Phase 2/Phase 3|365|Actual|Zosano Pharma Corporation||4|||f||||f||||||||||2017-10-10 22:17:19.842093|2017-10-10 22:17:19.842093
NCT02745379|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Buccal Fat Pad Derived Stem Cells in Maxillary Sinus Augmentation|Effect of Buccal Fat Pad Derived Mesenchymal Stem Cells Loaded on Allograft and Platelet-rich Plasma in Maxillary Sinus Augmentation|Recruiting||Phase 1|20|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-10-10 22:17:19.984183|2017-10-10 22:17:19.984183
NCT02745366|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Buccal Fat Pad Derived Stem Cells With Cortical Tenting in Posterior Mandible Reconstruction|The Effect of Buccal Fat Pad Derived Mesenchymal Stem Cells Loaded on Allograft and Platelet-rich Plasma in Posterior Mandible Augmentation|Recruiting||Phase 1|20|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||Undecided||2017-10-10 22:17:20.090094|2017-10-10 22:17:20.090094
NCT02745353|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-02-27|||May 2016||2016-05-01|February 2017|2017-02-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Naloxegol in Cancer Opioid-Induced Constipation|A Phase II, Randomized, Single Center, Pilot Feasibility Study to Evaluate Naloxegol for Opioid-Induced Constipation in Cancer Patients|Recruiting||Phase 2|60|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 22:17:20.179299|2017-10-10 22:17:20.179299
NCT02745340|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-05-03|||May 2016||2016-05-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Substitution of Acetate by Citrate in the Bicarbonate Based Hemodialysis|Effect of an Acetate-free Dialysis (Citrate Based) on Parameters of Central Hemodynamics, Dialysis Adequacy, Quality of Life and Immunological Parameters in Chronic Hemodialysis|Recruiting||N/A|100|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-10 22:17:20.26358|2017-10-10 22:17:20.26358
NCT02745327|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-25|||November 2014||2014-11-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|NOVEL||Nutrition, Overgrowth, and Vaccine Efficacy in Low-income Settings|A Longitudinal Study of Childhood Intestinal Bacterial Overgrowth, Vaccine Underperformance, and Malnutrition|Recruiting||N/A|275|Anticipated|University of Virginia|||1||f||||f||||||Samples With DNA|"     Blood, stool, and urine.   "|No||2017-10-10 22:17:20.348784|2017-10-10 22:17:20.348784
NCT02745314|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-04-16|||February 2010||2010-02-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|SAS-frailty||Frailty and Mortality in Older Old With Severe Aortic Stenosis|Effectiveness of Physical Frailty Measurement to Determine the Outcome of Elderly Patients With Severe Symptomatic Aortic Stenosis|Completed||N/A|605|Actual|Hospital de Meixoeiro|||1||f||||f||||||Samples Without DNA|"     Serum plasma samples   "|No|Not initially considered but open to external collaboration|2017-10-10 22:17:20.432278|2017-10-10 22:17:20.432278
NCT02745301|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-06-12|||April 2016||2016-04-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|June 2017|Anticipated|2017-06-01||Observational|||Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder|Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder|Recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||Samples With DNA|"     Patient urine specimens and bladder tumor specimens   "|||2017-10-10 22:17:20.500561|2017-10-10 22:17:20.500561
NCT02745288|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-11-20|||June 2016||2016-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Inferior Alveolar Nerve Block for Intraoperative Analgesia for Maxillofacial Cancer Surgery - RCT|Inferior Alveolar Nerve Block for Intraoperative Analgesia for Maxillofacial Cancer Surgery Requiring Unilateral Mandibular Resection-A Randomized Controlled Study|Completed||N/A|50|Actual|Tata Memorial Centre||2|||f||||t||||||||No||2017-10-10 22:17:20.578547|2017-10-10 22:17:20.578547
NCT02745275|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-05-08|||August 2017|Anticipated|2017-08-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|SHAPES||Supporting Healthy Aging by Peer Education and Support|Supporting Healthy Aging by Peer Education and Support (SHAPES) - A Stepped-Wedge Cluster Randomized Trial|Not yet recruiting||N/A|90|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 22:17:20.648425|2017-10-10 22:17:20.648425
NCT02745262|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-15|||March 2016||2016-03-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Observational|||Overall Survival and Disease-free Survival in Breast Cancer Patients Under COS|Retrospective Cohort Study of Overall Survival and Disease-free Survival in Breast Cancer Patients Who Underwent Controlled Ovarian Stimulation (COS)|Active, not recruiting||N/A|400|Actual|IVI Vigo|||2||f||||f||||||||No||2017-10-10 22:17:20.844176|2017-10-10 22:17:20.844176
NCT02745249|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-09-26|||July 2015||2015-07-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing MNCH Platform in Bangladesh|Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing Maternal, Newborn, and Child Health Platform in Bangladesh: A Cluster-randomized Operational Evaluation|Completed||N/A|3500|Actual|International Food Policy Research Institute||2|||f||||f||||||||||2017-10-10 22:17:20.923585|2017-10-10 22:17:20.923585
NCT02745236|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-10-24|||July 2016||2016-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of Nurse Practitioner Led-Care on Quality of Life in Patients With Atrial Fibrillation|The Effect of Nurse Practitioner-Led Care on Health Related Quality Of Life in Adult Patients With Atrial Fibrillation - A Randomized Trial|Recruiting||N/A|140|Anticipated|University of Alberta||2|||f||||t||||||||Undecided||2017-10-10 22:17:21.003153|2017-10-10 22:17:21.003153
NCT02745223|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-07-31|||July 2016||2016-07-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia|A Phase 2a, Double-blind, Randomized, Placebo-controlled, Repeated Administration, Crossover Study to Establish Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects|Completed||Phase 2|36|Actual|Orasis Pharmaceuticals Ltd.||2|||f||||t||||||||||2017-10-10 22:17:21.117584|2017-10-10 22:17:21.117584
NCT02745210|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-03-07|||September 2009||2009-09-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Non-invasive Clinical Imaging of Cerebral Metabolism Following Brain Injury Using 13C Magnetic Resonance Spectroscopy.|Non-invasive Clinical Imaging of Cerebral Metabolism Following Brain Injury Using 13C Magnetic Resonance Spectroscopy|Enrolling by invitation||N/A|15|Anticipated|Loma Linda University||1|||f||||f||||||||No||2017-10-10 22:17:21.224264|2017-10-10 22:17:21.224264
NCT02745197|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-06-21|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer|Factors That Regulate Components of a Nutritional Supplement to Reduce Muscle Loss and Fat Content in Cancer Patients|Not yet recruiting||Phase 2|88|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 22:17:21.28622|2017-10-10 22:17:21.28622
NCT02745184|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-10-27|||April 2016||2016-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis||Recruiting||Phase 1/Phase 2|20|Anticipated|Shanghai East Hospital||1|||f||||||||||||||2017-10-10 22:17:21.360301|2017-10-10 22:17:21.360301
NCT02745171|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-19|||January 2016||2016-01-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Continuous Behavior Assessment of the Effects of a Physical Therapy Program for Patients With Parkinson's Disease|Continuous Behavior Assessment of the Effects of a Physical Therapy Program for Patients With Parkinson's Disease|Recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||Undecided||2017-10-10 22:17:21.453529|2017-10-10 22:17:21.453529
NCT02745158|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-08-15|||July 2015|Actual|2015-07-01|March 2016|2016-03-01|December 2025|Anticipated|2025-12-01|July 2025|Anticipated|2025-07-01|10 Years|Observational [Patient Registry]|||The Fibrodysplasia Ossificans Progressiva (FOP) Connection Registry|FOP Connection: A Global Registry for the Fibrodysplasia Ossificans Progressiva Community|Recruiting||N/A|800|Anticipated|The International FOP Association|||1||f||||f||||||||||2017-10-10 22:17:21.536701|2017-10-10 22:17:21.536701
NCT02745145|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-07-27|||May 31, 2016|Actual|2016-05-31|July 2017|2017-07-01|December 17, 2019|Anticipated|2019-12-17|July 31, 2019|Anticipated|2019-07-31||Interventional|||Abituzumab in SSc-ILD|A Phase II, Randomized, Double-blind, Placebo Controlled, Parallel-group, Multicenter Trial to Evaluate the Efficacy and Safety of Abituzumab in Subjects With Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)|Recruiting||Phase 2|175|Anticipated|EMD Serono||3|||f||||t||||||||||2017-10-10 22:17:21.649784|2017-10-10 22:17:21.649784
NCT02745132|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-04-19|||June 2016||2016-06-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CICHepC||Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)|Personalized Medicine in HCV Infection: Cognitive Impairments and Brain Anomalies in Chronic Hepatitis C Infected Individuals. Characterization and Potential Reversibility With Direct Antiviral Agents.|Not yet recruiting||Phase 4|80|Anticipated|Instituto de Investigación Marqués de Valdecilla||1|||f||||f||||||||No||2017-10-10 22:17:21.843273|2017-10-10 22:17:21.843273
NCT02745119|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-09-11|||July 31, 2016|Actual|2016-07-31|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)|A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Lampalizumab in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration Who Have Completed a Roche-Sponsored Study|Recruiting||Phase 3|1800|Anticipated|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 22:17:21.975849|2017-10-10 22:17:21.975849
NCT02745106|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-06-01|||August 2015||2015-08-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy|Randomized Pilot Trial of Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy|Recruiting||Phase 2|50|Anticipated|Novosibirsk Scientific Research Institute for Circulatory Pathology||2|||f||||t||||||||Yes||2017-10-10 22:17:22.520945|2017-10-10 22:17:22.520945
NCT02745093|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-06-16|||September 2016||2016-09-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks|The Effectiveness, Safety, and Acceptability of Home-administered Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks: A Prospective Cohort Study in Mexico City|Not yet recruiting||Phase 4|648|Anticipated|Ibis Reproductive Health||2|||f||||f||||||||||2017-10-10 22:17:22.609258|2017-10-10 22:17:22.609258
NCT02745080|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-08-22|||April 3, 2017|Actual|2017-04-03|August 2017|2017-08-01|March 12, 2020|Anticipated|2020-03-12|November 21, 2019|Anticipated|2019-11-21||Interventional|EXCEED 1||Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis|A Randomized, Double-blind, Active Control, Multicenter Study to Evaluate the Efficacy at Week 52 of Secukinumab Monotherapy Compared With Adalimumab Monotherapy in Patients With Active Psoriatic Arthritis|Recruiting||Phase 3|850|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 22:17:22.724731|2017-10-10 22:17:22.724731
NCT02745067|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-09-23|||September 2016||2016-09-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Effectiveness of Enhanced Cognitive Behavioral Therapy (CBT-E) in the Treatment of Anorexia Nervosa|Effectiveness of Enhanced Cognitive Behavioral Therapy (CBT-E) in the Treatment of Anorexia Nervosa: a Prospective Multidisciplinary Study|Recruiting||N/A|100|Anticipated|Haukeland University Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:17:23.020728|2017-10-10 22:17:23.020728
NCT02745054|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-03-27|||August 2016||2016-08-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01|7 Days|Observational [Patient Registry]|SOAR||Safety of Oral Anticoagulants Registry|Safety of Oral Anticoagulants Registry (SOAR): A National, Hospital-Based, Sentinel Surveillance Study of the Clinical and Economic Impact of Bleeding and Bleeding Concerns Due to the Use of Oral Anticoagulants|Recruiting||N/A|1500|Anticipated|Hospital Quality Foundation|||1||f||||f||||||||No||2017-10-10 22:17:23.108422|2017-10-10 22:17:23.108422
NCT02745041|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-05-04|||December 2016||2016-12-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|FEISTY||Fibrinogen Early In Severe Trauma studY|Fibrinogen Concentrate vs Cryoprecipitate in Traumatic Haemorrhage: A Pilot Randomised Controlled Trial|Recruiting||Phase 2|100|Anticipated|Gold Coast Hospital and Health Service||2|||f||||t||||||||No||2017-10-10 22:17:23.219967|2017-10-10 22:17:23.219967
NCT02745028|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-15|||April 2016||2016-04-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Monosodium Glutamate on Gastric Emptying|Effect of a Single Dose of Monosodium Glutamate on Delayed Gastric Emptying in Children|Not yet recruiting||N/A|25|Anticipated|Hospital Italiano de Buenos Aires||1|||f||||f||||||||Yes|"The participant data to be shared will be the results of the 2nd radionuclide gastric emptying test in comparison to the first abnormal test.
The data will be entered once a month and it will be obtained from the Nuclear Medicine Unit"|2017-10-10 22:17:23.322322|2017-10-10 22:17:23.322322
NCT02745015|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2016-07-17|||December 2014||2014-12-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PARODIA1||Effect of Non Surgical Treatment of Periodontitis on Diabetes Control|Effect of Non Surgical Treatment of Periodontitis on Glycaemic Control in a Type 2 Diabetic Populations of Cameroon|Completed||N/A|45|Actual|Yaounde Central Hospital||2|||f||||f||||||||||2017-10-10 22:17:23.398401|2017-10-10 22:17:23.398401
NCT02745002|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-10-31|||April 2016||2016-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Navigated EBUS and Functional Imaging in Lung Cancer|Assessment of a Novel, Fast and Automatic CT-to-patient Registration Method During Navigated Bronchoscopy and Endobronchial Ultrasound Bronchoscopy (EBUS)|Recruiting||N/A|50|Anticipated|St. Olavs Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:17:23.471196|2017-10-10 22:17:23.471196
NCT02744989|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-05-30|||June 2016||2016-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|STIM'ZO||STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia|STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia (SCH)|Recruiting||N/A|138|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:17:23.569579|2017-10-10 22:17:23.569579
NCT02744976|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-15|||February 2016||2016-02-01|April 2016|2016-04-01||||December 2018|Anticipated|2018-12-01||Interventional|||Coronary Artery Disease Progression in Patients With Prediabetes|Coronary Artery Disease Progression by iMap Intravascular Ultrasound Analysis in Patients With Prediabetes|Recruiting||Phase 4|60|Anticipated|Pauls Stradins Clinical University Hospital||3|||f||||f||||||||No||2017-10-10 22:17:23.720883|2017-10-10 22:17:23.720883
NCT02744014|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-04-15|||March 2016||2016-03-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Add-on Therapy for Axial Spondyloarthritis|Evidence-Based Mindset & Physical Therapy for Add-on Treatment of Active Axial Spondyloarthritis: Safety and Efficacy|Not yet recruiting||N/A|24|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||Undecided||2017-10-10 22:17:31.597026|2017-10-10 22:17:31.597026
NCT02744963|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-06-05|||June 2016||2016-06-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CLEAN-Meds||Carefully seLected and Easily Accessible at No Charge Medications|Carefully seLected and Easily Accessible at No Charge Medications|Active, not recruiting||N/A|784|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||Yes|Individual participant data will be made available at the time of publication.|2017-10-10 22:17:23.825926|2017-10-10 22:17:23.825926
NCT02744950|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-15|||November 2013||2013-11-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparison of Scar Results and Time for Closures of Scalp Defects Via Pulley Sutures or Layered Repairs|A Prospective, Randomized Study to Evaluate the Efficacy of Pulley Closures Compared to Intermediate or Complex Closures for Reconstruction of Scalp Surgical Defects|Completed||N/A|21|Actual|Henry Ford Health System||2|||f||||f||||||||Yes|Via a research paper|2017-10-10 22:17:23.910765|2017-10-10 22:17:23.910765
NCT02744937|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-04-18|||April 2016||2016-04-01|April 2016|2016-04-01||||March 2019|Anticipated|2019-03-01||Interventional|||Continuing Low Dose Aspirin Before Prostate Biopsy|To Investigate Post-procedure Hemorrhage and Cardiovascular Events in Taiwanese Patients Who Continue or Discontinue Low-Dose Aspirin Before Transrectal Prostate Biopsy: a Prospective Randomized Trial|Not yet recruiting||Phase 4|150|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 22:17:23.986502|2017-10-10 22:17:23.986502
NCT02744924|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-17|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Intervention to Increase Physical Activity in Older Adults Using Citizen-science and Modern Technology|A Community-based Intervention to Increase Physical Activity Levels in Older Adults Using Citizen-science and Modern Technology|Completed||N/A|29|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 22:17:24.069187|2017-10-10 22:17:24.069187
NCT02744911|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Development of Software to Provide the SpeechVive Device Via the Internet|Development of a Telehealth Platform for Treatment With the SpeechVive Device|Not yet recruiting||N/A|110|Anticipated|SpeechVive, Inc||2|||f||||t|f|t|f|||||||2017-10-10 22:17:24.152016|2017-10-10 22:17:24.152016
NCT02744885|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-09-29|||February 2016||2016-02-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Crave Crush Behavioral Study||Completed||N/A|67|Actual|Oregon Research Institute||2|||f||||f||||||||No||2017-10-10 22:17:24.377029|2017-10-10 22:17:24.377029
NCT02744872|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-10-05|||September 2013||2013-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|CARCATS||Copenhagen Acute Renal Complications After Transplantations Study Group|Prospektivt Randomiseret Dobbeltblindt Placebo-kontrolleret Studie af, Calciumkanalblokade påbegyndt Inden Operation: Med Henblik på at Forebygge Ciclosporin Induceret Nefropati Efter Lungetransplantation|Completed||Phase 4|42|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-10 22:17:24.448353|2017-10-10 22:17:24.448353
NCT02744859|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-02-22|||April 2016||2016-04-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Do Warning Labels Decrease Soda Purchasing?|Do Warning Labels Decrease Soda Purchasing?|Completed||N/A|6000|Actual|Harvard University||4|||f||||f||||||||||2017-10-10 22:17:24.534367|2017-10-10 22:17:24.534367
NCT02744846|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-04-11|||February 2016||2016-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|ABX||Short- and Long-Term Effects of Antibiotics on Childhood Growth|The Patient-Centered Outcomes Research Network (PCORnet) Obesity Observational Study: Short- and Long-Term Effects of Antibiotics on Childhood Growth|Enrolling by invitation||N/A|600000|Anticipated|Harvard Pilgrim Health Care|||2||f||||f||||||||Yes|Data will be shared publicly per Patient-Centered Outcomes Research Institute (PCORI) regulations 12 months after study completion. De-identified individual level data and aggregate data will be shared.|2017-10-10 22:17:24.609237|2017-10-10 22:17:24.609237
NCT02744833|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-04-24|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)|A Randomized Phase I/II Study to Assess the Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-Level Deep Venous Thrombosis|Completed||Phase 1/Phase 2|16|Actual|GlycoMimetics Incorporated||2|||f||||f||||||||||2017-10-10 22:17:24.705853|2017-10-10 22:17:24.705853
NCT02744807|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-04-15|||May 2015||2015-05-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine Adhesions|Prevalence of Chronic Endometritis in Severe Intrauterine Adhesions and Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine|Completed||N/A|125|Actual|First Affiliated Hospital, Sun Yat-Sen University|||2||f||||t||||||Samples With DNA|"     endometrium   "|Yes||2017-10-10 22:17:24.892385|2017-10-10 22:17:24.892385
NCT02744794|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2017-04-25|||April 2015||2015-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:17:24.966246|2017-10-10 22:17:24.966246
NCT02744781|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-04-16|||April 2001||2001-04-01|April 2016|2016-04-01|March 2008|Actual|2008-03-01|March 2004|Actual|2004-03-01||Interventional|||Trunk Muscles and Lumbar Intervertebral Disc Degeneration in Combat Sports|Smaller Size and Asymmetry of Trunk Muscles in Combat Sports Athletes With Lumbar Intervertebral Disc Degeneration|Completed||N/A|69|Actual|National Institute of Technology, Hiroshima College||1|||f||||t||||||||Yes||2017-10-10 22:17:25.018747|2017-10-10 22:17:25.018747
NCT02744755|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-03-15||2017-02-14|March 2016||2016-03-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|January 2017|Actual|2017-01-01||Interventional|ADMYRA||Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis|A Randomized, Double-blind, Parallel-group, Multicenter Study to Demonstrate Similar Efficacy and to Compare Safety and Immunogenicity of GP2017 and Humira® in Patients With Moderate to Severe Active Rheumatoid Arthritis|Active, not recruiting||Phase 3|353|Actual|Sandoz||2|||f||||t||||||||Undecided||2017-10-10 22:17:25.361392|2017-10-10 22:17:25.361392
NCT02744729|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-08-08|||October 2015||2015-10-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients|Safety and Diagnostic Performance of 99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients|Recruiting||Early Phase 1|20|Anticipated|First Affiliated Hospital of Fujian Medical University||1|||f||||t||||||||Yes||2017-10-10 22:17:25.671943|2017-10-10 22:17:25.671943
NCT02744716|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2016-04-16|||May 2011||2011-05-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of Aspirin on Uterine Endometrial Repair Severe Intrauterine Adhesion|Effects of Aspirin and Intrauterine Balloon on the Post-operative Uterine Endometrial Repair and Reproductive Prognosis in Patients With Severe Intrauterine Adhesion: a Prospective Cohort Study|Completed||N/A|114|Actual|First Affiliated Hospital, Sun Yat-Sen University||3|||f||||t||||||||Yes||2017-10-10 22:17:25.762398|2017-10-10 22:17:25.762398
NCT02744690|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-07-08|||February 2016||2016-02-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia|Topical vs Injection Application of Mitomycin C Trabeculectomy Trial|Recruiting||N/A|100|Anticipated|Francis I. Proctor Foundation||2|||f||||f||||||||||2017-10-10 22:17:26.14082|2017-10-10 22:17:26.14082
NCT02744677|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-24|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|March 2018|Anticipated|2018-03-01||Interventional|||COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction|COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV|Recruiting||Phase 3|58|Anticipated|Edwards Lifesciences||1|||f||||t|f|t|f|t||||||2017-10-10 22:17:26.24537|2017-10-10 22:17:26.24537
NCT02744664|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-14|||April 2016||2016-04-01|April 2016|2016-04-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||Cryotherapy Combine Icotinib for Advanced NSCLC Treatment|A Single Arm, Open Label, Perspective Study to Determine the Efficacy and Safety of Icotinib Combine Cryotherapy for Advanced NSCLC Patients|Completed||Phase 4|60|Actual|Fuda Cancer Hospital, Guangzhou||1|||f||||f||||||||||2017-10-10 22:17:26.375267|2017-10-10 22:17:26.375267
NCT02744651|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-04-10|||February 17, 2017|Actual|2017-02-17|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract|EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract|Active, not recruiting||N/A|20|Anticipated|Region Skane||2|||f||||f|f|f||||||No||2017-10-10 22:17:26.473192|2017-10-10 22:17:26.473192
NCT02744638|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-11-16|||February 2015||2015-02-01|April 2016|2016-04-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis|Double-blind, Randomized, Controlled Trial to Evaluate the Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains (L. Crispatus, L. Gasseri, L. Rhamnosus, L. Jensenii) on Bacterial Vaginosis (BV) in Adult Women|Completed||N/A|36|Actual|Clinical Research Center Kiel GmbH||2|||f||||t||||||||No||2017-10-10 22:17:26.560824|2017-10-10 22:17:26.560824
NCT02744625|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-03-28|||April 2016||2016-04-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Physiologic Study of Cerebral Perfusion|Physiologic Study of Cerebral Perfusion|Completed||Phase 4|22|Actual|Centre de recherche du Centre hospitalier universitaire de Sherbrooke||4|||f||||f||||||||Undecided||2017-10-10 22:17:26.661166|2017-10-10 22:17:26.661166
NCT02744612|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-06-23|||June 20, 2016|Actual|2016-06-20|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma|A Multi-Center Phase II Trial of Ibrutinib Plus Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma|Recruiting||Phase 2|39|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 22:17:26.761222|2017-10-10 22:17:26.761222
NCT02744599|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-03-14|||October 2013||2013-10-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Feasibility Trial for Detecting Drug-induced Respiratory Depression and Prompting for Self-rescue|Feasibility Trial for Detecting Drug-induced Respiratory Depression and Prompting for Self-rescue|Completed||N/A|26|Actual|University of Utah||2|||f||||f||||||||No||2017-10-10 22:17:26.889079|2017-10-10 22:17:26.889079
NCT02744586|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-01-12|||January 2016||2016-01-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Interventional|||Zambia One Love Aim 3 Trial|A Randomized Control Study to Evaluate Novel Interventions to Reduce Risk Factors Associated With HIV, Neglected Tropical and Non-communicable Diseases Among Couples in Zambia|Active, not recruiting||N/A|3450|Actual|Emory University||2|||f||||f||||||||No||2017-10-10 22:17:26.955985|2017-10-10 22:17:26.955985
NCT02744573|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-04-15|||September 2011||2011-09-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Evaluation Of The Analgesia Nociception Index vs. Surgical Pleth Index Under General And Regional Anaesthesia|Evaluation Of The Analgesia Nociception Index vs. Surgical Pleth Index Under General And Regional Anaesthesia And The Effect Of Posture. A Prospective Randomized Controlled Trial.|Completed||N/A|60|Actual|University of Schleswig-Holstein|||4||f||||f||||||||No||2017-10-10 22:17:27.05255|2017-10-10 22:17:27.05255
NCT02744560|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2017-04-26|||March 2015||2015-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C|Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C|Active, not recruiting||N/A|30|Actual|Tanta University||1|||f||||||||||||||2017-10-10 22:17:27.13259|2017-10-10 22:17:27.13259
NCT02744547|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2017-04-26|||December 2015||2015-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C|Effect of Spirulina on Serum Hyaluronic Acid as a Marker for Liver Fibrosis in Beta Thalassemic Children With Hepatitis C|Active, not recruiting||N/A|60|Actual|Tanta University||2|||f||||f||||||||||2017-10-10 22:17:27.197793|2017-10-10 22:17:27.197793
NCT02744534|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Targeted Fusion Biopsy of the Prostate|Targeted Fusion Biopsy of the Prostate|Recruiting||Phase 2|36|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 22:17:27.285388|2017-10-10 22:17:27.285388
NCT02744521|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-04-16|||March 2016||2016-03-01|April 2016|2016-04-01||||April 2017|Anticipated|2017-04-01||Interventional|||Training Inmate Peer Educators in Detecting Tuberculosis in a Developing Country Prison: A Cluster Randomized Trial|Training Inmate Peer Educators in Detecting Tuberculosis in Prisons|Not yet recruiting||N/A|||Maastricht University||2|||f||||f||||||||Undecided||2017-10-10 22:17:27.394392|2017-10-10 22:17:27.394392
NCT02744508|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-18|2016-12-29|||July 2015||2015-07-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery||Recruiting||N/A|202|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:17:27.467885|2017-10-10 22:17:27.467885
NCT02744495|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-12-13|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|PONVACS||Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery|Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery (PONVACS)|Completed||Phase 3|502|Actual|Hôpital Privé de Parly II - Le Chesnay||2|||f||||f||||||||Yes|On demand|2017-10-10 22:17:27.548348|2017-10-10 22:17:27.548348
NCT02744482|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-08-11|||May 2016||2016-05-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|May 2018|Anticipated|2018-05-01||Interventional|PTH||Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis|Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis Double-blind Randomized Study Versus Placebo|Recruiting||Phase 3|68|Anticipated|University Hospital, Limoges||2|||f||||f||||||||No||2017-10-10 22:17:27.636052|2017-10-10 22:17:27.636052
NCT02744469|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-08-22|||April 12, 2016|Actual|2016-04-12|August 2017|2017-08-01|December 12, 2019|Anticipated|2019-12-12|January 12, 2018|Anticipated|2018-01-12||Observational|BeniDiT||Benin Population Diversity of Tuberculosis and Implications|Implications of the Population Structure of the Mycobacterium Tuberculosis Complex in Benin for Tuberculosis Presentation, Diagnosis and Outcome|Recruiting||N/A|1490|Anticipated|Laboratoire de Référence des Mycobactéries|||2||f||||f||||||Samples With DNA|"     Sputa will be collected at enrolment. Participants will be asked to provide an additional     (third) sputum. For the purpose of this study, this sputum will be added to the leftover 2     sputa provided for the routine diagnosis of tuberculosis in order to reach in total at least     5 mL sputum. DNA will be extracted from a part of the sputum for the genotypic     characterization Mycobacterium tuberculosis (spoligotype analysis).   "|||2017-10-10 22:17:27.72637|2017-10-10 22:17:27.72637
NCT02744456|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-10-19|||August 2014||2014-08-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||N-of-1 Trials for Blood Pressure Medications in Adults|A Pilot Study of N-of-1 Trials of Blood Pressure Medications in Adults With Hypertension|Recruiting||Phase 2|20|Anticipated|Columbia University||1|||f||||f||||||||Undecided||2017-10-10 22:17:27.903629|2017-10-10 22:17:27.903629
NCT02744443|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-15|||January 2015||2015-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Leucine Supplementation in Young Subjects Undergoing Resistance Training||Completed||N/A|60|Actual|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 22:17:28.007337|2017-10-10 22:17:28.007337
NCT02744430|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-10-05|||November 2016||2016-11-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain|A Double Blind Placebo Control Trial of Mirabegron for Medical Expulsive Therapy and to Manage Stent Pain for Ureteral Stones(Protocol # 01-16-20-02)|Not yet recruiting||Phase 2|104|Anticipated|Baylor College of Medicine||2|||f||||f||||||||Yes|Data will be published in a aggregate format after completion of study.|2017-10-10 22:17:28.075342|2017-10-10 22:17:28.075342
NCT02744417|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-07-28|||August 2010||2010-08-01|July 2017|2017-07-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|EsCAPE2||Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy|Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy|Completed||N/A|63|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-10 22:17:28.155374|2017-10-10 22:17:28.155374
NCT02744404|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-08-01|||September 2015||2015-09-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Point of Care Early Infant Diagnosis Patient Impact Study|Evaluation of the Clinical Impact of Point-of-Care HIV Early Infant Diagnostic Technologies|Recruiting||N/A|3000|Anticipated|Clinton Health Access Initiative Inc.|||2||f||||f||||||||||2017-10-10 22:17:28.248693|2017-10-10 22:17:28.248693
NCT02744391|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-12-27|||April 2016||2016-04-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||A Study of L-DOPA for Depression and Slowing in Older Adults|A Study of L-DOPA for Depression and Slowing in Older Adults|Recruiting||N/A|60|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||Yes||2017-10-10 22:17:28.342729|2017-10-10 22:17:28.342729
NCT02744378|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-19|||June 2014||2014-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus|Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus- A Double-blinded Randomized Clinical Trial in Sri Lanka|Completed||Phase 2|68|Actual|University of Peradeniya||2|||f||||f||||||||||2017-10-10 22:17:28.436244|2017-10-10 22:17:28.436244
NCT02744365|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-07-20|||April 2015||2015-04-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Observational|||Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications|Biobank of Data and of Human Biological Samples on Prematurity, Preeclampsia and Other Pregnancy Complications|Recruiting||N/A|7845|Anticipated|CHU de Quebec-Universite Laval|||5||f||||f||||||Samples With DNA|"     maternal plasma, maternal serum and buffy coat, maternal urine, cord blood   "|||2017-10-10 22:17:28.501236|2017-10-10 22:17:28.501236
NCT02744352|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Single Shot vs Catheter Infraclavicular Brachial Plexus Block After Distal Radius Fracture Repair|Comparison Between Single Shot Versus Continuous Infraclavicular Brachial Plexus Block for Postoperative Analgesia After Distal Radius Fracture: A Prospective Randomized Open Label Study|Recruiting||N/A|50|Anticipated|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 22:17:28.597935|2017-10-10 22:17:28.597935
NCT02744339|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-15|||March 2016||2016-03-01|April 2016|2016-04-01||||February 2019|Anticipated|2019-02-01||Interventional|DYNAMIC||Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction|Evaluation of the Pharmacodynamic Effects of Riociguat in Subjects With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction in a Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study|Recruiting||Phase 2|114|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-10 22:17:28.694427|2017-10-10 22:17:28.694427
NCT02744326|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-15|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Outcomes in Youth Visiting the ED With Mental Health Issues: a Pilot Text Based Intervention|Improving Outcomes for Youth Visiting the Emergency Department With Mental Health Issues|Not yet recruiting||N/A|800|Anticipated|Children's Hospitals and Clinics of Minnesota||2|||f||||f||||||||No||2017-10-10 22:17:28.821798|2017-10-10 22:17:28.821798
NCT02744313|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-11-18|||April 2016||2016-04-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic Use|MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic Use|Recruiting||N/A|12|Anticipated|Centre for Addiction and Mental Health|||1||f||||f||||||Samples Without DNA|"     Antipsychotic serum levels, GLP-1, glucagon, cytokines, c-peptide   "|No||2017-10-10 22:17:28.895503|2017-10-10 22:17:28.895503
NCT02744300|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-11|||June 2016||2016-06-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|BABI2||Balance After Baby Intervention for Women With Recent Gestational Diabetes|Diabetes Prevention in Women With a Recent History of Gestational Diabetes Mellitus|Recruiting||N/A|180|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 22:17:28.972755|2017-10-10 22:17:28.972755
NCT02744287|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-04-11|||November 2016||2016-11-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Prostate Stem Cell Antigen (PSCA)-Specific CAR T Cells In Subjects With Non-Resectable Pancreatic Cancer|A Feasibility and Safety Study of PSCA-Specific Chimeric Antigen Receptor Engineered T Cells (BPX-601) in Subjects With Non-Resectable Pancreatic Cancer|Recruiting||Phase 1|30|Anticipated|Bellicum Pharmaceuticals||1|||f||||f||||||||No||2017-10-10 22:17:29.079633|2017-10-10 22:17:29.079633
NCT02744274|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-19|||January 2016||2016-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study|Randomized, Assessor- and Participant-blinded, Controlled, and Parallel-design Approach to Investigate Whether Acupuncture Can Prevent or Postpone the Occurrence of Peripheral Neuropathy and Improve Quality of Life.|Recruiting||Phase 3|32|Anticipated|China Medical University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:17:29.159018|2017-10-10 22:17:29.159018
NCT02744261|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-02-27|||August 11, 2016|Actual|2016-08-11|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Observational|DRUM-S||Developing Rectal USPE Measures for Suppositories (Project DRUM-S)|Evaluating User Perceptions and Experiences of Dual Compartment Microbicide Formulations. Project 5.3: Developing Rectal USPE Measures for Suppositories (Project DRUM-S)|Active, not recruiting||N/A|34|Actual|The Miriam Hospital|||1||f||||t||||||||Undecided|as per individual agreement, provided data safety/confidentiality agreements are met|2017-10-10 22:17:29.236141|2017-10-10 22:17:29.236141
NCT02744248|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-01-09|||February 2016||2016-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase I , MTD, Pharmacokinetic, Safety/Tolerability, Efficacy of IOP Injection for MRI in Healthy Subjects|A Phase I Study to Determine the MTD and to Evaluate Pharmacokinetic, Safety/Tolerability, and Efficacy Profiles of IOP Injection for MRI Contrast Agent in Healthy Subjects|Completed||Phase 1|24|Actual|MegaPro Biomedical Co. Ltd.||2|||f||||t||||||||Undecided||2017-10-10 22:17:29.293724|2017-10-10 22:17:29.293724
NCT02744235|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-04-25|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Mainstream Sleep Tracking Devices vs Polysomnography|Sensitivity and Specificity of Mainstream Sleep Tracking Devices Compared to Polysomnography|Withdrawn||N/A|0|Actual|New York University School of Medicine||1||Unable to move forward due to funding|f||||f||||||||||2017-10-10 22:17:29.366076|2017-10-10 22:17:29.366076
NCT02744222|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-09-07|||August 10, 2017|Actual|2017-08-10|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|||Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis|An International Multicenter Double-blind Placebo-controlled Randomized Study to Compare the Efficacy, Safety and Tolerability of BCD-054 (JSC BIOCAD, Russia), 180 μg and 240 μg, Versus Avonex® (Biogen Idec Ltd., UK) in Patients With Relapsing-remitting Multiple Sclerosis|Recruiting||Phase 2/Phase 3|399|Anticipated|Biocad||4|||f||||f|f|f||||||||2017-10-10 22:17:29.426385|2017-10-10 22:17:29.426385
NCT02744209|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-15|||April 2016||2016-04-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients|Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients|Not yet recruiting||Phase 1|60|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Plasma; RNA from leukocytes.   "|No||2017-10-10 22:17:29.523884|2017-10-10 22:17:29.523884
NCT02744196|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-05-03|||January 2015||2015-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ALTERRA||"Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC BIOCAD) With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis"|"Multicenter Comparative Randomised Double-blind Placebo-controlled Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC BIOCAD) With Methotrexate in First Line of Biological Therapy of Patients With Active Rheumatoid Arthritis"|Active, not recruiting||Phase 3|159|Anticipated|Biocad||2|||f||||f||||||||Undecided||2017-10-10 22:17:29.581237|2017-10-10 22:17:29.581237
NCT02744183|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-17|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|||Training in the Fasted State, Glucose Metabolism and Energy Balance|Training in the Fasted State, Glucose Metabolism and Energy Balance|Recruiting||N/A|30|Anticipated|University of Bath||3|||f||||f||||||||||2017-10-10 22:17:29.685934|2017-10-10 22:17:29.685934
NCT02744170|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-10-07|||March 2016||2016-03-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Effects of Supplemental Oxygen Delivery Via Demand Versus Continuous Flow in Hypoxemic COPD Patients|Effects of Supplemental Oxygen Delivery Via Demand Versus Continuous Flow in Hypoxemic COPD Patients|Recruiting||N/A|70|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||6|||f||||f||||||||No||2017-10-10 22:17:29.795096|2017-10-10 22:17:29.795096
NCT02744157|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-04-19|||January 2008||2008-01-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|January 2008|Actual|2008-01-01||Interventional|||Long Term Effects of a Structured Lifestyle Program|Long Term Effects on Lifestyle Habits and Quality of Life in Individuals With Increased Cardiometabolic Risk Participating in a Structured Lifestyle Intervention Program|Completed||N/A|102|Actual|Karolinska University Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:17:30.013873|2017-10-10 22:17:30.013873
NCT02744144|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-05-31|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Wound Bacterial Microbiota and Their Antibiotic Resistance|Wound Bacterial Microbiota and Their Antibiotic Resistance: a Prospective Cohort Study of Hospitalized Patients Originating From the Syrian Armed Conflict|Completed||N/A|457|Actual|Karolinska Institutet|||2||f||||f||||||||Undecided||2017-10-10 22:17:30.094385|2017-10-10 22:17:30.094385
NCT02744131|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-08-30|||May 2016||2016-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|OCP||OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women|OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women|Recruiting||N/A|100|Anticipated|Kar Clinic & Hospital Pvt. Ltd.||2|||f||||f||||||||Yes||2017-10-10 22:17:30.211306|2017-10-10 22:17:30.211306
NCT02744118|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-06-13|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|HEMPP||Helping Eliminate Marijuana Use Through Pediatric Practice|Helping Eliminate Marijuana Use Through Pediatric Practice|Recruiting||N/A|1020|Anticipated|American Academy of Pediatrics||2|||f||||t||||||||No||2017-10-10 22:17:30.328808|2017-10-10 22:17:30.328808
NCT02744105|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-16|2017-04-26|||December 2015||2015-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C|Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C|Active, not recruiting||N/A|60|Actual|Tanta University||2|||f||||f||||||||||2017-10-10 22:17:30.440145|2017-10-10 22:17:30.440145
NCT02744092|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-14|||December 2016||2016-12-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|CANVAS||Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer|Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial (CANVAS Trial)|Recruiting||N/A|940|Anticipated|Alliance Foundation Trials, LLC.||3|||f||||t||||||||||2017-10-10 22:17:30.546372|2017-10-10 22:17:30.546372
NCT02744079|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-06-26|||September 10, 2017|Anticipated|2017-09-10|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|KetoBreast||Comparison of Healthy Diets on Breast Cancer Markers|A Pilot Presurgical Trial of Insulin Inhibition by a Ketogenic Diet in Operable Breast Cancer|Not yet recruiting||N/A|65|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t|f|f||||||||2017-10-10 22:17:31.06516|2017-10-10 22:17:31.06516
NCT02744066|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-03|||January 31, 2017|Actual|2017-01-31|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|NEATCAP||A Pilot Study to Evaluate Patient Tolerance and Nursing Ease-of-Use of a Novel Hearing Protection Device|A Pilot Study to Evaluate Patient Tolerance and Nursing Ease-of-Use of a Novel Hearing Protection Device to Reduce Exposure to Excessive Noise Among Patients Undergoing Neonatal Intensive Care|Recruiting||N/A|50|Anticipated|University of Pittsburgh||1|||f||||f|f|f||||||Undecided||2017-10-10 22:17:31.16983|2017-10-10 22:17:31.16983
NCT02744053|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-08|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Multimodality Breast Imaging for the Assessment of Tumor Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients|Multimodality Breast Imaging for the Assessment of Tumor Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients|Recruiting||Early Phase 1|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:17:31.279068|2017-10-10 22:17:31.279068
NCT02744040|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-09-01|||August 28, 2017|Actual|2017-08-28|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|April 2020|Anticipated|2020-04-01||Interventional|MERLIN||Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use|Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use|Recruiting||N/A|230|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f|f|f|||t|||||2017-10-10 22:17:31.390343|2017-10-10 22:17:31.390343
NCT02744001|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-09-21|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||The Reinforcing Value of Added Sugars|Diet Study: The Reinforcing Value of Added Sugars|Recruiting||N/A|45|Anticipated|USDA Grand Forks Human Nutrition Research Center||1|||f||||f||||||||||2017-10-10 22:17:31.707875|2017-10-10 22:17:31.707875
NCT02743988|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-14|||May 2015||2015-05-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Influence of Oxygen Target Range on Intermittent Hypoxemia in Preterm Infants|Influence of Oxygen Target Range on Intermittent Hypoxemia in Preterm Infants|Recruiting||N/A|36|Anticipated|University of Ulm||2|||f||||f||||||||No||2017-10-10 22:17:31.796585|2017-10-10 22:17:31.796585
NCT02743975|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PENGUIN||Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma|Intraoperative Detection of Cancer Tissue in Pancreatic Adenocarcinoma Using a VEGF-targeted Optical Fluorescent Imaging Tracer, A Multicentre Feasibility Dose Escalation Study|Recruiting||Phase 1/Phase 2|26|Anticipated|University Medical Center Groningen||1|||f||||t||||||||Undecided||2017-10-10 22:17:31.894506|2017-10-10 22:17:31.894506
NCT02743949|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-25|||July 14, 2016|Actual|2016-07-14|May 2017|2017-05-01|June 29, 2017|Anticipated|2017-06-29|June 22, 2017|Anticipated|2017-06-22||Interventional|||Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)|A Randomized, Double-Blind, Proof-of-Concept, Phase 2 Study to Evaluate the Efficacy and Safety of Once Daily Oral Vonoprazan 20 mg or Vonoprazan 40 mg Compared to Esomeprazole 40 mg for the Treatment of Subjects With Symptomatic Gastro-Esophageal Reflux Disease Who Have a Partial Response Following Treatment With a High Dose of Proton Pump Inhibitor|Recruiting||Phase 2|213|Anticipated|Takeda||3|||f||||f||||||||||2017-10-10 22:17:32.1001|2017-10-10 22:17:32.1001
NCT02743936|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-08-18|2016-07-08||April 2016||2016-04-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Mask Leak With Nasal Cannula in Noninvasive Positive Pressure Ventilation|Analysis of Face Mask Leak With Nasal Cannula in Noninvasive Positive Pressure Ventilation: A Randomized Crossover Trial|Completed||Phase 4|64|Actual|Brooke Army Medical Center||2|||f||||f||||||||No||2017-10-10 22:17:32.340683|2017-10-10 22:17:32.340683
NCT02743923|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-09-14|||April 2016||2016-04-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer|First Line Chemotherapy in KRAS Mutated Non-small Cell Lung Cancer Patients: a Phase III Comparing Cisplatin-pemetrexed With Carboplatin-paclitaxel-bevacizumab: NVALT 22|Recruiting||Phase 3|240|Anticipated|The Netherlands Cancer Institute||2|||f||||||||||||||2017-10-10 22:17:32.576096|2017-10-10 22:17:32.576096
NCT02743910|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-07-12|||July 2016||2016-07-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer|Plasma Tumor DNA and Pathologic Complete Response in Early-Stage, High-Risk Breast Cancer|Recruiting||N/A|229|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||Samples With DNA|"     Blood and tissue samples   "|||2017-10-10 22:17:32.793421|2017-10-10 22:17:32.793421
NCT02743897|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-09-26|||May 2016||2016-05-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|HCV||Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Kidney Transplants From Hepatitis C-Positive Donors|Open-Labeled Trial Of Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Kidney Transplants From Hepatitis C-Positive Donors|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:17:32.894887|2017-10-10 22:17:32.894887
NCT02743884|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-04-11|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Evaluating Heat Transfer With the Esophageal Cooling Device|Prospective, Interventional Study Evaluating Heat Transfer With the Esophageal Cooling Device|Completed||N/A|19|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-10 22:17:32.99496|2017-10-10 22:17:32.99496
NCT02743858|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-08-16|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Lymphedema Surveillance Study|A Prospective Surveillance Program for Assessment and Treatment of Breast Cancer-Related Lymphedema After Axillary Lymph Node Dissection|Recruiting||N/A|400|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"     breast tissue   "|||2017-10-10 22:17:33.194409|2017-10-10 22:17:33.194409
NCT02743845|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-30|||February 2010||2010-02-01|August 2017|2017-08-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|||Gene Discovery Core, The Manton Center||Recruiting||N/A|10000|Anticipated|Boston Children’s Hospital|||1||f||||f||||||Samples With DNA|"     DNA RNA Tissue Samples Cell lines   "|||2017-10-10 22:17:33.282921|2017-10-10 22:17:33.282921
NCT02743832|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-20|||July 2015||2015-07-01|April 2016|2016-04-01|June 2025|Anticipated|2025-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.|A Randomized，Multicenter，Prospectie，Controlled Clinical Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.|Recruiting||N/A|524|Anticipated|Sun Yat-sen University||4|||f||||t||||||||||2017-10-10 22:17:33.354968|2017-10-10 22:17:33.354968
NCT02743819|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-09-21|||July 2016||2016-07-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Phase II Study of Pembrolizumab and Ipilimumab Following Initial Anti-PD1/L1 Antibody (Formerly IRB15-1788)|Phase II Study of Pembrolizumab and Ipilimumab Following Initial Anti-PD1/L1 Antibody|Recruiting||Phase 2|70|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-10 22:17:33.443741|2017-10-10 22:17:33.443741
NCT02743806|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-05-11|||August 1, 2016|Actual|2016-08-01|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease|Entyvio (Vedolizumab IV) Extended Access Program in Ulcerative Colitis and Crohn's Disease|Recruiting||Phase 4|700|Anticipated|Takeda||1|||f||||f||||||||||2017-10-10 22:17:33.546412|2017-10-10 22:17:33.546412
NCT02743793|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-09-13|||June 2016||2016-06-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|ALLTOL||A Cohort Study of Operationally Tolerant Allograft Recipients|A Prospective Cohort Study of Operationally Tolerant Allograft Recipients (ITN063ST)|Recruiting||N/A|70|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-10 22:17:35.512189|2017-10-10 22:17:35.512189
NCT02743780|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-08-30|2017-08-01||March 2, 2016|Actual|2016-03-02|August 2017|2017-08-01|September 20, 2016|Actual|2016-09-20|September 20, 2016|Actual|2016-09-20||Interventional||This analysis population includes all randomized subjects who received at least one on-treatment measurement of IOP (Full Analysis Set).|A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma|A Three Part, First-in-human, Randomized, Double-masked, Placebo-Controlled, Safety, Tolerability and Early Efficacy Study of MGV354 in Healthy Subjects and in Patients With Ocular Hypertension or Glaucoma|Completed||Phase 1/Phase 2|191|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 22:17:35.641358|2017-10-10 22:17:35.641358
NCT02743767|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-11-09|||May 2015||2015-05-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|Papaya||Frequency of Airway Complications During General Anaesthesia After Introducing Five Handling Adaptations|Frequency of Airway Complications During General Anaesthesia After Introducing Five Handling Adaptations|Completed||N/A|7455|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 22:17:37.141816|2017-10-10 22:17:37.141816
NCT02743754|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-02-01|||June 10, 2016|Actual|2016-06-10|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Hyperbaric Oxygen Therapy and Acute Kidney Injury|Hyperbaric Oxygen Therapy for Cardiac Surgery-Associated Acute Kidney Injury: A First-in-Human Pilot Study|Recruiting||Phase 1/Phase 2|20|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 22:17:37.217217|2017-10-10 22:17:37.217217
NCT02743741|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-25|||July 2016||2016-07-01|August 2017|2017-08-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Interventional|||Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors|A Prospective Single-Arm, Multi-Centre, Study of the Efficacy and Safety of Lutetium-177 Octreotate (Lu-DOTATATE) Treatment With Individualized Dosimetry in Patients With 68Ga-DOTATATE Identified Somatostatin Receptor Positive Neuroendocrine Tumors|Recruiting||N/A|195|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 22:17:37.318051|2017-10-10 22:17:37.318051
NCT02743728|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-04-21|||May 2016||2016-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Perinatal Stroke: Understanding Brain Reorganization|Perinatal Stroke: Understanding Brain Reorganization Through Infant Neuroimaging and Neuromodulation|Recruiting||N/A|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 22:17:37.425586|2017-10-10 22:17:37.425586
NCT02743715|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-05-30|||April 2015||2015-04-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|FRONT||Transcranial Direct Current Stimulation (tDCS) for Treatment-Resistant Obsessive-Compulsive Disorder (FRONT)|Randomized, Sham-Controlled Trial of Transcranial Direct Current Stimulation (tDCS) for Treatment-Resistant Obsessive-Compulsive Disorder (FRONT)|Recruiting||N/A|44|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:17:37.527345|2017-10-10 22:17:37.527345
NCT02743702|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-05-30|2016-04-21||June 2012||2012-06-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Effectiveness of Respiratory Physiotherapy in Children With Neuromuscular Disease|Effectiveness of a Protocol of Respiratory Physiotherapy for Improvement or Maintenance of Respiratory Function, and Incidence of Respiratory Infections in Children With Neuromuscular Diseases, Compared With no Approach by Respiratory Physiotherapy of Respiratory Difficulties: A Randomized Clinical Trial With Two Groups in Parallel With Blinded Evaluator.|Completed||N/A|21|Actual|University of Seville||2|||f||||||||||||||2017-10-10 22:17:37.611282|2017-10-10 22:17:37.611282
NCT02743689|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-10-30|||March 2015||2015-03-01|October 2016|2016-10-01||||May 2016|Actual|2016-05-01||Observational|||Perioperative Risk Factors for Intensive Care Delirium After Cardiac Surgery|Incidence and Perioperative Risk Factors for Early Intensive Care Delirium Following Cardiac Surgery|Completed||N/A|191|Actual|Vilnius University|||1||f||||f||||||||No||2017-10-10 22:17:37.798314|2017-10-10 22:17:37.798314
NCT02743676|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-15|||January 2007||2007-01-01|April 2016|2016-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||A Retrospective, Observational Registry of Participants With Avian Influenza Infection|Avian/Pandemic Influenza Registry|Completed||N/A|648|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:17:37.864167|2017-10-10 22:17:37.864167
NCT02743663|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-04-18|||June 2014||2014-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|Wheezy ER||The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children|The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children|Recruiting||Phase 4|160|Anticipated|The Hospital for Sick Children|||2||f||||f||||||Samples With DNA|"     Venous blood samples collected and divided into DNA pellet, plasma, serum, and whole blood.     Small portion of sample sent for Total IgE and CBC. The eosinophil and IgE information will     be used to assist with categorizing wheezy subjects into API categories. The DNA sample will     be analyzed using genome-wide association studies (GWAS), and looking for single-nucleotide     polymorphism (SNPs) that are known to be associated with asthma. The whole blood samples will     be used for the basophil activation test; Urine samples; Nasal swab samples; Nasal brush     samples;   "|||2017-10-10 22:17:37.932873|2017-10-10 22:17:37.932873
NCT02743650|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-10-26|||February 2016||2016-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate|Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate|Recruiting||Early Phase 1|15|Anticipated|University of Utah||1|||f||||f||||||||No||2017-10-10 22:17:38.064966|2017-10-10 22:17:38.064966
NCT02743637|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-04-12|||February 2016|Actual|2016-02-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|SDX-0101||A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors|A Phase 1 Dose Escalation Study of SDX-7320 to Assess the Safety and Tolerability in Patients With Advanced Refractory or Late-Stage Solid Tumors|Recruiting||Phase 1|30|Anticipated|SynDevRx, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:17:38.185941|2017-10-10 22:17:38.185941
NCT02743624|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-01-18|||February 2016||2016-02-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Criteria Analysis for Ventilatory Support Adjustment of Mechanical Ventilation|Criteria Analysis for Ventilatory Support Adjustment of Mechanical Ventilation|Completed||N/A|27|Actual|University of Sao Paulo General Hospital||1|||f||||t||||||||No||2017-10-10 22:17:38.36098|2017-10-10 22:17:38.36098
NCT02743611|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-07-11|||April 14, 2017|Actual|2017-04-14|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Dose Finding Study Evaluating Safety and Feasibility in Patients With Relapsed or Refractory Myeloid Neoplasms|A Phase I Dose Finding Study Evaluating Safety and Feasibility of BPX-701 in Patients With Relapsed or Refractory Myeloid Neoplasms|Recruiting||Phase 1|48|Anticipated|Bellicum Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 22:17:38.435747|2017-10-10 22:17:38.435747
NCT02743585|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-03-27|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|RABbIT||Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT)|Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT - Rapid Blood Culture Intervention Trial)|Recruiting||N/A|832|Anticipated|Tan Tock Seng Hospital||2|||f||||f|f|t|t|f|t|||No||2017-10-10 22:17:38.623128|2017-10-10 22:17:38.623128
NCT02743572|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-14|||September 2015||2015-09-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Iron-fortified Parenteral Nutrition in the Prevention and Treatment of Anemia in Premature Infants|Iron-fortified Parenteral Nutrition in the Prevention and Treatment of Anemia in Premature Infants: A Randomized, Double-blind Controlled Study|Recruiting||N/A|150|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||5|||f||||t||||||||No||2017-10-10 22:17:38.738876|2017-10-10 22:17:38.738876
NCT02743559|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-19|||January 2017||2017-01-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Does Vitamin D Alter Bone's Response to Vibration?|Does Antenatal Vitamin D Supplementation Influence Bone's Postnatal Response to Mechanical Stimulation?|Not yet recruiting||N/A|50|Anticipated|Sheffield Children's NHS Foundation Trust||2|||f||||t||||||||Undecided||2017-10-10 22:17:38.839012|2017-10-10 22:17:38.839012
NCT02743533|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-04-24|||January 2006||2006-01-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01|10 Years|Observational [Patient Registry]|SILICARD||Cardiovascular Diseases in the Silesian Region in Poland.|Trends in the Incidence, Treatment and Prognosis of Cardiovascular Diseases in the Silesian Region in Poland. SILesIan CARdiovascular Database (SILICARD)|Recruiting||N/A|10000000|Anticipated|Silesian Centre for Heart Diseases|||1||f||||f||||||||||2017-10-10 22:17:39.059915|2017-10-10 22:17:39.059915
NCT02743520|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-16|||January 2017||2017-01-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|ADIOS||Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS)|Early Identification of Patients With Coexisting Atrial Fibrillation and Obstructive Sleep Apnea|Recruiting||N/A|200|Anticipated|University of Miami||1|||f||||t||||||||No||2017-10-10 22:17:39.146146|2017-10-10 22:17:39.146146
NCT02743507|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-17|||April 2016||2016-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||The Impact of Bundled Payments on Quality and Cost of Care|The Impact of the Bundled Payments for Care Improvement Program on Quality and Costs of Care|Active, not recruiting||N/A|440|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 22:17:39.226711|2017-10-10 22:17:39.226711
NCT02743494|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-10-03|||May 23, 2016|Actual|2016-05-23|October 2017|2017-10-01|October 11, 2024|Anticipated|2024-10-11|September 14, 2020|Anticipated|2020-09-14||Interventional|CheckMate 577||An Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer|A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal, or Gastroesophageal Junction Cancer|Recruiting||Phase 3|760|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:17:39.320212|2017-10-10 22:17:39.320212
NCT02743481|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-06-30|||April 10, 2016||2016-04-10|March 28, 2017|2017-03-28|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Observational|||Early Life Exposures in Agriculture|Early Life Exposures in Agriculture|Enrolling by invitation||N/A|60000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:17:40.147873|2017-10-10 22:17:40.147873
NCT02743468|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-06-30|||April 10, 2016||2016-04-10|March 30, 2017|2017-03-30|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Observational|||Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function|Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function|Not yet recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:17:40.24328|2017-10-10 22:17:40.24328
NCT02743455|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-10-05|||July 5, 2016|Actual|2016-07-05|August 16, 2017|2017-08-16|May 17, 2018|Anticipated|2018-05-17|December 29, 2017|Anticipated|2017-12-29||Interventional|||A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers|A Phase I, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA 720 Adjuvant in 18-45 Year Old Healthy Adults|Active, not recruiting||Phase 1|92|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f|||||t|f|||f|||||2017-10-10 22:17:40.358311|2017-10-10 22:17:40.358311
NCT02743442|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-09-04|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|ROBOPHYSE||Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland||Recruiting||N/A|8|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 22:17:40.535998|2017-10-10 22:17:40.535998
NCT02743429|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-11-08|||March 2015||2015-03-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma|Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma|Recruiting||Phase 2|40|Anticipated|University Medicine Greifswald||1|||f||||f||||||||||2017-10-10 22:17:40.623602|2017-10-10 22:17:40.623602
NCT02743416|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-05-13|||April 2016||2016-04-01|May 2016|2016-05-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01|5 Years|Observational [Patient Registry]|STROKESTOP II||Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II|Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II|Recruiting||N/A|8000|Anticipated|Karolinska University Hospital|||2||f||||f||||||||No||2017-10-10 22:17:40.734348|2017-10-10 22:17:40.734348
NCT02743403|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-05-01|||January 2016||2016-01-01|January 2016|2016-01-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Effects of TENS in Pain During Application of Carboxytherapy in Patients With Gynoid Lipodystrophy|Effects of Transcutaneous Electric Nerve Stimulation in Pain During Application of Carboxytherapy in Patients With Gynoid Lipodystrophy: Randomized Controlled Trial|Completed||N/A|84|Actual|Universidade Cidade de Sao Paulo||3|||f||||t||||||||Yes||2017-10-10 22:17:40.81797|2017-10-10 22:17:40.81797
NCT02743390|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension|Effects of the TNF-alpha Inhibiton on Blood Pressure, Hemodynamic Parameters and Biomarkers in Resistant Hypertension|Recruiting||Phase 4|10|Anticipated|University of Campinas, Brazil||2|||f||||f||||||||Undecided||2017-10-10 22:17:40.906874|2017-10-10 22:17:40.906874
NCT02743364|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2017-09-12|||September 19, 2016|Actual|2016-09-19|September 2017|2017-09-01||||August 1, 2018|Anticipated|2018-08-01||Interventional|||Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis|Statin Therapy to Reduce the Risk of Recurrent Pancreatitis|Recruiting||Phase 2|30|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-10 22:17:41.104669|2017-10-10 22:17:41.104669
NCT02743351|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-06-22|||June 2016||2016-06-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|September 2019|Anticipated|2019-09-01||Interventional|||Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies|A Phase 1 Non-randomized/2 Randomized Study of ProTmune™ (ex Vivo Programmed Mobilized Peripheral Blood Cells) for Allogeneic Hematopoietic Cell Transplantation in Adult Patients With Hematologic Malignancies|Recruiting||Phase 1/Phase 2|70|Anticipated|Fate Therapeutics||2|||f||||t||||||||No||2017-10-10 22:17:41.222281|2017-10-10 22:17:41.222281
NCT02743338|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-14|||March 2016||2016-03-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CompRest||CompRest - a Comparison Between Sleep Compression and Sleep Restriction for Treating Insomnia|CompRest - a Randomized Comparison Between Sleep Compression and Sleep Restriction for the Treatment of Insomnia|Recruiting||N/A|180|Anticipated|Karolinska Institutet||4|||f||||f||||||||Undecided||2017-10-10 22:17:41.358575|2017-10-10 22:17:41.358575
NCT02743325|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-08-21|||April 25, 2016|Actual|2016-04-25|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ALARA-SVT||As Low As Reasonable Achievable Fluoroscopy for SVT Ablation|Optimisation of Catheter Navigation With As Low As Reasonable Achievable Fluoroscopy for Amelioration of Ablation Success in Patients With SupraVentricular Tachycardia (ALARA-SVT)|Enrolling by invitation||N/A|120|Anticipated|Luzerner Kantonsspital||2|||f||||f||||||||||2017-10-10 22:17:41.453444|2017-10-10 22:17:41.453444
NCT02743312|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-10-13|||November 2015||2015-11-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|TWPS||Long-Term Effects of Torso-Weighting|Long-Term Effects of Balance-Based Torso-Weighting: Pilot Study|Completed||N/A|5|Actual|San Francisco State University||3|||f||||f||||||||||2017-10-10 22:17:41.531846|2017-10-10 22:17:41.531846
NCT02743299|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-08-08|||April 2013||2013-04-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|June 2013|Actual|2013-06-01||Interventional|||Investigation of a Novel Turbine-driven Ventilator for Use in Cardiopulmonary Resuscitation|Investigation of a Novel Turbine-driven Ventilator for Use in Cardiopulmonary Resuscitation|Completed||Early Phase 1|24|Actual|University of Utah||1|||f||||f||||||||No||2017-10-10 22:17:41.630204|2017-10-10 22:17:41.630204
NCT02743286|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-09-06|||April 2016||2016-04-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Sedentary Behavior Interrupted - A Pilot Study of Acute Interventions on Prolonged Sitting|Sedentary Behavior Interrupted - A Pilot Study of Acute Interventions on Prolonged Sitting|Completed||N/A|10|Actual|University of California, San Diego||4|||f||||t||||||||No||2017-10-10 22:17:41.692414|2017-10-10 22:17:41.692414
NCT02743273|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-04-18|||October 2015||2015-10-01|April 2016|2016-04-01||||August 2016|Anticipated|2016-08-01|3 Months|Observational [Patient Registry]|||Identification of Prognostic Urinary Biomarker for Acute Kidney Injury in Preterm Infants by Proteomics|Identification of Prognostic Urinary Biomarker for Acute Kidney Injury in Preterm Infants by Proteomics|Recruiting||N/A|30|Anticipated|Seoul National University Hospital|||1||f||||t||||||||Yes||2017-10-10 22:17:41.769584|2017-10-10 22:17:41.769584
NCT02743260|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-11-14|||April 2016||2016-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Drug Transporter Interaction Study PHENTRA_2015_KPUK|Single Centre in Vivo Cocktail Phenotyping Study on OATP1B1, OCT1/2, MATE1/2K, OAT1/3, and P-gp Drug Transporters in Healthy Volunteers|Active, not recruiting||Phase 4|24|Actual|University of Cologne||6|||f||||f||||||||Undecided||2017-10-10 22:17:41.838017|2017-10-10 22:17:41.838017
NCT02743247|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-04-14|||October 2015||2015-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy Adults|Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy Adults|Completed||Phase 1|18|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 22:17:41.952888|2017-10-10 22:17:41.952888
NCT02743234|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-11-20|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|August 2018|Anticipated|2018-08-01||Interventional|FACIT||Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection|Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection|Recruiting||Phase 3|64|Anticipated|University of Aarhus||3|||f||||t||||||||No||2017-10-10 22:17:42.037912|2017-10-10 22:17:42.037912
NCT02743221|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-10|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|TASCO1||A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy|An Open-label, Randomised, Non-comparative Phase 2 Study Evaluating S 95005 (TAS-102) Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Metastatic COlorectal Cancer Who Are Non-eligible for Intensive Therapy (TASCO1 Study).|Active, not recruiting||Phase 2|150|Anticipated|Servier||2|||f||||t|t|f|||t|||||2017-10-10 22:17:42.141877|2017-10-10 22:17:42.141877
NCT02743208|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-01-13|||January 2017||2017-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluation of a Short Femoral Stem in Total Hip Arthroplasty|Evaluation of a Short Femoral Stem in Total Hip Arthroplasty. A Comparative Study on Stability, Bone Remodelling and Patient Outcome.|Not yet recruiting||N/A|80|Anticipated|St. Olavs Hospital||2|||f||||f||||||||No||2017-10-10 22:17:42.448786|2017-10-10 22:17:42.448786
NCT02743195|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-08-02|||March 2016||2016-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Polyphenol/Prebiotic Blend Effects on GI Health and Microbial Composition|An Open Label Study to Investigate a Polyphenol/Prebiotic Blend on Microbial Composition in Otherwise Healthy Obese Males and Females|Completed||N/A|51|Actual|Pharmanex||1|||f||||f||||||||No||2017-10-10 22:17:42.535455|2017-10-10 22:17:42.535455
NCT02743182|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-14|||January 2015||2015-01-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients|HBsAg Loss Adding Pegylated Interferon Alfa-2a in HBeAg-negative Patients Treated With Nucleos(t)Ide Analogues.|Active, not recruiting||N/A|116|Anticipated|Parc de Salut Mar||2|||f||||f||||||||||2017-10-10 22:17:42.636868|2017-10-10 22:17:42.636868
NCT02743169|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-21|||April 1, 2017|Actual|2017-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|February 28, 2018|Anticipated|2018-02-28||Observational|||Improvement of Ambulance Response Times in Karachi, Pakistan|Spatial Analysis Optimization of Prehospital Services in Karachi, Pakistan to Improve Ambulance Response Times|Active, not recruiting||N/A|200|Anticipated|Johns Hopkins University|||2||f||||f||||||||||2017-10-10 22:17:42.704135|2017-10-10 22:17:42.704135
NCT02743156|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-04-24|||April 2016||2016-04-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|Mozart-II||Minimizing Contrast Utilization With IVUS Guidance in Coronary Angioplasty to Avoid Acute Nephropathy|Minimizing Contrast Utilization With IVUS Guidance in Coronary Angioplasty to Avoid Acute Nephropathy: The MOZART-II Study|Recruiting||Phase 4|300|Anticipated|InCor Heart Institute||2|||f||||f||||||||Undecided||2017-10-10 22:17:42.781102|2017-10-10 22:17:42.781102
NCT02743143|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-06-07|||December 2015||2015-12-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|LEXUS||Long-Term Exercise Training Therapy Versus Usual Care in Patients With Schizophrenia|Effectiveness of 1 Year Supervised Exercise Training Versus Usual Care on Cardiovascular Health, Functional Skills and Physical Fitness in Patients With Schizophrenia|Recruiting||N/A|60|Anticipated|St. Olavs Hospital||2|||f||||f||||||||No||2017-10-10 22:17:42.897383|2017-10-10 22:17:42.897383
NCT02743130|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-14|||September 2014||2014-09-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Berry Nectars Sweetened With Inverted Sugar on Post-meal Blood Sugar|Postprandial Glycemic Response to Berry Nectars Containing Inverted Sugar|Completed||N/A|18|Actual|University of Eastern Finland||3|||f||||f||||||||No||2017-10-10 22:17:43.008995|2017-10-10 22:17:43.008995
NCT02743117|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-10-02|2017-08-22||May 2, 2016|Actual|2016-05-02|October 2017|2017-10-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|FluMist|The intent-to-treat (ITT) population included all participants that were randomized and treated with investigational product.|Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season|A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults|Completed||Phase 4|301|Actual|MedImmune LLC||2|||f||||f|t|f||||||||2017-10-10 22:17:43.103908|2017-10-10 22:17:43.103908
NCT02743104|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-04-27|||May 2016||2016-05-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Ketamine vs Propofol for Sedation During Pediatric Bronchoscopy|Ketamine vs Propofol for Sedation During Pediatric Bronchoscopy|Suspended||N/A|150|Anticipated|Rabin Medical Center||2||Protocol being reconsidered|f||||f||||||||Yes|Group data will be published. No individual data will be made available.|2017-10-10 22:17:43.456148|2017-10-10 22:17:43.456148
NCT02743091|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-14|||January 2001||2001-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Idiopathic Pre-capillary Pulmonary Hypertension in ESKD Patients|Idiopathic Pre-capillary Pulmonary Hypertension in Patients With End-stage Kidney Disease|Completed||N/A|1988|Actual|Toujinkai Hospital|||1||f||||t||||||||No||2017-10-10 22:17:43.541549|2017-10-10 22:17:43.541549
NCT02743078|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-22|||April 12, 2017|Actual|2017-04-12|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma|Phase II Trial Of Optune® Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma|Recruiting||Phase 2|85|Anticipated|RTOG Foundation, Inc.||1|||f||||t|t|t|f|||||||2017-10-10 22:17:43.598151|2017-10-10 22:17:43.598151
NCT02743065|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-15|2016-04-27|||September 2016||2016-09-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|SUPER-China||HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China|Superselective Drug-Eluting Chemoembolization With HepaSphere in Unresectable Advanced HCC Patients: Safety & Efficacy Registry in China (SUPER-China)|Not yet recruiting||N/A|100|Anticipated|Fifth Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||||Undecided||2017-10-10 22:17:43.711429|2017-10-10 22:17:43.711429
NCT02743052|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-04-18|||October 2009||2009-10-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|OASIS-CANCER||Anticoagulation in Cancer Related Stroke|Optimal Anticoagulation Strategy In Stroke Related to CANCER (OASIS-CANCER Study)|Recruiting||N/A|400|Anticipated|Samsung Medical Center|||1||f||||f||||||||No||2017-10-10 22:17:43.82013|2017-10-10 22:17:43.82013
NCT02743039|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-11-09|||April 2016||2016-04-01|November 2016|2016-11-01|September 2022|Anticipated|2022-09-01|September 2020|Anticipated|2020-09-01||Interventional|NU2Gen||The Northwestern University Two-Generation Child and Family Outcomes Study of CAP Tulsa's CareerAdvance® Program|The Northwestern University Two-Generation Child and Family Outcomes Study of CAP Tulsa's CareerAdvance® Program|Recruiting||N/A|1000|Anticipated|Northwestern University||2|||f||||f||||||||Undecided||2017-10-10 22:17:43.895511|2017-10-10 22:17:43.895511
NCT02743026|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-22|||October 2015||2015-10-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||HIV and Sexually Transmitted Infection Prevention Intervention in the Northwest Territories|An Arts-based HIV and Sexually Transmitted Infection Prevention Intervention With Northern and Indigenous Youth in the Northwest Territories: Study Protocol for a Non-randomised Cohort Pilot Study|Recruiting||N/A|150|Anticipated|University of Toronto||1|||f||||f||||||||No|Small numbers in towns in the North make it difficult to share data without compromising confidentiality.|2017-10-10 22:17:43.99504|2017-10-10 22:17:43.99504
NCT02743013|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-08-22|||April 2016||2016-04-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers|Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993, Administered Via the Multi-dose Reservoir NEXThaler® Dry Powder Inhaler and Via a HFA-pressurised Metered Dose Inhaler With and Without Valved Holding Chamber, in Healthy Volunteers|Completed||Phase 1|50|Actual|Chiesi Farmaceutici S.p.A.||5|||f||||f||||||||||2017-10-10 22:17:44.095875|2017-10-10 22:17:44.095875
NCT02743000|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01||||August 2020|Anticipated|2020-08-01||Observational|||Food and the Brain|Emotion and Reward Processing in Binge Eating|Recruiting||N/A|60|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-10 22:17:44.185478|2017-10-10 22:17:44.185478
NCT02742987|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-18|2017-07-18||March 2014||2014-03-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Clopidogrel Versus Ticagrelor in Type-2 Diabetes|CLOpidogrel Versus TIcagreLor for Antiplatelet Maintenance in DIAbetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study|Completed||Phase 4|42|Actual|Campus Bio-Medico University||2|||f||||f||||||||||2017-10-10 22:17:44.271856|2017-10-10 22:17:44.271856
NCT02742974|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-04-14|||December 2015||2015-12-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|FROST||Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)|Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)|Recruiting||N/A|196|Anticipated|CAMC Health System||2|||f||||f||||||||No||2017-10-10 22:17:44.500548|2017-10-10 22:17:44.500548
NCT02742961|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-18|||April 2002||2002-04-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Impact of Peripheral Nerve Blockade on Outcomes After Total Knee Replacement|Impact of Peripheral Nerve Blockade on Outcomes After Total Knee Replacement|Completed||N/A|178214|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||||No||2017-10-10 22:17:44.619501|2017-10-10 22:17:44.619501
NCT02742948|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-14|||April 2016||2016-04-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section|The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section: Randomized Comparative Study|Not yet recruiting||Phase 2|600|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 22:17:44.687523|2017-10-10 22:17:44.687523
NCT02742935|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-12-14|||April 2016||2016-04-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects|An Open-Label, Single Center, Nonrandomized, Dose-Escalation Phase 1 Study to Evaluate Safety and Tolerability of SHR-1210 in Subjects With Advanced Solid Tumor|Enrolling by invitation||Phase 1|96|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||No||2017-10-10 22:17:44.760907|2017-10-10 22:17:44.760907
NCT02742922|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-04-25|||February 2016||2016-02-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|C-MAP||Multicenter Study to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP)|Multicenter RCT to Evaluate the Clinical and Cost-effectiveness of a Culturally Adapted Therapy (C-MAP) in Patients With a History of Self-harm|Recruiting||Phase 1|700|Anticipated|Pakistan Institute of Learning and Living||2|||f||||t||||||||Undecided||2017-10-10 22:17:44.831829|2017-10-10 22:17:44.831829
NCT02742909|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-07-12|||December 2015||2015-12-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease|Acute Effect of Recombinant Human Brain Natriuretic Peptide in Patients With Pulmonary Hypertension Associated With Acute Exacerbation of Chronic Pulmonary Disease|Recruiting||Phase 4|10|Anticipated|Shengjing Hospital||2|||f||||t||||||||||2017-10-10 22:17:44.936074|2017-10-10 22:17:44.936074
NCT02741375|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-15|||January 2014||2014-01-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Cerebral Oximetry As an Auxiliary Diagnostic Tool in the Diagnosis of Brain Death|Cerebral Oximetry As an Auxiliary Diagnostic Tool in the Diagnosis of Brain Death|Completed||Phase 4|78|Actual|Karadeniz Technical University|||2||f||||f||||||||Yes||2017-10-10 22:18:02.159367|2017-10-10 22:18:02.159367
NCT02742896|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2017-04-24|||December 2013||2013-12-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Observational|||Evaluation for Restoration of Erectile Dysfunction After Cardioversion Treatment Trial|Evaluation for Restoration of Erectile Dysfunction After Cardioversion Treatment Trial|Recruiting||N/A|358|Anticipated|Seoul St. Mary's Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:17:45.038455|2017-10-10 22:17:45.038455
NCT02742883|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|March 2019|Anticipated|2019-03-01||Interventional|||A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)|A Phase 2 Study of Atengenal (A-10) and Astugenal (AS2-1) in Diffuse, Intrinsic Pontine Glioma (DIPG)|Active, not recruiting||Phase 2|1|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-10 22:17:45.120771|2017-10-10 22:17:45.120771
NCT02742870|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-07-25|||April 2016||2016-04-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Diffusion MRI (Magnetic Resonance Imaging) Using ADC (Apparent Diffusion Coefficient) Histograms in the Evaluation of Adnexal Tumor Aggressiveness|Diffusion Magnetic Resonance Imaging Using ADC (Apparent Diffusion Coefficient) Histograms in the Evaluation of Adnexal Tumor Aggressiveness|Recruiting||N/A|100|Anticipated|Brugmann University Hospital|||1||f||||f||||||||||2017-10-10 22:17:45.337669|2017-10-10 22:17:45.337669
NCT02742857|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-06-15|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury|Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multimodality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury|Recruiting||Phase 1|20|Anticipated|Bioquark Inc.||1|||f||||t|f|f||||||Yes||2017-10-10 22:17:45.44493|2017-10-10 22:17:45.44493
NCT02742844|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-05-04|||August 2016||2016-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From Ulcers|An Interventional, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of APZ2 on Wound Healing of Chronic Venous Ulcer (CVU)|Recruiting||Phase 1/Phase 2|37|Anticipated|Rheacell GmbH & Co. KG||1|||f||||f||||||||Undecided||2017-10-10 22:17:45.540943|2017-10-10 22:17:45.540943
NCT02742831|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-03|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Pilot Intervention With Families of Children With Special Health Care Needs|A Theory-Based Intervention to Prevent Child Neglect in High-Risk|Recruiting||N/A|60|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:17:45.645582|2017-10-10 22:17:45.645582
NCT02742818|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-18|||September 2014||2014-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Interventional|||Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models|Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models|Completed||N/A|50|Actual|Hospital Israelita Albert Einstein||2|||f||||f||||||||||2017-10-10 22:17:45.7565|2017-10-10 22:17:45.7565
NCT02742805|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-03-08|||February 2016||2016-02-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation|Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation|Recruiting||Phase 4|20|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 22:17:45.840678|2017-10-10 22:17:45.840678
NCT02742792|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-10-07|||April 2016||2016-04-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Strength Training on Sleep Apnea in the Elderly|Effect of Strength Training on Sleep Apnea in the Elderly|Enrolling by invitation||N/A|40|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:17:45.931999|2017-10-10 22:17:45.931999
NCT02742779|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-02-24|||September 2015||2015-09-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy Volunteers|A Phase I, Randomized, Single and Multiple Ascending Dose, Placebo-Controlled, Double-Blind Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy Volunteers|Completed||Phase 1|95|Actual|Genentech, Inc.||10|||f||||||||||||||2017-10-10 22:17:46.021699|2017-10-10 22:17:46.021699
NCT02742766|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-08-09|||March 14, 2016|Actual|2016-03-14|August 2017|2017-08-01|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Interventional|||Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects|A Phase I, Randomized, Placebo-Controlled, Double-Blind (Sponsor Unblind), Three Part Study to Evaluate the Safety, Tolerability, Preliminary PK and PD of Single and Repeat Oral Doses of GSK3008356 in Healthy Subjects and Obese Subjects|Completed||Phase 1|104|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:17:46.123675|2017-10-10 22:17:46.123675
NCT02742753|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-21|||June 16, 2016|Actual|2016-06-16|September 2017|2017-09-01|September 14, 2017|Actual|2017-09-14|May 18, 2017|Actual|2017-05-18||Observational|||Impact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish Children|Impact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish Children|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-10 22:17:46.251937|2017-10-10 22:17:46.251937
NCT02742740|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-10-03|||September 1, 2017|Actual|2017-09-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials|Embodied Conversational Agent (ECA) as an Oncology Trial Advisor|Enrolling by invitation||N/A|50|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:17:46.338162|2017-10-10 22:17:46.338162
NCT02742727|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-12-04|||March 2016||2016-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma|Chimeric Antigen Receptor-Modified pNK Cells for CD7 Positive Relapsed or Refractory Leukemia and Lymphoma|Recruiting||Phase 1/Phase 2|10|Anticipated|PersonGen BioTherapeutics (Suzhou) Co., Ltd.||1|||f||||t||||||||Yes||2017-10-10 22:17:46.418145|2017-10-10 22:17:46.418145
NCT02742714|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-09-17|||July 2016||2016-07-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|PIANO||PillCam SBC System Functionality in Established and Suspected IBD Patients|Evaluation of PillCam SBC Capsule Endoscopy System Performance in Established and Suspected IBD Patients to Assess System Functionality by Visualizing and Assessing the Small Bowel and Colon|Completed||N/A|54|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-10 22:17:46.525951|2017-10-10 22:17:46.525951
NCT02742701|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-13|||April 2016||2016-04-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|DIAPAL||Diabetes and Palliative Care|Comparison of Glycosuria and Capillary Blood Glucose in Hospitalised Diabetic Patients|Not yet recruiting||N/A|180|Anticipated|Maison Médicale Jeanne Garnier|||1||f||||f||||||||No||2017-10-10 22:17:46.61199|2017-10-10 22:17:46.61199
NCT02742688|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-14|||March 2016||2016-03-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Effect of Intake of Pyrus Pyrifolia Var. Culta(Makino) NaKai Peel Extract on Body Fat and Blood Lipid.||Active, not recruiting||Phase 2/Phase 3|70|Actual|Hanyang University||2|||f||||t||||||||Undecided||2017-10-10 22:17:46.673036|2017-10-10 22:17:46.673036
NCT02742675|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-14|||March 2016||2016-03-01|April 2016|2016-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)|An Open-label、Randomized Prospective Phase II Trial of Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) of the Primary Tumor in Oligometastatic Prostate Cancer|Recruiting||Phase 2|200|Anticipated|Fudan University||2|||f||||f||||||||No||2017-10-10 22:17:46.749082|2017-10-10 22:17:46.749082
NCT02742662|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-08-15|||April 2016||2016-04-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|June 2017|Actual|2017-06-01||Interventional|||Smart Technology for Weight Loss and Metabolic Health|Smart Technology for Weight Loss and Metabolic Health- A Randomized Controlled Trial|Active, not recruiting||N/A|40|Anticipated|Temple University||2|||f||||f||||||||||2017-10-10 22:17:46.864637|2017-10-10 22:17:46.864637
NCT02742649|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-02-14|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Subjects With Open-angle Glaucoma or Ocular Hypertension|A Phase 1B, Multicenter, Randomized, Double-masked, Controlled Study to Evaluate the Efficacy and Safety of a Fixed Combination Bimatoprost/Timolol Ocular Insert Compared to Its Individual Components With Crossover to Timolol 0.5% in Subjects With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)|Completed||Phase 1/Phase 2|66|Actual|ForSight Vision5, Inc.||3|||f||||f||||||||No||2017-10-10 22:17:46.952672|2017-10-10 22:17:46.952672
NCT02742636|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-08-22|||May 31, 2016|Actual|2016-05-31|August 2017|2017-08-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|MUCH||When is the Best Moment to Remove the Urinary Catheter After Laparoscopic Hysterectomy?|When is the Best Moment to Remove the Urinary Catheter After Laparoscopic Hysterectomy: MUCH Study.|Completed||N/A|162|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 22:17:47.034746|2017-10-10 22:17:47.034746
NCT02742610|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-05-22|||November 2015||2015-11-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Smoking Cessation Intervention for Smokers With Depression Receiving Outpatient Psychiatric Treatment|Brief Mindfulness Cessation Training With EMA for Post-hospital Depressed Smokers|Recruiting||N/A|60|Anticipated|Fordham University||2|||f||||f||||||||Undecided||2017-10-10 22:17:47.246738|2017-10-10 22:17:47.246738
NCT02742597|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-05-03|||January 2016||2016-01-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|PACEinMM-ON||Patient-Centred Innovations for Persons With Multimorbidity - Ontario|Patient-Centred Innovations for Persons With Multimorbidity - Ontario|Recruiting||N/A|1980|Anticipated|Lawson Health Research Institute||4|||f||||f||||||||Yes|De-identified subsets of data will be transferred upon request to healthcare providers at collaborating institutions under separate ethics approvals as/if required. Any transfers will be conducted by secure file transfer between encrypted devices. Any health information transferred will be de-identified.|2017-10-10 22:17:47.344204|2017-10-10 22:17:47.344204
NCT02742584|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-19|||August 2012||2012-08-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Standardization of Cough Stress Test|A Randomized Comparative Study Correlating Cough Stress Test With Urodynamics And 24 Hour Pad Test In the Evaluation of Stress Urinary Incontinence|Completed||N/A|140|Actual|University Hospitals Cleveland Medical Center||4|||f||||t||||||||No||2017-10-10 22:17:47.499284|2017-10-10 22:17:47.499284
NCT02742571|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-06-24|||April 2016||2016-04-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|||Validation of PINI Score in ICU|Validation of PINI Score in ICU|Recruiting||N/A|10|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 22:17:47.594867|2017-10-10 22:17:47.594867
NCT02742558|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-06-15|||April 2016|Actual|2016-04-01|October 2016|2016-10-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine|A Randomized Observer Blinded Controlled Non Inferiority Trial to Evaluate the Safety and Immunogenicity of Locally Manufactured Inactivated Bivalent Whole Cell-oral Cholera Vaccine (WC-OCV) 'Cholvax' in Bangladeshi Healthy Adults and Children|Completed||Phase 2|2052|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||Yes|Data will be shared with International Vaccine Institute|2017-10-10 22:17:47.705354|2017-10-10 22:17:47.705354
NCT02742545|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-18|||April 2016||2016-04-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|MEA Research||Impact of MayoExpertAdvisor on Provider Adherence|Impact of MayoExpertAdvisor (MEA) on Provider Adherence to Guideline Recommended Treatment for Hyperlipidemia, Atrial Fibrillation, and Heart Failure|Enrolling by invitation||N/A|327|Anticipated|Mayo Clinic||2|||f||||f||||||||No|Patient identifiers will be removed from the data prior to submission to the researchers.|2017-10-10 22:17:47.827545|2017-10-10 22:17:47.827545
NCT02742532|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress|Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress|Not yet recruiting||N/A|80|Anticipated|University of California, San Francisco||2|||f||||t||||||||No||2017-10-10 22:17:47.946458|2017-10-10 22:17:47.946458
NCT02742519|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-10-04|||May 2016||2016-05-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Study to Evaluate Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Aged 3 Through 5 Years Who Have a Specified CFTR Gating Mutation|A Phase 3b, 2-part, Randomized, Double-blind, Placebo-controlled Crossover Study With a Long-term Open-label Period to Investigate Ivacaftor in Subjects With Cystic Fibrosis Aged 3 Through 5 Years Who Have a Specified CFTR Gating Mutation|Terminated||Phase 3|14|Actual|Vertex Pharmaceuticals Incorporated||3||Low enrollment.|f||||t||||||||||2017-10-10 22:17:48.073036|2017-10-10 22:17:48.073036
NCT02742506|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-10-04|||June 25, 2013|Actual|2013-06-25|October 2017|2017-10-01|June 25, 2019|Anticipated|2019-06-25|June 25, 2019|Anticipated|2019-06-25||Interventional|MUSICOREVEIL||Beneficial Effects of Music on Cognition and Consciousness Level|Beneficial Effects of Music on Cognition and Consciousness Level|Recruiting||N/A|240|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:17:48.212193|2017-10-10 22:17:48.212193
NCT02742493|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-10-25|||April 2016||2016-04-01|October 2016|2016-10-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|OrthRe10tion||RCT for the Effectiveness of 3 Orthodontic Retention Schemes on Post-treatment Stability and Gingival Recession|A Single-center, 3-arm, Parallel-group Randomized Controlled Trial to Evaluate the Effectiveness of Three Orthodontic Retention Schemes in Preventing Post-treatment Mandibular Arch Changes and Gingival Recession in Children and Adolescents|Recruiting||N/A|60|Anticipated|University of Athens||3|||f||||f||||||||Yes||2017-10-10 22:17:48.334568|2017-10-10 22:17:48.334568
NCT02742480|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01||||April 2017|Anticipated|2017-04-01||Observational|SEDMAN||Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)|Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)|Not yet recruiting||N/A|500|Anticipated|Hospital Mutua de Terrassa|||2||f||||||||||||||2017-10-10 22:17:48.482287|2017-10-10 22:17:48.482287
NCT02742467|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-18|||July 2016||2016-07-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|Creole||Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans|Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans|Not yet recruiting||Phase 4|702|Anticipated|University of Abuja||3|||f||||t||||||||||2017-10-10 22:17:48.585658|2017-10-10 22:17:48.585658
NCT02742454|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-05-25|||June 2016||2016-06-01|May 2017|2017-05-01|June 2023|Anticipated|2023-06-01|June 2021|Anticipated|2021-06-01||Interventional|||VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants|VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants|Recruiting||Phase 3|940|Anticipated|University of Virginia||2|||f||||t||||||||No||2017-10-10 22:17:48.712925|2017-10-10 22:17:48.712925
NCT02742428|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-04-29|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer|Preoperative Slow Ascites Drainage Versus Standard Care for Patients With Proven or Suspected Advanced Ovarian Cancer - a Hemodynamic Impact on Systemic Circulation, Patient's Nutritional Status and Quality of Life: a Randomized Trial.|Suspended||N/A|40|Anticipated|Gdynia Oncology Center||2||The protocol will be discussed and consulted. Potentially will resume.|f||||f|f|f||||||No||2017-10-10 22:17:49.043601|2017-10-10 22:17:49.043601
NCT02742415|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-03-06|||May 2016||2016-05-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Caring Hand Massage - an Intervention in Cancer Patients Undergoing Chemotherapy in an Outpatient Setting - a Pilot Study|Caring Hand Massage - an Intervention in Cancer Patients Undergoing Chemotherapy in an Outpatient Setting - a Pilot Study|Completed||N/A|40|Actual|Mayo Clinic||1|||f||||f||||||||Yes||2017-10-10 22:17:49.179744|2017-10-10 22:17:49.179744
NCT02742402|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-08-08|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|DIAMOND||DIAgnostic iMaging or Observation in Early Equivocal appeNDicitis|DIAgnostic iMaging or Observation in Early Equivocal appeNDicitis - a Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-10 22:17:49.276021|2017-10-10 22:17:49.276021
NCT02742389|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-02-01|||April 2016||2016-04-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Urodynamic Testing: Can we Improve Patient Experience?|An Intervention to Decrease Patient's Anxiety Prior to Urodynamic Testing: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Boston Urogynecology Associates||2|||f||||f||||||||No||2017-10-10 22:17:49.484987|2017-10-10 22:17:49.484987
NCT02742376|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-02-12|||April 2017|Anticipated|2017-04-01|February 2016|2016-02-01||||April 2018|Anticipated|2018-04-01||Interventional|||Comparison of Gait Parameters Between Floor and Sponge Surfaces and Special Shoes|Comparison of Gait Parameters Between Floor and Sponge Surfaces and Special Shoes in Individuals With Difficulties in Weight-bearing|Not yet recruiting||N/A|40|Anticipated|Hadassah Medical Organization||3|||f||||f|f|f||||||||2017-10-10 22:17:49.587912|2017-10-10 22:17:49.587912
NCT02742363|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-12-18|||December 2016||2016-12-01|December 2016|2016-12-01||||April 2018|Anticipated|2018-04-01||Observational|||Long Term Dental Effects in Adolescents Who Were Treated for Cancer in Childhood||Recruiting||N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-10-10 22:17:49.696595|2017-10-10 22:17:49.696595
NCT02742350|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-04-27|||September 10, 2015|Actual|2015-09-10|April 2017|2017-04-01|December 30, 2016|Actual|2016-12-30|September 30, 2016|Actual|2016-09-30||Interventional|||Effects of Muscle Trainins Inspiratory Linked to Cardiac Rehabilitation Post-operative of CABG Surgery|Effects of Inspiratory Muscle Training Hihg Intensity Linked to Cardiac Rehabilitation in Patients on Exercise Performance in the Post-operative of Coronary Artery Bypasssurgery: a Randomized Clinical Trial|Completed||N/A|20|Actual|Federal University of Health Science of Porto Alegre||2|||f||||f||||||||No||2017-10-10 22:17:49.785727|2017-10-10 22:17:49.785727
NCT02742337|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-04-14|||October 2015||2015-10-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease|Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease|Recruiting||N/A|30|Anticipated|Arthritis Northwest PLLC|||2||f||||f||||||Samples With DNA|"     Specimens Collected:        1. Blood: Monocytes        2. Mucosal Swab: Buccal cells   "|No||2017-10-10 22:17:49.888159|2017-10-10 22:17:49.888159
NCT02742324|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|RUXOPeg||Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg|Phase 1/2 Randomized Trial Combination of Ruxolitinib and Peg-interferon Alpha-2a in Patients With Primary Myelofibrosis Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis|Recruiting||Phase 1/Phase 2|42|Anticipated|French Innovative Leukemia Organisation||1|||f||||t||||||||Yes|e crf|2017-10-10 22:17:49.989505|2017-10-10 22:17:49.989505
NCT02742311|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-07-25|||January 2016||2016-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|EPCSV||EuroPainClinics® Study V (Prospective Observational Study)|EuroPainClinics® Study V (Prospective Observational Study)|Recruiting||N/A|500|Anticipated|Europainclinics z.ú.||2|||f||||t||||||||||2017-10-10 22:17:50.171897|2017-10-10 22:17:50.171897
NCT02742298|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-03-24|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|||Pompe Disease QMUS and EIM|Electrical Impedance Myography and Muscle Ultrasound: Longitudinal Measures in Pompe Disease|Recruiting||N/A|25|Anticipated|Duke University||2|||f||||f||||||||No||2017-10-10 22:17:50.285708|2017-10-10 22:17:50.285708
NCT02742285|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-05-25|||May 2016||2016-05-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Lumefantrine in Venous Plasma Versus Dried Capillary Blood Spot|Comparison of Lumefantrine Concentrations Measured in Venous Plasma Versus in Dried Capillary Blood Spot Samples in Healthy Volunteers.|Recruiting||Phase 4|16|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||Yes||2017-10-10 22:17:50.39227|2017-10-10 22:17:50.39227
NCT02742272|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-04-13|||September 2015||2015-09-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Clinical Decision Rule for Pediatric Intracranial Pathology|Development of a Clinical Decision Rule to Identify Pediatric Patients With Headache at Low Risk for Intra-cranial Pathology|Recruiting||N/A|500|Anticipated|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||No||2017-10-10 22:17:50.524788|2017-10-10 22:17:50.524788
NCT02742259|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-13|||May 2016||2016-05-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Observational|VPCA-B+PIV||Validation of the Prostate Cancer Assay - Beta+Pivotal|Prospective, Multi-Center Validation of the Prostate Cancer Assay|Not yet recruiting||N/A|375|Anticipated|Celsee Diagnostics|||2||f||||f||||||None Retained|"     10 ml blood draws   "|No||2017-10-10 22:17:50.623657|2017-10-10 22:17:50.623657
NCT02742246|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-04-24|||March 1, 2017|Actual|2017-03-01|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Efficacy and Mechanisms of CBT4CBT for Alcohol Use Disorders|Efficacy and Mechanisms of CBT4CBT for Alcohol Use Disorders|Recruiting||N/A|180|Anticipated|Yale University||3|||f||||t|f|f||||||No||2017-10-10 22:17:50.701437|2017-10-10 22:17:50.701437
NCT02742233|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-08-06|||November 2015||2015-11-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|DPP4i||Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers|A Controlled Clinical Trial of Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers|Recruiting||Phase 4|60|Anticipated|Xinqiao Hospital of Chongqing||2|||f||||t||||||||||2017-10-10 22:17:50.814303|2017-10-10 22:17:50.814303
NCT02742220|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-07-08|||March 2016||2016-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Isometric Handgrip Training on Blood Pressure of Peripheral Artery Disease Patients|Effects of Isometric Handgrip Training on Blood Pressure Reduction in Patients With Peripheral Artery Disease: A Randomized Clinical Trial|Recruiting||N/A|90|Anticipated|University of Pernambuco||2|||f||||f||||||||||2017-10-10 22:17:50.945581|2017-10-10 22:17:50.945581
NCT02742207|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2016-04-15|||May 2016||2016-05-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|AFCARD-II||Renal Function Post Cardioversion for Atrial Fibrillation|Evaluation of Renal Function and Fluid Balance of Patient Undergoing Electrical Cardioversion for Atrial Fibrillation|Not yet recruiting||N/A|150|Anticipated|Hadassah Medical Organization|||1||f||||t||||||||No||2017-10-10 22:17:51.057821|2017-10-10 22:17:51.057821
NCT02742194|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-04-13|||August 2015||2015-08-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Ginger Capsules for the Chronic Treatment of Obesity|Double-blind Placebo-controlled Clinical Trial of Ginger (Zingiber Officinale) Addition in the Obesity Treatment and Improvement Behavioral Profile|Recruiting||Phase 2|84|Anticipated|Federal University of Minas Gerais||2|||f||||t||||||||No||2017-10-10 22:17:51.134195|2017-10-10 22:17:51.134195
NCT02742181|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-13|||May 2016||2016-05-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Alvimopan as Rescue in Post op Ileus|A Prospective Randomized Control Trial of The Effectiveness of Entereg as a Rescue Treatment of Postoperative Ileus Following Colorectal Surgery|Not yet recruiting||Phase 3|142|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||No||2017-10-10 22:17:51.249775|2017-10-10 22:17:51.249775
NCT02742168|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-04-13|||January 2016||2016-01-01|April 2016|2016-04-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||99mTc-3PRGD2 SPECT/CT in Breast Cancer Patients|Clinical Study of 99mTc-3PRGD2 SPECT/CT in Diagnosis and Efficacy Evaluation of Breast Cancer|Recruiting||Early Phase 1|20|Anticipated|First Affiliated Hospital of Fujian Medical University||1|||f||||t||||||||Yes||2017-10-10 22:17:51.430955|2017-10-10 22:17:51.430955
NCT02742155|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-13|||May 2016||2016-05-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Play2Sleep: Using Play to Improve Infant Sleep|Play2Sleep: A Sequential Explanatory Mixed Methods Study of Using Infant Play to Improve Infant Sleep in Families Experiencing Infant Sleep Disturbance|Not yet recruiting||N/A|120|Anticipated|University of Calgary||2|||f||||f||||||||Yes|Following study completion, de-identified data will be submitted to the Child Data Centre of Alberta, a research and data facility operating under the authority of the Alberta Centre for Child, Family and Community Research.|2017-10-10 22:17:51.544538|2017-10-10 22:17:51.544538
NCT02742142|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-15|||October 2012||2012-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Fluoride Application on Preventing and Arresting Root Caries in Fluoridated and Non-fluoridated Areas|Randomized Clinical Trial on Preventing and Arresting Root Surface Caries Using Silver Diammine Fluoride Solution in Older Adults Living in Fluoridated and Non-fluoridated Areas|Completed||Phase 2/Phase 3|534|Actual|The University of Hong Kong||2|||f||||f||||||||No|Will consider individual request case by case|2017-10-10 22:17:51.63718|2017-10-10 22:17:51.63718
NCT02742129|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-01-20|||August 2016||2016-08-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|INDIE-HFpEF||Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF|Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF|Recruiting||Phase 2|100|Anticipated|Duke University||2|||f||||t||||||||Yes|After study completion, and upon site request, site specific participant data will be shared upon site requests. Sites may share this data with participants according to their individual institution's Institutional Review Board (IRB) policy.|2017-10-10 22:17:51.74811|2017-10-10 22:17:51.74811
NCT02742116|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-11-01|||July 2016||2016-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Evaluation of the Implementation of Expanded Carrier Screening Before Pregnancy in Hong Kong|Evaluation of the Implementation of Expanded Carrier Screening Before Pregnancy in Hong Kong|Completed||N/A|100|Actual|The University of Hong Kong|||1||f||||f||||||Samples With DNA|"     Saliva/swab shall be collected from patient/couple for Hereditary Disease DNA screening test     by DrGene.      Blood sample shall be taken by venipuncture of women for Fragile X carrier screening by     Prenatal Diagnostic Laboratory, Tsan Yuk Hospital   "|No||2017-10-10 22:17:51.959269|2017-10-10 22:17:51.959269
NCT02742103|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-09|||August 2016||2016-08-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction|A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction|Completed||Phase 2|83|Actual|CSL Behring||2|||f||||t||||||||||2017-10-10 22:17:52.021347|2017-10-10 22:17:52.021347
NCT02742090|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-26|||April 2016||2016-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluate the Efficacy and Safety of TGR-1202 in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy|A Phase 2 Study to Assess the Safety and Efficacy of TGR-1202 in Patients With Chronic Lymphocytic Leukemia (CLL) Who Are Intolerant to Prior BTK (Bruton Tyrosine Kinase) or PI3K-Delta (Phosphoinositide-3-kinase) Inhibitor Therapy|Recruiting||Phase 2|50|Anticipated|TG Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 22:17:52.176515|2017-10-10 22:17:52.176515
NCT02742077|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-12-15|||March 2016||2016-03-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|RAPID II||Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II|CorPath® 200 RAPID II Study (Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease)|Completed||N/A|20|Actual|Corindus Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:17:52.288689|2017-10-10 22:17:52.288689
NCT02742064|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-07-27|||February 2015||2015-02-01|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression|Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression|Active, not recruiting||N/A|899|Actual|Cogito Health Inc|||3||f||||f||||||||||2017-10-10 22:17:52.369222|2017-10-10 22:17:52.369222
NCT02742051|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-05-09|||June 2016||2016-06-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer|A Randomised Pilot Study of Neoadjuvant Everolimus Plus Letrozole Compared With FEC in Postmenopausal Patients With ER-positive, HER2-negative Breast Cancer|Recruiting||Phase 2|40|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||Undecided||2017-10-10 22:17:52.457557|2017-10-10 22:17:52.457557
NCT02742038|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-13|||March 2012||2012-03-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Effectiveness of Fluoride Varnish in the Prevention of Early Childhood Caries: A Randomized Controlled Trial|Effectiveness of Fluoride Varnish in the Prevention of Early Childhood Caries in Non-fluoridated Areas: A 24-month Randomized Controlled Trial|Completed||Phase 4|277|Actual|Universidad de la Frontera||2|||f||||t||||||||Yes||2017-10-10 22:17:52.575365|2017-10-10 22:17:52.575365
NCT02742025|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-13|||April 2017||2017-04-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|HEART-LINK||Effect of an Educational and Explanatory Program for a Surgical Act on Preoperative Anxiety|Evaluation of the Effect of an Educational and Explanatory Program for a Surgical Act Provided to the Patient Prior to Said Act on Preoperative Anxiety - a Pilot Study at the Nîmes University Hospital on Elective Coronary Angiography|Not yet recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 22:17:52.733294|2017-10-10 22:17:52.733294
NCT02742012|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-04-24|||June 2015||2015-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Validation of a Multimodal Indicator of Depth of Anesthesia|A Multicenter Validation Study of a Multimodal Indicator of Anesthesia Calculated From the Electroencephalogram and Standard Monitoring Parameters|Recruiting||N/A|250|Anticipated|Technische Universität München|||1||f||||t||||||||||2017-10-10 22:17:52.853151|2017-10-10 22:17:52.853151
NCT02741999|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-19|||April 2016||2016-04-01|September 2017|2017-09-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Observational|SAVE||A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early|A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early|Recruiting||N/A|200|Anticipated|Tufts Medical Center|||1||f||||f||||||||||2017-10-10 22:17:52.960157|2017-10-10 22:17:52.960157
NCT02741986|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-12-14|||October 2016||2016-10-01|December 2016|2016-12-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Observational|IDEALIST||Integrating Data, Algorithms and Clinical Reasoning for Surgical Risk Assessment|Integrating Data, Algorithms and Clinical Reasoning for Surgical Risk Assessment (IDEALIST)|Recruiting||N/A|60|Anticipated|University of Florida|||2||f||||f||||||||Yes|All deidentified data will be governed by University of Florida Integrated Data Repository. The investigators will comply with local, state, and federal laws, such as the Privacy Rule, a Federal regulation under the Health Insurance Portability and Accountability Act (HIPAA). The investigators will follow the general NIH data sharing guidance and provide a data sharing plan to be reviewed and approved by the relevant NIGMS Program Officer.|2017-10-10 22:17:53.046972|2017-10-10 22:17:53.046972
NCT02741973|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-03-21|||March 2016||2016-03-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|January 2017|Actual|2017-01-01||Interventional|||Yoga in School Sports - a Pilot Study in Germany|Yoga in School Sports - a Non-randomized Controlled Pilot Study in Germany|Active, not recruiting||N/A|102|Actual|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 22:17:53.140674|2017-10-10 22:17:53.140674
NCT02741960|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|Met Lupus||The Effect of Metformin on Reducing Lupus Flares|A Multicenter, Randomised, Double-blind Placebo Controlled Trial on the Efficacy and Safety of add-on Metformin to Conventional Immunosuppressants in Systemic Lupus Erythematosus|Recruiting||Phase 4|180|Anticipated|RenJi Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:17:53.210894|2017-10-10 22:17:53.210894
NCT02741947|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-14|||April 2014||2014-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Levodopa Benserazide Generic Formulation Versus the Originator|Clinical and Pharmacokinetics Study to Evaluate the Therapeutic Equivalence and Bioequivalence of Levodopa Benserazide Generic Formulation (Teva Italia) Versus the Originator (Madopar®)|Completed||Phase 4|44|Actual|IRCCS San Raffaele||2|||f||||t||||||||No||2017-10-10 22:17:53.301789|2017-10-10 22:17:53.301789
NCT02741921|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-15|||November 2015||2015-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Conventional Double-lumen Tube vs VivaSight DL|Ability of Anesthesiologist to Placid a Double-lumen Tube. A Randomized Crossover Cadaver Study Comparing VivaSight DL and Conventional Double-lumen Tube|Completed||N/A|27|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-10 22:17:53.450278|2017-10-10 22:17:53.450278
NCT02741908|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-04-15|||July 2011||2011-07-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Fixed Diet Plan and Calorie Counting Diet in Adolescents|Effects of Two Diet Techniques and Delivery Mode on Weight Loss, Metabolic Profile and Food Intake of Obese Adolescents: a Fixed Diet Plan and a Calorie Counting Diet|Completed||N/A|66|Actual|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 22:17:55.614282|2017-10-10 22:17:55.614282
NCT02741895|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-22|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Using Fitbit to Monitor Ambulation in Patients After Surgery.|Using Wearable Biosensors to Monitor Ambulation After Major Surgery: Optimizing Efficiency of Postoperative Recovery|Recruiting||N/A|140|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 22:17:55.784365|2017-10-10 22:17:55.784365
NCT02741882|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-02-18|||February 2016||2016-02-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Observational|||Zika and Microcephaly: Case-control Study|Rash Accompanied by Three or More Dengue-like Symptoms During Pregnancy and Microcephaly: Case-control Study|Completed||N/A|110|Actual|Laboratório Sabin|||2||f||||f||||||||No||2017-10-10 22:17:55.90206|2017-10-10 22:17:55.90206
NCT02741869|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-04-18|||May 2016||2016-05-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Photodisinfection for the Decolonization of Staphylococcus Aureus in Hemodialysis Patients|Photodisinfection for the Decolonization of Staphylococcus Aureus in Hemodialysis Patients|Not yet recruiting||Phase 3|30|Anticipated|McMaster University||1|||f||||f||||||||No||2017-10-10 22:17:56.003855|2017-10-10 22:17:56.003855
NCT02741856|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-09-20|||June 2016||2016-06-01|September 2016|2016-09-01|April 2023|Anticipated|2023-04-01|April 2021|Anticipated|2021-04-01||Interventional|SCOPE2||Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation|SCOPE2 - A Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients With Oesophageal Cancer Treated With Definitive Chemo-radiation With an Embedded Phase II Trial for Patients With a Poor Early Response Using Positron Emission Tomography (PET)|Recruiting||Phase 2/Phase 3|584|Anticipated|Velindre NHS Trust||4|||f||||t||||||||Undecided||2017-10-10 22:17:56.080321|2017-10-10 22:17:56.080321
NCT02741843|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-05|||October 2015||2015-10-01|May 2016|2016-05-01||||November 2015|Actual|2015-11-01||Interventional|||Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly|Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly: A Randomised Controlled Trial|Completed||N/A|||The University of Hong Kong||2|||f||||||||||||||2017-10-10 22:17:56.211553|2017-10-10 22:17:56.211553
NCT02741830|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-06-05|||April 7, 2016|Actual|2016-04-07|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Uterosacral Ligament Suspension vs Robotic Sacrocolpopexy|Long Term Outcomes of Uterosacral Ligament Suspension Versus Robotic Sacrocolpopexy|Recruiting||N/A|246|Anticipated|TriHealth Inc.|||2||f||||f||||||||No||2017-10-10 22:17:56.283312|2017-10-10 22:17:56.283312
NCT02741817|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-04-24|||June 26, 2016|Actual|2016-06-26|April 2017|2017-04-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|WILLOW ACS||WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW - ACS)|WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW - ACS)|Completed||Phase 4|20|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:17:56.372085|2017-10-10 22:17:56.372085
NCT02741804|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-06-23|||May 2016||2016-05-01|June 2016|2016-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Lifestyle Intervention Program for Cognitive Impairment|A Multi-domain Lifestyle Intervention Protocol to Detect Changes in Retinal Amyloid Among Individuals With Mild Cognitive Impairment|Not yet recruiting||N/A|150|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||No||2017-10-10 22:17:56.501382|2017-10-10 22:17:56.501382
NCT02741791|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-24|||March 2016||2016-03-01|August 2017|2017-08-01||||September 2017|Anticipated|2017-09-01||Interventional|STRIDE-1||A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder|STRIDE-1: A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects With Treatment Resistant Major Depressive Disorder|Recruiting||Phase 3|350|Anticipated|Axsome Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:17:56.616797|2017-10-10 22:17:56.616797
NCT02741778|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-04-14|||January 2015||2015-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction|Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction|Enrolling by invitation||N/A|120|Anticipated|Anhui Provincial Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:17:56.979452|2017-10-10 22:17:56.979452
NCT02741765|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-05|||November 2015||2015-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Exercise and Transcranial Magnetic Stimulation: Increasing Brain Plasticity in Parkinson's Disease|Exercise and Transcranial Magnetic Stimulation: Increasing Brain Plasticity in Parkinson's Disease|Recruiting||N/A|24|Anticipated|New York University School of Medicine||2|||||||f|f|t|f|f|f|||||2017-10-10 22:17:57.087226|2017-10-10 22:17:57.087226
NCT02741752|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-15|||January 2015||2015-01-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Influence of Cortical Bone Perforation on Guided Bone Regeneration in Humans|The Influence of Cortical Bone Perforation on Guided Bone Regeneration in Humans: A Randomized Clinical Trial|Completed||N/A|14|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||Undecided|AA|2017-10-10 22:17:57.224497|2017-10-10 22:17:57.224497
NCT02741739|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-10-13|||March 2016||2016-03-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects|A Randomized, Open-Label, Parallel Group Study of the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of REGN1033 Produced From Two Different Cell Lines in Healthy Subjects|Completed||Phase 1|28|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:17:57.302175|2017-10-10 22:17:57.302175
NCT02741726|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-07-10|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Analgesia by Single or Dual Acupoints Stimulation After Radical Breastectomy|Efficiency of Acupuncture-assisted Anesthesia With Single Acupoint or Dual Acupoints in Patients Undergoing Radical Operation of Breast Cancer: A Multi-center, Randomized, Double-blinded, Controlled Clinical Trial Study Type:Interventional|Recruiting||N/A|591|Anticipated|Fourth Military Medical University||3|||f||||||||||||||2017-10-10 22:17:57.411984|2017-10-10 22:17:57.411984
NCT02741713|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-06-29|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery|Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery|Completed||Phase 3|40|Actual|Wake Forest University Health Sciences||2|||f||||f|t|f|||f|||||2017-10-10 22:17:57.535397|2017-10-10 22:17:57.535397
NCT02741700|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-08-07|||May 31, 2017|Actual|2017-05-31|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|June 30, 2020|Anticipated|2020-06-30||Interventional|STRIDE-GO 2||SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO 2 Study|STorytelling to Improve DiseasE Outcomes in GoUT: The STRIDE-GO Study|Recruiting||N/A|300|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:17:57.707019|2017-10-10 22:17:57.707019
NCT02741687|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-01-03|||June 2016||2016-06-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Sitagliptin in Non-Diabetic Patients Undergoing General Surgery|Prevention of Stress Hyperglycemia With the Use of DPP-4 Inhibitors in Non-diabetic Patients Undergoing Non-cardiac Surgery, a Pilot Study|Recruiting||Phase 4|80|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 22:17:57.855606|2017-10-10 22:17:57.855606
NCT02741661|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-09-26|||July 2015||2015-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Influence of Myocardial Shortening on Coronary Tortuosity|Determinants of Coronary Tortuosity|Completed||N/A|70|Actual|Oregon Health and Science University|||2||f||||f||||||||Yes||2017-10-10 22:17:58.146461|2017-10-10 22:17:58.146461
NCT02741648|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-07-26|||July 2016||2016-07-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|RBC-mNIRS||RBC Irradiation, Anemia and Gut Injury|Red Blood Cell Transfusion and Digestive Tract Oxygenation in Preterm Infants 1250 Grams|Recruiting||N/A|220|Anticipated|Emory University|||4||f||||f||||||Samples Without DNA|"     Residual patient blood samples (obtained for routine clinical testing), urine, stool and     breast milk will be collected, frozen and stored. If a baby develops a digestive tract     complication, the stored specimens will be studied in the laboratory in an effort to identify     markers of a healthy digestive tract versus illness.      A sample of transfused RBCs will be obtained from the RBC unit at each RBC transfusion. If     the baby develops a digestive tract complication the stored specimens will be studied in the     laboratory to identify changes in the biochemical compounds of the transfused blood that may     have taken place over time.   "|||2017-10-10 22:17:58.220904|2017-10-10 22:17:58.220904
NCT02740543|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-13|||December 2013||2013-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Biomarkers of Irritant-Induced and Allergic Asthma|Biomarkers of Irritant-Induced and Allergic Asthma: Phase I and Phase II|Recruiting||Phase 2|300|Anticipated|New York University School of Medicine||4|||f||||f||||||||||2017-10-10 22:17:58.354876|2017-10-10 22:17:58.354876
NCT02740530|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-22|||April 2016||2016-04-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|NIBS||Improving Mobility and Cognition in Older Adults Using Non-Invasive Brain Stimulation|Improving Mobility and Cognition in Older Adults: Establishment of an Interdisciplinary Clinical Research Program Using Non-Invasive Brain Stimulation|Recruiting||N/A|40|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 22:17:58.458435|2017-10-10 22:17:58.458435
NCT02740491|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|REVIS||"Implementation of a Remission Consultation in the Management of Patients Treated for Localized Breast Cancer"|"Evaluation of the Implementation of a Remission Consultation in the Management of Patients Treated for Localized Breast Cancer"|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 22:17:58.680473|2017-10-10 22:17:58.680473
NCT02740465|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-05-04|||January 2016||2016-01-01|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|ACE||Anxiety and COPD Evaluation|Anxiety and COPD Evaluation (ACE)|Active, not recruiting||N/A|200|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:17:58.996978|2017-10-10 22:17:58.996978
NCT02740452|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-10-21|||September 2016||2016-09-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Anterior Cruciate Ligament Rupture|Ligamys Technique Versus Standard Technique for the Anterior Cruciate Ligament Rupture|Recruiting||N/A|80|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:17:59.088978|2017-10-10 22:17:59.088978
NCT02740439|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-10-14|||February 2016||2016-02-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|PATH||Persea Americana for Total Health (PATH ) Study|Investigating the Effects of Avocado Intake on Metabolism and Cognition: A Systems Approach|Recruiting||N/A|200|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 22:17:59.185808|2017-10-10 22:17:59.185808
NCT02740426|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-19|||August 2016||2016-08-01|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients|Peking University First Hospital|Recruiting||Phase 2|200|Anticipated|Peking University First Hospital||2|||f||||||||||||||2017-10-10 22:17:59.299277|2017-10-10 22:17:59.299277
NCT02740413|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-08-03|||January 11, 2016|Actual|2016-01-11|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study|Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto Af - A Swedish Cohort Study|Active, not recruiting||N/A|1|Anticipated|Pfizer|||2||f||||f||||||||||2017-10-10 22:17:59.392631|2017-10-10 22:17:59.392631
NCT02740400|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-11|||April 2015||2015-04-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|June 2016|Anticipated|2016-06-01||Interventional|||A Comparison Between EBUS-GS and CT-guided Lung Biopsy in Diagnosis of Peripheral Pulmonary Lesions.|Endobronchial Ultrasonography With a Guide Sheath Versus Computed Tomography-guided Transthoracic Needle Biopsy in the Diagnosis of Peripheral Pulmonary Lesions|Recruiting||N/A|120|Anticipated|Peking University People's Hospital||2|||f||||f||||||||No||2017-10-10 22:17:59.518093|2017-10-10 22:17:59.518093
NCT02741635|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-06-20|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:17:59.608886|2017-10-10 22:17:59.608886
NCT02741622|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-02-16|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients.|Effects of Aerobic Exercise Intensity on Affective States and Brain Derived Neurotropic Factor in Patients With Depression|Completed||N/A|21|Actual|St. Olavs Hospital||1|||f||||f||||||||||2017-10-10 22:17:59.648277|2017-10-10 22:17:59.648277
NCT02741609|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-09-26|||April 2016||2016-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALSIBDT||A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease|A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease|Recruiting||N/A|300|Anticipated|Advanced Laboratory Services, Inc.||1|||f||||f||||||||||2017-10-10 22:17:59.732773|2017-10-10 22:17:59.732773
NCT02741596|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-03-13|||September 2016||2016-09-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Long-term Safety and Efficacy Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE|HELP Study ExtensionTM: An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of DX-2930 for Prevention Against Acute Attacks of Hereditary Angioedema (HAE)|Active, not recruiting||Phase 3|220|Anticipated|Shire||2|||f||||t||||||||||2017-10-10 22:17:59.904013|2017-10-10 22:17:59.904013
NCT02741583|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-10-25|||May 2016||2016-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Kyrgyz Asthma Rehabilitation at High Altitude|Asthma Rehabilitation at High vs. Low Altitude: Randomized Controlled Parallel-group Trial|Completed||N/A|50|Actual|University of Zurich||2|||f||||f||||||||Undecided||2017-10-10 22:18:00.092815|2017-10-10 22:18:00.092815
NCT02741570|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-10-04|||August 4, 2016|Actual|2016-08-04|October 2017|2017-10-01|March 5, 2020|Anticipated|2020-03-05|January 17, 2019|Anticipated|2019-01-17||Interventional|CheckMate 651||Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Study Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|An Open Label, Randomized, Two Arm Phase III Study of Nivolumab in Combination With Ipilimumab Versus Extreme Study Regimen (Cetuximab + Cisplatin/Carboplatin + Fluorouracil) as First Line Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 3|490|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:18:00.222582|2017-10-10 22:18:00.222582
NCT02741557|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-01-16|||May 2016||2016-05-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)|An Open-label, Randomized, Two-way Crossover, Single Dose, Pivotal Bioequivalence Study of a Fixed-dose Combination of Dolutegravir and Rilpivirine in Healthy Volunteers|Completed||Phase 1|118|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-10 22:18:00.837374|2017-10-10 22:18:00.837374
NCT02741544|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-02-01|||March 2016||2016-03-01|February 2017|2017-02-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Observational|||Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM])|Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM])|Recruiting||N/A|450|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 22:18:00.935481|2017-10-10 22:18:00.935481
NCT02741531|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-02-22|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Partial Bladder Filling on Post-operative Time to Void in Minimally Invasive Gynecologic Procedures|The Effect of Partial Bladder Filling on Post-operative Time to Void in Minimally Invasive Gynecologic Procedures|Enrolling by invitation||N/A|60|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-10 22:18:01.020166|2017-10-10 22:18:01.020166
NCT02741518|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-02-12|||November 2016||2016-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|FMT Obesity||Fecal Microbiota Transplantation for the Treatment of Obesity|Fecal Microbiota Transplantation for the Treatment of Obesity|Recruiting||Phase 1/Phase 2|20|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 22:18:01.119051|2017-10-10 22:18:01.119051
NCT02741505|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-09-28|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|BEDTIME||Brain Sleep Deprivation MRI Effects (BEDTIME)|Open Masking, Micro Motionlogger Actigraph, 3T Siemens MRI, Sleep Deprivation, Nocturnal PSG|Not yet recruiting||N/A|20|Anticipated|New York University School of Medicine||1|||f||||t|f|t|f|f|f|||||2017-10-10 22:18:01.212603|2017-10-10 22:18:01.212603
NCT02741492|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-07-11|||April 2016||2016-04-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Transversus Abdominus Plane Catheters for Open Inguinal Hernia Repair|Continuous Transversus Abdominus Plane Block for Open Inguinal Hernia Repair|Recruiting||N/A|90|Anticipated|Benaroya Research Institute||2|||f||||t||||||||||2017-10-10 22:18:01.29932|2017-10-10 22:18:01.29932
NCT02741479|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-01-31|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effectiveness of Kinesio® Tex Tape on Gluteus Medius Activation in Dancers|The Effectiveness of Kinesio® Tex Tape on Gluteus Medius Activation in Dancers|Recruiting||N/A|40|Anticipated|New York University School of Medicine||3|||f||||f||||||||||2017-10-10 22:18:01.386191|2017-10-10 22:18:01.386191
NCT02741466|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-04-04|||March 15, 2016|Actual|2016-03-15|April 2017|2017-04-01|March 30, 2016|Actual|2016-03-30|March 30, 2016|Actual|2016-03-30||Interventional|SPF Assay||18750-Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:18:01.470201|2017-10-10 22:18:01.470201
NCT02741453|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-07-11|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|BIUS||Bilateral Internal Jugular Veins Ultrasound Scanning Prior to CVC Placement|Scanning of Bilateral Internal Jugular Veins With Ultrasound Prior to CVC Placement - Effect on Success and Complications|Completed||N/A|278|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 22:18:01.547429|2017-10-10 22:18:01.547429
NCT02741440|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-10-03|||April 4, 2016||2016-04-04|September 28, 2017|2017-09-28|March 2, 2019|Anticipated|2019-03-02|February 28, 2019|Anticipated|2019-02-28||Observational|||Natural History of Spinocerebellar Ataxia Type 7 (SCA7)|Natural History of Spinocerebellar Ataxia Type 7 (SCA7)|Recruiting||N/A|25|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:18:01.638697|2017-10-10 22:18:01.638697
NCT02741427|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-13|||September 2012||2012-09-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy of a Whitening Dentifrice on Tooth Discoloration|Safety, Acceptability and Efficacy of a Silica Dentifrice Containing Blue Pigment on Tooth Whitening: a Randomized Clinical Trial|Completed||Phase 4|75|Actual|Federal University of Paraíba||3|||f||||f||||||||No||2017-10-10 22:18:01.727833|2017-10-10 22:18:01.727833
NCT02741414|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-07-10|||June 2016||2016-06-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||A Multi-center Study for Eradication of Refractory Helicobacter Pylori|Construction and Application of the Treatment of Refractory Helicobacter Pylori Infection Based on the High-throughput Sequencing Technologies|Recruiting||N/A|4428|Anticipated|Taizhou Hospital||3|||f||||||||||||||2017-10-10 22:18:01.825425|2017-10-10 22:18:01.825425
NCT02741401|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-21|||March 2016||2016-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|COMMIS||COMplementary Hand-foot Massage to Improve Experience of illneSs Trial||Enrolling by invitation||N/A|102|Anticipated|Zuyderland Medisch Centrum||2|||f||||||||||||||2017-10-10 22:18:01.936264|2017-10-10 22:18:01.936264
NCT02741388|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-03-08|||October 2016|Actual|2016-10-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|SELINDA||A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP|A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP|Recruiting||Phase 1|60|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-10 22:18:02.016119|2017-10-10 22:18:02.016119
NCT02741362|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-03-02|||December 2015||2015-12-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome|A Phase I-II Open- Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Autologous Adipose Stem Cell (Adult Human) to Subjects With Refractory Rheumatoid Arthritis, Relapsing Systemic Lupus Erythematosus or Sharp's Syndrome|Terminated||Phase 1|2|Actual|Arkansas Heart Hospital||1||Primary Investigator no longer with institution|f||||f||||||||No||2017-10-10 22:18:02.246015|2017-10-10 22:18:02.246015
NCT02741336|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-09-12|||November 2015||2015-11-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Electrophysiologic Changes in Blacks Treated With CBT for Insomnia||Completed||N/A|10|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-10-10 22:18:02.440417|2017-10-10 22:18:02.440417
NCT02741323|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-04-10|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01||||April 2021|Anticipated|2021-04-01||Interventional|||Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients|Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients|Recruiting||Phase 2|130|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:18:02.507326|2017-10-10 22:18:02.507326
NCT02741310|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-09-09|||February 2016||2016-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Evaluate the Effect on Blood Pressure of AMG 334 Given Concomitantly With Subcutaneous Sumatriptan|Phase 1, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Effect on Blood Pressure of AMG 334 Given Concomitantly With Subcutaneous Sumatriptan (ImitrexTM) in Healthy Subjects|Completed||Phase 1|30|Actual|Amgen||2|||f||||f||||||||||2017-10-10 22:18:02.628225|2017-10-10 22:18:02.628225
NCT02741297|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2016-11-15|||April 2016||2016-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation|A Multi-Center Controlled Study to Characterize the Real-world Outcomes of High Rate Spinal Cord Stimulation Therapy Using Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System|Recruiting||N/A|60|Anticipated|Boston Scientific Corporation||1|||f||||f||||||||No||2017-10-10 22:18:02.695988|2017-10-10 22:18:02.695988
NCT02741284|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-07-24|||June 2016||2016-06-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|June 2017|Actual|2017-06-01||Interventional|O2C2||Oxygen for Intrauterine Resuscitation of Category II Fetal Heart Tracings|Oxygen for Category II Intrauterine Fetal Resuscitation: A Randomized, Noninferiority Trial|Active, not recruiting||N/A|120|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 22:18:02.769961|2017-10-10 22:18:02.769961
NCT02741271|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-03|||May 11, 2016|Actual|2016-05-11|August 2017|2017-08-01|January 17, 2018|Anticipated|2018-01-17|January 17, 2018|Anticipated|2018-01-17||Interventional|||Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)|A Phase III, Randomized, Active-controlled, Parallel-group Clinical Trial to Study the Efficacy and Long-term Safety of Mometasone Furoate/Formoterol Fumarate (MF/F, MK-0887A [SCH418131]), Compared With Mometasone Furoate (MF, MK-0887 [SCH032088]), in Children With Persistent Asthma|Active, not recruiting||Phase 3|160|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:18:02.85761|2017-10-10 22:18:02.85761
NCT02741258|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-04|||October 2015||2015-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Mepitel Film Treatment for the Prevention and Cutaneous Toxicity Due to Radiotherapy|Mepitel Film vs Standard of Care for the Radiotherapy Prevention and Cutaneous Toxicity in Patients With Post-surgery Breast Cancer|Recruiting||Phase 3|164|Anticipated|Oncology Institute of Southern Switzerland||2|||f||||f||||||||||2017-10-10 22:18:02.942928|2017-10-10 22:18:02.942928
NCT02741245|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-01-24|||June 2016||2016-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)|A Phase III, Randomized, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of MK-0653H in Japanese Patients With Hypercholesterolemia.|Completed||Phase 3|321|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-10 22:18:03.031108|2017-10-10 22:18:03.031108
NCT02741232|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-03-21|||March 2016||2016-03-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Perioperative Opioid Consumption Following Pectoral Nerve Block for Breast Cancer Surgery|Comparison of Perioperative Opioid Consumption Following Pectoral Nerve Block Under General Anesthesia for Breast Cancer Surgery: A Randomized Clinical Trial|Recruiting||N/A|50|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-10 22:18:03.115547|2017-10-10 22:18:03.115547
NCT02741219|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-04-13|||November 2015||2015-11-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section||Recruiting||Phase 4|264|Anticipated|Obstetrics & Gynecology Hospital of Fudan University||2|||f||||||||||||||2017-10-10 22:18:03.323019|2017-10-10 22:18:03.323019
NCT02741206|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-12-16|||June 2016||2016-06-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Preventing Postpartum Depression in Prenatal Care|Bellevue ROSE: Preventing Postpartum Depression in Prenatal Care|Recruiting||N/A|60|Anticipated|New York University School of Medicine||3|||f||||f||||||||||2017-10-10 22:18:03.42479|2017-10-10 22:18:03.42479
NCT02741193|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-12|||June 2015||2015-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)|Validation of Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS) in Patients With Epilepsy|Recruiting||N/A|14|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 22:18:03.527301|2017-10-10 22:18:03.527301
NCT02741167|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-05-03|||January 2016||2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy|Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy|Recruiting||N/A|90|Anticipated|University of Zurich|||1||f||||f||||||Samples Without DNA|"     Blood   "|No||2017-10-10 22:18:04.455892|2017-10-10 22:18:04.455892
NCT02741154|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-04|||August 12, 2016||2016-08-12|September 2017|2017-09-01|September 3, 2017|Actual|2017-09-03|August 24, 2017|Actual|2017-08-24||Interventional|AIPRICSI||Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI|Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI(Intracytoplasmic Sperm Injection) a Case Control Study|Completed||Phase 4|50|Actual|Minia University||2|||f||||f||||||||||2017-10-10 22:18:04.554363|2017-10-10 22:18:04.554363
NCT02741141|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-09-16|||September 2016||2016-09-01|September 2016|2016-09-01||||January 2018|Anticipated|2018-01-01||Interventional|PARTODYS||A Comparative Study of the Effect of Two Partographs on the Cesarean Section Rate in Women in Spontaneous Labour||Recruiting||N/A|750|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 22:18:04.668202|2017-10-10 22:18:04.668202
NCT02741128|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-06-28|||March 20, 2019|Anticipated|2019-03-20|June 2017|2017-06-01|March 18, 2021|Anticipated|2021-03-18|March 18, 2021|Anticipated|2021-03-18||Interventional|||Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults|Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults Aged 18 to 50 Years in Brazil|Not yet recruiting||Phase 2|150|Anticipated|Sanofi||2|||f||||t|f|f||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 22:18:04.784922|2017-10-10 22:18:04.784922
NCT02741115|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-08-24|||June 2016||2016-06-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FUEL||Fontan Udenafil Exercise Longitudinal Assessment Trial|Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL)|Recruiting||Phase 3|400|Anticipated|Mezzion Pharma Co. Ltd||2|||f||||t||||||||||2017-10-10 22:18:04.909036|2017-10-10 22:18:04.909036
NCT02741102|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-04-27|||June 2016||2016-06-01|April 2016|2016-04-01|January 2023|Anticipated|2023-01-01|June 2022|Anticipated|2022-06-01||Interventional|||Uterine Transplant in Absolute Uterine Infertility (AUIF)|Uterine Transplant in Absolute Uterine Infertility (AUIF)|Not yet recruiting||N/A|10|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||No||2017-10-10 22:18:05.157051|2017-10-10 22:18:05.157051
NCT02741089|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-07|||February 2016||2016-02-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|BSK||Bronchoscopy Registry|Bronchoscopy Registry|Recruiting||N/A|100|Anticipated|RWTH Aachen University|||1||f||||f||||||None Retained|"     Serum, Blood plasm   "|Undecided||2017-10-10 22:18:05.247396|2017-10-10 22:18:05.247396
NCT02741076|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-30||||||August 2017|2017-08-01||||February 2019|Anticipated|2019-02-01||Interventional|||Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain|A Randomized, Double-blind, Placebo-controlled, Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioid Analgesic Therapy for Chronic Pain.|Recruiting||Phase 4|820|Anticipated|Member Companies of the Opioid PMR Consortium||12|||f||||||||||||||2017-10-10 22:18:05.356117|2017-10-10 22:18:05.356117
NCT02741063|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-02|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Oxytocin Effect on Attentional Bias Towards Emotional Expression Faces in Individuals With High and Low Autistic Traits: A Functional Magnetic Resonance Imaging (fMRI) Study||Recruiting||Early Phase 1|120|Anticipated|University of Electronic Science and Technology of China||4|||f||||||||||||||2017-10-10 22:18:05.718857|2017-10-10 22:18:05.718857
NCT02741050|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-25|||August 2016||2016-08-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Primary Care-Based Physical Activity for Diabetic Latinas|Camino a La Salud: Adapting and Testing a Primary Care-Delivered Physical Activity Intervention for Latinas With Type II Diabetes|Recruiting||N/A|80|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 22:18:05.821743|2017-10-10 22:18:05.821743
NCT02741037|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-08-21|||January 2016||2016-01-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|||Unidas Por la Vida: A Healthy Lifestyle Intervention for High-risk Latina Dyads|Unidas Por la Vida: A Healthy Lifestyle Intervention for High-risk Latina Dyads|Enrolling by invitation||N/A|920|Anticipated|University of California, Irvine||3|||f||||t||||||||||2017-10-10 22:18:05.917886|2017-10-10 22:18:05.917886
NCT02741024|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-04-12|||October 2013||2013-10-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo|In Vivo Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Uncomplicated Falciparum Malaria: an Open-randomised, Non-inferiority Clinical Trial in South Kivu, DR Congo|Completed||Phase 4|288|Actual|Medecins Sans Frontieres, Netherlands||2|||f||||f||||||||Yes|Data are available on request in accordance with MSF's data sharing policy: http://fieldresearch.msf.org/msf/handle/10144/306488|2017-10-10 22:18:06.007072|2017-10-10 22:18:06.007072
NCT02741011|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-04-12|||February 2012||2012-02-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Radiological Examination of the Mentally Handicapped Patients|Computed Tomographic Assessment of the Maxillofacial Region of Mentally Handicapped or Uncooperative Patients Under Intravenous Sedation|Completed||N/A|98|Actual|Tokat Gaziosmanpasa University||1|||f||||t||||||||No||2017-10-10 22:18:06.113138|2017-10-10 22:18:06.113138
NCT02740998|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-17|||March 2016||2016-03-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|vMICROb||Long-Acting Progestin Contraception and the Vaginal Microbiome|Impact of Long-Acting Progestin Contraception on the Vaginal Microbiome|Recruiting||N/A|35|Anticipated|Boston Medical Center|||4||f||||t||||||Samples With DNA|"     Vaginal swabs for microbiome analysis and sexually transmitted infection testing.   "|No||2017-10-10 22:18:06.194193|2017-10-10 22:18:06.194193
NCT02740985|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-15|||June 17, 2016|Actual|2016-06-17|September 2017|2017-09-01|November 9, 2017|Anticipated|2017-11-09|November 9, 2017|Anticipated|2017-11-09||Interventional|||A Phase 1 Clinical Study of AZD4635 and Durvalumab in Patients With Advanced Solid Malignancies|A Phase I, Open-Label, Multicenter Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of AZD4635, Both as Monotherapy and in Combination With Durvalumab in Patients With Advanced Solid Malignancies.|Recruiting||Phase 1|51|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:18:06.287404|2017-10-10 22:18:06.287404
NCT02740972|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-07-31|||December 2016||2016-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)||Recruiting||Phase 2|16|Anticipated|NS Pharma, Inc.||3|||f||||t||||||||||2017-10-10 22:18:06.395004|2017-10-10 22:18:06.395004
NCT02740959|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-04-18|||March 2016||2016-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Effects of PG2 on Fatigue-Related Symptom Clusters|Effects of PG2 on Fatigue-Related Symptom Clusters|Recruiting||N/A|75|Anticipated|Taipei Medical University||2|||f||||f||||||||No||2017-10-10 22:18:06.531243|2017-10-10 22:18:06.531243
NCT02740946|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-14|||August 2011||2011-08-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Enhanced Function and Quality of Life Following 5 Months of Exercise Therapy for Patients With Rotator Cuff Tears|Enhanced Function and Quality of Life Following 5 Months of Exercise Therapy for Patients With Irreparable Rotator Cuff Tears - an Intervention Study|Completed||N/A|30|Actual|Northern Orthopaedic Division, Denmark||1|||f||||f||||||||Yes||2017-10-10 22:18:06.625137|2017-10-10 22:18:06.625137
NCT02740933|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-12|||April 2016||2016-04-01|April 2016|2016-04-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors|Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors|Not yet recruiting||Phase 1|40|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||Yes|We plan to present on and publish the data acquired from this study.|2017-10-10 22:18:06.739102|2017-10-10 22:18:06.739102
NCT02740920|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-08-14|||May 2016||2016-05-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Assessment of Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography (CT) Texture Analysis as a Predictive Biomarker|A Phase II Study of the Assessment of Response to Pembrolizumab in Metastatic Melanoma: CT Texture Analysis as a Predictive Biomarker|Recruiting||Phase 2|80|Anticipated|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-10 22:18:06.827714|2017-10-10 22:18:06.827714
NCT02740907|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-12|||August 2012||2012-08-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Premolar Autotransplantation in Juvenile Dentition: Quantitative Assessment of Vertical Bone and Soft Tissue Growth|Premolar Autotransplantation in Juvenile Dentition: Quantitative Assessment of Vertical Bone and Soft Tissue Growth|Completed||N/A|20|Actual|MKG-Praxisklinik|||1||f||||||||||||No||2017-10-10 22:18:06.917502|2017-10-10 22:18:06.917502
NCT02740894|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-12|||February 2016||2016-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?|Can Epidermal Growth Factor Receptor - Tyrosine Kinase Inhibitor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis of the Thoracic and Lumbar Spine?- A Retrospective Comparison With Platinum-based Chemotherapy|Completed||N/A|100|Actual|Taipei Veterans General Hospital, Taiwan|||2||f||||t||||||||||2017-10-10 22:18:06.975364|2017-10-10 22:18:06.975364
NCT02740881|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-04-24|||November 2015||2015-11-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CM-TSS||Web-Based Contingency Management Training for Addictions|Online Training Support System for Community-Based Substance Abuse Agencies|Active, not recruiting||N/A|150|Anticipated|Sheidow Consulting, Inc.||2|||f||||t||||||||No||2017-10-10 22:18:07.037958|2017-10-10 22:18:07.037958
NCT02740868|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-10-03|||August 2015||2015-08-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Xenon-129 Lung Magnetic Resonance Imaging: Study of Healthy Volunteers and Participants With Pulmonary Disease|Development of Hyperpolarized Xenon-129 Lung Magnetic Resonance Imaging: Comparative Pilot Study of Healthy Volunteers and Participants With Pulmonary Disease|Recruiting||Phase 2|30|Anticipated|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-10 22:18:07.110911|2017-10-10 22:18:07.110911
NCT02740855|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-02-09|||April 2016||2016-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Endtidal Ethanol in Sclerotherapy|Endtidal Ethanol in Sclerotherapy|Recruiting||N/A|70|Anticipated|University Hospital Inselspital, Berne|||1||f||||||||||||||2017-10-10 22:18:07.306653|2017-10-10 22:18:07.306653
NCT02740842|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-02-09|||April 2016||2016-04-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||A Follow-up Study on the Sustained Impact of Alive & Thrive Interventions on Infant and Young Child Feeding Practices|A Follow-up Study on the Sustained Impact of Alive & Thrive Behavior Change Communication Interventions on Infant and Young Child Feeding Practices in Bangladesh|Completed||Phase 3|2400|Actual|International Food Policy Research Institute||2|||f||||f||||||||Undecided||2017-10-10 22:18:07.380517|2017-10-10 22:18:07.380517
NCT02740829|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-04-14|||March 2015||2015-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Assessment of Intranasal Glucagon on Endogenous Glucose Production|Evaluation of the Effects of Intranasal Glucagon on Endogenous Glucose Production in Humans|Completed||Phase 1|10|Actual|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 22:18:07.448689|2017-10-10 22:18:07.448689
NCT02740816|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-04-26|||March 2016||2016-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Comparative Study of Menstrual Blood and Systemic Blood|Comparative Study of Menstrual Blood and Systemic Blood: Quantifying the Difference|Recruiting||N/A|30|Anticipated|Stanford University|||1||f||||f||||||Samples With DNA|"     Menstrual Blood and Systemic Blood   "|No||2017-10-10 22:18:07.509585|2017-10-10 22:18:07.509585
NCT02740621|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-07-06|||January 2016||2016-01-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|January 2017|Actual|2017-01-01||Observational|MIOP/TRAPS||The Impact of Opioids in Coronary Heart Disease|Evaluation of Past Medications in Patients With Coronary Heart Disease and Patients Hospitalized for a Non-cardiac Reason|Active, not recruiting||N/A|502|Actual|Ruhr University of Bochum|||2||f||||f||||||||||2017-10-10 22:18:08.973723|2017-10-10 22:18:08.973723
NCT02740803|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-06-04|||April 2016||2016-04-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Total Salivary Fluoride Concentration of Healthy Adult Subjects Following Toothbrushing With Different Formulations of Fluoridated Toothpastes With and Without Post-brushing Water Rinsing.|Total Salivary Fluoride Concentration of Healthy Adult Subjects Following Toothbrushing With Different Formulations of Fluoridated Toothpastes With and Without Post-brushing Water Rinsing. A Double Blinded Randomised Controlled Trial|Completed||N/A|120|Actual|University of Leeds||12|||f||||t||||||||Yes|"Participants will be informed that data will be anonymised so that they cannot be identified even in case of results dissemination (i.e peer-reviewed journals.
Age, gender, sex, salivary rate per minutes, fluoride ion concentrations in saliva prior to brushing and post-brushing at 1, 15, 30, 60 and 90 minutes."|2017-10-10 22:18:07.578027|2017-10-10 22:18:07.578027
NCT02740790|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-03-06|||September 2013||2013-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|||Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females|Immunogenicity and Safety of Recombinant Human Papillomavirus Bivalent(Type 16 and 18) Vaccine (Yeast) in Healthy Females|Active, not recruiting||Phase 2|1200|Actual|Shanghai Zerun Biotechnology Co.,Ltd||6|||f||||f||||||||No||2017-10-10 22:18:07.696294|2017-10-10 22:18:07.696294
NCT02740777|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-03-06|||February 2016||2016-02-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|November 2016|Actual|2016-11-01||Interventional|||Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females|Immunogenicity Study of a 2-dose Immunization Schedule of Recombinant Human Papillomavirus Virus-like Particle Vaccine (Type 16 and 18 L1 Proteins, Yeast) in Adolescent Females Aged 9 to 14 Years|Recruiting||Phase 2|900|Anticipated|Shanghai Zerun Biotechnology Co.,Ltd||3|||f||||t||||||||No||2017-10-10 22:18:07.783302|2017-10-10 22:18:07.783302
NCT02740764|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-04-28|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|OPTIM||Optimization of Drug Prescribing in an Elderly Population of Geriatric Consultations|Optimization of Drug Prescribing in an Elderly Population of Geriatric Consultations and Living at Home|Recruiting||N/A|302|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:18:07.88393|2017-10-10 22:18:07.88393
NCT02740751|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-15|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|Galactogogue||Efficacy of Herbal Galactogogues in Breastfeeding Mothers|Efficacy of Herbal Galactogogues on Weight Gain of the Newborns Within the First Month of Life in Breastfeeding Mothers|Recruiting||N/A|90|Anticipated|Dr. Sami Ulus Children's Hospital||3|||f||||f||||||||No||2017-10-10 22:18:07.99575|2017-10-10 22:18:07.99575
NCT02740738|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-07|||March 2016||2016-03-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Preoperative Pain Threshold and Rapid Recover Programs|Preoperative Pain Threshold and Rapid Recover Programs in Total Joint Arthroplasty|Recruiting||N/A|200|Anticipated|Duke University||1|||f||||f|f|f||||||||2017-10-10 22:18:08.088901|2017-10-10 22:18:08.088901
NCT02740725|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-14|||December 2014||2014-12-01|April 2016|2016-04-01||||November 2016|Anticipated|2016-11-01||Interventional|||The Role of Interactive Binocular Treatment System in Amblyopia Therapy||Recruiting||N/A|50|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:18:08.183837|2017-10-10 22:18:08.183837
NCT02740712|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-05-31|||March 2016||2016-03-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|March 2017|Actual|2017-03-01||Interventional|DDI||Pharmacokinetic Drug-Drug Interaction Study of Rucaparib|A Phase 1, Open-label, Multiple-probe Drug-drug Interaction Study to Determine the Effect of Rucaparib on Pharmacokinetics of Caffeine, S-Warfarin, Omeprazole, Midazolam, and Digoxin in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|16|Anticipated|Clovis Oncology, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:18:08.292967|2017-10-10 22:18:08.292967
NCT02740699|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-14|2017-08-22|||April 4, 2016||2016-04-04|August 10, 2017|2017-08-10|December 15, 2020|Anticipated|2020-12-15|December 15, 2020|Anticipated|2020-12-15||Interventional|||CT COMPARE: CT COronary Angiography to Measure PlAque REduction|CT COMPARE: CT COronary Angiography to Measure PlAque REduction|Recruiting||Phase 4|190|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:18:08.403733|2017-10-10 22:18:08.403733
NCT02740686|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-06-06|||July 2016||2016-07-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|CIMPRES-COPD||Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD|Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD|Recruiting||N/A|156|Anticipated|University of Lincoln|||4||f||||f||||||Samples Without DNA|"     Whole blood samples will be used on the day of collection and analysed before being     appropriately disposed of on the same day. Blood samples will be centrifuged with separated     plasma to be frozen at -80c for later analysis of cellular content. Sputum samples will also     be centrifuged with supernatant extracted and frozen -80c for later analysis.   "|No||2017-10-10 22:18:08.501453|2017-10-10 22:18:08.501453
NCT02740673|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-10-25|||January 2017||2017-01-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||Testing Cognitive Functions in Patients With COPD Using a Driving Simulator|Testing Cognitive Functions in Patients With COPD Using a Driving Simulator|Not yet recruiting||N/A|100|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-10-10 22:18:08.618645|2017-10-10 22:18:08.618645
NCT02740660|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-04-10|||April 2016||2016-04-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|CAMP||Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents|Effect on Body Composition With Albuterol and Caffeine Versus Placebo in Adolescents: A Pilot Study|Recruiting||N/A|20|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||No||2017-10-10 22:18:08.703676|2017-10-10 22:18:08.703676
NCT02740647|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-04-14|||April 2016||2016-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||The Efficiency of Postoperative Antibiotics in Orthognathic Surgery|The Efficiency of Postoperative Antibiotics in Orthognathic Surgery: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial|Not yet recruiting||N/A|25|Anticipated|The Baruch Padeh Medical Center, Poriya||2|||f||||t||||||||Undecided||2017-10-10 22:18:08.804178|2017-10-10 22:18:08.804178
NCT02740634|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-12-22|||May 2016||2016-05-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study|Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study|Recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:18:08.882138|2017-10-10 22:18:08.882138
NCT02740608|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-05-02|||October 2016||2016-10-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|VITTAL||Viability Testing and Transplantation of Marginal Livers|An Open Label, Non-randomised, Prospective, Single Arm, 2-part Trial, Using Normothermic Machine Liver Perfusion NMLP to Test Viability and Transplantation of Marginal Livers|Recruiting||N/A|22|Anticipated|University of Birmingham||1|||f||||t||||||||No||2017-10-10 22:18:09.05208|2017-10-10 22:18:09.05208
NCT02740595|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-12|||August 2015||2015-08-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||E-cigarettes and Blood Vessel Function|The Effects of Electronic Cigarettes on Endothelial Function and Oxidative Stress|Recruiting||N/A|120|Anticipated|University of California, Los Angeles||3|||f||||f||||||||No||2017-10-10 22:18:09.152218|2017-10-10 22:18:09.152218
NCT02740582|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-01-12|||October 2016||2016-10-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users|Effects of Tolcapone on Decision Making and Alcohol Intake Using a Laboratory Bar in Moderate to Heavy Social Drinkers|Recruiting||N/A|80|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:18:09.327347|2017-10-10 22:18:09.327347
NCT02740569|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-14|||April 2016||2016-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|OSASPI||Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement|Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement|Recruiting||N/A|60|Anticipated|Marmara University|||1||f||||t||||||Samples Without DNA|"     Blood samples for metabolic and cardiovascular markers   "|Undecided||2017-10-10 22:18:09.449892|2017-10-10 22:18:09.449892
NCT02740556|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-01-30|||February 2016||2016-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of HepCure Toolkit to Improve Harvoni Adherence|Evaluation of HepCure Toolkit to Improve Harvoni Adherence|Recruiting||N/A|99|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||No||2017-10-10 22:18:09.542609|2017-10-10 22:18:09.542609
NCT02740387|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-09-14|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Open Label Study of OTO-104 in Subjects With Meniere's Disease|A 1-Year, Phase 2, Open-Label Safety Study of OTO-104 Given at 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease|Terminated||Phase 2|34|Actual|Otonomy, Inc.||1||Negative Efficacy Results from the recently completed Phase 3 study 104-201506|f||||t||||||||||2017-10-10 22:18:09.640704|2017-10-10 22:18:09.640704
NCT02740374|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-01-30|||November 2015||2015-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ROTEM_SPINE||Evaluation of Thromboelastometry (ROTEM) During Spinal Surgery|A Prospective, Randomized, Parallel-group Single Center Study to Evaluate the Use of Thromboelastometry (ROTEM) in Patients Undergoing Spine Surgeries|Enrolling by invitation||N/A|110|Anticipated|Ohio State University||2|||f||||f||||||||No||2017-10-10 22:18:09.706726|2017-10-10 22:18:09.706726
NCT02740361|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-01|||February 15, 2017|Actual|2017-02-15|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|February 15, 2019|Anticipated|2019-02-15||Interventional|||Online Program to Reduce Depression in MS|International Deprexis Trial in Multiple Sclerosis (IDEMS) - a Multicenter Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|Charite University, Berlin, Germany||3|||f||||t|f|f||||||||2017-10-10 22:18:09.797174|2017-10-10 22:18:09.797174
NCT02740348|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-08-04|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|June 2017|Actual|2017-06-01||Interventional|||Point-of-Care Follow-Up With Primary Care After Emergency Department Discharge|Point-of-Care Follow-Up With Primary Care After Emergency Department Discharge|Completed||N/A|220|Actual|George Washington University||3|||f||||f||||||||||2017-10-10 22:18:09.918164|2017-10-10 22:18:09.918164
NCT02740335|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-10|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.|A Phase III, Randomized, Double-blind, Multicenter Study to Assess the Efficacy and Safety of OCTAPLEX, a Four-factor Prothrombin Complex Concentrate (4F-PCC), Compared to the 4F-PCC Beriplex® P/N (Kcentra), for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.|Recruiting||Phase 3|370|Anticipated|Octapharma||2|||f||||t|t|f||||||||2017-10-10 22:18:09.999076|2017-10-10 22:18:09.999076
NCT02740309|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-04-21|||April 2016||2016-04-01|April 2016|2016-04-01||||February 2017|Anticipated|2017-02-01||Interventional|||Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems|Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems|Not yet recruiting||N/A|90|Anticipated|New York University Langone Medical Center||2|||f||||f||||||||No||2017-10-10 22:18:10.216699|2017-10-10 22:18:10.216699
NCT02740296|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-01|||November 2015||2015-11-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|DENIM||Depression and Immune Function in Multiple Sclerosis (MS)|Depression and Immune Function in Multiple Sclerosis (MS)|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||4||f||||f||||||||||2017-10-10 22:18:10.291064|2017-10-10 22:18:10.291064
NCT02740283|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-04-14|||May 2016||2016-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|EDoGDM||The Early Diagnosis of Gestational Diabetes Mellitus Study||Not yet recruiting||N/A|300|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||1|||f||||||||||||||2017-10-10 22:18:10.368602|2017-10-10 22:18:10.368602
NCT02740270|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-09-14|||July 22, 2016|Actual|2016-07-22|September 2017|2017-09-01|May 3, 2019|Anticipated|2019-05-03|May 3, 2019|Anticipated|2019-05-03||Interventional|||Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas|A Phase I/Ib Open-label, Multi-center, Dose Escalation Study of GWN323 (Anti-GITR) as a Single Agent and in Combination With PDR001 (Anti-PD-1) in Patients With Advanced Solid Tumors and Lymphomas|Recruiting||Phase 1|264|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 22:18:10.434176|2017-10-10 22:18:10.434176
NCT02740257|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-07|||March 2016||2016-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Smartphone Application to Detect Skin Lesions|Skin Lesion Detection With Novel Total Body Digital Photography Smartphone Application|Recruiting||N/A|75|Anticipated|Northwestern University|||2||f||||f||||||||||2017-10-10 22:18:10.539025|2017-10-10 22:18:10.539025
NCT02740244|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-02-28|||January 2011||2011-01-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|February 2011|Actual|2011-02-01||Interventional|iTBS-BIP||Effect of Intermittent ThetaBurst Stimulation in Treatment-resistant Bipolar Depression|Effects of Intermittent Theta Burst Stimulation Applied Over the Left Dorsolateral Prefrontal Cortex in Patients With Treatment-resistant Bipolar Depression|Terminated||N/A|20|Actual|Hôpital le Vinatier||2||difficulties of recruitment|f||||f||||||||No||2017-10-10 22:18:10.612172|2017-10-10 22:18:10.612172
NCT02740231|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-07-27|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study on Visco-antalgic Intra-articular Administration in Symptomatic Knee Osteoarthritis|A Two-stage 6-month Multicentre, Randomised, Double-blind, Controlled Study on the Safety and Efficacy Intra-articular Administration of JTA-004 in Patients With Symptomatic Knee Osteoarthritis|Recruiting||Phase 2/Phase 3|164|Anticipated|Bone Therapeutics S.A||4|||f||||t||||||||||2017-10-10 22:18:10.67192|2017-10-10 22:18:10.67192
NCT02740218|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-29|||June 24, 2016|Actual|2016-06-24|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|APPRECIATE||A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice|APPRECIATE (Apremilast Clinical Treatment Experience in Psoriasis): A Multi-center, Retrospective Observational Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice|Recruiting||N/A|515|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 22:18:10.774723|2017-10-10 22:18:10.774723
NCT02740205|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-05|||October 2014||2014-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy and Safety of the Implementation of an Algorithm for Enteral Nutrition Support.|Efficacy and Safety of the Implementation of an Algorithm for Enteral Nutrition Support Compared With Traditional Practice in Non-critical Patients: Randomized Clinical Trial, Simple Blind.|Recruiting||N/A|45|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||||2017-10-10 22:18:11.164976|2017-10-10 22:18:11.164976
NCT02740192|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-14|||April 2016||2016-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pain Control After Total Knee Arthroplasty: Is There Benefit In Adding Single Shot Adductor Canal Block to Existing Multimodal Pain Regimen and Periarticular Injection Protocol?|Pain Control After Total Knee Arthroplasty: A Prospective, Double-blind Randomized Controlled Trial Examining the Benefit of a Combined Adductor-canal Nerve Block With Periarticular Infiltration Versus Periarticular Injection Alone|Recruiting||Early Phase 1|120|Anticipated|Henry Ford Health System||2|||f||||||||||||||2017-10-10 22:18:11.298876|2017-10-10 22:18:11.298876
NCT02740179|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-08-30|||January 2017||2017-01-01|August 2017|2017-08-01||||January 2023|Anticipated|2023-01-01||Interventional|||Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study)|Mineralocorticoid Receptor Antagonism for Cardiovascular Health in HIV--The MIRACLE HIV Study|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 22:18:11.432439|2017-10-10 22:18:11.432439
NCT02740166|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-12|||June 2013||2013-06-01|April 2016|2016-04-01||||January 2018|Anticipated|2018-01-01||Interventional|||Preventing Recurrent Bleeding After Eradication of Esophageal Varices|Banding Ligation Plus Propranolol Versus Banding Ligation to Prevent Rebleeding of Esophageal Varices|Recruiting||Phase 4|212|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||Yes||2017-10-10 22:18:11.557341|2017-10-10 22:18:11.557341
NCT02740153|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-01-23|||March 2016||2016-03-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||PCORI Urea Cycle Disorder Study|Comparative Effectiveness of Therapy in Rare Diseases: Liver Transplantation vs. Conservative Management of Urea Cycle Disorders|Recruiting||N/A|321|Anticipated|Children's Research Institute|||3||f||||f||||||||Undecided||2017-10-10 22:18:11.666587|2017-10-10 22:18:11.666587
NCT02740140|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-04-14|||June 2008||2008-06-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|June 2011|Actual|2011-06-01||Observational|||Epidemiology of H. Pylori Transmission|Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections|Completed||N/A|1750|Actual|Stanford University|||1||f||||f||||||Samples With DNA|"     Serum and PBMC   "|||2017-10-10 22:18:11.799587|2017-10-10 22:18:11.799587
NCT02740127|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-01-17|||June 2016||2016-06-01|January 2017|2017-01-01||||June 2019|Anticipated|2019-06-01||Interventional|||Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis|Prospective Randomized Clinical Trial to Evaluate the Use of Caudal Nerve Blocks in Adult Penile Prosthesis Surgery|Recruiting||Phase 3|104|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 22:18:11.889215|2017-10-10 22:18:11.889215
NCT02740114|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-08|||August 31, 2016|Actual|2016-08-31|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway|Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway: A Single-Blinded, Randomized, Controlled Study|Active, not recruiting||Phase 3|105|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 22:18:12.017539|2017-10-10 22:18:12.017539
NCT02740101|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-03-02|||November 2014||2014-11-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||The Role of Oxytocin in Modulating the Effects of Social Feedback on Achieving Personal Goals||Completed||Early Phase 1|62|Actual|University of Electronic Science and Technology of China||2|||f||||||||||||||2017-10-10 22:18:12.146627|2017-10-10 22:18:12.146627
NCT02740088|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-11|||May 2016||2016-05-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|||18F-NaF Uptake and Aortic Stenosis Progression|Clinical Value of 18F-sodium Fluoride Uptake at the Aortic Valve for Prediction of the Progression in Patients With Moderate Aortic Stenosis: a Prospective Study|Not yet recruiting||N/A|28|Anticipated|Seoul St. Mary's Hospital|||1||f||||f||||||||No||2017-10-10 22:18:12.246944|2017-10-10 22:18:12.246944
NCT02739009|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-10-04|||April 2016||2016-04-01|October 2017|2017-10-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|||First in Human of Single and Multiple Doses of MOR106||Completed||Phase 1|81|Actual|Galapagos NV||4|||f||||f||||||||||2017-10-10 22:18:23.569667|2017-10-10 22:18:23.569667
NCT02740075|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-04-11|||August 2015||2015-08-01|April 2016|2016-04-01||||June 2016|Anticipated|2016-06-01||Observational|||Effect of Mode of Transport Ventilation on Respiratory Parameters After Cardiac Surgery|Effect of Mode of Transport Ventilation on Respiratory Parameters After Cardiac Surgery|Recruiting||N/A|32|Anticipated|University of California, San Diego|||2||f||||f||||||||Undecided||2017-10-10 22:18:12.319539|2017-10-10 22:18:12.319539
NCT02740062|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-11|||March 2016||2016-03-01|April 2016|2016-04-01||||June 2016|Anticipated|2016-06-01||Interventional|NIBSNP||Non Invasive Brain Evaluation and Treatment for Neuropathic Pain|A Novel Non Invasive Brain EEG Based Evaluation and Treatment for Central Manifestation Characteristics of Neuropathic Pain|Recruiting||N/A|30|Anticipated|NIBS NeuroScience Technologies||2|||f||||f||||||||Undecided||2017-10-10 22:18:12.407572|2017-10-10 22:18:12.407572
NCT02740049|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-03-08|||January 27, 2016|Actual|2016-01-27|February 2016|2016-02-01|October 19, 2016|Actual|2016-10-19|October 19, 2016|Actual|2016-10-19||Interventional|||In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma|In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma|Completed||Early Phase 1|10|Actual|Imperial College London||1|||f||||f||||||||No||2017-10-10 22:18:12.500322|2017-10-10 22:18:12.500322
NCT02740036|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-07-18|||May 2016||2016-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Quality Control of CE-Certified Phonak Hearing Aids - 2016_06|Quality Control of CE-Certified Phonak Hearing Aids|Completed||N/A|||Sonova AG|||||f||||f||||||||||2017-10-10 22:18:12.586799|2017-10-10 22:18:12.586799
NCT02740023|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Quality Control of CE-Certified Phonak Hearing Aids - 2015_03|Quality Control of CE-Certified Phonak Hearing Aids|Completed||N/A|||Sonova AG|||||f||||f||||||||||2017-10-10 22:18:12.653863|2017-10-10 22:18:12.653863
NCT02740010|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-09-08|||March 2014||2014-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Observational|||The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus|Retrospective Observational Trial on the Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus|Completed||N/A|100|Actual|SIFI MedTech Srl|||1||f||||t||||||||Yes||2017-10-10 22:18:12.71272|2017-10-10 22:18:12.71272
NCT02739997|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-01|||April 8, 2016|Actual|2016-04-08|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|||Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)|A Multicenter, Open-label, Noncomparative, Japanese Phase III Study to Assess the Efficacy and Safety of Ceftolozane/Tazobactam (MK-7625A) Used in Combination With Metronidazole in Japanese Patients With Complicated Intra-abdominal Infection.|Completed||Phase 3|100|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 22:18:12.784959|2017-10-10 22:18:12.784959
NCT02739984|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-09-11|||May 17, 2016|Actual|2016-05-17|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|September 5, 2017|Actual|2017-09-05||Interventional|||A Study in Subjects With Type 2 Diabetes Mellitus With Hypercholesterolemia/Mixed Dyslipidemia|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Evolocumab (AMG 145) on LDL-C in Subjects With Type 2 Diabetes Mellitus and Hypercholesterolemia/Mixed Dyslipidemia|Completed||Phase 3|424|Actual|Amgen||2|||f||||f||||||||||2017-10-10 22:18:12.891567|2017-10-10 22:18:12.891567
NCT02739971|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-09|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||the Effect of Advanced Glycation End Products (AGEs) on Brain and Cognition|Effect of a Diet Low in Advanced Glycation End Products (AGEs) on Brain and Cognitive Function in Type 2 Diabetes|Recruiting||N/A|120|Anticipated|Sheba Medical Center||2|||f||||f||||||||Yes|MRI and blood tests|2017-10-10 22:18:13.143368|2017-10-10 22:18:13.143368
NCT02739958|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-04-11|||March 2016||2016-03-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx|Effects of Propofol-dexmedetomidine on Immune Function During Total Laryngectomy Surgery Compared With Isoflurane Anesthesia|Enrolling by invitation||N/A|40|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:18:13.247003|2017-10-10 22:18:13.247003
NCT02739945|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-04-14|||May 2011||2011-05-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|SPECTRE||Sonographic Examination Cubital Tunnel Release|Sonographic Follow-up of Patients With Cubital Tunnel Syndrome (CTS) Undergoing Open Neurolysis in Situ or Endoscopic Release: A Prospective Study|Completed||Phase 3|60|Actual|Ente Ospedaliero Cantonale, Bellinzona||2|||f||||f||||||||No||2017-10-10 22:18:13.334203|2017-10-10 22:18:13.334203
NCT02739932|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-10-28|||March 2015||2015-03-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|PROCAN||Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study|Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study|Recruiting||N/A|240|Anticipated|University of Calgary|||1||f||||f||||||||||2017-10-10 22:18:13.423217|2017-10-10 22:18:13.423217
NCT02739919|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-11-01|||June 2016||2016-06-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Bacterial Analysis of Kidney Stones Removed by Percutaneous Nephrolithotomy|Bacterial Analysis of Kidney Stones Removed by Percutaneous Nephrolithotomy|Recruiting||N/A|25|Anticipated|University of British Columbia|||1||f||||f||||||Samples With DNA|"     De-identified and study coded kidney stone and urine samples are collected, processed and     analysed in the research laboratory.   "|No||2017-10-10 22:18:13.522557|2017-10-10 22:18:13.522557
NCT02739906|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-08-17|||April 2016||2016-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM|A Randomised, Double Blind, Three-period Cross-over Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With Type 1 Diabetes Mellitus (T1DM)|Completed||Phase 1/Phase 2|36|Actual|Adocia||3|||f||||f||||||||||2017-10-10 22:18:13.608852|2017-10-10 22:18:13.608852
NCT02738099|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-11-14|||April 2016||2016-04-01|November 2016|2016-11-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Observational|||Risk Stratification of Patients Presenting With Cardiac Arrest|Risk Stratification of Patients Presenting With Cardiac Arrest|Recruiting||N/A|100|Anticipated|Essentia Health|||1||f||||f||||||||Undecided||2017-10-10 22:18:33.341819|2017-10-10 22:18:33.341819
NCT02739893|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-03-28|||January 2016||2016-01-01|March 2017|2017-03-01||||January 2018|Anticipated|2018-01-01||Interventional|||Usefulness of A Scope Guide Assisted Colonoscopy Versus Conventional Colonoscopy|Randomized Trial Comparing the Usefulness of A Scope Guide Assisted Colonoscopy Versus Conventional Colonoscopy|Active, not recruiting||N/A|300|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 22:18:13.707785|2017-10-10 22:18:13.707785
NCT02739880|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-06-20|||June 19, 2017|Actual|2017-06-19|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|INREG 1||Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule|Evaluation of the Effect of Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule: A Prospective, Bicentric, Pilot Study|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||f|f|f||||||||2017-10-10 22:18:13.777455|2017-10-10 22:18:13.777455
NCT02739867|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-01-16|||June 2016||2016-06-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Tumor-educated Platelets in Venous Thromboembolism|Platelet RNA Profiling to Detect Occult Cancer in Patients With Unprovoked Venous Thromboembolism|Recruiting||N/A|462|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     Platelet pellet, EDTA plasma, citrated plasma, and cell-free DNA   "|No||2017-10-10 22:18:13.867896|2017-10-10 22:18:13.867896
NCT02739854|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-06-02|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01|1 Year|Observational [Patient Registry]|||Prevalence of Atelectasis in Critical Trauma Patients|The Prevalence and Risk Factors for Lung Atelectasis in Patients With Critical Trauma Who Are Intubated and Mechanically Ventilated|Completed||N/A|338|Actual|Khon Kaen University|||1||f||||t||||||||||2017-10-10 22:18:13.9705|2017-10-10 22:18:13.9705
NCT02739841|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-09-09|||April 2016||2016-04-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Hemodynamic Responses to Ventilator Hyperinflation Technique|Acute Hemodynamic Responses to Ventilator Hyperinflation Technique in Critical Traumatic Patients With Pulmonary Complications|Recruiting||N/A|20|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-10-10 22:18:14.0311|2017-10-10 22:18:14.0311
NCT02739815|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-06-14|||April 2016||2016-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section|Comparative Study For Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section: A Randomised Controlled Trial|Completed||Phase 4|200|Actual|Talkha Central Hospital||4|||f||||f||||||||Undecided||2017-10-10 22:18:14.184255|2017-10-10 22:18:14.184255
NCT02739802|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-04-13|||March 15, 2016|Actual|2016-03-15|April 2017|2017-04-01|March 30, 2016|Actual|2016-03-30|March 30, 2016|Actual|2016-03-30||Interventional|SPF Assay||18751-Sun Protection Factor Assay.|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:18:14.293413|2017-10-10 22:18:14.293413
NCT02739789|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-06-07|||August 2016||2016-08-01|June 2017|2017-06-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Activating and Identifying Neural Responses to Social Rejection: a Combined tDCS and fMRI Study|Activating and Identifying Neural Responses to Social Rejection: a Combined Transcranial Direct Current Stimulation (tDCS) and Functional Magnetic Resonance Imaging (fMRI) Study|Recruiting||N/A|60|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-10-10 22:18:16.112912|2017-10-10 22:18:16.112912
NCT02739776|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-11|||April 2016||2016-04-01|April 2016|2016-04-01||||March 2017|Anticipated|2017-03-01||Observational|||Thermographic Imaging in Epidural Anesthesia|Infrared Thermographic Imaging for Early Assessment of Epidural Block Success in Obstetric Anesthesia|Not yet recruiting||N/A|50|Anticipated|John H. Stroger Hospital|||1||f||||f||||||||No||2017-10-10 22:18:16.194738|2017-10-10 22:18:16.194738
NCT02739763|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-05-27|||May 2016||2016-05-01|May 2016|2016-05-01|November 2020|Anticipated|2020-11-01|January 2020|Anticipated|2020-01-01||Interventional|CHMI-SIKA||Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)|Controlled Human Malaria Infection (CHMI) to Assess Human Immunity to P. Falciparum Using Sporozoites Administered by Direct Venous Inoculation|Recruiting||Phase 1|200|Anticipated|University of Oxford||1|||f||||t||||||||Yes|Study information will be made available through an open repository. The information to be made available will be anonymized so that there is no link to participants and will include data on antibody responses, parasite growth rates and any other data generated from samples obtained in this study, both generated from this current protocol or any future studies which will require additional ethical approval.|2017-10-10 22:18:16.254817|2017-10-10 22:18:16.254817
NCT02739750|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-04|||January 2016||2016-01-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|July 2019|Anticipated|2019-07-01||Observational|||Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease|Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease (CKD) Sub-study to Protocol Number 1308084213|Active, not recruiting||N/A|35|Actual|Indiana University|||1||f||||t||||||||||2017-10-10 22:18:16.340651|2017-10-10 22:18:16.340651
NCT02739737|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-14|||December 2013||2013-12-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Testing for the Presence of Authorship Bias in Peer Review|Testing for the Presence of Authorship Bias in Peer Review|Completed||N/A|119|Actual|University of Washington||2|||f||||f||||||||No||2017-10-10 22:18:16.41502|2017-10-10 22:18:16.41502
NCT02739724|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-12|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Benefits of Laparoscopy by Single Port Access for Adnexal Surgery|Comparison Between Classic and Single Port Access Laparoscopy for Adnexal Surgery on Postoperative Pain: a Randomized Study.|Active, not recruiting||N/A|108|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 22:18:16.484416|2017-10-10 22:18:16.484416
NCT02739711|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2016-08-03|||July 2016||2016-07-01|August 2016|2016-08-01|August 2021|Anticipated|2021-08-01|August 2017|Anticipated|2017-08-01||Interventional|REVERSE-FLOW||Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients With Myocardial Infarction and No-reflow|Prospective RandomizEd Study Comparing Glycoprotein IIb/IIIa Inhibitors VERsus Standard Therapy in patientS With Myocardial Infarction and Angiographic Evidence of No-reFLOW|Recruiting||Phase 4|120|Anticipated|University of Luebeck||2|||f||||t||||||||Undecided||2017-10-10 22:18:16.576464|2017-10-10 22:18:16.576464
NCT02739698|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-07-04|2017-03-28||July 2012|Actual|2012-07-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|November 2014|Actual|2014-11-01||Interventional|||Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia|Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia|Completed||Phase 2|32|Actual|Maimónides Biomedical Research Institute of Córdoba||2|||f||||f||||||||||2017-10-10 22:18:16.659526|2017-10-10 22:18:16.659526
NCT02739685|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-13|2017-04-12|||September 2016||2016-09-01|April 2017|2017-04-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|SCORE-CTO||Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion|Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Stents in Patients With Chronic Total Occlusion|Terminated||Phase 4|17|Actual|University of Luebeck||2||Slow enrollment, access to devices|f||||f||||||||Undecided||2017-10-10 22:18:16.884202|2017-10-10 22:18:16.884202
NCT02739672|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-01-24|||January 2, 2016|Actual|2016-01-02|April 2016|2016-04-01|April 6, 2016|Actual|2016-04-06|April 6, 2016|Actual|2016-04-06||Interventional|||Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, Replicate Crossover Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers|Completed||Phase 1|40|Actual|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||Undecided||2017-10-10 22:18:16.954459|2017-10-10 22:18:16.954459
NCT02739659|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-04-24|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer||Recruiting||N/A|61|Anticipated|Shanghai Proton and Heavy Ion Center||1|||f||||||||||||||2017-10-10 22:18:17.181563|2017-10-10 22:18:17.181563
NCT02739646|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-07-24|||July 2016||2016-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||The Representation of the Sensibility of the Breast on the Somatosensory Cortex|The Representation of the Sensibility of the Breast on the Somatosensory Cortex Using 7 Tesla fMRI: A Pilot Study|Recruiting||N/A|20|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 22:18:17.279643|2017-10-10 22:18:17.279643
NCT02739633|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-27|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas|Phase II Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas|Recruiting||Phase 2|47|Anticipated|Samyang Biopharmaceuticals Corporation||1|||f||||f||||||||No||2017-10-10 22:18:17.36453|2017-10-10 22:18:17.36453
NCT02739620|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-11-15|||April 2016||2016-04-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors|Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors|Recruiting||Phase 1/Phase 2|24|Anticipated|University of Vermont||2|||f||||f||||||||Yes|Research data (deidentified) which documents, supports and validates research findings will be stored on the University of Vermont College of Medicine computer system and will be made available upon final acceptance for publication of the major findings from the proposed studies. This includes raw data generated from all clinical and laboratory-based assessments under a data-sharing agreement.|2017-10-10 22:18:17.462418|2017-10-10 22:18:17.462418
NCT02739594|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-06-09|2016-06-09||February 2006||2006-02-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|COMPARE|Intent-to-Treat (ITT) Population: All participants who were randomized and received at least one dose of study medication and for whom at least one measurement of creatinine clearance (CrCl) was obtained.|Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma|COMPARE: Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Patients With Multiple Myeloma|Terminated||Phase 3|89|Actual|Hoffmann-La Roche|The Study was terminated as a result of slow recruitment. At the time of the decision to halt recruitment, the treatment duration was shortened to 40 weeks (instead of 92 weeks) for those participants who had not yet reached Week 48.|2||Slow recruitment|f||||||||||||||2017-10-10 22:18:17.699786|2017-10-10 22:18:17.699786
NCT02739581|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-08-29|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis|Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis|Not yet recruiting||N/A|140|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 22:18:18.647486|2017-10-10 22:18:18.647486
NCT02739568|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-11-29|||April 2016||2016-04-01|November 2016|2016-11-01||||October 2016|Actual|2016-10-01||Interventional|HAROSA3||Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA|Efficacy and Safety of Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness|Completed||Phase 3|202|Actual|Bioprojet||2|||f||||t||||||||||2017-10-10 22:18:18.741063|2017-10-10 22:18:18.741063
NCT02739555|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-07-24|||June 23, 2016||2016-06-23|December 2016|2016-12-01|November 23, 2020|Anticipated|2020-11-23|October 28, 2019|Anticipated|2019-10-28||Interventional|BISPHOO||Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma|Non-inferiority Trial of Three Cycles of Zoledronic Acid Versus Percutaneous Thermal Ablation in Osteoid Osteoma|Recruiting||Phase 3|100|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:18:18.917513|2017-10-10 22:18:18.917513
NCT02739542|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-12-28|||March 2016||2016-03-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|ARISE||Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)|Multi-center, Randomized, Double-blinded Assessment of Tecfidera® in Extending the Time to a First Attack in Radiologically Isolated Syndrome (RIS) (ARISE)|Recruiting||Phase 4|210|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 22:18:19.015212|2017-10-10 22:18:19.015212
NCT02739529|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-27|||April 2016||2016-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer|Dose-dense Paclitaxel (Genexol®-PM) Once a Week in Combination With Carboplatin Every 3 Weeks for Gynecologic Cancer (Adult Solid Tumor): a Phase I Trial|Recruiting||Phase 1|18|Anticipated|Samyang Biopharmaceuticals Corporation||3|||f||||f||||||||No||2017-10-10 22:18:19.118201|2017-10-10 22:18:19.118201
NCT02739516|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-05-17|||June 2014||2014-06-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility|Concomitant Administration of Follicle-stimulating Hormone at the Time of Human Chorionic Gonadotropin Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility|Completed||Phase 3|108|Actual|Benha University||2|||f||||||||||||||2017-10-10 22:18:19.200179|2017-10-10 22:18:19.200179
NCT02739503|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-01-06|||April 2016||2016-04-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Fetal Head Circumference as a Predictor of Operative Delivery|Fetal Head Circumference as a Predictor of Operative Delivery|Recruiting||N/A|500|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||No||2017-10-10 22:18:19.281875|2017-10-10 22:18:19.281875
NCT02739490|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-04-14|||April 2014||2014-04-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Effect of the Pelvic Loin Musculature Training on the Dynamic Hip Stabilization|Effect of the Pelvic Loin Musculature Training on the Dynamic Hip Stabilization: Random Clinical Trial|Completed||N/A|20|Actual|Universidade Estadual do Centro-Oeste||2|||f||||f||||||||Undecided||2017-10-10 22:18:19.375382|2017-10-10 22:18:19.375382
NCT02739477|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-05-03|||April 2016||2016-04-01|May 2016|2016-05-01||||August 2016|Anticipated|2016-08-01||Interventional|FORCE||Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen|Tolerance and Activity Assessment of High Doses of Favipiravir in Male Survivors With Ebola Virus in the Semen|Recruiting||Phase 2|18|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||||||||||||2017-10-10 22:18:19.439909|2017-10-10 22:18:19.439909
NCT02739464|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-06-28|||July 2015||2015-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|MP-10||Effect of In-Patient Exercise Training on Length of Hospitalization in Burned Patients|Randomized, Controlled, Multicenter Study of the Effect of In-Patient Exercise Training on Length of Hospitalization, Mental Health, and Physical Performance in Burned Patients|Recruiting||N/A|96|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||Yes|ONLY de-identified data will be deposited with main site (UTMB). Subsequently, if data is shared among all sites, it will be always in de-identified manner and stripped of all information that could identify the participant.|2017-10-10 22:18:19.540281|2017-10-10 22:18:19.540281
NCT02739451|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-06-19|||May 2016||2016-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|HIGH||A Randomised Controlled Trial of High-Flow Nasal Oxygen Versus Standard Oxygen Therapy in Critically Ill Immunocompromised Patients|A Randomised Controlled Trial of High-Flow Nasal Oxygen Versus Standard Oxygen Therapy in Critically Ill Immunocompromised Patients|Recruiting||N/A|778|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-10 22:18:19.693207|2017-10-10 22:18:19.693207
NCT02739438|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-17|||May 2016||2016-05-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|SELECT||The Study of ELEctronic Cigarette Toxicity in a Human Model in Vivo Model of Inflammation and Vascular Dysfunction|The Study of ELEctronic Cigarette Toxicity in a Human Model in Vivo Model of Inflammation and Vascular Dysfunction (SELECT)|Not yet recruiting||N/A|30|Anticipated|Queen's University, Belfast|||3||f||||t||||||Samples With DNA|"     Blood samples will be taken at initially for screening then at baseline, 24 hours after first     bronchoscopy, prior to the inhalation of LPS 6 weeks later and 24 hours post LPS inhalation.      Urine sample will be collected before both camera tests. Bronchoalveolar lavage fluid will be     taken at baseline then 6 weeks later.   "|No||2017-10-10 22:18:19.836247|2017-10-10 22:18:19.836247
NCT02739425|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-03-14|||September 22, 2016|Actual|2016-09-22|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SMART||The Efficacy of Sentimag in Detection of Sentinel Node Biopsy|SMART Study: Sentimag Along With Routine Technique in Detection of Sentinel Node Biopsy|Recruiting||N/A|283|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||1|||f||||t||||||||Undecided||2017-10-10 22:18:19.951961|2017-10-10 22:18:19.951961
NCT02739412|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-05-30|||November 2016||2016-11-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients|Efficacy of Low Dose, Subcutaneous Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients|Recruiting||Phase 2|12|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f||||||||No||2017-10-10 22:18:20.083552|2017-10-10 22:18:20.083552
NCT02739399|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-12-08|||February 2016||2016-02-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Effects of Phenylephrine on Cardiac Preload|The Dynamic Effects of Phenylephrine on Preload and Cardiac Output in Patients Under General Anaesthesia|Completed||Phase 4|26|Actual|Algemeen Ziekenhuis Maria Middelares||1|||f||||t||||||||No||2017-10-10 22:18:20.186251|2017-10-10 22:18:20.186251
NCT02739386|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-04-25|||February 29, 2016|Actual|2016-02-29|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Observational|||Study of Autoimmune Disease Complications Following Ipilimumab Treatment Among Melanoma Patients With Underlying Autoimmune Diseases|Evaluation of Hospitalization for Complications of Autoimmune Disease Following Ipilimumab Treatment Among Melanoma Patients With Underlying Autoimmune Diseases Treated in Routine Clinical Practices in the US|Completed||N/A|370|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:18:20.275507|2017-10-10 22:18:20.275507
NCT02739373|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-03-03|||April 2016||2016-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects|Randomized, Double-Blinded, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects|Completed||Phase 1|31|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:18:20.357694|2017-10-10 22:18:20.357694
NCT02739360|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-29|||May 4, 2016|Actual|2016-05-04|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820|An Open Label, Roll Over Study to Provide Idelalisib to Subjects Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820|Active, not recruiting||Phase 4|3|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-10 22:18:20.454689|2017-10-10 22:18:20.454689
NCT02739347|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-12-06|||May 2016||2016-05-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia|Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia|Recruiting||N/A|80|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Yes|Data will be open to sharing after primary findings of study have been published.|2017-10-10 22:18:20.533161|2017-10-10 22:18:20.533161
NCT02739334|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-14|||March 2016||2016-03-01|April 2016|2016-04-01||||June 2017|Anticipated|2017-06-01||Interventional|ENRICH||PALS-CATCH Intervention for Obesity Prevention Among At-risk Toddlers|PALS-CATCH Intervention for Obesity Prevention Among At-risk Toddlers|Recruiting||N/A|60|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 22:18:20.65571|2017-10-10 22:18:20.65571
NCT02739308|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-14|||April 2016||2016-04-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Proprioceptive Training on Neurofunctional Control and Ankle Sprains Incidence|Effects of Proprioceptive Training on Neurofunctional Control and Ankle Sprains Incidence in Fencers: a Randomized Controlled Trial|Recruiting||N/A|18|Anticipated|Federal University of Rio Grande do Sul||2|||f||||t||||||||||2017-10-10 22:18:20.874146|2017-10-10 22:18:20.874146
NCT02739295|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-10-28|||July 2016||2016-07-01|October 2016|2016-10-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|NeupoNET||G-CSF in the Treatment of Toxic Epidermal Necrolysis|Evaluation of G-CSF as a Treatment of Toxic Epidermal Necrolysis|Recruiting||Phase 4|10|Anticipated|University Hospital of Liege||2|||f||||f||||||||No||2017-10-10 22:18:21.008343|2017-10-10 22:18:21.008343
NCT02739282|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-12-20|||June 2016||2016-06-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs|Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs: Concrete Benefit, Correlation With Clinical Effects and Usefulness of Saliva Samples|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||Yes|Yes, for further studies on our site|2017-10-10 22:18:21.133734|2017-10-10 22:18:21.133734
NCT02739269|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-07-29|||April 2016||2016-04-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Antimullerian Hormone Versus Antral Follicle Count for Determination of Gonadotrophin Dosing in IVF|A Randomised Trial to Compare Antral Follicle Count and Serum Anti-Mullerian Hormone Level for Determination of Gonadotrophin Dosing in In-vitro Fertilisation|Recruiting||N/A|200|Anticipated|The University of Hong Kong||2|||f||||f||||||||Undecided|No such plan at the moment|2017-10-10 22:18:21.2444|2017-10-10 22:18:21.2444
NCT02739256|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-03-20|||February 2016||2016-02-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||Early Versus Late Voiding Trials After Prolapse Repair|Normal Voiding Function After Surgical Repair of Pelvic Organ Prolapse: A Randomized Trial Comparing Day of Surgery Retrograde Void Trials to Standard Postoperative Day One Retrograde Void Trials|Terminated||N/A|57|Actual|University of Pittsburgh||2||Institutional implementation of a same day discharge pathway|f||||f||||||||No||2017-10-10 22:18:21.386265|2017-10-10 22:18:21.386265
NCT02739243|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|PREPARE||A Clinical Trial on a Group Treatment for Distressed Caregivers of Cancer Patients|Addressing the Hidden Patient - A Randomised-controlled Trial of a Tailored Group Intervention for Caregivers of Cancer Patients (PREPARE)|Withdrawn||Phase 3|0|Actual|Heidelberg University||2||Enrolment slower than anticipated accrual.|f||||f||||||||Undecided||2017-10-10 22:18:21.517548|2017-10-10 22:18:21.517548
NCT02739230|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-14|||December 2013||2013-12-01|April 2016|2016-04-01||||October 2015|Actual|2015-10-01||Interventional|||Comparing Pain Relief Between Exparel® Injection vs. On-Q Catheter as the Postsurgical Analgesia Following Total Knee Arthroplasty (TKA)||Completed||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-10 22:18:21.607984|2017-10-10 22:18:21.607984
NCT02739217|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-04-11|||December 2015||2015-12-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome|A Phase 2, Single-Arm, Open-Label Study to Evaluate the Safety and Tolerability of PBI-4050 and of Its Effects on the Inflammatory, Fibrosis, Diabetes and Obesity Biomarkers in Subjects With Alström Syndrome|Recruiting||Phase 2|18|Anticipated|ProMetic BioSciences Inc.||1|||f||||t||||||||No||2017-10-10 22:18:21.789979|2017-10-10 22:18:21.789979
NCT02739204|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-11|||November 2013||2013-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma|Development of Novel Diagnostic Tools and Therapeutic Strategies for Oral Cancer|Recruiting||Phase 2|270|Anticipated|China Medical University Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:18:21.893383|2017-10-10 22:18:21.893383
NCT02739191|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|NEWTON||Negative Pressure Wound Therapy for Surgical Wounds of the Foot and Ankle|Negative Pressure Wound Therapy for Surgical Wounds of the Foot and Ankle|Recruiting||Phase 4|60|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 22:18:21.994797|2017-10-10 22:18:21.994797
NCT02739178|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-05-10|||April 2016||2016-04-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||The Sukhshanti Study: Effect of a Sanitation Intervention on Women's Health|The Sukhshanti Study: a Controlled Before-and-after Mixed Methods Study of the Effect of a Sanitation Intervention on Women's Health in Bihar, India|Enrolling by invitation||N/A|2400|Anticipated|University of Oklahoma||2|||f||||f||||||||Yes|De-identified data will be made available after completion of the study.|2017-10-10 22:18:22.07828|2017-10-10 22:18:22.07828
NCT02739165|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-07-12|||May 2016||2016-05-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis|Phase III Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Multicenter Randomized Placebo-controlled Double-blind Study to Assess the Efficacy and Safety of ART-123|Recruiting||Phase 3|74|Anticipated|Asahi Kasei Pharma Corporation||2|||f||||||||||||||2017-10-10 22:18:22.175503|2017-10-10 22:18:22.175503
NCT02739152|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-12|||April 2015||2015-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|TRIAGE||TRIAGE: TRIage of Sepsis At emerGency dEpartment|TRIAGE: TRIage of Sepsis At emerGency dEpartment|Recruiting||N/A|515|Anticipated|BioMérieux|||1||f||||t||||||||||2017-10-10 22:18:22.329962|2017-10-10 22:18:22.329962
NCT02739139|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-04-10|||February 2013||2013-02-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy Study of AlphaBRAIN Administered Orally|Randomized Double-blind, Placebo-Controlled, Parallel Group, Efficacy Study of AlphaBRAIN(TM) Administered Orally|Completed||Phase 2|73|Actual|Onnits Labs, LLC||2|||f||||||||||||||2017-10-10 22:18:22.482102|2017-10-10 22:18:22.482102
NCT02739126|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-04-10|||January 2015||2015-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|R-EBUST2||Comparing the Diagnostic Yield of Radial EBUS Guided Biopsies When Using a Thick (1.7mm) Vs. Thin (1.4 mm) USS Probe.|Comparing the Diagnostic Yield of Radial Endo-Bronchial Ultra-Sound Guided Biopsy When Using a Thick (1.7mm) With an Aspiration Needle Biopsy Vs. a Thin USS Probe (1.4mm), in Peripheral Lung Lesions.|Recruiting||N/A|88|Anticipated|Middlemore Hospital, New Zealand||2|||f||||t||||||||No||2017-10-10 22:18:22.568871|2017-10-10 22:18:22.568871
NCT02739087|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-10-31|||March 2015||2015-03-01|October 2016|2016-10-01|March 2025|Anticipated|2025-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Radiation-Free Heart Catheterization Using MRI|Radiation-Free Heart Catheterization Using MRI|Recruiting||Phase 1|50|Anticipated|Children's Research Institute||1|||f||||f||||||||No||2017-10-10 22:18:22.88677|2017-10-10 22:18:22.88677
NCT02739074|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-11|||March 2016||2016-03-01|March 2016|2016-03-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Observational|DIABOLOPIG||"Effectiveness of Metal Protheses Covered in Diabolo in Treatment of Necrosis of Origin Pancreatic: Trial DIABOLOPIG"||Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||||||||||||2017-10-10 22:18:23.023409|2017-10-10 22:18:23.023409
NCT02739061|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-05-03|||April 2016||2016-04-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder|Shanghai Mental Health Center in China|Recruiting||N/A|240|Anticipated|Shanghai Mental Health Center||3|||f||||f||||||||No||2017-10-10 22:18:23.098383|2017-10-10 22:18:23.098383
NCT02739048|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-20|||September 2015||2015-09-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.||Recruiting||N/A|80|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||||Undecided||2017-10-10 22:18:23.21923|2017-10-10 22:18:23.21923
NCT02739035|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|MUA||MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty|Manipulation Under Anesthesia (MUA) to Treat Postoperative Stiffness After Total Knee Arthroplasty: A Multicenter Randomized Clinical Trial|Recruiting||N/A|24|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 22:18:23.336749|2017-10-10 22:18:23.336749
NCT02739022|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-04-11|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Feasibility Trial of the Early Psychological Support for the Critically Ill|Feasibility Trial of the Early Psychological Support for the Critically Ill|Not yet recruiting||N/A|15|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 22:18:23.498377|2017-10-10 22:18:23.498377
NCT02738996|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-11|||May 2016||2016-05-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|Just_StandUp||Role of Interrupting Sedentary Time in Management of Type-2 Diabetes|Investigating the Response of Glycaemic Excursions in Type-2 Diabetes to Interrupting Prolonged Sedentary Behaviour (Sitting)|Not yet recruiting||N/A|24|Anticipated|Glasgow Caledonian University||6|||f||||f||||||||No||2017-10-10 22:18:23.690162|2017-10-10 22:18:23.690162
NCT02738983|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-11|||January 2012||2012-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||RT Plus EGFR-TKI for Wild-type NSCLC|Thoracic Radiotherapy Combined With EGFR-TKI for Wild-type Non-small Cell Lung Cancer|Recruiting||Phase 2|22|Anticipated|Hangzhou Cancer Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:18:23.803079|2017-10-10 22:18:23.803079
NCT02738957|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-14|||September 2009||2009-09-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Prenatal Counseling on Breastfeeding Rates in Twins|Effect of Prenatal Counseling on Breastfeeding Rates in Twins|Completed||N/A|116|Actual|University of Sao Paulo||2|||f||||f||||||||No|No data will be shared|2017-10-10 22:18:24.002247|2017-10-10 22:18:24.002247
NCT02738944|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-05-08|||November 2016||2016-11-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|SPIRIT||Study to Promote Innovation in Rural Integrated Telepsychiatry|Integrated vs. Referral Care for Complex Psychiatric Disorders in Rural FQHCs|Recruiting||N/A|1000|Anticipated|University of Washington||2|||f||||t||||||||Yes|If requested by the funding agency (the Patient Centered Outcomes Research Institute), a complete, cleaned and de-identified copy of the final quantitative dataset used to test the stated hypotheses will be made available to other researchers within one year of the study completion date. The final data set will include de-identified demographic and clinical data obtained from the telephone survey for all patients participating in the comparative effectiveness trial. Along with the data set, we will create a code book documenting all variables (e.g., common names for single questionnaire items, and scoring algorithms for derived variables).|2017-10-10 22:18:24.086444|2017-10-10 22:18:24.086444
NCT02738931|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-01-16|||May 2016||2016-05-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations|A Phase I, Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Lamivudine in Healthy Subjects|Completed||Phase 1|30|Actual|ViiV Healthcare||6|||f||||f||||||||||2017-10-10 22:18:24.247748|2017-10-10 22:18:24.247748
NCT02738918|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-05-31|||December 2014||2014-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BELACOR||Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.|Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study|Active, not recruiting||Phase 2|91|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||No||2017-10-10 22:18:24.383327|2017-10-10 22:18:24.383327
NCT02738905|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-12-16|||July 2016||2016-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease|Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease|Recruiting||Early Phase 1|15|Anticipated|University of Kansas Medical Center||1|||f||||f||||||||No||2017-10-10 22:18:24.459575|2017-10-10 22:18:24.459575
NCT02738892|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-11-17|||August 2015||2015-08-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Observational|||Preventing Preterm Birth in Zambia|Z 1401 - Preventing Preterm Birth in Zambia|Recruiting||N/A|4000|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     Blood, urine, vaginal, placental, and umbilical cord samples will be placed in a     biorepository for later analysis to identify inflammatory markers, chemokines, cytokines, and     infections contributing to parturition and preterm delivery.   "|||2017-10-10 22:18:24.540319|2017-10-10 22:18:24.540319
NCT02738879|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-29|||May 9, 2016|Actual|2016-05-09|August 2017|2017-08-01|January 29, 2018|Anticipated|2018-01-29|January 15, 2018|Anticipated|2018-01-15||Interventional|||Randomized Sitagliptin Withdrawal Study (MK-0431-845)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of the Continuation of Sitagliptin Compared With the Withdrawal of Sitagliptin During Initiation and Titration of Insulin Glargine (LANTUS®) in Subjects With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 3|700|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:18:24.639763|2017-10-10 22:18:24.639763
NCT02738866|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-10-05|||August 2016||2016-08-01|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor|Phase II Trial of Palbociclib With Fulvestrant in Individuals With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Who Have Progressed on Treatment With Palbociclib and an Aromatase Inhibitor|Recruiting||Phase 2|100|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 22:18:24.94849|2017-10-10 22:18:24.94849
NCT02738840|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-11-10|||October 2016||2016-10-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|October 2025|Anticipated|2025-10-01||Observational|Prodigy MRI||A Post-Market Study Evaluating the MR Conditional Neuromodulation Systems|A Post-Market Study Evaluating the MR Conditional Neuromodulation Systems|Recruiting||N/A|49|Anticipated|St. Jude Medical|||1||f||||f||||||||No||2017-10-10 22:18:25.176556|2017-10-10 22:18:25.176556
NCT02738827|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-05-30|||November 2015||2015-11-01|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|February 1, 2017|Actual|2017-02-01||Interventional|||Diode Laser Treatment of Bladder Tumors|Diode Laser Treatment of Pta Low Grade Bladder Tumors in the Outpatient Department.|Completed||N/A|21|Actual|University Hospital Bispebjerg and Frederiksberg||1|||f||||f||||||||No||2017-10-10 22:18:25.267115|2017-10-10 22:18:25.267115
NCT02738814|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-04-13|||April 2016||2016-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Propofol for Treatment on Emergence Agitation|Clinical Study on the Effects of Propofol for Treatment on Emergence Agitation After Sevoflurane Anesthesia in Pediatric Strabismus Surgery|Enrolling by invitation||Phase 4|100|Anticipated|Korea University Anam Hospital||2|||f||||t||||||||No||2017-10-10 22:18:25.349208|2017-10-10 22:18:25.349208
NCT02738801|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-09|||March 2016||2016-03-01|June 2017|2017-06-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|||Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690|Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter, Exploratory Phase IIa Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 Administered for 12 Weeks in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 2|23|Actual|Galapagos NV||2|||f||||t|f|f||||||Undecided||2017-10-10 22:18:25.475836|2017-10-10 22:18:25.475836
NCT02738788|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-07|||May 2015||2015-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|||Airway Changes in Patients Undergoing Elective Surgical Procedures in the Prone and Trendelenburg Positions|Assessing Intraoperative Airway Changes and Their Regression to Baseline in Patients Undergoing Elective Surgical Procedures in the Prone and Trendelenburg Positions|Active, not recruiting||N/A|180|Anticipated|Tufts Medical Center|||1||f||||f||||||||||2017-10-10 22:18:25.62396|2017-10-10 22:18:25.62396
NCT02738775|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-01-09|||April 2016||2016-04-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase 2 Study of Ublituximab in Patients With Relapsing Forms of Multiple Sclerosis|A Placebo-Controlled Multi-Center Phase 2 Study of Ublituximab, a Third-Generation Anti-CD20 Monoclonal Antibody, in Patients With Relapsing Forms of Multiple Sclerosis.|Recruiting||Phase 2|40|Anticipated|TG Therapeutics, Inc.||2|||f||||t||||||||Undecided|Data will be shared after study completion via publication|2017-10-10 22:18:25.694404|2017-10-10 22:18:25.694404
NCT02738762|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-09-05|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Glutamine Supplementation|Glutamine Supplementation Guided by Plasma Glutamine Levels|Not yet recruiting||N/A|80|Anticipated|Medical Centre Leeuwarden||2|||f||||f|f|f||||||||2017-10-10 22:18:25.813898|2017-10-10 22:18:25.813898
NCT02738749|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-04-11|||June 2014||2014-06-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study|Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study|Recruiting||N/A|450|Anticipated|Rhode Island Hospital||1|||f||||f||||||||No||2017-10-10 22:18:25.899978|2017-10-10 22:18:25.899978
NCT02738736|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|April 2018|Anticipated|2018-04-01||Interventional|COSIP-1||Clarifying Optimal Sodium Intake Project|Clarifying Optimal Sodium Intake Project- Objective 1|Recruiting||Phase 2|286|Anticipated|University College Hospital Galway||2|||f||||t||||||||No||2017-10-10 22:18:26.005342|2017-10-10 22:18:26.005342
NCT02738723|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-04-10|||January 2016||2016-01-01|April 2016|2016-04-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC|Stereotactic Body Radiation Therapy Compared With Intensity Modulated Radiation Therapy Concurrently With Chemotherapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Recruiting||Phase 2|50|Anticipated|Third Military Medical University||2|||f||||t||||||||No||2017-10-10 22:18:26.102875|2017-10-10 22:18:26.102875
NCT02738710|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Post-operative Pain at Umbilical Wound After Laparoscopic Cholecystectomy With Transumbilical Versus Infraumbilical Incision||Recruiting||N/A|100|Anticipated|Thammasat University||2|||f||||f||||||||Undecided||2017-10-10 22:18:26.214783|2017-10-10 22:18:26.214783
NCT02738697|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-11-01|||January 2016||2016-01-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection|The Clinical Randomized Trial of Adjuvant Chemotherapy With FOLFOX in HCC Patients at High Risk After Resection|Recruiting||Phase 3|290|Anticipated|Sun Yat-sen University||2|||f||||f||||||||No||2017-10-10 22:18:26.310265|2017-10-10 22:18:26.310265
NCT02738684|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-13|||April 2016||2016-04-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test|A Small Sample Exploratory Study to Predict Gefitinib' s Efficacy for Late Stage Lung Adenocarcinoma Patients by Plasma Free Nucleic Acids EGFR Gene Mutation Test|Not yet recruiting||N/A|100|Anticipated|Southwest Hospital, China|||1||f||||t||||||Samples With DNA|"     predict gefitinib' s efficacy for late stage lung adenocarcinoma patients by plasma free     nucleic acids EGFR gene mutation test   "|Yes||2017-10-10 22:18:26.426583|2017-10-10 22:18:26.426583
NCT02738671|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-03-14|||January 2016||2016-01-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Relationship Between Diabetes and Cognitive Impairment Based on Olfactory Function Assessment and Functional MRI|The Cross-sectional and Longitudinal Study of Relationship Between Diabetes and Cognitive Impairment by Olfactory Function Assessment and Functional MRI in Obese and Normal Weight Diabetic Patients|Recruiting||N/A|150|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|||3||f||||||||||||||2017-10-10 22:18:26.495153|2017-10-10 22:18:26.495153
NCT02738658|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-15|||March 2015||2015-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|BVS-Flow||Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year|Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated|Active, not recruiting||Phase 4|70|Anticipated|Institut d'Investigació Biomèdica de Bellvitge||2|||f||||f||||||||||2017-10-10 22:18:26.612596|2017-10-10 22:18:26.612596
NCT02738645|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit|A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit|Recruiting||N/A|800|Anticipated|Beijing Chao Yang Hospital|||1||f||||f||||||||||2017-10-10 22:18:26.700436|2017-10-10 22:18:26.700436
NCT02738632|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-11-22|||May 2015||2015-05-01|January 2016|2016-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients|Randomized, Double-Blind, Multi-Center, Phase 3 Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Hydrochlorothiazide Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients Not Controlled by Telmisartan/Amlodipine Combination|Completed||Phase 3|300|Anticipated|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||No||2017-10-10 22:18:26.788591|2017-10-10 22:18:26.788591
NCT02738619|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-13|||March 2016||2016-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Allergic Rhinitis, Immunotherapy and Vitamin d|Vitamin D Supplementation as an Adjuvant Therapy for Specific Immunotherapy in Patients With Allergic Rhinitis.|Recruiting||Phase 2/Phase 3|60|Anticipated|Hospital General de Mexico||2|||f||||t||||||||Yes||2017-10-10 22:18:26.865189|2017-10-10 22:18:26.865189
NCT02738606|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2017-08-17|||May 25, 2016|Actual|2016-05-25|August 2017|2017-08-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|LUNA||Trial of Liver Resection Versus No Surgery in Patients With Liver and Unresectable Pulmonary Metastases From Colorectal Cancer (Liver Resection With Unresectable Lung Nodules From Colorectal Adenocarcinoma - LUNA)|Randomized Controlled Phase II Trial of Liver Resection Versus No Surgery in Patients With Liver and Unresectable Pulmonary Metastases From Colorectal Cancer|Recruiting||Phase 2|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 22:18:26.964005|2017-10-10 22:18:26.964005
NCT02738593|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-11|||April 2016||2016-04-01|April 2016|2016-04-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Observational|||Detection Cell Free DNA in Lung Cancer Patients|Using Next Generation Sequencing (NGS) Method to Detect Circulating Free DNA (Cf-DNA) and Explore the Resistance and Prognosic Mechanism of Third Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine-kinase Inhibitor (TKI) in Advanced Non-small Cell Lung Cancer (NSCLC) Patients: a Single Center Study|Active, not recruiting||N/A|124|Anticipated|Sun Yat-sen University|||1||f||||f||||||Samples With DNA|"     periphereal blood 10ml,centrifuge:4℃、2400g、10min,extracted plasma and stored in -80°     refrigerator.      fresh tumor tissue sample,store in freezing medium within 2 hours. FFPE tumor tissue.   "|Undecided||2017-10-10 22:18:27.069133|2017-10-10 22:18:27.069133
NCT02738580|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-04-26|||October 18, 2016|Actual|2016-10-18|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ESTEFOL||Follicular Steroid Genesis in Controlled Ovarian Stimulation|Analysis of Follicular Steroid Synthesis During Controlled Ovarian Stimulation With Recombinant FSH vs HMG in GnRH Antagonist Cycles|Recruiting||Phase 4|110|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||t||||||||No||2017-10-10 22:18:27.137878|2017-10-10 22:18:27.137878
NCT02738567|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-10|||April 2016||2016-04-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|1 Day|Observational [Patient Registry]|||Assessment of Adverse Cardiac Events Using Local Anesthesia With Adrenaline||Not yet recruiting||N/A|500|Anticipated|Meir Medical Center|||2||f||||f||||||||No||2017-10-10 22:18:27.234328|2017-10-10 22:18:27.234328
NCT02738554|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Off Treatment Durability in Chronic Hepatitis B With Good Immune Control|Determining the Optimal Hepatitis B Surface Antigen Level for Treatment Cessation of Nucleoside Analogue Therapy in Chronic Hepatitis B: a Prospective Study|Recruiting||N/A|140|Anticipated|The University of Hong Kong||1|||f||||f||||||||No||2017-10-10 22:18:27.301726|2017-10-10 22:18:27.301726
NCT02738541|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-13|||August 2015||2015-08-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Anti-calculus Efficacy of a Dentrifice Containing Sodium Pyrophosphate and Potassium Pyrophosphate in Heavy Calculus Formers|Evaluation of Anti-calculus Efficacy of a Dentrifice Containing Sodium Pyrophosphate and Potassium Pyrophosphate in Heavy Calculus Formers|Completed||Phase 2|60|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||||||||||||2017-10-10 22:18:27.410735|2017-10-10 22:18:27.410735
NCT02738528|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-08|||September 2014||2014-09-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||MENTAL PRACTICE IN MOTOR LEARNING OF BRUSHING AND PARKINSON DISEASE|APPLICATION OF MENTAL PRACTICE IN MOTOR LEARNING OF BRUSHING ON PEOPLE WITH PARKINSON|Completed||N/A|35|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||No||2017-10-10 22:18:27.488053|2017-10-10 22:18:27.488053
NCT02738515|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-13|||July 2015||2015-07-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Boric Acid in Degree 2 Furcation Defect|Clinical Efficacy of Subgingivally Delivered 0.75% Boric Acid Gel as an Adjunct to Mechanotherapy in Chronic Periodontitis: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|48|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||||||||||||2017-10-10 22:18:27.549457|2017-10-10 22:18:27.549457
NCT02738502|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-08-17|||June 2016||2016-06-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|MONOGEST||Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors|An Open-label Phase II Pilot Study of Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors|Recruiting||Phase 2|120|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||Undecided||2017-10-10 22:18:27.638255|2017-10-10 22:18:27.638255
NCT02738489|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-11-22|||April 2016||2016-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Melanoma Subjects|An Open-Label, Single Center, Nonrandomized, Dose-Escalation Phase 1 Study to Evaluate Safety and Tolerability of SHR-1210 in Subjects With Advanced Melanoma|Enrolling by invitation||Phase 1|36|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||No||2017-10-10 22:18:27.769408|2017-10-10 22:18:27.769408
NCT02738476|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-07-19|||April 2016||2016-04-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|December 2019|Anticipated|2019-12-01|3 Years|Observational [Patient Registry]|||Outcomes of MAKOplasty Patellofemoral Arthroplasty in Younger Active Patients|Investigation of the Clinical Outcomes of Patellofemoral Arthroplasty Implanted With the MAKOplasty Knee Resurfacing System in Younger Active Patients|Recruiting||N/A|60|Anticipated|Cincinnati Sportsmedicine Research and Education Foundation|||1||f||||t||||||||||2017-10-10 22:18:27.843423|2017-10-10 22:18:27.843423
NCT02738463|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-11|||March 2016||2016-03-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|2 Months|Observational [Patient Registry]|LBW||Maternal Serum Ferritin and Low Neonatal Birth Weight|Role of Maternal Serum Ferritin in the Prediction of Low Neonatal Birth Weight|Active, not recruiting||N/A|64|Anticipated|Ain Shams Maternity Hospital|||2||f||||t||||||Samples Without DNA|"     serum   "|Yes||2017-10-10 22:18:27.914968|2017-10-10 22:18:27.914968
NCT02738450|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-05-09|||March 2016||2016-03-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|3 Star||Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome|A Phase Ib Multi-Center, Double-Blind, Randomized, Placebo-Controlled Dose Escalation Study of the Safety, Tolerability and Immunogenicity of ACI-24 in Adults With Down Syndrome|Recruiting||Phase 1|24|Anticipated|AC Immune SA||3|||f||||t||||||||Undecided||2017-10-10 22:18:28.010923|2017-10-10 22:18:28.010923
NCT02738437|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-11|||August 2011||2011-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Kryptonite - a Novel Osteosynthesis Method for Median Sternotomy|Kryptonite - a Novel Osteosynthesis Method for Median Sternotomy|Completed||N/A|8|Actual|Aarhus University Hospital||2|||f||||t||||||||Yes||2017-10-10 22:18:28.13665|2017-10-10 22:18:28.13665
NCT02738424|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-07-17|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ADC||Reproductibility of Lumbar Spine ADC Based on Different Post-processing Softwares|Reproductibility of Lumbar Spine ADC Based on Different Post-processing Softwares|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||||||2017-10-10 22:18:28.205496|2017-10-10 22:18:28.205496
NCT02738411|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-15|||May 12, 2017|Actual|2017-05-12|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|PrimiBiota||Influence of Intestinal Microbiota Implantation in Preterm Infants on Microbiota and Immune Orientation at 3 Years|Influence of Intestinal Microbiota Implantation Parameters in the Neonatal Period in Premature Infants on Microbiota Profiles and Immune Orientation at 3 Years of Age|Recruiting||N/A|130|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||Samples Without DNA|"     Blood samples will be drawn at 36 months for lymphocyte subpopulation characterization,     stimulation tests and biobanking. Fecal samples at indicated time points will also be banked     (bacterial rDNA will be extracted).   "|||2017-10-10 22:18:28.286449|2017-10-10 22:18:28.286449
NCT02738398|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-12-06|||April 2016||2016-04-01|December 2016|2016-12-01||||April 2017|Anticipated|2017-04-01||Interventional|||FDG PET/CT in Lung Cancer Staging|Optimizing Lung Cancer Nodal Staging With FDG PET/CT Through Improved Image Acquisition and Reconstruction|Recruiting||N/A|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:18:28.409244|2017-10-10 22:18:28.409244
NCT02738385|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|HIIT-Heart||Intensity Training and Cardiovascular Health in Colombian Adults|High Intensity Interval- vs Moderate Training on Biomarkers of Endothelial and Cardiovascular Health in Adults: Effect of Postprandial Period|Completed||N/A|30|Actual|Universidad Santo Tomas||2|||f||||t||||||||No||2017-10-10 22:18:28.467658|2017-10-10 22:18:28.467658
NCT02738372|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-07-12|||November 2016||2016-11-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01|24 Months|Observational [Patient Registry]|||Influence of Biopsychosocial Factors and Central Sensitization in Predicting the Recovery of Chronic Shoulder Pain|The Influence of Biopsychosocial Factors and Peripheral and/or Central Sensitization in Predicting the Recovery of Chronic Shoulder Pain: a Prospective Cohort Study. Study Protocol|Enrolling by invitation||N/A|242|Anticipated|University of Malaga|||1||f||||t||||||||||2017-10-10 22:18:28.53925|2017-10-10 22:18:28.53925
NCT02738359|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-17|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2023|Anticipated|2023-10-01|October 2020|Anticipated|2020-10-01|3 Years|Observational [Patient Registry]|FAMCAP||Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening|PHRC-K 2015 Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening, in First Degree Relatives of Patients With Colorectal Neoplasia: a Prospective Randomized Study.|Not yet recruiting||N/A|3250|Anticipated|Hôpital Edouard Herriot|||3||f||||f|f|f||||||||2017-10-10 22:18:28.61622|2017-10-10 22:18:28.61622
NCT02738346|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-22|||July 2013||2013-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CBPC||SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013|Randomized Study Comparing Two Strategies Carboplatin and Etoposide Topotecan in Patients With SCLC on the Second Row With Relapsed at Least Three Months After Initial Response to Chemotherapy With Platinum-etoposide 6 Cycles|Recruiting||Phase 3|164|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 22:18:28.997744|2017-10-10 22:18:28.997744
NCT02738333|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-05-19|||April 12, 2016|Actual|2016-04-12|May 2017|2017-05-01|May 11, 2017|Actual|2017-05-11|February 14, 2017|Actual|2017-02-14||Interventional|||Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection|A Phase 3b, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 2 HCV Infection|Completed||Phase 3|239|Actual|Gilead Sciences||3|||f||||f||f||||||||2017-10-10 22:18:29.12782|2017-10-10 22:18:29.12782
NCT02738320|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-08|||March 2014||2014-03-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Patient Centered Quality Reporting|Patient Centered Quality Reporting|Completed||N/A|225|Actual|University of California, Irvine||2|||f||||||||||||||2017-10-10 22:18:29.327122|2017-10-10 22:18:29.327122
NCT02738307|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-05-09|||March 2016||2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of High Altitude Exposure, Acclimatization and Re-exposure on Sustained Attention in Lowlanders|Effect of High Altitude Exposure, Acclimatization and Re-exposure on Global Cognitive Function|Recruiting||N/A|18|Anticipated|University of Calgary||1|||f||||f||||||||No||2017-10-10 22:18:29.421387|2017-10-10 22:18:29.421387
NCT02738294|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-04-13|||June 2013||2013-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB|Necessity Assessment of Magnifying Endoscopy With Narrow Band Imaging Targeted Biopsy Compared With Endoscopic Forceps Biopsy From White Light Endoscopy|Completed||N/A|211|Actual|Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||Undecided||2017-10-10 22:18:29.531349|2017-10-10 22:18:29.531349
NCT02738281|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-05-18|||November 2015||2015-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|||Natural History of Rett Syndrome & Related Disorders|Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol|Recruiting||N/A|1200|Anticipated|University of Alabama at Birmingham|||3||f||||t||||||||Yes|This consortium will follow the RDCRN agreement to share data. This plan releases data five years after acquisition.|2017-10-10 22:18:29.628189|2017-10-10 22:18:29.628189
NCT02738268|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2016-04-11|||January 2016||2016-01-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|DERMISHEAD||Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients|Low-level Laser Therapy as a Tool for the Prevention of Radiodermatitis in Head and Neck Cancer Patients|Recruiting||N/A|60|Anticipated|Hasselt University||2|||f||||f||||||||Undecided||2017-10-10 22:18:29.907595|2017-10-10 22:18:29.907595
NCT02738255|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-12|2016-04-14|||May 2016||2016-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Added Varnum Mouthpiece on Pharyngeal Collapsibility and Sleep Apnea Severity in Mouth Breathers.||Not yet recruiting||N/A|30|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||Yes||2017-10-10 22:18:30.0133|2017-10-10 22:18:30.0133
NCT02738242|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-04-17|||May 2016||2016-05-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Evaluation of Usability and Human Factors in the Novus System|Evaluation of Usability and Human Factors in the Novus System|Not yet recruiting||N/A|16|Anticipated|Bioness Neuromodulation||1|||f||||f||||||||No||2017-10-10 22:18:30.108295|2017-10-10 22:18:30.108295
NCT02738229|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-12|||July 2016||2016-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Should We Use Oral Valacyclovir in Acute Herpetic Gingivostomatitis in Children?|Should We Use Oral Valacyclovir in Acute Herpetic Gingivostomatitis in Children? A Randomized Controlled Trial|Recruiting||Phase 2|80|Anticipated|St. Justine's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:18:30.218771|2017-10-10 22:18:30.218771
NCT02738216|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-15|||March 2016||2016-03-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|WF2||Wellness for 2: Understanding How to Foster Well Being for Mom and Her Baby|Efficacy of a Prenatal Yoga Intervention for Antenatal Depression|Recruiting||N/A|178|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-10 22:18:30.31761|2017-10-10 22:18:30.31761
NCT02738203|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-12-09|||July 2016||2016-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SALUD||Self-Administered Lidocaine Gel for Pain Management With IUD Insertion and Endometrial Biopsy|Self-Administered Lidocaine Gel for Pain Management With IUD Insertion and Endometrial Biopsy: A Randomized Controlled Trial|Recruiting||Phase 3|330|Anticipated|Stanford University||4|||f||||f||||||||No||2017-10-10 22:18:30.410602|2017-10-10 22:18:30.410602
NCT02738190|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-08-29|||January 2015||2015-01-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|APPEAR||Albumin vs. Plasma for PEdiAtric pRiming Trial|Albumin vs. Plasma for PEdiAtric pRiming Trial|Completed||Phase 4|80|Actual|IRCCS Policlinico S. Donato||2|||f||||f||||||||No||2017-10-10 22:18:30.509409|2017-10-10 22:18:30.509409
NCT02738177|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2016-04-13|||November 2015||2015-11-01|April 2016|2016-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||Misoprostol Versus Effox as Cervical Ripening Agent Prior Surgical Evacuation|Misoprostol Versus Effox (Individually or in Combination) as Cervical Ripening Agent Prior to 1st Trimesteric Surgical Evacuation|Recruiting||Phase 2|90|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 22:18:30.612854|2017-10-10 22:18:30.612854
NCT02738164|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-07-17|||May 2016||2016-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|SCREEN||SEPSIS 3 Critera for Risk Stratification in Emergency Patients|Validation of the SEPSIS-3 Criterion for Sepsis and Septic Shock in the Emergency Department|Completed||N/A|879|Actual|Societe Française de Medecine d'urgence|||1||f||||f||||||||Undecided||2017-10-10 22:18:30.72635|2017-10-10 22:18:30.72635
NCT02738151|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-21|||May 19, 2016||2016-05-19|September 2017|2017-09-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist|A 24-week, Multicenter, Randomized, Open-label, Parallel-group StudyComparing the Efficacy and Safety of Toujeo® and Tresiba® in Insulin-NaivePatients With Type 2 Diabetes Mellitus Not Adequately Controlled With OralAntihyperglycemic Drug(s) GLP-1 Receptor Agonist|Completed||Phase 4|929|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:18:30.858549|2017-10-10 22:18:30.858549
NCT02738138|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-08|||October 31, 2015||2015-10-31|June 2017|2017-06-01|June 7, 2017|Actual|2017-06-07|March 15, 2017|Actual|2017-03-15||Interventional|EXPEDITION-2||A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)|A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection (EXPEDITION-2)|Completed||Phase 3|153|Actual|AbbVie||2|||f||||f||||||||||2017-10-10 22:18:31.253537|2017-10-10 22:18:31.253537
NCT02738125|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-16|||April 29, 2016||2016-04-29|August 2017|2017-08-01|April 1, 2029|Anticipated|2029-04-01|April 1, 2029|Anticipated|2029-04-01||Observational|SOTHIS||Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions|Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions|Recruiting||N/A|540|Anticipated|AbbVie|||1||f||||||||||||||2017-10-10 22:18:31.399745|2017-10-10 22:18:31.399745
NCT02738112|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-26|||March 2016||2016-03-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|||Hyoid Suspension to the Mandible for the Treatment of Obstructive Sleep Apnea|Hyoid Suspension to the Mandible for the Treatment of Obstructive Sleep Apnea|Recruiting||N/A|30|Anticipated|Abidin, Michael, M.D.|||1||f||||f||||||||No||2017-10-10 22:18:33.262269|2017-10-10 22:18:33.262269
NCT02738086|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-05-25|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|PABC||Physical Activity Behavior Change for Older Adults After Dysvascular Amputation|Physical Activity Behavior Change for Older Veterans After Dysvascular Amputation|Recruiting||N/A|32|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 22:18:33.431691|2017-10-10 22:18:33.431691
NCT02738073|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-04-08||||||April 2016|2016-04-01||||February 2017|Anticipated|2017-02-01||Interventional|||Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture||Recruiting||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-10 22:18:33.520194|2017-10-10 22:18:33.520194
NCT02738060|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-14|||September 2015||2015-09-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||The Effect of Baked Milk on Cow's Milk Allergy|Efficacy of Baked Milk in Accelerating Resolution of Cow's Milk Allergy|Recruiting||Phase 2|80|Anticipated|Shiraz University of Medical Sciences||1|||f||||t||||||||No|The personal data of patients will not be recorded in written article. Only the result of the study will be recorded.|2017-10-10 22:18:33.589836|2017-10-10 22:18:33.589836
NCT02738047|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-05-18|||March 2016||2016-03-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01|120 Days|Observational [Patient Registry]|RADAR-PGX||Reduction of Adverse Drug Events and Readmissions|Pharmacogenomic Test Assessment for Medication Management in the Advancement of Medicine|Recruiting||N/A|280000|Anticipated|MD Global, Inc.|||1||f||||t||||||||Undecided||2017-10-10 22:18:33.793244|2017-10-10 22:18:33.793244
NCT02738034|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-10-26|||April 2016||2016-04-01|October 2016|2016-10-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Cogmed Training Effect in Hypertensive Patients With Cognitive Impairment|Cogmed Training Effect in Hypertensive Patients With Cognitive Impairment: a Randomized Clinical Trial|Recruiting||N/A|32|Anticipated|University of Sao Paulo General Hospital||2|||f||||||||||||||2017-10-10 22:18:33.8726|2017-10-10 22:18:33.8726
NCT02738021|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-05|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Managing PPD at Gouverneur|Stepped Care for Postpartum Depression in Pediatric Primary Care: A Pilot Project at Gouverneur Health Services|Recruiting||N/A|40|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:18:33.960486|2017-10-10 22:18:33.960486
NCT02738008|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-06-26|||November 2016||2016-11-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection|A Multicenter, Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis B Virus (HBV) Infection|Terminated||Phase 2|12|Actual|Arrowhead Pharmaceuticals||1||Company decision to discontinue trial|f||||t||||||||No||2017-10-10 22:18:34.048092|2017-10-10 22:18:34.048092
NCT02737995|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-08-12|||May 2015||2015-05-01|August 2016|2016-08-01||||January 2016|Actual|2016-01-01||Interventional|||Iron Stores and Skeletal Muscle Metabolism in Chronic Heart Failure|A Pilot Feasibility Study on Iron Stores and Skeletal Muscle Metabolism in Chronic Heart Failure|Completed||Phase 1|8|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:18:34.131687|2017-10-10 22:18:34.131687
NCT02737982|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-06-14|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|EVA||Sex and Gender Differences in Ischemic Heart Disease - Endocrine Vascular Disease Approach|Sex and Gender Differences in Ischemic Heart Disease: From Bench to Bedside EVA (Endocrine Vascular Disease Approach)|Recruiting||N/A|210|Anticipated|University of Roma La Sapienza|||2||f||||t||||||Samples Without DNA|"     plasma, serum, urine   "|Undecided||2017-10-10 22:18:34.223828|2017-10-10 22:18:34.223828
NCT02737969|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-09-06|||April 2016||2016-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TEE/Angio Fusion Study|Use of Transesophageal Echocardiography/Angiography Fusion Software Prototype for Structural Heart Disease Procedures|Enrolling by invitation||N/A|25|Anticipated|New York University School of Medicine||1|||f||||f|f|t|f|f||||||2017-10-10 22:18:34.329942|2017-10-10 22:18:34.329942
NCT02737956|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-10|||March 2016||2016-03-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01|38 Months|Observational [Patient Registry]|||The Prognosis of Acute Myocardial Infarction in Xinjiang||Enrolling by invitation||N/A|1858|Actual|Xinjiang Medical University|||1||f||||t||||||||No||2017-10-10 22:18:34.405515|2017-10-10 22:18:34.405515
NCT02737943|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-14|||March 2016||2016-03-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|EMD-SCZ-SGS||Effect of Mebo Dressing Versus Standard Care on Managing Donor and Recipient Sites of Split-thickness Skin Graft|Randomized Single-center, Single-blind, Two-arm Parallel Group Trial of Using MEBO™ Dressing Versus Standard Care at Zagazig University Hospital in the Management of Donor and Recipient Sites of Split-thickness Skin Graft|Recruiting||Phase 1|40|Anticipated|Zagazig University||2|||f||||f||||||||||2017-10-10 22:18:34.464082|2017-10-10 22:18:34.464082
NCT02737930|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-07-16|||May 2016||2016-05-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|FLUORESCE||Fluoxetine for Visual Recovery After Ischemic Stroke|Fluoxetine for Visual Recovery After Ischemic Stroke|Recruiting||Phase 2|40|Anticipated|University of Rochester||2|||f||||||||||||||2017-10-10 22:18:34.578073|2017-10-10 22:18:34.578073
NCT02737904|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-08-18|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Effect of Active-Passive Trainer Cycling on Multiple Sclerosis|The Effect of Cycling Using Active-passive Trainers on Spasticity, Cardiovascular Fitness, Function and Quality of Life in People With Multiple Sclerosis|Completed||N/A|24|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-10 22:18:34.755631|2017-10-10 22:18:34.755631
NCT02737878|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-10-02|||April 2016||2016-04-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription|Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription: Understanding Training Type and Exploring Mechanisms|Recruiting||N/A|400|Anticipated|University of British Columbia||4|||f||||t||||||||||2017-10-10 22:18:34.914236|2017-10-10 22:18:34.914236
NCT02737865|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-05-22|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Superb Microvascular Imaging in Focal Nodular Hyperplasia|"The Fingerprint: Spoke-wheel Sign of Focal Nodular Hyperplasia: Assessment of Novel Ultrasound Approach Using Superb Microvascular Imaging Technique"|Recruiting||N/A|62|Anticipated|Samsung Medical Center||1|||f||||t||||||||No|Undecided|2017-10-10 22:18:35.023102|2017-10-10 22:18:35.023102
NCT02737852|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-11|2017-08-02|2017-07-06||March 2016||2016-03-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects||Completed||N/A|32|Actual|Church & Dwight Company, Inc.||1|||f||||||||||||||2017-10-10 22:18:35.116563|2017-10-10 22:18:35.116563
NCT02737839|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-02-21|||June 9, 2016|Actual|2016-06-09|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy|Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy|Recruiting||Phase 1|72|Anticipated|Washington University School of Medicine||1|||f||||f|f|f||||||No||2017-10-10 22:18:35.301459|2017-10-10 22:18:35.301459
NCT02737826|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-04-08|||May 2016||2016-05-01|March 2016|2016-03-01||||June 2019|Anticipated|2019-06-01||Interventional|||Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper|Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper|Not yet recruiting||N/A|150|Anticipated|Medical University of South Carolina||4|||f||||t||||||||Undecided||2017-10-10 22:18:35.456296|2017-10-10 22:18:35.456296
NCT02737813|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-07-28|||March 29, 2016|Actual|2016-03-29|July 2017|2017-07-01|November 15, 2016|Actual|2016-11-15|November 11, 2016|Actual|2016-11-11||Interventional|||Cardiac Output Changes During Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Cesarean Section|Cardiac Output Changes During Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Cesarean Section: An Randomization Trials|Completed||Phase 4|168|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 22:18:35.53372|2017-10-10 22:18:35.53372
NCT02737800|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-03-08|||August 2015||2015-08-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|GnRh||Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients|Effect of Prolonged GnRh Agonist Therapy on the Outcome of In-Vitro Fertilization& Embryo Transfer in Endometrioma Patients|Recruiting||N/A|88|Anticipated|Kasr El Aini Hospital||4|||f||||f||||||||No||2017-10-10 22:18:35.619984|2017-10-10 22:18:35.619984
NCT02737787|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-06-06|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of WT1 Vaccine and Nivolumab For Recurrent Ovarian Cancer|A Phase I Study of Concomitant WT1 Analog Peptide Vaccine With Montanide and GM-CSF in Combination With Nivolumab in Patients With Recurrent Ovarian Cancer Who Are in Second or Greater Remission|Recruiting||Phase 1|10|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:18:35.724367|2017-10-10 22:18:35.724367
NCT02737774|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-09|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation|A Single Armed Phase ⅡStudy of Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation|Not yet recruiting||Phase 2|60|Anticipated|Henan Cancer Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:18:35.832199|2017-10-10 22:18:35.832199
NCT02737761|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|REACH||Researching Emotions And Cardiac Health|Developing a Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: Qualitative Research Phase|Completed||N/A|30|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 22:18:35.910187|2017-10-10 22:18:35.910187
NCT02737748|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-07-13|||June 2, 2017|Actual|2017-06-02|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|March 2018|Anticipated|2018-03-01||Interventional|||TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds|A Phase I/II Study to Evaluate the Safety and Efficacy of TWB-103 in Adult Patients With Split-Thickness Skin Graft Donor Site Wounds (DSW)|Recruiting||Phase 1/Phase 2|30|Anticipated|Transwell Biotech Co., Ltd.||2|||f||||f|t|f||||||||2017-10-10 22:18:35.993388|2017-10-10 22:18:35.993388
NCT02737735|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2016-04-09|||March 2016||2016-03-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation||Recruiting||Phase 1|200|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||No||2017-10-10 22:18:36.090318|2017-10-10 22:18:36.090318
NCT02737722|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-09-01|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|August 2017|Actual|2017-08-01||Interventional|||Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus|A Phase I/IIa, Randomized Double Blind, Placebo-Controlled, Dose Escalating Study to Evaluate the Safety and Tolerability of Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus|Active, not recruiting||Phase 1/Phase 2|30|Actual|Lakewood-Amedex Inc||2|||f||||t||||||||||2017-10-10 22:18:36.177997|2017-10-10 22:18:36.177997
NCT02737319|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-12|||March 2011||2011-03-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CLEAR-CIN||A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN).|A Randomized Trial of Rosuvastatin in Elective Percutaneous Coronary Intervention to Prevent Contrast-induced (CLEAR-CIN).|Completed||Phase 4|493|Actual|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 22:18:39.812747|2017-10-10 22:18:39.812747
NCT02737709|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-09|||March 2016||2016-03-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Paclitaxel Detection in NSCLC Treated With TC Regimen|A Clinical Experience Trial to Detect the Plasma Paclitaxel Drug Concentration in Chinese Non -Small Cell Lung Cancer (NSCLC) Patients Treated With a Paclitaxel Plus Carboplatin (TC) Regimens, and Explore Individualized Treatment Using Pharmacokinetically-guided Dosing Strategy|Active, not recruiting||Phase 2|120|Anticipated|Sun Yat-sen University||1|||f||||t||||||||Undecided||2017-10-10 22:18:36.269459|2017-10-10 22:18:36.269459
NCT02737696|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-08-17|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Computer-based Prescription Opioid Abuse Prevention for Adolescents|Computer-based Prescription Opioid Abuse Prevention for Adolescents|Recruiting||N/A|400|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:18:36.372543|2017-10-10 22:18:36.372543
NCT02737683|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-03-01|||May 2016||2016-05-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|||Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia.|Heterogeneous Distribution of Health Literacy and Emotional State on Patients With Functional Dyspepsia.|Recruiting||N/A|100|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||No||2017-10-10 22:18:36.475968|2017-10-10 22:18:36.475968
NCT02737670|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-09-13|||August 2014||2014-08-01|April 2017|2017-04-01|August 2017|Actual|2017-08-01|March 2017|Actual|2017-03-01||Interventional|SECIST||Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus|Randomized Double Blind Controlled Trial on Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus|Completed||Phase 2|126|Actual|St Joseph University, Beirut, Lebanon||2|||f||||t||||||||||2017-10-10 22:18:36.545836|2017-10-10 22:18:36.545836
NCT02737657|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-11-14|||April 2016||2016-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|CRATOS||An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During Ramadan|Observational, Prospective, Parallel Cohort Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea on a Background Therapy of Metformin With or Without a DPP-4 Inhibitor During Ramadan Fasting in Patients With Type 2 Diabetes|Completed||Phase 4|379|Actual|Janssen-Cilag International NV|||2||f||||||||||||||2017-10-10 22:18:36.62596|2017-10-10 22:18:36.62596
NCT02737644|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-05-13|||March 2016||2016-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|PKNFCHD||Peri-conception Key Nutritional Factors and Congenital Heart Disease|Peri-conception Key Nutritional Factors and Primary Prevention of Congenital Heart Disease(CHD)|Recruiting||N/A|60000|Anticipated|Children's Hospital of Fudan University|||1||f||||t||||||Samples With DNA|"     Venous Blood   "|Undecided||2017-10-10 22:18:36.739193|2017-10-10 22:18:36.739193
NCT02737631|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-08-02|2017-08-02||February 2016||2016-02-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|HRIPT||Human Repeat Insult Patch Test to Evaluate Personal Lubricants||Completed||N/A|222|Actual|Church & Dwight Company, Inc.||1|||f||||||||||||||2017-10-10 22:18:36.839892|2017-10-10 22:18:36.839892
NCT02737618|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-02|2017-08-02||February 2016||2016-02-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon||Completed||N/A|35|Actual|Church & Dwight Company, Inc.||1|||f||||||t|f|||||||2017-10-10 22:18:36.983801|2017-10-10 22:18:36.983801
NCT02737605|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-03-27|||July 1, 2016|Actual|2016-07-01|March 2017|2017-03-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants|A Randomized, Double-Blind (Periods 1 to 3), Placebo- and Positive-Controlled, Single Dose, 4-Period, Crossover Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Subjects|Completed||Phase 1|65|Actual|Janssen Research & Development, LLC||6|||f||||f|f|||||||||2017-10-10 22:18:37.11602|2017-10-10 22:18:37.11602
NCT02737592|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-03-20|2017-01-30||March 2016||2016-03-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects||Completed||N/A|34|Actual|Church & Dwight Company, Inc.||1|||f||||||||||||||2017-10-10 22:18:37.225503|2017-10-10 22:18:37.225503
NCT02737579|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-10-31|||November 2013||2013-11-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||XFM: (X-ray Fused With MRI) Guided Cardiac Catheterization|XFM: (X-ray Fused With MRI) Guided Cardiac Catheterization|Recruiting||N/A|200|Anticipated|Children's Research Institute||1|||f||||f||||||||No||2017-10-10 22:18:37.365852|2017-10-10 22:18:37.365852
NCT02737566|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-09-26|||January 30, 2017|Actual|2017-01-30|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|Prevail II||Small Financial Incentives to Promote Smoking Cessation|Small Financial Incentives to Promote Smoking Cessation in Safety Net Hospital Patients|Recruiting||N/A|320|Anticipated|University of Oklahoma||2|||f||||f|f|f||||||||2017-10-10 22:18:37.458814|2017-10-10 22:18:37.458814
NCT02737553|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-04-15|||October 2015||2015-10-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Laparoscopic Enclosed Morcellation; Electromechanic Morcellation vs Vaginal Removal|Enclosed Electromechanical Morcellation and Vaginal Removal During Laparoscopic Myomectomy|Recruiting||N/A|60|Anticipated|Ege University||2|||f||||t||||||||No||2017-10-10 22:18:37.570146|2017-10-10 22:18:37.570146
NCT02737540|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-08-21|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Observational|SPAD||Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients|Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients|Recruiting||N/A|210|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-10 22:18:37.772918|2017-10-10 22:18:37.772918
NCT02737527|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-06-08|||April 2016||2016-04-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block|Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block: A Prospective Randomized Open-label Trial|Recruiting||N/A|50|Anticipated|Seoul National University||2|||f||||f||||||||||2017-10-10 22:18:37.888912|2017-10-10 22:18:37.888912
NCT02714543|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-03-15|||November 2013||2013-11-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study||Completed||Phase 3|74|Actual|The Oxford Dental College, Hospital and Research Center, Bangalore, India||2|||f||||f||||||||||2017-10-10 22:22:43.842431|2017-10-10 22:22:43.842431
NCT02737514|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-04-08|||December 2015||2015-12-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparing the ADR With Air Insufflation, Water Immersion and Water Exchange During Two-endoscopist Colonoscopy|A Randomized, Controlled Trial Comparing the Adenoma Detection Rate With Air Insufflation, Water Immersion and Water Exchange During Two-endoscopist Colonoscopy|Recruiting||N/A|450|Anticipated|Dalin Tzu Chi General Hospital||3|||f||||t||||||||||2017-10-10 22:18:38.023502|2017-10-10 22:18:38.023502
NCT02737501|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-09-05|||April 30, 2016|Actual|2016-04-30|September 2017|2017-09-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|ALTA-1L||ALTA-1L Study: A Phase 3 Study of Brigatinib Versus Crizotinib in ALK-positive Advanced Non-Small Cell Lung Cancer Patients|A Phase 3 Multicenter Open-label Study of Brigatinib (AP26113) Versus Crizotinib in Patients With ALK-positive Advanced Lung Cancer|Active, not recruiting||Phase 3|270|Actual|Ariad Pharmaceuticals||2|||f||||t|t|f||||||||2017-10-10 22:18:38.156462|2017-10-10 22:18:38.156462
NCT02737488|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-03-30|||February 1, 2016||2016-02-01|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Helping Children With Trauma|Helping Children With Trauma|Terminated||Phase 3|14|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:18:38.51566|2017-10-10 22:18:38.51566
NCT02737475|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-09-15|||June 16, 2016|Actual|2016-06-16|September 2017|2017-09-01|May 22, 2020|Anticipated|2020-05-22|February 24, 2019|Anticipated|2019-02-24||Interventional|||An Investigational Immuno-therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Patients With Solid Cancers That Are Advanced or Have Spread|A Phase 1/2a Study of BMS-986178 Administered Alone and in Combination With Nivolumab and/or Ipilimumab in Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|435|Anticipated|Bristol-Myers Squibb||7|||f||||f|t|f||||||||2017-10-10 22:18:38.607011|2017-10-10 22:18:38.607011
NCT02737462|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-09-22|||June 2016||2016-06-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome|A Phase I/II Study of CG200745 PPA to Determine the Maximum Tolerated Dose and Evaluate the Safety and Efficacy in Patients With Myelodysplastic Syndrome (MDS) Who Failed to Respond to Prior Hypomethylating Therapy|Recruiting||Phase 1/Phase 2|36|Anticipated|CrystalGenomics, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:18:38.803325|2017-10-10 22:18:38.803325
NCT02737449|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-11|||July 2016||2016-07-01|April 2017|2017-04-01|December 2100|Anticipated|2100-12-01|December 2100|Anticipated|2100-12-01|8 Years|Observational [Patient Registry]|||Corrona Japan Rheumatoid Arthritis (RA) Registry|Corrona Japan Rheumatoid Arthritis (RA) Registry|Enrolling by invitation||N/A|2000|Anticipated|Corrona, LLC.|||1||f||||f||||||||No||2017-10-10 22:18:38.898602|2017-10-10 22:18:38.898602
NCT02737436|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-12-12|||May 2010||2010-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|OT-MOM||Intranasal Oxytocin and Maternal Neglect|Intranasal Oxytocin: A Neuropharmacological Intervention for Maternal Neglect?|Recruiting||N/A|120|Anticipated|Baylor College of Medicine||2|||f||||f||||||||Undecided||2017-10-10 22:18:38.970857|2017-10-10 22:18:38.970857
NCT02737423|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-04-08|||June 2012||2012-06-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Vitamin D Treatment for Painful Diabetic Neuropathy|Vitamin D for the Treatment of Painful Diabetic Neuropathy|Completed||N/A|143|Actual|Baqai Institute of Diabetology and Endocrinology||1|||f||||t||||||||Undecided||2017-10-10 22:18:39.062196|2017-10-10 22:18:39.062196
NCT02737410|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-04-12|||June 2012||2012-06-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Resilience in Irritable Bowel Syndrome and Gut-focused Hypnotherapy|Resilience in Irritable Bowel Syndrome and Gut-focused Hypnotherapy: Longitudinal Study With Hypnotherapy Patients and Cross Sectional Control Group|Completed||N/A|74|Actual|Medical University of Vienna||2|||f||||f||||||||Yes|via www.figshare.com|2017-10-10 22:18:39.144981|2017-10-10 22:18:39.144981
NCT02737384|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-04-08|||May 2016||2016-05-01|April 2016|2016-04-01|November 2020|Anticipated|2020-11-01|September 2020|Anticipated|2020-09-01||Interventional|CD45RA||Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID)|Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID): Selective Depletion of Naive Cells From the Graft|Not yet recruiting||Phase 2|12|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 22:18:39.308913|2017-10-10 22:18:39.308913
NCT02737371|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-05-22|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Interventional|ORALMAD||Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects|F901318 - A Phase I, Double-Blind, Placebo Controlled, Multiple Ascending Oral Dose Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects|Completed||Phase 1|40|Actual|F2G Ltd.||6|||f||||f|f|f||||||No||2017-10-10 22:18:39.395974|2017-10-10 22:18:39.395974
NCT02737358|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-11-15|||August 2016||2016-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|||N-acetylcysteine for Tobacco Use Disorder|Evaluating N-acetylcysteine as a Pharmacotherapy for Tobacco Use Disorder|Recruiting||Phase 2|110|Anticipated|Medical University of South Carolina||2|||f||||f||||||||Yes||2017-10-10 22:18:39.490726|2017-10-10 22:18:39.490726
NCT02737345|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-03-14|||November 2015||2015-11-01|March 2017|2017-03-01||||April 2017|Anticipated|2017-04-01||Observational|||Correlation of Hepatitis C, Alcoholic Liver Disease, and Renal Failure With Hyperfibrinolysis in Liver Failure||Recruiting||N/A|75|Anticipated|University of Utah|||1||f||||||||||||||2017-10-10 22:18:39.582023|2017-10-10 22:18:39.582023
NCT02737332|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-10-26|||February 2016||2016-02-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|STAAR||A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer|A Randomized, Open-Label, Active-Controlled, Multi-Center Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer: The STAAR STUDY|Recruiting||Phase 2|50|Anticipated|Churchill Pharmaceutical LLC||2|||f||||f||||||||No||2017-10-10 22:18:39.669569|2017-10-10 22:18:39.669569
NCT02737306|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-02-01|||November 2016||2016-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|GVHD||Study of PRO 140 for Prophylaxis of Acute GVHD in Patients With AML or MDS Undergoing Allogeneic Stem-Cell Transplant.|Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of PRO 140 for Prophylaxis of Acute Graft-Versus-Host Disease in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Cell Transplantation.|Recruiting||Phase 2|60|Anticipated|CytoDyn, Inc.||2|||f||||t||||||||Undecided||2017-10-10 22:18:39.891279|2017-10-10 22:18:39.891279
NCT02737293|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-20|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Whole Egg Intake and the Mediterranean Diet|Whole Egg Intake and the Mediterranean Diet|Recruiting||N/A|20|Anticipated|USDA Grand Forks Human Nutrition Research Center||3|||f||||f||||||||||2017-10-10 22:18:39.992368|2017-10-10 22:18:39.992368
NCT02737280|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-09-08|||March 2016||2016-03-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||High Flow Nasal Cannula Use in Infants With Bronchiolitis|High Flow Humified Nasal Cannula Oxygen Therapy in Infants Younger Than 6 Months of Age With Viral Bronchiolitis Compared to Usual Oxygen Therapy : a Randomized Controlled Trial|Active, not recruiting||N/A|160|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-10 22:18:40.137447|2017-10-10 22:18:40.137447
NCT02737267|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-03-28|||November 2015||2015-11-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Obekit||Development of a Nutrigenetic Test for Personalized Prescription of Body Weight Loss Diets (Obekit)|Development of a Nutrigenetic Test for Personalized Prescription of Body Weight Loss Diets (Obekit)|Active, not recruiting||N/A|260|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||t||||||||No||2017-10-10 22:18:40.238927|2017-10-10 22:18:40.238927
NCT02737254|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-11-07|||March 2016||2016-03-01|February 2016|2016-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Oxytocin and Attachment-related Interpretation Bias|The Effect of Oxytocin on the Training of Attachment-related Interpretation Bias in Middle Childhood|Completed||Phase 4|100|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||No||2017-10-10 22:18:40.391137|2017-10-10 22:18:40.391137
NCT02737241|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2017-04-02|||June 1, 2015|Actual|2015-06-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH|Randomized Clinical Trial Comparing Low Power (50W) Holmium Laser Enucleation of the Prostate (HoLEP) Versus High Power (100W) HoLEP|Recruiting||Phase 4|100|Anticipated|Mansoura University||2|||f||||t||||||||No||2017-10-10 22:18:40.60611|2017-10-10 22:18:40.60611
NCT02737228|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-12|||March 2016||2016-03-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer|A Phase I/II Study of Combination Therapy of CG200745 PPA With Gemcitabine and Erlotinib to Determine the Maximum Tolerated Dose (MTD) and Evaluate the Safety and Efficacy for Locally Advanced Unresectable, or Metastatic Pancreatic Cancer|Recruiting||Phase 1/Phase 2|72|Anticipated|CrystalGenomics, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:18:40.696391|2017-10-10 22:18:40.696391
NCT02737215|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-03-15|||December 2015||2015-12-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|PAFOS||Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea|Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea: a Multicenter Study|Recruiting||Phase 2/Phase 3|144|Anticipated|University of Pernambuco||2|||f||||f||||||||No||2017-10-10 22:18:40.791892|2017-10-10 22:18:40.791892
NCT02737202|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-11-28|||April 2016||2016-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SLAM-2||Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis|Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis|Recruiting||Phase 2|28|Anticipated|Baylor College of Medicine||1|||f||||t||||||||No||2017-10-10 22:18:40.885131|2017-10-10 22:18:40.885131
NCT02737189|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-02-15|||July 2016||2016-07-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Basilar Artery Occlusion Chinese Endovascular Trial|Randomized Trial of Revascularization With Solitaire Stentriever Versus Best Medical Therapy in the Treatment of Acute Ischemic Stroke Due to Basilar Artery Occlusion Presenting Within 6-24 Hours of Symptom Onset|Recruiting||N/A|318|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t||||||||Undecided||2017-10-10 22:18:41.064084|2017-10-10 22:18:41.064084
NCT02737176|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-07-29|||April 2016||2016-04-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|TISOD||Tobacco Cessation Intervention Study for Oral Diseases|Efficacy of Tobacco Cessation for Improving Oral Diseases - Multicenter Prospective Trial|Recruiting||N/A|812|Anticipated|Association for the Japanese Academy of Maxillofacial Implants||2|||f||||f||||||||No||2017-10-10 22:18:41.360341|2017-10-10 22:18:41.360341
NCT02737163|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-04-26|||March 2016||2016-03-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|April 2019|Anticipated|2019-04-01||Observational|||Strata Programmable CSF Shunt Valve Study|Inadvertent Cerebral Spinal Fluid Valve Reprogramming: Prevalence and the Correlation With Signs, Symptoms, Radiographic Changes and the Exposure to Magnetic Fields.|Recruiting||N/A|1000|Anticipated|Johns Hopkins All Children's Hospital|||1||f||||f||||||||No||2017-10-10 22:18:41.467594|2017-10-10 22:18:41.467594
NCT02737150|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-04-12|||April 2016||2016-04-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|December 2018|Anticipated|2018-12-01||Interventional|SOLVE-TAVI||SecOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in TAVI|CompariSon of secOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in Transcatheter Aortic Valve Implantation (SOLVE-TAVI)|Recruiting||Phase 4|444|Anticipated|University of Luebeck||4|||f||||t||||||||Undecided||2017-10-10 22:18:41.544573|2017-10-10 22:18:41.544573
NCT02737137|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-04-12|||January 2016||2016-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Dynamic Multimodal Monitoring for Ultrasound Guided Peripheral Nerve Blockade|Monitoring Combining Neurostimulation and Ultrasound Guidance During the Realization of a Peripheral Nerve Block: Value of Objective Measurement of the Pressure of Injection of the Local Anesthetic|Recruiting||N/A|120|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||Undecided||2017-10-10 22:18:41.637875|2017-10-10 22:18:41.637875
NCT02737124|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-05-04|||February 16, 2017|Actual|2017-02-16|May 2017|2017-05-01|February 19, 2019|Anticipated|2019-02-19|February 19, 2018|Anticipated|2018-02-19||Interventional|||Acetaminophen Randomized Controlled Trial|Prospective Randomized Control Trial Assessing Effects of Pre-Operative Acetaminophen in Isolated Meniscectomy Patients|Recruiting||Phase 3|100|Anticipated|New York University School of Medicine||2|||f||||f|t|f|||f|||||2017-10-10 22:18:41.732068|2017-10-10 22:18:41.732068
NCT02737111|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-05-09|||June 2016||2016-06-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|FEPICCD||Families' Experiences of Paediatric ICC Diagnosis|How do Families Experience Receiving a Positive Diagnosis for an Inherited Cardiac Condition for a Child? The Experiences of Children With a Diagnosis, Their Parents and Siblings.|Not yet recruiting||N/A|30|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||1|||f||||f||||||||No|"All adult participants will be invited to a presentation of the research findings and will be given the option of receiving a final summary of the research findings once the study has been written up for publication.
All child participants will also be invited to attend a separate presentation of the findings and will be offered a child friendly summary of the results. The researcher will provide a contact email address should participants have any further questions regarding the study and/or results.
A report of the analysis will be written and a selection of anonymised quotations/extracts demonstrating each theme will be selected to accompany the report.
It is intended that the research will be published in a peer-reviewed journal."|2017-10-10 22:18:41.835326|2017-10-10 22:18:41.835326
NCT02737098|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-05-26|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|September 30, 2019|Anticipated|2019-09-30|June 1, 2019|Anticipated|2019-06-01||Interventional|||TOP Implementation Project|Implementation of Telemedicine Outreach for PTSD (TOP) in Small Rural CBOCs (QUE 15-282)|Recruiting||N/A|600|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 22:18:41.908055|2017-10-10 22:18:41.908055
NCT02737085|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-09-06|||March 2016||2016-03-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL)|the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL)|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Southwest Hospital, China||1|||f||||t||||||||Undecided||2017-10-10 22:18:42.022933|2017-10-10 22:18:42.022933
NCT02737072|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-08-18|||September 2016||2016-09-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of LY2510924 and Durvalumab in Participants With Solid Tumors|A Phase 1a/1b Study of CXCR4 Peptide Antagonist (LY2510924) Administered in Combination With the Anti-PD-L1 Antibody, Durvalumab (MEDI4736), in Advanced Refractory Solid Tumors|Active, not recruiting||Phase 1|45|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:18:42.104951|2017-10-10 22:18:42.104951
NCT02737059|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-08-28|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|||Effect of Naloxegol on Gastric, Small Bowel, and Colonic Transit in Healthy Subjects|A Phase I Randomized, Double-Blinded, Placebo-Controlled Study of the Effect of Naloxegol on Gastric, Small Bowel, and Colonic Transit in Healthy Subjects|Completed||Phase 1|72|Actual|Mayo Clinic||4|||f||||f|t|f||||||||2017-10-10 22:18:42.183419|2017-10-10 22:18:42.183419
NCT02737046|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2017-04-05|||December 12, 2016|Actual|2016-12-12|April 2017|2017-04-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma|A Phase II Trial of Belinostat as Consolidation Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma|Recruiting||Phase 2|20|Anticipated|University of Miami||1|||f||||t|t|f|||f|||||2017-10-10 22:18:42.277534|2017-10-10 22:18:42.277534
NCT02737033|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-17|||April 2016||2016-04-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder|Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder|Recruiting||Phase 4|60|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:18:42.380105|2017-10-10 22:18:42.380105
NCT02737020|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-08-17|||April 2016||2016-04-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder|Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder|Recruiting||Phase 4|60|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:18:42.481564|2017-10-10 22:18:42.481564
NCT02737007|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-05|||April 18, 2016|Actual|2016-04-18|May 2017|2017-05-01|May 12, 2016|Actual|2016-05-12|May 12, 2016|Actual|2016-05-12||Interventional|||A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607|A Microdose Study to Describe the Intravenous Pharmacokinetics of GSK3191607 in Healthy Male Subjects Following Administration of [14C]-GSK3191607|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:18:42.597496|2017-10-10 22:18:42.597496
NCT02736994|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-04-07|||April 2014||2014-04-01|November 2013|2013-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Assessment of the Impact of Probiotics on Biofilm Formation on Removable Acrylic Dentures|Assessment of the Impact of Probiotics on Biofilm Formation on Removable Acrylic Dentures|Completed||N/A|13|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||No||2017-10-10 22:18:42.700723|2017-10-10 22:18:42.700723
NCT02736981|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-12-07|||January 2016||2016-01-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|REACH||Low Intensity Weight Loss for Young Adults|Low Intensity Weight Loss for Young Adults|Recruiting||N/A|381|Anticipated|Virginia Commonwealth University||3|||f||||t||||||||No||2017-10-10 22:18:42.803182|2017-10-10 22:18:42.803182
NCT02736968|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-09-14|||August 19, 2016|Actual|2016-08-19|September 5, 2017|2017-09-05|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Auranofin Trial for GI Protozoa|Phase IIa Randomized, Single-blinded, Placebo-controlled Clinical Trial of the Reprofiled Drug Auranofin for GI Protozoa|Recruiting||Phase 2|136|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f|||||t|f|||f|||||2017-10-10 22:18:42.914767|2017-10-10 22:18:42.914767
NCT02736955|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-10-10|||March 2016||2016-03-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|||Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia||Enrolling by invitation||Phase 3|150|Anticipated|Neurocrine Biosciences||1|||f||||||||||||||2017-10-10 22:18:43.027504|2017-10-10 22:18:43.027504
NCT02736942|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-05-02|||May 2016||2016-05-01|May 2016|2016-05-01|May 2025|Anticipated|2025-05-01|May 2020|Anticipated|2020-05-01||Interventional|COLORIII||COLOR III Trial: Transanal vs Laparoscopic TME|COLOR III: A Multicentre Randomised Clinical Trial Comparing Transanal TME Versus Laparoscopic TME for Mid and Low Rectal Cancer|Enrolling by invitation||Phase 3|1098|Anticipated|VU University Medical Center||2|||f||||t||||||||No|We are not sharing confidential individual patient data.|2017-10-10 22:18:43.142778|2017-10-10 22:18:43.142778
NCT02736929|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-12-05|||April 2016||2016-04-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|November 2020|Anticipated|2020-11-01||Interventional|ACCEPT||The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk|The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk|Recruiting||N/A|120|Anticipated|Duke University||2|||f||||t||||||||No||2017-10-10 22:18:43.225938|2017-10-10 22:18:43.225938
NCT02736916|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-04-07|||March 2016||2016-03-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer|Hippocampal-Sparing Whole-Brain Radiation Therapy for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer|Recruiting||N/A|3|Anticipated|General Hospital of Ningxia Medical University||2|||f||||t||||||||No||2017-10-10 22:18:43.300326|2017-10-10 22:18:43.300326
NCT02736903|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-06-14|||December 2015||2015-12-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|May 30, 2016|Actual|2016-05-30||Interventional|PennFit||Mobile-based Online Social Network Intervention to Increase Physical Activity|Efficacy of Mobile-based Online Social Network Intervention to Increase Physical Activity Among Young African American Women|Active, not recruiting||N/A|91|Actual|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 22:18:43.373181|2017-10-10 22:18:43.373181
NCT02736890|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-04-05|||March 2016||2016-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury|Subcutaneous Injection of Botulinum Toxin A for At--Level Back Pain in Patients With Spinal Cord Injury|Recruiting||Phase 2|32|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||Yes|The following will be shared: demographic information, pain response to interventions, adverse events and functional outcomes. The above information will be obtain in the forms of questionnaires and surveys. The data will be available when the study concludes.|2017-10-10 22:18:43.451084|2017-10-10 22:18:43.451084
NCT02736877|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-08|||April 2016||2016-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Corneal Transplantation Guided by OCT RESCAN|Corneal Transplantation Guided by OCT RESCAN: Pre-op, Intra-op and Post-op Evaluation|Not yet recruiting||N/A|30|Anticipated|Federal University of São Paulo||2|||f||||f||||||||Yes|scientific publication|2017-10-10 22:18:43.599986|2017-10-10 22:18:43.599986
NCT02736864|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-08-07|||September 28, 2016|Actual|2016-09-28|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae|Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae|Recruiting||N/A|60|Anticipated|Federal University of Uberlandia|||1||f||||t||||||||||2017-10-10 22:18:43.671297|2017-10-10 22:18:43.671297
NCT02736851|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-09-27|||January 2009||2009-01-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Telemedicine to Manage Chronic Neck Pain at Home|Home-Based Telemedicine Management of Patients Affected by Chronic Neck Pain|Completed||N/A|94|Actual|Fondazione Salvatore Maugeri||2|||f||||t||||||||Yes|The research was supported by a grant from Lombardy Region. A final report was provided to Lombardy Region.|2017-10-10 22:18:43.744828|2017-10-10 22:18:43.744828
NCT02736838|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-05-03|||October 2016||2016-10-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|May 2017|Actual|2017-05-01||Interventional|POTER-DIC||Peripheral Perfusion and Oxygenation in Areas of Risk of Skin Integrity Impairment Exposed to Pressure Patterns.|Peripheral Perfusion and Oxygenation in Areas of Risk of Skin Integrity Impairment Exposed to Pressure Patterns. A Phase I Trial (POTER-DIC)|Enrolling by invitation||N/A|32|Anticipated|University of Malaga||1|||f||||f||||||||No||2017-10-10 22:18:43.805327|2017-10-10 22:18:43.805327
NCT02736825|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-06-29|||April 4, 2016|Actual|2016-04-04|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|January 20, 2017|Actual|2017-01-20||Interventional|||Simulines Non-Inferiority Pivotal Study|Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort|Terminated||N/A|260|Actual|Ulthera, Inc||2||The study data to date show the required primary study endpoint will not be met.|f||||t||||||||||2017-10-10 22:18:43.878801|2017-10-10 22:18:43.878801
NCT02736812|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2017-04-19|||April 2016||2016-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|PREHO-PLYO||Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO)|Interest of Pre-hospital Administration of Lyophilized Plasma to Prevent or Treat Coagulopathy Associated With Post-traumatic Hemorrhagic Shock (PREHO-PLYO Study )|Recruiting||Phase 3|140|Anticipated|French Defence Health Service||2|||f||||t||||||||No||2017-10-10 22:18:44.110566|2017-10-10 22:18:44.110566
NCT02736799|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-01-11|||March 2016||2016-03-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Interventional|||Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers|Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers: A Sham Device Controlled, Single Center Pilot Study|Completed||N/A|24|Actual|Vibrant Ltd.||4|||f||||||||||||||2017-10-10 22:18:44.398275|2017-10-10 22:18:44.398275
NCT02736786|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal Tumors|A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal Tumors|Recruiting||N/A|67|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 22:18:44.486771|2017-10-10 22:18:44.486771
NCT02736773|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-04-07|||November 2015||2015-11-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Flapless||Xenograft and Posterior Mandibular Socket Filling|Ridge Preservation With a Low Resorption Xenograft in Posterior Mandible Postextraction Sockets|Recruiting||N/A|30|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 22:18:44.593155|2017-10-10 22:18:44.593155
NCT02736760|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-11-10|||March 2016||2016-03-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|||Daylight-PDT With MAL for AK and Photodamaged Skin|Prospective, Randomized, Controlled, Multicenter, Two-armed, Study Comparing Daylight Photodynamic Therapy Using MAL With Cryosurgery for the Treatment and Prophylaxis of Actinic Keratoses in Photodamaged Skin of the Face|Active, not recruiting||Phase 4|58|Anticipated|University Hospital Regensburg||2|||f||||t||||||||||2017-10-10 22:18:44.731542|2017-10-10 22:18:44.731542
NCT02736747|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-08-01|||April 2016||2016-04-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|July 2017|Actual|2017-07-01||Interventional|||Effects of Cryotherapy on Ankle Movements and Gait of Spastic Hemiparetic Subjects|Immediate Effects of Cryotherapy on Neuromuscular Performance of Ankle Joint and on Gait Pattern of Chronic Spastic Hemiparetic Subjects Post-Stroke|Active, not recruiting||N/A|16|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-10-10 22:18:44.835581|2017-10-10 22:18:44.835581
NCT02736734|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-04-06|||October 2014||2014-10-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers|The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers|Completed||Phase 4|14|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||No||2017-10-10 22:18:44.928331|2017-10-10 22:18:44.928331
NCT02736721|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-08-11|2016-06-28||September 2003||2003-09-01|May 2016|2016-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||Analysis population included all enrolled participants.|Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML)|Multicenter Open Label Expanded Access-Program of Pegylated Interferon Alfa-2a (Pegasys) in Patients With Chronic Myelogenous Leukemia (CML)|Completed||Phase 3|41|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:18:45.025826|2017-10-10 22:18:45.025826
NCT02736708|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-10-27|||January 2013||2013-01-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|2 Years|Observational [Patient Registry]|PSCRegistry||Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures|Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for Primary Sclerosing Cholangitis Biliary Strictures|Recruiting||N/A|100|Anticipated|University of Colorado, Denver|||1||f||||f||||||||No||2017-10-10 22:18:45.380428|2017-10-10 22:18:45.380428
NCT02736682|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-12|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|SDvMD||Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section.|Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section in Mulago Hospital. A Randomized Clinical Trial.|Completed||Phase 4|174|Actual|Makerere University||2|||f||||t||||||||||2017-10-10 22:18:45.577642|2017-10-10 22:18:45.577642
NCT02736669|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-11-07|||October 2015||2015-10-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|CARE||CARE Trial: Comparing Different Levels of Calorie Reduction for Weight Loss|Fixed Versus Variable Energy Reduction During Behavioral Obesity Treatment|Recruiting||N/A|218|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||Yes|The PI will ensure all publications that result from project-related data will comply with the NIH public access policy and develop a system by which study data may be shared with other investigators within the scientific community. With UAB IRB permission, PI may develop a de-identified database, codebook, and mechanism by which data can be shared with qualified individuals/organizations. PI will keep a record of all individuals/res. teams who request/receive a copy of the data. Interested investigators will be asked to complete a request form stating specific aims of the analyses, analytic plan, available resources, proposed timeline, and goals. PI and team will review these requests to determine whether proposed analyses constitute significant exploration of the data, team has resources to complete request, and data will be adequately protected and managed. If any issues are problematic, PI and team will attempt to negotiate a fair resolution with investigators and NIH staff.|2017-10-10 22:18:45.669084|2017-10-10 22:18:45.669084
NCT02736656|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-12|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)||Recruiting||Phase 3|200|Anticipated|Supernus Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-10 22:18:45.774096|2017-10-10 22:18:45.774096
NCT02736643|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-10|2016-04-10|||April 2016||2016-04-01|April 2016|2016-04-01||||December 2018|Anticipated|2018-12-01|104 Weeks|Observational [Patient Registry]|||Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography|Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography (LDCT) - a Screening Program|Enrolling by invitation||N/A|6000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 22:18:45.846418|2017-10-10 22:18:45.846418
NCT02736630|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-12|||March 2016||2016-03-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|April 2016|Actual|2016-04-01|2 Months|Observational [Patient Registry]|GAPOHI||Incidence of Perioperative Hypothermia in Patients With Elective Surgery Under General Anesthesia in Turkey|National Epidemiology Survey on the Incidence of Perioperative Hypothermia in Patients With Elective Surgery Under General Anesthesia in Turkey|Active, not recruiting||N/A|3000|Anticipated|Turkish Society of Anesthesiology and Reanimation|||1||f||||t||||||||Yes||2017-10-10 22:18:45.907021|2017-10-10 22:18:45.907021
NCT02736617|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-09-20|||May 2016||2016-05-01|September 2017|2017-09-01||||July 2021|Anticipated|2021-07-01||Interventional|||Obinutuzumab in Combination With Ibrutinib in Treating Patients With Relapsed Mantle Cell Lymphoma|A Phase II Study of Obinutuzumab (GA-101) in Combination With Ibrutinib (I) for the Treatment of Relapsed Mantle Cell Lymphoma|Recruiting||Phase 2|20|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 22:18:45.988935|2017-10-10 22:18:45.988935
NCT02736604|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-04-25|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of Impact of Nitrous Oxide on PONV in Breast Surgeries|Evaluation of Impact of Nitrous Oxide on PONV in Breast Surgeries|Completed||N/A|250|Actual|Tata Memorial Hospital||2|||f||||t||||||||Yes||2017-10-10 22:18:46.084112|2017-10-10 22:18:46.084112
NCT02736591|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-07-03|||June 2016||2016-06-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|||Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response|Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response|Recruiting||Phase 3|210|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 22:18:46.158363|2017-10-10 22:18:46.158363
NCT02736578|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-07-12|||July 2016||2016-07-01|July 2017|2017-07-01|May 22, 2017|Actual|2017-05-22|April 24, 2017|Actual|2017-04-24||Interventional|||Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery|Intraoperative Pancreatic Cancer Detection Using Multimodality Molecular Imaging|Terminated||Phase 2|7|Actual|Stanford University||1||logistics|f||||t||||||||||2017-10-10 22:18:46.25792|2017-10-10 22:18:46.25792
NCT02736565|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-10-03|||October 2016||2016-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma|Phase I Trial of Pbi-shRNA™ EWS/FLI1 Type 1 Lipoplex (LPX) in Subjects With Advanced Ewing's Sarcoma|Recruiting||Phase 1|22|Anticipated|Strike Bio, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:18:46.356569|2017-10-10 22:18:46.356569
NCT02736552|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-16|||March 2016||2016-03-01|April 2016|2016-04-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.|A Prospective,Multicentral,Open-label,Randomized,Controlled,Phase III Clinical Trial to Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.|Recruiting||Phase 3|680|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:18:46.457887|2017-10-10 22:18:46.457887
NCT02736539|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-07-18|||April 15, 2017|Anticipated|2017-04-15|July 2017|2017-07-01|February 28, 2019|Anticipated|2019-02-28|December 31, 2018|Anticipated|2018-12-31||Interventional|||Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea|Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea|Withdrawn||Phase 3|0|Actual|Clasado Biosciences Ltd||2||Commercial strategy|f|||||t|f||||||||2017-10-10 22:18:46.597416|2017-10-10 22:18:46.597416
NCT02736526|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-07|||November 2015||2015-11-01|April 2016|2016-04-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|SOMIX||Study of Surgical Treatment Versus Observation in Children With Moderate Intermittent Exotropia|Long-term Prospective Randomized Controlled Clinical Study on Surgical Treatment of Moderate Intermittent Exotropia|Recruiting||N/A|280|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-10-10 22:18:46.687677|2017-10-10 22:18:46.687677
NCT02736513|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-06-19|||May 2016||2016-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases|Pilot, Phase 2 Study Assessing Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases|Recruiting||Phase 2|40|Anticipated|Rabin Medical Center||2|||f||||f||||||||Yes||2017-10-10 22:18:46.772809|2017-10-10 22:18:46.772809
NCT02736500|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-09-28|||July 2015||2015-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|LuX||Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors|Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors|Active, not recruiting||Phase 1/Phase 2|37|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||||2017-10-10 22:18:46.914932|2017-10-10 22:18:46.914932
NCT02736487|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-04-07|||November 2015||2015-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Short-term Portable Air Purifier Use on Occupant Health Indicators|Effect of Short-term Portable Air Purifier Use on Occupant Health Indicators|Completed||N/A|72|Actual|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||Undecided||2017-10-10 22:18:47.007514|2017-10-10 22:18:47.007514
NCT02736474|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-12|||May 2016||2016-05-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia|Effect of Naltrexone and Bupropion Combination on Weight Loss and Smoking Cessation in Obese, Cigarette-smoking Patients With Schizophrenia|Not yet recruiting||Phase 4|50|Anticipated|Shanghai Mental Health Center||2|||f||||f||||||||Undecided||2017-10-10 22:18:47.11179|2017-10-10 22:18:47.11179
NCT02736448|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-09-28|||May 2016||2016-05-01|September 2016|2016-09-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|Lu-Ca-S||177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors|177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors: a Randomized Phase II Study.|Recruiting||Phase 2|176|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||Undecided||2017-10-10 22:18:47.289046|2017-10-10 22:18:47.289046
NCT02736435|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-12-13|||March 2017||2017-03-01|December 2015|2015-12-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound||Not yet recruiting||Phase 3|30|Anticipated|Thunder Bay Regional Research Institute||2|||f||||t||||||||No||2017-10-10 22:18:47.377894|2017-10-10 22:18:47.377894
NCT02736422|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-05-04|||July 2011||2011-07-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Assessment of New Magnetic Resonance Imaging (MRI) Pulse Sequences for Imaging Hyperpolarised Xenon in Lung, Heart and Brain in Volunteers|Assessment of New Magnetic Resonance Imaging (MRI) Pulse Sequences for Imaging Hyperpolarised Xenon in Lung, Heart and Brain in Volunteers|Recruiting||Phase 1|40|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 22:18:47.471291|2017-10-10 22:18:47.471291
NCT02736409|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-06-27|||April 1, 2016||2016-04-01|June 2017|2017-06-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|ORBIT2||An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)|A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)|Recruiting||Phase 3|200|Anticipated|Shire||4|||f||||f||||||||||2017-10-10 22:18:47.552047|2017-10-10 22:18:47.552047
NCT02736396|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-12-13|||June 2016||2016-06-01|December 2016|2016-12-01|April 2020|Anticipated|2020-04-01|September 2019|Anticipated|2019-09-01||Observational|SIS||Southend Imaging Study|Southend Imaging Study|Recruiting||N/A|400|Anticipated|Southend University Hospital Foundation NHS Trust|||2||f||||f||||||||No||2017-10-10 22:18:49.512964|2017-10-10 22:18:49.512964
NCT02736383|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-07-28|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||Tranexamic Acid in Hip Fracture Surgery|Effectiveness of Tranexamic Acid (TXA) in Reducing Blood Loss in Hip Fracture Surgery|Completed||N/A|142|Actual|Spectrum Health Hospitals|||2||f||||f||||||||||2017-10-10 22:18:49.595661|2017-10-10 22:18:49.595661
NCT02736370|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-04-13|||May 2016||2016-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Early Weight Bearing for Ankle Fractures|Early Weight Bearing for Bimalleolar and Trimalleolar Ankle Fractures Without Syndesmotic Disruption|Enrolling by invitation||N/A|50|Anticipated|Spectrum Health Hospitals|||1||f||||f||||||||No||2017-10-10 22:18:49.651658|2017-10-10 22:18:49.651658
NCT02736357|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-05-12|||July 2015||2015-07-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|20 Years|Observational [Patient Registry]|LEO||The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study|The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study|Recruiting||N/A|12900|Anticipated|Mayo Clinic|||1||f||||t||||||Samples With DNA|"     Research blood draw collected at baseline. Research blood processed and stored as plasma,     serum and germline DNA. Tissue in excess of diagnosis stored in formalin fixed paraffin     embedded (FFPE) cored for use in Tissue Micro Array (TMA) and extraction of DNA and RNA from     tumor.   "|No|There is no plan to make individual participant data (IPD) available.|2017-10-10 22:18:49.707967|2017-10-10 22:18:49.707967
NCT02736344|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-07-03|||April 2016||2016-04-01|July 2016|2016-07-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|BIONICS||BIONICS - Pharmacokinetics (PK) Trial|BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study|Recruiting||Phase 3|12|Anticipated|Medinol Ltd.||1|||f||||t||||||||No||2017-10-10 22:18:49.837341|2017-10-10 22:18:49.837341
NCT02736331|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-02-03|||March 2016||2016-03-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|WBB2||Different Types of Fruits on Metabolic Function and Cognitive Performance|The Effect of Different Types of Fruits on Metabolic Function and Cognitive Performance|Active, not recruiting||N/A|40|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||No||2017-10-10 22:18:49.924766|2017-10-10 22:18:49.924766
NCT02736318|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-07|||April 2016||2016-04-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|TBF3||OD-PHOENIX in Talus Osteochondral Lesion|Treatment of Osteochondral Lesion of Talus With Processed Osteochondral Allograft|Not yet recruiting||Phase 1/Phase 2|15|Anticipated|TBF Genie Tissulaire||1|||f||||t||||||||Undecided||2017-10-10 22:18:50.126989|2017-10-10 22:18:50.126989
NCT02736305|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-31|||February 2016||2016-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of Regorafenib in Recurrent Epithelial Ovarian Cancer|An Open-Label, Single-Arm Phase 2 Clinical Trial Of Regorafenib in Patients With Multiply Recurrent Epithelial Ovarian Cancer|Recruiting||Phase 2|34|Anticipated|National Cancer Centre, Singapore||1|||f||||t||||||||||2017-10-10 22:18:50.20885|2017-10-10 22:18:50.20885
NCT02736279|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-11-03|||May 2015||2015-05-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Observational|||Impact of Tecfidera on Gut Microbiota|Measuring the Impact of Tecfidera on the Gut Microbiota: Does a Change in the Gut Flora Correlate With Gastrointestinal Disturbances Following Therapy Initiation?|Recruiting||N/A|25|Anticipated|EvergreenHealth|||1||f||||f||||||||Yes|After completion of all data analysis and submission of an abstract or article to a peer reviewed journal or professional meeting, each study subject may receive a copy of the aggregate data on their gut microbiome analyses from the study coordinator|2017-10-10 22:18:50.360967|2017-10-10 22:18:50.360967
NCT02736266|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-09|2017-03-01|||February 27, 2017|Actual|2017-02-27|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma|An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab (MK-3475) Before Cystectomy for Patients With Muscle-invasive Urothelial Bladder Cancer.|Recruiting||Phase 2|90|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t|f|f||||||Yes|No formal plan|2017-10-10 22:18:50.473055|2017-10-10 22:18:50.473055
NCT02736253|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-12|||June 2012||2012-06-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Observational|||Risk Factors for Three Critical Stages of the Diabetic Foot Infections|Determining of Independent Risk Factors for Three Critical Stages of the Diabetic Foot Infections Without Using the Well-known Classification Systems: Osteomyelitis, Amputation and Major Amputation|Completed||N/A|379|Actual|Ege University|||1||f||||t||||||||Undecided||2017-10-10 22:18:50.571825|2017-10-10 22:18:50.571825
NCT02736240|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-07|||April 2016||2016-04-01|April 2016|2016-04-01||||June 2017|Anticipated|2017-06-01||Interventional|||Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)|Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine Developed Cooperatively by YunNan Walvax Biotechnology Co., Lt and Yuxi Walvax Biotechnology Co., Lt Among 2-71 Months (the Youngest Could be 6 Weeks) Healthy Infants and Toddlers by Randomized Blind Method With Similar Control in Multi-centers.|Not yet recruiting||Phase 3|2760|Anticipated|Walvax Biotechnology Co., Ltd.||2|||f||||||||||||||2017-10-10 22:18:50.649818|2017-10-10 22:18:50.649818
NCT02736227|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-10-08|||March 2016||2016-03-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation|Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation|Recruiting||N/A|40|Anticipated|Northwestern University||1|||f||||f||||||||No||2017-10-10 22:18:50.723294|2017-10-10 22:18:50.723294
NCT02736214|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-05-02|||October 2014||2014-10-01|May 2017|2017-05-01|April 25, 2016|Actual|2016-04-25|March 2016|Actual|2016-03-01||Interventional|||Reproductive Life Plan-based Counseling With Men|Reproductive Life Plan-based Counseling With Men|Completed||N/A|229|Actual|Uppsala University||2|||f||||||||||||||2017-10-10 22:18:50.803985|2017-10-10 22:18:50.803985
NCT02736201|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-10-06|||May 2016||2016-05-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|T-Care||Capacitive Diathermy in the Lumbopelvic Pain|Mechanosensitivity, Morphological, Functional and Contractility Changes by the Capacitive Diathermy in Subjects With Lumbopelvic Pain: a Pilot Study, Single Blind, Randomized Controlled Clinical Trial|Recruiting||N/A|20|Anticipated|European University of Madrid||2|||f||||t||||||||||2017-10-10 22:18:50.899466|2017-10-10 22:18:50.899466
NCT02736188|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-09-14|||May 2, 2016|Actual|2016-05-02|September 2017|2017-09-01|May 18, 2020||2020-05-18|April 2020|Anticipated|2020-04-01||Interventional|||Study to Evaluate the Safety and Efficacy of Ace-ER Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy|Phase 3B Open-Label Extension Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)|Active, not recruiting||Phase 3|144|Actual|Ultragenyx Pharmaceutical Inc||1|||f||||f||||||||||2017-10-10 22:18:51.014125|2017-10-10 22:18:51.014125
NCT02736162|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-07|||April 2016||2016-04-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|||Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy|A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Routine Clinical Care in Patients With Epilepsy|Completed||N/A|61|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-10 22:18:51.197418|2017-10-10 22:18:51.197418
NCT02736149|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-08-22|||December 2016||2016-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|LIBERTY2||Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)|A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)|Active, not recruiting||Phase 2|45|Anticipated|Eiger BioPharmaceuticals||1|||f||||||||||||||2017-10-10 22:18:51.297137|2017-10-10 22:18:51.297137
NCT02736136|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-06-06|||April 2016||2016-04-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|JOIN||An Early Intervention to Increase Maternal Self-efficacy After Preterm Birth|An Early Intervention to Increase Maternal Self-efficacy After Preterm Birth|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||No||2017-10-10 22:18:51.408166|2017-10-10 22:18:51.408166
NCT02736123|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-09-18|||October 2016||2016-10-01|September 2017|2017-09-01|February 9, 2017|Actual|2017-02-09|February 9, 2017|Actual|2017-02-09||Interventional|||Neoadjuvant Combination Biotherapy With Ipilimumab and Nivolumab or Nivolumab Alone|Neoadjuvant Combination Biotherapy With Ipilimumab and Nivolumab or Nivolumab Alone in Patients With Locally/Regionally Advanced/Recurrent Melanoma: A Randomized Efficacy, Safety and Biomarker Study|Withdrawn||Phase 1/Phase 2|0|Actual|University of Pittsburgh||2||PI is closing the trial as he will be leaving the University of Pittsburgh Medical Center|f||||t||||||||||2017-10-10 22:18:51.492369|2017-10-10 22:18:51.492369
NCT02736110|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-12|||September 2014||2014-09-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|September 2016|Anticipated|2016-09-01|1 Year|Observational [Patient Registry]|RELIEVE||Registry of Celution Device for the Processing of Adipose Derived Regenerative Cells (ADRCs) to Treat Osteoarthritis|Registry of Celution Device for the Processing of Adipose Derived Regenerative Cells (ADRCs) for Intra-articular Delivery to Knees With Osteoarthritis|Withdrawn||N/A|0|Actual|Cytori Therapeutics|||1|Corporate decision|f||||f||||||||Yes||2017-10-10 22:18:51.665072|2017-10-10 22:18:51.665072
NCT02736097|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-07-29|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|February 28, 2017|Actual|2017-02-28|January 2017|Actual|2017-01-01||Observational|DEFINE||Drug Resistance Factors In Healthcare-associated Pneumonia|A Multicenter Study to Evaluate Predictive Factors for Multidrug Resistant Healthcare Associated Pneumonia in Critically Ill Patients|Completed||N/A|679|Actual|Critical Care Pharmacotherapy Trials Network|||1||f||||f||||||||||2017-10-10 22:18:51.729627|2017-10-10 22:18:51.729627
NCT02736084|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-07|||August 2013||2013-08-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|BEHOLD||Boosting Emotions & Happiness in Outpatients Living With Diabetes|A Positive Psychology Program for Patients With Type 2 Diabetes: A Pilot Study|Completed||N/A|15|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 22:18:51.839511|2017-10-10 22:18:51.839511
NCT02736071|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-07-03|||June 2016||2016-06-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|||Tramadol Versus Celecoxib for Reducing Pain During Operative Office Hysteroscopy|Tramadol Versus Celecoxib for Reducing Pain During Operative Office Hysteroscopy: A Double Blind Placebo Controlled Trial.|Recruiting||Phase 3|210|Anticipated|Cairo University||3|||f||||t||||||||No||2017-10-10 22:18:51.931793|2017-10-10 22:18:51.931793
NCT02736058|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-05-28|||February 2016||2016-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Surgical Classification of Abnormal Placentation||Recruiting||N/A|100|Anticipated|Cairo University||1|||f||||t||||||||Undecided||2017-10-10 22:18:52.025132|2017-10-10 22:18:52.025132
NCT02736045|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-04-12|||July 2015||2015-07-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Ameliorating Work Burnout and Medical Residents|The Impact of Work Burnout on Sleep Quality and Negative Emotions in Medical Residents: An Intervention for Improving Wellbeing in Graduate Medical Education|Recruiting||Phase 1/Phase 2|150|Anticipated|Larkin Community Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:18:52.10033|2017-10-10 22:18:52.10033
NCT02736032|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-12|||March 2016||2016-03-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist|Cryopreserved-thawed Embryo Transfer in Down or Non-down Regulated Hormonally Controlled Cycles: a Prospective, Randomized Study|Recruiting||Phase 3|310|Anticipated|Cairo University||2|||f||||t||||||||Yes||2017-10-10 22:18:52.19743|2017-10-10 22:18:52.19743
NCT02736019|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-07-03|||June 2016||2016-06-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|||Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women|Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women: A Double Blind Randomized Controlled Trial|Recruiting||Phase 3|210|Anticipated|Cairo University||3|||f||||t||||||||No||2017-10-10 22:18:52.308463|2017-10-10 22:18:52.308463
NCT02736006|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-06-12|||March 22, 2016|Actual|2016-03-22|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|DACODEC||Decreases in Diffusing Lung Capacity for Carbon Monoxide (DLCO) in Occupational Divers and Their Impact on Decompression Sickness Risks|Decreases in Diffusing Lung Capacity for Carbon Monoxide (DLCO) in Occupational Divers and Their Impact on Decompression Sickness Risks|Completed||N/A|16|Actual|University Hospital, Brest||1|||f||||f||||||||||2017-10-10 22:18:52.414924|2017-10-10 22:18:52.414924
NCT02735993|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-07|||October 2014||2014-10-01|April 2016|2016-04-01|March 2020|Anticipated|2020-03-01|December 2016|Anticipated|2016-12-01|5 Years|Observational [Patient Registry]|CREATE||Cardiac REgistry of Celution Device for the Processing of Adipose-derived Regenerative Cells|Cardiac REgistry of Celution Device for the Processing of Adipose-derived Regenerative Cells: Treatment and Evaluation (CREATE)|Withdrawn||N/A|0|Actual|Cytori Therapeutics|||1|Corporate decision|f||||||||||||||2017-10-10 22:18:52.498468|2017-10-10 22:18:52.498468
NCT02735967|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-07-18|||March 2016||2016-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||The Use of Diadynamic in Association With a Manual Therapy Program for Patients With Impingement Syndrome|The Use of Diadynamic in Association With a Manual Therapy Program for Patients With Impingement Syndrome: a Randomized Blind Clinical Trial|Completed||N/A|60|Actual|University of Nove de Julho||3|||f||||t||||||||Yes||2017-10-10 22:18:52.853629|2017-10-10 22:18:52.853629
NCT02735954|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-05-10|||September 2014||2014-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Colorado Marijuana Users Health Cohort|Colorado Marijuana Users Health Cohort|Recruiting||N/A|2000|Anticipated|National Jewish Health|||3||f||||f||||||Samples With DNA|"     Blood and urine will be collected and retained for study purposes to look at biomarkers and     correlated cannabinoid (THC) levels.   "|||2017-10-10 22:18:52.938697|2017-10-10 22:18:52.938697
NCT02735941|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-06-13|||June 13, 2017|Actual|2017-06-13|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases|Expression of G Protein-coupled Receptors and Ligands in Inflammatory Bowel Diseases and Colon Cancer|Active, not recruiting||N/A|31|Actual|Medical University of Graz|||4||f||||f||||||Samples Without DNA|"     blood, serum, biopsies   "|No||2017-10-10 22:18:53.020641|2017-10-10 22:18:53.020641
NCT02735928|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PARROT||Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor|Feasibility, Efficacy and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Cisplatin in Women With Recurrent Ovarian Cancer: an Open-label, Single-arm Phase I-II Clinical Trial|Recruiting||Phase 1/Phase 2|50|Anticipated|Catholic University of the Sacred Heart||1|||f||||f||||||||No||2017-10-10 22:18:53.097864|2017-10-10 22:18:53.097864
NCT02735915|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-08-25|||April 11, 2016|Actual|2016-04-11|August 2017|2017-08-01|November 15, 2018|Anticipated|2018-11-15|September 12, 2017|Anticipated|2017-09-12||Interventional|||Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older|Long Term Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine 1437173A and Assessment of Re-vaccination With 2 Additional Doses, in Healthy Subjects Aged 60 Years of Age and Older|Active, not recruiting||Phase 3|73|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 22:18:53.181635|2017-10-10 22:18:53.181635
NCT02735902|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-08-19|||April 2017||2017-04-01|August 2016|2016-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|AVATAR||Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1)|Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions - an Open, Multicenter Randomized Controlled Trial With Two Parallel Arms (1:1)|Not yet recruiting||Phase 4|170|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||||2017-10-10 22:18:53.289402|2017-10-10 22:18:53.289402
NCT02735889|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-11-04|||December 2015||2015-12-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Fizzy Drinks Study|The Effect of Different Levels of Carbonation in Drinks on Glycemic Response, Gastric Emptying, Satiety and Energy Intake|Completed||N/A|15|Actual|Clinical Nutrition Research Centre, Singapore||3|||f||||f||||||||No||2017-10-10 22:18:53.409137|2017-10-10 22:18:53.409137
NCT02735876|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2016-05-12|||May 2016||2016-05-01|April 2016|2016-04-01||||June 2020|Anticipated|2020-06-01||Interventional|||A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma|A Randomized, Multicenter, Open Label, Phase 3 Study of Acalabrutinib (ACP-196) in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib Alone in Subjects With Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL)|Withdrawn||Phase 3|0|Actual|Acerta Pharma BV||3|||f||||t||||||||Undecided||2017-10-10 22:18:53.484369|2017-10-10 22:18:53.484369
NCT02735863|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-08|2017-06-19|||May 2016||2016-05-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment|A Multi-center, Randomized, Double-blind, Placebo-controlled Phase IIa Trial to Compare the Safety of ABX464 Given at a Fixed Dose to Placebo in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment (Darunavir/Ritonavir or Darunavir/Cobicistat).|Completed||Phase 2|30|Actual|Abivax S.A.||2|||f||||t||||||||||2017-10-10 22:18:53.557796|2017-10-10 22:18:53.557796
NCT02735850|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-05-22|||December 2015|Anticipated|2015-12-01|April 2016|2016-04-01|June 2021|Anticipated|2021-06-01|February 2021|Anticipated|2021-02-01||Interventional|ImmunoSABR||Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR)|A Randomized Phase II Trial of the Combination of SBRT With L19-IL2 in Patients With Limited Metastatic Non-small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 2|0|Actual|Maastricht Radiation Oncology||4||Not yet submitted, unclear timelines|f||||f||||||||Undecided||2017-10-10 22:18:53.643791|2017-10-10 22:18:53.643791
NCT02735837|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-09-30|||January 2015||2015-01-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ®|The Effect of Non‐Surgical Periodontal Therapy With Adjunctive Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus (DM):A Randomized, Clinical Trial|Completed||Phase 2/Phase 3|24|Actual|Islamic Azad University, Tehran||2|||f||||t||||||||Yes||2017-10-10 22:18:53.721201|2017-10-10 22:18:53.721201
NCT02735824|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-04-28|||February 2016||2016-02-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Observational|GSI||Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies|Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies|Recruiting||N/A|500|Anticipated|University Children's Hospital, Zurich|||3||f||||f||||||Samples With DNA|"     DNA PBMC   "|Yes|planned publication in peer reviewed journals (PubMed)|2017-10-10 22:18:53.90786|2017-10-10 22:18:53.90786
NCT02735811|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-04-12|||March 2015||2015-03-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|OBSERVO||OBSERVational Registry on Long-term Outcome of ICD Patients|The Italian Multicentric OBSERVational Registry on Long-term Outcome of ICD Patients (OBSERVO-ICD Registry)|Recruiting||N/A|1300|Anticipated|Azienda Ospedaliera Cardinale G. Panico|||1||f||||f||||||||No||2017-10-10 22:18:54.006976|2017-10-10 22:18:54.006976
NCT02735798|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets|A Pilot Study of 64-Cu Labeled Brain PET/MRI for MM-302, a Novel HER2 Targeting Agent, in Advanced HER2+ Cancer With Brain Metastases|Withdrawn||Early Phase 1|0|Actual|University of California, San Francisco||1||The study was not started due to the sponsor choosing to not fund the trial.|f||||t||||||||Undecided||2017-10-10 22:18:54.120185|2017-10-10 22:18:54.120185
NCT02735785|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-01|||September 2014||2014-09-01|May 2017|2017-05-01||||January 2017|Actual|2017-01-01||Interventional|||Adapting the HOPE Social Media Intervention to Reduce Prescription Drug Abuse||Active, not recruiting||N/A|57|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-10-10 22:18:54.212263|2017-10-10 22:18:54.212263
NCT02735772|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-01-06|||September 2015||2015-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Transobturator Approach for Paravaginal Repair|Transobturator Approach for Paravaginal Repair a New Approach|Completed||N/A|20|Actual|Ain Shams Maternity Hospital||1|||f||||f||||||||No||2017-10-10 22:18:54.278893|2017-10-10 22:18:54.278893
NCT02735759|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-07-18|||July 2018|Anticipated|2018-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PAFC||Detecting Circulating Emboli in Patients With Acute Venous Thromboembolism|Detecting Circulating Emboli in Patients With Acute Venous Thromboembolism Using in Vivo Photoacoustic Flow Cytometry (PAFC)|Not yet recruiting||N/A|20|Anticipated|University of Arkansas||2|||f||||f|f|t|t|f||||||2017-10-10 22:18:54.363297|2017-10-10 22:18:54.363297
NCT02735746|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-09-06|||August 21, 2016|Actual|2016-08-21|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|HFFLI||Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis|Novel High Fidelity Functional Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis|Recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-10 22:18:54.450421|2017-10-10 22:18:54.450421
NCT02735733|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-20|||May 2016||2016-05-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Does Cold Saline Used to Inflate a Balloon Tamponade Catheter More Significantly Reduce Blood Loss From Postpartum Hemorrhage Than Room Temperature Saline?|Does Cold Saline Used to Inflate a Balloon Tamponade Catheter More Significantly Reduce Blood Loss From Postpartum Hemorrhage Than Room Temperature Saline?|Not yet recruiting||N/A|50|Anticipated|Baylor Research Institute||2|||f||||f||||||||No||2017-10-10 22:18:54.559989|2017-10-10 22:18:54.559989
NCT02735720|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-03-31|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|1 Year|Observational [Patient Registry]|CORE||The CardiOvascular Remodeling Following Endovascular Aortic Repair (CORE) Study|The CardiOvascular Remodeling Following Endovascular Aortic Repair (CORE) Study|Recruiting||N/A|24|Anticipated|University of Michigan|||2||f||||f||||||Samples With DNA|"     Blood testing will include complete blood count with platelets (including white blood cells,     hemoglobine, hematocrit, red blood cells), a basic metabolic panel (including sodium,     potassium, glucose, and calcium. Cardiac biomarkers testing will include natriuretic peptide     (BNP), amino-terminal pro-BNP (NT-pro-BNP) and Troponin T.      The investigators will not determine DNA of the patients.   "|No||2017-10-10 22:18:54.638319|2017-10-10 22:18:54.638319
NCT02735707|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-03-10|||December 2015||2015-12-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|REMAP-CAP||Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia|Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia|Recruiting||Phase 4|4000|Anticipated|UMC Utrecht||12|||f||||t||||||||Yes||2017-10-10 22:18:54.775564|2017-10-10 22:18:54.775564
NCT02735694|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-04-06|||September 2015||2015-09-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|June 2016|Anticipated|2016-06-01||Interventional|||Cycloserine in the Treatment of Sleep Apnea|Cycloserine in the Treatment of Sleep Apnea|Terminated||Phase 1|18|Actual|University of Manitoba||2||Analysis of initial sample shows negative results.|f||||t||||||||No|No plan has been made on sharing individual data|2017-10-10 22:18:54.961822|2017-10-10 22:18:54.961822
NCT02735681|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-04-18|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|April 2019|Anticipated|2019-04-01||Interventional|||Effect of Meibomian Gland Probing on Ocular Surface in Ocular Rosacea|Effect of Meibomian Gland Probing on Ocular Surface in Ocular Rosacea|Recruiting||N/A|20|Anticipated|University of Arkansas||2|||f||||f|f|f||||||No||2017-10-10 22:18:55.103745|2017-10-10 22:18:55.103745
NCT02735668|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-12|||February 2014||2014-02-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Physiotherapy in Chronic Shoulder Pain After Breast Cancer Treatment|Physiotherapy for Motor Patterns Disturbances in Chronic Shoulder Pain After Breast Cancer Treatment|Recruiting||N/A|80|Anticipated|University of Alcala||3|||f||||t||||||||No||2017-10-10 22:18:55.195022|2017-10-10 22:18:55.195022
NCT02735655|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-28|||April 2016||2016-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|||Global State of Digestive Endoscopy Training Survey|The Global Status and the Unmet Needs for Training in Endoscopy; a World Endoscopy Organization Web Based Survey|Recruiting||N/A|1000|Anticipated|Al-Azhar University|||1||f||||t||||||||No|Final results will be made available but not individual participant data.|2017-10-10 22:18:55.323908|2017-10-10 22:18:55.323908
NCT02735642|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-10-03|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|GIRLS||High-yield HIV Testing, Facilitated Linkage to Care, and Prevention for Female Youth in Kenya|High-yield HIV Testing, Facilitated Linkage to Care, and Prevention for Female Youth in Kenya (GIRLS)|Recruiting||N/A|108|Anticipated|Yale University||6|||f||||f|f|f||||||||2017-10-10 22:18:55.490692|2017-10-10 22:18:55.490692
NCT02735616|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-04-06|||April 2016||2016-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|3 Days|Observational [Patient Registry]|||Comparing the Behavior of the Cardiac Autonomic Regulation System During 24h in Patient Post Stroke and Controls|Comparing the Behavior of the Cardiac Autonomic Regulation System During 24h in Patient Post Stroke and Controls|Not yet recruiting||N/A|30|Anticipated|Rabin Medical Center|||2||f||||f||||||||No||2017-10-10 22:18:55.701734|2017-10-10 22:18:55.701734
NCT02735603|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-31|||April 2016||2016-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants|A Randomized, Double-Blind, Placebo- and Moxifloxacin Positive-Controlled (Open-Label), Cross-Over Study to Evaluate the Potential Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Subjects|Completed||Phase 1|84|Actual|Orexigen Therapeutics, Inc||6|||f||||f||||||||||2017-10-10 22:18:55.776906|2017-10-10 22:18:55.776906
NCT02735590|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-06|||July 2016||2016-07-01|April 2016|2016-04-01||||September 2018|Anticipated|2018-09-01||Interventional|CORTIS||The Correlate of Risk Targeted Intervention Study|A Randomized, Partially-blinded, Clinical Trial of Isoniazid and Rifapentine (3HP) Therapy to Prevent Pulmonary Tuberculosis in High-risk Individuals Identified by a Transcriptomic Correlate of Risk|Not yet recruiting||Phase 2/Phase 3|3200|Anticipated|University of Cape Town||2|||f||||t||||||||Yes|Publications|2017-10-10 22:18:55.883511|2017-10-10 22:18:55.883511
NCT02735577|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-09-20|||March 2016||2016-03-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Neural Mechanisms of Disulfiram Effects|Neurocognitive Mechanisms of Disulfiram Treatment of Alcohol Use Disorder|Recruiting||Phase 4|40|Anticipated|New York State Psychiatric Institute||1|||f||||t||||||||No||2017-10-10 22:18:55.980554|2017-10-10 22:18:55.980554
NCT02735564|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-06|||April 2016||2016-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Change in Reward System Activation and Gut Microbiota Following RYGB and Sleeve Gastrectomy for Weight Loss vs. Control-Heads Up Ancillary|Change in Reward System Activation and Gut Microbiota Following Roux-en-y and Sleeve Gastrectomy for Weight Loss as Compared to a Control- Heads Up Ancillary|Recruiting||N/A|25|Anticipated|Pennington Biomedical Research Center||3|||f||||f||||||||No||2017-10-10 22:18:56.079134|2017-10-10 22:18:56.079134
NCT02735551|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-06-05|||April 2016||2016-04-01|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|March 13, 2017|Actual|2017-03-13||Interventional|||LARC Forward Contraceptive Counseling at MHCC|Effectiveness of LARC Forward Contraceptive Counseling and Same Day Placement in a Community College Population: A Randomized Intervention Project|Terminated||Phase 4|3|Actual|Oregon Health and Science University||3||"Inadequate participant enrollment during enrollment period. Not able to extend due to funding   and PI time constraints."|f||||f||||||||No||2017-10-10 22:18:56.166034|2017-10-10 22:18:56.166034
NCT02735538|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-12|||July 2009||2009-07-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Observational|||Transcription Factor Runx2 in Necrotic Femoral Head Tissue|Transcription Factor Runx2 in Necrotic Femoral Head Tissue: Study Protocol for a Retrospective Non-randomized, Parallel-controlled Clinical Trial|Completed||N/A|30|Actual|Shengjing Hospital|||2||f||||f||||||||Undecided||2017-10-10 22:18:56.251455|2017-10-10 22:18:56.251455
NCT02735525|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-01-24|||June 2016||2016-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Feasibility Trial for Postoperative Wound Surveillance Using Smartphones|Feasibility Trial for Postoperative Wound Surveillance Using Smartphones|Completed||N/A|40|Actual|University of Wisconsin, Madison||1|||f||||f||||||||No||2017-10-10 22:18:56.321861|2017-10-10 22:18:56.321861
NCT02735512|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-03-24|||March 1, 2016|Actual|2016-03-01|March 2017|2017-03-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|||MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer|MDSC Clinical Assay for Cancer Detection and Monitoring in Bladder Carcinoma|Recruiting||N/A|63|Anticipated|University of Southern California|||3||f||||t|f|f||||Samples With DNA|"     Blood, urine   "|||2017-10-10 22:18:56.397345|2017-10-10 22:18:56.397345
NCT02735486|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-04-06|||February 2014||2014-02-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|G-CVD||Acute Effects of Ginger Extract Consumption on Risk Markers of Cardiovascular Disease|Randomized, Controlled Trial of Ginger Extract Consumption for Healthy Males at Risk of Developing Cardiovascular Disease|Completed||N/A|22|Actual|University of Reading||2|||f||||t||||||||No||2017-10-10 22:18:56.57189|2017-10-10 22:18:56.57189
NCT02735473|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-03-13|||June 2016||2016-06-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders|Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders|Recruiting||Phase 2|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 22:18:56.657686|2017-10-10 22:18:56.657686
NCT02735460|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-06|||March 2016||2016-03-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Usability of Andago V2.0 in Gait Rehabilitation of Stroke Patients|Single-center Usability Study of the Overground Gait and Balance Training Device Andago V2.0 in Patients With Gait Disorder After Stroke at a Center for Neurological Rehabilitation|Recruiting||Phase 2|15|Anticipated|Rehaklinik Zihlschlacht AG||1|||f||||f||||||||No||2017-10-10 22:18:56.756733|2017-10-10 22:18:56.756733
NCT02735447|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-14|||May 2016||2016-05-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study|Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study|Not yet recruiting||N/A|190|Anticipated|La-ser Europe Limited|||1||f||||f||||||||||2017-10-10 22:18:56.842573|2017-10-10 22:18:56.842573
NCT02735434|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-05-02|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|April 2017|Actual|2017-04-01||Interventional|||Internet-delivered Acceptance and Commitment Therapy for Patients With Health Anxiety|Internet-delivered Acceptance and Commitment Therapy for Patients With Health Anxiety: a Randomized Controlled Trial|Active, not recruiting||N/A|150|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-10 22:18:56.900094|2017-10-10 22:18:56.900094
NCT02735421|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-07-31|||May 13, 2016|Actual|2016-05-13|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|June 5, 2017|Actual|2017-06-05||Interventional|OSCAR||Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars|Effect of Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel Versus Vehicle Gel on the Risk of Formation of Atrophic Acne Scars in Moderate to Severe Acne Subjects|Active, not recruiting||Phase 4|67|Actual|Galderma||2|||f||||f||||||||||2017-10-10 22:18:57.000011|2017-10-10 22:18:57.000011
NCT02735408|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-04-06|||October 2015||2015-10-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Kinesiotape Tensiomyography in Low Back Region|Tensiomyography Effects of the Kinesiotape Tension in the Muscular Stiffness of the Low Back Region|Recruiting||Phase 1|50|Anticipated|Universidad Europea de Madrid||4|||f||||||||||||||2017-10-10 22:18:57.73328|2017-10-10 22:18:57.73328
NCT02735395|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-05-17|||July 2011||2011-07-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|May 2014|Actual|2014-05-01||Interventional|||Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis|Impact of Different Dosages and Time of Administration of Metronidazole and Amoxicillin in the Treatment of Generalized Chronic Periodontitis: A Randomized Clinical Trial|Active, not recruiting||Phase 4|110|Actual|University of Guarulhos||5|||f||||f||||||||||2017-10-10 22:18:57.834799|2017-10-10 22:18:57.834799
NCT02735382|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-06-01|||September 2016||2016-09-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study|Transforming the Treatment of Tobacco Use in Health Care: Seizing the Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking: Study 1: the EHR and Fax Referral Study|Enrolling by invitation||N/A|24|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||No||2017-10-10 22:18:58.002174|2017-10-10 22:18:58.002174
NCT02735369|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-04-03|||December 2014||2014-12-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR|A Phase II, Randomized, Placebo-Controlled, Study Assessing Efficacy and Safety of OC-10X Ophthalmic Suspension in the Treatment of Proliferative Diabetic Retinopathy|Terminated||Phase 2|40|Anticipated|OcuCure Therapeutics, Inc.||2|||f||||t||||||||Undecided||2017-10-10 22:18:58.10511|2017-10-10 22:18:58.10511
NCT02735356|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-13|||March 2016||2016-03-01|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|September 30, 2017|Anticipated|2017-09-30||Interventional|||Topical Itraconazole in Treating Patients With Basal Cell Cancer|A Case Study of the Effects of Topical Itraconazole on Pharmacodynamic Modulation of Hedgehog Target Gene Expression in Basal Cell Carcinomas in Patients|Active, not recruiting||Early Phase 1|9|Actual|Stanford University||1|||f||||t|t|f||||||||2017-10-10 22:18:58.2279|2017-10-10 22:18:58.2279
NCT02735343|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-31|||August 2016|Actual|2016-08-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|Check||The CHECK Trial: A Comparison of Headache Treatment in the Emergency Department: Compazine Versus Ketamine|The CHECK Trial: A Comparison of Headache Treatment in the Emergency Department: Compazine Versus Ketamine. A Multi-Center, Randomized, Double-Blind, Clinical Control Trial|Terminated||Phase 3|5|Actual|Mike O'Callaghan Federal Hospital||2||only recruited 5 patients at this location|f||||f||||||||Yes|De-identified data will be shared with University Medical Center of Southern Nevada via a Cooperative Research and Development Agreement. They are conducing the same study under a different IRB.|2017-10-10 22:18:58.32316|2017-10-10 22:18:58.32316
NCT02735330|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-04-11|||January 2013||2013-01-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|December 2015|Actual|2015-12-01||Interventional|INFARCT||Intraoperative Coeliac Plexus Alcohol Neurolysis Along With Frey's Procedure for a Better Pain Relief|Intra Operative Coeliac Plexus Neurolysis Combined With Frey's Procedure for Effective Pain Relief in Patients With Chronic Calcific Pancreatitis- A Prospective Randomized Double-blind Placebo Controlled Trial|Active, not recruiting||N/A|136|Actual|Madras Medical College||2|||f||||t||||||||Yes|with out showing the name of the participants we can disclose the data of the all participants|2017-10-10 22:18:58.428257|2017-10-10 22:18:58.428257
NCT02734992|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-04-05|||September 2014||2014-09-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2015|Actual|2015-03-01||Interventional|ALGEA||Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers|An Innovative Psychosocial Intervention for the Treatment of Chronic Pain Patients and Their Families|Active, not recruiting||N/A|180|Actual|University of Cyprus||2|||f||||f||||||||No||2017-10-10 22:19:01.883641|2017-10-10 22:19:01.883641
NCT02735317|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-06|||April 2016||2016-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT|Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT: A Single-center, Randomized Controlled Trial|Not yet recruiting||Phase 2|90|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:18:58.52532|2017-10-10 22:18:58.52532
NCT02735304|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-12-02|||October 2016||2016-10-01|December 2016|2016-12-01|July 2021|Anticipated|2021-07-01|April 2021|Anticipated|2021-04-01||Interventional|||Clinical Study 3MESPE Crowns|Clinical Pilot Study of: Astringent Retraction Paste, Imprint™ 4 VPS, Imprint 4™ Preliminary, Intra-oral Syringes, 3M ESPE New Temporary Restoration (SuPro 100 and Temporary Cement), RelyX™ Unicem™ 2 Automix Cement, Lava™ Plus Zirconia Crowns|Recruiting||N/A|20|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||No|no plans to share data|2017-10-10 22:18:58.642453|2017-10-10 22:18:58.642453
NCT02735291|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-03-13|||November 2015||2015-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|EECNTL||Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia|Single Arm, Two Phase, Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia|Recruiting||N/A|24|Anticipated|Sinobioway Cell Therapy Co., Ltd.||1|||f||||t||||||||No||2017-10-10 22:18:58.729762|2017-10-10 22:18:58.729762
NCT02735278|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-01-11|||May 2016||2016-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Are There Different Objective Fixation Disparity Values for Two Different Test Paradigms|Are There Different Objective Fixation Disparity Values for Two Different Test Paradigms: Similar to Reading Dot Presentation and Text Reading? - How This Phenomenon Can be Explained|Completed||N/A|24|Actual|University of Applied Sciences and Arts Northwestern Switzerland|||1||f||||t||||||||No||2017-10-10 22:18:58.824683|2017-10-10 22:18:58.824683
NCT02735265|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-04-11|||February 2015||2015-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Rehabilitation Effects on Balance With Kinect for Xbox Virtual Reality Games|Evaluation of the Rehabilitation Effects on Balance With Kinect for Xbox Virtual Reality Games for Patients With Stroke|Completed||N/A|60|Actual|Taipei Medical University Shuang Ho Hospital||2|||f||||t||||||||Yes||2017-10-10 22:18:58.888217|2017-10-10 22:18:58.888217
NCT02735252|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-06-06|||April 2016||2016-04-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||PROMOTE: Identifying Predictive Markers of Response for Prostate Cancer|"Precision Oncology and Molecular Targeting in Advanced Prostate Cancer: Identifying Predictive Markers of Response (The PROMOTE Study)"|Recruiting||N/A|500|Anticipated|University of California, San Francisco|||5||f||||t||||||Samples With DNA|"     Left-over blood and tissue samples   "|Undecided||2017-10-10 22:18:59.013902|2017-10-10 22:18:59.013902
NCT02735239|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-27|||June 2016||2016-06-01|July 2017|2017-07-01||||April 2021|Anticipated|2021-04-01||Interventional|||Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer|Phase 1/2 Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer|Recruiting||Phase 1/Phase 2|75|Anticipated|Ludwig Institute for Cancer Research||5|||f||||f||||||||||2017-10-10 22:18:59.140315|2017-10-10 22:18:59.140315
NCT02735226|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-18|||January 2014||2014-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|3 Months|Observational [Patient Registry]|SSSS||Stroke Prevention and Treatment System in Shanghai: a Network of Public Healthcare of Stroke|Shanghai Stroke Service System|Recruiting||N/A|100000|Anticipated|Shanghai Stroke Service System|||1||f||||t||||||||||2017-10-10 22:18:59.277309|2017-10-10 22:18:59.277309
NCT02735213|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-07-10|||March 2016||2016-03-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy|A Prospective Non-inferiority Study of the Use of Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy|Recruiting||Phase 2/Phase 3|88|Anticipated|The Eye Hospital of Wenzhou Medical University||2|||f||||t||||||||||2017-10-10 22:18:59.43281|2017-10-10 22:18:59.43281
NCT02735200|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2017-05-11|2017-01-28||April 2016||2016-04-01|May 2017|2017-05-01|December 30, 2016|Actual|2016-12-30|December 2016|Actual|2016-12-01||Interventional|||Topical Delivery of Vitamin D3 as Vitamin D Supplementation|Topical Delivery of Vitamin D3: A Randomized Controlled Trial (RCT)|Completed||Phase 2|550|Actual|Dammam University|we did have a limitation of not performing the absorption studies, which could have strenthened the study robustly.|2|||f||||t||||||||Yes||2017-10-10 22:18:59.541563|2017-10-10 22:18:59.541563
NCT02735174|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-02|||January 2016||2016-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|AFS4||Improving Asthma Care by Partnering With School Nurses to Bring Asthma Care Into the Inner-City Schools|Phase 4: Improving Asthma Outcomes By Facilitating Patient-Centered Care At School (Asthma-Free School)|Recruiting||N/A|30|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 22:18:59.922603|2017-10-10 22:18:59.922603
NCT02735161|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-08-22|||April 2016||2016-04-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Fatigue and Exercise Training in Patients With Sarcoidosis|Fatigue and Exercise Training in Patients With Sarcoidosis|Completed||N/A|40|Anticipated|LHL Helse||1|||f||||f||||||||||2017-10-10 22:19:00.021227|2017-10-10 22:19:00.021227
NCT02735148|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-01|||November 2014||2014-11-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||The Effects of Body Weight Supported Treadmill Training On Balance In Stroke Patients|The Effects of Body Weight Supported Treadmill Training On Static And Dynamic Balance In Stroke Patients: A Randomized-Single Blind Study|Completed||N/A|45|Actual|Istanbul University||3|||f||||f||||||||No||2017-10-10 22:19:00.126049|2017-10-10 22:19:00.126049
NCT02735135|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-06-16|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|SPA2-ARSFT-DUO||Comparison of 2 Mattresses for the Prevention of Bedsores by Measuring Skin Pressure in the Sacral Area|Comparison of 2 Mattresses for the Prevention of Bedsores, AIRSOFT DUO and SENTRY 1200 A PRESSION CONSTANTE, by Measuring Skin Pressure in the Sacral Area - a Multicenter Crossover Study|Not yet recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f|f|f||||||||2017-10-10 22:19:00.243696|2017-10-10 22:19:00.243696
NCT02735122|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-07|||April 2016||2016-04-01|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|November 2016|Actual|2016-11-01||Interventional|||Study of Acetaminophen (ACM) in Post-operative Dental Pain|A Randomized, Double-Blind, Placebo- and Active- Controlled, Single-Dose, Efficacy, Safety, and Pharmacokinetics Study of a Test Acetaminophen 500 mg Tablet in Postoperative Dental Pain|Completed||Phase 3|420|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||f||||||||Yes||2017-10-10 22:19:00.369658|2017-10-10 22:19:00.369658
NCT02735109|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-04-06|||April 2015||2015-04-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors|Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 22:19:00.465399|2017-10-10 22:19:00.465399
NCT02735096|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-08-03|||July 2016||2016-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Testing an Intraoral Electronic Balance Aid for Vestibular Imbalance|Palatal Device Providing In-situ Sensory Feedback for Patients With Vestibular Imbalance|Recruiting||N/A|15|Anticipated|Innervo Technology LLC||1|||f||||f||||||||Yes|Participants' age and history of illness (i.e., vestibular loss) will be shared. However, no personal identifiable information will be collected and shared.|2017-10-10 22:19:00.556152|2017-10-10 22:19:00.556152
NCT02735083|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-05-11|||November 9, 2016|Actual|2016-11-09|May 2017|2017-05-01|March 2040|Anticipated|2040-03-01|March 2040|Anticipated|2040-03-01||Interventional|||A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Malignancies Who Have Been Previously Administered With UCART19|Long-term Follow-up Study of Patients Who Have Previously Been Exposed to UCART19 (Allogeneic Engineered T-cells Expressing a Lentiviral-based Anti-CD19 Chimeric Antigen Receptor)|Recruiting||N/A|200|Anticipated|Servier||1|||f||||f|t|f||||||Yes|The datasets generated and/or analysed during the current study will be available upon request from www.servier.com after the Marketing Authorisation has been granted.|2017-10-10 22:19:00.662502|2017-10-10 22:19:00.662502
NCT02735070|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-06|||September 2016||2016-09-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold|Phase III Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold|Not yet recruiting||Phase 3|366|Anticipated|Brainfarma Industria Química e Farmacêutica S/A||2|||f||||f||||||||Yes|"The data that will be collected are: demographics data; medical history, disease characteristics; Likert scale; physician and patient perception about the study treatment; Sleep Questionnaire; evaluation for daily activities willingness; Safety Assessments; Vital Signs and Physical Examination; additional tests; Adverse Events.
All data collected for the study will be recorded, stored and retrieved through electronic case report form designed specifically for this study.
All information will be inserted in a database. All data collected for the study will be analyzed centrally by independent scientific consulting company designated for this purpose. The publication of the overall results of the study will be coordinated by the sponsor. The responsibility for the content of the publications will be shared between the sponsor and co-authors, who will participate in the review of the content and give consent for publication."|2017-10-10 22:19:00.769969|2017-10-10 22:19:00.769969
NCT02735057|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-04-14|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|April 2024|Anticipated|2024-04-01|April 2016|Actual|2016-04-01||Interventional|OSAGE||Chemoradiotherapy in Elderly Patients With Oesophagus Cancer|Phase I-II Study Chemoradiation in Elderly Patients With Oesophagus Cancer|Recruiting||Phase 1/Phase 2|54|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 22:19:00.890904|2017-10-10 22:19:00.890904
NCT02735031|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-05-29|||February 21, 2017|Actual|2017-02-21|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes|Effect of the GLP-1 Receptor Agonist Exenatide on Impaired Hypoglycaemic Awareness in Type 1 Diabetes|Recruiting||Phase 2/Phase 3|15|Anticipated|Radboud University||2|||f||||f|f|f||||||||2017-10-10 22:19:01.277133|2017-10-10 22:19:01.277133
NCT02735005|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-09|||August 2015||2015-08-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|September 26, 2016|Actual|2016-09-26||Interventional|PHV||Determining the Needs of Aging People With Disabilities|"Epidemiology of Aging of People With Disabilities - Gerontological Sector Rumilly-Annecy-Saint-Julien-Pays de Gex-Bellegarde : Description of the Population in an Attempt to Identify Ways to Implement to Meet the Needs in Aging"|Active, not recruiting||N/A|741|Actual|Centre Hospitalier de la Région d'Annecy||1|||f||||t||||||||||2017-10-10 22:19:01.663275|2017-10-10 22:19:01.663275
NCT02734056|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-14|2016-08-26||October 2015||2015-10-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Music During Labor Epidural Placement and Patient Satisfaction|Music During Labor Epidural Placement and Patient Satisfaction|Completed||N/A|100|Actual|Brigham and Women's Hospital||2|||f||||f||||||||Yes|Will publish in a medical journal|2017-10-10 22:19:13.90872|2017-10-10 22:19:13.90872
NCT02734979|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-04-24|||April 2016||2016-04-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|May 2019|Anticipated|2019-05-01||Interventional|Biobridge||Prospective Evaluation of the Biobridge Scaffold as an Adjunct to Lymph Node Transfer for Upper Extremity Lymphedema|Prospective Evaluation of the Biobridge Scaffold as an Adjunct to Vascularized Lymph Node Transfer for Upper Extremity Lymphedema|Recruiting||N/A|60|Anticipated|Stanford University||1|||f||||f||||||||Yes|The data will be published in peer review format and raw data will be available on request by individual investigators or institutions|2017-10-10 22:19:02.017|2017-10-10 22:19:02.017
NCT02734966|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-09-25|||December 2007||2007-12-01|September 2016|2016-09-01|December 2011|Actual|2011-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury|A Multi-center, Randomized, Double-blind, Active Control Phase II Study to Investigate Multiple Dosage and Treatments of Magnesium Isoglycyrrhizinate Injection to Cure the Acute Drug-induced Liver Injury|Completed||Phase 2|174|Actual|Chia Tai Tianqing Pharmaceutical Group Co., Ltd.||3|||f||||f||||||||Undecided||2017-10-10 22:19:02.157224|2017-10-10 22:19:02.157224
NCT02734953|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-01-31|||April 2016||2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH|Effects of iNO on Invasively Derived Pulmonary Vascular Parameters in Patients With Pulmonary Arterial Hypertension|Completed||Phase 2|10|Actual|Allegheny Singer Research Institute||1|||f||||f||||||||Yes|With sponsor to provide statistical analysis|2017-10-10 22:19:02.297782|2017-10-10 22:19:02.297782
NCT02734940|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-08-01|||July 11, 2016|Actual|2016-07-11|August 2017|2017-08-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Multimodal Analgesia in Cardiac Surgery (Pilot Study)|Multimodal Analgesia in Cardiac Surgery (Pilot Study)|Completed||Phase 4|3|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-10 22:19:02.421388|2017-10-10 22:19:02.421388
NCT02734927|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-01-17|||November 2012||2012-11-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Motivation and Executive Control in Schizophrenia|Motivation and Executive Control in Schizophrenia|Recruiting||N/A|70|Anticipated|Hôpital le Vinatier||2|||f||||t||||||||No||2017-10-10 22:19:02.54888|2017-10-10 22:19:02.54888
NCT02734914|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-11|||May 2016||2016-05-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure|Safety and Efficacy of Suctioning Flexible Ureteroscopy With Automatic Control of Renal Pelvic Pressure : A Clinical Randomized,Controlled Study|Not yet recruiting||N/A|60|Anticipated|The Affiliated Ganzhou Hospital of Nanchang University||2|||f||||t||||||||Yes||2017-10-10 22:19:02.653598|2017-10-10 22:19:02.653598
NCT02734901|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-19|||March 2016||2016-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effects of Acute Red Raspberry Consumption on Vascular Function in Healthy Individuals|Effects of Acute Red Raspberry Consumption on Vascular Function in Healthy Individuals|Completed||N/A|10|Actual|Heinrich-Heine University, Duesseldorf||3|||f||||f||||||||No||2017-10-10 22:19:02.739895|2017-10-10 22:19:02.739895
NCT02734888|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-05|||July 2015||2015-07-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Arterial Inflammation and E-Cigarettes|Arterial Inflammation and E-Cigarettes|Recruiting||N/A|30|Anticipated|University of California, Los Angeles||3|||f||||f||||||||||2017-10-10 22:19:02.842977|2017-10-10 22:19:02.842977
NCT02734875|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-11|||May 2016||2016-05-01|April 2016|2016-04-01||||March 2018|Anticipated|2018-03-01||Interventional|IQ-MATCH||Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology|Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology|Not yet recruiting||N/A|1400|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No|There is no plan to share individual participant data outside of the staff and participants themselves.|2017-10-10 22:19:02.942316|2017-10-10 22:19:02.942316
NCT02734862|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-22|||July 26, 2016|Actual|2016-07-26|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|STRIVE||CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis|A Phase 2, Multicenter, Randomized, Double-blind Study of the Safety, Tolerability, and Efficacy of Intravenous CD101 vs Intravenous Caspofungin Followed by Oral Fluconazole Step-down in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis|Recruiting||Phase 2|114|Anticipated|Cidara Therapeutics Inc.||3|||f||||f|t|f||||||||2017-10-10 22:19:03.046286|2017-10-10 22:19:03.046286
NCT02734849|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-31|||April 2016||2016-04-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Study to Evaluate Multiple Doses in Patients With Nasal Polyposis|A Phase 2, Randomized, Double-blind, Placebo-controlled, Study to Evaluate Multiple Doses of AK001 in Patients With Moderate to Severe Nasal Polyposis|Active, not recruiting||Phase 2|40|Actual|Allakos, Inc.||3|||f||||t||||||||||2017-10-10 22:19:03.281894|2017-10-10 22:19:03.281894
NCT02734836|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-07-05|||April 2016||2016-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|DESPERADO||Drug Eluting Stent for the Management of PERipheral Arterial Disease Of the SFA (DESPERADO-SFA Study)||Recruiting||N/A|20|Anticipated|Arkansas Heart Hospital||1|||f||||f||||||||||2017-10-10 22:19:03.406084|2017-10-10 22:19:03.406084
NCT02734823|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-04-08|||March 1, 2016|Actual|2016-03-01|April 2017|2017-04-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|||Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor|Long Term Effects of Tyrosine Kinase Inhibitors on Ovarian Reserve and Fertility, A Pilot Study|Recruiting||N/A|20|Anticipated|University of Southern California|||1||f||||t||||||Samples With DNA|"     Serum   "|||2017-10-10 22:19:03.514471|2017-10-10 22:19:03.514471
NCT02734810|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-05-19|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|February 28, 2017|Actual|2017-02-28|October 2016|Actual|2016-10-01||Interventional|SIMPLICITY||SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis|A Phase 3, Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency|Completed||Phase 3|15|Actual|Anthera Pharmaceuticals||2|||f||||t||||||||No||2017-10-10 22:19:03.63212|2017-10-10 22:19:03.63212
NCT02734797|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-10-25|||November 2015||2015-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|CONSEPT||Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant|Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant|Recruiting||N/A|50|Anticipated|University of Michigan Cancer Center|||1||f||||t||||||||No||2017-10-10 22:19:03.762016|2017-10-10 22:19:03.762016
NCT02734784|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-11|||February 2014||2014-02-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|TCPWRAAPT||Treatment of Chronic Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy|Clinical and Microbiological of Antimicrobial Photodynamic Therapy on Surgical Treatment of Chronic Periodontitis: a Double-blind Split-mouth Randomized Controlled Clinical Trial.|Completed||Phase 4|20|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:19:03.840989|2017-10-10 22:19:03.840989
NCT02734771|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-08-10|||June 2016||2016-06-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|BV mini CHP||A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)|Phase II Pilot Study of Brentuximab Vedotin, Rituximab and Dose Attenuated CHP in Elderly Patients With DLBCL|Recruiting||Phase 2|24|Anticipated|University of Rochester||1|||f||||t||||||||||2017-10-10 22:19:04.501465|2017-10-10 22:19:04.501465
NCT02734758|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-11|||August 2011|Actual|2011-08-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Markers of Atrial Fibrillation|Atrial Fibrillation in Ischemic Stroke: Strengthening Identification and Decisions to Anticoagulate|Recruiting||N/A|200|Anticipated|University of California, Davis|||2||f||||||||||||||2017-10-10 22:19:04.636747|2017-10-10 22:19:04.636747
NCT02734745|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-10-03|||April 1, 2016|Actual|2016-04-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Accuracy of Freestyle Libre|Accuracy of Flash Glucose Monitoring Freestyle Libre (Abbott) in Home Setting and In-patient Setting During Hypo - Hyperglycemia|Recruiting||N/A|48|Anticipated|University of Padova||1|||f||||f||||||||||2017-10-10 22:19:04.702398|2017-10-10 22:19:04.702398
NCT02734732|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-21|||April 2015||2015-04-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole|Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole|Recruiting||Phase 2|2800|Anticipated|Umeå University||2|||f||||t||||||||||2017-10-10 22:19:04.779399|2017-10-10 22:19:04.779399
NCT02734719|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Increasing Bone Density by Application of Surface Electrical Stimulation|Increasing Bone Density by Application of Surface Electrical Stimulation|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Belgrade||1|||f||||t||||||||||2017-10-10 22:19:04.882073|2017-10-10 22:19:04.882073
NCT02734706|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-05-12|||March 2016||2016-03-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of a LRC™ (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults|Efficacy of a Supplement Capsule Containing LRC™ (L. Reuteri NCIMB 30242) on Managing Cholesterol Levels in Adults|Recruiting||Phase 2|120|Anticipated|UAS Labs LLC||2|||f||||||||||||||2017-10-10 22:19:04.965103|2017-10-10 22:19:04.965103
NCT02734693|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-03-07|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.|A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting|Completed||Phase 3|130|Actual|Sunovion||2|||f||||t||||||||||2017-10-10 22:19:05.124985|2017-10-10 22:19:05.124985
NCT02734680|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2017-04-09|||February 2016||2016-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|IFCSLAPC||IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer|Intraoperative Radiotherapy(IORT) Followed by Concurrent Chemoradiotherapy(CCRT) or Stereotactic Radiotherapy(SBRT) for Locally Advanced Pancreatic Cancer|Recruiting||N/A|70|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 22:19:05.234374|2017-10-10 22:19:05.234374
NCT02734667|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-08-24|||February 2016||2016-02-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes|Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes|Recruiting||N/A|60|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:19:05.32461|2017-10-10 22:19:05.32461
NCT02734654|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-02-28|||November 2007||2007-11-01|February 2017|2017-02-01|January 2012|Actual|2012-01-01|February 2011|Actual|2011-02-01||Interventional|||Limb RIPC in Patients Undergoing Lung Lobectomy. Study of Oxidative Lung Damage|Pulmonary Remote Preconditioning by Ischemia-reperfusion in Lung Lobectomy. A Study on the Prevention of Oxidative Stress|Completed||N/A|53|Actual|Instituto de Salud Carlos III||2|||f||||f|f|f||||||No||2017-10-10 22:19:05.421356|2017-10-10 22:19:05.421356
NCT02734641|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-08-30|||August 2016||2016-08-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone|Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone|Recruiting||N/A|100|Anticipated|HaEmek Medical Center, Israel|||2||f||||f||||||||Undecided||2017-10-10 22:19:05.489415|2017-10-10 22:19:05.489415
NCT02734628|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-07|||March 2007||2007-03-01|April 2016|2016-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pilot Study to Assess Number of Patients for Main Trial|A Randomized, Double-blind, Single Center, Intra-individual Comparison Study With Repeated Application to Assess the Wound-healing Efficacy of a 5% Dexpanthenol Ointment Compared With Placebo in Patients With Superficial, Abrasive Wounds|Completed||Phase 4|28|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:19:05.567923|2017-10-10 22:19:05.567923
NCT02734108|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-04-11|||January 2016||2016-01-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|STAR||Transcranial Direct Current Stimulation (tDCS) and Anorexia Nervosa|Measuring the Effect of a Program of 20 Sessions of Transcranial Direct Current Stimulation With 2 Milli-ampere Targeting the Dorsolateral Prefrontal Cortex on the Symptoms of Anorexia Nervosa: An Open Label Uncontrolled Pilots Study|Recruiting||N/A|10|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||Undecided||2017-10-10 22:19:13.317927|2017-10-10 22:19:13.317927
NCT02734615|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-05|||April 27, 2016|Actual|2016-04-27|September 2017|2017-09-01|October 18, 2019|Anticipated|2019-10-18|October 18, 2019|Anticipated|2019-10-18||Interventional|||Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers|A Phase I/Ib, Open Label Study of LSZ102 Single Agent and LSZ102 in Combination With Either LEE011 (LSZ102 + LEE011) or BYL719 (LSZ102 + BYL719) in Patients With Advanced or Metastatic ER+ Breast Cancer Who Have Progressed After Endocrine Therapy|Recruiting||Phase 1|152|Anticipated|Novartis||5|||f||||f|t|f||||||||2017-10-10 22:19:05.657475|2017-10-10 22:19:05.657475
NCT02734602|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-12-01|||April 2016||2016-04-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Interventional|||Imaging SV2A in Mood Disorders|Imaging SV2A in Mood Disorders|Recruiting||N/A|30|Anticipated|Yale University||3|||f||||f||||||||No||2017-10-10 22:19:05.80184|2017-10-10 22:19:05.80184
NCT02734589|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-09-25|||January 24, 2017|Actual|2017-01-24|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Pilot Study of Fecal Transplantation Using a Unique Diet for Donor and Recipient in Mild to Moderate Treatment Refractory Colitis in Inflammatory Bowel Disease|Fecal Transplantation Using a Novel Conditioning Method for Donor and Recipient in Mild to Moderate Treatment Refractory Colitis in Inflammatory Bowel Disease|Recruiting||N/A|34|Anticipated|Wolfson Medical Center||3|||f||||f|f|f||||||||2017-10-10 22:19:07.476035|2017-10-10 22:19:07.476035
NCT02734576|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-01-02|||May 2016||2016-05-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Venous Sinus Stenting To Treat Intractable Pulsatile Tinnitus Caused By Venous Sinus Stenosis|Venous Sinus Stenting To Treat Intractable Pulsatile Tinnitus Caused By Venous Sinus Stenosis|Recruiting||Phase 1|20|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||Yes||2017-10-10 22:19:07.598635|2017-10-10 22:19:07.598635
NCT02734563|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-07-14|||January 2011||2011-01-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|||Collagen Alterations in Patients With Abdominal Wall Hernias|Collagen Alterations in Patients With Abdominal Wall Hernias|Completed||N/A|174|Actual|Bispebjerg Hospital|||2||f||||t||||||Samples Without DNA|"     Venous blood   "|||2017-10-10 22:19:07.677592|2017-10-10 22:19:07.677592
NCT02734550|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-08-08|||September 2016||2016-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|CandiSep||(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis|(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection Versus Culture Based Diagnosis in Patients With Severe Sepsis or Septic Shock|Recruiting||N/A|312|Anticipated|Center for Sepsis Control and Care, Germany||2|||f||||t||||||||||2017-10-10 22:19:07.743938|2017-10-10 22:19:07.743938
NCT02734537|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-07-07|||March 2016||2016-03-01|July 2017|2017-07-01|December 31, 2022|Anticipated|2022-12-31|December 2021|Anticipated|2021-12-01||Interventional|||Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery|Phase II Randomized Trial of Adjuvant Radiotherapy With or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 2|345|Anticipated|Eastern Cooperative Oncology Group||2|||f||||||||||||||2017-10-10 22:19:07.948831|2017-10-10 22:19:07.948831
NCT02734524|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-10-16|||March 2016||2016-03-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer|A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer|Recruiting||Phase 2|104|Anticipated|Southwest Hospital, China||2|||f||||f||||||||Undecided||2017-10-10 22:19:09.521701|2017-10-10 22:19:09.521701
NCT02734511|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-06|||September 2016||2016-09-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PROPOPAL2||Efficiency and Safety of a Procedural Sedation by Propofol on Terminally Ill Patients With Refractory Pain|Efficiency and Safety of a Procedural Sedation by Propofol Administered by Trained Doctors Who Are Not Anesthesiologists on Terminally Ill Patients With Refractory Pain Hospitalized in a Palliative Care Unit|Not yet recruiting||Phase 3|90|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||No||2017-10-10 22:19:09.648431|2017-10-10 22:19:09.648431
NCT02734498|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-03-07|||January 2017||2017-01-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Prospective Treatment Study of Catatonia Patients|Prospective Treatment Study of Catatonia Patients With Right Unilateral Electroconvulsive Treatment (RUL ECT) and Bilateral Electroconvulsive Treatment (BL ECT) Regimens|Recruiting||N/A|30|Anticipated|Wake Forest University Health Sciences||3|||f||||f||||||||No|Personal data of psychiatric patients will not be shared.|2017-10-10 22:19:09.733799|2017-10-10 22:19:09.733799
NCT02734485|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-12|||October 2013||2013-10-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|DeepTMSPARK||Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy|The Use of Deep TMS for the Treatment and Rehabilitation of Patients With Parkinson's Disease and Progressive Supranuclear Palsy|Completed||N/A|20|Actual|IRCCS San Raffaele||2|||f||||t||||||||Yes||2017-10-10 22:19:09.830763|2017-10-10 22:19:09.830763
NCT02734472|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-28|||July 2016||2016-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|C-BPCS||Blood Pressure Follow-up Study in Two Chinese Cohorts(C-BPCS)|Effect of the Interaction Between Environmental Factors and Genetic Predisposition on Long-term Blood Pressure in Chinese Population|Recruiting||N/A|5298|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||t||||||Samples With DNA|"     Meixian county adult salt-sensitive hypertension study is a family-based dietary     interventional study. Whole blood specimen was collected from each participant who underwent     a chronic salt load and potassium supplementation trial.Genomic DNA was extracted from whole     blood specimen using the GOLDMAG Whole Blood Genomic DNA Purification Kit.   "|||2017-10-10 22:19:09.925208|2017-10-10 22:19:09.925208
NCT02734095|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-11|||August 2016||2016-08-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Determining Predictors of Restenosis in Femoropopliteal Lesions|Determining Predictors of Restenosis. Intravascular Ultrasound in the Treatment of Femoropopliteal Lesions|Not yet recruiting||N/A|50|Anticipated|University of Campinas, Brazil||1|||f||||t||||||||Undecided||2017-10-10 22:19:13.584557|2017-10-10 22:19:13.584557
NCT02734082|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-04-11|||October 2013||2013-10-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||The Brain Heart Interaction in Acute Stroke|The Brain Heart Interaction in Acute Stroke|Completed||N/A|204|Actual|University Hospital Inselspital, Berne|||4||f||||t||||||||||2017-10-10 22:19:13.689462|2017-10-10 22:19:13.689462
NCT02734459|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-05|||November 2013||2013-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|TBO||A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin And Dexamethasone In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery|A Multi Center, Open Label, Randomized, Two- Treatment, Single Dose, Crossover, Bioequivalence Study To Compare The Pharmacokinetics Of Marketed Product TobraDex® (Tobramycin And Dexamethasone Ophthalmic Ointment) To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin 0.3% And Dexamethasone 0.1% W/W In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery|Completed||Phase 3|756|Actual|Semler Research Center Pvt. Ltd.||2|||f||||f||||||||||2017-10-10 22:19:10.019173|2017-10-10 22:19:10.019173
NCT02734446|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-05|||April 2014||2014-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2015|Actual|2015-02-01||Interventional|||To Evaluate the Efficacy of Supplementation With L. Reuteri + Vit. D3 in Asthmatic Children|Randomized Controlled Clinical Trial to Evaluate the Efficacy of Supplementation With L. Reuteri + Vit. D3 in Asthmatic Children|Completed||Phase 3|52|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||f||||||||Yes||2017-10-10 22:19:10.089726|2017-10-10 22:19:10.089726
NCT02734433|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-10-03|||June 2016|Actual|2016-06-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|June 13, 2017|Actual|2017-06-13||Interventional|||Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors|A Phase 1 Study of Single Agent Pexidartinib in Asian Subjects With Advanced Solid Tumors|Active, not recruiting||N/A|11|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-10 22:19:10.179741|2017-10-10 22:19:10.179741
NCT02734420|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-04-11|||September 2013||2013-09-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Effect of Photodynamic Therapy With Low-level Laser on Infected Dentin in Primary Teeth: A Controlled Clinical Trial|Effect of Photodynamic Therapy With Low-level Laser on Infected Dentin in Primary Teeth: A Controlled Clinical Trial|Recruiting||Phase 1|3|Anticipated|University of Nove de Julho||2|||f||||t||||||||Undecided||2017-10-10 22:19:10.257855|2017-10-10 22:19:10.257855
NCT02734407|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-09-26|||January 2015||2015-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|Endurance3||Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema|Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial|Enrolling by invitation||Phase 4|9|Anticipated|Retina-Vitreous Associates Medical Group||1|||f||||f||||||||||2017-10-10 22:19:10.356967|2017-10-10 22:19:10.356967
NCT02734394|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-08-17|||June 2014||2014-06-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|WELL-FIT||UW WELL-FIT Exercise Program for Cancer Patients|UW WELL-FIT Exercise Program for Cancer Patients|Recruiting||N/A|200|Anticipated|University of Waterloo||1|||f||||f||||||||||2017-10-10 22:19:10.451652|2017-10-10 22:19:10.451652
NCT02734381|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-07|2016-04-11|||October 2015||2015-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Observational|||Prevalence of Presenting Diseases for Elderly Patients Admitted to Emergency Department|Prevalence of Presenting Diseases for Elderly Patients Admitted to Emergency Department|Completed||N/A|36369|Actual|Adiyaman University Research Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:19:10.536309|2017-10-10 22:19:10.536309
NCT02734368|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-04-05|||February 2010||2010-02-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|February 2012|Actual|2012-02-01||Observational|||A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease||Terminated||N/A|53|Actual|University of Pennsylvania|||3|The longitudinal goal could not be completed due to CT scans not being performed at baseline.|f||||t||||||||||2017-10-10 22:19:10.599826|2017-10-10 22:19:10.599826
NCT02734355|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-02-01|2016-10-13||November 2015||2015-11-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation|Upstream-therapy by Telmisartan and Amlodipine Combination for Improvement of Left Atrial Mechanical Function After Pulmonary Vein Antrum Isolation|Completed||Phase 4|64|Actual|Research Institute for Complex Problems of Cardiovascular Diseases, Russia||2|||f||||f||||||||No||2017-10-10 22:19:10.685207|2017-10-10 22:19:10.685207
NCT02734342|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-05-23|||February 2016||2016-02-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Mixed Methods Assessment of Exercises for Knee OA|Mixed Methods Study to Evaluate Pain, Function, Postural Stabilisation, and Fear of Movement Following a Lower Limb Exercise Programme for Knee Osteoarthritis|Recruiting||N/A|44|Anticipated|University of Salford||1|||f||||t||||||||Yes|The results of the study will form part of the researcher's doctoral thesis and may be published anonymously in professional journals and/or as conference presentations.|2017-10-10 22:19:11.22801|2017-10-10 22:19:11.22801
NCT02734329|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-05-01|||April 2016||2016-04-01|May 2016|2016-05-01||||September 2020|Anticipated|2020-09-01||Interventional|||Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage||Recruiting||N/A|600|Anticipated|RenJi Hospital||2|||f||||||||||||||2017-10-10 22:19:11.31611|2017-10-10 22:19:11.31611
NCT02734316|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-18|||March 2016||2016-03-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 2017|Actual|2017-06-01|30 Days|Observational [Patient Registry]|||Management of Direct Oral Anti-Coagulants (DOACs) for Gastrointestinal Endoscopy Procedures|Management of Direct Oral Anti-Coagulants (DOACs) for Gastrointestinal Endoscopy Procedures: an Observational, Cross-sectional Study|Completed||N/A|531|Actual|Valduce Hospital|||1||f||||f||||||||||2017-10-10 22:19:11.413202|2017-10-10 22:19:11.413202
NCT02734303|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-09-15|||March 14, 2016||2016-03-14|July 27, 2017|2017-07-27|November 12, 2017|Anticipated|2017-11-12|November 12, 2017|Anticipated|2017-11-12||Observational|||Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test|Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test|Not yet recruiting||N/A|210|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:19:11.478158|2017-10-10 22:19:11.478158
NCT02734290|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-09-18|||February 23, 2016|Actual|2016-02-23|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer|A Pilot and Phase II Study to Assess the Safety, Tolerability and Efficacy of Pembrolizumab Plus Chemotherapy in Metastatic Triple Negative Breast Cancer Patients|Recruiting||Phase 1/Phase 2|88|Anticipated|Providence Health & Services||2|||f||||f||||||||||2017-10-10 22:19:11.546107|2017-10-10 22:19:11.546107
NCT02734277|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-11-17|||May 2016||2016-05-01|November 2016|2016-11-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|T1DES||Type 1 Diabetes Extension Study|Type 1 Diabetes Extension Study|Recruiting||N/A|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||t||||||Samples Without DNA|"     -  Blood or urine tests as needed to follow-up on potential long term safety concerns with          a particular therapeutic agent        -  Blood and urine samples for additional studies related to your diabetes   "|Yes|The plan is to share data in: 1.)ImmPort, a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools that are available to researchers who register online and subsequently receive DAIT approval; and 2.)TrialShare, a clinical trials research portal developed by the Immune Tolerance Network that makes data from the consortium's clinical trials publicly available without charge.|2017-10-10 22:19:11.670993|2017-10-10 22:19:11.670993
NCT02734264|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-05|||January 2008||2008-01-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Field Studies of Amebiasis in Bangladesh|Field Studies of Human Immunity to Amebiasis in Bangladesh: A Prospective Study of Children Ages 0-17 Years|Completed||N/A|629|Actual|University of Virginia|||1||f||||f||||||Samples With DNA|"     Serum and feces   "|Undecided||2017-10-10 22:19:11.793201|2017-10-10 22:19:11.793201
NCT02734251|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-05-20|||February 2016||2016-02-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Interventional|||Effect of Relora Supplement on Anxiety, Cognitive Performance & Mood Tested After Induced Stress|Effects of Magnolia and Phellodendron (Magnolia Officinalis and Phellodendron Amurense) Bark Extracts on Anxiety, Cognitive Performance, and Mood Tested After Induced Stress|Completed||N/A|36|Actual|InterHealth Nutraceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:19:11.904349|2017-10-10 22:19:11.904349
NCT02734238|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-18|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|OPS||Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery|Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery: a Randomized, Placebo Controlled Trial|Active, not recruiting||Phase 4|53|Actual|Pennington Biomedical Research Center||2|||f||||t||||||||||2017-10-10 22:19:12.01083|2017-10-10 22:19:12.01083
NCT02734225|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-04-14|||March 2009||2009-03-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|TKA_DP||Influences of Balance Training With a Dynamometric Platform in Total Knee Arthroplasty|Valoración de la Puesta en Marcha en Artroplastias Totales de Rodilla Mediante un Trabajo Postural en Plataforma Dinamometrica|Completed||N/A|69|Actual|University of Valencia||2|||f||||||||||||Undecided||2017-10-10 22:19:12.240724|2017-10-10 22:19:12.240724
NCT02734212|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-08-25|2017-04-24||November 2015||2015-11-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|ESS-P||Ending Self Stigma for PTSD|Reducing Internalized Stigma Among Veterans With PTSD: A Pilot Trial|Completed||N/A|57|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-10 22:19:12.333785|2017-10-10 22:19:12.333785
NCT02734199|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-04-28|||November 2014||2014-11-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|HER-SL||HER Salt Lake Initiative|Highly Effective Reversible Contraceptive Initiative—Salt Lake (HER-SL)|Active, not recruiting||N/A|3000|Anticipated|University of Utah|||3||f||||f||||||||No||2017-10-10 22:19:12.620074|2017-10-10 22:19:12.620074
NCT02734186|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-07-06|||March 14, 2016||2016-03-14|February 24, 2017|2017-02-24|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis|Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in Subjects With Schistosomiasis: A Pilot Study|Not yet recruiting||Phase 4|800|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:19:12.706223|2017-10-10 22:19:12.706223
NCT02734173|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-20|||July 2015||2015-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|3D||Pilot HCV Direct Acting Antiviral Therapy and Metabolism|Pilot Evaluation of the Influence of ABT450r, Ombitasvir, Dasabuvir +/- Ribavirin HCV Therapy on Insulin Resistance and Lipid Profile|Recruiting||Phase 4|24|Anticipated|Ottawa Hospital Research Institute||3|||f||||t||||||||||2017-10-10 22:19:12.801862|2017-10-10 22:19:12.801862
NCT02734160|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-12-06|||June 2016||2016-06-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer|A Phase 1b Dose-Escalation and Cohort-Expansion Study of the Safety, Tolerability, and Efficacy of a Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor (Galunisertib) Administered in Combination With the Anti-PD-L1 Antibody Durvalumab (MEDI4736) in Recurrent or Refractory Metastatic Pancreatic Cancer|Recruiting||Phase 1|37|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 22:19:12.894557|2017-10-10 22:19:12.894557
NCT02734147|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-07-07|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High Dose Intravenous Ascorbic Acid in Severe Sepsis|The Efficacy of Intravenous Ascorbic Acid in Patients With Severe Sepsis|Recruiting||Phase 2|40|Anticipated|Christiana Care Health Services||2|||f||||t||||||||||2017-10-10 22:19:13.043135|2017-10-10 22:19:13.043135
NCT02734134|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-26|||June 2016||2016-06-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection|One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection|Recruiting||N/A|308|Anticipated|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-10 22:19:13.123094|2017-10-10 22:19:13.123094
NCT02734121|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2017-07-07|||February 2014||2014-02-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PEGI||PEGI to Improve Shared Decision-Making for Breast Reconstruction|Pre-consultation Educational Group Intervention to Improve Shared Decision-Making for Postmastectomy Breast Reconstruction|Active, not recruiting||N/A|156|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:19:13.235509|2017-10-10 22:19:13.235509
NCT02734069|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-11|||February 2016||2016-02-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC|Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||N/A|132|Anticipated|Instituto Nacional de Cancerologia de Mexico|||2||f||||t||||||||Yes||2017-10-10 22:19:13.780353|2017-10-10 22:19:13.780353
NCT02734043|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-10|||March 2016||2016-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Roadmap for Succeeding in Bundled Payment for Orthopedic Joint Replacements|Roadmap for Succeeding in Bundled Payment for Orthopedic Joint Replacements|Active, not recruiting||N/A|100|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 22:19:14.18906|2017-10-10 22:19:14.18906
NCT02734030|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-04-11|||April 2015||2015-04-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Observational|||Knee Extensor Muscle Properties in Young Women Symptomatic and Asymptomatic for Anterior Knee Pain|Knee Extensor Muscle Inhibition and Neuromechanical and Morphological Properties in Young Women Symptomatic and Asymptomatic for Anterior Knee Pain|Active, not recruiting||N/A|32|Actual|Federal University of Rio Grande do Sul|||2||f||||f||||||||No||2017-10-10 22:19:14.256049|2017-10-10 22:19:14.256049
NCT02734017|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-05|||May 2016||2016-05-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|ConcReHosp||Impact of a Medication Review on Hospital Readmission: (ConcReHosp)|Impact of a Medication Review on Hospital Readmission: Study Protocol of a Randomized Controlled Trial|Not yet recruiting||N/A|1400|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:19:14.337095|2017-10-10 22:19:14.337095
NCT02733991|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-16|||December 2016||2016-12-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SMILE||Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes|Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes|Recruiting||N/A|210|Anticipated|Medtronic Diabetes||2|||f||||t|f|t|t|f|t|||No||2017-10-10 22:19:14.725059|2017-10-10 22:19:14.725059
NCT02733978|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-04-06|||June 2016||2016-06-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Ozone Therapy in the Treatment of Digital Ulcers in Patients With Systemic Sclerosis|Non-invasive Oxygen-Ozone Therapy in the Treatment of Digital Ulcers in Egyptian Patients With Systemic Sclerosis|Not yet recruiting||Phase 1|50|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:19:14.890574|2017-10-10 22:19:14.890574
NCT02733965|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-05|||April 2016||2016-04-01|March 2016|2016-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|PharmaOnco||Impact of Clinical Pharmacy Consultations in Patients With Cancer Treated With Oral Anti-cancer Therapies on the Rate of Serious Adverse Events|Impact of Clinical Pharmacy Consultations in Patients With Cancer Treated With Oral Anti-cancer Therapies on the Rate of Serious Adverse Events|Not yet recruiting||N/A|190|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 22:19:14.983886|2017-10-10 22:19:14.983886
NCT02733952|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-06|||August 2015||2015-08-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy|Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy|Recruiting||Phase 3|70|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||No||2017-10-10 22:19:15.082773|2017-10-10 22:19:15.082773
NCT02733939|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-03-06|||March 2016||2016-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TECH@HOME||Technologies to Reduce Caregiver Burden for Informal Caregivers of People With Dementia|Åldrande: en Innovativ Och teknologistödd hemmiljö för äldre Patienter Med Alzheimers Sjukdom, TECH@HOME.|Recruiting||N/A|320|Anticipated|Lund University||2|||f||||f||||||||Undecided||2017-10-10 22:19:15.181179|2017-10-10 22:19:15.181179
NCT02733926|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-05|||April 2016||2016-04-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|July 2016|Anticipated|2016-07-01||Interventional|ADELEWP1t7||Effect of Vegetation in Kindergartens on the Immune Response of Children|ADELE: Autoimmune Defense and Living Environment Acronym Description: Adele Comes From the Capitalized Words in the Following Words: Autoimmune DEfense and Living Environment|Not yet recruiting||N/A|100|Anticipated|Helsinki University||3|||f||||f||||||||Yes|Data will be available when the project has ended. Before it data will be available once the results have been published. Individual participants or families will not be recognizable in the public data set. If there is a danger that a person can be recognized, the data will not be made public. Finnish law and the decision of the ethical committee may limit public availability of data.|2017-10-10 22:19:15.277806|2017-10-10 22:19:15.277806
NCT02733913|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-08|||August 2014||2014-08-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation|Clinical Impact of Autonomic Modulation After Pulmonary Vein Isolation in Patients With Paroxysmal Atrial Fibrillation|Completed||N/A|50|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-10 22:19:15.368184|2017-10-10 22:19:15.368184
NCT02733900|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-08-22|||February 2016||2016-02-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|ONTF||Modifications of the Subchondral Bone in Aseptic Osteonecrosis of the Femoral Head|Study of Modifications of the Composition and Structure in the Aseptic Osteonecrosis of the Femoral Head and Etiopathogenic MRI Correlations|Recruiting||N/A|30|Anticipated|Lille Catholic University||2|||f||||f||||||||||2017-10-10 22:19:15.451658|2017-10-10 22:19:15.451658
NCT02733887|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-04-05|||February 2016||2016-02-01|April 2016|2016-04-01||||June 2017|Anticipated|2017-06-01||Interventional|||MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma|Research on the Lymphoma Staging and Therapeutic Evaluation of 18F-FDG PET/CT Comparing With Whole Body MRI IVIM Functional Imaging|Recruiting||N/A|66|Anticipated|Guangxi Medical University||1|||f||||t||||||||Undecided||2017-10-10 22:19:15.565661|2017-10-10 22:19:15.565661
NCT02733874|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-13|||April 2015||2015-04-01|April 2016|2016-04-01||||April 2016|Actual|2016-04-01||Interventional|||A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.||Completed||Phase 4|240|Actual|First Hospital of China Medical University||2|||f||||||||||||||2017-10-10 22:19:15.674589|2017-10-10 22:19:15.674589
NCT02733861|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-05|||May 2015||2015-05-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|May 2016|Anticipated|2016-05-01|3 Months|Observational [Patient Registry]|||Evaluation of the Related Factors Influencing the Stability of Dental Implants|Evaluation of the Related Factors Influencing the Stability of Dental Implants|Recruiting||N/A|1|Anticipated|Fourth Military Medical University|||1||f||||f||||||||No||2017-10-10 22:19:15.764785|2017-10-10 22:19:15.764785
NCT02733848|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-04-13|||February 2014||2014-02-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||CREON for the Treatment of Post-RYGB Hypoglycemia|A Proof-of-Concept Study Using Pancreatic Enzyme Replacement for the Treatment of Post-Roux-en-Y Gastric Bypass Hypoglycemia|Active, not recruiting||Phase 1|5|Anticipated|East Carolina University||3|||f||||f||||||||Yes||2017-10-10 22:19:15.855922|2017-10-10 22:19:15.855922
NCT02733835|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-02-05|||December 2016||2016-12-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||VPIA Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration|Novel Vital-sign Patient-assisted Intravenous Analgesia With Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration: a Prospective Cohort Study|Recruiting||Phase 4|25|Anticipated|KK Women's and Children's Hospital||1|||f||||t||||||||No||2017-10-10 22:19:15.936419|2017-10-10 22:19:15.936419
NCT02733822|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-05-16|||June 2016||2016-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study|A Pilot, Phase 1, Open-Labelled, 4 Period, Randomised, Crossover Study to Evaluate the Pharmacokinetics of Naloxone When Given by the IV, IM and Buccal Routes of Administration in Healthy Male Subjects|Not yet recruiting||Phase 1|4|Anticipated|King's College London||4|||f||||t||||||||Undecided|There is no plan to provide access to to raw data.|2017-10-10 22:19:16.032992|2017-10-10 22:19:16.032992
NCT02733809|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-08-20|||January 2014||2014-01-01|August 2017|2017-08-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|||Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma|Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 4|40|Anticipated|King Saud University||1|||f||||t||||||||||2017-10-10 22:19:16.125851|2017-10-10 22:19:16.125851
NCT02733796|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-18|||March 2016||2016-03-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Persistence of Zika Virus in Semen After Acute Infection|Persistence of Zika Virus in Semen After Acute Infection|Recruiting||N/A|20|Anticipated|Institute of Tropical Medicine, Belgium|||1||f||||t||||||Samples Without DNA|"     sera urine semen   "|||2017-10-10 22:19:16.24218|2017-10-10 22:19:16.24218
NCT02733783|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-04-05|||April 2016||2016-04-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Design of a Model to Study Functionality of the Trigeminal Nerve in Relation to Controlled Nasal Fractures|Design of a Model to Study Functionality of the Trigeminal Nerve in Relation to Controlled Nasal Fractures|Not yet recruiting||N/A|12|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-10 22:19:16.335724|2017-10-10 22:19:16.335724
NCT02733770|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-02-05|||April 2016||2016-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Chances in Portal System Flow After Two Bariatric Procedures|Comparison in Portal Flow After Sleeve Gastrectomy and Mini Gastric Bypass|Recruiting||N/A|60|Anticipated|Assuta Medical Center||2|||f||||t||||||||No||2017-10-10 22:19:16.405019|2017-10-10 22:19:16.405019
NCT02733757|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-08|||May 2013||2013-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Clonidine Added Lidocaine in Intraocular Pressure and Hemodynamics Ocular in Sub-Tenon's and Peribulbar Anesthesia|Effects of Clonidine Added to Lidocaine in Sub-Tenon's and Peribulbar Anesthesia: Assessments of Intraocular Pressure (IOP), Ocular Perfusion Pressure (OPP) and Ocular Pulse Amplitude (OPA)|Completed||Phase 2|80|Actual|Federal University of Minas Gerais||4|||f||||t||||||||Undecided||2017-10-10 22:19:16.487586|2017-10-10 22:19:16.487586
NCT02733744|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-09-28|||May 2016||2016-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Fecal Microbiota Transplantation After HSCT|A Pilot Study to Determine the Feasibility of Fecal MicrobiotaTransplantation (FMT) in Hematopoietic Stem Cell Transplantation (HSCT) Recipients|Active, not recruiting||Early Phase 1|19|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:19:16.567859|2017-10-10 22:19:16.567859
NCT02733731|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-04-08|||February 2016||2016-02-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis||Recruiting||Phase 1|80|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 22:19:16.640393|2017-10-10 22:19:16.640393
NCT02733718|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-04-08|||November 2015||2015-11-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||The Impact of Different Feeding Strategies During Packed Red Cell Transfusion on Intestinal Oxygenation|The Impact of Different Feeding Strategies During Packed Red Cell Transfusion on Intestinal Oxygenation|Recruiting||N/A|20|Anticipated|Marmara University||3|||f||||f||||||||Undecided||2017-10-10 22:19:16.722747|2017-10-10 22:19:16.722747
NCT02733705|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-20|||April 2016||2016-04-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intravenous Propofol and Fentanyl vs Propofol for Sedation in TRUS Biopsy|A Randomised Controlled Trial Comparing Combined Intravenous Propofol and Fentanyl Versus Intravenous Propofol Alone for Sedation in Patients Undergoing Transrectal Ultrasound-guided (TRUS) Prostate Biopsy|Recruiting||Phase 4|124|Anticipated|Mahidol University||2|||f||||f||||||||Undecided||2017-10-10 22:19:16.838705|2017-10-10 22:19:16.838705
NCT02733692|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-24|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation|Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation|Completed||N/A|110|Actual|City University of New York, School of Public Health||2|||f||||t||||||||||2017-10-10 22:19:17.007781|2017-10-10 22:19:17.007781
NCT02733679|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-25|||September 2016||2016-09-01|July 2017|2017-07-01||||February 2018|Anticipated|2018-02-01||Interventional|RAMP||Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone|Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone|Recruiting||Phase 4|30|Anticipated|NHS Tayside||2|||f||||f||||||||||2017-10-10 22:19:17.100262|2017-10-10 22:19:17.100262
NCT02733666|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-04-08|||May 2007||2007-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|September 2010|Actual|2010-09-01||Interventional|||Internal Fixation of Lateral Humeral Condyle Fractures With Absorbable Screws in Children|Open Reduction and Internal Fixation of Lateral Humeral Condyle Fractures With Absorbable Screws in Children|Completed||Phase 1|86|Actual|Children's Hospital of Chongqing Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:19:17.211021|2017-10-10 22:19:17.211021
NCT02733653|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-13|||May 25, 2016|Actual|2016-05-25|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|June 29, 2017|Actual|2017-06-29||Interventional|||Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)|A Prospective, Multicenter, Single-arm Clinical Trial of Jetstream Atherectomy System for the Treatment of Japanese Patients With Symptomatic Occlusive Atherosclerotic Lesions in the Superficial Femoral and/ or Proximal Popliteal Arteries|Active, not recruiting||N/A|60|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-10 22:19:17.289294|2017-10-10 22:19:17.289294
NCT02733640|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-04-05|||October 2012||2012-10-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?||Completed||N/A|42|Actual|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-10 22:19:17.400075|2017-10-10 22:19:17.400075
NCT02733627|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-07-21|||July 7, 2016|Actual|2016-07-07|July 2017|2017-07-01|July 12, 2017|Actual|2017-07-12|July 12, 2017|Actual|2017-07-12||Interventional|||To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1467335 in Healthy Male and Female Subjects (Double-blind, Randomised, Placebo-controlled Within Dose Groups)|Completed||Phase 1|36|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 22:19:17.469837|2017-10-10 22:19:17.469837
NCT02733614|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-06-20|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD|A Proof of Concept (POC) Clinical Trial for Post-Traumatic Stress Disorder (PTSD) With a First-In-Class Vasopressin 1a Receptor Antagonist (SRX246)|Recruiting||Phase 2|52|Anticipated|Azevan Pharmaceuticals||2|||f||||t||||||||No||2017-10-10 22:19:17.554444|2017-10-10 22:19:17.554444
NCT02733601|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-08-07|||May 29, 2016|Actual|2016-05-29|August 2017|2017-08-01|November 30, 2021|Anticipated|2021-11-30|November 30, 2021|Anticipated|2021-11-30|5 Years|Observational [Patient Registry]|BreCaReAl||Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria|BreCaReAl: Breast Cancers Registry in Algeria|Active, not recruiting||N/A|1501|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 22:19:17.657915|2017-10-10 22:19:17.657915
NCT02733588|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-06-07|||March 2016||2016-03-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|April 5, 2017|Actual|2017-04-05||Interventional|||Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients|A Phase 2 Proof-of-Concept Study of Sensor-Guided, Clinician-Administered Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Post-Prandial Hypoglycemia in Post-Bariatric Surgery Patients|Completed||Phase 2|8|Actual|Xeris Pharmaceuticals||1|||f||||f|t|f||||||No||2017-10-10 22:19:17.754436|2017-10-10 22:19:17.754436
NCT02733575|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-16|||September 2015||2015-09-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Compassion Focused Therapy for Distressing Experiences|A Case Series Study of Compassion Focused Therapy for Distressing Experiences|Recruiting||N/A|9|Anticipated|King's College London||1|||f||||f||||||||||2017-10-10 22:19:17.839761|2017-10-10 22:19:17.839761
NCT02733562|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2016-04-10|||January 2014||2014-01-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|April 2015|Actual|2015-04-01||Observational|Behavior||Results of Sleeve Gastrectomy Surgery in Relation With Eating Habits (After One Year)|The Effect of Different Eating Habits on Weight Loss in the First Year After Sleeve Gastrectomy|Completed||N/A|300|Actual|Assuta Medical Center|||4||f||||f||||||||No||2017-10-10 22:19:17.922184|2017-10-10 22:19:17.922184
NCT02733549|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-09|||September 2012||2012-09-01|April 2016|2016-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|3 Months|Observational [Patient Registry]|||Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction?|Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction?An ED Study|Completed||N/A|198|Actual|Adiyaman University Research Hospital|||2||f||||f||||||||Undecided||2017-10-10 22:19:17.97951|2017-10-10 22:19:17.97951
NCT02733536|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-07-25|||December 2016|Actual|2016-12-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Intubation During Spinal Immobilization|C-MAC Compared to Direct Laryngoscopy in Patients With Immobilized Cervical Spine by Unexperienced Physicians: A Randomized Crossover Manikin Trial|Completed||N/A|50|Actual|Medical University of Warsaw||3|||f||||f||||||||||2017-10-10 22:19:18.060195|2017-10-10 22:19:18.060195
NCT02733523|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-04-05|||July 2015||2015-07-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|AEQUALIS||Self-management, Health Literacy and Social Capital in Socioeconomically Disadvantaged Older Adults|Promoting Self-Management, Health Literacy And Social Capital In Socioeconomically Disadvantaged Older Adults To Reduce Later Life Health Inequalities: A Randomized Clinical Trial|Enrolling by invitation||N/A|390|Anticipated|Fundacio Salut i Envelliment UAB||2|||f||||f||||||||No||2017-10-10 22:19:18.163517|2017-10-10 22:19:18.163517
NCT02733510|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-05|||April 2016||2016-04-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||The Impact of Early Protocol Biopsy in Kidney Transplant|The Impact of Early Protocol Biopsy in Kidney Transplant Recipients Receiving TAC and MMF; a Prospective Observational Study|Recruiting||N/A|200|Anticipated|Samsung Medical Center|||2||f||||t||||||||Yes||2017-10-10 22:19:18.261503|2017-10-10 22:19:18.261503
NCT02733497|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-09|||January 2012||2012-01-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Cardiac Autonomic Changes After Endoscopic Thoracic Sympathectomy For Essential Palmar Hyperhidrosis|Cardiac Autonomic Changes After Endoscopic Thoracic Sympathectomy For Essential Palmar Hyperhidrosis: Results Of A Prospective, Randomized Study|Completed||N/A|60|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||t||||||||No||2017-10-10 22:19:18.368871|2017-10-10 22:19:18.368871
NCT02733484|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-03-09|||October 2015||2015-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity|Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity: a Randomized, Double-blind Controlled Trial|Recruiting||N/A|100|Anticipated|Shanghai 10th People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:19:18.449501|2017-10-10 22:19:18.449501
NCT02733471|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-05-25|||April 2016||2016-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|LIDOGTC||Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy|Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy|Recruiting||Phase 4|586|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-10 22:19:18.579907|2017-10-10 22:19:18.579907
NCT02733458|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-09-02|||March 2016||2016-03-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma|The Efficacy and Safety of Gemcitabine, Etoposide, Dexamethasone and Pegaspargase Chemotherapy (GELAD) With Sandwiched Radiotherapy in the Treatment of Stage IE/II Natural Killer/T-Cell Lymphoma: A Multicenter, Prospective Study|Recruiting||Phase 3|51|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||||2017-10-10 22:19:18.697926|2017-10-10 22:19:18.697926
NCT02733445|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-05|||December 2015||2015-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|||Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib|Assessment of Metabolic Outcomes Among Patients With Chronic Myelogenous Leukemia (CML) Initiating Therapy With a Tyrosine Kinase Inhibitor (TKI)|Completed||N/A|2650|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 22:19:18.831634|2017-10-10 22:19:18.831634
NCT02733432|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-05-01|||June 2016||2016-06-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections|A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis|Completed||Phase 2|125|Actual|Cidara Therapeutics Inc.||3|||f||||f|t|f||||||Undecided||2017-10-10 22:19:18.91447|2017-10-10 22:19:18.91447
NCT02733419|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-05|||December 2004||2004-12-01|April 2016|2016-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection|Open-label, Randomised and Multi-center Study Evaluating the Efficacy and Safety of an Optimised Background Antiretroviral Regimen (OB) Compared to OB Associated With Enfuvirtide in Previously Treated HIV-1 Infected Patients in Virological Success After a 28-week Induction Treatment With Enfuvirtide Plus OB|Completed||Phase 3|84|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:19:19.056678|2017-10-10 22:19:19.056678
NCT02733406|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-04-04|||April 2016||2016-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|HEAT||Hypotensive Effect of Anaesthesia With TCI|The Effect of Target Controlled Infusion as Opposed to Velocity Controlled Infusion on Hypotension at Induction of Total Intravenous Anaesthesia|Not yet recruiting||N/A|100|Anticipated|Umeå University||2|||f||||f||||||||No||2017-10-10 22:19:19.258251|2017-10-10 22:19:19.258251
NCT02733393|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-09-28|||September 2015||2015-09-01|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|September 5, 2017|Actual|2017-09-05||Interventional|||Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy|Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy- An Open Label Pilot Study|Completed||Phase 1|2|Actual|New York University School of Medicine||1|||f||||f|t|f|||t|||||2017-10-10 22:19:19.323102|2017-10-10 22:19:19.323102
NCT02733380|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-05-01|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma|The Efficacy and Safety of Chidamide Combined With VDDT Regimen（Vinorelbine，Liposomal Doxorubicin，Dexamethasone and Thalidomide） in Relapse and Refractory Patients With Diffuse Large B Cell Lymphoma|Recruiting||Phase 2|20|Anticipated|Henan Cancer Hospital||1|||f||||t||||||||||2017-10-10 22:19:19.401394|2017-10-10 22:19:19.401394
NCT02733367|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-04-05|||March 2016||2016-03-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Extension Study for Patients Entered Into Study Infacort 003|Open-label, Long-term Follow-up of Safety and Biochemical Disease Control of Infacort® in Neonates, Infants and Children With Congenital Adrenal Hyperplasia and Adrenal Insufficiency Previously Enrolled in the Infacort 003 Study|Recruiting||Phase 3|24|Anticipated|Diurnal Limited||1|||f||||t||||||||No||2017-10-10 22:19:19.515668|2017-10-10 22:19:19.515668
NCT02733354|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-06|2016-04-10|||June 2016||2016-06-01|April 2016|2016-04-01||||June 2019|Anticipated|2019-06-01||Observational|||Lifestyle Scenario Demonstration on Dialysis Modality|Impact of Lifestyle Scenario Demonstration on Patients'Decision-making of Dialysis Modality|Not yet recruiting||N/A|220|Anticipated|The Second Affiliated Hospital of Harbin Medical University|||2||f||||||||||||||2017-10-10 22:19:19.605041|2017-10-10 22:19:19.605041
NCT02733341|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-10-25|||July 2016||2016-07-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effect of IV Cangrelor and Oral Ticagrelor Study|The Effect of Intravenous Cangrelor and Oral Ticagrelor on Platelets, the Microcirculation and Myocardial Damage in Patients Admitted With STEMI Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Pilot Trial|Recruiting||Phase 4|100|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||2|||f||||t||||||||No||2017-10-10 22:19:19.662319|2017-10-10 22:19:19.662319
NCT02733328|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-04-24|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|NGAL||Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study|Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury|Recruiting||N/A|156|Anticipated|The Royal Wolverhampton Hospitals NHS Trust|||2||f||||t||||||||No||2017-10-10 22:19:19.757002|2017-10-10 22:19:19.757002
NCT02733315|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-10|||January 2014||2014-01-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effectiveness of the Diabetes Conversation Map Program Among Diabetic Patients in Taiwan|Long-term Effectiveness of the Diabetes Conversation Map Program: A Pre-post Education Intervention Study Among Diabetic Patients in Taiwan|Completed||N/A|95|Actual|Dalin Tzu Chi General Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:19:19.83336|2017-10-10 22:19:19.83336
NCT02733302|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-04|||April 2016||2016-04-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|APADIAB-ESPOIR||Hope Theory as Ability Determinant to Permanently Change the Adapted Physical Activity (APA) in Type 2 Diabetic Patients||Not yet recruiting||N/A|84|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 22:19:19.893101|2017-10-10 22:19:19.893101
NCT02733289|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-10-26|||June 2015||2015-06-01|October 2016|2016-10-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01|10 Years|Observational [Patient Registry]|SFPCERVIX||Standard Follow-up Program Cervix Cancer (SFP CERVIX)|Standard Follow-up Program Cervix Cancer (SFP CERVIX)|Recruiting||N/A|10000|Anticipated|University Medical Center Groningen|||1||f||||||||||||||2017-10-10 22:19:19.951811|2017-10-10 22:19:19.951811
NCT02733276|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-08-08|||January 2016||2016-01-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Electroacupuncture vs. Sham Electroacupuncture for Treatment of Fatigue in Patients With Inflammatory Bowel Disease|Randomized Study : Electroacupuncture vs. Sham Electroacupuncture for Treatment of Fatigue in Patients With Inflammatory Bowel Disease|Completed||N/A|54|Actual|Corporacion Parc Tauli||3|||f||||f||||||||||2017-10-10 22:19:20.012548|2017-10-10 22:19:20.012548
NCT02733263|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-05-26|||May 2016||2016-05-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|DEX||Resistant Maltodextrin Supplementation: Gastrointestinal Health|Resistant Maltodextrin Supplementation and the Effect on Fecal Bifidobacteria, Bowel Function, Dietary Intake and Quality of Life|Completed||N/A|64|Actual|University of Florida||6|||f||||f||||||||No||2017-10-10 22:19:20.078417|2017-10-10 22:19:20.078417
NCT02733250|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-03-15|||March 13, 2017|Actual|2017-03-13|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|URCOH-PMS-001||Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer|A Phase I/II Study of Pembrolizumab in Combination With Nab-Paclitaxel in Patients With Unresectable Stage III or Stage IV Non-Small Cell Lung Carcinoma|Recruiting||Phase 1/Phase 2|36|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f|f|f|||f|||Undecided||2017-10-10 22:19:20.166223|2017-10-10 22:19:20.166223
NCT02733237|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-02|||April 2015|Actual|2015-04-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Oxytocin Effects on the Tolerance of Infidelity||Completed||N/A|160|Actual|University of Electronic Science and Technology of China||4|||f||||||||||||||2017-10-10 22:19:20.271105|2017-10-10 22:19:20.271105
NCT02733224|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-06-01|||June 2016||2016-06-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|March 2017|Anticipated|2017-03-01||Observational|||Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance|Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance|Not yet recruiting||N/A|80|Anticipated|Rabin Medical Center|||1||f||||t||||||||No||2017-10-10 22:19:20.337867|2017-10-10 22:19:20.337867
NCT02733211|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-01-10|||May 2016||2016-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes|An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home|Active, not recruiting||N/A|28|Anticipated|Rabin Medical Center||2|||f||||f||||||||No||2017-10-10 22:19:20.395467|2017-10-10 22:19:20.395467
NCT02733198|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-01-27|||April 2016||2016-04-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|IPEP||Prognostication in Acute Pulmonary Embolism|Effect of a Prognostic Algorithm to Reduce Length of Stay in Acute Pulmonary Embolism: a Randomized Controlled Trial|Recruiting||N/A|500|Anticipated|Ministry of Health, Spain||2|||f||||t||||||||Undecided||2017-10-10 22:19:20.603859|2017-10-10 22:19:20.603859
NCT02733185|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-11-16|||October 2016||2016-10-01|November 2016|2016-11-01||||August 2021|Anticipated|2021-08-01||Interventional|TACT2||Trial to Assess Chelation Therapy 2|Trial to Assess Chelation Therapy 2|Recruiting||Phase 3|1200|Anticipated|Mt. Sinai Medical Center, Miami||4|||f||||t||||||||||2017-10-10 22:19:20.694797|2017-10-10 22:19:20.694797
NCT02733172|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-04-04|||July 2013||2013-07-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|Vulvodynia||Profiling Vulvodynia Based on Neurobiological and Behavioral Endophenotypes|Profiling Vulvodynia Based on Neurobiological and Behavioral Endophenotypes|Recruiting||N/A|200|Anticipated|University of California, Los Angeles|||1||f||||f||||||Samples With DNA|"     saliva samples   "|Yes||2017-10-10 22:19:20.835584|2017-10-10 22:19:20.835584
NCT02733159|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-04-04|||April 2016||2016-04-01|April 2016|2016-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PePS2||A Phase II Trial of Pembrolizumab in NSCLC PS2 Patients|A Phase II Trial of Pembrolizumab in Patients With Non-small Cell Lung Cancer and a Performance Status of 2|Not yet recruiting||Phase 2|60|Anticipated|University of Birmingham||1|||f||||f||||||||No||2017-10-10 22:19:20.926857|2017-10-10 22:19:20.926857
NCT02733146|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-06-01|||October 2015||2015-10-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|||Histones and Free-plasma DNA After Cardiac Arrest|Histones and Free-plasma DNA in the Days Following the Cardiac Arrest|Completed||N/A|42|Actual|University of Aarhus|||1||f||||f||||||||No||2017-10-10 22:19:21.064852|2017-10-10 22:19:21.064852
NCT02733133|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-10-18|||November 2016||2016-11-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|TRANSFERENCE||Product Transference Study of Testagen™ TDS®-Testosterone|A Single-Dose, Single Period, Phase II Pharmacokinetic Study To Examine Testagen™ TDS®-Testosterone For Its Potential To Be Inadvertently Transferred By Skin Contact After Dosing In Healthy Adult Subjects|Enrolling by invitation||Phase 2|96|Anticipated|Transdermal Delivery Solutions Corp||2|||f||||t||||||||No||2017-10-10 22:19:21.146125|2017-10-10 22:19:21.146125
NCT02733120|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-28|||October 2015||2015-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|ASD||Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder|Study on Metabolic Processes and Cognitive Functions in Adults and Adolescents With Autism Spectrum Disorder|Recruiting||N/A|80|Anticipated|Texas A&M University||2|||f||||f||||||||||2017-10-10 22:19:21.261689|2017-10-10 22:19:21.261689
NCT02733107|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-10|||March 2016||2016-03-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer|The Efficacy and Safety of Apatinib Combined With Etoposide in Advanced Non-small Cell Lung Cancer Patients Failed to Previous at Least 2rd Line Treatments|Recruiting||Phase 2|25|Anticipated|Third Military Medical University||1|||f||||t||||||||No||2017-10-10 22:19:21.376593|2017-10-10 22:19:21.376593
NCT02733094|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-06-27|||April 2016||2016-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum|Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum|Recruiting||Phase 1/Phase 2|5|Anticipated|Technische Universität München||1|||f||||f||||||||Undecided||2017-10-10 22:19:21.487942|2017-10-10 22:19:21.487942
NCT02733081|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-04-26|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|SIIT||Simplified IUD Insertion Technique|Simplified IUD Insertion Technique: A Randomized Controlled Trial|Not yet recruiting||N/A|440|Anticipated|Stanford University||2|||f||||f|f|f||||||||2017-10-10 22:19:21.586778|2017-10-10 22:19:21.586778
NCT02733068|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-04-04|||November 2014||2014-11-01|February 2016|2016-02-01|November 2020|Anticipated|2020-11-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.|A Phase III Double Blinded, Randomized Controlled Study to Evaluate Efficacy of Protection Against HPV-16 and 18 Related Diseases, Immunogenicity and Safety of HPV-16/18 Vaccine in Healthy Females Aged 18-30 Years|Active, not recruiting||Phase 3|12000|Actual|Shanghai Zerun Biotechnology Co.,Ltd||2|||f||||t||||||||No||2017-10-10 22:19:21.68625|2017-10-10 22:19:21.68625
NCT02733055|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Posturography as Biomarker of Oculomotor and Postural Control Integration|Posturography as Biomarker of Oculomotor and Postural Control Integration|Enrolling by invitation||N/A|150|Anticipated|Carrick Institute for Graduate Studies||1|||f||||f||||||||||2017-10-10 22:19:21.768094|2017-10-10 22:19:21.768094
NCT02733042|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2017-08-29|||May 11, 2016|Actual|2016-05-11|August 2017|2017-08-01|June 6, 2024|Anticipated|2024-06-06|June 6, 2024|Anticipated|2024-06-06||Interventional|FUSION NHL 001||A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia|A Phase 1/2, Open-label, Multi-center Study to Assess the Safety and Tolerability of Durvalumab (Anti-PDL1 Antibody) as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocitic Leukemia|Recruiting||Phase 1/Phase 2|265|Anticipated|Celgene||4|||f||||t||||||||||2017-10-10 22:19:21.862911|2017-10-10 22:19:21.862911
NCT02733029|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-08|||May 2016||2016-05-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection|Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection|Not yet recruiting||Phase 2|30|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 22:19:22.117069|2017-10-10 22:19:22.117069
NCT02733016|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-04-11|||October 1999||1999-10-01|April 2016|2016-04-01||||October 2013|Actual|2013-10-01|12 Years|Observational [Patient Registry]|SAAS||Seinäjoki Adult Asthma Study|Seinäjoki Adult Asthma Study: A 12-year Real-life Follow-up Study of New-onset Asthma Diagnosed at Adult Age and Treated in Primary and Specialized Care. Finnish Title: Diagnoosista Hoitotasapainoon: Voidaanko Aikuisen Astman Hoitotasapainoa Ennustaa Diagnoosivaiheen löydösten ja Astman Ilmiasun Perusteella?|Completed||N/A|259|Actual|Seinajoki Central Hospital|||1||f||||f||||||||No||2017-10-10 22:19:22.202035|2017-10-10 22:19:22.202035
NCT02733003|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-08-28|||September 2014||2014-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Implementation Research for Vulnerable Women in South Africa|Implementation Research for Vulnerable Women in South Africa|Recruiting||N/A|714|Anticipated|RTI International||1|||f||||f|f|f||||||||2017-10-10 22:19:22.318938|2017-10-10 22:19:22.318938
NCT02732990|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-04-04|||February 2014||2014-02-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Peripheral Metabolic Function in Chronic Heart Failure Patients|Peripheral Metabolic Function in Chronic Heart Failure Patients: Key to Lessen the Cardiac Load|Recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark||4|||f||||t||||||||||2017-10-10 22:19:22.453105|2017-10-10 22:19:22.453105
NCT02732977|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-05|||November 2014||2014-11-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|VP2HF||Mathematical Models Derived Indices for the Selection and Planning of a Specific Optimal Treatment to the Patient in Heart Failure|Mathematical Models Derived Indices for the Selection and Planning of a Specific Optimal Treatment to the Patient in Heart Failure|Active, not recruiting||N/A|30|Anticipated|University Hospital, Caen||1|||f||||f||||||||No||2017-10-10 22:19:22.549425|2017-10-10 22:19:22.549425
NCT02732964|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-08|||November 2015||2015-11-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Impact of Music on Satisfaction, Anxiety, and Hemodynamics During Spinal Anesthesia for Cesarean Delivery|Perioperative Music for Patients Undergoing Scheduled Cesarean Delivery: Impact on Satisfaction, Anxiety, and Hemodynamic Response to Spinal Anesthesia|Recruiting||Phase 1|150|Anticipated|Brigham and Women's Hospital||3|||f||||f||||||||No||2017-10-10 22:19:22.628979|2017-10-10 22:19:22.628979
NCT02732938|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-05|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CCR2i||Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients|Phase 1b/2 Study Of Pf-04136309 In Combination With Gemcitabine And Nab-paclitaxel In Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma|Active, not recruiting||Phase 2|21|Actual|Pfizer||1|||f||||f|t|f||||||||2017-10-10 22:19:23.35327|2017-10-10 22:19:23.35327
NCT02732925|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-06-12|||June 9, 2017|Actual|2017-06-09|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|May 2019|Anticipated|2019-05-01||Interventional|MELODY||To Compare Conservative Management Vs. Balloon Kyphoplasty in the Treatment of VCFs in Patients With Multiple Myeloma|Multiple Myeloma Spinal Disease Study; A Multi-centre, Prospective, Single Blinded, Randomized, Controlled Study to Compare Conservative Management Alone Vs. Balloon Kyphoplasty With the Treatment of VCFs in Patients With Multiple Myeloma|Recruiting||N/A|156|Anticipated|Royal National Orthopaedic Hospital NHS Trust||2|||f||||t|f|f||||||||2017-10-10 22:19:23.485865|2017-10-10 22:19:23.485865
NCT02732912|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-20|||November 25, 2016|Actual|2016-11-25|April 2017|2017-04-01|February 13, 2017|Actual|2017-02-13|February 13, 2017|Actual|2017-02-13||Interventional|||SleepSure: A Trial to Assess the Effects of Eye Masks and Earplugs on Hospital Inpatient Sleep|SleepSure: A Randomised Controlled Trial to Assess the Effects of Eye Masks and Earplugs on Hospital Inpatient Sleep|Completed||Phase 3|206|Actual|Oxford University Hospitals NHS Trust||2|||f||||f||||||||No|No plan is in place, but definitely data will be made available to anyone making a legitimate request|2017-10-10 22:19:23.582742|2017-10-10 22:19:23.582742
NCT02732886|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-14|||March 29, 2016|Actual|2016-03-29|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Betafoam Diabetes Mellitus Foot Study|A Pilot Study to Compare Efficacy of Medifoam® and Betafoam® as a New Dressing Including Povidone-iodine, in Patients With Diabetes Foot Ulcer|Recruiting||N/A|70|Anticipated|Mundipharma Korea Ltd||2|||f||||t||||||||||2017-10-10 22:19:23.780891|2017-10-10 22:19:23.780891
NCT02732873|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-04-08|||January 2018||2018-01-01|April 2016|2016-04-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|REKREATE||Porous Tissue Regenerative Silk Scaffold for Human Meniscal Cartilage Repair|A Multicentre Study Evaluating the Treatment of Meniscal Defects With a Meniscal Repair Scaffold, FibroFix™ Meniscus|Not yet recruiting||N/A|120|Anticipated|Orthox Limited||1|||f||||t||||||||||2017-10-10 22:19:23.86436|2017-10-10 22:19:23.86436
NCT02732860|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-07-11|||December 2015||2015-12-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|REFLECT||Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host|Prospective Evaluation of Freshly Implanted Cancers in Mice to Test Drug Response in Matching Host|Enrolling by invitation||N/A|60|Anticipated|University Health Network, Toronto|||3||f||||f||||||Samples With DNA|"     Whole Blood, Formalin fixed paraffin embedded blocks, fresh tumor tissue   "|No||2017-10-10 22:19:23.934076|2017-10-10 22:19:23.934076
NCT02732847|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-27|2016-04-08|||October 2007||2007-10-01|June 2006|2006-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Trial of Post-Dated Delayed Antibiotic Prescriptions|Post-Dated Versus Voluntary Delayed Antibiotic Prescriptions for Acute Respiratory Infections in Primary Care: A Randomized Trial|Completed||N/A|149|Actual|Memorial University of Newfoundland||2|||f||||f||||||||||2017-10-10 22:19:24.024777|2017-10-10 22:19:24.024777
NCT02732834|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-02-13|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Doctor-Patient Communication in Lung Cancer Care|Doctor-Patient Communication in Lung Cancer Care|Recruiting||N/A|66|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-10 22:19:24.131792|2017-10-10 22:19:24.131792
NCT02732821|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-06|||May 2015||2015-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||G-POEM for Treatment of Refractory Gastroparesis|Gastric Per-Oral Endoscopic Myotomy (G-POEM) for Treatment of Refractory Gastroparesis: A Pilot Study|Recruiting||Phase 2|30|Anticipated|Johns Hopkins University||1|||f||||t||||||||Undecided||2017-10-10 22:19:24.253895|2017-10-10 22:19:24.253895
NCT02732808|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-04-26|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dual Ovarian Stimulation in the Same IVF/ICSI Cycles for Treatment of Poor Ovarian Responders|Evaluation of Outcome of Double Stimulation and Egg Collection in the Same IVF/ ICSI Cycle in Poor Ovarian Responders|Completed||Phase 3|50|Actual|Royan Institute||1|||f||||t||||||||||2017-10-10 22:19:24.348469|2017-10-10 22:19:24.348469
NCT02732795|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-04-04|||July 2015||2015-07-01|March 2016|2016-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Predicting Risk Factors in Children With Obstructive Sleep Apnea Undergoing Adenotonsillectomy Surgery||Recruiting||N/A|60|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-10 22:19:24.459758|2017-10-10 22:19:24.459758
NCT02732782|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-09-28|||January 2016||2016-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Isometric vs. Eccentric Exercise in Chronic Achilles Tendinopathy|Effectiveness of Eccentric Exercise Compared to Isometric Exercise in Athletes With Chronic Achilles Tendinopathy|Recruiting||N/A|60|Anticipated|Humboldt-Universität zu Berlin||3|||f||||||||||||Undecided||2017-10-10 22:19:24.541844|2017-10-10 22:19:24.541844
NCT02732769|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-08|||February 2016||2016-02-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|Mask||Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask.|Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask.|Recruiting||N/A|58|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 22:19:26.361708|2017-10-10 22:19:26.361708
NCT02732743|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-03-01|||February 2016||2016-02-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Food Supplement Physiomanna® Baby in Pediatric Patients|An Open Label, Non-comparative Pilot Study to Assess the Efficacy and Safety of the Food Supplement Physiomanna® Baby in Pediatric Patients With a History of Functional Constipation|Completed||N/A|45|Actual|Iuppa Industriale Srl||1|||f||||t||||||||No||2017-10-10 22:19:26.575289|2017-10-10 22:19:26.575289
NCT02732730|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study|Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study|Recruiting||Phase 4|600|Anticipated|HIV Prevention Trials Network||2|||f||||t||||||||No|Data will be pooled by PID for central analysis by the Fred Hutch in Seattle, Washington|2017-10-10 22:19:26.68136|2017-10-10 22:19:26.68136
NCT02732717|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-04-07|||April 2016||2016-04-01|December 2015|2015-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||The Value of Prenatal Ultrasound in Complicated Twin Pregnancy and Its Correlation With Chromosomal Anomalies|The Value of Prenatal Ultrasound in the Diagnosis and Monitoring of Complicated Twin Pregnancy and Its Correlation With Chromosomal Anomalies of Twin|Not yet recruiting||N/A|580|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||f||||||||No||2017-10-10 22:19:26.793817|2017-10-10 22:19:26.793817
NCT02732704|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-06-16|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|July 2024|Anticipated|2024-07-01|July 2019|Anticipated|2019-07-01||Interventional|||JenaValve Pericardial TAVR Aortic Regurgitation Study|Safety and Effectiveness/Performance of the Transapical and Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)|Active, not recruiting||N/A|30|Anticipated|JenaValve Technology, Inc.||1|||f||||t||||||||No||2017-10-10 22:19:26.875377|2017-10-10 22:19:26.875377
NCT02732691|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-06-16|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|September 2023|Anticipated|2023-09-01|September 2018|Anticipated|2018-09-01||Interventional|||JenaValve Pericardial TAVR System Aortic Stenosis Study|Safety and Effectiveness/Performance of the Transapical and Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)|Active, not recruiting||N/A|60|Anticipated|JenaValve Technology, Inc.||1|||f||||t||||||||No||2017-10-10 22:19:26.991424|2017-10-10 22:19:26.991424
NCT02732678|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-08|||May 2016||2016-05-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|PROPAN||Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)||Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||No||2017-10-10 22:19:27.249924|2017-10-10 22:19:27.249924
NCT02732665|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Glycosaminoglycan Scores as Predictive Biomarkers in Advanced Renal Cell Carcinoma|Predictive Value of Glycosaminoglycan Scores in the Response to Treatment in Advanced Renal Cell Carcinoma|Recruiting||N/A|50|Anticipated|Chalmers University of Technology|||1||f||||f||||||Samples With DNA|"     Blood and urine.   "|||2017-10-10 22:19:27.340187|2017-10-10 22:19:27.340187
NCT02732652|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Observational|||Glycosaminoglycan Scores as Predictive Biomarkers in Confined Renal Cell Carcinoma|Predictive Value of Glycosaminoglycan Scores in the Definitive Diagnosis of Confined Renal Cell Carcinoma|Recruiting||N/A|100|Anticipated|Chalmers University of Technology|||1||f||||f||||||Samples With DNA|"     Blood, urine, and tumor tissue in paraffin or frozen   "|||2017-10-10 22:19:27.425697|2017-10-10 22:19:27.425697
NCT02732639|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-07-15|2016-07-15||October 2005||2005-10-01|July 2016|2016-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)|Open-label, Multicenter, Trial Evaluating Efficacy and Safety of Peginterferon Alfa-2a (PEGASYS®) in Patients With Chronic Hepatitis D (CHD)|Completed||Phase 3|31|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:19:27.501106|2017-10-10 22:19:27.501106
NCT02732626|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-05-28|||April 2016||2016-04-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ERASE-AF||The Low Voltage Guided Ablation Trail of Persistent Atrial Fibrillation|The Low Voltage Guided Ablation Trail of Persistent Atrial Fibrillation|Recruiting||N/A|320|Anticipated|Mödling Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:19:27.758957|2017-10-10 22:19:27.758957
NCT02732613|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-04-07|||April 2016||2016-04-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Selection of Laryngeal Mask Airway in Patients With Slender Somatotype|Selection of Laryngeal Mask Airway When Actual Body Weight Much Less Than Ideal Body Weight in Adult Patients|Not yet recruiting||N/A|118|Anticipated|Zhongshan People's Hospital, Guangdong, China||2|||f||||t||||||||Undecided||2017-10-10 22:19:27.867386|2017-10-10 22:19:27.867386
NCT02732600|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-06-21|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|September 30, 2019|Anticipated|2019-09-30|January 1, 2018|Anticipated|2018-01-01||Interventional|Peers on PACT||Evaluation of Peer Specialists on VA PACTs|Program Evaluation of Peer Specialists on VA PACTS: A Quality Improvement Project (QUE 15-289)|Enrolling by invitation||N/A|25|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:19:27.948006|2017-10-10 22:19:27.948006
NCT02732587|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-04-26|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|March 23, 2016|Actual|2016-03-23|March 15, 2016|Actual|2016-03-15||Interventional|||Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers|A Phase 1 Study Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers|Completed||Phase 1|5|Actual|Yale University||1|||f||||t||||||||||2017-10-10 22:19:28.096752|2017-10-10 22:19:28.096752
NCT02732574|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-09-14|||May 2016||2016-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Oscillating Positive Expiratory Pressure (OPEP) Therapy in High Risk Patients Following Cardiac Surgery|The Effectiveness of Oscillating Positive Expiratory Pressure (OPEP) Therapy in High Risk Patients Following Cardiac Surgery Surgery: A Randomized Clinical Trial|Not yet recruiting||N/A|162|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 22:19:28.172576|2017-10-10 22:19:28.172576
NCT02732561|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-07-18|2017-01-24||March 2016||2016-03-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless Adults|The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety|Completed||N/A|10|Actual|Wake Forest University Health Sciences|Data analyses done usually only matched pairs.|2|||f||||f||||||||||2017-10-10 22:19:28.288934|2017-10-10 22:19:28.288934
NCT02732548|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-14|||January 2016||2016-01-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||MIRODERM™ for Complex Wounds in an Inpatient Setting (MIRODERM CLOSure)|MIRODERM™ for Complex Wounds in an Inpatient Setting|Withdrawn||N/A|0|Actual|Miromatrix Medical Inc.||2||Study was never initiated|f||||f||||||||||2017-10-10 22:19:28.596595|2017-10-10 22:19:28.596595
NCT02732158|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-03-23|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Novel Laboratory Methods in Nutrition Studies|Feasibility of Novel Laboratory Methods for Use in Nutrition Studies|Completed||N/A|55|Actual|Abbott Nutrition||1|||f||||f||||||||No||2017-10-10 22:19:33.336729|2017-10-10 22:19:33.336729
NCT02732535|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-04-13|||August 2015||2015-08-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01|12 Months|Observational [Patient Registry]|||Natural Killer (NK) Cells Following Bariatric Surgery|The Natural Killer Cells Regulatory Role Against Hepatic Fibrosis Following Bariatric Surgery|Enrolling by invitation||N/A|40|Anticipated|Hadassah Medical Organization|||1||f||||t||||||||Undecided||2017-10-10 22:19:28.683886|2017-10-10 22:19:28.683886
NCT02732522|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-04-04|||October 2014||2014-10-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Interventional|CMVS||Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of Labor|Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of Labor: Randomized Clinical Trial|Completed||Phase 4|102|Actual|Universidad de la Republica||2|||f||||f||||||||||2017-10-10 22:19:28.753119|2017-10-10 22:19:28.753119
NCT02732509|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||Chronic Inflammation and Exercise Responsiveness|Chronic Inflammation and Exercise Responsiveness|Recruiting||N/A|45|Anticipated|Mayo Clinic|||2||f||||||||||||||2017-10-10 22:19:28.832364|2017-10-10 22:19:28.832364
NCT02732496|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-04-23|||June 2016||2016-06-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Computerized Working Memory Training in Children With ADHD and Comorbid Tourette Syndrome|Computerized Working Memory Training in Children With Attention-Deficit/Hyperactivity Disorder and Comorbid Tourette Syndrome|Enrolling by invitation||N/A|30|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:19:28.903427|2017-10-10 22:19:28.903427
NCT02732483|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-04|||April 2016||2016-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With Bleeding||Not yet recruiting||Phase 2|32|Anticipated|Yonsei University||1|||f||||f||||||||No|no plan to share data|2017-10-10 22:19:29.121661|2017-10-10 22:19:29.121661
NCT02732470|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-07|||April 2016||2016-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|LuQi||Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)|Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)|Not yet recruiting||N/A|40|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-10-10 22:19:29.229047|2017-10-10 22:19:29.229047
NCT02732457|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-08-30|||September 2014||2014-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|HSCT-HIV||Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected Patients|Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected Patients|Recruiting||N/A|10|Anticipated|Kirby Institute|||1||f||||f||||||Samples With DNA|"     PBMC, BMMC, lymph-node derived cells   "|||2017-10-10 22:19:29.310131|2017-10-10 22:19:29.310131
NCT02732444|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-08-01|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01|2 Days|Observational [Patient Registry]|||Erythrocytes Membrane Stability in COPD Patients in Long-Term Home Oxygen Therapy|Erythrocytes Membrane Stability in Chronic Obstructive Pulmonary Disease Patients in Long-Term Home Oxygen Therapy|Recruiting||N/A|200|Anticipated|Federal University of Uberlandia|||2||f||||f||||||||||2017-10-10 22:19:29.40308|2017-10-10 22:19:29.40308
NCT02732431|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-04|||October 2013||2013-10-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Obstructive Sleep Apnea and Down Syndrome: Clinical Examination Issue|Obstructive Sleep Apnea Screening and Down Syndrome in Childhood : the Reliability of the Clinical Examination|Recruiting||N/A|150|Anticipated|Fondation Lenval||1|||f||||f||||||||No||2017-10-10 22:19:29.527536|2017-10-10 22:19:29.527536
NCT02732418|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-06-16|||October 2016||2016-10-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Lower Dose Depo Provera® Contraceptive Injection|A Study to Evaluate Suppression of Ovulation Following a Single Subcutaneous Administration of Various Doses of Depo-Provera CI|Recruiting||Phase 1|60|Anticipated|FHI 360||4|||f||||t||||||||No|There is no plan to share individual participant data|2017-10-10 22:19:29.629478|2017-10-10 22:19:29.629478
NCT02732405|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-07|||May 2016||2016-05-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|GECOM||Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis|A Multicenter, Open Label, Pilot Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis (Child-Pugh A5 to A6) and No Response to PR or Prior Failure to First Generation Protease Inhibitors (PIs)|Not yet recruiting||Phase 3|120|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||No||2017-10-10 22:19:29.748039|2017-10-10 22:19:29.748039
NCT02732392|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-07|||November 2012||2012-11-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|SENTINELLE||Validation of Radioisotope Guided Lymphadenectomy for Loco-regional Staging in Patients With Intermediate or High-risk Prostate Cancer|Validation of Radioisotope Guided Lymphadenectomy for Loco-regional Staging in Patients With Intermediate or High-risk Prostate Cancer|Recruiting||N/A|200|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:19:29.844881|2017-10-10 22:19:29.844881
NCT02732379|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-01|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Aromatherapy on Postoperative Nausea, Vomiting|Evaluating the Efficacy of Aromatherapy on Postoperative Nausea, Vomiting|Recruiting||N/A|184|Anticipated|Tokat Gaziosmanpasa University||4|||f||||t||||||||||2017-10-10 22:19:29.937389|2017-10-10 22:19:29.937389
NCT02732366|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-07|||May 2016||2016-05-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Living in Fitness Together (LIFT): Testing an Innovative Fall Prevention Program|Living in Fitness Together (LIFT): Testing an Innovative Fall Prevention Program|Recruiting||N/A|48|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-10 22:19:30.118235|2017-10-10 22:19:30.118235
NCT02732353|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Absorption and Muscle-stimulating Effect of Hydrolyzed and Minced Beef|Absorption and Muscle-stimulating Effect of Hydrolyzed and Minced Beef|Not yet recruiting||N/A|10|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||No||2017-10-10 22:19:30.231013|2017-10-10 22:19:30.231013
NCT02732340|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2016-04-04|||October 2015||2015-10-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|TBSGPT||Triple-branch Stent Graft Placement and Hemi-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection|Triple-branch Stent Graft Placement and Hemi-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection: A Prospective, Multi-center, Randomized, Open-label, Parallel-group, Optimal Effect Comparative Clinical Trial|Recruiting||Early Phase 1|150|Anticipated|Fujian Medical University||2|||f||||t||||||||||2017-10-10 22:19:30.343902|2017-10-10 22:19:30.343902
NCT02732327|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-06-22|2017-06-22||May 17, 2016|Actual|2016-05-17|June 2017|2017-06-01|June 27, 2016|Actual|2016-06-27|June 27, 2016|Actual|2016-06-27||Interventional|||Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer|A Single-Center, Randomized, Open-label, Prospective, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime-Avibactam (CAZ-AVI) Plus Vancomycin or Linezolid Versus Standard of Care Plus Vancomycin or Linezolid as Empiric Therapy in Febrile Neutropenic Adults With Cancer|Terminated||Phase 2|2|Actual|Forest Laboratories||2||No longer aligned with the revised clinical development plan and commercial strategy|f||||f|t|f||||||No||2017-10-10 22:19:30.467756|2017-10-10 22:19:30.467756
NCT02732314|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-10-04|||March 2016||2016-03-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis|Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis|Completed||Phase 4|53|Actual|Procter & Gamble Beauty||4|||f||||f||||||||No||2017-10-10 22:19:30.683932|2017-10-10 22:19:30.683932
NCT02732301|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-04-19|||November 2015||2015-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|GAINDYSFUNCS||Postoperative Gastrointestinal Dysfunction After Cardiac Surgery - Occurrence and Search for Biomarkers|Gastrointestinal Dysfunktion Efter hjärtkirurgi - förekomst Samt sökande Efter Nya biomarkörer|Recruiting||N/A|500|Anticipated|Region Örebro County|||1||f||||f|f|f||||Samples Without DNA|"     Four plasma samples, 2 ml each, taken preoperatively and the three first postoperative days,     which are stored in an approved biobank.   "|No||2017-10-10 22:19:30.791971|2017-10-10 22:19:30.791971
NCT02732288|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-01-03|||May 2016||2016-05-01|January 2017|2017-01-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Exploratory Study of Melatonin Induced Sleep Regularization in Severe Brain Injury|Exploratory Study of Melatonin Induced Sleep Regularization in Severe Brain Injury|Recruiting||N/A|20|Anticipated|Rockefeller University||2|||f||||f||||||||Undecided||2017-10-10 22:19:30.86649|2017-10-10 22:19:30.86649
NCT02732262|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-05-11|||April 2016||2016-04-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|April 2017|Anticipated|2017-04-01||Interventional|||Optimal Dose of i.v Oxycodone for Postoperative Pain|Optimal Dose of i.v Oxycodone for Postoperative Pain After Laparoscopic Colorectal Surgery|Enrolling by invitation||Phase 3|135|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-10 22:19:31.086557|2017-10-10 22:19:31.086557
NCT02732249|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-02-28|||April 2016||2016-04-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment|A Randomized Clinical Trial of Clarithromycin/Bismuth Containing Quadruple Therapy for Helicobacter Pylori First-line Treatment|Recruiting||Phase 4|393|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||No||2017-10-10 22:19:31.168099|2017-10-10 22:19:31.168099
NCT02732236|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-04|||March 2013||2013-03-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01|5 Years|Observational [Patient Registry]|||Marginal Zone Lymphoma Cohort in Korea|Hepatitis B Virus Reactivation in Patients With Marginal Zone B-cell Lymphoma After Rituximab Containing Treatment: Consortium for Improving Survival of Lymphoma (CISL) Marginal Zone Lymphoma Cohort Study (MARCO)|Recruiting||N/A|500|Anticipated|Dong-A University Hospital|||1||f||||t||||||||Yes|We will share collected data with participated investigators in Korea|2017-10-10 22:19:31.275197|2017-10-10 22:19:31.275197
NCT02732223|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-07|||May 2014||2014-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Combined Bioactive Therapy Effects Over Cardiovascular Markers in Statin Treated Patients|Complementary Therapy of Omega 3 Fatty Acids, Plant Sterols and Polyphenols Over Cardiovascular Markers in Statin Treated Patients|Completed||N/A|53|Actual|Instituto Dante Pazzanese de Cardiologia||2|||f||||t||||||||Yes||2017-10-10 22:19:31.362093|2017-10-10 22:19:31.362093
NCT02732210|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-02-07|2016-10-24||July 2011||2011-07-01|February 2017|2017-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational||Full analysis set|Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis|Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice|Completed||N/A|935|Actual|Amgen|||1||f||||||||||||||2017-10-10 22:19:31.496277|2017-10-10 22:19:31.496277
NCT02732197|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-08|||August 2014||2014-08-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Effects of Sedation on Spinal Anesthesia-induced Maternal Hypotension|Effects of Sedation on Spinal Anesthesia-induced Maternal Hypotension in Preoperatively Anxious Parturients Undergoing Urgent Category-1 Cesarean Section: A Historical Cohort Study|Completed||N/A|102|Actual|Van Training and Research Hospital|||2||f||||f||||||||No||2017-10-10 22:19:33.039549|2017-10-10 22:19:33.039549
NCT02732184|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-08-15|||August 2016||2016-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS|A Phase 1 Dose-Escalation Study of AEB1102 (Co-ArgI-PEG) in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Refractory to Hypomethylating Agents|Recruiting||Phase 1|58|Anticipated|Aeglea Biotherapeutics||1|||f||||t||||||||||2017-10-10 22:19:33.131271|2017-10-10 22:19:33.131271
NCT02732171|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-01-13|||April 2016||2016-04-01|January 2017|2017-01-01||||April 2019|Anticipated|2019-04-01||Interventional|||PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer|PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer|Recruiting||Early Phase 1|600|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:19:33.26579|2017-10-10 22:19:33.26579
NCT02732145|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-09-18|||December 2011||2011-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|DATRIV||"The Diagnostic Accuracy of Three Rings Vulvoscopy for Detection of Vulvar Dermatosis"|"The Diagnostic Accuracy of Three Rings Vulvoscopy for Detection of Vulvar Dermatosis"|Recruiting||N/A|200|Anticipated|Ginekološka Poliklinika Dr. Vesna Harni|||4||f||||f||||||Samples With DNA|"     Vulvar samples for histopathological analysis   "|No||2017-10-10 22:19:33.403888|2017-10-10 22:19:33.403888
NCT02732132|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-08|||January 2015||2015-01-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||A Comparison of the Sedation During Endoscopy in Children|A Comparison of the Sedation With Intermittent Bolus Midazolam-Ketamine Versus Intermittent Bolus Propofol-Fentanyl During Endoscopy in Children: Randomized Trial|Completed||Phase 4|238|Actual|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||f||||||||No||2017-10-10 22:19:33.523682|2017-10-10 22:19:33.523682
NCT02732119|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-02-23|||June 14, 2016|Actual|2016-06-14|February 2017|2017-02-01|May 25, 2018|Anticipated|2018-05-25|May 25, 2018|Anticipated|2018-05-25||Interventional|TRINITI-1||Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.|A Phase I/II, Single Arm, Open-label Study of Ribociclib in Combination With Everolimus + Exemestane in the Treatment of Men and Postmenopausal Women With HR+, HER2- Locally Advanced or Metastatic Breast Cancer Following Progression on a CDK 4/6 Inhibitor|Recruiting||Phase 1/Phase 2|51|Anticipated|Novartis||1|||f||||t||||||||Undecided||2017-10-10 22:19:33.601436|2017-10-10 22:19:33.601436
NCT02732106|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-04-07|||April 2013||2013-04-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|September 2016|Anticipated|2016-09-01||Observational|||Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease|Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease|Active, not recruiting||N/A|20|Anticipated|Cytori Therapeutics|||1||f||||f||||||||||2017-10-10 22:19:33.808401|2017-10-10 22:19:33.808401
NCT02732093|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-05|2016-04-07|||April 2016||2016-04-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Does Stellate Ganglion Block Decrease Stress Response of Intubation?|Does Stellate Ganglion Block Decrease Stress Response of Intubation?|Not yet recruiting||Phase 2|60|Anticipated|Assiut University||2|||f||||t||||||||Yes||2017-10-10 22:19:33.871662|2017-10-10 22:19:33.871662
NCT02732080|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-17|||April 2016||2016-04-01|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Gradual Versus Abrupt Reperfusion in Primary PCI (GUARD)|Effect of Gradual Reperfusion on Myocardial Edema and Coronary Microvascular Integrity in Patients Undergoing Primary Percutaneous Coronary Intervention|Recruiting||Phase 4|30|Anticipated|Istanbul University||2|||f||||f||||||||||2017-10-10 22:19:33.992842|2017-10-10 22:19:33.992842
NCT02732067|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-10|||January 2016||2016-01-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Death Rate in Anesthesia, a Study in a Tertiary Hospital|Death Rate in Anesthesia: a Prospective Study of Two Years Period From a Tertiary Hospital|Recruiting||N/A|30|Anticipated|University of Jordan|||1||f||||f||||||||No||2017-10-10 22:19:34.097134|2017-10-10 22:19:34.097134
NCT02732054|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-17|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts|Comparison of Immunogenicity and Safety of 4 Standard Doses and 3 Standard Doses of Hepatitis B Vaccination in HIV-infected Adults Who Have CD4 < 200 Cells/mm3|Completed||Phase 4|16|Actual|Chiang Mai University||2|||f||||f||||||||No||2017-10-10 22:19:34.187527|2017-10-10 22:19:34.187527
NCT02732041|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-08-10|||May 2016||2016-05-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Asynchrony During Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome|Asynchrony During Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome|Recruiting||N/A|100|Anticipated|Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno|||1||f||||f||||||Samples Without DNA|"     plasma   "|No||2017-10-10 22:19:34.2593|2017-10-10 22:19:34.2593
NCT02732015|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-07-11|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Effects of Rolapitant on Nausea/Vomiting in Patients With Sarcoma Receiving Multi-Day Highly Emetogenic Chemotherapy (HEC) With Doxorubicin and Ifosfamide Regimen (AI)|Effects of Rolapitant on Nausea/Vomiting in Patients With Sarcoma Receiving Multi-Day Highly Emetogenic Chemotherapy (HEC) With Doxorubicin and Ifosfamide Regimen (AI)|Recruiting||Phase 2|91|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 22:19:34.352431|2017-10-10 22:19:34.352431
NCT02732002|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-04-07|||September 2016||2016-09-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|FCSA||Functional and Clinical Screening Assesment of the Shoulder Complex A New Methodological Model for Injury Management|Functional and Clinical Screening Assesment of the Shoulder Complex A New Methodological Model for Injury Management of Work Related Injuries|Not yet recruiting||N/A|110|Anticipated|Universidad Pública de Navarra||1|||f||||f||||||||No||2017-10-10 22:19:34.477825|2017-10-10 22:19:34.477825
NCT02731989|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-07-11|||July 24, 2017|Anticipated|2017-07-24|July 2017|2017-07-01|July 24, 2019|Anticipated|2019-07-24|July 24, 2018|Anticipated|2018-07-24||Observational|||Comparison Between the Clinical Assessment of the Undescended Testis and Its' Ultrasonographic Size|Comparison Between the Clinical Assessment of the Undescended Testis and Its' Ultrasonographic Size|Recruiting||N/A|60|Anticipated|Meir Medical Center|||2||f||||f||||||||||2017-10-10 22:19:34.566716|2017-10-10 22:19:34.566716
NCT02731976|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-08|||November 2011||2011-11-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|February 2012|Actual|2012-02-01||Interventional|||Microbiome Composition Changes on 4 Week Gluten-free Diet Challenge|The Influence of a Short-term Gluten-free Diet on the Human Gut Microbiome|Completed||N/A|21|Actual|University Medical Center Groningen||1|||f||||||||||||||2017-10-10 22:19:34.635836|2017-10-10 22:19:34.635836
NCT02731963|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-04-07|||September 2014||2014-09-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|||Mechanical Bowel Preparation for Elective Colorectal Anastomosis|Mechanical Bowel Preparation for Elective Colorectal Anastomosis: Randomized Clinical Trial.|Completed||Phase 3|81|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||Undecided||2017-10-10 22:19:34.707394|2017-10-10 22:19:34.707394
NCT02731950|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-03-31|||April 2015||2015-04-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Presternal Bupivacaine Plus Magnesium Sulfate Infusion After Cardiac Surgery|The Analgesic Efficacy of Magnesium Sulfate as an Adjuvant to Continuous Presternal Bupivacaine Infusion Through a Single Catheter After Cardiac Surgery; A Prospective Randomized Double Blind Study.|Completed||N/A|40|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:19:34.773205|2017-10-10 22:19:34.773205
NCT02731937|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-03|||April 2016||2016-04-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Clinical Evaluation of a Dual Energy CT System|Clinical Evaluation of a Dual Energy CT System|Completed||N/A|48|Actual|GE Healthcare||1|||f||||f|f|t|t|f|t|||No||2017-10-10 22:19:34.954871|2017-10-10 22:19:34.954871
NCT02731924|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-10-31|||May 2014||2014-05-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||Point of Care Ultrasound for Evaluation of Suspected Appendicitis in the Emergency Department|Point of Care Ultrasound for Evaluation of Suspected Appendicitis in the Emergency|Recruiting||N/A|261|Anticipated|WellSpan Health|||1||f||||f||||||||No||2017-10-10 22:19:35.042012|2017-10-10 22:19:35.042012
NCT02731911|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-16|||April 29, 2016|Actual|2016-04-29|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study|Phase 4, Open-label, Non-randomized, Prospective Study of OZURDEX® in the Treatment of Diabetic Macular Oedema - The AUSSIEDEX Study|Recruiting||N/A|250|Anticipated|Allergan|||1||f||||f|f|f||||||||2017-10-10 22:19:35.149035|2017-10-10 22:19:35.149035
NCT02731898|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-06-20|||June 2016||2016-06-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Observational|ISMV||Fourth International Study of Mechanical Ventilation From VENTILA GROUP|Fourth International Study of Mechanical Ventilation From VENTILA GROUP|Recruiting||N/A|3000|Anticipated|Hospital Universitario Getafe|||1||f||||t||||||||No||2017-10-10 22:19:35.274378|2017-10-10 22:19:35.274378
NCT02731885|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-04-04|||September 2014||2014-09-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Food Effect on Pharmacokinetic Parameters of ABX464|An Open, Randomized Study, to Investigate the Potential Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects|Completed||Phase 1|48|Actual|Abivax S.A.||2|||f||||f||||||||Undecided||2017-10-10 22:19:35.365369|2017-10-10 22:19:35.365369
NCT02731872|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-06-20|||January 2012||2012-01-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|September 2017|Anticipated|2017-09-01||Interventional|HHCOPD||The Effect of Oxygen Therapy With Airvo High-flow Heated Humidification|The Effect of Oxygen Therapy With Airvo High-flow Heated Humidification for Respiratory Insufficiency in Patients With Chronic Obstructive Pulmonary Disease|Active, not recruiting||N/A|200|Anticipated|Aalborg Universitetshospital||2|||f||||t||||||||No||2017-10-10 22:19:35.446915|2017-10-10 22:19:35.446915
NCT02731859|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-06-22|||January 2014||2014-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|2 Years|Observational [Patient Registry]|EBRD||EndoBarrier Register Deutschland-Safety and Efficacy of the Endoscopic Duodenal-Jejunal Bypass Sleeve|EndoBarrier Register Deutschland|Recruiting||N/A|1000|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||No||2017-10-10 22:19:35.53273|2017-10-10 22:19:35.53273
NCT02731846|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-07-20|||June 2016||2016-06-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Phase III, 4-week, Randomized, Double-blind Study to Compare 'Closed' Triple Therapy (FF/UMEC/VI), 'Open' Triple Therapy (FF/VI + UMEC) and Dual Therapy (FF/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||3||"It has been determined on June 10th that the 205165 study will not progress. This decision has   been made prior to study start, no patients were screened."|f||||f||||||||||2017-10-10 22:19:35.672905|2017-10-10 22:19:35.672905
NCT02731833|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-04-19|2017-01-20||April 1, 2016||2016-04-01|April 2017|2017-04-01|May 20, 2016|Actual|2016-05-20|May 1, 2016|Actual|2016-05-01||Interventional|||Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|Completed||Phase 4|229|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 22:19:35.798134|2017-10-10 22:19:35.798134
NCT02731820|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-08-03|||September 1, 2015|Actual|2015-09-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|ACAROS||Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia|Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia. A Randomized, Placebo-controlled, Double Blind Investigation.|Active, not recruiting||N/A|40|Actual|Istituto Ortopedico Rizzoli||2|||f||||t||||||||||2017-10-10 22:19:36.204729|2017-10-10 22:19:36.204729
NCT02731807|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2016-12-13|||September 2016||2016-09-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2016|Actual|2016-12-01||Interventional|||TA-65 Pharmacokinetic Study|A Pharmacokinetic And Relative Bioavailability Of Different Formulation Of Nutritional Supplement TA-65 In Healthy Volunteers: A Pilot, Replicate Cross-Over Study|Active, not recruiting||Phase 1|8|Actual|New York University School of Medicine||4|||f||||f||||||||||2017-10-10 22:19:36.321327|2017-10-10 22:19:36.321327
NCT02731794|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-05-14|||May 2016||2016-05-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist|Inflammatory Response and Clinical Outcome After On-pump Beating Coronary Artery Bypass Grafting Using Left Ventricular Assist Versus Biventricular Assist in Patients With Severe Left Ventricle Dysfunction|Recruiting||Phase 4|70|Anticipated|Henan Institute of Cardiovascular Epidemiology||2|||f||||t||||||||No||2017-10-10 22:19:36.432294|2017-10-10 22:19:36.432294
NCT02731781|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-06|||April 2016||2016-04-01|April 2016|2016-04-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01|2 Years|Observational [Patient Registry]|||Trauma Infant Neurological Score (TINS) as a Prognostic Factor and Guideline for CT Scan in Infants 24 Months Old or Less|Trauma Infant Neurological Score (TINS) as a Prognostic Factor and Guideline for CT Scan in Infants 24 Months Old or Less|Not yet recruiting||N/A|200|Anticipated|Laniado Hospital|||1||f||||f||||||||No||2017-10-10 22:19:36.540398|2017-10-10 22:19:36.540398
NCT02731768|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-09-18|||January 2016||2016-01-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|February 2017|Actual|2017-02-01||Interventional|||Nutrition, Exercise, and Technology for Weight Loss|Using Technology to Enhance Social Support for Weight Loss in Adults: The NETworks (Nutrition, Exercise, and Technology) Pilot Randomized Controlled Trial|Active, not recruiting||N/A|36|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-10 22:19:36.619013|2017-10-10 22:19:36.619013
NCT02731755|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-10-06|||January 2016||2016-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PROGRAIN2||Phenolic-rich Oats for Gut-bacteria Relief and Artery Improvement|Acute Cardiovascular Effects of Phenolic Rich Oats in Men With Above Average Blood Pressure|Recruiting||N/A|15|Anticipated|University of Reading||2|||f||||t||||||||Yes|Publish|2017-10-10 22:19:36.71821|2017-10-10 22:19:36.71821
NCT02731742|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-09-22|||June 22, 2016|Actual|2016-06-22|September 2017|2017-09-01|December 28, 2018|Anticipated|2018-12-28|December 28, 2018|Anticipated|2018-12-28||Interventional|||Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001)|A Phase 1/1b Trial of MK-1966 in Combination With SD-101 in Subjects With Advanced Malignancies|Recruiting||Phase 1|64|Anticipated|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-10 22:19:36.822716|2017-10-10 22:19:36.822716
NCT02731729|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-04|2017-06-09|||April 2016||2016-04-01|June 2017|2017-06-01|January 1, 2021|Anticipated|2021-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy|A Randomized, Phase 2 Study of Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy|Recruiting||Phase 2|70|Anticipated|Parker Institute for Cancer Immunotherapy||2|||f||||||||||||||2017-10-10 22:19:36.940737|2017-10-10 22:19:36.940737
NCT02731716|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-07-10|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transforming Primary Care Payment in Hawaii|Transforming Primary Care Payment in Hawaii|Enrolling by invitation||N/A|150|Anticipated|University of Pennsylvania||3|||f||||f||||||||||2017-10-10 22:19:37.055524|2017-10-10 22:19:37.055524
NCT02731703|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-13|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Observational|||Conventional, Overdenture and Palateless Overdenture Oral Health Impact Comparison Study|Evaluation of Patient Satisfaction Comparing Conventional, Overdenture and Palateless Overdenture Using Guided Maxillary Implant Placement|Recruiting||N/A|40|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 22:19:37.150232|2017-10-10 22:19:37.150232
NCT02731690|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-09-14|||April 29, 2016|Actual|2016-04-29|September 2017|2017-09-01|May 18, 2018|Anticipated|2018-05-18|April 2018|Anticipated|2018-04-01||Interventional|||A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER) Tablets in GNE Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy (HIBM)) Patients With Severe Ambulatory Impairment|A Phase 2 Open-label Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER) Tablets in GNE Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy (HIBM)) Patients With Severe Ambulatory Impairment|Active, not recruiting||Phase 2|45|Anticipated|Ultragenyx Pharmaceutical Inc||1|||f||||f||||||||||2017-10-10 22:19:37.263244|2017-10-10 22:19:37.263244
NCT02731677|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-01|||November 2015||2015-11-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Acupuncture as Adjuvant Therapy for Sleep Disorders in Parkinson's Disease|Acupuncture as Adjuvant Therapy for Sleep Disorders in Parkinson's Disease|Completed||N/A|22|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:19:37.353098|2017-10-10 22:19:37.353098
NCT02731664|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-08-02|||September 2012||2012-09-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|GLPMOT||GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans|GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans: Native GLP-1 Compared With Analogue ROSE-010 in Vitro|Recruiting||Phase 1|12|Anticipated|Uppsala University||2|||f||||f||||||||Yes|On request.|2017-10-10 22:19:37.414171|2017-10-10 22:19:37.414171
NCT02731651|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-08|||October 2014||2014-10-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Pneumoperitoneum on Human Ovary|Effect of CO2 Pneumoperitoneum on Human Ovary: Preliminary Study|Completed||N/A|20|Actual|Ege University||2|||f||||t||||||||Undecided||2017-10-10 22:19:37.519262|2017-10-10 22:19:37.519262
NCT02731638|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-04-18|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|MALIN||Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers||Enrolling by invitation||Phase 3|70|Anticipated|University of California, San Francisco||2|||f||||t||||||||Yes|De-identified data will be input into a database using double data entry at UCSF. Data will be stored at UCSF for about 10 years.|2017-10-10 22:19:37.588444|2017-10-10 22:19:37.588444
NCT02731625|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2017-03-10|||April 2016||2016-04-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Kettlebell Training Measured Across Power and Performance|Effects of a Regimented Kettlebell Training Program Across Measures of Power and Performance: A Randomized Controlled Trial|Terminated||N/A|20|Actual|Keller Army Community Hospital||2||Less enrollment than expected. Would have been grossly underpowered|f||||f||||||||No||2017-10-10 22:19:37.681253|2017-10-10 22:19:37.681253
NCT02731612|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-06-23|||May 8, 2017|Actual|2017-05-08|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ELICE_BD||Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients|A 6-Week Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)|Recruiting||Phase 3|150|Anticipated|University of British Columbia||2|||f||||f|t|f||||||No||2017-10-10 22:19:37.76768|2017-10-10 22:19:37.76768
NCT02731599|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-04-03|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||The Effects of Treadmill Training With Visual and Auditory Cues on Gait Parameters in Parkinsonian Patients in Advanced Stages of Disease.|The Effects of Treadmill Training With Visual and Auditory Cues on Gait Parameters in Parkinsonian Patients in Advanced Stages of Disease.|Recruiting||N/A|150|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini||1|||f||||f||||||||No||2017-10-10 22:19:37.91409|2017-10-10 22:19:37.91409
NCT02731586|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-10-04|||January 2016|Actual|2016-01-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|MSC&IMPLANTS||Effect on Allogenic Mesenchymal Stem Cells on Osseointegration of Dental Implants|Comparative Clinical Evaluation of Osseointegration of Dental Implants Placed With and Without, the Use of Dental Pulp-derived Allogenic Mesenchymal Stem Cells.|Enrolling by invitation||Early Phase 1|10|Actual|Sri Sai College of Dental Surgery and Research Centre||1|||f||||t||||||||||2017-10-10 22:19:37.994012|2017-10-10 22:19:37.994012
NCT02731573|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-04-06|||October 2016||2016-10-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery|A Phase Ib/II Prospective, Multicenter, Two Part Study; Part 1 - Open Label, Single Arm & Part 2 Randomized, Single-blinded (Study to Assess Safety and Efficacy of D-PLEX Concomitantly With Standard of Care vs. Standard of Care Alone in the Prevention of Primary Sternal Infection Post Cardiac Surgery.|Recruiting||Phase 1/Phase 2|80|Anticipated|PolyPid Ltd.||2|||f||||t|f|f||||||No||2017-10-10 22:19:38.095009|2017-10-10 22:19:38.095009
NCT02731547|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-12|||May 2016||2016-05-01|April 2016|2016-04-01||||June 2018|Anticipated|2018-06-01||Interventional|||Education Against Tobacco Randomized Trial in Bosnia and Herzegovina|Education Against Tobacco: Medical-student-delivered Smoking Prevention Programme for Secondary Schools in Bosnia and Herzegovina - Randomized Trial|Not yet recruiting||N/A|1500|Anticipated|University of Giessen||2|||f||||f||||||||Undecided||2017-10-10 22:19:38.309108|2017-10-10 22:19:38.309108
NCT02731534|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-01-04|||May 2016||2016-05-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia|Phase III Study of Z-213 in Subjects With Iron-deficiency Anemia|Active, not recruiting||Phase 3|200|Anticipated|Zeria Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:19:38.374266|2017-10-10 22:19:38.374266
NCT02731521|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-10-19|||January 2014||2014-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical Development of MR Spectroscopy and Imaging in Brain Cancers|Clinical Development of MR Spectroscopy and Imaging in Brain Cancers|Recruiting||N/A|175|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||Undecided||2017-10-10 22:19:38.440171|2017-10-10 22:19:38.440171
NCT02731508|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-04-01|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Repetitive Bihemispheric Transcranial Direct Current Stimulation After Stroke|Bihemispheric Modulation of the Motor Cortex by Repetitive Transcranial Direct Current Stimulation After Stroke|Unknown status|Recruiting|Phase 1/Phase 2|32|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||No||2017-10-10 22:19:38.687284|2017-10-10 22:19:38.687284
NCT02731495|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-06-06|||March 2015||2015-03-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients|Effect of Green Tea Epigallocatechin -3-gallate Supplementation on Traumatic Brain Injury Patients' Outcomes|Completed||Phase 2/Phase 3|30|Actual|National Nutrition and Food Technology Institute||2|||f||||t||||||||Undecided|undecided|2017-10-10 22:19:38.795136|2017-10-10 22:19:38.795136
NCT02731482|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-18|||June 2016||2016-06-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Short-and Long-term Effects of a Home-based Rehabilitation Program in Patients With Bronchiectasis|Short-and Long-term Effects of a Home-based Rehabilitation Program on Functional Capacity, Peripheral Muscle Strength and Quality of Life in Patients With Bronchiectasis: Randomized Controlled Trial|Recruiting||N/A|48|Anticipated|University of Nove de Julho||2|||f||||f||||||||No||2017-10-10 22:19:38.885966|2017-10-10 22:19:38.885966
NCT02731469|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-05-03|||August 2016||2016-08-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Tolerance, Safety and Immunogenicity of Single Injection of Increasing Doses of BCD-131 to Healthy Volunteers Compared to Mircera® and Aranesp®|Open Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Tolerance, Safety and Immunogenicity of Single Injection of Increasing Doses of BCD-131 to Healthy Volunteers Compared to Mircera® (F. Hoffman-La Roche Ltd., Switzerland) and Aranesp® (Amgen Europe B.V., Netherlands)|Not yet recruiting||Phase 1|66|Anticipated|Biocad||11|||f||||f||||||||No||2017-10-10 22:19:38.988281|2017-10-10 22:19:38.988281
NCT02731456|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2017-05-09|||March 2016||2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of High Altitude Exposure, Acclimatization and Re-exposure on Psychomotor Performance in Lowlanders|Effect of High Altitude Exposure, Acclimatization and Re-exposure on Psychomotor Performance and Sleep Quality in Lowlanders|Recruiting||N/A|18|Anticipated|University of Calgary||1|||f||||f||||||||No||2017-10-10 22:19:39.107775|2017-10-10 22:19:39.107775
NCT02731443|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-03-08|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||The Impact of Epilepsy Surgery on Dream Content|The Impact of Epilepsy Surgery on Dream Content|Recruiting||N/A|60|Anticipated|London Health Sciences Centre|||2||f||||f||||||||||2017-10-10 22:19:39.221597|2017-10-10 22:19:39.221597
NCT02731430|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-03|2016-04-06|||December 2015||2015-12-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Intrathecal Morphine for Postoperative Analgesia Following Laparoscopic Bariatric Surgery|Intrathecal Morphine for Postoperative Pain Management in Patients Undergoing Laparoscopic Bariatric Surgery|Active, not recruiting||Phase 2/Phase 3|100|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:19:39.347097|2017-10-10 22:19:39.347097
NCT02731417|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-04-06|||April 2016||2016-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Acupuncture Treatment for Post-partum Urinary Retention|Acupuncture Treatment for Post-partum Urinary Retention|Not yet recruiting||N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||Undecided||2017-10-10 22:19:39.444485|2017-10-10 22:19:39.444485
NCT02731404|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-06|||January 2015||2015-01-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|pressure||Intra-ocular Pressure and Ventilation|The Effects of High Frequency Jet Ventilation on Intra-ocular Pressure During Laparoscopic Operations (Lap. Cholecystectomy) With Positive Pressure Pneumoperitoneum|Completed||N/A|26|Actual|Western Galilee Hospital-Nahariya||2|||f||||f||||||||||2017-10-10 22:19:39.53122|2017-10-10 22:19:39.53122
NCT02731391|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-04-01|||April 2016||2016-04-01|April 2016|2016-04-01||||April 2019|Anticipated|2019-04-01||Interventional|||Clinical Research on Bowel Symptoms of Patient With Pelvic Organ Prolapse|Clinical Research on Bowel Symptoms of Patients With Pelvic Organ Prolapse|Recruiting||N/A|200|Anticipated|Peking University People's Hospital||2|||f||||f||||||||||2017-10-10 22:19:39.621609|2017-10-10 22:19:39.621609
NCT02731378|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-10-28|||December 2016||2016-12-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|April 2019|Anticipated|2019-04-01||Interventional|||Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia|Combination With Intravenous Iron Supplementation or Doubling Erythropoietin Dose for Patients With Chemotherapy-induced Anaemia Inadequately Responsive to Initial Erythropoietin Treatment Alone|Not yet recruiting||Phase 4|603|Anticipated|Shanghai East Hospital||3|||f||||f||||||||Undecided||2017-10-10 22:19:39.73137|2017-10-10 22:19:39.73137
NCT02731365|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-11-16|||February 2015||2015-02-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Concurrent DBS Local Field Potential Analysis and Stimulation in a Closed-Loop Neuromodulation Device|Concurrent Deep Brain Stimulation (DBS) Local Field Potential Analysis and Stimulation in a Closed-Loop Neuromodulation Device|Withdrawn||N/A|0|Actual|Ohio State University||1||Study stopped to await new generation of device anticipated to be released 2018.|f||||f||||||||No||2017-10-10 22:19:39.86551|2017-10-10 22:19:39.86551
NCT02731352|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-04-06|||February 2016||2016-02-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Study of Apatinib in Patients With Differentiated Thyroid Cancer|Study of Apatinib in Patients With Local Advanced 131iodine（131I）-Refractory/Resistant Differentiated Thyroid Cancer|Recruiting||Phase 2|10|Anticipated|Peking Union Medical College Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:19:39.951372|2017-10-10 22:19:39.951372
NCT02731339|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-07|||March 2015||2015-03-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Spinal Curvature, Mobility, and Low Back Pain Relationship in Women With and Without Urinary Incontinence||Completed||N/A|73|Actual|Ataturk Training and Research Hospital||2|||f||||||||||||||2017-10-10 22:19:40.064439|2017-10-10 22:19:40.064439
NCT02731326|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-19|||March 2015||2015-03-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|iHEART||iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology|iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology|Recruiting||N/A|300|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-10 22:19:40.160686|2017-10-10 22:19:40.160686
NCT02731313|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-09-08|2016-09-08||July 2012||2012-07-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma|Evaluation of Human HER-2 Status in Gastric and Gastro-Oesophageal Junction Cancer.|Completed||N/A|420|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:19:40.290773|2017-10-10 22:19:40.290773
NCT02731300|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-05-20|2016-04-08||August 2010||2010-08-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Transcranial Direct Current Stimulation, Treatment of Childhood Drug-Resistant Lennox-Gastaut Syndrome, A Pilot Study|Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome, A Pilot Study|Completed||Phase 4|22|Actual|Khon Kaen University|"The investigators could not ensure that the stimulation electrode was directly over the primary motor cortex.
The sample size was small."|2|||f||||t||||||||No||2017-10-10 22:19:40.639402|2017-10-10 22:19:40.639402
NCT02731287|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-04-06|||March 2014||2014-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Topical Timolol for Infantile Hemangioma in Early Proliferative Phase|Efficacy and Safety of Topical Timolol Maleate 0.5% Solution for Superficial Infantile Hemangioma in Early Proliferative Phase. A Randomized Clinical Trial|Recruiting||Phase 2|70|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-10 22:19:41.056583|2017-10-10 22:19:41.056583
NCT02731274|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-06|||January 2014||2014-01-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|||Physical Activity and Motor Memory in Pedal Dexterity|Physical Activity and Motor Memory in Pedal Dexterity|Completed||N/A|34|Actual|Instituto Politécnico de Castelo Branco||2|||f||||f||||||||No||2017-10-10 22:19:41.162375|2017-10-10 22:19:41.162375
NCT02731261|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-06|||January 2013||2013-01-01|April 2016|2016-04-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Chronic Effects of Exercise on Motor Memory Consolidation in Elderly People|Chronic Effects of Exercise on Motor Memory Consolidation in Elderly People|Completed||N/A|38|Actual|Instituto Politécnico de Castelo Branco||2|||f||||||||||||||2017-10-10 22:19:41.223712|2017-10-10 22:19:41.223712
NCT02731248|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2016-04-02|||April 2016||2016-04-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|POX||Pulse Oximeter Screening in Congenital Heart Disease|Pulse Oximeter Screening for Critical Congenital Heart Disease in Newborns|Recruiting||N/A|50000|Anticipated|Dr. Sami Ulus Children's Hospital|||1||f||||f||||||||No||2017-10-10 22:19:41.315107|2017-10-10 22:19:41.315107
NCT02731235|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-04-06|||January 2016||2016-01-01|April 2016|2016-04-01|March 2022|Anticipated|2022-03-01|March 2017|Anticipated|2017-03-01||Interventional|HITPALS||The Effect of Aerobic Exercise in Patients With Minor Stroke|High-intensity Training in Patients With Lacunar Stroke|Recruiting||N/A|84|Anticipated|Herlev Hospital||2|||f||||f||||||||No||2017-10-10 22:19:41.405932|2017-10-10 22:19:41.405932
NCT02731222|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-07-25|||November 9, 2015|Actual|2015-11-09|July 2017|2017-07-01|December 29, 2016|Actual|2016-12-29|December 17, 2015|Actual|2015-12-17|1 Day|Observational [Patient Registry]|||Prevalence of Onychodystrophy in Patients With Chronic Venous Disease of the Lower Limbs|Prevalence of Onychodystrophy in Patients With Chronic Venous Disease of the Lower Limbs|Completed||N/A|40|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f|f|f||||||||2017-10-10 22:19:41.502449|2017-10-10 22:19:41.502449
NCT02731027|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-29|||October 2015||2015-10-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Biomarkers of Spontaneous Recovery From Traumatic Spinal Cord Injury|Biomarkers of Spontaneous Recovery From Traumatic Spinal Cord Injury|Recruiting||N/A|100|Anticipated|Northwell Health|||2||f||||f||||||||||2017-10-10 22:19:45.173333|2017-10-10 22:19:45.173333
NCT02731209|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-04-02|||February 2016||2016-02-01|April 2016|2016-04-01||||February 2017|Anticipated|2017-02-01||Interventional|||Functional Urodynamic Changes in Chronic Kidney Disease Patients and Does Insertion of Urinary Catheter Delay the Need for Kidney Dialysis|Functional Urodynamic Changes in Chronic Kidney Disease Patients and Does Insertion of Urinary Catheter in Chronic Kidney Disease Patients Grade 4 Delay the Need for Kidney Dialysis|Recruiting||N/A|100|Anticipated|Assaf-Harofeh Medical Center||2|||f||||t||||||||||2017-10-10 22:19:41.579651|2017-10-10 22:19:41.579651
NCT02731196|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-06|||April 2016||2016-04-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Exercise Intervention Effects Following Lumbar Microdiscectomy|Comparison of Early Exercise Intervention Versus Late Exercise Intervention on Pain and Neurodynamic Mobility Following Unilateral Lumbar Microdiscectomy: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No||2017-10-10 22:19:41.67118|2017-10-10 22:19:41.67118
NCT02731183|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-08-08|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Efficacy and Safety of Fecal Microbiota Transplantation for Chronic Intestinal Pseudo-obstruction|Efficacy and Safety of Fecal Microbiota Transplantation in Treatment of Chronic Intestinal Pseudo-obstruction: a Preliminary Study|Completed||N/A|9|Actual|Jinling Hospital, China||1|||f||||t||||||||||2017-10-10 22:19:41.765942|2017-10-10 22:19:41.765942
NCT02731170|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-04-03|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Interventional|||Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease.|Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease.|Recruiting||N/A|439|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini||1|||f||||f||||||||No||2017-10-10 22:19:41.896912|2017-10-10 22:19:41.896912
NCT02731157|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-09-15|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Rejuvesol® Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions|Rejuvesol® Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions|Recruiting||Phase 4|4|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:19:41.982559|2017-10-10 22:19:41.982559
NCT02731144|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-01-29|||June 2016||2016-06-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|May 2017|Anticipated|2017-05-01||Interventional|||Optimized Caloric-proteic Nutrition in Septic and Septic Shock Patients|The Impact of Optimized Caloric-proteic Nutrition on Clinical Outcome and Physical Component Summary (PCS) of Quality of Life in Septic and Septic Shock Patients|Suspended||Phase 4|100|Anticipated|Hospital Sao Domingos||2||The protocol was modified substantially and will be resubmitted to Clinical Trial|f||||t||||||||Yes||2017-10-10 22:19:42.076191|2017-10-10 22:19:42.076191
NCT02731131|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-06-03|2016-06-03||September 2004||2004-09-01|June 2016|2016-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional||Intent-to-Treat (ITT) Population: All participants who received at least one dose of study medication.|A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)|A Randomized, Pilot, Open-Label, Monocenter, Efficacy and Safety Study Examining the Effects of Peginterferon Alfa-2a (Pegasys) With or Without Ribavirin (Copegus) in Patients With Chronic Hepatitis D|Completed||Phase 2|12|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:19:42.160188|2017-10-10 22:19:42.160188
NCT02731118|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-02|2017-07-10|||April 2016||2016-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Antisecretory Factor (AF) Effects on Intraocular-pressure|Antisecretory Factor (AF) Effects on Intraocular-pressure: a Placebo-controlled Randomised Study|Recruiting||Phase 3|50|Anticipated|St. Erik Eye Hospital||2|||f||||f||||||||||2017-10-10 22:19:42.591312|2017-10-10 22:19:42.591312
NCT02731105|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-18|||February 2015||2015-02-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|PREFECT||Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products|Pilot Study of Tolerability and Effectivity Following Application of Two Combination Topical Acne Products Clindamycin 1% and 0.025% Tretinoin Gel (Acnatac® Gel), Adapalen 0,1% and Benzoyl Peroxide 2,5% Gel (Epiduo® Gel)|Active, not recruiting||Phase 4|22|Actual|GWT-TUD GmbH||2|||f||||t||||||||||2017-10-10 22:19:42.676445|2017-10-10 22:19:42.676445
NCT02731092|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-18|||April 2016||2016-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants|Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants|Recruiting||Phase 1|30|Anticipated|University of Virginia||3|||f||||t||||||||Yes|At UVA and MTA with outside institutions|2017-10-10 22:19:44.593593|2017-10-10 22:19:44.593593
NCT02731079|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-01|||April 2016||2016-04-01|April 2016|2016-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Sleeve Gastrectomy Outcomes With Different Stapling Devices|Prospective Comparison of Sleeve Gastrectomy Outcomes With Different Stapling Devices|Not yet recruiting||N/A|150|Anticipated|William Beaumont Army Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:19:44.714444|2017-10-10 22:19:44.714444
NCT02731066|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Substrate Utilization, Exercise Performance, and Skeletal Muscle Response to Energy Deficit and Altitude Acclimatization|Substrate Utilization, Exercise Performance, and Skeletal Muscle Response to Energy Deficit and Altitude Acclimatization|Completed||N/A|21|Actual|United States Army Research Institute of Environmental Medicine||4|||f||||f||||||||Undecided||2017-10-10 22:19:44.818573|2017-10-10 22:19:44.818573
NCT02731053|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-26|||March 2016||2016-03-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|French Blues||Effectiveness Trial of the French Blues Indicated Depression Prevention Program|Pilot Effectiveness Trial of the French Blues Indicated Depression Prevention Program|Completed||Phase 4|72|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-10 22:19:44.927569|2017-10-10 22:19:44.927569
NCT02731040|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-04-15|||April 2016||2016-04-01|April 2016|2016-04-01||||April 2017|Anticipated|2017-04-01||Observational|||Exome Sequencing for Atypical Femoral Fractures|Whole Exome Sequencing to Identify Genetic Predisposition to Atypical Femoral Fractures in Women Using Bisphosphonates for Osteoporosis|Enrolling by invitation||N/A|36|Anticipated|Washington University School of Medicine|||2||f||||||||||||||2017-10-10 22:19:45.035399|2017-10-10 22:19:45.035399
NCT02731001|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-09-13|||August 2016||2016-08-01|September 2017|2017-09-01|October 2024|Anticipated|2024-10-01|April 2020|Anticipated|2020-04-01||Interventional|PRONTOX||Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer|Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer|Recruiting||N/A|98|Anticipated|Technische Universität Dresden||2|||f||||f||||||||||2017-10-10 22:19:45.427132|2017-10-10 22:19:45.427132
NCT02730988|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2017-04-17|||July 1, 2015|Actual|2015-07-01|April 2017|2017-04-01|April 17, 2017|Actual|2017-04-17|March 30, 2017|Actual|2017-03-30||Interventional|||Effect of High Protein Weight Loss for Seniors|Effect of High Protein Weight Loss for Seniors|Completed||N/A|96|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 22:19:45.536463|2017-10-10 22:19:45.536463
NCT02730975|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-03-09|||June 2014||2014-06-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|ABIFOOD01||Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer|Pharmacokinetic Food-effect Study of Abiraterone Acetate (A.A) in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)|Recruiting||Phase 1|42|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||3|||f||||t||||||||Undecided||2017-10-10 22:19:45.652845|2017-10-10 22:19:45.652845
NCT02730962|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-10|||June 2016||2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Interventional Bioremediation of Microbiota in Metabolic Syndrome|Interventional Bioremediation of Microbiota in Metabolic Syndrome|Active, not recruiting||Phase 2|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 22:19:45.958752|2017-10-10 22:19:45.958752
NCT02730949|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-04-01|||March 2014||2014-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||D-chiro-Inositol in Overweight Type 1 Diabetes Patients|A Pilot Study of D-Chiro-Inositol Plus Folic Acid in Overweight Patients With Type 1 Diabetes|Completed||Phase 3|26|Actual|Campus Bio-Medico University||2|||f||||f||||||||No||2017-10-10 22:19:46.076884|2017-10-10 22:19:46.076884
NCT02730936|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-02-10|||January 12, 2016|Anticipated|2016-01-12|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Antimicrobial Hernia Repair Device|Feasibility Study of the Antimicrobial Hernia Repair Device for Repair of Ventral or Incisional Hernia|Withdrawn||N/A|0|Actual|Cook Group Incorporated||1||Sponsor decision to discontinue the study.|f|||||f|t|f|f||||||2017-10-10 22:19:46.178111|2017-10-10 22:19:46.178111
NCT02730923|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-09-14|||April 2016||2016-04-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|VICTORIA||Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)|A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma|Recruiting||Phase 1/Phase 2|72|Anticipated|Centre Leon Berard||2|||f||||t||||||||||2017-10-10 22:19:46.26975|2017-10-10 22:19:46.26975
NCT02730910|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-12|||October 2015||2015-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|||Anthocyanin & Phenolic Acids Bioavailability & Antioxidant Capacity After Consumption of Purple Wheat Products in Adults|Bioavailability of Anthocyanins and Phenolic Acids and Changes in Blood Antioxidant Capacity After Consumption of Purple Wheat Anthocyanin-enriched Crackers and Granola Bars by Healthy Adult Participants|Active, not recruiting||N/A|16|Actual|University of Guelph||2|||f||||f||||||||||2017-10-10 22:19:46.513778|2017-10-10 22:19:46.513778
NCT02730897|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-04-01|||January 2016||2016-01-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01|1 Year|Observational [Patient Registry]|NUTS||Multicentric Analysis of Predictors of N1 Upstaging After Resection of cStage-I NSCLC|Multicentric Analysis of Predictors of N1 Upstaging After Resection of cStage-I NSCLC|Enrolling by invitation||N/A|1000|Anticipated|University Hospital, Gasthuisberg|||2||f||||f||||||||No||2017-10-10 22:19:46.611429|2017-10-10 22:19:46.611429
NCT02730884|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-10-05|||August 16, 2017|Actual|2017-08-16|October 2017|2017-10-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia|A Phase II Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia|Recruiting||Phase 2|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:19:46.694921|2017-10-10 22:19:46.694921
NCT02730871|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-07-24|||June 17, 2016|Actual|2016-06-17|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®|Safety and Efficacy With Twice Daily Brinzolamide 1%/Brimonidine 0.2% (SIMBRINZA®) as an Adjunctive Therapy to Travoprost 0.004%/Timolol 0.5% (DUOTRAV®)|Recruiting||Phase 4|300|Anticipated|Alcon Research||2|||f||||f||||||||||2017-10-10 22:19:46.810786|2017-10-10 22:19:46.810786
NCT02730858|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-04-15|||May 2016||2016-05-01|April 2017|2017-04-01|February 2023|Anticipated|2023-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Palliative And Oncology Care Model In Breast Cancer|A Collaborative Palliative and Oncology Care Model for Metastatic Breast Cancer|Recruiting||N/A|120|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 22:19:46.906983|2017-10-10 22:19:46.906983
NCT02730845|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-04-06|||December 2015||2015-12-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Intra-articular Versus Intravenous Dexmedetomidine in Arthroscopic Knee Surgeries Under Local Anesthesia|Intra-articular Versus Intravenous Administration of Dexmedetomidine in Arthroscopic Knee Surgeries: A Prospective Randomized Study|Recruiting||N/A|100|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:19:47.005364|2017-10-10 22:19:47.005364
NCT02730832|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-03-16|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|QUALITY||Validation of a Scale to Evaluate the Perception of Oral Health in Patients With Schizophrenia|Validation of Scale to Evaluate the Perception of Oral Health in Patients With Schizophrenia|Enrolling by invitation||N/A|112|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||f||||||||||2017-10-10 22:19:47.108943|2017-10-10 22:19:47.108943
NCT02730650|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-05-03|||December 31, 2016|Actual|2016-12-31|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|May 1, 2017|Actual|2017-05-01||Interventional|||Platelet Rich Therapy for Facial Rejuvenation|Assessing Outcomes for Platelet Rich Therapy for Facial Rejuvenation Using the FACE-Q Questionnaire|Active, not recruiting||N/A|30|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:19:48.762913|2017-10-10 22:19:48.762913
NCT02730819|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-23|2017-08-23||May 15, 2016|Actual|2016-05-15|August 2017|2017-08-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Interventional||19 participants were enrolled, but 3 did not return for any of the follow-up visits and were not included in any of the analyses.|Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma|An Open-Label Pilot Study Evaluating the Effectiveness and Tolerability of a Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma|Completed||Phase 2|19|Actual|Mayo Clinic||1|||f||||f|t|f||||||||2017-10-10 22:19:47.188234|2017-10-10 22:19:47.188234
NCT02730806|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-06|||June 2016||2016-06-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|NLP||Interventional Study Comparing NLP Protocol to the Common Practice Protocol in the Event of PPPTSD|A Comparative Interventional Study Evaluating the Neuro-Linguistic Programing (NLP) Intervention Protocol Compared to the Common Practice Following Post-partum Post-traumatic Stress Disorder (PPPTSD)|Not yet recruiting||N/A|60|Anticipated|Assuta Hospital Systems||2|||f||||f||||||||No||2017-10-10 22:19:47.462659|2017-10-10 22:19:47.462659
NCT02730793|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-02-21|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease|Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease|Recruiting||Phase 2|30|Anticipated|Virginia Commonwealth University||2|||f||||f|t|f||||||No|Individual participant data will be deidentified and will not be availalble.|2017-10-10 22:19:47.543462|2017-10-10 22:19:47.543462
NCT02730780|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-01-25|||June 2016||2016-06-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||The Natriuretic Peptide System in African-Americans.|The Natriuretic Peptide System in African-Americans.|Recruiting||N/A|80|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||Yes||2017-10-10 22:19:47.719937|2017-10-10 22:19:47.719937
NCT02730767|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-04-12|||August 2015||2015-08-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|SURfit||SURfit - A Physical Activity Intervention for Childhood Cancer Survivors|Effects of a 1-year Partially Supervised Exercise Program in Childhood Cancer Survivors - a Randomized Controlled Trial|Enrolling by invitation||N/A|150|Anticipated|University of Zurich||2|||f||||f||||||||Undecided||2017-10-10 22:19:47.906288|2017-10-10 22:19:47.906288
NCT02730754|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-01-09|||April 2016||2016-04-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|EDDMQoL-Pro||Emotional Disorders and Outcomes in Adults With Type 2 Diabetes Mellitus at Primary Care|Relationship Between Emotional Disorders (Diabetes Distress and Depression) and Outcomes (Self-care and Clinical) in Adults With Type 2 Diabetes Mellitus in Primary Care: A Retrospective Cohort Study|Completed||N/A|336|Actual|Universiti Putra Malaysia|||1||f||||t||||||||Yes|Anonymous data will be made available in figshare|2017-10-10 22:19:48.012928|2017-10-10 22:19:48.012928
NCT02730741|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-07-13|||June 2016||2016-06-01|July 2016|2016-07-01||||June 2016|Actual|2016-06-01||Interventional|PROVAME||Study of the Efficacy and Tolerance of Oral Treatment With a Total Freeze-dried Culture of Lcr Restituo® Sachets (Lactobacillus Rhamnosus Lcr35®) on Intolerance to Metformin (Diarrhoea) in Patients With Diabetes Type 2|Study of the Efficacy and Tolerance of Oral Treatment of Lcr Restituo® Sachets (Lactobacillus Rhamnosus Lcr35®) on Intolerance to Metformin (Diarrhoea) in Patients With Diabetes Type 2|Recruiting||Phase 2|60|Anticipated|Biose||3|||f||||t||||||||||2017-10-10 22:19:48.08689|2017-10-10 22:19:48.08689
NCT02730728|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-11-07|||November 2015||2015-11-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA|A Randomized Study of Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block for Postoperative Analgesia After Total Knee Arthroplasty|Completed||N/A|165|Actual|University of Pennsylvania||3|||f||||f||||||||No||2017-10-10 22:19:48.200407|2017-10-10 22:19:48.200407
NCT02730715|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-01|||November 2010||2010-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TReg Kidney||Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients|Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients|Suspended||N/A|30|Anticipated|University of Pennsylvania||2||Re-evaluation of amount of T Cell collection needed.|f||||f||||||||||2017-10-10 22:19:48.300666|2017-10-10 22:19:48.300666
NCT02730702|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-06-28|||September 2016||2016-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure|Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure|Active, not recruiting||N/A|600|Anticipated|American BioOptics, LLC|||1||f||||t||||||||Yes|The investigators will assure the confidentiality of all human subjects' data and will adhere to all HIPAA rules by, for example, de-identifying data as appropriate to ensure compliance with human subject confidentiality requirements. The investigators will share research outcomes through conference presentations, and through publications as soon as is feasible after peer review.|2017-10-10 22:19:48.389692|2017-10-10 22:19:48.389692
NCT02730689|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-04-01|||December 2014||2014-12-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone|A Randomized, Single-dose, Open, Crossover Clinical Trial to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone in Healthy Male Volunteers|Completed||Phase 1|66|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-10 22:19:48.470065|2017-10-10 22:19:48.470065
NCT02730676|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-09-12|||April 2016||2016-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Comparison of Pharmacokinetic Parameters Between Adopters of Electronic Cigarettes and a Historical Sample of Combustible Cigarette Smokers|A Study to Assess Nicotine Pharmacokinetic Parameters of Digital Vapor Cigarettes in Adopters and Compare Them to Nicotine Pharmacokinetic Parameters of Cigarettes in Smokers|Completed||N/A|44|Actual|R.J. Reynolds Vapor Company|||2||f||||f||||||Samples Without DNA|"     Plasma, urine, buccal cells   "|No||2017-10-10 22:19:48.546068|2017-10-10 22:19:48.546068
NCT02730637|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-06|||March 2016||2016-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Prevention of Acute Kidney Injury Through Biomarker-guided Nephrological Intervention|Prevention of Acute Kidney Injury Through Biomarker-guided Nephrological|Recruiting||N/A|250|Anticipated|Robert Bosch Medical Center||2|||f||||||||||||||2017-10-10 22:19:48.852472|2017-10-10 22:19:48.852472
NCT02730624|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-19|||March 2014||2014-03-01|March 2016|2016-03-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Interventional|||Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock|Population Pharmacokinetics and Pharmacodynamics Study of Piperacillin/Tazobactam During Early Phase in Critically Ill Patients With Severe Sepsis|Completed||Phase 4|50|Actual|Prince of Songkla University||1|||f||||f||||||||||2017-10-10 22:19:49.021536|2017-10-10 22:19:49.021536
NCT02730611|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-10-07|||April 2016||2016-04-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|METSLIVER||Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma|The Influence of Metabolic Syndrome and Circulating Bile Acid Levels on the Development of Hepatocellular Carcinoma and Biliary Tract Cancers|Recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     Feces, blood, liver biopsy   "|No||2017-10-10 22:19:49.144923|2017-10-10 22:19:49.144923
NCT02730598|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-02-02|||February 2016||2016-02-01|February 2017|2017-02-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Combined Application of Electrical Stimulated Antagonist Contraction During Walking (Walking Study)|Determining Efficacy of the Combined Application of Electrical Stimulated Antagonist Contraction During Walking With Sensory TENS for Increasing Strength and Decreasing Pain in Women With Frequent Knee Symptoms|Completed||N/A|28|Actual|University of Kansas Medical Center||2|||f||||f||||||||No||2017-10-10 22:19:49.26996|2017-10-10 22:19:49.26996
NCT02730585|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-08-31|||January 2010||2010-01-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|dCRPappend||Diagnostic Performance of C Reactive Protein and Delta CRP in Acute Appendicitis|Evaluation of the Performance of C-reactive Protein (CRP) Concentrations Variation (Delta CRP) in the Diagnosis of Acute Appendicitis in the ER|Completed||N/A|500|Actual|University of Monastir|||1||f||||f||||||||Undecided||2017-10-10 22:19:49.39133|2017-10-10 22:19:49.39133
NCT02730572|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-02-10|||September 2015||2015-09-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Concerta (Methylphenidate) -To-Generic Switch Study|Concerta-to-Generic Switch Study|Completed||N/A|1464|Actual|Janssen Research & Development, LLC|||2||f||||f||||||||||2017-10-10 22:19:49.490742|2017-10-10 22:19:49.490742
NCT02730559|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-04-05|||November 2012||2012-11-01|April 2016|2016-04-01||||June 2014|Actual|2014-06-01||Interventional|||Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial||Completed||N/A|32|Actual|The Hospital for Sick Children||2|||f||||||||||||||2017-10-10 22:19:49.612877|2017-10-10 22:19:49.612877
NCT02730546|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-09-01|||June 24, 2016|Actual|2016-06-24|March 2017|2017-03-01|April 15, 2018|Anticipated|2018-04-15|April 15, 2018|Anticipated|2018-04-15||Interventional|||Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery|Phase 1b/2 Clinical Trial of Neoadjuvant Pembrolizumab Plus Concurrent Chemoradiotherapy With Weekly Carboplatin and Paclitaxel in Adult Patients With Resectable, Locally Advanced Adenocarcinoma of the Gastroesophageal Junction or Gastric Cardia|Suspended||Phase 1/Phase 2|68|Anticipated|Mayo Clinic||1||for treatment amendment|f||||t||||||||||2017-10-10 22:19:49.712778|2017-10-10 22:19:49.712778
NCT02730533|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-07-19|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD|The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD: an Endoscopist-blinded Randomized Controlled Study|Completed||N/A|74|Actual|Xijing Hospital of Digestive Diseases||2|||f||||f||||||||||2017-10-10 22:19:49.931413|2017-10-10 22:19:49.931413
NCT02730520|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-09-09|||May 2016||2016-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Impact of Age on the Prevalence of Allergic Sensitization|Impact of Age on the Prevalence of Allergic Sensitization|Completed||N/A|1400|Actual|Brugmann University Hospital|||1||f||||f||||||||||2017-10-10 22:19:50.043231|2017-10-10 22:19:50.043231
NCT02730507|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-10-03|||October 2016||2016-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|PROFILE||Surgical Treatment of Spinal Deformity With Sagittal Imbalance Using Patient-specific Rods: A Multicenter, Controlled, Double- Blind Randomized Trial: The PROFILE Study|Surgical Treatment of Spinal Deformity With Sagittal Imbalance Using Patient-specific Rods: A Multicenter, Controlled, Double- Blind Randomized Trial: The PROFILE Study|Not yet recruiting||Phase 3|334|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||No||2017-10-10 22:19:50.130584|2017-10-10 22:19:50.130584
NCT02730494|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2016-04-07|||July 2015||2015-07-01|April 2016|2016-04-01||||January 2016|Actual|2016-01-01||Interventional|COMPRIGEL||Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation|Study Evaluating the Optimal Dosage for Equivalence Between a Tablet and Capsule Dosage Form of an Intravaginal Treatment With Total Freeze-dried Culture of Lcr Regenerans® (Lactobacillus Rhamnosus Lcr35®) on Vaginal Flora Colonisation in Healthy Women.|Completed||Phase 1|34|Actual|Biose||4|||f||||t||||||||||2017-10-10 22:19:50.216342|2017-10-10 22:19:50.216342
NCT02730481|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-05-02|||March 2016||2016-03-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies|A Dose Regimen-Finding Study to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Pharmacokinetics, and Activity of Oraxol in Subjects With Advanced Malignancies|Recruiting||Phase 1|30|Anticipated|Kinex Pharmaceuticals Inc||1|||f||||f||||||||No||2017-10-10 22:19:50.308413|2017-10-10 22:19:50.308413
NCT02730468|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-04-20|||April 2016||2016-04-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay|SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay|Recruiting||N/A|550|Anticipated|Karius, Inc.|||1||f||||f||||||Samples With DNA|"     Plasma   "|Undecided||2017-10-10 22:19:50.416275|2017-10-10 22:19:50.416275
NCT02730455|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-09-15|||July 18, 2016|Actual|2016-07-18|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|ACTION2||Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke|Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) in Acute Ischemic Stroke|Recruiting||Phase 2|270|Anticipated|Biogen||3|||f||||t||f||||||||2017-10-10 22:19:50.505018|2017-10-10 22:19:50.505018
NCT02730442|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-02-01|||February 2016|Actual|2016-02-01|April 2016|2016-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of Potential for Interaction of Fluconazole With F901318|An Open Label Study in Healthy Volunteers to Evaluate the Potential for Drug/Drug Interactions Between F901318 and Fluconazole|Completed||Phase 1|20|Actual|F2G Ltd.||1|||f||||f||||||||No||2017-10-10 22:19:50.88366|2017-10-10 22:19:50.88366
NCT02730429|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-04-01|||February 15, 2017|Actual|2017-02-15|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer|ENGOT-EN3-NSGO/PALEO: A Randomized, Double-blind, Placebo-controlled, Phase II Trial of Palbociclib in Combination With Letrozole Versus Placebo in Combination With Letrozole for Patients With Estrogen Receptor Positive Advanced or Recurrent Endometrial Cancer.|Recruiting||Phase 2|78|Anticipated|Nordic Society for Gynaecologic Oncology||2|||f||||t|f|f||||||Yes|As all endpoints are matured, the individual participant data will be shared.|2017-10-10 22:19:51.018733|2017-10-10 22:19:51.018733
NCT02730416|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-03-29|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer|ENGOT-EN1/FANDANGO: A Randomized Phase II Trial of First-line Combination Chemotherapy With Nintedanib / Placebo for Patients With Advanced or Recurrent Endometrial Cancer|Recruiting||Phase 2|148|Anticipated|Nordic Society for Gynaecologic Oncology||2|||f||||t||||||||No|Data will be evaluated without exposing identity of subjects|2017-10-10 22:19:51.129045|2017-10-10 22:19:51.129045
NCT02730403|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-05-15|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Observational|||TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051|Treatment-as-Usual Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With NIDA CTN-0051|Completed||N/A|211|Actual|New York University School of Medicine|||1||f||||t||||||||Yes||2017-10-10 22:19:51.231364|2017-10-10 22:19:51.231364
NCT02730390|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-31|||December 2009||2009-12-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Observational|||Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance|Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance|Completed||Phase 4|3087|Actual|Otsuka Pharmaceutical, Inc., Philippines|||1||f||||f||||||||Undecided||2017-10-10 22:19:51.32827|2017-10-10 22:19:51.32827
NCT02730377|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-07|||March 28, 2016|Actual|2016-03-28|September 2017|2017-09-01|August 26, 2019|Anticipated|2019-08-26|April 15, 2019|Anticipated|2019-04-15||Interventional|LIRA-PRIME||Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes|Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy and Treated in a Primary Care Setting|Active, not recruiting||Phase 4|1994|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 22:19:51.420412|2017-10-10 22:19:51.420412
NCT02730364|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-05-29|||February 1, 2017|Anticipated|2017-02-01|May 2017|2017-05-01|April 1, 2017|Anticipated|2017-04-01|April 1, 2017|Anticipated|2017-04-01||Interventional|||Russian Market Potential of Theraflu Night Powder as Oral Solution for Cold and Flu|An Open-label, Multicenter, Randomized, Parallel Group, Single-dose Study to Assess the Short Term Efficacy and Safety of Paracetamol 500 mg + Phenylephrine HCl 10 mg + Pheniramine Maleate 20 mg + Vitamin C 200 mg Powder for Oral Solution in Subjects With Symptoms of an Upper Respiratory Tract Infection|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||2||"The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's   decision."|f||||f|f|f||||||||2017-10-10 22:19:51.957141|2017-10-10 22:19:51.957141
NCT02730338|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-09-07|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|INTERVAL||INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer|INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer|Recruiting||N/A|866|Anticipated|Movember Foundation||2|||f||||t||||||||||2017-10-10 22:19:52.16304|2017-10-10 22:19:52.16304
NCT02730325|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-06-04|||December 2015||2015-12-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Impact of Serum-derived Bovine Immunoglobulin/Protein Isolate (SBI) on Clostridium Difficile (C. Difficile) Infection (CDI) in Hospitalized Ulcerative Colitis (UC) Patients|Active, not recruiting||N/A|100|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 22:19:52.413438|2017-10-10 22:19:52.413438
NCT02730312|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-08-10|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|July 2019|Anticipated|2019-07-01||Interventional|||PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies|A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®14045 in Patients With CD123-Expressing Hematologic Malignancies|Recruiting||Phase 1|66|Anticipated|Xencor, Inc.||1|||f||||f|t|f||||||||2017-10-10 22:19:52.561838|2017-10-10 22:19:52.561838
NCT02730299|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-09-24|||November 2016||2016-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Transplantation of Ex Vivo Expanded, UCB-derived, Stem & Progenitor Cells vs. Unmanipulated UCB for HM Patients|A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies|Recruiting||Phase 3|120|Anticipated|Gamida Cell ltd||2|||f||||t||||||||||2017-10-10 22:19:52.716454|2017-10-10 22:19:52.716454
NCT02730286|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-03-31|||June 2009||2009-06-01|March 2016|2016-03-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Observational|||Activity Limitations in Rheumatoid Arthritis|Factors Associated With Activity Limitations in Individuals With Rheumatoid Arthritis|Completed||N/A|81|Actual|Federal University of Minas Gerais|||1||f||||f||||||||No||2017-10-10 22:19:52.916741|2017-10-10 22:19:52.916741
NCT02730273|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-07-13|||March 2016||2016-03-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)|The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)|Completed||N/A|12|Actual|Fisher and Paykel Healthcare||1|||f||||t|f|f||||||||2017-10-10 22:19:53.015493|2017-10-10 22:19:53.015493
NCT02730260|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-10-31|2016-06-01||February 2005||2005-02-01|October 2016|2016-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Worksite Phone Counseling for Smoking Cessation|Worksite Phone Counseling for Smoking Cessation|Completed||N/A|518|Actual|Washington University School of Medicine||2|||f||||f||||||||Yes|Researchers interested in using individual participant data may contact the PI. Only de-identified baseline, 6 month, and 12 month data will be available.|2017-10-10 22:19:53.149337|2017-10-10 22:19:53.149337
NCT02730247|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-05|||April 21, 2017|Actual|2017-04-21|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|A Phase II Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|80|Anticipated|University of Pittsburgh||1|||f||||t|t|f|||f|||||2017-10-10 22:19:53.618832|2017-10-10 22:19:53.618832
NCT02730234|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-03-25|||April 2016||2016-04-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|JET-ISR||JetStream Atherectomy for the Treatment of In-stent Restenosis|JetStream Atherectomy for the Treatment of In-stent Restenosis of the Femoropopliteal Artery|Enrolling by invitation||N/A|140|Anticipated|Midwest Cardiovascular Research Foundation||1|||f||||t||||||||No|Data will be shared in aggregate in a manuscript. No plan to share individual patient data|2017-10-10 22:19:53.867991|2017-10-10 22:19:53.867991
NCT02730221|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-10-31|||January 2016||2016-01-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|AWIC||Administrative Workload in the Intensive Care Unit|Administrative Workload in the Intensive Care Unit (AWIC Study)|Recruiting||N/A|200|Anticipated|VU University Medical Center|||2||f||||f||||||||No||2017-10-10 22:19:54.007291|2017-10-10 22:19:54.007291
NCT02730208|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-07|||September 2016||2016-09-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study to Evaluate the Effect of VX-661 in Combination With Ivacaftor on Chest Imaging Endpoints in Subjects With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation|A Phase 2, Randomized, Placebo-Controlled, Double-blind Study to Evaluate the Effect of VX-661 in Combination With Ivacaftor on Chest Imaging Endpoints in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation|Active, not recruiting||Phase 2|40|Anticipated|Vertex Pharmaceuticals Incorporated||2|||f||||t||||||||||2017-10-10 22:19:54.111351|2017-10-10 22:19:54.111351
NCT02730195|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-06-01|||May 2016||2016-05-01|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia|Combination of Pioglitazone and Tyrosine Kinase Inhibitor (TKI) in Relapsed Chronic Myeloid Leukemia Following a First TKI Discontinuation|Recruiting||Phase 2|26|Anticipated|Emory University||1|||f||||t||||||||Undecided||2017-10-10 22:19:54.203577|2017-10-10 22:19:54.203577
NCT02730182|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-23|||March 2016||2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of High Altitude Exposure, Acclimatization and Re-exposure on Postural Control in Lowlanders|Effect of High Altitude Exposure, Acclimatization and Re-exposure on Postural Control in Lowlanders|Recruiting||N/A|18|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 22:19:54.303697|2017-10-10 22:19:54.303697
NCT02730169|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-09-07|||April 2016||2016-04-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism|A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism|Active, not recruiting||Phase 2|268|Anticipated|Mereo BioPharma||4|||f||||t||||||||||2017-10-10 22:19:54.398139|2017-10-10 22:19:54.398139
NCT02730156|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-23|||March 2016||2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of High Altitude Exposure, Acclimatization and Re-exposure on Right Ventricular Function in Lowlanders|Effect of High Altitude Exposure, Acclimatization and Re-exposure on Right Ventricular Function in Lowlanders|Recruiting||N/A|18|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 22:19:54.61218|2017-10-10 22:19:54.61218
NCT02730143|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-23|||March 2016||2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders|Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders|Recruiting||N/A|18|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 22:19:54.716532|2017-10-10 22:19:54.716532
NCT02730130|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-07-25|||April 2016||2016-04-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients|A Single Arm Phase II Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients|Active, not recruiting||Phase 2|17|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:19:54.814756|2017-10-10 22:19:54.814756
NCT02730117|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-31|||March 2016||2016-03-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Furosemide Stress Test Guiding Initiation of Renal Replacement Therapy|Does Early Initiation of Renal Replacement Therapy Have an Impact on 7-day Fluid Balance in Critically Ill Patients With Acute Kidney Injury With Positive Furosemide Stress Test?: a Multicenter Randomized Controlled Trial|Recruiting||N/A|116|Anticipated|Chulalongkorn University||2|||f||||t||||||||Yes||2017-10-10 22:19:54.911579|2017-10-10 22:19:54.911579
NCT02730104|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-07-13|||November 2015||2015-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Community-based Neuroendocrine Tumor (NET) Research Study|Prospective Observational Study in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated With Lanreotide Depot in a US Community Oncology Setting|Recruiting||N/A|100|Anticipated|Ipsen|||5||f||||f||||||||||2017-10-10 22:19:55.028043|2017-10-10 22:19:55.028043
NCT02730091|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-07-28|||February 2016||2016-02-01|July 2017|2017-07-01|February 2023|Anticipated|2023-02-01|February 2018|Anticipated|2018-02-01||Interventional|VICTORIANE||A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease|A Randomized Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease|Recruiting||Phase 3|340|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-10 22:19:55.147782|2017-10-10 22:19:55.147782
NCT02730078|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-04-10|||April 2016||2016-04-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|April 2017|Anticipated|2017-04-01||Interventional|VEMOFIT||Value-based Emotion-focused Educational Programme to Reduce Diabetes-related Distress|The Effectiveness of a Value-based Emotion-focused Educational Programme to Reduce Diabetes-related Distress in Malay Adults With Type 2 Diabetes (VEMOFIT): a Cluster Randomised Controlled Trial|Enrolling by invitation||N/A|200|Anticipated|Universiti Putra Malaysia||2|||f||||t||||||||Yes|Anonymous data will be accessible publicly via the figshare.|2017-10-10 22:19:55.250698|2017-10-10 22:19:55.250698
NCT02730065|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-08-06|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ADTSVD||Aerobic Dance Training in Small Vessel Disease|Effects of Aerobic Dance Training on Cognitive Functions, Mood and Physical Functions in Community Elderly Persons With Cerebral Small Vessel Disease|Recruiting||N/A|110|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:19:55.370488|2017-10-10 22:19:55.370488
NCT02730052|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-31|||June 2016||2016-06-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|ERNESTINA||Telemonitoring of Uncontrolled Hypertension|Estudio RioplateNsE Sobre Telemonitoreo en hIpertensos No-controlAdos|Not yet recruiting||Phase 4|300|Anticipated|Universidad de la Republica||2|||f||||t||||||||No||2017-10-10 22:19:55.513394|2017-10-10 22:19:55.513394
NCT02730039|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-08-08|||December 11, 2015|Actual|2015-12-11|August 2017|2017-08-01|December 11, 2020|Anticipated|2020-12-11|December 11, 2020|Anticipated|2020-12-11||Observational|||Meaning-Centered Psychotherapy Training for Cancer Care Providers|Meaning-Centered Psychotherapy Training for Cancer Care Providers|Recruiting||N/A|240|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:19:55.719112|2017-10-10 22:19:55.719112
NCT02730026|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-03-08|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of the Clinical Efficacy of Ketoprofen, Associated or Not With Omeprazole in Lower Third Molar Removal|Comparison of the Clinical Efficacy of Ketoprofen, Associated or Not With Omeprazole, in the Control of Pain, Swelling and Trismus in Lower Third Molar Removal|Completed||Phase 4|50|Actual|University of Sao Paulo||2|||f||||t||||||||Undecided||2017-10-10 22:19:55.824418|2017-10-10 22:19:55.824418
NCT02730013|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-27|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|MIND-FUN||Mind-motor Exercise to Improve Cognition and Functional Fitness|The MIND-FUN Research Study: Mind-motor Exercise to Improve Cognition and Functional Fitness|Completed||N/A|74|Actual|Western University, Canada||2|||f||||f||||||||||2017-10-10 22:19:55.923255|2017-10-10 22:19:55.923255
NCT02730000|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-08-28|||July 2016||2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cost-efficacy of Atraumatic Restorations (ART) Using Different Encapsulated Glass Ionomer Cement|Cost-efficacy of Atraumatic Restorations (ART) Using Different Encapsulated Glass Ionomer Cement|Active, not recruiting||Phase 4|150|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:19:56.023153|2017-10-10 22:19:56.023153
NCT02729987|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-05-03|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Increasing Engagement With Online Stress Management Interventions|Increasing Engagement With and Effectiveness of an Online CBT Based Stress Management Intervention for Employees Through the Use of an Online Facilitated Bulletin Board: Design of a Pilot Randomized Controlled Trial|Completed||N/A|84|Actual|University of Sussex||3|||f||||t||||||||Undecided||2017-10-10 22:19:56.133394|2017-10-10 22:19:56.133394
NCT02729974|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-04-28|||March 2016||2016-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|ROTEM||Use of ROTEM Intraoperatively in Women With Placenta Accreta|Use of ROTEM Intraoperatively in Women With Placenta Accreta|Enrolling by invitation||N/A|40|Anticipated|University of Utah||2|||f||||f||||||||No||2017-10-10 22:19:56.228805|2017-10-10 22:19:56.228805
NCT02729961|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-09-01|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 1, 2023|Anticipated|2023-02-01|February 1, 2023|Anticipated|2023-02-01||Interventional|||Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma|A Phase I/II Open-Label Dose-Finding Study of Ceritinib Combined With Brentuximab Vedotin for Front-Line Treatment of ALK-Positive Anaplastic Large Cell Lymphoma|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|University of Washington||1|||f||||t|t|f||||||||2017-10-10 22:19:56.31648|2017-10-10 22:19:56.31648
NCT02729948|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-08-25|||July 28, 2016|Actual|2016-07-28|August 2017|2017-08-01|July 28, 2018|Anticipated|2018-07-28|July 28, 2018|Anticipated|2018-07-28||Interventional|||Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus|Use of a Tethered Capsule Endoscope in Screening for Barrett's Esophagus|Recruiting||N/A|5|Anticipated|University of Washington||1|||f||||t|f|t||||||||2017-10-10 22:19:56.433917|2017-10-10 22:19:56.433917
NCT02729935|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-10-16|||March 2016||2016-03-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Parecoxib for Treatment of Catheter Related Bladder Discomfort|Efficacy and Tolerance of Parecoxib for Prevention of Catheter-related Bladder Discomfort in Patients Undergoing Catheterization After TURBT: A Prospective, Randomized, Placebo-controlled, Double-blind Study|Completed||Phase 4|60|Actual|University Tunis El Manar||2|||f||||f||||||||No||2017-10-10 22:19:56.513142|2017-10-10 22:19:56.513142
NCT02729922|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-11|||March 2016||2016-03-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|3 Years|Observational [Patient Registry]|||Registry of Patients With CardioMEMS|Registry of Patients With CardioMEMS|Enrolling by invitation||N/A|30|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 22:19:56.600294|2017-10-10 22:19:56.600294
NCT02729909|ClinicalTrials.gov processed this data on October 10, 2017|2016-04-01|2017-06-13|||March 2, 2016|Actual|2016-03-02|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Interventional|||Lubiprostone for Chronic Idiopathic Constipation Treatment|A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lubiprostone for the Treatment of Chronic Idiopathic Constipation|Completed||Phase 3|204|Anticipated|Takeda||2|||f||||f|f|f||||||||2017-10-10 22:19:56.668056|2017-10-10 22:19:56.668056
NCT02729883|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-05-30|||February 2016||2016-02-01|May 2017|2017-05-01||||February 2017|Actual|2017-02-01||Interventional|||Take the Fight in Supporting and Empowering Patients With Cancer|A Pilot Study of 'Take the Fight' as Community-Based Participatory Research|Terminated||N/A|54|Actual|Wake Forest University Health Sciences||1||Funding Issue|f||||t|f|f||||||||2017-10-10 22:19:56.942307|2017-10-10 22:19:56.942307
NCT02729870|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-07|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Oral Glucose Intervention for Children With Gastroenteritis and Ketosis|Oral Glucose Intervention for Children With Gastroenteritis and Ketosis|Not yet recruiting||N/A|500|Anticipated|University of Florida|||2||f||||t||||||||||2017-10-10 22:19:57.047456|2017-10-10 22:19:57.047456
NCT02729857|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-06-29|||March 2016||2016-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Postprandial Response After Intake of Meals With Different Fatty Acid Composition|Postprandial Response After Intake of Meals With Different Fatty Acid Composition in Patients With Familial Hypercholesterolemia and Healthy Subjects|Completed||N/A|31|Actual|University of Oslo||2|||f||||f||||||||No||2017-10-10 22:19:57.149343|2017-10-10 22:19:57.149343
NCT02729844|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01|2 Years|Observational [Patient Registry]|||Neolifes Heart - Pulmonary Hypertension in Preterm Children|Pulmonary Hypertension in Preterm Children Born at Gestational Age <30 Weeks: Prevalence, Risk Factors and Outcome|Recruiting||N/A|165|Anticipated|University Medical Center Groningen|||1||f||||t||||||||No|Only in case of clinical need, the data of the echocardiograph will be available.|2017-10-10 22:19:57.344495|2017-10-10 22:19:57.344495
NCT02729831|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-07-18|||April 2016||2016-04-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparative Effectiveness of Decision Support Strategies for Joint Replacement Surgery|Comparative Effectiveness of Decision Support Strategies for Joint Replacement Surgery: A Factorial Randomized Trial|Enrolling by invitation||N/A|1120|Anticipated|Massachusetts General Hospital||4|||f||||f||||||||Yes|As per requirements of the funder, the study team will create a complete, cleaned, de-identified copy of the final data set that will include survey data from participants. The PI will share a de-identified data set with outside investigators at no cost, according to approved Massachusetts General Hospital policies for data sharing. Investigators from other sites will be able to request the data and will be required to complete a data use agreement that ensures that all local Institutional Review Board requirements are met before using the data, that they will not attempt to identify any data in the dataset, and that they will not share the data set with anyone outside their project team, etc.|2017-10-10 22:19:57.451905|2017-10-10 22:19:57.451905
NCT02729818|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-05-02|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|March 2016|Actual|2016-03-01||Observational|||Adaptation Time Required for the Optimisation of Maia Microperimetry Visual Field Testing|Adaptation Time Required for the Optimisation of Maia Microperimetry Visual Field Testing|Active, not recruiting||N/A|40|Anticipated|University of Oxford|||1||f||||f||||||||Undecided||2017-10-10 22:19:57.560087|2017-10-10 22:19:57.560087
NCT02729805|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2016-03-31|||August 2015||2015-08-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Intraoperative Ketamine on Chronic Pain After Mastectomy|Effects of Intraoperative Intravenous Ketamine on Chronic Pain After Mastectomy|Recruiting||Phase 4|135|Anticipated|The University of Hong Kong||3|||f||||t||||||||Undecided||2017-10-10 22:19:57.64079|2017-10-10 22:19:57.64079
NCT02729792|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-27|||March 2016||2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|CARTBIND||Canadian rTMS Treatment and Biomarker Network in Depression Trial|Canadian rTMS Treatment and Biomarker Network in Depression Trial|Recruiting||N/A|202|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||Undecided||2017-10-10 22:19:57.77003|2017-10-10 22:19:57.77003
NCT02729779|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-08|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effectiveness of the Pilates Method Versus Aerobic Exercises in Elderly With Low Back Pain|Effectiveness of the Pilates Method Versus Aerobic Exercises in the Treatment of Chronic Non-specific Low Back Pain in the Elderly: Randomized Controlled Trial|Recruiting||N/A|74|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t|f|f||||||No||2017-10-10 22:19:57.929785|2017-10-10 22:19:57.929785
NCT02729766|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-08-09|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|DIVE||Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study|Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study|Completed||Phase 2/Phase 3|15|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 22:19:58.049829|2017-10-10 22:19:58.049829
NCT02729753|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-04-11|||April 2016||2016-04-01|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|March 2017|Actual|2017-03-01||Interventional|||Clinical Study to Evaluate CryoBalloon™ Full Ablation System for Ablation of Human Esophageal Epithelium|Clinical Study to Evaluate the CryoBalloon™ Full Ablation System for Ablation of Human Esophageal Epithelium|Active, not recruiting||N/A|12|Anticipated|C2 Therapeutics, Inc.||1|||f||||f||||||||No||2017-10-10 22:19:58.173465|2017-10-10 22:19:58.173465
NCT02729740|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-12-05|||June 2016||2016-06-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Interventional|SMART||Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil|SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil|Recruiting||Phase 4|1000|Anticipated|Penumbra Inc.||1|||f||||f||||||||No||2017-10-10 22:19:58.289917|2017-10-10 22:19:58.289917
NCT02729727|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-04-11|||March 2016||2016-03-01|September 2016|2016-09-01|December 31, 2017|Anticipated|2017-12-31|March 2017|Actual|2017-03-01||Interventional|||Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Undergoing Esophagectomy|Clinical Study to Evaluate the CryoBalloon™ Full Ablation System for the Ablation of Human Esophageal Epithelium in Patients Undergoing Esophagectomy|Active, not recruiting||N/A|5|Anticipated|C2 Therapeutics, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:19:58.407485|2017-10-10 22:19:58.407485
NCT02729714|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-04-05|||April 2016||2016-04-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||A Pilot Study of Suvorexant for Insomnia in Parkinson Disease|A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Suvorexant for Insomnia in Parkinson Disease|Recruiting||Phase 4|20|Anticipated|Burdick, Daniel, M.D.||2|||f||||f||||||||||2017-10-10 22:19:58.509372|2017-10-10 22:19:58.509372
NCT02729701|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-19|||April 2016||2016-04-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation|Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation in Peri or Post-menopausal Women at Moderate Risk for Development of Breast Cancer|Recruiting||Phase 2|40|Anticipated|University of Kansas Medical Center||1|||f||||t||||||||Yes|Results will be published in aggregate; no individual participant data will be made available.|2017-10-10 22:19:58.631818|2017-10-10 22:19:58.631818
NCT02729688|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-03-02|||March 2016||2016-03-01|March 2017|2017-03-01|March 1, 2017|Anticipated|2017-03-01|March 1, 2017|Anticipated|2017-03-01||Interventional|||Effectiveness of a Pressure Indicator Guided and a Conventional Bandaging in Treatment of Venous Leg Ulcer|Effectiveness of a Pressure Indicator Guided and a Conventional Bandaging in Treatment of Venous Leg Ulcer|Recruiting||N/A|90|Anticipated|Mahidol University||2|||f||||f||||||||No||2017-10-10 22:19:58.74226|2017-10-10 22:19:58.74226
NCT02729675|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-03-31|||September 2010||2010-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|Good to Go||Innovative Approaches to Increase F&V Intake Thru Worksites|Innovative Approaches to Increase F&V Intake Thru Worksites: The Fresh Initiative|Completed||Phase 2|1804|Actual|Brown University||3|||f||||t||||||||No||2017-10-10 22:19:58.849468|2017-10-10 22:19:58.849468
NCT02729662|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-03-01|||October 1, 2016||2016-10-01|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2017|Anticipated|2017-03-31||Interventional|||Efficacy of Tolvaptan on ADPKD Patients|Longitudinal Efficacy and Safety Study of Tolvaptan on Autosomal Dominant Polycystic Kidney Disease Patients (LET-PKD Study)|Recruiting||N/A|100|Anticipated|Kyorin University||1|||f||||t|f|f||||||No||2017-10-10 22:19:58.946296|2017-10-10 22:19:58.946296
NCT02729649|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-04-25|||January 2016||2016-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||ArmAssist Robotic Device for Arm Training||Completed||Phase 1/Phase 2|90|Actual|University of Belgrade||3|||f||||t||||||||||2017-10-10 22:19:59.054963|2017-10-10 22:19:59.054963
NCT02729636|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-04-25|||March 2016||2016-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Multi-pad FES System for Drop Foot Treatment||Recruiting||Early Phase 1|30|Anticipated|University of Belgrade||2|||f||||t||||||||||2017-10-10 22:19:59.150294|2017-10-10 22:19:59.150294
NCT02729623|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-07-22|||August 2016||2016-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|||The Pharmacokinetics, Safety, and Ease of Use of a Portable Metered-Dose Cannabis Inhaler|The Pharmacokinetics, Safety, and Ease of Use of a Portable Metered-Dose Cannabis Inhaler: A Phase 1a Study|Enrolling by invitation||Phase 1|12|Anticipated|Kite Systems||4|||f||||f||||||||Undecided||2017-10-10 22:19:59.238832|2017-10-10 22:19:59.238832
NCT02729610|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-31|||March 2016||2016-03-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Bronchial Blocker for One-lung Ventilation in Cardiac Surgery|The Use of Bronchial Blocker Versus Double Lumen Tube for One-lung Ventilation During Thoracoscope Assisted Mitral Valve Replacement|Not yet recruiting||Phase 4|58|Anticipated|Xijing Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:19:59.322869|2017-10-10 22:19:59.322869
NCT02729597|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-05|||May 2007||2007-05-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Observational|||Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study|Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study|Completed||N/A|49|Actual|University Hospital, Bonn|||3||f||||f||||||||Undecided||2017-10-10 22:19:59.422486|2017-10-10 22:19:59.422486
NCT02729584|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-31|||April 2013||2013-04-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Observational|||Gene Polymorphism of Taste Receptors and Circulating Endocannabinoids in Normal Weight and Obese Subjects||Completed||N/A|110|Actual|University of Cagliari|||2||f||||f||||||||No||2017-10-10 22:19:59.525197|2017-10-10 22:19:59.525197
NCT02729571|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-26|||September 2015||2015-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|MTBVAC-Ph1b||Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults|A Randomized, Double-blind, Dose-escalation Clinical Trial of the Safety, Reactogenicity and Immunogenicity of MTBVAC Compared to BCG Vaccine SSI, in Newborns Living in a Tuberculosis Endemic Region With a Safety Arm in Adults|Active, not recruiting||Phase 1/Phase 2|54|Anticipated|Biofabri, S.L||4|||f||||t||||||||Undecided||2017-10-10 22:19:59.585264|2017-10-10 22:19:59.585264
NCT02729558|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-04-08|||May 2015||2015-05-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Local Radiotherapy Following Complete Resection of a Brain Metastasis|Postoperative Local Stereotactic Radiotherapy Versus Observation Following a Complete Resection of a Single Brain Metastasis|Recruiting||Phase 3|70|Anticipated|VU University Medical Center||2|||f||||f||||||||No||2017-10-10 22:19:59.665831|2017-10-10 22:19:59.665831
NCT02729545|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-03-31|||January 2016||2016-01-01|March 2016|2016-03-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||The Efficacy and Safety Study of Acupuncture for Polycystic Ovarian Syndrome|The Efficacy and Safety Study of Dong's Extra-point Acupuncture for Improving Ovarian Function of Polycystic Ovarian Syndrome: a Randomised Controlled Trial|Active, not recruiting||Phase 2|60|Anticipated|Beijing Hospital of Integrated Traditional Chinese and Western Medicine||2|||f||||t||||||||Yes|to share data by publishing paper|2017-10-10 22:19:59.757001|2017-10-10 22:19:59.757001
NCT02729532|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-13|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Observational|||Effect of Xpert MTB/RIF on Patient Outcomes|Z 31411 - The Effect of Xpert MTB/RIF on Patient Health Outcomes and Empirical TB Treatment Among Persons Living With HIV/AIDS: A Parallel-Group Prospective Cohort Study Under Real-World Conditions in Lusaka, Zambia|Active, not recruiting||N/A|892|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-10 22:19:59.864509|2017-10-10 22:19:59.864509
NCT02729519|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-07-15|||June 2016||2016-06-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|December 2017|Anticipated|2017-12-01||Interventional|DIRECTAVI||TAVI Without Balloon Predilatation (of the Aortic Valve ) SAPIEN 3|Implantation of the Transcatheter Aortic Prosthesis SAPIEN 3 With or Without Prior Balloon Predilatation|Recruiting||N/A|240|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||Undecided||2017-10-10 22:19:59.985676|2017-10-10 22:19:59.985676
NCT02729506|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-04-05|||January 2016||2016-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma|Transarterial Radioembolization Versus Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma|Recruiting||Phase 4|150|Anticipated|King Faisal Specialist Hospital & Research Center||2|||f||||t||||||||Undecided||2017-10-10 22:20:00.076373|2017-10-10 22:20:00.076373
NCT02729493|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-03-13|||November 14, 2015|Actual|2015-11-14|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|EECLC||Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer|Single Arm,Two Phase,Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Liver Cancer|Recruiting||N/A|25|Anticipated|Sinobioway Cell Therapy Co., Ltd.||1|||f||||t||||||||No|No plans to share data.|2017-10-10 22:20:00.188353|2017-10-10 22:20:00.188353
NCT02729480|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-06-06|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Trial of Wireless CranioFacial Nerve Stimulation (CFNS) for the Treatment of CranioFacial Neuropathic Pain|Multi-center, Prospective, Controlled, Clinical Trial of Wireless CranioFacial Nerve Stimulation (CFNS) for the Treatment of CranioFacial Neuropathic Pain|Recruiting||N/A|65|Anticipated|StimRelieve, LLC||2|||f||||t|f|t|t|f||||Yes|De-identified participant data for all primary endpoints will be made available within 6 months of study completion.|2017-10-10 22:20:00.294376|2017-10-10 22:20:00.294376
NCT02729467|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-08-17|||March 2016||2016-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adults|An Open-Label Fixed-Sequence Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adult Subjects|Completed||Phase 1|33|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 22:20:00.418648|2017-10-10 22:20:00.418648
NCT02729454|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2016-09-27|||October 2015||2015-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Mental Practice in Parkinson's Disease|Effects of Mental Practice on the March and the Risk of Falls in People With Parkinson's Disease|Completed||N/A|18|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||No||2017-10-10 22:20:00.513004|2017-10-10 22:20:00.513004
NCT02729441|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-03-31|||April 2010||2010-04-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|ENDURE||Perindopril vs Ramipril for Persistence in MAU Reduction Study|Perindopril vs Ramipril for Persistence in MAU Reduction Study|Completed||Phase 3|23|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 22:20:00.592292|2017-10-10 22:20:00.592292
NCT02729428|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-07-19|||April 2016||2016-04-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||MRI Biomarkers and Exercise|MRI Biomarkers of Risk in Sedentary and Exercise Trained Humans|Recruiting||Early Phase 1|60|Anticipated|University of Wisconsin, Madison|||3||f||||f||||||||No||2017-10-10 22:20:00.675247|2017-10-10 22:20:00.675247
NCT02729415|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-07|||October 2016||2016-10-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|ASVF-2016||Point-of-Care Adipose-derived Cells for Hair Growth|Point-of-Care Adipose-derived Cells for Hair Growth|Recruiting||Early Phase 1|8|Anticipated|University of Florida||1|||f||||f|f|f||||||Undecided||2017-10-10 22:20:00.794523|2017-10-10 22:20:00.794523
NCT02729402|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-05-30|||November 2015||2015-11-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults|Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults|Enrolling by invitation||N/A|150|Anticipated|University of Utah||1|||f||||t||||||||No||2017-10-10 22:20:00.900495|2017-10-10 22:20:00.900495
NCT02729389|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-05-26|||June 2016||2016-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Influence of Monopoly Game on Subtle Behaviors|Influence of Monopoly Game on Subtle Behaviors|Recruiting||N/A|225|Anticipated|University of Florida||2|||f||||f||||||||No||2017-10-10 22:20:00.985791|2017-10-10 22:20:00.985791
NCT02729376|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-04-25|||March 2016||2016-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone|An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone in Healthy Male Subjects After Oral Administration|Completed||Phase 1|6|Actual|Novus Therapeutics, Inc||1|||f||||f||||||||No||2017-10-10 22:20:01.129183|2017-10-10 22:20:01.129183
NCT02729363|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-02-06|||April 2016||2016-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Feasibility of the PAINReportIt Guided Relaxation Intervention-Outpatient|The Feasibility of the PAINReportIt Guided Relaxation Intervention for Pain and Stress Symptoms in Adult Outpatients With Sickle Cell Disease|Recruiting||N/A|40|Anticipated|University of Florida||2|||f||||f||||||||No||2017-10-10 22:20:03.467963|2017-10-10 22:20:03.467963
NCT02729350|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-10-04|||April 2016||2016-04-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Feasibility of the PAINReportIt Guided Relaxation Intervention-INPATIENT|The Feasibility of the PAINReportIt Guided Relaxation Intervention for Pain and Stress in Adult Inpatients With Sickle Cell Disease|Recruiting||N/A|40|Anticipated|University of Florida||2|||f||||f||||||||No||2017-10-10 22:20:03.553095|2017-10-10 22:20:03.553095
NCT02729337|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-08-22|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Affecting the Epidemiology of HIV in Uganda|Affecting the Epidemiology of HIV in Uganda Through Older Adolescents|Not yet recruiting||N/A|200|Anticipated|Center for Innovative Public Health Research||2|||f||||f|f|f||||||||2017-10-10 22:20:03.654864|2017-10-10 22:20:03.654864
NCT02729324|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-05|||April 2016||2016-04-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT|Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT: A Single-center, Randomized Controlled Trial|Not yet recruiting||Phase 2|136|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:20:03.736641|2017-10-10 22:20:03.736641
NCT02729311|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-07-24|||July 2016||2016-07-01|July 2016|2016-07-01||||December 2018|Anticipated|2018-12-01||Interventional|Paired PLIÉ||Paired Integrative Exercise Program for People With Dementia and Caregivers|Paired Integrative Exercise Program for People With Dementia and Caregivers|Recruiting||N/A|120|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 22:20:03.825369|2017-10-10 22:20:03.825369
NCT02729298|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-10-02|||December 14, 2016|Actual|2016-12-14|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors|A Phase I, First-in-human, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-0903 Administered Daily for 21 Days to Patients With Advanced Solid Tumors|Recruiting||Phase 1|46|Anticipated|Tolero Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:20:03.923929|2017-10-10 22:20:03.923929
NCT02729285|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-09-20|||July 2014||2014-07-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Preoperative Ketorolac for Pain Control in Scleral Buckle Surgery|Preoperative Ketorolac for Intraoperative and Postoperative Pain Management in Scleral Buckling Surgery Under Retrobulbar Block Anesthesia: A Prospective, Randomized, Controlled Study|Completed||Phase 4|73|Actual|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 22:20:04.024509|2017-10-10 22:20:04.024509
NCT02729272|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-05-09|||April 2016||2016-04-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|ULMOST||Ultrasonic Versus Monopolar Energy-based Surgical Device in Colpotomy|Ultrasonic Versus Monopolar Energy-based Surgical Device in Colpotomy During Total Laparoscopic Hysterectomy in Terms of Surgical Smoke and Lateral Thermal Damage: a Randomized Controlled Trial (ULMOST Trial)|Recruiting||Phase 3|40|Anticipated|Kangbuk Samsung Hospital||2|||f||||f||||||||No||2017-10-10 22:20:04.665007|2017-10-10 22:20:04.665007
NCT02729259|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-08-30|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|H2OWC||H2O VR for Burns 2015|Water Friendly Virtual Reality for Burns|Recruiting||N/A|200|Anticipated|National Institute of General Medical Sciences (NIGMS)||3|||f||||f||||||||||2017-10-10 22:20:04.763898|2017-10-10 22:20:04.763898
NCT02729246|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-10-26|||October 2014||2014-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|Bariglykos||Bariatric Surgery for the Treatment of Type 2 Diabetes - Clinical Effects and Underlying Mechanisms|Bariatric Surgery for the Treatment of Type 2 Diabetes - Clinical Effects and Underlying Mechanisms|Recruiting||N/A|36|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-10 22:20:04.991081|2017-10-10 22:20:04.991081
NCT02729233|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01||||March 2020|Anticipated|2020-03-01||Interventional|||Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction|Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction|Not yet recruiting||N/A|30|Anticipated|University of Arkansas||1|||f||||f||||||||No||2017-10-10 22:20:05.110811|2017-10-10 22:20:05.110811
NCT02729220|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-04-05|||January 2012||2012-01-01|March 2016|2016-03-01||||December 2014|Actual|2014-12-01||Interventional|KOLIN||Respiratory and Cardiovascular Effects in COPD|Respiratory and Cardiovascular Effects in COPD - Report From a Bronchoscopy Investigation Based on the Obstructive Lung Disease In the Northern Sweden (OLIN) Studies|Completed||N/A|52|Actual|University Hospital, Umeå||4|||f||||f||||||||||2017-10-10 22:20:05.194005|2017-10-10 22:20:05.194005
NCT02729207|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-03-31|||June 2016||2016-06-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain|A Phase II, Randomized, Double-blind, Placebo Controlled, Proof of Concept Study to Investigate the Safety and Efficacy of the Esflurbiprofen Hydrogel Patch in Treatment of Acute Pain Associated With Ankle Injury|Not yet recruiting||Phase 2|||Teikoku Seiyaku Co., Ltd.||2|||||||t||||||||No||2017-10-10 22:20:05.317868|2017-10-10 22:20:05.317868
NCT02729194|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-28|||June 2016||2016-06-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma|Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma|Recruiting||Early Phase 1|16|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 22:20:05.447026|2017-10-10 22:20:05.447026
NCT02729181|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-05|||February 2014||2014-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Observational|||Assessment of Activities of Daily Living in Adults With Chronic Low Back Pain Using a Nonoperative Treatment Modality|Assessment of Activities of Daily Living in Adults With Chronic Low Back Pain Using a Nonoperative Treatment Modality: A Retrospective Study|Completed||N/A|116|Actual|Integrity Life Sciences|||1||f||||||||||||||2017-10-10 22:20:05.548318|2017-10-10 22:20:05.548318
NCT02729168|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-03-31|||October 2015||2015-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly|A Bridging Study to Evaluate Safety of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 5 Years Old|Completed||N/A|120|Actual|Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products||1|||f||||f||||||||Undecided||2017-10-10 22:20:05.614565|2017-10-10 22:20:05.614565
NCT02729155|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-03-31|||October 2015||2015-10-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Single-cycle Remote Ischemic Preconditioning and Postconditioning for Prevention of Contrast-Induced Nephropathy (SCRIP-CIN) Trial|Efficacy of Single-cycle Remote Ischemic Pre/Post-conditioning, for Prevention of Contrast-induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Coronary Angiography or Coronary Angioplasty at Phramongkutklao Hospital and Thammasat Hospital|Recruiting||Phase 3|596|Anticipated|Phramongkutklao College of Medicine and Hospital||4|||f||||f||||||||Yes||2017-10-10 22:20:05.730958|2017-10-10 22:20:05.730958
NCT02729142|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-09-30|||June 2016||2016-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRANSOS||Bone Microarchitecture in the Transplant Patient|Longitudinal Monitoring of Bone Microarchitecture by High Resolution Peripheral Quantitative Computed Tomography of (HR-pQCT) in the Transplant Patient|Recruiting||N/A|124|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:20:05.861868|2017-10-10 22:20:05.861868
NCT02729129|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-06|||April 2014||2014-04-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|FM-RADIO||Face Masks to Reduce the Adverse Effects of Diesel Exhaust Inhalation|Face Masks to Reduce the Adverse Effects of Diesel Exhaust Inhalation|Completed||N/A|22|Actual|Umeå University||2|||f||||f||||||||||2017-10-10 22:20:05.970947|2017-10-10 22:20:05.970947
NCT02729116|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-08-15|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients||Active, not recruiting||Phase 2/Phase 3|30|Anticipated|Khon Kaen University||2|||f||||f||||||||||2017-10-10 22:20:06.053094|2017-10-10 22:20:06.053094
NCT02729103|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-05|||October 31, 2016|Actual|2016-10-31|April 2017|2017-04-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Observational|||Treatment Patterns in Metastatic Prostate Cancer|Treatment Patterns, Mortality, Healthcare Resource Utilization, and Costs in Patients With Prostate Cancer With Bone Metastases: A Retrospective Database Analysis .|Completed||N/A|565|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:20:06.148292|2017-10-10 22:20:06.148292
NCT02729090|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-31|||May 2015||2015-05-01|March 2016|2016-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects of Exercise in the Functional Capacity, Central Artery and Rigidity Ankle Brachial Index|Effects of Combined Force Training Aerobic Versus Aerobic in the Functional Capacity, Central Artery and Rigidity Ankle Brachial Index in Patients With Peripheral Artery Disease|Recruiting||N/A|70|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:20:06.240585|2017-10-10 22:20:06.240585
NCT02729077|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-18|||July 2016||2016-07-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Risk Factors for Post-Operative Respiratory Complications in Patients at Risk for OSA|PERIOPERATIVE RISK FACTORS FOR POSTOPERATIVE RESPIRATORY COMPLICATIONS IN PATIENTS AT RISK FOR OBSTRUCTIVE SLEEP APNEA|Enrolling by invitation||N/A|324|Anticipated|Ohio State University|||2||f||||f||||||||||2017-10-10 22:20:06.336908|2017-10-10 22:20:06.336908
NCT02729064|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-09-01|||September 2016||2016-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose|Effect of Intranasal Insulin Administration on Glycaemia and Insulin Concentrations in Plasma and Cerebrospinal Fluid During Surgery|Recruiting||Phase 1|69|Anticipated|McGill University Health Center||3|||f||||f||||||||No||2017-10-10 22:20:06.410263|2017-10-10 22:20:06.410263
NCT02729051|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-11|||June 29, 2016|Actual|2016-06-29|September 2017|2017-09-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|||Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Phase IIIB, 24-week Randomised, Double-blind Study to Compare 'Closed' Triple Therapy (FF/UMEC/VI) With 'Open' Triple Therapy (FF/VI + UMEC), in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|1058|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:20:06.533659|2017-10-10 22:20:06.533659
NCT02729038|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-07-09|||June 29, 2016|Actual|2016-06-29|July 2017|2017-07-01|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Interventional|||Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function|A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function|Completed||Phase 1|31|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-10 22:20:06.984802|2017-10-10 22:20:06.984802
NCT02729012|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-01-11|||October 2015||2015-10-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|RinASol||Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study|Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With Allergic Rhinitis. RinASol- Pilot Study (Allergic Rhinitis Solution)|Completed||Phase 4|30|Actual|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy||2|||f||||f||||||||No||2017-10-10 22:20:07.252778|2017-10-10 22:20:07.252778
NCT02728999|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-01-24|||June 2013||2013-06-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Does Less Trendelenburg Make a Difference in Robotic Assisted Gynecological Procedures?|Does Less Trendelenburg Make a Difference in Robotic Assisted Gynecological Procedures?|Terminated||N/A|22|Actual|Advocate Health Care||2||Did not want to expose additional subjects to Arterial Line placement|f||||t||||||||Yes|Manuscript and conference presentation|2017-10-10 22:20:07.37543|2017-10-10 22:20:07.37543
NCT02728986|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-03-31|||January 2016||2016-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|EPIC||Cost Evaluation of Venous Leg Ulcers Management|Comparative and Prospective Evaluation of Direct Cost of Venous Leg Ulcers Management With Two Compression Systems|Recruiting||N/A|180|Anticipated|3M||2|||f||||f||||||||Undecided||2017-10-10 22:20:07.476894|2017-10-10 22:20:07.476894
NCT02728973|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-03-31|||February 2016||2016-02-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||ERAS Protocol on the Incidence of Postoperative Complications Following Intestinal Surgery|Effects of Enhanced Recovery After Surgery (ERAS) Protocol on the Incidence of Postoperative Complications Following Intestinal Surgery|Recruiting||N/A|200|Anticipated|First Affiliated Hospital of Chongqing Medical University|||2||f||||f||||||||Undecided||2017-10-10 22:20:07.577265|2017-10-10 22:20:07.577265
NCT02728960|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-03-20|||February 2015||2015-02-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Traumatic Brain Injury Biological Diagnosis Via High Definition Tractography Asymmetry Screening|TBI Biological Diagnosis Via High Definition Tractography Asymmetry Screening|Recruiting||N/A|140|Anticipated|New York University School of Medicine||3|||f||||f||||||||||2017-10-10 22:20:07.676999|2017-10-10 22:20:07.676999
NCT02728947|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-12-02|||May 2016||2016-05-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease|A Single Group and Open-label Study to Evaluate Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease|Completed||Phase 1|28|Actual|Luye Pharma Group Ltd.||4|||f||||f||||||||No||2017-10-10 22:20:07.775851|2017-10-10 22:20:07.775851
NCT02728934|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-18|||February 16, 2016|Actual|2016-02-16|April 2017|2017-04-01|February 25, 2021|Anticipated|2021-02-25|February 25, 2021|Anticipated|2021-02-25|3 Years|Observational [Patient Registry]|AWARE||Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis|Comparative and Pragmatic Study of Simponi Aria Versus Remicade in Rheumatoid Arthritis|Recruiting||N/A|1200|Anticipated|Janssen Scientific Affairs, LLC|||2||f||||f|f|||||||||2017-10-10 22:20:07.888841|2017-10-10 22:20:07.888841
NCT02728921|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-18|||April 2014||2014-04-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|AIR||The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery|The Importance of Albumin Infusion Rate for Plasma Volume Expansion. AIR. A Phase III Assessor Blinded Parallel Group Randomized Study|Completed||Phase 4|70|Actual|Region Skane||2|||f||||f||||||||Yes|The data collected in the current study will be available from the corresponding author on reasonable request.|2017-10-10 22:20:08.219041|2017-10-10 22:20:08.219041
NCT02728908|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-01-19|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Detecting Traumatic Intracranial Hemorrhage With Microwave Technology|Detecting Traumatic Intracranial Hemorrhage With Microwave Technology - An Open Study Evaluating the Diagnostic Accuracy of a Microwave-based Device to Detect Traumatic Intracranial Hemorrhage (TICH), by Comparing Measurements on Trauma Patients With Confirmed vs Excluded TICH|Recruiting||N/A|250|Anticipated|Sahlgrenska University Hospital, Sweden||1|||f||||f||||||||No||2017-10-10 22:20:08.320423|2017-10-10 22:20:08.320423
NCT02728895|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-11|||April 8, 2016|Actual|2016-04-08|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Dose Finding Study of Vedolizumab for Graft-Versus-Host Disease (GvHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|An Open-Label, Dose-Finding Study of Vedolizumab IV Plus Standard of Care for Graft-Versus-Host Disease (GvHD) Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|Recruiting||Phase 1|36|Anticipated|Takeda||3|||f||||f|t|f||||||||2017-10-10 22:20:08.410774|2017-10-10 22:20:08.410774
NCT02728882|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-03-21|||July 2, 2015|Actual|2015-07-02|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|EECBL||Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma|Single Arm, Two Phase, Multicenter Clinical Trial to Evaluating the Efficacy and Safety of the CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma|Recruiting||N/A|24|Anticipated|Sinobioway Cell Therapy Co., Ltd.||1|||f||||f|f|f||||||No|No plans to share data.|2017-10-10 22:20:08.501099|2017-10-10 22:20:08.501099
NCT02728869|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-08-16|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|HSRV||Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants|A Randomized Phase I/II Study to Evaluate Safety & Reactogenicity of Heat Stable Rotavirus Vaccine, in Healthy Adult; Followed by Evaluation of the Safety, Reactogenicity & Immunogenicity of a 3-dose Series in Infants Age 6-8 Weeks|Completed||Phase 1/Phase 2|100|Actual|MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd.||4|||f||||t||||||||||2017-10-10 22:20:08.575905|2017-10-10 22:20:08.575905
NCT02728856|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-03-30|||February 27, 2016|Actual|2016-02-27|March 2017|2017-03-01|February 27, 2016|Actual|2016-02-27|February 27, 2016|Actual|2016-02-27||Interventional|||Evaluation of the Irritation Potential of Products in Human Eyes.|Evaluation of the Irritation Potential of Products in Human Eyes|Completed||N/A|48|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:20:08.663975|2017-10-10 22:20:08.663975
NCT02728843|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-10-02|||July 2016||2016-07-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|SKY||Study of Parkinson's Early Stage With Deferiprone|A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease|Recruiting||Phase 2|140|Anticipated|ApoPharma||5|||f||||t||||||||||2017-10-10 22:20:08.892495|2017-10-10 22:20:08.892495
NCT02728466|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-06-21|||October 2014||2014-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Cocoa Procyanidins on Vascular Function|Investigation on the Effects of Cocoa Procyanidins on Vascular Function in Healthy Individuals|Completed||N/A|45|Actual|Heinrich-Heine University, Duesseldorf||3|||f||||f||||||||No||2017-10-10 22:20:15.5031|2017-10-10 22:20:15.5031
NCT02728830|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-03-11|||June 2016||2016-06-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers|A Pilot Study Investigating the Effect of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers of Mullerian Origin|Recruiting||Early Phase 1|15|Anticipated|Duke University||1|||f||||f||||||||No||2017-10-10 22:20:09.085072|2017-10-10 22:20:09.085072
NCT02728817|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-02-03|||February 2017|Anticipated|2017-02-01|February 2017|2017-02-01|March 2021|Anticipated|2021-03-01|February 2021|Anticipated|2021-02-01||Interventional|RADAR||Evaluation of the Radial Artery Deviation And Reimplantation Technique for Primary Hemodialysis Access Creation|Evaluation of the Radial Artery Deviation And Reimplantation Technique for Primary Hemodialysis Access Creation: a Multicenter Randomized Controlled Trial|Not yet recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f|f|f||||||No||2017-10-10 22:20:09.200157|2017-10-10 22:20:09.200157
NCT02728804|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-07-12|||April 2016||2016-04-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||S1417 CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer|Implementation of a Prospective Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer|Recruiting||N/A|374|Anticipated|Southwest Oncology Group|||1||f||||t||||||||||2017-10-10 22:20:09.477131|2017-10-10 22:20:09.477131
NCT02728791|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-06-12|||May 10, 2016|Actual|2016-05-10|June 2017|2017-06-01|December 10, 2017|Anticipated|2017-12-10|December 10, 2017|Anticipated|2017-12-10||Observational|CONDUCT||Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution|Comparaison de Mesure de débit Cardiaque Entre système Clearsight® et Thermodilution Transpulmonaire.|Recruiting||N/A|40|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 22:20:11.926345|2017-10-10 22:20:11.926345
NCT02728778|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2016-09-27|||September 2016||2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|August 2017|Anticipated|2017-08-01||Interventional|BTX-BPD||Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)|Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)|Recruiting||Phase 2|54|Anticipated|Hannover Medical School||2|||f||||f||||||||Undecided||2017-10-10 22:20:12.020778|2017-10-10 22:20:12.020778
NCT02728765|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-08-07|||July 5, 2016|Actual|2016-07-05|August 2017|2017-08-01|January 30, 2019|Anticipated|2019-01-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease|Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease|Recruiting||N/A|120|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:20:12.134041|2017-10-10 22:20:12.134041
NCT02728752|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-09-11|||February 27, 2017|Actual|2017-02-27|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|IIM||Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)|"Prospective, Double-blind, Randomized, Placebo-Controlled Phase III Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (ProDERM Study)"|Recruiting||Phase 3|94|Anticipated|Octapharma||2|||f||||t|t|f||||||||2017-10-10 22:20:12.223583|2017-10-10 22:20:12.223583
NCT02728739|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-02-13|||May 2016||2016-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MRAHF||Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients|Incidence of Significant Mitral Regurgitation in Patients Presenting With Acute Heart Failure: Journey to Tertiary Centre|Recruiting||N/A|500|Anticipated|Metanoic Health Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:20:12.344152|2017-10-10 22:20:12.344152
NCT02728726|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-08-15|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sugammadex vs Placebo to Prevent Residual Neuromuscular Block|Randomized Double--‐Blinded, Controlled Trial to Compare the Effectiveness of Sugammadex vs. Placebo to Prevent Residual Neuromuscular Block in the Post--‐Anesthesia Care Unit as Evaluated With a Non--‐Invasive Respiratory Volume Monitor|Enrolling by invitation||Phase 4|300|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:20:12.429455|2017-10-10 22:20:12.429455
NCT02728713|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-03-30|||August 2003||2003-08-01|March 2016|2016-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effect of Osteopathic Cranial Manipulative Medicine on Visual Function|Effect of Osteopathic Cranial Manipulative Medicine on Visual Function|Completed||N/A|113|Actual|Nova Southeastern University||2|||f||||||||||||||2017-10-10 22:20:12.496947|2017-10-10 22:20:12.496947
NCT02728700|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-05-24|||February 2016||2016-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT|Pilot Safety and Feasibility Trial of Mycophenolate and Sirolimus for Prevention of GVHD in Mismatched Unrelated and Related Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies|Recruiting||Phase 1/Phase 2|9|Anticipated|Stanford University||1|||f||||||||||||||2017-10-10 22:20:12.580095|2017-10-10 22:20:12.580095
NCT02728687|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-05-01|||March 15, 2017|Actual|2017-03-15|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy|A Double Blind, Randomized Crossover Study of Efficacy and Safety of Topical Menthol, With and Without Mannitol, in the Treatment of Painful Diabetic Peripheral Neuropathy|Recruiting||Phase 1/Phase 2|90|Anticipated|University of British Columbia||2|||f||||f|f|f|||f|||Yes|Age, sex, pain medications used, brief pain inventory pain interference and pain severity scores (BPI), DN4 (neuropathy questionnaire), % effectiveness and side effects of cream.|2017-10-10 22:20:12.76768|2017-10-10 22:20:12.76768
NCT02728674|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-08-23|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Management of Patients With Respiratory Symptoms in Sweden|Management of Patients With Respiratory Symptoms in Sweden|Completed||N/A|134|Actual|Skane University Hospital||4|||f||||f||||||||||2017-10-10 22:20:12.873154|2017-10-10 22:20:12.873154
NCT02728661|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-09-01|||May 2016||2016-05-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|PACE||Patient-Centered Weight Loss Program for Knee Replacement Patients|Patient-Centered Weight Loss Program for Knee Replacement Patients|Completed||Phase 1/Phase 2|16|Actual|Northwestern University||2|||f||||t||||||||||2017-10-10 22:20:12.967157|2017-10-10 22:20:12.967157
NCT02728648|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-03-30|||April 2016||2016-04-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Population Pharmacokinetic-Pharmacodynamic Study of Intravenous Oxycodone in Children|Population Pharmacokinetic-Pharmacodynamic Study of Intravenous Oxycodone in Children|Not yet recruiting||Phase 4|80|Anticipated|University of Malaya||1|||f||||f||||||||Undecided||2017-10-10 22:20:13.053206|2017-10-10 22:20:13.053206
NCT02728635|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-01-12|||April 2016||2016-04-01|January 2017|2017-01-01||||December 2020|Anticipated|2020-12-01||Interventional|Eiffel 2||Epigenetic Regulation of Human Adipose Tissue Distribution|Epigenetic Regulation of Human Adipose Tissue Distribution|Recruiting||Phase 1|27|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida||3|||f||||t||||||||No||2017-10-10 22:20:13.125899|2017-10-10 22:20:13.125899
NCT02728622|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-04-04|||March 2002||2002-03-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|||Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane|A Randomized Study of Chemotherapy Versus Hormonal Treatment in Patients With Ovarian Cancer Resistant or Refractory to Platinum and Taxane|Completed||Phase 3|241|Actual|Nordic Society for Gynaecologic Oncology||2|||f||||f||||||||No||2017-10-10 22:20:13.346117|2017-10-10 22:20:13.346117
NCT02728609|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-04|||March 2010||2010-03-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Observational|||An Analysis of Cytokine Concentration in Open Abdominal Closure of Trauma Patients|An Analysis of Cytokine Concentration in Open Abdominal Closure of Trauma Patients|Completed||N/A|40|Actual|University of Tennessee|||2||f||||f||||||None Retained|"     peritoneal fluid and blood samples   "|No||2017-10-10 22:20:13.479942|2017-10-10 22:20:13.479942
NCT02728596|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-07-12|||October 2016||2016-10-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|TrACER||S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)|A Pragmatic Trial to Evaluate a Guideline-Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as a Prophylaxis for Patients Receiving Chemotherapy With Intermediate Risk for Febrile Neutropenia - Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)|Recruiting||N/A|3960|Anticipated|Southwest Oncology Group||4|||f||||t||||||||||2017-10-10 22:20:13.612516|2017-10-10 22:20:13.612516
NCT02728583|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-01-18|||April 2016||2016-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||The Effects of a Spread With Added Plant Sterols and Omega-3 Fatty Acids on Blood Lipids|The Effects of a Low-fat Spread With Added Plant Sterol Esters and Fish Omega-3 Fatty Acids on Blood Lipids|Completed||N/A|260|Actual|Unilever R&D||2|||f||||f||||||||No||2017-10-10 22:20:14.353739|2017-10-10 22:20:14.353739
NCT02728570|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-14|||November 2013||2013-11-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Dietary Flavonoids on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome|Effect of Dietary Flavonoids on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome|Completed||N/A|30|Actual|Utah State University||2|||f||||f||||||||Yes|De-identified individual data will be deposited into a public repository as the data are published.|2017-10-10 22:20:14.446026|2017-10-10 22:20:14.446026
NCT02728557|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-05-12|||March 2016||2016-03-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|SSETD||Supportive and Supportive-Expressive Treatment for Depression|The Roles of the Therapeutic Alliance in Understanding the Effects of Attachment Orientations on Outcome in Psychotherapy|Recruiting||Phase 3|100|Anticipated|University of Haifa||2|||f||||||||||||||2017-10-10 22:20:14.547185|2017-10-10 22:20:14.547185
NCT02728544|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-04-04|||April 2016||2016-04-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|||Post Exercise Irisin Levels in PWS Patients|Post Exercise Irisin Levels in PWS Patients|Not yet recruiting||N/A|32|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||No||2017-10-10 22:20:14.639304|2017-10-10 22:20:14.639304
NCT02728531|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-02-02|||April 18, 2016||2016-04-18|February 2017|2017-02-01|April 30, 2023|Anticipated|2023-04-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma|A Pilot Study of Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma|Recruiting||Phase 1|15|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||No||2017-10-10 22:20:14.944275|2017-10-10 22:20:14.944275
NCT02728505|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-03-10|||April 12, 2016|Actual|2016-04-12|March 2017|2017-03-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|SinuSurf||SinuSurf vs. Saline Solution in Normal Subjects|Tolerability and Safety of Two Weeks of Twice-Daily Low-Concentration Sinusurf Sinus Irrigation Solution vs. Saline Solution in Normal Subjects|Completed||Phase 1|40|Actual|Vanderbilt University Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 22:20:15.150413|2017-10-10 22:20:15.150413
NCT02728492|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-05-02|||August 2013||2013-08-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy|Open-label Multicenter Multiple Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Gemcitabine + Cisplatin Chemotherapy (Second Line for Patients With Non-small Cell Lung Cancer) or Paclitaxel + Carboplatin Chemotherapy (Second Line for Patients With Non-small-cell Lung Cancer, Second and Subsequent Lines for Patients With Epithelial Ovarian Cancer)|Completed||Phase 1|51|Actual|NewVac LLC||7|||f||||t||||||||No|Final results will be published|2017-10-10 22:20:15.239421|2017-10-10 22:20:15.239421
NCT02728479|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-10-19|||January 2014||2014-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|12 Months|Observational [Patient Registry]|||Percutaneous Transluminal Angioplasty Registry|PTA Registry - an Observational Study of Percutaneous Transluminal Angioplasty|Recruiting||N/A|1000|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-10 22:20:15.374964|2017-10-10 22:20:15.374964
NCT02728453|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-20|||May 2016||2016-05-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|EMPATROPHY||SGLT2 Inhibition and Left Ventricular Mass|SGLT2 Inhibition With Empagliflozin in Patients With Type 2 Diabetes Mellitus: Influences on Left Ventricular Mass, Function, and Cardiac Lipid Content|Recruiting||Phase 4|60|Anticipated|Hannover Medical School||2|||f||||f||||||||||2017-10-10 22:20:15.628546|2017-10-10 22:20:15.628546
NCT02728440|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-11|||May 2010||2010-05-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism|Lipid Profile and Oxidative Stress Parameters of Patients With Idiopathic Hypogonadotropic Hypogonadism and the Change of These Parameters With Gonadotropin Replacement Therapy|Completed||N/A|30|Actual|Gulhane School of Medicine|||1||f||||t||||||||No||2017-10-10 22:20:15.76201|2017-10-10 22:20:15.76201
NCT02728427|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-30|||April 2016||2016-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|MSSPC||Multicenter Study on Suprapubic Catheterization Versus Transurethral Catheterization in Laparoscopic Surgery for Rectal Cancer|Multicenter Study on Comparing Suprapubic Catheterization Versus Traditional Transurethral Catheterization in Laparoscopic Surgery for Rectal Cancer|Recruiting||N/A|120|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-10 22:20:15.83793|2017-10-10 22:20:15.83793
NCT02728414|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-03-09|||October 2015||2015-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Type 2 Diabetes|Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Type 2 Diabetes: a Randomized, Double-blind Controlled Trial|Recruiting||N/A|100|Anticipated|Shanghai 10th People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:20:16.133072|2017-10-10 22:20:16.133072
NCT02728401|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-10-03|||December 2013||2013-12-01|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|GAPPSS||Genotypes and Phenotypes in Pediatric SIRS and Sepsis|Genotypes and Phenotypes in Pediatric SIRS and Sepsis (GAPPSS)|Recruiting||N/A|100|Anticipated|Seattle Children's Hospital|||3||f||||f||||||Samples With DNA|"     Type 1: whole blood (2.5 mL) collected daily into PAXgene Blood RNA tube (PreAnalytiX, Ref #     7621650). Type 2: whole blood (1 mL) collected daily into serum separation tube (BD     Vacutainer SST™ Tube with Silica Clot Activator, Polymer Gel, Silicone-Coated Interior, Ref #     367983). Type 3: whole blood (1 mL) collected on day 1 into lavender top Vacutainer (BD     Vacutainer, lavender top, K2 EDTA 7.2mg, Ref # 367861).   "|||2017-10-10 22:20:16.280774|2017-10-10 22:20:16.280774
NCT02728388|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-08-10|||August 2016||2016-08-01|August 2017|2017-08-01|August 2023|Anticipated|2023-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Photodynamic Therapy for Benign Dermal Neurofibromas|Topical Photodynamic Therapy (PDT) With Levulan® Kerastick® for Benign Dermal Neurofibromas Phase II|Recruiting||Phase 2|30|Anticipated|Medical College of Wisconsin||1|||f||||f||||||||||2017-10-10 22:20:16.389783|2017-10-10 22:20:16.389783
NCT02728375|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-04|||April 2016||2016-04-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Game-Based Rehabilitation Platform for Children With Neurodevelopmental Disorders and Acquired Brain Injuries|Innovative Game-Based Rehabilitation Platform for Children With Motor and Cognitive Impairments Due to Neuro-developmental Disorders and Acquired Brain Injuries|Not yet recruiting||N/A|60|Anticipated|University of Manitoba||2|||f||||t||||||||Undecided||2017-10-10 22:20:16.485151|2017-10-10 22:20:16.485151
NCT02728362|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-04-13|||April 2016||2016-04-01|April 2017|2017-04-01|April 2028|Anticipated|2028-04-01|April 2028|Anticipated|2028-04-01||Observational|||Suprapatellar Nailing of Tibial Shaft Fractures|Suprapatellar Nailing of Tibial Shaft Fractures: Long Term Follow Up|Enrolling by invitation||N/A|100|Anticipated|Spectrum Health Hospitals|||1||f||||f||||||||No||2017-10-10 22:20:16.58917|2017-10-10 22:20:16.58917
NCT02728349|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-10-12|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma|Phase 1 Trial of Tolerance and Pharmacokinetic of Chlorogenic Acid for Injection in the Advanced Glioblastoma Patients|Recruiting||Phase 1|30|Anticipated|Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd||1|||f||||f||||||||No||2017-10-10 22:20:16.654703|2017-10-10 22:20:16.654703
NCT02728323|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-04|||October 2013||2013-10-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Transversus Abdominis Plane Block in the Management of Acute Postoperative Pain Syndrome After Caesarean Section|Ultrasound-guided Transversus Abdominis Plane Block in the Management of Acute Postoperative Pain Syndrome After Caesarean Section: a Double-blind Randomized Controlled Clinical Trial|Terminated||Phase 3|96|Actual|San Salvatore Hospital of L'Aquila||2||Terminated|f||||t||||||||Yes|Data are available by Ethical Commitee request|2017-10-10 22:20:16.859298|2017-10-10 22:20:16.859298
NCT02728310|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-10-05|||September 2012||2012-09-01|October 2017|2017-10-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Local Continuous Wound Infusion of Anesthetics in the Management of Post-operative Pain After Total Hip Arthroplasty.|Local Continuous Wound Infusion and Local Infusion of Anaesthetics in the Management of Post-operative Pain and Rehabilitation After Total Hip Arthroplasty: a Double-blind Randomized Controlled Clinical Trial|Terminated||Phase 3|96|Actual|San Salvatore Hospital of L'Aquila||2||Terminated|f||||t||||||||||2017-10-10 22:20:16.949945|2017-10-10 22:20:16.949945
NCT02728297|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-04|||January 2010||2010-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Staged Extended Thoracoscopic Sympathicotomy for Palmo-axillo-plantar Hyperhidrosis|Staged Extended Thoracoscopic Sympathicotomy for Palmo-axillo-plantar Hyperhidrosis; a Pilot Study|Completed||N/A|42|Actual|Mansoura University||1|||f||||t||||||||No||2017-10-10 22:20:17.061552|2017-10-10 22:20:17.061552
NCT02728284|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-11-18|||December 2015||2015-12-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of Cardiac Function With Cardio-respiratory Synchronized MRI|Evaluation of Cardiac Function With Cardio-respiratory Synchronized MRI|Recruiting||N/A|100|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 22:20:17.141172|2017-10-10 22:20:17.141172
NCT02728271|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-07-28|||April 2016|Actual|2016-04-01|March 2016|2016-03-01|August 20, 2016|Actual|2016-08-20|July 22, 2016|Actual|2016-07-22||Interventional|||Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome|A Pilot Study of Immuno-ablation With Chemoimmunoradiation Followed by Autologous Hematopoietic Progenitor Cell (HPC) Transplant for Adult Subjects With Churg-Strauss Syndrome|Terminated||Early Phase 1|1|Actual|University of Pittsburgh||1||PI left the institution|f||||f||||||||||2017-10-10 22:20:17.232377|2017-10-10 22:20:17.232377
NCT02728258|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-22|||September 16, 2016|Actual|2016-09-16|August 2017|2017-08-01||||June 30, 2020|Anticipated|2020-06-30||Interventional|||Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer|A Phase II Evaluation of Copanlisib (BAY 80-6946), a Selective Inhibitor of PI3KCA, in Patients With Persistent or Recurrent Endometrial Carcinoma Harboring PIK3CA Hotspot Mutations|Suspended||Phase 2|84|Anticipated|NRG Oncology||1||Scheduled Interim Monitoring|f||||f||||||||||2017-10-10 22:20:17.322999|2017-10-10 22:20:17.322999
NCT02728245|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-03-30|||April 2016||2016-04-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|DOROSY||Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma|Randomized Phase 2 Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma|Not yet recruiting||Phase 2|72|Anticipated|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 22:20:17.570109|2017-10-10 22:20:17.570109
NCT02728232|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-04-14|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Internal Iliac Artery Ligation and Abnormally Invasive Placenta||Completed||N/A|50|Actual|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 22:20:17.675165|2017-10-10 22:20:17.675165
NCT02728219|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-30|||May 2012||2012-05-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|HCCTACEAFP||Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion|A Prospective Randomized Trial Comparing Treatment of Recurrent HCC With Repeat Hepatectomy,and Transcatheter Arterial Chemoembolization (TACE) With AFP Conversion|Completed||N/A|150|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 22:20:17.75543|2017-10-10 22:20:17.75543
NCT02728206|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-18|||June 12, 2016|Actual|2016-06-12|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation|A Phase 2, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir Fixed Dose Combination Administered for Four Weeks in Patients Infected With Chronic HCV in the Peri-Operative Liver Transplantation Setting|Recruiting||Phase 2|10|Anticipated|Gilead Sciences||1|||f||||t|t|f|||t|||||2017-10-10 22:20:17.850144|2017-10-10 22:20:17.850144
NCT02728193|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-30|||December 2012||2012-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Standard Treatments of Very-early Stage Hepatocellular Carcinoma|The Research on Standard Treatments of Very-early Stage Hepatocellular Carcinoma: a Randomized Clinical Trial|Completed||N/A|300|Actual|Eastern Hepatobiliary Surgery Hospital||3|||f||||t||||||||||2017-10-10 22:20:17.935929|2017-10-10 22:20:17.935929
NCT02728180|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-09-11|||March 2016||2016-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|XMAS||Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS)|Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS): A Multicenter, Prospective, Randomized, Open-label, Blinded Endpoint Clinical Trial.|Recruiting||Phase 4|720|Anticipated|Dongzhimen Hospital, Beijing||2|||f||||t||||||||||2017-10-10 22:20:18.013535|2017-10-10 22:20:18.013535
NCT02728167|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-30|||April 2016||2016-04-01|March 2016|2016-03-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|HIFU-AR||Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy|Randomized, Open-label, Phase II Study to Evaluate the Efficacy of High-Intensity Focused Ultrasound Assisted Hepatic Resection (HIFU-AR) on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy|Not yet recruiting||N/A|50|Anticipated|Centre Leon Berard||2|||f||||t||||||||No||2017-10-10 22:20:18.133957|2017-10-10 22:20:18.133957
NCT02728154|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-12-14|||October 2016||2016-10-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|October 2019|Anticipated|2019-10-01||Observational|||The Role of Gut Microbiota in Heart Failure and Pre-Heart Failure With Preserved Ejection Fraction|Characterize the Gut Microbiota in Subjects With Heart Failure and Pre-heart Failure With Preserved Ejection Fraction|Recruiting||N/A|220|Anticipated|University of Florida|||3||f||||f||||||Samples With DNA|"     Blood and stool samples   "|Undecided||2017-10-10 22:20:18.215194|2017-10-10 22:20:18.215194
NCT02728141|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-03-30|||November 2009||2009-11-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Healthy Infant Development Project - Sucrose Component|Timing, Duration and Severity of Infant Iron Deficiency: Developmental Impacts - Sucrose Component|Completed||N/A|424|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||Yes|On request after main findings are published.|2017-10-10 22:20:18.340488|2017-10-10 22:20:18.340488
NCT02728128|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-10-19|||August 2016||2016-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children||Recruiting||N/A|70|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     Plasma and urine samples will be retained for future studies once initial analyses have been     performed.   "|No||2017-10-10 22:20:18.616194|2017-10-10 22:20:18.616194
NCT02728115|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|February 2023|Anticipated|2023-02-01|October 2022|Anticipated|2022-10-01||Interventional|SAVE-DH||Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease|First in Human Study to Evaluate Safety of Cellavita HD Investigational Product After Intravenous Application in Participants With Huntington's Disease|Not yet recruiting||Phase 1|6|Anticipated|Azidus Brasil||2|||f||||t|f|f||||||||2017-10-10 22:20:18.733046|2017-10-10 22:20:18.733046
NCT02728102|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-30|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)|Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma With or Without Vaccination With Dendritic Cell/Myeloma Fusions (BMT CTN #1401)|Recruiting||Phase 2|188|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||t||||||||||2017-10-10 22:20:18.849104|2017-10-10 22:20:18.849104
NCT02728089|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-09-19|||April 14, 2016|Actual|2016-04-14|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|September 5, 2017|Actual|2017-09-05||Interventional|||Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)|A Multicenter, Open-label, Noncomparative, Japanese Phase III Study to Assess the Efficacy and Safety of Ceftolozane/Tazobactam (MK-7625A) in Japanese Patients With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection|Completed||Phase 3|115|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 22:20:19.039828|2017-10-10 22:20:19.039828
NCT02728076|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-06-12|||July 2016||2016-07-01|June 2017|2017-06-01|December 2024|Anticipated|2024-12-01|December 2021|Anticipated|2021-12-01||Interventional|||MRI-Based Preoperative Accelerated Partial Breast Irradiation|Phase II Study of MRI-Based Preoperative Accelerated Partial Breast Irradiation|Recruiting||Phase 2|40|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||No||2017-10-10 22:20:19.119871|2017-10-10 22:20:19.119871
NCT02728063|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-06-23|||March 2016||2016-03-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|PILATE||Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance|Effect of a Mixture of Probiotics, Lactibiane Tolérance® on Intestinal Permeability in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance|Recruiting||Phase 4|30|Anticipated|Pileje||1|||f||||f||||||||No||2017-10-10 22:20:19.239177|2017-10-10 22:20:19.239177
NCT02728037|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-10-05|||April 2016||2016-04-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain|Randomized Control Trial of Magnesium-Based Trigger Point Injections vs. Lidocaine-Only Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain|Recruiting||Phase 3|90|Anticipated|Queen's University||3|||f||||f||||||||||2017-10-10 22:20:19.547121|2017-10-10 22:20:19.547121
NCT02728024|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-26|||March 2014||2014-03-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Observational|ERASMUS||Assessing Psychosocial and Supportive Care Needs in Patients With Gliomas|Assessing Psychosocial and Supportive Care Needs in Patients With Gliomas|Completed||N/A|175|Actual|Johannes Gutenberg University Mainz|||2||f||||f||||||||No||2017-10-10 22:20:19.767174|2017-10-10 22:20:19.767174
NCT02728011|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-04|||October 2010||2010-10-01|March 2016|2016-03-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Pilot Trial Comparing Computerised Cognitive Exercises to Tetris in Adolescents With ADHD|A Double-Blind Randomized Pilot Trial Comparing Computerised Cognitive Exercises to Tetris in Adolescents With Attention-Deficit/Hyperactivity Disorder|Completed||N/A|18|Actual|Region Syddanmark||2|||f||||t||||||||Yes||2017-10-10 22:20:19.851204|2017-10-10 22:20:19.851204
NCT02727998|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-12-07|||December 2015||2015-12-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|PTSD||Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy|Combining Neurobiology and New Learning: Ketamine and Prolonged Exposure: A Potential Rapid Treatment for Post Traumatic Stress Disorder (PTSD)|Recruiting||Phase 2|40|Anticipated|Yale University||2|||f||||f||||||||No|Data from the initial stage of the investigation will be used to establish support for a Phase 3 RCT.|2017-10-10 22:20:19.950156|2017-10-10 22:20:19.950156
NCT02727985|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-10-12|||March 2016||2016-03-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|REDUCE||Opioid Reduction Following Spinal Cord Stimulation|Opioid Reduction Following Spinal Cord Stimulation: A Comparison of Two Protocols, Effect on Patient Quality of Life and Cost-Impact to the Healthcare System|Recruiting||Phase 4|120|Anticipated|Regina Qu'Appelle Health Region||2|||f||||f||||||||Undecided||2017-10-10 22:20:20.062185|2017-10-10 22:20:20.062185
NCT02727972|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-12-01|||August 2011||2011-08-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Examination of Glutamate and mGluR5 in Psychiatric Disorders|Examination of Glutamate and mGluR5 in Psychiatric Disorders|Recruiting||N/A|180|Anticipated|Yale University||3|||f||||f||||||||No||2017-10-10 22:20:20.160837|2017-10-10 22:20:20.160837
NCT02727959|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-18|||January 2017||2017-01-01|September 2017|2017-09-01|December 2030|Anticipated|2030-12-01|December 2019|Anticipated|2019-12-01||Observational|IBSENIII||Inflammatory Bowel Disease in South Eastern Norway|Inflammatory Bowel Disease in South Eastern Norway (IBSEN III). Clinical Epidemiology, Diagnostic and Prognostic Factors in Inflammatory Bowel Disease.|Recruiting||N/A|2000|Anticipated|Oslo University Hospital|||2||f||||f||||||||||2017-10-10 22:20:20.267755|2017-10-10 22:20:20.267755
NCT02727946|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-09-17|||May 2016||2016-05-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Tissue Perfusion Indices as Predictor of Outcome in Poly Trauma Patients|Central Venous-arterial Carbon Dioxide Pressure Difference in Correlation to Dynamic Changes of Serum Lactate as an Indicator of Tissue Perfusion in Polytruama Patients|Recruiting||N/A|40|Anticipated|Assiut University||1|||f||||t||||||||No||2017-10-10 22:20:20.346432|2017-10-10 22:20:20.346432
NCT02727920|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2017-03-01|||March 2016||2016-03-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effects of Energy Drinks|A Test of the Effects of Energy Drinks|Completed||N/A|228|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||No||2017-10-10 22:20:20.532505|2017-10-10 22:20:20.532505
NCT02727907|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-07-22|||July 2014||2014-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis|International, Multicenter, Double-blinded, Placebo-controlled, Randomized Study of the Efficacy and Safety of Drugs BCD-033 and Rebif for the Treatment of Patients With Relapsing-remitting Multiple Sclerosis|Active, not recruiting||Phase 2/Phase 3|147|Anticipated|Biocad||3|||f||||f||||||||||2017-10-10 22:20:20.614988|2017-10-10 22:20:20.614988
NCT02727881|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-04-25|||April 12, 2016|Actual|2016-04-12|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MAKO||Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD|OHR-1601: A Phase III Study of the Efficacy and Safety of Squalamine Lactate Ophthalmic Solution, 0.2% Twice Daily in Subjects With Neovascular Age-Related Macular Degeneration (AMD)|Active, not recruiting||Phase 3|230|Actual|Ohr Pharmaceutical Inc.||2|||f||||t||||||||No||2017-10-10 22:20:20.812164|2017-10-10 22:20:20.812164
NCT02727868|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-03-30|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PIG-A||Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans|Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans|Recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||Undecided||2017-10-10 22:20:21.135559|2017-10-10 22:20:21.135559
NCT02727855|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2017-08-18|||January 2016||2016-01-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|CVIS||Cholera Vaccine Investment Strategy in Bangladesh|Targeted Vaccination of Children in Urban Slums Against Cholera: Evaluation of a Potentially Cost-effective and Impactful Strategy for Deploying Oral Cholera Vaccine in Bangladesh|Active, not recruiting||N/A|75170|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh|||1||f||||t||||||Samples Without DNA|"     Specimens will be preserved for 5 years for future use.   "|||2017-10-10 22:20:21.225983|2017-10-10 22:20:21.225983
NCT02726750|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-10-03|||December 2015||2015-12-01|October 2016|2016-10-01||||December 2021|Anticipated|2021-12-01||Observational|||Prospective Observational Study of Clinical and Genomic Predictors of Progression to Myeloma in Asymptomatic Monoclonal Gammopathies|Prospective Observational Study of Clinical and Genomic Predictors of Progression to Myeloma in Asymptomatic Monoclonal Gammopathies|Recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||Samples With DNA|"     Blood (about 1-2 tablespoons) collected for biomarker testing every 6 months for 3 years.   "|||2017-10-10 22:20:21.311916|2017-10-10 22:20:21.311916
NCT02726737|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-01|||December 2014||2014-12-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Sodium Bicarbonate Buccal Infiltration on the Success of Inferior Alveolar Nerve Block|Effect of Sodium Bicarbonate Buccal Infiltration on the Success of Inferior Alveolar Nerve Block in the Mandibular First Molar With Symptomatic Irreversible Pulpitis: a Prospective, Randomized Double-blind Study|Completed||Phase 3|100|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||No||2017-10-10 22:20:21.396671|2017-10-10 22:20:21.396671
NCT02726724|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-04-01|||October 2015||2015-10-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Does the Presence of Observers Influence the Success of the Neonatal Endotracheal Intubation?|Does the Presence of Observers Influence the Success of the Neonatal Endotracheal Intubation?|Recruiting||N/A|51|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||t||||||||Yes||2017-10-10 22:20:21.4824|2017-10-10 22:20:21.4824
NCT02726711|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-01-13|||April 2016||2016-04-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic|Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Aim 1 of Rare Diseases Clinical Research Network (RDCRN) Project 2|Recruiting||Phase 1|32|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 22:20:21.567728|2017-10-10 22:20:21.567728
NCT02726698|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-10-19|||July 2016||2016-07-01|July 2016|2016-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|RACE V||Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation|Reappraisal of Atrial Fibrillation: Interaction Between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation - An Observational Exploratory Study on Pathophysiological Mechanisms of AF Progression and on the Role of LinQ/CareLink Guided Patient Tailored Therapy in Patients With Atrial Fibrillation|Recruiting||N/A|750|Anticipated|Maastricht University Medical Center|||1||f||||||||||||||2017-10-10 22:20:21.667221|2017-10-10 22:20:21.667221
NCT02726685|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effects of Respiratory Training on Respiratory and Functional Performance in Patients With Stroke|Effects of Respiratory Training on Respiratory and Functional Performance in Patients With Stroke|Not yet recruiting||N/A|70|Anticipated|Chung Shan Medical University||2|||f||||t||||||||Yes||2017-10-10 22:20:21.751134|2017-10-10 22:20:21.751134
NCT02727842|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-04|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:20:21.864078|2017-10-10 22:20:21.864078
NCT02727829|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-02-13|||May 1, 2016|Actual|2016-05-01|February 2017|2017-02-01|October 1, 2016|Actual|2016-10-01|October 1, 2016|Actual|2016-10-01||Observational|||The Assessment of Microcirculation in Brachial Plexus Block Using Perfusion Index and Capillary Filling Time|The Assessment of Microcirculation in Brachial Plexus Block Using Perfusion Index and Capillary Filling Time|Completed||N/A|50|Actual|Tokat Gaziosmanpasa University|||1||f||||t||||||||No||2017-10-10 22:20:21.898222|2017-10-10 22:20:21.898222
NCT02727803|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-09-26|||May 19, 2016|Actual|2016-05-19|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)|Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 22:20:22.032824|2017-10-10 22:20:22.032824
NCT02727790|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-06-06|||July 2014||2014-07-01|March 2016|2016-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Short Peripheral Electrical Stimulation (PES) on Blood Glucose|Effect of Short Peripheral Electrical Stimulation (PES) on Blood Glucose Lowering Action in Type 2 Diabetes Patients|Completed||N/A|12|Actual|Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-10-10 22:20:22.165549|2017-10-10 22:20:22.165549
NCT02727777|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-08-17|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Phase II Study of TAK228 in Relapsed Lymphoma|Phase II Study of TAK228 in Relapsed Lymphoma|Recruiting||Phase 1/Phase 2|75|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 22:20:22.229311|2017-10-10 22:20:22.229311
NCT02727764|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-06-27|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||ART-I02 in Patients With Rheumatoid Arthritis|A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Rheumatoid Arthritis|Recruiting||Phase 1|12|Anticipated|Arthrogen||3|||f||||t|f|f||||||No||2017-10-10 22:20:22.316633|2017-10-10 22:20:22.316633
NCT02727751|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-13|||March 2016||2016-03-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|T3MPO-3||A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C|An Open Label Long-Term Safety Study of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)|Recruiting||Phase 3|300|Anticipated|Ardelyx||1|||f||||f||||||||||2017-10-10 22:20:22.559771|2017-10-10 22:20:22.559771
NCT02727738|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-04-04|||January 2014||2014-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole|Randomized Open Clinical Study to Evaluate the Efficacy of Selenium Plus Methimazole for Treatment of Graves' Hyperthyroidism|Completed||N/A|30|Actual|University of Pisa||2|||f||||f||||||||No||2017-10-10 22:20:22.627725|2017-10-10 22:20:22.627725
NCT02727725|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-15|||January 2016||2016-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images|Establishing the Clinical Usefulness Of Dark Blood Late Gadolinium Enhancement Images For The Detection Of Small Subendocardial Left Ventricular Infarcts - An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images|Recruiting||N/A|80|Anticipated|Advocate Health Care||1|||f||||t||||||||Yes|Publication|2017-10-10 22:20:22.725017|2017-10-10 22:20:22.725017
NCT02727712|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-29|||April 2016||2016-04-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Studies of Application of Combined General Anesthesia and Bilateral TPVB in OPCABG|Studies of Application of Combined General Anesthesia and Bilateral Thoracic Paravertebral Block by Ropivacaine in Patients Undergoing Off-pump Coronary Artery Bridge Graft - a Random Double Blind Controlled Study|Not yet recruiting||Phase 4|60|Anticipated|Xiangya Hospital of Central South University||3|||f||||t||||||||Yes||2017-10-10 22:20:22.804198|2017-10-10 22:20:22.804198
NCT02727699|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-09-21|||March 23, 2017|Actual|2017-03-23|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|XanADu||A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)|XanADu: A Phase II, Double-Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to Alzheimer's Disease (AD)|Recruiting||Phase 2|174|Anticipated|Actinogen Medical||2|||f||||t|t|f||||||||2017-10-10 22:20:22.923361|2017-10-10 22:20:22.923361
NCT02727686|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-10-10|||April 2016||2016-04-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Post-Operative Water Load Following Transsphenoidal Pituitary Surgery|Post-Operative Water Load Following Transsphenoidal Pituitary Surgery|Recruiting||N/A|15|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||1|||f||||f||||||||No||2017-10-10 22:20:23.138916|2017-10-10 22:20:23.138916
NCT02727673|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-03-30|||December 2012||2012-12-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|||Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology|A Prospective Randomized Trial on the Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology|Completed||N/A|1000|Actual|Eastern Hepatobiliary Surgery Hospital|||3||f||||t||||||||||2017-10-10 22:20:23.323194|2017-10-10 22:20:23.323194
NCT02727660|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-10-21|||April 2016||2016-04-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)|A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD|Recruiting||Phase 3|2241|Anticipated|Pearl Therapeutics, Inc.||3|||f||||t||||||||||2017-10-10 22:20:23.412545|2017-10-10 22:20:23.412545
NCT02727647|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-01|||May 2015||2015-05-01|October 2015|2015-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients|Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients|Completed||Phase 4|16|Actual|Chulalongkorn University||2|||f||||f||||||||No||2017-10-10 22:20:23.715677|2017-10-10 22:20:23.715677
NCT02727634|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-11-28|||June 2016||2016-06-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Ultrapower; a Minimally Invasive Tool for Evaluation of Total Cardiac Power|Ultrapower, an In-house Developed System for Instantaneous Logging of Ultrasound Based Blood Flow, Blood Pressure and ECG.|Recruiting||N/A|30|Anticipated|Norwegian University of Science and Technology||1|||f||||f||||||||Undecided||2017-10-10 22:20:23.821381|2017-10-10 22:20:23.821381
NCT02727621|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-09-25|||April 2016||2016-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Dexmedetomidine Sedation and Cardiopulmonary Bypass|Dexmedetomidine Based Versus Propofol Based Anesthesia in Patients Undergoing Coronary Revascularization: a Randomized, Double-blind Controlled Study|Completed||Phase 2|100|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:20:23.924337|2017-10-10 22:20:23.924337
NCT02727608|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-18|||May 15, 2016|Actual|2016-05-15|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|ICC||Complement Inhibitor Eculizumab in Clinical Islet Transplantation|Induction With Complement Inhibitor Eculizumab in Clinical Islet Transplantation|Recruiting||Phase 2|10|Anticipated|Uppsala University||1|||f||||f||||||||No||2017-10-10 22:20:24.043508|2017-10-10 22:20:24.043508
NCT02727595|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-03-30|||April 2016||2016-04-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of CyclaPlex Implant for Correction of First Inter Metatarsal Angle in Subjects Suffering From Hallux Valgus Deformity||Not yet recruiting||N/A|5|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||No||2017-10-10 22:20:24.170168|2017-10-10 22:20:24.170168
NCT02727582|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-10-26|||July 2015||2015-07-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|July 2017|Anticipated|2017-07-01||Observational|PODrtb||Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment|Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment|Recruiting||N/A|142|Anticipated|University of Cape Town|||1||f||||f||||||||Yes|The investigators listed on the protocol comprise the study management group and are the custodians of the data generated from the study. All manuscripts arising from the data generated as a result of this study are to be approved by this group before submission for publication. Manuscripts arising from the trial will be submitted to peer-reviewed journals. In accordance with NIH public access policy the final peer-reviewed journal manuscripts will be submitted NIH Manuscript Submission System (NIHMS) upon acceptance for publication, and be made publicly available on PubMed Central no later than 12 months after the official date of publication. All presentations and publications will acknowledge the trial's funding sources. Authorship will follow the recommendations of the International Committee of Medical Journal Editors (ICMJE) and the study management group will resolve any problems of authorship and maintain the quality of publications|2017-10-10 22:20:24.267247|2017-10-10 22:20:24.267247
NCT02727569|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-29|||April 2016||2016-04-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|vFAST||Quantification of Agreement and Variability of a Newly Developed Visual Field Algorithm With the Reference Standard|Quantification of Agreement and Variability Characteristics of a Newly Developed Visual Field Algorithm With the Reference Standard: an Observational Study|Not yet recruiting||N/A|110|Anticipated|Moorfields Eye Hospital NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 22:20:24.364141|2017-10-10 22:20:24.364141
NCT02727556|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-05|||March 2016||2016-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Physiological Response and Visual Attention to Visual Food Images in Healthy Subjects and in Functional Dyspepsia Patients||Completed||N/A|30|Anticipated|University Hospital Tuebingen||2|||f||||||||||||||2017-10-10 22:20:24.454099|2017-10-10 22:20:24.454099
NCT02727543|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-01-17|||April 2016||2016-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|MedISAFE-BP||Medication Adherence Improvement Support App For Engagement - Blood Pressure|Medication Adherence Improvement Support App For Engagement - Blood Pressure|Completed||N/A|413|Actual|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 22:20:24.541704|2017-10-10 22:20:24.541704
NCT02727530|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-07-11|||April 2016||2016-04-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||The Effectiveness of the Manual Therapy on Infant Colic (MT-IF)|The Effects of Visceral Manual Therapy on Infant Colic Symptoms. A Controlled Clinical Trial|Completed||N/A|50|Actual|University of Seville||2|||f||||||||||||||2017-10-10 22:20:24.63451|2017-10-10 22:20:24.63451
NCT02727517|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-10-28|||April 2016||2016-04-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|NepCordIII||Early or Late Cord Clamping in the Depressed Neonate|Early or Late Cord Clamping in the Depressed Neonate - a Randomized Controlled Study in a Low-income Facility Setting for Improved Early Neonatal Outcome|Completed||N/A|90|Actual|Uppsala University||2|||f||||f||||||||No||2017-10-10 22:20:24.727573|2017-10-10 22:20:24.727573
NCT02727504|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-11-03|||May 2016||2016-05-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Observational|LOWAS||Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve|Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve|Recruiting||N/A|115|Anticipated|Rennes University Hospital|||1||f||||t||||||||No||2017-10-10 22:20:24.826841|2017-10-10 22:20:24.826841
NCT02727491|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-03-29|||March 2012||2012-03-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Does Pre and Postoperative Dextromethorphan Reduce Post-tonsillectomy Pain in Children?|A Prospective Randomized Double-blind Placebo Controlled Trial; Does Pre and Postoperative Dextromethorphan Reduce Post-tonsillectomy Pain in Children?|Completed||Phase 4|85|Actual|Queen's University||2|||f||||t||||||||No||2017-10-10 22:20:24.922531|2017-10-10 22:20:24.922531
NCT02727478|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-17|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|BETA-PD||Effectiveness and Implementation of the HiBalance Program in Clinical Practice|Highly Challenging Balance Training for People With Parkinson's Disease (the BETA-PD Study): Non-randomized Hybrid Effectiveness-implementation Trial|Recruiting||N/A|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:20:25.00416|2017-10-10 22:20:25.00416
NCT02727465|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-04-03|||March 2016||2016-03-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|Lock and Key||Host-pathogen Interactions in Meningococcal Disease: Finding the Key That Fits the Lock|Host-pathogen Interactions in Meningococcal Disease: Finding the Key That Fits the Lock|Withdrawn||N/A|0|Actual|Public Health England|||1||f||||f||||||Samples With DNA|"     DNA of bacteria and cases   "|No||2017-10-10 22:20:25.114121|2017-10-10 22:20:25.114121
NCT02727452|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Immediate Bonding and Caesarean Section|Effects of Immediate Bonding (Skin-to-skin Contact) During Caesarean Section- Psychobiological and Somatic Outcomes of Mother and Child|Not yet recruiting||N/A|360|Anticipated|Johann Wolfgang Goethe University Hospital||3|||f||||t||||||||||2017-10-10 22:20:25.181645|2017-10-10 22:20:25.181645
NCT02727439|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-29|||February 2016||2016-02-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Acute Exercise and Microvascular Function|Influence of Acute Exhausting Exercise on Microvascular Reactivity in Healthy Sedentary Subjects and Athletes|Recruiting||N/A|30|Anticipated|Josip Juraj Strossmayer University of Osijek||2|||f||||f||||||||No||2017-10-10 22:20:25.254385|2017-10-10 22:20:25.254385
NCT02727426|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-03|||February 2016||2016-02-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Dietary Salt and Microvascular Function|Influence of High Salt Diet on Microvascular Reactivity in Young Healthy Subjects|Recruiting||N/A|50|Anticipated|Josip Juraj Strossmayer University of Osijek||2|||f||||f||||||||No||2017-10-10 22:20:25.333108|2017-10-10 22:20:25.333108
NCT02727413|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-10-27|||June 2016||2016-06-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|Remove-Pilot||Inflammatory Mediator Profiles During Heart Valve Replacement Surgery|Inflammatory and Vasoactive Mediator Profiles and Pathogen Characterization During Heart Valve Replacement Surgery|Recruiting||N/A|120|Anticipated|Jena University Hospital|||2||f||||f||||||Samples Without DNA|"     Blood plasma   "|No||2017-10-10 22:20:25.418108|2017-10-10 22:20:25.418108
NCT02727400|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-08-30|||April 2016||2016-04-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|Mitenergy||Mitochondrial Energy Production in ART (Assisted Reproductive Technology )|Impact on Mitochondrial Energy Production in Different Patient Populations in Women Undergoing IVF-ICSI (in Vitro Fertilization-intracytoplasmic Sperm Injection)|Recruiting||N/A|60|Anticipated|IVI Madrid|||2||f||||f||||||Samples Without DNA|"     serum, follicular fluid and granulosa cells   "|No||2017-10-10 22:20:25.541959|2017-10-10 22:20:25.541959
NCT02727387|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-03-17|||May 2009||2009-05-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|EW-2||Protocol for the Treatment of Metastatic Ewing Sarcoma|Study With High Doses of Chemotherapy, Radiotherapy and Consolidation Therapy With Ciclofosfamide and Anticyclooxygenase 2, for the Metastatic Ewing Sarcoma|Recruiting||Phase 2|70|Anticipated|Italian Sarcoma Group||1|||f||||f||||||||No||2017-10-10 22:20:25.780125|2017-10-10 22:20:25.780125
NCT02727374|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-06-05|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FFALL_GER||Fear to Fall Reduction in Geriatric Patients Who Suffered Previous Falls|Fear to Fall Reduction in Geriatric Patients Who Suffered Previous Falls|Enrolling by invitation||N/A|52|Anticipated|University of Valencia||2|||f||||t||||||||Yes||2017-10-10 22:20:25.934741|2017-10-10 22:20:25.934741
NCT02727361|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-08-03|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|DYSCHOL||Role of the Striatal Cholinergic System in the Pathophysiology of Dystonia||Recruiting||N/A|40|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 22:20:26.032662|2017-10-10 22:20:26.032662
NCT02727348|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-03-29|||May 2014||2014-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Sciatic Nerve Blocks With or Without Femoral Block Versus Spinal Anaesthesia in Patients Undergoing Diabetic Foot Surgery|Haemodynamic and Pain Outcomes in Patients Undergoing Diabetic Foot Surgery Performed Under Sciatic Nerve Blocks With or Without Femoral Nerve Block Versus Spinal Anaesthesia|Completed||N/A|120|Actual|University of Malaya||2|||f||||f||||||||||2017-10-10 22:20:26.134811|2017-10-10 22:20:26.134811
NCT02727335|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-09-28|||May 2014||2014-05-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|CLINALK||Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements|Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements|Completed||N/A|318|Actual|Intergroupe Francophone de Cancerologie Thoracique|||1||f||||f||||||||||2017-10-10 22:20:26.217452|2017-10-10 22:20:26.217452
NCT02727322|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-09-26|||August 2016||2016-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery|A Randomized, Double-blind, Placebo-controlled Trial of Nitrofurantoin Prophylaxis During Catheterization for Acute Postoperative Urinary Retention After Pelvic Reconstructive Surgery|Recruiting||Phase 4|154|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:20:26.398871|2017-10-10 22:20:26.398871
NCT02727309|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-30|||October 2015||2015-10-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients|A Pilot Study of Second-line Treatment With Apatinib After Trans Arterial Chemoembolization (TACE) in Advanced Hepatocellular Carcinoma Patients|Recruiting||Phase 1/Phase 2|30|Anticipated|Beijing Cancer Hospital||1|||f||||||||||||||2017-10-10 22:20:26.495148|2017-10-10 22:20:26.495148
NCT02727296|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-04-01|||June 2016||2016-06-01|April 2016|2016-04-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|VAPOR-2||Volatile Anesthetic Protection Of Renal Transplants 2|Volatile Anesthetic Protection Of Renal Transplants 2|Not yet recruiting||N/A|520|Anticipated|University Medical Center Groningen||2|||f||||f||||||||No||2017-10-10 22:20:26.585967|2017-10-10 22:20:26.585967
NCT02727283|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-05-03|||November 26, 2015|Actual|2015-11-26|May 2017|2017-05-01|March 18, 2016|Actual|2016-03-18|March 18, 2016|Actual|2016-03-18||Interventional|||A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Ascending Dose Escalating, 4 Period Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of Single Doses of GSK3179106, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:20:26.665421|2017-10-10 22:20:26.665421
NCT02727270|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-11|||June 2016||2016-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CORT-PD||Measuring Cortisol Levels in Persons With Parkinson's (PD)|Measuring Cortisol Levels in Persons With Parkinson's (PD)|Recruiting||N/A|60|Anticipated|Oregon Health and Science University|||3||f||||f||||||||No||2017-10-10 22:20:26.786147|2017-10-10 22:20:26.786147
NCT02727257|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-07-28|||January 2015||2015-01-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of a Motor-cognitive Rehabilitation on Attention in Parkinsonian Patients|The Effect of a Motor-cognitive Rehabilitation on Attention in Parkinsonian Patients|Completed||N/A|103|Actual|Ospedale Generale Di Zona Moriggia-Pelascini||2|||f||||f||||||||No||2017-10-10 22:20:26.877935|2017-10-10 22:20:26.877935
NCT02727244|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-04-01|||April 2016||2016-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||The Association Between Pain Catastrophizing Scale Score and Postspinal Headache|Is There an Association Between Pain Catastrophizing Scale Score and Postspinal Headache in Patients Underwent Cesarean Section With Spinal Anesthesia?|Not yet recruiting||N/A|300|Anticipated|Tokat Gaziosmanpasa University|||1||f||||t||||||||No||2017-10-10 22:20:26.969525|2017-10-10 22:20:26.969525
NCT02727231|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-10-09|||March 2016||2016-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living Conditions|Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living Conditions|Completed||N/A|29|Actual|University of Cambridge||2|||f||||f||||||||||2017-10-10 22:20:27.041469|2017-10-10 22:20:27.041469
NCT02727218|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-04|||May 2016||2016-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Safety of Early Removal of Chest Tubes After Thoracoscopic Lung Biopsies|Effectiveness and Safety of Early Removal of Chest Tubes After Thoracoscopic Lung Resection and Biopsies ; a Prospective Randomized Controlled Study.|Not yet recruiting||N/A|60|Anticipated|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-10 22:20:27.135411|2017-10-10 22:20:27.135411
NCT02727205|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-29|||August 2013||2013-08-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch|A Multiple Site Study to Evaluate the Irritation and Sensitization Potential of Repeat Applications of Rotigotine Transdermal System, 1 mg/24 hr Versus Neupro (Rotigotine Transdermal System), 1 mg/24 hr in Healthy Volunteers|Completed||Phase 1|260|Actual|Inflamax Research Incorporated||1|||f||||f||||||||No||2017-10-10 22:20:27.211361|2017-10-10 22:20:27.211361
NCT02727192|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-10-31|||August 2015||2015-08-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Sleep Disordered Breathing in Patients With Paroxysmal Atrial Fibrillation|Sleep Disordered Breathing in Patients With Paroxysmal Atrial Fibrillation|Recruiting||N/A|120|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 22:20:29.034533|2017-10-10 22:20:29.034533
NCT02727179|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-29|||February 2005||2005-02-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|LapOpHuva||Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases|Prospective and Randomized Study Comparing Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases|Recruiting||N/A|200|Anticipated|Hospital Universitario Virgen de la Arrixaca||2|||f||||t||||||||No||2017-10-10 22:20:29.140893|2017-10-10 22:20:29.140893
NCT02727166|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-29|||November 2010||2010-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function|Efecto de Fructanos Paralelamente Hidrolizados Provenientes de Achicoria Sobre Las Sensaciones Abdominales|Completed||N/A|67|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||Undecided||2017-10-10 22:20:29.26176|2017-10-10 22:20:29.26176
NCT02727153|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-04-02|||January 2008||2008-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||"Ultra Enhanced Recovery After Surgery (E.R.A.S.) in Laparoscopic Colectomy for Cancer"|"Ultra Enhanced Recovery After Surgery (E.R.A.S.) in Laparoscopic Colectomy for Cancer: Discharge After the First Flatus? A Prospective, Randomized Trial"|Completed||Phase 3|765|Actual|AUSL Romagna Rimini||2|||f||||f||||||||Undecided||2017-10-10 22:20:29.342934|2017-10-10 22:20:29.342934
NCT02727140|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-05-02|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|||Yoga as a Supportive Therapy for Patients With Hypertension|Yoga as a Supportive Therapy for Patients With Hypertension: A Randomized Controlled Trial|Completed||N/A|75|Actual|Universität Duisburg-Essen||3|||f||||f||||||||No||2017-10-10 22:20:29.416953|2017-10-10 22:20:29.416953
NCT02727127|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-01-23|||September 2015||2015-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Brain Ion Homeostasis, Lithium and Bipolar Disorder|Brain Ion Homeostasis, Lithium and Bipolar Disorder|Recruiting||N/A|115|Anticipated|New York University School of Medicine|||2||f||||t||||||||No||2017-10-10 22:20:29.499599|2017-10-10 22:20:29.499599
NCT02727114|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-19|||February 2016||2016-02-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|PIDIC-1||Echographic Measurement of Skin Thickness in Children|Echographic Imaging Research to the Anatomical and Physiological Characteristics of the Skin in Children and Adolescents|Completed||N/A|259|Actual|Novosanis NV|||4||f||||f||||||||||2017-10-10 22:20:29.596767|2017-10-10 22:20:29.596767
NCT02727101|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-28|||November 2015||2015-11-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.|"Rational Polytherapy Using Perampanel Dual Therapy Anticonvulsant Combination Treatments of Adults With Refractory Focal Epilepsy : a Pilot Study."|Terminated||Phase 4|8|Actual|Mid-Atlantic Epilepsy and Sleep Center, LLC||12||slow enrollment|f||||f||||||||||2017-10-10 22:20:29.686941|2017-10-10 22:20:29.686941
NCT02727088|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-11-10|||September 2016||2016-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|PULPSAVE||Pulpotomy vs Pulpectomy Outcome.|Comparative Randomized Clinical Comparison of Pulp Chamber Pulpotomy and Root Canal Treatment (Pulpectomy) as a Permanent Endodontic Treatment of Mature Permanent Teeth: Analysis of Relationship Between Inflammation Biomarkers Pulpal Expression and Treatment Outcome|Recruiting||N/A|226|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 22:20:29.810476|2017-10-10 22:20:29.810476
NCT02727062|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-01-31|||January 2017||2017-01-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|June 2017|Anticipated|2017-06-01||Interventional|||Smartphone Pain App for Assessing Oral Mucositis Pain in Patients Receiving Head and Neck Radiation Therapy|Smartphone Pain App for Assessing Oral Mucositis Pain in Patients|Not yet recruiting||N/A|65|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||Undecided||2017-10-10 22:20:30.152512|2017-10-10 22:20:30.152512
NCT02727023|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-10-03|||December 2015|Actual|2015-12-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|August 2016|Actual|2016-08-01||Interventional|||Effect of OMM on Anandamide Levels in Saliva|Osteopathic Manipulative Lymphatic Pump Technique and Its Effects to the Endocannabinoid System Activity as Measured by AEA Levels Via Mass Spectrometry and Mood Analogue Scale|Completed||N/A|2|Actual|New York Institute of Technology||1|||f||||f|f|f||||||||2017-10-10 22:20:30.472043|2017-10-10 22:20:30.472043
NCT02727010|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-12-12|||November 2016||2016-11-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|MMOMA||Motherhood With MOtor Impairment Due to MAlady (Rare Disease)|Parenthood and Motherhood in Women With Motor Impairment and Disability Related to a Rare Disease|Recruiting||N/A|40|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||No||2017-10-10 22:20:30.559382|2017-10-10 22:20:30.559382
NCT02726997|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-09-19|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer|Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)|Recruiting||Phase 1/Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:20:30.67081|2017-10-10 22:20:30.67081
NCT02726984|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-06-01|||January 15, 2016|Actual|2016-01-15|June 2017|2017-06-01|February 15, 2018|Anticipated|2018-02-15|February 15, 2018|Anticipated|2018-02-15||Interventional|CARTIS||Carotid Plaque Assessment Using 18Fluorine (18F) -Sodium Fluoride Positron Emission Tomography (PET) /MR|Assessment of Symptomatic and Asymptomatic Carotid Plaques Using Hybrid Imaging 18F-sodium Fluoride PET/MR|Recruiting||N/A|15|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 22:20:30.817688|2017-10-10 22:20:30.817688
NCT02726971|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-04-06|2016-12-02||April 2016||2016-04-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion|A Prospective, Randomized, Controlled Trial Comparing 2 Different Doses of Estrogen Therapy After Hysteroscopic Adhesiolysis as an Adjuvant to Prevent Recurrence of Intrauterine Adhesions|Completed||Phase 1/Phase 2|141|Actual|Fu Xing Hospital, Capital Medical University||2|||f||||t||||||||Yes||2017-10-10 22:20:30.94799|2017-10-10 22:20:30.94799
NCT02726958|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-31|||March 2014||2014-03-01|August 2017|2017-08-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Observational|GLYTAVI||Early Postoperative Blood Glucose Variability and Outcome After TAVI|Early Postoperative Blood Glucose Variability and Outcome After TAVI : a Retrospective Single-centre Study|Completed||N/A|160|Actual|Centre Hospitalier Universitaire de Besancon|||2||f||||f||||||||||2017-10-10 22:20:31.32669|2017-10-10 22:20:31.32669
NCT02726945|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-10-03|||April 2016|Actual|2016-04-01|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Adipose-derived SVF for the Treatment of Knee OA|Use of Autologous Adipose-Derived Stromal Vascular Fraction to Treat Osteoarthritis of the Knee: A Controlled, Randomized, Double-Blinded Trial|Active, not recruiting||N/A|39|Actual|The GID Group||3|||f||||t||||||||||2017-10-10 22:20:31.442678|2017-10-10 22:20:31.442678
NCT02726932|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-09|||March 30, 2016|Actual|2016-03-30|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|March 2018|Anticipated|2018-03-01|90 Days|Observational [Patient Registry]|PERICLASS||Intra-abdominal View and Inflammatory Markers in Secondary Peritonitis - Correlation to Recovery|Intra-abdominal View and Inflammatory Markers in Secondary Peritonitis - Correlation to Recovery|Recruiting||N/A|300|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood sample   "|||2017-10-10 22:20:31.578336|2017-10-10 22:20:31.578336
NCT02726919|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-03-22|||February 2015||2015-02-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy|Prospective Open Label Evaluation of Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy: A Pilot Study|Recruiting||Phase 4|20|Anticipated|Mid-Atlantic Epilepsy and Sleep Center, LLC||1|||f||||f||||||||Undecided||2017-10-10 22:20:31.711991|2017-10-10 22:20:31.711991
NCT02726906|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-03-23|||July 2016||2016-07-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study|Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study|Recruiting||Phase 2|100|Anticipated|University of Southern California||2|||f||||f||||||||Undecided||2017-10-10 22:20:31.832576|2017-10-10 22:20:31.832576
NCT02726893|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-03-16|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||A Predictive Model for Inadequate Bowel Preparation Before Colonoscopy: Development and Validation|A Predictive Model for Inadequate Bowel Preparation Before Colonoscopy: Development and Validation|Completed||N/A|1504|Actual|Shandong University|||1||f||||t||||||||||2017-10-10 22:20:31.925528|2017-10-10 22:20:31.925528
NCT02726880|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-31|2017-06-23|||March 2016||2016-03-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Reducing Internet Gaming|Reducing Internet Gaming: A Pilot Psychotherapy Development Study|Recruiting||N/A|40|Anticipated|UConn Health||2|||f||||t||||||||No||2017-10-10 22:20:32.009892|2017-10-10 22:20:32.009892
NCT02726867|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-08-28|||February 2014||2014-02-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus|Evaluation of Efficacy and Safety of Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus|Withdrawn||Phase 3|0|Actual|Mid-Atlantic Epilepsy and Sleep Center, LLC||4||No participants enrolled|f||||f||||||||||2017-10-10 22:20:32.101224|2017-10-10 22:20:32.101224
NCT02726854|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-11-30|||April 2016||2016-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Apslpanc||Apatinib as Second-line Treatment of Advanced Pancreatic Cancer|Apatinib as Second-line Treatment of Advanced Pancreatic Cancer, Phase II Clinical Study of Open Arm|Recruiting||Phase 2|30|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||1|||f||||f||||||||Undecided||2017-10-10 22:20:32.192565|2017-10-10 22:20:32.192565
NCT02726841|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-09-12|||January 2013||2013-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Hybrid Treatment of Type B Aortic Dissection|Superiority Trial of Type b Aortic Dissection Treatment Combined With Implantation of Bare Metal Stent in Abdominal Part of Aorta Versus Conventional Type b Treatment|Enrolling by invitation||N/A|160|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 22:20:32.412158|2017-10-10 22:20:32.412158
NCT02726828|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-01-25|||October 2015||2015-10-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||intrathecaم Ketamine, Morphine and Both for Lower Abdominal Cancer Surgery Pain|Effects of Intrathecally Administered Ketamine, Morphine and Their Combination in Patients Undergoing Major Abdominal Cancer Surgery|Completed||Phase 2/Phase 3|90|Actual|Assiut University||3|||f||||t||||||||Undecided||2017-10-10 22:20:32.489392|2017-10-10 22:20:32.489392
NCT02726815|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Developing a Symptom List for Children With Cancer|Pain and Symptoms in Children With Advanced Cancer: a Longitudinal Study to Develop a Comprehensive Symptom Inventory|Recruiting||N/A|40|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||Yes|Plan to share internally at meetings as well as at conferences. Also plan to submit for publication in a peer reviewed journal.|2017-10-10 22:20:32.558848|2017-10-10 22:20:32.558848
NCT02726802|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-04|||January 2016||2016-01-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness of Two Different Entry Portal Pathways Into Primary Care for Musculoskeletal Injury|Effectiveness of Two Different Entry Portal Pathways Into Primary Care for Musculoskeletal Injury: A Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|102|Anticipated|Reynolds Army Community Hospital||2|||f||||||||||||||2017-10-10 22:20:32.62917|2017-10-10 22:20:32.62917
NCT02726789|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-02-06|||October 2012||2012-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B|Therapeutic Safety and Efficacy of Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B|Completed||Phase 2|5|Actual|Replicor Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:20:32.711811|2017-10-10 22:20:32.711811
NCT02726776|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-05|||September 2015||2015-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Suspension Syndrome|Suspension Syndrome|Completed||N/A|20|Actual|Institute of Mountain Emergency Medicine||2|||f||||f||||||||No||2017-10-10 22:20:32.834779|2017-10-10 22:20:32.834779
NCT02726763|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-09-21|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training|Pilot Study of Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training|Recruiting||N/A|16|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:20:32.946292|2017-10-10 22:20:32.946292
NCT02726672|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-23|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|August 2018|Anticipated|2018-08-01||Interventional|AIRSEP||Fatigue and Inspiratory Muscles Training in Patients With Multiple Sclerosis|Fatigue and Inspiratory Muscles Training Against Resistance in Patients With Multiple Sclerosis With Severe Disabilities|Recruiting||N/A|60|Anticipated|Lille Catholic University||2|||f||||f||||||||||2017-10-10 22:20:33.049216|2017-10-10 22:20:33.049216
NCT02726659|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-04|||May 2016||2016-05-01|April 2016|2016-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression|Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression: a Randomized, Double-blind, Placebo-controlled Trial|Not yet recruiting||Phase 3|56|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||Yes|A data sharing agreement will be in place between Lawson Health Research Institute and The National Institute for Mental Health Research.|2017-10-10 22:20:33.186101|2017-10-10 22:20:33.186101
NCT02726646|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-01-16|||June 2015||2015-06-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of Local Doxycycline in Smokers With Chronic Periodontitis|Evaluation of the Controlled Release System of Doxycycline in Periodontal Therapy in Smokers With Chronic Periodontitis.|Recruiting||Phase 2|40|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||Yes||2017-10-10 22:20:33.301138|2017-10-10 22:20:33.301138
NCT02726633|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-04-01|||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ProLung||Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer|Evaluate the Utility of the ProLung China Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer|Recruiting||N/A|500|Anticipated|Chinese Alliance Against Lung Cancer|||1||f||||t||||||||Undecided||2017-10-10 22:20:33.43785|2017-10-10 22:20:33.43785
NCT02726620|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Decision Support for Intraoperative Low Blood Pressure|Decision Support for Intraoperative Low Blood Pressure|Recruiting||N/A|16000|Anticipated|Vanderbilt University Medical Center||4|||f||||f||||||||No||2017-10-10 22:20:33.55532|2017-10-10 22:20:33.55532
NCT02726607|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-04-18|||August 2015||2015-08-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission|Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission|Enrolling by invitation||N/A|162|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||No||2017-10-10 22:20:33.925109|2017-10-10 22:20:33.925109
NCT02726594|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-01|||August 2015||2015-08-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Observational|||Evaluation of Patient Comfort and Image Quality in Magnetic Resonance Imaging|Evaluation of Patient Comfort and Image Quality in Magnetic Resonance Imaging|Recruiting||N/A|1000|Anticipated|University of Zurich|||2||f||||f||||||||No||2017-10-10 22:20:34.036498|2017-10-10 22:20:34.036498
NCT02726191|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-07-13|||January 2017||2017-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|July 2017|Actual|2017-07-01||Interventional|||Computerized Cognitive Training in Epilepsy|Computerized Cognitive Training in Epilepsy|Withdrawn||N/A|0|Actual|New York University School of Medicine||2||Study Lapsed|f||||f||||||||||2017-10-10 22:20:38.218175|2017-10-10 22:20:38.218175
NCT02726581|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-10-03|||April 21, 2016|Actual|2016-04-21|October 2017|2017-10-01|August 12, 2020|Anticipated|2020-08-12|November 12, 2018|Anticipated|2018-11-12||Interventional|CheckMate 602||An Investigational Immuno-therapy Study of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma|An Open-Label, Randomized Phase 3 Trial of Combinations of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma- CheckMate 602: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 602|Active, not recruiting||Phase 3|406|Anticipated|Bristol-Myers Squibb||3|||f||||t|t|f||||||||2017-10-10 22:20:34.151825|2017-10-10 22:20:34.151825
NCT02726568|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-03-31|||March 2016||2016-03-01|March 2016|2016-03-01||||March 2018|Anticipated|2018-03-01||Interventional|||High Dose Icotinib For NSCLC Patients Harboring EGFR Mutation With Brain Metastases|A Phase II Study to Determine the Efficacy and Safety of Icotinib For NSCLC Patients Harboring EGFR Mutation With Brain Metastases|Recruiting||Phase 2|30|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:20:34.631207|2017-10-10 22:20:34.631207
NCT02726555|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-10-31|||November 2015||2015-11-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin|Comparison Between Combined Therapy With Red Yeast Rice and Low-dose Statin and Standardized Statin: a Single-center, Non-inferiority, Randomized Clinical Trial|Recruiting||Phase 3|240|Anticipated|Wenzhou Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:20:34.748985|2017-10-10 22:20:34.748985
NCT02726542|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-08-28|||May 3, 2017|Actual|2017-05-03|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents|Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents|Recruiting||Early Phase 1|24|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||||2017-10-10 22:20:34.868586|2017-10-10 22:20:34.868586
NCT02726529|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-03-31|||August 2013||2013-08-01|March 2016|2016-03-01||||June 2015|Actual|2015-06-01||Interventional|Brighter Bites||Brighter Bites - Access, Continuity and Education With Fruits and Vegetables|Brighter Bites - Access, Continuity and Education With Fruits and Vegetables|Completed||N/A|710|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-10-10 22:20:34.966442|2017-10-10 22:20:34.966442
NCT02726516|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-11-30|||March 2016||2016-03-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Effects of PRJ-205 on Performance in Trained Young Subjects|Effects of PRJ-205 on Performance in Trained Young Subjects After Acute and Chronic Intake of the Study Product|Completed||N/A|20|Actual|Bioiberica||2|||f||||f||||||||Undecided||2017-10-10 22:20:35.094642|2017-10-10 22:20:35.094642
NCT02726503|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-06-01|||April 4, 2016|Actual|2016-04-04|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|HOPE||Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer|Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer (HOPE)|Recruiting||Phase 2|39|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||t||||||||||2017-10-10 22:20:35.211699|2017-10-10 22:20:35.211699
NCT02726490|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-11|||July 2016||2016-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|GGIG||Glyburide vs Glucovance in the Treatment of GDM|Glyburide vs Glucovance in the Treatment of Gestational Diabetes|Recruiting||N/A|134|Anticipated|Texas Tech University Health Sciences Center, El Paso||2|||f||||t||||||||No||2017-10-10 22:20:35.375653|2017-10-10 22:20:35.375653
NCT02726477|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-05-06|||April 2016||2016-04-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy and Safety of Wuling San on Breast Cancer-related Lymphedema|Efficacy and Safety of Wuling San on Breast Cancer-related Lymphedema|Recruiting||N/A|200|Anticipated|Fourth Affiliated Hospital of Guangxi Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:20:35.516575|2017-10-10 22:20:35.516575
NCT02726464|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-02-20|||March 2016||2016-03-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|March 2017|Anticipated|2017-03-01||Observational|PRiSM||Testing the Characteristics of Platelet Rich Plasma in Sports Medicine|Testing the Characteristics of Platelet Rich Plasma in Sports Medicine|Active, not recruiting||N/A|40|Actual|University of British Columbia|||1||f||||f||||||||Undecided||2017-10-10 22:20:35.675585|2017-10-10 22:20:35.675585
NCT02726451|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-02|||March 2016||2016-03-01|August 2017|2017-08-01|December 11, 2016|Actual|2016-12-11|November 7, 2016|Actual|2016-11-07||Interventional|||A Study to Examine the Effects of Cosmeceutical Therapy in Subjects Undergoing Full Facial Rejuvenation|A Post-Market, Randomized, Placebo-Controlled Study to Assess the Efficacy of Cosmeceutical Therapy in Subjects Undergoing Full Facial Rejuvenation|Completed||N/A|20|Actual|DeNova Research||2|||f||||f||||||||||2017-10-10 22:20:35.79143|2017-10-10 22:20:35.79143
NCT02726438|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-09-22|||April 2016||2016-04-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery|A Phase 1, Open-Label Pharmacokinetic Study to Investigate Drug Penetration in the Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery|Completed||Phase 1|17|Actual|Debiopharm International SA||2|||f||||f||||||||||2017-10-10 22:20:35.923556|2017-10-10 22:20:35.923556
NCT02726425|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-08-03|||July 2015||2015-07-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Women in Control: A Virtual World Study of Diabetes Self-Management|Women in Control: A Virtual World Study of Diabetes Self-Management. Translational Research to Improve Diabetes and Obesity Outcomes (R01)|Recruiting||N/A|228|Anticipated|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-10 22:20:36.036652|2017-10-10 22:20:36.036652
NCT02726412|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-04-25|||February 2016||2016-02-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||PACU Stay After Lower Limb Revascularisation|Perioperative Mechanisms for Postoperative Function - Case of Lower Extremities Revascularisation|Completed||N/A|156|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||Undecided||2017-10-10 22:20:36.195671|2017-10-10 22:20:36.195671
NCT02726399|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-07-17|||March 18, 2016|Actual|2016-03-18|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Ramucirumab With Trastuzumab and Capecitabine/Cisplatin in Patients With Metastatic HER2-Positive Gastroesophageal Junction and Gastric Cancer|Phase II Study of Ramucirumab With Trastuzumab and Capecitabine/Cisplatin in Patients With Metastatic HER2-Positive Gastroesophageal Junction and Gastric Cancer|Recruiting||Phase 2|37|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:20:36.291886|2017-10-10 22:20:36.291886
NCT02726386|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-08-29|||May 2016||2016-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||A Clinical Study Investigating Long Term Safety of ND0612, a Solution of Levodopa/Carbidopa Administered as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease|A Multicenter, International, Open-label, Safety Study of ND0612, a Solution of Levodopa/Carbidopa Delivered Via a Pump System as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease|Active, not recruiting||Phase 2|100|Anticipated|NeuroDerm Ltd.||2|||f||||t||||||||||2017-10-10 22:20:36.454806|2017-10-10 22:20:36.454806
NCT02726373|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2016-03-31|||January 2013||2013-01-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Intermittent vs. Continuous Walking in MS|The Effect of Intermittent vs. Continuous Walking Training on Walking Endurance and Fatigue in People With Multiple Sclerosis: a Randomized, Crossover Trial.|Completed||N/A|12|Actual|Hunter College of City University of New York||2|||f||||f||||||||No||2017-10-10 22:20:36.690715|2017-10-10 22:20:36.690715
NCT02726360|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-18|||December 14, 2015|Actual|2015-12-14|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Physician Use of Non-English Language Skills in Cancer Care|Physician Use of Non-English Language Skills in Cancer Care|Recruiting||N/A|24|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-10 22:20:36.778135|2017-10-10 22:20:36.778135
NCT02726347|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-09-12|||April 2016||2016-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pneumococcal Post-Vaccination Titers|Pneumococcal Post-Vaccination Titers|Recruiting||N/A|140|Anticipated|National Jewish Health||5|||f||||f||||||||||2017-10-10 22:20:36.943096|2017-10-10 22:20:36.943096
NCT02726334|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-02-23|||March 2016||2016-03-01|February 2017|2017-02-01||||April 2019|Anticipated|2019-04-01||Interventional|||A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.|A Phase I, Dose Escalation Study of BNC101 (Anti-LGR5 Humanized Monoclonal Antibody) in Patients With Metastatic Colorectal Cancer.|Recruiting||Phase 1|54|Anticipated|Bionomics Limited||2|||f||||t||||||||||2017-10-10 22:20:37.060902|2017-10-10 22:20:37.060902
NCT02726321|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-03-31|||September 2014||2014-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Observational|AtheroDetetect||Autonomic Testing in Subclinical Carotid Atherosclerosis|Early Detection of Subclinical Carotid Atherosclerosis Through Autonomic Testing|Completed||N/A|101|Actual|Universidade Camilo Castelo Branco|||1||f||||f||||||||No||2017-10-10 22:20:37.211173|2017-10-10 22:20:37.211173
NCT02726308|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-03-29|||May 2015||2015-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Dexamethasone With Super-hydration for Prevention of Postoperative Nausea and Vomiting|Dexamethasone Alone Versus in Combination With Intra-operative Super-hydration for Prevention of Postoperative Nausea and Vomiting in Female Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial|Completed||Phase 2|100|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:20:37.296091|2017-10-10 22:20:37.296091
NCT02726295|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-10-02|||September 2016|Actual|2016-09-01|October 2017|2017-10-01|October 2017|Actual|2017-10-01|October 2017|Actual|2017-10-01||Interventional|||The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study||Completed||Phase 4|112|Actual|Keimyung University Dongsan Medical Center||2|||f||||||||||||||2017-10-10 22:20:37.445089|2017-10-10 22:20:37.445089
NCT02726282|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-07-26|||March 2016||2016-03-01|July 2017|2017-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey|Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences|Withdrawn||N/A|0|Actual|Mayo Clinic|||1|funding not available|f||||f||||||||||2017-10-10 22:20:37.567105|2017-10-10 22:20:37.567105
NCT02726269|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-31|||June 2012||2012-06-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.|Helicobacter Pylori Eradication in Mexico With a Levofloxacin-containing Scheme Versus Clarithromycin-based Triple Therapy: a Randomized, Open-label, Non-inferiority, Phase 3b Trial.|Completed||Phase 3|230|Actual|Asofarma de México S.A de C.V.||2|||f||||f||||||||No||2017-10-10 22:20:37.651077|2017-10-10 22:20:37.651077
NCT02726256|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-04-15|||January 2007||2007-01-01|April 2016|2016-04-01|February 2026|Anticipated|2026-02-01|February 2026|Anticipated|2026-02-01||Observational|||G-CREDIT (Gangnam-Cohort for Risk Evaluation of Diabetes and Impaired Glucose Tolerance)||Not yet recruiting||N/A|500|Anticipated|Yonsei University|||1||f||||t||||||Samples Without DNA|"     Whole blood sample in EDTA containing tube would be refrigerated and used in developing a new     biomarker   "|Yes|This study has a plan to share data|2017-10-10 22:20:37.754827|2017-10-10 22:20:37.754827
NCT02726243|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-10-18|||November 2014||2014-11-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|DYSCOLIC||Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel Disease|Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel Disease - DYSCOLIC|Recruiting||N/A|240|Anticipated|Assistance Publique - Hôpitaux de Paris|||8||f||||f||||||Samples Without DNA|"     Stools   "|Undecided||2017-10-10 22:20:37.827066|2017-10-10 22:20:37.827066
NCT02726230|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-27|||January 2012||2012-01-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Bihar Family Health Initiative (Ananya)|Bihar Family Health Initiative (Ananya)|Completed||N/A|27633|Actual|University of California, San Diego||2|||f||||f||||||||Yes|Data from this study are public and available from the Bill and Melinda Gates Foundation|2017-10-10 22:20:37.929484|2017-10-10 22:20:37.929484
NCT02726217|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2017-05-04|||March 1, 2016|Actual|2016-03-01|May 2017|2017-05-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|||NYULMC CareSmarts Pilot|NYULMC-CareSmarts Study: A Pilot Study to Determine the Feasibility, Acceptability, and Potential Efficacy of an SMS-based Mobile Intervention to Enhance Type 2 Diabetes Self-management|Completed||N/A|26|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 22:20:38.011603|2017-10-10 22:20:38.011603
NCT02726204|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-12|||June 1, 2015|Actual|2015-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|May 5, 2016|Actual|2016-05-05||Interventional|||Evaluation of a Wearable Exoskeleton for Functional Arm Training|Evaluation of a Wearable Exoskeleton for Functional Arm Training (CAREX)|Active, not recruiting||N/A|35|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:20:38.115844|2017-10-10 22:20:38.115844
NCT02726178|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-04-29|2016-04-27||February 2010||2010-02-01|April 2017|2017-04-01|April 2012|Actual|2012-04-01|March 2011|Actual|2011-03-01||Interventional|||Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants|Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants < 32 Weeks Gestational Age: A Randomized Controlled Study|Completed||Phase 2|56|Actual|St. Justine's Hospital|1-the small number of patient recruted|2|||f||||f||||||||No||2017-10-10 22:20:38.356657|2017-10-10 22:20:38.356657
NCT02726152|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-11|||August 2016||2016-08-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|PECAS||Polymer Clips Versus Endoloops for Closure of the Appendiceal Stump During Emergency Laparoscopic Appendicectomy|Randomised Control Trial: Polymer Clips Versus Endoloops for Closure of the Appendiceal Stump During Emergency Laparoscopic Appendicectomy (The PECAS Trial)|Not yet recruiting||N/A|150|Anticipated|National Health Service, United Kingdom||2|||f||||f||||||||No||2017-10-10 22:20:38.736259|2017-10-10 22:20:38.736259
NCT02726139|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-03-31|||July 2016||2016-07-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|IFIE||Improved Factor VIII Inhibitor Evaluation|Improved Factor VIII Inhibitor Evaluation|Not yet recruiting||N/A|200|Anticipated|Boston VA Research Institute, Inc.|||2||f||||f||||||Samples Without DNA|"     frozen plasma   "|||2017-10-10 22:20:38.878978|2017-10-10 22:20:38.878978
NCT02726126|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-04-03|||March 2013||2013-03-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Transdermal Fentanyl and Melatonin Patches for Postoperative Pain Relief|Comparative Study Between Transdermal Fentanyl and Melatonin Patches on Postoperative Pain Relief After Lumber Laminectomy, a Double-blind, Placebo-controlled Trial|Completed||N/A|75|Actual|Ain Shams University|||3||f||||||||||||||2017-10-10 22:20:38.991878|2017-10-10 22:20:38.991878
NCT02726113|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-03-31|||October 2011||2011-10-01|September 2011|2011-09-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy|Vitamin D and Prostate Cancer: A Randomized Clinical Study|Completed||Phase 2|49|Actual|Medical University of South Carolina||2|||f||||f||||||||No||2017-10-10 22:20:39.103283|2017-10-10 22:20:39.103283
NCT02726100|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-06-12|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Interventional|||Systematic Medical Assessment, Referral and Treatment for Diabetes Care in China Using Lay Family Health Promoters|Systematic Medical Assessment, Referral and Treatment for Diabetes Care in China Using Lay Family Health Promoters|Not yet recruiting||N/A|2000|Anticipated|The George Institute for Global Health, China||2|||f||||t|f|f||||||No|Data are only accessed by investigators.|2017-10-10 22:20:39.238502|2017-10-10 22:20:39.238502
NCT02726087|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-08-02|||March 20, 2016||2016-03-20|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|QUALITY-AVR||Quality of Life After Ministernotomy Versus Full Sternotomy Aortic Valve Replacement|Health-related Quality of Life, Satisfaction and Outcomes After Ministernotomy Versus Full Sternotomy Aortic Valve Replacement. A Randomized Controlled Trial (QUALITY-AVR TRIAL)|Recruiting||N/A|96|Anticipated|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||2|||f||||t||||||||||2017-10-10 22:20:39.345749|2017-10-10 22:20:39.345749
NCT02726074|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-08-21|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures|Multicenter, Open-label Trial, Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Patients With Partial Onset Seizures With or Without Secondary Generalized Seizures|Active, not recruiting||Phase 4|106|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-10 22:20:39.4854|2017-10-10 22:20:39.4854
NCT02726061|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-08-17|||February 2016||2016-02-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Computer-based Dartmouth Research Problem Solving Therapy (DrPST) for Depression in Employee Assistance Programs (EAP)|A Computer-based Dartmouth Research Problem Solving Therapy Program (DrPST) for the Treatment of Depression in Employee Assistance Programs (EAP)|Recruiting||N/A|500|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-10 22:20:39.594058|2017-10-10 22:20:39.594058
NCT02726048|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-11-01|||April 2016||2016-04-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany|Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany|Active, not recruiting||N/A|4|Actual|Fisher and Paykel Healthcare||1|||f||||t||||||||No||2017-10-10 22:20:39.691318|2017-10-10 22:20:39.691318
NCT02726035|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-03|||September 2016||2016-09-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|NTX-SIB||Evaluation of Naltrexone as a Treatment for Self-injurious Behavior|Evaluation of Naltrexone as a Treatment for Self-Injurious Behavior|Not yet recruiting||Phase 4|10|Anticipated|Western Michigan University School of Medicine||2|||f||||t||||||||No||2017-10-10 22:20:39.772047|2017-10-10 22:20:39.772047
NCT02726022|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-07-05|2016-05-11||February 2007||2007-02-01|April 2016|2016-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational||Baseline analysis population included all enrolled participants.|A Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) Levels|A Quality of Life Study of PEGASYS® (Peginterferon-Alfa2a) in Combination With COPEGUS® (Ribavirin) in Patients With Chronic Hepatitis C and Persistently Normal ALT Levels|Completed||N/A|114|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:20:39.90687|2017-10-10 22:20:39.90687
NCT02725996|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2017-04-24|||April 2016||2016-04-01|March 2016|2016-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy||Not yet recruiting||Phase 2|140|Anticipated|Southwest Hospital, China||2|||f||||f||||||||Undecided||2017-10-10 22:20:40.441673|2017-10-10 22:20:40.441673
NCT02725983|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-31|||June 2014||2014-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2015|Actual|2015-02-01||Interventional|||Intra-oral Camera in Gingival Health|Psychological, Behavioral and Clinical Effects of Intra Oral Camera: a Randomized Control Trial on Adults With Gingivitis|Completed||N/A|78|Actual|University of Lisbon||2|||f||||f||||||||No||2017-10-10 22:20:40.538771|2017-10-10 22:20:40.538771
NCT02725970|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-31|||January 2011||2011-01-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|August 2012|Actual|2012-08-01||Observational|HEALTH||Healthy Eating and Lifestyle for Total Health|Healthy Eating and Lifestyle for Total Health|Completed||N/A|836|Actual|Baylor College of Medicine|||6||f||||t||||||||No||2017-10-10 22:20:40.627171|2017-10-10 22:20:40.627171
NCT02725944|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-10-20|||May 2016||2016-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|PROACTIA||Prediction and Detection of Occult Atrial Fibrillation in Patients After Acute Cryptogenic Stroke and TIA|Prediction and Detection of Occult Atrial Fibrillation in Patients After Acute Cryptogenic Stroke and Transient Ischemic Attack|Recruiting||N/A|250|Anticipated|University Hospital, Akershus|||1||f||||f||||||Samples With DNA|"     Blood samples   "|Yes||2017-10-10 22:20:40.798012|2017-10-10 22:20:40.798012
NCT02725931|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-29|||February 2013||2013-02-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD|Impact of Feedback on Physical Activity Levels and Health-related Outcomes of Patients With COPD During Pulmonary Rehabilitation|Completed||N/A|20|Actual|Aveiro University||1|||f||||f||||||||No||2017-10-10 22:20:40.877877|2017-10-10 22:20:40.877877
NCT02725918|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-28|||April 2016||2016-04-01|March 2016|2016-03-01|June 2020|Anticipated|2020-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Pemetrexed vs Pemetrexed Plus Cisplatin in Epidermal Growth Factor Receptor(EGFR)-Mutant NSCLC Patients After First Line EGFR Tyrosine Kinase Inhibitors (TKIs) Failure|Randomized Phase II Study of Pemetrexed Alone vs Pemetrexed Plus Cisplatin in Patients With EGFR Mutation-positive Advanced NSCLC After First Line EGFR-TKIs Failure|Not yet recruiting||Phase 2|150|Anticipated|Guangdong Association of Clinical Trials||2|||f||||||||||||||2017-10-10 22:20:40.95668|2017-10-10 22:20:40.95668
NCT02725905|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-04-18|||December 2015||2015-12-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|MSWEIGHT||Weight Management Counseling in Medical Schools|Weight Management Counseling in Medical Schools: A Randomized Controlled Trial|Enrolling by invitation||N/A|3311|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||No|The investigators plan to share data through the project website, publications, and presentations to key organizations. The plan is also to share the use of research tools, such as surveys, OSCE cases, and curricula materials, developed over the course of the study. At this time there is no plan to make individual participant data (IPD) available.|2017-10-10 22:20:41.046526|2017-10-10 22:20:41.046526
NCT02725892|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-09-07|||July 19, 2016|Actual|2016-07-19|September 2017|2017-09-01|July 28, 2022|Anticipated|2022-07-28|July 28, 2022|Anticipated|2022-07-28|72 Months|Observational [Patient Registry]|LuCaReAl||National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria|LuCaReAl: Lung Cancer Registry in Algeria.|Active, not recruiting||N/A|919|Actual|AstraZeneca|||1||f||||||||||||||2017-10-10 22:20:41.182086|2017-10-10 22:20:41.182086
NCT02725879|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-09|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Observational|THYROMETABOL||FGF-21 Levels and RMR in Children and Adolescents With Hashimoto's Thyroiditis (THYROMETABOL)|Association of Serum Fibroblast Growth Factor 21 (FGF-21) Levels With Resting Metabolic Rate (RMR), in Children and Adolescents With Hashimoto's Thyroiditis.|Not yet recruiting||N/A|60|Anticipated|Aristotle University Of Thessaloniki|||2||f||||f||||||Samples Without DNA|"     Serum samples   "|No||2017-10-10 22:20:41.275441|2017-10-10 22:20:41.275441
NCT02725866|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-08-16|||April 5, 2016||2016-04-05|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C - An Observational Study in Greece|Active, not recruiting||N/A|200|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:20:41.382149|2017-10-10 22:20:41.382149
NCT02725853|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-11-16|||June 2016||2016-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ENHANCE||Enhancing Recovery of Arm Movement in Stroke Patients|ENHANCE: Enhancing Brain Plasticity for Sensorimotor Recovery in Spastic Hemiparesis|Recruiting||N/A|60|Anticipated|McGill University||3|||f||||f||||||||No||2017-10-10 22:20:41.513032|2017-10-10 22:20:41.513032
NCT02725840|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-05-18|||May 2016||2016-05-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|BELLE||Breast Cancer Lung Late Effects|Early Markers of Subclinical Pulmonary Vascular Radiation Toxicity in Breast Cancer|Recruiting||N/A|55|Anticipated|University of Florida|||2||f||||f||||||Samples With DNA|"     blood plasma collection   "|Undecided||2017-10-10 22:20:41.627433|2017-10-10 22:20:41.627433
NCT02725827|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-08-12|||April 2016||2016-04-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Hyaluronan-enriched Embryo Transfer Medium for Frozen-thawed Embryo Transfer|Randomized Controlled Trial Comparing Hyaluronan-enriched Embryo Transfer Medium Versus Control for Frozen-thawed Embryo Transfer|Recruiting||N/A|550|Anticipated|The University of Hong Kong||2|||f||||||||||||||2017-10-10 22:20:41.745422|2017-10-10 22:20:41.745422
NCT02725814|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-13|||March 2016||2016-03-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|SPiN||Sucrose Practices for Pain in Neonates Part B|Sucrose Practices for Pain in Neonates Part B: Efficacy of Repeated Sucrose Administration, Infant Response to Administration, and Effect on Outcomes|Recruiting||N/A|160|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||No||2017-10-10 22:20:41.835441|2017-10-10 22:20:41.835441
NCT02725801|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2017-09-14|||February 2016||2016-02-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|January 17, 2018|Anticipated|2018-01-17||Interventional|||Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction|Randomized Clinical Trial Comparing 1-Port and 2-Port Tissue Expanders for Breast Reconstruction|Recruiting||N/A|60|Anticipated|University of Kentucky||2|||f||||f||||||||||2017-10-10 22:20:41.945939|2017-10-10 22:20:41.945939
NCT02725788|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-04-26|2017-03-13||September 2014||2014-09-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||All subjects randomized except 3 subjects who either failed to have the study dressing applied or whom the primary endpoint could not be ascertained|Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings|A Multi-Center, Prospective, Randomized Trial Comparing the Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings|Terminated||N/A|247|Actual|3M||2||Due to futility|f||||f||||||||No|Not required based on FDAA requirements|2017-10-10 22:20:42.056806|2017-10-10 22:20:42.056806
NCT02725775|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-11|||March 2016||2016-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Acute and Chronic Effects of 100% Florida Orange Juice Consumption on Cognitive Performance in 7-10 Year Old Children|A Study of the Acute and Chronic Effects of 100% Florida Orange Juice Consumption on Cognitive Performance in 7-10 Year Old UK School Children|Recruiting||N/A|100|Anticipated|University of Leeds||2|||f||||f||||||||Undecided||2017-10-10 22:20:42.375251|2017-10-10 22:20:42.375251
NCT02725762|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-06-30|||March 2016||2016-03-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|LIGHTSITE1||Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration|A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Single-Center Study to Assess the Safety and Efficacy of Photobiomodulation in Subjects With Dry Age-Related Macular Degeneration|Active, not recruiting||N/A|30|Anticipated|LumiThera, Inc.||2|||f||||f||||||||||2017-10-10 22:20:42.471372|2017-10-10 22:20:42.471372
NCT02725749|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-04-02|||January 2013||2013-01-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Low Level Laser Therapy Associated With Exercise in Subacromial Impingement Syndrome|Effect of Low Level Laser Therapy Associated With Exercise in Subacromial Impingement Syndrome: a Randomized, Double-blind Study|Completed||Phase 4|60|Actual|University of Sao Paulo General Hospital||3|||f||||f||||||||No||2017-10-10 22:20:42.552719|2017-10-10 22:20:42.552719
NCT02725736|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-28|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Tocolytic Therapy for Preterm Labor in Multiple Gestation|Tocolytic Therapy for Preterm Labor in Multiple Gestation|Not yet recruiting||Phase 3|140|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 22:20:42.625958|2017-10-10 22:20:42.625958
NCT02725723|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-31|||March 2016||2016-03-01|March 2016|2016-03-01||||March 2017|Anticipated|2017-03-01||Interventional|||Thermographic Images as an Objective Method for Assessing the Efficacy of Steroidal Epidural Injections|Thermographic Images as an Objective Method for Assessing the Efficacy of Steroidal Epidural Injections|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||No||2017-10-10 22:20:42.70154|2017-10-10 22:20:42.70154
NCT02725710|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-05-10|||August 2016||2016-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|GABA||Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration|Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration: a Randomized Controlled Trial|Recruiting||Phase 2|96|Anticipated|Duke University||2|||f||||t||||||||No||2017-10-10 22:20:42.885884|2017-10-10 22:20:42.885884
NCT02725697|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Treatment of Complaints Following Sports Injuries With Traditional Chinese Medicine|Treatment of Acute and Chronic Complaints Following Sports Injuries With Traditional Chinese Medicine (TCM) by Therapists in Switzerland - a Prospective Observational Study|Recruiting||N/A|60|Anticipated|Swiss Professional Organization for Traditional Chinese Medicine|||1||f||||f||||||||No||2017-10-10 22:20:43.009607|2017-10-10 22:20:43.009607
NCT02725684|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-09-29|||February 2015||2015-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Using Genomic Analysis to Guide Individual Treatment in Glioblastoma|Using Genomic Analysis to Guide Individual Treatment in Glioblastoma|Active, not recruiting||N/A|36|Actual|Rockefeller University|||1||f||||f||||||Samples With DNA|"     Unused samples retained   "|Yes|The data will be coded and shared with members of the collaboration.|2017-10-10 22:20:43.13497|2017-10-10 22:20:43.13497
NCT02725671|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-31|||April 2015||2015-04-01|March 2016|2016-03-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography|Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography|Recruiting||N/A|356|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 22:20:43.256317|2017-10-10 22:20:43.256317
NCT02725658|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-02-08|||December 2015||2015-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI|Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging in a Multi-Center Setting|Recruiting||N/A|200|Anticipated|University of California, Irvine||1|||f||||f||||||||No||2017-10-10 22:20:43.365795|2017-10-10 22:20:43.365795
NCT02725645|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-28|||June 2014||2014-06-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|BLSMA||Backpack Load and Spine Muscles Activity|Influence of Different Backpack Loading Conditions on Neck and Lumbar Muscles Activity of Elementary School Children|Completed||N/A|30|Actual|University Fernando Pessoa||1|||f||||f||||||||No||2017-10-10 22:20:43.566945|2017-10-10 22:20:43.566945
NCT02725632|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-04-25|||August 2015||2015-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS-OSA)|Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS-OSA)|Completed||N/A|50|Actual|Rhode Island Hospital||2|||f||||f||||||||No||2017-10-10 22:20:43.654047|2017-10-10 22:20:43.654047
NCT02725619|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-09-15|||April 2016||2016-04-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|June 2020|Anticipated|2020-06-01||Interventional|||CBT for Anxiety in Children With Autism|Neural Mechanisms of CBT for Anxiety in Children With Autism: Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Yale University||2|||f||||f||||||||Yes|All data generated by this study will be delivered to the National Database for Autism Research (NDAR) as required.|2017-10-10 22:20:43.770569|2017-10-10 22:20:43.770569
NCT02725606|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-08-15|||March 2016||2016-03-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer|A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Human Serum Albumin/Human Granulocyte-Colony Stimulating Factor(I) Fusion Protein for Injection (GW003) in Patients With Breast Cancer|Recruiting||Phase 1|30|Anticipated|Jiangsu T-Mab Biopharma Co.,Ltd||4|||f||||f||||||||||2017-10-10 22:20:43.884107|2017-10-10 22:20:43.884107
NCT02725580|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-03-28|||March 2016||2016-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Batten CLN6 Gene Therapy|Phase I/IIa Gene Transfer Clinical Trial for Variant Late Infantile Neuronal Ceroid Lipofuscinosis, Delivering the CLN6 Gene by Self-Complementary AAV9|Recruiting||Phase 1/Phase 2|6|Anticipated|Nationwide Children's Hospital||1|||f||||t||||||||||2017-10-10 22:20:44.273451|2017-10-10 22:20:44.273451
NCT02725554|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-29|2016-10-13|||January 2017||2017-01-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine|Prospective, Randomized, Controlled, Multi-Center Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine|Not yet recruiting||Phase 3|144|Anticipated|StimRelieve, LLC||2|||f||||t||||||||Yes|Within 6 months of end of study, data will be published. All study subject data will be anonymous.|2017-10-10 22:20:44.629241|2017-10-10 22:20:44.629241
NCT02725541|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|NATURE||Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer|Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer|Withdrawn||Phase 2|0|Actual|The Methodist Hospital System||1||loss of funding support|f||||t||||||||Yes|Data and materials on human subjects will be shared with other eligible investigators through appropriate means in accordance with the NIH policy on Sharing Research Data (NIH Guide, February 26, 2003). Data will be also shared with the funding agency and regulatory agencies as required. Data will be shared with other investigators within the limits of HIPAA and other patient confidentiality requirements. This will generally require removal of all patient identifiers for all source documents and the use of arbitrarily assigned one-way identifiers. In some cases, requestors will be asked to sign a formal data sharing agreement that will provide for a commitment to use data only for research purposes and not to identify individuals, keep the data secure, and destroy or return data after analyses are complete. Prior approval will be obtained from collaborating investigators, research sponsors, and/or other stake-holders before sharing if proprietary information or products are involved.|2017-10-10 22:20:44.75332|2017-10-10 22:20:44.75332
NCT02725528|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-29|||November 2016||2016-11-01|March 2016|2016-03-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|EXTEND||Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's|A Multi-Center, Randomized Controlled Trial Comparing The Clinical Effectiveness and Cost-Effectiveness of Collagenase Injection (Xiaflex) and Palmar Fasciectomy in the Management of Dupuytren's Disease|Not yet recruiting||Phase 3|128|Anticipated|McMaster University||2|||f||||t||||||||Undecided||2017-10-10 22:20:44.885062|2017-10-10 22:20:44.885062
NCT02725515|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-25|||February 2016||2016-02-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus|A Randomized, Double-Blinded, Placebo-Controlled Study of the Effect of XmAb®5871 on Systemic Lupus Erythematosus Disease Activity|Recruiting||Phase 2|90|Anticipated|Xencor, Inc.||2|||f||||f||||||||||2017-10-10 22:20:45.045894|2017-10-10 22:20:45.045894
NCT02725502|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-03-31|||July 2013||2013-07-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Incretin Axis in Type 1 Diabetes Mellitus|Effect of Linagliptin on Incretin Axis in Type 1 Diabetes|Recruiting||N/A|20|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||No||2017-10-10 22:20:45.227396|2017-10-10 22:20:45.227396
NCT02725476|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-06-29|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)|An Open-label, Single-arm, Pilot Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease|Recruiting||Phase 2|21|Anticipated|Xencor, Inc.||1|||f||||f||||||||||2017-10-10 22:20:45.481958|2017-10-10 22:20:45.481958
NCT02725463|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-09-12|||April 2016||2016-04-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Multichannel Vestibular Implant Early Feasibility Study|First-in-Human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals With Bilateral Severe-to-Profound Loss of Vestibular Sensation|Recruiting||N/A|60|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 22:20:45.558985|2017-10-10 22:20:45.558985
NCT02725450|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-31|||March 2014||2014-03-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|February 2015|Actual|2015-02-01||Interventional|||The Influence of Motor Imagery in Fine Motor Skills|The Influence of Motor Imagery in Fine Motor Skills of Individuals With Disabilities|Completed||N/A|42|Actual|Instituto Politécnico de Castelo Branco||1|||f||||f||||||||Undecided||2017-10-10 22:20:45.692951|2017-10-10 22:20:45.692951
NCT02725437|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-04-23|||February 15, 2016|Actual|2016-02-15|April 2017|2017-04-01|February 25, 2017|Actual|2017-02-25|February 25, 2017|Actual|2017-02-25||Interventional|||Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults|A Phase 1, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Safety, Tolerability, And Immunogenicity Of Two 3-dose Regimens Of Clostridium Difficile Vaccine Administered In Healthy Japanese Adults Aged 65 To 85 Years.|Completed||Phase 1|100|Actual|Pfizer||6|||f||||t||||||||||2017-10-10 22:20:45.768168|2017-10-10 22:20:45.768168
NCT02725424|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-04-13|||August 2015||2015-08-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|MATCH||Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer|A Randomized, Multicenter, Controlled Phase II Study to Compare Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gastric/Gastroesophageal Cancer|Recruiting||Phase 2|414|Anticipated|Chinese Academy of Medical Sciences||4|||f||||t||||||||Undecided||2017-10-10 22:20:45.876524|2017-10-10 22:20:45.876524
NCT02725411|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-10-02|||May 26, 2016|Actual|2016-05-26|October 2017|2017-10-01|June 13, 2019|Anticipated|2019-06-13|June 13, 2019|Anticipated|2019-06-13||Interventional|TANGO||Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain|A Phase 3 Randomized, Double-blind, Active-controlled, Multicenter Study Of The Long-term Safety And Efficacy Of Subcutaneous Administration Of Tanezumab In Japanese Adult Subjects With Chronic Low Back Pain|Recruiting||Phase 3|390|Anticipated|Pfizer||3|||f||||t|f|f||||||||2017-10-10 22:20:45.985148|2017-10-10 22:20:45.985148
NCT02725398|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-31|||December 2013||2013-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser Endomicroscopy|Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser Endomicroscopy|Recruiting||N/A|150|Anticipated|Xijing Hospital of Digestive Diseases||3|||f||||t||||||||Yes||2017-10-10 22:20:46.223988|2017-10-10 22:20:46.223988
NCT02725385|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-31|||March 2014||2014-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Stress and Coping in Caregivers of Younger Patients With Cancer|Stress and Coping in Caregivers of Pediatric Cancer Patients|Completed||N/A|163|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-10 22:20:46.34893|2017-10-10 22:20:46.34893
NCT02725372|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-08-15|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|INOvation-1||Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH|A Phase 3, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Efficacy, Safety, and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Symptomatic Subjects With PAH (Part 1 and Part 2)|Recruiting||Phase 3|188|Anticipated|Bellerophon||2|||f||||t||||||||||2017-10-10 22:20:46.442668|2017-10-10 22:20:46.442668
NCT02725359|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-12-19|||April 2016||2016-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PTUSGSCB||Tizanidine and Superficial Cervical Block on Pain After Thyroidectomy|Preemptive Single Dose Tizanidine and Ultrasound Guided Superficial Cervical Block on Pain After Thyroidectomy|Completed||Phase 4|60|Actual|Ataturk University||3|||f||||f||||||||||2017-10-10 22:20:48.440865|2017-10-10 22:20:48.440865
NCT02725346|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-05-18|||July 2015||2015-07-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|February 2016|Actual|2016-02-01||Interventional|||ArthroPlanner: A Surgical Planning Solution for Acromioplasty|ArthroPlanner: A Surgical Planning Solution for Acromioplasty|Active, not recruiting||N/A|67|Anticipated|La Tour Hospital||2|||f||||t||||||||||2017-10-10 22:20:48.549816|2017-10-10 22:20:48.549816
NCT02725333|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-05-18|||October 2014||2014-10-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|January 2015|Actual|2015-01-01||Interventional|||Does Shoulder Stabilizations Stabilize Shoulders?|Does Shoulder Stabilizations Stabilize Shoulders?|Completed||N/A|11|Actual|La Tour Hospital||1|||f||||t||||||||No||2017-10-10 22:20:48.648902|2017-10-10 22:20:48.648902
NCT02725320|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-05-01|||February 2016||2016-02-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|RCSOW||Rotator Cuff Surgical Outcomes in Women|Rotator Cuff Surgical Outcomes in Women|Recruiting||N/A|184|Anticipated|University of Calgary|||2||f||||f||||||||No||2017-10-10 22:20:48.75447|2017-10-10 22:20:48.75447
NCT02725307|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-05-03|||March 2016||2016-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Non-invasive Peri- and Postoperative Monitoring of Femoral Artery Balloon Angioplasty|Non-invasive Peri- and Postoperative Monitoring of Femoral Artery Balloon Angioplasty|Completed||N/A|30|Actual|Tampere University Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:20:48.853445|2017-10-10 22:20:48.853445
NCT02725294|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-28|||April 2016||2016-04-01|March 2016|2016-03-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Observational|||Understanding Patient Management of COPD Exacerbations||Not yet recruiting||N/A|500|Anticipated|VA Puget Sound Health Care System|||2||f||||f||||||||No||2017-10-10 22:20:48.927142|2017-10-10 22:20:48.927142
NCT02725255|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-09-03|||May 2015||2015-05-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Design and Clinical Evaluation of a School Meal With Deworming Properties|Design and Clinical Evaluation of a School Meal With Deworming Properties|Completed||Phase 2/Phase 3|326|Actual|Kenya Medical Research Institute||3|||f||||f||||||||Yes||2017-10-10 22:20:49.511218|2017-10-10 22:20:49.511218
NCT02725242|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-04-14|||March 2016||2016-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma|A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/Formoterol Turbuhaler (160/4.5 μg/d) and Twice-daily Budesonide Giona Easyhaler (400 μg/d) During Step-down Period in Well Controlled Asthma|Completed||Phase 3|77|Actual|Hat Yai Medical Education Center||2|||f||||t||||||||Undecided||2017-10-10 22:20:49.61924|2017-10-10 22:20:49.61924
NCT02725229|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-26|||June 2011||2011-06-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Parasternal Block and TENS for Cardiac Surgery|Comparison of Transcutaneous Electrical Nerve Stimulation and Parasternal Block for Postoperative Pain Management After Cardiac Surgery|Completed||N/A|120|Actual|Antalya Training and Research Hospital||3|||f||||f||||||||No||2017-10-10 22:20:49.717882|2017-10-10 22:20:49.717882
NCT02725203|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-05-05|||March 2016||2016-03-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients|Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients With a Cardiovascular Risk: a Clustered-randomized Controlled Trial in Primary Care|Active, not recruiting||N/A|297|Anticipated|UMC Utrecht||2|||f||||t||||||||Undecided|Not yet|2017-10-10 22:20:49.843934|2017-10-10 22:20:49.843934
NCT02725190|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-06-09|||April 2016||2016-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|NoSleepDiaph||Effects of Sleep Deprivation on Diaphragm Command During an Inspiratory Endurance Trial in Healthy Volunteers.|Effects of Sleep Deprivation on Diaphragm Command During an Inspiratory Endurance Trial in Healthy Volunteers.|Recruiting||N/A|16|Anticipated|Poitiers University Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:20:50.004229|2017-10-10 22:20:50.004229
NCT02725177|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ocular Sarcoidosis Open Label Trial of ACTHAR Gel|Ocular Sarcoidosis Open Label Trial of ACTHAR Gel|Recruiting||N/A|20|Anticipated|The Cleveland Clinic||1|||f||||f||||||||No||2017-10-10 22:20:50.095742|2017-10-10 22:20:50.095742
NCT02725164|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-02-10|||April 12, 2016|Actual|2016-04-12|February 2017|2017-02-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||Anesthetic Gas Leakage in Children During Tonsillectomy: a Comparison of Cuffed and Uncuffed Tracheal Tubes|Anesthetic Gas Leakage in Children During Tonsillectomy: a Comparison of Cuffed and Uncuffed Tracheal Tubes|Completed||N/A|31|Actual|State University of New York at Buffalo||2|||f||||f|f|f|||f|||No||2017-10-10 22:20:50.201034|2017-10-10 22:20:50.201034
NCT02725151|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-09-25|||August 2015||2015-08-01|March 2016|2016-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Acute Heart Failure Monitoring Via Inferior Vena Cava Ultrasound|Inferior Vena Cava Ultrasound for Monitoring Volume Status on the Treatment of Acute Heart Failure|Completed||N/A|64|Actual|Haseki Training and Research Hospital|||1||f||||f||||||||No|Already in the nearest congress will be shared as an oral presentation or poster|2017-10-10 22:20:50.295969|2017-10-10 22:20:50.295969
NCT02725138|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-10-12|||March 2016||2016-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Probiotics in the Gut Microbiota and H Pylori Density|The Efficacy of Lactobacillus Acidophilus and Lactobacillus Rhamnosus in the Modification of Gut Microbiota and Reduction of Helicobacter Pylori Bacterial Load- a Double Blind, Placebo Controlled, Randomized Trial|Recruiting||Phase 2/Phase 3|40|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 22:20:50.363233|2017-10-10 22:20:50.363233
NCT02725125|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-03-21|||November 2015||2015-11-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|EECSC||Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer|Single-arm,Two Phase,Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Stomach Cancer|Recruiting||N/A|19|Anticipated|Sinobioway Cell Therapy Co., Ltd.||1|||f||||t||||||||No|No plans to share data.|2017-10-10 22:20:50.458336|2017-10-10 22:20:50.458336
NCT02725112|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-06-23|||February 12, 2016|Actual|2016-02-12|June 2017|2017-06-01|June 17, 2016|Actual|2016-06-17|May 22, 2016|Actual|2016-05-22||Interventional|||Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers|A Phase 1, Randomized, Open-label, Single-dose, 6-period Study To Investigate The Effect Of In Vitro Dissolution Rate On The In Vivo Bioavailability Of Extended Release Formulations Of Pregabalin In Healthy Volunteers|Completed||Phase 1|25|Actual|Pfizer||6|||f||||f|t|f||||||||2017-10-10 22:20:50.542628|2017-10-10 22:20:50.542628
NCT02725099|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2017-01-09|||May 2016||2016-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients|Chewing Versus Traditional Oral Administration of Ticagrelor in ST-elevation Myocardial Infarction Patients - A Platelet Reactivity Study|Completed||Phase 4|50|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 22:20:50.747417|2017-10-10 22:20:50.747417
NCT02725086|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-11-09|||February 2016||2016-02-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers||Completed||Phase 1|56|Anticipated|Dong-A ST Co., Ltd.||2|||f||||||||||||||2017-10-10 22:20:50.843925|2017-10-10 22:20:50.843925
NCT02725073|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-04-12|||January 2016||2016-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PDT||Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma|Photodynamic Therapy Using a Novel Photosensitizer in Locally Advanced Hilar Cholangiocarcinoma|Recruiting||Phase 2|32|Anticipated|Asan Medical Center||1|||f||||t||||||||Yes||2017-10-10 22:20:50.937793|2017-10-10 22:20:50.937793
NCT02725060|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-05-26|||February 2016||2016-02-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|February 2021|Anticipated|2021-02-01||Interventional|||Autoimmune Basis for Postural Tachycardia Syndrome|Autoimmune Basis for Postural Tachycardia Syndrome|Recruiting||N/A|95|Anticipated|Vanderbilt University Medical Center||1|||f||||f||||||||||2017-10-10 22:20:51.048664|2017-10-10 22:20:51.048664
NCT02725047|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-01-13|||April 2016||2016-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of Cryotherapy in Pain Control, Function and Quality of Life in Individuals With Knee Osteoarthritis|The Effect of Cryotherapy in Pain Control, Function and Quality of Life in Individuals With Knee Osteoarthritis - Randomized Clinical Trial|Completed||N/A|60|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||No||2017-10-10 22:20:51.187236|2017-10-10 22:20:51.187236
NCT02725034|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2016-03-30|||January 2016||2016-01-01|March 2016|2016-03-01||||August 2016|Anticipated|2016-08-01||Interventional|||Diagnosis of Gastric Intestinal Metaplasia With High Definition Endoscopy and Optic Enhancement||Recruiting||N/A|160|Anticipated|Shandong University||2|||f||||||||||||||2017-10-10 22:20:51.299555|2017-10-10 22:20:51.299555
NCT02725021|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-06-02|||October 2016||2016-10-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Education Against Tobacco Randomized Trial in Brazil|Education Against Tobacco: Medical-student-delivered Smoking Prevention Programme for Secondary Schools in Brazil - Randomized Trial|Active, not recruiting||N/A|1500|Anticipated|University of Giessen||2|||f||||f||||||||Undecided||2017-10-10 22:20:51.389514|2017-10-10 22:20:51.389514
NCT02725008|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-30|||July 2015||2015-07-01|March 2016|2016-03-01||||July 2017|Anticipated|2017-07-01||Interventional|R2D2||Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation|A Randomized Double Blinded Placebo Controlled Trial of One Versus Two Doses of Oral Dexamethasone for the Treatment of Acute Asthma Exacerbation in the Pediatric Emergency Department (ED)|Recruiting||Phase 3|220|Anticipated|New York Methodist Hospital||2|||f||||t||||||||||2017-10-10 22:20:51.478981|2017-10-10 22:20:51.478981
NCT02724995|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-03-25|||February 2016||2016-02-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Finding Genes for Rare Diseases|Finding Genes for Rare Diseases|Active, not recruiting||N/A|1000|Anticipated|University of Kentucky|||1||f||||f||||||Samples With DNA|"     Blood Saliva   "|No||2017-10-10 22:20:51.59172|2017-10-10 22:20:51.59172
NCT02724982|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-03-25|||December 2015||2015-12-01|March 2016|2016-03-01||||February 2016|Actual|2016-02-01||Observational|||Body Image Satisfaction In Relation To Body Mass Index And Self- Esteem Among Chinese Female Students|Body Image Satisfaction In Relation To Body Mass Index And Self- Esteem Among Chinese Female Students: A Cross Sectional Study|Completed||N/A|176|Actual|Universiti Tunku Abdul Rahman|||1||f||||||||||||||2017-10-10 22:20:51.659725|2017-10-10 22:20:51.659725
NCT02724969|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-10-02|||February 9, 2017|Actual|2017-02-09|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|MILK||A Mobile, Semi-automated Text Message-based Intervention to Prevent Perceived Low or Insufficient Milk Supply|A Mobile, Semi-automated Text Message-based Intervention to Prevent Perceived Low or Insufficient Milk Supply|Recruiting||N/A|186|Anticipated|University of Pittsburgh||2|||f||||f|f|f||||||||2017-10-10 22:20:51.725295|2017-10-10 22:20:51.725295
NCT02724956|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-06-05|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AURAGAIN||Ambu Auragain Vs Teleflex LMA Supreme Study|Randomized Comparison of Ambu Auragain and Teleflex LMA Supreme Using Clinical and Fibreoptic Assessments in Elective Patients|Not yet recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|t|f|f||||Undecided||2017-10-10 22:20:51.833861|2017-10-10 22:20:51.833861
NCT02724943|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-25|||August 2012||2012-08-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|TXCORDRCT||Texas Childhood Obesity Research Demonstration (TX CORD) Project|Systems Approach to Obesity Prevention in Underserved Children in Texas (Randomized Controlled Trial)|Completed||N/A|549|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||No||2017-10-10 22:20:51.92787|2017-10-10 22:20:51.92787
NCT02724930|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-05-08|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|COPES||Cooperative Pain Education and Self-management|Cooperative Pain Education and Self-management|Not yet recruiting||N/A|1488|Anticipated|VA Connecticut Healthcare System||2|||f||||f|f|f||||||No||2017-10-10 22:20:52.073567|2017-10-10 22:20:52.073567
NCT02724917|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-07-11|||April 2016||2016-04-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia|A Phase 1b/2a, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APN1125 in Subjects With Schizophrenia|Suspended||Phase 1/Phase 2|30|Anticipated|CoMentis||4||Study halted by sponsor for business reasons|f||||f||||||||No||2017-10-10 22:20:52.180141|2017-10-10 22:20:52.180141
NCT02724904|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-03-21|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma|A Pilot Study of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed CNS Involvement by Lymphoma|Withdrawn||Phase 1/Phase 2|0|Actual|Massachusetts General Hospital||1||Drug logistics|f||||t|t|f|||f|||No||2017-10-10 22:20:52.285935|2017-10-10 22:20:52.285935
NCT02724891|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-03-25|||February 2015||2015-02-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Web-based Validation Pelvic Floor Questionnaires|Validation of Electronic (Web-based and Smartphone) Administration of Measures of Pelvic Floor Dysfunction|Recruiting||N/A|216|Anticipated|Columbia University|||2||f||||f||||||||||2017-10-10 22:20:52.400388|2017-10-10 22:20:52.400388
NCT02724878|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|October 2023|Anticipated|2023-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma|Phase II Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma|Recruiting||Phase 2|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-10 22:20:52.524489|2017-10-10 22:20:52.524489
NCT02724865|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-04-12|||January 2016||2016-01-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|COSH||Somnodent vs Herbst in Mild and Moderate OSA Patients|A Comparison Between Two Different Oral Appliance Therapies: Somnodent vs Herbst Appliance in Patients With Mild and Moderate OSA|Recruiting||Phase 4|140|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-10 22:20:52.68729|2017-10-10 22:20:52.68729
NCT02724852|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-03-31|||July 2011||2011-07-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|||MMR Vaccination Among HIV-infected Adults|Seroprevalence of Antibodies to Measles, Mumps, and Rubella, and Serologic Responses After Vaccination Among Human Immunodeficiency Virus (HIV)-1 Infected Adults in Northern Thailand|Completed||Phase 4|632|Actual|Chiang Mai University||2|||f||||f||||||||No||2017-10-10 22:20:52.789522|2017-10-10 22:20:52.789522
NCT02724839|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-08-21|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|STEP IN||Supporting Together Exercise and Play and Improving Nutrition|Innovations in the Management of Obesity and Inactivity in Pediatric Primary Care|Completed||N/A|40|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 22:20:52.88357|2017-10-10 22:20:52.88357
NCT02724826|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-24|||August 2000||2000-08-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2004|Actual|2004-08-01||Interventional|QII||Effects of Qigong and Exercise Therapy Among Patients With Chronic Neck Pain|Effects of Qigong and Exercise Therapy Among Patients With Chronic Neck Pain|Completed||N/A|122|Actual|Lund University||2|||f||||f||||||||No||2017-10-10 22:20:52.981102|2017-10-10 22:20:52.981102
NCT02724813|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-08-01|||November 2015||2015-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 30, 2017|Anticipated|2017-09-30||Interventional|||Tele-Rehabilitation Study for People With a History of Stroke|Tele-rehabilitation for Cognitive Disability Post Stroke: Enhancing Function in the Face of Geographical Disparities|Active, not recruiting||N/A|24|Anticipated|Baycrest||2|||f||||f||||||||||2017-10-10 22:20:53.095826|2017-10-10 22:20:53.095826
NCT02724800|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-06-23|||April 2016||2016-04-01|June 2016|2016-06-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|iBIT||Implementation of Brief Insomnia Treatments - Clinical Trial||Recruiting||N/A|96|Anticipated|VA Pittsburgh Healthcare System||2|||f||||f||||||||||2017-10-10 22:20:53.187798|2017-10-10 22:20:53.187798
NCT02724787|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-08-09|||June 13, 2016|Actual|2016-06-13|August 2017|2017-08-01|March 2, 2018|Anticipated|2018-03-02|January 18, 2018|Anticipated|2018-01-18||Interventional|(EMDA)||Using Emotion Regulation to Decrease Aggression in Veterans With PTSD|CAP - Using Emotion Regulation to Decrease Aggression in Veterans With PTSD|Recruiting||N/A|30|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 22:20:53.323385|2017-10-10 22:20:53.323385
NCT02724774|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-05-01|||November 2015||2015-11-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Collaborative Perinatal Mental Health and Parenting Support in Primary Care|Collaborative Perinatal Mental Health and Parenting Support in Primary Care|Enrolling by invitation||N/A|240|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 22:20:53.572598|2017-10-10 22:20:53.572598
NCT02724761|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-30|||September 2016||2016-09-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion|Prophylactic Racemic Epinephrine for the Prevention of Dysphagia in Patients Undergoing Anterior Cervical Discectomy and Fusion: A Randomized Control Trial|Not yet recruiting||N/A|90|Anticipated|Banner Health||2|||f||||f||||||||Yes|Data will be be presented in a research paper format and submitted to a journal following completion of the study.|2017-10-10 22:20:53.705856|2017-10-10 22:20:53.705856
NCT02724748|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-05-30|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|Violin||Managing Patient Aggression in Mental Health Services|The Effectiveness of User-driven Intervention to Manage Patient Aggression in Mental Health Services|Enrolling by invitation||N/A|28|Actual|University of Turku||2|||f||||t||||||||No||2017-10-10 22:20:53.884514|2017-10-10 22:20:53.884514
NCT02724735|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-09-20|||August 2016||2016-08-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder|A Longitudinal Observational Cohort Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder|Recruiting||N/A|220|Anticipated|Neuralstem Inc.|||1||f||||t||||||||Yes||2017-10-10 22:20:54.002944|2017-10-10 22:20:54.002944
NCT02724722|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-09-01|||March 2015||2015-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Family-based Childhood Behavior Intervention to Decrease Environmental Melamine and Phthalate Exposure|Family-based Childhood Behavior Intervention to Decrease Environmental Melamine and Phthalate Exposure|Completed||N/A|24|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-10 22:20:54.148713|2017-10-10 22:20:54.148713
NCT02724709|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-08-08|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01|2 Weeks|Observational [Patient Registry]|||Semi-automatic assessMent of Aortic Roots by Three-dimensional transoEsophageal echocaRdiography (SMARTER)|Semi-automatic assessMent of Aortic Roots by Three-dimensional transoEsophageal echocaRdiography (SMARTER)|Completed||N/A|77|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t||||||||Yes||2017-10-10 22:20:54.286415|2017-10-10 22:20:54.286415
NCT02724696|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-10-24|||January 2012||2012-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|RYTHMIC||French National Observatory of Patients With Thymic Epithelial Tumor|French National Observatory of Patients With Thymic Epithelial Tumor|Recruiting||N/A|1750|Anticipated|Intergroupe Francophone de Cancerologie Thoracique|||1||f||||f||||||||No||2017-10-10 22:20:54.42894|2017-10-10 22:20:54.42894
NCT02724683|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-04-29|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Weeks|Observational [Patient Registry]|||Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter.|Management of Symptomatic Malignant Ascites With an Patient-controlled, Vascular Catheter - a Validation Study.|Recruiting||N/A|170|Anticipated|Gdynia Oncology Center|||1||f||||f||||||||No||2017-10-10 22:20:54.548419|2017-10-10 22:20:54.548419
NCT02724670|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-24|||March 2016||2016-03-01|March 2016|2016-03-01|September 2028|Anticipated|2028-09-01|June 2020|Anticipated|2020-06-01||Interventional|M-basePro||Study of MR-based IGRT for Prostate Cancer|Single-arm Phase II Study of MR(Magnetic Resonance Imaging)-Based Image-guided Radiotherapy for Prostate Cancer|Active, not recruiting||Phase 2|78|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||Undecided||2017-10-10 22:20:54.737941|2017-10-10 22:20:54.737941
NCT02724657|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-01-20|||March 2016||2016-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Buteyko Method for Asthmatic Children With Mouth Breathing|THE EFFECTS OF THE BUTEYKO METHOD IN MOUTH BREATHING ASTHMATIC CHILDREN: A CONTROLLED RANDOMIZED STUDY|Completed||N/A|35|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||||||||||||2017-10-10 22:20:54.830751|2017-10-10 22:20:54.830751
NCT02724631|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-10-03|||November 2016|Actual|2016-11-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||TubeClear® Evaluation in Pediatric Patients (Phase I)|Evaluation of Efficacy of Use of TubeClear® to Restore Patency to Occluded Enteral Access Devices in Pediatric Patients (Phase I)|Recruiting||N/A|10|Anticipated|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-10-10 22:20:55.087384|2017-10-10 22:20:55.087384
NCT02724605|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-03-06|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Red Blood Cells Storage Duration on Biochemical Changes in Pediatric Patients|Is Intraoperative Red Blood Cells Transfusion With Different Storage Duration Has Effect on Some Biochemical Parameters in Pediatric Trauma Patients Need Intraoperative Transfusion?|Recruiting||Phase 2|30|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:20:55.360708|2017-10-10 22:20:55.360708
NCT02724579|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-09-27|||October 2016||2016-10-01|September 2017|2017-09-01||||May 2025|Anticipated|2025-05-01||Interventional|||Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma|A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients|Not yet recruiting||Phase 2|45|Anticipated|Children's Oncology Group||1|||f||||f||||||||||2017-10-10 22:20:55.568996|2017-10-10 22:20:55.568996
NCT02724566|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-08-21|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|APELINS-2||Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers|Influence of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers|Completed||Phase 1|9|Actual|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-10 22:20:55.77486|2017-10-10 22:20:55.77486
NCT02724553|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-11-28|||April 2016||2016-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Comparison of Haptic Orientation in Negative Dysphotopsia|Comparison of Horizontal and Vertical IOL Haptic Orientation in Negative Dysphotopsia.|Withdrawn||N/A|0|Actual|Loma Linda University||2||A recent publication answered the study question being asked|f||||t||||||||No||2017-10-10 22:20:55.875879|2017-10-10 22:20:55.875879
NCT02724540|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-09-23|||March 2016||2016-03-01|September 2016|2016-09-01||||March 2020|Anticipated|2020-03-01||Interventional|||Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver|Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver|Recruiting||Phase 3|12|Anticipated|Abramson Cancer Center of the University of Pennsylvania||3|||f||||t||||||||||2017-10-10 22:20:55.955064|2017-10-10 22:20:55.955064
NCT02724527|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-11-17|||April 2016||2016-04-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|SNO-7||Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 for Efficacy and Safety in Patients With CF Heterozygous for F508del-CFTR + Gating Mutation Being Treated With Ivacaftor|Active, not recruiting||Phase 2|19|Actual|Nivalis Therapeutics, Inc.||2|||f||||t||||||||No||2017-10-10 22:20:56.055792|2017-10-10 22:20:56.055792
NCT02724514|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-20|||January 2015||2015-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2016|Actual|2016-11-01||Observational|||Multi-Parametric Assessment of Breast Lymphedema|Multi-Parametric Assessment of Breast Lymphedema|Recruiting||N/A|60|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 22:20:56.176351|2017-10-10 22:20:56.176351
NCT02724501|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-11|2016-03-24|||April 2000||2000-04-01|March 2016|2016-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer|Clinical and Molecular Studies of the Tumour Suppressor Gene PTEN in Endometrioid Type Endometrial Cancer|Completed||N/A|217|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 22:20:56.24928|2017-10-10 22:20:56.24928
NCT02724488|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-07-31|||April 2015||2015-04-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|SPECIAL||Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies|Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies|Active, not recruiting||N/A|14|Actual|University Health Network, Toronto|||2||f||||f||||||Samples With DNA|"     Part 1: Archival tumor tissue, 3 tubes of whole blood Part 2: Fresh tumor tissue, 5 tubes of     whole blood at baseline, serial tubes of whole blood   "|||2017-10-10 22:20:56.328123|2017-10-10 22:20:56.328123
NCT02724475|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-28|||December 2012||2012-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus|Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized Controlled Trial|Completed||N/A|180|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 22:20:56.411823|2017-10-10 22:20:56.411823
NCT02724462|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-08-02|||May 27, 2017|Actual|2017-05-27|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Trial of An Innovative Smartphone Intervention for Smoking Cessation|Randomized Trial of An Innovative Smartphone Intervention for Smoking Cessation|Recruiting||N/A|1622|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f|f|f||||||||2017-10-10 22:20:56.494409|2017-10-10 22:20:56.494409
NCT02724449|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-05-11|2017-03-13||August 2014||2014-08-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermatitis (IAD)|A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermatitis (IAD)|Completed||N/A|16|Actual|3M||1|||f||||f||||||||No||2017-10-10 22:20:56.581219|2017-10-10 22:20:56.581219
NCT02724436|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-28|||December 2012||2012-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma|Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma: A Randomized Controlled Trial|Completed||N/A|200|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 22:20:56.786708|2017-10-10 22:20:56.786708
NCT02724423|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-11-03|||July 2016||2016-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects|An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions|Recruiting||Phase 1|45|Anticipated|Neurelis, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:20:56.879308|2017-10-10 22:20:56.879308
NCT02724410|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-25|||January 2011||2011-01-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Role of Intravenous Versus Home Oral Antibiotics in Perforated Appendicitis|Home Intravenous Versus Oral Antibiotics Following Appendectomy for Perforated Appendicitis in Children, a Randomized Controlled Trial|Completed||N/A|82|Actual|Carolinas Healthcare System||2|||f||||t||||||||Undecided||2017-10-10 22:20:56.981808|2017-10-10 22:20:56.981808
NCT02724397|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-01-30|||May 1, 2016|Actual|2016-05-01|January 2017|2017-01-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Linked Color Imaging/Magnifying Blue Laser Imaging vs. White Light for Adenomas and Serrated Lesions in Proximal Colon|Linked Color Imaging (LCI) and Magnifying Blue Laser Imaging (BLI) Versus Standard White Light for the Detection of Adenomas and Serrated Lesions in the Proximal Colon|Recruiting||N/A|350|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 22:20:57.068557|2017-10-10 22:20:57.068557
NCT02724384|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-12|||March 2016||2016-03-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluating the Safety, Tolerability and Preliminary Efficacy of Plasma in Improving the Appearance of Onychomycosis|A Multi-Center Pilot Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of the Plasma Treatment System in Improving the Appearance of Onychomycosis|Recruiting||N/A|75|Anticipated|Moe Medical Devices||3|||f||||||||||||||2017-10-10 22:20:57.1682|2017-10-10 22:20:57.1682
NCT02724371|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-08-22|||April 1, 2016|Actual|2016-04-01|August 2017|2017-08-01|September 1, 2026|Anticipated|2026-09-01|September 1, 2026|Anticipated|2026-09-01||Interventional|Athena||A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction|A Study of the Safety and Effectiveness of the Mentor Smooth and Textured Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction|Recruiting||N/A|400|Anticipated|Mentor Worldwide, LLC||2|||f||||f||||||||||2017-10-10 22:20:57.388372|2017-10-10 22:20:57.388372
NCT02724358|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-28|||December 2012||2012-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1||Completed||N/A|320|Actual|Eastern Hepatobiliary Surgery Hospital||4|||f||||t||||||||||2017-10-10 22:20:57.599879|2017-10-10 22:20:57.599879
NCT02724345|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-28|||January 2013||2013-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|||Postoperative Adjuvant TACE Treatment in CK18 Positive Patients|The Effect of Postoperative Adjuvant TACE Treatment in CK18 Positive Patients of Hepatocellular Carcinoma.|Completed||N/A|320|Actual|Eastern Hepatobiliary Surgery Hospital|||2||f||||t||||||Samples With DNA|"     tumor tissue   "|||2017-10-10 22:20:57.68781|2017-10-10 22:20:57.68781
NCT02724332|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-28|||November 2012||2012-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC|A Randomized Controlled Study on the Effect of Adjuvant Anti-recurrence Treatment With Rapamycin on Early-stage HCC With Overexpression of ASPH After Radical Surgery.|Completed||Phase 1|300|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 22:20:57.767971|2017-10-10 22:20:57.767971
NCT02724319|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-12-20|||May 2016||2016-05-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Implementation of CYP2C19 Genotyping to Guide Antiplatelet Therapy|Implementation of CYP2C19 Genotyping to Guide Antiplatelet Therapy for Patients Undergoing Cardiac Catheterization at UF Health Jacksonville|Recruiting||N/A|2500|Anticipated|University of Florida|||1||f||||f||||||Samples With DNA|"     As part of the study, patients will also be asked to provide consent for the collection and     storage of a blood sample to be deidentified and stored in the UF College of Pharmacy Center     for Pharmacogenomics Bank (IRB 201500133) for future research to examine additional genetic     determinants of effectiveness of antiplatelet therapy as well as asked to consent to the     sharing of their de-identified research data through database of Genotypes and Phenotypes     (dbGaP) .   "|Yes|Patients will be asked to also have a single blood sample collected which will be stored for future research, and the option to share data to the public NIH database of Genotypes and Phenotypes (dbGaP). dbGaP was developed to archive and distribute the data and results from studies that have investigated the interaction of genotype and phenotype in Humans.|2017-10-10 22:20:57.853893|2017-10-10 22:20:57.853893
NCT02724306|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-03-24|||March 2011||2011-03-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|PARC||Physical Activity Intervention With People at Increased Risk of Developing Colon Cancer|A Randomised Controlled Trial Investigating the Effect of a 12 Month Active Lifestyle Programme on Physiological Risk Markers and Physical Activity Behaviour in Those Diagnosed With Intermediate or High Risk for Colon Cancer|Completed||N/A|31|Actual|University of East Anglia||2|||f||||f||||||||No||2017-10-10 22:20:57.951968|2017-10-10 22:20:57.951968
NCT02723942|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-08-15|||June 2015|Actual|2015-06-01|March 2016|2016-03-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||CAR-T Cell Immunotherapy for HCC Targeting GPC3|Chimeric Antigen Receptor-Modified T Cell (CAR-T) Immunotherapy for Hepatocellular Carcinoma (HCC) Targeting Glypican-3 (GPC3)|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 22:21:01.54498|2017-10-10 22:21:01.54498
NCT02724293|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-03-30|||September 2014||2014-09-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy and Safety of Peri-operative Pregabalin After Radical Cystectomy|Analgesic Efficacy and Safety of Peri-operative Pregabalin Following Radical Cystectomy, a Prospective,Randomized, Double-blinded, Controlled Trial|Completed||Phase 2/Phase 3|60|Actual|Assiut University||4|||f||||f||||||||||2017-10-10 22:20:58.035797|2017-10-10 22:20:58.035797
NCT02724280|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-03-15|||September 1, 2016|Actual|2016-09-01|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|||Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy|Linked Color Imaging (LCI) System in the Identification of Normal Gastric Mucosa, Helicobacter Pylori Associated Gastritis and Gastric Atrophy|Completed||N/A|253|Actual|Affiliated Hospital to Academy of Military Medical Sciences|||2||f||||t||||||Samples Without DNA|"     Histological biopsies from gastric mucosa   "|Undecided||2017-10-10 22:20:58.116071|2017-10-10 22:20:58.116071
NCT02724267|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-28|2016-03-28|||November 2012||2012-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Targeted Internal Radiation Therapy in Advanced HCC Patients.|A Randomized Controlled Prospective Study of Targeted Internal Radiation Therapy in Patients With Advanced Hepatocellular Carcinoma.|Completed||N/A|200|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 22:20:58.214356|2017-10-10 22:20:58.214356
NCT02724254|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients|A Double-blind Placebo Controlled, Randomized, Phase II Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients|Recruiting||Phase 2|210|Anticipated|Aviragen Therapeutics||2|||f||||t||||||||||2017-10-10 22:20:58.298716|2017-10-10 22:20:58.298716
NCT02724241|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-24|||April 2015||2015-04-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||E-Cigarettes and SNA|The Effects of Electronic Cigarettes on Sympathetic Nerve Activity and Oxidative Stress|Recruiting||N/A|120|Anticipated|University of California, Los Angeles||3|||f||||f||||||||No||2017-10-10 22:20:58.431714|2017-10-10 22:20:58.431714
NCT02724228|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-08|||January 2016||2016-01-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|October 2022|Anticipated|2022-10-01||Interventional|ACH||A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)|A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of BMN 111 in Children With Achondroplasia|Enrolling by invitation||Phase 2|30|Anticipated|BioMarin Pharmaceutical||1|||f||||t||||||||No||2017-10-10 22:20:58.532465|2017-10-10 22:20:58.532465
NCT02724215|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-12-31|||March 2016||2016-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Effect of Sleep Apnea on Blood Pressure Control and Outcome Early After Subarachnoid Hemorrhage|Effect of Sleep Apnea on Blood Pressure Control and Outcome Early After Subarachnoid Hemorrhage|Recruiting||N/A|200|Anticipated|University Hospital, Bonn|||2||f||||f||||||||No||2017-10-10 22:20:58.639013|2017-10-10 22:20:58.639013
NCT02724202|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-31|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Curcumin in Combination With 5FU for Colon Cancer|A Pilot, Feasibility Study of Curcumin in Combination With 5FU for Patients With 5FU-Resistant Metastatic Colon Cancer|Recruiting||Early Phase 1|14|Anticipated|Baylor Research Institute||1|||f||||f||||||||Yes||2017-10-10 22:20:58.738238|2017-10-10 22:20:58.738238
NCT02724189|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-10-25|||April 2016||2016-04-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||The Evaluation of MyPreOp, an Online Preoperative Assessment Tool|The Evaluation of MyPreOp© (Online Pre-assessment Tool) Over a Conventional Nurse Led Pre-assessment Clinic: a Pilot and Feasibility Study.|Terminated||N/A|200|Actual|University College London Hospitals|||1|Lack of logistic capabilities at the study site|f||||f||||||||Yes|The investigators plan to publish anonymised study results on the Surgical Outcome Research Centre website. http://www.uclsource.com/|2017-10-10 22:20:58.852603|2017-10-10 22:20:58.852603
NCT02724176|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-25|||January 2012||2012-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer|Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer|Completed||N/A|140|Actual|Beijing Cancer Hospital||1|||f||||t||||||||No||2017-10-10 22:20:58.950768|2017-10-10 22:20:58.950768
NCT02724163|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01|December 2032|Anticipated|2032-12-01|December 2031|Anticipated|2031-12-01||Interventional|Myechild01||International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia|International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia - Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination With Induction Chemotherapy|Recruiting||Phase 3|700|Anticipated|University of Birmingham||7|||f||||t||||||||No||2017-10-10 22:20:59.052868|2017-10-10 22:20:59.052868
NCT02724150|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-12-26|||December 2020||2020-12-01|December 2016|2016-12-01|July 2021|Anticipated|2021-07-01|February 2021|Anticipated|2021-02-01||Interventional|||Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding|Low Dose Against High Dose of Proton Pump Inhibitors in Treatment Acute Peptic Ulcer Bleeding|Not yet recruiting||Phase 4|100|Anticipated|Damascus Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:20:59.234736|2017-10-10 22:20:59.234736
NCT02724137|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-20|||April 2016||2016-04-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Novel Physical Therapy Administered Physical Activity Intervention After TKR: A Pilot Study|A Novel Physical Therapy Administered Physical Activity Intervention After TKR: A Pilot Study|Active, not recruiting||N/A|43|Actual|University of Delaware||2|||f||||t||||||||||2017-10-10 22:20:59.343945|2017-10-10 22:20:59.343945
NCT02724124|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-26|||December 2015||2015-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Acute Effect of Static Stretching and Muscle Warming on the Functional Performance of College Volleyball Athletes||Completed||N/A|55|Actual|Universidade Federal do Rio Grande do Norte||5|||f||||t||||||||Yes|Each individual receives a report of their performance|2017-10-10 22:20:59.429112|2017-10-10 22:20:59.429112
NCT02724098|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-09-11|||April 2016||2016-04-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2016|Actual|2016-05-01||Interventional|ScDex||Bioavailability of Subcutaneous Dexmedetomidine|Bioavailability of Subcutaneously Given Dexmedetomidine in Healthy Volunteers|Completed||Phase 4|10|Actual|Turku University Hospital||2|||f||||f||||||||||2017-10-10 22:20:59.612519|2017-10-10 22:20:59.612519
NCT02724085|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-09-06|||December 18, 2015|Actual|2015-12-18|September 2017|2017-09-01|December 12, 2016|Actual|2016-12-12|September 28, 2016|Actual|2016-09-28||Interventional|||A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous TP-271 in Healthy Adult Subjects|Completed||Phase 1|57|Actual|Tetraphase Pharmaceuticals, Inc.||7|||f||||t||||||||||2017-10-10 22:20:59.689375|2017-10-10 22:20:59.689375
NCT02724072|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-04-28|||August 22, 2016|Actual|2016-08-22|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Thoraflex™ Hybrid IDE Study|Evaluation of the Thoraflex™ Hybrid Device for Use in the Repair or Replacement of the Ascending Aorta, Aortic Arch and Descending Aorta in an Open Surgical Procedure.|Recruiting||N/A|83|Anticipated|Terumo CVS||1|||f||||t||||||||No||2017-10-10 22:20:59.80271|2017-10-10 22:20:59.80271
NCT02724059|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-10-22|||November 2015||2015-11-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||The Role of Endobronchial Ultrasound Elastography in the Diagnosis of Mediastinal Lesions|The Role of Endobronchial Ultrasound Elastography in the Diagnosis of Mediastinal Lesions|Completed||N/A|56|Actual|Tanta University||1|||f||||t||||||||Undecided||2017-10-10 22:20:59.941113|2017-10-10 22:20:59.941113
NCT02724046|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-11|||April 22, 2017|Actual|2017-04-22|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|May 30, 2017|Actual|2017-05-30||Interventional|||Ciprofloxacin for the Prevention of Meningococcal Meningitis|Cluster-randomized Trial to Evaluate the Impact of Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response|Active, not recruiting||Phase 4|300|Actual|Epicentre||3|||f||||f|f|f||||||||2017-10-10 22:21:00.066725|2017-10-10 22:21:00.066725
NCT02724033|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-02-08|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparative Study of Superficial Cervical Plexus Block and Nerve of Arnold Block and Incidence of PONV for Inner Ear Surgery|Comparative Study of Superficial Cervical Plexus Block and Nerve of Arnold Block With Intravenous Antiemetic Drugs Dexamethasone and Ondansetron and Incidence of Post-operative Nausea Vomiting for Inner Ear Surgery|Recruiting||Phase 4|60|Anticipated|Indiana University||3|||f||||f||||||||||2017-10-10 22:21:00.161166|2017-10-10 22:21:00.161166
NCT02724020|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-05-10|||June 30, 2016|Actual|2016-06-30|May 2017|2017-05-01|November 30, 2020|Anticipated|2020-11-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma|A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Single-Agent MLN0128 and the Combination of MLN0128+MLN1117 Compared With Everolimus in the Treatment of Adult Patients With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma That Has Progressed on Vascular Endothelial Growth Factor-Targeted Therapy|Recruiting||Phase 2|189|Anticipated|Takeda||3|||f||||f|t|f||||||||2017-10-10 22:21:00.265249|2017-10-10 22:21:00.265249
NCT02724007|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2017-02-26|||January 2016||2016-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Does an International Version of ICISS Predict Mortality for Patients Admitted With Trauma in Four Public University Hospitals in Urban India?|Does an International Version of ICISS Predict Mortality for Patients Admitted With Trauma in Four Public University Hospitals in Urban India?|Completed||N/A|16047|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 22:21:00.473828|2017-10-10 22:21:00.473828
NCT02723994|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-12|||August 2016||2016-08-01|May 2017|2017-05-01|May 2024|Anticipated|2024-05-01|February 2024|Anticipated|2024-02-01||Interventional|||A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia|A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia|Recruiting||Phase 2|170|Anticipated|Incyte Corporation||1|||t||||t||||||||||2017-10-10 22:21:00.549459|2017-10-10 22:21:00.549459
NCT02723981|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-02-17|||April 2016||2016-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|COSTA||COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials|Prospective, Multi-centre, Randomized, Parallel Comparison to Evaluate the Safety and Efficacy of the Abluminal Sirolimus Coated Bio-engineered Stent (COMBO Stent) in Association With Short-term Single Antiplatelet Therapy in Patients With Coronary Artery Disease With an Indication for Chronic Oral Anticoagulant Therapy as Compared to a Guidelines-based Strategy|Withdrawn||Phase 4|0|Actual|IHF GmbH - Institut für Herzinfarktforschung||2||Regulatory authority approval for the initial study design could not be obtained|f||||t||||||||No||2017-10-10 22:21:01.023034|2017-10-10 22:21:01.023034
NCT02723968|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-24|||September 2009||2009-09-01|March 2016|2016-03-01|April 2012|Actual|2012-04-01|September 2009|Actual|2009-09-01||Interventional|D2M||Cystic Fibrosis Related Diabetes Screening.|Sensitivity and Specificity of Different Methods for Cystic Fibrosis-related Diabetes Screening.|Completed||N/A|29|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:21:01.203743|2017-10-10 22:21:01.203743
NCT02723955|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-04-24|||June 1, 2016||2016-06-01|April 2017|2017-04-01|June 21, 2019|Anticipated|2019-06-21|June 1, 2019|Anticipated|2019-06-01||Interventional|||Dose Escalation and Expansion Study of GSK3359609 in Subjects With Selected Advanced Solid Tumors (INDUCE-1)|A Phase I Open Label Study of GSK3359609 Administered Alone and in Combination With Anticancer Agents in Subjects With Selected Advanced Solid Tumors|Recruiting||Phase 1|304|Anticipated|GlaxoSmithKline||4|||f||||f||||||||||2017-10-10 22:21:01.33028|2017-10-10 22:21:01.33028
NCT02722291|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-30|||March 2016||2016-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Functional and Physiological Changes Induced by Pinhole Glasses in Presbyopia||Recruiting||N/A|40|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||1|||f||||||||||||||2017-10-10 22:21:19.504916|2017-10-10 22:21:19.504916
NCT02723929|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-03-17|||September 2016||2016-09-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of tDCS and tUS on Pain Perception in OA of the Knee|Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS) on the Perception of Pain and Functional Limitations Due to Osteoarthritis of the Knee|Recruiting||N/A|64|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||f||f||||||||2017-10-10 22:21:01.665631|2017-10-10 22:21:01.665631
NCT02723916|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-04-10|||September 2015||2015-09-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|||Parent Training in Pediatric Care: A Self Directed Tablet-Based Approach||Recruiting||N/A|312|Anticipated|Rush University Medical Center||2|||f||||t||||||||No||2017-10-10 22:21:01.852746|2017-10-10 22:21:01.852746
NCT02723903|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-03-24|||December 2015||2015-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hierarchical Treatment Based on Somatization Symptom Checklist|Efficacy of Hierarchical Treatment For Suspected Coronary Heart Disease Based on Somatization Symptom Checklist and Coronary Angiography|Recruiting||Phase 1/Phase 2|200|Anticipated|RenJi Hospital||4|||f||||f||||||||Undecided||2017-10-10 22:21:02.006529|2017-10-10 22:21:02.006529
NCT02723890|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-08-22|||July 2016||2016-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Efficacy and Safety of Using the Novel Tyto Device|The Efficacy and Safety of Using the Novel Tyto Device for Remote Physical Examination by a Physician as Compared to a Standard Medical Physical Examination|Recruiting||N/A|100|Anticipated|Rabin Medical Center||1|||f||||||||||||||2017-10-10 22:21:02.128338|2017-10-10 22:21:02.128338
NCT02723877|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-04-25|||April 2016||2016-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)|An Open Label, Non Randomized, Multicenter Phase 1/2b Study Investigating Safety and Efficacy of PQR309 and Eribulin Combination in Patients With Locally Advanced or Metastatic HER2 Negative and Triple-Negative Breast Cancer|Recruiting||Phase 1/Phase 2|60|Anticipated|PIQUR Therapeutics AG||1|||f||||f|f|f|||f|||Undecided||2017-10-10 22:21:02.246673|2017-10-10 22:21:02.246673
NCT02723864|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-30|2017-07-06|||March 22, 2016||2016-03-22|March 10, 2017|2017-03-10|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors|Phase I Study of Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors|Recruiting||Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:21:02.415834|2017-10-10 22:21:02.415834
NCT02723851|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||Determining the Optimal Cut-off Point of PEA by Corsens Device for Discriminating Between MI and Non-MI Subjects|An Open Label Study for Determining the Optimal Cut-off Point of Peak Endocardial Acceleration Measured by Corsens Device for Discriminating Between MI and Non-MI Subjects|Not yet recruiting||N/A|76|Anticipated|Corsens Medical LTD|||2||f||||f||||||||No||2017-10-10 22:21:02.534446|2017-10-10 22:21:02.534446
NCT02723838|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-03-03|||February 28, 2017|Anticipated|2017-02-28|March 2017|2017-03-01|February 28, 2018|Anticipated|2018-02-28|September 30, 2017|Anticipated|2017-09-30||Interventional|||Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder|A Phase 1b Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder|Withdrawn||Phase 1|0|Actual|Oncolytics Biotech||1||Company has reprioritized clinical plans to focus on later-stage studies.|f||||f|t|f||||||No||2017-10-10 22:21:02.61499|2017-10-10 22:21:02.61499
NCT02723825|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-24|||March 2016||2016-03-01|March 2016|2016-03-01|December 2026|Anticipated|2026-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Study of Prognostic Factors of the Distal Epiphysis of the Tibia Fracture Prognosis|A Multi Center Study of Prognostic Factors of the Distal Epiphysis of the Tibia Fracture|Not yet recruiting||N/A|200|Anticipated|Foshan Hospital of Traditional Chinese Medicine||3|||f||||f||||||||Undecided||2017-10-10 22:21:02.703167|2017-10-10 22:21:02.703167
NCT02723812|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-24|||November 2015||2015-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old|A Bridging Study to Evaluate Safety of GCFLU® One Dose (0.5ml) (Seasonal Influenza Vaccine) Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old|Completed||Phase 4|120|Actual|Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products||1|||f||||f||||||||Undecided||2017-10-10 22:21:02.812303|2017-10-10 22:21:02.812303
NCT02723799|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-30|||January 2012||2012-01-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|July 2012|Actual|2012-07-01||Interventional|HPP||Hope Promotion Program: Effectiveness in Palliative Patients|Promoting Hope at the End of Life: Effectiveness of a Hope Intervention Program in Palliative Patients|Completed||N/A|26|Actual|Instituto Politécnico de Leiria||2|||f||||f||||||||No||2017-10-10 22:21:02.907777|2017-10-10 22:21:02.907777
NCT02723786|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-05-08|||August 27, 2016|Actual|2016-08-27|May 2017|2017-05-01|November 23, 2018|Anticipated|2018-11-23|December 1, 2017|Anticipated|2017-12-01||Interventional|||Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation|A Phase 2 Pilot, Multicenter, Single Arm Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GSK1070806 Plus Standard of Care for the Prevention of Delayed Graft Function in Adult Subjects After Renal Transplantation|Recruiting||Phase 2|31|Anticipated|GlaxoSmithKline||1|||f||||f|f|f||||||||2017-10-10 22:21:02.996742|2017-10-10 22:21:02.996742
NCT02723760|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-24|||November 2015||2015-11-01|March 2016|2016-03-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|TRGDRA||99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis Patients|Clinical Study of 99mTc-3PRGD2 SPECT/CT in Diagnosis and Efficacy Evaluation of Rheumatoid Arthritis|Recruiting||Early Phase 1|40|Anticipated|First Affiliated Hospital of Fujian Medical University||1|||f||||t||||||||Yes||2017-10-10 22:21:03.762235|2017-10-10 22:21:03.762235
NCT02723734|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-05|||September 20, 2016|Actual|2016-09-20|July 2017|2017-07-01|May 31, 2021|Anticipated|2021-05-31|September 30, 2018|Anticipated|2018-09-30||Observational|VANDAAM||Validation Study on the Impact of Decipher® Testing - VANDAAM Study|A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non-African American Men With Prostate Cancer (VANDAAM Study)|Recruiting||N/A|240|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||2||f||||f|f|f||||Samples With DNA|"     One PCa biopsy specimen (collected at baseline for all participants). One PCa RP specimen     (only for those participants that select surgery). Blood Specimen (collected at baseline for     all participants if they agree to participate in blood draw).   "|||2017-10-10 22:21:03.962331|2017-10-10 22:21:03.962331
NCT02723721|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-08-22|||June 2016||2016-06-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|May 2019|Anticipated|2019-05-01||Interventional|PICAMEL||Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face|Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face - Study PICAMEL|Recruiting||Phase 2|26|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 22:21:04.065099|2017-10-10 22:21:04.065099
NCT02723708|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-06-22|||August 2016||2016-08-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Ventral Tegmental Area (VTA) Self-Activation in Attention Deficit Hyperactivity Disorder (ADHD)|Increasing Motivation in Attention Deficit Hyperactivity Disorder (ADHD) Via Self-activation of Ventral Tegmental Area (VTA)|Recruiting||N/A|40|Anticipated|Duke University||1|||f||||f||||||||No||2017-10-10 22:21:04.172355|2017-10-10 22:21:04.172355
NCT02723695|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-03-24|||March 2014||2014-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|ORIENTIMPLANT||Perception and Equilibrium After Cochlear Implantation|Assessment of Perceptual and Postural Performances Following a Cochlear Implantation|Recruiting||N/A|50|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 22:21:04.2619|2017-10-10 22:21:04.2619
NCT02723682|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-24|||March 2013||2013-03-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||National Health and Nutrition Examination Survey 24-hour Urine Collection Feasibility Study, 2013|National Health and Nutrition Examination Survey 24-Hour Urine Collection Feasibility Study, 2013|Completed||N/A|282|Actual|Centers for Disease Control and Prevention|||1||f||||f||||||||No|The NHANES 24-hour urine pilot study data set can be made available through the National Center for Health Statistics Research Data Center by submitting a research proposal at http://www.cdc.gov/rdc/.|2017-10-10 22:21:05.984141|2017-10-10 22:21:05.984141
NCT02723669|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-29|||April 2014||2014-04-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Relative Bioavailability of AR10 Compared to Reference Product|Open Label, Randomized, Two-Arm, Single-Dose, Two-Period, Crossover Study to Determine the Relative Bioavailability of AR10 (Acetylcysteine Effervescent Tablets) Compared to Reference Product in Healthy, Adult Subjects, Fasting|Completed||Phase 1|30|Actual|Arbor Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 22:21:06.058706|2017-10-10 22:21:06.058706
NCT02723656|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-03-03|||March 2016||2016-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Proactive Care Coordination for Cancer Survivors Who Smoke|Using Cancer Registry Data to Promote Proactive Tobacco Cessation Among Adult Cancer Survivors U48|Recruiting||N/A|600|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:21:06.143543|2017-10-10 22:21:06.143543
NCT02723643|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-29|||January 2016||2016-01-01|March 2016|2016-03-01||||December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|||Potential Associated Factors of Uncontrolled Hypertension|Initial Investigation on Potential Associated Factors of Uncontrolled Hypertension in Outpatient Department: A Prospective Registry Study|Recruiting||N/A|2000|Anticipated|Guangdong General Hospital|||1||f||||||||||Samples With DNA|"     Venous blood will be sampled for further DNA assessment after informed consent is obtained   "|||2017-10-10 22:21:06.237687|2017-10-10 22:21:06.237687
NCT02723630|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-03-24|||July 2013||2013-07-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Bioequivalence Study to Evaluate the Impact of Varying Crystalline Polymorph Forms for the Commercial Oral Capsule Formulation of 10-mg Lenvatinib in Healthy Volunteers|A Randomized, Three-treatment, Three-period, Six-sequence Crossover, Single-center, Bioequivalence Study to Evaluate the Impact of Varying Crystalline Polymorph Forms for the Commercial Oral Capsule Formulation of 10-mg Lenvatinib in Healthy Volunteers|Completed||Phase 1|60|Actual|Eisai Inc.||6|||f||||||||||||||2017-10-10 22:21:06.327149|2017-10-10 22:21:06.327149
NCT02723617|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-12-19|||April 2016||2016-04-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Dose-Response Effects of Lean Beef in a Mediterranean-Style Dietary Pattern on Cardiovascular Disease Risk Factors||Active, not recruiting||N/A|70|Anticipated|USDA Beltsville Human Nutrition Research Center||4|||f||||f||||||||No||2017-10-10 22:21:06.424483|2017-10-10 22:21:06.424483
NCT02723604|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-05-22|||March 2016||2016-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|June 30, 2017|Anticipated|2017-06-30||Interventional|||Low-Level Laser Therapy for Prevention of Oral Mucositis|A Phase II Prospective Trial of Low-Level Laser Therapy for Prevention of Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer|Recruiting||N/A|25|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||Yes|The same protocol will be opened separately at the University of Pittsburgh Medical Center, where an additional 25 patients will be enrolled. A Data Use Agreement will allow combination of the data for a total of 50 patients to be analyzed.|2017-10-10 22:21:06.526289|2017-10-10 22:21:06.526289
NCT02723591|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-10-05|||September 9, 2016|Actual|2016-09-09|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|ASTOUND||To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients|Astagraf XL® to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation|Recruiting||Phase 4|550|Anticipated|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 22:21:06.649809|2017-10-10 22:21:06.649809
NCT02723578|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-09-12|||December 2015||2015-12-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Pemetrexed and Erlotinib for Metastatic Colorectal Cancer|A Phase 2 Study of Pemetrexed and Erlotinib for Metastatic Colorectal Cancer Refractory to Standard Chemotherapy|Active, not recruiting||Phase 2|50|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 22:21:06.978637|2017-10-10 22:21:06.978637
NCT02723565|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-04-04|||April 2014||2014-04-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|USEFUL||Ultrasound to Evaluate Failure of Liberation From Mechanical Ventilation|Ultrasound to Evaluate Failure of Liberation From Mechanical Ventilation|Recruiting||N/A|50|Anticipated|University Health Network, Toronto|||1||f||||f|f|f||||||No||2017-10-10 22:21:07.071328|2017-10-10 22:21:07.071328
NCT02723552|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-23|||March 2016||2016-03-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01||Interventional|TEPHRA||Trial of Exercise to Prevent HypeRtension in Young Adults|Trial of Exercise to Prevent HypeRtension in Young Adults|Not yet recruiting||N/A|200|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 22:21:07.164436|2017-10-10 22:21:07.164436
NCT02723539|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-03-07|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI|A Phase 1b/2a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Adjunctive Treatment With Topically Applied MBN-101 in Patients With Moderate to Severe Diabetic Foot Infection (DFI)|Recruiting||Phase 1/Phase 2|100|Anticipated|Microbion Corporation||2|||f||||t|t|f||||||No||2017-10-10 22:21:07.286536|2017-10-10 22:21:07.286536
NCT02723526|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2016-03-30|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer|Development of a Prognostic Model for Metastatic Hormone-sensitive Prostate Cancer by Sequentially Analyzing the Expression of Tumor Markers in Circulating Tumor Cells|Recruiting||N/A|100|Anticipated|Fudan University|||1||f||||f||||||||No||2017-10-10 22:21:07.386119|2017-10-10 22:21:07.386119
NCT02723513|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2017-05-08|||April 1, 2016|Actual|2016-04-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD|Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult Chronic Obstructive Pulmonary Disease|Recruiting||N/A|50|Anticipated|Western University, Canada||1|||f||||f||||||||||2017-10-10 22:21:07.482301|2017-10-10 22:21:07.482301
NCT02723500|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-05-08|||August 2011||2011-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||129 Xenon MRI in Chronic Lung Disease|A Study Evaluating Hyperpolarized 129 Xenon Magnetic Resonance Imaging in Subjects With Chronic Lung Disease|Recruiting||N/A|100|Anticipated|Western University, Canada||1|||f||||f||||||||||2017-10-10 22:21:07.589602|2017-10-10 22:21:07.589602
NCT02723487|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-03-03|||April 2016||2016-04-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Ultrasound Guided Transversus Abdominis Plane Block in Pediatric Surgery|Postoperative Analgesic Efficacy of Transversus Abdominis Plane Block by Bupivacaine With Two Different Concentrations in Pediatric Patient Undergoing Laparoscopic Surgery|Recruiting||Phase 2|60|Anticipated|Assiut University||3|||f||||t||||||||Undecided||2017-10-10 22:21:07.714505|2017-10-10 22:21:07.714505
NCT02723474|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-05-08|||November 2007||2007-11-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||A Single-Centre Pilot Study Exploring the Utility of Magnetic Resonance Imaging in Patients With Chronic Lung Disease|A Single-Centre Pilot Study Exploring the Utility of Magnetic Resonance Imaging in Patients With Chronic Lung Disease|Recruiting||N/A|100|Anticipated|Western University, Canada||1|||f||||f||||||||||2017-10-10 22:21:07.825788|2017-10-10 22:21:07.825788
NCT02723461|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-26|2016-09-19|||March 2016||2016-03-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||Continuous Oxytocin Infusion Versus Pulsatile Intravenous Oxytocin for Augmentation of First Stage of Labor|Randomised Controlled Trial Comparing Continuous Intravenous Oxytocin Infusion With Pulsatile Administration of Intravenous Oxytocin for Augmentation of the First Stage of Labor|Recruiting||Phase 4|120|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:21:07.918951|2017-10-10 22:21:07.918951
NCT02723448|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-12-15|||December 2016||2016-12-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|RVCL||Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy|A Pilot Study of Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)|Recruiting||Phase 1|10|Anticipated|Washington University School of Medicine||1|||f||||f||||||||Yes|Data will be shared among the principal investigator and the sub-investigators.|2017-10-10 22:21:08.003864|2017-10-10 22:21:08.003864
NCT02723435|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-04-24|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant|An Open-Label Extension Study of Post-Transplant Maintenance Midostaurin (PKC412) in Elderly Patients (Age ≥ 60 Years) With FLT3-ITD/TKD Mutated AML Who Previously Received Midostaurin and Decitabine as Part of Study HEMAML0022 / CPKC412AUS27T|Not yet recruiting||Phase 2|20|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 22:21:08.136011|2017-10-10 22:21:08.136011
NCT02723422|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-01-27|||January 2017||2017-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|TAVR-PT||Transcatheter Aortic Valve Replacement (TAVR)-Pilot Trial|Intensive Versus Usual Home-based Physical Therapy to Promote Functional Recovery After Transcatheter Aortic Valve Replacement (TAVR): A Pilot Randomized Trial|Withdrawn||N/A|0|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:21:08.244947|2017-10-10 22:21:08.244947
NCT02723409|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-01-19|||January 2016||2016-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Techniques for Umbilical Reconstruction|Umbilicoplasty: A Randomized Controlled Trial of Techniques for Umbilical Reconstruction Following Abdominoplasty and Abdominally-based Free Tissue Transfer|Recruiting||N/A|175|Anticipated|New York University School of Medicine||5|||f||||||||||||||2017-10-10 22:21:08.335697|2017-10-10 22:21:08.335697
NCT02723396|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-03-23|||March 2016||2016-03-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|SA&M-I||Sleep, Awake & Move - Part I|Sleep & Move. Systematic Characterisation of Sleep Benefit in Parkinson's Disease. An Observational, Prospective Study|Recruiting||N/A|80|Anticipated|Neurocenter of Southern Switzerland|||1||f||||f||||||||No||2017-10-10 22:21:08.434572|2017-10-10 22:21:08.434572
NCT02723383|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-01-17|||June 2016||2016-06-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|BACLOREA||Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU|Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU: Study Protocol for a Randomised Controlled Against Placebo Trial|Recruiting||Phase 3|314|Anticipated|Nantes University Hospital||2|||f||||t||||||||No||2017-10-10 22:21:08.56448|2017-10-10 22:21:08.56448
NCT02723370|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-01-06|||May 2013||2013-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|STIC||Implementation of Evidence Based Practices for Colonoscopy: The Strategies to Improve Colonoscopy Study|Understanding Variability in Success of Quality Improvement for Colonoscopy|Completed||N/A|46184|Actual|Washington University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:21:08.706956|2017-10-10 22:21:08.706956
NCT02723357|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Impact of Family Financial Support on Parental Mental Health|The Impact of Family Financial Support on Parental Mental Health|Recruiting||N/A|150|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 22:21:08.907121|2017-10-10 22:21:08.907121
NCT02723344|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-07-26|||August 1, 2016|Actual|2016-08-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Biological Signatures, Probiotic Among Those With mTBI and PTSD|Biological Signature and Safety of an Immunomodulatory Probiotic Intervention for Veterans With Co-Occurring Mild TBI and PTSD|Recruiting||Phase 1|60|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:21:09.021145|2017-10-10 22:21:09.021145
NCT02723331|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-10|||December 30, 2016|Actual|2016-12-30|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates|Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates|Recruiting||Phase 2|50|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 22:21:09.157587|2017-10-10 22:21:09.157587
NCT02723318|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Impact of Family Financial Support on Cognition|The Impact of Family Financial Support on Cognition|Recruiting||N/A|150|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No|Participant consent did not include data sharing and there is no appropriate repository for data to be shared through.|2017-10-10 22:21:09.313244|2017-10-10 22:21:09.313244
NCT02723305|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-10-04|||May 2016||2016-05-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Cardiometabolic Profiles of Boys With Klinefelter Syndrome|Cardiometabolic Profiles of Pubertal Boys With Klinefelter Syndrome With or Without One Year of Exogenous Testosterone Treatment|Recruiting||N/A|10|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 22:21:09.42041|2017-10-10 22:21:09.42041
NCT02723292|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-04-19|||September 2011||2011-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||City of Rochester Teen Outreach Program (TOP™) Evaluation|City of Rochester Teen Outreach Program (TOP™) Evaluation|Completed||N/A|1188|Actual|University of Rochester||2|||f||||f||||||||Undecided||2017-10-10 22:21:09.569588|2017-10-10 22:21:09.569588
NCT02723279|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-27|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|October 2016|Actual|2016-10-01||Interventional|||Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women|A Comparison Study on Efficacies of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women|Completed||N/A|120|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-10 22:21:09.649473|2017-10-10 22:21:09.649473
NCT02723266|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-08|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|March 1, 2020|Anticipated|2020-03-01|November 30, 2019|Anticipated|2019-11-30||Interventional|||Supporting American Indian/Alaska Native Mothers and Daughters in Reducing Gestational Diabetes Risk|Supporting American Indian/Alaska Native Mothers and Daughters in Reducing Gestational Diabetes Risk|Not yet recruiting||N/A|600|Anticipated|University of Pittsburgh||2|||f||||t|f|f||||||||2017-10-10 22:21:09.754829|2017-10-10 22:21:09.754829
NCT02723253|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-03-29|||January 2005||2005-01-01|March 2016|2016-03-01|February 2012|Actual|2012-02-01|January 2008|Actual|2008-01-01||Interventional|||Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer|Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer: A Phase II Study.|Completed||Phase 2|18|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||f||||||||No||2017-10-10 22:21:09.859272|2017-10-10 22:21:09.859272
NCT02723240|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-09-14|||January 2016||2016-01-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|NuTide:301||NUC-3373 in Advanced Solid Tumours|A Two-part, Phase I Open Label, Dose Escalation and Expansion Study to Assess Safety, Pharmacokinetics and Clinical Activity of NUC-3373, a Nucleotide Analogue, in Participants With Advanced Solid Tumours|Recruiting||Phase 1|68|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 22:21:09.951336|2017-10-10 22:21:09.951336
NCT02723227|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Impact of Family Financial Support on Parental Stress|The Impact of Family Financial Support on Parental Stress|Recruiting||N/A|150|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No|Participant consent did not include data sharing and there is no appropriate repository to share data with|2017-10-10 22:21:10.08326|2017-10-10 22:21:10.08326
NCT02723214|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-07-28|||January 2012||2012-01-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Parameters Between a Frameless Brain Biopsy Method and the Standard Frame-based Stereotactic Biopsy|Comparison of Efficacy, Safety, Duration and Postoperative Hospitalization Between a Frameless Fiducial-less Brain Biopsy Method and the Standard Frame-based Stereotactic Biopsy|Completed||N/A|56|Actual|University Hospital of Patras||2|||f||||t||||||||No||2017-10-10 22:21:10.179765|2017-10-10 22:21:10.179765
NCT02723188|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-13|2016-10-26||September 2014||2014-09-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Modulation of Fear Extinction Processes Using Transcranial Electrical Stimulation|Modulation of Fear Extinction Processes Using Transcranial Electrical Stimulation|Completed||N/A|45|Actual|Tel Aviv University||3|||f||||f||||||||No||2017-10-10 22:21:10.449544|2017-10-10 22:21:10.449544
NCT02723175|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-03-23|||November 2014||2014-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||The Effects of CBT and (tDCS) on Fibromyalgia Patients|The Effects of Cognitive Behavioral Therapy and Transcranial Direct Current Stimulation (tDCS) on Fibromyalgia Patients|Recruiting||N/A|72|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-10 22:21:10.908539|2017-10-10 22:21:10.908539
NCT02723162|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-23|||January 2016||2016-01-01|March 2016|2016-03-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|||Translational Neuropsychopharmacology Research of Nicotine Addiction|Translational Neuropsychopharmacology Research of Nicotine Addiction|Active, not recruiting||N/A|100|Anticipated|Medical University of South Carolina||4|||f||||t||||||||||2017-10-10 22:21:11.03103|2017-10-10 22:21:11.03103
NCT02723149|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-12-01|||November 2015||2015-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|MJ-AAT||Marijuana Approach Bias Retraining and Neural Response in Youth|Marijuana Approach Bias Retraining and Neural Response in Youth|Active, not recruiting||N/A|40|Anticipated|Medical University of South Carolina||2|||f||||||||||||||2017-10-10 22:21:11.130492|2017-10-10 22:21:11.130492
NCT02723136|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-27|2016-05-14|||April 2016||2016-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|iSTART||Implementation of a Smartphone Application in Medical Education|Implementing a Smartphone Application to Optimise Academic Performance Among Medical Students: A Randomised Trial|Completed||N/A|80|Actual|Universidad de Valparaiso||2|||f||||f||||||||No|There is currently no plan to make individual participant data available.|2017-10-10 22:21:11.21884|2017-10-10 22:21:11.21884
NCT02723123|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-09-11|||April 2016||2016-04-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Non-invasive Support in Extremely Preterm Infants|Respiratory Behaviour of Extremely Preterm Infants Receiving Non-invasive Respiratory Support During the Immediate Post-extubation Period|Recruiting||N/A|30|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-10-10 22:21:11.330839|2017-10-10 22:21:11.330839
NCT02723110|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-06-21|||June 2015||2015-06-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|DIVA - PAM||Defining the Physiological Mechanisms of Risk Genes for Hyperglycaemia, Insulin Resistance and Type 2 Diabetes|Defining the Physiological Mechanisms of Risk Genes for Hyperglycaemia, Insulin Resistance and Type 2 Diabetes|Recruiting||N/A|40|Anticipated|University of Oxford|||2||f||||||||||Samples With DNA|"     EDTA plasma, serum, lithium heparin   "|||2017-10-10 22:21:11.45236|2017-10-10 22:21:11.45236
NCT02723097|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-10-04|||March 2016||2016-03-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Pilot Test of the Relaxation Response Resiliency Program (3RP) in Spanish Speaking World Trade Center Survivors With Post Traumatic Stress Disorder (PTSD)||Recruiting||N/A|20|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:21:11.578875|2017-10-10 22:21:11.578875
NCT02723084|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-11|||April 8, 2016||2016-04-08|May 2017|2017-05-01|March 24, 2017|Actual|2017-03-24|January 19, 2017|Actual|2017-01-19||Interventional|CERTAIN-2||A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection|A Randomized, Open-Label, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection (CERTAIN-2)|Completed||Phase 3|136|Actual|AbbVie||2|||f||||f||||||||||2017-10-10 22:21:11.678384|2017-10-10 22:21:11.678384
NCT02723071|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-03-24|||May 2005||2005-05-01|March 2016|2016-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)|An Open-label, Multicentre, Dose-escalating Phase I/II Trial of 3-weekly Ocrelizumab in Patients With Follicular Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 1/Phase 2|48|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:21:12.04511|2017-10-10 22:21:12.04511
NCT02723058|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-24|||December 2009||2009-12-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2012|Actual|2012-11-01||Interventional|ICMHM||The Integrated Care Model for Homeless Mothers|The Integrated Care Model for Homeless Mothers|Completed||N/A|67|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||No||2017-10-10 22:21:12.216762|2017-10-10 22:21:12.216762
NCT02723045|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-24|||April 2016||2016-04-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|October 2016|Anticipated|2016-10-01||Interventional|||Quality of Life of TEP vs Lichtenstein Hernioplasty|The Comparison of the Quality of Life and Outcomes in Patient's With Reducible Inguinal Hernias: Laparoscopic Totally Extra-peritoneal (TEP) Versus Modified Lichtenstein Hernioplasty|Not yet recruiting||N/A|100|Anticipated|Sarawak General Hospital||2|||f||||f||||||||No||2017-10-10 22:21:12.309455|2017-10-10 22:21:12.309455
NCT02723032|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-10-26|||March 2016||2016-03-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|OxyFrame||Validation of a Miniature SpO2 Sensor in Healthy Subjects and Patients With Long-term Oxygen Therapy.|Validation of a Miniature SpO2 Sensor in Healthy Subjects and Patients With Long-term Oxygen Therapy. A Prospective, Method Comparison, Proof of Concept Study.|Completed||N/A|36|Actual|University Hospital Inselspital, Berne||1|||f||||t||||||||||2017-10-10 22:21:12.3987|2017-10-10 22:21:12.3987
NCT02723019|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-12|||July 2016||2016-07-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|February 2020|Anticipated|2020-02-01||Interventional|Mi Puente||Mi Puente: My Bridge to Better Cardiometabolic Health and Well-Being|Mi Puente: My Bridge to Better Cardiometabolic Health and Well-Being|Recruiting||N/A|560|Anticipated|Scripps Whittier Diabetes Institute||2|||f||||t||||||||||2017-10-10 22:21:12.496182|2017-10-10 22:21:12.496182
NCT02723006|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-25|2017-06-05|||July 5, 2016|Actual|2016-07-05|June 2017|2017-06-01|November 15, 2018|Anticipated|2018-11-15|November 15, 2018|Anticipated|2018-11-15||Interventional|||Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma|An Open-Label, Phase 1b, Multi-Arm Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Patients With Advanced Melanoma|Recruiting||Phase 1|156|Anticipated|Takeda||3|||f||||f|t|f||||||||2017-10-10 22:21:12.619649|2017-10-10 22:21:12.619649
NCT02722993|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-23|||February 2016||2016-02-01|March 2016|2016-03-01||||March 2017|Anticipated|2017-03-01||Interventional|||Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders||Recruiting||Phase 2|100|Anticipated|Probi AB||2|||f||||f||||||||No||2017-10-10 22:21:12.784347|2017-10-10 22:21:12.784347
NCT02722980|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-05-12|||April 2016||2016-04-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|ProBone16||Efficacy of a Probiotic Product on Bone Mineral Density (BMD) in Healthy Women in Early Post-menopausal Phase|A Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Study Aiming to Evaluate the Efficacy on BMD and Safety of a Probiotic Product in a Population of Healthy Women in Early Post-menopausal Phase, During an Intervention Period of 12 Months|Recruiting||Phase 1/Phase 2|250|Anticipated|Probi AB||2|||f||||f||||||||No||2017-10-10 22:21:12.873634|2017-10-10 22:21:12.873634
NCT02722967|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-10-07|||March 2016||2016-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System|A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole|Completed||Phase 2|49|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||No||2017-10-10 22:21:12.973879|2017-10-10 22:21:12.973879
NCT02722954|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-04-13|||January 2016||2016-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid Tumors|A Phase 1b, Open-Label, Dose Escalation and Expansion Study of Demcizumab Plus Pembrolizumab in Patients With Locally Advanced or Metastatic Solid Tumors|Active, not recruiting||Phase 1|29|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-10 22:21:13.071066|2017-10-10 22:21:13.071066
NCT02722941|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-28|||June 10, 2016|Actual|2016-06-10|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT)|Evaluation of Panobinostat (LBH589) as Maintenance Therapy in Multiple Myeloma Following Autologous Hematopoietic Cell Transplantation|Recruiting||Phase 2|30|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-10 22:21:13.175721|2017-10-10 22:21:13.175721
NCT02722928|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-01-20|||August 2015||2015-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Ventilation With High Oxygen Content and Postoperative Pneumocephalus|Impact of Intraoperative Ventilation With High Oxygen Content to Reduce the Incidence and Extent of Postoperative Pneumocephalus in Patients Undergoing Craniotomies|Recruiting||N/A|160|Anticipated|Ohio State University||2|||f||||f||||||||No||2017-10-10 22:21:13.312781|2017-10-10 22:21:13.312781
NCT02722915|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-05-29|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|APIC-II||Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations||Recruiting||N/A|120|Anticipated|RWTH Aachen University||2|||f||||f||||||||||2017-10-10 22:21:13.419002|2017-10-10 22:21:13.419002
NCT02722902|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-07-24|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Carnitine Infusion and Insulin Resistance|Impact of L-Carnitine Infusion on Lipid Induced Insulin Resistance|Completed||N/A|17|Actual|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-10 22:21:13.538893|2017-10-10 22:21:13.538893
NCT02722889|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-03-20|||March 2016|Actual|2016-03-01|March 2016|2016-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||Aortic Elongation and Dissection|Ascending Aortic Length in Relation to Age and the Occurrence of Type A Aortic Dissection|Completed||N/A|298|Actual|Maastricht University Medical Center|||2||f||||f||||||||No||2017-10-10 22:21:13.658853|2017-10-10 22:21:13.658853
NCT02722876|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-24|||January 30, 2017|Actual|2017-01-30|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|EFCOR||The Efficacy of Rehabilitation Exercise on the Non-operative Limb Following Anterior Cruciate Ligament Reconstruction|The EFficacy of COntralateral Muscle Rehabilitation Exercise Following Anterior Cruciate Ligament Reconstruction (EFCOR)|Recruiting||N/A|44|Anticipated|Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust||2|||f||||t|f|f||||||No|Individual data will not be shared|2017-10-10 22:21:13.74129|2017-10-10 22:21:13.74129
NCT02722863|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-23|||November 2013||2013-11-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|Samsca PMS||Samsca Post Marketing Surveillance Study|"Post Marketing Surveillance Study of Safety and Efficacy of Samsca® Tablets Under the New Drug Re-Examination"|Recruiting||N/A|3000|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.|||1||f||||t||||||||Undecided||2017-10-10 22:21:13.855157|2017-10-10 22:21:13.855157
NCT02722850|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-11-29|||November 2014||2014-11-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Web-based Study for Cancer Survivors|A Lifestyle Intervention Via Email (ALIVE) for Cancer Survivors|Completed||N/A|258|Actual|University of North Texas Health Science Center||2|||f||||t||||||||Undecided|Once data are compiled, the investigators will decide whether it will be available for sharing|2017-10-10 22:21:13.95423|2017-10-10 22:21:13.95423
NCT02721745|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-03-07|||May 2016||2016-05-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|May 2016|Actual|2016-05-01||Interventional|Fatstim||Cause and Consequence of Neural Fatigue|Cause and Consequence of Neural Fatigue|Recruiting||N/A|216|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||6|||f||||f||||||||No||2017-10-10 22:21:25.900827|2017-10-10 22:21:25.900827
NCT02722837|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-09-21|||April 4, 2016|Actual|2016-04-04|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|June 26, 2017|Actual|2017-06-26||Interventional|||Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic Hepatitis C Virus Infection|A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Subjects With Chronic Hepatitis C Virus (HCV) Infection|Completed||Phase 3|119|Actual|Gilead Sciences||1|||f||||f||f||||||||2017-10-10 22:21:14.050168|2017-10-10 22:21:14.050168
NCT02722824|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-07-24|||November 2015||2015-11-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy of a Non-invasive Device for Alleviation of Parkinson's Disease Symptoms|Efficacy Investigation of a Non-invasive Wearable Electrostimulation Device for Alleviation of Parkinson's Disease Symptoms|Completed||N/A|24|Actual|Koç University||4|||f||||f||||||||||2017-10-10 22:21:14.176238|2017-10-10 22:21:14.176238
NCT02722811|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-20|||February 2016||2016-02-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|ESIETNKOA||Efficacy of Subcutaneous Injection of Etanercept for Moderate and Severe Knee Osteoarthritis|Efficacy of Subcutaneous Injection of Etanercept for Moderate and Severe Knee Osteoarthritis|Recruiting||N/A|60|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||Undecided|The investigators have not yet decided whether to share participants' data or not.|2017-10-10 22:21:14.29483|2017-10-10 22:21:14.29483
NCT02722785|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|PRESET||PeRioperative Study of Exercise Training in Patients With Operable Cancer of the Gastroesophageal Junction|PeRioperative Study of Exercise Training - a None-randomized Feasibility Study: Usual Care Observation vs Exercise Training Intervention in Patients With Operable Cancer of the Gastroesophageal Junction|Active, not recruiting||N/A|40|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 22:21:14.56097|2017-10-10 22:21:14.56097
NCT02722772|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-04-07|||February 2016||2016-02-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|EIAIETNKOA||Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee Osteoarthritis|Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee Osteoarthritis|Recruiting||N/A|60|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||Undecided|The investigators have not yet decided whether to share participants' data or not.|2017-10-10 22:21:14.658785|2017-10-10 22:21:14.658785
NCT02722746|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-14|||November 15, 2016|Actual|2016-11-15|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||The Prevention of Hypotension After Epidural Analgesia After Major Surgery|The Prevention of Hypotension After Epidural Analgesia After Major Surgery by Adding Epinephrine to Infusions to Counteract Sympathectomy: a Double- Blind, Controlled, Randomized, Prospective Dose-finding Study|Recruiting||N/A|250|Anticipated|University of Florida||3|||f||||f||||||||||2017-10-10 22:21:14.861112|2017-10-10 22:21:14.861112
NCT02722733|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-24|||March 2016||2016-03-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma|Safety and Efficacy of Stem Cell Mobilization Using G-CSF (Filgrastim) Alone Compared to Intermediate-dose Cytosine Arabinoside Plus G-CSF in Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients.|Recruiting||Phase 3|90|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||t||||||||||2017-10-10 22:21:14.991857|2017-10-10 22:21:14.991857
NCT02722720|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-06-28|||September 2015||2015-09-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral|Prospective, Randomized, Single Center Study of Atherothrombotic and Thromboembolic Events After Carotid Artery Stenting Using Transfemoral and Transradial Approach|Completed||N/A|200|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||No||2017-10-10 22:21:15.135282|2017-10-10 22:21:15.135282
NCT02722707|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-21||||||August 2017|2017-08-01||||||||Expanded Access|||Clinical Use of a Magnetic Anal Sphincter Augmentation Device, Trade Name FENIX|Clinical Use of a Magnetic Anal Sphincter Augmentation Device, Trade Name FENIX. A Humanitarian Use Device ( HUD), Which Has Recently Received a Humanitarian Device Exemption (HDE) From the Food and Drug Administration ( FDA)|Available||N/A|||Mayo Clinic|||||f||||||||||||||2017-10-10 22:21:15.310883|2017-10-10 22:21:15.310883
NCT02722694|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-09-12|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate|A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Abatacept 125mg Administered Subcutaneously in Chinese Subjects With Active Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate|Recruiting||Phase 3|360|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||No||2017-10-10 22:21:15.493961|2017-10-10 22:21:15.493961
NCT02722681|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-23|||February 2016||2016-02-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Developing a Biomarker for Monitoring Clinical Outcomes in Children With Spinal Lipoma.|Developing a Biomarker for Monitoring Clinical Outcomes in Children With Spinal Lipoma|Recruiting||N/A|50|Anticipated|Institute of Child Health|||3||f||||f||||||Samples With DNA|"     Blood samples will be stored during length of project.   "|No||2017-10-10 22:21:15.622458|2017-10-10 22:21:15.622458
NCT02722668|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-10-04|||May 15, 2017|Actual|2017-05-15|September 2017|2017-09-01|December 2029|Anticipated|2029-12-01|May 2028|Anticipated|2028-05-01||Interventional|||UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep|Transplantation of Umbilical Cord Blood From Unrelated Donors in Patients With Hematological Diseases Using a Non-Myeloablative Preparative Regimen|Recruiting||Phase 2|162|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t|t|f|||f|||||2017-10-10 22:21:15.785205|2017-10-10 22:21:15.785205
NCT02722655|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-08-17|||March 2008||2008-03-01|August 2017|2017-08-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01||Observational|CMC-DM||Cohort of Mexican Children With Diabetes Mellitus (CMC-DM)|Characteristics and Evolution of Diabetes Mellitus in Mexican Children: Cohort Study|Recruiting||N/A|500|Anticipated|Hospital Regional de Alta Especialidad del Bajio|||4||f||||f||||||||||2017-10-10 22:21:15.997462|2017-10-10 22:21:15.997462
NCT02722642|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-27|||March 2016||2016-03-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis|A Single-center, Non-randomized, Before-and-after Self Control Study of Bronchial Basal Cell Transplantation for Bronchiectasis Treatment|Recruiting||Phase 1/Phase 2|20|Anticipated|Regend Therapeutics||1|||f||||f||||||||No||2017-10-10 22:21:16.153017|2017-10-10 22:21:16.153017
NCT02722629|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-08-19|||June 2016||2016-06-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Prevalence of Respiratory Aspiration in Patients With COPD|Prevalence of Respiratory Aspiration in Patients With COPD: Cross-sectional Study|Recruiting||N/A|330|Anticipated|Hospital Italiano de Buenos Aires||1|||f||||t||||||||Yes||2017-10-10 22:21:16.315157|2017-10-10 22:21:16.315157
NCT02722616|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-03-06|||May 2015||2015-05-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Ultrasound Monitoring of Abdominal Soft Tissue|Ultrasound System For Non-Invasive, Real-Time Monitoring of Abdominal Soft Tissue|Active, not recruiting||N/A|65|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||Undecided||2017-10-10 22:21:16.438654|2017-10-10 22:21:16.438654
NCT02722603|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-09-01|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Study to Compare Gabapentin to Tramadol in Children|Randomized, Double-blind, Double-dummy, Active Controlled, Multicentre, Non-inferiority Phase-III Study to Compare Gabapentin Liquid Formulation to Tramadol in Children Experiencing Moderate to Severe Chronic Neuropathic or Mixed Pain|Recruiting||Phase 3|94|Anticipated|Pharmaceutical Research Management srl||2|||f||||t|f|f||||||||2017-10-10 22:21:16.549925|2017-10-10 22:21:16.549925
NCT02722590|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-31|||July 2016|Actual|2016-07-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||Post-Marketing Surveillance Study of Fycompa Film-coated Tablets in Korean Patients|Post-Marketing Surveillance of Fycompa Film-coated Tablets 2/4/6/8/10/12mg in Korean Patients|Recruiting||N/A|3000|Anticipated|Eisai Inc.|||1||f||||f||||||||||2017-10-10 22:21:16.735945|2017-10-10 22:21:16.735945
NCT02722577|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-05-18|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia|Usefulness of Unipolar and Bipolar Electrograms in Predicting Successful Ablation Site During Idiopathic Outflow Tract Ventricular Arrhythmia Ablation|Completed||N/A|20|Actual|St. Jude Medical|||1||f||||f||||||||No||2017-10-10 22:21:16.864223|2017-10-10 22:21:16.864223
NCT02722564|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-05-11|2017-05-11||August 2015||2015-08-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values||Completed||N/A|55|Actual|St. Luke's Hospital and Health Network, Pennsylvania||1|||f||||f||||||||||2017-10-10 22:21:16.954248|2017-10-10 22:21:16.954248
NCT02722551|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-12-02|||November 2016||2016-11-01|December 2016|2016-12-01|October 2022|Anticipated|2022-10-01|October 2017|Anticipated|2017-10-01||Interventional|RELIEF||CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study|The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve|Recruiting||Phase 1/Phase 2|200|Anticipated|Edwards Lifesciences||1|||f||||t||||||||No||2017-10-10 22:21:17.207237|2017-10-10 22:21:17.207237
NCT02722538|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-05-08|||May 2016||2016-05-01|May 2017|2017-05-01||||June 2017|Anticipated|2017-06-01||Interventional|||Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer|A Phase 1b, Multicenter, Open Label Study Evaluating Safety, Tolerability and Preliminary Efficacy of GemRIS 225 mg in Subjects With Muscle-Invasive Transitional Cell Carcinoma of the Bladder|Recruiting||Phase 1|26|Anticipated|Taris Biomedical LLC||2|||f|||||t|||||||||2017-10-10 22:21:17.432295|2017-10-10 22:21:17.432295
NCT02722525|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-10-06|||October 2014||2014-10-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|||Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer|Impact of Anti-androgen Treatment on Cardiac Function|Recruiting||N/A|30|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:21:17.563497|2017-10-10 22:21:17.563497
NCT02722512|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-19|||July 2016||2016-07-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine|A Phase I and Feasibility Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine for Pediatric Patients With Newly Diagnosed Intracranial High Grade Glioma and Recurrent Resectable Intracranial High Grade Glioma and Ependymoma|Recruiting||Phase 1|20|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-10 22:21:17.690818|2017-10-10 22:21:17.690818
NCT02722499|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-23|||March 2016||2016-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|FITEST||Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)|Financial Incentives Augmented Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)|Recruiting||N/A|60|Anticipated|Medical University of South Carolina||3|||f||||t||||||||||2017-10-10 22:21:17.79381|2017-10-10 22:21:17.79381
NCT02722486|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-01-31|||March 2016||2016-03-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Use of a Vibrotactile Balance Belt System for Vestibular Rehabilitation in the Pediatric Population|Use of a Vibrotactile Balance Belt System for Vestibular Rehabilitation in the Pediatric Population|Recruiting||Early Phase 1|30|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||No||2017-10-10 22:21:17.893554|2017-10-10 22:21:17.893554
NCT02722473|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|NSE-HYPERION||NSE Ancillary Study of The Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.|NSE Ancillary Study of The Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.|Recruiting||Phase 3|200|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||t||||||||||2017-10-10 22:21:18.006026|2017-10-10 22:21:18.006026
NCT02722460|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-30|||January 2016||2016-01-01|March 2016|2016-03-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01|12 Months|Observational [Patient Registry]|CPR||Resuscitation Registry - Surrogate Markers of Outcome After Cardiac Arrest|Prospective Registry of Cardiopulmonary Arrest Survivors - Surrogate Markers for Prognostication of Outcome After Cardiac Arrest|Recruiting||N/A|200|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||No||2017-10-10 22:21:18.164792|2017-10-10 22:21:18.164792
NCT02722447|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-05-01|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|RIDTS||Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis|Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis|Recruiting||Phase 3|1100|Anticipated|Università degli Studi dell'Insubria||2|||f||||t|f|f||||||Undecided||2017-10-10 22:21:18.256797|2017-10-10 22:21:18.256797
NCT02722434|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-05|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||MC5-A Scrambler Therapy or TENS Therapy in Treating Patients With Chemotherapy-Induced Peripheral Neuropathy|MC15C1 Randomized Scrambler Therapy vs TENS for the Treatment of Chemotherapy-Induced Peripheral Neuropathy|Active, not recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 22:21:18.382905|2017-10-10 22:21:18.382905
NCT02722421|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-06-21|||April 6, 2017|Actual|2017-04-06|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women|A Pharmacokinetic Evaluation of Increased Dose Levonorgestrel Implant and Efavirenz-Based Antiretroviral Therapy In HIV-Infected Ugandan Women|Active, not recruiting||Phase 2|28|Actual|University of Nebraska||1|||f||||t|f|f||||||||2017-10-10 22:21:18.491801|2017-10-10 22:21:18.491801
NCT02722408|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2017-08-24|||May 2016||2016-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|April 2017|Actual|2017-04-01||Interventional|||Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)|A Phase 2 Open-Label, Dose-Finding Study to Assess the Efficacy, Safety, and Tolerability of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid Lowering Therapy (COBALT-1)|Completed||Phase 2|8|Actual|Gemphire Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 22:21:18.592505|2017-10-10 22:21:18.592505
NCT02722395|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-04-05|||August 2016||2016-08-01|April 2017|2017-04-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Observational|||Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)|Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)|Completed||N/A|5|Actual|Duke University|||1||f||||f||||||||No||2017-10-10 22:21:18.710925|2017-10-10 22:21:18.710925
NCT02722382|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-03-21|||January 31, 2017|Actual|2017-01-31|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Putting Patients at the Center of Kidney Care Transitions (PREPARE NOW)|Putting Patients at the Center of Kidney Care Transitions|Enrolling by invitation||N/A|1000|Anticipated|Duke University||2|||f||||f|f|f||||||Undecided||2017-10-10 22:21:18.788306|2017-10-10 22:21:18.788306
NCT02722369|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-11-04|||December 2016||2016-12-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)|A Phase II, Multicentre, Randomised Trial Comparing Combination Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)|Not yet recruiting||Phase 2|112|Anticipated|University College, London||2|||f||||t||||||||Yes|On receipt of a request the recipient will consider the proposal, ensure relevant Chief Investigator/Trial Management Group are consulted and, if necessary, Trial Steering Committee and/or Cancer Trials Centre (CTC) Senior Management Group. Any shared data will be in an anonymised format|2017-10-10 22:21:18.881801|2017-10-10 22:21:18.881801
NCT02722356|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-03-08|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Outcomes After the Implementation of a New Oxytocin Protocol|Outcomes After Implementation of a New Oxytocin Protocol for the Prevention of Postpartum Hemorrhage in Non-emergent Cesarean Sections|Completed||N/A|64|Actual|C.R.Darnall Army Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:21:18.98266|2017-10-10 22:21:18.98266
NCT02722343|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-09-01|||April 2016||2016-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Exploratory Pharmacodynamic Study of Tenofovir-Based Products|Phase I Exploratory Pharmacodynamic Study of Tenofovir-Based Products|Completed||Phase 1|25|Actual|CONRAD||2|||f||||f||||||||No||2017-10-10 22:21:19.067204|2017-10-10 22:21:19.067204
NCT02722330|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-01-19|||April 2016||2016-04-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Evaluation of Cochlear Baha 5 SuperPower Sound Processor on the Baha Attract System|Evaluation of Audiological Outcomes and Subjective Benefits of Cochlear Baha® 5 SuperPower Sound Processor on the Baha® Attract™ System|Completed||N/A|23|Actual|Cochlear Bone Anchored Solutions||1|||f||||f||||||||Undecided||2017-10-10 22:21:19.168474|2017-10-10 22:21:19.168474
NCT02722317|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-28|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|||Intervention for Men Who Batter Women|Intimate Partner Violence: the Intervention for Men Who Batter Women|Completed||N/A|86|Actual|Santa Catarina Federal University|||1||f||||t||||||||No||2017-10-10 22:21:19.284993|2017-10-10 22:21:19.284993
NCT02722304|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-07-21|||June 22, 2016|Actual|2016-06-22|July 2017|2017-07-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2021|Anticipated|2021-07-01||Interventional|||Stage 1 Study of ARALAST NP and GLASSIA in A1PI|A Stage 1, Prospective, Randomized, Placebo-Controlled, Double- Blind Study to Evaluate the Safety and Efficacy of Alpha1-Proteinase Inhibitor (A1PI) Augmentation Therapy in Subjects With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 4|138|Anticipated|Baxalta US Inc.||5|||f||||t||||||||||2017-10-10 22:21:19.356972|2017-10-10 22:21:19.356972
NCT02722278|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-01-30|||March 2016|Actual|2016-03-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|inTUne||A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men|A Phase 3, Randomized, Active-controlled, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU) in Hypogonadal Men|Completed||Phase 3|222|Actual|Clarus Therapeutics, Inc.||2|||f||||f||||||||Yes|Individual patient data will be shared with all principal investigators following the completion of data analyses|2017-10-10 22:21:19.584474|2017-10-10 22:21:19.584474
NCT02722265|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-08-10|||March 2016||2016-03-01|August 2017|2017-08-01|July 8, 2017|Actual|2017-07-08|July 8, 2017|Actual|2017-07-08||Interventional|||Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension|Open-label, Multicenter, Interventional, Dose Titration Study to Assess the Long-term Study of CS-3150 2.5mg and 5mg Alone as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension|Completed||Phase 3|368|Actual|Daiichi Sankyo, Inc.||1|||f||||f|f|f||||||||2017-10-10 22:21:19.673685|2017-10-10 22:21:19.673685
NCT02722252|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-06-10|||April 2016||2016-04-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Observational|INCUBATE||Comparative Study of Two Embryo Culture Systems|Comparative Study of Two Embryo Culture Systems: Randomization of Attempts at In Vitro Fertilization With ICSI at the Centre for Medically Assisted Procreation at Dijon CHU|Recruiting||N/A|266|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-10 22:21:19.749409|2017-10-10 22:21:19.749409
NCT02722226|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-29|||March 2012||2012-03-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|DedSim||High Fidelity Simulation and Sedation Training of Non-anesthesiologists Residents|The Impact of a High Fidelity Simulation Based Sedation Training on the Performance of Non-anesthesiologists Residents for the Management of Complications Associated to Sedation.|Completed||N/A|32|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-10 22:21:20.187079|2017-10-10 22:21:20.187079
NCT02722213|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-03-13|||May 2016||2016-05-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Mindfulness & Stress Management Study for Cardiac Patients|Mindfulness-Based Stress Reduction as an Adjunct Intervention to Cardiac Rehabilitation: A Pilot Study|Active, not recruiting||N/A|47|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 22:21:20.264323|2017-10-10 22:21:20.264323
NCT02722200|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-09-30|||May 2016||2016-05-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger|Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger|Recruiting||Phase 1|30|Anticipated|Yale University||2|||f||||t||||||||Undecided||2017-10-10 22:21:20.373533|2017-10-10 22:21:20.373533
NCT02722187|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-03-24|||April 2015||2015-04-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Role of Microsurgery in Surgical Treatment of Varicocele.|The Role of Microsurgery in Surgical Treatment of Varicocele.|Recruiting||Phase 4|60|Anticipated|Medical University of Warsaw||2|||f||||||||||||||2017-10-10 22:21:20.564272|2017-10-10 22:21:20.564272
NCT02722174|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-10-03|||July 22, 2016|Actual|2016-07-22|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Fingerprinting of Impulsivity|Fingerprinting of Impulsivity in Four Diagnostic and Statistical Manual of Mental Disorders, Version 5 (DSM-5) Psychiatric Disorders That Have Been Clinically Associated With Impulsivity Using a Battery of Questionnaires and Behavioral Laboratory Tests|Recruiting||N/A|240|Anticipated|Boehringer Ingelheim|||6||f||||||||||||||2017-10-10 22:21:20.667274|2017-10-10 22:21:20.667274
NCT02722161|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-07-12|||April 2016||2016-04-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Olmutinib (BI 1482694) ADME Study|A Phase I, Open-label, Single-dose Trial to Investigate Metabolism and Pharmacokinetics of [14C]BI 1482694 Administered as Oral Solution in Healthy Male Volunteers|Completed||Phase 1|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:21:20.774448|2017-10-10 22:21:20.774448
NCT02722148|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-05-15|||March 2016||2016-03-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|IDiET||Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)|Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)|Enrolling by invitation||N/A|16|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f|f|t|t||f|||No|No plans to share data|2017-10-10 22:21:20.898518|2017-10-10 22:21:20.898518
NCT02722135|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-01-26|||November 2016||2016-11-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed|Open-label, Dose-escalating Trial to Evaluate the Tolerability, Toxicity, Safety, Pharmacokinetics, Pharmacodynamics and Activity of Volasertib Added to the Standard Intensive Salvage Chemotherapy Regimen With Liposomal Daunorubicine, Fludarabine and Cytarabine (DNX-FLA) Followed by Fludarabine and Cytarabine (FLA) in Children From 3 Months to Less Than 18 Years of Age With Acute Myeloid Leukaemia After Failure of the Front-line Therapy|Withdrawn||Phase 1|0|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:21:21.011562|2017-10-10 22:21:21.011562
NCT02722122|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-09-26|||May 2016||2016-05-01|September 2016|2016-09-01||||February 2017|Anticipated|2017-02-01||Interventional|||Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of AIR DNase™in Patients With Cystic Fibrosis Previously Treated With Pulmozyme®|A Proof-of-Concept, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of AIR DNase™in Patients With Cystic Fibrosis Previously Treated With Pulmozyme®|Recruiting||Phase 2|15|Anticipated|Protalix||1|||f||||||||||||||2017-10-10 22:21:21.12177|2017-10-10 22:21:21.12177
NCT02722109|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|(DUAL)||Dual Energy CT: A New Method for Better Dose Calculation in Proton Beam Therapy|Dual Energy CT: A New Method for Better Dose Calculation in Proton Beam Therapy|Enrolling by invitation||N/A|30|Anticipated|Aarhus University Hospital|||1||f||||f||||||||No|There is no plan to share data with other centers|2017-10-10 22:21:21.278409|2017-10-10 22:21:21.278409
NCT02722096|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-03-29|||March 2014||2014-03-01|March 2016|2016-03-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|FAV ss ALR||Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications|Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications|Recruiting||N/A|220|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 22:21:21.381237|2017-10-10 22:21:21.381237
NCT02722083|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-05-18|||May 7, 2016|Actual|2016-05-07|May 2017|2017-05-01|July 13, 2016|Actual|2016-07-13|May 27, 2016|Actual|2016-05-27||Interventional|||Exploratory Study for Allergy Relief Onset|A Single-blind, Randomized, Placebo Controlled, Crossover Pilot Study to Evaluate the Onset of Action of an Antihistamine in Subjects Following Allergen Exposure in an Allergen Chamber|Terminated||Phase 2|1|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:21:21.525757|2017-10-10 22:21:21.525757
NCT02722070|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-28|||March 2016||2016-03-01|January 2016|2016-01-01|March 2025|Anticipated|2025-03-01|March 2020|Anticipated|2020-03-01||Observational|||Processing Integration in Neurological Patients Using fMRI|Processing Integration in Neurological Patients Using fMRI|Not yet recruiting||N/A|150|Anticipated|Hadassah Medical Organization|||4||f||||f||||||||No||2017-10-10 22:21:21.617407|2017-10-10 22:21:21.617407
NCT02722057|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-06-26|||December 2015||2015-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||A Study to Confirm the Long-term Safety and Effectiveness of Kalydeco in Patients With Cystic Fibrosis Who Have an R117H-CFTR Mutation, Including Pediatric Patients|A Study in US Cystic Fibrosis Patients With the R117H-CFTR Mutation to Confirm the Long-term Safety and Effectiveness of Kalydeco, Including Patients <18 Years of Age, Combining Data Captured in the Cystic Fibrosis Foundation Registry From an Interventional Cohort and a Non-Interventional Cohort|Active, not recruiting||N/A|150|Anticipated|Vertex Pharmaceuticals Incorporated|||3||f||||||||||||||2017-10-10 22:21:21.717969|2017-10-10 22:21:21.717969
NCT02722044|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-04-19|||April 2016||2016-04-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Usability of an AI for M923 in Subjects With Moderate to Severe RA|An Open-label Single-arm Multicenter Study to Evaluate Usability of a Subcutaneous (SC) Autoinjector (AI) for a Proposed Adalimumab Biosimilar (M923) in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)|Completed||Phase 3|51|Actual|Momenta Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:21:21.790531|2017-10-10 22:21:21.790531
NCT02722018|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-08-17|||January 6, 2016|Actual|2016-01-06|August 2017|2017-08-01|September 13, 2016|Actual|2016-09-13|September 13, 2016|Actual|2016-09-13||Interventional|||Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810|A Phase I, Randomized, Open-Label, Single Center Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810 in Female Healthy Subjects on Non-Childbearing Potential|Completed||Phase 1|45|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-10 22:21:22.030948|2017-10-10 22:21:22.030948
NCT02722005|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Impact of Family Financial Support on Health Related Quality of Life|The Impact of Family Financial Support on Health Related Quality of Life|Recruiting||N/A|150|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No|Participant consents do not include data sharing beyond the study and there exists no appropriate repository for data sharing.|2017-10-10 22:21:22.156048|2017-10-10 22:21:22.156048
NCT02721992|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-10|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|GOCol||Graves' Orbitopathy and Hypercholesterolemia|A Prospective Study on the Association Between Graves' Orbitopathy and Hypercholesterolemia|Completed||N/A|250|Actual|University of Pisa|||2||f||||f||||||||||2017-10-10 22:21:22.253475|2017-10-10 22:21:22.253475
NCT02721979|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-08-08|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|July 1, 2020|Anticipated|2020-07-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||ARN-509 in Treating Patients With Prostate Cancer Who Are in Active Surveillance|A Phase 2 Study of ARN-509 in Active Surveillance Patients|Not yet recruiting||Phase 2|33|Anticipated|University of Washington||1|||f||||f|t|f||||||||2017-10-10 22:21:22.369883|2017-10-10 22:21:22.369883
NCT02721966|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-05-03|||October 3, 2016|Actual|2016-10-03|May 2017|2017-05-01|May 20, 2019|Anticipated|2019-05-20|May 20, 2019|Anticipated|2019-05-20||Interventional|MAXIMISE||Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement|MAXIMISE (Managing AXIal Manifestations in PsorIatic Arthritis With SEcukinumab), a Randomized, Double-blind, Placebo-controlled, Multicenter, 52 Week Study to Assess the Efficacy and Safety of Secukinumab 150 mg or 300 mg s.c. in Participants With Active Psoriatic Arthritis and Axial Skeleton Involvement Who Have Inadequate Response to Non Steroidal Anti-inflammatory Drugs (NSAIDs)|Recruiting||Phase 3|495|Anticipated|Novartis||3|||f||||f|f|f||||||||2017-10-10 22:21:22.50012|2017-10-10 22:21:22.50012
NCT02721953|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effects of Butyrate on Children With Obesity|Effects of Butyrate on Insulin Resistance in Children Affected by Obesity|Recruiting||Phase 2/Phase 3|40|Anticipated|Federico II University||2|||f||||f||||||||No||2017-10-10 22:21:22.664285|2017-10-10 22:21:22.664285
NCT02721940|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-28|||February 2012||2012-02-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|January 2015|Actual|2015-01-01||Interventional|||Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis|Local Administration of Enriched Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in the Early Stage of Osteonecrosis: a Prospective, Randomized, Parallel-controlled Clinical Trial|Active, not recruiting||N/A|100|Actual|Chinese PLA General Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:21:22.756959|2017-10-10 22:21:22.756959
NCT02721927|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-28|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Observational|||The Use of Emergency Department by Syrian Refugees and the Increasing Cost of Health Care|The Use of Emergency Department by Syrian Refugees and the Increasing Cost of Health Care|Completed||N/A|2000|Actual|Adiyaman University Research Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:21:22.847987|2017-10-10 22:21:22.847987
NCT02721914|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-07-11|||April 2016||2016-04-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|MAS-GAH||The Effectiveness of the Massage and the Hypopressive Abdominal Gymnastics on Low Back Pain (MAS-GAH)|The Effects of Massage Therapy and Hypopressive Abdominal Exercises on Chronic Non-specific Low Back Pain, Joint Mobility, Disability and the Patient's Quality of Life. A Controlled Clinical Trial|Completed||N/A|70|Actual|University of Seville||3|||f||||||||||||||2017-10-10 22:21:22.919723|2017-10-10 22:21:22.919723
NCT02721888|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-23|||July 2012||2012-07-01|February 2016|2016-02-01||||March 2016|Anticipated|2016-03-01||Interventional|LIRA-NAFLD/LIP||Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism|Effect of Liraglutide on Fatty Liver Content Evaluated by Proton-spectroscopy (1H-spectroscopy) and Lipoprotein Kinetic, in Patients With Type 2 Diabetes|Recruiting||Phase 4|120|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-10 22:21:23.100451|2017-10-10 22:21:23.100451
NCT02721875|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-12-19|||April 2016||2016-04-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes|An Open Label, Phase I Trial of Intravenous Administration of Volasertib as Monotherapy and in Combination With Azacitidine in Patients With Myelodysplastic Syndrome After Hypomethylating Agents Treatment Failure|Terminated||Phase 1|70|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:21:23.238674|2017-10-10 22:21:23.238674
NCT02721862|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-07-12|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy|Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy: A Prospective Randomized Multicenter Placebo-Controlled Trial|Recruiting||Phase 3|100|Anticipated|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-10 22:21:23.392856|2017-10-10 22:21:23.392856
NCT02721849|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-24|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Yoga for Chronic Headache in Adolescents|Randomisierte Kontrollierte Studie Zur Wirkung Von Yoga Bei Chronischen Kopfschmerzen im Jugendalter|Completed||N/A|45|Actual|Universität Duisburg-Essen||4|||f||||f||||||||||2017-10-10 22:21:23.499194|2017-10-10 22:21:23.499194
NCT02721836|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-05-23|||April 2016||2016-04-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||Yoga for Patients With Irritable Bowel Syndrome|Randomized Controlled Trial on Yoga for Irritable Bowel Syndrome|Completed||N/A|59|Actual|Universität Duisburg-Essen||2|||f||||f||||||||No||2017-10-10 22:21:23.597523|2017-10-10 22:21:23.597523
NCT02721823|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-05-09|||March 2016||2016-03-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|MBMCol||Randomized Controlled Trial of Stress Reduction and Lifestyle Modification for Ulcerative Colitis|Randomized Controlled Trial on the Effect of Stress Reduction and Lifestyle Modification on Disease Activity in Ulcerative Colitis|Recruiting||N/A|92|Anticipated|Universität Duisburg-Essen||2|||f||||f||||||||No||2017-10-10 22:21:23.687288|2017-10-10 22:21:23.687288
NCT02721810|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-19|||October 2016||2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PEI||Patient Engagement Initiative|Engaging Surrogates and Physicians to Ensure Concordant Critical Care|Recruiting||N/A|116|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 22:21:23.828353|2017-10-10 22:21:23.828353
NCT02721797|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-04-27|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|December 2020|Anticipated|2020-12-01||Observational|||Origins and Impact of EDS in Connective Tissues and Skin|Origins and Impact of EDS in Connective Tissues and Skin|Enrolling by invitation||N/A|35|Anticipated|University College, London|||5||f||||f||||||Samples Without DNA|"     Collagen in skin, tendon, ligament, vaginal tissue, uterine tissue.   "|No|No data will be shared outside of this research|2017-10-10 22:21:23.936323|2017-10-10 22:21:23.936323
NCT02721784|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|SMART||Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy|Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy (SMART)|Recruiting||Phase 1/Phase 2|10|Anticipated|University College, London||1|||f||||t||||||||Undecided||2017-10-10 22:21:24.050248|2017-10-10 22:21:24.050248
NCT02721771|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-04-24|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Acid-Base and Point of Care Ultrasound in Severe Preeclampsia|Acid-base Disturbances and Ultrasound Markers as Biological Predictors of Maternal and Fetal Outcomes in Severe Late Onset Preeclampsia|Completed||N/A|97|Actual|University of Cape Town|||1||f||||f||||||||||2017-10-10 22:21:25.744433|2017-10-10 22:21:25.744433
NCT02721758|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-22|||June 2015||2015-06-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|September 2016|Anticipated|2016-09-01||Interventional|UPBEAT||Understanding and Promoting Health Behaviour Change Amid Transition to Cardiac Rehabilitation|Design and Evaluation of a Brief Motivational Intervention to Promote Enrolment in Outpatient Cardiac Rehabilitation|Enrolling by invitation||N/A|100|Anticipated|University of Calgary||2|||f||||||||||||||2017-10-10 22:21:25.822011|2017-10-10 22:21:25.822011
NCT02721732|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-09-20|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Study for the Evaluation of Efficacy of Pembrolizumab (MK-3475) in Patients With Rare Tumors|Phase II Study for the Evaluation of Efficacy of Pembrolizumab (MK-3475) in Patients With Rare Tumors|Recruiting||Phase 2|250|Anticipated|M.D. Anderson Cancer Center||10|||f||||f|t|f||||||||2017-10-10 22:21:25.988146|2017-10-10 22:21:25.988146
NCT02721719|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-29|||May 2016||2016-05-01|March 2016|2016-03-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|||The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis|The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis|Not yet recruiting||N/A|60|Anticipated|University of British Columbia|||3||f||||f||||||Samples Without DNA|"     Blood & colonic biopsy tissue   "|No||2017-10-10 22:21:26.115383|2017-10-10 22:21:26.115383
NCT02721706|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-07-02|||January 2015||2015-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Cost-effectiveness Study of the New Nutrition Screening Tool CIPA at Hospital Admission|Cost-effectiveness Study of the CIPA Screening Method for Patients With Nutritional Risk at Hospital Admission|Active, not recruiting||N/A|824|Anticipated|University Hospital of the Nuestra Señora de Candelaria||2|||f||||f||||||||||2017-10-10 22:21:26.225366|2017-10-10 22:21:26.225366
NCT02721693|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-10-10|||April 2016||2016-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Troponin T in Chronic Obstructive Pulmonary Disease (COPD) Patients After Physical Exercise|COPD, Physical Exercise and Troponin T|Completed||N/A|20|Actual|LHL Helse||1|||f||||f||||||||No||2017-10-10 22:21:26.307351|2017-10-10 22:21:26.307351
NCT02721680|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-05-01|||December 2016||2016-12-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Refinement and Validation of an Awareness Training Program||Recruiting||N/A|1082|Anticipated|University of Arizona||2|||f||||||||||||||2017-10-10 22:21:26.376594|2017-10-10 22:21:26.376594
NCT02721667|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-03-30|||August 2016||2016-08-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|TECHNOMED||Telemonitoring and Protocolized Case Management for Hypertensive Community Dwelling Seniors With Complex Care Needs|Telemonitoring and Protocolized Case Management for Hypertensive Community Dwelling Seniors With Complex Care Needs|Recruiting||N/A|200|Anticipated|University of Alberta||2|||f||||t||||||||No||2017-10-10 22:21:26.47147|2017-10-10 22:21:26.47147
NCT02721654|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-04|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|PLUS||Plasma-Lyte 148® versUs Saline Study|Comparison of Plasmalyte 148® and Saline for Fluid Resuscitation and Intravenous Fluid Therapy in Critically Ill Adults|Recruiting||Phase 4|8800|Anticipated|The George Institute||2|||f||||t|f|f||||||||2017-10-10 22:21:26.73071|2017-10-10 22:21:26.73071
NCT02721641|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-02-13|2017-02-13||June 1999||1999-06-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Age was the only demographic variable collected for the study and was only collected from 32 participants. Gender, weight, and race were not collected under the protocol.|A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer|A Single Arm, Multi-Center, International, Continuation Trial of Recombinant Humanized Antibody Herceptin (Trastuzumab) in Patients With HER2-Overexpressing Tumors|Completed||Phase 3|69|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:21:27.183357|2017-10-10 22:21:27.183357
NCT02721628|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-22|||September 2015||2015-09-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus|Femtosecond Laser Assisted Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus|Recruiting||N/A|60|Anticipated|Sun Yat-sen University||2|||f||||f||||||||Undecided|undecided|2017-10-10 22:21:27.517806|2017-10-10 22:21:27.517806
NCT02721615|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-25|||September 2010||2010-09-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|ISCoPE||Injured Spinal Cord Pressure Evaluation|Evaluation of the Potential Adverse Effect of Pressure After Spinal Cord Injury|Recruiting||N/A|100|Anticipated|St George's, University of London||3|||f||||f||||||||No||2017-10-10 22:21:27.617187|2017-10-10 22:21:27.617187
NCT02721602|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-08-23|||February 2016||2016-02-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Families Preventing Diabetes Together|Families Preventing Diabetes Together|Completed||N/A|7|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:21:27.708211|2017-10-10 22:21:27.708211
NCT02721589|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-11-22|||April 2016||2016-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects|An Open-Label, Single Center, Nonrandomized, Dose-Escalation Phase 1 Study to Evaluate Safety and Tolerability of SHR-1210 in Subjects With Advanced Solid Tumors|Enrolling by invitation||Phase 1|45|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||No||2017-10-10 22:21:27.783729|2017-10-10 22:21:27.783729
NCT02721576|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-02-11|||September 2015||2015-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC|A Perspective Phase II Trial of Sodium Glycididazole Combined With Concurrent Chemoradiotherapy for Locally Recurrent Squamous Cell Esophageal Carcinoma|Recruiting||Phase 2|40|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||t||||||||No||2017-10-10 22:21:27.868087|2017-10-10 22:21:27.868087
NCT02721563|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-02-11|||September 2015||2015-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC|A Perspective Random Phase II Trial of Sodium Glycididazole Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced Squamous Cell Esophageal Carcinoma|Recruiting||Phase 2|104|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||t||||||||No||2017-10-10 22:21:27.972186|2017-10-10 22:21:27.972186
NCT02721550|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-02-11|||September 2015||2015-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC|A Perspective Phase II Trial of Sodium Glycididazole Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced Squamous Cell Esophageal Carcinoma|Recruiting||Phase 2|40|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||t||||||||No||2017-10-10 22:21:28.094943|2017-10-10 22:21:28.094943
NCT02721537|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-09-22|||September 2016||2016-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TRMC-004||Use of 31P MRS to Assess Brain NAD+ in Healthy Collegiate Athletes|Use of 31P MRS to Assess Brain NAD+ in Healthy Collegiate Athletes and a Comparison of the Effect of Nicotinamide Riboside Supplementation on Brain NAD+ Levels|Recruiting||N/A|48|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:21:28.293252|2017-10-10 22:21:28.293252
NCT02721524|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-22|||November 2015||2015-11-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Ring Versus Suture Annuloplasty For Functional Tricuspid Regurgitation In Rheumatic Mitral Valve Diseases|Comparison Between Outcomes Of Ring And Suture Annuloplasty For Functional Tricuspid Regurgitation In Rheumatic Mitral Valve Diseases|Recruiting||N/A|86|Anticipated|Shahid Gangalal National Heart Centre||2|||f||||t||||||||Undecided||2017-10-10 22:21:28.419019|2017-10-10 22:21:28.419019
NCT02721511|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-03-21|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|March 7, 2017|Actual|2017-03-07|March 7, 2017|Actual|2017-03-07||Interventional|DIVERSION-HF||A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen|A Pilot Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen, Administered Subcutaneously for the Treatment of Fluid Overload and to Evaluate the Feasibility for Home Treatment|Withdrawn||Phase 1/Phase 2|0|Actual|University of Michigan||1||Investigator decision based on new device information.|f||||f||||||||||2017-10-10 22:21:28.526711|2017-10-10 22:21:28.526711
NCT02721498|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-08-01|||September 2016||2016-09-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Improving Outcome Measures For Adult CF ACT Trials|Improving Outcome Measures For Physiotherapy Trials of Airway Clearance in Adults With Cystic Fibrosis|Active, not recruiting||N/A|106|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:21:28.619378|2017-10-10 22:21:28.619378
NCT02721485|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-05-01|||July 2016||2016-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FLUID||Crystalloid FLUID Choices for Resuscitation of Hospital Patients|Crystalloid FLUID Choices for Resuscitation of Hospital Patients: A Pragmatic Cluster Cross Over Pilot Trial|Recruiting||N/A|65000|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No|This is a cluster-randomized crossover study, with the hospital as the unit of randomization. Individual patient data will not be collected.|2017-10-10 22:21:28.747257|2017-10-10 22:21:28.747257
NCT02721472|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-09-11|||May 17, 2016|Actual|2016-05-17|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|PADRE||Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease|Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease|Recruiting||N/A|45|Anticipated|ADDMEDICA SASA||1|||f||||f||||||||||2017-10-10 22:21:28.869986|2017-10-10 22:21:28.869986
NCT02721459|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-07-05|||August 11, 2016|Actual|2016-08-11|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma|Phase I Study of Escalating Doses of XL888 With Vemurafenib Plus Cobimetinib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma|Recruiting||Phase 1|36|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 22:21:29.007311|2017-10-10 22:21:29.007311
NCT02721446|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-08-24|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|July 2017|Actual|2017-07-01||Interventional|||MINDSPACE Strategy for Risk Optimization|MINDSPACE Strategy for Risk Optimization, Knowledge, and Empowerment (MINDSPACE Stroke)|Active, not recruiting||N/A|641|Actual|Indiana Institute for Medical Research||2|||f||||t||||||||||2017-10-10 22:21:29.154114|2017-10-10 22:21:29.154114
NCT02721433|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-09-27|||August 2016||2016-08-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|REaCT-BTA||4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases|A Pragmatic Randomised, Multicentre Trial Comparing 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases From Either Castration-resistant Prostate Cancer or Breast Cancer - The REaCT-BTA Study|Recruiting||Phase 4|250|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-10 22:21:29.250649|2017-10-10 22:21:29.250649
NCT02721420|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-10-06|||March 2016||2016-03-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|PMC||Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in Malawi|Malaria Chemoprevention With Monthly Treatment With Dihydroartemisinin-Piperaquine for the Post-discharge Management of Severe Anaemia in Children Less Than 5 Years in Malawi|Recruiting||Phase 3|375|Anticipated|University of Malawi College of Medicine||5|||f||||t||||||||No||2017-10-10 22:21:29.380155|2017-10-10 22:21:29.380155
NCT02721407|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-03-08|||March 2016||2016-03-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|MendCART||Anti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma Patients|A Phase I Study of Anti-CD22:TCRz:4-1BB T-cells in Patient With CD22-Positive Recurrent Lymphoma That is Resistant or Refractory to Prior Anti-CD22:TCRz:CD28 Immunotherapy|Recruiting||Phase 1|20|Anticipated|Xinqiao Hospital of Chongqing||1|||f||||t||||||||Yes||2017-10-10 22:21:29.503728|2017-10-10 22:21:29.503728
NCT02721394|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-02-15|||February 2016||2016-02-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||FCT With Young Children With ID in the UK: A Feasibility Project V.1|Conducting Functional Communication Training (FCT) With Young Children With Intellectual Disabilities in NHS Settings in the UK: A Feasibility Project|Enrolling by invitation||N/A|8|Anticipated|University of Kent||2|||f||||f||||||||No||2017-10-10 22:21:29.590166|2017-10-10 22:21:29.590166
NCT02721381|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-05-01|||March 2015||2015-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparative Efficacy of Self-directed & Therapist-assisted Telehealth Parent Training Intervention for Children With ASD|Comparative Efficacy of a Self-directed and Therapist-assisted Telehealth Parent Training Intervention for Children With ASD|Recruiting||N/A|90|Anticipated|Michigan State University||3|||f||||f||||||||||2017-10-10 22:21:29.690106|2017-10-10 22:21:29.690106
NCT02721368|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-22|||January 2016||2016-01-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume|Clinical Study of Neuramis® Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume|Active, not recruiting||Phase 3|144|Anticipated|Medy-Tox||2|||f||||f||||||||Undecided||2017-10-10 22:21:29.832427|2017-10-10 22:21:29.832427
NCT02721355|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-08-29|||June 2013||2013-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis|Evaluation of a Health Food Supplement Containing Anti-Helicobacter Pylori Urease IgY Antibody on Patients With Chronic Gastritis in Hanoi, Vietnam|Completed||N/A|77|Actual|Immunology Research Institute in Gifu||2|||f||||t||||||||No||2017-10-10 22:21:29.919405|2017-10-10 22:21:29.919405
NCT02721342|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-11-16|||June 2009||2009-06-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Remission Clinic in Proteinuric Chronic Nephropathies|Remission Clinic: Computed Registry for the Ambulatory Follow up of Patients With Proteinuric Chronic Nephropathies Treated Based on a Standard Multipharmacological Model Aimed at Normalizing Proteinuria and Stabilizing the Renal Function|Recruiting||N/A|1500|Anticipated|Mario Negri Institute for Pharmacological Research|||1||f||||f||||||||No||2017-10-10 22:21:30.050472|2017-10-10 22:21:30.050472
NCT02721329|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-07-25|||June 2016||2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of APAP With SensAwake in OSA and Insomnia Patients|Evaluation of APAP With SensAwake in OSA and Insomnia Patients|Recruiting||N/A|48|Anticipated|Fisher and Paykel Healthcare||2|||f||||f||||||||||2017-10-10 22:21:30.237637|2017-10-10 22:21:30.237637
NCT02721316|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-22|||April 2016||2016-04-01|March 2016|2016-03-01|April 2020|Anticipated|2020-04-01|April 2016|Anticipated|2016-04-01||Interventional|SIPRéS||Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal|Randomized Study of Ambulatory Monitoring Nurse Under the Prevention of Recurrent Suicidal|Not yet recruiting||N/A|380|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||Undecided||2017-10-10 22:21:30.363042|2017-10-10 22:21:30.363042
NCT02721303|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-10-24|||May 2016||2016-05-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Appetite Regulation in Older-Aged Obese Individuals|Appetite Regulation in Older-Aged Obese Individuals|Recruiting||N/A|66|Anticipated|University of Colorado, Denver||3|||f||||f||||||||No||2017-10-10 22:21:30.47199|2017-10-10 22:21:30.47199
NCT02721290|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-03-21|||January 2016||2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of the Sensitive Cutaneous Block Distribution Following Femoral Nerve Block Using Two Femoral Block Techniques|Comparison of the Sensitive Cutaneous Block Distribution Following Femoral Nerve Block Using an Ultrasound Plus Neurostimulator Technique Versus an Approach Based on the Localization of the Femoral Artery.|Recruiting||N/A|80|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-10 22:21:30.585902|2017-10-10 22:21:30.585902
NCT02721277|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-03-03|2017-03-03||May 2016|Actual|2016-05-01|March 2017|2017-03-01|February 2, 2017|Actual|2017-02-02|December 2016|Actual|2016-12-01||Interventional|||SMOFlipid to Lessen the Severity of Neonatal Cholestasis|Compassionate Use of an Intravenous Fat Emulsion Comprised of Soy Oil, Medium Chain Triglycerides, Olive Oil, and Fish Oil for Neonates With Parenteral Nutrition Induced Liver Injury|Terminated||Phase 1/Phase 2|2|Actual|University of Florida||1|||f||||f|t|f||||||Undecided||2017-10-10 22:21:30.724852|2017-10-10 22:21:30.724852
NCT02721264|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-11-27|||March 2016||2016-03-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.|Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis: A Randomized Control Trial|Recruiting||N/A|112|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 22:21:31.347846|2017-10-10 22:21:31.347846
NCT02721251|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-17|||April 1, 2016|Actual|2016-04-01|August 2017|2017-08-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Influence of Exercise, Weight Loss, and Exercise Plus Weight Loss on Sleep Apnea|Influence of Exercise, Weight Loss, and Exercise Plus Weight Loss on Sleep Apnea|Recruiting||Phase 1|90|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||||2017-10-10 22:21:31.455158|2017-10-10 22:21:31.455158
NCT02721238|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-11-28|||March 2016||2016-03-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison of Colloid (20% Albumin) Versus Crystalloid (Plasmalyte) for Fluid Resuscitation in Cirrhotics With Sepsis Induced Hypotension.|Comparison of Colloid (20% Albumin) Versus Crystalloid (Plasmalyte) for Fluid Resuscitation in Cirrhotics With Sepsis Induced Hypotension.|Recruiting||N/A|90|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 22:21:31.591075|2017-10-10 22:21:31.591075
NCT02721225|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-09-21|||June 2015||2015-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Prebiotic in Preventing Low Birth Weight|Promoting Healthy Foetal and Post Natal Growth by Modulating Vaginal or Gut Micro Biota With Supplementation of Prebiotic Agent ( Fructooligosaccharide) in Pregnant Women- a Randomized Double Blind Community Based Clinical Trial.|Recruiting||Phase 1|210|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 22:21:31.722439|2017-10-10 22:21:31.722439
NCT02721212|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-03-22|||March 2016||2016-03-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Impact of a New Technology to Functional Recovery Upper Limb in Post Stroke Patients.|Impact of a New Technology to Functional Recovery Upper Limb in Post Stroke Patients: a Randomized Controlled Study|Not yet recruiting||N/A|54|Anticipated|Habilita S.p.A.||2|||f||||t||||||||Yes||2017-10-10 22:21:31.871041|2017-10-10 22:21:31.871041
NCT02721199|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-12-16|||January 2016||2016-01-01|January 2016|2016-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|EMGCOPD||EMG in COPD - Factor Analysis|Investigation of Factors Affecting Respiratory Muscle EMG Measurements During Hospital Admission With Acute Exacerbation of COPD|Completed||N/A|11|Actual|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 22:21:32.043429|2017-10-10 22:21:32.043429
NCT02721186|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-10-03|||April 30, 2016|Actual|2016-04-30|October 2017|2017-10-01|September 30, 2017|Actual|2017-09-30|December 31, 2016|Actual|2016-12-31||Interventional|MaDrAZ||Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar|Effectiveness of Mass Drug Administration (MDA) for Reducing Seasonal Malaria Transmission Towards Its Elimination in Hotspot Areas in Zanzibar - a Cluster-randomised Controlled Trial|Completed||N/A|22500|Actual|Karolinska Institutet||2|||f||||||||||||||2017-10-10 22:21:32.157393|2017-10-10 22:21:32.157393
NCT02718690|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-18|||December 2014||2014-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2015|Actual|2015-02-01||Interventional|||Importance of the Current Density in TENS|Importance of the Current Density: Effects of TENS About H-reflex. A Pilot Study|Completed||N/A|20|Actual|University of Castilla-La Mancha||2|||f||||f||||||||Yes||2017-10-10 22:21:58.435859|2017-10-10 22:21:58.435859
NCT02721173|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2017-01-17|||April 2016||2016-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris|Comparison of Safety and Efficacy of Tazarotene 0.1% Plus Clindamycin 1% Gel vs. Adapalene 0.1% Plus Clindamycin 1% Gel in the Treatment of Facial Acne Vulgaris: A Randomized Controlled Trial|Completed||Phase 4|60|Actual|All India Institute of Medical Sciences, Bhubaneswar||2|||f||||f||||||||No||2017-10-10 22:21:32.268274|2017-10-10 22:21:32.268274
NCT02721160|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-03-01|||December 2014||2014-12-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|NutriPBF||Measuring and Understanding the Effects of a Performance Based Financing Scheme Applied to Nutrition Services in Burundi|Measuring and Understanding the Effects of a Performance Based Financing Scheme Applied to Nutrition Services in Burundi|Active, not recruiting||N/A|90|Actual|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||Yes|"Anonymized data will be owned by the Government of Burundi (precisely: by ISTEEBU for the household data and by INSP for the facility data).
All anonymized data collected for this project (facility and household data) will be made available after the completion of data collection, upon request to the data owners and after the approval of their committee."|2017-10-10 22:21:32.366627|2017-10-10 22:21:32.366627
NCT02721147|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-04-11|||October 27, 2015|Actual|2015-10-27|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast Cancer|Pilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast Cancer|Recruiting||N/A|30|Anticipated|Fox Chase Cancer Center||2|||f||||f||||||||Undecided||2017-10-10 22:21:32.46187|2017-10-10 22:21:32.46187
NCT02721134|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-04-22|||March 2016||2016-03-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|BACTIDIAG||Diagnostic Performance of a New Bio-marker During Bacterial Sepsis|Diagnostic Performance of a New Bio-marker During Bacterial Sepsis|Recruiting||N/A|400|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||No||2017-10-10 22:21:32.562451|2017-10-10 22:21:32.562451
NCT02721121|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-25|||March 2016||2016-03-01|March 2016|2016-03-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Comparison of Circumferential Pulmonary Vein Isolation Alone Versus Linear Ablation in Addition to Circumferential Pulmonary Vein Isolation for Catheter Ablation in Persistent Atrial Fibrillation: Prospective Randomized Controlled Trial||Recruiting||N/A|220|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:21:32.642638|2017-10-10 22:21:32.642638
NCT02721108|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-18|||May 2016|Actual|2016-05-01|June 2016|2016-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|MEMPHIS||Mindfulness Meditation for Chronic Pelvic Pain Management|Mindfulness Meditation Using a Smart-phone Application for Women With Chronic Pelvic Pain|Completed||N/A|90|Actual|Queen Mary University of London||3|||f||||f||||||||||2017-10-10 22:21:32.724561|2017-10-10 22:21:32.724561
NCT02721095|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-05-01|||August 2014||2014-08-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaCl|Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaCl for Correction of Hypokalemia in Hospitalized Patients|Recruiting||Phase 4|84|Anticipated|Phramongkutklao College of Medicine and Hospital||2|||f||||t||||||||||2017-10-10 22:21:32.830608|2017-10-10 22:21:32.830608
NCT02721082|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-10-02|||September 2016||2016-09-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|||Changing the Default for Tobacco Treatment|Changing the Default for Tobacco Treatment|Enrolling by invitation||Phase 4|1000|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 22:21:32.928244|2017-10-10 22:21:32.928244
NCT02721069|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-07-29|||June 2016||2016-06-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects|A 12-Month Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)|Recruiting||Phase 3|80|Anticipated|Neurelis, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:21:33.029722|2017-10-10 22:21:33.029722
NCT02721056|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-02-02|||November 2015||2015-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers|A Phase I-II Study of NBTXR3 Activated by Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Cancers|Recruiting||Phase 1/Phase 2|200|Anticipated|Nanobiotix||1|||f||||t||||||||No||2017-10-10 22:21:33.146447|2017-10-10 22:21:33.146447
NCT02721043|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-03-23|||April 2016||2016-04-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies|Phase I, Open Label, Study Of Pgv001 A Multi-Peptide Therapeutic Vaccine Platform For Use In The Treatment Of Malignancies In The Adjuvant Setting|Recruiting||Phase 1|20|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||No||2017-10-10 22:21:33.269866|2017-10-10 22:21:33.269866
NCT02721030|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-05|||March 2016||2016-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01|2 Years|Observational [Patient Registry]|MAFHER||Mbarara Acute Heart Failure Registry|Mbarara Acute Heart Failure Registry: Opportunities to Improve Care of Patients Hospitalized With Acute Decompensated Heart Failure in Mbarara Regional Referral Hospital, Uganda|Active, not recruiting||N/A|217|Actual|Mbarara University of Science and Technology|||1||f||||f||||||||No|Not indicated|2017-10-10 22:21:33.388353|2017-10-10 22:21:33.388353
NCT02721017|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Cryoanalgesia vs. Epidural in the Nuss Procedure|Pain Control in the Nuss Procedure: A Prospective, Randomized Trial of Cryoanalgesia vs. Thoracic Epidural|Recruiting||Phase 4|20|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:21:33.475536|2017-10-10 22:21:33.475536
NCT02721004|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-07-01|||March 2009||2009-03-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis|Documentation of the Efficacy and Safety of RoActemra in the Treatment of Rheumatoid Arthritis|Completed||N/A|592|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:21:33.602756|2017-10-10 22:21:33.602756
NCT02718482|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-03-17|||April 2016||2016-04-01|March 2017|2017-03-01|April 2025|Anticipated|2025-04-01|October 2020|Anticipated|2020-10-01||Interventional|OsteoREC2015||Phase II Trial for the Treatment of Relapsed Osteosarcoma|Multicentric, Randomized Phase II Trial for the Treatment of Patients With Relapsed Osteosarcoma|Recruiting||Phase 2|100|Anticipated|Italian Sarcoma Group||2|||f||||f||||||||Yes||2017-10-10 22:22:01.747929|2017-10-10 22:22:01.747929
NCT02720991|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-22|||July 2014||2014-07-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks|A Pilot Study of the Acceptability and Feasibility of an Out-patient Regimen of Medical Abortion With Mifepristone and 400 mcg Sublingual Misoprostol at 71-77 and 78-84 Days Gestation|Completed||Phase 4|50|Actual|Gynuity Health Projects||1|||f||||f||||||||No||2017-10-10 22:21:33.684175|2017-10-10 22:21:33.684175
NCT02720978|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-05-25|||May 2016||2016-05-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Tearing of Membranes Before Birth - a Comparison Between Two Ways of Induction of Labor Pitocin Opposite Prostaglandin|Tearing of Membranes Before Birth - a Comparison Between Two Ways of Induction of Labor Pitocin Opposite Prostaglandin|Active, not recruiting||Phase 3|1200|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 22:21:33.76104|2017-10-10 22:21:33.76104
NCT02720965|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-25|||April 2016||2016-04-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|April 2016|Anticipated|2016-04-01||Interventional|R-CAPE||Remote Controlled Analgesia on Patient Experience|Effect of Perineural Catheter Analgesia on Patient Experience After Orthopedic Surgery|Not yet recruiting||N/A|300|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||Undecided||2017-10-10 22:21:33.843144|2017-10-10 22:21:33.843144
NCT02720952|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-11|2017-02-28||March 2015||2015-03-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Treatment of Adrenal Insufficiency in Children|A Phase 3 Open-label Study of Infacort® in Neonates, Infants and Children Less Than 6 Years of Age With Adrenal Insufficiency|Completed||Phase 3|24|Actual|Diurnal Limited||1|||f||||t||||||||No||2017-10-10 22:21:33.938595|2017-10-10 22:21:33.938595
NCT02720939|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-25|||January 2016||2016-01-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Observational|||ASD-specific Induced Pluripotent Stem Cells for Disease Modeling|ASD-specific Induced Pluripotent Stem Cells for Disease Modeling|Recruiting||N/A|20|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples With DNA|"     Peripheral blood will be collected in the INSEPACK Disposable Vacuum Venous Blood Specimen     collection Tube (Green Tube with li-Heparin) and each tube will contain 5-10ml of blood from     ASD probands and healthy controls.   "|||2017-10-10 22:21:34.204672|2017-10-10 22:21:34.204672
NCT02720926|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-03-25|||September 2011||2011-09-01|March 2016|2016-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer|A Phase 1 Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Upfront Treatment of Advanced Colorectal and Gastric Cancer With a Dose Expansion Cohort in Advanced Gastric Cancer|Terminated||Phase 1|3|Actual|National Cancer Centre, Singapore||1||Unafavourable toxicity profile|f||||f||||||||No||2017-10-10 22:21:34.286346|2017-10-10 22:21:34.286346
NCT02720913|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-02-09|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|January 11, 2017|Actual|2017-01-11|January 2017|Actual|2017-01-01||Interventional|||COR-KNOT Versus Manually Hand-tied Knots|COR-KNOT Versus Manually Hand-tied Knots|Completed||N/A|50|Actual|The Cleveland Clinic||2|||f||||f|f|f||||||No||2017-10-10 22:21:34.391513|2017-10-10 22:21:34.391513
NCT02720900|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-03-25|||December 2015||2015-12-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Prebiotic Intervention for Autism Spectrum Disorders|Effect of a Prebiotic (B-GOS) Supplementation on Microbiota and Gastrointestinal (GI) Symptoms in Children With Autism Spectrum Disorders (ASD)|Recruiting||Phase 1|42|Anticipated|Clasado Limited||2|||f||||t||||||||Yes|upon completion of the whole study, volunteers will be able to access their individual data following written request|2017-10-10 22:21:34.4687|2017-10-10 22:21:34.4687
NCT02720887|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-06-09|||May 1, 2016|Actual|2016-05-01|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|NAMIOTIC||Presence of Nanoparticles in the Amniotic Fluid|Single-center Prospective Descriptive Study Evaluating the Presence of Nanoparticles in the Amniotic Fluid in Pregnant Women|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     amniotic fluid   "|||2017-10-10 22:21:34.572602|2017-10-10 22:21:34.572602
NCT02720874|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-10-13|||December 2016||2016-12-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MAPPIT-RA||Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis|Multidisciplinary Approach to Patient-Physician Partnership In Treating To Target In Rheumatoid Arthritis|Not yet recruiting||N/A|150|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||f||||||||No||2017-10-10 22:21:34.681831|2017-10-10 22:21:34.681831
NCT02720861|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-25|||March 2015||2015-03-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|March 2016|Actual|2016-03-01|1 Year|Observational [Patient Registry]|||Prevalence of Genetic Polymporphism on RNF213 rs112735431 Gene in Non-cardioemboli Ischemic Cerebrovascular Disease|Prevalence of Genetic Polymporphism on RNF213 rs112735431 Gene in Non-cardioemboli Ischemic Cerebrovascular Disease: A Cross-sectional Study in Thai Patients|Recruiting||N/A|200|Anticipated|Chulalongkorn University|||1||f||||f||||||Samples With DNA|"     Blood sample.   "|No|Not Share|2017-10-10 22:21:35.11607|2017-10-10 22:21:35.11607
NCT02720848|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-23|||July 2016||2016-07-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Double/Single Balloon Enteroscopy Stiffening Wire RCT|A Randomized Clinical Trial of a Novel Stiffening Wire to Increase Depth of Insertion During Double and Single Balloon Enteroscopy|Recruiting||N/A|54|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 22:21:35.252459|2017-10-10 22:21:35.252459
NCT02720822|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-09-25|||August 2016||2016-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BEAMS||Breathlessness Exertion and Morphine Sulphate|A Pragmatic, Phase III, Multi-site, Double-blind, Placebo Controlled, Parallel Arm, Dose Increment Randomised Trial of Regular, Low Dose Extended Release Morphine for Chronic Refractory Breathlessness|Recruiting||Phase 3|171|Anticipated|Flinders University||12|||f||||t||||||||||2017-10-10 22:21:35.388666|2017-10-10 22:21:35.388666
NCT02720809|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-25|||May 2016||2016-05-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Health2016: Monitoring Chronic Disease and Risk Factors in the General Population|Helbred2016: Monitorering af Kroniske Sygdomme og Risikofaktorer i Befolkningen|Not yet recruiting||N/A|1500|Anticipated|Glostrup University Hospital, Copenhagen|||1||f||||f||||||Samples With DNA|"     serum, plasma, whole blood, urine   "|No||2017-10-10 22:21:35.713056|2017-10-10 22:21:35.713056
NCT02720796|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-10-05|||November 2015||2015-11-01|October 2017|2017-10-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma|A Prospective Correlative Trial of Personalized Patient-Derived Xenograft (PDX or TumorGraft) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma|Terminated||N/A|17|Actual|Champions Oncology||1||Recruitment barriers|f||||f||||||||||2017-10-10 22:21:35.803386|2017-10-10 22:21:35.803386
NCT02720783|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-02-06|||March 4, 2016|Actual|2016-03-04|February 2017|2017-02-01|October 12, 2016|Actual|2016-10-12|October 12, 2016|Actual|2016-10-12||Interventional|||Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary|A Phase I Study of a Novel Antimycotic Vaginal Pessary Formulation (Econazole Nitrate 150 mg + Benzydamine HCl 6 mg) Administered Once Daily for 3 Days to Healthy Women|Completed||Phase 1|49|Actual|Aziende Chimiche Riunite Angelini Francesco S.p.A||4|||f||||f||||||||No||2017-10-10 22:21:35.883914|2017-10-10 22:21:35.883914
NCT02720770|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-22|||January 2006||2006-01-01|March 2016|2016-03-01|January 2011|Actual|2011-01-01|January 2009|Actual|2009-01-01||Interventional|GH-XLH||Growth Hormone Treatment in Children With Hypophosphatemic Rickets|Proposition Pour un Traitement Par Hormone de Croissance Des Enfants Atteints de Rachitisme Hypophosphatemique Familial|Completed||Phase 1/Phase 2|19|Actual|Bicetre Hospital||1|||f||||t||||||||No||2017-10-10 22:21:35.985006|2017-10-10 22:21:35.985006
NCT02720744|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-30|||November 2016|Actual|2016-11-01|August 2017|2017-08-01||||April 2018|Anticipated|2018-04-01||Interventional|||Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy|A Double-blind, Randomized, Placebo Controlled, Two Arm Multi-center Study to Assess the Efficacy and Safety of a Once Nightly Formulation of Sodium Oxybate for Extended-Release Oral Suspension (FT218) for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Subjects With Narcolepsy|Recruiting||Phase 3|264|Anticipated|Flamel Ireland Limited||2|||f||||f||||||||||2017-10-10 22:21:36.17782|2017-10-10 22:21:36.17782
NCT02720731|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-07-11|||April 2016||2016-04-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|DIS-HANDI||Care-related Pain and Discomfort in People With Motor Disorder|Care-related Pain and Discomfort in Children and Adults With Motor Disorder in Medical Establishments|Recruiting||N/A|600|Anticipated|University Hospital, Brest|||2||f||||f||||||||||2017-10-10 22:21:36.505427|2017-10-10 22:21:36.505427
NCT02720705|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children|Transbucal Dexmedetomidine for the Prevention of Emergence Agitation After Sevoflurane Anaesthesia in Pre-school Children|Recruiting||Phase 2/Phase 3|150|Anticipated|Assiut University||3|||f||||t||||||||No||2017-10-10 22:21:36.728214|2017-10-10 22:21:36.728214
NCT02720692|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-05-16|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Evaluation of N1539 Following Major Surgery|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major Surgery|Completed||Phase 3|722|Actual|Recro Pharma, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:21:36.850428|2017-10-10 22:21:36.850428
NCT02720679|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-10-03|||June 17, 2016|Actual|2016-06-17|October 2017|2017-10-01|August 2026|Anticipated|2026-08-01|August 2026|Anticipated|2026-08-01|10 Years|Observational [Patient Registry]|||Investigation of the Genetics of Hematologic Diseases|Investigation of the Genetics of Hematologic Diseases|Recruiting||N/A|1716|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     Blood samples and bone marrow aspirate samples.   "|||2017-10-10 22:21:37.037466|2017-10-10 22:21:37.037466
NCT02720666|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2017-01-05|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability|K-001 Treatment of Advanced Pancreatic Cancer: Phase I Clinical Trial of Monotherapy's Tolerability|Completed||Phase 1|12|Actual|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||4|||f||||t||||||||No||2017-10-10 22:21:37.169137|2017-10-10 22:21:37.169137
NCT02720653|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-01-10|||July 2016||2016-07-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||Determinants of Olfactory Dysfunction in Chronic Rhinosinusitis|Determinants of Olfactory Dysfunction in Chronic Rhinosinusitis|Enrolling by invitation||N/A|1000|Anticipated|Oregon Health and Science University|||2||f||||f||||||Samples Without DNA|"     Mucus specimens will be collected and analyzed for cytokine profiles and proteomics   "|||2017-10-10 22:21:37.271705|2017-10-10 22:21:37.271705
NCT02720640|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-12-09|||May 2015||2015-05-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|OX-RI||Safety and Efficacy of the Alpha AMS Subretinal Implant|Safety and Efficacy of the Alpha AMS Subretinal Implant for Partial Restoration of Vision in Visually Impaired Participants With Degenerative Retinal Disease|Active, not recruiting||N/A|6|Actual|University of Oxford||1|||f||||t||||||||Undecided||2017-10-10 22:21:37.352809|2017-10-10 22:21:37.352809
NCT02720627|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-02-15|||October 2016||2016-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris|An Open Label Evaluation of the Adrenal Suppression Potential and Trough Plasma Concentrations of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every 12 Hours for Two Weeks in Subjects 9 to <12 Years of Age With Acne Vulgaris|Recruiting||Phase 2|20|Anticipated|Cassiopea SpA||1|||f||||f||||||||No||2017-10-10 22:21:37.439449|2017-10-10 22:21:37.439449
NCT02720601|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-23|2016-03-28|||November 2015||2015-11-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers|A Phase II Trial of Combination Irinotecan and Capecitabine as Second-Line Treatment for Patients With Locally Advanced/Metastatic Biliary Tract Cancers Who Progressed or Intolerant to Front-Line Gemcitabine and Platinum Combination|Withdrawn||Phase 2|0|Actual|New Mexico Cancer Care Alliance||1||Study was never submitted to the IRB and was never opened. The PI is leaving the institution.|f||||t||||||||||2017-10-10 22:21:37.68086|2017-10-10 22:21:37.68086
NCT02720588|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-25|||January 2016||2016-01-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Observational|||Investigating Neuroimaging Endophenotypes for Autism Spectrum Disorder|Investigating Neuroimaging Endophenotypes for Autism Spectrum Disorder|Recruiting||N/A|90|Anticipated|National Taiwan University Hospital|||3||f||||t||||||||||2017-10-10 22:21:37.775189|2017-10-10 22:21:37.775189
NCT02720575|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-02-27|||January 2016||2016-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Evaluation of the Bioavailability of Vitamin D2 in Yeast and Bread||Completed||N/A|10|Actual|Boston University||6|||f||||t||||||||||2017-10-10 22:21:37.854096|2017-10-10 22:21:37.854096
NCT02720562|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-25|||January 2015||2015-01-01|March 2016|2016-03-01||||December 2015|Actual|2015-12-01||Observational|||Addressing Motion and Confounds Issues in Resting fMRI- Application of Multi-echo EPI Scanning|Addressing Motion and Confounds Issues in Resting fMRI- Application of Multi-echo EPI Scanning|Completed||N/A|80|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-10 22:21:37.936178|2017-10-10 22:21:37.936178
NCT02720549|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-26|||February 2016||2016-02-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Remote Ischemic Postconditioning on Postoperative Renal Dysfunction in Patients Undergoing Valvular Heart Surgery||Recruiting||N/A|252|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:21:37.996468|2017-10-10 22:21:37.996468
NCT02720536|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-08-15|||August 16, 2016|Actual|2016-08-16|August 2017|2017-08-01|July 2, 2019|Anticipated|2019-07-02|July 2, 2019|Anticipated|2019-07-02||Interventional|||Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation|Open-label, Multicenter, Single Arm, Phase III Study to Collect Additional Safety and Efficacy Data With Deferasirox Film-coated Tablets in Patients Completing Study CICL670F2201|Active, not recruiting||Phase 3|53|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-10 22:21:38.086047|2017-10-10 22:21:38.086047
NCT02720523|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-08-15|||March 22, 2016||2016-03-22|August 2017|2017-08-01|July 19, 2020|Anticipated|2020-07-19|August 3, 2017|Actual|2017-08-03||Interventional|SELECTSUNRISE||A Study to Compare ABT-494 to Placebo in Subjects With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs|A Phase 2b/3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Japanese Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs|Active, not recruiting||Phase 2|192|Anticipated|AbbVie||6|||f||||t||||||||||2017-10-10 22:21:38.2036|2017-10-10 22:21:38.2036
NCT02720510|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-07|||June 2016||2016-06-01|October 2016|2016-10-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|PANORAMA4||A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)|A Randomized, Phase II Trial Evaluating the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) With or Without Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma|Recruiting||Phase 2|112|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 22:21:38.40299|2017-10-10 22:21:38.40299
NCT02720497|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-02-06|||September 2016||2016-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD|The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD: A Randomized Controlled Trial in Active Duty Military Personnel|Recruiting||N/A|160|Anticipated|University of Pennsylvania||2|||f||||t||||||||Undecided||2017-10-10 22:21:38.535865|2017-10-10 22:21:38.535865
NCT02720484|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-05-24|||March 2016||2016-03-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer|Phase II Study of Nivolumab (Anti-PD-1 Antibody) for Treatment of Metastatic Adrenocortical Carcinoma|Active, not recruiting||Phase 2|10|Actual|Northwestern University||1|||f||||t||||||||||2017-10-10 22:21:38.615439|2017-10-10 22:21:38.615439
NCT02720471|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-08-08|||September 14, 2015||2015-09-14|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|ALRIAL||Local Analgesia Versus Local Peroperative Infiltration After Total Hip Replacement|Local Analgesia Versus Local Peroperative Infiltration After Total Hip Replacement|Completed||Phase 3|84|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:21:38.69948|2017-10-10 22:21:38.69948
NCT02720458|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-08-22|||October 4, 2016|Actual|2016-10-04|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|PROPERSOM||Self Help Program for Hypnotics Withdrawal in Insomniac Patients|Self-help Program for Hypnotics Withdrawal in Chronic Insomniac Patients: A Randomized Controlled Clinical Trial|Recruiting||N/A|256|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 22:21:38.770972|2017-10-10 22:21:38.770972
NCT02720432|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-05-04|||June 29, 2016|Actual|2016-06-29|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Early Intervention in Infants With Perinatal Stroke|Early Intervention in Infants With Perinatal Stroke : CIMT Versus HABIT : a Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|University Ghent||3|||f||||f||||||||No||2017-10-10 22:21:39.219425|2017-10-10 22:21:39.219425
NCT02720419|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-07-17|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|June 2025|Anticipated|2025-06-01|December 2020|Anticipated|2020-12-01||Observational|IRIS Synergy||IRIS-Synergy Cohort in the IRIS-DES Registry|Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Recruiting||N/A|3000|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-10 22:21:39.359485|2017-10-10 22:21:39.359485
NCT02720406|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Topical Ketamine Analgesia in Children Undergoing Tonsillectomy: a Clinical and Serum Level Assays Study.|Topical Ketamine by Neubulization Method in Tonsillectomy|Recruiting||Phase 2/Phase 3|60|Anticipated|Assiut University||3|||f||||t||||||||No||2017-10-10 22:21:39.629751|2017-10-10 22:21:39.629751
NCT02720393|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of No-carrageenan Diet on Glucose Tolerance in Prediabetes|Impact of no Carrageenan Diet on Glucose Tolerance in Prediabetes|Recruiting||N/A|48|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||Undecided|If required, individual data without identifiers may be made available.|2017-10-10 22:21:39.766526|2017-10-10 22:21:39.766526
NCT02720380|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-01-20|||July 2015||2015-07-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Buteyko Method for Children With Asthma|Buteyko Method for Children With Asthma: a Randomized Controlled Trial|Completed||N/A|32|Actual|Universidade Federal do Rio Grande do Norte||2|||f|||||f|f||||||No||2017-10-10 22:21:39.910336|2017-10-10 22:21:39.910336
NCT02720367|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-10-18|||July 2016||2016-07-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||Safety and Tolerability of GemRIS 225 mg in Subjects With Non-Muscle-Invasive Bladder Cancer|A Phase 1b, Multicenter, Open Label Study Evaluating Safety, Tolerability and Preliminary Efficacy of GemRIS 225 mg in Subjects With Non-Muscle-Invasive Urothelial Carcinoma of the Bladder|Recruiting||Phase 1|30|Anticipated|Taris Biomedical LLC||1|||f||||||||||||||2017-10-10 22:21:40.049665|2017-10-10 22:21:40.049665
NCT02720354|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-21|||April 2016||2016-04-01|March 2016|2016-03-01||||March 2017|Anticipated|2017-03-01||Interventional|||"A Phase I Study of a Novel Tracer for Positron Emission Tomography PET Myocardial Perfusion Imaging MPI"||Not yet recruiting||Phase 1|12|Anticipated|Synektik S.A.||1|||f||||t||||||||No||2017-10-10 22:21:40.166183|2017-10-10 22:21:40.166183
NCT02720341|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-03-29|||April 2015||2015-04-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|VIT-ARMin||VIT-ARMin Virtual, Intensified and Patient-tailored Robotic Arm Therapy With the Exoskeleton Robot ARMin|Virtual, Intensified and Patient-tailored Robotic Arm Therapy With the Exoskeleton Robot ARMin|Recruiting||Early Phase 1|420|Anticipated|Swiss Federal Institute of Technology||1|||f||||t||||||||No||2017-10-10 22:21:40.235876|2017-10-10 22:21:40.235876
NCT02720328|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-21|||July 2015||2015-07-01|March 2016|2016-03-01||||January 2016|Actual|2016-01-01||Interventional|ADR-OAC||Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants|Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants|Completed||Phase 4|102|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||||||||||||2017-10-10 22:21:40.346183|2017-10-10 22:21:40.346183
NCT02720315|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-06-16|||February 2016||2016-02-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|||Intensive Cryotherapy in the Emergency Department for Acute Musculoskeletal Injuries|Intensive Cryotherapy in the Emergency Department (ICED) Versus Conventional Treatment for Acute Musculoskeletal Injuries: The ICED Randomized Controlled Trial|Enrolling by invitation||N/A|200|Anticipated|Stanford University||2|||f||||t||||||||No||2017-10-10 22:21:40.437821|2017-10-10 22:21:40.437821
NCT02720302|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-10-03|||March 2016|Actual|2016-03-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|TeleSOFT||Treatment of Overweight in Children on Distance|Treatment of Overweight in Children on Distance. A Comparison Between Consultations on the Hospital With Video-Consultations on Distance|Recruiting||N/A|120|Anticipated|Skane University Hospital||2|||f||||f||||||||||2017-10-10 22:21:40.51629|2017-10-10 22:21:40.51629
NCT02720289|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-21|||August 2011||2011-08-01|March 2016|2016-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Video-Based Social Learning or Didactics for Car Seat Education|Car Seat Education: What Works Best?|Completed||N/A|212|Actual|Phoenix Children's Hospital||2|||f||||f||||||||||2017-10-10 22:21:40.64693|2017-10-10 22:21:40.64693
NCT02720276|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-17|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|StrokeWalk||Sms Guided Training After Acute Stroke|Sms Guided Training After Acute Stroke: A Pilot Study|Completed||N/A|19|Actual|Uppsala County Council, Sweden||1|||f||||t||||||||||2017-10-10 22:21:40.735687|2017-10-10 22:21:40.735687
NCT02720263|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-12|||March 28, 2016|Actual|2016-03-28|September 2017|2017-09-01|June 9, 2017|Actual|2017-06-09|June 9, 2017|Actual|2017-06-09||Interventional|||A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia|A Phase 1 Multiple Ascending Oral Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia|Completed||Phase 1|48|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-10 22:21:40.827817|2017-10-10 22:21:40.827817
NCT02720250|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Omega-3 Fatty Acids Enriched Food and Microvascular Reactivity|Effect of Omega-3 Fatty Acids Enriched Chicken Eggs Consumption on Microvascular Reactivity and Lipid Profile in Young Healthy Subjects|Recruiting||N/A|50|Anticipated|Josip Juraj Strossmayer University of Osijek||2|||f||||f||||||||No||2017-10-10 22:21:40.943895|2017-10-10 22:21:40.943895
NCT02720237|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-14|||March 2016||2016-03-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|REDART||Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral Load|Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral Load: A Randomized Controlled Trial (RCT) in Antiretroviral Therapy (ART) Clinics in Vietnam|Active, not recruiting||N/A|441|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||No||2017-10-10 22:21:41.037691|2017-10-10 22:21:41.037691
NCT02720224|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-06-13|||February 2016||2016-02-01|January 2016|2016-01-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol|An Open-Label, Single Dose Study Designed to Assess the Mass Balance Recovery, Metabolite Profiles and Metabolite Identification of [14C]-Estetrol in Healthy Female Volunteers|Completed||Phase 1|6|Actual|Estetra||1|||f||||f||||||||No||2017-10-10 22:21:41.155115|2017-10-10 22:21:41.155115
NCT02720211|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-10-26|||August 2016||2016-08-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Spectacle Tints and Thin-Films for Migraine|Spectacle Tints and Thin-Films to Reduce Headache Frequency in Patients With Chronic Migraine|Recruiting||N/A|140|Anticipated|University of Utah||2|||f||||f||||||||No||2017-10-10 22:21:41.262546|2017-10-10 22:21:41.262546
NCT02720198|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-05-09|||January 23, 2017|Actual|2017-01-23|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD|A Randomized, Rater-blinded Trial Comparing Efficacy and Tolerability and Changes in Neurocognition and Apathy of a Switch to Levomilnacipran Extended Release (ER) Versus Adjunctive Quetiapine for Patients Who Have Shown Inadequate Relief With Selective Serotonin Reuptake Inhibitors (SSRIs) in Major Depressive Disorder (MDD)|Recruiting||Phase 3|60|Anticipated|Duke University||2|||f||||t|t|f||||||No||2017-10-10 22:21:41.377181|2017-10-10 22:21:41.377181
NCT02720185|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-06-14|||July 2016||2016-07-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR|Window of Opportunity Study of Dasatinib in Operable Triple Negative Breast Cancers With Nuclear Epidermal Growth Factor Receptor|Recruiting||Phase 2|19|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-10 22:21:41.475577|2017-10-10 22:21:41.475577
NCT02720172|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-21|||March 2016||2016-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Early Postoperative Home Exercise Program After Cervical Spine Surgery|A Randomized Trial of an Early Postoperative Home Exercise Program Versus Usual Care After Anterior Cervical Discectomy and Fusion Surgery|Recruiting||Phase 1/Phase 2|96|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 22:21:41.577758|2017-10-10 22:21:41.577758
NCT02720159|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-21|||December 2015||2015-12-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Interventional|POP||Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis (POP)|A Prospective, Early Feasibility Study to Characterize the Efficacy and Safety of a Percutaneous Osseointegrated Prosthesis|Recruiting||N/A|10|Anticipated|Encore Medical, L.P.||1|||f||||t||||||||||2017-10-10 22:21:41.668753|2017-10-10 22:21:41.668753
NCT02720146|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-05-04|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Effect of Platelet Lysate on Corneal Epithelial Wound healing---the Collection of Human Serum From Volunteers|The Effect of Platelet Lysate on Corneal Epithelial Wound healing---the Collection of Human Serum From Volunteers|Not yet recruiting||N/A|10|Anticipated|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-10 22:21:41.753511|2017-10-10 22:21:41.753511
NCT02720133|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-06-17|||July 2013||2013-07-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01|3 Months|Observational [Patient Registry]|||Ramadan Fasting Effects in Patients With Cardiovascular Risk Factors|Ramadan Fasting Effects in Patients With Cardiovascular Risk Factors|Completed||N/A|500|Actual|University of Monastir|||1||f||||t||||||||Undecided||2017-10-10 22:21:41.829153|2017-10-10 22:21:41.829153
NCT02720120|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2016-03-25|||October 2005||2005-10-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)|A Randomized Placebo-Controlled, Multi-Center, Phase I/II Study of the Safety of Escalating Single Intravenous Doses of Ocrelizumab (rhuMAb 2H7, RO4964913, PRO70769) in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Stable Doses of Concomitant Methotrexate But With Unsatisfactory Clinical Response|Terminated||Phase 1/Phase 2|175|Actual|Hoffmann-La Roche||8||The overall benefit risk profile of ocrelizumab was not favorable in RA|f||||||||||||||2017-10-10 22:21:41.944909|2017-10-10 22:21:41.944909
NCT02720107|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-03-29|||May 12, 2016|Actual|2016-05-12|March 2017|2017-03-01|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Interventional|||Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)|Long-term Follow up of Patients With Relapsing-remitting Multiple Sclerosis Enrolled in the Multicenter, Single-arm, Open-label Biobank Study (CFTY720DDE01), to Investigate Changes in Biomarkers After 48 Months of Treatment With 0.5 mg Fingolimod (FTY720)|Completed||Phase 4|133|Actual|Novartis||1|||f||||f||||||||||2017-10-10 22:21:42.115127|2017-10-10 22:21:42.115127
NCT02720094|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-10-02|||December 2016||2016-12-01|October 2017|2017-10-01||||September 30, 2021|Anticipated|2021-09-30||Interventional|||Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men|A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men|Recruiting||Phase 2/Phase 3|4500|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:21:42.245881|2017-10-10 22:21:42.245881
NCT02720068|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-22|2017-09-28|||May 2, 2016|Actual|2016-05-02|September 2017|2017-09-01|December 4, 2020|Anticipated|2020-12-04|December 4, 2020|Anticipated|2020-12-04||Interventional|||Study of MK-4280 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-4280-001)|A Phase 1 Trial of MK-4280 as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|240|Anticipated|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-10-10 22:21:44.11234|2017-10-10 22:21:44.11234
NCT02720055|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01||||July 2017|Anticipated|2017-07-01||Interventional|||Rehabilitation Workbook After Wrist Fracture.|Routine Exercises and Either a Psychological (Therapy-based) or a Placebo (Informational) Intervention Workbook After Distal Radius Fracture: A Double Blind Randomised Control Trial.|Recruiting||N/A|140|Anticipated|NHS Lothian||2|||f||||f||||||||No|All data will be anonymised|2017-10-10 22:21:44.225189|2017-10-10 22:21:44.225189
NCT02720042|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-05-16|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair|A Post-Market, Prospective, Multi-Center, Single-Arm Clinical Investigation of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair|Active, not recruiting||N/A|85|Actual|C. R. Bard||1|||f||||t||||||||Undecided||2017-10-10 22:21:44.31732|2017-10-10 22:21:44.31732
NCT02720029|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-11-01|||December 2016||2016-12-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Detection of Silent Aspiration Events Utilizing pH/Impedance Probes in Hospitalized Patients|Detection of Silent Aspiration Events Utilizing pH/Impedance Probes in Hospitalized Patients|Not yet recruiting||N/A|50|Anticipated|Vanderbilt University||1|||f||||f||||||||Yes||2017-10-10 22:21:44.413787|2017-10-10 22:21:44.413787
NCT02720016|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-07-14|||October 3, 2016|Actual|2016-10-03|July 2017|2017-07-01|March 31, 2020|Anticipated|2020-03-31|June 28, 2019|Anticipated|2019-06-28||Interventional|CBCT||Cognitive-Behavioral Conjoint Therapy (CBCT) Project|An Integrative Technology Approach to Home-based Conjoint Therapy for PTSD|Recruiting||N/A|360|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:21:44.523201|2017-10-10 22:21:44.523201
NCT02720003|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-01-13|||March 2016||2016-03-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries|A Prospective, Multicenter, Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries (LEVANT China)|Recruiting||N/A|147|Anticipated|C. R. Bard||1|||f||||f||||||||Undecided||2017-10-10 22:21:44.654421|2017-10-10 22:21:44.654421
NCT02719990|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-08-03|||January 2016||2016-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD|An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)|Recruiting||Phase 2|250|Anticipated|Versartis Inc.||2|||f||||f||||||||||2017-10-10 22:21:44.956532|2017-10-10 22:21:44.956532
NCT02719977|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-03-13|||May 16, 2016||2016-05-16|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Phase I/II Study of CX5461|A Phase I/II Study of CX5461|Recruiting||Phase 1/Phase 2|98|Anticipated|Canadian Cancer Trials Group||1|||f||||t||||||||Undecided||2017-10-10 22:21:45.24387|2017-10-10 22:21:45.24387
NCT02719964|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-09-27|||May 2016||2016-05-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Rehabilitation of Visual Attention Following mTBI|Rehabilitation of Visual Attention Following mTBI|Recruiting||N/A|120|Anticipated|United States Naval Medical Center, San Diego||4|||f||||f||||||||||2017-10-10 22:21:45.350014|2017-10-10 22:21:45.350014
NCT02719951|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-08-09|||April 2016||2016-04-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|TANGAU||Glutaminergic Transmission in Autism : Molecular Imaging Exploration|Glutaminergic Transmission in Autism : Molecular Imaging Exploration|Recruiting||Phase 1|42|Anticipated|University Hospital, Tours||3|||f||||t||||||||No|There is no plan to share data.|2017-10-10 22:21:45.514114|2017-10-10 22:21:45.514114
NCT02719938|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-09-15|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Triggered Palliative Care for Advanced Dementia|Triggered Palliative Care for Advanced Dementia|Active, not recruiting||N/A|120|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 22:21:45.630328|2017-10-10 22:21:45.630328
NCT02719925|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-08-01|||July 2016||2016-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|STRESSOM15||Mineral Water Rich in Magnesium and Perceived Stress in Healthy Consumers|Effect of One Month of Daily Consumption of Mineral Water Rich in Magnesium on Perceived Stress in Healthy Consumers.|Recruiting||N/A|256|Anticipated|My Goodlife SAS||2|||f||||f||||||||No||2017-10-10 22:21:45.726311|2017-10-10 22:21:45.726311
NCT02719912|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-21|||June 2016||2016-06-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|DOCK 1||Mitral Valve Replacement With MValve Dock and Lotus|Mitral Valve Replacement With the MValve Dock and A Percutaneous Transcatheter Heart Valve|Not yet recruiting||N/A|30|Anticipated|MValve Technologies Ltd||1|||f||||t||||||||||2017-10-10 22:21:45.859648|2017-10-10 22:21:45.859648
NCT02719899|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-24|2017-09-21|||March 20, 2016||2016-03-20|September 15, 2017|2017-09-15|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Observational|||Effect of Fasting and Refeeding on T-cell Fate|Pilot Study to Evaluate the Effect of Fasting and Refeeding on T-Cell Fate|Completed||N/A|28|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:21:45.962935|2017-10-10 22:21:45.962935
NCT02719886|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-12-08|||April 2016||2016-04-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|SUN||Timing of Serial Ultrasounds|Timing of Serial UltrasouNds in High-Risk Pregnancies: A Randomized Controlled Trial|Recruiting||N/A|228|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-10-10 22:21:46.040706|2017-10-10 22:21:46.040706
NCT02719873|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-07-14|||August 2016||2016-08-01|July 2017|2017-07-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Observational|||The Impact of Maternal Obesity on Pregnancy Outcomes in El-Minia Locality|The Impact of Maternal Obesity on Pregnancy Outcomes in El-Minia Locality a Case Control Survey Study|Completed||N/A|330|Actual|Minia University|||2||f||||t||||||||||2017-10-10 22:21:46.131739|2017-10-10 22:21:46.131739
NCT02719860|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-24|||September 2003||2003-09-01|March 2016|2016-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||High Tea Consumption on Smoking Related Oxidative Stress|A Chemoprevention Trial to Study the Effects of High Tea Consumption on Smoking Related Oxidative Stress|Completed||Phase 2|154|Actual|University of Arizona||3|||f||||||||||||||2017-10-10 22:21:46.223689|2017-10-10 22:21:46.223689
NCT02719847|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-10-07|||March 2016||2016-03-01|October 2016|2016-10-01||||March 2020|Anticipated|2020-03-01||Interventional|||Additive Value of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy|Additive Value of EBUS TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy|Recruiting||N/A|150|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:21:46.3042|2017-10-10 22:21:46.3042
NCT02719834|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-03-16|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Behavioral Expressions in Alzheimer's Disease|An Analgesic Trial to Reduce Pain and Behavior Disruptions in Nursing Home Residents With Alzheimer's Disease|Recruiting||N/A|30|Anticipated|University of Florida|||2||f||||t|f|f||||||Undecided||2017-10-10 22:21:46.41426|2017-10-10 22:21:46.41426
NCT02719821|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-11-29|||April 2016||2016-04-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|March 2020|Anticipated|2020-03-01||Interventional|||Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation|Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation|Active, not recruiting||N/A|18|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||No||2017-10-10 22:21:46.513938|2017-10-10 22:21:46.513938
NCT02719808|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-09-23|||March 2015||2015-03-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Study of Antiretroviral Therapy to Prevent HBV Intrauterine Infection|A Cohort Study of Tenofovir on Blocking HBV Intrauterine Infection|Recruiting||N/A|500|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||5||f||||f||||||Samples Without DNA|"     Blood, placenta tissue of HBeAg-positive pregnant women   "|No||2017-10-10 22:21:46.614421|2017-10-10 22:21:46.614421
NCT02719795|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-02-15|||April 2016||2016-04-01|April 2016|2016-04-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|PNBCP||Pectoral Nerves Blocks for Chronic Pain|Pectoral Nerves Blocks and Their Effect on Chronic Pain After Breast Cancer Surgery|Recruiting||Early Phase 1|140|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||t||||||||Yes||2017-10-10 22:21:46.712264|2017-10-10 22:21:46.712264
NCT02719782|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-21|||December 2015||2015-12-01|March 2016|2016-03-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|||TCR-Redirected T Cell Infusions to Treat Recurrent Hepatocellular Carcinoma Post Liver Transplantation|Phase I Study T Cell Receptor-Redirected T Cells Infusions to Treat Patients With Recurrent HBV-Related Hepatocellular Carcinoma Post Liver Transplantation|Recruiting||Phase 1/Phase 2|10|Anticipated|Lion TCR Pte. Ltd.||1|||f||||f||||||||No||2017-10-10 22:21:46.808594|2017-10-10 22:21:46.808594
NCT02719769|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-09-25|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|January 12, 2017|Actual|2017-01-12|May 2016|Actual|2016-05-01||Observational|||Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture|Evaluation of Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture Identification & Antimicrobial Susceptibility Testing|Completed||N/A|4009|Actual|Accelerate Diagnostics, Inc.|||1||f||||f||||||Samples Without DNA|"     Frozen positive blood cultures and bacterial and yeast isolates   "|||2017-10-10 22:21:47.012641|2017-10-10 22:21:47.012641
NCT02719756|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-24|||April 2016||2016-04-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2|Randomized, Open Prospective Study of the Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2|Not yet recruiting||Phase 4|100|Anticipated|Research Clinical Centre of the Russian Railways, JSC||2|||f||||f||||||||No||2017-10-10 22:21:47.119379|2017-10-10 22:21:47.119379
NCT02719743|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-08-25|||July 7, 2016|Actual|2016-07-07|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age|An Observer-blind, Dose Ranging Safety and Immunogenicity Study of GSK Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age|Active, not recruiting||Phase 2|185|Actual|GlaxoSmithKline||5|||f|||||f|f||||||||2017-10-10 22:21:47.226536|2017-10-10 22:21:47.226536
NCT02719730|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-06-10|||March 2016||2016-03-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Upgrade the Grains Study: Increasing Whole Grain Consumption in Low-income Children With Obesity|The Metabolic Impact of Concurrent Food Insecurity and Obesity|Enrolling by invitation||N/A|60|Anticipated|Children's Hospital & Research Center Oakland||2|||f||||f||||||||Undecided||2017-10-10 22:21:47.339573|2017-10-10 22:21:47.339573
NCT02719717|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-01-31|||June 2016||2016-06-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|VATS PA-ACE||Ultrasonic Energy for Pulmonary Artery Branch Sealing During VATS Lobectomy|Prospective, Multi-Center, International Phase 2 Trial of the Use of Ultrasonic Energy for Pulmonary Artery Branch Sealing During VATS Lobectomy|Recruiting||Phase 2|150|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t||||||||Yes||2017-10-10 22:21:47.423736|2017-10-10 22:21:47.423736
NCT02719704|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-21|||March 2015||2015-03-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||School-based Multicomponent Intervention on Physical Fitness Related to Health and Body Image|Effect of a Multicomponent Intervention Program on Physical Fitness Related to Health and Body Image: School-based Study With Adolescents of Florianópolis, Santa Catarina, Brazil|Completed||N/A|568|Actual|Santa Catarina Federal University||3|||f||||t||||||||Yes||2017-10-10 22:21:47.528158|2017-10-10 22:21:47.528158
NCT02719691|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-08-18|||May 13, 2016|Actual|2016-05-13|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer|A Phase Ib Study of the Combination of MLN0128 (Dual TORC1/2 Inhibitor) and MLN8237 (Aurora A Inhibitor, Alisertib) in Patients With Advanced Solid Tumors With an Expansion Cohort in Metastatic Triple-negative Breast Cancer (TNBC)|Recruiting||Phase 1|56|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 22:21:47.636035|2017-10-10 22:21:47.636035
NCT02719678|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-24|||January 1982||1982-01-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|December 1984|Actual|1984-12-01||Interventional|||Epidemiological Studies of Health Effects of General Examinations|Epidemiological Studies of Health Effects of General Examinations|Completed||N/A|17845|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||No|Data will be shared upon request and approval from the Ethics Committee.|2017-10-10 22:21:47.738524|2017-10-10 22:21:47.738524
NCT02719665|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-10-11|||March 2016||2016-03-01|March 2016|2016-03-01||||March 2020|Anticipated|2020-03-01||Interventional|||THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease|THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease|Recruiting||Phase 1|50|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-10 22:21:47.824171|2017-10-10 22:21:47.824171
NCT02719652|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-08-03|||November 2015||2015-11-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|June 2016|Actual|2016-06-01||Observational|||Vessel Wall and Perfusion Imaging in Intracranial Atherosclerosis|Vessel Wall and Perfusion Imaging in Intracranial Atherosclerosis|Recruiting||N/A|300|Anticipated|Capital Medical University|||2||f||||t||||||||Yes|The date of individual participant will be recorded in case report form(CRF),which will be stored technically|2017-10-10 22:21:47.971109|2017-10-10 22:21:47.971109
NCT02719639|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-06-15|||April 11, 2016|Actual|2016-04-11|June 2017|2017-06-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Observational|||OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS)|Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice.|Completed||N/A|7489|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 22:21:48.072892|2017-10-10 22:21:48.072892
NCT02719626|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-03-21|||April 2011||2011-04-01|February 2016|2016-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Improving The Safety And Nutritional Adequacy Of The Home Food Supply Of Elderly Recipients Of Home Delivered Meals|Improving The Safety And Nutritional Adequacy Of The Home Food Supply Of Elderly Recipients Of Home Delivered Meals|Completed||N/A|740|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||No|Aggregate results will be made available via website (in process).|2017-10-10 22:21:48.189074|2017-10-10 22:21:48.189074
NCT02719613|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-26|||July 11, 2016|Actual|2016-07-11|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 29, 2019|Anticipated|2019-04-29||Interventional|||Continuing Treatment for Subjects Who Have Participated in a Prior Protocol Investigating Elotuzumab|Continuing Treatment for Subjects Who Have Participated in a Prior Protocol Investigating Elotuzumab|Recruiting||Phase 2|21|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 22:21:48.383848|2017-10-10 22:21:48.383848
NCT02719600|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-24|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Motor Learning Through Virtual Reality Task in Individuals With Down Syndrome|Motor Learning Through Virtual Reality Task in Individuals With Down Syndrome|Completed||N/A|40|Actual|University of Sao Paulo||2|||f||||f||||||||No|No interest on sharing individual participant data|2017-10-10 22:21:48.533063|2017-10-10 22:21:48.533063
NCT02719587|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-24|||April 2009||2009-04-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Dietary Supplementation With Low-Dose Omega-3 Reduces Salivary TNF-α Levels in Patients With Chronic Periodontitis|Dietary Supplementation With Low-Dose Omega-3 Fatty Acids Reduces Salivary TNF-α Levels in Patients With Chronic Periodontitis|Completed||Early Phase 1|30|Actual|Ondokuz Mayıs University||2|||f||||t||||||||No||2017-10-10 22:21:48.601487|2017-10-10 22:21:48.601487
NCT02719574|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-05-05|||April 2016||2016-04-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Dose-Escalation Study of FT-2102 as a Single Agent and in Combination With Azacitidine in Patients With AML or MDS With an IDH1 Mutation|A Phase 1/1b, Multicenter, Open-label, Dose-Escalation Study of FT-2102 as a Single Agent and in Combination With Azacitidine in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome With an IDH1 Mutation|Recruiting||Phase 1|76|Anticipated|Forma Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 22:21:48.681228|2017-10-10 22:21:48.681228
NCT02719561|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-05-19|||June 2016||2016-06-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Fatigue Intervention Co-design Study in Teenagers and Young Adults With Cancer|Fatigue Intervention Co-design Study in Teenagers and Young Adults With Cancer|Completed||N/A|20|Actual|Cambridge University Hospitals NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:21:48.809232|2017-10-10 22:21:48.809232
NCT02719548|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-04-18|||February 2016||2016-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|BSD||Impact of Breast Shield Designs on Dynamics of Breast Pumping|Impact of Breast Shield Designs on Dynamics of Breast Pumping|Completed||N/A|15|Actual|Medela AG||3|||f||||f||||||||No||2017-10-10 22:21:48.877534|2017-10-10 22:21:48.877534
NCT02719535|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-08-13|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Corneal Biomechanics and Corneal Reshaping Therapy|Corneal Stiffness and Tangent Modulus to Predict the Rate of Corneal Curvature Change in Corneal Reshaping Therapy|Recruiting||N/A|60|Anticipated|The Hong Kong Polytechnic University||1|||f||||f||||||||||2017-10-10 22:21:48.964472|2017-10-10 22:21:48.964472
NCT02719522|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-04-12|||March 2016||2016-03-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Observational|SHIELD||Pipeline Flex With SHield Technology Embolization - An International MulticEnter ObservationaL Post Market StuDy|Pipeline Flex With SHield Technology Embolization - An International MulticEnter ObservationaL Post Market StuDy of Treated Intra Cranial Aneurysms (SHIELD)|Recruiting||N/A|200|Anticipated|Medtronic Neurovascular Clinical Affairs|||1||f||||t||||||||||2017-10-10 22:21:49.054428|2017-10-10 22:21:49.054428
NCT02719509|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-08-25|||February 2016||2016-02-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Emergency Department Cardiac Ultrasound|Prospective Evaluation of the Utility of Bedside Cardiac Ultrasound for Undifferentiated Chest Pain and Shortness of Breath in the Emergency Department|Completed||N/A|380|Actual|Minneapolis Medical Research Foundation|||1||f||||f||||||||Undecided||2017-10-10 22:21:49.1923|2017-10-10 22:21:49.1923
NCT02719496|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-08-05|||April 2016||2016-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PHYTOPARK||Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease|Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease|Recruiting||Phase 2|45|Anticipated|Nantes University Hospital||1|||f||||f||||||||No||2017-10-10 22:21:49.284211|2017-10-10 22:21:49.284211
NCT02716883|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-03-26|||January 2014||2014-01-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Early Amniotic Membrane Transplantation in Bacterial Keratitis|Early Amniotic Membrane Transplantation in Bacterial Keratitis|Active, not recruiting||N/A|14|Anticipated|Farabi Eye Hospital||2|||f||||f||||||||No||2017-10-10 22:22:16.883778|2017-10-10 22:22:16.883778
NCT02719483|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-21|||April 2014||2014-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|||Radial Extracorporeal Shock Wave Therapy for Spastic Plantar Flexor Muscles in Young Children With Cerebral Palsy|Applied Research in Children With Spastic Cerebral Palsy in the Extracorporeal Shock Wave Therapy|Completed||N/A|66|Actual|First Hospital of Jilin University||2|||f||||f||||||||No||2017-10-10 22:21:49.381117|2017-10-10 22:21:49.381117
NCT02719470|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-24|||January 2014||2014-01-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Does Cognitive Impairment Affect Rehabilitation Outcome in Parkinson's Disease?|Does Cognitive Impairment Affect Rehabilitation Outcome in Parkinson's Disease?|Completed||N/A|438|Actual|Ospedale Generale Di Zona Moriggia-Pelascini||5|||f||||f||||||||No||2017-10-10 22:21:49.59464|2017-10-10 22:21:49.59464
NCT02719457|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-10-27|||April 2016||2016-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|SMT||Spot Marching Exercise Test in Chronic Obstructive Pulmonary Disease|the Relationship Between Spot Marching Exercise Test and Six Minute Walk Test in Patient With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|30|Anticipated|Khon Kaen University||2|||f||||f||||||||||2017-10-10 22:21:49.694697|2017-10-10 22:21:49.694697
NCT02719444|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-03-13|||September 2016||2016-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:21:49.831891|2017-10-10 22:21:49.831891
NCT02719431|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-03-21|||January 2016||2016-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers||Completed||Phase 1|20|Actual|Kowa Research Institute, Inc.||1|||f||||f||||||||||2017-10-10 22:21:49.888501|2017-10-10 22:21:49.888501
NCT02719418|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-08-28|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 30, 2016|Actual|2016-09-30||Observational|STRIP||Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses|Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses|Active, not recruiting||N/A|28|Actual|Maisonneuve-Rosemont Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:21:49.996328|2017-10-10 22:21:49.996328
NCT02719405|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-07-07|||February 2016||2016-02-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Impact of Infant Formula on Resolution of Cow's Milk Allergy|A Prospective Randomized Controlled Trial to Evaluate the Effect of Infant Formula on the Resolution of Cow's Milk Allergy of Infancy|Terminated||Phase 2|49|Actual|Massachusetts General Hospital||3||Insufficient enrollment|f||||t||||||||||2017-10-10 22:21:50.193812|2017-10-10 22:21:50.193812
NCT02719392|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-10-21|||September 2016||2016-09-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression|A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression|Recruiting||Phase 4|40|Anticipated|Massachusetts General Hospital||4|||f||||t||||||||No||2017-10-10 22:21:50.312396|2017-10-10 22:21:50.312396
NCT02718430|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-28|||February 2016||2016-02-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis|VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis Under Second or Third Line Therapy to Examine Safety, Efficacy, and Immune Biomarkers After Treatment With VXM01|Active, not recruiting||Phase 1|6|Anticipated|Vaximm GmbH||1|||f||||t||||||||Yes||2017-10-10 22:21:50.549192|2017-10-10 22:21:50.549192
NCT02718404|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-09-28|||July 2015||2015-07-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|HIFU-Bone||3 Tesla Magnetic Resonance Guided High Intensity Focused Ultrasound in the Treatment of Pain From Bone Metastases of Solid Tumors|3 Tesla Magnetic Resonance Guided High Intensity Focused Ultrasound (MR-HIFU) in the Treatment of Pain From Bone Metastases of Solid Tumors|Recruiting||N/A|41|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-10 22:21:51.69031|2017-10-10 22:21:51.69031
NCT02718391|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-19|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ACDC||Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.|Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients: a Phase II Randomized Trial (ACDC Adjuvant Trial)|Recruiting||Phase 2|120|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||||2017-10-10 22:21:51.788304|2017-10-10 22:21:51.788304
NCT02718378|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-02-08|||March 2016||2016-03-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of Safety and Efficacy of Estetrol in Healthy Men|A Phase I, Double-blind, Randomised, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Multiple Dosages of Estetrol in Healthy Men|Completed||Phase 1|45|Actual|Pantarhei Oncology B.V.||4|||f||||||||||||||2017-10-10 22:21:51.884402|2017-10-10 22:21:51.884402
NCT02718365|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2017-05-10|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2024|Anticipated|2024-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC|A Multi-center, Prospective, Randomized Controlled Clinical Trial: Comparison Between Wedge Resection and Segmentectomy in the Surgical Treatment of Ground Glass Opacity-dominant Stage IA Non-small Cell Lung Cancer|Not yet recruiting||N/A|688|Anticipated|West China Hospital||2|||f||||t|f|f||||||No||2017-10-10 22:21:51.991861|2017-10-10 22:21:51.991861
NCT02718352|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-04-21|||March 2016||2016-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence|A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence|Recruiting||N/A|50|Anticipated|Yale University|||1||f||||f||||||||No||2017-10-10 22:21:52.082255|2017-10-10 22:21:52.082255
NCT02718339|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-03-20|||April 2016||2016-04-01|March 2016|2016-03-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||In-patient Asthma Counseling by Pulmonologist and Hospital Re-admission Rate||Not yet recruiting||N/A|164|Anticipated|Soroka University Medical Center||2|||f||||t||||||||||2017-10-10 22:21:52.15139|2017-10-10 22:21:52.15139
NCT02718326|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2017-08-24|||April 2016||2016-04-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Interventional|PANORAMA||Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)|A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy|Active, not recruiting||Phase 3|402|Actual|Regeneron Pharmaceuticals||3|||f||||t||||||||||2017-10-10 22:21:52.28012|2017-10-10 22:21:52.28012
NCT02718313|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-23|||April 2016||2016-04-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Observational|||Echocardiographic Findings and 30-days Outcomes for Intraventricular Conduction Delay in Patients Undergoing Elective Surgeries||Not yet recruiting||N/A|100|Anticipated|Yonsei University|||1||f||||f||||||||No|no plan to share data|2017-10-10 22:21:52.510693|2017-10-10 22:21:52.510693
NCT02719366|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-09-06|||March 2016||2016-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:21:52.567275|2017-10-10 22:21:52.567275
NCT02719353|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-09-06|||March 2016||2016-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:21:52.607291|2017-10-10 22:21:52.607291
NCT02719340|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-21|||November 2010||2010-11-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|October 2011|Actual|2011-10-01||Observational|||Short Segment Fixation in Thoracolumbar Osteoporotic Fracture|Short-segment Decompression and Reconstruction for Thoracolumbar Osteoporotic Fractures With Neurological Deficits: Clinical and Radiological Results of Minimum 2-year Follow-up|Completed||N/A|20|Actual|National Cheng-Kung University Hospital|||1||f||||f||||||||No||2017-10-10 22:21:52.650852|2017-10-10 22:21:52.650852
NCT02719327|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-07-14|||December 1, 2016|Actual|2016-12-01|July 2017|2017-07-01|November 30, 2021|Anticipated|2021-11-30|November 30, 2021|Anticipated|2021-11-30||Interventional|BRAVE-EPA||Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid|Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults|Recruiting||Phase 2/Phase 3|150|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||t|||||2017-10-10 22:21:52.713058|2017-10-10 22:21:52.713058
NCT02719314|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-07-18|||December 2015||2015-12-01|July 2017|2017-07-01|July 2029|Anticipated|2029-07-01|November 2025|Anticipated|2025-11-01|14 Years|Observational [Patient Registry]|Rh-GIOP||Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis|Non-interventional Clinical Trial to Establish a Glucocorticoid-induced Osteoporosis Databank for Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis and Therapy With Glucocorticoids|Recruiting||N/A|10000|Anticipated|Charite University, Berlin, Germany|||3||f||||f||||||||||2017-10-10 22:21:52.816001|2017-10-10 22:21:52.816001
NCT02719301|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-06-30|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Necklace-Shaped Sensor for Non-Invasive Monitoring of Stroke Volume and Cardiac Output|Necklace-Shaped Sensor for Non-Invasive Monitoring of Stroke Volume, Cardiac Output, Fluids, Heart Rate, Heart Rate Variability, and Respiration Rate|Completed||N/A|85|Actual|toSense, Inc.|||1||f||||f||||||||||2017-10-10 22:21:52.943751|2017-10-10 22:21:52.943751
NCT02719288|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-06|||February 2016||2016-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PATRICC||Peroneal and Achilles Tendon Repair Indications With CLARIX® CORD 1K|A Multi-center, Open Label, Economic Outcome Study Comparing the Recovery of Patients Receiving CLARIX® CORD 1K as an add-on Treatment During Surgical Tendon Repair to Control Patients Receiving Standard of Care Procedures|Recruiting||N/A|40|Anticipated|Amniox Medical, Inc.||2|||f||||f||||||||No||2017-10-10 22:21:53.01735|2017-10-10 22:21:53.01735
NCT02719275|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-21|||April 2016||2016-04-01|March 2016|2016-03-01||||April 2017|Anticipated|2017-04-01||Observational|SMMASH||Social Media Markers of Adolescents' Suicide Hazard|Social Media Markers of Adolescents' Suicide Hazard|Not yet recruiting||N/A|200|Anticipated|British Columbia Children's Hospital|||4||f||||t||||||||||2017-10-10 22:21:53.129046|2017-10-10 22:21:53.129046
NCT02719262|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reduced of Ambient Melamine Exposure by Melamine Workplace Intervention|Workplace Intervention and Reduced Ambient Melamine Exposure and Renal Damage in Melamine Tableware Manufacturing Workers|Enrolling by invitation||N/A|30|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:21:53.210746|2017-10-10 22:21:53.210746
NCT02719249|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-03-15|||January 2016||2016-01-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|SNOUFY||Fabry Disease Screening in ESRD Patients in West of France|Fabry Disease Prevalence in End-stage Renal Disease (ESRD) Patients on Dialysis or Transplant in West of France|Recruiting||N/A|500|Anticipated|Rennes University Hospital|||1||f||||t||||||||No||2017-10-10 22:21:53.29671|2017-10-10 22:21:53.29671
NCT02719236|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-27|||December 2015||2015-12-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|DAAvsDLA||Direct Anterior Approach Versus Direct Lateral Approach in Total Hip Arthroplasty|Direct Anterior Approach Versus Direct Lateral Approach in Cementless Total Hip Arthroplasty|Recruiting||N/A|100|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy||2|||f||||f||||||||||2017-10-10 22:21:53.393575|2017-10-10 22:21:53.393575
NCT02719223|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2017-05-08|||January 2017||2017-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of On-Line Hemodiafiltration Versus High Flux Hemodialysis on Hemodynamic Parameters in Patients With Intra-Dialytic Hypotension|The Effect of On-Line Hemodiafiltration Versus High Flux Hemodialysis on Hemodynamic Parameters in Patients With Intra-Dialytic Hypotension|Recruiting||N/A|20|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||f||||||||Undecided||2017-10-10 22:21:53.539777|2017-10-10 22:21:53.539777
NCT02719210|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-12-17|||January 2016||2016-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High Volume Plasma Exchange in Children With Acute Liver Failure|High Volume Plasma Exchange in Children With Acute Liver Failure-A Prospective Randomized Controlled Trial.|Recruiting||N/A|30|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 22:21:53.664959|2017-10-10 22:21:53.664959
NCT02719197|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-07-26|||February 19, 2016|Actual|2016-02-19|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders|Single-center, Double-blind, Placebo-controlled, Randomized, Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics (Including Food Effect), and Pharmacodynamics of an Oral Drug for Neurological Disorders in Healthy Male Subjects|Completed||Phase 1|72|Actual|Actelion||2|||f||||f||||||||||2017-10-10 22:21:53.755043|2017-10-10 22:21:53.755043
NCT02719184|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-10-03|||April 13, 2016|Actual|2016-04-13|October 2017|2017-10-01|January 14, 2020|Anticipated|2020-01-14|January 14, 2020|Anticipated|2020-01-14||Observational|||Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)|Observational Study in Healthy Subjects and Patients With COPD to Assess the Relationship Between Clinical, Imaging and Biomarker Measurements, and Progression of Emphysema Over Two Years [FOOTPRINTS™].|Recruiting||N/A|455|Anticipated|Boehringer Ingelheim|||5||f||||||||||Samples With DNA|"     Solube and imaging biomarkers   "|||2017-10-10 22:21:53.84498|2017-10-10 22:21:53.84498
NCT02719171|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-09-06|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|||BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis|A Randomised, Double-blind, Placebo-controlled, Proof-of-concept, Dose-ranging Study of BI 655066/ABBV-066/Risankizumabin Patients With Active Psoriatic Arthritis|Completed||Phase 2|185|Actual|AbbVie||5|||f||||t||||||||||2017-10-10 22:21:53.994114|2017-10-10 22:21:53.994114
NCT02719158|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-08-09|||February 2016||2016-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Dose Ranging Study of OTO-201 in AOMT|A 1-Month, Prospective, Multicenter, Randomized, Dose-Ranging, Sham-Controlled, Blinded Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Subjects|Completed||Phase 2|95|Actual|Otonomy, Inc.||3|||f||||f||||||||||2017-10-10 22:21:54.182741|2017-10-10 22:21:54.182741
NCT02719145|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-10-22|||October 2015||2015-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|||Circulating Micro RNAs Expression in Egyptian Bronchial Asthma and COPD Patients|Circulating Micro RNAs Expression in Egyptian Bronchial Asthma and COPD Patients|Completed||N/A|30|Actual|Tanta University|||3||f||||t||||||Samples With DNA|"     Serum   "|Undecided||2017-10-10 22:21:54.261248|2017-10-10 22:21:54.261248
NCT02719132|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-05-19|||July 2016||2016-07-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|FLORA||Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice|A Multicentre Randomised Open-Label Crossover 2-Period 2 Treatment Clinical Trial to Evaluate Effect of Dapagliflozin 10 mg Once Daily on the Quality of Life in Patients With Type 2 Diabetes|Withdrawn||Phase 4|0|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:21:54.450891|2017-10-10 22:21:54.450891
NCT02719119|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2017-04-04|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|June 2017|Anticipated|2017-06-01||Interventional|||Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding|Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding|Recruiting||N/A|60|Anticipated|West China Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:21:54.539802|2017-10-10 22:21:54.539802
NCT02719106|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-06-20|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|June 2023|Anticipated|2023-06-01|December 2018|Anticipated|2018-12-01||Observational|IRISUltimaster||IRIS Ultimaster Cohort in the IRIS-DES Registry|Evaluation of Effectiveness and Safety of Ultimaster® Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Recruiting||N/A|1000|Anticipated|Asan Medical Center|||1||f||||t|f|f||||||Undecided||2017-10-10 22:21:54.638246|2017-10-10 22:21:54.638246
NCT02719093|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2016-03-20|||July 2016||2016-07-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery|Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery|Not yet recruiting||Phase 4|100|Anticipated|U.O. Chirurgia Andrologica||1|||f||||f||||||||Undecided||2017-10-10 22:21:54.811169|2017-10-10 22:21:54.811169
NCT02719080|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-03-20|||December 2015||2015-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||The Relationship Between Cerebral State and Emotion in Anesthesiologist and Surgeon|Department of Anesthesiology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine|Completed||N/A|40|Actual|Ruijin Hospital|||1||f||||f||||||||||2017-10-10 22:21:54.891984|2017-10-10 22:21:54.891984
NCT02719067|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-20|||January 2016||2016-01-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Observational|||A Longitudinal Follow-up Imaging Study on Children and Adolescents With Autism Spectrum Disorder|A Longitudinal Follow-up Imaging Study on Children and Adolescents With Autism Spectrum Disorder|Recruiting||N/A|140|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-10 22:21:54.967195|2017-10-10 22:21:54.967195
NCT02719054|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-20|||January 2014||2014-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Community Based Depression Management and Child Development|Effect of Community Based Depression Management and Psychosocial Stimulation Intervention on Maternal Mental Health and Child Development: A Randomized Controlled Trial|Completed||N/A|300|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||Yes|We will share data with our collaborators|2017-10-10 22:21:55.068834|2017-10-10 22:21:55.068834
NCT02719041|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-03-20|||April 2016||2016-04-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study||Not yet recruiting||N/A|40|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||No||2017-10-10 22:21:55.262546|2017-10-10 22:21:55.262546
NCT02719028|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-03-19|||May 2016||2016-05-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia|A Prospective, Double Blind, Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia|Recruiting||Phase 2|120|Anticipated|Golden Biotechnology Corporation||4|||f||||f||||||||No||2017-10-10 22:21:55.372967|2017-10-10 22:21:55.372967
NCT02719015|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-09-28|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma|Phase I/II Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:21:55.526651|2017-10-10 22:21:55.526651
NCT02719002|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-02-06|||August 26, 2016|Actual|2016-08-26|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|PERFOCTAPS||Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials|Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials|Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||||||||||||2017-10-10 22:21:55.672046|2017-10-10 22:21:55.672046
NCT02718989|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-05-25|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Modulation of H-reflex After Application of Electric Currents in Healthy People|Modulation of H-reflex After Application of Electric Currents in Healthy People. Effects on Myotonometer Properties.A Pilot Study|Not yet recruiting||N/A|30|Anticipated|University of Castilla-La Mancha||3|||f||||f|f|f||||||Yes||2017-10-10 22:21:55.767974|2017-10-10 22:21:55.767974
NCT02718976|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-04-24|||March 2016||2016-03-01|February 2016|2016-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Shamrock - Ultrasound/MR Image Fusion Guided Lumbar Plexus Block|Shamrock - Ultrasound/MR Image Fusion Guided Lumbar Plexus Block|Completed||Phase 2|22|Actual|University of Aarhus||2|||f||||t||||||||No||2017-10-10 22:21:55.891012|2017-10-10 22:21:55.891012
NCT02718963|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-10-14|||August 2015||2015-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Treatment of Dysphagia by Using a Synchronized Electrical Stimulation Device|Treatment of Dysphagia by Using a Synchronized Electrical Stimulation Device|Completed||N/A|20|Actual|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:21:56.022758|2017-10-10 22:21:56.022758
NCT02718950|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-23|||June 2016||2016-06-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|i-LAB||Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans|Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans|Not yet recruiting||Phase 3|20|Anticipated|University of Campinas, Brazil||1|||f||||t||||||||No||2017-10-10 22:21:56.118106|2017-10-10 22:21:56.118106
NCT02718937|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-01-23|||March 2016||2016-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study|A Randomised, Phase 2a, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity Against Respiratory Syncytial Virus Infection, and the Pharmacokinetics of Multiple Oral Doses of BTA-C585 in the Virus Challenge Model|Completed||Phase 2|60|Actual|Aviragen Therapeutics||2|||f||||f||||||||||2017-10-10 22:21:56.220151|2017-10-10 22:21:56.220151
NCT02718924|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2017-07-05|||November 2015||2015-11-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Detecting Hypercoagulability in Morbidly Obese and Non Obese Parturients Following Cesarean Section Delivery|Thromboelastometry (ROTEM) For Detecting Hypercoagulability in Morbidly Obese and Non Obese Parturients Following Cesarean Section Delivery: An Observational Study|Recruiting||N/A|40|Anticipated|Corniche Hospital|||2||f||||f||||||||||2017-10-10 22:21:56.335475|2017-10-10 22:21:56.335475
NCT02718911|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-08-07|||June 2016||2016-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors|A Phase 1a/1b Trial Investigating the CSF-1R Inhibitor LY3022855 in Combination With Durvalumab (MEDI4736) or Tremelimumab in Patients With Advanced Solid Tumors|Recruiting||Phase 1|178|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:21:56.437095|2017-10-10 22:21:56.437095
NCT02718898|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-04-03|||April 2016||2016-04-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Interventional|IXORA-Q||A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis|A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Versus Placebo in Patients With Moderate-to-Severe Genital Psoriasis|Active, not recruiting||Phase 3|146|Anticipated|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 22:21:56.615309|2017-10-10 22:21:56.615309
NCT02718885|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients|Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients|Recruiting||Early Phase 1|20|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||No||2017-10-10 22:21:56.776934|2017-10-10 22:21:56.776934
NCT02718872|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-12-21|||January 2015||2015-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|FRUITFUL||Tobacco Cessation Training Program in Spanish-speaking Countries|Development and Dissemination of a Tobacco Cessation Training Program for Healthcare Professionals in Spanish-speaking Countries|Completed||N/A|300|Actual|Institut Català d'Oncologia||1|||f||||f||||||||No|NO plans for data sharing|2017-10-10 22:21:56.871539|2017-10-10 22:21:56.871539
NCT02718859|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-07-16|||March 2016||2016-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer|Study of the Combined Therapy of Irreversible Electroporation（IRE） and Nature Killer (NK) Cells for Advanced Pancreatic Cancer|Recruiting||Phase 1/Phase 2|60|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 22:21:56.935378|2017-10-10 22:21:56.935378
NCT02718846|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-23|||February 2013||2013-02-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets|A Multicenter, Randomized, Open-label Clinical Study With a Concurrent Control Group to Assess the Effectiveness and Safety of Combined Therapy With Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets for Patients With Meniere's Disease|Completed||Phase 4|220|Actual|Alvogen Korea||2|||f||||f||||||||No||2017-10-10 22:21:57.01556|2017-10-10 22:21:57.01556
NCT02718833|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-05-23|||June 2016||2016-06-01|May 2017|2017-05-01|September 2023|Anticipated|2023-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma|A Phase II Study of Elotuzumab in Combination With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma|Recruiting||Phase 2|46|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-10 22:21:57.092952|2017-10-10 22:21:57.092952
NCT02718820|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-04|||March 2016||2016-03-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|||Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer|Immunomodulation of Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (HNSCC) After Platinum Failure|Recruiting||Phase 1/Phase 2|22|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 22:21:57.216276|2017-10-10 22:21:57.216276
NCT02718807|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-01-10|||May 2016||2016-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||Rapid Prototyping Models for Patient Education|Use of 3-D Printed Models to Improve Patient Understanding During the Informed Consent Process: A Pilot Study|Completed||N/A|20|Actual|Milton S. Hershey Medical Center|||2||f||||f||||||||No|Data will not be shared with participants|2017-10-10 22:21:57.318849|2017-10-10 22:21:57.318849
NCT02718781|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-07-02|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Community Health Campaign: Fitter Families Project|Community Health Campaign: Fitter Families Project|Completed||N/A|953|Actual|The University of Hong Kong||3|||f||||t||||||||||2017-10-10 22:21:57.664046|2017-10-10 22:21:57.664046
NCT02718768|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-08-22|||March 2016||2016-03-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|Nerve||Study of Nerve Repair and Reconstruction Associated With Major Extremity Trauma|A Multi Center Prospective Observational Study of Nerve Repair and Reconstruction Associated With Major Extremity Trauma|Recruiting||N/A|450|Anticipated|Major Extremity Trauma Research Consortium|||1||f||||t||||||||||2017-10-10 22:21:57.767923|2017-10-10 22:21:57.767923
NCT02718755|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-20|||February 2018|Anticipated|2018-02-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies|Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies|Not yet recruiting||Phase 2|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:21:57.901114|2017-10-10 22:21:57.901114
NCT02718742|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-04-14|||June 2016||2016-06-01|April 2016|2016-04-01||||June 2021|Anticipated|2021-06-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer|Maintenance Nab-Paclitaxel After Cisplatin-Based Neoadjuvant Chemotherapy in Patients With High Risk Bladder Cancer|Withdrawn||Phase 2|0|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:21:58.039683|2017-10-10 22:21:58.039683
NCT02718729|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-03-31|||January 2014||2014-01-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|May 2016|Anticipated|2016-05-01||Interventional|||Anastomotic Leakage Following Laparoscopic Resection for Rectal Cancer|Anastomotic Leakage Following Laparoscopic Resection for Rectal Cancer|Recruiting||N/A|100|Anticipated|Mansoura University||1|||f||||t||||||||Undecided||2017-10-10 22:21:58.134239|2017-10-10 22:21:58.134239
NCT02718716|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-09-28|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia|A Multicenter, Open-label, Multiple-dose Study to Evaluate the Safety, Tolerability, and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia|Recruiting||Phase 2|30|Anticipated|UCB Pharma||2|||f||||t||||||||||2017-10-10 22:21:58.223323|2017-10-10 22:21:58.223323
NCT02718703|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-09-12|||February 2015||2015-02-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Project EV Minus Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation|Project EV Minus Regulatory Clinical Evaluation - System Accuracy, User Performance and System Use Evaluation|Completed||N/A|34|Actual|LifeScan||1|||f||||f||||||||No||2017-10-10 22:21:58.368404|2017-10-10 22:21:58.368404
NCT02718664|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-16|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity|Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity|Active, not recruiting||N/A|16|Actual|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-10 22:21:58.562749|2017-10-10 22:21:58.562749
NCT02718651|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-10-27|||March 2016||2016-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer|Identification of Response to ALK-targeted Treatment in Lung Cancer Patients by Monitoring Tumor DNA in Blood Samples|Recruiting||N/A|70|Anticipated|University of Aarhus|||1||f||||t||||||Samples With DNA|"     Blood samples - plasma   "|No||2017-10-10 22:21:58.635584|2017-10-10 22:21:58.635584
NCT02718638|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-05-01|||January 2013||2013-01-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|Hemodialysis||Effects of Physical Activities on the Expression of Nrf2 and Nf-kb Hemodialysis Patients|Effects of a Program of Strength Physical Activities on the Expression of Nrf2 and Nf-kb Hemodialysis Patients|Completed||N/A|40|Actual|Universidade Federal Fluminense||1|||f||||f||||||||||2017-10-10 22:21:58.704099|2017-10-10 22:21:58.704099
NCT02718625|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-03-23|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers|A Randomized Controlled Trial of Enzymatic Debridement of Pressure Ulcers With Clostridial Collagenase Ointment (SANTYL®) or Hydrogel (SoloSite®)|Terminated||Phase 4|3|Actual|Smith & Nephew, Inc.||2||Business Decision|f||||f||||||||Undecided||2017-10-10 22:21:58.771091|2017-10-10 22:21:58.771091
NCT02718612|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-02-15|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Prevalence and Determinants of Sarcopenic Obesity in Taiwanese Dialysis Patients|Association Between Sarcopenia and Sarcopenic Obesity With Metabolic and Cardiovascular Risk Factors in Taiwanese Dialysis Patients|Completed||N/A|70|Actual|Tungs’ Taichung Metroharbour Hospital|||1||f||||t||||||||Yes||2017-10-10 22:21:58.857811|2017-10-10 22:21:58.857811
NCT02718599|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-03-25|||December 2015||2015-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary Surgery|Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary Surgery|Recruiting||Phase 2|50|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:21:58.932546|2017-10-10 22:21:58.932546
NCT02718586|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-02-15|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Serum Level of Myokines and Protein Energy Wasting, Inflammation and Atherosclerosis in Hemodialysis Patients|Association of Serum Myokines and Protein Energy Wasting, Inflammation and Atherosclerotic Vascular Disease in Hemodialysis Patients|Completed||N/A|170|Actual|Tungs’ Taichung Metroharbour Hospital|||1||f||||t||||||||Yes||2017-10-10 22:22:00.752688|2017-10-10 22:22:00.752688
NCT02718573|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-10-06|||January 2015||2015-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Observational|||Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood|Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood|Active, not recruiting||N/A|74|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||||Yes||2017-10-10 22:22:00.826231|2017-10-10 22:22:00.826231
NCT02718560|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-04-03|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|HRPD||Handwriting Rehabilitation in Parkinson Disease|Effectiveness of Intensive Handwriting Rehabilitation in Subjects With Parkinson's Disease|Recruiting||N/A|180|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini||4|||f||||t||||||||No||2017-10-10 22:22:00.899382|2017-10-10 22:22:00.899382
NCT02718547|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-03-26|||March 26, 2017|Actual|2017-03-26|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|March 30, 2018|Anticipated|2018-03-30||Interventional|||The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema|The Effect of Reducing the Intraocular Pressure by Using Alphagan Drops and Macular Edema in Patients With Diabetic Macular Edema|Recruiting||N/A|25|Anticipated|Meir Medical Center||1|||f||||t|f|f||||||Undecided||2017-10-10 22:22:00.991052|2017-10-10 22:22:00.991052
NCT02718534|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-30|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2017|Actual|2017-08-01||Observational|ERTAS||Early Limb Rehabilitation Therapy Within 48 h of Acute Stroke Onset(ERTAS)|Effectiveness and Safeness of Early Limb Rehabilitation Therapy Within 48 h of Acute Stroke Onset: a Randomized Controlled Trial|Active, not recruiting||N/A|35|Actual|Shengjing Hospital|||2||f||||t||||||||||2017-10-10 22:22:01.08976|2017-10-10 22:22:01.08976
NCT02718521|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-19|2016-03-19|||March 2016||2016-03-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Adequate Hydration Therapy Combined With Intravenous Infusion of Isosorbide Dinitrate Prevention for CIN|Chinese People's Liberation Army General Hospital|Active, not recruiting||N/A|400|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 22:22:01.173749|2017-10-10 22:22:01.173749
NCT02718508|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-09-11|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|August 2017|Actual|2017-08-01||Interventional|e-Parenting||An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use|An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use|Active, not recruiting||N/A|36|Anticipated|Rhode Island Hospital||2|||f||||t||||||||||2017-10-10 22:22:01.291449|2017-10-10 22:22:01.291449
NCT02718495|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-07-21|||July 19, 2016|Actual|2016-07-19|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis|A Phase I/II, Multi-center, Randomized, Placebo-Controlled, Study Designed to Assess the Safety, Tolerability, and Pharmacokinetics of PTI-428 in Subjects With Cystic Fibrosis|Recruiting||Phase 1/Phase 2|136|Anticipated|Proteostasis Therapeutics, Inc.||3|||f||||t||||||||||2017-10-10 22:22:01.386031|2017-10-10 22:22:01.386031
NCT02718469|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-04-03|||December 22, 2015|Actual|2015-12-22|April 2017|2017-04-01|September 15, 2016|Actual|2016-09-15|September 15, 2016|Actual|2016-09-15||Interventional|||Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Monovalent Ebola Zaire Vaccine (rVSVN4CT1-EBOVGP1) Delivered by Intramuscular Injection in Healthy Adult Subjects|Completed||Phase 1|38|Actual|Profectus BioSciences, Inc.||4|||f||||t||||||||No||2017-10-10 22:22:01.930505|2017-10-10 22:22:01.930505
NCT02718456|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-04-18|||August 2013||2013-08-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|LINC||Overcoming Barriers to HIV/AIDS Care and ART Initiation|Overcoming Barriers to HIV/AIDS Care and ART Initiation|Active, not recruiting||N/A|315|Actual|University of Washington||3|||f||||f||||||||||2017-10-10 22:22:02.043164|2017-10-10 22:22:02.043164
NCT02718443|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-12-09|||May 2016||2016-05-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|August 2017|Anticipated|2017-08-01||Interventional|||VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma|VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma to Examine Safety, Tolerability, Immune and Biomarker Response to the Investigational VEGFR-2 DNA Vaccine VXM01|Recruiting||Phase 1|16|Anticipated|Vaximm GmbH||1|||f||||t||||||||Yes||2017-10-10 22:22:02.150914|2017-10-10 22:22:02.150914
NCT02718300|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2017-07-27|||June 2016||2016-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis|A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis|Recruiting||Phase 2|78|Anticipated|Incyte Corporation||2|||t||||f||||||||||2017-10-10 22:22:02.248801|2017-10-10 22:22:02.248801
NCT02718287|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of the Home Visiting Pilot Program on Early Childhood Outcomes in Fortaleza Brazil|Evaluation of the Home Visiting Pilot Programa Cresça Com Seu Filho (PCCSF) on Early Childhood Outcomes: a Cluster-Randomized Trial in Fortaleza Brazil|Enrolling by invitation||N/A|2520|Anticipated|Inter-American Development Bank||2|||f||||f||||||||||2017-10-10 22:22:02.448576|2017-10-10 22:22:02.448576
NCT02718274|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-09-05|||April 2016||2016-04-01|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|January 31, 2018|Anticipated|2018-01-31||Interventional|STAR Malawi||HIV Self-Testing Africa (STAR) Malawi: General Population|HIV Self-testing Africa (STAR) Malawi: General Population - A Cluster Randomized Trial of Providing HIV and Self-testing Kits Through Community-based Distribution Agents|Recruiting||N/A|5000|Anticipated|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-10-10 22:22:02.522765|2017-10-10 22:22:02.522765
NCT02718261|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-08-22|||February 2016||2016-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SIREN||Sup-Icu RENal (SIREN)|Sup-Icu RENal (SIREN) - a Sub-analysis of the Prospective SUP (Stress Ulcer Prophylaxis)-ICU Trial on the Risk of GI- Bleeding in ICU Patients Receiving Renal Replacement Therapy|Recruiting||Phase 4|3350|Anticipated|University Hospital Inselspital, Berne||2|||f||||||||||||||2017-10-10 22:22:02.617088|2017-10-10 22:22:02.617088
NCT02718235|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-23|||June 2016||2016-06-01|March 2016|2016-03-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|HCCIS||Prospective, Multicenter HCCIS Evaluation Study|Prospective, Multicenter Study to Evaluate the HCCIS as Prognosticator for Overall and Disease-free Survival of Patients After Resection of HCC|Not yet recruiting||N/A|200|Anticipated|University of Regensburg|||3||f||||t||||||Samples Without DNA|"     Tumor tissue for immunohistochemical analysis   "|No||2017-10-10 22:22:02.829743|2017-10-10 22:22:02.829743
NCT02718222|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-11-17|||September 2015||2015-09-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact and Performance of Institutionalizing Immediate Post-partum IUD Services|Studying the Impact and Performance of Institutionalizing Immediate Post-partum IUD Services as a Routine Part of Antenatal Counseling and Delivery Room Services in Nepal, Sri Lanka, Tanzania|Recruiting||N/A|64800|Anticipated|Harvard School of Public Health||2|||f||||t||||||||Yes|Investigators intend to make a de-identified dataset available after conclusion of the study.|2017-10-10 22:22:02.932145|2017-10-10 22:22:02.932145
NCT02718209|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-21|2016-03-21|||April 2016||2016-04-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Development of an In-vitro System to Identify Gynecologic Cancer Cells During Surgical Procedures||Not yet recruiting||N/A|60|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||No||2017-10-10 22:22:03.092207|2017-10-10 22:22:03.092207
NCT02718196|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-04-25|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Testing and Development of a Sleep Training Mobile Health Application|Testing and Development of a Sleep Training Mobile Health Application to Address Sleep Problems in the First Two Years of Life|Not yet recruiting||N/A|30|Anticipated|Yale University||1|||f||||f|f|f||||||No||2017-10-10 22:22:03.186607|2017-10-10 22:22:03.186607
NCT02718183|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-23|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|BLEIC||Effect on Periodontal Markers by Bleaching Intracoronal Technique|Effect on Periodontal Markers Interleukin-RANK by Walking Bleaching Non-Vital Technique: Clinical Randomized Double-blind Trial|Completed||N/A|50|Actual|University of Chile||2|||f||||f||||||||No||2017-10-10 22:22:03.277924|2017-10-10 22:22:03.277924
NCT02718170|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-12-14|||March 2015||2015-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Buried Intramedullary K-wire Fixation Compared With Plate and Screw Fixation in Unstable Extra-Articular Metacarpal Fractures|Buried Intramedullary K-wire Fixation Compared With Plate and Screw Fixation in Unstable Extra-Articular Metacarpal Fractures: A Randomized, Controlled Study|Enrolling by invitation||N/A|110|Anticipated|Greenville Health System||2|||f||||f||||||||No||2017-10-10 22:22:03.525171|2017-10-10 22:22:03.525171
NCT02718157|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-26|||August 10, 2016|Actual|2016-08-10|June 2017|2017-06-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Interventional|||Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains|Prospective Study for Clinical Validation of the Molecular-Based GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains in Vaginal/Rectal Swab Specimens, After Lim Broth Enrichment, From Pregnant Women|Completed||N/A|839|Actual|GenePOC||1|||f||||f||t|f|||||No||2017-10-10 22:22:03.632468|2017-10-10 22:22:03.632468
NCT02718144|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-09-18|||June 1, 2017|Actual|2017-06-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer|A Phase I/II Clinical Trial Assessing Safety and Efficacy of Estetrol (E4) in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer|Recruiting||Phase 1/Phase 2|18|Anticipated|Pantarhei Oncology B.V.||1|||f||||t|f|f||||||||2017-10-10 22:22:03.770539|2017-10-10 22:22:03.770539
NCT02718131|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-07-21|||March 2016||2016-03-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|May 2021|Anticipated|2021-05-01||Interventional|NF107-BMP2||A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)|A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)|Recruiting||Phase 2|54|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 22:22:03.917864|2017-10-10 22:22:03.917864
NCT02718118|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-12-24|||April 2016||2016-04-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines|A Prospective, Randomized, Multi-Center, Subject- and Evaluator-Blinded, Parallel Comparison of Dysport®, When Reconstituted at 1.5 mL and 2.5 mL, for the Treatment of Moderate to Severe Glabellar Lines.|Completed||Phase 4|60|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||No||2017-10-10 22:22:04.192522|2017-10-10 22:22:04.192522
NCT02718105|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-22|||April 2016||2016-04-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|||Maternal and Fetal Compatibility in ART-oocyte Donor Influences Live Birth Rate|Maternal KIR and Fetal HLA-C Compatibility in ART-oocyte Donor Influences Live Birth Rate a Prospective Controlled Cohort Study|Not yet recruiting||N/A|400|Anticipated|IVI Madrid|||1||f||||f||||||Samples With DNA|"     Genomic DNA will be obtained and will be studied in Professor Moffet laboratory in Cambridge     (department of Pathologí, University of Cambridge) KIR typing including copi number and HLA-C     loci will be performed as previously described (Hiby 2010, Jiang 2012). KIR haplotype regions     will be defined by the presence of the following KIR genes: Cen-A/2DL3; Tel-A/3DL1 and 2DS4;     Cen-B/2DL2 and 2DS2; Tel-B/2DS1 and 3DS1. The HLA-C ligands for KIRs will be divided into 2     groups: HLA-C1 and HLA-C2.   "|No||2017-10-10 22:22:04.335921|2017-10-10 22:22:04.335921
NCT02718092|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-09-29|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|August 23, 2017|Actual|2017-08-23|August 23, 2017|Actual|2017-08-23||Interventional|WON||Comparing Fully Covered, Self Expanding Metal Stent (FCSEMS) and Plastic Stents for EUS- Guided Drainage of WON|Randomized Trial Comparing Fully Covered, Self Expanding Metal Stent (FCSEMS) and Plastic Stents for EUS- Guided Drainage of Walled -Off Necrosis (WON)|Withdrawn||N/A|0|Actual|Indiana University||2||Decided not to pursue study|f||||t|f|t|f|f|f|||||2017-10-10 22:22:04.461131|2017-10-10 22:22:04.461131
NCT02718079|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-05-22|||March 2016||2016-03-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure|High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure-A Prospective Randomized Pilot Trial|Recruiting||N/A|40|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 22:22:04.595963|2017-10-10 22:22:04.595963
NCT02718066|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-09-02|||August 2016||2016-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer|A Phase 1b/2 Study to Assess the Safety and Efficacy of HBI-8000 in Combination With Nivolumab in Patients With Advanced Solid Tumors Including Melanoma, Renal Cell Carcinoma (RCC) and Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|78|Anticipated|HUYA Bioscience International||1|||f||||f||||||||No||2017-10-10 22:22:04.763893|2017-10-10 22:22:04.763893
NCT02718053|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-09-29|||July 2015||2015-07-01|September 2016|2016-09-01||||May 2016|Actual|2016-05-01||Observational|||Reliability of Spasticity Measurement With Lokomat||Suspended||N/A|20|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini|||2||f||||||||||||||2017-10-10 22:22:04.923911|2017-10-10 22:22:04.923911
NCT02718040|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-12-23|||April 2016||2016-04-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Emervel for the Correction of Lower Face Wrinkles & Folds|A Multi-Center Study to Evaluate the Perception of Facial Expressions Following Correction of Wrinkles and Folds in the Lower Face Using Emervel® Classic Lidocaine and Emervel® Deep Lidocaine|Completed||Phase 4|30|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||No||2017-10-10 22:22:05.028958|2017-10-10 22:22:05.028958
NCT02718014|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-18|||January 2015||2015-01-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|EPRNPPMP||Evaluation of Periodontal Response to Non Surgical Therapy in Pre and Post Menopausal Women With Periodontitis|Evaluation of Periodontal Response to Non Surgical Therapy in Pre and Post Menopausal Women With Periodontitis|Completed||Phase 1/Phase 2|60|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||t||||||||No||2017-10-10 22:22:05.805953|2017-10-10 22:22:05.805953
NCT02718001|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-01|||February 2015||2015-02-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Replacement (TMVR) Early Feasibility Study|Early Feasibility Study of the CardiAQ™ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems) For the Treatment of Moderate to Severe Mitral Regurgitation|Recruiting||Phase 1|28|Anticipated|Edwards Lifesciences||1|||f||||t||||||||||2017-10-10 22:22:05.899298|2017-10-10 22:22:05.899298
NCT02717975|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-03-25|||March 2016||2016-03-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effect of Catheter Valve Vs. Standard Catheter Removal in Outpatients|A Prospective, Multicenter, Randomized Trial: The Effect of Catheter Valve Vs. Standard Catheter Removal in Outpatient Settings on the Patient Discharge Timings|Recruiting||Phase 2/Phase 3|100|Anticipated|Medway NHS Foundation Trust||2|||f||||f||||||||Undecided||2017-10-10 22:22:06.253965|2017-10-10 22:22:06.253965
NCT02717962|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-05-03|||January 20, 2017|Actual|2017-01-20|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|September 2020|Anticipated|2020-09-01||Interventional|||Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma|Phase II Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma|Recruiting||Phase 2|48|Anticipated|DelMar Pharmaceuticals, Inc.||1|||t||||f|t|f||||||No|The Clinical Study Report for this trial will be prepared and provided to U.S. F.D.A. as required by applicable regulatory requirement(s). Each participating trial investigator will be provided a copy their patient data captured in the electronic data base for this trial.|2017-10-10 22:22:06.381254|2017-10-10 22:22:06.381254
NCT02717949|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-03-23|||February 2016||2016-02-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|Optimal||Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study|Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study|Active, not recruiting||Phase 4|1|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:22:06.522842|2017-10-10 22:22:06.522842
NCT02717936|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-03-24|||January 2016||2016-01-01|January 2016|2016-01-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|DesmoPEK||Investigation of Desmoplastic Squamous Cell Carcinoma|Prospektive Therapie-Studie Zur Behandlung Des Desmoplastischen Plattenepithelkarzinoms|Recruiting||N/A|73|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||Undecided||2017-10-10 22:22:06.635664|2017-10-10 22:22:06.635664
NCT02717923|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-04-03|||January 2014||2014-01-01|April 2016|2016-04-01||||January 2019|Anticipated|2019-01-01||Interventional|||A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer|Maintenance Treatment With Capecitabine Plus Cetuximab After First-line Modified Fluorouracil, Leucovorin, and Oxaliplatin(mFOLFOX6) Plus Cetuximab for Patients With KRAS Wild-type Metastatic Colorectal Cancer: a Single Arm, Open-label Clinical Trial|Recruiting||Phase 2|50|Anticipated|Huazhong University of Science and Technology||1|||f||||||||||||||2017-10-10 22:22:06.725575|2017-10-10 22:22:06.725575
NCT02717910|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Digital Health Game as an Intervention Supporting Tobacco-related Health Literacy in Early Adolescents|Digital Health Game as an Intervention Supporting Tobacco-related Health Literacy in Early Adolescents: a Feasibility Study|Completed||N/A|151|Actual|University of Turku||3|||f||||f||||||||||2017-10-10 22:22:06.88155|2017-10-10 22:22:06.88155
NCT02717897|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-23|||November 2011||2011-11-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Vitamin D and Disease Activity in Ulcerative Colitis|Association Between Vitamin D Level and Disease Activity in Ulcerative Colitis|Completed||N/A|248|Actual|University of Chicago|||1||f||||f||||||Samples Without DNA|"     1. Serum        2. Colon mucosal RNA        3. Formalin fixed paraffin embedded colon biopsy   "|No||2017-10-10 22:22:07.013316|2017-10-10 22:22:07.013316
NCT02717884|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-06-01|||May 2015||2015-05-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|TRANSATRA||Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP)|Phase I/II Study of Sensitization of Non-M3 Acute Myeloid Leukemia (AML) Blasts to All-trans Retinoic Acid (ATRA) by Epigenetic Treatment With Tranylcypromine (TCP), an Inhibitor of the Histone Lysine Demethylase 1 (LSD1)|Recruiting||Phase 1/Phase 2|60|Anticipated|University Hospital Freiburg||1|||f||||t||||||||No||2017-10-10 22:22:07.109545|2017-10-10 22:22:07.109545
NCT02717871|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-02-01|||March 2016||2016-03-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis|Swiss PACK-CXL (Photoactivated Chromophore for Infectious Keratitis Cross-linking) Multicenter Trial for the Treatment of Infectious Keratitis|Recruiting||Phase 3|252|Anticipated|University Hospital, Geneva||2|||f||||f||||||||Undecided||2017-10-10 22:22:07.269474|2017-10-10 22:22:07.269474
NCT02717858|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-24|||March 16, 2016|Actual|2016-03-16|July 2017|2017-07-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.|A Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects|Completed||Phase 1|52|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 22:22:07.561732|2017-10-10 22:22:07.561732
NCT02717845|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-07|||March 2016||2016-03-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|CISKO||CT Imaging Study for Knee Osteotomy (CISKO)|Computerized Tomography (CT) Scan Study of Bone Healing Following Open Wedge Proximal Tibial Osteotomy [CT Imaging Study for Knee Osteotomy (CISKO)]|Recruiting||N/A|10|Anticipated|North Cumbria University Hospitals NHS Trust||2|||f||||f||||||||Yes|Results to be published in peer-reviewed scientific journal|2017-10-10 22:22:07.65147|2017-10-10 22:22:07.65147
NCT02717819|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-07-06|||April 2016||2016-04-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|PEPOP||The Importance of Additional Protein to Benefit More From Training During and After Hospitalization|A Protein-enriched, Milk-based Supplement to Counteract Sarcopenia in Acutely Ill Geriatric Patients Offered Resistance Exercise Training During and After Hospitalisation - a Double-blinded, Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Copenhagen University Hospital at Herlev||2|||f||||f||||||||No||2017-10-10 22:22:07.846351|2017-10-10 22:22:07.846351
NCT02717806|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-07-18|||January 2017||2017-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|PATHway||Technology-enabled Cardiac Rehabilitation Through PATHway. Feasibility, Clinical Effectiveness and Cost-effectiveness|Technology-enabled Cardiac Rehabilitation Through PATHway. Feasibility, Clinical Effectiveness and Cost-effectiveness|Recruiting||N/A|120|Anticipated|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-10 22:22:08.01984|2017-10-10 22:22:08.01984
NCT02717793|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-03-25|||October 2013||2013-10-01|March 2016|2016-03-01||||December 2015|Actual|2015-12-01||Interventional|||Comparison Between Isotonic 1 Repetition Maximum Measurement With Isometric Muscle Strength Testing In Healthy Females|Comparison Between Isotonic 1 Repetition Maximum Measurement With Isometric Muscle Strength Testing In Healthy Females|Completed||Phase 1|30|Actual|Universiti Tunku Abdul Rahman||2|||f||||t||||||||No||2017-10-10 22:22:08.122068|2017-10-10 22:22:08.122068
NCT02717780|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-09-26|||February 2016||2016-02-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|DESAT||Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome|Respiratory Impact of Short Life Agents Used in Balanced Anesthesia on Patients Suffering or Suspected of Obstructive Sleep Apnea (OSA) Syndrome|Recruiting||Phase 4|60|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||No||2017-10-10 22:22:08.204934|2017-10-10 22:22:08.204934
NCT02717767|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-07-04|||July 2016||2016-07-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Observational|BIONAGA||Measuring Auto-fluorescence of White Corpuscles for the Early Diagnosis and the Monitoring of Pneumonia in ICU|Measuring Auto-fluorescence of White Corpuscles for the Early Diagnosis and the Monitoring of Pneumonia in Intensive Care Units|Recruiting||N/A|350|Anticipated|Nantes University Hospital|||1||f||||f||||||Samples Without DNA|"     tracheal aspirate and bronchoalveolar lavages   "|No||2017-10-10 22:22:08.32634|2017-10-10 22:22:08.32634
NCT02717754|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-20|2016-05-18|2016-05-18||December 2009||2009-12-01|May 2016|2016-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||Safety population included all participants who received at least one dose of study drug and have a safety assessment performed after initiation of treatment.|A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Participants|A Multiple-Center, Randomized, Double-blind, Multiple-Dose, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO0640796 (Oseltamivir) and Its Carboxylate Metabolite, RO0640802, Following Intravenous Administrations in Healthy Subjects|Completed||Phase 1|99|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:22:08.455894|2017-10-10 22:22:08.455894
NCT02717741|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-23|||May 2015||2015-05-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study of Tafetinib in Chinese Patients With Advanced Solid Tumor|A Phase I Study to Determine the Safety and Pharmacokinetic Study of Tafetinib in Patients With Advanced Solid Tumors|Recruiting||Phase 1|30|Anticipated|Nanjing Yoko Biomedical Co., Ltd.||1|||f||||f||||||||No||2017-10-10 22:22:09.440241|2017-10-10 22:22:09.440241
NCT02717728|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-06-29|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Effectiveness of Fascia Iliaca Nerve Block for Post Hip Arthroscopy|Effectiveness of Fascia Iliaca Nerve Block for Post Hip Arthroscopy Pain Management: A Randomized Double-blind, Placebo Controlled Study|Not yet recruiting||Phase 3|88|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f|||f|||||2017-10-10 22:22:09.51592|2017-10-10 22:22:09.51592
NCT02717715|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|SunRISe||SunRISe Study - Stroke Rehabilitation In Suriname|The Effect of a Tele-supervised Home Based Rehabilitation Program on Physical Fitness, Quality of Gait, Upper Limb Disability and Quality of Life in People After Chronic Stroke in a Urban Setting in Suriname. Randomised Controlled Trial.|Completed||N/A|20|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-10 22:22:09.617988|2017-10-10 22:22:09.617988
NCT02717702|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-04-03|||August 10, 2016|Actual|2016-08-10|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification|Abbott Stress-Delta Biomarkers for ACS Risk Stratification|Recruiting||N/A|333|Anticipated|Duke University|||1||f||||||||||||||2017-10-10 22:22:09.703038|2017-10-10 22:22:09.703038
NCT02717689|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-03-09|||January 2016||2016-01-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma|A Randomised Pragmatic Trial Of Corticosteroid Optimisation In Severe Asthma Using A Composite Biomarker Algorithm To Adjust Corticosteroid Dose Versus Standard Care|Recruiting||N/A|300|Anticipated|Belfast Health and Social Care Trust||2|||f||||t||||||||No||2017-10-10 22:22:09.805805|2017-10-10 22:22:09.805805
NCT02717676|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-06-29|||March 2016||2016-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|TSS||Prediction of Perineal Tears by Striae Gravidarum Score|Prediction of Perineal Tears During Labor by Estimation of Striae Gravidarum Score|Recruiting||N/A|250|Anticipated|Assiut University||2|||f||||t||||||||Yes||2017-10-10 22:22:09.957592|2017-10-10 22:22:09.957592
NCT02717663|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-05-17|||April 2016||2016-04-01|May 2016|2016-05-01|July 2021|Anticipated|2021-07-01|April 2020|Anticipated|2020-04-01||Interventional|||WalkIT Arizona: Walking Interventions Through Texting|WalkIT: Neighborhood Walkability and Moderation of Adaptive Walking Interventions|Recruiting||N/A|480|Anticipated|Arizona State University||4|||f||||t||||||||No||2017-10-10 22:22:10.033508|2017-10-10 22:22:10.033508
NCT02717650|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-02-03|||August 2016||2016-08-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|A-STEP/max||The Alfred Step Test Exercise Protocols (A-STEP and A-STEPmax): Developed for Adults With Cystic Fibrosis|Feasibility and Validation of the Alfred Step Test Exercise Protocols (A-STEP* and A-STEPmax): Developed to Assess Exercise Tolerance and Determine Maximum Oxygen Uptake in Adults With Cystic Fibrosis Across the Disease Spectrum|Recruiting||N/A|30|Anticipated|The Alfred||3|||f||||f||||||||No|No plan to share individual patient data.|2017-10-10 22:22:10.121435|2017-10-10 22:22:10.121435
NCT02717637|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-01-31|||February 2016||2016-02-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Observational|||Oxycodone in Serum After Postoperative Oral Oxycodone in Caesarean Sections Under Spinal Anesthesia|Gastrointestinal Uptake of Oxycodone After Caesarean Section in Spinal Anesthesia|Recruiting||N/A|50|Anticipated|University Hospital, Akershus|||1||f||||f||||||Samples Without DNA|"     Serum from blood   "|No||2017-10-10 22:22:10.249876|2017-10-10 22:22:10.249876
NCT02717624|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-10-03|||February 2016||2016-02-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|February 2021|Anticipated|2021-02-01||Interventional|||A Study of Acalabrutinib (ACP-196) in Combination With Bendamustine and Rituximab in Subjects With Mantle Cell Lymphoma|A Phase 1b, Multicenter, Open-label Study of Acalabrutinib (ACP-196) in Combination With Bendamustine and Rituximab (BR) in Subjects With Mantle Cell Lymphoma|Active, not recruiting||Phase 1|48|Anticipated|Acerta Pharma BV||2|||f||||f||||||||||2017-10-10 22:22:10.331078|2017-10-10 22:22:10.331078
NCT02717611|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-08-10|||January 2016||2016-01-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy|A Phase 2 Study of the Efficacy and Safety of ACP-196 in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy|Active, not recruiting||Phase 2|60|Actual|Acerta Pharma BV||1|||f||||t||||||||||2017-10-10 22:22:10.443777|2017-10-10 22:22:10.443777
NCT02717598|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-29|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|CSPVsHSP||Cold Snare Polypectomy Versus Hot Snare Polypectomy for Diminutive and Small Colorectal Polyps|Cold Snare Polypectomy Versus Hot Snare Polypectomy for Diminutive and Small Colorectal Polyps: a Randomized Controlled Trial|Completed||N/A|198|Actual|Wulumuqi General Hospital of Lanzhou Military Command||2|||f||||t|f|f||||||||2017-10-10 22:22:10.743819|2017-10-10 22:22:10.743819
NCT02717585|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-06-07|||March 2016||2016-03-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|FM-OSA||Effect of CPAP on Symptoms of Patients With Fibromyalgia and Obstructive Sleep Apnea|Effect of Continuous Positive Airway Pressure (CPAP) on Symptoms of Patients With Fibromyalgia Syndrome and Obstructive Sleep Apnea (OSA): A Prospective Randomized Controlled Clinical Trial|Recruiting||N/A|54|Anticipated|Women's College Hospital||2|||f||||f||||||||No||2017-10-10 22:22:10.880723|2017-10-10 22:22:10.880723
NCT02717572|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-03-02|||March 1, 2016|Actual|2016-03-01|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|||18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR|Reproducibility of 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR|Recruiting||N/A|30|Anticipated|Washington University School of Medicine|||1||f||||t|f|f||||||No||2017-10-10 22:22:11.007779|2017-10-10 22:22:11.007779
NCT02717559|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-11-01|||March 2016||2016-03-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|July 2025|Anticipated|2025-07-01||Observational|||Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): 10 Year Onsite Follow-up|Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): 10 Year Onsite Follow-up|Enrolling by invitation||N/A|434|Anticipated|Vanderbilt University|||1||f||||f||||||||No||2017-10-10 22:22:11.119394|2017-10-10 22:22:11.119394
NCT02717546|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-08|||February 2016||2016-02-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|February 2019|Anticipated|2019-02-01||Observational|||Zimmer® MotionLoc® in Distal Tibia Fractures|Zimmer® MotionLoc® in Distal Tibia Fractures: An Observational Study|Recruiting||N/A|40|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-10 22:22:11.188172|2017-10-10 22:22:11.188172
NCT02717533|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-03-22|||January 2014||2014-01-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Observational|||Blood Volume Analysis and Renal Outcomes in Hemodialysis|Blood Volume Analysis and Renal Outcomes in Hemodialysis|Completed||N/A|12|Actual|VA New York Harbor Healthcare System|||1||f||||||||||||||2017-10-10 22:22:11.311861|2017-10-10 22:22:11.311861
NCT02717520|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-11-16|||September 2015||2015-09-01|November 2016|2016-11-01|September 2022|Anticipated|2022-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Long Term Clinical Evaluation of a Posterior Glass Hybrid System vs. Composite Resin|Long Term Clinical Evaluation of a Posterior Glass Hybrid System vs. Composite Resin: a Controlled Clinical MultiCenter Study|Active, not recruiting||N/A|88|Anticipated|University of Zagreb||2|||f||||t||||||||||2017-10-10 22:22:11.401453|2017-10-10 22:22:11.401453
NCT02717507|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-14|||April 2016||2016-04-01|October 2016|2016-10-01||||April 2022|Anticipated|2022-04-01||Interventional|||Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors|Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Heart Failure (PREVENT-HF): A Phase 2b Randomized Placebo-Controlled (Carvedilol) Trial|Recruiting||Phase 2|250|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-10-10 22:22:11.505343|2017-10-10 22:22:11.505343
NCT02717494|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-05-05|||March 2016||2016-03-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women|Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women|Recruiting||Phase 2|345|Anticipated|Westat||6|||f||||t||||||||||2017-10-10 22:22:11.632155|2017-10-10 22:22:11.632155
NCT02717481|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-03-17|||April 2016||2016-04-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Observational|||Using US to Evaluate Aortic Aneurysm Size Based on 3D Co-registration to Previous CT Scan|Using Ultrasound to Evaluate Aortic Aneurysm Size Based on 3D Co-registration to Previous Computerized Tomography|Not yet recruiting||N/A|120|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||Undecided|undecided|2017-10-10 22:22:11.779709|2017-10-10 22:22:11.779709
NCT02717468|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-10-10|||February 2016||2016-02-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|CLEARSIGHT||Comparative Noninvasive Continuous Cardiac Output by the Clearsight With Invasive Monitoring by Pulsioflex in Abdominal Surgery|Comparative Noninvasive Continuous Cardiac Output by the Clearsight With Invasive Monitoring by Pulsioflex in Abdominal Surgery|Recruiting||N/A|30|Anticipated|Poitiers University Hospital||1|||f||||||||||||||2017-10-10 22:22:11.861629|2017-10-10 22:22:11.861629
NCT02717455|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-21|||June 28, 2016|Actual|2016-06-28|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|October 1, 2019|Anticipated|2019-10-01||Interventional|PBTC-047||Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma|Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma|Recruiting||Phase 1|40|Anticipated|Pediatric Brain Tumor Consortium||2|||f||||t||||||||||2017-10-10 22:22:11.938245|2017-10-10 22:22:11.938245
NCT02717442|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-09-14|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|AVERTS-2||Study of OTO-104 in Subjects With Unilateral Meniere's Disease|A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease|Terminated||Phase 3|176|Actual|Otonomy, Inc.||2||Negative Efficacy Results from the recently completed Phase 3 study 104-201506|f||||f||||||||||2017-10-10 22:22:12.099201|2017-10-10 22:22:12.099201
NCT02717429|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-02-21|||October 2015||2015-10-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|CERT-MS||Cognitive and Emotion Regulation Training in MS|Cognitive and Emotion Regulation Training in Multiple Sclerosis|Recruiting||N/A|60|Anticipated|Ohio State University||3|||f||||f||||||||No||2017-10-10 22:22:12.200369|2017-10-10 22:22:12.200369
NCT02717416|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-06-27|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Hemostatic Powder Following Injection Therapy Versus Conventional Dual Therapy for Endoscopic Hemostasis for Non-variceal Upper Gastrointestinal Bleeding||Recruiting||N/A|168|Anticipated|Yonsei University||2|||f||||f||||||||No|no plan to share data|2017-10-10 22:22:12.311427|2017-10-10 22:22:12.311427
NCT02717403|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-01-12|||April 2016||2016-04-01|January 2017|2017-01-01||||April 2018|Anticipated|2018-04-01||Interventional|||Effects of Social Networking on Chronic Disease Management in Arthritis|Phase 2 & Phase 3, Effects of Social Networking on Chronic Disease Management in Arthritis|Recruiting||Phase 2/Phase 3|240|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 22:22:12.412321|2017-10-10 22:22:12.412321
NCT02717390|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-21|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Bright by Three (BB3) Effectiveness Study|Bright by Three (BB3) Effectiveness Study|Not yet recruiting||N/A|200|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 22:22:12.510879|2017-10-10 22:22:12.510879
NCT02717377|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-17|||November 2013||2013-11-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Frequent Interruptions of Prolonged Sitting on Self-perceived Levels of Energy, Mood, Food Cravings and Cognitive Function||Completed||N/A|30|Actual|University of Colorado, Denver||3|||f||||f||||||||No|"This clinical trial is a small study (n=30) that received limited funding from Johnson and Johnson Company, a non-public funding company. Our data sharing plan will follow the NIH guidelines for data sharing plans of small clinical trials and not unique set of data that could benefit the community (http://grants.nih.gov/grants/policy/data_sharing/data_sharing_faqs.htm#901). Following the NIH definition of the timely release and sharing to be no later than the acceptance for publication of the main findings from the final data set, final research data will be shared through scientific publications after peer-review."|2017-10-10 22:22:12.597975|2017-10-10 22:22:12.597975
NCT02717364|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-26|||August 31, 2015|Actual|2015-08-31|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Yervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant Melanoma|Yervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant Melanoma|Recruiting||N/A|400|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:22:12.673972|2017-10-10 22:22:12.673972
NCT02717351|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-04-04|||March 16, 2016|Actual|2016-03-16|April 2017|2017-04-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Interventional|SPF Assay||18841- Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment- Darkening Dose.|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:22:12.761367|2017-10-10 22:22:12.761367
NCT02717338|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-09-21|||May 2016||2016-05-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Blood Donor Competence, Autonomy and Relatedness Enhancement|Blood Donor Competence, Autonomy and Relatedness Enhancement (Blood Donor CARE)|Enrolling by invitation||Phase 3|2240|Anticipated|Ohio University||8|||f||||t||||||||||2017-10-10 22:22:12.833726|2017-10-10 22:22:12.833726
NCT02717325|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2017-04-04|||March 16, 2016|Actual|2016-03-16|April 2017|2017-04-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Interventional|SPF Assay||18842 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay on Minimal Persistent Pigment-Darkening Dose|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:22:12.951121|2017-10-10 22:22:12.951121
NCT02717299|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-10-28|||November 2015||2015-11-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Making Sense Out of Total Knee Sensor Assisted Technology: A Randomized Control Trial|Making Sense Out of Total Knee Sensor Assisted Technology: A Randomized Control Trial|Recruiting||N/A|100|Anticipated|TriHealth Inc.||2|||f||||f||||||||Yes|Yes, Orthosensor receives the data collected.|2017-10-10 22:22:13.134926|2017-10-10 22:22:13.134926
NCT02717286|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-28|||January 2013||2013-01-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2013|Actual|2013-10-01||Interventional|||Restorative Treatment in First Molars Affected by Molar-Incisor Hypomineralization|Survival of Restorative Treatment in First Molars Affected by Molar-Incisor Hypomineralization|Completed||N/A|26|Actual|Universidade Federal do Paraná||2|||f||||t||||||||Yes||2017-10-10 22:22:13.254923|2017-10-10 22:22:13.254923
NCT02717273|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-22|||March 2009||2009-03-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of Incidence of Surgical Site Infections in Liver Transplant Patients on an Extended Course of Peri-operative Antibiotics (Three Days) as Compared to Standard of Care Consisting of a Single Dose Pre-operatively and Intra-operative Re-dosing|A Randomized, Prospective Study of Incidence of Surgical Site Infections in Liver Transplant Patients on an Extended Course of Peri-operative Antibiotics (Three Days) as Compared to Standard of Care Consisting of a Single Dose Pre-operatively and Intra-operative Re-dosing|Completed||Phase 3|102|Actual|National Institute of General Medical Sciences (NIGMS)||2|||f||||f||||||||Undecided||2017-10-10 22:22:13.356656|2017-10-10 22:22:13.356656
NCT02717260|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-09|||February 2, 2016|Actual|2016-02-02|May 2017|2017-05-01|September 29, 2016|Actual|2016-09-29|September 29, 2016|Actual|2016-09-29||Interventional|inhibistim||Inhibition Transcranial Random Noise Stimulation|Inhibition Control Modulation by Transcranial Random Noise Stimulation (tRNS ) on the Prefrontal Cortex Measured by Change in Go no Test|Completed||N/A|36|Actual|Hôpital le Vinatier||3|||f||||t||||||||No||2017-10-10 22:22:13.489473|2017-10-10 22:22:13.489473
NCT02717247|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-10-05|||February 2016||2016-02-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|tRNS-FA||Transcranial Random Noise Stimulation in Food Addiction Treatment|Effect of Transcranial Random Noise Stimulation of Prefrontal Cortex on Craving Supply Subject Suffering From Obesity|Recruiting||N/A|48|Anticipated|Hôpital le Vinatier||2|||f||||t||||||||No||2017-10-10 22:22:13.575667|2017-10-10 22:22:13.575667
NCT02717234|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-06-14|||February 2016||2016-02-01|March 2016|2016-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement|Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement|Completed||N/A|12|Actual|Nestlé||2|||f||||f||||||||No||2017-10-10 22:22:13.681773|2017-10-10 22:22:13.681773
NCT02717221|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-03-30|||November 2014||2014-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||In Vivo EGFR Molecular Classification|An EGFR-TKIs Benefit Non-small Cell Lung Carcinoma Patients Identification Strategy Using Molecular Imaging|Recruiting||N/A|100|Anticipated|Harbin Medical University||6|||f||||t||||||||Undecided||2017-10-10 22:22:13.748379|2017-10-10 22:22:13.748379
NCT02717208|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-12-07|||February 2016||2016-02-01|February 2016|2016-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Phase 1 Study for Safety and Tolerability of HL036|A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety, Local Tolerability and Pharmacokinetic Characteristics After Administration of Eye-drop HL036 in Healthy Korean Male Volunteers (Phase I)|Completed||Phase 1|20|Anticipated|HanAll BioPharma Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 22:22:13.84006|2017-10-10 22:22:13.84006
NCT02717195|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-10-05|||April 2016||2016-04-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|DayBreak||Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia|Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia|Recruiting||Phase 3|964|Anticipated|H. Lundbeck A/S||4|||f||||f||||||||||2017-10-10 22:22:13.931389|2017-10-10 22:22:13.931389
NCT02717182|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-08-10|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|CONCErTo||Classification of Patient Therapeutic Education Programs Components : Etude CONCErTo|Development of a Classification of the Components of Patient Therapeutic Education Interventions That Can Impact Their Results and Can Ensure Their Continued Existence CONCErTo Study|Recruiting||N/A|100|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||||2017-10-10 22:22:14.482827|2017-10-10 22:22:14.482827
NCT02717169|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-22|||March 2016||2016-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Promoting Health Knowledge Among University Students|Promoting Health Knowledge Among University Students by Using Personal Biometric Information|Recruiting||N/A|35|Anticipated|The University of Hong Kong||1|||f||||t||||||||Undecided||2017-10-10 22:22:14.584547|2017-10-10 22:22:14.584547
NCT02717156|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-19|||November 21, 2016|Actual|2016-11-21|April 2017|2017-04-01|November 21, 2020|Anticipated|2020-11-21|November 21, 2019|Anticipated|2019-11-21||Interventional|||Combination Therapy With Pembrolizumab and sEphB4-HSA in Previously Treated Urothelial Carcinoma|A Phase II Trial of sEphB4-HSA in Combination With Anti PD1 Antibody Pembrolizumab (MK-7435) for Metastatic Urothelial Cancer Refractory to Platinum|Recruiting||Phase 2|60|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 22:22:14.699956|2017-10-10 22:22:14.699956
NCT02717143|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-25|||April 2016||2016-04-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|April 2021|Anticipated|2021-04-01||Observational|MYOCARDITIRM||French National Observatory Tracking Viral Myocarditis: Mortality, Cardiovascular Events, Sequels on (Magnetic Resonance Imaging) MRI|French National Observatory Tracking Viral Myocarditis: Mortality, Cardiovascular Events, Sequels on (Magnetic Resonance Imaging) MRI|Not yet recruiting||N/A|700|Anticipated|French Cardiology Society|||1||f||||f||||||||No||2017-10-10 22:22:14.830457|2017-10-10 22:22:14.830457
NCT02717130|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-17|||March 2016||2016-03-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Aripiprazole, Abilify Maintena Collaborative Clinical Protocol|Aripiprazole, Abilify Maintena Collaborative Clinical Protocol|Recruiting||N/A|177|Anticipated|Florida Atlantic University||1|||f||||f||||||||No||2017-10-10 22:22:14.942029|2017-10-10 22:22:14.942029
NCT02717117|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-01-04|||June 2015||2015-06-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|MIC1||Magnetic Resonance Imaging of Motility in Crohn's 1|Reduced Intestinal Motility in Inflammatory Crohn's Disease - Optimisation Studies in Healthy Volunteers|Completed||N/A|15|Actual|University of Nottingham||1|||f||||f||||||||No||2017-10-10 22:22:15.106749|2017-10-10 22:22:15.106749
NCT02717104|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-01-18|||August 20, 2015|Actual|2015-08-20|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01|24 Months|Observational [Patient Registry]|||Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB in Femoropopliteal Arteries|A Prospective, Multicenter, Single Arm, Post-Market Registry Assessing the Clinical Use and Safety of the LUTONIX Drug Coated Balloon Catheter in Femoropopliteal Arteries|Recruiting||N/A|250|Anticipated|C. R. Bard|||1||f||||f||||||||No||2017-10-10 22:22:15.201299|2017-10-10 22:22:15.201299
NCT02717091|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-03-22|||July 2015||2015-07-01|March 2016|2016-03-01||||June 2017|Anticipated|2017-06-01||Interventional|||Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer|Phase II Study of Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer|Enrolling by invitation||Phase 2|50|Anticipated|Nagoya University||2|||f||||||||||||||2017-10-10 22:22:15.346363|2017-10-10 22:22:15.346363
NCT02717078|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-03-29|||March 28, 2017|Actual|2017-03-28|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||The LoBAG Diet and Type 2 Diabetes Mellitus|A Low Biologically Available Glucose and High Protein Diet for Treatment of Type 2 Diabetes Mellitus|Recruiting||N/A|24|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|f||||||No||2017-10-10 22:22:15.454204|2017-10-10 22:22:15.454204
NCT02717065|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-09-13|||June 2017|Anticipated|2017-06-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Variability of Tinnitus Characterization Tools and Investigation of Audiovisual Integration in Tinnitus Perception|Variability of Tinnitus Characterization Tools and Investigation of Audiovisual Integration in Tinnitus Perception|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||1||Personnel and funding was no longer available|f||||f|f|f||||||||2017-10-10 22:22:15.584473|2017-10-10 22:22:15.584473
NCT02717052|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-08-18|||May 2016||2016-05-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter|Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter and Its Relevance for Rapid Antidepressant Response|Recruiting||Phase 2|74|Anticipated|Medical University of Vienna||6|||f||||||||||||||2017-10-10 22:22:15.682287|2017-10-10 22:22:15.682287
NCT02717039|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-31|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PHIT||Pharmacogenomics of Heparin-Induced Thrombocytopenia|Pharmacogenomics of Heparin-Induced Thrombocytopenia|Recruiting||N/A|125|Anticipated|University of Arizona|||1||f||||f||||||Samples With DNA|"     Whole blood will be stored in freezers at minus 80 degrees   "|||2017-10-10 22:22:15.849587|2017-10-10 22:22:15.849587
NCT02717026|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-07-27|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|MIR||Multimodal Imaging of Retinal Vessels|Retinal Vessel Morphology in Multimodal Imaging|Active, not recruiting||N/A|120|Anticipated|Medical University of Graz|||1||f||||f||||||||||2017-10-10 22:22:15.943468|2017-10-10 22:22:15.943468
NCT02717013|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-02-28|||March 2016||2016-03-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||The Effect of HMB Supplementation on Adipose Tissue Inflammation and Metabolism|The Effect of HMB Supplementation on Adipose Tissue Inflammation and Metabolism|Terminated||N/A|10|Actual|Metabolic Technologies Inc.||4||Lack of recruitment of subjects.|f||||f||||||||No|No Individual Data will be shared. Data summaries will be available after publication..|2017-10-10 22:22:16.013519|2017-10-10 22:22:16.013519
NCT02717000|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-17|||April 2016||2016-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||NASH: Non-invasive Diagnostic Markers and Imaging|Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Patients With Non-alcoholic Fatty Liver Disease Using Markers and Imaging Techniques|Not yet recruiting||N/A|110|Anticipated|Maastricht University Medical Center|||2||f||||||||||Samples Without DNA|"     Blood, exhaled air, feces   "|||2017-10-10 22:22:16.093079|2017-10-10 22:22:16.093079
NCT02716987|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-02-07|||April 2016||2016-04-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study to Determine D-Amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-Dose Oral Administration|A Phase 1, Open-Label, Positron Emission Tomography Study in Healthy Subjects to Determine D-Amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-Dose Oral Administration|Completed||Phase 1|21|Actual|Takeda||2|||f||||f||||||||||2017-10-10 22:22:16.145005|2017-10-10 22:22:16.145005
NCT02716974|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-09-06|||June 2016||2016-06-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|oligo-mets||A Study of Definitive Therapy to Treat Prostate Cancer|A Phase II Study of Definitive Therapy for Newly Diagnosed Men With Oligometastatic Prostate Cancer|Recruiting||Phase 2|33|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:22:16.221188|2017-10-10 22:22:16.221188
NCT02716961|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-22|||January 2016||2016-01-01|November 2015|2015-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer|Prospective Cohort Study of Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy to Prevent Moderate-high Recurrence and Progression Risks of Muscle-invasive Bladder Cancer|Recruiting||N/A|208|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||||||||||||2017-10-10 22:22:16.321995|2017-10-10 22:22:16.321995
NCT02716948|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-28|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|||SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine|A Pilot Study of Stereotactic Radiosurgery Combined With Nivolumab in Patients With Newly Diagnosed Melanoma Metastases in the Brain and Spine|Recruiting||Phase 1|90|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:22:16.424204|2017-10-10 22:22:16.424204
NCT02716935|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-05-04|||March 2016||2016-03-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants|Effect of Supplementation With LNS Fortified With a Mixture of FOS and Inulin on Gut Microbiota Diversity and Functionality and Its Repercussion on Growth and Morbidity During Infancy in Rural Burkina Faso|Active, not recruiting||N/A|153|Actual|University Ghent||3|||f||||f||||||||Yes|Upon publication of the main findings, data will be shared on a public repository and made publicly available on request as per recently published guidance and regulations (BMJ 2016;352:i255)|2017-10-10 22:22:16.534041|2017-10-10 22:22:16.534041
NCT02716922|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-17|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|April 2018|Anticipated|2018-04-01||Interventional|||Cerclage for Singletons With Short Cervix Without Prior Preterm Birth|Cervical Cerclage for Singleton Gestations With Short Cervix and Without Prior Preterm Birth|Recruiting||Phase 3|300|Anticipated|Federico II University||2|||f||||f||||||||No||2017-10-10 22:22:16.615805|2017-10-10 22:22:16.615805
NCT02716909|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-11-15|||March 2016||2016-03-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth|Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth|Recruiting||Phase 3|300|Anticipated|Federico II University||2|||f||||t||||||||No||2017-10-10 22:22:16.696631|2017-10-10 22:22:16.696631
NCT02716896|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-08-01|||May 2016||2016-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer|Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer: A Pilot, Randomized-Controlled Non-Inferiority Trial|Enrolling by invitation||N/A|30|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 22:22:16.809599|2017-10-10 22:22:16.809599
NCT02716870|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-05-18|||June 2015||2015-06-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors|Effect of Important Food Sources of Fructose-containing Sugars on Cardiometabolic Risk Factors: A Series of Systematic Reviews and Meta-analyses of Controlled Trials to Inform Dietary Guidelines, Public Health Policy, and Future Trial Design|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:22:16.944554|2017-10-10 22:22:16.944554
NCT02716857|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-04-20|||March 2016||2016-03-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain|A Randomized Withdrawal, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Egalet® Abuse-deterrent, Extended-release (ADER) Oxycodone Tablet, Egalet-002, in Patients With Moderate-to-Severe Chronic Low Back Pain|Active, not recruiting||Phase 3|549|Actual|Egalet Ltd||2|||f||||f||||||||||2017-10-10 22:22:17.045104|2017-10-10 22:22:17.045104
NCT02716844|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-23|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect Of Exercises On Kinesiophobia, And Other Symptoms Related to Osteoporosis|The Effect Of The Clinical Pilates Exercises On Kinesiophobia, And Other Symptoms Related to Osteoporosis|Completed||N/A|47|Actual|Eastern Mediterranean University||2|||f||||f||||||||Undecided||2017-10-10 22:22:17.310459|2017-10-10 22:22:17.310459
NCT02716831|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-07-21|||May 2015||2015-05-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|INSPIRE||Improving Treatments for Bulimia Nervosa: Innovation in Psychological Interventions for Regulating Eating|Addressing Weight History to Improve Behavioral Treatments for Bulimia Nervosa|Recruiting||N/A|50|Anticipated|Drexel University||2|||f||||t||||||||||2017-10-10 22:22:17.434222|2017-10-10 22:22:17.434222
NCT02716818|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-07-13|||February 22, 2016|Actual|2016-02-22|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia|A Phase III Study of Efficacy, Safety and Tolerability of Chronocort® Compared With Standard Glucocorticoid Replacement Therapy in the Treatment of Congenital Adrenal Hyperplasia|Recruiting||Phase 3|110|Anticipated|Diurnal Limited||2|||f||||t||||||||||2017-10-10 22:22:17.577849|2017-10-10 22:22:17.577849
NCT02716805|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-09-07|||November 2016||2016-11-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Phase 1 Study to Assess Safety & Tolerability of Tremelimumab & Durvalumab, Administered With High Dose Chemotherapy and Autologous Stem Cell Transplant|A Phase 1 Study to Assess Safety and Tolerability of Tremelimumab and Durvalumab, Administered With High Dose Chemotherapy and Autologous Stem Cell Transplant (HDT/ASCT)|Active, not recruiting||Phase 1|6|Actual|Ludwig Institute for Cancer Research||4|||f||||f||||||||||2017-10-10 22:22:19.257627|2017-10-10 22:22:19.257627
NCT02716792|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-03-18|||January 2006||2006-01-01|March 2016|2016-03-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer|Randomized, Open Label Study to Evaluate Renal Safety of Intravenous Bondronat 6 mg Infusions Over 15 Minutes Versus 60 Minutes in Patients With Metastatic Bone Disease Due to Breast Cancer|Completed||Phase 3|334|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:22:19.369113|2017-10-10 22:22:19.369113
NCT02716779|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-18|2016-07-20|2016-06-06||April 2007||2007-04-01|March 2016|2016-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection|Randomized, Multicentric, Partially Double-Blinded Placebo-Controlled Phase II Study for Examining the Influence of Ribavirin on the Initial Virological Response With Treatment of Peginterferon Alfa-2a (40KD) and Ribavirin With a Six Week Pretreatment-Phase of Ribavirin/Placebo or PEG-Interferon Monotherapy in Treatment Naïve Patients With Chronic Hepatitis C Virus Genotype 1 Infection|Completed||Phase 2|68|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:22:19.548609|2017-10-10 22:22:19.548609
NCT02716766|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-25|||March 2016||2016-03-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)|Randomised Phase II Trial of Sorafenib, Capecitabine and Oxaliplatin (SECOX) Versus Single Agent Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 2|138|Anticipated|The University of Hong Kong||2|||f||||||||||||No||2017-10-10 22:22:20.882226|2017-10-10 22:22:20.882226
NCT02716753|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-06-11|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Interventional|SENAVA||Effects of Seminal Plasma on Pregnancy Rate With IVF|The Effects of Male Factors on the Success Rate of in Vitro Fertilization. Will Deposition of Seminal Plasma Around the External Cervical os Increase Pregnancy Rate?|Recruiting||N/A|350|Anticipated|Ostergotland County Council, Sweden||2|||f||||f||||||||No||2017-10-10 22:22:20.981252|2017-10-10 22:22:20.981252
NCT02716740|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-17|||January 2016||2016-01-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MUSCAADE||Study of Amino Acid Supplementation for Patients With an Excessive Loss of Muscular Body Mass After Obesity Surgery.|Pilot Study of Branched Amino Acid Supplementation for Patients With an Excessive Loss of Muscular Body Mass After Obesity Surgery.|Recruiting||N/A|60|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:22:21.099562|2017-10-10 22:22:21.099562
NCT02716727|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-05-26|||October 2016||2016-10-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Comparison of Two Gingival Displacement Procedures|Comparison of Two Gingival Displacement Procedures; a Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 22:22:21.191935|2017-10-10 22:22:21.191935
NCT02716701|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-12-07|||January 2016||2016-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Exercise in Multiple Sclerosis|Effects of Exercise on Brain Structure and Function in Multiple Sclerosis|Active, not recruiting||N/A|40|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||No||2017-10-10 22:22:21.403768|2017-10-10 22:22:21.403768
NCT02716688|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-04-18|||January 2016||2016-01-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||S-1 and Radiotherapy for Elderly Esophageal Cancer Patients|A Phase Ⅱ Study of S-1 With Concurrent Radiotherapy in Elderly Esophageal Cancer Patients|Recruiting||Phase 2|21|Anticipated|Zhejiang Provincial People’s Hospital||1|||f||||f||||||||||2017-10-10 22:22:21.48498|2017-10-10 22:22:21.48498
NCT02716675|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-13|||March 2016||2016-03-01|July 2017|2017-07-01||||July 2020|Anticipated|2020-07-01||Interventional|||Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men|A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men|Recruiting||Phase 2|2700|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-10 22:22:21.591807|2017-10-10 22:22:21.591807
NCT02716662|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-10-28|||January 2016||2016-01-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||Safety of Caprylic Triglycerides in ALS: A Pilot Study||Recruiting||Phase 1|10|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 22:22:21.860058|2017-10-10 22:22:21.860058
NCT02716649|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-02-26|||January 2016||2016-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Does an Indian Version of the International Classification of Disease Injury Severity Score Predict Mortality in Four Public Hospitals in Urban India?|Does an Indian Version of the International Classification of Disease Injury Severity Score Predict Mortality in Four Public Hospitals in Urban India?|Completed||N/A|16047|Actual|Karolinska Institutet|||1||f||||f||||||||Yes|Yes, by upload to public data repository such as figshare or equivalent|2017-10-10 22:22:21.929944|2017-10-10 22:22:21.929944
NCT02716636|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-03-22|||April 2016||2016-04-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|August 2016|Anticipated|2016-08-01||Interventional|||Fast Versus Slow Tenaculum Placement|Fast Versus Slow Tenaculum Placement for Office Procedures: A Randomized Controlled Trial|Not yet recruiting||N/A|100|Anticipated|University of Iowa||2|||f||||f||||||||||2017-10-10 22:22:22.019342|2017-10-10 22:22:22.019342
NCT02716623|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-05-05|||March 2016||2016-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|DEAL||The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer|The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer|Recruiting||N/A|5|Anticipated|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-10 22:22:22.104506|2017-10-10 22:22:22.104506
NCT02716610|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-17|||October 2013||2013-10-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Samba-02||Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes|Samba-02: An Investigation of the Dose-Response and Subject Variability of Inhaled Insulin in Subjects With Type 2 Diabetes|Completed||Phase 1/Phase 2|24|Actual|Dance Biopharm Inc.||5|||f||||f||||||||No||2017-10-10 22:22:22.197348|2017-10-10 22:22:22.197348
NCT02716597|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-09-06|||March 2016||2016-03-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock|Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock|Recruiting||Phase 4|100|Anticipated|University of Kentucky||2|||f||||f||||||||Undecided||2017-10-10 22:22:22.30665|2017-10-10 22:22:22.30665
NCT02716584|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-25|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Benefits of Physical Exercise in Schizophrenia|Physical Exercise Effects on Determinants of Social Integration in Schizophrenia|Recruiting||N/A|54|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:22:22.413999|2017-10-10 22:22:22.413999
NCT02716571|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-07-27|||March 28, 2016|Actual|2016-03-28|July 2017|2017-07-01|July 27, 2017|Actual|2017-07-27|June 2, 2017|Actual|2017-06-02||Interventional|||Recruiting Blood Donor With Allogeneic Natural Killer Cell|Recruiting Blood Donor With Allogeneic Natural Killer Cell Which Will be Used for HCC After TACE|Completed||N/A|90|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 22:22:22.504996|2017-10-10 22:22:22.504996
NCT02716558|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-04-14|||February 2016||2016-02-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||A Clinical Trial to Assess the Retention and Caries Preventive Effects of Moisture Tolerant Resin Sealant and ART Sealants||Active, not recruiting||Phase 4|93|Anticipated|Kamineni Institute of Dental Sciences||2|||f||||t||||||||Yes||2017-10-10 22:22:22.584809|2017-10-10 22:22:22.584809
NCT02716545|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-12-26|||March 2016||2016-03-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||the Efficiency of Endoscopic Treatment for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation|the Efficiency of Endoscopic Treatment for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation: the Study of the Bleeding Risks Stratification Model and Endoscopic Treatment|Recruiting||N/A|300|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||No||2017-10-10 22:22:22.66363|2017-10-10 22:22:22.66363
NCT02716532|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-06-02|||April 2016||2016-04-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|MCTs and ABI||Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI)|Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI)|Recruiting||N/A|25|Anticipated|Nestlé||1|||f||||f||||||||No||2017-10-10 22:22:22.754067|2017-10-10 22:22:22.754067
NCT02716519|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Use of Santyl Within an Accountable Care Organization|Clinical Outcomes for Chronic Ulcers Treated With Clostridial Collagenase (SANTYL®) Versus Standard Care Within the Continuum of Care of an Accountable Care Organization (ACO)|Withdrawn||Phase 4|0|Actual|Smith & Nephew, Inc.||2||Business Decision|f||||f||||||||Yes||2017-10-10 22:22:22.842051|2017-10-10 22:22:22.842051
NCT02716506|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-10-12|||January 2015||2015-01-01|October 2016|2016-10-01|January 2025|Anticipated|2025-01-01|December 2015|Actual|2015-12-01|5 Years|Observational [Patient Registry]|||FINPOP 2015: Incidence, Methods, Complications and Quality of Life of Pelvic Organ Prolapse Operations in Finland 2015|Finnish Pelvic Organ Prolapse Surgery Survey 2015: Incidence, Methods, Complications and Effect on Quality of Life of Pelvic Organ Prolapse Operations in Finland in 2015|Active, not recruiting||N/A|3200|Anticipated|Society for Gynecological Surgery in Finland|||1||f||||f||||||||No||2017-10-10 22:22:22.943879|2017-10-10 22:22:22.943879
NCT02716493|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-01-05|||November 2013||2013-11-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|TELErp||Feasibility of a 8-week Telerehabilitation Program for Patients With Thoracic Neoplasia Receiving Chemotherapy|Feasibility of an Eight-week Telerehabilitation Program for Patients With Unresectable Thoracic Neoplasia Receiving Chemotherapy|Active, not recruiting||N/A|5|Actual|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec||1|||f||||||||||||||2017-10-10 22:22:23.029978|2017-10-10 22:22:23.029978
NCT02716480|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-08-01|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|MYGOODTRIP||Health-connected Devices and Physical Activity Recovery in Bariatric Surgery Patients|Impact of the Use of Health-connected Devices on Recovery of Physical Activity in Obese Patients After Bariatric Surgery.|Recruiting||N/A|90|Anticipated|My Goodlife SAS||2|||f||||f||||||||No||2017-10-10 22:22:23.117241|2017-10-10 22:22:23.117241
NCT02716467|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-03-06|||April 2015||2015-04-01|March 2017|2017-03-01|May 15, 2016|Actual|2016-05-15|July 15, 2015|Actual|2015-07-15||Interventional|||Effect of Intercessory Prayer in Patients With Breast Cancer in Radiotherapy Treatment: Clinical Trial|Effect of Intercessory Prayer on the Levels of Psychological Variables, Spiritual and Biological of Patients With Breast Cancer in Radiotherapy Treatment: Clinical Trial|Completed||N/A|30|Actual|University of Sao Paulo||2|||f||||t||||||||Undecided||2017-10-10 22:22:23.223724|2017-10-10 22:22:23.223724
NCT02716454|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-04-26|||May 2016||2016-05-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|May 2021|Anticipated|2021-05-01||Interventional|ESPRIT||Early Surgery Versus Conservative Treatment in Patients With Ileocaecal Crohn's Disease|Early Surgery Versus Conservative Treatment in Patients With Ileocaecal Crohn's Disease - Prospective Randomized Study|Not yet recruiting||N/A|200|Anticipated|Czech Surgical Society||2|||f||||f||||||||Undecided||2017-10-10 22:22:23.306174|2017-10-10 22:22:23.306174
NCT02716441|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-05-03|||September 2016||2016-09-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|October 2020|Anticipated|2020-10-01||Observational|||Rotator Cuff Failure With Continuity|Failure With Continuity and Its Relation to Rotator Cuff Repair Clinical Outcomes|Recruiting||N/A|125|Anticipated|The Cleveland Clinic|||1||f||||f||||||||No||2017-10-10 22:22:23.445905|2017-10-10 22:22:23.445905
NCT02716428|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-01-27|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection|A Phase 2, Open-Label Study to Investigate the Safety and Efficacy of Faldaprevir and TD 6450 Alone and in Combination With Other Antivirals for 12 Weeks in Treatment-Naive Patients Chronically Infected With Genotype 1 Hepatitis C Virus|Active, not recruiting||Phase 2|25|Actual|Trek Therapeutics, PBC||2|||f||||f||||||||No||2017-10-10 22:22:23.531326|2017-10-10 22:22:23.531326
NCT02716415|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-22|||March 2015||2015-03-01|March 2016|2016-03-01||||March 2017|Anticipated|2017-03-01||Interventional|||Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants|Randomized Controlled Trial Comparing the Efficacy and Safety of Calmoseptine Ointment and Desitin Maximum Strength 40% Zinc Oxide Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants|Recruiting||Phase 4|326|Anticipated|University of the Philippines||2|||f||||f||||||||No||2017-10-10 22:22:23.646733|2017-10-10 22:22:23.646733
NCT02716402|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-27|||November 2015||2015-11-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Cyanotic Heart Disease and Thrombosis|Cyanotic Congenital Heart Disease: Prevalence of Pulmonary and Cerebral Thrombi-embolic Events|Recruiting||N/A|50|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||No||2017-10-10 22:22:23.741257|2017-10-10 22:22:23.741257
NCT02716389|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-04-18|||March 2016||2016-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Cervical Kinematics' Reliability: Zero Positioning Using a 3-D-bulls Eye Spirit Level||Completed||N/A|20|Actual|Goethe University||2|||f||||||||||||||2017-10-10 22:22:23.937815|2017-10-10 22:22:23.937815
NCT02716376|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-17|||April 2016||2016-04-01|March 2016|2016-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy|Treatment and Prevention of Middle Ear Morbidity in Head and Neck Cancer Patients Following Radiotherapy|Not yet recruiting||N/A|200|Anticipated|Zealand University Hospital||2|||f||||f||||||||No||2017-10-10 22:22:24.033194|2017-10-10 22:22:24.033194
NCT02716363|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-17|||November 2015||2015-11-01|March 2016|2016-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Rotational Atherectomy for Calcified lEsion By Smart Angioplasty Research Team (SMART-RACE)|SMart Angioplasty Research Team: A Multi-center, Open Study to Evaluation the Efficacy and Safety of Rotational Atherectomy With Drug Eluting Stent for Calcified LEsion in Korea (SMART-RACE) Trial|Recruiting||N/A|500|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:22:24.151361|2017-10-10 22:22:24.151361
NCT02716350|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-17|||March 2016||2016-03-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect of B-GOS on the Wellbeing and Ageing in Healthy 52-65 Years Old Individuals|A Double Blind, Placebo Controlled, Randomised, Single Centred, Parallel Study to Determine the Potential of B-GOS, to Beneficially Influence the Wellbeing and Ageing in Healthy 52-65 Years Old Individuals|Recruiting||Phase 2/Phase 3|60|Anticipated|Clasado Limited||2|||f||||t||||||||Yes|once the study is competed, codes will be unblinded and participants can receive their individual data upon written request - this is all listed in their information leaflets|2017-10-10 22:22:24.241722|2017-10-10 22:22:24.241722
NCT02716337|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-17|||October 2014||2014-10-01|March 2016|2016-03-01||||March 2015|Actual|2015-03-01||Interventional|||Target Versus Standard Human Milk Fortification in Very Low Birth Weight Preterm Infants||Completed||Early Phase 1|10|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||1|||f||||f||||||||No||2017-10-10 22:22:24.357931|2017-10-10 22:22:24.357931
NCT02716324|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-09-19|||March 2016||2016-03-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|ADHD-Link||Communication to Improve Shared Decision-Making in ADHD|Communication to Improve Shared Decision-Making in Attention-Deficit/Hyperactivity Disorder|Recruiting||Phase 3|300|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 22:22:24.437996|2017-10-10 22:22:24.437996
NCT02716311|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-08-31|||May 2016||2016-05-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|October 2018|Anticipated|2018-10-01||Interventional|ACE-Lung||Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer|Phase II Study Evaluating the Combination of Cetuximab With Afatinib as First-line Treatment for Patients With EGFR Mutated Non Small Cell Lung Cancer|Recruiting||Phase 2|170|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||f||||||||||2017-10-10 22:22:24.566859|2017-10-10 22:22:24.566859
NCT02716298|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-25|2017-01-30||March 2016||2016-03-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||A Dispensing Clinical of Fanfilcon A Lens Against Lotrafilcon B Lens Over 1 Month Wear Per Lens|A Dispensing Clinical of Fanfilcon A Lens Against Lotrafilcon B Lens Over 1 Month Wear Per Lens|Completed||N/A|49|Actual|Coopervision, Inc.||2|||f||||f||||||||No||2017-10-10 22:22:24.810847|2017-10-10 22:22:24.810847
NCT02716285|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-05-16|||August 17, 2016|Actual|2016-08-17|May 2017|2017-05-01|June 25, 2018|Anticipated|2018-06-25|January 25, 2018|Anticipated|2018-01-25||Interventional|PERSUADE||Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery|Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery|Recruiting||Phase 3|178|Anticipated|Maastricht University Medical Center||3|||f||||f||||||||No||2017-10-10 22:22:25.28566|2017-10-10 22:22:25.28566
NCT02716272|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-09-19|||April 2016||2016-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|MAPS2||Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients|A Randomized Phase II Study Evaluating Efficacy and Safety of 2nd or 3rd Line Treatment by Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients|Active, not recruiting||Phase 2|125|Actual|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||f||||||||||2017-10-10 22:22:25.467391|2017-10-10 22:22:25.467391
NCT02716259|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-04-02|||March 2016||2016-03-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Periodontal and Cardiovascular Diseases Project|Impact of Basic Periodontal Therapy in the Levels of Porphyromonas Gingivalis and Aggregatibacter Actinomycetemcomitans Subgingival and Its Association With Vascular Function|Recruiting||N/A|120|Anticipated|Universidad Complutense de Madrid||2|||f||||f||||||||Undecided||2017-10-10 22:22:25.618549|2017-10-10 22:22:25.618549
NCT02716246|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-17|||March 2016||2016-03-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase I/II Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH|Phase I/II Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA|Recruiting||Phase 1/Phase 2|9|Anticipated|Abeona Therapeutics, Inc||2|||f||||t|t|f||||||||2017-10-10 22:22:25.767864|2017-10-10 22:22:25.767864
NCT02716233|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-09-28|||April 2016||2016-04-01|September 2016|2016-09-01|April 2026|Anticipated|2026-04-01|April 2026|Anticipated|2026-04-01||Interventional|CAALL-F01||A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents|A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents|Recruiting||Phase 3|1578|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-10 22:22:25.890182|2017-10-10 22:22:25.890182
NCT02716220|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-02-02|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|April 2017|Anticipated|2017-04-01||Interventional|BIOSOLVE-III||Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III)|BIOTRONIKS - Acute Performance Of a Drug Eluting Absorbable Metal Scaffold (DREAMS 2G) in Patients With de Novo Lesions in NatiVE Coronary Arteries: BIOSOLVE-III|Active, not recruiting||N/A|61|Anticipated|Biotronik AG||1|||f||||t||||||||No||2017-10-10 22:22:26.092437|2017-10-10 22:22:26.092437
NCT02716207|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-10-10|||March 2016||2016-03-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife|Mono-Center Phase ǀ Study on Dose Escalation of Stereotactic Body Radiotherapy (SBRT) Treating Pancreatic Cancer Patients With CyberKnife|Recruiting||Phase 1|54|Anticipated|Changhai Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:22:26.195111|2017-10-10 22:22:26.195111
NCT02716194|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-18|||March 3, 2016|Actual|2016-03-03|April 2017|2017-04-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|||BAX 826 Dose-Escalation Safety Study|A Phase 1, Prospective, Open Label, Two Period, Fixed Sequence, Dose-Escalation Study of the PK and Safety of BAX 826 (PSA-rFVIII) in Previously Treated Patients With Severe (FVIII <1%) Hemophilia A|Completed||Phase 1|40|Actual|Baxalta US Inc.||3|||f||||f||||||||||2017-10-10 22:22:26.348628|2017-10-10 22:22:26.348628
NCT02716181|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-07-15|||January 2016||2016-01-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|May 2017|Anticipated|2017-05-01||Interventional|||"Efficacy of the Атопик Soothing Cream in Children With Mild to Moderate Atopic Dermatitis"|"A Double-Blind Randomized Placebo-Controlled Trial to Evaluate the Efficacy of the Атопик Soothing Cream in Children With Mild to Moderate Atopic Dermatitis"|Recruiting||N/A|66|Anticipated|Avanta Trading Ltd.||4|||f||||t||||||||Yes|Clinical parameters at the entry and at the end of study might be shared.|2017-10-10 22:22:26.518448|2017-10-10 22:22:26.518448
NCT02716168|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-01-04|||May 2016||2016-05-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|PSP||Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy|Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy - a Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|University of Southern Denmark||2|||f||||||||||||||2017-10-10 22:22:26.681237|2017-10-10 22:22:26.681237
NCT02716155|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-05-15|||October 16, 2016||2016-10-16||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:22:26.78725|2017-10-10 22:22:26.78725
NCT02714530|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-10-06|||October 2014||2014-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|ThoRaT||Thoracal Radiotherapy and Tarceva|Concomitant Radiotherapy and Erlotinib in Advanced Lung Cancer|Recruiting||Phase 2|150|Anticipated|Oslo University Hospital||2|||f||||t||||||||Yes|Publish results|2017-10-10 22:22:43.944345|2017-10-10 22:22:43.944345
NCT02716142|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-04-25|||March 2016||2016-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|RM-SLM||Rectal Misoprostol Versus Sublingual Misoprostol Prior to Myomectomy|Rectal Misoprostol Versus Sublingual Misoprostol in Decreasing Blood Loss Prior to Abdominal Myomectomy: A Randomized Double-blinded Clinical Trial|Recruiting||Phase 4|80|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:22:27.085519|2017-10-10 22:22:27.085519
NCT02716129|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-01-21|||March 2016||2016-03-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section|Post-cesarean Section Analgesic Potency and Side Effects of Intrathecal Morphine and Nalbuphine|Recruiting||Phase 2|70|Anticipated|Assiut University||2|||f||||f|t|f|||f|||Yes||2017-10-10 22:22:27.180211|2017-10-10 22:22:27.180211
NCT02716116|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-09-05|||April 2016||2016-04-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|February 2018|Anticipated|2018-02-01||Interventional|||A Trial of AP32788 in Non-Small Cell Lung Cancer|A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of the Oral EGFR/HER2 Inhibitor AP32788 in Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|105|Anticipated|Ariad Pharmaceuticals||5|||f||||f||||||||||2017-10-10 22:22:27.291933|2017-10-10 22:22:27.291933
NCT02716103|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-01-10|||May 2016||2016-05-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|MRD||Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis|Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment (Which May Include High Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT)) in Patients With AL Amyloidosis: Feasibility and Prognostic Significance|Recruiting||N/A|30|Anticipated|Boston Medical Center|||2||f||||f||||||Samples With DNA|"     Bone marrow and peripheral blood   "|No||2017-10-10 22:22:27.477835|2017-10-10 22:22:27.477835
NCT02716090|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-02-14||||||February 2017|2017-02-01||||November 2015|Anticipated|2015-11-01||Interventional|Narciso||Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris|National Clinical Trial, Phase III, Monocentric, Randomized, Open, Controlled, Parallel Study to Assess the Non-inferiority of Dalap Duo® Product (0,1% Adapalene and 2,5% Benzoyl Peroxide Gel Cream) Compared to Epiduo® (0,1% Adapalene and 2,5% Benzoyl Peroxide Gel) in the Treatment of Acne Vulgaris in Population of Men and Women|Withdrawn||Phase 3|0|Actual|Ache Laboratorios Farmaceuticos S.A.||2||Due to budget limitations, the company decided to withdraw this study.|f||||f||||||||||2017-10-10 22:22:27.62119|2017-10-10 22:22:27.62119
NCT02716077|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-12-06|||March 2016||2016-03-01|September 2016|2016-09-01||||March 2023|Anticipated|2023-03-01||Interventional|||Early FDG PET in Melanoma|Early FDG PET/CT Imaging as a Measure of Response in Patients With Melanoma on Pembrolizumab.|Recruiting||Early Phase 1|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:22:27.743564|2017-10-10 22:22:27.743564
NCT02716064|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-09-13|||December 2014||2014-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|TAPESTRY-CM||TAPESTRY for People With Cardiovascular and Metabolic Disease: A Pilot Study|Teams Advancing Patient Experience: Strengthening Quality for People With Cardiovascular and Metabolic Disease (TAPESTRY-CM): A Pilot Study|Completed||N/A|30|Actual|McMaster University||1|||f||||f||||||||||2017-10-10 22:22:27.836524|2017-10-10 22:22:27.836524
NCT02716051|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|WISLON||Wholebody MRI In Lung Cancer StagiNg|Initial Staging of Bronchopulmonary Neoplasia: Whole-body MRI Versus Pet Scanner|Not yet recruiting||N/A|36|Anticipated|University Hospital, Limoges||2|||f||||f||||||||No||2017-10-10 22:22:27.951919|2017-10-10 22:22:27.951919
NCT02716038|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-11|||June 7, 2016|Actual|2016-06-07|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC|A Single-arm, Phase II Study of Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in Resectable Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|30|Anticipated|Columbia University||1|||f||||t|t|f||||||No||2017-10-10 22:22:28.038428|2017-10-10 22:22:28.038428
NCT02716025|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-21|||October 2013||2013-10-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection||Completed||N/A|75|Actual|Ain Shams University|||2||f||||||||||||||2017-10-10 22:22:28.178062|2017-10-10 22:22:28.178062
NCT02716012|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-06-13|||March 1, 2016|Actual|2016-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|OUTREACH||First-in-Human Safety and Tolerability Study of MTL-CEBPA in Patients With Advanced Liver Cancer|A First-in-Human, Multi-centre, Open-label, Phase 1 Clinical Study With RNA Oligonucleotide Drug MTL-CEBPA to Investigate Its Safety and Tolerability in Patients With Advanced Liver Cancer|Recruiting||Phase 1|51|Anticipated|Mina Alpha Limited||1|||f||||f||||||||No||2017-10-10 22:22:28.246102|2017-10-10 22:22:28.246102
NCT02715999|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-01-24|||February 2016||2016-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Transversus Abdominis Plane Versus Quadratus Lumborum Block for Pediatrics|Transversus Abdominis Plane Versus Quadratus Lumborum Block for Pediatrics|Completed||Phase 4|50|Anticipated|Kahramanmaras Sutcu Imam University||2|||f||||f||||||||No||2017-10-10 22:22:28.40531|2017-10-10 22:22:28.40531
NCT02715986|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-04-24|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ECT-IM||Brain Changes in Severely Depressed Patients Before and After Treatment With Electroconvulsive Therapy|Structural-functional Brain Changes in Severely Depressed Patients Before and After Treatment With Electroconvulsive Therapy: an Exploratory Study|Recruiting||N/A|20|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 22:22:28.507252|2017-10-10 22:22:28.507252
NCT02715973|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-10-27|||January 2016||2016-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease|Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease|Recruiting||N/A|40|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 22:22:28.625493|2017-10-10 22:22:28.625493
NCT02714517|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-09-29|||July 2015||2015-07-01|September 2016|2016-09-01||||June 2016|Actual|2016-06-01||Interventional|||Efficacy of Hydrotherapy in Peripheral Neuropathy||Completed||N/A|40|Actual|Ospedale Generale Di Zona Moriggia-Pelascini||2|||f||||||||||||||2017-10-10 22:22:44.045015|2017-10-10 22:22:44.045015
NCT02715960|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-21|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules|Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules|Recruiting||Phase 2|500|Anticipated|Central South University||1|||f||||t||||||||Undecided|data not entered|2017-10-10 22:22:28.720547|2017-10-10 22:22:28.720547
NCT02715947|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-21|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate|Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate|Recruiting||Phase 2|400|Anticipated|Central South University||1|||f||||t||||||||Undecided||2017-10-10 22:22:28.83312|2017-10-10 22:22:28.83312
NCT02715934|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-06-05|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Glucose to Goal: A Model to Support Diabetes Management in Primary Care|Glucose to Goal: A Model to Support Diabetes Management in Primary Care|Recruiting||N/A|4400|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:22:28.975274|2017-10-10 22:22:28.975274
NCT02715921|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-03-16|||November 2015||2015-11-01|March 2016|2016-03-01||||June 2016|Anticipated|2016-06-01||Interventional|||Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study||Recruiting||N/A|25|Anticipated|MemorialCare Health System||1|||f||||||||||||||2017-10-10 22:22:29.127535|2017-10-10 22:22:29.127535
NCT02715908|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-11-21|||April 2016||2016-04-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active Rheumatoid Arthritis Despite Methotrexate (MTX)|A Multi-center, Single-arm, Open-label, Extension Clinical Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 50 mg Subcutaneous Weekly Injection When Co-administered With Methotrexate (MTX) for Additional 48 Weeks in Patients With Rheumatoid Arthritis Who Have Completed the Treatment Period of LG-ECCL002 Study.|Recruiting||Phase 3|165|Anticipated|LG Life Sciences||1|||f||||f||||||||Undecided||2017-10-10 22:22:29.219951|2017-10-10 22:22:29.219951
NCT02715895|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-06-01|||April 2016||2016-04-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Clinical Trial of Infant Formula-fed|A Clinical Trial of Infant Formula-fed|Not yet recruiting||N/A|216|Anticipated|Maternal and Child Health Care Hospital of Hainan Province||3|||f||||t||||||||Yes||2017-10-10 22:22:29.321685|2017-10-10 22:22:29.321685
NCT02715882|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-02-08|||November 2015||2015-11-01|July 2016|2016-07-01|December 31, 2017|Anticipated|2017-12-31|February 2017|Anticipated|2017-02-01||Interventional|||Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer|Randomized Single-blind Placebo-controlled Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer, With Different Doses and Regimens|Active, not recruiting||Phase 2|40|Actual|BioLab 612 LLC||4|||f||||f||||||||||2017-10-10 22:22:29.488709|2017-10-10 22:22:29.488709
NCT02715869|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-07-29|||March 2016||2016-03-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Interventional|||Impact of Variable Types of Preconditioning Upon the Inotrope Score in Adult Patients, Undergoing Cardiac Surgery|Impact of Variable Types of Preconditioning Upon the Inotrope Score in Adult Patients, Undergoing Cardiac Surgery|Completed||N/A|60|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 22:22:29.596581|2017-10-10 22:22:29.596581
NCT02715856|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-10-14|||April 2016||2016-04-01|October 2016|2016-10-01||||April 2019|Anticipated|2019-04-01||Interventional|||Using Telemonitoring to Optimize the Mobility of Cancer Survivors With Skeletal Metastases After Surgery to Preserve Limb Function|Using Telemonitoring to Optimize the Mobility of Cancer Survivors With Skeletal Metastases After Surgery to Preserve Limb Function|Recruiting||N/A|72|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 22:22:29.68957|2017-10-10 22:22:29.68957
NCT02715843|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-21|||December 2015||2015-12-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Expanded Access|||Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma|Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma Who Have Completed Phase I/Ib Study MT-3724_NHL_001_US|Available||N/A|||Molecular Templates, Inc.|||||||||||||||||||2017-10-10 22:22:29.787778|2017-10-10 22:22:29.787778
NCT02715830|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-17|||January 2014||2014-01-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Randomized Clinical Trial in Bellow-the-knee Angioplasty. Treatment of One or More Than One Artery.|Randomized Clinical Trial in Bellow-the-knee Angioplasty. Treatment of One or More Than One Artery.|Recruiting||Phase 4|80|Anticipated|Federal University of São Paulo||2|||f||||f||||||||No||2017-10-10 22:22:29.888358|2017-10-10 22:22:29.888358
NCT02715817|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-21|||June 2015||2015-06-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Virtual Rehabilitation and Therapeutic Exercise in the Treatment of Post-stroke Hemiparetic|The Effect of Virtual Rehabilitation With Nintendo Wii ® and Proprioceptive Neuromuscular Facilitation Exercises in the Treatment of Hemiparesis Poststroke Adults|Recruiting||N/A|30|Anticipated|Federal University of Bahia||3|||f||||f||||||||Undecided||2017-10-10 22:22:29.960721|2017-10-10 22:22:29.960721
NCT02715804|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-09-29|||February 2016||2016-02-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma|Recruiting||Phase 3|420|Anticipated|Halozyme Therapeutics||2|||f||||t||||||||||2017-10-10 22:22:30.121773|2017-10-10 22:22:30.121773
NCT02715791|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-10-02|||February 2016||2016-02-01|October 2017|2017-10-01|September 26, 2017|Actual|2017-09-26|December 2016|Actual|2016-12-01||Interventional|TAP-HC-DM||TAPESTRY With Health Connnectors for Diabetes Management|Teams Advancing Patient Experience: Strengthening Quality for People Through Health Connectors for Diabetes Management (TAPESTRY-HC-DM): A Feasibility RCT|Completed||N/A|50|Actual|McMaster University||2|||f||||f||||||||||2017-10-10 22:22:30.765548|2017-10-10 22:22:30.765548
NCT02715778|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-09-08|||February 2016||2016-02-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|||Translational Investigation of Gestational Environment on Neurobehavioral Function in Children|Translational Investigation of Gestational Environment on Neurobehavioral Function in Children|Enrolling by invitation||N/A|100|Anticipated|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-10 22:22:30.887234|2017-10-10 22:22:30.887234
NCT02715765|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-09-20|||July 2016||2016-07-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||The Use of Transcranial Electrical Stimulation for Hallucinations|The Use of Transcranial Electrical Stimulation for Hallucinations|Recruiting||Phase 2|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||Undecided||2017-10-10 22:22:30.978708|2017-10-10 22:22:30.978708
NCT02715752|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-04-24|||January 2016||2016-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin|A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin|Completed||N/A|1000|Actual|The Center for the Biology of Chronic Disease|||5||f||||f||||||||Undecided||2017-10-10 22:22:31.095737|2017-10-10 22:22:31.095737
NCT02715739|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-02-26|||January 2016||2016-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Is There a Difference in the Mortality Prediction Performance of Two ICISS Approaches for Trauma Patients Admitted to Hospitals in Urban India?||Completed||N/A|3921|Actual|Karolinska Institutet|||1||f||||||||||||||2017-10-10 22:22:31.199739|2017-10-10 22:22:31.199739
NCT02715713|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-10-14|||March 2016||2016-03-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Autonomic Manifestations of Testosterone Deficiency in Men|Autonomic Manifestations of Testosterone Deficiency in Men|Withdrawn||N/A|0|Actual|Texas Tech University Health Sciences Center|||2|Principal Investigator left the institution in August, 2016;|f||||f||||||||Undecided||2017-10-10 22:22:31.58129|2017-10-10 22:22:31.58129
NCT02715700|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-09-01|||September 2015||2015-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate the Effects of Multiple Doses of MK-1439 (Doravirine) on Pharmacokinetics of Methadone in Participants Requiring Methadone Maintenance Therapy (MK-1439-045)|A Multiple-Dose Clinical Trial to Study the Effect of MK-1439 (Doravirine) on Methadone Pharmacokinetics|Completed||Phase 1|14|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 22:22:31.657952|2017-10-10 22:22:31.657952
NCT02715687|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo.|Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo.|Not yet recruiting||Phase 3|400|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||Undecided||2017-10-10 22:22:31.74113|2017-10-10 22:22:31.74113
NCT02715674|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-21|||June 2015||2015-06-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Comparison the Effectiveness of Postoperative Incentive Spirometry and Noninvasive Mechanical Ventilation in Patients Following Craniotomy|Comparison the Effectiveness of Postoperative Incentive Spirometry and Noninvasive Mechanical Ventilation in Patients Following Craniotomy|Recruiting||N/A|60|Anticipated|Istanbul University||3|||f||||f||||||||No||2017-10-10 22:22:31.824213|2017-10-10 22:22:31.824213
NCT02715661|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|IHD||Cerebrovascular Outcomes in Ischemic Heart Disease|Cerebrovascular Outcomes in Ischemic Heart Disease Patients Undergoing Cardiac Rehabilitation|Not yet recruiting||N/A|270|Anticipated|Western University, Canada||3|||f||||f||||||||No||2017-10-10 22:22:31.924296|2017-10-10 22:22:31.924296
NCT02715648|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-02-14|||April 1, 2016|Actual|2016-04-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Using Phenazopyridine for In-office Cystoscopy|Using Phenazopyridine for In-office Cystoscopy|Recruiting||N/A|94|Anticipated|Boston Urogynecology Associates||2|||f||||f||||||||No||2017-10-10 22:22:32.010059|2017-10-10 22:22:32.010059
NCT02715635|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-10-20|||April 2016||2016-04-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Influence of Dietary Nitrate on Vascular Dysfunction and Inflammation|A Double-blind, Randomised, Placebo-controlled Parallel Study to Investigate the Effect of Dietary Nitrate on a Model of Vascular Dysfunction in Healthy Volunteers|Recruiting||Phase 1|64|Anticipated|Queen Mary University of London||2|||f||||f||||||||||2017-10-10 22:22:32.080757|2017-10-10 22:22:32.080757
NCT02715622|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01|3 Years|Observational [Patient Registry]|||A Prospective Study to Compare the Clinical Outcomes, Pain and Patient Quality of Life for Hernia Patients|A Prospective, Multicenter Post-Market Study to Evaluate and Compare the Clinical Outcomes, Pain and Patient Quality of Life After Open, Laparoscopic or Robotic Assisted Hernia (Incisional and Inguinal) Repair|Recruiting||N/A|900|Anticipated|Intuitive Surgical|||3||f||||f||||||||Undecided||2017-10-10 22:22:32.180668|2017-10-10 22:22:32.180668
NCT02715609|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-18|||June 15, 2016|Actual|2016-06-15|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma|A Phase I/II Dose-escalation Study of Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 1/Phase 2|18|Anticipated|Washington University School of Medicine||1|||f||||t|t|t|f|f|f|||No||2017-10-10 22:22:32.269922|2017-10-10 22:22:32.269922
NCT02715427|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-04-01|||April 2016||2016-04-01|April 2016|2016-04-01||||March 2018|Anticipated|2018-03-01||Interventional|MultiPAS||Enhanced Recovery After Hepatic Surgery (MultiPAS).|Enhanced Recovery After Hepatic Surgery Versus Conventional Care : a Controlled Randomized Monocentric Trial (MultiPAS).|Recruiting||N/A|80|Anticipated|University Hospital, Angers||2|||f||||||||||||||2017-10-10 22:22:35.581088|2017-10-10 22:22:35.581088
NCT02715596|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-08-28|||December 23, 2015|Actual|2015-12-23|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|hepaneck||Changes in Body Composition After EPA Supplementation in Head and Neck Patients|Relationship Between Changes in Body Composition and Supplementation With EPA in Patients Diagnosed With Squamous Cell Carcinoma of Head and Neck Locally Advanced (Stage III-IVb)|Recruiting||Phase 3|54|Anticipated|Institut Català d'Oncologia||2|||f||||f||||||||||2017-10-10 22:22:32.428556|2017-10-10 22:22:32.428556
NCT02715583|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-01-26|||March 2016||2016-03-01|January 2017|2017-01-01||||March 2017|Anticipated|2017-03-01||Interventional|||C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer|C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer|Recruiting||Early Phase 1|15|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:22:32.529604|2017-10-10 22:22:32.529604
NCT02715570|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945|A Randomised, Single-blind, Placebo-controlled, Study to Assess the Safety and Tolerability of Single Escalating and Repeat, Inhaled Doses of PC945 in Healthy Subjects Combined With a Randomised, Single-blind, Placebo-controlled, Parallel Group to Assess the Safety and Tolerability of a Single Dose of Inhaled PC945 in Subjects With Mild Asthma|Not yet recruiting||Phase 1|26|Anticipated|Pulmocide Ltd||3|||f||||f|f|f||||||||2017-10-10 22:22:32.60705|2017-10-10 22:22:32.60705
NCT02715557|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-04-21|||September 2014||2014-09-01|April 2017|2017-04-01||||September 2017|Anticipated|2017-09-01||Interventional|ARISE||Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers|Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers|Recruiting||Phase 2|125|Anticipated|3-C Institute for Social Development||2|||f||||f||||||||||2017-10-10 22:22:32.692423|2017-10-10 22:22:32.692423
NCT02715544|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-21|||January 2015||2015-01-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Play&Grow||Promoting Healthy Eating and Active Playtime by Connecting Preschool Children to Nature|Promoting Healthy Eating and Active Playtime by Connecting Preschool Children to Nature|Recruiting||N/A|240|Anticipated|The University of Hong Kong||2|||f||||t||||||||No|Hong Kong Ethics Committee|2017-10-10 22:22:32.795116|2017-10-10 22:22:32.795116
NCT02715531|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-01|||April 30, 2016|Actual|2016-04-30|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||A Study of the Safety and Tolerability of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors|An Open-Label, Multicenter Phase Ib Study of The Safety and Tolerability of Atezolizumab (Anti-PD-L1 Antibody) Administered in Combination With Bevacizumab and/or Other Treatments in Patients With Solid Tumors|Recruiting||Phase 1|291|Anticipated|Hoffmann-La Roche||5|||f||||||||||||||2017-10-10 22:22:32.903426|2017-10-10 22:22:32.903426
NCT02715518|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-12-20|||August 2016||2016-08-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|FRAME-AMI||FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease|Comparison of Clinical Outcomes Between Fractional Flow Reserve-guided Strategy and Angiography-guided Strategy in Treatment of Non-Infarction Related Artery Stenosis in Patients With Acute Myocardial Infarction|Recruiting||Phase 4|1292|Anticipated|Samsung Medical Center||2|||f||||t||||||||Yes|After publication of first manuscript and trial results, the de-identified data will be shared by permission of principle investigator, when asked|2017-10-10 22:22:33.096837|2017-10-10 22:22:33.096837
NCT02715505|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-10-05|||October 10, 2017|Anticipated|2017-10-10|October 2017|2017-10-01|May 18, 2020|Anticipated|2020-05-18|May 18, 2020|Anticipated|2020-05-18||Interventional|||Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)|A Single-arm, Open-label, Study to Evaluate the Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD) Undergoing Stem Cell Transplantation After Reduced Intensity Conditioning|Withdrawn||Phase 1/Phase 2|0|Actual|Novartis||1||study was cancelled with no patients|f||||t|t|f||||||||2017-10-10 22:22:33.216352|2017-10-10 22:22:33.216352
NCT02715492|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.|Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.|Not yet recruiting||Phase 3|40|Anticipated|Tanta University||2|||f||||t||||||||No||2017-10-10 22:22:33.29398|2017-10-10 22:22:33.29398
NCT02715479|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-01-17|||April 2016||2016-04-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176|A Two-way Drug Interaction Study to Evaluate the Effect of BMS-955176 on the Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176|Completed||Phase 1|14|Actual|ViiV Healthcare||3|||f||||f||||||||||2017-10-10 22:22:33.380972|2017-10-10 22:22:33.380972
NCT02715466|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2017-08-29|||April 2016||2016-04-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|GENIUS||Gelatin in ICU and Sepsis|Prospective, Controlled, Double-Blind, Randomized Multicentric Study On The Efficacy And Safety Of An Early Target Controlled Plasma Volume Replacement Therapy With A Balanced Gelatine Solution vs A Balanced Electrolyte Solution In Patients With Severe Sepsis|Recruiting||Phase 4|608|Anticipated|B. Braun Melsungen AG||2|||f||||t||||||||||2017-10-10 22:22:33.462171|2017-10-10 22:22:33.462171
NCT02715453|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|FRAMIP||Intervention in Frailty Versus Usual Care in Frail Patients After an Acute Myocardial Infarction|Randomized Comparison Between a Strategy of Intervention in Frailty Versus the Usual Care in Frail Patients After an Acute Myocardial Infarction|Recruiting||Phase 4|200|Anticipated|University of Valencia||2|||f||||f||||||||Undecided||2017-10-10 22:22:35.397333|2017-10-10 22:22:35.397333
NCT02715440|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-16|||February 2012||2012-02-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|BenzoFree||Stopping Benzodiazepines and Related Molecules Among Elderly Living in Residential Institutions|Stopping Benzodiazepines and Related Molecules Among Elderly Living in Residential Institutions: Feasibility and Impact on Sleep and Behavior|Completed||N/A|116|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:22:35.487793|2017-10-10 22:22:35.487793
NCT02715414|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-21|||June 2015||2015-06-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Family Groups for Urban Youth With Disruptive Behavior|Family Groups for Urban Youth With Disruptive Behavior|Recruiting||N/A|2956|Anticipated|NYU Silver School of Social Work||3|||f||||f||||||||Yes|All data collected in this project will be made available to the scientific community for educational, research, and non-profit purposes, and will meet the standards established by NIH and rigorous human subjects protection. Investigators in this proposal will adhere to NIH policy on data sharing as described in http://grants2.nih.gov/grants/policy/data_sharing/data_sharing_guidance.htm. Data request forms and procedures and policies for data sharing have been developed following these guidelines.|2017-10-10 22:22:35.661368|2017-10-10 22:22:35.661368
NCT02715401|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-03-21|||October 2015||2015-10-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers|A Randomized, Open-Label, Crossover, Single-Dose Study to Compare Pharmacokinetic Properties and Safety After Administration of HCP1303 Capsule and Co-administration of HGP1201 Tablet, HIP1402 Capsule Under Fed Condition in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 22:22:35.759825|2017-10-10 22:22:35.759825
NCT02715388|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-02-20|||January 2016||2016-01-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Proof of Concept - Digital Electro-optical Surgical Platform as Replacement for Operational Microscopes||Recruiting||N/A|5|Anticipated|Elbit Systems LTD||1|||f||||f||||||||No||2017-10-10 22:22:35.839003|2017-10-10 22:22:35.839003
NCT02715375|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-04-27|||March 2016||2016-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|CREON2000A||Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma|A Double Blind, Randomized, Sham Controlled Trial to Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma|Recruiting||N/A|228|Anticipated|General Innovations and Goods, Inc.||2|||f||||t||||||||||2017-10-10 22:22:35.935359|2017-10-10 22:22:35.935359
NCT02715362|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|July 2018|Anticipated|2018-07-01||Interventional|GPC3-CART||A Study of GPC3 Redirected Autologous T Cells for Advanced HCC|An Open-label, Uncontrolled, Single-arm Pilot Study to Evaluate Vascular Interventional Therapy Mediated GPC3-targeted Chimeric Antigen Receptor T Cells in Advanced Hepatocellular Carcinoma|Recruiting||Phase 1/Phase 2|30|Anticipated|Shanghai GeneChem Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:22:36.085973|2017-10-10 22:22:36.085973
NCT02715349|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-16|||September 2014||2014-09-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Psychoeducation for Vietnamese Families With a Patient With Schizophrenia|Psychoeducation for Vietnamese Families With a Patient With Schizophrenia|Completed||N/A|59|Actual|Danang Psychiatric Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:22:36.288542|2017-10-10 22:22:36.288542
NCT02715336|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-09-15|||October 2015||2015-10-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Efficacy and Safety of Medication Used to Stimulate Ovulation|A Randomized Controlled Trial of Pre-retrieval Triggering Methods in in Vitro Fertilization Patients Classified as Low, Normal or High Responder|Recruiting||Phase 4|666|Anticipated|Create Fertility Center||6|||f||||f||||||||||2017-10-10 22:22:36.40545|2017-10-10 22:22:36.40545
NCT02715323|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-05-08|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome|Exploring Immune Cell Signatures in Autoimmunity and Ocular Surface Stress|Recruiting||N/A|160|Anticipated|Singapore National Eye Centre|||1||f||||f||||||||No||2017-10-10 22:22:36.586996|2017-10-10 22:22:36.586996
NCT02715310|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-22|||March 2016||2016-03-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|HMHN||Haemodynamic Monitoring in Head and Neck Cancer Patients||Recruiting||N/A|50|Anticipated|Technische Universität München|||1||f||||f||||||Samples Without DNA|"     Blood parameters   "|||2017-10-10 22:22:36.690792|2017-10-10 22:22:36.690792
NCT02715297|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-16|||February 2016||2016-02-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|GlioCave/NOA17||Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma|Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma|Recruiting||Phase 2|162|Anticipated|Technische Universität München||2|||f||||t||||||||No||2017-10-10 22:22:36.7637|2017-10-10 22:22:36.7637
NCT02715284|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-07-13|||March 2016||2016-03-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|February 2020|Anticipated|2020-02-01||Interventional|GARNET||A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors|A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors|Recruiting||Phase 1|435|Anticipated|Tesaro, Inc.||1|||f||||t||||||||||2017-10-10 22:22:36.876724|2017-10-10 22:22:36.876724
NCT02715271|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-08-29|||April 2016||2016-04-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01|15 Days|Observational [Patient Registry]|SH-TBL||Study of TB Lesions Obtained in Therapeutical Surgery|Study of TB Lesions Obtained in Surgery: in Search of Best Biomarkers Correlating With TB Pathology, Clinical Features, MDR Cases and Prognostic|Enrolling by invitation||N/A|163|Actual|Fundació Institut Germans Trias i Pujol|||2||f||||t||||||Samples With DNA|"     For the prospective substudy only:      The following samples will be prospectively collected from patients undergoing therapeutical     surgery:        -  Tissue samples from the TB lesions        -  plasma        -  whole blood for RNA studies        -  urine   "|||2017-10-10 22:22:36.986556|2017-10-10 22:22:36.986556
NCT02715258|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-06-26||2017-06-13|March 2016||2016-03-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control|Completed||Phase 3|210|Actual|Theracos||2|||f||||t||||||||No||2017-10-10 22:22:37.075148|2017-10-10 22:22:37.075148
NCT02715245|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-03-16|||January 2013||2013-01-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Multiple Chronic Diseases: the RITH Trial|A Home-based Rehabilitation Program in Multiple Chronic Diseases: the RITH Trial|Active, not recruiting||N/A|300|Actual|Universidad de Almeria||2|||f||||t||||||||Yes|According to current legislation ( RD 1090/2015 , Decree 439/210 ) and Law 14/2007 on Biomedical and Health Sciences Research, which regulates the process of clinical trials / observational studies, is the responsibility of the investigator to report regularly to the Committee on Ethics in Research Almeria ( Almería CEI ) the progress of the clinical trial / observational study.|2017-10-10 22:22:37.233836|2017-10-10 22:22:37.233836
NCT02715232|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-12|||February 6, 2017|Actual|2017-02-06|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Effects of Sex Steroids on the Serotonin System|Effects of Sex Steroid Hormones on Serotonin Synthesis and Degradation Measured With PET|Recruiting||Phase 4|92|Anticipated|Medical University of Vienna||4|||f||||f|f|f||||||Yes||2017-10-10 22:22:37.320955|2017-10-10 22:22:37.320955
NCT02715219|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-01-30|||June 2015|Actual|2015-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||The Effect of an AEP on Patient's Knowledge Regarding Asthma Disease and Inhaler Technique: RCT|The Effect of an Asthma Education Programme on Patient's Knowledge Regarding Asthma Disease and Inhaler Technique: Randomized Control Trial|Completed||N/A|280|Actual|Clinical Research Centre, Malaysia||2|||f||||t||||||||Yes||2017-10-10 22:22:37.978991|2017-10-10 22:22:37.978991
NCT02715206|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-18|||July 2006||2006-07-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|kiR||Adaptation Processes in School-based Substance Abuse Prevention|Adaptation Processes in School-based Substance Abuse Prevention|Completed||N/A|2827|Actual|Penn State University||3|||f||||t||||||||Undecided||2017-10-10 22:22:38.05147|2017-10-10 22:22:38.05147
NCT02715193|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-02-06|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus|A Randomized, Placebo-controlled, Double-blind, In-patient Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 Following a Single Dose in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|21|Actual|REMD Biotherapeutics, Inc.||2|||f||||t||||||||||2017-10-10 22:22:38.147069|2017-10-10 22:22:38.147069
NCT02715180|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-21|||August 2015||2015-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Optimum Hand Position During Cardiopulmonary Resuscitation|Optimum Hand Position During Cardiopulmonary Resuscitation: Comparing Expiration and Inspiration View of the Scout Film of the Low Dose Chest Computed Tomography|Completed||N/A|127|Actual|Seoul National University Bundang Hospital||1|||f||||f||||||||No||2017-10-10 22:22:38.239399|2017-10-10 22:22:38.239399
NCT02715167|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|April 2016|Anticipated|2016-04-01||Interventional|FeNOTX||Predictive Factors in Response to Inhaled Corticoids in Chronic Cough||Not yet recruiting||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 22:22:38.299298|2017-10-10 22:22:38.299298
NCT02715154|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-03-24|||June 2015||2015-06-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Dexmedetomidine for Cesarean Section|Effect and Placental Transfer of Dexmedetomidine During Caesarean Section Under Epidural Anaesthesia|Completed||Phase 1|40|Actual|The First Affiliated Hospital with Nanjing Medical University||2|||f||||f|f|f||||||Yes||2017-10-10 22:22:38.368191|2017-10-10 22:22:38.368191
NCT02715141|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-06-17|||October 2015||2015-10-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|MOCCAS||Molecular Stool Testing for Colorectal Cancer Surveillance|Molecular Stool Testing for Colorectal Cancer Surveillance|Recruiting||N/A|4000|Anticipated|The Netherlands Cancer Institute|||1||f||||f||||||Samples With DNA|"     Stool samples will be collected. The stool samples will be used to test for the presence of     molecular stool markers.   "|No||2017-10-10 22:22:38.456546|2017-10-10 22:22:38.456546
NCT02715128|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal Cortex|Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal Cortex: fMRI Study in Major Depression|Not yet recruiting||N/A|30|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||||||||||||2017-10-10 22:22:38.64643|2017-10-10 22:22:38.64643
NCT02715115|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2017-02-07|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Safety Study of NNZ-2566 in Pediatric Rett Syndrome|A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome|Completed||Phase 2|82|Actual|Neuren Pharmaceuticals Limited||2|||f||||t||||||||||2017-10-10 22:22:38.746823|2017-10-10 22:22:38.746823
NCT02715102|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-08-16|||June 2016||2016-06-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Circulating Tumor DNA in Patients at High Risk for Lung Cancer|Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for Detection of Lung Cancer in Patients Undergoing Diagnostic or Therapeutic Bronchoscopy or Thoracotomy|Terminated||N/A|39|Actual|Pathway Genomics|||1|Patient accrual was slow due to exclusion of patients with prior cancers|f||||f||||||Samples With DNA|"     DNA will be extracted and run in the ctDNA assay. Patients will be asked to either consent or     not to consent to having their DNA extracted from the original specimen and their clinical     information kept for optional anonymized medical research in the future.   "|||2017-10-10 22:22:38.905255|2017-10-10 22:22:38.905255
NCT02715089|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-16|||December 2015||2015-12-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|PTHBC||Precise Treatment in Hepatobiliary Cancers (PTHBC)|Single Center, Single Arm, Open Study, to Explore and Evaluate the Precise Treatment in Hepatobiliary Cancers(PTHBC)|Recruiting||N/A|30|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||Samples With DNA|"     The samples, both tissue(s) and blood of patients should be provided for the next-generation     sequencing (NGS) test before screening.   "|Undecided|The data have the gene mutations information of patients.|2017-10-10 22:22:38.998702|2017-10-10 22:22:38.998702
NCT02715076|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-21|||January 2016||2016-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Ambient Temperature and Forced-air Warming on Intraoperative Core Temperature|The Effects of Ambient Temperature and Forced-air Warming on Intraoperative Core Temperature|Recruiting||N/A|394|Anticipated|Peking Union Medical College Hospital||6|||f||||f||||||||No||2017-10-10 22:22:39.114555|2017-10-10 22:22:39.114555
NCT02715063|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Cardiometabolic HIIT-RT Study|High Intensity Interval- vs Resistance or Combined- Training for Improving Cardiometabolic Health in Overweight Adults (Cardiometabolic HIIT-RT Study): Study Protocol for a Factorial Randomised Controlled Trial|Recruiting||N/A|60|Anticipated|Universidad Santo Tomas||4|||f||||t||||||||No||2017-10-10 22:22:39.24794|2017-10-10 22:22:39.24794
NCT02715050|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-10-18|||March 2016||2016-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Phototherapy Applied in Association With Muscular Training|Phototherapy Applied in Association With Muscular Training: Evaluation of Different Moments of Applications|Completed||N/A|48|Actual|University of Nove de Julho||4|||f||||t||||||||||2017-10-10 22:22:39.434664|2017-10-10 22:22:39.434664
NCT02715037|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-21|||June 2016||2016-06-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|May 2019|Anticipated|2019-05-01||Observational|||Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis|Mikrobiologi Ved svær Akut Tonsillit, peritonsillær Phlegmone og infektiøs Mononukleose|Not yet recruiting||N/A|350|Anticipated|Aarhus University Hospital|||4||f||||f||||||Samples With DNA|"     Throat swabs Blood samples   "|No||2017-10-10 22:22:39.577495|2017-10-10 22:22:39.577495
NCT02715024|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-17|2016-03-17|||September 2007||2007-09-01|March 2016|2016-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms|An Open-label, Randomized, Parallel Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms|Completed||Phase 4|52|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 22:22:39.717046|2017-10-10 22:22:39.717046
NCT02715011|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-28|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|October 29, 2020|Anticipated|2020-10-29|November 1, 2017|Anticipated|2017-11-01||Interventional|||Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML)|A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Subjects With Relapsed or Refractory AML|Recruiting||Phase 1|60|Anticipated|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 22:22:39.834877|2017-10-10 22:22:39.834877
NCT02714998|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-16|||January 2013||2013-01-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy|The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy|Completed||N/A|131|Actual|Ege University||3|||f||||t||||||||Undecided|The investigators have not decided to share patient data yet. However, it is possible if approved by ethical committee.|2017-10-10 22:22:39.966244|2017-10-10 22:22:39.966244
NCT02714985|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-18|||March 2016||2016-03-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01|12 Weeks|Observational [Patient Registry]|CHIK_urine||RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection|RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection|Suspended||N/A|20|Anticipated|Institute of Tropical Medicine, Belgium|||1||f||||t||||||Samples Without DNA|"     serum, urine   "|||2017-10-10 22:22:40.075228|2017-10-10 22:22:40.075228
NCT02714972|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-05-09|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|PHM3||Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents|Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents (PHM3)|Completed||Phase 2|35|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-10 22:22:40.217529|2017-10-10 22:22:40.217529
NCT02714959|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-23|||March 2016||2016-03-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IL-2 in Refractory Autoimmune Encephalitis|Effect of IL-2 in Refractory Autoimmune Encephalitis Patients: A Pilot Study|Not yet recruiting||Phase 1/Phase 2|10|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 22:22:40.333087|2017-10-10 22:22:40.333087
NCT02714946|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-03-16|||January 2016||2016-01-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|LARA||Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules|Prospective Randomized Comparative Study of the Effectiveness and Safety of Ultrasound-guided Laser and Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules|Recruiting||N/A|60|Anticipated|Campus Bio-Medico University||2|||f||||f||||||||No||2017-10-10 22:22:40.436214|2017-10-10 22:22:40.436214
NCT02714933|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-06-30|||September 2016||2016-09-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|ImagINI-CHEST||Thoracic MRI Imaging in Children|Thoracic Imaging in Children With Neither Irradiation Nor Injection, by a New MRI Protocol Including Advanced Zero Time Echo (ZTE)|Not yet recruiting||N/A|75|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 22:22:40.538472|2017-10-10 22:22:40.538472
NCT02714920|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-04|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|CHEMRAD||DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD)|DNA Repair Enzyme Signature Associated With Response to Chemo- and Radio-therapy in Head and Neck Cancer: ChemRadAssay|Recruiting||N/A|120|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:22:40.629455|2017-10-10 22:22:40.629455
NCT02714907|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-07-18|||February 2016||2016-02-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Clinical Data Validation of Novel Wireless Cortrium C3 Monitor for Continuous Electrocardiogram Measurements|Clinical Data Validation of Novel Wireless Cortrium C3 Monitor for Continuous Electrocardiogram Measurements|Completed||N/A|158|Actual|Cortrium||2|||f||||t||||||||||2017-10-10 22:22:40.71736|2017-10-10 22:22:40.71736
NCT02714894|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Observational|||Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study|Glutamatergic System and Response to Clozapine in Patients With Treatment-Resistant Schizophrenia: a Prospective Proton Magnetic Resonance Spectroscopy Study|Recruiting||N/A|108|Anticipated|Centre for Addiction and Mental Health|||3||f||||f||||||Samples With DNA|"     Blood sample   "|||2017-10-10 22:22:40.811571|2017-10-10 22:22:40.811571
NCT02714881|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-03-15|||April 2016||2016-04-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|April 2020|Anticipated|2020-04-01||Interventional|||Lipids, Inflammation, and CV Risk in RA|Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid Arthritis|Recruiting||N/A|75|Anticipated|Brigham and Women's Hospital||1|||f||||||||||||||2017-10-10 22:22:40.895979|2017-10-10 22:22:40.895979
NCT02714855|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-17|||October 2015||2015-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France|Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France - Cross-sectional Study|Completed||N/A|2081|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:22:41.054438|2017-10-10 22:22:41.054438
NCT02714842|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-09-27|||March 2016||2016-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Delayed Release Diclofenac Sodium Formulation vs Voltaren®|A Pharmacoscintigraphic Clinical Study to Investigate the in Vivo Behaviour of a Novel Delayed-release Formulation of Diclofenac in Comparison to the Voltaren® Enteric Coated Tablet Commercial Formulation in Healthy Volunteers|Completed||Phase 1|36|Actual|Bio-Images Research Ltd||4|||f||||f||||||||No||2017-10-10 22:22:41.139434|2017-10-10 22:22:41.139434
NCT02714829|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-21|||March 2016||2016-03-01|March 2016|2016-03-01||||July 2017|Anticipated|2017-07-01||Interventional|||Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2||Enrolling by invitation||Phase 3|88|Anticipated|BioAlpha Inc.||2|||f||||f||||||||No||2017-10-10 22:22:41.226048|2017-10-10 22:22:41.226048
NCT02714816|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-08-16|||April 2016||2016-04-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||Natural History Study of Patients With Leber Congenital Amaurosis Associated With Mutations in RPE65|Natural History Study of Patients With Leber Congenital Amaurosis Associated With Mutations in RPE65|Recruiting||N/A|40|Anticipated|MeiraGTx UK II Ltd|||1||f||||f||||||||||2017-10-10 22:22:41.284346|2017-10-10 22:22:41.284346
NCT02714803|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-03-16|||March 2015||2015-03-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Comparison of Different Massage Techniques Plus Conservative Applications in Low Back Pain|Assistant Professor|Completed||Phase 2|61|Actual|Ataturk Training and Research Hospital||3|||f||||||||||||||2017-10-10 22:22:41.477348|2017-10-10 22:22:41.477348
NCT02714790|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-22|||May 2015||2015-05-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|LAM-MMR||Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia|Ruolo Prognostico Della Malattia Minima Residua Nella Leucemia Mieloide Acuta|Completed||N/A|281|Actual|Azienda Ospedaliera Città della Salute e della Scienza di Torino|||1||f||||f||||||||Yes|paper publication|2017-10-10 22:22:41.576188|2017-10-10 22:22:41.576188
NCT02714777|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-03-20|||June 2016|Actual|2016-06-01|May 2016|2016-05-01|March 2017|Actual|2017-03-01|November 2016|Actual|2016-11-01||Observational|ANESPEDIA||General Anesthesia and Autonomic Nervous System in Children|General Anesthesia and Autonomic Nervous System in Children|Completed||N/A|45|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 22:22:41.660218|2017-10-10 22:22:41.660218
NCT02714764|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-09-20|||January 2016||2016-01-01|September 2017|2017-09-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|||Natural History and Outcome Measures in Alexander Disease|Natural History and Outcome Measures in Alexander Disease|Recruiting||N/A|100|Anticipated|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-10-10 22:22:41.738221|2017-10-10 22:22:41.738221
NCT02714751|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-19|||March 2016||2016-03-01|March 2016|2016-03-01||||February 2017|Anticipated|2017-02-01||Interventional|||Evaluation of an Informative Intervention to the ICU Team About the Presence of Asynchronies in Mechanically Ventilated Patients: Effect Over Incidence Reduction||Recruiting||N/A|166|Anticipated|Corporacion Parc Tauli||2|||f||||||||||||||2017-10-10 22:22:41.821159|2017-10-10 22:22:41.821159
NCT02714738|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-19|||March 2016||2016-03-01|August 2017|2017-08-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Infraclavicular Block: Decreased Incidence of Tourniquet Pain, Compared to Axillary Brachial Plexus Block?|The Ultrasound Guided Infraclavicular Block: Decreased Incidence of Tourniquet Pain, Compared to Axillary Brachial Plexus Block?|Completed||N/A|82|Actual|Cork University Hospital||2|||f||||f||||||||||2017-10-10 22:22:41.916743|2017-10-10 22:22:41.916743
NCT02714725|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-09-18|||January 2016||2016-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect Of Dexmedetomidine On Sublingual Microcirculation In Patients Undergoing On Pump CABG Surgery|Effect Of Dexmedetomidine Infusion On Sublingual Microcirculation In Patients Undergoing On Pump Coronary Artery Bypass Graft Surgery|Recruiting||Phase 4|70|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 22:22:42.008411|2017-10-10 22:22:42.008411
NCT02714556|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-30|||May 2016||2016-05-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|VIRCA||Changes in Ventilation Inhomogeneity and Respiratory Function Following Elective Caesarean Section Under Regional Anaesthesia|Changes in Ventilation Inhomogeneity and Respiratory Function Following Elective Caesarean Section Under Regional Anaesthesia: a Prospective Observational Study|Withdrawn||N/A|0|Actual|University Hospital, Geneva|||1|"Ethical approval not obtained yet as questioning the danger of providing 100% oxygen to   parturients."|f||||f||||||||No||2017-10-10 22:22:43.75498|2017-10-10 22:22:43.75498
NCT02714712|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-07-12|||August 2015||2015-08-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||SR-BI and Antiviral Treatment Response in HCV|Influence of Scavenger Receptor Class B Type I (SR-BI) Gene Polymorphisms on Antiviral Treatment Response, and Metabolism in Chronic Hepatitis C Patients|Completed||N/A|309|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||2||f||||f||||||Samples With DNA|"     All enrolled subjects were genotyped for the SNPs of the SCARB1 gene and IL28B gene. All     their blood specimens were collected into EDTA tubes. Human genomic DNA was extracted by     standard protocols with blood RBC lysis, cell lysis, DNA binding, wash and elution. Extracted     DNA normalized to 50 ng/µl was obtained. DNA quality was assessed by calculating the     absorbance ratio OD260 nm/280 nm using NanoDrop model ND-1000 (Thermo Scientific, Wilmington,     DE, USA). The SNP was genotyped by using the ABI TaqMan allelic discrimination kit and the     ABI7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA)   "|||2017-10-10 22:22:42.144412|2017-10-10 22:22:42.144412
NCT02714699|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-13|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Interventional|||Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy|Randomized Clinical Trial of Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium in Reducing Pain During Office Hysteroscopy|Completed||Phase 2/Phase 3|129|Actual|Assiut University||3|||f||||t||||||||||2017-10-10 22:22:42.218694|2017-10-10 22:22:42.218694
NCT02714686|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-08-31|||April 2016||2016-04-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Evaluation of a Mass Media Family Planning Campaign on the Uptake of Contraceptive Methods in Burkina Faso|Evaluation of a Mass Media Family Planning Campaign on the Uptake of Contraceptive Methods in Burkina Faso|Active, not recruiting||N/A|7515|Actual|Abdul Latif Jameel Poverty Action Lab||2|||f||||t||||||||Yes|After completion of the evaluation and publication of the study, anticipated in 2021, a de-identified version of the database will be made available to a broader audience for further academic or policy oriented studies. The datasets will contain all information collected from the surveys at baseline and endline, except for personal identifiers which will be removed to protect the identity of participants.|2017-10-10 22:22:42.311686|2017-10-10 22:22:42.311686
NCT02714673|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-07-03|||June 1, 2016||2016-06-01|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|October 1, 2018|Anticipated|2018-10-01||Observational|ADELC||Management of Patients on Long Term Anticoagulation Therapy Undergoing a Primary Total Hip of Knee Replacement|Management of Patients on Long Term Anticoagulation Therapy Undergoing a Primary Total Hip of Knee Replacement|Recruiting||N/A|600|Anticipated|Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique|||2||f||||f||||||||||2017-10-10 22:22:42.424881|2017-10-10 22:22:42.424881
NCT02714647|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-06-21|||March 2016||2016-03-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|May 26, 2017|Actual|2017-05-26||Interventional|||The Role of an Attention Demanding Activity for Priming Motor Learning|The Role of an Attention Demanding Activity for Priming Motor Learning|Completed||N/A|30|Actual|University of Utah||2|||f||||f||||||||||2017-10-10 22:22:42.583393|2017-10-10 22:22:42.583393
NCT02714634|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-03-15|||March 2016||2016-03-01|March 2016|2016-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|BIO 3||Clinical Trial Evaluating Methotrexate + Biologic Versus Methotrexate, Salazopyrine and Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate|Randomized Controlled Clinical Trial Evaluating Methotrexate + Biologic Versus Methotrexate, Salazopyrine and Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate|Not yet recruiting||Phase 4|286|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 22:22:42.685105|2017-10-10 22:22:42.685105
NCT02714621|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-01-11|||May 2016||2016-05-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|HIFU-Gynae||MR-HIFU for Recurrent Gynaecological Cancer|Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU): A Feasibility Study for Treating Recurrent Gynaecological Malignancies|Recruiting||N/A|35|Anticipated|Institute of Cancer Research, United Kingdom||2|||f||||||||||||||2017-10-10 22:22:42.783223|2017-10-10 22:22:42.783223
NCT02714608|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-03-19|||May 2016||2016-05-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)|A PhaseⅡa, Placebo Parallel Control, Central Randomized, Double Blind, Dosage Exploring and Multi-Center Study to Evaluate the Efficacy and Safety of Ginsenoside H Dripping Pills in Patients With Advanced NSCLC (Syndrome Of Qi-Deficiency)|Recruiting||Phase 2|144|Anticipated|Tasly Pharmaceuticals, Inc.||3|||f||||t||||||||No||2017-10-10 22:22:42.889061|2017-10-10 22:22:42.889061
NCT02714595|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-08|||March 1, 2016||2016-03-01|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|December 1, 2017|Anticipated|2017-12-01||Interventional|CREDIBLE - CR||Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens|A Multicenter, Randomized, Open-label Clinical Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens|Recruiting||Phase 3|150|Anticipated|Shionogi Inc.||2|||f||||f||||||||||2017-10-10 22:22:43.070162|2017-10-10 22:22:43.070162
NCT02714582|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-10-26|||March 2016||2016-03-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility, Appropriateness, Meaningfulness and Effectiveness of Bedside Shift Reporting|Patient Participation at the Bedside: Feasibility, Appropriateness, Meaningfulness and Effectiveness of Bedside Shift Reporting. A Matched Controlled Trial|Active, not recruiting||N/A|750|Actual|University Hospital, Ghent||2|||f||||f||||||||No||2017-10-10 22:22:43.510988|2017-10-10 22:22:43.510988
NCT02714569|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-03-10|||March 2016||2016-03-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia|A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Oral Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY3202328|Completed||Phase 1|58|Anticipated|Eli Lilly and Company||4|||f||||f||||||||No||2017-10-10 22:22:43.643239|2017-10-10 22:22:43.643239
NCT02714504|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-18|||August 2008||2008-08-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Fusarproph||Anti-mold Azole in the Prophylaxis for Invasive Fusariosis|Evaluation of the Efficacy of Anti-mold Azole Prophylaxis in High-risk Hematologic Patients With Baseline Superficial Skin Lesions Positive for Fusarium Spp|Completed||N/A|239|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||No||2017-10-10 22:22:44.121645|2017-10-10 22:22:44.121645
NCT02714491|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-09-29|||June 2015||2015-06-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|||Effects of Auditory Stimulation During Verticalization With Erigo in Patients With Disorder of Consciousness||Recruiting||N/A|15|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini||3|||f||||||||||||||2017-10-10 22:22:44.189357|2017-10-10 22:22:44.189357
NCT02714478|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-09-29|||April 2015||2015-04-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Interventional|||"Equistasi and Gait in Hemiparesis"|"Efficacy of Equistasi on the Gait of Patients Affected by Hemiparesis Due to Cerebrovascular Accident"|Recruiting||Phase 4|50|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini||2|||f||||||||||||||2017-10-10 22:22:44.291215|2017-10-10 22:22:44.291215
NCT02714465|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-03-31|||March 2016||2016-03-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|GKSHBO||Adverse Radiation Effects After Gamma Knife Radio Surgery and Hyperbaric Oxygen Therapy|Treatment of Adverse Radiation Effects After Gamma Knife Radiosurgery (GKS) by Hyperbaric Oxygen Therapy (HBO)|Recruiting||Phase 2|65|Anticipated|Niguarda Hospital||1|||f||||f||||||||||2017-10-10 22:22:44.510786|2017-10-10 22:22:44.510786
NCT02714452|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-06-15|||March 2016||2016-03-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Person-centred and Thriving Promoting Care Model for Residential Aged Care|A Person-centred and Thriving Promoting Care Model for Residential Aged Care|Active, not recruiting||Phase 2/Phase 3|865|Actual|Umeå University||2|||f||||f||||||||No||2017-10-10 22:22:44.609038|2017-10-10 22:22:44.609038
NCT02714439|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-05-17|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley|Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley|Recruiting||Early Phase 1|150|Anticipated|The University of Texas Medical Branch, Galveston||1|||f||||f|t|f|||f|||No||2017-10-10 22:22:44.70247|2017-10-10 22:22:44.70247
NCT02714426|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|MACS||A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults|A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults (The MACS Study: Mindfulness and Attentional Control in Seniors)|Recruiting||N/A|40|Anticipated|University of Florida||2|||f||||f||||||||Yes|De-identified data will be shared upon request by the study principal investigator. Data to be released will include the variables and participants included in any specific published manuscript, and will be eligible for release twelve months after the date of publication or e-publication in final form.|2017-10-10 22:22:44.83632|2017-10-10 22:22:44.83632
NCT02714413|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-07-07|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|March 10, 2017|Actual|2017-03-10||Interventional|||Effect of D-allulose in Addition to Oral Sucrose Load|Effect of D-allulose Ingestion on the Glucose and Insulin Response to a Standardized Oral Sucrose Load|Completed||Phase 2|50|Actual|University of Florida||5|||f||||f|f|f||||||||2017-10-10 22:22:44.981956|2017-10-10 22:22:44.981956
NCT02714400|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-02-16|||March 2016||2016-03-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea|The Impact of Venlafaxine on Apnea Hypopnea Index in Patients With Obstructive Sleep Apnea|Active, not recruiting||Phase 4|20|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 22:22:45.103633|2017-10-10 22:22:45.103633
NCT02714387|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-14|||February 2013||2013-02-01|September 2017|2017-09-01|January 2050|Anticipated|2050-01-01|January 2050|Anticipated|2050-01-01||Observational|ATLANREA||Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study|Prospective Cohort of Patients Hospitalized in West French Intensive Care Units.|Recruiting||N/A|3000|Anticipated|Nantes University Hospital|||1||f||||f||||||Samples Without DNA|"     Plasma, serum, peripheral blood mononuclear cells, RNA   "|||2017-10-10 22:22:45.213115|2017-10-10 22:22:45.213115
NCT02714374|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-06-26|||March 2016||2016-03-01|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Safety and Effect of GL-ONC1 Administered IV Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery|An Open Label, Non-randomized Phase 1b Study to Investigate the Safety and Effect of the Oncolytic Virus GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery for Curative-Intent or Palliative Resection|Active, not recruiting||Phase 1|36|Anticipated|University of California, San Diego||1|||f||||t||||||||No||2017-10-10 22:22:45.343803|2017-10-10 22:22:45.343803
NCT02714361|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-10-25|||September 2015||2015-09-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women|A Double Blind Randomised Controlled Trial to Investigate the Effect of Vitamin D3 Supplementation on Iron Absorption and Hepcidin Response in Marginally Deficient and Iron Deficient Women|Active, not recruiting||N/A|50|Actual|University of Chester||2|||f||||f||||||||Yes|The results are in the writing phase, and will be available in thesis form and possibly publication. It will be available in thesis form in 2017 and publication expected to be in 2018.|2017-10-10 22:22:45.433595|2017-10-10 22:22:45.433595
NCT02714348|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-18|||February 2014||2014-02-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Impact of Helminth Infections During Pregnancy on Humoral Vaccine Immunogenicity in Infants|Impact of Helminth Infections During Pregnancy on Humoral Vaccine Immunogenicity in Infants|Active, not recruiting||N/A|323|Anticipated|Centre de Recherche Médicale de Lambaréné|||1||f||||||||||||Yes|Publication|2017-10-10 22:22:45.539597|2017-10-10 22:22:45.539597
NCT02714335|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-21|||December 2010||2010-12-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients|An Observational Study to Determine the Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients in Taiwan|Completed||N/A|200|Actual|National Taiwan University|||1||f||||f||||||||Yes|• Type of publication e.g. poster, abstract, oral presentation etc. Poster and original article|2017-10-10 22:22:45.612918|2017-10-10 22:22:45.612918
NCT02714322|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-05-02|||June 2015||2015-06-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|May 2016|Actual|2016-05-01||Interventional|||MYL-1401A Efficacy and Safety Comparability Study to Humira®|Multicenter, Double-Blind, Randomized, 2-Arm, Parallel-Group, Equivalence Study Evaluating Efficacy and Safety Similarity of Mylan Adalimumab (MYL-1401A) Compared With Humira® in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis|Completed||Phase 3|294|Actual|Mylan Inc.||2|||f||||f|f|f|||f|||No||2017-10-10 22:22:45.676749|2017-10-10 22:22:45.676749
NCT02714309|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-07-04|||March 2016||2016-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Metabolic and Appetite Responses to a Whey Protein Preload Following Prior Exercise in Overweight Males|Acute Metabolic and Second Meal Appetite Responses to a Whey Protein Preload Following Prior Moderate Intensity Exercise in Overweight and Obese Males|Completed||N/A|12|Actual|Northumbria University||3|||f||||f||||||||No||2017-10-10 22:22:45.829888|2017-10-10 22:22:45.829888
NCT02714296|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-04-11|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Evaluating the Effectiveness of Colon Preparation for Endoscopy Using Specialized Clinical Nutrition|Phase IV Prospective Sinle Center Randomised Three-arm Controlled Study Evaluating the Effectiveness of Colon Preparation for Endoscopy Using Specialized Clinical Nutrition|Completed||Phase 4|150|Actual|Nutricia Advanced||3|||f||||f||||||||||2017-10-10 22:22:45.935545|2017-10-10 22:22:45.935545
NCT02714283|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-19|||January 2016||2016-01-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|August 1, 2018|Anticipated|2018-08-01||Observational|||Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis|Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis|Active, not recruiting||N/A|55000|Anticipated|Oregon Health and Science University|||1||f||||f||||||||||2017-10-10 22:22:46.029758|2017-10-10 22:22:46.029758
NCT02714270|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-07-31|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Paperless Partograph for Management of Low Risk Labor|A Randomized Clinical Trial of Paperless Versus Modified World Health Organization Partograph in Management of First Stage of Labour|Completed||N/A|370|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 22:22:46.133714|2017-10-10 22:22:46.133714
NCT02714257|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-05-08|||September 2016||2016-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|WISE||Working to Increase Stability Through Exercise|Integrating Patient-Centered Exercise Coaching Into Primary Care to Reduce Fragility Fracture|Recruiting||N/A|2100|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||No||2017-10-10 22:22:46.221868|2017-10-10 22:22:46.221868
NCT02714244|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-09-06|||January 2016||2016-01-01|December 2016|2016-12-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Evaluation of the E/e' Ratio of the Mitral Annulus in Predicting Fluid Responsiveness.|Evaluation of the E/e' Ratio of the Mitral Annulus Measured by Transesophageal Echocardiography in Predicting Fluid Responsiveness.|Completed||N/A|70|Anticipated|Montreal Heart Institute||1|||f||||f||||||||||2017-10-10 22:22:46.409126|2017-10-10 22:22:46.409126
NCT02714231|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-07-15|||March 2016||2016-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion|A Randomized Controlled Trial of 2 Different Methods for Pain Relief During Intrauterine Device Insertion|Completed||Phase 4|100|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 22:22:46.483903|2017-10-10 22:22:46.483903
NCT02714218|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-08-03|||March 24, 2016|Actual|2016-03-24|August 2017|2017-08-01|April 15, 2022|Anticipated|2022-04-15|April 20, 2017|Actual|2017-04-20||Interventional|||A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma|Phase IIIb/IV, Randomized, Double Blinded, Study of Nivolumab 3 mg/kg in Combination With Ipilimumab 1 mg/kg vs Nivolumab 1 mg/kg in Combination With Ipilimumab 3 mg/kg in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma|Active, not recruiting||Phase 3|483|Actual|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 22:22:46.571383|2017-10-10 22:22:46.571383
NCT02714205|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-04-24|||April 24, 2017|Actual|2017-04-24|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|FRAN||Flushing Reduction Associated With Nitrates|Flushing Reduction Associated With Nitrates|Recruiting||Phase 2|140|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||No||2017-10-10 22:22:46.782649|2017-10-10 22:22:46.782649
NCT02714192|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-18|||March 2013||2013-03-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety Study for Adolescents With Concussion|Evaluation of the Safety of Exercise Testing With Acutely Concussed Adolescent Athletes|Completed||N/A|54|Actual|University at Buffalo||2|||f||||f||||||||No||2017-10-10 22:22:46.886499|2017-10-10 22:22:46.886499
NCT02714179|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-16|||May 2015||2015-05-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Preemptive and Preventive Use of Paracetamol for Pain Relief After Cesarean Section|A Double Blind Randomised Controlled Trial of Preemptive and Preventive Use of Paracetamol for Pain Relief After Cesarean Section|Completed||Phase 4|54|Actual|Baskent University||2|||f||||t||||||||||2017-10-10 22:22:46.960225|2017-10-10 22:22:46.960225
NCT02714166|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-03-29|||February 26, 2016|Actual|2016-02-26|March 2017|2017-03-01|February 26, 2016|Actual|2016-02-26|February 26, 2016|Actual|2016-02-26||Interventional|||Evaluation of the Irritation Potential of Products in Human Eyes|Evaluation of the Irritation Potential of Products in Human Eyes|Completed||N/A|24|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:22:47.025479|2017-10-10 22:22:47.025479
NCT02714153|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-10-14|||April 2016||2016-04-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Bridge Occlusion Balloon in Lead Extraction Procedure|Bridge Occlusion Balloon Initial Use in Humans Study|Recruiting||N/A|25|Anticipated|Yale University||1|||f||||t||||||||No||2017-10-10 22:22:47.121254|2017-10-10 22:22:47.121254
NCT02714140|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-09-18|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|DCE-IMPACT||Does Preference-based HIV Testing Increase Uptake in High Risk Populations?|Does Preference-based HIV Testing Increase Uptake in High Risk Populations?|Not yet recruiting||N/A|1200|Anticipated|University of South Carolina||2|||f||||f|f|f||||||||2017-10-10 22:22:47.243471|2017-10-10 22:22:47.243471
NCT02714127|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-06-14|||September 2015||2015-09-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|BM-SOP||Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine (BM-SOP Study)|Collection of First-void Urine Samples for the Development of Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine: the BM-SOP Study|Completed||N/A|128|Actual|Universiteit Antwerpen|||2||f||||f||||||Samples With DNA|"     First-void urine samples and Cervicovaginal lavage fluid (VagLav) samples   "|No||2017-10-10 22:22:47.339889|2017-10-10 22:22:47.339889
NCT02714114|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-06-14|||September 2015||2015-09-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|AB-SOP||Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)|Collection of First-void Urine Samples for the Development of Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine: the AB-SOP Study|Completed||N/A|57|Actual|Universiteit Antwerpen|||2||f||||f||||||Samples With DNA|"     First-void urine samples and Blood samples   "|No||2017-10-10 22:22:47.431723|2017-10-10 22:22:47.431723
NCT02714101|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-15|||June 2012||2012-06-01|March 2016|2016-03-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional|||Equine-assisted Occupational Therapy for Children With Autism Spectrum Disorder|Effects of Hippotherapy on the Motivation and Social Interaction/Social Communication of Children With Autism|Completed||N/A|8|Actual|University of Alberta||1|||f||||f||||||||No||2017-10-10 22:22:47.512927|2017-10-10 22:22:47.512927
NCT02714088|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-10-17|||April 2016||2016-04-01|October 2016|2016-10-01||||August 2016|Actual|2016-08-01||Interventional|||The Effect of Novel High-intensity Interval Training on Physical Fitness in Older Adults||Completed||N/A|36|Actual|Teesside University||2|||f||||||||||||||2017-10-10 22:22:47.57381|2017-10-10 22:22:47.57381
NCT02714075|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-12-06|||April 2016||2016-04-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MM_Rice||Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Zinc, Citric Acid/Trisodium Citrate and EDTA|Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Different Zinc Compounds, Citric Acid/Trisodium Citrate and Sodium EDTA|Completed||N/A|30|Actual|Swiss Federal Institute of Technology||1|||f||||f||||||||No||2017-10-10 22:22:47.635129|2017-10-10 22:22:47.635129
NCT02714062|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-05-08|||March 2016||2016-03-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents||Completed||Phase 4|42|Actual|VIVUS, Inc.||3|||f||||f||||||||||2017-10-10 22:22:47.726711|2017-10-10 22:22:47.726711
NCT02714049|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-02-28|||January 2017||2017-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy|Two Arm Open Label Pilot Study of Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy|Recruiting||Phase 4|60|Anticipated|San Diego Sexual Medicine||2|||f||||f||||||||No||2017-10-10 22:22:47.811544|2017-10-10 22:22:47.811544
NCT02714036|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-08-10|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)|A Multi-Center, Open-Label Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)|Recruiting||Phase 1/Phase 2|35|Anticipated|MediciNova||1|||f||||f||||||||||2017-10-10 22:22:47.897998|2017-10-10 22:22:47.897998
NCT02714023|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-07-27|||March 22, 2017|Actual|2017-03-22|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|WASHITBEST||Water And Saline Head-to-head In The Blinded Evaluation Study Trial|Water And Saline Head-to-head In The Blinded Evaluation Study Trial|Recruiting||N/A|441|Anticipated|University of Missouri-Columbia||3|||f||||f|f|f||||||||2017-10-10 22:22:48.035834|2017-10-10 22:22:48.035834
NCT02714010|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-03-15|||August 2015||2015-08-01|March 2016|2016-03-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC|Whole Brain Radiotherapy Concurrent With EGFR-TKI Versus EGFR-TKI Alone in the Treatment of Non-small Cell Lung Cancer Patients With Brain Metastasis|Recruiting||Phase 3|601|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:22:48.132377|2017-10-10 22:22:48.132377
NCT02713997|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-03-03|||December 2016||2016-12-01|March 2017|2017-03-01|January 2024|Anticipated|2024-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Anti-inflammatory Therapy to Improve Outcomes After TPIAT|Anti-inflammatory Therapy to Improve Outcomes in Patients With Chronic Pancreatitis Undergoing Total Pancreatectomy Islet Autotransplantation|Recruiting||Phase 4|45|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-10 22:22:48.343294|2017-10-10 22:22:48.343294
NCT02713984|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2017-04-24|||March 2016||2016-03-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer|A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer|Recruiting||Phase 1/Phase 2|60|Anticipated|Southwest Hospital, China||1|||f||||f||||||||Undecided||2017-10-10 22:22:48.450753|2017-10-10 22:22:48.450753
NCT02713971|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-15|||January 2013||2013-01-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|GAMEPAD_PD||Biofeedback Rehabilitation in Parkinson's Disease|Wearable Sensor-based Biofeedback Training for Balance and Gait in Parkinson's Disease: a Pilot Randomized Controlled Trial.|Completed||N/A|42|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||||||||||||2017-10-10 22:22:48.56187|2017-10-10 22:22:48.56187
NCT02713958|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-15|||March 2016||2016-03-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|||The Efficacy of Telerehabilitation Program for Improvement of Upper Limb Function Among Adults Post Elbow Fractures|The Efficacy of Telerehabilitation Program for Improvement of Upper Limb Function Among Adults Post Elbow Fractures|Enrolling by invitation||N/A|24|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 22:22:48.677127|2017-10-10 22:22:48.677127
NCT02713945|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-04-24|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|RASTAT||Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome|Treatment With HMG-COA Reductase Inhibitor (Simvastatin) of Growth and Bone Abnormalities in Children With Noonan Syndrome: A Phase III Randomised, Double Blind, Placebo-controlled Therapeutic Trial|Recruiting||Phase 3|62|Anticipated|University Hospital, Toulouse||2|||f||||t|f|f||||||No||2017-10-10 22:22:48.779147|2017-10-10 22:22:48.779147
NCT02713932|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-15|||July 2010||2010-07-01|March 2016|2016-03-01||||July 2017|Anticipated|2017-07-01||Observational|||The Italian Society of Invasive Cardiology Registry on Percutaneous Aortic Valve|The Italian Society of Invasive Cardiology Registry on Percutaneous Aortic Valve|Recruiting||N/A|2000|Anticipated|Istituto Clinico Sant'Ambrogio|||1||f||||t||||||||Undecided|The decision will be made after study completion.|2017-10-10 22:22:48.940566|2017-10-10 22:22:48.940566
NCT02713919|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-01-11|||March 2016||2016-03-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PEINCA||Study to Test the Efficacy of the PRO-SELF® Plus Pain Control Program to Reduce Pain in Outpatients With Cancer|Mixed Methods Study to Test the Efficacy of the Adapted German PRO-SELF® Plus Pain Control Program, an Intervention Directed at Outpatients With Cancer and Their Family Caregivers to Reduce Pain and Related Symptoms|Recruiting||N/A|315|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-10 22:22:49.038789|2017-10-10 22:22:49.038789
NCT02713906|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-03-27|||September 2015||2015-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Materialise X-ray Knee Guides for Total Knee Arthroplasty|Prospective Monocentric Clinical Investigation Using the Materialise X-ray Knee Guides for Total Knee Arthroplasty|Recruiting||N/A|30|Anticipated|Materialise||1|||f||||f||||||||||2017-10-10 22:22:49.160912|2017-10-10 22:22:49.160912
NCT02713893|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-08-05|||September 2015||2015-09-01|August 2016|2016-08-01||||June 2016|Actual|2016-06-01||Interventional|||Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal Cream|A Phase I Study of a Novel Intravaginal Antimycotic Cream (Econazole Nitrate 1% Plus Benzydamine HCl 0.12%) Administered Once Daily for 15 Days to Healthy Women|Recruiting||Phase 1|60|Anticipated|Aziende Chimiche Riunite Angelini Francesco S.p.A||4|||f||||f||||||||No||2017-10-10 22:22:49.251344|2017-10-10 22:22:49.251344
NCT02713880|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-06-29|||January 2016||2016-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|BioTRAP||Biomarker for Patients With Transthyretin-Related Familial Amyloidotic Polyneuropathy|Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy - An International, Multicenter, Epidemiological Protocol|Recruiting||N/A|100|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectrometry 7, 5 ml     EDTA blood or a dry blood spot filter card are taken. To proof the correct diagnosis of     aTransthyretin-Related Familial Amyloidotic Polyneuropathy in those patients where up to the     enrollment in the study no genetic testing has been done, sequencing of a     Transthyretin-Related Familial Amyloidotic Polyneuropathy will be done.      The analyses are done in the Centogene AG Schillingallee 68 D-18057 Rostock Germany   "|||2017-10-10 22:22:49.400243|2017-10-10 22:22:49.400243
NCT02713867|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-10-03|||April 30, 2016|Actual|2016-04-30|October 2017|2017-10-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Interventional|CheckMate 384||A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks|A Dose Frequency Optimization, Phase IIIB/IV Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks|Recruiting||Phase 3|620|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:22:49.540487|2017-10-10 22:22:49.540487
NCT02713854|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-02|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|March 1, 2019|Anticipated|2019-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||BAP-EB as a Predictive Tool for Endometrial Receptivity and Pregnancy Outcome of IVF Treatment|Human Embryonic Stem Cell-derived Trophoblastic Spheroid (BAP-EB) as a Predictive Tool for Endometrial Receptivity and Pregnancy Outcome of in Vitro Fertilization Treatment|Recruiting||N/A|240|Anticipated|The University of Hong Kong||1|||f||||f|f|f||||||No||2017-10-10 22:22:50.159289|2017-10-10 22:22:50.159289
NCT02713841|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-15|||May 2013||2013-05-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Samba-01||Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes|Samba-01: A Phase 1/2 Trial Investigating the Pharmacokinetics, Pharmacodynamics and Safety of Inhaled Insulin in Subjects With Type 1 Diabetes|Completed||Phase 1/Phase 2|12|Actual|Dance Biopharm Inc.||5|||f||||f||||||||No||2017-10-10 22:22:50.258222|2017-10-10 22:22:50.258222
NCT02713828|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-03-10|||April 10, 2016||2016-04-10|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|April 2020|Anticipated|2020-04-01||Interventional|PrE0504||Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung|A Phase I/II Study of Glembatumumab Vedotin in Patients With gpNMB-Expressing, Advanced or Metastatic Squamous Cell Carcinoma of the Lung|Recruiting||Phase 1/Phase 2|52|Anticipated|PrECOG, LLC.||2|||f||||t|t|f||||||No|Data is proprietary.|2017-10-10 22:22:50.345442|2017-10-10 22:22:50.345442
NCT02713815|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-28|||June 2016||2016-06-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Novel Intervention for Amphetamine-type Stimulants Addiction|Glutamate and γ-aminobutyric Acid (GABA) Deficits in Prefrontal-striatal Circuits: it's Role in Amphetamine-type Stimulants Addiction and Novel Intervention|Not yet recruiting||N/A|240|Anticipated|Shanghai Mental Health Center||4|||f||||f||||||||No||2017-10-10 22:22:50.535077|2017-10-10 22:22:50.535077
NCT02713802|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-04-20|||March 2016||2016-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects|An Open-Label, Randomized, Two-Way Crossover Pilot Study of the Bioequivalence of Cudafol(R) and Diprivan(R) IV Administered as Single Intravenous Doses in Healthy Subjects|Completed||Phase 1|8|Actual|Cuda Anesthetics, LLC||2|||f||||f||||||||No||2017-10-10 22:22:50.629531|2017-10-10 22:22:50.629531
NCT02713789|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-03-15|||April 2015||2015-04-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED|A Double-blind, Placebo-controlled, Parallel Design, Randomized, Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene Transfer in Males With Erectile Dysfunction|Recruiting||Phase 2|35|Anticipated|Ion Channel Innovations||2|||f||||f||||||||Yes|publication|2017-10-10 22:22:50.704046|2017-10-10 22:22:50.704046
NCT02701868|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-07|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|Whoa Baby||Unintentional Overfeeding of Formula Fed Infants|Unintentional Overfeeding of Formula Fed Infants|Completed||N/A|172|Actual|Pennington Biomedical Research Center|||2||f||||f||||||||No||2017-10-10 22:24:55.225658|2017-10-10 22:24:55.225658
NCT02713776|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-15|||April 2016||2016-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|SOMILEO||Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical Treatment|Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical Treatment : Phase II Multicentric Randomized Double Bland Placebo Controlled Study|Not yet recruiting||Phase 2|78|Anticipated|Hospices Civils de Lyon||2|||f||||||||||||||2017-10-10 22:22:50.795418|2017-10-10 22:22:50.795418
NCT02713763|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2016-03-18|||April 2016||2016-04-01|March 2016|2016-03-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|RESUNET||Phase II Study to Evaluate Efficacy of Rechallenge With Sunitinib in Patients With Metastatic Pancreatic Neuroendocrine Tumor (pNETs) Who Previously Failed to Sunitinib|Phase II Study to Evaluate Efficacy of Rechallenge With Sunitinib in Patients With Metastatic Pancreatic Neuroendocrine Tumor (pNETs) Well Differentiated G1/2 Advanced or Metastatic Who Previously Failed to Sunitinib.|Not yet recruiting||Phase 2|36|Anticipated|Grupo Espanol de Tumores Neuroendocrinos||1|||f||||f||||||||||2017-10-10 22:22:50.871221|2017-10-10 22:22:50.871221
NCT02713750|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-15|||March 2013||2013-03-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||RH and Adolescents|Optimization of Reproductive Health Care for Female Adolescents Living With HIV (Reproductive Health in HIV-infected Female Adolescents)|Completed||N/A|77|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 22:22:50.988063|2017-10-10 22:22:50.988063
NCT02713737|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-05-14|||April 2016||2016-04-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||The Correlation Between Sleep Quality and Atrial Fibrillation Undergoing High-flow Nasal Cannula Oxygen (HFNC)|Impact of High-flow Nasal Cannula Oxygen (HFNC) Versus Noninvasive Ventilation Associated With Sleep Quality on Atrial Fibrillation in Hypoxemic Patients After Coronary Surgery|Recruiting||Phase 4|80|Anticipated|Henan Institute of Cardiovascular Epidemiology||2|||f||||f||||||||No||2017-10-10 22:22:51.064375|2017-10-10 22:22:51.064375
NCT02713698|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-04-18|||April 2016||2016-04-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Observational|||Propofol Pharmacokinetics and Pharmacodynamics Modelling|Modelling Propofol Pharmacokinetics and Pharmacodynamics During an Intravenous Anaesthesia Guided by the Bispectral Index (BIS)|Recruiting||N/A|60|Anticipated|Centro Hospitalar do Porto|||3||f||||||||||Samples Without DNA|"     Arterial blood samples will be collected in serum tubes and centrifuged at 2000 rpm for 15     minutes in order to obtain serum. Serum will be preserved at -80ºC until analysis.   "|||2017-10-10 22:22:51.333169|2017-10-10 22:22:51.333169
NCT02713685|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-08-11|||June 2015||2015-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Comparison of Combined Sciatic(Winnie's) Femoral Nerve Block, and Subarachnoid Block Anesthesia for Lower Limb Surgery|Comparison of Combined Sciatic(Winnie's) Femoral Nerve Block, and Subarachnoid Block Anesthesia for Lower Limb Surgery|Completed||N/A|60|Actual|Government Medical College, Haldwani||2|||f||||t||||||||Undecided||2017-10-10 22:22:51.401409|2017-10-10 22:22:51.401409
NCT02713659|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-09-19|||March 2016||2016-03-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ELPI||Early Literacy Promotion Intervention|Early Literacy Promotion Among Poor Urban Children in Philadelphia|Active, not recruiting||Phase 2|120|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 22:22:51.551324|2017-10-10 22:22:51.551324
NCT02713646|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-15|||March 2016||2016-03-01|March 2016|2016-03-01||||January 2018|Anticipated|2018-01-01||Observational|MRI-TN||Magnetic Resonance Imaging Study on Patients With Trigeminal Neuralgia|Applied Research on Patients With Trigeminal Neuralgia by Multi-planar Reconstruction, Curved Planar Reconstruction and Magnetic Resonance Virtual Endoscopy|Not yet recruiting||N/A|40|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||1||f||||t||||||||Yes||2017-10-10 22:22:51.619447|2017-10-10 22:22:51.619447
NCT02713633|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-09-13|||January 2016||2016-01-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Indwelling Double-J Ureteral Stent Versus Externalized Modified-Salle Stent for Pyeloplasty|Prospective Randomized Trial of Indwelling Double-J Ureteral Stent Versus Externalized Modified-Salle Stent for Pyeloplasty|Recruiting||N/A|80|Anticipated|Children's Hospital of Pittsburgh||2|||f||||f||||||||Yes|We are sharing de-identified data with University of Chicago|2017-10-10 22:22:51.710962|2017-10-10 22:22:51.710962
NCT02713620|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-04-17|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Hepatitis B Vaccination in HIV-infected Adults|Comparison of Immunogenicity of Four Doses and Four Double Doses vs. Standard Doses of Hepatitis B Vaccination in HIV-infected Adults: a Result From Randomized Controlled Trial at 3 Years After Vaccination|Completed||Phase 4|154|Actual|Chiang Mai University||4|||f||||f||||||||No||2017-10-10 22:22:53.593717|2017-10-10 22:22:53.593717
NCT02713607|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-04-17|||March 2016||2016-03-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Lipidome and Microbiome Profile of Acne|Lipidome and Microbiome Profile of Acne|Active, not recruiting||Phase 1/Phase 2|30|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 22:22:53.678687|2017-10-10 22:22:53.678687
NCT02713594|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-04-18|2016-11-08||April 2013||2013-04-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|||Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation|Wisconsin Tobacco Quit Line Centers for Medicaid Services Striving To Quit Evaluation Project|Completed||N/A|1900|Actual|University of Wisconsin, Madison||2|||f||||f||||||||No||2017-10-10 22:22:53.763425|2017-10-10 22:22:53.763425
NCT02713581|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-16|||January 3, 2017|Actual|2017-01-03|June 2017|2017-06-01|January 3, 2018|Anticipated|2018-01-03|January 3, 2018|Anticipated|2018-01-03||Observational|ActiMon||IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism|IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism|Recruiting||N/A|129|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-10 22:22:54.113995|2017-10-10 22:22:54.113995
NCT02713568|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-07-25|||May 2016||2016-05-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study)|Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study)|Recruiting||N/A|2500|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:22:54.211166|2017-10-10 22:22:54.211166
NCT02713555|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-06-22|||July 2016||2016-07-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Roux-en-Y Gastric Bypass or Gastric Sleeve Surgery on Type 2 Diabetes|Effects of Hepatic Insulin Resistance on Type 2 Diabetes Mellitus in Morbidly Obese Subjects Following Roux-en-Y Gastric Bypass Surgery or Gastric Sleeve Surgery|Not yet recruiting||N/A|32|Anticipated|University of Aarhus||3|||f||||f||||||||Yes|Anonymized transfer of data after study completion to the Danish Archive.|2017-10-10 22:22:54.329965|2017-10-10 22:22:54.329965
NCT02713542|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-08-23|||July 2016||2016-07-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Autologous Conditioned Plasma (ACP) Intra-articular (IA) Injections for Knee Osteoarthritis (OA)|Autologous Conditioned Plasma (ACP) Intra-articular (IA) Injections for Knee Osteoarthritis (OA)|Active, not recruiting||N/A|90|Actual|Arthrex, Inc.||2|||f||||f||||||||||2017-10-10 22:22:54.583021|2017-10-10 22:22:54.583021
NCT02713529|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-09-06|||April 14, 2016|Actual|2016-04-14|September 2017|2017-09-01|April 19, 2019|Anticipated|2019-04-19|March 18, 2019|Anticipated|2019-03-18||Interventional|||Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer|A Phase1b/2 Study Assessing Safety and Anti-tumor Activity of AMG 820 in Combination With Pembrolizumab in Select Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|197|Anticipated|Amgen||1|||f||||f|t|f||||||||2017-10-10 22:22:54.688963|2017-10-10 22:22:54.688963
NCT02713516|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-08-07|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD|Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders|Enrolling by invitation||N/A|40|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 22:22:54.818304|2017-10-10 22:22:54.818304
NCT02713503|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-03-17|||September 2013||2013-09-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Evaluating Electronic Devices in a Driving Simulator|HFCV Mobile Device Vehicle Integration Assessment|Completed||N/A|78|Actual|Clemson University|||1||f||||f||||||||No||2017-10-10 22:22:54.911902|2017-10-10 22:22:54.911902
NCT02713490|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-01-24|||March 2016||2016-03-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty|A Multicenter, Randomized, Double-Blind, Controlled Trial Comparing Local Infiltration Analgesia With EXPAREL to Local Infiltration Analgesia Without EXPAREL to Manage Postsurgical Pain Following Total Knee Arthroplasty|Active, not recruiting||Phase 4|300|Anticipated|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||Undecided||2017-10-10 22:22:54.994052|2017-10-10 22:22:54.994052
NCT02713477|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-06-28|||April 2016||2016-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus|A Randomized, Open Label, Placebo-controlled, 4-sequence, 4-period, 4-treatment Crossover Study to Investigate the Postprandial Glucodynamic Response to Single Dose of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|20|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 22:22:55.134566|2017-10-10 22:22:55.134566
NCT02713464|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-03-17|||January 2014||2014-01-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Does Maternal Instruction Prevent Kernicterus in Nigeria?|Effect of Education on Prevalence of Kernicterus in Five Regions in Nigeria|Completed||N/A|1765|Actual|Bilimetrix s.r.l.||3|||f||||t||||||||Undecided||2017-10-10 22:22:55.249629|2017-10-10 22:22:55.249629
NCT02713451|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-10-05|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|LOCO2||Liberal Oxygenation Versus Conservative Oxygenation in ARDS|Liberal Oxygenation Versus Conservative Oxygenation in Patients With Acute Respiratory Distress Syndrome : Impact on Mortality (LOCO2 Study)|Recruiting||Phase 3|850|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-10 22:22:55.338838|2017-10-10 22:22:55.338838
NCT02713438|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-01-03|||April 2016||2016-04-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Effects of Individual, Dyadic, and Collaborative Plans on Physical Activity in Parent-Child Dyads|Physical Activity, and Health-Related Quality of Life: Dyadic Research in the Context of Forming Individual, Dyadic, and Collaborative Plans (Trial 1: Parent-Child Dyads)|Recruiting||N/A|400|Anticipated|University of Social Sciences and Humanities, Warsaw||4|||f||||f||||||||Yes|Data will be made publicly available in 3 years after the completion of the trial|2017-10-10 22:22:55.446981|2017-10-10 22:22:55.446981
NCT02713425|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-23|||October 2016||2016-10-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Pediatric Anxiety Intervention With an Entertaining Video Game: Feasibility Study|Pediatric Anxiety Intervention With an Entertaining Video Game: Feasibility Study|Active, not recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 22:22:55.573061|2017-10-10 22:22:55.573061
NCT02713087|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-04-08|||September 2015||2015-09-01|February 2016|2016-02-01|August 2021|Anticipated|2021-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Vasopressor Effects in Anesthetized Patients|Influence of Vasopressors on Brain Oxygenation and Microcirculation in Anesthetized Patients With Cerebral Tumors|Recruiting||Phase 4|50|Anticipated|University of Aarhus||2|||f||||t||||||||No||2017-10-10 22:22:59.146741|2017-10-10 22:22:59.146741
NCT02713412|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-15|||April 2013||2013-04-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effects of Water and Glucose Drinks on Cardiovascular Function in Subjects With and Without Postprandial Hypotension|Cardiovascular Function and Postprandial Hypotension (PPH): Effect of an Oral Glucose Load on Cardiac Contractility, Cardiac Output, Diastolic Function and Endothelial Function - Relationship to Gastric Emptying|Completed||N/A|8|Actual|Royal Adelaide Hospital||2|||f||||f||||||||Yes|Anonymous study data (minus all demographic data which compromises confidentiality) will be made available in a publicly accessible depository after publication.|2017-10-10 22:22:55.647744|2017-10-10 22:22:55.647744
NCT02713399|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-05-19|||March 2016||2016-03-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||High-resolution Imaging of Tear Film Thickness in Contact Lenses Wearers With Optical Coherence Tomography (OCT). A Pilot Study|High-resolution Imaging of Tear Film Thickness in Contact Lenses Wearers With Optical Coherence Tomography (OCT). A Pilot Study|Recruiting||N/A|30|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-10-10 22:22:55.728294|2017-10-10 22:22:55.728294
NCT02713386|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-08-22|||May 18, 2016|Actual|2016-05-18|August 2017|2017-08-01||||September 30, 2020|Anticipated|2020-09-30||Interventional|||Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase I/II Study of Ruxolitinib With Front-Line Neoadjuvant and Post-surgical Therapy in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 1/Phase 2|162|Anticipated|NRG Oncology||2|||f||||f||||||||||2017-10-10 22:22:55.816223|2017-10-10 22:22:55.816223
NCT02713373|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-07-08|||August 5, 2016|Actual|2016-08-05|July 2017|2017-07-01|January 13, 2018|Anticipated|2018-01-13|January 13, 2018|Anticipated|2018-01-13||Interventional|||Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery|A Phase Ib/II Study of Cetuximab and Pembrolizumab in Metastatic Colorectal Cancer|Recruiting||Phase 1/Phase 2|42|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-10 22:22:55.997041|2017-10-10 22:22:55.997041
NCT02713360|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-06-06|||May 2016||2016-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Screening and Intervention Reducing Anxiety in Patients With Implanted Cardioverter Defibrillator (ICD)|Screening and Intervention Reducing Anxiety in Patients With Implanted Cardioverter Defibrillator (ICD) - Screen-ICD|Recruiting||N/A|88|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||No||2017-10-10 22:22:56.128139|2017-10-10 22:22:56.128139
NCT02713347|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-09-20|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|June 30, 2020|Anticipated|2020-06-30||Interventional|ADAPT||Advancing Symptom Alleviation With Palliative Treatment|Palliative Care to Improve Quality of Life in CHF and COPD|Recruiting||N/A|300|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:22:56.23071|2017-10-10 22:22:56.23071
NCT02713334|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-08-23|||February 25, 2016||2016-02-25|August 2017|2017-08-01|February 25, 2019|Anticipated|2019-02-25|February 25, 2019|Anticipated|2019-02-25||Observational|||Advanced Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling|Advanced Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling|Recruiting||N/A|450|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:22:56.474806|2017-10-10 22:22:56.474806
NCT02713321|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-11-16|||January 2017||2017-01-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Observational|||The Impact of Medicaid Health Homes on Patients With Diabetes|The Impact of Medicaid Health Homes on Patients With Diabetes|Not yet recruiting||N/A|13000|Anticipated|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||None Retained|"     Specify all types of biospecimens to be retained (e.g., whole blood, serum, white cells,     urine, tissue)   "|No||2017-10-10 22:22:56.569532|2017-10-10 22:22:56.569532
NCT02713308|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-10-03|||January 2017|Actual|2017-01-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|IMAGE-CRT||Impact of MultiPoint Pacing Technology in CRT Patients With Reduced RV-to-LV Delay|Impact of MultiPoint Pacing Technology in CRT Patients With Reduced RV-to-LV Delay|Recruiting||N/A|248|Anticipated|Monaldi Hospital|||2||f||||||||||||||2017-10-10 22:22:56.661518|2017-10-10 22:22:56.661518
NCT02713295|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-14|||June 16, 2016||2016-06-16|July 2017|2017-07-01|December 10, 2018|Anticipated|2018-12-10|December 10, 2018|Anticipated|2018-12-10||Observational|CONCORDIA||A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece|A Non-interventional Prospective Cohort Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece|Recruiting||N/A|280|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:22:56.79126|2017-10-10 22:22:56.79126
NCT02713282|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-30|||April 28, 2016|Actual|2016-04-28|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation|A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation In Patients With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation|Active, not recruiting||Phase 3|306|Actual|Janssen-Cilag Ltd.||1|||f||||f||f||||||||2017-10-10 22:22:56.989268|2017-10-10 22:22:56.989268
NCT02713269|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-12-27|||August 2016||2016-08-01|December 2016|2016-12-01||||August 2022|Anticipated|2022-08-01||Interventional|||Thermal Ablation and Stereotactic Spine Radiosurgery (SSRS)|A Phase II Clinical Trial Evaluating the Efficacy of Combining Thermal Ablation and Spine Stereotactic Radiosurgery for Patients With Spine Metastases With Moderate to Severe Epidural Involvement|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:22:57.172266|2017-10-10 22:22:57.172266
NCT02713100|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-03-21|||October 2014||2014-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Self Reported Level of Agitation of Patients Presenting to an Emergency Department|Self Reported Level of Agitation of Patients Presenting to an Emergency Department|Recruiting||N/A|200|Anticipated|Mt Sinai Hospital, Chicago|||1||f||||f||||||||No|Individual patient data will not be available to other researchers. Data will only be shared through publications and presentations once the study has been completed.|2017-10-10 22:22:59.047163|2017-10-10 22:22:59.047163
NCT02713256|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-06-01|||April 19, 2016|Actual|2016-04-19|June 2017|2017-06-01|April 24, 2017|Actual|2017-04-24|April 24, 2017|Actual|2017-04-24||Interventional|||A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease|An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment With CFZ533 in Patients With Graves' Disease|Completed||Phase 2|14|Actual|Novartis||1|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:22:57.287807|2017-10-10 22:22:57.287807
NCT02713243|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-11-10|||April 2016||2016-04-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.|A Double Blind, Randomized Placebo Controlled Crossover Multiple Dose Study of LJN452 to Assess Safety, Tolerability and Efficacy in Patients With Primary Bile Acid Diarrhea (pBAD).|Recruiting||Phase 2|30|Anticipated|Novartis||2|||f||||t||||||||||2017-10-10 22:22:57.380128|2017-10-10 22:22:57.380128
NCT02713230|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-04-28|||March 2016||2016-03-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL for Postsurgical Analgesia in Subjects Undergoing Total Shoulder Arthroplasty or Rotator Cuff Repair|Recruiting||Phase 3|120|Anticipated|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||Undecided||2017-10-10 22:22:57.491443|2017-10-10 22:22:57.491443
NCT02713217|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-05-15|||June 15, 2017|Anticipated|2017-06-15|May 2017|2017-05-01|December 1, 2020|Anticipated|2020-12-01|June 15, 2020|Anticipated|2020-06-15||Observational|Tele-PCMHI||Implementing a Blended Care Model That Integrates Mental Healthcare and Primary Care Using Telemedicine and Care Management for Patients With Depression or Alcohol Use Disorder in Small Primary Care Clinics|Adapting and Implementing the Blended Collaborative Care Model in CBOCs|Not yet recruiting||N/A|588|Anticipated|VA Office of Research and Development|||2||f||||f|f|f|||f|||Undecided||2017-10-10 22:22:57.712167|2017-10-10 22:22:57.712167
NCT02713204|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-07-05|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ONYX||Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection|A Randomized, Double-Masked, Active-Controlled Phase 2 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal REGN910-3 in Patients With Neovascular Age-Related Macular Degeneration|Active, not recruiting||Phase 2|365|Actual|Regeneron Pharmaceuticals||3|||f||||||||||||||2017-10-10 22:22:57.83944|2017-10-10 22:22:57.83944
NCT02713191|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-02-16|||March 2016||2016-03-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Dexmedetomidine vs. Midazolam Sedation for Endobronchial Ultrasound|Efficacy and Safety of Dexmedetomidine vs. Midazolam Sedation in Patients Undergoing Convex-probe Endobronchial Ultrasound: a Randomized Double Blind Trial|Completed||Phase 2/Phase 3|197|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 22:22:58.089108|2017-10-10 22:22:58.089108
NCT02713178|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-04-28|||March 2016||2016-03-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL for Postsurgical Analgesia in Subjects Undergoing Total Knee Arthroplasty|Recruiting||Phase 3|300|Anticipated|Pacira Pharmaceuticals, Inc||3|||f||||f||||||||Undecided||2017-10-10 22:22:58.177129|2017-10-10 22:22:58.177129
NCT02713165|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-07|||January 2016||2016-01-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Adding Raisins to the American Diet on Fecal Microbiota Composition|Effects of Adding Raisins to the American Diet on Fecal Microbiota Composition|Completed||N/A|18|Actual|University of Florida||1|||f||||f|f|f||||||||2017-10-10 22:22:58.466303|2017-10-10 22:22:58.466303
NCT02713152|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-06-13|||March 2016||2016-03-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|POSAG||Prevalence of Obstructive Sleep Apnoea in Glaucoma|POSAG: Prevalence of Obstructive Sleep Apnoea in Glaucoma|Recruiting||N/A|480|Anticipated|Papworth Hospital NHS Foundation Trust|||2||f||||f||||||||No|Will not be sharing individual participant data. All study data will be anonymised.|2017-10-10 22:22:58.559459|2017-10-10 22:22:58.559459
NCT02713139|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-15|||September 2013||2013-09-01|March 2016|2016-03-01||||March 2014|Anticipated|2014-03-01||Interventional|Frauen||Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.|Phase III, Multicenter, Randomized, Parallel, Open Label, Controlled and Comparative Study to Evaluate the Efficacy and Safety of the Association of Clotrimazole 200mg and Metronidazole 0,75% (Colpistatin 5DT®) Compared to Gynecological Flagyl®(Metronidazole 100mg/g) and the Vaginal Cream Gino-Canesten® 3 (Clotrimazole 20mg/g) in the Syndromic Treatment of the Vaginal Discharge From Different Etiologies.|Withdrawn||Phase 3|0|Actual|Ache Laboratorios Farmaceuticos S.A.||3||Due to budget limitations, the company decided to withdraw this study.|f||||t||||||||||2017-10-10 22:22:58.643167|2017-10-10 22:22:58.643167
NCT02713113|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-18|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery|Comparison of Three Different Doses Sugammadex Based on Ideal Body Weight for Reversal of Moderate Rocuronium-induced Neuromuscular Blockade in Laparoscopic Bariatric Surgery.|Completed||Phase 3|180|Actual|Assiut University||3|||f||||t||||||||||2017-10-10 22:22:58.943386|2017-10-10 22:22:58.943386
NCT02713074|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-16|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|PISOH||Povidone-iodine Versus Saline in Vaginal Cleansing Before Office Hysteroscopy|A Comparison Between Povidone-iodine and Normal Saline in Vaginal Cleansing Before Office Hysterosocpy: a Randomized Controlled Trial|Completed||Phase 3|147|Actual|Assiut University||2|||f||||f|f|f||||||||2017-10-10 22:22:59.280512|2017-10-10 22:22:59.280512
NCT02713061|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-08-24|||March 2016||2016-03-01|August 2016|2016-08-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants|An Open-label Phase 2 Study to Evaluate the Safety and Immnogenicity of a Single Subcutaneous Injection of Quadrivalent TAK-850 in Healthy Adult Subjects|Withdrawn||Phase 2|0|Actual|Takeda||1|||f||||f||||||||||2017-10-10 22:22:59.366305|2017-10-10 22:22:59.366305
NCT02713048|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-11-07|||October 2011||2011-10-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Sensitive Troponin I in Out-of-hospital Cardiac Arrest|Sensitive Troponin I and Coronary Anatomy in Patients With Out-of-hospital Cardiac Arrest|Recruiting||N/A|150|Anticipated|University Medical Centre Ljubljana|||3||f||||f||||||||No||2017-10-10 22:22:59.461608|2017-10-10 22:22:59.461608
NCT02713035|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients|Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients|Recruiting||N/A|150|Anticipated|University of Mississippi Medical Center||2|||f||||t||||||||No|All data will be reviewed by a member of the research team the same week it is collected in order to ensure completion and clarity. The research team will maintain an updated data tracking form indicating when participant data are collected, entered, and verified, as well as any corrections that are needed. The PI, clinical staff, and trained bachelors- or Master-level staff will collect the data, and will thus have access to participant identities. However, the investigators will safeguard against breaches of confidentiality by coding participant data by ID number rather than by name, and by keeping information linking these ID numbers to specific individuals in a locked file cabinet accessible only to project staff. Further, individuals will not be identified by name (nor will any identifying information be offered) when results from data are disseminated.|2017-10-10 22:22:59.578296|2017-10-10 22:22:59.578296
NCT02713009|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-03-14|||November 2015||2015-11-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MO-VITD||Impact of Maternal Body Weight on Vitamin D Status During Pregnancy|Investigation of the Impact of Maternal Body Weight on Vitamin D Status During Pregnancy: a Randomised Supplementation Study|Recruiting||N/A|240|Anticipated|University of Ulster||2|||f||||f||||||||||2017-10-10 22:22:59.852451|2017-10-10 22:22:59.852451
NCT02712996|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-02-13|||February 6, 2017|Actual|2017-02-06|February 2017|2017-02-01|November 3, 2018|Anticipated|2018-11-03|November 3, 2018|Anticipated|2018-11-03||Interventional|TBIC||Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children|Treatment Outcomes With Lisdexamfetamine Dimesylate (Vyvanse) in Children With Traumatic Brain Injury-Related Attention Deficits|Recruiting||Phase 4|30|Anticipated|Vanderbilt University Medical Center||2|||f||||f|t|f|||f|||||2017-10-10 22:22:59.970785|2017-10-10 22:22:59.970785
NCT02712983|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-04-26|||February 2, 2017|Actual|2017-02-02|April 2017|2017-04-01|September 10, 2018|Anticipated|2018-09-10|September 10, 2018|Anticipated|2018-09-10||Interventional|iBEST-1||Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection|A Randomized, Blinded, Parallel Group, Multi-center Dose-finding Study, to Assess the Efficacy, Safety and Tolerability of Different Doses of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection|Recruiting||Phase 2|180|Anticipated|Novartis||9|||f||||t|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:23:00.153025|2017-10-10 22:23:00.153025
NCT02712970|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-14|||January 2011||2011-01-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|||Staging System for Chronic Symptomatic Pilonidal Sinus Disease|A Proposed Staging System for Chronic Symptomatic Pilonidal Sinus Disease and Results in Patients Treated With Stage-based Approach|Completed||N/A|367|Actual|Trabzon Numune Training and Research Hospital|||5||f||||f||||||||No|because this is retrospective study.|2017-10-10 22:23:00.368482|2017-10-10 22:23:00.368482
NCT02712957|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-03-10|||March 2016||2016-03-01|March 2017|2017-03-01|November 24, 2016|Actual|2016-11-24|November 17, 2016|Actual|2016-11-17||Interventional|||A Proof-of-Concept Study Assessing NEO6860 in Osteoarthritis Pain|A Proof-of-Concept, Randomized, Double Blind, Placebo and Active Control, 3-Period, Crossover Design Study Assessing NEO6860 in Patients With Pain Associated With Osteoarthritis of the Knee|Completed||Phase 2|54|Actual|Neomed Institute||3|||f||||f||||||||No||2017-10-10 22:23:00.47246|2017-10-10 22:23:00.47246
NCT02712931|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-17|||March 2015||2015-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:23:00.688227|2017-10-10 22:23:00.688227
NCT02710916|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-06-14|||February 2016||2016-02-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|SOMAL||SD-OCT Multimodal Analysis in GLaucoma|SD-OCT Multimodal Analysis in GLaucoma|Recruiting||N/A|150|Anticipated|University Hospital, Bordeaux||3|||f||||f||||||||No||2017-10-10 22:23:20.874746|2017-10-10 22:23:20.874746
NCT02712918|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-03-15|||January 2014||2014-01-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Brief Behavioral Activation Treatment for Depression With Inpatients|An Evaluation of Brief Behavioral Activation Treatment for Depression With Moderate to Severely Depressed Inpatients - A Small Randomized Controlled Trial|Completed||N/A|23|Actual|Lovisenberg Diakonale Hospital||2|||f||||f||||||||||2017-10-10 22:23:00.730954|2017-10-10 22:23:00.730954
NCT02712905|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-04-10|||May 2016||2016-05-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies|A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies|Recruiting||Phase 1/Phase 2|108|Anticipated|Incyte Corporation||1|||f||||t||||||||||2017-10-10 22:23:00.810045|2017-10-10 22:23:00.810045
NCT02712892|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-14|||April 2016||2016-04-01|February 2016|2016-02-01|April 2018|Anticipated|2018-04-01|April 2016|Anticipated|2016-04-01||Observational|I-CAN||I-CAN Biocollection|IntraCranial ANeurysms: From Familial Forms to Pathophysiological Mechanisms|Not yet recruiting||N/A|1060|Anticipated|Nantes University Hospital|||1||f||||f||||||Samples With DNA|"     For one patient included:        -  2 Ethylenediaminetetraacetic acid (EDTA) tubes for DNA (5mL)        -  2 dry tubes for serum (5mL)   "|No||2017-10-10 22:23:00.910553|2017-10-10 22:23:00.910553
NCT02712879|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-06-10|||March 2016||2016-03-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SPO||Moderate Bleeding in Cardiac Surgery Post Operative|Bleeding Moderate Postoperative Cardiac Surgery and Prognostic Implications Anemia and Postoperative Transfusion: Prospective, Observational, Descriptive.|Recruiting||N/A|300|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||Undecided||2017-10-10 22:23:01.062477|2017-10-10 22:23:01.062477
NCT02712866|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-06-03|||July 2016||2016-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.|EARLY BIOMARKERS IN CIRCULATING α 4β7+ T CELLS TO PREDICT RESPONSE TO VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS|Not yet recruiting||N/A|24|Anticipated|Parc de Salut Mar|||1||f||||f||||||||No||2017-10-10 22:23:01.134783|2017-10-10 22:23:01.134783
NCT02712853|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-05-17|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Improving Autism Screening With Brain-Related miRNA|Improving Autism Screening With Brain-Related miRNA|Recruiting||N/A|300|Anticipated|Milton S. Hershey Medical Center|||2||f||||t||||||Samples Without DNA|"     Salivary RNA   "|No|IPD will not be made available|2017-10-10 22:23:01.215713|2017-10-10 22:23:01.215713
NCT02712840|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-03-14|||September 2015||2015-09-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparing Pregnancy Outcomes in Good Prognosis Patients Between Fresh and 'Freeze-All' Single Blastocyst Transfers|Pregnancy Outcomes in Good Prognosis Patients Utilizing Fresh Single Blastocyst Transfer vs. 'Freeze-All' and Delayed Frozen Single Blastocyst Transfer|Recruiting||N/A|118|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-10 22:23:01.317831|2017-10-10 22:23:01.317831
NCT02712827|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-18|||March 2016||2016-03-01|March 2016|2016-03-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of Different Meshes in Laparoscopic Hernia Repair|A Randomized Controlled Trial Comparing Short Term Outcomes of Self-gripping (Progrip) Mesh With Fibrin Glue Mesh Fixation in Laparoscopic Total Extraperitoneal (TEP) Inguinal Hernia Repair|Recruiting||N/A|150|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 22:23:01.434414|2017-10-10 22:23:01.434414
NCT02712814|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-09-02|||August 2016||2016-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Observational|||Subtypes of Provoked Vestibulodynia|Subtypes of Provoked Vestibulodynia: A Prospective Study to Evaluate a Diagnostic Algorithm in Regard to Different Treatment Modalities|Recruiting||N/A|500|Anticipated|Meir Medical Center|||6||f||||f||||||||No||2017-10-10 22:23:01.563557|2017-10-10 22:23:01.563557
NCT02712788|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-11-08|||April 2016||2016-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage|Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage|Recruiting||Phase 2|125|Anticipated|Indiana University||2|||f||||t||||||||No||2017-10-10 22:23:01.949986|2017-10-10 22:23:01.949986
NCT02712775|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-10-13|||March 2016||2016-03-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|June 2016|Anticipated|2016-06-01||Interventional|||Minocycline Administration During Human Liver Transplantation|Minocycline Administration During Human Liver Transplantation|Withdrawn||Phase 4|0|Actual|Medical University of South Carolina||2||Study logistics|f||||||||||||||2017-10-10 22:23:02.082594|2017-10-10 22:23:02.082594
NCT02712762|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-10-04|||June 2016||2016-06-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients|Dry Eye and Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients|Recruiting||N/A|30|Anticipated|Singapore National Eye Centre|||1||f||||f||||||||||2017-10-10 22:23:02.182406|2017-10-10 22:23:02.182406
NCT02712749|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-10-13|||September 2016||2016-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||"Binaural Beats as Non-drug Premedication in Elderly for Major Surgery."|"Binaural Beats as Non-drug Premedication for Anxiety Reduction in Elderly Submitted to Major Surgery. A Randomized Controlled Trial."|Recruiting||N/A|50|Anticipated|L'Azienda USL Nord Ovest||2|||f||||f||||||||No||2017-10-10 22:23:02.297745|2017-10-10 22:23:02.297745
NCT02712736|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-02-24|||July 1, 2016|Actual|2016-07-01|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|QOL in PSC||Quality of Life in Patients With Primary Sclerosing Cholangitis|Quality of Life in Primary Sclerosing Cholangitis|Recruiting||N/A|250|Anticipated|Duke University||1|||f||||f||||||||No||2017-10-10 22:23:02.402274|2017-10-10 22:23:02.402274
NCT02712723|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-24|||February 2016||2016-02-01|August 2017|2017-08-01|April 2023|Anticipated|2023-04-01|April 2018|Anticipated|2018-04-01||Interventional|FELINE||Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer|Femara (Letrozole) Plus Ribociclib (LEE011) or Placebo as Neo-adjuvant Endocrine Therapy for Women With ER-positive, HER2-negative Early Breast Cancer|Recruiting||Phase 2|120|Anticipated|University of Kansas Medical Center||3|||f||||t||||||||||2017-10-10 22:23:02.499953|2017-10-10 22:23:02.499953
NCT02712697|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-03-17|||June 2016||2016-06-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Integrative Medicine of IgA Nephropathy|Treatment of Shentong Granules Plus Prednisone on Patients With Severe IgA Nephropathy(Ying-deficiency of the Liver and Kidney Pattern): a Randomized, Double-blind,Placebo-controlled Multicentre Clinical Trial|Not yet recruiting||N/A|140|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-10 22:23:02.7676|2017-10-10 22:23:02.7676
NCT02712684|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-08-08|||July 2015||2015-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|CADMUS||Cancer Diagnosis by Multiparametric UltraSound of the Prostate|Multi-parametric Ultrasound Targeted Biopsies Compared to Multi-parametric MRI Targeted Biopsies in the Diagnosis of Clinically Significant Prostate Cancer|Recruiting||N/A|500|Anticipated|University College, London|||1||f||||t||||||||No||2017-10-10 22:23:02.910273|2017-10-10 22:23:02.910273
NCT02712671|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-05-30|||June 2013||2013-06-01|May 2017|2017-05-01|September 2024|Anticipated|2024-09-01|February 2016|Actual|2016-02-01||Observational|||Testing for Tuberculosis in the United Kingdom HIV Infected Population|Study of Systematic Tuberculosis Testing for Active, Sub-clinical and Latent Tuberculosis Infection in a United Kingdom Human Immunodeficiency Virus (HIV) Infected Cohort|Active, not recruiting||N/A|300|Anticipated|University College, London|||1||f||||f||||||Samples Without DNA|"     Blood plasma and serum   "|No||2017-10-10 22:23:03.048418|2017-10-10 22:23:03.048418
NCT02712658|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2017-01-29|||September 2015||2015-09-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Role of K+ and Ca2+ in Development of Muscle Fatigue||Completed||N/A|10|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-10 22:23:03.228114|2017-10-10 22:23:03.228114
NCT02712645|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-04-04|||February 2016||2016-02-01|April 2016|2016-04-01||||December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|||A Multicenter Breast Cancer Biospecimen Registry||Recruiting||N/A|700|Anticipated|Luminist, Inc.|||1||f||||||||||||||2017-10-10 22:23:03.334674|2017-10-10 22:23:03.334674
NCT02712632|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-11-29|||April 2016||2016-04-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|GoDARTS||Genetics of Diabetes Audit and Research in Tayside and Scotland|Genetics of Diabetes Audit and Research in Tayside and Scotland|Recruiting||Phase 4|6000|Anticipated|University of Dundee|||1||f||||f||||||Samples With DNA|"     At visit 1 blood samples will be collected for DNA and RNA extraction. Urine samples will be     collected to measure for biomarkers. Stool samples will be collected to measure for     microbiota. (Stool samples will only be collected from those patients who are initiated on     metformin therapy during the study period.      For those patients who are commenced on metformin therapy during the study a second study     visit is required where all blood, urine and stool samples will be repeated.   "|||2017-10-10 22:23:03.405685|2017-10-10 22:23:03.405685
NCT02712619|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-14|||May 2014||2014-05-01|March 2016|2016-03-01||||September 2014|Actual|2014-09-01||Interventional|||Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy Volunteers|An Open-label, Parallel Group Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of 250/1000 mg of Metformin IR After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 22:23:03.481546|2017-10-10 22:23:03.481546
NCT02712606|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-06-16|||March 2016||2016-03-01|June 2016|2016-06-01||||March 2017|Anticipated|2017-03-01||Observational|bluesensor||Accuracy of Pulse Oximeter With Hypoxemic Measurements|A Study About Accuracy of Pulse Oximeter With Hypoxemic Measurements (Blue Sensor) in Children With Cyanotic Congenital Heart Disease|Recruiting||N/A|280|Anticipated|Seoul National University Hospital|||1||f||||||||||||||2017-10-10 22:23:03.563922|2017-10-10 22:23:03.563922
NCT02712593|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-02-16|||March 2016||2016-03-01|February 2017|2017-02-01||||June 2017|Anticipated|2017-06-01||Interventional|15NRHC||A Study Investigating the Effects of Niagen™ in Healthy Adults.|A Randomized, Double-blind, Placebo Controlled Parallel Study Investigating the Effects of Niagen™ (Nicotinamide Riboside) on Niagen™ Metabolites in Healthy Adults.|Active, not recruiting||Phase 2|140|Anticipated|KGK Synergize Inc.||4|||f||||f||||||||||2017-10-10 22:23:03.639549|2017-10-10 22:23:03.639549
NCT02712580|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-03-14|||April 2016||2016-04-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|ELSTHER||Therapeutic Effect of the Wireless Micro Current Stimulation in Pediatric Deep Dermal Burns and Scald Injuries|Clinical Trial for Therapeutic Effect of Wireless Micro Current Stimulation Under Objectification of Combustion Depth by Laser Doppler Imaging in Children and Adolescents With Deep Dermal Burns and Scald Injuries|Not yet recruiting||N/A|188|Anticipated|Kinderkrankenhaus auf der Bult||4|||f||||t||||||||No||2017-10-10 22:23:03.747155|2017-10-10 22:23:03.747155
NCT02712567|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-12||||||October 2016|2016-10-01||||||||Expanded Access|||SARC021C: A Continuation Study of TH-CR-406/SARC021|A Continuation Study of TH-CR-406/SARC021 for the Remaining Subjects Enrolled in TH-CR-406/SARC021 in the US|No longer available||N/A|||Sarcoma Alliance for Research through Collaboration|||||||||||||||||||2017-10-10 22:23:03.878277|2017-10-10 22:23:03.878277
NCT02712541|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-03-14|||January 2016||2016-01-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Caregiver Burden and Wellbeing in Relatives of Intensive Care Unit Patients|Caregiver Burden and Wellbeing in Relatives of Intensive Care Unit Patients|Recruiting||N/A|130|Anticipated|Karolinska University Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:23:04.029486|2017-10-10 22:23:04.029486
NCT02712528|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-03-15|||May 2015||2015-05-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Recovery Profiles of Remifentanil-based Regimen for Cardiac Surgery|Recovery Profiles of Remifentanil-based vs. Sevoflurane-sufentanil Combined Regimen for Cardiac Surgery|Recruiting||Phase 4|82|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:23:04.126289|2017-10-10 22:23:04.126289
NCT02712515|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-03|||March 2016||2016-03-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||The Motor Network in Essential Tremor: Mechanisms of Therapy|The Motor Network in Essential Tremor: Mechanisms of Therapy|Recruiting||N/A|100|Anticipated|University of Florida|||2||f||||t||||||||||2017-10-10 22:23:04.227282|2017-10-10 22:23:04.227282
NCT02712502|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-14|||September 2014||2014-09-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|Levolet||Levofloxacin in Bacterial Rhinosinussitis|Open-label Comparative Safety and Efficacy Study of Levofloxacin and Amoxicillin Clavulanic Acid in Patients With Acute ,Bacterial Rhinosinusitis|Completed||N/A|100|Actual|Dr. Reddy's Laboratories Limited|||2||f||||f||||||||No||2017-10-10 22:23:04.326791|2017-10-10 22:23:04.326791
NCT02712489|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-12-28|||January 2015||2015-01-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Observational|ISST-003EF-UP||A Roll-over Observational Study for the Extended Follow-up of the Volunteers of the ISS T-003 Trial|A Roll-over Observational Study for the Extended Follow-up of the Volunteers of the ISS T-003 Trial (ISS T-003 EF-UP)|Completed||N/A|179|Actual|Istituto Superiore di Sanità|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 22:23:04.409317|2017-10-10 22:23:04.409317
NCT02712463|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2016-05-23|||July 2015||2015-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|REALAI||A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics|A Retrospective, Observational Study to Assess the Rate of Hospitalization in Patients With Schizophrenia Treated One Year Before With Oral Antipsychotics and One Year After With Long Acting Injectable Atypical Antipsychotics - REALAI Study|Completed||Phase 4|310|Actual|Janssen-Cilag Ltd.|||1||f||||f||||||||||2017-10-10 22:23:04.593754|2017-10-10 22:23:04.593754
NCT02712450|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-08-08|||January 2016||2016-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|REGESA||Tools Development for Geriatric Emergency Regulation|Tools Development for Geriatric Emergency Regulation at the Emergency Service Centre, in the Rhône Area|Active, not recruiting||N/A|1920|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:23:04.704205|2017-10-10 22:23:04.704205
NCT02712437|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-09-05|||March 16, 2016|Actual|2016-03-16|September 2017|2017-09-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer|Prospective Study Evaluating the Use of PROSPECT, a Cognitive Behavioral Therapy-based Internet Module, to Reduce Insomnia in Patients With Early Stage Breast Cancer|Terminated||N/A|4|Actual|University of Michigan Cancer Center||1||The study was terminated because of low accrual.|f||||t||||||||||2017-10-10 22:23:04.785254|2017-10-10 22:23:04.785254
NCT02712424|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-03-23|||March 2016||2016-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|DAR-PIA||DAR-901 TB Booster Vaccine to Prevent TB in Adolescents|A Phase 2, Randomized, Placebo-Controlled, Double-Blind, Study of the Prevention of Infection With Mycobacterium Tuberculosis Among Adolescents Who Have Previously Received BCG|Active, not recruiting||Phase 2|650|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 22:23:04.879116|2017-10-10 22:23:04.879116
NCT02712411|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-14|||July 2015||2015-07-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers|A Randomized, Open-Label, Crossover, Single-Dose Study to Compare Pharmacokinetic Properties and Safety After Administration of HCP1303 Capsule and Co-administration of HGP1201 Tablet, HIP1402 Capsule in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 22:23:04.961344|2017-10-10 22:23:04.961344
NCT02712398|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-05-17|||April 2016||2016-04-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|October 2017|Anticipated|2017-10-01||Interventional|ATLAS||A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair|A Prospective, Multi-center Trial of a Long-term Bio-Absorbable Mesh With Sepra Technology in Challenging Laparoscopic Ventral or Incisional Hernia Repair|Recruiting||N/A|120|Anticipated|C. R. Bard||1|||f||||f||||||||Undecided||2017-10-10 22:23:05.059436|2017-10-10 22:23:05.059436
NCT02712385|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2017-06-30|||March 2016||2016-03-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|SPRITE||SPRITE - A Feasibility and Pilot Study|Stroke Prevention Rehabilitation Intervention Trial of Exercise - SPRITE - A Feasibility and Pilot Study|Recruiting||N/A|75|Anticipated|Queen's University, Belfast||4|||f||||t||||||||||2017-10-10 22:23:05.227269|2017-10-10 22:23:05.227269
NCT02712372|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-01-05|||June 2016||2016-06-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male Subjects|A Phase I, Randomised, Single-Blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4831 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects|Terminated||Phase 1|104|Actual|AstraZeneca||10|||f||||f||||||||||2017-10-10 22:23:05.352914|2017-10-10 22:23:05.352914
NCT02701127|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-10|||March 2016||2016-03-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury||Active, not recruiting||Early Phase 1|60|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||f||||||||||2017-10-10 22:25:04.929785|2017-10-10 22:25:04.929785
NCT02712359|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-03|||June 1, 2016||2016-06-01|August 2017|2017-08-01|March 20, 2020|Anticipated|2020-03-20|March 20, 2020|Anticipated|2020-03-20||Interventional|||This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama in 2007-2008|Long Term Hepatitis A Virus (HAV) Antibody Persistence in Children Vaccinated With 1 Dose and Those Vaccinated With 2 Doses of Havrix® in Panama|Recruiting||N/A|600|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 22:23:05.959817|2017-10-10 22:23:05.959817
NCT02712346|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-06-28|||September 2015||2015-09-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Role of Endothelin-1 in Sickle Cell Disease|The Role of Endothelin-1 in Sickle Cell Disease|Recruiting||Phase 1|30|Anticipated|Augusta University||2|||f||||f||||||||||2017-10-10 22:23:06.062227|2017-10-10 22:23:06.062227
NCT02712333|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-05-05|2016-12-07||November 2015||2015-11-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Health Effects of Indoor Air Filtration in Healthy Chinese Adults|Health Effects of Indoor Air Filtration in Healthy Chinese Adults: An Intervention Study|Completed||N/A|60|Actual|Fudan University||2|||f||||t||||||||Undecided||2017-10-10 22:23:06.177855|2017-10-10 22:23:06.177855
NCT02712320|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-03|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|May 2017|Actual|2017-05-01||Interventional|||Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg|An Open-Label, Single-Arm Study of the Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate for Injectable Suspension (LMIS 50 mg) in Subjects With Advanced Prostate Carcinoma - SAFETY EXTENSION|Active, not recruiting||Phase 3|30|Actual|Foresee Pharmaceuticals Co., Ltd.||1|||f||||f|t|f||||||||2017-10-10 22:23:06.868684|2017-10-10 22:23:06.868684
NCT02712307|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of 5 and 10 Days Treatment With Penicillin Against Sore Throat Caused by Streptococci|A Randomized Controlled Study of 5 and 10 Days Treatment With Phenoxymethylpenicillin for Pharyngotonsillitis Caused by Streptococcus Group A|Recruiting||Phase 4|432|Anticipated|Public Health Agency of Sweden||2|||f||||t||||||||No||2017-10-10 22:23:07.037118|2017-10-10 22:23:07.037118
NCT02712294|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-07-05|||June 2014||2014-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Impact of Peripheral Neuromuscular Electrical Stimulation on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension|Impact of Peripheral Neuromuscular Electrical Stimulation on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension|Recruiting||N/A|30|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t||||||||||2017-10-10 22:23:07.257982|2017-10-10 22:23:07.257982
NCT02712281|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-06-15|||July 2016||2016-07-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety|Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety|Recruiting||N/A|40|Anticipated|Emory University||2|||f||||t||||||||No||2017-10-10 22:23:07.44599|2017-10-10 22:23:07.44599
NCT02712268|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-01-02|||September 2013||2013-09-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Intervention to Improve Prescribing in Elderly Patients|Intervention to Improve Appropriate Prescribing and Reduce Polypharmacy in Elderly Patients Admitted to an Internal Medicine Unit|Completed||N/A|450|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||Yes|De-identified individual participant data are available.|2017-10-10 22:23:07.573826|2017-10-10 22:23:07.573826
NCT02712255|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-09-23|||March 2016||2016-03-01|September 2016|2016-09-01||||March 2019|Anticipated|2019-03-01||Interventional|||Effects of Individual, Dyadic, and Collaborative Plans on Physical Activity in Patient-Partner Dyads|Physical Activity, and Health-Related Quality of Life: Dyadic Research in the Context of Forming Individual, Dyadic, and Collaborative Plans (Trial 2: Patient-Partner Dyads)|Recruiting||N/A|400|Anticipated|University of Social Sciences and Humanities, Warsaw||4|||f||||f||||||||Yes|Data will be made publicly available in 3 years after the completion of the trial|2017-10-10 22:23:07.674448|2017-10-10 22:23:07.674448
NCT02712242|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-14|||November 2013||2013-11-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||PRF for Accelerating Palatal Healing|The Effects of Platelet-Rich Fibrin on Palatal Wound Healing After Free Gingival Graft Harvesting: A Comparative Randomized Controlled Clinical Trial|Completed||N/A|125|Actual|Cukurova University||3|||f||||f||||||||No||2017-10-10 22:23:07.808435|2017-10-10 22:23:07.808435
NCT02712229|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-09-27|||April 2016||2016-04-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|June 2020|Anticipated|2020-06-01||Interventional|CONNECT||A Primary Palliative Care Intervention for Patients With Advanced Cancer|A Cluster Randomized Trial of a Primary Palliative Care Intervention (CONNECT) for Patients With Advanced Cancer|Recruiting||N/A|1486|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:23:07.89839|2017-10-10 22:23:07.89839
NCT02712216|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-11-22|||February 2016||2016-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Evaluation of Abdominal Wall Thickness at Possible Trocar Sites Based on Body Mass Index|Evaluation of Abdominal Wall Thickness at Possible Trocar Sites Based on Body Mass Index|Completed||N/A|50|Actual|University of Mississippi Medical Center||1|||f||||f||||||||No||2017-10-10 22:23:08.04136|2017-10-10 22:23:08.04136
NCT02712203|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-14|||July 2004||2004-07-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|July 2010|Actual|2010-07-01||Observational|||MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.|Measles-mumps-rubella and Measles-mumps-rubella-varicella Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.|Active, not recruiting||N/A|5808|Actual|CHU de Quebec-Universite Laval|||4||f||||f||||||||||2017-10-10 22:23:08.130023|2017-10-10 22:23:08.130023
NCT02712190|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-07-24|||March 2016||2016-03-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ANIV||Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation.|Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation.|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 22:23:08.229669|2017-10-10 22:23:08.229669
NCT02700906|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-03-01|||January 2014||2014-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Corticosteroid and Lidocain Injections for Tennis Elbow|Corticosteroid and Lidocain Injections for Tennis Elbow|Completed||N/A|60|Actual|Shin Kong Wu Ho-Su Memorial Hospital||2|||f||||f||||||||No||2017-10-10 22:25:07.52071|2017-10-10 22:25:07.52071
NCT02712177|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-17|||August 2008||2008-08-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|August 2010|Actual|2010-08-01||Observational|||Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization|Interaction Between Meningococcal Serogroup B Vaccine (Bexsero™) and Routine Infant Vaccines on the Risk of Occurrence and Recurrence of Adverse Events Following Immunization.|Active, not recruiting||N/A|4535|Actual|CHU de Quebec-Universite Laval|||7||f||||f||||||||No||2017-10-10 22:23:08.36261|2017-10-10 22:23:08.36261
NCT02712164|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-06-05|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Molecular, Histologic, and Clinical Analysis of Negative Pressure Wound Therapy (NPWT) for Split-thickness Skin Graft (STSG) Donor Sites|Molecular, Histologic, and Clinical Analysis of Negative Pressure Wound Therapy (NPWT) for Split-thickness Skin Graft (STSG) Donor Sites|Withdrawn||N/A|0|Actual|Brigham and Women's Hospital||2||Lack of resources.|f||||t|f|f||||||||2017-10-10 22:23:08.504735|2017-10-10 22:23:08.504735
NCT02712151|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-06-29|||August 2018|Anticipated|2018-08-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Efficacy of Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy|Efficacy of Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Pain Control in Laparoscopic Cholecystectomy: Prospective Randomized Controlled Trial in Pediatric Patients|Not yet recruiting||Phase 3|80|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f|||f|||||2017-10-10 22:23:08.601039|2017-10-10 22:23:08.601039
NCT02712125|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-14|||August 2013||2013-08-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Nitric Oxide Donors for Treatment of Isolated Oligohydramnios|Nitric Oxide Donors for Treatment of Isolated Oligohydramnios: A Pilot Study|Completed||Phase 2/Phase 3|100|Actual|Benha University||2|||f||||t||||||||||2017-10-10 22:23:08.865373|2017-10-10 22:23:08.865373
NCT02712112|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-14|||January 2016||2016-01-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs|Randomized Phase 2 Study of Intermittent vs Continuous Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors (GISTs)|Recruiting||Phase 2|50|Anticipated|Asan Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:23:08.952029|2017-10-10 22:23:08.952029
NCT02712099|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-04-09|2017-02-21||August 2015||2015-08-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational||Fifty pregnant women In whom the transabdominal scan revealed evidence of anterior placenta previa were recruited from the the Fetal Care Unit who fulfilled the inclusion criteria.|TUI 3D in Diagnosis of Placenta Accreta: Comparison With Gray-scale and Color Doppler Techniques|TUI 3D in Diagnosis of Placenta Accreta: Comparison With Gray-scale and Color Doppler Techniques|Completed||N/A|50|Actual|Ain Shams University|||1||f||||t||||||||Yes|"TUI 3D in Diagnosis of Placenta Accreta: Comparison with Gray-scale and Color Doppler Techniques
This is a prospective study which will include 50 patients who will be selected from the outpatient and inpatient obstetric Ain Shams university maternity hospital.
Patient consent should be taken first."|2017-10-10 22:23:09.048251|2017-10-10 22:23:09.048251
NCT02712086|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-22|||April 2016||2016-04-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|April 2016|Anticipated|2016-04-01||Interventional|PROTISLEEVE||Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery|Randomized Controlled Trial Prospective Single-center Open Evaluating the Efficacy of Supplementation (Adapted to the Post-operative Period) Current Protein After Bariatric Surgery Like Sleeve Gastrectomy|Not yet recruiting||N/A|74|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||Undecided||2017-10-10 22:23:09.350853|2017-10-10 22:23:09.350853
NCT02712073|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-04-12|||May 2015||2015-05-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|PREPA-CO||Predictive Score of the Bowel Preparation Quality Based on a Self-administered Questionnaire|Predictive Score of the Bowel Preparation Quality Based on a Self-administered Questionnaire|Recruiting||N/A|1260|Anticipated|University Hospital, Angers|||1||f||||f||||||||No||2017-10-10 22:23:09.435859|2017-10-10 22:23:09.435859
NCT02712060|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-05-12|||March 2016||2016-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Obstructive Sleep Apnoea in Children and Adolescents With Ehlers-Danlos Syndrome|Obstructive Sleep Apnoea in Children and Adolescents With Ehlers-Danlos Syndrome|Completed||N/A|50|Actual|University of Zurich|||2||f||||f||||||||||2017-10-10 22:23:09.519697|2017-10-10 22:23:09.519697
NCT02712047|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-05-08|||April 29, 2016|Actual|2016-04-29|May 2017|2017-05-01|February 21, 2017|Actual|2017-02-21|February 21, 2017|Actual|2017-02-21||Interventional|||A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.|A Randomised, Placebo-controlled, Double-blind, Two Period Crossover Study to Characterise the Exhaled Nitric Oxide Time Profile as a Biomarker of Airway Inflammation in Adult Asthma Patients Following Repeat Administration of Inhaled Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 mcg.|Completed||Phase 2|28|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 22:23:09.595116|2017-10-10 22:23:09.595116
NCT02712008|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-07-05|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|RUBY||Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema|A Randomized, Double-Masked, Active-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal REGN910-3 in Patients With Diabetic Macular Edema|Active, not recruiting||Phase 2|304|Actual|Regeneron Pharmaceuticals||3|||f||||t||||||||||2017-10-10 22:23:09.921982|2017-10-10 22:23:09.921982
NCT02711995|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-02-21|||September 2015||2015-09-01|February 2017|2017-02-01|September 29, 2016|Actual|2016-09-29|September 29, 2016|Actual|2016-09-29||Interventional|||Essential Voice Tremor: A Study of Botulinum Toxin Treatment and Injection Augmentation|Essential Voice Tremor: An Unblinded Crossover Study of Botulinum Toxin Treatment and Injection Augmentation|Completed||N/A|7|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||No||2017-10-10 22:23:10.103113|2017-10-10 22:23:10.103113
NCT02711982|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-16|||January 2010||2010-01-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Surgery for Traumatic Optic Neuropathy|Clinical Treatment of Traumatic Optic Neuropathy: Optic Nerve Decompression Randomized Controlled Study|Recruiting||N/A|2|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||No||2017-10-10 22:23:10.190699|2017-10-10 22:23:10.190699
NCT02711969|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-01-30|||March 2016||2016-03-01|March 2016|2016-03-01||||November 2016|Actual|2016-11-01||Interventional|||A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment|A PhaseⅠStudy of Apatinib Mesylate (YN968D1) 1,000mg in Patients With Unresectable Locally Advanced or Metastatic Gastric Cancer Failed to Standard Therapy|Recruiting||Phase 1|6|Anticipated|Bukwang Pharmaceutical||1|||f||||||||||||||2017-10-10 22:23:10.320469|2017-10-10 22:23:10.320469
NCT02711956|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-03-28|||December 2016||2016-12-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer|A Phase 1b Safety and Tolerability Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 1|58|Anticipated|Zenith Epigenetics||1|||f||||f||||||||No||2017-10-10 22:23:10.400254|2017-10-10 22:23:10.400254
NCT02711943|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-16|||July 2013||2013-07-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Observational|Levolet-R||Non Interventional Study of Levofloxacin in Chronic Prostatitis|Non-interventional (Observational) Study of the Administration of Levolet® R, Film-coated Tablets (Dr. Reddy's Laboratories Ltd., India) in Adults With Chronic Prostatitis in Routine Clinical Practice|Completed||N/A|500|Actual|Dr. Reddy's Laboratories Limited|||1||f||||f||||||||No||2017-10-10 22:23:10.505637|2017-10-10 22:23:10.505637
NCT02711930|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-07-07|||May 2016||2016-05-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Effect of Prone Positioning on Intra-ocular Pressure in ARDS Patients|Effect of Prone Positioning on Intra-ocular Pressure in Patients With Acute Respiratory Distress Syndrome (ARDS)|Recruiting||N/A|25|Anticipated|Sanjay Gandhi Postgraduate Institute of Medical Sciences|||1||f||||f||||||||||2017-10-10 22:23:12.256381|2017-10-10 22:23:12.256381
NCT02711917|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-16|||July 2015||2015-07-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane|Consumption of Rocuronium Under Etomidate-based Versus Propofol-based Maintenance of General Anesthesia Under Different Concentration of Sevoflurane- BIS Guided Clinical Trial in a Closed Loop Infusion System|Completed||N/A|175|Actual|Tianjin Medical University General Hospital||8|||f||||t||||||||Undecided||2017-10-10 22:23:12.364536|2017-10-10 22:23:12.364536
NCT02711904|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-03-16|||January 2011||2011-01-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|January 2011|Actual|2011-01-01||Interventional|REMEX||Concentrations of Remifentanil for Extubation|Effect of Two Plasma Concentrations of Remifentanil Through Target Controlled Anesthesia on Frequency and Intensity of Coughing During Extubation: Randomized Controlled Clinical Trial|Completed||Phase 4|110|Actual|Seganest||2|||f||||t||||||||No|The individual data of the participants (IPD) were only available to the ethics committee of the institution.|2017-10-10 22:23:12.500595|2017-10-10 22:23:12.500595
NCT02711865|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-03-13|||May 2016||2016-05-01|March 2016|2016-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer||Not yet recruiting||N/A|20|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||Samples Without DNA|"     Tumors that will be removed from women operated on for ovarian cancer.   "|No||2017-10-10 22:23:12.966085|2017-10-10 22:23:12.966085
NCT02711852|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-15|2017-07-28|||April 2016||2016-04-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||A Long-term, Continued Treatment and Follow-up Study in Subjects With Hematologic Malignancies Treated With Duvelisib (IPI-145)|A Long-term, Continued Treatment and Follow-up Study in Subjects With Hematologic Malignancies Treated With Duvelisib (IPI-145)|Active, not recruiting||Phase 2|500|Anticipated|Verastem, Inc.||1|||f||||f||||||||||2017-10-10 22:23:13.064581|2017-10-10 22:23:13.064581
NCT02711839|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-10-14|||August 2015||2015-08-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions|Office of Human Research, Taipei Medical University|Unknown status|Active, not recruiting|Phase 2/Phase 3|50|Actual|Taipei Medical University||2|||f||||t||||||||No||2017-10-10 22:23:13.150084|2017-10-10 22:23:13.150084
NCT02711826|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-07-18|||May 2016||2016-05-01|July 2017|2017-07-01|October 1, 2021|Anticipated|2021-10-01|October 1, 2021|Anticipated|2021-10-01||Interventional|TASK||Treg Therapy in Subclinical Inflammation in Kidney Transplantation|Treg Adoptive Therapy in Subclinical Inflammation in Kidney Transplantation (CTOT-21)|Recruiting||Phase 1/Phase 2|45|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-10 22:23:13.277732|2017-10-10 22:23:13.277732
NCT02711813|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-12-05|||March 2016||2016-03-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment|Study to Assess Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of TAB08 in Patients With Systemic Lupus Erythematosus, Not Adequately Controlled With Current Concomitant Therapy|Recruiting||Phase 2|60|Anticipated|Theramab LLC||3|||f||||f||||||||No||2017-10-10 22:23:13.547202|2017-10-10 22:23:13.547202
NCT02711800|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-10-05|||November 8, 2016|Actual|2016-11-08|October 2017|2017-10-01|September 18, 2017|Actual|2017-09-18|September 18, 2017|Actual|2017-09-18||Interventional|||The Probiotic Study: Using Bacteria to Calm Your Mind|Probiotic Treatment: The Role of the Gut Microbiome in Childhood Abdominal Pain and Anxiety|Completed||Phase 2|9|Actual|Duke University||1|||f||||t||||||||||2017-10-10 22:23:13.63277|2017-10-10 22:23:13.63277
NCT02711787|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-11|||July 2014||2014-07-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy of Robot-Assisted Rehabilitation of Hand Paralysis After Stroke|Efficacy of Short-Term Robot-Assisted Rehabilitation in Patients With Hand Paralysis After Stroke: a Randomized Clinical Trial|Completed||N/A|32|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||No||2017-10-10 22:23:13.721255|2017-10-10 22:23:13.721255
NCT02711774|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-11-15|||August 2016||2016-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Changes in Optic Nerve Sheath Diameter in Response to Various Levels of End Tidal Carbon Dioxide Levels|Changes in Optic Nerve Sheath Diameter in Response to Various Levels of End Tidal Carbon Dioxide Levels in Healthy Patients Under General Anaesthesia|Completed||N/A|30|Actual|All India Institute of Medical Sciences, New Delhi|||1||f||||t||||||||Undecided||2017-10-10 22:23:13.803641|2017-10-10 22:23:13.803641
NCT02711761|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-07-08|||September 2015||2015-09-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Ideal Depth of Guide Wire for Central Catheterization|Ideal Depth of Guide Wire for Right Internal Jugular Vein During Central Line Insertion|Completed||N/A|69|Actual|Seoul National University Hospital||3|||f||||||||||||||2017-10-10 22:23:13.875591|2017-10-10 22:23:13.875591
NCT02711748|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-16|||February 2016||2016-02-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Can Medical Personnel Properly Proceed in the Case of a Patient With Bradycardia?|Can Medical Personnel Properly Proceed in the Case of a Patient With Bradycardia?|Recruiting||N/A|80|Anticipated|Medical University of Warsaw||2|||f||||f||||||||Undecided||2017-10-10 22:23:13.964549|2017-10-10 22:23:13.964549
NCT02711735|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-16|||June 2016||2016-06-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety of RUTI® Vaccination in MDR-TB Patients|Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Investigate the Safety and Immunogenicity of RUTI® Therapeutic Vaccination in Patients With Multi-Drug Resistant Tuberculosis After Successful Intensive-phase Treatment.|Not yet recruiting||Phase 2|27|Anticipated|University Medical Center Groningen||2|||f||||t||||||||Yes||2017-10-10 22:23:14.05023|2017-10-10 22:23:14.05023
NCT02711722|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-04-14|||June 2015||2015-06-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||NAVA Unloading - Effects on Distribution of Ventilation|Reduced Unloading in NAVA Improves Distribution of Ventilation in ICU Patients|Recruiting||N/A|12|Anticipated|Karolinska University Hospital||5|||f||||t||||||||No||2017-10-10 22:23:14.134259|2017-10-10 22:23:14.134259
NCT02711709|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-23|||April 2016||2016-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care and Induced Frailty|"Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care Subtitle: The Acute Development and Persistence of Frailty, Comorbidity and Disability in Critically Ill Patients After Intra-abdominal Sepsis Induced Frailty"|Recruiting||N/A|100|Anticipated|University of Florida||1|||f||||f||||||||No||2017-10-10 22:23:14.249804|2017-10-10 22:23:14.249804
NCT02711696|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-10-26|||March 2014||2014-03-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Interventional|GluCED||Randomized Clincal Trial on the Effect of a Restricted Gluten Contamination Elimination Diet Among Celiacs [GluCED]|Randomized Clincal Trial on the Effect of a Restricted Gluten Contamination Elimination Diet in Achieving Complete Mucosal Healing Among Celiac Patients With Persisting Minimal Duodenal Lesions During Gluten Free Diet [GluCED]|Completed||N/A|30|Actual|Università degli Studi di Brescia||2|||f||||f||||||||No||2017-10-10 22:23:14.349812|2017-10-10 22:23:14.349812
NCT02711683|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-02-05|||March 2016||2016-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil|DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil : A Multi Center, Prospective Cohort Stud|Recruiting||N/A|120|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||f||||||||Yes||2017-10-10 22:23:14.429008|2017-10-10 22:23:14.429008
NCT02711670|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-03-16|||February 2014||2014-02-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium|Night-time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium|Recruiting||N/A|10|Anticipated|VA New York Harbor Healthcare System||1|||f||||f||||||||||2017-10-10 22:23:14.517816|2017-10-10 22:23:14.517816
NCT02711657|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-04-20|||January 2016||2016-01-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|June 2016|Actual|2016-06-01||Interventional|||Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease.|Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease.|Completed||N/A|50|Actual|Odense University Hospital||1|||f||||f||||||||No||2017-10-10 22:23:14.608967|2017-10-10 22:23:14.608967
NCT02711631|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation|Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation|Recruiting||N/A|20|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 22:23:14.792122|2017-10-10 22:23:14.792122
NCT02711618|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-05|||October 29, 2015|Actual|2015-10-29|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Non-Invasive Abdominal Fat Reduction With BMI Above 28|Clinical Study to Evaluate the Performance of the UltraShape Contour I V3 for Non-Invasive Abdominal Fat Reduction Among Patients With BMI Above 28|Active, not recruiting||N/A|47|Actual|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 22:23:14.887643|2017-10-10 22:23:14.887643
NCT02711605|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-04-05|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||UltraShape Device for Non-Invasive Fat Reduction in the Male Breast (Pseudogynecomastia)|Clinical Evaluation of the UltraShape Device for Non-Invasive Fat Reduction in the Male Breast (Pseudogynecomastia)|Recruiting||N/A|40|Anticipated|Syneron Medical||2|||f||||f|f|t|f|f||||Undecided||2017-10-10 22:23:14.989421|2017-10-10 22:23:14.989421
NCT02711592|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2017-04-28|||March 2016||2016-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study|Utilizing Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: A Pilot Study|Recruiting||N/A|12|Anticipated|TriHealth Inc.||1|||f||||f||||||||No||2017-10-10 22:23:15.204873|2017-10-10 22:23:15.204873
NCT02711579|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-05-18|||May 2016||2016-05-01|December 2016|2016-12-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|||Impact of Celecoxib on Electrophysiological Property in Brain of Healthy Volunteer|Impact of Selective Cyclooxygenase-2 Inhibitor, Celecoxib on Cortical Excitability and Electrophysiological Property in Brain of Healthy Volunteer: Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 1|40|Actual|Seoul National University Hospital||4|||f||||||||||||||2017-10-10 22:23:15.295587|2017-10-10 22:23:15.295587
NCT02711566|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-11|||January 2010||2010-01-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|MS-ROBOT||Robot-based Rehabilitation of Upper Limb Impairment in Multiple Sclerosis|Robot-based Assessment and Therapy in the Treatment of Upper Limb Impairment in Multiple Sclerosis: a Multi-center, Randomised Controlled Trial|Completed||N/A|41|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||Undecided||2017-10-10 22:23:15.386081|2017-10-10 22:23:15.386081
NCT02711553|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-09-08|||May 2016||2016-05-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer|Randomized, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment in Patients With Advanced or Metastatic Biliary Tract Cancer|Active, not recruiting||Phase 2|300|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:23:15.481811|2017-10-10 22:23:15.481811
NCT02711540|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-11|||February 2016||2016-02-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Retrospective Analysis of Procedural Aspects of Transcatheter Aortic Valve Implantation (TAVI) on Peri-procedural Stroke|Retrospective Analysis of Procedural Aspects of Transcatheter Aortic Valve Implantation (TAVI) on Peri-procedural Stroke Rates in the United Kingdom|Active, not recruiting||N/A|4000|Actual|Royal Sussex County Hospital|||2||f||||f||||||||No||2017-10-10 22:23:15.781712|2017-10-10 22:23:15.781712
NCT02711527|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-12|||February 2016||2016-02-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Activation on LDPC Cortex With Different Acupoints: An fNIRS Study|Activation on Left Dorsolateral Prefrontal Cortex LDPC With Different Acupoint-Combinations for Depression: An fNIRS Study|Recruiting||N/A|36|Anticipated|The University of Hong Kong||2|||f||||f||||||||No||2017-10-10 22:23:15.856464|2017-10-10 22:23:15.856464
NCT02711514|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-14|||December 2014||2014-12-01|March 2016|2016-03-01||||March 2017|Anticipated|2017-03-01||Observational|1000 Radials||Femoral Artery Crossover Rates of 1000 Consecutive Radial (or Ulnar) Artery Procedures in the Cardiac Cath Lab for Diagnostic Cardiac Catheterizations and/or Percutaneous Coronary Interventions.|Femoral Artery Crossover Rates of 1000 Consecutive Radial (or Ulnar) Artery Procedures in the Cardiac Cath Lab for Diagnostic Cardiac Catheterizations and/or Percutaneous Coronary Interventions|Enrolling by invitation||N/A|1000|Anticipated|Miami Cardiac and Vascular Institute|||1||f||||||||||||||2017-10-10 22:23:15.958556|2017-10-10 22:23:15.958556
NCT02711501|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-09-10|||March 2016||2016-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Comparison of Post-operative Complications of Bone Augmentation at Anterior of Maxilla After Periosteal Releasing Incision With Two Techniques Diode Laser and Scalpel||Completed||N/A|14|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:23:16.020657|2017-10-10 22:23:16.020657
NCT02711488|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-03-11|||March 2016||2016-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|PAAPAS-DC||Managing Adolescent Obesity at Local Level by Combining Primary and Secondary Intervention|Managing Adolescent Obesity at Local Level by Combining Primary and Secondary Intervention|Not yet recruiting||N/A|3000|Anticipated|Rio de Janeiro State University||2|||f||||t||||||||||2017-10-10 22:23:16.117046|2017-10-10 22:23:16.117046
NCT02711475|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-11|||May 2016||2016-05-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||Evaluation of Colonic Diminutive Polyps With Electronic Filters|"Remove and Discard Policy in Colonic Diminutive Polyps: is it Always Safe?"|Not yet recruiting||N/A|800|Anticipated|Ospedale Cardinal Massaia|||1||f||||f||||||||Undecided||2017-10-10 22:23:16.19939|2017-10-10 22:23:16.19939
NCT02710903|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-07-14|||May 2016||2016-05-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||IL29 and IL28B Variants Associated With Periodontal Disease Pathogenesis|IL29 and IL28B Variants Associated With Periodontal Disease Pathogenesis|Recruiting||N/A|220|Anticipated|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-10-10 22:23:20.989479|2017-10-10 22:23:20.989479
NCT02711462|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-11-04|||February 2016||2016-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234|A Phase 1, Double Blind, Third-Party Open, Randomized, Placebo Controlled, Single And Multiple Dose, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-06687234 In Healthy Subjects|Terminated||Phase 1|10|Actual|Pfizer||11||"The study was prematurely terminated on 06 October 2016 due to the potential risk of further   dosing in healthy subjects"|f||||f||||||||||2017-10-10 22:23:16.273983|2017-10-10 22:23:16.273983
NCT02711449|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-09-24|||April 2016||2016-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Preoperative Methylprednisolone to Patients Suspected of Appendicitis Undergoing Laparoscopy|Preoperative Methylprednisolone to Patients Suspected of Appendicitis Undergoing Laparoscopy|Completed||Phase 2|78|Actual|Nordsjaellands Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:23:16.401979|2017-10-10 22:23:16.401979
NCT02711436|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-14|||April 2016||2016-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Fast Magnetic Resonance Imaging as Compared to Computed Tomography Scan in Pediatric Orbital Cellulitis Imaging||Not yet recruiting||N/A|30|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||No||2017-10-10 22:23:16.517232|2017-10-10 22:23:16.517232
NCT02711423|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-05-10|||March 31, 2016|Actual|2016-03-31|May 2017|2017-05-01|September 28, 2016|Actual|2016-09-28|September 28, 2016|Actual|2016-09-28||Interventional|||A Single-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Gantenerumab Following Subcutaneous (SC) Administration in Healthy Volunteers|A Single-Center, Randomized, Investigator/Subject-Blind Single-Ascending Dose, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Gantenerumab Following SC Administration in Healthy Subjects|Completed||Phase 1|18|Actual|Hoffmann-La Roche||3|||f|||||f|f||||||||2017-10-10 22:23:16.603849|2017-10-10 22:23:16.603849
NCT02711410|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-17|||October 2009||2009-10-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|April 2014|Actual|2014-04-01||Observational|||The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients|The Influence of CYP2C19 Polymorphism on Antiplatelet Effects and Clinical Outcomes in Non-acute Stroke Patients Treated With Clopidogrel: The Contribution of Genetic Analysis to the Efficacy of Clopidogrel (Cognac) Study|Completed||N/A|518|Actual|National Cerebral and Cardiovascular Center|||1||f||||t||||||Samples With DNA|"     Genomic DNA was extracted from peripheral blood leukocytes. The genotypes of the CYP2C19*2     (c.681G>A, rs4244285), *3 (c.636G>A, rs4986893), and *17 (c.-806C > T, rs12248560) variants     were determined by the TaqMan genotype discrimination method (Applied Biosystems, Foster     City, CA, USA) using commercially available primers and probes purchased from the     Assay-on-Demand system.   "|No||2017-10-10 22:23:16.682555|2017-10-10 22:23:16.682555
NCT02711397|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-16|||April 2012||2012-04-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|DELIAC||Quantification of Gluten Peptides in Feces|Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-free Diet|Completed||N/A|272|Actual|Biomedal S.L.|||3||f||||f||||||Samples With DNA|"     Stool and blood samples   "|||2017-10-10 22:23:16.74582|2017-10-10 22:23:16.74582
NCT02711384|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-09-22|||October 2016||2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Determine the Effective Dose 95 of Sevoflurane in Adult Patients|Determine the Effective Dose 95 of Sevoflurane in Adult Patients Undergoing Cardiac Surgery Under Cardiopulmonary Bypass.|Recruiting||N/A|30|Anticipated|Instituto Dante Pazzanese de Cardiologia|||1||f||||t||||||||||2017-10-10 22:23:16.827329|2017-10-10 22:23:16.827329
NCT02711371|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-02-01|||July 2015||2015-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Social and Emotional Brain Function in Cannabis Users|Long-term Effects of Cannabis Use on Social and Emotional Brain Processes in Dependent Cannabis Users After a 28 Day Abstinence Period|Completed||N/A|43|Actual|University of Electronic Science and Technology of China|||2||f||||f||||||||||2017-10-10 22:23:16.911493|2017-10-10 22:23:16.911493
NCT02711358|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-11-28|||March 2016||2016-03-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|INDO-IUD||Indomethacin Use in Pain Relief During Intrauterine Device Insertion|Rectal Indomethacin Use in Pain Relief During Intrauterine Device Insertion: A Randomized Controlled Trial|Completed||Phase 4|120|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:23:16.979741|2017-10-10 22:23:16.979741
NCT02711345|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-14|||April 15, 2016|Actual|2016-04-15|September 2017|2017-09-01|September 10, 2018|Anticipated|2018-09-10|September 10, 2018|Anticipated|2018-09-10||Interventional|||A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers|A Phase I Dose Finding Study of Oral LTT462 in Adult Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations|Recruiting||Phase 1|81|Anticipated|Novartis||5|||f||||f|t|f||||||||2017-10-10 22:23:17.052773|2017-10-10 22:23:17.052773
NCT02711332|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-03-11|||June 2015||2015-06-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Investigating the Influence of Haemolysis on the Potassium Concentration After Capillary Blood Sampling|Investigating the Influence of Haemolysis on the Potassium Concentration After Capillary Blood Sampling|Completed||N/A|22|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-10 22:23:17.165964|2017-10-10 22:23:17.165964
NCT02711319|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-13|||December 2010||2010-12-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|SCI||Non-invasive Brain Stimulation for Gait Improvement in Patients With Spinal Cord Injury|Non-invasive Brain Stimulation in SCI|Completed||Phase 3|31|Actual|Institut Guttmann||2|||f||||f||||||||Undecided||2017-10-10 22:23:17.232164|2017-10-10 22:23:17.232164
NCT02711306|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-06-03|||May 2013||2013-05-01|March 2013|2013-03-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Effects of Konjac Glucomannan Noodle Intervention in Subjects With Metabolic Syndrome|Office of Human Research, Taipei Medical University|Completed||N/A|40|Actual|Taipei Medical University||2|||f||||t||||||||No||2017-10-10 22:23:17.297156|2017-10-10 22:23:17.297156
NCT02711293|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-03-16|||February 2016||2016-02-01|March 2016|2016-03-01||||November 2016|Anticipated|2016-11-01||Interventional|||The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression|The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression: A Non-inferiority Cluster-randomized Controlled Trial in Dar es Salaam, Tanzania|Recruiting||N/A|1000|Anticipated|Harvard School of Public Health||4|||f||||f||||||||||2017-10-10 22:23:17.384206|2017-10-10 22:23:17.384206
NCT02711280|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-10-11|||September 2015||2015-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Anesthetics on Oxidative Stress and Apoptosis Status in Children|The Effect of Sevoflurane and Propofol on Oxidative Stress and Apoptosis Status in Children Undergoing Hypospadias Repair Surgery|Completed||N/A|47|Actual|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 22:23:17.621339|2017-10-10 22:23:17.621339
NCT02711254|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-04-26|||October 2014||2014-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|Phantom||Phantom Knee System Clinical Trial|Feasibility of the Phantom Knee System in Improving Pain Relief and Function in Patients Needing Unloading of the Medial Compartment of the Knee: A Prospective, Multi-Center, Single-Arm First in Human Study|Active, not recruiting||N/A|40|Actual|Moximed||1|||f||||f||||||||Undecided||2017-10-10 22:23:17.855321|2017-10-10 22:23:17.855321
NCT02711241|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-01|2016-03-13|||June 2010||2010-06-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Optimal Analgesia in Acute Gastroenteritis|Optimal Analgesia in Acute Gastroenteritis in Emergency Department Setting: Dipyrone Versus Papaverine|Terminated||Phase 3|15|Actual|Hadassah Medical Organization||2||Not enough patients|f||||f||||||||||2017-10-10 22:23:17.944437|2017-10-10 22:23:17.944437
NCT02711228|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-24|||March 15, 2016||2016-03-15|August 2017|2017-08-01|December 26, 2017|Anticipated|2017-12-26|December 26, 2017|Anticipated|2017-12-26||Interventional|||Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules|Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules|Active, not recruiting||Phase 4|26|Actual|CSL Behring||1|||f||||f||||||||||2017-10-10 22:23:18.051933|2017-10-10 22:23:18.051933
NCT02711215|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-03-25|||May 2015||2015-05-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)||Recruiting||Phase 4|80|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-10-10 22:23:18.163055|2017-10-10 22:23:18.163055
NCT02711202|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-12|||January 2007||2007-01-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation|A Pilot, Open Single Centre, Prospective, Parallel Trail to Evaluate the Efficacy and Safety of Immunosuppressive Regimen Without Calcineurin Inhibitors and Steroids After Induction of Anti-CD52 and Anti-TNF-α Monoclonal Antibodies in Kidney Transplant Recipients|Completed||N/A|20|Actual|Institute for Clinical and Experimental Medicine||2|||f||||f||||||||No||2017-10-10 22:23:18.24692|2017-10-10 22:23:18.24692
NCT02711189|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-16|2017-06-30|||March 8, 2016||2016-03-08|February 24, 2017|2017-02-24|November 24, 2018|Anticipated|2018-11-24|November 24, 2018|Anticipated|2018-11-24||Interventional|||Oxytocin in Alcohol Use Disorder|Oxytocin in Alcohol Use Disorder: A Novel and Translational Approach|Not yet recruiting||Phase 1|32|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:23:18.335064|2017-10-10 22:23:18.335064
NCT02711176|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-06-07|||September 2016||2016-09-01|June 2017|2017-06-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|||Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection|Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection|Completed||Phase 4|212|Actual|Ilam University of Medical Sciences||2|||f||||f|f|||||||No||2017-10-10 22:23:18.438436|2017-10-10 22:23:18.438436
NCT02711163|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|ALYCE||Evaluation of the Hypoallergenicity of an Extensively Hydrolyzed Formula|Evaluation of the Hypoallergenicity of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow's Milk Protein Allergy|Recruiting||Phase 3|32|Anticipated|United Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:23:18.570891|2017-10-10 22:23:18.570891
NCT02711150|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-03-07|||May 3, 2016|Actual|2016-05-03|January 2016|2016-01-01|October 7, 2016|Actual|2016-10-07|October 7, 2016|Actual|2016-10-07||Interventional|||Effect of EPD on the Lumbar Acoustic Window at Term Pregnancy|Efficacy of the Epidural Positioning Device (EPD) on Optimising the Acoustic Target Window for Neuraxial Needle Placement|Completed||N/A|30|Actual|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 22:23:18.739125|2017-10-10 22:23:18.739125
NCT02711137|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-09|||May 2016||2016-05-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 1/2, Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies|A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies|Recruiting||Phase 1/Phase 2|230|Anticipated|Incyte Corporation||1|||f||||f||||||||No||2017-10-10 22:23:18.82431|2017-10-10 22:23:18.82431
NCT02711124|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-19|||February 2014||2014-02-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01|6 Months|Observational [Patient Registry]|||Relationship Between Level of Hemoglobin A1c and Platelet Function in Patients Undergoing Cardiac Surgery|Relationship Between Level of Glycosylated Hemoglobin and Platelet Function in Patients Undergoing Coronary Artery Bypass Grafting|Recruiting||N/A|130|Anticipated|Clinical Hospital Centre Zagreb|||2||f||||t||||||||No||2017-10-10 22:23:19.019504|2017-10-10 22:23:19.019504
NCT02711111|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-16|||April 2016||2016-04-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Bone-anchored Protraction on Maxillary Growth in the Young Child|Effect of Bone-anchored Protraction on Maxillary Growth in the Young Child|Not yet recruiting||N/A|20|Anticipated|Ziekenhuis Oost-Limburg||2|||f||||f||||||||||2017-10-10 22:23:19.172183|2017-10-10 22:23:19.172183
NCT02710344|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Using Telehealth to Improve Psychiatric Symptom Management|Automated Telehealth to Improve Psychiatric Self-Management and Community Tenure|Recruiting||N/A|300|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 22:23:27.280488|2017-10-10 22:23:27.280488
NCT02711098|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|IL-HYPERION||IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.|InterLeukine Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.|Recruiting||Phase 3|120|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||t||||||||||2017-10-10 22:23:19.298402|2017-10-10 22:23:19.298402
NCT02711085|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-03-11|||December 2015||2015-12-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|12 Months|Observational [Patient Registry]|SYMBIOME||Modeling Post-traumatic Pain and Recovery: The SYMBIOME Longitudinal Cohort Study|The Systematic Merging of Biology, Mental Health and Environment (SYMBIOME) Longitudinal Databanking Project|Recruiting||N/A|400|Anticipated|Lawson Health Research Institute|||1||f||||f||||||Samples With DNA|"     Saliva Blood Hair Stool   "|Yes|De-identified database will be made available on a cost-recovery basis as data accrue.|2017-10-10 22:23:19.46832|2017-10-10 22:23:19.46832
NCT02711072|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-03-14|||March 2016||2016-03-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Continuous Infusion for Pain Relief|Comparaison of Continuous Infusion of Local Anesthetic and Intrathecal Morphine for Pain Management in Elective Caeserean Section|Not yet recruiting||N/A|60|Anticipated|Tunisian Military Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:23:19.55519|2017-10-10 22:23:19.55519
NCT02711059|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2016-10-16|||October 2015||2015-10-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|IRIPH||Insulin Resistance in Primary Hyperparathyroidism|Insulin Resistance in Primary Hyperparathyroidism, a Non-classical Manifestation|Recruiting||N/A|80|Anticipated|Karolinska University Hospital||2|||f||||f||||||||No||2017-10-10 22:23:19.636804|2017-10-10 22:23:19.636804
NCT02711046|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-03-12|||March 2011||2011-03-01|March 2016|2016-03-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Use of Single Staged Nasolabial Flap in Oral Submucous Fibrosis|Evaluation of Change in Mouth Opening in Oral Submucous Fibrosis Patients After Surgical Excision of Fibrous Bands Along With Bilateral Coronoidotomy and Surgical Defect Coverage by Single Stage Extended Nasolabial Flap|Completed||N/A|11|Actual|Government College of Dentistry, Indore||1|||f||||t||||||||Undecided||2017-10-10 22:23:19.75107|2017-10-10 22:23:19.75107
NCT02711033|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-04-07|||October 2015||2015-10-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection|Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Spleen-preserving Splenic Hilum Lymph Nodes Dissection for Advanced Proximal Gastric Cancer: A Randomized Controlled Trial|Recruiting||Phase 2|144|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||f||||||||No||2017-10-10 22:23:19.838229|2017-10-10 22:23:19.838229
NCT02711020|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|PCTFORDEPFM||Psychological Treatment of Depression in Women With Fibromyalgia|Psychological Treatment of Depression in Women With Fibromyalgia: Differential Efficacy and Factors Predictive of Outcome|Recruiting||N/A|110|Anticipated|University of Barcelona||2|||f||||f||||||||No||2017-10-10 22:23:19.945071|2017-10-10 22:23:19.945071
NCT02711007|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01||||September 2018|Anticipated|2018-09-01||Interventional|||Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy|A Phase II Trial of Apatinib in Relapsed and Unresectable High-grade Osteosarcoma After Failure of Standard Multimodal Therapy|Recruiting||Phase 2/Phase 3|37|Anticipated|Peking University People's Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:23:20.11327|2017-10-10 22:23:20.11327
NCT02710994|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-12|||May 2014||2014-05-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||Pharmacodynamics and Safety of CDFR0209|A Randomized, Open Label, Two-way Crossover Designed Clinical Trial to Investigate the Pharmacodynamics and the Safety Between Repeated Doses of CDFR0209 in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Ajou University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:23:20.251161|2017-10-10 22:23:20.251161
NCT02710981|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-16|||June 2015||2015-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium|Effect of Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate on Endometrial Thickness in Infertile Women With Prior Clomiphene Citrate Failure Due to Thin Endometrium: a Prospective Self-controlled Clinical Trial|Completed||N/A|42|Actual|Assiut University||2|||f||||f||||||||No||2017-10-10 22:23:20.33538|2017-10-10 22:23:20.33538
NCT02710968|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-08-21|||August 2015||2015-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|FETO||Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH)|Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Left Congenital Diaphragmatic Hernia (CDH)|Recruiting||N/A|10|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 22:23:20.451145|2017-10-10 22:23:20.451145
NCT02710955|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|February 2017|Actual|2017-02-01||Interventional|SWAN||SWAN: Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01)|Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01)|Active, not recruiting||N/A|100|Anticipated|United Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:23:20.610905|2017-10-10 22:23:20.610905
NCT02710942|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-03-11|||March 2016||2016-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Testing myWHI: Online Self-guided Programs for Migraine|Testing the Feasibility of Two Self-guided Web-based Interventions for Adolescents and Young Adults With Migraine: A Pilot Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|IWK Health Centre||3|||f||||f||||||||No||2017-10-10 22:23:20.687432|2017-10-10 22:23:20.687432
NCT02710929|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-13|2016-10-17|||August 2015||2015-08-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||A Genome-wide Association Study on the Endophenotype of Spatial Working Memory in ADHD|A Genome-wide Association Study on the Endophenotype of Spatial Working Memory in Attention Deficit Hyperactivity Disorder|Recruiting||N/A|232|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples With DNA|"     15 ml blood will be withdrawn from the subjects (one heparin-rinsed tube for cell culture,     one EDTA rinsed tube for DNA extraction)   "|No||2017-10-10 22:23:20.790431|2017-10-10 22:23:20.790431
NCT02710890|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-09-28|||May 30, 2017|Actual|2017-05-30|September 2017|2017-09-01|August 14, 2020|Anticipated|2020-08-14|August 14, 2020|Anticipated|2020-08-14||Interventional|||Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.|A Multicenter, Open-Label Study to Investigate the Safety and Tolerability of Intravenous Lacosamide in Children (>= 4 to < 17 Years of Age) With Epilepsy|Recruiting||Phase 2/Phase 3|75|Anticipated|UCB Pharma||1|||f||||t|t|f|||t|||||2017-10-10 22:23:21.08953|2017-10-10 22:23:21.08953
NCT02710877|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-16|||December 2014||2014-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PA-RER||Intermittent Automated Devices for Labor Analgesia in Emilia Romagna|Pain Management During Labor: Use of Intermittent Drug Delivery Devices for Obstetric and Neonatal Outcome Improvement and Health-care Burden Reduction|Recruiting||N/A|900|Anticipated|University of Modena and Reggio Emilia||2|||f||||f||||||||No||2017-10-10 22:23:21.294366|2017-10-10 22:23:21.294366
NCT02710864|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-11|||June 2015||2015-06-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01|14 Days|Observational [Patient Registry]|||A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China||Recruiting||N/A|1500|Anticipated|Xiamen University|||1||f||||f||||||Samples With DNA|"     saliva /urine samples of the newborns   "|Undecided||2017-10-10 22:23:21.422918|2017-10-10 22:23:21.422918
NCT02710851|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-03-12|||March 2016||2016-03-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine|A PhaseⅡ Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Immunogenicity of the Recombinant (E.Coli) Human Papillomavirus Type 6/11 Bivalent Vaccine in Healthy Volunteers Aged 18-55 Years|Not yet recruiting||Phase 2|640|Anticipated|Xiamen University||4|||f||||f||||||||||2017-10-10 22:23:21.513543|2017-10-10 22:23:21.513543
NCT02710838|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-18|||January 2014||2014-01-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|June 2016|Anticipated|2016-06-01||Interventional|||The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer|The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer and Evaluate the Invasive Depth of Tumors|Recruiting||N/A|40|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||t||||||||Yes||2017-10-10 22:23:21.602294|2017-10-10 22:23:21.602294
NCT02710825|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-02-23|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|OSCAR||Osteopathy and Children With Congenital Heart Disease Surgery|Single Center Randomized Clinical Trial, That Evaluates the Effect of Osteopathic Care on Postoperative Pain in Children With Congenital Heart Disease Surgery|Completed||N/A|113|Actual|Hôpital Necker-Enfants Malades||2|||f||||f||||||||Undecided||2017-10-10 22:23:21.706728|2017-10-10 22:23:21.706728
NCT02710812|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-18|||January 2016||2016-01-01|March 2016|2016-03-01|August 2021|Anticipated|2021-08-01|January 2021|Anticipated|2021-01-01||Observational|ReSARCh||Rectal Sparing Approach After Preoperative Radio and/or Chemotherapy in Patients With Rectal Cancer|Rectal Sparing Approach After Preoperative Radio and/or Chemotherapy in Patients With Rectal Cancer|Recruiting||N/A|164|Anticipated|University of Padova|||1||f||||f||||||||No||2017-10-10 22:23:21.817738|2017-10-10 22:23:21.817738
NCT02710799|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-08-08|||June 2015||2015-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List|Evaluation of the Effectivity of Teleconsultations for Improving the Referrals From Primary Care to Specialized Care of Patients With Chronic Endocrinological Conditions|Completed||N/A|3470|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided|We plan to publish trial results in an indexed medical journal. The results will be reported by the authors and the authorship criteria from ICMJE will be followed. After publishing the main results of the trial the unidentified dataset will be available by contacting the authors and providing an analyses plan which will be evaluated by the study's main investigator.|2017-10-10 22:23:21.921835|2017-10-10 22:23:21.921835
NCT02710786|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-16|||May 2007||2007-05-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|August 2015|Actual|2015-08-01|5 Years|Observational [Patient Registry]|||Comorbidity Five Years After Gastric Bypass|Comorbidity Five Years After Gastric Bypass|Active, not recruiting||N/A|25000|Actual|Uppsala University|||1||f||||f||||||||No||2017-10-10 22:23:22.027261|2017-10-10 22:23:22.027261
NCT02710773|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-09-06|||April 2016||2016-04-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Backward Treadmill Training in Patients With Chronic Stroke|Effects of Backward Treadmill Training on Spasticity and Gait Ability in Patients With Chronic Stroke: a Randomized Controlled Trial|Recruiting||N/A|20|Anticipated|Universita di Verona||2|||f||||t||||||||No||2017-10-10 22:23:22.110018|2017-10-10 22:23:22.110018
NCT02710760|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-03-08|||July 2015||2015-07-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|QPM||Translating Adoption of Improved Varieties Into Nutritional Impact|Translating Adoption of Improved Varieties Into Nutritional Impact for Young Children: An RCT Exploring Strategies to Increase Consumption of Quality Protein Maize in Ethiopia|Completed||N/A|978|Actual|Harvard School of Public Health||3|||f||||f||||||||Yes|We will share completely deidentified data upon request after primary analyses have been been completed.|2017-10-10 22:23:22.213113|2017-10-10 22:23:22.213113
NCT02710747|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-11|||January 2015||2015-01-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|POWAT||The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.|The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.|Recruiting||Phase 4|500|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-10-10 22:23:22.333788|2017-10-10 22:23:22.333788
NCT02710734|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-09-08|||February 24, 2016|Actual|2016-02-24|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Risk Adapted Treatment for Muscle Invasive Bladder Cancer After Neoadjuvant Accelerated MVAC|A Phase II Trial of Risk Adapted Treatment for Muscle Invasive Bladder Cancer After Neoadjuvant Accelerated MVAC (RAT-MIBC)|Recruiting||Phase 2|38|Anticipated|Fox Chase Cancer Center||4|||f||||t|t|f|||f|||||2017-10-10 22:23:22.425931|2017-10-10 22:23:22.425931
NCT02710721|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-01-11|||April 2016||2016-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer|Clinical Study on the Efficacy of Fasting and Nutritional Therapy as a Complementary Treatment of Advanced Metastatic Prostate Cancer Undergoing Chemotherapy - an Exploratory Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||Undecided||2017-10-10 22:23:22.551148|2017-10-10 22:23:22.551148
NCT02710708|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-09-26|||May 27, 2016|Actual|2016-05-27|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China|Single-arm, Open-label, Interventional Study to Observe the Safety and Efficacy Profile of the Combined Oral Contraceptive YAZ®, a 24-day Cyclic Regimen Containing Drospirenone 3 mg and Ethinyl Estradiol 20 µg During a Treatment Duration of 6 Cycles: a Post-authorization Safety and Efficacy Study in Chinese Women|Recruiting||Phase 4|2000|Anticipated|Bayer||1|||f||||f||f||||||||2017-10-10 22:23:22.66958|2017-10-10 22:23:22.66958
NCT02710695|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||Pain in America: A Randomized Controlled Trial||Recruiting||N/A|50|Anticipated|University of Missouri, Kansas City||2|||f||||||||||||||2017-10-10 22:23:22.880698|2017-10-10 22:23:22.880698
NCT02710682|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-07-19|||May 2016||2016-05-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Tendon Fenestration Versus Surgery for the Treatment of Chronic Lateral Epicondylosis|Ultrasound-guided Tendon Fenestration Versus Open Surgery for the Treatment of Chronic Lateral Epicondylosis of the Elbow: a Prospective, Randomized, Single Blind, Pilot Study.|Recruiting||N/A|64|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-10 22:23:22.981635|2017-10-10 22:23:22.981635
NCT02710669|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-10-27|||October 2016||2016-10-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||New Formulations of Propafenone to Treat Atrial Fibrillation|Comparison of (R) and (S) Propafenone for Prevention of Atrial Fibrillation Induction|Recruiting||Phase 1/Phase 2|243|Anticipated|Vanderbilt University||3|||f||||t||||||||Undecided||2017-10-10 22:23:23.113578|2017-10-10 22:23:23.113578
NCT02710656|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-07-05|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|||Study Comparing Legflow Versus Bare Balloon Angioplasty for Treatment of Atherosclerotic Disease|Multicenter Randomized Controlled Trial Comparing Legflow - DCB (Cardionovum) Versus Bare Balloon Angioplasty for the Treatment of Atherosclerotic Disease in the Superficial Femoral & Popliteal Segment|Recruiting||N/A|130|Anticipated|Cardionovum GmbH||2|||f||||f||||||||||2017-10-10 22:23:23.224245|2017-10-10 22:23:23.224245
NCT02710630|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-05-08|2017-05-08||March 22, 2016|Actual|2016-03-22|May 2017|2017-05-01|June 10, 2016|Actual|2016-06-10|May 11, 2016|Actual|2016-05-11||Interventional||Treated set (TS): This set included all subjects that were dispensed study drug and were documented to have taken at least one dose of study drug.|Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects|Relative Bioavailability of Dabigatran After Single Oral Administration of Five Different Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects (an Open-label, Randomised, Single-dose, Six-period, Five-sequence Crossover Study)|Completed||Phase 1|35|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 22:23:23.734977|2017-10-10 22:23:23.734977
NCT02710617|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-08-30|||March 2016||2016-03-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System||Completed||N/A|109|Actual|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm|||||f||||||||||||||2017-10-10 22:23:24.574924|2017-10-10 22:23:24.574924
NCT02710604|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2017-09-12|||May 2016||2016-05-01|December 2016|2016-12-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||Phase 2, Multiple Ascending Dose Proof of Concept Study|A Phase 2, Randomized, Open-label, Ascending, Sequential Dose Group, Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of CMX157 in HBV-infected Subjects|Completed||Phase 2|62|Actual|ContraVir Pharmaceuticals, Inc.||5|||f||||t||||||||||2017-10-10 22:23:24.626858|2017-10-10 22:23:24.626858
NCT02710591|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-07-26|||March 2016||2016-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIM4DMD||Rimeporide in Patients With Duchenne Muscular Dystrophy|A Phase Ib, Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of Rimeporide in Patients With Duchenne Muscular Dystrophy|Recruiting||Phase 1|20|Anticipated|EspeRare Foundation||1|||f||||t||||||||||2017-10-10 22:23:24.725784|2017-10-10 22:23:24.725784
NCT02710578|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||Alcohol Effects on Driving-related Skills of Young Drivers|Acute and Residual Effects of Alcohol on Young Drivers' Performance of Driving Related Skills|Completed||N/A|30|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-10 22:23:24.837476|2017-10-10 22:23:24.837476
NCT02710565|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-08|||February 2016||2016-02-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|EBUS||Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma|Use of Endo Bronchial Ultrasound (EBUS) Trans Bronchial Needle Aspiration (TBNA) for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma|Completed||N/A|60|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 22:23:24.934045|2017-10-10 22:23:24.934045
NCT02710552|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-16|||April 2016||2016-04-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|3D||Low-dose Combination of Three Antihypertensive Drugs|Randomized Comparison of Fixed Low-dose Combination of THREE Antihypertensive Drugs Versus Fixed High-dose Combination of Two Antihypertensive Drugs in Arterial Hypertension (the 3D Trial)|Not yet recruiting||Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||No||2017-10-10 22:23:25.033347|2017-10-10 22:23:25.033347
NCT02710539|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-15|||April 2016||2016-04-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|ONE&ONLY||Once-daily Fixed Combination of Three Antihypertensive Drugs|Randomized Comparison of Once-daily Fixed combiNation vErsus freE-drug cOmbination of Three aNtihypertensive Agents in arteriaL hYpertension (the ONE&ONLY Trial)|Not yet recruiting||Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||No||2017-10-10 22:23:25.124509|2017-10-10 22:23:25.124509
NCT02710526|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-07|||February 2015||2015-02-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Phase II Pharmacokinetics Study of CAM2038|Phase II, Open Label, Randomized, Two Treatment Groups, Study Assessing Pharmacokinetics After Administration of the Once Weekly and Once Monthly, Long Acting Subcutaneous Injection of CAM2038 in Opioid Dependent Subjects With Chronic Pain|Active, not recruiting||Phase 2|50|Anticipated|Braeburn Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:23:25.209856|2017-10-10 22:23:25.209856
NCT02710513|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-16|||December 2014||2014-12-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|ProAliFun65||ProAliFun_6.5_Health Effects of a Functional Pasta Enriched With Barley Beta-glucans on Healthy Subjects|Technological and Clinical Innovative Protocols for the Production of Functional Foods - 6.5 (ProAliFun65)|Completed||N/A|28|Actual|Azienda Ospedaliero-Universitaria Consorziale||1|||f||||t||||||||Undecided||2017-10-10 22:23:25.400345|2017-10-10 22:23:25.400345
NCT02710500|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-11-21|||March 2016||2016-03-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies|Phase I Intramuscular Gene Transfer Clinical Trial for Dysferlin Deficiency Delivering the Dysferlin Gene by AAVrh74|Recruiting||Phase 1|6|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-10 22:23:25.604142|2017-10-10 22:23:25.604142
NCT02710487|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-03-23|||March 2016||2016-03-01|March 2016|2016-03-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|SA&M-II||Sleep, Awake & Move - Part II|Awake & Move. Role of Nocturnal Sleep and Rapid Eye Movement Sleep at Morning Awakening on Sleep Benefit in Parkinson's Disease. An Interventional Cross-over Study.|Recruiting||N/A|24|Anticipated|Neurocenter of Southern Switzerland||2|||f||||f||||||||No||2017-10-10 22:23:25.730462|2017-10-10 22:23:25.730462
NCT02710474|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-28|||January 24, 2017|Actual|2017-01-24|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Family Nurture Intervention in the NICU|Family Nurture Intervention in the NICU: A Multi-Site Trial|Recruiting||N/A|627|Anticipated|Columbia University||3|||f||||t|f|f||||||||2017-10-10 22:23:25.874484|2017-10-10 22:23:25.874484
NCT02710461|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2017-03-27|||March 2016||2016-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|POME-GRAPE-1||Grape and Pomegranate Polyphenols in Postprandial Glucose and Related Parameters|Acute Effects of Grape and Pomegranate Polyphenols as Modulators of Metabolic Syndrome in Humans|Completed||N/A|20|Actual|National Research Council, Spain||1|||f||||f||||||||||2017-10-10 22:23:26.03549|2017-10-10 22:23:26.03549
NCT02710448|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-04-25|||June 2012||2012-06-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||May Metformin be Used in Renal Failure?|May Metformin be Used in Renal Failure?|Completed||Phase 2|82|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-10 22:23:26.149851|2017-10-10 22:23:26.149851
NCT02710435|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-08-23|||March 2016||2016-03-01|August 2017|2017-08-01|August 2024|Anticipated|2024-08-01|July 2019|Anticipated|2019-07-01||Observational|||REDUCER-I: An Observational Study of the Neovasc Reducer™ System|REDUCER-I: An Observational Study of the Neovasc Reducer™ System|Recruiting||N/A|400|Anticipated|Neovasc Inc.|||3||f||||f||||||||||2017-10-10 22:23:26.262643|2017-10-10 22:23:26.262643
NCT02710422|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-09-01|||May 17, 2016|Actual|2016-05-17|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|MMEP||Miami Membrane for Potency (MMEP) Trial|Miami Membrane for Potency (MMeP) Trial to Assess the Impact of Dehydrated Human Amnion Membrane Allograft Placement During Robotic Radical Prostatectomy on Early Return of Erectile Function|Recruiting||Phase 2|280|Anticipated|University of Miami||2|||f||||t|t|f|||f|||||2017-10-10 22:23:26.514047|2017-10-10 22:23:26.514047
NCT02710409|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2016-08-30|||January 2016||2016-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older|A Double-blind,Randomized,Positive-controlled, Non-inferiority Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Chinese Subjects Aged 3 Years and Older|Completed||Phase 3|3664|Actual|Jiangsu Province Centers for Disease Control and Prevention||3|||f||||f||||||||Undecided||2017-10-10 22:23:26.653876|2017-10-10 22:23:26.653876
NCT02710396|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-03-10|||May 31, 2016|Actual|2016-05-31|March 2017|2017-03-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Genetic Predictors of Benefit to Pembrolizumab|Identifying Genetic Predictors of Durable Clinical Benefit to Pembrolizumab in Advanced or Recurrent Cancers|Recruiting||Phase 2|120|Anticipated|Columbia University||1|||f||||t|t|f||||||No||2017-10-10 22:23:26.783259|2017-10-10 22:23:26.783259
NCT02710370|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-04|||February 2016||2016-02-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans|Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans|Enrolling by invitation||N/A|32|Anticipated|University of Pittsburgh|||2||f||||f||||||Samples Without DNA|"     Intestinal samples, serum and plasma will be collected from patients who have had gastric     bypass surgery. Tissue samples will be processed for histo-morphological examination and for     RNA, protein and metabolomics analyses.   "|Undecided||2017-10-10 22:23:27.063491|2017-10-10 22:23:27.063491
NCT02710357|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-02-17|||March 2016||2016-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|SIMOECON||A Cost-effectiveness Analysis of the Single-implant Mandibular Overdenture Treatment|Single-implant Mandibular Overdenture or a Conventional Complete Denture? A Cost-effectiveness Analysis Alongside a Randomized Clinical Trial|Active, not recruiting||N/A|28|Anticipated|Universidade Federal de Goias||2|||f||||t||||||||||2017-10-10 22:23:27.185992|2017-10-10 22:23:27.185992
NCT02710331|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-06-20|||March 2016||2016-03-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|THC-ETOH-III||Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III|Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III|Recruiting||Phase 1|40|Anticipated|Yale University||4|||f||||f||||||||||2017-10-10 22:23:27.368278|2017-10-10 22:23:27.368278
NCT02710318|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-12|2017-07-18|||June 6, 2017|Actual|2017-06-06|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SINC||Synchronized Immunization NotifiCations|Synchronized Immunization NotifiCations|Enrolling by invitation||N/A|13000|Anticipated|Columbia University||2|||f||||f|f|f||||||||2017-10-10 22:23:27.475448|2017-10-10 22:23:27.475448
NCT02710305|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-01-08|||April 2016||2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|HBTB||Oral Hyoscine Butyl Bromide With Cervical Lidocaine Cream in Reducing Pain During Hysterosalpingography|Randomized Clinical Trial of Oral Hyoscine Butyl Bromide With Cervical Lidocaine Cream in Reducing Pain During Hysterosalpingography|Completed||Phase 2|140|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:23:27.556964|2017-10-10 22:23:27.556964
NCT02710292|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-05-08|2017-05-08||April 25, 2016|Actual|2016-04-25|May 2017|2017-05-01|September 14, 2016|Actual|2016-09-14|September 14, 2016|Actual|2016-09-14||Interventional||This analysis population includes all subjects who used the study device (Safety Analysis Set).|Clinical Evaluation of DAILIES TOTAL 1® Performance in a Japanese Population|Clinical Evaluation of DAILIES TOTAL 1® in Japanese Population - Comparison of Lens Centration Between DAILIES TOTAL 1® and 1-DAY ACUVUE® TruEye®|Completed||N/A|104|Actual|Alcon Research||2|||f||||f|||||f|||||2017-10-10 22:23:27.641314|2017-10-10 22:23:27.641314
NCT02710279|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-22|||February 2016||2016-02-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|SADS-CS||Response to Social Rejection in Suicidal Behavior|Response to Social Rejection in Suicidal Behavior|Unknown status|Recruiting|N/A|140|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||Undecided||2017-10-10 22:23:27.878571|2017-10-10 22:23:27.878571
NCT02710266|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-14|||February 2016||2016-02-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection||Recruiting||Phase 3|147|Anticipated|Yonsei University||3|||f||||f||||||||No||2017-10-10 22:23:27.968668|2017-10-10 22:23:27.968668
NCT02710253|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-06-16|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Trial of Salvage Radiation Therapy to Induce Systemic Disease Regression After Progression on Systemic Immunotherapy|Phase II Trial of Salvage Radiation Therapy to Induce Systemic Disease Regression After Progression on Systemic Immunotherapy|Recruiting||Phase 2|150|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:23:28.050863|2017-10-10 22:23:28.050863
NCT02710240|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-14|2016-09-23|||September 2015||2015-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Indocyanine Green for Central Nervous System Tumors|A Pilot/Feasibility Study of Intraoperative Image-Guided Surgery of CNS Tumors With Indocyanine Green and MR Spectroscopic Imaging|Recruiting||Phase 1/Phase 2|75|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:23:28.132688|2017-10-10 22:23:28.132688
NCT02710227|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-06-17|||September 2018|Anticipated|2018-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis|Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis|Not yet recruiting||N/A|80|Anticipated|Tanta University|||2||f||||t||||||||No||2017-10-10 22:23:28.201278|2017-10-10 22:23:28.201278
NCT02710214|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-05-04|||February 2016||2016-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MS-TSEC||A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis|Effect of a Tissue Selective Estrogen Complex on Menopausal Symptoms in Women With MS: A Pilot Trial.|Recruiting||Phase 2|24|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:23:28.280901|2017-10-10 22:23:28.280901
NCT02710201|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-15|||February 2013||2013-02-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Randomized-controlled Trial of Social Norm Interventions to Increase Physical Activity|A Randomized-controlled Trial of Social Norm Interventions to Increase Physical Activity|Completed||N/A|111|Actual|University of California, Merced||3|||f||||f||||||||Undecided||2017-10-10 22:23:28.3784|2017-10-10 22:23:28.3784
NCT02710188|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-10-17|||February 2016||2016-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation|A Phase 1 Relative Bioavailability Study in Healthy CYP2D6 Intermediate (IM) and Extensive Metaboliser (EM) Subjects, Designed to Evaluate the Pharmacokinetic (PK) Profile of HTL0009936 Following Single Dose Administration of Modified Release (MR) Prototype Formulations|Completed||Phase 1|14|Actual|Heptares Therapeutics Limited||2|||f||||t||||||||No||2017-10-10 22:23:28.450525|2017-10-10 22:23:28.450525
NCT02710175|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-03-11|||December 2015||2015-12-01|March 2016|2016-03-01||||August 2016|Anticipated|2016-08-01||Observational|||TSH And AMH in Infertile Women|TSH and AMH in Infertile Women|Enrolling by invitation||N/A|2|Actual|Ain Shams Maternity Hospital|||1||f||||||||||||||2017-10-10 22:23:28.525509|2017-10-10 22:23:28.525509
NCT02710162|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-03-23|||April 2016||2016-04-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)|Determination of Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)|Recruiting||Early Phase 1|120|Anticipated|University of Florida||1|||f||||f||||||||No||2017-10-10 22:23:28.577856|2017-10-10 22:23:28.577856
NCT02710149|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-10-02|||March 2016||2016-03-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies|A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies|Recruiting||Phase 1/Phase 2|45|Anticipated|Southwest Hospital, China||1|||f||||f||||||||Undecided||2017-10-10 22:23:28.727419|2017-10-10 22:23:28.727419
NCT02709772|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-04-18|||April 2016||2016-04-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|February 2017|Anticipated|2017-02-01||Interventional|||Provider Alerts to Reduce Unnecessary Care|Provider Alerts to Reduce Unnecessary Care|Active, not recruiting||N/A|50|Actual|Stanford University||2|||f||||f||||||||No||2017-10-10 22:23:33.312111|2017-10-10 22:23:33.312111
NCT02710136|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-04-26|||February 2016||2016-02-01|April 2017|2017-04-01|April 11, 2017|Actual|2017-04-11|April 11, 2017|Actual|2017-04-11||Interventional|||Cockroach Nasal Allergen Challenge Pilot|A Pilot Study to Assess Safety and Feasibility of Cockroach Nasal Allergen Challenge in Cockroach Sensitive Children and Adults With Asthma (ICAC-27)|Completed||Phase 1|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||Yes|Participant level data access will be made available to the public at some point in the future via the mechanism of the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-10 22:23:28.813546|2017-10-10 22:23:28.813546
NCT02710123|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-11|||January 2016||2016-01-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion|Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion|Recruiting||N/A|100|Anticipated|University at Buffalo||2|||f||||f||||||||No|No plan to share data|2017-10-10 22:23:28.905781|2017-10-10 22:23:28.905781
NCT02710110|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-03-23|||April 2016||2016-04-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS)|The Impact of Respiratory Strength Training in Individuals With Amyotrophic Lateral Sclerosis (ALS)|Recruiting||Early Phase 1|50|Anticipated|University of Florida||2|||f||||t|t|f||||||No||2017-10-10 22:23:28.993777|2017-10-10 22:23:28.993777
NCT02710097|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-06-20|||March 2016||2016-03-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|THC-ETOH-II||Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II|Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II|Active, not recruiting||Phase 1|40|Anticipated|Yale University||4|||f||||f||||||||||2017-10-10 22:23:29.124072|2017-10-10 22:23:29.124072
NCT02710084|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-06-28|||April 2016||2016-04-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome|Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome|Recruiting||Phase 2|40|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-10 22:23:29.233888|2017-10-10 22:23:29.233888
NCT02710071|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-05-20|||January 2015||2015-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|nebhctz||Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide|A Blinded Crossover Study of the 24 Hour Blood Pressure Response to Treatment of Obstructive Sleep Apnea Associated Hypertension With Nebivolol or Hydrochlorothiazide|Completed||Phase 4|34|Actual|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 22:23:29.359366|2017-10-10 22:23:29.359366
NCT02710058|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-09-07|||October 8, 2015|Actual|2015-10-08|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Experience of Arab American Women With Breast Cancer: In-depth Interviews|Experience of Arab American Women With Breast Cancer: In-depth Interviews A Qualitative Study to Explore the Influence of the Arab Culture on Coping With Breast Cancer|Recruiting||N/A|20|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:23:29.429691|2017-10-10 22:23:29.429691
NCT02710045|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-07-18|||November 2007||2007-11-01|July 2016|2016-07-01|May 2011|Actual|2011-05-01|March 2010|Actual|2010-03-01||Interventional|||The Interaction Between Measles and DTP Vaccination|The Interaction Between Live and Killed Vaccines: the Effect of the DTP Combined Vaccine on T Cell Memory Following Measles Vaccination|Completed||N/A|302|Actual|Medical Research Council Unit, The Gambia||3|||f||||f||||||||Yes|The transcriptome data will be de-identified and deposited in a public database after publication. The cytokine, flow cytometry and antibody data will be made available if required for publication and will be available upon request once published.|2017-10-10 22:23:29.500593|2017-10-10 22:23:29.500593
NCT02710032|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-08-16|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TransPrEP||TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru|TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru|Recruiting||N/A|90|Anticipated|University of California, Los Angeles||2|||f||||f|f|f||||||||2017-10-10 22:23:31.148554|2017-10-10 22:23:31.148554
NCT02710019|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-10|||April 2016||2016-04-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Good Shepherd: Back to Reality Series|Back to Reality Series - Harry's Journey: A Video Game About Under Age|Not yet recruiting||N/A|200|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 22:23:31.246377|2017-10-10 22:23:31.246377
NCT02710006|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-09-06|||February 2016||2016-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Automatic Volume Calculations During Three-dimensional Sonohysterography.|Feasibility and Reliability of Assessing Uterine Cavity Volume by SonoAVC in Women With Reproductive Failure.|Completed||N/A|100|Actual|Ludwin & Ludwin Gynecology, Private Medical Center||1|||f||||t||||||||No||2017-10-10 22:23:31.334409|2017-10-10 22:23:31.334409
NCT02709993|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-10|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Consolidation Therapy in Patients With Hematologic Malignancies|Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Low Dose GM-CSF, As Consolidation Treatment in Patients With Hematologic Malignancies|Recruiting||Phase 1/Phase 2|23|Anticipated|Kiromic, LLC||1|||f|||||t|f||||||||2017-10-10 22:23:31.427496|2017-10-10 22:23:31.427496
NCT02709980|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-10|||April 2016||2016-04-01|March 2016|2016-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Cognitive Behavior Therapy for Insomnia (CBT-I) in Persons With Traumatic Brain Injury (TBI)|Cognitive Behavior Therapy for Insomnia (CBT-I) in Persons With Traumatic Brain Injury (TBI)|Not yet recruiting||N/A|80|Anticipated|Johns Hopkins University||2|||f||||t||||||||Undecided||2017-10-10 22:23:31.508898|2017-10-10 22:23:31.508898
NCT02709967|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-11-23|||March 2016||2016-03-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|RISE||Research Initiative to Support the Empowerment of Girls|Cluster Randomized Trial on the Effectiveness of a Girls' Empowerment Programme on Early Childbearing, Marriage and School Dropout Among Adolescent Girls in Rural Zambia|Active, not recruiting||N/A|5000|Anticipated|University of Bergen||3|||f||||t||||||||Undecided|not yet determined|2017-10-10 22:23:31.588635|2017-10-10 22:23:31.588635
NCT02709954|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-06-19|||March 2016||2016-03-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|THC-ETOH-I||Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I|Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I|Recruiting||Phase 1|40|Anticipated|Yale University||4|||f||||f||||||||||2017-10-10 22:23:31.697129|2017-10-10 22:23:31.697129
NCT02709941|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-05-06|||March 2016||2016-03-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Inspiratory Muscle Strength Training for Sleep-related Breathing Disorders|Respiratory Strength Training Mitigates Hypertension and Sleep Fragmentation in Obstructive Sleep Apnea|Recruiting||N/A|30|Anticipated|University of Arizona||2|||f||||t||||||||||2017-10-10 22:23:31.799248|2017-10-10 22:23:31.799248
NCT02709928|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-12-15|||March 2016||2016-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects|A Phase 1, Double-blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Adult and Elderly Subjects|Completed||Phase 1|50|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||No||2017-10-10 22:23:31.907361|2017-10-10 22:23:31.907361
NCT02709902|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-05-03|||September 2015||2015-09-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris|A Multi-center, Double-blind, Randomized, Placebo, Controlled, Parallel-group Study, Comparing Adapalene/BP Gel, 0.3%/2.5% to EPIDUO® FORTE GEL and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris|Completed||Phase 1|460|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||No||2017-10-10 22:23:32.216596|2017-10-10 22:23:32.216596
NCT02709876|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-10-17|||April 2014||2014-04-01|February 2016|2016-02-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa||Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Stem Cells Arabia||1|||f||||f||||||||Yes||2017-10-10 22:23:32.54023|2017-10-10 22:23:32.54023
NCT02709863|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-10|||October 2015||2015-10-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests|Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests in Patients Undergoing Endoscopic Endonasal Transsphenoidal Surgery of Pituitary Gland|Recruiting||N/A|90|Anticipated|Istanbul University||3|||f||||f||||||||No||2017-10-10 22:23:32.617012|2017-10-10 22:23:32.617012
NCT02709850|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-05-08|||November 2015||2015-11-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Subjects With Familial Hypercholesterolemia|A Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ISIS 703802, Targeting ANGPTL3, Administered Subcutaneously to Healthy Volunteers With Elevated Triglycerides and Subjects With Familial Hypercholesterolemia|Recruiting||Phase 1/Phase 2|61|Anticipated|Ionis Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:23:32.746642|2017-10-10 22:23:32.746642
NCT02709837|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-15|||June 2013||2013-06-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|DREAM||Impact of Food Process and Mastication on Nutrient Bioavailability|Impact of Food Process and Mastication on Nutrient Bioavailability|Completed||N/A|10|Actual|Institut National de la Recherche Agronomique||4|||f||||f||||||||||2017-10-10 22:23:32.842304|2017-10-10 22:23:32.842304
NCT02709824|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-18|||December 2011||2011-12-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|CHX+ADS||Anti-staining Efficacy of Anti-Discoloration System (ADS) Added to Chlorhexidine (CHX)|Efficacy of an Anti-Discoloration System (ADS) to Reduce Dental Staining in a 0.12% Chlorhexidine-based Mouthwash|Completed||N/A|22|Actual|University of Milan||2|||f||||t||||||||No||2017-10-10 22:23:32.944225|2017-10-10 22:23:32.944225
NCT02709811|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-03-10|||August 2012||2012-08-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases|Safety and Feasibility of Electrochemotherapy in the Treatment of Unresectable Liver Metastases From Colorectal Adenocarninoma|Terminated||Phase 1/Phase 2|5|Actual|IGEA||1||Enrollment at study center below rate compatible with study completion.|f||||f||||||||||2017-10-10 22:23:33.027348|2017-10-10 22:23:33.027348
NCT02709798|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-03-17|||April 2016||2016-04-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|SF-STEMI||ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction|A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Effect of Shenfu Injection on Reperfusion Injury in Patients With Acute ST Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Pilot Trial|Recruiting||Phase 4|40|Anticipated|Beijing Anzhen Hospital||2|||f||||||||||||||2017-10-10 22:23:33.108817|2017-10-10 22:23:33.108817
NCT02709785|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-18|||March 2016||2016-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||SmartMouth Advanced Clinical Formula Clinical Research Design Protocol|SmartMouth Advanced Clinical Formula Clinical Research Design Protocol|Completed||N/A|76|Actual|St. Louis University||3|||f||||f||||||||No||2017-10-10 22:23:33.20802|2017-10-10 22:23:33.20802
NCT02709759|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Behavioral Interventions to Reduce Heavy Drinking Among MSM in HIV Primary Care|Behavioral Interventions to Reduce Heavy Drinking Among MSM in HIV Primary Care|Recruiting||Phase 2|224|Anticipated|Brown University||8|||f||||f||||||||No||2017-10-10 22:23:33.375918|2017-10-10 22:23:33.375918
NCT02709733|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-09-22|||January 2016||2016-01-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Virtual Rehabilitation for the Treatment of Motivational Deficits in Schizophrenia|Virtual Rehabilitation for the Treatment of Motivational Deficits in Schizophrenia|Recruiting||N/A|23|Anticipated|Centre for Addiction and Mental Health||1|||f||||f||||||||No||2017-10-10 22:23:34.000142|2017-10-10 22:23:34.000142
NCT02709720|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-19|||April 2016||2016-04-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|NORA||Locally Advanced Trial of Tri-weekly Metronomic Oral Vinorelbine and Cisplatin as Induction Therapy and Subsequent Concomitance With Radiation Therapy in Patients With Unresectable Non Small Cell Lung Cancer (NSCLC)|Phase II Clinical Trial With Metronomic Oral Vinorelbine and Tri-weekly Cisplatin as Induction Therapy and Subsequent Concomitantly With Radiotherapy (RT) in Patients With Lung Cancer (NSCLC) Locally Advanced Unresectable|Recruiting||Phase 2|67|Anticipated|Spanish Lung Cancer Group||1|||f||||t||||||||Undecided||2017-10-10 22:23:34.119801|2017-10-10 22:23:34.119801
NCT02709707|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-06-19|||March 2016||2016-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Lay-user Trial of the iGlucose Blood Glucose Monitoring System|A Lay User Study of the iGlucose, a Device for Self-Monitoring of Blood Glucose (SMBG), Marketed by the Smart Meter Corporation|Completed||N/A|153|Actual|Smart Meter Corporation|||1||f||||f||||||||No||2017-10-10 22:23:34.272969|2017-10-10 22:23:34.272969
NCT02709694|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-06-29|||March 2016||2016-03-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|MaRCH-on||Imaging Biomarkers in Crohn's Associated Spondyloarthritis|Imaging Biomarkers in Crohn's Associated Spondyloarthritis|Recruiting||N/A|30|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||Samples Without DNA|"     Blood for C-reactive Protein and stool samples for fecal microbial 16s rRNA sequencing   "|||2017-10-10 22:23:34.37624|2017-10-10 22:23:34.37624
NCT02709681|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-10-05|||November 2015||2015-11-01|March 2016|2016-03-01|July 2017|Actual|2017-07-01|November 2016|Actual|2016-11-01||Observational|||Hydroxyurea in the Treatment of Sickle Cell Disease|Hydroxyurea in Sickle Cell Disease: a Large Nation-wide Cohort Study From Italy|Completed||N/A|628|Actual|Società Italiana Talassemie ed Emoglobinopatie|||1||f||||f||||||||||2017-10-10 22:23:34.482182|2017-10-10 22:23:34.482182
NCT02709668|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-28|||August 2013||2013-08-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|BVMD||B Vitamins in MTHFR Positive Patients With Major Depression: A Post Hoc Analysis of Findings|Clinical Response and Homocysteine Reduction Using Reduced B-Vitamin Therapy in MTHFR C677T/A1298C Patients With Major Depressive Disorder : an Analysis of Findings|Completed||Phase 4|330|Actual|High Point Regional Health Systems||2|||f||||f||||||||No||2017-10-10 22:23:34.638926|2017-10-10 22:23:34.638926
NCT02709642|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-09-21|||June 2016||2016-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Brigham and Women's Healthy Weight Study|Brigham and Women's Healthy Weight Study: Randomized Controlled Trial of a Financial Incentive for Weight Maintenance|Active, not recruiting||N/A|42|Actual|Harvard Pilgrim Health Care||2|||f||||f||||||||||2017-10-10 22:23:35.181027|2017-10-10 22:23:35.181027
NCT02709629|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-10-13|||August 2015||2015-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||CCT for Older Diabetic Adults|The Effects of Computerized Cognitive Training on Diabetic Elderly, Who Are at High Risk for Dementia|Recruiting||N/A|120|Anticipated|Sheba Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:23:35.295688|2017-10-10 22:23:35.295688
NCT02709616|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-06-17|||March 2016||2016-03-01|March 2016|2016-03-01|June 2019|Anticipated|2019-06-01|March 2018|Anticipated|2018-03-01||Interventional|PERCELLVAC||Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)|Personalized Cellular Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma (PerCellVac)|Recruiting||Phase 1/Phase 2|20|Anticipated|Guangdong 999 Brain Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:23:35.398446|2017-10-10 22:23:35.398446
NCT02709603|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-09-06|||March 2016||2016-03-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|HBTB-DIC||Hyoscine Butyl Bromide in Reducing Pain During HSG|Randomized Clinical Trial of Oral Hyoscine Butyl Bromide in Reducing Pain During HSG|Completed||Phase 4|200|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:23:35.507176|2017-10-10 22:23:35.507176
NCT02709590|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-04-25|||March 2016||2016-03-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|DP-L||Diclofenac Potassium With Lidocaine Cream in Reducing Pain During HSG|Randomized Clinical Trial of Oral Diclofenac Potassium With Cervical Lidocaine Cream in Reducing Pain During HSG|Completed||Phase 3|140|Actual|Assiut University||2|||f||||t|f|f|||f|||Undecided||2017-10-10 22:23:35.604892|2017-10-10 22:23:35.604892
NCT02709577|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-11-01|2016-09-13||January 2007||2007-01-01|November 2016|2016-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||Device Cohort A had 10 Subjects, Device Cohort B had 8 subjects, Sham Cohort A had 4 subjects and Sham Cohort B had 5 subjects at Baseline|A Study of the GI Sleeve for the Treatment of Type 2 Diabetes|A Pilot Feasibility Sham Controlled Study of the GI Sleeve for the Treatment of Type 2 Diabetes|Completed||Phase 1/Phase 2|36|Actual|GI Dynamics||2|||f||||f||||||||Yes||2017-10-10 22:23:35.719978|2017-10-10 22:23:35.719978
NCT02709564|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-03-12|||April 2016||2016-04-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|SL-MISO||Sublingual Misoprostol in Decreasing Blood Loss Prior to Myomectomy|Single Dose Versus Two Doses of Sublingual Misoprostol in Decreasing Blood Loss Prior to Abdominal Myomectomy: A Randomized Double-blinded Clinical Trial|Recruiting||Phase 3|80|Anticipated|Assiut University||2|||f||||t||||||||No||2017-10-10 22:23:36.262714|2017-10-10 22:23:36.262714
NCT02709551|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-03-10|||February 2015||2015-02-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparative Intervention Study of Stress Reduction in Corporate Health Management|Comparative Intervention Study of Stress Reduction in Corporate Health Management: Evaluation of the Effects of Heart Rate Variability (HRV) Biofeedback Training, Mindfulness Based Intervention (MBI) and Mindfulness Based HRV-biofeedback|Completed||N/A|60|Actual|ARCIM Institute Academic Research in Complementary and Integrative Medicine||3|||f||||||||||||||2017-10-10 22:23:36.373773|2017-10-10 22:23:36.373773
NCT02709538|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-09-18|||April 2016||2016-04-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|GSP 301-303||Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)|A Double-Blind, Randomized, Parallel-Group Study to Evaluate Long-Term Safety, Tolerability, and Efficacy of a Fixed Dose Combination GSP 301 Nasal Spray Compared With Two Placebo Nasal Spray Formulations in Subjects (Aged 12 Years and Older) With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|600|Actual|Glenmark Specialty S.A.||3|||f||||||||||||||2017-10-10 22:23:36.463928|2017-10-10 22:23:36.463928
NCT02709525|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-15|||July 2012||2012-07-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|||Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human|Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human: a Split-mouth Randomized Triple-blind Clinical Trial|Completed||Phase 1/Phase 2|16|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-10 22:23:36.609987|2017-10-10 22:23:36.609987
NCT02709512|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-08-17|||October 2016||2016-10-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|ATOMIC||Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin|Randomized, Double-Blind, Phase 2/3 Study in Subjects With Malignant Pleural Mesothelioma With Low Argininosuccinate Synthetase 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ATOMIC-Meso Phase 2/3 Study)|Recruiting||Phase 2/Phase 3|386|Anticipated|Polaris Group||2|||f||||t||||||||||2017-10-10 22:23:36.699672|2017-10-10 22:23:36.699672
NCT02709499|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-10|||March 2016||2016-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of the Low-level Laser Therapy on Inflammatory Profile of the Patients With Coronary Artery Bypass Surgery|Effects of the Low-level Laser Therapy on Inflammatory Profile on Patients With Coronary Artery Bypass Surgery: A Randomized, Controlled Clinical Trail|Not yet recruiting||N/A|38|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||f||||||||No||2017-10-10 22:23:36.815599|2017-10-10 22:23:36.815599
NCT02709486|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-09-18|||March 2, 2016|Actual|2016-03-02|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|May 8, 2018|Anticipated|2018-05-08||Interventional|||Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.|A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study Of The Analgesic Efficacy And Safety Of The Subcutaneous Administration Of Tanezumab In Subjects With Osteoarthritis Of The Hip Or Knee|Recruiting||Phase 3|810|Anticipated|Pfizer||3|||f||||t|t|f||||||||2017-10-10 22:23:36.92344|2017-10-10 22:23:36.92344
NCT02709473|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-07-11|||March 2016||2016-03-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Propofol and Remifentanil Sequence on ED50 and ED95 of Rocuronium in Rapid Sequence Induction Anesthesia|Does the Choice of Administration Sequence of Propofol and Remifentanil Affect the ED50 and ED95 of Rocuronium for Rapid Sequence Induction of Anesthesia?|Completed||Phase 4|84|Actual|Ankara University||2|||f||||f||||||||No||2017-10-10 22:23:37.35504|2017-10-10 22:23:37.35504
NCT02709460|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-09-18|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Lateral Occlusion of Uterine Artery in Total Laparoscopic Hysterectomy|Lateral Versus Cervical Coagulation of the Uterine Artery in Benign Hysterectomy: A Randomized Controlled Study|Recruiting||N/A|60|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-10 22:23:37.449974|2017-10-10 22:23:37.449974
NCT02709447|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-04-06|||April 2015||2015-04-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||Dating Violence Prevention for Juvenile Justice Girls|Dating Violence Prevention for Juvenile Justice Girls|Recruiting||N/A|250|Anticipated|Northeastern University||2|||f||||t||||||||No||2017-10-10 22:23:37.538979|2017-10-10 22:23:37.538979
NCT02709434|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2016-03-11|||December 2016||2016-12-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Fatigue Management in Quiescent IBD|The Efficacy of a Structured Psychoeducational Inflammatory Bowel Disease Group on the Control of Fatigue in an Adult Outpatient Setting for Patients With Objectively Quiescent Disease.|Not yet recruiting||N/A|40|Anticipated|The Leeds Teaching Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 22:23:37.660282|2017-10-10 22:23:37.660282
NCT02709421|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-09-01|||February 2016||2016-02-01|June 2016|2016-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Risk Factors of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin|Risk Factors Related to Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-risk Patients Who Underwent ERCP and Received Prophylactic Rectal Indomethacin|Completed||N/A|790|Actual|Fourth Military Medical University|||1||f||||t||||||||||2017-10-10 22:23:37.74153|2017-10-10 22:23:37.74153
NCT02709408|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-08-01|||April 2016||2016-04-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01|30 Days|Observational [Patient Registry]|EURECA||European Prospective Cohort Study on Enterobacteriaceae Showing Resistance to Carbapenems|Prospective Observational Study to Assess the Risk Factors, Clinical Management and Outcomes of Hospitalized Patients With Serious Infections Caused by Carbapenem-resistant Enterobacteriaceae and Acinetobacter Baumannii|Recruiting||N/A|1025|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla|||4||f||||t||||||Samples With DNA|"     Bacteria (carbapenem-resistant and susceptible Enterobacteriaceae, carbapenem-resistant     Acinetobacter baumannii)   "|||2017-10-10 22:23:37.841286|2017-10-10 22:23:37.841286
NCT02709395|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-12-09|||February 2016||2016-02-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart|Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart|Completed||N/A|31|Actual|Wellspect HealthCare||1|||f||||f||||||||No||2017-10-10 22:23:38.143176|2017-10-10 22:23:38.143176
NCT02709382|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-08-25|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment||Completed||Phase 1|48|Actual|Wockhardt||1|||f||||f||||||||No||2017-10-10 22:23:38.213317|2017-10-10 22:23:38.213317
NCT02709369|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-04-17|||August 2011||2011-08-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||HIRREM Developmental Study|Functional and Physiological Effects of High-resolution, Relational, Resonance-based, Electroencephalic Mirroring (HIRREM) for Neurological, Cardiovascular and Psychophysiological Disorders|Recruiting||N/A|250|Anticipated|Wake Forest University Health Sciences||1|||f||||f||||||||No|Data will be shared in publications and presentations. No plan to formally make individual participant data available for this exploratory study|2017-10-10 22:23:38.286332|2017-10-10 22:23:38.286332
NCT02709356|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-03-27|||July 2015||2015-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|MCT-MA||Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease|Proof of Concepts: Can a Supplement Ketogenic Based MCT Oil Increases Cerebral Capture Ketones in People With Alzheimer's Disease?|Recruiting||N/A|20|Anticipated|Université de Sherbrooke||2|||f||||f||||||||Undecided||2017-10-10 22:23:38.392786|2017-10-10 22:23:38.392786
NCT02709343|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-05-01|||April 21, 2017|Actual|2017-04-21|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|ASSIST-CLAD||Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction|Phase 2 Randomised Controlled Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction (CLAD)|Recruiting||Phase 2|82|Anticipated|The University of Queensland||2|||f||||t|f|f||||||Yes|De-identified data will be analysed and shared with collaborators with the plan to publish the results.|2017-10-10 22:23:38.478285|2017-10-10 22:23:38.478285
NCT02709330|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-02-06|||April 2016|Actual|2016-04-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||ALS Reversals - Lunasin Regimen|An Open-label, Single-center, 12-month Trial of a Lunasin Regimen for Patients With Amyotrophic Lateral Sclerosis (ALS)|Active, not recruiting||Phase 2|50|Actual|Duke University||2|||f||||f|t|f||||||Yes|Participants will be assigned a global unique ID number (GUID), which will allow de-identified data sharing.|2017-10-10 22:23:38.57835|2017-10-10 22:23:38.57835
NCT02709304|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-11|||April 2016||2016-04-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy of Lidocaine Gel in Reducing Foley Catheter Discomfort in Surgical Patients|Exploring the Potential Efficacy of Lidocaine Gel in Reducing Discomfort in Patients Undergoing Surgical Procedures Requiring Foley Catheter Placement|Not yet recruiting||Phase 4|40|Anticipated|Creighton University||2|||f||||f||||||||Undecided||2017-10-10 22:23:38.904227|2017-10-10 22:23:38.904227
NCT02709291|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-01-02|||December 2016||2016-12-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Systematically Adapted Delivery of the Family Check-Up|Systematically Adapted Delivery of the Family Check-Up in Underserved Communities|Enrolling by invitation||N/A|50|Anticipated|University of Kentucky||2|||f||||f||||||||Undecided||2017-10-10 22:23:38.992714|2017-10-10 22:23:38.992714
NCT02709278|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-02-22|||March 2016||2016-03-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Aerosol BCG Challenge Trial in Healthy UK Adults|A Clinical Challenge Trial to Evaluate Controlled Human Infection With BCG Administered by the Aerosol Inhaled Route Compared With the Intradermal Route in Healthy, BCG-naïve, UK Adult Volunteers|Recruiting||Phase 1|60|Anticipated|University of Oxford||9|||f||||f||||||||Undecided||2017-10-10 22:23:39.099266|2017-10-10 22:23:39.099266
NCT02709252|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-10|||January 2011||2011-01-01|March 2016|2016-03-01||||December 2013|Actual|2013-12-01||Interventional|||Effect of the Pneumoperitoneum on Dynamic Variables Delta PP and PVI During Trendelenburg Position.|Effect of the Pneumoperitoneum on Dynamic Variables Delta PP and PVI During Trendelenburg Position.|Completed||Phase 2|50|Actual|Brugmann University Hospital||1|||f||||||||||||||2017-10-10 22:23:39.327311|2017-10-10 22:23:39.327311
NCT02709239|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-10-04|||April 2016||2016-04-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|March 2020|Anticipated|2020-03-01||Interventional|PANDA||Prenatal DHA and Neurofunctional Development|Prenatal Docosahexaenoic Acid (DHA) & Neurofunctional Development|Recruiting||N/A|340|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-10 22:23:39.402816|2017-10-10 22:23:39.402816
NCT02709018|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-20|||July 2016||2016-07-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|LOSe-PTSD||A Controlled Trial of Losartan in Posttraumatic Stress Disorder|Enhancing Fear Extinction Via Angiotensin Type 1 Receptor Inhibition: A Randomized Controlled Trial in Posttraumatic Stress Disorder|Recruiting||N/A|160|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 22:23:41.663421|2017-10-10 22:23:41.663421
NCT02709213|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-11-12|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Determination of the Aetiologies of Acute Colitis and Early Identification of Patients Requiring Diagnostic Colonoscopy|Colitis Prospective Cohort Study: Determining the Aetiologies of Acute Colitis and Developing a Diagnostic Score to Identify Patients Requiring Specific Investigations|Recruiting||N/A|200|Anticipated|University Hospital, Geneva|||1||f||||f||||||Samples Without DNA|"     Stools   "|No||2017-10-10 22:23:39.597451|2017-10-10 22:23:39.597451
NCT02709200|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-04-12|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery||Enrolling by invitation||N/A|200|Anticipated|Nationwide Children's Hospital|||2||f||||f||||||||No||2017-10-10 22:23:39.686816|2017-10-10 22:23:39.686816
NCT02709187|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-06-07|||March 2016||2016-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||DP-R208 Pharmacokinetic Study|DP-R208 Pharmacokinetic Study Phase I|Completed||Phase 1|37|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-10 22:23:39.772124|2017-10-10 22:23:39.772124
NCT02709174|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-03-10|||February 2014||2014-02-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models|Diagnosing Pulmonary Embolism in Pregnancy: Are Biomarkers and Clinical Prediction Models Useful?|Completed||N/A|59|Actual|Advocate Health Care|||2||f||||f||||||||||2017-10-10 22:23:39.874011|2017-10-10 22:23:39.874011
NCT02709161|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Effects of Amygdala Neurofeedback on Depressive Symptoms|Effects of Amygdala Neurofeedback on Depressive Symptoms|Recruiting||N/A|60|Anticipated|University of Pittsburgh||2|||f||||t||||||||Undecided||2017-10-10 22:23:39.950863|2017-10-10 22:23:39.950863
NCT02709148|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-25|||May 2016||2016-05-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||State-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With Deep Brain Stimulation (DBS)|State-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With DBS|Enrolling by invitation||Early Phase 1|4|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||Undecided||2017-10-10 22:23:40.059753|2017-10-10 22:23:40.059753
NCT02709135|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-02-01|||December 2016|Actual|2016-12-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|PARA-HEART||PARA-HEART Pilot Implementation|Can Pre-Hospital Use of the HEART Score and Abbott i-STAT® Point-of-Care Troponin Predict Major Adverse Cardiovascular Events: the PARA-HEART Pilot Implementation|Recruiting||N/A|500|Anticipated|Wake Forest University Health Sciences|||1||f||||f||||||||No||2017-10-10 22:23:40.149937|2017-10-10 22:23:40.149937
NCT02709122|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-09|||February 2016||2016-02-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Are EMS Personnel Prepared to Identify and Decompression of Tension Pneumothorax|Are EMS Personnel Prepared to Identify and Decompression of Tension Pneumothorax: A Randomized, Crossover Manikin Trial|Recruiting||N/A|80|Anticipated|Medical University of Warsaw||2|||f||||f||||||||Undecided||2017-10-10 22:23:40.27404|2017-10-10 22:23:40.27404
NCT02709109|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-10-03|||February 2016||2016-02-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation|A Phase 2a, Randomized, Double-blind, Placebo-controlled, Incomplete Block, Crossover Study to Evaluate the Safety and Efficacy of VX-371 in Subjects Aged 12 Years or Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation, and Being Treated With Orkambi|Completed||Phase 2|142|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||||||||||||2017-10-10 22:23:40.371554|2017-10-10 22:23:40.371554
NCT02709096|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-08-16|2017-07-18||April 2016||2016-04-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes|BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes|Completed||Phase 2|33|Actual|BioPharmX, Inc.||2|||f||||f||||||||||2017-10-10 22:23:40.564348|2017-10-10 22:23:40.564348
NCT02709083|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-10-19|||October 2016||2016-10-01|October 2016|2016-10-01|October 2023|Anticipated|2023-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia|First-Line Dasatinib or Nilotinib Followed by Response Guided Switch to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia|Recruiting||Phase 2|100|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 22:23:40.974534|2017-10-10 22:23:40.974534
NCT02709070|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-14|||March 2016||2016-03-01|March 2016|2016-03-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Resection+Highly Purified CTL Versus Resection Alone for HCC|Resection Combined With Highly-purified CTL Versus Resection Alone for HCC|Active, not recruiting||Phase 3|210|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Yes||2017-10-10 22:23:41.141797|2017-10-10 22:23:41.141797
NCT02709057|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-07-05|||April 2016||2016-04-01|April 2016|2016-04-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|T2D-GENE||Lifestyle Intervention in Individuals With Low or High Genetic Risk for Type 2 Diabetes|Effect of Lifestyle Intervention on Incident Diabetes in Individuals With Impaired Fasting Glucose and Low or High Genetic Risk for the Development of Type 2 Diabetes|Recruiting||N/A|1200|Anticipated|University of Eastern Finland||4|||f||||f||||||||No||2017-10-10 22:23:41.276719|2017-10-10 22:23:41.276719
NCT02709044|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-10|||February 2016||2016-02-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Fluid Resuscitation in Acute Pancreatitis|Randomized Trial of Standard vs. Enhanced Hydration in Patients With a Diagnosis of Acute Pancreatitis Within the First Hour of the Diagnosis|Recruiting||Phase 2/Phase 3|903|Anticipated|University Hospital Rijeka||2|||f||||||||||||||2017-10-10 22:23:41.404247|2017-10-10 22:23:41.404247
NCT02709031|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-10|||June 2016||2016-06-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|CHAMP||Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium|Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Navitas Pharma||2|||f||||f||||||||No||2017-10-10 22:23:41.569542|2017-10-10 22:23:41.569542
NCT02709005|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-09-28|||April 14, 2016|Actual|2016-04-14|July 19, 2017|2017-07-19|February 23, 2018|Anticipated|2018-02-23|February 23, 2018|Anticipated|2018-02-23||Interventional|||Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis|A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Assess the Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis|Recruiting||Phase 2|120|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-10 22:23:41.821026|2017-10-10 22:23:41.821026
NCT02708992|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-09-14|||April 28, 2016|Actual|2016-04-28|July 19, 2017|2017-07-19|July 31, 2017|Actual|2017-07-31|December 31, 2016|Actual|2016-12-31||Interventional|||Cefixime / Azithromycin pK Study|The Pharmacokinetics of Extended Duration High-Dose Cefixime Co-administered With Azithromycin for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study|Completed||Phase 1|10|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f|||||t|f|||f|||||2017-10-10 22:23:41.939926|2017-10-10 22:23:41.939926
NCT02708979|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-14|||February 2016||2016-02-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|StrEat||Stress and Eating Behavior Among University Students - an Randomized Controlled Trial|StrEat - Stress and Eating Behavior|Recruiting||N/A|50|Anticipated|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 22:23:42.046346|2017-10-10 22:23:42.046346
NCT02708966|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-18|||March 2016||2016-03-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance.|Effect of the Administration of Gymnema Sylvestre on Glycemic Control, Insulin Secretion and Insulin Sensitivity in Patients With Impaired Glucose Tolerance.|Recruiting||Phase 2|24|Anticipated|University of Guadalajara||2|||f||||f||||||||||2017-10-10 22:23:42.201253|2017-10-10 22:23:42.201253
NCT02708953|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-11-16|||May 2016||2016-05-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Thoracic Spine Thrust Manipulation for Cervicogenic Headaches: A Randomized Clinical Trial|Thoracic Spine Thrust Manipulation for Cervicogenic Headaches: A Randomized Clinical Trial|Recruiting||N/A|48|Anticipated|University of Colorado, Denver||2|||f||||f||||||||Undecided||2017-10-10 22:23:42.33142|2017-10-10 22:23:42.33142
NCT02708940|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-03-09|||February 2016||2016-02-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient Programs||Recruiting||N/A|150|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 22:23:42.480034|2017-10-10 22:23:42.480034
NCT02708914|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-14|||March 2016||2016-03-01|March 2016|2016-03-01||||February 2018|Anticipated|2018-02-01||Interventional|||Study to Compare the Safety and Efficacy of UB-851 and Eprex®|A Phase III Trial to Compare the Safety and Efficacy of Intravenous UB-851 and Eprex® With an Extension Safety Evaluation in Subjects With Renal Anemia on Hemodialysis|Not yet recruiting||Phase 3|228|Anticipated|UBI Pharma Inc.||2|||f||||||||||||||2017-10-10 22:23:42.71636|2017-10-10 22:23:42.71636
NCT02708888|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-09-08|||March 2016||2016-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness of Additional Trunk Exercises on Gait Performance|Effectiveness of Additional Trunk Exercises on Gait Performance: a Randomised Controlled Trial|Recruiting||N/A|60|Anticipated|Universiteit Antwerpen||2|||f||||f||||||||Undecided||2017-10-10 22:23:42.929418|2017-10-10 22:23:42.929418
NCT02708875|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-11|||December 2015||2015-12-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Microvascular Insulin Resistance and Mixed Meal Challenge|Microvascular Insulin Resistance and Mixed Meal Challenge|Recruiting||N/A|36|Anticipated|Menzies Institute for Medical Research||2|||f||||f||||||||||2017-10-10 22:23:43.144728|2017-10-10 22:23:43.144728
NCT02708862|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-31|||March 2016||2016-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Four Methods of Pre-oxygenation|Comparison of Emergency Department Preoxygenation Techniques in Healthy Volunteers|Completed||N/A|26|Actual|Minneapolis Medical Research Foundation||4|||f||||f||||||||Undecided||2017-10-10 22:23:43.277534|2017-10-10 22:23:43.277534
NCT02708849|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-01-05|||June 2015||2015-06-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||The Sustained Effects of Ketamine|The Sustained Effects of Ketamine|Active, not recruiting||Phase 1|3|Actual|Yale University||2|||f||||f||||||||||2017-10-10 22:23:43.360726|2017-10-10 22:23:43.360726
NCT02708836|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-01-24|||May 1, 2017|Anticipated|2017-05-01|January 2017|2017-01-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|LEPAGA||Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique|Limiting Emergence Phenomena After General Anesthesia for Laparoscopic Surgery With Combined Laryngeal Mask Airway and Endotracheal Tube Airway Management Technique|Not yet recruiting||N/A|140|Anticipated|Milton S. Hershey Medical Center||2|||f||||f|f|t|f|f||||No|IPD will be stored in REDCap, a HIPPA compliant secured and encrypted electronic database.|2017-10-10 22:23:43.461745|2017-10-10 22:23:43.461745
NCT02708823|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-08-08|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|DRP-Norm||Standardization of a Novel Self-administered Tablet Computer-based Clinical Screening Tool for Postoperative Delirium|Standardization of a Novel Self-administered Tablet Computer-based Clinical Screening Tool for Postoperative Delirium: A Neuropsychological Study in Non-surgical Volunteers|Completed||N/A|334|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-10 22:23:43.592498|2017-10-10 22:23:43.592498
NCT02708810|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-05-31|||November 2015||2015-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery|RAD 1501: A Phase II Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery|Recruiting||N/A|100|Anticipated|University of Alabama at Birmingham||1|||f||||f||||||||No||2017-10-10 22:23:43.683578|2017-10-10 22:23:43.683578
NCT02708797|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-17|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|MINOTAURE||Brainstem Grey Matter and Cerebral Autoregulation in Migraine With Aura.|Brainstem Grey Matter and Cerebral Autoregulation in Migraine With Aura : a MRI and Transcranial Doppler.|Completed||N/A|46|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 22:23:43.789244|2017-10-10 22:23:43.789244
NCT02708784|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-03-09|||September 2015||2015-09-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Observational|||An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica-|Function, Structure and Quality of Striated Muscles in Patients With Muscular Diseases - an MRI Study on Pompe Disease and Dystrophia Myotonica|Enrolling by invitation||N/A|60|Anticipated|University of Aarhus|||3||f||||t||||||||No||2017-10-10 22:23:43.89821|2017-10-10 22:23:43.89821
NCT02708771|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-10|||March 2016||2016-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|PROTEICA||Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity|Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity|Recruiting||Phase 3|42|Anticipated|Hospital San Juan de la Cruz||2|||f||||t||||||||||2017-10-10 22:23:44.023389|2017-10-10 22:23:44.023389
NCT02708758|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-02-28|||September 2015||2015-09-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Treatment for Gestational Diabetes Diagnosed by the IADPSG Criteria.|Efficacy of Treatment in Women With Gestational Diabetes Mellitus Diagnosed by One Altered Value by the International Association of Diabetes and Pregnancy Study Groups Criteria (IADPSG).|Recruiting||N/A|620|Anticipated|Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes||2|||f||||t||||||||||2017-10-10 22:23:44.146186|2017-10-10 22:23:44.146186
NCT02708745|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-10|||March 2016||2016-03-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SHOT||Screening for Hesitancy to Optimize Talk|Use of a Novel Parent-Report Measure to Improve Childhood Vaccine Uptake: The Screening for Hesitancy to Optimize Talk (SHOT) Study|Enrolling by invitation||N/A|160|Anticipated|Seattle Children's Hospital||2|||f||||f||||||||No||2017-10-10 22:23:44.249636|2017-10-10 22:23:44.249636
NCT02708732|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-04-19|||May 31, 2016|Actual|2016-05-31|April 2017|2017-04-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|||Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)|UK Utility Study in Diffuse Large B-Cell Lymphoma|Completed||N/A|91|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:23:44.343967|2017-10-10 22:23:44.343967
NCT02708719|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-10-07|||February 2016||2016-02-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Development of a MID for the 1-minute Sit-to-stand Test|Development of a Minimal Important Difference for the 1-minute Sit-to-stand Test|Recruiting||N/A|95|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||1|||f||||f||||||||No||2017-10-10 22:23:44.421457|2017-10-10 22:23:44.421457
NCT02708706|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-03-09|||August 2015||2015-08-01|December 2015|2015-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||The Efficacy of Ultrasound-guided Hydrodilatation With Hyaluronic Acid for Patients With Adhesive Capsulitis|The Efficacy of Ultrasound-guided Hydrodilatation With Hyaluronic Acid for Patients With Adhesive Capsulitis|Recruiting||N/A|70|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-10 22:23:44.520962|2017-10-10 22:23:44.520962
NCT02708693|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-03-09|||April 2013||2013-04-01|April 2013|2013-04-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy of Combined Ultrasound Guided Steroid Injection and Splinting in Patients With Carpal Tunnel Syndrome|Efficacy of Combined Ultrasound Guided Steroid Injection and Splinting in Patients With Carpal Tunnel Syndrome|Completed||N/A|52|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-10 22:23:44.628858|2017-10-10 22:23:44.628858
NCT02708680|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-09-14|||May 2016||2016-05-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In|A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 2 Study of Atezolizumab With or Without Entinostat in Patients With Advanced Triple Negative Breast Cancer, With a Phase 1b Lead in Phase|Recruiting||Phase 1/Phase 2|88|Anticipated|Syndax Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:23:44.74165|2017-10-10 22:23:44.74165
NCT02708667|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-09|||September 2015||2015-09-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients|An Observational Research on Relationship Between c-Met Gene Polymorphism, Promoter Methylation Level, Related Drug Metabolism Enzymes and Crizotinib's Hepatic Toxicity in Non-small Cell Lung Cancer Patients|Recruiting||N/A|50|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     whole blood, biopsy tissue   "|||2017-10-10 22:23:44.9287|2017-10-10 22:23:44.9287
NCT02708654|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-06-19|||May 22, 2016|Actual|2016-05-22|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|EMPOWER||Automated Hovering for Congestive Heart Failure Patients|Automated Hovering for Congestive Heart Failure Management: (EMPOWER) Electronic Monitoring of Patients Offers Way to Enhance Rehabilitation|Recruiting||Phase 3|500|Anticipated|University of Pennsylvania||2|||f||||t||||||||Yes|Only aggregate data will be shared, not on individual level|2017-10-10 22:23:45.043247|2017-10-10 22:23:45.043247
NCT02708641|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-06-19|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML|A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With Acute Myeloid Leukemia (AML) Who Are Not Transplantation Candidates|Recruiting||Phase 2|40|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 22:23:45.149536|2017-10-10 22:23:45.149536
NCT02708628|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-10-02|||December 2015||2015-12-01|March 2016|2016-03-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|||The Efficacy of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development|The Efficacy of Prophylactic Use of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development After Excision of Previous Scar|Completed||N/A|120|Actual|Suleymaniye Birth And Women's Health Education And Research Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:23:45.254218|2017-10-10 22:23:45.254218
NCT02708615|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-04-18|||November 2015||2015-11-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Speculum Insertion Study|A Randomized Controlled Trial of Gynecological Speculum Examination: Straight Horizontal Insertion vs. Vertical Insertion and Rotation|Enrolling by invitation||N/A|304|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-10-10 22:23:45.36631|2017-10-10 22:23:45.36631
NCT02708602|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||Correlation Between the Polymorphism ofβ2 AR and the Labor Progress After Labor Analgesia|Principal Investigator|Not yet recruiting||N/A|300|Anticipated|Nanjing Maternity and Child Health Care Hospital|||6||f||||||||||||||2017-10-10 22:23:45.453423|2017-10-10 22:23:45.453423
NCT02708589|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-03-09|||September 2015||2015-09-01|March 2016|2016-03-01||||September 2017|Anticipated|2017-09-01||Interventional|||The Effects of Probiotic Supplementation on the Results of Gastric Bypass Surgery|The Effects of Probiotic Supplementation on Anthropocentric, Nutrients Status, Inflammation, GI Hormones, Quality of Life, and Microflora in Patients Undergoing Gastric Bypass Surgery|Recruiting||Phase 2/Phase 3|50|Anticipated|National Nutrition and Food Technology Institute||2|||f||||||||||||||2017-10-10 22:23:45.552165|2017-10-10 22:23:45.552165
NCT02708576|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-13|||February 2016||2016-02-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Phase 1 Study of NGM313 in Healthy Adult Participants|A Phase 1 Randomized, Double Blind, Placebo Controlled, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of NGM313 in Healthy Overweight and Obese Adult Participants|Completed||Phase 1|151|Actual|NGM Biopharmaceuticals, Inc||2|||f||||f||||||||||2017-10-10 22:23:45.636544|2017-10-10 22:23:45.636544
NCT02708563|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-08-11|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|MATS||Meconium Aspiration and Tracheal Suctioning—Feasibility Study|Meconium Aspiration Syndrome and Non-vigorous Neonates-Pilot Study|Not yet recruiting||N/A|240|Anticipated|St. Louis University||2|||f||||f|f|f||||||||2017-10-10 22:23:45.722746|2017-10-10 22:23:45.722746
NCT02708550|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-09-29|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2017|Actual|2017-04-01||Interventional|IRMA12||Participatory Organizational Intervention for Improved Use of Assistive Devices for Patient Handling|Deltagerinvolverende Intervention for Bedre Brug af hjælpemidler i hospitalsvæsenet|Active, not recruiting||N/A|400|Anticipated|National Research Centre for the Working Environment, Denmark||2|||f||||||||||||||2017-10-10 22:23:45.797137|2017-10-10 22:23:45.797137
NCT02708537|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-08-21|||March 2016||2016-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Observational|||Effect of Plasma Rich in Growth Factors on Semen Quality|Effect of Plasma Rich in Growth Factors (PRGF) on Semen Quality|Active, not recruiting||N/A|58|Anticipated|IVI Bilbao|||1||f||||t||||||||||2017-10-10 22:23:45.875379|2017-10-10 22:23:45.875379
NCT02708524|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-09-22|2016-08-03||January 2016||2016-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||All subjects that were dispensed a study lens.|Clinical Study of Approved and Investigational Contact Lenses||Completed||N/A|554|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||t||||||||||2017-10-10 22:23:46.001299|2017-10-10 22:23:46.001299
NCT02708511|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-09-24|||August 2016||2016-08-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer|64Cu-DOTA-B-Fab as A PET Tracer for Evaluating CA6 Expression in Tumors: A First in Human Study|Recruiting||Phase 1|10|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:23:47.033737|2017-10-10 22:23:47.033737
NCT02708498|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-23|||April 9, 2015|Actual|2015-04-09|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 20, 2017|Actual|2017-06-20||Interventional|KUPA||Implementation of Knowledge-Based Palliative Care|Implementation of Knowledge-Based Palliative Care for Frail Older Persons in Nursing Homes|Active, not recruiting||N/A|1400|Anticipated|Lund University||4|||f||||f||||||||||2017-10-10 22:23:47.136328|2017-10-10 22:23:47.136328
NCT02708472|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-03-15|||April 2016||2016-04-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|April 2017|Anticipated|2017-04-01||Interventional|||Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation for the Treatment of Generalized Anxiety Disorder|Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation (sTMS) for the Treatment of Generalized Anxiety Disorder (GAD) -An Open Label Investigator Initiated Trial|Not yet recruiting||N/A|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||No||2017-10-10 22:23:48.841465|2017-10-10 22:23:48.841465
NCT02708459|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-08-29|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|TAP Donor||Transversus Abdominus Plane Block in Living Donor Hepatectomy||Completed||N/A|90|Actual|Mansoura University||3|||f||||t||||||||Yes||2017-10-10 22:23:48.921245|2017-10-10 22:23:48.921245
NCT02708446|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-07-13|||May 2014||2014-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion|A Randomized Controlled Trial to Compare Sublingual and Buccal Misoprostol Regimens After Mifepristone for Termination of Pregnancy 13 - 21 Weeks From Last Menstrual Period (LMP)|Recruiting||Phase 4|320|Anticipated|Gynuity Health Projects||2|||f||||f||||||||||2017-10-10 22:23:49.009219|2017-10-10 22:23:49.009219
NCT02708433|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-04-20|||March 2016||2016-03-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Outcomes of Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine|Pilot Study: Comparison of Buffered 1% vs. Non-Buffered 2% Lidocaine Used in Dental and Oral Surgical Procedures: Clinical Outcomes|Active, not recruiting||N/A|23|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No|No plans|2017-10-10 22:23:49.142034|2017-10-10 22:23:49.142034
NCT02708420|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2017-06-12|||January 1, 2016||2016-01-01|March 2016|2016-03-01|June 1, 2017|Actual|2017-06-01|May 18, 2017|Actual|2017-05-18||Interventional|||Does Glidescope Video Laryngoscope is Related to Less Hemodynamic Response?|Comparison of Hemodynamic Responses to Endotracheal Intubation With Glidescope Video Laryngoscope and Macintosh Direct Laryngoscope in Patients Undergoing Coronary Artery Bypass Surgery|Completed||N/A|70|Actual|Gata Haydarpasa Research Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:23:49.242449|2017-10-10 22:23:49.242449
NCT02708407|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-03-09|||January 2016||2016-01-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PD-HF||PD-HF: A Trial of Peritoneal Dialysis in Patients With Severe Heart Failure and Chronic Kidney Disease|PD-HF: A Multi-centre Randomised Controlled Trial of Intermittent Peritoneal Dialysis With Icodextrin-based Solutions on Patients With Severe Heart Failure and Stage 3-4 Chronic Kidney Disease|Recruiting||N/A|130|Anticipated|University of Nottingham||2|||f||||t||||||||Undecided||2017-10-10 22:23:49.33486|2017-10-10 22:23:49.33486
NCT02708394|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-03-01|||February 1, 2017|Actual|2017-02-01|March 2017|2017-03-01|January 2023|Anticipated|2023-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Molecular Mechanisms of Antipsychotic-induced Insulin Resistance|Molecular Mechanisms of Antipsychotic-induced Insulin Resistance in Healthy Volunteers|Recruiting||Phase 2|50|Anticipated|Wayne State University||2|||f||||t|t|f|||f|||No||2017-10-10 22:23:49.424048|2017-10-10 22:23:49.424048
NCT02708381|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-30|||March 11, 2015|Actual|2015-03-11|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|February 9, 2016|Actual|2016-02-09||Observational|||Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ Database|Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ Database|Active, not recruiting||N/A|31|Actual|H. Lee Moffitt Cancer Center and Research Institute|||1||f||||f|f|f||||||||2017-10-10 22:23:49.557726|2017-10-10 22:23:49.557726
NCT02708368|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-05-25|||March 2016||2016-03-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||SOP's for CKD-MBD-Biomarkers|Investigation to Develop Standard Operating Procedures (SOP) for the Determination of Innovative CKD-MBD(Chronic Kidney Disease - Mineral Bone Disorder)-Serum-(Plasma-)Parameters|Recruiting||N/A|32|Anticipated|RWTH Aachen University|||2||f||||f||||||Samples Without DNA|"     plasma   "|No||2017-10-10 22:23:49.735824|2017-10-10 22:23:49.735824
NCT02708355|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-03-08|2017-03-08||January 2016||2016-01-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Safety population included all participants who received at least 1 dose of study medication.|Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment|A Pilot Phase IV, Multicenter, Randomized, Double Blind, Placebo-Controlled, Parallel Study To Investigate The Correlation Between Ph Control And Heartburn Symptoms After 14 Days Of Proton Pump Inhibitor Treatment In Subjects With Frequent Heartburn|Completed||Phase 4|55|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 22:23:49.826671|2017-10-10 22:23:49.826671
NCT02708342|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-01-24|||April 2016||2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Observational, Retrospective Analysis in HIV-1 Infected Patients. (ORASWIRAL)|Observational, Retrospective Analysis to Evaluate Switching to Raltegravir Plus Abacavir/Lamivudine in HIV-1-Infected Patients. ORASWIRAL Study|Completed||N/A|100|Actual|Ospedale San Raffaele|||1||f||||f||||||||Yes|Abstract to Scientific Congress|2017-10-10 22:23:50.234351|2017-10-10 22:23:50.234351
NCT02708329|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-05-08|||January 2011||2011-01-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||T-provisional Stenting vs Mini-Crush in Chronic Total Occlusions (CTO)|Results of T-provisional and Mini Crush Stenting in Patients With Bifurcation Lesions After Chronic Coronary Arteries Occlusions Recanalization: A Prospective Randomized Single-center Study.|Completed||N/A|146|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||||||||||||2017-10-10 22:23:50.315368|2017-10-10 22:23:50.315368
NCT02708316|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-02-16|||April 2016||2016-04-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||The Gut Metagenome Research of Schizophrenia|The Gut Metagenome Research of Schizophrenia|Recruiting||N/A|200|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||||||||Samples With DNA|"     stool samples retained for sequencing faecal metagenome   "|||2017-10-10 22:23:50.422064|2017-10-10 22:23:50.422064
NCT02708303|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-12-20|||March 2016||2016-03-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Observational|||Mayo Clinic Foregut Surgery Report Card Questionnaire|Mayo Clinic Foregut Surgery Report Card Questionnaire|Recruiting||N/A|1000|Anticipated|Mayo Clinic|||1||f||||f||||||||No||2017-10-10 22:23:50.534751|2017-10-10 22:23:50.534751
NCT02708290|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-08-15|||September 2015||2015-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Brain Training Program for Children With ASD|Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Brain Training Program for Children With ASD|Recruiting||N/A|10000|Anticipated|ImagiRation, LLC|||6||f||||f||||||||||2017-10-10 22:23:50.632756|2017-10-10 22:23:50.632756
NCT02708277|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-04-21|2016-03-22||January 2011||2011-01-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ROABTIPWSIUA||Reproductive Outcome Affected by Two Adjunctive Treatments in Patients With Severe Intrauterine Adhesions|Reproductive Outcome Affected by Two Adjunctive Treatments in Patients With Infertility Due to Severe Intrauterine Adhesions.|Completed||N/A|93|Actual|First Affiliated Hospital, Sun Yat-Sen University|This study was conducted in a university hospital.If this was a multicenter study, the results should be more reasonable.|2|||f||||t||||||||Yes||2017-10-10 22:23:50.737562|2017-10-10 22:23:50.737562
NCT02708264|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-09|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Does Cervical Pessary Prevent Spontaneous Preterm Birth in Twin Pregnancies With Short Cervical Length?|Pessary in Prevention of Preterm Birth for Women With Twin Pregnancies and Short Cervical Length|Recruiting||Phase 3|300|Anticipated|Federico II University||2|||f||||t||||||||No||2017-10-10 22:23:51.086111|2017-10-10 22:23:51.086111
NCT02708251|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-07-11|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|GTN-IUD||Glyceryl Trinitrate Versus Lidocaine Cream for IUD Insertion|Topical Glyceryl Trinitrate Versus Lidocaine Cream as Analgesia for IUD Insertion: A Randomized Controlled Trial|Completed||Phase 4|150|Actual|Assiut University||3|||f||||t||||||||||2017-10-10 22:23:51.161384|2017-10-10 22:23:51.161384
NCT02708238|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-06-20|2016-04-15||April 2014||2014-04-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy of Matricariae Chamomilla L., Melissa Officinalis L. and Tyndallized Lactobacillus Acidophilus (H122) for Infantile Colics|Efficacy of a Standardized Extract of Matricariae Chamomilla L., Melissa Officinalis L. and Tyndallized Lactobacillus Acidophilus (H122) Compared With Lactobacillus Reuteri (DSM 17938) and With Simethicone for the Treatment of Infantile Colic|Completed||Phase 4|180|Actual|Federico II University|The absence of a placebo group and the open label design represent the main limitations of this study|3|||f||||f||||||||Yes|Publication|2017-10-10 22:23:51.242207|2017-10-10 22:23:51.242207
NCT02708225|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-03-14|||March 2016||2016-03-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|clowns||The Influence of Medical Clowns on the Performance of Pulmonary Function Tests Among Preschooler Children|The Influence of Medical Clowns on the Performance of Pulmonary Function Tests Among Preschooler Children|Not yet recruiting||N/A|200|Anticipated|Hillel Yaffe Medical Center||2|||f||||f||||||||Yes|study results and conclusions will be published|2017-10-10 22:23:51.524498|2017-10-10 22:23:51.524498
NCT02708212|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-12-04|2016-08-05||April 2016||2016-04-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional||Total 120 patients were randomly assigned to EGD-colonoscopy group (n=60) and colonoscopy-EGD group (n=60).|Optimal Procedural Sequence in Same-day Bidirectional Endoscopy: A Prospective Randomized Controlled Study|Optimal Procedural Sequence in Same-day Bidirectional Endoscopy With Moderate Sedation and Carbon Dioxide Insufflation: A Prospective Randomized Controlled Study|Completed||N/A|121|Actual|Evergreen General Hospital, Taiwan||2|||f||||f||||||||Undecided||2017-10-10 22:23:51.705496|2017-10-10 22:23:51.705496
NCT02708199|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-09|||January 2015||2015-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic|Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases in Myanmar Artemisinin Resistance Containment Zones and Malaria Antibody Kinetic Analysis|Completed||N/A|1179|Actual|Department of Medical Research, Lower Myanmar|||1||f||||f||||||Samples With DNA|"     Whole blood samples have been collected and DNA have been extracted and keep at -20 degree C     until analysis. Sera were also separately keep at -80 degree C until analysis.   "|Undecided|The data may be shared after publish.|2017-10-10 22:23:51.992738|2017-10-10 22:23:51.992738
NCT02708173|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-08-12|||March 2016||2016-03-01|March 2016|2016-03-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older||Completed||Phase 1|40|Actual|Beijing Chaoyang District Centre for Disease Control and Prevention||2|||f||||||||||||||2017-10-10 22:23:52.217531|2017-10-10 22:23:52.217531
NCT02708160|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-09|||March 2016||2016-03-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Assessment of Prevident Sodium Fluoride 1.1% Toothpaste Using an Intra-oral Remineralization-demineralization Model|Assessment of Prevident Sodium Fluoride 1.1% Toothpaste Using an Intra-oral Remineralization-demineralization Model|Not yet recruiting||Phase 2|30|Anticipated|Colgate Palmolive||3|||f||||f||||||||No||2017-10-10 22:23:52.299952|2017-10-10 22:23:52.299952
NCT02708147|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-07-02|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Impact of Respiratory Physiotherapy in Children With Bronchiolitis in the First Two Years of Life|Impact of Respiratory Physiotherapy in Children With Bronchiolitis in the First Two Years of Life|Not yet recruiting||N/A|52|Anticipated|Aveiro University||2|||f||||t|f|f||||||||2017-10-10 22:23:52.392683|2017-10-10 22:23:52.392683
NCT02708134|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-29|||March 2016||2016-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|pediRES-Q||Quality of Pediatric Resuscitation in a Multicenter Collaborative|Quality of Pediatric Resuscitation in a Multicenter Collaborative: An Observational Study|Recruiting||N/A|250|Anticipated|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-10-10 22:23:52.476145|2017-10-10 22:23:52.476145
NCT02708121|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-03-06|||March 3, 2017|Actual|2017-03-03|March 2017|2017-03-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Increasing Uptake of Behavioral Weight Loss Programs Among Primary Care Patients|Increasing Uptake of Behavioral Weight Loss Programs Among Primary Care Patients|Enrolling by invitation||N/A|60|Anticipated|Duke University||2|||f||||t|f|f||||||Undecided||2017-10-10 22:23:52.552971|2017-10-10 22:23:52.552971
NCT02708108|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-10-07|||May 2016||2016-05-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)|Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)|Recruiting||N/A|40|Anticipated|Children's Hospital Los Angeles||1|||f||||f||||||||No||2017-10-10 22:23:52.635349|2017-10-10 22:23:52.635349
NCT02708095|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2017-05-11|||March 2016||2016-03-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)|A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)|Active, not recruiting||Phase 2|300|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:23:52.740897|2017-10-10 22:23:52.740897
NCT02708082|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-09|||March 2016||2016-03-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Observational|||Glaucoma HFA / OCT Specificity Study|Glaucoma HFA / OCT Specificity Study|Not yet recruiting||N/A|90|Anticipated|Carl Zeiss Meditec, Inc.|||1||f||||t||||||||No||2017-10-10 22:23:52.996737|2017-10-10 22:23:52.996737
NCT02708069|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-06|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|February 2018|Anticipated|2018-02-01||Interventional|e-Unstuck||e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder|e-Unstuck: Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder|Recruiting||N/A|110|Anticipated|3-C Institute for Social Development||2|||f||||f|f|f||||||||2017-10-10 22:23:53.080448|2017-10-10 22:23:53.080448
NCT02708056|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-09|||January 2015||2015-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants|Sugammadex Given for the Reversal of Deep Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants: A Retrospective Study|Completed||Phase 4|26|Actual|Baskent University||1|||f||||||||||||||2017-10-10 22:23:53.177322|2017-10-10 22:23:53.177322
NCT02708043|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-03-09|||June 2012||2012-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Laryngeal Mask Airway for Adenoidectomies (LMAA)|The Use of Laryngeal Mask Airway for Adenoidectomies: An Experience of 814 Paediatric Patients|Completed||Phase 4|814|Actual|Baskent University||1|||f||||t||||||||||2017-10-10 22:23:53.241273|2017-10-10 22:23:53.241273
NCT02708030|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-13|||April 2016||2016-04-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|DIET||Dietary Therapy In Epilepsy Treatment (DIET-Trial): A Randomised Non Inferiority Trial Comparing KD, MAD & LGIT for Drug Resistant Epilepsy|Efficacy of Ketogenic Diet, Modified Atkins Diet and Low Glycemic Index Therapy Diet Among Children With Drug Resistant Epilepsy: A Randomised Non-Inferiority Trial|Active, not recruiting||N/A|165|Anticipated|All India Institute of Medical Sciences, New Delhi||3|||f||||f||||||||||2017-10-10 22:23:53.296013|2017-10-10 22:23:53.296013
NCT02708004|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-07-26|||June 1, 2016||2016-06-01|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects|A Single-center, Double-blind, Randomized, Placebo-controlled, Two-way Crossover Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects|Completed||Phase 1|24|Actual|Actelion||2|||f||||f||||||||||2017-10-10 22:23:53.458063|2017-10-10 22:23:53.458063
NCT02707991|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-08-15|||July 2016||2016-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|Care2Cure||Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection|Nurse Case Management to Improve Linkage to Hepatitis C Care and Treatment Initiation in HIV Co-infection: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||||2017-10-10 22:23:53.530817|2017-10-10 22:23:53.530817
NCT02707978|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-09-19|||April 2016||2016-04-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|||F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)|F 18 T807 Tau PET Imaging of Frontotemporal Dementia|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||1||Problems with contracts .|f||||f||||||||||2017-10-10 22:23:53.643792|2017-10-10 22:23:53.643792
NCT02707965|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-01|||June 8, 2017|Actual|2017-06-08|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|BEEP2b||Characterization of Epilepsy Patients BEEP 2b|Characterization of Epilepsy Patients At-risk for Adverse Outcomes Related to Switching Antiepileptic Drug Products: BEEP 2b Study|Enrolling by invitation||Phase 4|12|Anticipated|Food and Drug Administration (FDA)||2|||f||||f|t|f|||f|||||2017-10-10 22:23:53.71918|2017-10-10 22:23:53.71918
NCT02707939|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-11-08|||February 2016||2016-02-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Observational|||Observational Prospective Study on Behavioral Outcomes of Children With Autism Spectrum Disorder (ASD) in Comparison to Those Without Neurodevelopmental Diagnoses|Observational Prospective Study on Behavioral Outcomes of Children With Autism Spectrum Disorder (ASD) in Comparison to Those Without Neurodevelopmental Diagnoses|Recruiting||N/A|200|Anticipated|Boston Children’s Hospital|||2||f||||f||||||||No||2017-10-10 22:23:54.158417|2017-10-10 22:23:54.158417
NCT02707926|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-09-20|||September 2018|Anticipated|2018-09-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Observational|||The Lymphoid Tissue Pharmacology of Antiretroviral Drugs|The Lymphoid Tissue Pharmacology of Antiretroviral Drugs|Not yet recruiting||N/A|18|Anticipated|University of Nebraska|||1||f||||f||||||Samples Without DNA|"     Blood, urine, lymph node biopsy, colonoscopy biopsy of ileum and rectum   "|||2017-10-10 22:23:54.241362|2017-10-10 22:23:54.241362
NCT02707913|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-10|2016-09-05|||March 2016||2016-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations|Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations|Completed||Phase 1|17|Actual|Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited||2|||f||||t||||||||No|Study investigators and his/her study team members, domestic and foreign regulatory agencies, the Institutional Review Board/Ethics Committee (IRB/EC) involved in the study, and laboratories and other individuals and organizations that analyze the subjects' protected health information in connection with this study have access to the data or study|2017-10-10 22:23:54.319813|2017-10-10 22:23:54.319813
NCT02707354|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-28|||June 3, 2016|Actual|2016-06-03|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|June 2018|Anticipated|2018-06-01||Interventional|E-mage||Early Detection of Mucosal Abnormalities in Graft-versus-host Disease|Early Detection of Mucosal Abnormalities in Graft-versus-host Disease|Recruiting||N/A|20|Anticipated|Nantes University Hospital||1|||f||||f||||||||No||2017-10-10 22:24:00.567143|2017-10-10 22:24:00.567143
NCT02707900|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-09-20|||March 2016||2016-03-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Interventional|VORVAX||Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection|IGHID 11424 - A Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection (The VOR VAX Study)|Recruiting||Phase 1|12|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t||||||||No||2017-10-10 22:23:54.41847|2017-10-10 22:23:54.41847
NCT02707887|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-14|||January 2016||2016-01-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Technology Enhanced Behavioral Activation Treatment for Substance Use|Technology Enhanced Behavioral Activation Treatment for Substance Use|Recruiting||N/A|300|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-10 22:23:54.576215|2017-10-10 22:23:54.576215
NCT02707874|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-10-27|||October 2014||2014-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||PIB Versus CI Through a Popliteal Sciatic Nerve Catheter for Analgesia Following Major Ankle Surgery|Comparing the Delivery of Local Anesthetic by Programmed Intermittent Bolus Versus Continuous Infusion Through a Popliteal Sciatic Nerve Catheter for Analgesia Following Major Ankle Surgery|Recruiting||Phase 4|60|Anticipated|University Health Network, Toronto||2|||f||||f||||||||Yes|by publication|2017-10-10 22:23:54.71753|2017-10-10 22:23:54.71753
NCT02707861|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-04-25|||March 2016||2016-03-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1|A Phase 3, Multicenter, Expanded Access Study of Ibalizumab Plus an Optimized Background Regimen (OBR) in Treatment-Experienced Patients Infected With Multi-Drug Resistant (MDR) HIV-1|Recruiting||Phase 3|50|Anticipated|TaiMed Biologics Inc.||2|||f||||f||||||||No||2017-10-10 22:23:54.838398|2017-10-10 22:23:54.838398
NCT02707848|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-14|||September 2014||2014-09-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Observational|||Epidemiological Study for Psychiatric Disorder Among Children and Adolescents|Epidemiological Study for Psychiatric Disorder Among Children and Adolescents|Recruiting||N/A|4500|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-10 22:23:55.098447|2017-10-10 22:23:55.098447
NCT02707835|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-15|||February 2016||2016-02-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia Taping|The Effect of Edema Control in Patients With Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia Taping With Ultrasonography|Recruiting||N/A|90|Anticipated|National Taiwan University Hospital||3|||f||||f||||||||||2017-10-10 22:23:55.195923|2017-10-10 22:23:55.195923
NCT02707822|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-09|||January 2016||2016-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration|The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration|Recruiting||N/A|440|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:23:55.287172|2017-10-10 22:23:55.287172
NCT02707809|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-17|||August 2016||2016-08-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Dexmedetomidine on Microcirculation of Kidney Transplant Recipient|Effects of Perioperative Dexmedetomidine Infusion on Microcirculation and Kidney and Intestinal Injury in Kidney Transplant Recipients|Recruiting||Phase 4|70|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 22:23:55.369906|2017-10-10 22:23:55.369906
NCT02707796|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-11|||May 2016||2016-05-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Correlation Between Partial Oxygen Pressure and Oxygen Reserve Index|Evaluation of the Correlation Between Partial Oxygen Pressure and Oxygen Reserve Index, and Sensitivity and Specificity of Oxygen Reserve Index in Patients Undergoing Hemicolectomy|Not yet recruiting||N/A|240|Anticipated|Istanbul University||1|||f||||f||||||||||2017-10-10 22:23:55.472937|2017-10-10 22:23:55.472937
NCT02707783|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-03-20|||November 2015||2015-11-01|September 2016|2016-09-01|August 2020|Anticipated|2020-08-01|December 2017|Anticipated|2017-12-01||Observational|FEASTRU||Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina|Feasibility and Outcomes of Complete Coronary Revascularization Using Bioresorbable Vascular Scaffold in All-comer Patients With Stable and Unstable Angina: A Multi-centre Registry in Russian Population|Recruiting||N/A|2500|Anticipated|International Foundation for Development of Medical Science and Education Healthy Heart|||1||f||||t||||||||Undecided||2017-10-10 22:23:55.563512|2017-10-10 22:23:55.563512
NCT02707770|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-11-07|||April 2016||2016-04-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients|The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Diseases Patients|Recruiting||N/A|40|Anticipated|Imperial College Healthcare NHS Trust||2|||f||||f||||||||Undecided||2017-10-10 22:23:55.713791|2017-10-10 22:23:55.713791
NCT02707757|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-11-18|||July 2015||2015-07-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|PRIME||Treatment Response in Dialysis Anaemia|Predictors of Response to Treatment With Iron and Erythropoietin in Dialysis Anaemia|Active, not recruiting||Phase 4|200|Anticipated|Imperial College Healthcare NHS Trust||2|||f||||t||||||||||2017-10-10 22:23:55.809659|2017-10-10 22:23:55.809659
NCT02707744|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-21|||February 2016||2016-02-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|POP-ECG-HF-AF||A Study of Prolonged Electrocardiographic Monitoring in Patients With Heart Failure in Sinus Rhythm or Atrial Fibrillation|A Prospective Observational Study of Prolonged Electrocardiographic Monitoring in Patients With Heart Failure in Sinus Rhythm or Atrial Fibrillation|Active, not recruiting||N/A|100|Actual|Imperial College London|||2||f||||f||||||||||2017-10-10 22:23:55.895532|2017-10-10 22:23:55.895532
NCT02707731|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-08|||July 2015||2015-07-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Acute Effects of Neonatal Hydrokinesiotherapy in Newborn Preterm Hospitalized|Acute Effects of Neonatal Hydrokinesiotherapy in Newborn Preterm Hospitalized|Completed||N/A|15|Actual|Hospital Universitario Pedro Ernesto||1|||f||||f||||||||No||2017-10-10 22:23:55.983345|2017-10-10 22:23:55.983345
NCT02707718|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-24|||March 2016||2016-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|BIPS||Biomarkers for the Early Identification of Sepsis in the Emergency Department|Early Biomarkers of Sepsis Identification in the Emergency Department|Recruiting||N/A|300|Anticipated|Pitié-Salpêtrière Hospital|||1||f||||f||||||Samples Without DNA|"     plasma and sera   "|No||2017-10-10 22:23:56.061721|2017-10-10 22:23:56.061721
NCT02707705|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-08|||June 2015||2015-06-01|March 2016|2016-03-01||||February 2016|Actual|2016-02-01||Interventional|CESAUR||Preoperative Auricular Acupuncture in Elective Cesarean Section.|Premedication With an Auricular Acupuncture Protocol in Elective Cesarean Section .|Recruiting||N/A|90|Anticipated|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-10 22:23:56.163102|2017-10-10 22:23:56.163102
NCT02707692|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-11-01|||August 2016||2016-08-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Perturbing of HIV Reservoir With Immune Stimulation|Perturbing the HIV Reservoir With Immune Stimulation|Recruiting||N/A|56|Anticipated|University of California, San Diego||6|||f||||f||||||||No||2017-10-10 22:23:56.284896|2017-10-10 22:23:56.284896
NCT02707679|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-13|||May 2013||2013-05-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Effects of Mobilization With Movement and Kinesiotaping in Patellofemoral Pain Syndrome|Comparison of Short-Term Effects of Mobilization With Movement and Kinesiotaping on Pain, Function and Balance in Patellofemoral Pain Syndrome: A Randomized Control|Completed||N/A|35|Actual|Hacettepe University||2|||f||||f||||||||Yes||2017-10-10 22:23:56.448531|2017-10-10 22:23:56.448531
NCT02707666|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-12-28|||February 2016||2016-02-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|||A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma|A Pilot Window-of-opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma|Recruiting||Phase 1|15|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 22:23:56.555728|2017-10-10 22:23:56.555728
NCT02707653|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-03-08|||March 2016||2016-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research|Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research|Not yet recruiting||N/A|200|Anticipated|Gynuity Health Projects||1|||f||||f||||||||Undecided||2017-10-10 22:23:56.638646|2017-10-10 22:23:56.638646
NCT02707640|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-04-14|2016-04-14||August 2013||2013-08-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||The modified intent-to-treat (mITT) population included all participants who were consented, were randomized, and received at least 1 dose of double-blind study treatment.|A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N-Acetylcysteine in Patients With Idiopathic Pulmonary Fibrosis With Background Treatment of Pirfenidone|Completed||Phase 2|123|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:23:56.73868|2017-10-10 22:23:56.73868
NCT02707627|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-02-03|||October 2016||2016-10-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||Laser Therapy for Pediatric Burn Scars|A Randomized Controlled Trial Investigating the Use of Ablative Fractional Carbon Dioxide Laser Therapy to Improve Pediatric Burn Scars.|Recruiting||N/A|54|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-10 22:23:57.452763|2017-10-10 22:23:57.452763
NCT02707614|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-04-25|||February 2016||2016-02-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01|1 Day|Observational [Patient Registry]|||Why in PACU After Prostastectomy 2016|Perioperative Mechanisms for Postoperative Function - the Case of Prostastectomy|Completed||N/A|120|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||Undecided||2017-10-10 22:23:57.567898|2017-10-10 22:23:57.567898
NCT02707601|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-10-04|||April 1, 2016|Actual|2016-04-01|October 2017|2017-10-01|September 29, 2017|Actual|2017-09-29|September 14, 2017|Actual|2017-09-14||Interventional|Co-STARs||Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment|A Phase 3b Randomized, Open-label, Controlled Study of the Efficacy, Safety and Tolerability of 12 Weeks of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Subjects Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment, the HIV/HCV Co-STARs Study (Co-infection Treatment With Single Tablet Antiviral Regimens)|Completed||Phase 3|150|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-10 22:23:57.659305|2017-10-10 22:23:57.659305
NCT02707588|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-08|||April 2016||2016-04-01|March 2016|2016-03-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|PembroRad||Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC|A Phase II Randomized Study to Determine the Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Not yet recruiting||Phase 2|114|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||2|||f||||t||||||||Yes||2017-10-10 22:23:58.488254|2017-10-10 22:23:58.488254
NCT02707575|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-08|||March 2016||2016-03-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Cytokeratin 8 Level in Age-related Macular Degeneration|Cytokeratin 8 Level in Aqueous Humor, as a Prognostic Factor for Visual and Anatomical Outcomes After Ranibizumab (Lucentis) in Neovascular Age-related Macular Degeneration|Recruiting||N/A|40|Anticipated|Gangnam Severance Hospital||1|||f||||f||||||||No||2017-10-10 22:23:58.592136|2017-10-10 22:23:58.592136
NCT02707562|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-12-06|||February 2016||2016-02-01|March 2016|2016-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SAPHIRA1||Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation)|A Phase IIa, Open-label Study of Multiple Doses of GLPG1837 in Subjects With Cystic Fibrosis and the G551D Mutation|Completed||Phase 2|26|Actual|Galapagos NV||1|||f||||t||||||||||2017-10-10 22:23:58.704726|2017-10-10 22:23:58.704726
NCT02707549|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-08|||August 2015||2015-08-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Fluid Therapy During Brain Tumor Resection in Children|Comparison of Balanced Crystalloid Solution and 0,9% Sodium Chloride in Children Undergoing Brain Tumor Resection: a Randomized Controlled Trial|Recruiting||Phase 2|48|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 22:23:58.844014|2017-10-10 22:23:58.844014
NCT02707536|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-05-02|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Influence of Platelet-Rich Fibrin on Post-extraction Alveolar Ridge Healing/Preservation as a Stand-alone or Adjunct to Particulate Graft|Influence of Platelet-Rich Fibrin on Post-extraction Alveolar Ridge Healing/Preservation as a Stand-alone or Adjunct to Particulate Graft: A Clinical, Radiographic and Histological Evaluation|Completed||N/A|42|Actual|The University of Texas Health Science Center, Houston||4|||f||||f||||||||No||2017-10-10 22:23:58.968529|2017-10-10 22:23:58.968529
NCT02707523|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-10-18|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Prospective Pilot Clinical Trial of Azithromycin Treatment In RSV-Induced (Respiratory Syncytial Virus - Induced) Respiratory Failure In Children|Prospective Pilot Clinical Trial of Azithromycin Treatment In RSV-Induced Respiratory Failure In Children|Recruiting||Early Phase 1|48|Anticipated|University of Alabama at Birmingham||3|||f||||t||||||||||2017-10-10 22:23:59.092576|2017-10-10 22:23:59.092576
NCT02707510|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer||Recruiting||N/A|60|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||No||2017-10-10 22:23:59.250175|2017-10-10 22:23:59.250175
NCT02707497|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-11|||June 2016||2016-06-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of Recombinant Human Thrombopoietin on Septic Shock With Thrombocytopenia.|The Effect of Recombinant Human Thrombopoietin(rhTPO) on Septic Shock With Thrombocytopenia：a Prospective, Multi-center, Open-label, ,Randomized, Placebo-controlled Study.|Not yet recruiting||Phase 2/Phase 3|214|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 22:23:59.399488|2017-10-10 22:23:59.399488
NCT02707484|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-07-30|||March 2016||2016-03-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation|the Efficacy of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation: a Prospective Multi-center Randomized Controlled Clinical Trial|Recruiting||Phase 3|150|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||t||||||||||2017-10-10 22:23:59.531591|2017-10-10 22:23:59.531591
NCT02707471|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-05-04|||March 14, 2017|Actual|2017-03-14|April 2017|2017-04-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Improving Well-Being for Breast Cancer Patients|Improving Well-Being for Breast Cancer Patients Taking Adjuvant Endocrine Therapy|Recruiting||N/A|480|Anticipated|Duke University||2|||f||||f|f|f||||||||2017-10-10 22:23:59.707628|2017-10-10 22:23:59.707628
NCT02707458|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-08|||April 2016||2016-04-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|DEPEND||Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration|Dose-finding and Proof-of-concept Trial of Probucol to Increase Availability of CSF Apolipoprotein-E|Not yet recruiting||Phase 1/Phase 2|23|Anticipated|Douglas Mental Health University Institute||1|||f||||t||||||||Yes|Will share de-identified data upon completion and publication of trial|2017-10-10 22:23:59.789348|2017-10-10 22:23:59.789348
NCT02707445|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-11|||September 2011||2011-09-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|GENIUS||Genotyping Influences Outcome of Coronary Artery Stenting|Prospective Multi-center Registry of Genotyping Related Clopidogrel in Percutaneous Coronary Intervention Patients|Completed||N/A|5000|Actual|Korea University Anam Hospital||1|||f||||t||||||||No||2017-10-10 22:23:59.888086|2017-10-10 22:23:59.888086
NCT02707432|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2017-07-31|||March 27, 2017|Actual|2017-03-27|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Reducing Cardiovascular Disease Risk Factors in Rural Communities in North Carolina|Reducing Cardiovascular Disease Risk Factors in Rural Communities in North Carolina|Active, not recruiting||N/A|150|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t|f|f||||||||2017-10-10 22:23:59.975654|2017-10-10 22:23:59.975654
NCT02707419|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-08|||April 2014||2014-04-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Action Observation in Knee Replacement|Self-administered Action Observation Treatment Enhance the Efficacy of Inpatient Rehabilitation After Total Knee Replacement: A Randomized Controlled Trial|Completed||N/A|41|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||No||2017-10-10 22:24:00.077687|2017-10-10 22:24:00.077687
NCT02707406|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-02-20|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K|A Multi-center, Randomized, Controlled Study of Non-healing Diabetic Foot Ulcers (DFU) Treated With Standard of Care With or Without Cryopreserved Umbilical Cord Allograft (NEOX®CORD 1K)|Active, not recruiting||N/A|114|Anticipated|Tissue Tech Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:24:00.16361|2017-10-10 22:24:00.16361
NCT02707393|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-18|||April 2009||2009-04-01|October 2016|2016-10-01|January 2022|Anticipated|2022-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Allogeneic Stem Cell Transplantation for Children With CML|Allogeneic Stem Cell Transplantation for Children and Adolescents With CML: Conditioning Regimen, Donor Selection, Supportive Care and Diagnostic Procedures|Recruiting||Phase 2/Phase 3|160|Anticipated|St. Anna Kinderkrebsforschung||1|||f||||t||||||||Undecided||2017-10-10 22:24:00.282787|2017-10-10 22:24:00.282787
NCT02707380|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-29|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation|The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation|Completed||N/A|3|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:24:00.401938|2017-10-10 22:24:00.401938
NCT02707328|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-03-08|||January 2015||2015-01-01|March 2016|2016-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)|Phase I Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)|Recruiting||Phase 1|30|Anticipated|The Cooper Health System||1|||f||||f||||||||||2017-10-10 22:24:00.722772|2017-10-10 22:24:00.722772
NCT02707315|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-03-08|||January 2013||2013-01-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer||Unknown status|Recruiting|Early Phase 1|15|Anticipated|The Cooper Health System||1|||f||||t||||||||||2017-10-10 22:24:00.814181|2017-10-10 22:24:00.814181
NCT02707302|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-08|||January 2009||2009-01-01|March 2016|2016-03-01|January 2012|Actual|2012-01-01|June 2009|Actual|2009-06-01||Interventional|||Surgical Adhesive Drapes for Prevention and Healing of Wound Infections After Total Hip Arthroplasty|Iodophor-impregnated Versus Iodophor-free Adhesive Drapes for Prevention and Healing of Wound Infections After Total Hip Arthroplasty|Completed||N/A|120|Actual|Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine||2|||f||||t||||||||Undecided||2017-10-10 22:24:00.902699|2017-10-10 22:24:00.902699
NCT02707289|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-09-17|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Observational|OCEAN||Retrospective Collection of PillCam SB Movies|Retrospective Collection of PillCam SB Movies for Capsule Transit Time Analysis (OCEAN Study)|Active, not recruiting||N/A|20|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-10 22:24:00.978012|2017-10-10 22:24:00.978012
NCT02707276|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-08-31|||September 7, 2016|Actual|2016-09-07|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|LFMS||LFMS: Initial Trial in Geriatric Bipolar Depression|Low Field Magnetic Stimulation: Initial Trial in Geriatric Bipolar Depression|Active, not recruiting||N/A|30|Anticipated|Mclean Hospital||2|||f||||f||||||||||2017-10-10 22:24:01.041823|2017-10-10 22:24:01.041823
NCT02707263|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-04-25|||March 2016||2016-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients|Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients|Withdrawn||N/A|0|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:24:01.122394|2017-10-10 22:24:01.122394
NCT02707250|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-03-08|||March 2015||2015-03-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Oblique Subcostal Tap Block Efficacy in Laparoscopic Cholecystectomy|Oblique Subcostal Transverses Abdominal Plane Block in Laparoscopic Cholecystectomy|Recruiting||Phase 2/Phase 3|120|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy||4|||f||||t||||||||Undecided||2017-10-10 22:24:01.194082|2017-10-10 22:24:01.194082
NCT02707237|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-06-07|||March 2016||2016-03-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Maternal Counseling for Preterm Deliveries, Assessing an Effective Method of Counseling||Recruiting||N/A|40|Anticipated|John H. Stroger Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:24:01.288797|2017-10-10 22:24:01.288797
NCT02707224|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-09|2016-03-21|||January 2015||2015-01-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Clinical Trial to Compare the Pharmacokinetics of DP-R208|A Randomized, Single-dose, Open, Crossover Clinical Trial to Compare the Pharmacokinetics of DP-R208 (Candesartan Cilexetil and Rosuvastatin Calcium Fixed Dose Combinations) in Comparison to Each Component Administered Alone in Healthy Male Volunteers|Completed||Phase 1|40|Actual|Alvogen Korea||2|||f||||f||||||||No||2017-10-10 22:24:01.375572|2017-10-10 22:24:01.375572
NCT02707211|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-03-14|||June 2016||2016-06-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases|Immunization Against oxLDL in Patients With Lysosomal Lipid Diseases and Associated Metabolic Disorders|Not yet recruiting||Early Phase 1|20|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||Undecided||2017-10-10 22:24:01.447219|2017-10-10 22:24:01.447219
NCT02707198|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-04-24|||November 2015||2015-11-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|November 2020|Anticipated|2020-11-01||Interventional|||Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir|Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir|Enrolling by invitation||Phase 2|1190|Anticipated|St. Luke's Hospital of Duluth||3|||f||||f||||||||||2017-10-10 22:24:01.673024|2017-10-10 22:24:01.673024
NCT02707185|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2016-03-11|||June 2012||2012-06-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Physicians in Training and Critical Care Nurses Performance in Medical Code Events: Effect of Simulation-Based Training|Physicians in Training and Critical Care Nurses Performance in Medical Code Events: Effect of Simulation-Based Training|Completed||N/A|157|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||t||||||||||2017-10-10 22:24:01.775067|2017-10-10 22:24:01.775067
NCT02707172|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-03-03|2016-04-06||May 2013||2013-05-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Removal of Dermal Exposure to Phthalate Ester by Hand Washing|Soap and the Removal of Diethylhexyl Phthalate From Hands: N-of-1 and Cross-Over Designs|Completed||N/A|28|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:24:01.884596|2017-10-10 22:24:01.884596
NCT02707159|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2016-03-11|||November 2014||2014-11-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|PACT-ACT-v6||Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients|A Novel Therapy for Locally Advanced and Metastatic Pancreatic Cancer Based on Nanoparticle Albumin-bound Paclitaxel and Gemcitabine: Circulating Tumor Cells as a Potential Biomarker for Treatment Monitoring, -Response and Survival|Recruiting||Phase 2|70|Anticipated|Helse Stavanger HF||1|||f||||t||||||||||2017-10-10 22:24:02.126143|2017-10-10 22:24:02.126143
NCT02707146|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-09-13|||March 2016||2016-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2017|Actual|2017-07-01||Interventional|APP||Aligning Patients and Their Primary Care Providers|Aligning the Visit Priorities of Complex Patients and Their Primary Care Providers|Active, not recruiting||N/A|450|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-10 22:24:02.233499|2017-10-10 22:24:02.233499
NCT02707133|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-08|||April 2016||2016-04-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Validation of a Virtual Model of Service Delivery for Choroidal Nevi|Validation of a Virtual Clinic for Choroidal Nevomelanocytic Lesions: Safety, Patient Acceptability and Health Economics Analysis|Not yet recruiting||N/A|400|Anticipated|Central Manchester University Hospitals NHS Foundation Trust|||1||f||||t||||||||No||2017-10-10 22:24:02.344183|2017-10-10 22:24:02.344183
NCT02707120|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-07-12|||January 4, 2018|Anticipated|2018-01-04|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis|Randomized, Parallel Groups, Multicenter and Blind to Evaluators Clinical Trial, to Evaluate the Efficacy and Safety of PRGF-Endoret Eye Drops, in Patients With Stage 2 and 3 Neurotrophic Keratitis|Not yet recruiting||Phase 4|76|Anticipated|Biotechnology Institute IMASD||2|||f||||f|f|f||||||||2017-10-10 22:24:02.411068|2017-10-10 22:24:02.411068
NCT02707107|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-08-03|||March 2016||2016-03-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Escalating Doses of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Adult Human Subjects|Completed||Phase 1|20|Actual|Wockhardt||2|||f||||f||||||||No||2017-10-10 22:24:02.520684|2017-10-10 22:24:02.520684
NCT02707094|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-03-08|||January 2013||2013-01-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Pilot Study Examining the Efficacy of Biomodulator Treatment for Chronic Low Back Pain|A Pilot Study Examining the Efficacy of Biomodulator Treatment for Chronic Low Back Pain|Active, not recruiting||N/A|75|Actual|Brooke Army Medical Center||2|||f||||t||||||||No||2017-10-10 22:24:02.607998|2017-10-10 22:24:02.607998
NCT02707081|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-08|||June 2013||2013-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Intraperitoneal Versus Intravenous Lidocaine for Postcesarean Pain Relief|Efficacy of Intraperitoneal Versus Intravenous Lidocaine for Postcesarean Pain Relief|Completed||Phase 2/Phase 3|150|Actual|Benha University||3|||f||||||||||||||2017-10-10 22:24:02.724573|2017-10-10 22:24:02.724573
NCT02707068|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-03-03|||January 2016||2016-01-01|April 2016|2016-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|QOLITI||Quality Of LIfe Tool for IBD|Quality Of LIfe Tool for IBD (QOLITI): Pilot Testing of a Self-administered Intervention to Target Psychological Distress in Inflammatory Bowel Disease|Completed||N/A|62|Actual|King's College London||2|||f||||f||||||||No|The investigators seek to publish the results of the study which are going to be based on group statistics only, i.e. no individual patient data will be made available.|2017-10-10 22:24:02.82182|2017-10-10 22:24:02.82182
NCT02707055|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-11|2017-06-30|||March 2, 2016||2016-03-02|March 9, 2017|2017-03-09|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Novel Compound for Alcoholism Treatment: A Translational Strategy|A Novel Compound for Alcoholism Treatment: a Translational Strategy - Part II|Recruiting||Phase 2|55|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 22:24:02.944473|2017-10-10 22:24:02.944473
NCT02707042|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-07-13|||February 26, 2016||2016-02-26|July 12, 2017|2017-07-12|March 1, 2020|Anticipated|2020-03-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)|Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)|Recruiting||Phase 1|100|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:24:03.046246|2017-10-10 22:24:03.046246
NCT02707029|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-07-06|||February 25, 2016||2016-02-25|June 22, 2017|2017-06-22|February 9, 2026|Anticipated|2026-02-09|February 9, 2026|Anticipated|2026-02-09||Observational|||Clinical and Scientific Assessment of Pain and Painful Disorders|Clinical and Scientific Assessment of Pain and Painful Disorders|Enrolling by invitation||N/A|21|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:24:03.155542|2017-10-10 22:24:03.155542
NCT02707016|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-07|||December 2015||2015-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Different Doses of Sevoflurane During Induction of Anesthesia on Emergence Delirium in Children|Emergence Delirium in Children: a Randomized Clinical Trial of Different Doses of Sevoflurane During Induction of Anesthesia|Recruiting||N/A|80|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||No||2017-10-10 22:24:03.232144|2017-10-10 22:24:03.232144
NCT02706990|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-03-06|||January 2016||2016-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Fluoroscopic Analysis of Total Knee Replacement With a Kinematic Retaining or a Posterior Stabilized Design|In Vivo Kinematic Analysis of Total Knee Replacement With a Kinematic Retaining or a Posterior Stabilized Design During Activities of Daily Living|Completed||N/A|34|Actual|Limacorporate S.p.a||2|||f||||f||||||||||2017-10-10 22:24:03.439662|2017-10-10 22:24:03.439662
NCT02706977|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-01-31|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Dopamine DR||The Effect of Dopamine on Diabetic Retinopathy|The Effect of Dopamine on Diabetic Retinopathy|Enrolling by invitation||Phase 1|45|Anticipated|Emory University||4|||f||||t||||||||||2017-10-10 22:24:03.513417|2017-10-10 22:24:03.513417
NCT02706964|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-03-24|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Interventional|BCMetPats||Imaging the Patterns of Breast Cancer Early Metastases|Imaging the Patterns of Breast Cancer Early Metastases|Recruiting||N/A|30|Anticipated|University of Florida||1|||f||||f|f|f||||||Undecided||2017-10-10 22:24:03.609309|2017-10-10 22:24:03.609309
NCT02706600|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-09-13|||June 2015||2015-06-01|July 2015|2015-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|RESCUE||Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPD|RESCUE-COPD 1 Randomised Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPD|Completed||N/A|40|Actual|my mhealth Ltd||2|||f||||f||||||||No||2017-10-10 22:24:09.993305|2017-10-10 22:24:09.993305
NCT02706938|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|IBELGA||Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux Disease|Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux Disease: a Randomized Single-blind Study|Recruiting||N/A|124|Anticipated|Universidad Nacional de Colombia||2|||f||||f||||||||Undecided|Undecided|2017-10-10 22:24:04.200659|2017-10-10 22:24:04.200659
NCT02706925|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-02-08|||March 2016||2016-03-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||To Assess Safety, Tolerability and Pharmacokinetics of BI 443651 in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 443651 in Healthy Male Volunteers in a Partially Randomised, Single Blind, Placebo-controlled Trial|Completed||Phase 1|63|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:24:04.311113|2017-10-10 22:24:04.311113
NCT02706912|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-08-11|||February 2016||2016-02-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|VOTA||Virtual Occupational Therapy Application|Virtual Occupational Therapy Application|Completed||N/A|22|Actual|Barron Associates, Inc.||1|||f||||f||||||||||2017-10-10 22:24:04.387288|2017-10-10 22:24:04.387288
NCT02706899|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-07-26|||February 2016||2016-02-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS|A Phase 1/2 Study of Vadastuximab Talirine (SGN-CD33A) in Combination With Azacitidine in Patients With Previously Untreated International Prognostic Scoring System (IPSS) Intermediate-2 or High Risk Myelodysplastic Syndrome (MDS)|Suspended||Phase 1/Phase 2|142|Anticipated|Seattle Genetics, Inc.||2|||f||||t||||||||||2017-10-10 22:24:04.459466|2017-10-10 22:24:04.459466
NCT02706886|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-08-18|||March 2016||2016-03-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1|A Phase 1/2, Single-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of Subcutaneously Administered ALN-GO1 in Healthy Adult Subjects, and Patients With Primary Hyperoxaluria Type 1|Recruiting||Phase 1/Phase 2|64|Anticipated|Alnylam Pharmaceuticals||2|||f||||f|t|f||||||||2017-10-10 22:24:04.599796|2017-10-10 22:24:04.599796
NCT02706860|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-11|||June 2013||2013-06-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy of Different Perioperative Statin Regimens on the Protection Against Post Coronary Artery Bypass Grafting Major Adverse Cardio-cerebral Events||Completed||Phase 4|94|Actual|Cairo University||3|||f||||||||||||||2017-10-10 22:24:07.205812|2017-10-10 22:24:07.205812
NCT02706847|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-21|||March 15, 2016||2016-03-15|August 2017|2017-08-01|August 6, 2020|Anticipated|2020-08-06|April 3, 2017|Actual|2017-04-03||Interventional|SELECT-BEYOND||A Study to Compare ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs|A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs)|Active, not recruiting||Phase 3|450|Anticipated|AbbVie||4|||f||||t||||||||||2017-10-10 22:24:07.306013|2017-10-10 22:24:07.306013
NCT02706821|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-13|||February 2014||2014-02-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Anti-diabetic Effects of Persimmon Leaf Extract|An Eight-week, Randomized, Double-blind, Placebo-controlled Crossover Clinical Trial of Persimmon Leaf Extract on Anti-diabetes|Completed||N/A|34|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-10 22:24:08.339819|2017-10-10 22:24:08.339819
NCT02706808|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-04-17|||December 2015||2015-12-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|Starch||Resistant Starch Supplementation Effects on the Intestinal Tract Profile and Cardiovascular Markers in Renal Patients|Effects of Supplementation With Resistant Starch in the Profile of the Intestinal Tract and Cardiovascular Markers in Patients With Chronic Kidney Disease|Recruiting||N/A|30|Anticipated|Universidade Federal Fluminense||2|||f||||f||||||||||2017-10-10 22:24:08.417541|2017-10-10 22:24:08.417541
NCT02706795|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-02-02|||September 2015||2015-09-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia||Active, not recruiting||Phase 2|37|Actual|Revance Therapeutics, Inc.||3|||f||||||||||||||2017-10-10 22:24:08.519331|2017-10-10 22:24:08.519331
NCT02706782|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-08|||March 2016||2016-03-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|meso-CART||A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma|An Open-label, Uncontrolled, Single-arm Pilot Study to Evaluate Vascular Interventional Therapy Mediated Mesothelin-targeted Chimeric Antigen Receptor T Cells in Advanced Pancreatic Carcinoma|Recruiting||Phase 1|30|Anticipated|Shanghai GeneChem Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:24:08.636419|2017-10-10 22:24:08.636419
NCT02706769|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-02|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|PaSO||Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Pain|A Double-blind Randomised Parallel Group Trial of Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Related Pain|Recruiting||N/A|140|Anticipated|University of Edinburgh||2|||f||||f||||||||Undecided||2017-10-10 22:24:08.723141|2017-10-10 22:24:08.723141
NCT02706756|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-02-03|||March 2016||2016-03-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Conservative Intervention of Femoroacetabular Impingement Syndrome|Conservative Intervention of Femoroacetabular Impingement Syndrome: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Duke University||3||Similar studies already published by other researchers|f||||f||||||||No||2017-10-10 22:24:08.793286|2017-10-10 22:24:08.793286
NCT02706743|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-09-11|||January 2014||2014-01-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer|Effect of Radioiodine Remnant Ablation on Quality of Life in Patients With Differentiated Thyroid Cancer:a Prospective Cohort Study|Recruiting||N/A|300|Anticipated|Southern Medical University, China|||1||f||||||||||||||2017-10-10 22:24:08.867246|2017-10-10 22:24:08.867246
NCT02706730|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-09-14|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A 6-Month Extension Study of OTO-104 in Meniere's Disease|A 6-Month, Multicenter, Phase 3, Open-Label Extension Safety Study of OTO-104 Given At 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease|Terminated||Phase 3|189|Actual|Otonomy, Inc.||1||Negative Efficacy Results from the recently completed Phase 3 study 104-201506|f||||f||||||||||2017-10-10 22:24:08.936294|2017-10-10 22:24:08.936294
NCT02706717|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-06-26|||April 2016||2016-04-01|June 2017|2017-06-01|August 28, 2017|Anticipated|2017-08-28|June 5, 2017|Actual|2017-06-05||Interventional|||Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers|Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study|Active, not recruiting||Phase 2|93|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||Yes||2017-10-10 22:24:09.0063|2017-10-10 22:24:09.0063
NCT02706704|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-14|||February 2016||2016-02-01|February 2016|2016-02-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|IVAS||Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis|Efficacy of Intravitreal Adalimumab Compared to Subcutaneous Adalimumab in Patients With Non-infectious Uveitis|Recruiting||Phase 2|32|Anticipated|American University of Beirut Medical Center||2|||f||||t||||||||No||2017-10-10 22:24:09.134865|2017-10-10 22:24:09.134865
NCT02706691|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-10-02|||March 2018|Anticipated|2018-03-01|October 2017|2017-10-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Pan FGFR Kinase Inhibitor BGJ398 in Treating Patients With FGFR1-3 Translocated, Mutated, or Amplified Recurrent Head and Neck Cancer|Phase IIa Study of the Efficacy of Single Agent BGJ398 in FGFR1-3 Translocated, Mutated, or Amplified Squamous Cell Carcinoma of the Head and Neck|Not yet recruiting||Phase 2|30|Anticipated|University of Chicago||1|||f||||t|t|f||||||||2017-10-10 22:24:09.228971|2017-10-10 22:24:09.228971
NCT02706678|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-03-07|||December 2010||2010-12-01|March 2017|2017-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients|Efficacy and Safety of a Post-transplantation Switch From Cyclosporin to Tacrolimus Sustained-release Capsules in Renal Transplant Recipients: A Multi-center, Open-label, Uncontrolled Study|Completed||Phase 4|105|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-10 22:24:09.429919|2017-10-10 22:24:09.429919
NCT02706665|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-07|||December 2015||2015-12-01|March 2016|2016-03-01||||June 2016|Anticipated|2016-06-01||Observational|||Monitoring of Hypnosis State During General Anesthesia With Propofol by Patient State Index From SEDLine®|Modelling Pharmacokinetic/Pharmacodynamic of Propofol Based on PSI Values From the SEDline®|Recruiting||N/A|12|Anticipated|Hospital Universitario de Canarias|||1||f||||f||||||||||2017-10-10 22:24:09.549828|2017-10-10 22:24:09.549828
NCT02706652|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-06-30|||February 23, 2016||2016-02-23|February 3, 2017|2017-02-03|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Observational|||Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients|Prospective Screening for Patient Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients|Enrolling by invitation||N/A|900|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:24:09.633355|2017-10-10 22:24:09.633355
NCT02706639|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-10-03|||February 23, 2016||2016-02-23|October 2, 2017|2017-10-02|September 25, 2025|Anticipated|2025-09-25|September 25, 2025|Anticipated|2025-09-25||Observational|||Williams Syndrome (WS) and Supravalvular Aortic Stenosis (SVAS) DNA and Tissue Bank|Williams Syndrome (WS) and Supravalvular Aortic Stenosis (SVAS) DNA and Tissue Bank|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:24:09.70551|2017-10-10 22:24:09.70551
NCT02706626|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-04-03|||March 9, 2017|Actual|2017-03-09|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of Brigatinib After Treatment With Second-Generation ALK Inhibitors|Phase 2 Trial of Brigatinib After Treatment With Second-Generation ALK Inhibitors in Refractory ALK Rearranged Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|40|Anticipated|Criterium, Inc.||1|||f||||t|t|f||||||No||2017-10-10 22:24:09.796263|2017-10-10 22:24:09.796263
NCT02706613|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-09-13|||July 2015||2015-07-01|January 2016|2016-01-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|TROOPeR||Comparing Online Pulmonary Rehabilitation 'myPR' Versus Conventional Pulmonary Rehabilitation for Patients With COPD|A Randomised Controlled Research Study Comparing Online Pulmonary Rehabilitation 'myPR' Versus Conventional Pulmonary Rehabilitation for Patients With COPD|Completed||N/A|90|Actual|my mhealth Ltd||2|||f||||f||||||||No||2017-10-10 22:24:09.899558|2017-10-10 22:24:09.899558
NCT02706587|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|ENS||Neuromuscular Electrical Stimulation for Intensive Care Unit-acquired Weakness Assessment|Neuromuscular Electrical Stimulation for Intensive Care Unit-acquired Weakness|Recruiting||Phase 3|102|Anticipated|Institut Mutualiste Montsouris||2|||f||||f||||||||No||2017-10-10 22:24:10.085754|2017-10-10 22:24:10.085754
NCT02706574|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-07-11|||May 2016||2016-05-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|BASH||Brain Injury Assessment Study at Hennepin County Medical Center|Brain Injury Assessment Study at Hennepin County Medical Center|Enrolling by invitation||N/A|1200|Anticipated|Minneapolis Medical Research Foundation|||4||f||||f||||||Samples With DNA|"     Blood draws will be taken for both proteomic and genetic analysis at acute and follow-up time     points. The specimens will be used to test a specific set of biomarkers related to traumatic     brain injury, and they will also be retained for future discovery efforts of novel     biomarkers.   "|||2017-10-10 22:24:10.191418|2017-10-10 22:24:10.191418
NCT02706561|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-06-16|||December 8, 2015||2015-12-08|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery|Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery|Recruiting||N/A|310|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 22:24:10.275451|2017-10-10 22:24:10.275451
NCT02706548|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-15|||October 2014||2014-10-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|IMedS||Feasibility of the Integrative Medication Self-Management Intervention to Promote Medication Adherence|Feasibility of the Integrative Medication Self-Management Intervention to Promote Medication Adherence|Completed||Phase 1|34|Actual|University of Wisconsin, Milwaukee||2|||f||||f||||||||Yes|Single-subject data available in publications|2017-10-10 22:24:10.37834|2017-10-10 22:24:10.37834
NCT02706535|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-10|||May 5, 2016||2016-05-05|August 2017|2017-08-01|January 6, 2017|Actual|2017-01-06|January 6, 2017|Actual|2017-01-06||Interventional|||A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential|A Single Center, Two Part, Randomized, Open Label Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential|Completed||Phase 1|29|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:24:10.455498|2017-10-10 22:24:10.455498
NCT02706522|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-08-03|||October 24, 2016|Actual|2016-10-24|August 2017|2017-08-01|January 26, 2017|Actual|2017-01-26|November 15, 2016|Actual|2016-11-15||Interventional|||Effect of Oral Carbohydrate on Serum S-100β Protein and Development of Postoperative Delirium in Elderly Patients|Effect of Oral Carbohydrate on Serum S-100β Protein and Development of Postoperative Delirium in Elderly Patients|Completed||N/A|3|Actual|Gangnam Severance Hospital||2|||f||||t||||||||||2017-10-10 22:24:10.570045|2017-10-10 22:24:10.570045
NCT02706509|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-10|||March 2016||2016-03-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|Jaydess||Pain Management Associated With the Insertion of Jaydess® in Nulliparous Women|"Comparison Between the Analgesic Affects of Tramadol® and Verbal Anesthesia on Pain Management Associated With the Insertion of Jaydess® in Nulliparous Women"|Not yet recruiting||Phase 4|100|Anticipated|Meir Medical Center||2|||f||||t||||||||No||2017-10-10 22:24:10.645344|2017-10-10 22:24:10.645344
NCT02706496|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-03-07|||February 2015||2015-02-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Observational|||Age-related Changes in Posture Control and Cortex Activity Under a Dynamic Perturbation|Age-related Changes in Posture Control and Cortex Activity Under a Dynamic Perturbation|Completed||N/A|37|Actual|Taipei Veterans General Hospital, Taiwan|||3||f||||t||||||||No||2017-10-10 22:24:10.73249|2017-10-10 22:24:10.73249
NCT02706483|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-10-03|||January 2016||2016-01-01|October 2017|2017-10-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|IBS-C||Long Term Safety Study of Plecanatide|An Open Label, Long Term Safety and Tolerability Study of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|Completed||Phase 3|1500|Anticipated|Synergy Pharmaceuticals Inc.||1|||f||||f||||||||||2017-10-10 22:24:10.824057|2017-10-10 22:24:10.824057
NCT02706470|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-03-12|||May 2016||2016-05-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Use of Cyclosporin A for the Treatment of Recurrent Miscarriage|A Randomized, Controlled Trial of Cyclosporin A for Women With Unexplained Recurrent Miscarriage|Not yet recruiting||Phase 2/Phase 3|384|Anticipated|Fudan University||2|||f||||t||||||||No||2017-10-10 22:24:11.258384|2017-10-10 22:24:11.258384
NCT02706457|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-04-11|||October 2015||2015-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Post Intensive Care Syndrome|Do Improvements in Functionality on the ICU Give a Reduction of Post Intensive Care Syndrome|Completed||N/A|849|Actual|Medical Centre Leeuwarden|||1||f||||f||||||||No||2017-10-10 22:24:11.357299|2017-10-10 22:24:11.357299
NCT02706444|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-03-07|||March 2016||2016-03-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Drug-coated Balloon Versus Conventional Balloon Angioplasty in Hemodialysis Graft|A Prospective, Multicenter, Randomized, Controlled Trial for Comparison of Drug-coated Balloon Versus Conventional Balloon Angioplasty in Venous Anastomotic Stenosis of Hemodialysis Graft|Not yet recruiting||Phase 4|190|Anticipated|Konkuk University Medical Center||2|||f||||t||||||||No||2017-10-10 22:24:11.538006|2017-10-10 22:24:11.538006
NCT02706431|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-03-07|||December 2015||2015-12-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Oxygenation by 100% Oxygen Via High Flow Nasal Cannula in Surgical Patients|Evaluation of Oxygenation by 100% Oxygen Via High Flow Nasal Cannula During Apnea in Adult Elective Surgical ENT Patients|Enrolling by invitation||N/A|40|Anticipated|Karolinska University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:24:11.603051|2017-10-10 22:24:11.603051
NCT02706418|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-07|||March 2016||2016-03-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Clinical Massage Therapy as a Treatment for Carpal Tunnel Syndrome|A Standardised Massage Protocol as an Effective Treatment for Chronic Carpal Tunnel Syndrome|Not yet recruiting||N/A|40|Anticipated|Jing Advanced Massage Training||1|||f||||||||||||||2017-10-10 22:24:11.670847|2017-10-10 22:24:11.670847
NCT02705690|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-09|||May 2016||2016-05-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|BBAaBBT||Benchmarking the iOS Balance Application Against the Berg Balance Test|Benchmarking the iOS Balance Application Against the Berg Balance Test|Not yet recruiting||N/A|20|Anticipated|Stannah Stairlifts||1|||f||||t||||||||||2017-10-10 22:24:18.837872|2017-10-10 22:24:18.837872
NCT02706392|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-14|||March 16, 2016|Actual|2016-03-16|September 2017|2017-09-01||||December 1, 2021|Anticipated|2021-12-01||Interventional|||Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies|Phase I Study of Adoptive Immunotherapy for Advanced ROR1+ Malignancies With Defined Subsets of Autologous T Cells Engineered to Express a ROR1-Specific Chimeric Antigen Receptor|Recruiting||Phase 1|60|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f||||||||2017-10-10 22:24:11.942164|2017-10-10 22:24:11.942164
NCT02706379|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-03-07|||June 2015||2015-06-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Impact of Early Goal-Directed Therapy to Perfusion and Metabolism of Brain|The Impact of Early Goal-Directed Therapy to Perfusion and Metabolism of Brain in Septic Shock Patients|Active, not recruiting||N/A|26|Anticipated|Southeast University, China||1|||f||||f||||||||No|The data is personal, and will not share to others.|2017-10-10 22:24:12.052998|2017-10-10 22:24:12.052998
NCT02706340|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-09-06|||April 2015||2015-04-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Observational|PPIUD||Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study|Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study (PPIUD)|Recruiting||N/A|480|Anticipated|University of Pennsylvania|||2||f||||f||||||||No||2017-10-10 22:24:12.233571|2017-10-10 22:24:12.233571
NCT02706327|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-31|2017-01-25||January 2014||2014-01-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Comparison of Two Different Insole Types in Painful Flexible Flatfoot|Comparison of Two Different Insole Types on Pain, Quality of Life and Physical Performance in Painful Flexible Flatfoot|Completed||N/A|67|Actual|Eastern Mediterranean University|The young average age of our study population could limit the generalizability of our results and the two-month follow-up interval was sufficient to see the benefit of insoles but may not be long enough to determine whether the benefit will last.|3|||f||||f||||||||||2017-10-10 22:24:12.324481|2017-10-10 22:24:12.324481
NCT02706314|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01||||August 2017|Anticipated|2017-08-01||Observational|||Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks.|Pilot Observation of the Impact of Human Blood Serum From Critically Ill Patients With or Without Critical-illness-polyneuropathy on Intramural Neuronal Networks of Human Colon Samples|Recruiting||N/A|60|Anticipated|University of Rostock|||3||f||||f||||||Samples Without DNA|"     Serum probes will be stored at -80°C.   "|No||2017-10-10 22:24:12.778544|2017-10-10 22:24:12.778544
NCT02706301|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2017-03-06|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pain Coping Skills for Colorectal Cancer Survivors|Pain Coping Skills Training for Colorectal Cancer Survivors With Pain and Distress|Recruiting||N/A|80|Anticipated|Duke University||2|||f||||t||||||||No||2017-10-10 22:24:12.8719|2017-10-10 22:24:12.8719
NCT02706288|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-05|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|PE||Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health|The Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health in Metabolically Abnormal Obese Adults|Recruiting||N/A|20|Anticipated|Washington University School of Medicine||1|||f||||t|f|f||||||||2017-10-10 22:24:12.968588|2017-10-10 22:24:12.968588
NCT02706275|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-05-20|||March 2016||2016-03-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pilot Trial of External Warming in Septic Patients|Pilot Randomized Trial of External Warming in Critically Ill Adult Septic Patients|Recruiting||N/A|56|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 22:24:13.071999|2017-10-10 22:24:13.071999
NCT02706262|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-11|||February 2016||2016-02-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health|Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health|Recruiting||N/A|160|Anticipated|Washington University School of Medicine||5|||f||||t||||||||||2017-10-10 22:24:13.159395|2017-10-10 22:24:13.159395
NCT02706249|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-01-19|||April 2016||2016-04-01|January 2017|2017-01-01|October 2023|Anticipated|2023-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients|A Randomized, Phase II Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients|Recruiting||Phase 2|200|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-10 22:24:13.310289|2017-10-10 22:24:13.310289
NCT02706236|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2017-05-08|||April 2016||2016-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis|A Single-Center Prospective Randomized Placebo Controlled Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis|Withdrawn||Phase 2|0|Actual|Dartmouth-Hitchcock Medical Center||2||no funding was awarded|f||||t||||||||Yes|Within the confines of funding sponsors, and department of gastroenterology at Dartmouth|2017-10-10 22:24:13.417458|2017-10-10 22:24:13.417458
NCT02706223|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-05-03|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SuperDOT-C||A Cluster Randomised Trial of Pharmacy Led HCV Therapy Versus Conventional Treatment Pathways for HCV Positive Patients Receiving Daily OST in Pharmacies in Health Boards Within NHS Scotland.|A Cluster Randomised Trial of Pharmacy Led HCV Therapy Versus Conventional Treatment Pathways for HCV Positive Patients Receiving Daily OST in Pharmacies in Health Boards Within NHS Scotland|Recruiting||N/A|300|Anticipated|University of Dundee||2|||f||||t||||||||Undecided||2017-10-10 22:24:13.514991|2017-10-10 22:24:13.514991
NCT02706210|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-02-28|||September 2015|Actual|2015-09-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Observational|||Magnetic Resonance Imaging-based Comparative Research in Different Mild Cognitive Impairment Subtype||Recruiting||N/A|160|Anticipated|Mudanjiang Medical University|||2||f||||||||||||||2017-10-10 22:24:13.592818|2017-10-10 22:24:13.592818
NCT02706197|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-05-23|||December 2015||2015-12-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Oxygen Measurements in Subcutaneous Tumors by EPR Oximetry Using OxyChip|A Single-Institutional, Phase 1 Trial of Repeated Oxygen Measurements in Subcutaneous Tumors by Electron Paramagnetic Resonance (EPR) Oximetry Using an Implantable Oxygen Sensor (OxyChip)|Enrolling by invitation||Phase 1|60|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t|f|t|f|f||||Undecided||2017-10-10 22:24:13.666713|2017-10-10 22:24:13.666713
NCT02706184|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-03-02|||July 2015||2015-07-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|EcNO||E. Coli Nissle in Oncology|Randomized, Placebo Controlled Phase III Trial of a Microbiological Concomitant Therapy/Prevention of Chemotherapeutical Induced Diarrhea (Caused by Inflammation and an Impaired Intestinal Barrier) With E. Coli Nissle 1917 (EcN)-Suspension in Patients With Gastric and Colorectal Cancer|Recruiting||Phase 3|80|Anticipated|University of Hohenheim||2|||f||||f||||||||No||2017-10-10 22:24:13.760638|2017-10-10 22:24:13.760638
NCT02706171|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-03-07|||June 2015||2015-06-01|March 2016|2016-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Stereotactic Radiosurgery for Soft Tissue Sarcoma|Stereotactic Radiosurgery for Soft Tissue Sarcoma|Recruiting||Phase 2|36|Anticipated|The Cooper Health System||3|||f||||f||||||||||2017-10-10 22:24:13.859325|2017-10-10 22:24:13.859325
NCT02706158|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-13|||April 2016||2016-04-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Dietary Intervention Program for Pre-eclampsia in Women at Risk|Testing the Effect of a Dietary Intervention Program on the Incidence of Pre-eclampsia in Women at Risk|Not yet recruiting||N/A|120|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||No||2017-10-10 22:24:13.938371|2017-10-10 22:24:13.938371
NCT02706145|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-10-31|||March 2016||2016-03-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Using Media to Shift Social Norms of Violence Among Youth|Changing the Narrative: Using Media to Shift Social Norms of Violence Among Youth in West Louisville|Recruiting||N/A|8250|Anticipated|University of Louisville||2|||f||||f||||||||Yes|Will share data, but nothing with identifiers|2017-10-10 22:24:14.014519|2017-10-10 22:24:14.014519
NCT02706132|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-08|2016-03-08|||February 2014||2014-02-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation|MSC for ABO Incompatible Liver Transplantation|Recruiting||Phase 1/Phase 2|15|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||No||2017-10-10 22:24:14.088417|2017-10-10 22:24:14.088417
NCT02706119|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-04-03|||May 2016||2016-05-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|INSUPAR||Insulin in Total Parenteral Nutrition|Subcutaneous Versus Intravenous Basal Insulin in Non-critical Hospitalized Diabetic Patients That Receive Total Parenteral Nutrition|Recruiting||Phase 4|320|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||f||||||||Yes||2017-10-10 22:24:14.166823|2017-10-10 22:24:14.166823
NCT02706106|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2016-03-07|||November 2015||2015-11-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Assessment of a Knee Brace in Patients With Osteoarthritis|Assessment of a Knee Brace in Patients With Osteoarthritis|Active, not recruiting||Phase 4|108|Actual|Irmandade da Santa Casa de Misericordia de Sao Paulo||2|||f||||f||||||||Yes||2017-10-10 22:24:14.636788|2017-10-10 22:24:14.636788
NCT02706093|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-02-27|||March 2016||2016-03-01|February 2017|2017-02-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01||Interventional|HT||Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults|Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults|Active, not recruiting||N/A|120|Anticipated|University of Michigan||4|||f||||f||||||||No||2017-10-10 22:24:14.711311|2017-10-10 22:24:14.711311
NCT02706080|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-01|||January 2014||2014-01-01|September 2017|2017-09-01|February 2024|Anticipated|2024-02-01|January 2024|Anticipated|2024-01-01||Observational|RATED Registry||Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department|Registry of Patient With Antithrombotic Agents Admitted to an Emergency|Recruiting||N/A|10|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 22:24:14.798394|2017-10-10 22:24:14.798394
NCT02706054|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-03-07|||May 2012||2012-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|July 2014|Actual|2014-07-01||Interventional|||Treatment of Recent Onset Low Back Pain With Periradicular Injections of Meloxicam|Treatment of Recent Onset Low Back Pain With Periradicular Injections of Meloxicam: a Randomized, Double Blind, Placebo Controlled Cross-over Study|Completed||Phase 3|80|Actual|Istituto Ortopedico Rizzoli||2|||f||||f||||||||No||2017-10-10 22:24:14.981217|2017-10-10 22:24:14.981217
NCT02706041|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-07-13|||June 2016||2016-06-01|July 2016|2016-07-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|||Damage Control Laparotomy|Damage Control Laparotomy: A Randomized Controlled Trial|Recruiting||N/A|56|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||No||2017-10-10 22:24:15.080833|2017-10-10 22:24:15.080833
NCT02706028|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-07|||February 2013||2013-02-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Underwater Ultrasound Therapy on Hand Function and Quality of Life in Patients With Rheumatoid Arthritis|Effects of Underwater Ultrasound Therapy on Hand Function and Quality of Life in Patients With Rheumatoid Arthritis - a Randomized Controlled Study|Completed||N/A|50|Actual|Petz Aladar County Teaching Hospital||2|||f||||f||||||||No||2017-10-10 22:24:15.201027|2017-10-10 22:24:15.201027
NCT02706015|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-03-09|||October 2017|Anticipated|2017-10-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks|National, Phase III, Multicenter, Randomized, Double-Blind, Parallel, Non-Inferiority Trial to Evaluate the Efficacy and Safety of Cefaliv® Compared to the Neosaldina® in the Treatment of Migraine Attacks|Not yet recruiting||Phase 3|216|Anticipated|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f|f|f||||||||2017-10-10 22:24:15.288037|2017-10-10 22:24:15.288037
NCT02706002|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-07|||November 2015||2015-11-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|Fluoroscopy||Fluoroscopy Improves Femoral Stem Placement|Fluoroscopy Improves Femoral Stem Placement in Cementless Total Hip Arthroplasty|Completed||N/A|60|Actual|Okmeydani Training and Research Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:24:15.370027|2017-10-10 22:24:15.370027
NCT02705989|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-30|||August 18, 2016|Actual|2016-08-18|August 2017|2017-08-01|August 16, 2017|Actual|2017-08-16|August 16, 2017|Actual|2017-08-16||Interventional|||Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects|A Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD), and Non-Randomized, Bioavailability(BA) Study of BMS-986195 in Healthy Subjects|Completed||Phase 1|439|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-10 22:24:15.448585|2017-10-10 22:24:15.448585
NCT02705976|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-09-26|||September 2014||2014-09-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Prospective Trial of a Validated Algorithm for Warfarin Dosing|Prospective Trial of a Validated Algorithm for Warfarin Dosing|Completed||N/A|211|Actual|Aalborg Universitetshospital||2|||f||||f||||||||Undecided||2017-10-10 22:24:15.529815|2017-10-10 22:24:15.529815
NCT02705950|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-10|||December 2014||2014-12-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|ITB||Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP). Preliminary Study.|Effect of Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP) in Spinal Cord Injury (SCI) Patients. Preliminary Study.|Recruiting||N/A|12|Anticipated|Institut Guttmann||2|||f||||f||||||||No||2017-10-10 22:24:15.717003|2017-10-10 22:24:15.717003
NCT02705937|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-10-05|||September 13, 2017|Actual|2017-09-13|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|LactoXeros||Early Phase Study Comparing the Effectiveness of a Dairy Product With the Reference Treatment Aequasyal® on Dry Mouth Symptoms in Patients Suffering From Xerostomia Caused by Psychotropic Medications.|Early Phase Study Comparing the Effectiveness of a Dairy Product, Co-developed by Besancon University Hospital and the National School of Dairy Industry (ENIL), With the Reference Treatment Aequasyal® on Dry Mouth Symptoms in Patients Suffering From Xerostomia Caused by Psychotropic Medications.|Recruiting||N/A|32|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f|||||f|f||||||||2017-10-10 22:24:15.814553|2017-10-10 22:24:15.814553
NCT02705924|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-07-26|||April 2016||2016-04-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk|Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women (18-30 Years) Exposed to a High Familial Breast/Ovarian Cancer Risk|Recruiting||N/A|28|Anticipated|Centre Jean Perrin||2|||f||||f||||||||Undecided|answers to questionnaires|2017-10-10 22:24:15.914163|2017-10-10 22:24:15.914163
NCT02705911|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-07|||April 2015||2015-04-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|TRiHYP||TeleRehabilitation in Hypertension|Isometric Handgrip Exercise: a New Non-pharmacological Tool in the Management of High Blood Pressure?|Recruiting||N/A|60|Anticipated|Katholieke Universiteit Leuven||3|||f||||f||||||||||2017-10-10 22:24:16.016494|2017-10-10 22:24:16.016494
NCT02705898|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-02-14|||September 2015||2015-09-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women|Technology-Supported Physical Activity Intervention for Depressed Alcoholic Women|Recruiting||Phase 1|70|Anticipated|Butler Hospital||2|||f||||||||||||||2017-10-10 22:24:16.098565|2017-10-10 22:24:16.098565
NCT02705885|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-03-07|||June 2014||2014-06-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||IgY Efficacy on Periodontitis Patients|Evaluation of IgY Antibody Effectiveness in Supportive Therapy of Periodontitis Patients|Completed||N/A|60|Actual|Immunology Research Institute in Gifu||2|||f||||t||||||||||2017-10-10 22:24:16.202762|2017-10-10 22:24:16.202762
NCT02705872|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-11-15|||January 2017||2017-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Two Methods of Administration of the Epidural, by Programmed Intermittent Bolus or Continuous Perfusion, on the Incidence of Cesarean Sections and Instrumented Deliveries in Primiparous Women|Comparison of Two Methods of Administration of the Epidural, by Programmed Intermittent Bolus or Continuous Perfusion, on the Incidence of Cesarean Sections and Instrumented Deliveries in Primiparous Women|Not yet recruiting||Phase 2|784|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:24:16.279404|2017-10-10 22:24:16.279404
NCT02705677|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-09-22|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|||Biobanking of Rett Syndrome and Related Disorders|Biobanking of Rett Syndrome and Related Disorders Protocol|Recruiting||N/A|1200|Anticipated|University of Alabama at Birmingham|||3||f||||t||||||Samples With DNA|"     DNA and RNA from blood, plasma, hair follicles, skin biopsies   "|||2017-10-10 22:24:18.944974|2017-10-10 22:24:18.944974
NCT02705859|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-10-17|||April 2016||2016-04-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|May 2019|Anticipated|2019-05-01||Interventional|Panther||Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)|Phase Ib/II Clinical Trial of Copanlisib in Combination With Trastuzumab in Pretreated Recurrent or Metastatic HER2-positive Breast Cancer|Recruiting||Phase 1|19|Anticipated|Cancer Trials Ireland||1|||f||||t||||||||Undecided||2017-10-10 22:24:16.37959|2017-10-10 22:24:16.37959
NCT02705846|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-12|||September 2014||2014-09-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|GENPROS||Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations|Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutation in Cancer Predisposition Genes|Recruiting||N/A|1020|Anticipated|Institute of Cancer Research, United Kingdom|||4||f||||f||||||Samples With DNA|"     Saliva or blood samples will be collected from participants to analyse their DNA and look at     genetic modifiers of prostate cancer.      Tumour blocks will also be collected from patients where available.   "|||2017-10-10 22:24:16.481993|2017-10-10 22:24:16.481993
NCT02705833|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-21|||December 2015||2015-12-01|April 2017|2017-04-01|December 6, 2016|Actual|2016-12-06|December 6, 2016|Actual|2016-12-06||Observational|||Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada|Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada|Completed||N/A|591|Actual|Bristol-Myers Squibb|||1||f||||||||||||||2017-10-10 22:24:16.559741|2017-10-10 22:24:16.559741
NCT02705820|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-10-14|||April 2016||2016-04-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|SWIPE||Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy|A Phase II Study of Switch Maintenance Pembrolizumab in Patients With Non Small Cell Lung Cancer (NSCLC) Who do Not Progress After First Line Platinum Doublet Chemotherapy. (SWIPE)|Recruiting||Phase 2|48|Anticipated|Bank of Cyprus Oncology Centre||1|||f||||t||||||||No||2017-10-10 22:24:16.633254|2017-10-10 22:24:16.633254
NCT02705807|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-02-22|2017-02-22||May 2016||2016-05-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects|An Open Label, Single-arm Study Evaluating a New Thermostable Formulation of FLOLAN™ in Japanese Subjects With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 4|10|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:24:16.76281|2017-10-10 22:24:16.76281
NCT02705794|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-03-12|||June 2015||2015-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01|8 Months|Observational [Patient Registry]|||Comparison of Modified Mallampati Classification With M-TAC in Difficult Airway|Clinical Trial of Comparative Evaluation of Modified Mallampati Score and Modified Mallampati Score Along With Thyromental Distance, Anatomical Abnormalities and Cervical Mobility in Predicting Difficult Airway|Completed||N/A|200|Actual|Government Medical College, Haldwani|||1||f||||t||||||||Yes||2017-10-10 22:24:17.480253|2017-10-10 22:24:17.480253
NCT02705781|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-24|||March 23, 2016|Actual|2016-03-23|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Functionality and Accuracy of the smARTrack System in Real-Life ICU Settings|Functionality and Accuracy of the smARTrack System in Real-Life ICU Settings|Enrolling by invitation||N/A|20|Anticipated|ART Healthcare ltd.||1|||f||||||||||||||2017-10-10 22:24:17.531947|2017-10-10 22:24:17.531947
NCT02705768|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-09-17|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures|Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures|Completed||Phase 4|90|Actual|All India Institute of Medical Sciences, Bhubaneswar||3|||f||||f||||||||||2017-10-10 22:24:17.594015|2017-10-10 22:24:17.594015
NCT02705755|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-09-29|||May 2016||2016-05-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)|A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension|Recruiting||Phase 2|30|Anticipated|Theravance Biopharma R & D, Inc.||3|||f||||f||||||||||2017-10-10 22:24:17.698286|2017-10-10 22:24:17.698286
NCT02705742|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-06-06|||January 2016||2016-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis|Efficacy of Adipose Tissue Derived Autologous Repeated Mesenchymal Stem Cells Transplantation Via Hepatic Artery and Peripheral Vein in Patients With Liver Cirrhosis Due to HCV Hepatitis|Recruiting||Phase 1/Phase 2|5|Anticipated|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||1|||f||||t||||||||Undecided||2017-10-10 22:24:17.951179|2017-10-10 22:24:17.951179
NCT02705729|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-09-06|||May 2016||2016-05-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Clinical Performance of Posterior Glass Ionomer Restorations in Adolescents (KETAC)|Clinical Performance of a Newly Developed Glass Ionomer Restorative Material for Posterior Restorations in an Adolescent Population|Enrolling by invitation||N/A|80|Anticipated|Louisiana State University Health Sciences Center in New Orleans||2|||f||||f||||||||Undecided||2017-10-10 22:24:18.057046|2017-10-10 22:24:18.057046
NCT02705716|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-04-19|2017-01-18||March 1, 2016||2016-03-01|April 2017|2017-04-01|May 20, 2016|Actual|2016-05-20|May 20, 2016|Actual|2016-05-20||Interventional||Intent-to-treat (ITT) population included all the participants who were randomized, received at least one dose of the study treatment and provided at least one post-baseline assessment of efficacy.|Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity|Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|Completed||N/A|409|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:24:18.168829|2017-10-10 22:24:18.168829
NCT02705703|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-10|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Consolidation Therapy in Patients With Metastatic Solid Malignancies|Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen (TAPA)-Pulsed Dendritic Cell (DC) Therapy and Low Dose GM-CSF, as Consolidation Therapy in Patients With Metastatic Solid Malignancies|Recruiting||Phase 1/Phase 2|23|Anticipated|Kiromic, LLC||1|||f||||t|t|f||||||||2017-10-10 22:24:18.719535|2017-10-10 22:24:18.719535
NCT02705664|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-09-15|||January 2016||2016-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|OPEN||Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1%|Subject Adherence and Satisfaction for Treatment of Onychomycosis With Loceryl Nail Lacquer 5% Versus a Fungal Nail Treatment Set Containing Urea 40% Ointment and Bifonazole Cream 1%|Completed||Phase 4|22|Actual|Galderma||2|||f||||f||||||||||2017-10-10 22:24:19.205464|2017-10-10 22:24:19.205464
NCT02705651|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-08-29|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2024|Anticipated|2024-01-01|January 2023|Anticipated|2023-01-01||Interventional|SANO||Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment|Non-functioning Pancreatic Neuroendocrine Tumors (NF-pNETs) in Multiple Endocrine Neoplasia Type 1 (MEN1) Treated With Somatostatin Analogs (SA) Versus NO Treatment - a Prospective, Randomized, Controlled Multicenter Study|Not yet recruiting||Phase 3|180|Anticipated|Medical University of Vienna||2|||f||||t|f|f||||||||2017-10-10 22:24:19.314383|2017-10-10 22:24:19.314383
NCT02705638|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-09-12|||April 2016||2016-04-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|TIGR2||Treatment of IgG4-Related Disease With Revlimid and Rituximab|Treatment of IgG4-Related Disease With Revlimid and Rituximab: The TIGR2 Trial|Recruiting||Phase 1|10|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 22:24:19.426404|2017-10-10 22:24:19.426404
NCT02705625|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-24|||January 28, 2016|Actual|2016-01-28|August 2017|2017-08-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|||A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients|A Randomised, Double-blind Placebo-controlled Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of MIV-711 in Knee Joint Osteoarthritis|Completed||Phase 2|244|Actual|Medivir||3|||f||||t||||||||||2017-10-10 22:24:19.538679|2017-10-10 22:24:19.538679
NCT02705612|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-09|||September 2015||2015-09-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer|Efficacy and Safety of Radiotherapy Concurrently Combined With Cisplatin and Nimotuzumab for Patients With Locally Advanced Cervical Cancer|Recruiting||Phase 2|60|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-10 22:24:19.629709|2017-10-10 22:24:19.629709
NCT02705599|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-02-01|||January 2016||2016-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Stroke Mechanism Evolution in Intracranial Atherosclerotic Stenosis|Stroke Mechanism Evolution in Intracranial Atherosclerotic Stenosis|Recruiting||N/A|350|Anticipated|Chinese PLA General Hospital|||1||f||||f||||||||No||2017-10-10 22:24:19.763526|2017-10-10 22:24:19.763526
NCT02705586|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-08-01|||March 2016||2016-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|vMBSR||Video Based Mindfulness Based Stress Reduction|Video Based Mindfulness Based Stress Reduction|Completed||N/A|12|Actual|Oregon Health and Science University||1|||f||||f||||||||No||2017-10-10 22:24:19.865447|2017-10-10 22:24:19.865447
NCT02705573|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-07|||January 2016||2016-01-01|March 2016|2016-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation|Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation|Recruiting||Phase 3|100|Anticipated|Medical University of Vienna||2|||f||||||||||||||2017-10-10 22:24:19.95889|2017-10-10 22:24:19.95889
NCT02705560|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-05|||August 2015||2015-08-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|June 2016|Anticipated|2016-06-01||Interventional|||Assessment of Dietary Biomarkers and Metabolic Effects After the Intake of Milk and Cheese|Randomized, Controlled, Cross-Over Study to Assess Dietary Biomarkers and Metabolic Effects After a Single Dose of Milk and Cheese in Healthy Subjects|Recruiting||N/A|12|Anticipated|Centre Hospitalier Universitaire Vaudois||3|||f||||f||||||||||2017-10-10 22:24:20.072683|2017-10-10 22:24:20.072683
NCT02705547|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-09-20|||May 2016||2016-05-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 4, 2017|Actual|2017-08-04||Interventional|||Rosuvastatin (Crestor) in Friedreich Ataxia|Open-label Biomarker Study of Rosuvastatin (Crestor) for the Treatment of Patients With Friedreich Ataxia|Recruiting||Early Phase 1|12|Anticipated|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-10 22:24:20.196454|2017-10-10 22:24:20.196454
NCT02705534|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-04-05|||September 2016||2016-09-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|SL50||Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1|Sustained Viral Response Rate in 50 Subjects With Cirrhosis Due to Hepatitis C, Genotype 1, Treated With 12 Weeks of Sofosbuvir, Ledipasvir and Ribavirin|Active, not recruiting||Phase 3|50|Actual|Tehran University of Medical Sciences||1|||f||||f||||||||No||2017-10-10 22:24:20.330317|2017-10-10 22:24:20.330317
NCT02705521|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-07-19|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|GAME||Comparing Gamification With Remote Monitoring Against Standard Rehabilitation, for Patients After Arthroscopic Subacromial Decompression Surgery|A Multi-centre, Randomised, Controlled Study Comparing Gamification With Remote Monitoring Against Standard Rehabilitation, for Patients After Arthroscopic Subacromial Decompression Surgery|Recruiting||N/A|90|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:24:20.45349|2017-10-10 22:24:20.45349
NCT02705508|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-10-18|||February 2016||2016-02-01|March 2016|2016-03-01|September 2021|Anticipated|2021-09-01|February 2021|Anticipated|2021-02-01||Interventional|||PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma|Phase 2 Trial of PEG-ASP Combined With Etoposide and Gemcitabine (PEG) as First-line Chemotherapy to Treat NK/T-cell Lymphoma|Recruiting||Phase 2|60|Anticipated|Sun Yat-sen University||1|||f||||f||||||||Yes||2017-10-10 22:24:20.561456|2017-10-10 22:24:20.561456
NCT02705495|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-29|||May 2015||2015-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|SARUTI||Acupuncture for Prevention of Recurrent Urinary Tract Infections.|Segmental and Ear Acupuncture for Prevention of Recurrent Urinary Tract Infections(SARUTI Study): a Multicenter Randomized Controlled Trial|Recruiting||N/A|136|Anticipated|Medical University of Graz||2|||f||||f||||||||No||2017-10-10 22:24:20.654289|2017-10-10 22:24:20.654289
NCT02705313|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-08-31||||||August 2017|2017-08-01||||||||Expanded Access|||EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx|Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Patients With Inoperable, Somatostatin Receptor Positive, Neuroendocrine Tumors, Progressive Under Somatostatin Analogue Therapy|Available||N/A|||Advanced Accelerator Applications|||||||||||||||||||2017-10-10 22:24:24.185816|2017-10-10 22:24:24.185816
NCT02705482|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-07-13|||March 30, 2016|Actual|2016-03-30|July 2017|2017-07-01|April 25, 2023|Anticipated|2023-04-25|August 14, 2020|Anticipated|2020-08-14||Interventional|||A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors|A Phase 1 Multicenter, Open-label, Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Antitumor Activity of MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors|Recruiting||Phase 1|404|Anticipated|MedImmune LLC||2|||f||||f|t|f||||||||2017-10-10 22:24:20.742387|2017-10-10 22:24:20.742387
NCT02705469|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-10|||April 2016||2016-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer|A Phase 1 Safety and Tolerability Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1|44|Anticipated|Zenith Epigenetics||1|||f||||f||||||||||2017-10-10 22:24:20.892504|2017-10-10 22:24:20.892504
NCT02705456|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-05-08|||October 2014||2014-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|ECOP||Enamel Caries in Orthodontic Patients|Enamel Caries in Orthodontic Patients|Completed||N/A|150|Actual|Wuerzburg University Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:24:20.975382|2017-10-10 22:24:20.975382
NCT02705443|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-11-01|||February 2016||2016-02-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Early Identification of Suspected Deep Tissue Injury (sDTI)|Early Identification of Suspected Deep Tissue Injury (sDTI) Utilizing Long-Wave Thermographic Imaging (LWIT)|Recruiting||N/A|60|Anticipated|Wound Vision|||3||f||||f||||||||Undecided||2017-10-10 22:24:21.057764|2017-10-10 22:24:21.057764
NCT02705430|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-10-05|||December 2016||2016-12-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of EPA-DHA Supplement, Life Style Modification Standard Treatment on Clinical Outcome Lipid Membrane Composition in Type 2 Diabetes|Effect of EPA-DHA Supplementation, Life Style Modification or Standard Treatment on Clinical Outcome and Lipid Membrane Composition in Type 2 Diabetic Patients: a 3 Months Perspective Randomized Pilot Study.|Not yet recruiting||N/A|60|Anticipated|Rabin Medical Center||4|||f||||t||||||||No||2017-10-10 22:24:21.128729|2017-10-10 22:24:21.128729
NCT02705417|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-04|||January 2012||2012-01-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Observational|||Maximizing Native Arteriovenous Fistulae Rates.|Maximizing Native Arteriovenous Fistulae Rates. Is Routine Colour Doppler Vascular Mapping in Pre-operative Planning of Value? A Retrospective Study.|Completed||N/A|136|Actual|Medifil AE|||2||f||||f||||||||Yes||2017-10-10 22:24:21.205338|2017-10-10 22:24:21.205338
NCT02705404|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01|50 Years|Observational [Patient Registry]|||A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing|A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome|Recruiting||N/A|100|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     The patient will have some or all of the samples taken listed below:        -  Blood sample of 10 ml (2 teaspoons).        -  Up to two lung bronchoscopic or transbronchoscopic needle aspiration biopsies will be          given to the research study during an already scheduled bronchoscopy. In addition at the          time of the bronchoscopy a brushing or washing specimen could be collected for research.        -  A piece of lung or lymph node tissue taken at the time of the CT guided lung or lymph          node biopsy will be given to the research study.        -  A piece of lung tumor tissue removed during surgery will be given to the research study.        -  If pleural fluid is removed as part of the procedure(s) and there is any fluid left          after what is needed for your clinical care, it will be given to the research study.        -  DNA genome sequencing will be performed on the collected tissues, blood and fluid.   "|No||2017-10-10 22:24:21.287774|2017-10-10 22:24:21.287774
NCT02705391|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-05-22|||March 2016||2016-03-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|||Advanced MR Imaging in Sarcoma Patients|A Pilot Study of the Utility of Perfusion MRI and MR Elastography for Surgical Planning, Radiotherapy Target Delineation, and Treatment Response Evaluation in Newly Diagnosed Ewing Sarcoma, Rhabdomyosarcoma and Soft Tissue Sarcoma Patients|Recruiting||N/A|60|Anticipated|Mayo Clinic|||1||f||||||||||||||2017-10-10 22:24:21.358243|2017-10-10 22:24:21.358243
NCT02705378|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-03-28|||May 2017|Anticipated|2017-05-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|NaRC-ICU||The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit|The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit|Not yet recruiting||Phase 3|350|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||No||2017-10-10 22:24:21.424274|2017-10-10 22:24:21.424274
NCT02705365|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-08-29|2017-08-29||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|February 7, 2017|Actual|2017-02-07|January 31, 2017|Actual|2017-01-31||Interventional|||Patient Navigation for Lung Screening at MGH Community Health Centers|Patient Navigation for Lung Screening at MGH Community Health Centers|Completed||N/A|1200|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:24:21.516749|2017-10-10 22:24:21.516749
NCT02705352|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-07|||August 25, 2016|Actual|2016-08-25|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts|A Prospective, Randomized, Double-blinded Comparison of the Use of 5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts.|Recruiting||Phase 2|20|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||||2017-10-10 22:24:23.859948|2017-10-10 22:24:23.859948
NCT02705339|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-05-16|||May 2016||2016-05-01|May 2016|2016-05-01|April 2020|Anticipated|2020-04-01|November 2019|Anticipated|2019-11-01||Interventional|||Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)|Genomic Landscape of EGFR Mutant NSCLC Prior to Rociletinib and at the Time of Disease Progression Following Rociletinib|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||1||Clovis Oncology discontinued rociletinib.|f||||f||||||||No||2017-10-10 22:24:23.975931|2017-10-10 22:24:23.975931
NCT02705326|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-31|||January 2016||2016-01-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluating the Efficacy of Opti-Speech for Speech Treatment|Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment|Recruiting||N/A|30|Anticipated|Vulintus, Inc.||1|||f||||t||||||||No||2017-10-10 22:24:24.064027|2017-10-10 22:24:24.064027
NCT02705300|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-12-14|||May 2016||2016-05-01|December 2016|2016-12-01|March 2025|Anticipated|2025-03-01|August 2019|Anticipated|2019-08-01||Interventional|||Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer|A Randomized Investigation of Side Effects to FOLFOXIRI in Combination With Tocotrienol or Placebo as First Line Treatment of Metastatic Colorectal Cancer|Recruiting||Phase 2|70|Anticipated|Vejle Hospital||2|||f||||f||||||||||2017-10-10 22:24:24.347423|2017-10-10 22:24:24.347423
NCT02705287|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-11-04|||July 2015||2015-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Observational|||Vitamin D Dynamics in Women|Vitamin D Dynamics in Pregnant Women and Non-Pregnant Women of Reproductive Age|Active, not recruiting||N/A|10|Actual|Cornell University|||2||f||||t||||||Samples With DNA|"     Serum samples and extracted DNA sample (biospecimen retention will be both with and without     DNA)   "|No||2017-10-10 22:24:24.47348|2017-10-10 22:24:24.47348
NCT02705274|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-07-03|||February 2016||2016-02-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||PRP vs Bevacizumab for PDR Treatment|Panretinal Photocoagulation Versus Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy|Completed||Phase 2/Phase 3|30|Actual|Marashi Eye Clinic||2|||f||||||||||||||2017-10-10 22:24:24.666575|2017-10-10 22:24:24.666575
NCT02705261|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2017-05-09|||March 2016||2016-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Coaching for Confidence: Evaluating an Internet-based Program to Help Parents Help Children With Difficulty With Anxiety|Coaching for Confidence: Evaluating an Internet-based Program to Help Parents Help Children With Difficulty With Anxiety|Active, not recruiting||N/A|92|Actual|University of Manitoba||1|||f||||f||||||||No||2017-10-10 22:24:24.757121|2017-10-10 22:24:24.757121
NCT02705248|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-03-09|||December 2013||2013-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|June 2014|Actual|2014-06-01|1 Day|Observational [Patient Registry]|IRRM||Insulin Resistance in Recurrent Miscarriage|The Role of Insulin Resistance in Recurrent Miscarriage|Completed||N/A|80|Actual|Ain Shams Maternity Hospital|||2||f||||t||||||||Undecided||2017-10-10 22:24:24.844597|2017-10-10 22:24:24.844597
NCT02705235|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-03-29|||January 2016||2016-01-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Stress, Coping and Health Behaviors in Pregnancy||Completed||N/A|75|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-10 22:24:24.916858|2017-10-10 22:24:24.916858
NCT02705222|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-05-08|||February 2016||2016-02-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison Between D&C and Hysteroscopy in Management of AUB in Perimenopausal Women|Comparison Between Dilatation and Curettage and Hysteroscopy in Management of Abnormal Uterine Bleeding in Perimenopausal Women|Recruiting||Phase 4|100|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 22:24:24.987832|2017-10-10 22:24:24.987832
NCT02705209|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-04|||October 2015||2015-10-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Cayenne Pepper Cataplasm - Effect Study|Cayenne Pepper Cataplasm - Effect Study on Healthy Subjects and Subjects With Back Pain|Completed||N/A|20|Actual|Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation||2|||f||||f||||||||||2017-10-10 22:24:25.099391|2017-10-10 22:24:25.099391
NCT02705196|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-07-19|||November 2016||2016-11-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|November 2018|Anticipated|2018-11-01||Interventional|||LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer|Phase I/IIa Trial Evaluating Safety of LOAd703, an Armed Oncolytic Adenovirus for Pancreatic Cancer|Recruiting||Phase 1/Phase 2|26|Anticipated|Lokon Pharma AB||1|||f||||t||||||||||2017-10-10 22:24:25.202838|2017-10-10 22:24:25.202838
NCT02705183|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-09-16|||January 2016||2016-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|PORT||Post-operative RadioTherapy for Patients With Metastases of the Long Bones|Post-operative RadioTherapy for Patients With Metastases of the Long Bones: a Randomised Controlled Trial|Recruiting||N/A|250|Anticipated|Leiden University Medical Center||2|||f||||f||||||||No||2017-10-10 22:24:25.319586|2017-10-10 22:24:25.319586
NCT02705170|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-09-12|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|IMPAIRED||IMR Assessment in Patients With New Diagnosis of Left Ventricle Dilatation|Index of Microcirculatory Resistance (IMR) Assessment in Patients With New Diagnosis of Left Ventricular Dilatation Without Significant Coronary Artery Lesions: IMPAIRED Pilot Trial|Recruiting||N/A|30|Anticipated|University Hospital of Ferrara|||1||f||||t||||||||||2017-10-10 22:24:25.418144|2017-10-10 22:24:25.418144
NCT02705157|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-09-16|||January 2016||2016-01-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01|2 Years|Observational [Patient Registry]|OPTIMAL||The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones|The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones|Recruiting||N/A|900|Anticipated|Leiden University Medical Center|||1||f||||f||||||||No||2017-10-10 22:24:25.513098|2017-10-10 22:24:25.513098
NCT02705144|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-03-05|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Definition of the Status of the Human Lung Stem Cell Niches ex Vivo in Tissue Biopsies Performed in Patients With Emphysema and Interstitial Fibrosis|Definition of the Status of the Human Lung Stem Cell Niches ex Vivo in Tissue Biopsies Performed in Patients With Emphysema and Interstitial Fibrosis Compared to Non-diseased Areas|Not yet recruiting||N/A|20|Anticipated|Sheba Medical Center|||3||f||||f||||||Samples With DNA|"     Lung tissue biopsies   "|No||2017-10-10 22:24:25.614213|2017-10-10 22:24:25.614213
NCT02705131|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-09|||April 2016||2016-04-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Balance Chiropractic Therapy for Cervical Spondylotic Radiculopathy|Balance Chiropractic Therapy for Cervical Spondylotic Radiculopathy: a Randomized Parallel-controlled Trial|Not yet recruiting||N/A|240|Anticipated|Shaanxi University of Chinese Medicine||2|||f||||f||||||||No||2017-10-10 22:24:25.688018|2017-10-10 22:24:25.688018
NCT02705118|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-23|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|FAME-US||Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma|Evaluation of Performance of S-fusion for Radiofrequency Ablation of Hepatocellular Carcinoma: A Randomized, Prospective Study|Completed||N/A|82|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||No||2017-10-10 22:24:25.763244|2017-10-10 22:24:25.763244
NCT02705105|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-01-20|||December 2015||2015-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors|Open-label, Multicenter, Phase 1/2 Study of Mogamulizumab in Combination With Nivolumab in Subjects With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|188|Anticipated|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||t||||||||||2017-10-10 22:24:25.836041|2017-10-10 22:24:25.836041
NCT02705092|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-06-09|||February 2016||2016-02-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Immediate Effect of Subliminal Priming With Subliminal Reward Stimuli on Standing Balance in Healthy Young Adults|Immediate Effect of Subliminal Priming With Subliminal Reward Stimuli on Standing Balance in Healthy Young Adults: A Randomized Controlled Trial|Completed||N/A|50|Actual|Kibi International University||2|||f||||f||||||||No||2017-10-10 22:24:25.950909|2017-10-10 22:24:25.950909
NCT02705079|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-03-09|||August 2014||2014-08-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Observational|||Values of Enhanced Monitoring by EEG Recording (Narcotrend) for Sedation in Endoscopic Ultrasound|Values of Enhanced Monitoring by EEG Recording ( Narcotrend ) as an Adjunct to Standard Monitoring for Sedation in Endoscopic Ultrasonography|Recruiting||N/A|200|Anticipated|Ruhr University of Bochum|||1||f||||f||||||||Undecided||2017-10-10 22:24:26.009781|2017-10-10 22:24:26.009781
NCT02705066|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-10-31|||March 2016||2016-03-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Citicoline Effects on Cortical Membrane Structure and Function|Citicoline Effects on Cortical Membrane Structure and Function|Recruiting||N/A|60|Anticipated|Kyowa Hakko Bio Co., Ltd.||3|||f||||||||||||||2017-10-10 22:24:26.070761|2017-10-10 22:24:26.070761
NCT02705053|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-10-12|||February 2016||2016-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation|At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation|Completed||Phase 3|32|Actual|William Sansum Diabetes Center||2|||f||||t||||||||No||2017-10-10 22:24:26.161736|2017-10-10 22:24:26.161736
NCT02705040|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-03-06|||December 2013||2013-12-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Roles of microRNAs in the Development of Osteoporosis in Men - Preliminary Study|Roles of microRNAs in the Development of Osteoporosis in Men - Preliminary Study|Recruiting||N/A|30|Anticipated|Taipei Medical University WanFang Hospital|||3||f||||f||||||Samples Without DNA|"     Plasma, urine   "|No||2017-10-10 22:24:26.262558|2017-10-10 22:24:26.262558
NCT02705027|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-05|||August 2012||2012-08-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Comparison of Two Endoscopically Placed Nasojejunal Probes|Randomized, Controlled Comparison of Two Endoscopically Placed Nasojejunal Probes in Critically Ill Patients in Terms of Application Time and Technical Success|Recruiting||N/A|64|Anticipated|Ruhr University of Bochum||2|||f||||f||||||||No||2017-10-10 22:24:26.431394|2017-10-10 22:24:26.431394
NCT02705014|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-06|||January 2016||2016-01-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome|Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome|Recruiting||N/A|20|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-10 22:24:26.511536|2017-10-10 22:24:26.511536
NCT02705001|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-09|||January 2015||2015-01-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||Nurse Graduateness and Patient Outcomes: a Cross Sectional Pilot Study|Nurse Graduateness and Patient Outcomes: a Cross Sectional Pilot Study|Active, not recruiting||N/A|1252|Actual|Hamad Medical Corporation|||1||f||||f||||||||No||2017-10-10 22:24:26.615107|2017-10-10 22:24:26.615107
NCT02704988|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-06|||March 2015||2015-03-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Trial Comparing Carnoy's and GEWF Solutions|Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer|Recruiting||N/A|126|Anticipated|Hospital Moinhos de Vento||4|||f||||t||||||||No||2017-10-10 22:24:26.675817|2017-10-10 22:24:26.675817
NCT02704975|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-08-15|||March 2016||2016-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Dry Needling and Physical Therapy Versus Physical Therapy Alone Following Shoulder Stabilization Repair|Effectiveness of Trigger Point Dry Needling and Physical Therapy Versus Physical Therapy Alone Following Shoulder Stabilization Repair: A Randomized Controlled Trial|Active, not recruiting||N/A|39|Actual|Keller Army Community Hospital||2|||f||||f||||||||||2017-10-10 22:24:26.786806|2017-10-10 22:24:26.786806
NCT02704962|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-04|||January 2012||2012-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine|A Randomized, Double-blind, Comparison of the Efficacy and Safety of Olanzapine Versus Low-dose Olanzapine Plus Low-dose Trifluoperazine in the Treatment of Schizophrenia|Completed||Phase 4|94|Actual|Kaohsiung Kai-Suan Psychiatric Hospital||2|||f||||t||||||||||2017-10-10 22:24:26.885947|2017-10-10 22:24:26.885947
NCT02704949|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-04|||August 2015||2015-08-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Impact of Low Dose Fluoroscopy in Ureteroscopy|Impact of Low Dose Fluoroscopy in Ureteroscopy|Enrolling by invitation||N/A|94|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||No||2017-10-10 22:24:27.012482|2017-10-10 22:24:27.012482
NCT02704936|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-21|||December 2015||2015-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Analysis of Lipid Profiles in Samples Sperm and Seminal Plasma Under Artificial Insemination|Analysis of Lipid Profiles in Samples Sperm and Seminal Plasma Under Artificial Insemination|Recruiting||N/A|126|Anticipated|IVI Bilbao|||3||f||||f||||||||||2017-10-10 22:24:27.103051|2017-10-10 22:24:27.103051
NCT02704923|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-09|||February 2015||2015-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Atropine for Preventing Ventilator-Associated Pneumonia|Atropine for Preventing Ventilator-Associated Pneumonia|Completed||Phase 2|40|Actual|Universidade de Passo Fundo||2|||f||||f||||||||No||2017-10-10 22:24:27.193443|2017-10-10 22:24:27.193443
NCT02704910|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-06-21|||January 2012||2012-01-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|IPOLAP||Lateral Postural Inclination in Parkinson's Disease : Involvement of the Basal Ganglia ?|Lateral Postural Inclination in Parkinson's Disease : Involvement of the Basal Ganglia ?|Terminated||N/A|38|Actual|University Hospital, Grenoble||2||Not more patient with lateral deviation|f||||f||||||||||2017-10-10 22:24:27.27848|2017-10-10 22:24:27.27848
NCT02704897|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-07-31|||July 2016||2016-07-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|TWIST||Tracking Wound Infection With Smartphone Technology|Can a Smartphone-delivered Tool Facilitate the Assessment of Surgical Site Infection, and Result in Earlier Treatment? A Randomized-controlled Trial in Emergency Surgery Patients.|Recruiting||N/A|400|Anticipated|University of Edinburgh||2|||f||||f||||||||No||2017-10-10 22:24:27.356338|2017-10-10 22:24:27.356338
NCT02704884|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-08-11|||March 2016||2016-03-01|August 2016|2016-08-01||||June 2016|Actual|2016-06-01||Interventional|||Microbial Soy Milk Consumption, Inflammation and Renal Function Among Type 2 Diabetic Patients With Nephropathy||Completed||N/A|48|Actual|Isfahan University of Medical Sciences||2|||f||||||||||||||2017-10-10 22:24:27.442145|2017-10-10 22:24:27.442145
NCT02704871|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-08-23|||June 2015||2015-06-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|April 2016|Actual|2016-04-01||Observational|||The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS|To Assess the Performance of SeptiCyte® Lab to Diagnose Patients Identified as Suspected of Sepsis in General Medical and Surgical Wards With Infection-positive From Infection-negative SIRS|Active, not recruiting||N/A|66|Actual|Immunexpress|||1||f||||f||||||Samples With DNA|"     Whole blood and plasma specimens for nucleic acid and protein analysis   "|No|There is no plan to make individual participant data available.|2017-10-10 22:24:27.522807|2017-10-10 22:24:27.522807
NCT02704858|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-09-12|||April 2016||2016-04-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and Efficacy Study in Recurrent Grade IV Glioma|An Open-Label, Phase 1/2A Dose Escalation Study of Safety and Efficacy of NEO100 in Recurrent Grade IV Glioma|Recruiting||Phase 1/Phase 2|43|Anticipated|Neonc Technologies, Inc.||1|||f||||t||||||||||2017-10-10 22:24:27.61406|2017-10-10 22:24:27.61406
NCT02704845|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-10-19|||September 2015||2015-09-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain|Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain: An Exploration of Similarities and Differences|Completed||N/A|58|Actual|University of Dublin, Trinity College|||2||f||||||||||||||2017-10-10 22:24:27.755059|2017-10-10 22:24:27.755059
NCT02704832|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-11-08|||March 2016||2016-03-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|PREPARE||Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)|Role of Geriatric Intervention in Treatment of Older Patients With Cancer : a Phase III Randomized Study (PREPARE)|Recruiting||Phase 3|1500|Anticipated|Institut Bergonié||2|||f||||t||||||||Undecided||2017-10-10 22:24:27.882363|2017-10-10 22:24:27.882363
NCT02704819|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-10-25|||March 2016||2016-03-01|February 2016|2016-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|EMBalance||Proof of Concept Study of EMBalance Decision Support System to Evaluate Balance Disorders|A Decision Support System Incorporating a Validated Patient-specific, Multi-scale Balance Hyper Model Towards Early Diagnostic Evaluation and Efficient Management Plan Formulation of Balance Disorders (EMBalance)|Completed||N/A|200|Actual|University College, London||2|||f||||f||||||||No||2017-10-10 22:24:28.13937|2017-10-10 22:24:28.13937
NCT02704806|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2016-03-09|||April 2016||2016-04-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|ATAIA||Immunologic Analysis of Peripheral Blood and Aspirated Thromb In AMI Patients|Immunologic Analysis of Aspired Thromb and Circulatory Immune Cell in AMI Patients|Not yet recruiting||N/A|60|Anticipated|Jilin University|||1||f||||f||||||Samples With DNA|"     Thromb will be abtained with aspiration device during PCI intervention, peripheral blood will     be abtained as well for study.   "|||2017-10-10 22:24:28.253139|2017-10-10 22:24:28.253139
NCT02704793|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-05|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Cerebellar rTMS for Essential Tremor|Assessing Clinical Effectiveness of Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) on Severity of Motor Signs of Essential Tremor|Enrolling by invitation||N/A|30|Anticipated|Mashhad University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:24:28.299378|2017-10-10 22:24:28.299378
NCT02704780|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-08-11|||March 2016||2016-03-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||Two Different Regimens of Misoprostol in Retained Placenta|Umbilical Vein Injection of 800µg Misoprostol Versus 400 µg Misoprostol in the Treatment of Retained Placenta: A Multicenter, Randomized Double Blind Controlled Trial|Recruiting||Phase 2|516|Anticipated|Hawler Medical University||2|||f||||t||||||||||2017-10-10 22:24:28.386532|2017-10-10 22:24:28.386532
NCT02704767|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-09|||June 2016||2016-06-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma|Tarceva With or Without Apatinib in the First-line Therapy of Advanced Lung Adenocarcinoma With Mutant EGFR:a Phase II Study.|Not yet recruiting||Phase 2|60|Anticipated|The First Affiliated Hospital of Kunming Medical College||2|||f||||f||||||||Undecided||2017-10-10 22:24:28.493877|2017-10-10 22:24:28.493877
NCT02704754|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-05-06|||May 2016||2016-05-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Suvorexant and Trauma Related Insomnia|Suvorexant and Trauma Related Insomnia|Recruiting||Phase 4|105|Anticipated|Howard University||2|||f||||f||||||||Yes||2017-10-10 22:24:28.589093|2017-10-10 22:24:28.589093
NCT02704741|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2017-09-18|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments|Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments|Recruiting||N/A|80|Anticipated|Syneron Medical||1|||f||||f||||||||||2017-10-10 22:24:28.689367|2017-10-10 22:24:28.689367
NCT02703597|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-11-28|||May 2016||2016-05-01|November 2016|2016-11-01||||May 2018|Anticipated|2018-05-01||Interventional|||Smoking Prevention Through Social Connections Among Adolescents - ASPIRE|Smoking Prevention Through Social Connections Among Adolescents - ASPIRE|Recruiting||N/A|145|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 22:24:38.918262|2017-10-10 22:24:38.918262
NCT02704728|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-26|||December 2015||2015-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Bacteroides Thetaiotaomicron in Young People Aged 16 to 18 Years With Stable Crohn's Disease|A Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of Bacteroides Thetaiotaomicron in Young People Aged 16 to 18 Years With Stable Crohn's Disease|Recruiting||N/A|20|Anticipated|4DPharma PLC||2|||f||||f||||||||No||2017-10-10 22:24:28.781945|2017-10-10 22:24:28.781945
NCT02704689|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-17|||June 8, 2016|Actual|2016-06-08|April 2017|2017-04-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|APROPOS||AccuLIF® PROSPECTIVE PATIENT OUTCOMES STUDY|A Prospective Multi-Center Evaluation of a Hydraulic Expandable TLIF Cage for the Treatment of Degenerative Disc Disease of the Lumbar Spine|Terminated||N/A|9|Actual|Stryker Spine||1||Lack of subject enrollment|f||||f||||||||No||2017-10-10 22:24:29.17191|2017-10-10 22:24:29.17191
NCT02704676|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-17|||March 2016||2016-03-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Observational|||CA-125 and Severity of Pre-Eclampsia|CA-125 and Severity of Pre-Eclampsia|Not yet recruiting||N/A|120|Anticipated|Ain Shams Maternity Hospital|||3||f||||t||||||||Undecided||2017-10-10 22:24:29.256589|2017-10-10 22:24:29.256589
NCT02704663|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-03-09|||November 2014||2014-11-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Transumbilical Versus Lateral Transabdominal Removal of Benign Adnexal Masses Via Laparoscopy|Transumbilical Versus Lateral Transabdominal Removal of Benign Adnexal Masses Via Laparoscopy, a Randomized Trial|Active, not recruiting||N/A|42|Actual|Helsinki University Central Hospital||2|||f||||f||||||||No||2017-10-10 22:24:29.341055|2017-10-10 22:24:29.341055
NCT02704650|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-04-26|||May 2016||2016-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids|Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids|Withdrawn||N/A|0|Actual|Shaare Zedek Medical Center||2|||f||||t||||||||No||2017-10-10 22:24:29.452507|2017-10-10 22:24:29.452507
NCT02704637|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-02-23|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Evaluation of Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm|An Evaluation of Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm|Not yet recruiting||N/A|25|Anticipated|HeadSense Medical||1|||f||||f|f|f||||||No||2017-10-10 22:24:29.531862|2017-10-10 22:24:29.531862
NCT02704624|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-12-01|||December 2016||2016-12-01|September 2016|2016-09-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of Supplementation of Vitamin D in Patients With Crohn`s Disease|The Impact of Serum Vitamin D and Calcium Levels on the Body Composition, Bone Mineral Density, Muscle Strength, Exercise Tolerance, Fatigue and Inflammatory Activity in Patients With Crohn's Disease: a Randomized Controlled Trial|Not yet recruiting||Phase 4|110|Anticipated|Federal University of Juiz de Fora||2|||f||||t||||||||No||2017-10-10 22:24:29.6369|2017-10-10 22:24:29.6369
NCT02704611|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-09|||October 2015||2015-10-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Direct Current Stimulation for Treatment of Fibromyalgia|Direct Current Stimulation Versus Sham for Treatment of Fibromyalgia: a Double Blinded Randomized Controlled Trial|Unknown status|Recruiting|N/A|36|Anticipated|Assiut University||2|||f||||t||||||||No||2017-10-10 22:24:29.765429|2017-10-10 22:24:29.765429
NCT02704598|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-04|||October 2014||2014-10-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|DVT||Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.|Comparison of Recanalization Rate of Deep Venous Thrombosis in Lower Limbs in Patients Undergoing Treatment With Rivaroxaban Versus Warfarin.|Recruiting||N/A|150|Anticipated|Hospital do Servidor Publico Estadual||2|||f||||t||||||||No|We preserve confidential data.|2017-10-10 22:24:29.87095|2017-10-10 22:24:29.87095
NCT02704585|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-09|||January 2016||2016-01-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Comparison of Two Pulse Oximeters in Delivery Room|Comparison of Two Pulse Oximeters in Delivery Room: A Prospective Study|Recruiting||N/A|100|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||No||2017-10-10 22:24:29.970027|2017-10-10 22:24:29.970027
NCT02704559|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2017-02-14|||December 2015||2015-12-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects||Completed||Phase 1|40|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-10 22:24:30.192427|2017-10-10 22:24:30.192427
NCT02704546|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-03-09|||April 2016||2016-04-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Methylphenidate (Ritalin®) Effect During Exposure to Exercise and Heat Stress in ADD/ADHD Treated Patients|The Effect of the Drug Methylphenidate on Physiological Stress and Function During Exposure to Exercise and Heat Stress in ADD/ADHD Treated Patients|Not yet recruiting||N/A|20|Anticipated|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 22:24:30.269168|2017-10-10 22:24:30.269168
NCT02704533|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-04-24|||September 2016|Actual|2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Sequential Optimization of Dose and Schedule of PfSPZ Vaccine|Sequential Optimization of Dose and Schedule of PfSPZ Vaccine, Verified by Randomized, Controlled, Double-blind Immunization and Controlled Human Malaria Infection in Malaria-naïve, Healthy Adult Volunteers in Germany|Recruiting||Phase 1|63|Anticipated|Sanaria Inc.||13|||f||||f||||||||||2017-10-10 22:24:30.361197|2017-10-10 22:24:30.361197
NCT02704520|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-06-27|||March 2016||2016-03-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|June 2018|Anticipated|2018-06-01||Interventional|TRIGGER||Magnetic Resonance Tumour Regression Grade as Biomarker for Stratified Management of Rectal Cancer Patients|Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Imaging Biomarker to Stratify Management of Good and Poor Responders to Chemoradiotherapy: A Rectal Cancer Multicentre Randomised Control Trial|Recruiting||Phase 2/Phase 3|90|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||Yes||2017-10-10 22:24:30.503158|2017-10-10 22:24:30.503158
NCT02704507|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-03-05|||June 2015||2015-06-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Addition of a Topical Steroid to a Topical Retinoid in Acne Patients|Addition of a Topical Steroid to a Topical Retinoid: a Randomized, Split-face, Placebo-controlled, Double-blind, Single-center Clinical Study|Active, not recruiting||N/A|20|Actual|Carilion Clinic||2|||f||||||||||||||2017-10-10 22:24:30.664018|2017-10-10 22:24:30.664018
NCT02704494|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-10-03|||March 2016|Actual|2016-03-01|October 2017|2017-10-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|ReDNeph||Resveratrol's Effects in Diabetic Nephropathy|Resveratrol's Effects in Diabetic Nephropathy|Completed||Early Phase 1|60|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:24:30.745027|2017-10-10 22:24:30.745027
NCT02704481|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-07-29|||June 2016||2016-06-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Non-surgical Alternatives to Treatment of Failed Medical Abortion|Non-surgical Alternatives to Treatment of Failed Medical Abortion: A Randomized Controlled Double-blind Trial|Recruiting||Phase 4|326|Anticipated|Gynuity Health Projects||2|||f||||t||||||||No||2017-10-10 22:24:30.849282|2017-10-10 22:24:30.849282
NCT02704468|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-07-18|||January 2016||2016-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|2 Months|Observational [Patient Registry]|CAVIFGF21||FGF21 Can Help Predicting Arterial Stiffness Measured by Cardio-ankle Vascular Index in Renal Transplant Patients|FGF21 Can Help Predicting Arterial Stiffness Measured by Cardio-ankle Vascular Index in Renal Transplant Patients|Completed||N/A|100|Actual|Bangkok Metropolitan Administration Medical College and Vajira Hospital|||1||f||||t||||||||Yes|Data about CAVI and FGF 21|2017-10-10 22:24:30.989946|2017-10-10 22:24:30.989946
NCT02704455|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-05|||May 2016||2016-05-01|March 2016|2016-03-01|July 2030|Anticipated|2030-07-01|May 2030|Anticipated|2030-05-01||Observational|||Registry Study on Primary Ciliary Dyskinesia in Chinese Children|Registry Study on Primary Ciliary Dyskinesia in Chinese children-a Multicenter, Prospective Cohort Study|Not yet recruiting||N/A|100|Anticipated|Beijing Children's Hospital|||1||f||||t||||||||Yes||2017-10-10 22:24:31.090278|2017-10-10 22:24:31.090278
NCT02704442|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-04|||February 2016||2016-02-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Does Anxiety in Children on the Day of Surgery Impact Compliance in the Ophthalmology Clinic?|Does Anxiety in Children on the Day of Surgery Impact Compliance in the Ophthalmology Clinic?|Recruiting||N/A|82|Anticipated|Queen's University|||1||f||||f||||||||No||2017-10-10 22:24:31.16197|2017-10-10 22:24:31.16197
NCT02704429|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-02-28|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris|An Open-Label, Phase 2, Pilot Study Investigating the Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics of Oral Treatment With the BTK Inhibitor PRN1008 in Patients With Newly Diagnosed or Relapsing Pemphigus Vulgaris|Recruiting||Phase 2|25|Anticipated|Principia Biopharma, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:24:31.248124|2017-10-10 22:24:31.248124
NCT02704416|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-09-25|||July 2016||2016-07-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|BRAVE||Ablation in Brugada Syndrome for the Prevention of VF|Ablation in Brugada Syndrome for Prevention of VF - A Randomized, Multi-center Study of Epicardial Ablation in Brugada Syndrome Patients to Prevent Arrhythmia Recurrence|Recruiting||N/A|184|Anticipated|Pacific Rim Electrophysiology Research Institute||3|||f||||t||||||||||2017-10-10 22:24:31.396009|2017-10-10 22:24:31.396009
NCT02704390|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-03-04|||January 2016||2016-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD|An Extension Study to Evaluate the Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD|Recruiting||Phase 3|50|Anticipated|Orient Pharma Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:24:32.364792|2017-10-10 22:24:32.364792
NCT02704377|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-10-03|||May 2016||2016-05-01|October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|||Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors|Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors|Recruiting||N/A|120|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:24:32.48925|2017-10-10 22:24:32.48925
NCT02704364|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-13|||February 2016||2016-02-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis|A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of NGM282 Administered for 12 Weeks in Patients With Primary Sclerosing Cholangitis|Completed||Phase 2|62|Actual|NGM Biopharmaceuticals, Inc||3|||f||||t||||||||||2017-10-10 22:24:32.619079|2017-10-10 22:24:32.619079
NCT02704351|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-08-23|||February 2016||2016-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Suggamadex and Fast-track Cardiac Anesthesia in a Developing Country|Retrospective Chart Review of Fast-track Cardiac Anesthesia Using Suggamadex for Rapid Reversal of Neuromuscular Blockade Following Cardiac Surgery in a Developing Country|Completed||N/A|14|Actual|Nationwide Children's Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:24:32.784298|2017-10-10 22:24:32.784298
NCT02704338|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-04|||April 2016||2016-04-01|March 2016|2016-03-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|Treg||Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis|Phase 1 Clinical Trial Using Regulatory T Cells as Individualized Medicine to Evaluate the Safety and Efficacy in Autoimmune Hepatitis|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Nanjing Medical University||1|||f||||t||||||||||2017-10-10 22:24:32.850294|2017-10-10 22:24:32.850294
NCT02704325|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-11-04|||April 2016||2016-04-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|July 2018|Anticipated|2018-07-01||Interventional|||Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2|Phase I Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2|Withdrawn||Phase 1|0|Actual|Nationwide Children's Hospital||2|||f||||t||||||||No||2017-10-10 22:24:32.945233|2017-10-10 22:24:32.945233
NCT02704312|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-10-03|||November 30, 2015|Actual|2015-11-30|October 2017|2017-10-01|April 2020|Anticipated|2020-04-01|July 2018|Anticipated|2018-07-01||Interventional|PROCUBITUS||Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast Cancer|A Feasibility Study of Patient Comfort and Dosimetry Evaluation in Prone Breast Radiotherapy.|Recruiting||N/A|26|Anticipated|University Hospital Center of Martinique||1|||f||||f||||||||||2017-10-10 22:24:33.048784|2017-10-10 22:24:33.048784
NCT02704299|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-09|||March 2016||2016-03-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.|A Single-centered Clinical Trial of Surgery，Chemotherapy in Combination With Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.|Not yet recruiting||Early Phase 1|36|Anticipated|Cellular Biomedicine Group Ltd.||1|||f||||t||||||||Undecided||2017-10-10 22:24:33.148865|2017-10-10 22:24:33.148865
NCT02704286|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-03-04|||April 2015||2015-04-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Risk and Risk Perception of Knee Osteoarthritis in the US|Raising Awareness of Knee Osteoarthritis (OA) and Willingness to Undertake Behavioral Changes to Reduce Risk of Knee OA: Online Recruitment|Completed||N/A|380|Actual|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 22:24:33.227791|2017-10-10 22:24:33.227791
NCT02704273|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-06-22|||July 2016||2016-07-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|INCEPTUS||A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects|INCEPTUS: A Prospective, Non-Interventional Clinical Assessment Study in X Linked Myotubular Myopathy (XLMTM) Subjects Aged 3 Years and Younger|Active, not recruiting||N/A|16|Anticipated|Audentes Therapeutics|||1||f||||f||||||||||2017-10-10 22:24:33.313049|2017-10-10 22:24:33.313049
NCT02704260|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-12-15|||January 2016||2016-01-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|GOSSER||Genetic of SportS Induced Endofibrotic Remodeling|Endofibrose Vasculaire et génétique|Enrolling by invitation||N/A|5|Anticipated|University Hospital, Angers||1|||f||||t||||||||Undecided||2017-10-10 22:24:33.393982|2017-10-10 22:24:33.393982
NCT02704247|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-03-04|||April 2014||2014-04-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CARDIOSPACE||CARDIOSPACE Evaluation in Healthy Volunteers|Evaluation of CARDIOSPACE System in Healthy Volunteers for Physiological Research in Space Environment|Completed||N/A|2|Actual|University Hospital, Angers||1|||f||||t||||||||No||2017-10-10 22:24:33.497918|2017-10-10 22:24:33.497918
NCT02704234|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-06-12|||November 2015||2015-11-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Acupuncture for Vulvodynia: A Pre-pilot Study|Acupuncture for Vulvodynia: A Double-blinded Feasibility Pre-pilot Study|Completed||N/A|6|Actual|University of Illinois at Chicago||2|||f||||t|f|f||||||No||2017-10-10 22:24:33.594054|2017-10-10 22:24:33.594054
NCT02704221|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-06-16|||March 2016||2016-03-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Enhancing the Outcomes of a Behavioral Parent Training Intervention|Enhancing the Outcomes of a Behavioral Parent Training Intervention|Enrolling by invitation||N/A|20|Anticipated|University of Kentucky||2|||f||||f||||||||No||2017-10-10 22:24:33.677894|2017-10-10 22:24:33.677894
NCT02704208|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|April 2018|Anticipated|2018-04-01||Interventional|TWM||A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for Substance-using HIV+ Adults|A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for Substance-using HIV+ Adults|Recruiting||N/A|400|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 22:24:33.777321|2017-10-10 22:24:33.777321
NCT02704195|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-09-20|||April 2014||2014-04-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|STIMSYM||Subthalamic Nucleus Stimulation Effect on Gait Symmetry and Freezing of Gait|Subthalamic Nucleus Stimulation Effect on Gait Symmetry and Freezing of Gait|Terminated||N/A|12|Actual|University Hospital, Grenoble||2|||f||||f||||||||No||2017-10-10 22:24:33.872723|2017-10-10 22:24:33.872723
NCT02704182|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-03-08|||June 2015||2015-06-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|TDCSTKA||Transcranial Direct Current Stimulation for Postoperative Pain in Knee Arthroplasty|Role of Transcranial Direct Current Stimulation (tDCS) in Reduction of Pain and Postsurgical Opioid Consumption in Total Knee Arthroplasty (TKA)|Completed||N/A|46|Actual|Assiut University||2|||f||||f||||||||No||2017-10-10 22:24:33.954143|2017-10-10 22:24:33.954143
NCT02704169|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-09-21|||July 2013||2013-07-01|September 2017|2017-09-01||||June 2018|Anticipated|2018-06-01||Interventional|||Quantitative Endoscopy of H&N|Comparing GTV Delineation With and Without Spatially Registered Endoscopy|Suspended||Phase 2|40|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:24:34.025263|2017-10-10 22:24:34.025263
NCT02703584|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-06-28|||March 2016||2016-03-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation|Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation- A Randomized Controlled Trial|Recruiting||Phase 4|276|Anticipated|Mount Sinai Hospital, Canada||2|||f||||t||||||||No||2017-10-10 22:24:39.019727|2017-10-10 22:24:39.019727
NCT02704156|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Efficacy Study of Five-fraction Stereotactic Body Radiation Therapy to Locally Advanced Pancreatic Cancer|The Safety and Efficacy of Five-fraction Stereotactic Body Radiation Therapy Treating Locally Advanced Pancreatic Cancer With cyberKnife—a Phase II Clinical Study|Recruiting||Phase 2|140|Anticipated|Changhai Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:24:34.108828|2017-10-10 22:24:34.108828
NCT02704143|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-10|||October 2016||2016-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Combination of Stereotactic Body Radiation Therapy With S-1 for Treating Locally Advanced Pancreatic Cancer|The Safety and Efficacy of Combination of Stereotactic Body Radiation Therapy With S-1 in Treating Locally Advanced Pancreatic cancer--a Phase II Clinical Trial|Recruiting||Phase 2|190|Anticipated|Changhai Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:24:34.229882|2017-10-10 22:24:34.229882
NCT02704130|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma|Transarterial Embolization and Microwave Ablation Combination Therapy in Early-stage Hepatocellular Carcinoma: A Randomized Trial|Recruiting||N/A|100|Anticipated|Carolinas Healthcare System||2|||f||||t|f|t|f|||||||2017-10-10 22:24:34.344931|2017-10-10 22:24:34.344931
NCT02704117|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-11-28|||June 2015||2015-06-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Neurocircuitry of Obsessive-Compulsive Disorder: Modulation by Transcranial Direct Current Stimulation|Neurocircuitry of OCD: Effects Of Modulation|Recruiting||Phase 1|20|Anticipated|Butler Hospital||1|||f||||t||||||||||2017-10-10 22:24:34.454064|2017-10-10 22:24:34.454064
NCT02704091|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-07-13|||March 2016||2016-03-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ADIASE||Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults|Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults. A Multicentre, Randomized, Double Blind Placebo Controlled, Parallel, Groups Study|Recruiting||Phase 4|854|Anticipated|Ipsen||2|||f||||f||||||||||2017-10-10 22:24:34.650781|2017-10-10 22:24:34.650781
NCT02704078|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-16|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|TEAM||EBUS-TBNA vs EUS-B-FNA for Needle Aspiration of Mediastinal Lesions|Prospective Randomized Comparison of Trans-tracheal (EBUS-TBNA) Versus Trans-esophageal (EUS-B-FNA) Route as the Primary Approach for Fine Needle Aspiration of Mediastinal Lesions Using the Convex Probe Endobronchial Ultrasound (EBUS) Scope|Completed||N/A|100|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-10 22:24:34.775833|2017-10-10 22:24:34.775833
NCT02704065|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-04-15|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|||Recurrent AA Amyloidosis After Renal Transplantation|Recurrent AA Amyloidosis After Renal Transplantation: Effects on Allograft Survival|Completed||N/A|54|Actual|Istanbul University|||3||f||||f||||||||Undecided||2017-10-10 22:24:34.844859|2017-10-10 22:24:34.844859
NCT02704052|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-07|2016-11-02|||March 2016||2016-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose|Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose|Recruiting||Early Phase 1|300|Anticipated|University of Utah||2|||f||||t||||||||Undecided||2017-10-10 22:24:34.9181|2017-10-10 22:24:34.9181
NCT02704039|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-05-02|||January 2016||2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Observational|||Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin|Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin|Recruiting||N/A|480|Anticipated|University of Texas at Austin|||1||f||||f||||||||No||2017-10-10 22:24:34.992014|2017-10-10 22:24:34.992014
NCT02704026|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-04|||July 2015||2015-07-01|February 2016|2016-02-01||||July 2017|Anticipated|2017-07-01||Observational|||Nutritional Status and Body Composition in Childhood Inflammatory Bowel Disease|Nutritional Status and Body Composition in Children With Inflammatory Bowel Disease: A Prospective Cohort Study|Recruiting||N/A|50|Anticipated|Ankara University|||2||f||||f||||||||||2017-10-10 22:24:35.0559|2017-10-10 22:24:35.0559
NCT02704013|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-09|||April 2016||2016-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Urinary Biomarkers in Overactive Bladder in Children|Role of Urinary Neurotrophin and Cytokine Levels in Diagnosis and Management of Overactive Bladder in Children|Not yet recruiting||N/A|50|Anticipated|Children's Hospital Zagreb||1|||f||||f||||||||Undecided||2017-10-10 22:24:35.13064|2017-10-10 22:24:35.13064
NCT02704000|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-03|||January 2015||2015-01-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|July 2016|Anticipated|2016-07-01||Interventional|||Home Visiting Programs to Improve Early Childhood Development and Maternal Mental Health|Home Visiting Programs to Improve Early Childhood Development and Maternal Mental Health - Evidence From the Western Region Cohort Project|Active, not recruiting||N/A|900|Actual|University of Sao Paulo||3|||f||||f||||||||No||2017-10-10 22:24:35.220144|2017-10-10 22:24:35.220144
NCT02703987|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-09-04|||November 2015||2015-11-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|HYBRID||HYBRID: Hydrogen Breath Test in Lactose Digestion|A Randomized, Controlled, Double-blind, Cross-over, Single-centre Study to Investigate the Effect of a Fermented Infant Formula on Lactose Digestion in Lactose Intolerant Adults|Completed||N/A|28|Actual|Danone Asia Pacific Holdings Pte, Ltd.||2|||f||||f||||||||||2017-10-10 22:24:35.284666|2017-10-10 22:24:35.284666
NCT02703974|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-11-18|||March 2016||2016-03-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Nudging Handwashing: a Cluster-randomized Trial in Bangladesh|Nudging Handwashing: a Cluster-randomized Trial in Bangladesh|Completed||N/A|20|Actual|University of Oklahoma||4|||f||||f||||||||No|Data on individual participants will not be shared.|2017-10-10 22:24:35.475098|2017-10-10 22:24:35.475098
NCT02703961|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-15|||February 2016||2016-02-01|March 2016|2016-03-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer|Multicenter Study on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy With Cisplatin and Docetaxel Combined With Radiotherapy for Local Advanced Cervical Cancer|Recruiting||Phase 3|598|Anticipated|Fourth Military Medical University||2|||f||||t||||||||Yes||2017-10-10 22:24:35.603841|2017-10-10 22:24:35.603841
NCT02703948|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-07||2017-07-07|March 2016||2016-03-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation||Completed||N/A|60|Actual|Q-Med AB||1|||f||||f||||||||||2017-10-10 22:24:35.77213|2017-10-10 22:24:35.77213
NCT02703935|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-01-11|||January 2014||2014-01-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Effectiveness of an Adventure-based Training Programme to Reduce Fatigue for Childhood Cancer Survivors|Effectiveness of an Adventure-based Training Programme in Promoting Regular Physical Activity, Reducing Fatigue and Enhancing Quality of Life Among Hong Kong Chinese Childhood Cancer Survivors|Completed||N/A|222|Actual|The University of Hong Kong||2|||f||||f||||||||No||2017-10-10 22:24:35.861228|2017-10-10 22:24:35.861228
NCT02703922|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-08-29|||August 29, 2016|Actual|2016-08-29|August 2017|2017-08-01|September 28, 2020|Anticipated|2020-09-28|August 28, 2018|Anticipated|2018-08-28||Interventional|ECHORTON||Validation of a Diagnostic Algorithm of Giant Cell Arteritis|Validation d'un Algorithme Diagnostique de l'artérite Temporale Giganto-cellulaire basé Sur l'échographie-doppler Couleur Des artères Temporales Superficielles et Des Axes Cervico-encéphaliques|Recruiting||N/A|168|Anticipated|Poitiers University Hospital||1|||f||||f||||||||||2017-10-10 22:24:36.025427|2017-10-10 22:24:36.025427
NCT02703909|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-05-31|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|May 30, 2017|Actual|2017-05-30||Interventional|||Surgical Conditions During Laparoscopic Bariatric Surgery|A Prospective Randomized Clinical Trial Evaluating Surgical Conditions During Laparoscopic Bariatric Surgery With Deep Versus Moderate Neuromuscular Blockade|Active, not recruiting||Phase 4|144|Actual|University of Missouri-Columbia||4|||f||||f||||||||No||2017-10-10 22:24:36.207705|2017-10-10 22:24:36.207705
NCT02703896|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-08|||January 2012||2012-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|January 2012|Actual|2012-01-01||Interventional|||Prophylaxis for Aspiration of Gastric Contents.|"Effect of Orally Administered Two Successive Doses of PPIs and/ or H2RAs Without or With a Prokinetic Drug, on the Intragastric pH and Volume and Bile Refluxate in Adults Patients Undergoing Elective Surgery."|Completed||Phase 4|1920|Actual|King Saud University||5|||f||||t||||||||Yes||2017-10-10 22:24:36.327115|2017-10-10 22:24:36.327115
NCT02703883|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-03|||July 2012||2012-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Body Weight Support in Spinal Cord Injury|Effects of Body Weight-supported Treadmill Training on Center of Mass Control in Spinal Cord Injury, Measured With Inertial Sensors|Completed||N/A|17|Actual|University of Chile||1|||f||||t||||||||No||2017-10-10 22:24:36.453574|2017-10-10 22:24:36.453574
NCT02703870|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-03-03|||March 2013||2013-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study|Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study|Completed||Phase 1/Phase 2|19|Actual|University of Magdeburg||3|||f||||f||||||||No||2017-10-10 22:24:36.556313|2017-10-10 22:24:36.556313
NCT02703857|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-06-09|||February 2016||2016-02-01|June 2017|2017-06-01|September 20, 2016||2016-09-20|September 15, 2016|Actual|2016-09-15||Interventional|PROPHYLOXITINE||Study of Repeated Cefoxitin Administration in Major Abdominal Surgery Using a Microdialysis Technique||Completed||Phase 4|12|Actual|Poitiers University Hospital||1|||f||||||||||||||2017-10-10 22:24:36.678876|2017-10-10 22:24:36.678876
NCT02703844|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-06-13|||March 2016||2016-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vestibular Stimulation in Parkinson's Disease|Caloric Vestibular Stimulation in Parkinson's Disease|Recruiting||N/A|24|Anticipated|University of Kent||2|||f||||f||||||||Undecided|This has not been yet agreed upon.|2017-10-10 22:24:36.767835|2017-10-10 22:24:36.767835
NCT02703831|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-08|||May 2016||2016-05-01|March 2016|2016-03-01|May 2023|Anticipated|2023-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Single Versus Dual Spine Attending Surgeons in Complex Adult Deformity Surgery:|Single Versus Dual Spine Attending Surgeons in Complex Adult Deformity Surgery: A Cost-effectiveness Study Using Activity-based Costing|Not yet recruiting||N/A|60|Anticipated|Norton Leatherman Spine Center||2|||f||||f||||||||No|There is no plan to share individual level data.|2017-10-10 22:24:36.90376|2017-10-10 22:24:36.90376
NCT02703818|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-07-25|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|July 2017|Anticipated|2017-07-01||Interventional|UEP||SCS for the Treatment Of Chronic Pain of the Upper Extremities|Multi-Center, Prospective, Clinical Trial of the Senza™ Spinal Cord Stimulation (SCS) System in the Treatment Of Chronic Pain of the Upper Extremities|Active, not recruiting||N/A|64|Actual|Nevro Corp||1|||f||||f||||||||||2017-10-10 22:24:37.010735|2017-10-10 22:24:37.010735
NCT02703805|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-05-25|||May 2014||2014-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fit For Function: A Community Wellness Program for Persons With Stroke|Fit For Function: A Community Wellness Program for Persons With Stroke|Recruiting||N/A|216|Anticipated|McMaster University||2|||f||||f||||||||Yes|Results will be communicated to the Central South Regional Stroke Network and the Ontario Stroke System. Results will also be disseminated through professional organizations, the Ontario Ministry of Health and Long Term Care, peer reviewed conferences, provincial and national stroke forums, journal articles and special interest groups like the Stroke Recovery Group.|2017-10-10 22:24:37.097943|2017-10-10 22:24:37.097943
NCT02703792|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-04-03|||March 2016||2016-03-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|ECHO||Enhanced Care Home Outcomes: A Qualitative Study|Enhanced Care Home Outcomes (ECHO): An Evaluation of the Experiences of Staff and Stakeholders Working With an Integrated Care Home Support Service (CHSS)|Completed||N/A|19|Actual|Oxford Health NHS Foundation Trust|||4||f||||f||||||||Undecided||2017-10-10 22:24:37.252794|2017-10-10 22:24:37.252794
NCT02703376|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-03-03|||January 2016||2016-01-01|March 2016|2016-03-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery|Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery|Recruiting||Phase 1|8|Anticipated|Nagasaki University||1|||f||||t||||||||No||2017-10-10 22:24:42.428416|2017-10-10 22:24:42.428416
NCT02703779|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-11-17|||March 2016||2016-03-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)|An Exploratory Trial to Estimate the Proportion of Patients With Tumor Cell Contaminated, Flow Positive Leukapheresis Products Collected With and Without Bortezomib as In-vivo Purging Prior to Autologous Stem Cell Harvest for Multiple Myeloma|Recruiting||Phase 2|100|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:24:37.362388|2017-10-10 22:24:37.362388
NCT02703766|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-12-12|||April 2016||2016-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Weight Gain and Adipose Tissue|Pilot Study to Examine the Effects of Weight Gain on Adipose Tissue|Recruiting||N/A|14|Anticipated|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-10 22:24:37.510734|2017-10-10 22:24:37.510734
NCT02703753|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-09-12|||February 2016||2016-02-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TOP-mums, for a Healthy Start|TOwards Prepared Mums (TOP-mums), for a Healthy Start: A Lifestyle Intervention to Reduce Overweight and Smoking in Women With a Pregnancy Wish to Prevent Perinatal Morbidity|Recruiting||N/A|112|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 22:24:37.637854|2017-10-10 22:24:37.637854
NCT02703740|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-03-03|||January 2016||2016-01-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|March 2016|Anticipated|2016-03-01||Interventional|ECLAH||Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds|Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds|Recruiting||N/A|60|Anticipated|Laboratoires Genévrier||2|||f||||||||||||||2017-10-10 22:24:37.766536|2017-10-10 22:24:37.766536
NCT02703727|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-12-07|||November 2014||2014-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Medication Review Focusing on Anticoagulation Therapy in Swiss Community Pharmacies|Durchführung Einer Beobachtungsstudie im Rahmen Einer Masterarbeit Zur Identifikation Von Pharmaceutical Care Issues Bei Patienten, Welche Mit Oralen Antikoagulantien Behandelt Werden|Completed||N/A|90|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||No||2017-10-10 22:24:37.889499|2017-10-10 22:24:37.889499
NCT02703714|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-10-05|||April 2016||2016-04-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Pembrolizumab and GM-CSF in Biliary Cancer|Phase II Trial of Pembrolizumab (MK-3475) With GM-CSF Induction in Advanced Biliary Cancers|Recruiting||Phase 2|27|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:24:37.982935|2017-10-10 22:24:37.982935
NCT02703701|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-09-07|||October 2015||2015-10-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|MD at Triage||Role of Physician-at-Triage on Emergency Department (ED) Efficiency and Quality of Care|Effects of Attending Physician-at-Triage on Emergency Department Efficiency, Information Delivery and Patient Satisfaction|Completed||N/A|199|Actual|University of Florida|||2||f||||f|f|f||||||||2017-10-10 22:24:38.107908|2017-10-10 22:24:38.107908
NCT02703688|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-18|||March 31, 2017|Actual|2017-03-31|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|HHS||Environmental Influences on Early Childhood Obesity|Environmental Influences on Early Childhood Obesity: The Healthy Homes Study|Recruiting||N/A|28|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||Undecided||2017-10-10 22:24:38.195589|2017-10-10 22:24:38.195589
NCT02703675|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-19|||February 2016||2016-02-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CryoCollar||Effectiveness, Safety and Ease of Application of Excel Cryo Cooling Collar to Rapidly Reduce Core Brain Temperature|Effectiveness, Safety and Ease of Application of Excel Cryo Cooling Collar to Rapidly Reduce Core Brain Temperature|Recruiting||N/A|28|Anticipated|Ohio State University||3|||f||||f||||||||||2017-10-10 22:24:38.292441|2017-10-10 22:24:38.292441
NCT02703662|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-08|||March 2016||2016-03-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction|Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction - A Randomized Controlled Trial|Not yet recruiting||Phase 2/Phase 3|90|Anticipated|University of Calgary||2|||f||||f||||||||No||2017-10-10 22:24:38.377745|2017-10-10 22:24:38.377745
NCT02703649|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-06-15|||March 2016||2016-03-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Administration of Single High Dose Letrozole for Ovulation Induction|Administration of Single High Dose Letrozole for Ovulation Induction - A Randomized Controlled Trial|Recruiting||Phase 4|36|Anticipated|Mount Sinai Hospital, Canada||2|||f||||t||||||||No||2017-10-10 22:24:38.463117|2017-10-10 22:24:38.463117
NCT02703636|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-06-20|||May 10, 2016|Actual|2016-05-10|June 2017|2017-06-01|April 24, 2018|Anticipated|2018-04-24|April 24, 2018|Anticipated|2018-04-24||Interventional|ENA1stepswitch||Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease|A 24-week, Open-label, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patchwith 1-step Titration in Patients With Mild to Moderate Alzheimer's Disease (MMSE 10 - 23) Switched Directly From Cholinesterase Inhibitors (Donepezil, Galantamine)|Recruiting||Phase 4|120|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 22:24:38.557109|2017-10-10 22:24:38.557109
NCT02703623|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-09-28|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||A Dynamic Allocation Modular Sequential Trial of Approved and Promising Therapies in Men With Metastatic Castrate Resistant Prostate Cancer (DynaMO)|A Dynamic Allocation Modular Sequential Trial of Approved and Promising Therapies in Men With Metastatic Castrate Resistant Prostate Cancer (DynaMO)|Recruiting||Phase 2|265|Anticipated|M.D. Anderson Cancer Center||4|||f||||t|t|f||||||||2017-10-10 22:24:38.707862|2017-10-10 22:24:38.707862
NCT02703610|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-03-04|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Randomized Controlled Trial of Four Analgesics in Elderly ED Patients|Randomized Controlled Trial of Four Analgesics in Elderly ED Patients|Not yet recruiting||Phase 4|400|Anticipated|Montefiore Medical Center||4|||f||||t||||||||No||2017-10-10 22:24:38.838429|2017-10-10 22:24:38.838429
NCT02703571|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-08-01|||June 30, 2016|Actual|2016-06-30|August 2017|2017-08-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2018|Anticipated|2018-12-15||Interventional|||Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors|A Phase I/II Study of Safety and Efficacy of Ribociclib (LEE011) in Combination With Trametinib (TMT212) in Patients With Metastatic or Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|124|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 22:24:39.113843|2017-10-10 22:24:39.113843
NCT02703558|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-03|||March 2016||2016-03-01|March 2016|2016-03-01||||February 2017|Anticipated|2017-02-01||Interventional|EFLUC||Evaluation of Fluorescein Use During Cystoscopy|Evaluation of Fluorescein Use During Cystoscopy, a Randomized Control Trial|Not yet recruiting||N/A|100|Anticipated|Johns Hopkins University||3|||f||||f||||||||No||2017-10-10 22:24:39.246725|2017-10-10 22:24:39.246725
NCT02703545|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-09-07|||February 2014||2014-02-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|February 2019|Anticipated|2019-02-01|5 Years|Observational [Patient Registry]|CAPS Registry||International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs|International CAPS Registry: Operated Cases and Cases With Advanced Disease Among High-risk Individuals Participating in a Pancreatic Cancer Surveillance Program; a Case-control Study|Enrolling by invitation||N/A|100|Anticipated|Johns Hopkins University|||5||f||||f||||||||||2017-10-10 22:24:39.311473|2017-10-10 22:24:39.311473
NCT02703532|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-09-11|||January 2016||2016-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|CARE-CITE||Evaluation of a CarePartner-Integrated Telehealth Rehabilitation Program for Persons With Stroke|Evaluation of a CarePartner-Integrated Telehealth Rehabilitation Program for Persons With Stroke|Recruiting||Phase 1|96|Anticipated|Emory University||3|||f||||t||||||||||2017-10-10 22:24:39.406314|2017-10-10 22:24:39.406314
NCT02703519|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-06|2016-09-08|||November 2014||2014-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|OPSTAR||Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean Section|Optimierung Der Uterotomie-Wundheilung Nach Re-Sectio Caesarea|Completed||N/A|116|Actual|Martin-Luther-Universität Halle-Wittenberg||3|||f||||f||||||||No||2017-10-10 22:24:41.330727|2017-10-10 22:24:41.330727
NCT02703506|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-10-03|||March 2016|Actual|2016-03-01|October 2017|2017-10-01|July 2017|Actual|2017-07-01|December 2016|Actual|2016-12-01||Interventional|||Effectiveness of a Pain Education Program on Chronic Neck Pain Patients|Effectiveness of a Pain Education Program on Chronic Neck Pain Patients|Completed||N/A|44|Actual|University of Alcala||2|||f||||t||||||||||2017-10-10 22:24:41.410259|2017-10-10 22:24:41.410259
NCT02703493|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-12-06|||March 2010||2010-03-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer|A Phase I Trial of IMRT With Dose-Escalated Image-Guided Stereotactic Radiosurgery (SRS) Boost for Human Papilloma Virus (HPV)- Unassociated Oropharyngeal Cancer|Recruiting||Phase 1|45|Anticipated|Northwell Health||1|||f||||t||||||||Undecided||2017-10-10 22:24:41.486195|2017-10-10 22:24:41.486195
NCT02703480|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-01-20|||December 2015||2015-12-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparing the Efficacy and Morbidity of Two Vertical Ridge Augmentation Techniques|Comparison of d-PTFE Membrane With Titanium-mesh in Vertical Ridge Augmentation: A Split Mouth, Randomized Controlled Clinical Trial|Recruiting||N/A|15|Anticipated|Tufts University School of Dental Medicine||2|||f||||f||||||||No||2017-10-10 22:24:41.580919|2017-10-10 22:24:41.580919
NCT02703467|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-08-09|||August 1, 2015|Actual|2015-08-01|March 2016|2016-03-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|||Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma|Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma|Completed||N/A|57|Actual|Imperial College London|||2||f||||f|f|f||||Samples Without DNA|"     Serum   "|||2017-10-10 22:24:41.661561|2017-10-10 22:24:41.661561
NCT02703454|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-06-26|||February 2016||2016-02-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FIRMAP-AF||FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF)|Focal Impulse and Rotor Modulation Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation|Recruiting||Phase 4|170|Anticipated|Abbott Electrophysiology||2|||f||||t||||||||Undecided||2017-10-10 22:24:41.731287|2017-10-10 22:24:41.731287
NCT02703441|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-09-29|||May 2015||2015-05-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||FoodnGo-Empower: A Feasibility Study of Physical Activities and Nutrition of Older Patients by the Use of Technology|FoodnGo - Empower: A Feasibility Study|Completed||N/A|38|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-10 22:24:41.812194|2017-10-10 22:24:41.812194
NCT02703428|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-08-03|||July 2016||2016-07-01|January 2016|2016-01-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Observational|LUCY||TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair in Europe|The LUCY Study: TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair in Europe|Recruiting||N/A|60|Anticipated|TriVascular, Inc.|||1||f||||f||||||||Undecided||2017-10-10 22:24:41.915211|2017-10-10 22:24:41.915211
NCT02703415|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-07-22|||June 2016||2016-06-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Immune Response of Caudally Administrated Tramadol In Pediatric Lower Abdominal Surgery|Comparison Of Immune Response And Analgesic Effects Of Caudally Administrated Tramadol In Pediatric Lower Abdominal Surgery|Recruiting||Phase 2|60|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 22:24:42.004985|2017-10-10 22:24:42.004985
NCT02703402|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-03|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of an Exercise Program Under Supervision and Unsupervised in the Treatment of Low Back|Effects of an Exercise Program Under Supervision and Unsupervised in the Treatment of Low Back Pain: a Randomized Clinical Trial|Not yet recruiting||N/A|122|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:24:42.210992|2017-10-10 22:24:42.210992
NCT02703389|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-01-02|||January 2017||2017-01-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Knowledge Translation Upon Emergency Department Discharge|Video, Ear Infections & Antibiotic Stewardship: Knowledge Translation Upon Emergency Department Discharge|Recruiting||Phase 3|100|Anticipated|Hamilton Health Sciences Corporation||3|||f||||f||||||||||2017-10-10 22:24:42.303658|2017-10-10 22:24:42.303658
NCT02703363|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-02-26|||August 2016||2016-08-01|February 2017|2017-02-01||||August 2018|Anticipated|2018-08-01||Interventional|||Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression|Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression: A Factorial Design Randomised Controlled Trial|Recruiting||Phase 3|240|Anticipated|Pakistan Institute of Learning and Living||4|||f||||||||||||||2017-10-10 22:24:42.541964|2017-10-10 22:24:42.541964
NCT02703350|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-07-28|||March 2016||2016-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy|Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy|Completed||Phase 1|40|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:24:42.647024|2017-10-10 22:24:42.647024
NCT02703337|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-08-26|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy|Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 2 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy|Completed||Phase 1|28|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:24:42.741251|2017-10-10 22:24:42.741251
NCT02703324|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2016-08-25|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps|Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy|Completed||Phase 1|28|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:24:42.834154|2017-10-10 22:24:42.834154
NCT02703311|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-11-20|||August 2016||2016-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|REPAIR||REPAIR - transcatheteR rEPair of mitrAl Insufficiency With caRdioband System|REPAIR - transcatheteR rEPair of mitrAl Insufficiency With caRdioband System|Recruiting||N/A|50|Anticipated|Valtech Cardio Ltd||1|||f||||f||||||||Undecided||2017-10-10 22:24:42.922181|2017-10-10 22:24:42.922181
NCT02703298|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-24|||March 2016||2016-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients|A Phase I Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Solid Tumors in Asians|Recruiting||Phase 1|30|Anticipated|TaiRx, Inc.||1|||f||||||||||||||2017-10-10 22:24:43.053629|2017-10-10 22:24:43.053629
NCT02703285|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-11|||February 2016||2016-02-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Are Medical Personnel Can Correctly Recognize the Chest Sounds?|Are Medical Personnel Can Correctly Recognize the Chest Sounds?|Recruiting||N/A|120|Anticipated|Medical University of Warsaw||1|||f||||f||||||||Undecided||2017-10-10 22:24:43.137515|2017-10-10 22:24:43.137515
NCT02703272|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-09-21|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|March 21, 2024|Anticipated|2024-03-21|June 29, 2021|Anticipated|2021-06-29||Interventional|||A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma|A Randomized, Open-label, Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Patients With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma|Recruiting||Phase 3|96|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 22:24:43.223451|2017-10-10 22:24:43.223451
NCT02703259|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-05-02|||June 2016||2016-06-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management|Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management|Recruiting||Phase 4|150|Anticipated|Christiana Care Health Services||2|||f||||f||||||||No||2017-10-10 22:24:43.515189|2017-10-10 22:24:43.515189
NCT02703246|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-06-27|||January 2016||2016-01-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes|Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes|Enrolling by invitation||N/A|46|Anticipated|George Washington University||2|||f||||f||||||||No||2017-10-10 22:24:43.721441|2017-10-10 22:24:43.721441
NCT02703233|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-07-08|||March 2016||2016-03-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Effectiveness of Nitrous Oxide in the ED|A Randomized Control Trial of Nitrous Oxide Use in the Emergency Department|Withdrawn||Phase 4|0|Actual|Christiana Care Health Services||2||Feasibility|f||||f||||||||No||2017-10-10 22:24:43.803832|2017-10-10 22:24:43.803832
NCT02703220|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-06-13|||July 3, 2015|Actual|2015-07-03|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Sleep Apnea in Elderly|Pathophysiology-Guided Therapy for Sleep Apnea in the Elderly|Recruiting||Phase 4|100|Anticipated|VA Office of Research and Development||3|||f||||t|t|f|||f|||No||2017-10-10 22:24:43.87873|2017-10-10 22:24:43.87873
NCT02703207|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-06-13|||August 17, 2016|Actual|2016-08-17|June 2017|2017-06-01|February 28, 2019|Anticipated|2019-02-28|August 1, 2018|Anticipated|2018-08-01||Interventional|||Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD|Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD|Recruiting||N/A|108|Anticipated|VA Office of Research and Development||3|||f||||t|f|t|f|f|f|||No||2017-10-10 22:24:43.995771|2017-10-10 22:24:43.995771
NCT02703194|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-30|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Leflunomide for Maintenance of Remission in IgG4 Related Disease|A Study of Safety and Efficacy of Leflunomide for Maintenance of Remission in IgG4 Related Disease|Recruiting||Phase 4|66|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 22:24:44.111989|2017-10-10 22:24:44.111989
NCT02703181|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-05-03|||July 9, 2015|Actual|2015-07-09|May 2017|2017-05-01|September 10, 2015|Actual|2015-09-10|September 10, 2015|Actual|2015-09-10||Interventional|||Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers|A Randomized, Placebo-controlled, Double-Blind (Sponsor Unblind), Repeat Dose, Ascending Cohort, Dose Escalation Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban and Its Major Metabolite in Healthy Women Volunteers Following Administration of Repeat Dosing of Epelsiban|Completed||Phase 1|31|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:24:44.217686|2017-10-10 22:24:44.217686
NCT02703168|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-03-03|||July 2012||2012-07-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Long-term Performance of SLActive Implants After Immediate or Early Loading|Post-marketing Study to Document Long-term Performance of Straumann Tissue Level Implants With SLActive Surface in the Posterior Mandible and Maxilla After Immediate or Early Loading - Follow-up to Study CR 06/03|Completed||N/A|66|Actual|Institut Straumann AG|||2||f||||f||||||||No||2017-10-10 22:24:44.318374|2017-10-10 22:24:44.318374
NCT02703155|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-03-03|||October 2015||2015-10-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|HomeOGTT||The Use of Home Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes|The Use of Self-Administered Electronic Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes in Children With Cystic Fibrosis|Recruiting||N/A|30|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:24:44.385158|2017-10-10 22:24:44.385158
NCT02703142|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-10-16|||October 2015||2015-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Endoscopic Evaluation After Esophagectomy|Endoscopic Evaluation for the Postoperative Condition After Esophagectomy and Reconstruction|Completed||N/A|10|Actual|Nagasaki University|||1||f||||t||||||Samples With DNA|"     dmp-DNA   "|Yes||2017-10-10 22:24:44.474416|2017-10-10 22:24:44.474416
NCT02703129|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-03-03|||January 2010||2010-01-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Nutritional Intervention in Migraine|Nutritional Intervention Fin Migraine: A 12-week Open Study|Completed||N/A|52|Actual|Federal University of Minas Gerais||1|||f||||t||||||||||2017-10-10 22:24:44.560743|2017-10-10 22:24:44.560743
NCT02703116|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-10-18|||August 2016||2016-08-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Employing eSBI in HIV Testing for At-risk Youth|Employing eSBI in a Community-based HIV Testing Environment for At-risk Youth|Recruiting||N/A|450|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||Yes||2017-10-10 22:24:44.64027|2017-10-10 22:24:44.64027
NCT02703103|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-04-05|||February 2016||2016-02-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Chest Compression During Resuscitation|Use of a New Mechanical Chest Compression Machine LifeLine ARM for Cardiopulmonary Resuscitation by Paramedics: a Randomized, Crossover, Manikin Trial|Recruiting||N/A|50|Anticipated|Medical University of Warsaw||2|||f||||f||||||||Undecided||2017-10-10 22:24:44.750168|2017-10-10 22:24:44.750168
NCT02703090|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-07-12|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessing the Cortical Response to Noxious and Auditory Stimuli Using Near Infrared Spectroscopy in Subjects Under General Anesthesia|Assessing the Cortical Response to Noxious and Auditory Stimuli Using Near Infrared Spectroscopy in Subjects Under General Anesthesia|Recruiting||N/A|54|Anticipated|Boston Children’s Hospital||3|||f||||f||||||||||2017-10-10 22:24:44.866834|2017-10-10 22:24:44.866834
NCT02703064|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-09-14|||March 26, 2015|Actual|2015-03-26|August 2016|2016-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Furocyst - Poly Cystic Ovary Syndrome Study|To Study the Efficacy and Safety of Furocyst in Poly Cystic Ovary Syndrome Patients (PCOS)|Completed||N/A|107|Actual|Chemical Resources||1|||f||||f||||||||||2017-10-10 22:24:45.125651|2017-10-10 22:24:45.125651
NCT02703051|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-04-24|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects|A Phase 1, Open-Label Study to Evaluate the Pharmacodynamics, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects|Completed||Phase 1|54|Actual|GlycoMimetics Incorporated||3|||f||||f||||||||||2017-10-10 22:24:45.21654|2017-10-10 22:24:45.21654
NCT02703038|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-01-16|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|FRENSHOCK||French Observatory on the Management of Cardiogenic Shock in 2016|French Observatory on the Management of Cardiogenic Shock in 2016|Active, not recruiting||N/A|777|Actual|French Cardiology Society|||1||f||||f||||||||Undecided||2017-10-10 22:24:45.315443|2017-10-10 22:24:45.315443
NCT02703025|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-02-19|||September 2014||2014-09-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation of GCB-70 in Overweight Subjects|CLINICAL EVALUATION OF GCB-70 IN OVERWEIGHT SUBJECTS:An Add-On Study|Completed||N/A|105|Actual|Chemical Resources||1|||f||||f||||||||No||2017-10-10 22:24:45.402053|2017-10-10 22:24:45.402053
NCT02703012|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-10-25|||January 2016||2016-01-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|CLEAR||Clinical Application of Electrical Impedance Tomography for Individual Adjustment of Ventilator Settings|Pilot Clinical Study on Patient-Specific Adjustment of Ventilator Settings Using Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrome|Recruiting||N/A|20|Anticipated|University of Schleswig-Holstein||1|||f||||f||||||||Undecided||2017-10-10 22:24:45.477673|2017-10-10 22:24:45.477673
NCT02702999|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-11-21|||June 2016||2016-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|UP||Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial|Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial (UP Trial)|Recruiting||N/A|206|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-10-10 22:24:45.549094|2017-10-10 22:24:45.549094
NCT02702986|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-08-23|||February 2016||2016-02-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC)|Immunostimulating Interstitial Laser Thermotherapy in Patients With Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study|Recruiting||Phase 1|10|Anticipated|Universita di Verona||1|||f||||f||||||||||2017-10-10 22:24:45.636685|2017-10-10 22:24:45.636685
NCT02702973|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-08|||December 2015||2015-12-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|2 Years|Observational [Patient Registry]|CARI2b||Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy|Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy in Patients With Melanomas of the Skin|Recruiting||N/A|1|Anticipated|First Hospital of Jilin University|||1||f||||t||||||||Yes||2017-10-10 22:24:45.722177|2017-10-10 22:24:45.722177
NCT02702960|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-05-17|||March 2016||2016-03-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)|Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Fibrolamellar or Non-fibrolamellar Hepatocellular Carcinoma (HCC) Including Fibrolamellar HCC|Recruiting||Phase 2|6|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||Yes||2017-10-10 22:24:45.8153|2017-10-10 22:24:45.8153
NCT02702947|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-11-01|||March 2014||2014-03-01|May 2016|2016-05-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy of Prunus Domestica Extract in BPH|EFFICACY EVALUATION OF PRUNUS DOMESTICA EXTRACT ON BENIGN PROSTATE HYPERPLASIA (BPH): An Add on Study|Completed||Phase 4|160|Actual|Chemical Resources||1|||f||||f||||||||No||2017-10-10 22:24:45.939966|2017-10-10 22:24:45.939966
NCT02702934|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-08-09|||May 2015||2015-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Metabolic Effects of High-amylose Wheat-based Rusks.|Metabolic Effects of High-amylose Wheat-based Rusks in Healthy Subjects. A Pilot Study.|Completed||N/A|10|Actual|Federico II University||2|||f||||f||||||||||2017-10-10 22:24:46.013741|2017-10-10 22:24:46.013741
NCT02702921|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-05-30|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Powered Vascular Stapler in Video-Assisted Thoracoscopic (VAT) Lobectomies|A Prospective, Randomized, Controlled, Multi-Center Evaluation of a Powered Vascular Stapler in VAT Lobectomies|Completed||N/A|201|Actual|Ethicon Endo-Surgery||2|||f||||f||||||||No||2017-10-10 22:24:46.087102|2017-10-10 22:24:46.087102
NCT02702908|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-04|2017-08-24|||March 15, 2016|Actual|2016-03-15|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|BOCARP||Second Primary Cancers in Patients With Castration Resistant Prostate Cancer|Second Primary Cancers in Patients With Castration Resistant Prostate Cancer (BOCARP)|Active, not recruiting||N/A|6442|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:24:46.266158|2017-10-10 22:24:46.266158
NCT02702895|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-08-28|||June 2016||2016-06-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Assessment of ASPIRE and HOPE Adherence|Assessment of ASPIRE and HOPE Adherence|Recruiting||N/A|224|Anticipated|Microbicide Trials Network|||1||f||||f|f|f||||||||2017-10-10 22:24:46.344515|2017-10-10 22:24:46.344515
NCT02702882|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-09-14|||February 2014||2014-02-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||The Efficacy Study of FUROSAP: A Testosterone Booster Supplement In Humans.|Efficacy Evaluation of Furosap, a Testosterone Booster Supplement in Human Volunteers : An add-on Study|Completed||N/A|100|Actual|Chemical Resources||1|||f||||f||||||||||2017-10-10 22:24:46.465797|2017-10-10 22:24:46.465797
NCT02702869|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01|22 Years|Observational [Patient Registry]|||Prospective Data-collection System for the Comprehensive Appraisal of Cleft Care|Implementation of a Learning Health-care System at the Duke Cleft & Craniofacial Center to Enable Comprehensive Appraisal of Cleft Care for Outcomes Assessment, Comparative Effectiveness Research, and Quality Assurance and Improvement|Recruiting||N/A|1000|Anticipated|Duke University|||5||f||||t||||||||||2017-10-10 22:24:46.569449|2017-10-10 22:24:46.569449
NCT02702856|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-03|||May 2014||2014-05-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|||Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer|Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer|Completed||N/A|2000|Actual|Exosome Diagnostics, Inc.|||1||f||||f||||||Samples Without DNA|"     Prospectively collect approximately 25-40mL of random, non-DRE, non catheter urine, in a     standard, reduced size, clinical capture vessel.   "|Yes||2017-10-10 22:24:46.763527|2017-10-10 22:24:46.763527
NCT02702843|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-13|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Fluorescent Cholangiography vs White Light for Bile Ducts Identification|Efficacy Of Near Infrared Incisionless Fluorescent Cholangiography (NIFC) During Laparoscopic Cholecystectomy|Recruiting||N/A|1000|Anticipated|The Cleveland Clinic||2|||f||||t||||||||Yes|"Redcap will be used Data to be shared - pre-operative data including age, sex, laboratory values and imaging, intra-operative data including visualization of the extra-hepatic biliary structure with white light and with infrared light by the operating surgeon and the observer, any bile leak; post-operative data documenting any complications such as reaction to ICG or bile duct injury.
Data will be available as each center finishes up the follow of each individual patient (usually 2 weeks post operatively). Each center will update the data on Redcap on a monthly basis.
Data will be initially obtained on a pre-decided forms (approved by the IRB committee) and transferred to Redcap for electronic record keeping and analysis."|2017-10-10 22:24:46.853834|2017-10-10 22:24:46.853834
NCT02702830|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-08|||August 25, 2016|Actual|2016-08-25|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment|Understanding Exercise Intolerance After Treatment for Cancer|Recruiting||N/A|32|Anticipated|Wake Forest University Health Sciences|||1||f||||t|f|f||||||||2017-10-10 22:24:46.976456|2017-10-10 22:24:46.976456
NCT02702817|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-07-29|||August 1, 2012|Actual|2012-08-01|July 2017|2017-07-01|July 15, 2017|Actual|2017-07-15|March 31, 2017|Actual|2017-03-31||Interventional|||Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia|Investigations of Naproxen Treatment Effects in Pre-clinical Alzheimer's Disease (INTREPAD)|Completed||Phase 2|200|Actual|Douglas Mental Health University Institute||2|||f||||t||||||||||2017-10-10 22:24:47.071607|2017-10-10 22:24:47.071607
NCT02701881|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-07|||January 2016||2016-01-01|March 2016|2016-03-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|||Comparison of the PrimAry Long Versus Short Coverage With Drug-Eluting Stents for Long FemoRopopliteal Artery DiseasE (PARADE II): Investigator-initiated Clinical Study||Recruiting||Phase 4|220|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:24:55.135486|2017-10-10 22:24:55.135486
NCT02702804|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-05-12|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|HIIT-MS||High Intensity Interval Training for People With Mild Multiple Sclerosis: A Feasibility Study|High Intensity Interval Training for People With Mild Multiple Sclerosis: A Feasibility Study|Recruiting||N/A|12|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:24:47.168569|2017-10-10 22:24:47.168569
NCT02702791|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-03-03|||October 2015||2015-10-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|STEP||Sustaining Training Effects Through Physical Activity|Enhancing Physical Activity to Achieve Sustainable Benefits in Extrapulmonary Consequences of COPD|Recruiting||N/A|84|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-10 22:24:47.274954|2017-10-10 22:24:47.274954
NCT02702778|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-05-01|||February 2016||2016-02-01|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|December 31, 2016|Actual|2016-12-31||Interventional|||Delayed Release Prednisone in PMR|A Randomized, Open-label, Dose-ranging Study of Oral Delayed Release Prednisone in Patients With Untreated Polymyalgia Rheumatic (PMR)|Terminated||Phase 2|8|Actual|Dinora, Inc.||3||lack of study recruitment|f||||f||||||||No||2017-10-10 22:24:47.417454|2017-10-10 22:24:47.417454
NCT02702765|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-10-27|||February 2016||2016-02-01|October 2016|2016-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis|Macrophages and the Macrophage Activation Markers sCD163 and Mannose Receptor (sMR) in Patients With Wilsons Disease - Associations With Liver Disease Severity and Fibrosis|Recruiting||N/A|33|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-10-10 22:24:47.530839|2017-10-10 22:24:47.530839
NCT02702752|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2017-07-27|||November 2015||2015-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|DYNASDY||Dynamic Changes in SDF-1α Levels in Acute and Stabilized Heart Disease|Dynamic Changes in Stromal Cell-derived Factor-1α Levels in Acute and Stabilized Heart Disease - ACUTE MYOCARDIAL INFARCTION, ATRIAL FIBRILLATION, AND HEART FAILURE (THE DYNASDY STUDY)|Recruiting||N/A|80|Anticipated|Copenhagen University Hospital, Hvidovre||2|||f||||t||||||||||2017-10-10 22:24:47.63667|2017-10-10 22:24:47.63667
NCT02702739|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-08|||January 2015||2015-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|HCV||Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients|Efficacy and Safety of Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly Cirrhotic Patients: a Real Life Study|Completed||Phase 4|270|Actual|Azienda Ospedaliera San Camillo Forlanini||2|||f||||f||||||||No||2017-10-10 22:24:47.750575|2017-10-10 22:24:47.750575
NCT02702726|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-08-21|||January 12, 2016|Actual|2016-01-12|August 2017|2017-08-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|OFO||The Oil, Fats and Oleogel Study|The Oil, Fats and Oleogel (OFO) Study: Effects of Dietary Fats, Ingested in Two Physical Forms, on Acute Human Energy Balance, Appetitive and Glycemic Responses|Completed||N/A|16|Actual|Clinical Nutrition Research Centre, Singapore||5|||f||||f||||||||||2017-10-10 22:24:47.837291|2017-10-10 22:24:47.837291
NCT02702713|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-07-13|||February 2016||2016-02-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|PATHWAY-27||Pivotal Assessment of the Effects of Bioactive on Health and Wellbeing. From Human Genome to Food Industry|Investigation of the Effect of Daily Consumption of Bioactive Enriched Foods (BEF) on Biochemical and Anthropometric Markers of Metabolic Syndrome (MS)|Recruiting||Phase 2|800|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||4|||f||||t||||||||||2017-10-10 22:24:47.925404|2017-10-10 22:24:47.925404
NCT02702700|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-03-03|||January 2016||2016-01-01|February 2016|2016-02-01|June 2019|Anticipated|2019-06-01|December 2016|Anticipated|2016-12-01||Interventional|PDT-lipo||Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies|Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies: a Clinical Phase I Trial|Recruiting||Phase 1|20|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||t||||||||||2017-10-10 22:24:48.088254|2017-10-10 22:24:48.088254
NCT02702687|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-07-08|||May 2016||2016-05-01|July 2016|2016-07-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01||Interventional|CAPS||Childhood Asthma Perception Study|Childhood Asthma Perception Study|Recruiting||N/A|260|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||No||2017-10-10 22:24:48.205565|2017-10-10 22:24:48.205565
NCT02702674|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-03-03|||December 2015||2015-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of Coadministration of Oral Propranolol to Oxytocin on Induction of Labor|The Effect of Coadministration of Oral Propranolol to Oxytocin on Induction of Labor|Recruiting||Phase 3|242|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:24:48.310515|2017-10-10 22:24:48.310515
NCT02702661|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-10|||March 2013||2013-03-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|||PRCT of FICB vs LAI for Hip Arthroscopy|Fascia Iliaca Compartment Block and Local Anaesthetic Infiltration for Pain Control Following Hip Arthroscopic Surgery|Completed||N/A|46|Actual|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:24:48.393309|2017-10-10 22:24:48.393309
NCT02702648|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-07-26|||February 1, 2016||2016-02-01|July 2017|2017-07-01|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|||First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders|Single-center, Double-blind, Randomized, Placebo-controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including Food Effect), and Pharmacodynamics of an Oral Drug for Neurological Disorders in Healthy Subjects|Completed||Phase 1|128|Actual|Actelion||4|||f||||f||||||||||2017-10-10 22:24:48.479428|2017-10-10 22:24:48.479428
NCT02702635|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-08-14|||September 2015||2015-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging|Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging|Recruiting||N/A|50|Anticipated|Loma Linda University||1|||f||||f||||||||||2017-10-10 22:24:48.576651|2017-10-10 22:24:48.576651
NCT02702622|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-08-29|||March 2016||2016-03-01|August 2016|2016-08-01||||June 2016|Actual|2016-06-01||Interventional|||Vitamin A Equivalence of the Provitamin A in Biofortified Bananas||Completed||N/A|||Iowa State University|||||f||||||||||||||2017-10-10 22:24:48.685382|2017-10-10 22:24:48.685382
NCT02702609|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-06-21|||August 2, 2016|Actual|2016-08-02|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Assessment of Ridge Preservation Using Moldable Beta-tricalcium Phosphate Bone Grafting System|Prospective, Comparative Assessment of Alveolar Ridge Preservation Using GUIDOR® Easy-graft® Classic in Atraumatic Extraction Socket|Active, not recruiting||N/A|45|Actual|Sunstar Americas||2|||f||||f||||||||No||2017-10-10 22:24:48.745459|2017-10-10 22:24:48.745459
NCT02702596|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-05-01|||February 2016||2016-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||METRIC: Measurement, Education and Tracking in Integrated Care|METRIC: Measurement, Education and Tracking in Integrated Care: Strategies to Increase Patient Engagement and Reduce Mental Health Disparities Among Hispanics|Enrolling by invitation||N/A|150|Anticipated|The University of Texas at Arlington||2|||f||||f||||||||Undecided||2017-10-10 22:24:48.817672|2017-10-10 22:24:48.817672
NCT02702583|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-03|||December 2015||2015-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ORA-FEBRIS||The Oral Cavity as a Source of Febrile Neutropenia|The Oral Cavity as a Source of Febrile Neutropenia: An Observational Study in Cancer Patients Treated With Myelosuppressive Chemotherapy|Recruiting||N/A|200|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     Oral rinsing samples      Saliva samples   "|||2017-10-10 22:24:48.896434|2017-10-10 22:24:48.896434
NCT02702570|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-07|||May 2016||2016-05-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|CASA||Committed Actions for Successful Aging|Committed Actions for Successful Aging|Not yet recruiting||N/A|30|Anticipated|Mayo Clinic||1|||f||||f||||||||Undecided||2017-10-10 22:24:48.974451|2017-10-10 22:24:48.974451
NCT02702557|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-05-02|||February 2016||2016-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Unsupervised Elastic Band Exercises Performed by Frail Elderly Hospitalized Patients Monitored by the Bandcizer|Feasibility Study of Unsupervised Elastic Band Exercises Performed by Frail Elderly Hospitalized Patients Monitored by the Bandcizer as a Supplement to Usual Supervised Physiotherapy Sessions|Completed||N/A|15|Actual|Aalborg Universitetshospital||1|||f||||f||||||||||2017-10-10 22:24:49.04379|2017-10-10 22:24:49.04379
NCT02702544|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-08|||March 2016||2016-03-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Effect of Passive Leg Raising for Fluid Responsiveness|Effect of Passive Leg Rasing on Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal|Enrolling by invitation||N/A|80|Anticipated|Medical University of Warsaw||5|||f||||t||||||||||2017-10-10 22:24:49.121483|2017-10-10 22:24:49.121483
NCT02702531|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-10-18|||March 2016||2016-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Prospective, Randomized Comparison of the Use of FloShield Air System ® Versus the Referenced Technic (Water + Povidone-Iodine Solution) During Gynecologic Endoscopic Surgery to Evaluate the Operative Lens Vision Quality|Prospective, Randomized Comparison of the Use of FloShield Air System ® Versus the Referenced Technic (Water + Povidone-Iodine Solution) During Gynecologic Endoscopic Surgery to Evaluate the Operative Lens Vision Quality|Completed||Phase 4|100|Actual|Tenon Hospital, Paris||2|||f||||||||||||||2017-10-10 22:24:49.203385|2017-10-10 22:24:49.203385
NCT02702518|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-10-03|||April 2016||2016-04-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease|A Phase I/II Randomized Placebo-Controlled, Double-Blind, Single-Center, Tolerability and Preliminary Efficacy Clinical Trial of Recombinant Human Deoxyribonuclease (rhDNase) Eye Drops in Patients With Ocular Graft-Vs.-Host Disease|Recruiting||Phase 1/Phase 2|72|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||No||2017-10-10 22:24:49.284158|2017-10-10 22:24:49.284158
NCT02702505|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-07|||November 2014||2014-11-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MTA||Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT|Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT|Enrolling by invitation||Phase 4|50|Actual|Texas A & M University Baylor College Of Dentistry||2|||f||||f||||||||||2017-10-10 22:24:49.409947|2017-10-10 22:24:49.409947
NCT02702492|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-05-25|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|PANAMA||PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)|A Phase 1 Open-Label Study of the Safety, Tolerability and Efficacy of KPT-9274, a Dual Inhibitor of PAK4 and NAMPT, in Patients With Advanced Solid Malignancies or Non-Hodgkin's Lymphoma|Recruiting||Phase 1|175|Anticipated|Karyopharm Therapeutics Inc||2|||f||||f||||||||Yes||2017-10-10 22:24:49.650719|2017-10-10 22:24:49.650719
NCT02702479|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-05-14|||June 2014||2014-06-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk|Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk: A Series of Systematic Reviews and Meta-Analyses of Controlled Trials|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:24:49.778507|2017-10-10 22:24:49.778507
NCT02702466|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-07|||September 2015||2015-09-01|February 2016|2016-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|MUSKA||Active Prevention of Upper Limb Musculoskeletal Disorders in Thermal Environment (MUSKA).|Evaluation of the Effectiveness of Personalized Short and Intensive Educational SPA Therapy Prevention of Upper Limb Musculoskeletal Disorders (MSDs).|Recruiting||N/A|150|Anticipated|Association Francaise pour la Recherche Thermale||2|||f||||t||||||||Undecided||2017-10-10 22:24:49.887042|2017-10-10 22:24:49.887042
NCT02702453|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-06|||March 2016||2016-03-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners|True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners|Recruiting||N/A|250|Anticipated|University of Michigan||1|||f||||||||||||||2017-10-10 22:24:50.027171|2017-10-10 22:24:50.027171
NCT02702440|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-05-15|||May 2015||2015-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|||Meta-analyses of Liquid Versus Solid Calories and Body Weight|Effect of Liquid Versus Solid Calories on Body Weight: a Systematic Review and Meta-analysis of Controlled Feeding Trials|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:24:50.1131|2017-10-10 22:24:50.1131
NCT02702427|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-18|||June 2016||2016-06-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|April 2019|Anticipated|2019-04-01||Interventional|VISIT||Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation|Phase I/II: Treatment of Adenovirus and Cytomegalovirus Infection Post Human Allogeneic Stem Cell Transplantation With Short-term Expanded Virus-specific T Cells|Recruiting||Phase 1/Phase 2|30|Anticipated|St. Anna Kinderkrebsforschung||1|||f||||t||||||||No|not planned yet|2017-10-10 22:24:50.205795|2017-10-10 22:24:50.205795
NCT02702414|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-09-07|||May 31, 2016|Actual|2016-05-31|August 2017|2017-08-01|February 25, 2019|Anticipated|2019-02-25|August 24, 2017|Actual|2017-08-24||Interventional|||Study of Pembrolizumab (MK-3475) as Monotherapy in Adults With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)|A Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects With Previously Systemically Treated Advanced Hepatocellular Carcinoma (KEYNOTE-224)|Active, not recruiting||Phase 2|105|Actual|Merck Sharp & Dohme Corp.||1|||f||||t|t|f||||||||2017-10-10 22:24:50.303837|2017-10-10 22:24:50.303837
NCT02702388|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-05-16|||March 28, 2016|Actual|2016-03-28|May 2017|2017-05-01|October 30, 2020|Anticipated|2020-10-30|October 30, 2020|Anticipated|2020-10-30||Interventional|||A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile|A Multicenter, Randomized, Double-Blind Phase 2 Trial of Lenvatinib (E7080) in Subjects With 131I-Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24-mg Starting Dose, But Have a Better Safety Profile|Recruiting||Phase 2|161|Anticipated|Eisai Inc.||2|||f||||f||||||||||2017-10-10 22:24:50.714679|2017-10-10 22:24:50.714679
NCT02702375|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-08-22|||September 2015||2015-09-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases|Relation of Important Food Sources of Sugars With Incident Cardiometabolic Disease: A Series of Systematic Reviews and Meta-analyses to Inform Guidelines, Public Health Policy, and Future Research Design|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:24:51.004972|2017-10-10 22:24:51.004972
NCT02702362|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-07|||December 2014||2014-12-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||tDCS on Precuneus in MCS: Repeated Stimulations|Repeated Stimulation of the Precuneus in Chronic Patients in Minimally Conscious State: a Placebo-controlled Randomized Clinical Trial|Completed||Phase 2|33|Actual|Hangzhou Normal University||2|||f||||t||||||||||2017-10-10 22:24:51.118993|2017-10-10 22:24:51.118993
NCT02702349|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-07|||April 2016||2016-04-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||The Frequency of Positive Challenge Test to Penicillin in Children Suspected to Have Allergy to Penicillin|The Frequency of Positive Challenge Test to Penicillin in Children Suspected to Have Allergy to Penicillin|Not yet recruiting||N/A|200|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||No||2017-10-10 22:24:51.199186|2017-10-10 22:24:51.199186
NCT02702336|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-06-26|||March 2016||2016-03-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|EYTO-kids||EYTO-kids-Pilot: European Youth Tackling Obesity in Adolescents and Children.|EYTO-kids: European Youth Tackling Obesity in Adolescents and Children, Una intervención Para Mejorar Los Estilos de Vida (Estudio Piloto)|Completed||N/A|810|Actual|University Rovira i Virgili||2|||f||||f||||||||Undecided|Undecided|2017-10-10 22:24:51.278412|2017-10-10 22:24:51.278412
NCT02702323|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-03-02|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study|Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Zhejiang Cancer Hospital||2|||f||||f||||||||||2017-10-10 22:24:51.36139|2017-10-10 22:24:51.36139
NCT02702310|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-11-01|||April 2016||2016-04-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|||Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides|Prospective Observational Trial of Low-Dose Total Skin Electron Therapy in Mycosis Fungoides Using Rotisserie Technique|Recruiting||N/A|30|Anticipated|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-10-10 22:24:51.467508|2017-10-10 22:24:51.467508
NCT02702297|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-02-28|||January 2016||2016-01-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Observational|MuMFI-PPROM||Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes|Multimodales Monitoring Des Fetalen Inflammationsrisikos Bei frühem Vorzeitigen Blasensprung (PPROM)|Recruiting||N/A|60|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||1||f||||f||||||Samples Without DNA|"     Vaginal Fluid   "|||2017-10-10 22:24:51.588982|2017-10-10 22:24:51.588982
NCT02702284|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-06-16|||June 5, 2017|Actual|2017-06-05|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Advance Directives Completion Rates and an Intervention to Address Health Literacy in a Clinic Population|Advance Directives Completion Rates and an Intervention to Address Health Literacy in a Clinic Population|Recruiting||N/A|480|Anticipated|University of Florida||4|||f||||f|f|f||||||No||2017-10-10 22:24:51.704382|2017-10-10 22:24:51.704382
NCT02702271|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-04-11|||July 2018|Anticipated|2018-07-01|March 2016|2016-03-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|PINNACLE FLX||Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology|Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology|Withdrawn||N/A|0|Actual|Boston Scientific Corporation||1||Trial redesign|f||||t||||||||||2017-10-10 22:24:51.817125|2017-10-10 22:24:51.817125
NCT02702258|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-24|||February 2016||2016-02-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MB-BP||Mindfulness-Based Blood Pressure Reduction (MB-BP) Intervention Development|Mindfulness-Based Blood Pressure Reduction (MB-BP) Intervention Development: Effects on Self-Regulation Targets, Including Self Awareness, Emotion Regulation and Attention Control|Active, not recruiting||N/A|48|Actual|Brown University||1|||f||||t||||||||||2017-10-10 22:24:51.880296|2017-10-10 22:24:51.880296
NCT02702245|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-05-12|||January 2014||2014-01-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Two Doses of Thylakoids on OGTT|Thylakoids' Effect on Glucose Homeostasis and Appetite Regulation After an Oral Glucose Tolerance Test in Healthy Volunteers|Completed||N/A|21|Actual|Region Skane||3|||f||||f||||||||No||2017-10-10 22:24:51.960041|2017-10-10 22:24:51.960041
NCT02702219|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-09-22|||March 2016||2016-03-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Effect of Flexibility Training Versus Static Stretching on Hamstring Muscle Length and Patterns of Lumbar Flexion|Effect of Dynamic Flexibility Training Versus Prolonged Static Stretching on Length of the Hamstrings Muscles and Patterns of Lumbar Flexion in Healthy Adults -a Randomized Controlled Trial|Active, not recruiting||Phase 2|52|Actual|Luleå Tekniska Universitet||2|||f||||f||||||||No||2017-10-10 22:24:52.126344|2017-10-10 22:24:52.126344
NCT02702206|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-01-04|||August 2014||2014-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Ultrasound-guided Hyaluronic or Corticosteroid Injections in Patients With Chronic Subacromial Bursitis|Effect of Ultrasound-guided Hyaluronic or Corticosteroid Injections in Patients With Chronic Subacromial Bursitis|Completed||N/A|207|Actual|Shin Kong Wu Ho-Su Memorial Hospital||3|||f||||t||||||||||2017-10-10 22:24:52.194803|2017-10-10 22:24:52.194803
NCT02702193|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-03-14|||July 2013||2013-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SET-R||SET-Recovery/Healthy Home|Set-Enhanced Aftercare for Mothers in Substance Abuse Recovery and Their Children|Active, not recruiting||N/A|172|Anticipated|University of Miami||2|||f||||f||||||||Yes|The researcher will abide by NIH standards for sharing research resources developed through the study. Data will be made available no later than the date when the main findings are published. Upon request, electronic copies will be provided to researchers, along with data documentation. Data will not contain any personal identifiers. Researchers using these data will be asked to sign a data sharing agreement approved by the University of Miami. The primary purpose of this agreement will be to ensure that researchers using the dataset are aware of the potential risks to vulnerable groups, and take adequate protective steps.|2017-10-10 22:24:52.294342|2017-10-10 22:24:52.294342
NCT02702167|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-02|||March 2016||2016-03-01|March 2016|2016-03-01||||March 2018|Anticipated|2018-03-01||Interventional|||High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Bulimia and Anorexia Nervosa|A Randomized Sham-Controlled Study of High- and Low-frequency Repetitive Transcranial Magnetic Stimulation of the Dorsomedial Prefrontal Cortex in Bulimia and Anorexia Nervosa|Recruiting||N/A|240|Anticipated|University Health Network, Toronto||3|||f||||f||||||||Undecided||2017-10-10 22:24:52.606792|2017-10-10 22:24:52.606792
NCT02702154|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-02|||February 2016||2016-02-01|March 2016|2016-03-01||||February 2018|Anticipated|2018-02-01||Interventional|||High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Major Depression|A Randomized Sham-Controlled Study of High- and Low-frequency Repetitive Transcranial Magnetic Stimulation of the Dorsomedial Prefrontal Cortex in Major Depressive Disorder|Recruiting||N/A|240|Anticipated|University Health Network, Toronto||3|||f||||f||||||||Undecided||2017-10-10 22:24:52.708341|2017-10-10 22:24:52.708341
NCT02702141|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-09-28|||February 2016||2016-02-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma|A Phase 1, Open-label, Dose-escalation Study of SGN-CD19B in Patients With Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma|Recruiting||Phase 1|100|Anticipated|Seattle Genetics, Inc.||1|||f||||t||||||||||2017-10-10 22:24:52.808257|2017-10-10 22:24:52.808257
NCT02702128|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-05-18|||January 3, 2016|Actual|2016-01-03|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|LEFORTEXACYL||Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery|Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery|Recruiting||Phase 3|140|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||Undecided||2017-10-10 22:24:52.936189|2017-10-10 22:24:52.936189
NCT02702115|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-25|||May 24, 2017|Actual|2017-05-24|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I|A Phase I, Multicenter, Open-label, Single-dose, Dose-ranging Study to Assess the Safety and Tolerability of SB-318, a rAAV2/6-based Gene Transfer in Subjects With Mucopolysaccharidosis I (MPS I)|Recruiting||Phase 1|9|Anticipated|Sangamo Therapeutics||3|||f||||t|t|f||||||||2017-10-10 22:24:53.028861|2017-10-10 22:24:53.028861
NCT02702102|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-12-07|||December 2015||2015-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies|Imaging Inflammation in Patients With Diffuse Lewy Body Disease|Recruiting||Phase 2|16|Anticipated|Columbia University||1|||f||||f||||||||No||2017-10-10 22:24:53.123265|2017-10-10 22:24:53.123265
NCT02702089|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2016-03-03|||March 2016||2016-03-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|HiP||Hartmann's Versus Intersphincetric APE: A Prospective, Multicentre Study|Hartmann's Versus Intersphincetric APE: A Prospective, Multicentre Study|Not yet recruiting||N/A|200|Anticipated|Countess of Chester NHS Foundation Trust|||2||f||||f||||||||No||2017-10-10 22:24:53.345125|2017-10-10 22:24:53.345125
NCT02702076|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-05-01|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Apomorphine in Parkinson's Disease Patients With Visual Hallucinations|Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Continuous Subcutaneous Infusion in Parkinson's Disease Patients With Refractory Visual Hallucinations|Recruiting||Phase 2|35|Anticipated|University Medical Center Groningen||2|||f||||f|f|f|||f|||No||2017-10-10 22:24:53.436808|2017-10-10 22:24:53.436808
NCT02702063|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-02|||October 2015||2015-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|EC vs TTE||Calibrating Cardiac Output Measurement of Electrical Cardiometry With Transthoracic Echocardiography||Recruiting||N/A|75|Anticipated|Medical University of Vienna||3|||f||||f||||||||No||2017-10-10 22:24:53.589484|2017-10-10 22:24:53.589484
NCT02702050|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-09-27|||March 2016||2016-03-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Mechanical Stimulation on Mastectomy Scars|A Prospective Randomized Clinical Trial to Investigate the Effect of Mechanical Stimulation on Mastectomy Scars|Recruiting||N/A|108|Anticipated|The Queen Elizabeth Hospital||2|||f||||f||||||||No||2017-10-10 22:24:53.709198|2017-10-10 22:24:53.709198
NCT02702037|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-03-18|||March 1, 2016||2016-03-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|OPEN||Older Person's Exercise and Nutrition Study|Older Person's Exercise and Nutrition Study (OPEN): a Simple Physical Exercise Combined With Protein Supplement - Effects on Functional Status and Independence Among Older People: A Cluster Randomised Controlled Trial|Recruiting||N/A|120|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||Undecided||2017-10-10 22:24:53.821717|2017-10-10 22:24:53.821717
NCT02702024|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-02|||January 2014||2014-01-01|March 2016|2016-03-01||||January 2016|Actual|2016-01-01||Interventional|||The Effectiveness of Double Incision Technique in Uterus Preserving Surgery for Placenta Percreta||Completed||N/A|||Kanuni Sultan Suleyman Training and Research Hospital|||||f||||||||||||Yes||2017-10-10 22:24:53.954844|2017-10-10 22:24:53.954844
NCT02701998|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-03-21|||November 2015||2015-11-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|StEP||The Stroke and Exercise Program|Development and Pilot Testing of a Scalable mHealth Intervention to Promote Physical Activity in TIA and Stroke Survivors|Recruiting||N/A|70|Anticipated|The Miriam Hospital||2|||f||||t||||||||No||2017-10-10 22:24:54.161433|2017-10-10 22:24:54.161433
NCT02701985|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-03|2017-07-26|||July 5, 2016|Actual|2016-07-05|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|June 23, 2017|Actual|2017-06-23||Interventional|||A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2A Study to Assess the Efficacy of RO5459072 in Patients With Primary Sjogren's Syndrome|Completed||Phase 2|75|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:24:54.29261|2017-10-10 22:24:54.29261
NCT02701972|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-03|||March 2016||2016-03-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|BACE||Evaluation of Safety and Efficacy of the BACE™ Device in the Treatment of Functional Mitral Valve Regurgitation [FMR|Evaluation of Safety and Efficacy of the Basal Annuloplasty of the Cardia Externally (BACE™) [Basal Annuloplasty of the Cardia Externally] Device in the Treatment of Functional Mitral Valve Regurgitation [FMR]|Enrolling by invitation||Phase 1|60|Anticipated|Phoenix Cardiac Devices, Inc.||1|||f||||t||||||||No||2017-10-10 22:24:54.461588|2017-10-10 22:24:54.461588
NCT02701959|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-05-20|||April 2015||2015-04-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|LBP||Effect of Lettuce With Different Nitrate Contents on Blood Pressure|Growth of Lettuce With Different Content of Inorganic Nitrate as a Feeding Strategy for Placebo-controlled Nutritional Interventions to Test the Effects of Inorganic Nitrate on Human Health|Completed||Phase 1/Phase 2|20|Actual|Newcastle University||2|||f||||t||||||||No|I can't share the individual participants data because of the privacy of volunteers have been participated in this study and this already been mentioned in the application form of ethical approval.|2017-10-10 22:24:54.54255|2017-10-10 22:24:54.54255
NCT02701946|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2017-05-29|||March 2016||2016-03-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy of Modified Robert Jones Bandages on Reducing Invisible Blood Loss After Total Knee Arthroplasty|Efficacy of Modified Robert Jones Bandages on Reducing Invisible Blood Loss After Total Knee Arthroplasty: A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Mahidol University||2|||f||||f||||||||No||2017-10-10 22:24:54.630721|2017-10-10 22:24:54.630721
NCT02701933|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-02|||April 2014||2014-04-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Ketamine on Eye Movements, Perception and Brain Function|Effects of Ketamine on Eye Movements, Perception and Brain Function|Completed||N/A|24|Actual|University of Bonn||2|||f||||f||||||||No||2017-10-10 22:24:54.723577|2017-10-10 22:24:54.723577
NCT02701920|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-09-28|||March 2016||2016-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|HeartLight||HeartLight: Heart Rate Monitoring for Newborn Resuscitation|HeartLight: Heart Rate Monitoring for Newborn Resuscitation|Recruiting||N/A|184|Anticipated|University of Nottingham|||6||f||||f||||||||Yes||2017-10-10 22:24:54.832018|2017-10-10 22:24:54.832018
NCT02701907|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-02-09|||February 2016||2016-02-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|EXPRESS||EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies|Low Level of Genomic Alteration to Predict Exceptional and Unexpected Response to Targeted Therapies in Patients With Solid Tumors|Recruiting||N/A|264|Anticipated|UNICANCER||6|||f||||f||||||||No||2017-10-10 22:24:54.960003|2017-10-10 22:24:54.960003
NCT02701894|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-02|||December 2012||2012-12-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||ALA on Glycemic Control in T2DM Participants|The Effect of Alpha-Linolenic Acid on Glycemic Control in Participants With Type 2 Diabetes|Active, not recruiting||N/A|200|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-10 22:24:55.066254|2017-10-10 22:24:55.066254
NCT02701855|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-03-02|||October 2014||2014-10-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|EYEBRAIN||Retina Microvascular Remodeling and Cognitive Function In Hypertension|Retina Microvascular Remodeling and Cognitive Function In Hypertension : Eyebrain|Recruiting||N/A|160|Anticipated|Institute of Cardiometabolism and Nutrition, France|||3||f||||f||||||||||2017-10-10 22:24:55.296628|2017-10-10 22:24:55.296628
NCT02701842|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2017-08-22|||February 2016||2016-02-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||ImPACT Online Clinical Study|ImPACT Online Clinical Study|Completed||N/A|400|Actual|ImPACT Applications, Inc.||2|||f||||f||||||||||2017-10-10 22:24:55.406949|2017-10-10 22:24:55.406949
NCT02701816|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-07|||January 2016||2016-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Korean Multicenter Registry of INNOVA Stent for Femoropopliteal Artery Disease: (K-INNOVA Registry)||Recruiting||N/A|150|Anticipated|Yonsei University|||1||f||||f||||||||No||2017-10-10 22:24:55.573606|2017-10-10 22:24:55.573606
NCT02701803|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-03-02|||October 2015||2015-10-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Parkinson's KinetiGraph, PKG in Patients With Deep Brain Stimulation and Continuous Levodopa Infusion Therapy|Ambulatory Movement Registration in Patients With Deep Brain Stimulation and Continuous Intraduodenal Levodopa Therapy|Recruiting||N/A|30|Anticipated|Hospital District of Helsinki and Uusimaa|||1||f||||t||||||||No||2017-10-10 22:24:55.678329|2017-10-10 22:24:55.678329
NCT02701777|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-09|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Enhancing STDP After Spinal Cord Injury|Maximizing Spike - Timing Dependent Plasticity After Spinal Cord Injury|Not yet recruiting||Phase 4|500|Anticipated|VA Office of Research and Development||7|||f||||f|t|t|f|f|f|||Undecided||2017-10-10 22:24:55.781888|2017-10-10 22:24:55.781888
NCT02701764|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-09-25|||July 26, 2016|Actual|2016-07-26|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?|Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?|Recruiting||Phase 2/Phase 3|100|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 22:24:55.931792|2017-10-10 22:24:55.931792
NCT02701751|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|ATX||Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)|Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)|Recruiting||N/A|60|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-10 22:24:56.052107|2017-10-10 22:24:56.052107
NCT02701725|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-03-08|||March 2016||2016-03-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Observational|CRIHEM||Compensatory Reserve Index as a Hemodynamic Status Evaluation Tool in Patients|Compensatory Reserve Index as a Hemodynamic Status Evaluation Tool in Patients|Not yet recruiting||N/A|600|Anticipated|Meir Medical Center|||1||f||||t||||||||No||2017-10-10 22:24:56.214432|2017-10-10 22:24:56.214432
NCT02701712|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-10-31|||February 2016||2016-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MRgRT||Receiving Radiation Therapy in the MRgRT Research Facility|Receiving Radiation Therapy in the MRgRT Research Facility|Recruiting||N/A|150|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:24:56.308234|2017-10-10 22:24:56.308234
NCT02701699|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-10-31|||December 2014||2014-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer|A Feasibility Study of Hypoxia Imaging in Patients With Lung Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)|Recruiting||N/A|20|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:24:56.390692|2017-10-10 22:24:56.390692
NCT02701686|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-04-26|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||A Comparison of the Effectiveness of Two Approaches in Achieving Smoking Abstinence|A Comparison of the Effectiveness of Two Approaches (Quit Immediately: QI and Cut Down to Quit: CDTQ) in Achieving Smoking Abstinence Among Patients Having Follow-up in a GOPC: A Pilot Randomized Controlled Trial|Completed||N/A|100|Actual|The University of Hong Kong||2|||f||||f||||||||Undecided||2017-10-10 22:24:56.489135|2017-10-10 22:24:56.489135
NCT02701673|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-05-03|||June 2016||2016-06-01|May 2016|2016-05-01||||June 2019|Anticipated|2019-06-01||Interventional|||Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma|Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:24:56.574557|2017-10-10 22:24:56.574557
NCT02701660|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-04-13|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|July 2016|Actual|2016-07-01||Interventional|APPOSTEL||Adherence to Polypharmacy in Patients With Opioid Substitution Therapy Using Electronics|Remote-controlled Dispensing of Medication and Electronic Monitoring of Adherence in Ambulatory Patients With Opioid Dependency Syndrome and Polypharmacy - a Feasibility Trial|Active, not recruiting||N/A|5|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-10-10 22:24:56.687027|2017-10-10 22:24:56.687027
NCT02701114|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-07-11|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Proximal Versus Distal Adductor Canal Blocks for Total Knee Arthroplasty|A Comparison of Proximal Versus Distal Continuous Adductor Canal Blocks After Total Knee Arthroplasty|Completed||N/A|76|Actual|Benaroya Research Institute||2|||f||||t||||||||||2017-10-10 22:25:05.015876|2017-10-10 22:25:05.015876
NCT02701647|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-08-13|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of Combined rTMS and Treadmill Training on Walking in PD|Effects of Combined Repetitive Transcranial Magnetic Stimulation and Treadmill Training on Gait Performance in Parkinson's Disease: A Randomised Controlled Trial|Active, not recruiting||N/A|51|Actual|The Hong Kong Polytechnic University||3|||f||||f||||||||||2017-10-10 22:24:56.784547|2017-10-10 22:24:56.784547
NCT02701634|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-18|||May 27, 2016|Actual|2016-05-27|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Entospletinib, a Selective SYK Inhibitor, in Combination With Systemic Corticosteroids as First-Line Therapy in Subjects With Chronic Graft Versus Host Disease (cGVHD)|Recruiting||Phase 2|100|Anticipated|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 22:24:56.877146|2017-10-10 22:24:56.877146
NCT02701621|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-07|||September 2014||2014-09-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Aquatic Therapy Versus Land-Based Therapy for the Treatment of Balance Dysfunction in Parkinson's Disease|Aquatic Therapy Versus Land-Based Therapy for the Treatment of Balance Dysfunction in Parkinson's Disease: a Randomized, Controlled Study With 6-months Follow-up|Completed||N/A|34|Actual|Ospedale Generale Di Zona Moriggia-Pelascini||2|||f||||f||||||||No||2017-10-10 22:24:58.833755|2017-10-10 22:24:58.833755
NCT02701608|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-02-23|||March 2016||2016-03-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus|Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)|Recruiting||Phase 3|324|Anticipated|University Hospital, Tours||2|||f||||t||||||||No|there is no plan to share data|2017-10-10 22:24:58.929927|2017-10-10 22:24:58.929927
NCT02701595|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-02-23|||March 2016||2016-03-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus|Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)|Recruiting||Phase 3|324|Anticipated|University Hospital, Tours||2|||f||||t||||||||||2017-10-10 22:24:59.270171|2017-10-10 22:24:59.270171
NCT02701569|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-10-26|||July 2014||2014-07-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Rebound Exercise in Individuals With Type 2 Diabetes|Effect of Rebound Therapy on Metabolic Outcomes and Quality of Life in Nigerian Patients With Type 2 Diabetes|Completed||N/A|60|Actual|University of KwaZulu||2|||f||||f||||||||No|Data would not be shared|2017-10-10 22:24:59.78546|2017-10-10 22:24:59.78546
NCT02701556|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-05-30|2017-04-25||May 2015||2015-05-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Safety and Effectiveness Study of a New Contact Lens Cleaning and Disinfecting Solution|A Safety and Effectiveness Study of a New Contact Lens Cleaning and Disinfecting Solution|Completed||N/A|396|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-10 22:24:59.871782|2017-10-10 22:24:59.871782
NCT02701543|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-02-10|||October 2015||2015-10-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease|Prospective, Randomized, Multi-Center Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease With the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)|Recruiting||N/A|414|Anticipated|University of Leipzig||2|||f||||t||||||||Yes||2017-10-10 22:25:00.115155|2017-10-10 22:25:00.115155
NCT02701530|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-14|||August 2013||2013-08-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|RESPEKT||Smoking Cessation for Hospital Employees With Low Education.|Smoking Cessation for Hospital Employees With Low Education in the Capital Region of Denmark. The RESPEKT Study.|Completed||N/A|7003|Actual|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||Yes|Will be stored in safe database at Research Center for Prevention and Health|2017-10-10 22:25:00.208517|2017-10-10 22:25:00.208517
NCT02701517|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-03-02|||September 2003||2003-09-01|March 2016|2016-03-01||||November 2009|Actual|2009-11-01||Interventional|||Cyclosporine Plus Methotrexate or Alemtuzumab|Randomized Trial of Cyclosporine + CAMPATH-1H (ALEMTUZUMAB) vs. Cyclosporine + METHOTREXATE in Patients Diagnosed With Mature B-cell Neoplasms - Chronic Lymphocytic Leukemia and Low-grade Lymphomas - Receiving Allogeneic Hematopoietic Stem Cell Transplantation With Nonmyeloablative Conditioning Regimen|Suspended||Phase 2|72|Anticipated|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||2||"The trial was stopped before the targeted number of patients was reached due to lack of   support."|f||||f||||||||||2017-10-10 22:25:00.288373|2017-10-10 22:25:00.288373
NCT02701504|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-10-28|||October 2013||2013-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|SABOT||Undiagnosed Sleep Apnea and Bypass OperaTion|Association Between Sleep Apnea and Occurrence of Major Adverse Cardiovascular Events After Coronary Artery Bypass Grafting|Recruiting||N/A|800|Anticipated|National University, Singapore|||2||f||||f||||||||No||2017-10-10 22:25:00.397338|2017-10-10 22:25:00.397338
NCT02701491|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-02|||February 2016||2016-02-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of Ginger on Nausea and Vomiting During Acute Gastroenteritis in Children|Effect of Ginger on Nausea and Vomiting Related to Acute Gastroenteritis in Pediatric Age|Recruiting||Phase 1/Phase 2|150|Anticipated|Federico II University||2|||f||||f||||||||No||2017-10-10 22:25:00.487382|2017-10-10 22:25:00.487382
NCT02701478|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-11-16|||January 2016||2016-01-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||ANI and NoL Index Variations After Standard Nociceptive Stimulus at 0, 50, 25 % of Inhaled N2O in the Anesthetic Mixture|Assessment of the Intraoperative Analgesic Effect of 50%/50% N2O/O2 Inhalation by the Pain Index ANI Following a Standardized Electrical Stimulus in Patients Under Anesthesia. Comparison to the New NoL Analgesic Index.|Recruiting||Phase 4|40|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||No||2017-10-10 22:25:00.569302|2017-10-10 22:25:00.569302
NCT02701465|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-09-12|||January 2, 2016|Actual|2016-01-02|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Blood Flow - an Underlying Mechanism Behind Clinical Improvements in Patients With Subacromial Pain Syndrome?|Blood Flow - an Underlying Mechanism Behind Clinical Improvements in Patients With Subacromial Pain Syndrome?|Recruiting||N/A|24|Anticipated|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 22:25:00.65648|2017-10-10 22:25:00.65648
NCT02701452|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-22|||February 26, 2016|Actual|2016-02-26|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|COAGO||Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response|Prevalence of Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response After Ovarian Stimulation With a GnRH Antagonist|Recruiting||N/A|75|Anticipated|University Hospital, Lille||1|||f||||f||||||||||2017-10-10 22:25:00.753583|2017-10-10 22:25:00.753583
NCT02701439|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2016-03-02|||September 2012||2012-09-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|PTB||SMF to Improve Performance of Microscopy for the Diagnosis of PTB in a High HIV Prevalence Setting|Small Membrane Filtration (SMF) Method to Improve the Performance of Smear Microscopy for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting|Completed||N/A|1050|Actual|Epicentre|||2||f||||t||||||Samples With DNA|"     TB isolates from sputum samples   "|No||2017-10-10 22:25:00.841953|2017-10-10 22:25:00.841953
NCT02701426|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-22|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|OGAN||Obesity & Pregnancy: Factors Influencing Participation in a Physical Activity and Nutritional Counseling Program|Obesity and Pregnancy : Study of Factors Influencing Participation in a Program Combining Physical Activity and Nutritional Counseling|Recruiting||N/A|375|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 22:25:00.922853|2017-10-10 22:25:00.922853
NCT02701413|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-02-14|||March 2016||2016-03-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|VESPR||Vaginal Electrical Stimulation for Postpartum Neuromuscular Recovery|Vaginal Electrical Stimulation for Postpartum Neuromuscular Recovery|Recruiting||N/A|100|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 22:25:01.145489|2017-10-10 22:25:01.145489
NCT02701400|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-12-13|||April 2016||2016-04-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer|A Randomized Study of Tremelimumab Plus Durvalumab Combination With or Without Radiation in Relapsed Small Cell Lung Cancer|Recruiting||Phase 2|20|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 22:25:01.269404|2017-10-10 22:25:01.269404
NCT02701387|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-11-01|2016-11-01||August 2014||2014-08-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Patients presenting to the study site in need of at least two dental implants received one of each implant type: Easy (EZ) Plus and AnyRidge (AR).|Effect of Implant Thread Design on Implant Stability Quotient (ISQ) in Early Healing Period|The Effect of Implant Macro-Thread Design on Implant Stability in the Early Post-Operative Period: A Randomized, Controlled Pilot Study|Completed||N/A|7|Actual|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 22:25:01.402312|2017-10-10 22:25:01.402312
NCT02701374|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-21|||March 2016||2016-03-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia|TRK-700 An Early Phase II Study in Patients With Post-Herpetic Neuralgia —Double Blind Comparison With Placebo—|Completed||Phase 2|184|Actual|Toray Industries, Inc||3|||f||||f||||||||||2017-10-10 22:25:01.642272|2017-10-10 22:25:01.642272
NCT02701361|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-07-31|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|July 5, 2017|Actual|2017-07-05|May 1, 2017|Actual|2017-05-01||Interventional|||Mobile Mindfulness to Improve Psychological Distress After Critical Illness|Mobile Mindfulness to Improve Psychological Distress After Critical Illness|Completed||N/A|90|Actual|Duke University||3|||f||||t||||||||||2017-10-10 22:25:01.72179|2017-10-10 22:25:01.72179
NCT02701348|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-11-02|||May 2016||2016-05-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|May 2018|Anticipated|2018-05-01||Interventional|BARONET||Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers|Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers|Recruiting||N/A|40|Anticipated|NHS Tayside||1|||f||||t||||||||No|No individual data sharing|2017-10-10 22:25:01.884236|2017-10-10 22:25:01.884236
NCT02701335|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-08-25|||July 2016||2016-07-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Manual Therapy for Hand Osteoarthritis|Neural Manual vs. Robotic Assisted Mobilization to Improve Hand Range of Motion and Reduce Pain Hypersensitivity in Hand Osteoarthritis: a Randomized Controlled Trial|Enrolling by invitation||N/A|72|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||No||2017-10-10 22:25:02.038847|2017-10-10 22:25:02.038847
NCT02701322|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-07|||March 2016||2016-03-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Influence of Medical Clowning in Videofluoroscopic Examination of Pediatric Speech Disorder|Influence of Medical Clowning in Videofluoroscopic Examination of Pediatric Speech Disorder|Not yet recruiting||N/A|60|Anticipated|Meir Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:25:02.153856|2017-10-10 22:25:02.153856
NCT02701101|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-04-19|||April 2016||2016-04-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of the SEM Scanner 200 for the Detection of Early Pressure Ulcers: A Multi-Site Longitudinal Study|Evaluation of the SEM Scanner 200 for the Detection of Early Pressure Ulcers: A Multi-Site Longitudinal Study|Completed||N/A|189|Actual|Bruin Biometrics, LLC||2|||f||||f||||||||No||2017-10-10 22:25:05.10904|2017-10-10 22:25:05.10904
NCT02701309|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-09-07|||April 2016||2016-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|IronKids||Non-invasive Optical Detection of Iron Deficiency in Children|Non-invasive Optical Detection of Iron Deficiency in Children- Evaluation of a Fiber Optic Tissue Fluorescence Measurement to Determine the Erythrocyte Zinc Protoporphyrin-IX/Heme Ratio|Completed||N/A|100|Actual|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||Undecided|The principal investigator (PI, Prof. Dr. Dr. B. Koletzko) has access to the study data. The data may be shared with other researchers for specific research purposes if a written request with detailed description of objectives and goals, workplan and statistical analysis plan, strategy to protect data from other uses, publication strategy, and description of the research team and its qualification is provided. Based on the evaluation of proposals, the PI and study team will decided on a case by case basis which data can be provided.|2017-10-10 22:25:02.282807|2017-10-10 22:25:02.282807
NCT02701296|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-05-19|2017-05-19||January 2012||2012-01-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty|Assessment of Knee Pain in Patients Receiving Continuous Femoral Nerve Block Combined With Either Ultrasound Guided Posterior Capsular Injection or Selective Tibial Nerve Block Following Total Knee Arthroplasty|Completed||N/A|80|Actual|Saint Francis Care||2|||f||||f||||||||No||2017-10-10 22:25:02.413313|2017-10-10 22:25:02.413313
NCT02701283|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-04-24|||March 2016||2016-03-01|April 2017|2017-04-01|March 2026|Anticipated|2026-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients|Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement|Recruiting||N/A|1200|Anticipated|Medtronic Cardiovascular||2|||f||||t||||||||||2017-10-10 22:25:02.904548|2017-10-10 22:25:02.904548
NCT02701270|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-06-16|2016-04-12||September 2015||2015-09-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Three Fibres on Glycaemic and Insulinaemic Responses in Healthy Adult Volunteers|Randomised, Single-blinded, Controlled, Crossover and Acute Clinical Intervention to Assess the Effect of Three Fibres on Glycaemic and Insulinaemic Responses in Healthy Adult Volunteers|Completed||N/A|13|Actual|Danisco||4|||f||||f||||||||No||2017-10-10 22:25:03.208848|2017-10-10 22:25:03.208848
NCT02701257|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-29|||March 2016||2016-03-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas|The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas|Suspended||N/A|40|Anticipated|Massachusetts General Hospital||5|||f||||t||t|t|||||||2017-10-10 22:25:03.524666|2017-10-10 22:25:03.524666
NCT02701244|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-03-20|||July 2016||2016-07-01|March 2017|2017-03-01|July 2026|Anticipated|2026-07-01|July 2021|Anticipated|2021-07-01|10 Years|Observational [Patient Registry]|||A Registry Study of Breast Microseed Treatment|A Multicenter Registry Study of Breast Microseed Treatment for Early Stage Breast Cancer|Recruiting||N/A|420|Anticipated|Concure Oncology-Breast Microseed Inc.|||1||f||||t||||||||No||2017-10-10 22:25:03.800217|2017-10-10 22:25:03.800217
NCT02701231|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-03-08|||November 2015||2015-11-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer|Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer|Recruiting||N/A|200|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||No|Because of personal privacy, the research-related individual participant data do not intend for public sharing.|2017-10-10 22:25:03.95875|2017-10-10 22:25:03.95875
NCT02701218|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-01-07|||February 2016||2016-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||BPPV With CRP: Single Versus Multiple Cycles|Comparison of the Treatment Outcomes of Posterior Canal Benign Paroxysmal Positional Vertigo (BPPV) With Canalith Repositioning Procedure (CRP): Single Versus Multiple Cycles|Recruiting||N/A|114|Anticipated|Chiang Mai University||2|||f||||t||||||||Undecided||2017-10-10 22:25:04.112183|2017-10-10 22:25:04.112183
NCT02701205|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-07|||January 2015||2015-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis|A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Safety and Efficacy Study of Recombinant Human TNF Receptor-IgG Fusion Protein for Injection (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis|Recruiting||Phase 3|216|Anticipated|Shanghai Celgen Bio-Pharmaceutical Co.,Ltd||3|||f||||f||||||||Undecided||2017-10-10 22:25:04.255116|2017-10-10 22:25:04.255116
NCT02701192|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-03-07|||September 2007||2007-09-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2015|Actual|2015-12-01||Observational|Coccyx||Management of Coccydynia: A Prospective, Observational Study of Coccygectomy|Management of Coccydynia: A Prospective, Observational Study of Coccygectomy|Active, not recruiting||N/A|77|Actual|Carolinas Healthcare System|||1||f||||f||||||||Undecided||2017-10-10 22:25:04.387294|2017-10-10 22:25:04.387294
NCT02701179|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-08-21|||April 2016||2016-04-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|LIFE||1% vs. 2 % Lignocaine for Flexible Bronchoscopy|Comparison of 1% Versus 2% Lignocaine for Topical Anaesthesia in Flexible Bronchoscopy|Completed||N/A|500|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-10 22:25:04.471026|2017-10-10 22:25:04.471026
NCT02701166|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-04|||February 2016||2016-02-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|FITCH||The Effect of Bezafibrate on Cholestatic Itch|The Effect of Bezafibrate on Cholestatic Itch|Recruiting||Phase 3|84|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||Undecided||2017-10-10 22:25:04.569111|2017-10-10 22:25:04.569111
NCT02701140|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-09|||June 2016||2016-06-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|TAPER-S||Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease||Not yet recruiting||Phase 2|66|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||Undecided||2017-10-10 22:25:04.82624|2017-10-10 22:25:04.82624
NCT02701088|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-07-27|||December 2015||2015-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CANAL-IMRT-01||Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life|Phase II Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life|Suspended||Phase 2|66|Anticipated|Centre Francois Baclesse||1||Interim analysis|f||||t||||||||||2017-10-10 22:25:05.184972|2017-10-10 22:25:05.184972
NCT02701075|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-02-06|||September 2013||2013-09-01|February 2017|2017-02-01|August 31, 2017|Anticipated|2017-08-31|December 2016|Actual|2016-12-01||Interventional|||MC5-A Scrambler Therapy for the Treatment of Chronic Neuropathic Extremity Pain|MC5-A Scrambler Therapy for the Treatment of Chronic Neuropathic Extremity Pain|Active, not recruiting||N/A|58|Actual|Brooke Army Medical Center||2|||f||||f||||||||No||2017-10-10 22:25:05.277383|2017-10-10 22:25:05.277383
NCT02701062|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-14|||February 2016||2016-02-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|November 2019|Anticipated|2019-11-01||Interventional|ATLAS||AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)|AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)|Recruiting||Phase 4|2000|Anticipated|AtriCure, Inc.||2|||f||||f||||||||||2017-10-10 22:25:05.373867|2017-10-10 22:25:05.373867
NCT02701036|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-06-28|||April 2010||2010-04-01|June 2017|2017-06-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|20 Years|Observational [Patient Registry]|SPORTAX-NHS||Sporadic Degenerative Ataxia With Adult Onset: Natural History Study|Sporadic Degenerative Ataxia With Adult Onset: Natural History Study (SPORTAX-NHS)|Recruiting||N/A|300|Anticipated|Ataxia Study Group|||2||f||||t||||||Samples With DNA|"     2x9 ml EDTA blood samples. Blood samples are taken according to established protocols for     future genetic studies. The samples are sent to the Department of Medical Genetics (Tübingen,     Germany).   "|Undecided||2017-10-10 22:25:05.661297|2017-10-10 22:25:05.661297
NCT02701023|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-09-12||||||September 2017|2017-09-01||||||||Expanded Access|||Compassionate Use of MitoGel in Upper Tract Urothelial Carcinoma|Individual Patient Expanded Access - MitoGel for Upper Urinary Tract Urothelial Carcinoma|No longer available||N/A|||Jonsson Comprehensive Cancer Center|||||||||||||||||||2017-10-10 22:25:06.277445|2017-10-10 22:25:06.277445
NCT02701010|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-04|||November 2012||2012-11-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Behavioural Therapy Program for Female Overactive Bladder|Comparative Effectiveness of Three Different Teaching Methods in Behavioural Therapy Program for Female Overactive Bladder: A Randomized Controlled Trial|Completed||N/A|60|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||4|||f||||t||||||||Yes||2017-10-10 22:25:06.34126|2017-10-10 22:25:06.34126
NCT02700997|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-05|||March 2016||2016-03-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|August 2017|Actual|2017-08-01||Interventional|USLS||Uterosacral Ligament Suspension Clip|Uterosacral Ligament Suspension: A Radiographic Study of Anatomy and Suture Location|Active, not recruiting||N/A|17|Anticipated|TriHealth Inc.||1|||f||||f||||||||||2017-10-10 22:25:06.440884|2017-10-10 22:25:06.440884
NCT02700984|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2017-08-15|||March 30, 2016|Actual|2016-03-30|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|COMPASS-XT||A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial|An Observational Multicenter Clinical Study to Assess the Long-Term Safety of the CyPass Micro-Stent in Patients With Primary Open Angle Glaucoma Who Have Completed Participation in the COMPASS Trial|Active, not recruiting||N/A|282|Actual|Alcon Research||2|||f||||f|f|t|f|||||||2017-10-10 22:25:06.523431|2017-10-10 22:25:06.523431
NCT02700971|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-08-18|||June 2016||2016-06-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|RATIO||Microarray Prediction of Response to Nivolumab, Ipilimumab, or Combined Therapy in Subjects With Previously Untreated, Locally Advanced or Metastatic Melanoma|Rational Approach To Immuno-Oncology Microarray Prediction of Response to Nivolumab, Ipilimumab, or Combined Therapy in Subjects With Previously Untreated, Locally Advanced or Metastatic Melanoma|Recruiting||N/A|100|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||No||2017-10-10 22:25:06.664709|2017-10-10 22:25:06.664709
NCT02700958|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-03-04|||February 2016||2016-02-01|March 2016|2016-03-01||||August 2018|Anticipated|2018-08-01||Interventional|||Remote Ischemic Preconditioning as a Method Against Subclinical Renal Injury and Contrast-induced Nephropathy|Study of Remote Ischemic Preconditioning as a Preventative Method Against Subclinical Renal Injury and Contrast-induced Nephropathy|Recruiting||N/A|160|Anticipated|Tartu University Hospital||2|||f||||||||||||||2017-10-10 22:25:06.77442|2017-10-10 22:25:06.77442
NCT02700945|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-07-04|||March 2016||2016-03-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|November 2018|Anticipated|2018-11-01||Interventional|||Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin|Stroke AF - Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin|Recruiting||N/A|496|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f|f|t|f|f|f|||||2017-10-10 22:25:06.908741|2017-10-10 22:25:06.908741
NCT02700932|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-04-03|||January 20, 2016|Actual|2016-01-20|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Study to Evaluate the Performance of the PicoWayTM 1064 nm/ 785 nm/ 532nm Picosecond Laser for Tattoo Removal|Clinical Study to Evaluate the Performance of the PicoWayTM 1064 nm/ 785 nm/ 532nm Picosecond Laser for Tattoo Removal|Active, not recruiting||N/A|15|Actual|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 22:25:07.156031|2017-10-10 22:25:07.156031
NCT02700919|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-06-08|||April 2016||2016-04-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease|A Phase II, Two-Part, Randomised, Multi-Centre, Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Efficacy and Safety of BCT197 When Added on to Standard of Care for the Treatment of Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospitalisation in Adults|Active, not recruiting||Phase 2|282|Actual|Mereo BioPharma||3|||f||||t||||||||No||2017-10-10 22:25:07.241194|2017-10-10 22:25:07.241194
NCT02700893|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-09-14|||March 2016||2016-03-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|August 2016|Actual|2016-08-01||Interventional|||Cerebral NIRS Profiles During Premedication for Neonatal Intubation|Cerebral NIRS Profiles During Premedication for Neonatal Intubation|Active, not recruiting||Phase 2/Phase 3|28|Actual|Centre Hospitalier Intercommunal Creteil||2|||f||||t||||||||No||2017-10-10 22:25:07.619133|2017-10-10 22:25:07.619133
NCT02700880|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-14|||June 2014||2014-06-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|12 Months|Observational [Patient Registry]|WEARIT-III||LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry|Prospective Registry of Patients With Ischemic Heart Failure Using the LifeVest Wearable Cardioverter Defibrillator (WEARIT-III)|Recruiting||N/A|1000|Anticipated|Zoll Medical Corporation|||1||f||||f||||||||||2017-10-10 22:25:07.706344|2017-10-10 22:25:07.706344
NCT02700867|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-03-16|||February 2016||2016-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|IOACS||Trial Comparing Proximal Tibia and Proximal Humerus Infusion Rates Using the NIO Intraosseous Device|A Randomized Crossover Cadaver Trial Comparing Proximal Tibia and Proximal Humerus Infusion Rates Using the NIO Intraosseous Device During Simulated Cardiopulmonary Resuscitation Performed by Paramedics|Completed||N/A|84|Actual|Medical University of Warsaw||2|||f||||f||||||||Undecided||2017-10-10 22:25:07.811131|2017-10-10 22:25:07.811131
NCT02700854|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-16|||February 2016||2016-02-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|September 2017|Anticipated|2017-09-01||Interventional|HENRIC||Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2|Hypoxic-Ischemic Encephalopathy Therapy Optimization for Better Neuroprotection With Inhalative CO2 in Asphyxiated, Cooled, Mechanically Ventilated Neonates at Risk for Hypocapnia|Recruiting||Phase 1|10|Anticipated|Semmelweis University||1|||f||||t||||||||No||2017-10-10 22:25:07.890049|2017-10-10 22:25:07.890049
NCT02700841|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-06-13|||May 2016||2016-05-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Enhancing Anti-Myeloma Vaccine Response After Autologous Stem Cell Transplantation|Enhancing Anti-Myeloma Vaccine Response After Autologous Stem Cell Transplantation|Recruiting||Phase 2|26|Anticipated|Emory University||2|||f||||t||||||||Undecided||2017-10-10 22:25:08.005409|2017-10-10 22:25:08.005409
NCT02700828|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-16|||February 2016||2016-02-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|September 2017|Anticipated|2017-09-01||Interventional|CORTISoL||Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns|Prospective, Randomized, Double-blind, Cohort Study of Hydrocortisone vs Placebo in Systemic Low Blood Pressure During Hypothermia Treatment in Asphyxiated Newborns|Recruiting||Phase 2/Phase 3|32|Anticipated|Semmelweis University||2|||f||||f||||||||No||2017-10-10 22:25:08.134445|2017-10-10 22:25:08.134445
NCT02700815|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-10-02|||May 9, 2016|Actual|2016-05-09|October 2017|2017-10-01|July 21, 2017|Actual|2017-07-21|July 13, 2017|Actual|2017-07-13||Interventional|||Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain|A Randomized, Controlled Multi-centre Parallel Group Study to Assess the Efficacy and Safety of Multiple Doses of a Topically Applied Combination Containing Diclofenac 2% + Capsaicin 0.075% (2 g Formulation Per Application; 2-times Daily for 5 Days) Compared to Placebo, as Well as to Diclofenac 2% and Capsaicin 0.075% in Patients With Acute Back or Neck Pain|Completed||Phase 3|746|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 22:25:08.263792|2017-10-10 22:25:08.263792
NCT02700802|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-05-11|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|August 2022|Anticipated|2022-08-01|September 2020|Anticipated|2020-09-01||Interventional|||Mitigating Hunger and Food Insecurity Among Socioeconomically Disadvantaged Caregivers of Hospitalized Children|Mitigating Hunger and Food Insecurity Among Socioeconomically Disadvantaged Caregivers of Hospitalized Children|Withdrawn||N/A|0|Actual|University of Chicago||3||This research described in this protocol was not funded.|f||||f|f|f||||||||2017-10-10 22:25:08.381202|2017-10-10 22:25:08.381202
NCT02700789|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-03-01|||January 2015||2015-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|PULoVR||Pregnancies of Uncertain Location or Viability Research|Pregnancies of Uncertain Location or Viability Research|Completed||N/A|79|Actual|University of Nottingham|||1||f||||f||||||||No||2017-10-10 22:25:08.445856|2017-10-10 22:25:08.445856
NCT02700776|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-05-01|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Observational|1380GCC||1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer|1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer|Terminated||N/A|417|Actual|University of Maryland|||3||f||||t||||||Samples With DNA|"     Measure the level of GP88 in the blood of healthy women who are having mammography screening     for breast cancer. If study doctor refers subject for breast biopsy the investigator will     collect the information from the biopsy.   "|||2017-10-10 22:25:08.518509|2017-10-10 22:25:08.518509
NCT02700763|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-26|||December 6, 2016|Actual|2016-12-06|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||[18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis|PET Imaging of [18F]Dabrafenib Distribution and Kinetics in Brain Metastasis in Patients With BRAF Positive Metastastic Melanoma. A Feasibility Study.|Recruiting||N/A|10|Anticipated|University Medical Center Groningen||1|||f||||f||||||||||2017-10-10 22:25:08.608942|2017-10-10 22:25:08.608942
NCT02700750|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-03-01|||March 2016||2016-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Relation Between Macular and RNFL Thickness Measurement and Quality Grading in OCT|Relation Between Macular and RNFL Thickness Measurement and Quality Grading in OCT|Not yet recruiting||N/A|200|Anticipated|Meir Medical Center||1|||f||||f||||||||Undecided||2017-10-10 22:25:08.696738|2017-10-10 22:25:08.696738
NCT02700737|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-10-28|||May 2016||2016-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of Image-Based Modelling on Clinical Decisions in Coarctation of the Aorta|Evaluation of Image-Based Modelling on Clinical Decisions in Coarctation of the Aorta|Completed||N/A|206|Actual|London School of Economics and Political Science||2|||f||||f||||||||No||2017-10-10 22:25:08.756529|2017-10-10 22:25:08.756529
NCT02700724|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-10-31|||April 2016||2016-04-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Observation Versus Immediate Surgery of Low Risk Bladder Cancer|Observation Versus Immediate Surgery of Low Risk Bladder Cancer|Recruiting||N/A|100|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-10-10 22:25:08.841972|2017-10-10 22:25:08.841972
NCT02700711|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-10-02|||February 2016||2016-02-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Methylphenidate-Duloxetine Combinations for Cocaine Dependence|Randomized Clinical Trial: 03 (Methylphenidate and Duloxetine)|Recruiting||Phase 1|40|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-10 22:25:08.932439|2017-10-10 22:25:08.932439
NCT02700698|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-26|||September 2016||2016-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|MitoWomen||Mitochondrial Function in Circulating Cells and Muscle Tissue|Mitochondrial Function in Circulating Cells and Muscle Tissue|Recruiting||N/A|40|Anticipated|University of Arkansas|||2||f||||f||||||||||2017-10-10 22:25:09.053685|2017-10-10 22:25:09.053685
NCT02700685|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-09-13|||November 2016||2016-11-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Effect of Pycnogenol® on ADHD|Effect of Pycnogenol® Attention-Deficit Hyperactivity Disorder (ADHD): A Randomized, Double Blind, Placebo and Active Product Controlled Multicenter Trial|Not yet recruiting||Phase 3|144|Anticipated|Universiteit Antwerpen||3|||f||||||||||||||2017-10-10 22:25:09.160844|2017-10-10 22:25:09.160844
NCT02700672|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-03-02|||January 2013||2013-01-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Observational|ICGF||Influence of Cognition and Gait on Falls|Predicting Falls Among Institutionalized and Non-institutionalized Older Adults: The Role of Cognition and Gait Speed|Completed||N/A|50|Actual|Federal University of São Paulo|||2||f||||f||||||||||2017-10-10 22:25:09.289132|2017-10-10 22:25:09.289132
NCT02700659|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-03-04|||November 2012||2012-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||The Cxbladder Monitoring Study|A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC)|Recruiting||N/A|1050|Anticipated|Pacific Edge Limited|||1||f||||t||||||Samples With DNA|"     De-identified, consented participant samples of between 5mL and 15 mL of urine, stabilized in     the proprietary Cxbladder liquid, will be stored at -80ºC for further urinary diagnostic     assay development and improvement.   "|||2017-10-10 22:25:09.361827|2017-10-10 22:25:09.361827
NCT02700646|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|DAISY||Improving Motor Skill Development in Infants After Cardiac Surgery|Improving Motor Skill Development in Infants After Cardiac Surgery|Recruiting||N/A|90|Anticipated|University of Michigan||3|||f||||f||||||||||2017-10-10 22:25:09.474471|2017-10-10 22:25:09.474471
NCT02700633|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-02|||February 2016||2016-02-01|March 2016|2016-03-01||||July 2016|Anticipated|2016-07-01||Observational|||Does Permanent Pacemaker Status Confer Mortality Benefit in the Short Term Post TAVI|Does Permanent Pacemaker Status Confer Mortality Benefit in the Short Term Post TAVI|Active, not recruiting||N/A|4000|Actual|Royal Sussex County Hospital|||2||f||||f||||||||||2017-10-10 22:25:09.559795|2017-10-10 22:25:09.559795
NCT02700620|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-03-06|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Individually Tailored Web-based Cbt for Eating Disorders and the Role of Knowledge Acquisition|Individually Tailored Web-based Cbt for Eating Disorders and the Role of Knowledge Acquisition|Active, not recruiting||N/A|92|Actual|Linkoeping University||2|||f||||f||||||||Yes|Primary outcomes and background info on request.|2017-10-10 22:25:09.633292|2017-10-10 22:25:09.633292
NCT02700607|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-05-10|||June 2016||2016-06-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity|Impact of Intravascular Fluid Resuscitation on Whole Blood Viscosity During Coiling Embolization Procedure for Cerebral Artery Aneurysm|Not yet recruiting||N/A|20|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:25:09.720334|2017-10-10 22:25:09.720334
NCT02700594|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-03-04|||October 2013||2013-10-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Hip Versus Spinal Joint Mobilization on Hip Muscle Strength|Effect of Hip Versus Spinal Joint Mobilization on Hip Muscle Strength|Completed||N/A|28|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:25:09.797218|2017-10-10 22:25:09.797218
NCT02700581|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-01|||March 2016||2016-03-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Impact of Positive End-expiratory Pressure on Hepatic Venous Flow|Impact of Moderate Positive End-expiratory Pressure on Hepatic Venous Flow in Patients Undergoing Cardiac Surgery|Not yet recruiting||N/A|15|Anticipated|Konkuk University Medical Center||4|||f||||t||||||||No||2017-10-10 22:25:09.871158|2017-10-10 22:25:09.871158
NCT02700568|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-03-01|||January 2016||2016-01-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|FavorAx||Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors|Evaluation of the Safety and Efficacy of Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors|Recruiting||Phase 4|21|Anticipated|Kidney Cancer Research Bureau||1|||f||||f||||||||Undecided||2017-10-10 22:25:09.954433|2017-10-10 22:25:09.954433
NCT02700555|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-08-29|||February 2016||2016-02-01|August 2016|2016-08-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01|60 Months|Observational [Patient Registry]|SPRING||Surveillance of Metabolic Parameters in Patients With Colorectal Cancer|Surveillance of Metabolic Parameters in Patients Who Will Receive Chemotherapy After Surgical Resection of Colorectal Cancer: KBSMC Colon Cancer Cohort|Recruiting||N/A|500|Anticipated|Kangbuk Samsung Hospital|||1||f||||f||||||Samples Without DNA|"     Tumor tissue   "|Undecided||2017-10-10 22:25:10.081582|2017-10-10 22:25:10.081582
NCT02700542|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-04-03|||December 2013||2013-12-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Asthma and Pest Control Study: Demonstrating Return-on-Investment for In-Home Pest Control for Children With Persistent Asthma|Asthma and Pest Control Study: Demonstrating Return-on-Investment for In-Home Pest Control for Children With Persistent Asthma|Active, not recruiting||N/A|400|Anticipated|New York City Department of Health and Mental Hygiene||2|||f||||t||||||||No||2017-10-10 22:25:10.172291|2017-10-10 22:25:10.172291
NCT02700529|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-07-12|||June 2016||2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA)|Ubenimex in Adult Patients With Lymphedema of The Lower Limb: a Phase 2, RAndomized, Double-blind, Placebo-controlled Study of Efficacy, Safety, and Pharmacokinetics (ULTRA)|Recruiting||Phase 2|45|Anticipated|Eiger BioPharmaceuticals||2|||f||||||||||||||2017-10-10 22:25:10.310023|2017-10-10 22:25:10.310023
NCT02700516|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-04-03|||March 2015||2015-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Observational|||Recurrent Glomerulonephritis After Renal Transplantation|Recurrent Primary Glomerulonephritis After Renal Transplantation: Effects on Renal Allografts and Transplant Recipients|Completed||N/A|360|Actual|Istanbul University|||3||f||||f||||||||Undecided||2017-10-10 22:25:10.410958|2017-10-10 22:25:10.410958
NCT02700503|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-04-27|||November 2015||2015-11-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Finding the Patient's Voice Diabetes Prevention Programs|Finding the Patient's Voice: Development of Practical Approaches for Adolescent and Family Focused Diabetes Prevention Programs|Recruiting||N/A|360|Anticipated|Indiana University||1|||f||||f||||||||Undecided|undecided|2017-10-10 22:25:10.48404|2017-10-10 22:25:10.48404
NCT02700490|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-03-22|||June 2016||2016-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|JIWA||Evaluating the Clinical Cost-effectiveness of Two Primary Mental Health Service Frameworks in Yogyakarta, Indonesia|Evaluating the Clinical Cost-effectiveness of Two Primary Mental Health Service Frameworks in Yogyakarta, Indonesia|Recruiting||N/A|400|Anticipated|University of Cambridge||2|||f||||||||||||||2017-10-10 22:25:10.595463|2017-10-10 22:25:10.595463
NCT02700477|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-03-02|||July 2013||2013-07-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of Fenugreek Seed Extract In Type- 2 Diabetes: An Add-On Study|Clinical Evaluation of Fenugreek Seed Extract In Patients With Type- 2 Diabetes: An Add-On Study|Completed||Phase 4|154|Actual|Chemical Resources||2|||f||||t||||||||||2017-10-10 22:25:10.681643|2017-10-10 22:25:10.681643
NCT02700464|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-16|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma|The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma: A Multicenter, Prospective Blinded Pivotal Study|Recruiting||N/A|500|Anticipated|Nucleix Ltd.||2|||f||||f||||||||||2017-10-10 22:25:10.777567|2017-10-10 22:25:10.777567
NCT02700451|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-05-30|||March 2016||2016-03-01|May 2017|2017-05-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes|A Randomized Controlled Trial of Post-operative Acetaminophen Versus Nonsteroidal Anti-Inflammatory Drug (NSAID) Use on Lumbar Spinal Fusion Outcomes|Recruiting||N/A|300|Anticipated|Hospital for Special Surgery, New York||3|||f||||t||||||||No||2017-10-10 22:25:10.896996|2017-10-10 22:25:10.896996
NCT02700438|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-01|||January 2014||2014-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Glyceryl Trinitrate Ointment vs Posterior Tibial Nerve Stimulation in the Treatment of Anal Fissure|Perianal Application of Glyceryl Trinitrate 0.4% Ointment vs Percutaneous Posterior Tibial Nerve Stimulation in the Treatment of Chronic Anal Fissure|Completed||Phase 3|80|Actual|Hospital General Universitario Elche||2|||f||||t||||||||Yes||2017-10-10 22:25:11.018972|2017-10-10 22:25:11.018972
NCT02700425|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-08-03|||May 17, 2016|Actual|2016-05-17|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|His-SYNC||His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy|His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy|Recruiting||N/A|40|Anticipated|University of Chicago||2|||f||||f|f|t|f|||||||2017-10-10 22:25:11.109516|2017-10-10 22:25:11.109516
NCT02700412|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-22|||April 2015||2015-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||University of Alabama at Birmingham (UAB) Adult CBD Program|University of Alabama at Birmingham (UAB) Adult CBD Program|Recruiting||Phase 1|100|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-10 22:25:11.443498|2017-10-10 22:25:11.443498
NCT02700399|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-06-27|||July 2015||2015-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Study of Pulse Pressure During Tilttable and Erigo® in Adult Patients With Acquired Brain Injury|Randomized Crossover Study of Pulse Pressure on Respectively Tilt Table With Integrated Stepping Function (Erigo®) and Traditional Tilt Table in Adult Patients With Acquired Brain Injury|Completed||N/A|13|Actual|University of Aarhus||2|||f||||t||||||||No||2017-10-10 22:25:11.583993|2017-10-10 22:25:11.583993
NCT02700386|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-08-18|||August 26, 2016|Actual|2016-08-26|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes|Hypofractionated, Comprehensive Radiation Therapy for Node-Positive Breast Cancer|Recruiting||Phase 2|112|Anticipated|University of Colorado, Denver||1|||f||||t|f|t|f|f||||||2017-10-10 22:25:11.695468|2017-10-10 22:25:11.695468
NCT02700373|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-01-18|||March 2016||2016-03-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers|A Phase I, Single-Center, Double-Blind, Randomized, Single Ascending Dose Study of PDC-APB in Healthy Volunteers|Enrolling by invitation||Phase 1|32|Anticipated|Hapten Sciences, Inc.||2|||f||||t||||||||Yes||2017-10-10 22:25:11.821833|2017-10-10 22:25:11.821833
NCT02700347|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-04-12|||February 2016||2016-02-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers|Evaluating Pharmacokinetics and Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Boosted With Allopurinol in Healthy Volunteers|Completed||Phase 1|12|Actual|National University Hospital, Singapore||3|||f||||f||||||||||2017-10-10 22:25:12.051495|2017-10-10 22:25:12.051495
NCT02700334|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-05-01|||October 2015||2015-10-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes|Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes|Completed||Phase 4|24|Actual|University of Guadalajara||2|||f||||f||||||||||2017-10-10 22:25:12.171519|2017-10-10 22:25:12.171519
NCT02700321|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-11-18|||April 2016||2016-04-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|PROTRACH||Benefits of High Flow Nasal Cannula Oxygen for Preoxygenation During Intubation in Non Severely Hypoxemic Patients|A Prospective , Multicenter , Randomized, Controlled, Parallel-group , Open-label Trial Evaluating Benefits of High Flow Nasal Cannula (HFNC) Oxygen for Preoxygenation During Intubation in Non Severely Hypoxemic Patients|Recruiting||N/A|192|Anticipated|Nantes University Hospital||2|||f||||f||||||||No||2017-10-10 22:25:12.300054|2017-10-10 22:25:12.300054
NCT02700308|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-03-01|||March 2016||2016-03-01|March 2016|2016-03-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|KYPHO-01||A Study of Kyphoplasty and Vertebroplasty in the Treatment of Spine Metastases|A Randomized, Multicenter, Open-label, Bayesian-based Phase II Study of the Feasibility of Kyphoplasty in the Local Treatment of Spine Metastases From Solid Tumors|Not yet recruiting||Phase 2|60|Anticipated|Centre Leon Berard||2|||f||||f||||||||No||2017-10-10 22:25:12.453118|2017-10-10 22:25:12.453118
NCT02700295|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-11-28|||February 2016||2016-02-01|November 2016|2016-11-01||||March 2017|Anticipated|2017-03-01||Observational|||Long Term Effects of Multifocal Orthokeratology on Corneal and Choroidal Structures in Healthy Subjects With Myopia- A Pilot Study|Long Term Effects of Multifocal Orthokeratology on Corneal and Choroidal Structures in Healthy Subjects With Myopia- A Pilot Study|Recruiting||N/A|10|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 22:25:12.566364|2017-10-10 22:25:12.566364
NCT02700282|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-12-08|||March 2016||2016-03-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Backpack Carrying in Children With Cystic Fibrosis|Impact of Backpack Position on Lung Function and Oxygen Consumption in School-aged Children With Cystic Fibrosis|Completed||Phase 4|27|Actual|Groupe Hospitalier du Havre||2|||f||||f||||||||No||2017-10-10 22:25:12.656382|2017-10-10 22:25:12.656382
NCT02700269|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|VZNIGHT||Vanderbilt-Zambia Innovations in Global Health Technologies|Vanderbilt-Zambia Innovations in Global Health Technologies|Recruiting||N/A|200|Anticipated|Macha Research Trust, Zambia|||1||f||||||||||||||2017-10-10 22:25:12.752663|2017-10-10 22:25:12.752663
NCT02700256|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-07-26|||December 4, 2015|Actual|2015-12-04|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Electronic Reporting of Symptoms After Surgery|Electronic Patient-Reported Outcomes in Patients Recovering From Ambulatory Cancer Surgery: Measuring Early Postoperative Symptoms|Recruiting||N/A|100|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||t||||||||||2017-10-10 22:25:12.856265|2017-10-10 22:25:12.856265
NCT02700243|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2017-04-10|||March 14, 2016|Actual|2016-03-14|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|INTERACT||Increase Tolerance for Exercise and Raise Activity Through Connectedness Trial|Pilot RCT Study Using a Fitbit Device to Improve Exercise Tolerance in 80 Patients With Cystic Fibrosis|Active, not recruiting||N/A|40|Actual|Boston Children’s Hospital||2|||f||||f||||||||Yes|Participants will receive their graded exercise test scores as part of their clinical care and will be able to see their individual data relating to Fitbit on their own device.|2017-10-10 22:25:12.973077|2017-10-10 22:25:12.973077
NCT02700230|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-09-07|||October 2017|Anticipated|2017-10-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery|Phase I Trial of Intratumoral Administration of a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Unresectable or Recurrent Malignant Peripheral Nerve Sheath Tumor|Suspended||Phase 1|30|Anticipated|Mayo Clinic||1||Enrollment to Dose Level 1 is complete|f||||t|t|f||||||||2017-10-10 22:25:13.072329|2017-10-10 22:25:13.072329
NCT02700217|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-02-15|||February 2016||2016-02-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Does Adding Spinal Anaesthesia to a General Anaesthetic Technique Influence Readiness for Discharge in Patients Having Hand Assisted Laparoscopic Live Donor Nephrectomy||Recruiting||N/A|90|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:25:13.209261|2017-10-10 22:25:13.209261
NCT02700204|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-09-01|||September 2015||2015-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Histological Study to Evaluate Skin Changes After PicoWay® 1064 nm and 532nm Picosecond Fractional Laser Treatment|Histological Study to Evaluate Skin Changes After PicoWay® 1064 nm and 532nm Picosecond Fractional Laser Treatment|Completed||N/A|13|Actual|Syneron Medical||2|||f||||f||||||||Undecided||2017-10-10 22:25:13.300055|2017-10-10 22:25:13.300055
NCT02700191|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-06|||April 2016||2016-04-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Cardiovascular Diagnosis Using µ-Cor - an Interventional Pilot Trial|Cardiovascular Diagnosis Using µ-Cor - an Interventional Pilot Trial|Not yet recruiting||N/A|60|Anticipated|Kyma Medical Technologies||2|||f||||f||||||||No||2017-10-10 22:25:13.392535|2017-10-10 22:25:13.392535
NCT02700178|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-18|||April 2016||2016-04-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Biofeedback for Wheelchair Users|Development of a Biofeedback Intervention to Reduce the Risk of Upper Extremity Overuse Injury Following Paraplegia and Tetraplegia|Recruiting||N/A|15|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:25:13.45413|2017-10-10 22:25:13.45413
NCT02700165|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-06-20|||February 2016||2016-02-01|January 2016|2016-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Submandibular Submental Study|Non-Invasive Fat Reduction in the Chin Using Cryolipolysis|Completed||N/A|14|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-10 22:25:13.529044|2017-10-10 22:25:13.529044
NCT02700152|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-03-17|||January 2016||2016-01-01|March 2016|2016-03-01|November 2020|Anticipated|2020-11-01|June 2020|Anticipated|2020-06-01||Interventional|||Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Device for Non-Invasive Abdominal Fat Reduction|Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Device for Non-Invasive Abdominal Fat Reduction|Recruiting||N/A|60|Anticipated|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 22:25:13.598413|2017-10-10 22:25:13.598413
NCT02699957|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-06-27|||December 2015||2015-12-01|June 2017|2017-06-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01|2 Years|Observational [Patient Registry]|||Left Atrial Appendage Occlusion Registry (LAAO Registry)|Left Atrial Appendage Occlusion Registry (LAAO Registry)|Recruiting||N/A|3000|Anticipated|American College of Cardiology|||1||f||||f||||||||No||2017-10-10 22:25:15.168858|2017-10-10 22:25:15.168858
NCT02700139|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-06-14|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Shamir Aspheric Ophthalmic Lenses (MyLens) for Myopic Control Clinical Trial|Shamir Aspheric Ophthalmic Lenses (MyLens) for Myopic Control Clinical Trial|Active, not recruiting||N/A|80|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||Yes|The demographic data of subjects recruited in this study will be disclosed in this website|2017-10-10 22:25:13.681229|2017-10-10 22:25:13.681229
NCT02700126|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-03-07|||March 7, 2016|Actual|2016-03-07|March 2017|2017-03-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Observational|||Impact of Genetic Polymorphism on Propofol Requirement and Recovery for Total Intravenous Anesthesia for Clipping of Unruptured Cerebral Aneurysm in Korean Population||Completed||N/A|118|Actual|Yonsei University|||1||f||||t||||||Samples With DNA|"     Blood obtained from enrolled patients before surgery   "|No|no plan to share data|2017-10-10 22:25:13.753253|2017-10-10 22:25:13.753253
NCT02700113|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-02|||November 2014||2014-11-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|Phenotyping||Investigating Phenotypic Profiles of Children and Adolescents With ASD|Investigating Phenotypic Profiles of Minimally Verbal Children and Adolescents With ASD/Profiles of Abilities in Children and Adolescents With ASD|Recruiting||N/A|120|Anticipated|Boston University Charles River Campus|||1||f||||t||||||||No||2017-10-10 22:25:13.838583|2017-10-10 22:25:13.838583
NCT02700100|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-11|||June 2016||2016-06-01|September 2017|2017-09-01|April 2022|Anticipated|2022-04-01|June 2017|Actual|2017-06-01||Interventional|||Study to Assess Safety of the Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract Reconstruction|Prospective, Non-randomised, Open Label Clinical Study to Assess the Safety of the Bioabsorbable Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction|Active, not recruiting||N/A|12|Actual|Xeltis||1|||f||||t||||||||||2017-10-10 22:25:13.942085|2017-10-10 22:25:13.942085
NCT02700087|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-04|||February 2016||2016-02-01|March 2016|2016-03-01||||February 2017|Anticipated|2017-02-01||Interventional|||In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?|In Infants With Symptoms of Tracheomalacia or Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms? A Randomized, Controlled Trial|Recruiting||N/A|106|Anticipated|Stanford University||2|||f||||f||||||||No||2017-10-10 22:25:14.032795|2017-10-10 22:25:14.032795
NCT02700074|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-02|||February 2015||2015-02-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|BSL||Brain Mechanisms for Language Processing in Adolescents With Autism Spectrum Disorder|ACE (Autism Center of Excellence): Brain Mechanisms for Language Processing in Adolescents With Autism Spectrum Disorder|Recruiting||N/A|220|Anticipated|Boston University Charles River Campus|||4||f||||t||||||||No||2017-10-10 22:25:14.145824|2017-10-10 22:25:14.145824
NCT02700061|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-03-01|||February 2012||2012-02-01|August 2015|2015-08-01|February 2017|Anticipated|2017-02-01|April 2016|Anticipated|2016-04-01||Interventional|NARLE1||Effects of Upper Limb Motor and Robotic Training Over Neuroplasticity and Function Capacity|Effects of Upper Limb Motor Training and Upper Limb Robotic Training Over Neuroplasticity and Function Capacity: A Single-blind Randomized Clinical Trial With Patients With Stroke Sequelae|Unknown status|Active, not recruiting|Phase 2|51|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||No||2017-10-10 22:25:14.298567|2017-10-10 22:25:14.298567
NCT02700048|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-20|||June 2016||2016-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia|Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia|Active, not recruiting||Phase 1/Phase 2|18|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 22:25:14.396528|2017-10-10 22:25:14.396528
NCT02700035|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-06-26|||January 2017||2017-01-01|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|BZDDD||A Family-Centered Ojibwe Substance Abuse Prevention|A Randomized Control Trial (RCT) of a Family-Centered Ojibwe Substance Abuse Prevention|Enrolling by invitation||N/A|1500|Anticipated|University of Nebraska Lincoln||2|||f||||t||||||||No|Due to the nature of the collaboration with tribal entities, the data will not be made publicly available without approval of the collaborating tribal council government bodies.|2017-10-10 22:25:14.497992|2017-10-10 22:25:14.497992
NCT02700022|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-07-11|||October 2016|Actual|2016-10-01|July 2017|2017-07-01|February 12, 2019|Anticipated|2019-02-12|November 15, 2016|Actual|2016-11-15||Interventional|||A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas|A Phase I/Ib Study of Alisertib Plus R-EPOCH for Treatment of Myc-Positive Aggressive B-Cell Lymphomas|Active, not recruiting||Phase 1|24|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:25:14.603868|2017-10-10 22:25:14.603868
NCT02700009|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-10|||May 2016||2016-05-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Computer-assisted Cognitive-Behavior Therapy for Depression in Primary Care|Dissemination of Computer-assisted Cognitive-behavior Therapy for Depression in Primary Care|Recruiting||N/A|240|Anticipated|University of Louisville||2|||f||||t||||||||Undecided||2017-10-10 22:25:14.71742|2017-10-10 22:25:14.71742
NCT02699996|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-21|||October 2015||2015-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors|Peer Mentoring to Promote Follow-up Care Self-Management for Adolescent and Young Adult (AYA) Childhood Cancer Survivors|Recruiting||N/A|78|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 22:25:14.848587|2017-10-10 22:25:14.848587
NCT02699983|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-21|||May 20, 2015|Actual|2015-05-20|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Virtual Weight Loss Program in Maintaining Weight in African American Breast Cancer Survivors|Virtual Weight Loss Program for African-American Breast Cancer Survivors|Recruiting||N/A|70|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 22:25:14.969401|2017-10-10 22:25:14.969401
NCT02699944|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-26|||November 2015||2015-11-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Optimization of CRT Using an ECG Vest|Optimization of Cardiac Resynchronization Therapy Using an ECG Vest|Active, not recruiting||N/A|200|Anticipated|Allina Health System||1|||f||||f||||||||||2017-10-10 22:25:15.24641|2017-10-10 22:25:15.24641
NCT02699931|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-13|||March 2016||2016-03-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy of Electric 3D Versus Manual Toothbrushes in Patients With Fixed Orthodontic Appliances|A Randomized, Investigator-blinded, 3-month, Parallel Group Clinical Study to Compare the Efficacy of Electric 3D Toothbrushes Versus Manual Toothbrushes in Patients With Fixed Orthodontic Appliances|Recruiting||N/A|80|Anticipated|National and Kapodistrian University of Athens||2|||f||||f||||||||||2017-10-10 22:25:17.173824|2017-10-10 22:25:17.173824
NCT02699918|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-01-31|||December 1, 2015||2015-12-01|January 2017|2017-01-01|October 1, 2016|Actual|2016-10-01|April 1, 2016|Anticipated|2016-04-01||Interventional|MELA-SAS||Impact of Obstructive SAS on Metastatic Potential of Cutaneous Melanoma|Impact of Obstructive Sleep Apnea Syndrome on Metastatic Potential of Cutaneous Melanoma : Prospective Study in Patients With High Risk Melanoma|Withdrawn||Early Phase 1|0|Actual|AGIR à Dom||1||failure in regulatory statements|f||||f||||||||No||2017-10-10 22:25:17.265863|2017-10-10 22:25:17.265863
NCT02699905|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-01-11|||August 2016||2016-08-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|GPR43Sepsis||Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of Sepsis|Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of Sepsis|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center|||2|data was received from another source, therefore phlebotomy was not necessary|f||||t||||||Samples With DNA|"     10 mL of whole blood drawn at four time intervals during the study. Blood is centrifuged and     the Buffy coat separated and flash frozen in liquid nitrogen. Quantitative PCR analysis is     then performed to assess the expression of FFA2/GPR43 at different time points in the     patient's illness.   "|Yes||2017-10-10 22:25:17.362084|2017-10-10 22:25:17.362084
NCT02699892|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-09-02|2016-09-02||October 2007||2007-10-01|September 2016|2016-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|RITAM|Intention-to-treat (ITT) population included all participants, who received at least one dose of the drug under observation and had a subsequent post baseline assessment.|Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis|Post Marketing Non Interventional Clinical Research of Administration of Rituximab in Rheumatoid Arthritis|Completed||N/A|130|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:25:17.452801|2017-10-10 22:25:17.452801
NCT02699879|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-04-20|||February 16, 2012|Actual|2012-02-16|April 2017|2017-04-01|September 15, 2016|Actual|2016-09-15|September 15, 2016|Actual|2016-09-15||Observational|||Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)|Post-Authorisation Safety Study of Esbriet® (Pirfenidone): A Prospective Observational Registry to Evaluate Long-Term Safety in a Real-World Setting|Completed||N/A|1009|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:25:17.703998|2017-10-10 22:25:17.703998
NCT02699866|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-12-02|||February 2016||2016-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Implant Survival After Insertion of Bone Level Tapered (BLT) Implant Ø 2.9 mm in the Clinical Practice Setting|A Multi-Center, Prospective, Single Cohort, Post-Market Clinical Follow-Up (PMCF) Study to Assess Implant Survival After Insertion of Straumann® Bone Level Tapered (BLT) Implant Ø 2.9 mm in the Clinical Practice Setting|Recruiting||N/A|40|Anticipated|Institut Straumann AG||1|||f||||f||||||||No||2017-10-10 22:25:18.120299|2017-10-10 22:25:18.120299
NCT02699853|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-04-08|||April 12, 2016|Actual|2016-04-12|April 2017|2017-04-01|October 12, 2019|Anticipated|2019-10-12|October 12, 2018|Anticipated|2018-10-12||Interventional|||Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer|Prospective Randomized Comparison of Robotic Versus Open Radical Cystectomy|Recruiting||N/A|208|Anticipated|University of Southern California||2|||f||||t|f|f||||||||2017-10-10 22:25:18.327488|2017-10-10 22:25:18.327488
NCT02699840|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-13|||February 2016||2016-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Observational|||Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation|Observational Study of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Menactra® Administered in Individuals 2 Through 55 Years Old Under Standard Health Care Practice in the Russian Federation|Completed||N/A|100|Actual|Sanofi|||3||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 22:25:18.460126|2017-10-10 22:25:18.460126
NCT02699827|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-06-03|||March 2016||2016-03-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia|Adding Magnesium Sulphate to Epidural Levobupivacaine in Elective Caesarian Section for Patients With Preeclampsia|Completed||Phase 4|60|Actual|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 22:25:18.611205|2017-10-10 22:25:18.611205
NCT02699814|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-17|||March 2016||2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|H3||H3: Healthy Minds, Healthy Children, Healthy Chicago Project Evaluation|H3: Healthy Minds, Healthy Children, Healthy Chicago Project Evaluation|Recruiting||N/A|400|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-10 22:25:18.730699|2017-10-10 22:25:18.730699
NCT02699801|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-11-01|||January 2016||2016-01-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|DIRECT||Dexmedetomidine Use in ICU Sedation and Postoperative Recovery in Elderly Patients and Post-cardiac Surgery|Dexmedetomidine Use in ICU Sedation and Postoperative Recovery in Elderly Patients and Post-cardiac Surgery|Recruiting||N/A|70|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:25:18.836554|2017-10-10 22:25:18.836554
NCT02699788|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-03-02|||March 2016||2016-03-01|March 2016|2016-03-01||||March 2018|Anticipated|2018-03-01||Interventional|||Emergency Department MCG for Suspected Acute Coronary Syndrome|Emergency Department MCG for Suspected Acute Coronary Syndrome|Not yet recruiting||N/A|600|Anticipated|Tampa General Hospital||1|||f||||f||||||||No||2017-10-10 22:25:18.945945|2017-10-10 22:25:18.945945
NCT02699775|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-15|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Observational|TRITITOX||Effect of Repeated Botulinum Toxin Injection on Gait Pattern in Stroke Patients|Effect of 3 Consecutives Botulinum Toxin Injection on Gait Pattern in Stroke Patients|Not yet recruiting||N/A|30|Anticipated|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-10 22:25:19.022428|2017-10-10 22:25:19.022428
NCT02699762|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-10-28|||March 2016||2016-03-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|Armautotox||Upper Limb Botulinum Toxin Injection Combined With Self Rehabilitation|Randomised Controlled Trial to Evaluate the Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity on Upper Limb Function in Stroke|Recruiting||Phase 4|40|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||f||||||||No||2017-10-10 22:25:19.092273|2017-10-10 22:25:19.092273
NCT02699749|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-28|||March 1, 2016|Actual|2016-03-01|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors|An Open-Label, Phase 1, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 (CDC7) Inhibitor, in Adult Patients With Advanced Nonhematologic Tumors|Recruiting||Phase 1|100|Anticipated|Takeda||1|||f||||f|f|f||||||||2017-10-10 22:25:19.195285|2017-10-10 22:25:19.195285
NCT02699736|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-02-29|||January 1994||1994-01-01|February 2016|2016-02-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|30 Years|Observational [Patient Registry]|EuroSIDA||Clinical and Virological Outcome of European Patients Infected With HIV|EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV|Enrolling by invitation||N/A|20852|Actual|Rigshospitalet, Denmark|||10||f||||t||||||Samples Without DNA|"     2 x 1 ml plasma;   "|No||2017-10-10 22:25:19.324033|2017-10-10 22:25:19.324033
NCT02699723|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2016-12-09|||January 2017||2017-01-01|December 2016|2016-12-01|November 2019|Anticipated|2019-11-01|June 2018|Anticipated|2018-06-01||Interventional|||Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer|Oral Arsenic Trioxide and Itraconazole for the Treatment of Patients With Advanced Basal Cell Carcinoma|Not yet recruiting||N/A|5|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:25:19.969384|2017-10-10 22:25:19.969384
NCT02699710|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-03-28|||September 30, 2015|Actual|2015-09-30|March 2017|2017-03-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Interventional|QCL117578||Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects|A Phase I, Single Center, Randomized, Open-Label, Study Investigating the Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics of GDC-0853 and the Effect of GDC-0853 on the Pharmacokinetics of Methotrexate in Healthy Subjects|Completed||Phase 1|8|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-10 22:25:20.119556|2017-10-10 22:25:20.119556
NCT02699697|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-07-27|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis|A Prospective Randomized Phase II Study of 1 vs 2 Fractions of Palliative Radiation Therapy for Patients With Symptomatic Bone Metastasis|Recruiting||N/A|158|Anticipated|Wake Forest University Health Sciences||2|||f||||t|t|f||||||||2017-10-10 22:25:20.254405|2017-10-10 22:25:20.254405
NCT02699684|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-08-07|2017-08-07||May 12, 2016|Actual|2016-05-12|August 2017|2017-08-01|October 20, 2016|Actual|2016-10-20|October 20, 2016|Actual|2016-10-20||Interventional||This analysis population includes all randomized and exposed subjects (Full Analysis Set).|Comparison of Lotrafilcon B Lenses With Different Packaging Solutions|One Month Clinical Comparison of Two Lotrafilcon B Spherical Lenses With Different Packaging Solutions|Completed||N/A|82|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 22:25:20.36835|2017-10-10 22:25:20.36835
NCT02699671|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-06-20|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Observational|IRIS BVS AMI||IRIS-BVS AMI Registry|Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Acute Myocardial Infarction; A Multicenter, Prospective Observational Study|Recruiting||N/A|500|Anticipated|Asan Medical Center|||1||f||||t|f|f||||||Undecided||2017-10-10 22:25:20.652526|2017-10-10 22:25:20.652526
NCT02699658|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-03|||October 2013||2013-10-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Population Pharmacokinetics and Pharmacodynamics Modeling to Optimize Dosage Regimen of Levofloxacin||Completed||Phase 2|45|Actual|Prince of Songkla University||1|||f||||f||||||||||2017-10-10 22:25:20.754744|2017-10-10 22:25:20.754744
NCT02699619|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-09-29|||March 2016||2016-03-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Undisplaced Femoral Neck Fractures 2 Hansson Pins or 3 Pins Interlocked in Plate (Pinloc) Using RSA|Undisplaced Femoral Neck Fractures Treated With 2 Hansson Pins Without Plate or 3 Hansson Pins Interlocked in a Plate (Pinloc) - A Randomized Controlled Trial Using Radiostereometry|Recruiting||N/A|30|Anticipated|Oslo University Hospital||2|||f||||f||||||||Yes|International peer review journal|2017-10-10 22:25:20.994498|2017-10-10 22:25:20.994498
NCT02699593|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-06-15|2017-05-04||February 1, 2016|Actual|2016-02-01|June 2017|2017-06-01|April 1, 2016|Actual|2016-04-01|April 1, 2016|Actual|2016-04-01||Interventional||All subjects that were dispensed at least 1 study lens.|Clinical Evaluation of Approved Contact Lenses||Completed||N/A|142|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||t|f|t|f|f|t|||||2017-10-10 22:25:21.250119|2017-10-10 22:25:21.250119
NCT02699580|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-01-24|||September 30, 2015|Actual|2015-09-30|January 2017|2017-01-01|September 10, 2016|Actual|2016-09-10|September 10, 2016|Actual|2016-09-10||Interventional|||Protective Effect of Biodegradable Collagen Implant (Ologen) in Scleral Thinning After Strabismus Surgery||Completed||N/A|20|Actual|Yonsei University||2|||f||||f||||||||No|no plan to share individual participant data|2017-10-10 22:25:21.470532|2017-10-10 22:25:21.470532
NCT02699567|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-02-29|||November 2011||2011-11-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|April 2013|Actual|2013-04-01||Observational|FATYP||CD36 and Human Fat Taste Perception|CD36 Involvement on Fat Taste Perception and Fat Hedonic Value in Humans|Completed||N/A|97|Actual|Washington University School of Medicine|||4||f||||f||||||Samples With DNA|"     Extracted genomic DNA   "|No||2017-10-10 22:25:21.549282|2017-10-10 22:25:21.549282
NCT02699554|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-10-24|||September 2015||2015-09-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01|1 Year|Observational [Patient Registry]|||Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy|Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy|Recruiting||N/A|55|Anticipated|University of Washington|||1||f||||||||||||||2017-10-10 22:25:21.751415|2017-10-10 22:25:21.751415
NCT02699541|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-11|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|January 18, 2017|Actual|2017-01-18|October 2016|Actual|2016-10-01||Interventional|IMB-DSME||The Effectiveness of Diabetes Self-Management Education Program Based on Behavioural Change Theory|The Effectiveness of Information-Motivation-Behavioural Skills Model-based Diabetes Self-Management Education Among Patients With Type 2 Diabetes in Jordan|Completed||N/A|151|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-10 22:25:21.841847|2017-10-10 22:25:21.841847
NCT02699528|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-09-15|||May 2016||2016-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|||The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder|Does Methylphenidate, Prescribed for Attention Deficit Disorder, Influence Primary Enuresis in These Children?|Recruiting||N/A|50|Anticipated|Meir Medical Center|||1||f||||t||||||||No||2017-10-10 22:25:21.931209|2017-10-10 22:25:21.931209
NCT02699515|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-13|||March 11, 2016|Actual|2016-03-11|September 2017|2017-09-01|March 6, 2019|Anticipated|2019-03-06|May 14, 2018|Anticipated|2018-05-14||Interventional|||MSB0011359C (M7824) in Subjects With Metastatic or Locally Advanced Solid Tumors|A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of MSB0011359C (M7824) in Subjects With Metastatic or Locally Advanced Solid Tumors With Expansion to Selected Indications in Asia|Active, not recruiting||Phase 1|114|Actual|Merck KGaA||1|||f||||t||||||||||2017-10-10 22:25:22.00799|2017-10-10 22:25:22.00799
NCT02699502|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-03-03|||March 2016||2016-03-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Metabolic Therapy in Patients With Osteoporosis After Hip Fracture by an Orthopedic-rehabilitation-metabolic Team|Metabolic Therapy in Patients With Osteoporosis After Hip Fracture by Cooperation Orthopedic-rehabilitation-metabolic: Determination of Drug Treatment Regardless of Reaching the Follow-up Clinic|Not yet recruiting||N/A|250|Anticipated|Meir Medical Center||1|||f||||t||||||||No||2017-10-10 22:25:22.15235|2017-10-10 22:25:22.15235
NCT02699489|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-02-29|||January 2013||2013-01-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|MEnROL||Enhanced Recovery Open Versus Laparoscopic Donor Nephrectomy|Mansoura Enhanced Recovery Open Versus Laparoscopic Donor Nephrectomy (MEnROL): A Randomized Controlled Trial|Completed||Phase 3|224|Actual|Mansoura University||2|||f||||t||||||||Yes|Individual participant data are readily shared with requesting authorities|2017-10-10 22:25:22.220328|2017-10-10 22:25:22.220328
NCT02699476|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-03|||February 2016||2016-02-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Enhancing Cognitive and Neurobehavioral Functions After Repetitive Traumatic Brain Injuries (rTBI) in Retired NFL Players and Military Veterans.|Enhancing Cognitive and Neurobehavioral Functions After Repetitive Traumatic Brain Injuries (rTBI) in Retired NFL Players and Military Veterans.|Recruiting||N/A|60|Anticipated|Brain & Body Health Foundation||3|||f||||f||||||||No||2017-10-10 22:25:22.295802|2017-10-10 22:25:22.295802
NCT02699463|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-06-12|||December 2016||2016-12-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study|Assessment of the Effect of Positive Airway Pressure on Energy and Vitality in Mild Obstructive Sleep Apnea Patients: The Merge Study|Recruiting||N/A|240|Anticipated|ResMed||2|||f||||f||||||||No||2017-10-10 22:25:22.398886|2017-10-10 22:25:22.398886
NCT02699450|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-09-25|||April 27, 2016|Actual|2016-04-27|September 2017|2017-09-01|May 4, 2018|Anticipated|2018-05-04|September 15, 2017|Actual|2017-09-15||Interventional|BOULEVARD||A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema|A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema|Active, not recruiting||Phase 2|230|Actual|Hoffmann-La Roche||3|||f||||f|t|f||||||||2017-10-10 22:25:22.539279|2017-10-10 22:25:22.539279
NCT02699437|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-05-08|||April 2015||2015-04-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia|Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia|Recruiting||N/A|200|Anticipated|Mansoura University|||1||f||||f||||||Samples Without DNA|"     Blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant   "|Undecided||2017-10-10 22:25:22.772921|2017-10-10 22:25:22.772921
NCT02699424|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-06-27|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|December 2027|Anticipated|2027-12-01|December 2017|Anticipated|2017-12-01||Interventional|PROPER||Prospective Evaluation of 68-Ga-prostate Specific Membrane Antigen (PSMA)-Positron Emission Tomograph (PET) and Early Prostatic Specific Antigen (PSA) Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy|Prospective Evaluation of 68-Ga-PSMA -PET and Early PSA Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy|Recruiting||N/A|100|Anticipated|Lund University Hospital||1|||f||||f||||||||No||2017-10-10 22:25:22.864495|2017-10-10 22:25:22.864495
NCT02699398|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-02-29|||November 2011||2011-11-01|February 2016|2016-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Domiciliary VR Rehabilitation||Completed||N/A|39|Actual|Universitat Pompeu Fabra||2|||f||||||||||||||2017-10-10 22:25:23.088956|2017-10-10 22:25:23.088956
NCT02699385|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-06|||December 7, 2015|Actual|2015-12-07|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|August 3, 2017|Actual|2017-08-03||Interventional|||A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Prospective Study to Evaluate the Safety and Efficacy of Domperidone in 6-month-old to 12-year-old Pediatric Subjects With Nausea and Vomiting Due to Acute Gastroenteritis|Terminated||Phase 3|292|Actual|Janssen-Cilag International NV||2||Study prematurely terminated upon recommendation of IDMC due to lack of efficacy.|f||||t|f|f||||||||2017-10-10 22:25:23.171679|2017-10-10 22:25:23.171679
NCT02699372|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-11-01|||March 2016||2016-03-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RO6889450 in Healthy Volunteers|A Single-center, Randomized, Investigator/Subject-Blind, Adaptive Single-ascending Dose (Part 1) and Multiple Ascending Dose (Part 2), Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6889450 Following Oral Administration in Healthy Subjects|Recruiting||Phase 1|164|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:25:23.355512|2017-10-10 22:25:23.355512
NCT02699359|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-12-21|||May 2015||2015-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Indirect Intracranial Pressure Measurement in Patients With Suspected or Documented Concussion|Indirect Intracranial Pressure Measurement in Patients With Suspected or Documented Concussion|Recruiting||N/A|100|Anticipated|HeadSense Medical||1|||f||||f||||||||No||2017-10-10 22:25:23.469388|2017-10-10 22:25:23.469388
NCT02699346|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-12-21|||January 2015||2015-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|||An Evaluation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Patients After Concussion|An Open-Label, Non-Randomized Study Designed to Evaluate the Correlation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Patients After Concussion With Clinical Evaluation|Recruiting||N/A|100|Anticipated|HeadSense Medical||1|||f||||f||||||||No||2017-10-10 22:25:23.557167|2017-10-10 22:25:23.557167
NCT02699333|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-09-13|||May 2016||2016-05-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||Risk Factors for Microscopic Colitis|Risk Factors for Microscopic Colitis|Recruiting||N/A|1200|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"     40 ml of blood centrifuged and separated into plasma, buffy coat and red blood cells. A serum     separator tube will be used to collect an additional 10 ml of blood for serum.      During colonoscopy, four mucosal biopsies will be obtained from normal appearing mucosa in     the ascending colon, transverse colon, and descending/sigmoid colon during the withdrawal     phase of the exam from each patient (12 research biopsies). To improve orientation 2 biopsies     from each segment will be flattened onto filter paper using a forceps and placed together     into fixative. The remaining 2 biopsies from each area will be rinsed in sterile PBS to     ensure there is no contamination with fecal bacteria prior to freezing in liquid nitrogen.   "|||2017-10-10 22:25:23.64593|2017-10-10 22:25:23.64593
NCT02699320|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-03-03|||June 2015||2015-06-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|MSBS||Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications|Multi-center Clinical Research About Standard Diagnosis and Treatment of Neonate Severe Digestive System Malformation|Completed||N/A|33|Actual|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||4||f||||t||||||||No||2017-10-10 22:25:23.718211|2017-10-10 22:25:23.718211
NCT02699307|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-03|||June 2016||2016-06-01|July 2017|2017-07-01|June 4, 2017|Actual|2017-06-04|June 4, 2017|Actual|2017-06-04||Interventional|||Lifestyle Intervention for Adults With Diabetes|Lifestyle Intervention for Adults With Diabetes|Completed||N/A|35|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 22:25:23.825414|2017-10-10 22:25:23.825414
NCT02699294|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-07-11|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|July 11, 2017|Actual|2017-07-11|May 16, 2017|Actual|2017-05-16||Interventional|||The Effect Of Stretching Exercise on Pectoralis Minor Myofascial Latent Trigger Points|Comparison of Effectiveness of Two Different Stretching Exercises Combined With Pressure Release Technique on Latent Trigger Points in The Pectoralis Minor Muscle|Completed||N/A|40|Actual|Istanbul University||4|||f||||f|f|f||||||||2017-10-10 22:25:23.89546|2017-10-10 22:25:23.89546
NCT02699281|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-03-03|||October 2015||2015-10-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy of Ultra-micronized Palmitoylethanolamide (Um-PEA) in Geriatric Patients With Chronic Pain|N-of-1 Randomised Trials to Assess the Efficacy of Ultra-micronized Palmitoylethanolamide (Um-PEA) in Geriatric Patients With Chronic Pain|Recruiting||Phase 4|12|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||Undecided||2017-10-10 22:25:23.99218|2017-10-10 22:25:23.99218
NCT02699268|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-02-29|||December 2015||2015-12-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||A Clinical Study Aiming to Validate the Equipment: VoluSense Pediatrics (VSP)|Validation of VoluSense Pediatrics, a New Method of Infant Spirometry Based on Electromagnetic Inductance Plethysmography|Recruiting||N/A|50|Anticipated|Haukeland University Hospital|||1||f||||f||||||||No||2017-10-10 22:25:24.08481|2017-10-10 22:25:24.08481
NCT02699255|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-04-24|||October 2014||2014-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Ventricular Arrhythmias After Pulmonary Vein Isolation|A Single-center Observational Study to Examine the Occurrence of Ventricular Arrhythmias After Pulmonary Vein Isolation|Recruiting||N/A|500|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||Undecided||2017-10-10 22:25:24.158228|2017-10-10 22:25:24.158228
NCT02699242|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2017-06-19|||April 2015||2015-04-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Does Training on a Virtual Reality Bronchoscopy Simulator Improve Performance of Bronchoscopic Intubation in Patients?|Does Training on a Virtual Reality Bronchoscopy Simulator Improve Performance of Bronchoscopic Intubation in Patients?|Completed||N/A|34|Actual|University Health Network, Toronto||2|||f||||f||||||||Yes||2017-10-10 22:25:24.353441|2017-10-10 22:25:24.353441
NCT02699229|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-10-31|||April 2017||2017-04-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Observational|||Non-linear Multimodal Microendoscopy for Lung Cancer Pathology|Non-linear Multimodal Microendoscopy for Lung Cancer Pathology|Not yet recruiting||N/A|20|Anticipated|University Health Network, Toronto|||3||f||||f||||||||||2017-10-10 22:25:24.432016|2017-10-10 22:25:24.432016
NCT02699216|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-03-01|||January 2016||2016-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||BioCurrent Electrical Stimulation for the Treatment of Dry ARMD|BioCurrent Electrical Stimulation for the Treatment of Dry Age-Related Macular Degeneration|Recruiting||Phase 1/Phase 2|616|Anticipated|DuBois Vision Clinic||3|||f||||f||||||||No||2017-10-10 22:25:24.503196|2017-10-10 22:25:24.503196
NCT02699203|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-03-16|||December 2015||2015-12-01|February 2016|2016-02-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|||Detection of Salivary Insulin Following Meals|Detection of Salivary Insulin Following Low Versus High Carbohydrate Meals in Humans|Completed||N/A|16|Actual|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:25:24.592196|2017-10-10 22:25:24.592196
NCT02699190|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-04-19|||January 6, 2017|Actual|2017-01-06|April 2017|2017-04-01|April 1, 2020|Anticipated|2020-04-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies|LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies|Recruiting||N/A|50|Anticipated|Children's Hospital of Philadelphia||2|||f||||f|f|f||||||No|Individual participant data (IPD) only available to principal investigator, co-investigators, and trial staff.|2017-10-10 22:25:24.680469|2017-10-10 22:25:24.680469
NCT02699177|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-02-29|||April 2016||2016-04-01|February 2016|2016-02-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||In Vivo Measurements of Nasal Ciliary Beat Frequency by Using Interferometry|In Vivo Measurements of Nasal Ciliary Beat Frequency by Using Interferometry|Not yet recruiting||N/A|300|Anticipated|Hadassah Medical Organization|||2||f||||f||||||Samples Without DNA|"     nasal brush biopsies, EM samples   "|No||2017-10-10 22:25:24.780495|2017-10-10 22:25:24.780495
NCT02699164|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-08-15|||January 2014||2014-01-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Remission of Lumbar Disc Herniation by Physiotherapy|Lumbal Disk Herniasyonunda farklı Tedavi yöntemlerinin etkinliğinin karşılaştırılması|Completed||N/A|20|Actual|Hacettepe University||2|||f||||f||||||||No||2017-10-10 22:25:24.886346|2017-10-10 22:25:24.886346
NCT02699151|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-09-13|||April 14, 2016|Actual|2016-04-14|September 2017|2017-09-01|November 15, 2018|Anticipated|2018-11-15|August 9, 2018|Anticipated|2018-08-09||Observational|INSIGHTS-SVT||INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis|INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis (INSIGHTS-SVT)|Active, not recruiting||N/A|1210|Actual|GWT-TUD GmbH|||1||f||||f||||||||||2017-10-10 22:25:24.981746|2017-10-10 22:25:24.981746
NCT02699138|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-02-03|||October 2015||2015-10-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Obstructive Sleep Apnea and Arousal Threshold in Patients With Post-traumatic Stress Disorder|Obstructive Sleep Apnea and Arousal Threshold in Patients With Post-traumatic|Suspended||Early Phase 1|30|Anticipated|University of California, San Diego||2||Research fellow left institution|f||||||||||||||2017-10-10 22:25:25.076502|2017-10-10 22:25:25.076502
NCT02699125|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-02-29|||January 2015||2015-01-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|guanhctz||Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic|A Placebo Controlled Double Blinded Crossover Study of the Antihypertensive Efficacy of Guanfacine vs Hydrochlorothiazide in Obstructive Sleep Apnea (OSA) Associated Hypertension|Active, not recruiting||Phase 4|34|Anticipated|University of California, San Diego||2|||f||||f||||||||Undecided|Data may be shared with assurance of subject confidentiality|2017-10-10 22:25:25.165504|2017-10-10 22:25:25.165504
NCT02699112|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-12-14|||November 2015||2015-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CARE-NIV||Cardiac and Respiratory Function With Non-invasive Ventilation|Improvement of Cardiac Function and Neural Respiratory Drive Following Set up of Non-invasive Ventilation in Patients With Hypercapnic Respiratory Failure Caused by Obesity Hypoventilation Syndrome|Active, not recruiting||N/A|16|Actual|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 22:25:25.261461|2017-10-10 22:25:25.261461
NCT02699086|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-04-12|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)||Not yet recruiting||Phase 2|105|Anticipated|BioLite, Inc.||3|||f|||||t|f||||||||2017-10-10 22:25:25.483165|2017-10-10 22:25:25.483165
NCT02699073|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-02-28|||February 2016||2016-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|TEXCAN||Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib|Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib. A GERCOR Phase II Study|Recruiting||Phase 2|55|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||f||||||||No||2017-10-10 22:25:25.56702|2017-10-10 22:25:25.56702
NCT02699060|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-03-10|||February 2016||2016-02-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Experimental Study to Determine the Effects of Human Refluxate on Macrophage Phenotype and Plasticity and Its Correlation With Different Forms of Gastroesophageal Reflux Disease|Experimental Study to Determine the Effects of Refluxate (Human: Biliary, Gastric, Duodenogastric/Mixed) on Macrophage Phenotype and Macrophage Plasticity and Its Correlation With Different Forms of Gastroesophageal Reflux Disease (Non-erosive and Erosive) and Complications Thereof (Barrett's Esophagus): Motility Talent Group Study|Recruiting||N/A|90|Anticipated|I.M. Sechenov First Moscow State Medical University||1|||f||||f||||||||No||2017-10-10 22:25:25.691034|2017-10-10 22:25:25.691034
NCT02699047|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-06-29|||March 2015||2015-03-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|April 2016|Actual|2016-04-01||Interventional|||Fish Oil Supplementation in Gastrointestinal Cancer|Gastrointestinal Cancer: Effects of the Fish Oil Intake on Nutritional Status, Quality of Life and Immune and Metabolic Outcomes|Active, not recruiting||N/A|56|Actual|Universidade Federal de Santa Catarina||2|||f||||f||||||||No||2017-10-10 22:25:25.794331|2017-10-10 22:25:25.794331
NCT02699034|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-08-08|||March 2016||2016-03-01|August 2017|2017-08-01|October 5, 2016|Actual|2016-10-05|June 5, 2016|Actual|2016-06-05||Interventional|||Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter|Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter: Evaluation of a Tailored Interventional Guidance and Tracking System|Terminated||N/A|5|Actual|Heartcenter Leipzig GmbH||1||Recommendation by BfArM after interim analysis|f||||f||||||||||2017-10-10 22:25:25.90085|2017-10-10 22:25:25.90085
NCT02699021|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-09-20|||February 2016||2016-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:25:25.995034|2017-10-10 22:25:25.995034
NCT02699008|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-02-29|||January 2014||2014-01-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|HOPEmultiPFA||High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay|High On-treatment Platelet Reactivity to Adenosine Diphosphate Identified by Multiple Platelet Function Assay Guide to Modify Anti-platelet Strategy in Patients Undergoing Percutaneous Coronary Intervention|Completed||N/A|477|Actual|Wuhan Asia Heart Hospital||3|||f||||t||||||||||2017-10-10 22:25:26.034118|2017-10-10 22:25:26.034118
NCT02698995|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-08-09|||November 2015||2015-11-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|November 2016|Anticipated|2016-11-01||Interventional|||Perineural Low-dose Dexamethasone Added to Infraclavicular Block Anesthesia|Analgetic Efficiency of Single-shot Perineural Low Dose Dexamethasone Added to Infraclavicular Block Anesthesia for Upper Limb Surgery|Recruiting||Phase 3|180|Anticipated|Foisor Orthopedics Clinical Hospital||3|||f||||t||||||||No||2017-10-10 22:25:26.1262|2017-10-10 22:25:26.1262
NCT02698982|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-02-09|||May 2016||2016-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Optimized Anesthesia to Reduce Postoperative Cognitive Impairment in the Elderly|Impact of Tight Intraoperative Blood Pressure and Depth of Anesthesia Control on the Incidence of Postoperative Cognitive Impairment in Elderly Patients|Recruiting||N/A|45|Anticipated|Erasme University Hospital||3|||f||||||||||||||2017-10-10 22:25:26.26235|2017-10-10 22:25:26.26235
NCT02698969|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|||Recovery of Muscle Function After Deep Neuromuscular Block by Means of Diaphragm Ultrasonography|Recovery of Muscle Function After Deep Neuromuscular Block by Means of Dia-phragm Ultrasonography and Adductor Pollicis Acceleromyography: Comparison of Neostigmine vs. Sugammadex as Reversal Drugs.|Recruiting||Phase 4|58|Anticipated|University of Florence||2|||f||||t||||||||||2017-10-10 22:25:26.36578|2017-10-10 22:25:26.36578
NCT02698956|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-06-02|||July 2014|Actual|2014-07-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|February 2016|Actual|2016-02-01||Observational|SOURCE3||Observational Study to Evaluate Safety and Performance of SAPIEN 3 THV System in Real Life Practice.|Edwards SAPIEN 3 Aortic Bioprosthesis Multi-Region Outcome Registry.|Active, not recruiting||N/A|2000|Actual|Edwards Lifesciences|||1||f||||t|f|f||||||Undecided||2017-10-10 22:25:26.518864|2017-10-10 22:25:26.518864
NCT02698943|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2016-03-02|||September 2015||2015-09-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Glistenings and PCO Evaluation for the Envista MX60|Evaluation of Glistenings and Posterior Capsule Opacification Following Envista MX60 Intraocular Lens Implantation|Completed||N/A|60|Actual|Democritus University of Thrace|||1||f||||f||||||||No||2017-10-10 22:25:26.722979|2017-10-10 22:25:26.722979
NCT02698930|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-29|||February 2016||2016-02-01|February 2016|2016-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effect of Dexmedetomidine on Postoperative Renal Function in Infective Endocarditis Patients Undergoing Open Heart Surgery||Not yet recruiting||N/A|94|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:25:26.801634|2017-10-10 22:25:26.801634
NCT02698917|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-09-29|||March 2016||2016-03-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|COMACARE||Carbon Dioxide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation|Carbon Dioxide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation - Targeting High vs. Low Normal Values|Recruiting||N/A|120|Anticipated|Helsinki University Central Hospital||8|||f||||f||||||||||2017-10-10 22:25:26.894047|2017-10-10 22:25:26.894047
NCT02698904|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-28|||January 2016||2016-01-01|February 2016|2016-02-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|||Relaxation Training for People With Chronic Obstructive Pulmonary Disease (COPD)|A Quick Relaxation Training for People With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|39|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||t||||||||||2017-10-10 22:25:27.037321|2017-10-10 22:25:27.037321
NCT02698891|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-02|2017-10-02|||April 2016||2016-04-01|October 2017|2017-10-01|August 2023|Anticipated|2023-08-01|December 2019|Anticipated|2019-12-01||Interventional|||Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer|Feasibility and Safety of Avoiding Granulocyte Colony-stimulating Factor Prophylaxis During the Paclitaxel Portion of Dose Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen|Recruiting||Phase 2|125|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 22:25:27.117495|2017-10-10 22:25:27.117495
NCT02698878|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-07|||April 2014||2014-04-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|NutriHEP||Unloading Induced Effects on Local Glucose Uptake Into m. Soleus|Effects of Nutrition and Neuromuscular Electrical Stimulation on Local Glucose Uptake Into m. Soleus During 60 Days of Lower Leg Unloading|Completed||N/A|13|Actual|DLR German Aerospace Center||2|||f||||f||||||||||2017-10-10 22:25:27.211734|2017-10-10 22:25:27.211734
NCT02698852|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-03-13|||December 2015||2015-12-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|September 2017|Anticipated|2017-09-01||Interventional|OPC||A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)|A Prospective, Multicenter Trial Program in China to Evaluate the Efficacy and Safety of BuMA Supreme (eG Grafting) Biodegradable Polymer Sirolimus Eluting Stent in Patients With de Novo Coronary Lesions, OPC Trial|Recruiting||N/A|1000|Anticipated|Sino Medical Sciences Technology Inc.||1|||f||||t||||||||No||2017-10-10 22:25:27.332913|2017-10-10 22:25:27.332913
NCT02698839|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-03-13|||December 2015||2015-12-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|September 2017|Anticipated|2017-09-01||Interventional|RCT||A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)|A Prospective, Multicenter Trial Program in China to Evaluate the Efficacy and Safety of BuMA Supreme (eG Grafting) Biodegradable Polymer Sirolimus Eluting Stent in Patients With de Novo Coronary Lesions, RCT Trial|Recruiting||N/A|539|Anticipated|Sino Medical Sciences Technology Inc.||2|||f||||t||||||||No||2017-10-10 22:25:27.424853|2017-10-10 22:25:27.424853
NCT02698826|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-06-15|||April 2016||2016-04-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|REOX II||Reoxygenation After Cardiac Arrest II (REOX II Study)|Reoxygenation After Cardiac Arrest II (REOX II Study)|Recruiting||Phase 1|75|Anticipated|The Cooper Health System||1|||f||||t||||||||||2017-10-10 22:25:27.638334|2017-10-10 22:25:27.638334
NCT02698813|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-03-03|||December 2016||2016-12-01|February 2016|2016-02-01||||December 2018|Anticipated|2018-12-01||Interventional|||Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid||Not yet recruiting||Phase 1|30|Anticipated|South China Research Center for Stem Cell and Regenerative Medicine||2|||f||||t||||||||||2017-10-10 22:25:27.778505|2017-10-10 22:25:27.778505
NCT02698800|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-07-18|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Blue Blockers and Insomnia|Blocking Nocturnal Blue Light to Treat Insomnia: A Pilot Randomized Controlled Trial|Completed||N/A|15|Actual|Columbia University||2|||f||||t||||||||||2017-10-10 22:25:27.925028|2017-10-10 22:25:27.925028
NCT02697851|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-05-18|||July 2016||2016-07-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Pharmacokinetic Effect of Evotaz/Microgynon Co-administration|The Effect of Atazanavir/Cobicistat on the Pharmacokinetics of an Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel (Microgynon 30®) in Healthy Women|Recruiting||Phase 1|30|Anticipated|St Stephens Aids Trust||2|||f||||f||||||||Undecided||2017-10-10 22:25:28.036978|2017-10-10 22:25:28.036978
NCT02698787|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-01-04|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:25:28.169265|2017-10-10 22:25:28.169265
NCT02698761|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-01|||April 2016||2016-04-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive Crises|A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive Crises|Recruiting||N/A|20|Anticipated|Valley Anesthesiology Consultants||2|||f||||f||||||||No||2017-10-10 22:25:28.221828|2017-10-10 22:25:28.221828
NCT02698748|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-02-29|||January 2015||2015-01-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|Cloroquina||Evaluating the Role of Chloroquine for Malaria Elimination|Evaluating the Potential Role of Chloroquine in Preventing Infections During Elimination Campaigns: A Randomized, Single-blind, Placebo-controlled Trial in Asymptomatic Mozambican Adults|Completed||Phase 2/Phase 3|75|Actual|Centro de Investigacao em Saude de Manhica||2|||f||||f||||||||Undecided||2017-10-10 22:25:28.331231|2017-10-10 22:25:28.331231
NCT02698735|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-04-10|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients||Enrolling by invitation||N/A|6|Anticipated|University of Southern California||2|||f||||||||||||||2017-10-10 22:25:28.459258|2017-10-10 22:25:28.459258
NCT02698722|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-03-13|||February 2016||2016-02-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Video Decision Support Tool to Assist Patients in Dialysis Decision-making Versus Conservative Kidney Management|A Video Decision Support Tool to Assist Patients in Dialysis Decision-making Versus Conservative Kidney Management - A Pilot Randomized Control Trial|Recruiting||N/A|100|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 22:25:28.540846|2017-10-10 22:25:28.540846
NCT02698709|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-02-29|||May 2015||2015-05-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Astigmatic Vector Analysis of Posterior Cornea - a Comparison Among Healthy, Forme Fruste and Overt Keratoconus Corneas|Astigmatic Vector Analysis of Posterior Corneal Surface - a Comparison Among Healthy, Forme Fruste and Overt Keratoconus Corneas|Completed||N/A|698|Actual|University of Sao Paulo|||3||f||||t||||||||No||2017-10-10 22:25:28.640443|2017-10-10 22:25:28.640443
NCT02698696|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-02-29|||February 2014||2014-02-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|ECO-BIP||Validation of a Cognitive Remediation Program for Bipolar Disorders|Validation of a Cognitive Remediation Program for Bipolar Disorders|Recruiting||N/A|60|Anticipated|Centre hospitalier de Ville-Evrard, France||3|||f||||f||||||||||2017-10-10 22:25:28.788078|2017-10-10 22:25:28.788078
NCT02698683|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-29|||February 2014||2014-02-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Observational|||Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Patients|Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Intensive Care Patients: A Pilot Study|Completed||N/A|14|Actual|University of Sao Paulo|||2||f||||t||||||||No|there is no plan to share data|2017-10-10 22:25:28.921975|2017-10-10 22:25:28.921975
NCT02698670|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-06-07|||May 25, 2016|Actual|2016-05-25|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01|1 Month|Observational [Patient Registry]|TRUE-HD||Prospective Registry on User Experience With The Mapping System For Ablation Procedures|Prospective Registry on User Experience With The Mapping System For Ablation Procedures|Completed||N/A|577|Actual|Boston Scientific Corporation|||1||f||||f|f|f||||||No||2017-10-10 22:25:29.033438|2017-10-10 22:25:29.033438
NCT02697942|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-08-24|||February 2016||2016-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Hemodialysis-based Interventions to Preserve Cognitive Function|Hemodialysis-based Interventions to Preserve Cognitive Function|Suspended||N/A|90|Anticipated|Johns Hopkins Bloomberg School of Public Health||3|||f||||f||||||||No||2017-10-10 22:25:36.75617|2017-10-10 22:25:36.75617
NCT02698657|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-10-03|||February 22, 2016|Actual|2016-02-22|October 2017|2017-10-01|September 7, 2017|Actual|2017-09-07|September 7, 2017|Actual|2017-09-07||Interventional|||A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate|A Phase 1, Randomized, Placebo-controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate|Completed||Phase 1|30|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-10 22:25:29.19074|2017-10-10 22:25:29.19074
NCT02698644|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-02-29|||January 2016||2016-01-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate|Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate|Recruiting||Phase 1|25|Anticipated|Ain Shams University||1|||f||||t||||||||Undecided||2017-10-10 22:25:29.320558|2017-10-10 22:25:29.320558
NCT02698631|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-08-09|||January 2016||2016-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|ALICIA||Isolation of Pulmonary Veins With the Aid of Magnetic Resonance Imaging|Isolation of Pulmonary Veins With the Aid of Magnetic Resonance Imaging|Recruiting||Phase 4|154|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-10 22:25:29.403109|2017-10-10 22:25:29.403109
NCT02698618|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-27|||March 2016||2016-03-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|PREDICT||PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor|PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor|Not yet recruiting||Phase 4|50|Anticipated|Fundacion Investigacion Interhospitalaria Cardiovascular||2|||f||||t||||||||Undecided||2017-10-10 22:25:29.50945|2017-10-10 22:25:29.50945
NCT02698605|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-03-14|||August 2013||2013-08-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of the Arm Rehabilitation Device for Patients With Stroke|Design and Usability Evaluation of a Novel Robotic Bilateral Arm Rehabilitation Device for Patients With Stroke|Completed||N/A|17|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||No||2017-10-10 22:25:29.620895|2017-10-10 22:25:29.620895
NCT02698592|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-03-02|||January 2012||2012-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of Thermocool SF Catheter on the Common Cavo-tricuspid Isthmus Dependent Atrial Flutter Ablation|Comparative Study to Assess Safety and Efficacy of Catheters CelsiusTMDS® 8 mm, Thermocool® 3.5 mm of Irrigated Tip and Thermocool® SF in the Treatment of Cavo-tricuspid Isthmus Dependent Atrial Flutter|Active, not recruiting||Phase 4|150|Actual|Hospital Universitario Central de Asturias||3|||f||||f||||||||||2017-10-10 22:25:29.687586|2017-10-10 22:25:29.687586
NCT02698579|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-07-19|||January 2016||2016-01-01|July 2017|2017-07-01|November 2033|Anticipated|2033-11-01|November 2033|Anticipated|2033-11-01||Observational|||Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product|Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product|Enrolling by invitation||N/A|25|Anticipated|bluebird bio|||1||f||||f||||||||||2017-10-10 22:25:29.779241|2017-10-10 22:25:29.779241
NCT02698566|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-08-23|2017-06-26||March 21, 2016|Actual|2016-03-21|August 2017|2017-08-01|April 5, 2016|Actual|2016-04-05|April 5, 2016|Actual|2016-04-05||Interventional||All enrolled patients.|A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)|An Open-Label, Single-Arm Phase IIIb Study in Patients With Neovascular Age-Related Macular Degeneration or Macular Edema Secondary to Retinal Vein Occlusion to Evaluate the Usability of Lucentis® 0.5 mg Prefilled Syringe|Completed||Phase 3|35|Actual|Genentech, Inc.||1|||f||||f||||||||||2017-10-10 22:25:29.887472|2017-10-10 22:25:29.887472
NCT02698553|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-04-26|||May 23, 2016|Actual|2016-05-23|April 2017|2017-04-01|June 29, 2016|Actual|2016-06-29|June 29, 2016|Actual|2016-06-29||Interventional|||A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy Volunteers|An Open-label, Fixed Sequence Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Repeated Dose of Extended-release Bupropion Hydrochloride (Bupropion XL) Tablets 150 mg and 300 mg Once Daily in Chinese Healthy Volunteers|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:25:30.118929|2017-10-10 22:25:30.118929
NCT02698540|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-08-04|||November 28, 2016|Actual|2016-11-28|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||A Study of an Oral Nutritional Supplement in a Malnourished Population With GI Tolerance Impairment|A Prospective, Observational Study, of a High Calorie, Higher Protein Peptide Based Oral Nutrition Supplement (ONS) With Medium Chain Triglycerides (MCTs) in a Malnourished Population With GI Tolerance Impairment|Recruiting||N/A|150|Anticipated|Abbott Nutrition|||1||f||||f||||||||||2017-10-10 22:25:30.212748|2017-10-10 22:25:30.212748
NCT02698527|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-10-05|||June 2015||2015-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies|The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies|Recruiting||N/A|128|Anticipated|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||||2017-10-10 22:25:30.393422|2017-10-10 22:25:30.393422
NCT02698514|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-02|||February 2016||2016-02-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics|The Ratio of Hypnotic to Analgesic Potency of Sevoflurane and Desflurane : Randomized Controlled Trial|Recruiting||Phase 3|90|Anticipated|Kangbuk Samsung Hospital||2|||f||||f||||||||||2017-10-10 22:25:30.476905|2017-10-10 22:25:30.476905
NCT02698501|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-01-03|||August 2016||2016-08-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|UPSTREAM||Effects of Anti-TSLP in Patients With Asthma|Effects of Anti-TSLP on Airway Hyperresponsiveness and Mast Cell Phenotype in Asthma - A Randomized Double-blind, Placebo-controlled Trial of MEDI9929|Recruiting||Phase 2|40|Anticipated|University Hospital Bispebjerg and Frederiksberg||2|||f||||f||||||||No||2017-10-10 22:25:30.56568|2017-10-10 22:25:30.56568
NCT02694887|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-07-13|||March 2016||2016-03-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Observational|||Capillary and Venous Lactate in Emergency Department Patients|Agreement Between Capillary and Venous Lactate in Emergency Department Patients|Active, not recruiting||N/A|240|Actual|Chinese University of Hong Kong|||1||f||||f||||||||Yes||2017-10-10 22:26:05.104785|2017-10-10 22:26:05.104785
NCT02698488|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-08-29|||October 2016||2016-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Embryo Selection by Metabolomic Profiling of Embryo Culture Medium With Mass Spectroscopy as an Adjunct to Morphology|Embryo Selection by Metabolomic Profiling of Embryo Culture Medium With Mass Spectroscopy as an Adjunct to Morphology: a Randomized Controlled Trial|Not yet recruiting||N/A|300|Anticipated|Istanbul University||2|||f||||f||||||||No||2017-10-10 22:25:30.661479|2017-10-10 22:25:30.661479
NCT02698475|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-10-03|||May 13, 2016|Actual|2016-05-13|October 2017|2017-10-01|October 24, 2019|Anticipated|2019-10-24|September 14, 2018|Anticipated|2018-09-14||Interventional|CADMUS Jr||An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age|A Phase 3 Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Subjects Greater Than or Equal to 6 to Less Than 12 Years of Age|Recruiting||Phase 3|40|Anticipated|Janssen Research & Development, LLC||1|||f||||||f||||||||2017-10-10 22:25:30.741005|2017-10-10 22:25:30.741005
NCT02698462|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-07-03|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Adding Family History of Colorectal Cancer to the Dutch FIT-based Screening Program|Adding Family History of Colorectal Cancer to the FIT-based Screening Program in a Dutch Colorectal Cancer Population Sample|Active, not recruiting||N/A|6000|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 22:25:30.883838|2017-10-10 22:25:30.883838
NCT02698449|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-09|||September 2016||2016-09-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|RemCog-TC||Neurorehabilitation After Traumatic Brain Injury: Functional Magnetic Resonance Imaging Study|Cognitive Rehabilitation Combined to Transcranial Direct Current Stimulation Following Traumatic Brain Injury: Functional Magnetic Resonance Imaging Study|Not yet recruiting||N/A|80|Anticipated|University Hospital, Toulouse||4|||f||||f||||||||No||2017-10-10 22:25:32.565055|2017-10-10 22:25:32.565055
NCT02698423|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-06-02|2017-05-02||September 2011||2011-09-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|DEPIST||Feasibility and Acceptability of Offering Self-sampling to Non-attendees in Primary Care|Human Papillomavirus Testing Versus Liquid-based Cytology for Non-attendees of Cervical Cancer Screening: Results of a Randomised Controlled Trial|Completed||N/A|667|Actual|University Hospital, Geneva||2|||f||||f||||||||Yes|Data will be used for scientific publications.|2017-10-10 22:25:32.774024|2017-10-10 22:25:32.774024
NCT02698410|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-07-25|||July 2016||2016-07-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|ATLANT||Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.|Efficacy and Safety of Lanreotide ATG 120 mg in Combination With Temozolomide in Subjects With Progressive Well Differentiated Thoracic Neuroendocrine Tumors. A Phase II, Multicentre, Single Arm, Open-label Trial.|Recruiting||Phase 2|40|Anticipated|Ipsen||1|||f||||f||||||||||2017-10-10 22:25:33.025453|2017-10-10 22:25:33.025453
NCT02698397|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-10-28|||February 2016||2016-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:25:33.145807|2017-10-10 22:25:33.145807
NCT02698384|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-09-30|||January 2016||2016-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|ACRO-OPTIM||Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg|Optimisation of Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg|Terminated||N/A|4|Actual|Ipsen|||1|The study was terminated early due to insufficient potential for recruitment.|f||||f||||||||||2017-10-10 22:25:33.190578|2017-10-10 22:25:33.190578
NCT02698371|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-05-24|||November 2015||2015-11-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|SEMMAP||NCCL Direct Composite Restoration Performance With Self-Etch and Multimode Adhesives|NCCL Direct Composite Restoration Performance With Self-Etch and Multimode Adhesives Clinical Trial|Active, not recruiting||N/A|38|Actual|University Fernando Pessoa||6|||f||||t||||||||No||2017-10-10 22:25:33.295809|2017-10-10 22:25:33.295809
NCT02698358|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-02-29|||December 2015||2015-12-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Korean Multicenter Registry of EPIC Stent for Iliac Artery Disease: (K-EPIC Registry)||Recruiting||N/A|150|Anticipated|Yonsei University|||1||f||||f||||||||No||2017-10-10 22:25:33.532285|2017-10-10 22:25:33.532285
NCT02698345|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-02-29|||January 2016||2016-01-01|February 2016|2016-02-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Observational|||Korean Multicenter Prospective Registry of In.PACT DEB for Isolated Popliteal Artery Disease (K-POP Study)||Recruiting||N/A|100|Anticipated|Yonsei University|||1||f||||f||||||||No||2017-10-10 22:25:33.614339|2017-10-10 22:25:33.614339
NCT02698332|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-07-25|||March 2016||2016-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of a Diagnostic Algorithm for Urinary Tract Infection in General Practice|Effect of a Diagnostic Algorithm for Urinary Tract Infection on Appropriate Use of Antibiotics and Diagnostics in General Practice - a Cluster Randomized Trial|Completed||N/A|1550|Actual|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 22:25:33.691559|2017-10-10 22:25:33.691559
NCT02698319|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-08-15|||April 2015||2015-04-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|CTA||The Copenhagen Triage Algorithm|The Copenhagen Triage Algorithm|Completed||N/A|50000|Actual|Herlev Hospital||2|||f||||f||||||||||2017-10-10 22:25:33.786937|2017-10-10 22:25:33.786937
NCT02697929|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2017-06-28|||January 2014||2014-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sugammadex/Neostigmine and Liver Transplantation|Sugammadex Versus Neostigmine After Rocuronium Infusion During Liver Transplantation|Recruiting||N/A|40|Anticipated|Azienda Ospedaliera S. Maria della Misericordia||2|||f||||f||||||||Undecided||2017-10-10 22:25:36.842441|2017-10-10 22:25:36.842441
NCT02698306|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-28|||February 2015||2015-02-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison of the Use of Dexamethasone and Diclofenac Sodium in Immediate Post-Operative Care in Third Molar Surgery|Comparison of the Use of Dexamethasone and Diclofenac Sodium in Immediate Post-Operative Care in Third Molar Surgery|Recruiting||N/A|30|Anticipated|Hospital Geral de Vila Penteado||2|||f||||f||||||||No||2017-10-10 22:25:33.86806|2017-10-10 22:25:33.86806
NCT02698293|ClinicalTrials.gov processed this data on October 10, 2017|2016-03-01|2017-07-28|||November 2016|Actual|2016-11-01|July 2017|2017-07-01||||April 2019|Anticipated|2019-04-01||Interventional|||A Phase I Study of Photodynamic Therapy (PDT) for High-grade Anal Dysplasia and Microinvasive Anal Cancer|A Phase I Study of Photodynamic Therapy (PDT) for High-grade Anal Dysplasia and Microinvasive Anal Cancer|Recruiting||Phase 1|12|Anticipated|Abramson Cancer Center of the University of Pennsylvania||3|||f||||t||||||||||2017-10-10 22:25:33.970812|2017-10-10 22:25:33.970812
NCT02698280|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-03-06|||January 2016||2016-01-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma|Phase II Study of Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma|Recruiting||Phase 2|40|Anticipated|Huashan Hospital||1|||f||||||||||||||2017-10-10 22:25:34.070276|2017-10-10 22:25:34.070276
NCT02698267|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-06-07|||February 2016||2016-02-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Itraconazole on the Pharmacokinetics of BIIB074|An Open-label, Fixed-sequence, Phase 1 Study of the Effect of CYP3A4 Inhibition by Itraconazole on the Pharmacokinetics of BIIB074 in Healthy Subjects|Completed||Phase 1|16|Actual|Biogen||1|||f||||f||||||||||2017-10-10 22:25:34.190389|2017-10-10 22:25:34.190389
NCT02698254|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-09-21|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Pilot Trial of Dose-Volume Constraints for Reirradiation of Recurrent Brain Tumors|Pilot Trial of Dose-Volume Constraints for Reirradiation of Recurrent Brain Tumors|Recruiting||N/A|30|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 22:25:34.313737|2017-10-10 22:25:34.313737
NCT02698241|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-04-18|||April 2016||2016-04-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Observational|||Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure|Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure|Recruiting||N/A|200|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||No||2017-10-10 22:25:34.421288|2017-10-10 22:25:34.421288
NCT02698228|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-06-13|||March 2016||2016-03-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|RAPID||Regional Anaesthesia for Painful Injuries After Disasters|Regional Anaesthesia for Painful Injuries After Disasters (RAPID) Study: A Randomized Trial|Withdrawn||Phase 4|0|Actual|Epicentre||3||Study did not occur|f||||t||||||||Yes|The trial dataset will be made publicly available at the conclusion of the trial.|2017-10-10 22:25:34.534767|2017-10-10 22:25:34.534767
NCT02698215|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-01-24|||March 2016||2016-03-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Combining Varenicline and Naltrexone for Smoking Cessation|Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction|Recruiting||Phase 2|274|Anticipated|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-10 22:25:34.627781|2017-10-10 22:25:34.627781
NCT02698202|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-03|||March 2014||2014-03-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Screening for Breast Cancer With Digital Breast Tomosynthesis|Randomized Controlled Trial to Evaluate the Efficacy of Digital Breast Tomosynthesis in Reggio Emilia Breast Cancer Screening Program in the 45-74 Age Group|Recruiting||N/A|40000|Anticipated|Azienda Unità Sanitaria Locale Reggio Emilia||2|||f||||f||||||||||2017-10-10 22:25:34.726327|2017-10-10 22:25:34.726327
NCT02698189|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-08-28|||May 19, 2016|Actual|2016-05-19|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||A Dose Exploration Study With MK-8628 in Participants With Selected Hematologic Malignancies (MK-8628-005)|A Phase IB Trial With MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects With Selected Hematologic Malignancies|Active, not recruiting||Phase 1|56|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-10 22:25:34.813283|2017-10-10 22:25:34.813283
NCT02698176|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-05-23|||May 4, 2016|Actual|2016-05-04|May 2017|2017-05-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|||A Dose Exploration Study With MK-8628 in Participants With Selected Advanced Solid Tumors (MK-8628-006)|A Phase IB Dose Exploration Trial With MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects With Selected Advanced Solid Tumors|Terminated||Phase 1|13|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-10 22:25:34.90366|2017-10-10 22:25:34.90366
NCT02698163|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-22|||March 2016||2016-03-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Nanodiamond Modified Gutta Percha (NDGP) Composite for Non-surgical Root Canal Therapy (RCT) Filler Material|Nanodiamond Modified Gutta Percha (NDGP) Composite for Non-surgical Root Canal Therapy (RCT) Filler Material Applied by Vertical Condensation Obturation Procedure|Recruiting||N/A|30|Anticipated|University of California, Los Angeles||2|||f||||f||||||||Undecided||2017-10-10 22:25:35.013919|2017-10-10 22:25:35.013919
NCT02698150|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-09-08|||March 2016||2016-03-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2017|Anticipated|2017-09-01|12 Months|Observational [Patient Registry]|HERMES||Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing Mitraclip Transcatheter Repair|Evaluation of Remote Monitoring in Patients With Functional Mitral Regurgitation Undergoing Transcatheter Mitral Valve Edge-to-edge Repair With the Mitraclip System|Recruiting||N/A|55|Anticipated|Azienda Ospedaliero, Ferrarotto Alessi|||2||f||||f||||||||||2017-10-10 22:25:35.121776|2017-10-10 22:25:35.121776
NCT02698137|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|QUASIE2||Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)|Quality Assessment in ERCP: Risk Factors for Procedure-related Complications in Patients Undergoing ERCP in the Setting of an Endoscopy Training Program|Recruiting||N/A|1000|Anticipated|Clinical Hospital Colentina|||1||f||||f||||||||No||2017-10-10 22:25:35.242983|2017-10-10 22:25:35.242983
NCT02697721|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-08-24|||February 2016||2016-02-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Interventional|PTC-dementia||Powerful Tools for Caregivers of Dementia Patients|"Optimization of Powerful Tools for Caregivers of Dementia Patients"|Recruiting||N/A|60|Anticipated|Florida State University||2|||f||||f||||||||||2017-10-10 22:25:39.096888|2017-10-10 22:25:39.096888
NCT02698124|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-03-04|||March 2016||2016-03-01|March 2016|2016-03-01|December 2022|Anticipated|2022-12-01|August 2019|Anticipated|2019-08-01||Observational|PURPLE-D||Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice|Prospective Observation of the indUction Regimen for Acute Non-Promyelocytic Myeloid Leukemia in Elderly; Decitabine for Chemotherapy Unfit Korean Acute Myeloid Leukemia (AML) Patients in Real Practice|Not yet recruiting||N/A|136|Anticipated|Ulsan University Hospital|||1||f||||f||||||Samples With DNA|"     miRNA, TET, whole genome sequencing   "|No||2017-10-10 22:25:35.398229|2017-10-10 22:25:35.398229
NCT02698111|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-10-12|||November 2016||2016-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma|Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma：an Open-label,Phase 1 Study.|Not yet recruiting||Phase 1|18|Anticipated|Suzhou Zelgen Biopharmaceuticals Co.,Ltd||1|||f||||f||||||||Undecided||2017-10-10 22:25:35.5028|2017-10-10 22:25:35.5028
NCT02698098|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-28|||August 2012||2012-08-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|PSVCC||Comparative Evaluation of PUSPENs and C&Cs|Comparing Health & Social Outcomes Between Opioid-Dependent Individuals in Compulsory Drug Rehabilitation Centers and Voluntary Drug Treatment Clinics in Klang Valley, Malaysia|Terminated||N/A|281|Actual|University of Malaya|||2|1) Policy change affecting C&Cs; 2) interm analysis revealing overt differences|f||||f||||||||Yes|See links at end of this record for accessing de-identified data and documentation.|2017-10-10 22:25:35.587223|2017-10-10 22:25:35.587223
NCT02698085|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-06-06|||April 2016||2016-04-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Diacutaneous Fibrolysis on Carpal Tunnel Syndrome|Effectiveness of Physiotherapy Treatment With Diacuteneous Fibrolysis in Patients With Carpal Tunnel Syndrome|Completed||N/A|60|Actual|Universidad de Zaragoza||2|||f||||t||||||||No|The patient data were confidential and were assigned a number to each patient to maintain confidentiality|2017-10-10 22:25:35.692549|2017-10-10 22:25:35.692549
NCT02698072|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-07-19|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|April 2016|Actual|2016-04-01||Interventional|||Improvement in Pain and Function Following a Physiotherapy Program in Older Adults With Knee Osteoarthritis|Improvement in Pain and Function Following a Therapeutic Exercise Program and Dry Needling in Older Adults With Knee Osteoarthritis: A Randomized Double-blind Multicenter Controlled Clinical Trial|Completed||N/A|100|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-10 22:25:35.786426|2017-10-10 22:25:35.786426
NCT02698059|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-04|||January 2016||2016-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Post-marketing Surveillance of the Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea|A Multi-center, Two-stage, Single-arm, Prospective, First-night Order Cross-over, Evaluator-blind Study to Evaluate the Efficacy, Safety and Tolerance of the iNAP® Sleep Therapy System in Adults With Obstructive Sleep Apnea (OSA)|Recruiting||N/A|63|Anticipated|Somnics, Inc.||1|||f||||f||||||||No||2017-10-10 22:25:35.887827|2017-10-10 22:25:35.887827
NCT02698046|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-02-28|||August 2015||2015-08-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||Oral Iron Therapy in Chronic Heart Failure Patients|Oral Iron Therapy in Chronic Heart Failure Patients: a Randomized, Placebo-controlled and Double-blind Clinical Trial (Pilot Study) of Efficiency|Recruiting||Phase 3|36|Anticipated|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 22:25:36.000792|2017-10-10 22:25:36.000792
NCT02698020|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-10-26|||November 2015||2015-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ANOXneo||Optimized Oxygen Delivery During General Anesthesia in Newborn Infants|Oxygen Delivery During General Anesthesia in Newborn Infants: An Open Randomized Controlled Trial of Two Levels of Inspired Oxygen.|Recruiting||N/A|40|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-10 22:25:36.2074|2017-10-10 22:25:36.2074
NCT02698007|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-10-13|||April 2016||2016-04-01|February 2016|2016-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Benefits of Using Laryngeal Mask Airway to Keep Airway Potency During Fiber-optic Bronchoscopy||Completed||N/A|100|Anticipated|Rabin Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:25:36.305791|2017-10-10 22:25:36.305791
NCT02697981|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-03-13|||April 2016||2016-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Personalized Nutrition Counseling in Pregnant Women After Bariatric Surgery on Nutritional Status and Habits|The Effect of Personalized Tailored Nutrition Counseling in Pregnant Women After Bariatric Surgery on Compliance and Nutritional Habits|Not yet recruiting||N/A|60|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-10 22:25:36.477115|2017-10-10 22:25:36.477115
NCT02697968|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-05-03|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Electroacupuncture for Relieving Pain in Ankylosing Spondylitis|Electroacupuncture for Relieving Pain in Ankylosing Spondylitis: a Single-arm Pilot Study|Recruiting||N/A|20|Anticipated|The University of Hong Kong||1|||f||||||||||||||2017-10-10 22:25:36.566036|2017-10-10 22:25:36.566036
NCT02697955|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-03-24|||June 21, 2016|Actual|2016-06-21|September 2016|2016-09-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||The Effect of Subsartorial Saphenous Block on Postoperative Pain Following Major Ankle and Hind Foot Surgery|The Effect of Subsartorial Saphenous Block on Postoperative Pain Following Major Ankle and Hind Foot Surgery|Completed||Phase 4|18|Actual|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-10 22:25:36.663323|2017-10-10 22:25:36.663323
NCT02697916|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-05-04|||March 2016||2016-03-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|ADAPTABLE||Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term|Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness|Enrolling by invitation||N/A|20000|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 22:25:36.9639|2017-10-10 22:25:36.9639
NCT02697903|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-02|||January 2015||2015-01-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pomegranate Improve Biological Recovery Kinetics in Elite Weightlifter|Pomegranate Supplementation Accelerates the Recovery Kinetics of Muscle Damage, Muscle Soreness and Inflammatory Marker After Weightlifting Training Session.|Completed||N/A|9|Actual|The Higher Institute of Sport and Physical Education of Sfax||2|||f||||t||||||||Yes|Data will be shared with researchers outside the primary research group for reanalysis purpose.|2017-10-10 22:25:37.127746|2017-10-10 22:25:37.127746
NCT02697890|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-07|2017-04-07||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|Mucograft||Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft|Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft: A Randomized Controlled Clinical Trial and Radiographic Evaluation|Active, not recruiting||N/A|28|Actual|Tufts University School of Dental Medicine||2|||f||||f||||||||No||2017-10-10 22:25:37.229123|2017-10-10 22:25:37.229123
NCT02697877|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Observational|||Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements|Assessment and Prognostic Significance of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements During Regadenoson Stress Cardiac Magnetic Resonance|Recruiting||N/A|200|Anticipated|University of Illinois at Chicago|||1||f||||||||||||||2017-10-10 22:25:37.490472|2017-10-10 22:25:37.490472
NCT02697864|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-07-20|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study Comparing Amounts of Tafamidis In The Blood Without Food|A Phase 1, Open‑Label, Three Period Randomized, Single Dose Study To Estimate The Relative Bioavailability Of Pf‑06291826 (Tafamidis) Free Acid Tablet Formulation Versus Commercial Capsule In Healthy Subjects Under Fasted Conditions|Completed||Phase 1|12|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 22:25:37.577072|2017-10-10 22:25:37.577072
NCT02697838|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-03-22|||August 2016||2016-08-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer|Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer|Recruiting||N/A|20|Anticipated|Fujian Cancer Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:25:37.648539|2017-10-10 22:25:37.648539
NCT02697825|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-02-26|||September 2015||2015-09-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Intraocular Pressure Versus Optic Nerve Sheath Diameter|Correlation Between Intraocular Pressure and Optic Nerve Sheath Diameter|Recruiting||N/A|100|Anticipated|Rajiv Gandhi Cancer Institute & Research Center, India||1|||f||||t||||||||Undecided|It will be decide only after the completion of study|2017-10-10 22:25:37.726726|2017-10-10 22:25:37.726726
NCT02697812|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-09-18|||January 2014||2014-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Does the Speed of Sternal Retraction Affect Postoperative Pain Outcomes|Does the Speed of Sternal Retraction During Coronary Artery Bypass Graft Surgery Affect Postoperative Pain Outcomes: A Randomized Controlled Trial|Recruiting||N/A|316|Anticipated|Queen's University||2|||f||||t||||||||||2017-10-10 22:25:37.805478|2017-10-10 22:25:37.805478
NCT02697799|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-09-28|||August 2016||2016-08-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|September 2019|Anticipated|2019-09-01||Interventional|||A Randomized Trial of Recruitment Strategies for Research Participation|A Randomized Trial of Recruitment Strategies for Research Participation|Recruiting||N/A|576|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-10-10 22:25:37.890195|2017-10-10 22:25:37.890195
NCT02697786|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-10-27|||January 2016||2016-01-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|IMLPBIAVR||Neuromonitoring in Patients During Aortic Valve Replacement|The Impact of Intraoperative Microemboli Load on Postoperative Brain Injury in Patients Undergoing Aortic Valve Replacement Preformed With Two Different Surgical Approaches|Enrolling by invitation||Phase 3|60|Anticipated|University Medical Centre Ljubljana||2|||f||||||||||||Undecided||2017-10-10 22:25:38.243973|2017-10-10 22:25:38.243973
NCT02697773|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-09-18|||January 21, 2016|Actual|2016-01-21|September 2017|2017-09-01|May 15, 2018|Anticipated|2018-05-15|November 28, 2017|Anticipated|2017-11-28||Interventional|||Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee|A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study Of The Analgesic Efficacy And Safety Of A Dose Titration Regimen For The Subcutaneous Administration Of Tanezumab In Subjects With Osteoarthritis Of The Hip Or Knee|Recruiting||Phase 3|690|Anticipated|Pfizer||3|||f||||t|t|f||||||||2017-10-10 22:25:38.37598|2017-10-10 22:25:38.37598
NCT02697760|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-02|||September 2015||2015-09-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CZT||The CZT Dynamic Myocardial Perfusion Imaging|The Quantification, Clinical Application of Dynamic Imaging Using Cadmium-zinc-telluride (CZT) Cameras to Assess Myocardial Perfusion|Recruiting||N/A|300|Anticipated|Far Eastern Memorial Hospital|||1||f||||f||||||||No||2017-10-10 22:25:38.727382|2017-10-10 22:25:38.727382
NCT02697747|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-07-12|||November 2015||2015-11-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Identification of L3-L4 Interspace in Parturients|Identification of L3-L4 Interspace in Parturients|Recruiting||N/A|18|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-10 22:25:38.812995|2017-10-10 22:25:38.812995
NCT02697708|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-04-01|||February 2016||2016-02-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Retention of Potassium From Potatoes and Potassium Gluconate, and the Effect on Blood Pressure.|The Effect of Potatoes on Potassium Retention, Acid Base Balance, and Blood Pressure|Recruiting||N/A|40|Anticipated|Purdue University||4|||f||||t||||||||Undecided||2017-10-10 22:25:39.20197|2017-10-10 22:25:39.20197
NCT02697695|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-04-18|||October 2014||2014-10-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||Chronic Inflammation After Obesity Surgery|Impact of Obesity and Metabolic Surgery on Chronic Inflammation|Completed||N/A|500|Actual|Sana Klinikum Offenbach|||3||f||||f||||||||No||2017-10-10 22:25:39.321497|2017-10-10 22:25:39.321497
NCT02697682|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2017-08-08|||March 2016||2016-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study|Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study|Completed||N/A|20|Actual|Hvidovre University Hospital||1|||f||||t||||||||||2017-10-10 22:25:39.413834|2017-10-10 22:25:39.413834
NCT02697669|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-03|||August 2012||2012-08-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Role of Nuclear Imaging in Heart Failure|The Role of Nuclear Imaging in Heart Failure: Correlation With Cardiac Function and Metabolism, Biomarkers and Clinical Prognosis|Recruiting||N/A|200|Anticipated|Far Eastern Memorial Hospital|||1||f||||f||||||||No||2017-10-10 22:25:39.495734|2017-10-10 22:25:39.495734
NCT02697656|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-10-11|||November 2015||2015-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|IPSinPain||The Effectiveness of Individual Placement and Support in Chronic Pain Patients|A Randomized Controlled Trial Assessing the Effectiveness of the Individual Placement and Support Model for Patients With Chronic Pain in an Outpatient Hospital Pain Clinic|Recruiting||Phase 1/Phase 2|100|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 22:25:39.583095|2017-10-10 22:25:39.583095
NCT02697643|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-08-29|||February 2016||2016-02-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|BHCDS||A Clinical Decision Support Tool for Electronic Health Records|A Clinical Decision Support Tool for Electronic Health Records|Recruiting||Phase 2|250|Anticipated|Inflexxion, Inc.||2|||f||||t||||||||||2017-10-10 22:25:39.680889|2017-10-10 22:25:39.680889
NCT02697630|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-05-30|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|PEMDAC||Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye|A Multicenter Phase II Open Label Study to Evaluate Efficacy of Concomitant Use of Pembrolizumab and Entinostat in Adult Patients With Metastatic Uveal Melanoma|Not yet recruiting||Phase 2|29|Anticipated|Vastra Gotaland Region||1|||f||||f|f|f||||||No||2017-10-10 22:25:39.776502|2017-10-10 22:25:39.776502
NCT02697617|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-08-18|||January 26, 2016|Actual|2016-01-26|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|PIOPKD||Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease|Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney|Active, not recruiting||Phase 2|36|Actual|Indiana University||2|||f||||t||||||||||2017-10-10 22:25:39.880024|2017-10-10 22:25:39.880024
NCT02697604|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-02-27|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:25:39.966882|2017-10-10 22:25:39.966882
NCT02697591|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-08-02|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||An Open-Label, Dose-Escalation, Safety Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors|A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|146|Anticipated|Incyte Corporation||1|||f||||f||||||||||2017-10-10 22:25:40.016693|2017-10-10 22:25:40.016693
NCT02697578|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-08-18|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|September 15, 2018|Anticipated|2018-09-15|September 15, 2018|Anticipated|2018-09-15||Observational|||Artificial Intelligence: a New Alternative to Analyse the Relationship Between Calcium, Phosphorus and PTH Concentrations in Haemodialysis Patients and Preventing the Cardiovascular Risk.||Recruiting||N/A|100|Anticipated|Maimónides Biomedical Research Institute of Córdoba|||1||f||||f||||||||||2017-10-10 22:25:40.137416|2017-10-10 22:25:40.137416
NCT02697565|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-03-08|||April 2015||2015-04-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Healthy Caregivers-Healthy Children (HC2) Phase II|Healthy Caregivers-Healthy Children (HC2) Phase II: Integrating Culturally Sensitive Childhood Obesity Prevention Strategies Into Policy|Recruiting||N/A|1000|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 22:25:40.210751|2017-10-10 22:25:40.210751
NCT02697552|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-01-10|||March 2014||2014-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety Study of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma|A Phase 1 Open-label Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma|Completed||Phase 1|13|Actual|HUYA Bioscience International||1|||f||||t||||||||No||2017-10-10 22:25:40.342121|2017-10-10 22:25:40.342121
NCT02697539|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-02-26|||March 2011||2011-03-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|PFR||Plaque Formation Rate and Toothpaste|"Efficacy of a New Carbonate/Hydroxyapatite Nanocrystal Dentifrice on the Dental Plaque Index and the de Novo Plaque Formation Rate in Individuals Suffering From Gingivitis and/or Periodontitis"|Completed||N/A|74|Actual|University Hospital Muenster||2|||f||||f||||||||Undecided|we would provide data for meta analysies. But because this was not scheduled while prototcol approvement, this must be finally decided by the responisble ethic comittee.|2017-10-10 22:25:40.438395|2017-10-10 22:25:40.438395
NCT02697526|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-02-26|||January 2007||2007-01-01|February 2016|2016-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Differences in Radial Artery Occlusion From Two Different Compressive Methods Used in Patients in Order to Achieve Homeostasis After Transradial Catheterization and Their Repercussion in Artery Functionality and Hand Mobility|Influence of the Compression Method After Transradial Catheterization in Radial Artery|Completed||N/A|274|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-10 22:25:40.524513|2017-10-10 22:25:40.524513
NCT02697513|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2017-04-28|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||The 'Bekele Afessa Scan-Teach-Treat Approach'|The 'Bekele Afessa Scan-Teach-Treat Approach' to Improve Care of Patients With Acute Infection at the Gitwe Hospital in Gitwe/Rwanda|Active, not recruiting||N/A|1594|Actual|University of Salzburg||2|||f||||t||||||||No||2017-10-10 22:25:40.642379|2017-10-10 22:25:40.642379
NCT02697500|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-03-02|||March 2016||2016-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Pre-analytical Sample Handling Conditions and Their Effects on the Human Serum Metabolome||Completed||N/A|13|Actual|USDA Beltsville Human Nutrition Research Center|||1||f||||f||||||None Retained|"     serum and urine   "|||2017-10-10 22:25:40.708553|2017-10-10 22:25:40.708553
NCT02697487|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-04-20|||February 2016||2016-02-01|April 2017|2017-04-01|February 2027|Anticipated|2027-02-01|February 2026|Anticipated|2026-02-01||Observational|||UTSW Depression Cohort: A Longitudinal Study of Depression|UTSW Depression Cohort: A Longitudinal Study of Depression|Recruiting||N/A|100000|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples With DNA|"     Biospecimens being studied is as follows:        1. Blood        2. Normal Tissue        3. Saliva        4. Urine        5. Stool        6. Clinical waste products to include surgical waste tissue samples, placenta samples, and          biopsy samples.   "|Yes||2017-10-10 22:25:40.760781|2017-10-10 22:25:40.760781
NCT02697474|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-04-25|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Interventional|||Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.|Persistence of Anti-Hep B Antibodies at 9 to 10 Years of Age in Subjects Having Received Hep B Vaccine at Birth and a DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine at 2, 4 and 6 Months of Age, and Evaluation of Their Immune Memory Following a Challenge Re-vaccination With a Stand Alone Hep B Vaccine|Completed||Phase 3|150|Actual|Sanofi||2|||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at http://www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI).
Details on Data Sharing criteria and process for requesting access can be found at this web address: http://www.Clinicalstudydatarequest.com/Sanofi"|2017-10-10 22:25:40.845646|2017-10-10 22:25:40.845646
NCT02697461|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-05-02|||January 2016||2016-01-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|May 9, 2017|Anticipated|2017-05-09||Interventional|||Multisegmented Foot Motion in Patients With Lateral Ankle Sprains and Chronic Ankle Instability|Multisegmented Foot Motion in Patients With Lateral Ankle Sprains and Chronic Ankle Instability|Active, not recruiting||N/A|115|Actual|University of Virginia||2|||f||||f||||||||||2017-10-10 22:25:40.929806|2017-10-10 22:25:40.929806
NCT02697448|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-03-23|||February 2016||2016-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.|Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.|Recruiting||N/A|126|Anticipated|Medical University of South Carolina||2|||f||||t||||||||No||2017-10-10 22:25:41.030859|2017-10-10 22:25:41.030859
NCT02697435|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-15|||April 1, 2016|Actual|2016-04-01|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|March 1, 2018|Anticipated|2018-03-01||Interventional|||Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)|Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:25:41.108045|2017-10-10 22:25:41.108045
NCT02697422|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-06-08|||May 30, 2017|Actual|2017-05-30|June 2017|2017-06-01|February 28, 2021|Anticipated|2021-02-28|August 31, 2020|Anticipated|2020-08-31||Interventional|Vet-COACH||Veteran Peer Coaches Optimizing and Advancing Cardiac Health|Vet COACH (Veteran Peer Coaches Optimizing and Advancing Cardiac Health)|Recruiting||N/A|590|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Yes|"We will adhere to all VA 1200.12 policies to protect individual privacy & confidentiality of data. Data will be made available outside VA in response to a properly prepared Freedom of Information Act request submitted & evaluated by the VA Puget Sound FOIA Officer, or as passed down to the facility.
A unique study ID will label all data records to allow validation of results, but prevent data from being linked to individuals. Records across data sets can be cross-referenced using the study ID to verify accuracy of publication results. Research publications will be made available to the public via the National Library of Medicine PubMed Central website within one year after publication date(s). A Limited Dataset will be created & shared pursuant a Data Use Agreement that appropriately limits use of the dataset & prohibits recipients from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset."|2017-10-10 22:25:41.424684|2017-10-10 22:25:41.424684
NCT02697409|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2017-06-02|||March 2016||2016-03-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Education Against Tobacco Randomized Trial|Medical-student-delivered Smoking Prevention Program for Secondary Schools: The Education Against Tobacco Randomized Trial|Active, not recruiting||N/A|20000|Anticipated|University of Giessen||2|||f||||t||||||||Undecided||2017-10-10 22:25:41.619353|2017-10-10 22:25:41.619353
NCT02697396|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-06-01|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children|A Randomized Controlled Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children|Recruiting||N/A|200|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-10 22:25:41.737408|2017-10-10 22:25:41.737408
NCT02697383|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-26|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study|Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study|Recruiting||Phase 1|14|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:25:41.883994|2017-10-10 22:25:41.883994
NCT02697370|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-26|||April 2013||2013-04-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A|Efficacy and Cost Effectiveness of Standard Versus Pharmacokinetic Dosing During Factor VIII Prophylaxis in Adult Patients With Severe Haemophilia A|Completed||Phase 4|20|Actual|Hampshire Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 22:25:42.015944|2017-10-10 22:25:42.015944
NCT02697357|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-01|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Emotion Regulation Therapy to Address Distress Among Caregivers|Emotion Regulation Therapy to Address Distress Among Caregivers|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"     optional blood sample and a saliva sample   "|||2017-10-10 22:25:42.091681|2017-10-10 22:25:42.091681
NCT02697344|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-05-08|||April 14, 2017|Actual|2017-04-14|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||R-(-)-Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma|Phase 1/2 Trial of AT-101 in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed Symptomatic Multiple Myeloma|Recruiting||Phase 1/Phase 2|63|Anticipated|Mayo Clinic||1|||f||||t|t|f||||||||2017-10-10 22:25:42.172058|2017-10-10 22:25:42.172058
NCT02697331|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-02|||December 2015||2015-12-01|March 2016|2016-03-01||||October 2016|Anticipated|2016-10-01||Interventional|||Evaluation of the Role of Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation With Short Cervix: Randomised Controlled Trial|Evaluation of the Role of Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation With Short Cervix: Randomised Controlled Trial|Recruiting||Phase 3|130|Anticipated|Ain Shams University||2|||f||||||||||||||2017-10-10 22:25:42.315454|2017-10-10 22:25:42.315454
NCT02697318|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2017-08-23|||May 2016||2016-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of a New Method for Instilling Eye Drops|Evaluation of a New Method for Instilling Eye Drops|Recruiting||Early Phase 1|60|Anticipated|University of Waterloo||2|||f||||f||||||||||2017-10-10 22:25:42.414066|2017-10-10 22:25:42.414066
NCT02697305|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-27|2016-03-07|||September 2014||2014-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Incretin Effects of Branched Chain Amino Acids|Effect of Intravenously and Orally Administered Branched Chain Amino Acids on Incretin Response|Completed||N/A|18|Actual|Charles University, Czech Republic||3|||f||||f||||||||Yes||2017-10-10 22:25:42.493578|2017-10-10 22:25:42.493578
NCT02697292|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-08-17|||February 2016||2016-02-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy|A Randomized Double Blind Placebo Controlled Study of Intravenous Immunoglobulin (IVIG) Patients With Voltage Gated Potassium Channel Complex (VGKC) Antibody Associated Autoimmune Epilepsy|Recruiting||Phase 3|30|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:25:42.604842|2017-10-10 22:25:42.604842
NCT02697279|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Loop Drainage: Effectiveness in Treating Cutaneous Abscesses|Evaluation of Loop Drainage Technique Versus Standard Incision and Drainage for Treatment of Simple Soft Tissue Abscesses|Recruiting||N/A|178|Anticipated|University of Maryland||2|||f||||t||||||||No||2017-10-10 22:25:42.693292|2017-10-10 22:25:42.693292
NCT02697266|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-09-08|||March 2014||2014-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Observational|||The Effects of Night Call on Intellectual Performance|Individual Coping Strategies After Night Calls: Effects on Performing Clinical and Cognitive Tasks|Completed||N/A|21|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-10 22:25:42.78367|2017-10-10 22:25:42.78367
NCT02697253|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-01-26|||January 2016||2016-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Mechanisms Underlying Predictors of Success From Obesity Surgery|Mechanisms Underlying Predictors of Success From Obesity Surgery|Recruiting||N/A|100|Anticipated|Columbia University||4|||f|||||f|f|||f|||Undecided||2017-10-10 22:25:42.863991|2017-10-10 22:25:42.863991
NCT02697240|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-29|2016-02-29|||February 2016||2016-02-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome|A Phase 1 Dose Escalation Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome|Recruiting||Phase 1|14|Anticipated|University of Mississippi Medical Center||1|||f||||t||||||||No||2017-10-10 22:25:42.958879|2017-10-10 22:25:42.958879
NCT02697227|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-04-26|||August 2016|Actual|2016-08-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Behavioral Activation Therapy for Smoking Cessation|Low Reward Sensitivity and Behavioral Activation Therapy for Smoking Cessation|Recruiting||N/A|80|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 22:25:43.057275|2017-10-10 22:25:43.057275
NCT02697201|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-25|||July 2016||2016-07-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|DYNAMMO-T2D||Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)|Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO-T2D)|Recruiting||N/A|20|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 22:25:43.254107|2017-10-10 22:25:43.254107
NCT02697188|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-03-02|||November 2007||2007-11-01|February 2016|2016-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men|Phase IIa, Pilot, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men|Completed||Phase 2|12|Actual|Clarus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:25:43.35066|2017-10-10 22:25:43.35066
NCT02697175|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2017-03-22|||August 2016||2016-08-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Video Colposcopy in Women With Dysplasia|Does Live Video Colposcopy Reduces Anxiety in Women With Cervical Dysplasia? A Randomised Trial.|Completed||N/A|275|Actual|Zydolab - Institute of Cytology and Immune Cytochemistry||2|||f||||f||||||||No||2017-10-10 22:25:43.44214|2017-10-10 22:25:43.44214
NCT02697162|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-04|||June 2016||2016-06-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|December 2016|Anticipated|2016-12-01||Interventional|GuardianCath||Antiseptic-coated Intermittent Urinary Catheter|Antiseptic-coated Intermittent Urinary Catheter: Efficacy and Feasibility of Neurogenic Bladder Management and Prevention of Catheter-associated Urinary Tract Infections in Children|Not yet recruiting||Phase 2/Phase 3|50|Anticipated|Children's Hospital Zagreb||2|||f||||f||||||||Undecided||2017-10-10 22:25:43.528291|2017-10-10 22:25:43.528291
NCT02697149|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-07-20|||December 2015||2015-12-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Nonradiation-to-endoscopist Endoscopic Retrograde Cholangiopancreatography in Patients With Complexity Level I/II|The Effectiveness and Safety of Nonradiation-to-endoscopist Endoscopic Retrograde Cholangiopancreatography in Patients With Complexity Level I/II|Completed||N/A|219|Actual|Fourth Military Medical University|||2||f||||t||||||||||2017-10-10 22:25:43.621777|2017-10-10 22:25:43.621777
NCT02697136|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-03-16|||December 2015||2015-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TANGO||CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases|Phase 3, Multicenter, Randomized, 48 Week, Double Blind, Parallel Group, Placebo Controlled Study to Evaluate Efficacy and Safety of CER-001 on Vessel Wall Area in Patients With Genetically Defined Familial Primary Hypoalphalipoproteinemia|Recruiting||Phase 3|30|Anticipated|Cerenis Therapeutics, SA||2|||f||||t||||||||Undecided|To be determined|2017-10-10 22:25:43.714722|2017-10-10 22:25:43.714722
NCT02697123|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-09-21|||January 2016||2016-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01|5 Days|Observational [Patient Registry]|||Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients|Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients|Active, not recruiting||N/A|5|Actual|Baylor College of Medicine|||1||f||||t||||||||Undecided||2017-10-10 22:25:43.836976|2017-10-10 22:25:43.836976
NCT02697110|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-25|||November 2014||2014-11-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|FINEBRAINS||Family Inclusive Early Brain Stimulation|Family Inclusive Early Brain Stimulation|Active, not recruiting||N/A|480|Actual|University of Ibadan||2|||f||||t||||||||||2017-10-10 22:25:43.905466|2017-10-10 22:25:43.905466
NCT02697097|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-02-28|||April 2016||2016-04-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Observational|||Hip Muscle Strength in FAI Versus Normal Controls|Muscle Strength in Femoroacetabular Impingement: A Comparative Study of Patients With FAI Versus Normal Controls|Not yet recruiting||N/A|20|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||2||f||||f||||||||No||2017-10-10 22:25:43.97419|2017-10-10 22:25:43.97419
NCT02697084|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-02|||November 2014||2014-11-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Observational|IFACT||Individual Following in Anal Cancer With PET/CT|Individual Following in Anal Cancer With PET/CT|Recruiting||N/A|110|Anticipated|Centre Antoine Lacassagne|||1||f||||f||||||||No||2017-10-10 22:25:44.052838|2017-10-10 22:25:44.052838
NCT02697071|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-06-06|||February 2016||2016-02-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Ketamine for Acute Migraine in the Emergency Department|A Randomized Placebo-Controlled Trial of Sub-Dissociative Ketamine for Treatment of Acute Migraine-Type Headache in the Emergency Department|Completed||N/A|96|Anticipated|Carilion Clinic||2|||f||||||||||||||2017-10-10 22:25:44.12895|2017-10-10 22:25:44.12895
NCT02697058|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2017-04-07|||March 2016||2016-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer|Phase II Randomized Study of BAX2398 in Combination With 5-Fluorouracil and Calcium Levofolinate in Japanese Patients With Metastatic Pancreatic Cancer, Which Progressed or Recurred After Prior Gemcitabine-Based Therapy|Active, not recruiting||Phase 2|80|Anticipated|Baxalta US Inc.||3|||f||||t||||||||||2017-10-10 22:25:44.204093|2017-10-10 22:25:44.204093
NCT02697045|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-02-26|||April 2016||2016-04-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|ARILAI||Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch|Nautralsitic, Open-label, Single Arm Study Evaluating Effects of Aripiprazole LAI on Phychosocial&Congitive Functioning, Patient Reported Acceptability of Treatment Regarding QoL, Subjective Well-being Under Neuroleptic Medication in Sch|Not yet recruiting||Phase 4|180|Anticipated|Abdi İbrahim Otsuka||1|||f||||f||||||||Yes||2017-10-10 22:25:44.323491|2017-10-10 22:25:44.323491
NCT02697032|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-06-01|||February 2016||2016-02-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||FDHT PET and Bicalutamide in Metastatic Breast Cancer|FDHT-PET to Visualize the Effect on the Androgen Receptor Level by Bicalutamide|Recruiting||Phase 2|20|Anticipated|University Medical Center Groningen||1|||f||||t||||||||Undecided||2017-10-10 22:25:44.403764|2017-10-10 22:25:44.403764
NCT02697019|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-09-01|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Internet-delivered Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study|Internet-delivered Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study|Active, not recruiting||N/A|25|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 22:25:44.495548|2017-10-10 22:25:44.495548
NCT02697006|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-03-23|||January 2016||2016-01-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Synchronized Cardiac Assist for Cardiogenic Shock|Synchronized Cardiac Assist for Cardiogenic Shock. The SynCor Trial|Recruiting||N/A|45|Anticipated|Xenios AG|||1||f||||t||||||||No||2017-10-10 22:25:44.567847|2017-10-10 22:25:44.567847
NCT02696993|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-02-14|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-Small Cell Lung Cancer|Phase I/II Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|80|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 22:25:44.640545|2017-10-10 22:25:44.640545
NCT02696980|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-10-31|||April 2016||2016-04-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|April 2020|Anticipated|2020-04-01||Interventional|||PEEP as Rescue Therapy for Asthmatics With Elevated BMI|Increased Lung Volume as Rescue Therapy for Asthma|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Vermont||3|||f||||t||||||||Yes|Results will be published in the archival literature, and this will include a complete description of experimental and analytical methods used. All original experimental data will be stored and available to interested investigators with appropriate regulatory approvals in place.|2017-10-10 22:25:44.770688|2017-10-10 22:25:44.770688
NCT02696954|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-22|||November 2016||2016-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ALAQPQ||Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects|A Randomized, Open-Label Study to Evaluate Potential Pharmacokinetic Interactions of Orally Administered Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Adult Subjects|Recruiting||Phase 1/Phase 2|16|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-10 22:25:44.949527|2017-10-10 22:25:44.949527
NCT02696941|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-11-09|||February 2016||2016-02-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SMASH||SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis|SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis|Recruiting||Phase 1|23|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-10 22:25:45.056929|2017-10-10 22:25:45.056929
NCT02696928|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-03-03|||April 2016||2016-04-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|BlueAL||Methylene Blue Against Vivax Malaria in Ethiopia|Feasibility of Methylene Blue-based Combination Therapy in the Radical Treatment of Adult Patients With Plasmodium Vivax Malaria in Ethiopia: a Randomised Controlled Pilot Trial|Not yet recruiting||Phase 2|99|Anticipated|Heidelberg University||3|||f||||f||||||||Undecided||2017-10-10 22:25:45.259518|2017-10-10 22:25:45.259518
NCT02696915|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-04|||January 2015||2015-01-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Fascia Iliaca Compartment Block for Proximal-end Femur Fractures|Fascia Iliaca Compartment Block in Proximal End Femur Fractures, Does it Make a Difference?|Completed||N/A|60|Actual|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:25:45.379081|2017-10-10 22:25:45.379081
NCT02696902|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-09-22|||March 25, 2016|Actual|2016-03-25|September 2017|2017-09-01|February 19, 2021|Anticipated|2021-02-19|February 19, 2021|Anticipated|2021-02-19||Interventional|EVADE||Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects|A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa|Recruiting||Phase 2|286|Anticipated|MedImmune LLC||2|||f||||t|t|f|||t|||||2017-10-10 22:25:45.505637|2017-10-10 22:25:45.505637
NCT02696889|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-07-17|||February 2016||2016-02-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|ROSE||Rejuvenation of Premature Ovarian Failure With Stem Cells|Autologous Stem Cell Therapy for Premature Ovarian Failure|Recruiting||N/A|33|Anticipated|MD Stem Cells||1|||f||||t||||||||||2017-10-10 22:25:45.789331|2017-10-10 22:25:45.789331
NCT02696876|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|AURA||Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair|Safety and Efficacy of a Novel Synovium Brushing Method for Endogenous Mesenchymal Stem Cells Mobilisation During Knee Joint Microfracture for Cartilage Repair.|Recruiting||N/A|20|Anticipated|University of Leeds||2|||f||||f||||||||No||2017-10-10 22:25:45.892994|2017-10-10 22:25:45.892994
NCT02696863|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-13|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|RECAP 2||Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study||Recruiting||N/A|20|Anticipated|Institut de Cancérologie de la Loire|||1||f||||f||||||||||2017-10-10 22:25:46.018727|2017-10-10 22:25:46.018727
NCT02696850|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-04-26|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|||The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis|The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis|Completed||Phase 4|80|Actual|Washington University School of Medicine||2|||f||||t||||||||Yes||2017-10-10 22:25:46.110138|2017-10-10 22:25:46.110138
NCT02696837|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-05-28|||March 2016||2016-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Pediatric Inguinal Hernia Repair: Are Muscle Relaxants Necessary? Endotracheal Intubation vs Laryngeal Mask Airway|Safety Control Study in Pediatric Inguinal Hernia Repair: Are Muscle Relaxants Necessary? Endotracheal Intubation vs Laryngeal Mask Airway|Completed||N/A|80|Actual|Maltepe University||4|||f||||t||||||||Undecided||2017-10-10 22:25:46.22759|2017-10-10 22:25:46.22759
NCT02696824|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-08|||March 2016||2016-03-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South Africa|Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South Africa|Recruiting||N/A|160|Anticipated|University of Miami||2|||f||||t||||||||||2017-10-10 22:25:46.348986|2017-10-10 22:25:46.348986
NCT02696811|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-25|||October 2015||2015-10-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||The Effects of Foods on Cell Damage Study|Randomised 6-week, Parallel Group, Placebo Controlled Intervention Trial to Investigate the Effects of White Carrots on Inflammatory Markers and Lymphocyte DNA Damage|Recruiting||N/A|56|Anticipated|Newcastle University||2|||f||||f||||||||Undecided||2017-10-10 22:25:46.479143|2017-10-10 22:25:46.479143
NCT02696798|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-10-02|||April 2016||2016-04-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|COAST-W||A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis|A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis|Recruiting||Phase 3|300|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:25:46.605044|2017-10-10 22:25:46.605044
NCT02696265|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-06-01|||May 2016||2016-05-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|April 2018|Anticipated|2018-04-01||Interventional|CIPA||CFAE/Spatiotemporal Dispersion Guided Ablation Versus PVI Guided Ablation in Persistent AF|Complex Fractionated Atrial Electrocardiograms (CFAEs) Spatiotemporal Dispersion Guided Ablation Versus Pulmonary Vein Isolation (PVI) Guided Ablation in Persistent Atrial Fibrillation, a Multicenter Randomized Trial|Recruiting||N/A|120|Anticipated|Diagram B.V.||2|||f||||f||||||||Undecided||2017-10-10 22:25:53.814228|2017-10-10 22:25:53.814228
NCT02696785|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-10-02|||May 2016||2016-05-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|COAST-V||A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis|A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis|Recruiting||Phase 3|320|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:25:47.227751|2017-10-10 22:25:47.227751
NCT02696772|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-03-01|||October 2013||2013-10-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Effect of 24 h Severe Energy Restriction on Appetite Regulation and Ad-libitum Energy Intake|Effect of 24 h Severe Energy Restriction on Appetite Regulation and Ad-libitum Energy Intake in Lean Males and Females|Completed||N/A|18|Actual|Loughborough University||2|||f||||f||||||||No||2017-10-10 22:25:47.513699|2017-10-10 22:25:47.513699
NCT02696759|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-07-18|||July 2016||2016-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer|The Gut Microbiome and Gastrointestinal Toxicities as Determinants of the Response to Neoadjuvant Chemotherapies for Advanced Breast Cancer|Recruiting||N/A|40|Anticipated|University of Arkansas||1|||f||||f||||||||||2017-10-10 22:25:47.573993|2017-10-10 22:25:47.573993
NCT02696746|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-16|||February 2012||2012-02-01|August 2017|2017-08-01||||January 2019|Anticipated|2019-01-01||Observational|PCS||Painful Channelopathies Study|Painful Channelopathies Study|Recruiting||N/A|100|Anticipated|King's College London|||1||f||||f||||||Samples With DNA|"     1. The investigators will collect blood samples (30mls) from each subject, which will be          stored at -800C in a locked freezer. They will sequence known genes associated with          painful channelopathies: SCN9a and TRPA1. They will store DNA in order that it is          possible that other candidate genes associated with pain can be tested.        2. 3mm skin punch biopsies performed 10 cm above lateral malleolus for 2 different          purposes:             -  Nerve fibre density measurement             -  Fibroblasts cultures as these represent a useful tool in the future as a source of               cells the phenotype of which can be modulated for instance to generate induced               pluripotent stem cells   "|||2017-10-10 22:25:47.694693|2017-10-10 22:25:47.694693
NCT02696733|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-13|||February 2016||2016-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach|Ultrasound-Guided Obturator Nerve Block for Transurethral Procedures - Interadductor Approach|Recruiting||Phase 4|100|Anticipated|Medical University of Warsaw||1|||f||||f||||||||||2017-10-10 22:25:47.787951|2017-10-10 22:25:47.787951
NCT02696720|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-07-25|||April 2016||2016-04-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Trial of Lidocaine Patch for Lower Limb Amputation Pain|A Randomized Controlled Trial of Lidocaine Patch for Lower Limb Amputation Pain|Recruiting||Phase 2|20|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:25:47.890427|2017-10-10 22:25:47.890427
NCT02696707|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-09-15|||June 2016||2016-06-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|OTT 15-05||An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer|An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer|Recruiting||Early Phase 1|200|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No||2017-10-10 22:25:47.993207|2017-10-10 22:25:47.993207
NCT02696694|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-11-28|||February 2016||2016-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles|Impact of Serum Progesterone Levels on the Day of Embryo Transfer on the Success Rate in Egg Donation Cycles Under Hormonal Replacement|Completed||N/A|242|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA|||2||f||||f||||||Samples Without DNA|"     Blood sample   "|No||2017-10-10 22:25:48.073262|2017-10-10 22:25:48.073262
NCT02696681|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-03-17|||March 2016||2016-03-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|APPROACH||Addressing Psychosocial Comorbidities in HIV Treatment and Prevention|Addressing Psychosocial Comorbidities in HIV Treatment and Prevention: Phase 2|Recruiting||N/A|30|Anticipated|University of Miami||1|||f||||f||||||||||2017-10-10 22:25:48.160125|2017-10-10 22:25:48.160125
NCT02696668|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-03-08|||May 1, 2017|Anticipated|2017-05-01|March 2017|2017-03-01|March 1, 2020|Anticipated|2020-03-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Advances in Group-based Falls Rehabilitation|The Effect of a Modified FaME vs. a Multisensory Group Balance Programme on Falls Risk, Balance Confidence and Quality of Life in Older Adult Who Fall or Are at Risk of Falling|Not yet recruiting||N/A|100|Anticipated|King's College London||2|||f||||t|f|f||||||Undecided||2017-10-10 22:25:48.238762|2017-10-10 22:25:48.238762
NCT02696655|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-03-01|||February 2016||2016-02-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|LIFT||Lifestyle Intervention For Liver Transplantation|Development and Feasibility Testing of a Behavioural Intervention Targeting Multiple Lifestyle Behaviours to Improve Long Term Outcomes Following Liver Transplantation|Not yet recruiting||N/A|40|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust||1|||f||||f||||||||||2017-10-10 22:25:48.320109|2017-10-10 22:25:48.320109
NCT02696629|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-07-26|||February 2016||2016-02-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|November 2016|Actual|2016-11-01||Observational|||The Impact of Sleep Apnea Treatment on Physiology Traits in Chinese Patients With Obstructive Sleep Apnea|The Impact of Sleep Apnea Treatment on Physiology Traits in Chinese Patients With Obstructive Sleep Apnea|Active, not recruiting||N/A|60|Anticipated|Beijing Tongren Hospital|||3||f||||f||||||||||2017-10-10 22:25:50.249415|2017-10-10 22:25:50.249415
NCT02696616|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-10-27|||March 2016||2016-03-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 655088 Administered by Intravenous Infusion in Healthy Male Subjects (Single-blind, Partially Randomised Within Dose Groups, Placebo-controlled, Parallel Group Design)|Suspended||Phase 1|64|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:25:50.33915|2017-10-10 22:25:50.33915
NCT02696603|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-07-22|||March 2015||2015-03-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|mPower||Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)|Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)|Recruiting||N/A|20000|Anticipated|Sage Bionetworks||2|||f||||f||||||||Yes|Coded data authorized for sharing by participants will be made available for research purposes via Synapse, Sage Bionetworks' analysis platform. Coded data is study data that does not include participants names or other directly identifying information.|2017-10-10 22:25:50.41856|2017-10-10 22:25:50.41856
NCT02696590|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-01|||July 2015||2015-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients|Isfahan University of Medical Sciences|Completed||N/A|200|Actual|Isfahan University of Medical Sciences||4|||f||||t||||||||Undecided||2017-10-10 22:25:50.541714|2017-10-10 22:25:50.541714
NCT02696577|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-28|2016-03-12|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction||Completed||Phase 2|68|Actual|Assiut University||2|||f||||f||||||||Yes||2017-10-10 22:25:50.623402|2017-10-10 22:25:50.623402
NCT02696564|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-07-20|||May 23, 2017|Actual|2017-05-23|July 2017|2017-07-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|LEEP||Losartan Effects on Emphysema Progression|Losartan Effects on Emphysema Progression|Recruiting||Phase 4|220|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||||2017-10-10 22:25:50.71586|2017-10-10 22:25:50.71586
NCT02696551|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-01|||March 2016||2016-03-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Impact of Medical Education of Physician Action 2|Impact of Medical Education of Physician Action 2|Not yet recruiting||N/A|30|Anticipated|Shanxi Dayi Hospital||2|||f||||t||||||||||2017-10-10 22:25:50.866464|2017-10-10 22:25:50.866464
NCT02696538|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2016-04-01|||February 2016||2016-02-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Comparative Utility of Clinical Balance Measures in Traumatic Brain Injury|Comparative Utility of the Mini-BESTest, Berg Balance Scale, and Functional Gait Assessment to Predict Falls in Individuals After Traumatic Brain Injury|Recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f||||||||No||2017-10-10 22:25:50.945903|2017-10-10 22:25:50.945903
NCT02696525|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-09-30|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01|3 Years|Observational [Patient Registry]|||Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients|A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Stage ⅢA Non-small-cell Lung Cancer Patients|Recruiting||N/A|145|Anticipated|Peking University People's Hospital|||1||f||||t||||||Samples With DNA|"     Fresh tumor tissue, urine samples and blood samples were collected from each patient.      Time:Preoperative, 3 days and 3、6、12、18、24、30、36 months after surgery.   "|||2017-10-10 22:25:51.185791|2017-10-10 22:25:51.185791
NCT02696512|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-08-31|||March 2016||2016-03-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness|A Phase 1/2,Open-Label Study to Evaluate the Safety and Efficacy of the International Brain Research Foundation (IBRF) Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Patients With Severe Disorders of Consciousness|Recruiting||Phase 1/Phase 2|30|Anticipated|International Brain Research Foundation||2|||f||||f||||||||Yes||2017-10-10 22:25:51.319852|2017-10-10 22:25:51.319852
NCT02696499|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-05|||February 2016||2016-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Treatment of Uremic Pruritus With PA101B|Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis|Completed||Phase 2|70|Actual|Patara Pharma||2|||f||||f||||||||||2017-10-10 22:25:51.446749|2017-10-10 22:25:51.446749
NCT02696486|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-01-06|||November 2015||2015-11-01|January 2017|2017-01-01||||January 2017|Actual|2017-01-01||Interventional|||Exercise Training Effect in Patients With HF and PEF|Exercise Training Effect on Quality of Life and Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: A Pilot Study|Completed||N/A|16|Actual|MultiCare Health System Research Institute||1|||f||||f||||||||Undecided||2017-10-10 22:25:51.574951|2017-10-10 22:25:51.574951
NCT02696473|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-12-05|||March 2016||2016-03-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Bioavailability of Polyacetylenes From Carrots Study|Absorption of Naturally Present Compounds in Carrots and Their Appearance in Blood and Other Biofluids After Consumption (The Carrot Study)|Completed||N/A|6|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||f||||||||No||2017-10-10 22:25:51.666028|2017-10-10 22:25:51.666028
NCT02696460|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-02-25|||April 2010||2010-04-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy of 50% Nitrous Oxide/50% Oxygen Gas Premix in Chronic Leg Ulcer Debridement|Efficacy of Inhaled 50% Equimolar Nitrous Oxide/Oxygen Gas Premix (Kalinox®) as Compared to Topically Administered 5% Eutectic Mixture of Lidocaine/Prilocaine (EMLA®) in Chronic Leg Ulcer Debridement|Completed||N/A|21|Actual|Venenklinik Bellevue||2|||f||||f||||||||No||2017-10-10 22:25:51.767227|2017-10-10 22:25:51.767227
NCT02696447|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-18|||June 2016||2016-06-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|RIT||Radiation Impact on Thromboembolic Events|Radiation Therapy and Venous Thromboembolic Events|Recruiting||N/A|450|Anticipated|Institut de Cancérologie de la Loire|||1||f||||f||||||||||2017-10-10 22:25:51.894249|2017-10-10 22:25:51.894249
NCT02695511|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-02-24|||May 2007||2007-05-01|February 2016|2016-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|CALERIE-II||CALERIE Phase II Ancillary: Metabolic|CALERIE Phase II Ancillary 2: Metabolic Adaptation After Two Years of Caloric Restriction in Non Obese Humans|Completed||Phase 2|75|Actual|Pennington Biomedical Research Center||2|||f||||t||||||||Yes||2017-10-10 22:26:00.058382|2017-10-10 22:26:00.058382
NCT02696434|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-07-03|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL|A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL|Recruiting||Phase 3|92|Anticipated|Alkermes, Inc.||2|||f||||f||||||||||2017-10-10 22:25:52.006113|2017-10-10 22:25:52.006113
NCT02696421|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-01-09|||June 2015||2015-06-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|RAMEE||Ramadan and Energy Expenditure Study|Ramadan and Energy (RAMEE) Study|Active, not recruiting||N/A|45|Actual|Imperial College London Diabetes Centre|||1||f||||||||||||||2017-10-10 22:25:52.137945|2017-10-10 22:25:52.137945
NCT02696408|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-07-17|||June 27, 2016|Actual|2016-06-27|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|June 30, 2018|Anticipated|2018-06-30||Interventional|STOP MUCITES||Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mucositis During Hematopoietic Stem Cell (HSC) Transplantation|Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mucositis During Hematopoietic Stem Cell (HSC) Transplantation : a Randomized Double Blind Multicenter Prospective Phase III Trial|Recruiting||Phase 3|194|Anticipated|Institut de Cancérologie de la Loire||2|||f||||f||||||||||2017-10-10 22:25:52.211948|2017-10-10 22:25:52.211948
NCT02696395|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-02-25|||July 2015||2015-07-01|February 2016|2016-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|DePuy RSA RCT||RSA-measured in Vivo Migration and Micromotion in the DePuy Tri-Lock, Corail and Deltamotion Hip Replacement Components|RSA-measured in Vivo Migration and Micromotion in the DePuy Tri-lock, Corail and Deltamotion Hip Replacement Components: a Single-blinded Randomised Control Trial|Recruiting||N/A|40|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-10 22:25:52.33675|2017-10-10 22:25:52.33675
NCT02696382|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-07-26|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|April 1, 2020|Anticipated|2020-04-01|December 31, 2019|Anticipated|2019-12-31||Interventional|||Improving Function in Older Veterans With Hospital-Associated Deconditioning|Improving Function in Older Veterans With Hospital-associated Deconditioning|Recruiting||N/A|150|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:25:52.437316|2017-10-10 22:25:52.437316
NCT02696369|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-01|||December 2014||2014-12-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Trial to Evaluate the Efficacy on Local Anesthesia and Safety of 2% Lidocaine HCl With Different Epinephrine Concentration in Patients Undergoing Surgical Extraction of Impacted Lower Third Molars|A Multi-center, Randomized, Double-blind, Crossover, phase4 Trial to Evaluate the Efficacy on Local Anesthesia and Safety of 2% Lidocaine HCl With Different Epinephrine Concentration in Patients Undergoing Surgical Extraction of Impacted Lower Third Molars|Completed||Phase 4|65|Actual|Huons Co.,Ltd.||2|||f||||||||||||||2017-10-10 22:25:52.601343|2017-10-10 22:25:52.601343
NCT02696356|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-08-04|||April 2016||2016-04-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma|A Phase 1, Open-Label, Multi-Center, Multi-Dose Study of Intradermal GRN-1201 in HLA-A*02 Subjects With Resected Stage IIb, IIc or III Melanoma|Recruiting||Phase 1|18|Anticipated|GreenPeptide Co. Ltd.||3|||f||||f||||||||No||2017-10-10 22:25:52.686787|2017-10-10 22:25:52.686787
NCT02696343|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-04-18|||April 2016||2016-04-01|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|July 2020|Anticipated|2020-07-01||Interventional|||Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants|Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants|Recruiting||N/A|180|Anticipated|University of Nebraska Lincoln||2|||f||||t||||||||Undecided||2017-10-10 22:25:52.782898|2017-10-10 22:25:52.782898
NCT02696330|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-02-26|||September 2015||2015-09-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSI|Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSI|Recruiting||Phase 4|150|Anticipated|Ain Shams Maternity Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:25:53.012966|2017-10-10 22:25:53.012966
NCT02696317|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-06-05|2017-06-05||March 18, 2016|Actual|2016-03-18|June 2017|2017-06-01|June 6, 2016|Actual|2016-06-06|June 6, 2016|Actual|2016-06-06||Interventional||This analysis population includes all randomized subjects who were exposed to any study lenses used for parameter optimization, habitual lenses, or study lenses dispensed for 10-day wear (Full Analysis Set).|Clinical Evaluation of ACUVUE® OASYS® 1-Day and ACUVUE® OASYS®|Clinical Evaluation of ACUVUE® OASYS® 1-Day Daily Disposable Silicone Hydrogel Contact Lenses|Completed||N/A|84|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 22:25:53.116914|2017-10-10 22:25:53.116914
NCT02696304|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-03-01|||May 2015||2015-05-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|LEAMS||The Metabolic Syndrome Among Leukemia Survivors: Physiopathological Analysis|The Metabolic Syndrome Among Childhood Acute Leukemia Survivors: Physiopathological Analysis|Recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:25:53.452383|2017-10-10 22:25:53.452383
NCT02696291|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-06-21|||May 27, 2016|Actual|2016-05-27|June 2017|2017-06-01|March 2, 2017|Actual|2017-03-02|February 15, 2017|Actual|2017-02-15||Interventional|||Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects|Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects|Terminated||Phase 1|7|Actual|Emergent BioSolutions||5||"Study termination was precipitated by a decision from NIAID who will complete the study   (Cohorts 2 through 5) under NIAID sponsorship."|f||||t||||||||No||2017-10-10 22:25:53.578332|2017-10-10 22:25:53.578332
NCT02696278|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-07-13|||March 2016||2016-03-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Hummus for Health: Dietary Quality and Health Outcomes in Toddlers|Hummus for Health: Dietary Quality and Health Outcomes in Toddlers|Terminated||N/A|139|Actual|Baylor College of Medicine||2||"Study product voluntarily recalled by sponsor. Listeria identified at the manufacturing   facility (not in tested finished product)."|f||||f||||||||||2017-10-10 22:25:53.711526|2017-10-10 22:25:53.711526
NCT02696252|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-04-13|||January 2016||2016-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator|Comparison of G5® Mobile Continuous Glucose Monitoring System Accuracy When Using an Automated Applicator vs. a Manual Sensor Applicator|Completed||N/A|97|Actual|DexCom, Inc.|||1||f||||f||||||||Undecided||2017-10-10 22:25:53.948272|2017-10-10 22:25:53.948272
NCT02696239|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-03-01|||September 2010||2010-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Vaginal Cuff Closure in Robotic Hysterectomy|Vaginal Cuff Closure in Robotic Hysterectomy|Completed||N/A|90|Actual|Henry Ford Health System||3|||f||||f||||||||No||2017-10-10 22:25:54.033476|2017-10-10 22:25:54.033476
NCT02696213|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-03-18|||March 2016||2016-03-01|March 2016|2016-03-01||||February 2019|Anticipated|2019-02-01||Interventional|||Systematic, Comprehensive, One-to-One Training (SCOOT) for Scooter Skills: A Feasibility Study||Recruiting||N/A|40|Anticipated|University of British Columbia||2|||f||||||||||||||2017-10-10 22:25:54.224829|2017-10-10 22:25:54.224829
NCT02696200|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-01-05|||May 2015||2015-05-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Protection Against Potential Brain Injury During Competitive Football|Novel Protection Against Potential Brain Injury During Competitive Football Head Impacts|Active, not recruiting||N/A|62|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No|Results will be published however individual participant data will remain secure.|2017-10-10 22:25:54.320261|2017-10-10 22:25:54.320261
NCT02696187|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-09-13|||January 2016||2016-01-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Feasibility and Effects of KOL-webben in Patients With COPD|Feasibility and Effects of KOL-webben - an Internet Based Health Promotion Tool Directed Towards People With Chronic Obstructive Pulmonary Disease and Staff in the Primary Health Care in Sweden|Active, not recruiting||N/A|96|Anticipated|Umeå University||2|||f||||f||||||||No||2017-10-10 22:25:54.406526|2017-10-10 22:25:54.406526
NCT02696174|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-09|||April 2016||2016-04-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|HMI||Effectiveness of A Health Microinsurance Scheme for Private Primary Care in Malaysia|Effectiveness of A Health Microinsurance Scheme in Improving Health Equity and Clinical Outcomes for Private Primary Care in Kuala Lumpur, Malaysia|Not yet recruiting||N/A|114|Anticipated|Chulalongkorn University||2|||f||||t||||||||Yes||2017-10-10 22:25:54.498718|2017-10-10 22:25:54.498718
NCT02696161|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-16|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Platelet Rich Plasma and Perineural Injection Therapy for Carpal Tunnel Syndrome|The Long-term Effect of Platelet Rich Plasma and Perineural Injection Therapy in Patients With Carpal Tunnel Syndrome|Recruiting||N/A|52|Anticipated|Tri-Service General Hospital||2|||f||||t||||||||||2017-10-10 22:25:54.603608|2017-10-10 22:25:54.603608
NCT02696148|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-21|||March 14, 2016|Actual|2016-03-14|August 2017|2017-08-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|||A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years|A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 22:25:54.739775|2017-10-10 22:25:54.739775
NCT02696135|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-25|||March 2016||2016-03-01|February 2016|2016-02-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|CHCS||The Chinese Hypertrophic Cardiomyopathy Study(CHCS)|The Chinese Hypertrophic Cardiomyopathy Study(CHCS)|Not yet recruiting||N/A|1000|Anticipated|China National Center for Cardiovascular Diseases|||3||f||||t||||||Samples With DNA|"     In accordance with clinical diagnosis of patients with hypertropic cardiomyopathy   "|Undecided||2017-10-10 22:25:54.844404|2017-10-10 22:25:54.844404
NCT02696122|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-05-03|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||Quality of Recovery After Local Infiltration Under General Anesthesia Via Laryngeal Mask or Spinal Anesthesia for Inguinal Hernia Repair|Quality of Recovery After Local Infiltration Under General Anesthesia Via Laryngeal Mask or Spinal Anesthesia for Inguinal Hernia Repair.|Completed||N/A|70|Actual|Pontificia Universidade Catolica de Sao Paulo||2|||f||||f||||||||Undecided||2017-10-10 22:25:54.92043|2017-10-10 22:25:54.92043
NCT02696109|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-02-25|||February 2016||2016-02-01|December 2015|2015-12-01||||February 2017|Anticipated|2017-02-01||Interventional|C-BSCM||Cornerstone: Boundary Spanning Case Management and Peer Support for Transition Age Youth With Mental Disorders|Cornerstone: Boundary Spanning Case Management and Peer Support for Transition Age Youth With Mental Disorders|Not yet recruiting||N/A|60|Anticipated|New York University||2|||f||||f||||||||||2017-10-10 22:25:55.009391|2017-10-10 22:25:55.009391
NCT02696096|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-03-08|||August 2016||2016-08-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence|Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence|Recruiting||Phase 3|72|Anticipated|Butler Hospital||1|||f||||||||||||||2017-10-10 22:25:55.104571|2017-10-10 22:25:55.104571
NCT02696070|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-12-19|||July 2015||2015-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Nociceptive Pain Fiber Response|A Multi-Center, Randomized, Sham-Controlled, Double-Blind Study of Pulsed Electromagnetic Field (PEMF) Therapy to Evaluate Small Fiber Nerve Growth and Function in Subjects With Painful Peripheral Diabetic Neuropathy|Completed||N/A|22|Actual|Regenesis Biomedical, Inc.||2|||f||||f||||||||No||2017-10-10 22:25:55.258923|2017-10-10 22:25:55.258923
NCT02696057|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-06-30|||January 2014||2014-01-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Manual Therapy and Exercise in Patients With Chronic Low Back Pain|Bel-boyun ağrısı Nedeniyle başvuran Hastalarda farklı Fizyoterapi ve Manuel Terapi yöntemlerinin ağrı, Fonksiyon ve yaşam Kalitesi düzeyleri üzerin Etkisi|Completed||N/A|113|Actual|Hacettepe University||2|||f||||f||||||||No||2017-10-10 22:25:55.350351|2017-10-10 22:25:55.350351
NCT02696044|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-15|||June 2016||2016-06-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin|Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin: An Open-label, 10-subject Clinical Trial of UX007 (Triheptanoin) in the Treatment of Mitochondrial Dysfunction in Participants With Rett Syndrome, Dyskinesia, and Epilepsy|Recruiting||Phase 2|10|Anticipated|Emory University||6|||f||||f||||||||||2017-10-10 22:25:55.440856|2017-10-10 22:25:55.440856
NCT02696031|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-05-03|||April 29, 2016|Actual|2016-04-29|May 2017|2017-05-01|June 19, 2020|Anticipated|2020-06-19|April 26, 2019|Anticipated|2019-04-26||Interventional|||Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis|A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab to Evaluate the Safety, Tolerability and Efficacy up to 2 Years in Patients With Active Non-radiographic Axial Spondyloarthritis|Recruiting||Phase 3|555|Anticipated|Novartis||3|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:25:55.726181|2017-10-10 22:25:55.726181
NCT02696018|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-02-25|||July 2014||2014-07-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|DECIS||Diaphragmatic Echography in Critically Ill patientS|Evaluation of Diaphragmatic Displacement During Spontaneous Breathing Trials in Critically Ill Patients|Completed||N/A|44|Actual|Università degli Studi di Ferrara|||1||f||||f||||||||Undecided||2017-10-10 22:25:56.106718|2017-10-10 22:25:56.106718
NCT02696005|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-02-25|||March 2016||2016-03-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Hormone KLOTHO Level in Heart Failure Patients That Participate in Rehabilitation Programme|Hormone KLOTHO Level in Heart Failure Patients That Participate in Rehabilitation Programme|Not yet recruiting||N/A|30|Anticipated|Bnai Zion Medical Center|||2||f||||f||||||||No||2017-10-10 22:25:56.191641|2017-10-10 22:25:56.191641
NCT02695992|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-04-21|||February 2016||2016-02-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|RATAFII||Rate Control in Atrial Fibrillation II|Rate Control in Atrial Fibrillation II|Recruiting||Phase 4|240|Anticipated|Asker & Baerum Hospital||2|||f||||t||||||||No||2017-10-10 22:25:56.273645|2017-10-10 22:25:56.273645
NCT02695979|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-02-24|||August 2014||2014-08-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|April 2016|Anticipated|2016-04-01||Observational|||Changes of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation|Changes of Macrophage Migration Inhibitory Factor and Thyroid Hormones During Liver Transplantation. Association With Graft Dysfunction|Recruiting||N/A|55|Anticipated|Medical University of Vienna|||1||f||||f||||||Samples Without DNA|"     Blood, graft liver effluent, urine samples   "|No||2017-10-10 22:25:56.445318|2017-10-10 22:25:56.445318
NCT02695966|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-26|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|EVIS||EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer|A Feasibility Study Assessing the Ability of an Ex-vivo Assay to Measure AMD3100's Ability to Overcome Tumour Immune-privilege and Bring T-lymphocytes Into Contact With Neoplastic Targets.|Recruiting||N/A|20|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Tumour tissue sample Blood sample   "|||2017-10-10 22:25:56.527694|2017-10-10 22:25:56.527694
NCT02695953|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-03-22|||March 2016||2016-03-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Neurobiology of Posttraumatic Stress Disorder Dysfunction and Recovery Following Cognitive Processing Therapy|Neurobiology of Posttraumatic Stress Disorder Dysfunction and Recovery Following Cognitive Processing Therapy|Enrolling by invitation||N/A|102|Anticipated|Mclean Hospital|||1||f||||f||||||Samples With DNA|"     Saliva sample   "|Undecided||2017-10-10 22:25:56.610703|2017-10-10 22:25:56.610703
NCT02695940|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-05-08|||March 2016||2016-03-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis|A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis|Completed||Phase 2|69|Actual|LEO Pharma||2|||f||||f||||||||Undecided||2017-10-10 22:25:56.685525|2017-10-10 22:25:56.685525
NCT02695927|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-03-14|||March 2009||2009-03-01|March 2017|2017-03-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Rehabilitation Glasses for the Treatment of Hemispatial Neglect|Rehabilitation Glasses for the Treatment of Hemispatial Neglect|Recruiting||Phase 1|35|Anticipated|Beth Israel Deaconess Medical Center||4|||f||||f||||||||Yes|IPD will be shared upon publication of the data. Other researchers can contact PI to request this data.|2017-10-10 22:25:56.789203|2017-10-10 22:25:56.789203
NCT02695914|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-02-29|||January 2016||2016-01-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Observational|||Influence of Compound Qingre Granule on the Inflammatory Markers in Patient of FUO With Excess-heat Syndrome|Inflammatory Markers in Patient of FUO With Excess-heat Syndrome and the Influence of Compound Qingre Granule on the Inflammatory Markers|Enrolling by invitation||N/A|80|Anticipated|Beijing Friendship Hospital|||2||f||||f||||||Samples Without DNA|"     Exsanguinating and saving the blood in the refrigerator of -4 ℃.   "|No||2017-10-10 22:25:56.896977|2017-10-10 22:25:56.896977
NCT02695901|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-02-29|||March 2016||2016-03-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Different Mouthrinses in Plaque Formation|Anti-plaque Effect of 0.12% Chlorhexidine Gluconate Rinsing and Nanoparticle Solution of 0.3% Melaleuca Alternifolia: A Randomized Crossover Clinical Trial|Not yet recruiting||Phase 4|59|Anticipated|Universidade Federal de Santa Maria||2|||f||||||||||||||2017-10-10 22:25:56.979093|2017-10-10 22:25:56.979093
NCT02695888|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-27|||March 2016||2016-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Mobile Technology Monitoring System to Assess a Web-based Intervention for Teen Risky Driving|A Pilot Study of a Mobile Technology Monitoring System to Assess a Web-based Intervention for Teen Risky Driving|Active, not recruiting||N/A|20|Anticipated|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 22:25:57.065771|2017-10-10 22:25:57.065771
NCT02695875|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparative Study About the Effect of Aquatic Therapy vs Land-based Therapy in Women With Fibromyalgia|Comparative Study About the Effect of a Physical Therapy Protocol in Warm Water vs Land-based Therapy in Women With Fibromyalgia Syndrome|Enrolling by invitation||N/A|34|Anticipated|Universidade da Coruña||2|||f||||t||||||||Undecided||2017-10-10 22:25:57.152848|2017-10-10 22:25:57.152848
NCT02695862|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-09-23|||February 2016||2016-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||To Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding|To Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding: A Randomized Comparison|Recruiting||N/A|100|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 22:25:57.253033|2017-10-10 22:25:57.253033
NCT02695849|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-07-01|||March 2012||2012-03-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||A Study of Prevalence of EGFR Mutations in Participants With NSCLC|An Epidemiology Study of the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients Diagnosed With Non-squamous Non-small Cell Lung Cancer (NSCLC)|Completed||N/A|69|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:25:57.348028|2017-10-10 22:25:57.348028
NCT02695836|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-03|||March 1, 2016|Actual|2016-03-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|August 2018|Anticipated|2018-08-01||Interventional|INFORM||Improving Nursing Home Care Through Feedback On PerfoRMance Data|Improving Nursing Home Care Through Feedback On PerfoRMance Data (INFORM)|Active, not recruiting||N/A|119|Actual|University of Alberta||3|||f||||f||||||||Undecided||2017-10-10 22:25:57.431532|2017-10-10 22:25:57.431532
NCT02695823|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-10-27|||December 2015||2015-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TOH-HTIC||Incidence of Intracranial Hypertension During Liver Transplantation Estimated by Non-invasive Ultrasound Methods.|Incidence of Intracranial Hypertension During Liver Transplantation Estimated by Non-invasive Ultrasound Methods.|Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:25:57.561324|2017-10-10 22:25:57.561324
NCT02695810|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-08-12|||February 2016||2016-02-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes|Effect of Dapagliflozin, Metformin and Physical Activity on Glucose Variability, Body Composition and Cardiovascular Risk in Pre-diabetes|Recruiting||Phase 2|120|Anticipated|Steno Diabetes Center||4|||f||||t||||||||No||2017-10-10 22:25:57.684598|2017-10-10 22:25:57.684598
NCT02695797|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-02-29|||September 2015||2015-09-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody|Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody|Recruiting||Phase 4|40|Anticipated|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 22:25:57.836816|2017-10-10 22:25:57.836816
NCT02695784|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-05|||September 1, 2017|Anticipated|2017-09-01|April 2017|2017-04-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|PAD||Probiotics After Discharge|Probiotics After Discharge (PAD) Study: Impact on Microbiome, Health and Growth Outcomes|Not yet recruiting||Phase 4|40|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f|||||f|f||||||||2017-10-10 22:25:57.958353|2017-10-10 22:25:57.958353
NCT02695771|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-04-06|||April 2016||2016-04-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|BIC||The Bladder Instillation Comparison Study|A Prospective, Open-label Randomized Clinical Trial of a Single Bladder Instillation of Mitomycin C vs. Gemcitabine vs. No Additional Treatment Immediately After Transurethral Resection of Bladder Tumor (TURBT)|Recruiting||Phase 3|300|Anticipated|Spectrum Health Hospitals||3|||f||||f||||||||No||2017-10-10 22:25:58.034527|2017-10-10 22:25:58.034527
NCT02695758|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||December 2014||2014-12-01|February 2016|2016-02-01||||December 2015|Actual|2015-12-01||Interventional|||Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA|Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing Shoulder Arthroplasty (TSA): A Randomized Trial|Completed||N/A|156|Actual|Rothman Institute Orthopaedics||2|||f||||f||||||||||2017-10-10 22:25:58.161259|2017-10-10 22:25:58.161259
NCT02695745|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||September 2011||2011-09-01|February 2016|2016-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Experimental Biomarker Study for Pain Thresholds|Randomized, Double Blind, Positive- Controlled, Three-way Cross-over Human Experimental Biomarker Study of V116517 in Healthy Male Subjects|Completed||Phase 1|37|Actual|Purdue Pharma LP||3|||f||||f||||||||No||2017-10-10 22:25:58.227972|2017-10-10 22:25:58.227972
NCT02695732|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-02-25|||December 2015||2015-12-01|February 2016|2016-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding|Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding Comparing Carvedilol and Endoscopic Therapy: A Multicenter Randomized Controlled Trial|Recruiting||Phase 4|792|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 22:25:58.32818|2017-10-10 22:25:58.32818
NCT02695719|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-04-19|||April 25, 2016|Actual|2016-04-25|April 2017|2017-04-01|February 20, 2017|Actual|2017-02-20|February 20, 2017|Actual|2017-02-20||Interventional|||Lubiprostone for Treatment of Chronic Idiopathic Constipation|A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lubiprostone for the Treatment of Chronic Idiopathic Constipation|Completed||Phase 3|156|Actual|Takeda||2|||f||||f||||||||||2017-10-10 22:25:58.433376|2017-10-10 22:25:58.433376
NCT02695498|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-14|||March 2016||2016-03-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Mindfulness and Mechanisms of Pain Processing in Adults With Migraines|Mindfulness and Mechanisms of Pain Processing in Adults With Migraines|Recruiting||N/A|98|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-10 22:26:00.148883|2017-10-10 22:26:00.148883
NCT02695706|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-03-01|||April 2016||2016-04-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Interventional|||Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use|Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use and Evaluation of the Effectiveness Through the Self Awareness of the Research, of Clinical Evaluations and Instrumental Measurements|Not yet recruiting||Early Phase 1|35|Anticipated|LM Farma Indústria e Comércio Ltda.||1|||f||||t||||||||Undecided||2017-10-10 22:25:58.52342|2017-10-10 22:25:58.52342
NCT02695693|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-07|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|June 2017|Actual|2017-06-01||Interventional|||RCT of TeachTown in Autism Support Classrooms: Innovation and Exnovation|RCT of TeachTown in Autism Support Classrooms: Innovation and Exnovation|Active, not recruiting||N/A|212|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:25:58.590851|2017-10-10 22:25:58.590851
NCT02695680|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-09-26|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Observational|||Lung SBRT Motion Management (GCC 1619)|Modeling Respiration-induced Motion and Deformation of Tumors and Thoracic Organs for Personalized Motion Management in Lung SBRT|Not yet recruiting||N/A|44|Anticipated|University of Maryland|||1||f||||t|f|f||||||||2017-10-10 22:25:58.773252|2017-10-10 22:25:58.773252
NCT02695667|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-11-04|||February 2016||2016-02-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|1 Day|Observational [Patient Registry]|EatonOSAS||Genioglossus Strength and OSAS||Recruiting||N/A|44|Anticipated|University of New Mexico|||2||f||||f||||||||No||2017-10-10 22:25:58.855222|2017-10-10 22:25:58.855222
NCT02695654|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-11-05|||November 2015||2015-11-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Effectiveness of Ultrasound Guided Adductor Canal Block on Chronic Pain in Knee Osteoarthritis|Effectiveness of Ultrasound Guided Adductor Canal Blockade With Levobupivacaine and Clonidine on Chronic Pain in Knee Osteoarthritis|Completed||N/A|77|Actual|University Medical Centre Ljubljana|||1||f||||t||||||||Undecided||2017-10-10 22:25:58.970368|2017-10-10 22:25:58.970368
NCT02695641|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-02-29|||April 2016||2016-04-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients|A Phase 0 Study to Evaluate the Pharmacokinetics of Low-dose Bevacizumab and Its Efficacy on Reducing Plasma Free Vascular Endothelial Growth Factor-A (VEGF-A) in Hemodialysis Patients|Not yet recruiting||Early Phase 1|20|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:25:59.079267|2017-10-10 22:25:59.079267
NCT02695628|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-07-14|||September 13, 2016|Actual|2016-09-13|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer|Assessment of Treatment-Induced Tissue Hypoxia After Transcatheter Arterial Embolization of Hepatocellular Carcinoma: A Feasibility Study With [18F]FMISO PET/CT|Recruiting||Phase 1|5|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:25:59.201835|2017-10-10 22:25:59.201835
NCT02695615|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-02-29|||January 2014||2014-01-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01|1 Day|Observational [Patient Registry]|||Stress During Elective or Emergency Cesarean Operations|The Evaluation of the Effects of Stress During Elective or Emergency Cesarean Operations; Prospective, Randomized Clinical Trial|Completed||N/A|60|Actual|Umraniye Education and Research Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:25:59.333247|2017-10-10 22:25:59.333247
NCT02695602|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-05-09|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Trial Comparing Microdebrider-Assisted Inferior Turbinoplasty (MAIT) vs Submucous Resection (SMR)|Prospective Randomized Trial Comparing Microdebrider-Assisted Inferior Turbinoplasty (MAIT) vs Submucous Resection (SMR)|Terminated||N/A|2|Actual|New York University School of Medicine||2||Unable to recruit enough patients|f||||f||||||||||2017-10-10 22:25:59.404678|2017-10-10 22:25:59.404678
NCT02695576|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-04-24|||July 2007|Actual|2007-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Lumbar Fusion or Non-operative Care for Treatment of Presumed Discogenic Pain|Lumbar Fusion or Non-operative Care for Treatment of Presumed Discogenic Pain: A Randomized Study|Completed||N/A|74|Actual|Spinal Surgery Clinic, Strängnäs||2|||f||||f||||||||No||2017-10-10 22:25:59.500156|2017-10-10 22:25:59.500156
NCT02695563|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-03-03|||January 2014||2014-01-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on Inflammatory Mediators|Influence of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on PGE2, MMP-9, MMP-2, TIMP-1 and TIMP-2 Amniotic Fluid Concentrations|Completed||Phase 2|111|Actual|Università degli Studi di Ferrara||2|||f||||f||||||||No||2017-10-10 22:25:59.592062|2017-10-10 22:25:59.592062
NCT02695550|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-03-08|||March 2016||2016-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer|Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer|Recruiting||Phase 1|40|Anticipated|Centaurus Biopharma Co., Ltd.||1|||f||||t||||||||No||2017-10-10 22:25:59.690399|2017-10-10 22:25:59.690399
NCT02695524|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-02-24|||March 2016||2016-03-01|February 2016|2016-02-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Exercise Application in the Treatment of Patients With Shoulder Impingement|Effect of Strengthening of Periscapular Muscles With Addition of Neuromuscular Training on the Improvement of Pain and Disability in Patients With Shoulder Impingement: Randomized Controlled Trial|Not yet recruiting||Phase 2|60|Anticipated|University of Sao Paulo||2|||f||||t||||||||Yes|Publication of data in the form of article:07/2019|2017-10-10 22:25:59.915802|2017-10-10 22:25:59.915802
NCT02695485|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-02-29|||February 2006||2006-02-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|March 2013|Actual|2013-03-01||Interventional|||Sensory Reconstruction of the Digits|Sensory Reconstruction in Different Region of the Digits: A Review of 151 Cases|Completed||N/A|151|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||Yes||2017-10-10 22:26:00.297451|2017-10-10 22:26:00.297451
NCT02695472|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-02-23|||March 2016||2016-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of NSI-189 for Major Depressive Disorder|A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder|Active, not recruiting||Phase 2|220|Actual|Neuralstem Inc.||3|||f||||t||||||||Yes||2017-10-10 22:26:00.392173|2017-10-10 22:26:00.392173
NCT02695459|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-01-11|||March 2016||2016-03-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin|Phase II Study of Cisplatinum and Everolimus in Patients With Metastatic or Unresectable Neuroendocrine Carcinomas (NEC) of Extrapulmonary Origin|Recruiting||Phase 2|39|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-10 22:26:00.536438|2017-10-10 22:26:00.536438
NCT02695446|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-16|2017-07-17||March 2016||2016-03-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline|Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline|Completed||Phase 4|12|Actual|BioPharmX, Inc.||1|||f||||f||||||||||2017-10-10 22:26:00.648599|2017-10-10 22:26:00.648599
NCT02695433|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-02-06|||March 2016||2016-03-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|AV2||Replacing Refined Carbohydrates With Healthy Fats on Cardio-metabolic Markers|Effects of a Typical American Diet High in Refined Carbohydrates Compared to a Diet That Replaces Some Refined Carbohydrates With Healthy Fats on Cardiometabolic Health in Men and Women With Pre-diabetes and Metabolic Syndrome|Recruiting||N/A|120|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||No||2017-10-10 22:26:00.864057|2017-10-10 22:26:00.864057
NCT02695420|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-10|||April 14, 2016|Actual|2016-04-14|August 2017|2017-08-01|May 8, 2017|Actual|2017-05-08|April 6, 2017|Actual|2017-04-06||Interventional|||Safety, PK, and Efficacy of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure With Reduced Ejection Fraction|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure With Reduced Ejection Fraction|Completed||Phase 2|81|Actual|Amgen||4|||f||||t||||||||||2017-10-10 22:26:01.004258|2017-10-10 22:26:01.004258
NCT02695407|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-03-21|||September 2014||2014-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Radial Artery Stenosis Following PiCCO Catheter Implementation|Occurrence of Radial Artery Stenosis Following PICCO Catheter Cannulation|Recruiting||N/A|100|Anticipated|Medical University of Gdansk||2|||f||||f||||||||||2017-10-10 22:26:01.184874|2017-10-10 22:26:01.184874
NCT02695394|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-12-20|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study||Completed||N/A|60|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-10 22:26:01.277563|2017-10-10 22:26:01.277563
NCT02695381|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-09-08|||March 2016||2016-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness|A Randomized, Double-blind, Multiple-dose, Placebo-controlled Study to Evaluate the Efficacy and Safety of Etodolac-lidocaine Patch Applied Once Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness|Completed||Phase 3|100|Actual|MEDRx USA, Inc.||2|||f||||f||||||||No||2017-10-10 22:26:01.35402|2017-10-10 22:26:01.35402
NCT02695368|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-24|||February 2016||2016-02-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|EPOS||A Study to Evaluate the Effect of Air-filtration Through a Plasma Chamber on the Incidence of Surgical Site Infections in Orthopaedic Surgery|The Effect of Air-filtration Through a Plasma Chamber on the Incidence of Surgical Site Infections in Orthopaedic Surgery: a Double-blind, Randomized, Controlled Trial|Not yet recruiting||N/A|19000|Anticipated|Karolinska Institutet||3|||f||||f||||||||No||2017-10-10 22:26:01.428892|2017-10-10 22:26:01.428892
NCT02695355|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-29|||October 2006||2006-10-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|January 2013|Actual|2013-01-01||Interventional|||ERP Based Single-dose Predictions of Stimulants|Pediatric Attention Deficit Hyperactivity Disorder: Predicting Clinical Response to Stimulant Medication From Single-dose Changes in Event Related Potentials|Completed||Phase 2|87|Actual|Ostfold Hospital Trust||1|||f||||f||||||||No||2017-10-10 22:26:01.510172|2017-10-10 22:26:01.510172
NCT02695342|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Home Balance Pilot for Fall Reduction in COPD|Pilot Study of a Tailored Home Balance Exercise Program for Reducing Falls in Older Adults With COPD|Recruiting||N/A|35|Anticipated|McMaster University||1|||f||||f||||||||||2017-10-10 22:26:01.599937|2017-10-10 22:26:01.599937
NCT02695329|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-06-20|||May 24, 2016|Actual|2016-05-24|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Vanguard TKA With KneeAlign 2 and Without KneeAlign 2|Randomized Controlled Study Comparing Vanguard With KneeAlign2 Navigational System Versus Vanguard Conventional|Recruiting||N/A|100|Anticipated|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-10-10 22:26:01.696454|2017-10-10 22:26:01.696454
NCT02695316|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-01-31|||September 2015||2015-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|BRIDGE||Barrier-free Communication in Maternity Care of Allophone Migrants|Barrier-free Communication in Maternity Care of Allophone Migrants (Barrierefreie Kommunikation in Der Geburtshilflichen Versorgung Allophoner Migrantinnen)|Completed||N/A|82|Actual|Bern University of Applied Sciences||4|||f||||f||||||||No||2017-10-10 22:26:01.796917|2017-10-10 22:26:01.796917
NCT02695303|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-03-29|||February 23, 2016|Actual|2016-02-23|March 2017|2017-03-01|February 25, 2016|Actual|2016-02-25|February 25, 2016|Actual|2016-02-25||Interventional|SPF||18790 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment-Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:26:01.919455|2017-10-10 22:26:01.919455
NCT02695290|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-09-15|2017-08-09||March 17, 2016|Actual|2016-03-17|September 2017|2017-09-01|August 26, 2016|Actual|2016-08-26|August 26, 2016|Actual|2016-08-26||Interventional||Patients who receive at least one dose of afatinib will be included in the treated set. All data collected from the single patient who received study medication.|Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)|An Open-label, Single-arm Phase IV Study of Afatinib in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Who Have Poor Performance Status and Whose Tumors Have the Common Epidermal Growth Factor Receptor (EGFR) Mutations, Exon 19 Deletions or Exon 21(L858R) Substitution Mutations|Terminated||Phase 4|1|Actual|Boehringer Ingelheim|This study was stopped prematurely when only 1 patient had received afatinib treatment so it was not possible to draw any conclusion.|1|||f||||||||||||||2017-10-10 22:26:02.004973|2017-10-10 22:26:02.004973
NCT02695277|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-09-14|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|CEASE-AF||Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation|Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation|Recruiting||N/A|210|Anticipated|AtriCure, Inc.||2|||f||||f||||||||||2017-10-10 22:26:02.184631|2017-10-10 22:26:02.184631
NCT02695264|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-12-21|||August 2016||2016-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Non-invasive Intracranial Pressure (ICP) Monitoring in Pediatric Patients|Prospective Evaluation of Non-invasive Intracranial Pressure (ICP) Monitoring in Pediatric Patients Undergoing Invasive ICP Monitoring|Withdrawn||N/A|0|Actual|HeadSense Medical||1||Clinical Trial Agreement not executed|f||||f||||||||No||2017-10-10 22:26:02.295876|2017-10-10 22:26:02.295876
NCT02695251|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-02|||February 2016||2016-02-01|February 2016|2016-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|AGE-FR||AGE - Functional Reserve|Renal Hemodynamic, Functional and Metabolic Changes After AGEs (Advanced Glycation End Products) Load by Positron Emission Tomography (PET) and Blood Oxygen Level-Dependent (BOLD) - MRI. The AGE- Functional Reserve Study.|Completed||N/A|10|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:26:02.366972|2017-10-10 22:26:02.366972
NCT02695238|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-29|||December 2015||2015-12-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|PROPOP||Trial of Prophylactic Manual Rotation of Persistent Occiput Posterior Presentation During the Early Second Stage of Labor to Reduce Operative Delivery: a Prospective Multicenter Randomized Control Trial|Trial of Prophylactic Manual Rotation of Persistent Occiput Posterior Presentation During the Early Second Stage of Labor to Reduce Operative Delivery: a Prospective Multicenter Randomized Control Trial|Recruiting||N/A|408|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:26:02.435456|2017-10-10 22:26:02.435456
NCT02695225|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-24|||November 2010||2010-11-01|February 2016|2016-02-01||||October 2014|Actual|2014-10-01||Interventional|||Tobacco Cessation Interventions With Ohio Appalachian Smokers|Tobacco Cessation Interventions With Ohio Appalachian Smokers|Completed||N/A|707|Actual|Ohio State University||2|||f||||t||||||||||2017-10-10 22:26:02.506543|2017-10-10 22:26:02.506543
NCT02695212|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-26|2017-08-22|||July 2016||2016-07-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|HS||Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa|A Phase 2 Open-label Single Center Study to Evaluate the Efficacy of Apremilast for the Treatment of Moderate Hidradenitis Suppurativa|Completed||Phase 2|20|Actual|Florida Academic Dermatology Centers||1|||f||||f||||||||||2017-10-10 22:26:02.568185|2017-10-10 22:26:02.568185
NCT02695199|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-29|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Doppler Ultrasound Assisted Varicocelectomy Improve Sperm Qualities|Comparison Between Laparoscopic Doppler Ultrasound Assisted Laparoscopic Varicocelectomy and Microscopic Subinguinal Varicocelectomy|Recruiting||N/A|100|Anticipated|The Second Hospital of Shandong University||2|||f||||t||||||||Undecided||2017-10-10 22:26:02.641865|2017-10-10 22:26:02.641865
NCT02695186|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-02-29|||February 2016||2016-02-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|February 2016|Actual|2016-02-01||Observational|||Oxidative Stress in Intestinal Metaplasia and Metabolic Syndrome|Markers of Oxidative Stress and Inflammation in Patients With Intestinal Metaplasia and Metabolic Syndrome|Recruiting||N/A|180|Anticipated|General Hospital of Filiates|||3||f||||t||||||||Undecided||2017-10-10 22:26:02.910875|2017-10-10 22:26:02.910875
NCT02695160|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-10|||November 15, 2016|Actual|2016-11-15|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Ascending Dose Study of Genome Editing by Zinc Finger Nuclease Therapeutic SB-FIX in Subjects With Severe Hemophilia B|A Phase I, Open-Label, Ascending Dose Study to Assess the Safety and Tolerability of AAV2/6 Factor IX Gene Therapy Via Zinc Finger Nuclease (ZFN) Mediated Targeted Integration of SB-FIX in Adult Subjects With Severe Hemophilia B|Recruiting||Phase 1|12|Anticipated|Sangamo Therapeutics||3|||f||||t||f||||||||2017-10-10 22:26:03.123353|2017-10-10 22:26:03.123353
NCT02695147|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-02-24|||February 2016||2016-02-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Direct Aortic vs Subclavian Access for TAVI: a Review of the Outcomes in the UK|Direct Aortic vs Subclavian Access for TAVI: a Review of the Outcomes in the UK|Active, not recruiting||N/A|400|Anticipated|Royal Sussex County Hospital|||2||f||||f||||||||No||2017-10-10 22:26:03.233402|2017-10-10 22:26:03.233402
NCT02695134|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-19|||February 2016||2016-02-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Healing Touch Prior to Cardiac Rehab|Healing Touch Intervention in Post-Cardiac Event Patients Prior to Starting a Cardiac Rehab Program|Recruiting||N/A|124|Anticipated|Scripps Health||2|||f||||f||||||||||2017-10-10 22:26:03.30848|2017-10-10 22:26:03.30848
NCT02695108|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-12-13|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Scapular Stabilization Exercise on Neck Pain|Scapular Stabilization Exercise on Mechanical Neck Pain: A Randomized Control|Recruiting||N/A|25|Anticipated|Hacettepe University||2|||f||||f||||||||Yes||2017-10-10 22:26:03.525244|2017-10-10 22:26:03.525244
NCT02695069|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-06-07|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy Study of Random Placenta Margin Incision to Treat Complete Placenta Previa|Random Placenta Margin Incision for Hemorrhage Control During Cesarean Section of Complete Placenta Previa Pregnancies|Recruiting||Phase 2|100|Anticipated|Maternal and Child Health Hospital of Foshan||1|||f||||t||||||||Undecided||2017-10-10 22:26:03.819685|2017-10-10 22:26:03.819685
NCT02695043|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-10-05|||March 2016||2016-03-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||MMEPT for Traumatic Brain Injury|Multimedia Multicultural Educational Program for Traumatic Brain Injury|Recruiting||N/A|125|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:26:03.934206|2017-10-10 22:26:03.934206
NCT02695030|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-02-01||||||February 2017|2017-02-01||||||||Expanded Access|||Low-profile Visualized Intraluminal Support -HUD|MicroVention Low-profile Visualized Intraluminal Support (LVIS*) or LVIS Jr Humanitarian Use Device (LVIS HUD)|Available||N/A|||New York University School of Medicine|||||f||||||||||||||2017-10-10 22:26:04.05759|2017-10-10 22:26:04.05759
NCT02695017|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-10-17|||May 2016||2016-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Changes in Oxygen Saturation in Two Exercise Modalities|Comparison of Changes in Oxygen Saturation in Flywheel Exercise Versus Conventional Strength Machine|Completed||N/A|50|Actual|Centro Universitario La Salle||2|||f||||f||||||||Yes|Research publication|2017-10-10 22:26:04.148408|2017-10-10 22:26:04.148408
NCT02695004|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-29|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).|Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Phase 1 Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics of DKF-310 Intramuscular Injection in Healthy Male Volunteers|Recruiting||Phase 1|45|Anticipated|Dongkook Pharmaceutical Co., Ltd.||5|||f||||t||||||||No||2017-10-10 22:26:04.232298|2017-10-10 22:26:04.232298
NCT02694991|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-02-29|||September 2013||2013-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Osteopathic Manipulative Treatment Efficacy in Postoperative Pain|Osteopathic Manipulative Treatment Efficacy in Sternal Pain Management After Heart Surgery|Completed||Phase 4|80|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||Yes|to upload the data base file of all results of the present trial|2017-10-10 22:26:04.337865|2017-10-10 22:26:04.337865
NCT02694978|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-12-06|||February 2016||2016-02-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|FIRM||A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)|A Phase III, Randomized, Multicenter, Double-Blind, Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)|Active, not recruiting||Phase 3|2015|Actual|AMAG Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 22:26:04.429869|2017-10-10 22:26:04.429869
NCT02694965|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-02-17|||January 2016||2016-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma|Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma|Enrolling by invitation||N/A|40|Anticipated|Duke University|||1||f||||f||||||||Undecided||2017-10-10 22:26:04.53322|2017-10-10 22:26:04.53322
NCT02694952|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-06-01|||March 2016|Anticipated|2016-03-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PAVES||Non-inferiority Trial of Two Snake Antivenoms in CAR (PAVES)|Randomized, Double-blind, Non-inferiority Trial of Two Antivenoms for the Treatment of Snakebite With Envenoming|Withdrawn||N/A|0|Actual|Epicentre||2||Ministry of Health in country did not authorized the conduct of the study|f||||t||||||||No||2017-10-10 22:26:04.600849|2017-10-10 22:26:04.600849
NCT02694939|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-11-29|||May 2015||2015-05-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|STAND||STAND Community Trial|Effectiveness of MI Enhanced Behavior Therapy for Adolescents With ADHD|Recruiting||N/A|300|Anticipated|Florida International University||2|||f||||f||||||||||2017-10-10 22:26:04.690322|2017-10-10 22:26:04.690322
NCT02694926|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-03-02|||December 2014||2014-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||National Education Programme for Patients With Chronic Adrenal Insufficiency|National (German-wide) Education Programme for Patients With Chronic Adrenal Insufficiency|Recruiting||N/A|450|Anticipated|Wuerzburg University Hospital||1|||f||||f||||||||Yes|publication of collected data in medical journals and specialist congresses|2017-10-10 22:26:04.801969|2017-10-10 22:26:04.801969
NCT02694913|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-01-27|||November 2015|Actual|2015-11-01|January 2017|2017-01-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies|Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies|Recruiting||N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||Samples Without DNA|"     Whole blood will be taken to measure B-cell depletion. Any remaining sample will be stored     for 15 years in the biobank.   "|No||2017-10-10 22:26:04.916456|2017-10-10 22:26:04.916456
NCT02694900|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-03-12|||February 2016||2016-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SRPR||Single-rescuer Pediatric Resuscitation|Comparison of Three Different Chest Compressions Methods During Pediatric Cardiopulmonary Resuscitation: A Pilot, Randomized Crossover Manikin Trial|Completed||N/A|52|Actual|Medical University of Warsaw||2|||f||||f||||||||Undecided||2017-10-10 22:26:05.014148|2017-10-10 22:26:05.014148
NCT02694874|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-07-07|||February 2016||2016-02-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|ROSI||Rosiglitazone Adjunctive Therapy for Severe Malaria in Children|Rosiglitazone Adjunctive Therapy for Severe Malaria in Children|Recruiting||N/A|210|Anticipated|Centro de Investigacao em Saude de Manhica||2|||f||||f||||||||No||2017-10-10 22:26:05.172602|2017-10-10 22:26:05.172602
NCT02694861|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-08|||March 2016||2016-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study|A Multi-Center Single Arm One Year Prospective Follow-Up of Patients Treated With the CryoLife CardioGenesis Holmium:YAG Laser System for Transmyocardial Revascularization (The TMR 365 Study)|Recruiting||N/A|150|Anticipated|CryoLife, Inc.|||2||f||||f||||||||||2017-10-10 22:26:05.294719|2017-10-10 22:26:05.294719
NCT02694848|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-02-24|||February 2016||2016-02-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection|Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection Based on Population Pharmacokinetics and Therapeutic Effect:A Randomized, Controlled Trial|Not yet recruiting||Phase 4|120|Anticipated|China Academy of Chinese Medical Sciences||3|||f||||t||||||||No||2017-10-10 22:26:05.386353|2017-10-10 22:26:05.386353
NCT02694835|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-04-12|||March 2016||2016-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:26:05.500714|2017-10-10 22:26:05.500714
NCT02694822|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-23|||April 2016||2016-04-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||AGEN-1884, an Anti-CTLA-4 Antibody, in Advanced Solid Cancers|Study To Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of an Anti-CTLA-4 Human Monoclonal Antibody (AGEN1884), and to Estimate the Maximum Tolerated Dose in Subjects With Advanced or Refractory Cancer|Recruiting||Phase 1|48|Anticipated|Agenus Inc.||1|||f||||f|t|f||||||No||2017-10-10 22:26:05.540329|2017-10-10 22:26:05.540329
NCT02694809|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01||||September 2019|Anticipated|2019-09-01||Interventional|||Conjugated Estrogens/Bazedoxifene in Treating Patients With Ductal Carcinoma in Situ Undergoing Surgery|A Phase II Randomized-double Blinded Placebo Controlled Window of Opportunity Trial Comparing Conjugated Estrogens/Bazedoxifene to Placebo in Women Undergoing Surgical Therapy for Ductal Carcinoma in Situ (DCIS)|Recruiting||Phase 2|130|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 22:26:05.65094|2017-10-10 22:26:05.65094
NCT02694796|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-29|||September 2015||2015-09-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|THERMACTIVE||Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy|Long Term Impact of a Physical Activity Intervention Combining Workshop During a Balneotherapy and a Web and Smartphone-based Physical Activity Program After Balneotherapy, on Physical Activity Level : a Randomized Control Trial|Recruiting||N/A|462|Anticipated|Association Francaise pour la Recherche Thermale||2|||f||||t||||||||No||2017-10-10 22:26:06.32254|2017-10-10 22:26:06.32254
NCT02694770|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-04-22|||July 2016||2016-07-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||"A Study Evaluating the Efficacy and Safety of Neihulizumab vs Conventional Treatment to Treat Sr-aGvHD"|"A Phase II Study of Neihulizumab vs Conventional Treatment to Treat Steroid-refractory Acute Graft-vs-host Disease (Sr-aGvHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation"|Withdrawn||Phase 2|0|Actual|AbGenomics B.V Taiwan Branch||2||corporate decision|f||||t||||||||No||2017-10-10 22:26:06.547152|2017-10-10 22:26:06.547152
NCT02694757|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-09-16|||October 2016||2016-10-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy of Ostom-i Alert System at Decreasing Dehydration Related Complications|Pilot Study to Evaluate the Efficacy of Ostom-i Alert System at Decreasing Dehydration Related Complications in Patients With New Ileostomies|Not yet recruiting||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:26:06.640673|2017-10-10 22:26:06.640673
NCT02694731|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-05-05|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 29, 2016|Actual|2016-11-29||Interventional|||A Mindfulness Mobile Intervention Targeting Reductions in Food Cravings|A Mindfulness Mobile Intervention Targeting Reductions in Food Cravings|Completed||N/A|104|Actual|University of California, San Francisco||1|||f||||f||||||||Yes|The investigators will deposit anonymized individual-level data in a depository such as the Open Science Framework.|2017-10-10 22:26:06.871883|2017-10-10 22:26:06.871883
NCT02694718|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-11-21|2016-09-21||March 2005||2005-03-01|February 2016|2016-02-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional||Safety population included all the participants who received at least one dose of any of the study treatments and who had a baseline assessment.|A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer|A Phase II Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer|Completed||Phase 2|60|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:26:06.957916|2017-10-10 22:26:06.957916
NCT02694705|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-09-29|||February 2016||2016-02-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Assessment of Preoxygenation Strategies in the Prehospital Environment|Assessment of Preoxygenation Strategies in the Prehospital Environment|Completed||N/A|30|Actual|Queen Mary University of London||3|||f||||f||||||||No||2017-10-10 22:26:09.052057|2017-10-10 22:26:09.052057
NCT02694692|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-03-07|||January 2015||2015-01-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|TRAKC18||Trial of Repeated Analgesia With Kangaroo Care - 18 Month Follow-up|Trial of Repeated Analgesia With Kangaroo Care - 18 Month Follow-up|Recruiting||N/A|159|Anticipated|IWK Health Centre|||1||f||||f||||||||Undecided||2017-10-10 22:26:09.154224|2017-10-10 22:26:09.154224
NCT02694679|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-09-06|||June 2015||2015-06-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Randomized Controlled Trial of Social Network Targeting in Honduras|Randomized Controlled Trial of Social Network Targeting to Magnify Population-Level MNCH Behavior Change in Honduras|Recruiting||N/A|30000|Anticipated|Yale University||16|||f||||f||||||||||2017-10-10 22:26:09.25737|2017-10-10 22:26:09.25737
NCT02694666|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-06-13|||April 2015||2015-04-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Vibration Training for Preventing Falls in Healthy Population and Multiple Sclerosis|Effects of Controlled Whole-body Vibration Training on Preventing Falls Among Healthy Population and Ambulatory People With Multiple Sclerosis|Recruiting||N/A|440|Anticipated|Georgia State University||2|||f|||||f|f||||||Undecided||2017-10-10 22:26:09.383211|2017-10-10 22:26:09.383211
NCT02694640|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-09-18|||December 2015||2015-12-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors|Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors|Recruiting||N/A|150|Anticipated|University of South Carolina||3|||f||||f||||||||||2017-10-10 22:26:09.570341|2017-10-10 22:26:09.570341
NCT02694627|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-04-03|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Bandebereho Father Groups Randomized Control Trial in Rwanda|Bandebereho Father Groups: a Randomized Control Trial to Assess the Impact of Maternal, Newborn and Child Health Group Education for New and Expecting Fathers|Completed||N/A|2400|Anticipated|Promundo, United States||2|||f||||f||||||||No||2017-10-10 22:26:09.785961|2017-10-10 22:26:09.785961
NCT02694614|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-19|||March 2015||2015-03-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|July 2017|Actual|2017-07-01||Interventional|Oviva||Weight-loss Treatment Through Smartphone-assisted Dietary Coaching|Weight-loss Treatment of Overweight / Obesity Patients Through Smartphone-assisted Dietary Coaching: A Pre-post Pilot Study|Active, not recruiting||N/A|45|Actual|Oviva AG||1|||f||||t||||||||||2017-10-10 22:26:09.885898|2017-10-10 22:26:09.885898
NCT02694588|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-06-17|||June 2014||2014-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|Phen_IBD||Clinical and Molecular Phenotyping in IBD|Systematic Profiling of Anti-inflammatory Drugs for the Detection of Drug- Specific Response Signatures in the Treatment of Chronic Inflammatory Disorders|Recruiting||N/A|60|Anticipated|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-10 22:26:10.105038|2017-10-10 22:26:10.105038
NCT02694575|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|IGLOOS||The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes|The Impact of Glucose Lowering Therapies Including Dipeptidyl Peptidase-4 Inhibitor on Circulating Endothelial Progenitor Cells (EPCs) and Its Mobilising Factor Stromal Derived Factor-1α (SDF-1α) in Patients With Type 2 Diabetes|Recruiting||N/A|216|Anticipated|University of Leicester|||3||f||||t||||||Samples Without DNA|"     Peripheral Blood Mononuclear Cells (PBMCs) for subsequent EPC quantification:      PBMCs will be isolated from venous blood collected into a 9.7ml sodium heparin blood tube.     EPCs will be quantified as cells showing dual positivity for the cell surface / transmembrane     markers: CD24 and KDR (Kinase Insert Domain Receptor). SDF-1α analysis and the analysis of     biomarkers associated with the prevalence of circulating EPCs will be measured using sandwich     ELISA and multi-array ELISA technology in-line with manufacturer protocols. Analysis of     endogenous DPP4 will be assayed using a commercial colorimetric assay; again manufacturer     protocols will be followed. Biomarker and DPP4 analysis will be carried out in one batch on     stored sodium heparin plasma samples.   "|Yes|Clinically significant blood result data will be shared with the participant's General Practitioner when appropriate.|2017-10-10 22:26:10.195392|2017-10-10 22:26:10.195392
NCT02694549|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-07-18|||August 9, 2016|Actual|2016-08-09|July 2017|2017-07-01|November 10, 2016|Actual|2016-11-10|October 10, 2016|Actual|2016-10-10||Interventional|||CaveoVasc System - a New Femoral Vascular Access and Closure Device|Prospective, Single Arm Study to Assess the Performance and Safety of CaveoVasc System for Femoral Vascular Access and Closure Device|Terminated||N/A|12|Actual|CaveoMed GmbH||1|||f||||||||||||||2017-10-10 22:26:10.427745|2017-10-10 22:26:10.427745
NCT02694536|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-02-21|2016-09-12||August 1, 2006||2006-08-01|February 2017|2017-02-01|November 19, 2009|Actual|2009-11-19|November 19, 2009|Actual|2009-11-19||Interventional||Safety Population: All participants who received at least one dose of erlotinib.|A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer|A Phase IIIb Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer|Completed||Phase 3|80|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:26:10.516379|2017-10-10 22:26:10.516379
NCT02694523|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-10-04|||March 2016|Actual|2016-03-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|February 2017|Actual|2017-02-01||Interventional|||BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis|BI 655066/ABBV-066 (Risankizumab) Versus Adalimumab in a Randomized, Double Blind, Parallel Group Trial in Moderate to Severe Plaque Psoriasis to Assess Safety and Efficacy After 16 Weeks of Treatment and After Inadequate Adalimumab Treatment Response (IMMvent)|Completed||Phase 3|605|Actual|AbbVie||2|||f||||t||||||||||2017-10-10 22:26:10.932215|2017-10-10 22:26:10.932215
NCT02694510|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-23|||January 2014||2014-01-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Light Protection of TPN and Oxidative Stress in Preterm Infants|Impact of Protecting TPN Solution From Light on the Oxidant-antioxidant State of Preterm Infant|Recruiting||N/A|80|Anticipated|Mansoura University Children Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:26:11.12821|2017-10-10 22:26:11.12821
NCT02694497|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 31, 2017|Anticipated|2017-12-31||Observational|FemCure||Transmission of Genital and Extra-genital Chlamydia Trachomatis Infections in Women|Understanding Transmission of Genital and Extra-genital Chlamydia Trachomatis Infections in Women Receiving Routine Care; Implications for Control Strategies|Recruiting||N/A|400|Anticipated|Maastricht University Medical Center|||1||f||||t||||||Samples With DNA|"     Participants will collect a self-administered anorectal and vaginal swab at 8 time-points:     pre-treatment during the visit at the STI clinic at which the treatment is given (T0), and at     the end of weeks 1, 2, 4, 6, 8, 10, and 12. At T0, T4, T8 and T12 (visits at the clinic), the     participants take an additional self-administered anorectal and vaginal swab that is     otherwise exactly the same as the home-taken samples, but stored in a different buffer and     processed immediately, i.e. cooled at -80°C within 24 hours, to allow CT viability testing.     At the clinic visit, we will also consider to obtain a nurse-taken pharyngeal swab for later     CT testing. For self-collection of the anorectal and genital samples, participants receive     clear instructions.   "|||2017-10-10 22:26:11.32426|2017-10-10 22:26:11.32426
NCT02694484|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-07-17|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|TRANSFECMV||Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant|Search Cytomegalovirus (CMV) in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant|Completed||N/A|500|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-10-10 22:26:11.416987|2017-10-10 22:26:11.416987
NCT02694471|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-29|||August 2012||2012-08-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|BEDREST||Effect of 14 Day Bed Rest on Health Outcomes in Young and Older Participants|CB147 - Physical Activity and Nutrition for Quality Ageing|Completed||N/A|23|Actual|University of Primorska||2|||f||||f||||||||No|The data is shared among partners for various publications|2017-10-10 22:26:11.508118|2017-10-10 22:26:11.508118
NCT02694458|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-02-27|||February 23, 2016|Actual|2016-02-23|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|February 15, 2017|Actual|2017-02-15||Interventional|OPTIBAYE||Comparison of Two Dosage Adjustment Strategies of Vancomycin in Children|Comparison of Two Dosage Adjustment Strategies of Vancomycin in Children|Active, not recruiting||N/A|100|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 22:26:11.639558|2017-10-10 22:26:11.639558
NCT02694445|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-02-26|||January 2016||2016-01-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Observational|||Monetary Cost of Alzheimer's Disease in China|Monetary Cost of Alzheimer's Disease in China: Study Protocol for a Cluster Randomized Observational Study|Recruiting||N/A|2500|Anticipated|Beijing Friendship Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:26:11.733575|2017-10-10 22:26:11.733575
NCT02694432|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-09-30|||September 2016||2016-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Minding GOALS: An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control|An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control|Active, not recruiting||N/A|76|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:26:11.829834|2017-10-10 22:26:11.829834
NCT02694419|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-10|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Observational|OB-PCO||The Effect of Obesity on Endometrium in PCOS|Effect of Body Weight on Endometrial Ultrasonographic Characteristics in Polycystic Ovary Syndrome Patients|Completed||N/A|100|Actual|Assiut University|||4||f||||t||||||||||2017-10-10 22:26:11.936871|2017-10-10 22:26:11.936871
NCT02694406|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-01-08|||July 2015||2015-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|MRI-CAM||MRI Perfusion in Adnexal Masses|Added Value of MRI Perfusion in Evaluation of Complex Adnexal Masses|Recruiting||N/A|40|Anticipated|Assiut University|||1||f||||t||||||||Undecided||2017-10-10 22:26:12.015744|2017-10-10 22:26:12.015744
NCT02694393|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-02-23|||February 2016||2016-02-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis|Phase I/II Study of Inhaled Sodium Nitrite as an Antimicrobial for Pseudomonas Infection in Cystic Fibrosis|Recruiting||Phase 1/Phase 2|35|Anticipated|University of Pittsburgh||1|||f||||t||||||||No||2017-10-10 22:26:12.087809|2017-10-10 22:26:12.087809
NCT02694380|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Measuring the Effect of Radiation Therapy on Patient Activity Levels|Measuring the Effect of Radiation Therapy on Patient Activity Levels|Recruiting||N/A|40|Anticipated|University of Pittsburgh|||4||f||||t||||||||No||2017-10-10 22:26:12.195269|2017-10-10 22:26:12.195269
NCT02694367|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-02-26|||January 2015||2015-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|EPK-RM||Expression of EPK in Recurrent Miscarriage|MAP Kinase Signaling Pathways Through ERK and p-ERK Protein in Human Placenta of Women With Recurrent Miscarriage|Completed||N/A|39|Actual|Assiut University|||2||f||||t||||||||No||2017-10-10 22:26:12.288071|2017-10-10 22:26:12.288071
NCT02694354|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2016-05-03|||March 2016||2016-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Investigation of Single Rising Doses of BI 685509|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 685509 in Healthy Male Subjects|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:26:12.383439|2017-10-10 22:26:12.383439
NCT02694341|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-09-08|||December 2016||2016-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|BB-ATS||Bakri Balloon in Placenta Previa|Bakri Ballon With or Without Abdominal Traction Stitch in Management of Uterine Bleeding in Cases of Placenta Previa|Not yet recruiting||Phase 2|40|Anticipated|Assiut University||2|||f||||t||||||||Yes||2017-10-10 22:26:12.468216|2017-10-10 22:26:12.468216
NCT02694328|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-09-01|||February 2016||2016-02-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)|A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia|Recruiting||Phase 3|540|Anticipated|Alkermes, Inc.||2|||f||||f||||||||||2017-10-10 22:26:12.558048|2017-10-10 22:26:12.558048
NCT02694315|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-09-19|2016-03-11||October 2014||2014-10-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational||Raslan et al., 2013 reported accuracy of cervical length or Bishop score was 72% vs 63%. So, proportion of discordant pairs is 0.37. A sample of 200 would achieve a power of 80% to detect statistical significance for an effect size equivalent to odds ratio of 1.9. Two sided McNemar test was used with a confidence level 95%.|Cervical Length and Bishop Score in Preinduction Cervical Assessment Prior to Induction of Labor|Comparison Between Sonographic Cervical Length and Bishop Score in Preinduction Cervical Assessment Prior to Induction of Labor as Regards Induction Success|Completed||N/A|200|Actual|Ain Shams Maternity Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:26:12.816513|2017-10-10 22:26:12.816513
NCT02694302|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-09-26|||March 2014||2014-03-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Walkbot||Clinical Trial of Robot-assisted-gait-training (RAGT) in Stroke Patients|A Multi-center, Parallel and Randomized Design Clinical Trial of Robot-assisted-gait-training (RAGT) in Stroke Patients to Evaluate Its Efficacy, Safety and Superiority Over Conventional Gait Training|Completed||N/A|91|Actual|P&S Mechanics Co., Ltd.||2|||f||||f||||||||No||2017-10-10 22:26:13.040592|2017-10-10 22:26:13.040592
NCT02694289|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-04-03|||November 2016||2016-11-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|February 2020|Anticipated|2020-02-01||Interventional|||Effects of Metformin in Heart Failure Patients|Effects of Metformin in Heart Failure Patients|Recruiting||N/A|100|Anticipated|University of Kentucky||2|||f||||t||||||||No||2017-10-10 22:26:13.120786|2017-10-10 22:26:13.120786
NCT02694276|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-05-15|||December 2015||2015-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Internet-based Cognitive Behavior Therapy for Atrial Fibrillation|Internet-based Cognitive Behavior Therapy for Atrial Fibrillation|Recruiting||N/A|30|Anticipated|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 22:26:13.215471|2017-10-10 22:26:13.215471
NCT02694263|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-07-21|||July 2016||2016-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|Can Do Ramadan||Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan|A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan: Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen: The 'Can Do Ramadan' Study|Recruiting||Phase 4|116|Anticipated|University of Leicester||5|||f||||t||||||||No|There are no plans to make individual participant data (IPD) available. Abnormal blood results will be shared with the participant's general practitioner (GP) if it is considered to the clinically necessary.|2017-10-10 22:26:13.318705|2017-10-10 22:26:13.318705
NCT02694250|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-10-14|||November 2015||2015-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluation of Cervical Fusion With DTRAX® Cervical Cage With DTRAX Bone Screw|Evaluation of Cervical Fusion With DTRAX® Cervical Cage With DTRAX Bone Screw in Patients With Cervical Radiculopathy|Withdrawn||N/A|0|Actual|Providence Medical Technology, Inc.||1|||f||||f||||||||No||2017-10-10 22:26:13.496578|2017-10-10 22:26:13.496578
NCT02694237|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-04-28|||March 2016||2016-03-01|April 2016|2016-04-01||||April 2016|Actual|2016-04-01||Interventional|||The Age of OrthoInfo: A Randomized Controlled Trial Evaluating Patient Comprehension of Informed Consent in a Private Practice||Completed||N/A|66|Actual|University of Missouri, Kansas City||3|||f||||||||||||||2017-10-10 22:26:13.580851|2017-10-10 22:26:13.580851
NCT02694224|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-05-11|||April 2016||2016-04-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SHH-CM||Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients|A Randomized Phase II Pilot Study to Evaluate Safety and Efficacy of the Addition of Vismodegib to Standard Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients|Recruiting||Phase 2|40|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||t||||||||||2017-10-10 22:26:13.781128|2017-10-10 22:26:13.781128
NCT02694211|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-02-23|||May 2013||2013-05-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|SPA||Stress Prevention at Work: Intervention Efficacy and Implementation Process Evaluation|Stress Prevention at Work: Intervention Efficacy and Implementation Process Evaluation (SPA)|Completed||N/A|130|Actual|Karolinska Institutet||2|||f||||f||||||||No||2017-10-10 22:26:13.900685|2017-10-10 22:26:13.900685
NCT02694198|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2016-04-10|2016-03-07||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational||Depending on Francesco et al., 2005 who found that Fetal fibronectin positive test in 19 among 270 (7.0%) in women undergoing mid-trimester abortion. Assuming α=0.05 and confidence interval (CI)= 10.0% and by using PASS 11th release the minimal sample size is 120. With a possible 10.0% drop out of cases, the enrolled cases would be 135 cases.|Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion|Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion|Completed||N/A|135|Actual|Ain Shams Maternity Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:26:13.990161|2017-10-10 22:26:13.990161
NCT02694185|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-06-06|||October 1, 2016|Actual|2016-10-01|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|SEPPRMACI-ARM||Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications|Secondary Event Prevention Using Population Risk Management After PCI|Recruiting||N/A|4800|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-10 22:26:14.17554|2017-10-10 22:26:14.17554
NCT02694172|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-26|||September 2007||2007-09-01|February 2016|2016-02-01|April 2011|Actual|2011-04-01|June 2009|Actual|2009-06-01||Interventional|||Human Faecal Microbiota in Type 2 Diabetes|Analysis of the Diversity of Faecal Bacteria in Healthy and Type 2 Diabetic Subjects|Completed||N/A|67|Actual|Nestlé||3|||f||||f||||||||No||2017-10-10 22:26:14.270485|2017-10-10 22:26:14.270485
NCT02694159|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-04-27|||February 2016||2016-02-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Observational|||Physician Judgment and Machine Predictions|Physician Judgment and Machine Predictions: Improving Medical Decisions Using Machine Learning|Active, not recruiting||N/A|50000|Anticipated|University of Pennsylvania|||1||f||||f||||||||No||2017-10-10 22:26:14.364969|2017-10-10 22:26:14.364969
NCT02694146|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-20|||March 2016||2016-03-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|May 2017|Actual|2017-05-01||Interventional|COX||Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis|Clinical Trial Randomized, Double-blind Controlled, Phase III, to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis|Recruiting||Phase 3|74|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||f||||||||||2017-10-10 22:26:14.423425|2017-10-10 22:26:14.423425
NCT02694133|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2016-02-23|||January 2012||2012-01-01|February 2016|2016-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of Telerehabilitation in the Patients With Aphasia|Efficacy of Telerehabilitation in the Patients With Aphasia|Completed||N/A|4|Actual|Kaohsiung Veterans General Hospital.||1|||f||||t||||||||||2017-10-10 22:26:14.526873|2017-10-10 22:26:14.526873
NCT02694120|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-23|||February 2016||2016-02-01|February 2016|2016-02-01||||July 2016|Anticipated|2016-07-01|6 Months|Observational [Patient Registry]|SCALP||Study on Complications, EfficAcy and Costs of Large Polypectomy||Not yet recruiting||N/A|1000|Anticipated|Valduce Hospital|||1||f||||||||||||||2017-10-10 22:26:14.593886|2017-10-10 22:26:14.593886
NCT02694107|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-23|||July 2015||2015-07-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Effectiveness of Proprioceptive Training on Dynamic Postural Balance During Pregnancy|A Randomized Controlled Trial of Effectiveness of Proprioceptive Training on Dynamic Postural Balance During Pregnancy|Completed||N/A|39|Actual|Kafrelsheikh University||2|||f||||t||||||||No||2017-10-10 22:26:14.652121|2017-10-10 22:26:14.652121
NCT02694094|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-09-08|||March 2016||2016-03-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy|Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy|Enrolling by invitation||N/A|60|Anticipated|Johns Hopkins University|||2||f||||f||||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 22:26:14.723162|2017-10-10 22:26:14.723162
NCT02694081|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-12-29|||February 2016||2016-02-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric|The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction|Recruiting||Phase 2|100|Anticipated|Jilin University||2|||f||||t||||||||||2017-10-10 22:26:14.832406|2017-10-10 22:26:14.832406
NCT02694068|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-10-25|||April 2014||2014-04-01|October 2016|2016-10-01||||March 2019|Anticipated|2019-03-01||Observational|Bio-PD||Biological Determinants of Peritoneal Dialysis|Biological Determinants of Peritoneal Dialysis|Recruiting||N/A|4865|Anticipated|University of Washington|||4||f||||f||||||Samples With DNA|"     Blood, Dialysate, and DNA may be collected   "|No||2017-10-10 22:26:14.948894|2017-10-10 22:26:14.948894
NCT02694055|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-03-04|||January 2016||2016-01-01|March 2016|2016-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Pro-CCM||Trial of Proactive Community Case Management to Reduce Child Mortality|Proactive Community Case Management and Child Survival: A Cluster-Randomized Controlled Trial|Enrolling by invitation||N/A|22847|Anticipated|University of California, San Francisco||2|||f||||t||||||||Yes|IPD will be made available with publication and dissemination of final results after termination of the study in September 2018. However, all IPD made available will be anonymous. IPD includes anonymous quantitative and qualitative data on health seeking behaviour and health outcomes of the study participants.|2017-10-10 22:26:15.063263|2017-10-10 22:26:15.063263
NCT02694042|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-09-01|||April 2016||2016-04-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Mission is Remission®: How Can a Disease Self-management Website Change Care?|Mission is Remission®: How Can a Disease Self-management Website Change Care?|Enrolling by invitation||N/A|200|Anticipated|IWK Health Centre||2|||f||||f||||||||No|All collected data is self-reported. Participants will be offered the option of receiving a summary of the study results when they are available. These results are presented as group results (not individual).|2017-10-10 22:26:15.190374|2017-10-10 22:26:15.190374
NCT02694029|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-07-28|||February 2016||2016-02-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|VisionRT||Active Breathing Coordinator-based vs VisionRT-based Deep Inspiration Breath-hold for Radiation for Breast Cancer|Intra-patient Comparison of Active Breathing Coordinator-based vs VisionRT-based Deep Inspiration Breath-hold for Left-chest Wall Irradiation, a Pilot Study for Breast Cancer|Recruiting||N/A|10|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 22:26:15.309853|2017-10-10 22:26:15.309853
NCT02694016|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-09-19|||February 2016||2016-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Remote Ischemic Preconditioning in Patients Undergoing Isolated Aortic Valve Replacement Surgery|Remote Ischemic Preconditioning in Patients Undergoing Isolated Aortic Valve Replacement Surgery With a Biological Prosthesis: A Single Center Randomized Prospective Study|Terminated||N/A|4|Actual|Oulu University Hospital||2||Insufficient recruitment pace|f||||f||||||||||2017-10-10 22:26:15.409963|2017-10-10 22:26:15.409963
NCT02694003|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-03-07|||January 2018|Anticipated|2018-01-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|BNBD-NDD||Better Nights, Better Days for Children With Neurodevelopment Disorders|Development, Implementation, and Evaluation of an Internet-based Behavioural Sleep Intervention for Children With NDD and Insomnia|Not yet recruiting||N/A|240|Anticipated|IWK Health Centre||2|||f||||t|f|f||||||No|This trial will be reported at a group level only, not individual participant level.|2017-10-10 22:26:15.49424|2017-10-10 22:26:15.49424
NCT02693990|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-07-18|||February 2016||2016-02-01|July 2017|2017-07-01|February 2023|Anticipated|2023-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas|A Phase I/II Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas|Recruiting||Phase 1/Phase 2|60|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-10 22:26:15.598901|2017-10-10 22:26:15.598901
NCT02693977|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-04-05|||February 2015||2015-02-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|||Use of Sleep Endoscopy to Predict Outcomes of Pediatric Adenotonsillectomy|Use of Sleep Endoscopy to Predict Outcomes of Pediatric Adenotonsillectomy|Enrolling by invitation||N/A|450|Anticipated|Oregon Health and Science University|||1||f||||f||||||||No||2017-10-10 22:26:15.697509|2017-10-10 22:26:15.697509
NCT02693964|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-09-07|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 2017|Actual|2017-07-01||Observational|||Bone and Vascular Health in Postmenopausal Women With Type 1 Diabetes|Bone and Vascular Health in Postmenopausal Women With Type 1 Diabetes|Completed||N/A|100|Actual|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     blood and urine samples   "|||2017-10-10 22:26:15.778113|2017-10-10 22:26:15.778113
NCT02693951|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-01-04|||February 2016||2016-02-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficiency and Safety of Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices|Efficiency and Safety of Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 22:26:15.867017|2017-10-10 22:26:15.867017
NCT02693938|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-04-13|||January 2016||2016-01-01|April 2016|2016-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes|Investigating Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes to Design Innovative Therapies|Recruiting||N/A|30|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-10 22:26:15.975941|2017-10-10 22:26:15.975941
NCT02693925|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-09-19|||December 2014||2014-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|SRBD-Cardio||Sleep-related Breathing Disorders in Cardiological Outpatients|Sleep-related Breathing Disorders in Cardiological Outpatients From a German University Clinic - Prevalence, Classification, Diagnostic Accuracy|Active, not recruiting||N/A|90|Actual|Wissenschaftliches Institut Bethanien e.V|||1||f||||f||||||||No||2017-10-10 22:26:16.065594|2017-10-10 22:26:16.065594
NCT02693912|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-26|||September 2016||2016-09-01|February 2016|2016-02-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Observational|||Changes in Alveolar Macrophage Function During Acute Lung Injury|Changes in Alveolar Macrophage Function During Acute Lung Injury|Not yet recruiting||N/A|25|Anticipated|West China Hospital|||2||f||||f||||||Samples With DNA|"     bronchoalveolar lavage fluid will be collected which contains immune cells, including     macrophages.   "|No|no plan has been made to share data|2017-10-10 22:26:16.133114|2017-10-10 22:26:16.133114
NCT02693899|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-09|||May 27, 2016|Actual|2016-05-27|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|FLAM/FLAL||Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia|Monocentric, Biological, Uncontrolled, Prospective Study on the Feasibility of Plasma FLT3 Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated With Intensively for Acute Leukemia|Recruiting||N/A|80|Anticipated|Nantes University Hospital|||1||f||||f||||||Samples Without DNA|"     Plasma (15 maximum plasma tubes of 9 mL per patient during follow-up)   "|||2017-10-10 22:26:16.201404|2017-10-10 22:26:16.201404
NCT02693886|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-26|||April 2016||2016-04-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Effect of Single Colonoscopy on Colorectal Adenomas Detection|Clinical Study That Effect of Individualized Intervention of Single Colonoscopy on Colorectal Adenomas Detection|Not yet recruiting||N/A|10000|Anticipated|Wuxi People's Hospital|||4||f||||t||||||||Yes||2017-10-10 22:26:16.274466|2017-10-10 22:26:16.274466
NCT02693873|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-03-01|||March 7, 2016|Actual|2016-03-07|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 28, 2016|Actual|2016-11-28||Interventional|||STOP OA: A PILOT STUDY (GLA:D Canada) - Education and Targeted, Personalized Exercise for Hip and Knee Osteoarthritis|STOP OA: A PILOT STUDY - Adaptation and Evaluation of a Targeted, Evidence-based, Integrated Patient Education and Exercise Program to Prevent the Progression of Hip and Knee Osteoarthritis Symptoms|Active, not recruiting||N/A|61|Actual|University Health Network, Toronto||1|||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-10 22:26:16.333454|2017-10-10 22:26:16.333454
NCT02693860|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-02-28|||January 2016||2016-01-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Neoadjuvant J591 Treatment for Prostate Cancer|A Pilot Study of Neoadjuvant Monoclonal Antibody Humanised (hu) J591 for the Treatment of High and/or Intermediate−Risk Prostate Cancer|Recruiting||Phase 1|10|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-10 22:26:16.431728|2017-10-10 22:26:16.431728
NCT02693847|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-08-16|||February 2006||2006-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|||Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients|Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients|Recruiting||N/A|446|Anticipated|Hospital Universitario de Valme|||1||f||||f||||||Samples Without DNA|"     Serum samples are collected and immediately frozen for criopreservation   "|||2017-10-10 22:26:16.511592|2017-10-10 22:26:16.511592
NCT02693834|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-18|||January 2016||2016-01-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Two Different Types of Ankle Foot Orthoses on Gait Outcomes in Patients With Subacute Stroke.|Effects of Two Different Types of Ankle Foot Orthoses on Gait Outcomes in Patients With Subacute Stroke.|Recruiting||N/A|20|Anticipated|Texas Woman's University||1|||f||||f||||||||Undecided||2017-10-10 22:26:16.604025|2017-10-10 22:26:16.604025
NCT02693821|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-08-08|||December 2015||2015-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2016|Actual|2016-01-01||Interventional|PPP||Persistent Postoperative Pain|Persistent Postoperative Pain Incidence With Long Term Perioperative Gabapentin Used|Enrolling by invitation||Phase 4|55|Actual|Hospital Italiano de Buenos Aires||2|||f||||t||||||||||2017-10-10 22:26:16.716805|2017-10-10 22:26:16.716805
NCT02693808|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-08-09|||November 2015||2015-11-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|December 2018|Anticipated|2018-12-01||Interventional|||New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression|New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression|Enrolling by invitation||N/A|40|Anticipated|Haukeland University Hospital||2|||f||||f||||||||||2017-10-10 22:26:16.796996|2017-10-10 22:26:16.796996
NCT02693795|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-08-06|||May 2016||2016-05-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Baduanjin Exercise Prevents Post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER Trial)|Baduanjin Exercise Prevents Post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER Trial)|Not yet recruiting||N/A|110|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-10 22:26:16.980306|2017-10-10 22:26:16.980306
NCT02693782|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-05-01|||June 2015|Actual|2015-06-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|FFS||Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS)|Effect of Wheat Bran Extract Containing Arabinoxylan Oligosaccharides, on the Gut Microbiota Composition and Well-being in Healthy Aging Subjects PhD Project: New Targeted Prebiotic Approaches for Maintaining Human Health|Completed||N/A|21|Actual|University of Aberdeen||2|||f||||f||||||||No||2017-10-10 22:26:17.067436|2017-10-10 22:26:17.067436
NCT02693769|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-12-09|||July 2016||2016-07-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils|A Randomised, Single Blind, Cross-over Study to Compare a Fixed Dose Combination of Fluticasone Propionate / Formoterol Fumarate (Breath Actuated Inhaler (BAI)) With a Fixed Dose Combination of Indacaterol Maleate / Glycopyrronium Bromide (Ultibro® Breezhaler) in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils|Terminated||Phase 2/Phase 3|2|Actual|Mundipharma Research Limited||2||Recruitment issues|f||||f||||||||||2017-10-10 22:26:17.176187|2017-10-10 22:26:17.176187
NCT02693756|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-02-23|||February 2016||2016-02-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|MIGS-F||Home-based Motor Imagery for Gait Stability in Older Adults. A Cross-over Feasibility Study. (MIGS-F)|Home-based Motor Imagery Intervention for the Improvement of Gait Stability in Elderly Persons. A Cross-over Feasibility Study.|Recruiting||N/A|32|Anticipated|University of Applied Sciences of Western Switzerland||2|||f||||f||||||||No||2017-10-10 22:26:17.257236|2017-10-10 22:26:17.257236
NCT02693743|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-28|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|rTMS||Repetitive Transcranial Magnetic Stimulation as Treatment for Acute Suicidality in Adult Patients|Repetitive Transcranial Magnetic Stimulation as Treatment for Acute Suicidality in Adult Patients|Active, not recruiting||N/A|20|Anticipated|University of Arkansas||2|||f||||f|f|t|f|f||||No||2017-10-10 22:26:17.343405|2017-10-10 22:26:17.343405
NCT02693730|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-02-23|||January 2016||2016-01-01|January 2016|2016-01-01|January 2020|Anticipated|2020-01-01|July 2018|Anticipated|2018-07-01||Observational|PMVS-P||Phenotyping IBS: Perceptions and Modulations of Visceral Sensations|Perceptions and Modulations of Visceral Sensations|Recruiting||N/A|290|Anticipated|University of California, Los Angeles|||3||f||||t||||||Samples With DNA|"     Stool samples will be collected from both IBS and IBD subjects. A full stool analysis will be     performed on the stool of IBS subjects, whereas only calprotectin will be measured in the     stool of IBD subjects.      Blood will be collected from IBS subjects and HCs.   "|Yes|All data will be stripped of identifiers before data sharing|2017-10-10 22:26:17.452464|2017-10-10 22:26:17.452464
NCT02693717|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-04|||May 9, 2017|Actual|2017-05-09|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||A Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma|A Phase II Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma|Recruiting||Phase 2|25|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 22:26:17.552245|2017-10-10 22:26:17.552245
NCT02693704|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-10-03|2016-07-12||February 2016||2016-02-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|BHA(L&S)||Evaluation of a Binaural Spatialization Method for Hearing Aids|Evaluation of a Binaural Spatialization Method for Hearing Aids, in Terms of Speech Intelligibility, Speaker Localization and Subjective Preference.|Completed||Phase 2/Phase 3|40|Actual|Sonova AG||4|||f||||f||||||||No||2017-10-10 22:26:17.694906|2017-10-10 22:26:17.694906
NCT02693691|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-06-02|||May 2016||2016-05-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MEMS-HF||CardioMEMS European Monitoring Study for Heart Failure|CardioMEMS European Monitoring Study for Heart Failure|Recruiting||N/A|230|Anticipated|St. Jude Medical||1|||f||||f||||||||Undecided||2017-10-10 22:26:18.196768|2017-10-10 22:26:18.196768
NCT02693678|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-11-08|||April 2016||2016-04-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Real and Sham Diathermy vs Hand Massage in Lower Limbs Delayed Onset Muscle Soreness (DOMS)Effect on Knee Proprioception|Real or Sham Diathermy vs Hand Massage in Lower Limbs Delayed Onset Muscle Soreness (DOMS) in Skiers, Effect on Knee Joint Proprioception|Completed||N/A|24|Actual|Studi Fisioterapici di Montagna||3|||f||||t||||||||Yes||2017-10-10 22:26:18.29152|2017-10-10 22:26:18.29152
NCT02693665|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-30|||July 15, 2016|Actual|2016-07-15|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|FACE-TC||Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer|Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer|Recruiting||N/A|260|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-10 22:26:18.395317|2017-10-10 22:26:18.395317
NCT02693652|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-23|||November 2014||2014-11-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine|A Single Center, Open Labeled Phase I/IIa Study to Evaluate Safety, Tolerability and Efficacy of a Therapeutic Hepatitis B Vaccine in Oral Antiviral Drug-treated Chronic Hepatitis B Virus Carriers|Recruiting||Phase 1/Phase 2|36|Anticipated|CHA Vaccine Institute Co., Ltd.||4|||f||||f||||||||||2017-10-10 22:26:18.532583|2017-10-10 22:26:18.532583
NCT02693639|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-23|||February 2016||2016-02-01|February 2016|2016-02-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Prediction Value of PANX1 in Infection Post Liver Transplantation||Not yet recruiting||N/A|200|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||||||||||||2017-10-10 22:26:18.624381|2017-10-10 22:26:18.624381
NCT02693626|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-02-23|||April 2016||2016-04-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|HQ||Happy Quit for Smoking Cessation in China|The Efficacy of Mobile Phone-based Text Message Interventions ('Happy Quit') for Smoking Cessation in China|Not yet recruiting||N/A|1000|Anticipated|Central South University||2|||f||||f||||||||Yes|I would be happy to share the data with everyone.|2017-10-10 22:26:18.695361|2017-10-10 22:26:18.695361
NCT02693613|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-06-17|||February 2016||2016-02-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pharmacokinetic Study of ASP1517 With Kremezin®|Pharmacokinetic Study of ASP1517 − Evaluation of the Effect of Kremezin® on the Pharmacokinetics of ASP1517 in Non-elderly Healthy Adult Male Subjects, When Administered Concomitantly or in a Time Separated Manner.|Completed||Phase 1|34|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 22:26:18.764434|2017-10-10 22:26:18.764434
NCT02693600|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-06-07|||September 2014||2014-09-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|February 2016|Actual|2016-02-01||Interventional|||Comparison Between Hemitrapeziectomy and Total Trapeziectomy With Ligament Reconstruction and Tendon Interposition in Trapeziometacarpal Osteoarthritis II-III Eaton-Littler|Comparison Between Hemitrapeziectomy and Total Trapeziectomy With Ligament Reconstruction and Tendon Interposition in Trapeziometacarpal Osteoarthritis II-III Eaton-Littler|Completed||N/A|34|Actual|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-10 22:26:18.870061|2017-10-10 22:26:18.870061
NCT02693587|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-03-02|||November 2015||2015-11-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|1 Week|Observational [Patient Registry]|||Misodel or Angusta for Induction of Labour?|Misodel or Angusta for Induction of Labour? - a Medical Health Technology Assessment|Recruiting||N/A|420|Anticipated|Holbaek Sygehus|||2||f||||t||||||||||2017-10-10 22:26:18.97345|2017-10-10 22:26:18.97345
NCT02693548|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-23|||January 2004||2004-01-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|SAFEHEART||The Spanish Familial Hypercholesterolaemia Cohort Study|The Spanish Familial Hypercholesterolaemia Cohort Study|Recruiting||N/A|4141|Anticipated|Fundación Hipercolesterolemia Familiar|||2||f||||t||||||Samples With DNA|"     Venous blood samples were taken after 12 hours of fasting. Serum, plasma and DNA samples were     aliquoted and preserved at -80°C. Serum total cholesterol, triglycerides and HDL-cholesterol     levels were measured in a centralized laboratory using enzymatic methods   "|Yes|Available access for publication|2017-10-10 22:26:19.278027|2017-10-10 22:26:19.278027
NCT02693535|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-09-15|||March 2016||2016-03-01|September 2017|2017-09-01||||March 2019|Anticipated|2019-03-01||Interventional|TAPUR||TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer|Targeted Agent and Profiling Utilization Registry (TAPUR) Study|Recruiting||Phase 2|1060|Anticipated|American Society of Clinical Oncology||16|||f||||t||||||||||2017-10-10 22:26:19.387636|2017-10-10 22:26:19.387636
NCT02693522|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-02-26|||October 2003||2003-10-01|February 2016|2016-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency|Phase III of the Comparative Study on the Efficacy and Safety of Recombinant Somatropin Administered to Patients With Adult Growth Hormone Deficiency|Completed||Phase 3|52|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||||2017-10-10 22:26:19.643358|2017-10-10 22:26:19.643358
NCT02693509|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-03-20|||January 2005||2005-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|1 Year|Observational [Patient Registry]|||Get With The Guidelines-Heart Failure Registry|Get With The Guidelines-Heart Failure Registry|Recruiting||N/A|128026|Anticipated|American Heart Association|||1||f||||t||||||||Undecided||2017-10-10 22:26:19.725747|2017-10-10 22:26:19.725747
NCT02693496|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-06-12|||October 2015||2015-10-01|June 2017|2017-06-01|October 2025|Anticipated|2025-10-01|October 2025|Anticipated|2025-10-01||Observational|mLOWER||Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research|Mobile Lung Nodule Observatory for Worldwide, Evidenced - Based Research|Recruiting||N/A|10000|Anticipated|Chinese Alliance Against Lung Cancer|||1||f||||f||||||||No||2017-10-10 22:26:19.844547|2017-10-10 22:26:19.844547
NCT02693483|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-25|||April 2015||2015-04-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||Preoperative Vaginal Cleansing With Povidone Iodine and the Risk of Post Cesarean Endometritis|Preoperative Vaginal Cleansing With Povidone Iodine and the Risk of Post Cesarean Endometritis|Recruiting||Phase 4|306|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:26:20.051685|2017-10-10 22:26:20.051685
NCT02693470|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-25|||August 2014||2014-08-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)|The Difference of Circulating Endothelial-derived and Platelet-derived Microparticles in Patients With Psoriasis Successfully Treated With Stelara(Ustekinumab)|Recruiting||Phase 4|100|Anticipated|Chang Gung Memorial Hospital||1|||f||||f||||||||No||2017-10-10 22:26:20.134353|2017-10-10 22:26:20.134353
NCT02693457|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-18|||February 2016||2016-02-01|July 2017|2017-07-01||||February 2018|Anticipated|2018-02-01||Interventional|||Outcomes Following Suction Drain and Non-suction Drain Assisted Total Knee Arthroplasty|Outcomes Following Suction Drain and Non-suction Drain Assisted Total Knee Arthroplasty|Enrolling by invitation||N/A|30|Anticipated|Colorado Joint Replacement||2|||f||||f||||||||||2017-10-10 22:26:20.236959|2017-10-10 22:26:20.236959
NCT02693444|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-06-06|||May 1, 2016|Actual|2016-05-01|June 2017|2017-06-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Comparison of Strength and Constant Score Pre- and Post-Subacromial Injection for Full Thickness Rotator Cuff Tears|Comparison of Strength and Constant Score Pre- and Post-Subacromial Injection for Full Thickness Rotator Cuff Tears|Active, not recruiting||N/A|40|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-10 22:26:20.346969|2017-10-10 22:26:20.346969
NCT02693431|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-09|||June 29, 2016|Actual|2016-06-29|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|MUCO-ART||Impact of Art Therapy on Anxiety Identified During Hospitalizations Among Children With Cystic Fibrosis Aged 8 to 13|Impact of Art Therapy on Anxiety Identified During the Quarterly Update of Hospitalizations Among Children With Cystic Fibrosis Aged 8 to 13 - Pilot Study|Active, not recruiting||N/A|23|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 22:26:20.421754|2017-10-10 22:26:20.421754
NCT02693418|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-07|||August 2016||2016-08-01|August 2016|2016-08-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Duration of Effect of Acidform Gel on Vaginal pH|A Randomized, Placebo Controlled Pilot Study to Determine the Effect and Duration of Acidform Gel on Vaginal pH|Completed||Phase 1|100|Actual|Evofem Inc.||5|||f||||f||||||||||2017-10-10 22:26:20.482152|2017-10-10 22:26:20.482152
NCT02693405|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-22|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NEUROCOG-QOL||Executive and Socio-cognitive Functions in Survivors of Primary Brain Tumor: Impact on Patients' Quality of Life|Assessment of Executive and Socio-cognitive Functions in Child and Adult Survivors of Primary Brain Tumor: Impact on Patients' and Relatives' Quality of Life.|Not yet recruiting||N/A|160|Anticipated|University Hospital, Angers||2|||f||||t||||||||No||2017-10-10 22:26:20.565478|2017-10-10 22:26:20.565478
NCT02693392|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-01-23|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes|Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes: An Add-On Study|Recruiting||N/A|200|Anticipated|All India Institute of Medical Sciences, Bhubaneswar||2|||f||||f||||||||No||2017-10-10 22:26:20.642222|2017-10-10 22:26:20.642222
NCT02693379|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-02-22|||February 2015||2015-02-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Cervical Cancer Screening in Madagascar Using Smartphone Photos and Mobile Telemedicine|Cervical Cancer Screening in Madagascar: Usability of Mobile Telemedicine for Detection of Precancerous Lesions From Smartphone Photos|Completed||N/A|1041|Actual|University Hospital, Geneva||1|||f||||f||||||||Yes|Data will be used for scientific publications and congress presentations.|2017-10-10 22:26:20.759437|2017-10-10 22:26:20.759437
NCT02693366|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2017-06-03|||June 2015||2015-06-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|STEFOG||Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis|Safety Study of the Endovascular Infusion of Bone Marrow Derived Mononuclear Cells in Patients With Focal Segmental Glomerulosclerosis|Active, not recruiting||Phase 1|5|Anticipated|Universidade Federal do Rio de Janeiro||1|||f||||t||||||||Undecided||2017-10-10 22:26:20.876212|2017-10-10 22:26:20.876212
NCT02693353|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-02-22|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|January 2018|Anticipated|2018-01-01||Observational|||Epiretinal Membrane and Pseudophakic Cystoid Macular Edema|Association of Cystoid Macular Edema After Cataract Surgery in Patients With and Without Epiretinal Membrane|Recruiting||N/A|100|Anticipated|Loma Linda University|||2||f||||t||||||||Undecided||2017-10-10 22:26:21.136869|2017-10-10 22:26:21.136869
NCT02693340|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-06-23|||February 2016||2016-02-01|June 2016|2016-06-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Observational|IBDOT||Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease|Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease|Recruiting||N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     • Sampling period(s):        -  Blood: W0, W6, W14, W30 and W52 and relapse.        -  Biopsies and fecal: W0, W14 and M52 and relapse.   "|Undecided||2017-10-10 22:26:21.233164|2017-10-10 22:26:21.233164
NCT02693327|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-20|||April 2016||2016-04-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|||Microbiome and the Gut-Brain Axis|Microbiome and the Gut-Brain Axis|Completed||N/A|58|Actual|University of Florida|||2||f||||t|f|f||||||||2017-10-10 22:26:21.339521|2017-10-10 22:26:21.339521
NCT02693314|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-03-15|||March 2016||2016-03-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of Jarro-Dophilus EPS® Probiotic Formulations|Evaluation of Jarro-Dophilus EPS® Probiotic Formulations on Probiotic Survival, Fecal Microbiota, Gastrointestinal Function and General Wellness in Healthy Adults: a Randomized, Double-blind, Dose-response Study|Completed||Phase 1|75|Actual|University of Florida||3|||f||||f|f|f||||||Undecided||2017-10-10 22:26:21.447113|2017-10-10 22:26:21.447113
NCT02693301|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-05-21|||January 2016||2016-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of an Exercise Program for Children With Asthma|Effects of an Intra-hospital Exercise Program for Children With Asthma and Respiratory Symptoms|Recruiting||N/A|60|Anticipated|Universidad Europea de Madrid||2|||f||||f||||||||No||2017-10-10 22:26:21.560931|2017-10-10 22:26:21.560931
NCT02693288|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-10-07|||December 2015||2015-12-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|BNINF||Comparing Efficacity of Analgesia Between Ultrasound-guided Nerve Block and Local Infiltration After Wrist Fracture Surgery|Post Operative Analgesia After Wrist Fracture Surgery Under Regional Anesthesia: Randomized Trial, Open Study, With Evaluation of the Endpoint and Patient Blind (PROBE Design), Evaluating the Equivalence Between Ultrasound-guided Nerve Bloc and Local Infiltration|Completed||N/A|72|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 22:26:21.666794|2017-10-10 22:26:21.666794
NCT02693275|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-04-03|||April 2016||2016-04-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Reference Database Development for the Quotient® System iPad Test|Reference Database Development for the Quotient® System iPad Test (Ages 6 - 80 Years Old)|Completed||N/A|1333|Actual|Pearson/Clinical Assessment||1|||f||||f||||||||No||2017-10-10 22:26:21.755602|2017-10-10 22:26:21.755602
NCT02693262|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-10-24|||July 2016||2016-07-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|CLASS||Comparing Rate Response With CLS Versus Accelerometer ICD Settings in Heart Failure Patients With BIOTRONIK CRT-Ds|Rate Response With CLS Versus Accelerometer and Effect on Both Subjective Symptoms and Objective Outcomes in a Heart Failure Population Implanted With Cardiac Resynchronization With Defibrillator Device: The CLASS Trial|Recruiting||N/A|15|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 22:26:21.858335|2017-10-10 22:26:21.858335
NCT02693249|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-11-23|||February 2016||2016-02-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|PTC||Dysfunctional Posttraumatic Cognitions in Children and Adolescents|Dysfunctional Posttraumatic Cognitions in Children and Adolescents|Recruiting||N/A|170|Anticipated|University Children's Hospital, Zurich|||1||f||||f||||||||No||2017-10-10 22:26:21.979552|2017-10-10 22:26:21.979552
NCT02693236|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-02-23|||August 2014||2014-08-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer|Clinical Research of Genetically Modified Dendritic Cells in Combination With Cytokine-induced Killer Cell Treatment in Middle and Advanced Esophagus Cancer Patients|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||Yes||2017-10-10 22:26:22.07932|2017-10-10 22:26:22.07932
NCT02693223|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-03-20|||January 2003||2003-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|30 Days|Observational [Patient Registry]|GWTG-Stroke||Get With the Guidelines-Stroke Registry|Get With the Guidelines-Stroke Registry|Recruiting||N/A|3892063|Anticipated|American Heart Association|||1||f||||t||||||||Undecided||2017-10-10 22:26:22.168152|2017-10-10 22:26:22.168152
NCT02693210|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-10-29|||February 2001||2001-02-01|October 2016|2016-10-01|August 2004|Actual|2004-08-01|August 2002|Actual|2002-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid Arthritis|A Randomised, Double Dummy Controlled, Parallel Group Study of the Efficacy and Safety of MabThera (Rituximab) Alone or in Combination With Either Cyclophosphamide or Methotrexate, in Patients With Rheumatoid Arthritis|Completed||Phase 2|161|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-10 22:26:22.283914|2017-10-10 22:26:22.283914
NCT02693197|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-05-16|||February 2016||2016-02-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||PK Study of T-817 in Subjects With Hepatic Impairment|A Phase 1, Two-Part, Open-Label, Parallel-Cohort, Single-Dose Study to Determine the Pharmacokinetics of T-817MA in Adult Subjects With Hepatic Impairment and in Healthy Adult Subjects|Completed||Phase 1|36|Actual|Toyama Chemical Co., Ltd.||6|||f||||||||||||||2017-10-10 22:26:22.497634|2017-10-10 22:26:22.497634
NCT02693184|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-09-26|||March 2016||2016-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|FFQ||Validation of a Revised Food Frequency Questionnaire|Validation of a Revised Food Frequency Questionnaire in a Population of Elderly Men and Women With Fragility Fractures and Correlation With Bone Mineral Density and Biochemical Markers|Recruiting||N/A|45|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-10-10 22:26:22.612294|2017-10-10 22:26:22.612294
NCT02693171|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-02-03|||March 2016||2016-03-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|||Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients|A Post-Marketing Study to Further Assess the Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients|Terminated||N/A|13|Actual|United Therapeutics|||1|Significant short and intermediate-term drug supply shortages.|f||||t||||||||No||2017-10-10 22:26:22.72986|2017-10-10 22:26:22.72986
NCT02693158|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-06-14|||September 2016|Actual|2016-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|1 Year|Observational [Patient Registry]|Direct III||The Direct III Post Market Study|Direct Implantation of Sirolimus-Eluting Stents With Bioresorbable Drug Carrier Technology Utilizing the Svelte Drug-Eluting Coronary Stent: The Direct III Post Market Study|Recruiting||N/A|250|Anticipated|Svelte Medical Systems, Inc.|||1||f||||f||||||||Undecided||2017-10-10 22:26:22.849675|2017-10-10 22:26:22.849675
NCT02693145|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-03-28|||August 2016||2016-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|CoRECT||Cooperative Re-Engagement Controlled Trial (CoRECT)|Cooperative Re-Engagement Controlled Trial (CoRECT)|Recruiting||N/A|1800|Anticipated|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 22:26:22.972343|2017-10-10 22:26:22.972343
NCT02693119|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-06|||March 2016||2016-03-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide (MTP-131) Topical Ophthalmic Solution for the Treatment of Leber's Hereditary Optic Neuropathy|A Prospective, Randomized, Double-Masked, Vehicle Controlled, Phase 2 Clinical Study to Evaluate the Safety, Tolerability and Efficacy of Elamipretide (MTP-131) Topical Ophthalmic Solution in Subjects With Leber's Hereditary Optic Neuropathy (LHON)|Active, not recruiting||Phase 2|12|Actual|Stealth BioTherapeutics Inc.||4|||f||||f||||||||||2017-10-10 22:26:23.197269|2017-10-10 22:26:23.197269
NCT02693093|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-31|||December 2015||2015-12-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Dose Ranging Study Evaluating Efficacy and Safety of NI-03|A Phase 1, Single Dose PK and Safety Study With NI-03 Followed by a Phase 2, Randomized, Double-Blind, Parallel-Group Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 When Compared to Placebo in Subjects With Chronic Pancreatitis|Recruiting||Phase 1/Phase 2|128|Anticipated|Stason Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-10 22:26:23.36122|2017-10-10 22:26:23.36122
NCT02693080|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-06|||January 2016||2016-01-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy|A Pilot Study of Perfusion CT for Lung Tumors Treated With Stereotactic Ablative Radiation Therapy (SABR)|Recruiting||N/A|20|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:26:23.549802|2017-10-10 22:26:23.549802
NCT02693067|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-04-05|||July 2016||2016-07-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|July 2020|Anticipated|2020-07-01||Interventional|||A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver|A Phase 1 Study to Assess the Safety, Tolerability and Effectiveness of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver in the Reduction of Biochemical Markers and Symptoms Caused by Secretory Products|Recruiting||Phase 1|12|Anticipated|Provectus Pharmaceuticals||1|||f||||f||||||||No||2017-10-10 22:26:23.641862|2017-10-10 22:26:23.641862
NCT02693054|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-01-13|||April 2016||2016-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Efficacy Study for Various Skin Conditions|Characterizing Safety and Efficacy of Halo Hybrid Fractional Laser Treatments for Various Skin Conditions|Completed||N/A|34|Actual|Sciton||1|||f||||f||||||||No||2017-10-10 22:26:23.720228|2017-10-10 22:26:23.720228
NCT02693041|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-10-05|||June 2012||2012-06-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pregnancy Complications - A Probiotic Interventional Study|Pregnancy Complications - A Probiotic Interventional Study|Recruiting||N/A|120|Anticipated|Sahlgrenska University Hospital, Sweden||6|||f||||f||||||||||2017-10-10 22:26:23.790122|2017-10-10 22:26:23.790122
NCT02693028|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-10-05|||November 2015||2015-11-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||Lactobacillus Reuteri Feasibility Study on Probiotic Treatment and Perinatal Microbiome|Lactobacillus Reuteri Feasibility Study on Probiotic Lozenges, Probiotic Chewing Gum and Probiotic Capsules and Perinatal Microbiome Seeding During Pregnancy|Recruiting||N/A|30|Anticipated|Sahlgrenska University Hospital, Sweden||5|||f||||f||||||||||2017-10-10 22:26:23.920898|2017-10-10 22:26:23.920898
NCT02693015|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-02-25|||April 2004||2004-04-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|1 Year|Observational [Patient Registry]|||Impact of Time to Coronary Angiography on Survival for NSTEMI|Impact of Time to Coronary Angiography on Survival for NSTEMI: an Observation Study Using a Nationwide Registry|Completed||N/A|235986|Actual|University of Leeds|||1||f||||f||||||||||2017-10-10 22:26:24.023182|2017-10-10 22:26:24.023182
NCT02693002|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-03-29|||February 2016||2016-02-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Estrogen Diastolic Heart Failure|Heart Failure Prevention for Women: Preservation of Cardiac Function in the Peri-Menopausal Woman Through Hormone Therapy|Terminated||Phase 4|28|Anticipated|University of Kentucky||2||Enrollment goals not being met|f||||t||||||||Yes|The data will be provided to participants of the study.|2017-10-10 22:26:24.074227|2017-10-10 22:26:24.074227
NCT02692989|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-04-03|||January 2016||2016-01-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Observational|||The Safety of Anesthesia Management for Traumatic Hip Surgery in Elderly|The Safety of Anesthesia Management for Traumatic Hip Surgery in Elderly: A Retrospective Study in a Tertiary Hospital|Active, not recruiting||N/A|1270|Actual|University of Jordan|||1||f||||f||||||||No||2017-10-10 22:26:24.147703|2017-10-10 22:26:24.147703
NCT02692963|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-04-19|||April 2016||2016-04-01|August 2016|2016-08-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|BCG-EHMI||Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection|Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection|Completed||Phase 2|20|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 22:26:24.305369|2017-10-10 22:26:24.305369
NCT02692950|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-02-25|||February 2016||2016-02-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Patient Perception of Video Advance Care Planning|Perceptions of Advance Directive Formats-A Pilot Study|Recruiting||N/A|60|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 22:26:24.375095|2017-10-10 22:26:24.375095
NCT02692937|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-22|||January 2011||2011-01-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Is Chronic Whiplash-associated Pain of Neurogenic Origin?|Is Chronic Whiplash-associated Pain of Neurogenic Origin? A Study Protocol of a Randomized Controlled Trial Comparing Neurolysis of Peripheral Nerves With Traditional Neck-specific Exercise|Recruiting||N/A|80|Anticipated|Region Skane||2|||f||||||||||||||2017-10-10 22:26:24.462359|2017-10-10 22:26:24.462359
NCT02692924|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-06-30|||February 18, 2016||2016-02-18|February 8, 2017|2017-02-08|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Fetal Body Composition and Volumes Study|Fetal Body Composition and Volumes Study|Active, not recruiting||N/A|2973|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:26:24.565973|2017-10-10 22:26:24.565973
NCT02692911|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-06-30|||February 18, 2016||2016-02-18|June 14, 2017|2017-06-14|January 31, 2026|Anticipated|2026-01-31|January 31, 2026|Anticipated|2026-01-31||Observational|||Chile Biliary Longitudinal Study|Chile Biliary Longitudinal Study|Recruiting||N/A|35000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:26:24.629386|2017-10-10 22:26:24.629386
NCT02692898|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-06-30|||February 18, 2016||2016-02-18|February 3, 2017|2017-02-03|November 10, 2025|Anticipated|2025-11-10|November 10, 2024|Anticipated|2024-11-10||Observational|||Biomarker Analysis of Central Nervous System Tumors|Biomarker Analysis of Central Nervous System Tumors|Enrolling by invitation||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:26:26.289169|2017-10-10 22:26:26.289169
NCT02692521|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-18|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Human Milk Feeding Rates Post-NICU Discharge|Human Milk Feeding Rates Post-NICU Discharge|Active, not recruiting||N/A|1200|Anticipated|Mednax Center for Research, Education and Quality|||1||f||||||||||||||2017-10-10 22:26:30.180148|2017-10-10 22:26:30.180148
NCT02692885|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-06-30|||February 10, 2016||2016-02-10|April 17, 2017|2017-04-17|September 30, 2025|Anticipated|2025-09-30|October 31, 2020|Anticipated|2020-10-31||Observational|||Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism|The Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism|Enrolling by invitation||N/A|16|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:26:26.377788|2017-10-10 22:26:26.377788
NCT02692872|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-08-08|||February 8, 2016||2016-02-08|August 4, 2017|2017-08-04|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Screening for Alpha Thalassemia in Healthy Volunteers|Screening for Alpha Globin Deletions in Healthy Volunteers|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:26:26.445812|2017-10-10 22:26:26.445812
NCT02692859|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-24|2017-08-22|2016-09-05||September 2013||2013-09-01|July 2017|2017-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine|A Randomized, Positive-controlled, Non-inferiority Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine in Healthy Infants and Children|Completed||Phase 3|1992|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 22:26:26.524365|2017-10-10 22:26:26.524365
NCT02692846|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-25|2017-10-03|||February 8, 2016||2016-02-08|October 2, 2017|2017-10-02|December 21, 2020|Anticipated|2020-12-21|December 7, 2018|Anticipated|2018-12-07||Observational|||WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)|Williams Syndrome Skin and Vascular Elasticity Study (WS-SAVE Study)|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:26:26.794039|2017-10-10 22:26:26.794039
NCT02692833|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-09-18|||January 2016||2016-01-01|September 2016|2016-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01|7 Days|Observational [Patient Registry]|||Telomere Biology and AKI in Cardiac Surgery|Telomere Length and Telomerase Activity as a Predictor of Acute Kidney Injury Following Cardiac|Completed||N/A|254|Actual|Queen Mary University of London|||2||f||||f||||||Samples With DNA|"     Blood samples collected for:      Peripheral Blood Mononuclear Cells (PBMC) DNA extraction from buffy coat Right atrial tissue     samples (subset) Urine and plasma/serum for urinary biomarkers (subset)   "|||2017-10-10 22:26:26.872763|2017-10-10 22:26:26.872763
NCT02692820|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-19|||May 2016||2016-05-01|January 2017|2017-01-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|PrePro||Preventing Preterm Birth With Probiotics|Preventing Preterm Birth With Probiotics - Pilot Randomised Trial|Completed||N/A|304|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-10-10 22:26:26.958694|2017-10-10 22:26:26.958694
NCT02692807|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-05-15|||February 2016||2016-02-01|February 2017|2017-02-01|December 2035|Anticipated|2035-12-01|December 2020|Anticipated|2020-12-01||Interventional|HIPARTI||Arthroscopic Surgical Procedures vs Sham Surgery for Patients With Femoroacetabular Impingement and/or Labral Tears.|Arthroscopic Surgical Procedures Versus Sham Surgery for Patients With Femoroacetabular Impingement and/or Labral Tears. A Multicentre, International, Double-blinded Randomized, Controlled Trial.|Recruiting||N/A|140|Anticipated|Oslo University Hospital||3|||f||||f||||||||Undecided|Data will be shared across the sites participating in the HIPARTI and the HARP Study, according to the protocol and the decisions made by the Advisory Committee|2017-10-10 22:26:27.056911|2017-10-10 22:26:27.056911
NCT02692794|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-08-08|||October 2015||2015-10-01|August 2017|2017-08-01|June 20, 2016|Actual|2016-06-20|June 20, 2016|Actual|2016-06-20||Observational|||Large Scale Cerebral Oximetry During Sinus Endoscopy|Large Scale Cerebral Oximetry During Sinus Endoscopy|Completed||N/A|100|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||None Retained|"     Specify all types of biospecimens to be retained (e.g., whole blood, serum, white cells,     urine, tissue)   "|||2017-10-10 22:26:27.290547|2017-10-10 22:26:27.290547
NCT02692781|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-08-17|||February 2016||2016-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects|A Phase I, Randomized, Single-Blinded, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of MOD-6031 in Healthy Volunteers|Recruiting||Phase 1|40|Anticipated|Opko Biologics||5|||f||||||||||||||2017-10-10 22:26:27.375132|2017-10-10 22:26:27.375132
NCT02692768|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-06|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Effect of Music Therapy Intervention on Pain and Anxiety in Adult Patients Undergoing Total Shoulder Arthroplasty|The Effect of Music Therapy Intervention on Pain and Anxiety in Adult Patients Undergoing Total Shoulder Arthroplasty|Enrolling by invitation||N/A|105|Anticipated|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-10-10 22:26:27.474363|2017-10-10 22:26:27.474363
NCT02692729|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-11-09|||March 2016||2016-03-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Transverse Supraumbilical Versus Pfannenstiel Incision for Cesarean Section in Morbidly Obese Women|"Transverse Supraumbilical Versus Pfannenstiel Incision For Cesarean Section in Morbid Obese Patients A Single Blinded Randomized Controlled Trial"|Recruiting||N/A|72|Anticipated|Ain Shams University||2|||f||||t||||||||No||2017-10-10 22:26:27.908471|2017-10-10 22:26:27.908471
NCT02692716|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-09-22|||January 17, 2017|Actual|2017-01-17|September 2017|2017-09-01|October 16, 2018|Anticipated|2018-10-16|April 16, 2018|Anticipated|2018-04-16||Interventional|PIONEER 6||A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes|A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes|Active, not recruiting||Phase 3|3176|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 22:26:28.032475|2017-10-10 22:26:28.032475
NCT02692703|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-07-10|||April 22, 2016||2016-04-22|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|April 13, 2017|Actual|2017-04-13||Interventional|||A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)|A Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 - 6 Infection (MAGELLAN-2)|Completed||Phase 3|100|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 22:26:28.723862|2017-10-10 22:26:28.723862
NCT02692690|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-22|||May 2015||2015-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||TENS in Optimizer(R) Patients|Electromagnetic Interference by Transcutaneous Neuromuscular Electrical Stimulation in Patients With Optimizer(R) - a Pilot Safety Study|Completed||Phase 4|6|Actual|Medical University of Vienna||1|||f||||f||||||||No||2017-10-10 22:26:28.887824|2017-10-10 22:26:28.887824
NCT02692677|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-09-30|||March 2016||2016-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Assess the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ--42756493 to Healthy Male Participants|An Open-Label Phase 1 Study to Determine the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ-42756493 to Healthy Male Subjects|Completed||Phase 1|8|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 22:26:28.953753|2017-10-10 22:26:28.953753
NCT02692664|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-09-25|||April 2016||2016-04-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Observational|TAILOR||Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft|Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft|Recruiting||N/A|70|Anticipated|JOTEC GmbH|||1||f||||f||||||||||2017-10-10 22:26:29.057548|2017-10-10 22:26:29.057548
NCT02692651|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-05-26|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|||A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections|A Comparison of Fidaxomicin and Oral Vancomycin for the Treatment of Clostridium Difficile Infection (CDI) in Hospitalized Patients Receiving Concomitant Antibiotics for the Treatment of Concurrent Systemic Infections|Recruiting||Phase 4|250|Anticipated|University of Michigan||2|||f||||f|t|f|||f|||No||2017-10-10 22:26:29.150421|2017-10-10 22:26:29.150421
NCT02692638|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-02-07|||April 2016||2016-04-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Interventional|||Trial Comparing Early Laparoscopic Enterolysis Versus Nonoperative Management for High-grade SBO|Prospective, Randomized Trial Comparing Early Laparoscopic Enterolysis Versus a Time-limited Trial of Nonoperative Management for High-grade Small Bowel Obstruction|Recruiting||Phase 2|72|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-10 22:26:29.295059|2017-10-10 22:26:29.295059
NCT02692625|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-02-23|||January 2015||2015-01-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|||Consumption Effect of Probiotic Products on Salivary Cariogenic Bacterial Counts in Preschool Children.|Consumption Effect of Probiotic Products on Salivary Cariogenic Bacterial Counts in Preschool Children.|Recruiting||Phase 4|160|Anticipated|King Abdulaziz University||2|||f||||t||||||||Undecided||2017-10-10 22:26:29.422795|2017-10-10 22:26:29.422795
NCT02692612|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-02-22|||February 2016||2016-02-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Effects of Power-velocity Muscle Characteristics During Ageing||Not yet recruiting||N/A|80|Anticipated|Universitaire Ziekenhuizen Leuven|||3||f||||||||||||||2017-10-10 22:26:29.571516|2017-10-10 22:26:29.571516
NCT02692599|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-05-03|||January 2016||2016-01-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants|A Blind, Randomized and Controlled Clinical Trial With Live Attenuated Mumps Vaccines in Healthy Infants|Active, not recruiting||Phase 3|1150|Actual|Sinovac (Dalian) Vaccine Technology Co., Ltd.||2|||f||||f||||||||No||2017-10-10 22:26:29.652158|2017-10-10 22:26:29.652158
NCT02692586|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|FLARE||FlowTriever Pulmonary Embolectomy Clinical Study|FlowTriever Pulmonary Embolectomy Clinical Study|Enrolling by invitation||N/A|122|Anticipated|Inari Medical||1|||f||||t||||||||Undecided||2017-10-10 22:26:29.756418|2017-10-10 22:26:29.756418
NCT02692573|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-09-12|||December 2015||2015-12-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Prone or Supine Effect After Caesarean Delivery on Respiratory Outcomes in Full Term Infants|Prone or Supine Effect of Immediate Positioning After Scheduled Caesarean Delivery on Respiratory Outcomes in Full Term Infants|Recruiting||N/A|500|Anticipated|Montefiore Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:26:29.832794|2017-10-10 22:26:29.832794
NCT02692547|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-02-22|||December 2015||2015-12-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|DREAMED||Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes|Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes|Withdrawn||N/A|0|Actual|Medtronic||1||Study Cancelled|f||||f||||||||No||2017-10-10 22:26:30.015527|2017-10-10 22:26:30.015527
NCT02692534|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-01-31|||April 2016||2016-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Observational|||Cocaine Use and Outcomes of General Anesthesia|Cocaine Use and General Anesthesia: A Prospective Study of Cardiovascular and Anesthetic Effects|Recruiting||N/A|300|Anticipated|University of Texas Southwestern Medical Center|||2||f||||f||||||||No||2017-10-10 22:26:30.08079|2017-10-10 22:26:30.08079
NCT02692508|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-04-09|||January 2011||2011-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Prognosis of Subjects With Unexplainable Precordial Deep T-wave Inversion Without Wall Thickness> 15mm|Morphological and Functional Changes and Prognosis of Subjects With Unexplainable Precordial Deep T-wave Inversion Without Apical Wall Thickness> 15mm|Recruiting||N/A|100|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||f||||||||Yes||2017-10-10 22:26:30.258604|2017-10-10 22:26:30.258604
NCT02692469|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-22|||April 2016||2016-04-01|February 2016|2016-02-01|April 2026|Anticipated|2026-04-01|April 2021|Anticipated|2021-04-01||Interventional|DSvsSADI||Laparoscopic Single-Anastomosis Duodenal-Jejunal Bypass With Sleeve Gastrectomy vs Laparoscopic Duodenal Switch|Laparoscopic Single-Anastomosis Duodenal-Jejunal Bypass With Sleeve Gastrectomy vs Laparoscopic Duodenal Switch as a Primary Bariatric Procedure. 5 Year Patient Follow|Not yet recruiting||N/A|140|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 22:26:30.626992|2017-10-10 22:26:30.626992
NCT02692456|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-22|||June 2015||2015-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Patient Position on Computerized Tomography Guided Celiac Trunk Neurolysis|Efficacy of Patient Position After Computerized Tomography Guided Antero-crural Celiac Trunk Neurolysis on Upper Abdominal Malignancy Pain|Completed||N/A|34|Actual|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:26:30.725437|2017-10-10 22:26:30.725437
NCT02692443|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-03-29|||August 2015||2015-08-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Observational|SVRIII||SVR III: Brain Connectome and Neurodevelopmental Outcomes|Single Ventricle Reconstruction III: Brain Connectome and Neurodevelopmental Outcomes|Enrolling by invitation||N/A|240|Anticipated|University of Pittsburgh|||2||f||||t||||||||Yes|Data will be supplied in the required, standard de-identified format and made available without cost to researchers or analysts. Access to databases and associated software tools generated under the project will be available for educational, research and non-profit purposes.|2017-10-10 22:26:30.827164|2017-10-10 22:26:30.827164
NCT02692430|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-28|||April 2016||2016-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).|LARGE SPONTANEOUS PORTOSYSTEMIC SHUNTS (SPSSs) IN PATIENTS WITH LIVER CIRRHOSIS. CLINICAL AND RADIOLOGICAL CHARACTERISTICS.|Active, not recruiting||N/A|1000|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||1||f||||f||||||||||2017-10-10 22:26:30.923644|2017-10-10 22:26:30.923644
NCT02692417|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-06-05|||February 2016||2016-02-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Surface Stimulation for Female Sexual Dysfunction|Surface Stimulation for Female Sexual Dysfunction|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Michigan||2|||f||||t||||||||Undecided||2017-10-10 22:26:31.002668|2017-10-10 22:26:31.002668
NCT02692404|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-06-05|||January 2016||2016-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|LPPD||Labor Pain and Postpartum Behavioral Health Outcomes Study|Labor Pain and Postpartum Behavioral Health Outcomes Study|Recruiting||N/A|88|Anticipated|University of Pittsburgh|||2||f||||f||||||Samples With DNA|"     Saliva samples for DNA extraction   "|Undecided||2017-10-10 22:26:31.097535|2017-10-10 22:26:31.097535
NCT02692391|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-02-02|||July 2014||2014-07-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis|A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis|Recruiting||Phase 3|50|Anticipated|University of Pittsburgh||2|||f||||f||||||||Undecided||2017-10-10 22:26:31.234788|2017-10-10 22:26:31.234788
NCT02692378|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-09-30|||November 2015||2015-11-01|November 2015|2015-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|BicHD||Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)|A Feasibility Randomised Controlled Trial: Effects of Oral Sodium Bicarbonate Supplementation in Patients on Haemodialysis|Completed||Phase 4|44|Actual|Imperial College Healthcare NHS Trust||2|||f||||t||||||||No||2017-10-10 22:26:31.337209|2017-10-10 22:26:31.337209
NCT02692365|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-08-18|||September 2015||2015-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRI|Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRI|Completed||N/A|20|Actual|Hospital Sirio-Libanes||2|||f||||t||||||||||2017-10-10 22:26:31.438979|2017-10-10 22:26:31.438979
NCT02692352|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2016-02-25|||August 2012||2012-08-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Cognitive Rehabilitation of Executive Dysfunction - Goal Management Training in Patients With Acquired Brain Injury|Cognitive Rehabilitation of Executive Dysfunction - Goal Management Training in Patients With Acquired Brain Injury|Completed||N/A|70|Actual|Sunnaas Rehabilitation Hospital||2|||f||||f||||||||No||2017-10-10 22:26:31.515673|2017-10-10 22:26:31.515673
NCT02692339|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-02-14|||February 2016||2016-02-01|February 2017|2017-02-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01|36 Months|Observational [Patient Registry]|PrObe-L||Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma|Prospective Observational Study Evaluating the Safety of Lenalidomide/Dexamethasone Treatment in Patients With Relapsed or Refractory Multiple Myeloma|Recruiting||N/A|120|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 22:26:31.590159|2017-10-10 22:26:31.590159
NCT02692326|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-02-22|||August 2010||2010-08-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Impact of Cyclic Prolonged Parenteral Nutrition in Neonates|DECREASE OF CHOLESTASIS USING CYCLED PARENTERAL NUTRITION IN NEWBORNS REQUIRING PROLONGED PARENTERAL NUTRITION|Completed||N/A|50|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-10 22:26:31.704498|2017-10-10 22:26:31.704498
NCT02692313|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-02-09|||June 2016||2016-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Epineprhine||Dose Response of Epinephrine|Hypoglycemia Associated Autonomic Dysfunction Dose Response of Epinephrine|Recruiting||Early Phase 1|32|Anticipated|University of Maryland||4|||f||||t||||||||No||2017-10-10 22:26:31.802194|2017-10-10 22:26:31.802194
NCT02692300|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-01-24|||February 2016||2016-02-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|ENGAGES||EEG Guidance of Anesthesia (ENGAGES-CANADA)|Protocol for the Electroencephalography Guidance of Anesthesia to Alleviate Geriatric Syndromes (ENGAGES-CANADA) Study: a Pragmatic, Randomized Clinical Trial|Recruiting||N/A|1200|Anticipated|University of Manitoba||2|||f||||t||||||||Undecided||2017-10-10 22:26:31.922165|2017-10-10 22:26:31.922165
NCT02692287|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-02-25|||February 2016||2016-02-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||The Postpartum Haemorrhage (PPH) Butterfly Work Package 3|The Postpartum Haemorrhage (PPH) Butterfly Work Package 3, Phase I in Vivo Testing|Not yet recruiting||N/A|10|Anticipated|University of Liverpool||1|||f||||f||||||||No||2017-10-10 22:26:32.04596|2017-10-10 22:26:32.04596
NCT02692274|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-22|||April 2015||2015-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Observational|||Operational Assessment of Point-of-Care Diagnostics in Primary Healthcare Clinics|Evaluating the Accessibility and Utility of HIV-related Point of Care Diagnostic for Maternal Health in Rural South Africa|Completed||N/A|309|Actual|University of KwaZulu|||2||f||||f||||||Samples With DNA|"     Blood samples for evaluating the accuracy of HIV rapid tests in rural KwaZulu Natal   "|No||2017-10-10 22:26:32.153786|2017-10-10 22:26:32.153786
NCT02692261|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-22|||September 2014||2014-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Hyaluronic Matrix Efficacy for Maxillary Sinus Augmentation|Evaluation of Hyaluronic Matrix, Used With Xenograft, Efficacy in Sinus Augmentation by Histomorphometry and Micro Computed Tomography|Completed||N/A|13|Actual|Hacettepe University||2|||f||||f||||||||No||2017-10-10 22:26:32.245087|2017-10-10 22:26:32.245087
NCT02692248|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-06-08|||April 2016||2016-04-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to Autologous Stem Cell Transplantation|Multicentric Phase II Trial to Evaluate the Efficacy and Safety of Ibrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin and Dexamethasone Followed by Ibrutinib Maintenance in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non Candidates to ASCT|Recruiting||Phase 2|62|Anticipated|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||f||||||||No||2017-10-10 22:26:32.32377|2017-10-10 22:26:32.32377
NCT02692222|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-12-06|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Measurement of Pulse Pressure Variation and Cardiac Output by a New Application for Android™ (Captesia™)|Measurement of Pulse Pressure Variation (PPV) and Cardiac Output (CO) by a New Application for Android™ (Captesia™) : Comparison With PPV and CO Obtained by a Method of Transpulmonary Thermodilution.|Completed||N/A|57|Actual|Erasme University Hospital|||1||f||||f||||||||||2017-10-10 22:26:32.66425|2017-10-10 22:26:32.66425
NCT02692209|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-02-24|||December 2015||2015-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Multi-Reader Multi-Case Pivotal Trial|A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of the Fujifilm FFDM Plus DBT Versus FFDM Alone in the Detection of Breast Cancer|Completed||Phase 2|300|Actual|Fujifilm Medical Systems USA, Inc.||2|||f||||f||||||||No||2017-10-10 22:26:32.752256|2017-10-10 22:26:32.752256
NCT02692196|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-11-09|||June 2015||2015-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Fronto-limbic Functional Connectivity Via Real-time fMRI Neurofeedback|Voluntary Regulation of Fronto-limbic Functional Connectivity: A Proof-of-concept Real-time fMRI Study|Completed||N/A|24|Actual|University of Electronic Science and Technology of China||2|||f||||||||||||||2017-10-10 22:26:32.834836|2017-10-10 22:26:32.834836
NCT02692183|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||February 2016||2016-02-01|February 2016|2016-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Mapping Functional Networks of Brain Activity Using EEG in Patients With Essential Tremor or Parkinson Disease Before and After MR-guided Focused Ultrasound Thalamotomy for Tremor|Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) Signals in Patients With Essential Tremor or Parkinson Disease Before and After MR-guided Focused Ultrasound (FUS) Thalamotomy for Tremor|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-10 22:26:32.902035|2017-10-10 22:26:32.902035
NCT02692170|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-22|||December 2012||2012-12-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine|A Single Center, Randomized, Double Blinded PhaseI/IIa Exploratory Study to Evaluate Reactogenicity, Safety, Immunogenicity and Dose Response of a New Hepatitis B Vaccine in Human Adult|Completed||Phase 1/Phase 2|75|Actual|CHA Vaccine Institute Co., Ltd.||5|||f||||f||||||||||2017-10-10 22:26:32.964651|2017-10-10 22:26:32.964651
NCT02691988|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||December 2015||2015-12-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|WHISPER||Withdrawal of Inhaled Corticosteroids in Primary Care Patients With COPD|Withdrawal of Inhaled Corticosteroids and the Possible Effect on Exacerbation Rate in Primary Care Patients With COPD|Recruiting||N/A|620|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-10 22:26:34.434167|2017-10-10 22:26:34.434167
NCT02692157|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-10-25|||February 2016||2016-02-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|NT-814||NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study|NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study|Recruiting||Phase 1/Phase 2|12|Anticipated|New York State Psychiatric Institute||4|||f||||t||||||||Yes|Data will be shared via posters and talks at local and national conferences, as well as in publication form. The sharing of raw data will be done by request only, providing that there is a justifiable reason with a clear hypothesis and data analysis plan.|2017-10-10 22:26:33.036504|2017-10-10 22:26:33.036504
NCT02692144|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-22|||October 2015||2015-10-01|February 2016|2016-02-01||||January 2016|Actual|2016-01-01||Interventional|||Effect of an Optimized Savory Cluster on Glycemic and Insulinemic Responses in Healthy Individuals|Effect of an Optimized Savory Cluster on Glycemic and Insulinemic Responses in Healthy Individuals: A Randomized, Cross-over Study|Completed||N/A|25|Actual|PepsiCo Global R&D||3|||f||||f||||||||No||2017-10-10 22:26:33.113825|2017-10-10 22:26:33.113825
NCT02692131|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-09-27|||January 2016||2016-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|Strain||Comparison of Two Methods of Strain by Perioperative Transesophageal Echo in CABG : An Observational Study|Comparison of Two Different Methods of Obtaining Strain by Perioperative Transesophageal in Patients Undergoing Coronary Artery Bypass Grafting : An Observational Study|Completed||N/A|50|Actual|Postgraduate Institute of Medical Education and Research|||2||f||||t||||||||Undecided||2017-10-10 22:26:33.17627|2017-10-10 22:26:33.17627
NCT02692118|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-18|||December 2016|Actual|2016-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|Tusep||Inflammatory Mediators in Early Sepsis|Inflammatory Mediators in Sepsis as Indicator for Infection vs Inflammation|Recruiting||N/A|60|Anticipated|University Hospital Tuebingen|||1||f||||t||||||Samples With DNA|"     Blood samples   "|Undecided||2017-10-10 22:26:33.239075|2017-10-10 22:26:33.239075
NCT02692105|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-07-14|||May 2016||2016-05-01|July 2017|2017-07-01|April 2026|Anticipated|2026-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer|A Phase III Randomized Pilot Study of Low Dose Rate Compared to High Dose Rate Prostate Brachytherapy for Favourable Risk and Low Tier Intermediate Risk Prostate Cancer|Recruiting||Phase 3|60|Anticipated|British Columbia Cancer Agency||2|||f||||t||||||||||2017-10-10 22:26:33.31228|2017-10-10 22:26:33.31228
NCT02692092|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-09-26|||September 1991||1991-09-01|September 2016|2016-09-01|August 2091|Anticipated|2091-08-01|August 2091|Anticipated|2091-08-01|40 Years|Observational [Patient Registry]|HEJR||HealthEast Community Hip and Knee Replacement Registry|HealthEast Community Hip and Knee Replacement Registry|Recruiting||N/A|200000|Anticipated|HealthEast Care System|||1||f||||f||||||||No||2017-10-10 22:26:33.588655|2017-10-10 22:26:33.588655
NCT02692079|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-22|||February 2014||2014-02-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|T-PRF||The Effectiveness of Titanium-Prepared Platelet-Rich Fibrin on Angiogenic Biomarkers in Gingival Crevicular Fluid|The Effect of Titanium-Prepared Platelet-Rich Fibrin (T-PRF) Treatment on the Angiogenic Biomarkers in Gingival Crevicular Fluid (GCF) in Infrabony Defects of Patients With Chronic Periodontitis: A Randomized Controlled Clinical Trial|Completed||N/A|25|Actual|Kırıkkale University||2|||f||||f||||||||No||2017-10-10 22:26:33.70043|2017-10-10 22:26:33.70043
NCT02692066|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-07-24|||April 2016|Anticipated|2016-04-01|July 2017|2017-07-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine in Children With Liver Disease||Withdrawn||N/A|0|Actual|University of Colorado, Denver|||2|Funding not acquired|f||||f||||||||||2017-10-10 22:26:33.787846|2017-10-10 22:26:33.787846
NCT02692053|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-02-22|||February 2016||2016-02-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|COASEPT||Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers|Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers|Not yet recruiting||N/A|50|Anticipated|Central Hospital, Nancy, France||2|||f||||||||||||||2017-10-10 22:26:33.874281|2017-10-10 22:26:33.874281
NCT02692040|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-02-22|||January 2015||2015-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of the Gut Hormone Analogue G3215 in Adult Subjects|A Randomised, Placebo Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Gut Hormone Analogue G3215 in Adult Subjects|Recruiting||Phase 1|64|Anticipated|Imperial College London||8|||f||||t||||||||||2017-10-10 22:26:33.964175|2017-10-10 22:26:33.964175
NCT02692027|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-11-03|||February 2016||2016-02-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CASCADE||Same-day ART Initiation Versus Standard of Care After Positive HIV-test Result in Rural Lesotho|Same Day Community-based ART Initiation Versus Clinic-based Pre-ART Assessment and Counselling for Individuals Newly Tested HIV-positive During Community-based HIV Testing in Rural Lesotho - a Randomized Controlled Trial|Active, not recruiting||Phase 3|276|Actual|Swiss Tropical & Public Health Institute||2|||f||||t||||||||Undecided||2017-10-10 22:26:34.11445|2017-10-10 22:26:34.11445
NCT02692014|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-02-24|||January 2016||2016-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Observational|RIPPER||Risk Factors Promoting Coronary Plaque Progression In China|A Multicenter Retrospective Observational Study on Different Risk Factors in Coronary Artery Stenosis Progression of CHD in China|Active, not recruiting||N/A|2400|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||t||||||||||2017-10-10 22:26:34.245409|2017-10-10 22:26:34.245409
NCT02692001|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-29|||June 2015||2015-06-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|MealTrain||Child Friendly Menu Labelling and Food Choices|A Randomized Controlled Trial to Evaluate the Impact of Child Friendly Menu Labelling Designs on Food Choices by Parents and Children in an Inpatient Hospital Setting|Completed||N/A|163|Actual|The Hospital for Sick Children||2|||f||||f||||||||Yes|The investigators plan to publish in a peer reviewed journal, as well as presnt at national and international conferences (Canadian Pediatric Endocrine Group, International Conference for Obesity and Canadian Pediatric Society )|2017-10-10 22:26:34.324233|2017-10-10 22:26:34.324233
NCT02691975|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-03-23|||April 2016||2016-04-01|April 2016|2016-04-01|June 2020|Anticipated|2020-06-01|July 2018|Anticipated|2018-07-01||Interventional|||A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients|A Phase I/II, Open-Label, Dose-Escalation and -Expansion, Safety, Pharmacokinetics and Efficacy Study of SHR3680 in Patients With Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 1/Phase 2|140|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||No||2017-10-10 22:26:34.547299|2017-10-10 22:26:34.547299
NCT02691962|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-13|||May 2016||2016-05-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||XenMatrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias|A Post-Market, Prospective, Multicenter, Single-Arm Trial of XenMatrix™ AB Surgical Graft in All CDC Wound Class Ventral or Incisional Midline Hernias|Recruiting||N/A|75|Anticipated|C. R. Bard||1|||f||||f||||||||||2017-10-10 22:26:34.686022|2017-10-10 22:26:34.686022
NCT02691949|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-09-21|||February 2016||2016-02-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome|Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome|Enrolling by invitation||Phase 2|54|Anticipated|Kaohsiung Medical University||2|||f||||f||||||||No|We won't share our data|2017-10-10 22:26:34.808145|2017-10-10 22:26:34.808145
NCT02691936|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-28|||March 2016||2016-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|VeLVET||Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy|A Randomized Clinical Trial Comparing Vaginal Laser Therapy to Vaginal Estrogen Therapy in Women With Genitourinary Syndrome of Menopause|Suspended||N/A|196|Anticipated|The Cleveland Clinic||2||Sponsor requests IDE|f||||f||||||||||2017-10-10 22:26:34.897086|2017-10-10 22:26:34.897086
NCT02691923|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-29|||March 2016||2016-03-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker|Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker: Correlation With Preoperative MR, ALA-induced PpIX Fluorescence, and Histopathology|Recruiting||Phase 2|30|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 22:26:35.010984|2017-10-10 22:26:35.010984
NCT02691910|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||August 2014||2014-08-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection|Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine (PQ) for the Treatment of Uncomplicated Plasmodium Vivax Infection|Completed||Phase 2/Phase 3|204|Actual|Oswaldo Cruz Foundation||2|||f||||f||||||||No||2017-10-10 22:26:35.122606|2017-10-10 22:26:35.122606
NCT02691897|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-10-03|||March 2016||2016-03-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|METOD||Melatonin's Effects on Treatment Of Diabetes Mellitus|The Effects of Melatonin on Serum Glucose Levels of Patients With Type 2 Diabetes Mellitus|Enrolling by invitation||Early Phase 1|60|Anticipated|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:26:35.24783|2017-10-10 22:26:35.24783
NCT02691884|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-21|2016-03-07|||March 2016||2016-03-01|February 2016|2016-02-01|April 2020|Anticipated|2020-04-01|January 2018|Anticipated|2018-01-01||Observational|||The Effect of Pressure Exerted on the Maternal Abdominal Wall by the Ultrasound Probe on Fetal Heart Rate|The Effect of Pressure Exerted on the Maternal Abdominal Wall by the Ultrasound Probe on Fetal Heart Rate|Not yet recruiting||N/A|100|Anticipated|Meir Medical Center|||1||f||||f||||||||Yes||2017-10-10 22:26:35.376106|2017-10-10 22:26:35.376106
NCT02691871|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-22|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR|A Phase I, Open-label, Dose-escalation Study of Apatinib in Combination With Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)|Not yet recruiting||Phase 1|20|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||1|||f||||||||||||||2017-10-10 22:26:35.485568|2017-10-10 22:26:35.485568
NCT02691858|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-02-05|||April 2015||2015-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception|Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception: A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 22:26:35.564103|2017-10-10 22:26:35.564103
NCT02691845|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-09|||February 2016||2016-02-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|Project MOVE||Initiating and Maintaining Physical Activity in Depressed Individuals|Initiating and Maintaining Physical Activity in Depressed Individuals|Recruiting||N/A|240|Anticipated|Butler Hospital||3|||f||||f||||||||||2017-10-10 22:26:35.6819|2017-10-10 22:26:35.6819
NCT02691832|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||May 2016||2016-05-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|Dräger||Measuring Core Body Temperature Using a Novel Non-invasive Sensor|Measuring Core Body Temperature Using a Novel Non-invasive Sensor - a Follow up Study|Not yet recruiting||N/A|12|Anticipated|Sheba Medical Center||1|||f||||f||||||||No||2017-10-10 22:26:35.785565|2017-10-10 22:26:35.785565
NCT02691819|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||January 2015||2015-01-01|January 2016|2016-01-01||||January 2015|Actual|2015-01-01|9 Months|Observational [Patient Registry]|||Short Term and Long Term Effects of Single Stent and Embedded Balloon Angioplasty in the Treatment of Coronary Bifurcation Lesions|Short Term and Long Term Effects of Single Stent and Embedded Balloon Angioplasty in the Treatment of Coronary Bifurcation Lesions|Recruiting||N/A|60|Anticipated|Beijing Hospital|||1||f||||||||||||||2017-10-10 22:26:35.868434|2017-10-10 22:26:35.868434
NCT02691806|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||March 2016||2016-03-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01||Interventional|||New Indices for Prediction of Human Fatigue During Training Based on Non-invasive Methods|New Indices for Prediction of Human Fatigue During Training Based on Non-invasive Methods|Not yet recruiting||N/A|14|Anticipated|Sheba Medical Center||1|||f||||f||||||||No||2017-10-10 22:26:35.942261|2017-10-10 22:26:35.942261
NCT02691611|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-09-20|||December 2015||2015-12-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Observational|AATD_Epi||Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency|Defining Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency|Recruiting||N/A|19|Anticipated|National Jewish Health|||2||f||||t||||||||No||2017-10-10 22:26:37.158315|2017-10-10 22:26:37.158315
NCT02691793|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-02-15|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors|Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors|Not yet recruiting||Phase 4|25|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||t|||||2017-10-10 22:26:36.022983|2017-10-10 22:26:36.022983
NCT02691780|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-03-10|||December 23, 2016|Actual|2016-12-23|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors|Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors|Active, not recruiting||N/A|25|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-10 22:26:36.094052|2017-10-10 22:26:36.094052
NCT02691767|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-22|||May 2016||2016-05-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors|Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors|Not yet recruiting||N/A|25|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-10 22:26:36.165842|2017-10-10 22:26:36.165842
NCT02691754|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-24|||November 2012||2012-11-01|February 2016|2016-02-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Impact of a Free Distribution of Paracetamol to Osteoarthritic Patients on Non-steroidal Anti-inflammatory Drugs (NSAID) and Proton Pump Inhibitors (PPI) Prescription|A Cluster Randomised Trial to Measure the Impact of a Free Distribution of Paracetamol to Osteoarthritic Patients on Non-steroidal Anti-inflammatory Drugs (NSAID) and Proton Pump Inhibitors (PPI) Prescription|Completed||N/A|16|Actual|Azienda Unità Sanitaria Locale Reggio Emilia||2|||f||||f||||||||No||2017-10-10 22:26:36.23103|2017-10-10 22:26:36.23103
NCT02691741|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-28|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:26:36.305428|2017-10-10 22:26:36.305428
NCT02691728|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||February 2016||2016-02-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|||Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease|A Phase 4, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease|Not yet recruiting||Phase 4|40|Anticipated|Peter J. Ruane, M.D., Inc.||1|||f||||f||||||||||2017-10-10 22:26:36.354702|2017-10-10 22:26:36.354702
NCT02691715|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-04-26|||January 2016||2016-01-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Intrauterine Saline Washing for Detection Endometrial Disease in Patients With Abnormal Uterine Bleeding||Recruiting||N/A|400|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t||||||||||2017-10-10 22:26:36.436852|2017-10-10 22:26:36.436852
NCT02691702|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-07-24|||March 28, 2016|Actual|2016-03-28|July 2017|2017-07-01|February 10, 2017|Actual|2017-02-10|February 10, 2017|Actual|2017-02-10||Interventional|||Multiple Dose Study Of PF-05251749 In Healthy Volunteers|A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo And Active Comparator Controlled, Dose Escalation Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Escalating Doses Of Pf-05251749 In Healthy Adult And Elderly Subjects|Completed||Phase 1|97|Actual|Pfizer||3|||f||||f|t|f||||||||2017-10-10 22:26:36.520486|2017-10-10 22:26:36.520486
NCT02691689|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-05-02|||November 2015||2015-11-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions|Prospective, Monocentric Pilot Study for the Identification of Known or Novel Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions|Recruiting||N/A|21|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||||||||||||2017-10-10 22:26:36.610804|2017-10-10 22:26:36.610804
NCT02691676|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-05-08|||January 2014||2014-01-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Perioperative Fluid Therapy With Balanced Crystalloids|Perioperative Fluid Therapy With Balanced Crystalloids: a Comparative Randomized Prospective Open Label Study|Completed||Phase 3|112|Actual|University Hospital Olomouc||2|||f||||f||||||||No||2017-10-10 22:26:36.692977|2017-10-10 22:26:36.692977
NCT02691663|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-02-28|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Dietary Acid Load, Kidney Function and Disability in Elderly|Dietary Acid Load, Kidney Function and Disability in Elderly|Recruiting||N/A|80|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-10 22:26:36.778518|2017-10-10 22:26:36.778518
NCT02691650|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-05-01|||February 2016||2016-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|POCCET||Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma|Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma|Recruiting||N/A|100|Anticipated|University Hospital Heidelberg|||2||f||||f||||||Samples With DNA|"     A miniature amount (10 μl) of whole blood is needed for the serum cholinesterase activity     analysis. This blood specimen will be taken from otherwise routine blood gas analysis     collection, taken upon arrival into the emergency room, as a part of the standardized ICU     diagnostic and therapeutic procedure. The serum cholinesterase activity analysis, therefore,     doesn't require additional blood collection.   "|No||2017-10-10 22:26:36.867078|2017-10-10 22:26:36.867078
NCT02691637|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-02-20|||February 2006||2006-02-01|February 2016|2016-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients|Effect of Helicobacter Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients.|Recruiting||N/A|1500|Anticipated|Seoul National University Bundang Hospital|||2||f||||f||||||||No||2017-10-10 22:26:36.956061|2017-10-10 22:26:36.956061
NCT02691624|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-20|||October 2015||2015-10-01|February 2016|2016-02-01|January 2019|Anticipated|2019-01-01|May 2016|Anticipated|2016-05-01||Observational|||Study of the Change of Breast Cancer Patients' Upper Limb Lymphatic Drainage Pathway After Operation|Study of the Change of Breast Cancer Patients' Upper Limb Lymphatic Drainage Pathway After Operation|Recruiting||N/A|100|Anticipated|Peking University People's Hospital|||2||f||||f||||||||Undecided||2017-10-10 22:26:37.05586|2017-10-10 22:26:37.05586
NCT02691598|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-02-20|||February 2016||2016-02-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|February 2016|Anticipated|2016-02-01||Interventional|DHPOFFSAP||Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following Severe Acute Pancreatitis|Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following|Not yet recruiting||Phase 4|314|Anticipated|Nanjing University School of Medicine||2|||f||||t||||||||Yes||2017-10-10 22:26:37.418041|2017-10-10 22:26:37.418041
NCT02691585|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-23|||January 2016||2016-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Indian Ragas on Health - a Electrophysiological Study|Assessment of the Effect of Various Ragas of Indian Music on Electrophysiological Parameters and Salivary Stress Markers - a Randomized Control Trial|Recruiting||N/A|140|Anticipated|MS Ramaiah Medical College & Hospitals||4|||f||||t||||||||No||2017-10-10 22:26:37.552038|2017-10-10 22:26:37.552038
NCT02691572|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-05-27|||February 2016||2016-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Transversus Abdominis Plane Block Versus Wound Infiltration for Postcesarean Analgesia|Comparison Between Transversus Abdominis Plane Block and Wound Infiltration for Analgesia After Cesarean Delivery|Completed||N/A|80|Actual|Mansoura University||2|||f||||f||||||||No||2017-10-10 22:26:37.674458|2017-10-10 22:26:37.674458
NCT02691559|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-06-11|||August 2015||2015-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Possible Effect Of Amniotic Fluid pH On Neonatal Morbidities In Maternal Inflammation/Infection Associated Pregnancies|The Possible Effect Of Amniotic Fluid pH On Neonatal Morbidities In Maternal Inflammation/Infection Associated Pregnancies|Completed||N/A|184|Actual|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||||||||||||2017-10-10 22:26:37.816593|2017-10-10 22:26:37.816593
NCT02691546|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-02-20|||April 2016||2016-04-01|February 2016|2016-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|SCOPE||Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)|Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)|Not yet recruiting||N/A|2450|Anticipated|Istituto Nazionale di Ricovero e Cura per Anziani|||1||f||||f||||||Samples With DNA|"     plasma, serum, whole blood   "|No||2017-10-10 22:26:37.920507|2017-10-10 22:26:37.920507
NCT02691533|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-07-01|||February 2016||2016-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure|To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure|Recruiting||N/A|90|Anticipated|Institute of Liver and Biliary Sciences, India||3|||f||||f||||||||||2017-10-10 22:26:38.081832|2017-10-10 22:26:38.081832
NCT02691520|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-03-22|||September 2015||2015-09-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Epidemiology of Treatment Resistant Depression in Taiwan|Epidemiology of Treatment Resistant Depression in Taiwan|Completed||Phase 4|8356|Actual|Johnson & Johnson Pte Ltd|||1||f||||f||||||||||2017-10-10 22:26:38.195307|2017-10-10 22:26:38.195307
NCT02691507|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-01-16|2016-10-28||February 2016||2016-02-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema|A Clinical Trial to Determine the Therapeutic Benefit of an Investigational Over-The-Counter Cream on Dry, Itchy Skin of Adults and Children With Atopic Dermatitis.|Completed||Phase 2|53|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-10 22:26:38.381702|2017-10-10 22:26:38.381702
NCT02691494|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-09-14|||January 4, 2016||2016-01-04|September 2017|2017-09-01|January 15, 2019|Anticipated|2019-01-15|July 17, 2018|Anticipated|2018-07-17||Interventional|||Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)|A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women|Active, not recruiting||Phase 3|378|Actual|AbbVie||3|||f||||t||||||||||2017-10-10 22:26:41.046332|2017-10-10 22:26:41.046332
NCT02691481|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-22|||May 2014||2014-05-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Diabetes-Specific Nutritional Formulas Versus Oatmeal|Effect of Diabetes-specific Formulas on Glucose Metabolism and GLP-1 Secretion in Patients With Type 2 Diabetes|Completed||N/A|25|Actual|Joslin Diabetes Center||3|||f||||f||||||||No||2017-10-10 22:26:42.880148|2017-10-10 22:26:42.880148
NCT02691468|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-06-26|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Displacement Between PVC and Silicon DLT|Comparison of Displacement Between Polyvinyl Chloride(PVC) and Silicon Double-Lumen Endobronchial Tubes(DLT) During Change of Position|Completed||N/A|108|Actual|Yeungnam University College of Medicine||2|||f||||t||||||||No||2017-10-10 22:26:42.947284|2017-10-10 22:26:42.947284
NCT02691455|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-14|||February 2016||2016-02-01|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|ASSISTS||The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)|The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study|Enrolling by invitation||N/A|280|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-10 22:26:43.038985|2017-10-10 22:26:43.038985
NCT02691442|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-08-11|||December 2010||2010-12-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of the Analgesic Effect of Different Local Anesthetics in Interscalene Nerve Block for Shoulder Surgery|Comparison of the Analgesic Effect of the Local Anesthetics Ropicacaine, Levobupivacaine, and Levobupivacaine + Epinephrin Via Interscalene Nerve Block in Patients Undergoing Shoulder Arthroscopy Under General Anesthesia|Completed||Phase 4|30|Actual|University Hospital, Antwerp||3|||f||||f||||||||No||2017-10-10 22:26:43.274104|2017-10-10 22:26:43.274104
NCT02691429|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-06-05|||February 2016||2016-02-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|November 2016|Actual|2016-11-01||Interventional|||Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans|Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans|Completed||N/A|24|Anticipated|Federal University of São Paulo||2|||f||||f||||||||No||2017-10-10 22:26:43.39859|2017-10-10 22:26:43.39859
NCT02691416|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-06-10|2016-04-07||July 2014||2014-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Role of Propofol Postconditioning on Oxidative Stress and Cognitive Function|Role of Propofol Postconditioning on Oxidative Stress and Cognitive Function in Patients Undergoing Intracranial Aneurysm Surgery.|Completed||Phase 4|60|Actual|The Third Central Clinical College of Tianjin Medical University||2|||f||||t||||||||No||2017-10-10 22:26:43.563001|2017-10-10 22:26:43.563001
NCT02691403|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-21|||March 2016||2016-03-01|February 2016|2016-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||Quadratus Lumborum Block for Postoperative Analgesia After Colostomy Closure|Ultrasound-guided Quadratus Lumborum Block for Postoperative Analgesia After Colostomy: A Randomized Controlled Trial|Not yet recruiting||Phase 4|50|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-10-10 22:26:44.256123|2017-10-10 22:26:44.256123
NCT02691390|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-04-18|||April 2016||2016-04-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Exploration of the Potential Role of Brain Magnetic Stimulation in Preventing Relapse to Alcohol Abuse|Exploration of the Potential Role of Anterior Cingulate (ACC) dTMS Intervention of Relapse to Alcohol Abuse|Not yet recruiting||Phase 4|84|Anticipated|Soroka University Medical Center||2|||f||||t||||||||No||2017-10-10 22:26:44.33937|2017-10-10 22:26:44.33937
NCT02691377|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-02-26|||March 2016||2016-03-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Acupuncture for Primary Sjögren Syndrome|Efficacy and Safety of Acupuncture for Primary Sjögren Syndrome|Not yet recruiting||Phase 2|60|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||Undecided||2017-10-10 22:26:44.425283|2017-10-10 22:26:44.425283
NCT02691364|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||April 2016||2016-04-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Different Regulation of Immune Cells in Patients With Preeclampsia||Not yet recruiting||N/A|30|Anticipated|University Medical Center Groningen|||2||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 22:26:44.546179|2017-10-10 22:26:44.546179
NCT02691351|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-05-18|||March 2016||2016-03-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study|Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study|Recruiting||N/A|500|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:26:44.635955|2017-10-10 22:26:44.635955
NCT02691338|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-27|||February 2016||2016-02-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Monitoring Neurological Deterioration in Anaesthetised Patients With Electroencephalogram (EEG)|Monitoring Neurological Deterioration in Anaesthetised Patients With Electroencephalogram (EEG): Demonstration With Patients Undergoing Neurovascular Intervention After Cerebrovascular Attack (CVA).|Recruiting||N/A|60|Anticipated|Rambam Health Care Campus|||3||f||||f||||||||||2017-10-10 22:26:44.740747|2017-10-10 22:26:44.740747
NCT02691325|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-25|||March 14, 2016|Actual|2016-03-14|April 2017|2017-04-01|June 5, 2016|Actual|2016-06-05|June 5, 2016|Actual|2016-06-05||Interventional|||Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects|A Single Centre, Three Part, Randomised, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA™ Dry Powder Inhaler to Healthy Subjects|Completed||Phase 1|22|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-10 22:26:44.852666|2017-10-10 22:26:44.852666
NCT02691312|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-04-14|||July 2016||2016-07-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Pediatric Type 1 Diabetes and Retinopathy|Prevalence and Characterization of Retinopathy in Children With Type 1 Diabetes Using a Non-mydriatic Fundus Camera|Enrolling by invitation||N/A|500|Anticipated|University of Florida|||1||f||||f||||||||Undecided||2017-10-10 22:26:44.989205|2017-10-10 22:26:44.989205
NCT02691299|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-02-23|||September 2015||2015-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FALUCA||A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer|A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Clinical Trial in Patients With Advanced Non-squamous Non-small Cell Lung Cancer Treated With Fruquintinib|Recruiting||Phase 3|521|Anticipated|Hutchison Medipharma Limited||2|||f||||t||||||||Undecided||2017-10-10 22:26:45.108255|2017-10-10 22:26:45.108255
NCT02691286|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-24|||February 2016||2016-02-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Observational|||Circulating microRNAs in Patients With STEMI Complicated With Cardiogenic Shock|Prognostic Value of Circulating microRNAs in Patients With ST-elevation Myocardial Infarction (STEMI) Complicated by Cardiogenic Shock|Recruiting||N/A|142|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||t||||||Samples With DNA|"     EDTA and LiHe tubes with 10 ml of blood   "|No||2017-10-10 22:26:45.453731|2017-10-10 22:26:45.453731
NCT02691273|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-02-21|||March 2015||2015-03-01|January 2016|2016-01-01||||March 2017|Anticipated|2017-03-01||Interventional|||Applicability of Cellular Application in Diabetes Type 2 Patients.||Recruiting||Phase 1/Phase 2|10|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||No||2017-10-10 22:26:45.557734|2017-10-10 22:26:45.557734
NCT02691260|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2017-08-31|||April 2016||2016-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Incentivizing Behavior Change Skills to Promote Weight Loss|Incentivizing Behavior Change Skills to Promote Weight Loss|Recruiting||N/A|96|Anticipated|Duke University||4|||f||||t||||||||||2017-10-10 22:26:45.643552|2017-10-10 22:26:45.643552
NCT02691247|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-09-18|||February 2016||2016-02-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)|A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)|Recruiting||Phase 2|111|Anticipated|Caladrius Biosciences, Inc.||3|||f||||t||||||||||2017-10-10 22:26:45.796073|2017-10-10 22:26:45.796073
NCT02691234|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-02-21|||April 2016||2016-04-01|January 2016|2016-01-01||||April 2017|Anticipated|2017-04-01||Interventional|||Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers||Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||No||2017-10-10 22:26:46.031948|2017-10-10 22:26:46.031948
NCT02691221|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-12-05|||April 2016||2016-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients|ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients|Recruiting||N/A|25|Anticipated|Emory University||1|||f||||f||||||||No||2017-10-10 22:26:46.114025|2017-10-10 22:26:46.114025
NCT02691208|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-06-02|||August 2011||2011-08-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ACUP||Acupuncture and Breast Cancer Rehabilitation|Effectiveness of Acupuncture in Rehabilitation of Physical and Functional Disorders of Women Undergoing Breast câncer Surgery|Completed||N/A|48|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 22:26:46.21958|2017-10-10 22:26:46.21958
NCT02691195|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-08-24|||February 2016||2016-02-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Ultrasound-guided Serratus Plane Block for the Quality of Recovery After Modified Radical Mastectomy|Ultrasound-guided Serratus Plane Block for the Quality of Recovery After Modified Radical Mastectomy|Recruiting||Phase 4|72|Anticipated|Fujian Provincial Hospital||2|||f||||t||||||||No||2017-10-10 22:26:46.300368|2017-10-10 22:26:46.300368
NCT02691182|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-06-13|||March 2016||2016-03-01|June 2016|2016-06-01||||March 2019|Anticipated|2019-03-01||Interventional|||Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)||Recruiting||Phase 3|400|Anticipated|Supernus Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-10 22:26:46.40678|2017-10-10 22:26:46.40678
NCT02691143|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-01-27|2017-01-27||February 2016||2016-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|TBKTManip||The Effect of TheraBand® Kinesiology Tape on Post-manipulation Pain and Range of Motion|The Effect of TheraBand® Kinesiology Tape on Post-manipulation Pain and Range of Motion|Completed||N/A|50|Actual|Sport and Spine Rehab Clinical Research Foundation||2|||f||||f||||||||No||2017-10-10 22:26:46.784991|2017-10-10 22:26:46.784991
NCT02691130|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-03-15|||November 2015||2015-11-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults|A Multicenter, Randomized, Double-blind, Active-controlled Phase 2b Trial [Part of EU-funded UNISEC Project] to Assess the Immunogenicity & Safety of a BiondVax's Influenza Vaccine (M-001) Followed by H5N1 Vaccine in Healthy Adults|Recruiting||Phase 2|222|Anticipated|BiondVax Pharmaceuticals ltd.||3|||f||||t||||||||No|summary of data per group will be shared, not IPD.|2017-10-10 22:26:47.118183|2017-10-10 22:26:47.118183
NCT02691117|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-02-19|||January 2016||2016-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Topical Garlic Concentrate for Alopecia Areata in Children|Topical Garlic Concentrate for Alopecia Areata in Children: A Prospective Open Label Study|Recruiting||Phase 3|20|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||No|only aggregated data will be available to participants|2017-10-10 22:26:47.231382|2017-10-10 22:26:47.231382
NCT02691104|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-05-04|||January 2016||2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Use of the SMART COPD Physical Activity App in Pulmonary Rehabilitation|Use of the SMART COPD Physical Activity App in Pulmonary Rehabilitation: a Randomised Feasibility Study|Recruiting||N/A|30|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:26:47.322061|2017-10-10 22:26:47.322061
NCT02691078|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-08-08|||July 2016||2016-07-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors|Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors|Recruiting||Phase 2|39|Anticipated|Latin American Cooperative Oncology Group||1|||f||||t||||||||||2017-10-10 22:26:47.443233|2017-10-10 22:26:47.443233
NCT02691065|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-09-12|||October 2016||2016-10-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Protease Inhibitor vs. Raltegravir-based ART and Inflammation in HIV Infection|Effect of a Treatment Switch From Protease Inhibitor to Raltegravir-based ART on Myeloid Cell Inflammation in HIV-infected Patients.|Not yet recruiting||Phase 4|44|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 22:26:47.536986|2017-10-10 22:26:47.536986
NCT02691052|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-08-15|||December 2014||2014-12-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Observational|QoliXane||Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program|Non-interventional Study on Quality of Life, Efficacy and Tolerability of Nab-paclitaxel/Gemcitabine Firstline Therapy in Patients With Metastatic Pancreatic Cancer|Recruiting||N/A|600|Anticipated|Krankenhaus Nordwest|||1||f||||f||||||Samples Without DNA|"     Tumor containing tissues are collected for a translational program focusing on defining     prognostic and predictive factors.   "|||2017-10-10 22:26:47.61922|2017-10-10 22:26:47.61922
NCT02691039|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-02-19|||March 2014||2014-03-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||NEW Keiki Family Based Intervention to Combat Childhood Obesity|N.E.W. Keiki - Nutrition + Exercise + Weight Management Programs: Family-based Intervention to Combat Childhood Obesity in Hawai'i|Enrolling by invitation||N/A|300|Anticipated|Hawaii Pacific Health|||1||f||||f||||||||||2017-10-10 22:26:47.715437|2017-10-10 22:26:47.715437
NCT02691026|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-06-07|||June 2016||2016-06-01|June 2016|2016-06-01|December 2025|Anticipated|2025-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery|A Phase II Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery|Recruiting||Phase 2|18|Anticipated|Oslo University Hospital||1|||f||||f||||||||No||2017-10-10 22:26:47.78606|2017-10-10 22:26:47.78606
NCT02691013|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-09-15|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||The Impact of Ramelteon on Sleep and Delirium in Patients Who Undergo Pulmonary Thromboendarterectomy (PTE) Surgery|The Impact of Ramelteon on Sleep and Delirium in Patients Who Undergo Pulmonary Thromboendarterectomy (PTE) Surgery|Enrolling by invitation||N/A|120|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 22:26:47.876409|2017-10-10 22:26:47.876409
NCT02691000|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-10-26|||September 2015||2015-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|Light-Heart||The Light Heart Study: Daily Light Box Use for Depressive Symptoms in Patients With Stage B Heart Failure|The Light Heart Study: Daily Light Box Use for Depressive Symptoms in Patients With Stage B Heart Failure|Recruiting||N/A|122|Anticipated|University of California, San Diego||2|||f||||f||||||||Yes|Patient information will remain confidential.|2017-10-10 22:26:48.090041|2017-10-10 22:26:48.090041
NCT02690987|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-09-01|||August 2015||2015-08-01|October 2015|2015-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|GHADD||Gut Hormones in Obesity, Nicotine and Alcohol Dependence|Do Appetitive Gut Hormones Reduce Addictive and Eating Behaviours in Obesity, and Nicotine and Alcohol Dependence?|Recruiting||Early Phase 1|95|Anticipated|Imperial College London||3|||f||||t||||||||||2017-10-10 22:26:48.215405|2017-10-10 22:26:48.215405
NCT02690961|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-02|||March 2016||2016-03-01|February 2016|2016-02-01|June 14, 2016|Actual|2016-06-14|June 14, 2016|Actual|2016-06-14||Interventional|||Study of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers|Randomized, Double-blind Placebo-controlled Phase I Study to Assess Safety, Tolerance，Pharmacokinetics of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers|Completed||Phase 1|24|Actual|Tianjin Chasesun Pharmaceutical Co., LTD||6|||f||||f||||||||||2017-10-10 22:26:48.547634|2017-10-10 22:26:48.547634
NCT02690948|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-20|||February 2016||2016-02-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer|A Phase Ib Open Label Study of Pembrolizumab for Unresectable or Metastatic Basal Cell Carcinoma|Recruiting||Phase 2|24|Anticipated|Stanford University||2|||f||||t|t|f||||||||2017-10-10 22:26:48.635208|2017-10-10 22:26:48.635208
NCT02690922|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-23|||March 2016||2016-03-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|TCLDCWTTNDPP||Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients|The Combination of Lower Dosage of Chemotherapy With Tyrosine Kinase Inhibitor to Treat Newly Diagnosed ph+ Acute Lymphoblastic Leukemia Patients|Not yet recruiting||Phase 4|40|Anticipated|Tongji Hospital||1|||f||||f||||||||No||2017-10-10 22:26:48.891134|2017-10-10 22:26:48.891134
NCT02690909|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-05-10|||April 2016||2016-04-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study to Evaluate Safety and Efficacy of the Redy™ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension|A Prospective, Post-marketing, Single-arm, Open Label, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the ReDy™ Renal Denervation System in the Treatment of Patients With Uncontrolled Hypertension|Recruiting||N/A|55|Anticipated|Renal Dynamics GmbH||1|||f||||f||||||||No||2017-10-10 22:26:49.001422|2017-10-10 22:26:49.001422
NCT02690896|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-05-03|||January 2016||2016-01-01|May 2016|2016-05-01|August 2020|Anticipated|2020-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Caregiver Burden and Depression: Caring for Those Who Care for Others|Caregiver Burden and Depression: Caring for Those Who Care for Others|Recruiting||N/A|100|Anticipated|University of Central Florida||2|||f||||f||||||||No||2017-10-10 22:26:49.145902|2017-10-10 22:26:49.145902
NCT02690883|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-02-23|||March 2016||2016-03-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy|Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy: a 24- Week Study|Not yet recruiting||Phase 4|90|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:26:49.264118|2017-10-10 22:26:49.264118
NCT02690870|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2016-02-23|||January 2017||2017-01-01|February 2016|2016-02-01|March 2019|Anticipated|2019-03-01|May 2018|Anticipated|2018-05-01||Interventional|||Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF|Comparison of Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF: a Prospective Cohort Study|Not yet recruiting||Phase 4|210|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||Yes|Yes|2017-10-10 22:26:49.36526|2017-10-10 22:26:49.36526
NCT02690857|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-23|||May 2010||2010-05-01|February 2016|2016-02-01||||May 2010|Actual|2010-05-01||Interventional|OMEGAMUCO||Study of Docosahexanoic Acid in Patients With Cystic Fibrosis (CF)|Efficacy of Docosahexanoic Acid on Lipid Peroxidation in Subjects With Cystic Fibrosis|Completed||Phase 2|10|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-10-10 22:26:49.470064|2017-10-10 22:26:49.470064
NCT02690844|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-19|||April 2016||2016-04-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome|Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome|Not yet recruiting||Phase 4|90|Anticipated|University of Alberta||3|||f||||f||||||||No||2017-10-10 22:26:49.552053|2017-10-10 22:26:49.552053
NCT02690831|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-09-22|||December 2015||2015-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effects of Manual Therapy and Respiratory Muscle Training on the Maximal Inspiratory Pressure in Patients With Asthma|Effects of Manual Therapy and Respiratory Muscle Training on the Maximal Inspiratory Pressure in Patients With Asthma|Completed||N/A|40|Actual|Universidad Autonoma de Madrid||2|||f||||||||||||||2017-10-10 22:26:49.635262|2017-10-10 22:26:49.635262
NCT02690818|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-08-02|||April 2016||2016-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TXT4MED||Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging|Promoting Adherence to Treatment for Latent TB Infection Through Mobile Phone Text Messaging|Recruiting||N/A|40|Anticipated|University of Arizona||2|||f||||t||||||||No||2017-10-10 22:26:49.717224|2017-10-10 22:26:49.717224
NCT02690805|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-10-28|||May 2015||2015-05-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System|Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System|Recruiting||N/A|70|Anticipated|University of California, Irvine|||1||f||||f||||||||No||2017-10-10 22:26:49.813517|2017-10-10 22:26:49.813517
NCT02690792|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-02-13|||December 2009|Actual|2009-12-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease|Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease|Completed||N/A|70|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:26:49.896729|2017-10-10 22:26:49.896729
NCT02690779|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-03-23|||August 2015|Actual|2015-08-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Bowel Preparation Quality for Screening Colonoscopy|Impact of a Patient Educational Video on Bowel Preparation Quality for Screening Colonoscopy: a Quality Assurance Project|Completed||N/A|155|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:26:49.996074|2017-10-10 22:26:49.996074
NCT02690766|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-07-11|||March 2015||2015-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Translating Healthy Lifestyle Interventions for Cancer Survivors|Translating Healthy Lifestyle Interventions for Breast and Endometrial Cancer Survivors With Diabetes|Completed||Phase 2|17|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||No||2017-10-10 22:26:50.08641|2017-10-10 22:26:50.08641
NCT02690753|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Pressure Ulcer Prevention: a Turn and Positioning System Combined With Incontinence Care and Tailored/Standard Repositioning|A Turn and Positioning System and Standardized Incontinence Care Combined With Tailored Repositioning Versus a Standard Repositioning Protocol for Pressure Ulcer Prevention: A Multicenter Prospective Randomized Controlled Clinical Trial and Health Economical Analysis in a Hospital Setting|Recruiting||N/A|226|Anticipated|University Ghent||3|||f||||f||||||||||2017-10-10 22:26:50.158317|2017-10-10 22:26:50.158317
NCT02690740|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-23|||December 2012||2012-12-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|tqCPT||Titrated Quantitative Conjunctival Provocation Test (tqCPT)|Titrated Quantitative Conjunctival Provocation Test (tqCPT): Standardization and Validation of a New Clinical Endpoint|Completed||N/A|23|Actual|Zentrums für Rhinologie und Allergologie Wiesbaden||1|||f||||f||||||||No||2017-10-10 22:26:50.277512|2017-10-10 22:26:50.277512
NCT02690727|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-04-03|2016-12-15||February 2016||2016-02-01|February 2016|2016-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||"18 healthy volunteers were enrolled to get at least 12 completed subjects to demonstrate food effect.
Safety population included all participants who received at least 1 dose of study drug.
PK population included all the participants who provided PK in both period."|To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers|An Open Label, Randomized, Single Dose, Cross Over Study to Evaluate Food Effects on Relative Bioavailability of RP6530 Administered in Fasting and Fed Conditions in Healthy Volunteers|Completed||Phase 1|18|Actual|Rhizen Pharmaceuticals SA|"2 HV dropped in 2nd period in Fast Condition first, then Fed Condition sequence similarly, two HV dropped in second period in Fed Condition first sequence, therefore each treatment had 16 HV for AE evaluation; Fasting 16 and fed 16"|2|||f||||f||||||||No||2017-10-10 22:26:50.375249|2017-10-10 22:26:50.375249
NCT02690714|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-28|||May 4, 2016|Actual|2016-05-04|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|November 30, 2016|Actual|2016-11-30||Interventional|||A Study of ProMetic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia|A Phase 2/3, Open-Label, Repeat-Dose Study of the Pharmacokinetics, Efficacy, and Safety of ProMetic Plasminogen Intravenous Infusion in Subjects With Hypoplasminogenemia|Active, not recruiting||Phase 2/Phase 3|15|Actual|ProMetic BioTherapeutics, Inc||1|||t||||t||||||||||2017-10-10 22:26:50.775574|2017-10-10 22:26:50.775574
NCT02690701|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-05-11|||February 2016||2016-02-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|VIP-S||Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Secukinumab on Aortic Vascular Inflammation and Cardiometabolic Biomarkers After 12 Weeks of Treatment, Compared to Placebo, and up to 52 Weeks of Treatment With Secukinumab in Adult Subjects With Moderate to Severe Chronic Plaque-type Psoriasis|Recruiting||Phase 4|84|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 22:26:50.878894|2017-10-10 22:26:50.878894
NCT02690688|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-18|||March 2016||2016-03-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|||Intra-abdominal Pressure and Dynamic Preload Variables|The Influence of Pneumoperitoneum and Open Abdominal Surgery on Dynamic Preload Variables|Not yet recruiting||N/A|60|Anticipated|University of Luebeck|||2||f||||f||||||||Undecided||2017-10-10 22:26:50.985459|2017-10-10 22:26:50.985459
NCT02690675|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-24|||May 2006||2006-05-01|February 2016|2016-02-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Iron Supplement Effect on Child Development|Iron Supplement Effect Over Immune System and Neurobehavioral Child Development.|Completed||N/A|133|Actual|University Rovira i Virgili||2|||f||||t||||||||Yes|The investigators plan to share data in a submitted article in 2016|2017-10-10 22:26:51.062255|2017-10-10 22:26:51.062255
NCT02690662|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-10-27|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Influence of Hypocaloric Diet on Urinary Lithogenic Factors of Obese Patients With Kidney Stones|Influence of Hypocaloric Diet on Urinary Lithogenic Factors of Obese Patients With Kidney Stones|Recruiting||N/A|50|Anticipated|University of Sao Paulo General Hospital||1|||f||||f||||||||No|Condensed data will be available for consultation|2017-10-10 22:26:51.12835|2017-10-10 22:26:51.12835
NCT02690649|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-12-21|||January 2016||2016-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Keep it SIMPLE: Improving Anti-Coagulation Medication Adherence|Keep it SIMPLE: Improving Anti-Coagulation Medication Adherence for Patients With Non-valvular Atrial Fibrillation|Recruiting||N/A|250|Anticipated|Parkview Health||2|||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-10 22:26:51.217175|2017-10-10 22:26:51.217175
NCT02690636|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-05-29|||January 2016||2016-01-01|May 2016|2016-05-01|April 2021|Anticipated|2021-04-01|February 2021|Anticipated|2021-02-01||Interventional|||Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer|Conventional Versus Hypofractionated Adjuvant Radiotherapy in Node Positive Breast Cancer. Phase III, Open Label, Randomized Trial. Comparing Local Control, Cosmetic Outcome, Arm Lymph Edema and Health Economic Perspectives|Recruiting||Phase 3|500|Anticipated|Ain Shams University||2|||f||||t||||||||No||2017-10-10 22:26:51.350037|2017-10-10 22:26:51.350037
NCT02690623|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-08-05|||June 2016||2016-06-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Benefits and Cost-Effectiveness of a Pediatric Hospitalist Service : a Stepped Wedge Quality Improvement Trial|Benefits and Cost-Effectiveness of a Pediatric Hospitalist Service : a Stepped Wedge Quality Improvement Trial|Active, not recruiting||N/A|10000|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-10-10 22:26:51.59341|2017-10-10 22:26:51.59341
NCT02690610|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2016-10-22|||November 2015||2015-11-01|February 2016|2016-02-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Value of Rapid on Site Evaluation During EBUS-guided TBNA in the Diagnosis of Mediastinal Lesions|Value of Rapid on Site Evaluation During Endobronchial Ultrasound Guided Trans-bronchial Needle Aspiration (EBUS-TBNA) in the Diagnosis of Mediastinal Lesions|Completed||N/A|67|Actual|Tanta University||1|||f||||t||||||||Undecided||2017-10-10 22:26:51.68894|2017-10-10 22:26:51.68894
NCT02690597|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-05-06|||February 2015||2015-02-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|ANXYDOL||Validation and Pertinence of Anxiety Analogic Visual Scale in Pain Management|Validation and Pertinence of Anxiety Analogic Visual Scale in Pain Management by Mobile Acute Pain Team|Recruiting||N/A|50|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 22:26:51.767009|2017-10-10 22:26:51.767009
NCT02690584|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-17|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|||Metacognitive Therapy for Post-concussive Symptoms After Mild Traumatic Brain Injury|Metacognitive Therapy for Post-concussive Symptoms After Mild Traumatic Brain Injury|Recruiting||N/A|20|Anticipated|Norwegian University of Science and Technology||1|||f||||f|f|f||||||||2017-10-10 22:26:51.871242|2017-10-10 22:26:51.871242
NCT02690571|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-03-18|||October 2013||2013-10-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|BD100Broncho||Pulmonary Effects of 100% Biodiesel Exhaust|Pulmonary Effects of 100% Biodiesel Exhaust|Completed||N/A|15|Actual|Umeå University||2|||f||||f||||||||||2017-10-10 22:26:51.97537|2017-10-10 22:26:51.97537
NCT02690558|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-03-10|||May 2016||2016-05-01|March 2017|2017-03-01|May 2024|Anticipated|2024-05-01|September 2019|Anticipated|2019-09-01||Interventional|||Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy|Phase II Single Arm Study of Gemcitabine and Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Prior to Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer|Recruiting||Phase 2|39|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-10 22:26:52.050999|2017-10-10 22:26:52.050999
NCT02690545|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-12|||August 26, 2016|Actual|2016-08-26|September 2017|2017-09-01|October 2034|Anticipated|2034-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL|Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|31|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 22:26:52.200874|2017-10-10 22:26:52.200874
NCT02690532|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-08-14|||March 2016||2016-03-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Observational|||Gut Permeability Assessment in Celiac and Gluten Sensitive Children|The Role of Gut Permeability in Developing Celiac Disease and Non-Celiac Gluten Sensitivity|Recruiting||N/A|60|Anticipated|Mayo Clinic|||3||f||||f||||||||||2017-10-10 22:26:52.345463|2017-10-10 22:26:52.345463
NCT02690519|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-10-10|||January 2016||2016-01-01|March 2016|2016-03-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|SAPHIRA2||Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation)|A Phase IIa, Open-label Study of Two Doses of GLPG1837 in Subjects With Cystic Fibrosis and the S1251N Mutation|Completed||Phase 2|7|Actual|Galapagos NV||1|||f||||t||||||||||2017-10-10 22:26:52.441566|2017-10-10 22:26:52.441566
NCT02690506|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-05-17|||February 2016||2016-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Effect of Pregabalin on the Spinal Anesthesia|The Effect of Pregabalin on the Spinal Anesthesia: Randomized Controlled Placebo Study|Completed||N/A|44|Actual|Kyungpook National University||2|||f||||||||||||||2017-10-10 22:26:52.557344|2017-10-10 22:26:52.557344
NCT02690493|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-02-25|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||The Efficacy of an Acupuncture Protocol and Use of Taping in the Treatment of Spastic Upper Limb After Stroke|The Efficacy of an Acupuncture Protocol and Use of Taping in the Treatment of Spastic Upper Limb After Stroke|Completed||Phase 2|12|Actual|Federal University of Health Science of Porto Alegre||3|||f||||f||||||||No||2017-10-10 22:26:52.661043|2017-10-10 22:26:52.661043
NCT02690116|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-04-21|||February 2016||2016-02-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors|Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors|Recruiting||N/A|246|Anticipated|Arizona State University||3|||f||||f||||||||No||2017-10-10 22:26:56.839764|2017-10-10 22:26:56.839764
NCT02690480|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-10-17|||February 2016||2016-02-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|FLIPPER||Comparison of Efficacy and Tolerability of Fulvestrant+Placebo vs Fulvestrant+Palbociclib as First Line Therapy for Postmenopausal Women With HR+ Metastatic BC Treated With 5 Years of Hormonal Therapy Remaining Disease Free More Than 12 Months After Completion or Have de Novo Metastatic Disease|"A Randomized, Double-blind, Parallel-group, Multicentre, Phase II Study to Compare the Efficacy and Tolerability of Fulvestrant (FaslodexTM) 500mg With Placebo and Fulvestrant (FaslodexTM) 500mg in Combination With PD-0332991 (Palbociclib) as First Line Treatment for Postmenopausal Women With Hormone Receptor-positive Metastatic Breast Cancer, Who Have Completed at Least 5 Years of Adjuvant Endocrine Therapy and Remained Disease Free for More Than 12 Months Following Its Completion or Have de Novo Metastatic Disease. The FLIPPER Study"|Recruiting||Phase 2|190|Anticipated|Spanish Breast Cancer Research Group||2|||f||||f||||||||No||2017-10-10 22:26:52.830376|2017-10-10 22:26:52.830376
NCT02690467|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-07-24|||September 6, 2016|Actual|2016-09-06|January 2017|2017-01-01|July 31, 2017|Anticipated|2017-07-31|March 23, 2017|Actual|2017-03-23||Interventional|AGO 02||Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.|Efficacy, Safety and Acceptability of the New Pen Needle 33G x 4 mm: a Cross-over Randomised Non Inferiority Trial|Recruiting||N/A|80|Anticipated|Center for Outcomes Research and Clinical Epidemiology, Italy||2|||f||||f||||||||||2017-10-10 22:26:53.017341|2017-10-10 22:26:53.017341
NCT02690454|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2016-08-16|||November 2015||2015-11-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|HARMONIC||Which Platelet Function Test Best Reflects the In Vivo Plasma Concentrations of Ticagrelor and Its Active Metabolite?|Which Platelet Function Test Provides the Best Reflection of the in Vivo Plasma Concentrations of Ticagrelor and Its Active Metabolite? A Pharmacokinetic and Pharmacodynamic Study Including Patients With Myocardial Infarction.|Completed||N/A|45|Actual|Collegium Medicum w Bydgoszczy|||1||f||||f||||||||||2017-10-10 22:26:53.145819|2017-10-10 22:26:53.145819
NCT02690441|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-04|||March 2016||2016-03-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|PEXACOG||Physical Exercise Augmented CBT for GAD|Physical Exercise Augmented Cognitive Behaviour Therapy for Older Adults With Generalised Anxiety Disorder|Recruiting||Phase 2|70|Anticipated|Solli Distriktspsykiatriske Senter||2|||f||||f||||||||No||2017-10-10 22:26:53.23365|2017-10-10 22:26:53.23365
NCT02690428|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-01-30|||February 2016||2016-02-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers|To Evaluate the Safety & Palliative Treatment Effect on Patients With Solid Cancers by Immunostimulating Interstitial Laser Thermotherapy (imILT)|Recruiting||N/A|30|Anticipated|Clinical Laserthermia Systems AB||1|||f||||f||||||||No||2017-10-10 22:26:53.399997|2017-10-10 22:26:53.399997
NCT02690402|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-02-19|||April 2016||2016-04-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Fragility and Adapted Physical Activity|Fragility Multidisciplinary Evaluation and Adapted Physical Activity|Not yet recruiting||N/A|970|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||Undecided||2017-10-10 22:26:53.613242|2017-10-10 22:26:53.613242
NCT02690389|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-18|||January 2015||2015-01-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|EA&FLUM||Electro-acupuncture and Flumazenil's Effect on Sedation|The Sedation Effect of Electro-acupuncture on Bilateral Zusanli (ST 36) and Neiguan (PC 6) in General Anesthesia May Not be Mediated by the Benzodiazepines- GABA Pathway|Completed||N/A|80|Actual|Sichuan Cancer Hospital and Research Institute||4|||f||||t||||||||No|Data will not be share until it is published|2017-10-10 22:26:53.710476|2017-10-10 22:26:53.710476
NCT02690376|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-18|||March 2016||2016-03-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|MACE||An Observer Blinded Comparison of MACE and Conventional Upper Gastrointestinal Endoscopy in Upper GI Bleeding|An Observer Blinded Comparison of Magnetically Assisted Capsule Endoscopy and Conventional Upper Gastrointestinal Endoscopy in Upper GI Bleeding|Not yet recruiting||N/A|100|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:26:53.801045|2017-10-10 22:26:53.801045
NCT02690337|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-24|||January 2016||2016-01-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of DS-1123a in Advanced Solid Tumours|Phase 1, Open-label Study to Assess the Safety, Tolerability, and Pharmacokinetics of DS-1123a in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|27|Anticipated|Daiichi Sankyo, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:26:53.966522|2017-10-10 22:26:53.966522
NCT02690324|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-18|||November 2015||2015-11-01|November 2015|2015-11-01||||February 2018|Anticipated|2018-02-01||Interventional|||The Development of Skin Adhesive Patches for the Monitoring and Prediction of Mental Disorders||Recruiting||N/A|80|Anticipated|Samsung Medical Center||3|||f||||||||||||||2017-10-10 22:26:54.062147|2017-10-10 22:26:54.062147
NCT02690311|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-18|||August 2013||2013-08-01|August 2013|2013-08-01||||January 2014|Actual|2014-01-01||Interventional|||A Study on the Changes of the Biological Rhythm by Display Image Modulation||Completed||N/A|22|Actual|Samsung Medical Center||2|||f||||||||||||||2017-10-10 22:26:54.153447|2017-10-10 22:26:54.153447
NCT02690298|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-02-18|||September 2015||2015-09-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|RMI UVU||Evaluation of ExSpiron™ Measurements Derived Without Patient Specific Calibration|Evaluation of ExSpiron™ Non-Invasive Respiratory Volume Monitor Measurements Derived Without Patient Specific Calibration|Active, not recruiting||N/A|15|Actual|Respiratory Motion, Inc.|||1||f||||t||||||||||2017-10-10 22:26:54.212258|2017-10-10 22:26:54.212258
NCT02690285|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-05-03|||March 2016||2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Pilot Study of Rapid Haplotyping Procedure for Personalized Dosing of Dichloroacetate (DCA) in Healthy Volunteers|A Pilot Study of Rapid Haplotyping Procedure for Personalized Dosing of Dichloroacetate (DCA) in Healthy Volunteers Part 1: Rapid Haplotyping Procedure for Determining the Response of Patients to DCA. Part 2: Personalized Dosing of Dichloroacetate for the Treatment of Rare and Common Diseases|Active, not recruiting||Phase 1|50|Anticipated|University of Florida||2|||f||||f|t|f||||||Yes|Study participants will receive paper copy report of results GSTZ1 haplotype analysis and reports from routine blood studies.|2017-10-10 22:26:54.265154|2017-10-10 22:26:54.265154
NCT02690272|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-19|||February 2016||2016-02-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|LER-Psy-PAKT||"Lived Experience, Representations and Psychic Processes in Patients Awaiting Kidney Transplantation"|" Expérience Vécue, Représentations et Processus Psychiques Chez Les Sujets en Attente de Transplantation Rénale "|Not yet recruiting||N/A|40|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 22:26:54.339266|2017-10-10 22:26:54.339266
NCT02690259|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-01|||June 2014||2014-06-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Sentinel Lymph Node Detection in Endometrial Cancer|Near Infrared Fluorescent Technique for Sentinel Lymph Node Mapping in Endometrial Cancer|Recruiting||N/A|375|Anticipated|Region Skane||1|||f||||f||||||||||2017-10-10 22:26:54.423235|2017-10-10 22:26:54.423235
NCT02690246|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-08-16|||February 2016||2016-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 14, 2017|Actual|2017-08-14||Observational|||Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia|A Questionnaire Based Study on Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia (HHT)|Active, not recruiting||N/A|915|Actual|University Hospital, Essen|||2||f||||f||||||||||2017-10-10 22:26:54.526151|2017-10-10 22:26:54.526151
NCT02690233|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-04-19|||February 2016||2016-02-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|January 2017|Actual|2017-01-01||Observational|POETRYminor||Perioperative Endothelial Dysfunction in Patients Undergoing Minor Abdominal Surgery|Perioperative Endothelial Dysfunction in Patients Undergoing Minor Abdominal Surgery. The POETRY Minor Study.|Active, not recruiting||N/A|60|Actual|University Hospital Koge|||1||f||||f||||||Samples With DNA|"     The blood will be collected from a larger vein (e.g. the cubital vein).      Tetrahydrobiopterin: Blood is sampled into 4mL EDTA tubes. Immediately after withdrawal, a     minimum of 1mL blood is mixed with 25μL DTE. The mixture is centrifuged at 2000g for 5     minutes. Plasma is frozen and stored at -80°C.      Arginine and ADMA: Blood is sampled into 4mL EDTA tubes. Blood samples will be centrifuged at     3000g for 10 minutes, plasma frozen and stored at -80°C until analyzed with high performance     liquid chromatography.   "|No||2017-10-10 22:26:54.622875|2017-10-10 22:26:54.622875
NCT02690220|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-07|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|TiLOOP® PRO A||Anterior Pelvic Prolapse Reconstruction With TiLOOP® PRO A Polypropylene Mesh|National, Multicentre Post Market Surveillance Study on Anterior Pelvic Prolapse Reconstruction With a Titanium-coated Polypropylene Mesh (TiLOOP® PRO A)|Completed||N/A|54|Actual|pfm medical ag||1|||f||||t||||||||||2017-10-10 22:26:54.708176|2017-10-10 22:26:54.708176
NCT02690194|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-07-27|||August 2015||2015-08-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Prospective Study Investigating the Use of Relaxation Prior to Medical Procedures.|A Prospective Study Investigating the Use of Relaxation Prior to Medical Procedures|Recruiting||N/A|72|Anticipated|Boston Children’s Hospital||3|||f||||f||||||||No||2017-10-10 22:26:56.073475|2017-10-10 22:26:56.073475
NCT02690181|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-01-16|||March 2016||2016-03-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.|A Phase 2, Non-Randomized, Controlled, Open-Label, Parallel-Group, Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-pregnant Subjects.|Completed||Phase 2|80|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-10 22:26:56.20834|2017-10-10 22:26:56.20834
NCT02690168|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-09-19|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|July 2017|Actual|2017-07-01|March 27, 2017|Actual|2017-03-27||Observational|GLIMpSE||Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy||Completed||N/A|10|Anticipated|Pennington Biomedical Research Center|||1||f||||f||||||Samples Without DNA|"     Blood banking   "|||2017-10-10 22:26:56.3344|2017-10-10 22:26:56.3344
NCT02690155|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-04-04|||February 12, 2016|Actual|2016-02-12|April 2017|2017-04-01|March 1, 2016|Actual|2016-03-01|March 1, 2016|Actual|2016-03-01||Observational|RIVA-F||Real-world Comparative Effectiveness of Rivaroxaban Versus VKA|Real-world Comparative Effectiveness of Rivaroxaban Versus VKA|Completed||N/A|38831|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:26:56.482801|2017-10-10 22:26:56.482801
NCT02690142|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-10-07|||February 2016||2016-02-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035|A Phase I, Partially-randomised, Partially Double-blinded, Safety, Tolerability and Pharmacokinetic Study of ABY-035 in Healthy Subjects and Psoriasis Patients|Recruiting||Phase 1|64|Anticipated|Affibody||4|||f||||f||||||||No||2017-10-10 22:26:56.603343|2017-10-10 22:26:56.603343
NCT02690129|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-02-23|||February 2016||2016-02-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|VPM||Vaginal Progesterone for Treatment of Threatened Miscarriage|Vaginal Progesterone for Treatment of Threatened Miscarriage; Randomized Clinical Trial|Recruiting||N/A|290|Anticipated|Assiut University||2|||f||||t||||||||No||2017-10-10 22:26:56.731953|2017-10-10 22:26:56.731953
NCT02690103|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-23|||July 2012||2012-07-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV|Clinical Study of a Biological Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for the Treatment of Hepatitis C Infection|Completed||Phase 2|37|Actual|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 22:26:56.980413|2017-10-10 22:26:56.980413
NCT02690090|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-02-18|||February 2014||2014-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Observational|||Safety Study of Enoxaparin Prophylaxis in Critically Ill Adults With Severe Renal Insufficiency|Phase 4 Study Determining the Safety of Enoxaparin Prophylaxis in Critically Ill Adults With Severe Renal Insufficiency|Recruiting||Phase 4|30|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||No||2017-10-10 22:26:57.110658|2017-10-10 22:26:57.110658
NCT02690077|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-07-05|||June 2016||2016-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Family-Centered Cesarean Delivery|Family-Centered Cesarean: A Randomized Controlled Trial|Recruiting||N/A|508|Anticipated|Aurora Health Care||4|||f||||f||||||||||2017-10-10 22:26:57.215753|2017-10-10 22:26:57.215753
NCT02690064|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-11-07|||April 2015||2015-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CF-AOX||Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF|Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF|Recruiting||N/A|80|Anticipated|Augusta University||2|||f||||t||||||||Yes||2017-10-10 22:26:57.376439|2017-10-10 22:26:57.376439
NCT02690051|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-01-11|||October 2014||2014-10-01|February 2016|2016-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|BeSmooth||BeSmooth Study, Investigating the BeSmooth Peripheral Stent System for the Treatment of Iliac Lesions|BeSmooth Study, a Physician-initiated PMCF Trial Investigating the BeSmooth Peripheral Stent System for the Treatment of Iliac Lesions|Completed||Phase 4|70|Actual|Flanders Medical Research Program||1|||f||||t||||||||Undecided||2017-10-10 22:26:57.478495|2017-10-10 22:26:57.478495
NCT02690038|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-28|||September 2016||2016-09-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Ig PRx in AECOPD: Pilot Study|Feasibility and Safety of Immunoglobulin (Ig) Prophylactic Treatment in COPD Patients With Frequent Exacerbations: A Pilot Study|Recruiting||Phase 2|48|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:26:57.558113|2017-10-10 22:26:57.558113
NCT02690025|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-20|||February 2016||2016-02-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|glepaglutide||A Phase 2 Trial Testing ZP1848 in Patients With SBS|A Phase 2 Trial Testing ZP1848 in Patients With SBS|Completed||Phase 2|18|Actual|Zealand Pharma||3|||f||||f||||||||No||2017-10-10 22:26:57.67857|2017-10-10 22:26:57.67857
NCT02690012|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-15|||July 2016||2016-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|OTT 15-03||Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for the Management of Hypomagnesemia From Anti-Cancer Therapies|Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for the Management of Hypomagnesemia From Anti-Cancer Therapies|Recruiting||N/A|60|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 22:26:57.807785|2017-10-10 22:26:57.807785
NCT02689999|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-23|||February 2016||2016-02-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|||The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity|The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity|Completed||Phase 4|12|Actual|Neutec Ar-Ge San ve Tic A.Ş||1|||f||||f||||||||||2017-10-10 22:26:57.896424|2017-10-10 22:26:57.896424
NCT02689986|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-01-06|||January 2013||2013-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CAD5||Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease|The CAD5 Study::Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-randomized International Multicenter Trial on the Safety and Efficacy of Bendamustine and Rituximab Combination Therapy|Completed||Phase 2|43|Actual|Helse Fonna||1|||f||||t||||||||Yes|Data are to be shared between authors before final analysis and publication.|2017-10-10 22:26:57.968974|2017-10-10 22:26:57.968974
NCT02689960|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-06-19|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|June 1, 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|Vapreda||Vaginal Prednisone Administration for Prevention of Adrenal Crisis|Vaginal Prednisone Administration for Prevention of Adrenal Crisis - a Bioequivalence Study|Completed||Phase 2|12|Actual|Wuerzburg University Hospital||2|||f||||t||||||||Yes||2017-10-10 22:26:58.182129|2017-10-10 22:26:58.182129
NCT02689947|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-18|||March 2016||2016-03-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation of the Efficacy of Restylane Silk in the Correction of Tear Trough Deformity|Evaluation of the Efficacy of Restylane Silk in the Correction of Tear Trough Deformity|Not yet recruiting||N/A|30|Anticipated|Nashville Centre for Laser and Facial Surgery||1|||f||||f||||||||||2017-10-10 22:26:58.264001|2017-10-10 22:26:58.264001
NCT02689934|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-08-31|||April 2016||2016-04-01|August 2017|2017-08-01|March 9, 2017|Actual|2017-03-09|February 21, 2017|Actual|2017-02-21||Interventional|||Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia|Efficacy of Red Yeast Rice Based Nutraceutical (Monacolin K 10 mg/Dose) Plus Probiotic (Bifidobacterium Longum BB536 ®) in Patients With Moderate Hypercholesterolemia.|Completed||N/A|33|Actual|Montefarmaco OTC SpA||2|||f||||||||||||||2017-10-10 22:26:58.326565|2017-10-10 22:26:58.326565
NCT02689921|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-08-15|||April 2016||2016-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|NEOADAPT||NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer|A Phase II Study of NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab (NEOADAPT)|Recruiting||Phase 2|32|Anticipated|Midwestern Regional Medical Center||1|||f||||f||||||||||2017-10-10 22:26:58.424037|2017-10-10 22:26:58.424037
NCT02689908|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-02-18|||May 2015||2015-05-01|February 2016|2016-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Individualized Radiation Dose Control|Individualized Radiation Dose Control: Could Neck Circumference be a New Somatometric Parameter to Adjust Tube Current for Thorax CT?|Recruiting||N/A|100|Anticipated|Van Military Hospital||1|||f||||f||||||||Yes||2017-10-10 22:26:58.532516|2017-10-10 22:26:58.532516
NCT02689895|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2017-04-14|||February 2014|Actual|2014-02-01|April 2017|2017-04-01|January 31, 2017|Actual|2017-01-31|January 2017|Actual|2017-01-01||Interventional|ATF||Etiology of Treatment Failure in HIV Positive Children and Adolescents on Boosted Protease Inhibitor-based Regimens|Etiology of Treatment Failure in HIV Positive Children and Adolescents on Boosted Protease Inhibitor-based Regimens|Completed||N/A|50|Actual|University of Zimbabwe||2|||f||||f||||||||No||2017-10-10 22:26:58.627457|2017-10-10 22:26:58.627457
NCT02689882|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-18|||November 2015||2015-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||"Pharmacokinetic Study of Nicotinamide Riboside"|"Pharmacokinetic Study of Nicotinamide Riboside"|Completed||Phase 1|8|Actual|University of Washington||1|||f||||t||||||||Undecided||2017-10-10 22:27:00.569132|2017-10-10 22:27:00.569132
NCT02689869|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-07-24|||April 2016||2016-04-01|July 2017|2017-07-01|July 2022|Anticipated|2022-07-01|June 2018|Anticipated|2018-06-01||Interventional|Alternative||Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma|A Chemotherapy-free Combination of the Bruton's Tyrosine Kinase Inhibitor, Ibrutinib in Combination With GA 101 in Patients With Previously Untreated Follicular Lymphoma and a High Tumor Burden|Active, not recruiting||Phase 2|98|Actual|Ludwig-Maximilians - University of Munich||1|||f||||t||||||||||2017-10-10 22:27:00.660048|2017-10-10 22:27:00.660048
NCT02689856|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-23|||May 2015||2015-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|Hydro/Lido||Safety and Efficacy of Hydrocortisone and Lidocaine Treatment of Grade I and II Hemorrhoids|A Randomized, Dose-Ranging, Double Blind Study of Lidocaine Hydrochloride and/or Hydrocortisone Acetate (Alone or in Combination) in the 14-Day Twice-Daily Treatment of Grade I or II Hemorrhoids|Completed||Phase 2|211|Actual|Citius Pharmaceuticals, Inc.||7|||f||||f||||||||No||2017-10-10 22:27:00.752821|2017-10-10 22:27:00.752821
NCT02689843|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-10-03|||March 2016||2016-03-01|October 2017|2017-10-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|AntiPCO||Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS|Effects of Treatment With Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Serum Inflammatory Markers in Patients With Polycystic Ovary Syndrome (PCOS)|Completed||Early Phase 1|78|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-10-10 22:27:00.857742|2017-10-10 22:27:00.857742
NCT02689830|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-18|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|PARIS1||Prostate Embolization for Acute Urinary Retention Study|Prostate Embolization for Acute Urinary Retention Study (PARIS 1): An Open-label Prospective Study|Active, not recruiting||N/A|20|Actual|ClinSearch||1|||f||||f||||||||||2017-10-10 22:27:00.958605|2017-10-10 22:27:00.958605
NCT02689817|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-03-06|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Monitoring Physiologic Data in the Development of Pressure Ulcers|Monitoring Physiologic Data in the Development of Pressure Ulcers|Not yet recruiting||N/A|100|Anticipated|Johns Hopkins University||1|||f||||f|f|f||||||No||2017-10-10 22:27:01.064667|2017-10-10 22:27:01.064667
NCT02689804|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-06-30|2017-02-14||July 10, 2015|Actual|2015-07-10|June 2017|2017-06-01|February 3, 2017|Actual|2017-02-03|December 29, 2015|Actual|2015-12-29||Interventional||This is a cross-over study with the same 32 participants receiving each study drug. 34 participants were enrolled into this study but 2 participants discontinued. The final sample includes a total of 16 normal-BMI women and 16 obese-BMI women.|EC PK in Women With Normal and Obese BMI|Pharmacokinetics of Levonorgestrel and Ulipristal Acetate Emergency Contraception in Women With Normal and Obese Body Mass Index|Completed||Phase 4|34|Actual|Columbia University||2|||f||||t|t|f|||f|||||2017-10-10 22:27:01.195898|2017-10-10 22:27:01.195898
NCT02689791|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-02-18|||January 2012||2012-01-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Resistant Wheat Starch on Subjective Appetite and Food Intake in Healthy Adults|Effect of Resistant Wheat Starch on Subjective Appetite and Food Intake in Healthy Adults|Completed||N/A|31|Actual|Iowa State University||2|||f||||f||||||||Undecided||2017-10-10 22:27:02.005596|2017-10-10 22:27:02.005596
NCT02689778|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-08-29|||March 2016||2016-03-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy|Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy|Recruiting||Phase 3|62|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||No||2017-10-10 22:27:02.091161|2017-10-10 22:27:02.091161
NCT02689765|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2016-12-05|||February 2016||2016-02-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Anthocyanins on Metabolic Profiles in Subjects With Pre-diabetes|Effect of Anthocyanins on Metabolic Profiles in Subjects With Pre-diabetes: A Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 4|160|Actual|Sun Yat-sen University||2|||f||||f||||||||Undecided||2017-10-10 22:27:02.215723|2017-10-10 22:27:02.215723
NCT02689752|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-10-27|||July 2016||2016-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] Fruquintinib|A Phase One Open-Label Single-Radiolabeled Dose Study to Investigate the Absorption, Metabolism, And Excretion Of [14C] Fruquintinib (HMPL-013) in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Hutchison Medipharma Limited||1|||f||||f||||||||No||2017-10-10 22:27:02.315028|2017-10-10 22:27:02.315028
NCT02689739|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-02-18|||July 2015||2015-07-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Validation of Ultrasound in Predicting a Low Lying Placenta Throughout Pregnancy|Lower-extremity Blood fl ow and Velocity in Obese vs Nonobese Pregnant Women|Recruiting||N/A|200|Anticipated|The University of Texas Medical Branch, Galveston|||2||f||||f||||||||No|We do not plan to share data.|2017-10-10 22:27:02.410492|2017-10-10 22:27:02.410492
NCT02688478|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-27|||February 2, 2017|Actual|2017-02-02|September 2017|2017-09-01|February 2, 2019|Anticipated|2019-02-02|February 2, 2018|Anticipated|2018-02-02||Interventional|PAIR||The Phthalate-Allergen Immune Response Study|Effects of Phthalate Inhalation on Airway Immunology: A Controlled Human Exposure Study|Recruiting||N/A|20|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 22:27:14.298515|2017-10-10 22:27:14.298515
NCT02689726|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-12-01|||August 2015||2015-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL|A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL|Terminated||Phase 1|13|Actual|Genticel||1||Lack of efficacy in European Phase 2 study|f||||f||||||||No||2017-10-10 22:27:02.521018|2017-10-10 22:27:02.521018
NCT02689713|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-06-30|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent|Prospective, Randomized, Double-blind Controlled Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent at Skin Donor Sites|Not yet recruiting||Phase 1|100|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f|t|f||||||||2017-10-10 22:27:02.616905|2017-10-10 22:27:02.616905
NCT02689700|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-03-04|||July 2013||2013-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|MoChi-HCMV||Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns|Examination of Diaplacental Transfer of IgG-antibodies Against Human Cytomegalovirus (HCMV) and Varicella-Zoster-Virus (VZV) at Premature and Mature Newborns|Recruiting||N/A|450|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples Without DNA|"     Umbilical Cord blood; Blood from peripheral vene   "|No||2017-10-10 22:27:02.726208|2017-10-10 22:27:02.726208
NCT02689687|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-05-10|||February 2016||2016-02-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Automated Hovering for Congestive Heart Failure Patients: A Pilot Study|Automated Hovering to Improve Medication Adherence and Weight Management Among Congestive Heart Failure Patients: A Pilot Study|Completed||N/A|20|Actual|University of Pennsylvania||1|||f||||f||||||||No||2017-10-10 22:27:02.832569|2017-10-10 22:27:02.832569
NCT02689661|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-01-09|||November 2010||2010-11-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects|The Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects|Recruiting||N/A|230|Anticipated|University of Michigan|||2||f||||f||||||Samples Without DNA|"     Plasma or serum   "|No||2017-10-10 22:27:02.951356|2017-10-10 22:27:02.951356
NCT02689648|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-10-25|||February 2016||2016-02-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|LUFT||Long Term Follow up on Functional Gastrointestinal Disorder (FGID)|Long Term Follow up on Functional Gastrointestinal Disorder (FGID)|Recruiting||N/A|400|Anticipated|Umeå University|||1||f||||f||||||||No||2017-10-10 22:27:03.049217|2017-10-10 22:27:03.049217
NCT02689635|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-04-03|||November 2016||2016-11-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|February 2020|Anticipated|2020-02-01||Interventional|SALT||Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure|The Salt Trial: Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure|Recruiting||N/A|250|Anticipated|University of Kentucky||2|||f||||t||||||||No||2017-10-10 22:27:03.120084|2017-10-10 22:27:03.120084
NCT02689622|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-07-08|||April 2016||2016-04-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PREDICTOR||PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.|Best PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.|Recruiting||N/A|450|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 22:27:03.215152|2017-10-10 22:27:03.215152
NCT02689609|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-18|||January 2008||2008-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01|5 Years|Observational [Patient Registry]|||Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma|Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma|Active, not recruiting||N/A|149|Actual|The University of Hong Kong|||1||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-10 22:27:03.404193|2017-10-10 22:27:03.404193
NCT02689596|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-18|||October 2014||2014-10-01|February 2016|2016-02-01||||October 2015|Actual|2015-10-01||Interventional|||Oxytocin and Resting State fMRI|Intranasal Oxytocin and Resting State fMRI in Healthy Volunteers|Completed||N/A|||University Hospital Heidelberg||2|||f||||||||||||||2017-10-10 22:27:03.57931|2017-10-10 22:27:03.57931
NCT02689583|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-23|||March 2016||2016-03-01|February 2016|2016-02-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection|A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection|Not yet recruiting||N/A|3000|Anticipated|First Affiliated Hospital of Zhejiang University||2|||f||||||||||||||2017-10-10 22:27:03.661632|2017-10-10 22:27:03.661632
NCT02689570|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-18|||June 2011||2011-06-01|February 2016|2016-02-01||||January 2017|Anticipated|2017-01-01||Observational|VISCERA||Relation of Visceral Fat and Associated Cytokines With Early Cardiovascular Complications in Type 1 Diabetes.|Relation of Visceral Fat and Associated Cytokines With Early Cardiovascular Complications in Type 1 Diabetes: the VISCERA Study|Recruiting||N/A|150|Anticipated|University Hospital, Antwerp|||1||f||||f||||||Samples With DNA|"     EDTA sample   "|No||2017-10-10 22:27:03.75982|2017-10-10 22:27:03.75982
NCT02689557|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-12-15|||January 2016||2016-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|VEINEX||VEINEX : Venous Investigations During Exercise|VEINEX : Venous Investigations During Exercise|Recruiting||N/A|50|Anticipated|University Hospital, Angers||1|||f||||f||||||||No||2017-10-10 22:27:03.878271|2017-10-10 22:27:03.878271
NCT02689544|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-18|||June 2015||2015-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Static Stretching and Dynamic in Flexibility and Performance: Blind and Randomized Clinical Trial|Acute and Chronic Effects of Static and Dynamic Stretching on Flexibility and Neuromuscular and Functional Performance in Healthy Subjects: a Blinded and Randomized Clinical Trial|Completed||N/A|45|Actual|Universidade Federal do Rio Grande do Norte||3|||f||||t||||||||||2017-10-10 22:27:03.962569|2017-10-10 22:27:03.962569
NCT02689531|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-02-22|||February 2016||2016-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||CTTI Risk Factors for HABP/VABP Study|Prospective Observational Study of the Risk Factors for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)|Recruiting||N/A|6850|Anticipated|Duke University|||4||f||||f||||||||Yes|Following completion of the study, the results of this research will be written up in a manuscript to be submitted to a scientific journal. As part of the publication of results, CTTI will make the de-identified data from this study, and the underlying code and research provenance available not only in summary form but also via a web platform—with appropriate data governance and security—for other researchers to review.|2017-10-10 22:27:04.046242|2017-10-10 22:27:04.046242
NCT02689518|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2016-02-23|||April 2014||2014-04-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|EAGLE||EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection|Clinical and Genetic Assessment of Treatment Response in Patients With Age-related Macular Degeneration Using Intravitreal Aflibercept Injection|Recruiting||Phase 4|100|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-10-10 22:27:04.157092|2017-10-10 22:27:04.157092
NCT02689505|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-23|2017-10-02|||April 4, 2016|Actual|2016-04-04|October 2017|2017-10-01|July 29, 2018|Anticipated|2018-07-29|July 29, 2018|Anticipated|2018-07-29||Interventional|||Weekly BI 836880 in Patients With Advanced Solid Tumors|Phase I, Non-randomized, Open-label, Multi-center Dose Escalation Trial of BI 836880 Administered by Weekly Repeated Intravenous Infusions in Patients With Advanced Solid Tumors.|Recruiting||Phase 1|40|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:27:04.254339|2017-10-10 22:27:04.254339
NCT02689492|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-08-25|||December 11, 2015|Actual|2015-12-11|August 2017|2017-08-01|August 26, 2017|Anticipated|2017-08-26|August 26, 2017|Anticipated|2017-08-26||Observational|||SATisfaction and Adherence to COPD Treatment|SATisfaction and Adherence to COPD Treatment|Active, not recruiting||N/A|401|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 22:27:04.333388|2017-10-10 22:27:04.333388
NCT02689479|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-22|2016-02-22|||May 2013||2013-05-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||11C-5-HTP PET in Clinical Islet Transplantation|Evaluation of the Use of 11C-5-HTP PET to Calculate βCell Mass in Clinical Islet Transplantation (DAIT CIT-09)|Completed||N/A|8|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-10 22:27:04.438074|2017-10-10 22:27:04.438074
NCT02689466|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-20|2017-08-22|||February 8, 2016||2016-02-08|August 7, 2017|2017-08-07|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|||Cholinergic Receptor Imaging in Dystonia|Cholinergic Receptor Imaging in Dystonia|Recruiting||N/A|54|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:27:04.594453|2017-10-10 22:27:04.594453
NCT02689440|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-19|2017-04-03|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib|Recruiting||Phase 4|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:27:04.843179|2017-10-10 22:27:04.843179
NCT02689427|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-09|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Phase IIB Neoadjuvant Enzalutamide (ZT) Plus Taxol for Androgen Receptor (AR)-Positive Triple-Negative Breast Cancer (AR+ TNBC)|A Phase IIB Study of Neoadjuvant Enzalutamide (ZT) Regimen Therapy in Combination With Weekly Paclitaxel for Androgen Receptor (AR)-Positive Triple-Negative Breast Cancer|Recruiting||Phase 2|37|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:27:04.94856|2017-10-10 22:27:04.94856
NCT02689414|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-18|||January 2016||2016-01-01|February 2016|2016-02-01||||August 2018|Anticipated|2018-08-01||Interventional|||A Study of Remote Ischaemic Preconditioning in Patients With Atherosclerosis Undergoing Vascular Surgery||Recruiting||N/A|180|Anticipated|Tartu University Hospital||2|||f||||||||||||||2017-10-10 22:27:05.084448|2017-10-10 22:27:05.084448
NCT02689401|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer|MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer|Withdrawn||Phase 1|0|Actual|Dana-Farber Cancer Institute||1||Awaiting additional safety data|f||||t||||||||No||2017-10-10 22:27:05.248424|2017-10-10 22:27:05.248424
NCT02689388|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-07-13|||August 28, 2016|Actual|2016-08-28|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|RASAPOD||Evaluating the Addition of Regional Analgesia to Reduce Postoperative Delirium in Patients Having Hip Fracture Surgery.|The Use of Post-operative Regional Analgesia Rather Than Systemic Analgesia to Decrease the Incidence of Post-operative Delirium After Acute Hip Fracture Surgery? A Prospective Randomized-controlled Double-blinded Pilot Study.|Recruiting||N/A|50|Anticipated|Auckland City Hospital||2|||f||||t|f|f||||||||2017-10-10 22:27:05.334813|2017-10-10 22:27:05.334813
NCT02689375|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-02-18|||February 2015||2015-02-01|February 2016|2016-02-01||||August 2020|Anticipated|2020-08-01||Interventional|Maiden Back||A Prospective, Open Label, Pilot Study of Patient OutcoMes Following Successful TriAl of High Frequency SpInal CorD Stimulation at 10kHz (HF10™) Leading to Permanent Implant Compared to Trial Failure and Standard CarE for the TreatmeNt of Persistent Low BACK Pain of Neuropathic Origin|Rospective, Open Label, Pilot Study of Patient OutcoMes Following Successful TriAl of High Frequency SpInal CorD Stimulation at 10kHz (HF10™) Leading to Permanent Implant Compared to Trial Failure and Standard CarE for the TreatmeNt of Persistent Low BACK Pain of Neuropathic Origin|Recruiting||N/A|25|Anticipated|The Leeds Teaching Hospitals NHS Trust||1|||f||||f||||||||||2017-10-10 22:27:05.436714|2017-10-10 22:27:05.436714
NCT02687750|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-16|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Testing of Radiofrequency Coil for Clinical 19F MRI||Completed||N/A|4|Actual|Western University, Canada||1|||f||||||||||||||2017-10-10 22:27:23.210903|2017-10-10 22:27:23.210903
NCT02689362|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-19|||August 8, 2017|Actual|2017-08-08|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EVOLUTION||Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)|A Multicenter, Randomized, Double-Blind, Double-Dummy, Active Controlled Clinical Trial for the Validation of Optimum Dose and Preliminary Evaluation of Efficacy and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 2|144|Anticipated|Eurofarma Laboratorios S.A.||4|||f||||t|f|f||||||||2017-10-10 22:27:05.513584|2017-10-10 22:27:05.513584
NCT02689349|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-10-02|||August 2010||2010-08-01|September 2015|2015-09-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Esteem New Subject Enrollment Post Approval Study|Esteem Totally Implantable Hearing System New Subject Enrollment Post Approval Study|Recruiting||N/A|120|Anticipated|Envoy Medical Corporation||1|||f||||f||||||||||2017-10-10 22:27:05.640592|2017-10-10 22:27:05.640592
NCT02689336|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-02-08|||August 6, 2016|Actual|2016-08-06|February 2017|2017-02-01|May 31, 2020|Anticipated|2020-05-31|November 30, 2019|Anticipated|2019-11-30||Interventional|||Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors|Phase 2 Clinical Trial Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With the Genomically-Targeted Agent Erlotinib in Combination With Temozolomide|Recruiting||Phase 2|30|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||No||2017-10-10 22:27:05.764124|2017-10-10 22:27:05.764124
NCT02689323|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-06-19|||March 2016||2016-03-01|April 2017|2017-04-01|November 4, 2016|Actual|2016-11-04|November 4, 2016|Actual|2016-11-04||Interventional|TMS_INS||TMS Modulation of Insula-related Brain Networks|TMS Modulation of Insula-related Brain Networks|Completed||N/A|12|Actual|Duke University||1|||f||||f||||||||No||2017-10-10 22:27:05.878727|2017-10-10 22:27:05.878727
NCT02689310|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-03-21|||March 2016||2016-03-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers|Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers|Recruiting||Phase 4|58|Anticipated|New York City Health and Hospitals Corporation||4|||f||||f||||||||Undecided||2017-10-10 22:27:06.713945|2017-10-10 22:27:06.713945
NCT02689297|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-18|||September 2013||2013-09-01|February 2016|2016-02-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Three Different Oral Hygiene Regimes on Three Volatile Sulfur Compounds||Completed||Phase 4|30|Actual|Tokyo Medical and Dental University||2|||f||||||||||||||2017-10-10 22:27:06.835376|2017-10-10 22:27:06.835376
NCT02689284|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-07-25|||January 2016||2016-01-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer|A Phase 1b/2, Open Label, Dose Escalation Study of Margetuximab in Combination With Pembrolizumab in Patients With Relapsed/Refractory Advanced HER2+ Gastroesophageal Junction or Gastric Cancer|Recruiting||Phase 1/Phase 2|72|Anticipated|MacroGenics||2|||f||||f||||||||||2017-10-10 22:27:06.90779|2017-10-10 22:27:06.90779
NCT02689271|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-10-25|||April 2016||2016-04-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|INNOVATE||CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr|CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr|Recruiting||N/A|365|Anticipated|University College, London|||1||f||||t||||||Samples With DNA|"     Blood and urine samples   "|No||2017-10-10 22:27:07.241837|2017-10-10 22:27:07.241837
NCT02689258|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-26|||February 23, 2016|Actual|2016-02-23|September 2017|2017-09-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery|A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery|Completed||Phase 2|277|Actual|Heron Therapeutics||9|||f||||||||||||||2017-10-10 22:27:07.337295|2017-10-10 22:27:07.337295
NCT02689245|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2017-06-08|||February 26, 2016|Actual|2016-02-26|September 2016|2016-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.|Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.|Recruiting||N/A|130|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 22:27:07.472159|2017-10-10 22:27:07.472159
NCT02689232|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2017-06-08|||February 2016||2016-02-01|September 2016|2016-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed.|TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed: An Open Label Randomized Controlled Trial.|Recruiting||N/A|130|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||Undecided||2017-10-10 22:27:07.568295|2017-10-10 22:27:07.568295
NCT02689219|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-09-28|||March 9, 2016|Actual|2016-03-09|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors|A Multicenter Phase II Study of Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors|Recruiting||Phase 2|58|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 22:27:07.671699|2017-10-10 22:27:07.671699
NCT02689193|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-09-13|||September 2014||2014-09-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|IDIS||IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres|IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres|Recruiting||N/A|2500|Anticipated|Institute of Tropical Medicine, Belgium|||4||f||||f||||||Samples Without DNA|"     Whole blood, plasma, serum and urine.   "|||2017-10-10 22:27:08.042985|2017-10-10 22:27:08.042985
NCT02689180|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-02-22|||May 2015||2015-05-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|ReBIC-1||Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients|Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients With Left Ventricular Dysfunction - the Brazilian Research Network on Heart Failure|Recruiting||Phase 3|230|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||Undecided||2017-10-10 22:27:08.144639|2017-10-10 22:27:08.144639
NCT02689167|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-28|||February 2016||2016-02-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|SURF||Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma|Open Label, Randomised Multi-centre Phase II Study to Assess the Efficacy and Tolerability of Sunitinib by Dose Administration Regimen (Dose Modification or Dose Interruptions) in Patients With Advanced or Metastatic Renal Cell Carcinoma|Recruiting||Phase 2|248|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-10 22:27:08.255508|2017-10-10 22:27:08.255508
NCT02689154|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-14|||June 2016||2016-06-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||W8Loss2Go: mHealth Weight Management Strategy|W8Loss2Go: Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Pediatric Patients Referred to a Tertiary Care Center Weight Management Clinic|Completed||N/A|18|Actual|Children's Hospital Los Angeles||1|||f||||f||||||||||2017-10-10 22:27:08.343096|2017-10-10 22:27:08.343096
NCT02689141|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-05-11|||January 2016||2016-01-01|September 2016|2016-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)|Prospective, Open-label, Multicentre Phase-II Trial to Evaluate Efficacy and Safety of a Sequential Regimen of Bendamustine Followed by Ofatumumab and Ibrutinib Followed by Ibrutinib and Ofatumumab Maintenance in CLL Patients|Active, not recruiting||Phase 2|66|Actual|German CLL Study Group||1|||f||||f||||||||No||2017-10-10 22:27:08.429378|2017-10-10 22:27:08.429378
NCT02689128|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-22|||January 2016||2016-01-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Postoperative Nausea and Vomiting: to Estimate the Incidence and Risk Factors in a Tertiary Teaching Hospital|Postoperative Nausea and Vomiting: A Prospective Observational Study to Estimate the Incidence and Risk Factors Over One Year in a Tertiary Teaching Hospital|Recruiting||N/A|6000|Anticipated|University of Jordan|||1||f||||f||||||||No||2017-10-10 22:27:08.524189|2017-10-10 22:27:08.524189
NCT02689115|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-18|||November 2013||2013-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|June 2014|Actual|2014-06-01||Observational|NUIRA||NFKB1 and IKK Epsilon in Rheumatoid Arthritis|NF-KB1/IKK Epsilon Genetic Expression in Patients With Rheumatoid Arthritis|Completed||N/A|60|Actual|Asociación Científica Latina A.C.|||2||f||||f||||||||Undecided||2017-10-10 22:27:08.608181|2017-10-10 22:27:08.608181
NCT02689102|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-19|||October 28, 2015|Actual|2015-10-28|September 2017|2017-09-01|April 22, 2017|Actual|2017-04-22|April 22, 2017|Actual|2017-04-22||Observational|||Confocal Laser Endomicroscopy and Optical Coherence Tomography for Diagnosing ILD.|Confocal Laser Endomicroscopy and OCT for Diagnosing ILD, a Comparison With Imaging and Pathology.|Completed||N/A|20|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-10 22:27:08.690596|2017-10-10 22:27:08.690596
NCT02689089|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-07-05|||April 2016||2016-04-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Taima TB: 3HP Study|Acceptability and Completion Rates of a New 12 Dose Treatment (3 Month) Compared to the Standard Treatment for Latent TB Infection Treatment|Recruiting||Phase 4|450|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-10 22:27:08.77601|2017-10-10 22:27:08.77601
NCT02689076|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-06-13|||March 14, 2016|Actual|2016-03-14|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization|Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization|Recruiting||N/A|975|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:27:08.863954|2017-10-10 22:27:08.863954
NCT02689063|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-19|||October 26, 2016|Actual|2016-10-26|February 2016|2016-02-01|September 15, 2017|Actual|2017-09-15|June 30, 2017|Actual|2017-06-30||Interventional|||Maxigesic IV Phase 3 Bunionectomy Study|Maxigesic IV Bunionectomy Study- A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group and Placebo-Controlled Study|Completed||Phase 3|276|Actual|AFT Pharmaceuticals, Ltd.||4|||f||||f||||||||||2017-10-10 22:27:09.009973|2017-10-10 22:27:09.009973
NCT02689050|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-19|||January 13, 2016|Actual|2016-01-13|September 2017|2017-09-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Observational|||Optical Biopsy for Thoracic Lymph Nodes.|Needle Based CLE in Thoracic Lymph Nodes, a Comparison With Pathology.|Completed||N/A|40|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-10 22:27:09.175318|2017-10-10 22:27:09.175318
NCT02689037|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-04-04|||April 2016||2016-04-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis|Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis: Study Protocol of a Randomized Controlled Trial|Not yet recruiting||Phase 3|394|Anticipated|The 476th Hospital of People's Liberation Army||2|||f||||t||||||||Undecided||2017-10-10 22:27:09.254897|2017-10-10 22:27:09.254897
NCT02689024|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-11-23|||May 2016||2016-05-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|DEPTHip||Delirium in Elderly Patients With Trauma of the Hip|A Multicenter Randomized Controlled Trial in Elderly Patients With Hip Fractures Comparing Continuous Fascia Iliaca Compartment Block to Systemic Opioids and Its Effect on Delirium Occurrence|Recruiting||Phase 4|340|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||Yes|After an embargo period data can be shared, depending on research question, objectives, statistics and methodology.|2017-10-10 22:27:09.342606|2017-10-10 22:27:09.342606
NCT02689011|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-02-25|||January 2014||2014-01-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|UriKANE||Incidence of Urinary Retention in Patients Undergoing Unilateral Total Knee Arthroplasty- Comparison Between Continuous Epidural Analgesia and Single Shot Femoral Nerve Block- a Randomized Controlled Study (UriKANE)|Incidence of Urinary Retention in Patients Undergoing Unilateral Total Knee Arthroplasty- Comparison Between Continuous Epidural Analgesia and Single Shot Femoral Nerve Block- a Randomized Controlled Study (UriKANE)|Completed||N/A|60|Actual|Aga Khan University||2|||f||||t||||||||Yes||2017-10-10 22:27:09.529388|2017-10-10 22:27:09.529388
NCT02688998|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-09-15|||April 2016||2016-04-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|OTT 15-07||REaCT-vascular Access Her2 Negative Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without Trastuzumab|Simple, Prospective and Randomized Trial to Obtain Answers to Questions of Standard of Care: Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without Trastuzumab: A Study From the REthinking Clinical Trials Program (REaCT-vascular Access Her2 Negative).|Recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 22:27:09.626483|2017-10-10 22:27:09.626483
NCT02688985|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-09-25|||April 30, 2016|Actual|2016-04-30|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)|An Open-Label, Multicenter, Biomarker Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Patients With Relapsing Multiple Sclerosis or Primary Progressive Multiple Sclerosis|Recruiting||Phase 3|104|Anticipated|Genentech, Inc.||5|||f||||||||||||||2017-10-10 22:27:09.736404|2017-10-10 22:27:09.736404
NCT02688972|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-22|||July 2015||2015-07-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||The Accumulative Effect of Cold Water Immersion in Football Athletes||Completed||N/A|27|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||t||||||||||2017-10-10 22:27:09.887408|2017-10-10 22:27:09.887408
NCT02688959|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-10-26|||February 2016||2016-02-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)|A Feasibility/Pilot Trial of a Motor Attention Training Intervention for College Students With ADHD|Recruiting||N/A|125|Anticipated|University of Wisconsin, Madison||3|||f||||f||||||||||2017-10-10 22:27:09.97729|2017-10-10 22:27:09.97729
NCT02688946|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-22|||May 2014||2014-05-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|IMAGES||Imaging Microcirculation and Gross Hemodynamics in Elective Colorectal Surgery|Imaging Microcirculation And Gross Hemodynamic Assessment of the Bowel During Elective Colorectal Surgery|Recruiting||N/A|70|Anticipated|St. Antonius Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:27:10.087254|2017-10-10 22:27:10.087254
NCT02688933|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-06-21|||May 5, 2016|Actual|2016-05-05|June 2017|2017-06-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus|Randomized, Active-controlled, Parallel Group, 16-Week Open Label Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo (Insulin Glargine-U300) Versus Lantus in Patients With Type 1 Diabetes Mellitus|Completed||Phase 4|638|Actual|Sanofi||2|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 22:27:10.170079|2017-10-10 22:27:10.170079
NCT02688920|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-09-16|||March 2016||2016-03-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Intraluminal Imaging of Duodenal Layer Morphometry in Patients With and Without Type 2 Diabetes|A Single-center, Observational, Intraluminal Imaging Study of Duodenal Layer Morphometry in Patients With and Without Type 2 Diabetes Undergoing Endoscopy of the Upper Gastrointestinal Tract|Enrolling by invitation||N/A|30|Anticipated|Mayo Clinic|||2||f||||f||||||||||2017-10-10 22:27:10.559863|2017-10-10 22:27:10.559863
NCT02688907|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-22|||April 2016||2016-04-01|February 2016|2016-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation|Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation|Not yet recruiting||Phase 2|28|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:27:10.664101|2017-10-10 22:27:10.664101
NCT02688894|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-18|||March 2016||2016-03-01|February 2016|2016-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]|The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]|Not yet recruiting||N/A|392|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:27:10.761401|2017-10-10 22:27:10.761401
NCT02688881|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-04-25|||February 5, 2017|Actual|2017-02-05|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors|Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors|Recruiting||Phase 4|25|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||t|||||2017-10-10 22:27:10.840596|2017-10-10 22:27:10.840596
NCT02688868|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-18|||January 2015||2015-01-01|January 2015|2015-01-01|December 2020|Anticipated|2020-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )|The Safety and Effectiveness Evaluation of New Specifications (2.25mm) of FirehawkTM Sirolimus Target-eluting Coronary Stent System in the Treatment of Coronary Heart Disease: a Prospective, Multicenter, Single-group Study.|Recruiting||N/A|38|Anticipated|Shanghai MicroPort Medical (Group) Co., Ltd.||1|||f||||t||||||||No||2017-10-10 22:27:10.952027|2017-10-10 22:27:10.952027
NCT02688855|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-02-06|||January 23, 2017|Actual|2017-01-23|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures|Prospective, Randomized, Double-Blinded, Controlled Multi-Center Clinical Trial Evaluating the Use of Non-Invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures|Recruiting||N/A|217|Anticipated|Encore Medical, L.P.||2|||f||||f|f|t|f|f||||Undecided||2017-10-10 22:27:11.05754|2017-10-10 22:27:11.05754
NCT02687737|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-01-04|||May 2016||2016-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Tongue Motor Recruitment During Exercise|Genioglossus Motor Recruitment During Swallowing and Expiratory Loading Exercises|Completed||N/A|30|Actual|University of Florida||1|||f||||t||||||||Undecided||2017-10-10 22:27:23.266164|2017-10-10 22:27:23.266164
NCT02688842|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-07-31|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2016|Actual|2016-01-01||Interventional|Firehawk_38||Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease|The Safety and Effectiveness Evaluation of New Specifications (38mm) of FirehawkTM Sirolimus Target-eluting Coronary Stent System in the Treatment of Coronary Heart Disease: a Prospective, Multicenter, Single-group Study.|Active, not recruiting||N/A|38|Actual|Shanghai MicroPort Medical (Group) Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:27:11.17905|2017-10-10 22:27:11.17905
NCT02688829|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-18|||December 2009||2009-12-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2010|Actual|2010-01-01||Interventional|||The First-In-Man Pilot Study of Firehawk|The Initial Small-Scale Clinical Study of Rapamycin-Eluting Coronary Stent System of Microport (Firehawk)|Completed||N/A|21|Actual|Shanghai MicroPort Medical (Group) Co., Ltd.||1|||f||||t||||||||No||2017-10-10 22:27:11.27493|2017-10-10 22:27:11.27493
NCT02688816|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-17|||August 2014||2014-08-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Comparison of Cervical Cancer Screening Tests in HIV-infected Women in Lusaka, Zambia|Z 1313 - Comparison of Point-of-care Molecular Tests and Visual Inspection With Acetic Acid for Cervical Cancer Screening in HIV-infected Women in Lusaka, Zambia|Completed||N/A|200|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||No||2017-10-10 22:27:11.365487|2017-10-10 22:27:11.365487
NCT02688803|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-09-15|||August 2016||2016-08-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|OTT15-04||Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)|Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC) OTT 15-04|Recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute||3|||f||||f||||||||Undecided||2017-10-10 22:27:11.472312|2017-10-10 22:27:11.472312
NCT02688790|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-07-03|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection|Pharmacokinetics of a Single-Dose of Dalbavancin in Preterm Neonates to Infants Ages 3 Months With Suspected or Confirmed Bacterial Infection|Recruiting||Phase 1|12|Anticipated|Durata Therapeutics Inc., an affiliate of Allergan plc||3|||f||||f|t|f||||||||2017-10-10 22:27:11.593559|2017-10-10 22:27:11.593559
NCT02688777|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-07-12|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|May 31, 2020|Anticipated|2020-05-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||A Novel Strategy to Decrease Fall Incidence Post-Stroke|A Novel Strategy to Decrease Fall Incidence Post-Stroke|Recruiting||Phase 1/Phase 2|128|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:27:11.720795|2017-10-10 22:27:11.720795
NCT02688764|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-27|||June 2016||2016-06-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia|An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre, Phase 3 Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent CKD Patients With Hyperphosphataemia|Recruiting||Phase 3|130|Anticipated|Vifor Fresenius Medical Care Renal Pharma||2|||f||||t||||||||||2017-10-10 22:27:11.860529|2017-10-10 22:27:11.860529
NCT02688751|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-10-07|||February 2016||2016-02-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Contrast Enhanced Ultrasound, Endoleak Detection Following EVAR v1.3|Contrast Enhanced Ultrasound Endoleak Detection Compared To Time-Resolved Computer Tomography Angiography in High Risk Endovascular Aneurysm Repair (EVAR) Surveillance Patients.|Recruiting||N/A|74|Anticipated|Royal Liverpool and Broadgreen University Hospitals NHS Trust|||1||f||||f||||||||No||2017-10-10 22:27:12.156763|2017-10-10 22:27:12.156763
NCT02688738|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-17|||March 2015||2015-03-01|February 2016|2016-02-01||||December 2016|Anticipated|2016-12-01||Interventional|||Does Preoperative Administration of Oral Doxycycline Decrease the Colonization Rate of Propionibacterium Acnes in the Dermis of the Shoulder?|Does Preoperative Administration of Oral Doxycycline Decrease the Colonization Rate of Propionibacterium Acnes in the Dermis of the Shoulder?|Enrolling by invitation||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-10 22:27:12.271249|2017-10-10 22:27:12.271249
NCT02688725|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-04-03|||December 2014||2014-12-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients|Post-Mastectomy Surveillance to Detect Locally Recurrent Breast Cancer|Recruiting||N/A|100|Anticipated|Providence Health & Services||1|||f||||t||||||||No||2017-10-10 22:27:12.342488|2017-10-10 22:27:12.342488
NCT02688712|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-19|||June 2016||2016-06-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Interventional|||ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer|Phase II Study of TGFβ Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma|Recruiting||Phase 2|50|Anticipated|Providence Health & Services||1|||f||||f||||||||No||2017-10-10 22:27:12.439763|2017-10-10 22:27:12.439763
NCT02688699|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-05-01|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract|Italian Multicenter Prospective Randomized Trial to Compare Additive Hemostatic Efficacy of EndoClot System to Prevent Bleeding After Endoscopic Mucosal Resection or Endoscopic Submucosal Dissection of Lesions in the Gastrointestinal Tract|Not yet recruiting||Phase 4|288|Anticipated|University of Turin, Italy||2|||f|||||f|f||||||||2017-10-10 22:27:12.567016|2017-10-10 22:27:12.567016
NCT02688686|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-18|||February 2016||2016-02-01|February 2016|2016-02-01||||February 2018|Anticipated|2018-02-01||Interventional|||Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases|Safety and Efficacy of DC Vaccine Combined With Cytokine-induced Killer Cells in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases: a Phase I/II Study|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||Undecided||2017-10-10 22:27:12.646038|2017-10-10 22:27:12.646038
NCT02688673|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-18|||August 2014||2014-08-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||DC Vaccine Combined With CIK Cells in Patients With SCLC|Safety and Therapeutic Efficacy of DC Vaccine Combined With Cytokine-induced Killer Cells in Patients With Extensive-Stage Small- Cell Lung Cancer: a Phase I/II Study|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-10 22:27:12.726911|2017-10-10 22:27:12.726911
NCT02688647|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-09-23|||March 2016||2016-03-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Idiopathic Pulmonary Fibrosis|A Randomized, Phase 2, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Recruiting||Phase 2|36|Anticipated|Kadmon Corporation, LLC||2|||f||||f||||||||No||2017-10-10 22:27:12.961054|2017-10-10 22:27:12.961054
NCT02688634|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-12-14|||April 2016||2016-04-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|Cleft Palate||The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair|The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency Repair|Recruiting||Phase 4|100|Anticipated|University of Florida|||2||f||||f||||||||No||2017-10-10 22:27:13.091965|2017-10-10 22:27:13.091965
NCT02688621|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-10-24|||December 2015||2015-12-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|iREACH3||Internet Assisted Obesity Treatment Enhanced With Financial Incentives|Internet Assisted Obesity Treatment Enhanced With Financial Incentives|Recruiting||N/A|416|Anticipated|University of Vermont||2|||f||||f||||||||No||2017-10-10 22:27:13.193603|2017-10-10 22:27:13.193603
NCT02688608|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer|Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/ Undifferentiated Thyroid Cancer|Recruiting||Phase 2|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 22:27:13.303648|2017-10-10 22:27:13.303648
NCT02688595|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-03-13|||March 2016||2016-03-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Central Venous Catheterization Techniques in Neonates|Randomized Controlled Trial on Central Venous Catheterization Techniques in Neonates: Seldinger Versus Modified Seldinger|Recruiting||N/A|120|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:27:13.39459|2017-10-10 22:27:13.39459
NCT02688582|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-02-25|||March 2016||2016-03-01|February 2016|2016-02-01||||March 2017|Anticipated|2017-03-01||Interventional|||Target-controlled Infusion Model for Cefepime|A Study to Evaluate the Predictive Performance of a Target-controlled Infusion Model for the Administration of Cefepime to Intensive Care Patients|Not yet recruiting||N/A|20|Anticipated|Onze Lieve Vrouw Hospital||1|||f||||||||||||||2017-10-10 22:27:13.487839|2017-10-10 22:27:13.487839
NCT02688569|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SPIN-CWP||Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study|Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study|Not yet recruiting||N/A|20|Anticipated|University of Missouri-Columbia||2|||f||||t||||||||No||2017-10-10 22:27:13.569079|2017-10-10 22:27:13.569079
NCT02688556|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2017-02-15|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|Emerald||Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca|A Randomized, Multicenter, Double-Masked, Vehicle-Controlled Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca|Completed||Phase 3|745|Actual|Ocular Technologies SARL||2|||f||||f||||||||Undecided||2017-10-10 22:27:13.684814|2017-10-10 22:27:13.684814
NCT02688543|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-22|||March 2013||2013-03-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|March 2014|Actual|2014-03-01||Interventional|||Radiofrequency Ablation of Genicular Nerves for Advanced Osteoarthrosis of the Knee Joint 1 Year Follow-up.|Analgesic Effect and Functional Improvement Caused by Radiofrequency Ablation of Genicular Nerves in Patients With Advanced Osteoarthrosis of the Knee Joint Until 1 Year Following Treatment|Completed||N/A|25|Actual|Hospital General de Jerez de la Frontera||1|||f||||f||||||||No||2017-10-10 22:27:13.789938|2017-10-10 22:27:13.789938
NCT02688530|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-04-27|||May 2016||2016-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|SCB and IV Dex||Intravenous Dexamethasone for Prolongation of Analgesia Following Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy: A Randomized, Controlled, Phase IV Dose-Response Study|Intravenous Dexamethasone for Prolongation of Analgesia Following Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy: A Randomized, Controlled, Phase IV Dose-Response Study|Recruiting||Phase 4|140|Anticipated|Hospital for Special Surgery, New York||4|||f||||||||||||||2017-10-10 22:27:13.875065|2017-10-10 22:27:13.875065
NCT02688517|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-21|||February 2013||2013-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer|Targeted Genomic Analysis of Human Cancers|Recruiting||N/A|1100|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 22:27:13.980842|2017-10-10 22:27:13.980842
NCT02688504|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-12-23|||October 2016||2016-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|CESIR-U2||Health and Road Safety: Influence of Drugs Use and Health Status|CESIR-U2 : Influence of Drugs Use and Health Status|Recruiting||N/A|1200|Anticipated|University Hospital, Bordeaux|||2||f||||f||||||||||2017-10-10 22:27:14.100514|2017-10-10 22:27:14.100514
NCT02688491|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-02-24|||July 2016||2016-07-01|February 2016|2016-02-01|July 2026|Anticipated|2026-07-01|July 2026|Anticipated|2026-07-01||Interventional|||A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment|A Multi-site, Open, Perspective Study of Prognostic Value and Benefit From Adjuvant Targeted Therapy of Stage III Clear Cell Renal Cell Carcinoma Based on a CpG-methylation-based Assay|Not yet recruiting||N/A|300|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||Undecided||2017-10-10 22:27:14.200438|2017-10-10 22:27:14.200438
NCT02688465|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-07-26|||September 5, 2016|Actual|2016-09-05|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|September 2019|Anticipated|2019-09-01||Interventional|POMPRENELLE||Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).|Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).|Recruiting||Phase 4|15|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||f||||||||||2017-10-10 22:27:14.441265|2017-10-10 22:27:14.441265
NCT02688452|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-07-12|||December 2012||2012-12-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|December 2015|Actual|2015-12-01||Interventional|||Water Oxygenation and Brain Activity|Water Oxygenation and Brain Activity: A Magnetoencephalographic (MEG) Pilot Study|Completed||N/A|40|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:27:14.688065|2017-10-10 22:27:14.688065
NCT02688439|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-08-24|||March 2015||2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Ultrasound Guided Sciatic Nerve Block|Effect of Leg Positioning and Tourniquet Inflation on Onset and Duration of Ultrasound Guided Sciatic Nerve Block After Injection of Local Anesthetic|Recruiting||N/A|81|Anticipated|New York University School of Medicine||3|||f||||f||||||||||2017-10-10 22:27:14.836602|2017-10-10 22:27:14.836602
NCT02688426|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2016-03-21|||March 2015||2015-03-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Effects of the Low-level Laser Therapy on Functional Capacity of the Patients With Coronary Artery Bypass Surgery|Effects Acute of the Low-level Laser Therapy on Functional Capacity on Patients With Coronary Artery Bypass Surgery : A Randomized, Controlled Clinical Trail|Recruiting||N/A|15|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||f||||||||No||2017-10-10 22:27:14.995608|2017-10-10 22:27:14.995608
NCT02688387|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-08-08|||March 18, 2016|Actual|2016-03-18|August 2017|2017-08-01|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|||A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects|A Phase 1 Study to Demonstrate the Relative Bioavailability of Fixed Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects|Completed||Phase 1|106|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:27:15.656187|2017-10-10 22:27:15.656187
NCT02688374|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-01-16|||February 2016||2016-02-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers|A Single-Dose, Open-Label, Three-way Crossover Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Chinese Male Healthy Adult Smokers|Completed||Phase 1|45|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-10-10 22:27:15.851365|2017-10-10 22:27:15.851365
NCT02688361|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-06-28|||February 1, 2016|Actual|2016-02-01|June 2017|2017-06-01|April 13, 2016|Actual|2016-04-13|March 1, 2016|Actual|2016-03-01||Interventional|||A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution|A Randomized, Open-Label, Two-Period, Crossover Bioequivalence Study in Healthy Adult Subjects After Single Oral Dosing of a NCH-GSK Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil® Acetylcysteine 2% Oral Solution|Completed||Phase 1|46|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 22:27:16.000435|2017-10-10 22:27:16.000435
NCT02688348|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-24|||April 22, 2015|Actual|2015-04-22|August 2017|2017-08-01|April 22, 2021|Anticipated|2021-04-22|April 22, 2020|Anticipated|2020-04-22||Interventional|||Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer|Prospective Study of Bladder-Preservation Chemo-Radiotherapy (Partial Bladder Hypo-fractionated Radiotherapy) for Patients With Muscle-Invasive Bladder Cancer|Recruiting||N/A|50|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 22:27:16.134594|2017-10-10 22:27:16.134594
NCT02688335|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-09-05|||June 2018|Anticipated|2018-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|Cloud9||Home-Use Impact and Effectiveness of Cloud 9|Home-Use Impact and Effectiveness of Cloud 9|Suspended||N/A|100|Anticipated|Johns Hopkins University||1||Lack of funding.|f||||f|f|t|f|f|t|||||2017-10-10 22:27:16.250001|2017-10-10 22:27:16.250001
NCT02688322|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-19|||September 2014||2014-09-01|January 2015|2015-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections|Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections|Completed||Phase 4|18|Actual|Prince of Songkla University||1|||f||||f||||||||||2017-10-10 22:27:16.344388|2017-10-10 22:27:16.344388
NCT02688309|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-08-21|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|P3F2||Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases|Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases|Recruiting||N/A|120|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 22:27:16.440863|2017-10-10 22:27:16.440863
NCT02688296|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-05-01|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Fibulock||Effectiveness Of The Fibulock Intramedullary Nail|The Use Of A Fibular Intramedullary Nail For Fixation For Unstable Fibula Fractures|Recruiting||N/A|40|Anticipated|Sonoma Orthopedic Products, Inc.|||3||f||||f||||||||No||2017-10-10 22:27:16.555249|2017-10-10 22:27:16.555249
NCT02688283|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-17|||November 2015||2015-11-01|February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Interventional|||The Effect on Glycemic Responses and Subjective Ratings of Satiety of a Snack With or Without Ingredients to Slow Carbohydrate Digestion|Randomized, Controlled, Cross-over Study Comparing The Effect on Glycemic Responses and Subjective Ratings of Satiety of a Snack With or Without Ingredients to Slow Carbohydrate Digestion|Completed||N/A|20|Actual|PepsiCo Global R&D||3|||f||||f||||||||No||2017-10-10 22:27:16.651507|2017-10-10 22:27:16.651507
NCT02688270|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-02-21|||June 2016||2016-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon|A Double-blinded Crossover Study of Topical Formulation of Nitroglycerine, Vascana®, Versus Matching Vehicle in the Subjective and Physiologic Responses to Controlled Cold Challenge in Subjects With Raynaud's Phenomenon (RP) Secondary to Connective Tissue Disease|Completed||Phase 2|65|Actual|Covis Pharma S.à.r.l.||2|||f||||f||||||||No||2017-10-10 22:27:16.726473|2017-10-10 22:27:16.726473
NCT02688257|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-14|||September 2010|Actual|2010-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Assessing Treatment Response in Breast Cancer With Functional Imaging|Assessing Treatment Response of Breast Cancer Using Multimodal Functional Imaging|Active, not recruiting||N/A|53|Actual|Institute of Cancer Research, United Kingdom|||1||f||||f||||||||||2017-10-10 22:27:16.817766|2017-10-10 22:27:16.817766
NCT02688244|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-02-17|||November 2015||2015-11-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|ISAAC||Irrigation Versus Suction in Complicated Acute Appendicitis|Randomized Trial Comparing Irrigation Versus Suction in Laparoscopic Appendectomy for Complicated Acute Appendicitis in Adults|Recruiting||N/A|210|Anticipated|Hospital Universitario Virgen de la Arrixaca||2|||f||||t||||||||Undecided||2017-10-10 22:27:16.898718|2017-10-10 22:27:16.898718
NCT02688231|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-11|||January 2016||2016-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Task-oriented Upper Limb Training in MS|Intensity Dependent Clinical Effects of a Task-oriented Upper Limb Training in Multiple Sclerosis|Recruiting||Phase 2|45|Anticipated|Hasselt University||3|||f||||f||||||||||2017-10-10 22:27:17.062136|2017-10-10 22:27:17.062136
NCT02688218|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-18|||February 2016||2016-02-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Exercise Detection Study|Testing and Tuning a Multiparameter Exercise Detection Algorithm|Active, not recruiting||N/A|40|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 22:27:17.255565|2017-10-10 22:27:17.255565
NCT02688205|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-02-22|||March 2014||2014-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|||Correlation Between Cyriax's Functional Examination and Ultrasound Examination in Patients With Shoulder Pain|Correlation Between Cyriax's Functional Examination and Ultrasound Examination in Patients With Shoulder Pain|Completed||N/A|206|Actual|Shin Kong Wu Ho-Su Memorial Hospital|||2||f||||t||||||||Undecided||2017-10-10 22:27:17.40727|2017-10-10 22:27:17.40727
NCT02688192|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-09-21|||January 2, 2014|Actual|2014-01-02|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|TLC FIT||Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors|TLC FIT: A Novel Mobile Health Fitness Program for Adolescent and Young Adult (AYA) Childhood Cancer Survivors|Recruiting||N/A|108|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 22:27:17.524283|2017-10-10 22:27:17.524283
NCT02688179|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-08|||January 2016||2016-01-01|May 2017|2017-05-01||||September 2017|Anticipated|2017-09-01||Observational|||Neuroinflammation and Postoperative Delirium in Cardiac Surgery||Recruiting||N/A|400|Anticipated|Vanderbilt University Medical Center|||1||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-10 22:27:17.656404|2017-10-10 22:27:17.656404
NCT02688166|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-07|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Observational|||Cardiac MRI Biomarker Testing (GCC 1618)|Cardiac Magnetic Resonance Imaging and Biomarker Testing for Evaluating Cardiac Injury Resulting From Radiation Therapy in Lung and Breast Cancer: A Pilot Study|Not yet recruiting||N/A|10|Anticipated|University of Maryland|||2||f||||t|f|f||||||||2017-10-10 22:27:17.747095|2017-10-10 22:27:17.747095
NCT02688153|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-07-21|||October 2012||2012-10-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CADENCE||EDWARDS INTUITY Valve System CADENCE Study|A Randomized Comparison of the EDWARDS INTUITY Valve System anD commErcially Available Aortic Bioprostheses in Subjects uNdergoing surgiCal Aortic Valve replacEment|Completed||N/A|120|Actual|Edwards Lifesciences||2|||f||||f||||||||||2017-10-10 22:27:17.862299|2017-10-10 22:27:17.862299
NCT02688140|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-08-04|||June 2016||2016-06-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|November 2021|Anticipated|2021-11-01||Interventional|TUD-APOLLO-064||Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia|A Randomized Phase III Study to Compare Arsenic Trioxide (ATO) Combined to ATRA and Idarubicin Versus Standard ATRA and Anthracyclines-based Chemotherapy (AIDA Regimen) for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia|Recruiting||Phase 3|280|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-10 22:27:18.012291|2017-10-10 22:27:18.012291
NCT02688127|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-02-17|||August 2015||2015-08-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy of Tranexamic Acid In Reducing Blood Loss During Cesarean Section Because Of Placenta Previa|Efficacy of Tranexamic Acid In Reducing Blood Loss Among Pregnant Women During Cesarean Section Because Of Placenta Previa|Completed||Phase 1/Phase 2|52|Actual|Medical Research Council||2|||f||||t||||||||Yes||2017-10-10 22:27:18.206715|2017-10-10 22:27:18.206715
NCT02688114|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-06-26|||March 2016||2016-03-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus|Healing of the Esophageal Mucosa After Radiofrequency Ablation of Barrett's Esophagus|Enrolling by invitation||N/A|20|Anticipated|Dallas VA Medical Center||1|||f||||f||||||||No||2017-10-10 22:27:18.342248|2017-10-10 22:27:18.342248
NCT02688101|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-07-18|||February 2016||2016-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors|A Phase 1 Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors|Recruiting||Phase 1|60|Anticipated|Collaborative Medicinal Development Pty Limited||1|||f||||t||||||||||2017-10-10 22:27:18.44228|2017-10-10 22:27:18.44228
NCT02688088|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-31|||February 2016||2016-02-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body|Effects of Multiple Doses of Abemaciclib on the Pharmacokinetics of Cytochrome P450 (CYP) 1A2, CYP2C9, CYP2D6, and CYP3A Substrates (Caffeine, Warfarin, Dextromethorphan, and Midazolam) in Cancer Patients|Recruiting||Phase 1|48|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:27:18.556463|2017-10-10 22:27:18.556463
NCT02688075|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-13|||November 13, 2015|Actual|2015-11-13|April 2017|2017-04-01|September 4, 2017|Anticipated|2017-09-04|September 4, 2017|Anticipated|2017-09-04||Observational|CanCARE||An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada|Prospective, Observational, 12-month Assessment of Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada (CANadian CAnagliflozin REgistry: CanCARE)|Active, not recruiting||N/A|538|Actual|Janssen Inc.|||1||f||||f|f|||||||||2017-10-10 22:27:18.706221|2017-10-10 22:27:18.706221
NCT02688062|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2017-02-07|||January 2016||2016-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI|NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in Patients With Chronic Spinal Cord Injury|Recruiting||Phase 1/Phase 2|22|Anticipated|Chinese Academy of Sciences||2|||f||||f||||||||||2017-10-10 22:27:18.847603|2017-10-10 22:27:18.847603
NCT02688049|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2017-06-01|||January 2016||2016-01-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair|The Efficacy and Safety of NeuroRegen Scaffold™ Combined With Mesenchymal Stem Cells or Neural Stem Cells for Chronic Spinal Cord Injury Repair|Recruiting||Phase 1/Phase 2|30|Anticipated|Chinese Academy of Sciences||2|||f||||f||||||||||2017-10-10 22:27:18.951405|2017-10-10 22:27:18.951405
NCT02688036|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-02-17|||February 2016||2016-02-01|February 2016|2016-02-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|||Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC|Phase III Randomized Study of Hypofractionated vs Conventionally Fractionated Concurrent Chemo-radiotherapy for Limited Disease Small Cell Lung Cancer|Not yet recruiting||Phase 3|860|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||No||2017-10-10 22:27:19.049525|2017-10-10 22:27:19.049525
NCT02688023|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-17|||March 2014||2014-03-01|February 2016|2016-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer|A Pilot Phase II Study of Triplet Chemotherapy Regimen in Neoadjuvant Chemotherapy of Patients With Resectable Colorectal Cancer|Recruiting||Phase 2|50|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 22:27:19.145472|2017-10-10 22:27:19.145472
NCT02688010|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2016-12-15|||January 2016||2016-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of Reduced Noise Levels and Cycled Light on Visual and Neural Development in Preterm Infants|Effect of Reduced Noise Levels and Cycled Light on Visual and Neural Development in Preterm Infants|Recruiting||N/A|154|Anticipated|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 22:27:19.26306|2017-10-10 22:27:19.26306
NCT02687997|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-09-07|||February 2016||2016-02-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|SAILS||Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort|Prevalence of Sleep Apnea in a Lung Cancer Screening Cohort Meeting NLST Criteria|Completed||N/A|282|Actual|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz||2|||f||||f||||||||||2017-10-10 22:27:21.135496|2017-10-10 22:27:21.135496
NCT02687984|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-01-30|||February 2016||2016-02-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia|A Multicenter, Randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of RBP-7000 Using Poly (DL-lactide-co-glycolide) Polymer of Two Different Molecular Weights (Low and High Molecular Weights as Test Treatments) Compared to Intermediate Molecular Weight (Reference Treatment) Polymer in Subjects With Schizophrenia|Completed||Phase 1|44|Actual|Indivior Inc.||3|||f||||f||||||||No||2017-10-10 22:27:21.246195|2017-10-10 22:27:21.246195
NCT02687971|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-25|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨|A Randomized, Open Label, Multicenter Study to Determine the Efficacy and Safety of Combining Thermotherapy and a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨|Recruiting||Phase 2|130|Anticipated|Drugs for Neglected Diseases||2|||f||||t|f|f||||||Undecided||2017-10-10 22:27:21.359122|2017-10-10 22:27:21.359122
NCT02687958|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-02-07|||May 2015||2015-05-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|January 2017|Actual|2017-01-01||Interventional|||Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin|Phase II Randomized Multicenter Study of Everolimus as Maintenance Therapy for Metastatic Neuroendocrine Carcinoma With Pulmonary or Gastroenteropancreatic Origin|Recruiting||Phase 2|30|Anticipated|Gruppo Oncologico Italiano di Ricerca Clinica||2|||f||||t||||||||Undecided||2017-10-10 22:27:21.46622|2017-10-10 22:27:21.46622
NCT02687945|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-14|||May 2015||2015-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||PT vs no PT Following THA|Study to Evaluate Outpatient Physiotherapy in Total Hip Arthroplasty: A Prospective Randomized Controlled Trial|Completed||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-10 22:27:21.579007|2017-10-10 22:27:21.579007
NCT02687932|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-01-11|||March 2016||2016-03-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRIME||Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation|Multicenter, Randomized, Double-blind, Active-controlled Study to Assess the Efficacy of LCZ696 Compared to Valsartan on Reduction of Mitral Regurgitation in Patients With Left Ventricular Dysfunction and Secondary Functional Mitral Regurgitation of Stage B and C|Active, not recruiting||Phase 4|118|Actual|Asan Medical Center||2|||f||||t||||||||No||2017-10-10 22:27:21.642806|2017-10-10 22:27:21.642806
NCT02687906|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-07-12|||July 2016||2016-07-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Dose-finding, Pharmacokinetics, Safety, and Tolerability of Meropenem-Vaborbactam in Pediatric Subjects With Serious Bacterial Infections|An Open Label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of a Single Dose Infusion of Meropenem-Vaborbactam in Pediatric Subjects From Birth to Less Than 18 Years of Age With Serious Bacterial Infections|Recruiting||Phase 1|56|Anticipated|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||1|||f||||t||||||||||2017-10-10 22:27:21.851057|2017-10-10 22:27:21.851057
NCT02687893|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-09-07|||February 2016||2016-02-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Hypoglycemia on Sleep|A Randomized, Three-way, Cross-over Study to Assess the Impact of Nocturnal Hypoglycemia on Sleep in Patients With Type 1 Diabetes|Active, not recruiting||N/A|14|Anticipated|Oregon Health and Science University||3|||f||||f||||||||No||2017-10-10 22:27:21.990242|2017-10-10 22:27:21.990242
NCT02687880|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-18|2017-03-21|||September 30, 2017|Anticipated|2017-09-30|March 2017|2017-03-01|March 2026|Anticipated|2026-03-01|March 2026|Anticipated|2026-03-01||Observational|||Testicular Tissue Cryopreservation for Fertility Preservation in Male Patients Facing Infertility-causing Diseases or Treatment Regimens|Testicular Tissue Cryopreservation for Fertility Preservation in Male Patients Facing Infertility-causing Diseases or Treatment Regimens|Not yet recruiting||N/A|250|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     This study will provide a pool of research tissue that will be used to develop and test     methods for manipulation and cryopreservation of testicular tissue. Progress in these     investigations may open up a range of new fertility preservation techniques to patients that     currently have no options. At the same time, a substantial portion of the patient's tissue     will be cryopreserved and reserved for his own future use.   "|No||2017-10-10 22:27:22.211122|2017-10-10 22:27:22.211122
NCT02687867|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-04|||February 12, 2016|Actual|2016-02-12|April 2017|2017-04-01|March 1, 2016|Actual|2016-03-01|March 1, 2016|Actual|2016-03-01||Observational|DABI-F||Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist|Real-world Comparative Effectiveness of Dabigatran Versus VKA|Completed||N/A|56039|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:27:22.283807|2017-10-10 22:27:22.283807
NCT02687854|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-04-04|||February 12, 2016|Actual|2016-02-12|April 2017|2017-04-01|March 1, 2016|Actual|2016-03-01|March 1, 2016|Actual|2016-03-01||Observational|PIXI-F||Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist|Real-world Comparative Effectiveness of Apixaban Versus VKA|Completed||N/A|18591|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:27:22.381145|2017-10-10 22:27:22.381145
NCT02687841|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-17|||January 2016||2016-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury|A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury - A Open Label Randomized Control Trial|Recruiting||Phase 3|206|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-10 22:27:22.468754|2017-10-10 22:27:22.468754
NCT02687828|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-08-16|||February 18, 2016||2016-02-18|August 2017|2017-08-01|March 30, 2020|Anticipated|2020-03-30|March 30, 2020|Anticipated|2020-03-30||Observational|AMORE||A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients|A Prospective, Mono-Country and Multi-center Study to Observe Safety and Effectiveness of Adalimumab in KoREan Intestinal Behcet's Disease(BD) Patients|Recruiting||N/A|60|Anticipated|AbbVie|||1||f||||||||||||||2017-10-10 22:27:22.583166|2017-10-10 22:27:22.583166
NCT02687815|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-03-29|||February 2016||2016-02-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)|Vitamin D to Prevent Severe Asthma Exacerbations|Recruiting||Phase 2|400|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-10 22:27:22.687604|2017-10-10 22:27:22.687604
NCT02687802|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-03-31|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|EpiSync||Respiratory Mechanics and Patient-ventilator Asynchrony Index in Patients With Invasive Mechanical Ventilation|Respiratory Mechanics and Patient-ventilator Asynchrony Index in Patients With Invasive Mechanical Ventilation|Recruiting||N/A|110|Anticipated|University of Sao Paulo General Hospital|||1||f||||f||||||||No|No individual personal data will be disclosed|2017-10-10 22:27:22.805758|2017-10-10 22:27:22.805758
NCT02687789|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-02-16|||April 2014||2014-04-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis|A Prospective Parallel-design, Double-blind, Randomised, Controlled Investigation to Gain Clinical Experience and Further Knowledge About the Certified Medical Device Vaginal Suppository WO 3191 With Respect to Safety, Tolerability and Efficacy in the Post-Treatment of Bacterial Vaginosis|Completed||N/A|43|Actual|Dr. August Wolff GmbH & Co. KG Arzneimittel||2|||f||||f||||||||No||2017-10-10 22:27:22.9089|2017-10-10 22:27:22.9089
NCT02687776|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-03-24|||February 2016||2016-02-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Observational|||Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major Surgery|Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major Surgery|Recruiting||N/A|500|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||||No||2017-10-10 22:27:23.028771|2017-10-10 22:27:23.028771
NCT02687763|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-03-22|||December 2015||2015-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|ProQuad®||Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant|A Prospective, Multisite Study to Evaluate the Impact of Measles, Mumps, Rubella and Varicella ProQuad® Vaccination in Pediatric Patients 6-24 Months of Age Who Are Being Considered and/or Evaluated for Any Solid Organ Transplant|Recruiting||Phase 1/Phase 2|45|Anticipated|Medical University of South Carolina||1|||f||||f||||||||No||2017-10-10 22:27:23.118895|2017-10-10 22:27:23.118895
NCT02687724|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-04-05|||June 2016||2016-06-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|GOAL-ARC||Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis|GLM Dose Optimisation to Adequate Levels to Achieve Response in Colitis (GOAL-ARC). A Nationwide Multi-centred Randomised Controlled Trial (RCT) Investigating the Use of GLM Dose Adjustment in Ulcerative Colitis (UC).|Recruiting||Phase 4|136|Anticipated|University College Dublin||2|||f||||t||||||||||2017-10-10 22:27:23.365029|2017-10-10 22:27:23.365029
NCT02687698|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of a Lipidic and Proteic Controlled Diet on Parkinson's Disease|Effect of a Lipidic and Proteic Controlled Diet on Resting Energy Expenditure, Body Composition and Symptoms in Patients With Parkinson's Disease|Enrolling by invitation||N/A|36|Anticipated|University of Padova||2|||f||||f||||||||Undecided||2017-10-10 22:27:23.595634|2017-10-10 22:27:23.595634
NCT02687685|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-06-02|||February 2018|Anticipated|2018-02-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|CPPITLH||Clinical Trial of Immediate Skin to Skin Contact at Birth Early vs. Immediate (CPPITLH)|Randomized Clinical Trial of Immediate Skin to Skin Contact (SSC) at Birth, Early vs. Immediate, on the Duration of Exclusive Human Lactation in Full-term Newborns Treated at the Universidad de La Sabana Clinic|Not yet recruiting||N/A|300|Anticipated|Universidad de la Sabana||2|||f||||t|f|f||||||Yes|the committee required each month informations about adverse events and informs of recruitment each six months|2017-10-10 22:27:23.66581|2017-10-10 22:27:23.66581
NCT02687672|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-10-17|||January 2016||2016-01-01|February 2016|2016-02-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury|Transplantation of Purified Autologous Bone Marrow- or Leukapheresis-Derived CD34+ and CD133+ for Patients With Spinal Cord Injuries: A Long-Term Comparative Evaluation of Safety and Efficacy Study.|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Stem Cells Arabia||2|||f||||t||||||||Undecided||2017-10-10 22:27:23.853756|2017-10-10 22:27:23.853756
NCT02687659|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2016-02-19|||May 2014||2014-05-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|TEMIS||TEMIS: a Pilot Study to Evaluate a Device to Characterize Ambulatory Physical Activity|TEMIS: a Pilot Study to Evaluate a Device to Characterize Ambulatory Physical Activity|Completed||N/A|12|Actual|University Hospital, Angers||1|||f||||t||||||||||2017-10-10 22:27:23.935788|2017-10-10 22:27:23.935788
NCT02687646|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-20|||May 2016||2016-05-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Clinical Trial With MSC for Graft Versus Host Disease Treatment|Clinical Trial Phase I / II Graft Versus Host Disease Treatment Refractory to First-line Therapy With Sequential Infusion of Mesenchymal Cells Allogeneic Expanded Adipose Tissue in Vitro|Recruiting||Phase 1/Phase 2|15|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||1|||f||||t||||||||||2017-10-10 22:27:24.048078|2017-10-10 22:27:24.048078
NCT02687633|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-19|||September 2015||2015-09-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex|Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex|Recruiting||N/A|32|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 22:27:24.208088|2017-10-10 22:27:24.208088
NCT02687620|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-09-18|||September 2014||2014-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study|Does Immunogenicity Have an Influence on the Efficacy of Anti-tumor Necrosis Factor (Anti-TNF) Therapy in Patients With Ankylosing Spondylitis (AS): An Inception Cohort Study|Recruiting||N/A|350|Anticipated|Izmir Katip Celebi University|||1||f||||f||||||Samples With DNA|"     During the serum sample aquisition whole blood samples with EDTA will be collected and     stored.   "|Yes||2017-10-10 22:27:24.320185|2017-10-10 22:27:24.320185
NCT02687607|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-08-30|||January 2016||2016-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|CLARYS||CLARYS: CLinical Assessment of WEB® Device in Ruptured aneurYSms|CLinical Assessment of WEB® Device in Ruptured aneurYSms|Recruiting||N/A|50|Anticipated|Sequent Medical, Inc|||1||f||||f||||||||||2017-10-10 22:27:24.479146|2017-10-10 22:27:24.479146
NCT02687594|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-07-07|||April 2016||2016-04-01|July 2016|2016-07-01||||October 2018|Anticipated|2018-10-01||Observational|VERIFIE||Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)|Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis or Peritoneal Dialysis|Recruiting||N/A|1000|Anticipated|Vifor Fresenius Medical Care Renal Pharma|||1||f||||t||||||||||2017-10-10 22:27:24.572268|2017-10-10 22:27:24.572268
NCT02687581|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-10-12|||April 2016||2016-04-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia|Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia|Recruiting||N/A|56|Anticipated|Salus University||2|||f||||f||||||||No||2017-10-10 22:27:24.669755|2017-10-10 22:27:24.669755
NCT02687568|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-03-05|||May 2014||2014-05-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Observational|||Values of Enhanced Monitoring by EEG Recording (Narcotrend) for Sedation in Colonoscopy|Values of Enhanced Monitoring by EEG Recording ( Narcotrend ) as an Adjunct to Standard Monitoring for Sedation in Colonoscopy|Recruiting||N/A|200|Anticipated|Ruhr University of Bochum|||1||f||||f||||||||||2017-10-10 22:27:24.757966|2017-10-10 22:27:24.757966
NCT02687555|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-10-03|||February 2016||2016-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||The Role of Computerized Training in Post-Traumatic Stress Disorder|The Role of Computerized Training in Post-Traumatic Stress Disorder|Recruiting||Phase 1/Phase 2|80|Anticipated|Ruhr University of Bochum||2|||f||||f||||||||Yes|It is planned to make individual participant data available on publication of the associated study results, via a publically-available data repository such as Open Science Framework. Data made available will be the research data reported in the publication, with the exception of any data that could compromise participant anonymity.|2017-10-10 22:27:24.837906|2017-10-10 22:27:24.837906
NCT02687529|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-04-03|||October 2015||2015-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection|Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection|Recruiting||N/A|565|Anticipated|QIAGEN Gaithersburg, Inc|||2||f||||f||||||||||2017-10-10 22:27:25.272198|2017-10-10 22:27:25.272198
NCT02687516|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-04-10|||February 2014||2014-02-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||"Treatment of Severely Obese Children and Adolescents Employing Family-based Behavioral Social Facilitation Treatment"|"Treatment of Severely Obese Children and Adolescents in Common Health Care Settings: An Effectiveness Study Employing Family-based Behavioral Social Facilitation Treatment"|Recruiting||N/A|120|Anticipated|University of Bergen||2|||f||||f||||||||||2017-10-10 22:27:25.376451|2017-10-10 22:27:25.376451
NCT02687503|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-09-09|||December 2016||2016-12-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Impact of Probiotic Use on Immune Cell Function in Children|Impact of Probiotic Use on Immune Cell Function in Children|Not yet recruiting||N/A|40|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||No||2017-10-10 22:27:25.491381|2017-10-10 22:27:25.491381
NCT02687490|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-01-03|||February 2016||2016-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer|A Prospective, Single-center, Open-Label, Phase II Study of Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer|Recruiting||Phase 2|70|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-10 22:27:25.631075|2017-10-10 22:27:25.631075
NCT02687477|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-02-09|||February 2016||2016-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|PADN-OSA||PADN to Treat Severe Obstructive Sleep Apnea|Pulmonary Artery Denervation to Treat Severe Obstructive Sleep Apnea: a Single-center, Prospective, First-in-man Study（PADN-OSA）|Recruiting||Phase 1|20|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t||||||||||2017-10-10 22:27:25.7199|2017-10-10 22:27:25.7199
NCT02687464|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-01-06|||January 2016||2016-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|APPY||Appendectomy Versus Non-Operative Treatment For Acute Non-Perforated Appendicitis in Children|A Multicentre, Randomized Controlled Trial Comparing Appendectomy Versus Non-Operative Treatment For Acute Non-Perforated Appendicitis in Children|Recruiting||N/A|978|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||t||||||||No||2017-10-10 22:27:25.811278|2017-10-10 22:27:25.811278
NCT02687451|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-01-17|||March 2016||2016-03-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects|An Open-Label Single-Dose And Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study To Evaluate The Efficacy, Safety, Tolerability, And Pharmacokinetics Of Oxymorphone Hydrochloride (HCl) For Acute Moderate To Severe Postoperative Pain In Pediatric Subjects|Recruiting||Phase 3|100|Anticipated|Endo Pharmaceuticals||3|||f||||t||||||||||2017-10-10 22:27:25.929349|2017-10-10 22:27:25.929349
NCT02687438|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-11-16|||December 2015||2015-12-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery|The PIO III Study: In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery|Completed||N/A|20|Actual|ENT and Allergy Associates, LLP||1|||f||||f||||||||No||2017-10-10 22:27:26.030935|2017-10-10 22:27:26.030935
NCT02687425|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|SESPI||Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia|Phase 2 Study to Assess the Safety and Efficiency of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Phase Chronic Myelogenous Leukemia Patients|Not yet recruiting||Phase 2|20|Anticipated|Tongji Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:27:26.147445|2017-10-10 22:27:26.147445
NCT02687412|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-23|||April 2016||2016-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Fast-track Surgery After Gynecological Oncology Surgery||Not yet recruiting||N/A|120|Anticipated|Sichuan Cancer Hospital and Research Institute||2|||f||||f||||||||Yes||2017-10-10 22:27:26.243901|2017-10-10 22:27:26.243901
NCT02687399|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-16|||January 2016||2016-01-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (HESTAT)|A Phase II/III, Randomized, Controlled, Single Blind Study to Evaluate the Haemostatic Efficacy and Safety of Topically Applied TT-173 in Patients Undergoing Knee Arthroplasty|Recruiting||Phase 2/Phase 3|210|Anticipated|Thrombotargets Europe S.L||2|||f||||t||||||||Undecided||2017-10-10 22:27:26.366906|2017-10-10 22:27:26.366906
NCT02686502|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-04-08|||April 2016||2016-04-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|MoMaMo!||Motivation Makes the Move!|Motivation Makes the Move!|Recruiting||N/A|120|Anticipated|Helsinki University||3|||f||||f||||||||No||2017-10-10 22:27:35.841575|2017-10-10 22:27:35.841575
NCT02687386|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-10-12|||February 2016||2016-02-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|February 2021|Anticipated|2021-02-01||Interventional|ECREST||A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR|A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT (EEDVsMit) in Children With Recurrent / Refractory Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor (EGFR) (ECREST Study)|Recruiting||Phase 1|30|Anticipated|Sydney Children's Hospitals Network||1|||f||||t||||||||Undecided|De-identified data is planned to be shared with EnGeneIC.|2017-10-10 22:27:26.591764|2017-10-10 22:27:26.591764
NCT02687373|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya|Safety, Tolerability and Efficacy of PfSPZ Vaccine Administered by Direct Venous Inoculation (DVI) to Healthy Children and Infants 5 Months Through 9 Years of Age Living in an Area of High Malaria Transmission in Western Kenya: Age De-escalation and Dose Escalation and a Double Blind, Randomized Placebo-Controlled Trial for Safety and Efficacy|Recruiting||Phase 1/Phase 2|572|Anticipated|Sanaria Inc.||30|||f||||f||||||||||2017-10-10 22:27:26.700474|2017-10-10 22:27:26.700474
NCT02687360|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-02-19|||March 2016||2016-03-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Imaging the Effects of rTMS on Chronic Pain|Imaging the Effects of rTMS on Chronic Pain|Not yet recruiting||Phase 1|60|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-10 22:27:26.865271|2017-10-10 22:27:26.865271
NCT02687347|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-09-16|||February 2016||2016-02-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|UDOME||Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain|A Double Blind Randomized Clinical Trial to Investigate the Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic Therapy in Cancer Patients With Pain|Recruiting||Phase 3|204|Anticipated|McGill University Health Center||2|||f||||t||||||||Yes|"Demographic, cancer status, pain medication, symptom severity and side effects profile will be collected for each participant throughout the study
Data will be collected by clinical interview with research nurse
Data will be available to researchers immediately"|2017-10-10 22:27:26.994768|2017-10-10 22:27:26.994768
NCT02687334|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-05-08|||February 2016||2016-02-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Changes of Cerebral Oxygenation During Anesthesia Induction|Changes of Cerebral Oxygenation During Anesthesia Induction|Completed||N/A|33|Actual|China Medical University, China|||1||f||||t||||||||Yes||2017-10-10 22:27:27.096809|2017-10-10 22:27:27.096809
NCT02687321|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-07-16|||April 2016||2016-04-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|||The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer|The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer: First Prospective Multicentre Observational Study|Recruiting||N/A|150|Anticipated|Brno University Hospital|||1||f||||t||||||||||2017-10-10 22:27:27.185637|2017-10-10 22:27:27.185637
NCT02687308|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-12-20|||March 2016||2016-03-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|RRP2A||Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique|Open Retropubic Radical Prostatectomy With Anterograde Anatomical Dissection Technique (RRP2A), Compared With Walsh Open Anatomical Retrograde Radical Prostatectomy (RRP)|Recruiting||N/A|240|Anticipated|Rio de Janeiro State University||2|||f||||t||||||||Yes|through a table without identifying the name but with the initial and the registration number in the institution|2017-10-10 22:27:27.375017|2017-10-10 22:27:27.375017
NCT02687295|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-16|||January 2010||2010-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|May 2010|Actual|2010-05-01||Interventional|||Improvement of Metabolic Health After Thylakoid Supplementation|Metabolic Risk Markers and Body Weight Are Decreased by Green-plant Supplementation in a Pilot Study With Overweight-to-obese Middle-aged Men.|Completed||N/A|20|Actual|Region Skane||2|||f||||f||||||||No||2017-10-10 22:27:27.51048|2017-10-10 22:27:27.51048
NCT02687282|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-05-15|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|September 1, 2016|Actual|2016-09-01|August 15, 2016|Actual|2016-08-15||Observational|MSBAC||Mallampati Score Before and After Cesarean Delivery|Ramathibodi Hospital, Mahidol University|Completed||N/A|104|Actual|Ramathibodi Hospital|||1||f||||f||||||||No||2017-10-10 22:27:27.601869|2017-10-10 22:27:27.601869
NCT02687269|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-08-19|||October 2016||2016-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Ranolazine a Potential New Therapeutic Application|Ranolazine Myocardial Protection in Complete Coronary Artery Bypass Grafting: A Randomized-controlled Trial|Not yet recruiting||Phase 4|100|Anticipated|Policlinico Universitario Agostino Gemelli||2|||f||||f||||||||Yes||2017-10-10 22:27:27.693157|2017-10-10 22:27:27.693157
NCT02687256|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-03-22|||March 2016||2016-03-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set|Evaluation of Extended Infusion Set Wear Using the Medtronic Extended Wear Sof-set Infusion Set|Recruiting||Phase 3|20|Anticipated|Stanford University||2|||f||||t||||||||No|To maintain the integrity of this research study, the subject is told they may not have access to any health information developed as part of this study until it is completed.|2017-10-10 22:27:27.805954|2017-10-10 22:27:27.805954
NCT02687243|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-06|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|STM||StoryTelling Medicine Application Using a Virtual Reality Intervention|Assessing the Effects of an Interactive Virtual Reality Intervention in Reducing Preoperative Anxiety in Children Undergoing Elective Surgery: A Randomized Controlled Trial Study Protocol|Not yet recruiting||N/A|118|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 22:27:27.894964|2017-10-10 22:27:27.894964
NCT02687230|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-06-13|||July 2016||2016-07-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1|Phase 1 Study of 89Zr-DFO-HuMab-5B1 (MVT-2163) With HuMab-5B1 (MVT-5873) in Patients With Pancreatic Cancer or Other CA19-9 Positive Malignancies|Recruiting||Phase 1|28|Anticipated|MabVax Therapeutics, Inc.||3|||f||||t||||||||No||2017-10-10 22:27:28.011495|2017-10-10 22:27:28.011495
NCT02683590|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-08-14|||March 2016||2016-03-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|STOIC||STernectOmy Repair Efficiency of a Ceramic Implant|STernectOmy Repair Efficiency of a Ceramic Implant|Recruiting||N/A|3|Anticipated|University Hospital, Limoges||1|||f||||t||||||||||2017-10-10 22:28:10.765026|2017-10-10 22:28:10.765026
NCT02687217|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-04-02|2016-03-02||November 2011||2011-11-01|April 2016|2016-04-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional||"Group A: Control:
No supplemental oxygen throughout surgery.
Received oxygen 4L/min. in 2 hrs postoperative period through venturimask.
Group B: Test:
Hyperoxygenation ≥50% of oxygen by mask(non-rebreathing) was given through out the surgery.
Received 6L/min of oxygen through venturimask upto 2 hrs in post operative period."|Effect of Peri-operative Supplemental Oxygen in Wound Infection After Appendectomy|Role of Perioperative Hyperoxygenation in Wound Infection Following Surgery for Acute Appendicitis: A Randomised Controlled Trial.|Completed||N/A|60|Actual|Lady Hardinge Medical College|The study included a small sample size of 60 patients, randomized into equal study group and control group as the time limit restrictions of 12- 15 months as prescribed by the residency programme.|2|||f||||t||||||||Undecided||2017-10-10 22:27:28.145012|2017-10-10 22:27:28.145012
NCT02687204|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-08-31|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|March 2017|Actual|2017-03-01||Interventional|||Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients|Optimization of Enoxaparin Prophylaxis Using Real-time Anti-Factor Xa Levels in Major Reconstructive Surgery Patients|Active, not recruiting||N/A|250|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-10 22:27:28.755501|2017-10-10 22:27:28.755501
NCT02687191|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-29|||November 26, 2016|Actual|2016-11-26|September 2017|2017-09-01|June 18, 2018|Anticipated|2018-06-18|June 18, 2018|Anticipated|2018-06-18||Interventional|||Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage|A Phase 1b Multicenter, Open-label Study To Evaluate The Safety And Tolerability And Determine The Maximum Tolerated Dose Of Pf-05230907 In Subjects With Intracerebral Hemorrhage (Ich)|Recruiting||Phase 1|51|Anticipated|Pfizer||15|||f||||t|t|f||||||||2017-10-10 22:27:28.86469|2017-10-10 22:27:28.86469
NCT02687178|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-30|||October 2010||2010-10-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Canrenone as Add-on in Patients With Essential Hypertension|Efficacy and Safety of Canrenone as Add-on in Patients With Essential Hypertension-Italy (ESCAPE-IT)|Completed||Phase 4|180|Actual|University of Pavia||2|||f||||f||||||||||2017-10-10 22:27:29.076127|2017-10-10 22:27:29.076127
NCT02687165|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-02-02|||January 2016||2016-01-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PTLS||Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome|Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome|Recruiting||N/A|40|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-10-10 22:27:29.145989|2017-10-10 22:27:29.145989
NCT02687152|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-16|||March 2014||2014-03-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes|Effect of Arginase Inhibition on Microvascular Endothelial Function in Patients With Type 2 Diabetes and Microvascular Dysfunction.|Completed||Phase 1/Phase 2|24|Actual|Karolinska Institutet||1|||f||||f||||||||No||2017-10-10 22:27:29.227095|2017-10-10 22:27:29.227095
NCT02687139|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-03-06|||October 2015||2015-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma|Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma|Recruiting||N/A|30|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 22:27:29.29277|2017-10-10 22:27:29.29277
NCT02687126|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-03-14|2017-01-22||February 2016||2016-02-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Ultrasound Guided Technique for Internal Jugular Central Venous Catheterization in Pediatric Cardiac Surgical Patients|Ultrasound Guided Technique for Internal Jugular Central Venous Catheterization in Pediatric Cardiac Surgical Patients|Completed||N/A|106|Actual|Shahid Gangalal National Heart Centre|Disease conditions of the patients may affect the size of the internal jugular vein. We did not evaluate the outcome variables in different disease conditions.|1|||f||||t||||||||Undecided||2017-10-10 22:27:29.372847|2017-10-10 22:27:29.372847
NCT02687113|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-19|||March 2013||2013-03-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion|Pre-procedure Planning for Radiofrequency Ablation Using the Automatic Fusion Images of the Registrated 3D CT or MR-US Scans: Preliminary Study|Completed||N/A|240|Actual|Seoul National University Hospital||1|||f||||t||||||||No||2017-10-10 22:27:29.588112|2017-10-10 22:27:29.588112
NCT02687100|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-08-19|||October 2016||2016-10-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|BEnTS||The Effects of Beclomethasone Upper the Endotracheal Cuff on the Occurrence of Sore Throat at Extubation|Does Beclomethasone Instillation Above the Cuff of Endotracheal Tubes Decrease the Occurrence of Postoperative Sore Throat? A Randomized Controlled Trial|Not yet recruiting||Phase 4|40|Anticipated|Policlinico Universitario Agostino Gemelli||2|||f||||t||||||||Yes||2017-10-10 22:27:29.675633|2017-10-10 22:27:29.675633
NCT02687087|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-02-17|||March 24, 2016|Actual|2016-03-24|February 2017|2017-02-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Interventional|||A Study of Patients With Dry Mouth and Sticky Saliva During Radiotherapy|Assessing the Safety and Effectiveness of Visco-ease for the Treatment of Radiotherapy Induced Xerostomia in Head and Neck Cancer Patients|Completed||N/A|44|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||No||2017-10-10 22:27:29.875988|2017-10-10 22:27:29.875988
NCT02687074|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-17|||January 2016||2016-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of HFNC on Moderate and Severe Respiratory Failure Patients|Effects of High Flow Nasal Canula on Moderate and Severe Respiratory Failure Patients|Enrolling by invitation||N/A|246|Anticipated|Southeast University, China||1|||f||||t||||||||Undecided||2017-10-10 22:27:29.974758|2017-10-10 22:27:29.974758
NCT02687061|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-17|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01|1 Year|Observational [Patient Registry]|||Chronic Hepatitis B and C Recall Northern Holland|Retrieval of Patients Chronically Infected With Hepatitis B or Hepatitis C in Northern Holland|Not yet recruiting||N/A|300|Anticipated|Stichting MDL Holland-Noord|||2||f||||f||||||||||2017-10-10 22:27:30.082395|2017-10-10 22:27:30.082395
NCT02687048|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-10-01|||February 2016||2016-02-01|October 2017|2017-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Mindful Meditation for Chronic Stroke|The Impact of Mindful Meditation on Mobility, Cognition and Fall Risk in the Older Adult.|Completed||N/A|23|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:27:30.154284|2017-10-10 22:27:30.154284
NCT02687035|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-08-11|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|August 2026|Anticipated|2026-08-01|October 2017|Anticipated|2017-10-01||Interventional|The PARTNER II||The PARTNER II Trial: S3iCAP|The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)|Active, not recruiting||Phase 3|1822|Actual|Edwards Lifesciences||1|||f||||t||||||||||2017-10-10 22:27:30.260839|2017-10-10 22:27:30.260839
NCT02687022|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-02-19|||March 2016||2016-03-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Measurement Repeatability in Contemporary Aberrometry|A Comparative Study of Measurement Repeatability for Two Aberrometers|Not yet recruiting||N/A|60|Anticipated|Moorfields Eye Hospital NHS Foundation Trust||4|||f||||f||||||||Yes|The investigators plan to publish summary descriptive data and analyses. Anonymised individual data will be available to systematic reviewers on request.|2017-10-10 22:27:30.471508|2017-10-10 22:27:30.471508
NCT02687009|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-04-18|||April 17, 2017|Actual|2017-04-17|April 2017|2017-04-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|||A Study of Niclosamide in Patients With Resectable Colon Cancer|A Phase I Study of Niclosamide in Patients With Resectable Colon Cancer|Recruiting||Phase 1|18|Anticipated|Duke University||1|||f||||f|t|f||||||No||2017-10-10 22:27:30.575412|2017-10-10 22:27:30.575412
NCT02686996|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-03-09|||February 13, 2017|Actual|2017-02-13|March 2017|2017-03-01|June 12, 2020|Anticipated|2020-06-12|February 13, 2020|Anticipated|2020-02-13||Interventional|||The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk|The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk: a Double-blind, Placebo-controlled Trial|Recruiting||N/A|84|Anticipated|Monash University||2|||f||||t|f|f||||||No||2017-10-10 22:27:30.677152|2017-10-10 22:27:30.677152
NCT02686983|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-02-22|||March 2016||2016-03-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|DHC-GON-1||GON-block in Chronic Migraine: a Randomized, Double- Blind, Placebo-controlled Study|Greater Occipital Nerve Blockade for the Treatment of Chronic Migraine: a Randomized, Double- Blind, Placebo-controlled Study|Not yet recruiting||Phase 4|34|Anticipated|Danish Headache Center||2|||f||||t||||||||Undecided||2017-10-10 22:27:30.798664|2017-10-10 22:27:30.798664
NCT02686970|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-11-27|||November 2016||2016-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Observational|||Spanish Adaptation and Study of Reliability of the European Quality Questionnaire (EuroQ2)|Spanish Adaptation and Study of Reliability of the European Quality Questionnaire (EuroQ2)|Recruiting||N/A|200|Anticipated|Corporacion Parc Tauli|||1||f||||f||||||||No||2017-10-10 22:27:30.899534|2017-10-10 22:27:30.899534
NCT02686957|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-01-30|||July 2015||2015-07-01|January 2017|2017-01-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|||Recurrence and Pregnancy Post-repair of Obstetric Fistula in Guinea|Risk Factors of Fistula Recurrence and Pregnancy Outcomes Following Fistula Repair in Guinea|Completed||N/A|481|Actual|Centre National de Formation et de Recherche en Sante Rurale|||1||f||||f||||||||No|Such data will not be public unless requested and after prior authorization of the Guinean National Ethics Committee for Health Research.|2017-10-10 22:27:30.988994|2017-10-10 22:27:30.988994
NCT02686944|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-27|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|GIST||A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors|A Phase I Open-label Study Evaluating Safety and Efficacy of Intratumorally Administered Intuvax in Patients With Progressing Gastrointestinal Stromal Tumors (GIST) During Ongoing Second, Third or Fourth Line Treatment With Tyrosine Kinase Inhibition Therapy. A Prospective Single Armed, Open Label Phase I Safety and Efficacy Study|Recruiting||Phase 1|12|Anticipated|Immunicum AB||1|||f||||f||f||||||||2017-10-10 22:27:31.060079|2017-10-10 22:27:31.060079
NCT02686931|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-10-03|||January 2013||2013-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||The Investigation of Children With Developmental Delay and Children's Rehabilitation Common Case|The Investigation of Children With Developmental Delay and Children's Rehabilitation Common Case: A Longitudinal Study|Recruiting||N/A|2000|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||||No||2017-10-10 22:27:31.17339|2017-10-10 22:27:31.17339
NCT02686918|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|TIPA||Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse|Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse - TIPA|Not yet recruiting||N/A|100|Anticipated|Institut de Cancérologie de la Loire||1|||f||||f||||||||||2017-10-10 22:27:31.262975|2017-10-10 22:27:31.262975
NCT02686905|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-09-29|||January 2016||2016-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Vitamin Supplementation After Bariatric Surgery|Effects of Vitamin Supplementation on Micronutrient Blood Values, Body Composition, Waist-to-hip Ratio and Fasting Blood Glucose After Bariatric Surgery|Recruiting||N/A|30|Anticipated|California State Polytechnic University, Pomona||2|||f||||f||||||||No||2017-10-10 22:27:31.340685|2017-10-10 22:27:31.340685
NCT02686892|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-10|||January 2017||2017-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|INCIDENCIA||An Epidemiological Study of the Incidence of Inflammatory Bowel Disease in Spain|An Epidemiological Study of the Incidence of Inflammatory Bowel Disease in Spain|Recruiting||N/A|4000|Anticipated|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa|||2||f||||f||||||||||2017-10-10 22:27:31.487824|2017-10-10 22:27:31.487824
NCT02686879|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-07-05|||June 2016||2016-06-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Effect of Peripheral Defocus on Axial Growth in Hyperopes|The Effect of Peripheral Defocus on Axial Growth and Modulation of Refractive Error in Hyperopes|Recruiting||N/A|84|Anticipated|Aston University||4|||f||||f||||||||No||2017-10-10 22:27:31.654244|2017-10-10 22:27:31.654244
NCT02686866|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-16|||January 2016||2016-01-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Body Composition Measurements in Chronic Heart Failure|Comparing Body Composition Measurements - Bioelectrical Impedance Analysis and Dual-energy X-ray Absorptiometry - in Chronic Heart Failure|Recruiting||Phase 4|35|Anticipated|Hungarian Institute of Cardiology||1|||f||||f||||||||Undecided||2017-10-10 22:27:31.764943|2017-10-10 22:27:31.764943
NCT02686853|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-16|||January 2016||2016-01-01|February 2016|2016-02-01||||January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis|Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis Without Acquired Immune Deficiency Syndrome|Not yet recruiting||Phase 4|40|Anticipated|Hebei Medical University||1|||f||||||||||||||2017-10-10 22:27:31.851997|2017-10-10 22:27:31.851997
NCT02686840|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-08-13|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Sublingual Versus Vaginal Misoprostol In Medical Treatment of First Trimestric Missed Miscarriage|Sublingual Versus Vaginal Misoprostol In Medical Treatment of First Trimestric Missed Miscarriage: A Randomized Controlled Trial.|Completed||Phase 3|200|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:27:31.92738|2017-10-10 22:27:31.92738
NCT02686827|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-10-07|||October 2015||2015-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|BM4SIT||DBPC-trial of Subcutaneous Vitamin D3 Comparing Allergic Patients and Healthy Controls.|A Randomized, Double-blind, Placebo-controlled Study to Compare the Immune Effects of Multiple Doses of Vitamin D3 in Patients With Allergic Rhinitis/Rhino-conjunctivitis Caused by Birch Pollen and Healthy Control Subjects.|Completed||Phase 2|44|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||Undecided|The investigators have to discuss this within theEU project.|2017-10-10 22:27:32.018842|2017-10-10 22:27:32.018842
NCT02686814|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-04-28|||March 2016||2016-03-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|July 2018|Anticipated|2018-07-01||Interventional|||PERIGON Japan Trial|A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the 17mm MDT-2215 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease|Recruiting||N/A|20|Anticipated|Medtronic Cardiovascular||1|||f||||t||||||||||2017-10-10 22:27:32.162114|2017-10-10 22:27:32.162114
NCT02686801|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-18|||April 2014||2014-04-01|February 2016|2016-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|OPTIPREMA||Body Composition at Discharge and Neurological Development at 2 Years in Very Preterm Infants (OPTIPREMA)|Determinants of Body Composition at Discharge and Fat-Free Mass as an Indicator of Neurological Development at 2 Years in Very Preterm Infants : OPTIPREMA Study|Recruiting||N/A|400|Anticipated|Hôpital de la Croix-Rousse|||1||f||||f||||||||Undecided||2017-10-10 22:27:32.309573|2017-10-10 22:27:32.309573
NCT02686788|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-02-22|||August 2015||2015-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TMP001 in Relapsing-remitting Multiple Sclerosis|TMP001 in Relapsing-remitting Multiple Sclerosis: A Multicentre Open, Baseline-controlled Phase IIa Clinical Trial|Recruiting||Phase 2|55|Anticipated|Fraunhofer Institute for Molecular Biology and Applied Ecology||1|||f||||t||||||||||2017-10-10 22:27:32.388416|2017-10-10 22:27:32.388416
NCT02686775|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-15|||January 2016||2016-01-01|February 2016|2016-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PACO||The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients|The PACO Project: A Randomized Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients|Recruiting||N/A|306|Anticipated|Danish Cancer Society||2|||f||||f||||||||||2017-10-10 22:27:32.511841|2017-10-10 22:27:32.511841
NCT02686762|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-14|||January 26, 2016|Actual|2016-01-26|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|ENCORE-NF||Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis|A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial of Emricasan (IDN-6556-12), an Oral Caspase Inhibitor, in Subjects With Non-alcoholic Steatohepatitis (NASH) Fibrosis|Active, not recruiting||Phase 2|330|Anticipated|Conatus Pharmaceuticals Inc.||3|||f||||t||||||||||2017-10-10 22:27:32.632385|2017-10-10 22:27:32.632385
NCT02686749|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-09-01|||June 2016||2016-06-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|CATCH-AF||Catheter Ablation vs. Medical Therapy in Congested Hearts With AF|Catheter Ablation vs. Medical Therapy in Congested Hearts With AF (CATCH-AF in Patients With Impaired LV Function): An Early Ablation Strategy Study Impact on Health Care Utilization|Recruiting||Phase 4|220|Anticipated|The Cleveland Clinic||2|||f||||f|t|t|f|f|f|||||2017-10-10 22:27:32.88269|2017-10-10 22:27:32.88269
NCT02686736|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-01-30|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|||Internet-based Intervention to Prevent Risky Sexual Behaviors in Mexican Adolescents|Evaluation of the Effect of an Internet-based Educational Intervention to Prevent Risky Sexual Behaviors in Mexican Adolescents|Completed||N/A|456|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||Undecided||2017-10-10 22:27:33.011836|2017-10-10 22:27:33.011836
NCT02686723|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01|February 2024|Anticipated|2024-02-01|February 2023|Anticipated|2023-02-01||Interventional|REPILOG||Evaluation of Clinical and Biomechanical Correlation During Return to Sport After Anterior Cruciate Ligament Injury|Evaluation of Clinical and Biomechanical Correlation During Return to Sport After Anterior Cruciate Ligament Injury|Recruiting||N/A|70|Anticipated|University Hospital, Brest||2|||f||||f||||||||||2017-10-10 22:27:33.100842|2017-10-10 22:27:33.100842
NCT02686710|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients|Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients: a Randomized Clinical Trial|Not yet recruiting||Phase 4|21|Anticipated|Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy||3|||f||||||||||||||2017-10-10 22:27:33.310439|2017-10-10 22:27:33.310439
NCT02686697|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-02-22|||December 2015||2015-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CACTIS||Carnosine and Cognitive Training in Schizophrenia|A Double-blind, Placebo-controlled Study on the Effects of Combined L-Carnosine and Cognitive Training on Cognition in Schizophrenia|Recruiting||Phase 2/Phase 3|60|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 22:27:33.42657|2017-10-10 22:27:33.42657
NCT02686684|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|DTI||Tecfidera Diffusion Tensor Imaging|An Open-label, Observational, Single-blinded, Longitudinal Study to Evaluate the Effect of Dimethyl Fumarate on Gray and White Matter Pathology in Subjects With Relapsing Multiple Sclerosis|Completed||N/A|115|Actual|University at Buffalo|||2||f||||f||||||||||2017-10-10 22:27:33.58|2017-10-10 22:27:33.58
NCT02686671|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-05|||February 2016||2016-02-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Observational|||The Pull Test To Determine Responders To Subacromial Injection In Patients With Shoulder Impingement|A New Diagnostic Clinical Test To Determine Responders To Subacromial Injection In Patients With Shoulder Impingement: A Case Series|Recruiting||N/A|120|Anticipated|Texas Tech University Health Sciences Center|||1||f||||f||||||||||2017-10-10 22:27:33.674909|2017-10-10 22:27:33.674909
NCT02686658|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-20|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase 2/3 Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration|A Phase 2/3 Randomized, Double-Masked, Controlled Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration|Recruiting||Phase 2/Phase 3|300|Anticipated|Ophthotech Corporation||3|||f||||t||||||||||2017-10-10 22:27:33.791803|2017-10-10 22:27:33.791803
NCT02686645|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-09-26|||December 2016||2016-12-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection|Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection|Not yet recruiting||Phase 2/Phase 3|50|Anticipated|Queen Elizabeth II Health Sciences Centre||1|||f||||f||||||||No||2017-10-10 22:27:33.947155|2017-10-10 22:27:33.947155
NCT02686632|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-02-01|||September 2016||2016-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effectiveness of Palatal Brushing on Denture Stomatitis|Improving Practice Guidelines for the Treatment of Denture-related Erythematous Stomatitis: A Pragmatic International Multicenter Randomized Controlled Trial|Recruiting||N/A|52|Anticipated|Université de Montréal||2|||f||||t||||||||Undecided||2017-10-10 22:27:34.064735|2017-10-10 22:27:34.064735
NCT02686619|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-16|||November 2004||2004-11-01|February 2016|2016-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients|Multicentre, Prospective, Randomized, Open-label Study Comparing the Efficacy and Safety of CellCept With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Standard Immunosuppression Comprising CellCept and Long-term Continuation of Cyclosporine in Renal Transplant Recipients Receiving Induction by Zenapax and Treated With Corticosteroids for 8 Months|Completed||Phase 3|237|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:27:34.186681|2017-10-10 22:27:34.186681
NCT02686606|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-04-12|||January 2016||2016-01-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||A Trial to Investigate the Effect of Different Supplements on Fluid and Sodium Status in Short Bowel|A Randomised Controlled Crossover Trial to Investigate the Effect of Different Oral Nutritional Supplements on Fluid and Sodium Status in Patients With Short Bowel Intestinal Failure|Enrolling by invitation||N/A|20|Anticipated|London North West Healthcare NHS Trust||4|||f||||f||||||||Yes|Peer reviewed journal|2017-10-10 22:27:34.93253|2017-10-10 22:27:34.93253
NCT02686593|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-10-25|||February 2016||2016-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML|Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML|Recruiting||Phase 2|50|Anticipated|The University of Hong Kong||1|||f||||t||||||||No||2017-10-10 22:27:35.075414|2017-10-10 22:27:35.075414
NCT02686580|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-02-15|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|FIX-IT1||Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas|Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas|Not yet recruiting||Phase 3|12|Anticipated|Royal Devon and Exeter NHS Foundation Trust||1|||f||||f||||||||Undecided||2017-10-10 22:27:35.222335|2017-10-10 22:27:35.222335
NCT02686567|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-04-26|||February 2016||2016-02-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|February 2016|Actual|2016-02-01||Interventional|||Use of the TDT for Prevention of Anastomotic Leakage After Laparoscopic Anterior Resection for Rectal Cancer|The Use of the Transanal Drainage Tube for Prevention of Anastomotic Leakage After Laparoscopic Anterior Resection for Medium & Low Rectal Cancer|Recruiting||N/A|600|Anticipated|Third Military Medical University||2|||f||||t||||||||Yes|after the paper published|2017-10-10 22:27:35.309055|2017-10-10 22:27:35.309055
NCT02686554|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-07-20|||January 2016||2016-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Observational|||Identification of Proteostasis-related Biomarkers in Alzheimer´s Dementia|Elucidating the Proteostatis Network to Control Alzheimer's Disease - Identification of Proteostasis-related Biomarkers in Alzheimer´s Dementia|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||Samples With DNA|"     Blood, cerebrospinal fluid, urine   "|||2017-10-10 22:27:35.434281|2017-10-10 22:27:35.434281
NCT02686541|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-02-21|||April 2015||2015-04-01|February 2016|2016-02-01||||March 2017|Anticipated|2017-03-01||Expanded Access|ADEBT||Athrectomy and Drug Eluting Balloon Therapy (ADEBT) on the Femoral Popliteal Arteries|Athrectomy and Drug Eluting Balloon Therapy (ADEBT) on the Femoral Popliteal Arteries|Approved for marketing||N/A|||Changi General Hospital|||||f||||||||||||||2017-10-10 22:27:35.53102|2017-10-10 22:27:35.53102
NCT02686528|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-04-10|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Postoperative Hip Precautions After Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial|Are Postoperative Hip Precautions Necessary After a Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial|Recruiting||N/A|1000|Anticipated|Rush University Medical Center||2|||f||||f||||||||No||2017-10-10 22:27:35.629482|2017-10-10 22:27:35.629482
NCT02686515|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-02-17|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparative Effectiveness Research of Dual-task and Single-task Balance Training in People With Stroke|Comparative Effectiveness Research of Dual-task and Single-task Balance Training on Cognitive-motor Interference, Balance Confidence, Fall Prevention, Functional Performance, and Quality of Life in People With Stroke|Recruiting||N/A|48|Anticipated|Chang Gung University||2|||f||||t||||||||Undecided||2017-10-10 22:27:35.724767|2017-10-10 22:27:35.724767
NCT02686489|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-15|||March 2016||2016-03-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Humidity Therapy for Spontaneously Breathing Tracheostomy Patients|Large Volume Nebulizers Versus Heated Humidity in Spontaneously Breathing Tracheostomy Patients|Not yet recruiting||Phase 3|100|Anticipated|Rush University Medical Center||2|||f||||f||||||||No||2017-10-10 22:27:36.089926|2017-10-10 22:27:36.089926
NCT02686476|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-06-14|||March 2016||2016-03-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|March 2017|Actual|2017-03-01||Interventional|E-LIFT||Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes|Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes: A 12-week Randomized Clinical Study|Active, not recruiting||N/A|100|Actual|Medanta, The Medicity, India||2|||f||||t||||||||Undecided||2017-10-10 22:27:36.193818|2017-10-10 22:27:36.193818
NCT02686463|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-18|||April 2016||2016-04-01|February 2016|2016-02-01|June 2023|Anticipated|2023-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy|Diagnosis and Treatment of Laparoscopy for Malignant Ovarian Cancer: an Open-label, Parallel, Randomized, Controlled Clinical Trial of Efficacy and Safety|Not yet recruiting||N/A|150|Anticipated|Shengjing Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:27:36.289347|2017-10-10 22:27:36.289347
NCT02686450|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-04-19|||July 2014||2014-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:27:37.152288|2017-10-10 22:27:37.152288
NCT02686424|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-20|||March 2010||2010-03-01|February 2016|2016-02-01||||January 2015|Actual|2015-01-01||Observational|ONCO-RD010CRT||Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)|Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy|Suspended||N/A|250|Anticipated|Seoul National University Hospital|||1|paperwork delay|f||||f||||||||No||2017-10-10 22:27:37.441433|2017-10-10 22:27:37.441433
NCT02686411|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2017-07-05|||February 17, 2016|Actual|2016-02-17|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Palliative Care Consult Service vs Palliative Care Unit|A Prospective Evaluation of Satisfaction With Quality of Care on the Palliative Care Unit|Active, not recruiting||N/A|35|Actual|M.D. Anderson Cancer Center|||2||f||||f|f|f||||||||2017-10-10 22:27:37.508506|2017-10-10 22:27:37.508506
NCT02686398|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-02-15|||October 2013||2013-10-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis|Immunogenicity of a Trivalent Influenza Vaccine in Patients With Chronic Kidney Disease Undergoing Hemodialysis: MF59-adjuvanted Versus Non-adjuvanted Vaccines|Completed||Phase 4|174|Actual|Korea University Guro Hospital||2|||f||||||||||||||2017-10-10 22:27:37.636648|2017-10-10 22:27:37.636648
NCT02686385|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-02-08|||February 2016||2016-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury|Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury: A Prospective Randomized Controlled Trial|Terminated||N/A|4|Actual|Institute of Liver and Biliary Sciences, India||2||"Steroids were given for 2 patients who had biopsy proven Drug induced Liver Injury and both   have them developed sepsis."|f||||||||||||||2017-10-10 22:27:37.720507|2017-10-10 22:27:37.720507
NCT02686372|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-17|2016-03-21|||December 2015||2015-12-01|March 2016|2016-03-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|||TCR-Redirected T Cell Infusions to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation|Phase I Study of T Cell Receptor-Redirected T Cells Infusions for Preventing Hepatocellular Carcinoma Recurrence in Patients With HBV-Related Disease Post Liver Transplantation|Recruiting||Phase 1|10|Anticipated|Lion TCR Pte. Ltd.||1|||f||||f||||||||No||2017-10-10 22:27:37.795549|2017-10-10 22:27:37.795549
NCT02686359|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-15|||July 2011||2011-07-01|February 2016|2016-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|OPIODYN||Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)|Research of a Biological Marker for Chronic Orofacial Pain: Dosage of Opiorphin in Patients With Burning Mouth Syndrome|Completed||N/A|42|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 22:27:37.892438|2017-10-10 22:27:37.892438
NCT02686346|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-07-11|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|February 2017|Actual|2017-02-01||Interventional|BV-ICE||Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE|Phase I/II Feasibility Study of Brentuximab Vedotin in Refractory / Relapsed Hodgkin Lymphoma Patients Who Are Treated by Chemotherapy (ICE) in Second Line and Eligible for Autologous Transplantation|Recruiting||Phase 1/Phase 2|55|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-10 22:27:37.991354|2017-10-10 22:27:37.991354
NCT02686333|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-06-09|||March 2016||2016-03-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|February 1, 2017|Actual|2017-02-01||Interventional|||Meditation for Depression and Anxiety Symptoms in Dialysis Patients|Meditation Intervention for the Treatment of Depression and Anxiety Symptoms in Patients Undergoing Dialysis: A Randomized Control Trial|Active, not recruiting||Phase 3|50|Actual|Lady Davis Institute||2|||f||||t||||||||No|Individual data will be coded and anonymized. Anonymized data will not be shared.|2017-10-10 22:27:38.142597|2017-10-10 22:27:38.142597
NCT02686320|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-06-27|||March 2016||2016-03-01|June 2016|2016-06-01|December 2022|Anticipated|2022-12-01|July 2017|Anticipated|2017-07-01||Observational|PRESAGE||Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65|Prospective Study of Evolution of Rheumatoid Arthritis After 65 Years Old|Recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||No||2017-10-10 22:27:38.229743|2017-10-10 22:27:38.229743
NCT02686307|ClinicalTrials.gov processed this data on October 10, 2017|2007-12-21|2016-02-16|||June 2005||2005-06-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Predicting Blood Pressure in Patients Following Defibrillation|Predicting Blood Pressure in Patients Following Defibrillation in Patients With an ICD Implant|Completed||N/A|33|Actual|University of Utah|||1||f||||f||||||||No||2017-10-10 22:27:38.317817|2017-10-10 22:27:38.317817
NCT02686294|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-15|||February 2016||2016-02-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Repeated Dosing Clinical Trial of HL151|Repeated Dosing Clinical Trial to Assess the Pharmacokinetic Characteristics and Safety/Tolerability of HL151 Formulation in Healthy Male Subjects|Recruiting||Phase 1|30|Anticipated|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:27:38.382997|2017-10-10 22:27:38.382997
NCT02686281|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-04-18|||September 2012||2012-09-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes|A Double-Blind, Placebo-Controlled, Randomised, Two Part Study of the Safety and Pharmacokinetics of GMC-252 in A) Healthy Male Subjects, Including a Comparison of GMC-252 Dosing in the Fed and Fasted States ,and B) in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 1|19|Actual|Genmedica Therapeutics S.L.||2||Business reason|f||||f||||||||Undecided||2017-10-10 22:27:40.150783|2017-10-10 22:27:40.150783
NCT02686268|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-01-05|||February 2015||2015-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS|Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS|Recruiting||N/A|120|Anticipated|Washington University School of Medicine|||1||f||||t||||||Samples With DNA|"     Whole blood (DNA, Southern Blots), Serum, PBMCs (for reprogramming into iPSCs), and Cerebral     Spinal Fluid (CSF)   "|No|"The study design has a robust plan to share de-identified data (but personally identifiable data will not be shared). When study information is shared, it will be de-identified, meaning that the study will remove all personal identifiers so that all collected data and samples are stored under a unique subject ID study code (coded). In other words, the study has been designed to keep personal details separate from all samples and study information.
The results of this trial will be published in peer-reviewed journals. No personal identifiers will be included."|2017-10-10 22:27:40.239015|2017-10-10 22:27:40.239015
NCT02686255|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-04-27|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|May 2019|Anticipated|2019-05-01||Observational|||Hemoglobin Trend in Neonates and Toddlers Post Cardiac Surgery|Hemoglobin Trend in Neonates and Toddlers Post Cardiac Surgery|Recruiting||N/A|750|Anticipated|Rabin Medical Center|||1||f||||f||||||||No||2017-10-10 22:27:40.3439|2017-10-10 22:27:40.3439
NCT02686242|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-06-21|||December 2015||2015-12-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|SAW||Spinal Aesthesia in Women With Placenta Previa Percreta|Influence of Spinal Anaesthesia on Hemodynamic Stability in Women With Placenta Previa Percreta Undergoing Caesarean Section|Completed||N/A|68|Actual|Fourth Military Medical University|||2||f||||t||||||||Undecided||2017-10-10 22:27:40.423735|2017-10-10 22:27:40.423735
NCT02686229|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-03-10|||December 2015||2015-12-01|March 2016|2016-03-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01|10 Years|Observational [Patient Registry]|LoG-Glio||Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas|Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas: The LOG-Glio-Project|Recruiting||N/A|300|Anticipated|University of Ulm|||1||f||||t||||||Samples With DNA|"     Blood and tumor samples   "|No||2017-10-10 22:27:40.529518|2017-10-10 22:27:40.529518
NCT02686216|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-02-06|||December 2015||2015-12-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|April 2016|Actual|2016-04-01||Interventional|PET||Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )|Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects|Completed||Phase 1|24|Actual|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-10-10 22:27:40.599544|2017-10-10 22:27:40.599544
NCT02686203|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-15|||March 2016||2016-03-01|February 2016|2016-02-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluate the Effectiveness of Low Level Laser Therapy (LLT) Combined With Acupuncture|A Feasibility Study to Evaluate the Effectiveness of Low Level Laser Therapy Combined With Acupuncture as Palliative Treatment of Patients With Various Solid Malignancies Who Are no Longer Candidates for Active Oncological Therapies|Not yet recruiting||N/A|30|Anticipated|Erika Carmel ltd||1|||f||||f||||||||No||2017-10-10 22:27:40.666672|2017-10-10 22:27:40.666672
NCT02686190|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-03-16|||July 2012||2012-07-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|ALZ-Light||Effects of Light-therapy in Alzheimer's Disease|Effects of Bright Light to Improve Agitation and Sleep Disorders in Patients With Alzheimer's Disease|Completed||N/A|91|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:27:40.730031|2017-10-10 22:27:40.730031
NCT02686177|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-08-28|||May 18, 2016|Actual|2016-05-18|August 2017|2017-08-01|June 18, 2019|Anticipated|2019-06-18|June 18, 2019|Anticipated|2019-06-18||Interventional|ANGIOSAFE 1||Effect of GLP-1 on Angiogenesis|Effect of GLP-1 on Angiogenesis, Angiosafe Type 2 Diabetes Study 1|Recruiting||Phase 4|40|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:27:40.805284|2017-10-10 22:27:40.805284
NCT02686164|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-16|||May 12, 2016|Actual|2016-05-12|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|December 30, 2017|Anticipated|2017-12-30||Interventional|||Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors|An Open-Label Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|22|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-10 22:27:40.927126|2017-10-10 22:27:40.927126
NCT02686151|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-02-15|||April 2016||2016-04-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||The Letrozole Administration During Luteal Phase|The Randomized Clinical Trials of Letrozole Administration During Luteal Phase in Patients Who Have the Risk of Ovarian Hyperstimulation Syndrome|Not yet recruiting||Phase 3|50|Anticipated|The Affiliated Hospital of Inner Mongolia Medical University||2|||f||||f||||||||Undecided||2017-10-10 22:27:41.141973|2017-10-10 22:27:41.141973
NCT02686138|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-02-07|||December 2015||2015-12-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|T3MPO-2||A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C|A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)|Active, not recruiting||Phase 3|600|Anticipated|Ardelyx||2|||f||||f||||||||||2017-10-10 22:27:41.264389|2017-10-10 22:27:41.264389
NCT02686125|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-12-07|||March 2016||2016-03-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|||Registry of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia: Vercise DBS Dystonia Registry|Registry of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia: Vercise DBS Dystonia Registry|Recruiting||N/A|200|Anticipated|Boston Scientific Corporation|||1||f||||t||||||||||2017-10-10 22:27:41.606368|2017-10-10 22:27:41.606368
NCT02686112|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-15|||January 2007||2007-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|POTA||Pregnancy Outcome in Woman With Threatened Abortion|Pregnancy Outcome in Woman With Threatened Abortion|Completed||N/A|3000|Actual|Bnai Zion Medical Center|||1||f||||f||||||||No||2017-10-10 22:27:41.697175|2017-10-10 22:27:41.697175
NCT02686099|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-03-03|||July 2015||2015-07-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|SL360||Sternal Closure With SternaLock 360: First in Man Study|SternaLock 360 First in Man Study: A Prospective, Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Zimmer Biomet||2|||f||||f||||||||No||2017-10-10 22:27:41.768972|2017-10-10 22:27:41.768972
NCT02686086|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Pilot Comparison Study of Vibrating Mesh Versus Standard Jet Nebuliser for Bronchodilator Delivery in COPD|Chronic Obstructive Pulmonary Disease (COPD) Lung Volume and Symptom Scores Following Bronchodilator Therapy Administration by Vibrating Mesh and Standard Jet Nebulisers: A Pilot Comparison Study|Recruiting||N/A|60|Anticipated|Beaumont Hospital||2|||f||||f||||||||No||2017-10-10 22:27:41.874248|2017-10-10 22:27:41.874248
NCT02686073|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2017-07-10|||February 20, 2016|Actual|2016-02-20|July 2017|2017-07-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|||Effect of Maternal Body Mass Index on Labor Progress in Nulliparous Women|Revising the Norms of Labor Progress in Egyptian Nulliparous Women in Relation to Maternal Body Mass Index Categories|Completed||N/A|600|Actual|Cairo University|||3||f||||t||||||||||2017-10-10 22:27:41.961365|2017-10-10 22:27:41.961365
NCT02686060|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-11-28|||April 2016||2016-04-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|FRISBEE||In-line Filtration to Reduce Systemic Inflammatory Response Syndrome in Babies Born Very prEtErm|In-line Filtration to Reduce Systemic Inflammatory Response Syndrome in Babies Born Very prEtErm|Recruiting||N/A|140|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 22:27:42.039871|2017-10-10 22:27:42.039871
NCT02686047|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-14|||September 2014||2014-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparing One Intraarticular Injection of a Novel HYAJOINT Plus With Synvisc-One for the Treatment of Knee OA|Comparing Efficacy and Safety of a Single Intraarticular Injection of a Novel Crosslinked Hyaluronic Acid (HYAJOINT Plus) With Synvisc-One for the Treatment of Knee Osteoarthritis: A Randomized-Controlled, Double-Blind Trial|Completed||Phase 2/Phase 3|132|Actual|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||No||2017-10-10 22:27:42.144383|2017-10-10 22:27:42.144383
NCT02686021|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-01-23|||February 2016||2016-02-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|NovIbu||Potential Benefit of the Combination of Metamizole and Ibuprofen After Third Lower Molar Extraction|Potential Benefit of the Combination of Metamizole and Ibuprofen After Third Lower Molar Extraction|Recruiting||Phase 4|42|Anticipated|University Hospital, Basel, Switzerland||3|||f||||f||||||||Undecided||2017-10-10 22:27:42.381032|2017-10-10 22:27:42.381032
NCT02686008|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-08-23|||December 2016||2016-12-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC|A Pilot Pharmacodynamic Study to Assess the Anti-proliferative Activity a of the Poly ADP Ribose Polymerase (PARP) Inhibitor Olaparib in Patients With Human Papilloma Virus (HPV) Positive and Human Papilloma Virus (HPV) Negative Head and Neck Squamous Cell Carcinoma (HNSCC)|Not yet recruiting||Phase 1|20|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 22:27:42.598489|2017-10-10 22:27:42.598489
NCT02685995|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-10-04|||December 2015||2015-12-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TDC||VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC|Randomized Trial Comparing VectorFlow Tunneled Dialysis Catheter to Palindrome Tunneled Dialysis Catheter|Recruiting||N/A|80|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:27:42.689251|2017-10-10 22:27:42.689251
NCT02685982|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-06-27|||April 2016|Actual|2016-04-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Treating Major Depressive Disorder With Music and Low-frequency Rhythmic Sensory Stimulation|Examining the Effects of Music and Rhythmic Sensory Stimulation on Major Depressive Disorder|Active, not recruiting||N/A|20|Actual|University Health Network, Toronto||1|||f||||t||||||||Yes|Data will be stored and shared through Ontario Brain Institute platform (BRAIN-Code).|2017-10-10 22:27:42.805509|2017-10-10 22:27:42.805509
NCT02685969|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-03-01|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|||Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants|Characterization of Cerebral Amyloid Deposition With 18F‐Flutemetamol PET and of Glucose Metabolism With 18F‐FDG PET in Individuals Enrolled in the ALFA Project.|Recruiting||N/A|440|Anticipated|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation|||1||f||||f||||||||No||2017-10-10 22:27:42.906285|2017-10-10 22:27:42.906285
NCT02685787|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-02-18|||April 2012||2012-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|D_CareGiver||Early Counseling and Support for Alzheimer's Disease Caregivers|Can Early Counseling and Support for Alzheimer's Disease Caregivers Improve Burden? A Multi-centre Active Randomized Clinical Trial in Local Health Services|Recruiting||N/A|230|Anticipated|Azienda Sanitaria Locale N.1 dell'Umbria||2|||f||||t||||||||Undecided||2017-10-10 22:27:44.457175|2017-10-10 22:27:44.457175
NCT02685956|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-04-17|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Observational|||Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test|Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test|Completed||N/A|2500|Actual|Vela Diagnostics|||1||f||||f||||||Samples With DNA|"     Samples collected from an oral or genital site, submitted to a clinical laboratory for the     purpose of testing for the presence of HSV1 or HSV2.      Samples collected in universal viral transport media, using a plastic shaft swab made of     either polyester, cotton, rayon or Dacron.   "|No||2017-10-10 22:27:43.047775|2017-10-10 22:27:43.047775
NCT02685943|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-12-05|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Randomized Trial for Suicidal Patients|"Collaborative Assessment and Management of Suicidality (CAMS) in Comparison to Treatment as Usual (TAU) for Suicidal Patients: a Randomized Controlled Trial"|Active, not recruiting||N/A|80|Actual|Vestre Viken Hospital Trust||2|||f||||f||||||||No|Individual patient data will not be shared/ published|2017-10-10 22:27:43.182505|2017-10-10 22:27:43.182505
NCT02685930|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-11-10|||January 2016||2016-01-01|November 2016|2016-11-01||||January 2017|Anticipated|2017-01-01||Observational|||Pneumonia in the Intensive Care Unit (ICU) Setting|Pneumonia in the Intensive Care Unit (ICU) Setting|Recruiting||N/A|200|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples Without DNA|"     Microbiological: tracheal aspirate, bronchialalveolar lavage, blood cultures, viral PCR     multiplex from respiratory specimen Bronchialalveolar lavage: Cell count and differential   "|No||2017-10-10 22:27:43.290205|2017-10-10 22:27:43.290205
NCT02685917|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-14|||February 2016||2016-02-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Microfracture With/Without Collagen Augmentation in Patients Undergoing High Tibial Osteotomy|Effects of Microfracture With/Without Collagen Augmentation in Patients Undergoing High Tibial Osteotomy: A Randomized, Controlled, Double-Blind Trial|Not yet recruiting||N/A|30|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 22:27:43.409037|2017-10-10 22:27:43.409037
NCT02685904|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-26|||September 2016|Actual|2016-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis|Recruiting||Phase 3|90|Anticipated|TSH Biopharm Corporation Limited||2|||f||||f||||||||Undecided||2017-10-10 22:27:43.514811|2017-10-10 22:27:43.514811
NCT02685891|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-10-10|||June 2016||2016-06-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|BMS||Brain Maturation and Sleep|Exploring Diurnal Changes in Markers of Cortical Plasticity Using Multimodal Imaging in Healthy Children, Adolescents and Adults|Recruiting||N/A|90|Anticipated|University Children's Hospital, Zurich||2|||f||||t||||||||||2017-10-10 22:27:43.618795|2017-10-10 22:27:43.618795
NCT02685878|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-11-16|||September 2015||2015-09-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Outcomes of Women After Obstetric Fistula Repair|Physical, Psychological, and Reproductive Outcomes of Women After Obstetric Fistula Repair|Completed||N/A|297|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||Undecided||2017-10-10 22:27:43.708584|2017-10-10 22:27:43.708584
NCT02685865|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-09-13|||February 12, 2016|Actual|2016-02-12|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|July 10, 2017|Actual|2017-07-10||Interventional|WON-MVP||Comparison of FCSEMS and Plastic Stents|Randomized Trial Comparing Fully Covered, Self-Expanding Metal Stent and Plastic Stents for Endoscopic Ultrasound-guided Drainage of Walled-off Necrosis|Active, not recruiting||N/A|60|Actual|Florida Hospital||2|||f||||t||||||||||2017-10-10 22:27:43.785411|2017-10-10 22:27:43.785411
NCT02685852|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-10-10|||February 2016||2016-02-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||A Pilot Study Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia Post-RYGB|A Pilot Study Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia Post-RYGB|Recruiting||Phase 2|12|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-10 22:27:43.905428|2017-10-10 22:27:43.905428
NCT02685839|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-05-22|||May 2015||2015-05-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Development of an Intelligent POWER Rehabilitation Cluster Machine and Its Clinical Testing and Assessment||Enrolling by invitation||N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||Undecided||2017-10-10 22:27:44.01167|2017-10-10 22:27:44.01167
NCT02685826|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-27|||April 25, 2016|Actual|2016-04-25|September 2017|2017-09-01|August 8, 2024|Anticipated|2024-08-08|April 1, 2022|Anticipated|2022-04-01||Interventional|||A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Subjects With Newly Diagnosed Multiple Myeloma|A Phase 1b Multicenter, Open-label Study to Determine the Recommended Dose and Regimen of Durvalumab (MEDI4736) (DUR) in Combination With Lenalidomide (LEN) With and Without Low-dose Dexamethasone (Dex) in Subjects With Newly Diagnosed Multiple Myeloma (NDMM)|Suspended||Phase 1|121|Anticipated|Celgene||3||"FDA placed a full clinical hold on the study. The decision by the FDA was based on risks   identified in other trials for an anti-PD-1 antibody, pembrolizumab."|f||||f||||||||||2017-10-10 22:27:44.11114|2017-10-10 22:27:44.11114
NCT02685813|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-03-07|||February 2016||2016-02-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01|1 Year|Observational [Patient Registry]|||Incidence of Pregnancies and Births With Spina Bifida in Denmark in 2008-2014|Incidence of Pregnancies and Births With Spina Bifida in Denmark in 2008-2014|Recruiting||N/A|350000|Anticipated|Aarhus University Hospital|||1||f||||f||||||||Yes||2017-10-10 22:27:44.311975|2017-10-10 22:27:44.311975
NCT02685800|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-07-26|||October 2015||2015-10-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|10 Months|Observational [Patient Registry]|||Recurrent Failures in assIsted Reproductive Techniques (The FIRST Registry)|A Registry on Outcomes in Women Undergoing Assisted Reproductive Techniques After Recurrent Failures|Recruiting||N/A|624|Anticipated|Casa Sollievo della Sofferenza IRCCS|||1||f||||t||||||||Yes||2017-10-10 22:27:44.385772|2017-10-10 22:27:44.385772
NCT02685605|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-07-30|||June 2016||2016-06-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|June 2020|Anticipated|2020-06-01||Interventional|INTRAGO-II||Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme|A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II)|Recruiting||Phase 3|314|Anticipated|Universitätsmedizin Mannheim||2|||f||||t||||||||||2017-10-10 22:27:46.614659|2017-10-10 22:27:46.614659
NCT02685774|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-08-08|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, 2-way Crossover Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500 mg in Healthy Male Volunteers|Completed||Phase 1|26|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:27:44.574902|2017-10-10 22:27:44.574902
NCT02685761|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-09-12|||September 2015||2015-09-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Skin Incisions and Wound Complication Rates for C-sections in Obese Women|Randomized Controlled Trial of Wound Complication Rates Between Low Transverse, Midline Vertical, and High Transverse Skin Incisions in Women With a BMI of 40 or Above Undergoing a Cesarean Section for Delivery|Recruiting||N/A|309|Anticipated|Albany Medical College||3|||f||||t||||||||No||2017-10-10 22:27:44.670394|2017-10-10 22:27:44.670394
NCT02685748|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-08-08|||July 20, 2017|Actual|2017-07-20|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Aspirin in Young Psychotic Patients|Aspirin as Adjuvant Therapy in Young Psychotic Patients|Recruiting||Phase 2/Phase 3|100|Anticipated|Clinic for Psychiatric Disorders, Dr Laza Lazarevic||2|||f||||t|f|f||||||||2017-10-10 22:27:44.763859|2017-10-10 22:27:44.763859
NCT02685735|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-05-30|||February 2016||2016-02-01|May 2017|2017-05-01|February 2022|Anticipated|2022-02-01|December 2021|Anticipated|2021-12-01||Interventional|||Predicting, Understanding and Speeding Recovery After TKA|Predicting, Understanding, and Speeding Recovery After Total Knee Arthroplasty|Recruiting||Phase 4|300|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 22:27:44.885379|2017-10-10 22:27:44.885379
NCT02685722|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-18|||January 2012||2012-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|UC-MSCs||UC-MSCs Gel Treatment Difficult Healing of Skin Ulcers|Umbilical Cord Mesenchymal Stem Cells Between Gel Treatment Difficult Skin Ulcer Healing Efficacy and Safety of Random, Open, Before-and-after Study|Completed||Phase 1|20|Actual|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 22:27:45.149459|2017-10-10 22:27:45.149459
NCT02685709|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-22|||February 2016||2016-02-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|MPOWERED||Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly|A Phase 3, Randomized, Active Controlled Study to Evaluate Maintenance of Response, Safety and Patient Reported Outcomes in Acromegaly Patients Treated With Octreotide Capsules vs. Parenteral Somatostatin Receptor Ligands|Recruiting||Phase 3|150|Anticipated|Chiasma, Inc.||4|||f||||t||||||||||2017-10-10 22:27:45.266118|2017-10-10 22:27:45.266118
NCT02685696|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-14|||October 2013||2013-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Surgical Site Infection in Caesarean Section Using Alexis O Compared to Metal Retractors|To Investigate the Incidence of Surgical Site Infection in Low Risk Women Having a First Time Planned Caesarean Section Using the Alexis O Retractor and the Traditional Metal Retractor|Completed||N/A|200|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||No||2017-10-10 22:27:45.613161|2017-10-10 22:27:45.613161
NCT02685683|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2017-09-28|||April 4, 2016|Actual|2016-04-04|September 2017|2017-09-01|October 29, 2019|Anticipated|2019-10-29|January 23, 2018|Anticipated|2018-01-23||Interventional|||Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease|A Phase 2, Open-label Study to Explore the Pharmacodynamic and Clinical Effects of Mongersen (GED-0301) in Subjects With Active Crohn's Disease|Recruiting||Phase 2|20|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 22:27:45.764315|2017-10-10 22:27:45.764315
NCT02685670|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2017-03-14|||February 2016||2016-02-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|MatchCART||Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma|A Phase I/II Study of Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 Chimeric Antigen Receptor T-Cells in Patients With Refractory CD19+ B-lineage Leukemia/Lymphoma|Recruiting||Phase 1/Phase 2|20|Anticipated|The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine||1|||f||||t||||||||Undecided||2017-10-10 22:27:45.878146|2017-10-10 22:27:45.878146
NCT02685657|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-02-18|||September 2016||2016-09-01|February 2016|2016-02-01||||January 2018|Anticipated|2018-01-01||Interventional|||Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer|A Phase II Randomized Multicenter Open Label Prospective Study of Neoadjuvant Chemotherapy Docetaxel With or Without MEK Inhibitor SELUMETINIB in Patients With Early and Locally Advanced Triple Negative Breast Cancer|Not yet recruiting||Phase 2|164|Anticipated|Russian Academy of Medical Sciences||2|||f||||f||||||||No||2017-10-10 22:27:46.022949|2017-10-10 22:27:46.022949
NCT02685644|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-15|2016-02-15|||April 2016||2016-04-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Association Between Laparoscopic Removal of Endometriomas and Anti-mullerian Hormone Levels|Effects of Laparoscopic Endometrioma Removal on Anti-mullerian Hormone Levels|Not yet recruiting||N/A|102|Anticipated|Ankara University|||1||f||||f||||||Samples Without DNA|"     Blood serum samples   "|Yes||2017-10-10 22:27:46.132001|2017-10-10 22:27:46.132001
NCT02685631|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-02-06|||July 2015||2015-07-01|February 2017|2017-02-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Observational|RESiN||Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study|Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study|Recruiting||N/A|1000|Anticipated|Vanderbilt-Ingram Cancer Center|||1||f||||f||||||||Undecided|We plan on reporting group outcomes by tumor type or subtype. Individual records will be subject to HIPAA rules|2017-10-10 22:27:46.241383|2017-10-10 22:27:46.241383
NCT02685618|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-10-05|||February 2016||2016-02-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|ENDO-RCA||Endothelial Dysfunction in Resuscitated Cardiac Arrest|Safety and Efficacy of Low-dose Prostacyclin Administration and Blood Pressure Target in Addition to Standard Therapy, as Compared to Standard Therapy Alone, in Post-cardiac-arrest-syndrome Patients - a Randomized, Controlled, Double-blinded Investigator-initiated Trial.|Active, not recruiting||Phase 2|51|Actual|Rigshospitalet, Denmark||4|||f||||t||||||||||2017-10-10 22:27:46.463828|2017-10-10 22:27:46.463828
NCT02684513|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-09-14|||June 14, 2016|Actual|2016-06-14|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Oral Carbohydrate Consumption Prior to Cesarean Section|Impact of Oral Carbohydrate Consumption Prior to Cesarean Section on Preoperative Well-being|Recruiting||N/A|138|Anticipated|University of Florida||3|||f||||f||||||||||2017-10-10 22:27:56.945286|2017-10-10 22:27:56.945286
NCT02685592|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-09-04|||February 2016||2016-02-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|LM PDT||Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream|Photodynamic Therapy for Melanoma Precursor Lesion Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion (BF-200 ALA) as a Light Sensitizing Cream|Recruiting||Phase 4|15|Anticipated|Joint Authority for Päijät-Häme Social and Health Care||1|||f||||f||||||||No||2017-10-10 22:27:46.849444|2017-10-10 22:27:46.849444
NCT02685579|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-12-25|||June 2016||2016-06-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Observational|OSATDV||The Effect of Obstructive Sleep Apnea Treatment on Dizziness, Vertigo|The Effect of Obstructive Sleep Apnea Treatment on Dizziness, Vertigo|Withdrawn||N/A|0|Actual|Wolfson Medical Center|||1||f||||f||||||||No||2017-10-10 22:27:46.978528|2017-10-10 22:27:46.978528
NCT02685566|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-02-17|||August 2015||2015-08-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Fujifilm FFDM and DBT Reader Training Program|A Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Adequacy of the Fujifilm Full Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) Reader Training Program - A Pilot Study|Completed||Phase 2|100|Actual|Fujifilm Medical Systems USA, Inc.||2|||f||||f||||||||No||2017-10-10 22:27:47.061992|2017-10-10 22:27:47.061992
NCT02685553|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2017-03-04|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project|"Use of Near Infrared Technology as a Guide in Laparoscopic Resection of Pancreatic Lesions: the COLPAN Colour-and-resect Project"|Completed||Phase 1|10|Anticipated|Universita di Verona||1|||f||||||||||||||2017-10-10 22:27:47.155434|2017-10-10 22:27:47.155434
NCT02685540|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-04-03|||January 2016||2016-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Death Rate in Anesthesia: A Study in a Tertiary Hospital|Death Rate in Anesthesia: A Retrospective Study of Five Years Period From a Tertiary Hospital|Recruiting||N/A|792|Anticipated|University of Jordan|||1||f||||f||||||||No||2017-10-10 22:27:47.238389|2017-10-10 22:27:47.238389
NCT02685527|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-05-17|||February 2015||2015-02-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Observational|||Acute Gastroenteritis: Development of PCR Analysis and Algorithm for Fast Clarification of Isolation Indication|Acute Gastroenteritis: Development of PCR Analysis and Algorithm/Criteria for Fast Clarification of Isolation Indication|Completed||N/A|285|Actual|University of Southern Denmark|||1||f||||f||||||Samples Without DNA|"     feces for bacterial and virus determination   "|||2017-10-10 22:27:47.329979|2017-10-10 22:27:47.329979
NCT02685514|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-11-09|||October 2015||2015-10-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|HIFURGD||A Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease|A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease|Completed||N/A|22|Actual|The University of Hong Kong||1|||f||||t||||||||Undecided||2017-10-10 22:27:47.392168|2017-10-10 22:27:47.392168
NCT02685501|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-02-23|||January 2016||2016-01-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Menorrhagia, Dysmenorrhea and Iron Deficiency Among Young Women Soldiers and Effect on Activity|Menorrhagia, Dysmenorrhea and Iron Deficiency Among Young Women Soldiers|Recruiting||N/A|800|Anticipated|Hadassah Medical Organization|||2||f||||f||||||Samples Without DNA|"     CBC, ferritin   "|Undecided||2017-10-10 22:27:47.477998|2017-10-10 22:27:47.477998
NCT02685488|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-14|2016-10-28|||October 2015||2015-10-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Investigating Transcranial Ultrasound as a Potential Intervention for Depression|A Pilot Study: Investigating Transcranial Ultrasound as a Potential Intervention for Mild to Moderate Depression|Completed||N/A|26|Actual|University of Arizona||2|||f||||f||||||||No||2017-10-10 22:27:47.560549|2017-10-10 22:27:47.560549
NCT02685475|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-03-14|||February 2015||2015-02-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Axillary Block Properties in Diabetic Patients|Comparison of Ultrasound-Guided Axillary Brachial Plexus Block Properties in Diabetic and Non-diabetic Patients: A Prospective Observational Study|Completed||N/A|71|Actual|Istanbul University|||2||f||||f||||||||No||2017-10-10 22:27:47.647558|2017-10-10 22:27:47.647558
NCT02685462|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-12|||January 2016||2016-01-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin|A Phase 1 Open-Label Study in Healthy Adult Subjects to Assess the Effect of Cenicriviroc Mesylate (CVC) on the Pharmacokinetics (PK) of HMG-CoA Reductase Inhibitors (Rosuvastatin, Atorvastatin and Simvastatin), Caffeine and Digoxin|Active, not recruiting||Phase 1|36|Actual|Tobira Therapeutics, Inc.||6|||f||||f||||||||||2017-10-10 22:27:47.773419|2017-10-10 22:27:47.773419
NCT02685449|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-07-28|||February 2016||2016-02-01|January 2016|2016-01-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.|Insulin Requirement for Pure- Protein Meal in Children With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion - a Cross-over, Randomized Trial.|Recruiting||Phase 4|70|Anticipated|Medical University of Warsaw||2|||f||||f||||||||No||2017-10-10 22:27:47.952229|2017-10-10 22:27:47.952229
NCT02685423|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-05-24|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|LUMA||Light-deprivation Utilized to Mitigate Amblyopia|Optimized Visual Recovery in Adult Human Amblyopia Through Binocular Deprivation|Active, not recruiting||N/A|8|Anticipated|State University of New York College of Optometry||2|||f||||t||||||||Undecided||2017-10-10 22:27:48.195597|2017-10-10 22:27:48.195597
NCT02685410|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-02-10|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|June 18, 2016|Actual|2016-06-18|June 18, 2016|Actual|2016-06-18||Interventional|||Formative Research for an HIV Videogame for Young Black Women|Formative Research for an HIV Videogame for Young Black Women|Completed||N/A|21|Actual|Yale University||1|||f||||f||||||||No||2017-10-10 22:27:48.286437|2017-10-10 22:27:48.286437
NCT02685397|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-03-16|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|August 2041|Anticipated|2041-08-01|April 2025|Anticipated|2025-04-01||Interventional|PCS IX||Management of Castration-Resistant Prostate Cancer With Oligometastases|The Role of Stereotactic Body Radiotherapy in the Management of Castration-Resistant Prostate Cancer With Oligometastases: An Adaptive Phase II/III Randomized Trial.|Recruiting||Phase 2/Phase 3|130|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||f||||||||||2017-10-10 22:27:48.384932|2017-10-10 22:27:48.384932
NCT02685384|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-09-18|||January 2012||2012-01-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|PREVENTD||Post ACA Reform: Evaluation of Community Health Center Care of Diabetes|Post ACA Reform: Evaluation of Community Health Center Care of Diabetes|Active, not recruiting||N/A|2073222|Anticipated|Oregon Health and Science University|||2||f||||f||||||||||2017-10-10 22:27:48.512872|2017-10-10 22:27:48.512872
NCT02685371|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-02-12|||February 2016||2016-02-01|February 2016|2016-02-01||||February 2017|Anticipated|2017-02-01||Observational|SCOPED||Septal Shift for the Diagnosis of COnstrictive Pericarditis: The Impact of Inspiratory Effort Quantification on Deep Breathing Manoeuvres|Septal Shift for the Diagnosis of COnstrictive Pericarditis: The Impact of Inspiratory Effort Quantification on Deep Breathing Manoeuvres (SCOPED)|Not yet recruiting||N/A|60|Anticipated|Université de Sherbrooke|||1||f||||||||||||||2017-10-10 22:27:48.750242|2017-10-10 22:27:48.750242
NCT02685358|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-07-07|||March 1, 2017|Actual|2017-03-01|July 2017|2017-07-01|September 30, 2020|Anticipated|2020-09-30|February 29, 2020|Anticipated|2020-02-29||Interventional|||An RCT of a Primary Care-Based PTSD Intervention: Clinician-Supported PTSD Coach|An RCT of a Primary Care-Based PTSD Intervention: Clinician-Supported PTSD Coach|Recruiting||N/A|260|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:27:48.83061|2017-10-10 22:27:48.83061
NCT02685345|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-11-22|||January 2016||2016-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin|A Phase 2, Randomized, Double-blind, Placebo-controlled, add-on Study of DS-8500a in Japanese Patients With Type 2 Diabetes Mellitus Receiving Sitagliptin|Completed||Phase 2|85|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||Undecided||2017-10-10 22:27:48.934717|2017-10-10 22:27:48.934717
NCT02685332|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-03-23|||March 31, 2016|Actual|2016-03-31|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA|Phase I Dose Escalation Trial of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation (SB-PBI) For Early Stage Breast Cancer|Recruiting||Phase 1|75|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 22:27:49.062144|2017-10-10 22:27:49.062144
NCT02685319|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-06-19|||February 2016||2016-02-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|S48||Mapping Human Muscle Satellite Cell Fate By Real-Time Imaging|Mapping Human Muscle Satellite Cell Fate By Real-Time|Completed||N/A|7|Actual|Purdue University||1|||f||||f||||||||No||2017-10-10 22:27:49.157835|2017-10-10 22:27:49.157835
NCT02685306|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-03-08|||March 2016||2016-03-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer|A Phase II Study to Determine the Pathological Complete Response Rate and Immunomodulatory Effects of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer|Withdrawn||Phase 2|0|Actual|Peregrine Pharmaceuticals||2|||f||||f||||||||Undecided||2017-10-10 22:27:49.231504|2017-10-10 22:27:49.231504
NCT02685293|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-03-15|||December 9, 2016|Actual|2016-12-09|March 2017|2017-03-01|May 3, 2019|Anticipated|2019-05-03|May 3, 2019|Anticipated|2019-05-03||Interventional|||Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPD|A Randomized, Phase IIIb, Two-period , Double-blind, Two-treatment, Chronic-dosing (7 Days), Single-center Crossover Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease, Compared With Placebo|Recruiting||Phase 3|40|Anticipated|Pearl Therapeutics, Inc.||2|||f||||f||||||||Yes|AstraZeneca's policy is to share data with researchers if the request is in scope of our policy. The policy and additional information can be found on astrazenecaclinicaltrials.com.|2017-10-10 22:27:49.31854|2017-10-10 22:27:49.31854
NCT02685280|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-17|||October 2007||2007-10-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Rechargeable Neurostimulators in Deep Brain Stimulation for Psychiatric Disorders|Feasibility Study Regarding the Implantation and Use of Rechargeable Neurostimulators in Deep Brain Stimulation for Psychiatric Disorders (Either Obsessive-compulsive Disorder or Major Depression)|Completed||N/A|12|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||t||||||||No||2017-10-10 22:27:49.432407|2017-10-10 22:27:49.432407
NCT02685267|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-14|||February 2016||2016-02-01|September 2017|2017-09-01||||December 2018|Anticipated|2018-12-01||Interventional|Doce/Enza||Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer|A Phase II Randomized Prospective Trial of Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer (CRPC) Patients Progressing on Enzalutamide|Active, not recruiting||Phase 2|9|Actual|Prostate Cancer Clinical Trials Consortium||2|||f||||||||||||||2017-10-10 22:27:49.560006|2017-10-10 22:27:49.560006
NCT02685254|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-10-25|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Structured Skills Training Group in Treatment of ADHD in Adults|Effects of Structured Skills Training Group in Treatment of ADHD in Adults: a Controlled Multicentre Study|Active, not recruiting||N/A|120|Anticipated|University of Oslo||2|||f||||f||||||||No|Data from each site will be anonymised in the final analyses|2017-10-10 22:27:49.667736|2017-10-10 22:27:49.667736
NCT02685241|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-10-24|||June 2016||2016-06-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Monitoring of Biomarkers by Portable Breath Gas Sensors: an Exploratory Study|Monitoring of Biomarkers by Portable Breath Gas Sensors: an Exploratory Study|Recruiting||N/A|200|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 22:27:49.770995|2017-10-10 22:27:49.770995
NCT02683772|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-04-11|||February 2016||2016-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:28:09.216147|2017-10-10 22:28:09.216147
NCT02685228|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-13|||March 2016||2016-03-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SLOWDOSE001||Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer|Clinical Study of Low Dose of Decitabine Combined With Gemcitabine in First-line Treatment of Locally Advanced, Unresectable or Metastatic Pancreatic Cancer|Not yet recruiting||N/A|20|Anticipated|First Hospital of Jilin University||2|||f||||t||||||||No||2017-10-10 22:27:49.864694|2017-10-10 22:27:49.864694
NCT02685215|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-22|||March 2016||2016-03-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Prognostic Factors , Morbidity and Mortality in Patients With Muscular Dystrophies Admitted in ICU|Prognostic Factors, Morbidity, Mortality and Long Term Survival in Patients With Muscular Dystrophies Admitted in Intensive Care Unit|Active, not recruiting||N/A|280|Anticipated|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-10 22:27:49.936692|2017-10-10 22:27:49.936692
NCT02685202|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-05-17|||March 2016||2016-03-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea|The Course of Temporomandibular Pain in Response to Mandibular Advancement Therapy Among Adults With Temporomandibular Disorder and Obstructive Sleep Apnea|Completed||N/A|9|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||No||2017-10-10 22:27:50.019197|2017-10-10 22:27:50.019197
NCT02685189|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-17|||July 2006||2006-07-01|February 2016|2016-02-01|May 10, 2016|Actual|2016-05-10|May 10, 2016|Actual|2016-05-10||Observational|||Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)|Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)(WS)(ISNHP)|Terminated||N/A|55|Anticipated|InfaCare Pharmaceuticals Corporation|||2|Study stopped for business reasons and not for any safety reasons.|f||||f||||||||||2017-10-10 22:27:50.100854|2017-10-10 22:27:50.100854
NCT02685176|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-05-19|||September 2016||2016-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Head and Torso Rewarming Using a Human Model for Severe Hypothermia|Efficacy of Head and Torso Rewarming by Using a Human Model for Severe Hypothermia|Recruiting||N/A|8|Anticipated|University of Manitoba||3|||f||||f||||||||No||2017-10-10 22:27:50.167953|2017-10-10 22:27:50.167953
NCT02685163|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-18|||July 2015||2015-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Natural Antioxidant Ice-cream, Oxidative Stress and Vascular Function|Natural Antioxidant Ice-cream Acutely Reduces Oxidative Stress, Improves Vascular Function and Physical Performance in Healthy Subjects|Completed||N/A|14|Actual|University of Roma La Sapienza||2|||f||||f||||||||No||2017-10-10 22:27:50.268487|2017-10-10 22:27:50.268487
NCT02685150|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-02-19|||January 2016||2016-01-01|February 2016|2016-02-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease|The Role of Endoscopic Tri-Modal Imaging in Distinguishing Functional Dyspepsia From Reflux Disease|Recruiting||N/A|200|Anticipated|Chinese PLA General Hospital||4|||f||||t||||||||Yes|Data are available from the W Wang, MD.|2017-10-10 22:27:50.351786|2017-10-10 22:27:50.351786
NCT02685137|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-12|||April 2002||2002-04-01|January 2016|2016-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety of Stannsoporfin in Neonates|A Multicenter Study to Evaluate the Efficacy and Safety of Tin Mesoporphyrin (Stannsoporfin) to Reduce the Need for Phototherapy in Term and Near Term Infants.|Completed||Phase 3|185|Actual|InfaCare Pharmaceuticals Corporation||2|||f||||t||||||||||2017-10-10 22:27:50.503376|2017-10-10 22:27:50.503376
NCT02685124|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-12|||September 2015||2015-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|METABORANGE||Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).|"Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans: a Comparative Study Between Bahia and Cara Cara Orange Varieties."|Completed||Early Phase 1|21|Actual|University of Sao Paulo||3|||f||||t||||||||Yes|February 2017|2017-10-10 22:27:50.617344|2017-10-10 22:27:50.617344
NCT02685111|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-26|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)|Intermittent Every Other Days of 5 Shot-filgrastim Compared With Single Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide Chemotherapy (Intermittent G-CSF 105)|Recruiting||Phase 2|162|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-10 22:27:50.69513|2017-10-10 22:27:50.69513
NCT02685098|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-08-08|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|CHAMP||A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation|A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation|Recruiting||Phase 1|16|Anticipated|Indiana University||4|||f||||t||||||||||2017-10-10 22:27:50.86628|2017-10-10 22:27:50.86628
NCT02685085|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-12|||February 2016||2016-02-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Combined Method for Induction of Labor||Recruiting||Phase 2|300|Anticipated|Woman's Health University Hospital, Egypt||3|||f||||t||||||||Undecided||2017-10-10 22:27:51.015196|2017-10-10 22:27:51.015196
NCT02685072|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-06-27|||April 7, 2016|Actual|2016-04-07|June 2017|2017-06-01|September 1, 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|PANS||Progesterone Augmentation of Nicotine Replacement Therapy Study|Progesterone Augmentation of Nicotine Replacement Therapy Study|Recruiting||Phase 4|50|Anticipated|Yale University||2|||f||||t||||||||No|we will only make aggregate de-identified data available|2017-10-10 22:27:51.106585|2017-10-10 22:27:51.106585
NCT02685059|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-25|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|GeparNuevo||Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer|A Randomized Phase II Study to Investigate the Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Containing Chemotherapy in Triple Negative Breast Cancer (GeparNuevo)|Recruiting||Phase 2|174|Anticipated|German Breast Group||5|||f||||t||||||||||2017-10-10 22:27:51.226495|2017-10-10 22:27:51.226495
NCT02683382|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-11|||March 2016||2016-03-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|SDE||Effects of a Moisturizing Product on Dry Eye and Skin||Completed||N/A|52|Actual|Aromtech Ltd.||3|||f||||f||||||||No||2017-10-10 22:28:12.438591|2017-10-10 22:28:12.438591
NCT02685046|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|ImPACCT||Imatinib as Pre-operative Anti-Colon Cancer Targeted Therapy|Targeted Therapy With Imatinib for Treatment of Poor Prognosis Mesenchymal-type Resectable Colon Cancer: a Proof-of-concept Study in the Preoperative Window Period.|Recruiting||Phase 2|27|Anticipated|UMC Utrecht||1|||f||||t||||||||Undecided||2017-10-10 22:27:51.355043|2017-10-10 22:27:51.355043
NCT02685033|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-21|||March 15, 2016|Actual|2016-03-15|August 2017|2017-08-01|December 23, 2017|Anticipated|2017-12-23|December 23, 2017|Anticipated|2017-12-23||Interventional|DAL-MD-04||Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Subjects With Osteomyelitis|A Phase 2, Single-center, Open-label, Randomized, Comparator-controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Subjects With Osteomyelitis Known or Suspected to be Due to Gram- Positive Organisms|Active, not recruiting||Phase 2|80|Anticipated|Durata Therapeutics Inc., an affiliate of Allergan plc||2|||f||||f|f|f||||||||2017-10-10 22:27:51.463462|2017-10-10 22:27:51.463462
NCT02685007|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-06-06|||March 2, 2016|Actual|2016-03-02|June 2017|2017-06-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study|RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study|Recruiting||N/A|120|Anticipated|Takeda|||1||f||||f||||||||||2017-10-10 22:27:51.664072|2017-10-10 22:27:51.664072
NCT02684994|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-02-12|||October 2014||2014-10-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|CPT||Client-directed Cognitive Processing Therapy|Client-directed Cognitive Processing Therapy|Recruiting||N/A|70|Anticipated|University of Indianapolis||1|||f||||f||||||||No||2017-10-10 22:27:51.753892|2017-10-10 22:27:51.753892
NCT02684981|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-06-22|||November 11, 2015|Actual|2015-11-11|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|||Patient Convenience Study (RE-SONANCE)|Non-interventional Study Describing Patients´ Perception on Anticoagulant Treatment and Treatment Convenience When Treated With Pradaxa or Vitamine K Antagonist for Stroke Prevention in Non-Valvular Atrial Fibrillation|Completed||N/A|9513|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-10 22:27:51.851123|2017-10-10 22:27:51.851123
NCT02684968|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-05-01|||March 2016||2016-03-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Effects of Continuous Bilateral QL Analgesia After Open Abdominal Surgery|The Effects of Continuous Bilateral Quadratus Lumborum Analgesia on Pain, Opioid Consumption, and Opioid-related Complications After Open Abdominal Surgery: A Randomized Controlled Trial|Recruiting||Phase 4|126|Anticipated|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-10 22:27:51.959508|2017-10-10 22:27:51.959508
NCT02684955|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-01-12|||February 2016||2016-02-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|Neuro-E-CPR||Non-invasive Neurological Evaluation During CPR|Non-invasive Neurological Evaluation During Cardiopulmonary Resuscitation for Out of Hospital Cardiac Arrest Patients Neuro-E-CPR Study|Recruiting||N/A|150|Anticipated|University Hospital, Grenoble|||1||f||||t||||||||Undecided||2017-10-10 22:27:52.042484|2017-10-10 22:27:52.042484
NCT02684942|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-05-29|2016-10-12||October 2012||2012-10-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of Meperidine and Fentanyl on Pain Scale and QOL in Brachytherapy|Comparison of Meperidine and Fentanyl on Pain Scale and Quality of Life in Cervical Cancer Patients Receiving Brachytherapy: A Double-blind, Randomized Controlled Trial|Completed||Phase 4|40|Actual|Chulabhorn Cancer Center||6|||f||||t||||||||Yes||2017-10-10 22:27:52.154891|2017-10-10 22:27:52.154891
NCT02684929|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-18|||April 2013||2013-04-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Chronic Dietary Exposure to Branched Chain Amino Acids|Effects of Chronic Dietary Exposure to Branched Chain Amino Acids on Insulin Sensitivity Measures in Healthy Vegans and Omnivores|Completed||N/A|16|Actual|Charles University, Czech Republic||2|||f||||f||||||||Yes||2017-10-10 22:27:52.612278|2017-10-10 22:27:52.612278
NCT02684916|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-09-21|||October 2015||2015-10-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Chiropractic Treatment for Headache Among Children Aged 7-14|Effectiveness of Chiropractic Manipulation Treatment Versus Placebo Manipulation on Children Aged 7-14 Years With Headache and Musculoskeletal Problems. A Randomized Clinical Trial|Recruiting||N/A|200|Anticipated|Nordic Institute of Chiropractic and Clinical Biomechanics||2|||f||||f||||||||No||2017-10-10 22:27:52.716828|2017-10-10 22:27:52.716828
NCT02684903|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-13|||February 2016||2016-02-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|CAPS||Coaching Alternative Parenting Strategies (CAPS) Study|Coaching Alternative Parenting Strategies (CAPS) Study: Targeting Neurobiological and Behavioral Mechanisms of Self-regulation in High-risk Families|Enrolling by invitation||N/A|250|Anticipated|University of Oregon||2|||f||||t||||||||||2017-10-10 22:27:52.814501|2017-10-10 22:27:52.814501
NCT02684890|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-11-12|||March 2016||2016-03-01|November 2016|2016-11-01||||February 2018|Anticipated|2018-02-01||Observational|EMSLT||Detection of Emotions in a Spoken Language Among Tinnitus Patients|Detection of Emotions in a Spoken Language Among Tinnitus Patients|Recruiting||N/A|24|Anticipated|Wolfson Medical Center|||2||f||||f||||||||No||2017-10-10 22:27:53.192344|2017-10-10 22:27:53.192344
NCT02684877|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-13|2016-04-28|||January 2015||2015-01-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Fatigue One Year After ICU Discharge|Fatigue in Intensive Care Survivors One Year After Discharge|Completed||N/A|56|Actual|Università degli Studi di Ferrara|||1||f||||f||||||||Undecided||2017-10-10 22:27:53.300778|2017-10-10 22:27:53.300778
NCT02684864|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-02-12|||February 2016||2016-02-01|February 2016|2016-02-01|February 2024|Anticipated|2024-02-01|February 2021|Anticipated|2021-02-01||Observational|MenTOR||Meniscal Tear and Osteoarthritis Risk (MenTOR)|Does the Biological Response to Degenerative Meniscal Tears or to Their Intervention Predict Future Osteoarthritis?: The Meniscal Tear and Osteoarthritis Risk (MenTOR) Study|Not yet recruiting||N/A|313|Anticipated|University of Oxford|||1||f||||f||||||Samples With DNA|"     Blood samples (plasma, serum, DNA where consent is given), urine, synovial fluid (where an     appropriate clinically indicated procedure has been carried out to allow access).   "|No||2017-10-10 22:27:53.411182|2017-10-10 22:27:53.411182
NCT02684851|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-10-20|||October 2012||2012-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|TXA||The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery|The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery|Active, not recruiting||Phase 3|65|Actual|Carolinas Healthcare System||2|||f||||t||||||||Undecided|undecided|2017-10-10 22:27:53.541269|2017-10-10 22:27:53.541269
NCT02684838|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-26|||March 2016||2016-03-01|September 2017|2017-09-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Observational|VIGILANT||Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry|Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel® Wafer (Carmustine Implant) Used in Usual Medical Practice|Recruiting||N/A|500|Anticipated|Arbor Pharmaceuticals, Inc.|||1||f||||f|f|f||||Samples With DNA|"     Available biomarker data will be collected (e.g., MGMT, EGFR, and IDH 1&2) and exploratory     patient survival analysis will be conducted based upon biomarker status.   "|||2017-10-10 22:27:53.729825|2017-10-10 22:27:53.729825
NCT02684825|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-07-02|||October 2015||2015-10-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Interventional|SAFFO||Detection of Silent Atrial Fibrillation aFter Ischemic StrOke|Detection of Silent Atrial Fibrillation aFter Ischemic StrOke (SAFFO) Guided by Implantable Loop Recorder. Multicentre Italian Trial Based on Stroke Unit Network With Paired Cardio-Arrhythmology Units (Italian Neurocardiology Unit Network)|Recruiting||Phase 4|424|Anticipated|Azienda Policlinico Umberto I||2|||f||||t||||||||||2017-10-10 22:27:54.014409|2017-10-10 22:27:54.014409
NCT02684812|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-12|||July 2012||2012-07-01|February 2016|2016-02-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|ULTRA||Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.|Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage. A Prospective, Randomized, Multicenter Study.|Recruiting||Phase 2/Phase 3|950|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||Undecided||2017-10-10 22:27:54.145784|2017-10-10 22:27:54.145784
NCT02684799|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-04-18|||January 2016||2016-01-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination|A Phase 1, Single and Multiple-Dose, Open-Label Study in Healthy Subjects to Assess the Effect of the Acid Reducing Agents, Omeprazole (OME) and Famotidine (FAM), on the Pharmacokinetics (PK) of Cenicriviroc Mesylate (CVC)|Active, not recruiting||Phase 1|48|Actual|Tobira Therapeutics, Inc.||6|||f||||f||||||||||2017-10-10 22:27:54.279786|2017-10-10 22:27:54.279786
NCT02684786|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-17|||March 2016||2016-03-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension|A Phase I Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension|Not yet recruiting||Phase 1|30|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:27:54.381028|2017-10-10 22:27:54.381028
NCT02684773|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-04-25|||July 2014||2014-07-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|INHD||In-Centre Nocturnal Hemodialysis (INHD): A Long-Term Follow-Up Study|Impact Of In-Centre Nocturnal Hemodialysis On Cardiac Remodeling In End-Stage Renal Disease: A Long-Term Follow-Up Study|Completed||N/A|67|Actual|St. Michael's Hospital, Toronto|||2||f||||f||||||Samples Without DNA|"     Serum and Plasma sample collection   "|No||2017-10-10 22:27:54.496143|2017-10-10 22:27:54.496143
NCT02684760|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-06-14|||February 2016||2016-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Bioavailability Study Of PF-06651600 In Healthy Subjects|A Phase 1, Open Label, Single-dose 3-way Crossover Study To Evaluate The Relative Bioavailability Of A Solid Dose Formulation Of Pf-06651600 Under Fasting Conditions And The Effect Of A High Fat Meal On The Bioavailability Of The Solid Dosage Formulation Of Pf-06651600 In Healthy Subjects|Completed||Phase 1|14|Actual|Pfizer||6|||f||||f||||||||||2017-10-10 22:27:54.596126|2017-10-10 22:27:54.596126
NCT02684747|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-06-21|||February 2016||2016-02-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|||Detecting Autologous Transfusion by Measuring Alterations in the Dynamics of Red Blood Cell Maturation and Recycling|Detecting Autologous Transfusion by Measuring Alterations in the Dynamics of Red Blood Cell Maturation and Recycling|Active, not recruiting||Early Phase 1|40|Anticipated|University of Utah||2|||f||||t||||||||No||2017-10-10 22:27:54.705751|2017-10-10 22:27:54.705751
NCT02684734|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-17|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|PROVE-UC||Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis|Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis|Not yet recruiting||N/A|394|Anticipated|University of British Columbia|||2||f||||f||||||Samples With DNA|"     whole blood and tissue   "|No||2017-10-10 22:27:54.823608|2017-10-10 22:27:54.823608
NCT02684721|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-15|||March 2016||2016-03-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Does a Home-based Exercise Programme Affect Physical Capacity and Quality of Life in Patients With Pulmonary Embolism?|Does an 8-week Home-based Exercise Programme Affect Physical Capacity, Quality of Life, Sick Leave and Use of Psychoactive Drugs in Patients With Pulmonary Embolism. A Randomised Clinical Trial|Recruiting||N/A|140|Anticipated|Central Jutland Regional Hospital||2|||f||||f||||||||||2017-10-10 22:27:54.930684|2017-10-10 22:27:54.930684
NCT02684708|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-12-02|||October 2015||2015-10-01|December 2016|2016-12-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents|European Network-Paediatric Hodgkin Lymphoma Study Group (EuroNet-PHL) Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents|Recruiting||Phase 3|2200|Anticipated|University of Giessen||2|||f||||t||||||||No||2017-10-10 22:27:55.044668|2017-10-10 22:27:55.044668
NCT02684695|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2026|Anticipated|2026-01-01|January 2021|Anticipated|2021-01-01||Observational|JAQI||Juvenile Arthritis Quantitative Imaging|The Development and Validation of Quantitative Imaging Biomarkers as a Measure of Disease Activity in Juvenile Idiopathic Arthritis|Recruiting||N/A|200|Anticipated|University College London Hospitals|||2||f||||f||||||||No||2017-10-10 22:27:55.177952|2017-10-10 22:27:55.177952
NCT02684682|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-03-31|||February 2016||2016-02-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|||Frequency of Self-performed Mechanical Control of Plaque|Effect of Self-performed Mechanical Control of Plaque Frequency in Patients With Historic of Periodontitis and in Maintenance|Recruiting||N/A|39|Anticipated|Universidade Federal de Santa Maria||3|||f||||f||||||||No||2017-10-10 22:27:55.265551|2017-10-10 22:27:55.265551
NCT02684669|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-11-23|||February 2016||2016-02-01|November 2016|2016-11-01|January 2017||2017-01-01|September 2016|Actual|2016-09-01||Interventional|TCI-NX-BI||Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia During a Burn Injury|Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia During a Burn Injury. A Randomized, Placebo-controlled, Double-blind Crossover Study|Completed||Phase 2|80|Actual|University of Copenhagen||2|||f||||t||||||||No|No plan to make individual participant data (IPD) available|2017-10-10 22:27:55.364078|2017-10-10 22:27:55.364078
NCT02684656|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-22|||February 2016||2016-02-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Reduction of Oxalate and Inflammation by Hemodiafiltration vs. Hemodialysis|Pilot Study of Lowering Plasma Oxalate With Hemodiafiltration to Reduce Systemic Inflammation in Patients With End-Stage Renal Disease (ESRD)|Recruiting||N/A|20|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||No||2017-10-10 22:27:55.464237|2017-10-10 22:27:55.464237
NCT02684643|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-03-05|||January 2016||2016-01-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients|Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients|Recruiting||N/A|72|Anticipated|Huashan Hospital||3|||f||||t||||||||||2017-10-10 22:27:55.549305|2017-10-10 22:27:55.549305
NCT02684630|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-06-16|2017-04-19||January 28, 2016||2016-01-28|June 2017|2017-06-01|May 28, 2016|Actual|2016-05-28|May 28, 2016|Actual|2016-05-28||Interventional||The Safety Population was used to evaluate participant demographics and treatment emergent adverse events (TEAE).|Trima Accel® System Post Count Algorithm Study|A Multicenter Study to Evaluate Modified Postcount Algorithm Software on the Trima Accel® System in Volunteer Blood Donors|Completed||N/A|131|Actual|Terumo BCT||2|||f||||f||||||||No||2017-10-10 22:27:55.635219|2017-10-10 22:27:55.635219
NCT02684617|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-09-22|||March 29, 2016|Actual|2016-03-29|September 2017|2017-09-01|February 6, 2020|Anticipated|2020-02-06|February 6, 2020|Anticipated|2020-02-06||Interventional|KEYNOTE-155||Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155)|Phase Ib Trial of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Subjects With Hematologic Malignancies (KEYNOTE-155).|Recruiting||Phase 1|138|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 22:27:55.973042|2017-10-10 22:27:55.973042
NCT02684604|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-04-10|2016-03-03||March 2015||2015-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational||Normally distributed numerical variables were presented as mean and SD, and skewed variables as median and interquartile range. Comparison of normally distributed numerical data was done using the unpaired t test. Skewed data were compared using the Mann-Whitney U test. Ordinal data were compared using the chi-squared test for trend.|Anti-Helicobacter Pylori Antibodies (IgG) in Serum of Women With Unexplained Infertility|Anti-Helicobacter Pylori Antibodies (IgG) in Serum of Women With Unexplained Infertility|Completed||N/A|88|Actual|Ain Shams Maternity Hospital|||2||f||||t||||||||Undecided||2017-10-10 22:27:56.118348|2017-10-10 22:27:56.118348
NCT02684591|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-02-11|||January 2016||2016-01-01|February 2016|2016-02-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|ARRIVE||Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy|Aramchol Versus Placebo in the Treatment of HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy: A Randomized, Double-blinded, Allocation-concealed, Placebo-controlled Clinical Trial|Recruiting||Phase 2|50|Anticipated|University of California, San Diego||2|||f||||f||||||||Undecided||2017-10-10 22:27:56.426211|2017-10-10 22:27:56.426211
NCT02684578|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-29|||April 2016||2016-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|METforMIN||Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD|METforMIN: Metformin Administration for the Minimization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration|Recruiting||Phase 2|100|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||||2017-10-10 22:27:56.528295|2017-10-10 22:27:56.528295
NCT02684565|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-10-06|||October 2016||2016-10-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|BCAA||Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects|Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects|Recruiting||Phase 3|10|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 22:27:56.630172|2017-10-10 22:27:56.630172
NCT02684552|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-08-29|||February 2016||2016-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Non Invasive Ventilation During Physical Training in Cystic Fibrosis|Physiotherapist in Charge of the Study|Completed||N/A|8|Actual|Karolinska University Hospital||2|||f||||f||||||||No||2017-10-10 22:27:56.721457|2017-10-10 22:27:56.721457
NCT02684539|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-03-11|||April 2014||2014-04-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Autonomous Syncope Onset Prediction and Prevention|Autonomous Syncope Onset Prediction and Prevention An Open-label, One-centre Pilot Study on Healthy Subjects With the Erigo Tilt Table|Withdrawn||N/A|0|Actual|Swiss Federal Institute of Technology||1||project weill not be realized for organisational reasons|f||||f||||||||No||2017-10-10 22:27:56.805702|2017-10-10 22:27:56.805702
NCT02684526|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-12-15|||December 2011||2011-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Is Eovist Suitable for Arterial-Phase MR Imaging of Liver|Is Eovist Suitable for Arterial-Phase MR Imaging of Liver|Completed||N/A|198|Actual|University of Michigan||2|||f||||f||||||||No||2017-10-10 22:27:56.872605|2017-10-10 22:27:56.872605
NCT02684500|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-07-27|||April 11, 2016|Actual|2016-04-11|July 2017|2017-07-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|||Aneurysmal Subarachnoid Hemorrhage and Superior Mesenteric Artery Flow Study|Evaluation of Superior Mesenteric Artery Diameter and Flow in Aneurysmal Subarachnoid Hemorrhage Patients Undergoing Hypertensive Therapy for Cerebral Artery Vasospasm|Terminated||N/A|14|Actual|University of Florida|||1|Low patient population census|f||||f||||||||||2017-10-10 22:27:58.767879|2017-10-10 22:27:58.767879
NCT02684487|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-03-28|||December 2017|Anticipated|2017-12-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|July 2022|Anticipated|2022-07-01||Interventional|ViDISS||Vitamin D Status in Patients With Severe Sepsis|Vitamin D Status in Patients With Severe Sepsis: A Randomized Clinical Trial|Not yet recruiting||Phase 3|600|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f|||t|||Yes||2017-10-10 22:27:58.863479|2017-10-10 22:27:58.863479
NCT02684474|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-25||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access Protocol Using HBOC-201|Expanded Access Protocol Using HBOC-201 to Treat Patients With Life Threatening Anemia, for Whom Blood is Not an Option|Available||N/A|||Johns Hopkins University|||||||||||||||||||2017-10-10 22:27:58.961079|2017-10-10 22:27:58.961079
NCT02684461|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-08-25|||August 2016||2016-08-01|August 2017|2017-08-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Interventional|||Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel|Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel, Sequential Consolidation With Nab-paclitaxel Followed by Pembrolizumab and Concurrent Consolidation With Nab-paclitaxel and Pembrolizumab After Standard First-Line Induction Chemotherapy in Advanced NSCLC|Recruiting||Phase 2|105|Anticipated|UNC Lineberger Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-10 22:27:59.036435|2017-10-10 22:27:59.036435
NCT02684448|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-03-27|||January 2016||2016-01-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Observational|||Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair|A Retrospective Multi-Center Study for Evaluation of Clinical Outcomes in Inguinal Hernia Repair|Completed||N/A|1258|Actual|Intuitive Surgical|||2||f||||f||||||||No|Individual participant data will not be shared.|2017-10-10 22:27:59.143868|2017-10-10 22:27:59.143868
NCT02684435|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-10-03|||February 2016||2016-02-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|CEUS-CKD||Contrast-enhanced Ultrasound of the Kidney|Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD (CEUS CKD)|Recruiting||Phase 2|75|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-10 22:27:59.214561|2017-10-10 22:27:59.214561
NCT02684422|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-04-24|||July 2015||2015-07-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|May 2018|Anticipated|2018-05-01||Observational|TRI-STAR||Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)|TRI-STAR: Initial and Chronic MRSA Infection in CF (TRanslational Investigation of STaph. Aureus Resistance)|Recruiting||N/A|100|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples Without DNA|"     -  Sputum        -  Blood   "|No|No plans to share individual patient data since the research study does not affect clinical outcomes, i.e. this is an observational study.|2017-10-10 22:27:59.309655|2017-10-10 22:27:59.309655
NCT02684409|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-16|||August 2013||2013-08-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine|A Phase 1, Open Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine|Completed||Phase 1|37|Actual|Teva Pharmaceutical Industries||1|||f||||t||||||||||2017-10-10 22:27:59.395558|2017-10-10 22:27:59.395558
NCT02684396|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-06-02|2016-06-02||August 2014||2014-08-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional||All randomized participants.|Phase 1, TAK-648, Single-Rising Dose Study|A Phase 1, Randomized, Double-Blind, Placebo- Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single Oral TAK-648 Doses in Healthy Subjects|Completed||Phase 1|39|Actual|Takeda||6|||f||||f||||||||||2017-10-10 22:27:59.479735|2017-10-10 22:27:59.479735
NCT02684383|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2016-11-29||||||November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine|A Phase 1 Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine|Completed||Phase 1|14|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:28:00.707337|2017-10-10 22:28:00.707337
NCT02684370|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-08|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|December 2016|Actual|2016-12-01||Interventional|||BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis|BI 655066/ABBV-066 (Risankizumab) Versus Ustekinumab and Placebo Comparators in a Randomized Double Blind trIal for Maintenance Use in Moderate to Severe Plaque Type Psoriasis (UltIMMa-1)|Completed||Phase 3|500|Anticipated|AbbVie||3|||f||||t||||||||||2017-10-10 22:28:00.802796|2017-10-10 22:28:00.802796
NCT02684357|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-16|2017-09-08|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|December 2016|Actual|2016-12-01||Interventional|||BI 655066 Compared to Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis|BI 655066 Versus Ustekinumab and Placebo Comparators in a Randomized Double Blind trIal for Maintenance Use in Moderate to Severe Plaque Type Psoriasis-2 (UltIMMa-2)|Completed||Phase 3|500|Anticipated|AbbVie||3|||f||||||||||||||2017-10-10 22:28:01.054287|2017-10-10 22:28:01.054287
NCT02684344|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-07-18|||February 2016||2016-02-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention|Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention|Recruiting||N/A|160|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 22:28:01.405378|2017-10-10 22:28:01.405378
NCT02684331|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-04-24|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||CMR in Type 2 Diabetes Mellitus Patients|Cardiac Magnetic Resonance Imaging in Type 2 Diabetes Mellitus: The Mechanisms of Cardiac Function and Perfusion Dysfunction|Recruiting||N/A|300|Anticipated|Slagelse Hospital|||1||f||||t||||||Samples With DNA|"     EDTA-plasma Heparin-plasma Serum urine   "|No||2017-10-10 22:28:01.487929|2017-10-10 22:28:01.487929
NCT02684318|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-06-21|||July 2015||2015-07-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors|Phase Ib/II Study to Evaluate the Efficacy and Tolerability of PM01183 in Combination With Olaparib in Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|100|Anticipated|Poveda, Andrés, M.D.||7|||f||||f|f|f||||||No||2017-10-10 22:28:01.590367|2017-10-10 22:28:01.590367
NCT02684305|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-03-23|||April 2016||2016-04-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction|Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction|Not yet recruiting||Phase 3|320|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||No||2017-10-10 22:28:01.719773|2017-10-10 22:28:01.719773
NCT02684266|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-04-11|||February 2016||2016-02-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study of SHR6390 in Advanced Solid Tumor Patients|A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Solid Tumor Patients|Recruiting||Phase 1|40|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:28:02.430449|2017-10-10 22:28:02.430449
NCT02684253|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-02-22|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)|A Phase II Randomized Controlled Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)|Recruiting||Phase 2|40|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 22:28:02.565078|2017-10-10 22:28:02.565078
NCT02684240|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-05-08|||February 2016||2016-02-01|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis|A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis|Recruiting||Phase 2|30|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||Yes|Data will be shared once the trial is complete|2017-10-10 22:28:02.746291|2017-10-10 22:28:02.746291
NCT02684227|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-03-31|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer|A Phase II Study With a Limited Safety Lead-In of Enzalutamide in Combination With Carboplatin and Paclitaxel in Advanced Stage or Recurrent Endometrioid Endometrial Cancer|Recruiting||Phase 2|69|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 22:28:02.908044|2017-10-10 22:28:02.908044
NCT02684214|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Implementing Prevention Plus for Childhood Overweight and Obesity in Food Secure and Insecure Families||Enrolling by invitation||N/A|82|Anticipated|University of Tennessee||2|||f||||t||||||||||2017-10-10 22:28:03.128121|2017-10-10 22:28:03.128121
NCT02684201|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-08-18|||November 2015||2015-11-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|PhantomLimb||Epidural Spinal Cord Stimulation for Sensory Restoration and Phantom Limb Pain in Upper-Limb Amputees|Epidural Spinal Cord Stimulation for Sensory Restoration and Phantom Limb Pain in Upper-Limb Amputees|Recruiting||N/A|10|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 22:28:03.234375|2017-10-10 22:28:03.234375
NCT02684175|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2017-03-08|||January 2016||2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of In-Person Versus Remote Cochlear Implant Candidacy Evaluations|Comparison of Patient & Provider Outcomes With In-Person Versus Remote Cochlear Implant Candidacy Evaluations|Enrolling by invitation||N/A|42|Actual|University of Kentucky||2|||f||||t||||||||No||2017-10-10 22:28:03.548738|2017-10-10 22:28:03.548738
NCT02684162|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-03-31|||June 2016|Actual|2016-06-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||SGI-110 With Donor Lymphocyte Infusion (DLI) for Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing Post Allogeneic Stem Cell Transplantation (AlloSCT)|A Phase II Trial to Assess the Efficacy and Toxicity of SGI-110 With Donor Lymphocyte Infusion (DLI) for the Treatment of Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation|Recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 22:28:03.644575|2017-10-10 22:28:03.644575
NCT02684149|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-06-17|||February 2015||2015-02-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ToRRéa||Pain Impact Assessment of the Relational Touch During Arterial Puncture in ICU (TORREA)|Pain Impact Assessment of the Relational Touch During Arterial Puncture in ICU - TORREA|Completed||N/A|75|Actual|University Hospital, Angers||2|||f||||||||||||||2017-10-10 22:28:03.754594|2017-10-10 22:28:03.754594
NCT02684136|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-02-22|||February 2016||2016-02-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Suvorexant in Insomnia Co-morbid With Fibromyalgia|A Double-blind, Crossover, Study to Compare the Hypnotic, Daytime Sleepiness/Fatigue, and Pain Effects of Nighttime Administration of Suvorexant 20 mg Versus Placebo in Patients With Fibromyalgia and Comorbid Insomnia|Recruiting||Phase 4|30|Anticipated|Henry Ford Health System||2|||f||||f||||||||No||2017-10-10 22:28:03.840921|2017-10-10 22:28:03.840921
NCT02684123|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-04-11|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata|A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata|Active, not recruiting||N/A|30|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-10 22:28:03.952569|2017-10-10 22:28:03.952569
NCT02684110|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-16|||January 2016||2016-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:28:04.06083|2017-10-10 22:28:04.06083
NCT02684097|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-04-11|||January 2016||2016-01-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata|A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata|Recruiting||Phase 2|30|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-10 22:28:04.118154|2017-10-10 22:28:04.118154
NCT02684084|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2016-02-11|||November 2015||2015-11-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|COLLIDE||Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema|Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema: The COLLIDE Trial|Recruiting||Phase 4|60|Anticipated|North Toronto Eye Care Laser and Eye Specialists||2|||f||||f||||||||||2017-10-10 22:28:04.236197|2017-10-10 22:28:04.236197
NCT02684071|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-06-05|||February 2016||2016-02-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors|A Phase II Study of Intraventricular Methotrexate With Systemic Topotecan and Cyclophosphamide in Children With Recurrent or Progressive Malignant Brain Tumors|Recruiting||Phase 2|10|Anticipated|Nicklaus Children's Hospital f/k/a Miami Children's Hospital||1|||f||||t||||||||No||2017-10-10 22:28:04.38495|2017-10-10 22:28:04.38495
NCT02684045|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-08-16|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Observational|||Retrospective Chart Review to Assess Outcomes in Subjects That Received MAGNIFUSE® in the Posterolateral Lumbar Spine|A Retrospective Review of Charts to Assess Outcomes in Subjects That Received MAGNIFUSE® DBM in the Posterolateral Lumbar Spine|Completed||N/A|76|Actual|Medtronic Spinal and Biologics|||1||f||||||||||||||2017-10-10 22:28:04.647503|2017-10-10 22:28:04.647503
NCT02684032|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-28|||June 14, 2016|Actual|2016-06-14|September 2017|2017-09-01|November 24, 2019|Anticipated|2019-11-24|November 24, 2019|Anticipated|2019-11-24||Interventional|||A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer|Phase 1b Study To Assess The Safety, Tolerability, And Clinical Activity Of Gedatolisib In Combination With Palbociclib And Either Letrozole Or Fulvestrant In Women With Metastatic Or Locally Advanced/Recurrent Breast Cancer (Mbc)|Recruiting||Phase 1|120|Anticipated|Pfizer||5|||f||||f||||||||||2017-10-10 22:28:04.71898|2017-10-10 22:28:04.71898
NCT02684019|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-02-10|||January 2016||2016-01-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Goal Directed Propofol Sedation With Magnesium Sulphate Versus Dexmedetomidine for ERCP Procedure|Goal Directed Propofol Sedation With Magnesium Sulphate Versus Dexmedetomidine for ERCP Procedure|Recruiting||Phase 1/Phase 2|60|Anticipated|Theodor Bilharz Research Institute||4|||f||||f||||||||Undecided||2017-10-10 22:28:04.87616|2017-10-10 22:28:04.87616
NCT02684006|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-09-28|||March 23, 2016|Actual|2016-03-23|September 2017|2017-09-01|April 30, 2021|Anticipated|2021-04-30|December 1, 2018|Anticipated|2018-12-01||Interventional|||A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)|A Phase 3, Multinational, Randomized, Open-label, Parallel-arm Study Of Avelumab (msb0010718c) In Combination With Axitinib (Inlyta(Registered)) Versus Sunitinib (Sutent(Registered)) Monotherapy In The First-line Treatment Of Patients With Advanced Renal Cell Carcinoma|Recruiting||Phase 3|830|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 22:28:05.030482|2017-10-10 22:28:05.030482
NCT02683993|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-08-28|||February 2016||2016-02-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings|Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings|Active, not recruiting||N/A|20|Anticipated|Lumenis Ltd.||2|||f||||||||||||||2017-10-10 22:28:05.962601|2017-10-10 22:28:05.962601
NCT02683980|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2017-08-28|||February 2016||2016-02-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH|Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH|Active, not recruiting||N/A|20|Anticipated|Lumenis Ltd.||1|||f||||||||||||||2017-10-10 22:28:06.047117|2017-10-10 22:28:06.047117
NCT02683967|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-02-12|||November 2013||2013-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Impact of Acupuncture on the Success Rates of IVF (In Vitro Fertilisation) Treatments|The Impact of Acupuncture on the Success Rate of IVF Treatments|Completed||N/A|184|Actual|Homerton University Hospital NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:28:06.138235|2017-10-10 22:28:06.138235
NCT02683954|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-03-03|2016-02-28||December 2014||2014-12-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational||sixty patients were admitted to the wards to undergo laparoscopy for various indications and were included in this study|The Association Between Endometriosis, Obesity and nesfatin1|The Association Bet Endometriosis, Obesity and nesfatin1|Completed||N/A|60|Actual|Ain Shams Maternity Hospital|||2||f||||t||||||||Undecided||2017-10-10 22:28:06.233831|2017-10-10 22:28:06.233831
NCT02683941|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-09-29|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|SPINET||Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumors|A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumor Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumors|Recruiting||Phase 3|216|Anticipated|Ipsen||2|||f||||t|t|||||||||2017-10-10 22:28:07.568097|2017-10-10 22:28:07.568097
NCT02683928|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-08-24|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adult Patients With Moderate-to-severe Atopic Dermatitis (AD)|A Phase IIa, Double-Blind, Randomised, Placebo-controlled, Exploratory Study to Evaluate the Safety, Biological Activity and Pharmacokinetics of GBR 830 in Adult Patients With Moderate-to-Severe Atopic Dermatitis|Completed||Phase 2|64|Actual|Glenmark Pharmaceuticals S.A.||2|||f||||||||||||||2017-10-10 22:28:07.872107|2017-10-10 22:28:07.872107
NCT02683915|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-11|||September 2015||2015-09-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Reno-protective Effect of Brain Cooling in Newborn With Hypoxia|Acute Kidney Injury in Asphyxiated Infants Treated by Therapeutic Hypothermia|Recruiting||N/A|30|Anticipated|Mansoura University Children Hospital|||2||f||||t||||||||Undecided||2017-10-10 22:28:07.97443|2017-10-10 22:28:07.97443
NCT02683902|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-07|||March 2016||2016-03-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Hypocaloric Diet Associated With tDCS on Weight Loss and Metabolic Profile|The Effect of Hypocaloric Diet Associated With tDCS on Weight Loss and Metabolic Profile: a Pilot, Double Blind, Randomized, Placebo-controlled Study|Recruiting||N/A|20|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:28:08.0492|2017-10-10 22:28:08.0492
NCT02683889|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-11-03|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2020|Anticipated|2020-08-01||Interventional|||Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation|The Use of Acthar (ACTH) in Patients With Focal Segmental Glomerulosclerosis (FSGS) Who Have Developed Chronic Kidney Disease Stage V (CKD) or End Stage Renal Disease (ESRD) and Are Undergoing a Renal Transplant|Recruiting||Phase 3|20|Anticipated|Georgetown University||1|||f||||f||||||||Undecided||2017-10-10 22:28:08.157503|2017-10-10 22:28:08.157503
NCT02683876|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-10-02|||February 2016|Actual|2016-02-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|August 30, 2017|Actual|2017-08-30||Observational|||Exploratory Study of Relationships Between Malodor and Urine Metabolomics|Metabolomic Profiling of Urine Samples for the Identification of Novel Biomarkers and Mechanisms in the Diagnosis and Management of Malodor Associated With Metabolic Inefficiencies|Active, not recruiting||N/A|54|Actual|Mebo Research, Inc.|||2||f||||t||||||||||2017-10-10 22:28:08.351605|2017-10-10 22:28:08.351605
NCT02683863|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-03-21|||August 2015||2015-08-01|March 2017|2017-03-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers|An Open Label Study of the Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers in Subjects With Secondary Progressive Multiple Sclerosis|Completed||Phase 4|20|Anticipated|Multiple Sclerosis Center of Northeastern New York||4|||f||||f||||||||||2017-10-10 22:28:08.426974|2017-10-10 22:28:08.426974
NCT02683850|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-08-31|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Influence of an Omega-3 SPM Supplement on Quality of Life|Influence of an Omega-3 SPM Supplement on Quality of Life|Completed||Early Phase 1|44|Actual|National University of Natural Medicine||1|||f||||f||||||||No||2017-10-10 22:28:08.525255|2017-10-10 22:28:08.525255
NCT02683837|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-10-30|||April 2016||2016-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pupillometry Guided Remifentanil Administration In Pediatric Anesthesia|A Prospective Randomized Study Evaluating Pupillometry Guided Remifentanil Administration in Pediatric Anesthesia|Recruiting||N/A|56|Anticipated|University Hospital, Geneva||2|||f||||f||||||||No||2017-10-10 22:28:08.612985|2017-10-10 22:28:08.612985
NCT02683824|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-01-27|||January 2016||2016-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers|Detection of Integrin Alpha-v-Beta 6 in Pancreatic Cancer With [18F]-R01-MG-F2: a First in Human Study|Recruiting||N/A|25|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:28:08.710499|2017-10-10 22:28:08.710499
NCT02683811|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-07-27|||September 2015||2015-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|DDS-2||Effectiveness of the Updated Version of the School-based Program Diario Della Salute (DDS-2)|A Randomised Controlled Study for Evaluating the Effectiveness of the Updated Version of Diario Della Salute, a School-based Program for Prevention of Unhealthy and Risky Behaviours and Promotion of Well-being in Italian Pre-adolescents|Completed||N/A|3600|Actual|Azienda Sanitaria Locale CN2 Alba-Bra||2|||f||||f||||||||Yes||2017-10-10 22:28:08.82549|2017-10-10 22:28:08.82549
NCT02683798|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-01-16|||April 2016||2016-04-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||BEYOND Weight Loss Maintenance Study|Comparison of Two Weight Loss Maintenance Interventions in Counterweight Plus|Recruiting||N/A|90|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-10 22:28:08.927174|2017-10-10 22:28:08.927174
NCT02683785|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-09-28|||March 17, 2016|Actual|2016-03-17|September 2017|2017-09-01|November 29, 2017|Anticipated|2017-11-29|November 29, 2017|Anticipated|2017-11-29||Interventional|||A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis|A Multi-centre Phase IIa Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK3196165 in Subjects With Inflammatory Hand Osteoarthritis|Active, not recruiting||Phase 2|40|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:28:09.013|2017-10-10 22:28:09.013
NCT02683759|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-20|||February 2016||2016-02-01|February 2016|2016-02-01||||February 2017|Anticipated|2017-02-01||Interventional|||Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitis|The Efficacy and Tolerability of Bio-Enhanced Curcumin in Maintaining Remission in Patients With Ulcerative Colitis|Recruiting||Phase 3|50|Anticipated|Asian Institute of Gastroenterology, India||2|||f||||t||||||||No||2017-10-10 22:28:09.259585|2017-10-10 22:28:09.259585
NCT02683746|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-06-07|||March 16, 2016|Actual|2016-03-16|June 2017|2017-06-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|||Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus|A Repeat-dose Study in Subjects With Type 2 Diabetes Mellitus to Assess the Efficacy, Safety, Tolerability and Pharmacodynamics, of Albiglutide Liquid Drug Product|Completed||Phase 3|308|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:28:09.363954|2017-10-10 22:28:09.363954
NCT02683733|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-20|||February 2016||2016-02-01|February 2016|2016-02-01||||February 2017|Anticipated|2017-02-01||Interventional|||Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitis|The Efficacy and Tolerability of Bio-enhanced Curcumin (Diferuloylmethane) in the Induction of Remission in Patients With Mild to Moderate Ulcerative Colitis|Recruiting||Phase 3|50|Anticipated|Asian Institute of Gastroenterology, India||2|||f||||t||||||||No||2017-10-10 22:28:09.600262|2017-10-10 22:28:09.600262
NCT02683720|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-07-20|||July 2016||2016-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ProMO||Evaluating the Efficacy of a Novel Oral Supplement in Tackling Malnutrition in the Elderly|Evaluating the Efficacy of a Novel Oral Supplement in Tackling Malnutrition in the Elderly|Recruiting||N/A|82|Anticipated|Wageningen University||2|||f||||f||||||||No||2017-10-10 22:28:09.689724|2017-10-10 22:28:09.689724
NCT02683707|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-05-26|||March 2016||2016-03-01|May 2017|2017-05-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|PACIFY||The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)|The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial|Completed||Phase 4|212|Actual|Johns Hopkins University||2|||f||||f||||||||Undecided||2017-10-10 22:28:09.768594|2017-10-10 22:28:09.768594
NCT02683694|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-11-09|||February 2015||2015-02-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases|Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases|Recruiting||N/A|81|Anticipated|Vienna Institute for Research in Ocular Surgery||1|||f||||t||||||||Undecided||2017-10-10 22:28:09.884452|2017-10-10 22:28:09.884452
NCT02683681|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-06-02|||June 2008||2008-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|50 Years|Observational [Patient Registry]|||HF Tissue Registry|Heart Failure Intraoperative Tissue Sample Acquisition Registry|Enrolling by invitation||N/A|200|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||Samples With DNA|"     -  Tissue samples will be obtained at the time of LVAD implantation by keeping the part of          the left ventricular apex that the surgeon is removing in order to place the inflow          cannula of the LVAD. No extra tissue sample other than the tissue that has to be removed          as a part of a standard LVAD operation needs to be obtained.        -  Tissue samples will be acquired from the failing heart at the time of heart          transplantation, after it has been excised and a donor heart has been implanted in its          place.        -  Control tissue samples will be acquired intraoperatively during cardiac surgery wherein          any amount of excised tissue is routinely discarded.   "|No||2017-10-10 22:28:09.984472|2017-10-10 22:28:09.984472
NCT02683668|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-11-04|||February 2016||2016-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Airway Effects of Tiotropium in Patients With COPD|Targeting of the Small Airways in Patients With COPD: Airway Effects of Tiotropium - Respimat vs Handihaler|Recruiting||Phase 4|44|Anticipated|Imperial College London||3|||f||||t||||||||No||2017-10-10 22:28:10.06606|2017-10-10 22:28:10.06606
NCT02683655|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-11|||August 2015||2015-08-01|February 2016|2016-02-01||||October 2016|Anticipated|2016-10-01||Interventional|||Study of Apatinib in Metastatic Esophageal Cancer|Study of Apatinib in Metastatic Esophageal Cancer：A Open Label, Randomized Clinical Trial|Recruiting||Phase 2|40|Anticipated|Huai'an First People's Hospital||2|||f||||f||||||||||2017-10-10 22:28:10.227855|2017-10-10 22:28:10.227855
NCT02683642|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-08-12|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome|Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome|Recruiting||N/A|300|Anticipated|Fungal Infection Study Forum|||1||f||||f||||||||||2017-10-10 22:28:10.326066|2017-10-10 22:28:10.326066
NCT02683629|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-20|||February 2016||2016-02-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease|A Phase IIb, Randomised, Double-blind, Placebo-controlled, Dose-range Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease|Active, not recruiting||Phase 2|18|Anticipated|Living Cell Technologies||2|||f||||t||||||||||2017-10-10 22:28:10.444113|2017-10-10 22:28:10.444113
NCT02683616|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-16|||April 2015||2015-04-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FAMOSA||Fatty Acid Metabolism in Obstructive Sleep Apnea (FAMOSA)|Fatty Acid Metabolism in Obstructive Sleep Apnea (FAMOSA)|Recruiting||N/A|60|Anticipated|Faculty Hospital Kralovske Vinohrady||4|||f||||f||||||||No||2017-10-10 22:28:10.535586|2017-10-10 22:28:10.535586
NCT02683603|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-16|||April 2013||2013-04-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Aerosolised Colistin in Ventilator Associated Pneumonia|Efficacy and Toxicity of Aerosolised Colistin in Ventilator Associated Pneumonia: A Prospective, Randomized Trial|Completed||Phase 4|133|Actual|Tunis University||2|||f||||t||||||||Yes|yes of course the data is collected on individual cards which identified demographic, clinical and laboratory data for each patient participating. thereafter these data is entered on Statistical Package for Social Sciences (SPSS) software|2017-10-10 22:28:10.633156|2017-10-10 22:28:10.633156
NCT02683564|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-11|||February 2016||2016-02-01|February 2016|2016-02-01||||July 2017|Anticipated|2017-07-01||Interventional|||BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study|A Study of BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis on Stable Methotrexate: The UNIFORM Study|Not yet recruiting||Phase 3|548|Anticipated|Epirus Biopharmaceuticals (Switzerland) GmbH||2|||f||||f||||||||||2017-10-10 22:28:10.963987|2017-10-10 22:28:10.963987
NCT02683551|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-24|2016-06-08|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Comparison of QoL for Sutureless Thyroidectomy|Comparison of Effects of Energy Based Devices on Quality of Life After Sutureless Thyroidectomy?|Completed||N/A|193|Actual|Istanbul University|||2||f||||f||||||||||2017-10-10 22:28:11.040256|2017-10-10 22:28:11.040256
NCT02683538|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2016-04-02|||November 2011||2011-11-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|||Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies|Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies|Completed||Phase 2|196|Actual|Seoul National University Hospital||1|||f||||t||||||||No||2017-10-10 22:28:11.111435|2017-10-10 22:28:11.111435
NCT02683525|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-09-05|||February 3, 2016|Actual|2016-02-03|September 2017|2017-09-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation|Phase II Trial of Inhibition of Dipeptidyl Peptidase (DPP)-4 With Sitagliptin for the Prevention of Acute Graft Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|28|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 22:28:11.192126|2017-10-10 22:28:11.192126
NCT02683512|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-12-01|||December 2015||2015-12-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01|10 Years|Observational [Patient Registry]|GSDIVDB||Glycogen Storage Disease Type IV Database|Database for Information on Individuals Affected With Glycogen Brancher Deficiency, Also Known as Glycogen Storage Disease Type IV|Recruiting||N/A|200|Anticipated|Duke University|||1||f||||f||||||||No||2017-10-10 22:28:11.315261|2017-10-10 22:28:11.315261
NCT02683499|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-03-11|||April 2015||2015-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Marginal Fit of Porcelain Veneers After Finishing Prepared Surfaces With Ultrasonic Tips|A Double-blind Split-mouth Randomized Clinical Trail Evaluating Marginal Fit of Porcelain Laminate Veneers Following Finishing the Prepared Surfaces With Ultrasonic Tips Compared to the Conventional Way|Completed||N/A|27|Actual|Damascus University||2|||f||||t||||||||No||2017-10-10 22:28:11.415684|2017-10-10 22:28:11.415684
NCT02683486|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-09-28|||January 2016||2016-01-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Intelligent Oxygen Therapy During Activities of Daily Living|The Assessment of Intelligent Oxygen Therapy (iO2T) in Patients on Long-term Oxygen Therapy During Activities of Daily Living|Recruiting||N/A|30|Anticipated|Imperial College London||2|||f||||f||||||||No||2017-10-10 22:28:11.492609|2017-10-10 22:28:11.492609
NCT02683473|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-16|||February 2016||2016-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BabyEE||Measurement of Energy Metabolism in Infants|Measurement of Energy Metabolism in Infants: BabyEE Pilot|Recruiting||N/A|40|Anticipated|Pennington Biomedical Research Center|||1||f||||f||||||||||2017-10-10 22:28:11.572492|2017-10-10 22:28:11.572492
NCT02683460|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Patellar Resurfacing Under Subvastus Approach in Total Knee Arthroplasty|Comparison of Clinical Results of Patella Resurfacing Versus Patellar Retention Under Subvastus Approach in Total Knee Arthroplasty: A Randomized, Controlled, Double-Blind Trial|Not yet recruiting||N/A|100|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 22:28:11.651204|2017-10-10 22:28:11.651204
NCT02683434|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-07-12|||January 2016||2016-01-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effects of Kinesio Taping on Postural Stability in Young Soccer Players|Effects of Kinesio Taping on Postural Stability in Young Soccer Players|Completed||N/A|62|Actual|Baskent University||2|||f||||f||||||||||2017-10-10 22:28:11.841327|2017-10-10 22:28:11.841327
NCT02683421|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-12-14|||July 2016||2016-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging|Evaluation of Subcutaneous (SC) Injected Tc 99m Tilmanocept Localization in Active Rheumatoid Arthritis (RA) Subjects by SPECT and SPECT/CT Imaging|Completed||Phase 1|18|Anticipated|Navidea Biopharmaceuticals||4|||f||||f||||||||No||2017-10-10 22:28:12.108462|2017-10-10 22:28:12.108462
NCT02683408|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-08-14|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon|Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon|Completed||N/A|87|Actual|Primus Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:28:12.228911|2017-10-10 22:28:12.228911
NCT02683395|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-09-18|||March 2016||2016-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of PLX51107 in Advanced Malignancies|A Phase 1b Dose Escalation Study to Assess Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLX51107 in Subjects With Advanced Malignancies|Recruiting||Phase 1|60|Anticipated|Plexxikon||2|||f||||f||||||||||2017-10-10 22:28:12.342114|2017-10-10 22:28:12.342114
NCT02683369|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-25|||February 2016||2016-02-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women|Effects of a Commercially-available, Low-dose Iron Supplement (BloodBuilder®/Iron Response®) on Markers of Iron Status Among Premenopausal and Non-anemic, Iron-deficient Women|Completed||Phase 2/Phase 3|23|Actual|University of Maryland||1|||f||||f||||||||||2017-10-10 22:28:12.511497|2017-10-10 22:28:12.511497
NCT02683356|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-09-06|||March 2016||2016-03-01|September 2016|2016-09-01|March 2021|Anticipated|2021-03-01|December 2017|Anticipated|2017-12-01||Interventional|OPTICO-BVS||Optical Coherence Tomography to Improve Outcome for Coronary Revascularisation Using Bioresorbable Vascular Scaffolds|Optical Coherence Tomography to Improve Outcome for Coronary Revascularisation Using Bioresorbable Vascular Scaffolds|Recruiting||N/A|270|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||No||2017-10-10 22:28:12.595447|2017-10-10 22:28:12.595447
NCT02683343|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2016-02-16|||July 2016||2016-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||The Use of Ultrasound to Quantify Muscle Overlying the Carpal Tunnel||Unknown status|Not yet recruiting|N/A|100|Anticipated|Clalit Health Services|||2||f||||f||||||||||2017-10-10 22:28:12.679924|2017-10-10 22:28:12.679924
NCT02683330|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-02-17|||January 2016||2016-01-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|October 2016|Actual|2016-10-01||Interventional|MindPD||Distant Delivery of a Mindfulness-based Intervention for People Affected by Parkinson's Disease|Mindfulness-based Intervention for People Affected by Parkinson's Disease: A Distant-delivered Randomised Pilot Trial|Active, not recruiting||N/A|60|Anticipated|City, University of London||2|||f||||f||||||||No||2017-10-10 22:28:12.73968|2017-10-10 22:28:12.73968
NCT02683317|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-01-12|||February 2016||2016-02-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity|Effect of Enteral Administration of Docosahexaenoic Acid on Development of the Retinopathy of Prematurity|Enrolling by invitation||Phase 2|100|Anticipated|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||Undecided||2017-10-10 22:28:12.920684|2017-10-10 22:28:12.920684
NCT02683304|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-08-18|||March 10, 2017|Actual|2017-03-10|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|S100B-Céph||S100B in the Care of Non-traumatic Headaches in the Emergency Department|S100B Protein Measures in the Care of Non-traumatic Headaches in the Emergency Department|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||f|f|f||||||||2017-10-10 22:28:13.02411|2017-10-10 22:28:13.02411
NCT02683291|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-11|||January 2014||2014-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01||Interventional|||Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients|Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients: A Prospective Randomized Controlled Trial|Completed||Phase 4|48|Actual|Associação Médico Espírita de Botucatu||2|||f||||t||||||||No||2017-10-10 22:28:13.148507|2017-10-10 22:28:13.148507
NCT02683278|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-02-16|||November 2008||2008-11-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Fibromyalgia: Interventions for Pain and Mood Regulation|Fibromyalgia: Interventions for Pain and Mood Regulation|Completed||N/A|170|Actual|Arizona State University||3|||f||||f||||||||No||2017-10-10 22:28:13.256303|2017-10-10 22:28:13.256303
NCT02683265|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-11|||March 2016||2016-03-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|EF003||A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD|A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Aptensio XR® in Children Ages 4 to Under 6 Years Diagnosed With Attention Deficit-Hyperactivity Disorder (ADHD)|Not yet recruiting||Phase 4|150|Anticipated|Rhodes Pharmaceuticals, L.P.||2|||f||||t||||||||Undecided||2017-10-10 22:28:13.368314|2017-10-10 22:28:13.368314
NCT02683252|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-11|||January 2016||2016-01-01|January 2016|2016-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|AFRONT||Musculoskeletal Non-tumoral Pathology Quantitative Perfusion|Magnetic Resonance (MR) Imaging Quantitative Functional Perfusion Analysis of the Musculoskeletal System: Clinical Application in Non-tumoral Pathology|Recruiting||N/A|400|Anticipated|Central Hospital, Nancy, France||5|||f||||t||||||||||2017-10-10 22:28:13.505897|2017-10-10 22:28:13.505897
NCT02683239|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-16|||March 2016||2016-03-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|February 2018|Anticipated|2018-02-01||Interventional|FACT LTS & OA||Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip|A Phase 3 Randomized, Double-blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip|Recruiting||Phase 3|7000|Anticipated|Regeneron Pharmaceuticals||5|||f||||t||||||||||2017-10-10 22:28:13.63787|2017-10-10 22:28:13.63787
NCT02683226|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-05-10|||March 2015||2015-03-01|February 2015|2015-02-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS||Completed||Phase 4|30|Actual|University Medical Centre Ljubljana||2|||f||||||||||||||2017-10-10 22:28:13.992062|2017-10-10 22:28:13.992062
NCT02683213|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-09-21|||October 20, 2014||2014-10-20|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|EFFECTS||Efficacy of Fluoxetine - a Trial in Stroke|Establishing the Effect(s) and Safety of Fluoxetine Initiated in the Acute Phase of Stroke|Recruiting||Phase 3|1500|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 22:28:14.077224|2017-10-10 22:28:14.077224
NCT02683200|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-08-24|||June 3, 2015|Actual|2015-06-03|August 2016|2016-08-01|June 3, 2019|Anticipated|2019-06-03|June 3, 2018|Anticipated|2018-06-03||Interventional|||MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer|Stereotactic Body Radiotherapy for Liver Metastases and Hepatocellular Carcinoma Utilizing an MRI-Guided Tri-60Co Teletherapy System|Recruiting||N/A|20|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:28:14.197934|2017-10-10 22:28:14.197934
NCT02683187|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-07-25|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||DPP4 Inhibition & Beta Cell Function|Role of Alpha-cell GLP-1 in the Beta-cell Response to DPP-4 Inhibition|Recruiting||Phase 1|70|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 22:28:14.28974|2017-10-10 22:28:14.28974
NCT02683148|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-08-31|||September 13, 2016|Actual|2016-09-13|August 2017|2017-08-01|June 30, 2025|Anticipated|2025-06-30|June 30, 2025|Anticipated|2025-06-30||Interventional|||DHEA in Synovial Sarcoma Patients|A Phase I/II Clinical Trial of Dose-Escalating DHEA in Synovial Sarcoma Patients|Recruiting||Phase 1/Phase 2|47|Anticipated|Washington University School of Medicine||4|||f||||t|t|f||||||||2017-10-10 22:28:14.54967|2017-10-10 22:28:14.54967
NCT02683135|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-08-01|||November 2015||2015-11-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Lifestyle Control of Postprandial Hyperglycemia|Low-carbohydrate Diet, With or Without Exercise, for Improving Postprandial Glucose Control and Vascular Function in Type 2 Diabetes and Prediabetes.|Completed||N/A|16|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-10 22:28:14.655574|2017-10-10 22:28:14.655574
NCT02683122|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-02-24|||January 2016||2016-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|DIPOD||The DIPOD Study (Diagnosis Improvement of Pneumonia by Organ Dysfunction)|Improvement of Diagnosis of Hospital Acquired Pneumonia (HAP) Based on Early Organ Dysfunction|Completed||N/A|298|Actual|Centre Chirurgical Marie Lannelongue|||1||f||||f||||||||No||2017-10-10 22:28:14.737646|2017-10-10 22:28:14.737646
NCT02683109|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-12|2017-05-10|||March 8, 2016|Actual|2016-03-08|May 2017|2017-05-01|January 30, 2017|Actual|2017-01-30|January 9, 2017|Actual|2017-01-09||Interventional|||Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD|A 4-week, Randomised, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Tiotropium + Olodaterol Fixed Dose Combination (5/5 µg) Delivered by the Respimat® Inhaler Versus the Free Combination of Tiotropium 5 µg and Olodaterol 5 µg Delivered by Separate Respimat® Inhalers in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|221|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:28:14.808571|2017-10-10 22:28:14.808571
NCT02683096|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-04-25|||February 2016||2016-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|CMV||Screening for Congenital Cytomegalovirus Infection in Newborns|Screening for Congenital Cytomegalovirus Infection in Newborns With Failed Hearing Screen or Who Are Small for Gestational Age|Enrolling by invitation||N/A|75|Anticipated|Southern Illinois University|||2||f||||f||||||Samples Without DNA|"     saliva PCR assays   "|No||2017-10-10 22:28:15.042216|2017-10-10 22:28:15.042216
NCT02683083|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-11|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|CAM-VHH1||Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients|Phase I Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients: CAM-VHH1 Study|Recruiting||Phase 1|10|Anticipated|Camel-IDS NV||1|||f||||t||||||||No||2017-10-10 22:28:15.131225|2017-10-10 22:28:15.131225
NCT02683070|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-11|||March 2016||2016-03-01|February 2016|2016-02-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Pudendal Nerve Block for Catheter-related Bladder Discomfort Prevention|Comparison of Pudendal Nerve Block With Ropivacaine and Intravenous Tramadol for Prevention of Catheter-related Bladder Discomfort: a Randomized Controlled Trial|Not yet recruiting||N/A|94|Anticipated|West China Hospital||2|||f||||t||||||||Undecided|It is undecided whether to share IPD|2017-10-10 22:28:15.211891|2017-10-10 22:28:15.211891
NCT02683057|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-08-21|||May 2015||2015-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|||Influence of Physical Exercise on Semen Quality|Influence of Physical Exercise on Semen Quality|Recruiting||N/A|432|Anticipated|IVI Bilbao|||3||f||||t||||||||||2017-10-10 22:28:15.299383|2017-10-10 22:28:15.299383
NCT02683044|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-07-15|||February 2016||2016-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness And Safety Of Two Protocols For The Treatment Of Erectile Dysfunction With Low-Density Shock Waves|Randomized Clinical Trial To Evaluate The Comparative Effectiveness And Safety Of Two Protocols For The Treatment Of Erectile Dysfunction With Low-Density Shock Waves|Recruiting||N/A|206|Anticipated|Instituto para la Evaluación de la Calidad y Atención en Salud||2|||f||||f||||||||No||2017-10-10 22:28:15.37654|2017-10-10 22:28:15.37654
NCT02683031|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-08-17|||May 2014||2014-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Ca2+ Ionophore on Embryonic Development and Clinical Outcome in Cases With Previous Fertilization Arrest|A Prospective Randomized Controlled Trial Investigating Embryonic Development and Clinical Outcome After Using Ca2+ Ionophore in Cases With Previous Fertilization Arrest|Recruiting||N/A|50|Anticipated|TopLab Company for ART Laboratories Consultation and Training||2|||f||||t||||||||Undecided||2017-10-10 22:28:15.466783|2017-10-10 22:28:15.466783
NCT02683018|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-02-16|||March 2016||2016-03-01|February 2016|2016-02-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Investigation of Cannabis for Chronic Pain and Palliative Care|Investigation of Cannabis for Chronic Pain and Palliative Care|Not yet recruiting||Phase 1|70|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-10 22:28:15.549039|2017-10-10 22:28:15.549039
NCT02683005|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-09-13|||September 2016||2016-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|HIP||Study of Hepatitis C Treatment During Pregnancy|Phase I Pharmacokinetic and Safety Trial of Ledipasvir/Sofosbuvir Fixed Dose Combination in Pregnant Women With Chronic Hepatitis C Virus Infection|Recruiting||Phase 1|15|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 22:28:15.629826|2017-10-10 22:28:15.629826
NCT02682992|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-04-24|||June 2016||2016-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Low-Level Laser Therapy for Prevention of Oral Mucositis|A Phase II Prospective Trial of Low-Level Laser Therapy for Prevention of Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer|Recruiting||Phase 2|25|Anticipated|University of Pittsburgh||1|||f||||t||||||||Yes|The same protocol will be opened separately at the Karmanos Cancer Center, where an additional 25 patients will be enrolled. A Data Use Agreement will allow combination of the data for a total of 50 patients to be analyzed.|2017-10-10 22:28:15.718672|2017-10-10 22:28:15.718672
NCT02682979|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-07-25|||February 2016||2016-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Continuity of the Therapeutic Limitation Code: Analysis of the Variables of Admission in the Emergency Service That Are Associated With a Therapeutic Limitation Upon Exit|Continuity of the Therapeutic Limitation Code: Analysis of the Variables of Admission in the Emergency Service That Are Associated With a Therapeutic Limitation Upon Exit|Recruiting||N/A|100|Anticipated|Brugmann University Hospital|||1||f||||f||||||||||2017-10-10 22:28:15.815128|2017-10-10 22:28:15.815128
NCT02682966|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|||Direct Evaluation of Postoperative Myocardial Injury Using Coronary Computed Tomography Angiography After Non-Cardiac Surgery|Direct Evaluation of Postoperative Myocardial Injury Using Coronary Computed Tomography Angiography After Non-Cardiac Surgery|Enrolling by invitation||N/A|454|Anticipated|UMC Utrecht|||2||f||||f||||||||Undecided||2017-10-10 22:28:15.910387|2017-10-10 22:28:15.910387
NCT02682953|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-29|||October 2015||2015-10-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|||Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers|Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers|Withdrawn||Phase 2|0|Actual|University of Maryland||1||subject recruitment was not feasible due to changes in current standard of care treatment|f||||f||||||||||2017-10-10 22:28:15.980801|2017-10-10 22:28:15.980801
NCT02682940|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-02-28|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||T1 Diabetes Hypoglycemia Prevention Pilot|Type I Diabetes Hypoglycemia Prevention Pilot Study|Terminated||N/A|4|Actual|InSpark Technologies, Inc.||1||Insufficient Resources|f||||f||||||||Undecided||2017-10-10 22:28:16.064105|2017-10-10 22:28:16.064105
NCT02682927|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-09-09|||January 2016||2016-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome|A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome|Recruiting||Phase 3|130|Anticipated|Zogenix, Inc.||3|||f||||t||||||||||2017-10-10 22:28:16.158211|2017-10-10 22:28:16.158211
NCT02682914|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-10|||December 2013||2013-12-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01|3 Years|Observational [Patient Registry]|SKY||Stroke in Korean Young Adults Study||Recruiting||N/A|470|Anticipated|Hanyang University|||1||f||||t||||||||Undecided||2017-10-10 22:28:16.281898|2017-10-10 22:28:16.281898
NCT02682901|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-03-28|||June 2015||2015-06-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects|Impact of Timed Bromocriptine-QR Therapy Upon Measures of Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects|Recruiting||Phase 4|80|Anticipated|Eastern Virginia Medical School||2|||f||||f||||||||||2017-10-10 22:28:16.362096|2017-10-10 22:28:16.362096
NCT02682888|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-03-13|||December 8, 2015|Actual|2015-12-08|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Trait Anxiety and Defensive Networks||Recruiting||N/A|130|Anticipated|University of Electronic Science and Technology of China||4|||f||||||||||||||2017-10-10 22:28:16.449984|2017-10-10 22:28:16.449984
NCT02682875|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-10|||November 2015||2015-11-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01|4 Months|Observational [Patient Registry]|ANN||The Evaluation With Artificial Neural Network of Pain Scales in Children (ANN)|The Evaluation With Artificial Neural Network of Pain Scales in Children|Recruiting||N/A|140|Anticipated|Cukurova University|||1||f||||f||||||||Yes||2017-10-10 22:28:18.245387|2017-10-10 22:28:18.245387
NCT02682862|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-09-20|||August 2016||2016-08-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MAN05||Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics|Effects of Ultra-long Acting Bronchodilator Therapy Assessed by Impulse Oscillometry in Smoking Asthmatics Taking Inhaled Corticosteroids|Recruiting||Phase 4|16|Anticipated|University of Dundee||2|||f||||f||||||||No||2017-10-10 22:28:18.316096|2017-10-10 22:28:18.316096
NCT02682849|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-11-09|||May 2016||2016-05-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01|30 Days|Observational [Patient Registry]|||Active Clearance Technology (ACT) Registry|Prevention of Retained-Blood Outcomes With Active Clearance Technology- The ACT Registry|Recruiting||N/A|500|Anticipated|Mayo Clinic|||2||f||||||||||||No||2017-10-10 22:28:18.427298|2017-10-10 22:28:18.427298
NCT02682836|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-11|||October 2015||2015-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2017|Actual|2017-09-01||Interventional|||Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study|Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study|Active, not recruiting||N/A|40|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:28:18.499135|2017-10-10 22:28:18.499135
NCT02682823|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-07-20||2017-07-20|March 2016||2016-03-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Tocilizumab Real-Life Human Factors (RLHFs) Validation Study|Tocilizumab Real-Life Human Factors Validation Study Protocol|Completed||Phase 4|91|Actual|Hoffmann-La Roche||3|||f|||||t|t|t|f||||||2017-10-10 22:28:18.595927|2017-10-10 22:28:18.595927
NCT02682810|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-04-12|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|||Point of Care Virologic Testing to Improve Outcomes of HIV-Infected Children|Z 1303 - Point-of-Care Virologic Testing to Improve Outcomes of HIV-Infected Children|Recruiting||N/A|2876|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-10 22:28:18.71416|2017-10-10 22:28:18.71416
NCT02682797|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-08-05|||September 2013||2013-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Optical Coherence Tomography Evaluation of Retinoschisis and Retinal Detachment|Use of Spectral Domain Optical Coherence Tomography to Differentiate and Follow-up Senile Retinoschisis and Retinal Detachment|Completed||N/A|44|Actual|Medical University of Vienna|||1||f||||f||||||||No||2017-10-10 22:28:18.84089|2017-10-10 22:28:18.84089
NCT02682784|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-09-29|||July 2015||2015-07-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Neural Substrates of Emotion: Impact of Cocaine Dependence|Neural Substrates of Emotion: Impact of Cocaine Dependence|Recruiting||Phase 2|160|Anticipated|Medical University of South Carolina||4|||f||||f||||||||||2017-10-10 22:28:18.915234|2017-10-10 22:28:18.915234
NCT02682771|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-02-13|||November 2014||2014-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Positive Airway Pressure Versus Breathing Exercises With Load Inspiratory in Patients Undergoing Bariatric Surgery|Effects of Positive Airway Pressure and Incentive With Load Inspiratory on Lung Function and Respiratory Muscle in Post-bariatric Surgery - a Randomized and Blind Clinical Trial|Completed||N/A|60|Actual|Universidade Metodista de Piracicaba||3|||f||||t||||||||No||2017-10-10 22:28:19.073264|2017-10-10 22:28:19.073264
NCT02682758|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-01-23|||February 2016||2016-02-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Influence of Xenon Anaesthesia on Transpulmonary Pressure and Tidal Volume Distribution|Influence of Xenon Anaesthesia on Transpulmonary Pressure and Tidal Volume Distribution|Completed||Phase 4|20|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-10 22:28:19.308806|2017-10-10 22:28:19.308806
NCT02682745|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-12|||January 2016||2016-01-01|February 2016|2016-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Single Dosing Clinical Trial of HL151|Single Dosing Clinical Trial to Assess the Pharmacokinetic Characteristics and Safety/Tolerability of HL151 Formulation in Healthy Male Subjects|Active, not recruiting||Phase 1|30|Actual|Hanlim Pharm. Co., Ltd.||6|||f||||f||||||||||2017-10-10 22:28:19.410277|2017-10-10 22:28:19.410277
NCT02682732|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-04-11|||April 2016||2016-04-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Molecular Imaging to Capture Disease Heterogeneity in Acute Myeloid Leukemia|Molecular Imaging to Capture Disease Heterogeneity in Acute Myeloid Leukemia|Recruiting||N/A|10|Anticipated|Hamilton Health Sciences Corporation||1|||f||||f||||||||No|The data will be shared after the study is completed|2017-10-10 22:28:19.513073|2017-10-10 22:28:19.513073
NCT02682719|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-15|||December 2015||2015-12-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PARABLE||ARNI in Asymptomatic Patients With Elevated Natriuretic Peptide and Elevated Left Atrial Volume Index eLEvation|Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation (The PARABLE Study)|Recruiting||Phase 2|250|Anticipated|The Heartbeat Trust||2|||f||||t||||||||Yes||2017-10-10 22:28:19.619645|2017-10-10 22:28:19.619645
NCT02682706|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-04-13|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|MIBAT||Magnetic Resonance Imaging of Human Supraclavicular Brown Adipose Tissue - MIBAT Study|Magnetic Resonance Imaging of Human Supraclavicular Brown Adipose Tissue - MIBAT Study|Recruiting||N/A|25|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     plasma   "|No||2017-10-10 22:28:19.800822|2017-10-10 22:28:19.800822
NCT02682693|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-07-10|||February 13, 2017|Actual|2017-02-13|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|GeparX||Denosumab as an add-on Neoadjuvant Treatment (GeparX)|Investigating Denosumab as an add-on Neoadjuvant Treatment for RANK-positive or RANK-negative Primary Breast Cancer and Two Different Nab-Paclitaxel Schedules ; 2x2 Factorial Design (GeparX)|Recruiting||Phase 2|778|Anticipated|German Breast Group||4|||f||||t|f|f||||||||2017-10-10 22:28:19.88092|2017-10-10 22:28:19.88092
NCT02682680|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-10|||January 2016||2016-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|GOAL-RCT||Randomized Trial Comparing Colesevelam vs. Ezetimibe|Goal Achievement of A1c and LDL in a Randomized Trial Comparing Colesevelam vs. Ezetimibe as Add-on to Baseline Statin Therapy: The GOAL-RCT Trial|Recruiting||Phase 4|440|Anticipated|LMC Diabetes & Endocrinology Ltd.||2|||f||||f||||||||Undecided||2017-10-10 22:28:20.029914|2017-10-10 22:28:20.029914
NCT02682654|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2016-05-03|||February 2016||2016-02-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and Instability|A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and Instability|Completed||N/A|183|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:28:20.350195|2017-10-10 22:28:20.350195
NCT02682641|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-06-09|||May 2016||2016-05-01|June 2017|2017-06-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL|Multicentric Phase II Trial to Evaluate the Efficacy and Safety of Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of Mantle Cell Lymphoma|Recruiting||Phase 2|50|Anticipated|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||f||||||||No||2017-10-10 22:28:20.487375|2017-10-10 22:28:20.487375
NCT02682628|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-11|2017-03-29|||February 18, 2016|Actual|2016-02-18|March 2017|2017-03-01|February 22, 2016|Actual|2016-02-22|February 22, 2016|Actual|2016-02-22||Interventional|SFP||18791 - Sun Protection Factor Assay|Sun Protection Factor (SPF) Assay UVA Protection Factor Assay (UVAPF) Minimal Persistent Pigment-Darkening Dose (MPPD)|Completed||N/A|10|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:28:20.722422|2017-10-10 22:28:20.722422
NCT02679807|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-05-01|||February 2016||2016-02-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|MK EPRIC||Effect of Probiotic on Rhinovirus Induced Colds|Effect of Probiotic on Rhinovirus Induced Colds|Enrolling by invitation||N/A|250|Anticipated|University of Virginia||2|||f||||f||||||||Undecided||2017-10-10 22:28:47.374297|2017-10-10 22:28:47.374297
NCT02682615|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-03|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Non-invasive Cardiac Output Monitoring (esCCO™) in Critically Ill Patients Within ICU|Cardiac Output Monitoring System (esCCO™) in Comparison to Transcardiopulmonal Thermodilution Technique (PiCCO®) in Critically Ill Patients Within Interdisciplinary Surgical Intensive Care Units|Not yet recruiting||N/A|100|Anticipated|University of Schleswig-Holstein|||1||f||||f||||||||No||2017-10-10 22:28:20.823662|2017-10-10 22:28:20.823662
NCT02682602|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-01-11|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||THA Kinematics and Sound for Subjects for Normal, Diseased and Implanted Hips|In Vivo Determination of Total Hip Arthroplasty (THA) Kinematics and Sound for Subjects for Normal, Diseased and Implanted Hips|Active, not recruiting||N/A|21|Actual|The University of Tennessee, Knoxville|||2||f||||f||||||||No||2017-10-10 22:28:20.950763|2017-10-10 22:28:20.950763
NCT02682589|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-07-03|||April 2016||2016-04-01|July 2016|2016-07-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|OLCMECC||Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer|A Multicenter, Prospective, Randomized Clinical Trial to Investigate Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer|Recruiting||Phase 3|1080|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||No||2017-10-10 22:28:21.077013|2017-10-10 22:28:21.077013
NCT02682576|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-02-06|||April 2016||2016-04-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Brachial Artery Ultrasound Imaging: A Repeatability Study|Brachial Artery Ultrasound Imaging: A Repeatability Study|Completed||N/A|21|Actual|Everist Genomics, Inc||1|||f||||f||||||||No||2017-10-10 22:28:21.180953|2017-10-10 22:28:21.180953
NCT02682563|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-19|||February 2016||2016-02-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|RED||Renoprotective Effects of Dapagliflozin in Type 2 Diabetes|A Randomized, Double-blind, Comparator-controlled Trial to Assess the Effect of 12-week Treatment With Dapagliflozin Versus Gliclazide on Renal Physiology and Biomarkers in Metformin-treated Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 4|44|Anticipated|VU University Medical Center||2|||f||||f||||||||No||2017-10-10 22:28:21.285189|2017-10-10 22:28:21.285189
NCT02682550|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-02-10|||September 2014||2014-09-01|February 2016|2016-02-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|NTF-PT||Danger Response in Polytrauma Patients|Analysis of the Danger Response After Polytrauma Based on the National Polytrauma-serum-bank of the Trauma Research Network (NTF) of the German Society for Orthopaedics and Trauma (DGOU)|Recruiting||N/A|1000|Anticipated|University of Ulm|||2||f||||t||||||Samples With DNA|"     EDTA-Plasma and Serum (drawn from polytrauma patients with an injury severity score ≥25)   "|No||2017-10-10 22:28:21.553092|2017-10-10 22:28:21.553092
NCT02682537|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-04-20|||March 2015||2015-03-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||IC-BASAROTs: New Practice Method for More Accurate Bed-side Assessment of Individual Energy Expenditure|IC-BASAROTs: Verification of a New Practice Method for More Accurate Bed-side Assessment of Individual Energy Expenditure|Recruiting||N/A|1400|Anticipated|University of Applied Sciences Neubrandenburg|||18||f||||f||||||||Yes|The other study centers forward us pseudonymised participant data for evaluation. It might also be possible that we share selected pseudonymised participant data with the other study centers.|2017-10-10 22:28:21.674329|2017-10-10 22:28:21.674329
NCT02682524|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-10-07|||August 2015||2015-08-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Phase IV Clinical Trial to Evaluate the Efficacy and Safety of PlbCR and Aceclofenac in the Treatment of Patients With Osteoarthritis of the Knee||Completed||Phase 4|191|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 22:28:21.871461|2017-10-10 22:28:21.871461
NCT02682511|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-12|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension|A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)|Recruiting||Phase 2|34|Anticipated|Cumberland Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:28:21.96782|2017-10-10 22:28:21.96782
NCT02682498|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-07-05|2016-10-31||October 2013||2013-10-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj|A Double Blind, Randomized Clinical Trial Comparing Postoperative Narcotic Usage in Patients Receiving Periarticular Liposomal Bupivicaine vs. Those Patients Receiving Standard Periarticular Joint Injections|Completed||Phase 4|38|Actual|University of California, Irvine||2|||f||||f||||||||||2017-10-10 22:28:22.127338|2017-10-10 22:28:22.127338
NCT02682485|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-01-10|||January 2017||2017-01-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|SES-DTA||Serial Endoscopic Surveillance & Direct Topical Antibiotics to Define the Role of Microbes in Anastomotic Healing|A Multicenter, Phase II, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial of Serial Endoscopic Surveillance (SES) and Direct Topical Antibiotics (DTA) to Define the Role of Microbes in Anastomotic Healing|Not yet recruiting||Phase 2|200|Anticipated|University of Chicago||2|||f||||t||||||||No||2017-10-10 22:28:22.441099|2017-10-10 22:28:22.441099
NCT02682472|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-02-10|||August 2015||2015-08-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||SettleIN - Adjustment to Care in Dementia: An Intervention Feasibility Study v0.1|SettleIN - An Adjustment to Care Intervention for People With Dementia: A Feasibility Pilot Study in Care Homes|Recruiting||N/A|24|Anticipated|University College, London||1|||f||||t||||||||No|Anonymised and summarised data is planned for inclusion in an empirical paper to be submitted for publication. The summarised results will be fed back to participating care home managers and staff if desired.|2017-10-10 22:28:22.54645|2017-10-10 22:28:22.54645
NCT02682459|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-19|||February 2016||2016-02-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|EXTRA||ACE-inhibitors in Extracapillary Glomerulonephritis|A Pilot, Prospective, Randomized, Open-label, Blinded Endpoint (Probe) Histopathology Trial to Assess the Effects of ACE- Inhibition Therapy on Glomerular Proliferative Lesions in Patients With Extracapillary Glomerulonephritis|Recruiting||Phase 2|22|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||f||||||||||2017-10-10 22:28:22.638323|2017-10-10 22:28:22.638323
NCT02682446|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-10|||January 2007||2007-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Observational|||The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm|Prediction for the Development of Metachronous Gastric Cancer After Endoscopic Submucosal Dissection by Serum Pepsinogen|Completed||N/A|800|Actual|Kyungpook National University|||4||f||||f||||||Samples Without DNA|"     Serum pepsinogen, serum HP IgG   "|Undecided||2017-10-10 22:28:22.734847|2017-10-10 22:28:22.734847
NCT02682433|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-04-07|||April 2016||2016-04-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||3D Sonohysterography vs Hysteroscopy: Study for the Evaluation of Intrauterine Abnormalities|3D Sonohysterography vs Hysteroscopy: Study for the Evaluation of Intrauterine Abnormalities|Not yet recruiting||Phase 3|250|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||No||2017-10-10 22:28:22.832494|2017-10-10 22:28:22.832494
NCT02682420|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-10-28|||March 2016||2016-03-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||everlinQ endoAVF Europe (EU) Study|everlinQ endoAVF EU Study|Enrolling by invitation||N/A|125|Anticipated|TVA Medical Inc.||1|||f||||f||||||||No||2017-10-10 22:28:22.927987|2017-10-10 22:28:22.927987
NCT02682407|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-31|||February 2016||2016-02-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721|A Phase 2 Study to Evaluate the Safety and Effect on Proteinuria of OMS721 in Subjects With IgA Nephropathy, Lupus Nephritis, Membranous Nephropathy, or C3 Glomerulopathy Including Dense Deposit Disease|Recruiting||Phase 2|26|Anticipated|Omeros Corporation||2|||f||||f||||||||||2017-10-10 22:28:23.03631|2017-10-10 22:28:23.03631
NCT02682394|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-02-12|||September 2015||2015-09-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas|Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients With Pancreatic Cancer|Unknown status|Recruiting|N/A|30|Anticipated|Soroka University Medical Center|||1||f||||f||||||Samples With DNA|"     Cell-free DNA, CFD   "|No||2017-10-10 22:28:23.154325|2017-10-10 22:28:23.154325
NCT02682381|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-05-24|||June 23, 2016|Actual|2016-06-23|May 2017|2017-05-01|October 20, 2017|Anticipated|2017-10-20|October 20, 2017|Anticipated|2017-10-20||Interventional|||Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition|A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support|Active, not recruiting||Phase 3|34|Anticipated|Shire||3|||f||||t||||||||||2017-10-10 22:28:23.254231|2017-10-10 22:28:23.254231
NCT02682368|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-04-03|||October 1, 2015|Actual|2015-10-01|April 2017|2017-04-01|June 15, 2018|Anticipated|2018-06-15|September 30, 2017|Anticipated|2017-09-30||Interventional|POCUSS||Multicentric Point of Care UltraSound by Surgeons Trial|Multicentric Surgeon-Performed Point-Of-Care Ultrasound Versus Radiologist-Reported Study in Acute Gallbladder and Acute Diverticular Disease|Recruiting||N/A|400|Anticipated|Connolly Hospital Blanchardstown||2|||f||||t||||||||Yes|Results of the research will be available as anonymous data|2017-10-10 22:28:23.40296|2017-10-10 22:28:23.40296
NCT02682355|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-05-26|||February 2016||2016-02-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Optimizing Clinical Use of Polymyxin B|Optimizing Clinical Use of Polymyxin B: Teaching an Old Drug to Treat Superbugs|Recruiting||N/A|250|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"     -  Blood and Respiratory cultures from infection site.        -  Urine Samples for Proteomic testing.        -  Blood Specimen for Pharmacokinetic/Pharmacodynamic testing.   "|Yes||2017-10-10 22:28:23.554295|2017-10-10 22:28:23.554295
NCT02682342|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-12-28|||October 2016||2016-10-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Hyperglycemia and Mitochondrial Function in The Endothelium of Humans|Hyperglycemia and Mitochondrial Function in The Endothelium of Humans|Recruiting||N/A|15|Anticipated|Medical College of Wisconsin|||1||f||||f||||||Samples Without DNA|"     Plasma samples and endothelial cells obtained will be saved for banking for future studies as     possible.   "|Yes|The data may be available to qualified investigators following study completion and initial publication of the data with collaboration with the study PI.|2017-10-10 22:28:23.647149|2017-10-10 22:28:23.647149
NCT02682329|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-17|||February 2014||2014-02-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||Combination of Dental Bleaching Techniques, Randomized Clinical Trial|Combination of Dental Bleaching Techniques, Randomized Clinical Trial|Completed||Phase 4|120|Actual|Universidad Iberoamericana||4|||f||||t||||||||Undecided||2017-10-10 22:28:23.733799|2017-10-10 22:28:23.733799
NCT02682316|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-09-13|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Negative Pressure Wound Therapy in Post-Operative Incision Management|A Phase III Randomized Controlled Trial of Negative Pressure Wound Therapy in Post-Operative Incision Management|Recruiting||Phase 3|686|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 22:28:23.80969|2017-10-10 22:28:23.80969
NCT02682303|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-10-17|||March 2016||2016-03-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Elastic Bandage on Balance in Chronic Ankle Instability|Effect of Elastic Bandage on Measurements of Balance in Subjects With Chronic Ankle Instability: a Randomized Clinical Trial|Completed||N/A|28|Actual|Universidad Rey Juan Carlos||2|||f||||f||||||||||2017-10-10 22:28:23.9115|2017-10-10 22:28:23.9115
NCT02682290|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-23|||February 2016||2016-02-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|RHEOMUCO||Assessment of Rheological Parameters of Human Sputum.|Assessment of a Device Used for Measuring the Rheological Parameters of Human Sputum.|Recruiting||N/A|40|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||No||2017-10-10 22:28:24.103503|2017-10-10 22:28:24.103503
NCT02682277|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-21|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|October 31, 2016|Actual|2016-10-31|October 2016|Actual|2016-10-01||Interventional|||Efficacy of Polyglucosamine Long Term Treatment|Efficacy of Polyglucosamine for Weight Loss - in a Randomized, Double-blind, Placebo-controlled Clinical Investigation|Completed||N/A|100|Actual|Certmedica International GmbH||2|||f||||f||||||||||2017-10-10 22:28:24.19245|2017-10-10 22:28:24.19245
NCT02682264|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-06|||March 2016||2016-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris|An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris|Enrolling by invitation||Phase 3|600|Anticipated|Cassiopea SpA||1|||f||||f||||||||||2017-10-10 22:28:24.289814|2017-10-10 22:28:24.289814
NCT02682251|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-12-21|||February 2016||2016-02-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Engaging Patients in Heart Failure Management|Engaging Patients in Heart Failure Management|Recruiting||N/A|160|Anticipated|Parkview Health||1|||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-10 22:28:24.455644|2017-10-10 22:28:24.455644
NCT02682238|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-08-23|||February 2016||2016-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis|A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Local Tolerability of Topically Applied BBI-4000 (Sofpironium Bromide) 15% Gel in Subjects With Palmar Hyperhidrosis|Completed||Phase 2|50|Actual|Brickell Biotech, Inc.||2|||f||||f||||||||||2017-10-10 22:28:24.555845|2017-10-10 22:28:24.555845
NCT02682225|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-03-14|||March 25, 2016|Actual|2016-03-25|March 2017|2017-03-01|January 9, 2017|Actual|2017-01-09|January 9, 2017|Actual|2017-01-09||Interventional|||Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users|A Single-Center, Single-Dose, Double-Blind, Double-Dummy, Placebo-Controlled, Randomized Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Users of Perception-Altering Drugs|Completed||Phase 1|55|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-10 22:28:24.653901|2017-10-10 22:28:24.653901
NCT02682212|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-03-30|||March 2016||2016-03-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Obstetric Perineal Trauma and Physiotherapy|Obstetric Perineal Trauma, Pelvic Floor Symptoms and Early Physiotherapy Intervention|Recruiting||N/A|80|Anticipated|Landspitali University Hospital||2|||f||||f||||||||No||2017-10-10 22:28:24.79101|2017-10-10 22:28:24.79101
NCT02682199|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-01-13|||October 2015||2015-10-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Observational|NRR||Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation|Prospective Evaluation of Patient-Reported Xerostomia After Whole Brain Radiation|Recruiting||N/A|60|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-10 22:28:24.886931|2017-10-10 22:28:24.886931
NCT02682186|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-06|||February 1, 2016||2016-02-01|March 2017|2017-03-01|February 6, 2018|Anticipated|2018-02-06|February 1, 2018|Anticipated|2018-02-01||Interventional|PECS B&BS||Pectoral Nerve Block for Analgesia After Breast Augmentation|Effects of the Pectoral Blocks in the Prosthetic Breast Expansion Surgery : Prospective, Randomized, Double Blind Study.|Recruiting||Phase 3|80|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||Undecided||2017-10-10 22:28:24.969542|2017-10-10 22:28:24.969542
NCT02682173|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-07-25|||March 2013||2013-03-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver|MRI Fat Quantification of the Liver, Subcutaneous and Visceral Fatty Tissue in Patients Before and After Bariatric Surgery|Completed||N/A|15|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 22:28:25.074132|2017-10-10 22:28:25.074132
NCT02682160|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Pilot Study to Evaluate Daily Protein's Intake Following Bariatric Surgery by Using the Software Protein Assistant|Pilot Study to Evaluate the Evolution of Daily Protein Intake in Obese Patients With Recent Bariatric Surgery, Using the Software Protein Assistant.|Completed||N/A|38|Actual|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 22:28:25.163106|2017-10-10 22:28:25.163106
NCT02682147|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-08-14|||July 10, 2017|Actual|2017-07-10|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|February 2023|Anticipated|2023-02-01||Interventional|||Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema|Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema|Recruiting||Phase 4|80|Anticipated|University of Iowa||5|||f||||t|t|f|||f|||||2017-10-10 22:28:25.25714|2017-10-10 22:28:25.25714
NCT02682134|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-10|||November 2015||2015-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Sore Throat Prevention Following Intubation|Comparison Between Xylocaine Gel as Endotracheal Cuff Lubricant Versus Dexamethasone 8 mg Intravenously or Both for Sore Throat Prevention Following Intubation: Interventional Study|Completed||Phase 4|300|Actual|University of Jordan||3|||f||||f||||||||Yes||2017-10-10 22:28:25.378172|2017-10-10 22:28:25.378172
NCT02682121|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-01-26|||April 2012||2012-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|MAP-2||Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo|Metabolic Alterations in Platelet Study II|Completed||Phase 1|55|Actual|University of Utah||2|||f||||||||||||||2017-10-10 22:28:25.486994|2017-10-10 22:28:25.486994
NCT02682108|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-09-13|||April 2014||2014-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver Fibrosis|Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver Fibrosis in Patients With Chronic Viral Hepatitis|Completed||N/A|121|Actual|Mahidol University||1|||f||||f||||||||No|There is no a plan to make individual participant data available.|2017-10-10 22:28:25.569047|2017-10-10 22:28:25.569047
NCT02682095|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-09-07|||April 2016||2016-04-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||To Achieve Blood Pressure Control With Retained Quality of Life|Possibilities for Patients With Elevated Blood Pressure to Achieve Blood Pressure Control Without Affecting Quality of Life (the PEQ Study)|Not yet recruiting||N/A|600|Anticipated|Lund University|||4||f||||f||||||||Undecided||2017-10-10 22:28:25.661244|2017-10-10 22:28:25.661244
NCT02681718|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-01-09|||January 2016||2016-01-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CHAMP||Controlling Hyperglycemia Among Minority Population|Controlling Hyperglycemia Among Minority Population (CHAMP): A Randomized Controlled Trial of Two Diabetes Interventions for Underserved Communities|Recruiting||N/A|330|Anticipated|Sinai Health System||3|||f||||f||||||||No||2017-10-10 22:28:28.578109|2017-10-10 22:28:28.578109
NCT02682082|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-08-02|||March 2016||2016-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|EUS-CPN||EUS Guided Neurolysis Celiac Block w/wo Bupivacaine in Patient Being Treated Palliatively for Pancreatic Cancer|A Randomize Double-Blind Control Trial Study Comparing Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis W/Wo Bupivacaine In Patient Being Treated Palliatively For Pancreatic Cancer|Active, not recruiting||N/A|84|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-10 22:28:25.754594|2017-10-10 22:28:25.754594
NCT02682069|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-01-31|||February 2016||2016-02-01|November 2016|2016-11-01|January 5, 2017|Actual|2017-01-05|January 5, 2017|Actual|2017-01-05||Interventional|||Positive Predictive Value of the MolecuLight i:X Imaging Device to Predict the Presence of Bacteria in Chronic Wounds|A Prospective, Single-blind Evaluation of the Positive Predictive Value (PPV) of the MolecuLight i:X(TM) Imaging Device to Predict the Presence of Bacteria in Chronic Wounds|Completed||N/A|30|Actual|MolecuLight Inc.||1|||f||||f||||||||No||2017-10-10 22:28:25.862961|2017-10-10 22:28:25.862961
NCT02682056|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-07|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|GUMP||Glucose Measurement Using Microneedle Patches|Glucose Measurement Using Microneedle Patches|Recruiting||N/A|15|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 22:28:25.958927|2017-10-10 22:28:25.958927
NCT02682043|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-11-08|||February 2016||2016-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Parental Perspectives of Using Toy Cars on Social Interactions of Preschool Children With Mobility Impairments|Parental Perspectives of Using Modified Toy Cars on the Social Interactions of Preschool Children With Mobility Impairments.|Completed||N/A|5|Actual|University of Ulster||1|||f||||f||||||||Yes|On completion of study - data will be analyzed and disseminated through paper/ conference presentations. All data will be anonymized.|2017-10-10 22:28:26.081629|2017-10-10 22:28:26.081629
NCT02682030|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-07-26|||March 2016||2016-03-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Use of Airway Clearance Devices in ALS|Utilization of Pulmonary Clearance Devices in Amyotrophic Lateral Sclerosis|Recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-10 22:28:26.149689|2017-10-10 22:28:26.149689
NCT02682017|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-10|||August 2011||2011-08-01|February 2016|2016-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Effect of Consuming Pork From Seaweed Extract Fed Animals on Antioxidant Status|Effect of Consuming Pork From Animals Supplemented With Laminarin and Fucoidan Derived From the Brown Seaweed Laminaria Digitata on the Antioxidant Status of Human Participants.|Completed||N/A|40|Actual|University of Ulster||2|||f||||f||||||||||2017-10-10 22:28:26.240102|2017-10-10 22:28:26.240102
NCT02682004|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-12|||February 2016||2016-02-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||Serotonin, Leptin and Adiponectin Level in Patients With Postpartum Depression: Controlled Study|Serotonin, Leptin and Adiponectin Level in Patients With Postpartum Depression: Controlled Study|Recruiting||N/A|400|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital|||2||f||||t||||||||||2017-10-10 22:28:26.315411|2017-10-10 22:28:26.315411
NCT02681991|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-04|||January 2016||2016-01-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.||Completed||Phase 4|110|Actual|Daewon Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-10 22:28:26.395729|2017-10-10 22:28:26.395729
NCT02681978|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-10|||February 2014||2014-02-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|RIVENDEL||Ivabradine to Improve Endothelial Function in Patients With Coronary Artery Disease|Heart Rate Reduction by IVabradine for Improvement of ENDothELial Function in Patients With Coronary Artery Disease: the RIVENDEL Study|Completed||Phase 4|70|Actual|Campus Bio-Medico University||2|||f||||f||||||||Undecided||2017-10-10 22:28:26.471092|2017-10-10 22:28:26.471092
NCT02681965|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-02-20|||March 2016||2016-03-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|LEAN3||A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors|A Randomized Controlled Trial, Using a Mail and Video-based Weight Loss Program for Overweight or Obese Stage I-IIIC Breast Cancer Survivors.|Enrolling by invitation||N/A|200|Anticipated|Yale University||2|||f||||t||||||||Undecided||2017-10-10 22:28:26.564132|2017-10-10 22:28:26.564132
NCT02681952|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-04|||December 2015||2015-12-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure||Completed||Phase 4|153|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 22:28:26.659648|2017-10-10 22:28:26.659648
NCT02681939|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-04-18|||February 2016||2016-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Tulsi (Ocimum Sanctum) on Biochemical Parameters in Young Overweight and Obese Subjects|Effect of Supplementation of Tulsi (Ocimum Sanctum Linn.) on Metabolic Parameters and Liver Enzymes in Young Overweight and Obese Subjects|Completed||Phase 2|30|Actual|All India Institute of Medical Sciences, Bhubaneswar||2|||f||||f||||||||||2017-10-10 22:28:26.736734|2017-10-10 22:28:26.736734
NCT02681926|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-12|||December 2015||2015-12-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01|12 Months|Observational [Patient Registry]|VISITALY||Impact of a New Ablation Tracking Tool in Paroxysmal Atrial Fibrillation Ablation With Contact Force Technology|VISITALY-Impact of a New Ablation Tracking Tool in Paroxysmal Atrial Fibrillation Ablation With Contact Force Technology|Recruiting||N/A|210|Anticipated|Azienda Ospedaliero, Universitaria Pisana|||2||f||||f||||||||Undecided||2017-10-10 22:28:26.811131|2017-10-10 22:28:26.811131
NCT02681913|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-04-19|||February 2016||2016-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Adenosine as an Adjunct to Blood Cardioplegia|The Effect of Adenosine on Myocardial Protection in Intermittent Warm Blood Cardioplegia: A Randomized Placebo-controlled Trial|Recruiting||Phase 2|100|Anticipated|Amphia Hospital||2|||f||||f||||||||No||2017-10-10 22:28:26.883315|2017-10-10 22:28:26.883315
NCT02681900|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-09|||October 2014||2014-10-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Exploring Whether Self-affirmation Promotes Reduced Alcohol Consumption in Response to Narrative Health Information|Exploring Whether Experimentally Manipulated Self-affirmation Promotes Reduced Alcohol Consumption in Response to Narrative Health Information|Completed||N/A|142|Actual|University of Sussex||2|||f||||f||||||||Undecided||2017-10-10 22:28:26.994778|2017-10-10 22:28:26.994778
NCT02681887|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-03-07|||September 2016|Actual|2016-09-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Effect of Melatonin on Cardiometabolic Risk- FULL|Effect of Melatonin on Cardiometabolic Risk- FULL|Recruiting||Phase 3|120|Anticipated|Brigham and Women's Hospital||2|||f||||t|t|f|||t|||||2017-10-10 22:28:27.072363|2017-10-10 22:28:27.072363
NCT02681874|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-07-11|||December 2015||2015-12-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|SSC||Smart and Secure Children Program for Preschool Obesity|Feasibility Study of the Modified-Smart and Secure Children Program in Primary Care|Recruiting||N/A|30|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 22:28:27.163103|2017-10-10 22:28:27.163103
NCT02681861|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-01-09|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects|A Phase 1 Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects|Completed||Phase 1|74|Actual|Astellas Pharma Inc||2|||f||||t||||||||Undecided||2017-10-10 22:28:27.251036|2017-10-10 22:28:27.251036
NCT02681848|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-05-02|||July 2015||2015-07-01|May 2017|2017-05-01||||February 2018|Anticipated|2018-02-01||Observational|||What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?||Active, not recruiting||N/A|180000|Anticipated|University of Bristol|||1||f||||t||||||||||2017-10-10 22:28:27.494281|2017-10-10 22:28:27.494281
NCT02681835|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-03-08|||February 2016||2016-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Endotracheal Intubation in Prehospital Scenario|Comparison of the C-MAC and Macintosh Laryngoscopes for Tracheal Intubation in Different Intubator Positions. A Randomized, Crossover, Manikin Trial|Completed||N/A|78|Actual|Medical University of Warsaw||3|||f||||t||||||||Undecided||2017-10-10 22:28:27.607007|2017-10-10 22:28:27.607007
NCT02681822|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2017-04-24|||November 2015||2015-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|CHIMGEN||Multi-center Imaging Genetics Studies in China|Multi-center Imaging Genetics Studies in China|Recruiting||N/A|10000|Anticipated|Tianjin Medical University General Hospital|||1||f||||t||||||Samples With DNA|"     The investigators retain the peripheral blood drawn from antecubital vein in order to acquire     the genotype, whether the healthy young participants carry the risk allele of one specific     gene or not. No matter what genotypes the participants own, no specific intervention measure     will be done among the participants.   "|Yes|The investigators plan to share the IPD with the member institutes or hospitals after the total completion of the investigation.|2017-10-10 22:28:27.693968|2017-10-10 22:28:27.693968
NCT02681809|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-09-01|||December 2015||2015-12-01|March 2017|2017-03-01||||July 2019|Anticipated|2019-07-01||Interventional|CIRCLE||A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR|A Phase 2, Randomised, Double Masked, Sham Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total Posterior Vitreous Detachment (PVD) in Subjects With Non-proliferative Diabetic Retinopathy (NPDR)|Recruiting||Phase 2|115|Anticipated|ThromboGenics||3|||f||||||||||||||2017-10-10 22:28:27.822175|2017-10-10 22:28:27.822175
NCT02681796|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-03-16|||June 7, 2016|Actual|2016-06-07|March 2017|2017-03-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|E-PRO I||Epidural Analgesia Use in Pancreatic Resections|Epidural Analgesia Use in Pancreatic Resections|Recruiting||Phase 1|150|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||No||2017-10-10 22:28:28.025101|2017-10-10 22:28:28.025101
NCT02681783|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-02-11|||September 2016||2016-09-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PRaCTICAL||PRedictive Factors and Changes From Treatment in Idiopathic Polypoidal Choroidal Vasuclopathy Versus Central Serous Chorioretinopathy Versus Neovascular Age Related Macular Degeneration With afLibercept|PRedictive Factors and Changes From Treatment in Idiopathic Polypoidal Choroidal Vasuclopathy Versus Central Serous Chorioretinopathy Versus Neovascular Age Related Macular Degeneration With afLibercept|Not yet recruiting||Phase 4|120|Anticipated|Sunnybrook Health Sciences Centre||4|||f||||f||||||||Undecided||2017-10-10 22:28:28.148326|2017-10-10 22:28:28.148326
NCT02681770|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Observational|IDyAL||Individual and Dyadic Functioning, Adherence, and Quality of Life After Kidney Transplantation|Individual and Dyadic Functioning of Patients and Their Spouses After Kidney Transplantation With Regard to Adherence and Quality of Life|Enrolling by invitation||N/A|30|Anticipated|Hannover Medical School|||1||f||||f||||||||No||2017-10-10 22:28:28.237276|2017-10-10 22:28:28.237276
NCT02681757|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-12-01|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns|A Comparison of Mepitel Ag vs Antibiotic Ointment When Used With the Soft Cast Technique for the Treatment of Pediatric Hand and Foot Burns, a Prospective Study|Enrolling by invitation||Phase 4|100|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 22:28:28.313189|2017-10-10 22:28:28.313189
NCT02681744|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-11|||February 2016||2016-02-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Sarcopenia, Obesity, and Resistance Training|Effects of Resistance Training on Sarcopenic Obesity Index in Older Women: a RCT.|Recruiting||N/A|244|Anticipated|University of Brasilia||2|||f||||f||||||||Undecided||2017-10-10 22:28:28.418458|2017-10-10 22:28:28.418458
NCT02681731|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-06-12|||March 2016||2016-03-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Impact of Neuromonitoring During Cardiac Procedures|Impact of Neuromonitoring During Cardiothoracic Procedures: A Retrospective Analysis|Active, not recruiting||N/A|250000|Actual|Medtronic - MITG|||1||f||||f||||||||No|There is no individual participant data in this retrospective database study.|2017-10-10 22:28:28.512546|2017-10-10 22:28:28.512546
NCT02681705|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-08-16|||January 2010||2010-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Radiation Therapy and Combination Chemotherapy for Medulloblastoma|Phase 2 Study of Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Medulloblastoma|Recruiting||Phase 2|60|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||Yes||2017-10-10 22:28:28.672712|2017-10-10 22:28:28.672712
NCT02681692|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-04-07|||April 2016||2016-04-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Magnetic Endoscopic Imaging on Patient Pain During Colonoscopy|Effect of Magnetic Endoscopic Imaging on Patient Pain During Colonoscopy: a Randomized, Controlled Trial Using a Simple Colon Force Measurement Device|Recruiting||N/A|570|Anticipated|Shanghai Jiao Tong University School of Medicine||4|||f||||f||||||||||2017-10-10 22:28:28.778407|2017-10-10 22:28:28.778407
NCT02681679|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-02-11|||October 2014||2014-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery|Topical 0.1% Bromfenac Sodium for Intraoperative Pupil Dilation Maintenance and Prostaglandin E2 Inhibition in Femtosecond Laser-assisted Cataract Surgery|Completed||N/A|60|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:28:28.890928|2017-10-10 22:28:28.890928
NCT02681666|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-09-21|||July 1, 2017|Actual|2017-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MB-IBS-EAT||Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome|A Pilot, Randomized Trial of Mindfulness-based Irritable Bowel Syndrome Eating Awareness Training as Compared to the Standard Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Patients With IBS|Active, not recruiting||N/A|20|Actual|University of Miami||2|||f||||f|f|f||||||||2017-10-10 22:28:28.992913|2017-10-10 22:28:28.992913
NCT02681653|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-02-11|||January 2012||2012-01-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Study the Impact of Statins in Septic Shock|Prospective Randomized Study to Assess Impact of Statins in Septic Shock|Completed||N/A|40|Actual|Sanjay Gandhi Postgraduate Institute of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:28:29.101564|2017-10-10 22:28:29.101564
NCT02681640|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-04|||March 2016||2016-03-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|February 10, 2017|Actual|2017-02-10||Interventional|||uPAR PET/CT for Preoperative Staging of Breast Cancer Patients|Phase II Trial: uPAR PET/CT for Preoperative Staging of Breast Cancer Patients|Completed||Phase 2|50|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||No||2017-10-10 22:28:29.193996|2017-10-10 22:28:29.193996
NCT02681627|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-08-10|||November 2015||2015-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SiM||Sim (Scratch in Miscarriage) Study|Pilot Randomised Controlled Trial of the Effect of Endometrial Scratch in Recurrent Miscarriage on Pregnancy Outcomes|Recruiting||N/A|100|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust||2|||f||||f||||||||||2017-10-10 22:28:29.292577|2017-10-10 22:28:29.292577
NCT02681614|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-06-07|||July 21, 2016|Actual|2016-07-21|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning|Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning|Recruiting||N/A|6|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f|f|||No||2017-10-10 22:28:29.411585|2017-10-10 22:28:29.411585
NCT02681601|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-08-24|||July 19, 2016|Actual|2016-07-19|August 2016|2016-08-01|July 19, 2018|Anticipated|2018-07-19|July 19, 2018|Anticipated|2018-07-19||Interventional|||Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer|Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer|Recruiting||N/A|60|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 22:28:29.550911|2017-10-10 22:28:29.550911
NCT02681588|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-04-05|||July 2010||2010-07-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|MOBENN||Newborns of Obese Mothers|Impact of Maternal Obesity on Fetal Development and Perinatal Events. Analysis of the Determinants of Fetal Growth.|Completed||N/A|496|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:28:29.703475|2017-10-10 22:28:29.703475
NCT02681575|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-09-04|||March 2016||2016-03-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Meta-cognitive Functional Intervention for Adults With ADHD: A Pilot Efficacy Study|Meta-cognitive Functional Intervention for Adults (Cog-Fun - A) With Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Efficacy Study|Recruiting||N/A|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||Undecided||2017-10-10 22:28:29.782734|2017-10-10 22:28:29.782734
NCT02681562|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-12|||January 2016||2016-01-01|February 2016|2016-02-01||||January 2018|Anticipated|2018-01-01||Interventional|||Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients|"A Phase II, Open Label, Controlled Study of Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients: Biological Evaluation From a Window of Opportunity Trial"|Active, not recruiting||Phase 2|45|Actual|Istituti Ospitalieri di Cremona||2|||f||||||||||||||2017-10-10 22:28:29.873272|2017-10-10 22:28:29.873272
NCT02681549|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-12-15|||May 2016||2016-05-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer|A Phase 2 Trial of Pembrolizumab Plus Bevacizumab in Patients With Metastatic Melanoma or Non-small Cell Lung Cancer With Untreated Brain Metastases|Recruiting||Phase 2|53|Anticipated|Yale University||1|||f||||t||||||||No||2017-10-10 22:28:29.96353|2017-10-10 22:28:29.96353
NCT02681536|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-03-31|||February 2016||2016-02-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Miniflare Versus Long Protocol in Poor Responders||Recruiting||N/A|200|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||t||||||||Undecided||2017-10-10 22:28:30.076984|2017-10-10 22:28:30.076984
NCT02681523|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2016-08-30|||October 2015||2015-10-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ALERT||ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.|ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.|Recruiting||Phase 2|12|Anticipated|Imperial College London||1|||f||||t||||||||No|Not currently planned in the protocol.|2017-10-10 22:28:30.171699|2017-10-10 22:28:30.171699
NCT02681497|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-09-09|||March 2016||2016-03-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Use of Canagliflozin in Conjunction With Insulin in a Real-world Setting|Characteristics and Health Outcomes of Patients With Type 2 Diabetes Treated With Canagliflozin Added to Insulin Therapy in a Real-world Setting|Completed||N/A|269|Actual|Lawson Health Research Institute|||1||f||||f||||||||No||2017-10-10 22:28:30.355503|2017-10-10 22:28:30.355503
NCT02681484|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-02-09|||September 2002||2002-09-01|February 2016|2016-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effects of Speech-therapy in Hypertensive Patients|Speech Guided Breathing: a Modality to Influence Cardiovascular Regulation and Health Perception in Hypertensive Patients?|Completed||N/A|31|Actual|Klinik Arlesheim||2|||f||||f||||||||No||2017-10-10 22:28:30.43308|2017-10-10 22:28:30.43308
NCT02681471|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2016-02-11|||December 2013||2013-12-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia|Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia: A Comparison of the Effects on Plasma Electrolytes, Osmolarity and Hemoglobin|Completed||N/A|53|Actual|Istanbul University||2|||f||||f||||||||Undecided||2017-10-10 22:28:30.526543|2017-10-10 22:28:30.526543
NCT02681458|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-04-13|2016-03-15||August 2013||2013-08-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Observational|||Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran|The Comparison of Dermatophytosis and Other Fungal Infections Between Drug Users and Non Drug Users|Completed||N/A|1436|Actual|Islamic Azad University of Mashhad|||2||f||||f||||||Samples Without DNA|"     hair, nail, cutaneous lesions   "|Undecided|The investigators have not decided about this issue yet|2017-10-10 22:28:30.633198|2017-10-10 22:28:30.633198
NCT02681445|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-02-09|||February 2016||2016-02-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01|2 Years|Observational [Patient Registry]|||Non-invasive TB Triage and Patient Mapping Platform Using Breath Via Low-Cost Titanium Dioxide Nanotube Sensor||Not yet recruiting||N/A|1250|Anticipated|University of Utah|||5||f||||t||||||||||2017-10-10 22:28:30.862879|2017-10-10 22:28:30.862879
NCT02681432|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-02-23|||January 2012||2012-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|hipecova||Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer|Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel for the Treatment of Patients With Recurrent or Primary Advanced Ovarian Cancer : A Randomised Phase 3 Study|Recruiting||Phase 3|94|Anticipated|Hospital General de Ciudad Real||2|||f||||f||||||||No||2017-10-10 22:28:30.934786|2017-10-10 22:28:30.934786
NCT02681419|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-10-04|||January 2013||2013-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period|Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period|Recruiting||Phase 4|72|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-10-10 22:28:31.060157|2017-10-10 22:28:31.060157
NCT02681393|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-03-21|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Physical Activity Maintenance in Stroke|The Effectiveness of an Educational Brochure on Exercise and a Motivational Telephone Support in Physical Activity Maintenance for Stroke Survivors|Completed||N/A|50|Actual|McMaster University||2|||f||||f||||||||No|Individual participant data will not be made available.|2017-10-10 22:28:31.236363|2017-10-10 22:28:31.236363
NCT02681380|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-07-12|||September 2015||2015-09-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|EMPATHIE||Impact of a Relation Training on Empathy of Medical Student|Impact of a Relation Training, Balint-like, on Empathy of Medical Student in the 4th Year.|Completed||N/A|352|Actual|University of Paris 5 - Rene Descartes||2|||f||||f||||||||Undecided||2017-10-10 22:28:31.316021|2017-10-10 22:28:31.316021
NCT02681354|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-06-13|||November 2015||2015-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Dual Task Training in Elderly Using the BioRescue|What is the Influence of Dualtask-training With the BioRescue (Analyses and Rehabilitation of Mobility) on Static Balance, Dynamic Balance During Gait and Cognitive-motor Dual Tasks During Gait: A Randomized Controlled Trial|Completed||N/A|21|Actual|Hasselt University||2|||f||||f||||||||||2017-10-10 22:28:31.484689|2017-10-10 22:28:31.484689
NCT02681341|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-01-31|||February 2016||2016-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Vascular Post Market Review|Vascular Post Market Review|Active, not recruiting||N/A|10|Actual|Baylor Research Institute|||1||f||||f||||||||No||2017-10-10 22:28:31.568296|2017-10-10 22:28:31.568296
NCT02681328|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-19|||May 1, 2016|Actual|2016-05-01|September 2017|2017-09-01|December 1, 2022|Anticipated|2022-12-01|August 1, 2021|Anticipated|2021-08-01||Observational|||Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules|Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules|Recruiting||N/A|300|Anticipated|Jonsson Comprehensive Cancer Center|||2||f||||f||||||||||2017-10-10 22:28:31.626015|2017-10-10 22:28:31.626015
NCT02681315|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-09-09|||March 2016||2016-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Two Flow Rates of HHHFNC to Prevent Extubation Failure in Preterm Infants|HHHFNC to Prevent Extubation Failure in Preterm Infants: A Randomized Controlled Trial|Recruiting||Phase 3|40|Anticipated|Mansoura University Children Hospital||2|||f||||t||||||||||2017-10-10 22:28:31.710129|2017-10-10 22:28:31.710129
NCT02681302|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-08-08|||June 7, 2016|Actual|2016-06-07|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Interventional|CPIT001||Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence|Phase Ib-IIA Study of Combined Check Point Inhibition After Autologous Hematopoietic Stem Cell Transplantation in Patients at High Risk for Post-transplant Recurrence|Recruiting||Phase 1/Phase 2|42|Anticipated|Hackensack University Medical Center||1|||f||||f||||||||||2017-10-10 22:28:31.97793|2017-10-10 22:28:31.97793
NCT02681289|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-02-11|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Infant||Physiotherapy of At-Risk Infants, Physiotherapist or Family?|Physiotherapy of At-Risk Infants, Physiotherapist or Family? A Randomized Intervention Study|Completed||N/A|40|Actual|Hacettepe University||2|||f||||t||||||||Yes||2017-10-10 22:28:32.170494|2017-10-10 22:28:32.170494
NCT02681276|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-09|||October 2014||2014-10-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Clinical and Microbiological Evaluation of 0.5% Versus 3% Sodium Hypochlorite in Root Canal Treatment|Clinical and Microbiological Evaluation of 0.5% Versus 3% Sodium Hypochlorite in Root Canal Treatment|Recruiting||N/A|264|Anticipated|Göteborg University||2|||f||||f||||||||No|The data is going to be published at a Group level|2017-10-10 22:28:32.286801|2017-10-10 22:28:32.286801
NCT02681263|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-11-29|||April 2016||2016-04-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|TEMO-ESBL||Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae|Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae|Recruiting||Phase 4|50|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 22:28:32.437524|2017-10-10 22:28:32.437524
NCT02681250|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-01|||February 2015||2015-02-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Trial of Dental Implants in Titanium-zirconium Alloy|A Randomized Controlled Clinical Trial of Dental Implants in Titanium-zirconium Alloy|Recruiting||N/A|96|Anticipated|Vastra Gotaland Region||2|||f||||f||||||||No||2017-10-10 22:28:32.626584|2017-10-10 22:28:32.626584
NCT02681237|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-03-15|||April 29, 2016|Actual|2016-04-29|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|April 2021|Anticipated|2021-04-01||Interventional|||A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer|A Proof of Concept, Multi-centre, Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on PARP Inhibitor in Ovarian Cancer|Recruiting||N/A|30|Anticipated|University Health Network, Toronto||1|||f||||t|f|f||||||No||2017-10-10 22:28:32.745884|2017-10-10 22:28:32.745884
NCT02681224|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-02-27|||September 2015||2015-09-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest|TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest|Completed||N/A|17|Actual|Goldman, Butterwick, Fitzpatrick and Groff||4|||f||||f||||||||No||2017-10-10 22:28:32.840983|2017-10-10 22:28:32.840983
NCT02681211|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-05-03|||February 2016||2016-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|MigAcu||Auricular Acupuncture vs SOC in Migraine HA|A Randomized Trial Comparing Auricular Acupuncture and Intravenous Migraine Medications in the Treatment of Status Migrainosus in the Pediatric Emergency Department|Enrolling by invitation||N/A|80|Anticipated|University of Louisville||2|||f||||f||||||||No||2017-10-10 22:28:32.942255|2017-10-10 22:28:32.942255
NCT02681198|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-05-01|||February 2016||2016-02-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers|Lofexidine Pharmacokinetics in the Presence of Paroxetine, a Strong CYP2D6 Inhibitor, in Healthy Volunteers|Completed||Phase 1|24|Actual|US WorldMeds LLC||1|||f||||f||||||||No||2017-10-10 22:28:33.061765|2017-10-10 22:28:33.061765
NCT02681185|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-08-11|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Efficacy of a Virtual Care Clinic in the Management of Diabetes Mellitus|Efficacy of a Virtual Care Clinic in the Management of Diabetes Mellitus|Not yet recruiting||N/A|100|Anticipated|Endocrine Research Society||2|||f||||f|f|f||||||||2017-10-10 22:28:33.167142|2017-10-10 22:28:33.167142
NCT02681159|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-04-03|||January 2016||2016-01-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01|14 Days|Observational [Patient Registry]|||Critical Incidents Related to Anesthesia and Intensive Care: A Study in a Tertiary Hospital|Critical Incidents Related to Anesthesia and Intensive Care: A Prospective Study in a Tertiary Hospital|Active, not recruiting||N/A|150|Anticipated|University of Jordan|||1||f||||f||||||||No||2017-10-10 22:28:33.38912|2017-10-10 22:28:33.38912
NCT02681146|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-03-28|||June 2016||2016-06-01|November 2015|2015-11-01|February 2018|Anticipated|2018-02-01|March 2017|Anticipated|2017-03-01||Interventional|||A Stepped-wedge Cluster Randomized Controlled Trial for Evaluating an Intervention in Patients With Stroke Tailored Education in Addition to Physiotherapist Treatment||Not yet recruiting||N/A|320|Anticipated|University of Malaga||8|||f||||t||||||||Undecided||2017-10-10 22:28:33.459513|2017-10-10 22:28:33.459513
NCT02681133|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-09|||September 2014||2014-09-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Observational|||How is Physical Activity Level and Educational Expectations of Patient With Knee Osteoarthritis : Epidemiological Study in Spa Therapy|How is Physical Activity Level and Educational Expectations of Patient With Knee Osteoarthritis : Epidemiological Study in Spa Therapy|Completed||N/A|500|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 22:28:33.548766|2017-10-10 22:28:33.548766
NCT02681120|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-12-07|||October 2016||2016-10-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Observational|||Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast Cancer|Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast Cancer|Recruiting||N/A|40|Anticipated|Indiana University|||2||f||||t||||||||||2017-10-10 22:28:33.63374|2017-10-10 22:28:33.63374
NCT02681107|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-06-14|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|ACCEL||APBI: 27Gy in 5 Fractions for Early Breast Cancer|Accelerated Partial Breast Irradiation Using Five Daily Fractions: A Single Arm, Phase II, Prospective Cohort Study to Examine Cosmetic Outcomes and Toxicity (The ACCEL Trial)|Recruiting||N/A|274|Anticipated|AHS Cancer Control Alberta||1|||f||||t||||||||Yes|"At least one peer-review publication will be prepared by the investigators following the conclusion of the study. In addition, an abstract to report interim results following the 1-year, interim cosmetic evaluation may be submitted to the annual Canadian Association of Radiation Oncology and/or San Antonio Breast Cancer Symposium scientific meetings.
Authorship will include the named investigators involved in the development of the grant proposal plus additional authors proportional to subject accrual, participation in the cosmetic photograph review panels and/or other contributions to study analysis or success."|2017-10-10 22:28:33.775355|2017-10-10 22:28:33.775355
NCT02681094|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-10|2017-07-17|||February 26, 2016|Actual|2016-02-26|July 2017|2017-07-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|||A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes|A Multi-Center, Randomized, Double-Blind, Active-Controlled , Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin 5mg Co-administered With Dapagliflozin 5mg Compared to Saxagliptin 5mg or Dapagliflozin 5mg All Given as Add-on Therapy to Metformin inPatients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Alone|Completed||Phase 3|906|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 22:28:33.892076|2017-10-10 22:28:33.892076
NCT02681081|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-09-22|||February 2016||2016-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|OPTIMIZE||Optimizing Chronic Pain Treatment With Enhanced Neuroplastic Responsiveness|Optimizing Chronic Pain Treatment With Enhanced Neuroplastic Responsiveness|Recruiting||N/A|70|Anticipated|University of Florida||3|||f||||t|f|f||||||||2017-10-10 22:28:34.208578|2017-10-10 22:28:34.208578
NCT02681068|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-05-03|||January 2015||2015-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Observational|MicroTrans||MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation|MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation|Recruiting||N/A|1000|Anticipated|University of Cologne|||1||f||||t||||||||No||2017-10-10 22:28:34.307841|2017-10-10 22:28:34.307841
NCT02681055|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-21|||March 2016||2016-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects|An Open-Label Study To Evaluate The Efficacy, Safety, Tolerability and PK of MN-001 (Tipelukast) on HDL Function and Serum Triglyceride Levels in NASH and Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects With Hypertriglyceridemia|Recruiting||Phase 2|40|Anticipated|MediciNova||1|||f||||f||||||||||2017-10-10 22:28:34.384461|2017-10-10 22:28:34.384461
NCT02681042|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-02-11|||March 2015||2015-03-01|February 2016|2016-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|Lariat||Left Atrial Appendage Closure With SentreHeart Lariat® Device|Left Atrial Appendage Closure With SentreHeart Lariat® Device|Recruiting||N/A|50|Anticipated|Baylor Research Institute||1|||f||||t||||||||Undecided||2017-10-10 22:28:34.491716|2017-10-10 22:28:34.491716
NCT02681029|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-09|||November 2015||2015-11-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||The Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos|Evaluating the Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos at Royan Institute: A Phase 3, Randomized Controlled Trial|Recruiting||Phase 3|220|Anticipated|Royan Institute||2|||f||||t||||||||||2017-10-10 22:28:34.581807|2017-10-10 22:28:34.581807
NCT02681016|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-06|||March 2015||2015-03-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Interventional|PATRIOT||Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE|"Prospective rAndomized, Single-blind, multicenTral Control Clinical Trial of Sirolimus-eluting coRonary Stent Calypso (Angioline) vs Everolimus-elutIng cOronary stenT Xience Prime (Abbott Vascular)"|Recruiting||N/A|610|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 22:28:34.685979|2017-10-10 22:28:34.685979
NCT02680990|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-05-17|||December 2015||2015-12-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|REACT||Resilience and Exercise in Advanced Cancer Treatment|Prehabilitation for Patients With Aggressive Gastrointestinal Cancers Undergoing Neoadjuvant Therapy|Enrolling by invitation||N/A|60|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||No||2017-10-10 22:28:34.834186|2017-10-10 22:28:34.834186
NCT02680977|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-10-04|||February 2016||2016-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Mucuna Pruriens Therapy in Parkinson's Disease|Mucuna Pruriens Therapy in Parkinson's Disease: a Double-blind, Placebo-controlled, Randomized, Crossover Study.|Completed||Phase 2|18|Actual|ASST Gaetano Pini-CTO||3|||f||||f||||||||Undecided||2017-10-10 22:28:34.930052|2017-10-10 22:28:34.930052
NCT02680964|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-06-26|||February 2016||2016-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:28:35.054434|2017-10-10 22:28:35.054434
NCT02680951|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-07-24|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia|Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia: A Phase I Study (AflacLL1401)|Recruiting||Phase 1|18|Anticipated|Emory University||3|||f||||t|t|f||||||||2017-10-10 22:28:35.111097|2017-10-10 22:28:35.111097
NCT02680938|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-03-01|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor|Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor A Randomized Controlled Study|Recruiting||Phase 1|1|Anticipated|Ain Shams University||2|||f||||f||||||||Yes|The aim of the present study was to evaluate the effect of intraumbilical vein oxytocin on reducing the duration of the third stage of labor and the need for manual delivery of placenta, in comparison with normal saline administration|2017-10-10 22:28:35.268387|2017-10-10 22:28:35.268387
NCT02680925|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-04-22|||February 2016||2016-02-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Lung Protective Ventilation During Pulmonary Lobectomy in Children|The Influence of Lung Protective Ventilation During Pulmonary Lobectomy on Clinical Outcome in Pediatric Patients|Recruiting||N/A|114|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 22:28:35.353532|2017-10-10 22:28:35.353532
NCT02680912|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-20|||February 2016||2016-02-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|May 16, 2017|Anticipated|2017-05-16||Interventional|||Warm Needle Acupuncture vs Needle Acupuncture|Warm Needle Acupuncture vs. Needle Acupuncture for Osteoarthritis of the Knee: A Pilot Study|Active, not recruiting||N/A|14|Actual|London South Bank University||2|||f||||f||||||||No||2017-10-10 22:28:35.443788|2017-10-10 22:28:35.443788
NCT02680899|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-05-06|||February 2016||2016-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Adolescent Mental Health InSciEd Out|Adolescent Outcomes in Mental Health InSciEd Out|Completed||N/A|17|Actual|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 22:28:35.522953|2017-10-10 22:28:35.522953
NCT02680886|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-06-27|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Observational|SKINNOQ||PMCF-study Using Novosyn® Quick Suture Material for Skin Closure|Post-Marketing Clinical Follow-up (PMCF) Study for Skin Closure to Evaluate the Safety and Efficacy of Novosyn® Quick Suture Material. A Multicenter, International, Prospective, Observational Study|Recruiting||N/A|100|Anticipated|Aesculap AG|||1||f||||f||||||||No||2017-10-10 22:28:35.593243|2017-10-10 22:28:35.593243
NCT02680873|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-02-09|||March 2013||2013-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SASI||Efficacy of SASI Bypass for Type-2 Diabetic Obese Patients|Efficacy of Single Anastomosis Sleeve Ileal (SASI) Bypass for Type-2 Diabetic Obese Patients: Loop Gastric Bipartition, a Novel Metabolic Surgery Procedure.|Completed||N/A|50|Actual|Mansoura University||1|||f||||t||||||||Undecided||2017-10-10 22:28:37.374554|2017-10-10 22:28:37.374554
NCT02680860|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-02-09|||December 2014||2014-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:28:37.449684|2017-10-10 22:28:37.449684
NCT02680847|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-10-02|||January 21, 2016|Actual|2016-01-21|October 2017|2017-10-01|January 20, 2019|Anticipated|2019-01-20|January 20, 2019|Anticipated|2019-01-20||Interventional|||Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain|An Open-label Study To Evaluate The Pharmacokinetics And Safety Of Alo-02 (Oxycodone Hydrochloride And Naltrexone Hydrochloride) Extended-release Capsules In Children And Adolescents 7-17 Years Of Age Who Require Opioid Analgesia|Recruiting||Phase 4|140|Anticipated|Pfizer||1|||f||||f|t|f||||||||2017-10-10 22:28:37.492346|2017-10-10 22:28:37.492346
NCT02680834|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-01-27|||February 2016||2016-02-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||VLU Non-inferiority Study Comparing a Dual Action Pneumatic Compression Device to Multi-layer Bandaging|Randomized Trial Comparing a Dual Action Pneumatic Compression System Against Multi-Layer Bandaging Systems: A Non-inferiority Study|Active, not recruiting||N/A|204|Anticipated|Tactile Medical||2|||f||||t||||||||No||2017-10-10 22:28:37.641106|2017-10-10 22:28:37.641106
NCT02680821|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-10-13|||February 2016||2016-02-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Reconstruction of the Anterolateral Ligament (ALL) With Revision Anterior Cruciate Ligament (ACL) Surgery|Effect of Reconstruction of the Anterolateral Ligament (ALL) in Combination With Revision Anterior Cruciate Ligament (ACL) Surgery. A Clinical Randomized Trial|Recruiting||N/A|102|Anticipated|Aarhus University Hospital||2|||f||||t||||||||||2017-10-10 22:28:37.756858|2017-10-10 22:28:37.756858
NCT02680808|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-06-08|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe|An Open Label Study in Healthy Volunteers to Evaluate the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe|Completed||Phase 1|20|Actual|F2G Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:28:37.830491|2017-10-10 22:28:37.830491
NCT02680795|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-03-10|||March 2016||2016-03-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||To Evaluate the Safety and Pharmacokinetics of Belinostat in Patients Who Have Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes|An Open-label, Nonrandomized, Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Belinostat in Patients With Relapsed/Refractory Solid Tumors or Hematological Malignancies Who Have Wild-Type, Heterozygous, and Homozygous UGT1A1*28 Genotypes|Recruiting||Phase 1|18|Anticipated|Spectrum Pharmaceuticals, Inc||3|||f||||f||||||||No||2017-10-10 22:28:37.919408|2017-10-10 22:28:37.919408
NCT02680782|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-08-01|||January 2016||2016-01-01|August 2016|2016-08-01|August 2016|Anticipated|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||A Study Comparing Once-Daily vs. Twice-Daily Dosing of X4P-001 in Healthy Volunteers|A Phase 1 Study Comparing Once-Daily vs. Twice-Daily Dosing of X4P-001 in Healthy Volunteers|Active, not recruiting||Phase 1|15|Actual|X4 Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:28:38.14111|2017-10-10 22:28:38.14111
NCT02680769|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-06-10|||March 2016||2016-03-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Magnesium Supplementation in COPD|Daily Supplementation of Magnesium Citrate in Moderate-severe Chronic Obstructive Pulmonary Disease: a Randomized, Controlled, Double-blind Trial|Recruiting||N/A|76|Anticipated|University of Padova||2|||f||||t||||||||No||2017-10-10 22:28:38.232304|2017-10-10 22:28:38.232304
NCT02680743|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-20|||March 2016||2016-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit|Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit|Recruiting||N/A|60|Anticipated|University of Nebraska||1|||f||||f||||||||||2017-10-10 22:28:38.591582|2017-10-10 22:28:38.591582
NCT02680730|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Listening Project at the ADD Centre and Biofeedback Institute of Toronto|The Listening Project at the ADD Centre and Biofeedback Institute of Toronto|Recruiting||N/A|30|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-10 22:28:38.679214|2017-10-10 22:28:38.679214
NCT02680717|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-09-15|||March 2016||2016-03-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea|Comparative Effectiveness Trial of Topical Calcipotriene, Clobetasol, and Tacrolimus in the Treatment of Pediatric Plaque Morphea|Withdrawn||Phase 1|0|Actual|Medical College of Wisconsin||3||Unable to obtain IRB approval at all sites|f||||f||||||||||2017-10-10 22:28:38.770735|2017-10-10 22:28:38.770735
NCT02680704|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-06-02|||February 2016||2016-02-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure|Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure|Recruiting||N/A|20|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||t||||||||No||2017-10-10 22:28:38.848064|2017-10-10 22:28:38.848064
NCT02680691|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-05-11|||April 2015||2015-04-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Robot Assisted Gait Training in Patients With Infratentorial Stroke|The Effect of Robot Assisted Gait Training in Patients With Infratentorial Stroke|Recruiting||Phase 4|20|Anticipated|National Rehabilitation Center, Seoul, Korea||2|||f||||f||||||||No||2017-10-10 22:28:38.932034|2017-10-10 22:28:38.932034
NCT02680678|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-04-27|||April 2014||2014-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of the Timing of Colloid and Crystalloid Infusions on Postspinal Hypotension After Spinal Anesthesia for Caesarian Section|Prevention of Postspinal Hypotension After Spinal Anesthesia for Caesarian Section, the Comparison of Crystalloid and Colloid Infusions and Their Timing Via Perfusion Index and Plethysmographic Variability Index|Active, not recruiting||Phase 4|80|Actual|Balikesir University||4|||f||||f||||||||Yes||2017-10-10 22:28:39.045033|2017-10-10 22:28:39.045033
NCT02680665|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-09-29|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Ameparomo Capsules 250 mg Drug Use Investigation|Drug Use Investigation Of Paromomycin. (Regulatory Post Marketing Commitment Plan).|Active, not recruiting||N/A|200|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 22:28:39.147646|2017-10-10 22:28:39.147646
NCT02680652|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-10|||February 2016||2016-02-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||Improving the Diagnosis of Common Variable Immune Deficiency|Improving the Diagnosis of CVID by Analysis of Innate and Adaptive Signaling Pathways|Not yet recruiting||N/A|150|Anticipated|Stanford University|||2||f||||f||||||Samples With DNA|"     Whole exome analysis will be performed on all samples   "|Yes||2017-10-10 22:28:39.205791|2017-10-10 22:28:39.205791
NCT02680639|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-09-27|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Use of High Frequency Oscillations With NIV in Hypercapnic COPD Participants|The Use of High Frequency Oscillations With Noninvasive Ventilation (NIV) in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Participants|Recruiting||N/A|30|Anticipated|Philips Respironics||4|||f||||f||||||||No|There are no plans to share individual participant data (IPD), only aggregate data.|2017-10-10 22:28:39.27446|2017-10-10 22:28:39.27446
NCT02680626|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-09-29|||January 2016||2016-01-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Bilateral Transversus Abdominis Plane Block With or Without Magnesium|Bilateral Transversus Abdominis Plane Block With or Without Magnesium for Total Abdominal Hysterectomy With or Without Salpingo-oophorectomy: a Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Queen's University||2|||f||||t||||||||No||2017-10-10 22:28:39.373801|2017-10-10 22:28:39.373801
NCT02680613|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-04-12|||February 2016||2016-02-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|KCCPAS||Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania|Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania|Recruiting||N/A|600|Anticipated|Queen's University||3|||f||||f||||||||||2017-10-10 22:28:39.4972|2017-10-10 22:28:39.4972
NCT02680600|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-02-11|||March 2014||2014-03-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|INCED||Individualized Cefepime Dosing Study|Pharmacokinetic Evaluation of Cefepime Administrered Intravenously in Intensive Care Patients|Completed||N/A|20|Actual|Onze Lieve Vrouw Hospital||1|||f||||f||||||||No||2017-10-10 22:28:39.603641|2017-10-10 22:28:39.603641
NCT02680587|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-06-12|||April 28, 2016|Actual|2016-04-28|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|ORIOLE||Stereotactic Body Radiation for Prostate Oligometastases|Phase II Randomized Observation Versus Stereotactic Ablative RadiatIOn for OLigometastatic Prostate CancEr (ORIOLE) Trial|Recruiting||Phase 2|54|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||Undecided||2017-10-10 22:28:39.840701|2017-10-10 22:28:39.840701
NCT02680574|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-08-31|||February 2016||2016-02-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)|Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION)|Recruiting||Phase 3|2100|Anticipated|Akebia Therapeutics||2|||f||||t|t|f||||||||2017-10-10 22:28:40.028389|2017-10-10 22:28:40.028389
NCT02680561|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2016-08-22|||April 2016||2016-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma|A Double-Blind (Incorporating an Open Label Comparator), 3-Period, Crossover Study to Determine the Pharmacokinetic Profile and Tolerability of Single Doses of Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler Compared to ADVAIR® DISKUS® in Patients With Persistent Asthma 4 Through 11 Years of Age|Completed||Phase 1|20|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-10 22:28:40.792532|2017-10-10 22:28:40.792532
NCT02680548|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-06-15|||November 2015||2015-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|PREPLANS||Pilot RCT of Efficacy of Perineural Local Anesthetics and Steroids for Chronic Post-traumatic Ankle and Foot Pain|A Pilot Randomized Controlled Trial of Efficacy of Perineural Local Anesthetics and Steroids for Chronic Post-traumatic Neuropathic Pain in the Ankle and the Foot: The PREPLAN Study|Active, not recruiting||Early Phase 1|30|Anticipated|University Health Network, Toronto||3|||f||||f||||||||No||2017-10-10 22:28:40.900096|2017-10-10 22:28:40.900096
NCT02680522|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-08|||January 2014||2014-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety Study to Autonomic Rehabilitation o Parkinson's Disease|Study of Modulation Autonomic Heart Rate of Individuals With Parkinson's Disease and Healty Individuals Subject to a Training With Virtual Reality|Completed||N/A|30|Actual|Universidade Metodista de Piracicaba||2|||f||||t||||||||Yes|The data of the volunteers will be kept confidential , being only used the amount of data for publication in journals with the period until 2017|2017-10-10 22:28:41.094196|2017-10-10 22:28:41.094196
NCT02680509|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-09-27|||February 2016||2016-02-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Single-port Thoracoscopic Sympathicotomy for Treatment of Raynaud's Phenomenon, a Feasibility Study|Single-port Thoracoscopic Sympathicotomy for Treatment of Raynaud's Phenomenon, a Feasibility Study|Enrolling by invitation||N/A|10|Anticipated|University of Groningen||1|||f||||t||||||||||2017-10-10 22:28:41.17871|2017-10-10 22:28:41.17871
NCT02680483|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-01-05|||August 2016||2016-08-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01|1 Year|Observational [Patient Registry]|JoAFR||Atrial Fibrillation Registry in Jordan|Atrial Fibrillation Registry in Jordan|Recruiting||N/A|2000|Anticipated|Jordan Collaborating Cardiology Group|||1||f||||f||||||||Yes||2017-10-10 22:28:41.547016|2017-10-10 22:28:41.547016
NCT02680470|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-05|||August 2015||2015-08-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Virtual Observed Therapy for Patients With Tuberculosis|Virtual Observed Therapy for Patients With Tuberculosis|Completed||N/A|12|Actual|University of Edinburgh||1|||f||||f||||||||No||2017-10-10 22:28:41.637504|2017-10-10 22:28:41.637504
NCT02680457|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-11-07|||November 2013||2013-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|July 2015|Actual|2015-07-01||Interventional|Diabetes||Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus|Effect of the Administration of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus Drug-naïve|Completed||Phase 4|12|Actual|University of Guadalajara||2|||f||||f||||||||No||2017-10-10 22:28:41.741237|2017-10-10 22:28:41.741237
NCT02680444|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-08|||February 2012||2012-02-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|Reappraisal||Mindful Positive Reappraisal: a Daily Diary Randomized Controlled Trial|Exploring Daily Affective Changes in University Students With a Mindful Positive Reappraisal Intervention: a Daily Diary Randomized Controlled Trial|Completed||N/A|129|Actual|University of Guelph||3|||f||||f||||||||No|Individual participant data will not be available.|2017-10-10 22:28:41.83868|2017-10-10 22:28:41.83868
NCT02680431|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-02-08|||January 2016||2016-01-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1|Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1|Enrolling by invitation||N/A|100|Anticipated|Turku University Hospital|||2||f||||f||||||Samples With DNA|"     Free circulating DNA extracted from blood plasma   "|Undecided|Molecular biology results and relevant clinical information will be shared along publication. Some clinical information is subject to privacy issues and cannot be shared.|2017-10-10 22:28:41.937598|2017-10-10 22:28:41.937598
NCT02680418|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-03-29|||December 2015||2015-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pharmacokinetics of FDL169 in Healthy Female Subjects|A Phase I Dose Escalation Study to Assess the Pharmacokinetics (PK) of FDL169 in Healthy Female Volunteers|Completed||Phase 1|8|Actual|Flatley Discovery Lab LLC||6|||f||||f||||||||||2017-10-10 22:28:42.017073|2017-10-10 22:28:42.017073
NCT02680405|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-09-12|||April 2016||2016-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Identification of Epidermal Signatures in Patients With Atopic Dermatitis|Identification of Epidermal Signatures in Patients With Atopic Dermatitis|Recruiting||N/A|50|Anticipated|National Jewish Health|||2||f||||f||||||Samples With DNA|"     Skin biopsy, blood   "|||2017-10-10 22:28:42.129632|2017-10-10 22:28:42.129632
NCT02680392|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-02-10|||September 2015||2015-09-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||Functional Outcome and Analgesia in TKA: Radiofrequency vs Continuous Adductor Canal Block|Functional Outcome and Postoperative Analgesia in Total Knee Arthroplasty: a Comparison Between Continuous Adductor Canal Block and Pulsed and Thermal Radiofrequency of Saphenous and Genicular Nerves of the Knee|Recruiting||N/A|40|Anticipated|McGill University Health Center||2|||f||||f||||||||No||2017-10-10 22:28:42.242001|2017-10-10 22:28:42.242001
NCT02680379|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-12-16|||March 2016||2016-03-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|LovaMiX||Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome|A Pilot Study Exploring the Safety and Synergistic Effect of a Minocycline/Lovastatin Combined Treatment on the Behavior of Individuals With Fragile X Syndrome; Validation of New Biochemical and Neurophysiological Markers (LovaMix)|Recruiting||Phase 2|26|Anticipated|Université de Sherbrooke||2|||f||||t||||||||No||2017-10-10 22:28:42.384323|2017-10-10 22:28:42.384323
NCT02680366|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2016-03-24|||February 2016||2016-02-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells|A Multi-center, Randomized, Single-blind, Controlled Clinical Trial of Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells|Recruiting||Phase 2|144|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||Undecided||2017-10-10 22:28:42.501402|2017-10-10 22:28:42.501402
NCT02680353|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-09|2017-04-18|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Perioperative Analgesic Efficiency of Bilateral Superficial Cervical Plexus Block in Patients With Thyroidectomy|The Perioperative Analgesic Efficiency of Bilateral Superficial Cervical Plexus Block in Patients With Thyroidectomy|Completed||N/A|47|Actual|Tokat Gaziosmanpasa University||2|||f||||t||||||||No||2017-10-10 22:28:42.606255|2017-10-10 22:28:42.606255
NCT02680340|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-02-21|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|PR||POLARSTEM Retrospective Multicenter Study|Longterm Clinical Outcome Study of the Femoral Cementless Ti/HA Polarstem - A Multicenter Retrospective 10-years Follow-up Study|Completed||N/A|502|Actual|Smith & Nephew, Inc.|||1||f||||t||||||||No||2017-10-10 22:28:42.684895|2017-10-10 22:28:42.684895
NCT02680327|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-10|||October 2015||2015-10-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Observational|DIMAN||Advance Care Planning (ACP) in Elderly Cardiac Surgery Patients|A Feasibility Study on: Advance Care Planning (ACP) in Elderly Cardiac Surgery Patients|Recruiting||N/A|35|Anticipated|Montreal Heart Institute|||1||f||||f||||||||No||2017-10-10 22:28:42.775218|2017-10-10 22:28:42.775218
NCT02680314|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-02-08|||February 2016||2016-02-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix?|Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix?|Not yet recruiting||Phase 2|350|Anticipated|Montefiore Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:28:42.869456|2017-10-10 22:28:42.869456
NCT02680301|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-02-07|||March 2016||2016-03-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Topical Steroid Formulation and Wet Wraps|Comparing Efficacy of Topical Steroid Cream vs. Ointment Formulations Using Wet Dressings for Treatment of Atopic Dermatitis|Recruiting||Phase 4|75|Anticipated|Seton Healthcare Family||2|||f||||f||||||||Undecided||2017-10-10 22:28:42.970387|2017-10-10 22:28:42.970387
NCT02680288|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-03-16|||November 2015||2015-11-01|March 2016|2016-03-01|November 2019|Anticipated|2019-11-01|September 2018|Anticipated|2018-09-01||Interventional|LIVE||Lorcaserin Intra Venous Cocaine Effects|Lorcaserin Effects on Cocaine Craving and Drug-Reinforced Behavior|Recruiting||Phase 1/Phase 2|32|Anticipated|Midwest Biomedical Research Foundation||3|||f||||t||||||||No||2017-10-10 22:28:43.090871|2017-10-10 22:28:43.090871
NCT02680275|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-02-10|||July 2011||2011-07-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy of Dead Sea Peloid Gel in Chronic Endometritis|Efficacy of Intravaginal Dead Sea Peloid Gel Administration in Complex Treatment of Chronic Endometritis and Reproductive Disorders: Randomized Placebo-controlled Prospective Study|Completed||N/A|30|Actual|Scientific Center for Family Health and Human Reproduction Problems, Russia||1|||f||||t||||||||No|The study can generate the publications related to the outcomes. The investigator initiating the protocol (Protocol leader/coPI) will be the first (primary) author of the publication. The publication wil also could involve the names of the site investigators who have contributed to the study. The authorship order of the site investigators will be based upon personal contribution to the study, approved by the SCFHHRP (sponsor). The primary affiliation of the study is SCFHHRP.|2017-10-10 22:28:43.214514|2017-10-10 22:28:43.214514
NCT02680262|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-03-28|||March 2016||2016-03-01|January 2016|2016-01-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|CHOiCE||Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme|A Three-armed Randomised Controlled Trial of Non-participants in an Organised Cervical Cancer Screening Programme|Recruiting||N/A|9327|Anticipated|University of Aarhus||3|||f||||t||||||||No|The study is approved by the Danish Data Protection Agency, (j.no.:1-16-02-495-15)|2017-10-10 22:28:43.306413|2017-10-10 22:28:43.306413
NCT02680249|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-04-29|||February 2016||2016-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Food Effect Study of CTP-656 in Healthy Male Volunteers|A Phase 1 Single Center, Open-Label, Randomized, Three-Way Crossover Study of the Relative Bioavailability of a Single Dose of CTP-656 in a Fasted, Fed Low-Fat and Fed Moderate-Fat Condition in Healthy Male Subjects|Completed||Phase 1|15|Actual|Concert Pharmaceuticals||3|||f||||f||||||||||2017-10-10 22:28:43.428565|2017-10-10 22:28:43.428565
NCT02680236|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-02-08|||June 2015||2015-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Observational|||Art Therapy for Pain Relief in Breast Cancer Patients|Can Art Therapy Improve Breast Cancer Patients' Perception of Persistent Post Treatment Pain and Functioning? A Mixed Methods Pilot Study|Recruiting||N/A|20|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 22:28:43.530755|2017-10-10 22:28:43.530755
NCT02680223|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-08-30|||January 2016||2016-01-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy of Coloured Overlays and Lenses for Reading Difficulty|Efficacy of Coloured Overlays and Lenses for Adults With Reading Difficulty|Recruiting||N/A|36|Anticipated|City, University of London||2|||f||||f||||||||||2017-10-10 22:28:43.654549|2017-10-10 22:28:43.654549
NCT02680210|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-07-25|||January 2016||2016-01-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|IDENTITY||Self-defining Memories in Patients With a TBI|Self-defining Memories in Patients With a TBI and Their Relationships With Cognitive, Emotional and Behavioural Dimensions|Recruiting||N/A|40|Anticipated|Centre d'Investigation Clinique et Technologique 805||1|||f||||t||||||||No||2017-10-10 22:28:43.757807|2017-10-10 22:28:43.757807
NCT02680197|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-03-01|||February 29, 2016|Actual|2016-02-29|March 2017|2017-03-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|GlycoNEXT||Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD|Randomised, Double Blind, Placebo-controlled, Incomplete Block, 3-way Cross-over Study to Evaluate Efficacy and Safety of 4 Doses of Glycopyrronium Bromide (CHF5259) DPI in Moderate to Severe Patients With COPD|Completed||Phase 2|262|Actual|Chiesi Farmaceutici S.p.A.||5|||f||||f||||||||No||2017-10-10 22:28:43.864094|2017-10-10 22:28:43.864094
NCT02680184|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-10-03|||March 2016||2016-03-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy|A Multicenter, Two-Part, Open-Label, Phase 1B Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy in Subjects With Advanced Melanoma|Recruiting||Phase 1|160|Anticipated|Checkmate Pharmaceuticals||7|||f||||f||||||||||2017-10-10 22:28:44.036048|2017-10-10 22:28:44.036048
NCT02680171|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-08|||February 2016||2016-02-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Feasibility and Effectiveness Study of Implementing Prism Adaptation as a Treatment for Spatial Neglect After Stroke|Feasibility and Effectiveness Study of Implementing Prism Adaptation as a Treatment for Spatial Neglect After Right Hemisphere Stroke|Not yet recruiting||N/A|70|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||No||2017-10-10 22:28:44.369519|2017-10-10 22:28:44.369519
NCT02680158|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-04-07||2017-04-07|January 2016||2016-01-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||1-Day Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator|A Randomized, Controlled, Double-Masked, Multicenter Trial Designed to Evaluate Acute Tear Production With the Oculeve Intranasal Lacrimal Stimulator Compared to Two Control Applications in Patients With Aqueous Deficient Dry Eye|Completed||N/A|48|Actual|Oculeve, Inc.||6|||f||||f||||||||Undecided||2017-10-10 22:28:44.467786|2017-10-10 22:28:44.467786
NCT02680145|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-03-21|||March 2016||2016-03-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use|Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use|Recruiting||N/A|112|Anticipated|Mayo Clinic||1|||f||||t||||||||No||2017-10-10 22:28:44.593439|2017-10-10 22:28:44.593439
NCT02680132|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-08|||May 2011||2011-05-01|January 2016|2016-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE of Esomeprazole Mg DR Capsule 40 mg [Torrent,India] Versus Nexium 40 mg DR Capsule [ AastraZeneca LP, USA] in Healthy Subjects-Fed Condition|Completed||Phase 1|56|Actual|Torrent Pharmaceuticals Limited||2|||f||||f||||||||No||2017-10-10 22:28:44.713096|2017-10-10 22:28:44.713096
NCT02680119|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-08|||May 2011||2011-05-01|January 2016|2016-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||BE of Torrent's Esomeprazole Mg DR Capsules|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE Study of Esomeprazole Mg DR Capsule 40 mg [Torrent] Versus Nexium [AastraZeneca]- Sprinkled Over Apple Sauce in Subjects-Fasting Condition|Completed||Phase 1|56|Actual|Torrent Pharmaceuticals Limited||2|||f||||f||||||||No||2017-10-10 22:28:44.833592|2017-10-10 22:28:44.833592
NCT02680106|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-04-13|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|SPINNER01||Evaluation of the SPINNER Device for the Application of Wound Dressing: Treatment of Split Skin Graft Donor Sites|EVALUATION OF THE SPINNER™ DEVICE FOR THE APPLICATION OF WOUND DRESSING: TREATMENT OF SPLIT SKIN-GRAFT DONOR SITES. A Prospective, Safety and Efficacy, Open Labeled, Two Arms, Randomized, Multi Center, Controlled Study|Active, not recruiting||N/A|40|Actual|Nicast Ltd.||2|||f||||f||||||||No||2017-10-10 22:28:44.927323|2017-10-10 22:28:44.927323
NCT02680093|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-08|||February 2016||2016-02-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Birth Rate in Conservative Monitoring of Pregnancy Beyond the Date of Birth.|Birth Rate in Conservative Monitoring of Pregnancy Beyond the Date of Birth.|Not yet recruiting||N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||||No||2017-10-10 22:28:45.033071|2017-10-10 22:28:45.033071
NCT02680080|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-07-06|||December 2016||2016-12-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome|The Effect of Pink Grapefruit Juice on the QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome|Not yet recruiting||N/A|35|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 22:28:45.118159|2017-10-10 22:28:45.118159
NCT02680067|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-03-24|||December 8, 2015|Actual|2015-12-08|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NIR-ICG||NIR Fluorescence Imaging of Lymphatic Transport Using ICG|Near InfraRed Fluorescence Imaging of Lymphatic Transport Using Indocyanine Green|Recruiting||Phase 1|20|Anticipated|University of Rochester||1|||f||||f|t|f||||||Yes|Information of any type may be shared with researchers at other institutions. Subjects will be made aware of this in the informed consent form.|2017-10-10 22:28:45.205271|2017-10-10 22:28:45.205271
NCT02680054|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-09|||February 2016||2016-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Fat and Protein Study|Investigation of Appropriate Timing of Additional Insulin Dosing for Fat and Protein in Children With Type 1 Diabetes Using Multiple Daily Injections|Recruiting||Phase 4|40|Anticipated|Oxford University Hospitals NHS Trust||3|||f||||f||||||||||2017-10-10 22:28:45.323512|2017-10-10 22:28:45.323512
NCT02680041|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-04-11|||May 2016||2016-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|LOCATE||18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment|The Impact of 18F Fluciclovine (FACBC) PET/CT (Positron Emission Computed Tomography) on Management of Patients With Rising PSA (Prostate-specific Antigen) After Initial Prostate Cancer Treatment|Active, not recruiting||Phase 3|220|Actual|Blue Earth Diagnostics||1|||f||||f||||||||Undecided||2017-10-10 22:28:45.455067|2017-10-10 22:28:45.455067
NCT02680028|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-05-31|||December 2015||2015-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Short Versus Standard Intramedullary Nail for Trochanteric Hip Fractures|Randomised Trial of Trochanteric Hip Fractures Treated With Either a Short or Standard Length Intramedullary Nail|Recruiting||N/A|400|Anticipated|Peterborough and Stamford Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:28:45.572733|2017-10-10 22:28:45.572733
NCT02680015|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-03-24|||August 2010||2010-08-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Understanding the Effects of Intervention on the Brain in Autism|Understanding the Effects of Intervention on the Brain in Autism|Recruiting||N/A|400|Anticipated|Marquette University||2|||f||||f||||||||No||2017-10-10 22:28:45.670043|2017-10-10 22:28:45.670043
NCT02680002|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-08-18|||March 2016||2016-03-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|May 13, 2016|Actual|2016-05-13||Interventional|||Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant|Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant|Completed||Phase 2|422|Actual|Biomedical Advanced Research and Development Authority||6|||f||||t||||||||||2017-10-10 22:28:45.763794|2017-10-10 22:28:45.763794
NCT02679989|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-07-04|||February 2016||2016-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Met-IER||The Impact Of An Intermittent Energy Restricted Diet On Insulin Sensitivity In Men and Women With Central Obesity|A Randomised Controlled Trial Assessing The Impact Of An Intermittent Energy Restricted Diet On Weight Loss, Insulin Sensitivity and Heart Rate Variability In Men and Women With Central Obesity|Completed||N/A|42|Actual|King's College London||2|||f||||f||||||||Undecided||2017-10-10 22:28:45.900432|2017-10-10 22:28:45.900432
NCT02679976|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-07-27|2016-06-08||July 2015||2015-07-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||All subjects that were dispensed a study lens.|Marketed Contact Lens Real World Through Focus Curve||Completed||N/A|30|Actual|Johnson & Johnson Vision Care, Inc.||1|||f||||||||||||||2017-10-10 22:28:46.099916|2017-10-10 22:28:46.099916
NCT02679963|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-07-31|||January 2016||2016-01-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|PIPSeN||Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer|A Randomized Double-blind Phase II Trial Evaluating Maintenance Olaparib Versus Placebo in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer|Recruiting||Phase 2|600|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-10 22:28:46.344679|2017-10-10 22:28:46.344679
NCT02679950|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-01-27|||November 20, 2015|Actual|2015-11-20|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse|Understanding the Molecular and Genetic Differences Between GCT at the Time of the Initial Diagnosis and at Late Relapse|Active, not recruiting||N/A|6|Actual|Indiana University|||2||f||||f||||||Samples With DNA|"     Tumor tissue Blood samples   "|||2017-10-10 22:28:46.437762|2017-10-10 22:28:46.437762
NCT02679937|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-03-20|||June 2014||2014-06-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|December 27, 2016|Actual|2016-12-27||Interventional|POMC-Fit4Duty||Prevention of Obesity in Military Communities - Fit4Duty|Prevention of Obesity in Military Communities - Fit4Duty: Phase 2|Active, not recruiting||N/A|119|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||t||||||||No||2017-10-10 22:28:46.516974|2017-10-10 22:28:46.516974
NCT02679924|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-02-27|||November 2015||2015-11-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||A Slit Face Trial Using Micro-injections of Transparent Hyaluronic Acid Gel for Rejuvenation of the Cheek|A Single Center, Prospective, Randomized, Sham Controlled, Double Blind, Split Face Trial Using Micro-injections of Transparent Hyaluronic Acid Gel (Restylane® Silk) for Rejuvenation of the Aging Cheek|Active, not recruiting||N/A|20|Anticipated|Goldman, Butterwick, Fitzpatrick and Groff||2|||f||||f||||||||||2017-10-10 22:28:46.599141|2017-10-10 22:28:46.599141
NCT02679911|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-07-26|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|LOOP||Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer|Subject Adherence and Satisfaction for Treatment of Onychomycosis With Loceryl Nail Lacquer 5% Versus Ciclopirox Nail Lacquer|Completed||Phase 4|20|Actual|Galderma||2|||f||||f||||||||||2017-10-10 22:28:46.681183|2017-10-10 22:28:46.681183
NCT02679898|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-08|||September 2013||2013-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Whole Body Vibration and External Load Exercise Training on Cardiovascular and Autonomic Function in Obese Individuals|The Effect of the Combination of Whole Body Vibration and External Load Exercise Training on Cardiovascular and Autonomic Function in Obese Individuals|Completed||N/A|60|Actual|Florida State University||4|||f||||f||||||||No||2017-10-10 22:28:46.764726|2017-10-10 22:28:46.764726
NCT02679885|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-02-26|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Teriflunomide Male Transmission Study|Assay of Teriflunomide Concentrations in Males Taking Teriflunomide for Treatment of Multiple Sclerosis and Their Female Sexual Partners|Recruiting||N/A|40|Anticipated|Griffin Hospital|||1||f||||f||||||Samples Without DNA|"     Serum samples   "|||2017-10-10 22:28:46.84225|2017-10-10 22:28:46.84225
NCT02679872|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-12-16|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Observational|||Video-assisted Thoracoscopic Surgery Teams' Perception of Non-technical Skills|Important Non-technical Skills When Performing Video-assisted Thoracoscopic Surgery: Perceptions of the Operating Team|Completed||N/A|21|Actual|Copenhagen Academy for Medical Education and Simulation|||4||f||||f||||||||Undecided||2017-10-10 22:28:46.89453|2017-10-10 22:28:46.89453
NCT02679859|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-10|||July 2016||2016-07-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|BETTER pilot||B-type Natriuretic Peptide Guided Therapy to Improve Clinical Outcomes for Patients Undergoing Non-cardiac Surgery|A Prospective, Multi-centre, Randomised Trial of B-type Natriuretic Peptide Guided Therapy to Improve Clinical Outcomes for Patients Undergoing Non-cardiac Surgery: the BETTER Surgery Pilot Trial|Not yet recruiting||N/A|100|Anticipated|University of KwaZulu||2|||f||||f||||||||Undecided||2017-10-10 22:28:46.952067|2017-10-10 22:28:46.952067
NCT02679846|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-12-23|||February 2016||2016-02-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|SAVE||Safety of Antiepileptic Withdrawal in Long Term Video-EEG Monitoring|Safety of Antiepileptic Withdrawal in Long Term Video-EEG Monitoring|Recruiting||N/A|1440|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:28:47.020499|2017-10-10 22:28:47.020499
NCT02679833|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-18|||November 2014||2014-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status|Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status: A 3 Month Placebo Controlled Randomized Study|Completed||N/A|180|Actual|Saarland University||2|||f||||f||||||||No|Data sharing only between the two responsible study centers in a coded form, where participant ID is not shared.|2017-10-10 22:28:47.204831|2017-10-10 22:28:47.204831
NCT02679794|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-09-08|||December 2015||2015-12-01|September 2016|2016-09-01||||May 2017|Anticipated|2017-05-01||Interventional|||Impact of Egg Consumption on Carotenoid and Vitamin D Bioavailability in Pre- and Post-menopausal Women|Impact of Egg Consumption on Carotenoid and Vitamin D Bioavailability in Pre- and Post-menopausal Women|Active, not recruiting||N/A|20|Actual|Purdue University||2|||f||||||||||||||2017-10-10 22:28:47.449026|2017-10-10 22:28:47.449026
NCT02679781|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-08-18|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care|Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care|Not yet recruiting||Early Phase 1|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 22:28:47.620864|2017-10-10 22:28:47.620864
NCT02679768|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-02-08|||February 2016||2016-02-01|February 2016|2016-02-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|SAFEII||Electronic Self-monitoring With Closed Loop Feedback Focusing on Regulation of the Sleep-wake Cycle to Reduce Relapse of Depression After Discharge|SAFE II: Can Electronic Self-monitoring With Closed Loop Feedback Focusing on Regulation of the Sleep-wake Cycle Reduce Relapse of Depression After Discharge From a Psychiatric Ward?|Not yet recruiting||N/A|150|Anticipated|Mental Health Centre Copenhagen||2|||f||||f||||||||||2017-10-10 22:28:47.686935|2017-10-10 22:28:47.686935
NCT02679755|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-09-28|||March 9, 2016|Actual|2016-03-09|September 2017|2017-09-01|July 2, 2019|Anticipated|2019-07-02|July 2, 2019|Anticipated|2019-07-02||Interventional|||Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer|A Study Of Palbociclib In Combination With Letrozole As Treatment Of Post-menopausal Women With Hormone Receptor-positive, Her2-negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate|Recruiting||Phase 4|300|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 22:28:47.760004|2017-10-10 22:28:47.760004
NCT02679742|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-09-19|||March 1, 2017|Actual|2017-03-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|PSSMAR||Postacute Sarcopenia: Supplementation With β-hydroxyMethylbutyrate After Resistance Training|The PSSMAR Study (Postacute Sarcopenia, Supplementation With β-hydroxyMethylbutyrate After Resistance Training)|Recruiting||Phase 2|40|Anticipated|Parc de Salut Mar||2|||f||||f|f|f||||||||2017-10-10 22:28:47.924756|2017-10-10 22:28:47.924756
NCT02679716|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-11-08|||December 2014||2014-12-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Reconstruction of Pathological Changes of the Ophthalmic Artery in Patients With Retinal Artery Occlusion|Hemodynamic Computer-assisted Reconstruction of Pathological Changes at the Origin of the Ophthalmic Artery in Patients With Retinal Artery Occlusion|Recruiting||N/A|10|Anticipated|Vienna Institute for Research in Ocular Surgery||1|||f||||f||||||||Undecided||2017-10-10 22:28:48.208164|2017-10-10 22:28:48.208164
NCT02679703|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-02-09|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|February 2016|Actual|2016-02-01||Interventional|||Polarity Action in Electrical Stimulation Transcutaneous Donors for Treatment Areas Burned Patients|Polarity Action in Electrical Stimulation Transcutaneous for Treatment of Graft Donor Areas in Patients Autogenous Burned: Blind Randomized Clinical Trial|Not yet recruiting||N/A|60|Anticipated|University of Sao Paulo||3|||f||||t||||||||Undecided||2017-10-10 22:28:48.316695|2017-10-10 22:28:48.316695
NCT02679677|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-02-07|||April 2015||2015-04-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Evaluation of the Effects of Whole Body Vibration on the Lung Function of Patients With Stable COPD|Evaluation of the Effects of Whole Body Vibration Training With the Galileo Training Device on the Lung Function of Patients With Stable COPD|Recruiting||N/A|40|Anticipated|Heidelberg University||2|||f||||f||||||||Yes||2017-10-10 22:28:48.481043|2017-10-10 22:28:48.481043
NCT02679664|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-17|||November 2016||2016-11-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|SAVER||StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study|StAtins for Venous Event Reduction in Patients With Venous Thromboembolism: A Pilot Study Assessing Feasibility of an RCT to Evaluate if Generic Rosuvastatin Reduces the Risk of Recurrent VTE in Patients With Symptomatic Major VTE.|Recruiting||Phase 2|312|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-10 22:28:48.580089|2017-10-10 22:28:48.580089
NCT02679651|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2017-08-08|||January 2016||2016-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Diagnostic Modeling for Pedal Fat Pad Atrophy|Diagnostic Modeling for Pedal Fat Pad Atrophy|Active, not recruiting||N/A|20|Actual|University of Pittsburgh|||2||f||||t||||||||||2017-10-10 22:28:48.701838|2017-10-10 22:28:48.701838
NCT02679638|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-09|||February 2016||2016-02-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Observational|||Factors and Perceptions Affecting Treatment Choices of Breast Cancer Patients|Factors and Perceptions Affecting Treatment Choices of Breast Cancer Patients. Multi-center Cross-sectional Study in Israel Among Breast Cancer Survivors, With a Preliminary Qualitative Study|Not yet recruiting||N/A|450|Anticipated|University of Haifa|||4||f||||t||||||||No||2017-10-10 22:28:48.798743|2017-10-10 22:28:48.798743
NCT02679625|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-02-05|||November 2014||2014-11-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|FRESEDICU||Comparison of Non-Invasive Methods of Assessing Fluid Responsiveness in ED and ICU Patients|Comparison of Non-Invasive Methods of Assessing Fluid Responsiveness in ED and ICU Patients|Recruiting||N/A|50|Anticipated|Olive View-UCLA Education & Research Institute|||1||f||||f||||||||||2017-10-10 22:28:48.905735|2017-10-10 22:28:48.905735
NCT02679586|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-10|||June 2006||2006-06-01|February 2016|2016-02-01||||March 2013|Actual|2013-03-01||Interventional|||Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy|Evaluation of an Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy|Completed||Early Phase 1|25|Actual|University of Michigan Cancer Center||1|||f||||t||||||||No||2017-10-10 22:28:49.088401|2017-10-10 22:28:49.088401
NCT02679573|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-09-12|||December 14, 2016|Actual|2016-12-14|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|DEFINE-CABP||Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia|A Phase 3, Multicenter, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate the Safety and Efficacy of Intravenous to Oral Delafloxacin in Adult Subjects With Community-Acquired Bacterial Pneumonia|Recruiting||Phase 3|860|Anticipated|Melinta Therapeutics, Inc.||2|||f||||f|t|f||||||||2017-10-10 22:28:49.197195|2017-10-10 22:28:49.197195
NCT02679560|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-14|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures|Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures: a Randomized, Active Comparator-controlled, Blinded Trial|Active, not recruiting||Phase 2|34|Anticipated|University of California, Davis||2|||f||||f|t|f||||||||2017-10-10 22:28:49.436364|2017-10-10 22:28:49.436364
NCT02679547|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||The Effect of Breastfeeding on the Development of Appendicitis in Adults||Active, not recruiting||N/A|1500|Anticipated|Sisli Etfal Training & Research Hospital|||2||f||||f||||||||Undecided|Because the time period of this study is very short|2017-10-10 22:28:49.529055|2017-10-10 22:28:49.529055
NCT02679534|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-04-25|||April 2016||2016-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effectiveness of Hand Massage on the Pain of Cardiac Surgery Critically Ill|The Effectiveness of Hand Massage on the Pain of Cardiac Surgery Critically Ill- A Randomized Controlled Trial|Recruiting||N/A|76|Anticipated|McGill University||3|||f||||||||||||||2017-10-10 22:28:49.621351|2017-10-10 22:28:49.621351
NCT02679521|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-07|||October 2007||2007-10-01|February 2016|2016-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|RSWT_CPF||Radial Extracorporeal Shock Wave Treatment for Chronic Plantar Fasciopathy|The Effectiveness of Extracorporeal Shock Wave Therapy for Patients With Plantar Fasciitis Who Satisfy a Clinical Prediction Rule|Completed||N/A|50|Actual|Rocky Mountain University of Health Professions||2|||f||||f||||||||No||2017-10-10 22:28:49.746702|2017-10-10 22:28:49.746702
NCT02679508|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-04-04|||March 29, 2016|Actual|2016-03-29|April 2017|2017-04-01|February 28, 2022|Anticipated|2022-02-28|February 28, 2022|Anticipated|2022-02-28||Interventional|||Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety|Vonoprazan Study In Patients With Erosive Esophagitis to Evaluate Long-term Safety: A Study to Evaluate the Safety of Long-term Administration of Vonoprazan in Maintenance Treatment in Patients With Erosive Esophagitis (EE)|Active, not recruiting||Phase 4|202|Actual|Takeda||2|||f||||f||||||||||2017-10-10 22:28:49.831902|2017-10-10 22:28:49.831902
NCT02679495|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-10-12|||March 2015||2015-03-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Lifestyle Intervention for Prevention of Gastric Neoplasm|Positive Lifestyle Interventions for the Prevention of Gastric Pre-cancer and Cancer Occurrences in Patients With Chronic Atrophy Gastritis and Reccurence of Gastric Cancer After Edoscopic Resection|Recruiting||N/A|200|Anticipated|Shandong University||2|||f||||f||||||||Undecided||2017-10-10 22:28:49.969519|2017-10-10 22:28:49.969519
NCT02679482|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-06|2016-02-13|||September 2014||2014-09-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Observational|FPSPLTTCOAG||Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma|Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma|Recruiting||N/A|36|Anticipated|Fundación Oftalmológica Nacional|||2||f||||t||||||||Undecided||2017-10-10 22:28:50.050349|2017-10-10 22:28:50.050349
NCT02679469|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-04-17|2017-03-06||February 2016||2016-02-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects||Completed||Phase 1|7|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:28:50.163349|2017-10-10 22:28:50.163349
NCT02679456|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-02-17|||November 2015||2015-11-01|August 2016|2016-08-01|August 5, 2016|Actual|2016-08-05|August 5, 2016|Actual|2016-08-05||Interventional|||Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis|A Multicenter, Randomized, Evaluator Blinded, Active-Controlled Study to Evaluate the Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis|Completed||Phase 2|96|Actual|Scynexis, Inc.||3|||f||||f||||||||Undecided||2017-10-10 22:28:50.388018|2017-10-10 22:28:50.388018
NCT02679443|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-04-22|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PEMVITASTART||Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy|Optimum Duration of Vitamin B12 and Folate Supplementation in Non-squamous Non-small Cell Lung Cancer (NSCLC) Patients Undergoing Pemetrexed Containing Chemotherapy: a Randomized Controlled Trial|Completed||N/A|161|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||||||||||||2017-10-10 22:28:50.473385|2017-10-10 22:28:50.473385
NCT02679430|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-10-31|||May 2017||2017-05-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere Microspheres|Prospective Analysis of Prostatic Arterial Embolization|Not yet recruiting||N/A|16|Anticipated|Maimonides Medical Center||1|||f||||t||||||||No||2017-10-10 22:28:50.561135|2017-10-10 22:28:50.561135
NCT02679417|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-09-13|||August 2015||2015-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Effects of Type of Exercise in Non-alcoholic Fatty Liver Disease|The Effects of Type of Exercise on Hepatic Fat Content and Metabolic Profiles in Non-alcoholic Fatty Liver Disease: A Randomized Trial|Completed||N/A|38|Actual|Mahidol University||2|||f||||f||||||||No||2017-10-10 22:28:50.635721|2017-10-10 22:28:50.635721
NCT02679391|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-06|||January 2010||2010-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|June 2014|Actual|2014-06-01||Observational|||The Outcome of Abdominoplasty After Massive Weight Loss|The Outcome of Abdominoplasty After Massive Weight Loss; Comparison of Results From Plastic and General Surgical Units - a Retrospective Cohort Study|Completed||N/A|209|Actual|Karolinska Institutet|||3||f||||f||||||||No||2017-10-10 22:28:50.937375|2017-10-10 22:28:50.937375
NCT02679378|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-08-16|||October 2015||2015-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy|Clinical Study of the ClearSight™ System to Evaluate the Ability to Distinguish Malignant From Non-malignant Breast Tissue by Comparing MR Measurements of Freshly Excised Breast Tissue to Histopathology|Recruiting||N/A|220|Anticipated|Clear Cut Medical Ltd.|||1||f||||f||||||||||2017-10-10 22:28:51.001564|2017-10-10 22:28:51.001564
NCT02679365|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2017-07-30|||March 2016||2016-03-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Double Lock Versus Continuous Non-locking Technique for Closure of Rectus Sheath in Cesarean Sections on Post-operative Pain||Completed||N/A|150|Actual|Ain Shams Maternity Hospital||2|||f||||||||||||||2017-10-10 22:28:51.119178|2017-10-10 22:28:51.119178
NCT02679352|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|September 2023|Anticipated|2023-09-01|September 2020|Anticipated|2020-09-01||Interventional|||SMR Stemless Shoulder Arthroplasty Clinical Study|A Multicentre, Prospective Clinical Study Analysing Outcomes of Shoulder Arthroplasty With SMR STEMLESS|Recruiting||N/A|78|Anticipated|Limacorporate S.p.a||1|||f||||f||||||||No||2017-10-10 22:28:51.217049|2017-10-10 22:28:51.217049
NCT02679339|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-02-09|||January 2015||2015-01-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster (Shingles) Pain|A Phase Ib Pilot Multiple Dose, Randomized-Withdrawal, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster Pain|Terminated||Phase 1|1|Actual|Centrexion Therapeutics||2||Limited patient enrollment|f||||||||||||||2017-10-10 22:28:51.487838|2017-10-10 22:28:51.487838
NCT02679326|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2017-10-03|||May 2015||2015-05-01|January 2017|2017-01-01|May 28, 2017|Actual|2017-05-28|May 28, 2017|Actual|2017-05-28||Interventional|||Plantar Fasciitis and Therapeutic Ultrasound|The Efficacy of Treating Plantar Fasciitis With Therapeutic Ultrasound|Completed||N/A|51|Actual|Assuta Hospital Systems||2|||f||||f||||||||||2017-10-10 22:28:51.588441|2017-10-10 22:28:51.588441
NCT02679313|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-05-16|||February 2016||2016-02-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Lens Presentation on the Clinical Oculomotor Assessment at Near|Effect of Lens Presentation on the Clinical Oculomotor Assessment at Near|Completed||N/A|30|Actual|State University of New York College of Optometry||1|||f||||f||||||||No||2017-10-10 22:28:51.698803|2017-10-10 22:28:51.698803
NCT02679300|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-06|||January 2016||2016-01-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Virtual Reality and Pain Perception During Exercises for Patients With Chronic Non-specific Low Back Pain|The Influence of a Virtual Reality Environment on Pain Perception During Exercises for Patients With Chronic Non-specific Low Back Pain: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|Hasselt University||2|||f||||||||||||||2017-10-10 22:28:51.804513|2017-10-10 22:28:51.804513
NCT02679287|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-09-12|||February 2016||2016-02-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control|Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control|Recruiting||N/A|64|Anticipated|University of Virginia||2|||f||||t||||||||No||2017-10-10 22:28:51.916115|2017-10-10 22:28:51.916115
NCT02679274|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-02-17|||December 2015||2015-12-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents|Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents|Recruiting||Early Phase 1|30|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||No||2017-10-10 22:28:52.055207|2017-10-10 22:28:52.055207
NCT02679261|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-03-30|||June 2016||2016-06-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|BICATOR||Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve|Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve (BICATOR)|Recruiting||Phase 3|220|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||||2017-10-10 22:28:52.183073|2017-10-10 22:28:52.183073
NCT02679248|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-02-16|||January 2016||2016-01-01|February 2017|2017-02-01||||August 2017|Anticipated|2017-08-01||Interventional|15NBHN||A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults|A Double Blind, Placebo Controlled Parallel Study to Investigate the Effect of a Nitric Oxide Supplementation Product on Pre- and Mildly Hypertensive Adults.|Active, not recruiting||Phase 2|84|Anticipated|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-10 22:28:52.384687|2017-10-10 22:28:52.384687
NCT02679235|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-03-27|||April 2016||2016-04-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|BEAT7||Brain Energy and Aging With Triheptanoin|Brain Energy and Aging With Triheptanoin: The BEAT7 Study|Recruiting||Phase 1/Phase 2|26|Anticipated|Université de Sherbrooke||2|||f||||f||||||||Undecided||2017-10-10 22:28:52.518922|2017-10-10 22:28:52.518922
NCT02679222|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-03-27|||June 2015|Actual|2015-06-01|October 2016|2016-10-01|March 1, 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|Coco-MCT||Comparing the Ketogenic Effect of Coconut Oil and Different MCTs|Comparing the Ketogenic Effect of Coconut Oil and Different Medium-chain Triglycerides|Completed||N/A|10|Actual|Université de Sherbrooke||1|||f||||f||||||||Undecided||2017-10-10 22:28:52.621706|2017-10-10 22:28:52.621706
NCT02679209|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2017-07-16|||June 2015||2015-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Evaluation of Amnion Chorion Membrane and Demineralized Freeze-dried Bone Allograft in Periodontal Intrabony Defects|Clinical and Radiographic Evaluation of Amnion Chorion Membrane Compared to Demineralized Freeze-dried Bone Allograft in Management of Periodontal Intrabony Defects: A Randomized Controlled Clinical Trial|Completed||N/A|22|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 22:28:52.707725|2017-10-10 22:28:52.707725
NCT02679196|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-08-16|||July 2016||2016-07-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Safety, Pharmacokinetic and Pharmacodynamic Effect of KA2237 (PI3 Kinase p110β/δ Inhibitor) In B Cell Lymphoma|An Open Label Ascending Dose Study Evaluating the Safety/Tolerability, Pharmacokinetic and Pharmacodynamic Effects of KA2237 In Patients With B Cell Lymphoma|Recruiting||Phase 1|53|Anticipated|Karus Therapeutics Limited||1|||f||||f||||||||||2017-10-10 22:28:52.801949|2017-10-10 22:28:52.801949
NCT02679183|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-09|||January 2011||2011-01-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Honey||Medically-Graded Honey Supplementation Formula To Preterm Infants|Randomized Controlled Trial on Medically-Graded Honey Supplementation Formula (As a Prebiotic) To Preterm Infants|Completed||Early Phase 1|40|Actual|Cairo University||4|||f||||||||||||||2017-10-10 22:28:52.90989|2017-10-10 22:28:52.90989
NCT02679170|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-09-28|||June 29, 2016|Actual|2016-06-29|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|February 20, 2019|Anticipated|2019-02-20||Observational|||Prospective Observational Study To Identify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) And ALK Translocation And To Establish Their Therapeutic Management (IDEALK)|Prospective Observational Study To Identify Patients With Advanced/Metastatic Nsclc And Alk Translocation And To Establish Their Therapeutic Management (Idealk)|Recruiting||N/A|100|Anticipated|Pfizer|||1||f||||||||||||||2017-10-10 22:28:53.000004|2017-10-10 22:28:53.000004
NCT02679157|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-06-27|||January 2016||2016-01-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|PROGRESS-ICU||Prognostication of Need for Rehabilitation and Special Support in ICU Survivors|Prognostication of Need for Rehabilitation and Special Support in ICU Survivors. Two Studies Prognosticating Adverse Physical or Psychological Outcome|Recruiting||N/A|800|Anticipated|Karolinska University Hospital|||1||f||||t||||||||No||2017-10-10 22:28:53.141101|2017-10-10 22:28:53.141101
NCT02679144|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-25|||February 2016||2016-02-01|April 2017|2017-04-01|February 2025|Anticipated|2025-02-01|February 2020|Anticipated|2020-02-01||Interventional|NMTT||Neuroblastoma Maintenance Therapy Trial|NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)|Recruiting||Phase 2|258|Anticipated|Spectrum Health Hospitals||1|||f||||t||||||||Undecided||2017-10-10 22:28:53.305956|2017-10-10 22:28:53.305956
NCT02679131|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-03-10|||March 2016||2016-03-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.|An Open-label, Nonrandomized, Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Belinostat in Patients With Relapsed/Refractory Solid Tumors or Hematological Malignancies Who Have Mild, Moderate, and Severe Renal Impairment|Recruiting||Phase 1|24|Anticipated|Spectrum Pharmaceuticals, Inc||4|||f||||f||||||||No||2017-10-10 22:28:53.546845|2017-10-10 22:28:53.546845
NCT02679118|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-08-15|||February 2016||2016-02-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of the Ability to Detect Bowel Gas During Laparoscopic Surgery|Evaluation of the Ability to Detect Bowel Gas During Laparoscopic Surgery|Completed||N/A|8|Actual|Stanford University||1|||f||||f||||||||||2017-10-10 22:28:53.658148|2017-10-10 22:28:53.658148
NCT02679105|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2017-03-21|||May 2015||2015-05-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|October 2016|Actual|2016-10-01||Interventional|||Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy|Intralymphatic Immunotherapy in Increasing Doses up to 10 000 SQ-U -a Human Randomized Clinical Trial|Active, not recruiting||Phase 2/Phase 3|38|Actual|Karolinska Institutet||2|||f||||t||||||||Yes||2017-10-10 22:28:53.732983|2017-10-10 22:28:53.732983
NCT02679092|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-08-10|||April 2016||2016-04-01|August 2016|2016-08-01||||February 2018|Anticipated|2018-02-01||Interventional|||Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks|Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks|Active, not recruiting||N/A|100|Anticipated|Stanford University||4|||f||||f||||||||||2017-10-10 22:28:53.835089|2017-10-10 22:28:53.835089
NCT02679066|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-05|||January 2014||2014-01-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Short Forearm Casting Versus Below-elbow Splinting for Acute Immobilization of Distal Radius Fractures|Short Forearm Casting Versus Below-elbow Splinting for Acute Immobilization of Distal Radius Fractures|Suspended||N/A|120|Anticipated|Johns Hopkins University||2||Pending Institutional Review Board which requires ClinicalTrials number|f||||f||||||||No||2017-10-10 22:28:54.074523|2017-10-10 22:28:54.074523
NCT02679053|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-04-10|||October 2013||2013-10-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|February 2016|Actual|2016-02-01||Interventional|||Aerobic Exercise as add-on Treatment for Inpatients With Depression|Aerobic Exercise as add-on Treatment for Inpatients With Depression: Effects and Biomarkers|Completed||N/A|49|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||No||2017-10-10 22:28:54.148286|2017-10-10 22:28:54.148286
NCT02679040|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-01-30|||February 2016||2016-02-01|August 2016|2016-08-01|February 2024|Anticipated|2024-02-01|February 2019|Anticipated|2019-02-01||Interventional|HIST-RIC||Rate of Histological Response After Mastectomy and Mammary Reconstruction at the Close of Neo-adjuvant Chemotherapy and Radiotherapy|Rate of Histological Response After Mastectomy and Mammary Reconstruction at the Close of Neo-adjuvant Chemotherapy and Radiotherapy|Recruiting||Phase 2|162|Anticipated|Institut Paoli-Calmettes||1|||f||||t||||||||||2017-10-10 22:28:54.261364|2017-10-10 22:28:54.261364
NCT02679027|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-08-15|||January 2014||2014-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Difficult Intubation and Tongue Protrusion|New Test for Prediction of Difficult Intubation: Tongue Protrusion Movements|Completed||N/A|223|Actual|Trakya University||2|||f||||||||||||||2017-10-10 22:28:54.356824|2017-10-10 22:28:54.356824
NCT02678845|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-08-15|||November 2014||2014-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Project Collabri for Treatment of Depression|Project Collabri. The Effect of a Collaborative Care Model for Treatment of Depression in Primary Care in Denmark - A Cluster Randomized Clinical Superiority Trial|Recruiting||N/A|480|Anticipated|Mental Health Centre Copenhagen||2|||f||||t||||||||No||2017-10-10 22:28:58.612527|2017-10-10 22:28:58.612527
NCT02679014|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-08-24|||March 6, 2016|Actual|2016-03-06|August 2017|2017-08-01|August 28, 2016|Actual|2016-08-28|August 28, 2016|Actual|2016-08-28||Interventional|||A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Parallel Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease|Completed||Phase 1|19|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:28:54.419271|2017-10-10 22:28:54.419271
NCT02679001|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2017-09-27|||March 31, 2016|Actual|2016-03-31|September 2017|2017-09-01|March 2, 2019|Anticipated|2019-03-02|March 2, 2019|Anticipated|2019-03-02||Observational|||A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.|A COMPARATIVE OBSERVATIONAL STUDY FOLLOWING THE USE OF CONCOMITANT CORTICOSTEROID TREATMENT IN RA PATIENTS WHO ARE TREATED WITH A TNF INHIBITOR OR TOCILIZUMAB AS THEIR SECOND BIOLOGICAL TREATMENT|Recruiting||N/A|200|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:28:54.494857|2017-10-10 22:28:54.494857
NCT02678988|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-08|2016-11-01|||February 2016||2016-02-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers||Completed||Phase 1|189|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-10 22:28:54.61319|2017-10-10 22:28:54.61319
NCT02678975|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2017-04-10|||January 2017||2017-01-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|December 2019|Anticipated|2019-12-01||Interventional|||Disulfiram in Recurrent Glioblastoma|DIRECT (DIsulfiram REsponse as add-on to ChemoTherapy in Recurrent) Glioblastoma: A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|142|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||No||2017-10-10 22:28:54.704047|2017-10-10 22:28:54.704047
NCT02678962|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-31|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|COMIL||Comparison of Outcomes With Multifocal Intraocular Lenses|Comparison of Outcomes With Multifocal Intraocular Lenses|Recruiting||Phase 4|90|Anticipated|Wenzhou Medical University||6|||f||||t||||||||Undecided||2017-10-10 22:28:54.815722|2017-10-10 22:28:54.815722
NCT02678949|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-17|||March 2016||2016-03-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Changes in the Lung Clearance Index in Pediatric Patients With Asthma|Changes in the Lung Clearance Index as Measured by Multiple-breath Washout, in Pediatric Patients With Asthma After Challenge With Inhaled Steroids and Short-acting Bronchodilator|Not yet recruiting||N/A|105|Anticipated|Hospital Infantil de Mexico Federico Gomez||3|||f||||t||||||||Yes|Database|2017-10-10 22:28:56.613072|2017-10-10 22:28:56.613072
NCT02678936|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-02-05|||November 2015||2015-11-01|February 2016|2016-02-01||||November 2015|Actual|2015-11-01||Interventional|Aurora||Anal Fistula Repair With Platelet-rich Plasma|Anal fistUla Repair With Platelet-Rich plasmA (AURoRA)|Withdrawn||Phase 4|0|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 22:28:56.735549|2017-10-10 22:28:56.735549
NCT02678923|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-06-12|2017-06-12||December 3, 2015|Actual|2015-12-03|June 2017|2017-06-01|October 26, 2016|Actual|2016-10-26|October 26, 2016|Actual|2016-10-26||Interventional|PILOT|Safety population included all participants who received at least one infusion of study drug.|MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial|A Placebo-controlled, Double-blind, Randomized Trial to Compare the Effect of Treatment on Plaque Burden as Determined by Intravascular Ultrasound and to Evaluate the Efficacy, Pharmacokinetics, Safety, and Tolerability of MDCO-216 Given as Multiple Weekly Infusions in Subjects With a Recent Acute Coronary Syndrome|Completed||Phase 1/Phase 2|126|Actual|The Medicines Company||2|||f||||t|t|f||||||No||2017-10-10 22:28:56.826195|2017-10-10 22:28:56.826195
NCT02678910|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-06-27|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment|Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis Or Treatment Regimen|Recruiting||N/A|24|Anticipated|University of Kentucky||1|||f||||f|f|f||||||Yes|IPD excluding personal identifiers will be shared with the collaborators|2017-10-10 22:28:57.895111|2017-10-10 22:28:57.895111
NCT02678897|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-08-16|||March 2016||2016-03-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Pain and Medical Abortion Among Teenaged Women Compared to Adult Women|Pain and Medical Abortion - Predicting Factors of Pain and Optimal Pain Management Among Teenaged Women Compared to Adult Women|Recruiting||Phase 4|320|Anticipated|Helsinki University Central Hospital||2|||f||||t||||||||No||2017-10-10 22:28:58.007467|2017-10-10 22:28:58.007467
NCT02678884|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-12-28|||October 2014||2014-10-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study|A Pilot Study of 18F-FDG PET-CT Kinetic Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC)|Recruiting||N/A|20|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:28:58.242799|2017-10-10 22:28:58.242799
NCT02678871|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-02-15|||February 8, 2017|Actual|2017-02-08|February 2017|2017-02-01|April 2021|Anticipated|2021-04-01|June 2019|Anticipated|2019-06-01||Interventional|TAVI-LAAC||Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage|Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage|Recruiting||N/A|50|Anticipated|University Hospital Inselspital, Berne||1|||f||||t|f|f||||||No||2017-10-10 22:28:58.3564|2017-10-10 22:28:58.3564
NCT02678858|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-08-22|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of ISST in Schizophrenia|"Efficacy of Integrated Social Cognitive and Behavioral Skills Therapy (ISST) in Improving Functional Outcome in Schizophrenia"|Recruiting||N/A|180|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-10-10 22:28:58.459544|2017-10-10 22:28:58.459544
NCT02678832|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-02-16|||December 2015||2015-12-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Observational|||Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease|Social Cognitions and Norms Towards Physical Exercise Among Cancer Patients and Health Care Professionals|Enrolling by invitation||N/A|2150|Anticipated|Heidelberg University|||3||f||||f||||||||||2017-10-10 22:28:58.739566|2017-10-10 22:28:58.739566
NCT02678819|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|SIMMAX||Use of a Wearable Digital Cognitive Aid in Simulated Anesthesia and Intensive Care Crises.|Use of a Wearable Digital Cognitive Aid in Simulated Anesthesia and Intensive Care Crises.|Completed||N/A|52|Actual|Claude Bernard University||2|||f||||f||||||||No||2017-10-10 22:28:58.827756|2017-10-10 22:28:58.827756
NCT02678806|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-04-18|||December 2015||2015-12-01|April 2016|2016-04-01||||December 2025|Anticipated|2025-12-01||Interventional|RHCC:BCLC-A||Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and Microvascular Invasion||Recruiting||N/A|620|Anticipated|Guangxi Medical University||2|||f||||||||||||||2017-10-10 22:28:58.930235|2017-10-10 22:28:58.930235
NCT02678793|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-04-17|||December 2015||2015-12-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||An Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)|An Open-Label, Multiple-Dose Extension Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)|Completed||Phase 2|67|Actual|Centrexion Therapeutics||1|||f||||||||||||||2017-10-10 22:28:59.067507|2017-10-10 22:28:59.067507
NCT02678780|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-09-21|||October 2015||2015-10-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|July 2017|Anticipated|2017-07-01||Interventional|TALENT||Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors|Trial to Assess the Efficacy of Lenvatinib in Metastatic Neuroendocrine Tumors. (TALENT STUDY)|Recruiting||Phase 2|110|Anticipated|Grupo Espanol de Tumores Neuroendocrinos||2|||f||||f||||||||||2017-10-10 22:28:59.198519|2017-10-10 22:28:59.198519
NCT02678767|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-25|||February 2015||2015-02-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS|Ferumoxytol-enhanced Imaging and Quantitative Susceptibility Mapping in neuroAIDS|Recruiting||Phase 2|30|Anticipated|University of Hawaii||3|||f||||t||||||||No||2017-10-10 22:28:59.465129|2017-10-10 22:28:59.465129
NCT02678754|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-02-09|||February 2010||2010-02-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|9 Months|Observational [Patient Registry]|CMIR||Caris Molecular Intelligence Registry|A Registry of Caris Life Sciences® Molecular Intelligence™ Service (Biomarker Assessment Results) Intended for Correlation With Cancer Clinical Outcomes|Enrolling by invitation||N/A|8000|Anticipated|Caris Science, Inc.|||1||f||||t||||||||||2017-10-10 22:28:59.589246|2017-10-10 22:28:59.589246
NCT02678741|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-09-01|||February 2016||2016-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.|Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.|Recruiting||Phase 1/Phase 2|45|Anticipated|Cancer Insight, LLC||3|||f||||t||||||||||2017-10-10 22:28:59.650836|2017-10-10 22:28:59.650836
NCT02678728|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-07-31|||February 2016||2016-02-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Intraoperative Dexmedetomidine on Lung Protection Following Thoracic Aorta Surgery With Hypothermic Circulatory Arrest: a Double-blind Randomized Clinical Trial|Effect of Intraoperative Dexmedetomidine on Lung Protection Following Thoracic Aorta Surgery With Hypothermic Circulatory Arrest: a Double-blind Randomized Clinical Trial|Recruiting||Phase 4|52|Anticipated|Gangnam Severance Hospital||2|||f||||t||||||||||2017-10-10 22:28:59.800847|2017-10-10 22:28:59.800847
NCT02678715|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-01|||February 2016||2016-02-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy. Randomized Crossover Clinical Trial.|Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy.|Recruiting||N/A|6|Anticipated|University of Barcelona||6|||f||||f||||||||Undecided||2017-10-10 22:28:59.90878|2017-10-10 22:28:59.90878
NCT02678702|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-02-05|||August 2015||2015-08-01|October 2015|2015-10-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Cognitive Behavioral Therapy for Treatment of Insomnia in Patients With Major Depression|Treatment of Insomnia in Patients With Major Depression Disorder Using Cognitive Behavioral Therapy, Sleep Restriction and Stimulus Control Therapy. A Randomized, Controlled 8 Week Study|Recruiting||N/A|48|Anticipated|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-10 22:29:00.035459|2017-10-10 22:29:00.035459
NCT02678689|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-05-12|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||A Safety, Tolerability, and Efficacy Study of Intracerebroventricular BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease|A Phase 2, Open-Label, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Intracerebroventricular BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease|Enrolling by invitation||Phase 2|10|Anticipated|BioMarin Pharmaceutical||1|||f||||t|t|t|f|f||||||2017-10-10 22:29:00.156131|2017-10-10 22:29:00.156131
NCT02678676|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-05-30|2016-05-30||November 2004||2004-11-01|May 2016|2016-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01|10 Years|Observational [Patient Registry]||The observational study population consisted of participants who enrolled in this study after completing the final visit of PROactive study (NCT00174993).|An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications|An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications.|Completed||Phase 4|3599|Actual|Takeda|||2||f||||f||||||||||2017-10-10 22:29:00.387309|2017-10-10 22:29:00.387309
NCT02678663|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-01-30|||January 2016||2016-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Injection-Assisted Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Small Colorectal Polyps|Randomized Comparison of Injection-Assisted Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Small (6-10mm) Colorectal Polyps|Completed||N/A|164|Actual|Benizelion General Hospital||2|||f||||f||||||||No||2017-10-10 22:29:01.06491|2017-10-10 22:29:01.06491
NCT02677558|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-04|||January 2016||2016-01-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|CFOP||The Impact of Obesity on Cardiac Function in Pregnancy|The Impact of Obesity on Cardiac Function in Pregnancy|Recruiting||N/A|80|Anticipated|University of Cape Town|||2||f||||t||||||||No||2017-10-10 22:29:11.929185|2017-10-10 22:29:11.929185
NCT02678650|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-02-05|||January 2016||2016-01-01|February 2016|2016-02-01||||January 2017|Anticipated|2017-01-01||Interventional|||MicroRNA Mediates Volatile Anesthetics Preconditioning Induced Artery Protection|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Recruiting||Phase 4|60|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:29:01.168799|2017-10-10 22:29:01.168799
NCT02678637|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-08-14|||April 2016||2016-04-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|CMSMD||Calf Muscle Strength in Mitochondrial Diseases|Calf Muscle Strength in Patients Affected by Mitochondrial Diseases as Compared to Healthy Individuals|Completed||N/A|37|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-10 22:29:01.278305|2017-10-10 22:29:01.278305
NCT02678624|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-07|2016-08-15|||November 2014||2014-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Project Collabri for Treatment of Anxiety|Project Collabri. The Effects of a Danish Model of Collaborative Care for People With Anxiety in General Practice|Recruiting||N/A|1092|Anticipated|Mental Health Centre Copenhagen||2|||f||||t||||||||No||2017-10-10 22:29:01.37222|2017-10-10 22:29:01.37222
NCT02678611|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-07-28|||January 2016||2016-01-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Interventional|15BSHE||A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.|A Randomized, Double-blind, Placebo Controlled Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.|Completed||Phase 1|120|Actual|Elysium Health||3|||f||||f||||||||||2017-10-10 22:29:01.49035|2017-10-10 22:29:01.49035
NCT02678598|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-05|||March 2015||2015-03-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections|A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections|Completed||N/A|2555|Actual|Astellas Pharma Inc|||1||f||||f||||||||Undecided||2017-10-10 22:29:01.604196|2017-10-10 22:29:01.604196
NCT02678585|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-03-10|||December 2015||2015-12-01|March 2016|2016-03-01||||March 2016|Actual|2016-03-01||Interventional|||Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia|Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia|Completed||N/A|106|Actual|Assiut University||2|||f||||||||||||||2017-10-10 22:29:01.719413|2017-10-10 22:29:01.719413
NCT02678572|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-06-30|||January 2015||2015-01-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|FOCUS||Percutaneous Hepatic Perfusion vs Best Alternative Care in Patients With Hepatic-dominant Ocular Melanoma|A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients With Hepatic-Dominant Ocular Melanoma|Recruiting||Phase 3|240|Anticipated|Delcath Systems Inc.||5|||f||||t||||||||||2017-10-10 22:29:01.808976|2017-10-10 22:29:01.808976
NCT02678559|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-04-19|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PreDeARM||Preload Dependency Evaluation With Stroke Volume Variation During Alveolar Recruitment Manoeuvres|Preload Dependency Evaluation With Stroke Volume Variation During Alveolar Recruitment Manoeuvres|Completed||N/A|24|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:29:02.099301|2017-10-10 22:29:02.099301
NCT02678546|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-08-01|||January 2016||2016-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|3 Days|Observational [Patient Registry]|||Traditional Chinese Medicine Constitution Study and the Diagnosis and Treatment of Chronic Disease in Taiwan Population|Traditional Chinese Medicine Constitution Study and the Diagnosis and Treatment of Chronic Disease in Taiwan Population|Recruiting||N/A|150|Anticipated|China Medical University Hospital|||2||f||||f||||||||No||2017-10-10 22:29:02.229818|2017-10-10 22:29:02.229818
NCT02678533|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-04-11|||April 2016||2016-04-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|July 2018|Anticipated|2018-07-01||Interventional|FancoMob||Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor|Pilot Study Assessing the Feasibility of CD34+ Cells Mobilization and Collection After Treatment With G-CSF and Plerixafor in Patients With Fanconi Anemia for Subsequent Treatment by Gene Therapy|Recruiting||Phase 1/Phase 2|8|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 22:29:02.311197|2017-10-10 22:29:02.311197
NCT02678520|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-07-20|||December 2015||2015-12-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients|Phase II Randomized Clinical Trial Comparing 3-D Conformal Radiation Therapy (RT) vs. Intensity Modulated Radiation Therapy in Post- Prostatectomy Prostate Cancer Patients|Withdrawn||Phase 2|0|Actual|University of Kansas Medical Center||2||PI no longer at institution. Study terminated prior to enrolling subjects.|f||||t||||||||Undecided||2017-10-10 22:29:02.39956|2017-10-10 22:29:02.39956
NCT02678507|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-04-21||||||April 2017|2017-04-01||||September 2017|Anticipated|2017-09-01||Observational|POMAQ||A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire|A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ)|Active, not recruiting||N/A|800|Actual|Member Companies of the Opioid PMR Consortium|||1||f||||||||||||||2017-10-10 22:29:02.5027|2017-10-10 22:29:02.5027
NCT02678494|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-18|||June 9, 2016|Actual|2016-06-09|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Brain-Train Home Based Pain Treatment|Home Based Brain-Train Treatment of Central Neuropathic Pain Following Spinal Cord Injury|Recruiting||N/A|10|Anticipated|NHS Greater Glasgow and Clyde||1|||f||||f||||||||||2017-10-10 22:29:02.566192|2017-10-10 22:29:02.566192
NCT02678481|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-08-19|||November 2014||2014-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|Pro-Cure2014||MR-targeted vs. Random TRUS-guided Prostate Biopsy|MR-targeted vs. Random TRUS-guided Prostate Biopsy in Patients With High PSA Values and Previous Negative Biopsy Results: A Randomized Controlled Trial|Recruiting||N/A|90|Anticipated|Fondazione del Piemonte per l'Oncologia||2|||f||||f||||||||No||2017-10-10 22:29:02.639141|2017-10-10 22:29:02.639141
NCT02678468|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-12|||February 2016||2016-02-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Early Vision Screening in High-risk Children|Early Vision Screening With Automated Photorefraction in Pre-term, Low-birth- Weight and Development-delay Children in Far-Eastern Memorial Hospital, Taiwan|Recruiting||N/A|200|Anticipated|Far Eastern Memorial Hospital|||2||f||||f||||||||||2017-10-10 22:29:02.722146|2017-10-10 22:29:02.722146
NCT02678455|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-03-24|||March 2016||2016-03-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh|Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixture TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh|Active, not recruiting||Phase 2|192|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Undecided||2017-10-10 22:29:02.929384|2017-10-10 22:29:02.929384
NCT02678442|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle|Pilot-Feasibility Trial of EUS Guided Pancreas Fine Needle Core Biopsy for Whole Exome Sequencing and Genomic Profiling|Enrolling by invitation||N/A|25|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:29:03.034406|2017-10-10 22:29:03.034406
NCT02678429|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-11-01|||September 2016||2016-09-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Atlas Predicted DBS Settings in Essential Tremor|Atlas Predicted DBS Settings in Essential Tremor|Enrolling by invitation||Phase 4|30|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-10-10 22:29:03.122332|2017-10-10 22:29:03.122332
NCT02678403|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-02-04|||February 2016||2016-02-01|January 2016|2016-01-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|TENS-PAD||Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral Artery Disease TENS-PAD Study / TENS-AOMI|Efficacy of Transcutaneous Electrical Nerve Stimulation in the Improvement of Walking Distance in Patients With Peripheral Artery Disease With Intermittent Claudication|Not yet recruiting||Phase 3|100|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||No||2017-10-10 22:29:03.277513|2017-10-10 22:29:03.277513
NCT02678390|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-03-27|||September 2015||2015-09-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|Exercise-MCT||Physical Exercise and Ketone Production in Women With or Without Prediabetes|Stimulating the Production of Ketones Through the Combined Use of Physical Exercise and Dietary a Medium Chain Triglycerides (MCT) Supplement|Recruiting||N/A|20|Anticipated|Université de Sherbrooke||2|||f||||f||||||||Undecided||2017-10-10 22:29:03.379749|2017-10-10 22:29:03.379749
NCT02678377|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-18|||February 2016||2016-02-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence|The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence|Recruiting||Phase 4|100|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 22:29:03.477818|2017-10-10 22:29:03.477818
NCT02678364|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-08|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EnhanceDeggs||Effect of Vitamin D-biofortified Eggs on Wintertime Serum 25-hydroxyvitamin D in Adults: Randomized Controlled Trial|A Dietary Intervention Study Examining the Effect of Consumption of Vitamin D-enhanced Eggs on Winter-time Vitamin D Status in Adults|Completed||N/A|55|Actual|University College Cork||3|||f||||f||||||||No||2017-10-10 22:29:03.582668|2017-10-10 22:29:03.582668
NCT02678351|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-08-31|||June 2016||2016-06-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||68Ga-PSMA PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery|68Ga-PSMA PET/MRI for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer|Recruiting||Phase 2/Phase 3|200|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:29:03.684139|2017-10-10 22:29:03.684139
NCT02678338|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-08-10|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies|A Phase I Dose Escalation Trial of the Humanized Anti-CD47 Monoclonal Antibody Hu5F9-G4 in Haematological Malignancies (CAMELLIA)|Recruiting||Phase 1|40|Anticipated|Forty Seven, Inc.||1|||f||||t||||||||||2017-10-10 22:29:03.790317|2017-10-10 22:29:03.790317
NCT02678325|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-10-05|||May 2016||2016-05-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Basel Enteral High Protein Study|Tolerance of Early High Protein Nutrition of the Critically Ill: Comparison of a Protein-rich Enteral Formula With a Standardized High Carbohydrate Product on Total Calorie and Protein Intake|Recruiting||N/A|90|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 22:29:03.886972|2017-10-10 22:29:03.886972
NCT02678312|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-07-15|||November 3, 2016|Actual|2016-11-03|July 2017|2017-07-01|April 21, 2021|Anticipated|2021-04-21|April 21, 2021|Anticipated|2021-04-21||Interventional|||Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure|Multicenter, Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LCZ696 Followed by a 52-week Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared With Enalapril in Pediatric Patients From 1 Month to < 18 Years of Age With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction|Recruiting||Phase 2/Phase 3|360|Anticipated|Novartis||3|||f||||t||||||||||2017-10-10 22:29:03.978273|2017-10-10 22:29:03.978273
NCT02678299|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-05|||February 2016||2016-02-01|February 2016|2016-02-01||||June 2019|Anticipated|2019-06-01||Interventional|||Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study|Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study|Recruiting||Phase 1/Phase 2|84|Anticipated|University of Aarhus||1|||f||||f||||||||No||2017-10-10 22:29:04.119374|2017-10-10 22:29:04.119374
NCT02678286|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-12-14|||January 2016||2016-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Evaluation of N1539 Following Abdominoplasty Surgery|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of N1539 Following Abdominoplasty Surgery|Completed||Phase 3|219|Actual|Recro Pharma, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:29:04.230931|2017-10-10 22:29:04.230931
NCT02678273|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-11-06|||November 2016||2016-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Developing an Integrated Community of Care in Singapore|Developing an Integrated Community of Care for a Socioeconomically Disadvantaged Population in Singapore|Recruiting||N/A|600|Anticipated|Singapore General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:29:04.330999|2017-10-10 22:29:04.330999
NCT02678260|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-06-30|||February 19, 2016|Actual|2016-02-19|June 2017|2017-06-01|September 18, 2017|Anticipated|2017-09-18|September 18, 2017|Anticipated|2017-09-18||Interventional|||Phase I Study of PDR001 in Patients With Advanced Malignancies.|A Phase-I Study of PDR001 Administered to Japanese Patients With Advanced Malignancies|Active, not recruiting||Phase 1|18|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-10 22:29:04.419162|2017-10-10 22:29:04.419162
NCT02678247|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-01-16|||April 2016||2016-04-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Functional Performance Evaluation of NU-FlexSIV Socket|Functional Performance Evaluation of the Northwestern University Flexible Sub-Ischial Vacuum (NU-FlexSIV) Socket for Persons With Transfemoral Amputation|Recruiting||N/A|30|Anticipated|Northwestern University||2|||f||||f||||||||Yes|Upon request, the PI will share de-identified data and outcomes. If the requests are excessive, data will be made available via a link on the Northwestern University Prosthetics-Orthotics Center (NUPOC) website.|2017-10-10 22:29:04.511209|2017-10-10 22:29:04.511209
NCT02678234|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-06-21|||February 1, 2017|Anticipated|2017-02-01|June 2017|2017-06-01|April 1, 2017|Anticipated|2017-04-01|April 1, 2017|Anticipated|2017-04-01||Interventional|||Russian Market Potential of Theraflu Day Powder for Oral Solution for Cold and Flu|An Open-label, Multicenter, Randomized, Parallel Group, Single-dose Study to Assess the Short Term Efficacy and Safety of Paracetamol 500 mg + Phenylephrine HCl 10 mg + Vitamin C 200 mg Powder for Oral Solution in Subjects With Symptoms of an Upper Respiratory Tract Infection|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||2||"The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's   decision."|f||||f|f|f||||||||2017-10-10 22:29:04.632795|2017-10-10 22:29:04.632795
NCT02678221|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-05|||February 2016||2016-02-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction||Not yet recruiting||Phase 2|100|Anticipated|Assiut University||2|||f||||f||||||||Yes||2017-10-10 22:29:04.720528|2017-10-10 22:29:04.720528
NCT02678208|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-27|||February 2015||2015-02-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Tranexamic Acid on Uterine Blood Flow After Vaginal Delivery||Completed||Phase 2|200|Actual|Assiut University||2|||f||||f||||||||Yes||2017-10-10 22:29:04.808371|2017-10-10 22:29:04.808371
NCT02678195|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-11-08|||March 2016||2016-03-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi|Double-blind Randomized Controlled Clinical Trial of 3 Days Versus 5 Days Amoxicillin Dispersible Tablets for Chest-indrawing Childhood Pneumonia Among Children 2-59 Months of Age Presenting to Kamuzu Central Hospital in Lilongwe, Malawi|Recruiting||Phase 4|2000|Anticipated|Save the Children||2|||f||||||||||||||2017-10-10 22:29:04.894117|2017-10-10 22:29:04.894117
NCT02678182|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-05-30|||February 2015||2015-02-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|PLATFORM||Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial|Planning Treatment for Oesophago-gastric Cancer: a Randomised Maintenance Therapy Trial|Recruiting||Phase 2|616|Anticipated|Royal Marsden NHS Foundation Trust||4|||f||||t||||||||No|Following trial completion the trial will be submitted for publication to a peer reviewed journal|2017-10-10 22:29:04.980155|2017-10-10 22:29:04.980155
NCT02678169|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-26|||February 2016||2016-02-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|PROMISE||European Registry on the ACE Reperfusion Catheters and the Penumbra System in the Treatment of Acute Ischemic Stroke|A Prospective, Multicenter, Observational, Single-arm European Registry on the ACE Reperfusion Catheters and the Penumbra System in the Treatment of Acute Ischemic Stroke|Recruiting||Phase 4|210|Anticipated|Penumbra Inc.|||1||f||||t||||||||No||2017-10-10 22:29:05.103868|2017-10-10 22:29:05.103868
NCT02678156|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-09-06|||April 2016||2016-04-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|LYON||Assessment of the Performance of LYoplant® ONlay for Duraplasty|Assessment of the Performance of LYoplant® ONlay for Duraplasty. A Non-interventional, Multi-centre Post Market Clinical Follow-up (PMCF) Study.|Recruiting||N/A|60|Anticipated|Aesculap AG|||1||f||||f||||||||No||2017-10-10 22:29:05.196212|2017-10-10 22:29:05.196212
NCT02678143|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-02-23|||April 26, 2016|Actual|2016-04-26|February 2017|2017-02-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease|A Pilot Study of Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease|Recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t|t|t|f|f|f|||No||2017-10-10 22:29:05.280112|2017-10-10 22:29:05.280112
NCT02678130|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-11-01|||January 2015||2015-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||A Prospective Study of the InterFuse T(tm),|A Prospective Study of the InterFuse T(tm)|Recruiting||Phase 4|60|Anticipated|Vertebral Technologies, Inc.||2|||f||||f||||||||Yes|It is anticipated that data will be presented at scientific meetings and that a manuscript will be produced on the study|2017-10-10 22:29:05.399976|2017-10-10 22:29:05.399976
NCT02678117|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-29|||July 2015||2015-07-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Analgesic Potentials of Preoperative Pregabalin,Magnesium Sulphate and Their Combination in Acute Post-thoracotomy Pain|Analgesic Potentials of Preoperative Oral Pregabalin,Intravenous Magnesium Sulphate and Their Combination in Acute Post-thoracotomy Pain.(Randomized,Double-Blind Study)|Recruiting||Phase 3|120|Anticipated|National Cancer Institute, Egypt||4|||f||||f||||||||||2017-10-10 22:29:05.521476|2017-10-10 22:29:05.521476
NCT02678104|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-03-13|||October 2016||2016-10-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||The Influence of Intra-alveolar Application of Honey on Healing Following Extraction|The Influence of Intra-alveolar Application of Honey on Healing Following Molar Teeth Extraction: A Randomized Clinical Trial|Recruiting||Phase 2|100|Anticipated|Riyadh Colleges of Dentistry and Pharmacy||2|||f||||f||||||||No||2017-10-10 22:29:05.658331|2017-10-10 22:29:05.658331
NCT02678091|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-09-07|||February 2016||2016-02-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|PUCE||Ultrasound Exam With Doppler for the Etiological Diagnosis of Orbital Masses (PUCE)|Contribution of the Quantitative Analysis of the Ultrasound Exam With Doppler for the Etiological Diagnosis of Orbital Masses (PUCE)|Enrolling by invitation||N/A|200|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||f||||||||Undecided||2017-10-10 22:29:05.772362|2017-10-10 22:29:05.772362
NCT02678078|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-05-05|||February 2016||2016-02-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Characterization of Cancer Tissue Using 3D Biosynthetic Material|Characterization of Cancer Tissue Using 3D Biosynthetic Material|Recruiting||N/A|100|Anticipated|Technion, Israel Institute of Technology|||1||f||||f||||||Samples Without DNA|"     we will collect a liver biopsy and blood   "|Yes||2017-10-10 22:29:05.836234|2017-10-10 22:29:05.836234
NCT02678065|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-08-10|||April 2014||2014-04-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|INPCTFLEXION||In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions|In.Pact Flexion, a Physician Initiated Trial Investigating the Performance of the In.Pact Admiral Drug-eluting Balloon for the Treatment of Popliteal Lesions|Recruiting||Phase 4|100|Anticipated|Flanders Medical Research Program||1|||f||||t||||||||Undecided||2017-10-10 22:29:05.906566|2017-10-10 22:29:05.906566
NCT02678052|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-06-06|||December 1, 2015|Actual|2015-12-01|June 2017|2017-06-01|March 1, 2021|Anticipated|2021-03-01|March 1, 2021|Anticipated|2021-03-01||Observational|||OTIS Vedolizumab Pregnancy Exposure Registry|Organization of Teratology Information Specialists (OTIS) Vedolizumab Pregnancy Exposure Registry|Recruiting||N/A|200|Anticipated|Takeda|||2||f||||f||||||||||2017-10-10 22:29:06.126442|2017-10-10 22:29:06.126442
NCT02678039|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-08-10|2016-08-03||August 2012||2012-08-01|August 2017|2017-08-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters|Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters|Completed||N/A|100|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-10 22:29:06.237307|2017-10-10 22:29:06.237307
NCT02678026|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-04|||January 2016||2016-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pessary as Adjunctive Therapy to Cerclage for the Prevention of Preterm Birth|Pessary as Adjunctive Therapy to Cerclage for the Prevention of Preterm Birth|Recruiting||Phase 3|200|Anticipated|Federico II University||2|||f||||t||||||||||2017-10-10 22:29:07.251158|2017-10-10 22:29:07.251158
NCT02678013|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-20|||February 2016||2016-02-01|February 2016|2016-02-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC|Radiofrequency Ablation Combined With Highly-purified CTL vs. Radiofrequency Ablation Alone for Recurrent HCC|Active, not recruiting||Phase 3|210|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Yes||2017-10-10 22:29:07.345097|2017-10-10 22:29:07.345097
NCT02678000|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-09-13|||March 10, 2017|Actual|2017-03-10|September 2017|2017-09-01|August 6, 2018|Anticipated|2018-08-06|August 6, 2018|Anticipated|2018-08-06||Interventional|LHW090||Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function|A Two Part Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Renal Safety, Tolerability and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function on Angiotensin Receptor Blockers|Recruiting||Phase 2|40|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 22:29:07.439044|2017-10-10 22:29:07.439044
NCT02677987|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-06-26|||April 2016||2016-04-01|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||"The Light for the Brain Study"|Treating Cognitive Impairments in Cancer Patients Via Systematic Light Exposure|Recruiting||N/A|80|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 22:29:07.540105|2017-10-10 22:29:07.540105
NCT02677974|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-09-24|||November 2015||2015-11-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01|5 Years|Observational [Patient Registry]|||On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study|On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study|Recruiting||N/A|510|Anticipated|On-X Life Technologies, Inc.|||1||f||||f||||||||||2017-10-10 22:29:07.6799|2017-10-10 22:29:07.6799
NCT02677961|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-10-20|||June 2015||2015-06-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|5 Years|Observational [Patient Registry]|||An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry|An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry|Recruiting||N/A|150|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||f||||||||No||2017-10-10 22:29:07.837976|2017-10-10 22:29:07.837976
NCT02677948|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-09-05|||October 2016||2016-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|Phase I/II, Open Label, Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|Withdrawn||Phase 1/Phase 2|0|Actual|University of Michigan Cancer Center||1||FDA has placed all trials involving Pacritinib on Full Clinical Hold|f||||t||||||||||2017-10-10 22:29:07.925846|2017-10-10 22:29:07.925846
NCT02677935|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-08|||January 2015||2015-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Impact of Peer Education Program on Headache Disorders|Impact of Peer Education Program on Headache Disorders in Rural Communities, India: a Quasi-experimental Study|Completed||N/A|360|Actual|NMP Medical Research Institute||1|||f||||t||||||||Yes||2017-10-10 22:29:08.016348|2017-10-10 22:29:08.016348
NCT02677376|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-03-01|||June 2016||2016-06-01|March 2017|2017-03-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPC|Validation of Imaging-Based Biomarkers of Treatment Response in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide|Recruiting||N/A|30|Anticipated|University of Wisconsin, Madison|||1||f||||t||||||||Undecided||2017-10-10 22:29:15.205096|2017-10-10 22:29:15.205096
NCT02677922|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-09-28|||June 3, 2016|Actual|2016-06-03|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 15, 2018|Anticipated|2018-12-15||Interventional|||A Safety and Efficacy Study of Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus Subcutaneous Azacitidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML)|A Phase 1b/2 Open-label, Randomized Study of 2 Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine: Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus SC Azacitidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia Harboring an IDH1 or an IDH2 Mutation, Respectively, Who Are Not Candidates to Receive Intensive Induction Chemotherapy|Recruiting||Phase 1/Phase 2|127|Anticipated|Celgene||3|||f||||t||||||||||2017-10-10 22:29:08.106466|2017-10-10 22:29:08.106466
NCT02677909|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-07-19|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01|1 Month|Observational [Patient Registry]|||Computer-Aided, Non-Invasive, Acoustic Gastrointestinal Surveillance (AGIS) in ICU Patients|Computer-Aided, Non-Invasive, Acoustic Gastrointestinal Surveillance (AGIS) in ICU Patients|Not yet recruiting||N/A|100|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 22:29:08.356086|2017-10-10 22:29:08.356086
NCT02677896|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-08-15|||March 7, 2016|Actual|2016-03-07|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)|A Multinational, Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)|Recruiting||Phase 3|1100|Anticipated|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-10 22:29:08.455305|2017-10-10 22:29:08.455305
NCT02677883|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-09-18|||January 2016||2016-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Pleural Manometry on Chest Discomfort After Therapeutic Thoracentesis|Manometry- Versus Symptom-Guided Large Volume Thoracentesis: a Randomized Controlled Study|Active, not recruiting||N/A|128|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-10-10 22:29:08.993741|2017-10-10 22:29:08.993741
NCT02677870|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-04|||May 2016||2016-05-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effectiveness of Kuvan in Amish PKU Patients|"The Effectiveness of High-Dose Synthetic BH4 (Saproterin Dihydrochloride or Kuvan) in Amish PKU Patients"|Not yet recruiting||Phase 4|25|Anticipated|University Hospitals Cleveland Medical Center||3|||f||||f||||||||No||2017-10-10 22:29:09.082272|2017-10-10 22:29:09.082272
NCT02677857|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-07-18|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Developing a Healthy Lifestyle in Breast Cancer Survivors|Developing a Healthy Lifestyle in Breast Cancer Survivors|Terminated||N/A|7|Actual|University of Tennessee||3||Recruitment efforts were not effective.|f||||||||||||||2017-10-10 22:29:09.178422|2017-10-10 22:29:09.178422
NCT02677844|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-08-11|||February 2016||2016-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study of Abemaciclib in Healthy Participants|A Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Determine the Exposure-Response Relationship Between Abemaciclib and QT Interval in Healthy Subjects|Completed||Phase 1|40|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-10 22:29:09.261747|2017-10-10 22:29:09.261747
NCT02677831|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-03-30|||July 2008||2008-07-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|March 2013|Actual|2013-03-01||Observational|HALST||Healthy Aging Longitudinal Study in Taiwan|Healthy Aging Longitudinal Study in Taiwan (HALST)|Active, not recruiting||N/A|5664|Actual|National Health Research Institutes, Taiwan|||1||f||||f||||||Samples With DNA|"     whole blood, serum, urine.   "|No||2017-10-10 22:29:09.33993|2017-10-10 22:29:09.33993
NCT02677818|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-05-15|||May 2016||2016-05-01|July 2016|2016-07-01|August 2021|Anticipated|2021-08-01|January 2018|Anticipated|2018-01-01||Observational|||The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-platelet||Recruiting||N/A|1200|Anticipated|Zhujiang Hospital|||2||f||||f||||||||Yes||2017-10-10 22:29:09.408629|2017-10-10 22:29:09.408629
NCT02677805|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-02-01|||February 2016||2016-02-01|February 2016|2016-02-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|BLESS II||Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II|Randomized Double Blind Phase 3 Study to Assess the Efficacy and Safety of BoNT/A-DP in the Treatment of Glabellar Lines in Comparison With Placebo Followed by an Open Label Extension Study|Active, not recruiting||Phase 3|200|Anticipated|Croma-Pharma GmbH||2|||f||||f||||||||Undecided|This is not decided yet and will be changed accordingly when the decision has been made|2017-10-10 22:29:09.482204|2017-10-10 22:29:09.482204
NCT02677792|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-11-16|||February 2016||2016-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Wellness and Weight Family Group Project|Wellness and Weight Family Group Project|Recruiting||N/A|30|Anticipated|University of Mississippi Medical Center||1|||f||||f||||||||No||2017-10-10 22:29:09.549702|2017-10-10 22:29:09.549702
NCT02677779|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-10-13|2016-08-19||January 2016||2016-01-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|DULCIS||CO2-Laser Treatment in Patients With Diabetic Infected Foot Ulcers|A Randomised, Open Label, Controlled Clinical Study to Evaluate the Efficacy and Safety of CO2-Laser Treatment in Patients With Diabetic Infected Foot Ulcers|Completed||N/A|20|Actual|Azienda Ospedaliero-Universitaria Careggi||2|||f||||f||||||||No||2017-10-10 22:29:09.769349|2017-10-10 22:29:09.769349
NCT02677766|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-04-26|||February 2016||2016-02-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TO_EFFI15_14||Occupational Therapy in Complex Patients: a Pilot Study|Occupational Therapy in Complex Patients: a Pilot Study|Recruiting||Phase 2/Phase 3|40|Anticipated|University of Modena and Reggio Emilia||2|||f||||f||||||||Yes||2017-10-10 22:29:10.180253|2017-10-10 22:29:10.180253
NCT02677753|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-12|||August 2016||2016-08-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Percutaneous Nerve Evaluation With Fluoroscopy Versus Without|InterStim Implantation Rates Following Percutaneous Nerve Evaluation With Fluoroscopy Versus Without|Enrolling by invitation||N/A|60|Anticipated|University of Louisville||2|||f||||f||||||||Yes|"Age
Race
BMI
Preoperative diagnosis
Previous treatments for urinary urgency, frequency, retention, and/or urinary or fecal incontinence
Percent improvement in symptoms as determined by pre and post PNE voiding diaries
Whether or not InterStim implanted within 3 months of PNE
Date of PNE"|2017-10-10 22:29:10.296648|2017-10-10 22:29:10.296648
NCT02677740|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-08-30|||April 2016||2016-04-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity|Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity|Active, not recruiting||N/A|8|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 22:29:10.387873|2017-10-10 22:29:10.387873
NCT02677727|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-01-27|||July 1, 2015|Actual|2015-07-01|January 2017|2017-01-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor|A Study of the Natural History of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor|Recruiting||N/A|60|Anticipated|Indiana University|||1||f||||t|f|f||||Samples With DNA|"     DNA to use for future planned evaluations to predict patients at higher risks of developing     neuropathy   "|||2017-10-10 22:29:10.507797|2017-10-10 22:29:10.507797
NCT02677714|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-01-23|||April 2016||2016-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|||99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer|99mTc-rhAnnexin V-128 Imaging of Apoptosis and Cardiotoxicity in Relationship to Ventricular Function in Patients With Early Stage Breast Cancer Receiving Doxorubicin-Based Chemotherapy|Active, not recruiting||Phase 2|30|Anticipated|Advanced Accelerator Applications||1|||f||||t||||||||Undecided||2017-10-10 22:29:10.660183|2017-10-10 22:29:10.660183
NCT02677701|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-03-01|||April 2016||2016-04-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|TEACH||Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With CF|TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin|Recruiting||Phase 4|140|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-10 22:29:10.806537|2017-10-10 22:29:10.806537
NCT02677688|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-31|||January 2016||2016-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|LUPUS CTL EBV||Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE)|Restauration of EBV Control in SLE Phase 1-2 Trial Evaluating Adoptive Transfer of Autologous EBV- Specific Cytotoxic T Lymphocytes in SLE Treatment|Recruiting||Phase 1/Phase 2|10|Anticipated|Nantes University Hospital||1|||f||||f||||||||No||2017-10-10 22:29:11.036959|2017-10-10 22:29:11.036959
NCT02677662|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-05-11|||November 2015||2015-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|LAPSE||Longitudinal Acute Air Pollution Systemic Effects|Longitudinal Acute Air Pollution Systemic Effects (LAPSE)|Completed||N/A|30|Actual|Umeå University||2|||f||||f||||||||Undecided||2017-10-10 22:29:11.220554|2017-10-10 22:29:11.220554
NCT02677649|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-02-17|||December 2015||2015-12-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|||Microbiota Diversity and Composition and Polyphenol Bioavailability|Microbiota Diversity and Composition and Polyphenol Bioavailability: a Controlled Feeding Trial With a Plant Free Diet Containing Whole Cranberry Powder|Completed||N/A|11|Actual|Tufts University||2|||f||||f||||||||No||2017-10-10 22:29:11.315365|2017-10-10 22:29:11.315365
NCT02677636|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-08||||||September 2016|2016-09-01||||July 2016|Actual|2016-07-01||Interventional|MSRD-100||Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older|A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of MSRD-100 in Subjects >=3 Months of Age With Atopic Dermatitis|Withdrawn||Phase 3|0|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 22:29:11.399158|2017-10-10 22:29:11.399158
NCT02677623|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-01-08|||March 2015||2015-03-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of Ureteral Patency in the Post-indigo Carmine Era|Evaluation of Ureteral Patency in the Post-indigo Carmine Era|Completed||Phase 4|140|Actual|Columbia University||4|||f||||f||||||||Undecided||2017-10-10 22:29:11.493113|2017-10-10 22:29:11.493113
NCT02677610|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-08||||||September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|July 2016|Actual|2016-07-01||Interventional|MSRD-100||Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older|A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of MSRD-100 in Subjects >=3 Months of Age With Atopic Dermatitis|Withdrawn||Phase 3|0|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 22:29:11.576243|2017-10-10 22:29:11.576243
NCT02677597|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-08|||January 2016||2016-01-01|February 2016|2016-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma|An Open, Multicenter, Randomized Phase III Clinical Study on Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma|Recruiting||Phase 3|268|Anticipated|Fudan University||2|||f||||f||||||||Yes||2017-10-10 22:29:11.651057|2017-10-10 22:29:11.651057
NCT02677584|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-02-08|||March 2015||2015-03-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Prophylactic Versus Therapeutic Caffeine for Apnea of Prematurity|Prophylactic Versus Therapeutic Caffeine for Apnea of Prematurity|Recruiting||N/A|180|Anticipated|Mansoura University Children Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:29:11.730414|2017-10-10 22:29:11.730414
NCT02677571|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2017-02-02|||December 2015||2015-12-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|PVBvsPECS||PVB vs PECS Block in Breast Surgery|Thoracic Paravertebral Block Versus Pectoral Nerves Block (Modified PECS) Block in Breast Surgery|Completed||N/A|55|Actual|Istituti Ospitalieri di Cremona||2|||f||||f||||||||No||2017-10-10 22:29:11.839878|2017-10-10 22:29:11.839878
NCT02677545|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-04-26|||December 2016||2016-12-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|PRECISE-MRI||Ticagrelor Versus Clopidogrel in Carotid Artery Stenting|Prevention of Cerebral Ischaemia in Stent Treatment for Carotid Artery Stenosis - A Randomised Multi-centre Phase II Trial Comparing Ticagrelor Versus Clopidogrel With Outcome Assessment on MRI (PRECISE-MRI)|Recruiting||Phase 2|370|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||Yes|De-identified individual participant data will be available for further analyses. Specific requests will be considered by the Trial Steering Committee.|2017-10-10 22:29:12.058381|2017-10-10 22:29:12.058381
NCT02677532|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-08|||December 2011||2011-12-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|APERIVIP||Epidural Versus Wound Infusion Plus Morphine Bolus in Open Abdominal Aortic Aneurysm Repair|Analgesia Postoperatoria Mediante Catetere Perdurare e Analgesia Postoperatoria Mediante Infusione Continua Periferia Nell'Intervento Chirurgico Per Riparazione Chirurgica di Aneurismi Dell'Aorta Addominale: Tecniche a Confronto|Completed||Phase 4|51|Actual|University of Genova||2|||f||||f||||||||No||2017-10-10 22:29:12.16431|2017-10-10 22:29:12.16431
NCT02677519|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-08-24|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|EF004||A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD|A 12-Month Open Label Safety Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4-5 Years Diagnosed With Attention-Deficit/Hyperactivity Disorder (ADHD)|Not yet recruiting||Phase 4|120|Anticipated|Rhodes Pharmaceuticals, L.P.||7|||f||||t||||||||Undecided||2017-10-10 22:29:12.263988|2017-10-10 22:29:12.263988
NCT02677506|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-02-11|||January 2013||2013-01-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Infraclavicular or Supraclavicular Brachial Plexus Blocks for Elbow Surgery|A Randomized Comparison of Infraclavicular and Supraclavicular Brachial Plexus Blocks for Elbow Surgery|Completed||N/A|150|Actual|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 22:29:12.371572|2017-10-10 22:29:12.371572
NCT02677493|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-02-06|2016-06-21||October 2015||2015-10-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'|A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Phase III Study to Investigate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.' After Intramuscular Administration in Healthy Adult Subjects|Completed||Phase 3|1794|Actual|Il-Yang Pharm. Co., Ltd.||3|||f||||f||||||||No||2017-10-10 22:29:12.491233|2017-10-10 22:29:12.491233
NCT02677480|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-02-04|||November 2010||2010-11-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||The Effect of Probiotic Streptococci and pH-rising Components on the Oral Microbial Flora|The Effect of Probiotic Streptococci and pH-rising Components on the Oral Microbial Flora in Subjects With Reduced Salivary Secretion Rate|Completed||Phase 1|30|Actual|Göteborg University||2|||f||||f||||||||||2017-10-10 22:29:12.856035|2017-10-10 22:29:12.856035
NCT02677467|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-02-08|||March 2016||2016-03-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01|3 Months|Observational [Patient Registry]|CBECD||Correlation Between Epistaxis and Cardiovascular Disease|Epistaxis Correlate With Cardiovascular Disease?|Not yet recruiting||N/A|50|Anticipated|Hanyang University|||2||f||||t||||||Samples Without DNA|"     Blood sample for evaluating about cardiovasular risk.   "|Yes|The investigators make a registry for individual participant data and collect the registry and share it.|2017-10-10 22:29:12.929481|2017-10-10 22:29:12.929481
NCT02677454|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-11-14|||June 2015||2015-06-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of a Flash Glucose Monitoring System in Ambulatory Patients With Type 1 Diabetes|Evaluation of a Flash Glucose Monitoring System in Ambulatory Patients With Type 1 Diabetes|Completed||N/A|56|Actual|Vastra Gotaland Region||1|||f||||f||||||||No||2017-10-10 22:29:13.013566|2017-10-10 22:29:13.013566
NCT02677441|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-05-07|||February 2016||2016-02-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|AC Cons Chir||Conservative or Surgical Management of Rockwood Type III to V Acromioclavicular Dislocations|Conservative or Surgical Management of Rockwood Type III to V Acromioclavicular Dislocations: A Non-inferiority Randomized Study|Not yet recruiting||N/A|176|Anticipated|La Tour Hospital||2|||f||||t||||||||||2017-10-10 22:29:13.086483|2017-10-10 22:29:13.086483
NCT02677428|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-12|||December 1, 2015|Actual|2015-12-01|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|March 30, 2019|Anticipated|2019-03-30||Interventional|||Remotely-Delivered Benefits Counseling for Service Connection Applicants|Remotely-Delivered Benefits Counseling for Service Connection Applicants|Recruiting||N/A|170|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Undecided||2017-10-10 22:29:13.172915|2017-10-10 22:29:13.172915
NCT02677415|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2017-03-11|||September 2016|Actual|2016-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CANVAS||Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment|Impact of General vs Local Anesthesia on Neurological Function in Patients With Acute Ischemic Stroke Undergoing Endovascular Treatment|Recruiting||N/A|640|Anticipated|Beijing Tiantan Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:29:13.259215|2017-10-10 22:29:13.259215
NCT02677402|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-10-25|||December 2012||2012-12-01|October 2016|2016-10-01||||December 2013|Actual|2013-12-01||Interventional|||Effects of Various Modalities Water Immersion on Veins|Effects of Thermo Neutral Water Immersion, Cold-water Immersion and Contrast Water Therapy on Lower Limb Veins Calibres|Completed||N/A|10|Actual|University of Franche-Comté||3|||f||||f||||||||No||2017-10-10 22:29:13.340387|2017-10-10 22:29:13.340387
NCT02677389|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-05-01|||December 2015||2015-12-01|May 2017|2017-05-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin|Active Living After Cancer: Building a Physical Activity Intervention Into Clinical Care for Breast and Colorectal Cancer Survivors in Wisconsin|Recruiting||N/A|100|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-10 22:29:15.106228|2017-10-10 22:29:15.106228
NCT02677363|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-02-03|||February 2016||2016-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Functional Outcomes of Stay Strong Stay Healthy Program|Functional Outcomes of Stay Strong, Stay Healthy Program|Recruiting||N/A|50|Anticipated|University of Missouri-Columbia||1|||f||||f||||||||No||2017-10-10 22:29:15.290431|2017-10-10 22:29:15.290431
NCT02677350|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-09-13|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|March 2026|Anticipated|2026-03-01|March 2025|Anticipated|2025-03-01||Interventional|GALENE||AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PEri-fistula iNjEctions (GALENE)|A Phase I, Pilot Trial to Evaluate the Safety and Efficacy of Injection of Allogeneic Mesenchymal Bone-Marrow Derived Human Stem Cells in Patients With Fistulizing Crohn's Disease.|Not yet recruiting||Phase 1|20|Anticipated|University of Miami||1|||f||||t|t|f||||||||2017-10-10 22:29:15.383763|2017-10-10 22:29:15.383763
NCT02677337|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-02-15|||March 2016||2016-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||NCCN Renal Cell Registry|Novel Educational Interventions for Community Oncologists & Patients: Optimizing Renal Cell Carcinoma Outcomes Through Engagement|Completed||N/A|120|Actual|Duke University||2|||f||||f||||||||Undecided|This trial may potentially be published.|2017-10-10 22:29:15.473941|2017-10-10 22:29:15.473941
NCT02677324|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-07-26|||April 2016||2016-04-01|July 2017|2017-07-01|February 2023|Anticipated|2023-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia|Phase II Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia|Recruiting||Phase 2|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 22:29:15.543042|2017-10-10 22:29:15.543042
NCT02677311|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-05-11|||September 2015||2015-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient|Gonadotropin Releasing Hormone Agonist (GnRHa) Therapy and Ovarian Preservation in Pediatric and Adolescent Subject Receiving Chemoradiation Therap|Terminated||N/A|2|Actual|University of Kentucky||2||Unable to recruit required numbers for study.|f||||f||||||||Yes|"UK IRB/Office of Research Integrity
Law enforcement agencies when required by law
University of Kentucky representatives
UK Hospital
ACOG
Representatives of the National Cancer Institute (NCI), FDA, and other U.S. and international governmental regulatory agencies involved in overseeing research
Authorized representatives at the University of Cincinnati who are collaborating on this research.
Every research site of the study (including UK Healthcare and Cincinnati Children's and each site's research staff and medical staff)
Every health care provider who provides services to you in connection with the study
Any laboratories and other individuals and organizations that analyze your PHI in connection with the study
The Sponsor and the people and companies they use to oversee, administer and/or conduct the study
Kentucky Cancer Registry (KCR) to all follow-up assistance"|2017-10-10 22:29:15.648893|2017-10-10 22:29:15.648893
NCT02677298|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-02-01|||February 2016||2016-02-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|BLESS I||Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I|Randomized Double Blind Phase 3 Study to Assess the Efficacy and Safety of BoNT/A-DP in the Treatment of Glabellar Lines in Comparison With Placebo, Followed by an Open Label Extension Study|Active, not recruiting||Phase 3|700|Actual|Croma-Pharma GmbH||2|||f||||f||||||||Undecided|This is not decided yet and will be changed accordingly when the decision has been made.|2017-10-10 22:29:15.717007|2017-10-10 22:29:15.717007
NCT02677285|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-02-03|||January 2016||2016-01-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Bioimpedance Based Monitoring of Operation Wound and Skin Graft Healing|Bioimpedance Based Monitoring of Operation Wound and Skin Graft Healing|Enrolling by invitation||N/A|40|Anticipated|Tampere University Hospital|||2||f||||t||||||||No||2017-10-10 22:29:15.80477|2017-10-10 22:29:15.80477
NCT02677272|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Observational|FINE||Factors Predisposing to Inappropriate Transfers of Nursing Home Residents to Emergency Departments|Factors Predisposing to Inappropriate Transfers of Nursing Home Residents to Emergency Departments|Recruiting||N/A|1004|Anticipated|University Hospital, Toulouse|||1||f||||t||||||||No||2017-10-10 22:29:16.007734|2017-10-10 22:29:16.007734
NCT02677259|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-09|||May 2016||2016-05-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles|Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: a Randomized, Controlled Study|Not yet recruiting||Phase 2|506|Anticipated|One Fertility||2|||f||||f||||||||||2017-10-10 22:29:16.16136|2017-10-10 22:29:16.16136
NCT02677246|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-12|||December 2016||2016-12-01|October 2016|2016-10-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Denosumab for Prevention of Bone Complications After Bone Marrow Transplantation in Children|Phase 1 Trial of Denosumab for Prevention of Bone Complications After Allogenic Hematopoietic Stem Cell Transplantation in Children|Not yet recruiting||Phase 1|12|Anticipated|St. Justine's Hospital||1|||f||||t||||||||No||2017-10-10 22:29:16.274358|2017-10-10 22:29:16.274358
NCT02677233|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-05|2016-02-05|||June 2015||2015-06-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Association Between Vitamin D Deficiency and Preeclampsia: A Case Control Study||Completed||N/A|90|Actual|Ain Shams Maternity Hospital|||2||f||||t||||||Samples Without DNA|"     serum   "|No||2017-10-10 22:29:16.367676|2017-10-10 22:29:16.367676
NCT02677220|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-09-01|||May 2016||2016-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Implantation With the Nucleus CI532 Cochlear Implant in Adults|Implantation With the Nucleus CI532 Cochlear Implant in Adults|Active, not recruiting||N/A|1|Actual|Cochlear||1|||f||||f||||||||No||2017-10-10 22:29:16.427649|2017-10-10 22:29:16.427649
NCT02677207|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-11-28|||February 2016||2016-02-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|JNJ-DEP||The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive|The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive Symptoms in 80 Patients With Unipolar or Bipolar Depression: a Phase II Exploratory add-on Double Blind Placebo Controlled 2 Week Trial|Recruiting||Phase 2|80|Anticipated|CliniRx Tangent Research||2|||f||||f||||||||Yes||2017-10-10 22:29:16.504584|2017-10-10 22:29:16.504584
NCT02677194|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-04|||February 2016||2016-02-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|February 2017|Anticipated|2017-02-01||Interventional|HeaLed||HeaLED: Pilot Study of Skin Healing Under LED Exposure|Stimulation of Cutaneous Healing Processes With LED: a Controlled Comparative Study to Identify Optimal Settings|Not yet recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||No||2017-10-10 22:29:16.622389|2017-10-10 22:29:16.622389
NCT02677181|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-02-04|||January 2016||2016-01-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT|Prospective Study of Combined ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT|Recruiting||Phase 4|140|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||No||2017-10-10 22:29:16.702236|2017-10-10 22:29:16.702236
NCT02677168|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-09-18|||May 2016||2016-05-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|cNEP||cNEP for the Treatment of Obstructive Sleep Apnea|Continuous Negative External Pressure (cNEP) for the Treatment of Obstructive Sleep Apnea (OSA)|Recruiting||N/A|30|Anticipated|Sommetrics, Inc.||1|||f||||f||||||||||2017-10-10 22:29:16.857255|2017-10-10 22:29:16.857255
NCT02677155|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-11|||January 2016||2016-01-01|January 2016|2016-01-01|January 2024|Anticipated|2024-01-01|January 2020|Anticipated|2020-01-01||Interventional|Lymvac-2||Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma|Open Label, Phase II, Study: Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Patients With Stage III/IV Untreated and Relapsed Follicular Lymphoma|Recruiting||Phase 2|20|Anticipated|Oslo University Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:29:16.965674|2017-10-10 22:29:16.965674
NCT02677142|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-05-06|||April 2012||2012-04-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluating the Efficacy of a Group Social Skills Intervention|A Randomized Control Trial to Evaluate the Efficacy of a Group Social Skills Intervention for Childhood Survivors of Brain Tumours|Completed||N/A|95|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 22:29:17.095495|2017-10-10 22:29:17.095495
NCT02677129|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-04-11|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy|Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy|Completed||N/A|44|Actual|Goethe University||2|||f||||t||||||||No|Only pseudonymised data without the plan to share|2017-10-10 22:29:17.193153|2017-10-10 22:29:17.193153
NCT02677116|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-09-02|||August 2016||2016-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer|A Phase 1, Open-Label, Dose-Escalation Study of Olaratumab as a Single Agent and in Combination With Doxorubicin, Vincristine/Irinotecan, or High-Dose Ifosfamide in Pediatric Patients With Relapsed or Refractory Solid Tumors|Recruiting||Phase 1|70|Anticipated|Eli Lilly and Company||8|||f||||f||||||||||2017-10-10 22:29:17.280632|2017-10-10 22:29:17.280632
NCT02677103|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-03-24|||April 2013||2013-04-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparison of the Effect of Radial Shock Wave, Ultrasound-guided Needle Puncture, and Combination of Both in the Treatment of Calcific Tendinitis of the Shoulder|Comparison of the Effect of Radial Shock Wave, Ultrasound-guided Needle Puncture, and Combination of Both in the Treatment of Calcific Tendinitis of the Shoulder|Completed||N/A|61|Actual|Shin Kong Wu Ho-Su Memorial Hospital||3|||f||||t||||||||||2017-10-10 22:29:17.487105|2017-10-10 22:29:17.487105
NCT02677090|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-03-09|||January 2016||2016-01-01|January 2016|2016-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Fiber - TIC||Fiber Tolerability in Children Aged 3-7 Year|Fiber Tolerability In Children Aged 3-7 Year|Completed||N/A|36|Actual|Nestlé||4|||f||||f||||||||No||2017-10-10 22:29:17.582814|2017-10-10 22:29:17.582814
NCT02677077|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-10-02|||December 31, 2015|Actual|2015-12-31|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Clinical Disease Activity With Long Term Natalizumab Treatment|MRI and Clinical Disease Activity in Patients Treated Long Term With Natalizumab|Active, not recruiting||N/A|277|Actual|Biogen|||2||f||||f||||||||||2017-10-10 22:29:17.78511|2017-10-10 22:29:17.78511
NCT02677064|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-10-03|||February 2016||2016-02-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia|Observational Study to Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia|Recruiting||N/A|400|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:29:17.904746|2017-10-10 22:29:17.904746
NCT02677051|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-08-10|||February 2016||2016-02-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism|Sulforaphane in Autism: A Treatment Trial to Confirm Phenotypic Improvement With Sulforaphane Treatment in a New Jersey (NJ) Population of Individuals With Autism|Recruiting||Phase 2|40|Anticipated|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-10 22:29:17.999774|2017-10-10 22:29:17.999774
NCT02677038|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-10-05|||November 11, 2016|Actual|2016-11-11|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Olaparib for BRCAness Phenotype in Pancreatic Cancer|Olaparib for BRCAness Phenotype in Pancreatic Cancer: Phase II Study|Recruiting||Phase 2|24|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:29:18.106995|2017-10-10 22:29:18.106995
NCT02677025|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-06-07|||May 2014||2014-05-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|YWHC||Young Women's Health CoOp (Cooperative) in Cape Town|Seek, Test, Treat, & Retain Pilot for Out of School Teens at Risk in Cape Town|Completed||N/A|100|Actual|RTI International||2|||f||||t||||||||Yes|"After the main findings are published, we welcome other researchers who want to analyze the data in other ways. Before this time, however, we anticipate establishing a publication plan that involves other researchers and institutions. Analytic data sets will be prepared in accordance with the Privacy Rule of the Health Insurance Portability and Accountability Act (HIPAA; http://www.hhs.gov/ocr/) as limited data sets in which names and other personal health identifiers are removed, birthdays have been converted to age at intake, and other dates have been changed to be days before or after the date of intake."|2017-10-10 22:29:18.217495|2017-10-10 22:29:18.217495
NCT02677012|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-04-06|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Comparison of Time Associated With Techniques to Process Autologous Fat Grafts|A Randomized, Prospective Comparison of Time Associated With Techniques to Process Autologous Fat Grafts|Recruiting||N/A|50|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 22:29:18.326775|2017-10-10 22:29:18.326775
NCT02676999|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-02-08|||September 2014||2014-09-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|12 Months|Observational [Patient Registry]|||Clinical and Radiographical Analysis of the Distal Radioulnar Joint Following Implantation of a Scheker Total Distal Radioulnar Joint Prosthesis|Clinical and Radiographical Analysis of the Distal Radioulnar Joint Following Implantation of a Scheker Total Distal Radioulnar Joint Prosthesis|Recruiting||N/A|10|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-10 22:29:18.424773|2017-10-10 22:29:18.424773
NCT02676986|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-08-29|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ARB||Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer|Phase II Window of Opportunity Study of Short-term Preoperative Treatment With Enzalutamide (Alone or in Combination With Exemestane) in Patients With Primary Breast Cancer|Recruiting||Phase 2|235|Anticipated|Queen Mary University of London||2|||f||||f||||||||||2017-10-10 22:29:18.541653|2017-10-10 22:29:18.541653
NCT02676973|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-03-24|||March 2016||2016-03-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|ASPIRe||Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design|Three Arm Apical Suspension Trial for Post-Hysterectomy Vault Prolapse: Prospective Randomized Trial Involving Sacral Colpopexy, Transvaginal Mesh and Native Tissue Apical Repair|Recruiting||N/A|363|Anticipated|NICHD Pelvic Floor Disorders Network||3|||f||||t||||||||No||2017-10-10 22:29:18.919798|2017-10-10 22:29:18.919798
NCT02676960|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-06-28|||January 2016||2016-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Feasibility Study: MRI on 6 Months, 1 Year, and 2 Years Old Children Without Sedation|Feasibility Study: MRI on 6 Months, 1 Year, and 2 Years Old Children Without Sedation|Active, not recruiting||N/A|45|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-10-10 22:29:19.17904|2017-10-10 22:29:19.17904
NCT02676947|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-04-13|||January 2016||2016-01-01|April 2017|2017-04-01|September 30, 2017|Anticipated|2017-09-30|September 2017|Anticipated|2017-09-01||Interventional|TRANSFORM-UK||A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension|A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension|Recruiting||Phase 2|21|Anticipated|Papworth Hospital NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:29:19.277208|2017-10-10 22:29:19.277208
NCT02676934|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-03|||January 2015||2015-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|EtCntrl||End Tidal Control of Sevoflurane||Completed||N/A|40|Actual|Mansoura University||2|||f||||t||||||||Yes||2017-10-10 22:29:19.409689|2017-10-10 22:29:19.409689
NCT02676921|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-02-08|||March 2014||2014-03-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01|4 Weeks|Observational [Patient Registry]|HMSSM||The Osteogenic Potential of Human Maxillary Sinus Shneiderian Membrane|Phase 1: Study of the Osteogenic Potential of Human Maxillary Sinus Shneiderian Membrane|Completed||N/A|10|Actual|Lebanese University|||1||f||||t||||||Samples With DNA|"     Human sinus membrane   "|||2017-10-10 22:29:19.515657|2017-10-10 22:29:19.515657
NCT02676895|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-03-13|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Interventional|||A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults|A Phase 2a, Observer Blind, Randomized, Controlled, Single Center Study To Evaluate The Safety, Reactogenicity And Immunogenicity Of 2 Doses Of The GVGH 1790GAHB Vaccine Against Shigella Sonnei, Administered Intramuscularly In Adult Subjects From A Country Endemic For Shigellosis|Completed||Phase 2|72|Actual|GSK Vaccines Institute For Global Health S.r.l.||3|||f||||t||||||||Undecided||2017-10-10 22:29:19.692514|2017-10-10 22:29:19.692514
NCT02676882|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-06-08|||September 2016||2016-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy|EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy|Recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No|All data will be presented in aggregate to protect participant privacy.|2017-10-10 22:29:19.78911|2017-10-10 22:29:19.78911
NCT02676869|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-03-01|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|TACTI-mel||Phase 1 Study of IMP321 Adjuvant to Anti-PD-1 Therapy in Unresectable or Metastatic Melanoma|A Multicentre, Open Label, Dose Escalation, Phase 1 Study in Patients With Unresectable or Metastatic Melanoma Receiving IMP321 (LAG-3Ig Fusion Protein) as an Adjunctive Therapy to Anti-PD-1 Therapy With Pembrolizumab|Recruiting||Phase 1|18|Anticipated|Prima BioMed Australia Pty. Ltd.||1|||f||||t||||||||Undecided||2017-10-10 22:29:19.892305|2017-10-10 22:29:19.892305
NCT02676843|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-10-25|||April 2016||2016-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations|Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations|Enrolling by invitation||Phase 2|16|Anticipated|Columbia University||1|||f||||f||||||||Undecided||2017-10-10 22:29:20.085569|2017-10-10 22:29:20.085569
NCT02676830|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-16|||August 2014||2014-08-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312||Completed||Phase 1|13|Actual|Kowa Research Institute, Inc.||1|||f||||||||||||||2017-10-10 22:29:20.160483|2017-10-10 22:29:20.160483
NCT02676284|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-02-03|||May 2013||2013-05-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Durolane SJ for Treatment of Rhizarthrosis|Study of the Clinical and Biomechanical Effectiveness of Durolane SJ in Rhizarthrosis|Completed||Phase 4|36|Actual|Zambon SAU||1|||f||||f||||||||No||2017-10-10 22:29:25.355389|2017-10-10 22:29:25.355389
NCT02676817|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-02-03|||April 2015||2015-04-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Observational|ENHANCE||Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative Colitis|Probe-based Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative Colitis: Development and Validation of the ENHANCE Score|Recruiting||N/A|100|Anticipated|European Georges Pompidou Hospital|||2||f||||t||||||Samples Without DNA|"     Colonic biopsies wre taken during colonoscopy in order to assess the histological     inflammation and to correlate the result with pCLE description.   "|||2017-10-10 22:29:20.246902|2017-10-10 22:29:20.246902
NCT02676804|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PDEX||Exercise Dosing Trial for Individuals With Parkinson's Disease|Exercise Dosing Trial for Individuals With Parkinson's Disease|Recruiting||N/A|120|Anticipated|University of Virginia||1|||f||||f||||||||Undecided|If data is shared, Investigators plan to obtain a material transfer agreement.|2017-10-10 22:29:20.322717|2017-10-10 22:29:20.322717
NCT02676791|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-10-28|||February 2016||2016-02-01|October 2016|2016-10-01|April 2022|Anticipated|2022-04-01|February 2022|Anticipated|2022-02-01||Interventional|LOCARE||Influence of Esophageal Washout on Local Carcinoma Recurrence After Curative Resection|Influence of Esophageal Washout on Local Carcinoma Recurrence After Curative Resection - a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Technische Universität Dresden||2|||f||||t||||||||No||2017-10-10 22:29:20.408983|2017-10-10 22:29:20.408983
NCT02676778|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-06-26|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma|A Phase 2 Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma|Recruiting||Phase 2|35|Anticipated|Eisai Inc.||1|||f||||f||||||||||2017-10-10 22:29:20.491914|2017-10-10 22:29:20.491914
NCT02676765|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-07-11|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy|Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy|Recruiting||N/A|30|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-10 22:29:20.591461|2017-10-10 22:29:20.591461
NCT02676752|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-02-01|||September 2016|Actual|2016-09-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors With Lymphedema and Fibrosis|Assessing Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors|Recruiting||N/A|80|Anticipated|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-10-10 22:29:20.818906|2017-10-10 22:29:20.818906
NCT02676739|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-12-28|||August 2016||2016-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Adderall XR and Cognitive Impairment in MS|A Double-blind Placebo Controlled Study of Mixed-amphetamine Salts, Extended Release (Adderall XR) for Cognitive Impairment in MS|Recruiting||Phase 2/Phase 3|180|Anticipated|London Health Sciences Centre||3|||f||||f||||||||||2017-10-10 22:29:20.936739|2017-10-10 22:29:20.936739
NCT02676726|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-02-03|||July 2014||2014-07-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|STELLA-2||STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer|STELLA 2 Trial: Staging of Endometrial and Ovarian Cancer Comparing the Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Lymphadenectomy of Aortic Nodes, Evaluating Complications|Recruiting||N/A|208|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||||2017-10-10 22:29:21.070038|2017-10-10 22:29:21.070038
NCT02676713|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2016-02-17|||December 2014||2014-12-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Traditional Chinese Medicine Sequential Treatment for Endometriosis Associated Infertility|Activating Blood, Dredging Liver and Nourishing Kidney Sequential Treatment for Endometriosis Associated Infertility - a Randomized Double-blind Placebo Controlled Study|Recruiting||Phase 2|204|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||No||2017-10-10 22:29:21.221381|2017-10-10 22:29:21.221381
NCT02676700|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-08-18|||February 2016||2016-02-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Pelvic Floor Muscle Training and Kaatsu Training for Women With Stress Urinary Incontinence|The Effect of Pelvic Floor Muscle Training With or Without Kaatsu Training for Women With Stress Urinary Incontinence|Recruiting||N/A|40|Anticipated|Herlev Hospital||2|||f||||t||||||||No||2017-10-10 22:29:21.361901|2017-10-10 22:29:21.361901
NCT02676687|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-04|||January 2016||2016-01-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Supratotal Resection for Gliomas Within Noneloquent Areas|Supratotal Resection for Gliomas Within Noneloquent Areas: A Single Center Prospective Randomized Controlled Clinical Trial|Recruiting||N/A|120|Anticipated|Southwest Hospital, China||2|||f||||t||||||||No||2017-10-10 22:29:21.466275|2017-10-10 22:29:21.466275
NCT02676674|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-07-19|||March 2016||2016-03-01|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|VITD-001||Vitamin D Levels Following Topical Application of Vitamin D Ointment|Vitamin D Levels in Subjects With Vitamin D Deficiency Following Topical Application of Three Doses of Vitamin D Ointment - A Proof of Concept Study|Completed||Phase 1|10|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 22:29:21.571865|2017-10-10 22:29:21.571865
NCT02676661|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-02-05|||October 2014||2014-10-01|January 2016|2016-01-01|December 2022|Anticipated|2022-12-01|October 2022|Anticipated|2022-10-01|5 Years|Observational [Patient Registry]|||Evaluation of the Prevalence and Risk Factors for Patients With Peri-implant Disease|The Prevalence and Risk Factors for Patients With Peri-implant Disease： A Prospective Study|Recruiting||N/A|350|Anticipated|Fourth Military Medical University|||2||f||||t||||||||Yes||2017-10-10 22:29:21.66936|2017-10-10 22:29:21.66936
NCT02676648|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-02-09|||February 2016||2016-02-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Web-Delivered Interventions for Blood Sugar Control for Individuals With Type 2 Diabetes|Randomized Trial of Web-Delivered Interventions for Blood Sugar Control for Individuals With Type 2 Diabetes|Active, not recruiting||N/A|64|Anticipated|University of Michigan||8|||f||||f||||||||No||2017-10-10 22:29:21.766256|2017-10-10 22:29:21.766256
NCT02676635|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-02-08|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|SAVE||Safety Voice for Ergonomics as a Preventive Approach for Work-related Musculoskeletal Disorders in Masonry Apprentices|National Center for Construction Safety and Health Research and Translation: Safety Voice for Ergonomics|Recruiting||N/A|96|Anticipated|Eastern Washington University||3|||f||||f|f|f||||||Undecided||2017-10-10 22:29:21.880163|2017-10-10 22:29:21.880163
NCT02676622|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2017-02-02|||April 2013||2013-04-01|February 2017|2017-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Autologous Stem Cell Transplant for Refractory Crohn's Disease|A Pilot Study of Autologous Hematopoietic Stem Cell Transplantation With Post-Transplant Ultra Low-Dose IL-2 for Refractory Crohn's Disease|Withdrawn||Phase 2|0|Actual|Nationwide Children's Hospital||1||PI moved to a different institution.|f||||t||||||||||2017-10-10 22:29:21.967549|2017-10-10 22:29:21.967549
NCT02676609|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-11-28|||February 2016||2016-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|GLUCAL||Impact of Food Carbohydrate and Insulin Dose Computing by on Smart Phone on Glucose Control in Patients With Diabetes|Assessment of the Impact of Food Carbohydrate and Insulin Dose Computing by an Application on Smart Phone on Glucose Control in Patients With Type 1 Diabetes|Completed||N/A|30|Actual|University Hospital, Montpellier||2|||f||||f||||||||Undecided||2017-10-10 22:29:22.064396|2017-10-10 22:29:22.064396
NCT02676596|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-11|||April 2014||2014-04-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects||Completed||Phase 1|120|Actual|Kowa Research Institute, Inc.||6|||f||||t||||||||||2017-10-10 22:29:22.162035|2017-10-10 22:29:22.162035
NCT02676583|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2017-05-28|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effectiveness of Tonsil Fossa Closure in Pain Relief After Tonsillectomy in Children|Effectiveness of Tonsil Fossa Closure in Pain Relief After Tonsillectomy in Children: Randomized Clinical Trial, Double-blind, Controlled Study|Active, not recruiting||N/A|131|Anticipated|Clinica Olfact||3|||f||||||||||||||2017-10-10 22:29:22.283572|2017-10-10 22:29:22.283572
NCT02676570|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-06|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method|Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method - Retrospective Study Using Residual Storage Tissue Specimen|Not yet recruiting||N/A|50|Anticipated|Seoul St. Mary's Hospital|||1||f||||f||||||Samples Without DNA|"     Study specimen : Tissue Study content analysis: To determine fungal species and genetic     mutations associated with drug resistance by extracting fungal DNA, but not patients' genetic     information   "|No||2017-10-10 22:29:22.402949|2017-10-10 22:29:22.402949
NCT02676557|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-02-05|||April 2014||2014-04-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01|6 Months|Observational [Patient Registry]|||The Lamina Cribrosa (LC) Changes in the Eyes After Laser-Assisted in Situ Keratomileusis (LASIK)|The Lamina Cribrosa (LC) Morphologic Changes in the Eyes After Laser-Assisted in Situ Keratomileusis (LASIK)|Completed||N/A|40|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:29:22.474573|2017-10-10 22:29:22.474573
NCT02676544|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2017-04-10|||December 2015||2015-12-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)|Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)|Recruiting||Phase 1/Phase 2|50|Anticipated|Rhode Island Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:29:22.554083|2017-10-10 22:29:22.554083
NCT02676531|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-02-05|||November 2015||2015-11-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Walking Meditation Exercise in Breast Cancer Patients|Effects of Walking Meditation on Vascular Function in Breast Cancer Patients Receiving Anthracyclines Chemotherapy|Enrolling by invitation||N/A|36|Actual|Chulalongkorn University||2|||f||||t||||||||Undecided||2017-10-10 22:29:23.164247|2017-10-10 22:29:23.164247
NCT02676505|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-02-04|||November 2015||2015-11-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01|6 Months|Observational [Patient Registry]|RCT||Effect of the Length of Second Stage of Labor in Primigravidae on Maternal & Neonatal Outcomes|Effect of the Length of Second Stage of Labor in Primigravidae on Maternal & Neonatal Outcomes|Active, not recruiting||Phase 4|434|Anticipated|Kasr El Aini Hospital|||2||f||||t||||||||||2017-10-10 22:29:23.396915|2017-10-10 22:29:23.396915
NCT02676492|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-08-17|||March 2016|Actual|2016-03-01|August 2016|2016-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||A Naturalistic Study Investigating Sleep and Cognitive Learning in Children With and Without Tic Disorders|A Naturalistic Study Investigating Sleep and Cognitive Learning in Children With and Without Tic Disorders|Completed||N/A|32|Actual|King's College London|||2||f||||f||||||||||2017-10-10 22:29:23.473286|2017-10-10 22:29:23.473286
NCT02676479|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-05-27|||February 2016||2016-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Uterine Irrigation Method in Infertility Patients Who Require PGD|The Histological and Genetic Investigation of Cells, Fluid and Tissue in the Uterine Cavity, Using the Uterine Irrigation Method, in Patients Who Suffer From Unexplained Infertility and Hereditary Genetic Disease, and Who Require PGD Scans.|Enrolling by invitation||N/A|30|Anticipated|Istanbul University||1|||f||||f||||||||No||2017-10-10 22:29:23.571512|2017-10-10 22:29:23.571512
NCT02676271|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-02-05|||March 2015||2015-03-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Observational|||The Long Term Outcome of Varus Derotational Osteotomy for Legg-Calvé-Perthes' Disease|The Long Term Outcome of Varus Derotational Osteotomy for Legg-Calvé-Perthes' Disease|Completed||N/A|35|Actual|Assaf-Harofeh Medical Center|||1||f||||||||||||||2017-10-10 22:29:25.461935|2017-10-10 22:29:25.461935
NCT02676466|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-06-02|||February 2016||2016-02-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ENRGISE||The ENRGISE Pilot Study|The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study|Recruiting||Phase 2|300|Anticipated|University of Florida||6|||f||||t|t|f||||||Yes|The investigator will make the data and associated documentation available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for ENRGISE study approved research purposes and not to identify any individual human participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.|2017-10-10 22:29:23.655141|2017-10-10 22:29:23.655141
NCT02676453|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-05|||September 2014||2014-09-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Dental Hygienist Support Promotes Good Oral Health in Nursing Homes|Dental Hygienist Support Promotes Good Oral Health in Nursing Homes|Completed||N/A|31|Actual|Public Dental Health, Varmland||2|||f||||f||||||||No||2017-10-10 22:29:23.805593|2017-10-10 22:29:23.805593
NCT02676440|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-02-03|||July 2015||2015-07-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||A Study to Measure the Effect of a Toothpaste and Serum or a Standard Fluoride Toothpaste on Gingival Health Over a Six Month Period.|A Study to Measure the Effect of a Toothpaste Containing Zinc Citrate Trihydrate Used in Combination With a Serum Containing Zinc Sulphate Heptahydrate and a Standard Fluoride Toothpaste on Gingival Health Over a Six Month Period.|Active, not recruiting||Phase 3|250|Anticipated|Unilever R&D||2|||f||||f||||||||||2017-10-10 22:29:23.87299|2017-10-10 22:29:23.87299
NCT02676427|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-25|||September 2015||2015-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|FRIEND||Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination|"Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination - FRIEND Study"|Recruiting||N/A|60|Anticipated|Charles University, Czech Republic|||1||f||||f||||||||No||2017-10-10 22:29:23.95594|2017-10-10 22:29:23.95594
NCT02676414|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-02-05|||August 2015||2015-08-01|February 2016|2016-02-01||||July 2016|Anticipated|2016-07-01||Interventional|||Validation of a Hypertension Education Program|"Validation of the Hypertension Education Program of the German Hypertension League (DHL©) My Blood Pressure - OK!"|Recruiting||N/A|134|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 22:29:24.049312|2017-10-10 22:29:24.049312
NCT02676401|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-09-15|||February 2016||2016-02-01|September 2017|2017-09-01||||August 2017|Actual|2017-08-01||Interventional|||An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy||Completed||Phase 2|241|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-10-10 22:29:24.128509|2017-10-10 22:29:24.128509
NCT02676388|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-03-13|||June 2015||2015-06-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Freeze-dried vs Fresh Fecal Microbiota Transplantation in Patients With Slow Transit Constipation|Freeze-dried vs Fresh Fecal Microbiota Transplantation in Patients With Slow Transit Constipation: a Randomized Controlled Study|Recruiting||Phase 2|50|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 22:29:24.206425|2017-10-10 22:29:24.206425
NCT02676375|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-07-12|||January 2014||2014-01-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment|Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment|Completed||Phase 4|45|Actual|Brentwood Biomedical Research Institute||3|||f||||f||||||||||2017-10-10 22:29:24.303006|2017-10-10 22:29:24.303006
NCT02676362|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-08|||March 2008||2008-03-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Methodological Evaluation of Gingival Crevicular Fluid Volume and Elastase Level|Methodological Evaluation of Gingival Crevicular Fluid Volume and Elastase Levels: Sequential Sampling, Length of Sampling Time And Two Different Sampling Methods|Completed||N/A|20|Actual|Baskent University||3|||f||||t||||||||Yes||2017-10-10 22:29:24.382435|2017-10-10 22:29:24.382435
NCT02676336|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-09-21|||February 2016||2016-02-01|September 2017|2017-09-01||||January 2018|Anticipated|2018-01-01||Interventional|||A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness||Active, not recruiting||N/A|120|Anticipated|BioPharmX, Inc.||3|||f||||||||||||||2017-10-10 22:29:24.636862|2017-10-10 22:29:24.636862
NCT02676323|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-06-07|||May 3, 2016|Actual|2016-05-03|April 2017|2017-04-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome|A Phase I and Dose Expansion Cohort Study of Panobinostat in Combination With Fludarabine and Cytarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome|Recruiting||Phase 1|36|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-10 22:29:24.929419|2017-10-10 22:29:24.929419
NCT02676310|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2017-03-15|||March 2016||2016-03-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)|Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Bimatoprost Topical Solution in the Treatment of Androgenetic Alopecia in Men|Terminated||Phase 1|53|Actual|Allergan||5|||f||||t||||||||||2017-10-10 22:29:25.120802|2017-10-10 22:29:25.120802
NCT02676297|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-04|2016-07-13|||January 2016||2016-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products|Phase I Randomised, Three-period Cross-over Study in Healthy Male and Female Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Two Test Products With Spiriva Respimat Comparator Product|Completed||Phase 1|26|Actual|3M||3|||f||||t||||||||Yes|will share summary data|2017-10-10 22:29:25.256566|2017-10-10 22:29:25.256566
NCT02676258|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2016-07-05|||June 2015||2015-06-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Clinical Comparison of Two Daily Disposable Silicone Hydrogel Soft Contact Lens|A Prospective Randomized Controlled Study to Evaluate the Clinical Performance of Si-Hy Silicone Hydrogel Soft Contact Lens|Completed||N/A|60|Actual|Visco Vision Inc.||2|||f||||f||||||||No||2017-10-10 22:29:25.546492|2017-10-10 22:29:25.546492
NCT02676245|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-02-03|||September 2013||2013-09-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Parent Education and Choice About Newborn Screening and Bloodspot Retention|Parent Education and Choice About Newborn Screening and Bloodspot Retention|Completed||N/A|664|Actual|University of Utah||3|||f||||f||||||||||2017-10-10 22:29:25.63694|2017-10-10 22:29:25.63694
NCT02676232|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-01|||September 2014||2014-09-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||DARWeb: an Online Psychosocial Intervention for Children With Recurrent Abdominal Pain and Their Families.|DARWeb: an Online Psychosocial Intervention for Children With Recurrent Abdominal Pain and Their Families.|Recruiting||N/A|70|Anticipated|Universitat Oberta de Catalunya||2|||f||||f||||||||No||2017-10-10 22:29:25.728436|2017-10-10 22:29:25.728436
NCT02676219|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-02-03|||July 2015||2015-07-01|February 2016|2016-02-01||||October 2015|Actual|2015-10-01||Interventional|||Pilot Study Utilising an Impression Technique to Capture in Vivo Images of Teeth|Pilot Study to Investigate the Reparative Effect of a Two Phase Oral Care Product Containing Containing Sodium Monofluorophosphate and Sodium Fluoride on Enamel Against a Dietary Acid Exposure Utilising an Impression Technique to Capture in Vivo Images of Teeth|Completed||Phase 3|10|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-10 22:29:25.850712|2017-10-10 22:29:25.850712
NCT02676206|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-08|||February 2016||2016-02-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Music Therapy in Procedural Sedation in the Emergency Department|Music Therapy in Procedural Sedation in the Emergency Department|Not yet recruiting||N/A|60|Anticipated|University of New Mexico||2|||f||||t||||||||No||2017-10-10 22:29:25.941012|2017-10-10 22:29:25.941012
NCT02676193|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-01|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|CASA||Effect of Packaging on Smoking Perceptions and Behavior|Effect of Packaging on Smoking Perceptions and Behavior: A Randomized Trial|Recruiting||N/A|450|Anticipated|University of California, San Diego||3|||f||||f||||||||||2017-10-10 22:29:26.044487|2017-10-10 22:29:26.044487
NCT02676180|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-06-20|||March 2016||2016-03-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01|1 Month|Observational [Patient Registry]|DETECT I||Detecting Bladder Cancer Using the UroMark Test.|A Prospective Observational Study to Determine the Negative Predictive Value of UroMark to Rule Out the Presence of Bladder Cancer in Patients With Haematuria.|Active, not recruiting||N/A|3700|Actual|University College, London|||1||f||||f||||||Samples With DNA|"     Urine will be collected for analysis using UroMark assay.   "|No||2017-10-10 22:29:26.133362|2017-10-10 22:29:26.133362
NCT02676167|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-05-02|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|SOPHOCLES||Public Health Targeting of PrEP at HIV Positives' Bridging Networks|Public Health Targeting of PrEP at HIV Positives' Bridging Networks|Recruiting||N/A|250|Anticipated|University of Chicago||1|||f||||f|f|f||||||||2017-10-10 22:29:26.223661|2017-10-10 22:29:26.223661
NCT02676154|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-11-01|||February 2016||2016-02-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|February 2017|Anticipated|2017-02-01||Interventional|||Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)|A Phase II, Open-Label Exploratory Study Investigating the Efficacy of Toviaz for Treatment of Adult Patients With Spinal Cord Injury With Neurogenic Detrusor Overactivity for Amelioration of Autonomic Dysreflexia(PIIR-AK-TOVIAZ-AD)|Recruiting||Phase 2|20|Anticipated|University of British Columbia||1|||f||||t||||||||Undecided|Data collected during the study will be used by the investigator to communicate results of the study to the research community. Data will mostly be communicated as a pooled data set; in the event that individual participant data is communicated, it will be represented with the unique study identifier which does not identify the individual participant.|2017-10-10 22:29:26.316063|2017-10-10 22:29:26.316063
NCT02676141|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-11-03|||January 2016||2016-01-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Responsiveness of the German Version of the Neck Disability Index (NDI-G)|Responsiveness of the German Version of the Neck Disability Index (NDI-G)|Recruiting||N/A|50|Anticipated|Balgrist University Hospital|||1||f||||f||||||||No||2017-10-10 22:29:26.416277|2017-10-10 22:29:26.416277
NCT02676128|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-04-10|||March 2016||2016-03-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Mobile Health Application to Improve HIV Medication Adherence|Mobile Health Application to Improve HIV Medication Adherence|Recruiting||N/A|80|Anticipated|Rhode Island Hospital||2|||f||||t||||||||||2017-10-10 22:29:26.491948|2017-10-10 22:29:26.491948
NCT02676115|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-08-04|||February 2015||2015-02-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Medipore Tape Study|The Use of Wound Taping Protocol to Improve Cosmetic Scar After Anterior Cruciate Ligament (ACL) Reconstruction|Completed||N/A|60|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:29:26.591927|2017-10-10 22:29:26.591927
NCT02676102|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-01-26|||February 2015||2015-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||RCT Comparing Tailored Versus Targeted Organ Donation Video Education|Community Based Research to Improve Organ Donor Registration Among Black Men - Aim 2 Randomized Trial Comparing Tailored Versus Targeted Videos.|Recruiting||N/A|1338|Anticipated|New York University School of Medicine||3|||f||||f||||||||||2017-10-10 22:29:26.687872|2017-10-10 22:29:26.687872
NCT02676089|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-10-13|||March 2016||2016-03-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|TRIGGER||TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)|A 52 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 3-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 200/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRRONIUM BROMIDE) TO CHF 1535 200/6 µg pMDI (FIXED COMBINATION OF EXTRAFINE BECLOMETHASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE) ALONE OR ON TOP OF OPEN-LABEL TIOTROPIUM 2.5 µg RESPIMAT® IN PATIENTS WITH ASTHMA UNCONTROLLED ON HIGH DOSES OF INHALED CORTICOSTEROIDS IN COMBINATION WITH LONG-ACTING ß2-AGONISTS|Recruiting||Phase 3|1435|Anticipated|Chiesi Farmaceutici S.p.A.||3|||f||||t||||||||||2017-10-10 22:29:26.784085|2017-10-10 22:29:26.784085
NCT02676076|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-10-13|||February 2016||2016-02-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TRIMARAN||TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA|A 52 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 2-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 100/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRRONIUM BROMIDE) TO CHF 1535 100/6 µg pMDI (FIXED COMBINATION OF EXTRAFINE BECLOMETHASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE) IN PATIENTS WITH ASTHMA UNCONTROLLED ON MEDIUM DOSES OF INHALED CORTICOSTEROIDS IN COMBINATION WITH LONG ACTING ß2 AGONISTS|Recruiting||Phase 3|1148|Anticipated|Chiesi Farmaceutici S.p.A.||2|||f||||t||||||||||2017-10-10 22:29:26.870483|2017-10-10 22:29:26.870483
NCT02676063|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-04-10|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Observational|LyTONEPAL||Long Term Prognostic of Neonatal Hypoxic Ischemic Encephalopathy With Hypothermia Treatment|Long Term Prognostic of Neonatal Hypoxic Ischemic Encephalopathy in the Era of Neuroprotective Treatment With Hypothermia|Recruiting||N/A|800|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 22:29:26.960185|2017-10-10 22:29:26.960185
NCT02676050|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-05-02|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|DUAL||Visualising c-MET and Activated Neutrophils in Lung Cancer|Exploratory Study to Optically Visualise Activated Neutrophils and the Proto-oncogene, c-MET, in Lung Cancer Using DUAL Colour Fibre-based Endomicroscopy|Not yet recruiting||Phase 1|20|Anticipated|University of Edinburgh||1|||f||||t|f|f||||||No||2017-10-10 22:29:27.116817|2017-10-10 22:29:27.116817
NCT02676037|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-02|||February 2016||2016-02-01|February 2016|2016-02-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01|9 Months|Observational [Patient Registry]|||Diagnosis of Hallux Valgus by Using a Foot Pressure Platform as an Alternative to Radiological Images||Not yet recruiting||N/A|70|Anticipated|University of Dundee|||1||f||||||||||||Undecided||2017-10-10 22:29:27.197346|2017-10-10 22:29:27.197346
NCT02676024|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-08-10|||July 5, 2017|Actual|2017-07-05|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|CONTOUR||Consolidating Tools for Outcomes in Resuscitation|Consolidating Tools for Outcomes in Resuscitation (CONTOUR)|Recruiting||N/A|456|Anticipated|Ottawa Hospital Research Institute||4|||f||||t|f|f||||||||2017-10-10 22:29:27.253035|2017-10-10 22:29:27.253035
NCT02676011|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-09-25|||February 2016||2016-02-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Brad Arrhythmia Induced by Repeated Succinylcholine During Gynecological Laparoscopic Surgery|Prevention of Brad Arrhythmia Induced by Repeated Succinylcholine by Atropine Sulfate During Gynecological Laparoscopic Surgery: a Randomized Controlled Trial|Completed||Phase 2|120|Actual|Assiut University||4|||f||||t||||||||Undecided||2017-10-10 22:29:27.359184|2017-10-10 22:29:27.359184
NCT02675998|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-01-29|||January 2016||2016-01-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Interventional|||An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)|An 8-week, Multicenter, Randomized, Double-Blind, Parallel Group Study With a 4-week, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Efficacy, Safety, and Tolerability of Tenapanor to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)|Completed||Phase 3|219|Actual|Ardelyx||4|||f||||f||||||||||2017-10-10 22:29:27.46639|2017-10-10 22:29:27.46639
NCT02675985|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-06-19|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Early Intensive Physical Therapy in Subarachnoid Hemorrhage|Effects of Early Intensive Physical Therapy for Patients With Subarachnoid Hemorrhage in a Neurological ICU|Recruiting||N/A|40|Anticipated|University of Colorado, Denver||1|||f||||f||||||||No||2017-10-10 22:29:27.620678|2017-10-10 22:29:27.620678
NCT02675972|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-05-15|||January 2014||2014-01-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Observational|BPV||Which Parameters of Short-term Blood Pressure Variability Best Predict Early Outcomes in Acute Ischemic Stroke|Association of 24-hour Blood Pressure Variability With Early Outcomes in Patients With Acute Non Cardiogenic Ischemic Stroke|Completed||N/A|260|Actual|Dongguan People's Hospital|||2||f||||t||||||Samples Without DNA|"     fasting glucose, creatine, BNP, CRP,BUN,cholesterol, LDL,HDL   "|No|Under regulations of local ethic committee, data concerning individual privacy are not allowed to release.|2017-10-10 22:29:27.719274|2017-10-10 22:29:27.719274
NCT02675959|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-05|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|NYMC-571||Myeloablative Conditioning and Haplo AlloSCT for Patients With Sickle Cell Disease|Safety and Efficacy of Prophylactic Defibrotide in Patients With Sickle Cell Disease Following Myeloablative Conditioning and Haploidentical Stem Cell Transplantation|Recruiting||Phase 2|40|Anticipated|New York Medical College||1|||f||||t|t|f||||||Undecided||2017-10-10 22:29:27.787852|2017-10-10 22:29:27.787852
NCT02675946|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-02-20|||February 2016||2016-02-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of CGX1321 in Subjects With Advanced Solid Tumors|A Phase 1 Open-label Dose Escalation Study of CGX1321 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|71|Anticipated|Curegenix Inc.||1|||f||||f||||||||No||2017-10-10 22:29:27.883508|2017-10-10 22:29:27.883508
NCT02675933|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-11-04|||February 2016||2016-02-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|ASD||Satisfaction Rates Among Parents of Children With Autism in the ED|What Factors Effect Parental Satisfaction During Their Visit to a Pediatric Emergency Department Among Parents of Children With Autism?|Recruiting||N/A|116|Anticipated|Seton Healthcare Family||2|||f||||t||||||||No||2017-10-10 22:29:27.986036|2017-10-10 22:29:27.986036
NCT02675920|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-05-30|||November 2014||2014-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Study of HCC High Risk Group Using Two Surveillance Tools|A Prospective Cohort Study to Compare Contrast Enhanced Liver CT and Ultrasonography for Hepatocellular Carcinoma Surveillance in High-risk Group of HCC: Preliminary Study|Active, not recruiting||N/A|139|Actual|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 22:29:28.088275|2017-10-10 22:29:28.088275
NCT02675907|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-08-31|2017-07-24||January 2016||2016-01-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation of N1539 Following Bunionectomy Surgery|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of N1539 Following Bunionectomy|Completed||Phase 3|201|Actual|Recro Pharma, Inc.||2|||f||||f||||||||||2017-10-10 22:29:28.178733|2017-10-10 22:29:28.178733
NCT02675894|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-04-04|||November 2013||2013-11-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|January 2016|Actual|2016-01-01||Interventional|||Radiofrequency Ablation Using Cooled-Wet Electrode|Switching Bipolar Radiofrequency Ablation Using Cooled-Wet Electrode for Treatment of Hepatocellular Carcinoma: A Preliminary Study|Active, not recruiting||N/A|77|Actual|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 22:29:29.033734|2017-10-10 22:29:29.033734
NCT02675881|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-12-05|||July 2013||2013-07-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|July 2015|Actual|2015-07-01||Interventional|||Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®)|Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®) for Treatment of Focal Liver Malignancies: A Preliminary Study|Active, not recruiting||N/A|60|Actual|Seoul National University Hospital||2|||f||||t||||||||Yes||2017-10-10 22:29:29.128187|2017-10-10 22:29:29.128187
NCT02675868|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-10-12|||January 2016||2016-01-01|April 2016|2016-04-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Effects of Vasopressors on Immune Response|The Effects of Different Vasopressors on the Innate Immune Response During Experimental Human Endotoxemia, a Pilot Proof-of-principle Study|Completed||Phase 4|40|Actual|Radboud University||4|||f||||f||||||||No||2017-10-10 22:29:29.362755|2017-10-10 22:29:29.362755
NCT02675855|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-07-12|||January 2016||2016-01-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers|A Multicenter, Randomized, Single-Blind Study Comparing the Efficacy of GrafixPRIME® to Active Comparator for the Treatment of Chronic Diabetic Foot Ulcers|Completed||Phase 4|75|Actual|Osiris Therapeutics||2|||f||||f||||||||||2017-10-10 22:29:29.528198|2017-10-10 22:29:29.528198
NCT02675842|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-04|||February 2016||2016-02-01|January 2016|2016-01-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Investigation of Cannabis for Pain and Inflammation in Lung Cancer|Investigation of Cannabis for Pain and Inflammation in Lung Cancer|Not yet recruiting||Phase 1|30|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-10 22:29:29.695268|2017-10-10 22:29:29.695268
NCT02675829|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-08-09|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers|A Phase 2 Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers|Recruiting||Phase 2|100|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-10 22:29:29.817596|2017-10-10 22:29:29.817596
NCT02675816|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-08-10|||August 2015||2015-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|RCT||Inspire® Upper Airway Stimulation System|Inspire® Upper Airway Stimulation System: Randomized Control Trial / European Post-Market Study|Terminated||Phase 4|16|Actual|Inspire Medical Systems, Inc.||1||"Study halted due to low recruitment. Reimbursement changes require a larger study with   additional centers and therefore, a new study planned as replacement."|f||||f||||||||Yes||2017-10-10 22:29:29.94584|2017-10-10 22:29:29.94584
NCT02675803|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-28|||December 2010||2010-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients|A Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of VAY736 in Rheumatoid Arthritis Patients|Active, not recruiting||Phase 2|65|Actual|Novartis||2|||f||||f||||||||||2017-10-10 22:29:30.159923|2017-10-10 22:29:30.159923
NCT02675790|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-03-24|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|SPRINT||Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa|Hydroxyurea for Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa|Recruiting||Phase 3|60|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||No||2017-10-10 22:29:30.287397|2017-10-10 22:29:30.287397
NCT02675764|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-03-31|||January 2016||2016-01-01|March 2017|2017-03-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|||Sensory Stimulation to Enhance Hand Function Post Stroke|Sensory Stimulation to Enhance Hand Function Post Stroke|Completed||N/A|14|Actual|Medical University of South Carolina||2|||f||||f||||||||No||2017-10-10 22:29:30.544228|2017-10-10 22:29:30.544228
NCT02675751|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-08-10|||February 3, 2016|Actual|2016-02-03|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced Wavescan Studio™ System and Star S4 IR™|A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-guided PRK Correction of Myopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and the Star S4 IR™ Excimer Laser System|Active, not recruiting||N/A|334|Anticipated|Abbott Medical Optics||1|||f||||f|f|t|t|f||||||2017-10-10 22:29:30.679794|2017-10-10 22:29:30.679794
NCT02675738|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-02-04|||December 2015||2015-12-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Observational|NCP-1||Reliability of the Preoperative Work-up in Patients Submitted to Surgery for Cystic Neoplasms of the Pancreas|Reliability of the Preoperative Work-up in a Prospective Series of Patients Submitted to Surgery for Cystic Neoplasms of the Pancreas|Recruiting||N/A|150|Anticipated|Universita di Verona|||1||f||||||||||||||2017-10-10 22:29:30.764675|2017-10-10 22:29:30.764675
NCT02675725|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-03-23|||November 2015||2015-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Kinetics of the Sublingual Microcirculation During Fluid Bolus|Kinetics of the Sublingual Microcirculation During the Treatment of a Postoperative Shock|Recruiting||N/A|25|Anticipated|Medical Centre Leeuwarden|||1||f||||f||||||||No||2017-10-10 22:29:30.844875|2017-10-10 22:29:30.844875
NCT02675712|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-02-04|||April 2015||2015-04-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Observational|||Effect of African Drumming in Mood Disorders|The Effect of African Drumming on on Mental Well-being Among Adults With Acute Mood Disorder|Completed||N/A|13|Actual|University of Stellenbosch|||1||f||||f||||||||No||2017-10-10 22:29:30.963828|2017-10-10 22:29:30.963828
NCT02675699|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-12-02|||October 2015||2015-10-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|OFTEN||The Optimising Family Engagement in HENRY (OFTEN) Study|Effectiveness of an Implementation Optimisation Intervention Aimed at Increasing Parent Engagement in HENRY, a Childhood Obesity Prevention Programme: a Cluster Randomised Controlled Trial|Recruiting||Phase 3|864|Anticipated|University of Leeds||2|||f||||f||||||||Undecided|Data IP is held with the HENRY organisation|2017-10-10 22:29:31.049078|2017-10-10 22:29:31.049078
NCT02675686|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-02-02|||December 2010||2010-12-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|BIOMAN||Amniotic Biomarkers in the Prediction of Postpartum Renal Function.|Amniotic Biomarkers Research for Prediction of Postnatal Renal Function in Fetus With a Bilateral Abnormal Renal Development: National, Multicenter, Prospective and Non-interventional Study of Diagnostic Validation.|Active, not recruiting||N/A|358|Actual|University Hospital, Toulouse||2|||f||||f||||||||Undecided||2017-10-10 22:29:31.150341|2017-10-10 22:29:31.150341
NCT02675673|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-06-21|||September 2011||2011-09-01|June 2016|2016-06-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Feeding Tube in Cancer Patients|A Randomized Comparison of Enteral Feeding for Head and Neck (HNC) Cancer Patients|Withdrawn||N/A|0|Actual|University Health Network, Toronto||2||Logistical issues|f||||t||||||||||2017-10-10 22:29:31.298808|2017-10-10 22:29:31.298808
NCT02675660|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-09-06|||April 2014||2014-04-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|April 2015|Actual|2015-04-01||Interventional|||Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects|Study to Evaluate the Safety, Tolerability, Kinetics, and Dynamics of Single and Multiple Doses of an Oral Formulation of L-Homoarginine|Completed||Phase 1|20|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||No||2017-10-10 22:29:31.375567|2017-10-10 22:29:31.375567
NCT02675647|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2016-02-04|||December 2015||2015-12-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|HEPOIRINE||Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients|Heparin Management for Cardiopulmonary Bypass in Cardiac Surgery: A Prospective, Comparative and Randomized Study Evaluating a Dosage Based on the Ideal Body Weight in Obese Patients|Recruiting||Phase 4|60|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 22:29:31.468059|2017-10-10 22:29:31.468059
NCT02675621|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-04|||October 2015||2015-10-01|February 2016|2016-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults|Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults|Recruiting||N/A|46|Anticipated|PepsiCo Global R&D||4|||f||||f||||||||Undecided||2017-10-10 22:29:31.957927|2017-10-10 22:29:31.957927
NCT02675608|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-01-12|||August 2015||2015-08-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Observational|||Vaccine Efficacy in Diabetic and Elderly Patients|Vaccine Efficacy in Diabetic and Elderly Patients|Completed||N/A|164|Actual|Tulane University|||9||f||||f||||||Samples Without DNA|"     plasma, serum, PBMCs, urine, saliva   "|||2017-10-10 22:29:32.058715|2017-10-10 22:29:32.058715
NCT02675595|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-04|||January 2016||2016-01-01|January 2016|2016-01-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01|1 Day|Observational [Patient Registry]|||5D Versus Conventional 2D Fetal Echocardiography During Second Trimester of Pregnancy|Prospective Evaluation of Fetal Intelligent Navigation Echocardiography (FINE)(5D) Versus Conventional 2D Echocardiography in Comprehensive Fetal Cardiac Imaging in the Second Trimester of Pregnancy|Recruiting||N/A|80|Anticipated|Ain Shams University|||1||f||||f||||||||Undecided||2017-10-10 22:29:32.165536|2017-10-10 22:29:32.165536
NCT02675582|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-04|||June 2015||2015-06-01|February 2016|2016-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Investigation of the Acute Calming Effects of Drinks Containing Herbal Extracts in Healthy Adults|Investigation of the Acute Calming Effects of Drinks Containing Herbal Extracts in Healthy Adults|Recruiting||N/A|72|Anticipated|PepsiCo Global R&D||4|||f||||f||||||||Undecided||2017-10-10 22:29:32.241718|2017-10-10 22:29:32.241718
NCT02675569|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-27|||May 2016||2016-05-01|October 2016|2016-10-01|November 2021|Anticipated|2021-11-01|May 2019|Anticipated|2019-05-01||Interventional|ACCESS HD||ACCESS HD: Comparing Catheters to Fistulas in Elderly Patients Starting Hemodialysis|ACCESS HD Pilot: A Randomized Trial Comparing Catheters to Fistulas in Elderly patientS Starting HemoDialysis|Recruiting||N/A|100|Anticipated|University of Calgary||2|||f||||f||||||||No||2017-10-10 22:29:32.353651|2017-10-10 22:29:32.353651
NCT02675556|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-08-25|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|June 2025|Anticipated|2025-06-01|March 2024|Anticipated|2024-03-01||Interventional|ANU||Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression|A Phase I, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Treatment Resistant Depression.|Recruiting||Phase 1|88|Anticipated|University of Miami||3|||f||||t|t|f||||||||2017-10-10 22:29:32.531112|2017-10-10 22:29:32.531112
NCT02675543|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-01|2017-05-01||June 2015||2015-06-01|May 2017|2017-05-01||||December 2015|Actual|2015-12-01||Interventional|||Vitreous Inflammation in Standard and Heavy Silicone Oil||Completed||N/A|70|Actual|Università degli Studi di Brescia||2|||f||||f||||||||||2017-10-10 22:29:32.638841|2017-10-10 22:29:32.638841
NCT02675530|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-02-04|||December 2007||2007-12-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism|Parallel Effects of Ketamine and Schizophrenia on Neurocognitive Function|Completed||Phase 1|33|Actual|Yale University||1|||f||||f||||||||||2017-10-10 22:29:32.883299|2017-10-10 22:29:32.883299
NCT02675348|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-05-07|||January 2016||2016-01-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|Beef||Beef Protein Supplementation in Endurance Athletes|Effects of Meat Protein Administration on Body Composition, Strength, Muscle Structure, Immunological and Haematological Markers in Endurance Athletes|Completed||N/A|24|Actual|University of Greenwich||3|||f||||t||||||||Yes||2017-10-10 22:29:36.762594|2017-10-10 22:29:36.762594
NCT02675517|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-04-21|||January 13, 2016|Actual|2016-01-13|April 2017|2017-04-01|April 11, 2017|Actual|2017-04-11|March 10, 2017|Actual|2017-03-10||Observational|||Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice|Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice|Completed||N/A|1750|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 22:29:32.955269|2017-10-10 22:29:32.955269
NCT02675504|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-08-12|||March 2016||2016-03-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Observational|TROUILLOMETRE||Validation of a Scale of Self-assessment of Fear Faces in Children 4 to 12 Years|Validation of a Scale of Self-assessment of Fear Faces in Children 4 to 12 Years: Scary Scale|Recruiting||N/A|483|Anticipated|University Hospital, Limoges|||1||f||||f||||||||No||2017-10-10 22:29:33.026153|2017-10-10 22:29:33.026153
NCT02675465|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-06-26|||January 2016||2016-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221|An Open-Label, Fixed-Sequence, Ascending-Dose, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous Infusions of ATB200 Co-Administered With Oral AT2221 in Adult Subjects With Pompe Disease|Active, not recruiting||Phase 1/Phase 2|18|Anticipated|Amicus Therapeutics||2|||f||||f||||||||||2017-10-10 22:29:33.263147|2017-10-10 22:29:33.263147
NCT02675452|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-06-12|||June 13, 2016|Actual|2016-06-13|June 2017|2017-06-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||AMG 176 First in Human Trial in Subjects With Relapsed or Refractory Multiple Myeloma.|A Phase 1 First in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 176 in Subjects With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1|85|Anticipated|Amgen||3|||f||||f|t|f||||||||2017-10-10 22:29:33.391587|2017-10-10 22:29:33.391587
NCT02675439|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-07-07|||March 2016||2016-03-01|July 2017|2017-07-01||||March 2020|Anticipated|2020-03-01||Interventional|||Study of the Safety and Efficacy of MIW815 (ADU-S100) in Patients With Advanced/Metastatic Solid Tumors or Lymphomas|A Phase I, Open Label, Multicenter Study of the Safety and Efficacy of MIW815 (ADU-S100) Administered by Intratumoral Injection to Patients With Advanced/Metastatic Solid Tumors or Lymphomas|Recruiting||Phase 1|75|Anticipated|Aduro Biotech, Inc.||1|||f||||||||||||||2017-10-10 22:29:33.499671|2017-10-10 22:29:33.499671
NCT02675413|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-07-19|||April 2016||2016-04-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS|Mechanisms of Action of Dimethyl Fumarate in Relapsing MS|Withdrawn||Phase 4|0|Actual|Washington University School of Medicine||1||Principal Investigator decided to withdraw.|f||||f||||||||Undecided|Unclear what results may be available for sharing. We plan to publish group analysis.|2017-10-10 22:29:36.160547|2017-10-10 22:29:36.160547
NCT02675400|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-07|||December 2015||2015-12-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)|Treatments for Fathers With Attention Deficit/Hyperactivity Disorder (ADHD) and Their At-Risk Children (Fathers Too)|Recruiting||Phase 4|22|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||Yes|participants will receive an study report at the end of the study.|2017-10-10 22:29:36.252181|2017-10-10 22:29:36.252181
NCT02675387|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-02-03|||October 2015||2015-10-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy of External Cold and a Vibrating Device in Reducing Discomfort of Dental Injections in Children|Efficacy of External Cold and a Vibrating Device in Reducing Discomfort of Dental Injections in Children - A Split Mouth Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|Riyadh Colleges of Dentistry and Pharmacy||2|||f||||t||||||||Undecided||2017-10-10 22:29:36.36445|2017-10-10 22:29:36.36445
NCT02675374|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-11-15|||June 2016||2016-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HIPPIE||Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation||Recruiting||Phase 3|48|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 22:29:36.47801|2017-10-10 22:29:36.47801
NCT02675361|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-05-30|||July 2016||2016-07-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of a Transition Program for Adolescents With Congenital Heart Disease in the Transition to Adulthood|Effectiveness of a Transition Program to Empower Adolescents With Congenital Heart Disease in the Transition to Adulthood: the STEPSTONES Project|Recruiting||N/A|189|Anticipated|Göteborg University||3|||f||||f||||||||Yes|Coded files will be available only for research purposes. Information will be given after a letter with the intention of the study has been submitted to the Steering Committee who will determine whether to approve or deny the application.|2017-10-10 22:29:36.604887|2017-10-10 22:29:36.604887
NCT02675335|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-09-14|||March 2016||2016-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|SitaDFU||Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin|Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin|Withdrawn||Phase 3|0|Actual|Medical University Innsbruck||2|||f||||t||||||||No||2017-10-10 22:29:36.900637|2017-10-10 22:29:36.900637
NCT02675309|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-03-23|||February 2016||2016-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects||Completed||Phase 1|28|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-10 22:29:37.104464|2017-10-10 22:29:37.104464
NCT02675296|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-04|||September 2015||2015-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Regional and Long Term Outcomes of Acute Kidney Injury in England From 2000 to 2015 - A National Database Study|Regional and Long Term Outcomes of Acute Kidney Injury in England From 2000 to 2015 - A National Database Study|Completed||N/A|54680|Actual|Derby Hospitals NHS Foundation Trust|||1||f||||f||||||||Yes|Data is freely available from HSCIC|2017-10-10 22:29:37.351416|2017-10-10 22:29:37.351416
NCT02675283|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-12-02|||July 2016||2016-07-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting|Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting: A Feasibility Study|Recruiting||N/A|500|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:29:37.452714|2017-10-10 22:29:37.452714
NCT02675270|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-08-08|||August 2011||2011-08-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia||Active, not recruiting||N/A|41|Actual|Georgetown University||1|||f||||||||||||||2017-10-10 22:29:37.582498|2017-10-10 22:29:37.582498
NCT02675257|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-08-08|||July 2015||2015-07-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|DDCT||Depression and Diabetes Control Trial|Depression and Diabetes Control Trial|Recruiting||N/A|212|Anticipated|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||t||||||||No||2017-10-10 22:29:37.696088|2017-10-10 22:29:37.696088
NCT02675244|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-09-14|||May 2016||2016-05-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery|Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery|Recruiting||N/A|400|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|f|f||||||||2017-10-10 22:29:37.929328|2017-10-10 22:29:37.929328
NCT02675218|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-05-29|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|BMA2||Bone MicroArchitecture Abatacept (BMA2)|Bone MicroArchitecture Abatacept in Rheumatoid Arthritis Patients (BMA2)|Recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"     Blood samples will be performed to determine the predictive value of joint inflammation.   "|No||2017-10-10 22:29:38.857207|2017-10-10 22:29:38.857207
NCT02675205|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-02-03|||December 2015|Actual|2015-12-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|TIC-TAC||Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm|Ticagrelor Versus Clopidogrel for Platelet Inhibition in Patients Undergoing Neurovascular Stenting for Intracranial Aneurysm|Recruiting||Phase 3|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 22:29:38.978047|2017-10-10 22:29:38.978047
NCT02675192|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-09-29|||February 2016||2016-02-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|BioAge||Biological Aging of Skeletal Muscles in Humans|Biological Aging of Skeletal Muscles in Humans, a Monocentric, Prospective Study|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"     Urinary and blood samples will be taken, and a muscle biopsy will be performed.   "|No||2017-10-10 22:29:39.077352|2017-10-10 22:29:39.077352
NCT02675179|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-05-29|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PELVI-EOS||EOS® Versus Spiral CT Technique for Achieving a Pelvimetry in Suites of Obstructed Labor.|EOS® Versus Spiral CT Technique for Achieving a Pelvimetry in Suites of Obstructed Labor: Comparative Single-center Prospective Study - PELVIC-EOS.|Recruiting||N/A|64|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||No||2017-10-10 22:29:39.18569|2017-10-10 22:29:39.18569
NCT02675166|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-08-11|||October 2015||2015-10-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Observational|SALTO-2||Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes|SALTO -2 ( Long Term Monitoring In Oncology ) : Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes, Multicentric Study|Recruiting||N/A|544|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 22:29:39.44387|2017-10-10 22:29:39.44387
NCT02675153|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-06-06|||March 1, 2015||2015-03-01|June 2017|2017-06-01|December 30, 2019|Anticipated|2019-12-30|September 2019|Anticipated|2019-09-01||Interventional|||To Evaluate the Efficacy and Safety of Sirolimus for Crohn's Disease With Stenosis|Efficacy and Safety of Sirolimus in the Treatment of Crohn's Disease With Stenosis|Recruiting||Phase 4|50|Anticipated|The Second Hospital of Nanjing Medical University||1|||f||||t||||||||||2017-10-10 22:29:39.568453|2017-10-10 22:29:39.568453
NCT02675140|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-02-04|||March 2012||2012-03-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Hookworm Elimination and Vitamin A Intervention on Iron Status of Preschool Children in Sichuan, China|Chengdu Women's and Children's Central Hospital|Completed||Phase 4|209|Actual|Chengdu Maternal and Children's Health Care Hospital||3|||f||||t||||||||Yes|It is my pleasure to share some data with other researcher who are interested in this theme.|2017-10-10 22:29:39.709897|2017-10-10 22:29:39.709897
NCT02675127|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-03|||December 2015||2015-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)|Open Label, Randomized, Single Dose, Two-way Crossover Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK) in Healthy Human Volunteers Under Fasting Condition.|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||Undecided||2017-10-10 22:29:39.7977|2017-10-10 22:29:39.7977
NCT02675114|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-09-13|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|March 2027|Anticipated|2027-03-01|October 2018|Anticipated|2018-10-01||Interventional|P3||The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis|A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement|Recruiting||N/A|1328|Anticipated|Edwards Lifesciences||2|||f||||t|f|t|f|f||||||2017-10-10 22:29:39.939299|2017-10-10 22:29:39.939299
NCT02675101|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-12|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|NO-POPs||Nuts and Olestra for Persistent Organic Pollutant Reduction (NO-POPs) Trial|Nuts and Olestra for Persistent Organic Pollutant Reduction (NO-POPs) Trial: A Pilot Investigation|Completed||N/A|45|Actual|University of California, San Diego||3|||f||||f||||||||||2017-10-10 22:29:40.372231|2017-10-10 22:29:40.372231
NCT02675088|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-02-05|||March 2016||2016-03-01|February 2016|2016-02-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer|Randomized Phase III Study Comparing Different Thoracic Radiotherapy Regimens in Patients With Extensive Stage Small Cell Lung Cancer Who Respond to Chemotherapy|Not yet recruiting||Phase 3|186|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||No||2017-10-10 22:29:40.555505|2017-10-10 22:29:40.555505
NCT02675075|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-09-21|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS|DESIPHER Speech Degradation as an Indicator of Physiological Degeneration in ALS|Active, not recruiting||N/A|10|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|||||2017-10-10 22:29:40.654968|2017-10-10 22:29:40.654968
NCT02675062|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-05-01|||August 2015||2015-08-01|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Observational|||Habitual Physical Activity and Sedentary Behavior Following Total Knee Arthroplasty|The Effect of Total Knee Arthroplasty on Habitual Physical Activity, Sedentary Behaviour and Health Outcomes in Patients With Osteoarthritis|Completed||N/A|80|Actual|University of Witwatersrand, South Africa|||1||f||||f||||||||No||2017-10-10 22:29:40.755093|2017-10-10 22:29:40.755093
NCT02675049|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-29|||January 2016||2016-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia|Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia|Completed||Phase 2|100|Actual|Tianjin Medical University Cancer Institute and Hospital||4|||f||||t||||||||Undecided||2017-10-10 22:29:40.861659|2017-10-10 22:29:40.861659
NCT02675036|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-01|||September 2014||2014-09-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Interceptive Study of Ectopic Eruption of Permanent Maxillary Canine Teeth|Interceptive Study of Ectopic Eruption of Permanent Maxillary Canine Teeth|Recruiting||N/A|70|Anticipated|University of Tromso||2|||f||||f||||||||||2017-10-10 22:29:40.953026|2017-10-10 22:29:40.953026
NCT02675023|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-04-19|||January 2016||2016-01-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Assessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy Subjects|A Randomized, Open-label, Two-arm, Parallel Group, Single Dose Study to Assess the Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy Subjects|Completed||Phase 1|603|Actual|Momenta Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-10 22:29:41.05206|2017-10-10 22:29:41.05206
NCT02675010|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-03-14|||June 2014||2014-06-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study|Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Multicenter Study|Active, not recruiting||N/A|400|Anticipated|Mansoura University||1|||f||||f||||||||Undecided||2017-10-10 22:29:41.155464|2017-10-10 22:29:41.155464
NCT02674997|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-11-30|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||GAS-Hem Feasibility Study|A New Patient-centric Outcome Measure for Patients With Hemophilia: Testing the Feasibility of GAS-Hem in Pediatric, Adolescent and Adult Hemophilia A Patients|Completed||N/A|44|Actual|Baxalta US Inc.|||1||f||||f||||||||||2017-10-10 22:29:41.237888|2017-10-10 22:29:41.237888
NCT02674984|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-05-04|||May 2016||2016-05-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Road to Discovery for Combination Probiotic BB-12 With LGG in Treating Autism Spectrum Disorder|Road to Discovery for Combination Probiotic BB-12 With LGG in Treating Autism Spectrum Disorder|Recruiting||Phase 1/Phase 2|30|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Undecided||2017-10-10 22:29:41.348113|2017-10-10 22:29:41.348113
NCT02674971|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-07-14|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|Lower CD||Lowering Caloric Density of the Diet||Active, not recruiting||N/A|60|Anticipated|University of Tennessee||2|||f||||||||||||||2017-10-10 22:29:41.468352|2017-10-10 22:29:41.468352
NCT02674958|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-04-24|||May 2016||2016-05-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|August 2020|Anticipated|2020-08-01||Interventional|TROPHIC 3||Mobilization of Endothelial Progenitor Cells and Aspirin|Mobilization of Endothelial Progenitor Cells Following Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Randomized Controlled Trial of Aspirin|Recruiting||Phase 3|20|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||Undecided||2017-10-10 22:29:41.555543|2017-10-10 22:29:41.555543
NCT02674945|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-25|||September 2014||2014-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase|Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase|Recruiting||Phase 2|75|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||No|Individual data will not be shared. De-identified group data will be made available|2017-10-10 22:29:41.660778|2017-10-10 22:29:41.660778
NCT02674932|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-03-15|||February 2016||2016-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Character Strengths Intervention Among Psychiatrically Hospitalized Youth|Assessment of a Character Strengths Intervention in Improving Treatment Outcomes Among Psychiatrically Hospitalized Youth|Enrolling by invitation||N/A|210|Anticipated|University of Michigan||3|||f||||f||||||||No||2017-10-10 22:29:41.739477|2017-10-10 22:29:41.739477
NCT02674919|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-06-24|||February 2016||2016-02-01|March 2016|2016-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Nordic Hamstring and Repeated-sprint Ability in Football (Soccer) Players|The Efficacy of a 10-week Intervention, Using the Nordic Hamstring Exercise, on Repeated-sprint Ability in Football (Soccer) Players - a Randomized Controlled Trial|Completed||N/A|35|Actual|Hvidovre University Hospital||2|||f||||f||||||||No||2017-10-10 22:29:41.815059|2017-10-10 22:29:41.815059
NCT02674906|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-07-12|||February 2016||2016-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|HECICS||Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)|Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes. Heparin vs Citrate in Cellsaver (HECICS).|Recruiting||N/A|50|Anticipated|Ziekenhuis Oost-Limburg||2|||f||||f||||||||Undecided||2017-10-10 22:29:41.901642|2017-10-10 22:29:41.901642
NCT02674893|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-04|||February 2014||2014-02-01|February 2016|2016-02-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|GLP1 et Goût||Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes|Comparative Study of Gustatory Performance, Sensory Specific Satiation, Liking and Wanting in Patients With Type 2 Diabetes|Recruiting||Phase 4|||Centre Hospitalier Universitaire Dijon||3|||f||||||||||||||2017-10-10 22:29:41.98476|2017-10-10 22:29:41.98476
NCT02674880|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-02|||March 2016||2016-03-01|February 2016|2016-02-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|HAEC-DONA||Hyaluronic Acid in Acute Exacerbation of COPD - Duration Of Noninvasive Assistance|Use of High-molecular Weight Hyaluronan in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Diseases Treated With Non-invasive Ventilation: Feasibility and Outcomes|Not yet recruiting||Phase 2|80|Anticipated|Campus Bio-Medico University||2|||f||||f||||||||Undecided||2017-10-10 22:29:42.190219|2017-10-10 22:29:42.190219
NCT02674867|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-08-18|||June 2016||2016-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CLEAC||CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)|ANRS EP59 CLEAC : Physiopathological Study of Immunovirological Evolution of Perinatally HIV-1 Infected Children Depending on Early (Before 6 Months) or Late (After 2 Years) Antiretroviral Therapy Introduction.|Recruiting||N/A|80|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||f||||||||||2017-10-10 22:29:42.289121|2017-10-10 22:29:42.289121
NCT02674854|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-07-25|||February 2016||2016-02-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension||Completed||Phase 3|750|Actual|Aerie Pharmaceuticals||3|||f||||||||||||||2017-10-10 22:29:42.417441|2017-10-10 22:29:42.417441
NCT02674841|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-16|||February 2016||2016-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Live Feedback to Increase Adherence in Adolescents With Patellofemoral Pain|Efficacy of Live Feedback to Increase Objectively Monitored Adherence to Prescribed, Home-based, Exercise Therapy-dosage in 15 to 19 Year Old Adolescents With Patellofemoral Pain. A Randomized Controlled Superiority Trial|Completed||N/A|40|Actual|Aalborg University||2|||f||||f||||||||Yes|No later than 1 year after the final follow-up, a completely anonymised data set to an appropriate data archive for sharing purposes will be delivered.|2017-10-10 22:29:42.513962|2017-10-10 22:29:42.513962
NCT02674828|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-12-05|||January 2016||2016-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Physical Activity and Glycemic Control in Adolescents|Physical Activity and Glycemic Control in Adolescents|Recruiting||N/A|60|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-10 22:29:42.613765|2017-10-10 22:29:42.613765
NCT02674815|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-05-17|||February 2016||2016-02-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PHIIT||Preoperative High Intensity Interval Training: The PHIIT Trial|Preoperative High Intensity Interval Training in Patients Scheduled for Colorectal and Thoracic Surgery: The PHIIT Trial|Completed||N/A|20|Actual|University of Dublin, Trinity College||1|||f||||||||||||||2017-10-10 22:29:42.751863|2017-10-10 22:29:42.751863
NCT02674802|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-03|||December 2015||2015-12-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Observational|RAEHPI||Reinfection After Eradication of Helicobacter Pylori Infection|Reinfection After Eradication of Helicobacter Pylori Infection in Adult :A National Multicentre Study|Recruiting||N/A|3500|Anticipated|The First Affiliated Hospital of Nanchang University|||2||f||||f||||||||Undecided||2017-10-10 22:29:42.860003|2017-10-10 22:29:42.860003
NCT02674789|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-02-01|||December 2015||2015-12-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Ionized Magnesium in Athletes|Ionized Magnesium Concentration in Athletes and Exercise Induced Changes in Ionized Magnesium|Active, not recruiting||N/A|18|Actual|Wageningen University||2|||f||||f||||||||Yes|Participants receive a letter with their personal information. VO2max, body weight and height, total Magnesium and ionized magnesium will be communicated.|2017-10-10 22:29:42.952104|2017-10-10 22:29:42.952104
NCT02674776|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-06-17|||September 2015||2015-09-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute Gout|A Clinical Trial About the Efficacy and Safety of HuZhen Capsule in Treating Patients With Acute Gout: A 72 Hours, Multi-center, Randomized, Double-blind, Parallel Placebo Compared Clinical Trial|Active, not recruiting||Phase 3|480|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 22:29:43.017665|2017-10-10 22:29:43.017665
NCT02674763|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-09-23|||March 2016||2016-03-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia|A Phase 1, Multi-center, Open-label Study of IMGN779 Administered Intravenously in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia|Recruiting||Phase 1|124|Anticipated|ImmunoGen, Inc.||4|||f||||t||||||||||2017-10-10 22:29:43.102595|2017-10-10 22:29:43.102595
NCT02674750|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-04-03|||January 2016||2016-01-01|April 2017|2017-04-01||||January 2018|Anticipated|2018-01-01||Interventional|||Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations|Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Including Patients With MYC Alterations|Recruiting||Phase 2|200|Anticipated|Curis, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:29:43.211339|2017-10-10 22:29:43.211339
NCT02674737|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-03|||January 2016||2016-01-01|January 2016|2016-01-01||||May 2016|Anticipated|2016-05-01||Interventional|||Evaluation of the Effect of Appropriate Sedation for Patients After Gastrectomy: A Prospective Randomised Controlled Study||Recruiting||N/A|80|Anticipated|Chinese Medical Association||2|||f||||t||||||||Yes|Main results and conclusion will be available|2017-10-10 22:29:43.362522|2017-10-10 22:29:43.362522
NCT02674724|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||The Effect of Resistance Training in Parkinson Disease: A Pilot Study|The Effect of Resistance Training on Balance in Patients With Parkinson Disease: A Pilot Study|Recruiting||N/A|63|Anticipated|University of Sao Paulo General Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:29:43.45189|2017-10-10 22:29:43.45189
NCT02674711|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-12-06|||August 2015||2015-08-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|SOULCS||Study of Opioid Use After Lumbar and Cervical Spine Surgery|The Effect of a Brief Pre-operative Pain Medication Educational Video on Post-operative Prescriptoin Opioid Medication Use in Patients Undergoing Spine Surgery. A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Brooke Army Medical Center||2|||f||||f||||||||Yes|Any data sharing must first go through a Data Sharing Agreement approved by the Defense Health Agency.|2017-10-10 22:29:43.564996|2017-10-10 22:29:43.564996
NCT02674698|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-10-03|||February 2016||2016-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|CNHDashboard||Disseminating a Dashboard for VA Purchased Community Nursing Homes|Disseminating a Dashboard for VA Purchased Community Nursing Homes|Enrolling by invitation||N/A|18|Anticipated|Providence VA Medical Center||4|||f||||f||||||||No|No data will be shared|2017-10-10 22:29:43.68468|2017-10-10 22:29:43.68468
NCT02674685|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2017-08-08|||March 11, 2016|Actual|2016-03-11|August 2017|2017-08-01|June 26, 2019|Anticipated|2019-06-26|June 26, 2019|Anticipated|2019-06-26||Observational|||Vfend Special Investigation For Prophylaxis|Vfend Special Investigation For Prophylaxis|Active, not recruiting||N/A|200|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 22:29:43.769118|2017-10-10 22:29:43.769118
NCT02674672|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-23|||September 2015||2015-09-01|February 2016|2016-02-01||||September 2017|Anticipated|2017-09-01||Interventional|||A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter System|A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter System|Recruiting||Phase 4|40|Anticipated|B.Braun Médical - CoE Chasseneuil||1|||f||||f||||||||Undecided||2017-10-10 22:29:43.831598|2017-10-10 22:29:43.831598
NCT02674659|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-09-20|||February 2016||2016-02-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||The Effect of Resistance Training on Proprotein Subtilisin Convertase Kexin 9 Level After Coronary Bypass Surgery|The Effect of Resistance Training on Proprotein Subtilisin Convertase Kexin 9 (PCSK-9) Level in Patients After Coronary Bypass Surgery|Active, not recruiting||Phase 3|78|Anticipated|National Cardiovascular Center Harapan Kita Hospital Indonesia||2|||f||||t||||||||Undecided||2017-10-10 22:29:43.910964|2017-10-10 22:29:43.910964
NCT02674646|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-02-03|||February 2016||2016-02-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ROSETTA||RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial|RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial|Not yet recruiting||Phase 2|74|Anticipated|Technische Universität München||2|||f||||f||||||||No||2017-10-10 22:29:43.993895|2017-10-10 22:29:43.993895
NCT02674633|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-08-01|||May 2016||2016-05-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|STARS-ADHD||Software Treatment for Actively Reducing Severity of ADHD|A Randomized, Controlled, Parallel-group, Intervention Study to Assess At-home, Game-based Digital Therapy for Treating Pediatric Participants Ages 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)|Active, not recruiting||N/A|330|Anticipated|Akili Interactive Labs, Inc.||2|||f||||f||||||||||2017-10-10 22:29:44.072653|2017-10-10 22:29:44.072653
NCT02674620|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-02-02|||June 2015||2015-06-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Trial of Aerobic Treadmill Exercise Treatment for Concussion|Randomized Controlled Trial of Aerobic Treadmill Exercise Treatment for Concussion|Recruiting||N/A|120|Anticipated|Panam Clinic||2|||f||||f||||||||||2017-10-10 22:29:44.202328|2017-10-10 22:29:44.202328
NCT02674607|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-23|||October 2015||2015-10-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children|the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children|Active, not recruiting||Phase 4|60|Actual|Tanta University||2|||f||||t||||||||||2017-10-10 22:29:44.292894|2017-10-10 22:29:44.292894
NCT02674594|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-04-06|||October 2014||2014-10-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US|An Early Evaluation of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation (NVAF) Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin in the US|Completed||N/A|30000|Actual|Bristol-Myers Squibb|||4||f||||f||||||||||2017-10-10 22:29:44.369661|2017-10-10 22:29:44.369661
NCT02674581|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-05-02|||March 10, 2016|Actual|2016-03-10|May 2017|2017-05-01|May 24, 2016|Actual|2016-05-24|May 24, 2016|Actual|2016-05-24||Interventional|||A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction|An Open-label Study to Evaluate the Pharmacokinetics and Safety of BMS-663068 in Subjects With Normal Renal Function and Subjects With Mild, Moderate, Severe, and End‑Stage Renal Dysfunction (ESRD)|Completed||Phase 1|30|Actual|ViiV Healthcare||5|||f||||f||||||||||2017-10-10 22:29:44.445244|2017-10-10 22:29:44.445244
NCT02674568|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-06-15|||March 8, 2016|Actual|2016-03-08|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer (TRINITY)|An Open-label, Single-Arm, Phase 2 Study Evaluating the Efficacy, Safety and Pharmacokinetics of Rovalpituzumab Tesirine (SC16LD6.5) for Third-line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer (TRINITY)|Active, not recruiting||Phase 2|339|Actual|Stemcentrx||1|||f||||t||||||||No||2017-10-10 22:29:44.53366|2017-10-10 22:29:44.53366
NCT02674555|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-26|||November 15, 2016|Actual|2016-11-15|July 2017|2017-07-01|November 15, 2016|Actual|2016-11-15|November 15, 2016|Actual|2016-11-15||Interventional|||A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors|A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors Harboring Epidermal Growth Factor Receptor (EGFR) Mutations|Withdrawn||Phase 1|0|Actual|Astellas Pharma Inc||1||Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.|f||||f||||||||||2017-10-10 22:29:44.722163|2017-10-10 22:29:44.722163
NCT02674542|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-11-10|||February 2015||2015-02-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Observational|||Family Planning Intentions and Practices Among Women With Poor Obstetric Outcome|Family Planning Intentions and Practices Among Women Who Have Experienced a Poor Obstetric Outcome: a Qualitative Study|Completed||N/A|60|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||No||2017-10-10 22:29:44.812696|2017-10-10 22:29:44.812696
NCT02674529|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-03-30|||September 2016||2016-09-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|SONRISA||Study of Neural Responses Induced by Antidepressant Effects||Recruiting||Phase 2/Phase 3|70|Anticipated|University of Pittsburgh||2|||f||||t||||||||Yes|The study will follow NIMH schedule for data sharing for clinical trials. The schedule allows for descriptive data to be submitted - but not shared - ongoing and results associated with a finding - both positive and negative - to be submitted prior to the communication of a result. Once a result is communicated, either through publication and/or on the NDCT website the data specifically defined to the clinical trial will then be shared.|2017-10-10 22:29:44.879097|2017-10-10 22:29:44.879097
NCT02674516|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-04-25|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Repeated Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior|The Effect of Repeated Transcranial Direct Current Stimulation of the Prefrontal Cortex on Antisocial and Aggressive Behavior|Active, not recruiting||N/A|30|Actual|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 22:29:44.958816|2017-10-10 22:29:44.958816
NCT02674503|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-05-26|||December 12, 2016|Actual|2016-12-12|May 2017|2017-05-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Impact of a Mobility Program|Impact of a Hospital Mobility Program on Function After Discharge|Recruiting||N/A|226|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Yes|No detailed plans at this time.|2017-10-10 22:29:45.176104|2017-10-10 22:29:45.176104
NCT02674490|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-03-25|||April 1, 2016||2016-04-01|March 2017|2017-03-01|June 30, 2021|Anticipated|2021-06-30|March 31, 2021|Anticipated|2021-03-31||Interventional|SLISSE||Stimulating Language in Subacute StrokE|Effects of Transcranial Direct Current Stimulation (tDCS) Plus Language Therapy for Naming in Subacute Left Hemisphere Stroke|Recruiting||N/A|50|Anticipated|Johns Hopkins University||2|||f||||t||||||||Yes|"Upon completion of the projects and dissemination of primary study results, the analysis data files will be made available to the public, along with the final version of the study protocol, the data dictionary, and brief instructions (Read me file). The public use data files and the accompanying documents will be made available through the National Technical Information Service (NTIS)."|2017-10-10 22:29:45.277491|2017-10-10 22:29:45.277491
NCT02674477|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-04-20|||February 29, 2016|Actual|2016-02-29|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TETAT||Treatment Engagement With Technology-assisted Treatment|Treatment Engagement With Technology-assisted Treatment|Enrolling by invitation||N/A|100|Anticipated|Johns Hopkins University||2|||f||||||||||||||2017-10-10 22:29:45.390451|2017-10-10 22:29:45.390451
NCT02674464|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-09-18|||September 1, 2016|Actual|2016-09-01|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|RICH LIFE||Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project)|Comparative Effectiveness of Health System vs. Multilevel Interventions to Reduce Hypertension Disparities|Enrolling by invitation||N/A|1890|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 22:29:45.477262|2017-10-10 22:29:45.477262
NCT02674451|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-02-28|||August 2014||2014-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIPC-CIN||Remote Ischemic Preconditioning to Prevent Contrast Nephropathy|Remote Ischemic Preconditioning to Prevent Contrast-induced Nephropathy in Patients With Stable and Unstable Coronary Disease Undergoing Coronary Angiography.|Recruiting||Phase 2|250|Anticipated|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 22:29:45.589582|2017-10-10 22:29:45.589582
NCT02674087|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-02-03|||April 2014||2014-04-01|January 2016|2016-01-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01|3 Years|Observational [Patient Registry]|NEHAVI||Prospective Monitoring of Children Born in Haute Vienne From Uterine Life to Adulthood||Recruiting||N/A|9000|Anticipated|University Hospital, Limoges|||1||f||||f||||||||||2017-10-10 22:29:49.904182|2017-10-10 22:29:49.904182
NCT02674438|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-01-04|||October 2016||2016-10-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|COACH||Comparison of Outcomes and Access to Care for Heart Failure Trial|Comparison of Outcomes and Access to Care for Heart Failure Trial|Not yet recruiting||Phase 3|4000|Anticipated|Institute for Clinical Evaluative Sciences||2|||f||||f||||||||No|Due to Ontario privacy regulations, unable to share data|2017-10-10 22:29:45.675005|2017-10-10 22:29:45.675005
NCT02674425|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-10-24|||September 2016||2016-09-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Observational|||Wearable Dark-adaptometer in Normal Adult Healthy Volunteers|Evaluation of a Novel Wearable Light-emitting System for Measuring Dark-adaptation Thresholds in Normal Adult Healthy Volunteers|Recruiting||N/A|20|Anticipated|University of Liverpool|||2||f||||||||||||||2017-10-10 22:29:45.763361|2017-10-10 22:29:45.763361
NCT02674412|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-08-10|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|||Buspirone for Functional Dysphagia|Placebo-controlled, Randomized, Double-blind, Cross-over Style Trial of Buspirone in Functional Dysphagia|Completed||N/A|10|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 22:29:45.845266|2017-10-10 22:29:45.845266
NCT02674399|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-08-28|||February 16, 2016|Actual|2016-02-16|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis|A Phase 2, Double-Blind, Randomized, Controlled Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Treatment of Osteoarthritis|Active, not recruiting||Phase 2|28|Actual|Nature Cell Co. Ltd.||2|||f||||f||||||||||2017-10-10 22:29:45.921203|2017-10-10 22:29:45.921203
NCT02674386|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-10-02|||July 8, 2016|Actual|2016-07-08|October 2017|2017-10-01|July 12, 2019|Anticipated|2019-07-12|July 12, 2019|Anticipated|2019-07-12||Interventional|||Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement|A Phase 3, Multicenter, Long-term Observational Study Of Subjects From Tanezumab Studies Who Undergo A Total Knee, Hip Or Shoulder Replacement|Recruiting||Phase 3|250|Anticipated|Pfizer||1|||f||||t|t|f||||||||2017-10-10 22:29:46.095795|2017-10-10 22:29:46.095795
NCT02674373|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-02-02|||September 2015||2015-09-01|February 2016|2016-02-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Observational|PLAGAST||Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment|Prognostic and Predictive Impact of Circulating Tumor DNA in Advanced and Localized Gastric Cancer Treatment|Recruiting||N/A|200|Anticipated|Association des Gastroentérologues Oncologues|||2||f||||f||||||Samples With DNA|"     circulating tumor DNA   "|No||2017-10-10 22:29:47.438096|2017-10-10 22:29:47.438096
NCT02674360|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-03-30|||May 2016||2016-05-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||RCT Regarding SDM Online Training and Face-to-face SDM Training|Randomized Controlled Trial Regarding (RCT) Innovative Dissemination Strategies for a Brief Shared Decision Making (SDM) Intervention for Oncologists: Web-based SDM Online Training and Individualized, Context-based Face-to-face SDM Training|Recruiting||N/A|180|Anticipated|University Hospital Heidelberg||3|||f||||f||||||||No||2017-10-10 22:29:47.547507|2017-10-10 22:29:47.547507
NCT02674347|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-08-03|||February 2016||2016-02-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Escalating Doses of Intravenous Zidebactam in Healthy Adult Human Subjects|Completed||Phase 1|21|Actual|Wockhardt||2|||f||||f||||||||No||2017-10-10 22:29:47.68051|2017-10-10 22:29:47.68051
NCT02674334|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-09|2016-11-09||October 2012||2012-10-01|August 2017|2017-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|BCP||Prospective Evaluation of Cognitive Outcomes After Anesthesia on Patients in the Beach Chair Position|Prospective Evaluation of Cognitive Outcomes After Anesthesia on Patients in the Beach Chair Position|Completed||N/A|90|Actual|West Virginia University|It is difficult to generalize the results of the study, few CDEs, to similar populations. Intubation may be related to the occurrence of CDEs or may have been related to patient co-morbidities and not the actual intubation.|2|||f||||f||||||||||2017-10-10 22:29:47.76748|2017-10-10 22:29:47.76748
NCT02674321|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-03|||July 2014||2014-07-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)|A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome|Completed||Phase 1|23|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-10 22:29:48.017188|2017-10-10 22:29:48.017188
NCT02674308|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-06-01|||March 31, 2015|Actual|2015-03-31|June 2017|2017-06-01|June 30, 2022|Anticipated|2022-06-30|July 1, 2021|Anticipated|2021-07-01||Observational|Entyvio PASS||Entyvio (Vedolizumab) Long Term Safety Study|Entyvio (Vedolizumab) Long-term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab to Other Biologic Agents in Patients With Ulcerative Colitis or Crohn's Disease|Recruiting||N/A|5000|Anticipated|Takeda|||2||f||||f||||||||||2017-10-10 22:29:48.115938|2017-10-10 22:29:48.115938
NCT02674295|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-03|2016-09-01|||March 2016||2016-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Mass Balance Study With a Microtracer Dose of 14C-esketamine in Healthy Male Participants|An Open-label, Single-dose Mass Balance Study With a Microtracer Dose of 14C-esketamine in Healthy Male Subjects|Completed||Phase 1|8|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 22:29:48.599718|2017-10-10 22:29:48.599718
NCT02674282|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-27|||January 2014||2014-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Maximum Oxygen Uptake in ACL-injured Professional Soccer Players|Maximum Oxygen Uptake in ACL-injured Professional Soccer Players|Active, not recruiting||N/A|20|Actual|University of Sao Paulo||2|||f||||f||||||||Undecided||2017-10-10 22:29:48.687038|2017-10-10 22:29:48.687038
NCT02674074|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-25|||June 2011||2011-06-01|February 2016|2016-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Evaluation of Corneal Temperature by Infrared Thermography in Glaucoma Patients|Evaluation of Corneal Temperature by Infrared Thermography in Glaucoma Patients|Completed||N/A|40|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||No||2017-10-10 22:29:51.641801|2017-10-10 22:29:51.641801
NCT02674269|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-06-15|||October 2016|Anticipated|2016-10-01|June 2017|2017-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|INTIMO2||"Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence (INTIMO2)"|"A Randomized Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botulinum Toxin (Botox®) Formulations, in Idiopathic OAB Patients With Urinary Incontinence (INTIMO2)"|Withdrawn||Phase 1/Phase 2|0|Actual|UroGen Pharma Ltd.||3||"UroGen's RTGelTM delivery system technology for use with neurotoxins licensed to Allergan plc   before the activation of this trial."|f||||f||||||||||2017-10-10 22:29:48.768439|2017-10-10 22:29:48.768439
NCT02674256|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-02-03|||March 2014||2014-03-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|CRH||The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers|The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers: A Randomized, Single-blind, Placebo-controlled Study|Completed||Phase 4|15|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 22:29:48.861302|2017-10-10 22:29:48.861302
NCT02674243|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-02-09|||November 2015||2015-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion|Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion: a Randomized Controlled Trial Study|Recruiting||Phase 3|60|Anticipated|Chiang Mai University||2|||f||||t||||||||Undecided||2017-10-10 22:29:48.949904|2017-10-10 22:29:48.949904
NCT02674230|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-07-18|||July 2011||2011-07-01|July 2017|2017-07-01|June 2026|Anticipated|2026-06-01|June 2026|Anticipated|2026-06-01|10 Years|Observational [Patient Registry]|OCEAN||OCEAN Registry: Obesity and Clock for Elegant Aging Registry|OCEAN Registry: Obesity and Clock for Elegant Aging Registry 肥胖控制及生理時鐘之研究計畫|Recruiting||N/A|2000|Anticipated|Chang Gung Memorial Hospital|||3||f||||t||||||Samples With DNA|"     A. Serum. B. White blood cells. C. Adipose tissue. (If receiving liposuction, plastic     surgery, bariatric surgery, dermatological procedure, intra-abdominal operation, and     cardiovascular surgery)   "|||2017-10-10 22:29:49.045019|2017-10-10 22:29:49.045019
NCT02674217|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-09-01|||May 2015||2015-05-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells|Outpatient Hematopoietic Grafting in Patients With Multiple Sclerosis Employing Autologous Non-cryopreserved Peripheral Blood Stem Cells: A Feasibility Study|Enrolling by invitation||N/A|200|Anticipated|Centro de Hematología y Medicina Interna||1|||f||||t||||||||||2017-10-10 22:29:49.125529|2017-10-10 22:29:49.125529
NCT02674204|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-08-29|||May 5, 2016|Actual|2016-05-05|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|STOP||STOP Heart Disease in Breast Cancer Survivors Trial|Statin Therapy Operates to Prevent (STOP) Heart Disease in Breast Cancer Survivors Trial|Recruiting||Phase 2|90|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-10 22:29:49.187641|2017-10-10 22:29:49.187641
NCT02674191|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-02|||March 2016||2016-03-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Posterior Segment Intrusion Using Miniplates|Evaluation of Posterior Segment Intrusion Using Miniplates in Skeletal ClassII Hyperdivergent Adolescence: A Randomized Control Trial|Not yet recruiting||N/A|22|Anticipated|Cairo University||2|||f||||f||||||||Undecided||2017-10-10 22:29:49.297326|2017-10-10 22:29:49.297326
NCT02674178|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-02-02|||June 2012||2012-06-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women|FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women|Completed||Phase 4|235|Actual|Cairo University||2|||f||||t||||||||No||2017-10-10 22:29:49.380543|2017-10-10 22:29:49.380543
NCT02674165|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-02|||April 2012||2012-04-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|HART||Evaluation of Haitian American Responsible Teens|Evaluation of Haitian American Responsible Teens|Completed||Phase 3|637|Actual|Boston Medical Center||2|||f||||f||||||||No||2017-10-10 22:29:49.442991|2017-10-10 22:29:49.442991
NCT02674152|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-10-02|||January 5, 2016|Actual|2016-01-05|October 2017|2017-10-01|January 11, 2019|Anticipated|2019-01-11|January 11, 2019|Anticipated|2019-01-11||Interventional|||Dose Finding Study of BI 836880 in Patients With Solid Tumors|A First-in Human Phase I, Non-randomised, Open-label, Multi-center Dose Escalation Trial of BI 836880 Administered by Repeated Intravenous Infusions in Patients With Solid Tumors.|Recruiting||Phase 1|80|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:29:49.502009|2017-10-10 22:29:49.502009
NCT02674139|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2016-09-26|||February 2016||2016-02-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison Between Intrauterine Contraceptive Device Insertion During Cesarean Section Vs Conventional Application|Comparative Study of Intrauterine Contraceptive Device Insertion During Caesarean Section Versus Conventional Application|Enrolling by invitation||Phase 4|8|Anticipated|Beni-Suef University||2|||f||||t||||||||Undecided||2017-10-10 22:29:49.571609|2017-10-10 22:29:49.571609
NCT02674126|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-11-04|||January 2016||2016-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Efficacy of Maternal Sound for Pediatric Patients Undergoing Cardiac Surgery|When Are Parents Helpful? A Randomized Clinical Trial of the Efficacy of Maternal Sound for Pediatric Patients Undergoing Cardiac Surgery|Completed||Phase 2|106|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:29:49.644352|2017-10-10 22:29:49.644352
NCT02674113|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2017-02-09|||October 2015||2015-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Regional Anesthesia in Hip Arthroscopy|Use of Regional Anesthesia in Hip Arthroscopy|Withdrawn||N/A|0|Actual|University of Missouri-Columbia||2||determined not to be feasible at our site|f||||f||||||||||2017-10-10 22:29:49.713131|2017-10-10 22:29:49.713131
NCT02674100|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-09-29|||January 2016||2016-01-01|September 2017|2017-09-01|January 2030|Anticipated|2030-01-01|January 2025|Anticipated|2025-01-01|2 Years|Observational [Patient Registry]|||American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry|AHPBA Pancreatic Irreversible Electroporation (IRE) Registry for Pancreatic Cancer|Recruiting||N/A|500|Anticipated|University of Louisville|||1||f||||f||||||||||2017-10-10 22:29:49.802536|2017-10-10 22:29:49.802536
NCT02674061|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-09-06|||February 25, 2016|Actual|2016-02-25|September 2017|2017-09-01|September 18, 2019|Anticipated|2019-09-18|September 18, 2019|Anticipated|2019-09-18||Interventional|||Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)|A Phase II, Open-label, Single-arm, Multicenter Study to Evaluate Efficacy and Safety of Pembrolizumab Monotherapy in Subjects With Advanced Recurrent Ovarian Cancer (KEYNOTE-100)|Active, not recruiting||Phase 2|325|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:29:51.724755|2017-10-10 22:29:51.724755
NCT02674048|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-01-02|||September 2015||2015-09-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|SESAME||Metvix Daylight PDT in Actinic Keratosis|Observational Study to Evaluate Clinical Practice and Satisfaction With Metvix® Daylight Photodynamic Therapy (PDT) in the Treatment of Mild and/or Moderate Actinic Keratosis of the Face and/or the Scalp|Completed||N/A|406|Actual|Galderma|||1||f||||f||||||||No||2017-10-10 22:29:51.828973|2017-10-10 22:29:51.828973
NCT02674035|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-02-02|||June 2012||2012-06-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Plication of the Rectus Abdominis in Two Planes and in One Continuous Suture Plan|Plication of the Rectus Abdominis in Two Planes and in One Continuous Suture Plan|Completed||Phase 4|30|Actual|Federal University of São Paulo||3|||f||||t||||||||No||2017-10-10 22:29:51.903594|2017-10-10 22:29:51.903594
NCT02674022|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-03|||February 2016||2016-02-01|February 2016|2016-02-01||||September 2016|Anticipated|2016-09-01||Interventional|||Screening for Metabolic Problems in Mothers of Children With Autism and Typically Developing Children|Screening for Metabolic Problems in Women, and Possible Treatment With Vitamin/Mineral Supplement|Not yet recruiting||N/A|120|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:29:51.98324|2017-10-10 22:29:51.98324
NCT02674009|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2017-10-02|||September 17, 2015|Actual|2015-09-17|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|NIELS||Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)|Non-Interventional Study to Investigate the Effectiveness, Safety and Utilization of Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions (NIELS)|Active, not recruiting||N/A|67|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:29:52.060082|2017-10-10 22:29:52.060082
NCT02673996|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-08-15|||January 2016||2016-01-01|August 2016|2016-08-01|December 2022|Anticipated|2022-12-01|January 2022|Anticipated|2022-01-01||Observational|||POTS Adrenergic Ab (CIHR Aims #1&2)|The Pathophysiological Role of Adrenergic Antibodies in Postural Tachycardia Syndrome (Aims #1&2)|Recruiting||N/A|125|Anticipated|University of Calgary|||2||f||||f||||||Samples Without DNA|"     Serum for antibody assay; plasma for cytokine assessment; plasma for catecholamines   "|No||2017-10-10 22:29:52.174703|2017-10-10 22:29:52.174703
NCT02673983|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-02-04|||February 2016||2016-02-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety and Efficacy Study of the FTRD System for Obtaining Full-thickness Intestinal Biopsies|Endoscopic Full-thickness Biopsy of the Intestine|Not yet recruiting||N/A|40|Anticipated|Region Skane||1|||f||||f||||||||No||2017-10-10 22:29:52.292855|2017-10-10 22:29:52.292855
NCT02673970|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-09-08|||October 2014||2014-10-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|September 2017|Anticipated|2017-09-01||Observational|ICIT||Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma|Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma|Recruiting||N/A|200|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||f||||||Samples With DNA|"     Cllection of cell free DNA for mutational analysis   "|Yes||2017-10-10 22:29:52.364674|2017-10-10 22:29:52.364674
NCT02673957|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Analysis of Local and Circulating Compounds Released Following Blood Pressure Cuff Inflation|Analysis of Local and Circulating Compounds Released Following Hypoxia Induced by Blood Pressure Cuff Inflation|Recruiting||N/A|20|Anticipated|University of New England|||1||f||||t||||||Samples With DNA|"     Peripheral venous blood samples, which are processed by centrifuge. The plasma will be     extracted and retained for analysis, with the rest of the sample discarded.   "|No||2017-10-10 22:29:52.562923|2017-10-10 22:29:52.562923
NCT02673944|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-05-17|2016-04-12||January 2016||2016-01-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Portable Pves Study|An Accuracy Study to Assess the Performance of the Peritron+ in Measuring Vesical Pressure in Patients in Comparison With Standard Urodynamic Measurements|Completed||N/A|10|Actual|Laborie Medical Technologies Inc.||1|||f||||f||||||||||2017-10-10 22:29:52.640957|2017-10-10 22:29:52.640957
NCT02673931|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-06-17|||February 2016||2016-02-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|GLORIOUS||GLP-1 and Hyperoxia for Organ Protection in Heart Surgery|Efficacy of Glucagon-like-peptide-1 Agonists and Restrictive vs. Liberal FiO2 in Patients Undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement - a 2-by-2 Factorial Designed, Randomized Clinical Study|Recruiting||N/A|1080|Anticipated|Rigshospitalet, Denmark||4|||f||||t||||||||No||2017-10-10 22:29:52.791346|2017-10-10 22:29:52.791346
NCT02673918|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-01-09|||February 2016||2016-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|BRECOR||The Breast Cancer Online Rehabilitation Program|The Breast Cancer Online Rehabilitation Program: A Feasibility Study of Individually Tailored Online Rehabilitation After Breast Cancer Surgery The Copenhagen BRECOR Program|Active, not recruiting||N/A|58|Actual|University of British Columbia||1|||f||||f||||||||No||2017-10-10 22:29:52.908586|2017-10-10 22:29:52.908586
NCT02673905|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-06-22|||November 2016||2016-11-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|NosetoKnee2||Clinical Trial for the Regeneration of Cartilage Lesions in the Knee|Randomized, Multi-center Phase II Clinical Trial for the Regeneration of Cartilage Lesions in the Knee Using Nasal Chondrocyte-based Tissue (N-TEC) or Nasal Chondrocyte-based Cell (N-CAM)-Therapies|Recruiting||N/A|108|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||No||2017-10-10 22:29:53.019597|2017-10-10 22:29:53.019597
NCT02673892|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-04-26|||February 2016||2016-02-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|PODS||Patient Oriented Discharge Summary Impact Study|The Impact of a Patient-Centered Discharge Summary (PODS) on Patient Experience and Health Outcomes Following Discharge: A Multicenter Randomized Controlled Trial|Recruiting||N/A|760|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:29:53.140092|2017-10-10 22:29:53.140092
NCT02673879|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-01|||February 2016||2016-02-01|February 2016|2016-02-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|IMPI-2||IMPI 2 - A Trial of Intrapericardial Alteplase in Large Pericardial Effusion|A Trial of Complete Percutaneous Pericardial Drainage Facilitated by Intrapericardial Alteplase Compared to Conventional Pericardiocentesis When Indicated in Adults With Large Pericardial Effusion Due to Tuberculous and Non-tuberculous Pericarditis|Recruiting||Phase 3|2176|Anticipated|University of Cape Town||2|||f||||t||||||||Yes|Individual patient data will be made available on request at the end of the study, subject to approval by the Steering Committee of the IMPI-2 Trial.|2017-10-10 22:29:53.242578|2017-10-10 22:29:53.242578
NCT02673866|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-07-26|||February 2016||2016-02-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)|A Randomized Double-Blind Placebo and Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)|Withdrawn||Phase 2|0|Actual|Daiichi Sankyo, Inc.||5||reassessment of phase 2 study indication|f||||f||||||||||2017-10-10 22:29:53.362292|2017-10-10 22:29:53.362292
NCT02673853|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-02-01|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Assessment of Residual Paralysis in Patients Who Receive Mini-dose Atracurium During Supraglottic Airway Insertion|Assessment of Residual Paralysis in Patients Who Receive Mini-dose Atracurium During Supraglottic Airway Insertion|Not yet recruiting||N/A|400|Anticipated|National University Hospital, Singapore|||1||f||||f||||||||No||2017-10-10 22:29:53.456161|2017-10-10 22:29:53.456161
NCT02673840|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-02-03|||March 2015||2015-03-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|KETODEN||Ketotifen as a Treatment for Vascular Leakage During Dengue Fever|Ketotifen as a Treatment for Vascular Leakage During Dengue Fever (KETODEN)|Recruiting||Phase 4|110|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-10 22:29:53.546569|2017-10-10 22:29:53.546569
NCT02673827|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-01|||April 2014||2014-04-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|||Progressive Muscle Relaxation Effect on Sleep Quality, Depression and Stress in People With Multiple Sclerosis|Effect of Progressive Muscle Relaxation as a Nursing Intervention on Sleep Quality, Depression and Stress in People With Multiple Sclerosis|Completed||Phase 2|40|Actual|Federal University of Espirito Santo||2|||f||||f||||||||No||2017-10-10 22:29:53.658141|2017-10-10 22:29:53.658141
NCT02673814|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-07-28|||February 2016||2016-02-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer|An Open-Label, Randomized, Phase II Trial of Durvalumab (MEDI4736) With or Without Bavituximab in Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Peregrine Pharmaceuticals||3|||f||||t||||||||||2017-10-10 22:29:53.726894|2017-10-10 22:29:53.726894
NCT02673801|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-02-03|||August 2015||2015-08-01|August 2015|2015-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Optimized Referral of Knee Patients to the Orthopedic Outpatient Clinic|OPtimeret Kirurgisk Visitation af Knæartrose Patienter (OPKVIK)|Completed||N/A|226|Actual|Central Jutland Regional Hospital|||1||f||||f||||||||No|Data can be provided upon request, for instance for meta-analysis.|2017-10-10 22:29:53.797403|2017-10-10 22:29:53.797403
NCT02673788|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Observational|||Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Intraventricular Hemorrhage|Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Intraventricular Hemorrhage|Enrolling by invitation||N/A|9|Anticipated|Samsung Medical Center|||1||f||||f||||||||No||2017-10-10 22:29:53.881879|2017-10-10 22:29:53.881879
NCT02673775|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-09-11|||January 2016||2016-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Air Pollution Study: The Effect of Ozone on the Lung|Activated Macrophages and Ozone Toxicity|Recruiting||N/A|58|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 22:29:53.946988|2017-10-10 22:29:53.946988
NCT02673762|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-05-23|||January 2016||2016-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Salivary Transcriptome Biomarkers for Early Diabetes Detection|Salivary Transcriptome Biomarkers for Early Diabetes Detection|Recruiting||N/A|180|Anticipated|PeriRx|||3||f||||f||||||Samples With DNA|"     Salivary mRNA and cDNA   "|No||2017-10-10 22:29:54.067218|2017-10-10 22:29:54.067218
NCT02673749|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-04-04|||February 2016||2016-02-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance|A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Two Doses of RP-G28 in Subjects With Lactose Intolerance|Completed||Phase 2/Phase 3|377|Actual|Ritter Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:29:54.1572|2017-10-10 22:29:54.1572
NCT02673736|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-09-18|||February 2016||2016-02-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor|A Phase 1 Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX73086 as a Single Agent in Subjects With Advanced Solid Tumors and in Subjects With Locally Advanced or Refractory Tenosynovial Giant Cell Tumor (TGCT)|Active, not recruiting||Phase 1|66|Anticipated|Plexxikon||1|||f||||f||||||||||2017-10-10 22:29:54.36922|2017-10-10 22:29:54.36922
NCT02673723|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2017-02-21|||March 2016||2016-03-01|February 2017|2017-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||The Application of Docozine Combined With Sufentanil for Awake Tracheal Intubation|The Application of Docozine Combined With Sufentanil for Awake Tracheal Intubation—a Multiple Center, Randomized, Controlled，Double Blinded Clinical Trial|Recruiting||Phase 4|400|Anticipated|The First Affiliated Hospital of Anhui Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:29:54.458063|2017-10-10 22:29:54.458063
NCT02673528|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-01|||January 2015||2015-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Observational|||Laparoscopic Assisted or Total Laparoscopic Appendectomy|Laparoscopic Assisted or Total Laparoscopic Appendectomy in Patients With Uncomplicated Acute Appendicitis: a Matched Case-control, Cost-utility Study|Completed||N/A|451|Actual|Medical Park Gaziantep Hospital|||3||f||||t||||||Samples Without DNA|"     appendectomy material   "|No||2017-10-10 22:29:56.2381|2017-10-10 22:29:56.2381
NCT02673710|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-12-12|||March 2016||2016-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Survivors Treated With Chemotherapy Combined With Bevacizumab|A MULTICENTER NON-INTERVENTIONAL STUDY EXPLORING THE IMPACT OF SARCOPENIA ON THE OUTCOMES OF COLORECTAL CANCER SURVIVORS TREATED WITH A CHEMOTHERAPY COMBINED WITH BEVACIZUMAB|Recruiting||N/A|200|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:29:54.56375|2017-10-10 22:29:54.56375
NCT02673697|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-04-11|||March 2016||2016-03-01|April 2017|2017-04-01|January 2023|Anticipated|2023-01-01|January 2019|Anticipated|2019-01-01||Interventional|PERSIST-AVR||Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement|Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement A Controlled Randomized Trial in the Surgical Treatment of Aortic Valve Disease|Recruiting||N/A|1234|Anticipated|LivaNova||2|||f||||t||||||||No||2017-10-10 22:29:54.725088|2017-10-10 22:29:54.725088
NCT02673684|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-02-07|||February 2016||2016-02-01|February 2017|2017-02-01|May 1, 2016|Actual|2016-05-01|May 1, 2016|Actual|2016-05-01||Interventional|NSS||Effects of Neuro-Stim System on Pain, Sleep, and Opioid Use|Double Blind, Randomized, Sham-Controlled Study on the Effects of Neuro-Stim System on Pain, Sleep, and Opioid Use in Pain Patients|Terminated||N/A|11|Actual|Defense and Veterans Center for Integrative Pain Management||2||Lost funding from sponsor|f||||f|f|t|f|f||||No||2017-10-10 22:29:55.028651|2017-10-10 22:29:55.028651
NCT02673671|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-24|||February 2016||2016-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GTECHPOI||G-Tech Feasibility Study for Early Detection of a Post-op Ileus|Measurement Of GI Myoelectric Activity In Patients At Risk For Or Who Have A Post-Operative Ileus (POI) - Monitoring/ Recording GI Myoelectric Activity For Early Detection of A POI|Recruiting||Phase 1/Phase 2|150|Anticipated|G-Tech Corporation||2|||f||||f||||||||Yes|Analyses planned to be presented at scientific meetings and published in peer reviewed medical journals.|2017-10-10 22:29:55.145293|2017-10-10 22:29:55.145293
NCT02673658|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-02-09|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CAN-Do||Project for Cognitive Advancement in Infants With Neuromotor Disorders|Project for Cognitive Advancement in Infants With Neuromotor DisOrders:The CAN-DO Project|Recruiting||N/A|24|Anticipated|Duquesne University||2|||f||||f||||||||Undecided|No plan to make individual participant data available|2017-10-10 22:29:55.241934|2017-10-10 22:29:55.241934
NCT02673645|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-07-07|||August 2015||2015-08-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Remediating Academic Skill Deficits Among Disadvantaged Youth||Active, not recruiting||N/A|1848|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-10 22:29:55.341344|2017-10-10 22:29:55.341344
NCT02673632|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-02|2016-02-03|||February 2016||2016-02-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Observational|||The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS|The Influence of Anti-Müllerian Hormone on Ovarian Responsiveness to Ovulation Induction With Gonadotrophins in Women With Polycystic Ovarian Syndrome|Not yet recruiting||N/A|30|Anticipated|Ain Shams Maternity Hospital|||1||f||||t||||||||||2017-10-10 22:29:55.439856|2017-10-10 22:29:55.439856
NCT02673619|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-03-21|||March 2016||2016-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects|A Phase 2a Study to Evaluate the Clinical Effect, Pharmacokinetics, Safety and Tolerability of Topically Applied Umeclidinium in Subjects With Primary Palmar Hyperhidrosis|Completed||Phase 2|58|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:29:55.518042|2017-10-10 22:29:55.518042
NCT02673606|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-01|||January 2013||2013-01-01|February 2016|2016-02-01||||January 2017|Anticipated|2017-01-01||Interventional|||Impact of Estrogen on Fear Extinction|The Influence of Estrogen on the Fear Extinction Network in Humans|Recruiting||Phase 1/Phase 2|150|Anticipated|Massachusetts General Hospital||3|||f||||||||||||||2017-10-10 22:29:55.644462|2017-10-10 22:29:55.644462
NCT02673593|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-03|||July 2015||2015-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects|A Randomised, Double-Blind, Placebo-Controlled, Single Ascending Dose and Multiple Dose Phase I Study to Assess the Safety, Pharmacokinetics and Effect of Food on Orally Administered DS102 in Healthy Subjects|Completed||Phase 1|57|Actual|DS Biopharma||8|||f||||f||||||||||2017-10-10 22:29:55.736889|2017-10-10 22:29:55.736889
NCT02673580|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-11|||January 2016||2016-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Tele-patient-reported Outcomes (telePRO) in Clinical Practice|Tele-patient-reported Outcomes (telePRO) in Clinical Practice - Effect of Patient-initiated Versus Fixed Interval telePRO Based Outpatient Follow-up|Active, not recruiting||N/A|593|Actual|University of Aarhus||2|||f||||||||||||No||2017-10-10 22:29:55.854321|2017-10-10 22:29:55.854321
NCT02673567|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-08-04|||March 31, 2016|Actual|2016-03-31|August 2017|2017-08-01|February 10, 2017|Actual|2017-02-10|December 16, 2016|Actual|2016-12-16||Interventional|||To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Administration of TEV-48125 (Single Ascending Doses and Single Doses up to 900 mg) in Japanese and Caucasian Healthy Subjects|Completed||Phase 1|64|Actual|Teva Pharmaceutical Industries||4|||f||||f|t|f||||||||2017-10-10 22:29:55.952056|2017-10-10 22:29:55.952056
NCT02673554|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-01|||May 2004||2004-05-01|February 2016|2016-02-01||||December 2008|Actual|2008-12-01||Interventional|||The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP|The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of Glucose-dependent Insulinotropic Polypeptide (GIP) in Patients With Type 2 Diabetes is Not Caused by Rapid Tachyphylaxis|Completed||Phase 1|30|Actual|Diabeteszentrum Bad Lauterberg im Harz||3|||f||||f||||||||No||2017-10-10 22:29:56.053781|2017-10-10 22:29:56.053781
NCT02673541|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-05-08|||February 2016||2016-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of a Lumen- Apposing, Covered, Self-Expanding Metal Stent (Axios™) Versus Multiple Double Pigtail Stents|Randomized, Multi-Center, Comparative and Cost Effectiveness Study of a Lumen- Apposing, Covered, Self-Expanding Metal Stent (Axios™) Versus Multiple Double Pigtail Stents in the Management of Walled Off Pancreatic Necrosis|Recruiting||N/A|20|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:29:56.133922|2017-10-10 22:29:56.133922
NCT02673515|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-08-02|||April 2015||2015-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|InterFast||The Impact of Intermittent Fasting on Human Metabolism and Cell Autophagy|The Impact of Intermittent Fasting on Human Metabolism and Cell Autophagy|Active, not recruiting||N/A|60|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-10 22:29:56.321648|2017-10-10 22:29:56.321648
NCT02673502|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-08-30|||May 2016||2016-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pre-operative Carbohydrate Drink to Preserve Peri-operative Insulin Sensitivity|Impact of Pre-operative Carbohydrate Drink Provision on Attenuating Peri-operative Insulin Resistant in Major Abdominal Surgery: a Pilot Study|Recruiting||N/A|30|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 22:29:56.411063|2017-10-10 22:29:56.411063
NCT02673489|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-06-01|||March 15, 2016|Actual|2016-03-15|June 2017|2017-06-01|May 26, 2017|Actual|2017-05-26|March 2, 2017|Actual|2017-03-02||Interventional|||A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection|A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection|Completed||Phase 3|78|Actual|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 22:29:56.511002|2017-10-10 22:29:56.511002
NCT02673476|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-01-03|||February 2016||2016-02-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus|A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness|Completed||Phase 2|9|Actual|Alios Biopharma Inc.||2|||f||||t||||||||No|No data will be shares|2017-10-10 22:29:56.746489|2017-10-10 22:29:56.746489
NCT02673463|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-24|||January 2015||2015-01-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|IMPRESS-AF||Spironolactone in Atrial Fibrillation|Improved Exercise Tolerance in Participants With PReserved Ejection Fraction by Spironolactone on Myocardial Fibrosis in Atrial Fibrillation|Active, not recruiting||Phase 4|250|Anticipated|University of Birmingham||2|||f||||t||||||||Undecided||2017-10-10 22:29:56.885326|2017-10-10 22:29:56.885326
NCT02673450|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-06-27|||September 2018|Anticipated|2018-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.|PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit. A Prospective Cohort Study.|Suspended||N/A|200|Anticipated|Zealand University Hospital|||1|Lack of lab ressources|f||||t||||||Samples With DNA|"     21 ml of blood from each patient is kept in a biobank for 10 years   "|No||2017-10-10 22:29:56.976027|2017-10-10 22:29:56.976027
NCT02673437|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-10-27|||September 2015||2015-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|ROSE ACS||Rivaroxaban ACS Specialist Cohort Event Monitoring Study|An Observational Post-authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (XARELTO®) Initiated in Secondary Care for the Prevention of Atherothrombotic Events in Patients Who Have Had Acute Coronary Syndrome in England and Wales|Recruiting||N/A|2386|Anticipated|Drug Safety Research Unit, Southampton, UK|||2||f||||f||||||||||2017-10-10 22:29:57.060039|2017-10-10 22:29:57.060039
NCT02673424|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-07-07|||June 2016||2016-06-01|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|December 2021|Anticipated|2021-12-01||Interventional|FLAVOUR||Fractional FLow Reserve And IVUS for Clinical OUtcomes in Patients With InteRmediate Stenosis|Comparison of Clinical Outcomes Between Imaging and Physiology-guided Intervention Strategy in Patients With Intermediate Stenosis: Fractional FLow Reserve And IVUS for Clinical OUtcomes in Patients With InteRmediate Stenosis (FLAVOUR)|Recruiting||N/A|1700|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:29:57.155255|2017-10-10 22:29:57.155255
NCT02673411|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|October 2016|Actual|2016-10-01||Observational|||Ultrasonography SWE for Hepatic Fibrosis Evaluation|Diagnostic Performance of Shear Wave Elastography for Fibrosis Evaluation: Preliminary Study|Recruiting||N/A|158|Anticipated|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 22:29:57.278954|2017-10-10 22:29:57.278954
NCT02673398|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-09-29|||October 27, 2016||2016-10-27|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Neratinib in Treating Older Patients With Metastatic HER2-Positive Breast Cancer|Phase II Study of Neratinib in Patients 60 and Older With HER2 Positive Metastatic Breast Cancer|Recruiting||Phase 2|40|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 22:29:57.391011|2017-10-10 22:29:57.391011
NCT02673385|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-08-12|||March 2016||2016-03-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|BRAZMAMAN||Study of the Impact of Administering t the Scale of Brazelton on the Mother's Confidence in Her Newborn Born Premature at the Approach of Returning Home|Study of the Impact of Administering t the Scale of Brazelton on the Mother's Confidence in Her Newborn Born Premature at the Approach of Returning Home|Recruiting||N/A|160|Anticipated|University Hospital, Limoges|||2||f||||f||||||||||2017-10-10 22:29:57.538959|2017-10-10 22:29:57.538959
NCT02673372|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-09-02|||February 2016||2016-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Geriatric Ketamine for Pain Management Study|Low-Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department Geriatric Population: A Prospective, Randomized, Double-Blind Study.|Recruiting||Phase 4|90|Anticipated|Maimonides Medical Center||2|||f||||f||||||||||2017-10-10 22:29:57.621873|2017-10-10 22:29:57.621873
NCT02673359|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-09|||February 2016||2016-02-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Short Cervix and History of PTL and/or MTM|Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Sonographic Short Cervix and History of Preterm Labor and/or Midtrimester Miscarriage|Recruiting||Phase 4|220|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 22:29:57.727372|2017-10-10 22:29:57.727372
NCT02673346|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-23|||January 2015||2015-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2015|Actual|2015-08-01||Observational|Wellness||Employee Wellness Survey|Assessing Tobacco Use and Treatment Preferences Among Alaska Yukon-Kuskokwim Health Corporation Employees|Completed||N/A|467|Actual|Mayo Clinic|||1||f||||f||||||||Yes||2017-10-10 22:29:57.831669|2017-10-10 22:29:57.831669
NCT02673333|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-08-29|||February 2016||2016-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma|A Phase II Clinical Trial of Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma|Recruiting||Phase 2|39|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:29:57.894714|2017-10-10 22:29:57.894714
NCT02673320|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-03|||March 2016||2016-03-01|February 2016|2016-02-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|DS3CS||Prospective Study for Delay in Surgical Treatment of Traumatic Cervical Central Cord Injury in Canal Stenosis|Prospective Study for Delay in Surgical Treatment of Traumatic Cervical Central Cord Injury in Canal Stenosis|Not yet recruiting||N/A|72|Anticipated|Nantes University Hospital||2|||f||||f||||||||No||2017-10-10 22:29:57.997108|2017-10-10 22:29:57.997108
NCT02673307|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-13|||March 2016||2016-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Chewing Gum and Gastric Emptying of Water||Completed||N/A|20|Actual|Hôpital Edouard Herriot||2|||f||||||||||||||2017-10-10 22:29:58.129279|2017-10-10 22:29:58.129279
NCT02673294|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-03|||February 2014||2014-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Chronicity Dependence of a Balance Training in Adults Post-stroke|Chronicity Dependence of a Balance Training in Adults Post-stroke|Completed||N/A|47|Actual|Hospitales Nisa||3|||f||||||||||||||2017-10-10 22:29:58.206032|2017-10-10 22:29:58.206032
NCT02673281|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-02-16|||January 2016||2016-01-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Activation of Brain Centers by Short-term Walnut Consumption in Obesity|Activation of Brain Centers Responsible for Decreasing Appetite and Improvement of the Cardiometabolic Profile by Short-term Walnut Consumption in Obesity: A Pilot Study|Active, not recruiting||N/A|10|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No|Individual Participant data will be kept confidential.|2017-10-10 22:29:58.275728|2017-10-10 22:29:58.275728
NCT02673255|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-03-13|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program|Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program|Enrolling by invitation||Phase 1|300|Anticipated|Biomat USA, Inc.||2|||f||||t||||||||Yes||2017-10-10 22:29:58.507326|2017-10-10 22:29:58.507326
NCT02673242|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-04-26|||November 2015||2015-11-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disorder||Completed||N/A|3|Actual|Sykehuset Innlandet HF||2|||f||||||||||||No||2017-10-10 22:29:58.6482|2017-10-10 22:29:58.6482
NCT02673229|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-10-02|||January 2014||2014-01-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparison of Collagenase Santyl Ointment With Antibiotic Ointment in the Outpatient Care of Minor Partial Thickness Burns|Comparison of Collagenase Santyl Ointment With Antibiotic Ointment in the Outpatient Care of Minor Partial Thickness Burns|Suspended||Phase 4|100|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 22:29:58.727576|2017-10-10 22:29:58.727576
NCT02673216|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-10-12|||March 2015||2015-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Infection and Adverse Pregnancy Outcome|Infection and Adverse Pregnancy Outcome|Recruiting||N/A|1500|Anticipated|Statens Serum Institut|||2||f||||f||||||Samples With DNA|"     Serum Vaginal Swabs   "|No||2017-10-10 22:29:58.817085|2017-10-10 22:29:58.817085
NCT02673203|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-08-15|||February 2016||2016-02-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects|Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects|Recruiting||Phase 1|60|Anticipated|Yale University||4|||f||||f||||||||No||2017-10-10 22:29:58.890697|2017-10-10 22:29:58.890697
NCT02673177|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-02|||February 2016||2016-02-01|February 2016|2016-02-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|TRVL||Trial of Robotic Versus Laparoscopic-assisted Radical Resection for Rectal Cancer|A Randomized, Prospective Trial of Robotic Versus Laparoscopic-assisted Radical Resection for Rectal Cancer in Urinary, Erectile Function and Anal Function|Not yet recruiting||N/A|225|Anticipated|Southwest Hospital, China||2|||f||||t||||||||Yes||2017-10-10 22:29:58.986715|2017-10-10 22:29:58.986715
NCT02673164|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-03-20|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|SCIENCE||Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease|Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease - SCIENCE A European Multi-Centre Trial|Recruiting||Phase 2|138|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||Yes|Data can be shared for Scientific collaboration|2017-10-10 22:29:59.057508|2017-10-10 22:29:59.057508
NCT02673151|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-05-24|||May 20, 2017|Actual|2017-05-20|May 2017|2017-05-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment|68Ga-PSMA PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy in Patients With Elevated PSA|Recruiting||Phase 2|60|Anticipated|Stanford University||1|||f|||||t|f||||||||2017-10-10 22:29:59.146088|2017-10-10 22:29:59.146088
NCT02673138|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-06-15|||January 2016||2016-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion|Effect of Canagliflozin in T1DM After Interruption of Continuous Subcutaneous Insulin Infusion|Active, not recruiting||N/A|10|Actual|Yale University||2|||f||||f||||||||No||2017-10-10 22:29:59.245115|2017-10-10 22:29:59.245115
NCT02673125|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-03-14|||December 2015||2015-12-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Prospective Paired Study on the Effectiveness of MitoGrade|Prospective Paired Study on the Effectiveness of MitoGrade|Recruiting||N/A|60|Anticipated|Reprogenetics||1|||f||||f||||||||||2017-10-10 22:29:59.328197|2017-10-10 22:29:59.328197
NCT02673112|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-14|||April 2016||2016-04-01|October 2016|2016-10-01|February 2020|Anticipated|2020-02-01|September 2019|Anticipated|2019-09-01||Interventional|STEP||Study of an Exercise Program (STEP) for Youth With Concussion|Study of an Exercise Program (STEP) for Youth With Concussion|Recruiting||N/A|100|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||No||2017-10-10 22:29:59.405431|2017-10-10 22:29:59.405431
NCT02673099|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2017-05-08|||August 2013||2013-08-01|May 2017|2017-05-01|February 1, 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||The Benefit of Оn-Line High Convection Volume Hemodiafiltration Treatment Versus High Flow Dialysis on Reduction of Oxidative Stress and Health Related Quality of Life in Dialysis Patients|The Benefit of Оn-Line High Convection Volume Hemodiafiltration Treatment Versus High Flow Dialysis on Reduction of Oxidative Stress and Health Related Quality of Life in Dialysis Patients|Completed||N/A|45|Actual|Western Galilee Hospital-Nahariya||1|||f||||f||||||||No||2017-10-10 22:29:59.477933|2017-10-10 22:29:59.477933
NCT02673086|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-06-15|||December 2015||2015-12-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Retroclavicular Versus Coracoid Approach for Infraclavicular Brachial Plexus Block|Could the Retroclavicular Block Alternative for Ultrasound-guided Infraclavicular Block: A Prospective Randomized Controlled Trial|Completed||N/A|100|Actual|Antalya Training and Research Hospital||2|||f||||f||||||||No||2017-10-10 22:29:59.534059|2017-10-10 22:29:59.534059
NCT02673073|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|AWARE-HF||Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure Management|Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure Management (AWARE-HF)|Recruiting||Phase 2/Phase 3|1220|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||No||2017-10-10 22:29:59.600666|2017-10-10 22:29:59.600666
NCT02673060|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-03-28|||July 2014||2014-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||A Trial of MBC-11 in Patients With CIBD|A Phase 1 Multicenter, Open-label, Dose-escalation Trial of MBC-11, an Etidronate-ara-C Conjugate in Patients With Malignant Tumors With Cancer-induced Bone Disease (CIBD)|Completed||Phase 1|16|Actual|Osteros Biomedica Ltd||1|||f||||t||||||||No||2017-10-10 22:29:59.678181|2017-10-10 22:29:59.678181
NCT02673047|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-21|||February 2016||2016-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|BOREAL||Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder||Completed||N/A|474|Actual|Allergan|||1||f||||f||||||||||2017-10-10 22:29:59.738457|2017-10-10 22:29:59.738457
NCT02673021|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-07-12|||February 2016||2016-02-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|May 2018|Anticipated|2018-05-01||Interventional|MARK 1A||MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)|MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)|Recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:30:00.111935|2017-10-10 22:30:00.111935
NCT02672995|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-08-15|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial|Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial|Recruiting||Phase 1|36|Anticipated|National Taiwan University Hospital||1|||f||||t|f|f||||||||2017-10-10 22:30:00.29968|2017-10-10 22:30:00.29968
NCT02672982|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-07-24|||December 8, 2014|Actual|2014-12-08|July 2017|2017-07-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|FUSAM||Follow Up of Severely Malnourished Children (FUSAM)|Follow Up of Severely Malnourished Children (FUSAM): Effectiveness of a Combined Nutrition Psychosocial Intervention on Health and Development.|Completed||N/A|427|Actual|Action Contre la Faim||2|||f||||t||||||||||2017-10-10 22:30:00.390788|2017-10-10 22:30:00.390788
NCT02672969|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-30|||August 2015||2015-08-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||The Evaluation of Pre-Post Smoke Evacuation Uses on Surgical Smoke and Bio-Aerosols in Operating Rooms|The Evaluation of Pre-Post Smoke Evacuation Uses on Surgical Smoke and Bio-Aerosols in Operating Rooms at a University Hospital, Thailand|Recruiting||N/A|128|Anticipated|Mahidol University||2|||f||||f||||||||Undecided||2017-10-10 22:30:00.492758|2017-10-10 22:30:00.492758
NCT02672956|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-10-29|||September 2015||2015-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Different Umbilical Port Entry Techniques in Terms of Cosmetic Results|Comparison of Different Umbilical Port Entry Techniques in Terms of Cosmetic Results|Recruiting||N/A|105|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||3|||f||||t||||||||||2017-10-10 22:30:00.584856|2017-10-10 22:30:00.584856
NCT02672943|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-01-31|||January 2016||2016-01-01|January 2016|2016-01-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Parkinson Disease Before and After Medication and Rehabilitation Treatment|The Role of Noradrenergic Network, and Its Association With Autonomous Dysfunction,Cerebral Autoregulation and microRNA in Parkinson Disease Before and After Medication and Rehabilitation Treatment|Active, not recruiting||N/A|60|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||No||2017-10-10 22:30:00.672117|2017-10-10 22:30:00.672117
NCT02672930|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-08-15|||July 2015||2015-07-01|January 2016|2016-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|1 Day|Observational [Patient Registry]|||How Much Reliable iv Calcium for the Treatment of Hyperkalemia?|How Much Reliable iv Calcium for the Treatment of Hyperkalemia?|Completed||N/A|80|Actual|Haseki Training and Research Hospital|||1||f||||f||||||||No||2017-10-10 22:30:00.753338|2017-10-10 22:30:00.753338
NCT02672917|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-08-28|||January 2016||2016-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies|Phase I Safety and Tolerability Study of Human Monoclonal Antibody 5B1 (MVT-5873) as Monotherapy and With Chemotherapy in Subjects With Pancreatic Cancer or Other CA19-9 Positive Malignancies|Recruiting||Phase 1|68|Anticipated|MabVax Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:30:00.833608|2017-10-10 22:30:00.833608
NCT02672904|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-10|||January 2013||2013-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||KTP vs CO2 Laser for the Treatment of Laryngeal Carcinoma|Comparison Between the Use of KTP Laser vs. CO2 Laser for Endoscopic Surgical Removal of Malignant Neoplasms of the Vocal Cords|Recruiting||N/A|40|Anticipated|Kaplan Medical Center||2|||f||||t||||||||No||2017-10-10 22:30:00.941273|2017-10-10 22:30:00.941273
NCT02672891|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-01-31|||May 2011||2011-05-01|January 2016|2016-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Intrauterine Balloon Tamponade in the Management of Postpartum Hemorrhage|Intrauterine Balloon Tamponade in the Management of Postpartum Hemorrhage in a Low Resource Setting|Completed||N/A|50|Actual|Menoufia Obstetrics and Gynecology Group||1|||f||||t||||||||Yes|Yes|2017-10-10 22:30:01.066397|2017-10-10 22:30:01.066397
NCT02672878|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-02-20|||April 2014||2014-04-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2016|Actual|2016-12-01||Interventional|RIBS VI||Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI)|Prospective Study of Bioresorbable Vascular Scaffold Treatment in Patients With In-stent Restenosis|Not yet recruiting||Phase 4|130|Anticipated|Spanish Society of Cardiology||1|||f||||f||||||||||2017-10-10 22:30:01.158331|2017-10-10 22:30:01.158331
NCT02672852|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-10-05|||February 29, 2016|Actual|2016-02-29|October 2017|2017-10-01|August 3, 2018|Anticipated|2018-08-03|November 1, 2016|Actual|2016-11-01||Interventional|||BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment|BI 655066 / ABBV-066 (Risankizumab) Versus Placebo In a Multicenter Randomized Double-blind Study in Patients With Moderate to Severe Chronic Plaque Psoriasis Evaluating the Efficacy and Safety With Randomized Withdrawal and Re-treatment (IMMhance)|Active, not recruiting||Phase 3|500|Anticipated|AbbVie||2|||f||||t||||||||||2017-10-10 22:30:01.489678|2017-10-10 22:30:01.489678
NCT02672839|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-05-17|||February 2016||2016-02-01|March 2016|2016-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation|A Single-Center, Randomized, Open-Label, 2-Period Complete Crossover Study to Compare the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation in Healthy Adult Subjects|Completed||Phase 1|12|Actual|Ligand Pharmaceuticals||4|||f||||f||||||||Yes||2017-10-10 22:30:01.734969|2017-10-10 22:30:01.734969
NCT02672826|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-31|||June 2013||2013-06-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|ADIPENDO||Description of the Endothelial Phenotypes From the Subcutaneous Abdominal and Gluteo-femoral Adipose Tissues in Women|Description of the Endothelial Phenotypes From the Subcutaneous Abdominal and Gluteo-femoral Adipose Tissues in Women|Recruiting||N/A|50|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 22:30:01.853004|2017-10-10 22:30:01.853004
NCT02672813|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-04|||July 2015||2015-07-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Ultrasound Guided Pectoral Nerve I and II Blocks in Multimodal Analgesia for Breast Surgery|Ultrasound Guided Pectoral Nerve I and II Blocks in Multimodal Analgesia for Breast Surgery: A Randomized Single Blinded Control Trial|Recruiting||Phase 4|32|Anticipated|B.P. Koirala Institute of Health Sciences||2|||f||||t||||||||||2017-10-10 22:30:01.944856|2017-10-10 22:30:01.944856
NCT02672800|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-06-12|||March 2016||2016-03-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||A Psychosocial Intervention for Bereaved Spousal Caregivers of Persons With Dementia|"A Psychosocial Intervention for Bereaved Spousal Caregivers of Persons With Dementia: Adapting the Finding Balance Tool"|Recruiting||N/A|60|Anticipated|University of Saskatchewan||2|||f||||||||||||||2017-10-10 22:30:02.071837|2017-10-10 22:30:02.071837
NCT02672787|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-11-02|||February 2016||2016-02-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A ED-based Intervention to Improve Antihypertensive Adherence|A Randomized, ED-based Intervention to Improve Antihypertensive Adherence|Recruiting||N/A|350|Anticipated|Vanderbilt University||2|||f||||t||||||||Yes||2017-10-10 22:30:02.203722|2017-10-10 22:30:02.203722
NCT02672774|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-31|||October 2015||2015-10-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|IM-ANG||Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal Cancers|Study of Minimally Invasive Endoscopic IMaging Methods for the Evaluation of neoANGiogenesis in Gastrointestinal Cancers|Recruiting||N/A|50|Anticipated|University of Medicine and Pharmacy Craiova||2|||f||||t||||||||Undecided||2017-10-10 22:30:02.321777|2017-10-10 22:30:02.321777
NCT02672761|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-08|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|MBSR2015||Effect of 8 Weeks of MBSR Training on Neuroplasticity and Improvement of Attention, Memory and Well-Being|MBSR Improves Memory and Attention Due to a Stress Reduction as Opposed to Specific Memory Training|Recruiting||N/A|140|Anticipated|Universitätsmedizin Mannheim||4|||f||||t||||||||No||2017-10-10 22:30:02.430748|2017-10-10 22:30:02.430748
NCT02672748|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-05-01|||November 2015||2015-11-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|GR||Growing Resilience in Wind River Indian Reservation|Growing Resilience: an RCT on the Health Impact of Gardens With Wind River Indian Reservation|Recruiting||N/A|400|Anticipated|University of Wyoming||2|||f||||t||||||||No|IPD will be made available to each individual participant, but otherwise only the data summaries will be made available to non-partner parties unless individually arranged and approved by the IRB and project Community Advisory Board. The Northern Arapaho and the Eastern Shoshone tribes co-own the data with the research teams (and Eastern Shoshone Tribal Health and Northern Arapaho Tribal Health are entities of the tribal governments).|2017-10-10 22:30:02.518468|2017-10-10 22:30:02.518468
NCT02672735|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-11-12|||July 2015||2015-07-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Influence of a Corrective Exercise Training Program on Measures of Functional Movement Among Active-Duty Firefighters|Influence of a Corrective Exercise Training Program on Measures of Functional Movement Among Active-Duty Firefighters|Active, not recruiting||N/A|51|Actual|University of Wisconsin, Milwaukee||2|||f||||f||||||||No||2017-10-10 22:30:02.632055|2017-10-10 22:30:02.632055
NCT02672722|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-10|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Assessment of the Changes in Cortical and Medullary Renal Blood Flow During Exercise in Healthy Subjects Using Contrast Enhanced Ultrasound|Assessment of the Changes in Cortical and Medullary Renal Blood Flow During Exercise in Healthy Subjects Using Contrast Enhanced Ultrasound|Recruiting||Phase 1/Phase 2|19|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-10 22:30:02.737641|2017-10-10 22:30:02.737641
NCT02672709|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-08-29|||April 2016||2016-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Apixaban in Hemodialysis|Pharmacokinetics and Pharmacodynamics of Apixaban in End-stage Renal Disease Patients on Hemodialysis|Completed||Phase 4|7|Actual|Jewish General Hospital||1|||f||||f||||||||||2017-10-10 22:30:02.843662|2017-10-10 22:30:02.843662
NCT02672696|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-06|||May 2015||2015-05-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|INOPEG||Interest of Navigation for the Treatment of Pertrochanteric Fractures With the Gamma 3 Nail|Interest of Navigation for the Treatment of Pertrochanteric Fractures With the Gamma 3 Nail|Recruiting||N/A|60|Anticipated|Hôpital du Valais||2|||f||||f||||||||No||2017-10-10 22:30:02.924887|2017-10-10 22:30:02.924887
NCT02672683|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-06-27|||July 2016||2016-07-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|MIRRACLE||Non Invasive Detection of Cardiac Allograft Rejection by Circulating microRNAs|Non Invasive Detection of Acute Rejection by Circulating microRNAs in Cardiac Transplantation: a Multicenter Prospective Study|Not yet recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 22:30:03.022497|2017-10-10 22:30:03.022497
NCT02672670|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effects of a Coping-oriented Supportive Programme (COSP) for People With Spinal Cord Injury During Inpatient Rehabilitation||Recruiting||N/A|100|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||No||2017-10-10 22:30:03.117937|2017-10-10 22:30:03.117937
NCT02672657|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-25|||February 2016||2016-02-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Observational|DEQOLAGE||Determinants of Quality Of Life in AGEd Cancer Patients|Assessing the Evolution and Determinants of Quality of Life in Elderly Cancer Patients and Their Caregivers: a Prospective Multicenter Observational Cohort Study.|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 22:30:03.213151|2017-10-10 22:30:03.213151
NCT02672644|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-07-15|||March 2016||2016-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Non-comparative Evaluation of Facial Expressions Following Lower Face Correction Using Emervel Classic and Emervel Deep|A Single-Center, Non-Comparative Study to Evaluate Subject Recovery Following Correction of Bilateral Nasolabial Folds Using Emervel® Classic Lidocaine and Emervel® Deep Lidocaine|Completed||Phase 4|20|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||No||2017-10-10 22:30:03.344548|2017-10-10 22:30:03.344548
NCT02672618|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-02|||November 2015||2015-11-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|||Clinical Research to Explore Manifestations of Heart Failure Using Infrared Thermal Imaging Technology|Clinical Research to Explore Manifestations of Heart Failure Using Infrared Thermal Imaging Technology|Recruiting||N/A|200|Anticipated|The Second Affiliated Hospital of Chongqing Medical University|||3||f||||t||||||||Yes||2017-10-10 22:30:03.511364|2017-10-10 22:30:03.511364
NCT02672605|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-07-29|||November 2015||2015-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Measurement of Individual Level of Abortion Stigma Study|Measurement of Individual-Level Abortion Stigma Resulting From Pennsylvania State-Mandated Abortion Consent Language: A Pilot Randomized Controlled Trial|Completed||N/A|51|Actual|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 22:30:03.612415|2017-10-10 22:30:03.612415
NCT02672592|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|TestIL||Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome|Effects of IL-1 Beta on the Hypothalamic-pituitary-gonadal (HPG) Axis in Men With Obesity and Metabolic Syndrome - The TestIL Trial|Completed||Phase 3|70|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 22:30:03.693519|2017-10-10 22:30:03.693519
NCT02672579|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-20|||May 2015||2015-05-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|SKIS||Study of Kids Itch Severity (SKIS)|"Study of Kids Itch Severity (SKIS): Validation and Mobilization of Pediatric Pruritus Outcome Instruments"|Enrolling by invitation||N/A|235|Anticipated|Emory University|||4||f||||f||||||||||2017-10-10 22:30:03.851008|2017-10-10 22:30:03.851008
NCT02672566|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-07-25|||June 1, 2016|Actual|2016-06-01|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|March 30, 2018|Anticipated|2018-03-30||Interventional|GROWTH||Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction|Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction. Randomized Multicenter Trial|Recruiting||Phase 3|162|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t|f|f||||||||2017-10-10 22:30:04.069683|2017-10-10 22:30:04.069683
NCT02672553|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-01-29|||May 2012||2012-05-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|CADENCE-MIS||EDWARDS INTUITY Valve System CADENCE-MIS Study|A Randomized Comparison of the EDWARDS INTUITY Valve Sys-tem anD commErcially Available Aortic Bioprostheses in Subjects uNdergoing surgiCal Aortic Valve Replacement Using Minimally Inva-Sive Techniques|Completed||Phase 4|100|Actual|Edwards Lifesciences||2|||f||||f||||||||||2017-10-10 22:30:04.297009|2017-10-10 22:30:04.297009
NCT02672540|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-03-30|||August 2016||2016-08-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients|A Phase II, Multicenter, Single-Blind, Randomized Study of the Safety and Effectiveness of SANGUINATE™ Versus Normal Saline in Adult Sickle Cell Disease Patients With Vaso-Occlusive Crisis (VOC)|Recruiting||Phase 2|30|Anticipated|Prolong Pharmaceuticals||2|||f||||f|f|f|||t|||No||2017-10-10 22:30:04.488514|2017-10-10 22:30:04.488514
NCT02672527|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-06-08|||January 2015||2015-01-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|TSAR||Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma|A Randomized Phase III Trial Comparing Trabectedin (Yondelis®) to the Best Supportive Care in Patients With Advanced Soft Tissue Sarcoma|Recruiting||Phase 3|100|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-10 22:30:04.696674|2017-10-10 22:30:04.696674
NCT02672514|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-02-07|2016-02-05||February 2010||2010-02-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|April 2012|Actual|2012-04-01||Interventional|||Does MiECC Improve Outcome in Diabetic Patients Undergoing Elective Coronary Bypass Grafting?|Does Minimal Extracorporeal Circulation Improve Outcome in Diabetic Patients Undergoing Elective Coronary Bypass Grafting?|Completed||N/A|104|Actual|Herzzentrum Coswig|only a single-Center study; a small number of study participants.|2|||f||||f||||||||||2017-10-10 22:30:04.897782|2017-10-10 22:30:04.897782
NCT02672501|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-02-01|||January 2016||2016-01-01|February 2016|2016-02-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia|Open-labeled, Uncontrolled, Single-arm Pilot Study to Evaluate Cellular Immunotherapy Using CD19-targeted Chimeric Antigen Receptor Engineered T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia|Recruiting||Phase 1/Phase 2|30|Anticipated|Shanghai GeneChem Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:30:05.568508|2017-10-10 22:30:05.568508
NCT02672488|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-02-02|||December 2015||2015-12-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Metformin Plus Sorafenib for Advanced HCC|Safety and Efficacy of Metformin Plus Sorafenib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma(BCLC-C): A Phase 2 Randomized Study|Recruiting||Phase 2|82|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||f||||||||Yes||2017-10-10 22:30:05.699875|2017-10-10 22:30:05.699875
NCT02672475|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-14|||March 2016||2016-03-01|October 2016|2016-10-01||||January 2020|Anticipated|2020-01-01||Interventional|||Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer|A Phase Ib Trial of LY2157299 (TGFβR1 Kinase Inhibitor) With Paclitaxel in Patients With Triple Negative Metastatic Breast Cancer|Recruiting||Phase 1|29|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 22:30:05.831534|2017-10-10 22:30:05.831534
NCT02672462|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-02-02|||December 2015||2015-12-01|February 2016|2016-02-01||||June 2016|Anticipated|2016-06-01||Interventional|||Renal Denervation for the Treatment of Hypertension: A Pilot Safety and Efficacy Study|The Safety and Efficacy of a Renal Denervation System in Treating Patients With Hypertension: A Pilot Study|Recruiting||N/A|20|Anticipated|Shanghai Golden Leaf MedTec Co. Ltd||1|||f||||||||||||||2017-10-10 22:30:05.95437|2017-10-10 22:30:05.95437
NCT02672449|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-02-01|||May 2015||2015-05-01|January 2016|2016-01-01|January 2020|Anticipated|2020-01-01|December 2015|Actual|2015-12-01||Interventional|||Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer|Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer|Active, not recruiting||N/A|65|Anticipated|European Institute of Oncology||1|||f||||t||||||||No||2017-10-10 22:30:06.034259|2017-10-10 22:30:06.034259
NCT02672436|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-07-02|||March 15, 2017|Actual|2017-03-15|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||ENERGI-F703 for Diabetic Foot Ulcers Phase II Study|A Randomized, Double-Blind, Vehicle-controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of ENERGI-F703 in Subjects With Diabetic Foot Ulcers|Recruiting||Phase 2|105|Anticipated|Energenesis Biomedical Co., Ltd.||2|||f||||f|t|f||||||||2017-10-10 22:30:06.136565|2017-10-10 22:30:06.136565
NCT02672423|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-11-03|||February 2016||2016-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study of Abemaciclib in Healthy Participants|A Bioequivalence Study Comparing Abemaciclib Capsule and Tablet Formulations and Effect of Food on Abemaciclib Tablet Pharmacokinetics in Healthy Subjects|Completed||Phase 1|86|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:30:06.244573|2017-10-10 22:30:06.244573
NCT02672397|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2017-04-04|||November 2014||2014-11-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||The Effect of a Culturally Sensitive Educational Intervention on Acceptance of Neuraxial Anesthesia|The Effect of a Culturally Sensitive Educational Intervention on Acceptance of Neuraxial Anesthesia in Hispanic and Caucasian Parturients: A Randomized Controlled Trial|Completed||N/A|200|Actual|Oregon Health and Science University||4|||f||||f||||||||No||2017-10-10 22:30:06.33655|2017-10-10 22:30:06.33655
NCT02672371|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-07-11|||June 2017|Anticipated|2017-06-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effects of Sensory Training On Pain Modulation, Cognition and Time to Fatigue in Healthy Adults|The Effects of Sensory Training On Pain Modulation, Cognition and Time to Fatigue in Healthy Adults|Withdrawn||N/A|0|Actual|Spaulding Rehabilitation Hospital||2||Study was not approved for the IRB; we then had no funds to reapply|f||||f|f|f||||||||2017-10-10 22:30:06.580704|2017-10-10 22:30:06.580704
NCT02672189|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-06-27|||February 2015||2015-02-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms|A Randomized Controlled Trial of Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms|Active, not recruiting||Phase 3|265|Anticipated|The Netherlands Cancer Institute||3|||f||||f||||||||||2017-10-10 22:30:08.649415|2017-10-10 22:30:08.649415
NCT02672358|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2017-04-24|||October 31, 2017|Anticipated|2017-10-31|April 2017|2017-04-01|March 10, 2020|Anticipated|2020-03-10|March 10, 2020|Anticipated|2020-03-10||Interventional|||Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC|A Phase II, Multi-center, Single Arm, Open Label Study to Assess Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer|Not yet recruiting||Phase 2|10|Anticipated|Novartis||1|||f||||f|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:30:06.700055|2017-10-10 22:30:06.700055
NCT02672345|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-10|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01|1 Year|Observational [Patient Registry]|||Systemic Inflammatory Response Evaluation With the Use of Inhaled Anesthetic Sevoflurane During CPB|Systemic Inflammatory Response Evaluation With the Use of Inhaled Anesthetic Sevoflurane During CPB|Recruiting||N/A|100|Anticipated|Instituto Dante Pazzanese de Cardiologia|||2||f||||t||||||||||2017-10-10 22:30:07.422822|2017-10-10 22:30:07.422822
NCT02672332|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-12-20|||February 2016||2016-02-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||P3 Study in Acne Comparing Once Daily SB204 and Vehicle|A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of SB204 and Vehicle Gel Once Daily in the Treatment of Acne Vulgaris|Active, not recruiting||Phase 3|1306|Actual|Novan, Inc.||2|||f||||f||||||||No||2017-10-10 22:30:07.545982|2017-10-10 22:30:07.545982
NCT02672319|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-25|||April 2014||2014-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||EUS-guided Glue Injection for Varices Study|Endoscopic Ultrasound (EUS) Guided Cyanoacrylate Injection for Variceal Obturation as Secondary Prophylaxis for Patients at High Risk for Recurrent Gastroesophageal Variceal Bleeding|Recruiting||N/A|30|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:30:07.756153|2017-10-10 22:30:07.756153
NCT02672306|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-01-29|||May 2016||2016-05-01|January 2016|2016-01-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|SEESUPAD||Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease|Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|South China Research Center for Stem Cell and Regenerative Medicine||2|||f||||t||||||||Yes||2017-10-10 22:30:07.838392|2017-10-10 22:30:07.838392
NCT02672293|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-09-30|||January 2013||2013-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Determining Oral Phosphate Tolerance Across the Spectrum of Glomerular Filtration Rate|Determining Oral Phosphate Tolerance Across the Spectrum of Glomerular Filtration Rate|Recruiting||N/A|50|Anticipated|Queen's University||1|||f||||f||||||||No||2017-10-10 22:30:07.922998|2017-10-10 22:30:07.922998
NCT02672280|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-01-31|||May 2016||2016-05-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SEESCMMSCTSD||Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects||Not yet recruiting||Phase 1/Phase 2|30|Anticipated|South China Research Center for Stem Cell and Regenerative Medicine||2|||f||||||||||||Undecided||2017-10-10 22:30:08.0175|2017-10-10 22:30:08.0175
NCT02672267|ClinicalTrials.gov processed this data on October 10, 2017|2016-02-01|2016-10-05|||July 2014||2014-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction|A Phase III, Double-blinded, Single Center, Randomized, Placebo Controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Single Intravenous Dose of Allogeneic Ischemia Tolerant Human Mesenchymal Bone Marrow Cells to Subjects With Acute Myocardial Infarction|Completed||Phase 3|50|Actual|Altaco XXI, LLP||2|||f||||t||||||||Undecided||2017-10-10 22:30:08.101817|2017-10-10 22:30:08.101817
NCT02672254|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-29|||January 2016||2016-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||New Strategies Against Cutaneous Squamous Cell Carcinoma|"Investigation in Vitro of New Strategies Alternative to Surgery Against Cutaneous Squamous Cell Carcinoma: Topical Chemotherapy Followed by Superficial Radiotherapy."|Completed||N/A|3|Actual|Corporacion Parc Tauli|||3||f||||t||||||Samples With DNA|"     A431NS cell cultures from ATCC of human cutaneous squamous carcinoma.   "|Undecided||2017-10-10 22:30:08.255081|2017-10-10 22:30:08.255081
NCT02672241|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-31|2016-09-11|||January 2016||2016-01-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Interventional|||Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children|Phase 2 Study of Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children|Recruiting||Phase 2|30|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||Yes||2017-10-10 22:30:08.317232|2017-10-10 22:30:08.317232
NCT02672228|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-07-18|||October 2015||2015-10-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MalariaSense||Feasibility of the Vapor Nanobubble Technology for Malaria Diagnostics (MalariaSense)|Feasibility of the Vapor Nanobubble Technology (MalariSense) for Malaria Diagnostics|Completed||N/A|208|Actual|Medical Research Council Unit, The Gambia||1|||f||||f||||||||||2017-10-10 22:30:08.423098|2017-10-10 22:30:08.423098
NCT02672215|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-31|||September 2014||2014-09-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|March 2015|Actual|2015-03-01||Interventional|StartToStand||RCT Computer-tailored Intervention on Workplace Sitting|The Effectiveness of a Web-based Computer-tailored Intervention on Workplace Sitting: a Randomized Controlled Trial|Active, not recruiting||N/A|1061|Actual|University Ghent||3|||f||||f||||||||No||2017-10-10 22:30:08.497007|2017-10-10 22:30:08.497007
NCT02672202|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-09-26|||February 2016||2016-02-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Shifting Pain Modulation From Pro-to Anti-nociceptive|Shifting Pain Modulation From Pro-to Anti-nociceptive: Individualized Prevention of Post Operative Pain|Terminated||N/A|9|Actual|Rambam Health Care Campus||3||Recruitment rate was slow so we could not complete the study.|f||||f||||||||||2017-10-10 22:30:08.566063|2017-10-10 22:30:08.566063
NCT02672176|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-10-02|||February 2016||2016-02-01|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|P2E2T2||Improving Health in Diabetes Project|Patient and Provider Engagement and Empowerment Through Technology (P2E2T2) Program to Improve Health in Diabetes|Active, not recruiting||N/A|300|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 22:30:08.782858|2017-10-10 22:30:08.782858
NCT02672163|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-08-23|||February 2016||2016-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Autologous Atrial Appendage Derived Cells in the Treatment of Heart Failure|Epicardial Delivery of Autologous Atrial Appendage Micrografts During Coronary Artery Bypass Surgery - Safety and Feasibility Study|Recruiting||N/A|26|Anticipated|Helsinki University Central Hospital||2|||f||||t||||||||No||2017-10-10 22:30:08.870235|2017-10-10 22:30:08.870235
NCT02672150|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-01-30|||April 2015||2015-04-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|(JJ-TRAILS)||Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System|Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System: Multi-site Implementation Study|Enrolling by invitation||N/A|360|Anticipated|Chestnut Health Systems||3|||f||||f||||||||Yes|The coordinating center is charged with creating de-identified versions of agency, staff and client level service data available at the end of the study.|2017-10-10 22:30:08.970469|2017-10-10 22:30:08.970469
NCT02672137|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-02-02|||January 2010||2010-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|AMI-OPTIMA||Knowledge Translation for Patients With Acute Coronary Syndromes|Knowledge Translation to Promote Evidence-based Medical Therapy in Acute Coronary Syndromes|Completed||N/A|4604|Actual|Montreal General Hospital||2|||f||||f||||||||No||2017-10-10 22:30:11.140923|2017-10-10 22:30:11.140923
NCT02672124|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-01-30|||September 2015||2015-09-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||A New Micro Swim-up Procedure for Sperm Preparation in ICSI Treatment||Recruiting||N/A|100|Anticipated|Cervesi Hospital, Cattolica, Italy|||1||f||||||||||||||2017-10-10 22:30:11.221784|2017-10-10 22:30:11.221784
NCT02672111|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-06-12|||November 2015||2015-11-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder|An Open-Label Multicenter Study Assessing the Long-Term Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injection Depot of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder|Completed||N/A|228|Actual|Braeburn Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:30:11.298254|2017-10-10 22:30:11.298254
NCT02672098|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-09-26|||July 14, 2016|Actual|2016-07-14|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer|Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer|Recruiting||Phase 1|20|Anticipated|Loma Linda University||1|||f||||f||||||||||2017-10-10 22:30:11.434607|2017-10-10 22:30:11.434607
NCT02672085|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-08-18|||June 2015||2015-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PRP Randomized||In Vivo Clinical and Radiological Effects of Platelet-rich Plasma on Interstitial Supraspinatus Lesion: Randomized Study|In Vivo Clinical and Radiological Effects of Platelet-rich Plasma on Interstitial Supraspinatus Lesion: Randomized Study|Recruiting||N/A|84|Anticipated|La Tour Hospital||2|||f||||f||||||||||2017-10-10 22:30:11.519364|2017-10-10 22:30:11.519364
NCT02672072|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-29|||January 2016||2016-01-01|January 2016|2016-01-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Observational|SISTRESSREA||Simulation-based Education for Managing Stress in ICU Nurses|Simulation-based Education for Managing Stress in ICU Nurses|Not yet recruiting||N/A|400|Anticipated|Assistance Publique Hopitaux De Marseille|||2||f||||||||||||||2017-10-10 22:30:11.607489|2017-10-10 22:30:11.607489
NCT02672059|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-08-16|||February 2011||2011-02-01|August 2017|2017-08-01||||June 2019|Anticipated|2019-06-01||Observational|PINS||Pain In Neuropathy Study|Pain In Neuropathy Study|Recruiting||N/A|700|Anticipated|King's College London|||1||f||||f||||||Samples With DNA|"     1. We will collect blood samples (30mls) from each subject, which will be stored at -800C          in a locked freezer. All samples will eventually be transported to King's College for          storage in compliance with The Human Tissues Act. DNA will be taken for studies in          genetics polymorphisms or mutations within genes which may modify the risk of a person          developing a neuropathic pain and/or the severity of neuropathic pain, if and only if          patients agree. Genetic analysis will be strictly restricted to the neuropathic pain          field, and data will be anonymised after blood has been taken from patients. If blood          chemistry and HbA1c is not available from primary care, these will also be checked. We          will also assess new potential metabolic biomarkers in the serum of patients that can          shed a light into mechanisms for the development of neuropathy and pain.        2. IENFD assessed via one 3mm skin punch biopsies performed 10 cm above lateral malleolus.   "|||2017-10-10 22:30:11.693015|2017-10-10 22:30:11.693015
NCT02672046|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-05-11|||January 2016||2016-01-01|January 2016|2016-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Optimized Referral of Knee Patients at the Clinic of Sports Injuries|Danish Title: Optimeret Visitation af Midaldrende knæpatienter Med Symptomer Muligvis Relateret Til Meniskskade|Completed||N/A|182|Actual|Central Jutland Regional Hospital|||1||f||||f||||||||No||2017-10-10 22:30:11.891776|2017-10-10 22:30:11.891776
NCT02672033|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-24|||September 1, 2015|Actual|2015-09-01|August 2017|2017-08-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma|Neoadjuvant Accelerated Hypofractionated Radiation Therapy Immediately Prior to Radical Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Pilot Study|Recruiting||N/A|10|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t|f|t|f|||||||2017-10-10 22:30:11.971734|2017-10-10 22:30:11.971734
NCT02672020|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-29|||November 2015||2015-11-01|January 2016|2016-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|COMETETACTIC||Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card|The COMETE Network, Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card|Recruiting||N/A|450|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 22:30:12.081766|2017-10-10 22:30:12.081766
NCT02671994|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-27|||January 2016||2016-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|GOAT||Geriatric and Oncologic Assessment Before Treatment|Significance of Geriatric Assessment for Optimal Treatment of Older Cancer Patients|Recruiting||N/A|200|Anticipated|Odense University Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:30:12.337064|2017-10-10 22:30:12.337064
NCT02671968|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-07-25|||February 2016||2016-02-01|July 2017|2017-07-01||||July 14, 2017|Actual|2017-07-14||Interventional|||Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)|Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)|Completed||N/A|141|Actual|Science Consulting in Diabetes||2|||f||||||||||||||2017-10-10 22:30:12.427822|2017-10-10 22:30:12.427822
NCT02671955|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-24|||January 27, 2016|Actual|2016-01-27|August 2017|2017-08-01|August 23, 2019|Anticipated|2019-08-23|April 10, 2018|Anticipated|2018-04-10||Interventional|||A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer|An Open-label, First-in-Human, Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-61610588, a Fully Human IgG1 Kappa Anti-VISTA (V-domain Ig Suppressor of T-cell Activation) Monoclonal Antibody, in Subjects With Advanced Cancer|Terminated||Phase 1|12|Actual|Janssen Research & Development, LLC||4||Janssen business decision|f||||f||f||||||||2017-10-10 22:30:12.540437|2017-10-10 22:30:12.540437
NCT02671942|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-04-05|||March 2016||2016-03-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|||A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients||Recruiting||Phase 2|120|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||4|||f||||f||||||||No|Have no plan to make individual participant data available.|2017-10-10 22:30:12.665422|2017-10-10 22:30:12.665422
NCT02671929|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-09-01|||September 2015||2015-09-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|KEN||Translation and Development of an Online Self-help Intervention With Subsequent Feasibility Study|Translation and Development of an Online Self-help Intervention With Subsequent Feasibility Study as an After Care After Inpatient Psychosomatic Treatment|Completed||Phase 1/Phase 2|83|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||No||2017-10-10 22:30:12.753004|2017-10-10 22:30:12.753004
NCT02671916|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-08-31|||January 2015||2015-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|1 Year|Observational [Patient Registry]|QoL_ICU||Health and Quality of Life One Year After Discharge From the Intensive Care Unit (ICU)|Health and Quality of Life One Year After Discharge From the ICU: in Time Not Limited Quality Control After Intensive Medical Treatment|Recruiting||N/A|1500|Anticipated|Klinik Hirslanden, Zurich|||1||f||||f||||||||No||2017-10-10 22:30:12.828207|2017-10-10 22:30:12.828207
NCT02671903|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-09-01|||January 2016||2016-01-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|HOPE-HF||The His Optimised Pacing Evaluated for Heart Failure Trial (HOPE-HF).|AV Optimisation Delivered With Direct His Bundle Pacing, in Patients With Heart Failure, Long PR Without Left Bundle Branch Block: Randomised Multi-centre Clinical Outcome Study.|Recruiting||N/A|160|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-10 22:30:12.924414|2017-10-10 22:30:12.924414
NCT02671890|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-06-22|||February 25, 2016|Actual|2016-02-25|December 2016|2016-12-01|May 5, 2021|Anticipated|2021-05-05|May 5, 2021|Anticipated|2021-05-05||Interventional|||Disulfiram and Gemcitabine Hydrochloride in Treating Patients With Unresectable Solid Tumors or Metastatic Pancreatic Cancer|Phase 1 Trial and Randomized, Double-blinded, Placebo-Controlled Expansion Cohort Study of Disulfiram and Gemcitabine in Solid Tumor and Pancreas Cancer Patients|Recruiting||Phase 1|74|Anticipated|Mayo Clinic||2|||f||||||||||||||2017-10-10 22:30:13.094805|2017-10-10 22:30:13.094805
NCT02671877|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2017-03-02|||January 2016||2016-01-01|March 2017|2017-03-01|March 1, 2017|Anticipated|2017-03-01|October 2016|Actual|2016-10-01||Observational|TubeDiff||Preoperative Fibroscopy as a Predictor of the Difficulty of Laryngoscopy and Intubation|Preoperative Fibroscopy as a Predictor of the Difficulty of Laryngoscopy and Intubation|Recruiting||N/A|200|Anticipated|IRCCS San Raffaele|||1||f||||f||||||||No||2017-10-10 22:30:13.209927|2017-10-10 22:30:13.209927
NCT02671864|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-08-28|||April 11, 2016|Actual|2016-04-11|August 2017|2017-08-01|April 11, 2022|Anticipated|2022-04-11|April 11, 2022|Anticipated|2022-04-11||Interventional|ANGIOSAFE 2||Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy|Impact of Incretin-mimetic Hypoglycaemic Drugs on Diabetic Retinopathy in Type 2 Diabetic Patients and Study of Biomarkers in the Development of Severe Retinopathy: Angiosafe-T2D Study 2|Recruiting||N/A|7200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:30:13.292515|2017-10-10 22:30:13.292515
NCT02671851|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-02-09|||January 2014||2014-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Ultrasound-Guided Thoracic Paravertebral Blocks in Patients Undergoing Reduction Mammoplasty|Ultrasound-Guided Bilateral Thoracic Paravertebral Blocks as an Adjunct to General Anaesthesia in Patients Undergoing Reduction Mammoplasty: A Historical Cohort Study|Completed||N/A|64|Actual|Istanbul University|||2||f||||f||||||||No||2017-10-10 22:30:13.506146|2017-10-10 22:30:13.506146
NCT02671838|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-19|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||A Musculoskeletal Ultrasound Program to Improve Disease Modifying Anti-Rheumatic Drugs Adherence in Rheumatoid Arthritis|Developing a Musculoskeletal Ultrasound Program as an Intervention to Improve Disease Modifying Anti-Rheumatic Drugs Adherence in Rheumatoid Arthritis: A Randomized Controlled Trial|Not yet recruiting||N/A|132|Anticipated|Singapore General Hospital||2|||f||||f||||||||No||2017-10-10 22:30:13.605072|2017-10-10 22:30:13.605072
NCT02671825|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-11-10|||January 2016||2016-01-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects|A Phase 1 Single Center, Single Group, 7-way Crossover Pilot Pharmacokinetic Study to Evaluate the Disposition of Active Component Following Single Inhaled Doses of Five Formulations of PUR0200 Compared to Reference Product in Healthy Adult Subjects|Completed||Phase 1|42|Actual|Pulmatrix Inc.||7|||f||||f||||||||||2017-10-10 22:30:13.687683|2017-10-10 22:30:13.687683
NCT02670694|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-02-01|||June 2011||2011-06-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|RDCRN||Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW|Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi|Completed||N/A|804|Actual|Baylor College of Medicine|||4||f||||f||||||||No||2017-10-10 22:30:24.150338|2017-10-10 22:30:24.150338
NCT02671812|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2017-02-13|||November 27, 2014|Actual|2014-11-27|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Observational|||Outcome After Dental Implant Treatment|Longterm Outcome After Dental Implant Treatment|Enrolling by invitation||N/A|150|Anticipated|Folktandvården Stockholms län AB|||1||f||||f||||||Samples With DNA|"     Saliva and gingival fluid   "|No||2017-10-10 22:30:13.78682|2017-10-10 22:30:13.78682
NCT02671799|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-04-03|||January 2016||2016-01-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of the Minimally Invasive VenTouch™ System in the Treatment of Functional Mitral Valve Regurgitation (FMR)|Evaluation of the Minimally Invasive VenTouch™ System in the Treatment of Functional Mitral Valve Regurgitation (FMR): First-In-Man Continuation Study|Active, not recruiting||Phase 1|15|Anticipated|Mardil Medical||1|||f||||t||||||||No||2017-10-10 22:30:13.860068|2017-10-10 22:30:13.860068
NCT02671786|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-01-29|||May 2011||2011-05-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SAMMAN||Community Based Management of Severe Malnutrition in Tribal Area of Melghat- Cluster Randomized Control Field Trial|Community Based Management of Severe Malnutrition in Under 5 Children in Tribal Area of Melghat, Maharashtra- Cluster Randomized Control Field Trial|Completed||N/A|824|Actual|MAHAN Trust||2|||f||||||||||||||2017-10-10 22:30:13.951071|2017-10-10 22:30:13.951071
NCT02671773|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-02-01|||June 2014||2014-06-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|MIA||Characterising the Microbiota in Asthma|Characterising the Microbiota in Asthma|Completed||N/A|72|Actual|University of Nottingham|||3||f||||f||||||Samples With DNA|"     Sputum samples to be retained containing bacterial DNA   "|||2017-10-10 22:30:14.057351|2017-10-10 22:30:14.057351
NCT02671747|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-05-10|||August 2015||2015-08-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Pilot: Mind Over Matter: Healthy Bowels, Healthy Bladder|Pilot Testing for Mind Over Matter: Healthy Bowels, Healthy Bladder|Active, not recruiting||N/A|30|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||Yes||2017-10-10 22:30:14.257415|2017-10-10 22:30:14.257415
NCT02671734|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-29|||June 2014||2014-06-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Improving the Informed Consent Process for Youth Undergoing Pediatric Endoscopy and Their Parents|Using Media to Improve the Informed Consent Process for Youth Undergoing Pediatric Endoscopy and Their Parents|Completed||N/A|77|Actual|Huang, Jeannie, M.D.||2|||f||||f||||||||No||2017-10-10 22:30:14.331737|2017-10-10 22:30:14.331737
NCT02671721|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2017-03-28|||March 2016||2016-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Intraoperative Protective Ventilation and Postoperative Pulmonary Complications|Intraoperative Protective Ventilation and Postoperative Pulmonary Complications|Completed||N/A|35|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-10 22:30:14.399377|2017-10-10 22:30:14.399377
NCT02671695|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-30|2016-10-23|||April 2015||2015-04-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia|Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia|Active, not recruiting||N/A|40|Actual|Tanta University||2|||f||||t||||||||||2017-10-10 22:30:14.594641|2017-10-10 22:30:14.594641
NCT02671682|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis|Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis and Clinically Isolated Syndrome|Recruiting||N/A|60|Anticipated|University of Ulm|||2||f||||f||||||Samples Without DNA|"     Eluate (Immunadsorption) and Plasma (Plasmapheresis)   "|No||2017-10-10 22:30:14.681792|2017-10-10 22:30:14.681792
NCT02671669|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-03-30|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology|Empowering Individuals Post-Cardiopulmonary Outpatient Rehabilitation to Continue to Live a Heart Healthy Lifestyle: Utilizing Mobile Health Technology|Recruiting||N/A|100|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:30:14.796327|2017-10-10 22:30:14.796327
NCT02671656|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-01-29|||March 2016||2016-03-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|URICA||Study of the Reliability of a Device (HumanSens Plus) Allowing Immediate Measurement Uric Acid in the Blood Obtained by Finger Tip Puncture.|Reliability Assessment of the HumaSens Plus Measurement of Uricemia in Capillary Blood|Not yet recruiting||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 22:30:14.891017|2017-10-10 22:30:14.891017
NCT02671643|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-13|||October 2014||2014-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|ACT AA||To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma|To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma Followed at a Subspecialty Clinic|Recruiting||N/A|80|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 22:30:14.990946|2017-10-10 22:30:14.990946
NCT02671630|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-01-29|||June 2013||2013-06-01|January 2016|2016-01-01||||October 2013|Actual|2013-10-01||Interventional|||Computerized Cognitive Training Program for Older Persons With Mild Dementia||Completed||N/A|30|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:30:15.259776|2017-10-10 22:30:15.259776
NCT02671617|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-01-26|||August 2016||2016-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|eHIITCa||Preoperative HIIT in Elderly Cancer Patients|A Randomised Control Trial to Assess Efficacy of Preoperative High Intensity Interval Training in Elderly Patients Scheduled for Oncological Abdominal Surgery|Recruiting||N/A|48|Anticipated|University of Nottingham||2|||f||||f||||||||No|No individual patient data will be made available.|2017-10-10 22:30:15.32907|2017-10-10 22:30:15.32907
NCT02671604|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-31|||January 2014||2014-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01|2 Months|Observational [Patient Registry]|||Rhabdomyolysis and Robot-assisted Radical Prostatectomy|Is Rhabdomyolysis an Anesthetic Complication in Patients Undergoing Robot-assisted Radical Prostatectomy?|Completed||N/A|52|Actual|Umraniye Education and Research Hospital|||1||f||||f||||||||No||2017-10-10 22:30:15.426869|2017-10-10 22:30:15.426869
NCT02671591|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-01-31|||February 2016||2016-02-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|MI-PrEP||A Pilot Study of PrEP Acceptance Among Young Black MSM|A Pilot Study of PrEP Acceptance Among Young Black MSM|Not yet recruiting||N/A|50|Anticipated|University of Kentucky||2|||f||||f||||||||No||2017-10-10 22:30:15.494754|2017-10-10 22:30:15.494754
NCT02671578|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-28|||November 2006||2006-11-01|January 2016|2016-01-01|November 2008|Actual|2008-11-01|November 2007|Actual|2007-11-01||Interventional|BIS-01||Bispectral Index and Clinical Parameters Evaluation in Dental Procedures|Bispectral Index and Clinical Parameters Evaluation in Different Dental Procedures With Nitrous Oxide and Oxygen Sedation|Completed||Phase 4|100|Actual|University of Campinas, Brazil||1|||f||||f||||||||No||2017-10-10 22:30:15.563379|2017-10-10 22:30:15.563379
NCT02671565|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-08-10|||February 2016||2016-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Comparative Effectiveness of Hyaluronic Acid Injections for Management of Knee Osteoarthritis|Comparative Effectiveness of Hyaluronic Acid Injections to Prevent/Delay Knee Surgical Interventions Among Patients With Knee Osteoarthritis|Completed||N/A|13849|Actual|University of Arkansas|||3||f||||f||||||||||2017-10-10 22:30:15.642825|2017-10-10 22:30:15.642825
NCT02671552|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-18|||January 2013||2013-01-01|October 2016|2016-10-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery|Contrast-Enhanced Ultrasound for the Evaluation of Renal Cell Carcinoma Cryoablation|Withdrawn||N/A|0|Actual|Thomas Jefferson University||1||Terminated by the IRB|f||||f||||||||||2017-10-10 22:30:15.722125|2017-10-10 22:30:15.722125
NCT02671539|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-04-10|||January 2016||2016-01-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|THOR||THOR - Tübingen Choroideremia Gene Therapy Trial|THOR - Tübingen Choroideremia Gene Therapy Trial Open Label Phase 2 Clinical Trial Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1)|Active, not recruiting||Phase 2|6|Actual|STZ eyetrial||1|||f||||t||||||||No||2017-10-10 22:30:15.806224|2017-10-10 22:30:15.806224
NCT02671526|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-11-22|||December 2015||2015-12-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|HAND||Cognitive Remediation for HIV-associated Neurocognitive Dysfunction|Plasticity-based Adaptive Cognitive Remediation (PACR) for HIV-associated Neurocognitive Dysfunction|Completed||N/A|19|Actual|Posit Science Corporation||1|||f||||t||||||||||2017-10-10 22:30:15.916441|2017-10-10 22:30:15.916441
NCT02671513|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-04-11|||January 2016||2016-01-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|||A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients|A Tolerability and Pharmacokinetics Phase 1 Study of SHR6390 in Advanced Melanoma Patients|Recruiting||Phase 1|30|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||No||2017-10-10 22:30:15.984513|2017-10-10 22:30:15.984513
NCT02671500|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-08-09|||April 19, 2016|Actual|2016-04-19|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV|A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects With Chronic HCV|Active, not recruiting||Phase 3|375|Actual|Gilead Sciences||1|||f||||f|t|f|||t|||||2017-10-10 22:30:16.212562|2017-10-10 22:30:16.212562
NCT02671487|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-01-29|||January 2016||2016-01-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Mind-Body Skills Groups for Behavioral and Emotional Problems in War-Traumatized Male Adolescents in Gaza|Mind-Body Skills Groups for Behavioral and Emotional Problems in War-Traumatized Male Adolescents in Gaza|Recruiting||N/A|104|Anticipated|The Center for Mind-Body Medicine||2|||f||||f||||||||Undecided||2017-10-10 22:30:16.374337|2017-10-10 22:30:16.374337
NCT02671474|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-07-07|||January 2016||2016-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Valve Leaflet Motion in Sutureless Bioprosthetic Aortic Valves||Completed||N/A|47|Actual|Karolinska University Hospital|||||f||||||||||||||2017-10-10 22:30:16.475463|2017-10-10 22:30:16.475463
NCT02671461|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-04-26|||April 25, 2016|Actual|2016-04-25|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||"Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or Mini Strokes"|A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack|Completed||Phase 2|16|Actual|Bristol-Myers Squibb||4|||f||||t||||||||||2017-10-10 22:30:16.551402|2017-10-10 22:30:16.551402
NCT02671448|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-10-03|||January 2016||2016-01-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Pilot Trial of Homebound Stem Cell Transplantation|Pilot Trial of Homebound Stem Cell Transplantation|Recruiting||N/A|15|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:30:16.718341|2017-10-10 22:30:16.718341
NCT02671435|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-10-04|||February 22, 2016|Actual|2016-02-22|September 2017|2017-09-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|||A Study of Durvalumab (MEDI4736) and IPH2201 in Solid Tumors|A Phase 1 Study of Durvalumab and IPH2201 in Adult Subjects With Select Advanced Solid Tumors|Recruiting||Phase 1|208|Anticipated|MedImmune LLC||1|||f||||f||||||||||2017-10-10 22:30:16.824108|2017-10-10 22:30:16.824108
NCT02671422|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-10-03|||March 9, 2016|Actual|2016-03-09|October 2017|2017-10-01|November 1, 2021|Anticipated|2021-11-01|April 1, 2021|Anticipated|2021-04-01||Observational|||LUME BioNIS: a Biomarker Study in Patients With NSCLC|A Non-interventional Biomarker Study in Patients With Non-Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Tumour Histology Eligible for Treatment With Vargatef® According to the Approved Label.|Recruiting||N/A|300|Anticipated|Boehringer Ingelheim|||1||f||||||||||Samples With DNA|"     FPE tumour tissue and one blood sample. A buccal swab may replace the blood sample if not     available.   "|||2017-10-10 22:30:16.955077|2017-10-10 22:30:16.955077
NCT02671409|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Translational Study of the Effects of Neural Mobilization in Patients With Lomboisquiatalgia|Translational Study of the Effects of Neural Mobilization in Patients With Lomboisquiatalgia|Recruiting||N/A|40|Anticipated|University of Sao Paulo||2|||f||||t||||||||Yes|semi-annual report|2017-10-10 22:30:17.153089|2017-10-10 22:30:17.153089
NCT02671396|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-01-28|||August 2013||2013-08-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Virtual Reality Based Training on Posture Stability in Parkinson's Disease|Effects of Virtual Reality Based Training on Posture Stability in Individuals With Parkinson's Disease|Completed||N/A|20|Actual|National Yang Ming University||2|||f||||t||||||||Undecided||2017-10-10 22:30:17.247478|2017-10-10 22:30:17.247478
NCT02671383|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-07-11|||July 2016||2016-07-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|DRV||Evaluation of Low-dose Darunavir in a Switch Study|A Randomised, Open Label Switch Study Comparing Darunavir/Ritonavir 400mg/100mg Daily With Lopinavir/Ritonavir 800mg/200mg Daily, in HIV-positive Participants|Recruiting||Phase 3|300|Anticipated|University of Witwatersrand, South Africa||2|||f||||t||||||||Undecided||2017-10-10 22:30:17.320562|2017-10-10 22:30:17.320562
NCT02671370|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-05-08|||January 2016||2016-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Observational|||Cervical Range of Motion in Neck Pain Patients: A Mixed Methods Study|Cervical Range of Motion in Neck Pain Patients: A Mixed Methods Study|Completed||N/A|30|Actual|Balgrist University Hospital|||1||f||||f||||||||No|no there is not|2017-10-10 22:30:17.426424|2017-10-10 22:30:17.426424
NCT02671357|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-04-06|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|ERAMIP||Enhanced Recovery After Minimally Invasive Pancreaticoduodenectomy|Enhanced Recovery After Minimally Invasive Pancreaticoduodenectomy With Stented Pancreaticogastrostomy and Roux-en-y Gastro-enterostomy|Completed||N/A|51|Actual|University Hospital, Gasthuisberg|||1||f||||f||||||||No||2017-10-10 22:30:17.507335|2017-10-10 22:30:17.507335
NCT02671344|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-08-21|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Observational|||Determining the Genetic Profile in Semen Donors With Pregnancy, Donor Versus no Pregnancy Obtained in TRA|Determination of Gene Profiling in Semen Donors With Pregnancy Versus no Donor Gestation, Obtained in Assisted Reproduction Treatments|Suspended||N/A|30|Anticipated|IVI Bilbao|||3|could not be obtained enough sperm RNA is highly fragmented and very difficult to purify.|f||||f||||||Samples With DNA|"     Determination of gene profiles characterizing the set of mRNA from donor seminal samples   "|||2017-10-10 22:30:17.617026|2017-10-10 22:30:17.617026
NCT02671331|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-07-05|||January 2016||2016-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Observational|||Loop Duodenal Switch Surgery in Morbidly Obese Patients|The Effect of Loop Duodenal Switch Surgery in Morbidly Obese Patients on Weight Loss at One Year|Terminated||N/A|1|Actual|Medical College of Wisconsin|||1|Principal investigator terminated study due to low enrollment.|f||||f||||||||No||2017-10-10 22:30:17.702071|2017-10-10 22:30:17.702071
NCT02671318|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-08-15|||September 2015||2015-09-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|December 2019|Anticipated|2019-12-01||Interventional|StopCMV||Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence|Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence in Kidney Transplant Recipients (StopCMV: S=Sirolimus CMV= Cytomegalovirus)|Recruiting||Phase 4|250|Anticipated|Hospital do Rim e Hipertensão||2|||f||||t||||||||Undecided||2017-10-10 22:30:17.785032|2017-10-10 22:30:17.785032
NCT02671305|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-25|||April 2016||2016-04-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|PCI-T||Delivery Room Assistance With the Placental Circulation Intact|Delivery Room Assistance With the Placental Circulation Intact: Effects on Early Postnatal Adaptation and Outcome of Preterm Babies. Study Protocol for a Randomized Control Trial (the PCI-trial)|Recruiting||N/A|20|Anticipated|University of Florence||2|||f||||f||||||||No||2017-10-10 22:30:17.90714|2017-10-10 22:30:17.90714
NCT02671292|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-02|||July 2015||2015-07-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|POMC-A||Preventing Obesity in Military Communities-Adolescents|Preventing Obesity in Military Communities-Adolescents|Recruiting||N/A|300|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||t||||||||||2017-10-10 22:30:18.014206|2017-10-10 22:30:18.014206
NCT02671279|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-07-03|||August 2016||2016-08-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|PreBar||Low Calorie Diet in Morbidly Obese Patients|Effect of 6 Days Low Calorie Diet Before Bariatric Surgery|Recruiting||N/A|14|Anticipated|Haukeland University Hospital||1|||f||||f||||||||||2017-10-10 22:30:18.163023|2017-10-10 22:30:18.163023
NCT02671266|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-04-27|||December 2014||2014-12-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Oxytocin Administration in BDD and OCD|Effect of Intranasal Oxytocin on Social Cognition|Recruiting||Phase 2|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 22:30:18.249089|2017-10-10 22:30:18.249089
NCT02671253|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-31|||October 2015||2015-10-01|January 2016|2016-01-01||||January 2018|Anticipated|2018-01-01||Observational|||Myomectomies:Tumor Characteristics and Clinical Implications|Myomectomies:Tumor Characteristics and Clinical Implications|Recruiting||N/A|100|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||||No||2017-10-10 22:30:18.351768|2017-10-10 22:30:18.351768
NCT02671240|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-05-19|||October 24, 2016|Actual|2016-10-24|May 2017|2017-05-01|October 24, 2021|Anticipated|2021-10-24|October 24, 2021|Anticipated|2021-10-24||Observational|PROBA-PD||Prognosis of Behavioral Addiction in Parkinson's Disease||Recruiting||N/A|200|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||||No||2017-10-10 22:30:18.422275|2017-10-10 22:30:18.422275
NCT02671227|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-01-26|||August 2016||2016-08-01|August 2016|2016-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Intrathecal Mg in Gynecologic Laparoscopic Surgeries.|Effects of Addition of Magnesium Sulfate in Spinal Anesthesia on Surgeon Satisfaction and Postoperative Pain in Gynecologic Laparoscopic Surgeries.|Completed||Phase 2|50|Anticipated|Assiut University||2|||f||||t||||||||Yes||2017-10-10 22:30:18.491033|2017-10-10 22:30:18.491033
NCT02671214|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-02-01|||November 2010||2010-11-01|January 2016|2016-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||The Effect of Selected Fibres and Flours in Flat Bread on Post-prandial Blood Glucose Responses|The Effect of Selected Fibres and Flours in Flat Bread on Post-prandial Blood Glucose Responses|Completed||N/A|42|Actual|Unilever R&D||12|||f||||f||||||||||2017-10-10 22:30:18.562234|2017-10-10 22:30:18.562234
NCT02671201|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-05-01|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Observational|||Training Concepts in Emergency Ultrasonography|Training Concepts in Emergency Ultrasonography for Medical Students|Not yet recruiting||N/A|100|Anticipated|University of Cologne|||3||f||||f||||||||No|No plan to share data.|2017-10-10 22:30:18.664879|2017-10-10 22:30:18.664879
NCT02671188|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-07-12|||June 1, 2018|Anticipated|2018-06-01|July 2017|2017-07-01|August 9, 2019|Anticipated|2019-08-09|August 9, 2019|Anticipated|2019-08-09||Interventional|||A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis|A Multi-centre, Randomised, Double-blind (Sponsor Open), Placebo-controlled, Repeat Dose, Proof of Mechanism Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis|Not yet recruiting||Phase 1|18|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 22:30:18.742357|2017-10-10 22:30:18.742357
NCT02671175|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-10-05|||May 2016||2016-05-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|PMC||Post-discharge Malaria Chemoprevention(PMC) Study|Malaria Chemoprevention With Monthly Treatment With Dihydroartemisinin-piperaquine for the Post-discharge Management of Severe Anaemia in Children Aged Less Than 5 Years in Uganda and Kenya: A Two-arm Randomised Placebo Controlled Trial|Recruiting||Phase 3|2212|Anticipated|Liverpool School of Tropical Medicine||2|||f||||t||||||||Yes|Individual, de-identified participant data will be made available for meta-analyses as soon as the data analysis is completed, with the understanding that results of the meta-analysis will not be published prior to the results of the individual trial without prior agreement of the investigators. No later than 5 years after the publication of the trial a fully de-identified data set will be available for sharing purposes|2017-10-10 22:30:18.868157|2017-10-10 22:30:18.868157
NCT02671162|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-02-01|||July 2015||2015-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus|Evaluation the Effect of Fumaria Parviflora L. on Uremic Pruritus of End-stage Renal Disease Patients: A Randomized Double- Blind Placebo-controlled Clinical Trial|Completed||Phase 2|63|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||Yes||2017-10-10 22:30:19.130806|2017-10-10 22:30:19.130806
NCT02671149|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-02-01|||September 2015||2015-09-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||The Effect of Small Changes in Hydration on Cognition|How do Small Changes in Hydration Influence Cognition: A Mechanistic Investigation|Active, not recruiting||N/A|130|Anticipated|Swansea University||2|||f||||f||||||||||2017-10-10 22:30:19.223462|2017-10-10 22:30:19.223462
NCT02671136|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-09-28|||October 2015||2015-10-01|September 2017|2017-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Hyperbaric Oxygen Therapy as Adjunctive Therapy to Scaling and Root-planing in the Management of Periodontitis in Patients With Type 2 Diabetes|Hyperbaric Oxygen Therapy as Adjunctive Therapy to Scaling and Root-planing in the Management of Periodontitis in Patients With Type 2 Diabetes|Terminated||N/A|3|Actual|Loma Linda University||2|||f||||f||||||||||2017-10-10 22:30:19.312396|2017-10-10 22:30:19.312396
NCT02671123|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-04|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Does Co-registration of OCT and Angiography Reduce Geographic Miss of Stent Implantation?|Evaluation of Effect of Co-registration Between Optical Coherence Tomography (OCT) and Coronary Angiography Onto OCT Guided Percutaneous Coronary Intervention (PCI)|Recruiting||N/A|200|Anticipated|St. Francis Hospital, New York||2|||f||||f||||||||Undecided|Presently not a plan to share data|2017-10-10 22:30:19.39712|2017-10-10 22:30:19.39712
NCT02671110|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-01-29|||August 2013||2013-08-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Trial Comparing Two Approaches to Weight Loss|A Randomized Trial Comparing Two Approaches to Weight Loss|Completed||N/A|98|Actual|Bowling Green State University||2|||f||||f||||||||||2017-10-10 22:30:19.509778|2017-10-10 22:30:19.509778
NCT02671097|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-09-07|||February 2016||2016-02-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate|A Phase 1, Open Label, Fixed-sequence Study to Evaluate the Effect of BAY1841788 (ODM-201) on Drug Transporters Using Rosuvastatin as Probe Substrate and to Assess Pharmacokinetics and Safety of BAY1841788 in Female and Male Volunteers|Completed||Phase 1|30|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:30:19.59952|2017-10-10 22:30:19.59952
NCT02671084|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-08-01|||February 2016||2016-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Sevoflurane and Percutaneous Coronary Intervention by Stent|Use of Sevoflurane in Patients Submitted a Percutaneous Coronary Intervention by Stent|Active, not recruiting||Phase 4|1254|Anticipated|Instituto Dante Pazzanese de Cardiologia||2|||f||||t||||||||||2017-10-10 22:30:19.698538|2017-10-10 22:30:19.698538
NCT02671071|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-02-22|||April 2016||2016-04-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|December 2017|Anticipated|2017-12-01|3 Years|Observational [Patient Registry]|||Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I Study|Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I Study|Recruiting||N/A|800|Anticipated|Latin American Cooperative Oncology Group|||1||f||||t||||||||||2017-10-10 22:30:19.801688|2017-10-10 22:30:19.801688
NCT02669069|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-07-28|||May 2016||2016-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment Evaluation of Neuromodulation for Tinnitus (TENT-A)|Treatment Evaluation of Neuromodulation for Tinnitus (TENT-A)|Active, not recruiting||N/A|342|Anticipated|Neuromod Devices Ltd.||3|||f||||t|f|f||||||||2017-10-10 22:30:41.909898|2017-10-10 22:30:41.909898
NCT02671058|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-26|||March 2016||2016-03-01|July 2017|2017-07-01|May 24, 2016|Actual|2016-05-24|May 24, 2016|Actual|2016-05-24||Interventional|||Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories|Randomized, Open Label, Crossover Study Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Administered as a Suppository With the Sephure® Rectal Suppository Applicator Compared With Cortenema in Healthy Subjects|Completed||Phase 1|16|Actual|Cristcot LLC||2|||f||||f||||||||||2017-10-10 22:30:20.026129|2017-10-10 22:30:20.026129
NCT02671045|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-28|||April 2015||2015-04-01|January 2016|2016-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer|A Prospective Observational Study of Comprehensive Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer|Recruiting||N/A|1100|Anticipated|Cota Inc.|||7||f||||f||||||||No||2017-10-10 22:30:20.124972|2017-10-10 22:30:20.124972
NCT02671032|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-01-31|||December 2015||2015-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CLTD5626||CHANGE Feasibility Study|Characterisation of Audiological Outcomes With the Nucleus CI532 Cochlear Implant in Adult Subjects.|Recruiting||N/A|12|Anticipated|Cochlear||1|||f||||f||||||||Undecided|Data may be presented at international cochlear implant conferences.|2017-10-10 22:30:20.280272|2017-10-10 22:30:20.280272
NCT02671019|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-08-30|||November 2015||2015-11-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care|Comparing Effectiveness and Costs of Internet-based Treatment for Problematic Alcohol Use and Face-to-face Treatment in Addiction Care: A Randomized Controlled Trial|Recruiting||N/A|350|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:30:20.387381|2017-10-10 22:30:20.387381
NCT02671006|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-09-13|||March 2016|Actual|2016-03-01|December 2016|2016-12-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Observational|CUBIC||Monitoring Chronic Urticaria Basophil Irritability by Cytometry|Monitoring Chronic Urticaria Basophil Irritability by Cytometry (Monocentric Study)|Completed||N/A|60|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f|f|f||||Samples With DNA|"     Blood sample will be collected during a venipuncture required for the medical follow up and     should not interfere with the usual treatment.   "|||2017-10-10 22:30:20.526065|2017-10-10 22:30:20.526065
NCT02670993|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-09-19|||January 2016||2016-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|LACME||Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease|Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease. Multicenter Study LACME|Completed||N/A|59|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:30:20.62759|2017-10-10 22:30:20.62759
NCT02670980|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-23|||January 2016||2016-01-01|January 2017|2017-01-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|IRIS 2||Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy|Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy|Active, not recruiting||N/A|10|Anticipated|Pixium Vision SA||1|||f||||f||||||||No||2017-10-10 22:30:20.731399|2017-10-10 22:30:20.731399
NCT02670967|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-02-01|||September 2014||2014-09-01|August 2015|2015-08-01||||September 2015|Anticipated|2015-09-01||Observational|||Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials|Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials|Unknown status|Active, not recruiting|N/A|500|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-10 22:30:20.8357|2017-10-10 22:30:20.8357
NCT02670954|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-28|||October 2015||2015-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of the Effect of Appropriate Sedation for Patients After Abdominal Surgeries : A Prospective Randomised Controlled Study||Completed||N/A|154|Actual|Chinese Medical Association||2|||f||||f||||||||Yes|basic characteristics of participant,interventions, primary and secondary outcomes, main results|2017-10-10 22:30:20.912526|2017-10-10 22:30:20.912526
NCT02670941|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-09-01|||January 2016||2016-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Aromatherapy for Chemotherapy-induced Symptoms|Aromatherapy for Management of Chemotherapy-induced Symptoms|Recruiting||Early Phase 1|120|Anticipated|University of Rochester||4|||f||||t||||||||No||2017-10-10 22:30:21.017689|2017-10-10 22:30:21.017689
NCT02670928|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-14|||July 20, 2015|Actual|2015-07-20|April 2017|2017-04-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|||Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.|Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.|Completed||Phase 4|100|Actual|Novartis||2|||f||||f||||||||||2017-10-10 22:30:21.199538|2017-10-10 22:30:21.199538
NCT02670915|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-09-28|||May 4, 2016|Actual|2016-05-04|September 2017|2017-09-01|March 5, 2018|Anticipated|2018-03-05|February 4, 2018|Anticipated|2018-02-04||Interventional|onset®7||Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes|Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes|Recruiting||Phase 3|803|Anticipated|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-10 22:30:21.320602|2017-10-10 22:30:21.320602
NCT02670902|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-09-20|||December 2016||2016-12-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Intervention for Persons Leaving Residential Substance Abuse Treatment|Intervention for Persons With Co-Occurring Disorders Leaving Residential Tx|Not yet recruiting||N/A|60|Anticipated|New York University||2|||f||||f||||||||No||2017-10-10 22:30:21.689824|2017-10-10 22:30:21.689824
NCT02670889|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-23|||November 2016||2016-11-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Urease Inhibitor Drug Treatment for Urea Cycle Disorders|Manipulating the Gut Microbiome in Urea Cycle Disorders|Not yet recruiting||Phase 1/Phase 2|16|Anticipated|Children's Research Institute||2|||f||||t||||||||No||2017-10-10 22:30:21.787489|2017-10-10 22:30:21.787489
NCT02670876|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-01-28|||January 2014||2014-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||Effectiveness of an Anti-bullying Intervention for Adolescent Perpetrators|Effectiveness of an Anti-bullying Intervention for Adolescent Perpetrators: Using Tools Measuring Brain Function and Structure, Cognition and Behavior.|Completed||N/A|27|Actual|Seoul National University Childrens Hospital||1|||f||||||||||||||2017-10-10 22:30:21.877104|2017-10-10 22:30:21.877104
NCT02670863|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-07|||January 21, 2016|Actual|2016-01-21|September 2017|2017-09-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Safety and Efficacy Study|Safety and Efficacy of a New Term Infant Formula Supplemented With A Prebiotic: a Doubleblind, Randomized, Controlled Trial|Completed||Phase 3|239|Actual|Nestlé||2|||f||||f|f|f||||||||2017-10-10 22:30:21.944587|2017-10-10 22:30:21.944587
NCT02670850|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-02-02|||August 1, 2013|Actual|2013-08-01|July 2016|2016-07-01|July 31, 2016|Actual|2016-07-31|July 31, 2016|Actual|2016-07-31||Interventional|||Intervention Program for Patients With Mild Cognitive Impairment|A Model of Family Caregiving and Model-based Intervention Program for Family Caregivers of Patients With Mild Cognitive Impairment|Completed||N/A|60|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-10 22:30:22.024949|2017-10-10 22:30:22.024949
NCT02670837|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-02-17|||August 4, 2016|Actual|2016-08-04|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of Cellutome System for Treatment of Individual Lesions in EB Pts|Study of Epidermal Grafting Using the CelluTome Epidermal Harvesting System for the Treatment of Individual Lesions in Persons With Epidermolysis Bullosa [MT2015-36]|Recruiting||N/A|40|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t|f|t|f||f|||||2017-10-10 22:30:22.101609|2017-10-10 22:30:22.101609
NCT02670824|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-08-16|||December 2015||2015-12-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage|Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects|Completed||Phase 1|48|Actual|AegisCN LLC||2|||f||||t||||||||No||2017-10-10 22:30:22.203062|2017-10-10 22:30:22.203062
NCT02670811|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-11|2016-07-05||August 2013||2013-08-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Antihypertensive Effect of Fermented Milk With Lactococcus Lactis on Prehypertensive Subjects|Randomized Double-blind Controlled Clinical Study of the Antihypertensive Effect of Fermented Milk With Lactococcus Lactis NRRL-B50571|Completed||Phase 3|36|Actual|Centro de Investigación en Alimentación y Desarrollo A.C.||2|||f||||f||||||||Undecided||2017-10-10 22:30:22.279382|2017-10-10 22:30:22.279382
NCT02670798|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-11-10|||August 2015||2015-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Thromboelastography Transfusion Protocol for Pediatric Neuromuscular Scoliosis Surgery|Implementation of a Thromboelastography Guided Transfusion Protocol in Pediatric Neuromuscular Scoliosis Surgery|Recruiting||N/A|50|Anticipated|Washington University School of Medicine||2|||f||||t||||||||No||2017-10-10 22:30:23.039546|2017-10-10 22:30:23.039546
NCT02670785|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-08-21|||February 15, 2016|Actual|2016-02-15|August 2017|2017-08-01|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Interventional|||A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy|A Phase 2, Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate Safety and Efficacy of Three Doses of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy|Completed||Phase 2|203|Actual|Warner Chilcott||4|||f||||f|t|f||||||||2017-10-10 22:30:23.165238|2017-10-10 22:30:23.165238
NCT02670772|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-28|||July 2012||2012-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|D4T||Dose Optimisation of Stavudine for the Treatment of HIV Infection|A Randomised, Double-Blind, Multi-Centre, Parallel-Group Phase 3b Study to Demonstrate Non-inferiority of Stavudine (20 mg Twice Daily) Compared With Tenofovir Disoproxil Fumarate (300 mg Once Daily) When Administered in Combination With Lamivudine and Efavirenz in Antiretroviral-Naive Patients Infected With HIV-1|Completed||Phase 3|1077|Actual|University of Witwatersrand, South Africa||2|||f||||t||||||||Undecided||2017-10-10 22:30:23.345106|2017-10-10 22:30:23.345106
NCT02670746|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-01-23|||October 2015||2015-10-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|TRUST||A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer|Non-interventional Observational Post-authorization Study to Assess Clinical and Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Routine Clinical Practice Treating Pancreatic Cancer (TRUST)|Recruiting||N/A|200|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 22:30:23.649258|2017-10-10 22:30:23.649258
NCT02670733|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-03-24|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Effect of Increased Positive End-expiratory Pressure on Intracranial Pressure in Different Respiratory Mechanic in Acute Respiratory Distress Syndrome||Completed||N/A|30|Actual|Capital Medical University|||2||f||||||||||||||2017-10-10 22:30:23.804658|2017-10-10 22:30:23.804658
NCT02670720|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-02-15|||December 2015||2015-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|OPuS-4||Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema|OPuS-4: An Open-label Study to Evaluate the Long-term Safety of Avoralstat in Subjects With Hereditary Angioedema|Terminated||Phase 3|6|Actual|BioCryst Pharmaceuticals||1||"preceding efficacy study of avoralstat in its current formulation was not significant and does   not support continued development"|f||||t||||||||||2017-10-10 22:30:23.892377|2017-10-10 22:30:23.892377
NCT02670707|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-07-12|||March 2016||2016-03-01|July 2017|2017-07-01|January 2025|Anticipated|2025-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)|Randomization of Cytarabine Monotherapy Versus Standard-of-Care Vinblastine/Prednisone for Frontline Treatment of Langerhans Cell Histiocytosis (TXCH LCH0115)|Recruiting||Phase 3|124|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 22:30:24.026581|2017-10-10 22:30:24.026581
NCT02670681|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-30|||November 2015||2015-11-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of Aerobic Exercise on Blood Pressure Levels of Resistant Hypertensive Subjects|Effects of Different Intensities of Aerobic Exercise on Blood Pressure Levels of Resistant Hypertensive Subjects|Recruiting||N/A|100|Anticipated|Federal University of Paraíba||3|||f||||f||||||||No|Individual data are not the most important points of this study, but the results for the overall sample (external validity of the results found).|2017-10-10 22:30:24.287853|2017-10-10 22:30:24.287853
NCT02670668|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-01-28|||January 2016||2016-01-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer|Single Centre，Exploratory，Parallel and Retrospective Study to Analysis the Mutation and Expression of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer|Not yet recruiting||N/A|100|Anticipated|Fudan University||2|||f||||f||||||||Undecided||2017-10-10 22:30:24.387397|2017-10-10 22:30:24.387397
NCT02670655|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-01-28|||June 2014||2014-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis|Efficacy of Iontophoresis-assisted Ablative Fractional Laser Photodynamic Therapy With Short Incubation Time for the Treatment of Actinic Keratosis: 12-month Follow-up Results of a Prospective, Randomised, Comparative Trial|Completed||Phase 1|45|Actual|Dong-A University||3|||f||||f||||||||No||2017-10-10 22:30:24.507963|2017-10-10 22:30:24.507963
NCT02670642|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-01-28|||August 2001||2001-08-01|January 2016|2016-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|NEED||Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD|On Demand vs Continuous Treatment of Endoscopy Negative Subjects With Gastroesophageal Reflux Disease (GERD) With Esomeprazole 20-mg Once Daily Over a 6 Months Long Term Treatment Phase. An Open, Randomised, Multicenter Study. NEED.|Completed||Phase 3|877|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:30:24.639464|2017-10-10 22:30:24.639464
NCT02670616|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-05-18|||May 2016||2016-05-01|May 2016|2016-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma|Phase II Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma 54179060LYM2003 (Nick Name: IVORY Study)|Recruiting||Phase 2|24|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 22:30:24.980673|2017-10-10 22:30:24.980673
NCT02670603|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-04-26|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis|A Prospective Randomized Controlled Trial of Evonail® Solution for Prevention or Treatment of Onycholysis in Breast Cancer Patients Who Received Neoadjuvant/Adjuvant Docetaxel Chemotherapy|Completed||N/A|100|Actual|Samsung Medical Center||2|||f||||t||||||||No||2017-10-10 22:30:25.092464|2017-10-10 22:30:25.092464
NCT02670590|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-07-09|||January 2011||2011-01-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ct-NAFLD||NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary Life|NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary Life|Completed||N/A|150|Actual|Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele||1|||f||||f||||||||||2017-10-10 22:30:25.16716|2017-10-10 22:30:25.16716
NCT02670577|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-06-26|||November 2015||2015-11-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|April 30, 2017|Actual|2017-04-30|2 Months|Observational [Patient Registry]|IMPACt||Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry|Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry|Active, not recruiting||N/A|481|Anticipated|Agendia|||4||f||||f||||||||||2017-10-10 22:30:25.225442|2017-10-10 22:30:25.225442
NCT02670564|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-02-27|||April 2013||2013-04-01|February 2017|2017-02-01|April 2023|Anticipated|2023-04-01|April 2018|Anticipated|2018-04-01||Interventional|||ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)|Allogeneic Stem Cell Transplant for Children and Adolescents With Acute Lymoblastic Leukemia FORUM - Pharmacogenomic Study (add-on Study)|Recruiting||Phase 4|1000|Anticipated|Swiss Pediatric Oncology Group||3|||f||||t||||||||Undecided||2017-10-10 22:30:25.326698|2017-10-10 22:30:25.326698
NCT02670551|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-06-24|||March 2016||2016-03-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Patients With Bipolar I Depression|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression|Recruiting||Phase 3|480|Anticipated|Forest Laboratories||3|||f||||f||||||||||2017-10-10 22:30:25.485458|2017-10-10 22:30:25.485458
NCT02670538|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-06-24|||March 2016||2016-03-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Patients With Bipolar I Disorder|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression|Recruiting||Phase 3|480|Anticipated|Forest Laboratories||3|||f||||f||||||||||2017-10-10 22:30:25.656913|2017-10-10 22:30:25.656913
NCT02670525|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-04-30|||February 2016||2016-02-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|March 2019|Anticipated|2019-03-01||Interventional|||Matched Targeted Therapy For High-Risk Leukemias|Matched Targeted Therapy (MTT) Recommendation for Patients With Recurrent, Refractory, or High Risk Leukemias|Recruiting||N/A|200|Anticipated|Dana-Farber Cancer Institute||2|||f||||f||||||||No||2017-10-10 22:30:25.806339|2017-10-10 22:30:25.806339
NCT02669056|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-04-27|||January 2016||2016-01-01|January 2016|2016-01-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Brainstem and Prematurity|Brainstem Assesment in a Cohort of Very Preterm Babies (Less Than 28 Weeks)|Recruiting||N/A|34|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:30:41.991777|2017-10-10 22:30:41.991777
NCT02670512|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-09-07|||June 2016||2016-06-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|July 2019|Anticipated|2019-07-01||Interventional|CONNECT||Assessment of Telehome Monitoring in Patients on Peritoneal Dialysis: A Multicentre Randomized Controlled Trial|Assessment of Telehome Monitoring in Patients on Peritoneal Dialysis (CONNECT Trial): A Multicentre Randomized Controlled Trial|Recruiting||N/A|500|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-10 22:30:25.952392|2017-10-10 22:30:25.952392
NCT02670499|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-06-26|||November 18, 2015|Actual|2015-11-18|June 2017|2017-06-01|June 23, 2017|Actual|2017-06-23|February 7, 2017|Actual|2017-02-07||Interventional|GAP-Flex||Study Comparing GAP-Flex to CPM Therapy in Treatment of TKR|A Randomized Controlled Multicenter Study Comparing GAP-FLEX to Continuous Passive Motion (CPM) Therapy in Combination With Standard of Care Physical Therapy in Subjects With Total Knee Replacement (TKR)|Completed||N/A|28|Actual|Xeras Medical Technologies||2|||f||||f||||||||No||2017-10-10 22:30:27.775638|2017-10-10 22:30:27.775638
NCT02670486|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-05-09|||August 2014||2014-08-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|AVUDE||Audiovisual Stimulus During Urodynamics|Audiovisual Stimulus During Urodynamics to Provoke Detrusor Overactivity|Completed||N/A|218|Actual|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||No||2017-10-10 22:30:27.849122|2017-10-10 22:30:27.849122
NCT02670473|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-17|2017-01-30||January 2016||2016-01-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional||34 subjects completed the study and included in the baseline analysis.|Clinical Performance of Existing Wearers of Enfilcon A Following a Refit With Fanfilcon A Lenses for 4 Weeks|Clinical Performance of Existing Wearers of Enfilcon A Following a Refit With Fanfilcon A Lenses for 4 Weeks|Completed||N/A|35|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 22:30:27.943559|2017-10-10 22:30:27.943559
NCT02670460|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-04-14|||October 2015||2015-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing, a First in Human Trial|Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing, a First in Human Trial|Completed||N/A|24|Actual|Lungpacer Medical Inc.||1|||f||||f||||||||Undecided|Discussing a publication for FIH|2017-10-10 22:30:28.681836|2017-10-10 22:30:28.681836
NCT02670447|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-08-16|||January 2017||2017-01-01|August 2016|2016-08-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Observational|PEPsy||Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies|Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies: A Multicentric Study|Not yet recruiting||N/A|80|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"     Blood samples will be taken for every patient to make toxicological tests.   "|No||2017-10-10 22:30:28.900971|2017-10-10 22:30:28.900971
NCT02670434|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-06-07|||January 2016||2016-01-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia||Terminated||Phase 3|216|Actual|Kowa Research Institute, Inc.||3|||f||||||||||||||2017-10-10 22:30:29.052162|2017-10-10 22:30:29.052162
NCT02670421|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-03-22|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Stress Management Intervention in Women's Heart Clinic, Heart SMART Program|Stress Management Intervention in Women's Heart Clinic, Heart SMART Program|Completed||N/A|50|Actual|Mayo Clinic||2|||f||||f|f|f||||||No||2017-10-10 22:30:29.231676|2017-10-10 22:30:29.231676
NCT02670408|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-07-11|||January 2016||2016-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation|Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation, a Multicenter Study (INTERHEART)|Recruiting||N/A|300|Anticipated|University of Alberta|||1||f||||f||||||Samples Without DNA|"     Biopsy extract containing RNA   "|||2017-10-10 22:30:29.311015|2017-10-10 22:30:29.311015
NCT02670395|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2016-09-23|||April 2016||2016-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study to Investigate the Safety, Tolerability, Food Effect, and Pharmacokinetics of JNJ-54416076 in Healthy Participants|A Double Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, Food Effect, and Pharmacokinetics of JNJ-54416076 in Healthy Male Subjects|Completed||Phase 1|64|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 22:30:29.453841|2017-10-10 22:30:29.453841
NCT02670382|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-12-28|||March 2016||2016-03-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids|Role of EPA and DHA in Fish Oil on Inflammation and Lipoprotein Metabolism|Recruiting||N/A|24|Anticipated|Tufts University||3|||f||||f||||||||No|The objective of this study is to provide critical information regarding both common and distinctive roles of the omega-3 fatty acids EPA and DHA in systemic inflammation and lipid metabolism.|2017-10-10 22:30:29.539543|2017-10-10 22:30:29.539543
NCT02670356|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-04-24|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study Comparing Fish Oil and Krill Oil|Study Comparing Fish Oil and Krill Oil|Terminated||N/A|2|Actual|Tufts University||2||Study stopped by the company funding the study|f||||f||||||||No||2017-10-10 22:30:29.727241|2017-10-10 22:30:29.727241
NCT02668640|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-08-21|||May 5, 2016||2016-05-05|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China|Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China|Recruiting||N/A|200|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:30:47.718051|2017-10-10 22:30:47.718051
NCT02670330|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-04-25|||May 2015||2015-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa|An Open Label Multi-Center Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa|Active, not recruiting||N/A|150|Anticipated|Scioderm, Inc.||1|||f||||f||||||||||2017-10-10 22:30:29.924689|2017-10-10 22:30:29.924689
NCT02670317|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-03-16|||September 2016|Actual|2016-09-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|FIL-GALILEO||Phase II Study About Combination CHOP-21, Obinutuzumab and Ibrutinib in Untreated Young High Risk DLBCL Patients.|Multicenter Phase II Single Arm Open-label Study on the Feasibility, Safety and Efficacy of Combination of CHOP-21 Supplemented With Obinutuzumab and Ibrutinib in Untreated Young High Risk Diffuse Large B-cell Lymphoma (DLBCL) Patients.|Terminated||Phase 2|1|Actual|Fondazione Italiana Linfomi ONLUS||1||GA101-CHOP not advantage from rituximab-CHOP|f||||f||||||||No||2017-10-10 22:30:30.102502|2017-10-10 22:30:30.102502
NCT02670291|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-05-26|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|cTBS-AH||Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation|Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation|Recruiting||N/A|86|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||No||2017-10-10 22:30:30.389066|2017-10-10 22:30:30.389066
NCT02670278|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-27|||May 2014||2014-05-01|January 2016|2016-01-01||||August 2018|Anticipated|2018-08-01||Observational|INSPIRE||Evolutionary and Sociocultural Aspects of Human Milk Composition||Recruiting||N/A|960|Anticipated|Washington State University|||11||f||||f||||||Samples With DNA|"     milk, feces, saliva   "|No||2017-10-10 22:30:30.5763|2017-10-10 22:30:30.5763
NCT02670265|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-01-28|||June 2012||2012-06-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|NUPAN||Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions|Early Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions (NUPAN), a Prospective Randomized Interventional Trial|Completed||N/A|100|Actual|University Medicine Greifswald||2|||f||||f||||||||No||2017-10-10 22:30:30.693898|2017-10-10 22:30:30.693898
NCT02670239|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-27|||May 2014||2014-05-01|January 2016|2016-01-01||||January 2018|Anticipated|2018-01-01||Observational|||Pharmacokinetics of Imipenem During Ex Vivo Lung Perfusion (EVLP)||Recruiting||N/A|30|Anticipated|University of Turin, Italy|||1||f||||||||||||||2017-10-10 22:30:30.902003|2017-10-10 22:30:30.902003
NCT02670226|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-14|||March 2016||2016-03-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|METABOMU||Muscular Biomarkers in Amyotrophic Lateral Sclerosis|Metabolomics and Transcriptomics Approaches to Identify Muscular Biomarkers in Amyotrophic Lateral Sclerosis|Recruiting||N/A|40|Anticipated|University Hospital, Tours||2|||f||||f||||||||No||2017-10-10 22:30:30.9852|2017-10-10 22:30:30.9852
NCT02670213|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-08-25|||March 16, 2016|Actual|2016-03-16|August 2017|2017-08-01|September 30, 2024|Anticipated|2024-09-30|September 30, 2024|Anticipated|2024-09-30||Observational|||A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan|A Multicentre, Non-interventional Post Marketing Study of Safety and Effectiveness of NovoThirteenR (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan|Enrolling by invitation||N/A|8|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 22:30:31.096058|2017-10-10 22:30:31.096058
NCT02670200|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-27|||March 2016||2016-03-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|ICBT_MAC||Internet-delivered Psycho-oncological Support|MAC-CBT Used as Internet-delivered Psycho-oncological Support|Not yet recruiting||N/A|180|Anticipated|Neuropsychiatrischen Zentrums Hamburg-Altona||2|||f||||f||||||||No|No this ist not planned yet.|2017-10-10 22:30:31.198794|2017-10-10 22:30:31.198794
NCT02670187|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-07-26|||January 2016||2016-01-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers|Phase I, Open-label, Dose Ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of GLS-5300, Administered IM Followed by Electroporation in Healthy Volunteers|Active, not recruiting||Phase 1|75|Actual|GeneOne Life Science, Inc.||3|||f||||t||||||||Yes||2017-10-10 22:30:31.30333|2017-10-10 22:30:31.30333
NCT02670174|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-05-04|||September 2015||2015-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Influence of Kinetic Chain Training on the Treatment Outcome of Overhead Athletes With Impingement|Influence of Kinetic Chain Training on the Treatment Outcome of Overhead Athletes With Shoulder Impingement Syndrome|Active, not recruiting||N/A|38|Actual|University Ghent||3|||f||||f||||||||No||2017-10-10 22:30:31.3948|2017-10-10 22:30:31.3948
NCT02670161|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2017-01-14|||May 2016||2016-05-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Quality Improvement and Practice Based Research in Neurology Using the EMR|Quality Improvement and Practice Based Research in Neurology Using the Electronic Medical Record|Enrolling by invitation||Phase 4|3300|Anticipated|NorthShore University HealthSystem Research Institute||3|||f||||f||||||||No||2017-10-10 22:30:31.507124|2017-10-10 22:30:31.507124
NCT02670148|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-06-28|||April 2016||2016-04-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ACT3||Assessment of Chiropractic Treatment: Strength and Balance|Assessment of Chiropractic Treatment: Strength and Balance|Recruiting||N/A|110|Anticipated|RAND||2|||f||||t||||||||No||2017-10-10 22:30:31.601927|2017-10-10 22:30:31.601927
NCT02670135|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-01-29|||June 2015||2015-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Clinical Investigation of the Effects of Colgate Total Toothpaste as Compared to a Matching Placebo on Periodontal Disease and Systemic Inflammatory Markers|Clinical Investigation of the Effects of Colgate Total Toothpaste as Compared to a Matching Placebo on Periodontal Disease and Systemic Inflammatory Markers|Unknown status|Active, not recruiting|Phase 4|303|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-10-10 22:30:31.715098|2017-10-10 22:30:31.715098
NCT02670122|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-03-06|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC|Prospective, Multicenter, Non Randomized, Single Arm Study to Evaluate Safety of Transarterial Chemoembolization (TACE) With Doxorubicin Eluting 100 µ Microspheres in Patients With Non Resectable Hepatocellular Carcinoma|Active, not recruiting||N/A|130|Actual|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz|||1||f||||f||||||||No||2017-10-10 22:30:31.828191|2017-10-10 22:30:31.828191
NCT02670109|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-09-13|||November 2015||2015-11-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients|High-dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients Without Complete Pathological Response to Neoadjuvant Chemotherapy|Recruiting||Phase 2|20|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||1|||f||||f||||||||No||2017-10-10 22:30:31.91874|2017-10-10 22:30:31.91874
NCT02670096|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-01-23|||January 2016||2016-01-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||A Single-center Pilot Study Evaluating the Immediate Effects of Low-dose Acetazolamide on Respiratory Control in Subjects With Treatment Emergent Sleep Disordered Breathing|A Single-center Pilot Study Evaluating the Immediate Effects of Low-dose Acetazolamide on Respiratory Control in Subjects With Treatment Emergent Sleep Disordered Breathing|Withdrawn||N/A|0|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:30:32.032321|2017-10-10 22:30:32.032321
NCT02670083|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-25|||March 22, 2016|Actual|2016-03-22|September 2017|2017-09-01|July 31, 2021|Anticipated|2021-07-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of Crenezumab in Patients With Prodromal to Mild Alzheimer's Disease|Recruiting||Phase 3|750|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:30:32.177804|2017-10-10 22:30:32.177804
NCT02670070|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-05-10|||March 2016||2016-03-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone|A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics, Safety, and Tolerability of the Combination of Gemigliptin/Rosuvastatin 50/20 mg in Comparison to Each Component Gemigliptin 50 mg and Rosuvastatin 20 mg Administered in Healthy Male Volunteers|Enrolling by invitation||Phase 1|37|Actual|LG Life Sciences||2|||f||||f||||||||No||2017-10-10 22:30:32.934351|2017-10-10 22:30:32.934351
NCT02670057|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-01-26|||November 2015||2015-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean|Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean|Recruiting||N/A|10|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:30:33.03149|2017-10-10 22:30:33.03149
NCT02670044|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-25|||March 31, 2016|Actual|2016-03-31|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients Aged >/= 60 Years With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy|A Phase IB/II Multi-Arm Study With Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients Aged >/= 60 Years With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy|Recruiting||Phase 1/Phase 2|140|Anticipated|Hoffmann-La Roche||4|||f||||||||||||||2017-10-10 22:30:33.125561|2017-10-10 22:30:33.125561
NCT02670031|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-12-08|||January 2016||2016-01-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|||REMODEL: Hypertensive Heart Disease|Response of the Myocardium to Hypertrophic Conditions in the Adult Population|Recruiting||N/A|500|Anticipated|National Heart Centre Singapore|||3||f||||t||||||Samples With DNA|"     Blood samples will be collected from all participants.   "|No||2017-10-10 22:30:33.284229|2017-10-10 22:30:33.284229
NCT02670018|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-01-31|||August 2015||2015-08-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone|A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of the Combination of Gemigliptin/Metformin HCl Sustained Release 50/2000 mg(25/1000 mg x 2 Tablets) in Comparison to Each Component Gemigliptin 50 mg and Metformin HCl Extended Release 2000 mg(1000 mg x 2 Tablets) Administered in Healthy Male Volunteers|Enrolling by invitation||Phase 1|25|Actual|LG Life Sciences||2|||f||||f||||||||No||2017-10-10 22:30:33.406531|2017-10-10 22:30:33.406531
NCT02670005|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-07-24|||July 2016||2016-07-01|January 2016|2016-01-01||||December 2017|Anticipated|2017-12-01||Observational|||Fractional Flow Reserve Versus Angiography for Guiding Selective Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction||Enrolling by invitation||N/A|600|Anticipated|Nanjing Medical University|||2||f||||f||||||||No||2017-10-10 22:30:33.507176|2017-10-10 22:30:33.507176
NCT02669992|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-01-27|||April 2015||2015-04-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|LISTO||Loop Ileostomy Closure:Stapled or Hand-sewn Anastomoses? Suture or Mesh Closure of the Stoma Site?|Loop Ileostomy Closure.Stapled or Hand-sewn Anastomoses? Suture or Mesh Closure of the Stoma Site in the Abdominal Wall. A Prospective Randomised Multicenter Trial.|Recruiting||N/A|400|Anticipated|Karolinska University Hospital||4|||f||||f||||||||No||2017-10-10 22:30:33.575217|2017-10-10 22:30:33.575217
NCT02669979|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-02-01|||January 2016||2016-01-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Domiciliary Professional Oral Care for Dependent Elderly|Domiciliary Professional Oral Care for Dependent Elderly - Access to Improved Oral and General Health?|Recruiting||N/A|366|Anticipated|Karolinska Institutet||2|||f||||f||||||||No|Data will be be published in scientific papers but not on individual level, only group level|2017-10-10 22:30:33.714461|2017-10-10 22:30:33.714461
NCT02669966|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-03-23|||March 2016||2016-03-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCR|Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCR|Recruiting||N/A|6|Anticipated|University of Florida||1|||f||||f|f|f||||||No||2017-10-10 22:30:33.857911|2017-10-10 22:30:33.857911
NCT02669953|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-05-24|||December 2015||2015-12-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|OPHTH-010915||Aflibercept in Recurrent or Persistent CNV|Response to Aflibercept After Previous Intravitreal Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration|Recruiting||N/A|80|Anticipated|Medical University of Vienna|||4||f||||||||||||||2017-10-10 22:30:33.998282|2017-10-10 22:30:33.998282
NCT02669940|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-07-21|||April 15, 2016||2016-04-15|July 2017|2017-07-01|July 4, 2017|Actual|2017-07-04|July 4, 2017|Actual|2017-07-04||Observational|HCV RWE||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation - An Observational, Multi-Center Study|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation - An Observational, Multi-Center Study|Completed||N/A|158|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 22:30:34.143708|2017-10-10 22:30:34.143708
NCT02669927|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-01-29|||January 2013||2013-01-01|January 2016|2016-01-01||||January 2016|Actual|2016-01-01||Observational|||Frailty and Postoperative Shock||Completed||N/A|53|Actual|Université Catholique de Louvain|||1||f||||||||||||||2017-10-10 22:30:34.274874|2017-10-10 22:30:34.274874
NCT02669914|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-07-18|||September 12, 2016|Actual|2016-09-12|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors|A Phase II Study of MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors|Recruiting||Phase 2|136|Anticipated|Washington University School of Medicine||3|||f||||t|t|f||||||||2017-10-10 22:30:34.336965|2017-10-10 22:30:34.336965
NCT02669901|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Substance Use Disorder|Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Substance Use Disorder|Recruiting||N/A|400|Anticipated|University of New Mexico||1|||f||||t||||||||Yes||2017-10-10 22:30:34.451885|2017-10-10 22:30:34.451885
NCT02669888|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-02-13|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Indigo Naturalis in Treating Atopic Dermatitis Topically|Efficacy and Safety of Topical Indigo Naturalis in Treating Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|48|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||No||2017-10-10 22:30:34.536341|2017-10-10 22:30:34.536341
NCT02669875|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-10|||May 31, 2017|Anticipated|2017-05-31|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|STOPP||Serelaxin To Lower Portal Pressure|Serelaxin To Lower Portal Pressure in Patients With Cirrhosis and Portal Hypertension|Not yet recruiting||Phase 2|20|Anticipated|University of Edinburgh||2|||f||||f|f|f||||||No||2017-10-10 22:30:34.626933|2017-10-10 22:30:34.626933
NCT02669862|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2016-12-13|||October 2013||2013-10-01|December 2016|2016-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study of A-101 Solution in Subjects With Common Warts.|A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Solution in Subjects With Common Warts.|Completed||Phase 2|92|Actual|Aclaris Therapeutics, Inc.||3|||f||||||||||||||2017-10-10 22:30:34.713512|2017-10-10 22:30:34.713512
NCT02669836|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-02-07|||April 2016||2016-04-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia|Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia|Recruiting||N/A|216|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 22:30:34.92085|2017-10-10 22:30:34.92085
NCT02669823|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-07-19|||April 1, 2016|Actual|2016-04-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|PALUBAC||Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region|Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region|Completed||N/A|930|Actual|Sysmex Europe GmbH|||2||f||||||||||||||2017-10-10 22:30:35.224675|2017-10-10 22:30:35.224675
NCT02669810|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-12|||October 2015||2015-10-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|EXCELLENT||EXpanded CELL ENdocardiac Transplantation (EXCELLENT)|A Multicentric Controlled Phase I / IIb Study Evaluating the Safety and the Efficacy of in Vitro Expanded Peripheral Blood CD34+ Stem Cells Output by the StemXpand® Automated Process, and Injected in Patients With an Acute Myocardial Infarction and a Left Ventricle Ejection Fraction (LVEF) Remaining Below or Equal to 45% After PTCA and Stent(s) Implantation Versus Standard of Care.|Recruiting||Phase 2|44|Anticipated|CellProthera||2|||f||||t||||||||||2017-10-10 22:30:35.3372|2017-10-10 22:30:35.3372
NCT02669043|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-07-18|2017-02-24||July 2016||2016-07-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects|Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects|Terminated||N/A|8|Actual|Massachusetts General Hospital||1||Funding ended.|f||||t||||||||||2017-10-10 22:30:42.073921|2017-10-10 22:30:42.073921
NCT02669784|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-01-20|||February 2016||2016-02-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||CTA Volume Dose Reduction Study|Does Reduction in Contrast Administration Dose in Computed Tomography Arteriograms Degrade Image Quality? A Single Institutional Review of an Ultra-low Contrast Dose Protocol|Recruiting||N/A|180|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 22:30:35.573819|2017-10-10 22:30:35.573819
NCT02669771|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-09-25|||December 1, 2014|Actual|2014-12-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Long-Term Specified Drug Use-Results Survey for Xtandi Capsule|Xtandi® Capsules 40 mg Protocol for Long-Term Specified Drug Use-Results Survey|Active, not recruiting||N/A|1018|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 22:30:35.660702|2017-10-10 22:30:35.660702
NCT02669758|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-05-02|||January 2016||2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia|A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects With Schizophrenia|Enrolling by invitation||Phase 3|390|Anticipated|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 22:30:35.848124|2017-10-10 22:30:35.848124
NCT02669745|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-28|2017-01-23|||November 2015||2015-11-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients|The Study of Molecular Risk Panels in Chinese Breast Cancer Patient Using Mammaprint, TargetPrint, BluePrint and Research Gene Panel Assays.|Recruiting||N/A|50|Anticipated|Agendia|||1||f||||f||||||||Undecided||2017-10-10 22:30:35.982026|2017-10-10 22:30:35.982026
NCT02669732|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-12-12|||January 2016||2016-01-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic Clamp|A Phase 2, Randomized, Placebo-controlled, Double-blind, Crossover Study of DS-8500a to Evaluate the Effects on Pancreatic Beta Cell Function in Japanese Patients With Type 2 Diabetes Mellitus.|Completed||N/A|21|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:30:36.0713|2017-10-10 22:30:36.0713
NCT02669719|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-28|||January 2016||2016-01-01|January 2016|2016-01-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC|A Randomized Phase II Study to Evaluate Efficacy and Safety of DCVAC/LuCa Added to Chemotherapy With Carboplatin and Pemetrexed vs Chemotherapy Alone in Patients With Stage IV Non-small Cell Lung Cancer|Recruiting||Phase 2|70|Anticipated|Shanghai Chest Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:30:36.169812|2017-10-10 22:30:36.169812
NCT02669706|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-06-29|||March 2015||2015-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia|Assessment of the Safety and Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia in Patients With Hematologic Malignancies and Stem Cell Transplant Recipients.|Completed||Phase 2|50|Actual|University of Illinois at Chicago|||1||f||||f||||||||Yes||2017-10-10 22:30:36.292529|2017-10-10 22:30:36.292529
NCT02669693|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-03-22|||December 2015||2015-12-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Olives on Glycaemic Response in Vivo|Effect of Olives on Glycaemic Response in Vivo|Completed||N/A|16|Actual|University of Leeds||2|||f||||||||||||||2017-10-10 22:30:36.39226|2017-10-10 22:30:36.39226
NCT02669680|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-09-05|||February 2016||2016-02-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Granulocyte Colony Stimulating Factor (G-CSF) to Treat Acute-on-chronic Liver Failure|Granulocyte Colony Stimulating Factor (G-CSF) to Treat Acute-on-chronic Liver Failure: A Multicentre Randomized Trial|Recruiting||N/A|292|Anticipated|University of Leipzig||2|||f||||t||||||||No||2017-10-10 22:30:36.488334|2017-10-10 22:30:36.488334
NCT02669667|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-07-11|||February 18, 2016|Actual|2016-02-18|June 2017|2017-06-01|June 12, 2017|Actual|2017-06-12|November 17, 2016|Actual|2016-11-17||Interventional|||Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects|A Phase 1a Randomized, Blinded, Placebo-controlled, Single-ascending Dose Study to Evaluate the Safety and Tolerability of MEDI9314 in Healthy Adult Subjects|Completed||Phase 1|44|Actual|MedImmune LLC||6|||f||||f||||||||||2017-10-10 22:30:36.604171|2017-10-10 22:30:36.604171
NCT02669654|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-08-31|||November 2015||2015-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Day-care||Effectiveness Trial of Day-care vs. Usual Care of Severe Pneumonia & Malnutrition in Children|Effectiveness Trial of Day-care Versus Usual Care Management of Severe Pneumonia With or Without Malnutrition in Children Using the Existing Health System of Bangladesh|Recruiting||Phase 4|4000|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 22:30:36.727424|2017-10-10 22:30:36.727424
NCT02669641|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-01-27|||January 2016||2016-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|SteatoSPC||Complex Imaging Assessment of Steatosis|Complex Imaging Assessment of Steatosis in Patients Under Treatment With Combination Silimarin, Phyllanthus Niruri and Choline|Recruiting||Phase 4|50|Anticipated|University of Medicine and Pharmacy Craiova||1|||f||||t||||||||Undecided||2017-10-10 22:30:36.819647|2017-10-10 22:30:36.819647
NCT02669628|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2017-02-24|||February 2016||2016-02-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Antimullerian Hormone in Endometriomas|Anti-mullerian Hormone in Ovarian Reserve Evaluation After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery. A Pilot Study.|Recruiting||N/A|40|Anticipated|Hospital Universitari de Bellvitge|||2||f||||f||||||||Yes|The individual participant data should be available 6 months after the procedure|2017-10-10 22:30:36.923414|2017-10-10 22:30:36.923414
NCT02666976|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-01-24|||July 2014||2014-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker||Completed||Phase 4|20|Actual|Yonsei University||1|||f||||f||||||||No||2017-10-10 22:31:03.91856|2017-10-10 22:31:03.91856
NCT02669615|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-07-20|||November 1, 2016|Actual|2016-11-01|July 2017|2017-07-01|July 19, 2017|Actual|2017-07-19|June 9, 2017|Actual|2017-06-09||Interventional|||Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation|A Phase II, Open-Label, Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation|Completed||Phase 2|24|Actual|Medical College of Wisconsin||1|||f||||t|t|f||||||||2017-10-10 22:30:37.033812|2017-10-10 22:30:37.033812
NCT02669602|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-02-01|||December 1999||1999-12-01|January 2016|2016-01-01|December 2075|Anticipated|2075-12-01|December 2050|Anticipated|2050-12-01||Observational|||Dynamic Mediterranean Prospective Cohort: the SUN Project|Dynamic Mediterranean Prospective Cohort: the SUN Project|Enrolling by invitation||N/A|22500|Actual|Clinica Universidad de Navarra, Universidad de Navarra|||1||f||||f||||||Samples With DNA|"     Saliva   "|Yes||2017-10-10 22:30:37.14151|2017-10-10 22:30:37.14151
NCT02669589|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-25|||March 2016||2016-03-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|February 2020|Anticipated|2020-02-01||Interventional|RICH||Investigating Different Anticoagulants for Renal Replacement Therapy|Regional Citrate Versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury|Recruiting||Phase 4|1450|Anticipated|University Hospital Muenster||2|||f||||t||||||||||2017-10-10 22:30:37.243171|2017-10-10 22:30:37.243171
NCT02669563|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-02-23|||December 2015||2015-12-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients|An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients|Completed||Early Phase 1|16|Actual|University of Michigan||2|||f||||f||f||||||No||2017-10-10 22:30:37.586932|2017-10-10 22:30:37.586932
NCT02669550|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-09-23|||July 2012||2012-07-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Disposcope Endoscope and Fiberoptic Bronchoscope|A Comparison of Disposcope Endoscope and Fiberoptic Bronchoscope During Awake Orotracheal Intubation in Obese Patients With Anticipated Difficult Airway : A Prospective, Randomised and Controlled Clinical Trial|Completed||N/A|40|Actual|The First Hospital of Qinhuangdao||2|||f||||t||||||||||2017-10-10 22:30:37.69835|2017-10-10 22:30:37.69835
NCT02669537|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-27|||May 2016||2016-05-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Utility of the GoPro Hero 3 Camera as an Educational Tool For Vaginal Surgical Skills|Utility of the GoPro Hero 3 Camera as an Educational Tool For Vaginal Surgical Skills|Not yet recruiting||N/A|70|Anticipated|University Hospitals Cleveland Medical Center||4|||f||||f||||||||||2017-10-10 22:30:37.791418|2017-10-10 22:30:37.791418
NCT02669524|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes|Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes - the Role of Glucagon|Completed||N/A|20|Actual|University Hospital, Gentofte, Copenhagen||12|||f||||f||||||||Undecided||2017-10-10 22:30:37.877075|2017-10-10 22:30:37.877075
NCT02669511|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-04-13|||November 2015||2015-11-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|||PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma|Open-label, Non-randomized, Phase 2 Study Evaluating Efficacy and Safety of PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma|Recruiting||Phase 2|21|Anticipated|PIQUR Therapeutics AG||1|||f||||f|t|||||||Undecided||2017-10-10 22:30:38.025488|2017-10-10 22:30:38.025488
NCT02669498|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-01-24|||November 2013||2013-11-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal|Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal|Recruiting||N/A|128|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||No||2017-10-10 22:30:38.173353|2017-10-10 22:30:38.173353
NCT02669485|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-29|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||The Impact of Indocyanine Green-enhanced Fluorescence Imaging on Bowel Transection in Left-sided Colorectal Resection|A Prospective Study to Investigate the Impact of Using Indocyanine Green-enhanced Fluorescence Imaging on the Location of Bowel Transection in Patients Undergoing Left-sided Colorectal Resection|Recruiting||N/A|30|Anticipated|The University of Hong Kong||1|||f||||t||||||||No||2017-10-10 22:30:38.29164|2017-10-10 22:30:38.29164
NCT02669472|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-27|||April 2009||2009-04-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|LWVB||Fresh to You: Multilevel Approaches in Low Income Housing to Increase F&V Intake|Fresh to You: Multilevel Approaches in Low Income Housing to Increase F&V Intake|Completed||Phase 2|1598|Actual|Brown University||2|||f||||f||||||||No|We will make aggregate data available to share.|2017-10-10 22:30:38.397761|2017-10-10 22:30:38.397761
NCT02669459|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-27|||March 2016||2016-03-01|October 2015|2015-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|TopIC-2||Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol|A Randomized, Single Blinded Trial to Evaluate the Efficacy of Imiquimod in Women With Residual/Recurrent Cervical Intraepithelial Neoplasia (CIN) After Previous Treatment|Not yet recruiting||Phase 3|433|Anticipated|Erasmus Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:30:38.473301|2017-10-10 22:30:38.473301
NCT02669446|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-06-20|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Ectoin® Lozenges in the Treatment of Acute Viral Pharyngitis|Non Interventional Clinical Investigation of Ectoin® Lozenges in the Treatment of Acute Viral Pharyngitis|Completed||N/A|90|Actual|Bitop AG|||3||f||||t||||||||||2017-10-10 22:30:38.597589|2017-10-10 22:30:38.597589
NCT02669433|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-09-27|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study|A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)|Active, not recruiting||Phase 2|240|Actual|Axovant Sciences Ltd.||3|||f||||t||||||||||2017-10-10 22:30:38.849676|2017-10-10 22:30:38.849676
NCT02669420|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-01-27|||January 2015||2015-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|MIS||Misoprostol for Second Trimester Pregnancy Termination|Intra Uterine Extra Amniotic (200 μg ) Versus Vaginal (200 μg) Misoprostol for Second Trimester Pregnancy Termination: Randomized Controlled Trial|Completed||Phase 2|180|Actual|Assiut University||2|||f||||t||||||||Yes||2017-10-10 22:30:39.126362|2017-10-10 22:30:39.126362
NCT02669407|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-04-24|||January 1, 2017||2017-01-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Splanchnic Nerve Anesthesia in Heart Failure|Splanchnic Nerve Block for Acute Heart Failure|Recruiting||N/A|10|Anticipated|Duke University||1|||f||||t||||||||||2017-10-10 22:30:39.236104|2017-10-10 22:30:39.236104
NCT02669394|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-06-02|||January 2016||2016-01-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Reshaping the Path of Vascular Cognitive Impairment (VCI)|Reshaping the Path of Vascular Cognitive Impairment With Resistance Training|Recruiting||N/A|88|Anticipated|University of British Columbia||2|||f||||t||||||||No||2017-10-10 22:30:39.39237|2017-10-10 22:30:39.39237
NCT02669381|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-07-13|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 1, 2017|Anticipated|2017-08-01||Interventional|||Phenylalanine Requirements in Healthy Pregnant Women|Dietary Phenylalanine Requirements During Different Stages of Gestation in Healthy Pregnant Women|Recruiting||N/A|30|Anticipated|University of British Columbia||1|||f||||f|f|f||||||||2017-10-10 22:30:39.517271|2017-10-10 22:30:39.517271
NCT02669368|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-29|||March 2015||2015-03-01|January 2016|2016-01-01||||March 2016|Anticipated|2016-03-01||Interventional|||Magnesium Sulfate Effects on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy|Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy|Active, not recruiting||Phase 2|75|Anticipated|Assiut University||3|||f||||||||||||||2017-10-10 22:30:39.614487|2017-10-10 22:30:39.614487
NCT02669355|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-01-27|||October 2015||2015-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Effect of Wearing of White Coat on Patient Satisfaction in Indian Out Patient Department (OPD) Setting|Observational Study to Determine the Effect of Wearing of White Coat on Patient Satisfaction in Indian Out Patient Department (OPD) Setting|Completed||N/A|123|Actual|Columbia Asia|||1||f||||t||||||||||2017-10-10 22:30:39.715846|2017-10-10 22:30:39.715846
NCT02669342|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-04-04|||August 2016||2016-08-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Sharklet Catheter Study|Randomized Controlled Trial for the Early Clinical Experience and Evaluation of the Radiance Clear Sharklet Silicone Foley Catheter|Recruiting||Phase 1|32|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:30:39.806797|2017-10-10 22:30:39.806797
NCT02669329|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-06-20|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|ARM||CoolSculpting the Upper Arm Study|CoolSculpting the Upper Arm Using a Vacuum Applicator|Completed||N/A|30|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-10 22:30:39.938252|2017-10-10 22:30:39.938252
NCT02669316|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-03-30|||January 2008||2008-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|CARDIONAFLD||Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver|Adherence to Mediterranean Diet and Physical Exercise Profile in NAFLD: Relationship With Echocardiography Measures in Non-diabetic Subjects.|Completed||N/A|660|Actual|Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele|||1||f||||f||||||||No||2017-10-10 22:30:40.042014|2017-10-10 22:30:40.042014
NCT02669303|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-06-27|||September 2015||2015-09-01|June 2017|2017-06-01|January 1, 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ShIP||Platelet-rich Plasma (PRP) Injection for Treating Shoulder Subacromial Impingement Syndrome|Comparing Subacromial Injection of Platelet-rich Plasma Versus Methylprednisolone in the Treatment of Shoulder Subacromial Impingement Syndrome|Terminated||N/A|19|Actual|American University of Beirut Medical Center||2||low recruitment rate and high rate of loss-to-followup|f||||f||||||||No||2017-10-10 22:30:40.116387|2017-10-10 22:30:40.116387
NCT02669290|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-27|||January 2007||2007-01-01|January 2016|2016-01-01||||January 2017|Anticipated|2017-01-01||Interventional|MUGA CRT||Use of 3-D Blood Pool Scintigraphy to Guide Left Ventricular Pacing Lead Placement in Patients Requiring Cardiac Resynchronization Therapy|Use of 3-D Blood Pool Scintigraphy to Guide Left Ventricular Pacing Lead Placement in Patients Requiring Cardiac Resynchronization Therapy (MUGA-CRT)|Recruiting||N/A|60|Anticipated|University of California, San Francisco||2|||f||||f||||||||Undecided||2017-10-10 22:30:40.217153|2017-10-10 22:30:40.217153
NCT02669277|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-27|||August 2015||2015-08-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Safety, Tolerability and Efficacy of Single Dose Low Cost Minipool Intravenous Immunoglobulins in Moderately Severe Newly Diagnosed ITP|Safety, Tolerability and Efficacy of Single Dose Low Cost Minipool Intravenous Immunoglobulins in Moderately Severe Newly Diagnosed ITP: A Prospective Randomized Study|Recruiting||Phase 2|72|Anticipated|Ain Shams University||3|||f||||f||||||||||2017-10-10 22:30:40.320294|2017-10-10 22:30:40.320294
NCT02669264|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-08-04|||March 2016||2016-03-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)|A Phase 1, Open-label, Adaptive Dose-escalation, Multicenter Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Anti-tumor Activity of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)|Recruiting||Phase 1|60|Anticipated|ADC Therapeutics SARL||1|||f||||f||||||||||2017-10-10 22:30:40.429695|2017-10-10 22:30:40.429695
NCT02668835|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-05-01|||November 2015||2015-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|February 2017|Actual|2017-02-01||Observational|GADGET-PD||GADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson's Disease Trial|GADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson's Disease Trial|Active, not recruiting||N/A|67|Actual|Scripps Translational Science Institute|||2||f||||f||||||||||2017-10-10 22:30:45.405233|2017-10-10 22:30:45.405233
NCT02669251|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-10-04|||January 20, 2016||2016-01-20|May 25, 2017|2017-05-25|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||AZD9668, an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation|A Phase 1b/2 Study of AZD9668, an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 1/Phase 2|34|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:30:40.56387|2017-10-10 22:30:40.56387
NCT02669238|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-01-17|||June 2017||2017-06-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|January 2020|Anticipated|2020-01-01||Interventional|END-IMPACT||Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis|Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis|Not yet recruiting||Phase 2/Phase 3|160|Anticipated|Centre Hospitalier Universitaire de la Réunion||2|||f||||t||||||||No||2017-10-10 22:30:40.665374|2017-10-10 22:30:40.665374
NCT02669225|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-29|2017-07-11|||January 20, 2016||2016-01-20|July 3, 2017|2017-07-03|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Interventional|||Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People|Characterization of Brain Amyloid-beta (A-beta) Retention During Wakefulness And Following Emergence From Sleep In Healthy Subjects|Recruiting||Early Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:30:40.742462|2017-10-10 22:30:40.742462
NCT02669199|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-27|||January 2012||2012-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MSCs||MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound|Between Umbilical Cord Mesenchymal Stem Cells Sources Sweat Gland Samples of Large Area Skin Wound Injury Patients Before and After the Transplant Center, Open, Random, Own More Controlled Clinical Trials|Completed||Phase 1|20|Actual|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 22:30:40.904681|2017-10-10 22:30:40.904681
NCT02669186|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-06-22|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effects of Anesthetic Technique on NK Cells|Effects of Anesthetic Technique on Natural Killer Cell Population and Cytotoxicity|Not yet recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center||2|||f||||t|f|f||||||Undecided||2017-10-10 22:30:40.966542|2017-10-10 22:30:40.966542
NCT02669173|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-01-05|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma|Targeting Myeloid Derived Suppressor Cells in Recurrent Glioblastoma: Phase 0/1 Trial of Low Dose Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma|Recruiting||Phase 1|12|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:30:41.034538|2017-10-10 22:30:41.034538
NCT02669160|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-01-06|||December 2015||2015-12-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|EOMEC/CP||Tolerance of a Motorized Orthosis Reproducing Walking Movement vs Conventional Standing-up Devices in Child With CP|Tolerance of a Motorized Orthosis Reproducing Walking Movement Versus Conventional Passive Standing-up Devices in Children With Cerebral Palsy : A Non-inferiority, Randomised, Multicenter, Controlled Trial|Recruiting||N/A|36|Anticipated|Lille Catholic University||2|||f||||f||||||||No||2017-10-10 22:30:41.115331|2017-10-10 22:30:41.115331
NCT02669147|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-03|||November 2015||2015-11-01|January 2016|2016-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|DELC||A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC|A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC|Enrolling by invitation||N/A|200|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||t||||||||||2017-10-10 22:30:41.218518|2017-10-10 22:30:41.218518
NCT02669134|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-01-28|||March 2016||2016-03-01|January 2016|2016-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CRICKET||CRT Improved Clinical Response UK Trial|CRT Improved Clinical Response UK Trial: A Multi-centre, Prospective, Randomized, Cross-over, Double Blind Study|Not yet recruiting||Phase 3|200|Anticipated|Aston University||2|||f||||t||||||||||2017-10-10 22:30:41.277361|2017-10-10 22:30:41.277361
NCT02669121|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-08-04|||February 17, 2016|Actual|2016-02-17|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|August 7, 2017|Anticipated|2017-08-07||Interventional|||Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults|Phase IIb, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Immunogenicity of the Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Healthy Adults Aged 18 - 49 Years|Recruiting||Phase 2|3400|Anticipated|Takeda||2|||f||||t|t|f||||||||2017-10-10 22:30:41.352305|2017-10-10 22:30:41.352305
NCT02669108|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-04-25|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|||PET-MRI for Functional Imaging of the Testis: A Feasibility Study|PET-MRI for Functional Imaging of the Testis: A New Methodology for Evaluation of the Infertile Male|Withdrawn||N/A|0|Actual|New York University School of Medicine||1||lack of funding|f||||f|f|t|f|f|f|||||2017-10-10 22:30:41.462845|2017-10-10 22:30:41.462845
NCT02669095|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-05-04|2017-03-17||January 2016||2016-01-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||All subjects that were dispensed a study lens.|Clinical Evaluation of Approved and Investigational Contact Lenses||Completed||N/A|150|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||t||||||||||2017-10-10 22:30:41.543459|2017-10-10 22:30:41.543459
NCT02669082|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-08-09|||February 1, 2017|Actual|2017-02-01|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy|The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy|Recruiting||Phase 4|30|Anticipated|Takeda||1|||f||||f|f|f||||||||2017-10-10 22:30:41.816966|2017-10-10 22:30:41.816966
NCT02669030|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-01-28|||February 2016||2016-02-01|January 2016|2016-01-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia|A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia|Not yet recruiting||Phase 4|74|Anticipated|Institute for Advanced Medical Research, Alpharetta, GA||2|||f||||f||||||||||2017-10-10 22:30:42.258356|2017-10-10 22:30:42.258356
NCT02669017|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-08-18|||March 2016||2016-03-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)|A Phase 1 Dose-escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)|Recruiting||Phase 1|175|Anticipated|ADC Therapeutics SARL||1|||f||||f||||||||||2017-10-10 22:30:43.967925|2017-10-10 22:30:43.967925
NCT02669004|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-01-29|||June 2015||2015-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Intermittent Epidural Bolus Versus Epidural Infusion for Posterior Spinal Fusion After Adolescent Idiopathic Scoliosis|Patient-controlled Intermittent Epidural Bolus Versus Epidural Infusion for Posterior Spinal Fusion After Adolescent Idiopathic Scoliosis|Completed||Phase 4|47|Actual|Inonu University||2|||f||||f||||||||No||2017-10-10 22:30:44.110907|2017-10-10 22:30:44.110907
NCT02668991|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-12-16|||July 2015||2015-07-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort|A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort|Completed||Early Phase 1|186|Actual|Janssen Research & Development, LLC|||3||f||||f||||||||||2017-10-10 22:30:44.193172|2017-10-10 22:30:44.193172
NCT02668978|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-01-28|||March 2016||2016-03-01|January 2016|2016-01-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial Using HEMOPATCH|Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection With Hemopatch™ Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial|Not yet recruiting||Phase 2/Phase 3|144|Anticipated|Quirón Madrid University Hospital||2|||f||||f||||||||No||2017-10-10 22:30:44.32759|2017-10-10 22:30:44.32759
NCT02668965|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-01-28|||December 2015||2015-12-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||The Effects of Intrauterine Infusion of hCG at the Time of Embryo Transfer|The Effects of Intrauterine Infusion of Human Chorionic Gonadotropin at the Time of Embryo Transfer on IVF/ICSI Outcomes: Randomized, Double-blind Controlled Study|Recruiting||N/A|200|Anticipated|Mahidol University||2|||f||||t||||||||Yes||2017-10-10 22:30:44.426036|2017-10-10 22:30:44.426036
NCT02668952|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Fluid Chloride and AKI in Cardiopulmonary Bypass|The Impact of Low Chloride Containing Fluids on Acute Kidney Injury After Cardiopulmonary Bypass as Assayed by Urinary [TIMP2*IGFBP7]|Recruiting||Phase 2|30|Anticipated|University of New Mexico||2|||f||||f||||||||Yes|Upon publication of study results, qualified researchers may contact the PI for the deidentified dataset.|2017-10-10 22:30:44.509987|2017-10-10 22:30:44.509987
NCT02668926|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-12-22|||May 2016||2016-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|LisDex||Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine.|Endocrine and Emotional Effects of Lisdexamfetamine and d- Amphetamine: a Placebo-controlled Study in Healthy Subjects (LisDexStudy)|Completed||Phase 1|24|Actual|University Hospital, Basel, Switzerland||3|||f||||t||||||||No||2017-10-10 22:30:44.607799|2017-10-10 22:30:44.607799
NCT02668913|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-02-23|||February 2016||2016-02-01|February 2016|2016-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer|LCC-CARIS-01: A Pilot Feasibility Study to Assess the Use of Molecular Profiling to Determine Choice of Treatment for Patients With Gynecological Cancer|Recruiting||Phase 1/Phase 2|72|Anticipated|University of Leeds||1|||f||||f||||||||||2017-10-10 22:30:44.707425|2017-10-10 22:30:44.707425
NCT02668900|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-04-21|||April 2016||2016-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator Replacement|Evaluation of Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator Replacement: A Feasibility Study|Recruiting||N/A|80|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||No||2017-10-10 22:30:44.898827|2017-10-10 22:30:44.898827
NCT02668887|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-07-24|||April 2016||2016-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Employment and Quality of Life in Patients With Malignant Melanoma|A Prospective Cohort Study on Employment and Quality of Life in Patients With Malignant Melanoma|Active, not recruiting||N/A|221|Actual|Fachklinik Hornheide an der Universität Münster|||1||f||||f||||||||||2017-10-10 22:30:45.063008|2017-10-10 22:30:45.063008
NCT02668874|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-06-13|||February 2015||2015-02-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||A Clinical Trial Comparing Isolite® vs. Cotton Roll Isolation in the Placement of Dental Sealants|A Clinical Trial Comparing Isolite® vs Cotton Roll Isolation in the Placement of Dental Sealants|Active, not recruiting||N/A|99|Actual|University of Iowa||2|||f||||f||||||||Undecided||2017-10-10 22:30:45.139279|2017-10-10 22:30:45.139279
NCT02668861|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-12-03|||May 2016||2016-05-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Oral Vitamin D3 on Chronic Rhinosinusitis Treatment in Adults With Lower Vitamin D Levels|Influence of Oral Vitamin D3 on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyposis and Lower Vitamin D Levels|Recruiting||Phase 3|40|Anticipated|The First Affiliated Hospital of Shanxi Medical University||2|||f||||||||||||||2017-10-10 22:30:45.223119|2017-10-10 22:30:45.223119
NCT02668848|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-06-22|||January 2016||2016-01-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke.|The Fluid Therapy Strategy of the Patients With Acute Ischemic Stroke and a Bun/Cr Ratio Less Than 15.|Recruiting||Phase 2/Phase 3|250|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:30:45.318596|2017-10-10 22:30:45.318596
NCT02668809|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-07-06|||June 2014||2014-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Oral Hygiene Intervention Pilot Study|Iowa Nursing Facility Oral Hygiene Intervention: A Pilot Study|Active, not recruiting||N/A|390|Anticipated|University of Iowa||3|||f||||f||||||||||2017-10-10 22:30:45.580014|2017-10-10 22:30:45.580014
NCT02668796|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-09-29|||January 2016||2016-01-01|September 2016|2016-09-01||||September 2016|Actual|2016-09-01||Interventional|||To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.|A Phase III Investigator-Blind, Randomized, Parallel-Group, Placebo- Controlled, Multicentre Study to Evaluate the Therapeutic Equivalence and Safety of Estradiol Vaginal Tablets 10 mcg and Vagifem® (Estradiol Vaginal Tablets) 10 mcg (Novo Nordisk Inc.) Administered for 14 Days and Compare Both Active Treatments to a Placebo Control in Female Subjects With Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy Associated With Menopause.|Completed||Phase 3|522|Actual|Glenmark Pharmaceuticals Ltd. India||3|||f||||f||||||||No||2017-10-10 22:30:45.6981|2017-10-10 22:30:45.6981
NCT02668757|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-06-08|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|HeartHab||HeartHab, Can a Patient-tailored Application Support Coronary Artery Disease Patients During Rehabilitation?|Pilot Study, How the HeartHab Application Can Support Coronary Artery Disease Patients in Their Rehabilitation Program?|Recruiting||N/A|30|Anticipated|Hasselt University||1|||f||||f|f|f||||||No||2017-10-10 22:30:45.979679|2017-10-10 22:30:45.979679
NCT02668744|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-04|||September 1, 2016|Actual|2016-09-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|May 2019|Anticipated|2019-05-01||Interventional|||A School-based Gardening Obesity Intervention for Low-income Minority Children|Texas Sprouts: A School-based Gardening Obesity Intervention for Low-income Minority Children|Recruiting||N/A|4800|Anticipated|University of Texas at Austin||2|||f||||t||||||||No|No individual data will be shared. Only aggregate data.|2017-10-10 22:30:46.063003|2017-10-10 22:30:46.063003
NCT02668718|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-02-01|||March 2004||2004-03-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer|Adjuvant Radiation Therapy vs. Watchful Waiting in Prostate Cancer Patients With Positive Margins or Capsular Penetration After Radical Prostatectomy|Active, not recruiting||Phase 3|250|Actual|Helsinki University Central Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:30:46.175827|2017-10-10 22:30:46.175827
NCT02668705|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2016-11-22|||September 2015||2015-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Agent-Enhanced Document Explanation|Research Ethics and Safety Promoted by Embodied Conversational Technology|Terminated||N/A|101|Actual|Boston Medical Center||3||Interim analysis showed no difference between either arm of the intervention.|f||||f||||||||No||2017-10-10 22:30:46.247913|2017-10-10 22:30:46.247913
NCT02668679|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2017-09-12|||March 30, 2016|Actual|2016-03-30|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Dream Doctors in Children Undergoing Digestive Endoscopic Procedures|The Effect of Dream Doctors in Children Undergoing Digestive Endoscopic Procedures: Physiological and Biological Assessment of Emotional and Cognitive Consequences|Recruiting||N/A|100|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-10 22:30:46.422604|2017-10-10 22:30:46.422604
NCT02668666|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-08-23|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer|A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016|Recruiting||Phase 2|71|Anticipated|Big Ten Cancer Research Consortium||1|||f||||t||||||||||2017-10-10 22:30:46.546812|2017-10-10 22:30:46.546812
NCT02668653|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-09-28|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|QuANTUM-First||Quizartinib With Standard of Care Chemotherapy and as Maintenance Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)|A Phase 3, Double-Blind, Placebo-controlled Study of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy, and Administered as Maintenance Therapy in Subjects 18 to 75 Years Old With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia|Recruiting||Phase 3|536|Anticipated|Daiichi Sankyo, Inc.||2|||f||||t|t|f||||||||2017-10-10 22:30:46.860739|2017-10-10 22:30:46.860739
NCT02668627|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-04-24|||December 2013||2013-12-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)|MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)|Recruiting||N/A|120|Anticipated|Samsung Medical Center|||1||f||||f||||||||Yes||2017-10-10 22:30:47.839918|2017-10-10 22:30:47.839918
NCT02668614|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-01-26|||February 2016||2016-02-01|January 2016|2016-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Early Detection of Skin Cancer With Sensor Technology|Early Detection of Skin Cancer Using Millimetre-Wave Waveguide Reflectometers|Not yet recruiting||Phase 2|60|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||Undecided||2017-10-10 22:30:47.931467|2017-10-10 22:30:47.931467
NCT02668601|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-03-15|||August 2010||2010-08-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Maternal GDM in Hispanic Youth: Risk for Obesity|Maternal Gestational Diabetes in Hispanic Youth: Obesity and Insulin Resistance|Active, not recruiting||N/A|80|Anticipated|University of Southern California|||2||f||||t||||||||||2017-10-10 22:30:48.015728|2017-10-10 22:30:48.015728
NCT02668588|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-02-01|||October 22, 2015|Actual|2015-10-22|February 2017|2017-02-01|July 19, 2016|Actual|2016-07-19|July 19, 2016|Actual|2016-07-19||Interventional|||Extended-release of Octreotide (LF-PB) for the Treatment of Seroma|A Multicentre, Double Blind, Randomized Placebo Controlled Trial to Assess the Effect of LF-PB on Seroma Formation in Women With Breast Cancer Undergoing Axillary Lymph Node Dissection|Completed||Phase 2|48|Actual|Chemi S.p.A.||2|||f||||f||||||||Undecided||2017-10-10 22:30:48.097037|2017-10-10 22:30:48.097037
NCT02668575|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-22|||February 2016||2016-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Integrating Supportive Care in Cystic Fibrosis|Integrating Supportive Care in Cystic Fibrosis: A Pilot Study|Recruiting||N/A|50|Anticipated|University of Pittsburgh||2|||f||||f||||||||Yes|It is possible that the investigators may use the information obtained from this study in other research studies examining the treatment of Cystic Fibrosis. This information may also be shared with other researchers here and at other research centers, but those researchers will never be provided with any personal identifiers that would allow them to learn participant's identity.|2017-10-10 22:30:48.22901|2017-10-10 22:30:48.22901
NCT02668562|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-09-27|||February 2016||2016-02-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|RAPID CABG||Timing of Coronary Artery Bypass Surgery Among Patients With Acute Coronary Syndromes Initially on Ticagrelor|Reassessment of Anti-Platelet Therapy Using InDividualized Strategies -Ticagrelor in Patients With Acute Coronary Syndromes Treated by Coronary Artery Bypass Graft Surgery - A Pharmacodynamic and Clinical Study to Decrease Bleeding Risks and Ischemic Complications - The RAPID-TITRATE CABG Study|Recruiting||N/A|143|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||No||2017-10-10 22:30:48.339035|2017-10-10 22:30:48.339035
NCT02668549|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-04-26||||||April 2017|2017-04-01||||January 2018|Anticipated|2018-01-01||Observational|||"Cross-Sectional Study to Define and Validate Doctor/Pharmacy Shopping as Outcomes Suggestive of Abuse and/or Addiction"|"Cross-Sectional Study to Define and Validate Doctor/Pharmacy Shopping as Outcomes Suggestive of Abuse and/or Addiction"|Active, not recruiting||N/A|164000|Anticipated|Member Companies of the Opioid PMR Consortium|||2||f||||||||||||||2017-10-10 22:30:48.450129|2017-10-10 22:30:48.450129
NCT02668536|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-08-23|||August 2016||2016-08-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||A Sunscreen Based on Bioadhesive Nanoparticles|Assessing the Safety and Efficacy of Multifunctional Skin-adhesive Nanoparticles for UV Protection in Humans|Not yet recruiting||Phase 1|25|Anticipated|Yale University||4|||f||||t||||||||No||2017-10-10 22:30:48.534466|2017-10-10 22:30:48.534466
NCT02668523|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-01-06|||December 2015||2015-12-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects|A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc., RAINDROP® NEAR VISION INLAY for the Improvement of Near and Intermediate Vision in Pseudophakic Subjects|Recruiting||Phase 3|400|Anticipated|ReVision Optics, Inc.||1|||f||||f||||||||No||2017-10-10 22:30:48.622216|2017-10-10 22:30:48.622216
NCT02668510|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-05-12|||January 2016||2016-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort|A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy With Platelet Rich Plasma Versus Extracorporeal Shock Wave Therapy in a High Demand Cohort With Resistant Plantar Fasciitis|Recruiting||N/A|30|Anticipated|William Beaumont Army Medical Center||2|||f||||f||||||||Yes||2017-10-10 22:30:48.91532|2017-10-10 22:30:48.91532
NCT02668497|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-31|||January 2016||2016-01-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||Kinematic Characterization of Upper Limb Parkinson's Disease Tremor for Optimized Botulinum Toxin Type A Therapy||Recruiting||Phase 2|50|Anticipated|Western University, Canada||2|||f||||f||||||||||2017-10-10 22:30:49.041274|2017-10-10 22:30:49.041274
NCT02668484|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-03-08|||January 2016||2016-01-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|REBOOT||REpositionable Versus BallOOn-expandable Prosthesis for Trans-catheter Aortic Valve Implantation|Randomized Comparison of Repositionable and Balloon-Expandable Prostheses in Patients Undergoing Trans-catheter Aortic Valve Implantation|Active, not recruiting||N/A|116|Actual|Klinikum der Universitaet Muenchen||2|||f||||t||||||||No||2017-10-10 22:30:49.146953|2017-10-10 22:30:49.146953
NCT02668471|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-04-25|||August 2015||2015-08-01|April 2017|2017-04-01|August 30, 2016|Actual|2016-08-30|August 30, 2016|Actual|2016-08-30||Interventional|||U/S Guided vs. Traditional Palpation for Radial Artery Cannulation|Ultrasound-guided Compared With Traditional Palpation Radial Artery Cannulation in Critically Ill Children|Completed||N/A|84|Actual|Ramathibodi Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:30:49.248481|2017-10-10 22:30:49.248481
NCT02668445|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-03-04|||November 2015||2015-11-01|February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Interventional|Glyconcurrent||Molecular Response After Concurrent Exercise With Low Glycogen|The Effects of Glycogen Availability on the Skeletal Muscle Molecular Response After Concurrent Exercise|Active, not recruiting||N/A|14|Actual|Wageningen University||2|||f||||f||||||||||2017-10-10 22:30:49.47547|2017-10-10 22:30:49.47547
NCT02668432|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-05-24|||May 2016||2016-05-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock|Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock|Enrolling by invitation||Phase 4|200|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f|f|f||||||No||2017-10-10 22:30:49.562514|2017-10-10 22:30:49.562514
NCT02668419|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-28|||January 2010||2010-01-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Electrical Stimulation Improves Exercise Tolerance in Patients With Advanced Heart Failure on Continuous Dobutamine Use|Neuromuscular Electrical Stimulation Improves Exercise Tolerance in Patients With Advanced Heart Failure on Continuous Dobutamine Use - A Randomized Controlled Trial|Completed||N/A|49|Actual|Federal University of São Paulo||2|||f||||f||||||||No|No subject data will be made public. However, all participants were given the principal investigator's e-mail address and phone number in order to ask questions or receive their assessment results.|2017-10-10 22:30:49.667441|2017-10-10 22:30:49.667441
NCT02668406|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-06-13|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Observational|||Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis|Establishment of a Reference Clinical Sample Panel Allowing for the Development and Proof-of-concept Validation of an In-vitro Diagnostic Test for the Diagnosis of Melioidosis|Recruiting||N/A|3600|Anticipated|Institute of Tropical Medicine, Belgium|||3||f||||f||||||Samples Without DNA|"     Blood (phase A and B) and voided urine samples (only phase A)   "|||2017-10-10 22:30:49.752385|2017-10-10 22:30:49.752385
NCT02668393|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-10-03|||March 7, 2016|Actual|2016-03-07|October 2017|2017-10-01|July 12, 2018|Anticipated|2018-07-12|July 12, 2018|Anticipated|2018-07-12||Interventional|||Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma|An Open Label Phase I of Oral Nintedanib Plus Weekly Docetaxel Therapy in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma After Failure of Platinum -Based First Line Chemotherapy|Recruiting||Phase 1|30|Anticipated|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 22:30:49.852839|2017-10-10 22:30:49.852839
NCT02668380|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-01-28|||September 2015||2015-09-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|March 2018|Anticipated|2018-03-01||Observational|AHEAD-G202||An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer|An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer|Recruiting||N/A|300|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||||||2017-10-10 22:30:49.948114|2017-10-10 22:30:49.948114
NCT02668367|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-01-06|||November 2015||2015-11-01|January 2017|2017-01-01||||February 2016|Actual|2016-02-01||Interventional|||Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers|A Sequential-Cohort, Double-Blind, Placebo-Controlled, Multiple Ascending Oral Dose Study of the Safety and Pharmacokinetics of BTA-C585 in Healthy Volunteers|Completed||Phase 1|36|Actual|Aviragen Therapeutics||2|||f||||f||||||||||2017-10-10 22:30:50.066324|2017-10-10 22:30:50.066324
NCT02668354|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-27|2017-06-26|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Observational|||Cancer in Infants: South Egypt Cancer Institute Experience|Cancer in Infants: South Egypt Cancer Institute Experience|Recruiting||N/A|250|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:30:50.154888|2017-10-10 22:30:50.154888
NCT02668341|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-03-03|||October 2015||2015-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|PsoBarrier||Cross Sectional Analysis of Healthcare for Psoriasis in 5 European Countries|PsoBarrierEU - Barrier Analysis of Guideline-Compliant Healthcare for Psoriasis in Europe|Enrolling by invitation||N/A|2500|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||5||f||||t||||||||Undecided||2017-10-10 22:30:50.23269|2017-10-10 22:30:50.23269
NCT02668328|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-10-18|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Cochlear-Vestibular Ganglion (CVG) in Newly Diagnosed Type 2 Diabetes Patients|CGV in Newly Diagnosed Type 2 Diabetes Patients: Effect of Dietary Interventions in the Human Microbiome|Withdrawn||N/A|0|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 22:30:50.324927|2017-10-10 22:30:50.324927
NCT02668315|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-05-08|||January 2016||2016-01-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant|A Phase I-II Open-label Study of UM171 Expanded Cord Blood in a Fed-batch Culture System (UFCB-001) in Patients Who Need an Allogeneic Hematopoietic Stem Cell Transplant But Lack a Suitable Donor|Recruiting||Phase 1/Phase 2|25|Anticipated|Maisonneuve-Rosemont Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:30:50.390725|2017-10-10 22:30:50.390725
NCT02668302|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-11-22|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||The PIO II Study of In-office Placement of a Steroid-eluting Sinus Implant|The PIO II Study: A Randomized Controlled Blinded Trial to Evaluate the Safety and Efficacy of In-office Placement of a Steroid-eluting Sinus Implant Post-ethmoidectomy|Completed||Phase 4|40|Actual|Collin County Ear Nose & Throat||2|||f||||f||||||||No||2017-10-10 22:30:50.508501|2017-10-10 22:30:50.508501
NCT02668289|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-07-11|||January 2016||2016-01-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Periodontal Phenotype Study (Tooth Extraction)|Periodontal Phenotype and Supracrestal Soft Tissue Dimentions - Clinical Correlations and Their Impact on Post-extraction Volumetric Changes|Active, not recruiting||N/A|65|Anticipated|University of Iowa||1|||f||||f||||||||||2017-10-10 22:30:50.60574|2017-10-10 22:30:50.60574
NCT02668276|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-31|||April 2016||2016-04-01|October 2016|2016-10-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|ENACT||Engaging Newly Diagnosed Men About Cancer Treatment Options|The Impact of a Gene Expression Profile on Treatment Choice and Outcome Among Minority Men Newly Diagnosed With Prostate Cancer: A Randomized Trial|Recruiting||N/A|300|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-10 22:30:50.703852|2017-10-10 22:30:50.703852
NCT02668263|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-28|||November 2015||2015-11-01|January 2016|2016-01-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Investigating the Use of Drains and (Internal) Quilting Sutures on Seroma Formation Following Mastectomy|Randomised Clinical Trial Investigating the Use of Drains and Quilting Sutures on Seroma Formation Following Mastectomy - A Pilot Study|Recruiting||N/A|120|Anticipated|North Tees and Hartlepool NHS Foundation Trust||3|||f||||f||||||||No||2017-10-10 22:30:50.805255|2017-10-10 22:30:50.805255
NCT02668250|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-08-22|||February 3, 2017|Actual|2017-02-03|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|OPTI-AGED||Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality|The OPTI-AGED Study : Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality in Elderly Patients. A Randomized, Multicentre, Prospective Controlled Study|Recruiting||N/A|2500|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t|f|f||||||||2017-10-10 22:30:50.918186|2017-10-10 22:30:50.918186
NCT02668237|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-08-16|||June 9, 2016|Actual|2016-06-09|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|OptiPAC||Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAP|Impact on Anti-infectious Treatments of the Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Community-acquired Pneumonia of Children at Pediatric Emergencies|Recruiting||N/A|500|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 22:30:51.233126|2017-10-10 22:30:51.233126
NCT02668224|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-08-25|||February 2015||2015-02-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|NEUROVIB||Chronic Effects of Tendon Vibrations on the Neuromechanical Muscular Properties.|Chronic Effects of Tendon Vibrations on the Neuromechanical Muscular Properties : Pilot Study, Interventional, Prospective, Longitudinal.|Completed||N/A|46|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:30:51.336975|2017-10-10 22:30:51.336975
NCT02668211|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-12-13|||November 2016||2016-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TOPAZ||Radiostereometric Analysis (RSA) of the PROFEMUR® Preserve Classic Femoral Components|Radiostereometric Analysis (RSA) of the PROFEMUR® Preserve Classic Femoral Components|Withdrawn||N/A|0|Actual|MicroPort Orthopedics Inc.||1||Not feasible - RSA machine not available. RSA images needed for study endpoints|f||||f||||||||||2017-10-10 22:30:51.510727|2017-10-10 22:30:51.510727
NCT02668198|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-11-19|||January 2016||2016-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Assessing a Endoscopic Mucosal Resection Site Using Different Endoscopic Imaging Methods|Diagnostic Accuracy of Using Colonoscope With Near Focus Capability in Detecting Residual Colorectal Neoplastic Tissue After EMR: a Prospective Study|Recruiting||N/A|200|Anticipated|Mayo Clinic||4|||f||||f||||||||No||2017-10-10 22:30:51.596219|2017-10-10 22:30:51.596219
NCT02668185|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-03-27|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|NK3R||Neuropeptide Treatment for Hot Flushes During the Menopause|Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes|Active, not recruiting||Phase 2|30|Anticipated|Imperial College London||2|||f||||t||||||||No||2017-10-10 22:30:51.686241|2017-10-10 22:30:51.686241
NCT02668172|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-08-02|||August 2015||2015-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|PAPE||Pasireotide LAR and Pegvisomant Study in Acromegaly|Efficacy and Safety of Pasireotide Long Acting Release (LAR) in Combination With Weekly Pegvisomant in Previously Controlled Acromegaly Patients on Combination Treatment of Long-Acting Somatostatin Analogues and Weekly Pegvisomant|Active, not recruiting||Phase 4|60|Actual|Erasmus Medical Center||3|||f||||t||||||||||2017-10-10 22:30:51.780733|2017-10-10 22:30:51.780733
NCT02668159|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-03-06|||August 2015||2015-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|BONITO||Pilot Study on Metabolic Effects of Fish Peptides and Vitamin D|Cardiometabolic Health Effects and Mechanisms of Action of Fish Nutrients|Active, not recruiting||N/A|20|Anticipated|Laval University||4|||f||||f||||||||||2017-10-10 22:30:51.889319|2017-10-10 22:30:51.889319
NCT02668146|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-09-08|||October 2015||2015-10-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor|A Double-Blind, Cross-Over, Placebo-Controlled Efficacy and Tolerability Study of Perampanel and Essential Tremor|Active, not recruiting||Phase 2|16|Actual|VA Greater Los Angeles Healthcare System||2|||f||||t||||||||No||2017-10-10 22:30:51.981994|2017-10-10 22:30:51.981994
NCT02668133|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-20|||April 18, 2017|Actual|2017-04-18|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 19, 2017|Actual|2017-07-19||Interventional|||Zinc Absorption From SQ-LNS With and Without Phytase|Efficacy of Exogenous Phytase Added to Small Quantity Lipid Nutrient Supplements (SQ-LNS) on the Fractional and Total Absorption of Zinc Among Young Children in the Gambia: A Double-blind Randomized Controlled Trial With a Cross-over Design|Recruiting||N/A|50|Anticipated|Medical Research Council Unit, The Gambia||2|||f||||t|f|f||||||||2017-10-10 22:30:52.074368|2017-10-10 22:30:52.074368
NCT02668120|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-08-22|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|IHC||Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic|Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic (IHC)|Recruiting||N/A|54|Anticipated|University Hospital, Lille|||3||f||||f|f|f||||||||2017-10-10 22:30:52.178128|2017-10-10 22:30:52.178128
NCT02668107|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-08-15|||August 2015||2015-08-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Electromyographic Activity of Preterm Newborns Submitted to Hammock Positioning|Electromyographic Activity of Preterm Newborns Submitted to Hammock Positioning : a Randomized Clinical Trial|Active, not recruiting||N/A|65|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||t||||||||||2017-10-10 22:30:52.26577|2017-10-10 22:30:52.26577
NCT02668094|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-05-10|||February 2016||2016-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Pregabalin on Pain of Propofol Injection|The Effect of Pregabalin on Pain of Propofol Injection|Completed||N/A|120|Actual|Kyungpook National University||3|||f||||t||||||||No||2017-10-10 22:30:52.343678|2017-10-10 22:30:52.343678
NCT02668081|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-26|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparing the Effects of EST and EPBD in Patients With Acute Biliary Pancreatitis|Prospective Randomized Study Comparing the Effects of Endoscopic Sphincterotomy (EST) and Endoscopic Papillary Balloon Dilation (EPBD) in Patients With Acute Biliary Pancreatitis (ABP)|Recruiting||N/A|39|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-10 22:30:52.436673|2017-10-10 22:30:52.436673
NCT02668068|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-02-07|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells|A Multicenter, Randomized, Single-blind, Parallel-group Study of Combined Large Volume WLL With Clinical Grade Umbilical Cord Mesenchymal Stem Cells(MSC) Transplantation for Treatment of Pneumoconiosis|Recruiting||Phase 1|80|Anticipated|Chinese Academy of Sciences||2|||f||||f||||||||||2017-10-10 22:30:52.541143|2017-10-10 22:30:52.541143
NCT02668055|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-28|||January 2012||2012-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TB4||Slow-release Tb4 Collagen and Chitosan Porous Sponge Scaffolds Skin Substitute Treatment is Difficult to Heal Wounds|Slow-release Tb4 Collagen and Chitosan Porous Sponge Scaffolds Skin Substitutes Treatment of Difficult to Heal Wounds Single-center Randomized Parallel Controlled Clinical Studies|Completed||Phase 1|20|Actual|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 22:30:52.641445|2017-10-10 22:30:52.641445
NCT02668042|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-28|||January 2012||2012-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MSCs||The Activity of Tissue Engineering Skin Substitutes|Living Tissue Engineering Skin Substitutes Safety and Efficacy Studies for the Treatment of Difficult to Heal Wounds|Completed||Phase 1|20|Actual|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 22:30:52.717897|2017-10-10 22:30:52.717897
NCT02668029|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-28|||April 2012||2012-04-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis|Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis Normoxemic at Rest Who Desaturate on Exercise|Completed||Phase 2|32|Actual|University of Siena||2|||f||||f||||||||No||2017-10-10 22:30:52.796701|2017-10-10 22:30:52.796701
NCT02668016|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-08-26|||March 2016||2016-03-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|SAMSON||Self-Assessment Method for Statin Side-effects Or Nocebo|Self-Assessment Method for Statin Side-effects Or Nocebo|Recruiting||Phase 4|50|Anticipated|Imperial College London||3|||f||||t||||||||||2017-10-10 22:30:52.897855|2017-10-10 22:30:52.897855
NCT02668003|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-04-04|||May 2016||2016-05-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|MAmMOTH||The Maintaining Musculoskeletal Health Study|The MAintaining MusculOskeleTal Health (MAmMOTH) Study|Active, not recruiting||N/A|1002|Actual|University of Aberdeen||2|||f||||f||||||||Undecided|After completion of the study individual participant data will be made available to other researchers on request as decided by the study data management committee.|2017-10-10 22:30:52.997733|2017-10-10 22:30:52.997733
NCT02667990|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-01-28|||August 2015||2015-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Maximal Plantar Pressure and Comfort Evaluation of Orthopedic Stilettos|"Maximal Plantar Pressure and Comfort Evaluation During Normal Every Day Use of an Orthopedic Stiletto, a Normal Stiletto and a Control Trainer Shoe"|Completed||N/A|22|Actual|Copenhagen University Hospital, Hvidovre||1|||f||||t||||||||||2017-10-10 22:30:53.142681|2017-10-10 22:30:53.142681
NCT02667977|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-01-26|||October 2014||2014-10-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Reexamining Hypotonic Intravenous Fluid Use|Reexamining Hypotonic Intravenous Fluid Use in Pediatric Patients With Gastroenteritis.|Withdrawn||N/A|0|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2||Difficulty getting labs in this setting. After pilot study, this study was not continued.|f||||f||||||||||2017-10-10 22:30:53.222089|2017-10-10 22:30:53.222089
NCT02667964|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-01-26|||November 2015||2015-11-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|||FGF-21 and Exercise in Relation to Insulin Secretion|FGF-21 During Physical Exercise in Patients With Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus and Healthy Controls|Recruiting||N/A|60|Anticipated|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-10 22:30:53.318477|2017-10-10 22:30:53.318477
NCT02667938|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-10-12|||March 2015||2015-03-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules|A Multicenter, Randomized, Double-blind, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules|Completed||Phase 3|510|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||No||2017-10-10 22:30:53.509012|2017-10-10 22:30:53.509012
NCT02667925|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-10-10|||March 2016||2016-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ISOTOVE||Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin|Study of the Isotopic Distribution of Intraperitoneal Postoperative Locoregional Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin|Withdrawn||N/A|0|Actual|Centre Jean Perrin||1||Because of the obsolescence of the study|f||||f||||||||No||2017-10-10 22:30:53.59611|2017-10-10 22:30:53.59611
NCT02667912|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-11-14|||January 2013||2013-01-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Distal Renal Denervation|Anatomically Optimized Distal Renal Denervation for Treatment of Resistant Hypertension|Active, not recruiting||Phase 1/Phase 2|55|Actual|Federal State Budgetary Scientific Institution, Research Institute of Cardiology||2|||f||||f||||||||||2017-10-10 22:30:53.695107|2017-10-10 22:30:53.695107
NCT02667717|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-06-12|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|AlgoMIR||Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy|Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy in the Complex Regional Pain Syndrome of the Upper Limb : a Multicentric Randomized Open Study.|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||No||2017-10-10 22:30:55.459538|2017-10-10 22:30:55.459538
NCT02667899|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2016-01-28|||November 2015||2015-11-01|January 2016|2016-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||The Consciousness Variation of Deep Brain and Transcranial Magnetic Stimulation for Disorders of Consciousness Patients|The Consciousness Variation of Deep Brain Stimulation (DBS) and Transcranial Magnetic Stimulation (TMS) for Disorders of Consciousness(DOC) Patients in a Large Scale Randomised Trial|Recruiting||N/A|75|Anticipated|Huashan Hospital||3|||f||||t||||||||Yes|Ok. All participant data which can be shared will include these patient's clinical information, consciousness level and prognosis scores. Who want to share data can email to our group for data and we will glad to share.|2017-10-10 22:30:53.797766|2017-10-10 22:30:53.797766
NCT02667886|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-29|||January 2016||2016-01-01|September 2017|2017-09-01||||March 2019|Anticipated|2019-03-01||Interventional|||Trial of X4P-001 in Patients With Advanced Renal Cell Carcinoma|A Phase 1/2 Trial of X4P-001 as Single Agent and in Combination With Axitinib in Patients With Advanced Renal Cell Carcinoma|Recruiting||Phase 1/Phase 2|83|Anticipated|X4 Pharmaceuticals||3|||f||||||||||||||2017-10-10 22:30:53.885115|2017-10-10 22:30:53.885115
NCT02667873|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-07-17|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors|A Phase 1 Trial of SL-801, a Novel Inhibitor of XPO1 Nuclear Export, in Patients With Advanced Solid Tumors|Recruiting||Phase 1|50|Anticipated|Stemline Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 22:30:54.004942|2017-10-10 22:30:54.004942
NCT02667860|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-09-28|||May 20, 2015|Actual|2015-05-20|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Intra-corporeal vs Extra-corporeal Anastomosis in Laparoscopically Assisted Right Hemicolectomy|Intra-corporeal vs Extra-corporeal Anastomosis in Laparoscopically Assisted Right Hemicolectomy|Recruiting||N/A|140|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-10 22:30:54.109413|2017-10-10 22:30:54.109413
NCT02667847|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-02-02|||December 2012||2012-12-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Observational|||Preoperative Anxiety Evaluation: a New Visual Smileys Scale|Preoperative Anxiety Evaluation: a New Visual Smileys Scale|Completed||N/A|200|Actual|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 22:30:54.204218|2017-10-10 22:30:54.204218
NCT02667834|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-01-17|||October 2014||2014-10-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|SCIT-VF||Efficiency of the French Translation Social Cognition and Interactive Training (SCIT)Program|Efficiency of the French Translation Program:Social Cognition and Interactive Training (SCIT) of Negative Symptoms in Schizophrenia|Recruiting||N/A|80|Anticipated|Hôpital le Vinatier||2|||f||||t||||||||No||2017-10-10 22:30:54.261769|2017-10-10 22:30:54.261769
NCT02667808|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-02-08|||August 2011||2011-08-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|HIV KAP||Exploring the Impact of HIV and ART on Knowledge, Attitudes and Practices in Reproductive Health in Lilongwe, Malawi|Exploring the Impact of HIV and ART on Knowledge, Attitudes and Practices in Reproductive Health in Lilongwe, Malawi|Completed||N/A|562|Actual|Emory University|||2||f||||f||||||||||2017-10-10 22:30:54.581074|2017-10-10 22:30:54.581074
NCT02667795|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-26|||October 2016||2016-10-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Improving Physical Fitness Prior to Colorectal Surgery: A Pilot Study||Not yet recruiting||N/A|40|Anticipated|York Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:30:54.679924|2017-10-10 22:30:54.679924
NCT02667782|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-02|||February 18, 2016|Actual|2016-02-18|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Feasibility Study on the Use of Mindfulness-based Intervention for Family Carers of People With Dementia|Use of a Mindfulness-based Intervention for Family Carers of People With Dementia in the Community: A Feasibility Study|Active, not recruiting||N/A|53|Actual|The Hong Kong Polytechnic University||2|||f||||t|f|f||||||||2017-10-10 22:30:54.736166|2017-10-10 22:30:54.736166
NCT02667769|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-08-15|||August 2014||2014-08-01|August 2016|2016-08-01||||June 2016|Actual|2016-06-01||Interventional|||Comparison of Two Protocols on the Implementation of a Fasting Day in Type 1 Diabetes|Comparison of Two Protocols on the Implementation of a Fasting Day to Check the Basal Insulin Replacement in Type 1 Diabetes: Complete Fasting Compared to the Permission for Carbohydrate- and Calorie-free Food|Active, not recruiting||N/A|20|Anticipated|Diabeteszentrum Bad Lauterberg im Harz||2|||f||||f||||||||Undecided||2017-10-10 22:30:54.834195|2017-10-10 22:30:54.834195
NCT02667756|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-02-12|||June 2010||2010-06-01|February 2016|2016-02-01|February 2020|Anticipated|2020-02-01|February 2017|Anticipated|2017-02-01||Observational|KICK||Predicting Osteoarthritis Risk Following Knee Injury.|Identification of Prognostic Biomarkers for Osteoarthritis Risk Following Knee Injury: the Knee Injury Cohort @ the Kennedy Study|Active, not recruiting||N/A|150|Actual|University of Oxford|||1||f||||f||||||Samples With DNA|"     Samples include blood (plasma, serum, whole blood RNA, and where consent given, DNA), urine     and where undergoing a relevant clinical procedure to allow sampling, synovial fluid.   "|No||2017-10-10 22:30:55.078024|2017-10-10 22:30:55.078024
NCT02667743|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-04-26|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC||Recruiting||Phase 3|468|Anticipated|Shanghai Yizhong Biotechnology Co., Ltd.||2|||f||||||||||||||2017-10-10 22:30:55.176592|2017-10-10 22:30:55.176592
NCT02667730|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-02-14|||June 2015||2015-06-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|May 2018|Anticipated|2018-05-01||Interventional|CALF||Correlation Between Acute Analgesia and Long-Term Function Following Ankle Injuries|Correlation Between Acute Analgesia and Long-Term Function Following Ankle|Recruiting||Phase 4|160|Anticipated|Canadian Department of National Defense||4|||f||||f||||||||No||2017-10-10 22:30:55.310287|2017-10-10 22:30:55.310287
NCT02667704|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-03-02|2017-03-02||February 2016||2016-02-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||Treated set (TS), full analysis set in the sense of ICH-E9: all subjects from the entered set (all subjects who entered the trial, whether treated or not) who were documented to have received 1 dose of trial medication.|Influence of Bosentan on the Pharmacokinetics of Nintedanib|Influence of Bosentan on the Pharmacokinetics of Nintedanib in Healthy Male Subjects|Completed||Phase 1|13|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:30:55.61287|2017-10-10 22:30:55.61287
NCT02667691|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-26|||February 2016||2016-02-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|May 2017|Anticipated|2017-05-01||Interventional|SORESCAL||Evaluation of SODB® in Metabolic Adaptations in Overweight Women|Evaluation of SODB®, Associated With a Caloric Restriction, in Metabolic Adaptations in Overweight Women: Randomized Double-blind Study Versus Placebo|Not yet recruiting||N/A|32|Anticipated|Bionov||2|||f||||f||||||||Undecided||2017-10-10 22:30:55.971836|2017-10-10 22:30:55.971836
NCT02667678|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-09-01|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|HIVOL2||5 Years Follow-up Evaluation of Deterioration Kidney Biomarkers of HIV Patients|5 Years Follow-up Evaluation of Deterioration Kidney Biomarkers of HIV Patients : HIVOL 2 Study.|Recruiting||Phase 4|235|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 22:30:56.123011|2017-10-10 22:30:56.123011
NCT02667665|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-06-01|||February 19, 2016|Actual|2016-02-19|June 2017|2017-06-01|November 15, 2016|Actual|2016-11-15|November 15, 2016|Actual|2016-11-15||Observational|QuQu||Verification Study and Reactivity Study for the Validity of QuQu Scale|"Verification Study and Reactivity Study for the Validity of a Novel Dementia Rating Scale QUick QUestion Scale for Alzheimer's Disease Dementia"|Completed||N/A|240|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||2||f||||f||||||||||2017-10-10 22:30:56.260886|2017-10-10 22:30:56.260886
NCT02667652|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-02-22|||January 2016||2016-01-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|||The Curative Effect of the Length of the Jejunum Exclusion in Grstric Bypass Surgery for Type 2 Diabetes|The Curative Effect of the Length of the Jejunum Exclusion in Grstric Bypass Surgery for Type 2 Diabetes:a Randomized Controlled Trials|Active, not recruiting||N/A|50|Actual|Third Military Medical University||2|||f||||t||||||||Yes|Ethics Committee of Daping Hospital|2017-10-10 22:30:56.372713|2017-10-10 22:30:56.372713
NCT02667639|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-04-20|||January 2016||2016-01-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||First in Human Study for RPH-104|A Randomized, Double-blind, Placebo-controlled, Single-center, Phase I, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RPH-104 in Healthy Subjects|Active, not recruiting||Phase 1|35|Actual|TRPHARM||2|||f||||t||||||||||2017-10-10 22:30:56.502263|2017-10-10 22:30:56.502263
NCT02667626|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-10-27|||November 2015||2015-11-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|SCPR||Reproductive Health Survivorship Care Plan|Intervening on Reproductive Health in Young Breast Cancer Survivors|Recruiting||Phase 3|196|Anticipated|University of California, San Diego||2|||f||||f||||||||Yes|Interested investigators may apply for deidentified data from this study|2017-10-10 22:30:56.614943|2017-10-10 22:30:56.614943
NCT02667613|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-01-28|||June 2015||2015-06-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|change_CP||Changes in Everydaylife Activity of Children With CP During HABIT-ILE|Effet de la réadaptation Sur Les déficiences, Limitations d'activité et Restriction de la Participation Des Enfants présentant Des lésions Neurologiques Non-évolutives. Part IIb|Recruiting||N/A|40|Anticipated|Université Catholique de Louvain||2|||f||||f||||||||No||2017-10-10 22:30:56.741507|2017-10-10 22:30:56.741507
NCT02667600|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-06-20|||May 2016||2016-05-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Blood Loss Measurement During Cesarean Delivery|Study Assessing Blood Loss Measurement During Cesarean Delivery With Triton Device|Recruiting||N/A|80|Anticipated|Stanford University|||1||f||||f||||||||Undecided||2017-10-10 22:30:56.873751|2017-10-10 22:30:56.873751
NCT02667587|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-10-03|||May 5, 2016|Actual|2016-05-05|October 2017|2017-10-01|January 8, 2022|Anticipated|2022-01-08|May 29, 2019|Anticipated|2019-05-29||Interventional|CheckMate548||An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)|A Randomized Phase 3 Single Blind Study of Temozolomide Plus Radiation Therapy Combined With Nivolumab or Placebo in Newly Diagnosed Adult Subjects With MGMT-Methylated (Tumor O6-methylguanine DNA Methyltransferase) Glioblastoma|Recruiting||Phase 3|693|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:30:56.990152|2017-10-10 22:30:56.990152
NCT02667574|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-08-22|||November 2014||2014-11-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|VISMONEO||Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)|Phase II Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)|Active, not recruiting||Phase 2|55|Actual|University Hospital, Lille||1|||f||||t||||||||||2017-10-10 22:30:57.528324|2017-10-10 22:30:57.528324
NCT02667561|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-02-02|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%|Phase I Clinical Trial for Evaluation of Pharmacokinetics, Pharmacodynamics and Safety of Testosterone Gel 1% for Topical Use, After Administration of Three Different Doses (2.2 mg, 4.4 mg, 8.8 mg and Placebo) for 28 Consecutive Days in Post-menopausal Women.|Not yet recruiting||Phase 1|64|Anticipated|Biolab Sanus Farmaceutica||4|||f||||f|f|f||||||No||2017-10-10 22:30:57.650578|2017-10-10 22:30:57.650578
NCT02667548|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-26|||January 2016||2016-01-01|January 2016|2016-01-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|P-PUSH||Prospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital|Prospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital of China Medical University|Not yet recruiting||N/A|7000|Anticipated|Shengjing Hospital|||1||f||||f||||||Samples With DNA|"     A venous blood sample of 10mL will be collected before discharge for biomarker analysis and     storage for future genetic studies.   "|No|We will not share IPD to protect our data very well.|2017-10-10 22:30:57.724362|2017-10-10 22:30:57.724362
NCT02666989|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-27|||February 2016||2016-02-01|January 2016|2016-01-01||||February 2017|Anticipated|2017-02-01||Interventional|||Open-Label Placebo for the Treatment of Depression||Not yet recruiting||N/A|100|Anticipated|Shalvata Mental Health Center||2|||f||||f||||||||||2017-10-10 22:31:03.820444|2017-10-10 22:31:03.820444
NCT02667535|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-07-13|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure|Pharmacokinetics, Pharmacodynamics and Safety Comparative Trial of Isosorbide Mononitrate Gel in Participants With Anal Fissure and Healthy Volunteers.|Withdrawn||Phase 1|0|Actual|Biolab Sanus Farmaceutica||4||Study has been cancelled and it has not been initiated.|f||||f|f|f||||||||2017-10-10 22:30:57.806968|2017-10-10 22:30:57.806968
NCT02667522|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-12|||April 2016||2016-04-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|SNAP||Shaping Neural Activity Through Parenting|Targeting Biomarkers of Risk for Depression and Anxiety Through a Parenting Intervention|Recruiting||Phase 2|160|Anticipated|Stony Brook University||2|||f||||t||||||||Undecided||2017-10-10 22:30:57.883557|2017-10-10 22:30:57.883557
NCT02667509|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-04-12|||January 2005||2005-01-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||The Evolutionary Model of Mild-to-moderate Myopia in China|The Evolutionary Model of Mild-to-moderate Myopia in China|Completed||N/A|852441|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 22:30:57.959429|2017-10-10 22:30:57.959429
NCT02667496|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-04-05|||November 2016||2016-11-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease|A Study Examining the Safety and Activity of Innate Immune System Stimulation With Leukine® (Sargramostim) to Reduce Brain Amyloid Load in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease|Withdrawn||Phase 2|0|Actual|Sanofi||2||Slow recruitment|f||||t||||||||||2017-10-10 22:30:58.023187|2017-10-10 22:30:58.023187
NCT02667483|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-10-03|||October 2015|Actual|2015-10-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of DS-5141b in Patients With Duchenne Muscular Dystrophy|Phase I/II Study of DS-5141b: Open-label Study of DS-5141b in Patients With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 1/Phase 2|6|Anticipated|Daiichi Sankyo, Inc.||1|||f|||||f|f||||||||2017-10-10 22:30:58.103917|2017-10-10 22:30:58.103917
NCT02667470|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-01-26|||September 2009||2009-09-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|RESORT part 2||Reproducibility Study of OABSS and Its Response to Treatment|Overactive Bladder Symptom Scores (OABSS) Responsiveness Before and After Anticholinergic Treatment in Women With Overactive Bladder (OAB)|Completed||Phase 4|50|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-10 22:30:58.170145|2017-10-10 22:30:58.170145
NCT02667457|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-07-13|||April 2016||2016-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis|99mTc-rhAnnexin V-128 SPECT Imaging of Apoptosis in Asymptomatic Patients With Carotid Atherosclerotic Plaque|Recruiting||Phase 2|45|Anticipated|Advanced Accelerator Applications||2|||f||||t||||||||||2017-10-10 22:30:59.917284|2017-10-10 22:30:59.917284
NCT02667444|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-12-20|||February 2016||2016-02-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne|A Phase 3 Multi-Center, Randomized, Dboule-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of Once Daily SB204 and Vehicle Gel in the Treatment of Acne Vulgaris|Active, not recruiting||Phase 3|1300|Anticipated|Novan, Inc.||2|||f||||f||||||||No||2017-10-10 22:31:00.048592|2017-10-10 22:31:00.048592
NCT02667431|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-09-15|||January 2016||2016-01-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Observational|CUTI||Cancer of the Uterus and Treatment of Stress Urinary Incontinence|Cancer of the Uterus and Treatment of Stress Urinary Incontinence|Recruiting||N/A|556|Anticipated|Women and Infants Hospital of Rhode Island|||1||f||||f||||||||No||2017-10-10 22:31:00.236398|2017-10-10 22:31:00.236398
NCT02667418|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-07-17|||December 21, 2015|Actual|2015-12-21|July 2017|2017-07-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|OpTION||Optimal Treatment for Recurrent Clostridium Difficile|CSP #596 - Optimal Treatment for Recurrent Clostridium Difficile Infection|Recruiting||Phase 4|546|Anticipated|VA Office of Research and Development||3|||f||||t|t|f|||t|||||2017-10-10 22:31:00.315836|2017-10-10 22:31:00.315836
NCT02667405|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-01-27|||December 2012||2012-12-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Short Term Effect of Hot Packs and Whirlpool for Increasing Total Active Motion at the Wrist|The Short Term Effect of Hot Packs and Whirlpool for Increasing Total Active Motion at the Wrist|Completed||N/A|61|Actual|Western University, Canada||2|||f||||f||||||||No||2017-10-10 22:31:00.43705|2017-10-10 22:31:00.43705
NCT02667392|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-07-12|||July 3, 2017|Actual|2017-07-03|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|March 30, 2018|Anticipated|2018-03-30||Interventional|||Biofeedback to Increase Propulsion During Walking After Stroke|Biofeedback to Increase Propulsion During Walking After Stroke|Recruiting||Phase 1|30|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:31:00.526377|2017-10-10 22:31:00.526377
NCT02667379|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-05-06|||February 2016||2016-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Skin Tests in Cat Allergic Patients With Cat Dander Samples Obtained Before and After Vaccinating the Cat|Evaluation of Skin Prick Tests in Cat Allergic Patients With Cat Dander Samples Obtained Before and After Vaccinating the Cat|Completed||N/A|7|Actual|University of Zurich||1|||f||||f||||||||No||2017-10-10 22:31:00.77084|2017-10-10 22:31:00.77084
NCT02667366|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effectiveness and Cost-effectiveness of Telephone-delivered Psychotherapy for Depression in Primary Care|Improving Access to Evidence-based Treatment for Depression: Effectiveness and Cost-effectiveness of Telephone-delivered Cognitive Behavioral Therapy (CBT) in Primary Care|Recruiting||N/A|216|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 22:31:00.850719|2017-10-10 22:31:00.850719
NCT02667353|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-27|||June 2011||2011-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|June 2014|Actual|2014-06-01||Interventional|||Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression|Structural Brain Plasticity in Elderly Depressed Patients Following Electroconvulsive Therapy|Completed||N/A|110|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||t||||||||Undecided||2017-10-10 22:31:00.984126|2017-10-10 22:31:00.984126
NCT02667340|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-25|||February 2016||2016-02-01|January 2016|2016-01-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Superstarch and Physical/Cognitive Performance Following a Simulated Soccer Game|Effects of Starch Produced From Heat-treated Corn (Superstarch) Supplementation on Skills, Cognitive Function and Physical Performance During/Following a Simulated Soccer Game|Not yet recruiting||N/A|15|Anticipated|University of Western Ontario, Canada||2|||f||||t||||||||No||2017-10-10 22:31:01.115602|2017-10-10 22:31:01.115602
NCT02667327|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-08-08|||July 2015||2015-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer|A Phase 3, Randomized, Double-blind, Parallel-group, Vehicle Controlled, Multicenter Study of the Efficacy and Safety of Granexin Gel in the Treatment of Diabetic Foot Ulcer (GAIT 1)|Recruiting||Phase 3|552|Anticipated|FirstString Research, Inc.||3|||f||||t||||||||No||2017-10-10 22:31:01.205966|2017-10-10 22:31:01.205966
NCT02667314|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-09-21|||February 2016||2016-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|PACE||The Effect of Solving Jigsaw Puzzles on Visuospatial Cognition in Older Adults: Jigsaw Puzzles As Cognitive Enrichment|Jigsaw Puzzles As Cognitive Enrichment|Completed||N/A|100|Actual|University of Ulm||2|||f||||f||||||||Undecided||2017-10-10 22:31:01.344702|2017-10-10 22:31:01.344702
NCT02667301|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-01-11|||January 2014||2014-01-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|ETDA||Eustachian Tube Dysfunction Assessment|Investigation of Activities of Paratubal Muscles for Opening Eustachian Tube as Assessed by Simultaneous Electromyography and Tympanic Air Exchange Observations|Completed||N/A|55|Actual|Stratejik Yenilikci Girisimler Ltd.||1|||f||||f||||||||Undecided|IPD for all participants are available|2017-10-10 22:31:01.465803|2017-10-10 22:31:01.465803
NCT02667288|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2016-12-01|||January 2016||2016-01-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||An Open-Label Safety Study of A-101 Solution|An Open-Label Study of the Safety of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face.|Completed||Phase 3|147|Actual|Aclaris Therapeutics, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:31:01.579633|2017-10-10 22:31:01.579633
NCT02667262|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-04-26||||||April 2017|2017-04-01||||September 2017|Anticipated|2017-09-01||Observational|||An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data|An Observational Study to Develop Computable Algorithms for Identifying Opioid Abuse and Addiction Based on Administrative Claims Data|Active, not recruiting||N/A|4000|Anticipated|Member Companies of the Opioid PMR Consortium|||1||f||||||||||||||2017-10-10 22:31:01.751514|2017-10-10 22:31:01.751514
NCT02667249|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-01-25|||August 2011||2011-08-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Observational|||Compliance of Clinical Pathways in Elective Laparoscopic Cholecystectomy: Evaluation of Different Implementation Methods|Compliance of Clinical Pathways in Elective Laparoscopic Cholecystectomy: Evaluation of Different Implementation Methods|Completed||N/A|241|Actual|University Hospital Tuebingen|||2||f||||f||||||||No||2017-10-10 22:31:01.821219|2017-10-10 22:31:01.821219
NCT02667223|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-10-19|||February 2016||2016-02-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase|A Phase 1, Open Label, Randomized, Single Dose, Dose Escalation Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab (pf 04950615) Alone And In Co Mixture With Recombinant Human Hyaluronidase (rhuph20, Pf 06744547) In Healthy And Hypercholesterolemic Adult Subjects|Terminated||Phase 1|60|Actual|Pfizer||5||"The study was terminated early on July 8, 2016 due to business priorities regarding study   execution."|f||||f||||||||||2017-10-10 22:31:01.965131|2017-10-10 22:31:01.965131
NCT02667210|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-04-26||||||April 2017|2017-04-01||||June 2017|Anticipated|2017-06-01||Observational|||Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review|Retrospective Cohort Study to Evaluate the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Diversion, Abuse and/or Addiction by Medical Record Review|Active, not recruiting||N/A|590|Anticipated|Member Companies of the Opioid PMR Consortium|||4||f||||||||||||||2017-10-10 22:31:02.065478|2017-10-10 22:31:02.065478
NCT02667197|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-04-26||||||April 2017|2017-04-01||||September 2017|Anticipated|2017-09-01||Observational|||Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1B|Study to Validate Coded Medical Terminologies Used to Identify Opioid-Related Overdose in the Postmarketing Databases Employed in PMR Study 1B|Active, not recruiting||N/A|800000|Anticipated|Member Companies of the Opioid PMR Consortium|||1||f||||||||||||||2017-10-10 22:31:02.133804|2017-10-10 22:31:02.133804
NCT02667184|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-01-30|||May 2016||2016-05-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Healthy Human Subjects|The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Health Human Subjects|Completed||N/A|21|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||No||2017-10-10 22:31:02.205182|2017-10-10 22:31:02.205182
NCT02667171|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|CORe||COPD Online Rehabilitation (CORe)|COPD Online Rehabilitation (CORe) - a Randomized, Multicenter Telemedicine Intervention Study|Recruiting||Phase 4|134|Anticipated|University Hospital Bispebjerg and Frederiksberg||2|||f||||t||||||||Undecided||2017-10-10 22:31:02.285741|2017-10-10 22:31:02.285741
NCT02667158|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-04-26||||||April 2017|2017-04-01||||December 2018|Anticipated|2018-12-01||Observational|||A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion|A Survey Study to Evaluate the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion|Enrolling by invitation||N/A|842|Anticipated|Member Companies of the Opioid PMR Consortium|||4||f||||||||||||||2017-10-10 22:31:02.410578|2017-10-10 22:31:02.410578
NCT02667145|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-01-25|||November 2014||2014-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Assistive Device for Hand Osteoarthritis|Self-care Program Evaluation With Focus on Assistive Devices for Individuals With Hand Osteoarthritis|Completed||N/A|39|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||No|No individual participant data will be shared|2017-10-10 22:31:02.611352|2017-10-10 22:31:02.611352
NCT02667132|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-02-23|||December 2015||2015-12-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Granulomatous Mastitis Current Approach and Treatment|Granulomatous Mastitis Current Approach and Treatment (Multicentric Study) Granulomatous Mastitis Working Group|Enrolling by invitation||N/A|400|Anticipated|Granulomatous Mastitis Working Group|||3||f||||t||||||||Yes|DATA COLLECTION A shared excel file at the following website http://sanko.edu.tr/GranulamatozMastit has been created to record the data simultaneously. Each researcher can add the data at the file by using username and password. After data collection, the data will be presented mean+StDv. Statistical analysis will include Mann-Whitney U test, student's t test and chi-square test and statistical significance will set at P< 0.05. The treatment group in this study will be divided as medical, surgical and medical+surgical and the comparison among these groups will be conducted to reach the aims determined in expected outcomes section. The sample size and power analysis were conducted and the results indicated that at least 100 samples in each group are required to achieve the statistical significance at P< 0.05 with 90% power. The estimated total cases are expected over 400 cases.|2017-10-10 22:31:02.694536|2017-10-10 22:31:02.694536
NCT02667119|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Integrated Treatment for Posttraumatic Stress Disorder and Substance Abuse in Young Adults|Treating Co-Occurring PTSD and Substance Abuse in High-Risk Transition Age Youth|Recruiting||N/A|40|Anticipated|UConn Health||2|||f||||f||||||||Undecided||2017-10-10 22:31:02.77561|2017-10-10 22:31:02.77561
NCT02667106|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-25|||October 2015||2015-10-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Phase I Pharmacokinetic Study of RX0041-2|Systemic Pharmacokinetics of Acute, Topical, Intranasal Administration of RX0041-002 in Healthy Male and Female Subjects|Completed||Phase 1|30|Actual|Pharmaceutical Project Solutions, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:31:02.883675|2017-10-10 22:31:02.883675
NCT02667093|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-08-09|||January 2013||2013-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Samples From Leukemia Patients and Their Donors to Identify Specific Antigens|Bone Marrow and Peripheral Blood (PB) Samples From Patients With Leukemia and PB From Their BM Donors (BMD) to Identify Leukemia-Specific Antigens (LSA) and Graft Versus Host Disease Antigens (GVHDA) for Use in Cellular Immunotherapy|Recruiting||N/A|50|Anticipated|PersImmune, Inc|||1||f||||f||||||Samples With DNA|"     Samples will be shipped to Persimmune for processing and storage with results shared with Dr.     Ball and his lab at UCSD.   "|||2017-10-10 22:31:02.968974|2017-10-10 22:31:02.968974
NCT02667080|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-01-23|||April 2014||2014-04-01|January 2017|2017-01-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional|||Sperm Quality in Consecutive Sperm Samples After 4-7 Days and 2 Hours of Sexual Abstinence|Parameters of Sperm Quality in Consecutive Sperm Samples From Males Partners of Couples Seeking Treatment for Infertility|Completed||N/A|43|Actual|Aalborg University||2|||f||||f||||||||No||2017-10-10 22:31:03.065805|2017-10-10 22:31:03.065805
NCT02667067|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|January 2023|Anticipated|2023-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Investigation of the Simplify® Cervical Artificial Disc|Clinical Study Protocol for the Investigation Of The Simplify® Cervical Artificial Disc|Recruiting||N/A|150|Anticipated|Simplify Medical Inc.||2|||f||||f||||||||||2017-10-10 22:31:03.156311|2017-10-10 22:31:03.156311
NCT02667054|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-05-15|||September 2014||2014-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Topical Anesthetic for Procedures Through the Nose|A Phase III Investigation Of Topical Application Of RX0041-002 On Safety And Efficacy In Local (Topical) Anesthesia For Diagnostic Procedures And Surgeries On Or Through The Accessible Mucous Membranes Of The Nasal Cavities|Completed||Phase 3|648|Actual|Pharmaceutical Project Solutions, Inc.||3|||f||||f||||||||No|Data will only be submitted to FDA.|2017-10-10 22:31:03.282783|2017-10-10 22:31:03.282783
NCT02667041|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-11-03|||May 2015||2015-05-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||NeuroQore rTMS (Monophasic vs. Biphasic) for Major Depressive Disorder: A Randomized Controlled Pilot Trial|NeuroQore Repetitive Transcranial Magnetic Monophasic vs. Biphasic Stimulation For Major Depressive Disorder: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|University of Ottawa||3|||f||||||||||||||2017-10-10 22:31:03.390257|2017-10-10 22:31:03.390257
NCT02667028|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-25|||October 2015||2015-10-01|January 2016|2016-01-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|R-PUSH||Retrospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital|Retrospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital of China Medical University|Recruiting||N/A|3000|Anticipated|Shengjing Hospital|||1||f||||f||||||||No|We will not share IPD to protect our data very well.|2017-10-10 22:31:03.480541|2017-10-10 22:31:03.480541
NCT02667015|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-03-25|||May 2012||2012-05-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SUD/Anx||Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity|Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity|Completed||Phase 2|41|Actual|Hartford Hospital||2|||f||||f||||||||||2017-10-10 22:31:03.594414|2017-10-10 22:31:03.594414
NCT02667002|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-27|||November 2015||2015-11-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Anatomic Results Between Bilateral and Conventional Abdominal Sacral Hysteropexy|Randomized Single Blind Controlled Trial of Comparison of Anatomic and Sexual Outcomes Between Conventional and Bilateral Sacral Hysteropexy|Active, not recruiting||N/A|30|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||3|||f||||t||||||||Yes|Data will be available within 1 week of study completion.|2017-10-10 22:31:03.70253|2017-10-10 22:31:03.70253
NCT02666963|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-03-03|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults|A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults|Recruiting||Phase 1|86|Anticipated|Reata Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:31:04.00075|2017-10-10 22:31:04.00075
NCT02666937|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-05-02|||December 2015||2015-12-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|SLIM||Safe Limits in Saturation in the ICU (SLIM-study)|Safe Limits in Saturation in the ICU (SLIM-study)|Recruiting||N/A|200|Anticipated|VU University Medical Center|||3||f||||f||||||||||2017-10-10 22:31:04.282386|2017-10-10 22:31:04.282386
NCT02666924|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-05-08|||June 2016||2016-06-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|CCDS||Cooking Classes for Chinese Canadian Patients Living With Diabetes|The Effects of Attending Language and Culturally Appropriate Cooking Classes on Glycemic Control, Diabetes Knowledge and Self-management in Chinese-Canadian Patients Living With Diabetes Mellitus Type Two: A Pilot Study|Not yet recruiting||N/A|100|Anticipated|Vancouver General Hospital||2|||f||||f||||||||No||2017-10-10 22:31:04.392048|2017-10-10 22:31:04.392048
NCT02666911|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-08-04|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Assessing the Comparability of 2D and 4D Ultrasound Measurements|Assessing the Comparability of 2D and 4D Ultrasound Measurements of Human Carpal Tunnel Synovium, Median Nerve and Tendon Displacement|Withdrawn||N/A|0|Actual|Mayo Clinic||2||Equipment to run the study was not available|f||||f|f|t|f|f|f|||||2017-10-10 22:31:04.476386|2017-10-10 22:31:04.476386
NCT02666898|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-16|||October 2015||2015-10-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|December 2017|Anticipated|2017-12-01||Interventional|ICLL07GAI||Phase II Trial GA101 Inbrutinib B CLL|"Phase II, Multicenter, Trial, Exploring Chemo-free Treatment (GA101+Ibrutinib) and MRD-driven Strategy in Previously Untreated Symptomatic B-chronic Lymphocytic Leukemia Medically Fit A Study From the Goelams/GCFLLC/MW Intergroup"|Recruiting||Phase 2|12|Anticipated|French Innovative Leukemia Organisation||1|||f||||t||||||||Undecided||2017-10-10 22:31:04.546803|2017-10-10 22:31:04.546803
NCT02666885|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-25|||July 2015||2015-07-01|December 2015|2015-12-01||||June 2018|Anticipated|2018-06-01||Interventional|||Personalised Postoperative Radiochemotherapy in Patients With Head and Neck Cancer|Personalised Postoperative Radiochemotherapy in Patients With Head and Neck Cancer and Development of a Multi-parametric Decision Support System for Personalised Medicine in Radiation Oncology|Recruiting||Phase 2|49|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||Yes||2017-10-10 22:31:04.642787|2017-10-10 22:31:04.642787
NCT02666872|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-25|||June 2013||2013-06-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|December 2015|Actual|2015-12-01||Interventional|PROMOVAQ||Evaluation of an Intervention PROMOting VAccination in Maternity in Quebec|Evaluation of a New Educational Strategy Promoting Vaccination in Maternity in Quebec Based on Motivational Interviewing Techniques: PROMOVAQ Study|Active, not recruiting||N/A|2719|Actual|Université de Sherbrooke||2|||f||||t||||||||||2017-10-10 22:31:04.724336|2017-10-10 22:31:04.724336
NCT02666859|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-09-24|||January 2016||2016-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Virtual Reality Prosthetic Training and Rehabilitation|The Use of Virtual Reality to Enhance Upper Limb Prosthetic Training and Rehabilitation|Recruiting||Early Phase 1|30|Anticipated|University of South Florida||2|||f||||t||||||||||2017-10-10 22:31:04.805715|2017-10-10 22:31:04.805715
NCT02666846|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-25|||March 2015||2015-03-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model|A Randomised, Double Blind, Cross Over Clinical Study in Healthy Human Volunteers to Assess the Efficacy and Safety of Three Different Topical Analgesics (DCF100, TIB200 And SPR300) Versus Placebo and Active Control(s) in a Model of UV-Induced Inflammatory Pain|Completed||Phase 1|60|Actual|Futura Medical Developments Ltd.||11|||f||||f||||||||No||2017-10-10 22:31:04.884681|2017-10-10 22:31:04.884681
NCT02666833|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-09-14|||June 2016||2016-06-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Observational|PERFIS||Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers|Polarization Enhanced Wide Field Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers|Enrolling by invitation||N/A|40|Anticipated|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-10 22:31:04.992298|2017-10-10 22:31:04.992298
NCT02666820|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-28|||December 2010||2010-12-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Endoscopic Papillary Large Balloon Dilatation Versus Mechanical Lithotripsy for Large Stones|Endoscopic Papillary Large Balloon Dilatation Versus Sphincterotomy +/- Mechanical Lithotripsy for Removal of Bile Duct Stones With a Mean Stone > 20 mm : A Randomized Controlled Study|Completed||N/A|85|Actual|Prince of Songkla University||2|||f||||t||||||||No|The individual data of patients participating in the study are not available for public sharing since we did not obtain the consent to share the data of patient|2017-10-10 22:31:05.088982|2017-10-10 22:31:05.088982
NCT02666807|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-01-25|||June 2015||2015-06-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Ginger Supplementation on NF-KB in Peripheral Blood Mononuclear Cells in Type 2 Diabetes Mellitus|Effects of Oral Ginger Supplementation on NF-KB (Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells) in Peripheral Blood Mononuclear Cells (PBMC) and Glycemic and Lipid Profiles in Patients With Type 2 Diabetes Mellitus|Completed||N/A|50|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 22:31:05.173131|2017-10-10 22:31:05.173131
NCT02665663|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-27|||February 2016||2016-02-01|January 2016|2016-01-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)|Measure of the Strength of the Tongue in Patients With Amyotrophic Lateral Sclerosis and Relation With Swallowing Disorders|Not yet recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-10 22:31:17.234236|2017-10-10 22:31:17.234236
NCT02666794|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-07-20|||July 12, 2017|Actual|2017-07-12|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Trial on the Impact of Technical Anesthetic in Pregnancies With Intrauterine Growth Restriction|Comparative Clinical Trial on the Impact of Technical Anesthetic in Uterine Tone and Fetal Heart Rate in Pregnancies With Intrauterine Growth Restriction|Recruiting||N/A|74|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|f|f||||||||2017-10-10 22:31:05.395786|2017-10-10 22:31:05.395786
NCT02666781|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-02-08|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|||Postoperative Rostral Fluid Shift and Obstructive Sleep Apnea|The Contribution of Rostral Shift of Fluid to Postoperative Worsening of Obstructive Sleep Apnea Severity in Surgical Patients - A Prospective Cohort Study|Recruiting||N/A|25|Anticipated|University Health Network, Toronto|||1||f||||f||||||||Undecided||2017-10-10 22:31:05.57149|2017-10-10 22:31:05.57149
NCT02666768|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-05-03|||February 2016||2016-02-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||ACTIMMUNE in Intermediate Osteopetrosis|Open-label Early Phase 2 Study With a Single Arm of Interferon Gamma-1b Treatment of Osteopetrosis|Recruiting||Phase 2|10|Anticipated|Los Angeles Biomedical Research Institute||1|||f||||f||||||||||2017-10-10 22:31:05.694454|2017-10-10 22:31:05.694454
NCT02666755|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-28|||January 2016||2016-01-01|January 2016|2016-01-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||Novel Detection System for Lung Cancer Curative Effect Monitoring|Novel Detection System for Detecting Epidermal Growth Factor Receptor Mutation in Plasma in Non-small Cell Lung Cancer|Not yet recruiting||N/A|160|Anticipated|Fourth Military Medical University|||1||f||||t||||||Samples With DNA|"     Each specimen was collected into one 10mL EDTA-containing vacutainer and was spun into plasma     within 4 hours of collection. cfDNA was extracted from 2 mL of plasma, and the final DNA     eluent was frozen at- 20℃ until genotyping   "|Undecided||2017-10-10 22:31:05.838561|2017-10-10 22:31:05.838561
NCT02666742|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-03-21|||February 16, 2017|Actual|2017-02-16|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|STROKE-VT||Safety and Efficacy of Post Ablation Apixaban Use for Reduction of the Risk of Cerebrovascular Events in Patients Undergoing Ventricular Tachycardia Radiofrequency Catheter Ablation|Safety and Efficacy of Post Ablation Apixaban Use for Reduction of the Risk of Cerebrovascular Events in Patients Undergoing Ventricular Tachycardia Radiofrequency Catheter Ablation|Recruiting||Phase 4|110|Anticipated|University of Kansas Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 22:31:05.924971|2017-10-10 22:31:05.924971
NCT02666729|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-07-07|||July 2016||2016-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|FORMIDIBLE||Use of a Novel Contact Force Sensing Catheter for AF Ablation - Impact of TactiCath on Dormant Conduction Across the Pulmonary Veins|Use of a Novel Contact Force Sensing Catheter for AF Ablation - Impact of TactiCath on Dormant Conduction Across the Pulmonary Veins|Withdrawn||N/A|0|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-10 22:31:06.029308|2017-10-10 22:31:06.029308
NCT02666716|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-04-06|||May 2015||2015-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|PACIFIC||Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients|Pharmacokinetics of Fluconazole Given Intravenously as Prophylaxis or Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit (PACIFIC)|Completed||N/A|20|Actual|Radboud University|||1||f||||t||||||Samples Without DNA|"     Plasma samples for determination of fluconazole and free fluconazole   "|||2017-10-10 22:31:06.122908|2017-10-10 22:31:06.122908
NCT02666703|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-11-02|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|May 2017|Anticipated|2017-05-01||Interventional|IMEECCACS||Extracorporeal Cytokine Adsorption in Cardiac Surgery|Immunomodulatory Effect of Extracorporeal Cytokine Adsorption in Cardiac Surgery|Recruiting||Phase 3|60|Anticipated|University Medical Centre Ljubljana||3|||f||||t||||||||||2017-10-10 22:31:06.209405|2017-10-10 22:31:06.209405
NCT02666690|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-06-08|||July 2011||2011-07-01|June 2016|2016-06-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|VARIA-DCE-US||Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast|Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast|Completed||N/A|59|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 22:31:06.33012|2017-10-10 22:31:06.33012
NCT02666677|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-27|||January 2016||2016-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|INVITE||INVITE Study: Invasive Instrumentation in Trauma Patients in the Shock Room|Invasive Instrumentation in Trauma Patients in the Shock Room: A Online-survey for Anaesthesia Departments in Germany|Recruiting||N/A|1500|Anticipated|Universitätsklinikum Köln|||1||f||||f||||||||No||2017-10-10 22:31:06.415332|2017-10-10 22:31:06.415332
NCT02666664|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-14|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)|A Randomized, Double-blind, Placebo-controlled, Multicenter Long-term Safety and Tolerability Study of ETC-1002 in Patients With Hyperlipidemia at High Cardiovascular Risk Who Are Not Adequately Controlled by Their Lipid-Modifying Therapy|Active, not recruiting||Phase 3|2233|Actual|Esperion Therapeutics||2|||f||||t||||||||||2017-10-10 22:31:06.507777|2017-10-10 22:31:06.507777
NCT02666651|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-31|||May 2016||2016-05-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|Tolvaptan||Regional Tolvaptan Registry|Regional Tolvaptan Registry|Recruiting||Phase 4|25|Anticipated|Cardiology Research UBC||2|||f||||f||||||||Undecided||2017-10-10 22:31:06.796787|2017-10-10 22:31:06.796787
NCT02666625|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-06-08|||December 2010||2010-12-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|7 Years|Observational [Patient Registry]|BIO-F||Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank|Study of Iatrogenic Effects of Treatment for Childhood Cancer - Constitution of a Biological Samples Bank as Part of a Cohort of Patients (Cohort FCCSS)|Recruiting||N/A|6000|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||1||f||||f||||||||||2017-10-10 22:31:07.020934|2017-10-10 22:31:07.020934
NCT02666612|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-01-25|||August 2008|Actual|2008-08-01|January 2017|2017-01-01|August 2023|Anticipated|2023-08-01|August 2023|Anticipated|2023-08-01||Interventional|Liquid Biopsy||Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer|Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer|Recruiting||N/A|2240|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 22:31:07.913784|2017-10-10 22:31:07.913784
NCT02666599|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-11-13|||February 2014||2014-02-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Per-operating Use of a Probe for Detection of β+|Per-operating Use of a Probe for Detection of β+|Recruiting||Phase 1/Phase 2|60|Anticipated|University of Lausanne Hospitals||1|||f||||f||||||||No||2017-10-10 22:31:08.009797|2017-10-10 22:31:08.009797
NCT02666586|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-08|||January 2016||2016-01-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control|Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control|Recruiting||N/A|60|Anticipated|University of Manitoba||5|||f||||||||||||||2017-10-10 22:31:08.119284|2017-10-10 22:31:08.119284
NCT02666560|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-08-04|2016-04-18||April 2015||2015-04-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Does Increasing Auditory Cueing Affect Gait Parameters in Children With Cerebral Palsy During a Functional Task?|Does Increasing Auditory Cueing Affect Gait Parameters in Children With Cerebral Palsy During a Functional Task?|Completed||N/A|19|Actual|Institute of Child Health||2|||f||||f||||||||No||2017-10-10 22:31:08.337918|2017-10-10 22:31:08.337918
NCT02666547|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-11-13|||December 2014||2014-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis|Value of PET/ CT in the 68Ga-NODAGA-RGD for the Evaluation of the Tumoral Neoangiogenesis|Recruiting||Phase 1|120|Anticipated|University of Lausanne Hospitals||1|||f||||f||||||||No||2017-10-10 22:31:08.611412|2017-10-10 22:31:08.611412
NCT02666534|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-27|||January 2012||2012-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of AFL-assisted PDT in Microinvasive Squamous Cell Carcinoma|A Randomised Trial Comparing Methyl Aminolaevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: Results From a 24-month Follow-up|Completed||Phase 1|45|Actual|Dong-A University||2|||f||||f||||||||No||2017-10-10 22:31:08.715538|2017-10-10 22:31:08.715538
NCT02666521|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-10-24|||December 2012||2012-12-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Hypoglycaemia in People With Type 2 Diabetes in Primary Care|Study to Determine the Frequency and Associated Predictors of Hypoglycaemia in People With Type 2 Diabetes Mellitus Managed in Primary Care|Active, not recruiting||N/A|2327|Actual|University of Leicester|||1||f||||f||||||||||2017-10-10 22:31:08.830213|2017-10-10 22:31:08.830213
NCT02666495|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-02-15|||January 2016||2016-01-01|January 2016|2016-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series|Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series|Enrolling by invitation||N/A|15|Anticipated|NHS Lothian||1|||f||||f||||||||||2017-10-10 22:31:09.054553|2017-10-10 22:31:09.054553
NCT02666482|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-09-26|||January 2016||2016-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Using Technology to Help Low-income and Latino Smokers Quit|Using Technology to Help Low-income and Latino Smokers Quit|Recruiting||N/A|1000|Anticipated|i4Health||1|||f||||f||||||||Undecided||2017-10-10 22:31:09.149063|2017-10-10 22:31:09.149063
NCT02666469|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-02-22|||October 2015||2015-10-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||HBOT Global Functioning After Stroke|Hyperbaric Oxygen and Focused Rehabilitation Program: A Feasibility Study in Improving Global Functioning After Stroke|Recruiting||N/A|40|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:31:09.257305|2017-10-10 22:31:09.257305
NCT02666456|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-25|||April 2016||2016-04-01|January 2016|2016-01-01||||March 2019|Anticipated|2019-03-01||Observational|||The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain|DOLORisk: Understanding Risk Factors and Determinants for Neuropathic Pain - The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain|Not yet recruiting||N/A|1500|Anticipated|University of Kiel|||2||f||||f||||||||No||2017-10-10 22:31:09.374074|2017-10-10 22:31:09.374074
NCT02666443|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-09-02|||September 2016||2016-09-01|September 2016|2016-09-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Low Dose Dexamethasone in Supraclavicular Blocks|Low Dose Dexamethasone as an Adjuvant to Supraclavicular Brachial Plexus Blocks: A Prospective Randomized, Double Blinded, Control Study|Recruiting||N/A|306|Anticipated|University of Calgary||3|||f||||f||||||||Undecided|"I am not sure what the entirety of a yes answer entails, or with whom the data would be shared. Hence, undecided."|2017-10-10 22:31:09.441124|2017-10-10 22:31:09.441124
NCT02666430|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-09-12|||December 2015||2015-12-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus Patients|An Open-label, Randomized, Multi-center, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients: An Extension Study|Active, not recruiting||Phase 3|138|Anticipated|Mylan Inc.||2|||f||||f||||||||||2017-10-10 22:31:09.717574|2017-10-10 22:31:09.717574
NCT02666417|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-08-22|||January 2016||2016-01-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|FeGOS||Iron Absorption From a Micronutrient Powder Containing Galacto-oligosaccharides (GOS)|Testing Iron Absorption From a New Micronutrient Powder Containing Galacto-oligosaccharides (GOS) for Fortification of Infant Foods in Sub-Saharan Africa|Completed||N/A|64|Actual|Swiss Federal Institute of Technology||2|||f||||t||||||||Yes|Data will be published in a peer-review journal.|2017-10-10 22:31:09.971587|2017-10-10 22:31:09.971587
NCT02666404|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-08-21|||January 2016||2016-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|VoluKid||Impact of Amount of Fluid for Circulatory Resuscitation on Renal Function in Patients in Shock|Impact of Amount of Fluid for Circulatory Resuscitation on Renal Function in Patients in Shock: Evaluating the Combination of Intraabdominal Pressure and Renal Resistive Index With Hemodynamic Parameters for Guidance of Shock Therapy - A Multicenter International Clinical Trial|Recruiting||N/A|100|Anticipated|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-10 22:31:10.087096|2017-10-10 22:31:10.087096
NCT02666391|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-24|||May 2016||2016-05-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD)||Not yet recruiting||Phase 1/Phase 2|64|Anticipated|South China Research Center for Stem Cell and Regenerative Medicine||2|||f||||t||||||||||2017-10-10 22:31:10.185427|2017-10-10 22:31:10.185427
NCT02666378|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-01-25|||March 2016||2016-03-01|January 2016|2016-01-01|July 2021|Anticipated|2021-07-01|December 2020|Anticipated|2020-12-01||Interventional|||Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer|Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer|Not yet recruiting||N/A|190|Anticipated|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-10 22:31:10.271772|2017-10-10 22:31:10.271772
NCT02666365|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-01-09|||March 2017||2017-03-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Continuous v Bolus Infusion of Cefazolin During Ventral Hernia Repair|Pharmacokinetic Comparison of Cefazolin Redosing Strategy for Surgical Prophylaxis. Bolus Dose vs Continuous Infusion|Not yet recruiting||N/A|30|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||No||2017-10-10 22:31:10.387028|2017-10-10 22:31:10.387028
NCT02666352|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-23|||January 22, 2016|Actual|2016-01-22|May 2017|2017-05-01|January 16, 2017|Actual|2017-01-16|January 16, 2017|Actual|2017-01-16||Interventional|||A Study of the Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029)|A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-3682 and MK-8408 When Coadministered to Subjects With Moderate and Severe Hepatic Insufficiency|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-10 22:31:10.49309|2017-10-10 22:31:10.49309
NCT02666339|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-03-23|||May 2016||2016-05-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|JDM||Mélisses Garden: Effect on Anxious State in Adult Patients Hospitalized in Psychiatry|Mélisses Garden: Effect of the Mediation by Care-garden on Anxious State in Adult Patients Hospitalized in Psychiatry (Prospective, Monocentric, Controlled, Randomized, Open in Two Parallel Groups Study)|Recruiting||N/A|190|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:31:10.588418|2017-10-10 22:31:10.588418
NCT02666326|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-10-26|||January 2016||2016-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|AROMI||Accelerated Rule Out of Myocardial Infarction|Accelerated Rule-Out of Acute Myocardial Infarction, Using Copeptin and High Sensitive Troponin T - the AROMI Trial|Recruiting||N/A|4772|Anticipated|Aarhus University Hospital Skejby||2|||f||||t||||||||Undecided||2017-10-10 22:31:10.699091|2017-10-10 22:31:10.699091
NCT02666313|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||WEB-Based Physiotherapy for People With Axial Spondyloarthritis|WEB-Based Physiotherapy for People With Axial Spondyloarthritis: A Cohort Study|Recruiting||N/A|50|Anticipated|University of Glasgow||1|||f||||f||||||||Undecided||2017-10-10 22:31:10.831279|2017-10-10 22:31:10.831279
NCT02666287|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-12|||January 27, 2016|Actual|2016-01-27|May 2017|2017-05-01|June 3, 2016|Actual|2016-06-03|June 3, 2016|Actual|2016-06-03||Interventional|||GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)|An Open Label, Six-period Cross-over, Single and Repeat Dose Study to Determine the Pharmacokinetics of Fluticasone Furoate and GSK961081 When Administered Alone, in Combination, or Concurrently Via the ELLIPTA|Completed||Phase 1|48|Actual|GlaxoSmithKline||6|||f||||f|f|f||||||||2017-10-10 22:31:11.045696|2017-10-10 22:31:11.045696
NCT02666274|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-11-24|||December 2015||2015-12-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|||Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread|Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread|Recruiting||N/A|45|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     stool samples   "|No||2017-10-10 22:31:11.186524|2017-10-10 22:31:11.186524
NCT02666261|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-10-02|||March 4, 2016|Actual|2016-03-04|October 2017|2017-10-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany|A Non-interventional Study on the Epidemiology and Testing of HER2 in Breast Cancer in Germany|Recruiting||N/A|15000|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:31:11.298223|2017-10-10 22:31:11.298223
NCT02666248|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-06-08|||January 2016||2016-01-01|June 2017|2017-06-01||||January 2031|Anticipated|2031-01-01||Observational|||Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies|Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies|Enrolling by invitation||N/A|8|Anticipated|University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:31:11.686823|2017-10-10 22:31:11.686823
NCT02666235|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-07-19|||July 2011||2011-07-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|RIC-COR||Remote Ischaemic Conditioning and Coronary Endothelial Function (RIC-COR)|A Randomised Controlled Trial of the Effect of Remote Ischaemic Conditioning on Coronary Endothelial Function in Patients With Angina.|Completed||Phase 2|60|Actual|NHS National Waiting Times Centre Board||2|||f||||f||||||||No|There is no data sharing plan, but we have no objection|2017-10-10 22:31:11.762917|2017-10-10 22:31:11.762917
NCT02666222|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-03-31|2016-01-29||August 2010||2010-08-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Observational|||The Esteem® Hearing Implant Post Approval Study|To Evaluate the Long-term Safety and Efficacy of the Esteem® Hearing Implant in Subjects Suffering From Moderate to Severe Hearing Loss|Completed||Phase 4|51|Actual|Envoy Medical Corporation|"Study endpoints do not account for natural progression of hearing loss over 5-year follow-up.
Fitting methods for pre-implant hearing aid were not strictly controlled in the protocol."||1||f||||t||||||||No||2017-10-10 22:31:11.93398|2017-10-10 22:31:11.93398
NCT02666209|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-08-25||||||August 2017|2017-08-01||||||||Expanded Access|||Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma|Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma|No longer available||N/A|||Dana-Farber Cancer Institute|||||||||||||||||||2017-10-10 22:31:12.426571|2017-10-10 22:31:12.426571
NCT02666196|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-01-24|||September 2015||2015-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|DAA-I||A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects|A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects|Completed||Phase 1|18|Actual|National University Hospital, Singapore||4|||f||||t||||||||No||2017-10-10 22:31:12.533015|2017-10-10 22:31:12.533015
NCT02666183|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-05-16|||April 2016||2016-04-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Online Information and Support for Distance Caregivers|Online Information and Support for Distance Caregivers|Recruiting||N/A|613|Anticipated|Case Comprehensive Cancer Center||3|||f||||f|f|f||||||||2017-10-10 22:31:12.636706|2017-10-10 22:31:12.636706
NCT02666170|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-26|||January 2016||2016-01-01|January 2016|2016-01-01||||September 2016|Anticipated|2016-09-01||Interventional|||Effects of Alpha-acid Lipoic in PCOS Women|Effects of 6 Months of Alpha-Lipoic Acid Treatment on Clinical, Endocrine ed Metabolic Features in Women Affected by PCOS|Not yet recruiting||N/A|40|Anticipated|Catholic University of the Sacred Heart||1|||f||||||||||||||2017-10-10 22:31:12.764587|2017-10-10 22:31:12.764587
NCT02666157|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-02-14|||January 2016||2016-01-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DARING-AF||Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation|Comparison of Efficacy and Safety Among DAbigatran, RIvaroxaban, and ApixabaN in Patients HavinG Non-Valvular Atrial Fibrillation in Taiwan (DARING-AF Study)|Recruiting||Phase 4|3672|Anticipated|National Cheng-Kung University Hospital||3|||f||||f||||||||Undecided||2017-10-10 22:31:12.871908|2017-10-10 22:31:12.871908
NCT02666144|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-04-25|||February 2016||2016-02-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Comparison of Optic Nerve Head and Retinal Nerve Fiber Layer Parameters Derived From Two Different Methods of Scan Alignment||Completed||N/A|48|Actual|Heidelberg Engineering GmbH|||2||f||||f||||||||||2017-10-10 22:31:13.052212|2017-10-10 22:31:13.052212
NCT02666131|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-08-08|||July 2015||2015-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Granexin Gel to Treat Diabetic Foot Ulcer|A Phase 3, Randomized, Double-blind, Parallel-group, Multicenter Study Investigating the Safety and Efficacy of Granexin Gel in the Treatment of Diabetic Foot Ulcer (GAIT 2)|Recruiting||Phase 3|368|Anticipated|FirstString Research, Inc.||2|||f||||t||||||||No||2017-10-10 22:31:13.11923|2017-10-10 22:31:13.11923
NCT02666118|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-07-28|||February 2013||2013-02-01|July 2017|2017-07-01|January 31, 2019|Anticipated|2019-01-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Efficacy of Nerve Blockade Performed Prior to Surgical Intervention Versus Following Surgical Intervention|Randomized Prospective Comparison of Analgesic Efficacy of Peripheral Nerve Blockade Performed Prior to Surgical Intervention Versus Following Surgical Shoulder Repair|Enrolling by invitation||N/A|144|Anticipated|Children's Hospital Medical Center, Cincinnati||4|||f||||||||||||||2017-10-10 22:31:13.226741|2017-10-10 22:31:13.226741
NCT02666105|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-10-04|||August 2016||2016-08-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Exemestane in Post-Menopausal Women With NSCLC|Phase II Trial of Exemestane in Previously Treated Post-Menopausal Women With Advanced Non-Small Cell Lung Cancer|Recruiting||Phase 2|56|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-10 22:31:13.324101|2017-10-10 22:31:13.324101
NCT02666092|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-01-17|||February 2015||2015-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|ABCFish2||Anisakis Blastocystis Cryptosporidium Fish Serology|Protists and Nematodes Fish Parasites: From Their Circulation in Ecosystems to Their Impact on Human Health - Role of Anisakidae and/or Fish Flesh Antigens in Fish Allergies.|Completed||N/A|105|Actual|University Hospital, Lille|||2||f||||f||||||Samples Without DNA|"     Serum samples   "|No||2017-10-10 22:31:13.474449|2017-10-10 22:31:13.474449
NCT02666079|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-31|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomised Trial of LightPath Imaging in Breast Cancer Surgery|A Randomised, Controlled, Multi-centre Clinical Study to Evaluate the Outcomes Following the Intra-operative Use of the LightPathTM Imaging System Compared to Standard Practice in Wide Local Excision (WLE) for Breast Cancer|Recruiting||Phase 4|442|Anticipated|Lightpoint Medical Limited||2|||f||||f|f|f||||||Undecided||2017-10-10 22:31:13.58533|2017-10-10 22:31:13.58533
NCT02666066|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-03-28|||January 2016||2016-01-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|Radiomics||Radiomics for Prediction of Survival in GBM|Radiomics for the Prediction of Survival in GBM After Radiotherapy With/Without Temozolomide|Recruiting||N/A|250|Anticipated|Maastricht Radiation Oncology|||1||f||||f||||||||No||2017-10-10 22:31:13.75953|2017-10-10 22:31:13.75953
NCT02665286|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-09-06|||March 2016||2016-03-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Orphenadrine and Methocarbamol for LBP|Methocarbamol and Orphenadrine for Acute, Non-traumatic, Non-radicular Low Back Pain: A Randomized, Placebo Controlled, 3-armed Study|Recruiting||Phase 4|240|Anticipated|Montefiore Medical Center||3|||f||||t||||||||No||2017-10-10 22:31:22.242682|2017-10-10 22:31:22.242682
NCT02666053|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-09-07|||January 27, 2016|Actual|2016-01-27|September 2017|2017-09-01|February 22, 2016|Actual|2016-02-22|February 22, 2016|Actual|2016-02-22||Interventional|||A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy Subjects|A Study to Assess the Effect of a High-fat Meal and Increased Gastric pH on the Bioavailability of an Extended-release Formulation of BMS-663068 in Healthy Subjects|Completed||Phase 1|72|Actual|ViiV Healthcare||3|||f||||f|t|f||||||||2017-10-10 22:31:13.887201|2017-10-10 22:31:13.887201
NCT02666040|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-25|||November 2009||2009-11-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|SUPERMESH||Study on Ultrapro vs Polypropylene: Early Results From a Multicentric Experience in Surgery for Hernia|A Multicenter Prospective Randomized Study Of Comparison Between Semi-Absorbable Prosthesis And Totally Nonabsorbable Prosthesis In Inguinal Hernia Surgery|Active, not recruiting||N/A|1200|Anticipated|Istituto Clinico Humanitas||2|||f||||f||||||||||2017-10-10 22:31:14.130354|2017-10-10 22:31:14.130354
NCT02666027|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-01-30|||January 2017|Anticipated|2017-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FIVA||The Use of the Fluid IV Alert Monitor to Decrease the Incidence of Undetected Empty IV Bag in Dimmed Operating Rooms|The Use of the Fluid IV Alert (FIVA) Monitor to Decrease the Incidence of Undetected Empty Intravenous Bag in Dimmed Operating Rooms|Not yet recruiting||N/A|90|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-10 22:31:14.243723|2017-10-10 22:31:14.243723
NCT02666014|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-08-30|||June 2015||2015-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Sugammadex Versus Neostigmine for Postoperative Nausea and Vomiting After Laparoscopic Gynaecological Surgery|Comparison of Sugammadex Versus Neostigmine in Women at High Risk of Postoperative Nausea and Vomiting After Laparoscopic Gynaecological Surgery: A Randomized Controlled Trial|Recruiting||Phase 3|300|Anticipated|KK Women's and Children's Hospital||2|||f||||t||||||||Yes||2017-10-10 22:31:14.381111|2017-10-10 22:31:14.381111
NCT02666001|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-08-08|||January 12, 2016|Actual|2016-01-12|August 2017|2017-08-01|June 29, 2016|Actual|2016-06-29|June 29, 2016|Actual|2016-06-29||Interventional|||A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone|A Phase 1, Open-Label, Drug-Drug Interaction Study Between Methadone and BMS-663068; and Between Buprenorphine/Naloxone and BMS-663068|Completed||Phase 1|32|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-10 22:31:14.56664|2017-10-10 22:31:14.56664
NCT02665988|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-11-08|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|tDCS||Adjunctive Transcranial Direct Current Stimulation|A Single-Blind, Randomized Control Trial of Adjunctive Transcranial Direct Current Stimulation (tDCS) for Chronic Pain Among Patients Receiving Specialized, Inpatient Multi-Modal Pain Management|Recruiting||Phase 2|36|Anticipated|Baylor College of Medicine||2|||f||||f||||||||No|Description of data may affect potential subject's awareness of sham versus real transcranial Direct Current Stimulation (tDCS)|2017-10-10 22:31:14.69239|2017-10-10 22:31:14.69239
NCT02665975|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-06-27|||August 2016||2016-08-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Internet-based Versus Face-to-face Clinical Care for Tinnitus|Internet-based Versus Face-to-face Clinical Care for Tinnitus: A Multi-study Randomised Control Trial|Active, not recruiting||N/A|80|Anticipated|Anglia Ruskin University||2|||f||||t||||||||Yes||2017-10-10 22:31:14.823114|2017-10-10 22:31:14.823114
NCT02665962|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-09-23|||July 2015||2015-07-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Interventional|||Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer|Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer|Recruiting||N/A|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:31:14.977314|2017-10-10 22:31:14.977314
NCT02665936|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-27|||October 2015||2015-10-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Effect of Epidural Dexamethasone on Labor Analgesia|Epidural Levobupivacaine Versus A Combination of Levobupivacaine and Dexamethasone in Parturients Receiving Epidural for Vaginal Delivery Analgesia: A Comparative, Dose Ranging and Safety Evaluation Study|Active, not recruiting||Phase 2|90|Anticipated|Kasr El Aini Hospital||3|||f||||||||||||||2017-10-10 22:31:15.079161|2017-10-10 22:31:15.079161
NCT02665923|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Gastric Emptying in Children|Gastric Emptying in Pediatric Patients|Recruiting||N/A|110|Anticipated|Columbia University|||5||f||||f||||||||||2017-10-10 22:31:15.192793|2017-10-10 22:31:15.192793
NCT02665910|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-04-18|||May 2016||2016-05-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients|A Phase I, Randomized, Placebo-Controlled, Multiple Doses Escalation Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics of SHR0302 in Patients With RA|Not yet recruiting||Phase 1|48|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 22:31:15.33626|2017-10-10 22:31:15.33626
NCT02665897|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-06-08|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Observational|PET||Pre-eclampsia and Biochemical Markers|Correlation Between Complications of Pre-eclampsia and Detection of Novel Biochemical Markers|Completed||N/A|90|Actual|Assiut University|||3||f||||t||||||||Yes||2017-10-10 22:31:15.457676|2017-10-10 22:31:15.457676
NCT02665884|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-01-24|||February 2016||2016-02-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Diurnal Fluctuations of Intraocular Pressure in EX-Press Valve Blebs in Glaucoma Patients||Not yet recruiting||N/A|40|Anticipated|Hillel Yaffe Medical Center|||2||f||||f||||||||No||2017-10-10 22:31:15.54742|2017-10-10 22:31:15.54742
NCT02665871|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-08-12|||March 2016||2016-03-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older||Enrolling by invitation||Phase 1|80|Actual|Beijing Chaoyang District Centre for Disease Control and Prevention||4|||f||||||||||||||2017-10-10 22:31:15.667013|2017-10-10 22:31:15.667013
NCT02665858|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-01-24|||February 2016||2016-02-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension||Not yet recruiting||N/A|50|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||No||2017-10-10 22:31:15.756563|2017-10-10 22:31:15.756563
NCT02665845|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-01-20|||February 2016||2016-02-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|COMBOMESA||Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).|Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis: A Protocol of a Multi-center Prospective Randomized Investigator Blinded Trial.|Recruiting||Phase 3|160|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:31:15.855869|2017-10-10 22:31:15.855869
NCT02665832|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-25|||January 2016||2016-01-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of DWJ1351 in Healthy Male Volunteers|A Randomized, Open-label, Single-Dose, 2-Way Cross-over Study To Compare the Safety and Pharmacokinetic Characteristics of Combination of Amlodipine, Olmesartan and Rosuvastatin and DWJ1351 in Healthy Male Volunteers|Not yet recruiting||Phase 1|58|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||t||||||||||2017-10-10 22:31:16.022478|2017-10-10 22:31:16.022478
NCT02665819|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-08-11|||September 2015||2015-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|SALTO-BIO||Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility.|SALTO-BIO (Long Term Follow up in Oncology) - PanCareLIFE. Long Term Support for Pediatric Cancer Survivors in Rhône-Alpes. Evaluation of Women Fertility.|Recruiting||N/A|84|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"     25 ml of blood for each patient will be necessary to measure the AMH and FSH hormones rates.   "|No||2017-10-10 22:31:16.104277|2017-10-10 22:31:16.104277
NCT02665806|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-01-25|||January 2016||2016-01-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis|Ciclesonide vs Fluticasone Propionate Nasal Sprays in Patients With Nasal Poplyposis; a Randomized Clinical Trial|Not yet recruiting||Phase 3|32|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||No||2017-10-10 22:31:16.226322|2017-10-10 22:31:16.226322
NCT02665793|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-06-21|||August 2016|Actual|2016-08-01|June 2017|2017-06-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|TRACEextension||Mechanisms Underlying Peanut Allergic Reactions in TRACE Peanut Study Participants: Extension Study|Mechanisms Underlying the Change in Threshold or Severity of Peanut-allergic Reactions in TRACE Peanut Study Participants - Extension Study|Completed||N/A|17|Actual|Imperial College London||2|||f||||t||||||||Yes|De-identified data will be made public through the Integrated approaches to food allergen and allergy management (iFAAM) collaboration|2017-10-10 22:31:16.32487|2017-10-10 22:31:16.32487
NCT02665780|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-03|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessing the Effect of Periodontal Debridement, Tongue Cleaning and Mouth Rinsing for the Treatment of Oral Malodour|Assessing the Effect of Periodontal Debridement, Tongue Cleaning and Mouth Rinsing for the Treatment of Oral Malodour|Not yet recruiting||N/A|30|Anticipated|University of British Columbia||1|||f||||f|f|f||||||No||2017-10-10 22:31:16.454262|2017-10-10 22:31:16.454262
NCT02665767|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-24|||March 2015||2015-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|TIAT||Telementoring for Identifying the Appendix Using Telesonography|A Feasibility Study of Telementoring for Identifying the Appendix Using Smartphone-based Telesonography|Completed||N/A|30|Actual|Hanyang University||2|||f||||t||||||||||2017-10-10 22:31:16.534817|2017-10-10 22:31:16.534817
NCT02665754|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-07-30|||July 2016||2016-07-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|ILIT-T||Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis|The Efficacy and Adverse Effect of Intralymphatic Immunotherapy With Tyrosine S®, Allergen Extract for Immunotherapy, in Patients With Allergic Rhinitis Induced by House Dust Mite, Dog, and Cat Allergen|Recruiting||Phase 1|40|Anticipated|Gachon University Gil Medical Center||2|||f||||t||||||||No||2017-10-10 22:31:16.62143|2017-10-10 22:31:16.62143
NCT02665741|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-05-24|||January 2016||2016-01-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope Attachments|Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope Attachments|Completed||N/A|126|Actual|University of California, Davis||3|||f||||t||||||||Yes||2017-10-10 22:31:16.748595|2017-10-10 22:31:16.748595
NCT02665728|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-07-25||2017-07-25|December 2015||2015-12-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects|A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects|Completed||Phase 2|33|Actual|Braintree Laboratories||1|||f||||f||||||||||2017-10-10 22:31:16.844989|2017-10-10 22:31:16.844989
NCT02665715|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2016-07-20|||August 2015||2015-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?|Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?|Completed||N/A|10|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-10 22:31:16.917456|2017-10-10 22:31:16.917456
NCT02665702|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-24|||January 2016||2016-01-01|January 2016|2016-01-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas|Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas of the Prospective, Single Arm Phase II Clinical Study|Recruiting||Phase 2|76|Anticipated|Fudan University||1|||f||||f||||||||Undecided||2017-10-10 22:31:17.006337|2017-10-10 22:31:17.006337
NCT02665689|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-31|||January 2016||2016-01-01|January 2016|2016-01-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|DORO||Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab|Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab|Recruiting||Phase 4|120|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||No||2017-10-10 22:31:17.082101|2017-10-10 22:31:17.082101
NCT02665676|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-02-24|||January 2018|Anticipated|2018-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Observational|||Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience|Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience|Not yet recruiting||N/A|420|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:31:17.162251|2017-10-10 22:31:17.162251
NCT02665650|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-25|2017-09-19|||May 2016||2016-05-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma|A Phase 1b Dose Escalation Study to Assess the Safety of AFM13 in Combination With Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (KEYNOTE- 206)|Recruiting||Phase 1|33|Anticipated|Affimed GmbH||1|||f||||t||||||||||2017-10-10 22:31:17.345322|2017-10-10 22:31:17.345322
NCT02665637|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-08-24|||December 2015||2015-12-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin|A Randomized, Double-blind, Two-arm, Parallel-group, Single Dose Study to Compare the Pharmacokinetics, Safety and Immunogenicity of Two Formulations of Trastuzumab (CT-P6 and US-licensed Herceptin) in Healthy Subjects|Completed||Phase 1|70|Actual|Celltrion||2|||f||||t||||||||||2017-10-10 22:31:17.491524|2017-10-10 22:31:17.491524
NCT02665624|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2016-01-24|||April 2015||2015-04-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Adding Stewed Apricot Juice to Senna Improves the Right-Side and Overall Colon Cleansing Quality for Colonoscopy Preparation|Adding Stewed Apricot Juice to Senna Improves the Right-Side and Overall Colon Cleansing Quality for Colonoscopy Preparation|Completed||Phase 4|128|Actual|Camlıca Erdem Hospital||2|||f||||t||||||||Yes||2017-10-10 22:31:17.567819|2017-10-10 22:31:17.567819
NCT02665611|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-02-07|||February 2016||2016-02-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence|The Effect of Remote Monitoring and Support for Patients Suffering From Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence to Treatment|Not yet recruiting||N/A|300|Anticipated|Assuta Hospital Systems||2|||f||||t||||||||Yes||2017-10-10 22:31:17.648044|2017-10-10 22:31:17.648044
NCT02665598|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-04-09|||April 2016||2016-04-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Observational|POPRES||Prognostic Observation of Posterior Reversible Encephalopathy Syndrome|Prognostic Observation of Posterior Reversible Encephalopathy Syndrome|Recruiting||N/A|400|Anticipated|Yantai Yuhuangding Hospital|||1||f||||t||||||||Yes||2017-10-10 22:31:17.723197|2017-10-10 22:31:17.723197
NCT02665585|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-14|||November 2014||2014-11-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|3PCAS||Plaque Prolapse Prevention Carotid Artery Stenting (3PCAS)|Plaque Prolapse Prevention Carotid Artery Stenting (3PCAS) Randomized Controlled Trial|Completed||N/A|58|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-10 22:31:17.80919|2017-10-10 22:31:17.80919
NCT02665572|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-06-20|||August 2015||2015-08-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Outcome of Renal Transplant on a Defunctionalized Bladder|Outcome of Renal Transplant on a Defunctionalized Bladder. A Randomized Controlled Trial|Recruiting||N/A|32|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 22:31:17.88649|2017-10-10 22:31:17.88649
NCT02665546|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-29|||March 2016||2016-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis|Evaluation of Exercise Capacity and Mechanisms of Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis|Recruiting||N/A|60|Anticipated|InCor Heart Institute|||2||f||||t||||||||||2017-10-10 22:31:18.045632|2017-10-10 22:31:18.045632
NCT02665533|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-08-18|||January 2016||2016-01-01|January 2016|2016-01-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of Two Pharmacological Protocols for Pre-emptive Analgesia in Impacted Third Molar Surgery|Evaluation of Two Pharmacological Protocols for Pre-emptive Analgesia in Impacted Third Molar Surgery|Completed||N/A|18|Actual|Federal University of the Valleys of Jequitinhonha and Mucuri||2|||f||||t||||||||||2017-10-10 22:31:18.15744|2017-10-10 22:31:18.15744
NCT02665520|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-01-26|||October 2015||2015-10-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Penile Intracavernosal Stem Cells Therapy for Erectile Dysfunction|Phase 1 Study of the Use of Autologous Penile Stem Cells in Men With Erectile Dysfunction|Recruiting||Phase 2|30|Anticipated|Elaj medical centers||2|||f||||t||||||||||2017-10-10 22:31:20.17257|2017-10-10 22:31:20.17257
NCT02665507|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2017-02-28|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|LLL&Pilots||Light Therapy for the Treatment of Back Pain in Pilots (LLL&Pilots)|Evaluation of the Efficacy of Light Therapy for the Treatment of Back Pain in Pilots|Not yet recruiting||N/A|40|Anticipated|Hebrew University of Jerusalem||2|||f||||f|f|t|f||f|||No||2017-10-10 22:31:20.264656|2017-10-10 22:31:20.264656
NCT02665494|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-24|2016-09-22|||January 2016||2016-01-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors|Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors|Recruiting||N/A|500|Anticipated|Fondazione del Piemonte per l'Oncologia|||1||f||||f||||||||No||2017-10-10 22:31:20.345308|2017-10-10 22:31:20.345308
NCT02665481|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-05-24|||April 2015||2015-04-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|MEDEX||Mindfulness-Based Stress Reduction, Health Education and Exercise|Remediating Age Related Cognitive Decline: Mindfulness-Based Stress Reduction and Exercise|Recruiting||N/A|580|Anticipated|Washington University School of Medicine||4|||f||||t||||||||Yes|Contact PI. Estimated date of availability December 2020.|2017-10-10 22:31:20.448293|2017-10-10 22:31:20.448293
NCT02665468|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-07-31|||February 1, 2016|Actual|2016-02-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|October 31, 2016|Actual|2016-10-31||Interventional|eHealth PEI||eHealth Partnered Evaluation Initiative|eHealth Partnered Evaluation Initiative (PEC 15-470)|Active, not recruiting||N/A|900|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:31:20.569919|2017-10-10 22:31:20.569919
NCT02665442|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-01-23|||January 2016||2016-01-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|EsoSure||Retracting the Esophagus During AF Ablation|Esophageal Stylet as a Strategy to Minimize the Risk of Esophageal Injury During the Atrial Fibrillation Catheter Ablation Procedure.|Not yet recruiting||N/A|40|Anticipated|Northeast Scientific, Inc.||2|||f||||f||||||||Yes|Data will be shared through publications.|2017-10-10 22:31:20.775409|2017-10-10 22:31:20.775409
NCT02665429|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-06-23|||February 1, 2016|Actual|2016-02-01|June 2017|2017-06-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||A Quality Improvement Project to Investigate Individual Provider Variation in Opioid Prescribing From the Emergency Department|A Quality Improvement Project to Investigate Individual Provider Variation in Opioid Prescribing From the Emergency Department|Completed||N/A|109|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||No||2017-10-10 22:31:20.876721|2017-10-10 22:31:20.876721
NCT02665416|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-27|||January 25, 2016|Actual|2016-01-25|September 2017|2017-09-01|July 18, 2018|Anticipated|2018-07-18|July 18, 2018|Anticipated|2018-07-18||Interventional|||Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of RO7009789 With Vanucizumab in Participants With Metastatic Solid Tumors|An Open-Label, Multicenter, Dose Escalation Phase Ib Study With Expansion Cohorts to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Therapeutic Activity of RO7009789 (CD40 Agonistic Monoclonal Antibody) in Combination With Vanucizumab (Anti-Ang2 and Anti-VEGF Bi-Specific Monoclonal Antibody) in Patients With Metastatic Solid Tumors|Recruiting||Phase 1|170|Anticipated|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 22:31:21.085561|2017-10-10 22:31:21.085561
NCT02665403|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-01-22|||November 2012||2012-11-01|January 2016|2016-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Play Interventions to Reduce Anxiety and Negative Emotions in Hospitalized Children|Play Interventions to Reduce Anxiety and Negative Emotions in Hospitalized Children|Completed||N/A|304|Actual|The University of Hong Kong||2|||f||||t||||||||No|No plan for making the data available to the public|2017-10-10 22:31:21.221967|2017-10-10 22:31:21.221967
NCT02665390|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-02-10|||February 2016||2016-02-01|February 2016|2016-02-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|PCPLC||Percutaneous Cryoablation Peripheral Lung Cancer|Percutaneous Cryoablation for the Treatment of Medically Inoperable Peripheral Lung Cancer|Not yet recruiting||N/A|30|Anticipated|Shanghai Chest Hospital||1|||f||||f||||||||No||2017-10-10 22:31:21.317226|2017-10-10 22:31:21.317226
NCT02665377|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-04-20|||September 2016||2016-09-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Prevention of Akute Kidney Injury, Hearttransplant, ANP|Prevention of Akute Kidney Injury With Human Atrial Natriuretic Peptide in Patients Undergoing Heart Transplant.|Recruiting||Phase 3|100|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||No||2017-10-10 22:31:21.414318|2017-10-10 22:31:21.414318
NCT02665364|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-03-27|||September 2015||2015-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of IFN-K in Systemic Lupus Erythematosus|A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus|Recruiting||Phase 2|178|Anticipated|Neovacs||2|||f||||t||||||||||2017-10-10 22:31:21.535512|2017-10-10 22:31:21.535512
NCT02665351|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-28|||February 2011||2011-02-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections|A Phase 2, Pilot, Open-label, Randomized Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult Hospitalized Subjects With Confirmed Influenza Infection|Completed||Phase 2/Phase 3|16|Actual|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-10 22:31:21.812501|2017-10-10 22:31:21.812501
NCT02665338|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-26|||January 2015||2015-01-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||TMS-fMRI for Neural Pathway in Smokers|Repetitive TMS Modulates Dorsal Lateral Prefrontal-Ventral Medial Prefrontal Pathway to Decrease Craving in Smokers|Recruiting||N/A|30|Anticipated|Medical University of South Carolina||2|||f||||||||||||||2017-10-10 22:31:21.90569|2017-10-10 22:31:21.90569
NCT02665325|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-06-18|||January 2016||2016-01-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma|Cognitive Functions and Mood During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma|Recruiting||N/A|100|Anticipated|The Affiliated Hospital of Inner Mongolia Medical University|||3||f||||f||||||||Undecided||2017-10-10 22:31:21.985376|2017-10-10 22:31:21.985376
NCT02665312|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-09-22|||January 2016||2016-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine|CHEmotherapy-induced Cardiotoxicity and Study of risK Factor Correlation in Patients With Colorectal Cancer Receiving Oral or INfusional Fluoropyrimidine Treatment - CHECKPOINT|Recruiting||N/A|200|Anticipated|Fondazione del Piemonte per l'Oncologia|||1||f||||f||||||||Undecided||2017-10-10 22:31:22.086205|2017-10-10 22:31:22.086205
NCT02665299|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-08-16|||January 2016||2016-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|April 2017|Actual|2017-04-01||Observational|||Plasma ctDNA in Patients Undergoing Diagnostic Colonoscopy|Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for the Detection of Colon Cancer in Patients Undergoing Diagnostic Colonoscopy|Completed||N/A|206|Actual|Pathway Genomics|||1||f||||f||||||Samples With DNA|"     Blood is drawn and DNA is purified from the plasma. The DNA is analyzed for circulating tumor     DNA. The DNA will be stored for up to 10 years.   "|||2017-10-10 22:31:22.179141|2017-10-10 22:31:22.179141
NCT02665273|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-09-06|||July 2015||2015-07-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Greater Occipital Nerve Block With Bupivacaine for Acute Migraine|A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine|Recruiting||Phase 4|78|Anticipated|Montefiore Medical Center||2|||f||||t||||||||No||2017-10-10 22:31:22.342608|2017-10-10 22:31:22.342608
NCT02665260|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-03-23|2016-12-06||July 2012||2012-07-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum|Randomized Pilot Study Investigating the Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum|Completed||Phase 2|94|Actual|Montefiore Medical Center||4|||f||||f||||||||No||2017-10-10 22:31:22.438238|2017-10-10 22:31:22.438238
NCT02665247|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-10-05|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|August 2018|Anticipated|2018-08-01||Interventional|||Impact of Sleep Workshops in College Students|Impact of Sleep Workshops in College Students|Not yet recruiting||N/A|160|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:31:22.96647|2017-10-10 22:31:22.96647
NCT02665234|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-24|||January 2016||2016-01-01|September 2016|2016-09-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease|A Safety and Efficacy Study of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye Disease|Completed||Phase 3|400|Actual|Mimetogen Pharmaceuticals USA, Inc.||2|||f||||f||||||||No||2017-10-10 22:31:23.063047|2017-10-10 22:31:23.063047
NCT02665208|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-15|||March 2015||2015-03-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2015|Actual|2015-09-01||Interventional|||A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients|Mobile Phone Messaging to Support Smoking Cessation Among Office-based Buprenorphine and Inpatient Detoxification Patients: a Pilot Study|Active, not recruiting||N/A|203|Actual|New York University School of Medicine||3|||f||||f|f|f||||||||2017-10-10 22:31:23.237188|2017-10-10 22:31:23.237188
NCT02665195|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-13|||January 2016||2016-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|60 Days|Observational [Patient Registry]|||Prospective Registry of Multiplex Testing (PROMPT)|Prospective Registry of Multiplex Testing (PROMPT): Phase II|Recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     saliva specimen   "|||2017-10-10 22:31:23.325651|2017-10-10 22:31:23.325651
NCT02665182|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-23|||July 2012||2012-07-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|EleScro||Up-positioning of the Testes as Supportive Therapy in Patients With Acute Orchitis|Up-positioning of the Testes as Supportive Therapy in Patients With Acute Orchitis - a Randomized Controlled Trial|Active, not recruiting||N/A|70|Anticipated|Medical University of Warsaw||2|||f||||f||||||||No||2017-10-10 22:31:23.446219|2017-10-10 22:31:23.446219
NCT02665169|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-15|||March 2016||2016-03-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|KFPS||Kuopio Fall Prevention Study.|Randomized Fall Prevention Trial For Aging Females by Providing Supervised Exercises and Free Use of Municipal Recreation Facilities.|Active, not recruiting||N/A|914|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-10-10 22:31:23.547444|2017-10-10 22:31:23.547444
NCT02665156|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-10-04|||January 2016||2016-01-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|||Time Efficiency of Intracorporeal Orthotopic Diversion With Robotic Staplers After Robot Assisted Radical Cystectomy|Phase 2 Clinical Trial to Assess Time Efficiency of Intracorporeal Orthotopic Diversion With Robotic Staplers After Robot Assisted Radical Cystectomy|Recruiting||N/A|33|Anticipated|Regina Elena Cancer Institute||1|||f||||f||||||||||2017-10-10 22:31:23.649138|2017-10-10 22:31:23.649138
NCT02665143|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-12-13|||June 2016||2016-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia|A Phase I-II Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|60|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 22:31:23.738863|2017-10-10 22:31:23.738863
NCT02665130|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-12|||December 2014||2014-12-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of Tai Chi and Pulmonary Rehabilitation on the Effect of Indacaterol in Treatment naïve COPD Participants|State Key Laboratory of Respiratory Disease|Completed||Phase 4|120|Actual|State Key Laboratory of Respiratory Disease||2|||f||||t||||||||Yes||2017-10-10 22:31:23.847092|2017-10-10 22:31:23.847092
NCT02665117|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate|Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate|Recruiting||N/A|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 22:31:23.941027|2017-10-10 22:31:23.941027
NCT02665104|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-03-08|||April 2015||2015-04-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Middle Cerebral Artery Velocity and Oxygen Saturation of the Brain During Carotid Endarterectomy|Investigation of Blood Flow Velocity in the MCA and Oxygen Saturation of the Brain During Carotid Endarterectomy in Local Anesthesia in Patients With and Without Neurological Symptoms Using Transcranial Doppler (TCD) and INVOS Monitor|Recruiting||N/A|100|Anticipated|University of Debrecen|||2||f||||t||||||||||2017-10-10 22:31:24.088804|2017-10-10 22:31:24.088804
NCT02665091|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-22|||February 2015||2015-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Peer Education Program for HIV/AIDS Related Sexual Behaviors of Secondary School Students|Impact of Peer Education Program on HIV/AIDS Related Sexual Behaviors of Secondary School Students in Rural Communities, India: a Quasi-experimental Study.|Completed||N/A|560|Actual|NMP Medical Research Institute||1|||f||||t||||||||Yes|YES|2017-10-10 22:31:24.187293|2017-10-10 22:31:24.187293
NCT02665078|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-10-31|||January 2015||2015-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules|Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules Using Resected Human Lungs|Recruiting||N/A|40|Anticipated|University Health Network, Toronto|||1||f||||f||||||||Yes|Through Publication|2017-10-10 22:31:24.263358|2017-10-10 22:31:24.263358
NCT02665052|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-26|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|June 28, 2019|Anticipated|2019-06-28|December 3, 2018|Anticipated|2018-12-03||Interventional|TeleBATRAC||Translating Intensive Arm Rehabilitation in Stroke to a Telerehabilitation Format|Translating Intensive Arm Rehabilitation in Stroke to a Telerehabilitation Format|Recruiting||Phase 3|78|Anticipated|VA Office of Research and Development||3|||f||||t|f|t|f|f|t|||No||2017-10-10 22:31:24.51035|2017-10-10 22:31:24.51035
NCT02665039|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-26|||April 2014||2014-04-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|VINGEM||A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function|A Multicenter, Randomized Phase II Trial of Vinflunine/Gemcitabine vs Carboplatin/Gemcitabine as First Line Treatment in Patients With Metastatic Urothelial Carcinoma Unfit for Cisplatin Based Chemotherapy Due to Impaired Renal Function.|Recruiting||Phase 2|60|Anticipated|Karolinska University Hospital||2|||f||||t||||||||No||2017-10-10 22:31:24.623291|2017-10-10 22:31:24.623291
NCT02665026|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-23|2016-08-23|||January 2016||2016-01-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Surgery for Rectal Cancer|A Single Center, Open, Randomized Clinical Trials, Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Total Mesorectal Excision for Middle and Low Rectal Cancer|Recruiting||N/A|250|Anticipated|Huashan Hospital||1|||f||||t||||||||Yes|Individual participant data for all primary and secondary outcome measures will be made available within 6 months of study completion.|2017-10-10 22:31:24.756032|2017-10-10 22:31:24.756032
NCT02665013|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-25|||April 2016||2016-04-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|REDIVAC||Reducing Delay of Vaccination in Children Study|Reducing Delay of Vaccination in Children Study|Recruiting||N/A|500|Anticipated|Kaiser Permanente||3|||f||||f||||||||No||2017-10-10 22:31:24.903356|2017-10-10 22:31:24.903356
NCT02665000|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-03-21|||August 2014||2014-08-01|March 2016|2016-03-01||||June 2018|Anticipated|2018-06-01||Interventional|||Evaluating the Effects of a Structured Training Program on the Learning Curve of Residents in Laparoscopic Surgery|A Randomised Controlled Trial Evaluating the Effects of a Structured Training Program on the Learning Curve of Residents in the Field of Laparoscopic Surgery (STAR Trial)|Recruiting||N/A|20|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||Undecided||2017-10-10 22:31:25.027381|2017-10-10 22:31:25.027381
NCT02664987|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-09-08|2016-09-08||September 2015||2015-09-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ACE||Analgesic Treatment for Cancer Pain in South East Asia|A Cross-sectional Study to Investigate the Pain Control Status in Cancer Patients in South East Asian Countries|Completed||N/A|462|Actual|Mundipharma Pte Ltd.|||1||f||||f||||||||||2017-10-10 22:31:25.132955|2017-10-10 22:31:25.132955
NCT02664974|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-26|||December 2008||2008-12-01|January 2016|2016-01-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer|Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer: A Multicenter Randomized Clinical Trial|Completed||Phase 3|79|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-10 22:31:25.383478|2017-10-10 22:31:25.383478
NCT02664961|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-11-01|||March 2016||2016-03-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)|A Phase 2A Study of TRC105 (With Option to Add Bevacizumab) in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)|Recruiting||Phase 2|30|Anticipated|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||No||2017-10-10 22:31:25.611852|2017-10-10 22:31:25.611852
NCT02664948|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-11-23|||June 2014||2014-06-01|December 2015|2015-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Early Geriatric Follow-up in Older Acute Medical Patients|Early Geriatric Follow-up After Hospital Discharge in Older Acute Medical Patients - a Quasi Randomized Controlled Trial|Completed||N/A|2096|Actual|University of Aarhus||2|||f||||f||||||||No||2017-10-10 22:31:25.730738|2017-10-10 22:31:25.730738
NCT02664935|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer|National Lung Matrix Trial: Multi-drug, Genetic Marker-directed, Non-comparative, Multi-centre, Multi-arm Phase II Trial in Non-small Cell Lung Cancer|Recruiting||Phase 2|620|Anticipated|University of Birmingham||8|||f||||t||||||||No||2017-10-10 22:31:25.845897|2017-10-10 22:31:25.845897
NCT02664922|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2016-01-22|||May 2012||2012-05-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Anesthetic Techniques in EP Patients|Anesthetic Techniques and the Effect on Cardiac Electrophysiology Procedures|Active, not recruiting||Phase 4|120|Anticipated|University of California, Los Angeles||4|||f||||t||||||||No||2017-10-10 22:31:26.046423|2017-10-10 22:31:26.046423
NCT02664909|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-01-13|||January 2016||2016-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty|Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty|Recruiting||Phase 4|102|Anticipated|UConn Health||2|||f||||t||||||||||2017-10-10 22:31:26.163244|2017-10-10 22:31:26.163244
NCT02664896|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-06-14|||April 2013||2013-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|||Pain Phenotypes in Knee Osteoarthritis|Determination of Pain Phenotypes in Older Adults With Knee Osteoarthritis|Completed||N/A|187|Actual|University of Colorado, Denver|||2||f||||f||||||None Retained|"     1mL of whole blood will be taken for analysis of inflammatory factors including IL-1beta,     IL-6, IL-8, TNF, and C-Reactive Protein. Samples will be stored at University of Colorado     Hospital until analysis is complete. Samples will then be destroyed.   "|||2017-10-10 22:31:26.283126|2017-10-10 22:31:26.283126
NCT02664883|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-04-08|||September 8, 2015|Actual|2015-09-08|April 2017|2017-04-01|September 8, 2019|Anticipated|2019-09-08|September 8, 2018|Anticipated|2018-09-08||Observational|||Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer|MDSC Clinical Assay for Cancer Detection and Monitoring in Renal Cell Carcinoma|Recruiting||N/A|63|Anticipated|University of Southern California|||3||f||||t|f|f||||Samples With DNA|"     Blood and urine samples   "|||2017-10-10 22:31:26.399848|2017-10-10 22:31:26.399848
NCT02664870|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-05-22|||January 2016||2016-01-01|May 2017|2017-05-01|January 2026|Anticipated|2026-01-01|January 2019|Anticipated|2019-01-01||Observational|||Evaluation of Biomarkers in Human Synovial Fluid|Prospective Biological and Clinical Databank for the Evaluation of Biomarkers in Human Synovial Fluid|Recruiting||N/A|500|Anticipated|Duke University|||3||f||||f||||||Samples Without DNA|"     Biospecimen retention would include the collection and storage of synovial fluid samples from     the hip, shoulder, and knee.   "|||2017-10-10 22:31:26.525657|2017-10-10 22:31:26.525657
NCT02664857|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-31|||July 2016||2016-07-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Vitamin D Supplementations and Postoperative Pain|Effect of Vitamin D Supplementation on Postoperative Pain and Sedation-agitation|Recruiting||Phase 4|60|Anticipated|Cukurova University||2|||f||||f||||||||No||2017-10-10 22:31:26.624103|2017-10-10 22:31:26.624103
NCT02664844|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-22|||September 2013||2013-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Physical Activity and Food Intake Interaction: Effect of Weight Loss in Obese Adolescent|Physical Activity and Food Intake Interaction: Effect of Weight Loss in Obese Adolescent|Completed||N/A|20|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 22:31:26.735571|2017-10-10 22:31:26.735571
NCT02664831|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-26|||January 2016||2016-01-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|PCAS||Neuregulin-1, Lipidomics, and Inflammation After Resuscitation From Cardiac Arrest|Neuregulin-1, Lipidomics, and Inflammation After Resuscitation From Cardiac Arrest|Recruiting||N/A|40|Anticipated|Maine Medical Center|||1||f||||f||||||Samples Without DNA|"     Whole blood will be assayed for cellular components, neuregulin, ERBB receptors, and lipids   "|||2017-10-10 22:31:26.813386|2017-10-10 22:31:26.813386
NCT02664818|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-22|||January 2012||2012-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01|1 Year|Observational [Patient Registry]|China-HF||Study of China Heart Failure Registry to Investigate Characteristics of Patients in China|China Heart Failure Registry Study: A Multicenter, Prospective Investigation of Clinical Characteristics, Treatment, and Outcome of Patients Hospitalized With Heart Failure|Recruiting||N/A|15000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t||||||||Yes|Data were abstracted by printed Case Report Form and entered into a web-based data center (http://103.31.202.60/subFW/). Hospitals that did not complete electronic CRF (eCRF) would send printed CRF to data center. Trained clinicians or staffs would enter these data into web-based eCRF.|2017-10-10 22:31:26.906213|2017-10-10 22:31:26.906213
NCT02664805|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-08|||February 2016||2016-02-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema|A Phase 2a, Proof of Concept Trial, Testing Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema|Completed||Phase 2|91|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:31:27.009029|2017-10-10 22:31:27.009029
NCT02664792|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-02-22|||August 2014|Actual|2014-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer|Use of [18]F-FDG - PET/CT in Brazil Unified Health System (SUS) as an Alternative Non-invasive Method for Staging of Lung Cancer|Completed||N/A|108|Actual|Latin American Cooperative Oncology Group||1|||f||||f||||||||Undecided||2017-10-10 22:31:27.089768|2017-10-10 22:31:27.089768
NCT02664779|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-22|||January 2016||2016-01-01|January 2016|2016-01-01||||January 2017|Anticipated|2017-01-01||Interventional|||Determination and Comparison of Short-term Effectiveness of Three Methods Used for Recognition of Arrhythmias in People With Different Degrees of Medical Training (Advanced Life Support Workshop Participants-ALS): Randomized Controlled Educational Experiment.||Recruiting||Phase 3|84|Anticipated|Universidad Nacional de Colombia||3|||f||||t||||||||||2017-10-10 22:31:27.207047|2017-10-10 22:31:27.207047
NCT02664766|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-26|||January 2014||2014-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|July 2014|Actual|2014-07-01||Interventional|||Effects of Long-term Exercise on Various Parameters in Heavy Drinkers|Effects of Long-term Exercise on Psychological, Physiological, Biochemical and Alcohol-related Parameters in Heavy Drinkers|Completed||N/A|13|Actual|University of Thessaly||2|||f||||f||||||||No||2017-10-10 22:31:27.307779|2017-10-10 22:31:27.307779
NCT02664753|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-06-16|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|CarniSave||L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury|L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial|Not yet recruiting||Phase 3|272|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t|f|f||||||||2017-10-10 22:31:27.41221|2017-10-10 22:31:27.41221
NCT02663739|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-02-08|||March 2015||2015-03-01|February 2017|2017-02-01|November 2022|Anticipated|2022-11-01|November 2017|Anticipated|2017-11-01||Observational|||Zenith® TXD Post-market Surveillance in Japan|Zenith TXD Dissection Stent Graft System Usage Results Surveillance in Japan for Treating Acute Complicated Stanford Type B Aortic Dissection|Recruiting||N/A|48|Anticipated|Cook Group Incorporated|||1||f||||||||||||||2017-10-10 22:31:40.36604|2017-10-10 22:31:40.36604
NCT02664740|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-06-19|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|PhagoPied||Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus|Comparison of the Efficacy of Standard Treatment Associated With Phage Therapy Versus Standard Treatment Plus Placebo for Diabetic Foot Ulcers Monoinfected by Staphylococcus Aureus: a Randomized, Multi-centre, Controlled, 2-parallel-group, Double-blind, Superiority Trial|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t|f|f||||||||2017-10-10 22:31:27.608777|2017-10-10 22:31:27.608777
NCT02664727|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-27|||January 2014||2014-01-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Effects of Acute Exercise on Various Parameters in Individuals With Alcohol Use Disorders|Effects of Acute Exercise on Psychological, Physiological, Biochemical and Alcohol-related Parameters in Individuals With Alcohol Use Disorders|Completed||N/A|13|Actual|University of Thessaly||2|||f||||f||||||||No||2017-10-10 22:31:27.785854|2017-10-10 22:31:27.785854
NCT02664714|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-01-22|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Individual Pelvic Floor Muscle Training Versus Individual With Group Versus Group for Stress Urinary Incontinence|The Effects of Individual Pelvic Floor Muscle Training Versus Individual Treatment With Progression to Group Versus Group Training for Women With Stress Urinary Incontinence: Protocol for a Randomized Controlled Trial|Not yet recruiting||N/A|90|Anticipated|Universidade Federal de Sao Carlos||3|||f||||t||||||||Undecided||2017-10-10 22:31:27.895022|2017-10-10 22:31:27.895022
NCT02664701|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-10-27|||January 2017||2017-01-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|G-PACTS||Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts|Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial|Not yet recruiting||N/A|240|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||||2017-10-10 22:31:27.996949|2017-10-10 22:31:27.996949
NCT02664688|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-02-28|||July 2015||2015-07-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Lumbar Stabilization Exercises vs Flexor Exercises in Degenerative Spondylolisthesis|Lumbar Stabilization Exercises vs Flexor Exercises in Patients With Chronic Low Back Pain and Degenerative Spondylolisthesis|Recruiting||N/A|92|Anticipated|National Institute of Rehabilitation, Mexico||2|||f||||f||||||||Undecided||2017-10-10 22:31:28.160939|2017-10-10 22:31:28.160939
NCT02664675|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-01-27|||April 2014||2014-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|April 2015|Actual|2015-04-01|1 Day|Observational [Patient Registry]|DUOROPA||Cellular and Molecular Inflammatory Mechanisms Leading to Bone Resorption in Peri-implantitis Vs Periodontitis|Comparison of Cytokines Production and Cellular Recruitment in Gingival Crevicular Fluid (GCF) and Granulation Tissue From Periodontitis, Peri-implantitis and Healthy Patients Leading to Activation of Osteoclasts and Bone Resorption|Completed||N/A|33|Actual|University of Paris 5 - Rene Descartes|||3||f||||f||||||Samples Without DNA|"     Gingiva samples   "|||2017-10-10 22:31:28.249032|2017-10-10 22:31:28.249032
NCT02664662|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2016-01-22|||September 2015||2015-09-01|September 2015|2015-09-01||||September 2016|Anticipated|2016-09-01||Interventional|||The Validation of Tailored Rehabilitated Education in Breast Cancer Survivors After Surgery||Unknown status|Recruiting|N/A|100|Anticipated|Taipei Medical University||2|||f||||t||||||||Yes||2017-10-10 22:31:28.322515|2017-10-10 22:31:28.322515
NCT02664649|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-02-20|||August 26, 2016|Actual|2016-08-26|February 2017|2017-02-01|April 2, 2019|Anticipated|2019-04-02|April 2, 2019|Anticipated|2019-04-02||Interventional|ATLANTIS||Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis|Anti-Thrombotic Strategy to Lower All Cardiovascular and Neurologic Ischemic and Hemorrhagic Events After Trans-Aortic Valve Implantation for Aortic Stenosis|Recruiting||Phase 3|1510|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:31:28.444827|2017-10-10 22:31:28.444827
NCT02664636|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-08-25|||February 2016||2016-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ERASM||Cortical Reorganization Models for Motor Areas and Inter-hemispheric Equilibrium Post-stroke: a Pilot Study|Pilot Study on the Development of Cortical Reorganization Models for Motor Areas and Inter-hemispheric Equilibrium in the Post-stroke Early Recovery Phase Evaluated by Functional Near-infrared Spectroscopy (fNIRS)|Completed||N/A|10|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||No||2017-10-10 22:31:28.571721|2017-10-10 22:31:28.571721
NCT02664623|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-08-09|||July 13, 2016|Actual|2016-07-13|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CalciCoach||Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS Patients|Effectiveness of Personalized Nutrition Advice Delivered Via Dietary Consultations for Optimizing Dietary Calcium Intake in Patients With Multiple Sclerosis (MS) and Monitored as Outpatients: a Randomized, Single-blind, Bicentric Study|Recruiting||N/A|182|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 22:31:28.686077|2017-10-10 22:31:28.686077
NCT02664610|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-04-17|2016-12-15||February 2014|Actual|2014-02-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Community Study to Reduce High Blood Pressure Through Text Messaging (REACH OUT)|REACH OUT: to Reduce High Blood Pressure|Completed||N/A|94|Actual|University of Michigan|high lost to follow up rate. Unknown why participants did not complete the study|2|||f||||f||||||||No||2017-10-10 22:31:28.919131|2017-10-10 22:31:28.919131
NCT02664597|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-02|||December 15, 2016|Actual|2016-12-15|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ASCORDIA01||ADNEXMR Scoring System: Impact of an MR Scoring System on Therapeutic Strategy of Pelvic Adnexal Masses|ADNEXMR Scoring System: Impact of an MR Scoring System on Therapeutic Strategy of Pelvic Adnexal Masses|Recruiting||N/A|606|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-10 22:31:29.318349|2017-10-10 22:31:29.318349
NCT02664584|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-26|||December 2008||2008-12-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|TUDA||The Trinity, Ulster and Department of Agriculture Cohort Study||Active, not recruiting||N/A|5186|Actual|University of Ulster|||2||f||||f||||||Samples With DNA|"     Blood samples Buccal swabs Buffy coats   "|No||2017-10-10 22:31:29.452863|2017-10-10 22:31:29.452863
NCT02664571|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-06-16|||January 2018|Anticipated|2018-01-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|FBB ACC||Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis|Evaluation of Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis|Not yet recruiting||N/A|32|Anticipated|Centre Hospitalier Universitaire de Nīmes||4|||f||||f|f|f||||||||2017-10-10 22:31:29.544784|2017-10-10 22:31:29.544784
NCT02664558|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-08-21|||April 2016||2016-04-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|LIBERTY||A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)|A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)|Active, not recruiting||Phase 2|61|Actual|Eiger BioPharmaceuticals||2|||f||||||||||||||2017-10-10 22:31:29.684506|2017-10-10 22:31:29.684506
NCT02664545|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-05-24|||April 2016||2016-04-01|May 2017|2017-05-01|May 2028|Anticipated|2028-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Bridge-Enhanced ACL Repair vs ACL Reconstruction|A Prospective, Randomized, Controlled, Clinical Trial Evaluating the Non-Inferiority of Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR) to Anterior Cruciate Ligament Reconstruction With an Autologous Tendon Graft (ACLR)|Active, not recruiting||N/A|100|Actual|Boston Children’s Hospital||2|||f||||t||t|t|||||No||2017-10-10 22:31:29.869996|2017-10-10 22:31:29.869996
NCT02664532|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-02-12|2016-02-12||January 2010||2010-01-01|February 2016|2016-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||ASA grade I & II patients aged between 18 to 70 years of both genders undergoing elective surgery requiring general anesthesia with oral endotracheal intubation were included in the study.|Miller Straight Blade vs Macintosh Blade|Miller Straight Blade With Paraglossal Technique Compared to the Macintosh Blade in Respect to Visualization of Larynx and Ease of Intubation|Completed||N/A|150|Actual|Tata Main Hospital|Blinding of laryngoscope to the laryngoscopist was not possible. The study was conducted in predicted non-difficult airways and cannot be extrapolated in difficult airway situations.|2|||f||||f||||||||No||2017-10-10 22:31:29.979173|2017-10-10 22:31:29.979173
NCT02664519|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Mechanisms of Muscle Blood Flow Dysregulation and Exercise Intolerance in Chronic Kidney Disease|Mechanisms of Muscle Blood Flow Dysregulation and Exercise Intolerance in Chronic Kidney Disease|Recruiting||N/A|30|Anticipated|University of Texas Southwestern Medical Center||3|||f||||t||||||||||2017-10-10 22:31:30.380265|2017-10-10 22:31:30.380265
NCT02664506|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-12-12|||March 2014||2014-03-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Theory-Driven Treatment of Language and Cognitive Processes in Aphasia|Theory-Driven Treatment of Language and Cognitive Processes in Aphasia|Recruiting||Phase 1|130|Anticipated|Temple University||1|||f||||f||||||||No||2017-10-10 22:31:30.509213|2017-10-10 22:31:30.509213
NCT02664493|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-04-05|||February 2016||2016-02-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||The Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline Changes|The Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline Changes: An Open-Label, Randomized Clinical Trial|Recruiting||N/A|154|Anticipated|Samsung Medical Center||2|||f||||t||||||||No||2017-10-10 22:31:30.604698|2017-10-10 22:31:30.604698
NCT02664480|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-22|||January 2016||2016-01-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Observational|||Assesment of Salivary Alpha-amylase Levels Before and After Ovulation|Assesment of Salivary Alpha-amylase Levels Before and After Ovulation: A Randomized Controlled Trial|Enrolling by invitation||N/A|100|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi|||2||f||||f||||||Samples Without DNA|"     salivary amylase   "|No||2017-10-10 22:31:30.729449|2017-10-10 22:31:30.729449
NCT02664467|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-09-19|||May 2016||2016-05-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Chronobiology, Sleep Related Risk Factors and Light Therapy in Perinatal Depression: the Life-ON Project|Chronobiology, Sleep Related Risk Factors and Light Therapy in Perinatal Depression: the Life-ON Project|Recruiting||Phase 2|500|Anticipated|Ospedale Regionale di Lugano||2|||f||||f||||||||||2017-10-10 22:31:30.803176|2017-10-10 22:31:30.803176
NCT02664454|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-07-24|||May 24, 2016|Actual|2016-05-24|June 2017|2017-06-01|August 24, 2018|Anticipated|2018-08-24|August 24, 2018|Anticipated|2018-08-24||Interventional|CEPIA||Compared Efficacy of Nurse-led and GP-led Geriatric Assessment in PrImary Care|Compared Efficacy of Nurse-led and GP-led Geriatric Assessment in PrImary Care: A Pragmatic Three-arm Cluster Randomized Controlled Trial|Recruiting||N/A|750|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 22:31:30.916558|2017-10-10 22:31:30.916558
NCT02664441|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-04-28|||March 2016||2016-03-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|ECHO||Energy Balance & Weight Loss in Craniopharyngioma-related Hypothalamic Obesity|Glucagon-Like Peptide-1 Agonist Effects on Energy Balance in Hypothalamic Obesity|Recruiting||Phase 3|48|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||No||2017-10-10 22:31:31.029863|2017-10-10 22:31:31.029863
NCT02664428|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2017-01-11|||November 2015||2015-11-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|August 2016|Actual|2016-08-01||Interventional|||Measuring the Impact of Dietary Supplementation With a New Baking Product on Gut Microbiota and Cholesterol Metabolism|Measuring the Impact of Dietary Supplementation With New Baking Product PreBIOil on Gut Microbiota and Cholesterol Metabolism|Completed||N/A|65|Actual|Fondazione Edmund Mach||2|||f||||f||||||||||2017-10-10 22:31:31.17169|2017-10-10 22:31:31.17169
NCT02664402|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-26|2017-06-30|||January 18, 2016||2016-01-18|January 5, 2017|2017-01-05|January 5, 2017|Actual|2017-01-05|July 31, 2016|Actual|2016-07-31||Observational|||Tool to Assess Psycho-Social-Spiritual Healing: Cognitive Interviewing|Analysis of a Tool to Assess Psycho Social Spiritual Healing: Cognitive Interviewing|Completed||N/A|44|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:31:31.382287|2017-10-10 22:31:31.382287
NCT02664389|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-06-13|||February 2016||2016-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PANEL||Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation|Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation|Recruiting||N/A|600|Anticipated|University Hospital, Rouen||5|||f||||f||||||||No||2017-10-10 22:31:31.459858|2017-10-10 22:31:31.459858
NCT02664376|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-07-25|||January 2016||2016-01-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Prevalence of Sarcopenia and Its Geriatric Features|Prevalence of Sarcopenia and Its Geriatric Features|Recruiting||N/A|50|Anticipated|Brugmann University Hospital|||1||f||||f||||||||No||2017-10-10 22:31:31.55638|2017-10-10 22:31:31.55638
NCT02664363|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-02-06|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|February 2024|Anticipated|2024-02-01|February 2020|Anticipated|2020-02-01||Interventional|ExCeL||EGFRvIII CAR T Cells for Newly-Diagnosed GBM|EGFRvIII Chimeric Antigen Receptor (CAR) Gene-modified T Cells for Patients With Newly-Diagnosed GBM During Lymphopenia|Recruiting||Phase 1|48|Anticipated|Duke University||1|||f||||f|t|f||||||Undecided||2017-10-10 22:31:31.643274|2017-10-10 22:31:31.643274
NCT02664350|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-08-08|||April 2016||2016-04-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Precision Medicine Guided Treatment for Cancer Pain|Precision Medicine Guided Treatment for Cancer Pain|Recruiting||N/A|200|Anticipated|University of Florida|||2||f||||t|f|f||||Samples With DNA|"     genotyping   "|||2017-10-10 22:31:31.742539|2017-10-10 22:31:31.742539
NCT02664337|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-22|||February 2016||2016-02-01|May 2017|2017-05-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Conjoint Analysis of Patient Preferences in Joint Interventions|Conjoint Analysis of Patient Preferences in Joint Interventions|Recruiting||N/A|2310|Anticipated|Duke University||2|||f||||f||||||||No||2017-10-10 22:31:31.858005|2017-10-10 22:31:31.858005
NCT02664324|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-05-02|||March 2016||2016-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|MSPT||MSPT Device Usability Study|The Multiple Sclerosis Performance Test (MSPT) Device for Functional Assessment of Multiple Sclerosis (MS) Patients|Completed||N/A|60|Actual|Biogen|||1||f||||f||||||||||2017-10-10 22:31:31.946455|2017-10-10 22:31:31.946455
NCT02664311|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-02-24|2017-02-24||February 2013||2013-02-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Randomized Comparison of the Use of JET and Conventional Ventilation in Pulmonary Vein Isolation|A Randomized Comparison of the Use of JET and Conventional Ventilation in Pulmonary Vein Isolation|Terminated||N/A|21|Actual|Beth Israel Deaconess Medical Center||2||under enrollment|f||||t||||||||Yes|Publication in scientific journal|2017-10-10 22:31:32.026642|2017-10-10 22:31:32.026642
NCT02664298|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-22|||January 2007||2007-01-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01|36 Months|Observational [Patient Registry]|ILICRAN||Prospective Registry of Immediate/Delayed Loading of Implants in the Cranial Bone-grafted Severely Atrophic Jaw||Recruiting||N/A|120|Anticipated|AZ Sint-Jan AV|||1||f||||f||||||||No||2017-10-10 22:31:32.427199|2017-10-10 22:31:32.427199
NCT02664285|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-11-06|||January 2016||2016-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Closure Versus Non Closure of Subcutaneous Tissue After Cesarean Section in Diabetic Patients|Closure Versus Non Closure of Subcutaneous Tissue After Cesarean Section in Diabetic Patients|Completed||N/A|136|Actual|Ain Shams University||2|||f||||t||||||||Yes|The aim of this study is to determine the surgical site infection rate and the patient's satisfaction for closure of subcutaneous tissue versus non closure of subcutaneous tissue after cesarean delivery in women with diabetes mellitus.|2017-10-10 22:31:32.509821|2017-10-10 22:31:32.509821
NCT02664272|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-09-05|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Intraoperative Case Series Study: Trial Rasp Position Versus SL-PLUS™ MIA Ti/HA Femoral Hip Stem Position|Intraoperative Case Series Study: Trial Rasp Position Versus SL-PLUS™ MIA Ti/HA Femoral|Completed||N/A|40|Actual|Smith & Nephew, Inc.|||1||f||||f||||||||||2017-10-10 22:31:32.580163|2017-10-10 22:31:32.580163
NCT02664259|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-30|||January 2016||2016-01-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||UTB-VBN-EBUS With or Without Fluoroscopy for the Diagnosis of PPLs|Ultrathin Bronchoscopy With Virtual Bronchoscopic Navigation and Endobronchial Ultrasound for the Diagnosis of Peripheral Pulmonary Lesions Without Fluoroscopy: a Randomized Controlled Trial|Not yet recruiting||N/A|400|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||||2017-10-10 22:31:32.645133|2017-10-10 22:31:32.645133
NCT02664246|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-01-26|||January 2015||2015-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method|Chinese People's Liberation Army General Hospital|Completed||N/A|10000|Actual|Chinese PLA General Hospital|||1||f||||t||||||||||2017-10-10 22:31:32.728367|2017-10-10 22:31:32.728367
NCT02664233|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-10-29|||June 2015||2015-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Connecting Smartphones With Electronic Health Record to Facilitate Behavioral Goal Monitoring in Diabetes Care|Connecting Smartphones With Electronic Health Record to Facilitate Behavioral Goal Monitoring in Diabetes Care|Completed||Early Phase 1|60|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 22:31:32.807364|2017-10-10 22:31:32.807364
NCT02664220|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-05-24|||April 2016||2016-04-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis|A Randomized Pilot Trial of Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis|Recruiting||Phase 2|120|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-10 22:31:32.920979|2017-10-10 22:31:32.920979
NCT02664207|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-02|||December 2015||2015-12-01|May 2017|2017-05-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Extended Criteria For Fetal Myelomeningocele Repair|Extended Criteria For Fetal Myelomeningocele Repair: A Pilot Study|Recruiting||N/A|20|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||Undecided||2017-10-10 22:31:33.022548|2017-10-10 22:31:33.022548
NCT02664194|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-10-08|||January 2016||2016-01-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|COOL-MI InCor||Hypothermia as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction|Hypothermia as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction|Recruiting||Phase 3|70|Anticipated|University of Sao Paulo General Hospital||3|||f||||t||||||||Undecided||2017-10-10 22:31:33.130481|2017-10-10 22:31:33.130481
NCT02664181|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-08-23|||June 6, 2017|Actual|2017-06-06|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|PRECISE||Pharmacologically Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With Non-Small Cell Lung Cancer|Phase II Trial of Nivolumab, an Immune Checkpoint Inhibitor, Alone or in Combination With Oral Decitabine/Tetrahydrouridine as Second Line Therapy for Non-Small Cell Lung Cancer|Recruiting||Phase 2|60|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-10 22:31:33.384721|2017-10-10 22:31:33.384721
NCT02664168|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-05-26|||January 2016||2016-01-01|May 2016|2016-05-01||||February 2018|Anticipated|2018-02-01||Interventional|||A Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO™) or Standard Care Dressings (AQUACEL® Ag SURGICAL Dressing)|A Prospective, Randomized, Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO™) or Standard Care Dressings (AQUACEL® Ag SURGICAL Dressing)|Recruiting||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-10 22:31:33.568495|2017-10-10 22:31:33.568495
NCT02664155|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-03-23|||November 2016||2016-11-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|VERDICT||Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants|Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants|Recruiting||Phase 3|800|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t||||||||No||2017-10-10 22:31:33.714958|2017-10-10 22:31:33.714958
NCT02664142|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-09-02|||June 2015||2015-06-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||BIS Monitoring of the Depth of Anaesthesia in Children|Monitoring the Depth of Anaesthesia in Children in the Course of a Surgical Procedure Using the BIS Monitor - Prospective Randomized Study|Recruiting||N/A|200|Anticipated|University Hospital Ostrava||2|||f||||f||||||||No||2017-10-10 22:31:34.028592|2017-10-10 22:31:34.028592
NCT02664129|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-25|||December 2015||2015-12-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|VideoInsight||Video as a Tool to Improve Insight in Schizophrenia|Video Self-observation as a Therapeutic Tool for Improving the Insight of Patients With Schizophrenia Disorders|Recruiting||N/A|60|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 22:31:34.145699|2017-10-10 22:31:34.145699
NCT02664116|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-02-01|||January 2016||2016-01-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine|IM Ketorolac vs Diclofenac Potassium Powder for Oral Solution (Cambia) for the Acute Treatment of Severe Migraine|Recruiting||Phase 4|40|Anticipated|Scripps Health||2|||f||||f||||||||No|Individual Patient Data will not be made available|2017-10-10 22:31:34.26067|2017-10-10 22:31:34.26067
NCT02664103|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-21|||January 23, 2016|Actual|2016-01-23|September 2017|2017-09-01|December 4, 2017|Anticipated|2017-12-04|December 4, 2017|Anticipated|2017-12-04||Interventional|METRO-ABC||Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer|A Phase II Open-label Randomized Study of a Fixed-dose Combination of Capecitabine and Cyclophosphamide Administered at Different Doses/Regimens With Metronomic Schedule in Patients With Metastatic Breast Cancer|Active, not recruiting||Phase 2|54|Anticipated|Sanofi||3|||f||||t||||||||||2017-10-10 22:31:34.403852|2017-10-10 22:31:34.403852
NCT02664090|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-01-31|||January 20, 2016|Actual|2016-01-20|January 2017|2017-01-01|January 18, 2017|Actual|2017-01-18|January 18, 2017|Actual|2017-01-18||Observational|||Hemodynamic Assessment With Trans-esophageal Doppler (TED) During Prone Ventilation in ARDS Patients|Hemodynamic Assessment With Trans-esophageal Doppler (TED) During Prone Ventilation in Patients With Acute Respiratory Distress Syndrome (ARDS)|Completed||N/A|26|Actual|Sanjay Gandhi Postgraduate Institute of Medical Sciences|||1||f||||f||||||||||2017-10-10 22:31:34.557607|2017-10-10 22:31:34.557607
NCT02664077|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-20|||June 2016||2016-06-01|February 2017|2017-02-01|January 2025|Anticipated|2025-01-01|November 2023|Anticipated|2023-11-01||Interventional|ARGO||A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer|A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer|Recruiting||Phase 3|1118|Anticipated|NSABP Foundation Inc||2|||f||||t||||||||||2017-10-10 22:31:34.668482|2017-10-10 22:31:34.668482
NCT02664064|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-08-11|||January 2016||2016-01-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|PUP||Evaluation of Prevent in Underserved Populations|Evaluation of an Online Diabetes Prevention Program Adapted for Safety Net Users|Active, not recruiting||N/A|300|Anticipated|Omada Health, Inc.||2|||f||||f||||||||||2017-10-10 22:31:34.942668|2017-10-10 22:31:34.942668
NCT02664051|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-01-21|||August 2013||2013-08-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Mast Cells in Acid-induced Intestinal Permeability|The Role of Mast Cells on Duodenal Permeability After Duodenal Acid Perfusion in Healthy Volunteers|Recruiting||Phase 4|20|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 22:31:35.058098|2017-10-10 22:31:35.058098
NCT02664025|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-09-06|||March 2016||2016-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|VE||Simulation in Teaching Vaginal Examination|The Benefits of Simulation in Teaching Vaginal Examination for Women During Labor: a Randomized Controlled Study|Completed||N/A|120|Actual|Assiut University||2|||f||||t||||||||Yes||2017-10-10 22:31:35.271392|2017-10-10 22:31:35.271392
NCT02664012|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-06-02|||January 2016||2016-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Menthol Electronic Cigarettes vs Combustible Menthol Cigarettes and Nicotine Gum|A Single-Center, Randomized, Open-Label, Crossover Study to Assess Elements of Abuse Liability for Three Menthol Electronic Cigarettes|Completed||N/A|71|Actual|R.J. Reynolds Vapor Company||5|||f||||f||||||||No||2017-10-10 22:31:35.350032|2017-10-10 22:31:35.350032
NCT02663999|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-06-10|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers|A Two-Period, Randomized, Open-Label, Crossover Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers|Completed||Phase 1|15|Actual|Acorda Therapeutics||2|||f||||f||||||||||2017-10-10 22:31:35.515191|2017-10-10 22:31:35.515191
NCT02663986|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-05|||February 1, 2015||2015-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|February 28, 2017|Actual|2017-02-28||Interventional|||Organizational Skill Training (OST) in Schools|A School-Based Program to Improve Children's Organizational Skills|Active, not recruiting||N/A|33|Actual|New York University School of Medicine||1|||f||||f|f|f||||||||2017-10-10 22:31:35.619206|2017-10-10 22:31:35.619206
NCT02663973|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-02-22|||January 2016||2016-01-01|February 2017|2017-02-01|April 2021|Anticipated|2021-04-01|December 2017|Anticipated|2017-12-01||Observational|||Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III|Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III|Recruiting||N/A|3000|Anticipated|Latin American Cooperative Oncology Group|||1||f||||f||||||||Undecided||2017-10-10 22:31:35.734551|2017-10-10 22:31:35.734551
NCT02663960|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-01-25|||August 2015||2015-08-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Compare Efficacy and Simplicity of Regional Citrate Anticoagulation With Fixed Dose Versus Adjusted Citrate Program|Is Regional Citrate Anticoagulation With Fixed Citrate Blood Concentration More Effective and Easy-to-handle Than Adjusted-dose Protocol in Adult Critically Ill Patients? A Cohort Study|Recruiting||Phase 4|63|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:31:35.939224|2017-10-10 22:31:35.939224
NCT02663947|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-25|||January 2016||2016-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Observational|||Comparison of Optic Nerve Sheath Diameter Measured by Ultrasonography Before and After Ventriculoperitoneal Shunt Surgery in Adult Patients With Hydrocephalus||Not yet recruiting||N/A|40|Anticipated|Yonsei University|||1||f||||f||||||||No||2017-10-10 22:31:36.041316|2017-10-10 22:31:36.041316
NCT02663934|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-09|2017-09-21|||August 2016||2016-08-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|Ex/HIV||Exercise Training to Improve Brain Health in Older HIV+ Individuals|Exercise Training to Improve Brain Health in Older HIV+ Individuals|Recruiting||N/A|170|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 22:31:36.133963|2017-10-10 22:31:36.133963
NCT02663921|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-12|||September 2015||2015-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Visible Light Study|Determination of the Minimal Dose of Visible Light Required to Achieve Immediate Pigment Darkening, Persistent Pigment Darkening, and Delayed Tanning for Fitzpatrick Skin Types IV-VI Utilizing Two Visible Light Sources.|Recruiting||N/A|25|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:31:36.242903|2017-10-10 22:31:36.242903
NCT02663895|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study to Evaluate the Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis|A Pilot Study to Evaluate the Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis|Recruiting||Phase 2|12|Anticipated|Stanford University||1|||f||||f||||||||Undecided||2017-10-10 22:31:36.550171|2017-10-10 22:31:36.550171
NCT02663882|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-01-23|||April 2016|Actual|2016-04-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Self-Control and Adult Cigarette Smokers|Self-Control and Adult Cigarette Smokers|Recruiting||N/A|80|Anticipated|Yeshiva University||2|||f||||f||||||||No||2017-10-10 22:31:36.690805|2017-10-10 22:31:36.690805
NCT02663869|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-05-02|||September 2016|Actual|2016-09-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|Aging_in_HIV||Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles|Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles|Recruiting||N/A|1600|Anticipated|University of Modena and Reggio Emilia|||3||f||||f||||||||No||2017-10-10 22:31:36.774202|2017-10-10 22:31:36.774202
NCT02663856|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-12-07|||September 2016||2016-09-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|MySAwH||My Smart Age With HIV: Smartphone Self-assessment of Frailty|My Smart Age With HIV (MySAwH): Smartphone Self-assessment of Frailty and Information - Communication Technology to Promote Healthy Ageing in HIV.|Recruiting||N/A|300|Anticipated|University of Modena and Reggio Emilia|||1||f||||f||||||||No||2017-10-10 22:31:36.853112|2017-10-10 22:31:36.853112
NCT02663843|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-04-27|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|June 1, 2017|Anticipated|2017-06-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||Low Skill Fibreoptic Intubation I-gel vs Air-Q|Comparison of 'Low Skill Fibreoptic Tracheal Intubation' Via I-gel® and Air-Q® Supraglottic Airway Devices in Patients With Simulated Difficult Airways.|Recruiting||N/A|30|Anticipated|Singapore General Hospital||2|||f||||f||||||||No||2017-10-10 22:31:36.922838|2017-10-10 22:31:36.922838
NCT02663830|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-08-13|||January 10, 2016|Actual|2016-01-10|August 2017|2017-08-01|March 12, 2017|Actual|2017-03-12|January 10, 2017|Actual|2017-01-10||Interventional|||The Effect of Sildenafil Citrate on the Success Rate of Ovulation Induction Using Clomiphene|The Effect of Sildenafil Citrate on the Success Rate of Ovulation Induction Using Clomiphene: A Randomized Controlled Trial.|Completed||Phase 2|210|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:31:37.009969|2017-10-10 22:31:37.009969
NCT02663817|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-08-15|||November 2013||2013-11-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy|DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy|Recruiting||N/A|100|Anticipated|University of Miami||2|||f||||f|f|f||||||||2017-10-10 22:31:37.082281|2017-10-10 22:31:37.082281
NCT02662699|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-05-18|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Clinical Signs and Symptoms of Anemia in Patients Over 75 Years|Clinical Signs and Symptoms of Anemia in Patients Over 75 Years|Recruiting||N/A|40|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 22:31:39.083029|2017-10-10 22:31:39.083029
NCT02662686|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-30|||January 2016||2016-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MitoScore||"Study for the Evaluation of MitoScore Marker in the Diagnosis of Embryo Viability in Euploids Embryos"|"Randomized Multi-centric Prospective Study for the Evaluation of MitoScore Marker in the Diagnosis of Embryo Viability in Euploids Embryos."|Recruiting||N/A|1718|Anticipated|Igenomix||2|||f||||f||||||||No||2017-10-10 22:31:39.170693|2017-10-10 22:31:39.170693
NCT02662673|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-05-23|||January 13, 2014|Actual|2014-01-13|May 2017|2017-05-01|January 23, 2017|Actual|2017-01-23|January 2016|Actual|2016-01-01||Interventional|IDITOP-3||Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device|Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device|Completed||N/A|39|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:31:39.32094|2017-10-10 22:31:39.32094
NCT02662660|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-01-20|||January 2012||2012-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Analgesia iv vs Epidural Analgesia vs Port-sites Infiltration After Laparoscopic Sleeve Gastrectomy|Postoperative Pain After Laparoscopic Sleeve Gastrectomy: Comparison of Isolated Intravenous Analgesia, Epidural Analgesia Associated With Analgesia iv and Port-sites Infiltration With Bupivacaine Associated With Analgesia iv|Completed||Phase 3|147|Actual|Hospital General Universitario Elche||3|||f||||t||||||||No||2017-10-10 22:31:39.406599|2017-10-10 22:31:39.406599
NCT02662647|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-23|||April 2015||2015-04-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML||Recruiting||Phase 2|120|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||Yes||2017-10-10 22:31:39.51267|2017-10-10 22:31:39.51267
NCT02662634|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-03-24|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer|A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer|Recruiting||Phase 2|20|Anticipated|GU Research Network, LLC||4|||f||||f||||||||Undecided||2017-10-10 22:31:39.602817|2017-10-10 22:31:39.602817
NCT02663804|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-10-31|||April 2014||2014-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:31:39.753059|2017-10-10 22:31:39.753059
NCT02663791|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-04-10|||January 2016||2016-01-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Observational|||Alcohol Consumption and Arterial Stiffness: A Longitudinal Study of Pulse Wave Velocity in the Whitehall II Cohort||Completed||N/A|10308|Actual|University College, London|||1||f||||t||||||||Yes|Researchers can request access to anonymised data: http://www.ucl.ac.uk/whitehallII/data-sharing|2017-10-10 22:31:39.801861|2017-10-10 22:31:39.801861
NCT02663778|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-02-03|||April 2016||2016-04-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|March 2020|Anticipated|2020-03-01||Interventional|PRIMA||Task Specific Timing and Coordination Exercise to Improve Mobility in Older Adults: Program to Improve Mobility in Aging|Task Specific Timing and Coordination Exercise to Improve Mobility in Older Adults|Recruiting||N/A|248|Anticipated|University of Pittsburgh||2|||f||||t||||||||Undecided||2017-10-10 22:31:40.064233|2017-10-10 22:31:40.064233
NCT02663765|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2016-12-17|||January 2016||2016-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|ANC||Lack of Antenatal Care in Primiparas|Impact of Lack of Antenatal Care in Primiparas on Maternal and Perinatal Outcomes|Completed||N/A|512|Actual|Assiut University|||1||f||||t||||||||No||2017-10-10 22:31:40.18051|2017-10-10 22:31:40.18051
NCT02663726|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-09-20|||February 2016||2016-02-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Adapted Yoga for Inactive Older Adults|A Pilot Randomised Controlled Trial Investigating the Effects of a 10-week Yoga Intervention on Physical Function and Health-related Quality of Life in Physically-inactive Older Adults|Completed||N/A|52|Actual|Northumbria University||2|||f||||f||||||||Undecided||2017-10-10 22:31:40.517759|2017-10-10 22:31:40.517759
NCT02663713|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-07-13|||January 2017||2017-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|ALTIC||A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction|A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction|Completed||Phase 4|20|Actual|University of Patras||2|||f||||f||||||||||2017-10-10 22:31:40.621276|2017-10-10 22:31:40.621276
NCT02663700|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-09-14|||April 7, 2016|Actual|2016-04-07|August 28, 2017|2017-08-28|April 20, 2019|Anticipated|2019-04-20|April 20, 2019|Anticipated|2019-04-20||Interventional|||Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso|Dose Escalation Study of Sanaria's Irradiated Sporozoite Vaccine (PFSPZ Vaccine), Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of PfSPZ Vaccine in Malaria-Experienced Adults in Burkina Faso.|Active, not recruiting||Phase 1|112|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f|||||t|f|||f|||||2017-10-10 22:31:40.745324|2017-10-10 22:31:40.745324
NCT02663687|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-12-09|||April 2016||2016-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects|A Randomized, Double-blind, Placebo-controlled, Ascending Dose, Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single Intravenous and Subcutaneous Doses of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects|Completed||Phase 1|48|Actual|Shire||2|||f||||f||||||||||2017-10-10 22:31:40.866124|2017-10-10 22:31:40.866124
NCT02663674|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-21|||December 29, 2015|Actual|2015-12-29|July 19, 2017|2017-07-19|January 15, 2021|Anticipated|2021-01-15|December 15, 2020|Anticipated|2020-12-15||Interventional|||Early Fluconazole Treatment for Coccidiodomycosis Pneumonia|A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (FLEET-Valley Fever)|Recruiting||Phase 4|1000|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-10 22:31:40.998195|2017-10-10 22:31:40.998195
NCT02663661|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-06-15|||February 2016||2016-02-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression Index|Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression Index|Recruiting||N/A|63|Anticipated|University of Virginia||3|||f||||t||||||||Undecided||2017-10-10 22:31:41.142331|2017-10-10 22:31:41.142331
NCT02663648|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-04-18|||June 2016||2016-06-01|January 2016|2016-01-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|||Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders|Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders|Withdrawn||N/A|0|Actual|Shandong University|||1|No eligible patient was enrolled.|f||||t||||||||||2017-10-10 22:31:41.262239|2017-10-10 22:31:41.262239
NCT02663635|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-26|||January 2016||2016-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Simulated Clinical Use Testing on Safe'N'Sound 1ML Stalked Passive Delivery System With Add-On Extended Finger Flanges|Simulated Clinical Use Testing on Safe'n'Sound 1mL Staked Passive Delivery System With add-on Extended Finger Flanges|Completed||Phase 3|30|Actual|Nemera La Verpilliere||1|||f||||f||||||||||2017-10-10 22:31:41.341117|2017-10-10 22:31:41.341117
NCT02663622|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-06-28|||August 2016||2016-08-01|June 2017|2017-06-01||||June 2020|Anticipated|2020-06-01||Interventional|||A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant|A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant|Recruiting||Phase 2|204|Anticipated|OncoImmune, Inc.||2|||f||||t||||||||No||2017-10-10 22:31:41.4289|2017-10-10 22:31:41.4289
NCT02663609|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-02-14|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|RE-KLAIM||Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome|Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome|Enrolling by invitation||N/A|30|Anticipated|Corcept Therapeutics|||1||f||||f||||||||No||2017-10-10 22:31:41.548263|2017-10-10 22:31:41.548263
NCT02663596|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-03-07|||January 2017||2017-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy Solution|A Prospective, Open-Label Study of the Safety and Therapeutic Drug Monitoring of Continuous Infusion Vancomycin Through the Addition of the Vancomycin Into the Continuous Renal Replacement Therapy Solution|Recruiting||Phase 1|10|Anticipated|Drexel University||1|||f||||f||||||||||2017-10-10 22:31:41.611471|2017-10-10 22:31:41.611471
NCT02663583|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-07-21|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell|Observational Parallel Cohort Study of Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell Carcinoma|Recruiting||N/A|44|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-10-10 22:31:41.701189|2017-10-10 22:31:41.701189
NCT02663570|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-12-03|||June 2015||2015-06-01|December 2016|2016-12-01||||January 2016|Actual|2016-01-01||Interventional|||Effects of Melatonin in PCOS Women|Effects of 6 Months of Melatonin Treatment on Clinical, Endocrine ed Metabolic Features in Women Affected by PCOS|Recruiting||N/A|40|Anticipated|Catholic University of the Sacred Heart||1|||f||||||||||||||2017-10-10 22:31:41.793275|2017-10-10 22:31:41.793275
NCT02663375|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-02-12|||November 2013||2013-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01|1 Year|Observational [Patient Registry]|TA-SAVI2||ACURATE TA™ Valve Implantation Registry: SAVI 2|Symetis ACURATE TA™ Valve Implantation Using TransApical Access:SAVI2 Registry|Completed||N/A|250|Actual|Symetis SA|||1||f||||f||||||||||2017-10-10 22:31:44.06081|2017-10-10 22:31:44.06081
NCT02663557|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-05-18|||July 2014|Actual|2014-07-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|June 2016|Actual|2016-06-01||Observational|||The Influence of day-to Day BPV on Long-term Adverse Outcomes in Patients Ischemic Stroke|Evaluating the Influence of Day-to-day Blood Pressure Variation in Acute Ischemic Stroke on Adverse Outcomes in Long-term Post-stroke Followup|Completed||N/A|400|Actual|Dongguan People's Hospital|||4||f||||t||||||||No|The data will not be shared with respect to the privacy of patients info.|2017-10-10 22:31:42.050371|2017-10-10 22:31:42.050371
NCT02663544|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-02-24|||January 2016||2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)|The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)|Recruiting||N/A|72|Anticipated|Fred Hutchinson Cancer Research Center||3|||f||||f||||||||Yes|Anonymized blood samples and study data may be shared with outside investigators who sign confidentiality pledges (from participants who have given written consent for the use of study specimen and data for 'other research' only).|2017-10-10 22:31:42.133741|2017-10-10 22:31:42.133741
NCT02663531|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-12-01|||April 2016||2016-04-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease|Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease|Recruiting||N/A|150|Anticipated|Medical University of Vienna||3|||f||||t||||||||||2017-10-10 22:31:42.289114|2017-10-10 22:31:42.289114
NCT02663518|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-13|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors|A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects With Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors|Recruiting||Phase 1|270|Anticipated|Trillium Therapeutics Inc.||14|||f||||f||||||||||2017-10-10 22:31:42.430184|2017-10-10 22:31:42.430184
NCT02663505|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-02-10|||February 2016||2016-02-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Development Of An ICU Risk Score|I See You Risk Your ICU Capacity - Development Of An ICU Risk Score Discriminating Reasonable and Non-Reasonable ICU Admissions|Recruiting||N/A|8000|Anticipated|University of Schleswig-Holstein|||1||f||||f||||||||No||2017-10-10 22:31:42.611198|2017-10-10 22:31:42.611198
NCT02663492|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-21|||August 2014||2014-08-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Interventional|||Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients|Transcutaneous Electrical Acupoint Stimulation Ameliorates Chemotherapy-Induced Bone Marrow Suppression in Lung Cancer Patients|Recruiting||N/A|300|Anticipated|Tongji University||3|||f||||t||||||||No||2017-10-10 22:31:42.71717|2017-10-10 22:31:42.71717
NCT02663479|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-21|||September 2015||2015-09-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Nutraceutical Supplement in the Management of Hypertension|Proprietary Lipid-Lowering Nutraceutical Supplement in the Management of Hypertension|Recruiting||Phase 1/Phase 2|40|Anticipated|Thorne Research Inc.||2|||f||||||||||||No||2017-10-10 22:31:42.850728|2017-10-10 22:31:42.850728
NCT02663466|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-25|||January 2015||2015-01-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Observational|||Off-midline Closure Errors as a Risk Factor for Recurrence Following Limberg Flap in Patients With Pilonidal Sinus|Importance of Erroneous Off-midline Closure as a Recurrence Factor in Limberg Flap Reconstruction in Sacrococcygeal Pilonidal Sinus: a Multicenter, Matched-case-control Study|Completed||N/A|180|Actual|Medical Park Gaziantep Hospital|||2||f||||t||||||||No||2017-10-10 22:31:42.967282|2017-10-10 22:31:42.967282
NCT02663453|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-05-30|2017-04-30||December 2013||2013-12-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition|Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition: A Two-Center, Double-Blind Randomized Clinical Trial|Completed||Phase 3|44|Actual|Thammasat University||2|||f||||t||||||||No||2017-10-10 22:31:43.108735|2017-10-10 22:31:43.108735
NCT02663440|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-21|||January 2016||2016-01-01|January 2016|2016-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme||Recruiting||Phase 2|41|Anticipated|Zhejiang Cancer Hospital||1|||f||||||||||||||2017-10-10 22:31:43.544756|2017-10-10 22:31:43.544756
NCT02663427|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-01-25|||January 2016||2016-01-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Serological Screening of Gastric Cancer in Wuxi Region|Serological Screening of Gastric Cancer in Wuxi Region|Not yet recruiting||N/A|5000|Anticipated|Wuxi People's Hospital||4|||f||||t||||||||Yes||2017-10-10 22:31:43.644227|2017-10-10 22:31:43.644227
NCT02663414|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|Atlas-PMCF||European Post-Market Study for Medial Knee Osteoarthritis Treated With the Atlas Knee System for Load Reduction|European Post-Market, Prospective, Multi-Center, Single-Arm Study to Evaluate Symptom Relief in Subjects With Medial Knee Osteoarthritis Treated With the Atlas Knee System for Load Reduction|Withdrawn||N/A|0|Actual|Moximed||1||Study indefinitely postponed|f||||f||||||||||2017-10-10 22:31:43.725471|2017-10-10 22:31:43.725471
NCT02663401|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-29|||March 2016||2016-03-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|5-C CROUS||Impact of a Front-of-pack Nutrition Label on the Nutritional Quality of Purchases in Campus Cafeterias|Impact of a Front-of-pack Nutrition Label on the Nutritional Quality of Purchases in Campus Cafeterias|Completed||N/A|1000|Anticipated|University of Paris 13||2|||f||||f||||||||||2017-10-10 22:31:43.81569|2017-10-10 22:31:43.81569
NCT02663388|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-26|||January 2016||2016-01-01|October 2016|2016-10-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01|10 Years|Observational [Patient Registry]|OBESEPI||Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)|Influence of Vitamins Status on Severe Obesity Related Complications|Recruiting||N/A|20000|Anticipated|University of Lorraine|||1||f||||||||||Samples With DNA|"     blood, liver, fat tissue (subcutaneous, visceral, mesenteric), small bowell, feces   "|||2017-10-10 22:31:43.916087|2017-10-10 22:31:43.916087
NCT02663349|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-03|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness|Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness|Enrolling by invitation||N/A|60|Anticipated|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-10 22:31:44.354873|2017-10-10 22:31:44.354873
NCT02663336|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-10-31|||December 2015||2015-12-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Prevalence of Masked Hypertension in Nephrological Patients|Prevalence of Masked Hypertension in Nephrological Patients|Recruiting||N/A|100|Anticipated|Waid City Hospital, Zurich|||1||f||||f||||||||||2017-10-10 22:31:44.477847|2017-10-10 22:31:44.477847
NCT02663323|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-11-30|||February 2016||2016-02-01|November 2016|2016-11-01||||December 2019|Anticipated|2019-12-01||Interventional|MeRes-1 Extend||Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System|MeRes-1 Extend: A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions|Recruiting||Phase 2/Phase 3|64|Anticipated|Meril Life Sciences Pvt. Ltd.||1|||f||||t||||||||No||2017-10-10 22:31:44.606113|2017-10-10 22:31:44.606113
NCT02663310|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-02-03|||July 2015||2015-07-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Treatment for Chronic Spinal Cord Injury: Surgery With Rehabilitation vs Rehabilitation|Surgical Decompression/Untethering Combined With Weight Bearing Rehabilitation in Chronic Spinal Cord Injury Subjects|Recruiting||N/A|30|Anticipated|Kunming Tongren Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:31:44.748418|2017-10-10 22:31:44.748418
NCT02663297|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2017-09-12|||July 15, 2016|Actual|2016-07-15|September 2017|2017-09-01|August 2034|Anticipated|2034-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Administration of T Lymphocytes for Prevention of Relapse of Lymphomas|Phase I Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Prevention of Relapse of CD30+ Lymphomas After High Dose Therapy and Autologous Stem Transplantation (ATLAS)|Recruiting||Phase 1|18|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 22:31:44.891492|2017-10-10 22:31:44.891492
NCT02663284|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-11-02|||April 2012||2012-04-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ANI-ALGO||Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome|Evaluation of Non-invasive Monitor of Physiodoloris Pain in Patients With Complex Regional Pain Syndrome Treated by Nerve Block (Prospective Monocenter Study)|Completed||N/A|30|Actual|Hopital Foch||1|||f||||f||||||||||2017-10-10 22:31:45.288213|2017-10-10 22:31:45.288213
NCT02663271|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-09-22|||August 2016||2016-08-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma|A Phase 2, Multi-center, Single Arm, Histologically Controlled Study Testing the Combination of TTFields and Pulsed Bevacizumab Treatment in Patients With Bevacizumab-refractory Recurrent Glioblastoma|Recruiting||Phase 2|25|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 22:31:45.399557|2017-10-10 22:31:45.399557
NCT02663258|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-07-31|||January 2016||2016-01-01|January 2016|2016-01-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|ADAPTeM||A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)|An Explorative Phase II Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)|Withdrawn||Phase 2|0|Actual|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 22:31:45.563916|2017-10-10 22:31:45.563916
NCT02663245|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-08-31|||December 2015||2015-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||INTEGRA Study: Primary Care Intervention in Type 2 Diabetes Patients With Poor Glycaemic Control|INTEGRA Study: Intervention in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control on Primary Health Care.|Recruiting||N/A|648|Anticipated|Jordi Gol i Gurina Foundation||3|||f||||f||||||||||2017-10-10 22:31:45.649129|2017-10-10 22:31:45.649129
NCT02663232|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-03-03|2016-03-03||June 2013||2013-06-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational||All participants enrolled in the study were included in the analysis.|Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma|Epidemiological Study of V600 BRAF Mutation in Spanish Patients Diagnosed With Metastatic Melanoma: ABSOLUT-BRAF Study|Completed||N/A|264|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:31:45.7794|2017-10-10 22:31:45.7794
NCT02663219|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-24|||March 2016||2016-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States|Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States|Recruiting||N/A|356|Anticipated|HIV Prevention Trials Network||2|||f||||f||||||||No||2017-10-10 22:31:46.470507|2017-10-10 22:31:46.470507
NCT02663206|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-08-29|||September 2016||2016-09-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders|Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in the Treatment of Medical Refractory Spastic Esophageal Disorders: A Randomized Trial|Not yet recruiting||Phase 2|50|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 22:31:46.618602|2017-10-10 22:31:46.618602
NCT02663193|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-02-17|||December 2015||2015-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|REAAcT||Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability|A Multicenter, Two-arm, Prospective, Observational Study to Characterize the Tolerability of Treatment With Enzalutamide or Abiraterone Acetate (With Prednisone) for Metastatic Castration-Resistant Prostate Cancer (mCRPC)|Completed||N/A|108|Actual|Janssen Scientific Affairs, LLC|||2||f||||f||||||||||2017-10-10 22:31:46.754847|2017-10-10 22:31:46.754847
NCT02663180|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-01-24|||January 2016||2016-01-01|January 2017|2017-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Effects of an Educational Program on Depression Literacy and Stigma Among Secondary School Students in Jazan City|Effects of an Educational Program on Depression Literacy and Stigma Among Students of Secondary Schools in Jazan City|Recruiting||N/A|360|Anticipated|University of Jazan||2|||f||||t||||||||||2017-10-10 22:31:46.902852|2017-10-10 22:31:46.902852
NCT02663167|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-11-25|||January 2016||2016-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Internet-based Cognitive-behavior Therapy for Children With Obsessive-compulsive Disorder|Internet-based Cognitive-behavior Therapy for Children With Obsessive-compulsive Disorder: a Pilot Trial|Completed||N/A|11|Actual|Karolinska Institutet||1|||f||||||||||||||2017-10-10 22:31:47.001601|2017-10-10 22:31:47.001601
NCT02663154|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-01-25|||July 2014||2014-07-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Aromatherapy for Postoperative Nausea and Vomiting in Children|Aromatherapy for Postoperative Nausea and Vomiting in Children: A Single Blind Randomized Clinical Trial|Completed||Phase 2|39|Actual|IWK Health Centre||2|||f||||f||||||||||2017-10-10 22:31:47.101822|2017-10-10 22:31:47.101822
NCT02663141|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-07-03|||June 2015||2015-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema||Completed||Phase 2|57|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:31:47.200183|2017-10-10 22:31:47.200183
NCT02663128|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-05-25|||January 2016||2016-01-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study of Lanabecestat (LY3314814) in Healthy Participants|A Bioequivalence and Food Effect Study in Healthy Subjects Administered 2 Different Tablet Formulations of LY3314814|Completed||Phase 1|18|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:31:47.286383|2017-10-10 22:31:47.286383
NCT02663115|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-08-15|||January 2016||2016-01-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Observational|LIPAMUS-HF||Influence of Severe Heart Failure to Function and Molecular Biological Parameters of Catabolism in the Human Diaphragm and Peripheral Skeletal Muscle||Recruiting||N/A|75|Anticipated|Heartcenter Leipzig GmbH|||3||f||||f||||||||||2017-10-10 22:31:47.366413|2017-10-10 22:31:47.366413
NCT02663102|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-09-19|||October 21, 2016|Actual|2016-10-21|September 2017|2017-09-01|June 10, 2020|Anticipated|2020-06-10|June 10, 2020|Anticipated|2020-06-10||Observational|||Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.|Assessment of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information in Korea.|Recruiting||N/A|720|Anticipated|GlaxoSmithKline|||1||f||||||||||||||2017-10-10 22:31:47.471036|2017-10-10 22:31:47.471036
NCT02663089|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2017-04-28|||February 8, 2016|Actual|2016-02-08|April 2017|2017-04-01|March 17, 2016|Actual|2016-03-17|March 17, 2016|Actual|2016-03-17||Interventional|||A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects|An Open-label Study in Healthy Male Subjects, to Determine the Excretion Balance and Pharmacokinetics of [14C]-GSK961081, Administered as a Single Intravenous Microtracer (Concomitant With an Inhaled Non-radiolabelled Dose) and a Single Oral Dose|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:31:47.571685|2017-10-10 22:31:47.571685
NCT02663076|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-09-04|||April 2016||2016-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01|18 Months|Observational [Patient Registry]|XARENO||Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry|Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry|Recruiting||N/A|2500|Anticipated|GWT-TUD GmbH|||3||f||||f||||||||||2017-10-10 22:31:47.694261|2017-10-10 22:31:47.694261
NCT02663063|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-30|||December 2015||2015-12-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||The Application of Evidence-Based Chinese Complementary and Alternative Medicine (CAM) in Hospice Palliative Care in Taiwan|The Application of Evidence-Based Chinese Complementary and Alternative Medicine (CAM) in Hospice Palliative Care in Taiwan-The Second and Third Year Project.|Enrolling by invitation||N/A|494|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||Undecided|Undecided|2017-10-10 22:31:47.968234|2017-10-10 22:31:47.968234
NCT02663050|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-02-26|||February 2016||2016-02-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||The Effect of Kinesio Taping Application for Dysmenorrhea|The Effect of Kinesio Taping Application for Dysmenorrhea: A Randomized Controlled Clinical Trial|Not yet recruiting||N/A|150|Anticipated|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||3|||f||||f||||||||Yes|We will share the data monthly|2017-10-10 22:31:48.167824|2017-10-10 22:31:48.167824
NCT02663037|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-05-22|||May 2016|Actual|2016-05-01|May 2016|2016-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Simple Segmentation Tool to Understand Elderly Health Status and Needs|Developing A Simple Segmentation Tool to Understand Elderly Health Status and Needs in Singapore|Completed||N/A|200|Actual|National University, Singapore|||1||f||||f||||||||Undecided||2017-10-10 22:31:48.251369|2017-10-10 22:31:48.251369
NCT02663024|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-01-21|||December 2016||2016-12-01|January 2016|2016-01-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Idursulfase-beta (GC1111) in Hunter Syndrome|Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Idursulfase-beta (GC1111) in Hunter Syndrome (Mucopolysaccharidosis II) Patients|Not yet recruiting||Phase 2|20|Anticipated|Green Cross Corporation||4|||f||||f||||||||No||2017-10-10 22:31:48.326541|2017-10-10 22:31:48.326541
NCT02663011|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-21|||August 2015||2015-08-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Language Error Type Evaluation in Developmental Delay Preschool Children by PLS-C||Completed||N/A|54|Actual|Taipei Medical University Hospital|||5||f||||||||||||||2017-10-10 22:31:48.416672|2017-10-10 22:31:48.416672
NCT02662998|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-11-24|||January 2016||2016-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|UHEAR-BIS||Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Older Cancer Patients Within a Comprehensive Geriatric Assessment - BIS|Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Older Cancer Patients Within a Comprehensive Geriatric Assessment - BIS|Completed||N/A|45|Actual|General Hospital Groeninge|||1||f||||||||||||||2017-10-10 22:31:48.4934|2017-10-10 22:31:48.4934
NCT02662985|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-05-01|||August 22, 2016|Actual|2016-08-22|May 2017|2017-05-01|September 3, 2019|Anticipated|2019-09-03|April 20, 2018|Anticipated|2018-04-20||Interventional|PDUS||Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)|A 52-week, Multicenter Study to Assess the Time Course of Response to Secukinumab on Joint Inflammation Using Power Doppler Ultrasonography in Patients With Active Psoriatic Arthritis|Recruiting||Phase 3|218|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 22:31:48.556447|2017-10-10 22:31:48.556447
NCT02662972|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-02-10|||May 2016||2016-05-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.|Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.|Recruiting||Phase 1/Phase 2|10|Anticipated|Norwegian University of Science and Technology||1|||f||||t||||||||||2017-10-10 22:31:48.716186|2017-10-10 22:31:48.716186
NCT02662959|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-01-21|||April 2015||2015-04-01|November 2015|2015-11-01||||May 2018|Anticipated|2018-05-01||Interventional|||Irinotecan as 3rd Line Therapy in Gastric Cancer|A Phase II Study of Irinotecan as Single Agent in the Third Line Treatment of Unresectable or Metastatic Gastric Cancer.|Recruiting||Phase 2|93|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-10 22:31:48.808509|2017-10-10 22:31:48.808509
NCT02662946|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-21|2016-01-25|||January 2016||2016-01-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Intestinal Vascolarization With Indocianine Green Angiography During Rectal Resection or Left Colectomy|Evaluation of Intestinal Vascolarization by Intraoperative Angiography With Indocianine Green During Laparoscopi Rectal Resection or Left Colectomy: Predictive Value on Anastomotic Leak.|Recruiting||N/A|208|Anticipated|Scientific Institute San Raffaele||2|||f||||f||||||||Yes||2017-10-10 22:31:48.890074|2017-10-10 22:31:48.890074
NCT02662933|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-25|||January 2009|Actual|2009-01-01|January 2016|2016-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)|Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)|Completed||N/A|82|Actual|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-10 22:31:48.974689|2017-10-10 22:31:48.974689
NCT02662920|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-25|||August 2010||2010-08-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Observational|||Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)|Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)|Completed||N/A|209|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-10 22:31:49.042749|2017-10-10 22:31:49.042749
NCT02662907|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-04-21|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|February 2026|Anticipated|2026-02-01|February 2026|Anticipated|2026-02-01||Interventional|||Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy|Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|t|f|||||||2017-10-10 22:31:49.105569|2017-10-10 22:31:49.105569
NCT02662894|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-01-25|||July 2017|Anticipated|2017-07-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.|Efficacy of Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.|Not yet recruiting||Phase 3|632|Anticipated|EMS||4|||f||||f|f|f||||||||2017-10-10 22:31:49.238292|2017-10-10 22:31:49.238292
NCT02662881|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-09-13|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|March 2019|Anticipated|2019-03-01|5 Years|Observational [Patient Registry]|REGP-44-00||Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE|Post-Market Data Collection for Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE|Enrolling by invitation||N/A|100|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-10 22:31:49.348056|2017-10-10 22:31:49.348056
NCT02662868|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-02-22|||June 2015||2015-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Observational|||Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments|Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments|Completed||N/A|767|Actual|Latin American Cooperative Oncology Group|||1||f||||f||||||||||2017-10-10 22:31:49.435788|2017-10-10 22:31:49.435788
NCT02662855|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-21|||November 2014||2014-11-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy of Favipiravir Against Severe Ebola Virus Disease|Efficacy of Favipiravir Against Severe Ebola Virus Disease|Completed||Phase 2|77|Actual|Beijing Institute of Pharmacology and Toxicology||2|||f||||t||||||||||2017-10-10 22:31:49.554286|2017-10-10 22:31:49.554286
NCT02662842|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-04-12|||January 2016||2016-01-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study|BD FlowSmart™ User Claims Study|Completed||N/A|75|Actual|Becton, Dickinson and Company|||1||f||||f|f|f||||||No||2017-10-10 22:31:49.64338|2017-10-10 22:31:49.64338
NCT02662829|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-07-18|||December 2015||2015-12-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)|Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)|Recruiting||N/A|1160|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-10 22:31:49.752758|2017-10-10 22:31:49.752758
NCT02662816|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-07-25|||June 2016||2016-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Non-invasive Quantification of Muscle and Liver Glutathione GSH-MRS|Feasibility Study of the Quantification of Glutathione Concentrations in Muscle and Liver Using in Vivo Proton Magnetic Resonance Spectroscopy (1H MRS)in Human|Completed||N/A|6|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 22:31:49.90432|2017-10-10 22:31:49.90432
NCT02662803|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-02-21|||January 2015||2015-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|GAD_exercise||Clinical, Neurophysiological and Neuroendocrine Effects of Aerobe Exercise in Generalized Anxiety Disorder (GAD)|Clinical, Neurophysiological and Neuroendocrine Effects of Aerobe Exercise in Generalized Anxiety Disorder (GAD)|Enrolling by invitation||N/A|40|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||No||2017-10-10 22:31:50.000982|2017-10-10 22:31:50.000982
NCT02662790|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-21|||February 2014||2014-02-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Dexamethasone on Fetal and Uteroplacental Doppler|Effects of Antenatal Dexamethasone Administration on Fetal and Uteroplacental Doppler Waveforms in Women at Risk for Preterm Birth|Completed||Phase 2|50|Actual|Assiut University||1|||f||||||||||||||2017-10-10 22:31:50.147376|2017-10-10 22:31:50.147376
NCT02662777|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-11-25|||January 2015||2015-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|2 Weeks|Observational [Patient Registry]|||Eso-Sponge Registry|International, Prospective, Multicenter Registry Designed to Collect Clinical Evidence for Endoscopic Vacuum Treatment Using Eso-SPONGE® for Anastomotic Leakage After Esophageal Resection or Iatrogenic or Spontaneous Esophageal Perforation.|Recruiting||N/A|200|Anticipated|Aesculap AG|||1||f||||f||||||||No||2017-10-10 22:31:50.242637|2017-10-10 22:31:50.242637
NCT02662764|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-08-07|||September 28, 2016|Actual|2016-09-28|August 2017|2017-08-01|May 5, 2017|Actual|2017-05-05|April 14, 2017|Actual|2017-04-14||Interventional|||Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg|A Multicenter, Open-Label Trial to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg|Completed||Phase 3|320|Actual|AcelRx Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:31:50.428131|2017-10-10 22:31:50.428131
NCT02662751|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-05-23|||April 2017||2017-04-01|May 2016|2016-05-01|October 2021|Anticipated|2021-10-01|November 2018|Anticipated|2018-11-01||Interventional|VASCU||Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA|The Impact of Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke or Transient Ischemic Attack in Comparison With Usual Care: a Randomized, Controlled, Open Trial|Not yet recruiting||N/A|260|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 22:31:50.539576|2017-10-10 22:31:50.539576
NCT02662738|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-10-25|||January 2016||2016-01-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of a Natural Extract on Glucose Fluxes After Consumption of a Wheat Product|The Effect of a Natural Extract on Glucose Fluxes After Consumption of a Wheat Product|Completed||N/A|12|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-10 22:31:50.67114|2017-10-10 22:31:50.67114
NCT02662725|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-22|||September 2012||2012-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IPI+RTS||Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases|A Multicenter Phase II Study of Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases|Completed||Phase 2|73|Actual|University Hospital, Lille||1|||f||||t||||||||No||2017-10-10 22:31:50.783993|2017-10-10 22:31:50.783993
NCT02662621|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-08-30|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|EXODIAG||Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors|Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for Early Diagnosis of Malgnant Solid Tumors|Recruiting||N/A|80|Anticipated|Centre Georges Francois Leclerc||2|||f||||f||||||||||2017-10-10 22:31:50.901496|2017-10-10 22:31:50.901496
NCT02662608|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-22|2017-05-17|2017-04-03||December 29, 2015|Actual|2015-12-29|May 2017|2017-05-01|March 6, 2016|Actual|2016-03-06|March 6, 2016|Actual|2016-03-06||Interventional|||Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC)|NOTCH 1 Inhibitor Brontictuzumab for Adenoid Cystic Carcinoma Bearing Two Activating NOTCH1 Mutations|Completed||N/A|1|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||No||2017-10-10 22:31:51.004845|2017-10-10 22:31:51.004845
NCT02662595|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-22|||March 2016||2016-03-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|mimi||mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau|Mimi - mHealth to Increase Measles Immunization. A Randomized Controlled Trial.|Not yet recruiting||N/A|1050|Anticipated|Bandim Health Project||3|||f||||f||||||||||2017-10-10 22:31:51.168815|2017-10-10 22:31:51.168815
NCT02662582|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-05|||June 30, 2016|Actual|2016-06-30|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease|A Phase 2a, Randomized, Double-blind, Placebo-controlled, Two Period, Crossover Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease|Recruiting||Phase 2|40|Anticipated|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 22:31:51.252633|2017-10-10 22:31:51.252633
NCT02662569|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-07|||April 14, 2016|Actual|2016-04-14|September 2017|2017-09-01|December 4, 2017|Anticipated|2017-12-04|December 4, 2017|Anticipated|2017-12-04||Interventional|||A Double-blind, Randomized Study in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia|A Double-blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Safety and Efficacy of AMG 145 in Combination With Statin Therapy in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia|Active, not recruiting||Phase 3|986|Actual|Amgen||4|||f||||t||||||||||2017-10-10 22:31:51.370094|2017-10-10 22:31:51.370094
NCT02662556|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-01-25|2016-11-07||March 2016||2016-03-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With Post-Operative Pain|A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With Post-Operative Pain|Completed||Phase 3|140|Actual|AcelRx Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:31:51.873724|2017-10-10 22:31:51.873724
NCT02662543|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-12-20|||February 2015||2015-02-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|ERVS||The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines|The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children Aged < 18 Years After Introduction of Rotavirus Vaccines|Active, not recruiting||N/A|2260|Actual|University of Tartu|||1||f||||t||||||Samples With DNA|"     Fecal samples   "|No||2017-10-10 22:31:52.147491|2017-10-10 22:31:52.147491
NCT02662530|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-10-31|||February 2016||2016-02-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical and Kinematic Assessment for Determination of Botox® Injection Parameters in Cervical Dystonia|Comparison of Clinical and Kinematic Assessment in the Determination of Botox® Injection Parameters in Cervical Dystonia Patients|Recruiting||Phase 2|50|Anticipated|Western University, Canada||2|||f||||f||||||||||2017-10-10 22:31:52.263072|2017-10-10 22:31:52.263072
NCT02662517|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-05-02|||March 2016||2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|BMProfile||Growth Hormones and Cells in Human Milk Depending on Gestational Age|Growth Hormones and Cells in Human Milk Depending on Gestational Age and Lactation Phase|Recruiting||N/A|100|Anticipated|University Hospital of Cologne|||1||f||||f||||||Samples Without DNA|"     human breast milk, umbilical chord blood   "|No||2017-10-10 22:31:52.422301|2017-10-10 22:31:52.422301
NCT02662504|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-22|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|MesoPDT||Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma|Pilot Study of the Feasibility of Intrapleural Photodynamic Therapy in a Multimodal Treatment Combining Extended Pleurectomy/Decortication, Adjuvant Chemotherapy and Prophylactic Radiotherapy in Patients With Malignant Pleural Mesothelioma|Recruiting||Phase 2|6|Anticipated|University Hospital, Lille||1|||f||||t|f|f||||||||2017-10-10 22:31:52.520279|2017-10-10 22:31:52.520279
NCT02662491|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-24|||January 2016||2016-01-01|January 2016|2016-01-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Effects of Vitamin D and Calcium Supplementation on Health and Well-being of Vitamin D Deficient UAE Citizens|Effects of Vitamin D and Calcium Supplementation on Health of UAE Citizens|Recruiting||Phase 4|432|Anticipated|United Arab Emirates University||4|||f||||t||||||||Yes||2017-10-10 22:31:52.656823|2017-10-10 22:31:52.656823
NCT02662478|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-02-03|||June 2008||2008-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Laparoscopic Resection of Large Gastric Stromal Tumors|Accuracy and Feasibility of a Morpho-anatomical Classification Oriented Laparoscopic Resection of Gastric Stromal Tumors in Advanced Laparoscopic Surgery Center: a Prospective Cohort Study|Completed||N/A|23|Actual|Medical Park Gaziantep Hospital|||1||f||||t||||||Samples Without DNA|"     gastric resection material   "|No||2017-10-10 22:31:52.809553|2017-10-10 22:31:52.809553
NCT02662465|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-25|||December 2015||2015-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Oral Manifestations in Children With Cancer|Oral Manifestations of Leukemia and Anticancer Treatment in Childhood|Recruiting||N/A|60|Anticipated|Universidade Federal do Rio Grande do Norte||3|||f||||f||||||||No||2017-10-10 22:31:52.923346|2017-10-10 22:31:52.923346
NCT02662452|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-07-28|||January 2016||2016-01-01|January 2016|2016-01-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||First-in-Human Single and Multiple Dose of GLPG2222|Randomized, Double-blind, Placebo-controlled, First-in-Human Study of GLPG2222 in Healthy Male Subjects|Completed||Phase 1|40|Actual|Galapagos NV||4|||f||||f||||||||No||2017-10-10 22:31:53.051438|2017-10-10 22:31:53.051438
NCT02662439|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-31|||February 2016||2016-02-01|May 2017|2017-05-01||||December 2018|Anticipated|2018-12-01||Interventional|||Bioimpedance Analysis in Chronic Heart Failure|Role of the Bioimpedance Analysis in Guiding the Diuretic Therapy in Chronic Heart Failure - A Randomized Controlled Trial|Suspended||N/A|240|Anticipated|Semmelweis University||2|||f||||||||||||||2017-10-10 22:31:53.178129|2017-10-10 22:31:53.178129
NCT02662426|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2016-02-14|||April 2016||2016-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Lingdancao Granules in the Treatment of Seasonal Influenza|Randomized, Double-Blinded, Oseltamivir-and-Placebo-Controlled Clinical Study About Lingdancao Granules in the Treatment of Seasonal Influenza|Not yet recruiting||Phase 3|318|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||3|||f||||t||||||||||2017-10-10 22:31:53.2973|2017-10-10 22:31:53.2973
NCT02662413|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-13|||January 2016||2016-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|ACT2||To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma|To Determine the Measurement Properties of the ACT in an Adolescent Population With Persistent Asthma Followed at a Subspecialty Clinic.|Recruiting||N/A|80|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 22:31:53.419417|2017-10-10 22:31:53.419417
NCT02662400|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2017-01-15|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies|Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies After Stem Cell Transplantation in T2DM|Completed||Phase 2/Phase 3|7|Actual|Postgraduate Institute of Medical Education and Research||1|||f||||t||||||||No||2017-10-10 22:31:53.556581|2017-10-10 22:31:53.556581
NCT02662387|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-07-21|2017-04-06||February 2, 2016|Actual|2016-02-02|July 2017|2017-07-01|June 15, 2016|Actual|2016-06-15|May 19, 2016|Actual|2016-05-19||Interventional|HFNC||External Nasal Dilator and Oxygen Therapy in Respiratory Failure|Use of External Nasal Dilator as an Adjuvant to High-Flow Nasal Cannula Oxygen Therapy in Children With Acute Respiratory Failure: A Prospective Randomized Controlled Trial|Completed||N/A|55|Actual|Loma Linda University||2|||f||||t||||||||||2017-10-10 22:31:53.651951|2017-10-10 22:31:53.651951
NCT02662374|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-21|||September 2015||2015-09-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Oral Hygiene Regimen in Patients on HCT|Efficacy of Two Different Oral Hygiene Regimens on the Incidence and Severity of Oral Mucositis in Patients Receiving Hematopoietic Stem Cell Transplantation - A Randomized Controlled Trial|Enrolling by invitation||Phase 4|45|Anticipated|Riyadh Colleges of Dentistry and Pharmacy||3|||f||||t||||||||Undecided||2017-10-10 22:31:54.095916|2017-10-10 22:31:54.095916
NCT02662361|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-05-05|||October 2014||2014-10-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Evaluation of the Prevalence and Risk Factors for Patients With Peri-implant Disease：a Retrospective Study|The Prevalence and Risk Factors for Patients With Peri-implant Disease：a Retrospective Study|Recruiting||N/A|131|Anticipated|Fourth Military Medical University|||2||f||||t||||||||Yes||2017-10-10 22:31:54.201126|2017-10-10 22:31:54.201126
NCT02662348|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-20|||February 2016||2016-02-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System|T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System|Enrolling by invitation||Phase 1|6|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||Yes|Nov 2017 ( Anticipated)|2017-10-10 22:31:54.304324|2017-10-10 22:31:54.304324
NCT02662335|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-02|||May 2016||2016-05-01|March 2017|2017-03-01||||December 13, 2016|Actual|2016-12-13||Interventional|||Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors|Computerized Cognitive Retraining in Breast Cancer Survivors|Active, not recruiting||N/A|15|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-10 22:31:54.426195|2017-10-10 22:31:54.426195
NCT02662322|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-08-21|||March 10, 2016|Actual|2016-03-10|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|March 6, 2017|Actual|2017-03-06||Interventional|KTHYPE||Effect of Language and Confusion on Pain During Peripheral Intravenous Catheterization (KTHYPE)|Effect of Language and Confusion on Pain During Peripheral Intravenous|Active, not recruiting||N/A|300|Anticipated|Rennes University Hospital||3|||f||||f||||||||||2017-10-10 22:31:54.532694|2017-10-10 22:31:54.532694
NCT02662309|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-08-29|||February 2016||2016-02-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|ABACUS||Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder|A Phase II Study Investigating Preoperative MPDL3280A in Operable Transitional Cell Carcinoma of the Bladder (ABACUS)|Recruiting||Phase 2|85|Anticipated|Queen Mary University of London||1|||f||||t||||||||||2017-10-10 22:31:54.641831|2017-10-10 22:31:54.641831
NCT02662296|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-25|||March 2016||2016-03-01|September 2017|2017-09-01||||February 2022|Anticipated|2022-02-01||Interventional|||Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant|A Phase II, Non-Randomized, Single Institution, Clinical Trial of Signal Transduction Inhibitors, Ibrutinib or Idelalisib, to Treat Patients With Persistent or Relapsed B-Cell Malignancies Following Allogeneic Hematopoietic Cell Transplantation|Withdrawn||Phase 2|0|Actual|Fred Hutchinson Cancer Research Center||1||Low enrollment|f||||t||||||||||2017-10-10 22:31:54.843207|2017-10-10 22:31:54.843207
NCT02662283|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-02-01|||May 2016||2016-05-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy|Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy —— A Prospective, Randomized, Controlled, Multi-Center Clinical Trial|Not yet recruiting||Phase 2/Phase 3|75|Anticipated|Sun Yat-sen University||3|||f||||f||||||||||2017-10-10 22:31:54.956295|2017-10-10 22:31:54.956295
NCT02662270|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-14|||January 2017|Actual|2017-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|QEEGFP||QEEG and Qualitative EEG for the Identidification of Abnormal Patterns in Fibromyalgia Patients|Quantitative and Qualitative EEG From Fibromyalgia Patients for the Identification of Abnormal Patterns on Closed Eyes EEG|Recruiting||N/A|150|Anticipated|Spanish Foundation for Neurometrics Development|||2||f||||f||||||||||2017-10-10 22:31:55.056792|2017-10-10 22:31:55.056792
NCT02662257|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-04|||April 2015||2015-04-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Impact of Anesthesia Maintenance Methods on Incidence of Postoperative Delirium|Impact of Inhalational Versus Intravenous Anesthesia Maintenance Methods on Incidence of Postoperative Delirium in Elderly Patients After Cancer Surgery: An Open-label, Randomized Controlled Trial|Recruiting||Phase 4|1200|Anticipated|Peking University First Hospital||2|||f||||t|t|f|||t|||||2017-10-10 22:31:55.163208|2017-10-10 22:31:55.163208
NCT02662244|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2016-10-27|||September 2015||2015-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma|Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma|Completed||N/A|32|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-10 22:31:55.351123|2017-10-10 22:31:55.351123
NCT02662231|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-04-01|||January 2016||2016-01-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Observational|GlobalSurg 2||Determining the Worldwide Epidemiology of Surgical Site Infections After Gastrointestinal Surgery|Determining the Worldwide Epidemiology of Surgical Site Infections After Gastrointestinal Surgery|Recruiting||N/A|10000|Anticipated|University of Edinburgh|||1||f||||f||||||||Yes|Individual participant data will be made available upon request, to enable patient level meta-analysis|2017-10-10 22:31:55.436596|2017-10-10 22:31:55.436596
NCT02662218|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-06-20|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Observational Study of Clinical Performance of a Sterile, Bacteria-binding, Super-absorbent Wound Dressing|Prospective, Multicenter, Observational Study to Evaluate the Clinical Performance of a Sterile, Bacteria-binding, Super-absorbent Wound Dressing|Completed||N/A|32|Actual|BSN Medical GmbH|||1||f||||f||||||||||2017-10-10 22:31:55.532469|2017-10-10 22:31:55.532469
NCT02662205|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-03-28|||January 2016||2016-01-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Group Yoga Therapy at a College Counseling Center|A Controlled Trial of Group Yoga Therapy at a College Counseling Center|Withdrawn||N/A|0|Actual|Oklahoma State University||3||We did not get adequate referrals.|f||||f||||||||||2017-10-10 22:31:55.599832|2017-10-10 22:31:55.599832
NCT02662192|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-11|||April 2016||2016-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|WTL||Fitness, Hearing and Quality of Life in Older Adults With Hearing Loss. Walk, Talk and Listen for Your Life|Targeting Functional Fitness, Hearing and Health-Related Quality of Life in Older Adults With Hearing Loss. Walk, Talk and Listen for Your Life, A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:31:57.693821|2017-10-10 22:31:57.693821
NCT02662179|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-07-14|||November 2015||2015-11-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Are the Fried Criteria Predictive of a Functional Decline in Older People With Solid Malignant Tumors?|Are the Fried Criteria Predictive of a Functional Decline in Older People With Solid Malignant Tumors?|Recruiting||N/A|30|Anticipated|Brugmann University Hospital|||1||f||||f||||||||||2017-10-10 22:31:57.805566|2017-10-10 22:31:57.805566
NCT02662166|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-01-19|||July 2014||2014-07-01|January 2016|2016-01-01||||July 2017|Anticipated|2017-07-01||Interventional|MIB||MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer|Magnetic Resonance Imaging of Bladder Cancer|Recruiting||N/A|150|Anticipated|Turku University Hospital||1|||f||||f||||||||||2017-10-10 22:31:57.919908|2017-10-10 22:31:57.919908
NCT02662153|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-04-26||||||April 2017|2017-04-01||||September 2019|Anticipated|2019-09-01||Observational|||Incidence and Predictors of Opioid Overdose and Death in ER/LA Opioid Users as Measured by Diagnoses and Death Records|Incidence and Predictors of Opioid Overdose and Death Among ER/LA Opioid Analgesics Users as Measured by Diagnoses and Death Records - a Retrospective Database Study|Active, not recruiting||N/A|10000|Anticipated|Member Companies of the Opioid PMR Consortium|||1||f||||||||||||||2017-10-10 22:31:58.012542|2017-10-10 22:31:58.012542
NCT02662140|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-12-28|||January 2016||2016-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mobile Health Solutions for Behavioral Skill Implementation Through Homework|Mobile Health Solutions for Behavioral Skill Implementation Through Homework|Withdrawn||N/A|0|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:31:58.082303|2017-10-10 22:31:58.082303
NCT02662127|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-10|||April 2016||2016-04-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Standing, Lying and Stockings on Blood Bio-markers (v.1)|Local Endogenous Biomarkers in the Later Stages of Chronic Venous Disease Versus Controls During Gravitational Stress, Prolonged Elevation Recovery and Compression|Recruiting||N/A|31|Anticipated|London North West Healthcare NHS Trust||1|||f||||f||||||||No||2017-10-10 22:31:58.155153|2017-10-10 22:31:58.155153
NCT02662114|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-20|||December 2015||2015-12-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|EU-TREAT||Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus|A European Multi-centre, Retrospective, Non-interventional Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus|Completed||N/A|2302|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 22:31:58.258313|2017-10-10 22:31:58.258313
NCT02662101|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-20|||January 2014||2014-01-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Impact of Oxidized Silver Wound Dressings on Wound Bacteria|Molecular Microbial Ecology as a Diagnostic Tool to Identify Mode of Action and New Targets for Oxidized Silver Wound Dressings|Completed||N/A|17|Actual|Exciton Technologies Inc.||1|||f||||f||||||||No||2017-10-10 22:31:58.378564|2017-10-10 22:31:58.378564
NCT02662088|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-05-04|||June 2016||2016-06-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01|5 Years|Observational [Patient Registry]|LLOS||Laparoscopic-lavage Observational Study|Laparoscopic-lavage Observational Study|Not yet recruiting||N/A|500|Anticipated|University of Turin, Italy|||1||f||||f||||||||Yes||2017-10-10 22:31:58.482145|2017-10-10 22:31:58.482145
NCT02662075|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-01-26|||April 2015|Actual|2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Electronic Cigarettes on Platelets, Endothelium and Inflammation|Acute Effects of Electronic Cigarettes on Platelet, Vascular Endothelial Function, and Inflammation in Healthy Active Smokers|Withdrawn||N/A|0|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:31:58.760665|2017-10-10 22:31:58.760665
NCT02662062|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-05-17|||August 2016||2016-08-01|May 2017|2017-05-01|January 2024|Anticipated|2024-01-01|September 2023|Anticipated|2023-09-01||Interventional|PCR-MIB||Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer|Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer|Recruiting||Phase 2|30|Anticipated|Australian and New Zealand Urogenital and Prostate Cancer Trials Group||1|||f||||t||||||||No||2017-10-10 22:31:58.870566|2017-10-10 22:31:58.870566
NCT02662049|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-20|||February 2014||2014-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:31:58.990054|2017-10-10 22:31:58.990054
NCT02662036|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-06-22|||February 29, 2016|Actual|2016-02-29|June 2017|2017-06-01|May 31, 2019|Anticipated|2019-05-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Analgesic Efficacy of Liposomal Bupivacaine vs. Bupivacaine HCL as a Tap Block After Abdominally Based Autologous Breast Reconstruction|A Prospective Trial to Assess Analgesic Efficacy of Liposomal Bupivacaine vs. Bupivacaine HCL as a Tap Block After Abdominally Based Autologous Breast Reconstruction|Recruiting||Phase 2|156|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||No||2017-10-10 22:31:59.042122|2017-10-10 22:31:59.042122
NCT02662023|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-02-09|||February 2016||2016-02-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Continuous TAP Blocks: Relative Effects of a Basal Infusion vs. Repeated Bolus Doses|Continuous Transversus Abdominis Plane Nerve Blocks: Relative Effects of a Basal Infusion vs. Repeated Bolus Doses (A Randomized, Double-Masked, Active-Control, Split-Body, Crossover Study)|Completed||Phase 4|24|Actual|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 22:31:59.157984|2017-10-10 22:31:59.157984
NCT02662010|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-06-06|||March 2016||2016-03-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|||The Relationship Between Advanced Glycation Endproducts and Diabetes|The Relationship of Advanced Glycation Endproducts in the Anterior Lens Capsule to Glycemic Status and Diabetic Retinopathy: A Cross Sectional Study of Patients With and Without Type 2 Diabetes Mellitus Undergoing Cataract Surgery|Recruiting||N/A|80|Anticipated|University of Colorado, Denver|||1||f||||t||||||Samples With DNA|"     Buffy Coat   "|No||2017-10-10 22:31:59.262137|2017-10-10 22:31:59.262137
NCT02661997|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-06-05|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|March 31, 2021|Anticipated|2021-03-31|December 30, 2020|Anticipated|2020-12-30||Interventional|NIGWVI||Novel Interventions for GWVI|Novel Interventions for Gulf War Veterans' Illnesses|Recruiting||N/A|120|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:31:59.353426|2017-10-10 22:31:59.353426
NCT02661984|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-05-11|||January 2016||2016-01-01|May 2017|2017-05-01|May 31, 2017|Anticipated|2017-05-31|November 2016|Actual|2016-11-01||Observational|||Measurement of FeNO in Young Children With the NIOX VERO|A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode|Active, not recruiting||N/A|102|Actual|Aerocrine AB|||2||f||||f||||||||No||2017-10-10 22:31:59.475153|2017-10-10 22:31:59.475153
NCT02661971|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-03-06|||June 2016||2016-06-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|RAMSES/FLOT7||FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)|Perioperative RAMucirumab in Combination With FLOT Versus FLOT Alone for reSEctable eSophagogastric Adenocarcinoma - RAMSES - a Phase II/III Trial of the AIO|Recruiting||Phase 2/Phase 3|908|Anticipated|Krankenhaus Nordwest||2|||f||||t||||||||||2017-10-10 22:31:59.575459|2017-10-10 22:31:59.575459
NCT02661776|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-27|||March 24, 2016|Actual|2016-03-24|September 2017|2017-09-01|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Observational|||The Change of NK Cell Activity After Head and Neck Cancer Surgery||Completed||N/A|29|Actual|Yonsei University|||1||f||||f||||||Samples With DNA|"     blood obtained from enrolled patients before and after surgery   "|||2017-10-10 22:32:01.426653|2017-10-10 22:32:01.426653
NCT02661958|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-10-03|||May 2016||2016-05-01|May 2017|2017-05-01|October 2017|Actual|2017-10-01|October 2017|Actual|2017-10-01||Interventional|||Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris|A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks|Completed||Phase 2|660|Anticipated|Sol-Gel Technologies, Ltd.||6|||f||||f||||||||||2017-10-10 22:31:59.708332|2017-10-10 22:31:59.708332
NCT02661945|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-07-10|||July 2015||2015-07-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Usefulness of Near-focus With Narrow-band Imaging|Usefulness of Near-focus With Narrow-band Imaging for Determining Gastric Tumor Margin|Recruiting||N/A|200|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-10 22:31:59.865086|2017-10-10 22:31:59.865086
NCT02661932|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-01-20|||November 2012||2012-11-01|January 2016|2016-01-01|December 2021|Anticipated|2021-12-01|March 2017|Anticipated|2017-03-01||Interventional|Brovale||Fertility Preservation in Breast Cancer Patients|Efficiency and Safety Study of Ovarian Stimulation With Letrozole for Fertility Preservation in Breast Cancer Patients|Recruiting||Phase 4|54|Anticipated|Erasme University Hospital||1|||f||||f||||||||No||2017-10-10 22:31:59.965715|2017-10-10 22:31:59.965715
NCT02661919|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-03-22|||February 2014||2014-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Assessment of the Emfit Mattress Sensor for Detection and Alarm of Night-time Generalized Tonic-clonic Seizures.|Assessment of the Emfit Mattress Sensor (L-4060SLC) and Monitor (DVM-GPRS-V2) and Their Acoustic and Cloud Interface Notification Capabilities as a Nocturnal Detection System for Movements Associated With Generalized Tonic-clonic Seizures.|Enrolling by invitation||N/A|50|Anticipated|Emfit, Corp.||1|||f||||f||||||||||2017-10-10 22:32:00.130701|2017-10-10 22:32:00.130701
NCT02661906|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of SKY on Psychosocial Parameters of Type 2 Diabetic Patients After a 12 Week Intervention|Effect of SKY on Anxiety, Depression and Quality of Life of Type 2 Diabetic Patients After a 12 Week Intervention in a Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Dasman Diabetes Institute||2|||f||||f||||||||||2017-10-10 22:32:00.215491|2017-10-10 22:32:00.215491
NCT02661893|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-05-04|||January 2016||2016-01-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922|An Open-Label Drug Interaction Study to Assess the Pharmacokinetics of JNJ-42847922 When Administered Alone and in Combination With Rifampin in Healthy Male and Female Subjects|Completed||Phase 1|14|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 22:32:00.313095|2017-10-10 22:32:00.313095
NCT02661880|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-20|||April 2016||2016-04-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||The Role of Music in Palliative Care: A Proposal for a Rural Based Initiative in Music Based Interventions|The Role of Music in Palliative Care: A Proposal for a Rural Based Initiative in Music Based Interventions|Not yet recruiting||N/A|30|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||No||2017-10-10 22:32:00.403186|2017-10-10 22:32:00.403186
NCT02661867|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2016-01-22|||January 2002||2002-01-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2007|Actual|2007-12-01||Observational|||Pelvic Floor Function Evaluation of Singleton Primiparae After Vaginal Delivery and Cesarean Section|Pelvic Floor Function Evaluation of Singleton Primiparae After Vaginal Delivery and Cesarean Section: Seven to Twelve-Year Long Observational Cohort Study|Completed||N/A|865|Actual|Brno University Hospital|||2||f||||f||||||||No||2017-10-10 22:32:00.58994|2017-10-10 22:32:00.58994
NCT02661854|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-03-02|||June 21, 2016|Actual|2016-06-21|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MM09||Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy|Double Blind, Placebo-controlled, Dose Finding, Prospective, Multicenter Clinical Trial for the Treatment of Rhinitis/Rhinoconjunctivitis Against a Mixture of Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Allergen Extract|Recruiting||Phase 2|180|Anticipated|Inmunotek S.L.||9|||f||||f|f|f||||||No||2017-10-10 22:32:00.676859|2017-10-10 22:32:00.676859
NCT02661841|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-06-01|||February 2016||2016-02-01|June 2016|2016-06-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Effectiveness of Lung Impedance Guided Preemptive Therapy of Chronic Heart Failure Patients With Preserved Ejection Fraction (LVEF ≥ 45%) in Our Hospital's Outpatient Clinic||Recruiting||N/A|300|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||No||2017-10-10 22:32:00.873607|2017-10-10 22:32:00.873607
NCT02661815|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-07-25|||June 15, 2016|Actual|2016-06-15|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer|A Phase 1b Study of Weekly Paclitaxel And Oral Ricolinostat For The Treatment Of Recurrent Platinum Resistant Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer|Active, not recruiting||Phase 1|54|Anticipated|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-10 22:32:01.088911|2017-10-10 22:32:01.088911
NCT02661802|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2016-01-22|||January 2012||2012-01-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger Syndrome|Acute Effects of 40% Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger Syndrome|Completed||N/A|30|Actual|Federal University of São Paulo||1|||f||||f||||||||No|No participant data will be shared. However, all enrolled subjects were provided the principal investigator's phone number and e-mail address in order to receive test results and ask questions.|2017-10-10 22:32:01.200572|2017-10-10 22:32:01.200572
NCT02661789|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-19|||January 2011||2011-01-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|GnRHa||Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression|Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression|Completed||N/A|63|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||Yes|Via database of Center for Integrated Molecular Brain Imaging (Knudsen et al 2016, NeuroImage) data will be available for neuroscience research community contingent on approval by scientific board|2017-10-10 22:32:01.285586|2017-10-10 22:32:01.285586
NCT02661763|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-11-04|||September 2015||2015-09-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Rheumatic Heart Disease Study in Lusaka|Prevalence of Rheumatic Heart Disease in Zambian Schoolchildren: an Echocardiographic Screening Study Involving Task-shifting to General Radiographers|Completed||N/A|1024|Actual|University of Zambia|||1||f||||t||||||||No||2017-10-10 22:32:01.516943|2017-10-10 22:32:01.516943
NCT02661750|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-03-23|||January 2016||2016-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy|Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy|Recruiting||N/A|100|Anticipated|Gastroenterology Services, Ltd.|||5||f||||t||||||||No||2017-10-10 22:32:01.615147|2017-10-10 22:32:01.615147
NCT02661737|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-21|||January 2015||2015-01-01|January 2016|2016-01-01|May 2018|Anticipated|2018-05-01|October 2016|Anticipated|2016-10-01||Observational|||Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volumes||Active, not recruiting||N/A|503|Actual|LG Life Sciences|||1||f||||||||||||||2017-10-10 22:32:01.724537|2017-10-10 22:32:01.724537
NCT02661724|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-19|||April 2015||2015-04-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Take Charge of Burn Pain|Take Charge of Burn Pain: A Randomized Controlled Trial of a Web-based Self-Management Intervention to Improve Burn Pain Outcomes|Recruiting||Phase 1/Phase 2|256|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-10 22:32:01.783493|2017-10-10 22:32:01.783493
NCT02661711|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-09-13|||March 2016||2016-03-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|AMOUR||Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study|Prospective Non-randomised Exploratory Study to Assess the Safety and Efficacy of Aflibercept (Eylea) in Cystoid Macular Oedema (CMO) Associated With Retinitis Pigmentosa (RP)|Active, not recruiting||Phase 2|30|Actual|Moorfields Eye Hospital NHS Foundation Trust||1|||f||||t||||||||No|Individual patient data will not be disclosed publically, all the data will be anonymised and analysed in accordance with the Data Protection Act|2017-10-10 22:32:01.895035|2017-10-10 22:32:01.895035
NCT02661698|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-11-07|||February 2016||2016-02-01|September 2016|2016-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Plasma Diurnal Variation in and Absorption of EPA and DHA|Diurnal Variation of Plasma Concentration of EPA and DHA and Absorption of Doses Taken at Hora Somni|Completed||N/A|39|Actual|Northumbria University||4|||f||||f||||||||||2017-10-10 22:32:01.995356|2017-10-10 22:32:01.995356
NCT02661685|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-03-30|||May 2016|Actual|2016-05-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety Study of Adoptive Transfer of Autologous IKDC-like Cells|An Immunotherapy for Metastatic Cancer Patients by Adoptive Transfer of Autologous IKDC-like Cells - Phase 1 Clinical Trial|Recruiting||Phase 1|9|Anticipated|National Defense Medical Center, Taiwan||1|||f||||t||||||||Undecided||2017-10-10 22:32:02.106086|2017-10-10 22:32:02.106086
NCT02661672|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-02-13|||October 2016||2016-10-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo in Patients With Brain Hemorrhage|INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo in Patients With Brain Hemorrhage: A Prospective Multicenter Registry|Recruiting||Phase 2|200|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-10 22:32:02.233498|2017-10-10 22:32:02.233498
NCT02661659|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-05-10|||June 2016||2016-06-01|May 2017|2017-05-01||||February 2018|Anticipated|2018-02-01||Interventional|||A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy|A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy|Withdrawn||Phase 1|0|Actual|University of Chicago||2|||f||||f||||||||||2017-10-10 22:32:02.365073|2017-10-10 22:32:02.365073
NCT02661646|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-04-26|||December 2015||2015-12-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced PCD|Assessment of Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device at Home|Recruiting||N/A|300|Anticipated|Tactile Medical|||1||f||||f||||||||No||2017-10-10 22:32:02.46913|2017-10-10 22:32:02.46913
NCT02661633|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-09-28|||January 29, 2016|Actual|2016-01-29|February 2017|2017-02-01|July 31, 2017|Actual|2017-07-31|January 31, 2017|Actual|2017-01-31||Observational|AheadCAS-HS||Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes|Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization in High School Athletes|Completed||N/A|177|Actual|BrainScope Company, Inc.|||2||f||||f||||||||||2017-10-10 22:32:02.572197|2017-10-10 22:32:02.572197
NCT02661620|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-05-22|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|August 2026|Anticipated|2026-08-01|August 2021|Anticipated|2021-08-01||Observational|||REDAPT Retrospective-Prospective Modular Stem Study|A Retrospective-Prospective Study of REDAPT™ Revision Femoral System Modular Stem|Active, not recruiting||N/A|133|Actual|Smith & Nephew, Inc.|||1||f||||f||||||||No||2017-10-10 22:32:02.661887|2017-10-10 22:32:02.661887
NCT02661607|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-07-02|||October 2014||2014-10-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement|A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement in Critical Care Environments|Completed||N/A|100|Actual|University of Göttingen||1|||f||||f||||||||||2017-10-10 22:32:02.754534|2017-10-10 22:32:02.754534
NCT02661204|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-04-07|||January 2016||2016-01-01|April 2016|2016-04-01||||January 2021|Anticipated|2021-01-01||Observational|||Diagnostic Performance of an Automated Breast Ultrasound System (ABUS)|Diagnostic Performance of an Automated Breast Ultrasound System (ABUS): a Single Centre Study|Recruiting||N/A|250|Anticipated|University of Zurich|||4||f||||||||||||||2017-10-10 22:32:06.64979|2017-10-10 22:32:06.64979
NCT02661581|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-11-01|||November 2013||2013-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PLEASED||Peer-led, Empowerment-based, Approach to Self-management Efforts in Diabetes|Peer-led, Empowerment-based, Approach to Self-management Efforts in Diabetes: A Randomized Controlled Trial (The PLEASED Trial)|Active, not recruiting||N/A|80|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:32:02.935096|2017-10-10 22:32:02.935096
NCT02661568|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-19|||September 2014||2014-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)|Anticoagulation Treatment Patterns and Persistence After Acute Venous Thromboembolism in the UK in Routine Clinical Practice: A Retrospective Database Study of the Clinical Practice Research Datalink and the Hospital Episode Statistics Dataset|Completed||N/A|38409|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:32:03.041567|2017-10-10 22:32:03.041567
NCT02661555|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Aerobic Exercise and Brain Health in Multiple Sclerosis|Effects of Aerobic Exercise on Brain Health in People With Multiple Sclerosis|Recruiting||N/A|85|Anticipated|University of Aarhus||2|||f||||f||||||||No||2017-10-10 22:32:03.105395|2017-10-10 22:32:03.105395
NCT02661542|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-07-07|||January 2016||2016-01-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas|A Phase 1/2a, Dose-escalation Study of FF-10502-01 for the Treatment of Advanced Solid Tumors and Lymphomas|Recruiting||Phase 1/Phase 2|84|Anticipated|Fujifilm Pharmaceuticals U.S.A., Inc.||11|||f||||f||||||||||2017-10-10 22:32:03.211248|2017-10-10 22:32:03.211248
NCT02661529|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-01-21|||January 2016||2016-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts|Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts|Recruiting||N/A|100|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:32:03.537149|2017-10-10 22:32:03.537149
NCT02661516|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-19|||July 2014||2014-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists|Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-Valvular Atrial Fibrillation Treated With Vitamin K Antagonists|Completed||N/A|16513|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:32:03.629414|2017-10-10 22:32:03.629414
NCT02661503|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-10|||July 2016||2016-07-01|May 2017|2017-05-01|September 2025|Anticipated|2025-09-01|March 2020|Anticipated|2020-03-01||Interventional|||HD21 for Advanced Stages|HD21 for Advanced Stages Treatment Optimization Trial in the First-line Treatment of Advanced Stage Hodgkin Lymphoma; Comparison of 6 Cycles of Escalated BEACOPP With 6 Cycles of BrECADD|Recruiting||Phase 3|1500|Anticipated|University of Cologne||2|||f||||t||||||||||2017-10-10 22:32:03.708584|2017-10-10 22:32:03.708584
NCT02661490|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-06-09|||February 1, 2016|Actual|2016-02-01|June 2017|2017-06-01|September 27, 2017|Anticipated|2017-09-27|September 27, 2017|Anticipated|2017-09-27||Interventional|||Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population|A Phase II, Randomized, Double-blind, Safety and Immunogenicity Trial of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in Healthy Elderly Adults|Active, not recruiting||Phase 2|320|Actual|Takeda||5|||f||||t||||||||||2017-10-10 22:32:03.833466|2017-10-10 22:32:03.833466
NCT02661477|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-04-21|||May 2016||2016-05-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Hypogamma Int1||Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial|Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial|Not yet recruiting||Phase 2|20|Anticipated|Turku University Hospital||2|||f||||f||||||||No||2017-10-10 22:32:03.98936|2017-10-10 22:32:03.98936
NCT02661451|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-08-01|||September 2016|Actual|2016-09-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)|Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure: A Randomized Trial (TAVR UNLOAD)|Recruiting||N/A|600|Anticipated|Cardiovascular Research Foundation, New York||2|||f||||t||||||||||2017-10-10 22:32:04.342531|2017-10-10 22:32:04.342531
NCT02661438|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-04-06|||January 2016||2016-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo|Multicenter Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation in Subjects With Non-Cystic Fibrosis Bronchiectasis (NCFB) or Chronic Obstructive Pulmonary Disease (COPD) Using Matching Placebo|Completed||N/A|46|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:32:04.487782|2017-10-10 22:32:04.487782
NCT02661425|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-09-09|||December 2015||2015-12-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Retrospective Study of IBS-D Patients Previously Receiving SBI|Retrospective Study of Irritable Bowel Syndrome With Diarrhea (IBS-D) Patients Previously Receiving Serum-derived Bovine Serum Immunoglobulin (SBI)|Completed||N/A|165|Actual|Entera Health, Inc|||2||f||||f||||||||No||2017-10-10 22:32:04.583348|2017-10-10 22:32:04.583348
NCT02661412|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-19|||January 2001||2001-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Observational|IMLOAD||Immediate Loading of Implants in the Partially or Completely Edentulous Jaw||Active, not recruiting||N/A|150|Actual|AZ Sint-Jan AV|||1||f||||f||||||||No||2017-10-10 22:32:04.722609|2017-10-10 22:32:04.722609
NCT02661399|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-04-28|||November 2014||2014-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Peripheral Blood Biomarkers Associated With CIPN|Investigation of Peripheral Blood Biomarkers Associated With CIPN|Enrolling by invitation||N/A|100|Actual|St. Louis University|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 22:32:04.797696|2017-10-10 22:32:04.797696
NCT02661386|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-20|||January 2016||2016-01-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|EMAP||Esophageal Manometry During Recovery From Anesthesia: Pilot Study|Esophageal Manometry During Recovery From Anesthesia: Pilot Study|Not yet recruiting||N/A|10|Anticipated|University of California, San Francisco||1|||f||||f||||||||No||2017-10-10 22:32:04.859333|2017-10-10 22:32:04.859333
NCT02661373|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-07-12|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor|Phase 1a, First-In-Human, Dose-Escalation Study of (+)-SJ000557733 (SJ733), an Oral, Novel Inhibitor of Plasmodium Falciparum Plasma Membrane Protein PfATP4|Recruiting||Phase 1|40|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-10 22:32:04.937109|2017-10-10 22:32:04.937109
NCT02661360|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-01-26|||September 2015||2015-09-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Swaddling on Infants During Feeding|Effects of Swaddling During Bottle Feeding on Infants Born Preterm|Completed||N/A|30|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:32:05.053261|2017-10-10 22:32:05.053261
NCT02661347|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-10-04|||February 2016||2016-02-01|October 2017|2017-10-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia|Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia|Terminated||N/A|1|Actual|Northwell Health||2|||f||||t||||||||||2017-10-10 22:32:05.144865|2017-10-10 22:32:05.144865
NCT02661334|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-07-31|||August 2015||2015-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|MUSSCLE||Measuring Uniformed Servicemembers' Fitness Scores on Creatine Loading and Exercise|Measuring Uniformed Servicemembers' Fitness Scores on Creatine Loading and Exercise (MUSSCLE)|Enrolling by invitation||N/A|180|Anticipated|David Grant U.S. Air Force Medical Center||4|||f||||t||||||||||2017-10-10 22:32:05.236585|2017-10-10 22:32:05.236585
NCT02661321|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-19|||December 2011||2011-12-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Location and Timing of Inhaler Use, Exacerbations and Physical Activity in Chronic Obstructive Pulmonary Disease|Location and Timing of Inhaler Use, Exacerbations and Physical Activity in Chronic Obstructive Pulmonary Disease|Completed||N/A|35|Actual|VA Puget Sound Health Care System|||1||f||||f||||||||No||2017-10-10 22:32:05.325949|2017-10-10 22:32:05.325949
NCT02661308|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-03-13|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|LYS||Reducing Cancer Side-effects With Systematic Light Exposure|Reducing Cancer Side-effects With Systematic Light Exposure|Recruiting||N/A|72|Anticipated|Aarhus University Hospital||2|||f||||||||||||||2017-10-10 22:32:05.391668|2017-10-10 22:32:05.391668
NCT02661295|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-18|||July 2015||2015-07-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A Study of Ferric Citrate to Improve Inflammation and Lipid Levels|The Effect of Ferric Citrate on Inflammation and Lipid Levels in Patients on Hemodialysis|Recruiting||Phase 4|60|Anticipated|Winthrop University Hospital||1|||f||||f||||||||||2017-10-10 22:32:05.489928|2017-10-10 22:32:05.489928
NCT02661282|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-09-06|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Glioblastoma (GBM) Patients|A Phase I/II Clinical Trial of Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Glioblastoma (GBM) Patients|Recruiting||Phase 1/Phase 2|54|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 22:32:05.592111|2017-10-10 22:32:05.592111
NCT02661269|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-23|||November 2015||2015-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Relation Between the Increase of Peripheral Edema by Fluid Therapy and the Decrease in Microcirculatory Vesseldensity|Relation Between the Increase of Peripheral Edema by Fluid Therapy and the Decrease in Microcirculatory Vesseldensity|Recruiting||N/A|110|Anticipated|Medical Centre Leeuwarden|||2||f||||f||||||||||2017-10-10 22:32:05.694434|2017-10-10 22:32:05.694434
NCT02661256|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-18|||June 2014||2014-06-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates|Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates|Completed||N/A|7|Actual|Winthrop University Hospital||2|||f||||t||||||||||2017-10-10 22:32:05.786147|2017-10-10 22:32:05.786147
NCT02661243|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-05-09|||May 2015||2015-05-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Implantology and Sjögren's Syndrome|Implantology and Sjögren's Syndrome: a Multicenter Prospective Cohort Study|Recruiting||N/A|120|Anticipated|VU University Medical Center||4|||f||||t||||||||No||2017-10-10 22:32:05.871268|2017-10-10 22:32:05.871268
NCT02661230|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-02-16|||March 2015||2015-03-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|VRICUGAMING||Virtual Reality Exercise on the Intensive Care Unit in Heart Patients|Design of a Cognitive Motor Intervention Using a Video Game to Enhance Brain Activity: A Feasibility Study Including Healthy Participants and Heart Patients on the Intensive Care Unit|Completed||N/A|30|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 22:32:06.016924|2017-10-10 22:32:06.016924
NCT02661178|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-08-24|||December 2015|Actual|2015-12-01|January 2017|2017-01-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|||First in Man Clinical Trial of Emodepside (BAY 44-4400)|A Phase 1, Blinded, Randomized, Placebo Controlled, Parallel-Group, Single-Dose, Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects|Completed||Phase 1|79|Actual|Drugs for Neglected Diseases||2|||f||||||||||||||2017-10-10 22:32:06.868328|2017-10-10 22:32:06.868328
NCT02661165|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-05-05|||June 2016||2016-06-01|May 2017|2017-05-01|March 31, 2021|Anticipated|2021-03-31|April 30, 2018|Anticipated|2018-04-30||Observational|||How Does the Spirituality of Patients With Type 2 Diabetes Influence Their Self-management?|Exploratory Study: How Does the Spirituality of a Group of British People With Type 2 Diabetes Impact Their Coping and Self-management of Their Condition?|Recruiting||N/A|8|Anticipated|University of Southampton|||1||f||||f||||||||No||2017-10-10 22:32:06.994543|2017-10-10 22:32:06.994543
NCT02661152|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-11-22|||September 2016||2016-09-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|DAHANCA30||DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.|DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification With Nimorazole During Radiotherapy/Chemoradiotherapy of Squamous Cell Carcinoma of the Head and Neck.|Recruiting||Phase 3|1262|Anticipated|Danish Head and Neck Cancer Group||2|||f||||t||||||||No||2017-10-10 22:32:07.073999|2017-10-10 22:32:07.073999
NCT02661139|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-19|||June 2013||2013-06-01|January 2016|2016-01-01|December 2023|Anticipated|2023-12-01|December 2020|Anticipated|2020-12-01|36 Months|Observational [Patient Registry]|O-BRIDGE||Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction||Recruiting||N/A|55|Anticipated|AZ Sint-Jan AV|||1||f||||f||||||||No||2017-10-10 22:32:07.182913|2017-10-10 22:32:07.182913
NCT02661126|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-08-28|||January 19, 2016|Actual|2016-01-19|August 2017|2017-08-01|August 26, 2016|Actual|2016-08-26|August 26, 2016|Actual|2016-08-26||Interventional|||Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030)|A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-3682B (MK-3682/MK-5172/MK-8408 Fixed Dose Combination) When Administered to Subjects With Moderate and Severe Renal Insufficiency|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-10 22:32:07.276284|2017-10-10 22:32:07.276284
NCT02661113|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-22|||May 2009||2009-05-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma: Phase II|Phase II Portion of Trial of Dasatinib (Sprycel) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Sponsor withdrew support; Study did not progress to Phase II (Phase I registration NCT00895960)|f||||f||||||||||2017-10-10 22:32:07.365984|2017-10-10 22:32:07.365984
NCT02661100|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-12-05|||January 2017||2017-01-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients|A Phase I/II Trial of CDX-1401 (a Vaccine Consisting of a Human Monoclonal Antibody Specific for DEC-205, Fused to Full-length Tumor Antigen NY-ESO-1) in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Case Comprehensive Cancer Center||1||Drug unavailable|f||||t||||||||||2017-10-10 22:32:07.466488|2017-10-10 22:32:07.466488
NCT02661087|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-03-24|||November 2012||2012-11-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|August 2016|Actual|2016-08-01||Interventional|||Comparing Intra Uterine Synechiae Occurence Using Bipolar Energy Compared With Monopolar Energy in Myoma Resection on Women Having Menorraghia and/or Infertility|MONOBISY: Randomized Controlled Trial Comparing Intra Uterine Synechiae Occurence Using Bipolar Energy Compared With Monopolar Energy in Myoma Resection on Women Having Menorraghia and/or Infertility|Recruiting||N/A|178|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:32:07.574559|2017-10-10 22:32:07.574559
NCT02661074|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-10-26|||November 2014||2014-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|ABCFish1||Anisakis Blastocystis Cryptosporidium Fish Prevalence|Protists and Nematodes Fish Parasites: From Their Circulation in Ecosystems to Their Impact on Human Health - Prevalence of Fish Allergy in Occupational Settings.|Completed||N/A|486|Actual|University Hospital, Lille|||3||f||||f||||||||No||2017-10-10 22:32:08.198253|2017-10-10 22:32:08.198253
NCT02661061|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-05-18|||December 2015||2015-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KINDRED||Ketamine for Relapse Prevention in Recurrent Depressive Disorder|Ketamine for Relapse Prevention in Recurrent Depressive Disorder: a Randomised, Controlled, Pilot Trial: the KINDRED Trial|Recruiting||Phase 1|40|Anticipated|St Patrick's Hospital, Ireland||2|||f||||t||||||||No|None envisaged: data will be anonymised|2017-10-10 22:32:08.312955|2017-10-10 22:32:08.312955
NCT02661048|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-01-20|||January 2016||2016-01-01|January 2016|2016-01-01|January 2021|Anticipated|2021-01-01|December 2016|Anticipated|2016-12-01||Interventional|||CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation|CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia|Not yet recruiting||N/A|10|Anticipated|CyberHeart Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:32:08.434426|2017-10-10 22:32:08.434426
NCT02661035|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-10-04|||March 9, 2017|Actual|2017-03-09|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|||Allo HSCT Using RIC for Hematological Diseases|Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) for the Treatment of Hematological Diseases [MT2015-32]|Recruiting||Phase 2|124|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f||||||||2017-10-10 22:32:08.527308|2017-10-10 22:32:08.527308
NCT02661022|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-01-30|||January 2016||2016-01-01|January 2016|2016-01-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma|A Phase 1/2 Open Label Study of SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|32|Anticipated|Stemline Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 22:32:08.703883|2017-10-10 22:32:08.703883
NCT02661009|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-20|||January 2016||2016-01-01|December 2015|2015-12-01||||September 2016|Anticipated|2016-09-01||Observational|||Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)|Human EGFR(Epidermal Growth Factor Receptor) Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)|Not yet recruiting||N/A|1000|Anticipated|GenoSaber|||2||f||||t||||||||||2017-10-10 22:32:08.867744|2017-10-10 22:32:08.867744
NCT02660996|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-03-14|||July 2014||2014-07-01|March 2017|2017-03-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Effectiveness of the Advocate Lutheran General Survivorship Center Programs|Assessing the Effectiveness of the Advocate Lutheran General Survivorship Center Programs on Patients' Quality of Life, Distress Level, and Satisfaction|Recruiting||N/A|60|Anticipated|Advocate Health Care|||1||f||||t||||||||Yes|Conference presentation and publication|2017-10-10 22:32:08.946495|2017-10-10 22:32:08.946495
NCT02660983|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-06-26|||August 5, 2013|Actual|2013-08-05|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Donepezil Hydrochloride (E2020) in Patients With Dementia Associated With Cerebrovascular Disease|Recruiting||Phase 4|324|Anticipated|Eisai Inc.||2|||f||||f||||||||||2017-10-10 22:32:09.038049|2017-10-10 22:32:09.038049
NCT02660970|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-09-01|||January 2016||2016-01-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of the Therapeutic Effect of Acupressure Therapy and Iberogast ® (STW-5) in Children With Functional Nausea|Comparison of the Therapeutic Effect of Acupressure Therapy and Iberogast ® (STW-5) in Children With Functional Nausea - a Randomized Clinical Trial With Sham-conditions|Recruiting||N/A|120|Anticipated|University Hospital, Basel, Switzerland||4|||f||||t||||||||||2017-10-10 22:32:09.181829|2017-10-10 22:32:09.181829
NCT02660957|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-05-07|||August 2015||2015-08-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Smoking Cessation Among People Attending A&E|Effectiveness of a Brief, Self-determination Intervention for Smoking Cessation (Immediate or Progressive) Among People Attending Emergency Departments: a Randomised Controlled Trial|Recruiting||N/A|1566|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:32:09.287331|2017-10-10 22:32:09.287331
NCT02660944|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2017-09-26|||January 2016||2016-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)|A Phase 2a, Double-blind, Placebo-Controlled Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)|Recruiting||Phase 2|50|Anticipated|Resolve Therapeutics||2|||f||||f||||||||||2017-10-10 22:32:09.384159|2017-10-10 22:32:09.384159
NCT02660931|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-06-01|||November 2016||2016-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|PAR4||Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research|Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research|Recruiting||N/A|10000|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 22:32:09.526783|2017-10-10 22:32:09.526783
NCT02660918|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Decreasing Postoperative Pain Following Endometrial Ablation|Decreasing Postoperative Pain Following Endometrial Ablation: A Randomized Controlled Trial|Completed||N/A|84|Actual|Christiana Care Health Services||2|||f||||f||||||||No||2017-10-10 22:32:09.624726|2017-10-10 22:32:09.624726
NCT02660905|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-04-25|||April 2016||2016-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|CTN289||HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection|Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (ECF/TAF) Switch Followed by Ledipasvir-Sofosbuvir Antiviral HCV Therapy in HIV-HCV Co-Infection: A CIHR Canadian HIV Trials Network-Gilead Pilot Trial Proposal|Active, not recruiting||Phase 3|25|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||Undecided||2017-10-10 22:32:09.712772|2017-10-10 22:32:09.712772
NCT02660892|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2017-07-13|||May 26, 2016|Actual|2016-05-26|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|July 5, 2017|Actual|2017-07-05||Interventional|||Determination of Threonine Requirements in Healthy School-aged Children|Determination of Threonine Requirements and the Metabolic Availability of Threonine From Food Sources in Healthy School-aged Children|Recruiting||N/A|6|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-10 22:32:09.820065|2017-10-10 22:32:09.820065
NCT02660879|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-18|||December 2013||2013-12-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|InhalerEdu||The Effect of Video Education on Inhaler Use Technique|The Effect of Video Education on Improving Inhaler Use Technique|Completed||N/A|50|Actual|Northwestern University||2|||f||||f||||||||||2017-10-10 22:32:09.892001|2017-10-10 22:32:09.892001
NCT02660866|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-12-16|||July 2016||2016-07-01|December 2016|2016-12-01||||July 2017|Anticipated|2017-07-01||Interventional|XLPADTRACE||Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)|Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)|Recruiting||Phase 4|200|Anticipated|North Texas Veterans Healthcare System||2|||f||||t||||||||Yes|Deidentified study results will be shared through clinicaltrials.gov and other publically available portals.|2017-10-10 22:32:09.954779|2017-10-10 22:32:09.954779
NCT02660853|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-01-20|||June 2015||2015-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers|Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Imperial College London|||1||f||||f||||||Samples With DNA|"     Sputum cells   "|||2017-10-10 22:32:10.078125|2017-10-10 22:32:10.078125
NCT02660840|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-07-25|||January 2016||2016-01-01|July 2016|2016-07-01||||June 2016|Actual|2016-06-01||Interventional|||Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations|Interventional, Open-label, Randomised, Crossover, Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations - Film Coated Tablet (Test Treatment) - 0.5 mg, 1 mg and 5 mg (H. Lundbeck A/S, Denmark) and Coated Tablet (Fluanxol®) - 0.5 mg, 1 mg and 5 mg (H. Lundbeck A/S, Denmark) in Healthy Volunteers|Completed||Phase 1|84|Actual|H. Lundbeck A/S||6|||f||||f||||||||Undecided||2017-10-10 22:32:10.149586|2017-10-10 22:32:10.149586
NCT02660827|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2017-07-12|||April 18, 2016|Actual|2016-04-18|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes|Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes|Recruiting||N/A|200|Anticipated|Medtronic Diabetes||1|||f||||t||||||||||2017-10-10 22:32:10.266414|2017-10-10 22:32:10.266414
NCT02660814|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-20|||July 2014||2014-07-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Chemerin and Interleukin-6 Levels of Gingival Crevicular Fluid in Obese Individuals Following Periodontal Treatment|Effects of Non-Surgical Periodontal Treatment on the Gingival Crevicular Fluid Levels of Chemerin in Obese Patients With Chronic Periodontitis|Completed||Early Phase 1|72|Actual|Bulent Ecevit University||4|||f||||f||||||||||2017-10-10 22:32:10.433585|2017-10-10 22:32:10.433585
NCT02660801|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Spinal Manipulation and Spinal Mobilization Effects in Participants With and Without Back Pain|Spinal Manipulation and Spinal Mobilization Effects in Participants With and Without Back Pain|Recruiting||N/A|50|Anticipated|Université du Québec à Trois-Rivières||2|||f||||f||||||||No||2017-10-10 22:32:10.517127|2017-10-10 22:32:10.517127
NCT02660788|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-20|||February 2013||2013-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women|A Randomised Study of Screening Mammography Return Rates in Overdue Women Due to Standard Screening Mammography Program of British Columbia (Smpbc) Reminders Versus Reminder Letters Signed by Women's Family Physicians|Completed||N/A|5638|Actual|British Columbia Cancer Agency||2|||f||||f||||||||No||2017-10-10 22:32:10.607987|2017-10-10 22:32:10.607987
NCT02660775|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-12|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|(ClaCoS)||Social Cognitive Assessment in Autism and Schizophrenia|Social Cognitive Assessment in Psychiatry - Validation of a New Battery: ClaCoS|Recruiting||N/A|440|Anticipated|Hôpital le Vinatier||3|||f||||t||||||||||2017-10-10 22:32:10.854193|2017-10-10 22:32:10.854193
NCT02660762|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-06-16|||January 2016||2016-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL|A Prospective Phase II Trial of Modified MRC UKALL Ⅻ/ECOG E2993 Regimen in the Treatment of Low Risk Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia for Young Adults|Recruiting||Phase 2|100|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 22:32:10.98042|2017-10-10 22:32:10.98042
NCT02660749|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-20|||May 2015||2015-05-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Observational|||The Effect Of Tramadol, Metamizol and Dexketoprofen Combination On Chronic Pain Development After Heart Surgery|The Effect Of Tramadol, Metamizol and Dexketoprofen Combination On Chronic Pain Development After Heart Surgery|Active, not recruiting||N/A|80|Actual|Tobb University of Economics and Technology|||1||f||||t||||||||||2017-10-10 22:32:11.174272|2017-10-10 22:32:11.174272
NCT02660736|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-11-08|||February 2016||2016-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects|A Randomized, Double-blind, Single-dose, Crossover Study to Compare Two Albiglutide Drug Products for Bioequivalence in Healthy Adult Subjects|Completed||Phase 1|59|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:32:11.247663|2017-10-10 22:32:11.247663
NCT02660723|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-03-27|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|February 2017|Actual|2017-02-01||Interventional|Cytokinage||Impact of Aging on Cytokine Production by Innate Immune Cells|To Investigate the Impact of Aging on Cytokine and Chemokine Production by Peripheral Blood Immune Cells|Active, not recruiting||N/A|50|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||No||2017-10-10 22:32:11.371945|2017-10-10 22:32:11.371945
NCT02660710|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2017-05-02|||March 2016||2016-03-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|March 2021|Anticipated|2021-03-01||Interventional|||Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma|LCCC 1335: A Single-Arm Phase I/II Clinical Trial of Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma in Malawi|Recruiting||Phase 2|40|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:32:11.461|2017-10-10 22:32:11.461
NCT02660697|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-01-22|||December 2007||2007-12-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||3D Radiographic Evaluation of a Novel Implant Site Development Technique|3D Radiographic Evaluation of Post-extraction Healing Following Treatment With a Novel Implant Site Development Technique|Completed||Phase 4|43|Actual|Semmelweis University||2|||f||||f||||||||No||2017-10-10 22:32:11.595155|2017-10-10 22:32:11.595155
NCT02660684|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-02-29|||February 2008||2008-02-01|February 2016|2016-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor|A Historically-controlled, Multi-center Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule, Prograf Injection) and Methotrexate Combination Therapy for Prevention of GVHD in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor|Completed||Phase 4|39|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 22:32:11.703715|2017-10-10 22:32:11.703715
NCT02660671|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-05-03|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Behavioral Economic Approaches to Increase Colorectal Cancer Screening|Behavioral Economic Approaches to Increase Colorectal Cancer Screening|Completed||N/A|2250|Actual|University of Pennsylvania||3|||f||||f||||||||Undecided||2017-10-10 22:32:11.822404|2017-10-10 22:32:11.822404
NCT02660658|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2017-02-24|||January 2016||2016-01-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Optimal Single Dose Intrathecal Dexmedetomidine for Postoperative Analgesia|Optimal Single-dose Intrathecal Dexmedetomidine for Postoperative Analgesia After Lower Limb Surgery|Recruiting||N/A|15|Anticipated|Mansoura University||1|||f||||t||||||||Undecided||2017-10-10 22:32:11.926336|2017-10-10 22:32:11.926336
NCT02660645|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-08-17|||April 2014||2014-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|BLCCR||Blue Light Cystoscopy With Cysview® Registry|Blue Light Cystoscopy With Cysview® Registry|Recruiting||N/A|2000|Anticipated|Photocure|||1||f||||f||||||||||2017-10-10 22:32:12.040306|2017-10-10 22:32:12.040306
NCT02660632|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2016-01-16|||January 2016||2016-01-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Epidural Block vs. Rectus Sheath Block on Postoperative Pulmonary Function|Effect of Thoracic Epidural Analgesia vs Rectus Sheath Catheters on Postoperative Pulmonary Function After Midline Laparotomy: A Prospective Randomized Controlled Study|Recruiting||N/A|40|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:32:12.165099|2017-10-10 22:32:12.165099
NCT02660619|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-18||||||January 2016|2016-01-01||||May 2017|Anticipated|2017-05-01||Observational|||Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication|Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication|Active, not recruiting||N/A|600|Anticipated|Member Companies of the Opioid PMR Consortium|||2||f||||||||||||||2017-10-10 22:32:12.271236|2017-10-10 22:32:12.271236
NCT02660606|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-18||||||January 2016|2016-01-01||||November 2015|Actual|2015-11-01||Observational|POMAQ||A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire|A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ)|Completed||N/A|54|Actual|Member Companies of the Opioid PMR Consortium|||4||f||||||||||||||2017-10-10 22:32:12.360534|2017-10-10 22:32:12.360534
NCT02660593|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2016-04-26|||March 2016||2016-03-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy and Safety ofSanGrow Decoction for Patients With Diabetes|SanGrow Decoction in Patients With Diabetes- Single Center, Open, and Non-randomized Study|Recruiting||N/A|20|Anticipated|Shidaihuajing Institute for Diabetic Research||1|||f||||f||||||||No||2017-10-10 22:32:12.466012|2017-10-10 22:32:12.466012
NCT02660580|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2017-10-04|||February 16, 2016|Actual|2016-02-16|October 2017|2017-10-01|August 3, 2020|Anticipated|2020-08-03|December 31, 2016|Actual|2016-12-31||Interventional|AURIEL-PsO||MSB11022 in Moderate to Severe Chronic Plaque Psoriasis|A Randomized, Double-blind Trial to Evaluate the Efficacy, Safety and Immunogenicity of MSB11022 Compared With Humira® in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Active, not recruiting||Phase 3|458|Actual|EMD Serono||2|||f||||t||||||||||2017-10-10 22:32:12.574496|2017-10-10 22:32:12.574496
NCT02660567|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2016-01-20|||February 2016||2016-02-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Amr's Maneuver and Postpartum Hemorrhage|The Impacts of Using Amr's Maneuver (Cervical Traction) on Atonic Postpartum Hemorrhage; Multi-centre Randomized Controlled Study|Not yet recruiting||N/A|4866|Anticipated|ClinAmygate||2|||f||||t||||||||Yes||2017-10-10 22:32:12.857889|2017-10-10 22:32:12.857889
NCT02660554|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-09-21|||January 2016||2016-01-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||PCR to Guide Antibiotic Therapy for Pneumonia|A Randomized Clinical Trial to Compare Early Pneumonia Diagnosis Using Polymerase Chain Reaction to Usual Care in Critically Ill Adults|Recruiting||N/A|44|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 22:32:12.929224|2017-10-10 22:32:12.929224
NCT02660541|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-05-11|||June 21, 2016|Actual|2016-06-21|May 2017|2017-05-01|May 2017|Actual|2017-05-01|February 28, 2017|Actual|2017-02-28||Interventional|||Burn Wound Management of Betafoam® and Allevyn® Ag|A Pilot Study to Compare Efficacy of Allevyn® Silver Dressing and Betafoam® in Patients With Wound of Acute Burn Injury|Completed||N/A|32|Actual|Mundipharma Korea Ltd||2|||f||||t||||||||Undecided||2017-10-10 22:32:13.020376|2017-10-10 22:32:13.020376
NCT02660528|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-19|2017-07-11|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder|Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder: An Open-Label Trial|Recruiting||Phase 2|15|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 22:32:13.089762|2017-10-10 22:32:13.089762
NCT02660515|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-12-29|||January 2016||2016-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RADAR||Operative Treatment of Intra-Articular Distal Radius Fractures With Versus Without Wrist Arthroscopy|Operative Treatment of Intra-Articular Distal Radius Fractures With Versus Without Wrist Arthroscopy, a Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Maasstad Hospital||2|||f||||f||||||||||2017-10-10 22:32:13.178212|2017-10-10 22:32:13.178212
NCT02660502|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-05-27|||January 2016||2016-01-01|January 2016|2016-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects|A Double-blind, Comparator-controlled, Randomised, Three-period Crossover Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects|Completed||Phase 1|15|Actual|Adocia||4|||f||||f||||||||||2017-10-10 22:32:13.259915|2017-10-10 22:32:13.259915
NCT02660489|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-08-15|||October 2015||2015-10-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of OC459 on the Response to Rhinovirus Challenge in Asthma|Effect of the CRTH2 Antagonist OC459 on the Response to Rhinovirus Challenge in Asthma|Recruiting||Phase 2|28|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-10 22:32:13.341808|2017-10-10 22:32:13.341808
NCT02660476|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-06-01|||October 2014||2014-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|QUDOS||Qatar Universal Diabetes Outcomes (QUDOS) Study|Qatar Universal Diabetes Outcomes (QUDOS) Study|Recruiting||N/A|1700|Anticipated|Weill Cornell Medical College in Qatar|||2||f||||t||||||Samples With DNA|"     Blood, urine, saliva and stool samples   "|||2017-10-10 22:32:13.456235|2017-10-10 22:32:13.456235
NCT02660463|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-01-20|||January 2016||2016-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|30 Days|Observational [Patient Registry]|||Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany|Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany|Recruiting||N/A|500|Anticipated|Kerckhoff Klinik|||1||f||||f||||||||||2017-10-10 22:32:13.536016|2017-10-10 22:32:13.536016
NCT02660450|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-17|||February 2016||2016-02-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Interventional|||Relationship Between Aerobic Prescription Methods|Relationship Between Methods of Aerobic Prescription: Heart Rate vs. VO2 Load vs. Self Selected|Not yet recruiting||N/A|36|Anticipated|Universidade Federal do Rio de Janeiro||3|||f||||t||||||||Undecided||2017-10-10 22:32:13.664174|2017-10-10 22:32:13.664174
NCT02660437|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-07|||March 2016||2016-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|||pCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD|Carbon Dioxide Partial Pressure Oscillations During Exercise: Relation to Cerebral Blood Flow Regulation and and to the Prevalence of Cognitive Dysfunction in COPD|Recruiting||N/A|160|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||No||2017-10-10 22:32:13.769579|2017-10-10 22:32:13.769579
NCT02660424|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-10-03|||December 2015||2015-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee|A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee|Completed||Phase 2|124|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||||||||||||2017-10-10 22:32:13.949645|2017-10-10 22:32:13.949645
NCT02660411|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-09-04|||April 2015||2015-04-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|April 2020|Anticipated|2020-04-01||Interventional|||Impact of Anesthesia Maintenance Methods on Long-term Survival Rate|Impact of Inhalational Versus Intravenous Anesthesia Maintenance Methods on Long-term Survival Rate in Elderly Patients After Cancer Surgery: an Open-label, Randomized Controlled Trial|Recruiting||Phase 4|1200|Anticipated|Peking University First Hospital||2|||f||||t|t|f|||t|||||2017-10-10 22:32:14.087494|2017-10-10 22:32:14.087494
NCT02660398|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-19|||January 2016||2016-01-01|January 2016|2016-01-01||||January 2017|Anticipated|2017-01-01||Interventional|||Incidence and Severity of Residual Neuromuscular Blockade|Incidence and Severity of Residual Neuromuscular Blockade With Application of a Protocol for Paralysis and Neostigmine Reversal of Rocuronium|Recruiting||Phase 4|80|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-10 22:32:14.325223|2017-10-10 22:32:14.325223
NCT02660385|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-12-07|||October 2015||2015-10-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|HSS||Insomnia Self-Management in Heart Failure|Cognitive Behavioral Therapy for Insomnia: A Self-Management Strategy for Chronic Illness in Heart Failure|Recruiting||Phase 2/Phase 3|200|Anticipated|Yale University||2|||f||||t||||||||Undecided||2017-10-10 22:32:14.422909|2017-10-10 22:32:14.422909
NCT02660372|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-12-14|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia|A Multi-center, Randomized, Observer-blind, Parallel Group, 8-weeks Non-inferiority Clinical Trial to Compare the Efficacy and Safety of Two Brands of Simeticone for Symptomatic Treatment of Functional Dyspepsia in Adults|Completed||Phase 3|210|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||Undecided||2017-10-10 22:32:16.619469|2017-10-10 22:32:16.619469
NCT02660359|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-07-13|||July 2016||2016-07-01|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|September 2019|Anticipated|2019-09-01||Interventional|CONTENT2||Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2|A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis|Recruiting||Phase 3|408|Anticipated|Ipsen||4|||f||||t||||||||||2017-10-10 22:32:16.771731|2017-10-10 22:32:16.771731
NCT02660346|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-01-05|||November 2015||2015-11-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB|A Multi-center Prospective Randomized Open Label Study of Utilizing Interleukin 10 (IL-10) Levels as a Guide for Antibiotic Selection for Methicillin Resistant Staphylococcus Aureus Bacteremia|Recruiting||Phase 4|50|Anticipated|Sharp HealthCare||2|||f||||f||||||||No|We do not plan on sharing any IPD with other researchers until the study is complete.|2017-10-10 22:32:17.102873|2017-10-10 22:32:17.102873
NCT02660333|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-04-12|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Prebiotic or Synbiotic on Inflammatory Response and Indicators of Nutritional Status in Obesity|Effect of Prebiotic or Synbiotic Supplementation on Inflammatory Response and Indicators of Nutritional Status in Individuals With Morbid Obesity: A Randomized Clinical Trial, Placebo-controlled and Triple Blind|Recruiting||N/A|30|Anticipated|Universidade Federal de Santa Catarina||3|||f||||f||||||||Undecided||2017-10-10 22:32:17.347448|2017-10-10 22:32:17.347448
NCT02660320|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-03-30|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|Dermabrasion||Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin|Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin|Recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||Undecided||2017-10-10 22:32:17.476718|2017-10-10 22:32:17.476718
NCT02660307|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-01-23|||February 2014||2014-02-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||A Stress Reduction Program for Companies|A Randomized Controlled Trial With a Follow-up Evaluation of a Stress Reduction Program for Companies - PROGRESS|Completed||N/A|41|Actual|Centro de estudos em Atenção Plena||2|||f||||t||||||||Yes||2017-10-10 22:32:17.595449|2017-10-10 22:32:17.595449
NCT02660294|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2016-03-19|||March 2016||2016-03-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Intrauterine Autologous PRP Infusion Compared to HRT for Enhancing Endometrial Thickness in Patients Undergoing ICSI|Intrauterine Autologous Platelet -Enriched Plasma Infusion Compared to Hormonal Replacement Therapy for Enhancing Endometrial Thickness in Patients Undergoing ICSI|Recruiting||Phase 1/Phase 2|30|Anticipated|Ain Shams University||2|||f||||t||||||||Undecided||2017-10-10 22:32:17.689431|2017-10-10 22:32:17.689431
NCT02660281|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-06-01|||October 2015||2015-10-01|June 2017|2017-06-01|October 2026|Anticipated|2026-10-01|October 2025|Anticipated|2025-10-01||Interventional|HaploOnly||URMC Related Haplo-identical Donor BMT|Haploidentical Donor Hematopoietic Stem Cell Transplantation|Recruiting||Phase 1|50|Anticipated|University of Rochester||5|||f||||t||||||||||2017-10-10 22:32:17.789861|2017-10-10 22:32:17.789861
NCT02659332|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-20|||February 2015||2015-02-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Laser Treatment of Bladder Tumors in the Outpatient Department|Diode Laser Treatment of Pta Low Grade Bladder Tumors in the Outpatient Department|Enrolling by invitation||N/A|20|Anticipated|Bispebjerg Hospital||1|||f||||t||||||||||2017-10-10 22:32:26.030372|2017-10-10 22:32:26.030372
NCT02660268|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-10-25|||March 2016||2016-03-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|OSCAR-PH||Contribution of a Clinical Pathway for the Treatment of Hip Prosthesis Infections|Evaluation of the Implementation of a Clinical Pathway for Improving the Performance of Medical and Surgical Management of Hip Prosthesis Infections|Recruiting||N/A|192|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 22:32:17.933435|2017-10-10 22:32:17.933435
NCT02660255|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-05-02|||February 2016||2016-02-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Expanded Access|CBD||Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy|Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy|Available||N/A|||University of Nebraska|||||||||||||||||||2017-10-10 22:32:18.062861|2017-10-10 22:32:18.062861
NCT02660242|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-03-10|||January 2016||2016-01-01|March 2017|2017-03-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes|The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes|Completed||Phase 2|15|Actual|Jaeb Center for Health Research||4|||f||||f||||||||||2017-10-10 22:32:18.138645|2017-10-10 22:32:18.138645
NCT02660216|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-18|||November 2014||2014-11-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|MILF-I||A Modified Minimally Invasive Approach Towards Le Fort I Osteotomy: a Prospective Study||Active, not recruiting||N/A|20|Actual|AZ Sint-Jan AV|||1||f||||f||||||||No||2017-10-10 22:32:18.358098|2017-10-10 22:32:18.358098
NCT02660203|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-05-03|||May 2016||2016-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|KPDP||Impact of Forced Expiration On Pleural Drainage Duration (KPDP)|Impact of Ipsilateral Decubitus Forced Expiration On Duration of Pleural Drainage After Pulmonary Surgery in Children : Randomized Trial|Recruiting||N/A|140|Anticipated|University Hospital, Tours||2|||f||||f||||||||||2017-10-10 22:32:18.429223|2017-10-10 22:32:18.429223
NCT02660190|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-02-25|||February 2016||2016-02-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|August 2017|Anticipated|2017-08-01||Interventional|DaBlaCa-11||Photodynamic Diagnosis (PDD) in Flexible Cystoscopy|Photodynamic Diagnosis (PDD) in Flexible Cystoscopy - DaBlaCa-11|Recruiting||Phase 3|696|Anticipated|Aarhus University Hospital||2|||f||||t||||||||No||2017-10-10 22:32:18.575052|2017-10-10 22:32:18.575052
NCT02660177|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PPMS||Pharmacokinetics of Intravenous Metamizole in Children Less Than 6 Years Old|Single Center, Open-label, Prospective Study to Characterize the Pharmacokinetics of Metamizole and Its Metabolites Following Intravenous Administration in Children Less Than 6 Years Old|Recruiting||Phase 2|39|Anticipated|University Children's Hospital Basel||1|||f||||t||||||||No||2017-10-10 22:32:18.670674|2017-10-10 22:32:18.670674
NCT02660164|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-15|||November 2015||2015-11-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion|A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion|Recruiting||N/A|700|Anticipated|Jan Medical, Inc.|||2||f||||f||||||||||2017-10-10 22:32:18.7652|2017-10-10 22:32:18.7652
NCT02660151|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-11-27|||February 2016||2016-02-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema|Prospective, Randomized Crossover Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema|Recruiting||N/A|80|Anticipated|Eye-yon Medical||2|||f||||f||||||||Undecided||2017-10-10 22:32:18.912495|2017-10-10 22:32:18.912495
NCT02660138|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-07-13|||March 2016||2016-03-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|May 2019|Anticipated|2019-05-01||Interventional|CONTENT1||Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1|A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis|Recruiting||Phase 3|408|Anticipated|Ipsen||4|||f||||t||||||||||2017-10-10 22:32:19.110589|2017-10-10 22:32:19.110589
NCT02660125|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-17|2017-03-18|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Endometrial Injury and Implantation Rates Before First ICSI Cycle|Does Local Endometrial Injury Improve Implantation Rates in Women Undergoing Their First ICSI Cycle.|Completed||N/A|100|Actual|Cairo University||2|||f||||t||||||||Undecided||2017-10-10 22:32:19.440397|2017-10-10 22:32:19.440397
NCT02660112|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||(+) Epicatechin to Treat Friedreich's Ataxia|A Phase II, Open Label Prospective Single Center Drug Study Evaluating the Safety and Efficacy of (+)-Epicatechin in Subjects With Friedreich's Ataxia|Recruiting||Phase 2|10|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 22:32:19.520785|2017-10-10 22:32:19.520785
NCT02660099|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-09-05|||July 2015||2015-07-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Internet Delivered CBT for OCD in Adolescents With ASD - A Clinical Case Series|Internet Delivered Cognitive Behavior Therapy for Obsessive-compulsive Disorder in Adolescents With Autism Spectrum Disorder - A Clinical Case Series|Completed||N/A|4|Actual|Karolinska Institutet||1|||f||||f||||||||Undecided||2017-10-10 22:32:19.620668|2017-10-10 22:32:19.620668
NCT02660086|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|ChooseWell 365||Promoting Employee Health Through The Worksite Food Environment|Promoting Employee Health Through The Worksite Food Environment|Recruiting||N/A|600|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:32:19.742353|2017-10-10 22:32:19.742353
NCT02660073|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-08-01|||October 2015||2015-10-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Skeletal Muscle Hypertrophy and Cardio-Metabolic Benefits After Spinal Cord Injury|Skeletal Muscle Hypertrophy and Cardio-Metabolic Benefits After Spinal Cord Injury|Recruiting||N/A|48|Anticipated|United States Department of Defense||2|||f||||t||||||||||2017-10-10 22:32:19.848395|2017-10-10 22:32:19.848395
NCT02660060|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-17|||May 2015||2015-05-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mg|Bioequivalence Study of 0.25 mg Pramipexole Tablets Produced by PT Dexa Medica for PT Ferron Par Pharmaceuticals in Comparison With the Comparator Product (Sifrol® 0.25 mg Tablet, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany for Boehringer Ingelheim International, GmbH, Germany)|Completed||N/A|23|Actual|Dexa Medica Group||2|||f||||f||||||||No||2017-10-10 22:32:19.953038|2017-10-10 22:32:19.953038
NCT02660047|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-10-13|||August 2015||2015-08-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|MAGNA VICTORIA||Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent|Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus and South Asian Descent|Recruiting||Phase 4|50|Anticipated|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 22:32:20.052789|2017-10-10 22:32:20.052789
NCT02660034|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-13|||January 2016||2016-01-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|||The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Subjects With Advanced Solid Tumors|A Phase 1/1b, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics and Antitumor Activity of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Combination With the PARP Inhibitor BGB-290 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|230|Anticipated|BeiGene||2|||f||||||||||||||2017-10-10 22:32:20.218545|2017-10-10 22:32:20.218545
NCT02660021|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-18|||July 2010||2010-07-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|12 Months|Observational [Patient Registry]|3D-VIRTOG||Prospective Registry of 3-dimensional Virtual Treatment Planning of Orthognathic Surgery||Recruiting||N/A|1000|Anticipated|AZ Sint-Jan AV|||1||f||||f||||||||No||2017-10-10 22:32:20.337701|2017-10-10 22:32:20.337701
NCT02660008|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-06-14|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon|A Randomized, Double-blind Trial of Single Doses of ZP4207 Administered s.c. to Hypoglycemic Type 1 Diabetic Patients to Describe the Pharmacokinetics and Pharmacodynamics of ZP4207 as Compared to Marketed Glucagon|Completed||Phase 2|81|Actual|Zealand Pharma||2|||f||||f||||||||||2017-10-10 22:32:20.417376|2017-10-10 22:32:20.417376
NCT02659995|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-02|||February 2016||2016-02-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|||Relationship Between Blood Glucose Levels and Variability and Infections Development in Critically Ill Patient|Relationship Between Blood Glucose Levels and Variability and Infections Development in Critically Ill Patient|Recruiting||N/A|3300|Anticipated|Università Politecnica delle Marche|||1||f||||f||||||||||2017-10-10 22:32:20.524207|2017-10-10 22:32:20.524207
NCT02659982|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-08-01|||April 2015|Actual|2015-04-01|September 2016|2016-09-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Observational|||Evaluation of EarlySense Home Care Tele-monitoring Device -For Early Detection of Deterioration For Cardiac Patients at Home|Study Protocol for Evaluation of EarlySense Home Care Tele-monitoring Device - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion For Early Detection of Deterioration For Cardiac Patients at Home|Completed||N/A|50|Actual|EarlySense Ltd.|||1||f||||t||||||||||2017-10-10 22:32:20.634256|2017-10-10 22:32:20.634256
NCT02659956|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-06-30|||January 12, 2016||2016-01-12|December 6, 2016|2016-12-06|August 26, 2041|Anticipated|2041-08-26|February 26, 2041|Anticipated|2041-02-26||Observational|||Pathological Basis of MRI Signal Changes in Multiple Sclerosis|The Pathological Basis of MRI Signal Changes in Multiple Sclerosis: A Longitudinal In Vivo-to-Postmortem Study|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:32:20.70966|2017-10-10 22:32:20.70966
NCT02659943|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-20|2017-09-12|||January 12, 2016||2016-01-12|August 28, 2017|2017-08-28|December 1, 2021|Anticipated|2021-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies|T Cells Expressing a Fully-Human Anti-CD19 Chimeric Antigen Receptor for Treating B-cell Malignancies|Recruiting||Phase 1|64|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:32:20.797678|2017-10-10 22:32:20.797678
NCT02659917|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-01-20|||August 2008||2008-08-01|January 2016|2016-01-01|August 2010|Actual|2010-08-01|February 2009|Actual|2009-02-01||Interventional|||Performance of Glass-ionomer Cements: 2-year Follow-up|Performance of Glass-ionomer Cements in the Pit and Fissure Sealing and Atraumatic Restorative Treatment: a Randomized 2-year Clinical Trial|Completed||Phase 1|147|Actual|University of Campinas, Brazil||4|||f||||t||||||||No||2017-10-10 22:32:21.005651|2017-10-10 22:32:21.005651
NCT02659904|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-16|||February 2015||2015-02-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||The Quantitative Changes in Palatal Donor Sites Thickness After Free Gingival Graft Harvesting|The Quantitative Changes in Palatal Donor Sites Thickness After Free Gingival Graft Harvesting|Completed||Early Phase 1|40|Actual|Ondokuz Mayıs University||2|||f||||t||||||||||2017-10-10 22:32:21.221943|2017-10-10 22:32:21.221943
NCT02659891|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-04-19|||May 2016||2016-05-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||IVIg to Treat BK Viremia in Kidney Transplant Recipients|Immunoglobulin (Privigen®) Therapy to Treat BK Viremia and Prevent Alloimmune Activation in Kidney Transplant Recipients|Recruiting||Phase 1|60|Anticipated|Massachusetts General Hospital||2|||f||||||||||||||2017-10-10 22:32:21.333258|2017-10-10 22:32:21.333258
NCT02659878|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-03-08|||February 2015||2015-02-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Observational|||Takotsubo Cardiomyopathy in Patients Suffering From Acute Non-traumatic Subarachnoid Hemorrhage|Incidence, Influencing Factors and Outcome of Takotsubo Cardiomyopathy in Patients Suffering From Acute Non-traumatic Subarachnoid Hemorrhage|Recruiting||N/A|150|Anticipated|University of Debrecen|||1||f||||t||||||||||2017-10-10 22:32:21.46783|2017-10-10 22:32:21.46783
NCT02659865|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-18|2016-07-11|||January 2016||2016-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study of LY3039478 in Healthy Participants|A Single Ascending Dose Study for the Evaluation of the Effects of LY3039478 on the QT/Corrected QT Interval in Healthy Subjects and Pilot Relative Bioavailability|Completed||Phase 1|29|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:32:21.611837|2017-10-10 22:32:21.611837
NCT02659852|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-09-05|||January 2016||2016-01-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction|A Prospective Randomized Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction|Recruiting||N/A|70|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:32:21.728879|2017-10-10 22:32:21.728879
NCT02659839|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-16|2016-10-26|||July 2015||2015-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting|Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting: A Prospective Cohort Study|Completed||N/A|142|Actual|Pontificia Universidad Catolica de Chile|||1||f||||f||||||||Undecided||2017-10-10 22:32:21.824435|2017-10-10 22:32:21.824435
NCT02659826|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-01-15|||October 2015||2015-10-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Non-invasive Stimulation on Central Nervous System Excitability|Effects of Non-invasive Stimulation on Central Nervous System Excitability of Healthy Volunteers|Recruiting||N/A|15|Anticipated|Universidade Federal de Pernambuco||6|||f||||t||||||||||2017-10-10 22:32:21.910708|2017-10-10 22:32:21.910708
NCT02659813|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-25|||August 2016||2016-08-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|ArchWireRaCE||Orthodontic Archwire Effectiveness Trial|ArchWire-RaCE: Orthodontic Archwires: a Randomised Clinical Trial of Effectiveness|Not yet recruiting||N/A|64|Anticipated|University of Dundee||2|||f||||t||||||||No||2017-10-10 22:32:22.054218|2017-10-10 22:32:22.054218
NCT02659800|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-05-25|||November 2015||2015-11-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|November 2019|Anticipated|2019-11-01||Interventional|||IL-7 in Increasing Low CD4 Counts After Concurrent Radiation and Temozolomide Treatment in Patients With High Grade Gliomas|The Effect of IL-7 (CYT107) on CD4 Counts in Patients With High Grade Gliomas and Severe Treatment-Related CD4 Lymphopenia After Concurrent Radiation and Temozolomide|Suspended||N/A|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center||5||Drug expired, waiting on stability testing|f||||t||||||||Yes||2017-10-10 22:32:22.180273|2017-10-10 22:32:22.180273
NCT02659787|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-11-15|||June 2016||2016-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|BED||Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology|Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology|Recruiting||N/A|60|Anticipated|University of Chicago||3|||f||||f||||||||||2017-10-10 22:32:22.364175|2017-10-10 22:32:22.364175
NCT02659774|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-11-01|||January 2015||2015-01-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Smoking Cessation in Workplaces in Hong Kong [Phase II]|Assessing the Corporate Environment in Promoting Tobacco Control and Evaluation of a Smoking Cessation Programme in Workplaces in Hong Kong|Active, not recruiting||N/A|600|Anticipated|The University of Hong Kong||4|||f||||t||||||||||2017-10-10 22:32:22.484013|2017-10-10 22:32:22.484013
NCT02659761|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Interventional|TAISTR||Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs|A Prospective, Single Arm, Open-label 96 Week Observational Trial of the Tolerability, Adherence and Efficacy of a Dolutegravir/Abacavir/Lamivudine Single Tablet Regimen in HIV-1 Antibody Positive People Living With HIV With a History of Injection Drug Use Switching From Existing ART or Starting Treatment After Discontinuation of ART|Not yet recruiting||Phase 4|50|Anticipated|University College Dublin||1|||f||||t||||||||||2017-10-10 22:32:22.591063|2017-10-10 22:32:22.591063
NCT02659748|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|May 2016|Actual|2016-05-01||Interventional|DMFMHM||Milk Fat Intake and Metabolic Health Markers|Examining the Effects of Consuming a Diet Comprising of Milk Fat on Metabolic Health Markers|Active, not recruiting||N/A|21|Actual|University of Vermont Medical Center||2|||f||||t||||||||Yes||2017-10-10 22:32:22.699391|2017-10-10 22:32:22.699391
NCT02659735|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-07-04|||December 2015||2015-12-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation|A Phase 1, Open-label, 2-panel, Randomized, Crossover Study in Healthy Adult Subjects to Assess the Relative Oral Bioavailability of a Single 600-mg Dose of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation, Under Fed and Fasted Conditions|Completed||Phase 1|90|Actual|Janssen Research & Development, LLC||10|||f||||f||||||||||2017-10-10 22:32:22.794333|2017-10-10 22:32:22.794333
NCT02659722|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-11-01|||January 2014||2014-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Observational|||InterFuse® S and T for the Treatment of Scoliosis, Spondylolisthesis and Degenerative Disc Disease (DDD)|A Multi-Center Prospective Study of Vertebral Technologies, Inc. (VTI) InterFuse® S and InterFuse® T for the Treatment of Scoliosis, Spondylolisthesis and Degenerative Disc Disease.|Recruiting||N/A|200|Anticipated|Vertebral Technologies, Inc.|||1||f||||t||||||||Yes|Presentations by investigator(s) at scientific meetings, submission of manuscript to peer reviewed journal|2017-10-10 22:32:22.937888|2017-10-10 22:32:22.937888
NCT02659709|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-08|||June 2015||2015-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|GlaucomaApp||Electronic Applications for Patients With Glaucoma|A Smartphone- and Tablet-Based Application for Patients With Glaucoma|Completed||N/A|100|Actual|Wills Eye||1|||f||||f||||||||Yes||2017-10-10 22:32:23.046707|2017-10-10 22:32:23.046707
NCT02659683|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-02-02|||May 2011||2011-05-01|November 2015|2015-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions|An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE of Esomeprazole Mg DR Capsule 40 mg [Torrent,India] Versus Nexium 40 mg DR Capsule [ AastraZeneca LP, USA] in Healthy Subjects-Fasted Condition.|Completed||Phase 1|54|Actual|Torrent Pharmaceuticals Limited||2|||f||||t||||||||No||2017-10-10 22:32:23.199502|2017-10-10 22:32:23.199502
NCT02659670|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-11-01|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Internet Surveys and Their Impact on Adherence to Brimonidine Topical Gel and QOL in Patients With Rosacea|Internet Surveys and Their Impact on Adherence to Brimonidine Topical Gel and QOL in Patients With Rosacea|Recruiting||Phase 4|20|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-10 22:32:23.277141|2017-10-10 22:32:23.277141
NCT02659657|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-11-28|||March 2016||2016-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prophylaxis Roles of IL-2 Treatment on Acute GVHD After Transplantation|Prophylaxis Roles of Low Dose of IL-2 Treatment on Acute GVHD After Haploidentical Transplantation|Recruiting||Phase 2|70|Anticipated|Peking University People's Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:32:23.376155|2017-10-10 22:32:23.376155
NCT02659644|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-01-19|||December 2015||2015-12-01|January 2016|2016-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of Oral L-citrulline in Sickle Cell Disease|A Phase I Dose-Ranging Study of Oral L-citrulline in Steady-State Sickle Cell|Recruiting||Phase 1|16|Anticipated|University of Mississippi Medical Center||1|||f||||t||||||||No||2017-10-10 22:32:23.487566|2017-10-10 22:32:23.487566
NCT02659631|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-28|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||PF-06671008 Dose Escalation Study in Advanced Solid Tumors|A Phase 1 Dose Escalation Study Evaluating The Safety And Tolerability Of Pf-06671008 In Patients With Advanced Solid Tumors|Recruiting||Phase 1|110|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 22:32:23.57885|2017-10-10 22:32:23.57885
NCT02659618|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-26|||April 2016||2016-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma|Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma|Enrolling by invitation||N/A|30|Anticipated|Rush University Medical Center|||1||f||||f||||||Samples Without DNA|"     Venous blood and serum will be drawn and shipped to Genentech for analysis.   "|||2017-10-10 22:32:23.696869|2017-10-10 22:32:23.696869
NCT02659605|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-19|||January 2016||2016-01-01|January 2016|2016-01-01||||January 2017|Anticipated|2017-01-01||Interventional|CLAMP||Cord Clamping Level Above or Below Mother's Perineum|Cord Clamping Level Above or Below Mother's Perineum|Not yet recruiting||N/A|64|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-10-10 22:32:23.770094|2017-10-10 22:32:23.770094
NCT02659592|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-19|||January 2004||2004-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Transplantation of Frozen Thawed Ovarian Tissue High Reproductive Performance|Transplantation of Frozen Thawed Ovarian Tissue Demonstrates High Reproductive Performance and the Need to Revise Restrictive Criteria|Completed||Phase 3|20|Actual|Sheba Medical Center||1|||f||||f||||||||No||2017-10-10 22:32:23.868639|2017-10-10 22:32:23.868639
NCT02659579|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-10-26|||February 2016||2016-02-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluating the Effectiveness of the Reader Organisation's Get Into Reading Intervention|Evaluating the Effectiveness of the Reader Organisation's Get Into Reading Intervention|Active, not recruiting||N/A|100|Anticipated|University of Liverpool||2|||f||||f||||||||Yes|With the consent of participating adults, the data will be donated to the UK data archive.|2017-10-10 22:32:23.93783|2017-10-10 22:32:23.93783
NCT02659566|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-06-30|||January 12, 2016||2016-01-12|February 27, 2017|2017-02-27|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, Mali|Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Ouelessebougou, Mali|Not yet recruiting||N/A|700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:32:24.026772|2017-10-10 22:32:24.026772
NCT02659553|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-12|||January 2015||2015-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Impact of Graft Steatosis on Post-operative Complications After Liver Transplantation|Impact of Graft Steatosis on Post-operative Complications After Liver Transplantation|Completed||N/A|271|Actual|Sohag University|||3||f||||t||||||||Undecided||2017-10-10 22:32:24.106275|2017-10-10 22:32:24.106275
NCT02659540|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-10-04|||July 2016||2016-07-01|October 2016|2016-10-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Pilot Study to Evaluate the Safety and Efficacy of Combination Checkpoint Blockade Plus External Beam Radiotherapy in Subjects With Stage IV Melanoma|A Pilot (Phase 1) Study to Evaluate the Safety and Efficacy of Combination Checkpoint Blockade (Ipilimumab and Nivolumab) Plus External Beam Radiotherapy in Subjects With Stage IV Melanoma|Recruiting||Phase 1|18|Anticipated|Ludwig Institute for Cancer Research||2|||f||||f||||||||||2017-10-10 22:32:24.200241|2017-10-10 22:32:24.200241
NCT02659527|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-09-13|||January 2016||2016-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PET/MRI in Patients With Suspected Prostate Cancer|Randomized Assessment of Patients With Clinically Suspected Prostate Cancer After Multiparametric Metabolic Hybrid Imaging to Evaluate Its Potential Clinical Domain: A Prospective, Randomized, Multi-arm, Multi-treatment Clinical Trial|Recruiting||Phase 3|220|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 22:32:24.296221|2017-10-10 22:32:24.296221
NCT02659514|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-07|||February 2016||2016-02-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Poziotinib in Patients With HER2-Positive Metastatic Breast Cancer|A Phase 2 Study of Poziotinib in Patients With HER2-Positive Metastatic Breast Cancer (MBC) Who Have Received Prior HER2 Regimens for MBC|Recruiting||Phase 2|70|Anticipated|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||No||2017-10-10 22:32:24.370158|2017-10-10 22:32:24.370158
NCT02659501|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-09-11|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|September 2016|Actual|2016-09-01||Interventional|||Liposomal Bupivacaine in Implant Based Breast Reconstruction|Liposomal Bupivacaine in Implant Based Breast Reconstruction|Completed||N/A|24|Actual|Loma Linda University||2|||f||||f||||||||||2017-10-10 22:32:24.625481|2017-10-10 22:32:24.625481
NCT02659488|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-15|||September 2015||2015-09-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects|Effect of Lisdexamfetamine on Prefrontal Brain Dysfunction in Binge Eating Disorder|Recruiting||Phase 2|40|Anticipated|Lindner Center of HOPE||1|||f||||f||||||||Yes|Study will be published in a peer-reviewed journal|2017-10-10 22:32:24.764096|2017-10-10 22:32:24.764096
NCT02659475|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-09-19|||September 2015||2015-09-01|January 2016|2016-01-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)|Open-label Phentermine/Topiramate Extended Release (PHEN/TPM ER; Qsymia®) in Ten Subjects With Overweight or Obesity and DSM-V Binge Eating Disorder (BED)|Completed||Phase 2|10|Actual|Lindner Center of HOPE||1|||f||||f||||||||||2017-10-10 22:32:24.861377|2017-10-10 22:32:24.861377
NCT02659462|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2016-01-19|||October 2015||2015-10-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|||Cardio Pulmonary Exercise Testing in Patients Post the Fontan Palliation in Comparison With Patients With Repaired Congenital Heart Disease and Healthy Volunteers.|Cardio Pulmonary Exercise Testing in Patients Post the Fontan Palliation in Comparison With Patients With Repaired Congenital Heart Disease and Healthy Volunteers.|Enrolling by invitation||N/A|45|Anticipated|Rambam Health Care Campus|||3||f||||f||||||||||2017-10-10 22:32:24.951562|2017-10-10 22:32:24.951562
NCT02659449|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-06-22|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|EvICoMaB||Assessing the Impact of Different Compression of the Hand Versus Free Hand on the Implementation of the Precision Grip|Assessing the Impact of Different Compression of the Hand (Made to Measure Gloves / Compression Bandaging) Versus Free Hand on the Implementation of the Precision Grip|Recruiting||N/A|50|Anticipated|Hôpital Léon Bérard|||1||f||||f||||||||||2017-10-10 22:32:25.051993|2017-10-10 22:32:25.051993
NCT02659436|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-12-28|||January 2016||2016-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Imagery-based CBT for Social Anxiety Disorder: Piloting a Treatment Augmentation Protocol|Imagery-based CBT for Social Anxiety Disorder: Piloting a Treatment Augmentation Protocol|Completed||N/A|9|Actual|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-10 22:32:25.142372|2017-10-10 22:32:25.142372
NCT02659423|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-01-24|||January 2016||2016-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Multi-College Bystander Efficacy Evaluation|Growing Researcher and College Communities Supporting Violence Prevention Research|Enrolling by invitation||N/A|24|Anticipated|University of Kentucky|||3||f||||f||||||||No||2017-10-10 22:32:25.245821|2017-10-10 22:32:25.245821
NCT02659410|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-19|||November 2015||2015-11-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|August 2016|Anticipated|2016-08-01||Interventional|||Impact of Thermal Stress on Pulmonary Absorption and Toxicokinetics of 3 Organic Solvents|Studying the Impact of Thermal Stress (Heat) Representative of Occupational Settings on Pulmonary Absorption and Toxicokinetics of 3 Organic Solvents|Recruiting||N/A|5|Anticipated|Université de Montréal||1|||f||||f||||||||||2017-10-10 22:32:25.341354|2017-10-10 22:32:25.341354
NCT02659397|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-12-20||2016-12-14|December 2015||2015-12-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg|A Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Adding ETC-1002 180 mg to Atorvastatin 80 mg Background Therapy in Statin-Treated Patients|Completed||Phase 2|68|Actual|Esperion Therapeutics||2|||f||||f||||||||Undecided||2017-10-10 22:32:25.492697|2017-10-10 22:32:25.492697
NCT02659384|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01||||January 2021|Anticipated|2021-01-01||Interventional|||Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer|A Phase II Study of the Anti-PDL1 Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid to Investigate Safety and Efficacy of This Combination in Recurrent Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma|Recruiting||Phase 2|160|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||5|||f||||t||||||||||2017-10-10 22:32:25.647781|2017-10-10 22:32:25.647781
NCT02659371|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-08-03|||January 2015||2015-01-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|January 2015|Actual|2015-01-01||Interventional|MAMMARED||Weight Loss Prior Mamma Reduction - A Pilot Study|Weight Loss by Low Energy Diet as Treatment Prior Mamma Reduction in Overweight Women - A Pilot Study|Completed||N/A|6|Actual|Copenhagen University Hospital at Herlev||1|||f||||f||||||||||2017-10-10 22:32:25.754403|2017-10-10 22:32:25.754403
NCT02659358|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-09-20|||January 24, 2016|Actual|2016-01-24|September 2017|2017-09-01|August 24, 2017|Actual|2017-08-24|August 24, 2017|Actual|2017-08-24||Observational|||Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer|The Biosensor Study: Exploratory Study Evaluating the Use of Wearable Biosensors and Patient Reported Outcomes (PROs) to Assess Performance Status and Distress in Patients With Cancer|Completed||N/A|37|Actual|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 22:32:25.83821|2017-10-10 22:32:25.83821
NCT02659345|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-01-25|||May 2015||2015-05-01|January 2017|2017-01-01|January 25, 2017|Actual|2017-01-25|January 25, 2016|Actual|2016-01-25||Interventional|||Evaluating the Effectiveness of Art Therapy on Mood, Anxiety, and Pain Levels in Cancer Patients|Evaluating the Effectiveness of Art Therapy on Mood, Anxiety, and Pain Levels in Cancer Patients Undergoing Chemotherapy Treatment|Completed||N/A|50|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-10 22:32:25.944519|2017-10-10 22:32:25.944519
NCT02659306|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-09-12|||September 2016||2016-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|||Metformin Immunotherapy in HIV Infection|The Effect of Metformin on HIV Reservoir Size in Non-diabetic Antiretroviral Therapy (ART) Treated Participants: the Lilac Study|Recruiting||Phase 1|22|Anticipated|McGill University Health Center||1|||f||||t||||||||||2017-10-10 22:32:26.274845|2017-10-10 22:32:26.274845
NCT02659293|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-21|||April 26, 2016|Actual|2016-04-26|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma|Phase 3 Randomized Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma|Recruiting||Phase 3|180|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-10 22:32:26.388545|2017-10-10 22:32:26.388545
NCT02659280|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-14|||March 16, 2016|Actual|2016-03-16|September 2017|2017-09-01|November 10, 2017|Anticipated|2017-11-10|October 24, 2017|Anticipated|2017-10-24||Interventional|TELE||"Using Store and Forward Tele-health as an Adjunct to Traditional Outpatient or Home Health Physical Therapy"|"Using Store and Forward Tele-health as an Adjunct to Traditional Outpatient or Home Health Physical Therapy"|Active, not recruiting||N/A|47|Actual|Minneapolis Medical Research Foundation||2|||f||||f||||||||||2017-10-10 22:32:26.522005|2017-10-10 22:32:26.522005
NCT02659267|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-04-06|||October 2014||2014-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|VAMOS||Evaluation of a Strategy Designed to Promote Physical and Healthy Eating|"Evaluation of a Strategy Designed to Promote Physical and Healthy Eating Between Users of the Health Academy Program in Belo Horizonte, Minas Gerais - VAMOS BEAGÁ"|Completed||N/A|256|Actual|Universidade Federal de Santa Catarina||2|||f||||f||||||||Undecided||2017-10-10 22:32:26.648805|2017-10-10 22:32:26.648805
NCT02659254|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-07-10|||January 2016||2016-01-01|September 2016|2016-09-01|October 2021|Anticipated|2021-10-01|May 2016|Actual|2016-05-01||Interventional|FUTURE-I||A First-in-Man Study of the Firesorb BVS (FUTURE-I)|A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease: FUTURE-I|Active, not recruiting||N/A|45|Actual|Shanghai MicroPort Medical (Group) Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:32:26.760036|2017-10-10 22:32:26.760036
NCT02659241|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-03-16|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Pilot Study of Induction Wee1 Inhibition in Ovarian Cancer|A Pilot Study of Wee1 Inhibition Induction Prior to Tumor Reductive Surgery in Ovarian Cancer|Recruiting||Early Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:32:26.874357|2017-10-10 22:32:26.874357
NCT02659228|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-25|||December 2016||2016-12-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|||Assessing Covert Consciousness in Unresponsive Patients|Assessing the Potential for 'Covert Consciousness' in Unresponsive Patients|Not yet recruiting||N/A|60|Anticipated|University of Michigan||3|||f||||||||||||||2017-10-10 22:32:26.979092|2017-10-10 22:32:26.979092
NCT02659215|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-09-29|||December 2015||2015-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|FastTRACK||HyaloFAST Trial for Repair of Articular Cartilage in the Knee|A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast® With BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control|Recruiting||N/A|200|Anticipated|Anika Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 22:32:27.058581|2017-10-10 22:32:27.058581
NCT02659202|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-14|||January 2016||2016-01-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Spinal Stimulation During Exercise in Heart Failure|Spinal Cord Stimulation to Inhibit Afferent Feedback During Exercise in Heart Failure|Recruiting||N/A|40|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:32:27.201535|2017-10-10 22:32:27.201535
NCT02659189|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-01-19|||March 2016||2016-03-01|January 2016|2016-01-01|January 2020|Anticipated|2020-01-01|December 2016|Anticipated|2016-12-01|3 Years|Observational [Patient Registry]|||Hospitalary Chronic Obstructive Pulmonary Disease Registry|Hospitalary Chronic Obstructive Pulmonary Disease Registry|Not yet recruiting||N/A|300|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-10 22:32:27.278272|2017-10-10 22:32:27.278272
NCT02659176|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-03-14|||January 2011||2011-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Trans-perineal Repair With or Without Limited Internal Sphincterotomy for Treatment of Type I Anterior Rectocele|Comparative Study Between Trans-perineal Repair With or Without Limited Internal Sphincterotomy in Treatment of Type I Anterior Rectocele: A Randomized Controlled Trial|Completed||N/A|60|Actual|Mansoura University||2|||f||||t||||||||No||2017-10-10 22:32:27.346085|2017-10-10 22:32:27.346085
NCT02659163|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|STRIVE||An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease|An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease|Not yet recruiting||Early Phase 1|68|Anticipated|Massachusetts General Hospital||2|||f||||f|f|f||||||||2017-10-10 22:32:27.413892|2017-10-10 22:32:27.413892
NCT02659150|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-04-25|||May 18, 2016|Actual|2016-05-18|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis|A Multicenter, Open-Label, Proof-of-Activity Study of the Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis|Enrolling by invitation||Phase 4|21|Anticipated|Massachusetts General Hospital||1|||f||||f|t|f|||t|||No||2017-10-10 22:32:27.530447|2017-10-10 22:32:27.530447
NCT02659137|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-14|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|HESITATE||HV Electrophysiology Study In Transcatheter Aortic Valve Implantation Patients|HV Electrophysiology Study In Transcatheter Aortic Valve Implantation Patients|Recruiting||N/A|100|Anticipated|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-10 22:32:27.601957|2017-10-10 22:32:27.601957
NCT02659124|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-05-02||||||May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|April 2017|Anticipated|2017-04-01||Interventional|||Comparison of AmnioFix Laser and Standard of Care Treatment|Comparison of AmnioFix Laser and Standard of Care in Patients Seeking Laser Facial Treatment|Withdrawn||N/A|0|Actual|University of California, San Francisco||1||The current protocol did not satisfy IRB requirements|f||||f||||||||No||2017-10-10 22:32:27.666145|2017-10-10 22:32:27.666145
NCT02659111|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-09-06|||January 2016||2016-01-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|iNPhys||Effects of Physical Training in iNPH|Effects of Physical Training in Shunt-operated Patients With Idiopathic Normal Pressure Hydrocephalus|Recruiting||N/A|128|Anticipated|Linkoeping University||2|||f||||f||||||||||2017-10-10 22:32:27.733232|2017-10-10 22:32:27.733232
NCT02659098|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-06-30|||March 21, 2016|Actual|2016-03-21|June 2017|2017-06-01|November 30, 2022|Anticipated|2022-11-30|December 29, 2018|Anticipated|2018-12-29||Interventional|PRELUDE||A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy|A Phase 2b, Multicenter, Double-masked, Randomized Study Evaluating the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Subjects With Visual Acuity Impairment Associated With Geographic Atrophy Secondary to Age Related Macular Degeneration|Recruiting||Phase 2|285|Anticipated|Janssen Research & Development, LLC||4|||f||||t||f||||||||2017-10-10 22:32:27.819876|2017-10-10 22:32:27.819876
NCT02659085|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-08-08|||February 2015||2015-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder|A Randomized Controlled Non-inferiority Trial Comparing Ketamine With ECT in Patients With Major Depressive Disorder|Recruiting||Phase 2/Phase 3|200|Anticipated|Region Skane||2|||f||||t||||||||||2017-10-10 22:32:27.938171|2017-10-10 22:32:27.938171
NCT02659072|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-03-16|||January 2016||2016-01-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|PREEV||Infectious Risk of Vaginal Ultrasound Examination: Evaluation and Modeling From Human Papillomavirus (HPV)|Infectious Risk of Vaginal Ultrasound Examination: Evaluation and Modeling From Human Papillomavirus (HPV)|Recruiting||N/A|1000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 22:32:28.028784|2017-10-10 22:32:28.028784
NCT02659059|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-07-24|||February 10, 2016|Actual|2016-02-10|July 2017|2017-07-01|January 24, 2022|Anticipated|2022-01-24|June 9, 2019|Anticipated|2019-06-09||Interventional|CheckMate 568||Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs. Chemotherapy Alone (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer|A Study of Nivolumab in Combination With Ipilimumab (Part 1); and Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs. Chemotherapy Alone (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|450|Anticipated|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 22:32:28.109444|2017-10-10 22:32:28.109444
NCT02659046|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-03-22|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Severe Traumatic Brain Injury|The Effect of Different Emergency Medical Systems on the Prognosis of Traumatic Brain Injury|Completed||N/A|266|Actual|Tampere University Hospital|||2||f||||f||||||||No||2017-10-10 22:32:28.799907|2017-10-10 22:32:28.799907
NCT02659033|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-05-22|||March 2016||2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|CEREMI||Impact of the Choice of 3rd Generation Cephalosporins on the Emergence of Resistance in the Microbiota Intestinal.|Impact of the Choice of 3rd Generation Cephalosporins on the Emergence of Resistance in the Microbiota Intestinal.|Active, not recruiting||Phase 3|22|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-10 22:32:28.920895|2017-10-10 22:32:28.920895
NCT02659020|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-10-04|||March 2016||2016-03-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|August 2019|Anticipated|2019-08-01||Interventional|ANNOUNCE 2||A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma|A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma|Recruiting||Phase 1/Phase 2|310|Anticipated|Eli Lilly and Company||3|||f||||t||||||||||2017-10-10 22:32:29.097868|2017-10-10 22:32:29.097868
NCT02659007|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-15|||September 2014||2014-09-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|LeNY||Less Neuropathy After Yoga- Managing Diabetic Neuropathy With Yoga|Less Neuropathy After Yoga|Completed||Phase 1|15|Actual|Colorado State University||1|||f||||f||||||||No||2017-10-10 22:32:29.510731|2017-10-10 22:32:29.510731
NCT02658994|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-21|||October 2014||2014-10-01|January 2016|2016-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|THPP+||Thinking Healthy Program Peer Delivered Plus|Thinking Healthy Program - Peer Delivered in Pakistan - Child-Focused|Recruiting||N/A|560|Anticipated|Human Development Research Foundation, Pakistan||2|||f||||t||||||||||2017-10-10 22:32:29.593914|2017-10-10 22:32:29.593914
NCT02658981|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-08-28|||August 2016||2016-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Anti-LAG-3 or Urelumab Alone and in Combination With Nivolumab in Treating Patients With Recurrent Glioblastoma|A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination With Anti-PD-1 in Patients With Recurrent GBM|Recruiting||Phase 1|68|Anticipated|Sidney Kimmel Comprehensive Cancer Center||4|||f||||t||||||||||2017-10-10 22:32:29.692215|2017-10-10 22:32:29.692215
NCT02658968|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-04-06|||January 2016||2016-01-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)|A Phase 1 Dose Finding Study of Lutetium (177Lu)-Lilotomab Satetraxetan (Betalutin®) in Patients With Relapsed/Refractory, Diffuse Large B-cell Lymphoma, Not Eligible for Autologous Stem Cell Transplant|Recruiting||Phase 1|18|Anticipated|Nordic Nanovector||1|||f||||f|t|f||||||No||2017-10-10 22:32:29.892941|2017-10-10 22:32:29.892941
NCT02658955|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-09|||June 2016||2016-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PHACPA||Changing Technique of Abdominal Wall Closure (PHACPA)|Changing Technique of Abdominal Wall Closure According to European Hernia Society (EHS) Guidelines in a General Hospital|Recruiting||N/A|400|Anticipated|Hospital del Mar||2|||f||||f||||||||||2017-10-10 22:32:30.052544|2017-10-10 22:32:30.052544
NCT02658942|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-19|||May 2010||2010-05-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2012|Actual|2012-05-01||Interventional|||Flexible Ureteroscopy Versus ESWL in the Management of Lower Calyceal Stones|Flexible Ureteroscopy Versus ESWL in the Management of Lower Calyceal Stones: A Prospective Randomized Study|Completed||N/A|60|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 22:32:30.149644|2017-10-10 22:32:30.149644
NCT02658929|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-12|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of bb2121 in Multiple Myeloma|A Phase 1 Study of bb2121 in BCMA-Expressing Multiple Myeloma|Recruiting||Phase 1|50|Anticipated|Celgene||1|||f||||f||||||||||2017-10-10 22:32:30.26545|2017-10-10 22:32:30.26545
NCT02658916|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-09-20|||February 19, 2016|Actual|2016-02-19|September 2017|2017-09-01|December 21, 2020|Anticipated|2020-12-21|August 31, 2020|Anticipated|2020-08-31||Interventional|||Extension Study of BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in CN002003|A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients With Progressive Supranuclear Palsy Who Participated in Study CN002003|Active, not recruiting||Phase 1|48|Actual|Biogen||3|||f||||f||||||||||2017-10-10 22:32:30.439519|2017-10-10 22:32:30.439519
NCT02658903|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-01-19|||January 2016||2016-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter|Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter|Recruiting||Phase 1|54|Anticipated|Oxys Medical AG||2|||f||||f||||||||||2017-10-10 22:32:30.542249|2017-10-10 22:32:30.542249
NCT02658890|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-10-02|||February 18, 2016|Actual|2016-02-18|October 2017|2017-10-01|February 28, 2020|Anticipated|2020-02-28|April 29, 2019|Anticipated|2019-04-29||Interventional|||An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread.|A Phase 1/2a Study of BMS-986205 Administered in Combination With Nivolumab (Anti-PD-1 Monoclonal Antibody) and in Combination With Both Nivolumab and Ipilimumab (Anti-CTLA-4 Monoclonal Antibody) in Advanced Malignant Tumors|Recruiting||Phase 1/Phase 2|907|Anticipated|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 22:32:30.671386|2017-10-10 22:32:30.671386
NCT02658877|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-09-05|||January 2016||2016-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Sputum-derived Cellular Targets After Xolair (Omalizumab)|In Situ Analysis of Sputum-derived Cellular Targets After Xolair (Omalizumab).|Recruiting||Phase 4|30|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:32:30.975343|2017-10-10 22:32:30.975343
NCT02658864|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-19|||April 2005||2005-04-01|January 2016|2016-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets|Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets in Healthy Chinese Subjects|Completed||Phase 1|12|Actual|Wuhan Union Hospital, China||3|||f||||t||||||||||2017-10-10 22:32:31.151272|2017-10-10 22:32:31.151272
NCT02658851|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-09-08|||June 2016||2016-06-01|September 2017|2017-09-01|June 27, 2017|Actual|2017-06-27|June 27, 2017|Actual|2017-06-27||Interventional|||Cold Plasma for the Reduction of Lymphoceles Following PLND|Application of Cold Plasma Energy for Reduction of Lymphoceles Following Pelvic Lymph Node Dissection During Robot-Assisted Radical Prostatectomy|Completed||N/A|100|Actual|Bovie Medical Corporation||1|||f||||f||t|f|f|f|||||2017-10-10 22:32:31.221192|2017-10-10 22:32:31.221192
NCT02658838|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-19|||April 2015||2015-04-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|August 2016|Anticipated|2016-08-01||Interventional|||The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI|The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI|Unknown status|Active, not recruiting|Phase 4|300|Anticipated|Beijing Anzhen Hospital||3|||f||||t||||||||||2017-10-10 22:32:31.307735|2017-10-10 22:32:31.307735
NCT02658825|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-06-15|||January 2016||2016-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants|A Double-blind, Double-dummy, Randomized, 3-Period Cross-over, Placebo- and Positive-controlled Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Subjects|Completed||Phase 1|66|Actual|Janssen Research & Development, LLC||8|||f||||f||||||||||2017-10-10 22:32:31.406824|2017-10-10 22:32:31.406824
NCT02658812|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-09-14|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Talimogene Laherparepvec (T-VEC) for Breast Cancer Local Recurrence|A Phase II Study Using Talimogene Laherparepvec as a Single Agent for Inflammatory Breast Cancer (IBC) or Non-IBC Patients With Inoperable Local Recurrence|Recruiting||Phase 2|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:32:31.530575|2017-10-10 22:32:31.530575
NCT02658799|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-09|2016-01-19|||January 2000||2000-01-01|January 2016|2016-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Effects of a Cyclic NSAID Regimen on Levels of GCF PGE-E2 and IL-1beta|A Cyclic Regimen of Diclofenac Potassium May be Efficacious in the Management of Chronic Periodontitis in Adults|Completed||Phase 2|49|Actual|Baskent University||2|||f||||t||||||||Undecided||2017-10-10 22:32:31.64915|2017-10-10 22:32:31.64915
NCT02658786|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-08-16|||January 2016||2016-01-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease|Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease: A Hospital Based Retrospective Followed by Prospective Cohort Study|Recruiting||N/A|3000|Anticipated|Institute of Liver and Biliary Sciences, India|||3||f||||f||||||||No||2017-10-10 22:32:31.749718|2017-10-10 22:32:31.749718
NCT02658773|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-08-07|||January 2016||2016-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Lidocaine-prilocaine Cream on IUD Insertion Pain|Effect of Cervical Lidocaine-prilocaine Cream on IUD Insertion Pain: A Randomized Controlled Trial|Completed||Phase 2|120|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:32:31.822162|2017-10-10 22:32:31.822162
NCT02658760|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-10-12|||June 2015||2015-06-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Dexmedetomidine and Bupivacaine With Bupivacaine in Ultrasonography Guided Fascia Iliaca Compartment Block in Adults|Comparison of Dexmedetomidine and Bupivacaine With Bupivacaine Alone on the Quality of Ultrasonography Guided Fascia Iliaca Compartment Block in Adults Undergoing Femur Fracture Fixation Surgery|Recruiting||Phase 3|60|Anticipated|Hormozgan University of Medical Sciences||2|||f||||t||||||||No||2017-10-10 22:32:31.893678|2017-10-10 22:32:31.893678
NCT02658565|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-01-10|||January 2016||2016-01-01|December 2016|2016-12-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation|Surgical Staging for the Treatment of Endometrial Cancer Based on IOC|Recruiting||Phase 2|400|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-10 22:32:37.181039|2017-10-10 22:32:37.181039
NCT02658747|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2017-05-03|||May 25, 2016|Actual|2016-05-25|May 2017|2017-05-01|July 25, 2016|Actual|2016-07-25|July 25, 2016|Actual|2016-07-25||Observational|||Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK|A Retrospective Chart Review to Describe the Rate of Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK|Completed||N/A|120|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:32:31.997006|2017-10-10 22:32:31.997006
NCT02658721|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-15|||January 2013||2013-01-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Systemic or Adjunct Tramadol Addition to Lidocaine Used for IVRA in Patients Undergoing Hand Surgery|Effects of Addition of Systemic Tramadol or Adjunct Tramadol to Lidocaine Used for Intravenous Regional Anesthesia in Patients Undergoing Hand Surgery|Completed||Phase 3|60|Actual|Bagcilar Training and Research Hospital||3|||f||||f||||||||||2017-10-10 22:32:34.894542|2017-10-10 22:32:34.894542
NCT02658708|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-22|||October 12, 2015|Actual|2015-10-12|September 2017|2017-09-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|||Bright Light on Fatigue in Women Being Treated for Breast Cancer|Bright Light on Fatigue in Women Being Treated for Breast Cancer: A Pilot Study|Completed||Phase 1|19|Actual|Washington University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:32:35.032556|2017-10-10 22:32:35.032556
NCT02658695|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-01-21|||April 2015||2015-04-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01|8 Weeks|Observational [Patient Registry]|||Evaluation of the Relationship Between Air Bubbles Depth and Pregnancy Rate in ICSI Cycles|Evaluation of the Relationship Between Air Bubbles Depth and Pregnancy Rate in ICSI Cycles|Recruiting||N/A|82|Anticipated|Ain Shams Maternity Hospital|||2||f||||t||||||||||2017-10-10 22:32:35.201463|2017-10-10 22:32:35.201463
NCT02658682|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-10-13|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Interventional|||Secondary Prevention of Depression Applying an Experimental Attentional Bias Modification Procedure|Secondary Prevention of Depression Applying an Experimental Attentional Bias Modification Procedure|Active, not recruiting||N/A|350|Anticipated|University of Oslo||2|||f||||f||||||||||2017-10-10 22:32:35.311297|2017-10-10 22:32:35.311297
NCT02658656|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-01|||August 1, 2016|Actual|2016-08-01|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|June 30, 2020|Anticipated|2020-06-30||Interventional|(PEPSCI)||Powered Exoskeletons in Persons With SCI|CSP #2003 - Exoskeleton Assisted-Walking in Persons With SCI: Impact on Quality of Life|Recruiting||N/A|160|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|f|||||2017-10-10 22:32:35.557825|2017-10-10 22:32:35.557825
NCT02658643|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-15|2016-07-27|||January 2016||2016-01-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Analysis of Biliodigestive Anastomosis Techniques (BDA)|Randomized Controlled Study to Determine the Difference in Time and Complication Rate for Biliodigestive Anastomosis by Continuous Versus Interrupted Suture Technique|Recruiting||N/A|80|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-10 22:32:35.851516|2017-10-10 22:32:35.851516
NCT02658630|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-01-16|||February 2016||2016-02-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|SRT4||Neurophysiological and Kinematic Predictors of Response in Chronic Stroke|Neurophysiological and Kinematic Predictors of Response in Chronic Stroke|Recruiting||Phase 2|96|Anticipated|VA Maryland Health Care System||1|||f||||t||||||||||2017-10-10 22:32:35.968539|2017-10-10 22:32:35.968539
NCT02658617|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-01-14|||March 2010||2010-03-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|April 2010|Actual|2010-04-01||Observational|||Functional Neuroanatomy and Regional Metabolism Before and After Treatment With Duloxetine|Functional Neuroanatomy and Regional Metabolism Before and After Treatment With Duloxetine: A Combined fMRI and MRS Study in Major Depression|Completed||N/A|20|Actual|University of Zurich|||2||f||||f||||||||||2017-10-10 22:32:36.067778|2017-10-10 22:32:36.067778
NCT02658604|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-19|||January 2016||2016-01-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Home Medication Reviews by Pharmacists in Ontario, Canada|Home Medication Review Services for Non-homebound Community Pharmacy Patients: Evaluation of Medication Management Issues in Non-homebound Patients and Characterization of Ideal Target Population for Home-based Medication Reviews.|Completed||N/A|100|Actual|University of Waterloo|||1||f||||f||||||||No||2017-10-10 22:32:36.14687|2017-10-10 22:32:36.14687
NCT02658591|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-09-25|||January 2016||2016-01-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|January 31, 2018|Anticipated|2018-01-31||Interventional|||Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control|Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control|Active, not recruiting||N/A|60|Anticipated|University of Toronto||5|||f||||t||||||||||2017-10-10 22:32:36.250817|2017-10-10 22:32:36.250817
NCT02658578|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-05-29|||February 2015||2015-02-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Peripheral Nerve Stimulation and Motor Training in Stroke|Peripheral Nerve Stimulation and Motor Training to Enhance Hand Function After Stroke|Recruiting||N/A|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 22:32:37.060828|2017-10-10 22:32:37.060828
NCT02658383|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-08-15|||August 2015||2015-08-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Community-Engaged Research: A Tool to Advance Cookstove Interventions|Community-Based Participatory Research: A Tool to Advance Cookstove Interventions|Active, not recruiting||N/A|222|Actual|Colorado State University||2|||f||||t||||||||||2017-10-10 22:32:39.605537|2017-10-10 22:32:39.605537
NCT02658552|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-09-13|||October 2015||2015-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|||A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Benign Thyroid Nodules|A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Benign Thyroid Nodules|Completed||N/A|22|Actual|The University of Hong Kong||1|||f||||t||||||||||2017-10-10 22:32:37.292998|2017-10-10 22:32:37.292998
NCT02658539|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-21|||February 2016||2016-02-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|BODYCON||Impact of Physiological, Lifestyle and Genetic Factors on Body Composition|Impact of Physiological, Lifestyle and Genetic Factors on Body Composition|Recruiting||N/A|1196|Anticipated|University of Reading|||1||f||||f||||||Samples With DNA|"     A fasting blood sample will be taken at the end of the study visit for the measurement of     fasting lipids (total and high density lipoprotein-cholesterol, triacylglycerol and     non−esterified fatty acids), glucose, insulin, C-reactive protein and for vitamin D status.      The buffy coat (consisting of white blood cells) will be isolated from the blood sample for     genotyping analysis.   "|||2017-10-10 22:32:37.41289|2017-10-10 22:32:37.41289
NCT02658526|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-05-04|||December 2015||2015-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||Cognitive Changes in Childs After Anesthesia / Surgery|Role of Anesthesia / Surgery on Cognitive Function in Child|Recruiting||N/A|90|Anticipated|Heidelberg University|||3||f||||f||||||||No||2017-10-10 22:32:37.531695|2017-10-10 22:32:37.531695
NCT02658513|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer|Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer|Recruiting||N/A|35|Anticipated|Royal Surrey County Hospital NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 22:32:37.636422|2017-10-10 22:32:37.636422
NCT02658500|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-14|||January 2014||2014-01-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||Short and Long Term Effect of Early Infant Feeding and Nutritional Status on the Children's Health||Recruiting||N/A|300|Anticipated|Beijing Sanyuan Foods Co Ltd||2|||f||||t||||||||No||2017-10-10 22:32:37.751068|2017-10-10 22:32:37.751068
NCT02658487|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-06-27|||March 2016||2016-03-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|VITAL||Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia|Phase II Trial of Vosaroxin in Combination With Infusional Cytarabine in Patients With Untreated AML|Recruiting||Phase 2|61|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||Undecided||2017-10-10 22:32:37.879485|2017-10-10 22:32:37.879485
NCT02658474|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-09-12|||August 2016||2016-08-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|February 2019|Anticipated|2019-02-01||Interventional|||Multidisciplinary Group Based Treatment of Patients With Chronic Pain|Multidisciplinary Group Based Treatment of Patients With Chronic Pain. A Randomized Controlled Trial Comparing Acceptance Commitment Therapy and Treatment in a Primary Care Setting|Recruiting||N/A|120|Anticipated|University of Tromso||2|||f||||f||||||||No||2017-10-10 22:32:38.021132|2017-10-10 22:32:38.021132
NCT02658461|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-03-28|2016-02-18||February 2012||2012-02-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational||Each arm included 12 observations of an episode of care independent of the person being treated. By design of the study, some individuals may have been observed more than once and there may have been fewer than 12 actual participants in each arm.|An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC)|Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations for the Treatment of Patients With HER2-Positive Early Breast Cancer (EBC)|Completed||N/A|36|Actual|Hoffmann-La Roche|The focus of the observation in this study was the HCP rather than the person being treated, so number of observations is reported everywhere instead of number of participants. Number of participants was not collected.||3||f||||||||||||||2017-10-10 22:32:38.151059|2017-10-10 22:32:38.151059
NCT02658448|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-09-11|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||GTx-024 as a Treatment for Stress Urinary Incontinence in Women|GTx-024 as a Treatment for Stress Urinary Incontinence in Women: A Proof of Concept Study|Active, not recruiting||Phase 2|19|Actual|GTx||1|||f||||f||||||||||2017-10-10 22:32:39.041829|2017-10-10 22:32:39.041829
NCT02658435|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-16|||February 2016||2016-02-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|September 2016|Actual|2016-09-01||Interventional|||Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)|A Phase 1, Multi-center, Single-masked, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Ophthalmologic Safety and Pharmacodynamics of 300mg Single Doses of Tafenoquine (SB 252263) in Adult Healthy Volunteers|Active, not recruiting||Phase 1|384|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-10 22:32:39.152391|2017-10-10 22:32:39.152391
NCT02658422|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-05|||August 18, 2015|Actual|2015-08-18|May 2017|2017-05-01|September 21, 2015|Actual|2015-09-21|September 21, 2015|Actual|2015-09-21||Interventional|||Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions|An Open-label Balanced, Randomised, Single Dose, Two-way Crossover Study to Determine the Bioequivalence of GW483100 10 mg Tablets (Containing Montelukast Sodium Equivalent to 10 mg of Montelukast) Relative to Reference Montelukast Sodium 10 mg Tablets (Containing Montelukast Sodium Equivalent to 10 mg of Montelukast) in Healthy Male and Female Volunteers Under Fasting Conditions|Completed||Phase 1|32|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:32:39.272243|2017-10-10 22:32:39.272243
NCT02658409|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-02-25|||November 2015||2015-11-01|January 2016|2016-01-01||||November 2015|Actual|2015-11-01||Interventional|||A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study|A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Non-inferiority, Phase III Study to Investigate the Efficacy (Immunogenicity) and Safety of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)|Active, not recruiting||Phase 3|1630|Actual|Green Cross Corporation||2|||f||||t||||||||||2017-10-10 22:32:39.370386|2017-10-10 22:32:39.370386
NCT02658396|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-06-30||||||June 2017|2017-06-01|January 2022|Anticipated|2022-01-01|May 2019|Anticipated|2019-05-01||Interventional|||GO-203-2C + Bortezomib For Relapsed Or Refractory MM|A Phase I Trial of the MUC1 Inhibitor, GO-203-2c, in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma|Withdrawn||Phase 1|0|Actual|Dana-Farber Cancer Institute||1||Study was never open due to lack of funding|f||||t||||||||||2017-10-10 22:32:39.482866|2017-10-10 22:32:39.482866
NCT02658370|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-15|||August 2011||2011-08-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||An Animated Home-based Physical Exercise Program as a Treatment Option for Patients With Rheumatoid Arthritis|A Prospective Pilot Study to Evaluate an Animated Home-based Physical Exercise Program as a Treatment Option for Patients With Rheumatoid Arthritis|Completed||N/A|30|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||No||2017-10-10 22:32:39.683943|2017-10-10 22:32:39.683943
NCT02658357|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-10-07|||October 2015||2015-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant|Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant|Active, not recruiting||Phase 2|50|Anticipated|Braeburn Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:32:39.772553|2017-10-10 22:32:39.772553
NCT02658344|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-12-18|||July 2015||2015-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis|Multicenter, Randomized, Double-Blind, Placebo Controlled Phase Ⅱb Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis|Completed||Phase 2|24|Actual|Biostar||2|||f||||t||||||||||2017-10-10 22:32:39.856855|2017-10-10 22:32:39.856855
NCT02658331|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-14|||March 2015||2015-03-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Evaluation of the FilmArray BioThreat-E Test|Clinical Evaluation of the BioFire FilmArray® BioThreat-E Test for the Diagnosis of Ebola Virus Disease in West Africa|Completed||N/A|156|Actual|BioMérieux|||1||f||||f||||||Samples With DNA|"     Whole blood Urine Saliva   "|No||2017-10-10 22:32:39.980913|2017-10-10 22:32:39.980913
NCT02658318|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-15|||January 2011||2011-01-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Postoperative Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations||Completed||N/A|92|Actual|AZ Sint-Jan AV|||2||f||||f||||||||No||2017-10-10 22:32:40.061822|2017-10-10 22:32:40.061822
NCT02658305|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-14|||October 2014||2014-10-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Transoral Versus Transbuccal Placement of Bicortical Screws During Orthognathic Surgery||Completed||N/A|509|Actual|AZ Sint-Jan AV|||2||f||||f||||||||No||2017-10-10 22:32:40.151415|2017-10-10 22:32:40.151415
NCT02658292|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-09-08||||||September 2016|2016-09-01||||July 2016|Actual|2016-07-01||Interventional|||Safety and Efficacy of NAFT900 in Children With Tinea Capitis|A Double-Blind, Randomized, Vehicle-Control, Multicenter Study to Evaluate the Efficacy and Safety of NAFT900 in Children With Tinea Capitis Aged 6 to < 13 Years|Withdrawn||Phase 2|0|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 22:32:40.234872|2017-10-10 22:32:40.234872
NCT02658279|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-09-22|||January 22, 2016|Actual|2016-01-22|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype|A Proof-of-Concept, Pilot Study of Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype|Recruiting||N/A|44|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:32:40.341494|2017-10-10 22:32:40.341494
NCT02658266|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-09-13|||February 2016||2016-02-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Resistance Training in Adults With Complex Congenital Heart Disease|Effect of Resistance Training in Adults With Complex Congenital Heart Disease|Recruiting||N/A|40|Anticipated|Umeå University||2|||f||||f||||||||||2017-10-10 22:32:40.492381|2017-10-10 22:32:40.492381
NCT02658253|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-03-23|||January 2016||2016-01-01|January 2016|2016-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|PRIMALVAC||Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults|Phase Ia/Ib, Randomized, Double Blinded, Dose Escalation Trial to Evaluate the Safety and Immunogenicity in Healthy European and Burkinabe Adults of a Placental Malaria Vaccine Candidate (PRIMVAC) Formulated With Alhydrogel ® or GLA-SE|Recruiting||Phase 1|68|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||10|||f||||t||||||||No||2017-10-10 22:32:40.612885|2017-10-10 22:32:40.612885
NCT02658240|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration|Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration for Pain Management After Total Hip Arthroplasty: A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:32:40.738257|2017-10-10 22:32:40.738257
NCT02658188|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-02-03|||December 2007||2007-12-01|February 2016|2016-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients|Long-term Study - Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients|Completed||Phase 3|182|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-10 22:32:40.996761|2017-10-10 22:32:40.996761
NCT02655354|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-05-18|||October 2015||2015-10-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|TSOS6||A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity||Recruiting||N/A|960|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 22:33:11.162984|2017-10-10 22:33:11.162984
NCT02658175|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-07-26|||December 31, 2015|Actual|2015-12-31|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome|ISIS 304801-CS7 The APPROACH Open Label Study Volanesorsen (ISIS 304801) An Open-Label Study of Volanesorsen Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)|Recruiting||Phase 3|60|Anticipated|Ionis Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-10 22:32:41.259113|2017-10-10 22:32:41.259113
NCT02658162|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-01-14|||June 2016||2016-06-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant Patients|A Randomized, Placebo-controlled, Prospective, Single-blind, Single Center Phase 2 Study of the Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Recipients of a Donation After Brain Death Kidney Transplant|Not yet recruiting||Phase 2|60|Anticipated|Prolong Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:32:41.41526|2017-10-10 22:32:41.41526
NCT02658149|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-09-11|||May 2016||2016-05-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty|Psoas Compartment Block Versus Periarticular Local Anesthetic Infiltration for Pain Management for Total Hip Arthroplasty: A Prospective, Randomized Study|Recruiting||Phase 4|100|Anticipated|William Beaumont Hospitals||2|||f||||t|t|f||||||||2017-10-10 22:32:41.50147|2017-10-10 22:32:41.50147
NCT02658136|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-10-03|||February 2016||2016-02-01|October 2017|2017-10-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||Right Ventricular Function and Exercise Capacity in Patients With Continuous-flow Left Ventricular Assist Devices|Computed Tomography Estimated Right Ventricular Function and Exercise Capacity in Patients With Continuous-flow Left Ventricular Assist Devices|Completed||N/A|15|Actual|Rigshospitalet, Denmark||1|||f||||f|f|f||||||||2017-10-10 22:32:41.62746|2017-10-10 22:32:41.62746
NCT02658123|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-25|||April 2016||2016-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Reducing Readmissions in High-Risk Ostomates|Reducing Readmissions in High-Risk Ostomates|Recruiting||N/A|300|Anticipated|Washington University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:32:41.708209|2017-10-10 22:32:41.708209
NCT02658110|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-14|||July 2015||2015-07-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Metabolic and Appetite Responses to Altered Timing of Whey Protein Ingestion|Acute Metabolic and Appetite Responses to Altered Timing of Whey Protein Ingestion in Overweight and Obese Males|Completed||N/A|14|Actual|Northumbria University||4|||f||||f||||||||No||2017-10-10 22:32:41.823194|2017-10-10 22:32:41.823194
NCT02658097|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-15|||May 11, 2017|Actual|2017-05-11|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Randomized Two Arm Phase II Trial of Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC|A Phase II Trial of Pembrolizumab Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC|Recruiting||Phase 2|48|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|t|f|||f|||||2017-10-10 22:32:41.928887|2017-10-10 22:32:41.928887
NCT02658084|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-04-19|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|||Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer|A Phase I/II Study to Evaluate the Safety and Efficacy of Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Miami||2|||f||||t|t|f||||||Undecided||2017-10-10 22:32:42.045839|2017-10-10 22:32:42.045839
NCT02658071|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-06-12|||March 15, 2016|Actual|2016-03-15|June 2017|2017-06-01|September 15, 2018|Anticipated|2018-09-15|September 15, 2018|Anticipated|2018-09-15||Observational|TRIGGERFISH||Measurement of Ocular Tensional Fluctuation by Triggerfish Lens Before and After Cataract Surgery in Patients With Exfoliative Glaucoma||Recruiting||N/A|10|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 22:32:42.183779|2017-10-10 22:32:42.183779
NCT02658058|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-01-25|||November 2015||2015-11-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Pre-procedural Ultrasound Techniques Versus Conventional Landmark Technique of Spinal Anesthesia in Elderly Patients|A Randomized Controlled Trial of Pre-procedural Ultrasound Techniques Versus the Conventional Landmark Technique of Spinal Anesthesia in Elderly Patients|Recruiting||N/A|180|Anticipated|American University of Beirut Medical Center||3|||f||||f||||||||No||2017-10-10 22:32:42.297406|2017-10-10 22:32:42.297406
NCT02658045|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-01-14|||February 2016||2016-02-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|CPOM||A Clinical Evaluation of the Oxitone Non-invasive Oximeter|A Clinical Evaluation of the Oxitone Non-invasive Oximeter. Method Comparison Study vs. a Standard Clinical Pulse-oximeter Monitor. A Prospective Open Study|Not yet recruiting||Phase 1|40|Anticipated|Meir Medical Center|||2||f||||f||||||||||2017-10-10 22:32:42.414444|2017-10-10 22:32:42.414444
NCT02658032|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-09-14|||January 2016||2016-01-01|December 2016|2016-12-01|January 2024|Anticipated|2024-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)|Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)|Recruiting||Phase 2|276|Anticipated|Yale University||4|||f||||t||||||||||2017-10-10 22:32:42.520383|2017-10-10 22:32:42.520383
NCT02658019|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-15|||May 6, 2016|Actual|2016-05-06|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma|Phase II Study of Pembrolizumab (Keytruda®) in Advanced Hepatocellular Carcinoma (HCC)|Recruiting||Phase 2|28|Anticipated|University of Miami||1|||f||||t|t|f||||||||2017-10-10 22:32:42.648336|2017-10-10 22:32:42.648336
NCT02658006|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-09-12|||November 2015||2015-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|TechnoPeriOp||Evaluation of Monitoring TECHNOlogies in the PERI-OPerative Care of Cardiac Surgical Patients|Evaluation of Multimodal Monitoring Technologies in the Peri-operative Care of Cardiac Surgical Patients|Completed||N/A|120|Actual|Montreal Heart Institute|||1||f||||f||||||||No||2017-10-10 22:32:42.786423|2017-10-10 22:32:42.786423
NCT02657993|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-17|||March 2016||2016-03-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence|Hypnosis to Reduce Aromatase Inhibitor (AI) Associated Musculoskeletal Pain and to Improve AI Adherence: An RCT to Explore Efficacy and Cost Effects|Recruiting||N/A|200|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 22:32:42.91408|2017-10-10 22:32:42.91408
NCT02657980|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-01-24|||April 2015||2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder|The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder|Completed||Phase 3|96|Actual|Ybrain Inc.||2|||f||||t||||||||||2017-10-10 22:32:43.038873|2017-10-10 22:32:43.038873
NCT02657967|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-02-28|||May 2015||2015-05-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01|3 Years|Observational [Patient Registry]|NICMR||Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy|Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy (NICM-Registry)|Recruiting||N/A|1950|Anticipated|Winthrop University Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood specimens obtained with subject permission, will be retained for the purpose of     future genetic research.   "|No||2017-10-10 22:32:43.155876|2017-10-10 22:32:43.155876
NCT02657941|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-07-05|||December 9, 2015|Actual|2015-12-09|July 2017|2017-07-01|December 20, 2017|Anticipated|2017-12-20|September 30, 2017|Anticipated|2017-09-30||Interventional|HYVIE||Early and Short Psycho-educational Lifestyle Intervention|Early and Short Psycho-educational Lifestyle Intervention to Prevent Weight Gain Induced by Psychotropic Drugs in Adults With Severe Mental Illness: a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Hôpital le Vinatier||2|||f||||t||||||||||2017-10-10 22:32:43.351874|2017-10-10 22:32:43.351874
NCT02657928|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-05-08|||July 8, 2016|Actual|2016-07-08|February 2017|2017-02-01|July 2021|Anticipated|2021-07-01|June 2021|Anticipated|2021-06-01||Interventional|||Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer|A Phase 2 Trial of Ribociclib (LEE011) and Letrozole in ER Positive Relapsed Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinomas, and Endometrial Cancers.|Recruiting||Phase 2|40|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:32:43.493441|2017-10-10 22:32:43.493441
NCT02657915|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-03-21|||March 2016||2016-03-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|RENEWed||Long-Term Assessment of Remyelinating Therapy|A Multicenter, Follow-Up Study to Assess Long-Term Electrophysiologic and Clinical Outcomes in Subjects Previously Enrolled in Study 215ON201|Completed||N/A|52|Actual|Biogen|||1||f||||f||||||||||2017-10-10 22:32:43.64452|2017-10-10 22:32:43.64452
NCT02657902|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-15|||January 2009||2009-01-01|January 2016|2016-01-01||||January 2015|Actual|2015-01-01||Observational|||Does an Additional Antirotation U-Blade (RC) Lagscrew Improve Treatment of AO/OTA (Orthopaedic Trauma Association) 31 A1-3 Fractures With Gamma 3 Nail?|Does an Additional Antirotation U-Blade (RC) Lagscrew Improve Treatment of AO/OTA (Orthopaedic Trauma Association) 31 A1-3 Classified Fractures With Gamma 3 Nail?|Completed||N/A|135|Actual|Medical University of Vienna|||2||f||||||||||||||2017-10-10 22:32:43.779658|2017-10-10 22:32:43.779658
NCT02657889|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-24|||March 2016||2016-03-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|March 2018|Anticipated|2018-03-01||Interventional|TOPACIO||Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer|Phase 1/2 Clinical Study of Niraparib in Combination With Pembrolizumab (MK-3475) in Patients With Advanced or Metastatic Triple-Negative Breast Cancer and in Patients With Recurrent Ovarian Cancer|Recruiting||Phase 1/Phase 2|114|Anticipated|Tesaro, Inc.||1|||f||||f||||||||||2017-10-10 22:32:43.861294|2017-10-10 22:32:43.861294
NCT02657876|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-10-03|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers|An Open-Label, Prospective, Multicenter, Safety, and Tolerability Study of ExpressGraft-C9T1 Skin Tissue in the Treatment of Diabetic Foot Ulcers|Not yet recruiting||Phase 1|6|Anticipated|Stratatech, a Mallinckrodt Company||1|||f||||t|t|f||||||||2017-10-10 22:32:44.063415|2017-10-10 22:32:44.063415
NCT02657863|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-05-10|||November 2014||2014-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Cancer DNA in Blood and Urine|Non-invasive Detection of Cancer DNA in Blood and Urine|Active, not recruiting||N/A|45|Actual|Sidney Kimmel Comprehensive Cancer Center|||3||f||||t||||||Samples Without DNA|"     Urine and Blood   "|Undecided||2017-10-10 22:32:44.151443|2017-10-10 22:32:44.151443
NCT02657850|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-13|||March 2018||2018-03-01|January 2016|2016-01-01||||March 2019|Anticipated|2019-03-01||Observational|||Head and Neck Cancer Treatment Related Dysphagia|Multi-Institution Longitudinal Evaluation of Head and Neck Cancer Treatment - Related Dysphagia|Not yet recruiting||N/A|250|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||3||f||||t||||||||Yes||2017-10-10 22:32:44.235447|2017-10-10 22:32:44.235447
NCT02657837|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|MRH||Measures of Respiratory Health (MRH)|Measures of Respiratory Health|Recruiting||N/A|300|Anticipated|The Hospital for Sick Children|||3||f||||f||||||||||2017-10-10 22:32:44.376227|2017-10-10 22:32:44.376227
NCT02657824|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-02-07|||August 2015||2015-08-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01|2 Months|Observational [Patient Registry]|||Rapid and Easy Evaluation of Cardiac Systolic Function by Means of Mitral Valve Movements in the Emergency Department|Rapid and Easy Evaluation of Cardiac Systolic Function by Means of Mitral Valve Movements in the Emergency Department|Completed||N/A|113|Actual|Bozyaka Training and Research Hospital|||1||f||||f||||||||No||2017-10-10 22:32:44.473937|2017-10-10 22:32:44.473937
NCT02657811|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-02-19|||October 2016|Actual|2016-10-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Time-Lapse Incubation for Embryo Culture - Morphokinetics and Environmental Stability|Time-Lapse Incubation for Embryo Culture - The Impact of Morphokinetics and Environmental Stability on Reproductive Outcomes|Recruiting||N/A|372|Anticipated|Shaare Zedek Medical Center||3|||f||||t||||||||||2017-10-10 22:32:44.575217|2017-10-10 22:32:44.575217
NCT02657798|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-25|||June 2016||2016-06-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|July 2017|Anticipated|2017-07-01||Observational|||RESIST: Understanding the Role of Depression in Heart Disease|Resist: What Are the Mechanisms Involved in Depression and Antidepressant Resistance That Increase Cardiovascular Risk?|Recruiting||N/A|90|Anticipated|University College, London|||3||f||||f||||||Samples With DNA|"     Saliva, peripheral blood mononuclear cells, blood serum, blood plasma, RNA   "|No||2017-10-10 22:32:44.988039|2017-10-10 22:32:44.988039
NCT02657785|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-09-25|||September 2010||2010-09-01|September 2016|2016-09-01|December 2024|Anticipated|2024-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy|Treatment of Primary CNS Lymphoma With Systemic R-IDARAM Chemotherapy and Intrathecal Immunochemotherapy|Enrolling by invitation||Phase 2/Phase 3|100|Anticipated|Navy General Hospital, Beijing||1|||f||||f||||||||Undecided||2017-10-10 22:32:45.090372|2017-10-10 22:32:45.090372
NCT02657772|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-10-03|||November 2013|Actual|2013-11-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|18 Months|Observational [Patient Registry]|ULTRA||Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms|Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms|Recruiting||N/A|100|Anticipated|University of Maryland|||1||f||||f||||||||||2017-10-10 22:32:45.183459|2017-10-10 22:32:45.183459
NCT02657759|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-19|||December 2015||2015-12-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|CARDICHOL 1||EFFECTS OF CARDICHOL, AN HERBAL DIETARY SUPPLEMENT, IN MODERATE HYPERCHOLESTEROLEMIA|EFFECTS OF CARDICHOL, AN HERBAL DIETARY SUPPLEMENT, IN MODERATE HYPERCHOLESTEROLEMIA|Recruiting||N/A|50|Anticipated|Direct Plantes||2|||f||||f||||||||Undecided||2017-10-10 22:32:45.304241|2017-10-10 22:32:45.304241
NCT02657746|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-03-02|||May 1, 2016|Actual|2016-05-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|COBRA-BPS||Primary Care Strategies to Reduce High Blood Pressure: A Cluster Randomized Trial in Rural Bangladesh, Pakistan and Sri Lanka|Primary Care Strategies to Reduce High Blood Pressure: A Cluster Randomized Trial in Rural Bangladesh, Pakistan and Sri Lanka|Enrolling by invitation||N/A|2550|Anticipated|Duke-NUS Graduate Medical School||2|||f||||t||||||||||2017-10-10 22:32:45.471926|2017-10-10 22:32:45.471926
NCT02657733|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-11-01|||July 2015||2015-07-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison Study Between Nellcor Respiration Rate Technology (RRoxi) and Masimo Acoustic Respiration Rate (RRa)|Comparison Study Between Nellcor Respiration Rate Technology (RRoxi) and Masimo Acoustic Respiration Rate (RRa)|Completed||Phase 4|29|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-10 22:32:45.601183|2017-10-10 22:32:45.601183
NCT02657720|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-11-01|||July 2015||2015-07-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison Between Different Technologies That Measure Respiratory Rate|Comparison Between Different Technologies That Measure Respiratory Rate|Completed||Phase 4|29|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-10 22:32:45.718748|2017-10-10 22:32:45.718748
NCT02657707|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-01-30|||April 2016||2016-04-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis|Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)|Recruiting||N/A|295|Anticipated|Microvention-Terumo, Inc.||1|||f||||t||||||||||2017-10-10 22:32:45.843504|2017-10-10 22:32:45.843504
NCT02657694|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-02-14|||July 1, 2015|Actual|2015-07-01|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|January 1, 2017|Actual|2017-01-01|1 Year|Observational [Patient Registry]|REDEMPTION||Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods|Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods|Enrolling by invitation||N/A|10000|Anticipated|FixHepC|||3||f||||t||||||||Yes||2017-10-10 22:32:46.148355|2017-10-10 22:32:46.148355
NCT02657681|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-08-08|||October 2015||2015-10-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)|Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)|Recruiting||Phase 2|50|Anticipated|Fundación de investigación HM||2|||f||||||||||||||2017-10-10 22:32:46.255642|2017-10-10 22:32:46.255642
NCT02657668|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-13|||September 2013||2013-09-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|January 2014|Actual|2014-01-01||Interventional|||Emotion Focused Therapy in Irritable Bowel Syndrome Patients|Pilot Study of Efficacy of Emotion Focused Therapy on Stress, Resiliency and Coping Strategies in Irritable Bowel Syndrome Patients|Completed||N/A|52|Actual|Islamic Azad University, Najafabad Branch||2|||f||||f||||||||Yes|according to inclusion and exclusion criteria selected|2017-10-10 22:32:46.390675|2017-10-10 22:32:46.390675
NCT02657655|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Kinesia 360 Parkinson's Monitoring Study|Kinesia 360 Multi-Center Parkinson's Monitoring Study|Active, not recruiting||N/A|45|Anticipated|Great Lakes NeuroTechnologies Inc.||1|||f||||f||||||||||2017-10-10 22:32:46.486818|2017-10-10 22:32:46.486818
NCT02657642|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-15|||January 2016||2016-01-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Observational|OMAGE-P||The OMAGE (Optimization of Medication in AGEd) Transitional Care-Pathway: Impact on Readmissions|The OMAGE (Optimization of Medication in AGEd) Transitional Care-Pathway: Impact on Readmissions|Not yet recruiting||N/A|484|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||No||2017-10-10 22:32:46.63992|2017-10-10 22:32:46.63992
NCT02657629|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-01-19|2016-01-19||December 2009||2009-12-01|January 2016|2016-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Comparison of Feeding Strategies for Hypoplastic Left Heart Syndrome Infants|Comparison of Feeding Strategies After Stage 1 Procedures for Hypoplastic Left Heart Syndrome Infants: A Randomized Controlled Trial|Completed||N/A|28|Actual|Columbia University||2|||f||||f||||||||||2017-10-10 22:32:46.724504|2017-10-10 22:32:46.724504
NCT02657616|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-13|||December 2015||2015-12-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Observational|||Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA|Stroke Prophylaxis of Patients With Atrial Fibrillation: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to Vitamin-k-antagonists Based on an Analysis of German Claims Data|Completed||N/A|204464|Actual|Institut für Pharmakoökonomie und Arzneimittellogistik e.V.|||3||f||||||||||||||2017-10-10 22:32:47.096061|2017-10-10 22:32:47.096061
NCT02657603|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-16|||January 2016||2016-01-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Interventional|||Continuous Adductor Canal Block With a New Catheter - Primary Placement and Secondary Repositioning|Continuous Adductor Canal Block With a New Catheter - Primary Placement and Secondary Repositioning|Recruiting||N/A|16|Anticipated|Hillerod Hospital, Denmark||2|||f||||f||||||||||2017-10-10 22:32:47.200836|2017-10-10 22:32:47.200836
NCT02657590|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Observational|||Documentation of Cardiac Arrhythmias After Open Heart Surgery|Documentation of Cardiac Arrhythmias After Open Heart Surgery|Not yet recruiting||N/A|200|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||Undecided||2017-10-10 22:32:47.336239|2017-10-10 22:32:47.336239
NCT02657577|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-16|||February 2016||2016-02-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||REseArCH INteGration in Women, Infants, and Children|REseArCH INteGration in Women, Infants, and Children: REACHING WIC|Active, not recruiting||N/A|628|Actual|Pennington Biomedical Research Center|||1||f||||f||||||||||2017-10-10 22:32:47.424532|2017-10-10 22:32:47.424532
NCT02657564|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-08-01|||January 2016||2016-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Renal Safety of Bowel Preparation With Polyethylene Glycol|The Renal Safety of Bowel Preparation With Polyethylene Glycol for Colonoscopy: A Prospective Cohort Study|Recruiting||N/A|1152|Anticipated|Evergreen General Hospital, Taiwan||1|||f||||t||||||||No||2017-10-10 22:32:47.537277|2017-10-10 22:32:47.537277
NCT02657551|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-05-19|||January 2016||2016-01-01|May 2017|2017-05-01|October 2022|Anticipated|2022-10-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer|A Phase II Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer|Recruiting||Phase 2|33|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No|There are no plans to share individual participant data. However, at the end of the study, results will be presented and published.|2017-10-10 22:32:47.65002|2017-10-10 22:32:47.65002
NCT02657538|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-07-07|2016-05-25||July 2014||2014-07-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|December 2014|Actual|2014-12-01||Interventional|||Validation of Near-infrared Light Transillumination for Interproximal Enamel Caries Detection|Validation of Near-infrared Light Transillumination for Interproximal Enamel Caries Detection: A Clinical Controlled Trial|Completed||N/A|35|Actual|University of Bern||2|||f||||f||||||||||2017-10-10 22:32:47.764875|2017-10-10 22:32:47.764875
NCT02657525|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-02-03|||January 2016||2016-01-01|February 2016|2016-02-01|January 2020|Anticipated|2020-01-01|December 2016|Anticipated|2016-12-01|3 Years|Observational [Patient Registry]|AECOPD-IRS||Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study|Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study|Active, not recruiting||N/A|7600|Anticipated|China-Japan Friendship Hospital|||1||f||||t||||||||Undecided||2017-10-10 22:32:48.024913|2017-10-10 22:32:48.024913
NCT02657512|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2016-05-24|||January 2016||2016-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|RICHAR||Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects|Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects : RICHAR Study|Completed||Phase 1|12|Actual|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||No||2017-10-10 22:32:48.095929|2017-10-10 22:32:48.095929
NCT02657499|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-09-18|||January 2012||2012-01-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|PACE||Post Affordable Care Act Evaluation|Post Affordable Care Act: Evaluation of Community Health Centers|Enrolling by invitation||N/A|555901|Anticipated|Oregon Health and Science University|||2||f||||f||||||||||2017-10-10 22:32:48.188443|2017-10-10 22:32:48.188443
NCT02657486|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-09-08|||January 2016||2016-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder|Pilot Study of BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder|Recruiting||N/A|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:32:48.267009|2017-10-10 22:32:48.267009
NCT02657473|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-09-05|||August 2016||2016-08-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|BATTLE||Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis|Long-term Inhaled Nebulized Tobramycin in Patients With Non-cystic Fibrosis Bronchiectasis. A Randomized Placebo Controlled Trial. The BATTLE Study Bronchiectasis And Tobramycin SoluTion InhaLation ThErapy.|Recruiting||Phase 2/Phase 3|52|Anticipated|Medical Center Alkmaar||2|||f||||||||||||||2017-10-10 22:32:48.379535|2017-10-10 22:32:48.379535
NCT02657460|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-11-01|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion|Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion|Recruiting||Phase 2|90|Anticipated|Wuhan Union Hospital, China||2|||f||||t||||||||||2017-10-10 22:32:48.473732|2017-10-10 22:32:48.473732
NCT02657447|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|September 2018|Anticipated|2018-09-01||Interventional|||Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)|A Phase 1, Open Label, Randomized Study to Assess Pharmacokinetics, Biodistribution and Radiation Dosimetry of Lutetium (177Lu) Lilotomab Satetraxetan (Betalutin®) Radioimmunotherapy in Patients With Relapsed Non-Hodgkin Lymphoma|Not yet recruiting||Phase 1|8|Anticipated|Nordic Nanovector||2|||f||||f|f|f||||||||2017-10-10 22:32:48.593572|2017-10-10 22:32:48.593572
NCT02657239|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-08-16|||May 2015||2015-05-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|MOVE UP||Mobility & Vitality Lifestyle Program|Health Promotion and Disease Prevention Research Center|Recruiting||N/A|400|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 22:32:51.8459|2017-10-10 22:32:51.8459
NCT02657434|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-08-01|||April 30, 2016|Actual|2016-04-30|August 2017|2017-08-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)|A Phase III, Open-Label, Randomized Study of Atezolizumab (MPDL3280A, Anti-Pd-L1 Antibody) in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Patients Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer|Recruiting||Phase 3|568|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:32:48.729461|2017-10-10 22:32:48.729461
NCT02657421|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-07-24|||November 2015||2015-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01|24 Months|Observational [Patient Registry]|||OLIF25™ /OLIF51™ Study|A Multi-Center, Prospective, Observational Study to Assess Outcomes for Patients Treated for Lumbar Spinal Conditions Using an OLIF25™ and/or OLIF51™Approach|Active, not recruiting||N/A|174|Actual|Medtronic Spinal and Biologics|||1||f||||t||||||||||2017-10-10 22:32:49.538482|2017-10-10 22:32:49.538482
NCT02657408|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-14|2017-03-10|||March 2016||2016-03-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Clinical Trial to Assess Pharmacodynamic Effects on Segmental Endotoxin Induced Inflammatory Response of BI 1026706 Versus Placebo|A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase I Trial in Healthy Male Current Smoker Subjects to Assess Pharmacodynamic Effects on Segmental Endotoxin Induced Inflammatory Response and Safety of 4 Weeks Oral Administration of BI 1026706|Completed||Phase 1|57|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:32:49.67451|2017-10-10 22:32:49.67451
NCT02657395|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-07-21|||October 2015||2015-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Root Coverage Using a Xenograph for Treatment of Gingival Recession|PriMatrix Utilization to Achieve Dental Root Coverage|Completed||Phase 1|12|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:32:49.777454|2017-10-10 22:32:49.777454
NCT02657382|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-06-19|||September 2015||2015-09-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MIBS||Mental Stress Ischemia: Biofeedback Study|Effects of Biofeedback on Myocardial Blood Flow Changes During Mental Stress in Patients With Coronary Artery Disease|Active, not recruiting||N/A|25|Actual|Emory University||2|||f||||f||||||||||2017-10-10 22:32:49.895817|2017-10-10 22:32:49.895817
NCT02657369|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-06-30|||July 7, 2016|Actual|2016-07-07|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)|An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)|Recruiting||Phase 2|76|Anticipated|Eisai Inc.||1|||f||||f||||||||||2017-10-10 22:32:50.049541|2017-10-10 22:32:50.049541
NCT02657356|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-09-29|||September 2016||2016-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST|A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension|Recruiting||Phase 3|200|Anticipated|Reata Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 22:32:50.278896|2017-10-10 22:32:50.278896
NCT02657343|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-03-24|||March 9, 2016|Actual|2016-03-09|March 2017|2017-03-01|February 2023|Anticipated|2023-02-01|February 2019|Anticipated|2019-02-01||Interventional|||An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.|An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.|Recruiting||Phase 1/Phase 2|86|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-10 22:32:50.968196|2017-10-10 22:32:50.968196
NCT02657330|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-05|||January 2016||2016-01-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of SBP-101 in Pancreatic Cancer|A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma|Active, not recruiting||Phase 1|72|Anticipated|Sun BioPharma Inc||1|||f||||t||||||||||2017-10-10 22:32:51.085164|2017-10-10 22:32:51.085164
NCT02657317|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-09-18|||January 2016||2016-01-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans|Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in a Combat-Injured Veterans Population|Recruiting||N/A|130|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 22:32:51.19874|2017-10-10 22:32:51.19874
NCT02657304|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-09-29|||March 2016||2016-03-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|CoachSAS||Effect of Early Education on the Observance of CPAP Treatment|Effect of Early Education and Information of Sleep Apnea on the Observance of CPAP Treatment|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:32:51.300753|2017-10-10 22:32:51.300753
NCT02657291|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-02-11|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CPI||Costoclavicular vs Paracoracoid Approach to Infraclavicular Brachial Plexus Block: a Feasibility Study|Costoclavicular vs Paracoracoid Approach to Infraclavicular Brachial Plexus Block: a Feasibility Study|Recruiting||N/A|70|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||Undecided||2017-10-10 22:32:51.412946|2017-10-10 22:32:51.412946
NCT02657278|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-13|||January 2016||2016-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Cardiopulmonary Exercise Test in Peripheral Arterial Disease|The Influence of Peripheral Arterial Disease (PAD) on the Onset of Lactate Threshold (LT) in Patients Undergoing Cardiopulmonary Exercise Test (CPET)|Recruiting||N/A|30|Anticipated|Aintree University Hospitals NHS Foundation Trust||1|||f||||t||||||||No||2017-10-10 22:32:51.558567|2017-10-10 22:32:51.558567
NCT02657265|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-02-20|||January 2016||2016-01-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||SpineJack® Versus Conservative Treatment Study|Prospective Multicenter Randomized Study Comparing Two Standard Treatments: SpineJack® System and Conservative Orthopedic Management in Acute Traumatic Vertebral Fractures Types A1 and A3.1 According to the Magerl Classification|Recruiting||N/A|100|Anticipated|Vexim SA||2|||f||||f|f|f||||||No||2017-10-10 22:32:51.641678|2017-10-10 22:32:51.641678
NCT02657213|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-19|||February 2016||2016-02-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|July 2017|Actual|2017-07-01||Interventional|ALPPHY||Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia|Study of Minimed 640G Insulin Pump With SmartGuard in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia|Recruiting||N/A|20|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 22:32:52.046783|2017-10-10 22:32:52.046783
NCT02657200|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-01-12|||September 2015||2015-09-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|KAP-abortion||Knowledge, Attitude and Practices of Flemish Midwifes Regarding Spontaneous Abortion|Knowledge, Attitude and Practices of Flemish Midwifes Regarding Spontaneous Abortion|Recruiting||N/A|3000|Anticipated|University Ghent||1|||f||||f||||||||||2017-10-10 22:32:52.174588|2017-10-10 22:32:52.174588
NCT02657187|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-02-14|||February 2016||2016-02-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||The Neuromuscular Effect of Rocuronium in Patient|The Neuromuscular Effect of Rocuronium in Patient Measuring Muscle Mass by Bioelectrical Impedance Analysis|Recruiting||N/A|80|Anticipated|Korea University Anam Hospital||4|||f||||t||||||||||2017-10-10 22:32:52.264697|2017-10-10 22:32:52.264697
NCT02657161|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-13|||February 2015||2015-02-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant|Phase I Study to Determine the Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant|Completed||Phase 1|37|Actual|Yisheng Biopharma (Singapore) Pte. Ltd.||3|||f||||t||||||||No||2017-10-10 22:32:52.479833|2017-10-10 22:32:52.479833
NCT02657148|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-07-24|||May 2016||2016-05-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Immediate Postpartum Nexplanon Placement in Opioid Dependent Women|A Prospective Observational Clinical Trial to Compare the Effect of Immediate Postpartum Nexplanon Placement Versus Standard Postpartum Contraceptive Care on Consistent Contraceptive Use and Rapid Repeat Pregnancy in Opioid Dependent Women.|Active, not recruiting||N/A|200|Actual|University of Pittsburgh|||2||f||||t||||||||||2017-10-10 22:32:52.590481|2017-10-10 22:32:52.590481
NCT02657135|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-05-19|||January 2014||2014-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|TEAM-TBI||Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury|Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury|Active, not recruiting||N/A|120|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 22:32:52.717586|2017-10-10 22:32:52.717586
NCT02657122|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-07-17|||December 2015||2015-12-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects|A Double-blinded, Randomized, Placebo-controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TD-1473 in Healthy Subjects|Completed||Phase 1|72|Actual|Theravance Biopharma R & D, Inc.||4|||f||||f||||||||||2017-10-10 22:32:52.8362|2017-10-10 22:32:52.8362
NCT02657109|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2015|Actual|2015-03-01||Interventional|||Influence of a Rehabilitation in Valve Replacement on Heart Rate Variability and Oxidative Stress|Influence of Early Mobilization Protocol in Heart Valve Replacement on Heart Rate Variability and Oxidative Stress|Recruiting||Early Phase 1|30|Anticipated|Universidade Metodista de Piracicaba||2|||f||||t||||||||Yes|The data of the volunteers will be kept confidential , being only used the amount of data for publication in journals with the period until 2017|2017-10-10 22:32:54.85922|2017-10-10 22:32:54.85922
NCT02657096|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-05-10|||January 2014||2014-01-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Decontaminant Agent in the Treatment of Chronic Periodontitis|Effectiveness of an Oral Decontaminant Agent in Addition to Non-surgical Therapy of Chronic Periodontitis: A Split Mouth Study|Completed||N/A|36|Actual|University of Messina||2|||f||||t||||||||Undecided||2017-10-10 22:32:54.989474|2017-10-10 22:32:54.989474
NCT02657083|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-09-19|||January 2016||2016-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PHYSI-DREAM||Prevention of Hypoglycemia After Exercise Using Closed Loop System in Children and Adolescents With Type 1 Diabetes|Prevention of Hypoglycemia After Exercise Using DreaMed Substance Administration Device in Children and Adolescents With Type 1 Diabetes (The PHYSI-DREAM Study)|Completed||N/A|20|Actual|University of Ljubljana, Faculty of Medicine||2|||f||||f||||||||||2017-10-10 22:32:55.097655|2017-10-10 22:32:55.097655
NCT02657070|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-14|||March 2014||2014-03-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Counteracting Learned Non-use Through Augmented Visuomotor Feedback in Virtual Reality (RGS)|Desaprendiendo la parálisis Aprendida Con RGS en Pacientes Afectos de Ictus|Completed||N/A|23|Actual|Universitat Pompeu Fabra||2|||f||||||||||||||2017-10-10 22:32:55.20087|2017-10-10 22:32:55.20087
NCT02657057|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-08-16|||November 2015||2015-11-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB|Effects of Transcutaneous and Percutaneous Posterior Tibial Nerve Stimulation on Idiopathic Overactive Bladder Syndrome: Randomized Clinical Trial|Completed||N/A|68|Actual|Instituto Médico Tecnológico SL||2|||f||||f||||||||||2017-10-10 22:32:55.293922|2017-10-10 22:32:55.293922
NCT02657044|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|September 2018|Anticipated|2018-09-01||Interventional|MATILDA||EMR Versus ESD for Resection of Large Distal Non-pedunculated Colorectal Adenomas|Multicenter, Randomised Controlled Trial Comparing Endoscopic Mucosal Resection (EMR) And Endoscopic Submucosal dissecTIon (ESD) for Resection of Large Distal Non-pedunculated Colorectal Adenomas (MATILDA-trial)|Recruiting||N/A|212|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-10 22:32:55.39284|2017-10-10 22:32:55.39284
NCT02657031|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-03-21|||March 17, 2016|Actual|2016-03-17|March 2017|2017-03-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|||The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine|The Check Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine. A Multi-Center, Randomized Double-Blind, Clinical Control Trial.|Completed||Phase 4|53|Actual|University Medical Center of Southern Nevada||2|||f||||f||||||||Yes|This is a multi-center study that will share redacted data with investigators from the other site9s)|2017-10-10 22:32:55.504255|2017-10-10 22:32:55.504255
NCT02657018|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-12-13|||April 2016||2016-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MOBIGAME||Mobile Exergaming in Type 2 Diabetes|Mobile Exergaming for Health - Effects of a Serious Game Application for Smartphones on Physical Activity and Exercise Adherence in Type 2 Diabetes Mellitus (Randomized Controlled Trial)|Recruiting||N/A|42|Anticipated|University of Basel||2|||f||||f||||||||No||2017-10-10 22:32:55.624024|2017-10-10 22:32:55.624024
NCT02657005|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-10-13|||May 2016||2016-05-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||TK216 in Patients With Relapsed or Refractory Ewing Sarcoma|A Phase 1, Dose Escalation Study of Intravenous TK216 in Patients With Relapsed or Refractory Ewing Sarcoma|Recruiting||Phase 1|45|Anticipated|Oncternal Therapeutics, Inc||1|||f||||f||||||||No||2017-10-10 22:32:55.734|2017-10-10 22:32:55.734
NCT02656992|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-01-13|||September 2014||2014-09-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Effects of High Intensity Inspiratory Muscle Training on Exercise Capacity in Patients With Bronchiectasis|Effects of High Intensity Inspiratory Muscle Training on Exercise Capacity in Patients With Bronchiectasis|Recruiting||N/A|44|Anticipated|Hacettepe University||2|||f||||f||||||||||2017-10-10 22:32:56.026568|2017-10-10 22:32:56.026568
NCT02656979|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-01-13|||December 2013||2013-12-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Blood Flow of Ophthalmic Artery and Glaucoma|Blood Flow of Ophthalmic Artery and Its Relationship to Structural Properties of the Optic Nerve and Intraocular Pressure in Glaucoma|Recruiting||N/A|125|Anticipated|Umeå University||2|||f||||f||||||||||2017-10-10 22:32:56.134452|2017-10-10 22:32:56.134452
NCT02656966|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-06-27|||December 2015||2015-12-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|AcuAnx||Auricular Acupuncture for Treatment of Preoperative Anxiety|Auricular Acupuncture vs. Standard Therapy for Treatment of Preoperative Anxiety in Patients Scheduled for Ambulatory Gynaecological Surgery - a Pilot Non-randomized Controlled Trial|Completed||Phase 2|42|Actual|University Medicine Greifswald||2|||f||||f||||||||Undecided||2017-10-10 22:32:56.253116|2017-10-10 22:32:56.253116
NCT02656953|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-04-14|||March 2015||2015-03-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||The Impact of Lenses on Musculoskeletal and Visual Complaints in VDU Workers With Neck Complaints|The Impact of Wearing VDU Lenses Versus Progressive Lenses on Musculoskeletal and Visual Complaints in VDU Workers With Work Related Neck Complaints: A Randomized Controlled Trial|Completed||N/A|40|Actual|University Ghent||2|||f||||f||||||||No||2017-10-10 22:32:56.34129|2017-10-10 22:32:56.34129
NCT02656940|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-12|||February 2013||2013-02-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Dietary Lipids, Energy Expenditure and Obesity Biomarkers|Effects of Dietary Lipid Modulation in Energy Expenditure, Body Composition, Obesity-related Biomarkers and Gene Expression of Peroxisome Proliferator-Activated Receptors Alpha and Gamma 2 in Adipose Tissue of Obese Women|Completed||N/A|32|Actual|Universidade Federal do Rio de Janeiro||3|||f||||f||||||||||2017-10-10 22:32:56.423985|2017-10-10 22:32:56.423985
NCT02656927|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-07-27|||May 2016||2016-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SCI||Evaluation of a Specialized Yoga Program for Persons With Spinal Cord Injury (SCI)|Evaluation of a Specialized Yoga Program for Persons With Spinal Cord Injury: A Randomized Controlled Trial|Completed||N/A|22|Actual|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-10 22:32:56.540079|2017-10-10 22:32:56.540079
NCT02656914|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-01-20|||July 2017|Anticipated|2017-07-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of EMS Association to Resfenol® to Treat Flu Symptoms|Phase III, National, Multicenter, Randomized, Open Trial, to Assess the Non Inferiority EMS Association Compared to Resfenol® to Treat Flu Symptoms|Not yet recruiting||Phase 3|326|Anticipated|EMS||2|||f||||t|f|f||||||||2017-10-10 22:32:56.633936|2017-10-10 22:32:56.633936
NCT02656901|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-07-03|||January 2016||2016-01-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Early Postoperative Cognitive Dysfunction After Closed Loop Anesthesia vs Inhalational Anesthesia or TIVA|Incidence of Early Postoperative Cognitive Dysfunction After Closed Loop Anesthesia vs Inhalational Anesthesia or TIVA|Completed||N/A|132|Actual|University of Foggia||4|||f||||f||||||||No||2017-10-10 22:32:56.737754|2017-10-10 22:32:56.737754
NCT02656888|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-01-20|||July 2017|Anticipated|2017-07-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparison of EMS Association to Nasaliv® to Treat Flu Symptoms|Phase III, National, Multicenter, Randomized, Open Trial, to Assess the Non Inferiority of EMS Association Compared to Nasaliv® to Treat Flu Symptoms|Not yet recruiting||Phase 3|274|Anticipated|EMS||2|||f||||t|f|f||||||||2017-10-10 22:32:56.855104|2017-10-10 22:32:56.855104
NCT02656875|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-12-28|||December 2015||2015-12-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|ATHENA-1||A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain|A Phase 3, Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain for Which Parenteral Opioid Therapy is Warranted|Recruiting||Phase 3|900|Anticipated|Trevena Inc.||1|||f||||f||||||||||2017-10-10 22:32:56.95465|2017-10-10 22:32:56.95465
NCT02656862|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-03-07|||October 2015||2015-10-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|1 Day|Observational [Patient Registry]|RESFANDI||Causes of Acute Undifferentiated Fever in Outpatients in the Democratic Republic of Congo|Causes of Acute Undifferentiated Fever in Outpatients in the Democratic Republic of Congo|Completed||N/A|301|Actual|Institute of Tropical Medicine, Belgium|||1||f||||f||||||||Undecided||2017-10-10 22:32:57.062287|2017-10-10 22:32:57.062287
NCT02654444|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-01-12|||May 2013||2013-05-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|May 2014|Actual|2014-05-01||Observational|||Semi-Quantification of Her2/Neu Protein Expression in Formalin Fixed, Paraffin-Embedded Normal and Neoplastic Tissue|Concordance Study of Her2 Expression Level in Breast Cancer Tissues|Completed||N/A|3|Actual|Applied Spectral Imaging Ltd.|||3||f||||f||||||||||2017-10-10 22:34:55.934472|2017-10-10 22:34:55.934472
NCT02656849|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-06-29|||February 2016||2016-02-01|June 2016|2016-06-01|May 2023|Anticipated|2023-05-01|October 2019|Anticipated|2019-10-01||Interventional|||BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors|A Phase II Study of BAY 1000394 in MCL1-Amplified, MYC-Amplified, CCNE1-Amplified Tumors|Withdrawn||Phase 2|0|Actual|Dana-Farber Cancer Institute||1||Development of BAY1000394 has been terminated by Bayer.|f||||t||||||||||2017-10-10 22:32:57.135608|2017-10-10 22:32:57.135608
NCT02656836|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-15|||November 2015||2015-11-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Home Tonometry With the I-care Tonometer for Glaucoma|Home Tonometry for Monitoring Glaucoma:a Pilot Study of the Icare Home Tonometer|Recruiting||N/A|20|Anticipated|Queen's University, Belfast|||1||f||||f||||||||Undecided||2017-10-10 22:32:57.212322|2017-10-10 22:32:57.212322
NCT02656823|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-17|||November 24, 2015|Actual|2015-11-24|September 2016|2016-09-01||||June 30, 2022|Anticipated|2022-06-30||Interventional|||Implant-fixed Restorations With ANKYLOS 6.6 mm Implants in the Edentulous Maxilla - A 5-year Follow-up Study|Implant-fixed Restorations With Short Implants in the Edentulous Maxilla - A Clinical Investigation Over a 5-year Follow-up Period|Recruiting||N/A|56|Anticipated|Dentsply Sirona Implants||1|||f||||||||||||||2017-10-10 22:32:57.300328|2017-10-10 22:32:57.300328
NCT02656810|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-08-02|||December 2015||2015-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Comparison Study of PF708 and Forteo in Healthy Subjects|A Double-Masked, Randomized, Two-Treatment Cross-over Study Comparing the Pharmacokinetics of PF708 and Forteo Administered by Subcutaneous Injection in Healthy Adult Subjects|Completed||Phase 1|70|Actual|Pfenex, Inc||2|||f||||f||||||||Undecided||2017-10-10 22:32:57.393499|2017-10-10 22:32:57.393499
NCT02656797|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-25|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis|Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis|Not yet recruiting||Phase 2|108|Anticipated|Soroka University Medical Center||2|||f||||t|f|f||||||No||2017-10-10 22:32:57.506495|2017-10-10 22:32:57.506495
NCT02656784|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2017-06-21|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|May 3, 2017|Actual|2017-05-03|December 2016|Actual|2016-12-01||Interventional|||The Efficacy of TBCT Compared to ERP in the Treatment of OCD Patients, by the Assessment of Magnetic Resonance.|The Resonance Assessment in Magnetic Measurement of the Effect of Psychotherapy in Obsessive-compulsive Disorder in a Randomized Clinical Trial|Completed||N/A|96|Actual|Universidade Estadual do PiauÍ||3|||f||||t||||||||No||2017-10-10 22:32:57.642974|2017-10-10 22:32:57.642974
NCT02656771|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-08-25|||January 2016||2016-01-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Evaluation of Stability of Two Uncemented Hip Implants Used for Total Hip Arthroplasty|Evaluation of Uncemented Echo Bi-Metric Full Proximal Profile THA Stem Versus Uncemented Bi-Metric Porous Primary THA Stem in a Randomized Controlled Trial Using RSA and DXA|Recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark||2|||f||||||||||||||2017-10-10 22:32:57.741915|2017-10-10 22:32:57.741915
NCT02656758|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-09|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intensive Executive Function Training|A Randomized Controlled Study on the Effect of Intensive Functional Training on Children With Attention Deficit Hyperactivity Disorder|Enrolling by invitation||N/A|80|Anticipated|Peking University||2|||f||||t||||||||||2017-10-10 22:32:57.861603|2017-10-10 22:32:57.861603
NCT02656745|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-01-30|||May 2016||2016-05-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Trial of Smoking Cessation Mobile Phone Program|Clinical Trial of Mobile-Based Intervention for Smoking Cessation|Active, not recruiting||N/A|416|Actual|Click Therapeutics, Inc.||1|||f||||t||||||||No||2017-10-10 22:32:58.078876|2017-10-10 22:32:58.078876
NCT02656732|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-21|||June 2014||2014-06-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Amnion Chorion Membrane in Comparison to Subepithelial Connective Tissue Graft in Gingival Recession Coverage|Clinical Evaluation of Amnion Chorion Membrane in Comparison to Subepithelial Connective Tissue Graft in Gingival Recession Coverage: A Randomized Controlled Clinical Trial.|Completed||N/A|20|Actual|Cairo University||2|||f||||f||||||||No||2017-10-10 22:32:58.185143|2017-10-10 22:32:58.185143
NCT02656719|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-10-17|||August 2015||2015-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Comparison Between Bronchoscopy and Real- Time Ultrasound Guided Percutaneous Tracheostomy|Comparison Between Bronchoscopy and Real- Time Ultrasound Guided Percutaneous Dilatational Tracheostomy for Safety, Complications and Efficiency in Critically Ill Patient|Completed||N/A|80|Actual|Tepecik Training and Research Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:32:58.282656|2017-10-10 22:32:58.282656
NCT02656706|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-03|||July 2016||2016-07-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Interventional|||BrUOG 324: Adjuvant Nivolumab and Low Dose Ipilimumab for Stage III and Resected Stage IV Melanoma: A Phase II Brown University Oncology Research Group Trial||Recruiting||Phase 2|25|Anticipated|Brown University||1|||f||||t||||||||||2017-10-10 22:32:58.388457|2017-10-10 22:32:58.388457
NCT02656693|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-16|||February 2016||2016-02-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|PROPS||Integrating Online Weight Management With Primary Care Support|Integrating Online Weight Management With Primary Care Support: Patient-Centered Strategies for Addressing Overweight and Obesity in Primary Care|Active, not recruiting||N/A|840|Actual|Brigham and Women's Hospital||3|||f||||f|f|f||||||||2017-10-10 22:32:58.51725|2017-10-10 22:32:58.51725
NCT02656680|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-07-25|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Mentoring in mHealth and Social Networking Interventions for CVD Risk Reduction|Mentoring in mHealth and Social Networking Interventions for CVD Risk Reduction|Not yet recruiting||N/A|160|Anticipated|University of Massachusetts, Worcester||2|||f||||t|f|f||||||||2017-10-10 22:32:58.624286|2017-10-10 22:32:58.624286
NCT02656667|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-04-25|||June 2016||2016-06-01|June 2016|2016-06-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|ESNM||Effect of Neuromuscular Electrical Stimulation Versus Cycle Ergometer Training in a Pulmonary Rehabilitation Program|Effect of Neuromuscular Electrical Stimulation Versus Cycle Ergometer Training in a Pulmonary Rehabilitation Program|Recruiting||N/A|102|Anticipated|University Hospital, Brest||2|||f||||f||||||||No||2017-10-10 22:32:58.745757|2017-10-10 22:32:58.745757
NCT02656654|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-14|||April 2015||2015-04-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|COCOON||COrporeal Compression at the ONset of Severe Sepsis and Septic Shock|Pilot Study to Evaluate the Efficacy of and the Tolerance to a Body Bandage to Maintain Fluid Balance in Patients With Severe Sepsis or in Septic Shock in an ICU|Unknown status|Recruiting|N/A|47|Anticipated|Centre Hospitalier Universitaire Dijon|||||f||||f||||||||No||2017-10-10 22:32:58.896496|2017-10-10 22:32:58.896496
NCT02656641|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-07-18|||November 2015||2015-11-01|July 2017|2017-07-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|||Using the PHQ-9 and GAD-7 as Feedback Instruments in Brief Psychotherapy|Using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder 7-Item Scale (GAD-7) as Feedback Instruments in Brief Psychotherapy|Completed||N/A|81|Actual|Christiana Care Health Services||3|||f||||f||||||||||2017-10-10 22:32:58.997691|2017-10-10 22:32:58.997691
NCT02656628|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-01-20|||May 2015||2015-05-01|January 2016|2016-01-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01|6 Months|Observational [Patient Registry]|DLS||Observational Patient Registry of the Dynamic Locking Screws|A Multi-Center Prospective, Observational Patient Registry of the Dynamic Locking Screws in Metaphyseal and Diaphyseal Shaft Fractures of the Humerus, Femur and Tibia|Withdrawn||N/A|0|Actual|Synthes GmbH|||1|Due to the voluntary recall of the study device (DLS 3.7mm and DLS 5.0mm)|f||||f||||||||||2017-10-10 22:32:59.099156|2017-10-10 22:32:59.099156
NCT02656615|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-03-22|||January 2016||2016-01-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|ABI-RE||Abiraterone-Rechallenge Study for CRPC Patients|An Open Label Biomarker Driven Phase II Clinical Trial of Abiraterone Acetate (AA) Re-Challenge in Patients With Metastatic Castration-Resistant Prostate Cancer and Prior Response to AA|Terminated||Phase 2|4|Actual|Cantonal Hospital of St. Gallen||1||Lack of Patient accrual|f||||f||||||||No||2017-10-10 22:32:59.188604|2017-10-10 22:32:59.188604
NCT02656602|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-14|||February 2013||2013-02-01|January 2016|2016-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|PAVO-E-EDUC||Computer-assisted Instruction Before Colonoscopy is as Effective as Nurse Counselling, a Controlled Trial|Computer-assisted Instruction Before Colonoscopy is as Effective as Nurse Counselling, a Controlled Trial (PAVO-E-EDUC)|Completed||N/A|385|Actual|Medical Center Alkmaar||2|||f||||f||||||||No||2017-10-10 22:32:59.300925|2017-10-10 22:32:59.300925
NCT02656589|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-12|||June 2015||2015-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin|A Perspective Study of the Predictive Value of microRNA in Patients With HER2 Positive Advanced Stage Breast Cancer Who Were Treated With Herceptin|Recruiting||N/A|300|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|||2||f||||t||||||||||2017-10-10 22:32:59.408482|2017-10-10 22:32:59.408482
NCT02656576|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-21|||March 2012|Actual|2012-03-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|HPV-BIOFRO||Detection of Human Papillomavirus in Polymerase Chain for Suspicious Lesions of the Amygdala: Concordance Smear-Biopsy|Detection of Human Papillomavirus in Polymerase Chain for Suspicious Lesions of the Amygdala: Concordance Smear-Biopsy|Completed||N/A|80|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 22:32:59.559973|2017-10-10 22:32:59.559973
NCT02656563|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-10-13|||October 2015||2015-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|RAND||Radium 223 Following Intermittent ADT|Phase II, Randomized, Open Label to Evaluate Efficacy,Safety of Radium 223 in Prolonging the Off Treatment Interval in Men With Rising PSA Post-rad, or Post-prostatectomy Without Bone Mets on Intermittent Androgen Ablation Therapy|Withdrawn||Phase 2|0|Actual|Canadian Urology Research Consortium||2|||f||||t||||||||||2017-10-10 22:32:59.652993|2017-10-10 22:32:59.652993
NCT02656550|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-09|||November 11, 2015|Actual|2015-11-11|June 2017|2017-06-01|January 2026|Anticipated|2026-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility|Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Factor Infertility|Recruiting||N/A|10|Anticipated|Baylor Research Institute||1|||f||||t||||||||Undecided||2017-10-10 22:32:59.738489|2017-10-10 22:32:59.738489
NCT02656537|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-10-03|||August 2015||2015-08-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||EnSite™ HD Grid Catheter AF/AT Mapping Study|EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia|Active, not recruiting||N/A|200|Anticipated|St. Jude Medical||1|||f||||f||||||||||2017-10-10 22:32:59.8582|2017-10-10 22:32:59.8582
NCT02656524|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-06-16|||May 16, 2016|Actual|2016-05-16|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||Stivarga Real Life Evidence in Hungary|Effectiveness of Stivarga (Regorafenib) for Patients With Metastatic Colorectal Cancer in the Hungarian Real World Setting|Completed||N/A|400|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:32:59.960772|2017-10-10 22:32:59.960772
NCT02656511|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-09-13|||December 2015||2015-12-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|DGVTRU||"Immediate Initiation of Antiretroviral Therapy During Hyperacute HIV Infection"|"Immediate Initiation of Antiretroviral Therapy During Hyperacute HIV Infection"|Recruiting||Phase 4|24|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 22:33:00.067826|2017-10-10 22:33:00.067826
NCT02656498|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-03-24|||January 2016||2016-01-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease|An Open Label, Multicenter Study for Evaluation of the Clinical Utility of [18F]THK-5351 Positron Emission Computed Tomography in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, Subjects With Alzheimer's Disease and Subjects With Other Neurodegenerative Diseases|Recruiting||Phase 2|180|Anticipated|Asan Medical Center||4|||f||||f||||||||||2017-10-10 22:33:00.192387|2017-10-10 22:33:00.192387
NCT02656485|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-04-03|2017-04-03||August 5, 2015|Actual|2015-08-05|April 2017|2017-04-01|July 15, 2016|Actual|2016-07-15|March 1, 2016|Actual|2016-03-01||Interventional||All subjects were adult men or women, between the ages of 18 and 45 years.|A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris|A Double Blind, Placebo-Controlled, Single Center, Randomized, Sequential, Ascending 14-Day Multiple Dose Study in Subjects With Acne Vulgaris to Evaluate the Safety, Tolerability and Preliminary Efficacy of B244 Delivered as a Topical Spray|Completed||Phase 1/Phase 2|36|Actual|AOBiome LLC||4|||f||||f||||||||||2017-10-10 22:33:00.298402|2017-10-10 22:33:00.298402
NCT02656472|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-04-18|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|TXAEACA||A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery|A Pilot Study Comparing Anti-Inflammatory Effects Of Tranexamic Acid Versus Epsilon Aminocaproic Acid In Pediatric Congenital Heart Surgery|Completed||Phase 4|22|Actual|Advocate Health Care||2|||f||||t||||||||||2017-10-10 22:33:00.825594|2017-10-10 22:33:00.825594
NCT02656459|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-04-24|||January 2016||2016-01-01|April 2017|2017-04-01||||July 2017|Anticipated|2017-07-01||Observational|||Longitudinal Gene Expression Profiling in Adults After Traumatic Injury|Longitudinal Gene Expression Profiling in Adults After Traumatic Injury|Recruiting||N/A|50|Anticipated|Stanford University|||1||f||||f||||||Samples Without DNA|"     Whole blood RNA specimens will be retained up to 3 years after study end.   "|||2017-10-10 22:33:00.914234|2017-10-10 22:33:00.914234
NCT02656446|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-04-28|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Accuracy of Depth and Landmark Assessment Using Neuraxial Ultrasound Devices|Accuracy of Depth and Landmark Assessment Using Neuraxial Ultrasound Devices|Completed||N/A|50|Actual|Stanford University|||1||f||||f||||||||||2017-10-10 22:33:01.002079|2017-10-10 22:33:01.002079
NCT02656433|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2017-09-14|||March 1, 2017|Actual|2017-03-01|September 2017|2017-09-01|December 28, 2017|Anticipated|2017-12-28|September 13, 2017|Actual|2017-09-13||Interventional|BrainInjury||tES With Random Noise Stimulation Applied to Children With Brain Injury|Transcranial Noninvasive Brain Stimulation With Random Noise for Children With Congenital or Acquired Brain Injury|Recruiting||N/A|50|Anticipated|Spanish Foundation for Neurometrics Development||2|||f||||t|f|f||||||||2017-10-10 22:33:01.074952|2017-10-10 22:33:01.074952
NCT02656420|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-05-23|||January 2016||2016-01-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Broccoli Sprout Dose Response|Broccoli Sprout Dose Response|Completed||Phase 1/Phase 2|170|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||No||2017-10-10 22:33:01.34574|2017-10-10 22:33:01.34574
NCT02656407|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|FUSIMAGINE||Intraoperative Functional Ultrasound|Doppler Ultrasonore Ultrasensible Peropératoire du Cerveau - Vers Une Aide Temps Reel à la Cartographie Corticale Fonctionnelle|Recruiting||N/A|50|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-10 22:33:01.453118|2017-10-10 22:33:01.453118
NCT02656394|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-12|||January 2016||2016-01-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101|Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101 - Proof of Concept, Safety, and Efficacy Study|Recruiting||Phase 2|50|Anticipated|GLIA LLC||2|||f||||t||||||||Undecided||2017-10-10 22:33:01.574417|2017-10-10 22:33:01.574417
NCT02656381|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-06-30|||December 29, 2015||2015-12-29|March 6, 2017|2017-03-06|January 4, 2036|Anticipated|2036-01-04|January 4, 2036|Anticipated|2036-01-04||Observational|||Uveitis/Intraocular Inflammatory Disease Biobank (iBank)|Uveitis/Intraocular Inflammatory Disease Biobank (iBank)|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:33:01.670791|2017-10-10 22:33:01.670791
NCT02656368|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-13|||January 2015||2015-01-01|March 2015|2015-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis|Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis|Completed||N/A|30|Actual|Kamedis Ltd.||1|||f||||t||||||||No||2017-10-10 22:33:01.767512|2017-10-10 22:33:01.767512
NCT02656355|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-13|||January 2015||2015-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gait Initiation Difficulty and Anticipatory Postural Adjustment (APA) Impairment in People With PD - Evaluation and Training||Recruiting||N/A|90|Anticipated|Chang Gung University||6|||f||||t||||||||||2017-10-10 22:33:01.880172|2017-10-10 22:33:01.880172
NCT02656342|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-10-05|||November 2015||2015-11-01|October 2017|2017-10-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients?|Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients? A Randomized, Double-blind, Placebo-controlled National Study|Active, not recruiting||Phase 4|160|Anticipated|Haukeland University Hospital||3|||f||||f||||||||||2017-10-10 22:33:02.00309|2017-10-10 22:33:02.00309
NCT02656329|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-10-04|||January 2016||2016-01-01|October 2017|2017-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|ADMIRE-ICD||International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device|AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%|Recruiting||Phase 3|2001|Anticipated|GE Healthcare||2|||f||||t||||||||||2017-10-10 22:33:02.159387|2017-10-10 22:33:02.159387
NCT02656316|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-04-28|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The Effects of Multi-focal tDCS on Motor-cognitive Dysfunctions in Parkinson's Disease|The Effects of Multi-focal Transcranial Direct Current Stimulation (tDCS) on Motor-cognitive Dysfunctions and Freezing of Gait in Patients With Parkinson's Disease: A Randomized Controlled Trial|Recruiting||N/A|85|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:33:02.469648|2017-10-10 22:33:02.469648
NCT02656303|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-09-07|||January 2016||2016-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||An Open-Label Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304|A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination With TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304|Recruiting||Phase 2|300|Anticipated|TG Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 22:33:02.586996|2017-10-10 22:33:02.586996
NCT02656290|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-07-21|||December 2015||2015-12-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|COMMENCE-P||COMMENCE Pulmonary: Clinical Evaluation of Edwards Pericardial Aortic Bioprosthesis (Model 11000A) for Pulmonary Valve Replacement|Prospective, Non‐Randomized, Single Arm, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic Bioprosthesis (Model 11000A) for Pulmonary Valve Replacement|Recruiting||N/A|100|Anticipated|Edwards Lifesciences||1|||f||||t||||||||||2017-10-10 22:33:02.667161|2017-10-10 22:33:02.667161
NCT02656277|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-01-30|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy of First Time Anterior Shoulder Decision Tool|Efficacy of First Time Anterior Shoulder Decision Tool in a Randomized Control Trial|Completed||N/A|210|Actual|Duke University||2|||f||||f||||||||No||2017-10-10 22:33:02.75561|2017-10-10 22:33:02.75561
NCT02656264|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-04-18|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||The Chronic Pain Incidence After Elective and Urgent Cesarean Sections|The Chronic Pain Incidence After Elective and Urgent Cesarean Sections|Completed||N/A|200|Actual|Tokat Gaziosmanpasa University|||1||f||||t||||||||Undecided||2017-10-10 22:33:02.829927|2017-10-10 22:33:02.829927
NCT02656238|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-08-18|||February 2015||2015-02-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|3 Years|Observational [Patient Registry]|||New International CTEPH Database|New International CTEPH Database|Active, not recruiting||N/A|1019|Actual|International CTEPH Association|||1||f||||f||||||||||2017-10-10 22:33:03.012816|2017-10-10 22:33:03.012816
NCT02656212|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-04-26|||September 2015||2015-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Epicatechin||Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)|Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)|Completed||Phase 1|15|Actual|Veterans Medical Research Foundation||2|||f||||t||||||||||2017-10-10 22:33:03.282072|2017-10-10 22:33:03.282072
NCT02656199|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2016-01-13|||January 2015||2015-01-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Observational|||Change In Diaphragmatic Thickness Predicts Extubation Success|Can the Diaphragm Predict the Course of Mechanical Ventilation? A Prospective Study Evaluating Several M-Mode Ultrasound Measured Diaphragmatic Parameters and Their Effects on Weaning From Mechanical Ventilation|Recruiting||N/A|100|Anticipated|Albert Einstein Healthcare Network|||1||f||||f||||||||No||2017-10-10 22:33:03.371019|2017-10-10 22:33:03.371019
NCT02656186|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-01-15|||May 2015||2015-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Supplementation With Nutrients Modulating IGF-1 and Cytokines in Elderly People at Risk of Undernutrition|Supplementation With Nutrients Modulating IGF-1 Negatively Correlated With Changes in the Levels of Proinflammatory Cytokines in Community-dwelling Elderly People at Risk of Undernutrition|Completed||Phase 3|60|Actual|Yonsei University||1|||f||||t||||||||||2017-10-10 22:33:03.458569|2017-10-10 22:33:03.458569
NCT02656173|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-13|2017-08-31|||January 25, 2016|Actual|2016-01-25|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)|A Phase 4, Double-Blind, Randomized, Placebo-controlled Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With OAB Symptoms, While Taking the Alpha Blocker,Tamsulosin, for BPH|Completed||Phase 4|730|Actual|Astellas Pharma Inc||2|||f||||f|t|f|||t|||||2017-10-10 22:33:03.541714|2017-10-10 22:33:03.541714
NCT02656160|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-07-14|2017-03-29||January 2016||2016-01-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|APIGLOSS||Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults|The Effect of Dalfampridine (4-aminopyridine) on Genioglossus Muscle Activity During Wakefulness and Sleep in Healthy Control Subjects|Completed||Phase 2|13|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 22:33:03.737279|2017-10-10 22:33:03.737279
NCT02656147|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL|Phase I Study of γδT Cells Expressing an Anti-CD19 Chimeric Receptor in Children and Young Adults With B Cell Malignancies|Not yet recruiting||Phase 1|48|Anticipated|Beijing Doing Biomedical Co., Ltd.||3|||f||||f|f|f||||||||2017-10-10 22:33:03.970068|2017-10-10 22:33:03.970068
NCT02656134|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-02|2016-01-12|||March 2015||2015-03-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01|2 Years|Observational [Patient Registry]|||Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)|Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis: A Prospective Clinical, Immunopathologic and Molecular Analysis|Recruiting||N/A|55|Anticipated|University of Sao Paulo|||1||f||||t||||||Samples With DNA|"     Small bowel biopsies and blood samples   "|||2017-10-10 22:33:04.049576|2017-10-10 22:33:04.049576
NCT02656121|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-02-14|||February 2016||2016-02-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|PCOSD||Does Vitamin D Break the Vicious Circle of Polycystic Ovarian Syndrome of Insuline Resistance ?|Advances in Pathogenesis and Management of Polycystic Ovarian Syndrome in Arab Girls and Women: Role of Vitamin D Status, Adipokines, Follistatin, and Vitamin D Supplementation Therapy|Recruiting||Phase 2|210|Anticipated|Ain Shams University||2|||f||||t||||||||Yes||2017-10-10 22:33:04.157702|2017-10-10 22:33:04.157702
NCT02656108|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-07-07|||May 2016|Actual|2016-05-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Omission of Controlled Cord Traction During Active Management of Third Stage of Labor|Omission of Controlled Cord Traction During Active Management of Third Stage of Labor. A Single Blinded Randomized Controlled Trial|Recruiting||N/A|320|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:33:04.258808|2017-10-10 22:33:04.258808
NCT02656095|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-09-26|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment|Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment|Active, not recruiting||N/A|12|Actual|University of Colorado, Denver|||1||f||||t||||||||||2017-10-10 22:33:04.460105|2017-10-10 22:33:04.460105
NCT02656082|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|TARGET-DLE||Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus|A Single Arm, Simon's 2-stage Minimax Design, Phase II Open Label Trial to Investigate the Efficacy and Safety of Intra-dermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus|Recruiting||Phase 2|25|Anticipated|University of Leeds||1|||f||||t||||||||||2017-10-10 22:33:04.53787|2017-10-10 22:33:04.53787
NCT02656069|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-05-24|||February 10, 2017|Actual|2017-02-10|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Efficacy of G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics|G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adult Patients With T1DM: A Phase 3, Multi-center, Randomized, Blinded, 2-Way Crossover Study to Evaluate Efficacy and Safety|Recruiting||Phase 3|100|Anticipated|Xeris Pharmaceuticals||2|||f||||f|t|f||||||No||2017-10-10 22:33:04.689221|2017-10-10 22:33:04.689221
NCT02656056|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-02-17|||January 2016||2016-01-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome|Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome|Recruiting||Phase 1|20|Anticipated|Yale University||2|||f||||f||||||||Undecided||2017-10-10 22:33:04.815604|2017-10-10 22:33:04.815604
NCT02656043|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-27|||September 2015||2015-09-01|November 2016|2016-11-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel|A Phase 1 and 2 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, Efficacy, and Exposure of up to 12 Weeks of XPF-005 Treatment in Healthy Volunteers and Subjects With Acne Vulgaris|Completed||Phase 1/Phase 2|213|Actual|Xenon Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-10 22:33:04.926265|2017-10-10 22:33:04.926265
NCT02656030|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-02-12|||November 2015||2015-11-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Specific Training for Deep Neck Muscle|Effects of Specific Training of Deep Cervical Muscles in Chronic Mechanical Neck Pain|Recruiting||N/A|60|Anticipated|Khon Kaen University||3|||f||||t||||||||Undecided||2017-10-10 22:33:05.050968|2017-10-10 22:33:05.050968
NCT02656017|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-06-27|||May 2016||2016-05-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Interventional|TAME||Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease|Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease|Recruiting||Phase 2|96|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-10 22:33:05.15001|2017-10-10 22:33:05.15001
NCT02656004|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-12|||August 2013||2013-08-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Essential Oil of Eucalyptus Effect on Cardiovascular Responses|Essential Oil of Eucalyptus Effect on Cardiovascular Responses During Recovery of Elderly and Isometric Resistance Exercise|Completed||N/A|20|Actual|Universidade Federal do vale do São Francisco||2|||f||||t||||||||No||2017-10-10 22:33:05.275314|2017-10-10 22:33:05.275314
NCT02655991|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-01-12|||March 2008||2008-03-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|HCL||Homecoming Line: Telephone Support for Veterans|Homecoming Line: Telephone Support for Veterans|Completed||N/A|358|Actual|VA Palo Alto Health Care System||2|||f||||f||||||||||2017-10-10 22:33:05.352736|2017-10-10 22:33:05.352736
NCT02655978|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-08-02|||January 2016||2016-01-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder Type I|Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder Type I|Recruiting||N/A|75|Anticipated|University Hospitals Cleveland Medical Center|||3||f||||t||||||||||2017-10-10 22:33:05.458872|2017-10-10 22:33:05.458872
NCT02655965|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-04-24|||May 2016||2016-05-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|DESIGN||Double-blind Study to Assess effectIveness of Pectoral Nerves Block After Breast Surgery on Piritramide Consumption|A Randomised, Double-blind, Placebo-controlled Study to Assess the effectIveness of Pectoral Nerves Block (PECS) After Breast Surgery on Piritramide Consumption|Recruiting||Phase 3|74|Anticipated|Jules Bordet Institute||2|||f||||f||||||||No||2017-10-10 22:33:05.555965|2017-10-10 22:33:05.555965
NCT02655952|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-01-04|||April 2016||2016-04-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients|Phase Ib Dose Escalating Study to Evaluate the Safety, Tolerability and Pharmacodynamic Response of Foxy-5 in Patients With Metastatic Breast-, Colon- or Prostate Cancer|Recruiting||Phase 1|15|Anticipated|WntResearch AB||1|||f||||f||||||||||2017-10-10 22:33:05.663257|2017-10-10 22:33:05.663257
NCT02655939|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-24|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study to Assess the Efficacy and Safety of Reflex Plus™ in Osteoarthritis|Double Blind, Randomized, Multicentre, Placebo Controlled Study to Assess the Efficacy and Safety of Reflex Plus™ in Osteoarthritis|Completed||Phase 4|258|Actual|Vedic Lifesciences Pvt. Ltd.||2|||f||||f||||||||||2017-10-10 22:33:05.765977|2017-10-10 22:33:05.765977
NCT02655926|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-03-01|||September 2012||2012-09-01|July 2015|2015-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Deep Brain Stimulation for Severe Obsessive Compulsive Disorder|Deep Brain Stimulation for Severe Obsessive Compulsive Disorder: Efficacy and Mechanisms of Ventral Striatum and Subthalamic Nucleus Targets|Completed||N/A|6|Actual|University College, London||2|||f||||f||||||||||2017-10-10 22:33:05.858379|2017-10-10 22:33:05.858379
NCT02655913|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-08-19|||December 2015||2015-12-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|VCONSCLC||Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer|Phase I-II Study of Vitamin C Infusion in Combination With Local mEHT on Non Small Cell Lung Cancer Patients|Recruiting||Phase 1/Phase 2|75|Anticipated|Clifford Hospital, Guangzhou, China||2|||f||||t||||||||Undecided||2017-10-10 22:33:05.953473|2017-10-10 22:33:05.953473
NCT02655900|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-01-12|||August 2013||2013-08-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Use of 3D Ultrasound to Predict Anal Sphincter Defects|Use of 3D Ultrasound to Predict Anal Sphincter Defects|Completed||N/A|250|Actual|Croydon University Hospital|||1||f||||t||||||||||2017-10-10 22:33:06.082462|2017-10-10 22:33:06.082462
NCT02655887|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-06-14|||June 15, 2016||2016-06-15||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:33:06.140655|2017-10-10 22:33:06.140655
NCT02655874|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-04-20|||April 2016||2016-04-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|TROPICS1||Tropical Influenza Control Strategies for the Elderly|A Single-centre, Randomised, Observer-blind, Active Comparator-controlled, Superiority Trial of the Immune Response to Six-monthly Versus Annual Standard Dose Inactivated Trivalent Influenza Vaccination in the Elderly|Recruiting||Phase 4|200|Anticipated|Tan Tock Seng Hospital||2|||f||||f||||||||No||2017-10-10 22:33:06.186169|2017-10-10 22:33:06.186169
NCT02655861|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-09-01|||June 2015||2015-06-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|||A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis|Prospective Evaluation of Infants and Children With Congenital Ichthyosis|Recruiting||N/A|30|Anticipated|Yale University|||1||f||||f||||||Samples With DNA|"     Saliva or blood   "|||2017-10-10 22:33:06.282757|2017-10-10 22:33:06.282757
NCT02655848|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-10-07|||July 2012||2012-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|BITE||Tenotomy or Tenodesis of Long Head Biceps in Arthroscopic Rotator Cuff Repair|Long Head Biceps Tenodesis or Tenotomy in Arthroscopic Rotator Cuff Repair: An International Multicenter Prospective Randomized Clinical Trial|Recruiting||N/A|98|Anticipated|Onze Lieve Vrouwe Gasthuis||2|||f||||f||||||||Undecided||2017-10-10 22:33:06.382104|2017-10-10 22:33:06.382104
NCT02655835|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-12|||September 2014||2014-09-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|December 2015|Actual|2015-12-01||Interventional|IMMI||Internet Mindfulness Meditation Intervention|Internet Mindfulness Meditation Intervention|Active, not recruiting||N/A|52|Actual|Oregon Health and Science University||2|||f||||f||||||||No||2017-10-10 22:33:06.523946|2017-10-10 22:33:06.523946
NCT02655822|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-18|||January 2016||2016-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers|A Phase 1/1b, Open-Label, Multicenter, Repeat-Dose, Dose-Selection Study of CPI-444 as Single Agent and in Combination With Atezolizumab in Patients With Selected Incurable Cancers|Recruiting||Phase 1|534|Anticipated|Corvus Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-10 22:33:06.616581|2017-10-10 22:33:06.616581
NCT02655809|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-03-06|||May 2015||2015-05-01|January 2016|2016-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Physica KR Fluoroscopy Study|Physica KR: In Vivo Kinematic Analysis of a Novel Total Knee Replacement Implant|Recruiting||N/A|23|Anticipated|Limacorporate S.p.a||1|||f||||||||||||||2017-10-10 22:33:06.865572|2017-10-10 22:33:06.865572
NCT02655796|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-28|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||A Device for Screening of Fall Risk in the Elderly|Evaluation of Screening Accuracy of a Device for Fall Risk Assessment in the Elderly: a Cross-sectional Study With a Futility Design|Completed||Phase 2|184|Actual|Istituto Ortopedico Galeazzi||2|||f||||t||||||||||2017-10-10 22:33:06.926189|2017-10-10 22:33:06.926189
NCT02655783|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-10-27|||January 2013||2013-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|DEXTRONS||Use of Normal Saline With or Without Dextrose During Induction of Labor in Nulliparous|Utilisation parentérale de Normal Salin Avec ou Sans Dextrose Durant l'Induction du Travail Chez Les Nullipares|Completed||N/A|200|Actual|Université de Sherbrooke||2|||f||||f||||||||Yes|Oral presentation at the Society of Maternal and Fetal Medicine annual meeting (January 2017, Las Vegas) Manuscript in preparation|2017-10-10 22:33:07.008092|2017-10-10 22:33:07.008092
NCT02655770|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-08-01|||February 2016||2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients|Influence of Liraglutide on Diastolic Cardiac Function and Myocardial Perfusion as Determined by Magnetic Resonance Imaging in Patients With Type 2 Diabetes: a Double-blind Randomized Parallel-group Trial|Recruiting||Phase 4|40|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 22:33:07.080723|2017-10-10 22:33:07.080723
NCT02655757|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2017-02-02|||December 2015||2015-12-01|February 2017|2017-02-01|March 10, 2017|Anticipated|2017-03-10|February 2, 2017|Actual|2017-02-02||Interventional|||Effect of Sitagliptin on Progression of Coronary Intermediate Lesion|Effect of Sitagliptin on Progression of Coronary Intermediate Lesion in Patients With Coronary Heart Disease Complicated With Type 2 Diabetes|Recruiting||Phase 4|120|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-10 22:33:07.187345|2017-10-10 22:33:07.187345
NCT02655744|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-04-17|||November 2015||2015-11-01|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute||Recruiting||N/A|25|Anticipated|Chang Gung Memorial Hospital|||1||f||||||||||||||2017-10-10 22:33:07.270867|2017-10-10 22:33:07.270867
NCT02655731|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-09-30|||December 2015||2015-12-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|HEURECA||HeartLight Guided - Pure Pulmonary Vein Isolation Regardless of Concomitant Atrial Substrate|HeartLight Guided - Pure Pulmonary Vein Isolation Regardless of Concomitant Atrial Substrate|Recruiting||N/A|100|Anticipated|Cardioangiologisches Centrum Bethanien||1|||f||||t||||||||||2017-10-10 22:33:07.356478|2017-10-10 22:33:07.356478
NCT02655718|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-01-13|||October 2015||2015-10-01|January 2016|2016-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|NOCA||Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis|Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis|Recruiting||N/A|200|Anticipated|Russian Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 22:33:07.442237|2017-10-10 22:33:07.442237
NCT02655705|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-04-14|||August 2014||2014-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparison Study of Psoriasis Severity Assessment Tools|Comparison of the Performance of Subjective or Objective Psoriasis Severity Assessment Tools for the Assessment of the Improvement of Psoriasis After Oral Cyclosporine A or Methotrexate Treatment|Completed||Phase 4|34|Actual|Seoul National University Hospital||2|||f||||t||||||||Yes|De-identified individual participant data for all primary and secondary outcome measures will be made available within 6 months of study completion.|2017-10-10 22:33:07.536601|2017-10-10 22:33:07.536601
NCT02655692|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-08-21|||April 18, 2016|Actual|2016-04-18|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||CAP-Ketamine for Antidepressant Resistant PTSD|CAP-Ketamine for Antidepressant Resistant PTSD|Recruiting||Phase 2|198|Anticipated|VA Office of Research and Development||3|||f||||t|t|f||||||||2017-10-10 22:33:07.61628|2017-10-10 22:33:07.61628
NCT02655679|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-10|||December 2015||2015-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||An Ascending Multiple Dose Study of VTP-38543 in Adult Patients With Mild to Moderate Atopic Dermatitis|A Randomized, Double-Blind, Vehicle-Controlled Ascending Multiple Dose and Clinical Proof-Of-Concept Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTP-38543 in Adult Patients With Mild to Moderate Atopic Dermatitis|Completed||Phase 1/Phase 2|104|Actual|Vitae Pharmaceuticals, Inc.||5|||f||||f||||||||No||2017-10-10 22:33:07.71816|2017-10-10 22:33:07.71816
NCT02655666|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-10-03|||April 2015||2015-04-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Qingdao: Insulin Pump Follow-Up Program|Qingdao: Insulin Pump Follow-up Program|Terminated||N/A|16|Actual|Medtronic Diabetes|||1||f||||f||||||||Undecided||2017-10-10 22:33:07.839404|2017-10-10 22:33:07.839404
NCT02655653|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-05-04|||October 2008||2008-10-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery|A Randomized, Double-blinded Trial Comparing the Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery|Completed||N/A|114|Actual|Montefiore Medical Center||2|||f||||f||||||||||2017-10-10 22:33:08.439916|2017-10-10 22:33:08.439916
NCT02655640|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-08-03|||October 2015||2015-10-01|September 2015|2015-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis|The Impact of Illness Perceptions and Their Determinants on Health Related Outcomes in Patients With Systemic Lupus Erythematosus and Systemic Sclerosis|Completed||N/A|241|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-10 22:33:08.515967|2017-10-10 22:33:08.515967
NCT02655627|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-01-31|||April 2015|Actual|2015-04-01|January 2017|2017-01-01|September 1, 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Internet Based Exercise Training in Type 2 Diabetes|Can Internet Based Exercise Training Be an Alternative to Supervised Group Exercise Training in Patients With Type 2 Diabetes?|Completed||N/A|61|Actual|Biruni University||3|||f||||||||||||||2017-10-10 22:33:08.593965|2017-10-10 22:33:08.593965
NCT02655614|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-10-02|||May 31, 2016|Actual|2016-05-31|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|August 31, 2018|Anticipated|2018-08-31||Interventional|||A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis|A Phase I, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Single- and Multiple-Ascending-Dose Study to Determine Initial Safety, Tolerability, and Pharmacokinetics of GDC-0134 in Patients With Amyotrophic Lateral Sclerosis|Recruiting||Phase 1|72|Anticipated|Genentech, Inc.||4|||f|||||t|||||||||2017-10-10 22:33:08.78916|2017-10-10 22:33:08.78916
NCT02655601|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-12-05|||May 2016||2016-05-01|December 2016|2016-12-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|BMX-HGG||Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001|A Phase 1/2 Trial for Patients With Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide, and BMX-001|Recruiting||Phase 1/Phase 2|66|Anticipated|BioMimetix JV, LLC||3|||f||||f||||||||No||2017-10-10 22:33:08.978009|2017-10-10 22:33:08.978009
NCT02655588|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-03-10|||September 2014||2014-09-01|March 2017|2017-03-01|October 20, 2016|Actual|2016-10-20|October 20, 2016|Actual|2016-10-20||Interventional|||A Computerized Intervention for Depression|A Computerized Intervention for Depression|Completed||N/A|45|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||Undecided||2017-10-10 22:33:09.132194|2017-10-10 22:33:09.132194
NCT02655575|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-09-08|||October 2015||2015-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|LODIP||Assessment and Treatment of Patients With Long-term Dizziness in Primary Care|Assessment and Treatment of Patients With Long-term Dizziness in Primary Care|Recruiting||N/A|125|Anticipated|Bergen University College||2|||f||||f||||||||||2017-10-10 22:33:09.240558|2017-10-10 22:33:09.240558
NCT02655562|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-08-25|||April 2016||2016-04-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough|Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough：A Prospective, Open Label, Randomized and Placebo-Controlled Trial|Recruiting||Phase 4|200|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:33:09.389355|2017-10-10 22:33:09.389355
NCT02655549|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-07-07|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects|A Phase 1a Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Study Assessing Safety and Immunogenicity of Px563L and RPA563 Administered by Intramuscular Injection in Healthy Adult Volunteers|Completed||Phase 1|54|Actual|Pfenex, Inc||3|||f||||f||||||||||2017-10-10 22:33:09.520228|2017-10-10 22:33:09.520228
NCT02655536|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-09-20|||July 2016||2016-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|BRILLIANT||Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial|A Phase II, Open Label, Multicenter Study of Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in Patients With EGFR Mutant Non-small Cell Lung Cancer Who Have Brain Metastases|Recruiting||Phase 2|109|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:33:09.630923|2017-10-10 22:33:09.630923
NCT02655523|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-12-09|||December 2015||2015-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparison of Dexamethasone and Triamcinolone for Ultrasound-guided Occipital C2 Nerve Blocks|A Comparison of Dexamethasone and Triamcinolone in Combination With Bupivacaine for Ultrasound-guided Occipital C2 Nerve Blocks: A Randomized Controlled Trial|Recruiting||Phase 4|75|Anticipated|Northwestern University||3|||f||||f||||||||No||2017-10-10 22:33:09.753119|2017-10-10 22:33:09.753119
NCT02655510|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-11-09|||February 2016||2016-02-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TREAT 008||Use of F-652 in Patients With Alcoholic Hepatitis|An Open-Label, Cohort Dose Escalation Study to Assess the Safety and Efficacy of F-652 in Patients With Alcoholic Hepatitis|Recruiting||Phase 1/Phase 2|24|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:33:09.874369|2017-10-10 22:33:09.874369
NCT02655497|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-11-17|||September 2015||2015-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Maintaining Independence in Everyday Life Among Seniors With Subjective Cognitive Complaints|Maintaining Independence in Everyday Life Among Seniors With Subjective Cognitive Complaints|Completed||N/A|16|Actual|Baycrest||2|||f||||t||||||||||2017-10-10 22:33:09.994356|2017-10-10 22:33:09.994356
NCT02655484|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-07-15|||January 2016||2016-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Carbon Dioxide Rebreathing During Exercise Assisted by Non-invasive Ventilation|Evaluation of Carbon Dioxide Rebreathing During Exercise Assisted by Non-invasive Ventilation|Completed||N/A|18|Actual|Guangzhou Institute of Respiratory Disease||1|||f||||t||||||||||2017-10-10 22:33:10.096953|2017-10-10 22:33:10.096953
NCT02655471|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-01-11|||March 2016||2016-03-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection|Effect of Raltegravir in Patients With Myelopathy/Tropical Spastic Paraparesis Associated With Infection by Human T-Lymphotropic Virus 1 (HTLV-1). Pilot Study|Not yet recruiting||Early Phase 1|10|Anticipated|Universidad Peruana Cayetano Heredia||1|||f||||f||||||||||2017-10-10 22:33:10.182633|2017-10-10 22:33:10.182633
NCT02655458|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-08-15|||January 2016||2016-01-01|August 2017|2017-08-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Interventional|||Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma|Phase 1 Study of Elotuzumab in Combination With Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma|Completed||Phase 1|15|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-10 22:33:10.300597|2017-10-10 22:33:10.300597
NCT02655445|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-01-11|||January 2012||2012-01-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randomized Controlled Trial Investigating Optimal Treatment for Chronic Subdural Hematoma|Compact Trial - A Randomized Controlled Trial Investigating Optimal Treatment for Chronic Subdural Hematoma|Recruiting||N/A|150|Anticipated|Universitair Ziekenhuis Brussel||3|||f||||f||||||||||2017-10-10 22:33:10.407433|2017-10-10 22:33:10.407433
NCT02655432|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-11-30|||January 2016||2016-01-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|POPH||Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population|Évaluation de l'Utilisation d'un Photoscreener Comme méthode de dépistage Des problèmes Ophtalmologiques pédiatriques en Haïti|Withdrawn||Early Phase 1|0|Actual|Université de Montréal|||1|waiting for ethic board approval|f||||f||||||||No||2017-10-10 22:33:10.509562|2017-10-10 22:33:10.509562
NCT02655406|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-07-04|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|COMFETTI||COMpression Following Endovenous TreatmenT of Incompetent Varicose Veins (COMFETTI)|COMpression Following Endovenous TreatmenT of Incompetent Varicose Veins (COMFETTI)|Recruiting||N/A|180|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-10 22:33:10.8465|2017-10-10 22:33:10.8465
NCT02655393|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-01-05|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects|A Single (Part A) and Multiple (Part B) Dose Study of AMAZ-02, a Food Derived Ingredient to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Profile in Healthy Elderly Subjects|Completed||Phase 1|60|Actual|Amazentis SA||9|||f||||f||||||||||2017-10-10 22:33:10.934265|2017-10-10 22:33:10.934265
NCT02655380|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-06-26|||August 2018|Anticipated|2018-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Remifentanil Requirement for Acceptable Intubating Condition|Remifentanil Requirement for Acceptable Intubating Condition With Two Dose Ketamine Without Neuromuscular Blocking Agent in Children|Not yet recruiting||Phase 4|60|Anticipated|Ajou University School of Medicine||2|||f|||||f|f||||||||2017-10-10 22:33:11.015939|2017-10-10 22:33:11.015939
NCT02655367|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-08-31|||November 2015||2015-11-01|January 2016|2016-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|Oatmet||The Effect of Oat Processing on Gastric Emptying and Satiety Induced After Consuming Porridge|The Effect of Oat Processing on Gastric Emptying and Satiety Induced After Consuming Porridge|Completed||N/A|8|Actual|Quadram Institute||2|||f||||f||||||||||2017-10-10 22:33:11.084201|2017-10-10 22:33:11.084201
NCT02655341|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-01-12|||January 2016||2016-01-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|HYD-AMI||Hydration Status Assessment Through Body Composition Monitoring in Patients With Acute Myocardial Infarction|Hydration Status Assessment Through Body Composition Monitoring And Renal Artery Stenosis Evaluation in Patients With Acute Myocardial Infarction Referred For Primary PCI|Recruiting||N/A|400|Anticipated|Grigore T. Popa University of Medicine and Pharmacy|||1||f||||f||||||||||2017-10-10 22:33:11.365673|2017-10-10 22:33:11.365673
NCT02655328|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-01-11|||March 2009||2009-03-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|SALBEXO||Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and Doping|Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and Doping|Completed||Phase 4|14|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 22:33:11.450004|2017-10-10 22:33:11.450004
NCT02655315|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-05-18|||February 2016||2016-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FAIRPARKII||Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease|"Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone"|Recruiting||Phase 2|338|Anticipated|University Hospital, Lille||2|||f||||t||||||||Undecided||2017-10-10 22:33:11.515461|2017-10-10 22:33:11.515461
NCT02655302|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-06-06|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|COPD1722||Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD|Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD|Not yet recruiting||N/A|100|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 22:33:11.728852|2017-10-10 22:33:11.728852
NCT02655289|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-05-02|||February 2016||2016-02-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain Patients|Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain Patients - A Randomized, Double-blind, Placebo-controlled Cross-over Pilot Study|Recruiting||N/A|20|Anticipated|University Hospital Freiburg||2|||f||||f||||||||No||2017-10-10 22:33:11.843004|2017-10-10 22:33:11.843004
NCT02655276|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-02-01|||January 2016||2016-01-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children|Effects of Sublingual Microencapsulated Glycine on Attentional Difficulties and Hyperactivity in Prepuberal Children - A Placebo-controlled, Double-blind, Randomized, Cross-over Study|Recruiting||N/A|30|Anticipated|University Hospital Freiburg||2|||f||||f||||||||No||2017-10-10 22:33:11.935665|2017-10-10 22:33:11.935665
NCT02655263|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-10-04|||January 2016||2016-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion|Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion|Active, not recruiting||N/A|10|Anticipated|University of Aarhus||3|||f||||t||||||||||2017-10-10 22:33:12.026986|2017-10-10 22:33:12.026986
NCT02655250|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-01-11|||September 2015||2015-09-01|December 2015|2015-12-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Observational|||Neonatal Microbiome Validity Study|The Neonatal Microbiome Study: Validity of Biologic Sample Collection Methods|Active, not recruiting||N/A|5|Actual|State University of New York at Buffalo|||1||f||||f||||||Samples With DNA|"     Stool and breast milk samples will be collected. Bacterial DNA will be isolated and stored.     Human DNA will not be retained in these samples.   "|||2017-10-10 22:33:12.114599|2017-10-10 22:33:12.114599
NCT02655237|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-02|||March 5, 2016|Actual|2016-03-05|June 2017|2017-06-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids|A Multicenter, Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-385 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids|Completed||Phase 3|288|Actual|Takeda||3|||f||||f|f|f||||||||2017-10-10 22:33:12.172021|2017-10-10 22:33:12.172021
NCT02655224|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-08|||May 24, 2016|Actual|2016-05-24|June 2017|2017-06-01|May 12, 2017|Actual|2017-05-12|May 12, 2017|Actual|2017-05-12||Interventional|||A Placebo-Controlled, Phase 3 Study of TAK-385 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-385 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids|Completed||Phase 3|70|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 22:33:14.251607|2017-10-10 22:33:14.251607
NCT02655211|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-04-13|||December 2016||2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LIBERTI||Laser Induced Bioengineered Remodeling of Thermally Injured Skin Trial|Laser Induced Bioengineered Remodeling of Thermally Injured Skin Trial: The Sequential Multiple Assignment Randomized Trial (SMART) Approach to Treatment of Hypertrophic Burn Scars|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||12||Due to staff shortages we are closing the study.|f||||t||||||||||2017-10-10 22:33:14.351644|2017-10-10 22:33:14.351644
NCT02655185|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-01-11|||February 2016||2016-02-01|January 2016|2016-01-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||Novel Risk Factors of Atrial Fibrillation in Patients With Chronic Heart Failure|Study to Evaluate Association of Blood Lipid Levels With Atrial Fibrillation Incidence in Patients With Chronic Heart Failure|Not yet recruiting||N/A|300|Anticipated|Yangzhou No.1 People's Hospital|||1||f||||t||||||||No||2017-10-10 22:33:14.553325|2017-10-10 22:33:14.553325
NCT02655172|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-03-09|||May 2016||2016-05-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|GRASP||Have a Good Grasp of the Worldthe World|"Study on the Links Between Action and Perception in Schizophrenia,  Have a Good Grasp of the World "|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:33:14.620751|2017-10-10 22:33:14.620751
NCT02655159|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-10-28|||January 2016||2016-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|AMBER||Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice|Retrospective Observational Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice|Terminated||N/A|46|Actual|Celgene Corporation|||1|"Given the infeasibility to achieve the study population together with the loss of originality   in the scientific rationale, it was considered to cancel the study"|f||||f||||||||||2017-10-10 22:33:14.7118|2017-10-10 22:33:14.7118
NCT02655146|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2016-01-12|||December 2015||2015-12-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .|Implantation in Frozen Embryo Transfer|Recruiting||Phase 4|700|Anticipated|Chong Qing Reproducive and Genetic Institute||2|||f||||t||||||||Undecided||2017-10-10 22:33:14.821537|2017-10-10 22:33:14.821537
NCT02655133|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-05-02|||January 2016||2016-01-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients.|Effects on Sublingual Microcirculation of IgGAM Immunoglobulins (Pentaglobin®) in Severe Septic/Septic Shock Patients: a Randomized Controller Trial.|Recruiting||Phase 2|20|Anticipated|Università Politecnica delle Marche||2|||f||||t||||||||No||2017-10-10 22:33:14.930826|2017-10-10 22:33:14.930826
NCT02655120|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-02-01|||March 2005||2005-03-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|BMP7||Autologous Bone Marrow and BMP7 Treatment in the Necrosis in the Femoral Head of the Adult|Evaluation of the Efficiency of Autologous Bone Marrow no Concentrated to Associate at BMP7 Treatment of Necrosis of the Femoral Head of the Adult|Active, not recruiting||N/A|80|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 22:33:15.195222|2017-10-10 22:33:15.195222
NCT02655107|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-12-18|||February 2015||2015-02-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Non-invasive Measurement of Hemoglobin in Infants and Neonates|Non-invasive Measurement of Hemoglobin in Infants and Neonates: Comparison With CO-oximetrie and Point-of-care Devices.|Completed||N/A|60|Actual|University of Schleswig-Holstein|||1||f||||f||||||||No||2017-10-10 22:33:15.305825|2017-10-10 22:33:15.305825
NCT02655094|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2017-06-03|||February 2016||2016-02-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Unilateral Pulmonary Edema After Minimal-invasive Mitral Valve Surgery|Unilateral Pulmonary Edema After Minimal-invasive Mitral Valve Surgery: a Retrospective Single Center Observation|Completed||N/A|256|Actual|University of Schleswig-Holstein|||1||f||||f||||||||No||2017-10-10 22:33:15.399129|2017-10-10 22:33:15.399129
NCT02655081|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-09-29|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|IMPACT||Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy|Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy|Completed||Phase 2|48|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 22:33:15.476235|2017-10-10 22:33:15.476235
NCT02655068|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-26|||May 2012||2012-05-01|July 2017|2017-07-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer|Efficacy of Monitoring Strategies Following Definitive Therapy for Locally Advanced Head and Neck Cancer: A Randomized, Phase III Trial of PET/CT vs. CT Surveillance|Terminated||Phase 3|38|Actual|University of Pittsburgh||2||due to non-feasibility|f||||t||||||||||2017-10-10 22:33:15.570356|2017-10-10 22:33:15.570356
NCT02655055|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-05-11|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2017|Actual|2017-01-01||Interventional|ALTRUYST||Bone Density in Voluntary Apheresis Blood Donors|Randomized Longitudinal Study of Apheresis Voluntary Blood Donors' Bone Density|Active, not recruiting||N/A|58|Actual|Blood Center of Wisconsin||2|||f||||f||||||||No||2017-10-10 22:33:15.683817|2017-10-10 22:33:15.683817
NCT02655042|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-04-06||||||April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|ReaCT-X||Long-Term Follow-up of the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis|A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis|Withdrawn||N/A|0|Actual|RepliCel Life Sciences, Inc.|||2|Study conduct does not meet corporate objectives of sponsor|f||||f||||||||||2017-10-10 22:33:15.78992|2017-10-10 22:33:15.78992
NCT02655029|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-03-23|||November 25, 2015|Actual|2015-11-25|March 2017|2017-03-01|December 21, 2016|Actual|2016-12-21|December 2016|Actual|2016-12-01|4 Months|Observational [Patient Registry]|CONTROL-3||Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination|Prospective, Non-interventional Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination, in a Greek Population With Hypertension|Completed||N/A|2285|Actual|Servier Hellas Pharmaceuticals Ltd.|||1||f||||f||||||||||2017-10-10 22:33:15.889926|2017-10-10 22:33:15.889926
NCT02655016|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-05-24|||April 2016||2016-04-01|February 2017|2017-02-01||||August 2019|Anticipated|2019-08-01||Interventional|||A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy|Recruiting||Phase 3|330|Anticipated|Tesaro, Inc.||2|||f||||t||||||||||2017-10-10 22:33:16.000223|2017-10-10 22:33:16.000223
NCT02655003|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-02-14|||January 7, 2016|Actual|2016-01-07|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|TIME||Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropscyhiatric Symptoms|TIME - Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropscyhiatric Symptoms|Completed||N/A|229|Actual|Sykehuset Innlandet HF||2|||f||||f||||||||||2017-10-10 22:33:16.306192|2017-10-10 22:33:16.306192
NCT02654977|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-10-17|||April 2015||2015-04-01|October 2016|2016-10-01|February 2025|Anticipated|2025-02-01|February 2025|Anticipated|2025-02-01||Interventional|||CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy|CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Recombinant Human Leptin (METRELEPTIN) in Various Forms of Partial Lipodystrophy|Recruiting||Phase 2|15|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-10 22:33:16.921635|2017-10-10 22:33:16.921635
NCT02654964|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-12-01|||November 2015||2015-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cancer Stem Cell High-Throughput Drug Screening Study|A Phase 0/1 Study of Combination Drug Therapy For Glioblastoma Based on Personalized Cancer Stem Cell (CSC) High-Throughput Drug Screening (HTS)|Recruiting||Phase 1|10|Anticipated|Swedish Medical Center||1|||f||||t||||||||||2017-10-10 22:33:17.016197|2017-10-10 22:33:17.016197
NCT02654951|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-03-30|||January 2016||2016-01-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Reaching in Stroke|Reducing Compensatory Movements in Stroke Therapy Through the Use of Robotic Devices and Augmented Feedback|Completed||N/A|23|Actual|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:33:17.110382|2017-10-10 22:33:17.110382
NCT02654938|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-09-19|||July 2015||2015-07-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer|Multicenter, Randomized, Single-blind Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer|Completed||Phase 1|32|Actual|Panacela Labs LLC||2|||f||||f||||||||||2017-10-10 22:33:17.20977|2017-10-10 22:33:17.20977
NCT02654925|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-07-27|||March 2016||2016-03-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|MYTH||Myeloid to Adipocyte Transdifferentiation in Human Cells|Myeloid to Adipocyte Transdifferentiation in Human Cells|Recruiting||N/A|50|Anticipated|University of Colorado, Denver|||4||f||||f||||||||||2017-10-10 22:33:17.341126|2017-10-10 22:33:17.341126
NCT02654912|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-12-20|||February 2016||2016-02-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|CORE Zambia||Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration|Community-led Responses for Elimination (CoRE): A Cluster Randomized Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration in Malaria Elimination Areas in Southern Province Zambia|Recruiting||Phase 4|4800|Anticipated|PATH||2|||f||||t||||||||||2017-10-10 22:33:17.448219|2017-10-10 22:33:17.448219
NCT02654899|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-04-02|||November 2015||2015-11-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Single Dose Study of PF-06815345 in Healthy Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess Safety, Tolerability, And Pharmacokinetics Of Single Escalating Oral Doses Of Pf-06815345, As Well As Characterize The Pharmacokinetics Of Two Formulations And Effect Of Food On Pharmacokinetics Of One Formulation Of Pf‑06815345 Administered To Healthy Adult Subjects|Active, not recruiting||Phase 1|25|Actual|Pfizer||5|||f||||f||||||||||2017-10-10 22:33:17.567933|2017-10-10 22:33:17.567933
NCT02654886|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-11|||October 2015||2015-10-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|ExercisPompe||Safety and Effectiveness of Resistance Exercise Training in Patients With Pompe Disease.|Safety and Effectiveness of Resistance Exercise Training in Patients With Late Onset Pompe Disease- A Pilot Study|Recruiting||N/A|10|Anticipated|University of California, Irvine||1|||f||||t||||||||Yes|Individual participant data will be made available to partcipants after data is published in a peer reviewed journal.|2017-10-10 22:34:48.886313|2017-10-10 22:34:48.886313
NCT02654873|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-10-12|||December 2015||2015-12-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|October 2016|Actual|2016-10-01||Observational|||Is Routine Use of Histopathological Examination Necessary After Cholecystectomy ?||Active, not recruiting||N/A|1000|Actual|Sisli Etfal Training & Research Hospital|||3||f||||f||||||Samples Without DNA|"     cholecystectomy specimens   "|Undecided|Because the time period of this study is very short|2017-10-10 22:34:48.989104|2017-10-10 22:34:48.989104
NCT02654860|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-09-21|||November 2016||2016-11-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia|Two-part Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia in Patients Scheduled for Hip Replacement Surgery|Recruiting||Phase 1/Phase 2|69|Anticipated|Sintetica SA||4|||f||||t||||||||||2017-10-10 22:34:49.070428|2017-10-10 22:34:49.070428
NCT02654847|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-08-29|||January 2016||2016-01-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Norepinephrine To Prevent Hypotension After Spinal Anesthesia For Cesarean Delivery: A Dose Finding Study|Norepinephrine To Prevent Hypotension After Spinal Anesthesia For Cesarean Delivery: A Dose Finding Study|Completed||N/A|40|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||6|||f||||f||||||||No||2017-10-10 22:34:49.175359|2017-10-10 22:34:49.175359
NCT02654834|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-09-08|||May 2014||2014-05-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Observational|||Oxidative Stress in OR Personnel|Oxidative Stress Status During Anesthesia in Pediatric Surgical Room Staff Versus Non-operating Room Personnel: Pilot Study|Recruiting||N/A|40|Anticipated|Nationwide Children's Hospital|||2||f||||f||||||Samples With DNA|"     Two 5 mL blood samples collected at the start of a work week and at the end of a work week.   "|No||2017-10-10 22:34:49.29645|2017-10-10 22:34:49.29645
NCT02654821|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-01-09|||March 2012||2012-03-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|TCR||Study With T-cel Receptor Gene Therapy in Metastatic Melanoma|Multicenter Phase I/IIa Study Using T-cell Receptor Gene Therapy in Metastatic Melanoma|Recruiting||Phase 1/Phase 2|25|Anticipated|The Netherlands Cancer Institute||1|||f||||t||||||||Undecided||2017-10-10 22:34:49.368679|2017-10-10 22:34:49.368679
NCT02654808|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-19|||March 2016||2016-03-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||AirSeal®Insufflation Trocar/CO2 Absorption Study|A Comparison of CO2 Absorption During Gynecologic Laparoscopy Using the AirSeal® Valveless Trocar System Versus Standard Insufflation Trocars at Intra-abdominal Pressures of 10 mmHg and 15 mmHg - a Randomized Controlled Trial|Not yet recruiting||N/A|132|Anticipated|Columbia University||4|||f||||f||||||||||2017-10-10 22:34:49.445752|2017-10-10 22:34:49.445752
NCT02654795|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-12|||August 2013||2013-08-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|ASSAM||Assessment of Left Atrial Appendage Morphology in Patients After Ischemic Stroke|AssesSment of the Left Atrial Appendage morphoLogy in Patients aAfter ischeMic Stroke|Recruiting||N/A|200|Anticipated|Centre of Postgraduate Medical Education||2|||f||||f||||||||No||2017-10-10 22:34:49.542891|2017-10-10 22:34:49.542891
NCT02654782|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-09-21|||January 2016||2016-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Lactated Ringer's Versus 5% Human Albumin: Cardiac Surgical Patients|Lactated Ringer's Versus 5% Human Albumin: A Double-Blinded, Randomized, Prospective Study in Cardiac Surgical Patients|Recruiting||N/A|70|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:34:49.615278|2017-10-10 22:34:49.615278
NCT02654769|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-12|2017-06-26|||February 2015||2015-02-01|June 2017|2017-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis|Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities|Completed||Phase 3|441|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-10 22:34:49.693031|2017-10-10 22:34:49.693031
NCT02654756|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-18|||May 2013||2013-05-01|January 2016|2016-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Risk of Chronic Kidney Disease Progression|Risk of Chronic Kidney Disease Progression|Active, not recruiting||N/A|623|Actual|Winthrop University Hospital|||1||f||||f||||||||||2017-10-10 22:34:49.798568|2017-10-10 22:34:49.798568
NCT02654743|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-10-25|||January 2016||2016-01-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||Open Label of Clinical Trial of Sulforaphane in Children With Autism|An Examination of Changes in Urinary Metabolites With Use of an Antioxidant Supplement, Sulforaphane, in School-aged Children With Autism|Enrolling by invitation||Phase 2|40|Anticipated|University of California, San Francisco||1|||f||||f||||||||No||2017-10-10 22:34:49.859155|2017-10-10 22:34:49.859155
NCT02654730|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-09-08|||December 2015||2015-12-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|September 2016|Actual|2016-09-01||Interventional|SAFEPRIM-II||Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia|Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia|Terminated||Phase 2/Phase 3|61|Actual|London School of Hygiene and Tropical Medicine||5||"Enrollment took longer than anticipated; it was financially and logistically impossible to   recruit the final cohort (G6PDd 0.4mg/kg PQ)."|f||||t||||||||Yes|WWARN|2017-10-10 22:34:49.922486|2017-10-10 22:34:49.922486
NCT02654717|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-08-02|||November 2015||2015-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp||Completed||Phase 2|111|Actual|Promius Pharma, LLC||2|||f||||f||||||||No||2017-10-10 22:34:52.577338|2017-10-10 22:34:52.577338
NCT02654704|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2017-07-05|||November 2015||2015-11-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Vaccination Responses in Young and Older Adults|Vaccination Responses in Young and Older Adults|Recruiting||N/A|60|Anticipated|Michigan State University|||6||f||||f||||||Samples With DNA|"     If the volunteers agree,tissue is stored for usage in future research without identifiers.     This includes cells from blood and saliva and extracted DNA, RNA and protein. The cells may     be used to grow a new cell line that may be maintained in the laboratory.   "|||2017-10-10 22:34:52.662122|2017-10-10 22:34:52.662122
NCT02654691|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-04-21|||June 2016||2016-06-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|April 2017|Actual|2017-04-01||Observational|DOLORISK-CIPN||Chronic Neuropathy Following Chemotherapy|DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Chronic Neuropathy Following Chemotherapy|Active, not recruiting||N/A|63|Actual|Danish Pain Research Center|||1||f||||f||||||Samples With DNA|"     Blood samples   "|Yes|Data is shared among collaborators (DOLORisk consortium)|2017-10-10 22:34:52.74961|2017-10-10 22:34:52.74961
NCT02654678|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-12|||March 2016||2016-03-01|January 2016|2016-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|LENA-WP10||Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril|Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Ethicare GmbH||1|||f||||t||||||||Yes|Serious Adverse Event information|2017-10-10 22:34:52.833641|2017-10-10 22:34:52.833641
NCT02654665|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-09-07|||March 2014||2014-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CGH-LiNASH||Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults|Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults|Recruiting||Phase 3|36|Anticipated|Changi General Hospital||3|||f||||f||||||||||2017-10-10 22:34:52.959994|2017-10-10 22:34:52.959994
NCT02654639|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-30|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|October 2019|Anticipated|2019-10-01||Interventional|ALEXANDRIA||Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer|An Open-Label, Multi-center, Phase 2 Study of Switch Maintenance With TAS-102 Plus Bevacizumab Following Oxaliplatin or Irinotecan-Based Fluoropyrimidine-Containing Induction Chemotherapy in Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|4|Actual|Georgetown University||1|||f||||t||||||||||2017-10-10 22:34:53.120253|2017-10-10 22:34:53.120253
NCT02653365|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-01-12|||March 2012||2012-03-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|||Predictors of Non-invasive Ventilation Failure in Patients With Acute Cardiogenic Pulmonary Edema||Completed||N/A|118|Actual|Beijing Chao Yang Hospital|||1||f||||||||||||||2017-10-10 22:35:07.017372|2017-10-10 22:35:07.017372
NCT02654626|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-05-13|||October 2015||2015-10-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects|A Randomized, Single-blind, Placebo-controlled, Sequential Parallel-Group and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-7072 in Healthy Subjects|Completed||Phase 1|16|Actual|KBP Biosciences||4|||f||||t||||||||||2017-10-10 22:34:53.195965|2017-10-10 22:34:53.195965
NCT02654613|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-02-01|||June 1, 2015|Actual|2015-06-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|SUTHI||Scaling up TB and HIV Treatment Integration|Addressing Challenges in Scaling up TB and HIV Treatment Integration in Public Health Settings in South Africa|Recruiting||N/A|8000|Anticipated|Centre for the AIDS Programme of Research in South Africa||2|||f||||t||||||||No||2017-10-10 22:34:53.263685|2017-10-10 22:34:53.263685
NCT02654600|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-05-21|||June 2014||2014-06-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2014|Actual|2014-06-01||Observational|COMPLI||Variations of the Lung Compliance During Extracorporeal Circulation and Post Operative Pulmonary Complications|Variations of the Lung Compliance During Extracorporeal Circulation and Post Operative Pulmonary Complications|Completed||N/A|60|Actual|Centre Chirurgical Marie Lannelongue|||1||f||||f||||||||||2017-10-10 22:34:54.589542|2017-10-10 22:34:54.589542
NCT02654587|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-11|||February 2016||2016-02-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|ATALANTE 1||Study of OSE2101 Versus Standard Treatment as 2nd or 3rd Line in HLA-A2 Positive Patients With Advanced NSCLC|A Randomized Parallel Group Phase III Trial of OSE2101 as 2nd or 3rd Line Compared With Standard Treatment (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Locally Advanced (IIIB) Unsuitable for Radiotherapy or Metastatic (IV) Non-Small-Cell Lung Cancer. (OSE2101C301)|Active, not recruiting||Phase 3|131|Actual|OSE Immunotherapeutics||2|||f||||t||||||||||2017-10-10 22:34:54.663317|2017-10-10 22:34:54.663317
NCT02654574|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-05-19|||June 2014||2014-06-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|IADL||Comparison of Two Modes of Administration of the IADL Questionnaire, Assessing the Level of Functional Autonomy of Patients to Carry Out the Tasks of Daily Living: Randomized Controlled Trial Among Patients of a Memory Clinic|Comparison of Two Modes of Administration of the IADL Questionnaire|Completed||N/A|299|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:34:54.893637|2017-10-10 22:34:54.893637
NCT02654561|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-01-12|||May 2016||2016-05-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|||Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation|Phase 3 Study of the Efficacy and Safety of Unfractionated Heparin in Patients With Severe Sepsis/Septic Shock With Suspected DIC|Unknown status|Not yet recruiting|Phase 3|700|Anticipated|China Medical University, China||2|||f||||f||||||||||2017-10-10 22:34:54.95549|2017-10-10 22:34:54.95549
NCT02654548|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-12|||June 2013||2013-06-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Sebum Excretion in Neonates of Women With Polycystic Ovary Syndrome (PCOS)|Sebum Excretion in Neonates of Women With Polycystic Ovary Syndrome (PCOS): Does Increased Skin Greasiness in the First Week of Life Predict Subsequent Development of the Syndrome? A Cohort Study|Recruiting||N/A|20|Anticipated|Homerton University Hospital NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:34:55.148584|2017-10-10 22:34:55.148584
NCT02654535|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-05-13|||October 2015||2015-10-01|September 2015|2015-09-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Observational|||Meta-analyses of Nuts and Risk of Obesity|Nuts in Relation to Markers of Adiposity, Overweight, and Obesity: A Series of Systematic Reviews and Meta-analyses of Randomized Controlled Trials and Prospective Cohort Studies|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:34:55.232778|2017-10-10 22:34:55.232778
NCT02654522|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-05-15|||January 2016||2016-01-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers|The Use of a Recombinant DNA-based Hyaluronidase (RDNAH/ Hylenex Recombinant) to Dissolve Fixed Amounts of a Variety of Popular Hyaluronic Acid (HA) Dermal Fillers in Human Subjects.|Completed||Phase 1|15|Actual|Steve Yoelin M.D. Medical Associates, Inc.||2|||f||||f||||||||||2017-10-10 22:34:55.351294|2017-10-10 22:34:55.351294
NCT02654496|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-01-14|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Gut Microbiota Post Roux-en-Y Gastric Bypass Surgery|The Gut Microbiota in Patients Post Roux-en-Y Gastric Bypass Surgery|Recruiting||N/A|18|Anticipated|North Dakota State University|||3||f||||t|||||||"     Fecal Samples and Plasma/Serum Samples   "|No||2017-10-10 22:34:55.541723|2017-10-10 22:34:55.541723
NCT02654483|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-08-23|||July 2016||2016-07-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients|A Phase 2 Trial of Neurokinin-1 Receptor Antagonist for the Treatment of Itch in Epidermolysis Bullosa Patients|Recruiting||Phase 2|14|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 22:34:55.6447|2017-10-10 22:34:55.6447
NCT02654470|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-02-16|||February 2018|Anticipated|2018-02-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|April 2019|Anticipated|2019-04-01||Observational|||Watchman FLX Left Atrial Appendage Closure Device Post Approval Study|Watchman FLX Left Atrial Appendage Closure Device Post Approval Study|Not yet recruiting||N/A|300|Anticipated|Boston Scientific Corporation|||1||f||||f|f|f||||||No||2017-10-10 22:34:55.742235|2017-10-10 22:34:55.742235
NCT02654457|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-01-12|||December 2013||2013-12-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|May 2014|Actual|2014-05-01||Observational|||Identification and Semi-Quantification of Ki-67 Protein Expression Status|Identification and Semi-Quantification of Ki-67 Protein Expression Status in Formalin Fixed, Paraffin-embedded Normal and Neoplastic Breast Tissue|Completed||N/A|3|Actual|Applied Spectral Imaging Ltd.|||3||f||||f||||||||||2017-10-10 22:34:55.84351|2017-10-10 22:34:55.84351
NCT02654431|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-01-12|||May 2013||2013-05-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|||Identification and Semi -Quantification of ER/PR Proteins Expression|Identification and Semi -Quantification of ER/PR Proteins Expression Status in Formalin Fixed, Paraffin-embedded Normal and Neoplastic Tissue|Completed||N/A|350|Actual|Applied Spectral Imaging Ltd.|||3||f||||f||||||||||2017-10-10 22:34:56.016986|2017-10-10 22:34:56.016986
NCT02654418|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-09-01|||February 2016||2016-02-01|February 2017|2017-02-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Interventional|||Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm|A Randomized, Double-blind, Comparative, Effectiveness and Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm|Completed||N/A|226|Actual|Cosmo Technologies Ltd||2|||f||||f||||||||||2017-10-10 22:34:56.136278|2017-10-10 22:34:56.136278
NCT02654405|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-08-11|||April 2016||2016-04-01|August 2016|2016-08-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Sodium Butyrate For Improving Cognitive Function In Schizophrenia|Sodium Butyrate As A Treatment For Improving Cognitive Function In Schizophrenia|Withdrawn||Phase 2/Phase 3|0|Actual|Nathan Kline Institute for Psychiatric Research||2||"Nathan Kline Institute (NKI) decided not to accept study grant from Stanley Medical Research   Foundation. because of budget considerations."|f||||f||||||||Undecided|Stanley foundation requests: Based on the terms of your award, Stanley Medical Research Institute (SMRI) now requires submission of the individual patient data from all SMRI funded studies. In order to make the process as efficient as possible and provide a secure location for study data, National Institute of Mental Health (NIMH) is graciously allowing SMRI access to their National Database for Clinical Trials (NDCT) to collect and house data|2017-10-10 22:34:56.249634|2017-10-10 22:34:56.249634
NCT02654392|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-09|2016-01-12|||February 2016||2016-02-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Plant Omega-3 and Omega-6 Fatty Acids on Exercise Performance|Effect of Plant Omega-3 and Omega-6 Fatty Acids on Exercise Performance|Not yet recruiting||N/A|18|Anticipated|University of Western Ontario, Canada||2|||f||||t||||||||No||2017-10-10 22:34:56.367|2017-10-10 22:34:56.367
NCT02654379|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-22|||December 18, 2015|Actual|2015-12-18|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe|MabThera Drug Utilisation Study and Patient Alert Card Evaluation in Non-Oncology Patients in Europe: An Infusion Centre-Based Approach|Recruiting||N/A|1000|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:34:56.516779|2017-10-10 22:34:56.516779
NCT02654366|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-09-14|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Community Supported Risk Reduction for Syringe Exchange Participants|Social Network Intervention for Syringe Exchange Registrants|Recruiting||N/A|183|Anticipated|Johns Hopkins University||1|||f||||f|f|f||||||||2017-10-10 22:34:56.933481|2017-10-10 22:34:56.933481
NCT02654353|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-09|2016-01-12|||February 2012||2012-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach|A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach|Completed||Phase 4|100|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-10 22:34:57.052835|2017-10-10 22:34:57.052835
NCT02654340|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-03|||March 2015||2015-03-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|TuScCom||Genetic Heterogeneity and Genotype-phenotype Correlation of Children and Adults With Tuberous Sclerosis Complex|Epidemiological Study of the Genetic Heterogeneity and Genotype-phenotype Correlation of Children and Adults With Tuberous Sclerosis Complex|Recruiting||N/A|100|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry one dry     blood spot filter card are taken. To proof the correct diagnosis in those patients where up     to the enrollment in the study no genetic testing has been done, sequencing will be done. The     analyses are done in the Centogene AG, Schillingallee 68, 18057 Rostock, Germany   "|||2017-10-10 22:34:57.161933|2017-10-10 22:34:57.161933
NCT02654327|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2017-05-24|||March 2016||2016-03-01|May 2017|2017-05-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|REST||pRotective vEntilation With Veno-venouS Lung assisT in Respiratory Failure|pRotective vEntilation With Veno-venouS Lung assisT in Respiratory Failure|Recruiting||Phase 3|1120|Anticipated|Belfast Health and Social Care Trust||2|||f||||t||||||||Yes||2017-10-10 22:34:57.277579|2017-10-10 22:34:57.277579
NCT02654314|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-10|||July 2016||2016-07-01|August 2016|2016-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|PODIUM||Prevention of Delirium in Inpatients Utilizing Melatonin|Prevention of Delirium in Inpatients Utilizing Melatonin|Recruiting||Phase 3|650|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 22:34:57.417398|2017-10-10 22:34:57.417398
NCT02654301|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-01-12|||June 2014||2014-06-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Beneficial Effect of Xylose Consumption on Postprandial Hyperglycemia|Beneficial Effect of Xylose Consumption on Postprandial Hyperglycemia in Subjects With Normal Glucose Level and Impaired Fasting Glucose|Completed||N/A|80|Actual|Yonsei University||4|||f||||f||||||||||2017-10-10 22:34:57.554783|2017-10-10 22:34:57.554783
NCT02654288|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-24|||January 2016||2016-01-01|December 2015|2015-12-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After Chemotherapy|Dynamic Changes of the Serum Level of Immunoglobulin G4(IgG4) and Interleukin-10(IL-10) in the Patients of Pancreatic Cancer After Gemcitabine-based Chemotherapy|Recruiting||N/A|300|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||Samples Without DNA|"     The IgG4 in serum from peripheral blood will be detected.(4ml/test)   "|||2017-10-10 22:34:57.67045|2017-10-10 22:34:57.67045
NCT02654275|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-11|||February 2016||2016-02-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Proprioceptive Intervention Training on Power Capacity, Proprioceptive Ability and Technique of Young Swimmers||Not yet recruiting||N/A|100|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||No||2017-10-10 22:34:57.78651|2017-10-10 22:34:57.78651
NCT02654262|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-09-23|||January 2013||2013-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|STAR||Soft Tissue and Bone Development in Young Girls|Obesity and Bone Development in Young Girls|Recruiting||N/A|450|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||Samples With DNA|"     serum, saliva   "|||2017-10-10 22:34:57.898493|2017-10-10 22:34:57.898493
NCT02654249|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2017-03-30|||December 2015||2015-12-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|THD-LIGA||Prospective Randomized Trial About THD Versus Ligasure Hemorrhoidectomy for Grade III and IV Hemorrhoids|Prospective Multicenter Randomized Trial About Transanal Hemorrhoidal Dearterialization With Mucopexy (THD) Versus Ligasure Hemorrhoidectomy for Grade III and IV Hemorrhoids|Recruiting||N/A|80|Anticipated|Hospital Universitari de Bellvitge||2|||f||||f||||||||||2017-10-10 22:34:57.996741|2017-10-10 22:34:57.996741
NCT02654236|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-08-15|||April 2016||2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling|Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling|Recruiting||N/A|45|Anticipated|Indiana University||3|||f||||t||||||||||2017-10-10 22:34:58.182998|2017-10-10 22:34:58.182998
NCT02654223|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-03-10|||December 30, 2015|Actual|2015-12-30|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|MG56||Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy|Double Blind, Placebo-controlled, Dose Finding, Prospective, Multicenter Clinical Trial for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy|Recruiting||Phase 2|180|Anticipated|Inmunotek S.L.||9|||f||||f|f|f||||||No||2017-10-10 22:34:58.311831|2017-10-10 22:34:58.311831
NCT02654210|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-23|||February 2015||2015-02-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Observational|LoewenKIDS||LoewenKIDS - Infections and the Development of the Immune System|LoewenKIDS - Infections and the Development of the Immune System|Recruiting||N/A|1000|Anticipated|Helmholtz Centre for Infection Research|||1||f||||f||||||Samples With DNA|"     Nasal swabs nasal: Microbiome Nasal swabs: Virus detection Stool sample: Microbiome Stool     sample. Pathogen Detection Blood sample   "|||2017-10-10 22:34:58.509578|2017-10-10 22:34:58.509578
NCT02654197|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-01-11|||June 2016||2016-06-01|December 2015|2015-12-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli Children|Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli Children|Not yet recruiting||N/A|600|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||Samples With DNA|"     Blood samples will be taken for analysis and will be retained for later investigation.   "|No||2017-10-10 22:34:58.614344|2017-10-10 22:34:58.614344
NCT02654184|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-11-04|||January 2016||2016-01-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Right Lateral Positioning and Its Effect on Induction of General Anesthesia for Children|Right Lateral Positioning and Its Effect on Induction of General Anesthesia for Children|Completed||Phase 2|100|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:34:58.702475|2017-10-10 22:34:58.702475
NCT02654171|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-03-31|||May 27, 2016|Actual|2016-05-27|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|VICTOR||Viral Inhibition in Children for Treatment of RSV|A Randomized, Double-blind, Placebo-controlled, 2-Part Study of Orally Administered AK0529 to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Effect of Single and Multiple Dosing in Hospitalized Infants With Respiratory Syncytial Virus Infection|Recruiting||Phase 2|78|Anticipated|Ark Biosciences Inc.||2|||f||||t||||||||No||2017-10-10 22:34:58.798124|2017-10-10 22:34:58.798124
NCT02654158|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-05-18|||August 2013||2013-08-01|January 2016|2016-01-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection|Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection|Completed||N/A|2400|Actual|Guangzhou Yipinhong Pharmaceutical CO.,LTD|||2||f||||t||||||||Undecided||2017-10-10 22:34:58.920921|2017-10-10 22:34:58.920921
NCT02654145|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-07-12|||March 17, 2016|Actual|2016-03-17|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients|A Multi-centre, Open Label, Single Arm, 32-week Treatment Study in Subjects With Severe Eosinophilic Asthma Not Optimally Controlled With Current Omalizumab Treatment Who Are Switched From Omalizumab to Mepolizumab 100mg Subcutaneous (Study Number 204471- the OSMO Study)|Completed||Phase 4|145|Actual|GlaxoSmithKline||1|||t||||f|t|f||||||||2017-10-10 22:34:59.034474|2017-10-10 22:34:59.034474
NCT02654132|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-09-27|||March 16, 2016|Actual|2016-03-16|September 2017|2017-09-01|April 22, 2019|Anticipated|2019-04-22|November 14, 2017|Anticipated|2017-11-14||Interventional|||An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)|An Open Label, Randomized Phase 2 Trial of Pomalidomide/Dexamethasone With or Without Elotuzumab in Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)|Active, not recruiting||Phase 2|121|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 22:34:59.395348|2017-10-10 22:34:59.395348
NCT02654119|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-09-22|||December 2015||2015-12-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Patients With Stage I-II HER2/Neu Positive Breast Cancer After Surgery|A Phase II Study of Adjuvant Therapy Using a Regimen of Cyclophosphamide, Paclitaxel With Trastuzumab in Stage I-II HER2/Neu Positive Breast Cancer Patients|Recruiting||Phase 2|75|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-10 22:34:59.676201|2017-10-10 22:34:59.676201
NCT02654106|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2017-06-05|||October 2011||2011-10-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SRTRBM||Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases|Fractionated Stereotactic Radiotherapy Combined With Temozolomide for Refractory Brain Metastases: A Single-arm, Single-center Phase II Trial|Completed||Phase 2|65|Actual|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-10 22:34:59.872024|2017-10-10 22:34:59.872024
NCT02654093|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-03-10|||January 2016||2016-01-01|January 2016|2016-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Drug-drug Interaction Study of DP-R213|A Randomized, Open-label, Single-dose, 3-period, 6-sequence Crossover Study to Evaluate the Safety and the Pharmacokinetics After Oral Concurrent Administration of Raloxifene, Cholecalciferol in Healthy Korean Male Subjects|Completed||Phase 1|24|Actual|Alvogen Korea||6|||f||||f||||||||No||2017-10-10 22:35:00.010164|2017-10-10 22:35:00.010164
NCT02654080|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-09-06|||March 2016||2016-03-01|September 2017|2017-09-01||||July 2019|Anticipated|2019-07-01||Interventional|||Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected Adults|A Phase 1 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy HIV-Uninfected Adult Participants|Active, not recruiting||Phase 1|15|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:35:00.168117|2017-10-10 22:35:00.168117
NCT02654067|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-04-30|||January 2016||2016-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Evaluation of Mallampati Score Changes in Pregnancy|Evaluation of Mallampati Score Changes in Pregnancy|Recruiting||N/A|30|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||||2017-10-10 22:35:00.299828|2017-10-10 22:35:00.299828
NCT02654054|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-14|||November 7, 2015||2015-11-07|August 2017|2017-08-01|December 7, 2018|Anticipated|2018-12-07|May 17, 2018|Anticipated|2018-05-17||Interventional|||Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women|A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women|Active, not recruiting||Phase 3|400|Anticipated|AbbVie||3|||f||||t||||||||||2017-10-10 22:35:00.408803|2017-10-10 22:35:00.408803
NCT02654041|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-11-14|||March 2016||2016-03-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients|Phase II, Open-label, Prospective, Single-arm, Single-center Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients|Suspended||Phase 2|30|Anticipated|Musli Thyropeutics Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:35:00.790077|2017-10-10 22:35:00.790077
NCT02654028|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2017-06-09|||February 2016||2016-02-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|AT/HCC||Association Between Autologous Transfusion and Recurrence Among Patients With HCC After Resection|Association Between Autologous Transfusion and Tumor Recurrence Among Patients With Hepatocellular Carcinoma After Resection|Recruiting||N/A|200|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-10 22:35:00.885094|2017-10-10 22:35:00.885094
NCT02654015|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2017-08-11|||June 30, 2017|Actual|2017-06-30|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||INVEST: Minimally Invasive Endoscopic Surgery vs. Medical Management in Supratentorial Intraparenchymal Hemorrhage|INVEST: A Single Arm, Feasibility Study of Minimally Invasive Endoscopic Surgical Treatment With Apollo for Supratentorial Intracerebral Hemorrhage (ICH)|Recruiting||N/A|50|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|f|t|f|f||||||2017-10-10 22:35:00.998914|2017-10-10 22:35:00.998914
NCT02654002|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-07-26|||January 2016||2016-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674, and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics|A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674, and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics|Completed||Phase 1|120|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-10 22:35:01.128308|2017-10-10 22:35:01.128308
NCT02653989|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-11-22|||December 2016||2016-12-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)|An International, Phase 2, Open-Label, Efficacy and Safety Study of MDV9300 in Patients With an Incomplete Response Following Salvage Therapy or Autologous Stem Cell Transplantation for Relapsed or Refractory CD20+ Diffuse Large B-Cell Lymphoma|Withdrawn||Phase 2|0|Actual|Medivation, Inc.||1|||f||||t||||||||||2017-10-10 22:35:01.25033|2017-10-10 22:35:01.25033
NCT02653976|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)|Asian Multinational Phase 2 Study of SP-02L (Darinaparsin for Injection) in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)|Recruiting||Phase 2|65|Anticipated|Solasia Pharma K.K.||1|||f||||f||||||||||2017-10-10 22:35:01.342802|2017-10-10 22:35:01.342802
NCT02653963|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-01-12|||September 2014||2014-09-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||Triamcinolone for Ahmed Glaucoma Valve|Adjunctive Triamcinolone Acetonide for Ahmed Glaucoma Valve Implantation|Recruiting||N/A|106|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||Undecided||2017-10-10 22:35:01.478368|2017-10-10 22:35:01.478368
NCT02653950|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-10|||February 2016||2016-02-01|January 2016|2016-01-01||||February 2019|Anticipated|2019-02-01||Interventional|||Traditional Septoplasty Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum|Traditional Septoplasty Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum: A Prospective, Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|Rambam Health Care Campus||2|||f||||||||||||||2017-10-10 22:35:01.603009|2017-10-10 22:35:01.603009
NCT02653937|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-01-10|||March 2013||2013-03-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||The Effect of Shigyakusan Used for IBS and MUPS Diagnosed by Abdominal N Line Tenderness|The Effect of Shigyakusan Used for Irritable Bowel Syndrome and Medically Unexplained Physical Symptoms Diagnosed by Abdominal N Line Tenderness|Completed||N/A|1|Actual|Nakatani Clinic||1|||f||||f||||||||||2017-10-10 22:35:01.676897|2017-10-10 22:35:01.676897
NCT02653924|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-13|||January 2016||2016-01-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||The Comparison of Microbial Adherence to Various Sutures in Patients Undergoing Oral Surgery|The Comparison of Microbial Adherence to Various Sutures in Patients Undergoing Oral Surgery|Not yet recruiting||N/A|30|Anticipated|Hadassah Medical Organization||4|||f||||f||||||||No||2017-10-10 22:35:01.7528|2017-10-10 22:35:01.7528
NCT02653911|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-03-01|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Electroacupuncture on Hormonal and Glycometabolic Profiles in Women With Polycystic Ovary Syndrome: Study Protocol|Efficacy of Electroacupuncture on Hormonal and Glycometabolic Profiles in Women With Polycystic Ovary Syndrome: a Randomized, Sham-controlled Trial|Not yet recruiting||N/A|72|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||No||2017-10-10 22:35:01.845169|2017-10-10 22:35:01.845169
NCT02653898|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-28|||January 2016||2016-01-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Malaria Elimination Pilot Study in Military Forces in Cambodia|Defining Effective, Appropriate, Implementable Strategies for Malaria Elimination in Military Forces in Cambodia as a Model for Mobile Populations|Recruiting||Phase 4|1200|Anticipated|Armed Forces Research Institute of Medical Sciences, Thailand||4|||f||||f||||||||Yes|The preliminary results, final report and key data will be shared with a broad array of stakeholders from Cambodia, the region, bilateral and multilateral implementing partners, and donor organizations.|2017-10-10 22:35:01.935542|2017-10-10 22:35:01.935542
NCT02653885|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-11|2016-01-12|||January 2011||2011-01-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Haematologic Predictors and Clinical Outcome in Cardiac Surgery|Haematologic Predictors and Clinical Outcome in Cardiac Surgery|Completed||N/A|1500|Actual|Ankara University|||1||f||||f||||||||||2017-10-10 22:35:02.063246|2017-10-10 22:35:02.063246
NCT02653859|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-01-10|||January 2016||2016-01-01|October 2015|2015-10-01||||May 2016|Anticipated|2016-05-01||Observational|||Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules|Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells(CTC) in Benign and Malignant Lung Nodules|Unknown status|Not yet recruiting|N/A|50|Anticipated|GenoSaber|||1||f||||t||||||||||2017-10-10 22:35:02.370644|2017-10-10 22:35:02.370644
NCT02653846|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-09-07|||June 2015||2015-06-01|September 2016|2016-09-01|June 2022|Anticipated|2022-06-01|June 2017|Anticipated|2017-06-01||Observational|||Correlation of Liver and Spleen Stiffness by RT-2D-SWE and Severity of Portal Hypertension by HVPG|Correlation of Liver and Spleen Stifness as Assesed by Real Time 2-Dimensional Shear Wave Elastography With Severity of Portal Hypertension and Clinical Outcomes in Patients With Compensated Advanced Chronic Liver Disease|Recruiting||N/A|50|Anticipated|University Hospital Dubrava|||1||f||||f||||||||No||2017-10-10 22:35:02.46351|2017-10-10 22:35:02.46351
NCT02653833|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-03-02|||December 2015||2015-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy|Skeletal Muscle Blood Flow in Becker Muscular Dystrophy|Recruiting||Early Phase 1|19|Anticipated|Cedars-Sinai Medical Center||2|||f||||f|t||||f|||No||2017-10-10 22:35:02.581958|2017-10-10 22:35:02.581958
NCT02653820|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-10|||February 2016||2016-02-01|January 2016|2016-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Complementary Effect of Reflexology on Chemotherapy-Induced Nausea and Vomiting||Not yet recruiting||Phase 2|40|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||No||2017-10-10 22:35:02.70866|2017-10-10 22:35:02.70866
NCT02653807|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-03-17|||September 2015||2015-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of Two Manual Therapy Techniques on Ankle Dorsiflexion|The Immediate Effects of Two Manual Therapy Techniques on Ankle Musculoarticular Stiffness and Dorsiflexion Range of Motion in People With Chronic Ankle Rigidity: A Randomized Clinical Trial|Completed||N/A|40|Actual|Université Catholique de Louvain||2|||f||||f||||||||No||2017-10-10 22:35:02.805911|2017-10-10 22:35:02.805911
NCT02653794|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-04-12|||January 2015||2015-01-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||The Variations of Macular Thickness in Juvenile Subjects|The Variations of Macular Thickness in Juvenile Subjects With Mild-to-Moderate Refractive Error|Completed||N/A|364|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 22:35:02.898424|2017-10-10 22:35:02.898424
NCT02653781|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-01-15|||March 2016||2016-03-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Implementation of Realistic Simulation as Patient Safety Improvement Method|Implementation of Realistic Simulation as Patient Safety Improvement Method: Controlled Trial|Enrolling by invitation||Early Phase 1|150|Anticipated|University of Brasilia||2|||f||||t||||||||||2017-10-10 22:35:02.986743|2017-10-10 22:35:02.986743
NCT02653755|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2017-07-23|||May 2016||2016-05-01|July 2017|2017-07-01|June 2023|Anticipated|2023-06-01|June 2019|Anticipated|2019-06-01||Interventional|||The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer|The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer|Recruiting||Phase 2|1380|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 22:35:03.194935|2017-10-10 22:35:03.194935
NCT02652442|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-05-26|||January 4, 2016|Actual|2016-01-04|May 2017|2017-05-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||Otolith Dysfunction|Vestibular Rehabilitation and Otolith Dysfunction|Recruiting||N/A|30|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:35:19.572628|2017-10-10 22:35:19.572628
NCT02653742|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-03|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children|Prospective, Randomized, Allocation-Concealed, Blinded Study Designed to Compare Ketorolac Sublingual and Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children|Recruiting||Phase 4|150|Anticipated|Albany Medical College||3|||f||||t|||||t|||||2017-10-10 22:35:03.334281|2017-10-10 22:35:03.334281
NCT02653729|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-12|||September 2015||2015-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|cbtpaps||Cbt for Psychosis and Affect on Psychosis Symptoms|Cognitive Behaviour Therapy for Psychosis in First Episode Patient and the Outcome of Cognitive Behaviour Therapy on Psychotic Symptoms|Completed||Phase 2|50|Actual|Bahauddin Zakariya University||2|||f||||t||||||||||2017-10-10 22:35:03.497446|2017-10-10 22:35:03.497446
NCT02653716|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|BeST?-||Effectiveness and Cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health|BeST?- The Best Services Trial (BeST?): Effectiveness and Cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health|Not yet recruiting||Phase 3|462|Anticipated|University of Glasgow||2|||f||||t||||||||||2017-10-10 22:35:03.617864|2017-10-10 22:35:03.617864
NCT02653703|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-11|||October 2014||2014-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain|High-concentration L-menthol as a Counter-irritant to TRPA1-induced Neurogenic Inflammation, Thermal and Mechanical Hyperalgesia Caused by Trans-cinnamaldehyde|Completed||N/A|14|Actual|Aalborg University||2|||f||||f||||||||Undecided||2017-10-10 22:35:03.753158|2017-10-10 22:35:03.753158
NCT02653677|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-10|||February 2015||2015-02-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Glycemic and Hormone Responses After the Intake of Four Types of Bread.|Glycemic and Hormone Responses and Satiety After the Intake of Four Types of Bread.|Completed||N/A|16|Actual|University of Turin, Italy||4|||f||||f||||||||||2017-10-10 22:35:03.854247|2017-10-10 22:35:03.854247
NCT02653664|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-09-29|||September 2014||2014-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|CPSS||Chronic Pain Skills Study|Hypnosis and Meditation for Pain Management in Veterans: Efficacy and Mechanisms|Enrolling by invitation||N/A|343|Anticipated|University of Washington||3|||f||||t|f|f||||||||2017-10-10 22:35:03.952487|2017-10-10 22:35:03.952487
NCT02653651|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2016-07-26|||January 2016||2016-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effects of Perioperative Intravenous Lidocaine and Ketamine on Acute and Chronic Pain After Open Nephrectomy|A Comparison Between the Effects of Perioperative Intravenous Lidocaine and Ketamine on Acute and Chronic Pain After Open Nephrectomy: A Prospective, Double-blind, Randomized, Placebo Controlled Study|Completed||Phase 4|60|Actual|University Tunis El Manar||3|||f||||f||||||||No||2017-10-10 22:35:04.060984|2017-10-10 22:35:04.060984
NCT02653638|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-12-01|||February 2016||2016-02-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Blood Brain Flow and Exercise|Cerebral Vasodilator Responses in Sedentary and Exercise Trained Humans|Recruiting||Early Phase 1|60|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||No||2017-10-10 22:35:04.161147|2017-10-10 22:35:04.161147
NCT02653625|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-06-20|||March 14, 2016|Actual|2016-03-14|June 2017|2017-06-01|August 31, 2017|Anticipated|2017-08-31|August 3, 2017|Anticipated|2017-08-03||Interventional|||PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis|PERSEUS: A Phase 2 Proof of Concept Study Investigating the Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis|Active, not recruiting||Phase 2|24|Actual|Tobira Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 22:35:04.292942|2017-10-10 22:35:04.292942
NCT02653612|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-18|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Intraoperative Imaging of Pulmonary Adenocarcinoma|Intraoperative Imaging of Pulmonary Adenocarcinoma|Recruiting||Phase 1|48|Anticipated|VA Office of Research and Development||1|||f||||f|t|f|||f|||||2017-10-10 22:35:04.390753|2017-10-10 22:35:04.390753
NCT02653599|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-02-09||2017-02-09|December 2015||2015-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Multi-Center Study to Evaluate the Efficacy and Safety of TTP273 Following 12 Weeks Administration in Subjects With Type 2 Diabetes Mellitus on a Stable Dose of Metformin|Completed||Phase 2|174|Actual|vTv Therapeutics||3|||f||||f|t|f||||||||2017-10-10 22:35:04.484248|2017-10-10 22:35:04.484248
NCT02653586|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-05-07|||May 2013||2013-05-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Prevention Program Promoting Self Resilience,Positive Self-Image and Body Image Among Adolescence Aged 15-17|"In Favor of Resilience Self Prevention Program Promoting Positive Self-Image and Body Image Among Adolescence Aged 15-17"|Completed||N/A|209|Actual|Tel Hai College||2|||f||||t||||||||||2017-10-10 22:35:04.634436|2017-10-10 22:35:04.634436
NCT02653573|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-10-26|||September 2015||2015-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|myHEART||Young Adult Hypertension Feasibility Study|myHEART (My Hypertension Education and Reaching Target) Program: a Feasibility Study of a Young Adult Hypertension Intervention|Completed||N/A|9|Actual|University of Wisconsin, Madison||1|||f||||f||||||||Undecided||2017-10-10 22:35:04.701594|2017-10-10 22:35:04.701594
NCT02653560|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-06-16|2016-05-10||September 2012||2012-09-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Randomized cross over design so total number of subjects = 30|Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension|Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension|Completed||Phase 4|30|Actual|University of Texas Southwestern Medical Center||4|||f||||t||||||||||2017-10-10 22:35:04.783941|2017-10-10 22:35:04.783941
NCT02653547|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-10-25|||January 2016||2016-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Influence of Treatment Duration and Stimulation Frequency on rTMS in Chronic Tinnitus|Influence of Treatment Duration and Stimulation Frequency on Repetitive Transcranial Magnetic Stimulation in Chronic Tinnitus|Recruiting||N/A|80|Anticipated|University of Regensburg||4|||f||||t||||||||Undecided||2017-10-10 22:35:05.063784|2017-10-10 22:35:05.063784
NCT02653534|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-26|2016-10-06|||November 2015||2015-11-01|December 2015|2015-12-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|KMC-LBW||Impact of Promoting Community Initiated Kangaroo Mother Care (KMC) for Low Birth Weight Infants|Impact of Promoting Community Initiated Kangaroo Mother Care (KMC) for Low Birth Weight Infants|Recruiting||N/A|10500|Anticipated|Society for Applied Studies||2|||f||||t||||||||||2017-10-10 22:35:05.166124|2017-10-10 22:35:05.166124
NCT02653508|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-01-08|||September 2011||2011-09-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|April 2012|Actual|2012-04-01||Interventional|FETA||Evaluating the Efficacy of the Feeding Exercise Trial in Adolescents (FETA Project) in Central Greece|Evaluating the Efficacy of the Feeding Exercise Trial in Adolescents (FETA Project) in Central Greece|Completed||N/A|181|Actual|University of Thessaly||3|||f||||f||||||||Yes|"The data will be published
The data will be given in the Ministry of Education and Religious Affairs, Sport and Culture of Greece"|2017-10-10 22:35:05.344553|2017-10-10 22:35:05.344553
NCT02653495|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-09-01|2017-06-08||January 2016||2016-01-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Impact of Metabolic Syndrome on Flu Vaccine Efficacy|Impact of Metabolic Syndrome on Flu Vaccine Efficacy|Terminated||N/A|17|Actual|Rockefeller University|Inclusion Criteria hard to meet among population: many individuals do not self-identify as having metabolic syndrome, participants must have untreated metabolic syndrome. Challenges led to early termination with sample size not being attainable.|2||Target accrual not met|f||||f||||||||||2017-10-10 22:35:05.439413|2017-10-10 22:35:05.439413
NCT02653482|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-06-07|||March 3, 2016|Actual|2016-03-03|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|DEFINE-HF||Dapagliflozin Effect on Symptoms and Biomarkers in Diabetes Patients With Heart Failure|Dapagliflozin Effect on Symptoms and Biomarkers in Diabetes Patients With Heart Failure|Recruiting||Phase 4|250|Anticipated|Saint Luke's Health System||2|||f||||t||||||||Undecided||2017-10-10 22:35:05.834536|2017-10-10 22:35:05.834536
NCT02653469|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-03-02|||September 2015||2015-09-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy|Pulse Pressure Variation With Augmented Ventilation to Predict Fluid Responsiveness in the Patients Undergoing Open Laparotomy Surgery|Completed||N/A|38|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:35:06.000797|2017-10-10 22:35:06.000797
NCT02653456|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-03|||April 7, 2016|Actual|2016-04-07|August 2017|2017-08-01|July 14, 2017|Actual|2017-07-14|May 3, 2017|Actual|2017-05-03||Interventional|||Evaluating Plaque Photoablation Using an Excimer Laser in Patients With Lower Extremity Vascular Disease|A Prospective, Multi Center Pilot Study Evaluating Plaque Photoablation Using the RA-308 Excimer Laser in Subjects With Symptomatic Infrainguinal Lower Extremity Vascular Disease|Completed||N/A|49|Actual|Ra Medical Systems||1|||f||||f||t|f|f||||||2017-10-10 22:35:06.067522|2017-10-10 22:35:06.067522
NCT02653443|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-01-26|||December 2015||2015-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study|A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study to Assess the Recovery and Lifespan of Radiolabeled Autologous INTERCEPT Treated Apheresis Platelet Components Suspended in Nominal 35% Plasma and 65% InterSol Stored for 6 or 7 Days|Active, not recruiting||Phase 2|24|Anticipated|Cerus Corporation||2|||f||||f||||||||||2017-10-10 22:35:06.267155|2017-10-10 22:35:06.267155
NCT02653430|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-04-25|||February 2012||2012-02-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Mechanism Study of Bariatric Surgery to Treat Moderate to Severe Obesity in Han Chinese Population|Efficacy and Mechanism Study of Bariatric Surgery to Treat Moderate to Severe Obesity in Han Chinese Population|Recruiting||N/A|100|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||||2017-10-10 22:35:06.435236|2017-10-10 22:35:06.435236
NCT02653417|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-11-16|||December 2015||2015-12-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms|A Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms|Active, not recruiting||Phase 2|300|Anticipated|Radius Health, Inc.||4|||f||||f||||||||No||2017-10-10 22:35:06.530591|2017-10-10 22:35:06.530591
NCT02653404|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-05-04|||April 2015||2015-04-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|April 2019|Anticipated|2019-04-01||Observational|TBTubercolar||IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection|Observational Study to Compare IGRA and Mantoux Test in Children With Suspected Latent or Active TB Infection|Recruiting||N/A|50|Anticipated|University of Siena|||1||f||||f||||||||||2017-10-10 22:35:06.609203|2017-10-10 22:35:06.609203
NCT02653391|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-07-31|||December 2015||2015-12-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)|PART A: A PROSPECTIVE, RANDOMIZED, DOUBLE-MASKED, VEHICLE CONTROLLED, PAIRED-EYE PHASE 1/2 CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF ELAMIPRETIDE TOPICAL OPHTHALMIC SOLUTION IN SUBJECTS WITH FCED PRESENTING WITH MILD TO MODERATE CORNEAL EDEMA PART B: A PROSPECTIVE, RANDOMIZED, DOUBLE-MASKED, VEHICLE CONTROLLED, PHASE 1/2 CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF ELAMIPRETIDE TOPICAL OPHTHALMIC SOLUTION IN SUBJECTS WITH FCED PRESENTING WITH MILD TO MODERATE CORNEAL EDEMA|Active, not recruiting||Phase 1/Phase 2|27|Anticipated|Stealth BioTherapeutics Inc.||2|||f||||f||||||||||2017-10-10 22:35:06.76243|2017-10-10 22:35:06.76243
NCT02653378|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-08|||November 2009||2009-11-01|January 2016|2016-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|DEXDER||The Effects of Acute Caloric Deprivation on Odour Identification and Food Reward|The Effects of Acute Caloric Deprivation on Odour Identification and Food Reward|Completed||N/A|10|Actual|University of Ottawa||2|||f||||f||||||||No||2017-10-10 22:35:06.89505|2017-10-10 22:35:06.89505
NCT02653352|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-01-08|||March 2005||2005-03-01|November 2015|2015-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Prevention of Excessive Weight Gain by Discouraging Students From Drinking Sodas|School Randomised Trial on Prevention of Excessive Weight Gain by Discouraging Students From Drinking Sodas|Completed||N/A|1140|Actual|Rio de Janeiro State University||2|||f||||f||||||||||2017-10-10 22:35:07.136107|2017-10-10 22:35:07.136107
NCT02653339|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2016-04-21|||June 2016||2016-06-01|January 2016|2016-01-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.||Not yet recruiting||N/A|180|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-10 22:35:07.259307|2017-10-10 22:35:07.259307
NCT02653326|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Technological Platforms and Telerehabilitation in Heart Surgery|Integrative Technological Platforms for Telerehabilitation for Patients With Heart Surgery: A Pilot Randomised Trial|Completed||N/A|60|Anticipated|Universidad de Valparaiso||2|||f||||f||||||||No||2017-10-10 22:35:07.424813|2017-10-10 22:35:07.424813
NCT02653313|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-09-26|||December 2015||2015-12-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ParvOryx02||Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer|A Non-controlled, Single Arm, Open Label, Phase II Study of Intravenous and Intratumoral Administration of ParvOryx in Patients With Metastatic, Inoperable Pancreatic Cancer|Recruiting||Phase 1/Phase 2|7|Anticipated|Oryx GmbH & Co. KG||1|||f||||t||||||||||2017-10-10 22:35:07.612534|2017-10-10 22:35:07.612534
NCT02653300|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-06-25|||September 2017|Anticipated|2017-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)|An Open-Label Pilot Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Potential of Oral Insulin to Reduce Liver Fat Content and Fibrosis in Patients With Nonalcolholic Steatohepatitis (NASH)|Not yet recruiting||Phase 2|30|Anticipated|Oramed, Ltd.||1|||f||||f|f|f|||f|||No||2017-10-10 22:35:07.753502|2017-10-10 22:35:07.753502
NCT02653287|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-09-13|||April 2018|Anticipated|2018-04-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|LIFT||Lupus Intervention for Fatigue Trial|Lupus Intervention for Fatigue Trial|Not yet recruiting||N/A|200|Anticipated|Northwestern University||2|||f||||t|f|f||||||||2017-10-10 22:35:07.891679|2017-10-10 22:35:07.891679
NCT02653274|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-05-25|||October 2015||2015-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|AMORE||Assessment of Millet, Oat and Rye Porridge Breakfasts Glucose and Gastric Emptying|Gastrointestinal and Blood Glucose Responses to Breakfast Porridges Made From Different Grains: A Magnetic Resonance Imaging Pilot Study in Healthy Volunteers|Completed||N/A|16|Actual|University of Nottingham||4|||f||||f||||||||||2017-10-10 22:35:08.057375|2017-10-10 22:35:08.057375
NCT02653261|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-10-09|||January 2016||2016-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Safety and Efficacy of Intravenous Tranexamic Acid in Endoscopic Transurethral Resections in Urology|Safety and Efficacy of Intravenous Tranexamic Acid in Reducing Blood Transfusion After Endoscopic Transurethral Resections in Urology: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study|Completed||Phase 4|131|Actual|University Tunis El Manar||2|||f||||f||||||||No||2017-10-10 22:35:08.184211|2017-10-10 22:35:08.184211
NCT02653248|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-12-09|||August 2010||2010-08-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SBRT for Organ Confined Prostate Cancer|Phase I Study of Stereotactic Body Radiation Therapy (SBRT) for Organ Confined Prostate Cancer|Active, not recruiting||Phase 1|36|Actual|Northwell Health||3|||f||||t||||||||||2017-10-10 22:35:08.336886|2017-10-10 22:35:08.336886
NCT02653235|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-08|||January 2016||2016-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|||Impact of Immune Challenge on Triple Network Connectivity in Humans|"Exploring the Impact of Peripheral Immune Challenge on the Triple Network and Dorsal Nexus Functional Connectivity in Humans"|Not yet recruiting||N/A|20|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||No||2017-10-10 22:35:08.473458|2017-10-10 22:35:08.473458
NCT02653222|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-02-08|||February 2016||2016-02-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|SCRATCH||Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension|Feasibility Study of Perivascular Computer Tomography-guided Ethanol Sympatholysis for the Treatment of Therapy-resistant Arterial Hypertension|Recruiting||Phase 2|15|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||No||2017-10-10 22:35:09.618558|2017-10-10 22:35:09.618558
NCT02653209|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-27|||November 1, 2016|Actual|2016-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|TriMaster||TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.|TriMaster: Randomised Double-Blind Crossover Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes Who Have Suboptimal Glycaemic Control on Dual Therapy With Metformin and a Sulphonylurea|Recruiting||Phase 4|600|Anticipated|NIHR Exeter Clinical Research Facility||3|||f||||t||||||||||2017-10-10 22:35:09.816421|2017-10-10 22:35:09.816421
NCT02653196|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-08-14|||September 2015||2015-09-01|June 2017|2017-06-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors|A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors|Terminated||Early Phase 1|1|Actual|Montefiore Medical Center||1||The Principal Investigator left the institution.|f||||t||||||||||2017-10-10 22:35:09.995763|2017-10-10 22:35:09.995763
NCT02653170|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-07-07|||January 2016||2016-01-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|MISTT||Michigan Stroke Transitions Trial|The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program|Recruiting||N/A|315|Anticipated|Michigan State University||3|||f||||f|f|f||||||||2017-10-10 22:35:10.385313|2017-10-10 22:35:10.385313
NCT02653157|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-13|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Observational|||Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn|IGHID 11519 - Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn|Active, not recruiting||N/A|48|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples Without DNA|"     Gram-negative bacterial isolates   "|||2017-10-10 22:35:10.506864|2017-10-10 22:35:10.506864
NCT02653144|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-03-15|||March 2016||2016-03-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block|Double Blinded Randomized Controlled Study Evaluating the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block in Patients Undergoing Ambulatory Shoulder Surgery|Recruiting||Phase 4|105|Anticipated|Montefiore Medical Center||3|||f||||t||||||||No||2017-10-10 22:35:10.611902|2017-10-10 22:35:10.611902
NCT02653131|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-10|2016-12-05|||January 2016||2016-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|DPP-4||The Use of DPP-4 Inhibitors in Short Bowel Syndrome|The Use of Dipeptidyl Peptidase-4 Inhibitor Influences the Absorption of Intestine in Short Bowel Syndrome|Recruiting||Phase 4|40|Anticipated|Stanley Dudrick's Memorial Hospital||2|||f||||f||||||||No|All data is a part of a research|2017-10-10 22:35:10.722059|2017-10-10 22:35:10.722059
NCT02653118|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-17|||January 22, 2016|Actual|2016-01-22|August 2017|2017-08-01|January 1, 2024|Anticipated|2024-01-01|January 1, 2024|Anticipated|2024-01-01||Observational|||Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)|A Registry-Based Extension of Protocol V503-001 in Countries With Centralized Cervical Cancer Screening Infrastructures to Evaluate the Long-Term Effectiveness, Immunogenicity, and Safety of Multivalent Human Papillomavirus (HPV) L1 Virus- Like Particle (VLP) Vaccine as Administered to 16- to 26- Year- Old Women|Active, not recruiting||N/A|4453|Anticipated|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-10-10 22:35:10.81751|2017-10-10 22:35:10.81751
NCT02653105|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-11|||February 2016||2016-02-01|January 2016|2016-01-01|February 2026|Anticipated|2026-02-01|February 2026|Anticipated|2026-02-01||Interventional|||Women at Risk of Breast Cancer and OLFM4|Evaluation of the Circulating Concentration of Olfactomédine 4 (OLFM4) in Women With a BRCA1 or 2 Gene Mutation or at High Risk of Developing Breast Cancer, According to the Imaging|Not yet recruiting||N/A|300|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||f||||||||||2017-10-10 22:35:10.913603|2017-10-10 22:35:10.913603
NCT02653092|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-08-29|||June 2016||2016-06-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Reprometabolic Syndrome Mediates Subfertility in Obesity|Reprometabolic Syndrome Mediates Subfertility in Obesity|Recruiting||N/A|30|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:35:11.077667|2017-10-10 22:35:11.077667
NCT02653079|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-11-24|||June 2016||2016-06-01|June 2016|2016-06-01|February 2022|Anticipated|2022-02-01|February 2019|Anticipated|2019-02-01||Observational|IMMO-LDRT01||Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and Receiving LDRT|Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and Receiving Local Low Dose Radiation Therapy (LDRT)|Recruiting||N/A|150|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||Samples With DNA|"     Serum, Plasma, Blood cells   "|Undecided||2017-10-10 22:35:11.338132|2017-10-10 22:35:11.338132
NCT02653066|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-05-09|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||HealtheRx Survey for Pulmonary Research Registry Recruitment|HealtheRx Survey for Pulmonary Research Registry Recruitment|Active, not recruiting||N/A|200|Anticipated|University of Chicago||3|||f||||f||||||||||2017-10-10 22:35:11.436103|2017-10-10 22:35:11.436103
NCT02653040|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-10-25|||December 2015||2015-12-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Light as an Aid for Recovery in Psychiatric Inpatients|Light as an Aid for Recovery in Psychiatric Inpatients: A Pragmatic Randomized Controlled Pilot Trial|Recruiting||N/A|60|Anticipated|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-10 22:35:11.55376|2017-10-10 22:35:11.55376
NCT02653027|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-08|||January 2016||2016-01-01|January 2016|2016-01-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Interventional|LIGHT-CF||Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del|A Study of the Effect of Combination Lumacaftor and Ivacaftor on Glucose Tolerance in Persons With Cystic Fibrosis Who Are Homozygous for the Phe508del Cystic Fibrosis Transmembrane Conductance Regulator Mutation.|Not yet recruiting||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 22:35:11.657457|2017-10-10 22:35:11.657457
NCT02653014|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-02-28|||July 2015|Actual|2015-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|December 2016|Actual|2016-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment|An Open-Label, Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects With a Separate Panel in Subjects With Mild to Moderate Renal Impairment|Active, not recruiting||Phase 1/Phase 2|26|Actual|KBP Biosciences||6|||f||||t||||||||No||2017-10-10 22:35:11.738197|2017-10-10 22:35:11.738197
NCT02653001|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-08-21|||January 2016||2016-01-01|August 2017|2017-08-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01||Interventional|||The QIB Colon Model|Stool Sample Collection for Research Using the In-vitro QIB Colon Model|Enrolling by invitation||N/A|20|Anticipated|Quadram Institute||1|||f||||f||||||||||2017-10-10 22:35:11.832004|2017-10-10 22:35:11.832004
NCT02652988|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-02-22|||January 2016||2016-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Home-based Transcranial Direct Current Stimulation in Fibromyalgia Patients|Home-based Transcranial Direct Current Stimulation in Fibromyalgia Patients. Phase II, Randomized, Double-blind, Single-center Clinical Trial|Recruiting||N/A|32|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:35:11.903649|2017-10-10 22:35:11.903649
NCT02652975|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-05-02|||September 2015||2015-09-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|March 2018|Anticipated|2018-03-01||Interventional|ABCDE||Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium|Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium|Active, not recruiting||N/A|76|Actual|University of Aarhus||3|||f||||f||||||||No||2017-10-10 22:35:12.021311|2017-10-10 22:35:12.021311
NCT02652962|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-05-06|||January 2016||2016-01-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|STAGE||Gelesis200 Safety and Tolerability Study and Effects on Glycemic and Appetite Parameters|A Randomized, Double-blind, Placebo-Controlled, 4-Period Study Assessing the Safety, Tolerability and Glycemic and Appetite Effects of Gelesis200 Using Two Different Timings of Administration in Overweight and Obese Subjects|Completed||N/A|24|Actual|Gelesis, Inc.||8|||f||||f||||||||||2017-10-10 22:35:12.1137|2017-10-10 22:35:12.1137
NCT02652949|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-05-02|||March 2016||2016-03-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|VEVO||Valiant Evo US Clinical Trial|Valiant Evo US Clinical Trial|Recruiting||N/A|100|Anticipated|Medtronic Endovascular||1|||f||||t||||||||No||2017-10-10 22:35:13.750525|2017-10-10 22:35:13.750525
NCT02652936|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-12-05|||October 2015||2015-10-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Pharmacokinetics Study of AF-130 in Healthy Subjects|A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of AF-130 in Healthy Subjects|Completed||Phase 1|80|Actual|Afferent Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:35:13.951941|2017-10-10 22:35:13.951941
NCT02652923|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-17|||January 2016||2016-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Contrast Ultrasound Detection of Sentinel Lymph Nodes|Contrast Ultrasound Detection of Sentinel Lymph Nodes in Breast Cancer Patients|Recruiting||Phase 1/Phase 2|112|Anticipated|Thomas Jefferson University||2|||f||||t||||||||Yes|De-identified data will be made available to the research community upon request after the completion of the study in accordance with NIH rules and regulations.|2017-10-10 22:35:14.057437|2017-10-10 22:35:14.057437
NCT02652910|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-04-25|||December 2015||2015-12-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|MeCAR||Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma|A Two-Arm, Single-Center, Open-Label Pilot Study of IL-2 Programmed or IL-7/IL-15 Programmed Anti-CD19:TCRz:CD28 T-cells in Patient With CD19-Positive Lymphoma That is Resistant or Refractory to Chemotherapy|Recruiting||Phase 1/Phase 2|20|Anticipated|Xinqiao Hospital of Chongqing||2|||f||||t||||||||||2017-10-10 22:35:14.174454|2017-10-10 22:35:14.174454
NCT02652897|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-01-23|||May 2016||2016-05-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Hemostasis Alterations in Neurosurgical Patients|Prospective Study on Hemostasis Alterations in Patients Undergoing Neuro Surgical Glioma Resection|Recruiting||N/A|120|Anticipated|Hospitales Universitarios Virgen del Rocío|||2||f||||t||||||||No||2017-10-10 22:35:14.274582|2017-10-10 22:35:14.274582
NCT02652884|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-04-04|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|Corthyroid||Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy|Evaluation of Potential Benefits of Using Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy|Recruiting||Phase 4|110|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||Undecided||2017-10-10 22:35:14.39158|2017-10-10 22:35:14.39158
NCT02652871|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-21|||May 2016|Actual|2016-05-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 1b, Open-label Study of LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Recruiting||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:35:14.515702|2017-10-10 22:35:14.515702
NCT02652858|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-10-07|||January 2016||2016-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|CAPD-CPB||Central and Peripheral Arterial Pressure Decoupling In Cardio-Pulmonary Bypass|Central and Peripheral Arterial Pressure Decoupling In Cardio-Pulmonary Bypass|Completed||N/A|40|Actual|Hospices Civils de Lyon||1|||f||||f||||||||Undecided||2017-10-10 22:35:14.734553|2017-10-10 22:35:14.734553
NCT02652845|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-01-08|||March 2015||2015-03-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|WE||Wellness Engagement Project, Petersburg|Wellness Engagement Project, Petersburg|Terminated||N/A|20|Actual|Virginia Commonwealth University||2||Study Design was changed - no longer prospectively assigning participants|f||||f||||||||||2017-10-10 22:35:14.821831|2017-10-10 22:35:14.821831
NCT02652832|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-12|||December 2010|Actual|2010-12-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|Plasti-Stim||Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels|Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels|Recruiting||N/A|200|Anticipated|Hôpital le Vinatier||8|||f||||t||||||||||2017-10-10 22:35:14.933888|2017-10-10 22:35:14.933888
NCT02652819|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-08-23|||December 2015||2015-12-01|August 2017|2017-08-01|June 13, 2017|Actual|2017-06-13|January 24, 2017|Actual|2017-01-24||Interventional|||FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis|Completed||Phase 3|154|Actual|FibroGen||2|||f||||t||||||||||2017-10-10 22:35:15.088884|2017-10-10 22:35:15.088884
NCT02652806|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-08-23|||December 2015||2015-12-01|February 2017|2017-02-01|June 14, 2017|Actual|2017-06-14|January 24, 2017|Actual|2017-01-24||Interventional|||FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease|A Phase 3, Randomized, Open-Label, Active-Controlled Study of Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease on Dialysis|Completed||Phase 3|305|Actual|FibroGen||2|||f||||t||||||||||2017-10-10 22:35:15.312961|2017-10-10 22:35:15.312961
NCT02652429|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-08-04|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH|An Open-Label Long-Term Safety Study of Inhaled Nitric Oxide (iNO) for PAH|Active, not recruiting||Phase 3|22|Anticipated|Bellerophon||1|||f||||t||||||||||2017-10-10 22:35:19.691287|2017-10-10 22:35:19.691287
NCT02652793|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-08-16|||July 2015||2015-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Osteosimply014||Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia|Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia|Recruiting||N/A|45|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-10 22:35:15.510051|2017-10-10 22:35:15.510051
NCT02652780|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-02-22|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|REVERSE||Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation|Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene|Active, not recruiting||Phase 3|36|Anticipated|GenSight Biologics||2|||f||||t||||||||No||2017-10-10 22:35:15.658797|2017-10-10 22:35:15.658797
NCT02652767|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-08-07|||January 2016||2016-01-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|RESCUE||Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation|A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene|Active, not recruiting||Phase 3|36|Anticipated|GenSight Biologics||2|||f||||t||||||||||2017-10-10 22:35:15.787247|2017-10-10 22:35:15.787247
NCT02652754|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-28|||September 2015||2015-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers|Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Diabetic Foot Ulcers|Recruiting||Phase 1|16|Anticipated|FirstString Research, Inc.||1|||f||||t||||||||||2017-10-10 22:35:15.955245|2017-10-10 22:35:15.955245
NCT02652741|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-08|||January 2016||2016-01-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|LENA-WP09||Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease|Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease|Not yet recruiting||Phase 2/Phase 3|50|Anticipated|Ethicare GmbH||1|||f||||t||||||||Yes|Serious Adverse Event information|2017-10-10 22:35:16.095799|2017-10-10 22:35:16.095799
NCT02652728|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-01-08|||January 2016||2016-01-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|LENA-WP08||Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy|Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy|Not yet recruiting||Phase 2/Phase 3|50|Anticipated|Ethicare GmbH||1|||f||||t||||||||Yes|Serious Adverse Event information|2017-10-10 22:35:16.281893|2017-10-10 22:35:16.281893
NCT02652715|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-01-26|||January 2016||2016-01-01|September 2016|2016-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma|A Pilot Feasibility Trial of the Tolerability of Oral Salvia Hispanica and Its Effect on Blood Fatty Acids and Stool Microbiome in Patients With Treated Non-Hodgkin Lymphoma|Recruiting||N/A|30|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:35:16.484812|2017-10-10 22:35:16.484812
NCT02652702|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-04-04|||December 2016||2016-12-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|STAPLER||Study Comparing Circular Stapler-assisted Colostomy vs Hand-stitching Colostomy of Colorectal Cancer Patients|Randomized Clinical Trial Comparing the Safety and Efficiency of Circular Stapler-assisted Colostomy With Hand-stitching Colostomy for Colorectal Cancer Patients|Recruiting||Phase 2|60|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-10-10 22:35:16.77427|2017-10-10 22:35:16.77427
NCT02652689|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-07-27|||April 2016||2016-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Diagnosis of Pulmonary Embolism by Doppler Signals|Transthoracic Parametric Doppler Assessment of Lung Doppler Signals in Acute Pulmonary Embolism|Recruiting||N/A|60|Anticipated|Echosense Ltd.||1|||f||||f||||||||||2017-10-10 22:35:16.90237|2017-10-10 22:35:16.90237
NCT02652676|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-03-16|||January 2016||2016-01-01|March 2017|2017-03-01|December 2027|Anticipated|2027-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life|Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life|Recruiting||N/A|14|Anticipated|Loma Linda University||1|||f||||f||||||||||2017-10-10 22:35:17.002846|2017-10-10 22:35:17.002846
NCT02652663|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-08|||January 2016||2016-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Liver MRI for Colorectal Cancer Liver Metastasis: Comparative Effectiveness Research for the Choice of Contrast Agents||Active, not recruiting||N/A|500|Anticipated|Yonsei University|||2||f||||f||||||||No|no plant to shae data|2017-10-10 22:35:17.127113|2017-10-10 22:35:17.127113
NCT02652650|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-06-03|||December 2015||2015-12-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone|A Phase 1, Open-label Study in Healthy Female Subjects to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone|Completed||Phase 1|18|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 22:35:17.185303|2017-10-10 22:35:17.185303
NCT02652637|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-12-04|||February 2016||2016-02-01|December 2016|2016-12-01||||January 2019|Anticipated|2019-01-01||Interventional|||MOBILE Trial. Mechanical and Oral Antibiotic Bowel Preparation Versus no Bowel preparatIon for eLEctive Colectomy - a Multicenter, Prospective, Randomized, Controlled Trial.|MOBILE Trial. Mechanical and Oral Antibiotic Bowel Preparation Versus no Bowel preparatIon for eLEctive Colectomy - a Multicenter, Prospective, Randomized, Controlled Trial.|Recruiting||Phase 4|415|Anticipated|Helsinki University Central Hospital||2|||f||||||||||||||2017-10-10 22:35:17.310715|2017-10-10 22:35:17.310715
NCT02652624|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-04-07|||February 1, 2016|Actual|2016-02-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women|A Phase 3, Randomized, Open Label Study to Evaluate the Safety and Efficacy of Switching to a Fixed Dose Combination (FDC) of GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) From Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF), Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate (E/C/F/TDF) or Atazanavir + Ritonavir + Emtricitabine/Tenofovir Disoproxil Fumarate (ATV+RTV+FTC/TDF) in Virologically Suppressed HIV-1 Infected Women|Active, not recruiting||Phase 3|471|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 22:35:17.420792|2017-10-10 22:35:17.420792
NCT02652611|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-03-31|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SIS||Sacroiliac (SI) Screws: The Effect of SI Screw Removal on Patient-Reported Pain and Functional Outcomes|The Effect of Sacroiliac (SI) Screw Removal on Patient-Reported Pain and Functional Outcomes After Open or Closed Reduction and Internal Fixation of Pelvic Fractures|Recruiting||N/A|150|Anticipated|University of Maryland||2|||f||||t||||||||No||2017-10-10 22:35:17.65629|2017-10-10 22:35:17.65629
NCT02652598|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-01-17|||November 2015||2015-11-01|January 2017|2017-01-01||||January 2020|Anticipated|2020-01-01||Interventional|||Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD|A Proof of Concept Open-label Study to Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With Traumatic Brain Injury (TBI), Other Acquired Brain Injuries (ABI), or a Diagnosis of Neurocognitive Disorder (NCD)|Enrolling by invitation||Phase 2|100|Anticipated|Sheppard Pratt Health System||1|||f||||t||||||||||2017-10-10 22:35:17.777993|2017-10-10 22:35:17.777993
NCT02652585|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-26|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|September 4, 2017|Actual|2017-09-04|August 25, 2017|Actual|2017-08-25||Interventional|TEMANX||Validation of a Test System for Development of Medications for Alcoholism|Validation of a Test System for Development of Medications for Alcoholism|Completed||Phase 3|46|Actual|Technische Universität Dresden||2|||f||||t||||||||||2017-10-10 22:35:17.873666|2017-10-10 22:35:17.873666
NCT02652572|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-07-28|||September 2015||2015-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers|Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers|Recruiting||Phase 1|16|Anticipated|FirstString Research, Inc.||1|||f||||t||||||||||2017-10-10 22:35:17.984989|2017-10-10 22:35:17.984989
NCT02652559|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-06-08|||June 2016||2016-06-01|June 2016|2016-06-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|RECONSIDER||Initiation of Long-term Non-invasive Ventilation in COPD|Treatment of Chronic Respiratory Failure in COPD Patients With Non-invasive Ventilation: Starting at Home and Selecting the Right Patient|Recruiting||Phase 3|72|Anticipated|University Medical Center Groningen||2|||f||||t||||||||No||2017-10-10 22:35:18.129645|2017-10-10 22:35:18.129645
NCT02652546|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-09|2017-10-05|||December 24, 2015||2015-12-24|July 12, 2017|2017-07-12|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)|A Phase 1 Study of CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy|Completed||Phase 1|36|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:35:18.28619|2017-10-10 22:35:18.28619
NCT02652533|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-01-30|||September 2016||2016-09-01|January 2017|2017-01-01|March 2024|Anticipated|2024-03-01|March 2018|Anticipated|2018-03-01||Observational|||Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia|Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia|Recruiting||N/A|50|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||No||2017-10-10 22:35:18.405654|2017-10-10 22:35:18.405654
NCT02652520|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-11|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation (OXYOP)|Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation|Active, not recruiting||Phase 1|60|Actual|University Hospital, Brest||1|||f||||t||||||||||2017-10-10 22:35:18.554209|2017-10-10 22:35:18.554209
NCT02652507|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-04-04|||June 2016||2016-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Dexmedetomidine and Ketamine in MRI|Effect of a Combination of Dexmedetomidine and Ketamine Anesthesia on Upper Airway Morphology in Children|Recruiting||Phase 1|22|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 22:35:18.721068|2017-10-10 22:35:18.721068
NCT02652494|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-01-27|||January 2016||2016-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|APRIL||Observational Study of Apremilast in Patients With Psoriasis in The Netherlands|Observational Study of Apremilast Use and Effectiveness Over a One Year Treatment Period in Patients With Psoriasis in The Netherlands|Recruiting||N/A|200|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 22:35:18.845314|2017-10-10 22:35:18.845314
NCT02652481|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-17|||January 2016||2016-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|April 30, 2017|Actual|2017-04-30||Interventional|ENABLE MRI||Expanding MRI Access for Patients With New and Existing ICDs and CRT-Ds ( ENABLE MRI)||Active, not recruiting||N/A|500|Anticipated|Boston Scientific Corporation||1|||f||||f|f|t|t|f||||||2017-10-10 22:35:18.987242|2017-10-10 22:35:18.987242
NCT02652468|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-08-17|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma|A Pilot Study to Assess Engraftment Using CliniMACS TCR-α/β and CD19 Depleted Stem Cell Grafts From Haploidentical Donors for Hematopoietic Progenitor Cell Transplantation in Patients With Relapsed Lymphoma|Recruiting||N/A|14|Anticipated|University of Wisconsin, Madison||1|||f||||t|f|t|f|f||||||2017-10-10 22:35:19.306196|2017-10-10 22:35:19.306196
NCT02652455|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-09-13|||March 2, 2016|Actual|2016-03-02|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma|A Pilot Clinical Trial Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma|Recruiting||Early Phase 1|12|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 22:35:19.437548|2017-10-10 22:35:19.437548
NCT02652416|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-02-08|||September 2016||2016-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BI 1026706 in Healthy Chinese and Japanese Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses and Multiple Oral Doses of BI 1026706 in Healthy Chinese and Japanese Male Volunteers (Randomised, Double-blind, Placebo-controlled Trial)|Completed||Phase 1|72|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 22:35:19.833797|2017-10-10 22:35:19.833797
NCT02652403|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-07|||March 2015||2015-03-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Simplified Versus Conventional Technique for Complete Denture Fabrication.|Quality of Life, Patient Satisfaction, Quality of Dentures, Masticatory Efficiency, Presence of Temporomandibular Dysfunction and Costs Analysis of Simplified and Conventional Techniques for Complete Denture Fabrication|Completed||Phase 2|42|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||||2017-10-10 22:35:19.936806|2017-10-10 22:35:19.936806
NCT02652390|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-09-26|||February 2016||2016-02-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Local Steroid Injection vs Placebo in Carpal Tunnel Syndrome|Extended Follow-up of a Randomized Placebo-controlled Trial of Local Steroid Injection in Carpal Tunnel Syndrome|Completed||Phase 4|111|Actual|Region Skane||3|||f||||t||||||||||2017-10-10 22:35:20.061372|2017-10-10 22:35:20.061372
NCT02652377|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-01-20|||January 10, 2016|Actual|2016-01-10|January 2017|2017-01-01|December 27, 2016|Actual|2016-12-27|December 27, 2016|Actual|2016-12-27||Interventional|||EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients|A Randomized, Double-Blind, Pbo-Controlled, Study of EDP-494 to Evaluate the Safety and PK of SAD/FE in Healthy Subjects and MAD in Healthy and in Subjects With CHC Infection (POC)|Completed||Phase 1|100|Actual|Enanta Pharmaceuticals||4|||f||||f||||||||No|Once the clinical study report has been submitted to the appropriate Regulatory authorities, a lay person summary will be provided to all study subjects by mail or email.|2017-10-10 22:35:20.16474|2017-10-10 22:35:20.16474
NCT02652364|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||October 2015||2015-10-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Strong Ion Gap as Prognostic Indicator for Adult Patients Admitted With Shock to the Intensive Care Units|Strong Ion Gap as Prognostic Indicator for Adult Patients Admitted With Shock to the Intensive Care Units|Recruiting||N/A|112|Anticipated|Singapore General Hospital|||1||f||||f||||||||||2017-10-10 22:35:20.258034|2017-10-10 22:35:20.258034
NCT02652351|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-05-20|||March 2016||2016-03-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|May 2016|Anticipated|2016-05-01||Interventional|||Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis|Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis|Recruiting||Phase 1|20|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||1|||f||||t||||||||Undecided||2017-10-10 22:35:20.349164|2017-10-10 22:35:20.349164
NCT02652338|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-01-07|||April 2014||2014-04-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Dietary Supplement on Symptom Awareness and Heart Rhythm in Patients With Cardiac Arrhythmia|Influence of a Specific Micronutrient Combination on Symptom Awareness and Heart Rhythm in Patients With Cardiac Arrhythmia|Completed||Phase 3|74|Actual|Trommsdorff GmbH & Co. KG||2|||f||||f||||||||||2017-10-10 22:35:20.47072|2017-10-10 22:35:20.47072
NCT02652325|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-08||||||January 2016|2016-01-01||||February 2016|Anticipated|2016-02-01||Interventional|||Nasal Swab studyComparison of Effectiveness of Povidone-iodine Versus Saline Versus 3M Skin and Nasal Antiseptic 5% Povidone-Iodine USP Swabs for Decolonizing Intranasal MSSA/MRSA|Comparison of Effectiveness of Povidone-iodine Versus Saline Versus 3M Skin and Nasal Antiseptic 5% Povidone-Iodine USP Swabs for Decolonizing Intranasal MSSA/MRSA|Active, not recruiting||N/A|||Rothman Institute Orthopaedics||3|||f||||||||||||||2017-10-10 22:35:20.571978|2017-10-10 22:35:20.571978
NCT02652312|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-11-09|||February 2016||2016-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Dexmedetomidine and Desflurane Consumption|Effect of Dexmedetomidine Infusion on Desflurane Consumption and Hemodynamics During BIS Guided Laparoscopic Surgery: A Randomized Controlled Study|Completed||N/A|40|Actual|Theodor Bilharz Research Institute||2|||f||||f||||||||No||2017-10-10 22:35:20.658787|2017-10-10 22:35:20.658787
NCT02652299|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2016-09-26|||March 2016||2016-03-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Fibrocytes in Early and Longstanding Rheumatoid Arthritis|Fibrocytes in Early and Longstanding Rheumatoid Arthritis|Recruiting||N/A|60|Anticipated|Odense University Hospital|||3||f||||f||||||Samples With DNA|"     Peripheral blood, Synovial tissue biopsies   "|||2017-10-10 22:35:20.816901|2017-10-10 22:35:20.816901
NCT02652286|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-04-18|||January 2016||2016-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pulmonary Artery Harmonic Ace+7 Energy Sealing in VATS Lobectomy|Pulmonary Artery Harmonic Ace+7 Energy Sealing in VATS Lobectomy|Completed||Early Phase 1|20|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-10 22:35:20.954115|2017-10-10 22:35:20.954115
NCT02652273|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-11|||January 2016||2016-01-01|January 2016|2016-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|ICoSRA||Inhibition of Co-Stimulation in Rheumatoid Arthritis|Inhibition of Co-Stimulation in Rheumatoid Arthritis|Not yet recruiting||Phase 4|25|Anticipated|NHS Greater Glasgow and Clyde||1|||f||||f||||||||||2017-10-10 22:35:21.036909|2017-10-10 22:35:21.036909
NCT02652260|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-09-20|||March 4, 2016|Actual|2016-03-04|September 2017|2017-09-01|August 23, 2018|Anticipated|2018-08-23|February 26, 2018|Anticipated|2018-02-26||Interventional|||Effects of Switching From ATRIPLA^TM (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)|Phase IIb, Double-Blinded, Multicenter, Randomized Study to Assess the Effect on Central Nervous System (CNS) Toxicity of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Subjects.|Recruiting||Phase 2|84|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:35:21.150952|2017-10-10 22:35:21.150952
NCT02652247|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-11-01|||January 2016||2016-01-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients|Serial, Non-invasive Molecular Analysis of Exhaled Breath Condensate to Define the Pulmonary Flora in Critically Injured, Ventilated Adults: The Clinical Trial|Recruiting||N/A|350|Anticipated|Vanderbilt University||4|||f||||f||||||||No||2017-10-10 22:35:21.277904|2017-10-10 22:35:21.277904
NCT02652234|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-08|||August 2015||2015-08-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of Endostar Subcutaneous Injection in NSCLC|A Single-arm, Open-label Study to Investigate the Safety, Tolerability and Pharmacokinetics of Endostar Subcutaneous Injection in Chinese Advanced NSCLC Patients|Recruiting||Phase 1|8|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:35:21.376252|2017-10-10 22:35:21.376252
NCT02652221|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-06-13|2017-01-31||June 2014||2014-06-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional||Presenting for MR elastography|Determination of Liver Stiffness in Chronic Liver Disease Patients by Acoustic Radiation Force Imaging (ARFI) Ultrasound|Determination of Liver Stiffness in Chronic Liver Disease Patients by Acoustic Radiation Force Imaging (ARFI) Ultrasound|Completed||N/A|55|Actual|Children's Hospital Medical Center, Cincinnati|1)Did not compare ARFI from multiple vendors to MR elastography, 2)No histologic reference standard|1|||f||||f||||||||No||2017-10-10 22:35:21.480302|2017-10-10 22:35:21.480302
NCT02652208|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2017-08-28|2017-04-04||January 2016||2016-01-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||Comparative Effectiveness of Decision Aids for Stable Chest Discomfort|Randomized Trial Comparing Effectiveness of Two Patient Decision Aids for Stable Chest Discomfort|Completed||N/A|34|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:35:21.694737|2017-10-10 22:35:21.694737
NCT02652195|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-09-19|||November 2016||2016-11-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II|Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II|Recruiting||Phase 2|88|Anticipated|University of Utah||2|||f||||f||||||||||2017-10-10 22:35:22.11367|2017-10-10 22:35:22.11367
NCT02652182|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-07-24|||January 2016||2016-01-01|July 2016|2016-07-01||||January 2017|Anticipated|2017-01-01||Observational|||Short-term Air Pollution Exposure and In-hospital Outcomes in Patients With Acute Myocardial Infraction|Short-term Air Pollution Exposure and In-hospital Outcomes in Patients With Acute Myocardial Infraction|Enrolling by invitation||N/A|600|Anticipated|Nanjing Medical University|||2||f||||f||||||||No||2017-10-10 22:35:22.201474|2017-10-10 22:35:22.201474
NCT02652169|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-05-29|||June 2014||2014-06-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Interventional|PRF-TAT||PRF With Topical Antibiotics or Antiseptics in Chronical Wounds Version 1.4|Platelet Rich Fibrin in Combination With Topical Antibiotics or Antiseptics in the Treatment of Chronic Wounds - a Prospective, Randomized, Active Controlled, Double Blind Pilot Trial With an Observer-blinded Control Group|Recruiting||N/A|120|Anticipated|Medical University of Vienna||4|||f||||t||||||||Undecided||2017-10-10 22:35:22.264816|2017-10-10 22:35:22.264816
NCT02652156|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-03-09|||November 2015||2015-11-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||TAP Block for Postoperative Pain Control|Transversus Abdominis Plane (TAP) Block Study for Postoperative Pain Control|Terminated||Phase 3|12|Actual|Midwestern Regional Medical Center||3||Operational barriers at the site.|f||||f||||||||||2017-10-10 22:35:22.369816|2017-10-10 22:35:22.369816
NCT02652143|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-08|||January 2016||2016-01-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy?|Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy? A Sibling Oocyte, Prospective, Multi-centric, Randomized, Open Study, Clinical Study in Subjects With Subfertility Undergoing Assisted Reproductive Medical Treatment|Recruiting||N/A|35|Anticipated|Anecova SA||2|||f||||t||||||||Undecided||2017-10-10 22:35:22.458229|2017-10-10 22:35:22.458229
NCT02652130|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-10-12|||October 2015||2015-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD|Safety Follow-up Through 180 Days of Treatment With Remestemcel-L in Study MSB-GVHD001 in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD|Recruiting||Phase 3|60|Anticipated|Mesoblast, Ltd.|||1||f||||t||||||||||2017-10-10 22:35:22.540807|2017-10-10 22:35:22.540807
NCT02652117|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||July 2007||2007-07-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Regional Anesthesia in Cardiac Pediatric Patients Less Than 5 Years Old|Retrospective Review of Regional Anesthesia in Cardiac Pediatric Patients|Completed||N/A|545|Actual|University of Iowa|||1||f||||t||||||||||2017-10-10 22:35:22.769122|2017-10-10 22:35:22.769122
NCT02652104|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2016-01-08|||January 2006||2006-01-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01|2 Years|Observational [Patient Registry]|||Deep Brain Stimulation in HUCH Region Between 2006 and 2014|A Review of the Clinical Outcome of Deep Brain Stimulation in the Patients With Advanced Parkinson's Disease in Helsinki and Uusimaa Hospital Between 2006 to 2014|Completed||N/A|140|Actual|Hospital District of Helsinki and Uusimaa|||1||f||||t||||||||||2017-10-10 22:35:22.850376|2017-10-10 22:35:22.850376
NCT02652091|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-29|||February 5, 2016|Actual|2016-02-05|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|August 11, 2017|Actual|2017-08-11||Observational|||Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction|Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction|Completed||N/A|146|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:35:22.928546|2017-10-10 22:35:22.928546
NCT02652078|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-11-01|||June 2015||2015-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|SLICC||Shockwave Therapy in Lower Limb Intermittent Calf Claudication|Extracorporeal Shockwave Therapy in the Treatment of Intermittent Claudication Symptoms in Peripheral Vascular Disease|Recruiting||N/A|100|Anticipated|University of Hull||2|||f||||f||||||||||2017-10-10 22:35:23.073799|2017-10-10 22:35:23.073799
NCT02652065|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-08-26|||February 2016||2016-02-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MicroPso||Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis|Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis|Recruiting||N/A|22|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 22:35:23.176734|2017-10-10 22:35:23.176734
NCT02652052|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|HTSS||Hematopoietic Stem Cell Transplant Survivors Study (HTSS Study)|Hematopoietic Stem Cell Transplant Survivors Study (HTSS Study)|Recruiting||N/A|10|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:35:23.29252|2017-10-10 22:35:23.29252
NCT02652039|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-24|||October 2014||2014-10-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Interactionality of Music Preference and Individual Variables in Pain Perception and Management|Interactionality of State-Trait Music Preference, Individual Variability, and Music Characteristics as a Multi-Axis Paradigm for Context-Specific Pain Perception and Management|Completed||N/A|35|Actual|University of Iowa|||1||f||||t||||||||||2017-10-10 22:35:23.396865|2017-10-10 22:35:23.396865
NCT02652026|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2016-10-18|||June 2013||2013-06-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Non-surgical Periodontal Treatment on HbA1c in Type 2 Diabetic Patients|Effect of Non-surgical Periodontal Treatment on HbA1c in Type 2 Diabetic Patients|Completed||N/A|90|Actual|University of Barcelona||2|||f||||f||||||||||2017-10-10 22:35:23.488804|2017-10-10 22:35:23.488804
NCT02652013|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-08|||December 2015||2015-12-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|COGNISEP||Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis|Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis|Recruiting||N/A|80|Anticipated|Pôle Saint Hélier||2|||f||||f||||||||||2017-10-10 22:35:23.579147|2017-10-10 22:35:23.579147
NCT02652000|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-12-11|||October 2009||2009-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy|Retrospective Analysis of Quality of Life After Permanent Interstitial Iodine Seed Brachytherapy for Prostate Cancer|Completed||N/A|50|Actual|Kantonsspital Graubuenden|||1||f||||f||||||||||2017-10-10 22:35:23.673543|2017-10-10 22:35:23.673543
NCT02651987|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-07-28|||November 2015||2015-11-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|CLARINET FORTE||Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg|Efficacy and Safety of Lanreotide Autogel® 120 mg Administered Every 14 Days in Well Differentiated, Metastatic or Locally Advanced, Unresectable Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg Administered Every 28 Days|Recruiting||Phase 2|100|Anticipated|Ipsen||1|||f||||t||||||||||2017-10-10 22:35:23.782772|2017-10-10 22:35:23.782772
NCT02651974|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-03-27|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|March 2017|Actual|2017-03-01||Interventional|||Evidence Based Colorectal Cancer Screening for the Uninsured - Sub-study|Evidence Based Colorectal Cancer Screening for the Uninsured - Sub-study|Active, not recruiting||N/A|15152|Actual|University of Texas Southwestern Medical Center||3|||f||||f||||||||Undecided||2017-10-10 22:35:23.955236|2017-10-10 22:35:23.955236
NCT02651961|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-04-12|||July 2016||2016-07-01|April 2016|2016-04-01||||June 2020|Anticipated|2020-06-01||Interventional|IPRO||Cost-effectiveness Evaluation of One Stage Versus Two Stage Exchange for Chronically Infected Total Hip and Total Knee Prostheses|Cost-effectiveness Evaluation of One Stage Versus Two Stage Exchange for Chronically Infected Total Hip and Total Knee Prostheses|Not yet recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||2|||f||||t||||||||||2017-10-10 22:35:24.050732|2017-10-10 22:35:24.050732
NCT02651948|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-09-07|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Transperineal, MRI-guided, Prostate Biopsy|Transperineal, MRI-guided, Prostate Biopsy: First Step to Focal Treatment of Prostate Cancer|Recruiting||Phase 4|90|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 22:35:24.163414|2017-10-10 22:35:24.163414
NCT02651935|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-08-30|||August 2015||2015-08-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Intellivent ASV in COPD Patients|A Randomized Controlled Trial Comparing a Fully Closed Loop Ventilation Mode (Intellivent ASV) With Pressure Controlled + Pressure Support Ventilation in COPD Patients|Recruiting||N/A|224|Anticipated|Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital||2|||f||||f||||||||||2017-10-10 22:35:24.235682|2017-10-10 22:35:24.235682
NCT02651922|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-04-04|2016-04-21||September 2014||2014-09-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational||A total of 156 patients participated in the study. Two patients were excluded from the analysis, because they received Benzodiazepines (Tavor, Lexostad). One patient was 17 years of age when documented in the study. The overall study population considered in the analyses was 154 patients.|Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®|Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®|Completed||N/A|154|Actual|Pascoe Pharmazeutische Praeparate GmbH|||1||f||||f||||||||No||2017-10-10 22:35:24.330081|2017-10-10 22:35:24.330081
NCT02651909|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-06-20|||April 2016||2016-04-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Utilization of TEG to Monitor Rivaroxaban Activity|Utilization of Thromboelastography to Monitor Rivaroxaban Activity in Trauma and Emergency Surgery Patients|Recruiting||N/A|100|Anticipated|University of Pittsburgh|||2||f||||f||||||||||2017-10-10 22:35:24.703889|2017-10-10 22:35:24.703889
NCT02651896|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-08-24|||December 20, 2015|Actual|2015-12-20|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer|Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer: a Prospective Cohort.|Recruiting||N/A|130|Anticipated|Hospital Sirio-Libanes|||1||f||||t||||||||||2017-10-10 22:35:24.806412|2017-10-10 22:35:24.806412
NCT02651883|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-09-22|||April 2016||2016-04-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|MBMT-3||Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3|Effect of HPV Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3|Recruiting||N/A|510|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 22:35:24.911168|2017-10-10 22:35:24.911168
NCT02651870|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-01-08|||March 2015||2015-03-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy|A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy|Unknown status|Recruiting|Phase 3|135|Anticipated|Chong Kun Dang Pharmaceutical||3|||f||||f||||||||||2017-10-10 22:35:25.012378|2017-10-10 22:35:25.012378
NCT02651857|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-04-27|||November 2015||2015-11-01|January 2016|2016-01-01|April 27, 2017||2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|||Exploratory Study of Upper and Lower Endoscopic Fuse System|Exploratory Study of Upper and Lower Endoscopic Fuse System|Completed||N/A|1000|Anticipated|EndoChoice Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:35:25.117438|2017-10-10 22:35:25.117438
NCT02651844|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-06-09|||April 2016|Actual|2016-04-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|MIPRA||Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.|Mifepristone Treatment for Breast Cancer Patients Expressing Levels of Progesterone Receptor Isoform A (PRA) Higher Than Those of Isoform B (PRB): Neoadjuvant Therapy.|Recruiting||N/A|20|Anticipated|Hospital Provincial Magdalena V. de Martínez||1|||f||||t||||||||Undecided||2017-10-10 22:35:25.176118|2017-10-10 22:35:25.176118
NCT02651831|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-19|||July 2015||2015-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|FACT-ICM||Development and Validation of a Health-related Quality of Life Instrument|Development and Validation of a Health-related Quality of Life Instrument: Functional Assessment of Cancer Therapy - Immune Checkpoint Modulators, an Investigator Initiated Study (FACT-ICM).|Recruiting||N/A|85|Anticipated|University Health Network, Toronto|||5||f||||f||||||||||2017-10-10 22:35:25.294153|2017-10-10 22:35:25.294153
NCT02651818|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-11-07|||October 2014||2014-10-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|SOLOIST||Changes in Quality of Life Following Surgical Treatment of Benign Non-toxic Goiter|The Impact of Surgical Treatment of Benign Non-toxic Goiter on Quality of Life|Active, not recruiting||N/A|104|Anticipated|University of Southern Denmark|||1||f||||f||||||||Undecided||2017-10-10 22:35:25.387505|2017-10-10 22:35:25.387505
NCT02651805|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-07-13|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|July 30, 2017|Anticipated|2017-07-30|July 30, 2017|Anticipated|2017-07-30||Interventional|||Mechanical Insufflator-exsufflator to Control Mucus Hypersecretion in Patients in Palliative Care - A Feasibility Study|Mechanical Insufflator-exsufflator to Manage Respiratory Secretion in Patients in Palliative Care - A Feasibility Study|Recruiting||N/A|50|Anticipated|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-10-10 22:35:25.470239|2017-10-10 22:35:25.470239
NCT02651792|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-04-27|||January 2015||2015-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Ketamine- Propofol Versus Pethidine- Propofol in ERCP|Ketamine-propofol Versus Pethidine-propofol for Sedating Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP)|Completed||Phase 2|50|Actual|Assiut University||2|||f||||||||||||||2017-10-10 22:35:25.562209|2017-10-10 22:35:25.562209
NCT02651779|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-05-12|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|VIPAR||Internal Plate Fixation vs. Plaster in Complete Articular Distal Radial Fractures|Internal Plate Fixation vs. Plaster in Complete Articular Distal Radial Fractures|Recruiting||N/A|90|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 22:35:25.649887|2017-10-10 22:35:25.649887
NCT02651766|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-08|||May 2009||2009-05-01|January 2016|2016-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|SKM||The Effects of Cupping Massage in Patients With Chronic Neck Pain - A Randomized Controlled Trial|Randomised Controlled Trial on the Influence of Cupping Massage on Pain Intensity and Sensory Mechanical and Pain Thresholds in Patients With Chronic Non Specific Neck Pain|Completed||N/A|50|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-10 22:35:25.762482|2017-10-10 22:35:25.762482
NCT02651753|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-08|2016-07-05|||January 2016||2016-01-01|January 2016|2016-01-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337|A Randomized, Open-label, Single Oral Dose, 2-way Crossover Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 in Healthy Male Volunteers.|Completed||Phase 1|48|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||No||2017-10-10 22:35:25.855771|2017-10-10 22:35:25.855771
NCT02651740|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-04-10|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea|Efficacy and Safety Evaluation of Rifaximin Combined Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea|Recruiting||Phase 2/Phase 3|10|Anticipated|Shanghai Zhongshan Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:35:25.949552|2017-10-10 22:35:25.949552
NCT02651727|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-07-25|||September 2015||2015-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects|A Phase 1 Study of VS-4718, a Focal Adhesion Kinase Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Subjects With Advanced Cancer|Terminated||Phase 1|13|Actual|Verastem, Inc.||3||the company's decision to de-prioritize 4718 development|f||||f||||||||||2017-10-10 22:35:26.035738|2017-10-10 22:35:26.035738
NCT02651714|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-02-28|||January 2016||2016-01-01|February 2017|2017-02-01||||September 2017|Anticipated|2017-09-01||Interventional|||Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis|Recruiting||Phase 2|150|Anticipated|Vanda Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:35:26.131714|2017-10-10 22:35:26.131714
NCT02651701|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-08-08|||January 2016||2016-01-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|August 8, 2017|Actual|2017-08-08||Observational|||Rectal Cancer Staging Using Whole Body MR-PET|Preoperative Imaging for Rectal Cancer Staging Using Whole Body MR-PET|Active, not recruiting||N/A|71|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-10 22:35:26.227386|2017-10-10 22:35:26.227386
NCT02651688|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-07-25|||January 2016||2016-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene|A Randomized, Double Blind, Placebo-Controlled, Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene|Completed||Phase 2|50|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-10-10 22:35:26.305734|2017-10-10 22:35:26.305734
NCT02651675|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-03-15|||March 2016||2016-03-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)|A Phase 1/2a, Single Ascending IV Dose Clinical Trial Investigating Human Low Density Lipoprotein Receptor (LDLR) Gene Therapy in Subjects With Homozygous Familial Hypercholesterolemia (HoFH).|Recruiting||Phase 1/Phase 2|12|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:35:26.42983|2017-10-10 22:35:26.42983
NCT02651662|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-06-16|||November 2015||2015-11-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of REGN2810 and REGN1979 in Patients With Lymphoma||Recruiting||Phase 1|154|Anticipated|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:35:26.835333|2017-10-10 22:35:26.835333
NCT02651649|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-01-07|||February 2016||2016-02-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pregnancy, Sleep Disordered Breathing and Peripartum Complications|Is Sleep Disordered Breathing During Pregnancy a Modifiable Risk Factor for Fetal Growth Restriction?|Not yet recruiting||N/A|50|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 22:35:27.001591|2017-10-10 22:35:27.001591
NCT02651636|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-01-07|||June 2014||2014-06-01|January 2016|2016-01-01||||July 2015|Actual|2015-07-01||Interventional|||Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women|Effects of Combined Therapy With Myo-inositol and Alpha-Lipoic Acid on Clinical, Endocrine and Metabolic Features in Women Affected by Polycystic Ovary Syndrome|Completed||N/A|40|Actual|Catholic University of the Sacred Heart||1|||f||||||||||||||2017-10-10 22:35:27.105596|2017-10-10 22:35:27.105596
NCT02651623|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-10-11|||January 2016||2016-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|Zoloft||Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects|A Phase 1, Single Center Randomized, Three-way Crossover, Double-blinded, Placebo- And Moxifloxacin-controlled Thorough Qt (Tqt) Study To Determine The Effects Of Sertraline (Zoloft (Registered)) On The Cardiac Repolarization In Healthy Subjects|Completed||Phase 1|54|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 22:35:27.200197|2017-10-10 22:35:27.200197
NCT02651610|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-07-07|||December 2015||2015-12-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer|An Open-Label, Randomized, Phase II/III Trial of Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer|Withdrawn||Phase 2/Phase 3|0|Actual|Peregrine Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:35:27.341283|2017-10-10 22:35:27.341283
NCT02651597|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-02-15|||April 2016||2016-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||A Study of the Effect of Oats on Post Prandial Glucose Response|A Randomized, Controlled, Cross-over Study of the Effect of Oats on Post Prandial Glucose Response|Active, not recruiting||N/A|24|Actual|University of Manitoba||3|||f||||f||||||||||2017-10-10 22:35:27.517088|2017-10-10 22:35:27.517088
NCT02651584|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-11-17|||December 2015||2015-12-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence|A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multi-center Trial Assessing the Efficacy and Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Treatment of Adult Outpatients With Opioid Use Disorder|Completed||Phase 3|429|Actual|Braeburn Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 22:35:27.683747|2017-10-10 22:35:27.683747
NCT02651571|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-06-16|||March 2016||2016-03-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Survival Rates of Patients With Mobile Bearing Total Knee Arthroplasty After 10 Years||Not yet recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||No||2017-10-10 22:35:27.926462|2017-10-10 22:35:27.926462
NCT02651558|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-02-06|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|January 2017|Actual|2017-01-01||Interventional|BP||Optical System to Continuously Measure Arterial Blood Pressure|Comparison of an Optical System to Continuously Measure Arterial Blood Pressure Against a Gold-standard Arterial Catheter|Active, not recruiting||N/A|40|Anticipated|Centre Suisse d'Electronique et Microtechnique SA||1|||f||||f||||||||||2017-10-10 22:35:28.007161|2017-10-10 22:35:28.007161
NCT02651545|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-04-24|||February 2014||2014-02-01|October 2016|2016-10-01|August 5, 2019|Anticipated|2019-08-05|August 5, 2018|Anticipated|2018-08-05||Observational|||Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis|Teriflunomide (Aubagio) Effects on Cognitive and Vocational Outcomes, as Related to Neurodegeneration in Multiple Sclerosis: A Prospective, Observational, Single-blinded Study.|Recruiting||N/A|60|Anticipated|State University of New York at Buffalo|||2||f||||f||||||||||2017-10-10 22:35:28.112478|2017-10-10 22:35:28.112478
NCT02651532|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-11-07|||January 2016||2016-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Confocal Endomicroscopy Utility (p-CLE) in Irritable Bowel Syndrome|Confocal Endomicroscopy Utility for Diagnosing Mucosa Micro-inflammation in Patients With Irritable Bowel Syndrome|Recruiting||N/A|100|Anticipated|Instituto Ecuatoriano de Enfermedades Digestivas|||2||f||||t||||||Samples Without DNA|"     Histological biopsies of the colonic mucosal   "|Undecided||2017-10-10 22:35:28.232319|2017-10-10 22:35:28.232319
NCT02651519|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-03-23|||January 2016||2016-01-01|January 2016|2016-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation|Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation|Completed||Phase 4|105|Actual|China Medical University, China||2|||f||||t||||||||Undecided||2017-10-10 22:35:28.38537|2017-10-10 22:35:28.38537
NCT02651506|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-05-10||||||May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Interventional|||Electromagnetic Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung Nodules|Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung Nodules: Comparison of Outcomes and Costs in a Public Healthcare System|Withdrawn||Phase 2|0|Actual|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||No||2017-10-10 22:35:28.523944|2017-10-10 22:35:28.523944
NCT02651493|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-10-24|||February 2013||2013-02-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Digital Dysmorphology Project|Down Syndrome Detection From Facial Photographs Using Machine Learning Techniques|Recruiting||N/A|750|Anticipated|Children's Research Institute||2|||f||||f||||||||||2017-10-10 22:35:28.644675|2017-10-10 22:35:28.644675
NCT02651480|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-06-13|||February 2016||2016-02-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Nutritional Intervention in Police Officers|A Nutritional Intervention in Police Officers|Suspended||N/A|20|Anticipated|Physicians Committee for Responsible Medicine||2||Sponsor put plans on hold|f||||t||||||||||2017-10-10 22:35:28.817101|2017-10-10 22:35:28.817101
NCT02651467|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-08-28|2016-12-22||January 1, 2016||2016-01-01|January 2017|2017-01-01|April 22, 2016|Actual|2016-04-22|April 1, 2016|Actual|2016-04-01||Interventional||Safety population was defined as all the participants who were randomized and received at least one dose of study treatment during the study.|A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli.|A Clinical Study Investigating the Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity|Completed||N/A|221|Actual|GlaxoSmithKline||3|||f||||t||||||||||2017-10-10 22:35:28.951276|2017-10-10 22:35:28.951276
NCT02651454|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-07-25|||December 2015||2015-12-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -|A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -|Recruiting||Phase 4|120|Anticipated|Gachon University Gil Oriental Medical Hospital||3|||f||||f||||||||Undecided||2017-10-10 22:35:29.527876|2017-10-10 22:35:29.527876
NCT02651441|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-05-23|||February 2016||2016-02-01|January 2016|2016-01-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|||D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)|Randomized, Controlled Study of the Safety and Efficacy of D-CIK Immune Cell Combined With Chemotherapy for Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|60|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||2|||f||||t||||||||Undecided||2017-10-10 22:35:29.673576|2017-10-10 22:35:29.673576
NCT02651428|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-02-07|||December 2015||2015-12-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection|Phase 3 Prospective, Multicenter, Double-blind, Randomized, Active Control Study to Demonstrate Safety & Effectiveness of Neutrolin in Preventing Catheter-related Bloodstream Infection in Subjects on Hemodialysis for End Stage Renal Disease|Recruiting||Phase 3|632|Anticipated|CorMedix||2|||f||||t||||||||No||2017-10-10 22:35:29.817249|2017-10-10 22:35:29.817249
NCT02651415|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-07-11|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PARICCA||Phase II Study of Perindopril and Regorafenib in mCRC|A Phase II Trial of the Effect of Perindopril on HFSR Incidence and Severity in Patients Receiving Regorafenib With Refractory Metastatic Colorectal Carcinoma (mCRC)|Active, not recruiting||Phase 2|12|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-10 22:35:29.958975|2017-10-10 22:35:29.958975
NCT02651402|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-01-09|||February 2016||2016-02-01|January 2017|2017-01-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||A Hybrid Effectiveness-Implementation Trial of Group CBT in Urban Schools|A Hybrid Effectiveness-Implementation Trial of Group Cognitive Behavior Therapy (CBT) in Urban Schools|Recruiting||N/A|534|Anticipated|Children's Hospital of Philadelphia||3|||f||||f||||||||No||2017-10-10 22:35:30.099958|2017-10-10 22:35:30.099958
NCT02651389|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-04-13|||February 18, 2016|Actual|2016-02-18|April 2017|2017-04-01|September 29, 2016|Actual|2016-09-29|September 29, 2016|Actual|2016-09-29||Observational|ESPPADON||Evaluation of Tests Performance on a New Digital Orthoptic Platform|Evaluation de la Performance d'Une Nouvelle Plateforme de Tests de dépistage Orthoptique numériques|Completed||N/A|96|Actual|University Hospital, Brest|||1||f||||f||||||||No||2017-10-10 22:35:30.204304|2017-10-10 22:35:30.204304
NCT02651376|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-08-26|||September 2015|Actual|2015-09-01|September 2015|2015-09-01|August 2017|Actual|2017-08-01|April 2017|Actual|2017-04-01||Interventional|||Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients|Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients|Completed||Phase 1/Phase 2|20|Actual|Beijing 302 Hospital||1|||f||||t||||||||||2017-10-10 22:35:30.289196|2017-10-10 22:35:30.289196
NCT02651363|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-04-17|||March 2016||2016-03-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Diclofenac 25mg/Paracetamol 500 mg and Diclofenac 50 mg/Paracetamol 500 mg for Patients With Pain|Incidence of Adverse Events, Risk Factors, and Drug Utilization Factors Related to Treatment With Diclofenac 25 MG/Paracetamol 500 MG and Diclofenac 50 MG/Paracetamol 500 MG in Patients From Metropolitan Lima|Completed||N/A|374|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:35:30.385775|2017-10-10 22:35:30.385775
NCT02651350|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2017-07-14|||December 2015||2015-12-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI|A Randomized Controlled Clinical Trial on the Efficacy and Safety of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-induced Liver Injury|Recruiting||Phase 1/Phase 2|72|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||||2017-10-10 22:35:30.483487|2017-10-10 22:35:30.483487
NCT02651337|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-07-06|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters|Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters|Recruiting||Phase 3|30|Anticipated|Alcyone Lifesciences, Inc.||1|||f||||t||||||||||2017-10-10 22:35:30.655945|2017-10-10 22:35:30.655945
NCT02651324|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-06-29|||May 2013|Actual|2013-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis|A Prospective, Randomized, Double-Blind, Controlled Trial Evaluating the Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis|Active, not recruiting||Phase 4|50|Anticipated|Albany Medical College||2|||f||||f||||||||||2017-10-10 22:35:30.737662|2017-10-10 22:35:30.737662
NCT02651129|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-11-15|||January 2016||2016-01-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||BC Women's Hospital Noise Pilot|Assessment of Noise in BC Women's Hospital Operating Rooms|Completed||N/A|10|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-10 22:35:33.954886|2017-10-10 22:35:33.954886
NCT02651311|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-01-26|||January 16, 2016|Actual|2016-01-16|January 2017|2017-01-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||Ultrasound Guided Intermediate Cervical Plexus Block for Congenital Muscular Torticollis|Randomized Controlled Trial of the Postoperative Analgesic Efficacy of Ultrasound Guided Intermediate Cervical Plexus Block for Unipolar Sternocleidomastoid Release in Patient With Congenital Muscular Torticollis|Completed||Phase 4|32|Actual|Ajou University School of Medicine||2|||f|||||f|f||||||||2017-10-10 22:35:30.820079|2017-10-10 22:35:30.820079
NCT02651298|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-02|2016-01-07|||January 2014||2014-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||CO2-laser Treatment for Caesarean Section Scars|Fractional CO2-laser Treatment of Caesarean Section Scars - A Randomized Controlled Split-scar Trial With Long Term Follow-up Assessment|Completed||N/A|12|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-10 22:35:30.901636|2017-10-10 22:35:30.901636
NCT02651285|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||January 2016||2016-01-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of G-CSF Supplemented IVF Medium in Patients Undergoing IVF|G-CSF Supplemented Medium for IVF Embryo Culture in Patients Undergoing IVF|Recruiting||Phase 4|180|Anticipated|Centre for Endocrinology and Reproductive Medicine, Italy||2|||f||||t||||||||Yes||2017-10-10 22:35:30.981871|2017-10-10 22:35:30.981871
NCT02651272|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-03-15|||July 2015||2015-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MENSCH||Macitentan in Pulmonary Hypertension of Sickle Cell Disease|The Safety and Efficacy of Macitentan for Treatment of Pulmonary Hypertension in Sickle Cell Disease|Recruiting||Phase 1|10|Anticipated|Boston University||1|||f||||t||||||||No|Currently there is no plan to share IPD.|2017-10-10 22:35:31.072299|2017-10-10 22:35:31.072299
NCT02651259|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-10-02|||February 15, 2017|Actual|2017-02-15|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluating the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-Infected and HIV-1-Uninfected Pregnant and Postpartum Women With Latent Tuberculosis Infection|A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women With Latent Tuberculosis Infection|Recruiting||Phase 1/Phase 2|82|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t|t|f||||||||2017-10-10 22:35:31.17446|2017-10-10 22:35:31.17446
NCT02651246|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-07-19|||December 2015||2015-12-01|July 2016|2016-07-01||||December 2021|Anticipated|2021-12-01|10 Years|Observational [Patient Registry]|||Optional Sub-study to Intraoperative Imaging With ICG Registry|Optional Sub-study to Intraoperative Imaging With ICG Registry|Recruiting||N/A|500|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:35:31.286866|2017-10-10 22:35:31.286866
NCT02651233|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-02|2016-01-07|||March 2014||2014-03-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Observational|||Factors That Influence Adipose Derived Regenerative Cells' Yield and Viability|Factors That May Influence Yield and Viability of Extracted Adipose Derived Regenerative Cells' Per Gram of Fat Tissue|Completed||N/A|46|Actual|Clinical Centre of Serbia|||1||f||||f||||||||No||2017-10-10 22:35:31.355977|2017-10-10 22:35:31.355977
NCT02651220|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-11-23|||November 2015||2015-11-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|||Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris||Completed||Phase 3|1000|Actual|Actavis Inc.||3|||f||||f||||||||No||2017-10-10 22:35:32.985067|2017-10-10 22:35:32.985067
NCT02651207|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-02-16|||November 2016||2016-11-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Ethyl Chloride Spray Versus Subcutaneous Lidocaine Anaesthetic Prior to Contraceptive Implant Insertion|Study Looking at Acceptability of Using Ethyl Chloride Spray Versus Subcutaneous Lidocaine Anaesthetic Prior to Contraceptive Implant Insertion|Withdrawn||N/A|0|Actual|Tayside Medical Science Centre|||2|decided not to do study. This will be run as a service evaluation instead|f||||t|f|f||||||No||2017-10-10 22:35:33.095408|2017-10-10 22:35:33.095408
NCT02651181|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-01-08|||June 2016||2016-06-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes The DREAMED Trail|Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREAMED Trail|Recruiting||N/A|10|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-10 22:35:33.399604|2017-10-10 22:35:33.399604
NCT02651168|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||March 2016||2016-03-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study|Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study|Not yet recruiting||Phase 4|50|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-10 22:35:33.53288|2017-10-10 22:35:33.53288
NCT02651155|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-04-19|||March 2, 2016|Actual|2016-03-02|April 2017|2017-04-01|January 11, 2017|Actual|2017-01-11|January 11, 2017|Actual|2017-01-11||Interventional|||Lubiprostone for the Treatment of Chronic Idiopathic Constipation|A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lubiprostone for the Treatment of Chronic Idiopathic Constipation|Completed||Phase 3|204|Actual|Takeda||2|||f||||f||||||||||2017-10-10 22:35:33.62284|2017-10-10 22:35:33.62284
NCT02651142|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||January 2015||2015-01-01|January 2016|2016-01-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A Randomized, Controlled Trial of Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer||Recruiting||N/A|200|Anticipated|Shandong University||2|||f||||f||||||||||2017-10-10 22:35:33.857483|2017-10-10 22:35:33.857483
NCT02651090|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI|Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced Computed Tomography and/or Magnetic Resonance Imaging Using Sonazoid|Withdrawn||Phase 3|0|Actual|Northeastern Ohio Radiology Research and Education Fund||1||Sponsor terminated study before enrollment Sponsor terminated study before enrollment|f||||f|t|f||||||||2017-10-10 22:35:34.309118|2017-10-10 22:35:34.309118
NCT02651077|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-07|||November 2013||2013-11-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|ENDOTOX||Endometriosis and Brominated Flame Retardant (ENDOTOX Study)|Looking for a Link Between Endometriosis and Exposure to Lipophilic Environmental Chemicals Like Brominated Flame Retardant (ENDOTOX Study)|Completed||N/A|76|Actual|Nantes University Hospital|||2||f||||f||||||Samples Without DNA|"     omental adipose tissue   "|||2017-10-10 22:35:34.408067|2017-10-10 22:35:34.408067
NCT02651064|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-06|||June 2010||2010-06-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|HIP||USDA Healthy Incentives Pilot|USDA Healthy Incentives Pilot (HIP)|Completed||N/A|55095|Actual|Abt Associates||2|||f||||f||||||||Yes|Public use dataset available by request from USDA Food & Nutrition Service.|2017-10-10 22:35:34.521131|2017-10-10 22:35:34.521131
NCT02651051|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||April 2014||2014-04-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Metabolic and Appetite Parameters Following Addition of Whey Protein to a Fat-based Breakfast|The Influence of Whey Protein Addition to a Fat-based Breakfast on Metabolic and Appetite Parameters Following a Second Meal|Completed||N/A|10|Actual|Northumbria University||2|||f||||f||||||||||2017-10-10 22:35:34.647952|2017-10-10 22:35:34.647952
NCT02651038|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-01-07|||May 2012||2012-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01||Interventional|Mica-HDF||Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration|Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration|Completed||Phase 4|10|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-10-10 22:35:34.761032|2017-10-10 22:35:34.761032
NCT02651025|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||January 2016||2016-01-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Effects of Resistance Training on Physical Activity in Daily Life and Functional Capacity in Hemodialysis Patients|Effects of Resistance Training on Physical Activity in Daily Life, Muscle Function and Functional Capacity in Patients With End Stage Renal Disease on Hemodialysis: a Randomised Controlled Trial|Recruiting||N/A|29|Anticipated|Federal University of Juiz de Fora||2|||f||||f||||||||||2017-10-10 22:35:34.859433|2017-10-10 22:35:34.859433
NCT02651012|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-12-05|||March 2015||2015-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SC1401||Study to Evaluate the Efficacy and Safety of 1.5 mg/kg/Day of Sarecycline vs Placebo in the Treatment of Acne Vulgaris|A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 1.5 mg/kg Per Day of Sarecycline Compared to Placebo in the Treatment of Acne Vulgaris|Withdrawn||Phase 3|0|Actual|Sadick Research Group||2||study held elsewhere by separate sponsor|f||||f||||||||||2017-10-10 22:35:34.991528|2017-10-10 22:35:34.991528
NCT02650999|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-12-19|||January 2016||2016-01-01|December 2016|2016-12-01||||January 2019|Anticipated|2019-01-01||Interventional|||Phase I/II Study of Pembrolizumab in Patients Failing to Respond to or Relapsing After Anti-CD19 Chimeric Antigen Receptor Modified T Cell Therapy for Relapsed or Refractory CD19+ Lymphomas|Phase I/II Study of Pembrolizumab in Patients Failing to Respond to or Relapsing After Anti-CD19 Chimeric Antigen Receptor Modified T Cell Therapy for Relapsed or Refractory CD19+ Lymphomas|Recruiting||Phase 1/Phase 2|12|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:35:35.099058|2017-10-10 22:35:35.099058
NCT02650986|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-07-08|||June 30, 2017|Actual|2017-06-30|July 2017|2017-07-01|October 20, 2019|Anticipated|2019-10-20|October 20, 2018|Anticipated|2018-10-20||Interventional|||Gene-Modified T Cells in Treating Patients With Locally Advanced or Stage IV Solid Tumors Expressing NY-ES0-1|A Phase I/IIa Study of TGFß Blockade in TCR-Engineered T-Cell Cancer Immunotherapy in Patients With Advanced Malignancies|Recruiting||Phase 1/Phase 2|24|Anticipated|Roswell Park Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 22:35:35.191568|2017-10-10 22:35:35.191568
NCT02650973|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-07-28|||February 2016||2016-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta|A Randomized, Single-Blind, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® in Healthy Subjects|Completed||Phase 1|122|Actual|Coherus Biosciences, Inc.||3|||f||||f||||||||||2017-10-10 22:35:35.310973|2017-10-10 22:35:35.310973
NCT02650960|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-07-10|||February 2016||2016-02-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||Life Balance and Bimanual Activities After Stroke|Life Balance and Bimanual Activities After Stroke|Recruiting||N/A|120|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||||||||||||2017-10-10 22:35:35.417865|2017-10-10 22:35:35.417865
NCT02650934|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||June 2015||2015-06-01|June 2015|2015-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|HF-EXPRESS||Predictors of Heart Failure After ST-segment Elevation Myocardial Infarction (HF-EXPRESS)||Recruiting||N/A|312|Anticipated|Dr. Nafiz Korez Sincan State Hospital|||2||f||||t||||||Samples With DNA|"     Peripheral Blood specimen   "|||2017-10-10 22:35:35.575141|2017-10-10 22:35:35.575141
NCT02650921|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-09-20||2017-09-20|December 2015||2015-12-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Effectiveness and Safety of Restylane Lyft With Lidocaine in the Dorsal Hand|A Randomized, Evaluator Blinded, Split-hand Study to Evaluate the Effectiveness and Safety of Restylane Lyft With Lidocaine Compared to no Treatment for Injection in the Dorsal Hand to Correct Volume Deficit|Completed||N/A|117|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-10 22:35:35.665598|2017-10-10 22:35:35.665598
NCT02650908|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-06-16|||January 2016||2016-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Is Abrasion of the Suture Area Essential for Healing of a Meniscus Lesion?|Does the Avivement of Suturing Area is Essential for Healing a Meniscus Lesion ?|Not yet recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 22:35:35.894868|2017-10-10 22:35:35.894868
NCT02650895|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-06|||February 2014||2014-02-01|January 2016|2016-01-01||||January 2015|Actual|2015-01-01||Interventional|||Safety Study of CD24Fc When Administered Intravenously in Healthy Adult Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of CD24Fc When Administered Intravenously in Healthy Adult Subjects|Completed||Phase 1|40|Actual|OncoImmune, Inc.||2|||f||||||||||||||2017-10-10 22:35:35.958603|2017-10-10 22:35:35.958603
NCT02650882|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-01-07|||April 2013||2013-04-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Inspiratory Muscle Training on the Performance of Handball Athletes|Effect of Inspiratory Muscle Training on the Performance of Handball Athletes|Completed||N/A|19|Actual|Universidade Metodista de Piracicaba||2|||f||||t||||||||||2017-10-10 22:35:36.060702|2017-10-10 22:35:36.060702
NCT02650869|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-01-07|||July 2012||2012-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Probiotics||Role of Probiotics for Prevention of NEC in Preterm VLBW Infants|Role of Probiotics for Prevention of Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants: A Double Blind Randomized Controlled Trial|Completed||Phase 3|60|Actual|Sylhet M.A.G.Osmani Medical College||2|||f||||t||||||||||2017-10-10 22:35:36.147059|2017-10-10 22:35:36.147059
NCT02650856|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-01-07|||September 2015||2015-09-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Blood Loss Reduction After Total Knee Arthroplasty. A Comparison Between Topical Tranexamic Acid and Platelet Rich Plasma|Blood Loss Reduction After Total Knee Arthroplasty. A Comparison Between Topical Tranexamic Acid and Platelet Rich Plasma: Controlled Clinical Trial|Recruiting||Phase 3|50|Anticipated|Universidad Autonoma de Nuevo Leon||2|||f||||t||||||||Undecided||2017-10-10 22:35:36.257415|2017-10-10 22:35:36.257415
NCT02650843|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-04-27|||January 2015||2015-01-01|April 2017|2017-04-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Observational|NMDAT||Non-motor Symptoms and Brain Dopamine Transporter Binding|Non-motor Symptoms and Brain Dopamine Transporter Binding: An Observational Study in Parkinsonism|Enrolling by invitation||N/A|1000|Anticipated|Turku University Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:35:36.383894|2017-10-10 22:35:36.383894
NCT02650830|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-07|||September 2015||2015-09-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress||Recruiting||N/A|300|Anticipated|Yonsei University|||3||f||||f||||||Samples Without DNA|"     serum (blood), whole blood   "|No|no plan to share data|2017-10-10 22:35:36.48446|2017-10-10 22:35:36.48446
NCT02650817|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-04-12|||December 2015||2015-12-01|April 2017|2017-04-01||||May 2018|Anticipated|2018-05-01||Interventional|||A Phase IB Study to Evaluate the Effect of RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer|A Phase IB Study to Evaluate the Effect of RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer Lesions Using 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography Imaging|Active, not recruiting||Phase 1|16|Anticipated|Radius Health, Inc.||1|||f||||f||||||||||2017-10-10 22:35:36.576836|2017-10-10 22:35:36.576836
NCT02650791|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-08-28|||October 2016||2016-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|PATH||Platelet Transfusion Requirements in Hematopoietic Transplantation|Platelet Transfusion Requirements in Hematopoietic Transplantation(PATH Pilot)|Recruiting||Phase 3|100|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:35:36.828282|2017-10-10 22:35:36.828282
NCT02650778|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-12|||October 2014||2014-10-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2017|Actual|2017-01-01||Observational|ABUS||Automated Breast Ultrasound Screening|Automated Breast Ultrasound Screening in Women With Dense Breasts (BIRADS 3 or 4) and BIRADS Category 1 or 2 Mammogram Assigning BIRADS 3 Lesions to Yearly Follow-up|Enrolling by invitation||N/A|2000|Anticipated|Northeastern Ohio Radiology Research and Education Fund|||1||f||||f||||||||||2017-10-10 22:35:36.943851|2017-10-10 22:35:36.943851
NCT02650765|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-10-20|||November 2015||2015-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|S100||S100 Biomarker in the Acute Management of Mild Head Injuries|S100 Biomarker in the Acute Management of Mild Head Injuries|Recruiting||N/A|1000|Anticipated|Tampere University Hospital|||1||f||||f||||||Samples With DNA|"     Emergency department:      - S-S100B      Storage, -70 degrees celsius freezer:        -  Serum 50 microlitres divided into 8 vials (Eppendorf)        -  Plasma divided into 3 vials (Eppendorf)        -  Whole blood (EDTA)   "|||2017-10-10 22:35:37.00441|2017-10-10 22:35:37.00441
NCT02650752|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-08-14|||January 6, 2016||2016-01-06|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases|Phase I Study of Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases|Recruiting||Phase 1|36|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:35:37.092458|2017-10-10 22:35:37.092458
NCT02650739|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-06|||May 2013||2013-05-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Observational|||Optical Coherence Tomography-based Positioning for Macular Hole Surgery|Duration of Prone Positioning After Macular Hole Surgery Determined by Swept Source Optical Coherence Tomography|Completed||N/A|125|Actual|Kyorin University|||2||f||||f||||||||No||2017-10-10 22:35:37.21419|2017-10-10 22:35:37.21419
NCT02650726|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-01-07|||November 2014||2014-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) Function|Effect of Purification Anthocyanins on HDL and Endothelial Function in Subjects With Type 2 Diabetes Mellitus: A Randomized, Double-Blinded, Placebo-Controlled Trial|Completed||Early Phase 1|80|Actual|Sun Yat-sen University||2|||f||||t||||||||Undecided|It depends on the Sponsor Investigator|2017-10-10 22:35:37.292068|2017-10-10 22:35:37.292068
NCT02650713|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-20|||January 7, 2016|Actual|2016-01-07|September 2017|2017-09-01|July 24, 2019|Anticipated|2019-07-24|April 10, 2019|Anticipated|2019-04-10||Interventional|||A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors|An Open-Label, Multicenter, Dose Escalation and Expansion Phase Ib Study to Evaluate the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors|Recruiting||Phase 1|125|Anticipated|Hoffmann-La Roche||2|||f||||f||||||||||2017-10-10 22:35:37.375513|2017-10-10 22:35:37.375513
NCT02650700|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-14|||April 2016||2016-04-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|SPLEENIR||Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC|Spleen Radiotherapy Decreases Severe Chemotherapy Induced Thrombocytopenia (CIT) for the Multi-center Randomized Controlled Study in Advanced NSCLC(SPLEENIR)|Not yet recruiting||Phase 2|146|Anticipated|Xinqiao Hospital of Chongqing||2|||f||||t||||||||||2017-10-10 22:35:37.525194|2017-10-10 22:35:37.525194
NCT02650687|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-02-01|||October 2015||2015-10-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||Optimizing Postoperative Cognition the Elderly|Optimizing Postoperative Cognition the Elderly|Recruiting||N/A|175|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||||||2017-10-10 22:35:37.599069|2017-10-10 22:35:37.599069
NCT02650674|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-09-13|||October 2015||2015-10-01|September 2017|2017-09-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products|Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products|Completed||N/A|24|Actual|Mondelēz International, Inc.||6|||f||||f||||||||||2017-10-10 22:35:37.694849|2017-10-10 22:35:37.694849
NCT02650661|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-01-07|||December 2015||2015-12-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Positively|A Randomized Controlled Trial of Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Positively in Cancer Survivors|Recruiting||N/A|485|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-10 22:35:37.804505|2017-10-10 22:35:37.804505
NCT02650648|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-08|||January 2016||2016-01-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma|Phase I Study of the Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma|Recruiting||Phase 1|36|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:35:37.952014|2017-10-10 22:35:37.952014
NCT02650635|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-10-17|||February 2016||2016-02-01|June 2016|2016-06-01||||May 2021|Anticipated|2021-05-01||Interventional|||TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors|Phase IB Study Investigating the Tolerability, Immunomodulatory Impacts and, Therapeutic Correlates of the Novel Toll-like Receptor 8 Agonist Motolimod (MOTO) Plus Cyclophosphamide (CTX) Treatment of Advanced Solid Tumors|Active, not recruiting||Phase 1|4|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:35:38.048492|2017-10-10 22:35:38.048492
NCT02650622|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-01-06|||June 2015||2015-06-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|May 2018|Anticipated|2018-05-01||Observational|||Genetic and Metabolic Disease in Children|Genetic Regulators of Metabolism and Development in Children|Recruiting||N/A|1550|Anticipated|University of Texas Southwestern Medical Center|||3||f||||f||||||Samples With DNA|"     There are 3 cohorts in this study:      Cohort 1: healthy newborns Cohort 2: healthy children aged 0-18 years old Cohort 3: Children     with genetic/metabolic disorders and their families      Blood samples will be collected from all the three cohorts for isolation of plasma for     metabolomic analysis.      In addition, DNA will be extracted from the blood samples of cohort 3 patients for genomic     sequencing, and skin fibroblast cells will be collected from the proband patients in cohort     3.   "|Undecided||2017-10-10 22:35:38.175802|2017-10-10 22:35:38.175802
NCT02650609|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-25|||June 24, 2016|Actual|2016-06-24|August 2017|2017-08-01|June 24, 2019|Anticipated|2019-06-24|December 24, 2018|Anticipated|2018-12-24||Interventional|SUCRE||Treatment of Chronic Subdural Hematoma by Corticosteroids|Treatment of Chronic Subdural Hematoma by Corticosteroids|Recruiting||Phase 3|202|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-10 22:35:38.377911|2017-10-10 22:35:38.377911
NCT02650596|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2016-01-07|||January 2016||2016-01-01|January 2016|2016-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of GLP-1 on Chronic Heart Failure|Effects of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With Type 2 Diabetes|Recruiting||N/A|68|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 22:35:38.547903|2017-10-10 22:35:38.547903
NCT02650583|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-11-07|||December 2015||2015-12-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children|Enhancing Connections Program in Palliative Care: Taking Care of the Children|Recruiting||N/A|48|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 22:35:38.644376|2017-10-10 22:35:38.644376
NCT02650570|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-12-08|||December 2015||2015-12-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Mitochondrial Respiratory Function in Mammalian Skeletal Muscle|Mitochondrial Respiratory Function in Mammalian Skeletal Muscle: Metabolic Insights Into Cancer and Burn Cachexia Through Comparative Physiology of Humans and Marine Mammals|Recruiting||N/A|20|Anticipated|The University of Texas Medical Branch, Galveston|||2||f||||f||||||Samples Without DNA|"     Plasma will be collected and retained in the PI lab.   "|No||2017-10-10 22:35:38.767219|2017-10-10 22:35:38.767219
NCT02650544|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-01-06|||December 2015||2015-12-01|January 2016|2016-01-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression|Efficacy and Safety Analyses of Mirtazapine in the Treatment of Malignant Tumor Related Depression: A Phase II, Placebo-controlled, Randomized, Double-blinded Clinical Trial in Advanced Non-small Cell Lung Cancer Patients|Active, not recruiting||Phase 2|236|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided||2017-10-10 22:35:38.969642|2017-10-10 22:35:38.969642
NCT02650531|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-01-17|||May 2015||2015-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|Nor-Coast||Norwegian COgnitive Impairment After STroke (NorCOAST) Study|Norwegian COgnitive Impairment After STroke (NorCOAST) Study|Recruiting||N/A|1000|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-10 22:35:39.096897|2017-10-10 22:35:39.096897
NCT02650518|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-01-07|||December 2015||2015-12-01|January 2016|2016-01-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|CARCUTI||Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections|Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections (CARCUTI)|Recruiting||Phase 2/Phase 3|500|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-10 22:35:39.200468|2017-10-10 22:35:39.200468
NCT02650505|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-19|||February 2016||2016-02-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel|A Randomized, Controlled Study to Evaluate the Sensitizing Potential of LEO 43204 Gel and Gel Vehicle in Healthy Volunteers Using a Repeat Insult Patch Test Design|Completed||Phase 1|233|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:35:39.337462|2017-10-10 22:35:39.337462
NCT02650492|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-01-31|||October 2015||2015-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma|Exploratory Study on Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma|Recruiting||N/A|5|Anticipated|Clinical Laserthermia Systems AB||1|||f||||f||||||||||2017-10-10 22:35:39.429563|2017-10-10 22:35:39.429563
NCT02650479|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2017-01-26|||January 2016||2016-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of the Effects of Intravenous Exenatide on Cardiac Repolarization|Two-Part, Randomized, Placebo and Active-Controlled, Double-Blind, Thorough QT Study Evaluating the Effects of Intravenous Exenatide on Cardiac Repolarization in Healthy Male and Female Volunteers|Completed||Phase 1|82|Actual|Intarcia Therapeutics||4|||f||||f||||||||No||2017-10-10 22:35:39.549907|2017-10-10 22:35:39.549907
NCT02650466|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-03-28|||December 2013||2013-12-01|March 2017|2017-03-01|September 26, 2016|Actual|2016-09-26|August 20, 2016|Actual|2016-08-20||Interventional|||Nanopulse Efficacy Study for the Treatment of Common Warts|Nanopulse Efficacy Study for the Treatment of Common Warts|Completed||N/A|24|Actual|University of Southern California||1|||f||||f||||||||||2017-10-10 22:35:39.689128|2017-10-10 22:35:39.689128
NCT02650453|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-07|||September 2009||2009-09-01|December 2015|2015-12-01|September 2029|Anticipated|2029-09-01|September 2019|Anticipated|2019-09-01||Observational|||Ongoing Registry of Deep Venous Reconstructions|Ongoing Registry of Deep Venous Reconstructions|Recruiting||N/A|1000|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||No||2017-10-10 22:35:39.782472|2017-10-10 22:35:39.782472
NCT02650440|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-05-02|2016-12-23||November 2014||2014-11-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Discrete Versus Rhythmic Gait Training|Robot-assisted Locomotor Training After Severe Stroke: Discrete Versus Rhythmic Movement|Completed||N/A|20|Actual|University of Sao Paulo||2|||f||||t||||||||Undecided||2017-10-10 22:35:39.882877|2017-10-10 22:35:39.882877
NCT02650427|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-27|||February 2016||2016-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|HCC-DPPIV||A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection|A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection|Recruiting||Phase 1|15|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-10 22:35:40.280529|2017-10-10 22:35:40.280529
NCT02650414|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-15|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||CD22 Redirected Autologous T Cells for ALL|Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells in Pediatric Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia|Recruiting||Phase 1|15|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:35:40.369528|2017-10-10 22:35:40.369528
NCT02650401|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-06-23|||December 2015||2015-12-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions|A Phase 1/1b, Open-Label, Dose-Escalation and Expansion Study of Entrectinib (RXDX 101) in Children and Adolescents With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions|Recruiting||Phase 1|190|Anticipated|Ignyta, Inc.||5|||f||||f||||||||||2017-10-10 22:35:40.463602|2017-10-10 22:35:40.463602
NCT02650388|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-01-06|||November 2015||2015-11-01|December 2015|2015-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Frailty and Cognitive Function Assessment of TAVI Patients|Frailty and Cognitive Function Assessment of TAVI Patients (The Hungarian Frailty Score) - Observational, Prospective, Singe Center Study|Recruiting||Phase 4|100|Anticipated|Hungarian Institute of Cardiology||1|||f||||f||||||||||2017-10-10 22:35:40.641687|2017-10-10 22:35:40.641687
NCT02650375|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-01-20|||October 2015||2015-10-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Metatinib Tromethamine Tablet|A Phase Ib Clinical Study of the Tolerance, Safety and Preliminary Efficacy Observation of Single-/Multiple- Doses of Metatinib Tromethamine Tablets in Patients With Advanced or Metastatic Solid Tumor|Recruiting||Phase 1|24|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:35:40.744102|2017-10-10 22:35:40.744102
NCT02650362|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|TACTIC||STructural And FunCTional Brain Alterations by HIgh FrequenCy Spinal Cord Stimulation|STructural And FunCTional Brain Alterations by HIgh FrequenCy Spinal Cord Stimulation: a Combined Voxel-based Morphometry and Resting State Functional Connectivity Study|Recruiting||N/A|10|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-10 22:35:40.844168|2017-10-10 22:35:40.844168
NCT02650349|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|SCRATCHY||StruCtuRal And FuncTional Brain Alterations by Conventional Spinal Cord Stimulation And High DensitY Stimulation|StruCtuRal And FuncTional Brain Alterations by Conventional Spinal Cord Stimulation And High DensitY Stimulation: a Combined Voxel-based Morphometry and Resting State Functional Connectivity Study|Recruiting||N/A|20|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-10 22:35:40.952436|2017-10-10 22:35:40.952436
NCT02650336|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-01-06|||October 2013||2013-10-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ACTIN||Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial|Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial|Completed||N/A|592|Actual|Sun Yat-sen University|||2||f||||f||||||Samples Without DNA|"     Morning blood samples were received from all volunteers after an 8-h overnight fast. The     investigators obtained the blood samples used to measure preoperative serum uric acid,     baseline serum creatinine (SCr) (prior to the pre-procedural hydration), blood urea nitrogen     (BUN), fasting blood glucose, random blood glucose, electrolytes before PCI, serum lipids,     albumin, hemoglobin, and other standard clinical parameters. Blood samples were left to clot     for one hour and then centrifuged at 1500 ×g for 10 min. Plasma samples were accumulated and     stored at −80 °C until analysis.   "|No||2017-10-10 22:35:41.058076|2017-10-10 22:35:41.058076
NCT02650323|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-02-14|||March 2016||2016-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01|1 Year|Observational [Patient Registry]|Campania RESCA||Observational Registry on Acute Coronary Syndromes in Campania|Registro Campano Delle Sindromi Coronariche Acute|Not yet recruiting||N/A|10000|Anticipated|Federico II University|||1||f||||t||||||||||2017-10-10 22:35:41.136384|2017-10-10 22:35:41.136384
NCT02650310|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-01-07|||April 2015||2015-04-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Interventional|EmbryoTemp||New Device to Maintain the Embryo Temperature During Transfer|A New System for Preventing Thermal Stress During Embryo Transfer|Recruiting||N/A|352|Anticipated|Instituto Bernabeu||2|||f||||f||||||||||2017-10-10 22:35:41.2267|2017-10-10 22:35:41.2267
NCT02650297|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-01-07|||October 2009||2009-10-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||The Effect of Combined Decongestive Therapy and Pneumatic Compression Pump on Body Image in Patients With Lymphedema|The Effect of Combined Decongestive Therapy and Pneumatic Compression Pump on Body Image in Patients With Lymphedema Secondary to Breast Cancer Treatment|Completed||Phase 1/Phase 2|42|Actual|Islamic Azad University, Kazeroun||2|||f||||f||||||||No||2017-10-10 22:35:41.314276|2017-10-10 22:35:41.314276
NCT02650284|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-10-12|||August 2015||2015-08-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot|A Prospective, Randomised Controlled Trial Evaluating Total Knee Replacement With the Stryker Triathlon Primary Total Knee System, Compared to Bicompartmental Knee Replacement With Restoris MCK Multicompartmental Knee System Performed Using Stryker's Robotic-arm Assisted Surgery System, Mako|Recruiting||Phase 4|70|Anticipated|Stryker South Pacific||2|||f||||f||||||||||2017-10-10 22:35:41.41592|2017-10-10 22:35:41.41592
NCT02650271|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-06-08|||July 2015||2015-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Adjuvant Entecavir for Postoperative HBV-HCC|Adjuvant Entecavir for Hepatitis B Virus Related Hepatocellular Carcinoma After Curative Hepatic Resection|Recruiting||Phase 2/Phase 3|120|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-10 22:35:41.494379|2017-10-10 22:35:41.494379
NCT02650258|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-09-15|||December 2015||2015-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|CADENCE-Adults||Cadence and Intensity Across the Adult Lifespan|Cadence and Intensity Across the Adult Lifespan|Recruiting||N/A|260|Anticipated|University of Massachusetts, Amherst|||3||f||||f||||||||||2017-10-10 22:35:41.589303|2017-10-10 22:35:41.589303
NCT02650245|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-10-12|||October 2015||2015-10-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Breath and Blood Ammonia Response to an Oral Protein Challenge|Breath and Blood Ammonia Response to an Oral Protein Challenge|Completed||N/A|12|Actual|St. Luke's Hospital and Health Network, Pennsylvania||1|||f||||f||||||||||2017-10-10 22:35:41.681482|2017-10-10 22:35:41.681482
NCT02650232|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-02-29|||December 2015||2015-12-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SOMNO-BRS||Pilot Study to Evaluate the Somnotouch Device to Quantify Spontaneous Baroreflex Sensitivity|Pilot Study to Evaluate the Somnotouch Device to Quantify Spontaneous Baroreflex Sensitivity in Healthy Subjects and in Patients With Heart Failure|Recruiting||N/A|60|Anticipated|University Hospital, Angers||3|||f||||t||||||||||2017-10-10 22:35:41.864141|2017-10-10 22:35:41.864141
NCT02650219|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-02-23|2016-01-07||January 2010||2010-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Auto-antibodies Prevalence and CD1 Role in Gaucher Disease|Prevalence of Autoantibodies in the Gaucher Disease and the Role of CD1 Molecules in Immune Manifestations of This Disease|Completed||N/A|60|Actual|Hospital St. Joseph, Marseille, France|||2||f||||f||||||||No||2017-10-10 22:35:41.99272|2017-10-10 22:35:41.99272
NCT02650206|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-01-07|||January 2015||2015-01-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood|Effect of Liraglutide on Macrophage Polarization in Human Adipose Tissue and Peripheral Blood|Recruiting||Phase 4|56|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 22:35:42.347168|2017-10-10 22:35:42.347168
NCT02650193|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-10-03|||December 2015|Actual|2015-12-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.|A Phase 1-2 Ascending Dose Study To Assess The Pharmacodynamics, Pharmacokinetics, And Safety Of Hsp-130 In Subjects With Non-metastatic Breast Cancer Following Single Dose And Multiple-dose Administration By Subcutaneous Injection|Recruiting||Phase 2|24|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 22:35:42.458214|2017-10-10 22:35:42.458214
NCT02650167|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-07-08|||January 2016||2016-01-01|July 2016|2016-07-01||||January 2018|Anticipated|2018-01-01||Interventional|COLOSTRUM||Impact of Oropharyngeal Administration of Colostrum in the First 48 Hours of Life Term Premature Newborn ≤ 32 Weeks of Amenorrhea||Recruiting||N/A|116|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 22:35:42.668583|2017-10-10 22:35:42.668583
NCT02650154|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-10-17|||August 2013||2013-08-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||The Effects of the Anesthetic Ketamine in Young Children Undergoing Procedural Sedation|The Effects of the Anesthetic Ketamine in Young Children Undergoing Procedural Sedation|Completed||N/A|70|Actual|The Hospital for Sick Children|||2||f||||f||||||Samples With DNA|"     Blood and plasma samples   "|No||2017-10-10 22:35:42.754284|2017-10-10 22:35:42.754284
NCT02650115|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-04-10|||April 6, 2017|Actual|2017-04-06|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|MICRONACH||Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples (MICRONACH)|Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples|Recruiting||N/A|300|Anticipated|Centre Hospitalier Departemental Vendee|||1||f||||f||||||||||2017-10-10 22:35:43.062202|2017-10-10 22:35:43.062202
NCT02650102|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-07|||January 2013||2013-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment|The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment|Recruiting||Phase 1/Phase 2|200|Anticipated|Shanxi Medical University||2|||f||||t||||||||Yes||2017-10-10 22:35:43.146881|2017-10-10 22:35:43.146881
NCT02650089|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-01-06|||July 2013||2013-07-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Resistance Exercise Modify Cardiovascular Responses of Professors During Teaching and Sleep|Resistance Exercise Modify Cardiovascular Responses of Professors During Teaching and Sleep|Completed||N/A|10|Actual|Universidade Federal do vale do São Francisco||3|||f||||t||||||||No||2017-10-10 22:35:43.272078|2017-10-10 22:35:43.272078
NCT02650076|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-04-10|||January 2016||2016-01-01|April 2016|2016-04-01||||April 2016|Actual|2016-04-01||Interventional|||A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects||Completed||Phase 1|||Sanwa Kagaku Kenkyusho Co., Ltd.||1|||f||||||||||||||2017-10-10 22:35:43.363365|2017-10-10 22:35:43.363365
NCT02650063|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-06-28|||December 2015||2015-12-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||A Pharmacokinetic Study of DE-117 Ophthalmic Solution in Healthy Adult Male Subjects - Phase I Study -|A Pharmacokinetic Study of DE-117 Ophthalmic Solution in Healthy Adult Male Subjects - Phase I Study -|Completed||Phase 1|14|Actual|Santen Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:35:43.434092|2017-10-10 22:35:43.434092
NCT02650050|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-02-06|||January 19, 2016|Actual|2016-01-19|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|LAMED||Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).|Micropulsed Laser in Association With Intravitreal Injections of Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).|Recruiting||N/A|40|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f||||||||||2017-10-10 22:35:43.498779|2017-10-10 22:35:43.498779
NCT02650037|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-07|||November 2014||2014-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Observational|||The Air Test: A New Simple, Non-invasive Method to Diagnose Anesthesia-induced Atelectasis|Estudio de validación de la pulsioximetría Como método diagnóstico no Invasivo de Atelectasia Pulmonar y de la Efectividad de la Maniobra de Capacidad Vital Para la reversión de la Atelectasia Durante el Postoperatorio|Completed||N/A|181|Actual|Fundación para la Investigación del Hospital Clínico de Valencia|||1||f||||f||||||||||2017-10-10 22:35:43.578541|2017-10-10 22:35:43.578541
NCT02650024|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-04-11|||January 2016||2016-01-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes|Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes|Recruiting||Phase 4|72|Anticipated|University of California, San Diego||3|||f||||t||||||||||2017-10-10 22:35:43.63888|2017-10-10 22:35:43.63888
NCT02650011|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-25|2017-02-03|||October 2015||2015-10-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease|The Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease: Multicenter, Prospective Cohort Study|Recruiting||N/A|1520|Anticipated|Chuncheon Sacred Heart Hospital|||1||f||||f||||||||||2017-10-10 22:35:43.764545|2017-10-10 22:35:43.764545
NCT02649998|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-07-27|||January 2017||2017-01-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF|Comparison of Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in Patients With Acute Decompensated Heart Failure: A Randomized Controlled Trial|Not yet recruiting||N/A|174|Anticipated|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-10 22:35:43.883268|2017-10-10 22:35:43.883268
NCT02649985|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-11-08|||January 2016||2016-01-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease|Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease|Recruiting||Phase 1/Phase 2|50|Anticipated|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-10 22:35:43.997531|2017-10-10 22:35:43.997531
NCT02649972|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-06-08|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Single-agent Cobimetinib for Adults With Histiocytic Disorders|Phase II Trial of Single-agent Cobimetinib for Adults With Histiocytic Disorders|Recruiting||Phase 2|18|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:35:44.093315|2017-10-10 22:35:44.093315
NCT02649959|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-07-18|||October 2015||2015-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||An Open Label Study of CM-AT for the Treatment of Children With Autism|An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin|Recruiting||Phase 3|405|Anticipated|Curemark||1|||f||||f||||||||||2017-10-10 22:35:44.191092|2017-10-10 22:35:44.191092
NCT02649946|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-01|||June 2016||2016-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:35:44.432857|2017-10-10 22:35:44.432857
NCT02649933|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-05-11|||November 2015||2015-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Detection of Sleep Apnea Syndrome (OSA) in Pregnant Women and Assessment of Impact of OSA on Pregnancy Course|Detection of Sleep Apnea Syndrome (OSA) With Watch PAT 200 in Pregnant Women and Assessment of Impact of OSA on Intra-uterine Fetal Growth and Maternal Well-being|Terminated||N/A|8|Actual|Centre Hospitalier Universitaire Saint Pierre|||1|one investigator left the study site|f||||f||||||||No||2017-10-10 22:35:44.477664|2017-10-10 22:35:44.477664
NCT02649920|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-10|||June 2016||2016-06-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|BALLODINO||Comparing the Efficiency of Cervical Ripening BALLoon (Cook) to the DINOprostone (Propess) for the Cervical Maturation in Case of Unfavorable Cervix (Bishop <6) in the Population of Obese Pregnant Women (BMI >= 30 kg/m²)|Pilot, Comparative, Not Randomized, Two Centers Study Comparing the Efficiency of Cervical Ripening BALLoon (Cook) to the DINOprostone (Propess) for the Cervical Maturation in Case of Unfavorable Cervix (Bishop <6) in the Population of Obese Pregnant Women (BMI >= 30 kg/m²)|Terminated||N/A|2|Actual|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-10 22:35:44.557213|2017-10-10 22:35:44.557213
NCT02649907|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-01-06|||October 2015||2015-10-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|RepDiet||Effects of Weight Loss on Nutritional Mediated Hormone Secretion|Analysis of the Variability of Appetite and Energy Regulating Hormones to an Acute Nutritive Stimulation by Different Combinations of Macronutrients|Recruiting||N/A|50|Anticipated|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-10-10 22:35:44.641084|2017-10-10 22:35:44.641084
NCT02649894|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-05-25|||May 2016||2016-05-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SWIFT||A Clinical Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural Effusions Compared to Approved Pleural Catheter.||Recruiting||N/A|119|Anticipated|CareFusion||2|||f||||t||||||||||2017-10-10 22:35:44.722534|2017-10-10 22:35:44.722534
NCT02649881|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-07-13|||May 2015||2015-05-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|OCT pathology||Diagnosis of Macrophage Coronary Plaque by Optical Tomographic Imaging|Diagnosis of Macrophage Coronary Plaque by Optical Tomographic Imaging : A Comparative Study With Coronary Artery of the Transplanted or Autopsy Heart|Recruiting||N/A|20|Anticipated|Asan Medical Center|||1||f||||f||||||||No|This is not publicly funded trial.|2017-10-10 22:35:44.859115|2017-10-10 22:35:44.859115
NCT02649868|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-06-30|||January 4, 2016||2016-01-04|December 20, 2016|2016-12-20|January 16, 2019|Anticipated|2019-01-16|January 15, 2018|Anticipated|2018-01-15||Interventional|||LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment With Transarterial Embolization (TAE) Alone or Combined With Thermal Ablation|A Phase II Study Using LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment With Transarterial Embolization (TAE) Alone or Combined With Thermal Ablation|Recruiting||Phase 2|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:35:44.94031|2017-10-10 22:35:44.94031
NCT02649855|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-07|2017-08-22|||January 4, 2016||2016-01-04|August 17, 2017|2017-08-17|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer|Docetaxel and Prostvac for Metastatic Castration Sensitive Prostate Cancer|Recruiting||Phase 2|74|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 22:35:45.032487|2017-10-10 22:35:45.032487
NCT02649842|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-06-29|||January 2016||2016-01-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|||Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Lens (IOL)|Post-Approval Study of the TECNIS® Toric IOL Extended Cylinder Range (ECR), Models ZCT450, ZCT525 and ZCT600|Recruiting||N/A|90|Anticipated|Abbott Medical Optics||3|||f||||f||||||||||2017-10-10 22:35:45.138113|2017-10-10 22:35:45.138113
NCT02649829|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-10-05|||August 1, 2017|Actual|2017-08-01|October 2017|2017-10-01|November 2021|Anticipated|2021-11-01|October 2020|Anticipated|2020-10-01||Interventional|MESODEC||Autologous Dendritic Cell Vaccination in Mesothelioma|First-line Immunotherapy Using Wilms' Tumor Protein 1 (WT1)-Targeted Dendritic Cell Vaccinations for Malignant Pleural Mesothelioma|Recruiting||Phase 1/Phase 2|20|Anticipated|University Hospital, Antwerp||1|||f||||f|f|f||||||||2017-10-10 22:35:45.219377|2017-10-10 22:35:45.219377
NCT02649816|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-01-06|||March 2011||2011-03-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|March 2012|Actual|2012-03-01||Observational|||Effectiveness of Resin Sealants: Retrospective Cohort Study|A Retrospective Cohort Study on Clinical Success of Resin Sealants|Completed||N/A|88|Actual|University of Campinas, Brazil|||1||f||||t||||||||No||2017-10-10 22:35:45.39099|2017-10-10 22:35:45.39099
NCT02649803|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2016-08-12|||March 2016||2016-03-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Pediatric Asthma Control Under Community Management Model in China|Pediatric Asthma Control Under Community Management Model in China|Enrolling by invitation||N/A|800|Anticipated|Shanghai Children's Medical Center||1|||f||||t||||||||No||2017-10-10 22:35:45.470056|2017-10-10 22:35:45.470056
NCT02649790|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-09-22|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications|A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-8602 in Patients With Relapsed/Refractory Cancer Indications|Recruiting||Phase 1/Phase 2|103|Anticipated|Karyopharm Therapeutics Inc||1|||f||||f||||||||||2017-10-10 22:35:45.564807|2017-10-10 22:35:45.564807
NCT02649777|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-10|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Observational|||Normal Values of Oxidative Stress, Taurine, and Related Markers|Normal Values of Oxidative Stress, Taurine, and Related Markers|Active, not recruiting||N/A|25|Anticipated|University of Colorado, Denver|||1||f||||f||||||||No||2017-10-10 22:35:45.677565|2017-10-10 22:35:45.677565
NCT02649764|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-12|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||LY2606368 in Combination With Cytarabine and Fludarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HRMDS)|Phase 1 A/B Study of LY2606368 in Combination With Cytarabine and Fludarabine in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HRMDS)|Recruiting||Phase 1|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:35:45.759254|2017-10-10 22:35:45.759254
NCT02649751|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-08-17|||February 2016||2016-02-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|ROSCO-CF||Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|A Phase II, Dose Ranging, Multicenter, Double-blind, Placebo Controlled Study to Evaluate Safety and Effects of (R)-Roscovitine in Adults Subjects With Cystic Fibrosis, Carrying 2 Cystic Fibrosis Causing Mutations With at Least One F508del-CFTR Mutation and Chronically Infected With Pseudomonas Aeruginosa, a Study Involving 36 CF Patients (24 Treated, 12 Controls). ROSCO-CF.|Recruiting||Phase 2|36|Anticipated|University Hospital, Brest||3|||f||||t||||||||||2017-10-10 22:35:46.039341|2017-10-10 22:35:46.039341
NCT02649738|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-08-24|||December 2015||2015-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Corneal Tissue Inlay for Keratoconus|Use of Preserved Corneal Tissue Inlay to Treat Keratoconus|Recruiting||N/A|20|Anticipated|Cornea and Laser Eye Institute||1|||f||||f||||||||||2017-10-10 22:35:46.229291|2017-10-10 22:35:46.229291
NCT02649725|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-05-01|||January 2016||2016-01-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01|3 Months|Observational [Patient Registry]|||Patients Satisfaction With the Outcomes of Expensive Cytotoxic Agents|Prospective Questionnaire Based Observational Study Measuring the Degree of Patient's Satisfaction With the Outcomes of Expensive Cytotoxic Agents.|Recruiting||N/A|1800|Anticipated|Ain Shams University|||1||f||||f||||||||No||2017-10-10 22:35:46.316759|2017-10-10 22:35:46.316759
NCT02649712|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-06-30|||January 2016||2016-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction|Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction|Enrolling by invitation||N/A|68|Anticipated|Xuzhou Central Hospital||2|||f||||t|f|f||||||||2017-10-10 22:35:46.422739|2017-10-10 22:35:46.422739
NCT02649699|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-01-04|||February 2016||2016-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Multi-Parametric Brain Cancer MRI|Quantitative and Multi-Parametric 3D Magnetic Resonance Imaging of Primary Brain Tumors|Active, not recruiting||N/A|30|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||No||2017-10-10 22:35:46.517972|2017-10-10 22:35:46.517972
NCT02649686|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-08-14|||April 21, 2016|Actual|2016-04-21|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab|A Phase 1b Pharmacodynamic Study of Durvalumab (MEDI4736) in Patients With HER-2 Positive Metastatic Breast Cancer (MBC) Receiving Trastuzumab|Active, not recruiting||Phase 1|15|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-10 22:35:46.609023|2017-10-10 22:35:46.609023
NCT02649673|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-22|||March 23, 2016|Actual|2016-03-23|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 27, 2018|Anticipated|2018-07-27||Interventional|||LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies|Phase Ib Dose-Escalation Study of LCL161 in Combination With Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer (SCLC) and Select Gynecologic Malignancies|Recruiting||Phase 1/Phase 2|52|Anticipated|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-10 22:35:46.710025|2017-10-10 22:35:46.710025
NCT02649660|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-05-05|||October 2015||2015-10-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Lipidomics and Functional Analyses of Platelets in Fabry Disease|Lipidomics and Functional Analyses of Platelets in Fabry Disease|Recruiting||N/A|32|Anticipated|Spital Linth|||1||f||||f||||||Samples Without DNA|"     Blood plasma, serum and platelet isolates   "|||2017-10-10 22:35:46.818951|2017-10-10 22:35:46.818951
NCT02649647|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-02-17|||February 2016||2016-02-01|January 2016|2016-01-01|February 2026|Anticipated|2026-02-01|February 2022|Anticipated|2022-02-01||Interventional|PERN||Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy|Multicenter Randomized Trial of Sphincter-Preserving Surgery With Proximally Extended Resection Margin on Bowel Function and Anastomotic Complication for Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy|Recruiting||N/A|420|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:35:46.936147|2017-10-10 22:35:46.936147
NCT02649634|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-01-27|2016-08-03||September 2007||2007-09-01|January 2017|2017-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|BWLP+MI||Does Motivational Interviewing Improve Behavioral Weight Loss Outcomes for Obesity?|Adding Motivational Interviewing to a Behavioral Weight Loss Treatment for Obesity: A Randomized Controlled Trial|Completed||N/A|135|Actual|University of Calgary||2|||f||||f||||||||Yes|Data uploaded to Zenodo.org|2017-10-10 22:35:47.087865|2017-10-10 22:35:47.087865
NCT02649621|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-06|||August 2011||2011-08-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)|The Effect of in Vivo Cultured Limbal Stem Cells in the Treatment of Unilateral Corneal Stem Cell Damage|Completed||Phase 1|10|Actual|Royan Institute||1|||f||||t||||||||No||2017-10-10 22:35:48.110141|2017-10-10 22:35:48.110141
NCT02649608|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-03-28|||January 2016||2016-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients|Interventional, Open-label, Exploratory Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Lu AE04621 and the Active Metabolite Lu AA40326 After Ascending Oral Doses of Lu AE04621 to Patients With Parkinson's Disease|Completed||Phase 1|15|Actual|H. Lundbeck A/S||1|||f||||t||||||||||2017-10-10 22:35:48.218372|2017-10-10 22:35:48.218372
NCT02649595|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-09-30|||April 2014||2014-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BC||Bridge Copenhagen - Respite Care for Homeless People|Bridge Copenhagen - Respite Care for Homeless People|Completed||N/A|96|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 22:35:48.337954|2017-10-10 22:35:48.337954
NCT02649582|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-06-15|||December 2015||2015-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADDIT-GLIO||Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients|Adjuvant Dendritic-Cell Immunotherapy Plus Temozolomide Following Surgery and Chemoradiation in Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 1/Phase 2|20|Anticipated|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-10 22:35:48.44898|2017-10-10 22:35:48.44898
NCT02649569|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-06-27|||June 2015||2015-06-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer|Continuous Activity Monitoring During Fractionated Radiotherapy: A Pilot Study|Active, not recruiting||N/A|41|Actual|Albert Einstein College of Medicine, Inc.|||1||f||||f||||||||||2017-10-10 22:35:48.562189|2017-10-10 22:35:48.562189
NCT02649556|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-08-09|||September 30, 2015|Actual|2015-09-30|August 2017|2017-08-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2|A 26-week Extension Study to Determine the Biological and Functional Changes in Healthy Smokers Who Switched From Conventional Cigarettes (CC) to Tobacco Heating System 2.2 (THS 2.2) Compared to Those Who Continued to Smoke CC in the ZRHR-ERS-09-US Study|Completed||N/A|672|Actual|Philip Morris Products S.A.||2|||f||||f|f|f||||||||2017-10-10 22:35:48.667518|2017-10-10 22:35:48.667518
NCT02649543|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-01-06|||January 2012||2012-01-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Surgical Site Infection Rate Between Primary, Delayed Primary and Vacuum Assisted Closures.|Comparison of Surgical Site Infection Rate Between Primary, Delayed Primary and Vacuum Assisted Closures. A Prospective Randomized Study.|Completed||N/A|81|Actual|Tecnologico de Monterrey||3|||f||||t||||||||||2017-10-10 22:35:48.814558|2017-10-10 22:35:48.814558
NCT02649530|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-09-29||||||September 2016|2016-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma|An Open Label, Non-randomized Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma|Withdrawn||Phase 2|0|Actual|University of Michigan Cancer Center||1||funding withdrawn|f||||t||||||||||2017-10-10 22:35:48.914561|2017-10-10 22:35:48.914561
NCT02649517|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-05|||January 2016||2016-01-01|January 2016|2016-01-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Interventional|FHID||Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction|Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated Heart Failure With Ischemic Systolic Dysfunction|Recruiting||N/A|60|Anticipated|Russian Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 22:35:49.047669|2017-10-10 22:35:49.047669
NCT02649504|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-01-31|||June 2019|Anticipated|2019-06-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia|The Study of Immunotherapy With Rituximab and Pulse Dexamethasone Followed by With Mycophenolate Mofetil or Placebo in Adult Patients With Persistent and Chronic Immune Thrombocytopenia|Not yet recruiting||Phase 3|182|Anticipated|Weill Medical College of Cornell University||2|||f||||t|t|f|||f|||||2017-10-10 22:35:49.17229|2017-10-10 22:35:49.17229
NCT02649309|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-01-06|||October 2015||2015-10-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|SCRIP||Single-cycle Remote Ischemic Preconditioning and Postconditioning (SCRIP) Trial|Effect of Single-cycle Remote Ischemic Preconditioning and Postconditioning on Myocardial Injury in Patients Undergoing Emergency and Elective Percutaneous Intervention in Phramongkutklao Hospital and Thammasat University|Recruiting||Phase 3|370|Anticipated|Phramongkutklao College of Medicine and Hospital||4|||f||||f||||||||Yes||2017-10-10 22:35:52.714367|2017-10-10 22:35:52.714367
NCT02649491|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-01-05|||November 2015||2015-11-01|January 2016|2016-01-01|March 2019|Anticipated|2019-03-01|November 2017|Anticipated|2017-11-01||Observational|PREDICT||Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy|Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy|Recruiting||N/A|120|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Patients will be asked to provide stool and urine samples and complete symptom assessment     questionnaires at 6 time points: baseline (before treatment), 2 and 6 weeks after starting     radiotherapy, 6 months after completion of radiotherapy and 12 and 24 months after completion     of treatment. In addition, patients will be asked to provide a rectal swab and a saliva     sample, which will be stored and potentially used at a later stage to characterize any     differences in the microbial populations present. (Funding will be sought elsewhere to     analyse these samples).   "|||2017-10-10 22:35:49.294399|2017-10-10 22:35:49.294399
NCT02649478|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-01-13|||August 2014||2014-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate|A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma|Completed||N/A|1430|Actual|Roxane Laboratories||3|||f||||f||||||||||2017-10-10 22:35:49.404502|2017-10-10 22:35:49.404502
NCT02649465|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-01-05|||January 2016||2016-01-01|November 2015|2015-11-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD|Pleiotropic Effects and Safety of Sodium Glucose Co-transporter 2 Inhibitor Versus Sulfonylurea in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver|Recruiting||Phase 4|40|Anticipated|Kanazawa University||2|||f||||t||||||||||2017-10-10 22:35:51.176221|2017-10-10 22:35:51.176221
NCT02649452|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-02-06|||November 2015||2015-11-01|February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Interventional|||Acute Effects of Vibration on Shoulder Flexibility - Experimental Controlled Trial||Recruiting||N/A|40|Anticipated|Universiti Tunku Abdul Rahman||2|||f||||||||||||||2017-10-10 22:35:51.31537|2017-10-10 22:35:51.31537
NCT02649439|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-10-05|||December 10, 2015||2015-12-10|September 13, 2017|2017-09-13|October 1, 2019|Anticipated|2019-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Prostvac in Patients With Biochemically Recurrent Prostate Cancer|Prostvac in Patients With Biochemically Recurrent Prostate Cancer|Recruiting||Phase 2|80|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:35:51.427674|2017-10-10 22:35:51.427674
NCT02649426|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|RADIANCE-HTN||A Study of the ReCor Medical Paradise System in Clinical Hypertension|"The RADIANCE-HTN Study. A Study of the ReCor Medical Paradise System in Clinical Hypertension"|Recruiting||N/A|292|Anticipated|ReCor Medical, Inc.||2|||f||||t||||||||||2017-10-10 22:35:51.520635|2017-10-10 22:35:51.520635
NCT02649413|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-01-11|||March 2016||2016-03-01|December 2015|2015-12-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|AJSNS||Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome|Adjusted Steroid Therapy in Children With Idiopathic Nephrotic Syndrome|Not yet recruiting||Phase 4|75|Anticipated|Rabin Medical Center||1|||f||||t||||||||No||2017-10-10 22:35:51.921115|2017-10-10 22:35:51.921115
NCT02649400|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-01-08|||August 2013||2013-08-01|January 2016|2016-01-01||||August 2014|Actual|2014-08-01||Observational|||Assessment of Functional Capacity and Inflammatory Markers in Women With Heart Failure With Preserved Ejection Fraction|Assessment of Functional Capacity, Inflammatory Markers and Autonomic Function in Women With Heart Failure With Preserved Ejection Fraction and Previous Coronary Artery Disease|Active, not recruiting||N/A|50|Actual|Federal University of São Paulo|||1||f||||f||||||Samples With DNA|"     Venous blood and plasma.   "|No||2017-10-10 22:35:52.00983|2017-10-10 22:35:52.00983
NCT02649387|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-10-20|||February 2016||2016-02-01|August 2016|2016-08-01||||May 2021|Anticipated|2021-05-01||Interventional|MERIT||Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy|Minimal Residual Disease Eradication With Ibrutinib Therapy (MERIT) in Patients With Chronic Lymphocytic Leukemia After Frontline Therapy|Recruiting||Phase 2|35|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:35:52.095191|2017-10-10 22:35:52.095191
NCT02649374|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-11-07|||February 2016||2016-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gut Microbiome and Gestational Diabetes Mellitus|Gut Microbiome and Gestational Diabetes Mellitus|Recruiting||N/A|400|Anticipated|Rabin Medical Center||3|||f||||t||||||||No||2017-10-10 22:35:52.201245|2017-10-10 22:35:52.201245
NCT02649361|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-07-25|||January 2016||2016-01-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)|A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Compare the Efficacy and Safety of Anlotinib Versus Placebo in Patients With Esophageal Squamous Cell Carcinoma(ALTER1102)|Recruiting||Phase 2|144|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||f||||||||Undecided||2017-10-10 22:35:52.293649|2017-10-10 22:35:52.293649
NCT02649348|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-04-23|||December 2015||2015-12-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Preoperative Exercise in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome|Effects of Preoperative Exercise in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome: A Multicenter Prospective Randomised Controlled Trial|Recruiting||N/A|54|Anticipated|Qingdao University||2|||f||||t||||||||No||2017-10-10 22:35:52.436258|2017-10-10 22:35:52.436258
NCT02649335|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-01-05|||July 2015||2015-07-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NSBB||To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites|To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites|Recruiting||Phase 3|190|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 22:35:52.528147|2017-10-10 22:35:52.528147
NCT02649322|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2016-09-28|||December 2015||2015-12-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy|Randomized, Controlled Trial of Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy.|Enrolling by invitation||N/A|100|Anticipated|Orlando Health, Inc.||2|||f||||f||||||||No||2017-10-10 22:35:52.622732|2017-10-10 22:35:52.622732
NCT02649296|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-09-27|||October 2015||2015-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Skanlab Regarding Knee Arthrosis|Effect of Skanlab Regarding Knee Arthrosis|Recruiting||N/A|16|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-10 22:35:52.834902|2017-10-10 22:35:52.834902
NCT02649283|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-09-28|||October 2016||2016-10-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Performance of OrbiSymm in Subjects Referred to Contra Lateral Breast Symmetrisation|Phase IV, Multicenter, Open Label, Non Randomized Comparative Group Study to Assess the Safety and Performance of the OrbiSymm in Subjects Referred to Contra Lateral Breast Symmetrisation Following Breast Reconstruction Post Mastectomy|Not yet recruiting||N/A|60|Anticipated|Orbix Medical Ltd.||2|||f||||f||||||||||2017-10-10 22:35:52.91643|2017-10-10 22:35:52.91643
NCT02649270|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-01-10|||January 2014||2014-01-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis|Single and Multiple Dose -Based Tolerability, Safety and Pharmacokinetic Phase 1 Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Patients With Psoriasis|Recruiting||Phase 1|40|Anticipated|Biotech Pharmaceutical Co., Ltd.||4|||f||||t||||||||||2017-10-10 22:35:53.025003|2017-10-10 22:35:53.025003
NCT02649257|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-01-11|||July 2014||2014-07-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Influence of an Capsular Tension Ring on the Rotation of an Intraocular Lens (Aspira®-aA Also Known as MC 6125 AS)|Influence of an Capsular Tension Ring on the Rotation of an Intraocular Lens (Aspira®-aA Also Known as MC 6125 AS)|Completed||N/A|100|Actual|Medical University of Vienna||1|||f||||||||||||||2017-10-10 22:35:53.159518|2017-10-10 22:35:53.159518
NCT02649244|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-05|||January 2015||2015-01-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||The Family Caregiver Training Program for Caregivers of People With Dementia|The Family Caregiver Training Program for Caregivers of People With Dementia: A Randomized Control Trial|Completed||Phase 1/Phase 2|36|Actual|Nova Southeastern University||2|||f||||f||||||||||2017-10-10 22:35:53.254159|2017-10-10 22:35:53.254159
NCT02649231|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-09-26|||January 2016||2016-01-01|September 2016|2016-09-01||||January 2019|Anticipated|2019-01-01||Interventional|KARE||Ketamine for Reduction of Alcoholic Relapse|Reducing Relapse in Severe Alcohol Use Disorder With the NMDA Receptor Antagonist Ketamine|Recruiting||Phase 2|96|Anticipated|University College, London||4|||f||||t||||||||||2017-10-10 22:35:53.362567|2017-10-10 22:35:53.362567
NCT02649218|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-08-21|||May 24, 2016|Actual|2016-05-24|August 2017|2017-08-01|June 13, 2019|Anticipated|2019-06-13|June 13, 2019|Anticipated|2019-06-13||Interventional|||A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients|An Open Label, Multicenter, Extension Study to Evaluate the Long-term Safety of QGE031 240 mg s.c. Given Every 4 Weeks for 52 Weeks in Chronic Spontaneous Urticaria Patients Who Completed Study CQGE031C2201|Active, not recruiting||Phase 2|240|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 22:35:53.480677|2017-10-10 22:35:53.480677
NCT02649205|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-01-30|||February 2016||2016-02-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Observational Study on Chronic Kidney Disease Treatment With a Ketosteril Supplemented Protein-restricted Diet|Characterisation of Patient Profile and Contemporary Treatment of Pre-dialytic Chronic Kidney Disease (CKD) in Patients Receiving a Restricted Protein Diet Supplemented With Ketosteril® - a Drug Utilisation Study (DUS)|Recruiting||N/A|180|Anticipated|Fresenius Kabi|||1||f||||f||||||||||2017-10-10 22:35:53.881417|2017-10-10 22:35:53.881417
NCT02649192|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-07-10|||January 21, 2016|Actual|2016-01-21|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children|A Double-Blind, Randomized, Placebo-Controlled Study of Antibody Induction by Vitamin Supplementation at the Time of Influenza Virus Vaccinations in Children|Recruiting||Phase 2|100|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|t|f||||||||2017-10-10 22:35:54.03921|2017-10-10 22:35:54.03921
NCT02649179|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Local Infiltration With Ropivacaine Improves Postoperative Pain Control in Patients|Local Infiltration With Ropivacaine Improves Postoperative Pain Control in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Placebo Controlled, Double-blind Trial|Recruiting||N/A|140|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-10 22:35:54.189345|2017-10-10 22:35:54.189345
NCT02649153|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-06-09|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|SP/GC-HCC||Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection|Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection|Recruiting||Phase 3|240|Anticipated|Guangxi Medical University||3|||f||||t||||||||Yes||2017-10-10 22:35:54.457904|2017-10-10 22:35:54.457904
NCT02649140|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-01-05|||December 2015||2015-12-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Effect of Vinegar Consumption on 24-hour Urinary Risk Factors Associated With Stone Formation|The Effect of Vinegar Consumption on 24-hour Urinary Risk Factors Associated With Calcium Oxalate Urinary Stone Formation: a Randomised Controlled Trial|Recruiting||N/A|50|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||f||||||||Undecided||2017-10-10 22:35:54.6019|2017-10-10 22:35:54.6019
NCT02649127|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-09-08|||February 2011|Actual|2011-02-01|September 2016|2016-09-01|May 2017|Actual|2017-05-01|August 2016|Actual|2016-08-01||Interventional|||The Role of Exercise in the Treatment of PTSD Symptoms|The Role of Exercise in the Treatment of PTSD|Completed||N/A|72|Actual|The University of Texas Health Science Center at San Antonio||4|||f||||t||||||||||2017-10-10 22:35:54.760186|2017-10-10 22:35:54.760186
NCT02649114|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-05-10|||August 2015||2015-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Eating Disorders With and Without Childhood Trauma|Treatment of Eating Disorders With and Without Childhood Trauma: A Randomized Controlled Trial|Recruiting||N/A|86|Anticipated|Modum Bad||2|||f||||f||||||||No||2017-10-10 22:35:54.921317|2017-10-10 22:35:54.921317
NCT02649101|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2016-01-05|||October 2015||2015-10-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer|Thalidomide Plus Chemotherapy Versus Chemotherapy Alone: A Phase II Study in Advanced Breast Cancer|Recruiting||Phase 2|60|Anticipated|Zhejiang Cancer Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:35:55.069967|2017-10-10 22:35:55.069967
NCT02649088|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-01-06|||April 2013||2013-04-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Observational|MICRODAIMON||Sublingual Microcirculation Monitoring in ICU|Sublingual Microcirculation Monitoring in ICU|Completed||N/A|100|Actual|Università Politecnica delle Marche|||1||f||||f||||||||No||2017-10-10 22:35:55.215351|2017-10-10 22:35:55.215351
NCT02649075|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-10-02|||February 2016|Actual|2016-02-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Pilot Study Evaluating Serum-Derived Bovine Immunoglobulin / Protein Isolate in the Dietary Management of Mild to Moderate Crohn's Disease|Terminated||N/A|7|Actual|Entera Health, Inc||2||Lack of enrollment.|f||||f||||||||||2017-10-10 22:35:55.334771|2017-10-10 22:35:55.334771
NCT02649062|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-30|||December 2015||2015-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals|Study of the Pharmacodynamics of NGM282 on Colonic Transit, Bile Acid Homeostasis, and Fecal Fat in Subjects With Functional Constipation and Healthy Individuals|Completed||Phase 1/Phase 2|31|Actual|NGM Biopharmaceuticals, Inc||3|||f||||f||||||||No||2017-10-10 22:35:55.492366|2017-10-10 22:35:55.492366
NCT02649049|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-09-21|||January 2015||2015-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|||Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)|Assessment of Dietary Intakes of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)|Completed||N/A|1200|Actual|National Nutrition and Food Technology Institute|||2||f||||||||||||||2017-10-10 22:35:55.572262|2017-10-10 22:35:55.572262
NCT02649036|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-08-03|||December 2014||2014-12-01|January 2016|2016-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Social Inequalities in Emergency Call and Emergency Response Patterns|Social Inequalities in Emergency Call and Emergency Response Patterns|Completed||N/A|80829|Actual|Emergency Medical Services, Capital Region, Denmark|||2||f||||f||||||||||2017-10-10 22:35:55.650941|2017-10-10 22:35:55.650941
NCT02649023|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-07-27|||January 2016||2016-01-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|POPLITEA||Deep Venous Thrombosis After Hepatobiliopancreatic Surgery|Pre- and Early Postoperative Deep Venous Thrombosis in Patients Undergoing Oncological Hepatic or Panreatic Resection|Recruiting||N/A|200|Anticipated|Technische Universität Dresden|||2||f||||t||||||Samples Without DNA|"     Circulating tumor cells evaluation   "|No||2017-10-10 22:35:55.721228|2017-10-10 22:35:55.721228
NCT02649010|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-06-21|||January 2016||2016-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Performance Evaluation of the Enlite 3 Sensor|A Performance Evaluation of the Enlite 3 Sensor|Withdrawn||N/A|0|Actual|Medtronic Diabetes||2||Business Decision|f||||f||||||||||2017-10-10 22:35:55.804293|2017-10-10 22:35:55.804293
NCT02648997|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-04-20|||March 2016||2016-03-01|April 2017|2017-04-01|July 2023|Anticipated|2023-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma|A Single Arm, Open-Label Phase II Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma|Recruiting||Phase 2|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 22:35:55.879494|2017-10-10 22:35:55.879494
NCT02648984|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-05-02|||September 2014||2014-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With Closed Ventricular Septal Defect|Ad Hoc Analysis for the Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With a Closed Ventricular Septal Defect|Completed||N/A|45|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-10 22:35:55.991105|2017-10-10 22:35:55.991105
NCT02648971|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-03-14|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Controlled Trial to Compare Single Versus Two Portal Knee Arthroscopy Techniques|A Randomized Controlled Trial to Compare Single Portal Versus Two Portal Knee Arthroscopy Techniques in Patients With Meniscal Injuries and Articular Cartilage Pathology|Enrolling by invitation||N/A|110|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-10 22:35:56.076948|2017-10-10 22:35:56.076948
NCT02648958|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-07-14|||December 2015||2015-12-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations|Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Unilateral Total Knee Replacement - a Randomized, Controlled Trial|Enrolling by invitation||N/A|68|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 22:35:56.164925|2017-10-10 22:35:56.164925
NCT02648945|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-02-06|||November 2015||2015-11-01|February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Interventional|||Effects of Low and High Intensity Exercise in Improving Working Memory Among Students With Anxiety Symptoms|A Comparative Study Between Effects of Low and High Intensity Exercise in Improving Working Memory Among Students With Anxiety Symptoms|Recruiting||N/A|30|Anticipated|Universiti Tunku Abdul Rahman||2|||f||||f||||||||||2017-10-10 22:35:56.24741|2017-10-10 22:35:56.24741
NCT02648932|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-09-08|||February 4, 2016|Actual|2016-02-04|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients|The Rapid Study: Randomized (RA) Phase (P) II Study To Expedite Allogeneic Transplant With Immediate (I) Haploidentical Plus Unrelated Cord Donor (D) Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients|Recruiting||Phase 2|180|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 22:35:56.314941|2017-10-10 22:35:56.314941
NCT02648919|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-10-24|||December 2015||2015-12-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer|Phase II Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer|Recruiting||Phase 2|30|Anticipated|University of Hawaii||1|||f||||t||||||||No||2017-10-10 22:35:56.413392|2017-10-10 22:35:56.413392
NCT02648906|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-11-01|||July 2015||2015-07-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Interventional|||A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients||Recruiting||Phase 4|128|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||t||||||||||2017-10-10 22:35:56.502937|2017-10-10 22:35:56.502937
NCT02648893|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-02-13|||September 2018|Anticipated|2018-09-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Effect Of A Biofortified Food Basket On Micronutrient Status And Immune And Cognitive Function Among Infants In India|Effect Of A Biofortified Food Basket On Micronutrient Status And Immune And Cognitive Function In The First 1000 Days Of Life In India|Not yet recruiting||N/A|200|Anticipated|Cornell University||2|||f||||t|f|f||||||||2017-10-10 22:35:56.573809|2017-10-10 22:35:56.573809
NCT02648880|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-05-01|||May 10, 2016|Actual|2016-05-10|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|January 20, 2017|Actual|2017-01-20||Interventional|||Preoperative Exercise in Pancreatic Cancer|The Effects of a Preoperative Exercise Intervention During Neoadjuvant Therapy in Patients With Pancreatic Cancer|Active, not recruiting||N/A|3|Actual|University of Colorado, Denver||2|||f||||f||||||||No|This is a small, non-FDA Regulated pilot study of an exercise intervention.|2017-10-10 22:35:56.856533|2017-10-10 22:35:56.856533
NCT02648867|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-07-18|||December 2015||2015-12-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of Maternal Feedback to Shorten Pushing Efforts During Labor|Evaluation of Continuous Maternal Feedback to Shorten Second Stage Labor|Terminated||N/A|10|Actual|Clinical Innovations, LLC||2||Device was unacceptable to patients and did not provide expected outputs|f||||f||||||||||2017-10-10 22:35:56.970998|2017-10-10 22:35:56.970998
NCT02648854|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-02-05|||October 2015||2015-10-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, 2-way Crossover Study to Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers|Completed||Phase 1|26|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:35:57.065021|2017-10-10 22:35:57.065021
NCT02648841|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-05|||July 2015||2015-07-01|January 2016|2016-01-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.||Recruiting||Phase 3|588|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:35:57.164546|2017-10-10 22:35:57.164546
NCT02648828|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-08-25|||July 2015||2015-07-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|UPS||Understanding Physician Signout Risk Perception|Understanding Physician Signout Risk Perception|Completed||N/A|132|Actual|University of Pittsburgh|||3||f||||f||||||||||2017-10-10 22:35:57.25064|2017-10-10 22:35:57.25064
NCT02648815|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-10-27|||January 2010||2010-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Management of Pancreatitis: the Role of Supportive and Drainage Treatment|Management of Moderate and Severe Forms of Acute Pancreatitis|Active, not recruiting||N/A|100|Anticipated|University Clinical Center Tuzla||2|||f||||t||||||||Undecided||2017-10-10 22:35:57.326205|2017-10-10 22:35:57.326205
NCT02648789|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-01-05|||May 2015||2015-05-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||Validation of DNA Methylation Biomarkers for Oral Cancer Detection|Validation of DNA Methylation Biomarkers for Oral Cancer Detection|Recruiting||N/A|50|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||t||||||Samples With DNA|"     oral swab, non-cancerous matched tissue and tumor tissue   "|||2017-10-10 22:35:57.514663|2017-10-10 22:35:57.514663
NCT02648776|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-01-07|||January 2016||2016-01-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|RABA-HASDE||Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly|Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly; A Prospective Cohort Study at a Taiwanese Academic Medical Center|Enrolling by invitation||Phase 4|1400|Anticipated|China Medical University Hospital|||8||f||||f||||||Samples With DNA|"     A single set of blood and urine samples taken in cohorts taking sedative-hypnotic     medications, used to evaluate pharmacokinetic and pharmcogenetic parameters.   "|||2017-10-10 22:35:57.59812|2017-10-10 22:35:57.59812
NCT02648763|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-12-19|||November 2015||2015-11-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Observational|||Staging Procedures to Diagnose Malignant Pleural Mesothelioma|Staging Procedures to Diagnose Malignant Pleural Mesothelioma|Recruiting||N/A|200|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 22:35:57.709545|2017-10-10 22:35:57.709545
NCT02648750|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-01-06|||June 2015||2015-06-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Stroke Self-Management Delivered by Rehabilitation Assistants Within an Early Supported Discharge Service|A Stroke Self-Management Programme Delivered by Rehabilitation Assistants Within an Early Supported Discharge Service: A Feasibility Randomised Controlled Trial|Completed||N/A|15|Actual|University of Plymouth||2|||f||||f||||||||No||2017-10-10 22:35:57.77404|2017-10-10 22:35:57.77404
NCT02648568|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-25|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|HYPNOSOM||Does Hypnosis Improve Severe Sleepwalking ?|Does Hypnosis Improve Severe Sleepwalking ?|Recruiting||N/A|75|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:35:59.334365|2017-10-10 22:35:59.334365
NCT02648737|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-11-29|||October 2016||2016-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Cognitive Behavioural Therapy for Anxiety Disorders in PD|Cognitive Behavioural Therapy for Anxiety Disorders in Patients With Parkinson's Disease: a Randomized, Controlled Trial of the Clinical Effectiveness and Changes in Cerebral Connectivity|Recruiting||N/A|60|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||Yes|Treatment module will be made available for public use. Study data will be published in peer-reviewed journals.|2017-10-10 22:35:57.852785|2017-10-10 22:35:57.852785
NCT02648711|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-04-18|||October 2015||2015-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Alternative Dosing for CRLX101 Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors|Evaluation of an Alternative Schedule for CRLX101 Alone in Combination With Bevacizumab and in Combination With mFOLFOX6 in Subjects With Advanced Solid Tumor Malignancies|Active, not recruiting||Phase 1|61|Anticipated|NewLink Genetics Corporation||3|||f||||f||||||||No||2017-10-10 22:35:58.185103|2017-10-10 22:35:58.185103
NCT02648698|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-05-23|||January 2016||2016-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||RCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis|A Prospective, Randomized, Placebo-controlled Trial on the Effect of Antibiotic Therapy on Endometrial Response in Women With Chronic Endometritis|Recruiting||N/A|82|Anticipated|Fu Xing Hospital, Capital Medical University||2|||f||||f||||||||Undecided||2017-10-10 22:35:58.315984|2017-10-10 22:35:58.315984
NCT02648685|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2017-05-23|||November 30, 2015|Actual|2015-11-30|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 31, 2017|Anticipated|2017-07-31||Observational|||The Study to Investigate the Contribution of Fasting and Post-prandial Blood Glucose to Overall Glycaemia in T2DM|The Study to Investigate the Contribution of Fasting and Post-prandial Blood Glucose to Overall Glycaemia in Subjects With Normal Glycaemic Metabolism and Type 2 Diabetes|Recruiting||N/A|400|Anticipated|West China Hospital|||2||f||||f||||||||||2017-10-10 22:35:58.444911|2017-10-10 22:35:58.444911
NCT02648672|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-17|||December 2015||2015-12-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|||BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects|A Single Ascending Dose Study to Examine the Safety, Tolerability, and Pharmacokinetic Profile of BPN14770 in Healthy Male and Female Subjects|Completed||Phase 1|32|Actual|Tetra Discovery Partners||2|||f||||f||||||||No||2017-10-10 22:35:58.558592|2017-10-10 22:35:58.558592
NCT02648659|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-02-19|||March 2, 2016|Actual|2016-03-02|February 2017|2017-02-01|February 14, 2017|Actual|2017-02-14|January 6, 2017|Actual|2017-01-06||Interventional|||The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients|The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in Helicobacter Pylori Patients|Completed||Phase 4|50|Actual|Kyungpook National University||3|||f||||f||||||||No||2017-10-10 22:35:58.634973|2017-10-10 22:35:58.634973
NCT02648633|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-05-26|||May 24, 2016|Actual|2016-05-24|May 2017|2017-05-01|February 21, 2017|Actual|2017-02-21|February 21, 2017|Actual|2017-02-21||Interventional|||Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma|A Pilot Study to Evaluate the Feasibility of the Combined Use of Stereotactic Radiosurgery With Nivolumab and Concurrent Valproate in Patients With Recurrent Glioblastoma|Terminated||Phase 1|4|Actual|University of Virginia||1||"The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study   was terminated early."|f||||t||||||||No||2017-10-10 22:35:58.811829|2017-10-10 22:35:58.811829
NCT02648620|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-01|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|January 2017|Actual|2017-01-01||Interventional|PREVEIL||Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon|A Prospective, Multi-Center, Single-Arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects With De Novo Lesions of the Femoropopliteal Artery|Active, not recruiting||N/A|13|Actual|SurModics, Inc.||1|||f||||f||||||||||2017-10-10 22:35:58.918285|2017-10-10 22:35:58.918285
NCT02648607|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-06|2016-01-06|||January 2016||2016-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|MOPS||Management of Chronic Post-Partum Pelvic Girdle Pain Study|Management of Chronic Post-Partum Pelvic Girdle Pain Study: Evaluating Effectiveness of Combined Physiotherapy and a Dynamic Elastomeric Fabric Orthoses|Recruiting||N/A|8|Anticipated|University of Plymouth||1|||f||||t||||||||||2017-10-10 22:35:59.034039|2017-10-10 22:35:59.034039
NCT02648594|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-10-10|||October 2016||2016-10-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|HARNO||Efficacy Assessment of CT-guided Hook Wire Localization of Lung Nodes Before Thoracoscopy|"Efficacy Assessment of CT-guided Hook Wire Localization of Lung Nodes With Medical Device  Fil d'Ariane  Laurane médical Before Thoracoscopy- HARNO Trial"|Active, not recruiting||Phase 2|30|Anticipated|Centre Jean Perrin||1|||f||||f||||||||||2017-10-10 22:35:59.151866|2017-10-10 22:35:59.151866
NCT02648581|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-03-21|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|STELABEC||Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease|A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease|Not yet recruiting||Phase 2|30|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||No||2017-10-10 22:35:59.220227|2017-10-10 22:35:59.220227
NCT02648555|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-06|||May 2016||2016-05-01|January 2016|2016-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|W+D||A Lifestyle Intervention to Improve in Vitro Fertilization Results|A Lifestyle Intervention to Improve in Vitro Fertilization Results|Not yet recruiting||N/A|240|Anticipated|Hospital dos Servidores do Estado do Rio de Janeiro||2|||f||||t||||||||||2017-10-10 22:35:59.449066|2017-10-10 22:35:59.449066
NCT02648542|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-01-05|||March 2013||2013-03-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effects of Compensatory Auditory Stimulation and Transcranial Direct Current Stimulation on Tinnitus Perception|The Effects of Compensatory Auditory Stimulation and Transcranial Direct Current Stimulation on Tinnitus Perception|Completed||N/A|17|Actual|Soterix Medical||2|||f||||t||||||||Yes|De-identified data will be shared if requested|2017-10-10 22:35:59.560683|2017-10-10 22:35:59.560683
NCT02648529|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-08|||September 2008||2008-09-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|DYNAMAT||Brain Maturation in Children With Localization Related Epilepsy|Dynamic Regional Brain Maturation in Children With Localization Related Epilepsy|Active, not recruiting||N/A|101|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:35:59.6801|2017-10-10 22:35:59.6801
NCT02648516|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-08-26|||October 2016|Actual|2016-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Safety and Efficacy of Allogenic Adoptive Immune Therpy for Immune Reconstitution in Chronic HIV-1 Infected Patients|Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution Failure in Chronic HIV-1 Infected Patients|Recruiting||Phase 1/Phase 2|20|Anticipated|Beijing 302 Hospital||1|||f||||t||||||||||2017-10-10 22:35:59.771697|2017-10-10 22:35:59.771697
NCT02648503|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-01-06|||March 2016||2016-03-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Deep Neuromuscular Block and Sugammadex Versus Standard of Care on Quality of Recovery in Patient Undergo Elective Laparoscopic Cholecystectomy||Not yet recruiting||Phase 4|120|Anticipated|Ho Chi Minh City University of Medicine and Pharmacy||2|||f||||t||||||||Yes||2017-10-10 22:35:59.865995|2017-10-10 22:35:59.865995
NCT02648490|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2017-01-24|||September 2016||2016-09-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers|A Prospective,Open-label, Dose Escalation Phase 1 Study to Investigate the Safety, and Tolerability and to Determine the Maximum Tolerated Dose and Recommended Phase 2 Dose of a HLX07, in Patients With Advanced Solid Cancers.|Recruiting||Phase 1|21|Anticipated|Henlix, Inc||1|||f||||f||||||||Undecided||2017-10-10 22:36:00.108699|2017-10-10 22:36:00.108699
NCT02648477|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-29|||March 4, 2016||2016-03-04|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer|MK-3475 (Pembrolizumab) in Combination With an Anthracycline or Anti-estrogen Therapy in Patients With Triple Negative and Hormone Receptor Positive (HR+ HER2-) Metastatic Breast Cancer|Recruiting||Phase 2|56|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-10 22:36:00.243375|2017-10-10 22:36:00.243375
NCT02648464|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-16|||February 2016||2016-02-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|OXI||Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial|Hydroxychloroquine for the Prevention of Recurrent Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial|Recruiting||Phase 4|200|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-10 22:36:00.449903|2017-10-10 22:36:00.449903
NCT02648451|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-01-05|||January 2015||2015-01-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Acceptability and Tolerance Study of New Oral Nutritional Supplement|Tolerance and Acceptability of AYMES ROME|Completed||N/A|17|Actual|Aymes International Limited||1|||f||||f||||||||No||2017-10-10 22:36:00.589566|2017-10-10 22:36:00.589566
NCT02648438|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-26|2017-03-29|2017-01-24||January 12, 2016|Actual|2016-01-12|March 2017|2017-03-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects|An Open Label, Partially Randomized, Four-period Study in Healthy Male Subjects to Investigate the Bioavailability and Pharmacokinetics of a Single Dose of AZD7594 When Administered Intravenously, Orally and Inhaled Via Two Different Dry Powder Inhalers (DPI) and a Pressurized Metered-dose Inhaler (pMDI)|Completed||Phase 1|30|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:36:00.679816|2017-10-10 22:36:00.679816
NCT02648425|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2017-04-24|||August 2014||2014-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin With Capecitabine|Phase I Study to Evaluate the Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-Fluorouracil or Cisplatin and Capecitabine|Recruiting||Phase 1|24|Anticipated|Aslan Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:36:01.318263|2017-10-10 22:36:01.318263
NCT02648412|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-12-21|||April 2012||2012-04-01|December 2016|2016-12-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Pupillary Dilation After Incremental Tetanic Stimulations Under Ketamine Sedation|Pupillary Diameter Variation After Standardized Tetanic Stimulations of Incremental Intensities in Patients Under Ketamine Sedation|Completed||N/A|24|Actual|Hôpital Armand Trousseau||1|||f||||t||||||||||2017-10-10 22:36:01.436309|2017-10-10 22:36:01.436309
NCT02648399|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2016-01-06|||December 2015||2015-12-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma||Recruiting||N/A|300|Anticipated|Fujian Medical University||2|||f||||f||||||||No||2017-10-10 22:36:01.530042|2017-10-10 22:36:01.530042
NCT02648386|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-04-14|||January 2016||2016-01-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery|Bone Marrow Mononuclear Cells or Human Umbilical Cord-derived Mesenchymal Stem Cells Combined With NeuroRegen Scaffold™ Transplantation for the Improvement of Erectile Function in Men After Rectal Cancer Surgery|Recruiting||Phase 1/Phase 2|34|Anticipated|Chinese Academy of Sciences||4|||f||||t||||||||||2017-10-10 22:36:01.619521|2017-10-10 22:36:01.619521
NCT02648373|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-01-05|||October 2014||2014-10-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Patient Education for Patients With Back Pain Referred to Physical Therapy|Effect of a Patient Education Intervention for Patients With Low Back Pain Referred to Physical Therapy|Completed||N/A|76|Actual|University of Utah||2|||f||||f||||||||||2017-10-10 22:36:01.728852|2017-10-10 22:36:01.728852
NCT02648360|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-12-27|||January 2016||2016-01-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Text Messaging for Physical Activity & Healthy Eating|Evaluation of a Text Messaging Program for Physical Activity and Healthy Eating for Underserved Hispanic Patients|Completed||Phase 3|12|Actual|University of Miami||1|||f||||f||||||||No||2017-10-10 22:36:01.82265|2017-10-10 22:36:01.82265
NCT02648347|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-31|||December 2015||2015-12-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)|Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction of Anemia in Subjects With Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CORRECTION)|Recruiting||Phase 3|1000|Anticipated|Akebia Therapeutics||2|||f||||t||||||||||2017-10-10 22:36:02.018177|2017-10-10 22:36:02.018177
NCT02648334|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-06-18|||November 2016||2016-11-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|DCB-SFA||Randomized Comparison of DCB for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease|Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: Prospective, Multicenter, Randomized, Controlled Trial|Recruiting||N/A|1080|Anticipated|Asan Medical Center||2|||f||||t||||||||No|This is not publicly funded trial.|2017-10-10 22:36:03.048151|2017-10-10 22:36:03.048151
NCT02648321|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-05|||September 2013||2013-09-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Motivational Intervention for Physical Activity in Psychosis|Motivational Intervention of Exercise in Patients With Psychosis|Completed||N/A|82|Actual|The University of Hong Kong||2|||f||||f||||||||No||2017-10-10 22:36:03.257437|2017-10-10 22:36:03.257437
NCT02648308|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-01-05|||October 2015||2015-10-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Observational|5AsT-MD2||Extension of the 5As Team Study for Improved Provider Obesity Management to Physicians and Medical Trainees (Part 2)|Extension of the 5As Team Study for Improved Provider Obesity Management to Physicians and Medical Trainees (Part 2)|Recruiting||N/A|50|Anticipated|University of Alberta|||1||f||||f||||||||||2017-10-10 22:36:03.367108|2017-10-10 22:36:03.367108
NCT02648295|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-01-04|||December 2015||2015-12-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Observational|||Effects of IV Tranexamic Acid on the Thromboelastogram in Patients Undergoing Total Hip or Knee Arthroplasty|Effects of IV Tranexamic Acid on the Thromboelastogram in Patients Undergoing Total Hip or Knee Arthroplasty|Active, not recruiting||N/A|60|Anticipated|West Virginia University|||1||f||||t||||||||||2017-10-10 22:36:03.476828|2017-10-10 22:36:03.476828
NCT02648282|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-10-05|||July 2016||2016-07-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Study With CY, Pembrolizumab, GVAX, and SBRT in Patients With Locally Advanced Pancreatic Cancer|A Phase II Study of GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine in Combination With PD-1 Blockade Antibody (Pembrolizumab) and Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Locally Advanced Adenocarcinoma of the Pancreas|Recruiting||Phase 2|54|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:36:03.536781|2017-10-10 22:36:03.536781
NCT02648269|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-01-26|||December 2015||2015-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels|A Phase I Single Ascending Dose Safety, Pharmacokinetic and Pharmacodynamics Study of SEL-212 in Subjects With Elevated Blood Uric Acid|Completed||Phase 1|63|Actual|Selecta Biosciences, Inc.||3|||f||||f||||||||||2017-10-10 22:36:03.641797|2017-10-10 22:36:03.641797
NCT02648256|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-12-06|||January 2016||2016-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|PNEUMOQUANT||Pneumocystis Pneumonia Diagnosis in HIV- Patients|Pneumocystis Pneumonia Diagnosis in HIV- Patients: Assessment of the Real Time Polymerase Chain Reaction Quantification on Oropharyngeal Rinse|Recruiting||N/A|1250|Anticipated|Rennes University Hospital||1|||f||||t||||||||||2017-10-10 22:36:03.728266|2017-10-10 22:36:03.728266
NCT02648243|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-04-03|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Impact of a Pharmacist-delivered Discharge and Follow-up Intervention for Patients With Acute Coronary Syndromes in Qatar|Impact of a Pharmacist-delivered Discharge and Follow-up Intervention for Patients With Acute Coronary Syndromes in Qatar: a Randomized Controlled Trial|Recruiting||N/A|375|Anticipated|Qatar University||3|||f||||t||||||||Yes||2017-10-10 22:36:03.980803|2017-10-10 22:36:03.980803
NCT02648230|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-01-31|||October 2015||2015-10-01|January 2017|2017-01-01|December 8, 2016|Actual|2016-12-08|December 8, 2016|Actual|2016-12-08||Interventional|PERFORM||PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evaluation of FFR Measurements|PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evaluation of cORonary Fractional Flow Reserve Measurements|Completed||N/A|75|Actual|Columbia University||1|||f||||f||||||||||2017-10-10 22:36:04.094297|2017-10-10 22:36:04.094297
NCT02648204|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-22|||January 6, 2016|Actual|2016-01-06|September 2017|2017-09-01|May 19, 2017|Actual|2017-05-19|April 17, 2017|Actual|2017-04-17||Interventional|||Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes|Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes|Completed||Phase 3|1201|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-10 22:36:04.396255|2017-10-10 22:36:04.396255
NCT02648191|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-09-29|||March 2016||2016-03-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|OBESITE||Preoperative Treatment With Noninvasive Intra-auricular Vagus Nerve Stimulation Pending Bariatric Surgery|Preoperative Treatment With Noninvasive Intra-auricular Vagus Nerve Stimulation Pending Bariatric Surgery. A Randomized, Controlled, Double-blind Trial|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:36:04.99596|2017-10-10 22:36:04.99596
NCT02648178|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-03-25|||June 2016||2016-06-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers|Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers|Recruiting||N/A|40|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 22:36:05.129245|2017-10-10 22:36:05.129245
NCT02648165|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-10-13|||April 2015||2015-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure|Secondary Prevention of Depression Through Group-based Acceptance and Commitment Therapy Preceded by an Experimental Attentional Bias Modification Procedure|Recruiting||N/A|200|Anticipated|Sorlandet Hospital HF||4|||f||||f||||||||No||2017-10-10 22:36:05.224511|2017-10-10 22:36:05.224511
NCT02648152|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-10-17|||March 2009||2009-03-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|Polarstem I||Polarstem Cementless Hip Stem|Multicenter Clinical Observation Using the Cementless Version of the POLARSTEM|Active, not recruiting||N/A|225|Actual|Smith & Nephew, Inc.|||1||f||||t||||||||No||2017-10-10 22:36:05.349322|2017-10-10 22:36:05.349322
NCT02648139|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-01-05|||December 2008||2008-12-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|February 2010|Actual|2010-02-01||Interventional|||A Randomized, Controlled, Double-blind Clinical Trial of Surinam Cherry Dentifrice With Anti-gingivitis Properties|A Randomized, Controlled, Double-blind Clinical Trial of a Eugenia Uniflora Linn. (Surinam Cherry) Dentifrice With Anti-gingivitis Properties|Completed||Phase 1/Phase 2|50|Actual|Federal University of Paraíba||2|||f||||t||||||||||2017-10-10 22:36:05.422097|2017-10-10 22:36:05.422097
NCT02648126|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-01-05|||November 2015||2015-11-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa|Research of Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa Produced by Immunobiological Technology Institute (Bio-Manguinhos) From Oswaldo Cruz Foundation (Bio-Manguinhos / Fiocruz)|Enrolling by invitation||Phase 4|531|Anticipated|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||1|||f||||f||||||||||2017-10-10 22:36:05.488045|2017-10-10 22:36:05.488045
NCT02648113|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-10-17|||March 2016||2016-03-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|October 2018|Anticipated|2018-10-01||Interventional|REALITY||Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia.|Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia. The REALITY (REstrictive And LIberal Transfusion Strategies in Patients With Acute mYocardial Infarction) Randomized Trial.|Recruiting||N/A|630|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:36:05.563287|2017-10-10 22:36:05.563287
NCT02648100|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-06-19|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|DIATRIBBE||Basal Like Bladder Cancer : Signature and Therapeutic|Identification and Treatments of Basal Like Bladder Cancer (Study on Human Tumor Samples and Animal Models)|Recruiting||N/A|911|Anticipated|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||Samples With DNA|"     Tumor tissue : frozen (n=120), FFPE (n=911)   "|Yes||2017-10-10 22:36:05.695146|2017-10-10 22:36:05.695146
NCT02648087|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-01-05|||January 2016||2016-01-01|December 2015|2015-12-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|NEOSAS||Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer|Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer|Not yet recruiting||N/A|1200|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 22:36:05.783767|2017-10-10 22:36:05.783767
NCT02648074|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-01-04|||March 2014||2014-03-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|ERA||Eosinophil Induced Remodelling in Asthma|Eosinophil Induced Airway Smooth Muscle Remodelling in Asthma|Recruiting||N/A|30|Anticipated|Lithuanian University of Health Sciences||2|||f||||f||||||||No||2017-10-10 22:36:05.839229|2017-10-10 22:36:05.839229
NCT02648061|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-01-17|||January 2016||2016-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Transitions Between Clinical Circulatory States After Out-of-hospital Cardiac Arrest|Transitions Between Clinical Circulatory States After Out-of-hospital Cardiac Arrest|Recruiting||N/A|40|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||Samples Without DNA|"     blood samples   "|No||2017-10-10 22:36:05.937868|2017-10-10 22:36:05.937868
NCT02648048|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-02-17|||January 2016||2016-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Safety and Tolerability Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis|A Single Arm, Multicenter, Open-label, Phase 1b Study to Assess the Safety and Tolerability of Oral Vismodegib in Combination With Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 1|21|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:36:06.013974|2017-10-10 22:36:06.013974
NCT02648035|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-09-27|||September 30, 2016|Actual|2016-09-30|September 2017|2017-09-01|September 2, 2018|Anticipated|2018-09-02|September 2, 2018|Anticipated|2018-09-02||Observational|||EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis|Multicenter, Post-Marketing, Non-Interventional, Observational Study to Evaluate Persistence to Tocilizumab SC as Monotherapy or in Combination With cDMARD Treatment in RA Patients in Greece: the EMBRACE-SC Study.|Recruiting||N/A|200|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:36:06.119438|2017-10-10 22:36:06.119438
NCT02648022|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-05-05|2016-05-05||January 2012||2012-01-01|May 2016|2016-05-01|February 2014|Actual|2014-02-01|January 2013|Actual|2013-01-01||Interventional|||Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment|Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorders With Chronic Hepatitis C Receiving Direct Acting Antiviral Treatment|Completed||N/A|83|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-10 22:36:06.327751|2017-10-10 22:36:06.327751
NCT02648009|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-12-05|||April 2016||2016-04-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection|Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection|Recruiting||Phase 1|30|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 22:36:06.874136|2017-10-10 22:36:06.874136
NCT02647996|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-04-27|||March 2015||2015-03-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|Connectivite||Functional Connectivity Measurement After Severe Traumatic Brain Injury|Functional Connectivity Measurement After Severe Traumatic Brain Injury|Recruiting||N/A|34|Anticipated|University Hospital, Grenoble|||2||f||||f||||||||||2017-10-10 22:36:06.953579|2017-10-10 22:36:06.953579
NCT02647983|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-09-07|||April 2016||2016-04-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection|Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection|Recruiting||Phase 1|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 22:36:07.032449|2017-10-10 22:36:07.032449
NCT02647970|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-01-12|||February 2016||2016-02-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SEM||Stearoyl-CoA Desaturase and Energy Metabolism in Humans|Stearoyl-CoA Desaturase and Energy Metabolism in Humans|Completed||N/A|14|Actual|University of Oslo||2|||f||||t||||||||||2017-10-10 22:36:07.110324|2017-10-10 22:36:07.110324
NCT02647957|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-26|2016-05-10|||January 2016||2016-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|QICS||A Study of the Efficacy of the Code Stroke in Spain|Indicators for Quality Assessment of Hospitalized Ischemic Stroke Patients. A Study of the Efficacy of the Code Stroke in Spain|Completed||N/A|240|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||No||2017-10-10 22:36:08.866297|2017-10-10 22:36:08.866297
NCT02647931|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-09-18|||November 2015||2015-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Role of Therapy for Muscle Tension Dysphagia|Muscle Tension Dysphagia Treatment Efficacy|Recruiting||N/A|120|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:36:09.087631|2017-10-10 22:36:09.087631
NCT02647918|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-09-21|||December 2015||2015-12-01|September 2017|2017-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function|A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function|Active, not recruiting||Phase 1|44|Anticipated|Lexicon Pharmaceuticals||5|||f||||f||||||||||2017-10-10 22:36:09.158585|2017-10-10 22:36:09.158585
NCT02647905|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-08-08|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PRECISEII||Evaluation of the Accuracy of an Implanted Glucose Sensor|A Prospective, Multicenter Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor, PRECISE II|Completed||N/A|90|Actual|Senseonics, Inc.||1|||f||||f||||||||No||2017-10-10 22:36:09.253716|2017-10-10 22:36:09.253716
NCT02647892|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia|Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia|Enrolling by invitation||Phase 4|200|Anticipated|University of Nebraska||4|||f||||f||||||||Undecided||2017-10-10 22:36:09.34492|2017-10-10 22:36:09.34492
NCT02647879|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-03-27|||January 2016||2016-01-01|October 2016|2016-10-01|May 2031|Anticipated|2031-05-01|December 2018|Anticipated|2018-12-01||Observational|TraPHepC||Treatment as Prevention for Hepatitis C in Iceland|Treatment as Prevention for Hepatitis C in Iceland. A Nationwide Campaign for Reducing Disease Burden Using Combination Antiviral Treatment|Recruiting||N/A|1000|Anticipated|Landspitali University Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:36:09.444037|2017-10-10 22:36:09.444037
NCT02647866|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-10-04|||December 2015||2015-12-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study (Induction Therapy) & Long-term Extension Therapy of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderately Active UC|Active, not recruiting||Phase 2|60|Anticipated|Kyowa Kirin Pharmaceutical Development, Inc.||2|||f||||f||||||||||2017-10-10 22:36:09.964127|2017-10-10 22:36:09.964127
NCT02647853|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-01-05|||October 2014||2014-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers|A Randomized, Placebo-controlled, Double-blind, Multiple-ascending-dose, Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel|Completed||Phase 1|16|Actual|Topokine Therapeutics, Inc.||3|||f||||f||||||||No||2017-10-10 22:36:10.307465|2017-10-10 22:36:10.307465
NCT02647840|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-10-25|||May 2016||2016-05-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||The Effects of Voice Therapy Based on the Estill Voice Model: a Feasibility Study|The Effects of Voice Therapy Based on the Estill Voice Model: a Feasibility Study|Recruiting||N/A|20|Anticipated|Royal Devon and Exeter NHS Foundation Trust||1|||f||||f||||||||No||2017-10-10 22:36:10.402452|2017-10-10 22:36:10.402452
NCT02647827|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-08-16|||December 2015||2015-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|PIAII||Acupuncture or Metformin for Insulin Resistance in Women With PCOS|Acupuncture or Metformin for Insulin Resistance in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial|Recruiting||Phase 2|303|Anticipated|Karolinska Institutet||3|||f||||t||||||||||2017-10-10 22:36:10.540776|2017-10-10 22:36:10.540776
NCT02647814|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-07-11|||February 2016||2016-02-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Salud al Día: Engaging Latino Parents in Pediatric Primary Care|Salud al Día: Engaging Latino Parents in Pediatric Primary Care|Active, not recruiting||N/A|158|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 22:36:10.684253|2017-10-10 22:36:10.684253
NCT02647801|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-03-06|||September 2015||2015-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SMASH||Self-control and Mindfulness Within Ambulatorily Assessed Network Systems Across Health Related Domains|The SMASH Study: Self-control and Mindfulness Within Ambulatorily Assessed Network Systems Across Health Related Domains|Completed||N/A|137|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-10 22:36:10.817142|2017-10-10 22:36:10.817142
NCT02647788|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-07-26|||December 2015||2015-12-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Acetaminophen/Codeine vs Acetaminophen/Ibuprofen for Pain Control and Patient Satisfaction After Hand Surgery|Pilot Study, Blinded Randomized Control Trial, Single Center Study to Compare Acetaminophen & Codeine Versus Ibuprofen/Acetaminophen for Pain Control and Patient Satisfaction After Ambulatory Hand Surgery|Recruiting||Phase 4|126|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:36:10.95153|2017-10-10 22:36:10.95153
NCT02647775|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-08-03|||January 2016||2016-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Hemodynamic and Inflammatory Responses in Thoracic Surgery|Hemodynamic and Inflammatory Responses in Thoracic Surgery: Hemodynamic and Inflammatory Responses Following Video-assisted Thoracoscopic Surgery|Enrolling by invitation||N/A|100|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:36:11.069978|2017-10-10 22:36:11.069978
NCT02647762|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-06-01|||September 2016||2016-09-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis|A Phase 3, Randomized, Double-Blind, Active- and Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of CF101 Compared to Methotrexate in the Treatment of Early Rheumatoid Arthritis|Not yet recruiting||Phase 3|525|Anticipated|Can-Fite BioPharma||4|||f||||f||||||||||2017-10-10 22:36:11.202578|2017-10-10 22:36:11.202578
NCT02647749|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-01-04|||May 2015||2015-05-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|CARRY||Non-invasive Mapping of Rhythm Disorders||Recruiting||N/A|1200|Anticipated|University Hospital, Bordeaux||6|||f||||f||||||||||2017-10-10 22:36:11.340968|2017-10-10 22:36:11.340968
NCT02647736|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-08-02|||September 2012||2012-09-01|August 2016|2016-08-01||||July 2016|Actual|2016-07-01||Interventional|||Copeptin in Normal- to Hyperosmolar States|Kinetics of Copeptin in Healthy Volunteers - a Prospective International Study|Completed||N/A|90|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-10 22:36:11.438226|2017-10-10 22:36:11.438226
NCT02647723|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|NAPS||Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation|Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation: A Randomized Controlled Study in African American Women Living in Low-income Urban Environments|Recruiting||N/A|162|Anticipated|University of Chicago||2|||f||||t||||||||No||2017-10-10 22:36:11.505183|2017-10-10 22:36:11.505183
NCT02647710|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-05-09|||June 2010||2010-06-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|July 15, 2016|Actual|2016-07-15||Interventional|PHAT Life||PHAT Life: Preventing HIV/AIDS Among Teens in Juvenile Justice|PHAT Life: Preventing HIV/AIDS Among Teens in Juvenile Justice|Active, not recruiting||N/A|349|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-10 22:36:11.584477|2017-10-10 22:36:11.584477
NCT02647697|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-02-09|||January 2016||2016-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers|A Single Oral Dose Study of the Safety, Tolerability, and Pharmacokinetic Profile of Radiprodil in Adult Healthy Volunteers|Completed||Phase 1|10|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-10 22:36:11.664166|2017-10-10 22:36:11.664166
NCT02647684|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Triple P for Parents of Children With a Diagnosis of Cancer|Triple P for Parents of Children With a Diagnosis of Cancer|Completed||Phase 1/Phase 2|4|Actual|University of Manchester||1|||f||||t||||||||||2017-10-10 22:36:11.751503|2017-10-10 22:36:11.751503
NCT02647671|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-03-28|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Aquamin and Prevention of Colon Cancer|The Effects of Calcium in Conjunction With Multi-mineral Supplementation (Aquamin) on Gut Microbes and Microbially-derived Metabolites in Subjects at Risk for Colon Cancer in a Randomized Controlled Trial|Recruiting||Phase 1|30|Anticipated|University of Michigan||3|||f||||t||||||||Yes||2017-10-10 22:36:11.825485|2017-10-10 22:36:11.825485
NCT02647658|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-10-02|||May 2016||2016-05-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Interventional|TARGET||Targeted Interventions to Prevent Chronic Low Back Pain in High Risk Patients|Targeted Interventions to Prevent Chronic Low Back Pain in High Risk Patients: A Multi-Site Pragmatic RCT|Enrolling by invitation||N/A|3000|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:36:11.934972|2017-10-10 22:36:11.934972
NCT02647645|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-07-27|||September 2015||2015-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Cognitive Training With and Without tDCS to Improve Cognition in HIV|Cognitive Training With and Without tDCS to Improve Cognition in HIV|Terminated||N/A|23|Actual|Nova Southeastern University||2||Pilot study protocol terminated to begin expanded study.|f||||f||||||||||2017-10-10 22:36:12.134952|2017-10-10 22:36:12.134952
NCT02646124|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-09-06|||June 2015||2015-06-01|April 2016|2016-04-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Diazepam for Acute LBP|Adding Diazepam to Standard Management of Acute, Non-radicular Low Back Pain. An Emergency Department Based Randomized Comparative Effectiveness Study|Completed||Phase 4|116|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 22:36:24.887498|2017-10-10 22:36:24.887498
NCT02647632|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-06-28|||January 2016||2016-01-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|||Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir|Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir|Completed||Phase 2|26|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||||||||||||2017-10-10 22:36:12.230764|2017-10-10 22:36:12.230764
NCT02647619|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-12-04|||October 2013||2013-10-01|December 2016|2016-12-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF|A Randomized Controlled Trial (RCT) Comparing Clostridium Histolyticum With Needle Aponeurotomy.|Active, not recruiting||Phase 4|80|Anticipated|University Hospital, Akershus||2|||f||||t||||||||No||2017-10-10 22:36:12.330201|2017-10-10 22:36:12.330201
NCT02647606|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-04|||January 2016||2016-01-01|January 2016|2016-01-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Comparison of the Videolaryngoscopes With Manual In-line Stabilization|Comparison of the McGrath Videolaryngoscope and the Pentax-AWS With the Macintosh Laryngoscope for Nasotracheal Intubation in Patients With Manual In-line Stabilization|Not yet recruiting||N/A|120|Anticipated|Ajou University School of Medicine||3|||f||||f||||||||No||2017-10-10 22:36:12.430044|2017-10-10 22:36:12.430044
NCT02647593|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-04|||June 2006||2006-06-01|January 2016|2016-01-01||||October 2013|Actual|2013-10-01||Observational|||The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis|The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis Showing the High Level of Aminotransferase and the Establishment of New Nomenclature ; Gallstone Hepatitis|Enrolling by invitation||N/A|50|Anticipated|Gangnam Severance Hospital|||2||f||||f||||||||No||2017-10-10 22:36:12.532149|2017-10-10 22:36:12.532149
NCT02647580|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-07-24|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Appetite Regulation in Children With Failure to Thrive|Appetite-regulating Hormones, the Gut Microbiome and the Metabolome in Children With Failure to Thrive|Completed||N/A|45|Actual|University of Copenhagen|||1||f||||f||||||Samples With DNA|"     Plasma, serum, feces, urine   "|||2017-10-10 22:36:12.601844|2017-10-10 22:36:12.601844
NCT02647567|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-01-04|||May 2015||2015-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|Caffeine||Caffeine Intake and Additive Effects on Cognition|Can Caffeine Intake Combined With Aerobic Exercise Leads to Cognitive Improvement and Psychomotor Performance in Trained Individuals?|Completed||N/A|20|Actual|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||Undecided||2017-10-10 22:36:12.693784|2017-10-10 22:36:12.693784
NCT02647554|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2016-12-11|||December 2016||2016-12-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China|A Prospective, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled, Trial of Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China|Recruiting||Phase 4|384|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||No||2017-10-10 22:36:12.799517|2017-10-10 22:36:12.799517
NCT02647541|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-05|||February 2011||2011-02-01|January 2016|2016-01-01|November 2013|Actual|2013-11-01|February 2013|Actual|2013-02-01||Interventional|||Preoperative Nutritional Intervention and Outcomes of Children Submitted to Heart Surgery for Congenital Heart Diseases|Preoperative Nutritional Intervention and Outcomes Postoperative of Children Submitted to Heart Surgery for Congenital Heart Diseases|Completed||N/A|11|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:36:12.952796|2017-10-10 22:36:12.952796
NCT02647528|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-12-05|||March 2016||2016-03-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Chromogenix||A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris|A Randomized, Blinded, Single-Centered, Placebo-Controlled Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris|Withdrawn||Phase 4|0|Actual|Sadick Research Group||2||funding withdrawn|f||||t||||||||No||2017-10-10 22:36:13.046404|2017-10-10 22:36:13.046404
NCT02647502|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-03-06|||December 2015||2015-12-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis|A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis|Active, not recruiting||Phase 1|36|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-10-10 22:36:13.236975|2017-10-10 22:36:13.236975
NCT02647489|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-28|||May 2016||2016-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|PAMVAC||Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted|Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Adjuvanted With Alhydrogel, GLA-SE or GLA-LSQ in Healthy Malaria-Naïve Adults and Healthy, Lifelong Malaria-Exposed, Nulligravid Adult Women|Recruiting||Phase 1|66|Anticipated|University Hospital Tuebingen||11|||f||||t||||||||||2017-10-10 22:36:13.337048|2017-10-10 22:36:13.337048
NCT02647476|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2016-01-04|||November 2004||2004-11-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|December 2010|Actual|2010-12-01||Interventional|||Postoperative Enteral Immunonutrition in Gastric Cancer|The Impact of Postoperative Enteral Immunonutrition on Postoperative Complications and Survival in Gastric Cancer Patients|Completed||Phase 3|98|Actual|Jagiellonian University||2|||f||||t||||||||No||2017-10-10 22:36:13.487539|2017-10-10 22:36:13.487539
NCT02647463|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluating the Efficacy of ABC for High-Risk Parent and Infants|Evaluating the Efficacy of ABC for High-Risk Parent and Infants|Recruiting||Phase 2/Phase 3|120|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-10-10 22:36:13.584839|2017-10-10 22:36:13.584839
NCT02647450|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-10-19|||January 2016||2016-01-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|GICEE||GI Consequences Economic Evaluation|An Exploratory Assessment of the Cost Impact of Managing GI Consequences of Cancer Treatment Outside of a Specialist Clinic|Recruiting||N/A|250|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 22:36:13.691574|2017-10-10 22:36:13.691574
NCT02647437|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-08-29|||June 2013||2013-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia|Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Patients With Schizophrenia|Recruiting||N/A|30|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:36:13.795119|2017-10-10 22:36:13.795119
NCT02647424|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-10-26|||December 2015||2015-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparison of Letrozole and Clomifene Citrate|A Comparison of Hormonal Profile and the Follicular Development Between Letrozole and Clomifene Citrate in Anovulatory Women With Polycystic Ovary Syndrome and Ovulatory Women|Recruiting||N/A|40|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:36:13.903482|2017-10-10 22:36:13.903482
NCT02647411|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-01-05|||August 2015||2015-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Increased Prevalence of Myopia in a Ophthalmologic Hospital in Goiânia - Goiás|Increased Prevalence of Myopia in a Ophthalmologic Hospital in Goiânia - Goiás|Completed||N/A|16971|Actual|Instituto de Olhos de Goiania|||2||f||||t||||||||||2017-10-10 22:36:14.037116|2017-10-10 22:36:14.037116
NCT02647398|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-06-17|||January 2016||2016-01-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|||Study Comparing Two Strategies of Exercise in Breast and Colon Cancer Survivors and Their Impact on Fatigue|Randomized Study Comparing Two Strategies of Physical Activity in Long-term Breast and Colon Cancer Survivors and Their Impact on Fatigue|Recruiting||Phase 2|32|Anticipated|Puerta de Hierro University Hospital||2|||f||||f||||||||||2017-10-10 22:36:14.097762|2017-10-10 22:36:14.097762
NCT02647385|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-06-20|||December 2015||2015-12-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation|Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation|Active, not recruiting||N/A|50|Actual|Hospital Sirio-Libanes||2|||f||||t||||||||||2017-10-10 22:36:14.211439|2017-10-10 22:36:14.211439
NCT02647372|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-08-15|||June 2012||2012-06-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Deep Brain Stimulation for Parkinson's Disease: the Globus Pallidus Internus Versus Subthalamic Nucleus|Deep Brain Stimulation for the Treatment of Parkinson's Disease: Comparative Analysis of Clinical Effect of Stimulation of the Globus Pallidus Internus and Subthalamic Nucleus|Active, not recruiting||N/A|30|Anticipated|Hospital Sirio-Libanes||2|||f||||t||||||||||2017-10-10 22:36:14.298178|2017-10-10 22:36:14.298178
NCT02647359|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-08-02|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|STAR||Study of Ataluren in Patients With Aniridia|STAR: A Phase 2, Multicenter, Randomized, Double Masked, Placebo Controlled Study of the Safety and Efficacy of Ataluren (PTC124) for the Treatment of Nonsense Mutation Aniridia|Active, not recruiting||Phase 2|39|Actual|PTC Therapeutics||2|||f||||t||||||||||2017-10-10 22:36:14.387138|2017-10-10 22:36:14.387138
NCT02647346|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-04|||November 2013||2013-11-01|January 2016|2016-01-01||||July 2015|Actual|2015-07-01||Interventional|||In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers|In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers|Completed||N/A|132|Actual|Podimetrics, Inc.||1|||f||||f||||||||No||2017-10-10 22:36:14.466252|2017-10-10 22:36:14.466252
NCT02647333|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-12-19|||March 2015||2015-03-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Intervention With Omega Fatty Acids in High-risk Patients|Intervention With Omega Fatty Acids in High-risk Patients With Hypertriglyceridemic Waist|Completed||Phase 2|40|Actual|Haukeland University Hospital||2|||f||||f||||||||||2017-10-10 22:36:14.544463|2017-10-10 22:36:14.544463
NCT02647320|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-03-20|||January 2016||2016-01-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin|A Randomized, Double-Blind, Placebo-Controlled With Active Comparator, 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin|Completed||Phase 2|298|Actual|Daiichi Sankyo, Inc.||5|||f||||f||||||||Undecided||2017-10-10 22:36:14.634714|2017-10-10 22:36:14.634714
NCT02647307|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-08-25|||February 2016||2016-02-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040b|A Phase I, Open Label, Parallel Group Study to Evaluate the Effect of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of a DS 1040b IV Infusion Administered to Healthy Male Subjects|Completed||Phase 1|48|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:36:14.988074|2017-10-10 22:36:14.988074
NCT02647294|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-09-16|||February 2016||2016-02-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Polyunsaturated Fatty Acids in Patients With NAFLD.|Nutrition-based Therapy of Liver Disease of Different Origin: Effect of n-3 Polyunsaturated Fatty Acid in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome.|Active, not recruiting||N/A|60|Anticipated|General University Hospital, Prague||2|||f||||f||||||||||2017-10-10 22:36:15.102507|2017-10-10 22:36:15.102507
NCT02646722|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-04|||January 2016||2016-01-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||Relation Between Withdrawal Movement for Rocuronium and Emergence Agitation|Relation Between Withdrawal Movement on Rocuronium Injection and Emergence Agitation and Pain in Preschool Ages: Observational Study|Not yet recruiting||N/A|40|Anticipated|Ajou University School of Medicine|||4||f||||f||||||||No||2017-10-10 22:36:19.943363|2017-10-10 22:36:19.943363
NCT02647268|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-07-12|||January 2016||2016-01-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Effect of Magnesium Sulphate Pre-exposure on Oxytocin-induced Contractility in Desensitized Human Myometrium - an in Vitro Study|Effect of Magnesium Sulphate Pre-exposure on Oxytocin-induced Contractility in Desensitized Human Myometrium - an in Vitro Study|Completed||N/A|26|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||3|||f||||f||||||||||2017-10-10 22:36:15.410936|2017-10-10 22:36:15.410936
NCT02647255|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-04-04|||December 2015||2015-12-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RESCUE||Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy|Randomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis of IgA NEphropathy (RESCUE Study)|Enrolling by invitation||Phase 2/Phase 3|150|Anticipated|Peking University First Hospital||2|||f||||t||||||||||2017-10-10 22:36:15.530685|2017-10-10 22:36:15.530685
NCT02647242|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-01-05|||February 2016||2016-02-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|BEAT PARK 2||Proof of Concept BeatPark|Pilot Study on Feasibility and Safety of a Gait Auto-rehabilitation Program by Rhythmic Auditory Cueing Delivered by BeatHealth in Patients With Parkinson's Disease.|Not yet recruiting||N/A|60|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 22:36:15.673214|2017-10-10 22:36:15.673214
NCT02647229|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-09-27|||October 2014||2014-10-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Colonic Irrigation for Colonoscopy Preparation|Measuring the Effectiveness and Utility of Colonic Irrigation for Bowel Preparation in Patients Undergoing Screening or Surveillance Colonoscopy|Withdrawn||N/A|0|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:36:15.767207|2017-10-10 22:36:15.767207
NCT02647216|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-04-19|||December 2015||2015-12-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Mindfulness for Breast Cancer|Mindfulness Training to Improve Well-being in Post-Treatment Breast Cancer Patients|Recruiting||N/A|60|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:36:15.867652|2017-10-10 22:36:15.867652
NCT02647203|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-01-05|||July 2014||2014-07-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|MIT-RCTalca||Non-invasive Treatment of Root Caries in Older Adults|Non-invasive Therapy With Fluoridated Toothpastes for Root Caries in Independently-living Older Adults|Active, not recruiting||Phase 1|316|Actual|University of Talca||2|||f||||f||||||||No||2017-10-10 22:36:15.995558|2017-10-10 22:36:15.995558
NCT02647190|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2017-06-01|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older|A Phase I Study to Determine the Safety and Pharmacokinetics of Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older|Withdrawn||Phase 1|0|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:36:16.133479|2017-10-10 22:36:16.133479
NCT02647177|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-04|||May 2015||2015-05-01|January 2016|2016-01-01|December 2025|Anticipated|2025-12-01|December 2016|Anticipated|2016-12-01|1 Year|Observational [Patient Registry]|||A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions|A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions|Recruiting||N/A|1000|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples With DNA|"     Cyst aspirate   "|||2017-10-10 22:36:16.229356|2017-10-10 22:36:16.229356
NCT02647164|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-05|||January 2016||2016-01-01|September 2015|2015-09-01||||September 2018|Anticipated|2018-09-01||Observational|||The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring|The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring|Not yet recruiting||N/A|360|Anticipated|GenoSaber|||1||f||||t||||||||||2017-10-10 22:36:16.316928|2017-10-10 22:36:16.316928
NCT02647151|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-01-05|||December 2015||2015-12-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel|Comparative Intraindividual Study, About the Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between Acid Methyl Aminolevulinate Cream and Aminolevulinic Gel|Recruiting||Phase 4|50|Anticipated|Fundación Instituto Valenciano de Oncología||2|||f||||f||||||||||2017-10-10 22:36:16.381253|2017-10-10 22:36:16.381253
NCT02647138|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-01-06|||December 2015||2015-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of White Noise In High Noise Environment|The Effect of White Noise In High Noise Environment|Recruiting||Early Phase 1|20|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||No|There is no plan to make IPD available.|2017-10-10 22:36:16.492736|2017-10-10 22:36:16.492736
NCT02647125|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2016-12-22|||October 2015||2015-10-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC|A Phase II Study of Comparing Huachansu Combination With Thoracic Radiotherapy Versus Radiotherapy Alone For Esophageal Squamous Cell Carcinoma|Recruiting||Phase 2|134|Anticipated|Fudan University||2|||f||||t||||||||No||2017-10-10 22:36:16.583055|2017-10-10 22:36:16.583055
NCT02647112|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-12|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma|Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma A Multicenter, Prospective Blinded Study|Recruiting||N/A|350|Anticipated|Nucleix Ltd.||2|||f||||f||||||||||2017-10-10 22:36:16.664751|2017-10-10 22:36:16.664751
NCT02647099|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-05|2016-09-08|||March 2016||2016-03-01|September 2016|2016-09-01|January 2023|Anticipated|2023-01-01|March 2021|Anticipated|2021-03-01||Interventional|ALASCCA||Adjuvant Low Dose Aspirin in Colorectal Cancer|A Randomized Double-blind Placebo-controlled Study With ASA Treatment in Colorectal Cancer Patients With Mutations in the PI3K Signaling Pathway|Recruiting||Phase 3|816|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 22:36:16.780093|2017-10-10 22:36:16.780093
NCT02647086|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-08-18|||December 2015||2015-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)|An Open-Label, Drug-Drug Interaction Study to Examine the Effects of Dupilumab on the Pharmacokinetics of Selected Cytochrome P450 Substrates in Adult Patients With Moderate to Severe Atopic Dermatitis|Completed||Phase 1|14|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:36:16.884377|2017-10-10 22:36:16.884377
NCT02647073|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-07-20|||August 2016|Anticipated|2016-08-01|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|MOVE||The Mobile Monitoring of Vital Signs in Opioid Users|A Pilot Study to Evaluate the Feasibility of Mobile Monitoring of Vital Signs in Opioid Users|Withdrawn||N/A|0|Actual|University of British Columbia||1||Ongoing issues with the device and software that were provided by the sponsor.|f||||f||||||||||2017-10-10 22:36:16.997098|2017-10-10 22:36:16.997098
NCT02647060|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-01-18|||January 2016||2016-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|November 2016|Actual|2016-11-01||Observational|||The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH|The Exercise Capacity and Quality of Life in the Patients With Idiopathic Pulmonary Arterial Hypertension and Secondary Pulmonary Hypertension|Recruiting||N/A|30|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-10 22:36:17.098541|2017-10-10 22:36:17.098541
NCT02647047|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-01-05|||January 2016||2016-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery|Spinal Analgesia Versus Epidural Analgesia in Minor Laparotomic Liver Surgery in an Enhanced Recovery Programme: A Randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|Ospedale San Raffaele||2|||f||||t||||||||||2017-10-10 22:36:17.194059|2017-10-10 22:36:17.194059
NCT02647034|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-01-04|||July 2009||2009-07-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|||Stress Ventricular Function in Evaluating Patients With Pulmonary Hypertension|Using the Stress Ventricular Function Assessment to Evaluate the Long-term Prognosis and Treatment Outcome in Patients With Pulmonary Hypertension|Recruiting||N/A|300|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-10 22:36:17.338877|2017-10-10 22:36:17.338877
NCT02647021|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-10-11|||February 2016||2016-02-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TARGET||Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors|Evaluating Outcomes From a Combined Supervised Therapeutic and Physical Exercise Program for Post-surgical Head and Neck Cancer Survivors: A Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-10 22:36:17.428514|2017-10-10 22:36:17.428514
NCT02647008|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-09-11|||February 2016||2016-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Pain Relief During Unsedated Office Hysteroscopy by Applying TENS|Pain Relief During Unsedated Office Hysteroscopy by Applying Transcutaneous Electrical Nerve Stimulation (TENS): A Randomized Double-blind Placebo-controlled Trial|Completed||N/A|138|Actual|Cardenal Herrera University||3|||f||||f||||||||No||2017-10-10 22:36:17.534372|2017-10-10 22:36:17.534372
NCT02646995|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-01-30|||January 2016||2016-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) Patients||Recruiting||N/A|28|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-10 22:36:17.617734|2017-10-10 22:36:17.617734
NCT02646982|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-11|||June 2016||2016-06-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|CEDAR||Candesartan's Effects on Alzheimer's Disease And Related Biomarkers|Candesartan's Effects on Alzheimer's Disease And Related Biomarkers|Recruiting||Phase 2|72|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 22:36:17.69715|2017-10-10 22:36:17.69715
NCT02646969|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-07-04|||October 2015||2015-10-01|July 2016|2016-07-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life|Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life|Recruiting||N/A|690|Anticipated|Nestlé||3|||f||||t||||||||||2017-10-10 22:36:17.808868|2017-10-10 22:36:17.808868
NCT02646956|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-01-04|||May 2014||2014-05-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|TNNS||Taste Preferences for Nutritive and Non Nutritive Sweeteners Among Children and Adults|Taste Preferences for Nutritive and Non Nutritive Sweeteners Among Children and Adults|Completed||N/A|82|Actual|Monell Chemical Senses Center|||2||f||||f||||||Samples With DNA|"     Salivary samples obtained for genotyping of taste receptor genes   "|No||2017-10-10 22:36:17.888835|2017-10-10 22:36:17.888835
NCT02646943|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2016-01-05|||July 2013||2013-07-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational|SaMi-Trop||Longitudinal Study of Patients With Chronic Chagas Cardiomyopathy in Brazil (SaMi_Trop Project)|Longitudinal Study of Patients With Chronic Chagas Cardiomyopathy in Brazil (SaMi_Trop Project)|Completed||N/A|1959|Actual|University of Sao Paulo|||1||f||||t||||||||Yes|The Dataset will be open access for two years at the end of the data collection process (August, 2018). In the meantime, applications to use the data should be made by contacting the researchers of the SaMi-Trop cohort and filling up the application form. The questionnaires and interviewer guides of the baseline will also be available in electronic formats at http://www.ufsj.edu.br/tecnologiasemsaude_pesquisa/projetos.php|2017-10-10 22:36:17.96175|2017-10-10 22:36:17.96175
NCT02646930|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-06-21|||January 2016||2016-01-01|June 2017|2017-06-01||||January 2018|Anticipated|2018-01-01||Interventional|CEIVF||Chronic Endometritis and IVF|The Impact of Chronic Endometritis on IVF Pregnancy and Pregnancy Loss Rates|Recruiting||N/A|60|Anticipated|Duke University||1|||f||||f||||||||Undecided||2017-10-10 22:36:18.048317|2017-10-10 22:36:18.048317
NCT02646917|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-09-29|||December 2015||2015-12-01|January 2017|2017-01-01|July 25, 2017|Actual|2017-07-25|December 2016|Actual|2016-12-01||Interventional|||SkinPen Efficacy on Acne Scars on the Face and/or Back|A Single-Center Trial to Evaluate the Efficacy and Tolerability of SkinPen on Male and Female Subjects' Acne Scars on the Face and/or Back|Completed||N/A|65|Actual|Bellus Medical, LLC||1|||f||||f||||||||||2017-10-10 22:36:18.138059|2017-10-10 22:36:18.138059
NCT02646904|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-03-15|||February 2016||2016-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis|Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis|Recruiting||Phase 4|68|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy||2|||f||||f||||||||Yes|"The IPD collected will be available on February 2017.
The following participant data will be shared:
Nasal patency
Nasal symptom score
Demographic characteristics
All IPD will be obtained from statistical analysis on the dedicated database in which all data are stored."|2017-10-10 22:36:18.206989|2017-10-10 22:36:18.206989
NCT02646891|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-06-09|||February 2016||2016-02-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Immunogenicity Study of Trivalent P2-VP8 Subunit Rotavirus Vaccine in Adults, Toddlers and Infants|Phase I/II Double-blind, Randomized, Placebo-controlled, Descending Age, Dose-escalation Study of the Safety, and Immunogenicity of the Trivalent P2-VP8 Subunit Rotavirus Vaccine in Healthy South African Adults, Toddlers and Infants|Active, not recruiting||Phase 1/Phase 2|609|Actual|PATH||18|||f||||t||||||||No||2017-10-10 22:36:18.426931|2017-10-10 22:36:18.426931
NCT02646878|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-05-10|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics|A Feasibility Study to Evaluate the Performance of the Harmony 1 Sensors in Adults and Pediatrics|Not yet recruiting||N/A|20|Anticipated|Medtronic Diabetes||2|||f||||f|f|t|t|f|f|||No||2017-10-10 22:36:18.572855|2017-10-10 22:36:18.572855
NCT02646865|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-12-05|||January 2016||2016-01-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|SCE-CBT||Self-Compassion Enhanced CBT vs. Standard CBT for Social Anxiety (SCE-CBT)|A Randomized Controlled Trial on the Efficacy of Self-Compassion Enhanced CBT vs. Standard CBT for Social Anxiety|Active, not recruiting||N/A|60|Anticipated|Babes-Bolyai University||2|||f||||f||||||||No||2017-10-10 22:36:18.693321|2017-10-10 22:36:18.693321
NCT02646852|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-03-02|||March 2016||2016-03-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I Study of DFP-13318 in Patients With Advanced Solid Tumors|A Phase I Study of DFP-13318 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|72|Anticipated|Delta-Fly Pharma, Inc.||1|||f||||||||||||||2017-10-10 22:36:18.809589|2017-10-10 22:36:18.809589
NCT02646826|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-11-22|||January 2016||2016-01-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial|Paxerol™ (a Novel Formulation of Acetaminophen and Ibuprofen) for Treatment of Nocturia - A Phase II Placebo-Controlled Trial|Recruiting||Phase 2|100|Anticipated|Wellesley Pharmaceuticals, LLC||4|||f||||f||||||||No||2017-10-10 22:36:19.017768|2017-10-10 22:36:19.017768
NCT02646813|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-10-31|||February 2016||2016-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of Intra and Extraluminal Bronchial Blocker in Adults|A Comparison of Intraluminal and Extraluminal Placement of the Arndt Bronchial Blockers for Adult Thoracic Surgery|Completed||N/A|42|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 22:36:19.150851|2017-10-10 22:36:19.150851
NCT02646800|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-02-18|||March 2014||2014-03-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp|A Multi-center, Open-label, Non-comparative Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp|Terminated||Phase 4|105|Actual|Astellas Pharma Inc||1||Due to administrative reasons|f||||f||||||||Undecided||2017-10-10 22:36:19.242442|2017-10-10 22:36:19.242442
NCT02646787|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-08-30|||October 2015||2015-10-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|H2OWC||Virtual Reality Water Friendly Wound Care|Water Friendly Virtual Reality for Burns|Recruiting||N/A|200|Anticipated|University of Washington||3|||f||||f||||||||||2017-10-10 22:36:19.378598|2017-10-10 22:36:19.378598
NCT02646774|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-03-07|||March 2014||2014-03-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis|A Multi-center, Open-label, Non-comparative Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Aspergillosis (CFDA Commitment)|Terminated||Phase 4|43|Actual|Astellas Pharma Inc||1||Due to administrative reasons|f||||f||||||||Undecided||2017-10-10 22:36:19.479668|2017-10-10 22:36:19.479668
NCT02646761|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-01-31|||April 2016||2016-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||interACTION: A Portable Joint Function Monitoring and Training System for Remote Rehabilitation Following TKA|interACTION: A Portable Joint Function Monitoring and Training System for Remote Rehabilitation Following Total Knee Arthroplasty|Recruiting||N/A|60|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:36:19.599272|2017-10-10 22:36:19.599272
NCT02646748|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-14|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|||Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors|A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of Pembrolizumab + INCB Combinations in Advanced Solid Tumors|Recruiting||Phase 1|201|Anticipated|Incyte Corporation||2|||f||||f||||||||||2017-10-10 22:36:19.695742|2017-10-10 22:36:19.695742
NCT02646735|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-12-30|||December 2015||2015-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|FRIEND||Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients|A Randomized, Open Label, Multi-Centre Study to Compare the Efficacy and Tolerability of Fulvestrant 500mg With Exemestane for Postmenopausal Advanced Breast Cancer Patients|Recruiting||Phase 2|148|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||No||2017-10-10 22:36:19.826963|2017-10-10 22:36:19.826963
NCT02646709|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-04|||January 2016||2016-01-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||The Effect of Different Dose of Ketamine With Low Dose Rocuronium in Children|The Effect of Different Doses of Ketamine on Tracheal Intubating Conditions Using Low Dose Rocuronium in Children|Not yet recruiting||Phase 4|60|Anticipated|Ajou University School of Medicine||3|||f||||f||||||||No||2017-10-10 22:36:20.064952|2017-10-10 22:36:20.064952
NCT02646696|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-04|||January 2013||2013-01-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||Reliability Study Using Electrodermal Activity to Measure Sensory Processing in Children With and Without Autism Spectrum Disorder|Reliability of Electrodermal Activity: Quantifying Sensory Processing in Children With Autism Spectrum Disorder|Completed||N/A|32|Actual|Barpak Geriatric Health Services, Inc. d/b/a Barpak Occupational Therapy|||2||f||||f||||||||No||2017-10-10 22:36:20.181101|2017-10-10 22:36:20.181101
NCT02646683|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-04|||July 2015||2015-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|LOVE-CD||A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study|An Open Label Interventional Phase 4 Study to Evaluate Efficacy, Safety and Mucosal Healing of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study (LOw Countries VEdolizumab in CD Study)|Recruiting||Phase 4|260|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 22:36:20.269182|2017-10-10 22:36:20.269182
NCT02646670|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-01-03|||July 2015||2015-07-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema|Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema|Completed||Phase 4|20|Actual|Instituto de Olhos de Goiania||4|||f||||t||||||||||2017-10-10 22:36:20.456506|2017-10-10 22:36:20.456506
NCT02646657|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-04|||July 2015||2015-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|LOVE-UC||An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis|An Open Label Interventional Phase 4 Study to Evaluate Efficacy, Safety and Mucosal Healing of Early Versus Late Use of Vedolizumab in Ulcerative Colitis: the LOVE-UC Study (LOw Countries VEdolizumab in UC Study)|Recruiting||Phase 4|120|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 22:36:20.539723|2017-10-10 22:36:20.539723
NCT02646644|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-05-04|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|HET-NET||Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis|Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis|Completed||N/A|38|Actual|University Medical Center Groningen|||1||f||||f||||||||No||2017-10-10 22:36:20.701314|2017-10-10 22:36:20.701314
NCT02646631|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-07-12|||September 2016||2016-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Behavioral and Educational Tools to Improve Epilepsy Care|Behavioral and Educational Tools to Improve Epilepsy Care|Recruiting||N/A|60|Anticipated|New York University School of Medicine||3|||f||||||||||||||2017-10-10 22:36:20.773115|2017-10-10 22:36:20.773115
NCT02646618|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-13|||April 2016||2016-04-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention|Get Social: Randomized Trial of a Social Network Delivered Lifestyle Intervention|Recruiting||N/A|328|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||No||2017-10-10 22:36:20.873298|2017-10-10 22:36:20.873298
NCT02646605|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-04|||May 2013||2013-05-01|January 2016|2016-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Depression Amongst HIV Positive Patients in Lilongwe|Prevalence of Depression Amongst HIV Positive Patients Attending ART Clinic at Lighthouse Clinic, Lilongwe|Completed||N/A|206|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||No||2017-10-10 22:36:21.006553|2017-10-10 22:36:21.006553
NCT02646592|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-05-02|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Effect of a Bolus of 10 µg/kg of Alfentanil on the Pupillary Pain Index|Effect of a Bolus of 10 µg/kg of Alfentanil on the Pupillary Pain Index|Completed||N/A|14|Actual|Hôpital Armand Trousseau||1|||f||||||||||||||2017-10-10 22:36:21.086054|2017-10-10 22:36:21.086054
NCT02646579|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-06-05|||November 2015||2015-11-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only|Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only Among Individuals With Chronic Lower Extremity Conditions|Recruiting||N/A|34|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 22:36:21.152695|2017-10-10 22:36:21.152695
NCT02646566|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-01-23|||March 2016|Actual|2016-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study of APD421 as PONV Treatment (Prior Prophylaxis)|Randomised, Double-blind, Placebo-controlled Study of APD421 (Amisulpride for IV Injection) as Treatment of Established Post-operative Nausea and Vomiting, in Patients Who Have Had Prior Prophylaxis|Completed||Phase 3|705|Actual|Acacia Pharma Ltd||3|||f||||t||||||||No||2017-10-10 22:36:21.240358|2017-10-10 22:36:21.240358
NCT02646553|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-14|||May 2012||2012-05-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Saliva Cortisol Measurement as a Screening Test for Suspicious Cushings Syndrome in Children.|Saliva Cortisol Measurement as a Screening Test for Suspicious Cushings Syndrome in Children.|Recruiting||N/A|70|Anticipated|Haukeland University Hospital|||1||f||||t||||||Samples Without DNA|"     the investigators collect saliva and urine from the patients, for analysis of the hormone     cortisol.   "|||2017-10-10 22:36:21.326168|2017-10-10 22:36:21.326168
NCT02646540|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-04-12|||January 2016||2016-01-01|April 2017|2017-04-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|ADD-IT||AiDing Diuresis wIth Tolvaptan (ADD-IT)|AiDing Diuresis wIth Tolvaptan (ADD-IT)|Recruiting||Phase 1|30|Anticipated|Emory University||3|||f||||f|t|f||||||||2017-10-10 22:36:21.408504|2017-10-10 22:36:21.408504
NCT02646527|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|DT-plus||Dignity Therapy+: A Brief Psychological and Existential Intervention for Dying Patients and Their Families.|Dignity Therapy+: a Brief Psychological and Existential Intervention for Dying Patients and Their Families. A Randomized Controlled Trial|Recruiting||N/A|160|Anticipated|University of Zurich||3|||f||||t||||||||Undecided||2017-10-10 22:36:21.516232|2017-10-10 22:36:21.516232
NCT02646514|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-06|||September 2015||2015-09-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study||Recruiting||N/A|48|Anticipated|Yonsei University||2|||f||||f||||||||Undecided||2017-10-10 22:36:21.587019|2017-10-10 22:36:21.587019
NCT02646501|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-04|||September 2015||2015-09-01|January 2016|2016-01-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|||Prospective Randomized Clinical Trial for Effect of Stellate Ganglion Block in Medically Refractory Ventricular Tachycardia||Recruiting||N/A|20|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:36:21.662184|2017-10-10 22:36:21.662184
NCT02646475|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-08-01|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Metabolic Effects of Angiotensin-(1-7)|Metabolic Effects of Angiotensin-(1-7)|Recruiting||Phase 1|19|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 22:36:21.860784|2017-10-10 22:36:21.860784
NCT02646462|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-01-06|||June 2015||2015-06-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer|Systematic Lymph Node Sampling and Analysis in Patients Undergoing Radical Resection for Pancreatic Cancer. A National Danish Study|Recruiting||N/A|200|Anticipated|Odense University Hospital|||1||f||||t||||||||No||2017-10-10 22:36:21.968048|2017-10-10 22:36:21.968048
NCT02646449|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-03-14|2016-12-22||June 2015||2015-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|YAAD-P||Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial|Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial|Completed||Phase 2|11|Actual|University of Pittsburgh||2|||f||||f||||||||No||2017-10-10 22:36:22.03813|2017-10-10 22:36:22.03813
NCT02646436|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-02|||November 30, 2014||2014-11-30|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Peritoneal Dialysis as an Option of Unplanned Initiation of Chronic Dialysis|Peritoneal Dialysis as an Option of Unplanned Initiation of Chronic Dialysis|Recruiting||N/A|188|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||t||||||||||2017-10-10 22:36:22.411693|2017-10-10 22:36:22.411693
NCT02646423|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-05-09|||January 2016||2016-01-01|May 2016|2016-05-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|PROCEED||Effect of a Patient-Centered Decision App on TOLAC|Effect of a Patient-Centered Decision App on TOLAC: An RCT|Recruiting||N/A|1320|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:36:22.543907|2017-10-10 22:36:22.543907
NCT02646410|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-31|||August 2014||2014-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SMC||Optimization of Seasonal Malaria Chemoprevention (SMC) Delivery|Optimal Delivery of Seasonal Malaria Chemoprevention and Its Effects on the Acquisition of Malaria Immunity|Recruiting||Phase 4|10000|Anticipated|University of Bamako||4|||f||||f||||||||||2017-10-10 22:36:22.70089|2017-10-10 22:36:22.70089
NCT02646397|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-31|||February 2016||2016-02-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BEAHIT||Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension|Comparison of Efficacy and Safety Between Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension: a Randomized Controlled Trial|Not yet recruiting||Phase 4|508|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:36:22.814729|2017-10-10 22:36:22.814729
NCT02646384|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-12-28|||August 2016||2016-08-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Ovarian Tissue Cryopreservation in Children|Ovarian Tissue Freezing For Fertility Preservation In Girls Facing A Fertility Threatening Medical Diagnosis Or Treatment Regimen: A Study By The National Physicians Cooperative of the Oncofertility Consortium At Northwestern University|Recruiting||N/A|100|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 22:36:22.950604|2017-10-10 22:36:22.950604
NCT02646371|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-08-23|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|September 2016|Actual|2016-09-01||Interventional|||Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a|Phase 2b, Double-blind, Placebo-controlled Efficacy Challenge Study With a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a|Completed||Phase 2|67|Actual|LimmaTech Biologics AG||2|||f||||f||||||||||2017-10-10 22:36:23.039454|2017-10-10 22:36:23.039454
NCT02646358|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2016-12-20|||January 2016||2016-01-01|December 2016|2016-12-01||||November 2016|Actual|2016-11-01||Interventional|||Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer|A Phase 1, Open-Label, Non-Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Vepoloxamer in Subjects With Varying Degrees of Renal Impairment and Healthy Matched Control Subjects With Normal Renal Function|Completed||Phase 1|27|Actual|Mast Therapeutics, Inc.||5|||f||||f||||||||Yes||2017-10-10 22:36:23.127953|2017-10-10 22:36:23.127953
NCT02646345|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2015-12-31|||July 2012||2012-07-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Surgical Checklist Success in Latin America|WHO Surgical Safety Checklist Implementation and Its Impact in Perioperative Morbidity and Mortality in an Academic Medical Center in Chile|Completed||N/A|70639|Actual|Pontificia Universidad Catolica de Chile|||2||f||||f||||||||No||2017-10-10 22:36:23.227329|2017-10-10 22:36:23.227329
NCT02646332|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-09-27|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy|Comparing the Efficacy and Impact on Gastrointestinal Microbiota of Reverse Hybrid Therapy and Concomitant Therapy in Helicobacter Pylori Eradication|Recruiting||N/A|438|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-10 22:36:23.320598|2017-10-10 22:36:23.320598
NCT02646319|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-09-19|||January 2016|Actual|2016-01-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|September 5, 2017|Actual|2017-09-05||Interventional|||Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations|A Pilot Study of a Rapid Access Platform for Investigational Drugs (RAPID) in Advanced Cancers|Active, not recruiting||Phase 2|2|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:36:23.444348|2017-10-10 22:36:23.444348
NCT02646306|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-03-22|||July 2015||2015-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Observational|SRPT-Iphase||A New Shoulder Proprioceptive Rehabilitative Tool (SRPT) for the Evaluation of the Role of the Shoulder During Reaching|A New Neurocognitive Interpretation of the Shoulder Position Sense During Reaching|Completed||N/A|44|Actual|University of Roma La Sapienza|||2||f||||t||||||||||2017-10-10 22:36:23.585858|2017-10-10 22:36:23.585858
NCT02646293|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-06-27|||May 2016||2016-05-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|12 Months|Observational [Patient Registry]|||Nephron Sparing Renal Surgery and Total Nephrectomy|Nephron Sparing Renal Surgery and Total Nephrectomy - Functional Adaptation, Preservation and Prediction of Kidney Function|Recruiting||N/A|40|Anticipated|University Hospital Roskilde|||1||f||||f||||||||No||2017-10-10 22:36:23.679435|2017-10-10 22:36:23.679435
NCT02646280|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-05-17|||July 2015||2015-07-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Myofascial Massage in the Treatment of Chronic Low Back Pain|The Myofascial Massage in the Treatment of Chronic Non-specific Low Back Pain: the Experience of Contact|Completed||N/A|51|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-10 22:36:23.772456|2017-10-10 22:36:23.772456
NCT02646267|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-01-04|||March 2016||2016-03-01|January 2016|2016-01-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients|The Efficacy and Safety of Dabigatran Etexilate and Different Intensity Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation|Enrolling by invitation||Phase 4|210|Anticipated|The First Affiliated Hospital with Nanjing Medical University||3|||f||||t||||||||No||2017-10-10 22:36:23.869524|2017-10-10 22:36:23.869524
NCT02646254|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2015-12-31|||June 2014||2014-06-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|TOF||Myocardial Protection and Clinical Outcome in Patients Undergoing Tetralogy of Fallot Repair : A Randomized Study of Two Different Cardioplegia Technique|MYOCARDIAL PROTECTION AND CLINICAL OUTCOME IN PATIENTS UNDERGOING TETRALOGY OF FALLOT REPAIR: A RANDOMIZED STUDY OF TWO CARDIOPLEGIC TECHNIQUES|Completed||Phase 4|56|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 22:36:23.975728|2017-10-10 22:36:23.975728
NCT02646241|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2017-03-23|||January 2, 2016|Actual|2016-01-02|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Biopsy Protocol of Upper Gastrointestinal Subepithelial Tumors:Diagnostic Accuracy of EUS-FNB Versus Unroofing Biopsy||Recruiting||N/A|125|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:36:24.052687|2017-10-10 22:36:24.052687
NCT02646228|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-02-15|||February 4, 2016|Actual|2016-02-04|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer|Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer|Recruiting||N/A|500|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:36:24.139262|2017-10-10 22:36:24.139262
NCT02646215|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-04-19|||August 2015||2015-08-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Inspiratory Muscle Training in Ehlers Danlos Patients||Completed||N/A|20|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||No||2017-10-10 22:36:24.243233|2017-10-10 22:36:24.243233
NCT02646202|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Scleroligation for Eradication of Gastroesophageal Varices.|Scleroligation is a Safe and Effective New Technique for Eradication of Gastroesophageal Varices.|Recruiting||Phase 3|90|Anticipated|Tanta University||3|||f||||t||||||||Undecided||2017-10-10 22:36:24.318956|2017-10-10 22:36:24.318956
NCT02646189|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-01-04|||August 2011||2011-08-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients|Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients|Completed||Phase 1/Phase 2|12|Actual|Replicor Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:36:24.423212|2017-10-10 22:36:24.423212
NCT02646176|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2015-12-31|||October 2008||2008-10-01|December 2015|2015-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|TBI-CER||Comparative Effectiveness of Rehabilitation Interventions for Traumatic Brain Injury|Comparative Effectiveness of Rehabilitation Interventions for Traumatic Brain Injury|Completed||N/A|2130|Actual|Ohio State University|||1||f||||f||||||||Yes|A complete de-identified dataset will be made available to the public within 9 months of completion of the analysis.|2017-10-10 22:36:24.523268|2017-10-10 22:36:24.523268
NCT02646163|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2016-01-04|||January 2009||2009-01-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients|Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients|Completed||Phase 1/Phase 2|8|Actual|Replicor Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:36:24.595686|2017-10-10 22:36:24.595686
NCT02646150|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-06-18|||December 2015||2015-12-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Observational|MR CLI||Clinical Use of Magnetic Resonance Perfusion Imaging to Qualitatively Assess Adequate Distal Perfusion After Endovascular Revascularization in Critical Limb Ischemia|Clinical Use of Magnetic Resonance Perfusion Imaging to Qualitatively Assess Adequate Distal Perfusion After Endovascular Revascularization in Critical Limb Ischemia|Recruiting||N/A|20|Anticipated|Asan Medical Center|||1||f||||f||||||||No|This trial is not publicly funded clinical trial.|2017-10-10 22:36:24.68803|2017-10-10 22:36:24.68803
NCT02646137|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma|Comparison of Single Session Transarterial Chemoembolization Combined With Microwave Ablation or Radiofrequency Ablation in Treatment of Hepatocellular Carcinoma: A Randomized Controlled Study|Recruiting||Phase 3|50|Anticipated|Tanta University||3|||f||||t||||||||Undecided||2017-10-10 22:36:24.804534|2017-10-10 22:36:24.804534
NCT02646111|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-04|||January 2016||2016-01-01|January 2016|2016-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||"Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors (PI) Failures"|An Open-label, Multi-center Study to Evaluate Sustained Virologic Response With Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Genotype 1 Chronic Hepatitis C Virus Infected Patients With Past PI Failure|Not yet recruiting||Phase 3|120|Anticipated|Tel-Aviv Sourasky Medical Center||4|||f||||f||||||||Undecided||2017-10-10 22:36:24.962975|2017-10-10 22:36:24.962975
NCT02646098|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-03-21|||November 2015||2015-11-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SAAL||CD34+ Selected ASCT for Aggressive Lymphomas|CD34+ Selected Versus Unselected Autologous Stem Cell Transplantation in Advanced Stage Mantle Cell and Diffuse Large B-cell Lymphoma Patients, a Randomized Phase II Study|Recruiting||Phase 2|64|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 22:36:25.060102|2017-10-10 22:36:25.060102
NCT02646085|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-08-30|||July 2016||2016-07-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Multiparametric Imaging in Multiple Myeloma|Multiparametric Imaging in Multiple Myeloma|Recruiting||Phase 1|10|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 22:36:25.160155|2017-10-10 22:36:25.160155
NCT02646072|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2016-01-04|||August 2014||2014-08-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients|The Effect of Preoperative Topical Ketorolac 0.45% on Aqueous Cytokine Levels and Macular Thickness in Diabetic and Non Diabetic Patients Undergoing Cataract Surgery|Completed||Phase 4|80|Actual|University of Malaya||4|||f||||f||||||||Undecided||2017-10-10 22:36:25.256463|2017-10-10 22:36:25.256463
NCT02646059|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-07-30|||November 2015||2015-11-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||The Effective Ways of Recruiting Lapsed Blood Donors: a Stratified Randomized Pilot Study||Completed||N/A|1188|Actual|Guangzhou Blood Center||3|||f||||f||||||||||2017-10-10 22:36:25.370811|2017-10-10 22:36:25.370811
NCT02646046|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-09-07|||October 2015||2015-10-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Combining Performance of Call EMS and Simultaneous Chest Compressions in a Lone Rescuer CPR|A Study of Evaluation of Effectiveness on the Combining Performance of Call Emergency Medical System (EMS) and Simultaneous Chest Compressions With One Hand in a Lone Rescuer CPR: a Simulation Study Using the Manikin|Completed||N/A|110|Actual|Konkuk University Medical Center||2|||f||||t||||||||No||2017-10-10 22:36:25.454582|2017-10-10 22:36:25.454582
NCT02646033|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-01-04|||September 2015||2015-09-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Observational|||Quantitative Rise in Intraocular Pressure in Steep Trendelenburg Position|Quantitative Rise in Intraocular Pressure in Steep Trendelenburg Position|Recruiting||N/A|100|Anticipated|Rajiv Gandhi Cancer Institute & Research Center, India|||1||f||||f||||||||||2017-10-10 22:36:25.567678|2017-10-10 22:36:25.567678
NCT02646020|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-02|||December 2015||2015-12-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|EGFR-TKIs||Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment|Aprepitant vs. Desloratadine in Non-small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Related Pruritus: A Prospective, Randomized Control, Double-blinded, Phase II Clinical Trial|Active, not recruiting||Phase 2|130|Anticipated|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 22:36:25.63691|2017-10-10 22:36:25.63691
NCT02646007|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-07-18|||November 2015||2015-11-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease|Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation for Human Avascular Necrosis of the Lunate Bone of the Wrist (Kienbock`s Disease)|Recruiting||Phase 1|30|Anticipated|Royan Institute||1|||f||||t||||||||||2017-10-10 22:36:25.736253|2017-10-10 22:36:25.736253
NCT02645994|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2016-01-04|||July 2014||2014-07-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Anesthetic Depth Control Using CLADS vs. TCI in Patients With LVSDF|Comparison of the Efficiency of Anesthetic Depth Control Using Closed Loop Anesthesia Delivery System vs. Manual Control Using Target Controlled Infusion in Patients With Moderate to Severe Left Ventricular Systolic Dysfunction|Completed||N/A|40|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 22:36:25.826424|2017-10-10 22:36:25.826424
NCT02645981|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-03-21|||March 2016||2016-03-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma|Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma: a Controlled,Multicentre,Randomised, Phase 3 Trial|Recruiting||Phase 2/Phase 3|660|Anticipated|Suzhou Zelgen Biopharmaceuticals Co.,Ltd||2|||f||||t||||||||No||2017-10-10 22:36:25.914418|2017-10-10 22:36:25.914418
NCT02645968|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-05-10|||May 2014||2014-05-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01|5 Years|Observational [Patient Registry]|EXCITING||Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING|Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING|Recruiting||N/A|600|Anticipated|Heidelberg University|||1||f||||f||||||||||2017-10-10 22:36:26.013147|2017-10-10 22:36:26.013147
NCT02645955|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-07-13|||June 2014||2014-06-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01|3 Months|Observational [Patient Registry]|MHD HEV||Epidemiological Study of Hepatitis E Virus in Maintenance Hemodialysis Patients||Active, not recruiting||N/A|436|Actual|Xiamen University|||2||f||||t||||||||||2017-10-10 22:36:26.130674|2017-10-10 22:36:26.130674
NCT02645942|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-09-17|||October 2016||2016-10-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|CARNIMET||L-carnitine for Reducing Cardio-metabolic Risk in Patients With Obstructive Sleep Apnea|L-carnitine for Reducing Cardio-metabolic Risk in Patients With Obstructive Sleep Apnea - Double Blind Randomized Clinical Trial|Not yet recruiting||N/A|200|Anticipated|Poznan University of Medical Sciences||2|||f||||t||||||||No||2017-10-10 22:36:26.18803|2017-10-10 22:36:26.18803
NCT02645929|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-03|2017-06-08|||April 2016||2016-04-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Observational|||Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT)|Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT) for Posttraumatic Stress Disorder|Recruiting||N/A|25|Anticipated|New York State Psychiatric Institute|||1||f||||f||||||||No|No. We will be happy to release anonymized group data, beginning with its publication.|2017-10-10 22:36:27.907507|2017-10-10 22:36:27.907507
NCT02645916|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-03-14|||December 2015||2015-12-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean Patients With Cold Hypersensitivity in the Hands|Efficacy and Safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean Patients With Cold Hypersensitivity in the Hands|Recruiting||Phase 4|66|Anticipated|Gachon University Gil Oriental Medical Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:36:27.996824|2017-10-10 22:36:27.996824
NCT02645903|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-01-05|||May 2015||2015-05-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy|Ultrasound-guided Transversus Abdominis Plane Block for Postoperative Analgesia in Living Donor Hepatectomy: Randomized Controlled Double-blinded Trial|Completed||Phase 4|50|Actual|Inonu University||2|||f||||f||||||||No||2017-10-10 22:36:28.094431|2017-10-10 22:36:28.094431
NCT02645890|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-01-11|||November 2015||2015-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CKD-397||Study to Compare the Safety and Pharmacokinetics of CKD-397|A Randomized, Open-label, Oral Single Dosing, Two-way Crossover Clinical Trial to Evaluate the Safety and Pharmacokinetic Profiles of CKD-397 in Healthy Male Subjects|Completed||Phase 1|36|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:36:28.191911|2017-10-10 22:36:28.191911
NCT02645877|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-01-04|||January 2005||2005-01-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Trends of the Pre-hospital Emergency Care Spectrum in Beijing From 2005 to 2014: A Retrospective Analysis|Ten-year Trends in the Pre-hospital Emergency Care Spectrum in Beijing From 2005 to 2014: A Multicenter, Retrospective, Observational Study|Completed||N/A|3909746|Actual|Peking University People's Hospital|||1||f||||f||||||||No||2017-10-10 22:36:28.294781|2017-10-10 22:36:28.294781
NCT02645864|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-04-05|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma|Apatinib and Irinotecan Combination as Second-line Treatment in Esophageal Squamous Cell Carcinoma: a Phase I Dose Escalation Study|Recruiting||Phase 1|9|Anticipated|Peking University||1|||f||||t||||||||No||2017-10-10 22:36:28.382075|2017-10-10 22:36:28.382075
NCT02645851|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2016-09-29|||January 2016||2016-01-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|RAVEXO||RApid Fluid Volume EXpansion in Patients in Shock After the Initial Phase of Resuscitation.|RApid Fluid Volume EXpansion (RVE) in Critically Ill Patients With Acute Circulatory Failure After the Initial Phase of Resuscitation. A Single-center, Open-label, Randomized Study Comparing 3 Strategies of RVE in Orléans, France.|Recruiting||N/A|135|Anticipated|Centre Hospitalier Régional d'Orléans||3|||f||||f||||||||No||2017-10-10 22:36:28.48401|2017-10-10 22:36:28.48401
NCT02645838|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-01-03|||April 2016||2016-04-01|January 2016|2016-01-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Motivational Interviewing for Smoking Cessation|Motivational Interviewing Versus Brief Advice for Smoking Cessation in General Practice|Not yet recruiting||N/A|210|Anticipated|Capital Medical University||2|||f||||f||||||||Yes|Individual patient data will be available.|2017-10-10 22:36:28.583635|2017-10-10 22:36:28.583635
NCT02645825|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-07-11|||May 2016||2016-05-01|June 2016|2016-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|EGAS||Predictive Character Analysis of Ganglionic Echography for the Diagnostic of Benin or Malignant Superficial Adenopathy|Analyse du caractère prédictif de l'échographie Ganglionnaire Pour le Diagnostic de bégninité ou malignité d'Une adénopathie Superficielle|Recruiting||N/A|300|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 22:36:28.664989|2017-10-10 22:36:28.664989
NCT02645812|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2016-07-11|||March 2016||2016-03-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|EAMG||"Validation of the French Version of the Fatigue Score Brief Fatigue Inventory ( BFI)."|"Validation de la Version française du Score de Fatigue  Brief Fatigue Inventory (BFI)"|Recruiting||N/A|1200|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-10-10 22:36:28.914293|2017-10-10 22:36:28.914293
NCT02645799|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-01-31|||April 2016||2016-04-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|BLADE||BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY|Biorest Liposomal Alendronate Administration for Diabetic Patients Undergoing Drug-Eluting Stent Percutaneous Coronary Intervention|Recruiting||Phase 2|270|Anticipated|BIOrest Ltd.||2|||f||||t|f|f||||||||2017-10-10 22:36:29.0818|2017-10-10 22:36:29.0818
NCT02645786|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2015-12-31|||September 2009||2009-09-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Observational|||Thyrotropin Over-suppression and Heart|Cardiac Effects of Thyrotropin Over-Suppression With Levothyroxine in Young Women With Differentiated Thyroid Cancer|Completed||N/A|31|Actual|Chuncheon Sacred Heart Hospital|||2||f||||f||||||Samples Without DNA|"     serum and plasma   "|No|We have no plan to share the data with other investigator.|2017-10-10 22:36:29.228983|2017-10-10 22:36:29.228983
NCT02645773|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-02-08|||September 2015||2015-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring|Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring|Completed||N/A|16|Actual|Bispebjerg Hospital||4|||f||||t||||||||||2017-10-10 22:36:29.309703|2017-10-10 22:36:29.309703
NCT02645760|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-08-10|2016-06-17||October 2015||2015-10-01|December 2015|2015-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CSENSLBP|The data was presented as means, standard deviations (SD) and 95% CI. The statistical analysis performed using SPSS version 16.0 for windows (IBM Corporation, Armonk, NY, USA). The Shapiro-Wilk used to test for the normality of the data.|Effectiveness of Core Stabilization Exercise in Patients With Subacute Non-Specific Low Back Pain|Comparison of Core Stabilization Exercise and Physical Therapy Treatment in Patients With Subacute Non-specific Low Back Pain|Completed||N/A|38|Actual|Khon Kaen University||2|||f||||t||||||||Yes||2017-10-10 22:36:29.400754|2017-10-10 22:36:29.400754
NCT02645747|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-04|2017-08-18|||January 21, 2016|Actual|2016-01-21|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|RETRO CRVO||Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion|RETRO CRVO: Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion|Active, not recruiting||N/A|122|Actual|Bayer|||1||f||||f|f|f||||||||2017-10-10 22:36:29.709731|2017-10-10 22:36:29.709731
NCT02645734|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-02|2016-01-04||||||October 2015|2015-10-01||||February 2016|Anticipated|2016-02-01||Interventional|||The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema|The Comparison Between the Therapeutic Effect of Intravitreal Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema|Unknown status|Recruiting|Phase 2/Phase 3|133|Anticipated|Shahid Beheshti University of Medical Sciences||3|||f||||t||||||||||2017-10-10 22:36:29.800399|2017-10-10 22:36:29.800399
NCT02645721|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-02|2017-05-24|||January 2016||2016-01-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ICBT-AUD||Internet Based Cognitive Behavior Treatment for Alcohol Use Disorders|Internet Based Cognitive Behavior Treatment for Alcohol Use Disorders - a Randomized Controlled Trial|Active, not recruiting||N/A|166|Actual|Karolinska Institutet||3|||f||||f||||||||Undecided||2017-10-10 22:36:29.889385|2017-10-10 22:36:29.889385
NCT02645708|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-02-13|||August 2015||2015-08-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||External Physical Vibration Lithecbole(EPVL) Versus Traditional Row of Stone After Retrograde Intrarenal Surgery(RIRS)|External Physical Vibration Lithecbole(EPVL) Contrast With the Traditional Row of Stone Effect After Retrograde Intrarenal Surgery(RIRS): A Multi-center Prospective Randomized Controlled Trial|Recruiting||N/A|180|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||f||||||||Undecided||2017-10-10 22:36:29.992408|2017-10-10 22:36:29.992408
NCT02645695|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-01-01|||February 2014||2014-02-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||What is the Effective Pulmonary Physiotherapy Method in Critically Care Patients?|Can High Frequency Chest Wall Oscillation Accelerate the Discharged of Intubated Intensive Care Patients?|Completed||N/A|30|Actual|Erzincan University||2|||f||||f||||||||No||2017-10-10 22:36:30.084367|2017-10-10 22:36:30.084367
NCT02645682|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-05-09|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Anti-infective Central Venous Catheter on Catheter-related Infection in Critically Patients|The Effects of Anti-infective Central Venous Catheter(CVC) on Catheter-related Bloodstream Infection(CRBSI) in Critical Care Patients: a Multiple-center, Randomized, Control Study|Recruiting||N/A|1818|Anticipated|West China Hospital||2|||f||||||||||||||2017-10-10 22:36:30.168072|2017-10-10 22:36:30.168072
NCT02645669|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-01-04|||February 2014||2014-02-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Effect of a Locally Delivered Probiotic in Periodontitis|Effect of a Locally Delivered Probiotic as an Adjunct To Scaling And Root Planing In The Management Of Chronic Periodontitis|Completed||Phase 2|30|Actual|SVS Institute of Dental Sciences||2|||f||||t||||||||No|Data will be shared after publishing the study.|2017-10-10 22:36:30.282733|2017-10-10 22:36:30.282733
NCT02645656|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-01-04|||December 2013||2013-12-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF)|Topical Application of Curcumin Incorporated in Orabase in OSMF Patients|Active, not recruiting||Phase 2|30|Actual|SVS Institute of Dental Sciences||1|||f||||t||||||||No|Data will be released after publishing the findings.|2017-10-10 22:36:30.367561|2017-10-10 22:36:30.367561
NCT02645643|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2016-05-25|||December 2015||2015-12-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Medical Education Intervention for Medical Students|Intervention to Promote Medical Students Empathy, Well-being and Study emotion-a Randomized Clinical Trial.|Active, not recruiting||Phase 3|200|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:36:30.463844|2017-10-10 22:36:30.463844
NCT02645630|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-12-08|||December 2015||2015-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Effects of Pain, Disability and Cervicokinesthesia After Cervical Manipulation|Effects of Pain, Disability, Widespread Pressure Pain Sensitivity, and Cervicokinesthesia After Cervical Manipulation in Patients With Mechanical Neck Pain|Completed||N/A|55|Actual|Universidad Rey Juan Carlos||3|||f||||t||||||||No||2017-10-10 22:36:30.540381|2017-10-10 22:36:30.540381
NCT02645617|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety Evaluation of Advantage Anti-Caries Varnish|Phase 1 Safety Evaluation of Advantage Anti-Caries Varnish|Recruiting||Phase 1|12|Anticipated|Advantage Dental Services, LLC||1|||f||||f||||||||No||2017-10-10 22:36:30.726369|2017-10-10 22:36:30.726369
NCT02645604|ClinicalTrials.gov processed this data on October 10, 2017|2016-01-01|2017-06-30|||December 10, 2015||2015-12-10|June 1, 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|February 28, 2020|Anticipated|2020-02-28||Observational|||Artemether-lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali|Artemether-Lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali|Recruiting||N/A|1700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:36:30.822399|2017-10-10 22:36:30.822399
NCT02645591|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-11-21|||November 2016||2016-11-01|November 2016|2016-11-01||||November 2019|Anticipated|2019-11-01||Interventional|||Randomized AmnioFix Study During Radical Prostatectomy|Neurovascular Bundle Protection With an Amnion/Chorion Membrane Allograft to Improve Postoperative Functional Recovery: A Randomized Comparison to Standard Techniques|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 22:36:30.911343|2017-10-10 22:36:30.911343
NCT02645578|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-31|||January 2016||2016-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|ACES||Asia Coma Electrical Stimulation (the ACES Trial)|Asia Coma Electrical Stimulation Trial: an Asian Multicenter Randomized Controlled Trial to Assess the Efficacy and Safety of Right Median Nerve Stimulation for Traumatic Coma|Not yet recruiting||Phase 3|360|Anticipated|RenJi Hospital||2|||f||||t||||||||Yes||2017-10-10 22:36:31.003966|2017-10-10 22:36:31.003966
NCT02645500|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-31|||September 2015||2015-09-01|December 2015|2015-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Training Program and Mobile Health Message on Promoting Family Holistic Health|The Efficacy of Training Programme and Mobile Health Message on Promoting Family Holistic Health|Recruiting||N/A|400|Anticipated|The University of Hong Kong||2|||f||||t||||||||No||2017-10-10 22:36:32.915988|2017-10-10 22:36:32.915988
NCT02645565|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-03-02|||December 2015||2015-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis|Comparison of Intravenous Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Proliferative Lupus Nephritis|Completed||Phase 4|75|Actual|Jawaharlal Institute of Postgraduate Medical Education & Research||2|||f||||f||||||||||2017-10-10 22:36:31.091882|2017-10-10 22:36:31.091882
NCT02645552|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-31|||January 2016||2016-01-01|December 2015|2015-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Pre-hospital Administration of Tranexamic Acid for Moderate and Severe Traumatic Brain Injury|Pre-hospital Administration of Tranexamic Acid for Adults With Moderate and Severe Traumatic Brain Injury: a Randomized, Double-blinded, Placebo-controlled Trial|Not yet recruiting||Phase 3|400|Anticipated|RenJi Hospital||2|||f||||f||||||||||2017-10-10 22:36:31.188276|2017-10-10 22:36:31.188276
NCT02644434|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-11-15|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CIT-RESOLVE||Conventional Versus Intentional StraTegy in Lesions With High Risk PrEdiction of Side Branch OccLusion in InterVEntion|A Randomized Comparison of Conventional Versus Intentional StraTegy in Patients With High Risk PrEdiction of Side Branch OccLusion in Coronary Bifurcation InterVEntion: the CIT-RESOLVE Trial|Not yet recruiting||N/A|566|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t||||||||||2017-10-10 22:36:31.313835|2017-10-10 22:36:31.313835
NCT02644421|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-01-04|||November 2015||2015-11-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|LMR||Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica)|Phase Ib Randomized, Double-Blind, Latin Square Crossover, Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 v. Lidocaine v. Placebo in Lumbar Radiculopathy|Recruiting||Phase 1|18|Anticipated|Brigham and Women's Hospital||3|||f||||t||||||||No||2017-10-10 22:36:31.408533|2017-10-10 22:36:31.408533
NCT02644408|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-07-02|||October 2014||2014-10-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Megestrol Acetate on the Quality of Life of Patients With Esophageal Carcinoma|Two-arm Phase III Study of Effect of Megestrol Acetate on the Quality of Life of Patients With Esophageal Carcinoma in the Chemoradiotherapy|Recruiting||Phase 3|210|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology||2|||f||||t||||||||No||2017-10-10 22:36:31.506646|2017-10-10 22:36:31.506646
NCT02644395|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-06-15|||January 18, 2013|Actual|2013-01-18|June 2017|2017-06-01|December 19, 2016|Actual|2016-12-19|December 17, 2015|Actual|2015-12-17||Interventional|TT||Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus|Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus|Completed||Phase 3|49|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 22:36:31.632077|2017-10-10 22:36:31.632077
NCT02644382|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-03-22|||December 2015||2015-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Improving Surgical Decision-making in Young Women With Breast Cancer|Improving Surgical Decision-making in Young Women With Breast Cancer|Enrolling by invitation||N/A|80|Anticipated|Dana-Farber Cancer Institute|||3||f||||f||||||||||2017-10-10 22:36:31.707413|2017-10-10 22:36:31.707413
NCT02644369|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-12-09|||March 2016||2016-03-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|January 2021|Anticipated|2021-01-01||Interventional|INSPIRE||Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors|Investigator-initiated Phase II Study of Pembrolizumab Immunological Response Evaluation|Recruiting||Phase 2|100|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 22:36:31.790119|2017-10-10 22:36:31.790119
NCT02644356|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2017-01-30|2016-01-08||July 2011||2011-07-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CTPC||Complementary Therapies in Palliative Care|Palliative Care Provider Online Education in Evidence-Based Complementary Therapies|Completed||Phase 1|51|Actual|Collinge and Associates, Inc.||1|||f||||f||||||||||2017-10-10 22:36:31.899384|2017-10-10 22:36:31.899384
NCT02643251|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-08-23|2017-06-02||December 2015||2015-12-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy|A Multicenter, Randomized, Double Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1%, to Clonidine Hydrochloride Gel Comparator in the Management of Painful Diabetic Neuropathy|Completed||Phase 2|138|Actual|BioDelivery Sciences International||2|||f||||f||||||||||2017-10-10 22:36:32.173058|2017-10-10 22:36:32.173058
NCT02643238|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-30|||October 2011||2011-10-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Interventional|BrainPort||Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation|Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation|Recruiting||N/A|30|Anticipated|Akron Children's Hospital||2|||f||||f||||||||No||2017-10-10 22:36:32.653806|2017-10-10 22:36:32.653806
NCT02645539|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-07-05|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:36:32.736242|2017-10-10 22:36:32.736242
NCT02645526|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-01-17|||January 2016||2016-01-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Is a Woolen Cap Effective in Maintaining Normothermia in Preterm Infants During Kangaroo Mother Care?|Is a Woolen Cap Effective in Maintaining Normothermia in Preterm Infants During Kangaroo Mother Care?|Completed||Phase 4|300|Actual|University Hospital Padova||2|||f||||t||||||||No||2017-10-10 22:36:32.772897|2017-10-10 22:36:32.772897
NCT02645513|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2015-12-31|||January 2015||2015-01-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||Text Message Reminders to Health Workers on Malaria, Pneumonia, and Diarrhea Case Management in Malawi|The Effect of Mobile Phone Text Message Reminders on Health Workers' Adherence to Malaria and Other Disease Case Management Guidelines in Malawi|Active, not recruiting||N/A|182|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-10 22:36:32.842653|2017-10-10 22:36:32.842653
NCT02644577|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-30|||June 2012||2012-06-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients||Completed||Phase 4|110|Actual|China Medical University, China||2|||f||||t||||||||||2017-10-10 22:36:40.037949|2017-10-10 22:36:40.037949
NCT02645487|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2015-12-30|||December 2015||2015-12-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|SRS||Stereotactic Radiosurgery (SRS) for Brain Metastasis|A Phase I Dose-Escalation Study of Stereotactic Radiosurgery (SRS) for Brain Metastasis Without Whole Brain Radiation (WBRT)|Recruiting||Phase 1|180|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-10 22:36:33.014271|2017-10-10 22:36:33.014271
NCT02645474|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-07-13|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|October 31, 2019|Anticipated|2019-10-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Is PECS Block Equivalent to Paravertebral Block in Preventing Postoperative Pain After Breast Surgery?|Is PECS Block Equivalent to Paravertebral Block in Preventing Postoperative Pain After Breast Surgery? A Randomized, Controlled, Double-blind, Multicenter Trial|Not yet recruiting||Phase 4|86|Anticipated|Ospedale Regionale Bellinzona e Valli||2|||f||||t|f|f||||||||2017-10-10 22:36:33.102751|2017-10-10 22:36:33.102751
NCT02645448|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2015-12-30|||November 2014||2014-11-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Glycemic Responses and of the Autonomic Cardiac Function in Diabetes Type-2 Women Post Resistance Exercise|Glycemic Responses and of the Autonomic Cardiac Function in Diabetes Type-2 Women Post Resistance Exercise of Different Intensities|Completed||N/A|12|Actual|Universidade Federal do vale do São Francisco||2|||f||||t||||||||No||2017-10-10 22:36:33.418807|2017-10-10 22:36:33.418807
NCT02645435|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-31|||December 2015||2015-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Consequence of the Learning Curve in Direct Anterior Approach for Total Hip Replacement|Consequence of the Learning Curve in Direct Anterior Approach for Total Hip Replacement|Completed||Phase 4|69|Actual|Azienda Ospedaliera Bolognini di Seriate Bergamo||2|||f||||f||||||||||2017-10-10 22:36:33.509422|2017-10-10 22:36:33.509422
NCT02645422|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-02-22|||December 2015||2015-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|PeLi||Genetic Determinants and Clinical Consequences of Early-onset Severe Obesity|Genetic Determinants and Clinical Consequences of Early-onset Severe Obesity|Enrolling by invitation||N/A|400|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood, serum   "|No||2017-10-10 22:36:33.590358|2017-10-10 22:36:33.590358
NCT02645409|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-09-26|||December 29, 2015|Actual|2015-12-29|September 2017|2017-09-01|April 2, 2019|Anticipated|2019-04-02|April 2, 2018|Anticipated|2018-04-02||Interventional|||Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma|Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma|Recruiting||N/A|20|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 22:36:33.670757|2017-10-10 22:36:33.670757
NCT02645396|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-04-11|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Cohort Study of Cytomegalovirus（CMV） Infection Among Pregnant Women and Their Newborns in China|A Cohort Study of Cytomegalovirus（CMV） Infection Among Pregnant Women and Their Newborns in China|Recruiting||N/A|5000|Anticipated|Xiamen University|||1||f||||f||||||Samples With DNA|"     blood/urine samples of the pregnant women; saliva /urine samples of the newborns   "|||2017-10-10 22:36:33.780483|2017-10-10 22:36:33.780483
NCT02645383|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2015-12-30|||May 2014||2014-05-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|July 2014|Actual|2014-07-01||Interventional|||PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System|An Observational Prospective Study of Comparing Pain Responses With Pattern Laser Platform and Conventional Laser System During the Panretinal Photocoagulation in Proliferative Diabetic Retinopathy|Completed||N/A|30|Actual|Kocatepe University||2|||f||||f||||||||||2017-10-10 22:36:33.871815|2017-10-10 22:36:33.871815
NCT02645370|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2015-12-30|||February 2016||2016-02-01|December 2015|2015-12-01||||July 2017|Anticipated|2017-07-01||Interventional|||Efficacy and Safety of Danzhen|"Efficacy and Safety of Danzhen in the Preventive Treatment of Migraine:A Prospective Real-World Study."|Not yet recruiting||Phase 1|3300|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-10 22:36:33.983118|2017-10-10 22:36:33.983118
NCT02645357|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-02-08|||November 2015||2015-11-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|ONCO-CODES||Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer Patients|Effect on Professional Practice and Health Care Outcomes of Computerized Evidence-based Information System and Clinical Decision Support: A Randomized Controlled Trial in Orthopaedics (GR-2009-1606736)|Completed||N/A|15431|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||||2017-10-10 22:36:34.078494|2017-10-10 22:36:34.078494
NCT02645344|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-01-03|||June 2013||2013-06-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Repetitive Transcranial Magnetic Stimulation Combined With Sensory Cueing on Unilateral Neglect in Subacute Patients With Right Hemispheric Stroke|Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) Combined With Sensory Cueing (SC) on Unilateral Neglect in Subacute Patients With Right Hemispheric Stroke: A Randomized Controlled Study|Completed||N/A|60|Actual|The Hong Kong Polytechnic University||3|||f||||f||||||||No||2017-10-10 22:36:34.1606|2017-10-10 22:36:34.1606
NCT02645331|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-31|||February 2013||2013-02-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||"Remind to Move Treatment Versus Constraint-induced Movement Therapy for Children With Hemiplegic Cerebral Palsy"|"Remind to Move Treatment Versus Constraint-induced Movement Therapy for Children With Hemiplegic Cerebral Palsy: A Randomized Controlled Trial"|Completed||N/A|73|Actual|The Hong Kong Polytechnic University||3|||f||||f||||||||||2017-10-10 22:36:34.24173|2017-10-10 22:36:34.24173
NCT02645318|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2015-12-30|||May 2015||2015-05-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung Cancer|A Prospective Study of Circulating Tumor DNA Detection by Targeted Sequencing in Surgical Non-Small Cell Lung Cancer Patients|Completed||N/A|95|Actual|Peking University People's Hospital|||1||f||||t||||||Samples With DNA|"     Fresh tumor tissue, peripheral blood cells, and plasma samples were collected from each     patient.   "|||2017-10-10 22:36:34.318886|2017-10-10 22:36:34.318886
NCT02645305|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-30|||June 2015||2015-06-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease|Evaluation of Safety and Efficacy of Autologous Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Science Ho Chi Minh City||1|||f||||t||||||||No||2017-10-10 22:36:34.393249|2017-10-10 22:36:34.393249
NCT02645292|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2015-12-30|||October 2015||2015-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Comparison Between Stair Climbing and One Mile Walking in Relation to Cardiorespiratory Fitness|Comparison Between Stair Climbing and One Mile Walking in Relation to Cardiorespiratory Fitness|Completed||Phase 1|34|Actual|Universiti Tunku Abdul Rahman||2|||f||||f||||||||No|It is confidential|2017-10-10 22:36:34.487895|2017-10-10 22:36:34.487895
NCT02645279|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2015-12-31|||January 2015||2015-01-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Comparison of Oral 30 % Dextrose and iv Midazolam Sedation During MRI in Neonates|Comparison of Oral 30 % Dextrose and iv Midazolam Sedation During MRI in Neonates|Active, not recruiting||Phase 4|112|Actual|Baskent University||2|||f||||f||||||||||2017-10-10 22:36:34.562866|2017-10-10 22:36:34.562866
NCT02645266|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2015-12-30|||March 2016||2016-03-01|December 2015|2015-12-01||||August 2016|Anticipated|2016-08-01||Interventional|||Mean Visual Acuity Changes Following Five Injections of Aflibercept|Mean Visual Acuity Changes Following Five Injections of Aflibercept and the Relationship Between Ocular and Serum Cytokine Levels and Mean Visual Acuity Gains in DME Patients|Not yet recruiting||N/A|48|Anticipated|McMaster University||1|||f||||||||||||||2017-10-10 22:36:34.638603|2017-10-10 22:36:34.638603
NCT02645240|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-08-28|||October 2015||2015-10-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Predictive Factors of Intestinal Infraction in Acute Mesenteric Ischemia|Predictive Factors of Intestinal Infraction in Patients With Acute Mesenteric Ischemia|Completed||Phase 4|97|Actual|Mansoura University||1|||f||||t||||||||||2017-10-10 22:36:34.864276|2017-10-10 22:36:34.864276
NCT02645227|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-01|||January 2015||2015-01-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Platelet-rich Fibrin With 1.2% Rosuvastatin in Chronic Periodontitis Treatment|Platelet-rich Fibrin With 1.2% Rosuvastatin for the Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|90|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||f||||||||||2017-10-10 22:36:34.944906|2017-10-10 22:36:34.944906
NCT02645214|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-02-13|||June 2015||2015-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|ASCOT||Antiseptic Scrub Contamination and Transmission Trial|Antiseptic Scrub Contamination and Transmission Trial: A Randomized Controlled Trial to Evaluate the Impact of Antiseptic Scrubs on Bacterial Contamination.|Completed||N/A|40|Actual|Duke University||3|||f||||f||||||||No|Individual participant data will not be shared.|2017-10-10 22:36:35.0327|2017-10-10 22:36:35.0327
NCT02645201|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2017-08-18|||January 2016||2016-01-01|August 2017|2017-08-01|August 18, 2017|Anticipated|2017-08-18|August 18, 2017|Anticipated|2017-08-18||Interventional|Gastrus||The Effect of Probiotic Combination on Helicobacter Pylori Infection in Children|Effect of a Probiotic Combination (Gastrus®) on Adverse Effects of Therapy and on Eradication Rate of Helicobacter Pylori Infection in Children|Withdrawn||N/A|0|Actual|University Medical Centre Ljubljana||2||The research protocol was completely changed.|f||||f||||||||||2017-10-10 22:36:35.12399|2017-10-10 22:36:35.12399
NCT02645188|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-03-11|||December 2015||2015-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Cueing on Gluteus Maximus Recruitment|Effects of Cueing on Gluteus Maximus and Hamstring Recruitment During the Bridging Exercise|Completed||N/A|30|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:36:35.216579|2017-10-10 22:36:35.216579
NCT02645175|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-10-20|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue|A Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Safety Profile and Ability of TW1025 to Decrease Fatigue|Terminated||Phase 2|3|Actual|Meriyana Bio Inc.||2||Business Decision|f||||t||||||||Yes|Each study site has at least three monitors for the study and all of data will send to Data Center in DSG immediately for all study physicians reference.|2017-10-10 22:36:35.283425|2017-10-10 22:36:35.283425
NCT02645162|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2015-12-31|||December 2015||2015-12-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|LEAPS||Youth Leaders for Early Childhood Assuring Children Are Prepared for School|A Cluster Randomized Control Trial to Evaluate the Efficacy and Feasibility of a Community-based Preschool Programme and Community Engagement Strategy Led by Community Youth Leaders in Rural Pakistan|Recruiting||Phase 3|300|Anticipated|Aga Khan University||2|||f||||f||||||||Undecided||2017-10-10 22:36:35.381727|2017-10-10 22:36:35.381727
NCT02645149|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|MatchMel||Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma|Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma|Not yet recruiting||Phase 4|1000|Anticipated|Melanoma Institute Australia||3|||f||||t|f|f|||f|||||2017-10-10 22:36:35.480212|2017-10-10 22:36:35.480212
NCT02645136|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2015-12-30|||January 2014||2014-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||The Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence|The Effects of Pilates Method in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence: : a Randomized Control Trial|Completed||N/A|115|Actual|Universidade Estadual de Londrina||3|||f||||f||||||||Yes||2017-10-10 22:36:35.624658|2017-10-10 22:36:35.624658
NCT02645123|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-05-03|2016-05-12||December 2011||2011-12-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|SpinMob||Gait in Low Back Pain Patients After Spinal Mobilization|Gait Analysis of Chronic Low Back Pain Patients Before and After the Application of Spinal Mobilization|Completed||N/A|75|Actual|University of Ioannina||3|||f||||f||||||||Yes|individual participant's grade of disc degeneration has been shared as an appendix in an already published article: http://dx.doi.org/10.1080/10669817.2016.1184435. Please note that no more IPD will be shared.|2017-10-10 22:36:35.702975|2017-10-10 22:36:35.702975
NCT02645110|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2015-12-31|||January 2016||2016-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|March 2016|Anticipated|2016-03-01||Interventional|||Evaluation of Effectiveness and Mildness of Whole-natural Hand-wash Formulations|Openly, Controlled Interventional Trial for Evaluating the Effectiveness of Whole-natural Hand-wash Formulations in Bacterial Removal and Openly Randomized Trial for Estimating the Relative Mildness of the Formulations|Not yet recruiting||N/A|100|Anticipated|Mother's Choice Ltd||2|||f||||t||||||||Yes||2017-10-10 22:36:36.169087|2017-10-10 22:36:36.169087
NCT02645097|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-01-27|||July 2014||2014-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Ideal Anatomic Location for Saphenous Nerve Blocks: A Prospective Clinical Evaluation|Ideal Anatomic Location for Saphenous Nerve Blocks: A Prospective Clinical Evaluation|Completed||N/A|30|Actual|Milton S. Hershey Medical Center||2|||f||||f|f|f||||||No||2017-10-10 22:36:36.252738|2017-10-10 22:36:36.252738
NCT02645084|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-07-03|||February 2015||2015-02-01|July 2017|2017-07-01|October 30, 2016|Actual|2016-10-30|April 1, 2016|Actual|2016-04-01||Interventional|FR-QUENT||Identifying Patients With Hereditary and Familial Colorectal Cancer by Using an Online Risk Tool|Identifying the Risk of Hereditary and Familial Colorectal Cancer in Colorectal Cancer Patients by Using an Online Risk Tool: An Evaluation Based on a Stepped Wedge Design|Completed||N/A|104|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 22:36:36.335019|2017-10-10 22:36:36.335019
NCT02645071|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-30|||July 2015||2015-07-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Brief Program in Reducing Sedentary Behavior and Promoting Physical Exercise|FAMILY Project: Brief Program in Reducing Sedentary Behavior and Promoting Physical Exercise|Recruiting||N/A|400|Anticipated|The University of Hong Kong||1|||f||||t||||||||No||2017-10-10 22:36:36.413308|2017-10-10 22:36:36.413308
NCT02645058|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-12-31|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||RIRS Versus ESWL for the Treatment of Renal Stones|Retrograde Intrarenal Surgery (RIRS) Versus Extracorporeal Shock Waves Lithotripsy (ESWL) for the Treatment of Renal Stones Measuring 6-20 mm: A Prospective Randomized Study|Recruiting||N/A|150|Anticipated|University of Turin, Italy||2|||f||||t||||||||||2017-10-10 22:36:36.506667|2017-10-10 22:36:36.506667
NCT02645045|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-01-24|||December 11, 2015|Actual|2015-12-11|January 2017|2017-01-01|February 10, 2016|Actual|2016-02-10|February 10, 2016|Actual|2016-02-10||Observational|||Evaluation of Factors Affecting the Tear-film Lipid Layer Thickness||Completed||N/A|350|Actual|Yonsei University|||2||f||||t||||||||No|no plan to share IPD|2017-10-10 22:36:36.621339|2017-10-10 22:36:36.621339
NCT02645032|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-01-04|||April 2016||2016-04-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine|A Randomized, Observer-Blinded, Phase I Study to Assess the Safety and Immunogenicity of Vi-DT Conjugate Vaccine Compared to Vi-Polysaccharide (Typhim Vi®, Sanofi Pasteur) Typhoid Vaccine in Healthy Filipino Adults and Children|Not yet recruiting||Phase 1|144|Anticipated|International Vaccine Institute||2|||f||||f||||||||No||2017-10-10 22:36:36.807432|2017-10-10 22:36:36.807432
NCT02645006|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-31|||May 2015||2015-05-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|CTNF||Workshop for Primary Prevention of Falls. CHANGING TO NEVER FALL. CTNF|Effectiveness of an Intervention by a Health Education Workshop Compared With the Usual Advice to Reduce the Incidence of Falls in Independent 65 Years and Older Not Institutionalized. Primary Prevention.CHANGING TO NEVER FALL. CTNF|Recruiting||Phase 2|316|Anticipated|Sociedad Madrileña de Medicina de Familia y Comunitaria||2|||f||||t||||||||||2017-10-10 22:36:36.965719|2017-10-10 22:36:36.965719
NCT02644993|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-10-12|||November 2015||2015-11-01|October 2016|2016-10-01||||November 2025|Anticipated|2025-11-01||Interventional|||Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy||Recruiting||N/A|400|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:36:37.083888|2017-10-10 22:36:37.083888
NCT02644980|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-12-31|||December 2015||2015-12-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery|Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery,A Randomized Controlled Double-Blinded Study|Not yet recruiting||Phase 4|110|Anticipated|Xijing Hospital||2|||f||||f||||||||||2017-10-10 22:36:37.172705|2017-10-10 22:36:37.172705
NCT02644967|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-09-21|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination With Ipilimumab or Pembrolizumab in Patients With Metastatic Melanoma|A Phase 1/2 Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination With Ipilimumab or Pembrolizumab in Patients With Metastatic Melanoma|Recruiting||Phase 1/Phase 2|100|Anticipated|Idera Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 22:36:37.267145|2017-10-10 22:36:37.267145
NCT02644954|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-31|||January 2016||2016-01-01|December 2015|2015-12-01||||June 2016|Anticipated|2016-06-01||Interventional|||Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis|Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis: A Prospective Randomized Double Blind Controlled Study|Not yet recruiting||Phase 3|40|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 22:36:37.380603|2017-10-10 22:36:37.380603
NCT02644941|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-08-08|||May 24, 2016|Actual|2016-05-24|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis|An Assessment of Humacyte's Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison With ePTFE Grafts as Conduits for Hemodialysis (HUMANITY)|Recruiting||Phase 3|350|Anticipated|Humacyte, Inc.||2|||f||||t||||||||||2017-10-10 22:36:37.482193|2017-10-10 22:36:37.482193
NCT02644928|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-10-14|||March 2016||2016-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Weight Loss in Obese Kidney Disease Patients After Bariatric Surgery|Effects of Weight Loss on Renal Function in Obese Patients With Chronic Kidney Disease Undergoing Bariatric Surgery|Recruiting||N/A|22|Anticipated|Hospital Universitario 12 de Octubre|||1||f||||f||||||Samples Without DNA|"     In this study, blood and urine samples will be collected to determine the effect of weight     loss in proteinuria and renal function.   "|No||2017-10-10 22:36:37.653418|2017-10-10 22:36:37.653418
NCT02644915|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-30|||March 2016||2016-03-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|I/R||Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients|Effect of Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients: A Single-Center, Double-Blinded, Randomised Controlled Trial|Not yet recruiting||N/A|150|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-10 22:36:37.724548|2017-10-10 22:36:37.724548
NCT02644902|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-02-23|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|THP-TACTS||Technology Assisted Cascade Training and Supervision of Community Health Workers for Thinking Healthy Programme|Effectiveness of Technology Assisted Cascade Training and Supervision of Community Health Workers in Delivering Thinking Healthy Program for Perinatal Depression in a Post-conflict Area of Pakistan- Protocol of a Randomized Controlled Trial|Completed||N/A|80|Actual|Human Development Research Foundation, Pakistan||2|||f||||t||||||||No||2017-10-10 22:36:37.81758|2017-10-10 22:36:37.81758
NCT02644889|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-01-06|||January 2016||2016-01-01|November 2015|2015-11-01||||November 2018|Anticipated|2018-11-01||Observational|||EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment|Epidermal Growth Factor Receptor (EGFR) Mutation Detection From Advanced Non-small Cell Lung Cancer Tissue and Plasma in Tyrosine Kinase Inhibitor (TKI) Treatment|Not yet recruiting||N/A|100|Anticipated|GenoSaber|||1||f||||f||||||||||2017-10-10 22:36:37.888119|2017-10-10 22:36:37.888119
NCT02644876|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-09-14|||September 1, 2015|Actual|2015-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications|Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications in High-risk Patients: a Randomized, Double-blind, and Placebo Controlled Study|Recruiting||Phase 4|864|Anticipated|Peking University First Hospital||2|||f||||t|f|f||||||||2017-10-10 22:36:37.942916|2017-10-10 22:36:37.942916
NCT02644863|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-05-23|||December 2015||2015-12-01|December 2015|2015-12-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer|Phase II Clinical Study of Patients Randomized, Open, Controlled Evaluation of Autologous Tumor Tissue Antigen Sensitized DC-CIK Cells Combined With Chemotherapy in the Treatment of Patients With Esophageal Resection|Recruiting||Phase 2|60|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||2|||f||||f||||||||Undecided||2017-10-10 22:36:38.053803|2017-10-10 22:36:38.053803
NCT02644850|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-30|||October 2015||2015-10-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01|3 Years|Observational [Patient Registry]|||Comparison of Gated Blood-pool SPECT and Echocardiogram for Ventricular Function|Comparison of Gated Blood-pool SPECT Using CZT Camera and Echocardiogram for Ventricular Ejection Fraction Estimation|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||No||2017-10-10 22:36:38.145267|2017-10-10 22:36:38.145267
NCT02644837|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||AuraGain and iGel Crossover Comparison|Randomised Crossover Comparison of the Ambu AuraGain and the iGel in Anaesthetised Adults|Recruiting||N/A|46|Anticipated|NHS Tayside||2|||f||||t||||||||No||2017-10-10 22:36:38.214965|2017-10-10 22:36:38.214965
NCT02644824|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-04-25|||July 2012||2012-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Biventricular Pacing in Children With Congenital Heart Disease|Biventricular Pacing in Children With Wide QRS After Surgery for Congenital Heart Disease|Recruiting||N/A|72|Anticipated|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-10 22:36:38.319479|2017-10-10 22:36:38.319479
NCT02644811|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-19|||November 2009|Actual|2009-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Miniscrews as Anchorage Device for Orthodontic Treatment|Miniscrews as Anchorage Device for Orthodontic Treatment - Randomized Controlled Trials on Anchorage Capacity, Cost Efficiency and Patient Acceptance|Active, not recruiting||N/A|80|Actual|Region Gävleborg||2|||f||||f||||||||||2017-10-10 22:36:38.405992|2017-10-10 22:36:38.405992
NCT02644798|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-12-31|||April 2015||2015-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Gene Polymorphism in ARDS|The Role of Polymorphism in Prognosis of Acute Respiratory Distress Syndrome (ARDS)and Phenotype Patients to Guide Therapy|Recruiting||N/A|400|Anticipated|Southeast University, China|||1||f||||f||||||Samples With DNA|"     Peripheral blood   "|Undecided||2017-10-10 22:36:38.514985|2017-10-10 22:36:38.514985
NCT02644785|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-03-21|||January 2016|Actual|2016-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Serum Tryptase Levels During Cardiac Surgery, Diagnosis and Treatment Decisions for Allergic Reactions|Investigation of Anaphylactic Reaction in Cases Undergoing Cardiac By-Pass Surgery|Completed||N/A|30|Actual|Mustafa Kemal University|||1||f||||t||||||||No||2017-10-10 22:36:38.585019|2017-10-10 22:36:38.585019
NCT02644772|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-01-31|||October 2015|Actual|2015-10-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|INCA R-ACE||Preventing Repeat Hospitalisations in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Risk Factors for Re-exacerbation After a Chronic Obstructive Pulmonary Disease (COPD) Exacerbation|Recruiting||N/A|250|Anticipated|Beaumont Hospital|||1||f||||f||||||||||2017-10-10 22:36:38.664159|2017-10-10 22:36:38.664159
NCT02644759|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-03-01|||February 2014||2014-02-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus|Efficacy and Safety of Transplantation of Autologous Stem Cells Into Pancreatic Artery, Combined With Immunomodulation for the Treatment of Type 1 Diabetes Mellitus|Recruiting||Phase 1/Phase 2|100|Anticipated|Stem Cells Arabia||1|||f||||f||||||||||2017-10-10 22:36:38.757597|2017-10-10 22:36:38.757597
NCT02644746|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2016-12-04|||March 2016||2016-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy and Safety of Acupuncture for Degenerative Lumbar Spinal Stenosis|Efficacy and Safety of Acupuncture for Degenerative Lumbar Spinal Stenosis: Protocol for a Randomized Placebo-controlled Trial|Recruiting||N/A|80|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||Undecided|Individual participant data (IPD) will be preserved, when the paper submitted, if the journal ask IPD, it will be uploaded as a supplement.|2017-10-10 22:36:38.845288|2017-10-10 22:36:38.845288
NCT02644733|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2017-02-06|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|Ghada||Effect of Different Body Position on Intraabdominal Pressure in Mechanically Ventilated Patients|Lecturer in Critical Care Nursing Department|Recruiting||N/A|60|Anticipated|Assiut University|||1||f||||t||||||||Yes|the patient's assessment sheet will be used to collect the data by the researcher|2017-10-10 22:36:38.929288|2017-10-10 22:36:38.929288
NCT02644720|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2015-12-31|||January 2014||2014-01-01|December 2015|2015-12-01|January 2019||2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Neural Compensation, Visual Function and Visual Quality After Monofocal or Multifocal Intraocular Lens Implantation|Neural Compensation, Visual Function and Visual Quality in Senile Cataract Patients After Monofocal or Multifocal Intraocular Lens Implantation|Recruiting||N/A|50|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:36:39.016788|2017-10-10 22:36:39.016788
NCT02644707|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-30|||March 2015||2015-03-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|THYROSEL||Selenium Supplementation in Youths With Autoimmune Thyroiditis|L-selenomethionine Supplementation in Children and Adolescents With Autoimmune Thyroiditis: a Randomized Blind Placebo-controlled Clinical Trial|Recruiting||Phase 4|100|Anticipated|Aristotle University Of Thessaloniki||2|||f||||f||||||||No||2017-10-10 22:36:39.12358|2017-10-10 22:36:39.12358
NCT02644694|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-02-06|||March 2016||2016-03-01|June 2016|2016-06-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy|A Prospective, Multi-Center, Single-Dose, Phase 1 Clinical Trial Designed to Evaluate the Pharmacokinetics of Dexamethasone Phosphate Ophthalmic Solution Delivered Via the EyeGate® II Drug Delivery System in Patients Undergoing Vitrectomy for Macular Hole Repair or Epiretinal Membrane Peeling|Completed||Phase 1|10|Actual|Eyegate Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:36:39.225961|2017-10-10 22:36:39.225961
NCT02644681|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-10-04|||February 2016||2016-02-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01|2 Years|Observational [Patient Registry]|NIMAS||Neurophysiological Intraoperative Monitoring During Aortic Surgery|Neurophysiological Intraoperative Monitoring During Aortic Surgery|Recruiting||N/A|100|Anticipated|Scientific Institute San Raffaele|||1||f||||f||||||||||2017-10-10 22:36:39.295889|2017-10-10 22:36:39.295889
NCT02644668|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-08-17|||December 2015||2015-12-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of CK-2127107 in Patients With Spinal Muscular Atrophy|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients With Spinal Muscular Atrophy (SMA)|Recruiting||Phase 2|72|Anticipated|Cytokinetics||4|||f||||t||||||||||2017-10-10 22:36:39.365496|2017-10-10 22:36:39.365496
NCT02644655|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2015-12-31|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Immunotherapy Using Autologous T Cell-Engineered With CD19-specific Chimeric Antigen Receptor for the Treatment of Recurrent /Refractory B Cell Leukemia|A Clinical Study Using Autologous T Cell Engineered With Chimeric Antigen Receptor Targeting to CD19（Cluster of Differentiation Antigen 19) in Treating Patients With Recurrent /Refractory B Cell Leukemia|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Second Military Medical University||1|||f||||||||||||||2017-10-10 22:36:39.52034|2017-10-10 22:36:39.52034
NCT02644642|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2015-12-30|||January 2016||2016-01-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Utility of Disconnection Technique for One Lung Ventilation|Utility of Disconnection Technique for One Lung Ventilation: a Comparison of a Double Lumen Endobronchial Tube With a Bronchial Blocker|Not yet recruiting||N/A|38|Anticipated|Ajou University School of Medicine||2|||f||||f||||||||||2017-10-10 22:36:39.616888|2017-10-10 22:36:39.616888
NCT02644629|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2016-08-13|||April 2016||2016-04-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Intra-nasal vs. Intra-venous Ketamine Administration|Intra-nasal vs. Intra-venous Ketamine Administration as an add-on to Antidepressant Therapy|Recruiting||Phase 4|60|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-10 22:36:39.686604|2017-10-10 22:36:39.686604
NCT02644603|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-06-24|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer|Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer: a Multicenter, Randomized, Controlled Clinical Study|Active, not recruiting||N/A|214|Actual|Shanghai Zhongshan Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:36:39.856939|2017-10-10 22:36:39.856939
NCT02644590|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2015-12-30|||February 2016||2016-02-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|||The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1|The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1|Not yet recruiting||Early Phase 1|30|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 22:36:39.961318|2017-10-10 22:36:39.961318
NCT02644564|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2016-12-06|||September 2015||2015-09-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Early Clinical Examination and Ultrasonography Screening of Acute Soft Tissue Shoulder Injuries|Early Clinical Examination and Ultrasonography Screening of Acute Soft Tissue Shoulder Injuries|Active, not recruiting||N/A|120|Anticipated|Oslo University Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:36:40.113649|2017-10-10 22:36:40.113649
NCT02644551|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-04-24|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis|The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis: a Phase 2, Randomized, Double-blind Study|Recruiting||Phase 2|120|Anticipated|9305-9954 Quebec Inc||3|||f||||f||||||||Undecided||2017-10-10 22:36:40.184415|2017-10-10 22:36:40.184415
NCT02644538|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2015-12-30|||December 2015||2015-12-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides|A Randomized, Controlled, Open-label, Multicenter Clinical Trial to Evaluate the Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides|Not yet recruiting||Phase 4|196|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||Undecided|still undecided|2017-10-10 22:36:40.270094|2017-10-10 22:36:40.270094
NCT02644525|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-31|2017-06-30|||December 21, 2015||2015-12-21|December 13, 2016|2016-12-13|November 1, 2019|Anticipated|2019-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa|A Double-Blinded, Randomized, Placebo-Controlled Dose Escalation Study to Examine the Microfilaricidal Kinetics and Safety of Imatinib for the Treatment of Loa Loa|Not yet recruiting||Phase 2|200|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:36:40.346642|2017-10-10 22:36:40.346642
NCT02644499|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-03-03||||||March 2017|2017-03-01|February 27, 2017|Actual|2017-02-27|November 17, 2016|Actual|2016-11-17||Interventional|||Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis|Comparison of Combination Disease Modifying Antirheumatic Drugs (DMARDs) With Single Drug (Methotrexate) Therapy in Early Rheumatoid Arthritis|Completed||Phase 4|186|Actual|Jawaharlal Institute of Postgraduate Medical Education & Research||2|||f||||f||||||||No||2017-10-10 22:36:40.4303|2017-10-10 22:36:40.4303
NCT02644486|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-08-09|||January 2016||2016-01-01|August 2016|2016-08-01||||March 2018|Anticipated|2018-03-01||Interventional|||A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy||Recruiting||N/A|99|Anticipated|Nanjing University School of Medicine||3|||f||||||||||||||2017-10-10 22:36:40.634018|2017-10-10 22:36:40.634018
NCT02644473|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-01-22|||February 2016||2016-02-01|December 2015|2015-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients||Not yet recruiting||Phase 4|1400|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-10 22:36:40.769306|2017-10-10 22:36:40.769306
NCT02644460|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-07-14|||February 2016||2016-02-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|AflacST1501||Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors|Abemaciclib in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma, and in Children With Recurrent and Refractory Solid Tumors Including Malignant Brain Tumors|Recruiting||Phase 1|50|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 22:36:40.899437|2017-10-10 22:36:40.899437
NCT02644447|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-07-25|||October 2015||2015-10-01|December 2015|2015-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF|The Safety and Efficacy Assessment of Human Umbilical Cord-derived Mesenchymal Stem Cells (HUC-MSCs) With Injectable Collagen Scaffold Transplantation in Woman With Premature Ovarian Failure (POF)|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Chinese Academy of Sciences||2|||f||||t||||||||||2017-10-10 22:36:41.077835|2017-10-10 22:36:41.077835
NCT02644343|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-07-18|||January 2016||2016-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:36:41.22135|2017-10-10 22:36:41.22135
NCT02644330|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2015-12-30|||October 2015||2015-10-01|December 2015|2015-12-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect|A Randomized Controlled Trial of Minimally Invasive Transthoracic Device Closure in the Treatment of Patients With Perimembranous Ventricular Septal Defect|Recruiting||Phase 2/Phase 3|100|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-10 22:36:41.290248|2017-10-10 22:36:41.290248
NCT02644317|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-30|||December 2015||2015-12-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Balance Influence of Shoe Inserts on Motor Development Delayed Children|Chung Shan Medical University Hospital Institutional Review Board|Enrolling by invitation||N/A|100|Anticipated|Chung Shan Medical University||2|||f||||f||||||||||2017-10-10 22:36:41.418057|2017-10-10 22:36:41.418057
NCT02644304|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-06-28|||May 2015||2015-05-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome|Clomiphene Citrate Plus Cabergoline Versus Clomiphene Citrate Alone in Treatment of Polycystic Ovary Syndrome Associated Infertility|Recruiting||Phase 2|88|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-10 22:36:41.532798|2017-10-10 22:36:41.532798
NCT02644291|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2017-05-31|||May 2016||2016-05-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors|Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors|Recruiting||Phase 1|21|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||Undecided|A peer reviewed publication in a medical journal with the results from the study is planned upon completion of the study,that may/may not have data from individual participants compliant with HIPPA protection.|2017-10-10 22:36:41.669986|2017-10-10 22:36:41.669986
NCT02641457|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-28|||March 2014||2014-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis|Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis|Completed||Phase 3|2|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-10-10 22:37:20.827552|2017-10-10 22:37:20.827552
NCT02644278|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-03-22|||February 2016||2016-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy|An Open-Label, Phase 1, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|90|Anticipated|Vertex Pharmaceuticals Incorporated||1|||f||||||||||||||2017-10-10 22:36:41.861762|2017-10-10 22:36:41.861762
NCT02644265|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2017-04-29|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01|1 Year|Observational [Patient Registry]|CONNECT-ME||CONNECT-ME: Consciousness in Neurocritical Care Cohort Study Using fMRI and EEG|CONNECT-ME: CONsciousness in NEurocritical Care cohorT Study Using fMRI and EEG|Recruiting||N/A|100|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||Samples With DNA|"     Blood (serum), cerebrospinal fluid   "|||2017-10-10 22:36:42.07149|2017-10-10 22:36:42.07149
NCT02644252|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-08-03|||January 2016||2016-01-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|Toco-Pulm||Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer|Tocotrienol as a Nutritional Supplement in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 3|190|Anticipated|Vejle Hospital||4|||f||||t||||||||||2017-10-10 22:36:42.209788|2017-10-10 22:36:42.209788
NCT02644239|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-12-28|||June 2012||2012-06-01|December 2015|2015-12-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|Ketonutri||Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy|Classic Ketogenic Diet and Modified: Evaluation of the Therapeutic Potential and Impact on the Oxidative Profile, Lipidomic, Inflammatory and Size of Lipoproteins in Children and Adolescents With Refractory Epilepsy|Recruiting||N/A|60|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:36:42.363533|2017-10-10 22:36:42.363533
NCT02644226|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-05-17|||November 2015||2015-11-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Laryngeal Mask Airway (LMA) Complication in Children|Retrospective Investigation of Perioperative Upper Airway Complications After Anesthesia Using Supraglottic Airway Devices in Children: Comparison of Desflurane and Sevoflurane|Completed||N/A|3528|Actual|Seoul National University Bundang Hospital|||2||f||||f||||||||No||2017-10-10 22:36:42.542815|2017-10-10 22:36:42.542815
NCT02644213|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-29|||January 2016||2016-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Evaluation of Physical and Cognitive Performance After Simulated Road March Combines Physical and Cognitive Load Using a Virtual Reality Environment|Evaluation of Physical and Cognitive Performance After Simulated Road March Combines Physical and Cognitive Load Using a Virtual Reality Environment|Not yet recruiting||N/A|12|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 22:36:42.659275|2017-10-10 22:36:42.659275
NCT02644200|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-28|||June 2013||2013-06-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|GT||Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis|Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis: a Prospective, Randomized, Single-blind Controlled Clinical Trial|Completed||Phase 3|60|Actual|University of Roma La Sapienza||2|||f||||f||||||||No||2017-10-10 22:36:42.795168|2017-10-10 22:36:42.795168
NCT02644187|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-09|||December 2015||2015-12-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol|Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol|Completed||N/A|30|Anticipated|Vastra Gotaland Region||4|||f||||t||||||||||2017-10-10 22:36:42.950276|2017-10-10 22:36:42.950276
NCT02644174|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-04-11|||May 2016||2016-05-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||The Impact of Bariatric Surgery Induced Weight Loss on Lung Function in Adolescents|The Impact of Bariatric Surgery Induced Weight Loss on Lung Function in Adolescents|Recruiting||N/A|60|Anticipated|Rabin Medical Center|||1||f||||f||||||||Yes|Peer reviewed journal|2017-10-10 22:36:43.085683|2017-10-10 22:36:43.085683
NCT02644161|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-09-04|||October 2015||2015-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|PSD2||Can Acupuncture Treat Post-stroke Depression?|A Multisite, Assessor-blinded, Randomized Controlled Trial of Acupuncture for Post-stroke Depression|Recruiting||N/A|138|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:36:43.2389|2017-10-10 22:36:43.2389
NCT02644148|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2016-08-10|||February 2016||2016-02-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients|The Effect of Uncut Roux-en-Y Gastrojejunostomy on Quality of Life After Laparoscopic Distal Gastrectomy for Early Gastric Cancer Patients|Recruiting||Phase 2|150|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||Yes|Data will be open access.|2017-10-10 22:36:43.446103|2017-10-10 22:36:43.446103
NCT02644122|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-12-12|||November 2016||2016-11-01|December 2016|2016-12-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Interventional|||SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes|A Phase II Open Label Study of the PI3 Kinase (PI-3) Inhibitor, SF1126, in Patients With Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes|Recruiting||Phase 2|29|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-10 22:36:43.728404|2017-10-10 22:36:43.728404
NCT02644109|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-08-01|2016-06-21||October 2015||2015-10-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|ACTICOL||Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols|Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols In Chilean Subjects With Hypercholesterolemia|Completed||Phase 4|52|Actual|University of Chile||2|||f||||f||||||||No||2017-10-10 22:36:43.85497|2017-10-10 22:36:43.85497
NCT02644096|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-07-12|2016-01-15||September 2004||2004-09-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|September 2007|Actual|2007-09-01||Interventional|Rehab-THR||Rehabilitation of Patients After THR - Based on Patients´Selfrated Health|Rehabilitation of Patients Aged 65 and Over After Total Hip Replacement - Based on Patients´Health Status|Completed||Phase 1|175|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-10 22:36:44.227117|2017-10-10 22:36:44.227117
NCT02644083|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-09-26|||February 2016||2016-02-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Tecfidera and MRI for Brain Energy in MS|Modulation of Cerebral Grey Matter High Energy Phosphate Metabolites in Multiple Sclerosis by Dimethyl Fumarate|Recruiting||N/A|21|Anticipated|Oregon Health and Science University|||1||f||||t||||||||||2017-10-10 22:36:44.495595|2017-10-10 22:36:44.495595
NCT02644070|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-28|||June 2011||2011-06-01|December 2015|2015-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||mp3 vs Apatos in Post-extractive Sockets|A Prospective Randomized-controlled Multicenter Clinical and Histological Study of Extraction Site Augmentation With mp3 vs. Apatos|Completed||N/A|30|Actual|Tuscan Dental Institute||3|||f||||f||||||||||2017-10-10 22:36:44.575132|2017-10-10 22:36:44.575132
NCT02644057|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-03-11|||March 2016||2016-03-01|March 2016|2016-03-01||||September 2016|Anticipated|2016-09-01||Interventional|DOMICAS||Dobutamaine Versus Milrinone in Cardiorenal Syndrome|Comparison of Dobutamine Versus Milrinone for Renal Recovery in Patients With Cardiorenal Syndrome-A Prospective Cohort Study in Patients With Acute Decompensated Heart Failure|Recruiting||Phase 2|78|Anticipated|Maimonides Medical Center||2|||f||||f||||||||||2017-10-10 22:36:44.661114|2017-10-10 22:36:44.661114
NCT02644044|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-12-28|||January 2016||2016-01-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|ITMTXPMS||Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study|Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study|Not yet recruiting||Early Phase 1|30|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||||2017-10-10 22:36:44.766267|2017-10-10 22:36:44.766267
NCT02644031|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-29|||December 2015||2015-12-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||Evaluation of Post-endodontic Pain After Root Canal Treatment With Two Rotary Systems : Mtwo & Safe-sider|Evaluation of Post-endodontic Pain After Root Canal Treatment With Two Rotary Systems : Mtwo & Safe-sider|Recruiting||N/A|150|Anticipated|Zahedan University of Medical Sciences||3|||f||||t||||||||Undecided||2017-10-10 22:36:44.844085|2017-10-10 22:36:44.844085
NCT02644018|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-06-07|||January 2016||2016-01-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ACCORD||Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.|Double Blind Randomized Placebo-controlled Multicenter Study to Evaluate Clinical Efficacy and Safety of Ingavirin®, Capsules 30 mg, in 3-6 Years Old Patients With Influenza and Other Acute Respiratory Viral Infections in the Course of Standard Therapy|Completed||Phase 3|190|Actual|Valenta Pharm JSC||2|||f||||f||||||||No||2017-10-10 22:36:44.936883|2017-10-10 22:36:44.936883
NCT02644005|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-08-22|||July 7, 2017|Actual|2017-07-07|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|December 31, 2017|Anticipated|2017-12-31||Observational|AVAS||Automated Control of Mechanical Ventilation During General Anaesthesia|Automated Control of Mechanical Ventilation During General Anaesthesia - A Bicentric Prospective Observational Trial|Recruiting||N/A|100|Anticipated|University of Schleswig-Holstein|||1||f||||f||||||||||2017-10-10 22:36:45.123136|2017-10-10 22:36:45.123136
NCT02643992|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-30|2017-02-03|||June 2013||2013-06-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|CORIDA||Per-procedural Concentration of Direct Oral Anticoagulants||Completed||N/A|270|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||||||||||||2017-10-10 22:36:45.229493|2017-10-10 22:36:45.229493
NCT02643979|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-11|||December 2015||2015-12-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy|Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy|Recruiting||Phase 4|100|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 22:36:45.301103|2017-10-10 22:36:45.301103
NCT02643966|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-01-25|||December 2015||2015-12-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|DBTUST||Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT|"Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT (Also Known as DBTUST-Dense Breast Tomosynthesis / Ultrasound Screening Trial)"|Recruiting||N/A|6200|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 22:36:45.440411|2017-10-10 22:36:45.440411
NCT02643953|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2015-12-30|||January 2016||2016-01-01|December 2015|2015-12-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Increasing Women's Access to Skilled Pregnancy Care to Reduce Maternal Mortality in Nigeria|Increasing Women's Access to Skilled Pregnancy Care to Reduce Maternal and Perinatal Mortality in Nigeria: A Randomized Control Trial|Not yet recruiting||N/A|100|Anticipated|University of Ottawa||2|||f||||t||||||||Undecided||2017-10-10 22:36:45.557313|2017-10-10 22:36:45.557313
NCT02643940|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-08-08|||October 2015||2015-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|IMPACT-CTO||The Physiological Impact of CTO PCI on Coronary Pressure Measurements and Correlation in Donor Vessel|The Physiological IMPACT of Coronary Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) on Coronary Pressure -‐Derived Measurements, Its Correlation in the Donor Vessel and the Influence of Collateral Circulation|Recruiting||N/A|42|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust|||1||f||||f||||||Samples Without DNA|"     Blood samples (standard care no extra samples collected)   "|||2017-10-10 22:36:45.666717|2017-10-10 22:36:45.666717
NCT02643927|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-31|||February 2013||2013-02-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy of 8 vs 4 Sessions Mindfulness-based Programs in a Non-clinical Population|Efficacy of 8 vs 4 Sessions Mindfulness-based Programs in a Non-clinical Population: a Controlled Study|Completed||Early Phase 1|99|Actual|Hospital Miguel Servet||3|||f||||f||||||||Undecided||2017-10-10 22:36:45.809083|2017-10-10 22:36:45.809083
NCT02643914|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-06-29|||September 2015||2015-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings|Using Control Systems to Predict Individualized Dynamics of Nicotine Cravings|Active, not recruiting||N/A|23|Actual|Stony Brook University||1|||f||||f||||||||||2017-10-10 22:36:45.89946|2017-10-10 22:36:45.89946
NCT02643901|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-08-15|||September 2015||2015-09-01|September 2016|2016-09-01|October 10, 2016|Actual|2016-10-10|October 10, 2016|Actual|2016-10-10||Interventional|||Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects|The Single-Dose Tolerability and PK/PD Study of Recombinant (Expressed by Pichia Pastoris) Human Serum Albumin/Human Granulocyte-Colony Stimulating Factor(I) Fusion Protein for Injection (GW003) in Healthy Subjects|Completed||Phase 1|26|Actual|Jiangsu T-Mab Biopharma Co.,Ltd||5|||f||||f||||||||||2017-10-10 22:36:46.030472|2017-10-10 22:36:46.030472
NCT02643875|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-06-20|||February 26, 2016|Actual|2016-02-26|June 2017|2017-06-01|November 18, 2016|Actual|2016-11-18|November 18, 2016|Actual|2016-11-18||Interventional|||Investigation of the Effect of Short-term Orthokeratology With Increased Compression Factor on Ocular Parameters|Investigation of the Effect of Short-term Orthokeratology With Increased Compression Factor on Ocular Parameters|Completed||N/A|39|Actual|The Hong Kong Polytechnic University||2|||f||||||||||||||2017-10-10 22:36:47.891463|2017-10-10 22:36:47.891463
NCT02643849|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-10-03|||August 2016|Actual|2016-08-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men|Use of The Spanner® Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men Unfit for Other Treatments|Recruiting||N/A|105|Anticipated|SRS Medical||1|||f||||f||||||||||2017-10-10 22:36:48.126919|2017-10-10 22:36:48.126919
NCT02643836|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-08-10|||January 2017||2017-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|PEMF||Pulsed Electromagnetic Field (PEMF) Therapy for Post-Concussive Syndrome|Pulsed Electromagnetic Field (PEMF) Therapy for Post-Concussive Syndrome|Not yet recruiting||Phase 2|76|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||t||||||||||2017-10-10 22:36:48.245909|2017-10-10 22:36:48.245909
NCT02643823|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-05-23|||January 2016||2016-01-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis|Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis|Recruiting||Phase 1|40|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||2|||f||||t||||||||Undecided||2017-10-10 22:36:48.351801|2017-10-10 22:36:48.351801
NCT02643810|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-03-05|||June 2015||2015-06-01|March 2017|2017-03-01|March 5, 2017|Actual|2017-03-05|March 5, 2017|Actual|2017-03-05||Interventional|||Exercise Training in Adults With Corrected Tetralogy of Fallot|Influence of Different Types of Exercise Training on Selected Cardiovascular Parameters in Adult Individuals With Corrected Tetralogy of Fallot|Completed||N/A|27|Actual|University Medical Centre Ljubljana||3|||f||||||||||||||2017-10-10 22:36:48.485321|2017-10-10 22:36:48.485321
NCT02643797|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-10-12|||February 2016||2016-02-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|MAC||Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings|Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings|Enrolling by invitation||N/A|600|Anticipated|Scripps Whittier Diabetes Institute||2|||f||||t||||||||||2017-10-10 22:36:48.640356|2017-10-10 22:36:48.640356
NCT02643784|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-28|||December 2015||2015-12-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|AIS||Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke|Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke|Not yet recruiting||Phase 4|100|Anticipated|RenJi Hospital||2|||f||||t||||||||Yes||2017-10-10 22:36:48.743278|2017-10-10 22:36:48.743278
NCT02643771|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2015-12-30|||January 2013||2013-01-01|December 2015|2015-12-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Clinical and Microbiological Evaluation of Periodontal Treatment of Diabetic Patients: A Longitudinal Study|Clinical and Microbiological Evaluation of Non-surgical Periodontal Treatment of Diabetic and Non-diabetic Patients: A Longitudinal Study|Recruiting||Phase 2|144|Anticipated|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||No||2017-10-10 22:36:48.823654|2017-10-10 22:36:48.823654
NCT02643758|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-06-14|||January 25, 2016|Actual|2016-01-25|June 2017|2017-06-01|February 28, 2019|Anticipated|2019-02-28|January 30, 2019|Anticipated|2019-01-30||Interventional|||Myopia Control Using Soft Bifocal Lenses|Randomised Clinical Trial: Myopia Control Using Soft Bifocal Lenses|Active, not recruiting||N/A|109|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||||2017-10-10 22:36:49.074681|2017-10-10 22:36:49.074681
NCT02643745|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-01-02|||February 2015||2015-02-01|January 2016|2016-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|AKIIcor||Nephrologic Intervention in Patients Waiting for Cardiac Surgery|Nephrologic Intervention in Patients Waiting for Cardiac Surgery|Recruiting||N/A|1100|Anticipated|Hospital Universitari de Bellvitge||2|||f||||f||||||||||2017-10-10 22:36:49.190123|2017-10-10 22:36:49.190123
NCT02643732|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-01-10|||November 2016||2016-11-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|FaST-MP||Fatigue in Sarcoidosis - Treatment With Methylphenidate|Fatigue in Sarcoidosis - A Feasibility Study Investigating the Treatment of Fatigue in Stable Sarcoidosis Patients Using Methylphenidate|Recruiting||N/A|30|Anticipated|University of East Anglia||2|||f||||t||||||||Yes|Plan for anonymised data to be available through data repository for analysis by other researchers with permission of team.|2017-10-10 22:36:49.305406|2017-10-10 22:36:49.305406
NCT02643719|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2016-12-02|||December 2015||2015-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Migraine Treatment in ED|Evaluation of a Behavioral Program for Migraineurs in the Emergency Department.|Recruiting||N/A|100|Anticipated|New York University School of Medicine||4|||f||||t||||||||||2017-10-10 22:36:49.442556|2017-10-10 22:36:49.442556
NCT02643706|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2015-12-28|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|REACTION||Relationship Between ALDH2 and CIN|Relationship Between the Gene Polymorphism of Aldehyde Dehydrogenase 2 and Contrast Induced Nephropathy|Recruiting||N/A|500|Anticipated|Qilu Hospital of Shandong University|||2||f||||f||||||Samples With DNA|"     5 ml vein blood samples were collected from peripheral vein before coronary angiography or     percutaneous coronary intervention.The blood is used to detecte the renal function , the     genotype of aldehyde dehydrogenase 2 and aldehyde dehydrogenase activity. Another 5 ml vein     blood samples were collected from peripheral vein to detecte the renal function 24-72 hours     after the surgery. The samples would be centrifuged and saved in a -80℃ ultra-low temperature     refrigerator.   "|||2017-10-10 22:36:49.559557|2017-10-10 22:36:49.559557
NCT02643693|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-09-27|||December 2015||2015-12-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|||User Acceptability of P3L|User Acceptability of a Nicotine Lactate Delivery System Relative to the VUSE e-Cigarette System and Combustible Cigarette Comparators|Completed||N/A|24|Actual|Philip Morris Products S.A.||6|||f||||f||||||||No||2017-10-10 22:36:49.642651|2017-10-10 22:36:49.642651
NCT02643680|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-11-01|||November 2015||2015-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|||Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites|Clinical Efficacy of the Novel Biocellulose Wound Dressing Containing Silk Sericin and Polyhexamethylene Biguanide for Split-thickness Skin Graft Donor Sites|Recruiting||Phase 2|32|Anticipated|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 22:36:49.754594|2017-10-10 22:36:49.754594
NCT02643667|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-06-06|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer|A Phase 1/2 Study of Ibrutinib as Neoadjuvant Therapy in Patients With Localized Prostate Cancer|Recruiting||Phase 1/Phase 2|36|Anticipated|University of California, San Francisco||3|||f||||t||||||||Undecided||2017-10-10 22:36:49.865025|2017-10-10 22:36:49.865025
NCT02643654|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-02-27|||December 2015||2015-12-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB|A Double-blind, Randomised, Placebo-controlled Clinical Trial of the Efficacy of MABp1, a- First-in-class True Human Antibody Targeting Interleukin-1alpha, in Patients With Hidradenitis Suppurativa Not Eligible for antiTNF Therapy|Completed||Phase 2|20|Actual|University of Athens||2|||f||||f||||||||No||2017-10-10 22:36:49.953745|2017-10-10 22:36:49.953745
NCT02643641|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-01-18|||January 2016||2016-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response|Study to Evaluate the Effect of Different Pre-seasonal BM32 Dosing Schedules on the Rapid Induction of a Protective IgG Immune Response|Completed||Phase 2|130|Actual|Biomay AG||4|||f||||f||||||||Yes||2017-10-10 22:36:50.063037|2017-10-10 22:36:50.063037
NCT02643628|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-09-27|||November 2015||2015-11-01|December 2016|2016-12-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Pilot Study to Evaluate the Safety and Effectiveness of Microneedling and Bellafill to Treat Facial Acne Scars||Completed||N/A|45|Actual|Suneva Medical, Inc.||2|||f||||f||||||||||2017-10-10 22:36:50.178902|2017-10-10 22:36:50.178902
NCT02643615|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-07-05|2016-03-28||September 2014||2014-09-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SightSaver||Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery|A Pilot Study to Determine the Efficacy and Safety of Detecting Subtle Visual Changes During Visual Evoked Potential (VEP) Monitoring Using SightSaver ™ Flash Visual Evoked Potential Stimulator in Spine Prone Surgery|Completed||N/A|20|Actual|Ohio State University||2|||f||||f|f|t|f|f||||||2017-10-10 22:36:50.262437|2017-10-10 22:36:50.262437
NCT02643602|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-30|||December 2005||2005-12-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Does Bicarbonate in Addition to Theophylline Reduce CIN?|Does Bicarbonate in Addition to Theophylline Reduce Contrast Induced Nephropathy Compared to Sodium Chloride?|Completed||N/A|152|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-10 22:36:50.578192|2017-10-10 22:36:50.578192
NCT02643589|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-30|||June 2013||2013-06-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation|Dose Study of Antithymocyteglobulin in Haploidentical Hematopoietic Stem Cell Transplantation for Acute Graft-versus-host Disease Prophylaxis|Recruiting||N/A|200|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-10 22:36:50.679609|2017-10-10 22:36:50.679609
NCT02643576|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-12-28|||April 2013||2013-04-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|May 2015|Actual|2015-05-01||Interventional|GAPS||Grocery Assistance Program Study|Designing a Food Benefit Program to Optimize Diet Quality for Obesity Prevention|Active, not recruiting||N/A|296|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||t||||||||||2017-10-10 22:36:50.781173|2017-10-10 22:36:50.781173
NCT02643563|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-26|2017-01-18|||January 2016||2016-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Analgesic Duration of Long Acting Local Anesthetics for Low Volume Ultrasound-guided Interscalene Brachial Plexus Block|Comparison of the Analgesic Duration of 0.5% Bupivacaine With 1:200,000 Epinephrine Versus 0.5% Ropivicaine Versus 1 % Ropivicaine for Low Volume Ultrasound-guided Interscalene Brachial Plexus Block|Recruiting||N/A|60|Anticipated|Sunnybrook Health Sciences Centre||3|||f||||t||||||||||2017-10-10 22:36:50.877397|2017-10-10 22:36:50.877397
NCT02643550|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-11-24|||December 2015||2015-12-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study of IPH2201 (Monalizumab) and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Phase 1b/2 Trial of IPH2201 And Cetuximab in Patients With Human Papillomavirus (HPV) (+) and HPV (-) Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1/Phase 2|70|Anticipated|Innate Pharma||1|||f||||f||||||||||2017-10-10 22:36:51.118677|2017-10-10 22:36:51.118677
NCT02643537|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2015-12-28|||January 1992||1992-01-01|December 2015|2015-12-01||||December 2015|Actual|2015-12-01||Observational|||Associated Pathologies Following Luxatio Erecta Humeri: A Retrospective Analysis of 31 Cases and Diagnostic Algorithm||Completed||N/A|31|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-10 22:36:51.241084|2017-10-10 22:36:51.241084
NCT02643524|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-07-17|||December 7, 2015|Actual|2015-12-07|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Weight Change With Controlled Ankle Movement (CAM) Walker Boot Use|Weight Change With Controlled Ankle Movement (CAM) Walker Boot Use|Enrolling by invitation||N/A|50|Anticipated|Milton S. Hershey Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:36:51.316936|2017-10-10 22:36:51.316936
NCT02643511|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-12-30|||September 2015||2015-09-01|December 2015|2015-12-01|July 2025|Anticipated|2025-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Hemiablative Focal Brachytherapy Pilot Study|Focal Low Dose Rate ( LDR) Brachytherapy: Hemi-ablative Treatment With LDR for Patients With Low and Low-tier Intermediate Risk Prostate Cancer|Recruiting||Phase 2|20|Anticipated|St George Hospital, Australia||1|||f||||f||||||||||2017-10-10 22:36:51.42753|2017-10-10 22:36:51.42753
NCT02643498|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-08-16|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer|A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer|Recruiting||Phase 1|36|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:36:51.528108|2017-10-10 22:36:51.528108
NCT02643485|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-01-30|||December 2015||2015-12-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|PEDfore||Pedobarographic Changes After Forefoot Reconstruction|Dynamic Pedobarography With a New Insole After Forefoot Reconstruction|Recruiting||N/A|40|Anticipated|Technische Universität München|||2||f||||f||||||||No||2017-10-10 22:36:51.641734|2017-10-10 22:36:51.641734
NCT02643472|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-03-13|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|February 2017|Actual|2017-02-01||Interventional|GPS||GPS (Giving Parents Support): Parent Navigation After NICU Discharge|GPS (Giving Parents Support): Parent Navigation After NICU Discharge|Active, not recruiting||N/A|300|Anticipated|Children's Research Institute||2|||f||||f||||||||No||2017-10-10 22:36:51.724951|2017-10-10 22:36:51.724951
NCT02643459|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-06-19|||January 2016||2016-01-01|June 2017|2017-06-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|suPAR||Risk Stratification in Acute Care: The Meaning of suPAR Measurement in Triage|Introduction of Soluble Urokinase Plasminogen Activating Receptor in Acute Care as a Prognostic Biomarker to Strengthen Risk Stratification of Acutely Admitted Patients|Completed||N/A|20000|Actual|Herlev Hospital||2|||f||||t||||||||No||2017-10-10 22:36:51.827194|2017-10-10 22:36:51.827194
NCT02643446|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-07-31|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Observational|IPV||Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine|Serological Survey on Monitoring the Population Immunity and Positive Rate After Vaccination of Inactivated Poliovirus Vaccine|Completed||N/A|809|Actual|Centers for Disease Control and Prevention, China|||12||f||||f||||||Samples With DNA|"     Serum, Whole blood   "|||2017-10-10 22:36:51.929964|2017-10-10 22:36:51.929964
NCT02643433|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-07-29|||August 2015||2015-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MR+JE||Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines|Immunogenicity of Co-administration of Measles Containing Vaccine and Japanese Encephalitis Alive Vaccines|Completed||Phase 4|1043|Actual|Centers for Disease Control and Prevention, China||2|||f||||f||||||||Yes|we will share the serum results with the participants after completing laboratory test. and we will publish articles to share our research.|2017-10-10 22:36:52.102566|2017-10-10 22:36:52.102566
NCT02643420|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-08-07|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|ADVANCE||RAnDomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast CANCEr Patients Receiving Docetaxel and Cyclophosphamide|RAnDomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast CANCEr Patients Receiving Docetaxel and Cyclophosphamide (TC) (ADVANCE)|Active, not recruiting||Phase 3|405|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||f||||||||||2017-10-10 22:36:52.247456|2017-10-10 22:36:52.247456
NCT02643407|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2015-12-30|||October 2015||2015-10-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer|Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer :A Randomized, Open, Parallel, Multicentre, Phase Ⅲ Study|Recruiting||Phase 3|488|Anticipated|Guangdong Association of Clinical Trials||2|||f||||t||||||||||2017-10-10 22:36:52.391079|2017-10-10 22:36:52.391079
NCT02643394|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-05-31|||October 2015||2015-10-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficacy of Oral vs. Intravenous Acetaminophen|The Comparative Efficacy of Oral vs. Intravenous Acetaminophen in Sinus Surgery Patients|Recruiting||Phase 4|100|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 22:36:52.543665|2017-10-10 22:36:52.543665
NCT02643381|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-06-07|||June 2016||2016-06-01|June 2016|2016-06-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|EvK||Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial|Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial|Recruiting||Phase 4|825|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No|Aggregate anonymous data will be published in accord with our IRB approval.|2017-10-10 22:36:52.671325|2017-10-10 22:36:52.671325
NCT02643368|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-03-08|||December 2015||2015-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine|Assessing Immunogenicity of Type 2 Monovalent Oral Poliovirus Vaccine Administered at One, Two or Four Week Intervals and When Coadministered With Inactivated Poliovirus Vaccine in an Urban Area in Bangladesh|Completed||Phase 4|760|Actual|Centers for Disease Control and Prevention||4|||f||||t||||||||||2017-10-10 22:36:52.822151|2017-10-10 22:36:52.822151
NCT02643355|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-10-05|||November 2015||2015-11-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED|Utility of Olanzapine in the Treatment of Opioid Withdrawal in the Emergency Department|Recruiting||N/A|70|Anticipated|Minneapolis Medical Research Foundation||2|||f||||t||||||||||2017-10-10 22:36:52.946004|2017-10-10 22:36:52.946004
NCT02643342|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-06-20|||February 20, 2016||2016-02-20|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye|A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye|Recruiting||N/A|90|Anticipated|The Hong Kong Polytechnic University||3|||f||||f||||||||||2017-10-10 22:36:53.073822|2017-10-10 22:36:53.073822
NCT02643329|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-07-21|||January 2016||2016-01-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations|Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations|Completed||Phase 1|17|Actual|Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited||2|||f||||t||||||||No|Study investigators and his/her study team members, domestic and foreign regulatory agencies, the IRB/EC involved in the study, healthcare providers who provide services to subjects in connection with this study, and laboratories and other individuals and organizations that analyze the subjects' protected health information in connection with this study have access to the data or study.|2017-10-10 22:36:53.228233|2017-10-10 22:36:53.228233
NCT02643316|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-29|2017-08-23|||December 2015||2015-12-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study|Morning-Only 4 Liter Polyethylene Glycol vs. Split Dose for Afternoon Colonoscopies, a Randomized Endoscopist-Blinded Prospective Study|Active, not recruiting||N/A|200|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 22:36:53.364301|2017-10-10 22:36:53.364301
NCT02643303|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-07-11|||December 28, 2016|Actual|2016-12-28|July 2017|2017-07-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers|A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab (MEDI4736) Plus the Toll-like Receptor Agonist PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers|Recruiting||Phase 1/Phase 2|102|Anticipated|Ludwig Institute for Cancer Research||4|||f||||f||||||||||2017-10-10 22:36:53.477995|2017-10-10 22:36:53.477995
NCT02643290|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-02-28|||April 23, 2015|Actual|2015-04-23|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Efficacy of Peak Scoliosis Brace in Pain Management For Adult Scoliosis Patients|Efficacy of Peak Scoliosis Brace in Pain Management For Adult Scoliosis Patients|Completed||N/A|20|Actual|Aspen Medical Products||1|||f||||f|f|t|f|f||||||2017-10-10 22:36:53.639719|2017-10-10 22:36:53.639719
NCT02643277|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-07-14|||December 2014||2014-12-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Effectiveness of Automated Mobile Phone Based Text Messaging on the Improvement of Glycaemic Outcomes|A Pilot Study On The Effectiveness Of Using Automated Mobile Phone Text Messaging In Improving Glycaemic Control Among Newly Detected Type 2 Diabetic Patients|Active, not recruiting||N/A|244|Actual|India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals||2|||f||||t||||||||Undecided||2017-10-10 22:36:53.738856|2017-10-10 22:36:53.738856
NCT02643264|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-28|||November 2015||2015-11-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) of the Insula for Treatment of Alcohol Addiction|Repetitive Transcranial Magnetic Stimulation (rTMS) of the Insula for Treatment of Alcohol Addiction|Recruiting||N/A|84|Anticipated|Linkoeping University||2|||f||||t||||||||Yes||2017-10-10 22:36:53.851253|2017-10-10 22:36:53.851253
NCT02643225|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-26|2016-07-11|2016-01-22||April 2015||2015-04-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational||The patients will be divided into two groups, 40 pregnant women as case group with gestational diabetes mellitus and 40 non diabetic pregnant women as control group after being approved by the local hospital ethics and research committee|The Role of Umbilical Cord Thickness in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus|The Role of Umbilical Cord Thickness, Interventricular Septum Thickness and HbA1C Levels in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus|Completed||N/A|80|Actual|Ain Shams University|||2||f||||t||||||||||2017-10-10 22:36:53.978984|2017-10-10 22:36:53.978984
NCT02643212|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-10-25|||May 2016||2016-05-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|CIRROXABAN||Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis||Recruiting||Phase 3|160|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-10 22:36:54.286271|2017-10-10 22:36:54.286271
NCT02643199|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-06-16|2017-04-04||December 2015||2015-12-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|||Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy|Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy|Completed||N/A|90|Actual|Ain Shams University|||1||f||||t||||||||Yes|Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy|2017-10-10 22:36:54.550995|2017-10-10 22:36:54.550995
NCT02643186|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-29|||July 2015||2015-07-01|December 2015|2015-12-01||||July 2017|Anticipated|2017-07-01||Interventional|||Vaginal Misoprostol Versus Bilateral Uterine Artery Ligation in Decreasing Blood Loss in Trans-abdominal Myomectomy|Vaginal Misoprostol Versus Bilateral Uterine Artery Ligation in Decreasing Blood Loss in Trans-abdominal Myomectomy , a Randomized Control Trail|Recruiting||Phase 4|62|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 22:36:54.726995|2017-10-10 22:36:54.726995
NCT02643147|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-28|||January 2015||2015-01-01|December 2015|2015-12-01||||June 2016|Anticipated|2016-06-01||Interventional|IMPROVE-HF||Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)|Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)|Recruiting||Phase 4|170|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||t||||||||||2017-10-10 22:36:55.002405|2017-10-10 22:36:55.002405
NCT02643134|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-28|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||External Physical Vibration Lithecbole Versus Traditional Row of Stone After Extracorporeal Shockwave Lithotripsy(ESWL)|External Physical Vibration Lithecbole Contrast With the Traditional Row of Stone Effect After ESWL: A Multi-center Prospective Randomized Controlled Trial|Unknown status|Recruiting|N/A|180|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||f||||||||||2017-10-10 22:36:55.147208|2017-10-10 22:36:55.147208
NCT02643121|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-31|||January 2014||2014-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Utility of Presepsin in Children Sepsis|Diagnostic and Prognostic Utility of Presepsin for Sepsis and Systemic Inflammatory Response Syndrome in Children|Active, not recruiting||N/A|100|Anticipated|Brno University Hospital|||2||f||||f||||||||||2017-10-10 22:36:55.245888|2017-10-10 22:36:55.245888
NCT02643108|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-09-26|||June 30, 2017|Actual|2017-06-30|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|EVA||Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women|Randomized Controlled Clinical Trial of Lateral Episiotomy Versus no Episiotomy in Vacuum Assisted Delivery in Non-parous Women|Recruiting||N/A|800|Anticipated|Karolinska Institutet||2|||f||||t|f|f||||||||2017-10-10 22:36:55.339457|2017-10-10 22:36:55.339457
NCT02643095|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2015-12-28|||December 2015||2015-12-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy of Scleral Contact Lenses for Daily Wear for Regular and Irregular Refractive Errors Compared to Habitually Worn Scleral Lenses||Not yet recruiting||N/A|40|Anticipated|Ohio State University||1|||f||||||||||||||2017-10-10 22:36:55.461817|2017-10-10 22:36:55.461817
NCT02643082|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-03-15|||December 23, 2015|Actual|2015-12-23|March 2017|2017-03-01|January 26, 2017|Actual|2017-01-26|January 26, 2017|Actual|2017-01-26||Interventional|||A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD|A Randomized, Double-Blind, Two Treatment, Two Period, Chronic Dosing (2 Weeks), Cross-Over, Single-Center Study to Evaluate the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD|Completed||Phase 3|20|Actual|Pearl Therapeutics, Inc.||2|||f||||f||||||||Yes|AstraZeneca's policy is to share data with researchers if the request is in scope of our policy. The policy and additional information can be found on astrazenecaclinicaltrials.com.|2017-10-10 22:36:55.524515|2017-10-10 22:36:55.524515
NCT02643069|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-08-23|||February 2014||2014-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|FRAILCLINIC||Clinical Intervention in Frail Older People (FRAILCLINIC)|Feasibility and Effectiveness of Frailty Screening and Management Programs Implemented in Different Clinical Settings (FRAILCLINIC)|Recruiting||N/A|1300|Anticipated|Hospital Universitario Getafe||2|||f||||t||||||||||2017-10-10 22:36:55.62396|2017-10-10 22:36:55.62396
NCT02643056|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-29|||January 2011||2011-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|S10PANI01||Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cancer|Phase II Study to Investigate the Efficacy of Panitumumab in Platinum-resistant Advanced Head and Neck Squamous Cance|Completed||Phase 2|32|Actual|Southern Europe New Drug Organization||1|||f||||f||||||||No||2017-10-10 22:36:55.7226|2017-10-10 22:36:55.7226
NCT02643043|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-30|||July 26, 2017|Actual|2017-07-26|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Observational|||UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch|UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch: Hoosier Cancer Research Network GU15-217|Recruiting||N/A|200|Anticipated|Hoosier Cancer Research Network|||1||f||||t||||||Samples With DNA|"     Collect and store whole blood and archival tumor tissue (biospecimens) from subjects and     linking molecular and biological information from those biospecimens to clinical data in     order to promote future translational research in metastatic urothelial cancer. Any DNA     analysis of blood is for research purposes only.   "|||2017-10-10 22:36:55.797758|2017-10-10 22:36:55.797758
NCT02643030|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-28|||March 2012||2012-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Hypercapnia During Shoulder Arthroscopy|The Effect of Hypercapnia on Regional Cerebral Oxygen Saturation in the Sitting Position|Completed||N/A|40|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-10 22:36:55.905965|2017-10-10 22:36:55.905965
NCT02643017|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-28|||December 2015||2015-12-01|December 2015|2015-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Dexmedetomidine on Postoperative Cognitive Function in Patients Undergoing Shoulder Arthroscopy With Beach Chair Position Under Desflurane Anesthesia||Recruiting||N/A|100|Anticipated|Yonsei University||2|||f||||f||||||||No|There is no plan to share the data.|2017-10-10 22:36:55.981069|2017-10-10 22:36:55.981069
NCT02643004|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-07-20|2017-02-13||December 2015||2015-12-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||The Clinical Comparison of Senofilcon A and Stenfilcon A Contact Lenses|The Clinical Comparison of Senofilcon A and Stenfilcon A Contact Lenses|Completed||N/A|70|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 22:36:56.099274|2017-10-10 22:36:56.099274
NCT02642991|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-07-25|||November 2015||2015-11-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Dispensing Study for a New Study Test Lens|Dispensing Study for a New Study Test Lens|Completed||N/A|25|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 22:36:56.851277|2017-10-10 22:36:56.851277
NCT02642978|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-06-28|||September 1, 2015|Actual|2015-09-01|June 2017|2017-06-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases|The Safety and Effect of Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer： Randomized Control Trial Study|Recruiting||Phase 2/Phase 3|100|Anticipated|Fudan University||2|||f||||t|f|f||||||No||2017-10-10 22:36:56.970376|2017-10-10 22:36:56.970376
NCT02642965|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-06-21|||April 2016||2016-04-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Liposomal Cytarabine-Daunorubicin CPX-351, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 1/2 Study of CPX-351 (NSC# 775341) Alone Followed by Fludarabine, Cytarabine, and G-CSF (FLAG) for Children With Relapsed Acute Myeloid Leukemia (AML)|Recruiting||Phase 1/Phase 2|56|Anticipated|Children's Oncology Group||1|||f||||t||||||||||2017-10-10 22:36:57.069104|2017-10-10 22:36:57.069104
NCT02642952|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-02-11|||January 2016||2016-01-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|||Impact of Grafts and Endografts for Abdominal Aneurysms on Arterial Stiffness.|Impact of Aortic Grafts After Open and Endovascular Repair in Central Hemodynamics and Arterial Stiffness Measured by Non-invasive Methods in Patients With Abdominal Aortic Aneurysms.|Recruiting||N/A|52|Anticipated|Hospital Universitario Ramon y Cajal|||2||f||||t||||||||||2017-10-10 22:36:57.294352|2017-10-10 22:36:57.294352
NCT02642939|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-08-26|||December 2015||2015-12-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II Study of Treatment With Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Two or More Previous Chemotherapy Regimens|Recruiting||Phase 2|40|Anticipated|Check, Jerome H., M.D., Ph.D.||1|||f||||f||||||||||2017-10-10 22:36:57.376925|2017-10-10 22:36:57.376925
NCT02642926|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-08-05|||December 2012||2012-12-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of the Efficiency of Bipolar Energy Versus Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia|Randomized Controlled Trial Comparing the Efficiency of the Bipolar Energy Compared With the Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia|Completed||N/A|98|Actual|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:36:57.46038|2017-10-10 22:36:57.46038
NCT02642900|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-12-25|||July 2009||2009-07-01|December 2015|2015-12-01|July 2011|Actual|2011-07-01|February 2011|Actual|2011-02-01||Interventional|||Photodynamic Therapy Against Candida Spp. in Complete Denture Wearers|Photodynamic Therapy Against Candida Spp. in Complete Denture Wearers: a Randomized Clinical Trial|Completed||Phase 4|22|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:36:57.655167|2017-10-10 22:36:57.655167
NCT02642887|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-26|||March 2015||2015-03-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||A Modified Tunnel Approach in Treatment of Gingival Recession|Evaluation of Root Coverage Outcome Using a Modified Tunnel Approach Versus Tunnel Technique: A Randomized Clinical Trial|Active, not recruiting||N/A|30|Actual|Al-Azhar University||2|||f||||f||||||||||2017-10-10 22:36:57.827028|2017-10-10 22:36:57.827028
NCT02642874|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients|Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients|Not yet recruiting||Phase 3|200|Anticipated|Tanta University||2|||f||||t||||||||Undecided||2017-10-10 22:36:57.907721|2017-10-10 22:36:57.907721
NCT02642861|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis|Cyclobenzaprine Treatment for Muscle Cramps in Cirrhotic Patients|Not yet recruiting||Phase 3|200|Anticipated|Tanta University||2|||f||||t||||||||Undecided||2017-10-10 22:36:57.999038|2017-10-10 22:36:57.999038
NCT02642848|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-01-01|||June 2015||2015-06-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|HTOSC||Clinical Outcomes of Open Wedge High Tibial Osteotomy With Autologous Bone Marrow or Adipose-derived Stem Cell Therapy|Clinical Outcomes of Open Wedge High Tibial Osteotomy With Autologous Bone Marrow or Adipose-derived Stem Cell Therapy|Recruiting||N/A|52|Anticipated|Catholic Kwandong University||3|||f||||t||||||||||2017-10-10 22:36:58.099565|2017-10-10 22:36:58.099565
NCT02642822|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-07-13|||October 2014||2014-10-01|December 2015|2015-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||The Epidemiologic Study of Human Cytomegalovirus（CMV） in Female Students of Xiamen University|The Epidemiologic Study of Human Cytomegalovirus （CMV）in Female Students of Xiamen University|Completed||N/A|102|Actual|Xiamen University|||1||f||||f||||||||||2017-10-10 22:36:58.282228|2017-10-10 22:36:58.282228
NCT02642796|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2017-03-21|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Transcutaneous Nerve Stimulation for Post-operative Acute and Chronic Pain|Comparison of the Efficacy of Two Different Transcutaneous Electrical Nerve Stimulation Application Sites in Reducing Postoperative Pain After Hip Fracture Surgery|Recruiting||N/A|120|Anticipated|Mustafa Kemal University||3|||f||||t||||||||No||2017-10-10 22:36:58.50073|2017-10-10 22:36:58.50073
NCT02642783|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-29|||November 2015||2015-11-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Sensory Properties of Bowel Cleansing Solutions|Sensory Evaluation of Laxative Bowel Solutions Used Prior to Colonoscopy|Completed||N/A|14|Actual|American University of Beirut Medical Center||2|||f||||t||||||||No||2017-10-10 22:36:58.643074|2017-10-10 22:36:58.643074
NCT02642770|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-26|2016-09-27|||August 2015||2015-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||3D & Speckle Tracking Together as a Marker for Early Outcome in Cardiac Surgery|3D & Speckle Tracking Together as a Sensitive Marker for Early Outcome in Patients With Left Ventricular Dysfunction Undergoing Cardiac Surgery|Completed||N/A|73|Actual|Postgraduate Institute of Medical Education and Research|||1||f||||f||||||||Undecided||2017-10-10 22:36:58.726574|2017-10-10 22:36:58.726574
NCT02642757|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2016-10-10|||December 2015||2015-12-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Alcohol Brief Counseling in Primary Care|Effectiveness of a Brief Intervention for Reducing the Alcohol Use in Risky Users Delivered by Paramedics in Primary Care|Recruiting||N/A|262|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||No||2017-10-10 22:36:58.80184|2017-10-10 22:36:58.80184
NCT02642744|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-10-27|||October 2015||2015-10-01|October 2016|2016-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Improving Coordination and Transitions of Care in Stroke Patients|Improving Coordination and Transitions of Care for Stroke Patients With an Attending Nurse: a Comparative Effectiveness Single Center Study Comparing Models of Nursing Care|Recruiting||Phase 3|300|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:36:58.901536|2017-10-10 22:36:58.901536
NCT02642731|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2016-03-29|||September 2013||2013-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|dexpolvi||Kidney Biomarkers of Acute Kidney Injury in Patients With Knee Arthroplasty|Kidney Biomarkers of Acute Kidney Injury in Patients With Knee Arthroplasty|Completed||N/A|30|Actual|Kuopio University Hospital|||2||f||||f||||||Samples Without DNA|"     plasma for measurement of renal markers Urine for measurement of renal markers   "|No||2017-10-10 22:36:58.990462|2017-10-10 22:36:58.990462
NCT02642718|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2016-01-01|||April 2001||2001-04-01|January 2016|2016-01-01|November 2001|Actual|2001-11-01|October 2001|Actual|2001-10-01||Interventional|||Pre-operative Ketorolac Administration Has no Pre-emptive Analgesic Effect Following Total Abdominal Hysterectomy|Pre-operative Ketorolac Administration Has no Pre-emptive Analgesic Effect Following Total Abdominal Hysterectomy|Completed||Phase 4|48|Actual|Hospital Arquitecto Marcide||2|||f||||f||||||||No||2017-10-10 22:36:59.08026|2017-10-10 22:36:59.08026
NCT02642705|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2015-12-24|||September 2015||2015-09-01|December 2015|2015-12-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|HYPINT||High Intensity Interval Training and Hypoxic Conditioning in Obese Patients|New Treatment Modalities in Obese Patients: High Intensity Interval Training and Hypoxic Conditioning|Recruiting||N/A|120|Anticipated|University Hospital, Grenoble||6|||f||||f||||||||No||2017-10-10 22:36:59.224252|2017-10-10 22:36:59.224252
NCT02642692|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-25|2016-09-01|||June 2015||2015-06-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Hamstrings X Patellar Tendon for ACL Reconstruction in Soccer Players - RCT|Hamstrings X Patellar Tendon for Anterior Cruciate Ligament Reconstruction in Soccer Players - RCT|Recruiting||N/A|60|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||f||||||||No||2017-10-10 22:36:59.346926|2017-10-10 22:36:59.346926
NCT02642666|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-05-24|||December 2015||2015-12-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||The Effects of Yoga on Attention, Impulsivity and Hyperactivity in Pre-school Age Children|The Effects of Yoga on Attention, Impulsivity and Hyperactivity in Pre-school Age Children With ADHD Symptoms|Completed||N/A|23|Actual|University of California, Davis||2|||f||||f||||||||No|Individual participants data will be de-identified and analyzed as a group.|2017-10-10 22:36:59.556005|2017-10-10 22:36:59.556005
NCT02642653|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-05-24|||January 2016||2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome|Combining Lovastatin and a Parent-Implemented Language Intervention in a Multimodal Treatment for Fragile X Syndrome|Recruiting||Phase 4|104|Anticipated|University of California, Davis||2|||f||||t|t|f||||||Undecided||2017-10-10 22:36:59.674032|2017-10-10 22:36:59.674032
NCT02642640|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-12-08|||November 2016||2016-11-01|December 2016|2016-12-01||||June 2019|Anticipated|2019-06-01||Interventional|||Interaction of Melatonin and MTNR1B Genotype on Glucose Control|Interaction of Melatonin and MTNR1B Genotype on Glucose Control|Recruiting||N/A|24|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 22:36:59.790009|2017-10-10 22:36:59.790009
NCT02642627|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-05-09|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area|The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area|Completed||N/A|41|Actual|Suneva Medical, Inc.||1|||f||||f||||||||No||2017-10-10 22:36:59.908467|2017-10-10 22:36:59.908467
NCT02642614|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-06-27|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD|A Phase I Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of BI 1026706 Administered Orally as Tablets Twice Daily for 4 Weeks to Patients With COPD in Order to Evaluate Safety, Tolerability, Pharmacokinetics and Effect on Inflammation|Completed||Phase 1|120|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 22:36:59.979912|2017-10-10 22:36:59.979912
NCT02642601|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2015-12-24|||March 2014||2014-03-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Role of Indomethacin in Difficult Embryo Transfer.|Role of Indomethacin in Cases of Difficult Embryo Transfer in Intra Cytoplasmic Sperm Injection Cycles|Recruiting||Phase 2/Phase 3|100|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 22:37:00.100587|2017-10-10 22:37:00.100587
NCT02642588|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of a Commercially Available Carbohydrate Rich Gel on Maternal Fatigue: A Randomized Controlled Trial|Effect of a Commercially Available Carbohydrate Rich Gel on Maternal Fatigue: A Randomized Controlled Trial|Not yet recruiting||N/A|190|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 22:37:00.190781|2017-10-10 22:37:00.190781
NCT02642575|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-05-08|2017-03-28||December 2015||2015-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational||67 women were recruited from the Fetal Care Unit who fulfilled the inclusion criteria. Verbal consent was obtained from participants who were included into the study.|Automated Folliculometry Using Five-Dimensional Ultrasound|Automated Folliculometry Using Five-Dimensional Ultrasound|Completed||N/A|67|Actual|Ain Shams University|||1||f||||t||||||||Yes|The aim of the study to evaluate Five-Dimensional Ultrasound in automated measurement of ovarian follicles with controlled ovarian stimulation in contrast to the conventional 2D ultrasound|2017-10-10 22:37:00.268592|2017-10-10 22:37:00.268592
NCT02642562|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-02-15|||August 2016||2016-08-01|February 2017|2017-02-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|IRONMAN||Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN|Effectiveness of Intravenous Iron Treatment vs Standard Care in Patients With Heart Failure and Iron Deficiency: a Randomised, Open-label Multicentre Trial (IRONMAN)|Recruiting||Phase 4|1300|Anticipated|University of Glasgow||2|||f||||t||||||||Yes|Data will be made available when analysis of the main pre-specified endpoints, sub-groups and sub-studies have been completed.|2017-10-10 22:37:00.439862|2017-10-10 22:37:00.439862
NCT02642549|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2015-12-24|||April 2016||2016-04-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Girls for Health: Empowering Rural Girls' Transition From School to Employment as Health Workers|Girls for Health: Empowering Rural Girls' Transition From School to Employment as Health Workers|Not yet recruiting||N/A|2700|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 22:37:00.578063|2017-10-10 22:37:00.578063
NCT02642536|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-09-01|2017-02-17||January 1, 2011|Actual|2011-01-01|September 2017|2017-09-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|MH MOVE!||Improving Obesity Self-Care Among Mentally Ill Veterans|Improving Obesity Self-care Among Mentally Ill Veterans|Completed||N/A|44|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-10 22:37:00.682854|2017-10-10 22:37:00.682854
NCT02642523|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-06-10|||August 2016||2016-08-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Natriuretic Peptides and Metabolic Risk in Obesity|Natriuretic Peptides and Metabolic Risk in Obesity|Not yet recruiting||Early Phase 1|40|Anticipated|Vanderbilt University||3|||f||||t||||||||||2017-10-10 22:37:01.103303|2017-10-10 22:37:01.103303
NCT02642510|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-27|2017-06-21|||June 2014||2014-06-01|June 2017|2017-06-01|February 20, 2017|Actual|2017-02-20|February 20, 2017|Actual|2017-02-20||Interventional|||Improving Patient Education for Lymphoma and Leukemia Inpatients|Improving Patient Education for Newly Diagnosed Lymphoma and Acute Leukemia Inpatients|Completed||N/A|78|Actual|Emory University||2|||f||||f||||||||||2017-10-10 22:37:01.190546|2017-10-10 22:37:01.190546
NCT02642497|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-01-01|||August 2015||2015-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional|||Local Ketamine Instillation for Postoperative Analgesia|Efficacy of Postoperative Analgesia Offered by Local Ketamine Wound Instillation Following Total Thyroidctomy; a Randomized, Double-blind, Controlled-clinical Trial|Completed||Phase 2/Phase 3|90|Actual|Assiut University||3|||f||||f||||||||Undecided||2017-10-10 22:37:01.264112|2017-10-10 22:37:01.264112
NCT02642484|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-10-17|||October 2016||2016-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis|Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis|Not yet recruiting||Phase 3|200|Anticipated|Tanta University||2|||f||||t||||||||Undecided||2017-10-10 22:37:01.34082|2017-10-10 22:37:01.34082
NCT02642471|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2015-12-29|||December 2015||2015-12-01|December 2015|2015-12-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Sentinel Lymph Node Biopsy Versus Systematic Pelvic Lymphadenectomy in Early-stage Cervival Cancer|Application of Sentinel Lymph Node Biopsy (SLNB) in Early-stage Cervical Cancer: A Prospective Study|Recruiting||Phase 3|800|Anticipated|Sun Yat-sen University||4|||f||||t||||||||||2017-10-10 22:37:01.422186|2017-10-10 22:37:01.422186
NCT02642458|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-10-07|||March 2016||2016-03-01|October 2016|2016-10-01||||January 2020|Anticipated|2020-01-01||Observational|PerFECT||Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients|Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients: A Cohort Study of Patients Treated Either With Docetaxel and Trastuzumab or Docetaxel, Trastuzumab and Pertuzumab|Recruiting||N/A|300|Anticipated|University Hospital Tuebingen|||2||f||||t||||||||Undecided||2017-10-10 22:37:01.527687|2017-10-10 22:37:01.527687
NCT02642445|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-01-09|||December 2016||2016-12-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RSDAH||Renal Sympathetic Denervation From The Adventitia on Hypertension|Efficacy and Safety of Renal Sympathetic Denervation From The Adventitia on Hypertension in Patients With Primary Aldosteronism|Recruiting||N/A|60|Anticipated|Henan Institute of Cardiovascular Epidemiology||2|||f||||t||||||||||2017-10-10 22:37:01.679115|2017-10-10 22:37:01.679115
NCT02642432|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-28|2017-08-29|2017-08-17|2017-02-10|December 7, 2015|Actual|2015-12-07|August 2017|2017-08-01|February 10, 2017|Actual|2017-02-10|October 27, 2016|Actual|2016-10-27||Interventional|EXPEDITION-1||A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis|A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis (EXPEDITION-1)|Completed||Phase 3|146|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 22:37:01.764258|2017-10-10 22:37:01.764258
NCT02642419|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-12-26|||January 2015||2015-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AFIRE||Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study|Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study (AFIRE Study)|Recruiting||Phase 4|2200|Anticipated|Japan Cardiovascular Research Foundation||2|||f||||t||||||||||2017-10-10 22:37:02.241416|2017-10-10 22:37:02.241416
NCT02642406|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-10-07|||December 2015||2015-12-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Observational|SERAPHINA||Therapy Management With Nab-Paclitaxel in Daily Routine|Safety, Efficacy and Patient Reported Outcomes of Advanced Breast Cancer Patients: Therapy Management With Nab-Paclitaxel in Daily Routine - SERAPHINA|Recruiting||N/A|1200|Anticipated|University Hospital Tuebingen|||1||f||||t||||||Samples With DNA|"     Blood samples   "|Undecided||2017-10-10 22:37:02.418526|2017-10-10 22:37:02.418526
NCT02642393|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-06-27|||June 2016||2016-06-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|February 2020|Anticipated|2020-02-01||Interventional|SURE-PD3||Study of Urate Elevation in Parkinson's Disease, Phase 3|A Randomized, Double-blind, Placebo-controlled Trial of Urate-elevating Inosine Treatment to Slow Clinical Decline in Early Parkinson's Disease|Recruiting||Phase 3|270|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||Yes|De-identified data; per policies of NIH/NINDS and the PSG (Parkinson Study Group)|2017-10-10 22:37:02.718039|2017-10-10 22:37:02.718039
NCT02642380|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-04-18|||November 2015||2015-11-01|December 2015|2015-12-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)|Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP): a Prospective, Randomized Controlled Trial|Withdrawn||Phase 4|0|Actual|Shandong University||2||No eligible patient was enrolled.|f||||t||||||||||2017-10-10 22:37:03.114667|2017-10-10 22:37:03.114667
NCT02642367|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-11-21|||January 2016||2016-01-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Stylet Use for McGrath Videolaryngoscope|Comparison of With or Without Use of Stylet for Endotracheal Intubation With McGrath Videolaryngoscope|Completed||Phase 4|140|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-10 22:37:03.224792|2017-10-10 22:37:03.224792
NCT02642354|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-07-25|||November 2015||2015-11-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||One Week Assessment of a Lens With a Novel Optical Profile|One Week Assessment of a Lens With a Novel Optical Profile|Completed||N/A|20|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 22:37:03.318549|2017-10-10 22:37:03.318549
NCT02642341|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-07-25|||November 2015||2015-11-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||One Week Assessment of a New Study Test Lens|One Week Assessment of a New Study Test Lens|Completed||N/A|40|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 22:37:03.505423|2017-10-10 22:37:03.505423
NCT02642328|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2015-12-25|||January 2016||2016-01-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|Strength||High Intensity Interval Training With Strength/Power Exercises on VO2Max|Effects of Eight Sessions of High Intensity Interval Training (HIIT) With Strength/Power Exercises on VO2Max Gains and Aerobic Performance|Not yet recruiting||N/A|16|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-10 22:37:03.677425|2017-10-10 22:37:03.677425
NCT02642315|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-02-13|||January 2016||2016-01-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|XP-IIT-0034||The Effect of Horizant (Gabapentin Enacarbil) on Augmentation|To Examine the Effect of Horizant (Gabapentin Enacarbil) in Primary Restless Legs Syndrome (RLS) Patients Who Are on Dopaminergic Agents and Exhibiting Augmentation|Recruiting||N/A|50|Anticipated|University of Missouri-Columbia||1|||f||||f||||||||||2017-10-10 22:37:03.780003|2017-10-10 22:37:03.780003
NCT02642302|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2015-12-25|||December 2015||2015-12-01|December 2015|2015-12-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|Performance||Rest Time on Gain Aerobic and Anaerobic Performance|Can The Rest Interval Time Provide Superior Gains on VO2max, Aerobic and Anaerobic Performance Obtained With High Intensity Interval Training (HIIT)? a Randomized Controlled Study|Not yet recruiting||N/A|36|Anticipated|Universidade Federal do Rio de Janeiro||3|||f||||t||||||||||2017-10-10 22:37:03.882128|2017-10-10 22:37:03.882128
NCT02642289|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-03-11|||December 2015||2015-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Probiotics: Clinical Intervention Trial in Patients With Fibromyalgia|Probiotics: Clinical Intervention Trial in Patients With Fibromyalgia|Completed||N/A|60|Actual|Universidad de Almeria||3|||f||||t||||||||||2017-10-10 22:37:03.975932|2017-10-10 22:37:03.975932
NCT02642276|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-09-19|||June 2015||2015-06-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Exercise Training in Individuals With Peripheral Arterial Disease|Influence of Different Types of Exercise Training on Selected Cardiovascular Parameters in Individuals With Peripheral Arterial Disease|Completed||N/A|36|Actual|University Medical Centre Ljubljana||3|||f||||||||||||||2017-10-10 22:37:04.075373|2017-10-10 22:37:04.075373
NCT02642263|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-05-01|||February 1, 2018|Anticipated|2018-02-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain|Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain, A Prospective Randomised Study|Not yet recruiting||Phase 4|78|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f||||||||2017-10-10 22:37:04.158135|2017-10-10 22:37:04.158135
NCT02642250|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2015-12-30|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HA||Comparative Evaluation of Herbal and Allopathic Drugs for the Treatment of Chronic Diarrhea|Chemical, Biological and Comparative Clinical Evaluation of Entoban to Determine Safety and Efficacy for the Treatment of Chronic Diarrhea|Completed||Phase 2/Phase 3|70|Actual|Shifa Ul Mulk Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:37:04.244684|2017-10-10 22:37:04.244684
NCT02642237|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-04-20|||December 2015||2015-12-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|January 2017|Actual|2017-01-01||Interventional|LPS-Fluenz||The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response|The Effects of an Endotoxin Challenge on the Immune Response Elicited by a Subsequent Challenge With Fluenz in Healthy Volunteers, an Explorative Study|Active, not recruiting||N/A|40|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-10 22:37:04.323719|2017-10-10 22:37:04.323719
NCT02642224|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2016-12-11|||May 2014||2014-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|TSI||Trauma Services Intervention to Prevent Violence|Trauma Services Intervention to Prevent Violence|Recruiting||N/A|200|Anticipated|University of Pittsburgh||1|||f||||t||||||||Yes|Data will be archived and made available to qualified investigators|2017-10-10 22:37:04.417386|2017-10-10 22:37:04.417386
NCT02642211|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2016-01-05|||January 2014||2014-01-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||IOP Changes Associated With SICS and Phako|An Evaluation of Intraocular Pressure Reduction Following Phacoemulsification and Manual Small Incision Cataract Surgery: A Randomized Controlled Trial|Completed||Early Phase 1|500|Actual|Robin, Alan L., M.D.||2|||f||||f||||||||Yes|plan to share in paper form and at national meetings|2017-10-10 22:37:04.510562|2017-10-10 22:37:04.510562
NCT02642185|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-08-15|||December 2015||2015-12-01|August 2017|2017-08-01|December 2028|Anticipated|2028-12-01|December 2021|Anticipated|2021-12-01|10 Years|Observational [Patient Registry]|MAVERRIC||Microwave Ablation Versus Resection for Resectable Colorectal Liver Metastases|Microwave Ablation Versus Resection for Resectable Colorectal Liver Metastases|Recruiting||N/A|100|Anticipated|Karolinska Institutet|||2||f||||f||||||||||2017-10-10 22:37:04.658337|2017-10-10 22:37:04.658337
NCT02642172|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2016-10-29|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Prebiotics in Patients With Non-alcoholic Liver Disease|A Randomized, Double - Blind Study With Two Parallel Arms for 4 Months (20 Weeks), Evaluating the Effectiveness of the Prebiotics in Patients With Non-alcoholic Liver Disease.|Recruiting||N/A|60|Anticipated|Kaplan Medical Center||2|||f||||f||||||||No||2017-10-10 22:37:04.764168|2017-10-10 22:37:04.764168
NCT02642159|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-06-21|||March 15, 2016||2016-03-15|June 2017|2017-06-01|May 18, 2017|Actual|2017-05-18|March 17, 2017|Actual|2017-03-17||Interventional|||Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)|A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab Versus Usual Care in Patients With Type 2 Diabetes and Mixed Dyslipidemia at High Cardiovascular Risk With Non-HDL-C Not Adequately Controlled With Maximally Tolerated Statin Therapy|Completed||Phase 4|413|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:37:04.87604|2017-10-10 22:37:04.87604
NCT02642146|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2015-12-29|||January 2016||2016-01-01|December 2015|2015-12-01||||December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|||Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study||Not yet recruiting||N/A|200|Anticipated|Seoul National University Hospital|||1||f||||||||||||||2017-10-10 22:37:05.217189|2017-10-10 22:37:05.217189
NCT02642133|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-29|||June 2014||2014-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Breastfeeding Improvement Following Tongue-tie and Lip-tie Release|Breastfeeding Improvement Following Tongue-tie and Lip-tie Release: A Prospective Cohort Study|Completed||N/A|237|Actual|The Oregon Clinic||1|||f||||f||||||||||2017-10-10 22:37:05.296644|2017-10-10 22:37:05.296644
NCT02642120|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-29|||January 2016||2016-01-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Dental Support and the Second Stage of Labor Among Multiparous Women|Dental Support and the Second Stage of Labor Among Multiparous Women|Not yet recruiting||Phase 3|500|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||Yes||2017-10-10 22:37:07.129223|2017-10-10 22:37:07.129223
NCT02642107|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|NPC-CTVn||Individualized Elective Neck Irradiation Based on MRI in NPC Patients|The Prospective Randomized Study of Individualized Elective Neck Irradiation Based on MRI in Patients With Nasopharyngeal Carcinoma|Recruiting||Phase 3|396|Anticipated|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 22:37:07.219165|2017-10-10 22:37:07.219165
NCT02642081|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-01-06|||January 2016||2016-01-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Acute Kidney Injury in Patients With Heart Failure|Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Acute Kidney Injury in Patients With Heart Failure|Not yet recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:37:07.414223|2017-10-10 22:37:07.414223
NCT02642068|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-12-24|||August 2014||2014-08-01|December 2015|2015-12-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Neuropsychology, Neuroimage and Neurophysiology in Adults With ADHD|Neuropsychology, Neuroimage and Neurophysiology in Adults With Attention-Deficit Hyperactivity Disorder: An Endophenotype and Follow-up Study|Recruiting||N/A|300|Anticipated|National Taiwan University Hospital|||3||f||||t||||||Samples With DNA|"     The subjects will receive blood withdrawal. The blood sample will be used for establishing     lymphoblastoid cell lines, which will be used for molecular genetic experiments   "|||2017-10-10 22:37:07.511908|2017-10-10 22:37:07.511908
NCT02642055|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-12-20|||December 2015||2015-12-01|May 2016|2016-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy of Neuro+ Attention Training|Efficacy of NEURO+ Attention Training: A Randomized, Controlled, Blinded, Clinical Trial|Completed||N/A|60|Actual|Neuro+||2|||f||||f||||||||No||2017-10-10 22:37:07.58652|2017-10-10 22:37:07.58652
NCT02642029|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-08-02|||January 2016||2016-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study|Cerebellar Transcranial Magnetic Stimulation (cTMS) in Psychotic Disorders: Effect on Time Perception, Executive Function, and Mood and Psychotic Symptoms|Recruiting||N/A|200|Anticipated|Mclean Hospital||2|||f||||f||||||||||2017-10-10 22:37:10.990677|2017-10-10 22:37:10.990677
NCT02641262|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-10-26|||August 2016||2016-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|||Henan STEMI Registry|Henan ST-segment Elevation Myocardial Infarction (STEMI) Registry|Recruiting||N/A|5000|Anticipated|Henan Institute of Cardiovascular Epidemiology|||1||f||||t||||||||||2017-10-10 22:37:30.445579|2017-10-10 22:37:30.445579
NCT02642016|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-03-28|||December 2015||2015-12-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Solid Tumors|A Phase 1, Open-label, Dose-escalation and Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CDX-0158 in Adult Patients With KIT Positive Advanced Solid Tumors.|Recruiting||Phase 1|36|Anticipated|Celldex Therapeutics||1|||f||||f|t|f||||||||2017-10-10 22:37:11.094684|2017-10-10 22:37:11.094684
NCT02642003|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-10-15|||June 2014||2014-06-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis|To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis|Completed||Phase 3|259|Actual|Sir Ganga Ram Hospital||2|||f||||||||||||||2017-10-10 22:37:11.187322|2017-10-10 22:37:11.187322
NCT02641990|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-03-21|||December 2015||2015-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects|A Phase 1, Randomized, Double-blind, Placebo-Controlled, Crossover Study to Assess the Effect of ITCA 650 on the Pharmacokinetics and Pharmacodynamics of a Combination Oral Contraceptive in Healthy Premenopausal Female Subjects|Completed||Phase 1|28|Actual|Intarcia Therapeutics||2|||f||||f||||||||No||2017-10-10 22:37:11.275816|2017-10-10 22:37:11.275816
NCT02641977|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-29|||August 2015||2015-08-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|MTX||Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate|Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate Enroled in the Ratingener Rheuma-Kohorte|Active, not recruiting||N/A|271|Actual|Ruhr University of Bochum|||1||f||||f||||||||||2017-10-10 22:37:11.374383|2017-10-10 22:37:11.374383
NCT02641964|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-03-28|||November 2015||2015-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Risk Factors for ARDS in Patients With Acute Necrotizing Pancreatitis|Risk Factors for ARDS in Patients With Acute Necrotizing Pancreatitis|Suspended||N/A|350|Anticipated|Nanjing Medical University|||2|"In some enrolled cases, key data were missing. Therefore,we plan to collect more cases through   overtime."|f||||f||||||||Yes||2017-10-10 22:37:11.435022|2017-10-10 22:37:11.435022
NCT02641951|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2016-02-05|||November 2015||2015-11-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Stellate Ganglionic Block Versus Stellate Ganglionic Block Plus Pecs II Block for Mastectomy Pain|Stellate Ganglionic Block Versus Combined Stellate Ganglionic Block and Modified Pectoral Nerve Block in Treatment of Post Mastectomy Pain Syndrome.|Enrolling by invitation||N/A|40|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:37:11.502181|2017-10-10 22:37:11.502181
NCT02641938|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-08-01|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury|Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: a Double-blind Randomized Clinical Trial|Recruiting||Phase 4|38|Anticipated|Gangnam Severance Hospital||2|||f||||t||||||||||2017-10-10 22:37:11.572754|2017-10-10 22:37:11.572754
NCT02641925|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-05-31|||August 2015||2015-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Omentectomy for Metabolic Syndrome in Gastric Cancer Patients|The Effect of Visceral Fat Removal for Gastric Cancer Patients With Metabolic Syndrome, Randomized Pilot Study: Omentectomy for Metabolic Syndrome (OMS)|Recruiting||N/A|60|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||f||||||||Yes||2017-10-10 22:37:11.651964|2017-10-10 22:37:11.651964
NCT02641912|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-24|2017-06-09|2016-11-30||March 9, 2016|Actual|2016-03-09|June 2017|2017-06-01|April 15, 2016|Actual|2016-04-15|April 15, 2016|Actual|2016-04-15||Interventional|||Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms|A Clinical Study to Evaluate the Efficacy of an Experimental Mouthwash Formulation|Completed||N/A|100|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:37:12.064786|2017-10-10 22:37:12.064786
NCT02641899|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-01-26|||December 2015||2015-12-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs|A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied Drug/Drug Interaction (DDI) Probe Compounds|Completed||Phase 1|33|Actual|Intarcia Therapeutics||1|||f||||f||||||||No||2017-10-10 22:37:16.675841|2017-10-10 22:37:16.675841
NCT02641886|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2017-07-27|||October 2015||2015-10-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Study of Jian Pi Yi Shen Hua Tan Granules in Cognitive Impairment After Acute Cerebral Infarction|A Study to Evaluate the Safety and Efficacy of Jian Pi Yi Shen Hua Tan Granules in Patients With Cognitive Impairment After Acute Cerebral Infarction|Recruiting||N/A|300|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||2|||f||||t||||||||||2017-10-10 22:37:16.771167|2017-10-10 22:37:16.771167
NCT02641873|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-03-21|||December 2015||2015-12-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer|A Phase I Study of BBI608 Administered With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer|Completed||Phase 1|4|Actual|Sumitomo Dainippon Pharma Co., Ltd.||1|||f||||||||||||||2017-10-10 22:37:16.890057|2017-10-10 22:37:16.890057
NCT02641860|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-02-10|||December 2015||2015-12-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis|A Phase I, Randomized, Single-centered, Double-blinded Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis|Recruiting||Phase 1|18|Anticipated|Cellular Biomedicine Group Ltd.||3|||f||||t||||||||||2017-10-10 22:37:17.05227|2017-10-10 22:37:17.05227
NCT02641665|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-10-05|||January 2016||2016-01-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Plasma Biomarkers in Cardiac Valve Surgery|Measurement of Four Plasma Biomarkers for Risk Stratification and Determination of Functional Recovery After Cardiac Valve Surgery|Recruiting||N/A|250|Anticipated|University Hospital of Liege|||1||f||||f||||||Samples Without DNA|"     Arterial blood   "|||2017-10-10 22:37:18.823227|2017-10-10 22:37:18.823227
NCT02641847|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-24|||July 2015||2015-07-01|December 2015|2015-12-01||||June 2021|Anticipated|2021-06-01||Interventional|||TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature|Efficacy and Safety Study of TA(E)C-GP Versus A(E)C-T for the High Risk Triple-negative Breast Cancer Patients Predicted by the Messenger RNA (mRNA)-Long Non-coding RNA (lncRNA) Signature and Validation of the Signature's Efficacy|Recruiting||Phase 2/Phase 3|503|Anticipated|Fudan University||3|||f||||t||||||||||2017-10-10 22:37:17.160187|2017-10-10 22:37:17.160187
NCT02641834|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-12-14|||January 2016||2016-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|CARDIVEG||Prevention of Cardiovascular Disease With Med or Veg Diets|Prevention of Cardiovascular Disease With the Vegetarian Diet: the CARDIVEG Study|Completed||N/A|100|Actual|Azienda Ospedaliero-Universitaria Careggi||2|||f||||f||||||||Yes||2017-10-10 22:37:17.283967|2017-10-10 22:37:17.283967
NCT02641821|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-23|||October 2015||2015-10-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension|Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension: a Multi-center, Open-label, Observational Study|Recruiting||Phase 4|700|Anticipated|Peking University First Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:37:17.369049|2017-10-10 22:37:17.369049
NCT02641808|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2017-09-14|||August 1, 2016||2016-08-01|September 2017|2017-09-01||||July 31, 2018|Anticipated|2018-07-31||Interventional|Flushing||Does Follicular Flushing Improve the Outcome in Monofollicular IVF Therapy?|Does Follicular Flushing Improve the Outcome in Monofollicular IVF Therapy?|Enrolling by invitation||Phase 3|164|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 22:37:17.458719|2017-10-10 22:37:17.458719
NCT02641795|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-01-24|||July 2014||2014-07-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|MIRACI||Robotic Assisted Cochlear Implantation Feasibility Study|Robotic Assisted Cochlear Implantation Feasibility Study|Recruiting||N/A|13|Anticipated|University Hospital Inselspital, Berne||1|||f||||t||||||||||2017-10-10 22:37:17.540601|2017-10-10 22:37:17.540601
NCT02641782|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2017-02-01|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|January 30, 2017|Actual|2017-01-30|December 23, 2016|Actual|2016-12-23||Interventional|NB2013-HR||NB2013-HR German (GPOH) / Dutch (DCOG) Trial|Randomized Phase 2 Trial Comparing Experimental Immunotherapy in Recurrent High Risk Neuroblastoma Patients With Standard Immunotherapy in Patients With Recurrent and Newly Diagnosed High Risk Neuroblastoma|Terminated||Phase 2|3|Actual|University of Cologne||2||Antibody supply was discontinued by United Therapeutics Corporation.|f||||t||||||||No||2017-10-10 22:37:17.651938|2017-10-10 22:37:17.651938
NCT02641769|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-02-25|||January 2014||2014-01-01|December 2015|2015-12-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.|Intra-Testicular Transplantation of Purified Autologous Clusters of Differentiation (CD) 34+,133+, and Mesenchymal Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.|Recruiting||Phase 1/Phase 2|50|Anticipated|Stem Cells Arabia||1|||f||||f||||||||Undecided||2017-10-10 22:37:17.783732|2017-10-10 22:37:17.783732
NCT02641756|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-03-20|||April 2016||2016-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|HIV-STAR||HIV Sequencing After Treatment Interruption to Identify the Clinically Relevant Anatomical Reservoir|In Depth Sampling and Subsequent Treatment Interruption to Identify the Anatomical Reservoir|Active, not recruiting||N/A|10|Anticipated|University Hospital, Ghent||1|||f||||f||||||||Undecided||2017-10-10 22:37:17.895225|2017-10-10 22:37:17.895225
NCT02641743|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2015-12-28|||January 2009||2009-01-01|December 2015|2015-12-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Clinical Trial for Liquid Food (Inslow)|Increased Insulinogenic Indexes Following Liquid Food (Inslow) Intake in Impaired Glucose Tolerance and Type-2 Diabetic Subjects.|Completed||N/A|36|Actual|Shanghai Meiji Health Science and Technology Co., Ltd.||2|||f||||t||||||||No||2017-10-10 22:37:17.983124|2017-10-10 22:37:17.983124
NCT02641730|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-10-03|||December 15, 2015|Actual|2015-12-15|October 2017|2017-10-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Guselkumab for the Treatment of Subjects With Palmoplantar Pustulosis|Recruiting||Phase 3|225|Anticipated|Janssen Pharmaceutical K.K.||3|||f||||t||f||||||||2017-10-10 22:37:18.079139|2017-10-10 22:37:18.079139
NCT02641717|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-08-25|||November 2015||2015-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Validity of Patient-Collected Wet Mounts|Validity of Patient-Collected Wet Mounts|Completed||N/A|77|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||No||2017-10-10 22:37:18.327655|2017-10-10 22:37:18.327655
NCT02641704|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||The Development Path|A Descriptive Study of Characteristics and Progression of Citizens Assigned to a Multidisciplinary Program Focusing on Moving Citizens From Unemployment and Social Security Benefits to Employment and Education|Recruiting||N/A|200|Anticipated|University of Southern Denmark|||1||f||||t||||||||||2017-10-10 22:37:18.452251|2017-10-10 22:37:18.452251
NCT02641691|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-02-22|||May 27, 2016|Actual|2016-05-27|February 2017|2017-02-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Five Fractions of Radiotherapy Followed by FOLFOX Chemotherapy as Organ-Sparing Treatment for Low Risk Rectal Cancer|Pilot Study of Five Fractions of Radiotherapy Followed by FOLFOX Chemotherapy as Organ-Sparing Treatment for Low Risk Rectal Cancer|Recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t|t|t|f|f|f|||No||2017-10-10 22:37:18.569485|2017-10-10 22:37:18.569485
NCT02641678|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-01-20|||March 2013||2013-03-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|TRACK-AF||Follow-up of Kryptogenic Stroke Patients With Implantable vs. Non-invasive Devices to Detect Atrial Fibrillation.|Follow-up of Kryptogenic Stroke Patients With Implantable vs. Non-invasive Devices to Detect Atrial Fibrillation.|Completed||N/A|106|Actual|University Hospital Muenster|||1||f||||f||||||||No||2017-10-10 22:37:18.734247|2017-10-10 22:37:18.734247
NCT02641470|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-28|||January 2014||2014-01-01|December 2015|2015-12-01||||February 2014|Actual|2014-02-01||Interventional|||The Effect of DA9301 on Tablet Computer-Induced Asthenopia|Clinical Trial to Investigate the Effect of DA9301 on Tablet Computer-induced Asthenopia in Humans|Completed||N/A|60|Actual|DongGuk University||2|||f||||f||||||||||2017-10-10 22:37:20.752197|2017-10-10 22:37:20.752197
NCT02641652|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-05|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ATRAX||A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension|A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension (ATRAX Trial)|Not yet recruiting||Phase 4|136|Anticipated|University Hospital Olomouc||2|||f||||f|t|f|||t|||||2017-10-10 22:37:18.913498|2017-10-10 22:37:18.913498
NCT02641639|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-10-02|||June 2016|Actual|2016-06-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer|FOCUS: A Multicenter, Multinational, Double-Blind, 2-Arm, Randomized, Phase 2/3, Study of Physician's Choice Chemotherapy ([PCC] Weekly Paclitaxel or Pegylated Liposomal Doxorubicin [PLD]) Plus Bevacizumab and CA4P Versus PCC Plus Bevacizumab and Placebo for Subjects With Platinum-Resistant, Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Suspended||Phase 2/Phase 3|436|Anticipated|Mateon Therapeutics||2|||f||||t||||||||||2017-10-10 22:37:19.034416|2017-10-10 22:37:19.034416
NCT02641626|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2016-07-15|||January 2016||2016-01-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|COUPE||Coronariography in OUt of hosPital Cardiac arrEst|Randomized Study About the Efficacy of an Urgent Coronariography in Patients With a Non-diagnostic Electrocardiogram Following Out of Hospital Cardiac Arrest.|Recruiting||N/A|166|Anticipated|Hospital San Carlos, Madrid||2|||f||||f||||||||||2017-10-10 22:37:19.263886|2017-10-10 22:37:19.263886
NCT02641613|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-08-31|||January 2016||2016-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Retroclavicular Versus Supraclavicular Brachial Plexus Block for Hand and Forearm Surgery|The Efficacy of Retroclavicular Versus Supraclavicular Brachial Plexus Block in Patients Undergoing Forearm and Hand Surgery: a Randomized Controlled Double-blinded Trial.|Recruiting||Phase 4|120|Anticipated|Hôpital du Valais||2|||f||||f||||||||Undecided||2017-10-10 22:37:19.383693|2017-10-10 22:37:19.383693
NCT02641600|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-05-10|||December 2015||2015-12-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|RECVEN||Elastic Compression in Chronic Venous Disease|Randomised Trial Comparing the Effectiveness of Elastic Compression in Treating Chronic Venous Disease (CEAP C2-C5)|Recruiting||N/A|30|Anticipated|University of Patras||2|||f||||f||||||||||2017-10-10 22:37:19.670953|2017-10-10 22:37:19.670953
NCT02641587|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-08-09|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|August 2016|Actual|2016-08-01||Interventional|||Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.|A Randomized, Controlled, Open-label, 2-arm Parallel Group, Single Center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Healthy Smokers Switching to the Carbon Heated Tobacco Product 1.2 (CHTP 1.2), Compared to Continuing to Use Combustible Cigarettes, for 5 Days in Confinement Followed by 85 Days in an Ambulatory Setting.|Active, not recruiting||N/A|121|Actual|Philip Morris Products S.A.||2|||f||||f||||||||||2017-10-10 22:37:19.773425|2017-10-10 22:37:19.773425
NCT02641574|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-23|||January 2009||2009-01-01|December 2015|2015-12-01||||November 2015|Actual|2015-11-01||Observational|||Relation Between Complication in Repeated Cesarean Sections, Newborn Outcome and Surgical Characteristics and Maternal Information|Relation Between Complication in Repeated Cesarean Sections Compared With Newborn Outcome,Surgical Characteristics and Maternal Information|Completed||N/A|5000|Actual|Rambam Health Care Campus|||4||f||||||||||||||2017-10-10 22:37:19.84686|2017-10-10 22:37:19.84686
NCT02641548|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-10-21|||December 2015||2015-12-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Silicone Sock as Treatment of Deep Heel Fissures in People With Diabetes|Silicone Sock as Treatment of Deep Heel Fissures in People With Diabetes -a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Region Örebro County||2|||f||||f||||||||No|Only group level data will be published|2017-10-10 22:37:20.069013|2017-10-10 22:37:20.069013
NCT02641535|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-28|||February 2016||2016-02-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluating the Physiological Strain Induced by a BC Membrane Protective Garment Under Exercise-heat Stress Compared to a Protective Coverall|Evaluating the Physiological Strain Induced by a BC Membrane Protective Garment Under Exercise-heat Stress Compared to a Protective Coverall|Not yet recruiting||N/A|12|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 22:37:20.175752|2017-10-10 22:37:20.175752
NCT02641522|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-03-08|||March 2016||2016-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes|Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes|Active, not recruiting||Early Phase 1|10|Anticipated|Benaroya Research Institute||1|||f||||f||||||||Yes||2017-10-10 22:37:20.280352|2017-10-10 22:37:20.280352
NCT02641509|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-11-01|||January 2016||2016-01-01|November 2016|2016-11-01||||January 2017|Anticipated|2017-01-01||Interventional|||Accuracy in Resection of Non-pedunculated Colonic Lesions 5-20 mm With/Without Using NBI||Recruiting||N/A|918|Anticipated|Valduce Hospital||2|||f||||f||||||||||2017-10-10 22:37:20.366225|2017-10-10 22:37:20.366225
NCT02641496|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-26|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Cognitive Behavioral Therapy to Increase CPAP Adherence in Veterans With PTSD|Cognitive Behavioral Therapy to Increase CPAP Adherence in Veterans With PTSD|Recruiting||N/A|144|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:37:20.461231|2017-10-10 22:37:20.461231
NCT02641483|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-26|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Stimulation for Colonic Motility|Afferent Stimulation to Evoke Recto-colonic Reflex for Colonic Motility|Not yet recruiting||N/A|10|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 22:37:20.654139|2017-10-10 22:37:20.654139
NCT02641444|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-04-03|||April 2016||2016-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects|Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects|Recruiting||N/A|22|Anticipated|University of North Carolina, Chapel Hill|||4||f||||f||||||||No||2017-10-10 22:37:20.932166|2017-10-10 22:37:20.932166
NCT02641431|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-12-29|||November 2015||2015-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|BRUGADA_I||Epicardial Ablation in Brugada Syndrome|Electrical Substrate Elimination in Brugada Syndrome. Results in 135 Consecutive Patients|Completed||N/A|135|Actual|IRCCS Policlinico S. Donato||1|||f||||t||||||||No||2017-10-10 22:37:21.06125|2017-10-10 22:37:21.06125
NCT02641418|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-12-28|||May 2015||2015-05-01|December 2015|2015-12-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|SEIC||Optimising the Efficacy, Patient Perception and Uptake of an Exercise Programme in People in Intermittent Claudication|Optimising the Efficacy, Patient Perception and Uptake of an Exercise Programme in People in Intermittent Claudication|Recruiting||N/A|120|Anticipated|University of Hull||1|||f||||f||||||||No||2017-10-10 22:37:21.197515|2017-10-10 22:37:21.197515
NCT02641405|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-08-18|||November 2015||2015-11-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|September 2019|Anticipated|2019-09-01||Interventional|PAGE||Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study|Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study|Recruiting||N/A|126|Anticipated|I.R.C.C.S. Fondazione Santa Lucia||2|||f||||f||||||||||2017-10-10 22:37:21.303566|2017-10-10 22:37:21.303566
NCT02641392|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-10-02|||July 25, 2016|Actual|2016-07-25|October 2017|2017-10-01|December 31, 2021|Anticipated|2021-12-31|November 30, 2021|Anticipated|2021-11-30||Interventional|||A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Mongersen GED-0301 Maintenance Therapy in Subjects With Crohn's Disease|Recruiting||Phase 3|1300|Anticipated|Celgene||5|||f||||t||||||||||2017-10-10 22:37:21.519435|2017-10-10 22:37:21.519435
NCT02641379|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-06-23|2016-04-28||May 2003||2003-05-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Baseline characteristics are presented for the safety population which included all participants who received at least on dose of (either) study drug and had at least one post-baseline safety assessment.|A Study of Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC)|Randomized, Multicenter Study to Find Optimal Treatment Duration in Patients With Chronic Hepatitis C and Subtype 1 or 4 Depending on HCV RNA Level at Week 8 and Week 12|Completed||Phase 4|737|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-10 22:37:22.967757|2017-10-10 22:37:22.967757
NCT02641366|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-06-01|||January 2016||2016-01-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Electromagnetic Tracking to Measure Tremor|Noninvasive Electromagnetic Tracking of Upper Extremity Motion Kinetics for Patients With Severe Tremor Disorders|Completed||N/A|20|Actual|University of Florida|||2||f||||f||||||||No||2017-10-10 22:37:27.765528|2017-10-10 22:37:27.765528
NCT02641353|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-03-25|||January 2016||2016-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and a Study to Assess Effect of Food on the Pharmacokinetic (PK) of the Oral Suspension|A Phase 1, Open-Label, Randomized Three-Period, Six-Sequence Crossover Study In Healthy Adult Subjects To Evaluate The Bioavailablity Of An Oral Suspension Formulation Relative To The Tablet Formulation Of Apremilast And To Assess The Effect Of Food On The Pharmacokinetics Of The Oral Suspension Formulation|Completed||Phase 1|34|Anticipated|Celgene Corporation||3|||f||||f||||||||||2017-10-10 22:37:27.839042|2017-10-10 22:37:27.839042
NCT02641340|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-03-28|||January 2016||2016-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Fentanyl Sublingual Spray in Opioid Naive Participants|A Phase 1, Multiple Ascending Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fentanyl Sublingual Spray in Opioid Naive Subjects|Completed||Phase 1|96|Actual|INSYS Therapeutics Inc||12|||f||||t||||||||||2017-10-10 22:37:27.938147|2017-10-10 22:37:27.938147
NCT02641327|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-11-30|||December 2015||2015-12-01|September 2016|2016-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Monitoring Changes in Blood Pressure|Protocol for Evaluation of EarlySense: A Contact-less Device for Monitoring Changes in Blood Pressure|Completed||N/A|100|Actual|EarlySense Ltd.|||2||f||||t||||||||Undecided||2017-10-10 22:37:28.042498|2017-10-10 22:37:28.042498
NCT02641314|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|October 2018|Anticipated|2018-10-01||Interventional|METRO-NB2012||Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma|Phase 2 Trial of Metronomic Treatment in Children and Adolescents With Recurrent or Progressive Neuroblastoma (NB)|Recruiting||Phase 2|26|Anticipated|University of Cologne||1|||f||||t||||||||Yes||2017-10-10 22:37:28.107981|2017-10-10 22:37:28.107981
NCT02641301|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-11-28|||December 2015||2015-12-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|OBEMO2||Sustained-release Morphine Pharmacokinetics in Roux-en-Y Gastric Bypass Subjects|Study of the Concentrations of Long Acting Morphine After Oral Absorption in Subjects Who Underwent Gastric Bypass (OBEMO 2)|Active, not recruiting||Phase 4|24|Actual|Hopital Lariboisière||2|||f||||f||||||||Undecided||2017-10-10 22:37:28.20856|2017-10-10 22:37:28.20856
NCT02641288|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-22|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Intraperitoneal Ropivacaine Irrigation in Bariatric Surgery|Intraperitoneal Ropivacaine Irrigation in Patients Undergoing Bariatric Surgery|Completed||Phase 3|110|Actual|Hospital General Universitario Elche||2|||f||||t||||||||||2017-10-10 22:37:30.300564|2017-10-10 22:37:30.300564
NCT02641275|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ZRM-CMD-P||Self-management Training for Parents With Chronic Muscular Dystrophia|Self-management Training for Parents With Chronic Muscular Dystrophia|Not yet recruiting||N/A|80|Anticipated|University Children's Hospital, Zurich||2|||f||||f||||||||||2017-10-10 22:37:30.370044|2017-10-10 22:37:30.370044
NCT02641249|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-03-29|2016-11-14||October 2014||2014-10-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional||Premature neonates (23 to <34 weeks gestational age) Diagnosis of apnea of prematurity|Non-invasive Intervention for Apnea of Prematurity|Neuromodulation of Limb Proprioceptive Afferents Using a Vibratory Device to Decrease Apnea, Intermittent Hypoxia and Bradycardia of Prematurity.|Completed||N/A|19|Actual|University of California, Los Angeles||2|||f||||f||||||||Yes|"Available online as supporting information:
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157349#sec019"|2017-10-10 22:37:30.537482|2017-10-10 22:37:30.537482
NCT02641236|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-07-18|||March 2016||2016-03-01|July 2017|2017-07-01|May 2023|Anticipated|2023-05-01|October 2019|Anticipated|2019-10-01||Interventional|||Gut Decontamination In Pediatric Allogeneic Hematopoietic|A Randomized Phase 2 Study to Examine the Impact of Gut Decontamination on Intestinal Microbiome Composition in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients|Recruiting||Phase 2|28|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 22:37:30.847857|2017-10-10 22:37:30.847857
NCT02641223|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-05-24|||November 2015||2015-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Evaluation of Objective Outcomes With the Use of an Activity Tracker During the Trial Period of Spinal Cord Stimulation||Completed||N/A|9|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-10 22:37:31.032484|2017-10-10 22:37:31.032484
NCT02641210|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-12-28|||January 2015||2015-01-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Impact of Periodontal Treatment on Serum Levels of Hepcidin and Hemoglobin|Impact of Periodontal Treatment on Serum Levels of Hepcidin and Hemoglobin: a Clinical Trial|Completed||Phase 4|63|Actual|Federal University of Maranhao||2|||f||||t||||||||||2017-10-10 22:37:31.129912|2017-10-10 22:37:31.129912
NCT02641197|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-02-06|||April 2016|Actual|2016-04-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study|Vascular Reactivity Assessment by AngioDefender -- A Repeatability and Reproducibility Study|Recruiting||N/A|40|Anticipated|Everist Genomics, Inc||1|||f||||f||||||||No||2017-10-10 22:37:31.251747|2017-10-10 22:37:31.251747
NCT02641184|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-02-13|||December 2015||2015-12-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction|A Multicenter Prospective Observational Study to Evaluate the Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction (AMI)|Enrolling by invitation||N/A|3000|Anticipated|Zhejiang Provincial People’s Hospital|||1||f||||f||||||Samples With DNA|"     Blood specimens for biomarker analysis and storage for future genetic studies   "|No|No plan to share data|2017-10-10 22:37:31.440679|2017-10-10 22:37:31.440679
NCT02641171|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-28|||December 2015||2015-12-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Observational|||Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort|Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort|Recruiting||N/A|20|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||Samples Without DNA|"     exhaled air samples blood samples fecal samples   "|Yes||2017-10-10 22:37:31.529888|2017-10-10 22:37:31.529888
NCT02641158|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-22|||December 2015||2015-12-01|December 2015|2015-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CTN 0064||Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.|CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.|Enrolling by invitation||N/A|684|Anticipated|Columbia University||2|||f||||t||||||||Yes|Information about the study and the de-identified study data will be available at https://datashare.nida.nih.gov/ within 18 months of the date the data are locked, as per the procedures of the National Drug Abuse Treatment Clinical Trials Network.|2017-10-10 22:37:31.719789|2017-10-10 22:37:31.719789
NCT02641145|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-05-16|||April 2016||2016-04-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|MICA||Molecular Imaging of Primary Amyloid Cardiomyopathy|Molecular Imaging of Primary Amyloid Cardiomyopathy|Recruiting||N/A|100|Anticipated|Brigham and Women's Hospital||3|||f||||f||||||||Yes||2017-10-10 22:37:31.886926|2017-10-10 22:37:31.886926
NCT02641132|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-23|||September 2015||2015-09-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PHB-MMC1||Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.|The Comparison of Endothelial Cell Count in Pterygium Surgery Relating to the Timing of MMC Application.|Unknown status|Not yet recruiting|Phase 4|62|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-10 22:37:32.026979|2017-10-10 22:37:32.026979
NCT02641119|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-07-26|||August 2014||2014-08-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||Resuscitation Fluid Choice and Clinical Outcomes|Association of Resuscitation Fluid Choice and Clinical Outcomes in Critically Ill Patients|Active, not recruiting||N/A|65800|Anticipated|University of Pittsburgh|||2||f||||f||||||||||2017-10-10 22:37:32.135188|2017-10-10 22:37:32.135188
NCT02641106|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|VMALT||VDOT for Monitoring Adherence to LTBI Treatment|Video Directly Observed Therapy (VDOT) to Monitor Short-Course LTBI Treatment|Recruiting||N/A|310|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 22:37:32.230046|2017-10-10 22:37:32.230046
NCT02641093|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-07-29|||January 2016||2016-01-01|July 2016|2016-07-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma|Phase II Investigation of Adjuvant Combined Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 2|80|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-10 22:37:32.372419|2017-10-10 22:37:32.372419
NCT02641080|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-01-04|||January 2016||2016-01-01|January 2016|2016-01-01||||August 2016|Anticipated|2016-08-01||Interventional|||Evaluating the Need for Pneumatic Compression Devices|Evaluating the Need for Pneumatic Compression Devices: A Randomized-controlled Trial (RCT) of Aspirin Versus Aspirin and Pneumatic Compression Devices|Not yet recruiting||N/A|500|Anticipated|West Virginia University||2|||f||||t||||||||||2017-10-10 22:37:32.506809|2017-10-10 22:37:32.506809
NCT02641067|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-06-10|||January 2016||2016-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study Evaluating the Pharmacokinetics of Doravirine in Participants With Severe Renal Impairment (MK-1439-051)|An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of MK-1439 (Doravirine) in Subjects With Severe Renal Impairment|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:37:32.612356|2017-10-10 22:37:32.612356
NCT02641054|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-07-20|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease|Double-Blind Randomized Placebo-Controlled Cross-Over Phase IIa Trial to Evaluate Efficacy of CVXL-0107 on Parkinson-Related Symptoms and Levodopa-Induced Dyskinesia in Advanced Parkinson's Disease Patients Using a Levodopa Challenge Test|Completed||Phase 2|21|Actual|CleveXel Pharma||2|||f||||f||||||||||2017-10-10 22:37:32.710322|2017-10-10 22:37:32.710322
NCT02641041|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-10-07|||February 2016||2016-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants|A Randomized, Blinded, Placebo-Controlled, Single- and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB033 in Healthy Japanese Subjects|Completed||Phase 1|24|Actual|Biogen||3|||f||||f||||||||||2017-10-10 22:37:32.819432|2017-10-10 22:37:32.819432
NCT02641028|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-25||2017-09-18|December 2015||2015-12-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|September 13, 2016|Actual|2016-09-13||Interventional|||A Study in a Human Laboratory Model of Smoking Behavior|A Randomized, Double-Blind, Placebo-Controlled, Crossover Design Study of CERC-501 in a Human Laboratory Model of Smoking Behavior|Completed||Phase 2|71|Actual|Cerecor Inc||2|||f||||f||||||||||2017-10-10 22:37:32.91651|2017-10-10 22:37:32.91651
NCT02641015|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-01-16|||December 2015||2015-12-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|RESCUING||Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)|A Retrospective Observational Study to Assess the Clinical Management and Outcomes of Hospitalised Patients With Complicated Urinary Tract Infection in Countries With High Prevalence of Multidrug Resistant Gram-negative Bacteria.|Completed||N/A|1028|Actual|Institut d'Investigació Biomèdica de Bellvitge|||1||f||||t||||||||||2017-10-10 22:37:33.014766|2017-10-10 22:37:33.014766
NCT02641002|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-08-30|||March 1, 2016|Actual|2016-03-01|August 2017|2017-08-01|July 10, 2019|Anticipated|2019-07-10|July 10, 2019|Anticipated|2019-07-10||Interventional|||A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)|A Phase 1, Open-label, Dose Finding Study of CC-90002, a Monoclonal Antibody Directed Against CD47, in Subjects With Acute Myeloid Leukemia and High-Risk Myelodsplastic Syndrome|Recruiting||Phase 1|71|Anticipated|Celgene||1|||f||||f||||||||||2017-10-10 22:37:33.196846|2017-10-10 22:37:33.196846
NCT02640989|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-22|||October 2014||2014-10-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military|Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military|Completed||Phase 4|292|Actual|Center for Disease Prevention and Control of Beijing Military Region||3|||f||||t||||||||||2017-10-10 22:37:33.325578|2017-10-10 22:37:33.325578
NCT02640976|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-22|||June 2013||2013-06-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program|Assessing the Relation Between Hormone Receptors Gene Polymorphism and Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program|Completed||Early Phase 1|216|Actual|Cairo University||2|||f||||t||||||||Yes||2017-10-10 22:37:33.476743|2017-10-10 22:37:33.476743
NCT02640963|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-03-18|||January 2015||2015-01-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Feasibility and Benefits of Group Based Exercise in Residential Aged Care Adults|Feasibility and Benefits of Group Based Exercise in Residential Aged Care Adults: a Pilot Study for the GrACE Programme|Completed||N/A|37|Actual|Bond University||2|||f||||f||||||||No||2017-10-10 22:37:33.597681|2017-10-10 22:37:33.597681
NCT02640950|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-25|||December 2015||2015-12-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||An Open Label Trial of TMS Therapy for Bipolar Depression|An Open Label Trial of TMS Therapy for Bipolar Depression|Recruiting||N/A|50|Anticipated|Sheppard Pratt Health System||1|||f||||f||||||||||2017-10-10 22:37:33.777098|2017-10-10 22:37:33.777098
NCT02640937|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-22|||November 2011||2011-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Observational|||Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections|Biofilm Formation Increases Treatment Failure in Staphylococcus Epidermidis Device-related Osteomyelitis in Human Patients|Completed||N/A|124|Actual|BG Unfallklinik|||1||f||||f||||||Samples Without DNA|"     Bacterial samples from orthopaedic device realted infections   "|||2017-10-10 22:37:33.952651|2017-10-10 22:37:33.952651
NCT02640924|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-03-18|||January 2016||2016-01-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular Carcinoma|Proton Beam Radiotherapy Versus Switching Control Radiofrequency Ablation for Patients With Medium (>3, ≦5 cm) or Large (>5, ≦7cm) Treatment-naive Hepatocellular Carcinoma|Recruiting||Phase 3|166|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 22:37:34.061407|2017-10-10 22:37:34.061407
NCT02640911|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-07-29|||November 2010||2010-11-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Observational|||An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia||Recruiting||N/A|3000|Anticipated|Shanghai Mental Health Center|||1||f||||f||||||||||2017-10-10 22:37:34.772784|2017-10-10 22:37:34.772784
NCT02640898|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-03-13|||December 2015||2015-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric Cancer|the Ethic Committee of Shanghai General Hospital|Recruiting||N/A|500|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||Undecided||2017-10-10 22:37:34.871355|2017-10-10 22:37:34.871355
NCT02640885|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2015-12-23|||May 2015||2015-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||The Foley's Catheter Balloon to the Bleeding From Placenta Previa|Use of Foley's Catheter Balloon Tamponade to Control Placental Site Bleeding Resulting From Placenta Previa During Cesarean Section|Completed||Phase 2|15|Actual|Assiut University||1|||f||||f||||||||Undecided||2017-10-10 22:37:34.977819|2017-10-10 22:37:34.977819
NCT02640872|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-02-25|||July 2015|Actual|2015-07-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Observational|HAPPY||A Prospective Cohort Study of Aged People for Chronic Diseases|A Hospital-based Prospective Cohort Study With Aged People to Elucidate Predictive Factors Including Muscle and Fat Mass for Chronic Diseases and Mortality|Recruiting||N/A|1000|Anticipated|Seoul National University Bundang Hospital|||1||f||||t||||||Samples With DNA|"     for measuring biomarkers   "|No||2017-10-10 22:37:35.06078|2017-10-10 22:37:35.06078
NCT02640846|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-02-02|||December 2015||2015-12-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SCLM||Effects of Levosimendan and Milrinone on Left and Right Ventricular Function in Septic Cardiomyopathy|Potential Differences Between Levosimendan and Milrinone on Hemodynamic Variables in Patients With Septic Cardiomyopathy|Recruiting||Phase 4|30|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||No||2017-10-10 22:37:35.222167|2017-10-10 22:37:35.222167
NCT02640833|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2016-07-22|||July 2016||2016-07-01|July 2016|2016-07-01|February 2021|Anticipated|2021-02-01|January 2020|Anticipated|2020-01-01||Interventional|||A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor|A Phase 1b/2 Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor|Withdrawn||Phase 1|0|Actual|AbbVie||1||Study Stopped|f||||f||||||||||2017-10-10 22:37:35.326319|2017-10-10 22:37:35.326319
NCT02640820|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-08-01|||December 2015||2015-12-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)|A Prospective, Phase 2a Study to Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) in Subjects Ages 18 - 65 Years|Recruiting||Phase 2|40|Anticipated|RXi Pharmaceuticals, Corp.||2|||f||||t||||||||No||2017-10-10 22:37:35.477313|2017-10-10 22:37:35.477313
NCT02640807|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-04-24|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|IRIS-7-B||A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients|A Multicenter, Randomized, Double-blinded, Placebo-controlled Study of Two Dosing Frequencies of Recombinant Interleukin-7 (CYT107) Treatment to Restore Absolute Lymphocyte Counts in Sepsis Patients.|Active, not recruiting||Phase 2|30|Anticipated|Revimmune||3|||f||||t||||||||No||2017-10-10 22:37:35.579402|2017-10-10 22:37:35.579402
NCT02640794|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-05-10|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Interventional|ARTE||Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI|Aspirin Versus Aspirin + ClopidogRel as Antithrombotic Treatment Following Transcatheter Aortic Valve Implantation With the Edwards Valve. A Randomized Study (the ARTE Trial)|Active, not recruiting||Phase 4|222|Actual|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec||2|||f||||f||||||||Undecided||2017-10-10 22:37:35.70877|2017-10-10 22:37:35.70877
NCT02640781|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-22|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction|Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction: a Prospective, Multicenter Study|Not yet recruiting||N/A|70|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:37:35.862937|2017-10-10 22:37:35.862937
NCT02640768|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-12-22|||January 2012||2012-01-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Governance of Diabetes Management in Non-specialistic Hospital Settings|Governance of Diabetes Management in Non-specialistic Hospital Settings|Completed||N/A|1449|Actual|Azienda Ospedaliero-Universitaria di Parma||2|||f||||f||||||||||2017-10-10 22:37:35.967094|2017-10-10 22:37:35.967094
NCT02640742|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-07-14|||December 2015||2015-12-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|ACQUIRE-2||Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting|Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting-A Cross-sectional Study of Adult Asthma Patients in Japan|Completed||N/A|1232|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 22:37:36.235317|2017-10-10 22:37:36.235317
NCT02640716|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-07-11|||October 2015||2015-10-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|May 8, 2017|Actual|2017-05-08||Interventional|Cog-VACCINE||Cog-VACCINE: Cognitive Training in Patients With Vascular Cognitive Impairment, no Dementia|The Cog-VACCINE Study: a Randomized Controlled Clinical Trial to Evaluate the Effect of Cognitive Training in Patients With Vascular Cognitive Impairment, no Dementia|Active, not recruiting||N/A|60|Actual|Beijing Friendship Hospital||2|||f||||f||||||||||2017-10-10 22:37:37.103675|2017-10-10 22:37:37.103675
NCT02640703|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2016-11-29|||March 2015||2015-03-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Morning vs. Evening Vaccination on Hypoxia and Bradycardia of Preterm Infants: a Randomised Controled Trial|Effect of Morning vs. Evening Vaccination on Hypoxia and Bradycardia of Preterm Infants: a Randomised Controled Trial|Active, not recruiting||Phase 3|16|Actual|University Hospital Tuebingen||2|||f||||f||||||||No||2017-10-10 22:37:37.205466|2017-10-10 22:37:37.205466
NCT02640690|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-07|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|July 1, 2019|Anticipated|2019-07-01||Interventional|PSL II||Trauma-Sensitive Yoga for Female Veterans With PTSD Who Experienced Military Sexual Trauma|Trauma-sensitive Yoga for Female Veterans With PTSD Who Experienced Military Sexual Trauma|Recruiting||N/A|210|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:37:37.300604|2017-10-10 22:37:37.300604
NCT02640677|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-05-31|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Observational|||Safety of 4CMenB Exposure During Pregnancy|4CMenB Pregnancy Registry: an Observational Study of the Safety of 4CMenB Exposure in Pregnant Women and Their Offspring.|Recruiting||N/A|50|Anticipated|GlaxoSmithKline|||1||f||||||||||||||2017-10-10 22:37:37.422988|2017-10-10 22:37:37.422988
NCT02640651|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-09-06|||December 2015||2015-12-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||An Study of Transcranial Direct Current Stimulation in Adults With ADHD|An Open Label Pilot Study of Transcranial Direct Current Stimulation in Adults With ADHD|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 22:37:37.714047|2017-10-10 22:37:37.714047
NCT02640638|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-07-14|||February 2016||2016-02-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|January 2020|Anticipated|2020-01-01||Interventional|CRADEL||A RCT of CenteringPregnancy on Birth Outcomes|Reducing Disparities in Birth Outcomes: a Randomized Controlled Trial of CenteringPregnancy|Recruiting||N/A|3160|Anticipated|Clemson University||2|||f||||t||||||||||2017-10-10 22:37:37.896273|2017-10-10 22:37:37.896273
NCT02640625|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-01-05|||January 2016||2016-01-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Improving Prognosis in HIV Infection|Adjuvant Mucosal Therapy in HIV-infected Men With Insufficient Response to Antiretroviral Therapy|Enrolling by invitation||Phase 1/Phase 2|60|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-10-10 22:37:37.997251|2017-10-10 22:37:37.997251
NCT02640599|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-12-27|||October 2015||2015-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stationary Bike Study|The Effect of Vestibular and Exertion Training on Gait, Balance and Dizziness in Individuals With Concussion|Recruiting||N/A|44|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:37:38.459607|2017-10-10 22:37:38.459607
NCT02640586|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-07-31|||January 10, 2016|Actual|2016-01-10|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI|Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI|Recruiting||N/A|1000|Anticipated|Beijing Cancer Hospital||1|||f||||t|f|f||||||||2017-10-10 22:37:38.572716|2017-10-10 22:37:38.572716
NCT02640573|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-08-25|||December 2015||2015-12-01|August 2017|2017-08-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE)|Treatment of Adult Patients With Hemoglobin SC Disease|Recruiting||Phase 2|41|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 22:37:38.72131|2017-10-10 22:37:38.72131
NCT02640560|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-23|||October 2012||2012-10-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish|One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish|Completed||N/A|200|Actual|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||2||f||||f||||||||||2017-10-10 22:37:38.817896|2017-10-10 22:37:38.817896
NCT02640547|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-04-03|||November 2015||2015-11-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C|Real World Evidence (RWE) of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Poland (HCV RWE PMOS)|Completed||N/A|394|Actual|AbbVie|||5||f||||f||||||||||2017-10-10 22:37:38.912662|2017-10-10 22:37:38.912662
NCT02640534|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-05-10|||March 24, 2016|Actual|2016-03-24|May 2017|2017-05-01|June 2026|Anticipated|2026-06-01|October 2018|Anticipated|2018-10-01||Interventional|||Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone|Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone (IMPROVE TRIAL): A Randomized, Open Label, Phase II Trial|Recruiting||Phase 2|168|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||No||2017-10-10 22:37:39.068775|2017-10-10 22:37:39.068775
NCT02640521|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-12-08|||August 2015||2015-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Smoking Cessation Peds Asthma|Pilot Testing an Intervention to Increase Implementation of Evidence-based Guidelines to Achieve Smoking Cessation in Smoking Parents of Inner-city Children With Asthma|Withdrawn||N/A|0|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:37:39.309276|2017-10-10 22:37:39.309276
NCT02640508|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-08-07|||May 2016||2016-05-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Eribulin and Lenvatinib in Advanced Solid Tumors|Phase II Trial of Eribulin and Lenvatinib in Advanced Solid Tumors (CTMS# 15-2139)|Recruiting||Phase 2|39|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-10 22:37:39.433582|2017-10-10 22:37:39.433582
NCT02640495|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-12-22|||April 2016||2016-04-01|December 2015|2015-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|ARIMTIA||Artemisinin Resistance In Malaria Treated With IV Artesunate|A Multicenter, Prospective, Observational Study to Assess the Effi-cacy of Artesunate in Malaria Treated With Parenteral Artesunate in Areas With Artemisinin Resistance A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)|Not yet recruiting||N/A|132|Anticipated|University of Oxford|||1||f||||t||||||Samples Without DNA|"     Blood sample   "|||2017-10-10 22:37:39.587097|2017-10-10 22:37:39.587097
NCT02640482|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-17|2017-08-17|2016-10-21|November 2015|Actual|2015-11-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|September 2016|Actual|2016-09-01||Interventional|ENDURANCE-2|Safety population: All participants who received at least one dose of study drug.|A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection|A Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 2 Infection (ENDURANCE-2)|Completed||Phase 3|304|Actual|AbbVie||3|||f||||f||||||||||2017-10-10 22:37:39.718186|2017-10-10 22:37:39.718186
NCT02640469|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-01-05|||December 2016||2016-12-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Alcohol Versus Chlorhexidine With and Without Water|Efficacy of the Use of Alcohol-bases Solutions Versus Chlorhexidine With or Without Water for Hand Sanitation Prior to Surgical Procedure|Withdrawn||N/A|0|Actual|New York University School of Medicine||3|||f||||f||||||||||2017-10-10 22:37:40.104899|2017-10-10 22:37:40.104899
NCT02640456|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-04-26|||April 2016||2016-04-01|April 2016|2016-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Microbiology of Para- og Retropharyngeal Abscess|Mikrobiologi Ved Para- og Retropharyngeal Absces|Recruiting||N/A|72|Anticipated|Aarhus University Hospital|||2||f||||f||||||Samples With DNA|"     Tonsillar surface swabs, pus aspirates, tonsillar tissues, sera   "|||2017-10-10 22:37:40.192068|2017-10-10 22:37:40.192068
NCT02640443|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-12-22|||October 2015||2015-10-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|SPPD||Sulfamethoxazole for the Treatment of Primary PREPL Deficiency|Sulfamethoxazole for the Treatment of Primary PREPL Deficiency (In Dutch: Sulfamethoxazole Ter Behandeling Van Primaire PREPL deficiëntie)|Unknown status|Enrolling by invitation|Phase 2|15|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-10 22:37:40.323199|2017-10-10 22:37:40.323199
NCT02640430|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-03-21|||October 2016||2016-10-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Randomized Trial of the FreeAspire Versus PEP-bottle After Acute Exacerbation in COPD Patients|A Preliminary Randomized Trial of the FreeAspire Versus PEP-bottle After Acute Exacerbation in COPD Patients With Mucus Hypersecretion and Decreased Cough Efficiency.|Recruiting||N/A|40|Anticipated|Maugeri Foundation||2|||f||||t||||||||Yes|publication|2017-10-10 22:37:40.423248|2017-10-10 22:37:40.423248
NCT02640417|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-02|||March 2016||2016-03-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Nucleotides and B Vitamins in the Treatment of Low Back Pain|Avaliação clínica-terapêutica Comparativa em Lombalgias de Etiologia Traumato-compressivas Utilizando-se Vitaminas do Complexo B e nucleotídeos|Active, not recruiting||Phase 4|300|Actual|Fundação Educacional Serra dos Órgãos||2|||f||||f||||||||||2017-10-10 22:37:40.533121|2017-10-10 22:37:40.533121
NCT02640391|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-07-23|||January 2016||2016-01-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|PINQLE||Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis|Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis: Prospective Observational Multicenter Study|Recruiting||N/A|150|Anticipated|Kyungpook National University|||1||f||||t||||||||No||2017-10-10 22:37:40.707837|2017-10-10 22:37:40.707837
NCT02640378|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-24|||December 2014||2014-12-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Semiquantitative Urine Pregnancy Test Results At ≥9 Weeks of Gestation||Completed||N/A|122|Actual|Gynuity Health Projects|||1||f||||f||||||||No||2017-10-10 22:37:40.809207|2017-10-10 22:37:40.809207
NCT02640365|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-01-30|||November 18, 2015|Actual|2015-11-18|January 2017|2017-01-01|December 7, 2016|Actual|2016-12-07|December 7, 2016|Actual|2016-12-07||Interventional|DOUBLIRI||A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer|A Phase Ib Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer - DOUBLIRI|Completed||Phase 1|10|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||f||||||||No||2017-10-10 22:37:40.861517|2017-10-10 22:37:40.861517
NCT02640352|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-22|||December 2015||2015-12-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|||The Efficacy of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children|A Randomized, Double Blind, Placebo-controlled Study to Investigate the Effect of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children|Recruiting||N/A|556|Anticipated|Probi AB||2|||f||||f||||||||No||2017-10-10 22:37:40.970206|2017-10-10 22:37:40.970206
NCT02640339|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-07-20|||February 2016||2016-02-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease|Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease|Recruiting||N/A|170|Anticipated|New York University School of Medicine|||6||f||||f|f|f||||||||2017-10-10 22:37:41.057834|2017-10-10 22:37:41.057834
NCT02640326|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-03-15|||March 2016||2016-03-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|UCATh||McMaster Catheterization for Thoracoscopic Surgery Study|A Prospective Randomized Control Trial Comparing Routine Urinary Catheterization vs. No-Urinary Catheterization at the Time of Thoracoscopic Pulmonary Resection (McMaster Catheterization for Thoracoscopic Surgery Study - UCATh Study)|Recruiting||N/A|50|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 22:37:41.175482|2017-10-10 22:37:41.175482
NCT02640313|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-05-17|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ESCAPPE||18F-choline and 18F-FDG PET-MR of Symptomatic Carotid Plaques|Evaluation of Symptomatic Carotid Artery Plaques With Positron Emission Tomography-magnetic Resonance Imaging (ESCAPPE)|Recruiting||Phase 3|14|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||No||2017-10-10 22:37:41.404564|2017-10-10 22:37:41.404564
NCT02640300|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-01-05|||May 1999||1999-05-01|January 2016|2016-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Switching Antipsychotics: Abrupt Discontinuation Versus Overlap|Switching Antipsychotics: Abrupt Discontinuation Versus Overlap|Completed||Phase 4|33|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 22:37:41.509415|2017-10-10 22:37:41.509415
NCT02640287|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-08-10|||February 2016||2016-02-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|November 2, 2019|Anticipated|2019-11-02||Interventional|WAL-KU||Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia|Expression of Ku70/XRCC6 and Others NHEJ Components in Waldenström's Macroglobulinemia in Comparison With Others B-cell Lymphoproliferative Disorders and Normal B Cells.|Recruiting||N/A|80|Anticipated|Central Hospital, Nancy, France||3|||f||||t||||||||||2017-10-10 22:37:41.694687|2017-10-10 22:37:41.694687
NCT02640274|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-11-02|||November 2013||2013-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Individual Nurse-led Counselling Programme for Patients Early Discharged After Myocardial Infarction.|Self-management Behaviour After an Individual Nurse-led Counselling Programme for Patients Early Discharged After Myocardial Infarction: A Randomised Controlled Trial.|Completed||N/A|71|Actual|Central Norway Regional Health Authority||2|||f||||||||||||||2017-10-10 22:37:41.797317|2017-10-10 22:37:41.797317
NCT02640261|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-02-02|||January 2016||2016-01-01|December 2015|2015-12-01|April 2018|Anticipated|2018-04-01|January 2017|Anticipated|2017-01-01||Observational|||Observational Prospective Study of the Success of Single Embryo Transfer Implantation Related to Level of Follicular Fluid Cytokines Expression in Low Responders Infertile Patients Treated With r-hLH add-on Therapy in a Second Controlled Ovarian Stimulation Cycle.||Recruiting||N/A|100|Anticipated|Centro di Procreazione Assistita Demetra|||2||f||||f||||||Samples Without DNA|"     Follicular Fluid   "|||2017-10-10 22:37:41.910393|2017-10-10 22:37:41.910393
NCT02640248|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-02-01|||November 2015||2015-11-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Endotracheal Tube Intracuff Pressure and Leak Around the Cuff During Retractor Placement for Adenotonsillectomy|Endotracheal Tube Intracuff Pressure and Leak Around the Cuff During Retractor Placement for Adenotonsillectomy|Enrolling by invitation||N/A|200|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 22:37:42.004862|2017-10-10 22:37:42.004862
NCT02640235|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-09-07|||February 24, 2016|Actual|2016-02-24|September 2017|2017-09-01|October 29, 2017|Anticipated|2017-10-29|July 21, 2017|Actual|2017-07-21||Interventional|CELSTAT||Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding|A Prospective, Randomized, Controlled Study to Evaluate the Effectiveness and Safety of CELSTAT as an Adjunct to Hemostasis for Tissue Bleeding in Cardiothoracic, General, and Vascular Surgery.|Active, not recruiting||N/A|260|Actual|Baxter Healthcare Corporation||2|||f||||t||||||||||2017-10-10 22:37:42.097501|2017-10-10 22:37:42.097501
NCT02640222|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-08-01|||June 30, 2013|Actual|2013-06-30|August 2017|2017-08-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Observational|||APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study|APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study|Active, not recruiting||N/A|18000|Anticipated|Bristol-Myers Squibb|||8||f||||f||||||||||2017-10-10 22:37:42.252069|2017-10-10 22:37:42.252069
NCT02640209|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-09-27|||December 2015||2015-12-01|September 2016|2016-09-01||||February 2018|Anticipated|2018-02-01||Interventional|||Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)|Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)|Recruiting||N/A|15|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:37:42.3647|2017-10-10 22:37:42.3647
NCT02640196|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-24|||March 2015||2015-03-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Videolaryngoscopes for Double Lumen Tube Intubations in Simulated Easy and Difficult Airway|A Comparison of Three Videolaryngoscopes for Double-lumen Tubes Intubation in Simulated Easy and Difficult Airways|Completed||N/A|21|Actual|Dammam University||4|||f||||t||||||||No||2017-10-10 22:37:42.452912|2017-10-10 22:37:42.452912
NCT02640183|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-22|||September 2015||2015-09-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||EMLA Cream in Hysteroscopy Practice|Lidocaine-Prilocaine (EMLA®) Cream in Hysteroscopy Practice: A Prospective Randomized Non-blinded Controlled Study|Not yet recruiting||Phase 2|184|Anticipated|Ain Shams Maternity Hospital||2|||f||||||||||||||2017-10-10 22:37:42.547813|2017-10-10 22:37:42.547813
NCT02640170|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-04-08|||December 2015||2015-12-01|April 2016|2016-04-01||||December 2021|Anticipated|2021-12-01|5 Years|Observational [Patient Registry]|||Intraoperative Imaging With ICG Registry|Intraoperative Imaging With ICG Registry|Not yet recruiting||N/A|500|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:37:42.615333|2017-10-10 22:37:42.615333
NCT02639975|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-09-15|||December 2015||2015-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||"First-in-human Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers"|"Randomized, Double Blind, Placebo Controlled First-in-human Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-677 ( 100 mg, 200 mg, 400 mg and 600 mg ) in Healthy Young Male Volunteers"|Completed||Phase 1|32|Actual|Palobiofarma SL||8|||f||||f||||||||||2017-10-10 22:37:44.801997|2017-10-10 22:37:44.801997
NCT02640157|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-08-17|2017-08-17|2017-02-08|December 2015||2015-12-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|ENDURANCE-3|All participants who received at least 1 dose of study drug (safety population)|A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection|A Randomized, Open-Label, Active-Controlled, Multicenter Study to Compare Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Co-Administered With Daclatasvir in Adults With Chronic Hepatitis C Virus Genotype 3 Infection (ENDURANCE-3)|Completed||Phase 3|506|Actual|AbbVie||3|||f||||f|t|f||||||||2017-10-10 22:37:42.708728|2017-10-10 22:37:42.708728
NCT02640144|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-01-23|||February 2017|Anticipated|2017-02-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||The Influence of Hyaluronic Acid Injection Following Knee Arthroscopy|The Influence of Hyaluronic Acid Injection Following Knee Arthroscopy|Not yet recruiting||Phase 4|60|Anticipated|Ziv Medical Center||2|||f||||f||||||||||2017-10-10 22:37:43.382213|2017-10-10 22:37:43.382213
NCT02640131|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-08-08|||January 2014||2014-01-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|BSHR||A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study|A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study|Recruiting||N/A|96|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:37:43.503926|2017-10-10 22:37:43.503926
NCT02640118|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-10-24|||August 2015||2015-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Px-Lixi||The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects|The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects -a Delineation of Extrapancreatic Effects|Completed||N/A|24|Actual|University Hospital, Gentofte, Copenhagen||4|||f||||f||||||||Undecided||2017-10-10 22:37:43.621438|2017-10-10 22:37:43.621438
NCT02640105|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-21|||June 2014||2014-06-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|12 Months|Observational [Patient Registry]|CHAD||Cluster Headache, Addictions and Vascular Function|Cluster Headache (CH), Addictions and Vascular Function|Recruiting||N/A|150|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 22:37:43.720319|2017-10-10 22:37:43.720319
NCT02640092|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-11-01|||December 2015||2015-12-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Longitudinal Evaluation of [18F]MNI-798 as a PET Radioligand for Imaging Tau in the Brain of Patients With Alzheimer's Disease Compared to Healthy Volunteers|Longitudinal Evaluation of GTP1 as a PET Radioligand for Imaging Tau in the Brains of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers|Recruiting||Phase 1|60|Anticipated|Genentech, Inc.||1|||f||||||||||||||2017-10-10 22:37:43.828381|2017-10-10 22:37:43.828381
NCT02640079|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-04-21|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea|A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea|Active, not recruiting||N/A|24|Anticipated|University of California, Los Angeles||1|||f||||||||||||||2017-10-10 22:37:43.959451|2017-10-10 22:37:43.959451
NCT02640066|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-06-08|||June 2016||2016-06-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Acupuncture for Acute Viral Lower Respiratory Infection in Hospitalized Children|Acupuncture for Acute Viral Lower Respiratory Infection in Hospitalized Children: A Single Blinded Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Ziv Hospital||2|||f||||f||||||||No||2017-10-10 22:37:44.076776|2017-10-10 22:37:44.076776
NCT02640040|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-03-17|||August 2015||2015-08-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||The Effect of Combined Surgery in Management of Congenital Pseudarthrosis of Tibia|The Effect of Combined Surgery in Management of Congenital Pseudarthrosis of Tibia|Recruiting||N/A|100|Anticipated|Hunan Children's Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:37:44.35241|2017-10-10 22:37:44.35241
NCT02640027|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-21|||February 2016||2016-02-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|T-SCHF||The Use of Telemedicine Tool in Supracondylar Humerus Fractures in Children|Telemedicine in Supracondylar Humerus Fractures|Not yet recruiting||N/A|50|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 22:37:44.477664|2017-10-10 22:37:44.477664
NCT02640014|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-02-27|||December 2015||2015-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Oral Immunotherapy in Food Allergy in Finland|Specific Oral Immunotherapy in Food Allergy - Real-life Long-term Follow up (After Milk Oral Immunotherapy), Effect on Health-related Quality of Life and Cost-utility Analyses|Enrolling by invitation||N/A|250|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||No||2017-10-10 22:37:44.548012|2017-10-10 22:37:44.548012
NCT02640001|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-10-13|||July 2015||2015-07-01|July 2015|2015-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||PCR Technique to Identify Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus in Nasal and Respiratory Tract Samples|Impact of the Introduction in a Heart Surgery ICU of a PCR Technique (Cepheid Xpert® SA Nasal Complete Assay) to Identify Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus in Nasal and Respiratory Tract Samples|Completed||N/A|200|Actual|Hospital General Universitario Gregorio Marañon|||1||f||||f||||||||||2017-10-10 22:37:44.63175|2017-10-10 22:37:44.63175
NCT02639988|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-06-27|||March 2016||2016-03-01|June 2016|2016-06-01|March 2025|Anticipated|2025-03-01|March 2023|Anticipated|2023-03-01||Observational|INSPIRED||Impact of Rheumatoid Arthritis on the Course of Type 2 Diabetes During a Longitudinal Follow-up of 5 Years|Impact of Rheumatoid Arthritis on Type 2 Diabetes Mellitus|Recruiting||N/A|1000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 22:37:44.696099|2017-10-10 22:37:44.696099
NCT02639962|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-05-31|||September 2014||2014-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|S-20130009||Characteristics of Culprit Lesion and Changes in Plaque Composition. A Dual Energy Cardiac CT Study|Characteristics of Culprit Lesion and Changes in Plaque Composition During Follow up in NSTEMI. A Dual Energy Cardiac CT Study|Recruiting||N/A|135|Anticipated|Odense University Hospital|||2||f||||t||||||Samples Without DNA|"     Blood samples for analyses as hs-CRP, Interleukins and other inflammatory agents.   "|||2017-10-10 22:37:44.886971|2017-10-10 22:37:44.886971
NCT02639949|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-09-12|||January 2010||2010-01-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|September 2013|Actual|2013-09-01||Interventional|||Measuring and Improving Medication Adherence in Kidney Transplant Patients|The Use of Random Telephone Calls to Measure Immunosuppressive Therapy Adherence in Patients With Renal Transplants|Completed||N/A|45|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-10-10 22:37:44.988669|2017-10-10 22:37:44.988669
NCT02639936|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-08-05|||December 2015||2015-12-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|TBnet#54||New Generation IGRA in Immunocompromised Individuals|Performance of a New Generation IGRA in Immunocompromised Individuals|Recruiting||N/A|2000|Anticipated|Tuberculosis Network European Trialsgroup|||6||f||||f||||||Samples Without DNA|"     Stimulated plasma samples   "|||2017-10-10 22:37:45.056241|2017-10-10 22:37:45.056241
NCT02639923|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-23|||January 2016||2016-01-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|mRNA||The Clinical Relevance of Micro RNAs in Mild Traumatic Brain Injury|The Clinical Relevance of Micro RNAs in Mild Traumatic Brain Injury A Pilot Study|Recruiting||N/A|150|Anticipated|Medical University of Vienna|||3||f||||f||||||Samples With DNA|"     7ml serum are drawn from peripheral blood   "|||2017-10-10 22:37:45.21075|2017-10-10 22:37:45.21075
NCT02639910|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-04|||November 2016||2016-11-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Study to Evaluate Efficacy and Safety of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS)|A Phase II, Two-Cohort, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of MOR00208 Combined With Idelalisib or Venetoclax in Patients With Relapsed or Refractory CLL/SLL Previously Treated With Bruton's Tyrosine Kinase (BTK) Inhibitor|Recruiting||Phase 2|120|Anticipated|MorphoSys AG||1|||f||||t||||||||||2017-10-10 22:37:45.327689|2017-10-10 22:37:45.327689
NCT02639897|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2017-10-03|||October 2016||2016-10-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Evaluation of Functional Dimensions of Macintosh Laryngoscope Blade During Direct Laryngoscopy in Patients With Normal Mouth Opening|Evaluation of Functional Dimensions of Macintosh Blade During Laryngoscopy in Patients With Normal Mouth Opening: Development of a Feasibility Model for Facilitation of Laryngoscopy in Cases of Mouth Opening Restriction Due to Submucous Fibrosis|Recruiting||N/A|100|Anticipated|Sir Ganga Ram Hospital|||1||f||||t||||||||||2017-10-10 22:37:45.5177|2017-10-10 22:37:45.5177
NCT02637791|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-22|||November 2009||2009-11-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional|WiiSTAR||A Low Cost Virtual Reality System for Home Based Rehabilitation of the Upper Limb Following Stroke|A Low Cost Virtual Reality System for Home Based Rehabilitation of the Upper Limb Following Stroke|Completed||Phase 1|27|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-10 22:37:45.735379|2017-10-10 22:37:45.735379
NCT02637778|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-02-19|||February 2016||2016-02-01|December 2015|2015-12-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|MoKaRi-Diet||Modulation of Cardiovascular Risk Factors by the Diet|Intervention Study - Modulation of Cardiovascular Risk Factors by Personal Nutritional Counselling and Daily Menu Plans|Completed||N/A|60|Actual|University of Jena||2|||f||||f||||||||||2017-10-10 22:37:45.80781|2017-10-10 22:37:45.80781
NCT02637765|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-08-09|||July 2014||2014-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|LIVE||Life ImproVed by Exercise (LIVE Trial)|Effect of a Short Program (8 Week) of Increased Physical Activity on Quality of Life of Sedentary Women With Previous Breast Cancer. A Prospective Randomized Trial.|Recruiting||N/A|206|Anticipated|European Institute of Oncology||2|||f||||f||||||||||2017-10-10 22:37:46.017166|2017-10-10 22:37:46.017166
NCT02637752|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-18|||September 2011||2011-09-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Nutrition and Physical Activity Counselling|Efficacy of Nutrition and Physical Activity Counselling for Pre-adolescent Children in a Dental Setting: A Randomized Clinical Trial|Completed||N/A|168|Actual|University of Toronto||2|||f||||f||||||||Yes||2017-10-10 22:37:46.171869|2017-10-10 22:37:46.171869
NCT02637739|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-01-06|||January 2014||2014-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hysteroscopy for Pregnancy of Unknown Location|Office Hysteroscopy as a Diagnostic Tool of Pregnancy of Unknown Location|Recruiting||N/A|30|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital||1|||f||||t||||||||||2017-10-10 22:37:46.295954|2017-10-10 22:37:46.295954
NCT02637726|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-21|||February 2006||2006-02-01|December 2015|2015-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Bispectral Index Under Propofol Anesthesia in Children : a Study Between TIVA and TCI|Bispectral Index Under Propofol Anesthesia in Children : a Comparative Randomised Study Between TIVA and TCI|Completed||N/A|66|Actual|Hôpital Armand Trousseau||4|||f||||f||||||||No||2017-10-10 22:37:46.401669|2017-10-10 22:37:46.401669
NCT02637713|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-08-15|||April 2016||2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|24 Months|Observational [Patient Registry]|MaRSS||Management of Reflux After Sleeve Using Stretta|Radiofrequency Energy Delivery to the Lower Esophageal Sphincter (Stretta) in Sleeve Gastrectomy Patients With GERD|Recruiting||N/A|80|Anticipated|Montefiore Medical Center|||1||f||||f||||||||||2017-10-10 22:37:46.551002|2017-10-10 22:37:46.551002
NCT02637700|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-07-12|||July 2016||2016-07-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|IVIg-SFN||Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy|Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy: a Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety.|Recruiting||Phase 2|60|Anticipated|Academisch Ziekenhuis Maastricht||2|||f||||t||||||||||2017-10-10 22:37:46.68383|2017-10-10 22:37:46.68383
NCT02633722|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-03-31|||January 2016||2016-01-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Intermittent Fasting for Metabolic Health, Does Meal Timing Matter?|Intermittent Fasting for Metabolic Health, Does Meal Timing Matter?|Recruiting||N/A|24|Anticipated|University of Adelaide||3|||f||||f||||||||Undecided||2017-10-10 22:38:58.948709|2017-10-10 22:38:58.948709
NCT02637687|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-08|||December 2015||2015-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|SCOUT||Oral TRK Inhibitor LOXO-101 (Larotrectinib) for Treatment of Advanced Pediatric Solid or Primary Central Nervous System Tumors|A Phase 1/2 Study of the Oral TRK Inhibitor LOXO101 (Larotrectinib) in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors|Recruiting||Phase 1/Phase 2|84|Anticipated|Loxo Oncology, Inc.||1|||t||||f|t|f||||||||2017-10-10 22:37:46.830551|2017-10-10 22:37:46.830551
NCT02637674|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-12|||January 2016||2016-01-01|January 2016|2016-01-01|January 2022|Anticipated|2022-01-01|January 2019|Anticipated|2019-01-01||Interventional|ATU||Uterine Allotransplantations Using Uterine Grafts From Brain-dead Female Donors|Uterine Allotransplantations Using Uterine Grafts From Brain-dead Female Donors|Recruiting||Phase 1|10|Anticipated|University Hospital, Limoges||1|||f||||t||||||||||2017-10-10 22:37:47.013415|2017-10-10 22:37:47.013415
NCT02637661|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-01-08|||June 2015||2015-06-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|ELC-AMI-CHN||Earlobe Crease as Risk Factors of Acute Myocardial Infarction in Chinese Population|Earlobe Crease as Risk Factors of Acute Myocardial Infarction in Chinese Population|Recruiting||N/A|236|Anticipated|Liaoning University of Traditional Chinese Medicine|||2||f||||f||||||||||2017-10-10 22:37:47.173985|2017-10-10 22:37:47.173985
NCT02639884|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-08-04|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:37:47.310668|2017-10-10 22:37:47.310668
NCT02639871|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-08-02|||June 28, 2016|Actual|2016-06-28|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Observational|HDeNERGY||Dynamic Neuroimaging Biomarkers in Huntington's Disease|Validation of Molecular Neuroimaging Biomarkers in Huntington's Disease in View of Therapeutic Trials Targeting the Krebs Cycle|Recruiting||N/A|80|Anticipated|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 22:37:47.367871|2017-10-10 22:37:47.367871
NCT02639858|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-04-27|||October 2015||2015-10-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC|A Phase II Study to Evaluate the Efficacy and Safety of Docetaxel-PM in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 2|31|Anticipated|Samyang Biopharmaceuticals Corporation||1|||f||||f||||||||||2017-10-10 22:37:47.482865|2017-10-10 22:37:47.482865
NCT02639845|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-24|||November 2013||2013-11-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Eye Drop Application Monitor, Pilot Study|A Novel Eye Drop Application Monitor to Assess Patient Compliance With a Prescribed Regimen|Recruiting||N/A|500|Anticipated|Retina Health Center|||1||f||||f||||||||Undecided||2017-10-10 22:37:47.609367|2017-10-10 22:37:47.609367
NCT02639832|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-08-04|||December 2015||2015-12-01|August 2016|2016-08-01||||December 2019|Anticipated|2019-12-01||Observational|||A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.||Active, not recruiting||N/A|210|Actual|Cynvenio Biosystems|||1||f||||||||||||||2017-10-10 22:37:47.73419|2017-10-10 22:37:47.73419
NCT02639819|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-07-05|||June 2016|Anticipated|2016-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|MANICHAN-PILOT||Management of Intracerebral Hemorrhage With Aminocaproic Acid - Pilot Study|A Pilot Study of Ultra-Early Intravenous ɛ-Aminocaproic Acid in Spontanteous Intracerebral Hemorrhage|Withdrawn||Phase 1|0|Actual|The University of Texas Health Science Center at San Antonio||1||Study was withdrawn from IRB review on 03/08/16|f||||t||||||||||2017-10-10 22:37:47.894518|2017-10-10 22:37:47.894518
NCT02639806|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-06-01|||January 2016||2016-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||General Anesthesia for Endovascular Thrombectomy; A Pilot Study.|General Anesthesia for Endovascular Thrombectomy; A Pilot Study.|Enrolling by invitation||N/A|77|Anticipated|University of Saskatchewan|||2||f||||f||||||||||2017-10-10 22:37:48.00011|2017-10-10 22:37:48.00011
NCT02639793|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-24|||January 2016||2016-01-01|December 2015|2015-12-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|MRICEMAN||Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)|A Nationwide Multicenter Trial Assessing the Effects of Catheter Ablation on Burden of Atrial Fibrillation Recorded by Implantable Cardiac Monitor|Not yet recruiting||Phase 4|300|Anticipated|University of Oulu||3|||f||||t||||||||Undecided||2017-10-10 22:37:48.10806|2017-10-10 22:37:48.10806
NCT02639780|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-10-26|||December 2015||2015-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Biochemical Alterations of Stored Erythrocyte Membranes|Biochemical Alterations of Stored Erythrocyte Membranes|Recruiting||N/A|36|Anticipated|Medical University of Vienna|||6||f||||f||||||Samples Without DNA|"     packed red blood cells   "|No||2017-10-10 22:37:48.228711|2017-10-10 22:37:48.228711
NCT02639767|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-12-05|||December 2015||2015-12-01|December 2016|2016-12-01||||December 2016|Actual|2016-12-01||Interventional|||Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma|A Phase I Study of Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma|Withdrawn||Phase 1|0|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-10 22:37:48.341749|2017-10-10 22:37:48.341749
NCT02639754|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-03-01|||December 2015||2015-12-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria|Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria|Enrolling by invitation||N/A|320|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||No||2017-10-10 22:37:48.435667|2017-10-10 22:37:48.435667
NCT02639741|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-02-01|||November 2014||2014-11-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|February 2015|Actual|2015-02-01||Interventional|||Preoperative Melatonin or Vitamin C Administration on Postoperative Analgesia|Comparison Of The Effects Of Preoperative Melatonin Or Vitamin C Administration On Postoperative Analgesia|Active, not recruiting||Phase 4|55|Anticipated|Cukurova University||3|||f||||f||||||||No||2017-10-10 22:37:48.540387|2017-10-10 22:37:48.540387
NCT02639728|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-22|||November 2015||2015-11-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||The Effect of Coffee Consumption in Enhancing Recovery of Bowel Function Following Colorectal Surgery.|Prospective Study of the Effect of Coffee Consumption in Enhancing Recovery of Bowel Function Following Colorectal Surgery.|Active, not recruiting||N/A|300|Actual|Cedars-Sinai Medical Center||3|||f||||f||||||||||2017-10-10 22:37:48.664582|2017-10-10 22:37:48.664582
NCT02639715|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-22|||January 2014||2014-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|||Morphometrics and Morphokinetics of Thawed Oocytes and Embryos|Morphometrics and Morphokinetics of Thawed Oocytes and Embryos|Completed||N/A|1272|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-10 22:37:48.764736|2017-10-10 22:37:48.764736
NCT02639702|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-08-19|||August 2016||2016-08-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia|Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia: A Pilot, Double-Blind, Randomized Controlled Trial|Recruiting||Phase 4|30|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 22:37:48.815565|2017-10-10 22:37:48.815565
NCT02639689|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-23|||September 2013||2013-09-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|WALKAIDE||Evaluation of the Increase of the Driving Speed With Walkaide® Medical Device|Evaluation of the Increase of the Driving Speed After the Apparatus by Walkaide® Medical Device in Deficits Levator Foot of Central Origin.|Recruiting||Phase 1/Phase 2|40|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 22:37:48.924353|2017-10-10 22:37:48.924353
NCT02639676|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-29|||November 2015||2015-11-01|August 2016|2016-08-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Observational|||Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development|The Effects of Maternal Preeclampsia on the Development of Pulmonary and Vascular Dysfunction in Infants|Recruiting||N/A|200|Anticipated|Indiana University|||2||f||||f||||||Samples With DNA|"     Blood, Cord Blood, and Placenta Samples.   "|||2017-10-10 22:37:49.029918|2017-10-10 22:37:49.029918
NCT02639663|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-21|||January 2016||2016-01-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Dental Support Device During Breastfeeding as a Mean for Pain Control|Dental Support Device During Breastfeeding as a Mean for Pain Control|Not yet recruiting||Phase 3|700|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||No||2017-10-10 22:37:49.13411|2017-10-10 22:37:49.13411
NCT02639650|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-20|||March 2016||2016-03-01|December 2015|2015-12-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor|A Prospective Randomized Multicenter Clinical Control Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor|Not yet recruiting||Phase 3|214|Anticipated|Women's Hospital School Of Medicine Zhejiang University||2|||f||||||||||||||2017-10-10 22:37:49.225132|2017-10-10 22:37:49.225132
NCT02639624|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2017-07-27|||January 2016||2016-01-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|||Altering Bicarbonate Delivery During Hemodialysis to Affect Filtration of Indoxyl Sulfate|Altering Bicarbonate Delivery During Hemodialysis to Affect Filtration of Indoxyl Sulfate|Withdrawn||N/A|0|Actual|New York University School of Medicine||2||07/27/2017 Unable to contact research team to confirm reason for withdrawing study.|f||||f|t|f||||||||2017-10-10 22:37:49.513789|2017-10-10 22:37:49.513789
NCT02639611|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-08-02|||July 2013||2013-07-01|August 2016|2016-08-01||||February 2016|Actual|2016-02-01||Interventional|||Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders|Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders|Withdrawn||N/A|0|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 22:37:49.589355|2017-10-10 22:37:49.589355
NCT02639585|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-24|||December 2015||2015-12-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|ESDAC||Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C|Efficacy and Safety of Daclatasvir Plus Asunaprevir Treatment in Patients With Chronic Hepatitis C : Prospective Cohort Study|Recruiting||Phase 4|32|Anticipated|Pusan National University Hospital||1|||f||||f||||||||No||2017-10-10 22:37:49.74089|2017-10-10 22:37:49.74089
NCT02639572|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2015-12-20|||January 2014||2014-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Evaluation of SilOss® in Periodontal Surgery|Evaluation of the Efficacy of a Novel Synthetic Bone Regeneration Material (Sil-Oss®) In the Treatment of Periodontal Intrabony Osseous Defects|Completed||Phase 2|30|Actual|SVS Institute of Dental Sciences||2|||f||||t||||||||No|Data will be shared after publishing the results|2017-10-10 22:37:49.821739|2017-10-10 22:37:49.821739
NCT02639559|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-09-14|||March 31, 2016|Actual|2016-03-31|September 2017|2017-09-01|April 30, 2023|Anticipated|2023-04-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies|A Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies|Recruiting||Phase 2|48|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||||2017-10-10 22:37:49.896654|2017-10-10 22:37:49.896654
NCT02639013|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2015-12-20|||December 2015||2015-12-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Interventional|Ghada||an Educational Program About Abdominal Compartment Syndrome|Temporal Trend Analysis of Nurse's Knowledge and Practice Before and After Implementing an Educational Program Regarding Abdominal Compartment Syndrome|Enrolling by invitation||Phase 3|50|Anticipated|Assiut University||1|||f||||t||||||||||2017-10-10 22:37:57.252187|2017-10-10 22:37:57.252187
NCT02639546|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-09-27|||May 20, 2016|Actual|2016-05-20|September 2017|2017-09-01|February 21, 2023|Anticipated|2023-02-21|February 21, 2023|Anticipated|2023-02-21||Interventional|iMATRIXcobi||Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors|A Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Cobimetinib In Pediatric and Young Adult Patients With Previously Treated Solid Tumors|Recruiting||Phase 1/Phase 2|50|Anticipated|Hoffmann-La Roche||2|||f||||f||||||||||2017-10-10 22:37:50.015403|2017-10-10 22:37:50.015403
NCT02639533|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-12-21|||December 2014||2014-12-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Brain Response to Single Dose of Pregabalin in Fibromyalgia|Pregabalin Acute Effects on Cortical Excitability, Psychophysical Parameters, and Serum Markers of Neuroplastic Processes in Fibromyalgia: a Placebo Controlled, Double Blinded, Randomized, Crossover Clinical Trial|Active, not recruiting||Phase 2/Phase 3|27|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:37:52.040592|2017-10-10 22:37:52.040592
NCT02639520|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-07-26|||December 2015||2015-12-01|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|June 2017|Actual|2017-06-01||Interventional|||Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs|A Double-blind, Controlled, Parallel-group, Randomized, Multicenter Clinical Trial to Assess the Efficacy and Safety of a Herbal Drug Containing Centaury, Lovage Root and Rosemary Leaf (CLR) in Comparison to Fosfomycin Trometamol for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections (uUTIs) in Women|Completed||Phase 3|659|Actual|Bionorica SE||2|||f||||f||||||||||2017-10-10 22:37:52.127882|2017-10-10 22:37:52.127882
NCT02639507|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2015-12-30|||June 2015||2015-06-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|June 2017|Anticipated|2017-06-01||Observational|ICV-DME||International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients|International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients - the ICV-DME Study|Recruiting||N/A|100|Anticipated|Mayo Clinic|||1||f||||t||||||||||2017-10-10 22:37:52.205548|2017-10-10 22:37:52.205548
NCT02639481|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-22|2016-04-25|||January 2016||2016-01-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|EriCOS||Erigo®Pro Coma Outcome Study - Study on the Effectiveness of a Robotic Tilt Table Device for Recovery of Consciousness|Erigo®Pro Coma Outcome Study - Study on the Effectiveness of a Robotic Tilt Table Device for Recovery of Consciousness|Recruiting||Phase 3|156|Anticipated|Ludwig-Maximilians - University of Munich||3|||f||||f||||||||||2017-10-10 22:37:52.352519|2017-10-10 22:37:52.352519
NCT02639468|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-05-02|||April 2016||2016-04-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SVEIT||Electric Impedance Tomography|Electric Impedance Tomography|Recruiting||N/A|30|Anticipated|Centre Suisse d'Electronique et Microtechnique SA||1|||f||||f||||||||No||2017-10-10 22:37:52.444677|2017-10-10 22:37:52.444677
NCT02639455|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-05-10|||February 2016||2016-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Survey of the Collective 16s rRNA Genes From Bacterial Populations From Exercising and Non-exercising Participants||Completed||N/A|165|Actual|University of Wisconsin, Madison||3|||f||||t||||||||Undecided|De-identified participant data may be made available within 12 months after completion of the study if the study is published.|2017-10-10 22:37:52.508597|2017-10-10 22:37:52.508597
NCT02639442|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-09-25|||December 2015||2015-12-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia|Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia|Recruiting||Phase 1/Phase 2|15|Anticipated|ProArc Medical||1|||f||||f||||||||Undecided||2017-10-10 22:37:52.568518|2017-10-10 22:37:52.568518
NCT02639429|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-09|||January 2016||2016-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|CROWN||Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial|The Efficacy of Transcervical Foley Balloon Plus Vaginal Misoprostol Versus Vaginal Misoprostol Alone For Cervical Ripening In Nulliparous Obese Women: A Randomized, Comparative Effectiveness Trial|Recruiting||Phase 4|250|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 22:37:52.641214|2017-10-10 22:37:52.641214
NCT02639416|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-11-02|||January 2016||2016-01-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SAM||Hypoallergenic and Anti-inflammatory Feeds in Malawian Children With Severe Acute Malnutrition (SAM)|Hypoallergenic and Anti-inflammatory Feeds to Treat Intestinal Inflammation in Malawian Children With Severe Acute Malnutrition: A Pilot Randomized Controlled Clinical Trial (SAM)|Recruiting||N/A|120|Anticipated|Liverpool School of Tropical Medicine||3|||f||||t||||||||Yes||2017-10-10 22:37:52.731349|2017-10-10 22:37:52.731349
NCT02639403|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-21|||October 2003||2003-10-01|December 2015|2015-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Palliative Short-Course Radiotherapy in Rectal Cancer|Palliative Short-Course Radiotherapy in Rectal Cancer: A Phase II Study|Completed||Phase 2|18|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||f||||||||||2017-10-10 22:37:52.927743|2017-10-10 22:37:52.927743
NCT02639390|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-06-12|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Robotic Training for Stroke Neurorehabilitation|Task-Specific Upper-Extremity Robotic Training for Stroke Neurorehabilitation|Not yet recruiting||Phase 2|38|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 22:37:53.004314|2017-10-10 22:37:53.004314
NCT02639377|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2015-12-21|||October 2012||2012-10-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis|Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis: a Randomised Controlled Clinical Trial|Completed||Phase 2|29|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||No||2017-10-10 22:37:53.112513|2017-10-10 22:37:53.112513
NCT02639364|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-24|||May 2015||2015-05-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Airway Pressure Release Ventilation (APRV) Protocol Early Used in Acute Respiratory Distress Syndrome|the Effects and Safety of the Early Application of Bi-level Airway Pressure Ventilation-airway Pressure Release Ventilation(BILEVEL-APRV) Protocol and Conventional Ventilation Strategy Were Compared in ARDS Patients|Recruiting||N/A|200|Anticipated|West China Hospital||2|||f||||t||||||||No||2017-10-10 22:37:53.208635|2017-10-10 22:37:53.208635
NCT02639351|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-01-16|||March 2016||2016-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine|A Phase 1, Randomized, Observer-Blind, Dosage-Escalation Study to Evaluate the Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine Compared to Aluminium Hydroxide Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine in Healthy Adults (18-45 Years of Age).|Active, not recruiting||Phase 1|80|Anticipated|GlaxoSmithKline||5|||f||||t||||||||||2017-10-10 22:37:53.313272|2017-10-10 22:37:53.313272
NCT02639325|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-09-21|||December 18, 2015||2015-12-18|March 14, 2017|2017-03-14|September 1, 2020|Anticipated|2020-09-01|September 1, 2020|Anticipated|2020-09-01||Observational|||Tumor Related Epilepsy|Tumor Related Epilepsy|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:37:53.621781|2017-10-10 22:37:53.621781
NCT02639312|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-06-30|||December 17, 2015||2015-12-17|June 21, 2017|2017-06-21|November 1, 2034|Anticipated|2034-11-01|November 1, 2034|Anticipated|2034-11-01||Observational|||Natural History of Craniofacial Anomalies and Developmental Growth Variants|Natural History of Craniofacial Anomalies and Developmental Growth Variants|Recruiting||N/A|2400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:37:53.713351|2017-10-10 22:37:53.713351
NCT02639299|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-07-13|||December 17, 2015||2015-12-17|July 12, 2017|2017-07-12|March 31, 2026|Anticipated|2026-03-31|September 30, 2025|Anticipated|2025-09-30||Observational|||Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge|Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:37:53.795186|2017-10-10 22:37:53.795186
NCT02639286|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-10-03|||December 17, 2015||2015-12-17|September 26, 2017|2017-09-26|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension|A Randomized, Double Blind, Placebo-Controlled Study to Assess Efficacy, Safety and Tolerability of ISIS 304801 in Patients With Partial Lipodystrophy With an Open-Label Extension|Recruiting||Phase 2|20|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:37:53.873466|2017-10-10 22:37:53.873466
NCT02639260|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-23|2017-10-05|||December 10, 2015||2015-12-10|May 19, 2017|2017-05-19|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases|A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases|Recruiting||Phase 1|24|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:37:54.090398|2017-10-10 22:37:54.090398
NCT02639234|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-07-27|||March 2016||2016-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer|A Phase 2 Study of Vigil™ Augmented Autologous Tumor Cell Immunotherapy in Combination With Nivolumab PD-1 Inhibitor for Patients With Advanced Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Gradalis, Inc.||1|||f||||f||||||||||2017-10-10 22:37:54.529164|2017-10-10 22:37:54.529164
NCT02639221|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-09-27|||January 2016||2016-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects|PXT002331 A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects|Completed||Phase 1|64|Actual|Prexton Therapeutics||2|||f||||||||||||||2017-10-10 22:37:54.65419|2017-10-10 22:37:54.65419
NCT02639208|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-07-26|||December 2015||2015-12-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Novel Social Media Intervention For Older Br CA Patients|Improving Support for Older Patients Receiving Neo/Adjuvant Chemotherapy for Breast Cancer Using a Novel Social Media Intervention|Recruiting||N/A|100|Anticipated|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-10 22:37:54.738655|2017-10-10 22:37:54.738655
NCT02639195|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-01-30|||December 2015||2015-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||The Impact of Small Bowel Obstruction (SBO) on Quality of Life (QOL)|The Impact of Small Bowel Obstruction (SBO) on Quality of Life (QOL); the Efficacy of a Manual Physical Therapy to Improve QOL in Subjects With a History of SBO|Active, not recruiting||N/A|350|Anticipated|Clear Passage Therapies, Inc|||2||f||||f||||||||Undecided||2017-10-10 22:37:54.875335|2017-10-10 22:37:54.875335
NCT02639182|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-06-06|||May 24, 2016|Actual|2016-05-24|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|January 31, 2018|Anticipated|2018-01-31||Interventional|||A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma|A Multi-Center, Open Label, Randomized Phase 2 Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma|Recruiting||Phase 2|134|Anticipated|Astellas Pharma Inc||2|||f||||t||||||||Undecided||2017-10-10 22:37:54.989521|2017-10-10 22:37:54.989521
NCT02639156|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-21|||July 2015||2015-07-01|August 2015|2015-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Acceptability and Tolerance of New Oral Nutritional Supplement|Evaluation of Tolerance and Acceptability of AYMES 'LONDON' Product|Completed||N/A|22|Actual|Aymes International Limited||1|||f||||f||||||||||2017-10-10 22:37:55.314322|2017-10-10 22:37:55.314322
NCT02639143|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-20|||December 2015||2015-12-01|November 2015|2015-11-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|||Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients|Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the Infarct-related Artery in STEMI Patients: A Prospective Randomized Trial of Ticagrelor Versus Clopidogrel|Not yet recruiting||Phase 4|50|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||||2017-10-10 22:37:55.416743|2017-10-10 22:37:55.416743
NCT02639130|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-08-15|||February 2008||2008-02-01|August 2016|2016-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes|Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Type 2-diabetic Patients Using Exendin [9-39] as a GLP-1 Receptor Antagonist|Completed||Phase 4|67|Actual|Diabeteszentrum Bad Lauterberg im Harz||2|||f||||f||||||||Undecided||2017-10-10 22:37:55.572319|2017-10-10 22:37:55.572319
NCT02639117|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-03-01|||November 2015||2015-11-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|November 2, 2016|Actual|2016-11-02||Interventional|PDT-Vismo||Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas|Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas|Recruiting||Phase 1|12|Anticipated|University of Arizona||1|||f||||t||||||||Undecided||2017-10-10 22:37:55.725873|2017-10-10 22:37:55.725873
NCT02639104|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-24|||December 2015||2015-12-01|December 2015|2015-12-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Could Cervical Postural Changes Affect the Long Thoracic Nerve Electromyographic Findings?|Could Cervical Postural Changes Affect the Long Thoracic Nerve Electromyographic Findings?|Active, not recruiting||N/A|100|Anticipated|Baskent University||2|||f||||f||||||||Undecided||2017-10-10 22:37:55.885227|2017-10-10 22:37:55.885227
NCT02639091|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-09-18|||February 3, 2016|Actual|2016-02-03|September 2017|2017-09-01|March 28, 2019|Anticipated|2019-03-28|March 28, 2018|Anticipated|2018-03-28||Interventional|||Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors|An Open Label Phase Ib Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Maximum Tolerated Dose of Anetumab Ravtansine in Combination With Pemetrexed 500 mg/m2 and Cisplatin 75 mg/m2 in Subjects With Mesothelin-expressing Predominantly Epithelial Mesothelioma or Nonsquamous Non-small-cell Lung Cancer|Recruiting||Phase 1|30|Anticipated|Bayer||1|||f||||f|t|f||||||||2017-10-10 22:37:56.040064|2017-10-10 22:37:56.040064
NCT02639078|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-03-03|||November 2015||2015-11-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Single Ascending Dose Study of TD-0714 in Healthy Subjects|A Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD−0714 in Healthy Subjects|Completed||Phase 1|56|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||||2017-10-10 22:37:56.191417|2017-10-10 22:37:56.191417
NCT02639065|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-06-08|||April 2016||2016-04-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of Durvalumab (MEDI4736) in Esophageal Cancer|A Phase II Study Evaluating Safety and Efficacy of Durvalumab (MEDI4736) Following Multi-modality Therapy in Esophageal Cancer: Big Ten Cancer Research Consortium BTCRC-ESO14-012|Recruiting||Phase 2|26|Anticipated|Big Ten Cancer Research Consortium||1|||f||||t||||||||No||2017-10-10 22:37:56.314759|2017-10-10 22:37:56.314759
NCT02639052|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-03-16|2016-11-28||February 2016||2016-02-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||Itch Relieving Effect of Botox: a Study in Healthy Subjects|Itch Relieving Effect of Botox: a Study in Healthy Subjects|Completed||Phase 1/Phase 2|35|Actual|Temple University||2|||f||||f||||||||No||2017-10-10 22:37:56.48021|2017-10-10 22:37:56.48021
NCT02639039|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-28|||February 2013||2013-02-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Cortisone Injection vs Trigger Point Dry Needling Fin the Treatment of Greater Trochanter Pain Syndrome: A Pilot Study|Cortisone Injection vs Trigger Point Dry Needling Fin the Treatment of Greater Trochanter Pain Syndrome: A Pilot Study|Completed||Phase 4|50|Actual|Scott and White Hospital & Clinic||2|||f||||f||||||||No||2017-10-10 22:37:57.070752|2017-10-10 22:37:57.070752
NCT02639026|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-07-05|||January 2016|Actual|2016-01-01|July 2017|2017-07-01||||December 2018|Anticipated|2018-12-01||Interventional|||Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers|Phase I Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers|Recruiting||Phase 1|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:37:57.156968|2017-10-10 22:37:57.156968
NCT02639000|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-10-03|||July 2010||2010-07-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|BlastoTrans||Effects of Blastocyst Stage Compared With Cleavage Stage Embryo Transfer in Women Below 39 Years|Effects of Blastocyst Stage Embryo Transfer Compared With Cleavage Stage Embryo Transfer in Women ≤ 38 Years|Completed||N/A|388|Actual|Istituto Clinico Humanitas||2|||f||||t||||||||||2017-10-10 22:37:57.523594|2017-10-10 22:37:57.523594
NCT02638987|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-03-01|||September 2015||2015-09-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||EMG Activity Before, During and After Dry Needling|EMG Activity, Muscle Tone, Elasticity and Stiffness of the Upper Trapezius Before, During and After Dry Needling|Completed||N/A|24|Actual|University Ghent||2|||f||||f||||||||||2017-10-10 22:37:57.654038|2017-10-10 22:37:57.654038
NCT02638974|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-07-31|||February 29, 2016|Actual|2016-02-29|July 2017|2017-07-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|COVER||Skin Camouflage for Women Prisoners With Self-Harm Scarring|Feasibility and Acceptability of Medical Skin Camouflage for Recovery of Women With Self-Harm Scarring in Prison|Recruiting||N/A|40|Anticipated|University of Manchester||2|||f||||f||||||||||2017-10-10 22:37:57.793277|2017-10-10 22:37:57.793277
NCT02638961|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-17|||October 2015||2015-10-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|TRAINING-HF||Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of HFpEF|Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction|Completed||N/A|52|Actual|Universitat Jaume I||4|||f||||t||||||||||2017-10-10 22:37:57.924991|2017-10-10 22:37:57.924991
NCT02638948|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2017-09-26|||February 16, 2016|Actual|2016-02-16|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 29, 2018|Anticipated|2018-03-29||Interventional|||Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis|Phase 2, Randomized, Multi-Center, Double-Blind, Dose-Ranging, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety/Pharmacokinetics of BMS-986142 in Subjects With Moderate to Severe Rheumatoid Arthritis With an Inadequate Response to Methotrexate With or Without TNF Inhibitors|Recruiting||Phase 2|280|Anticipated|Bristol-Myers Squibb||3|||f||||t|t|f||||||||2017-10-10 22:37:58.102268|2017-10-10 22:37:58.102268
NCT02638935|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-10-02|||February 2016||2016-02-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 Lesions|Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 Lesions: Can Patient Selection for Biopsy be Improved? - A Confirmatory Multi-Center-Study|Recruiting||N/A|1000|Anticipated|Heidelberg University||4|||f||||t||||||||||2017-10-10 22:37:58.628412|2017-10-10 22:37:58.628412
NCT02638922|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2016-04-05|||January 2014||2014-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|TallgirlsDK||Evaluation and Treatment of Tall Statured Girls|Evaluation of 304 Danish Girls With Tall Stature: Phenotypic Characteristics and Effects of Oral Administration of Natural 17β-Estradiol|Active, not recruiting||N/A|304|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||No||2017-10-10 22:37:58.790827|2017-10-10 22:37:58.790827
NCT02638909|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-04-13|||December 2015||2015-12-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies|A Phase II, Multicenter, Single-Arm Study of Oral Ceritinib in Adult Patients With ALK and ROS1 Activated Gastrointestinal Malignancies|Recruiting||Phase 2|30|Anticipated|Criterium, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:37:58.881385|2017-10-10 22:37:58.881385
NCT02638896|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2015-12-24|||January 2016||2016-01-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis|Efficacy and Safety of Etanercept Dose Reduction in Patients With Ankylosing Spondylitis|Not yet recruiting||Phase 4|100|Anticipated|Health and Family Planning Commission of Guangdong||3|||f||||f||||||||No||2017-10-10 22:37:58.99828|2017-10-10 22:37:58.99828
NCT02637648|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-18|||December 2015||2015-12-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|September 2016|Anticipated|2016-09-01||Interventional|SOinCH||Sodium Oxybate in Patients With Episodic and Chronic Cluster Headache|Safety and Efficacy of Sodium Oxybate in the Prophylaxis of Headache and Sleep Disturbances in Patients With Chronic and Episodic Cluster Headache|Not yet recruiting||Phase 3|60|Anticipated|Klinik Barmelweid||2|||f||||t||||||||||2017-10-10 22:37:59.09989|2017-10-10 22:37:59.09989
NCT02637635|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-09-29|||October 2012||2012-10-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Does Autologous Fat Transplantation Improve Results and Reduce Complications in Breast Reconstruction With Implants?|Does Pre-treatment With Autologous Fat Transplantation Improve Results and Reduce Complication Rate After Breast Reconstruction With Implants? A Randomized Controlled Study|Recruiting||N/A|54|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:37:59.201195|2017-10-10 22:37:59.201195
NCT02637596|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-24|||February 2013||2013-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|||Quality of Life After Radiofrequency Ablation of Pancreatic Cancer|Quality of Life After Intraoperative Radiofrequency Ablation of Pancreatic Cancer|Completed||N/A|1|Actual|Brno University Hospital||1|||f||||f||||||||Yes|Publication as manuscript|2017-10-10 22:37:59.495869|2017-10-10 22:37:59.495869
NCT02637583|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-10-05|||September 27, 2017|Actual|2017-09-27|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels|Sequential Versus Simultaneous Vaccination With Pneumococcal Conjugate Vaccine (Prevenar 13) and Pneumococcal Polysaccharide Vaccine (Pneumovax 23) in Elderly: Immunological Memory and Antibody Levels|Recruiting||Phase 4|132|Anticipated|Jena University Hospital||3|||f||||f|f|f|||f|||||2017-10-10 22:37:59.57305|2017-10-10 22:37:59.57305
NCT02637570|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-08-09|||October 2015||2015-10-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Hibiscus Tea and Green Tea Supplements on Athletic Performance, Blood Pressure, Muscle Damage Indices and Oxidative Stress||Completed||N/A|60|Actual|Isfahan University of Medical Sciences||3|||f||||||||||||||2017-10-10 22:37:59.690444|2017-10-10 22:37:59.690444
NCT02638883|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-09-23|||January 2016||2016-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:37:59.800051|2017-10-10 22:37:59.800051
NCT02638870|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2015-12-23|||January 2016||2016-01-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Observational|||Colonoscopy-related Pain Predicts the Treatment Response of Amitriptyline in Patients With Irritable Bowel Syndrome|Colonoscopy-related Pain Predicts the Treatment Response of Amitriptyline in Patients With Irritable Bowel Syndrome|Not yet recruiting||N/A|118|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:37:59.850654|2017-10-10 22:37:59.850654
NCT02638857|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-30|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma|A Controlled Clinic Trial of Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen in Combination With Transcatheter Arterial Chemoembolization in Treating Patients With Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Second Military Medical University||2|||f||||||||||||||2017-10-10 22:37:59.930347|2017-10-10 22:37:59.930347
NCT02638844|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-07-04|||December 2015||2015-12-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|ARDStrain||Assessment of Right Ventricular 2d-strain in Acute Respiratory Distress Syndrome|ARDStrain : Assessment of Right Ventricular 2d-strain in Acute Respiratory Distress Syndrome|Recruiting||N/A|50|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||||No||2017-10-10 22:38:00.097225|2017-10-10 22:38:00.097225
NCT02638831|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-03-09|||March 2013||2013-03-01|March 2017|2017-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Ketorol Gel in Gonarthrosis and Low Back Pain|Open Label Randomized Study for Evaluating Efficacy and Safety of Ketorolac Tromethamine and Ketoprofen in Gel in Patients With Gonarthrosis and Low Back Pain|Completed||Phase 4|240|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-10 22:38:00.166158|2017-10-10 22:38:00.166158
NCT02638818|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-10-02|||August 2016||2016-08-01|October 2017|2017-10-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Observational|||Outcomes in Minimally Invasive Versus Open Pancreaticoduodenectomy|A Pilot Study Evaluating Health-related Quality of Life Endpoints in Patients Undergoing Minimally Invasive Versus Open Pancreaticoduodenectomy|Enrolling by invitation||N/A|60|Anticipated|Duke University|||2||f||||f||||||||||2017-10-10 22:38:00.236667|2017-10-10 22:38:00.236667
NCT02638805|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-06-22|||December 2015||2015-12-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide|An Open-Label, Multi-Center, Randomized, Phase 3b Study to Evaluate the Safety and Tolerability of Switching to One of Two Dosing Strategies of ITCA 650 in Patients With Type 2 Diabetes Receiving Stable Doses of Liraglutide|Active, not recruiting||Phase 3|136|Actual|Intarcia Therapeutics||2|||f||||f||||||||No||2017-10-10 22:38:00.30951|2017-10-10 22:38:00.30951
NCT02638792|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2016-07-07|||December 2015||2015-12-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Internet-Based Exposure Therapy Vs. Stress-Management Training for Worry|Internet-Based Exposure Therapy Vs. Stress-Management Training for Worry: A Randomized Controlled Trial|Completed||N/A|311|Actual|Karolinska Institutet||3|||f||||f||||||||No||2017-10-10 22:38:00.558356|2017-10-10 22:38:00.558356
NCT02638779|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-08|||December 11, 2015|Actual|2015-12-11|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|REALISM||REAnimation Low Immune Status Markers|REAnimation Low Immune Status Markers|Recruiting||N/A|700|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:38:00.651691|2017-10-10 22:38:00.651691
NCT02638766|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-02-22|||November 2015||2015-11-01|February 2017|2017-02-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|REGISTRI||Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST|Phase II, Single Arm, Non-randomized and Multicenter Clinical Trial of Regorafenib as a Single Agent in the First-line Setting for Patients With Metastatic and/or Unresectable KIT/PDGFR Wild Type GIST|Recruiting||Phase 2|39|Anticipated|Grupo Espanol de Investigacion en Sarcomas||1|||f||||f||||||||No||2017-10-10 22:38:00.765824|2017-10-10 22:38:00.765824
NCT02638753|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-19|2017-08-02|||January 2016||2016-01-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy of Education on Neurophysiology of Pain Combined to Hypnosis in Patients With Chronic Low Back Pain|Efficacy of Education on Neurophysiology of Pain Combined to Hypnosis in Patients With Chronic Low Back Pain|Completed||N/A|100|Actual|Universidade Cidade de Sao Paulo||2|||f||||f||||||||||2017-10-10 22:38:00.936515|2017-10-10 22:38:00.936515
NCT02638740|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2017-04-14|||June 2015||2015-06-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||To Study the Beneficial Effect of Mustard Oil and Salt Massaging With Oral Prophylaxis in Patients With Gum Diseases|To Assess the Efficacy of Mustard Oil and Salt Massage as an Adjunct to Scaling and Root Planing in Patients With Chronic Periodontitis: A Clinical Study|Completed||N/A|54|Actual|Government College of Dentistry, Indore||2|||f||||t||||||||Undecided||2017-10-10 22:38:01.035554|2017-10-10 22:38:01.035554
NCT02638532|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-04-25|||January 2016||2016-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Volumetric Analysis in Autologous Fat Grafting to the Foot|Volumetric Analysis in Autologous Fat Grafting to the Foot|Active, not recruiting||N/A|50|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 22:38:02.478658|2017-10-10 22:38:02.478658
NCT02638727|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-12-19|||December 2015||2015-12-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Assessment of Short-term Effect of L-Citrulline on Endothelial Function and Vasodilation in Known CAD Patients|Assessment of Short-term Effect of L-Citrulline on Endothelial Function and Vasodilation in Known CAD Patients:A Randomized Crossover Clinical Trial|Recruiting||N/A|30|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-10-10 22:38:01.159571|2017-10-10 22:38:01.159571
NCT02638714|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-10-17|||April 2013||2013-04-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells|Treatment of Optic Neuropathies Using Autologous Bone-Marrow Derived Clusters of Differentiation (CD) 34+, 133+, and 271+ Stem Cells: A Pilot Study|Active, not recruiting||Phase 1/Phase 2|100|Anticipated|Stem Cells Arabia||1|||f||||t||||||||||2017-10-10 22:38:01.267272|2017-10-10 22:38:01.267272
NCT02638701|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-11-08|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms|Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms|Not yet recruiting||Phase 1/Phase 2|8|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 22:38:01.346561|2017-10-10 22:38:01.346561
NCT02638688|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-22|||September 2012||2012-09-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Measurement of Fibroid Volume and 2D, 3D US|Uterine Fibroid Volume After Myomectomy Compared to Pre-operative Measurement by Two and Three-dimensional Ultrasound|Completed||N/A|3|Actual|Zagazig University|||3||f||||t||||||||||2017-10-10 22:38:01.438962|2017-10-10 22:38:01.438962
NCT02638675|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-10-25|||January 2017||2017-01-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Financial Health Incentives to Promote Physical Activity Among Hospital Employees: A Randomized Control Trial|Examining Financial Health Incentives to Promote Physical Activity Among Inactive Hospital Employees: A Web-based Randomized Control Trial|Not yet recruiting||N/A|164|Anticipated|University of Toronto||2|||f||||f||||||||No|There is no plan to make individual participant data available|2017-10-10 22:38:01.50265|2017-10-10 22:38:01.50265
NCT02638662|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-01-18|||July 2010|Actual|2010-07-01|January 2017|2017-01-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Stress Level and the Relationship With IVF Outcomes.|Does Stress Affect In-Vitro Fertilization (IVF) Outcome?|Recruiting||N/A|300|Anticipated|Weill Medical College of Cornell University|||3||f||||f||||||||No||2017-10-10 22:38:01.606387|2017-10-10 22:38:01.606387
NCT02638649|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath|Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath|Not yet recruiting||N/A|376|Anticipated|Yale University|||1||f||||f||||||||No||2017-10-10 22:38:01.728311|2017-10-10 22:38:01.728311
NCT02638636|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-12-13|||December 2015||2015-12-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Internet-based Exposure-based Therapy for Fibromyalgia: A Randomized Controlled Trial.|Internet-based Exposure-based Therapy for Fibromyalgia: A Randomized Controlled Trial.|Completed||N/A|140|Actual|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 22:38:01.829161|2017-10-10 22:38:01.829161
NCT02638623|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-22|||October 2015||2015-10-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|Hydration||Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery|Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery and Reduce Complications in Arthroplasty Patients?|Recruiting||N/A|50|Anticipated|West Virginia University||2|||f||||t||||||||||2017-10-10 22:38:01.91667|2017-10-10 22:38:01.91667
NCT02638610|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-22|||January 2016||2016-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Interventional|||Assessment of Changes of Periocular Skin Sensation Following Eyelid and Ocular Surface Surgeries|Assessment of Changes of Periocular Skin Sensation Following Eyelid and Ocular Surface Surgeries|Not yet recruiting||N/A|60|Anticipated|Meir Medical Center||1|||f||||f||||||||Undecided||2017-10-10 22:38:02.00279|2017-10-10 22:38:02.00279
NCT02638597|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-08-04|||February 2015||2015-02-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|GEMNIC||Gemfibrozil for Nicotine Smoking Cessation|Gemfibrozil for Nicotine Smoking Cessation|Recruiting||Phase 2|20|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-10 22:38:02.068697|2017-10-10 22:38:02.068697
NCT02638584|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-03-01|||December 2015||2015-12-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.|Effects of Ilaprazole 20mg on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone Endoscopic Submucosal Dissection(ESD) for Gastric Adenoma or Early Gastric Cancer.|Recruiting||Phase 4|176|Anticipated|Il-Yang Pharm. Co., Ltd.||2|||f||||t||||||||Undecided|not yet decided|2017-10-10 22:38:02.156487|2017-10-10 22:38:02.156487
NCT02638571|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-02-24|||January 19, 2016|Actual|2016-01-19|February 2017|2017-02-01|November 22, 2016|Actual|2016-11-22|November 22, 2016|Actual|2016-11-22||Interventional|||Evaluation Nutrition Education Intervention on Pulse and Cereal Mix for Complementary Food in Southern Ethiopia|Evaluation of the Effectiveness of Nutrition Education Intervention Among Rural Mothers on Pulse and Cereal Mix Complementary Food and Nutritional Status of Children Age 6-24 Months in Sidama Zone, Southern Ethiopia|Completed||N/A|772|Actual|University of Saskatchewan||2|||f||||f||||||||No|Only mean (or median) data will be published. If there are correlations or regressions the r or r2 will be published|2017-10-10 22:38:02.251758|2017-10-10 22:38:02.251758
NCT02638558|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-09-04|||January 2016||2016-01-01|December 2015|2015-12-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||"Evaluation of the Impact of Direct Conversation With Patients in the Compliance With the Split-dose Regimen Preparation for Colonoscopy Scheduled in the First Part of the Morning"||Completed||N/A|286|Actual|Valduce Hospital||2|||f||||||||||||||2017-10-10 22:38:02.337365|2017-10-10 22:38:02.337365
NCT02638545|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-02-06|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Hemodynamic Effects of Dexmedetomidine in Septic Shock|Effects of Dexmedetomidine on Pressor Response to Norepinephrine in Patients With Septic Shock|Completed||Phase 3|37|Actual|University of Roma La Sapienza||1|||f||||f||||||||No||2017-10-10 22:38:02.400724|2017-10-10 22:38:02.400724
NCT02638519|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-06-22|||June 2016||2016-06-01|March 2016|2016-03-01||||June 2019|Anticipated|2019-06-01||Interventional|||HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease|Hyperpolarized Xenon-129 Functional Magnetic Resonance Imaging of Healthy Volunteers and Participants With Alzheimer's Disease|Recruiting||Early Phase 1|120|Anticipated|Thunder Bay Regional Research Institute||2|||f||||f||||||||||2017-10-10 22:38:02.567193|2017-10-10 22:38:02.567193
NCT02638506|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-21|2016-01-05|||January 2016||2016-01-01|January 2016|2016-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches|Randomized Controlled Trial Evaluating the Additive Value of Intranasal Fentanyl on Ibuprofen in the Pain Management of Children With Moderate to Severe Headaches|Not yet recruiting||Phase 4|120|Anticipated|St. Justine's Hospital||2|||f||||f||||||||No||2017-10-10 22:38:02.675506|2017-10-10 22:38:02.675506
NCT02638493|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-04-24|2017-03-02||December 2015|Actual|2015-12-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||The Compartmental Biology of HIV in the Male Genital Tract|IGHID 11526 - The Compartmental Biology of HIV in the Male Genital Tract|Completed||N/A|26|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||Samples With DNA|"     Blood and semen samples   "|No||2017-10-10 22:38:02.780918|2017-10-10 22:38:02.780918
NCT02638480|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-06-27|||November 2015||2015-11-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|KneeMD||Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty Patients|A Prospective Randomized Trial to Examine the Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty Patients|Recruiting||N/A|100|Anticipated|Anne Arundel Health System Research Institute||2|||f||||f||||||||||2017-10-10 22:38:03.415249|2017-10-10 22:38:03.415249
NCT02638467|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-10-27|||November 2015||2015-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy|Allogeneic Haematopoietic Stem Cell Transplantation From a Matched Donor in Patients With Chronic Myeloid Leukemia Failing to Gain Normal Hemopoiesis Under TKIs Therapy|Recruiting||Phase 2|20|Anticipated|University of Milano Bicocca||1|||f||||t||||||||||2017-10-10 22:38:03.545478|2017-10-10 22:38:03.545478
NCT02638441|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-21|||January 2016||2016-01-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Psychological Profile of Women With Infertility in Egypt: A Comparative Study|Psychological Profile of Women With Infertility in Egypt: A Comparative Study|Not yet recruiting||N/A|400|Anticipated|Ain Shams Maternity Hospital|||1||f||||t||||||||Yes||2017-10-10 22:38:03.792878|2017-10-10 22:38:03.792878
NCT02638428|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-10-17|||December 2015||2015-12-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy|Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy|Recruiting||Phase 2|90|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 22:38:03.872594|2017-10-10 22:38:03.872594
NCT02638415|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-20|||December 2015||2015-12-01|December 2015|2015-12-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varices|The Effect of HVPG-Guided Individualized Therapy in Patients With Cirrhosis Related Esophagogastric Variceal Hemorrhage For Secondary Prophylaxis:A Randomized Controlled Trial|Recruiting||Phase 4|500|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 22:38:03.992554|2017-10-10 22:38:03.992554
NCT02638402|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-20|2016-05-11|||May 2016||2016-05-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|||Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers|Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers|Not yet recruiting||N/A|250|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||No||2017-10-10 22:38:04.101491|2017-10-10 22:38:04.101491
NCT02638389|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-06-12|||November 2015||2015-11-01|June 2017|2017-06-01|October 2025|Anticipated|2025-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care|Phase III Multicentric Study Evaluating the Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care|Recruiting||Phase 3|250|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-10-10 22:38:04.167677|2017-10-10 22:38:04.167677
NCT02638376|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-12-22|||March 2013||2013-03-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluating the Safety and Efficacy of the KXL System for Corneal Collagen Cross-Linking in Eyes Having Keratoconus|A Study Evaluating the Safety and Efficacy of the KXL System With vibeX Rapid (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes Having Keratoconus and Post LASIK Ectasia|Recruiting||Phase 3|66|Anticipated|Singapore Eye Research Institute||2|||f||||f||||||||||2017-10-10 22:38:04.300029|2017-10-10 22:38:04.300029
NCT02638363|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-22|||August 2015||2015-08-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01||Observational|||An Investigation of General Predictors for CBT Outcome for Anxiety Disorders in a Naturalistic Setting|An Investigation of General Predictors for Cognitive Behavioral Therapy Outcome for Anxiety Disorders in a Naturalistic Setting|Recruiting||N/A|110|Anticipated|University of Copenhagen|||1||f||||t||||||||||2017-10-10 22:38:04.439689|2017-10-10 22:38:04.439689
NCT02638350|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-08-21|||December 7, 2015|Actual|2015-12-07|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ECHOP||Performance Evaluation of Clinical Ultrasound in Management of Acute Pulmonary Edema in Elderly Patient|Performance Evaluation of Clinical Ultrasound in Management of Acute Pulmonary Edema in Elderly Patient Over 65 Years, Admitted to a Host of Vital Emergency Services|Recruiting||N/A|123|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-10 22:38:04.519265|2017-10-10 22:38:04.519265
NCT02633527|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-04|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|July 25, 2016|Actual|2016-07-25|July 25, 2016|Actual|2016-07-25||Interventional|||Efficacy and Safety of SPN-812 ER in Children With ADHD||Completed||Phase 2|222|Actual|Supernus Pharmaceuticals, Inc.||5|||f||||||||||||||2017-10-10 22:39:00.472368|2017-10-10 22:39:00.472368
NCT02638337|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-08-30|||January 26, 2016|Actual|2016-01-26|August 2017|2017-08-01|July 12, 2017|Actual|2017-07-12|June 23, 2017|Actual|2017-06-23||Interventional|||Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause|A Phase 3, Randomized, Double-blind, Placebocontrolled Multicenter Study to Evaluate the Efficacy and Safety of Ospemifene in Patients With Moderate to Severe Vaginal Dryness, a Symptom of Vulvo-vaginal Atrophy (VVA) Due to Menopause|Completed||Phase 3|600|Actual|Shionogi Inc.||2|||f||||f||||||||||2017-10-10 22:38:04.661284|2017-10-10 22:38:04.661284
NCT02638324|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-12-17|||December 2014||2014-12-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Heart-RND||Supportive Treatment of Severe Heart Failure by Renal Denervation|Supportive Treatment of Severe Heart Failure by Renal Denervation|Recruiting||N/A|40|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-10 22:38:05.148515|2017-10-10 22:38:05.148515
NCT02638311|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-17|||May 2015||2015-05-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test|Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test|Completed||N/A|769|Actual|Trinity Biotech|||1||f||||f||||||Samples With DNA|"     EDTA plasma samples   "|No||2017-10-10 22:38:05.276298|2017-10-10 22:38:05.276298
NCT02638298|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-05-03|||December 2015||2015-12-01|December 2015|2015-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds|Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds. A Prospective Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|Medical University of South Carolina||2|||f||||t||||||||Yes|"Data safety and monitoring will be provided by the Hollings Cancer Center DSMC. This committee will serve for all sites. The DSMC meets 6 times a year and reviews all MUSC IRB adverse events, protocol deviations/violations, early stopping rules and internal audit results. The PI will be responsible for identifying, reviewing monthly, and reporting adverse events.
Individual participant data will not be shared between the sites. All data will be deidentified and linked with a code."|2017-10-10 22:38:05.362417|2017-10-10 22:38:05.362417
NCT02638285|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-18|||January 2009||2009-01-01|December 2015|2015-12-01||||August 2009|Actual|2009-08-01||Interventional|||Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI||Completed||Phase 4|86|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||Yes||2017-10-10 22:38:05.484129|2017-10-10 22:38:05.484129
NCT02638272|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-18|||January 2009||2009-01-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|February 2014|Actual|2014-02-01||Interventional|||Early Outcomes of Radical Debridement Versus no Debridement Under Different Surgical Procedures|Outcomes of Radical Debridement Versus no Debridement Under Different Surgical Procedures for the Treatment of Thoracic and Lumbar Spinal Tuberculosis|Completed||N/A|74|Actual|The Second Hospital of Anhui Medical University||1|||f||||||||||||||2017-10-10 22:38:05.571457|2017-10-10 22:38:05.571457
NCT02638259|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-06-29|||November 27, 2015|Actual|2015-11-27|June 2017|2017-06-01|June 12, 2017|Actual|2017-06-12|December 29, 2016|Actual|2016-12-29||Interventional|EQUIRA||Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis|A Randomized, Double-blind, Parallel-group Phase III Study to Demonstrate Equivalent Efficacy and to Compare Safety & Immunogenicity of GP2015 and Enbrel® (EU Authorized) in Patients With Moderate to Severe, Active Rheumatoid Arthritis|Completed||Phase 3|376|Actual|Sandoz||2|||f||||t||||||||Yes|Via CSR|2017-10-10 22:38:05.662401|2017-10-10 22:38:05.662401
NCT02638246|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2015-12-18|||April 2011||2011-04-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Incentives for Internet-based Adherence to SMBG for Teens With T1D|Incentives for Internet-based Glucose Testing in Adolescent Type 1 Diabetes|Completed||N/A|52|Actual|Rowan University||2|||f||||f||||||||No|Only upon request|2017-10-10 22:38:05.997124|2017-10-10 22:38:05.997124
NCT02638233|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-12-18|||September 2015||2015-09-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy|Direct Observed Therapy With Ledipasvir/Sofosbuvir in Treatment-naïve Patients With Chronic Genotype 1 HCV (Hepatitis C Virus) Infection Receiving Opiate Substitution Therapy|Recruiting||Phase 4|40|Anticipated|Wilhelminenspital Vienna||1|||f||||f||||||||||2017-10-10 22:38:06.077972|2017-10-10 22:38:06.077972
NCT02638220|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-09-13|||September 2015||2015-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Cerebrotendinous Xanthomatosis (CTX) Prevalence Study|An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts|Recruiting||N/A|500|Anticipated|Retrophin, Inc.|||1||f||||f||||||||||2017-10-10 22:38:06.189418|2017-10-10 22:38:06.189418
NCT02638207|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-29|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|CIDP||Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy|Prospective, Double-blind, Randomized, Multicenter Phase III Study Evaluating Efficacy and Safety of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly(Radiculo)Neuropathy|Recruiting||Phase 3|140|Anticipated|Octapharma||3|||f||||t|t|f||||||||2017-10-10 22:38:06.43702|2017-10-10 22:38:06.43702
NCT02638194|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2015-12-18|||July 2014||2014-07-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|October 2014|Actual|2014-10-01||Interventional|||Adverse Health Effects of Mainstream and Secondhand Hookah Smoke in NYC Hookah Bars|Adverse Health Effects of Mainstream and Secondhand Hookah Smoke in NYC Hookah Bars|Completed||N/A|26|Actual|New York University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:38:06.576531|2017-10-10 22:38:06.576531
NCT02638181|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-01-08|||July 2013||2013-07-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Expression of Matrix Metalloproteinase 13, Tissue Inhibitor of Metalloproteinases 3, and Calcium-sensing Receptor in Human Trabecular Meshwork|The Expression of Matrix Metalloproteinase 13（MMP13）, Tissue Inhibitor of Metalloproteinases 3（TIMP13）, and Calcium-sensing Receptor（CaSR） in Human Trabecular Meshwork|Completed||N/A|60|Actual|Tianjin Medical University Eye Hospital||1|||f||||t||||||||||2017-10-10 22:38:06.667674|2017-10-10 22:38:06.667674
NCT02638168|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-19|||January 2016||2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With ADHD|Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With Attention Deficit Hyperactivity Disorder: A Randomized Placebo-controlled Pilot Study|Recruiting||Phase 4|38|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 22:38:06.740957|2017-10-10 22:38:06.740957
NCT02638155|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-10-18|||August 2016||2016-08-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Food Addiction and Hormone Study|Food Addition and Hormone Study|Recruiting||N/A|30|Anticipated|Texas Tech University|||2||f||||f||||||Samples With DNA|"     Blood   "|No||2017-10-10 22:38:06.838285|2017-10-10 22:38:06.838285
NCT02638142|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-06-03|||December 2015||2015-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|DIUR-AHF||Loop Diuretic Therapy in Acutely Decompensated Heart Failure|Continuous Versus Bolus Intermittent Loop Diuretic Infusion in Acutely Decompensated Heart Failure: Evaluation of Renal Function, Congestion Signs, BNP and Outcome|Recruiting||N/A|240|Anticipated|University of Siena|||2||f||||t||||||Samples Without DNA|"     blood samples   "|No||2017-10-10 22:38:06.935918|2017-10-10 22:38:06.935918
NCT02638129|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-02-21|2016-10-05||January 2016||2016-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Naltrexone/Bupropion Cardiovascular Outcomes Study|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease|Terminated||Phase 4|67|Actual|Orexigen Therapeutics, Inc|As this study was prematurely terminated, analysis of the primary and secondary outcome measures was not performed and analysis of safety was limited in scope.|4|||f||||f||||||||||2017-10-10 22:38:07.109958|2017-10-10 22:38:07.109958
NCT02638116|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-04-14|||January 2016||2016-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults|Open-Label, Sequential-Design Drug Interaction Study of the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults|Completed||Phase 1|20|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 22:38:07.96484|2017-10-10 22:38:07.96484
NCT02638103|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-10-05|||March 31, 2016|Actual|2016-03-31|October 2017|2017-10-01|April 6, 2018|Anticipated|2018-04-06|April 6, 2018|Anticipated|2018-04-06||Interventional|HALO||Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine|A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine|Active, not recruiting||Phase 3|1578|Actual|Teva Pharmaceutical Industries||2|||f||||f|t|f||||||||2017-10-10 22:38:09.904007|2017-10-10 22:38:09.904007
NCT02638090|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-07-12|||February 24, 2016|Actual|2016-02-24|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)|A Phase I/II Study of Pembrolizumab and Vorinostat in Patients With Immune Therapy Naïve and Immune Therapy Pretreated Stage IV NSCLC|Recruiting||Phase 1/Phase 2|100|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||4|||f||||f|t|f||||||||2017-10-10 22:38:10.638535|2017-10-10 22:38:10.638535
NCT02638077|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2015-12-18|||October 2015||2015-10-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|DTCC||Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China|A Multi-center, Prospective Study to Observe the Initial Management of Patients With Differentiated Thyroid Cancer in the Real World in China (DTCC Study)|Recruiting||N/A|2000|Anticipated|Huazhong University of Science and Technology|||1||f||||t||||||None Retained|"     tumors samples will retained for detecting gene mutation   "|No|Not yet|2017-10-10 22:38:10.863934|2017-10-10 22:38:10.863934
NCT02638064|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-12-20|||March 2013||2013-03-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|||Treatment of Pilonidal Sinus Disease Using Surgiflo as a Sealant: A New Concept|Treatment of Pilonidal Sinus Disease Using Surgiflo as a Sealant: A New Concept|Completed||N/A|50|Actual|Mansoura University||1|||f||||t||||||||||2017-10-10 22:38:10.991404|2017-10-10 22:38:10.991404
NCT02638051|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-04-15|2015-12-23||January 2014||2014-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|OTMA-RII||Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT|Local Modulated Electro-Hyperthermia in Combination With Traditional Chinese Medicine Versus Intraperitoneal Chemoinfusion in Treatment of Peritoneal Carcinomatosis With Malignant Ascites: A Phase II Randomized Trial|Completed||Phase 2|260|Actual|Galenic Research Institute Ltd|"Absence of the detailed peritoneal carcinomatosis characteristics.
Absence of a survival analysis. These limitations are related to the restricted funding of the trial."|2|||f||||f||||||||No||2017-10-10 22:38:11.121577|2017-10-10 22:38:11.121577
NCT02638038|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-08-24|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|December 12, 2016|Actual|2016-12-12|December 12, 2016|Actual|2016-12-12||Interventional|||This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-naïve RRMS for ≤ 3 Years|A 6-month, Double-blind, Randomized, Parallel-group, Multicenter Study Comparing Safety and Efficacy of Monotherapy With INT131 1 mg or 3 mg or Placebo Administered Orally Once Daily in Treatment Naïve Patients (Who Never Received Disease Modifying Treatment) With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|228|Actual|InteKrin Therapeutics, Inc.||3|||f||||t||||||||||2017-10-10 22:38:11.832866|2017-10-10 22:38:11.832866
NCT02638025|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-20|||January 2010||2010-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2011|Actual|2011-07-01||Observational|||Anterior Segment Spectral-domain Optical Coherence Tomography in Patients With Closed Globe Injury|Anterior Segment Spectral-domain Optical Coherence Tomography in Patients With Closed Globe Injury|Completed||N/A|16|Actual|Huizhou Municipal Central Hospital|||1||f||||t||||||||||2017-10-10 22:38:11.9049|2017-10-10 22:38:11.9049
NCT02638012|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-01-10|||December 2015||2015-12-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)|Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)|Recruiting||N/A|10|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-10-10 22:38:11.956799|2017-10-10 22:38:11.956799
NCT02637999|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-08-21|||February 13, 2014|Actual|2014-02-13|August 2017|2017-08-01|January 21, 2016|Actual|2016-01-21|January 21, 2016|Actual|2016-01-21||Interventional|||Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With Chronic Hepatitis Delta|Randomized Open-label Substudy of Daily Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative Chronic Hepatitis B Co-infected With Hepatitis Delta|Completed||Phase 1/Phase 2|24|Actual|Hepatera Ltd.||3|||f||||f||||||||||2017-10-10 22:38:12.054343|2017-10-10 22:38:12.054343
NCT02637986|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-08-13|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pregnancy|The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pregnancy - a Prospective Randomized Double Blind Placebo-control Study|Not yet recruiting||N/A|320|Anticipated|HaEmek Medical Center, Israel||4|||f|||||f|f||||||||2017-10-10 22:38:12.157539|2017-10-10 22:38:12.157539
NCT02637973|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-12-14|||December 2015||2015-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|EmLiFa||Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes|Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes|Recruiting||Phase 4|72|Anticipated|German Diabetes Center||2|||f||||f||||||||||2017-10-10 22:38:12.261307|2017-10-10 22:38:12.261307
NCT02637960|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-08-23|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|EQUINOC||Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)|A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)|Completed||Phase 2/Phase 3|432|Actual|Vantia Ltd||2|||f||||f||||||||||2017-10-10 22:38:12.393402|2017-10-10 22:38:12.393402
NCT02637947|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-07|||January 2016||2016-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|MAGNETIC-VT||Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population|A Prospective, Multi-center, Post Market Randomized Controlled Trial Comparing VT Ablation Outcomes Using Remote MAGNETIC Navigation Guided Substrate Mapping and Ablation Versus Manual Approach in a Low LVEF Population|Recruiting||N/A|386|Anticipated|Stereotaxis||2|||f||||f||||||||||2017-10-10 22:38:12.696397|2017-10-10 22:38:12.696397
NCT02637934|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-07-11|||December 2015||2015-12-01|July 2016|2016-07-01||||December 2018|Anticipated|2018-12-01||Interventional|||Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT|Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT|Recruiting||Phase 1|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:38:12.882123|2017-10-10 22:38:12.882123
NCT02637921|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-09-15|||March 2012||2012-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|November 2013|Actual|2013-11-01||Interventional|PlanHab||Planetary Habitat Simulation: Bone Metabolism Studies|Planetary Habitat Simulation: The Combined Effects of Bed Rest and Normobaric Hypoxia Upon Bone and Mineral Metabolism (WP3)|Completed||N/A|14|Actual|University of Nottingham||3|||f||||t||||||||No||2017-10-10 22:38:12.959809|2017-10-10 22:38:12.959809
NCT02637908|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-08-09|||September 2015||2015-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Mindfulness Training for Head Start Parents|Head Start Parenting|Completed||N/A|42|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 22:38:13.05328|2017-10-10 22:38:13.05328
NCT02637895|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Vortioxetine for Posttraumatic Stress Disorder|Evaluation of the Efficacy of Vortioxetine for Posttraumatic Stress Disorder|Recruiting||Phase 4|80|Anticipated|University of Miami||2|||f||||t||||||||No||2017-10-10 22:38:13.141073|2017-10-10 22:38:13.141073
NCT02637882|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2015-12-20|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|Ghada||The Effect of Applying Multidisciplinary Bundle Intervention on the Delirium Incidence in Critically Ill Patients|The Effect of Applying Multidisciplinary Bundle Intervention on the Delirium Incidence in Critically Ill Patients|Enrolling by invitation||Phase 2|50|Anticipated|Assiut University||3|||f||||t||||||||Yes|the patient's assessment sheet will be used to collect the data,the researcher will interview with the patient to complete the sleeping quality sleeping questionnaire and delirium scale|2017-10-10 22:38:13.252127|2017-10-10 22:38:13.252127
NCT02637869|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-06-19|||July 2015||2015-07-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|eCHANGE||Evaluating Community Health Centers' Adoption of a New Global Capitation Payment|Evaluating Community Health Centers' Adoption of a New Global Capitation Payment|Active, not recruiting||N/A|400000|Anticipated|Oregon Health and Science University|||2||f||||f||||||||||2017-10-10 22:38:13.340753|2017-10-10 22:38:13.340753
NCT02637856|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-07-31|||February 11, 2016|Actual|2016-02-11|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)|An Open-Label Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Relapsing Remitting Multiple Sclerosis Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment|Active, not recruiting||Phase 3|611|Actual|Genentech, Inc.||1|||f|||||t|f||||||||2017-10-10 22:38:13.460943|2017-10-10 22:38:13.460943
NCT02637843|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-08-12|||December 2015||2015-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|ACCESS-I||Randomized Comparison of Sheaths for Radial Access|Randomized Comparison of Coated Slender Versus Un-coated Traditional Sheath|Completed||N/A|1000|Actual|Aarhus University Hospital Skejby||2|||f||||f||||||||No||2017-10-10 22:38:13.761498|2017-10-10 22:38:13.761498
NCT02637830|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-22|||January 2012||2012-01-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||In Situ Remineralisation Response of Different Artificial Caries-like Enamel Lesions to Home-care and Professional Fluoride Treatments||Completed||N/A|12|Actual|University of Sao Paulo||3|||f||||||||||||||2017-10-10 22:38:13.85692|2017-10-10 22:38:13.85692
NCT02637817|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-08-09|||January 2016||2016-01-01|August 2016|2016-08-01||||June 2019|Anticipated|2019-06-01||Observational|PWML||MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates|MRI-based Biomarkers for the Prognosis Judgement of Punctate White Matter Lesions in Neonates: a Longitudinal Multicenter Study|Recruiting||N/A|600|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||2||f||||||||||||||2017-10-10 22:38:13.946401|2017-10-10 22:38:13.946401
NCT02637557|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-25||2017-09-25|March 2016||2016-03-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||A Randomized, Double-blind, Placebo-controlled,Trial of IW-3718 for 8 Weeks in Patient With Symptomatic GERD|A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Trial of IW-3718 Administered Orally for 8 Weeks to Patients With Symptomatic GERD That Persists Despite Treatment With Proton Pump Inhibitors|Completed||Phase 2|282|Actual|Ironwood Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-10 22:38:14.138738|2017-10-10 22:38:14.138738
NCT02637544|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-02-02|||April 2014||2014-04-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|April 2016|Anticipated|2016-04-01||Interventional|||Treatment Efficiency of Acupuncture in Non Chronified Pain Patients With TMDs|Wirksamkeit Von Akupunktur Auf Den Nicht Chronifizierten Schmerz Bei Craniomandibulärer Dysfunktion - Eine Randomisierte, Placebokontrollierte Klinische Studie|Recruiting||N/A|40|Anticipated|University of Heidelberg Medical Center||2|||f||||f||||||||||2017-10-10 22:38:14.473431|2017-10-10 22:38:14.473431
NCT02637531|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-08-25|||December 2015||2015-12-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549|A Phase 1/1b First-In-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549 Monotherapy and in Combination With Nivolumab in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|175|Anticipated|Infinity Pharmaceuticals, Inc.||7|||f||||f||||||||||2017-10-10 22:38:14.571563|2017-10-10 22:38:14.571563
NCT02637518|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-08-23|||May 2015||2015-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|August 2016|Anticipated|2016-08-01||Observational|FRAILTOOLS||Comprehensive Validation of Frailty Assessment Tools in Older Adults in Different Clinical and Social Settings|A Comprehensive Validation of Frailty Assessment Tools to Screen and Diagnose Frailty in Different Clinical and Social Settings and to Provide Instruments for Integrated Care in Older Adults.|Recruiting||N/A|1940|Anticipated|Hospital Universitario Getafe|||5||f||||t||||||||Yes||2017-10-10 22:38:14.733066|2017-10-10 22:38:14.733066
NCT02637505|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-03-30|||January 2016||2016-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Norwegian Cartilage Project - Microfracture|Focal Cartilage Defects in the Knee - A Randomized Controlled Trial Comparing Arthroscopic Microfracture With Arthroscopic Debridement|Recruiting||N/A|114|Anticipated|University Hospital, Akershus||2|||f||||t||||||||No||2017-10-10 22:38:14.854937|2017-10-10 22:38:14.854937
NCT02637492|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-08-22|||February 2016||2016-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|PREDICCMI||Development and Validation of a Clinical Prediction Rule for Lower Limb Critical Limb Ischaemia (PREDICCMI)|Development and Validation of a Clinical Prediction Rule for Lower Limb Critical Limb Ischaemia (PREDICCMI)|Recruiting||N/A|600|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 22:38:14.964923|2017-10-10 22:38:14.964923
NCT02637479|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-18|||December 2015||2015-12-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Hyporadoul||Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery|Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery: A Multicenter, Prospective, Randomized Study|Recruiting||N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-10-10 22:38:15.088528|2017-10-10 22:38:15.088528
NCT02637466|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-09-29|||July 2016||2016-07-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers|A Double-blind, Placebo-controlled, Randomized Study of Vortioxetine Treatment on Major Depression, Cognition, and Systemic Inflammatory Biomarkers Associated With Depression and Cancer Progression in Women With Breast Cancer.|Withdrawn||Phase 4|0|Actual|University of Miami||2||Funding not received|f||||t||||||||||2017-10-10 22:38:15.189051|2017-10-10 22:38:15.189051
NCT02637453|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-17|||June 2015||2015-06-01|December 2015|2015-12-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Additional Linear Ablation Beyond Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation|Additional Linear Ablation Perpendicular to the Pulmonary Vein Isolation Line Reduces the Recurrence Rate of Paroxysmal Atrial Fibrillation (ALA-PAF)|Recruiting||Phase 4|390|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 22:38:15.279138|2017-10-10 22:38:15.279138
NCT02637440|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2015-12-21|||December 2015||2015-12-01|December 2015|2015-12-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|FAIO||The Use Of FFR Guided PCI Versus Complete Revascularization and Treatment Of Infarct Related Artery Only In Patients With STEMI|Multi Centre Open Label Randomised Controlled Parallel-group Three Arm Trial To Compare The Use Of Fractional Flow Reserve (FFR) Guided and Angiographically Guided Revascularization To The Treatment Of Infarct Related Artery Only In Patients With STEMI And Multivessel Disease|Not yet recruiting||Phase 3|560|Anticipated|University of Limerick||3|||f||||t||||||||||2017-10-10 22:38:15.393086|2017-10-10 22:38:15.393086
NCT02637427|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-05-22|||January 2016||2016-01-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|||Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures|Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures|Recruiting||Phase 3|110|Anticipated|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-10 22:38:15.528241|2017-10-10 22:38:15.528241
NCT02637414|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-06-20|||January 2016||2016-01-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Flourishing App: Evaluation of the Effectiveness of a Well-being Application for Mobile Devices|Flourishing App: Evaluation of the Effectiveness of a Well-being Application for Mobile Devices|Completed||N/A|500|Actual|Hospital Israelita Albert Einstein||2|||f||||t||||||||||2017-10-10 22:38:15.629184|2017-10-10 22:38:15.629184
NCT02637401|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-05-18|||March 2015||2015-03-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|January 2016|Actual|2016-01-01||Observational|||Group Dialectical Behavioural Therapy for Mood Instability Within Bipolar Disorder: An Open Trial|Group Dialectical Behavioural Therapy for Mood Instability Within Bipolar Disorder: An Open Trial|Active, not recruiting||N/A|13|Actual|University of Exeter|||1||f||||f||||||||Undecided|Data woudl potentially be shared on Open Repository Exeter (University of Exeter's open data repository)|2017-10-10 22:38:15.715518|2017-10-10 22:38:15.715518
NCT02637388|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-09-26|||March 2016||2016-03-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Beta-glucan on Energy Intake and Satiety|The Effect of a Breakfast Meal Containing 4g Oat Beta-glucan on Perceived Satiety and ad Libitum Food Intake in Normal-weight and Overweight Subjects. A Double-blinded, Randomized, Placebo-controlled Cross-over Study.|Enrolling by invitation||N/A|36|Anticipated|Queen Margaret University||2|||f||||f||||||||No||2017-10-10 22:38:15.79828|2017-10-10 22:38:15.79828
NCT02637375|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-05-26|||May 2016||2016-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer|A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer|Withdrawn||N/A|0|Actual|University of Chicago||1||Study never opened (terminated as study drug no longer available)|f||||f||||||||||2017-10-10 22:38:15.917113|2017-10-10 22:38:15.917113
NCT02637362|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-10-04|||October 2016||2016-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Optimal Analgesia for Forefoot Surgery|Optimal Analgesia Following Metatarsal Surgery: A Prospective Randomised, Single-Blind Sham-Controlled Trial of Three Strategies|Not yet recruiting||N/A|69|Anticipated|Queen Elizabeth Hospital NHS Foundation Trust||3|||f||||f||||||||No||2017-10-10 22:38:16.012303|2017-10-10 22:38:16.012303
NCT02637349|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-09-26|||March 2016||2016-03-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|POST||Polaris Oncology Survivor Transition (POST) System|Polaris Oncology Survivor Transition (POST) System|Not yet recruiting||Phase 2|230|Anticipated|Polaris Health Directions||2|||f||||f||||||||Undecided||2017-10-10 22:38:16.105699|2017-10-10 22:38:16.105699
NCT02637336|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-21|||March 2014||2014-03-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Study to Investigate Effects of Different Therapies for the Treatment of Hypertension|Acute Cardiovascular Responses in Hypertensive Individuals|Completed||N/A|12|Actual|Universidade Federal do vale do São Francisco||4|||f||||t||||||||||2017-10-10 22:38:16.227243|2017-10-10 22:38:16.227243
NCT02637323|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-08-08|||November 2015||2015-11-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study to Characterize the Systemic PK and Local Extent and Duration of Exposure of TCA From FX006 in Patients With OA of the Knee|An Open-label, Single Administration Study to Characterize the Systemic Pharmacokinetics and Local Extent and Duration of Exposure of Triamcinolone Acetonide From FX006 in Patients With Osteoarthritis of the Knee|Completed||Phase 2|81|Actual|Flexion Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:38:16.328238|2017-10-10 22:38:16.328238
NCT02637310|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-03-29|||December 2015||2015-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis|A Multi Center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of N02RS1 in Patients With Acute Bronchitis|Completed||Phase 2|108|Actual|PharmaKing||2|||f||||t||||||||||2017-10-10 22:38:16.437265|2017-10-10 22:38:16.437265
NCT02637297|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-08-16|||January 8, 2016|Actual|2016-01-08|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|February 9, 2017|Actual|2017-02-09||Interventional|||Hypnotherapy in Treating Chronic Pain in Cancer Survivors|Hypnosis for Pain Management With Cancer Survivors|Completed||N/A|39|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-10 22:38:16.509566|2017-10-10 22:38:16.509566
NCT02637284|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-17|||October 2015||2015-10-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||PCO-02 - Safety and Pharmacokinetics Trial|Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source.|Unknown status|Active, not recruiting|Phase 1|42|Anticipated|PharmaCotherapia d.o.o.||8|||f||||f||||||||||2017-10-10 22:38:16.62413|2017-10-10 22:38:16.62413
NCT02637271|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-08-31|||January 2016||2016-01-01|December 2015|2015-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BRDI||Brain Response to Dietary Interventions|Neural Correlates of a Nutritionally Balanced Total Meal Replacement, 3 Week Dietary Exposure: An fMRI Study|Completed||N/A|32|Actual|Texas Tech University||2|||f||||f||||||||No||2017-10-10 22:38:16.7591|2017-10-10 22:38:16.7591
NCT02637258|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-18|||December 2015||2015-12-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01|1 Month|Observational [Patient Registry]|||Can Optic Nerve Sheath Diameter Measurement Predict Negative Neurological Outcome ?|Can Bedside Ultrasonographic Measurements of Optic Nerve Sheath Diameter Following the Return of Spontaneous Circulation Predict Negative Neurological Outcome in Out of Hospital Cardiac Arrest Patients?|Recruiting||N/A|203|Anticipated|Emergency Medicine Association of Turkey|||1||f||||f||||||||||2017-10-10 22:38:16.891937|2017-10-10 22:38:16.891937
NCT02637245|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-07-25|||May 2015||2015-05-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|May 2018|Anticipated|2018-05-01||Observational|||Imaging Parameters and DME Treatment Response|Imaging Parameters Predicting Treatment Response in Patients With Diabetic Macular Edema|Recruiting||N/A|150|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 22:38:17.093523|2017-10-10 22:38:17.093523
NCT02637232|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-05-17|||October 2015||2015-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|MUSE||Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)|Mirvaso® Utilisation and Patient Satisfaction Evaluation|Completed||N/A|302|Actual|Galderma|||1||f||||f||||||||||2017-10-10 22:38:17.355451|2017-10-10 22:38:17.355451
NCT02637219|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-18|||March 2006||2006-03-01|December 2015|2015-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Innate Immune Response in COPD|Innate Immune Response in COPD|Completed||N/A|30|Actual|VA Puget Sound Health Care System|||1||f||||f||||||||||2017-10-10 22:38:17.487189|2017-10-10 22:38:17.487189
NCT02637206|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-07-14|||October 27, 2015|Actual|2015-10-27|July 2017|2017-07-01|December 2, 2015|Actual|2015-12-02|December 2, 2015|Actual|2015-12-02||Interventional|||Skin Irritation Study of GSK2894512 Cream|Skin Irritation Study of GSK2894512 Cream-An Evaluator-Blinded Study to Evaluate the Skin Irritation of GSK2894512 Cream and Placebo Following Single Application by Simple-Patch Test and Photo-Patch Test, and Repeat Application Under Non-occlusive Condition in Healthy Japanese Subjects|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:38:17.578448|2017-10-10 22:38:17.578448
NCT02637193|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-08-17|||December 2015||2015-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects|A Single Center, Three Period, Randomized, Three-way Crossover, Double-blind Placebo And Moxifloxacincontrolled Study To Assess The Effects Of Effexor Xr On Cardiac Repolarization In Healthy Adult Subjects|Completed||Phase 1|54|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 22:38:17.723728|2017-10-10 22:38:17.723728
NCT02637180|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2017-09-18|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|December 7, 2017|Anticipated|2017-12-07|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Secondary Prevention of Osteoporotic Fractures: a Multiple Center Fracture Liaison Service in Greece|A Multiple Center, Prospective Study Targeting the Secondary Prevention of Fractures in Greece: Evaluation of the Fracture Liaison Service in Multiple Hospital Settings|Active, not recruiting||N/A|1000|Anticipated|Hellenic Society for the Study of Bone Metabolism|||1||f||||f||||||||||2017-10-10 22:38:17.861121|2017-10-10 22:38:17.861121
NCT02637167|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-10-31|||March 2016||2016-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||GutHeart: Targeting Gut Microbiota to Treat Heart Failure|GutHeart: Targeting Gut Microbiota to Treat Heart Failure|Recruiting||Phase 2|150|Anticipated|Oslo University Hospital||3|||f||||t||||||||Yes||2017-10-10 22:38:18.012643|2017-10-10 22:38:18.012643
NCT02637154|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-21|||October 2015||2015-10-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Motivational Interview in Adolescents With Poorly Controlled Type 1 Diabetes|The Effect of Motivational Interview and Intensive Education on HbA1C Values and Glucose Variability in Adolescents With Poorly Controlled Type 1 Diabetes|Recruiting||N/A|60|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||No||2017-10-10 22:38:18.189381|2017-10-10 22:38:18.189381
NCT02637141|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2017-08-06|||March 30, 2016||2016-03-30|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|June 30, 2017|Actual|2017-06-30||Interventional|||A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease|Active, not recruiting||Phase 2|64|Actual|Celimmune||3|||f||||t||||||||||2017-10-10 22:38:18.381943|2017-10-10 22:38:18.381943
NCT02637128|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2015-12-18|||March 2014||2014-03-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria|In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated Plasmodium Falciparum Malaria in Malawi, 2014|Completed||Phase 4|452|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||Undecided||2017-10-10 22:38:18.526344|2017-10-10 22:38:18.526344
NCT02637115|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-10-24|||December 2015||2015-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|Microbes4U||Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome|Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome Related to Obesity|Recruiting||N/A|100|Anticipated|Université Catholique de Louvain||4|||f||||f||||||||Undecided||2017-10-10 22:38:18.665694|2017-10-10 22:38:18.665694
NCT02637102|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-21|||November 2015||2015-11-01|November 2015|2015-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||The UK CAVIAR Study|The UK CArdiac and Vascular Surgery Interventional Anaemia Response Study: An Observational Cohort Study to Determine the Impact and Effect of Anaemia in Patients Awaiting Vascular and Cardiac Surgery|Not yet recruiting||N/A|432|Anticipated|University College, London|||1||f||||||||||||||2017-10-10 22:38:18.814137|2017-10-10 22:38:18.814137
NCT02637089|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|PD-MCI||Longitudinal Study of Mild Cognitive Impairment in Parkinson's Disease|Longitudinal Comparison of the Nature and Evolution of Mild Cognitive Impairment in Individuals With and Without Parkinson's Disease Characterized by Neuroimaging, Clinical Assessments and Genotyping|Recruiting||N/A|200|Anticipated|University of Calgary|||4||f||||f||||||Samples With DNA|"     50 ml of blood will be collected from all participants to analyze biomarkers and DNA for     genes of interest   "|||2017-10-10 22:38:18.924319|2017-10-10 22:38:18.924319
NCT02637076|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-07-18|||January 2016||2016-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Xyrem and Brain Dopamine in Narcolepsy|Does Xyrem Influence Brain Dopamine in Patients With Narcolepsy? A PET Imaging Investigation|Recruiting||Phase 4|15|Anticipated|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-10-10 22:38:19.065343|2017-10-10 22:38:19.065343
NCT02637063|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-01-24|2016-10-12||November 2013||2013-11-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Prehype||Interactive Web Program and Health Coaching for Prehypertensive Adults|Interactive Web Program and Health Coaching for Prehypertensive Adults|Completed||N/A|203|Actual|Oregon Center for Applied Science, Inc.||3|||f||||f||||||||No||2017-10-10 22:38:19.22605|2017-10-10 22:38:19.22605
NCT02637050|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-27|||March 3, 2016|Actual|2016-03-03|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|June 30, 2020|Anticipated|2020-06-30||Observational|EMEA CTEPH||A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries|EMEA CTEPH Registry: An International Prospective Registry Investigating the Epidemiology, Diagnosis and Treatment of CTEPH Patients in EMEA Countries|Recruiting||N/A|200|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 22:38:20.269119|2017-10-10 22:38:20.269119
NCT02637011|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-19|||September 2014||2014-09-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Observational|DACAPO||Surviving ARDS: The Influence of Quality of Care and Individual Patient Characteristics on Quality of Life|Influence of Quality of Care and Individual Patient Characteristics on Quality of Life/ Return to Work in Survivors of the Acute Respiratory Distress Syndrome (ARDS): Prospective, Observational, Multi-centre Cohort Study|Recruiting||N/A|2000|Anticipated|University Hospital Regensburg|||1||f||||f||||||||No||2017-10-10 22:38:20.816785|2017-10-10 22:38:20.816785
NCT02636998|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-06-28|||June 2015||2015-06-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|||Nutrition and Cognitive Function in Preadolescents|Nutrition and Cognitive Function in Preadolescents|Recruiting||N/A|116|Anticipated|Arkansas Children's Hospital Research Institute|||2||f||||f||||||Samples Without DNA|"     Blood samples and salivary samples   "|||2017-10-10 22:38:20.940142|2017-10-10 22:38:20.940142
NCT02636985|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-17|||December 2011||2011-12-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Application of Ultrasonic Elastography in Lung Lesions|Transthoracic Ultrasound Elastography in Pulmonary Lesions and Diseases|Completed||N/A|45|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:38:21.054767|2017-10-10 22:38:21.054767
NCT02636972|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-21|||November 2014||2014-11-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||The Progression From Dysmenorrhoea to Chronic Pelvic Pain|The Progression From Dysmenorrhoea to Chronic Pelvic Pain: Investigation of the Role of Chronic Inflammatory Pain Phenotype in Peripheral Blood as a Potential Biomarker.|Active, not recruiting||N/A|56|Anticipated|University of Adelaide|||7||f||||f||||||Samples With DNA|"     Blood sample retained for future analysis (may include DNA analysis)   "|No||2017-10-10 22:38:21.149218|2017-10-10 22:38:21.149218
NCT02636959|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-05-18|||December 2015||2015-12-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||A Postoperative Study on HVSI vs LVSI Treatment of Chronic Rhinosinusitis|High Volume Saline Irrigation in the Post-operative Management of Chronic Rhinosinusitis: A Multicenter Randomized Single-Blind Controlled Trial|Recruiting||Early Phase 1|20|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:38:21.288321|2017-10-10 22:38:21.288321
NCT02636946|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-31|||February 24, 2016|Actual|2016-02-24|August 2017|2017-08-01|July 29, 2020|Anticipated|2020-07-29|November 26, 2019|Anticipated|2019-11-26||Interventional|||A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension|A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension|Recruiting||Phase 3|160|Anticipated|Allergan||2|||f||||f||||||||||2017-10-10 22:38:21.422278|2017-10-10 22:38:21.422278
NCT02636933|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-01-03|||March 2015||2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters|Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters (PRE-AR) (PREMATURELY BORN CHILDREN- ASTHMA AND ALLERGIC RHINITIS )|Recruiting||N/A|52|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||2||f||||f||||||||Yes|"The IPD collected will be available on december 2020.
The following participant data will be shared:
Pulmonary function tests
Demographic characteristics
All IPD will be obtained from statistical analysis on the dedicated database in which all data are stored."|2017-10-10 22:38:21.768408|2017-10-10 22:38:21.768408
NCT02636920|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-03-15|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TEP||"Study and Development of Application Models of Therapeutic Education to the Patient (TEP) in Asthmatic Children"|"Study and Development of Application Models of Therapeutic Education to the Patient (TEP) in Asthmatic Children"|Recruiting||N/A|50|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy||2|||f||||f|f|f||||||||2017-10-10 22:38:22.056578|2017-10-10 22:38:22.056578
NCT02636907|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-09-11|2017-09-11||January 6, 2016|Actual|2016-01-06|September 2017|2017-09-01|June 29, 2017|Actual|2017-06-29|June 21, 2016|Actual|2016-06-21||Interventional||Safety Analysis Set (SAF): The SAF contained all patients in the all subjects enrolled set (ENR) who received at least 1 dose of trial drug or attempted to inject it as indicated by the questionnaire on self-injection with autoinjector.|Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe|Assessment of Real-life Patient Handling Experience of BI 695501 Administered Subcutaneously With an Autoinjector in Patients With Rheumatoid Arthritis: an Open-label, Interventional Clinical Trial Followed by an Extension Phase of BI 695501 Administered With a Prefilled Syringe|Completed||Phase 2|77|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:38:22.194676|2017-10-10 22:38:22.194676
NCT02636894|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-02-12|||March 2016||2016-03-01|February 2016|2016-02-01||||August 2016|Anticipated|2016-08-01||Interventional|||Evaluation of the Efficacy of Restylane Silk in the Treatment of Cheek Fold (Radial Smile Lines)|Evaluation of the Efficacy of Restylane Silk in the Treatment of Cheek Fold (Radial Smile Lines)|Not yet recruiting||N/A|30|Anticipated|Nashville Centre for Laser and Facial Surgery||1|||f||||f||||||||No||2017-10-10 22:38:22.592679|2017-10-10 22:38:22.592679
NCT02636881|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-07-22|||March 2016||2016-03-01|July 2016|2016-07-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|ACI||Autologous Cartilage Implantation vs Arthroscopic Debridement|Focal Cartilage Defects in the Knee -A Randomized Controlled Trial Comparing Autologous Chondrocyte Implantation With Arthroscopic Debridement|Recruiting||N/A|82|Anticipated|University Hospital, Akershus||2|||f||||t||||||||No||2017-10-10 22:38:22.688323|2017-10-10 22:38:22.688323
NCT02636699|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-07|||December 2015||2015-12-01|September 2017|2017-09-01|August 18, 2017|Actual|2017-08-18|August 18, 2017|Actual|2017-08-18||Interventional|PEPITES||Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy|A Double-blind, Placebo-controlled, Randomized Phase 3 Pivotal Trial to Assess the Efficacy and Safety of Peanut Epicutaneous Immunotherapy With Viaskin Peanut in Peanut-allergic Children|Completed||Phase 3|356|Actual|DBV Technologies||2|||f||||t||||||||||2017-10-10 22:38:24.825395|2017-10-10 22:38:24.825395
NCT02636868|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-02-17|||December 2015||2015-12-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Trial to Assess the Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age|A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome|Recruiting||Phase 2|240|Anticipated|Windtree Therapeutics||3|||f||||t||||||||||2017-10-10 22:38:22.836074|2017-10-10 22:38:22.836074
NCT02636855|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-24|||December 2015||2015-12-01|July 2017|2017-07-01|November 2025|Anticipated|2025-11-01|November 2025|Anticipated|2025-11-01||Observational|||Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination|A Screening Protocol to Determine Tumor Antigen Expression and HLA Sub-Type for Eligibility Determination for Clinical Trials Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs in Subjects With Solid and Hematological Malignancies|Recruiting||N/A|300|Anticipated|Adaptimmune|||1||f||||f||||||Samples With DNA|"     Tumor biopsy   "|||2017-10-10 22:38:23.223124|2017-10-10 22:38:23.223124
NCT02636842|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2016-07-13|||December 2015||2015-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder|A Phase 1, Randomized, Open-label, Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole Lauroxil Following Administration to the Deltoid or Gluteal Muscle in Adults With Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|47|Actual|Alkermes, Inc.||1|||f||||f||||||||No||2017-10-10 22:38:23.40315|2017-10-10 22:38:23.40315
NCT02636829|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-09-14|||March 2016||2016-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|QALCIMUM||Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis|Validation of Self-administered Questionnaire Specifically for Assessing Calcium Intake (QALCIMUM®) in Patients With Multiple Sclerosis (MS) or Chronic Inflammatory Arthritis|Completed||N/A|100|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 22:38:23.520158|2017-10-10 22:38:23.520158
NCT02636803|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-03-02|||November 2017|Anticipated|2017-11-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults|An Open Comparative Study of the Efficacy of Different Doses of Oxfendazole Compared to Single Dose Albendazole in the Treatment of Trichuris Trichiura Infection in Adults|Not yet recruiting||Phase 2|200|Anticipated|Johns Hopkins Bloomberg School of Public Health||4|||f||||t|t|f||||||Yes|posting to CT.gov and publication|2017-10-10 22:38:23.762443|2017-10-10 22:38:23.762443
NCT02636790|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-21|||December 2015||2015-12-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Early Versus Late Surgical Wait Times|Is Prioritization of the Sinus Surgical Waitlist Required?|Not yet recruiting||Early Phase 1|20|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:38:23.899971|2017-10-10 22:38:23.899971
NCT02636777|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-05-12|||December 2015||2015-12-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Predictors of Self-management in Patients With Chronic Low Back Pain|Predictors of Self-management in Patients With Chronic Low Back Pain|Recruiting||N/A|400|Anticipated|University of Nottingham|||1||f||||f||||||||No||2017-10-10 22:38:24.031219|2017-10-10 22:38:24.031219
NCT02636764|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-03-23|||December 2016||2016-12-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|osteoarthritis||Influence of Using Physical Therapy Resources for Knee Osteoarthritis|Influence of Using Physical Therapy Resources for Knee Osteoarthritis|Active, not recruiting||N/A|100|Anticipated|University of Nove de Julho||5|||f||||t||||||||||2017-10-10 22:38:24.156281|2017-10-10 22:38:24.156281
NCT02636751|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-07-01|||January 2016||2016-01-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Interventional|||Effects of Tele- or In-person Prehabilitation in Candidates Awaiting Total Hip or Knee Arthroplasty|Effects of a Tele-prehabilitation Program or an In-person Prehabilitation Program Compared to a Usual Care Control Group in Participants Awaiting Total Hip or Knee Arthroplasty: A Pilot Single Blind Randomized Controlled Trial|Recruiting||N/A|36|Anticipated|Université de Montréal||3|||f||||f||||||||||2017-10-10 22:38:24.29945|2017-10-10 22:38:24.29945
NCT02636738|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2015-12-17|||January 2016||2016-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Vela China Study: in Cutting And Hemostasis For Gastrointestinal Epithelial Neoplasia In Chinese Population|A Prospective, Multicenter, Single-arm, Non-controlled Study to Evaluate The Safety and Utility of VelaTM XL Thulium Laser in Cutting And Hemostasis For Gastrointestinal Epithelial Neoplasia In Chinese Population|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-10 22:38:24.431178|2017-10-10 22:38:24.431178
NCT02636725|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-09-08|||April 19, 2016|Actual|2016-04-19|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas|A Phase II Trial of Concurrent Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma (ASPS) and Other Soft Tissue Sarcomas (STS)|Recruiting||Phase 2|30|Anticipated|University of Miami||1|||f||||t|t|f||||||||2017-10-10 22:38:24.52528|2017-10-10 22:38:24.52528
NCT02635958|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-08-07|||December 2015||2015-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Observational|InBody||InBody Validation Study|Validation of the InBody 770® for the Assessment of Body Composition|Active, not recruiting||N/A|176|Actual|Mayo Clinic|||4||f||||f||||||||||2017-10-10 22:38:34.104952|2017-10-10 22:38:34.104952
NCT02636686|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-10-27|||December 2015||2015-12-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Extension Study of Drisapersen in DMD Subjects|An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in Subjects With Duchenne Muscular Dystrophy.|Terminated||Phase 3|24|Actual|BioMarin Pharmaceutical||3|||f||||t||||||||Undecided||2017-10-10 22:38:25.007357|2017-10-10 22:38:25.007357
NCT02636673|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-08-29|||November 2015||2015-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Robotic-assisted Versus Laparoscopic Sigmoid Resection|Robotic-assisted Versus Laparoscopic Sigmoid Resection: a Retrospective Chart Review of Benign and Malignant Sigmoid Disease|Completed||N/A|518|Actual|Intuitive Surgical|||2||f||||f||||||||||2017-10-10 22:38:25.226257|2017-10-10 22:38:25.226257
NCT02636660|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-12-17|||June 2012||2012-06-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|September 2013|Actual|2013-09-01||Observational|||Health-related Quality of Life and Nursing-sensitive Outcomes in Mechanically Ventilated Patients|Health-related Quality of Life and Nursing-sensitive Outcomes in Mechanically Ventilated Patients in an Intensive Care Unit|Completed||N/A|184|Actual|Hospital Universitari Vall d'Hebron Research Institute|||1||f||||||||||||||2017-10-10 22:38:25.317774|2017-10-10 22:38:25.317774
NCT02636647|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-11-25|||October 2015||2015-10-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Fecal Transplant in Recurrent Hepatic Encephalopathy|Safety and Tolerability of Fecal MicrobiotaTransplantation in Cirrhosis and Hepatic Encephalopathy|Completed||Phase 1|20|Actual|Hunter Holmes Mcguire Veteran Affairs Medical Center||2|||f||||t||||||||No||2017-10-10 22:38:25.413753|2017-10-10 22:38:25.413753
NCT02636634|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-04-08|||June 2010||2010-06-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|CV-METANEC||Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain Metastases|Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain Metastases. CV-METANEC|Completed||Phase 3|90|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 22:38:25.491534|2017-10-10 22:38:25.491534
NCT02636621|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-07-14|||October 2013||2013-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Oral Appliance for Upper Airway Resistance Syndrome|Efficacy of Oral Appliance for Upper Airway Resistance Syndrome: Randomized, Parallel, Placebo, Controlled Study|Recruiting||N/A|60|Anticipated|Associação Fundo de Incentivo à Pesquisa||2|||f||||f||||||||||2017-10-10 22:38:25.582272|2017-10-10 22:38:25.582272
NCT02636608|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-07-05|||November 27, 2015||2015-11-27|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|VERITAS||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary - VERITAS|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary - VERITAS|Active, not recruiting||N/A|255|Anticipated|AbbVie|||5||f||||f||||||||||2017-10-10 22:38:25.690224|2017-10-10 22:38:25.690224
NCT02636595|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-08-17|2017-08-17|2017-01-31|November 2015|Actual|2015-11-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|ENDURANCE-4||The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)|A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)|Completed||Phase 3|121|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 22:38:25.81093|2017-10-10 22:38:25.81093
NCT02636582|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-18|2017-09-04|||June 14, 2016|Actual|2016-06-14|August 2017|2017-08-01|March 14, 2019|Anticipated|2019-03-14|March 14, 2019|Anticipated|2019-03-14||Interventional|||Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer|VADIS Trial: Phase II Trial of Nelipeimut-S Peptide Vaccine in Women With DCIS of the Breast|Recruiting||Phase 2|108|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-10 22:38:25.990296|2017-10-10 22:38:25.990296
NCT02636556|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-02-28|||January 2013||2013-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Chemoradiotherapy for Inoperable Locally Advanced (Stage Ⅲ/Ⅳa) Thymoma or Thymic Carcinoma|Phase Ⅱ Study of Concurrent Chemoradiotherapy for Inoperable Locally Advanced (Stage Ⅲ/Ⅳa) Thymoma or Thymic Carcinoma|Recruiting||Phase 2|56|Anticipated|Fudan University||1|||f||||t||||||||No||2017-10-10 22:38:26.203993|2017-10-10 22:38:26.203993
NCT02636543|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2015-12-17|||June 2015||2015-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|LIPEG||Evaluation of the Information Letter to Relatives in the Context of Genetic Assessments|Evaluation of the Information Letter to Relatives in the Context of Genetic Assessments|Completed||N/A|325|Actual|University Hospital, Bordeaux|||5||f||||f||||||||||2017-10-10 22:38:26.416527|2017-10-10 22:38:26.416527
NCT02636530|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-08-01|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Two Exercise Programs on Bone Strength and Architecture|Effect of Two Exercise Programs on Bone Strength and Architecture|Recruiting||N/A|50|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 22:38:26.56468|2017-10-10 22:38:26.56468
NCT02636517|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-01-09|||December 2015||2015-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fecal Microbiome Transplant|Fecal Microbiome Transplant in Pediatric C. Difficile|Recruiting||N/A|50|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||No||2017-10-10 22:38:26.719762|2017-10-10 22:38:26.719762
NCT02636504|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-17|||February 2016||2016-02-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Evaluation of Three Pulp Vitality Tests|Evaluation of Three Pulp Vitality Tests|Not yet recruiting||N/A|150|Anticipated|Columbia University|||1||f||||f||||||||Undecided||2017-10-10 22:38:26.904811|2017-10-10 22:38:26.904811
NCT02634996|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-21|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:38:43.24124|2017-10-10 22:38:43.24124
NCT02636491|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-07-06|||December 2015||2015-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|DREAM5||Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D)|Open-label, 3 Center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of 60 Hours Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy at T1D Patients at Home|Completed||Phase 1/Phase 2|45|Actual|Kinderkrankenhaus auf der Bult||2|||f||||t||||||||No||2017-10-10 22:38:27.011904|2017-10-10 22:38:27.011904
NCT02636478|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-12-18|||April 2013||2013-04-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Travelling in Patients With Sleep Related Breathing Disorders|Travel Activities in Patients With Sleep Related Breathing Disorders|Completed||N/A|345|Actual|Wissenschaftliches Institut Bethanien e.V|||2||f||||f||||||||||2017-10-10 22:38:27.132125|2017-10-10 22:38:27.132125
NCT02636465|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-12-16|||March 2014||2014-03-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Hypoxia in Flight Simulation in Obese Patients|Hypoxia in Flight Simulation in Obese Patients|Completed||N/A|21|Actual|Wissenschaftliches Institut Bethanien e.V|||3||f||||f||||||||||2017-10-10 22:38:27.254078|2017-10-10 22:38:27.254078
NCT02636452|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-01-05|||September 2013||2013-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Cardiopulmonary Exercise Testing in Interstitial Lung Disease|Cardiopulmonary Exercise Testing in Interstitial Lung Disease|Recruiting||N/A|50|Anticipated|Wissenschaftliches Institut Bethanien e.V|||1||f||||f||||||||||2017-10-10 22:38:27.383686|2017-10-10 22:38:27.383686
NCT02636439|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-05-08|||August 2015||2015-08-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|July 2021|Anticipated|2021-07-01||Interventional|SECRET-II||Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)|Study of the Effects Caloric Restriction and Exercise Training in Patients With Heart Failure and a Normal Ejection Fraction|Recruiting||N/A|84|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-10 22:38:27.530503|2017-10-10 22:38:27.530503
NCT02636426|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-17|||September 2015||2015-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SOPRANO||Sorafenib Administered Using a High-dose, Pulsatile Regimen: a Phase I Exposure Escalation Study|Sorafenib Administered Using a High-dose, Pulsatile Regimen in Patients With Advanced Solid Malignancies: a Phase I Exposure Escalation Study|Recruiting||Phase 1|40|Anticipated|VU University Medical Center||1|||f||||t||||||||||2017-10-10 22:38:27.767596|2017-10-10 22:38:27.767596
NCT02636413|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-12-27|||October 2015||2015-10-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance|Evaluation of the Impact of LacTEST on Diagnostic Thinking and on Patient Management, and of the Reproducibility (Test-Retest), for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance|Completed||Phase 4|1|Actual|VenterPharma||2|||f||||f||||||||No||2017-10-10 22:38:27.973657|2017-10-10 22:38:27.973657
NCT02636400|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-05-11|||February 2014||2014-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Immediate Intra Uterine Isemination (IUI) Versus Expectant Management in Postoperative Endometriosis Patients|Is Postoperative IUI Better Than Expectant Management in Infertile Endometriosis Patients With Good Prognosis Based on EFI Score?|Active, not recruiting||N/A|24|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||f||||||||2017-10-10 22:38:28.183061|2017-10-10 22:38:28.183061
NCT02636387|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-09-12|||January 2016||2016-01-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease|Desmopressin as a Therapy for Nocturnal Enuresis in Patients With Sickle Cell Disease|Recruiting||Phase 3|118|Anticipated|Montefiore Medical Center||2|||f||||t||||||||No|Each individual|2017-10-10 22:38:28.33786|2017-10-10 22:38:28.33786
NCT02636374|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-01|||November 2012||2012-11-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Guided Imagery: Reducing Stress and Improving Well-being in Pregnant Adolescents|Guided Imagery: Reducing Stress and Improving Well-being in Pregnant Adolescents|Enrolling by invitation||N/A|35|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-10 22:38:28.516674|2017-10-10 22:38:28.516674
NCT02636361|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-02-25|||December 2015||2015-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study of Various Formulations of LY900014 in Healthy Participants|Pharmacokinetics, Glucodynamics, Safety, and Tolerability of Multiple LY900014 Formulations|Completed||Phase 1|36|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-10 22:38:28.627701|2017-10-10 22:38:28.627701
NCT02636348|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-10-27|||July 2015||2015-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|MCRD-PI||Evaluation of Calcium and Vitamin D Supplementation During Marine Corps Training|Evaluation of Calcium and Vitamin D Supplementation for Optimizing Bone Health During Marine Corps Recruit Training|Completed||N/A|380|Actual|United States Army Research Institute of Environmental Medicine||4|||f||||f||||||||||2017-10-10 22:38:28.750019|2017-10-10 22:38:28.750019
NCT02636335|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-06-28|||January 2016||2016-01-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|LEXI-MO||Light, Exercise Intensity and Mood in Overweight|Light, Exercise Intensity and Mood in Overweight|Completed||N/A|26|Actual|University of Basel||2|||f||||f||||||||||2017-10-10 22:38:28.883709|2017-10-10 22:38:28.883709
NCT02636322|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-09-11|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|||Smart Start: Study of Rituximab, Lenalidomide, and Ibrutinib Combined With Chemotherapy For Patients With High Risk Diffuse Large B-Cell Lymphoma|A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib Combined With Chemotherapy For Patients With High Risk Diffuse Large B-Cell Lymphoma|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:38:28.9927|2017-10-10 22:38:28.9927
NCT02636296|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-18|||August 2010||2010-08-01|December 2015|2015-12-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||The Effects of 12 Weeks Pilates-inspired Exercise Training on Functional Performance in Older Women|The Effects of 12 Weeks Pilates-inspired Exercise Training on Functional Performance in Older Women: a Randomized Study|Completed||N/A|40|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:38:29.317577|2017-10-10 22:38:29.317577
NCT02636283|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-06-16|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease|Use of Entresto (Sacubitril/Valsartan) for the Treatment of Peripheral Arterial Disease|Recruiting||Phase 2|40|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|t|f|||f|||No||2017-10-10 22:38:29.447381|2017-10-10 22:38:29.447381
NCT02636270|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-05-31|||December 2015||2015-12-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2016|Actual|2016-12-01||Interventional|||IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency|Treatment With Recombinant Human Insulin-like Growth Factor 1 (rhIGF-1) in Patients With Pappalysin-2 (PAPP-A2) Gene Mutation.|Active, not recruiting||Phase 1/Phase 2|7|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||Undecided|De-identifiable data may be shared with physician that is treating the only other two patients in the world with this genetic mutation.|2017-10-10 22:38:29.554004|2017-10-10 22:38:29.554004
NCT02636244|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-10-18|||February 2017||2017-02-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Efficacy Study of SHAPE Gel in Alopecia Areata|A Multi-Center, Open-Label Phase 2 Study to Evaluate the Safety and Efficacy of SHAPE Gel, a Histone Deacetylase Inhibitor, in Patients With Alopecia Areata|Not yet recruiting||Phase 2|40|Anticipated|TetraLogic Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:38:29.759233|2017-10-10 22:38:29.759233
NCT02636231|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-12-16|||November 2015||2015-11-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Endostar for Locally Recurrent Nasopharyngeal Carcinoma|A Phase II Randomized Controlled Study to Compare Endostar and IMRT vs. IMRT Alone for Locally Recurrent Nasopharyngeal Carcinoma Patients|Recruiting||Phase 2|96|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:38:29.870203|2017-10-10 22:38:29.870203
NCT02636218|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KIND||Ketamine Infusion in Neurologic Deficit|A Pilot Study of Sub-anesthetic Ketamine Infusion for Neuroprotection After Aneurysmal Subarachnoid Hemorrhage: Effects on White Matter Integrity, Inflammatory Biomarkers and Neurocognitive Outcome|Recruiting||Phase 2/Phase 3|50|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||No||2017-10-10 22:38:30.078694|2017-10-10 22:38:30.078694
NCT02636205|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-10-12|||July 2014||2014-07-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||The Use of Armeo Spring in Upper Extremity Rehabilitation|The Use of Armeo Spring in Upper Extremity Rehabilitation|Suspended||N/A|15|Anticipated|St Mary's Hospital for Children||1||"Primary investigator changed. Study protocol may under go change with addition of new   investigators."|f||||f||||||||Yes||2017-10-10 22:38:30.284172|2017-10-10 22:38:30.284172
NCT02636192|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-04-12|||July 31, 2015|Actual|2015-07-31|April 2017|2017-04-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Observational|||Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents|Incidence of Diabetic Ketoacidosis Among Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors or Other Antihyperglycemic Agents- A Retrospective, Observational, New-User Cohort Study Using 4 Administrative Claims Databases in the US|Completed||N/A|200000|Actual|Janssen Research & Development, LLC|||2||f||||f|f|||||||||2017-10-10 22:38:30.398318|2017-10-10 22:38:30.398318
NCT02636179|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Observational|EMCeFIV||Evaluation of the Prevalence of Asthma in a Cohort of Children Born After IVF (Aged 11-15) Compared With a Control Group|Evaluation of the Prevalence of Asthma in a Cohort of Children Born After In Vitro Fertilization (Aged 11-15) Compared With Spontaneously Conceived Children of the Same Age Range|Recruiting||N/A|1792|Anticipated|Hospital St. Joseph, Marseille, France|||2||f||||t||||||||||2017-10-10 22:38:30.530329|2017-10-10 22:38:30.530329
NCT02636153|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-08-16|||May 2016||2016-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||the Effects of Different Dietary Phosphorus Intake on the Circadian Pattern of Serum Phosphate in Normal Subjects|the Effects of Different Dietary Phosphorus Intake on the Circadian Pattern of Serum Phosphate in Normal Subjects|Completed||N/A|6|Actual|Huashan Hospital||2|||f||||t||||||||||2017-10-10 22:38:30.868781|2017-10-10 22:38:30.868781
NCT02636140|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-11-01|||February 2016||2016-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Color and Pupil Function|Effect of Light Spectrum on Pupil Function|Completed||N/A|10|Actual|VA Palo Alto Health Care System||1|||f||||f||||||||||2017-10-10 22:38:30.972634|2017-10-10 22:38:30.972634
NCT02636127|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-07-06|||December 2015||2015-12-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis|Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis|Recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||No||2017-10-10 22:38:31.047392|2017-10-10 22:38:31.047392
NCT02636114|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-17|||January 2015||2015-01-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Effect of Scaling and Root Planing on Serum Renal Function Markers in Chronic Periodontitis Subjects.|Effect of Scaling and Root Planing on Serum Renal Function Markers in Systematically Healthy Chronic Periodontitis Subjects - A Control Clinical Trial.|Completed||N/A|51|Actual|Maharashtra University of Health Sciences||2|||f||||t||||||||Yes|renal function markers report|2017-10-10 22:38:31.150374|2017-10-10 22:38:31.150374
NCT02636101|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-03-22|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|BODYGUARD||Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study|Xamiol® Gel in BODY Psoriasis : lonG-term Management of Psoriasis vUlgARis With Xamiol® Gel in Daily Clinical Practice of Russian Dermatologists. A Long-term Observational, Prospective Study|Active, not recruiting||N/A|645|Actual|LEO Pharma|||1||f||||f||||||||No||2017-10-10 22:38:31.269|2017-10-10 22:38:31.269
NCT02636088|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-06|||January 2011||2011-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|LERFOX-C||Definitive Chemoradiotherapy and Cetuximab in the Treatment of Locally Advanced Esophageal Cancer|A Phase II Study With Oxaliplatin + 5-FU + Ceuximab and Radiotherapy for the Treatment of Non-resectable, Locally Advanced But Not Metastatic Cancer of Oesophagus or the Cardia.|Active, not recruiting||Phase 2|51|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-10-10 22:38:31.36179|2017-10-10 22:38:31.36179
NCT02636075|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2015-12-18|||December 2015||2015-12-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Observational|||"Parathyroid Tissues Anatomic Localizations Are Displaced Downward in Parathyroid Hyperplasia Cases"|"Parathyroid Tissues Anatomic Localizations Are Displaced Downward in Parathyroid Hyperplasia Cases"|Enrolling by invitation||N/A|125|Actual|SB Istanbul Education and Research Hospital|||4||f||||f||||||||||2017-10-10 22:38:31.460973|2017-10-10 22:38:31.460973
NCT02636062|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-04-26|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Observational|||Predictors of Coronary Artery Calcium Progression in Adults With a Prior Zero Coronary Artery Calcium Score|Predictors of Coronary Artery Calcium Progression in Adults With a Prior Zero Coronary Artery Calcium Score|Not yet recruiting||N/A|1000|Anticipated|San Antonio Military Medical Center|||2||f||||f||||||Samples With DNA|"     The biological specimens collected in this study will be used for future testing and     evaluation of exploratory systemic biomarkers with respect to prediction of coronary artery     disease (CAD) progression and incident development of CAD. Specifically, samples are being     collected to investigate pro-fibrotic and pro-inflammatory makers and the effect on CAD     development and progression as measured by coronary artery calcification (CAC). DNA samples     will be tested for genetic factors and identify trends amongst patients with CAC development,     particularly focusing on those with aggressive, multivessel CAC development.   "|No||2017-10-10 22:38:31.546048|2017-10-10 22:38:31.546048
NCT02636036|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-02-15|||January 2016||2016-01-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|SPICE||Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors|A Phase I Multicenter, Open Label Study of Enadenotucirev Combined With PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors|Recruiting||Phase 1|30|Anticipated|PsiOxus Therapeutics Ltd||1|||f||||t||||||||No||2017-10-10 22:38:31.754424|2017-10-10 22:38:31.754424
NCT02636023|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-02-10|||August 2015||2015-08-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Correlation Between the SPhENo-Cardiograph™, a Seismocardiograph Device, and GE Vivid Q, an Echocardiograph, for Known Systemic Timing Intervals (STI)|A Clinical Study to Determine the Correlation Between the SPhENo-Cardiograph™, a Seismocardiograph Device, and GE Vivid Q, an Echocardiograph, for Known Systemic Timing Intervals (STI).|Completed||N/A|34|Actual|Heart Force Medical Inc.||1|||f||||f||||||||||2017-10-10 22:38:31.886058|2017-10-10 22:38:31.886058
NCT02636010|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-12-08|||June 2016||2016-06-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Pembrolizumab (MK-3475) in MM Patients With Residual Disease|Phase II, Multicenter, Open Label, Clinical Trial of the Anti-PD1 Monoclonal Antibody Pembrolizumab (MK-3475) as Consolidation Therapy in Multiple Myeloma Patients With Residual Disease After Treatment|Recruiting||Phase 2|20|Anticipated|PETHEMA Foundation||1|||f||||t||||||||Undecided||2017-10-10 22:38:33.66623|2017-10-10 22:38:33.66623
NCT02635997|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-16|||January 2013||2013-01-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America|Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America|Completed||N/A|425|Actual|Pontifical Catholic University of Argentina|||1||f||||f||||||||||2017-10-10 22:38:33.798238|2017-10-10 22:38:33.798238
NCT02635984|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-03-25|||November 2015||2015-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FOND-O||Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens|Randomized, Placebo Controlled Study of FOND (Fosaprepitant, Ondansetron, Dexamethasone) Versus FOND+O (FOND Plus Olanzapine) for the Prevention of Chemotherapy Induced Nausea and Vomiting in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens|Recruiting||Phase 3|110|Anticipated|Augusta University||2|||f||||t||||||||No||2017-10-10 22:38:33.885825|2017-10-10 22:38:33.885825
NCT02635971|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2015-12-18|||December 2015||2015-12-01|December 2015|2015-12-01||||November 2020|Anticipated|2020-11-01||Interventional|||Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer|A Randomized Controlled Phase II Study on Intra-arterial Versus Intravenous Chemotherapy Infusion With Gemcitabine and Oxaliplatin for Locally Advanced Pancreatic Cancer|Not yet recruiting||Phase 2|168|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 22:38:33.995203|2017-10-10 22:38:33.995203
NCT02635945|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-09-15|||April 2016||2016-04-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients.|A Study to Assess the Efficacy of a 5-day, Once Daily 10- mg PBF-680 Oral Administration Course to Attenuate Allergen Bronchoprovocation-induced Late Asthmatic Responses (LAR) in Asthmatic Patients Controlled on Low-to-medium Dose Inhaled Corticosteroid Maintenance Monotherapy and Inhaled Short Acting Beta-2 Agonist as Rescue Bronchodilator|Recruiting||Phase 2|16|Anticipated|Palobiofarma SL||2|||f||||f||||||||No||2017-10-10 22:38:34.175565|2017-10-10 22:38:34.175565
NCT02635932|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-16|||September 2014||2014-09-01|December 2015|2015-12-01||||July 2016|Anticipated|2016-07-01||Interventional|||Effectiveness of Trapeziometacarpal Splint||Recruiting||Phase 4|60|Anticipated|Federal University of São Paulo||2|||f||||||||||||||2017-10-10 22:38:34.286904|2017-10-10 22:38:34.286904
NCT02635919|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-07-20|||April 2016||2016-04-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|mSMART-Ib||Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence|Stage Ib Trial of mSMART: Mobile Application Based Personalized Solutions and Tools for Medication Adherence of Rx Pills|Recruiting||N/A|60|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:38:34.36814|2017-10-10 22:38:34.36814
NCT02635906|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-03-09|||March 2016||2016-03-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Interventional|||Reduced in Bed Rest After Coronary Arteriography or Coronary Angioplasty|Effectiveness of Reduced in Bed Rest After Coronary Arteriography or Coronary Angioplasty in Patients With Acute Coronary Syndrome: 4 Hours Versus 2 h.Clinical Trial|Not yet recruiting||N/A|296|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 22:38:34.47832|2017-10-10 22:38:34.47832
NCT02635893|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-12-01|||October 2015||2015-10-01|December 2016|2016-12-01|October 2020|Anticipated|2020-10-01|December 2019|Anticipated|2019-12-01||Interventional|||Lower Limb Function After Spinal Cord Injury|Corticospinal Excitability of Leg Muscles After Spinal Cord Injury|Recruiting||Phase 4|257|Anticipated|University of Miami||3|||f||||f||||||||Undecided||2017-10-10 22:38:34.71324|2017-10-10 22:38:34.71324
NCT02635880|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-08-19|||September 2015||2015-09-01|January 2016|2016-01-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||A Clinical Evaluation of a Novel Multi-Wavelength Laser for Benign Pigmented Lesion Removal|A Clinical Evaluation of a Novel Multi-Wavelength Laser for Benign Pigmented Lesion Removal|Completed||N/A|37|Actual|Cutera Inc.||1|||f||||f||||||||No||2017-10-10 22:38:34.829878|2017-10-10 22:38:34.829878
NCT02635867|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-02-27|||June 2015|Actual|2015-06-01|February 2017|2017-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||Clinical Comparison of Vital Pulp Capping Restorative Protocols|Clinical Comparison of Vital Pulp Capping Restorative Protocols: A Randomized Controlled Double-Blind, Prospective Study|Recruiting||N/A|150|Anticipated|University of Illinois at Chicago||2|||f||||||||||||||2017-10-10 22:38:34.899143|2017-10-10 22:38:34.899143
NCT02635841|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-06-27||||||November 2015|2015-11-01||||||||Expanded Access|||Compassionate Use of Deferiprone in Patients With PKAN|The Compassionate Use of Deferiprone in Patients With Pantothenate Kinase-Associated Neurodegeneration|Available||N/A|||ApoPharma|||||||t||||||||||||2017-10-10 22:38:35.160323|2017-10-10 22:38:35.160323
NCT02635828|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-03-24|2016-03-28||October 2009||2009-10-01|March 2017|2017-03-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Interventional|||Effectiveness of Triple Therapy With Palonosetron for PON Prophylaxis|Studying the Effectiveness of Triple Therapy With Palonosetron, Dexamethasone and Promethazine for Prevention of Post Operative Nausea and Vomiting in High Risk Patients Undergoing Neurological Surgery and General Anesthesia|Completed||Phase 4|40|Actual|Ohio State University|Our study also presented certain limitations that should be mentioned. To begin with, the study was designed without a control group; therefore, we were not able to compare the results from this regimen.|1|||f||||f||||||||No|IPD will not be shared with other researchers.|2017-10-10 22:38:35.26284|2017-10-10 22:38:35.26284
NCT02635815|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2016-03-02|||January 2012||2012-01-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal Hypertension|Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal Hypertension|Completed||N/A|60|Actual|Ain Shams University|||2||f||||t||||||||||2017-10-10 22:38:35.564794|2017-10-10 22:38:35.564794
NCT02635802|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation|the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation|Not yet recruiting||Phase 4|1500|Anticipated|The First Affiliated Hospital of Zhengzhou University||3|||f||||t||||||||||2017-10-10 22:38:35.657044|2017-10-10 22:38:35.657044
NCT02635789|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-02-01|||December 2015|Actual|2015-12-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)|A Double-blind, Randomized, Placebo-controlled Phase III Trial to Investigate the Efficacy and Safety of NPC-12G Gel (Topical Formulation of Sirolimus) to Angiofibroma and Other Skin Lesions in Patients With Tuberous Sclerosis Complex|Completed||Phase 3|62|Actual|Nobelpharma||2|||f||||f||||||||||2017-10-10 22:38:35.75405|2017-10-10 22:38:35.75405
NCT02635776|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-09-15|||December 2015||2015-12-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|PALISADE||Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)|Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)|Active, not recruiting||Phase 3|500|Anticipated|Aimmune Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 22:38:35.873966|2017-10-10 22:38:35.873966
NCT02635763|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2015-12-18|||October 2015||2015-10-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Peripheral Nerve Blocks in Elderly Patients With Hip Fracture|A Randomized Controlled Trial of Comparing Two Methods of Nerve Block in Combination With Laryngeal Mask Anesthesia Effect for Hip Fracture on Post-operative Quality of Recovery in Elderly Patients|Recruiting||N/A|60|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||2|||f||||f||||||||||2017-10-10 22:38:36.084416|2017-10-10 22:38:36.084416
NCT02635750|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-02-07|||January 2016||2016-01-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Investigation of Pharmacokinetic Drug-drug Interaction of BI 409306 and Donepezil in Healthy Male and Female Subjects|A Study to Investigate the Pharmacokinetic Drug-drug Interaction Following Oral Administration of BI 409306 and Donepezil in Healthy Male and Female Subjects|Completed||Phase 1|32|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 22:38:36.182738|2017-10-10 22:38:36.182738
NCT02635737|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-12-16|||February 2016||2016-02-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Magnetic Seed Localisation of Breast Cancers|Safety and Feasibility Study of Magnetic Seed Markers to Localise Breast Cancers for Surgical Excision|Not yet recruiting||N/A|25|Anticipated|University Hospital of South Manchester NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 22:38:36.253868|2017-10-10 22:38:36.253868
NCT02635724|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-17|2017-01-30|||December 2015||2015-12-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza|A Phase 3, Multicenter, Single-arm, Open-label, Study to Evaluate the Safety, Pharmacokinetics and Effectiveness of Intravenous Peramivir in Elderly Subjects With Acute Uncomplicated Influenza Infection and in Subjects With Acute Uncomplicated Influenza Infection at Higher Risk for Influenza Complications|Recruiting||Phase 3|120|Anticipated|BioCryst Pharmaceuticals||1|||f||||f||||||||No||2017-10-10 22:38:36.422376|2017-10-10 22:38:36.422376
NCT02635711|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Taekwondo for Children With Developmental Coordination Disorder|A Randomised Controlled Trial of the Effectiveness of Adapted Taekwondo Training on Skeletal Development and Motor Proficiency in Pre-pubertal Children With Developmental Coordination Disorder|Recruiting||N/A|104|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:38:36.545745|2017-10-10 22:38:36.545745
NCT02635698|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-12-05|||November 2015||2015-11-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|Opti-WIN||Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight|Opti-WIN: Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight|Active, not recruiting||N/A|330|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 22:38:36.650169|2017-10-10 22:38:36.650169
NCT02635685|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|January 2023|Anticipated|2023-01-01|January 2017|Anticipated|2017-01-01||Interventional|CDS-AF||Clinical Decision Support for Stroke Prevention in Atrial Fibrillation|Clinical Decision Support for Stroke Prevention in Atrial Fibrillation - a Cluster Randomized Trial in the Primary Care Setting|Recruiting||N/A|442105|Anticipated|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-10 22:38:36.754461|2017-10-10 22:38:36.754461
NCT02635659|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-09-29|||December 2015||2015-12-01|December 2015|2015-12-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Proof of Concept Study; The Effect of an Encapsulated Nutrient Mixture on Ileal Brake Activation|The Effect of an Encapsulated Nutrient Mixture on Ileal Brake Activation: A Double-blind Randomized Study to Investigate the Effects on Body Weight, Food Intake and Satiety.|Completed||N/A|62|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 22:38:36.973138|2017-10-10 22:38:36.973138
NCT02635633|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-12-16|||August 2015||2015-08-01|December 2015|2015-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept|Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept|Enrolling by invitation||N/A|10|Anticipated|University Hospital, Ghent||1|||f||||t||||||||||2017-10-10 22:38:37.165396|2017-10-10 22:38:37.165396
NCT02635620|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2015-12-16|||October 2015||2015-10-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|EQualLife||Changes in Psychological and Somatic Parameters Associated With Changing From Smoking to E-cigarettes|Changes in Lung Function Parameters, Bronchial Reactivity, State of Health and Smoking Behaviour Associated With Changing From Conventional Smoking to Electronic Cigarettes|Recruiting||N/A|80|Anticipated|Ludwig-Maximilians - University of Munich|||2||f||||f||||||||No||2017-10-10 22:38:37.2672|2017-10-10 22:38:37.2672
NCT02635607|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2015-12-16|||January 2016||2016-01-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|GnRH||Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol|A RCT Study to Evaluate the Safety and Efficacy of the Fixed Day-5 Antagonist Protocol Versus the Flexible Antagonist Protocol for the Controlled Ovarian Stimulation in Chinese Women With Predicted High Ovarian Response|Not yet recruiting||N/A|200|Anticipated|Chong Qing Reproducive and Genetic Institute||2|||f||||t||||||||Undecided||2017-10-10 22:38:37.355427|2017-10-10 22:38:37.355427
NCT02635594|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-09-06|||December 2015||2015-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effects of Carnipure® Tartrate on Postprandial Endothelial Function and Recovery|Effects of Carnipure® Tartrate on Postprandial Endothelial Function and Recovery From Physical Exertion in Healthy People - a Randomized, Double-blind, Placebo-controlled, Two-way Cross-over Study|Completed||N/A|36|Actual|Lonza Ltd.||2|||f||||f||||||||||2017-10-10 22:38:37.47444|2017-10-10 22:38:37.47444
NCT02635581|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-03-01|||December 2008||2008-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A DEXA Clinical Study to Evaluate the Osteointegrative Potential of Trabecular Titanium™||Completed||N/A|84|Actual|Limacorporate S.p.a||1|||f||||f||||||||||2017-10-10 22:38:37.55949|2017-10-10 22:38:37.55949
NCT02635568|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-08-29|||November 2016|Actual|2016-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Duration of Marijuana Concentration in Breast Milk- A Pilot Study|Duration of Marijuana Concentration in Breast Milk- A Pilot Study|Recruiting||N/A|20|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     Maternal breast milk, maternal urine, maternal plasma   "|||2017-10-10 22:38:37.644412|2017-10-10 22:38:37.644412
NCT02635555|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-02-11|||April 2016|Actual|2016-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effects of Height and Weight Adjusted Dose of Local Anesthetic.|The Effects of Height and Weight Adjusted Dose of Local Anesthetic Compared to Standard Dose for Spinal Anesthesia in Elective Cesarean Section|Recruiting||N/A|160|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 22:38:37.727082|2017-10-10 22:38:37.727082
NCT02635542|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-15|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|September 15, 2017|Actual|2017-09-15||Interventional|||Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery|Prospective, Randomized Trial Comparing Effect of General Anesthesia With and Without Neuromuscular Blockade on Postoperative Pulmonary Complications in Elective Cardiac Surgical Patients|Completed||Phase 4|100|Actual|University of Chicago||2|||f||||t||||||||||2017-10-10 22:38:37.823004|2017-10-10 22:38:37.823004
NCT02635516|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-18|||April 2014||2014-04-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Traumatic Brain Injury in Veterans and Near-Infrared Phototherapy|Treatment of Mild and Moderate Traumatic Brain Injury in Veterans Using Near-Infrared Phototherapy|Completed||N/A|13|Actual|Cerehealth Corp.||1|||f||||f||||||||Yes|De-identified participant relevant demographic data will be reported. De-identified individual data analyses will be reported.|2017-10-10 22:38:37.993651|2017-10-10 22:38:37.993651
NCT02635503|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-09-01|||November 2015||2015-11-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer|A Prospective Randomized Controlled Trial Comparing Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) Versus Conventional Laparoscopic Surgery for Sigmoid Colon or Rectal Cancer|Recruiting||Phase 3|366|Anticipated|Cancer Institute and Hospital, Chinese Academy of Medical Sciences||2|||f||||t||||||||No||2017-10-10 22:38:38.067945|2017-10-10 22:38:38.067945
NCT02635490|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-12-16|||April 2013||2013-04-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01|1 Month|Observational [Patient Registry]|||Is Prophylactic Antibiotics Necessary In Otherwise Healthy Adult Patients Undergoing Ureteroscopic Procedures for Ureteral Stones?||Completed||Early Phase 1|52|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||1||f||||f||||||||||2017-10-10 22:38:38.153303|2017-10-10 22:38:38.153303
NCT02635477|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-02-10|||January 2016||2016-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|AAIMASP||Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults|Get Going: Fellow-Led Trial of an Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults Transitioning From a Cardiovascular Hospitalization to Home|Recruiting||N/A|150|Anticipated|American College of Cardiology||2|||f||||t||||||||||2017-10-10 22:38:38.215429|2017-10-10 22:38:38.215429
NCT02635464|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-19|||October 2015||2015-10-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy|The Safety and Efficacy Assessment of Human Umbilical Cord-derived Mesenchymal Stem Cells (hUC-MSCs) With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy|Recruiting||Phase 1/Phase 2|45|Anticipated|Chinese Academy of Sciences||3|||f||||f||||||||||2017-10-10 22:38:38.376807|2017-10-10 22:38:38.376807
NCT02635451|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-17|||January 2016||2016-01-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes|The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes|Not yet recruiting||N/A|40|Anticipated|Ain Shams Maternity Hospital|||2||f||||t||||||||||2017-10-10 22:38:38.452158|2017-10-10 22:38:38.452158
NCT02635425|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2016-04-19|2016-03-21||November 2015||2015-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Aspiration of Limited Number of Follicles to Prevent Severe Ovarian Hyperstimulation Syndrome|Aspiration of Limited Number of Eggs to Prevent Severe OHSS in Suspected Cases|Completed||N/A|30|Actual|Ain Shams Maternity Hospital||2|||f||||f||||||||||2017-10-10 22:38:38.801604|2017-10-10 22:38:38.801604
NCT02635412|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-02-11|||March 2016||2016-03-01|February 2016|2016-02-01||||March 2018|Anticipated|2018-03-01||Interventional|MAP||Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial||Not yet recruiting||N/A|200|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-10 22:38:39.032037|2017-10-10 22:38:39.032037
NCT02635399|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-11-11|||January 2016||2016-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Additional DJ (Duodenojejunostomy)-Pexy on Reduction in Delayed Gastric Emptying Following Pylorus-preserving Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial||Recruiting||N/A|78|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:38:39.107157|2017-10-10 22:38:39.107157
NCT02635386|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-05-08|||March 2016||2016-03-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||DAPA, EQW, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)|Comparison of Dapagliflozin (DAPA) and Once-weekly Exenatide (EQW), Co-administered or Alone, DAPA/ Glucophage (DAPA/MET ER) and Phentermine/Topiramate (PHEN/TPM) ER on Metabolic Profiles and Body Composition in Obese PCOS Women|Recruiting||Phase 3|135|Anticipated|Woman's||5|||f||||t||||||||No|Inidivual data will only be shared with participant|2017-10-10 22:38:39.185435|2017-10-10 22:38:39.185435
NCT02635373|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-10-13|||December 2015||2015-12-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|EuCalNet||European Calciphylaxis Registry Network|European Calciphylaxis Registry Network|Recruiting||N/A|1000|Anticipated|RWTH Aachen University|||1||f||||f||||||||||2017-10-10 22:38:39.308041|2017-10-10 22:38:39.308041
NCT02635360|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-24|||January 2016||2016-01-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer|A Randomized Phase II Study of Chemoradiation and Pembrolizumab for Locally Advanced Cancer|Recruiting||Phase 2|88|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-10 22:38:39.408354|2017-10-10 22:38:39.408354
NCT02635347|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-01-16|||November 2015||2015-11-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study|Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study|Recruiting||Phase 1|50|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||No||2017-10-10 22:38:39.555363|2017-10-10 22:38:39.555363
NCT02635334|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-10-04|||November 2015||2015-11-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Asthma in the Elderly: The Effect of Montelukast|Asthma in the Elderly: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study of the Effect of Montelukast|Completed||Phase 4|26|Actual|Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.||2|||f||||f||||||||No||2017-10-10 22:38:39.687833|2017-10-10 22:38:39.687833
NCT02635321|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-04-05|||November 2015||2015-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||MRI and Muscle Involvement in Patients With Mutations in GMPPB|MRI and Muscle Involvement in Patients With Mutations in GMPPB|Completed||N/A|4|Actual|Rigshospitalet, Denmark|||1||f||||||||||||||2017-10-10 22:38:39.788896|2017-10-10 22:38:39.788896
NCT02635308|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-15|||April 2013||2013-04-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Enhancing Rehabilitation After Hip Fracture|Enhanced Rehabilitation Targeting Strength and Movement Pattern Symmetry Following Hip Fracture|Completed||N/A|24|Actual|University of Utah||1|||f||||f||||||||||2017-10-10 22:38:39.866469|2017-10-10 22:38:39.866469
NCT02635295|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-15|||January 2015||2015-01-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Mobile Cooperation During the Clinical Practicum|Mobile Cooperation During the Clinical Practicum|Completed||N/A|108|Actual|University of Turku||2|||f||||f||||||||No||2017-10-10 22:38:39.980053|2017-10-10 22:38:39.980053
NCT02635282|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-03-23|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|March 23, 2017|Actual|2017-03-23|March 23, 2017|Actual|2017-03-23||Interventional|||IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D|Intranasal Ketamine Versus Intranasal Midazolam Plus Fentanyl in Treating Pain Associated With Incision and Drainage of Abscesses in the Pediatric Emergency Department: A Randomized Controlled Trial|Completed||Phase 4|19|Actual|University of Tennessee Health Science Center||2|||f||||f||||||||||2017-10-10 22:38:40.078826|2017-10-10 22:38:40.078826
NCT02635269|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-08-31|||January 2016||2016-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy|Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy|Recruiting||N/A|128|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 22:38:40.175502|2017-10-10 22:38:40.175502
NCT02635256|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-05-04|||December 2015||2015-12-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|HYPOSTAT||Hypofractionated Radiosurgery for Localised Prostate Cancer|Hypofractionated Radiosurgery for Localised Prostate Cancer|Recruiting||N/A|85|Anticipated|University of Schleswig-Holstein||1|||f||||f||||||||||2017-10-10 22:38:40.297769|2017-10-10 22:38:40.297769
NCT02635243|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-09-01|||April 2016||2016-04-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia|SAR438544 - Clinical & Exploratory Pharmacology|Withdrawn||Phase 1|0|Actual|Sanofi||3|||f||||f||||||||||2017-10-10 22:38:40.423239|2017-10-10 22:38:40.423239
NCT02635230|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-15|||June 2014||2014-06-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01|24 Months|Observational [Patient Registry]|WOEST 2||What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.|An International Prospective Registry on Concomitant Use of Oral Anticoagulants and P2Y12 Inhibitors in Patients With Atrial Fibrillation or Heart Valve Prosthesis Undergoing Coronary Revascularisation.|Recruiting||N/A|2200|Anticipated|R&D Cardiologie|||1||f||||f||||||||||2017-10-10 22:38:40.533288|2017-10-10 22:38:40.533288
NCT02635217|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-02-14|||December 2015||2015-12-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Same Day Bidirectional Endoscopies - Does the Sequence of Procedures or Choice of Insufflator Matter?|Same Day Bidirectional Endoscopies - Does the Sequence of Procedures or Choice of Insufflator Matter?|Recruiting||N/A|200|Anticipated|Queen's University||4|||f||||t||||||||No||2017-10-10 22:38:40.664136|2017-10-10 22:38:40.664136
NCT02634450|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2017-07-24|||September 2015||2015-09-01|July 2017|2017-07-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Early Infant Diagnosis Point of Care Pilot|Evaluation of Point-Of-Care Testing Assays for Early Infant in Mozambique-Cluster Randomised Trial|Completed||N/A|179|Actual|Instituto Nacional de Saúde, Mozambique||2|||f||||f||||||||||2017-10-10 22:38:48.86201|2017-10-10 22:38:48.86201
NCT02635204|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-02-07|||December 2015||2015-12-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis|A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days|Completed||Phase 3|267|Actual|Promius Pharma, LLC||2|||f||||f||||||||No||2017-10-10 22:38:40.788503|2017-10-10 22:38:40.788503
NCT02635191|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-16|||March 2014||2014-03-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|||Tailored Therapy for Helicobacter Pylori in Children|Tailored Therapy Versus Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Randomized Trial|Recruiting||Phase 4|200|Anticipated|Beijing Children's Hospital||2|||f||||t||||||||||2017-10-10 22:38:40.957125|2017-10-10 22:38:40.957125
NCT02635178|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-16|||August 2014||2014-08-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Brief Anxiety Sensitivity Treatment for Obsessive Compulsive Symptoms|Randomized Control Trial Examining a Brief Anxiety Sensitivity Cognitive Concerns Intervention for Obsessive Compulsive Symptoms|Completed||N/A|60|Actual|Florida State University||2|||f||||||||||||||2017-10-10 22:38:41.067093|2017-10-10 22:38:41.067093
NCT02635165|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2015-12-15|||November 2015||2015-11-01|December 2015|2015-12-01||||November 2017|Anticipated|2017-11-01||Interventional|EMVOLS||Medico-Economic Analysis of Management of Flail Chest Between Medical Treatment and Surgical Treatment With Stracos|Medico-Economic Analysis of Management of Flail Chest Between Medical Treatment and Surgical Treatment With Stracos|Recruiting||N/A|310|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 22:38:41.15144|2017-10-10 22:38:41.15144
NCT02635152|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-18|||September 2015||2015-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Interpretation Bias Modification for Body Dysmorphic Disorder|Evaluation of an Internet-Based Treatment for Body Dysmorphic Disorder|Recruiting||N/A|40|Anticipated|Florida State University||2|||f||||f||||||||||2017-10-10 22:38:41.241403|2017-10-10 22:38:41.241403
NCT02635139|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2017-04-22|||December 2015||2015-12-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Influence of Meal Skipping on Macronutrient Oxidation and Glucose Metabolism Under Isocaloric Conditions|Influence of Meal Skipping on Macronutrient Oxidation and Glucose Metabolism Under Isocaloric Conditions|Completed||N/A|17|Actual|University of Hohenheim||2|||f||||f||||||||No||2017-10-10 22:38:41.340081|2017-10-10 22:38:41.340081
NCT02635113|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-07-14|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Falls Prevention: Gait-Synchronized Vibration System|Falls Prevention Using a Gait-Synchronized Vibration System|Not yet recruiting||N/A|40|Anticipated|New York University School of Medicine||1|||f||||f|f|f||||||||2017-10-10 22:38:41.441524|2017-10-10 22:38:41.441524
NCT02635100|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-11-23|||May 2015||2015-05-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Multinight CPAP for Sleep Apnea Patients|Evaluation of a Multinight (MNT) CPAP Titration Algorithm in Patients With Sleep Apnea.|Terminated||N/A|1|Actual|New York University School of Medicine||1||PI has left the institution|f||||f||||||||||2017-10-10 22:38:41.559865|2017-10-10 22:38:41.559865
NCT02635087|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-29|||December 2015||2015-12-01|December 2015|2015-12-01|July 2025|Anticipated|2025-07-01|July 2020|Anticipated|2020-07-01||Observational|||microRNAs Tool for Stratifying Stage II Colon Cancer|microRNAs Tool for Stratifying Stage II Colon Cancer:a Perspective Study of Adjuvant Chemotherapy|Recruiting||N/A|630|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||f||||||Samples Without DNA|"     We will use the samples to make q-RT-PCR of our miRNA tool,then predict the patients as high     risk one or not.   "|||2017-10-10 22:38:41.657351|2017-10-10 22:38:41.657351
NCT02635074|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-08-24|||November 2016||2016-11-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase I Dose Escalation Study of Ibrutinib With Idarubicin/Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia|Recruiting||Phase 1|18|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:38:41.757461|2017-10-10 22:38:41.757461
NCT02635061|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-07-21|||August 25, 2016|Actual|2016-08-25|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer|A Phase 1b Study of the Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer|Recruiting||Phase 1|41|Anticipated|Celgene||1|||f||||||||||||||2017-10-10 22:38:42.088834|2017-10-10 22:38:42.088834
NCT02635048|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-17|||December 2015||2015-12-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Mini-PCNL Versus Standard-PCNL For The Management of 20-40 mm Size Kidney Stones|Efficacy and Safety of Mini-PCNL Versus Standard-PCNL For The Management of 20-40 mm Size Kidney Stones: A Multi-center Randomized Controlled Trial|Recruiting||N/A|1950|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||f||||||||||2017-10-10 22:38:42.219174|2017-10-10 22:38:42.219174
NCT02635035|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-01-19|||November 2015||2015-11-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT|Efficacy of Lisdexamfetamine in Adults With Attention Deficit Hyperactivity Disorder (ADHD) and Sluggish Cognitive Tempo (SCT)|Recruiting||Phase 2|120|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:38:42.365742|2017-10-10 22:38:42.365742
NCT02635022|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-20|||September 2015||2015-09-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study|Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study in Rural Area|Recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-10 22:38:42.532038|2017-10-10 22:38:42.532038
NCT02635009|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-06-20|||December 2015||2015-12-01|June 2016|2016-06-01||||April 2022|Anticipated|2022-04-01||Interventional|||Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer|Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer|Recruiting||Phase 2/Phase 3|304|Anticipated|NRG Oncology||2|||f||||t||||||||||2017-10-10 22:38:42.658109|2017-10-10 22:38:42.658109
NCT02634983|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-09-12|||June 3, 2016|Actual|2016-06-03|September 2017|2017-09-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|||QVA Mechanistic Efficacy Study (Receptor Effects, Etc)|A Randomized, Double-blind, Placebo-controlled, Two-period Crossover Study to Assess the Effect of Inhaled QVA149 on Global and Regional Lung Function and Gas Exchange in Patients With Moderate to Severe COPD|Recruiting||Phase 3|34|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 22:38:43.297461|2017-10-10 22:38:43.297461
NCT02634970|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-02-14|||March 2016|Anticipated|2016-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CANARI||CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab|CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab|Withdrawn||Phase 4|0|Actual|Novartis||1|||f||||f||||||||||2017-10-10 22:38:43.416112|2017-10-10 22:38:43.416112
NCT02634957|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-11-09|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery|Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery|Recruiting||N/A|100|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-10 22:38:43.510733|2017-10-10 22:38:43.510733
NCT02634944|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-10-02|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||The Use of the VOMS Tool With Military Personnel to Track mTBI Recovery and RTD Status|The Use of the VOMS Tool With Military Personnel to Track Mild Traumatic Brain Injury Recovery and Return to Duty Status|Not yet recruiting||N/A|650|Anticipated|University of Pittsburgh||4|||f||||f|f|f||||||||2017-10-10 22:38:43.61935|2017-10-10 22:38:43.61935
NCT02634931|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-21|||December 2015||2015-12-01|December 2015|2015-12-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex|A Long-term, Single-arm, Open-label Trial of NPC-12G (Topical Formulation of Sirolimus) to Angiofibroma and Other Skin Lesions in Patients With Tuberous Sclerosis Complex|Not yet recruiting||Phase 3|80|Anticipated|Nobelpharma||1|||f||||f||||||||||2017-10-10 22:38:43.704158|2017-10-10 22:38:43.704158
NCT02634918|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Ultrasonography in Hemophilic Joint Disease and Serum Markers|Ultrasonography in Hemophilic Joint Disease|Recruiting||N/A|30|Anticipated|Northwell Health|||3||f||||f||||||Samples Without DNA|"     plasma samples for angiogenic and cartilage degradation markers   "|||2017-10-10 22:38:43.822453|2017-10-10 22:38:43.822453
NCT02634905|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-12-14|||February 2016||2016-02-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|EDUDA||A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months|A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months|Recruiting||N/A|250|Anticipated|Nantes University Hospital||2|||f||||f||||||||No||2017-10-10 22:38:43.94788|2017-10-10 22:38:43.94788
NCT02634892|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-08-24|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Pressure Redistributing Overlay With Targeted Cooling Technology (PRO-TECT) for Pressure Ulcer Prevention|Pressure Redistributing Overlay With Targeted Cooling Technology (PRO-TECT) for Pressure Ulcer Prevention|Not yet recruiting||N/A|128|Anticipated|University of Pittsburgh||2|||f||||f|f|t|f|f|f|||||2017-10-10 22:38:44.08316|2017-10-10 22:38:44.08316
NCT02634879|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-07-05|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Behavioral Economics in Provider Incentive Design|Behavioral Economics in Provider Incentive Design|Active, not recruiting||N/A|83|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-10 22:38:44.173362|2017-10-10 22:38:44.173362
NCT02634866|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-17|||January 2015||2015-01-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Observational|ASSECURE||Cardiovascular Response to Exercise in Hypertension|Multivariate ASSEssment of CardiovascUlar Response to the Controlled Exercise in Patients With Hypertension - Prospective and Observational Study (ASSECURE Study)|Recruiting||N/A|120|Anticipated|Military Institute of Medicine, Poland|||3||f||||f||||||||Undecided||2017-10-10 22:38:44.243764|2017-10-10 22:38:44.243764
NCT02634853|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-03-24|||December 2015||2015-12-01|September 2016|2016-09-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye|A Safety and Efficacy Study of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye|Completed||Phase 3|429|Actual|Mimetogen Pharmaceuticals USA, Inc.||2|||f||||f||||||||||2017-10-10 22:38:44.321907|2017-10-10 22:38:44.321907
NCT02634840|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-01-04|||January 2013||2013-01-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Assessment of Nerve Function After Mandible Surgery With a Modified Bilateral Sagittal Split Osteotomy Technique|A Modified Technique of Mandibular Ramus Sagittal Split Osteotomy for Prevention of Inferior Alveolar Nerve Injury: A Prospective Cohort Study and Outcome Assessment|Completed||N/A|57|Actual|Chang Gung Memorial Hospital||1|||f||||f||||||||No||2017-10-10 22:38:44.402519|2017-10-10 22:38:44.402519
NCT02634827|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-10-10|||December 2015||2015-12-01|August 2016|2016-08-01||||April 2020|Anticipated|2020-04-01||Interventional|||Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation|A Phase II Study of Combination Midostaurin and Decitabine (MIDDAC) in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia and FLT3 Mutation|Recruiting||Phase 2|26|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:38:44.489192|2017-10-10 22:38:44.489192
NCT02634814|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-04-16|||October 2015||2015-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The KNEEhabilitation Study: Improving Disability in Individuals With Knee Osteoarthritis|Improving Disability in Knee Osteoarthritis by Targeting Neuromuscular Deficits|Recruiting||N/A|90|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-10 22:38:44.593863|2017-10-10 22:38:44.593863
NCT02634801|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-12-08|||January 2016||2016-01-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment|A 24-Week Multicenter, Randomized, Open-Label, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients With Moderate-to-Severe Plaque Psoriasis Who Are Naive to Systemic Treatment With an Extension Period|Active, not recruiting||Phase 3|162|Anticipated|Eli Lilly and Company||3|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 22:38:44.683814|2017-10-10 22:38:44.683814
NCT02634788|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-08-03|2017-06-01||January 29, 2016|Actual|2016-01-29|June 2017|2017-06-01|June 24, 2016|Actual|2016-06-24|June 24, 2016|Actual|2016-06-24||Interventional||Safety Population included all participants who were treated with the study drug.|Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain|A Phase 3, Randomized, Double Blind, Multiple Dose, Parallel Group, Placebo Controlled Study of Buprenorphine Sublingual Spray (0.5 mg TID, 0.25 mg TID, and 0.125 mg TID) for the Treatment of Moderate to Severe Pain|Completed||Phase 3|322|Actual|INSYS Therapeutics Inc||4|||f||||f||||||||||2017-10-10 22:38:44.842224|2017-10-10 22:38:44.842224
NCT02634775|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|UToPaed_3||Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Interventional Study|Part 3 of: 'Conceptualisation and Validation of a Paradigm Based on Uraemic Toxins for Management of Chronic Kidney Disease in Paediatric Patients (UToPaed)'|Recruiting||N/A|60|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-10-10 22:38:45.928355|2017-10-10 22:38:45.928355
NCT02634762|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-03-07|||January 2011||2011-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|30 Days|Observational [Patient Registry]|ACUTE||Acute Congestive Heart Failure Urgent Care Evaluation|Acute Congestive Heart Failure Urgent Care Evaluation: Prospective Validation of the Emergency Heart Failure Mortality Risk Grade 7-day and 30-day Algorithms in the Emergency Department|Recruiting||N/A|1800|Anticipated|Institute for Clinical Evaluative Sciences|||1||f||||f||||||||||2017-10-10 22:38:46.018133|2017-10-10 22:38:46.018133
NCT02634749|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-05-11|||April 2015||2015-04-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|OTIS||OTIS - Optimized Complementary Feeding Study|OTIS - Optimized Complementary Feeding Study|Recruiting||N/A|250|Anticipated|Umeå University||2|||f||||f||||||||||2017-10-10 22:38:46.188002|2017-10-10 22:38:46.188002
NCT02634736|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-05-01|||February 2016||2016-02-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|February 2017|Actual|2017-02-01||Interventional|Profexs||Cluster RCT of Falls Prevention Exergames for Older Adults|A Multi-centre, Cluster Randomised Controlled Trial Comparing Falls Prevention Exergames With Remote Monitoring Against Standard Falls Prevention Programmes for Community Dwelling Older Adults at Risk of Falls.|Recruiting||N/A|108|Anticipated|University of Manchester||2|||f||||f||||||||No||2017-10-10 22:38:46.348928|2017-10-10 22:38:46.348928
NCT02634723|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-06-28|||December 2015||2015-12-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A|Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A|Completed||N/A|21|Actual|Baxalta US Inc.|||1||f||||f||||||||||2017-10-10 22:38:46.479411|2017-10-10 22:38:46.479411
NCT02634710|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-06-06|||February 2016||2016-02-01|June 2017|2017-06-01|December 2025|Anticipated|2025-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall|Pilot Study Evaluating Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall|Recruiting||Phase 2|32|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||No||2017-10-10 22:38:46.606424|2017-10-10 22:38:46.606424
NCT02634697|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-03-21|||April 2015||2015-04-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation|Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:38:46.700659|2017-10-10 22:38:46.700659
NCT02634684|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-04-26|||July 2014||2014-07-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.|Pharmacologic Augmentation of Neurocognition and Cognitive Training in Psychosis|Recruiting||Phase 2|160|Anticipated|University of California, San Diego||2|||f||||t||||||||No||2017-10-10 22:38:46.839414|2017-10-10 22:38:46.839414
NCT02634671|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-01-17|||November 2015||2015-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|FaSchi22||Perception of Facial Emotions in Schizophrenia and 22q11 Deletion Syndrome|Facial Expression Perception by Intensity in Schizophrenia and 22q11.2 Deletion Syndrome: Neural Electrophysiological Evidence by Means of Fast Periodic Visual Stimulation|Active, not recruiting||N/A|120|Anticipated|Hôpital le Vinatier||2|||f||||t||||||||||2017-10-10 22:38:46.99665|2017-10-10 22:38:46.99665
NCT02634658|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-05-03|||June 2009||2009-06-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|April 2014|Actual|2014-04-01||Interventional|||The Diagnosis and Incidence of Critical Illness Polyneuromyopathy in Medical and Neurosurgical ICU Patients|The Diagnosis and Incidence of Critical Illness Polyneuromyopathy in Medical and Neurosurgical ICU Patients|Completed||N/A|120|Actual|University of Colorado, Denver||2|||f||||f||||||||Undecided||2017-10-10 22:38:47.086392|2017-10-10 22:38:47.086392
NCT02634645|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-03-17|||January 2015||2015-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)|A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium|Recruiting||N/A|5000|Anticipated|University of Colorado, Denver|||2||f||||f||||||||||2017-10-10 22:38:47.209017|2017-10-10 22:38:47.209017
NCT02634632|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-18|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DA||Assessments and Recommendations for the Implementation of Advance Directives in Oncology|Assessments and Recommendations for the Implementation of Advance Directives in Oncology|Recruiting||N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:38:47.353435|2017-10-10 22:38:47.353435
NCT02634619|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-07-05|||November 2015||2015-11-01|July 2016|2016-07-01||||December 2020|Anticipated|2020-12-01||Interventional|DvV||A Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty|A Randomized Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty|Recruiting||N/A|160|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:38:47.438308|2017-10-10 22:38:47.438308
NCT02634606|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-12-15|||December 2015||2015-12-01|May 2015|2015-05-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|TRF||Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood|Effects of a Tocotrienol-Enriched Fraction of Palm Oil on Serum Lipids in Hypercholesterolemic Subjects|Terminated||Phase 3|13|Actual|University of California, Los Angeles||3||Unable to obtain supplement for this study. Unable to recruit.|f||||f||||||||||2017-10-10 22:38:47.562305|2017-10-10 22:38:47.562305
NCT02634593|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-04-14|||June 2016||2016-06-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy|The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy|Recruiting||N/A|30|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||No||2017-10-10 22:38:47.667933|2017-10-10 22:38:47.667933
NCT02634580|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-06-07|||February 27, 2016|Actual|2016-02-27|June 2017|2017-06-01|May 28, 2018|Anticipated|2018-05-28|November 2, 2017|Anticipated|2017-11-02||Interventional|GAUSS-4||Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4|A Double-blind, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Evolocumab, Compared With Ezetimibe, in Hypercholesterolemic Japanese Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor Due to Muscle Related Side Effects|Active, not recruiting||Phase 3|61|Actual|Amgen||4|||f||||t|t|f||||||||2017-10-10 22:38:47.770836|2017-10-10 22:38:47.770836
NCT02634567|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-09-14|||April 2016||2016-04-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Attention/Working Memory Rehabilitation in Multiple Sclerosis: A Pilot Project Using Cogmed Working Memory Training||Recruiting||N/A|30|Anticipated|London Health Sciences Centre||2|||f||||||||||||||2017-10-10 22:38:47.981774|2017-10-10 22:38:47.981774
NCT02634554|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-28|||May 30, 2016||2016-05-30||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:38:48.09967|2017-10-10 22:38:48.09967
NCT02634541|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-02-22|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PETSPA||Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis|The Efficacy of Adalimumab and Conventional Antirheumatic Drugs in Alleviating Axial and Aortic Inflammation Detected in PET/CT in Patients With Axial Spondyloarthritis|Recruiting||Phase 4|60|Anticipated|Helsinki University||2|||f||||f||||||||No||2017-10-10 22:38:48.148945|2017-10-10 22:38:48.148945
NCT02634528|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-07-24|||November 16, 2016|Actual|2016-11-16|July 2017|2017-07-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal|Single-center, Randomized, Double-blind, 2-treatment, 2-period Crossover Trial in Healthy Subjects to Demonstrate PK Bioequivalence and to Compare the PD Properties of Julphar Insulin N and Huminsulin® Basal|Active, not recruiting||Phase 1|85|Anticipated|Julphar Gulf Pharmaceutical Industries||2|||f||||f||||||||||2017-10-10 22:38:48.275535|2017-10-10 22:38:48.275535
NCT02634515|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2015-12-23|||December 2014||2014-12-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal|A Randomized, Single-center, Double-blind, 2-period Crossover, Euglycemic Glucose Clamp Study in Healthy Subjects to Demonstrate PK and PD Equivalence of Julphar Insulin R and Huminsulin® Normal|Completed||Phase 1|26|Actual|Julphar Gulf Pharmaceutical Industries||2|||f||||f||||||||||2017-10-10 22:38:48.379509|2017-10-10 22:38:48.379509
NCT02634502|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-17|||October 2013||2013-10-01|December 2015|2015-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis|Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis: Correlation Analysis of Prognosis and microRNA Expression|Recruiting||Phase 2|30|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-10 22:38:48.478653|2017-10-10 22:38:48.478653
NCT02634489|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2015-12-16|||March 2009||2009-03-01|December 2015|2015-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||EC905 Pharmacokinetic Profile Study|An Open-label, Parallel Group, Randomized, Two-way Crossover, Multiple Dose Study to Compare the Pharmacokinetic Profiles of Solifenacin Succinate and Tamsulosin HCl Following Co-administration of Single Entity Tablets and Administration of Three Different Dose Strengths of the Combination Tablet EC905|Completed||Phase 1|46|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 22:38:48.561545|2017-10-10 22:38:48.561545
NCT02634476|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-10-24|||June 2014||2014-06-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Can Cognitive-bias Modification Training During Inpatient Alcohol Detoxification Reduce Relapse Rates Post-discharge?|Can Cognitive-bias Modification Training During Inpatient Alcohol Detoxification Reduce Relapse Rates Post-discharge?|Completed||N/A|83|Actual|Turning Point||2|||f||||f||||||||Undecided||2017-10-10 22:38:48.665583|2017-10-10 22:38:48.665583
NCT02634463|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-04-21|||November 9, 2015|Actual|2015-11-09|April 2017|2017-04-01|November 9, 2016|Actual|2016-11-09|November 9, 2016|Actual|2016-11-09||Interventional|||Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone|Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone|Completed||Phase 1|85|Actual|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-10 22:38:48.776174|2017-10-10 22:38:48.776174
NCT02634437|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2016-09-07|||December 2015||2015-12-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects|A Single-Dose, Open-Label, Pharmacokinetic Study Of Ulipristal Acetate In Healthy Subjects With Normal Renal Function And Patients With Moderately Or Severly Impaired Renal Function|Recruiting||Phase 1|24|Anticipated|Forest Laboratories||3|||f||||f||||||||||2017-10-10 22:38:48.95133|2017-10-10 22:38:48.95133
NCT02634424|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-09-01|||December 2015||2015-12-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|OBTC||PK Driven Prophylaxis for Hemophilia A|Interest of Preventive Personalized Treatment in Hemophilia A|Active, not recruiting||N/A|12|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:38:49.041167|2017-10-10 22:38:49.041167
NCT02634411|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-08-23|||June 2016||2016-06-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|iDIAPASON||Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)|Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia : a Randomized Controlled Study (iDIAPASON)|Recruiting||N/A|600|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:38:49.119346|2017-10-10 22:38:49.119346
NCT02634398|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-01-16|||December 2015||2015-12-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||A Post Market Study on DRG Stimulation in FBSS (SYMPATHY)|A Post Market ObServational StudY on the Effect of DRG StiMulation in PATients witH Chronic Pain Following Surgical Lumbar DiscectomY (Failed Back Surgery Syndrome): SYMPATHY|Withdrawn||N/A|0|Actual|St. Jude Medical|||1|Lack of enrollments|f||||f||||||||||2017-10-10 22:38:49.258825|2017-10-10 22:38:49.258825
NCT02634385|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-07-26|||November 2015||2015-11-01|July 2016|2016-07-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|ZILPAREMZ||Zero Ischemia Laparoscopic Partial Nephrectomy|Zero Ischemia Laparoscopic Partial Nephrectomy in Combination With Superselective Renal Artery Embolization for Small Renal Masses: A Feasibility Trial|Withdrawn||Phase 2/Phase 3|0|Actual|St. Joseph's Healthcare Hamilton||1||No funding to start project.|f||||||||||||||2017-10-10 22:38:49.316627|2017-10-10 22:38:49.316627
NCT02634372|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-08-08|||March 2016||2016-03-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||EMDR vs Supportive Therapy in Relapse Prevention in Traumatized Bipolar Patients|Single-blind, Randomized Controlled Comparison of EMDR Versus Supportive Therapy in Affective Relapse Prevention in Bipolar Patients With a History of Trauma|Not yet recruiting||N/A|82|Anticipated|FIDMAG Germanes Hospitalàries||2|||f||||f||||||||||2017-10-10 22:38:49.402406|2017-10-10 22:38:49.402406
NCT02634359|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-01-11|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of EarlySense for Monitoring Ovulation Cycles and Detection of Early Stages of Pregnancy in Home Environment|Protocol for Evaluation of EarlySense - a Contact-less Heart and Respiration Device for Monitoring Ovulation Cycles and Detection of Early Stages of Pregnancy in Home Environment|Recruiting||N/A|100|Anticipated|EarlySense Ltd.||3|||f||||t||||||||Undecided||2017-10-10 22:38:49.516334|2017-10-10 22:38:49.516334
NCT02634346|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-07-07|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|June 7, 2017|Actual|2017-06-07|May 25, 2017|Actual|2017-05-25||Interventional|||A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)|A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects With Acute Exacerbation of Schizophrenia|Completed||Phase 3|403|Actual|Alkermes, Inc.||3|||f||||f||||||||||2017-10-10 22:38:49.606545|2017-10-10 22:38:49.606545
NCT02634333|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-09-29|||January 2016||2016-01-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Anti-VEGF Treatment for Prevention of PDR/DME|Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk|Recruiting||Phase 3|322|Anticipated|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-10 22:38:49.752984|2017-10-10 22:38:49.752984
NCT02634320|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-08-10|||December 2015||2015-12-01|August 2017|2017-08-01|July 11, 2017|Actual|2017-07-11|July 11, 2017|Actual|2017-07-11||Interventional|||A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia|Safety and Tolerability of Initiating Aripiprazole Lauroxil in Subjects With Schizophrenia Who Are Inadequately Treated With Paliperidone Palmitate or Risperidone Long Acting Injection|Completed||Phase 4|51|Actual|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 22:38:51.672572|2017-10-10 22:38:51.672572
NCT02634307|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-16|2017-09-15|||December 2015||2015-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1|A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis|Recruiting||Phase 3|935|Anticipated|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 22:38:51.805316|2017-10-10 22:38:51.805316
NCT02634294|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-10-15|||August 2015||2015-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT|Induction of Graft Versus Tumor Effect of Pegylated Interferon Alpha-2b for Patients With Relapsed Hematological Malignancies After Allogeneic Stem Cell Transplantation|Recruiting||Phase 4|50|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||No|There is no plan to make individual participant date available before publication|2017-10-10 22:38:52.233655|2017-10-10 22:38:52.233655
NCT02634281|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-26|||February 2016||2016-02-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?|Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?|Recruiting||Phase 4|242|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-10 22:38:52.329562|2017-10-10 22:38:52.329562
NCT02634268|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-10-05|||May 12, 2017|Actual|2017-05-12|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|INSIGHT COPD||INtervention Study In overweiGHT Patients With COPD|INtervention Study In overweiGHT Patients With COPD|Recruiting||N/A|1000|Anticipated|Seattle Institute for Biomedical and Clinical Research||2|||f||||t|f|f||||||||2017-10-10 22:38:52.433811|2017-10-10 22:38:52.433811
NCT02634242|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-15|||April 2008||2008-04-01|December 2015|2015-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study on the Antiaging Effect of Chinese Herb Drink|Study on the Antiaging Effect of Chinese Herb Drink|Completed||N/A|60|Actual|Chung Shan Medical University||2|||f||||t||||||||||2017-10-10 22:38:52.680576|2017-10-10 22:38:52.680576
NCT02634229|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-02-15|||September 2012||2012-09-01|August 2015|2015-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|DIAMONO||Predisposition Genes in Monogenic Diabetes (DIAMONO)|Constitution of a Cohort of Families With Monogenic Diabetes to Identify Novel Causes of Non Auto-immune Diabetes Mellitus in Children and Young Adults|Completed||N/A|96|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 22:38:52.760262|2017-10-10 22:38:52.760262
NCT02634216|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-02-08|||January 2015||2015-01-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|June 2016|Actual|2016-06-01||Interventional|Carpos T1D||Effects of Capros in Patients With Type-1 Diabetes|Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes|Active, not recruiting||N/A|20|Anticipated|Ohio State University||1|||f||||f||||||||||2017-10-10 22:38:52.8307|2017-10-10 22:38:52.8307
NCT02634203|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-09-28|||January 2016||2016-01-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|RACE||Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension|Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension|Recruiting||N/A|124|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 22:38:52.913942|2017-10-10 22:38:52.913942
NCT02634190|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-02-22|||June 2009||2009-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Observational|||Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens|Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HPV HC2® Test in Women 30 Years of Age or Older Using LBC ThinPrep® Pap Test Specimens|Active, not recruiting||N/A|10000|Actual|Hologic Deutschland GmbH|||2||f||||f||||||Samples With DNA|"     liquid based cytology LBC Specimens (ThinPrep® Pap Test)   "|No||2017-10-10 22:38:53.009155|2017-10-10 22:38:53.009155
NCT02634177|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-08-17|||January 2016||2016-01-01|August 2017|2017-08-01|July 25, 2017|Actual|2017-07-25|July 25, 2017|Actual|2017-07-25||Interventional|||Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD|An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)|Completed||N/A|370|Anticipated|Genomind, LLC||2|||f||||f||||||||||2017-10-10 22:38:53.093336|2017-10-10 22:38:53.093336
NCT02634164|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-04-25|||December 2015||2015-12-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|AA+GLU||The Effects of Leucine and Isoleucine on Glucose Metabolism|The Effects of Leucine and Isoleucine on Glucose Metabolism|Completed||N/A|12|Actual|Texas Woman's University||4|||f||||f||||||||No||2017-10-10 22:38:53.220105|2017-10-10 22:38:53.220105
NCT02634151|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-08-24|||November 2016||2016-11-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Interventional|ROYAL-1||A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins|A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy|Completed||Phase 2|105|Actual|Gemphire Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:38:53.398883|2017-10-10 22:38:53.398883
NCT02634138|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-06-01|||November 2015||2015-11-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Neuromuscular Electrical Stimulation in Patients With Critical Limb Ischaemia|Neuromuscular Electrical Stimulation in Patients With Critical Limb Ischaemia|Recruiting||N/A|20|Anticipated|Imperial College London||1|||f||||t||||||||||2017-10-10 22:38:53.539335|2017-10-10 22:38:53.539335
NCT02633020|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2017-08-06|||March 30, 2016||2016-03-30|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|July 21, 2017|Actual|2017-07-21||Interventional|||Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease, an In Situ Small Bowel T Cell Lymphoma|Active, not recruiting||Phase 2|24|Anticipated|Celimmune||2|||f||||t||||||||||2017-10-10 22:38:53.629367|2017-10-10 22:38:53.629367
NCT02633007|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-06-10|||December 2015||2015-12-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma|A Phase 1 Study of the Safety and Pharmacokinetics (PK) of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma|Completed||Phase 1|25|Actual|Acorda Therapeutics||2|||f||||f||||||||||2017-10-10 22:38:53.719366|2017-10-10 22:38:53.719366
NCT02634125|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-07-13|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:38:53.796785|2017-10-10 22:38:53.796785
NCT02634112|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-12-15|||January 2016||2016-01-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01|1 Month|Observational [Patient Registry]|ANACARE||Spanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)|Spanish National Registry of Anastomotic Leakage in Rectal Cancer Surgery. Observational, Prospective and Multicenter Study|Not yet recruiting||N/A|2000|Anticipated|Hospital Universitario La Fe|||1||f||||f||||||||||2017-10-10 22:38:53.839267|2017-10-10 22:38:53.839267
NCT02633917|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-14|||June 2011||2011-06-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Motor Control Exercises vs Standard Exercises in Unspecific Low Back Pain|Motor Control Exercises vs Standard Exercises in Patients With Unspecific Low Back Pain|Completed||N/A|84|Actual|Universidad Complutense de Madrid||2|||f||||t||||||||||2017-10-10 22:38:56.664875|2017-10-10 22:38:56.664875
NCT02634099|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-08-04|||January 2016||2016-01-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|Hemoped||A Comparison of Three Methods of Hemoglobin Monitoring in Pediatric Patients Undergoing Major Surgery|Hemoglobin Monitoring During High Bleeding Risk Surgery in Pediatric Patients: Equivalence Study of Hemoglobin Transcutaneous Saturation and Hemocue With Total Serum Hemoglobin|Recruiting||N/A|50|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-10-10 22:38:53.892907|2017-10-10 22:38:53.892907
NCT02634086|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-17|||April 2004||2004-04-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|April 2016|Anticipated|2016-04-01||Observational|LOTUS||Long-term Outcome of Triple-vessel Coronary Artery Disease Underwent Three Different Strategies (LOTUS)|Long-term Outcome of Triple-vessel Coronary Artery Disease Underwent Three Different Strategies (LOTUS)|Recruiting||N/A|10000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||3||f||||t||||||||Undecided||2017-10-10 22:38:53.971431|2017-10-10 22:38:53.971431
NCT02634073|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-05-03|2016-10-28||January 1, 2016||2016-01-01|February 2017|2017-02-01|March 11, 2016|Actual|2016-03-11|March 1, 2016|Actual|2016-03-01||Interventional|||A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers|An Open-label Single-Center, 4-Period William's Cross-Over Design Drug Interaction Trial to Determine the Effects of Sorbitol-Containing Solutions on Lamivudine Exposure Following Administration of Lamivudine Oral Solution in Healthy Adult Subjects|Completed||Phase 4|16|Actual|ViiV Healthcare||4|||f||||f||||||||||2017-10-10 22:38:54.110465|2017-10-10 22:38:54.110465
NCT02634060|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-08-17|||June 2016||2016-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|HELP-AID||Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny|Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny|Recruiting||N/A|140|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-10 22:38:55.357652|2017-10-10 22:38:55.357652
NCT02634047|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-15|||September 2015||2015-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Use of McGrath Videolaryngoscope to Assist Transesophageal Echocardiography Probe Insertion in Intubated Patients|Use of McGrath Videolaryngoscope to Assist Transesophageal Echocardiography Probe Insertion in Intubated Patients: A Prospective Randomized Controlled Trial|Completed||N/A|80|Actual|Antalya Training and Research Hospital||2|||f||||f||||||||||2017-10-10 22:38:55.447419|2017-10-10 22:38:55.447419
NCT02634034|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-08|||December 2015||2015-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers||Completed||Phase 1|18|Actual|Kowa Research Institute, Inc.||3|||f||||f||||||||||2017-10-10 22:38:55.517799|2017-10-10 22:38:55.517799
NCT02634021|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-05-02|||July 2015||2015-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Loading of Midazolam or Dexmedetomidine on Hemodynamics|Hemodynamic Change Between Loading of Dexmedetomidine or Midazolam as a Sedative Agents During Knee Arthroscopy|Recruiting||Phase 4|130|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:38:55.590657|2017-10-10 22:38:55.590657
NCT02634008|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-06-07|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|June 2018|Anticipated|2018-06-01||Interventional|TARGET3D||Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P|An Open Label, Multicentre, International Pilot Study of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir With or Without Ribavirin or Glecaprevir/Pibrentasvir for People With Recently Acquired Hepatitis C Virus Infection With or Without HIV Co-infection.|Active, not recruiting||Phase 3|90|Anticipated|Kirby Institute||3|||f||||t||||||||No||2017-10-10 22:38:55.779824|2017-10-10 22:38:55.779824
NCT02633995|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-14|||December 2015||2015-12-01|December 2015|2015-12-01||||February 2016|Anticipated|2016-02-01||Observational|||Spinal Anaesthesia and Severe Preeclampsia|Spinal Anesthesia in Severe Preeclampsia and Its Impact on Hemodynamics (Case Control Study)|Recruiting||N/A|60|Anticipated|Kasr El Aini Hospital|||2||f||||||||||||||2017-10-10 22:38:55.921753|2017-10-10 22:38:55.921753
NCT02633982|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-14|||September 2015||2015-09-01|November 2015|2015-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|2 Years|Observational [Patient Registry]|GENeRAL||GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence|Registry Study on the Effectiveness of Rivaroxaban in Patients With Non-valvular Atrial Fibrillation Managed by General Practitioners(GENERAL Study)|Recruiting||N/A|5000|Anticipated|Japan Cardiovascular Research Foundation|||1||f||||t||||||||||2017-10-10 22:38:56.032782|2017-10-10 22:38:56.032782
NCT02633969|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-01-27|||December 2015||2015-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age|A Phase IIA, Open-label, Safety and Pharmacokinetic Study of Indomethacin Capsules in Pediatric Subjects 6 to <17 Years of Age With Mild to Moderate Acute Postoperative Pain Following Elective Surgery|Completed||Phase 2|30|Actual|Iroko Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 22:38:56.149408|2017-10-10 22:38:56.149408
NCT02633956|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-06-14|||December 2015||2015-12-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|March 2017|Actual|2017-03-01||Interventional|CONTROL||Combination OCA and Statins for Monitoring of Lipids (CONTROL)|A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis|Active, not recruiting||Phase 2|80|Anticipated|Intercept Pharmaceuticals||4|||f||||t||||||||||2017-10-10 22:38:56.249332|2017-10-10 22:38:56.249332
NCT02633943|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-04-03|||September 2013||2013-09-01|April 2017|2017-04-01|March 2031|Anticipated|2031-03-01|March 2031|Anticipated|2031-03-01||Observational|||Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy|Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector|Enrolling by invitation||N/A|71|Anticipated|bluebird bio|||1||f||||f||||||||||2017-10-10 22:38:56.408722|2017-10-10 22:38:56.408722
NCT02633930|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-01-15|||December 2015||2015-12-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy|Helicobacter Pylori Eradication With Berberine Hydrochloride, Lansoprazole, Amoxicillin and Bismuth Versus Clarithromycin Bismuth, Lansoprazole and Amoxicillin: A Randomized, Open-label, Non-inferiority, Phase Ⅳ Trial|Completed||Phase 4|566|Actual|Xijing Hospital of Digestive Diseases||2|||f||||t||||||||No||2017-10-10 22:38:56.522479|2017-10-10 22:38:56.522479
NCT02633904|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|FSODDH||Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH)|Investigation of the Value of Femoral Shortening Osteotomy During Open Treatment of Developmental Dislocation of the Hip in Waliking Age Group|Not yet recruiting||N/A|200|Anticipated|Tongji Hospital||2|||f||||t||||||||Yes|The single-center data will be published in the form of case-control study.|2017-10-10 22:38:56.755738|2017-10-10 22:38:56.755738
NCT02633891|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-08-28|||January 2, 2017|Actual|2017-01-02|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|July 1, 2020|Anticipated|2020-07-01||Interventional|||Metabolic Syndrome and Fall Risk|Metabolic Syndrome and Fall Risk|Recruiting||N/A|55|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:38:56.887405|2017-10-10 22:38:56.887405
NCT02633878|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-20|||December 2015||2015-12-01|December 2015|2015-12-01||||July 2018|Anticipated|2018-07-01||Interventional|||Chinese Herbal Medicine and Micronized Progesterone for Threatened Miscarriage RCT||Not yet recruiting||N/A|1656|Anticipated|Heilongjiang University of Chinese Medicine||4|||f||||f||||||||||2017-10-10 22:38:57.443869|2017-10-10 22:38:57.443869
NCT02633865|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-04-18|||May 2012||2012-05-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01|9 Months|Observational [Patient Registry]|||Patient Participation in Free Cataract Surgery|Patient Participation in Free Cataract Surgery: The Low-income Elderly in Urban China|Completed||N/A|883|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 22:38:57.573266|2017-10-10 22:38:57.573266
NCT02633852|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-14|||January 2016||2016-01-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema|A 12-month, Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen (TER) of Aflibercept (EYLEA) 2mg /0.05 ml as a Second Line Treatment for Diabetic Macular Edema|Unknown status|Not yet recruiting|Phase 4|48|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-10 22:38:57.66117|2017-10-10 22:38:57.66117
NCT02633839|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-07-13|||December 2015||2015-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults|A Phase 1 Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults|Completed||Phase 1|60|Actual|Acorda Therapeutics||2|||f||||f||||||||||2017-10-10 22:38:57.748342|2017-10-10 22:38:57.748342
NCT02633826|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-01-20|||November 2015||2015-11-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|||Pre-formed Alloreactivity in Renal Transplant Recipients|The Role of Pre-formed Alloreactive T Cells on Acute Rejection Episodes and Long-term Graft Outcome in Patients After Living Donor Renal Transplantation|Recruiting||N/A|150|Anticipated|Saarland University|||1||f||||f||||||Samples Without DNA|"     Serum   "|No||2017-10-10 22:38:57.839675|2017-10-10 22:38:57.839675
NCT02633813|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-05-09|||March 2015||2015-03-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||BE Study of Naftifine HCL|A Randomized, Prospective Multicenter, Double Blind, Parallel Assignment Placebo Controlled BE Study Of Naftifine Hydrochloride 2% Topical Cream With Naftin® In Patients With Tinea Pedis Using Clinical Endpoints|Completed||Phase 3|693|Actual|Genzum Life Sciences||3|||f||||f||||||||Undecided||2017-10-10 22:38:57.967947|2017-10-10 22:38:57.967947
NCT02633800|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-19|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )|Randomized, Placeo-controlled, Double-blind Phase 2 Study of Patritumab (U3-1287) in Combination With Cetuximab Plus Platinum-based Therapy in First Line Setting in Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 2|87|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-10 22:38:58.107316|2017-10-10 22:38:58.107316
NCT02633787|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-09-21|2016-08-01||December 2015||2015-12-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier|Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately Four Years Earlier|Completed||Phase 4|110|Actual|Sanofi||1|||f||||f||||||||||2017-10-10 22:38:58.294636|2017-10-10 22:38:58.294636
NCT02633774|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-14|||November 2015||2015-11-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial Fibrillation|Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial Fibrillation: Prospective Randomized Trial|Recruiting||N/A|200|Anticipated|Yonsei University||2|||f||||f||||||||No||2017-10-10 22:38:58.578391|2017-10-10 22:38:58.578391
NCT02633761|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-07-15|||April 2015||2015-04-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death|Mifepristone and Misoprostol Versus Misoprostol Alone for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: A Randomized, Placebo-controlled Double-blinded Trial|Recruiting||Phase 3|200|Anticipated|Gynuity Health Projects||2|||f||||t||||||||||2017-10-10 22:38:58.668357|2017-10-10 22:38:58.668357
NCT02633748|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-10-07|||September 2015||2015-09-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Mindfulness Intervention to Improve Symptomology Among Cancer Survivors; Focus on Sleep and Stress Improvement|Mindfulness Intervention to Improve Symptomology Among Cancer Survivors; Focus on Sleep and Stress Improvement|Completed||N/A|36|Actual|Greenville Health System||2|||f||||f||||||||||2017-10-10 22:38:58.786486|2017-10-10 22:38:58.786486
NCT02633735|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-06-09|||June 1, 2017|Actual|2017-06-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|Appy-CDS||EHR-based Decision Support for Pediatric Acute Abdominal Pain in Emergency Care|EHR-based Decision Support for Pediatric Acute Abdominal Pain in Emergency Care|Enrolling by invitation||N/A|8200|Anticipated|HealthPartners Institute||2|||f||||t|f|f||||||No||2017-10-10 22:38:58.865082|2017-10-10 22:38:58.865082
NCT02633709|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-02-23|||January 2016||2016-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7034067 (RG7916) Given by Mouth in Healthy Volunteers|A Single-Center, Randomized, Investigator/Subject-Blind, Adaptive Single-Ascending-Dose(SAD), Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including the Effect of Food and the Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of RO7034067), and Pharmacodynamics of RO7034067 Following Oral Administration in Healthy Subjects|Completed||Phase 1|33|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-10-10 22:38:59.079992|2017-10-10 22:38:59.079992
NCT02633696|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-07-08|||October 2013||2013-10-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|||Study to Investigate the Absolute Bioavailability of Oral Sylibin|Open Label, Randomized, 2 Way-crossover Study to Investigate the Absolute Bioavailability of Oral Sylibin|Completed||Phase 1|8|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||f||||||||||2017-10-10 22:38:59.184919|2017-10-10 22:38:59.184919
NCT02633683|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-03-02|||January 2016||2016-01-01|December 2015|2015-12-01|July 2024|Anticipated|2024-07-01|May 2024|Anticipated|2024-05-01||Interventional|RLS||An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS|A Multicenter Open-Label Extension Study to Evaluate the Efficacy and Safety of HORIZANT (Gabapentin Enacarbil) Extended-Release Tablets in Adolescents Aged 13 to 17 Years Old With Moderate-to-Severe Primary Restless Legs Syndrome|Recruiting||Phase 4|144|Anticipated|XenoPort, Inc.||1|||f||||f||||||||No||2017-10-10 22:38:59.409878|2017-10-10 22:38:59.409878
NCT02633670|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-10-03|||June 2016||2016-06-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Hemopatch Versus No Hemopatch (Renal Transplant)|A Prospective Randomized Trial of Hemopatch Versus No Hemopatch For the Intraoperative Hemostasis During Deceased Donor Renal Transplant|Recruiting||N/A|20|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-10 22:38:59.506931|2017-10-10 22:38:59.506931
NCT02633657|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-03-02|||January 2016||2016-01-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|RLS||A Pharmacokinetic and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS|A Multicenter, Open-label, Single-dose Pharmacokinetic and Safety Evaluation of HORIZANT (Gabapentin Enacarbil Extended-release Tablets) in Adolescents Aged 13 to 17 Years Old With Moderate-to-severe Primary Restless Legs Syndrome|Recruiting||Phase 1|12|Anticipated|XenoPort, Inc.||1|||f||||f||||||||No||2017-10-10 22:38:59.610816|2017-10-10 22:38:59.610816
NCT02633644|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-22|||September 2015||2015-09-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Endovascular NeuromoDulation Treatment fOr Heart Failure Patients (ENDO-HF)|The Harmony System for the Treatment of Heart Failure Patients - A Safety and Performance Study|Recruiting||Phase 2|30|Anticipated|Enopace Biomedical||1|||f||||f||||||||||2017-10-10 22:38:59.716646|2017-10-10 22:38:59.716646
NCT02633631|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-11-09|||January 2015||2015-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|C3||Contraceptive Choice Center|The Center for Contraceptive Excellence: an Innovative Health Services Delivery and Payment Model|Recruiting||N/A|10025|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-10-10 22:38:59.797507|2017-10-10 22:38:59.797507
NCT02633618|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-14|||August 2005||2005-08-01|December 2015|2015-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Analgecine for the Treatment of Neuropathic Pain|The Clinical Study of Analgecine for the Treatment of Neuropathic Pain|Completed||Phase 3|135|Actual|VanWorld Pharmaceutical (Rugao) Company Limited||2|||f||||t||||||||||2017-10-10 22:38:59.87584|2017-10-10 22:38:59.87584
NCT02633605|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-16|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of First Sense Breast Exam® to the University of Toledo Mammography and Biopsy Results|Comparison of First Sense Breast Exam® to the University of Toledo Mammography and Biopsy Results|Not yet recruiting||N/A|400|Anticipated|First Sense Medical, LLC||1|||f||||f||||||||Undecided||2017-10-10 22:38:59.948027|2017-10-10 22:38:59.948027
NCT02633592|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-16|||November 2014||2014-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|SEAT||Seated Evaluation of Anorectal funcTion by High Resolution Anorectal Manometry|Seated Evaluation of Anorectal funcTion by High Resolution Anorectal Manometry: a Randomized Comparison of Measurements in the Seated and Left Lateral Positions|Completed||N/A|60|Actual|University of Zurich||2|||f||||t||||||||||2017-10-10 22:39:00.033722|2017-10-10 22:39:00.033722
NCT02633579|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-12-14|||October 2012||2012-10-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways|The Role of Induced Phase 3 Contractions in the Control of Hunger and Food Intake|Completed||N/A|28|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||||2017-10-10 22:39:00.131216|2017-10-10 22:39:00.131216
NCT02633553|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-08-11|||November 2015||2015-11-01|August 2016|2016-08-01||||November 2018|Anticipated|2018-11-01||Interventional|||Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection|An Open-label, Multi-center, Randomized Phase III Study of Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection|Recruiting||N/A|1|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 22:39:00.298529|2017-10-10 22:39:00.298529
NCT02633540|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-06-14|||November 16, 2015|Actual|2015-11-16|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function|A Phase II Investigation of Contralateral Arytenoid Sparing IMRT for T1a and T2a Larynx Cancer With Detailed Analysis of Post-treatment Laryngeal Function|Recruiting||Phase 2|30|Anticipated|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-10 22:39:00.382921|2017-10-10 22:39:00.382921
NCT02633514|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-08-11|||November 2015||2015-11-01|August 2016|2016-08-01||||November 2018|Anticipated|2018-11-01||Interventional|||Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma|A Randomized Phase III Study of Adjuvant Radiotherapy Versus Adjuvant Radiochemotherapy in Patients With Incomplete ResectionThymoma or Thymic Carcinoma|Recruiting||Phase 3|1|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 22:39:00.555888|2017-10-10 22:39:00.555888
NCT02633501|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-09-12|||June 2016||2016-06-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)|P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)|Recruiting||Phase 2|280|Anticipated|Guerbet||4|||f||||f||||||||||2017-10-10 22:39:00.663115|2017-10-10 22:39:00.663115
NCT02633488|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-05-30|||June 2014||2014-06-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|EJB044||Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome|Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome|Completed||N/A|19|Actual|University of Virginia||2|||f||||f||||||||No|Data will be reported as composite for the entire population. In some figures individual data point are displayed but not identified with individual subjects.|2017-10-10 22:39:00.768225|2017-10-10 22:39:00.768225
NCT02633475|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-02-14|||August 2015||2015-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Interleukin-10 Promoter-1082A/G Polymorphism and Idiopathic Recurrent Miscarriage Risk|Association Between Interleukin-10 Promoter-1082A/G Polymorphism With Idiopathic Recurrent Miscarriage Risk of Chinese Han|Recruiting||N/A|200|Anticipated|Fourth Affiliated Hospital of Guangxi Medical University|||2||f||||t||||||Samples With DNA|"     blood samples   "|No||2017-10-10 22:39:00.904877|2017-10-10 22:39:00.904877
NCT02633462|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-16|||May 2015||2015-05-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Non-surgical Periodontal Therapy and Myo-inositol in Polycystic Ovary Syndrome Women Having Chronic Periodontitis|Effect of Non-surgical Periodontal Therapy Along With Myo-inositol on High Sensitivity C-reactive Protein and Insulin Resistance in Polycystic Ovary Syndrome Women Having Chronic Periodontitis: A Randomized Controlled Trial|Active, not recruiting||Phase 2|56|Anticipated|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t||||||||||2017-10-10 22:39:00.999976|2017-10-10 22:39:00.999976
NCT02633449|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-08-21|||February 2016||2016-02-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Psychotherapy Plus: Combining Cognitive Behavioral Therapy With tDCS|Augmentation of Cognitive-Behavioral Psychotherapy With Prefrontal Direct Current Stimulation in Major Depression (Psychotherapy Plus)|Recruiting||N/A|192|Anticipated|Charite University, Berlin, Germany||3|||f||||t||||||||||2017-10-10 22:39:01.081168|2017-10-10 22:39:01.081168
NCT02633436|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-08-11|||December 2015||2015-12-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Observational|||Research on the Role of SLC1A5 in the Development of Esophageal Cancer|Research on the Role of the Amino Acid Transporter SLC1A5 in the Development of Esophageal Cancer|Recruiting||N/A|100|Anticipated|Fourth Affiliated Hospital of Guangxi Medical University|||2||f||||t||||||Samples With DNA|"     Tissue specimens of esophageal cancer patients will be collected and stored in liquid     nitrogen after operations   "|Undecided||2017-10-10 22:39:01.183577|2017-10-10 22:39:01.183577
NCT02633423|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-02-01|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Expiratory Flow Limitation and Mechanical Ventilation During Cardiopulmonary Bypass in Cardiac Surgery|Expiratory Flow Limitation and Mechanical Ventilation During Cardiopulmonary Bypass in Cardiac Surgery|Not yet recruiting||N/A|189|Anticipated|Ospedale San Raffaele||3|||f||||t||||||||||2017-10-10 22:39:01.278801|2017-10-10 22:39:01.278801
NCT02633410|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2015-12-16|||July 2007||2007-07-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Transtibial Versus Anteromedial Femoral Tunnel Technique in ACL Reconstruction|Prospective Randomized Clinical Study Comparing Anteromedial Portal Versus Transtibial Technique for Femoral Tunnel Positioning in Anterior Cruciate Ligament Reconstruction With Hamstring Autograft|Completed||N/A|96|Actual|Panam Clinic||2|||f||||f||||||||||2017-10-10 22:39:01.375483|2017-10-10 22:39:01.375483
NCT02633397|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-10-02|||April 11, 2017|Actual|2017-04-11|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases|A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases|Recruiting||Phase 2|100|Anticipated|University of Pittsburgh||2|||f||||t|t|f||||||||2017-10-10 22:39:01.465158|2017-10-10 22:39:01.465158
NCT02633384|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-07-11|||August 2011||2011-08-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|July 2015|Actual|2015-07-01||Interventional|||Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions|Incidence and Severity of Parenteral Nutrition Associated Cholestasis in Neonates Subjected to Major Surgery, Using Two Mixed Intravenous Lipid Emulsions|Terminated||Phase 4|52|Actual|Centro Hospitalar de Lisboa Central||2||One of the intravenous lipid emulsions was retired from the market|f||||t||||||||||2017-10-10 22:39:01.613817|2017-10-10 22:39:01.613817
NCT02633371|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-02-13|||February 2016||2016-02-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults|A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults|Active, not recruiting||N/A|7|Actual|University of Colorado, Denver||1|||f||||f||||||||No||2017-10-10 22:39:01.704388|2017-10-10 22:39:01.704388
NCT02633358|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-07-28|||November 2015||2015-11-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Anti-inflammatory Effect of Therapeutic Hypothermia in Acute Myocardial Infarction Complicated With Cardiogenic Shock|Anti-inflammatory Effect of Therapeutic Hypothermia in Acute Myocardial Infarction Complicated With Cardiogenic Shock|Recruiting||Phase 2/Phase 3|50|Anticipated|China Medical University Hospital||1|||f||||t||||||||No||2017-10-10 22:39:01.78293|2017-10-10 22:39:01.78293
NCT02631629|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-10-17|||November 2015||2015-11-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ODIN_FOOD||Food-based Solutions for Optimal Vitamin D Nutrition and Health|Food-based Solutions for Optimal Vitamin D Nutrition and Health|Completed||N/A|143|Actual|Technical University of Denmark||4|||f||||t||||||||Undecided||2017-10-10 22:39:21.773117|2017-10-10 22:39:21.773117
NCT02633345|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-06-14|||September 2015||2015-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Effects on Tablets Containing Probiotic Candidate Strains|Effects on Tablets Containing Probiotic Candidate Strains on Clinical and Cytokine Markers of Gingival Inflammation and Composition of the Salivary Microbiome|Completed||N/A|50|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 22:39:01.889149|2017-10-10 22:39:01.889149
NCT02633319|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-06-21|||August 1, 2015|Actual|2015-08-01|June 2017|2017-06-01|March 1, 2017|Actual|2017-03-01|December 31, 2016|Actual|2016-12-31||Interventional|SPACAPS||Malezi Na Kilimo Bora - Skilful Parenting and Agribusiness Child Abuse Prevention Study|Malezi ne Kilimo Bora (Good Parenting and Farming) - Skilful Parenting and Agribusiness Child Abuse Prevention Study (SPACAPS)|Completed||N/A|248|Actual|University of Oxford||4|||f||||f||||||||||2017-10-10 22:39:01.977206|2017-10-10 22:39:01.977206
NCT02633306|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-08-26|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Transcranial Magnetic Stimulation for Facial Pain|Complex Oro-Facial Pain: Functional Imaging Characterization and Treatment With Transcranial Magnetic Stimulation|Recruiting||Phase 1|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||No||2017-10-10 22:39:02.09475|2017-10-10 22:39:02.09475
NCT02633293|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-09-20|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE|An Open-Label Extension Study of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease|Enrolling by invitation||Phase 2/Phase 3|266|Anticipated|United Therapeutics||1|||f||||t||||||||||2017-10-10 22:39:02.204781|2017-10-10 22:39:02.204781
NCT02633280|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-09-25|||April 2016||2016-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|September 2017|Actual|2017-09-01||Observational|BmiRCOPD||Biomarkers for Diagnosis and Treatment of COPD|"A Predictive Molecular Biology Signature for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease"|Recruiting||N/A|195|Anticipated|University of Cantanzaro|||3||f||||t||||||Samples Without DNA|"     blood   "|||2017-10-10 22:39:02.454804|2017-10-10 22:39:02.454804
NCT02633267|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-04-13|||January 2016||2016-01-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety|1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety|Recruiting||N/A|300|Anticipated|University of Michigan||2|||f||||t|f|f||||||||2017-10-10 22:39:02.540747|2017-10-10 22:39:02.540747
NCT02633254|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-04-06|||December 2015||2015-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Targeted Vessel Ablation of Type 3 Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound|Targeted Vessel Ablation of Type 3 Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound|Terminated||N/A|6|Actual|UMC Utrecht||1|||f||||t||||||||No||2017-10-10 22:39:02.64011|2017-10-10 22:39:02.64011
NCT02633241|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-03-08|||March 2, 2017|Actual|2017-03-02|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging|A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging|Recruiting||Phase 4|30|Anticipated|Boston Children’s Hospital||1|||f||||t|t|f||||||No||2017-10-10 22:39:02.725499|2017-10-10 22:39:02.725499
NCT02633228|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-06-28|||December 2014||2014-12-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Visual Acuity After the Combined Binocular Implantation of +2.0 Diopters and +3.0 Diopters Oculentis Multifocal Intraocular Lenses.|Evaluation of the Visual Acuity After the Implantation of an Oculentis +2.0 Diopters (Torical) Bifocal Intraocular Lens (MplusX (Toric) LU-313 MF20T/LS-313 MF20) in the Distance Dominant Eye, in Combination With a +3.0 Diopters Oculentis Bifocal Intraocular Lens (MplusX (Toric) LU-313 MF30T/LS-313 MF30) in the Fellow Eye.|Completed||Phase 4|15|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||No||2017-10-10 22:39:02.971501|2017-10-10 22:39:02.971501
NCT02633215|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-07-11|2017-06-15||March 2005||2005-03-01|July 2017|2017-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Enhancing Plasticity in Stroke Patients With Severe Motor Deficit|Enhancing Cortical Plasticity With Nerve Stimulation in Stroke Patients With Severe Motor Deficit|Completed||N/A|36|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 22:39:03.104743|2017-10-10 22:39:03.104743
NCT02633202|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-06-26|||November 2015||2015-11-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era|Prospective Non-inferior Clinical Trial Comparing Concurrent Chemoradiotherapy or Radiotherapy Alone in Patients With Intermediate Risk Nasopharyngeal Carcinoma in Intensity-modulated Radiotherapy Era|Recruiting||Phase 3|280|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:39:03.488531|2017-10-10 22:39:03.488531
NCT02633189|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-07-14|||April 2016||2016-04-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|BEVERLY||Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer|A Randomized Open-label Phase 3 Trial Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer|Recruiting||Phase 3|200|Anticipated|National Cancer Institute, Naples||2|||f||||t||||||||||2017-10-10 22:39:03.631905|2017-10-10 22:39:03.631905
NCT02633176|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-14|||January 2015||2015-01-01|December 2015|2015-12-01||||January 2023|Anticipated|2023-01-01||Interventional|||Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma|Phase Ⅲ Randomized Trial of Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel Induction Chemotherapy Followed by Concurrent Chemoradiation in Previously Untreated Patients Metastatic Nasopharyngeal Carcinoma|Recruiting||Phase 3|120|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-10-10 22:39:03.938108|2017-10-10 22:39:03.938108
NCT02633163|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-29|||July 2018|Anticipated|2018-07-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||MsciSLE: MSCs in SLE Trial|A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus|Suspended||Phase 2|81|Anticipated|Medical University of South Carolina||3||Opening a mini trial to determine safety and efficacy|f||||t|t|f||||||||2017-10-10 22:39:04.136029|2017-10-10 22:39:04.136029
NCT02633150|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-12-07|||October 2015||2015-10-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|POLYGIR||Assessing the Value of Red Grapes Polyphenol Supplementation on Metabolic Parameters in Obese Insulinoresistant Subjects|Assessing the Value of Red Grapes Polyphenol Supplementation on Metabolic Parameters in Obese Insulinoresistant Subjects : Study Randomized Versus Placebo|Recruiting||N/A|46|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 22:39:04.253222|2017-10-10 22:39:04.253222
NCT02633137|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-04-06|||December 14, 2015||2015-12-14|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma|Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma: A Phase II Study|Recruiting||Phase 2|45|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:39:04.360465|2017-10-10 22:39:04.360465
NCT02633124|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-02-01|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MultilineNEO||Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.|Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants: Randomized Controlled Multicenter Study of Edelvaiss Multiline NEO Device|Recruiting||N/A|280|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 22:39:04.517216|2017-10-10 22:39:04.517216
NCT02633111|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-07-07|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas|DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas|Recruiting||N/A|500|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:39:04.75048|2017-10-10 22:39:04.75048
NCT02633098|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|May 2023|Anticipated|2023-05-01|October 2020|Anticipated|2020-10-01||Interventional|NeoART||A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer|Phase II Randomised, Double Blind, Placebo Controlled Trial of Neoadjuvant Artesunate in Stage II/III Colorectal Cancer|Recruiting||Phase 2|200|Anticipated|St George's, University of London||2|||f||||t||||||||||2017-10-10 22:39:05.019401|2017-10-10 22:39:05.019401
NCT02633085|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-07-11|||February 2016||2016-02-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Fixed Bearing Versus Mobile Bearing Patient Satisfaction and Clinical Outcome Study|A Retrospective, Consecutive Series, Single Surgeon Study Comparing Patient Satisfaction and Clinical Outcomes in Patients With Fixed Bearing Versus Mobile Bearing Unicompartmental Knee Arthroplasty|Recruiting||N/A|200|Anticipated|Medacta USA|||1||f||||f||||||||||2017-10-10 22:39:05.240992|2017-10-10 22:39:05.240992
NCT02633072|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-06-28|||September 2014||2014-09-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Visual Acuity After the Combined Binocular Implantation of +2.75 Diopters and +3.25 Diopters Tecnis Multifocal Intraocular Lenses.|Evaluation of the Visual Acuity After the Implantation of a Tecnis +2.75 Diopters Bifocal Intraocular Lens (Tecnis ZKB00) in the Distance Dominant Eye, in Combination With a +3.25 Diopters Tecnis Bifocal Intraocular Lens (Tecnis ZLB00) in the Fellow Eye.|Completed||Phase 4|15|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-10 22:39:05.343866|2017-10-10 22:39:05.343866
NCT02633059|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-07-17|||December 30, 2015|Actual|2015-12-30|June 2017|2017-06-01|May 13, 2021|Anticipated|2021-05-13|May 13, 2021|Anticipated|2021-05-13||Interventional|||Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma|Phase 1 / 2 Trial of Idasanutlin in Combination With Ixazomib and Dexamethasone in Patients With 17p Deleted, Relapsed Multiple Myeloma|Recruiting||Phase 1/Phase 2|53|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:39:05.436726|2017-10-10 22:39:05.436726
NCT02633046|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-25|||May 2016||2016-05-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|PODOCYTE||Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS|Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic Focal Segmental Glomerulosclerosis: A 2 Part Prospective Study of H.P. Acthar® Gel (PODOCYTE)|Recruiting||Phase 4|236|Anticipated|Mallinckrodt||4|||f||||f||||||||||2017-10-10 22:39:05.643269|2017-10-10 22:39:05.643269
NCT02633033|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-09-22|||November 2015||2015-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|24 Months|Observational [Patient Registry]|||Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse|A Prospective Observational Registry of H.P. Acthar® Gel for the Treatment of Multiple Sclerosis Relapse|Recruiting||N/A|260|Anticipated|Mallinckrodt|||1||f||||f||||||||||2017-10-10 22:39:05.830279|2017-10-10 22:39:05.830279
NCT02632994|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-08-24||||||August 2016|2016-08-01||||||||Expanded Access|||Protocol for Continued Patient Access to Study Drug|Protocol for Continued Patient Access to Study Drug|Available||N/A|||Eli Lilly and Company|||||||||||||||||||2017-10-10 22:39:06.055506|2017-10-10 22:39:06.055506
NCT02632981|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-16|||July 2014||2014-07-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||IL-32 Levels in Patients With Chronic Periodontitis|IL-32 Levels in Gingival Crevicular Fluid and Saliva of Patients With Chronic Periodontitis After Periodontal Treatment.|Completed||Phase 1|54|Actual|Bulent Ecevit University||2|||f||||f||||||||||2017-10-10 22:39:06.114186|2017-10-10 22:39:06.114186
NCT02632955|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-10-03|||December 2015||2015-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|DEBEFF||Drug Eluting Balloon for Early Fistula Failure Trial|Drug Eluting Balloon for Early Fistula Failure Trial|Recruiting||N/A|70|Anticipated|King Faisal Specialist Hospital & Research Center||2|||f||||f||||||||||2017-10-10 22:39:06.272199|2017-10-10 22:39:06.272199
NCT02632942|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-10-03|||September 2015||2015-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|CAVO||Criteria for Accessory Vein Obliteration Trial.|Assessing Clinical Utility of the Criteria for Accessory Vein Obliteration for Failing Arteriovenous Fistula.|Recruiting||N/A|50|Anticipated|King Faisal Specialist Hospital & Research Center||2|||f||||f||||||||||2017-10-10 22:39:06.371764|2017-10-10 22:39:06.371764
NCT02632929|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|||Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue|Prevention of Amputation in a High Risk Population With Comprehensive Care and Amniotic Tissue|Active, not recruiting||N/A|20|Actual|Boise VA Medical Center|||1||f||||f||||||||No|This is a pilot study.|2017-10-10 22:39:06.490763|2017-10-10 22:39:06.490763
NCT02632916|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2016-11-24|||August 2016||2016-08-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Denosumab for the Treatment of Osteoporosis in Children: A Pilot Study|A Single-Blinded, Randomized, Controlled, Phase 2 Pilot Study to Evaluate the Safety and Efficacy of Denosumab Compared to Zoledronic Acid for the Treatment of Osteoporosis in Children|Recruiting||Phase 2|20|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||t||||||||Yes||2017-10-10 22:39:06.613309|2017-10-10 22:39:06.613309
NCT02632903|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-06-15|||October 2016||2016-10-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study|Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study|Recruiting||Phase 2|4|Anticipated|Children's Hospital of Eastern Ontario||1|||f||||t||||||||Yes||2017-10-10 22:39:06.69752|2017-10-10 22:39:06.69752
NCT02632890|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-06-14|||November 29, 2016|Actual|2016-11-29|June 2017|2017-06-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Observational|||Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries|Evaluation of the Effectiveness of the Abatacept (Orencia®) IV and SC Patient Alert Cards in Patients With Rheumatoid Arthritis in European Economic Area Countries|Completed||N/A|203|Actual|Bristol-Myers Squibb|||3||f||||f||||||||||2017-10-10 22:39:08.382261|2017-10-10 22:39:08.382261
NCT02632877|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-14|||January 2014||2014-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers|Efficacy of Pirfenidone Gel Combined With Modified Oxide Diallyl Disulfide (MODD) Versus Ketanserin for the Treatment of Diabetic Foot Ulcers|Completed||Phase 1/Phase 2|60|Actual|University of Guadalajara||2|||f||||f||||||||||2017-10-10 22:39:08.568135|2017-10-10 22:39:08.568135
NCT02632864|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-01-12|||December 2015||2015-12-01|January 2016|2016-01-01||||October 2019|Anticipated|2019-10-01||Interventional|||Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial||Recruiting||Phase 2|66|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:39:08.663184|2017-10-10 22:39:08.663184
NCT02632851|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-06-20|||December 2015||2015-12-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution|Non-interventional Multicentric Study on Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution|Completed||N/A|135|Actual|Bitop AG|||2||f||||t||||||||||2017-10-10 22:39:08.75201|2017-10-10 22:39:08.75201
NCT02632838|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-09-27|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|September 2017|Actual|2017-09-01||Interventional|||Improve Hypertension Monitoring and Self-management by Using mHealth|Utilizing a Mobile Health (mHealth) Application to Improve Hypertension Monitoring and Self-management in an Underserved Community: A Pilot Study|Active, not recruiting||N/A|35|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 22:39:08.841072|2017-10-10 22:39:08.841072
NCT02632825|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-12-16|||May 2015||2015-05-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of Nasal High Flow Therapy on Ventilation and Gas Exchange in Healthy Newborns|Effects of Nasal High Flow Therapy on Ventilation and Gas Exchange During Wakefulness and Sleep in Healthy Newborn Babies in a Randomized Crossover Study Design|Unknown status|Recruiting|N/A|20|Anticipated|Research Center of Maternal and Child Health Protection, Armenia||2|||f||||f||||||||||2017-10-10 22:39:08.923435|2017-10-10 22:39:08.923435
NCT02632812|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-01-31|2016-03-18||October 2014||2014-10-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo|Double-blind Trial on the Gastrointestinal Integrity Evaluation After Daily Naproxen 1100 mg + Rebamipide 200mg for 7 Days Versus Naproxen 1100mg + Placebo for 7 Days|Completed||Phase 1|24|Actual|Biolab Sanus Farmaceutica||2|||f||||f||||||||No||2017-10-10 22:39:09.017082|2017-10-10 22:39:09.017082
NCT02632799|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-12-14|||January 2015||2015-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Airway Pressure During Nasal High Flow and CPAP in Neonates|Airway Pressure During Nasal High Flow and CPAP in Neonates|Completed||N/A|10|Actual|Research Center of Maternal and Child Health Protection, Armenia||4|||f||||f||||||||||2017-10-10 22:39:09.541735|2017-10-10 22:39:09.541735
NCT02632786|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-03-30|||March 2016||2016-03-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRONTO||The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis|A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction|Active, not recruiting||Phase 2|100|Anticipated|Prothena Therapeutics Ltd.||2|||f||||t||||||||||2017-10-10 22:39:09.664459|2017-10-10 22:39:09.664459
NCT02632773|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-09-12|||August 2015||2015-08-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Interventional|||Parent Language Intervention for Autism|The Role of Parent Phenotype in Parent-Mediated Language Interventions for Autism|Recruiting||N/A|108|Anticipated|Northwestern University||4|||f||||t||||||||||2017-10-10 22:39:09.893811|2017-10-10 22:39:09.893811
NCT02632760|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-01-05|||June 2016||2016-06-01|December 2016|2016-12-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|ITACS||Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery|Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery|Recruiting||Phase 4|1000|Anticipated|Bayside Health||2|||f||||t||||||||Undecided||2017-10-10 22:39:10.623097|2017-10-10 22:39:10.623097
NCT02632747|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-10-03|||May 10, 2016|Actual|2016-05-10|October 2017|2017-10-01|January 26, 2018|Anticipated|2018-01-26|January 19, 2018|Anticipated|2018-01-19||Interventional|||Empagliflozin and ACEi Effects on Hyperfiltration in Type 1 Diabetes (BETWEEN Study)|A Double-blind, Placebo Controlled, Cross-over Renal Mechanistic Trial to Assess the Effect of Adding Empagliflozin Versus Placebo on Renal Hyperfiltration in Patients With Type 1 Diabetes on a Background of the Angiotensin Converting Enzyme Inhibitor (ACEi) Ramipril: BETWEEN Study|Recruiting||Phase 2|62|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:39:10.779037|2017-10-10 22:39:10.779037
NCT02632734|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-12-14|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CoreBone||The Use of CoreBone Coral Particles vs. Cones for Preservation of Alveolar Bone|Comparison Between CoreBone Coral Particles and CoreBone Coral Cones as Graft After Extraction Sockets for Alveolar Ridge Preservation|Not yet recruiting||N/A|10|Anticipated|The Baruch Padeh Medical Center, Poriya||2|||f||||t||||||||||2017-10-10 22:39:10.880216|2017-10-10 22:39:10.880216
NCT02632721|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-10-02|||June 16, 2016|Actual|2016-06-16|October 2017|2017-10-01|October 12, 2019|Anticipated|2019-10-12|October 12, 2019|Anticipated|2019-10-12||Interventional|||A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)|An Open-label, Phase I/II Trial to Determine the Maximum Tolerated Dose and Investigate Safety, Pharmacokinetics and Efficacy of BI 836858 in Combination With Decitabine in Patients With Acute Myeloid Leukemia|Recruiting||Phase 2|150|Anticipated|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 22:39:10.998258|2017-10-10 22:39:10.998258
NCT02632708|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-07-19|||December 2015||2015-12-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation|A Phase 1, Multicenter, Open-Label, Safety Study of AG-120 or AG-221 in Combination With Induction Therapy and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation|Recruiting||Phase 1|120|Anticipated|Agios Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-10 22:39:11.180314|2017-10-10 22:39:11.180314
NCT02632695|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-03-22|||April 2015||2015-04-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|FOOTFIT||Physical Activity Interventions for Leg Ulcer Patients|Physical Activity Interventions for Leg Ulcer Patients|Recruiting||N/A|40|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 22:39:11.367202|2017-10-10 22:39:11.367202
NCT02632682|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-11-30|||February 2016||2016-02-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|||Confocal Laser Endomicroscopy vs Conventional Histology for the Identification of Intestinal Metaplasia|Real-time Diagnosis of Barrett's Esophagus: Comparing Confocal Laser Endomicroscopy With Conventional Histology for the Identification of Specialized Intestinal Metaplasia|Completed||N/A|172|Actual|Minnesota Institute for Minimally Invasive Surgery|||1||f||||f||||||||No||2017-10-10 22:39:11.494241|2017-10-10 22:39:11.494241
NCT02632669|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-12-17|||November 2013||2013-11-01|December 2015|2015-12-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|HAPpy||Hemi-Ablative Prostate Brachytherapy|A Prospective Stage 2S Clinical Trial Evaluating Hemi-Ablative Low Dose Rate (LDR) Brachytherapy for Localised Prostate Cancer|Recruiting||N/A|34|Anticipated|Royal Surrey County Hospital NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 22:39:11.57574|2017-10-10 22:39:11.57574
NCT02632656|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-02-10|||December 2015||2015-12-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|PEARL-HF||Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study|Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples Without DNA|"     Peripheral blood collected at various time points during CHF therapy, processed for ex-RNAs   "|||2017-10-10 22:39:11.673018|2017-10-10 22:39:11.673018
NCT02632643|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-04-07|||January 2016||2016-01-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Assessment of the Efficacy of a Sensorimotor Approach After Maximum Three Sessions in Subjects With TMD With Hypertonia|Assessment of the Efficacy of a Sensorimotor Approach After Maximum Three Sessions in Subjects With Symptomatic Temporomandibular Dysfunction (TMD) With Hypertonia: A Prospective, Multicenter Case Study.|Active, not recruiting||N/A|110|Actual|Osteovox||1|||f||||f||||||||||2017-10-10 22:39:11.915142|2017-10-10 22:39:11.915142
NCT02632630|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-03-21|||March 2016||2016-03-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NutriSuP||Nutrition Supplementation in Hospitalized Patients|Nutrition Supplementation in Hospitalized Patients: A Randomized Controlled Trial|Recruiting||Phase 2|100|Anticipated|Lawson Health Research Institute||4|||f||||f||||||||||2017-10-10 22:39:12.02935|2017-10-10 22:39:12.02935
NCT02632617|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-09-17|||December 2015||2015-12-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01|30 Days|Observational [Patient Registry]|REPLACE||coRonary assEssment of Preoperative vaLvulopathy pAtients Using ComputEd Tomographic Angiography (REPLACE)|coRonary assEssment of Preoperative vaLvulopathy pAtients Using ComputEd Tomographic Angiography (REPLACE)|Recruiting||N/A|2644|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||2||f||||t||||||||Yes||2017-10-10 22:39:12.183718|2017-10-10 22:39:12.183718
NCT02632604|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-15|||January 2014||2014-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Computerized Cognitive Training for the Elderly|Computerized Cognitive Training for the Elderly|Recruiting||N/A|150|Anticipated|Universidade Federal do Rio de Janeiro||3|||f||||f||||||||||2017-10-10 22:39:12.344585|2017-10-10 22:39:12.344585
NCT02632578|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-15|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|||Influenza Vaccine in HIV Study|A Comparison of Immune Responses to the Licensed Trivalent Inactivated Influenza Vaccine in HIV-positive and HIV-negative Subjects|Completed||N/A|57|Actual|University of Melbourne|||2||f||||f||||||Samples With DNA|"     Serum, plasma, peripheral blood mononuclear cells   "|No||2017-10-10 22:39:12.470786|2017-10-10 22:39:12.470786
NCT02632565|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-14|||December 2009||2009-12-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Intra-Articular 0.5 % Lidocaine Injection for Osteoarthritis|Intra-Articular 0.5 % Lidocaine Injection Under Ultrasound Guidance in Chronic Knee Pain Due To Osteoarthritis|Completed||Phase 4|52|Actual|Baskent University||2|||f||||f||||||||No||2017-10-10 22:39:12.571467|2017-10-10 22:39:12.571467
NCT02632552|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-09-26|||February 19, 2018|Anticipated|2018-02-19|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|May 29, 2020|Anticipated|2020-05-29||Interventional|TACT||A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD|A Technology-Assisted Care Transition Intervention for Veterans With Chronic Heart Failure or Chronic Obstructive Pulmonary Disease|Not yet recruiting||N/A|600|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:39:12.671673|2017-10-10 22:39:12.671673
NCT02632539|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-12-12|||January 2016||2016-01-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Air-impingement Manipulation to Clear Subglottic Secretion to Prevent VAP in Prolonged Intubated Patients|Air-impingement Manipulation to Clear Subglottic Secretion to Prevent Ventilator Associated Pneumonia in Prolonged Intubated Patients：a Randomized Controlled Trial|Not yet recruiting||Phase 3|220|Anticipated|Beijing Chao Yang Hospital||2|||f||||f||||||||||2017-10-10 22:39:12.810112|2017-10-10 22:39:12.810112
NCT02632513|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-11|||May 2014||2014-05-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Passive Ultrasonic Irrigation on Success of Primary Endodontic Treatment|Effect of Passive Ultrasonic Irrigation on Success of Primary Endodontic Treatment|Completed||N/A|70|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t||||||||||2017-10-10 22:39:13.137911|2017-10-10 22:39:13.137911
NCT02632500|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-06-09|||April 2016||2016-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MANI-CPR||Manikin Study on Different Protocols of CPR (MANI-CPR)|Multicenter internAtional raNdomized Controlled manIkin Study on Different Protocols of CPR (MANI-CPR)|Recruiting||N/A|576|Anticipated|Pavia nel Cuore||4|||f||||f||||||||||2017-10-10 22:39:13.244487|2017-10-10 22:39:13.244487
NCT02632487|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-04-14|||April 2016||2016-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Wearable Technology to Reduce Sedentary Behavior and CVD Risk in Older Adults|Wearable Technology to Reduce Sedentary Behavior and CVD Risk in Older Adults|Recruiting||N/A|60|Anticipated|University of Florida||2|||f||||t||||||||||2017-10-10 22:39:13.414288|2017-10-10 22:39:13.414288
NCT02632474|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-01-18|||April 2015||2015-04-01|January 2017|2017-01-01||||December 2016|Actual|2016-12-01||Interventional|||ART Drug Dosage Adjustment in HIV-infected Population|ART Drug Dosage Adjustment Using FSCII in Chinese HIV-infected Population|Completed||Phase 4|10|Actual|Shanghai Public Health Clinical Center||1|||f||||f||||||||||2017-10-10 22:39:13.51217|2017-10-10 22:39:13.51217
NCT02632461|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-09-27|||December 2015||2015-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|DIETMobile||Dietary Intervention Examining Tracking With Mobile Devices|The Dietary Intervention Examining Tracking With Mobile Devices Study|Completed||Phase 1|81|Actual|University of South Carolina||2|||f||||f||||||||Undecided||2017-10-10 22:39:13.593862|2017-10-10 22:39:13.593862
NCT02632448|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-10-04|||May 2016||2016-05-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of LY2880070 in Patients With Advanced or Metastatic Cancer|A Phase 1b/2a Two-Part Open-Label Multicenter Study to Evaluate the Safety and Efficacy of LY2880070 as Monotherapy and in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer|Recruiting||Phase 1/Phase 2|93|Anticipated|Esperas Pharma Inc.||6|||f||||f||||||||||2017-10-10 22:39:13.711132|2017-10-10 22:39:13.711132
NCT02632435|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-09-15|||April 2016||2016-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|OTT 15-06||Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.|A Pragmatic Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment OTT 15-06 A Study From the REthinking Clinical Trials Program (REaCT-vascular Access Trastuzumab Study).|Recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 22:39:13.846413|2017-10-10 22:39:13.846413
NCT02632422|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-12-05|||October 2015||2015-10-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||AIH-induced Walking Recovery After Subacute SCI|Intermittent Hypoxia-Induced Recovery of Overground Walking in Persons With Subacute SCI|Recruiting||N/A|125|Anticipated|Emory University||5|||f||||f||||||||||2017-10-10 22:39:13.933172|2017-10-10 22:39:13.933172
NCT02632409|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-10-03|||February 11, 2016|Actual|2016-02-11|October 2017|2017-10-01|May 1, 2020|Anticipated|2020-05-01|April 30, 2020|Anticipated|2020-04-30||Interventional|CheckMate 274||An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer|A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab Versus Placebo in Subjects With High Risk Invasive Urothelial Carcinoma (CheckMate 274: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 274)|Recruiting||Phase 3|640|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:39:14.098893|2017-10-10 22:39:14.098893
NCT02632396|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-11-22|||March 2016||2016-03-01|November 2016|2016-11-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Ixazomib After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission|A Phase I/II Study of MLN9708 as Post-Transplant Maintenance for Patients With Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplant in First Remission|Recruiting||Phase 1/Phase 2|62|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 22:39:15.085013|2017-10-10 22:39:15.085013
NCT02632383|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-04-07|||December 2015||2015-12-01|December 2015|2015-12-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|||Young With Diabetes Type 1 - Test of an mHealth App|Young With Diabetes Type 1 - Test of an mHealth App|Completed||N/A|140|Anticipated|Nordsjaellands Hospital||2|||f||||f||||||||No||2017-10-10 22:39:15.197178|2017-10-10 22:39:15.197178
NCT02627547|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-08|||September 2013||2013-09-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Impact of Training Status on Bioavailability of Flavanones|Impact of Training Status of Endurance Athletes on Bioavailability of Flavanones|Completed||N/A|13|Actual|University of Glasgow||1|||f||||f||||||||||2017-10-10 22:40:15.026857|2017-10-10 22:40:15.026857
NCT02632370|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-08-07|||May 2016||2016-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor|A Multicenter Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor in Patients With Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study|Recruiting||Phase 2|100|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|t|f||||||||2017-10-10 22:39:15.303229|2017-10-10 22:39:15.303229
NCT02632357|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-02-28|||December 2015||2015-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Longitudinal Experimental Study on ULNTT and Cervico-Thoracic Spine Motion Patterns Relationship|Longitudinal Experimental Study on ULNTT1 and Cervico-Thoracic Spine Motion Patterns Relationship|Completed||N/A|23|Actual|University of Milano Bicocca||2|||f||||t||||||||No||2017-10-10 22:39:15.439985|2017-10-10 22:39:15.439985
NCT02632344|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-10-03|||April 2016||2016-04-01|October 2017|2017-10-01|June 2023|Anticipated|2023-06-01|October 2019|Anticipated|2019-10-01||Interventional|||Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement|Pembrolizuamb for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement|Recruiting||Phase 2|22|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:39:15.51826|2017-10-10 22:39:15.51826
NCT02632331|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-14|||January 2009||2009-01-01|December 2015|2015-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825|Pharmacokinetic (PK) Study of ASP8825 - Evaluation of the Effect of Food on the Pharmacokinetics|Completed||Phase 1|18|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 22:39:15.636773|2017-10-10 22:39:15.636773
NCT02632318|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-11-01|||September 2016||2016-09-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Dawn Simulation and Postural Hypotension|Dawn Simulation as a Passive Countermeasure to Postural Hypotension in Healthy Older Adults|Recruiting||Phase 4|36|Anticipated|VA Palo Alto Health Care System||2|||f||||f||||||||Yes|Anonymized individual participant data will be made available upon request following publication of summary data.|2017-10-10 22:39:15.731643|2017-10-10 22:39:15.731643
NCT02632305|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-02-01|||July 2016||2016-07-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer|A Multicentre, Open-label Phase II Study of Nab-paclitaxel in Combination With Gemcitabine + Cisplatin as First Line Treatment in Patients With Unresectable Biliary Tract Cancer|Recruiting||Phase 2|45|Anticipated|AHS Cancer Control Alberta||1|||f||||t||||||||No||2017-10-10 22:39:15.807941|2017-10-10 22:39:15.807941
NCT02632292|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-04-12|||January 2016||2016-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|SUGAR-EVE||EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus|EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus|Terminated||Phase 4|33|Actual|University of Luebeck||2||Slow enrollment|f||||f||||||||||2017-10-10 22:39:15.889819|2017-10-10 22:39:15.889819
NCT02632279|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-11|||November 2015||2015-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Tryptophan Depletion in PD Patients Treated With STN DBS|Tryptophan Depletion in Parkinson's Disease Patients Treated With Deep Brain Stimulation of the Subthalamic Nucleus: Effects on Mood and Motor Functions|Recruiting||N/A|30|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 22:39:15.986375|2017-10-10 22:39:15.986375
NCT02632266|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-11-22|||July 2015||2015-07-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants|Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants|Recruiting||Phase 4|52|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:39:16.097489|2017-10-10 22:39:16.097489
NCT02632253|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-09-27|||January 2016||2016-01-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|January 2020|Anticipated|2020-01-01||Interventional|HIIT-GUCH||Effects of High-intensity Interval Training on Exercise Capacity in Patients With Grown-up Congenital Heart Disease|Effects of High-intensity Interval Training on Exercise Capacity in Patients With Grown-up Congenital Heart Disease (GUCH)|Recruiting||N/A|40|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 22:39:16.224415|2017-10-10 22:39:16.224415
NCT02632240|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-16|||October 2014||2014-10-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Collagen Matrix With Tunnel Technique Compared to CTG for the Treatment of Periodontal Recessions|Collagen Matrix With Tunnel Technique Compared to CTG for the Treatment of Periodontal Recessions - Randomized Clinical Trial|Completed||N/A|28|Actual|Medical University of Silesia||2|||f||||f||||||||||2017-10-10 22:39:16.335934|2017-10-10 22:39:16.335934
NCT02632227|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2016-06-16|||December 2015||2015-12-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Observational|||Fluid Responsiveness Using TFU (Transfontanel Ultrasound) in Children With Congenital Heart Disease|Prediction of Fluid Responsiveness Using TFU (Transfontanel Ultrasound) in Children With Congenital Heart Disease After Cardiac Surgery|Recruiting||N/A|30|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-10 22:39:16.426849|2017-10-10 22:39:16.426849
NCT02632214|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-01-17|||April 2014||2014-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PLASMODY||Plasticity and Cross-modal Interactions in Profoundly Deaf Adults|Plasticity and Cross-modal Interactions for Oral Communication in Profoundly Deaf Adults|Completed||N/A|17|Actual|University Hospital, Grenoble||3|||f||||t||||||||||2017-10-10 22:39:16.497542|2017-10-10 22:39:16.497542
NCT02632201|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-30|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis|A Clinical Study of Adoptive Cellular Immunotherapy Using Pluripotent Killer T Cells Expressing Antibodies for Human Epidermal Growth Factor Receptor-2 (HER2) in Treating Patients With HER2-Positive Advanced Gastric Cancer With Liver Metastasis|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Second Military Medical University||2|||f||||||||||||||2017-10-10 22:39:16.56949|2017-10-10 22:39:16.56949
NCT02632188|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-30|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma|A Controlled Clinic Trial to Survey the Outcome of Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen in Treating Patients Underwent Radical Surgery for Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Second Military Medical University||2|||f||||||||||||||2017-10-10 22:39:16.684577|2017-10-10 22:39:16.684577
NCT02632175|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-08-24|||November 26, 2015||2015-11-26|August 2017|2017-08-01|July 28, 2023|Anticipated|2023-07-28|May 19, 2023|Anticipated|2023-05-19||Interventional|||Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis|A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Ulcerative Colitis Who Completed the Study M11-290|Enrolling by invitation||Phase 3|93|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-10 22:39:16.790294|2017-10-10 22:39:16.790294
NCT02632162|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-07-11|||May 2016||2016-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|SDB-ZRW||Prevalence, Severity and Natural Course of Sleep Apnea After Cardiac Surgery|Prevalence, Severity and Natural Course of Sleep Apnea After Cardiac Surgery|Recruiting||N/A|450|Anticipated|Zürcher RehaZentrum Wald|||2||f||||f||||||||||2017-10-10 22:39:16.886976|2017-10-10 22:39:16.886976
NCT02632149|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2016-10-07|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Trial to Assess Vagus Nerve Stimulation Therapy in Children With Lennox-Gastaut Syndrome|The Clinical Research on PINS Vagus Nerve Stimulator for Treatment of Lennox-Gastaut in Children|Recruiting||Early Phase 1|31|Anticipated|Beijing Pins Medical Co., Ltd||1|||f||||t||||||||||2017-10-10 22:39:16.993506|2017-10-10 22:39:16.993506
NCT02632136|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-15|||November 2015||2015-11-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Lap TAP Block for Laparoscopic TEP Inguinal Hernia Repair: a Prospective, Double-blinded, Randomized, Clinical Trial|Laparoscopic-assisted Transversus Abdominis Plane (TAP) Block for Laparoscopic Total Extra Peritoneal (TEP) Inguinal Hernia Repair: a Prospective, Double-blinded, Randomized, Clinical Trial|Recruiting||Phase 3|86|Anticipated|Mayo General Hospital, Ireland||2|||f||||t||||||||Yes||2017-10-10 22:39:17.095857|2017-10-10 22:39:17.095857
NCT02632123|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2017-02-23|||December 2015||2015-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis|Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis|Recruiting||N/A|500|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-10 22:39:17.187599|2017-10-10 22:39:17.187599
NCT02632097|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2017-03-01|||March 2013||2013-03-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|Histoacryl1||Histoacryl™ vs. Suture for Mesh Fixation in Lichtenstein Hernioplasty: A Randomized Prospective Double-Blinded Study|Randomized Prospective Double-Blinded Study of Histoacryl™Mesh Fixation Compared to Conventional Non-absorbable Suture Fixation During Lichtenstein Hernioplasty|Completed||N/A|370|Actual|Hospital Plató||2|||f||||f||||||||No||2017-10-10 22:39:17.602469|2017-10-10 22:39:17.602469
NCT02632084|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-11|||March 2010||2010-03-01|December 2015|2015-12-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Observational|||Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours|Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours|Completed||N/A|30|Actual|The Leeds Teaching Hospitals NHS Trust|||1||f||||||||||||||2017-10-10 22:39:17.71939|2017-10-10 22:39:17.71939
NCT02632071|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-08-24|||February 2016||2016-02-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer|Multi-center Phase IB Trial of ACY-1215 (Ricolinostat) Combined With Nab-paclitaxel in Unresectable or Metastatic Breast Cancer|Recruiting||Phase 1|24|Anticipated|Columbia University||4|||f||||t||||||||||2017-10-10 22:39:17.794077|2017-10-10 22:39:17.794077
NCT02632058|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-14|||August 2015||2015-08-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Observational|||Efficacy of Treatment for Tinnitus|Efficacy of Treatment for Tinnitus Based on Cognitive Behavioural Therapy in an Inpatient Setting: a 10-year Retrospective Outcome Analysis|Active, not recruiting||N/A|500|Anticipated|Psychiatrische Dienste Graubuenden|||1||f||||t||||||||No||2017-10-10 22:39:17.917652|2017-10-10 22:39:17.917652
NCT02632045|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer|A Randomized Phase II Trial of Fulvestrant With or Without Ribociclib After Progression on Aromatase Inhibition Plus Cyclin-dependent Kinase 4/6 Inhibition in Patients With Unresectable or Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer|Recruiting||Phase 2|132|Anticipated|Columbia University||2|||f||||t|t|f||||||||2017-10-10 22:39:17.99589|2017-10-10 22:39:17.99589
NCT02632019|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2015-12-30|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract|A Clinical Study of Adoptive Cellular Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen in Treating Patients With Advanced Malignant Tumor of Biliary Tract|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Second Military Medical University||2|||f||||||||||||||2017-10-10 22:39:18.261797|2017-10-10 22:39:18.261797
NCT02632006|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2015-12-30|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma|A Clinical Study of Adoptive Cellular Immunotherapy Using Pluripotent Killer T Cells Expressing Antibodies for Programmed Death 1 (PD-1) in Treating Patients With Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Second Military Medical University||2|||f||||||||||||||2017-10-10 22:39:18.410365|2017-10-10 22:39:18.410365
NCT02631993|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-12-11|||October 2014||2014-10-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Photochemotherapy and Graft-versus-leukemia in Acute-leukemia|Photochemotherapy of Acute Graft-versus-host Disease (aGVHD) of the Skin - is Graft-versus-leukemia Preserved in Patients Transplanted for Acute Leukemia?|Completed||N/A|47|Actual|Karolinska University Hospital|||1||f||||f||||||||||2017-10-10 22:39:18.54111|2017-10-10 22:39:18.54111
NCT02631980|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-05-04|||October 2015||2015-10-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|HepciFer||HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?|Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?|Completed||Phase 3|50|Actual|University Hospital, Geneva||2|||f||||t||||||||No||2017-10-10 22:39:18.643873|2017-10-10 22:39:18.643873
NCT02631967|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2017-02-13|||November 2015||2015-11-01|February 2017|2017-02-01|November 2022|Anticipated|2022-11-01|November 2017|Anticipated|2017-11-01||Interventional|SuPREMeCD||Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease|A New Anastomotic Technique After Ileocecal Resection for Crohn's Disease. Kono-s Anastomosis vs Stapled Side-to-side Anastomosis: a Randomized Controlled Trial|Recruiting||N/A|132|Anticipated|Federico II University||2|||f||||f||||||||||2017-10-10 22:39:18.73993|2017-10-10 22:39:18.73993
NCT02631954|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-13|2016-01-06|||September 2015||2015-09-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers||Completed||Phase 1|24|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:39:18.847495|2017-10-10 22:39:18.847495
NCT02631941|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-09-28|||January 2016||2016-01-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Clinical Study to Evaluate Z7200 Pharmacokinetics Profile|An Open-Label, Randomized, Five-Period Cross-over, Single-dose Study to Compare Pharmacokinetics Profiles of Z7200 Midium Strength and Symbicort Turbohaler, With and Without Charcoal Blockade in Healthy Volunteers.|Completed||Phase 1|91|Actual|Zambon SpA||5|||f||||f||||||||||2017-10-10 22:39:18.945859|2017-10-10 22:39:18.945859
NCT02631928|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-08-01|||February 2016||2016-02-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III|Single-center, Randomized, Double-blind, 2-treatment, 2-period Crossover Trial in Healthy Subjects to Demonstrate PK Bioequivalence and to Compare the PD Properties of Julphar Insulin 30/70 and Huminsulin® Profil III|Completed||Phase 1|73|Actual|Julphar Gulf Pharmaceutical Industries||2|||f||||f||||||||||2017-10-10 22:39:19.049073|2017-10-10 22:39:19.049073
NCT02631902|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2017-05-02|||October 2015||2015-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Diabetes em Movimento® - Community-based Lifestyle Intervention Program for Patients With Type 2 Diabetes|Diabetes em Movimento® - Community-based Lifestyle Intervention Program for Patients With Type 2 Diabetes: Effects on Health and Well-being|Active, not recruiting||N/A|90|Actual|University of Trás-os-Montes and Alto Douro||3|||f||||f||||||||||2017-10-10 22:39:19.152682|2017-10-10 22:39:19.152682
NCT02631889|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-12|||March 2016||2016-03-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Study to Assess the Effectiveness of Transcollation Technology to Reduce Bleeding in Lung Surgery|A Prospective, Randomized, Controlled Study to Assess the Effectiveness of Transcollation Technology to Reduce Bleeding in Lung Surgery|Not yet recruiting||N/A|170|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||Undecided||2017-10-10 22:39:19.25115|2017-10-10 22:39:19.25115
NCT02631876|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-09-06|||November 2016||2016-11-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|FORWARD I||PH3 Study of Mirvetuximab Soravtansine vs Investigator's Choice of Chemotherapy in Women With FRa+ Adv. EOC, Primary Peritoneal or Fallopian Tube Cancer|FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer|Recruiting||Phase 3|333|Anticipated|ImmunoGen, Inc.||2|||f||||t||||||||||2017-10-10 22:39:19.348827|2017-10-10 22:39:19.348827
NCT02631863|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2017-04-14|||February 2016||2016-02-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)|A Pilot Study of Photodynamic Therapy (PDT) Using Aminolaevulinic Acid (ALA) in Patients With HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)|Recruiting||Phase 2|60|Anticipated|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||2|||f||||f||||||||||2017-10-10 22:39:19.717224|2017-10-10 22:39:19.717224
NCT02631850|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-03-23|||November 2015||2015-11-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effectiveness of Virtual Reality Gaming Therapy Versus CI Therapy for Upper Extremity Rehabilitation|Video Game Rehabilitation for Outpatient Stroke (VIGoROUS): A Multi-center Comparative Effectiveness Trial of In-home Gamified Constraint-induced Movement Therapy for Rehabilitation of Chronic Upper Extremity Hemiparesis.|Recruiting||N/A|224|Anticipated|Ohio State University||4|||f||||f||||||||Yes|Data will be made public 1 year after study completion.|2017-10-10 22:39:19.807889|2017-10-10 22:39:19.807889
NCT02631837|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-08-18|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|July 15, 2017|Actual|2017-07-15|February 24, 2017|Actual|2017-02-24||Interventional|HALON||Hysterectomy by Transabdominal Laparoscopy or NOTES|Hysterectomy for Benign Gynaecological Disease by Natural Orifice Transluminal Endoscopic Surgery or Laparoscopy|Completed||N/A|70|Actual|Imelda Hospital, Bonheiden||2|||f||||t||||||||||2017-10-10 22:39:19.931106|2017-10-10 22:39:19.931106
NCT02631824|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-09-11|||November 2015||2015-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|AFIF||Radiologic and Clinical Outcomes of Augmentation in Fragility Intertrochanteric Hip Fracture Treatment|Radiologic and Clinical Outcomes of Augmentation in Fragility Intertrochanteric Hip Fracture Treatment: A Randomized Multicenter Clinical Trial|Recruiting||N/A|90|Anticipated|Hospital Infantil Universitario de San Jose||2|||f||||f||||||||No||2017-10-10 22:39:20.033534|2017-10-10 22:39:20.033534
NCT02631811|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-06-07|||November 2015||2015-11-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Interventional|Pablo Hemato||Early Palliative Care in Patient With Acute Leukaemia|Impact on Quality of Life of an Early Management Supportive Care of Patients With Acute Leukemia in First Relapse.|Recruiting||N/A|80|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||No||2017-10-10 22:39:20.181691|2017-10-10 22:39:20.181691
NCT02631798|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-02-17|||December 2015||2015-12-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Chromocolonoscopy With Food-grade Dyes|Mucosal Staining After Oral Administration of Food Grade Dyes in Subjects Undergoing Outpatients Colonoscopy|Recruiting||N/A|30|Anticipated|University of Schleswig-Holstein||1|||f||||f||||||||||2017-10-10 22:39:20.271342|2017-10-10 22:39:20.271342
NCT02631785|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-15|||February 2016||2016-02-01|December 2015|2015-12-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|FCPA||Fear Conditioning, Extinction and Its Recall in Anxious Youth|Fear Conditioning, Extinction and Its Recall in Anxious Youth: Identifying Neuro- Cognitive Abnormalities and Their Relation to Pediatric Anxiety Treatment Outcomes|Not yet recruiting||N/A|60|Anticipated|University of Haifa||2|||f||||f||||||||||2017-10-10 22:39:20.348051|2017-10-10 22:39:20.348051
NCT02631772|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-12-01|||June 2016||2016-06-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients|LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients|Recruiting||Phase 4|230|Anticipated|Medical University of South Carolina||4|||f||||t||||||||||2017-10-10 22:39:20.444459|2017-10-10 22:39:20.444459
NCT02631759|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-10-03|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|November 2016|Anticipated|2016-11-01||Interventional|PEACH||Prevention of Epileptic Seizures in Acute intraCerebral Haemorrhage|Prevention of Epileptic Seizures in Acute intraCerebral Haemorrhage|Not yet recruiting||Phase 3|104|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:39:20.55088|2017-10-10 22:39:20.55088
NCT02631746|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-15|2017-07-26|||June 3, 2016|Actual|2016-06-03|July 2017|2017-07-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma|Phase II Trial of Nivolumab for HTLV-Associated Adult T Cell Leukemia/Lymphoma|Recruiting||Phase 2|20|Anticipated|National Cancer Institute (NCI)||1|||||||f||||||||||2017-10-10 22:39:20.644452|2017-10-10 22:39:20.644452
NCT02631720|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-11-23|||December 2015||2015-12-01|November 2016|2016-11-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||CLAD Phenotype Specific Risk Factors and Mechanisms.|A Prospective Multicenter Observational Cohort Study to Define the Risks Factors, Mechanisms, and Manifestations of Chronic Lung Allograft Dysfunction (CLAD) Phenotypes (CTOT-20).|Recruiting||N/A|800|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     Peripheral whole blood samples: DNA, RNA, Plasma, Serum Bronchoalveolar lavage (BAL):     aliquots with DNA, cells, supernatant   "|||2017-10-10 22:39:21.017985|2017-10-10 22:39:21.017985
NCT02631707|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-12-11|||May 2015||2015-05-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of High Protein Diets on Weight Loss and Lean Muscle Mass in Patients Awaiting Bariatric Surgery|The Effect of High Protein Diets on Weight Loss and Lean Muscle Mass in Patients Awaiting Bariatric Surgery|Recruiting||N/A|24|Anticipated|University of Auckland, New Zealand||2|||f||||t||||||||||2017-10-10 22:39:21.155164|2017-10-10 22:39:21.155164
NCT02631694|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-11|||April 2016||2016-04-01|December 2015|2015-12-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Disruption of Memory Reconsolidating as a Treatment for Panic Disorder|Targeting Fear Memory by Disrupting the Process of Reconsolidating: A New Intervention for Panic Disorder|Not yet recruiting||Phase 2|60|Anticipated|VU University of Amsterdam||3|||f||||||||||||||2017-10-10 22:39:21.26582|2017-10-10 22:39:21.26582
NCT02631681|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-08-15|||August 2014||2014-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation Therapy|Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation Therapy|Recruiting||N/A|230|Anticipated|Herlev Hospital||1|||f||||f||||||||No||2017-10-10 22:39:21.357567|2017-10-10 22:39:21.357567
NCT02631668|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2016-08-15|||January 2016||2016-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients|The Efficacy and Safety of Vitamin C for Iron Supplementation Therapy in Adult Patients With Iron Deficiency Anemia(IDA)|Recruiting||Phase 4|600|Anticipated|Huashan Hospital||3|||f||||f||||||||No||2017-10-10 22:39:21.463353|2017-10-10 22:39:21.463353
NCT02631655|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-04-26|||December 2015||2015-12-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|POSEIDON||POSitron Emission Imaging Using 18F-FDOPA in Neurooncology|Study of the Impact of 18F-FDOPA Positon Emission Tomography on Therapeutic Proposals Made at Neurooncology Multidisciplinary Case Conferences|Recruiting||N/A|110|Anticipated|Centre Antoine Lacassagne||1|||f||||f||||||||||2017-10-10 22:39:21.591272|2017-10-10 22:39:21.591272
NCT02631642|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-08-15|||March 23, 2016|Actual|2016-03-23|August 2017|2017-08-01|February 28, 2017|Actual|2017-02-28|October 26, 2016|Actual|2016-10-26||Interventional|||A Study of HMPL-689 in Healthy Volunteers|A Phase I,Randomized,Double Blinded,Placebo-controlled,Dose-escalating Study of the Safety,Tolerability and Pharmacokinetics of HMPL-689 in Healthy Volunteers|Completed||Phase 1|48|Actual|Hutchison Medipharma Limited||2|||f||||f||||||||||2017-10-10 22:39:21.677111|2017-10-10 22:39:21.677111
NCT02631616|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-11|||February 2016||2016-02-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET|Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET|Not yet recruiting||Phase 1|30|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||Undecided||2017-10-10 22:39:21.877921|2017-10-10 22:39:21.877921
NCT02631603|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2017-09-30|||April 2015||2015-04-01|September 2017|2017-09-01|April 2024|Anticipated|2024-04-01|April 2023|Anticipated|2023-04-01||Interventional|chILD-EU_EAA||Stop Exogenous Allergic Alveolitis (EAA) in Childhood|Stop Exogenous Allergic Alveolitis (EAA) in Childhood: Healthy Into Adulthood - A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Prednisolone Treatment and Course of Disease|Suspended||Phase 2|45|Anticipated|Ludwig-Maximilians - University of Munich||2||funding pending|f||||t||||||||||2017-10-10 22:39:21.967762|2017-10-10 22:39:21.967762
NCT02631590|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-07-28|||June 28, 2016|Actual|2016-06-28|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma|Phase II Study of Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma|Recruiting||Phase 2|25|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-10 22:39:22.09961|2017-10-10 22:39:22.09961
NCT02631577|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2017-10-02|||December 31, 2015|Actual|2015-12-31|October 2017|2017-10-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Obinutuzumab Plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma|A PHASE Ib/II STUDY EVALUATING THE SAFETY AND EFFICACY OF ATEZOLIZUMAB IN COMBINATION WITH OBINUTUZUMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA|Suspended||Phase 1|46|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:39:22.279673|2017-10-10 22:39:22.279673
NCT02631564|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-14|2015-12-14|||June 2015||2015-06-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01|12 Months|Observational [Patient Registry]|||Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis|An Observational Study of TACE Hepatic Arterial Infusion of Oxaliplatin, Irinotecan and Raltitrexed Treatment for Refractory Liver Metastasis From Colorectal Cancer|Recruiting||N/A|200|Anticipated|Fudan University|||1||f||||t||||||||Undecided||2017-10-10 22:39:22.477892|2017-10-10 22:39:22.477892
NCT02631551|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-05-17||2017-05-17|March 2016||2016-03-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|GSP 301-301||Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)|A Double-Blind, Randomized, Parallel-Group, Comparative Study to Evaluate the Efficacy, Safety and Tolerability of a Fixed Dose Combination GSP 301 Nasal Spray (NS) Compared With Placebo Nasal Spray and Individual Monotherapy Formulations (Comparators) in Subjects (Aged 12 Years and Older) With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 3|1176|Actual|Glenmark Specialty S.A.||4|||f||||||||||||||2017-10-10 22:39:22.613045|2017-10-10 22:39:22.613045
NCT02631525|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-11|||August 2014||2014-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Recovery Profile Comparison Between Remifentanil-propofol or Desflurane Anesthesia Monitored With Bispectral Index.|A Comparison of Post-operative Recovery Between Remifentanil-propofol and Remifentanil-desflurane Anesthesia Guided by Bispectral Index Monitoring|Completed||Phase 4|40|Actual|Federal University of Minas Gerais||2|||f||||f||||||||Undecided||2017-10-10 22:39:23.721917|2017-10-10 22:39:23.721917
NCT02631512|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-07-22|||October 2015||2015-10-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Woulgan in Diabetic Foot Ulcer|Evaluation of Woulgan in Diabetic Foot Ulcer Compared With a Commercial Hydrogel|Recruiting||Phase 4|80|Anticipated|Biotec Pharmacon ASA||2|||f||||f||||||||||2017-10-10 22:39:23.821453|2017-10-10 22:39:23.821453
NCT02631499|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-20|||December 2015||2015-12-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation|Post-hepatectomy Adjuvant Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Preoperative CTC Level ≥2: a Multicenter Randomized Controlled Trial in China|Not yet recruiting||Phase 4|256|Anticipated|Fudan University||2|||f||||f||||||||Undecided||2017-10-10 22:39:23.912175|2017-10-10 22:39:23.912175
NCT02631486|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-10-18|||April 2016||2016-04-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Does Early Mobilisation Improve Outcomes After Rotator Cuff Repair?|Does Early Mobilisation After Surgical Repair of Rotator Cuff Tears Improve Biomechanical and Clinical Outcomes?|Recruiting||N/A|34|Anticipated|University of Central Lancashire||2|||f||||t||||||||No||2017-10-10 22:39:24.07282|2017-10-10 22:39:24.07282
NCT02631473|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-12-06|||November 2015||2015-11-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Interventional|||PK of Efavirenz & Lopinavir Nano-formulations in Healthy Volunteers|Pharmacokinetics of Efavirenz and Lopinavir Nano-formulations in HIV Negative Healthy Volunteers: an Adaptive Design Study|Suspended||Phase 1|50|Anticipated|St Stephens Aids Trust||6||Study is on hold whilst a grant application for further funding is put together|f||||t||||||||||2017-10-10 22:39:24.161898|2017-10-10 22:39:24.161898
NCT02631460|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2015-12-15|||December 2015||2015-12-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|||S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC|A Randomized Phase II Study of S1 Plus Carboplatin Followed by Maintenance S1versus Pemetrexed Plus Carboplatin Followed by Maintenance Pemetrexed in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer|Recruiting||Phase 2|470|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:39:24.292916|2017-10-10 22:39:24.292916
NCT02631447|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-04-20|||November 2016|Actual|2016-11-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|April 2021|Anticipated|2021-04-01||Interventional|SECOMBIT||Sequential Combo Immuno and Target Therapy (SECOMBIT) Study|A Three Arms Prospective, Randomized Phase II Study to Evaluate the Best Sequential Approach With Combo Immunotherapy (Ipilimumab/Nivolumab) and Combo Target Therapy (LGX818/MEK162) in Patients With Metastatic Melanoma and BRAF Mutation|Recruiting||Phase 2|230|Anticipated|Fondazione Melanoma Onlus||3|||f||||t||||||||No||2017-10-10 22:39:24.400204|2017-10-10 22:39:24.400204
NCT02631434|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-11|||August 2013||2013-08-01|December 2015|2015-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Comparison Between Sit-to-stand Test and Six-minute Walk Test in Chronic Obstructive Pulmonary Disease||Completed||N/A|20|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-10 22:39:24.688383|2017-10-10 22:39:24.688383
NCT02631421|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-08-02|||January 2015||2015-01-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH|Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH|Recruiting||N/A|60|Anticipated|Vanderbilt University Medical Center|||2||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 22:39:24.764686|2017-10-10 22:39:24.764686
NCT02631408|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-12|2017-10-03|||August 2015||2015-08-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|iVRCT||Intrawound Vancomycin Powder in Spinal Fusion Surgery|Application of Intrawound Vancomycin Powder to Reduce Surgical Site Infections in Spinal Fusion Surgery - A Prospective, Randomized, Controlled Trial|Recruiting||Phase 4|440|Anticipated|Orthopedic Hospital Vienna Speising||2|||f||||f||||||||||2017-10-10 22:39:24.855952|2017-10-10 22:39:24.855952
NCT02631395|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-01-27|||September 2014||2014-09-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of a Shoulder Training Program to Prevent Shoulder Pain Among Girls in Junior Team Handball|The Effect of a Shoulder Training Program to Prevent Shoulder Pain Among Girls in Junior Team Handball|Completed||N/A|106|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||No||2017-10-10 22:39:24.941095|2017-10-10 22:39:24.941095
NCT02631382|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-09-20|||November 2015||2015-11-01|December 2015|2015-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Wet Cupping (AlHijamah); Double Versus Single Cupping Technique|Wet Cupping (AlHijamah); Double Versus Single Cupping Technique in Chronic Low Back Pain Patients: Randomized Comparative Clinical Trial, Pilot Study Saudi Arabia, 2015|Completed||N/A|70|Actual|National Center for Complementary and Alternative Medicine, Saudi Arabia||2|||f||||f||||||||Undecided||2017-10-10 22:39:25.019552|2017-10-10 22:39:25.019552
NCT02631369|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-05-03|||December 2015||2015-12-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CySLO||Measuring Cyclotorsion on Scanning Laser Ophthalmoscopy (SLO)-Fundus Photographs|Measuring Cyclotorsion on Scanning Laser Ophthalmoscopy (SLO)-Fundus Photographs Using the Integrated Algorithm by Heidelberg Spectralis|Recruiting||N/A|80|Anticipated|University of Zurich||3|||f||||f||||||||||2017-10-10 22:39:25.111277|2017-10-10 22:39:25.111277
NCT02631356|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-16|||November 2015||2015-11-01|December 2015|2015-12-01||||May 2016|Anticipated|2016-05-01||Interventional|||The Effect of Succinylated Gelatin on the Blood Viscosity and Oxygen Delivery||Recruiting||Phase 4|12|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 22:39:25.214554|2017-10-10 22:39:25.214554
NCT02631343|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-02-16|||December 2015||2015-12-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|CKMC-DEV||Community Kangaroo Mother Care for Improving Child Survival and Brain Development in Low Birth Weight Newborns|A Community-based Model of Delivery of Kangaroo Mother Care for Improving Child Survival and Brain Development in Low Birth Weight Newborns|Recruiting||N/A|550|Anticipated|Society for Applied Studies||2|||f||||f||||||||||2017-10-10 22:39:25.32014|2017-10-10 22:39:25.32014
NCT02631330|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-12|||December 2015||2015-12-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|FAREMAVA||Effect on Falls Reduction of a Multimodal Intervention in Frail and Pre-frail Elderly Community-dwelling People|Effect on Falls Reduction of a Multimodal Intervention in Frail and Pre-frail Elderly Community-dwelling People in Madeira Island (Portugal) and Valencia (Spain)|Recruiting||Phase 3|466|Anticipated|Hospital de la Ribera||2|||f||||t||||||||||2017-10-10 22:39:27.256563|2017-10-10 22:39:27.256563
NCT02631317|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2016-02-04|||July 2014||2014-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|3 Months|Observational [Patient Registry]|PROMISE||Hospital Processes Reengineering of Intravenous Thrombolysis in Acute Ischemic Stroke in China|Hospital Processes Reengineering of Intravenous Thrombolysis in Acute Ischemic Stroke in China|Completed||N/A|2178|Actual|First Affiliated Hospital of Jinan University|||1||f||||t||||||||||2017-10-10 22:39:27.385291|2017-10-10 22:39:27.385291
NCT02631304|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-10-04|||July 2015||2015-07-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|DECCEP||Delirium in Elderly Undergoing Cardiac Surgery and the Significance of CholinEsterase Activity|Delirium in Elderly Undergoing Cardiac Surgery and the Significance of CholinEsterase Activity Measured by Point of Care Method - a Prospective Observational Study|Active, not recruiting||N/A|100|Anticipated|RWTH Aachen University|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:39:27.477524|2017-10-10 22:39:27.477524
NCT02631291|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-06-13|||November 2015||2015-11-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Promoting Widowed Elders Lifestyle After Loss|A Randomized Pilot Study of Behavioral Self-monitoring to Promote Mental Health Among Spousally Bereaved Older Adults|Recruiting||N/A|60|Anticipated|University of Pittsburgh||3|||f||||t||||||||No||2017-10-10 22:39:27.627165|2017-10-10 22:39:27.627165
NCT02631278|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-12-11|||December 2014||2014-12-01|December 2015|2015-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|RFA||Radio Frequency Ablation (RFA STUDY )|Tissue Effect in Extirpated Uterine Fibroid Tissue Using Existing Olympus Radiofrequency Probes for Fibroids Ablation (Radio Frequency Ablation RFA STUDY )|Recruiting||N/A|10|Anticipated|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-10 22:39:27.745726|2017-10-10 22:39:27.745726
NCT02631265|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-09-12|||January 2016||2016-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Insulin-based Strategies to Prevent Hypoglycemia During Exercise|Reduction of Basal Insulin to Prevent Hypoglycemia During Exercise in Adults With Type 1 Diabetes Using Insulin Pump Therapy|Completed||N/A|22|Actual|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-10 22:39:27.858348|2017-10-10 22:39:27.858348
NCT02631252|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-07-26|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia|A Phase I Study of Combination Chemotherapy With Mitoxantrone and Etoposide (VP-16) Combined With an Autophagy Inhibitor, Hydroxychloroquine (HCQ), for the Treatment of Patients With Relapsed Acute Myelogenous Leukemia (AML)|Recruiting||Phase 1|36|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 22:39:27.962256|2017-10-10 22:39:27.962256
NCT02631239|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2016-10-08|||November 2015||2015-11-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Interventional|||MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma|The Efficacy and Safety of Etoposide, Dexamethasone, Peg-asparaginase or Plus Methotrexate With Sandwiched Radiotherapy in the Treatment of Stage I to II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type|Recruiting||Phase 3|256|Anticipated|Ruijin Hospital||2|||f||||f||||||||||2017-10-10 22:39:28.082401|2017-10-10 22:39:28.082401
NCT02631226|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-02-10|||February 2016||2016-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|EME||Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted to the Hospital.|Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted in the Hospital: a Multicenter Study (EME Study).|Recruiting||N/A|580|Anticipated|Corporacion Parc Tauli|||1||f||||t||||||||Undecided||2017-10-10 22:39:28.182901|2017-10-10 22:39:28.182901
NCT02631213|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-05|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:39:28.419046|2017-10-10 22:39:28.419046
NCT02631200|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-04-03|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|ACREDiT||Advance Care Planning With Older Patients Who Have End-stage Kidney Disease|Advance Care Planning With Older Patients Who Have End-stage Kidney Disease: Feasibility of a Deferred Entry Randomised Controlled Trial Incorporating a Mixed Methods Process Evaluation|Recruiting||N/A|80|Anticipated|Queen's University, Belfast||2|||f||||f||||||||Undecided||2017-10-10 22:39:28.471267|2017-10-10 22:39:28.471267
NCT02631187|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-21|||March 2016||2016-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|BET||Feasibility Study of Balloon Eustachian Tuboplasty (BET)|Feasibility Study of Balloon Eustachian Tuboplasty (BET) for Grade 2 and 3 Pars Tensa Retractions|Recruiting||N/A|20|Anticipated|Plymouth Hospitals NHS Trust||1|||f||||f||||||||Undecided||2017-10-10 22:39:28.607664|2017-10-10 22:39:28.607664
NCT02631174|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-12-11|||June 2015||2015-06-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support|Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support|Recruiting||Phase 1|42|Anticipated|Children's Hospital Medical Center, Cincinnati||5|||f||||t||||||||||2017-10-10 22:39:28.716817|2017-10-10 22:39:28.716817
NCT02631161|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-11|||November 2015||2015-11-01|December 2015|2015-12-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions|Randomized Controlled Trial on Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions|Recruiting||N/A|130|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 22:39:28.859016|2017-10-10 22:39:28.859016
NCT02631148|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-03-07|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MAST||Effects of Melatonin Supplementation on Renal Physiology in a Habitual Sleep Restricted Population.|Effects of Melatonin Supplementation on Renal Physiology in a Habitual Sleep Restricted Population.|Recruiting||Phase 3|80|Anticipated|Brigham and Women's Hospital||2|||f||||t|t|f|||t|||No||2017-10-10 22:39:28.977581|2017-10-10 22:39:28.977581
NCT02631122|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-08-12|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Supraclavicular Block vs Retroclavicular Block: Incidence of Phrenic Nerve Paralysis|Ultrasound Guided Supraclavicular Brachial Plexus Block vs Retroclavicular Brachial Plexus Block: Comparison of Impact on Ipsilateral Diaphragmatic Function|Recruiting||N/A|80|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:39:29.250863|2017-10-10 22:39:29.250863
NCT02631109|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-08-03|||December 2015||2015-12-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|||L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis|L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis|Recruiting||Phase 3|120|Anticipated|Beijing Friendship Hospital||1|||f||||t||||||||||2017-10-10 22:39:29.38237|2017-10-10 22:39:29.38237
NCT02631096|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-04-12|||December 2015||2015-12-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy|A Phase 2a Single-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety, Anti Viral Activity, and Pharmacokinetics of ARB-001467 in Non Cirrhotic, HBeAg Negative and Positive Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy|Recruiting||Phase 2|36|Anticipated|Arbutus Biopharma Corporation||4|||f||||t||||||||Undecided||2017-10-10 22:39:29.51959|2017-10-10 22:39:29.51959
NCT02631083|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-08-01|||November 14, 2014|Actual|2014-11-14|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||The Influence of Glucose Flux on Fat Synthesis in a Whole Body Calorimeter|The Impact of a Low Glycaemic Index (GI) Diet on Daily Blood Glucose Profiles and Energy Flux in Male Chinese Adults.|Completed||N/A|15|Actual|Clinical Nutrition Research Centre, Singapore||2|||f||||f||||||||||2017-10-10 22:39:29.677826|2017-10-10 22:39:29.677826
NCT02630537|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-10|||October 2011||2011-10-01|December 2015|2015-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients|Clinical Validation of Lophius Kits T-Track® CMV and T-Track® EBV to Assess the Functionality of Cell-mediated Immunity (CMI) in Hemodialysis Patients|Completed||N/A|133|Actual|Lophius Biosciences GmbH|||1||f||||||||||||||2017-10-10 22:39:34.873756|2017-10-10 22:39:34.873756
NCT02631070|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-09-28|||February 9, 2016|Actual|2016-02-09|September 2017|2017-09-01|June 25, 2019|Anticipated|2019-06-25|June 25, 2019|Anticipated|2019-06-25||Interventional|MEDALIST||A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes|A Phase 3, Double-blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo for the Treatment of Anemia Due to the IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in Subjects With Ring Sideroblasts Who Require Red Blood Cell Transfusions.|Active, not recruiting||Phase 3|229|Actual|Celgene||2|||f||||t||||||||||2017-10-10 22:39:29.771361|2017-10-10 22:39:29.771361
NCT02631044|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-09-26|||December 2015||2015-12-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (NHL)|A Phase 1, Multicenter, Open-Label Study of JCAR017, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells, for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL)|Recruiting||Phase 1|274|Anticipated|Juno Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 22:39:30.134048|2017-10-10 22:39:30.134048
NCT02631031|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-08-14|||November 2015||2015-11-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|||Chronopharmacology of Valsartan in Normotensive Subjects|A Comparative Pharmacokinetic and Pharmacodynamic Study of Morning Versus Evening Administration of Valsartan in Healthy Adults|Completed||Phase 1|24|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-10 22:39:30.455368|2017-10-10 22:39:30.455368
NCT02631018|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-04-17|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Sisters in Health: A Weight Loss Study for African American Women|Sisters in Health: A Weight Loss Study for African American Women|Completed||N/A|84|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 22:39:30.562167|2017-10-10 22:39:30.562167
NCT02631005|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-04-28|||March 2016||2016-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Walk SLE||Walk With Ease Program For Patients With Systemic Lupus Erythematosus|Walk With Ease Program For Patients With Systemic Lupus Erythematosus|Recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t||||||||No||2017-10-10 22:39:30.658808|2017-10-10 22:39:30.658808
NCT02630992|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-09-15|||December 2015||2015-12-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|December 2016|Actual|2016-12-01||Interventional|||Reduced Clavulanate Formulation of Amoxicillin-Clavulanate in Children 6-23 Months With Acute Otitis Media|Reduced Clavulanate Formulation of Amoxicillin-Clavulanate in Children 6-23 Months With Acute Otitis Media|Completed||Phase 3|70|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 22:39:30.780838|2017-10-10 22:39:30.780838
NCT02630979|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-03-26|||November 2015||2015-11-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Oncologists Satisfaction With Outcomes of Some Cytotoxic Agents|Prospective Observational Questionnaire Based Study Measuring Oncology Physicians Knowledge and Satisfaction With the Outcomes of Expensive Cytotoxic Agents|Recruiting||N/A|150|Anticipated|Ain Shams University|||1||f||||t||||||Samples Without DNA|"     No biospecimen   "|Yes||2017-10-10 22:39:30.889863|2017-10-10 22:39:30.889863
NCT02630966|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-09-08|||August 10, 2016|Actual|2016-08-10|September 2017|2017-09-01|March 9, 2019|Anticipated|2019-03-09|November 3, 2018|Anticipated|2018-11-03||Interventional|ENTERPRISE||Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease|A Randomized Double-Blind Phase 4 Study to Evaluate the Safety and Proportion of Subjects With Fistula Healing in 2 Dose Regimens of Entyvio (Vedolizumab IV) in the Treatment of Fistulizing Crohn's Disease (ENTERPRISE)|Recruiting||Phase 4|100|Anticipated|Takeda||2|||f||||f||||||||||2017-10-10 22:39:30.989356|2017-10-10 22:39:30.989356
NCT02630940|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-06-30|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Exhaled Breath Condensate Biomarkers and Cough in IPF|Exhaled Breath Condensate Biomarkers and Cough in People With Idiopathic Pulmonary Fibrosis|Completed||N/A|52|Actual|University of East Anglia|||1||f||||f||||||||||2017-10-10 22:39:31.281182|2017-10-10 22:39:31.281182
NCT02630927|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-06-27|||December 2015||2015-12-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Safety and Tolerability Study of AG-519 in Healthy Subjects|A Phase I Randomized, Double-blind, Five-Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of AG-519, the Relative Bioavailability of Prototype Tablet Formulations Compared With a Suspension Formulation, and to Evaluate the Pharmacokinetics of a Selected Tablet Formulation Under Fed and Fasted Conditions in Healthy Subjects|Terminated||Phase 1|108|Actual|Agios Pharmaceuticals, Inc.||5||"Agios is no longer developing its second pyruvate kinase-R (PKR) activator, AG-519, and   withdrew its investigational new drug (IND) application in December 2016"|f||||f||||||||||2017-10-10 22:39:31.359908|2017-10-10 22:39:31.359908
NCT02630914|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2015-12-15|||September 2015||2015-09-01|December 2015|2015-12-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|HT2AF||Medical and Surgical Hybrid Treatment of Atrial Fibrillation.|Medical and Surgical Hybrid Treatment of Atrial Fibrillation: Epicardial and Endocardial Combined Approach.|Recruiting||N/A|12|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||No||2017-10-10 22:39:31.45758|2017-10-10 22:39:31.45758
NCT02630901|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-12-06|||March 2016||2016-03-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis|A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of PRX003 Administered by Intravenous Infusion in Subjects With Psoriasis|Recruiting||Phase 1|56|Anticipated|Prothena Biosciences Limited||2|||f||||f||||||||No||2017-10-10 22:39:31.55533|2017-10-10 22:39:31.55533
NCT02630888|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-10|||August 2014||2014-08-01|December 2015|2015-12-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|ARIQUELI-ME||Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients|Efficacy of the Combination of Memantine in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Young Patients to Previous Combination Therapy of Quetiapine Plus Lithium or Quetiapine Plus Aripiprazole|Recruiting||Phase 2|44|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:39:31.669341|2017-10-10 22:39:31.669341
NCT02630875|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-03-28|||August 2015||2015-08-01|March 2017|2017-03-01|March 17, 2017|Actual|2017-03-17|March 17, 2017|Actual|2017-03-17||Interventional|||A4250, an IBAT Inhibitor in Pediatric Cholestasis|An Exploratory Phase II Study to Demonstrate the Safety and Efficacy of A4250 in Children With Cholestatic Pruritus|Completed||Phase 2|24|Actual|Albireo||6|||f||||t||||||||||2017-10-10 22:39:31.776267|2017-10-10 22:39:31.776267
NCT02630862|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-12-10|||September 2010||2010-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|ICAR||Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization|Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization: Effect of Antithrombotic Treatment|Completed||N/A|240|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-10 22:39:31.868414|2017-10-10 22:39:31.868414
NCT02630849|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-14|||October 2011||2011-10-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Does a Multimodal no‐Compression Suture Technique of the Intercostal Space Reduce Chronic Post‐Thoracotomy Pain?|Does a Multimodal no‐Compression Suture Technique of the Intercostal Space Reduce Chronic Post‐Thoracotomy Pain? A Prospective Randomized Study|Completed||N/A|380|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-10 22:39:31.968572|2017-10-10 22:39:31.968572
NCT02630836|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-03-16|||December 2015||2015-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture|A Pilot Clinical Trial of ex Vivo Expanded Allogenic Adult Stem Cells Combined With Allogenic Human Bone Tissue (XCEL-MT-OSTEO-BETA) in Proximal Femur Fractures in Elderly Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Banc de Sang i Teixits||2|||f||||f||||||||||2017-10-10 22:39:32.046918|2017-10-10 22:39:32.046918
NCT02630823|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-02-23|||February 5, 2016|Actual|2016-02-05|February 2017|2017-02-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||MK-3475 Immunotherapy in Endometrial Carcinoma|Immunotherapy With MK-3475 in Surgically Resectable Endometrial Carcinoma|Recruiting||Phase 1|9|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||No||2017-10-10 22:39:32.143251|2017-10-10 22:39:32.143251
NCT02630810|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-14|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Early Versus Late Hydration After Cesarean Section (CS)|Early Versus Late Oral Hydration After Cesarean Section: A Randomized Controlled Study|Completed||N/A|267|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||No||2017-10-10 22:39:32.244917|2017-10-10 22:39:32.244917
NCT02630797|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-11-19|||December 2016||2016-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Blueberries on Bone Turnover|Berries and Bones:The Effect of Polyphenolic Metabolites From Blueberries on Bone Turnover|Not yet recruiting||Early Phase 1|22|Anticipated|Purdue University||4|||f||||t||||||||Undecided||2017-10-10 22:39:32.311769|2017-10-10 22:39:32.311769
NCT02630784|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-11-16|||April 2015||2015-04-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|VNI Versus||Efficacy and Safety of Non-invasive Ventilation by Calibrated Leak in the Treatment of Respiratory Acidosis in ICU||Recruiting||N/A|20|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 22:39:32.412157|2017-10-10 22:39:32.412157
NCT02630771|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-10-04|||January 2016||2016-01-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Multimodal Assessment of Sensory Processing and Brain Features in Patients With Chronic Orofacial Pain|Multimodal Assessment of Sensory Processing and Brain Features in Patients With Chronic Orofacial Pain|Recruiting||N/A|64|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||3||f||||f||||||||||2017-10-10 22:39:32.510261|2017-10-10 22:39:32.510261
NCT02630758|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-14|||February 2013||2013-02-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Mindfulness-Based Yoga Intervention for Women With Depression|Mindfulness-Based Yoga Intervention for Women With Depression|Completed||N/A|40|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||No||2017-10-10 22:39:32.604223|2017-10-10 22:39:32.604223
NCT02630745|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-09-22|||June 2015|Actual|2015-06-01|December 2015|2015-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Immediate Verses Delayed Surgical Periodontal Therapy After Endodontic Treatment in Endo Perio Lesion With Communication|"Evaluation of the Effect of Immediate and Delayed Surgical Periodontal Therapy After Non-surgical Endodontic Treatment on Periodontal Healing in Concurrent Endodontic Periodontal Lesion With Communication-A Randomized Clinical Trial"|Completed||N/A|40|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t||||||||||2017-10-10 22:39:32.695509|2017-10-10 22:39:32.695509
NCT02630732|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-06-19|||January 2016||2016-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|B²asic||Back School or Brain School for Patients Undergoing Surgery for Lumbar Radiculopathy?|Back School or Brain School for Patients Undergoing Surgery for Lumbar Radiculopathy? A Randomized Controlled Trial With Two-year Follow-up|Recruiting||N/A|100|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-10 22:39:32.848259|2017-10-10 22:39:32.848259
NCT02630719|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-09-27|||January 2016||2016-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Timolol Eye Drops in the Treatment of Acute Migraine Headache|Timolol Eye Drops in the Treatment of Acute Migraine Headache|Recruiting||N/A|100|Anticipated|University of Missouri, Kansas City||2|||f||||f||||||||||2017-10-10 22:39:33.04339|2017-10-10 22:39:33.04339
NCT02630524|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-02-08|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Diet Composition and Cardiometabolic Risk Reduction in Adults With SCI|Diet Composition and Cardiometabolic Risk Reduction in Adults With SCI|Recruiting||N/A|70|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 22:39:34.930946|2017-10-10 22:39:34.930946
NCT02630706|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-08-02|||December 16, 2015|Actual|2015-12-16|August 2017|2017-08-01|December 28, 2017|Anticipated|2017-12-28|December 28, 2017|Anticipated|2017-12-28||Interventional|||A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 26-Week Multicenter Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformin Monotherapy|Active, not recruiting||Phase 3|495|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-10 22:39:33.151754|2017-10-10 22:39:33.151754
NCT02630693|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-03-22|||December 16, 2015|Actual|2015-12-16|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study Comparing Two Different Schedules of Palbociclib Plus Second Line Endocrine Therapy in Women With Estrogen Receptor Positive, HER2 Negative Advanced/Metastatic Breast Cancer|Randomized Phase II Study Comparing Two Different Schedules of Palbociclib Plus Second Line Endocrine Therapy in Women With Estrogen Receptor Positive, HER2 Negative Advanced/Metastatic Breast Cancer|Active, not recruiting||Phase 2|180|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||No||2017-10-10 22:39:33.264294|2017-10-10 22:39:33.264294
NCT02630680|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-05-04|||October 2015||2015-10-01|May 2017|2017-05-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Observational|DUS-BLI800||Eziclen Drug Utilisation in Real Life Setting|A Multicentre, European, Observational, Drug Utilisation Study (DUS) of BLI800 (Eziclen®/Izinova®) as a Bowel Cleansing Preparation|Completed||N/A|1286|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 22:39:33.421127|2017-10-10 22:39:33.421127
NCT02630667|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-12-07|||June 2012||2012-06-01|December 2016|2016-12-01||||May 2016|Actual|2016-05-01||Interventional|||The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition|The Acute Effects of Fortified Nutritional Supplementation on Cognition, Memory, & Achievement|Completed||N/A|113|Actual|University of Illinois at Urbana-Champaign||4|||f||||f||||||||||2017-10-10 22:39:33.527708|2017-10-10 22:39:33.527708
NCT02630654|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-07-25|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|EXPLAIN||Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs|Exploratory, Non-Interventional Study For Evaluating The Diagnostic, Prognostic And Response-Predictive Value Of A Multi Biomarker Approach In Metastatic GEP NETs|Recruiting||N/A|350|Anticipated|Ipsen|||2||f||||f||||||Samples With DNA|"     Frozen plasma will be saved in a biobank   "|||2017-10-10 22:39:33.64407|2017-10-10 22:39:33.64407
NCT02630641|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2017-05-04|||October 2015||2015-10-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|EQUINOXE||Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone.|Impact of the Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone (GnRH) Agonist Therapy Initiated by the Urologist in the Routine Practice. Evaluation by the Patient and the Partner.|Active, not recruiting||N/A|1000|Anticipated|Ipsen|||1||f||||f||||||||||2017-10-10 22:39:33.844701|2017-10-10 22:39:33.844701
NCT02630628|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2016-10-24|||September 2015||2015-09-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis|A Randomized Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus and Corticosteroids in Comparison With Mycophenolate Mofetil and Corticosteroids in Subjects With Class III/IV±V Lupus Nephritis|Recruiting||Phase 4|200|Anticipated|The University of Hong Kong||2|||f||||f||||||||No||2017-10-10 22:39:33.963921|2017-10-10 22:39:33.963921
NCT02630602|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2015-12-14|||March 2014||2014-03-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|LODYN||Functional Goat Cheese Effect in Lipid Profile Change|Functional Goat Cheese Effect in Lipid Profile Change|Completed||Phase 4|60|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-10 22:39:34.182278|2017-10-10 22:39:34.182278
NCT02630589|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-05-05|||July 2016||2016-07-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Implantation of an Auditory Brainstem Implant for the Treatment of Incapacitating Unilateral Tinnitus|Implantation of an Auditory Brainstem Implant for the Treatment of Incapacitating Unilateral Tinnitus|Recruiting||N/A|10|Anticipated|University Medical Center Groningen||1|||f||||f||||||||Undecided||2017-10-10 22:39:34.274028|2017-10-10 22:39:34.274028
NCT02630576|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-03-08|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|NEAT-2||Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy (Volunteers|Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy Volunteers|Completed||N/A|20|Actual|University of Debrecen||4|||f||||t||||||||||2017-10-10 22:39:34.371325|2017-10-10 22:39:34.371325
NCT02630563|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-11|2016-04-19|2016-03-14||May 2003||2003-05-01|December 2015|2015-12-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional||All Patient Population included all participants who were enrolled in the trial|Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids|A Study of the Safety, Tolerability and Pharmacokinetics of Oral CellCept® (Mycophenolate Mofetil, MMF) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids|Terminated||Phase 2|9|Actual|Hoffmann-La Roche|Part I of the study was terminated early with 9 participants enrolled (8 of which were evaluable for PK), and Part II of the study was not performed due to extremely slow recruitment and the infrequent use of the combination of triple therapy.|1||"Due to extremely slow recruitment, infrequent use of combination triple therapy (MMF,   cyclosporine, steroids), study was discontinued; Part 2 was not conducted."|f||||||||||||||2017-10-10 22:39:34.475445|2017-10-10 22:39:34.475445
NCT02630550|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-10|||November 2015||2015-11-01|December 2015|2015-12-01||||October 2016|Anticipated|2016-10-01||Observational|||Validation of the Cheetah NICOM by Comparison to TEE During Open Vascular Surgery - Pilot Study|Validation of the Cheetah NICOM by Comparison to TEE During Open Vascular Surgery - Pilot Study|Recruiting||N/A|20|Anticipated|Maisonneuve-Rosemont Hospital|||2||f||||f||||||||||2017-10-10 22:39:34.776268|2017-10-10 22:39:34.776268
NCT02630498|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-02-11|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PCPSPAULS||Preventing Chronic Post Surgical Pain After Limb Surgery|The Role of Single Shot Brachial Plexus Block in Preventing Chronic Post Surgical Pain After Upper Limb Trauma Surgery|Recruiting||N/A|200|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 22:39:35.131928|2017-10-10 22:39:35.131928
NCT02630485|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-10|||December 2015||2015-12-01|December 2015|2015-12-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|GLC||Graceful Lifestyle Changes Study for PCOS and Infertility|Graceful Lifestyle Changes Intervention Study for Women With PCOS and Infertility|Not yet recruiting||N/A|240|Anticipated|University of British Columbia||4|||f||||f||||||||||2017-10-10 22:39:35.260122|2017-10-10 22:39:35.260122
NCT02630446|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-02-18|||January 2016||2016-01-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|June 2017|Anticipated|2017-06-01||Interventional|||An In-home Respite Care Program to Support Informal Caregivers of People With Dementia|Effectiveness and Cost-effectiveness of an In-home Respite Care Program to Support Informal Caregivers of People With Dementia: a Comparative Study|Recruiting||N/A|372|Anticipated|University Ghent||2|||f||||f||||||||||2017-10-10 22:39:35.753989|2017-10-10 22:39:35.753989
NCT02630433|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-09-18|||August 2009||2009-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Trial of Index Cholecystectomy Versus Scheduled Cholecystectomy in Biliary Pancreatitis|Randomised Controlled Trial of Index Cholecystectomy Versus Scheduled Cholecystectomy in Biliary Pancreatitis|Active, not recruiting||N/A|70|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 22:39:35.884631|2017-10-10 22:39:35.884631
NCT02630420|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-08-23|||January 2017||2017-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer|Combination of Cetuximab & MWT Inhibitor Savolitinib in the Treatment of Ras Wild-Type Colorectal Cancer|Not yet recruiting||Phase 1|33|Anticipated|Yale University||1|||f||||t||||||||||2017-10-10 22:39:35.98697|2017-10-10 22:39:35.98697
NCT02630407|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-09-12|||December 2012||2012-12-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|HA-ACL||Early Viscosupplementation After ACL Reconstruction: a Randomized Controlled Trial|Early Post-op. Viscosupplementation After Primary Anterior Cruciate Ligament (ACL) Reconstruction: a Randomized, Placebo Controlled Trial|Completed||Phase 4|60|Actual|Istituto Ortopedico Rizzoli||2|||f||||t|f|f||||||||2017-10-10 22:39:36.076042|2017-10-10 22:39:36.076042
NCT02630394|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-11|||September 2015||2015-09-01|December 2015|2015-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease|A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease|Recruiting||Phase 1|15|Anticipated|University of Mississippi Medical Center||1|||f||||t||||||||||2017-10-10 22:39:36.179458|2017-10-10 22:39:36.179458
NCT02630368|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-29|||September 2015||2015-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|METROmaJX||A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)|A Phase I/II Study of Metronomic Cyclophosphamide and Oncolytic Poxvirus JX-594 in Patients With Advanced Breast Cancer and Advanced Soft Tissue Sarcoma (METROmaJX)|Recruiting||Phase 1/Phase 2|118|Anticipated|Institut Bergonié||4|||f||||t||||||||||2017-10-10 22:39:36.464726|2017-10-10 22:39:36.464726
NCT02630355|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-14|||January 2016||2016-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Remote Ischaemic Preconditioning to Prevent Dialysis Induced Cardiac Injury|Randomized Controlled Trial of Remote Ischaemic Preconditioning to Protect Against Dialysis Induced Cardiac Injury in Haemodialysis: Low Vs. High Intensity|Not yet recruiting||Phase 2|80|Anticipated|Western University, Canada||4|||f||||f||||||||No||2017-10-10 22:39:36.639715|2017-10-10 22:39:36.639715
NCT02630342|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-09-28|||January 2016||2016-01-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||The Use of a Mock MRI Scanner for Reducing the Use of Anesthesia in Children Undergoing Clinical MRI Scans|The Use of a Mock MRI Scanner for Reducing the Use of Anesthesia in Children Undergoing Clinical MRI Scans|Recruiting||N/A|160|Anticipated|University of Calgary||5|||f||||f||||||||No||2017-10-10 22:39:36.745809|2017-10-10 22:39:36.745809
NCT02630329|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-08-18|||December 2015||2015-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|NOTABLE||Notes Adnexectomy for Benign Pathology Compared to Laparoscopic Excision|Adnexectomy for Benign Gynaecological Pathology by Natural Orifice Transluminal Endoscopy or Laparoscopy|Recruiting||Phase 2|66|Anticipated|Imelda Hospital, Bonheiden||2|||f||||t||||||||||2017-10-10 22:39:36.881249|2017-10-10 22:39:36.881249
NCT02630303|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-03-29|||January 2016||2016-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin|Phase I Study of High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin|Completed||Phase 1|60|Actual|VA Northern California Health Care System||2|||f||||t||||||||||2017-10-10 22:39:37.631026|2017-10-10 22:39:37.631026
NCT02630290|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-08-10|||December 2015||2015-12-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|ADRIB||Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Block (ADRIB Trial)|Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Plexus Block, a Randomized Controlled Study|Completed||Phase 4|60|Actual|Guangzhou First People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:39:37.7444|2017-10-10 22:39:37.7444
NCT02630277|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-10|||January 2016||2016-01-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|ELYSIAN||Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN|Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept Injection (ELYSIAN)|Not yet recruiting||Phase 2|30|Anticipated|Valley Retina Institute||2|||f||||f||||||||||2017-10-10 22:39:37.900789|2017-10-10 22:39:37.900789
NCT02630264|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2015-12-10|||June 2013||2013-06-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck|A Randomized, Open-label, Multi-center Phase III Study Designed to Evaluate the Safety and Efficacy of E10A in Patients With Recurrent/Unresectable Squamous Cell Carcinoma of the Head and Neck Region|Recruiting||Phase 3|540|Anticipated|Guangzhou Double Bioproducts Co., Ltd||2|||f||||f||||||||No||2017-10-10 22:39:38.000607|2017-10-10 22:39:38.000607
NCT02630251|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-04-24|||April 25, 2016||2016-04-25|April 2017|2017-04-01|May 20, 2019|Anticipated|2019-05-20|May 20, 2019|Anticipated|2019-05-20||Interventional|||Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors|A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors|Recruiting||Phase 1|60|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:39:38.118056|2017-10-10 22:39:38.118056
NCT02630238|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-01-18|||January 2016||2016-01-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||The Effect of Branched-Chain Amino Acid Supplementation and Exercise on Body Composition During Energy Restriction|The Effect of Branched-Chain Amino Acid Supplementation and Exercise on Body Composition During Energy Restriction|Recruiting||N/A|16|Anticipated|University of Western Ontario, Canada||2|||f||||t||||||||||2017-10-10 22:39:38.235368|2017-10-10 22:39:38.235368
NCT02630225|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-08-18|||January 2016||2016-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HIFI||Helping Individuals With Firearm Injuries|Helping Individuals With Firearm Injuries: A Cluster Randomized Trial|Recruiting||N/A|300|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 22:39:38.333579|2017-10-10 22:39:38.333579
NCT02630212|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-23|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|RALAD||The Relationship Between ALDH2 and Aortic Dissection|The Relationship Between ALDH2 and Aortic Dissection|Not yet recruiting||N/A|400|Anticipated|Qilu Hospital of Shandong University|||2||f||||t||||||Samples With DNA|"     4 ml vein blood samples were collected from aortic dissection or controls in tubes containing     EDTA. The samples would be centrifuged and saved in a -80℃ ultra-low temperature     refrigerator.      1 cm2 of aorta specimen were collected from patients operated on for Type A dissection, and     refrigerated with liquid nitrogen.   "|||2017-10-10 22:39:38.445384|2017-10-10 22:39:38.445384
NCT02630199|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-02-15|||December 2015|Actual|2015-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|February 5, 2016|Actual|2016-02-05||Interventional|||Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer|Phase I, Open-Label Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer|Recruiting||Phase 1|21|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 22:39:38.509791|2017-10-10 22:39:38.509791
NCT02630186|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-09-08|||January 2016||2016-01-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC|A Phase 1b/2 Study of the Safety and Efficacy of Rociletinib (CO-1686) Administered in Combination With MPDL3280A in Patients With Activating EGFR Mutation-positive (EGFRm) Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1/Phase 2|3|Actual|Clovis Oncology, Inc.||1|||f||||f||||||||||2017-10-10 22:39:38.604893|2017-10-10 22:39:38.604893
NCT02630173|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-15|||May 2014||2014-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation of Endodontic Status on Periodontal Healing of Concomitant Endodontic Periodontal Lesions|Evaluation of Endodontic Status on Periodontal Healing of Concomitant Endodontic Periodontal Lesions|Completed||N/A|28|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t||||||||||2017-10-10 22:39:38.72281|2017-10-10 22:39:38.72281
NCT02630160|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-10-10|||March 2013||2013-03-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|ILIACPCPTHR||The Influence of Local Infiltration Analgesia by Catheter in Postoperative Control Pain After Total Hip Replacement|The Influence of Local Infiltration Analgesia by Catheter in Postoperative Control Pain After Total Hip Replacement|Completed||Phase 4|100|Actual|Parc de Salut Mar||4|||f||||f||||||||||2017-10-10 22:39:38.843986|2017-10-10 22:39:38.843986
NCT02630147|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-14|||September 2015||2015-09-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Vanilla||Effects of Vanilla on Hypoxic Intermittent Events in Premature Infants|Effects of Vanilla on Hypoxic Intermittent Events in Premature Infants|Recruiting||N/A|30|Anticipated|Université de Sherbrooke||2|||f||||t||||||||||2017-10-10 22:39:38.966602|2017-10-10 22:39:38.966602
NCT02630134|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-07-13|||March 2011||2011-03-01|July 2017|2017-07-01|October 2012|Actual|2012-10-01|June 2011|Actual|2011-06-01||Interventional|||Device for Monitoring Pain During Intraoperative, Pre/Post Surgical Periods: Comparison With Standard of Care Monitoring|MyHealthTrendsTM Device for Pain for Monitoring Pain During the Intraoperative, Pre and Post Surgical Periods: Comparison With Standard of Care Pain Monitoring.|Terminated||N/A|6|Actual|New York University School of Medicine||1||Study stopped, recruitment difficult, subject compliance very difficult.|f||||f|f|f||||||||2017-10-10 22:39:39.097693|2017-10-10 22:39:39.097693
NCT02630121|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-09-21|||November 2016||2016-11-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Oxymetazoline Hydrochloride in Comibination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea|Effect of Oxymetazoline Hydrochloride in Comibination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea. A Double Blinded Placebo Controlled, Crossover Prospective Trial.|Not yet recruiting||Phase 4|52|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-10 22:39:39.184027|2017-10-10 22:39:39.184027
NCT02630108|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-10-17|||December 2015||2015-12-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma|Clinical Study of Transarterial Chemoembolization (TACE) Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma|Recruiting||Phase 3|280|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 22:39:39.300545|2017-10-10 22:39:39.300545
NCT02630095|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-14|||December 2015||2015-12-01|December 2015|2015-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT|Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis：A Zelen-design Multicenter Randomized Controlled Trial|Not yet recruiting||Phase 4|96|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 22:39:39.52775|2017-10-10 22:39:39.52775
NCT02630082|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-12-10|||April 2011||2011-04-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|HVTN 914||Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru|A Cohort Study in Lima, Peru to Evaluate Feasibility of Measuring Immune Responses & Activation Levels in the Foreskin & Rectosigmoid Mucosa in HIV-negative, Uncircumcised Men Who Have Sex With Men & Who Are at High Risk for HIV Acquisition|Completed||N/A|29|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||f||||||||||2017-10-10 22:39:39.65998|2017-10-10 22:39:39.65998
NCT02630069|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-07-27|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||CDP-choline Treatment in ATS Users|Cytidine-5'-Diphosphate-choline Treatment in Amphetamine Type Stimulant-using Adolescents|Recruiting||Phase 2|160|Anticipated|Ewha Womans University Mokdong Hospital||3|||f||||t||||||||||2017-10-10 22:39:39.805754|2017-10-10 22:39:39.805754
NCT02630056|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-14|||December 2015||2015-12-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer|Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy|Not yet recruiting||N/A|90|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University|||1||f||||f||||||||||2017-10-10 22:39:39.914449|2017-10-10 22:39:39.914449
NCT02630043|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-04-27|||December 2015||2015-12-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Tolcapone With Oxaliplatin for Neuroblastoma|A Phase I Trial of Tolcapone Alone and in Combination With Oxaliplatin in Patients With Relapsed or Refractory Neuroblastoma|Recruiting||Phase 1|21|Anticipated|Spectrum Health Hospitals||1|||f||||t||||||||||2017-10-10 22:39:39.97276|2017-10-10 22:39:39.97276
NCT02630030|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma|Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma|Recruiting||Early Phase 1|3|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 22:39:40.126421|2017-10-10 22:39:40.126421
NCT02630017|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-10-04|||January 2018|Anticipated|2018-01-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|MOBE||Motivated Behavior in Adults With and Without ADHD|Motivated Behavior in Adults With and Without ADHD|Not yet recruiting||Phase 2|30|Anticipated|University of Arkansas||2|||f||||t|t|f|||f|||||2017-10-10 22:39:40.218806|2017-10-10 22:39:40.218806
NCT02630004|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-09-05|||November 2015||2015-11-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|MUCOMEL||Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation|Phase IB-II Clinical Trial of Melatonin Oral Gel for the Prevention and Treatment of Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation.|Active, not recruiting||Phase 1/Phase 2|84|Actual|Spherium Biomed||2|||f||||f||||||||||2017-10-10 22:39:40.300987|2017-10-10 22:39:40.300987
NCT02629991|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-03-08|||October 2015||2015-10-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|December 2016|Actual|2016-12-01||Interventional|OXT-PWS||Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome|Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome|Active, not recruiting||Phase 2|24|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 22:39:40.448303|2017-10-10 22:39:40.448303
NCT02629978|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-14|||October 2015||2015-10-01|October 2015|2015-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Radiofrequency Ablation of Malignant Pulmonary Nodules|Efficacy and Safety of Radiofrequency Ablation of Malignant Pulmonary Nodules|Active, not recruiting||N/A|500|Anticipated|Chinese PLA General Hospital||1|||f||||f||||||||||2017-10-10 22:39:40.558957|2017-10-10 22:39:40.558957
NCT02629965|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-20|||February 12, 2016|Actual|2016-02-12|July 2017|2017-07-01|April 17, 2017|Actual|2017-04-17|March 24, 2017|Actual|2017-03-24||Interventional|||Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients|A Randomised, Double-blinded, Active-controlled 2-way Cross Over Trial to Assess the Effects of 6 Weeks Treatment of Once Daily Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination Delivered by RESPIMAT Inhaler Compared With Tiotropium Delivered by RESPIMAT Inhaler on Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|184|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:39:40.64863|2017-10-10 22:39:40.64863
NCT02629952|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-09-11|||November 2015||2015-11-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Metabolic Benefits of Drinking Blueberry Tea in Type 2 Diabetes|Metabolic Benefits of Drinking Blueberry Tea in Type 2 Diabetes|Recruiting||N/A|36|Anticipated|Menzies Institute for Medical Research||2|||f||||f||||||||||2017-10-10 22:39:41.021845|2017-10-10 22:39:41.021845
NCT02629939|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-09-13|||September 2016||2016-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Basic Knowledge of CPR Among Close Relatives of Heart Patients-check Status Quo and Attemp to Establish a Potential Plan to Implement This Knowledge|Basic Knowledge of CPR Among Close Relatives of Heart Patients-check Status Quo and Attemp to Establish a Potential Plan to Implement This Knowledge|Recruiting||N/A|270|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-10 22:39:41.180568|2017-10-10 22:39:41.180568
NCT02629926|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-12-14|||October 2010||2010-10-01|December 2015|2015-12-01||||October 2015|Actual|2015-10-01||Observational|||Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors|A Phase IV, Single-Centre, Non-Randomised, Controlled, Open-Label Study to Assess the Use of Growth Hormone (GH) Replacement Therapy (NutropinAq®) During Transition in GH Deficient Survivors of Childhood Cancer to Optimise Somatic Growth & Well-Being|Recruiting||Phase 4|60|Anticipated|The Leeds Teaching Hospitals NHS Trust|||2||f||||f||||||||||2017-10-10 22:39:41.313281|2017-10-10 22:39:41.313281
NCT02629913|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-10-17|||January 2016||2016-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Is Internet-based Self-help Effective for the Treatment of Insomnia Disorder?||Completed||N/A|56|Actual|University of Zurich||2|||f||||||||||||||2017-10-10 22:39:41.445912|2017-10-10 22:39:41.445912
NCT02629900|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-01-18|||January 2016||2016-01-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||The Effect of Time Restricted Feeding on Fat Mass in Overweight Women|The Effect of Time Restricted Feeding on Fat Mass in Overweight Women|Recruiting||N/A|16|Anticipated|University of Western Ontario, Canada||1|||f||||t||||||||No||2017-10-10 22:39:41.544832|2017-10-10 22:39:41.544832
NCT02629887|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-25|||October 31, 2017|Anticipated|2017-10-31|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Non-inflatable Supraglottic Airway (NI-SGA) vs. Face Mask (FM) as a Primary Interface Device for Neonatal Resuscitation|Non-inflatable Supraglottic Airway (NI-SGA) vs. Face Mask (FM) as a Primary Interface Device for Neonatal Resuscitation: A Pilot Study|Not yet recruiting||N/A|60|Anticipated|University of Oklahoma||2|||f||||t|f|t|f|f|f|||||2017-10-10 22:39:41.674918|2017-10-10 22:39:41.674918
NCT02629874|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-06-22|||February 2015||2015-02-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||PK/PD of EA-230 During Endotoxemia|Randomized Double Blind Placebo-controlled Clinical Safety, Tolerability and Pharmacokinetic/-Dynamic Study on the Effects of Escalating Single Intravenous Doses of EA-230 on the Innate Immune Response During Experimental Human Endotoxemia|Completed||Phase 1|60|Actual|Radboud University||4|||f||||t||||||||||2017-10-10 22:39:41.854808|2017-10-10 22:39:41.854808
NCT02629861|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-23|||January 31, 2016|Actual|2016-01-31|August 2017|2017-08-01|May 31, 2017|Actual|2017-05-31|April 11, 2017|Actual|2017-04-11||Interventional|||Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 vs Placebo for the Preventive Treatment of Episodic Migraine|Completed||Phase 3|878|Actual|Teva Pharmaceutical Industries||3|||f||||f|t|f||||||||2017-10-10 22:39:42.005949|2017-10-10 22:39:42.005949
NCT02629848|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-10|||July 2012||2012-07-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer|A Global Phase 3, Randomized, Placebo Controlled, Double-Blind Trial of AMG 706 in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer (Asian Phase 3 Study)|Terminated||Phase 3|401|Actual|Takeda||2||Sponsor decision to terminate the study because the study did not meet the primary endpoint.|f||||t||||||||||2017-10-10 22:39:42.53994|2017-10-10 22:39:42.53994
NCT02629835|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-03-21|||January 2016||2016-01-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks|A Randomized Comparison Between Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks|Completed||Phase 2/Phase 3|150|Actual|Montreal General Hospital||2|||f||||f||||||||||2017-10-10 22:39:42.668061|2017-10-10 22:39:42.668061
NCT02629822|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-17|||January 14, 2016|Actual|2016-01-14|August 2017|2017-08-01|November 29, 2018|Anticipated|2018-11-29|December 28, 2017|Anticipated|2017-12-28||Interventional|DRIVE BEYOND||Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)|A Phase IIa Multicenter, Open-Label Clinical Trial to Evaluate the Safety and Efficacy of MK-1439A in Treatment-Naïve HIV-1 Infected Subjects With Selected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Transmitted Resistance Mutations|Active, not recruiting||Phase 2|10|Actual|Merck Sharp & Dohme Corp.||1|||f||||f|t|f||||||||2017-10-10 22:39:42.823698|2017-10-10 22:39:42.823698
NCT02629809|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-15|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||First-line Therapy With Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA-101) (iFCG) for Patients With Chronic Lymphocytic Leukemia (CLL)|First-line Therapy With Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA-101) (iFCG) for Patients With Chronic Lymphocytic Leukemia (CLL) With Mutated IGHV Gene and Non-del(17p)|Recruiting||Phase 2|45|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:39:42.945349|2017-10-10 22:39:42.945349
NCT02629796|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-02-03|||April 2014|Actual|2014-04-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|BIOMARK||Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy|Biomarker to Predict the Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients: a Transcriptomic Study|Recruiting||N/A|45|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||||||||||||2017-10-10 22:39:43.14681|2017-10-10 22:39:43.14681
NCT02629783|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-09-13|||March 2016||2016-03-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|PsychShoP||Psychomotor Therapy as Complimentary Treatment to Patients With Shoulder Pain.|Psychomotor Therapy as Complimentary Treatment to Patients With Shoulder Pain - a Randomized Controlled Trial.|Recruiting||N/A|100|Anticipated|Vejle Hospital||2|||f||||f||||||||||2017-10-10 22:39:43.321115|2017-10-10 22:39:43.321115
NCT02629770|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-09-22|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CLIRIFA||Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections|Clindamycin-Rifampin Interactions: Effect of Rifampin's Enzyme-induction (Cytochrome P450 3A4/3A5) on Plasma Clindamycin Concentrations, With Clindamycin Given Intravenously and Orally to Treat Bone-and-joint Infections|Recruiting||N/A|40|Anticipated|Groupe Hospitalier Diaconesses Croix Saint-Simon|||1||f||||||||||||||2017-10-10 22:39:43.446152|2017-10-10 22:39:43.446152
NCT02629757|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-11|||April 2015||2015-04-01|December 2015|2015-12-01|May 2018|Anticipated|2018-05-01|April 2017|Anticipated|2017-04-01||Interventional|β-elemene||A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment|A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment|Recruiting||Phase 3|100|Anticipated|Sun Yat-sen University||1|||f||||f||||||||Undecided||2017-10-10 22:39:43.539992|2017-10-10 22:39:43.539992
NCT02629744|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-11-01|||December 2015||2015-12-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Auto-injector in Healthy Participants|A PHASE 1, OPEN-LABEL, SINGLE-ARM STUDY IN HEALTHY SUBJECTS TO EVALUATE PAIN, TOLERABILITY, SAFETY, AND USABILITY OF A PREFILLED AUTOINJECTOR TO SELF-ADMINISTER ETROLIZUMAB SUBCUTANEOUSLY|Completed||Phase 1|27|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-10 22:39:43.650198|2017-10-10 22:39:43.650198
NCT02629731|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-08|||July 1, 2016|Actual|2016-07-01|August 2017|2017-08-01|November 30, 2019|Anticipated|2019-11-30|September 30, 2019|Anticipated|2019-09-30||Interventional|ODRS||Orthotic Dose Response Study|Quantitative Prescription of Foot Orthoses: A Dose-Response Study of Kinematics in Patients With Foot and Ankle Pain Using Biplane Fluoroscopy|Recruiting||N/A|90|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||||2017-10-10 22:39:43.743719|2017-10-10 22:39:43.743719
NCT02629718|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-11|||December 2015||2015-12-01|December 2015|2015-12-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|SYSGO-003||Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer|A Trial of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer|Not yet recruiting||Phase 3|700|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:39:43.874123|2017-10-10 22:39:43.874123
NCT02629705|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-02-17|||October 2015||2015-10-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|December 23, 2016|Actual|2016-12-23||Interventional|||Study of Carrageenan's Effect on Insulin Resistance in Humans|Investigation of the Effect of Carrageenan as Food Additive on Insulin Resistance in Humans|Active, not recruiting||N/A|20|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 22:39:43.991905|2017-10-10 22:39:43.991905
NCT02629692|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-09-23|||March 2016||2016-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of K0706|A Safety, Tolerability, Pharmacokinetic Study of K0706 in Healthy and Chronic Myeloid Leukemia Subjects|Recruiting||Phase 1/Phase 2|105|Anticipated|Sun Pharma Advanced Research Company Limited||2|||f||||f||||||||No||2017-10-10 22:39:44.114781|2017-10-10 22:39:44.114781
NCT02629679|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-11|||September 2014||2014-09-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|June 2015|Actual|2015-06-01||Observational|SESA||Sports, Education and Consumption of Substances in Adolescents|Prospective Analysis of the Factors Associated With Substance Use and Misuse in Adolescents|Active, not recruiting||N/A|1000|Actual|University Hospital of Split|||4||f||||f||||||||||2017-10-10 22:39:44.19994|2017-10-10 22:39:44.19994
NCT02629666|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-02-23|||July 2016||2016-07-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|October 2018|Anticipated|2018-10-01||Interventional|SitLESS||Exercise Referral Schemes Enhanced by Self-Management Strategies to Battle Sedentary Behaviour|Exercise Referral Schemes Enhanced by Self-Management Strategies to Battle Sedentary Behaviour|Recruiting||N/A|1338|Anticipated|University Ramon Llull||3|||f||||f||||||||||2017-10-10 22:39:44.322855|2017-10-10 22:39:44.322855
NCT02629653|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-11|||December 2013||2013-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Body Cooling During Carotid Endarterectomy: No-profit, Open, Mono-centric, Feasibility Study|Body Cooling During Carotid Endarterectomy: No-profit, Open, Mono-centric, Feasibility Study|Completed||N/A|10|Actual|S. Andrea Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:39:44.438496|2017-10-10 22:39:44.438496
NCT02629640|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-21|||January 2016||2016-01-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Enhanced CJD Surveillance in the Older Population|Enhanced CJD Surveillance in the Older Population|Recruiting||N/A|300|Anticipated|University of Edinburgh|||1||f||||t||||||Samples With DNA|"     -  Blood samples        -  Brain tissue   "|||2017-10-10 22:39:44.546686|2017-10-10 22:39:44.546686
NCT02629627|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-10|||March 2016||2016-03-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome|Effect of the Administration of Conjugated Linoleic Acid / Leucine Plus Metformin on Visceral Fat in Patients With Metabolic Syndrome|Not yet recruiting||Phase 2|104|Anticipated|Centro Universitario de Ciencias de la Salud, Mexico||4|||f||||f||||||||No||2017-10-10 22:39:44.681888|2017-10-10 22:39:44.681888
NCT02629614|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-11-20|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:39:44.82317|2017-10-10 22:39:44.82317
NCT02629601|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-09-27|||May 2016||2016-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluating Incentive Designs to Increase Physical Activity Goal Adherence in a Wellness Program|Evaluating Incentive Designs to Increase Physical Activity Goal Adherence in a Wellness Program|Withdrawn||Phase 3|0|Actual|University of Pennsylvania||5||Change plans and no longer testing these interventions|f||||f||||||||No||2017-10-10 22:39:44.878554|2017-10-10 22:39:44.878554
NCT02629575|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-02-21|||January 2014||2014-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01|9 Months|Observational [Patient Registry]|ISAR2000||Coroflex ISAR 2000 Registry|Coroflex ISAR 2000 Postmarket Surveillance Non-Interventional Study|Active, not recruiting||N/A|2877|Actual|B. Braun Melsungen AG|||1||f||||f||||||||Undecided||2017-10-10 22:39:45.113353|2017-10-10 22:39:45.113353
NCT02629549|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-06-11|||October 2015||2015-10-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||Intraoperative Imaging of Pituitary Adenomas by OTL|A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma|Active, not recruiting||Phase 1|50|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:39:45.336178|2017-10-10 22:39:45.336178
NCT02629536|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-09|||March 2016||2016-03-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|MIGRANT||Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study.|Effect on Migraine Frequency of Combined Anti-oxidant Therapy: N-acetylcysteine, Vitamin E and Vitamin C (NEC): The MIGRANT Study|Not yet recruiting||Phase 3|90|Anticipated|University of Notre Dame Australia||2|||f||||f||||||||||2017-10-10 22:39:47.130586|2017-10-10 22:39:47.130586
NCT02629523|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-07-31|||June 2016||2016-06-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|LiquidLung-A||Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA|A Phase II, Open-Label, Multicentre Study to Assess the Anti-tumour Activity of Afatinib in Patients With Activating Epidermal Growth Factor Receptor Mutation in Circulating Tumor DNA|Recruiting||Phase 2|21|Anticipated|Chonnam National University Hospital||1|||f||||f||||||||No||2017-10-10 22:39:47.255287|2017-10-10 22:39:47.255287
NCT02629510|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-05-27|||January 2015||2015-01-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|TACO||The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)|A Randomized Controlled Trial Evaluating the Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) in Patients With Cervical Intraepithelial Neoplasia or Cervical Cancer|Active, not recruiting||Phase 4|268|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-10 22:39:47.396|2017-10-10 22:39:47.396
NCT02629497|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-06-13|||November 2015||2015-11-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|June 2017|Actual|2017-06-01||Interventional|||Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus|Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus|Active, not recruiting||Early Phase 1|88|Anticipated|University of Michigan||4|||f||||f||||||||No||2017-10-10 22:39:47.518774|2017-10-10 22:39:47.518774
NCT02629484|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-02-27|||February 1, 2016|Actual|2016-02-01|February 2017|2017-02-01|January 26, 2018|Anticipated|2018-01-26|January 26, 2017|Actual|2017-01-26||Interventional|ECHONOFII||Trial of Focused Cardiac Ultrasound for Fractured Neck of Femur Surgery|A Pilot Study to Assess Feasibility, Compliance, Safety and Group Separation for a Multicentre Randomised Trial of Preoperative Focused Cardiac Ultrasound for Fractured Neck of Femur Surgery|Active, not recruiting||N/A|100|Actual|University of Melbourne||2|||f||||t||||||||||2017-10-10 22:39:47.671356|2017-10-10 22:39:47.671356
NCT02629471|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-31|||February 6, 2017|Actual|2017-02-06|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of the Effects of Light Flashes on the Visual System|Study of the Effects of Light Flashes on the Visual System|Recruiting||N/A|60|Anticipated|LightGuard||1|||f||||f|f|f||||||||2017-10-10 22:39:47.781157|2017-10-10 22:39:47.781157
NCT02629458|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-02-18|||July 2015||2015-07-01|December 2015|2015-12-01||||August 2016|Anticipated|2016-08-01||Interventional|SABRTOOTHv1||A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection|A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy (SABR) With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer (NSCLC) cOnsidered Higher Risk of Complications From Surgical Resection|Recruiting||N/A|54|Anticipated|The Leeds Teaching Hospitals NHS Trust||1|||f||||t||||||||Undecided||2017-10-10 22:39:47.897941|2017-10-10 22:39:47.897941
NCT02629445|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-10|||November 2015||2015-11-01|December 2015|2015-12-01||||November 2016|Anticipated|2016-11-01||Interventional|HIPACE||HIPACE High Frequency Low Energy Pacing to Terminate Fast Ventricular Arrythmias|High Frequency Low Energy Pacing to Terminate Fast Ventricular Arrythmias|Recruiting||N/A|24|Anticipated|The Leeds Teaching Hospitals NHS Trust||1|||f||||f||||||||||2017-10-10 22:39:47.990529|2017-10-10 22:39:47.990529
NCT02629432|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-05-10|||December 2013||2013-12-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|1 Day|Observational [Patient Registry]|MR-COPD||Image-Based Structural and Functional Phenotyping of the COSYCONET Cohort Using MRI and CT|Image-Based Structural and Functional Phenotyping of the COSYCONET Cohort Using MRI and CT (MR COPD)|Completed||N/A|602|Actual|University Hospital Heidelberg|||1||f||||t||||||||Yes|Pseudonymized Data from structured image reads will be transferred to the central COSYCONET data bank in Hannover. Application form for project proposals and data retrieval can be downloaded here: http://www.asconet.net/html/cosyconet/projects?clps4835_49326291=1|2017-10-10 22:39:48.085338|2017-10-10 22:39:48.085338
NCT02627157|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-03-03|||December 2015||2015-12-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Measurements of Corneal Biomechanical Properties Using a Dynamic Scheimpflug Analyzer for Young Healthy Adults in South Korea||Recruiting||N/A|500|Anticipated|Yonsei University|||1||f||||f||||||||Undecided|Undecided yet|2017-10-10 22:40:19.30314|2017-10-10 22:40:19.30314
NCT02629419|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-04-18|||November 2015||2015-11-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CAMB||CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis|A Phase 2a Efficacy, Safety, Tolerability, and PK Study of Encochleated Amphotericin B (CAMB/MAT2203) in Patients With Mucocutaneous Candidiasis Who Are Refractory or Intolerant to Standard Non-Intravenous Therapies|Recruiting||Phase 2|16|Anticipated|Matinas BioPharma Nanotechnologies, Inc.||1|||f||||t||||||||||2017-10-10 22:39:48.355782|2017-10-10 22:39:48.355782
NCT02629406|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-05-15|||November 2015||2015-11-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|HYKRAND||Studies on the Adaptive Responses to Hypoxia|Studies on the Adaptive Responses (Cardiovascular, Respiratory and Angiogenetic) to Hypoxia in Patients With Type 1 Diabetes Compared to Controls|Completed||N/A|30|Actual|Karolinska University Hospital|||2||f||||t||||||Samples With DNA|"     whole blood, serum   "|||2017-10-10 22:39:48.547861|2017-10-10 22:39:48.547861
NCT02629393|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-08-18|||May 2016||2016-05-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A|A Phase 2/3, Multicenter, Multinational, Open Label Study to Evaluate the Efficacy and Safety of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A|Active, not recruiting||Phase 2/Phase 3|5|Anticipated|Alexion Pharma GmbH||1|||f||||t||||||||||2017-10-10 22:39:48.689537|2017-10-10 22:39:48.689537
NCT02629380|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-09-12|||December 2012||2012-12-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|HA-MEN||Early Viscosupplementation After Partial Meniscectomy: a Randomized Controlled Trial|Early Viscosupplementation After Partial Meniscectomy: a Double Blind, Placebo Controlled Randomized Trial|Completed||Phase 4|90|Actual|Istituto Ortopedico Rizzoli||2|||f||||t||||||||||2017-10-10 22:39:48.851914|2017-10-10 22:39:48.851914
NCT02629367|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-11|||January 2016||2016-01-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Influence of Vorapaxar on Thrombin Generation and Coagulability||Not yet recruiting||Phase 4|100|Anticipated|Inova Health Care Services||4|||f||||f||||||||No||2017-10-10 22:39:49.006832|2017-10-10 22:39:49.006832
NCT02629354|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-03-31|2017-01-27||November 2015||2015-11-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Randomized population: all subjects randomized to a treatment sequence.|To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet|A Single Center, Single Dose, Open Label, Randomized, Two Period, Two Sequence Crossover Study to Evaluate the Relative Bioavailibility of Ibuprofen From a Fixed-dose Combination Tablet Containing Ibuprofen 400 mg and Caffeine 100 mg and a Tablet of Ibuprofen 400 mg in at Least 30 Healthy Males and Females Under Fed Conditions|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:39:49.158042|2017-10-10 22:39:49.158042
NCT02629341|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-10|||January 2015||2015-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|bonefoods||Functional Yogurt Powder Effect on Bone Health Biomarkers|Functional Yogurt Powder Effect on Bone Health Biomarkers|Completed||Phase 3|79|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-10 22:39:49.706194|2017-10-10 22:39:49.706194
NCT02629328|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-08-05|||September 2015||2015-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|CTRS||CardioCel Tri-leaflet Repair Study|CardioCel Tri-leaflet Repair Study; a Prospective, Non-randomised, Single Arm, Multi-centre Clinical Investigation|Terminated||N/A|28|Actual|Admedus Regen Pty Ltd.||1||"due to slow and inconsistent enrolment. As per ISO-14155 all subjects currently enrolled will   be followed up under the approved Clinical Investigation Plan"|f||||t||||||||||2017-10-10 22:39:49.816859|2017-10-10 22:39:49.816859
NCT02629315|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2015-12-11|||May 2012||2012-05-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Carnoy`s Solution Versus Formalin in Rectal Cancer Specimens Following Neoadjuvant Chemoradiation: a Randomized Trial|Lymph Node Yield After Specimen Fixation With Carnoy`s Solution and 10% Neutral Buffered Formaldehyde in Patients With Rectal Cancer Specimens Following Neoadjuvant Chemoradiation: a Randomized Trial|Completed||N/A|130|Actual|Instituto do Cancer do Estado de São Paulo||2|||f||||f||||||||||2017-10-10 22:39:49.924979|2017-10-10 22:39:49.924979
NCT02629289|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-07-14|||August 2015||2015-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants|A Phase 1 Study Assessing The Pharmacodynamic And Pharmacokinetic Equivalence Of HSP-130 With US-approved Neulasta (Registered) And EU-approved Neulasta (Registered) Administered As A Single Subcutaneous Dose To Healthy Volunteers|Completed||Phase 1|153|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 22:39:50.124382|2017-10-10 22:39:50.124382
NCT02629276|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-01-26|||August 2014|Actual|2014-08-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||Somatosensory Phenotype of Patients Suffering From Unspecific Neck and Arm Pain|Somatosensory Profiles in Patients With Non Specific Neck Arm Pain With and Without Positive Neurodynamic Tests|Completed||N/A|40|Actual|Swiss Paraplegic Centre Nottwil|||1||f||||f||||||||No||2017-10-10 22:39:50.239908|2017-10-10 22:39:50.239908
NCT02629263|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-07-13|||September 2015||2015-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|VF&GC||The Effect of Viscous Fiber on Glycemic Control in Individuals With Diabetes|The Effect of Viscous Fibre on Glycemic Control in Individuals With Diabetes|Active, not recruiting||N/A|1000|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-10 22:39:50.335707|2017-10-10 22:39:50.335707
NCT02629250|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-02-14|||December 2015||2015-12-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|SNODES||Supernormal Oxygen Delivery for Elderly Surgical Patients|A Randomized Controlled Study of Supernormal Oxygen Delivery Goal-directed Therapy for Elderly Patients Undergoing Proximal Femoral Surgery.|Recruiting||N/A|70|Anticipated|Guangzhou First People's Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:39:50.447573|2017-10-10 22:39:50.447573
NCT02629237|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-12-09|||October 2015||2015-10-01|December 2015|2015-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Satisfaction After Glaucoma Surgery in Rural China|Impact of Multifaceted Education on Satisfaction After Glaucoma Surgery in Rural China|Recruiting||N/A|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:39:50.683526|2017-10-10 22:39:50.683526
NCT02629224|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2016-02-03|||February 2008||2008-02-01|February 2016|2016-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis|Pharmacokinetic (PK) Study of ASP8825 - Evaluation of Pharmacokinetics in Patients With Impaired Renal Function and Haemodialysis|Completed||Phase 1|18|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 22:39:50.902885|2017-10-10 22:39:50.902885
NCT02629211|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-08-21|||June 2016||2016-06-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD|Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD|Recruiting||N/A|50|Anticipated|Smart Medical Systems Ltd.||1|||f||||f||||||||||2017-10-10 22:39:51.071765|2017-10-10 22:39:51.071765
NCT02629198|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-09|||October 2012||2012-10-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||The Effect of Body Weight on Vitamin D Metabolism|The Effect of Body Weight on Vitamin D Metabolism|Completed||N/A|112|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||3||f||||f||||||Samples With DNA|"     serum, plasma, urine, DNA   "|No||2017-10-10 22:39:51.220343|2017-10-10 22:39:51.220343
NCT02629185|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-09|||September 2010||2010-09-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Effects of Obesity on Bone Structure and Strength|The Effects of Obesity on Bone Structure and Strength|Completed||N/A|258|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||3||f||||f||||||Samples With DNA|"     Serum, plasma, urine, DNA   "|||2017-10-10 22:39:51.332311|2017-10-10 22:39:51.332311
NCT02629172|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-08-21|||January 5, 2016||2016-01-05|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1|Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1|Active, not recruiting||N/A|3000|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:39:51.528091|2017-10-10 22:39:51.528091
NCT02629146|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-03-10|||December 2015||2015-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|GabA01||Analgesic Effects of Midazolam in Human Volunteers|A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled, Three-way Cross-over Study of the Analgesic Effects of Midazolam Versus Placebo With Fentanyl as an Active Control in Human Volunteers|Completed||Phase 4|24|Actual|Wilhelminenspital Vienna||3|||f||||f||||||||No||2017-10-10 22:39:53.586237|2017-10-10 22:39:53.586237
NCT02629133|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-11-02|||March 2016||2016-03-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Intervention for Battered Sheltered Women With Substance Use (Open Trial and Randomized Trial)|Computer-Based Intervention for Battered Sheltered Women With Substance Use (Open Trial and Randomized Trial)|Recruiting||N/A|50|Anticipated|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||No||2017-10-10 22:39:53.705505|2017-10-10 22:39:53.705505
NCT02629107|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-06-30|||December 2, 2015||2015-12-02|January 24, 2017|2017-01-24|February 27, 2018|Anticipated|2018-02-27|February 27, 2018|Anticipated|2018-02-27||Observational|||Functional Magnetic Resonance Imaging Sleep Study With Auditory Stimuli|An All-Night Functional Magnetic Resonance Imaging Sleep Study With Auditory Stimuli|Recruiting||N/A|173|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:39:53.954271|2017-10-10 22:39:53.954271
NCT02629094|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-10|2017-09-12|||December 2, 2015||2015-12-02|September 11, 2017|2017-09-11|September 11, 2017|Actual|2017-09-11|September 11, 2017|Actual|2017-09-11||Interventional|||Cardiometabolic Effects of Eplerenone in HIV Infection|Cardiometabolic Effects of Eplerenone in HIV Infection|Terminated||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:39:54.137041|2017-10-10 22:39:54.137041
NCT02629081|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-07-11|||March 2015||2015-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|||Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease|Image-Enhanced Endoscopy for the Diagnosis of Non-Erosive Reflux Disease: A Prospective Case-Control Trial|Completed||N/A|90|Actual|Yale University|||1||f||||f||||||||Undecided||2017-10-10 22:39:54.27867|2017-10-10 22:39:54.27867
NCT02629068|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-10-25|||October 2016||2016-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||PURPOSE: A Social Media Intervention for Parent Support|Parents United With Responsive Parents for Online Support and Education PURPOSE: A Social Media Intervention for Parent Support|Recruiting||N/A|128|Anticipated|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-10 22:39:54.408464|2017-10-10 22:39:54.408464
NCT02629055|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-06-08|||November 2015||2015-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Respiratory EMG for NIV Titration in Stable COPD Patients|EMG Measurements of Respiratory Muscles for the Titration of Nocturnal Non-invasive Ventilation in Stable Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial|Terminated||N/A|1|Actual|University Medical Center Groningen||2||Insufficient recruitment during the predefined time frame for the study|f||||t||||||||||2017-10-10 22:39:54.533214|2017-10-10 22:39:54.533214
NCT02629042|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-08-22|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PULPISOLONE||Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis|Efficacy of Oral Prednisolone Versus Partial Endodontic Treatment on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis of Mandibular Molars: Non Inferiority Randomized Clinical Trial|Recruiting||Phase 3|120|Anticipated|University Hospital, Bordeaux||2|||f||||f|f|f||||||||2017-10-10 22:39:54.642455|2017-10-10 22:39:54.642455
NCT02629029|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-10-31|||May 2015||2015-05-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Interventional|||Multi-Modality Imaging for Head & Neck Cancer Free Flap Design Assessment|Multi-Modality Imaging for Head & Neck Cancer Free Flap Design and Assessment|Recruiting||N/A|30|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:39:54.848195|2017-10-10 22:39:54.848195
NCT02629016|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-09|||September 2015||2015-09-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Stress Reduction: A Pilot Study With Adolescents|Stress Reduction: A Pilot Study With Adolescents|Active, not recruiting||N/A|320|Anticipated|Oregon Health and Science University||3|||f||||||||||||||2017-10-10 22:39:54.979024|2017-10-10 22:39:54.979024
NCT02629003|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-10-06|||December 2015||2015-12-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||[11C]Cimbi-36 Dosimetry|Evaluation of Radiation Dose for [11C]Cimbi-36|Recruiting||Phase 1|10|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 22:39:55.090775|2017-10-10 22:39:55.090775
NCT02628990|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-09|||June 2005||2005-06-01|December 2015|2015-12-01|November 2005|Actual|2005-11-01|August 2005|Actual|2005-08-01||Interventional|||Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks|The Effect of Plant Stanol Ester Yoghurt Drinks With or Without Added Camelina Oil on Serum Lipids in Comparison to Placebo in Subjects With Mildly to Moderately Elevated Serum Cholesterol Concentrations|Completed||N/A|155|Actual|Raisio Group||5|||f||||f||||||||||2017-10-10 22:39:55.222152|2017-10-10 22:39:55.222152
NCT02628977|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-12-28|||November 2015||2015-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Sleep Health Education and Social Support Among Blacks With OSA|Tailored Peer-Based Sleep Health Education and Social Support Among Blacks With Obstructive Sleep Apnea|Recruiting||N/A|398|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:39:55.401566|2017-10-10 22:39:55.401566
NCT02628964|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-07|||May 2015||2015-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy|Assessing the Use of Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy|Active, not recruiting||N/A|100|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:39:55.573023|2017-10-10 22:39:55.573023
NCT02628951|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-02-10|||May 26, 2016|Actual|2016-05-26|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis|Phase II Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis|Recruiting||Phase 2|61|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:39:55.719972|2017-10-10 22:39:55.719972
NCT02628938|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-04-05|2016-02-23||March 2014||2014-03-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Miswak and Miswak Extract on Oral Malodor|Effect of Miswak and Miswak Extract on Oral Malodor|Completed||Phase 2|212|Actual|Riyadh Colleges of Dentistry and Pharmacy||3|||f||||f||||||||||2017-10-10 22:39:55.893292|2017-10-10 22:39:55.893292
NCT02628925|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-10|||September 2014||2014-09-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Observational|Nu-DESC DK||Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale|Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale (Nu-DESC DK)|Completed||N/A|20|Actual|Naestved Hospital|||2||f||||f||||||||||2017-10-10 22:39:56.561255|2017-10-10 22:39:56.561255
NCT02628912|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-08-14|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers|Pilot Study of Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers|Recruiting||N/A|15|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"     blood   "|||2017-10-10 22:39:56.651963|2017-10-10 22:39:56.651963
NCT02628899|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-06-13|||January 2016||2016-01-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis||Recruiting||N/A|200|Anticipated|Medstar Health Research Institute||3|||f||||t||||||||||2017-10-10 22:39:56.795815|2017-10-10 22:39:56.795815
NCT02628886|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-08-28|||March 11, 2016|Actual|2016-03-11|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|PROPEL||Protecting From Pneumococcus in Early Life (The PROPEL Trial)|A Randomized, Controlled, Double-blind, Phase 3 Trial to Evaluate the Effects of Maternal or Neonatal Pneumococcal Conjugate Vaccination on Pneumococcal Carriage in Infants up to Nine Months of Age - The PROPEL Trial|Recruiting||Phase 3|600|Anticipated|Medical Research Council Unit, The Gambia||3|||f||||t||||||||||2017-10-10 22:39:56.969346|2017-10-10 22:39:56.969346
NCT02628873|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-08-31|||December 2015||2015-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|HyCoSy||Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement|Can Contrast Infused Sonography Using Air Bubbles Replace Hysterosalpingogram as the Diagnostic Evaluation of Fallopian Tube Patency Following Hysteroscopic Sterilization Using Essure|Enrolling by invitation||N/A|36|Anticipated|Wright State University||2|||f||||f|f|t|f|f|f|||||2017-10-10 22:39:57.08814|2017-10-10 22:39:57.08814
NCT02628860|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-03-27|||January 2014||2014-01-01|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|FCM||Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy|Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy|Recruiting||Phase 2|48|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||No||2017-10-10 22:39:57.232014|2017-10-10 22:39:57.232014
NCT02628834|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-12-09|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Acute Effect of Fascial Mobilization on Gait in Patients With Multiple Sclerosis|Investigating the Acute Effect of Fascial Mobilization on Dynamic Walking Parameters in Patients With Multiple Sclerosis: A Crossover Controlled Group Study|Not yet recruiting||N/A|20|Anticipated|Hacettepe University||3|||f||||t||||||||||2017-10-10 22:39:57.492064|2017-10-10 22:39:57.492064
NCT02628821|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-09|||January 2012||2012-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||The Effectiveness of Non-Invasive Ventilation Use in Preterm Infants.|Effectiveness of Synchronized Non-Invasive Ventilation to Prevent Invasive Mechanical Ventilation Use in Preterm Infants.|Completed||N/A|45|Actual|Hospital General Universitario Gregorio Marañon|||1||f||||t||||||||||2017-10-10 22:39:57.848747|2017-10-10 22:39:57.848747
NCT02628808|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-12-09|||August 2008||2008-08-01|November 2015|2015-11-01|August 2018|Anticipated|2018-08-01|August 2016|Anticipated|2016-08-01||Observational|||Susceptibility Genes in Autism Spectrum Disorders|Search of Susceptibility Genes in Autism Spectrum Disorders|Recruiting||N/A|1000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||t||||||Samples With DNA|"     DNA from subjects will be stored in the biobank of our study. From some patients with     deleterious mutations in synaptic genes, cells (PBMC, Keratinocytes ou Fibroblasts) will be     sampled from derivation in Induced Pluripotent Stem Cells.   "|||2017-10-10 22:39:57.94972|2017-10-10 22:39:57.94972
NCT02628795|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-09-07|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|TWEAK||Overcoming TWEAK Signaling to Restore Muscle and Mobility After Joint Replacement|Overcoming TWEAK Signaling to Restore Muscle and Mobility After Joint Replacement|Recruiting||N/A|88|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 22:39:58.067544|2017-10-10 22:39:58.067544
NCT02628782|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-01|||November 2013||2013-11-01|March 2017|2017-03-01||||November 2017|Anticipated|2017-11-01||Interventional|InSealVCD||InSeal VCD Large Bore Vascular Closure Device Safety and Effectiveness Clinical Study|InSeal VCD Large Bore Vascular Closure Device Clinical Study|Recruiting||N/A|60|Anticipated|InSeal Medical Ltd.||1|||f||||f||||||||||2017-10-10 22:39:58.211001|2017-10-10 22:39:58.211001
NCT02628769|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-01-13|||July 2015||2015-07-01|July 2016|2016-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease|A Single-center, Double-blind, Randomised, Placebo-controlled Crossover Study to Evaluate the Effect of Solithromycin on Airway Inflammation in Male and Female Patients With Chronic Obstructive Pulmonary Disease|Terminated||Phase 2|5|Actual|Imperial College London||2|||f||||t||||||||||2017-10-10 22:39:58.32129|2017-10-10 22:39:58.32129
NCT02628756|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-10|||June 2013||2013-06-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Endometrial Injury in Women With Unexplained Infertility|Endometrial Injury Does Not Improve Pregnancy Rates in Women With Unexplained Infertility|Completed||N/A|120|Actual|Mansoura Integrated Fertility Center||1|||f||||f||||||||||2017-10-10 22:39:58.511793|2017-10-10 22:39:58.511793
NCT02628743|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-07|||January 20, 2016|Actual|2016-01-20|July 2017|2017-07-01|April 23, 2021|Anticipated|2021-04-23|April 23, 2021|Anticipated|2021-04-23||Interventional|||A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Participants With Spinal Muscular Atrophy (SMA)|Multicenter, Open-Label, Single Arm Study to Evaluate Long-Term Safety, Tolerability, and Effectiveness of 10 mg/kg Olesoxime in Patients With SMA|Active, not recruiting||Phase 2|129|Actual|Hoffmann-La Roche||1|||f|||||t|f||||||||2017-10-10 22:39:58.609576|2017-10-10 22:39:58.609576
NCT02628730|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-07-03|||February 2016||2016-02-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRAISE||Pulmonary Vein Reconnection Following Ablation Index-guided Ablation: a Success Evaluation|Pulmonary Vein Reconnection Following Ablation Index-guided Ablation: a Success Evaluation (PRAISE)|Active, not recruiting||N/A|40|Actual|Liverpool Heart and Chest Hospital NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:39:58.809407|2017-10-10 22:39:58.809407
NCT02628717|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-09-02|||July 2013||2013-07-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|December 2016|Actual|2016-12-01|3 Years|Observational [Patient Registry]|AURIC||Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)|Interferon/Ribavirin-Free Sofosbuvir Based Treatment Regimens In Patients With Advanced Liver Disease - Results Of A Real-Life Austrian Ribavirin-/Interferon Free Cohort (AURIC)|Completed||N/A|558|Actual|Medical University of Vienna|||4||f||||f||||||||||2017-10-10 22:39:59.000463|2017-10-10 22:39:59.000463
NCT02628704|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-28|||December 2015||2015-12-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|SCORE||Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma|Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Selinexor (KPT-330), Carfilzomib, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With a Proteasome Inhibitor and an Immunomodulatory Drug|Withdrawn||Phase 2|0|Actual|Karyopharm Therapeutics Inc||2|||f||||t||||||||Yes||2017-10-10 22:39:59.110708|2017-10-10 22:39:59.110708
NCT02628691|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-08-22|||December 17, 2015|Actual|2015-12-17|August 2017|2017-08-01|July 12, 2017|Actual|2017-07-12|July 12, 2017|Actual|2017-07-12||Observational|HCV-Monitoring||Monitoring Liver Disease Progression in Hepatitis C/HIV Co-infected Patients With No-to-moderate Fibrosis, in Phnom Penh, Cambodia|Monitoring Liver Disease Progression in Hepatitis C/HIV Co-infected Patients With No-to-moderate Fibrosis, in Phnom Penh, Cambodia (HCV-Monitoring)|Terminated||N/A|70|Anticipated|Institute of Tropical Medicine, Belgium|||1|All patients were started on HCV treatment|f||||f||||||Samples Without DNA|"     Left over biological samples (whole blood plasma and serum)   "|||2017-10-10 22:39:59.25798|2017-10-10 22:39:59.25798
NCT02628678|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-08-29|||November 2015||2015-11-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers|An Open-label Study to Evaluate the Effect of Diet on the Tolerability of FOS, a Commercially Available Prebiotic, in Healthy Volunteers|Completed||N/A|7|Actual|Kaleido Biosciences||1|||f||||||||||||||2017-10-10 22:39:59.385763|2017-10-10 22:39:59.385763
NCT02628470|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-04-24|||December 2016|Actual|2016-12-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effects of Cervical Manipulation and Mobilization on Salivary Cortisol Concentrations|Effects of Cervical Manipulation and Mobilization on Salivary Cortisol Concentrations|Completed||N/A|54|Actual|University of Alcala||3|||f||||t|f|f||||||Undecided||2017-10-10 22:40:01.661146|2017-10-10 22:40:01.661146
NCT02628665|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-10|||October 2015||2015-10-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer|Two-arm Phase III Trial Comparing Different Time of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer|Recruiting||Phase 3|40|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology||2|||f||||t||||||||||2017-10-10 22:39:59.50115|2017-10-10 22:39:59.50115
NCT02628652|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-02-22|||October 2015||2015-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study to Evaluate the Tolerability of Prebiotics on the Microbiota|A Randomised, Single-Blind, Controlled Study to Evaluate the Tolerability of Prebiotics on the Microbiota|Completed||N/A|45|Actual|Kaleido Biosciences||3|||f||||||||||||||2017-10-10 22:39:59.665996|2017-10-10 22:39:59.665996
NCT02628639|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-10|||January 2016||2016-01-01|December 2015|2015-12-01||||December 2017|Anticipated|2017-12-01||Interventional|CONPHIDENSE||Optimizing the Evaluation of Awareness in Disorders of Consciousness|Using High-resolution Electroencephalography to Optimize the Evaluation of Awareness in Patients With Disorders of Consciousness|Not yet recruiting||N/A|28|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 22:39:59.797417|2017-10-10 22:39:59.797417
NCT02628626|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-18|||November 2015||2015-11-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of Colesevelam in Fecal Incontinence|A Placebo Controlled Study of Colesevelam in Fecal Incontinence|Recruiting||Phase 3|60|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:39:59.91135|2017-10-10 22:39:59.91135
NCT02628613|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2015-12-10|||April 2015||2015-04-01|December 2015|2015-12-01|December 2025|Anticipated|2025-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Neoadjuvant Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Epirubicin for TEKT4 Variation Breast Cancer Patients|Comparison of Paclitaxel Plus Carboplatin and Vinorelbine Plus Epirubicin for Neoadjuvant Chemotherapy in Locally Advanced (IIb-IIIc) HER-2(-) Breast Cancer With TEKT4 Variation: Efficiency and Safety|Recruiting||Phase 3|94|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 22:40:00.094314|2017-10-10 22:40:00.094314
NCT02628600|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-09-27|||December 2015||2015-12-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212||Enrolling by invitation||Phase 3|200|Anticipated|Insmed Incorporated||1|||f||||||||||||||2017-10-10 22:40:00.255014|2017-10-10 22:40:00.255014
NCT02628587|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-09|||February 2016||2016-02-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Patent Versus Generic Clopidogrel in Acute Coronary Syndrome|Comparison of Platelet Reactivity in Patients With Acute Coronary Syndrome Given Patent Clopidogrel Versus Generic Clopidogrel: Randomized Controlled Trial|Not yet recruiting||Phase 4|60|Anticipated|Hospital Central San Luis Potosi, Mexico||2|||f||||f||||||||Undecided||2017-10-10 22:40:00.403981|2017-10-10 22:40:00.403981
NCT02628574|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-02-13|||December 2015||2015-12-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Dose Escalation Study of TRX518 in Adults With Advanced Solid Tumors|A Two Part, Phase 1, Multicenter, Open-label Study of TRX518 in Adults With Advanced Solid Tumors Part A: A Dose-Escalation Study of Multi-dose TRX518 Monotherapy Part B: An Expansion Cohort of Multi-dose TRX518 Monotherapy at the Maximum Tolerated Dose|Recruiting||Phase 1|44|Anticipated|Leap Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 22:40:00.498627|2017-10-10 22:40:00.498627
NCT02628561|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-04-03|||January 2016||2016-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Transcranial Direct Current Stimulation Associate to Constraint Induced Movement Therapy Over Premotor Cortex in Severe Stroke||Completed||Phase 1/Phase 2|60|Actual|Federal University of Paraíba||3|||f||||f||||||||||2017-10-10 22:40:00.641446|2017-10-10 22:40:00.641446
NCT02628548|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-08-01|||November 2015||2015-11-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Neural Correlates of Successful Cognitive Aging|Neural and Cognitive Changes Associated With Mental Training in Older Adults|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:40:00.780857|2017-10-10 22:40:00.780857
NCT02628535|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-10-04|||September 2015||2015-09-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety Study of MGD009 in B7-H3-expressing Tumors|Phase 1, First-in-Human, Open Label, Dose Escalation Study of MGD009, A Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART) Protein in Patients With Unresectable or Metastatic B7-H3-Expressing Neoplasms|Recruiting||Phase 1|114|Anticipated|MacroGenics||1|||f||||f||||||||||2017-10-10 22:40:00.917362|2017-10-10 22:40:00.917362
NCT02628522|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-10|||December 2014||2014-12-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|||A Novel Method for Chronic Anal Fissure Treatment|A Novel Method for Chronic Anal Fissure Treatment: Adipose Derived Regenerative Cells - A Pilot Study|Completed||N/A|6|Actual|Clinical Centre of Serbia||1|||f||||f||||||||No||2017-10-10 22:40:01.141881|2017-10-10 22:40:01.141881
NCT02628509|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-02-08|||August 2012|Actual|2012-08-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|WiTAVi||Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedure|Onset and Offset of Von Willebrand Factor Multimemirization Defects in Cardiovascular Disease: the Case of the Molecular Sensor of Blood Flow|Recruiting||N/A|500|Anticipated|University Hospital, Lille|||1||f||||f||||||||No||2017-10-10 22:40:01.269741|2017-10-10 22:40:01.269741
NCT02628496|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-09-08|||April 2015||2015-04-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Confocal Laser Microlaryngoscopy (CLMx)|Confocal Laser Microlaryngoscopy (CLMx): A Novel Tool for Noninvasive Evaluation of Laryngeal Lesions|Withdrawn||N/A|0|Actual|Washington University School of Medicine||1||Lost funding/staff|f||||f||||||||No||2017-10-10 22:40:01.441996|2017-10-10 22:40:01.441996
NCT02628483|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-12-13|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Comparator Trial on the Relative Efficacy of Two Triglyceride Forms of Fish Oil|A Randomized, Double-blind, Parallel Clinical Trial to Compare the Relative Efficacy of Two Triglyceride Forms of Fish Oil, Ultimate Omega®, and a Comparator Product, in Improving Red Blood Cell Fatty Acid Profiles in Healthy Adults (FORCE Study)|Completed||Phase 2|60|Actual|Nordic Pharma, USA||2|||f||||f||||||||No||2017-10-10 22:40:01.557403|2017-10-10 22:40:01.557403
NCT02628457|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-10|||December 2015||2015-12-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Did MRI Appearance of Supraspinatus Muscle Atrophy Changes After Repair of All Kind of Rotator Cuff Tear?|Did MRI Appearance of Supraspinatus Muscle Atrophy Changes After Repair of All Kind of Rotator Cuff Tear?|Active, not recruiting||N/A|209|Actual|CM Chungmu Hospital|||3||f||||t||||||||No|Sharing of data on the website is against the policy of IRB Korea|2017-10-10 22:40:01.798667|2017-10-10 22:40:01.798667
NCT02628444|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-06-28|||May 2, 2016|Actual|2016-05-02|June 2017|2017-06-01|March 19, 2020|Anticipated|2020-03-19|March 19, 2020|Anticipated|2020-03-19||Interventional|||Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age|Immunogenicity and Safety of Tetravalent Dengue Vaccine Given in 1 , 2 , or 3 Dose Schedules (STAGE I) Followed by a Single Booster Injection of the Same Vaccine (STAGE II) 1 or 2 Years After the Last Primary Dose in Healthy Subjects 9 to 50 Years of Age in Colombia and the Philippines|Active, not recruiting||Phase 2|1050|Actual|Sanofi||3|||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-10 22:40:01.928688|2017-10-10 22:40:01.928688
NCT02628431|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2016-09-06|||October 2015||2015-10-01|September 2016|2016-09-01||||September 2016|Anticipated|2016-09-01||Observational|||The Application of the ELFI-TECH Monitor for Perioperative Hemodynamic Measurements|The Application of the ELFI-TECH Monitor for Measurement of Blood Pressure, Cardiac Output and Extend of Regional and Neuraxial Anesthesia: The Elfitor Study|Recruiting||N/A|60|Anticipated|Leiden University Medical Center|||2||f||||t||||||||Undecided||2017-10-10 22:40:02.060967|2017-10-10 22:40:02.060967
NCT02628418|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-08-03|2016-02-05||May 2013||2013-05-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Feasibility and Efficacy of a Robotic Device for Hand Rehabilitation|Feasibility and Efficacy of a Robotic Device for Hand Rehabilitation in Hemiplegic Stroke Patients: a Randomized Pilot Controlled Study|Completed||N/A|30|Actual|Fondazione Salvatore Maugeri||2|||f||||f||||||||||2017-10-10 22:40:02.183488|2017-10-10 22:40:02.183488
NCT02628405|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-05-23|||May 2016||2016-05-01|May 2017|2017-05-01|January 2023|Anticipated|2023-01-01|May 2018|Anticipated|2018-05-01||Interventional|||R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma|Phase I/II, Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) With Lenalidomide (R2-ICE) in Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Recruiting||Phase 1/Phase 2|63|Anticipated|Academic and Community Cancer Research United||1|||f||||t||||||||||2017-10-10 22:40:02.660064|2017-10-10 22:40:02.660064
NCT02628392|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-01-11|||November 2015||2015-11-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)|A Phase 2, Randomized, Double-blind, Dose Finding Study of DS-8500a in Japanese Patients With Type 2 Diabetes Mellitus|Completed||N/A|368|Actual|Daiichi Sankyo, Inc.||5|||f||||f||||||||||2017-10-10 22:40:03.033948|2017-10-10 22:40:03.033948
NCT02628379|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-04-10|||May 2015||2015-05-01|April 2017|2017-04-01||||March 2017|Actual|2017-03-01||Observational|||Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary|A Prospective Observational Trial Evaluating Outcomes of FoundationOne - Directed Matched Targeted Therapy in Patients With Cancer of Unknown Primary (CUP)|Completed||N/A|500|Anticipated|Foundation Medicine|||3||f||||f||||||||||2017-10-10 22:40:03.193914|2017-10-10 22:40:03.193914
NCT02628366|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-12-08|||April 2016||2016-04-01|October 2015|2015-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|MY TEMP||Major Cardiovascular and Other Patient-important Outcomes With Personalized dialYsate TEMPerature|Major Cardiovascular and Other Patient-important Outcomes With Personalized dialYsate TEMPerature|Enrolling by invitation||N/A|82|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-10 22:40:03.303853|2017-10-10 22:40:03.303853
NCT02628353|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-01-31|||December 2015||2015-12-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|PHENOLPRESS||Effect of a Specific Phenolic Compound on Blood Pressure|Randomized, Cross-over, Double Blinded, Placebo-controlled Study for the Evaluation of the Postprandial Effect of a Specific PHENOLic Compound on Blood PRESSure|Recruiting||Phase 3|11|Anticipated|Technological Centre of Nutrition and Health, Spain||2|||f||||f||||||||||2017-10-10 22:40:03.491277|2017-10-10 22:40:03.491277
NCT02628340|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-08-01|||June 2014||2014-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|RESACHRON||Comprehensive Analysis of HIV Reservoirs in Chronically Infected HIV-1 Treated Patients|Comprehensive Analysis of HIV Reservoirs in Chronically Infected HIV-1 Treated Patients With a Low Total Cell-associated Blood HIV-DNA|Completed||N/A|20|Actual|Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida|||1||f||||t||||||||||2017-10-10 22:40:03.645213|2017-10-10 22:40:03.645213
NCT02628327|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-08|||June 2015||2015-06-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Observational|FIPSS||Factors Influencing Patient Satisfaction in a Glaucoma Population|Factors Influencing Patient Satisfaction in a Glaucoma Population|Completed||N/A|250|Actual|Wills Eye|||1||f||||f||||||||Yes|A manuscript has been submitted to the Journal of Medical Quality|2017-10-10 22:40:03.743298|2017-10-10 22:40:03.743298
NCT02628314|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-05-30|||July 2015||2015-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Reliability of Pupil Response to Acute Pain|Reliability of Pupil Response to Acute Pain|Recruiting||N/A|80|Anticipated|Wake Forest University Health Sciences|||1||f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-10 22:40:03.8525|2017-10-10 22:40:03.8525
NCT02628301|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-07-25|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|DESIRE||Microvascular Dysfunction and the Development of Whole-body Insulin Resistance|Is Microvascular Dysfunction an Early Phenomenon in the Development of Skeletal Muscle Insulin Resistance? A Dietary Intervention Study in Healthy Men|Completed||N/A|20|Actual|VU University Medical Center||2|||f||||t||||||||||2017-10-10 22:40:03.958949|2017-10-10 22:40:03.958949
NCT02624284|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-05-02|||November 2015||2015-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RDR||tDCS Effects on Resisting Smoking: Dose Ranging Study|tDCS Effects on Resisting Smoking: Dose Ranging Study|Recruiting||N/A|130|Anticipated|University of Pennsylvania||3|||f||||f||||||||||2017-10-10 22:40:56.891536|2017-10-10 22:40:56.891536
NCT02628288|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-12-08|||December 2015||2015-12-01|November 2015|2015-11-01|November 2020|Anticipated|2020-11-01|March 2020|Anticipated|2020-03-01||Interventional|COBRAII||COmplex Bifurcation PCI: AXXESS Device + Absorb BVS, vs Modified T Stenting With Absorb BVS|COmplex Bifurcation Lesions: a RAndomized Comparison Between the AXXESS Device in Combination With Absorb BVS, and Modified T Stenting With Absorb BVS: an OCT Study.|Not yet recruiting||N/A|60|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 22:40:04.103521|2017-10-10 22:40:04.103521
NCT02628275|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2016-09-07|||December 2015||2015-12-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|MoMA||Impact of Mild or Moderate Physical Activity and Progression of Subclinical Atherosclerosis|Will Mild vs. Moderate Physical Activity Suffice to Abate the Progression of Subclinical Atherosclerosis in Sedentary Adults?|Recruiting||N/A|270|Anticipated|Laval University||3|||f||||f||||||||||2017-10-10 22:40:04.243692|2017-10-10 22:40:04.243692
NCT02628262|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-08|||April 2013||2013-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Observational|||Fundus Autofluorescence After Macular Hole Surgery|Fundus Autofluorescence Images in Gas-filled Eyes Immediately After Macular Hole Surgery|Completed||N/A|27|Actual|Kyorin University|||1||f||||f||||||||No||2017-10-10 22:40:04.373829|2017-10-10 22:40:04.373829
NCT02628249|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-05-01|||September 2015||2015-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|EA||Rate-limiting Amino Acids in Endurance-trained Athlete|Application of Indicator Amino Acid Oxidation Method to Investigate the Rate-limiting Amino Acids in Endurance Trained Athlete|Active, not recruiting||N/A|5|Anticipated|University of Toronto||5|||f||||f||||||||||2017-10-10 22:40:04.452292|2017-10-10 22:40:04.452292
NCT02628236|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-09-13|2017-08-14||February 2016||2016-02-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)|A Pharmacokinetic Study of Levulan Kerastick (Aminolevulinic Acid HCl) for Topical Solution, 20% Under Maximal Use Conditions|Completed||Phase 2|14|Actual|DUSA Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:40:04.567853|2017-10-10 22:40:04.567853
NCT02628223|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-01-25|||September 2014||2014-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma|A Randomized Trial of 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma|Enrolling by invitation||N/A|111|Anticipated|Temple University||2|||f||||t||||||||No||2017-10-10 22:40:05.463391|2017-10-10 22:40:05.463391
NCT02628197|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-10|||December 2013||2013-12-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Periodontitis on Bone Mineral Density in Postmenopausal Women|Effect of Periodontitis on Bone Mineral Density in Postmenopausal Women|Completed||N/A|68|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t||||||||||2017-10-10 22:40:05.665349|2017-10-10 22:40:05.665349
NCT02628184|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-02-03|||January 2016||2016-01-01|February 2016|2016-02-01||||September 2016|Anticipated|2016-09-01||Observational|||A Case Study of a Maternity Service Development Programme|A Case Study of a Maternity Service Development Programme and Its Influence on Inter-agency Collaboration|Recruiting||N/A|20|Anticipated|University of Southampton|||1||f||||f||||||||||2017-10-10 22:40:05.738205|2017-10-10 22:40:05.738205
NCT02628171|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Impact of Cashew Nuts in the Human Diet: Measured Energy Value and Effects on Cardiovascular Disease Risk Factors||Completed||N/A|42|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 22:40:05.816513|2017-10-10 22:40:05.816513
NCT02628158|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-08|||April 2013||2013-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Observational|||Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane|Correlation of Postoperative Vision and Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane|Completed||N/A|91|Actual|Kyorin University|||1||f||||f||||||||Undecided||2017-10-10 22:40:05.896116|2017-10-10 22:40:05.896116
NCT02628145|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-25|||August 2015||2015-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|RESTORE-ME||Effects of a Resistance Training Program in Older Women With Sarcopenia|Effects of a Resistance Training Program in Older Women With Sarcopenia|Completed||N/A|25|Actual|University of Rhode Island||2|||f||||f||||||||Undecided||2017-10-10 22:40:05.957668|2017-10-10 22:40:05.957668
NCT02628132|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-12-12|||July 2016||2016-07-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients|Study of the Safety, Tolerability and Efficacy of the Investigational Anti PD-L1 Monoclonal Antibody Durvalumab in Combination With Paclitaxel in Patients With Metastatic Triple Negative PD-L1 Positive Breast Cancer|Recruiting||Phase 1/Phase 2|34|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-10-10 22:40:06.058092|2017-10-10 22:40:06.058092
NCT02628119|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-10-03|||October 2015||2015-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|FBI||Access Flow Based Intervention for Management of Arteriovenous Hemodialysis Access Dysfunction.|Access Flow Based Intervention for Management of Arteriovenous Hemodialysis Access Dysfunction. A Prospective Randomized Controlled Study.|Recruiting||N/A|140|Anticipated|King Faisal Specialist Hospital & Research Center||2|||f||||t||||||||Yes||2017-10-10 22:40:06.280388|2017-10-10 22:40:06.280388
NCT02628106|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-11-02|2016-03-10||December 2015||2015-12-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional||age > 18 years|Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy|Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients|Completed||Phase 4|21|Actual|West China Hospital|the small study population and absence of a placebo group and healthy volunteers.|1|||f||||t||||||||No||2017-10-10 22:40:06.3726|2017-10-10 22:40:06.3726
NCT02628093|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-10|||February 17, 2016|Actual|2016-02-17|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||A ProspectiveTrial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery|A Randomized Controlled Trial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery|Recruiting||N/A|60|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-10 22:40:06.522548|2017-10-10 22:40:06.522548
NCT02628080|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-04-12|||May 2016||2016-05-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|November 2017|Anticipated|2017-11-01||Interventional|ATOM||Atovaquone as Tumour HypOxia Modifier|Pre-operative Window of Opportunity Study of the Effects of Atovaquone on Hypoxia in Non-small Cell Lung Carcinoma|Recruiting||Early Phase 1|30|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-10 22:40:06.611082|2017-10-10 22:40:06.611082
NCT02628054|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-12-08|||February 2015||2015-02-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers|Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers|Completed||N/A|16|Actual|University of Oxford||2|||f||||f||||||||||2017-10-10 22:40:06.910397|2017-10-10 22:40:06.910397
NCT02628041|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-02-28|||October 2015||2015-10-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|HDRvsLDR||HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer|A Phase II Randomized Trial Evaluating Acute and Late Toxicity of High-Dose Rate Brachytherapy and Low-Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer|Active, not recruiting||Phase 2|30|Actual|CHU de Quebec-Universite Laval||2|||f||||t||||||||Undecided||2017-10-10 22:40:06.998903|2017-10-10 22:40:06.998903
NCT02628028|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-10-04|||August 2016||2016-08-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|August 2018|Anticipated|2018-08-01||Interventional|RAjuvenate||A Study of LY3337641 in Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase 2 Study to Evaluate the Safety and Efficacy of LY3337641 in Adult Subjects With Rheumatoid Arthritis: The RAjuvenate Study|Recruiting||Phase 2|276|Anticipated|Eli Lilly and Company||8|||f||||f||||||||||2017-10-10 22:40:07.100585|2017-10-10 22:40:07.100585
NCT02628015|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2016-03-11|||March 2016||2016-03-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Theory of Mind in Preschool Children, School Children, Youths and Adults Born Preterm or Full-term|Theory of Mind Bei Ehemals früh- Und Reifgeborenen Vorschulkindern, Schulkindern, Jugendlichen Und Erwachsenen|Recruiting||N/A|480|Anticipated|University of Bonn|||8||f||||f||||||||||2017-10-10 22:40:09.218585|2017-10-10 22:40:09.218585
NCT02628002|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-05-04|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging|Comparison of Anti-gravity Treadmill Exercise and Regadenoson Tc-99m Tetrofosmin Single-photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging|Completed||N/A|49|Actual|University of Cincinnati||2|||f||||t||||||||No||2017-10-10 22:40:09.313673|2017-10-10 22:40:09.313673
NCT02627989|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-02-09|||December 2015||2015-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Observational|Ointment TS-AD||An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids|An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids|Completed||N/A|55|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:40:09.403898|2017-10-10 22:40:09.403898
NCT02627976|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-08|||February 2016||2016-02-01|December 2015|2015-12-01|August 2018|Anticipated|2018-08-01|February 2017|Anticipated|2017-02-01||Interventional|||Breast Edema Compression Vest|The Effect of Wearing a Compression Vest on Patient Reported Pain, Quality of Life and Degree of Breast Edema.|Not yet recruiting||N/A|40|Anticipated|UMC Utrecht||1|||f||||t||||||||Undecided||2017-10-10 22:40:09.488131|2017-10-10 22:40:09.488131
NCT02627963|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-08-22|||April 2016||2016-04-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study to Compare Tivozanib Hydrochloride to Sorafenib in Subjects With Refractory Advanced RCC|A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib Hydrochloride to Sorafenib in Subjects With Refractory Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 3|322|Anticipated|AVEO Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:40:09.597283|2017-10-10 22:40:09.597283
NCT02627950|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-10-24|||December 2015||2015-12-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|MonAMI||Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction|Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction|Recruiting||Phase 4|138|Anticipated|University of Luebeck||3|||f||||f||||||||||2017-10-10 22:40:10.189976|2017-10-10 22:40:10.189976
NCT02627937|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-12-09|||June 2015||2015-06-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Actual|2015-12-01||Observational|PEDOSA||Clinical Predictors of Pediatric OSAHS|Clinical Predictors of Pediatric Obstructive Sleep Apnea/Hypopnea Syndrome|Unknown status|Recruiting|N/A|88|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||||||2017-10-10 22:40:10.327425|2017-10-10 22:40:10.327425
NCT02627924|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-07-07|||November 18, 2015||2015-11-18|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|ROCKA||Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab|Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab (ROCKA Study)|Active, not recruiting||N/A|100|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:40:10.427751|2017-10-10 22:40:10.427751
NCT02627742|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-09-11|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Evaluation of The MetaNeb® System to Reduce Postoperative Pulmonary Complications|Evaluation of a Practice Change to Include The MetaNeb® System to Reduce Postoperative Pulmonary Complications|Completed||N/A|419|Actual|Hill-Rom||1|||f||||f||||||||||2017-10-10 22:40:13.355986|2017-10-10 22:40:13.355986
NCT02627911|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-11-18|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|WP6-2||Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control|DIABELOOP WP6.2 : Crossover Evaluation of Glycemic Control Provided for Three Days by the Artificial Pancreas Diabeloop Compared to Conventional Treatment by External Insulin Pump in Patients With Type 1 Diabetes in Sedentary Position, Outstanding Meals and Physical Activity .|Completed||Phase 2|36|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||||2017-10-10 22:40:10.535756|2017-10-10 22:40:10.535756
NCT02627898|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-10|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes Mellitus|Effect of Green Tea Extract Administration on Arterial Stiffness in Patients With Type 2 Diabetes Mellitus|Not yet recruiting||Phase 2|24|Anticipated|Centro Universitario de Ciencias de la Salud, Mexico||2|||f||||f||||||||||2017-10-10 22:40:10.649204|2017-10-10 22:40:10.649204
NCT02627885|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-10|||December 2015||2015-12-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|Patrik||Internet-CBT for Parkinsons Disease|Internet-based Cognitive Behavioral Therapy to Increase Function and Quality of Life for Patients With Parkinsons Disease|Recruiting||N/A|64|Anticipated|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 22:40:11.449717|2017-10-10 22:40:11.449717
NCT02627872|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-01-31|||March 2007||2007-03-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|COSMIC||Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease|Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease|Active, not recruiting||N/A|120|Actual|Karolinska Institutet|||3||f||||f||||||Samples With DNA|"     Bronchoalveolar lavage (BAL) cells, BAL fluid, bronchial biopsies, airway epithelial     brushings, serum, plasma, and blood cells have been collected.   "|Yes|The deidentified clinical phenotype data has been disseminated through peer reviewed publication|2017-10-10 22:40:11.59706|2017-10-10 22:40:11.59706
NCT02627859|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-09-20|||June 2014||2014-06-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthritis Pain of the Ankle|A 26 Week Multicenter Prospective Open Label Clinical Study Evaluating a Single Intra-articular Injection of DUROLANE SJ1ml for Treatment of OA Pain of the Ankle|Active, not recruiting||Phase 4|37|Actual|Bioventus LLC||1|||f||||f||||||||Yes||2017-10-10 22:40:11.729466|2017-10-10 22:40:11.729466
NCT02627846|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-08|||June 2015||2015-06-01|December 2015|2015-12-01|September 2030|Anticipated|2030-09-01|September 2016|Anticipated|2016-09-01||Interventional|LAMA||Laser Ablation Versus Mechanochemical Ablation Trial|A Randomised Clinical Trial Comparing Endovenous Laser Ablation and Mechanochemical Ablation (ClariVein®) in the Management of Superficial Venous Insufficiency|Recruiting||Phase 4|140|Anticipated|University of Hull||2|||f||||t||||||||||2017-10-10 22:40:11.848014|2017-10-10 22:40:11.848014
NCT02627833|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2015-12-09|||October 2015||2015-10-01|December 2015|2015-12-01||||July 2016|Anticipated|2016-07-01||Observational|FRABO-03||Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BO|Lungfunction, Lung Clearance Index, Bronchial Inflammation and Epigenetics of Patients With Bronchiolitis Obliterans|Recruiting||N/A|20|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples With DNA|"     Cells of induced Sputum, blood sample   "|||2017-10-10 22:40:12.195341|2017-10-10 22:40:12.195341
NCT02627820|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-08-09|||January 2016||2016-01-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart|An 18 Month Open Label Study Of The Tolerability And Efficacy Of An Antisense Oligonucleotide In Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy (Senile Systemic Amyloidosis)|Withdrawn||Phase 2|0|Actual|Brigham and Women's Hospital||1|||f||||||||||||||2017-10-10 22:40:12.381265|2017-10-10 22:40:12.381265
NCT02627807|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-01-09|||December 2015||2015-12-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma|Prospective Non-inferiority Randomized Trial Comparing Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation and Traditional Clinical Target Volume in Radiotherapy for Nasopharyngeal Carcinoma|Recruiting||N/A|378|Anticipated|Sun Yat-sen University||2|||f||||f||||||||No||2017-10-10 22:40:12.525049|2017-10-10 22:40:12.525049
NCT02627781|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-08-31|||November 2015||2015-11-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01|6 Months|Observational [Patient Registry]|DIALAPP||Diagnostic Algorithm for Appendizitis (DIALAPP)|Evaluation of Diagnostic Algorithm for Suspected Acute Appendicitis|Recruiting||N/A|400|Anticipated|Goethe University|||1||f||||t||||||||||2017-10-10 22:40:12.829092|2017-10-10 22:40:12.829092
NCT02627768|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-10-03|||December 17, 2015|Actual|2015-12-17|October 2017|2017-10-01|December 21, 2020|Anticipated|2020-12-21|December 1, 2020|Anticipated|2020-12-01||Observational|PsaBio||A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis|Assessment of STELARA® (Ustekinumab) and Tumor Necrosis Factor Alpha Inhibitor Therapies in Patients With Psoriatic Arthritis in Standard Health-Care Practice; A Prospective, Observational Cohort|Recruiting||N/A|1400|Anticipated|Janssen Pharmaceutica N.V., Belgium|||2||f||||f||f||||||||2017-10-10 22:40:12.946357|2017-10-10 22:40:12.946357
NCT02627755|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-02-22|||November 21, 2016|Actual|2016-11-21|February 2017|2017-02-01|November 21, 2017|Anticipated|2017-11-21|October 2017|Anticipated|2017-10-01||Interventional|||GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways.|GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways. Assessment of a New Procedure for Endotracheal Intubation in Patients With Suspected Difficult Airways|Active, not recruiting||N/A|160|Anticipated|Hospital de Manises||2|||f||||f|f|f||||||||2017-10-10 22:40:13.263115|2017-10-10 22:40:13.263115
NCT02627729|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-09|||June 2009||2009-06-01|December 2015|2015-12-01|February 2014|Actual|2014-02-01|April 2012|Actual|2012-04-01||Interventional|||J-Pouch vs Side-to-End Anastomosis After Hand-Assisted Laparoscopic Low Anterior Resection for Rectal Cancer|J-Pouch vs Side-to-End Anastomosis After Hand-Assisted Laparoscopic Low Anterior Resection for Rectal Cancer: Short and Long-Term Outcomes of a Prospective Randomized Trial|Completed||N/A|74|Actual|Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi||2|||f||||f||||||||||2017-10-10 22:40:13.447606|2017-10-10 22:40:13.447606
NCT02627716|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-30|||December 2014||2014-12-01|May 2017|2017-05-01|July 2022|Anticipated|2022-07-01|January 2022|Anticipated|2022-01-01||Interventional|SOS||Joint Crisis Plan Effectiveness in Preventing Relapses in Schizophrenia and Schizoaffective Disorder|Effectiveness of a Joint Crisis Plan (SOS Plan) in Preventing Relapses in Patients Diagnosed With Schizophrenia and Schizoaffective Disorder|Recruiting||N/A|210|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 22:40:13.516999|2017-10-10 22:40:13.516999
NCT02627703|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-07-18|||May 2010||2010-05-01|July 2016|2016-07-01||||December 2017|Anticipated|2017-12-01||Observational|||(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer|A Prospective Clinical Utility Study of the Impact of the 21 Gene Recurrence Score® Assay (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer in Multiple BC Cancer Agency Centres|Recruiting||N/A|80|Anticipated|British Columbia Cancer Agency|||1||f||||f||||||||No||2017-10-10 22:40:13.626675|2017-10-10 22:40:13.626675
NCT02627690|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-02-01|||September 2014||2014-09-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|PRONOCELDIAB||Nephrologic Prognosis 10 Years After Diabetes Cell Therapy|Nephrologic Prognosis 10 Years After Diabetes Cell Therapy|Recruiting||N/A|50|Anticipated|University Hospital, Lille|||2||f||||f||||||Samples With DNA|"     serum and DNA   "|No||2017-10-10 22:40:13.698312|2017-10-10 22:40:13.698312
NCT02627677|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-09-05|||December 2015||2015-12-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Interventional|OPTIC-2L||A Study Comparing Ponatinib and Nilotinib in Patients With Chronic Myeloid Leukemia|A Randomized, Open-label Study of Ponatinib Versus Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase Following Resistance to Imatinib|Recruiting||Phase 3|600|Anticipated|Ariad Pharmaceuticals||3|||f||||t||||||||||2017-10-10 22:40:13.772282|2017-10-10 22:40:13.772282
NCT02627664|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-16|||March 2011|Actual|2011-03-01|May 2017|2017-05-01|February 9, 2017|Actual|2017-02-09|February 9, 2017|Actual|2017-02-09||Observational|ProdDiGYPark||Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease|Prospective Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease|Completed||N/A|70|Actual|University Hospital, Lille|||1||f||||t|f|f||||||No||2017-10-10 22:40:13.888557|2017-10-10 22:40:13.888557
NCT02627651|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-07-18|||January 2015||2015-01-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Interventional|||The Cardiac Autonomic System Response to Activity and Cognitive Tasksinjury|The Cardiac Autonomic System Response to Activity and Cognitive Tasks in Children Post Acquired Brain|Completed||N/A|36|Actual|Alyn Pediatric & Adolecent Rehabilitation Center||2|||f||||||||||||||2017-10-10 22:40:13.961934|2017-10-10 22:40:13.961934
NCT02627638|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-08-29|||April 2014||2014-04-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Cancer Patient Perceptions of the Osteopathy Treatment: a Qualitative Study|Cancer Patient Perceptions of the Osteopathy Treatment: a Qualitative Study|Completed||N/A|20|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:40:14.029038|2017-10-10 22:40:14.029038
NCT02627625|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-07-13|||November 2015||2015-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products|Phase I Randomised, Five-period Cross-over Study in Healthy Male and Female Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Three Test Products With Two Reference Products|Completed||Phase 1|31|Actual|3M||5|||f||||t||||||||Undecided|summary data will be available|2017-10-10 22:40:14.08991|2017-10-10 22:40:14.08991
NCT02627612|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-11-08|||June 2014||2014-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of ProVetus/Sponsorship Initiative|Evaluation of ProVetus/Sponsorship Initiative|Recruiting||N/A|600|Anticipated|Teachers College, Columbia University||3|||f||||f||||||||No||2017-10-10 22:40:14.286944|2017-10-10 22:40:14.286944
NCT02627599|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-02-26|||May 2015||2015-05-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|BRVB-OCD||A Prospective Observational Study of the Breath Responsive Variable Bolus Oxygen Conserving Device|A Study to Evaluate Improvement in the Quality of Life and Health and Economic Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)|Active, not recruiting||N/A|35|Actual|StratiHealth|||1||f||||t||||||||No|Results will be submitted for publication in peer review|2017-10-10 22:40:14.416915|2017-10-10 22:40:14.416915
NCT02627586|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-02|||June 2015||2015-06-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|September 2019|Anticipated|2019-09-01||Interventional|HIIT-EARLY||High-Intensity Interval Training Early After Left Ventricular Myocardial Infarction|High Intensity Interval Training & Early Adverse Remodelling After Left Ventricular mYocardial Infarction (HIIT-EARLY): A Randomized Controlled Exercise Intervention Study|Enrolling by invitation||N/A|144|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 22:40:14.567602|2017-10-10 22:40:14.567602
NCT02627573|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-08-21|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT|Randomized Trial of GVHD Prophylasxis With Post-transplantation Cyclophocphomide (PTCy) or Thymoglobulin in Unrelated SCT Recepients With Chronic Myeloproliferative Neoplasms and Myelodisplatic Syndrome|Recruiting||Phase 2|60|Anticipated|St. Petersburg State Pavlov Medical University||2|||f||||t||||||||||2017-10-10 22:40:14.707252|2017-10-10 22:40:14.707252
NCT02627560|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-06|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing Mastectomy|The Effect of Topical Administration of Tranexamic Acid on Postoperative Bleeding and Seroma Formation in Patients Undergoing Mastectomy: A Prospective Placebo-controlled Double Blinded Randomized Study|Recruiting||Phase 4|200|Anticipated|St. Olavs Hospital||2|||f||||t|f|f||||||No||2017-10-10 22:40:14.88339|2017-10-10 22:40:14.88339
NCT02627534|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-10|||April 2014||2014-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Adjunct Photodynamic Therapy in the Treatment of Type 2 Diabetic Patients With Chronic Periodontitis|Local Effects of Adjunct Photodynamic Therapy in the Treatment of Type 2 Diabetic Patients With Chronic Periodontitis: Split-mouth Randomized Triple-blind Clinical Trial|Completed||N/A|20|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||||2017-10-10 22:40:15.146117|2017-10-10 22:40:15.146117
NCT02627521|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-02-15|||July 2015||2015-07-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CABG-TIME||Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor|Optimizing Timing of Coronary Artery Bypass Surgery in Patients Presenting With Acute Coronary Syndrome and Treated With Second Generation ADP Receptor Antagonist|Recruiting||Phase 4|260|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||Undecided||2017-10-10 22:40:15.277293|2017-10-10 22:40:15.277293
NCT02627508|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-30|||December 2015||2015-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pilot Trial of Pregnenolone in Autism|Randomized Controlled Pilot Trial of Pregnenolone in Autism|Recruiting||Phase 2|40|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:40:15.401721|2017-10-10 22:40:15.401721
NCT02627495|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-03-17|||December 2015||2015-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Predicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees|Predicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees|Recruiting||N/A|50|Anticipated|Spaulding Rehabilitation Hospital||1|||f||||f||||||||||2017-10-10 22:40:15.542823|2017-10-10 22:40:15.542823
NCT02627482|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2017-04-28|||September 2015||2015-09-01|April 2017|2017-04-01|November 11, 2016|Actual|2016-11-11|November 8, 2016|Actual|2016-11-08||Observational|||Ambulatory Fetal Heart Rate Monitoring in Small Babies|The Feasibility of Employing Ambulatory Fetal Heart Rate Monitoring in Small for Gestational Age Fetuses at Risk of Stillbirth.|Completed||N/A|30|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 22:40:15.64539|2017-10-10 22:40:15.64539
NCT02627469|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-02-22|||August 2007||2007-08-01|February 2016|2016-02-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Oral Hygiene Care and Microflora in Elderly Residents|Effect of Weekly Professional Oral Care, During 12 Months, on the Composition of the Oral Flora and Related Variables in Dependent Elderly Residents|Completed||N/A|68|Actual|Karolinska Institutet||2|||f||||f||||||||Yes|Published data will not be able to connect with an specific individual but each participant is allowed to by request take part of their own data.|2017-10-10 22:40:15.720129|2017-10-10 22:40:15.720129
NCT02627456|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-08-01|||October 8, 2015||2015-10-08|July 31, 2017|2017-07-31|August 31, 2018|Anticipated|2018-08-31|February 28, 2018|Anticipated|2018-02-28||Interventional|||Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) in Healthy African Adults in Mali|Dose Escalating and Randomized, Placebo-Controlled, Double-Blind Study to Assess Safaty, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) in Healthy African Adults in Mali|Recruiting||Phase 1|500|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 22:40:15.809261|2017-10-10 22:40:15.809261
NCT02627443|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2017-09-04|||November 4, 2016|Actual|2016-11-04|May 2017|2017-05-01||||November 30, 2020|Anticipated|2020-11-30||Interventional|||Carboplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Phase 1 Dose Escalation and Randomized Phase 2 Trial of Carboplatin and Gemcitabine With or Without VX-970 in First Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer|Recruiting||Phase 1/Phase 2|150|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 22:40:15.921878|2017-10-10 22:40:15.921878
NCT02627430|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-09|2016-07-22|||March 2016||2016-03-01|July 2016|2016-07-01||||March 2019|Anticipated|2019-03-01||Interventional|||Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer|A Phase 1 Study of PARP Inhibitor BMN 673 and HSP90 Inhibitor AT13387 for Treatment of Advanced Solid Tumors With Expansion in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer|Withdrawn||Phase 1|0|Actual|National Cancer Institute (NCI)||1||Other - Protocol moved to Withdrawn|f||||||||||||||2017-10-10 22:40:16.117656|2017-10-10 22:40:16.117656
NCT02627417|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-07-24|||December 2015||2015-12-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|DAPS-ITP||Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia|Prospective Multicenter Randomized Open-label Controlled Trial Assessing Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia|Recruiting||Phase 3|216|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:40:16.260378|2017-10-10 22:40:16.260378
NCT02627404|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-12-08|||September 2013||2013-09-01|November 2015|2015-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|GAN||Study of the Genetic and Environmental Factors of Vulnerability in Bipolar Disorders|Study of the Genetic and Environmental Factors of Vulnerability in Bipolar Disorders|Recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 22:40:16.397462|2017-10-10 22:40:16.397462
NCT02627391|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-07-03|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|ESTIMATE||Early Surgery for Patients With Asymptomatic Aortic Stenosis|Early Surgery for Patients With Asymptomatic Aortic Stenosis|Recruiting||N/A|360|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t|f|f||||||||2017-10-10 22:40:16.531523|2017-10-10 22:40:16.531523
NCT02627378|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-09|||September 2012||2012-09-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Saudi Outcomes of ECMO-treated MERS-CoV Patients|Extracorporeal Membrane Oxygenation Support for Middle East Respiratory Syndrome Induced Respiratory Failure|Completed||Phase 1|35|Actual|Dammam University||2|||f||||t||||||||No||2017-10-10 22:40:16.635849|2017-10-10 22:40:16.635849
NCT02627365|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-12-09|||January 2016||2016-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MM||Motivation Matters Study|Motivation Matters! Randomized Clinical Trial of Theory Based SMS to Support Treatment as Prevention in High-Risk Women|Recruiting||N/A|210|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 22:40:16.757221|2017-10-10 22:40:16.757221
NCT02627339|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-11-17|||August 2012||2012-08-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01|1 Day|Observational [Patient Registry]|SPARCS||Building a Database of Results From People Without Eye Problems|A Prospective Study of Controls to Build a Normative Database for the Spaeth/Richman Contrast Sensitivity Test (SPARCS)|Completed||N/A|208|Actual|Wills Eye|||1||f||||f||||||||No||2017-10-10 22:40:16.95405|2017-10-10 22:40:16.95405
NCT02627326|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2015-12-08|||May 2014||2014-05-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Chlorhexidine Intracanal Medicament in Periodontal Healing in Concomitant Endo Perio Lesion With Communication|Evaluation of Effectiveness of Chlorhexidine Intracanal Medicament on Periodontal Healing in Concomitant Endodontic and Periodontal Disease With Communication : A Randomized Controlled Clinical Trial|Completed||Phase 2|60|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t||||||||||2017-10-10 22:40:17.051921|2017-10-10 22:40:17.051921
NCT02627313|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-12-08|||May 2016||2016-05-01|December 2015|2015-12-01||||May 2018|Anticipated|2018-05-01||Interventional|||Tumor Bed Dose Delivery Using A Breast Specific Radiosurgery Device, The Gammapod: (A Clinical Feasibility Study)|Tumor Bed Dose Delivery Using A Breast Specific Radiosurgery Device, The Gammapod: (A Clinical Feasibility Study)|Not yet recruiting||N/A|20|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-10 22:40:17.156554|2017-10-10 22:40:17.156554
NCT02627300|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-08-10|||March 2016||2016-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial|Clinical Phase III Study to Monitor the Safety, Tolerability and Efficacy of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial|Recruiting||Phase 3|35|Anticipated|Octapharma||1|||f||||t||||||||||2017-10-10 22:40:17.22809|2017-10-10 22:40:17.22809
NCT02627287|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-03-01|||December 2015||2015-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®|A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen|Completed||Phase 1|150|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 22:40:17.337736|2017-10-10 22:40:17.337736
NCT02627274|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-09-25|||December 7, 2015|Actual|2015-12-07|September 2017|2017-09-01|September 21, 2019|Anticipated|2019-09-21|September 21, 2019|Anticipated|2019-09-21||Interventional|||A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 in Participants With Advanced and/or Metastatic Solid Tumors|An Open-label, Multicenter, Dose-escalation, Phase I Study to Evaluate Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281, an Immunocytokine Consisting of Interleukin 2 Variant (IL-2v) Targeting Fibroblast Activation Protein-Alpha (FAP), in Patients With Advanced and/or Metastatic Solid Tumors|Recruiting||Phase 1|60|Anticipated|Hoffmann-La Roche||1|||f|||||t|f||||||||2017-10-10 22:40:17.430906|2017-10-10 22:40:17.430906
NCT02627261|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-31|||November 2015||2015-11-01|July 2017|2017-07-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Observational|MMRD||Multiple Myeloma Minimal Residual Disease|Comparison of Three Methods to Evaluate Residual Disease in Multiple Myeloma|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     a gene sequencing technology will be used on bone marrow samples to detect residual disease   "|||2017-10-10 22:40:17.742974|2017-10-10 22:40:17.742974
NCT02627248|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-08|||October 2015||2015-10-01|December 2015|2015-12-01|October 2025|Anticipated|2025-10-01|October 2025|Anticipated|2025-10-01||Interventional|||Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery||Recruiting||Phase 4|200|Anticipated|Shandong University||4|||f||||f||||||||||2017-10-10 22:40:17.852864|2017-10-10 22:40:17.852864
NCT02627235|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-07-26|||July 2015||2015-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|June 2017|Actual|2017-06-01||Interventional|DIAL||The Deep South IVR-based Active Lifestyle Study|The Deep South IVR-based Active Lifestyle (DIAL) Study|Active, not recruiting||N/A|62|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 22:40:17.975079|2017-10-10 22:40:17.975079
NCT02627222|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-08-24|||December 2015||2015-12-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|CASSAVITA II||The Efficacy of Pro-vitamin A Biofortified Cassava on Vitamin A Status in Nigerian Preschool Children|The Efficacy of Pro-vitamin A Biofortified Cassava on Vitamin A Status in Nigerian Preschool Children|Completed||N/A|176|Actual|Wageningen University||2|||f||||t||||||||||2017-10-10 22:40:18.12992|2017-10-10 22:40:18.12992
NCT02627209|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-09|||June 2014||2014-06-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|February 2016|Anticipated|2016-02-01||Interventional|uveitis||The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis|Non-infectious and Infectious Uveitis Diagnosis|Recruiting||N/A|280|Anticipated|Dünyagöz Hospital||2|||f||||t||||||||||2017-10-10 22:40:18.293954|2017-10-10 22:40:18.293954
NCT02627183|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-04-07|||December 2015||2015-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|NEURO-AF||Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training|Circulating Brain-derived Neurotrophic Factor (BDNF) in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training: A Pilot Study (NEURO-AF)|Recruiting||N/A|200|Anticipated|Ottawa Heart Institute Research Corporation|||2||f||||f||||||Samples With DNA|"     Blood samples.   "|||2017-10-10 22:40:19.10538|2017-10-10 22:40:19.10538
NCT02627170|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-05-18|||December 2015||2015-12-01|December 2015|2015-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Measurements of Corneal Biomechanical Properties Using a Dynamic Scheimpflug Analyzer for Normal Adults in South Korea||Completed||N/A|250|Actual|Yonsei University|||1||f||||f||||||||Undecided|undecided yet|2017-10-10 22:40:19.213124|2017-10-10 22:40:19.213124
NCT02627144|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-07-26|2016-06-02||January 2008||2008-01-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational||Safety set included all participants who have received at least once one dose of bevacizumab.|Bevacizumab in Metastatic Renal Cancer|AVASTIN® First Line in Metastatic Renal Cancer|Completed||N/A|365|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:40:19.423605|2017-10-10 22:40:19.423605
NCT02627131|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-08|||April 2014||2014-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Autologous Bone Marrow Stem Cell Therapy for Autism|Autologous Bone Marrow Stem Cell Therapy for Autism: An Open Label Uncontrolled Clinical Trial|Completed||Phase 2|24|Actual|Vinmec International Hospital||1|||f||||f||||||||Yes|The data without personal identifiers will be published on Dryad.|2017-10-10 22:40:20.021218|2017-10-10 22:40:20.021218
NCT02627118|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-04-08|||April 2015||2015-04-01|April 2017|2017-04-01|July 11, 2016|Actual|2016-07-11|July 11, 2016|Actual|2016-07-11||Interventional|bisphenol-A||Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H|Clinical Study To Elucidate The Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR When Compared to a Non-BPA Containing Dialyzer, the Nipro ELISIO-15H|Completed||N/A|10|Actual|UConn Health||2|||f||||f||||||||||2017-10-10 22:40:20.140562|2017-10-10 22:40:20.140562
NCT02627092|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-10-05|||January 2016|Actual|2016-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|IMPACT||IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles|An Innovative Approach to Understanding and Controlling Transmission of HAIs|Active, not recruiting||N/A|424|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:40:20.37575|2017-10-10 22:40:20.37575
NCT02627079|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-07-07|||February 2016||2016-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ICanSTEP : Increasing Physical Activity With Text Messaging|ICanSTEP: Increasing Physical Activity in Cancer Survivors Through a Text-messaging Exercise Motivation Program|Recruiting||N/A|30|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:40:20.502507|2017-10-10 22:40:20.502507
NCT02627066|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2015-12-09|||December 2015||2015-12-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|VCE||Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise|Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise|Not yet recruiting||Early Phase 1|50|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 22:40:20.651095|2017-10-10 22:40:20.651095
NCT02627053|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-05-01|||December 2015||2015-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study|Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study|Recruiting||Phase 3|100|Anticipated|Università degli Studi dell'Insubria||1|||f||||t||||||||||2017-10-10 22:40:20.790515|2017-10-10 22:40:20.790515
NCT02627040|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-02-13|||November 2015||2015-11-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Intertrochanteric Femoral Fracture Fixation Trial|A Prospective Randomized Trial of Intertrochanteric Femoral Fractures Treated With a Single Screw Versus a Two-integrated Screw Cephalo-medullary Nail.|Recruiting||N/A|95|Anticipated|Florida Orthopaedic Institute||2|||f||||f||||||||No|There is no plan to share data.|2017-10-10 22:40:20.88546|2017-10-10 22:40:20.88546
NCT02627027|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-01-05|||August 2015||2015-08-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, 2-way Crossover Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers|Completed||Phase 1|26|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:40:20.99343|2017-10-10 22:40:20.99343
NCT02627014|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-08-07|||July 2015||2015-07-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders|Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders|Completed||N/A|45|Actual|Cardenal Herrera University||2|||f||||t||||||||||2017-10-10 22:40:21.113787|2017-10-10 22:40:21.113787
NCT02627001|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2016-07-23|2016-05-01||September 2014||2014-09-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Nu-Mask Intraoral Airway Device Versus Conventional Bag Valve Mask Ventilation Crossover Trial|Comparison of Air Leak During Ventilation With Nu-Mask Intraoral Airway Device Versus Conventional Bag Valve Mask in a Cadaver Model: A Randomized Crossover Trial|Completed||Phase 4|27|Actual|Brooke Army Medical Center||2|||f||||f||||||||No||2017-10-10 22:40:21.224274|2017-10-10 22:40:21.224274
NCT02626988|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-01-30|||November 2015||2015-11-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||The Role of Agricultural Biodiversity in The Diet: a Vietnamese Study|The Role of Agricultural Biodiversity in The Diet: a Vietnamese Study|Active, not recruiting||N/A|180|Actual|Bioversity International||2|||f||||t||||||||Undecided||2017-10-10 22:40:21.460863|2017-10-10 22:40:21.460863
NCT02626975|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-05-18|||August 14, 2015|Actual|2015-08-14|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|MRI-DT4||MRI Study of Ballooning and Ligamentisation Short Transplants ACL Hamstring According to Technical DT4|MRI Study of Ballooning and Ligamentisation Short Transplants ACL Hamstring According to Technical DT4|Recruiting||N/A|60|Anticipated|University Hospital, Lille|||1||f||||f||||||||No||2017-10-10 22:40:21.553076|2017-10-10 22:40:21.553076
NCT02626962|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-03|||April 2016|Actual|2016-04-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|GEM1402||Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma|Phase II Multicenter, Non Randomized, Open Label Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma|Active, not recruiting||Phase 2|48|Actual|Grupo Español Multidisciplinar de Melanoma||1|||f||||t||||||||Undecided||2017-10-10 22:40:21.648122|2017-10-10 22:40:21.648122
NCT02626949|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-09-11|||March 2016||2016-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults|Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults|Recruiting||N/A|120|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 22:40:21.960724|2017-10-10 22:40:21.960724
NCT02626936|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-06-09|||January 2016||2016-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation|A Single-blind, Randomized, Two-way, Cross-over Study to Examine the Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation Combined With a Simplified Qualitative Meal-size Estimation in Adults With Type 1 Diabetes|Completed||Phase 2|10|Actual|Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||No||2017-10-10 22:40:22.140669|2017-10-10 22:40:22.140669
NCT02626923|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-09|||July 2012||2012-07-01|December 2015|2015-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients|Observational Study of the Safety and Efficacy of Nucleoside Reverse Transcriptase Inhibitor Backbones With Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in Antiretroviral Therapy-Naive Patients and First-Switch Subjects|Completed||N/A|51|Actual|Southwest Infectious Disease Clinical Research, Inc.|||1||f||||f||||||||||2017-10-10 22:40:22.372835|2017-10-10 22:40:22.372835
NCT02626884|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01||||September 2019|Anticipated|2019-09-01||Interventional|IRENO||Ibrutinib in Relapsed Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL)|Ibrutinib in Relapsed Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL)|Recruiting||Phase 2|36|Anticipated|University of Cologne||1|||f||||t||||||||||2017-10-10 22:40:22.730044|2017-10-10 22:40:22.730044
NCT02626871|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-05-01|||January 2002||2002-01-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|CAREAVR||Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation|Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation|Completed||N/A|850|Actual|University of Turku|||1||f||||f||||||||Undecided||2017-10-10 22:40:22.82535|2017-10-10 22:40:22.82535
NCT02626858|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-12-07|||February 2012||2012-02-01|February 2012|2012-02-01|July 2015|Actual|2015-07-01|December 2013|Actual|2013-12-01||Interventional|||Optimizing the Delineation of the Tumour Bed in Breast Irradiation|Optimizing the Delineation of the Tumour Bed in Breast Irradiation|Completed||N/A|25|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||t||||||||||2017-10-10 22:40:22.922804|2017-10-10 22:40:22.922804
NCT02626845|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-04-20|||December 2015||2015-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RENTGPA||Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis|Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis|Recruiting||Phase 4|28|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||No||2017-10-10 22:40:23.035031|2017-10-10 22:40:23.035031
NCT02626832|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-12-08|||February 2010||2010-02-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Interventional|REGAVP||Regulation of Arginine-vasopressin (AVP)|Regulation of Arginine-vasopressin (AVP) in Psychiatric Disorders|Completed||N/A|25|Actual|Yale University||4|||f||||f||||||||||2017-10-10 22:40:23.180223|2017-10-10 22:40:23.180223
NCT02626819|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-07-11|||August 3, 2015|Actual|2015-08-03|July 2017|2017-07-01|March 12, 2018|Anticipated|2018-03-12|May 31, 2017|Actual|2017-05-31||Interventional|||Improving Weight Management at the VA|Improving Weight Management at VA: Enhancing the MOVE!23 for Primary Care (CDA 10-206)|Active, not recruiting||N/A|45|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:40:23.28496|2017-10-10 22:40:23.28496
NCT02626806|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-12-08|||November 2013||2013-11-01|December 2015|2015-12-01||||June 2016|Anticipated|2016-06-01||Observational|EUROCAD||Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease|Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease|Recruiting||N/A|150|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-10 22:40:23.398299|2017-10-10 22:40:23.398299
NCT02626793|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-05-17|||August 3, 2015|Actual|2015-08-03|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|July 30, 2017|Anticipated|2017-07-30||Observational|||A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions|Long-term Documentation of the Utilization of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions (LAPIS-Pso)|Recruiting||N/A|500|Anticipated|Celgene|||2||f||||f|f|f||||||||2017-10-10 22:40:23.507467|2017-10-10 22:40:23.507467
NCT02626780|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-04-28|||December 2015||2015-12-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Adipose-derived SVF for Treatment of Alopecia|Adipose-derived Stromal Vascular Fraction (SVF) Injections to Stimulate Hair Regrowth for Androgenetic Alopecia|Completed||N/A|8|Actual|The GID Group||1|||f||||f||||||||||2017-10-10 22:40:23.815886|2017-10-10 22:40:23.815886
NCT02626767|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-07|||February 2011||2011-02-01|December 2015|2015-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Effect of Novel High-intensity Interval Training on Health and Fitness Outcomes in English Adolescents|Effect of Novel High-intensity Interval Training on Cardiometabolic Health and Physical Activity Levels in English Adolescents: A School-based Exploratory Controlled Before-and-after Trial|Completed||N/A|101|Actual|Teesside University||2|||f||||f||||||||No|Only group level data will be published from this study.|2017-10-10 22:40:23.891395|2017-10-10 22:40:23.891395
NCT02626754|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-06-20|||August 2015||2015-08-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population|A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population|Enrolling by invitation||Phase 2|122|Anticipated|Taipei Veterans General Hospital, Taiwan||1|||f||||f||||||||Yes||2017-10-10 22:40:23.967131|2017-10-10 22:40:23.967131
NCT02626741|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-08|||February 2015||2015-02-01|December 2015|2015-12-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|SlimWell||Effect of a Meal Replacement on Weight Loss Obesity Patients With Metabolic Syndrome|Effect of a Meal Replacement on Weight Loss Obesity Patients With Metabolic Syndrome : A Randomized Controlled Trial|Recruiting||Phase 3|138|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-10 22:40:24.059258|2017-10-10 22:40:24.059258
NCT02626728|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2016-11-21|||September 2015||2015-09-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|TAMIS||A Prospective Feasibility Study for TAMIS|A Prospective Quality Assurance Feasibility Study of Laparoscopic Assisted Transanal Minimally Invasive Surgery (TAMIS) for Rectal Cancer|Completed||N/A|25|Actual|Hvidovre University Hospital|||1||f||||t||||||||No||2017-10-10 22:40:24.160974|2017-10-10 22:40:24.160974
NCT02626715|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-04-05|||September 4, 2015|Actual|2015-09-04|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS|A Phase II Study of Myeloablative and Reduced-Intensity Conditioning Regimens for Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|16|Anticipated|University of Pittsburgh||2|||f||||t|t|f|||f|||No||2017-10-10 22:40:24.220591|2017-10-10 22:40:24.220591
NCT02626702|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-10-31|||July 2015||2015-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Immune Modulators and IVF|Immune Modulators in Women Undergoing IVF----a Prospective Study|Recruiting||N/A|500|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-10-10 22:40:24.309408|2017-10-10 22:40:24.309408
NCT02626689|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-04-06|||March 1, 2016|Actual|2016-03-01|April 2017|2017-04-01|January 3, 2017|Actual|2017-01-03|January 3, 2017|Actual|2017-01-03||Observational|||To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care|Burden of Beta-Thalassemia - Quality of Life and Health Care Resource Utilization- A Prospective Observational Study|Completed||N/A|100|Actual|Celgene|||2||f||||f||||||||||2017-10-10 22:40:24.382134|2017-10-10 22:40:24.382134
NCT02626676|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-02-17|||November 2015||2015-11-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|EPIC||Educational Programme Impact on Serum Phosphate Control|Nutrition Educational Programme Impact on Serum Phosphate Control|Completed||N/A|180|Actual|University of Sao Paulo||1|||f||||t||||||||No||2017-10-10 22:40:24.479086|2017-10-10 22:40:24.479086
NCT02626650|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-04-05|||December 2015|Actual|2015-12-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Recent Experiences With Concussions|Recent Experiences and Presentation Format: Study of Concussion Symptom Elicitation|Withdrawn||N/A|0|Actual|University of Pennsylvania||4|||f||||f||||||||No|Data will be analyzed by the research team and reported only in aggregate, so individual participant data will not be shared or made publicly available.|2017-10-10 22:40:24.647608|2017-10-10 22:40:24.647608
NCT02626637|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-05-23|||November 2015||2015-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|KAM||KAM: Kids Are Moving|KAM: Kids Are Moving; An Exercise Program for Children With Cancer|Completed||N/A|31|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 22:40:24.781951|2017-10-10 22:40:24.781951
NCT02626624|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-07-18|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:40:24.886042|2017-10-10 22:40:24.886042
NCT02626598|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-07|||December 2015||2015-12-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01|26 Weeks|Observational [Patient Registry]|||A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines|A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines|Enrolling by invitation||Phase 4|30|Anticipated|Skin Care and Laser Physicians of Beverly Hills|||1||f||||f||||||||||2017-10-10 22:40:25.05452|2017-10-10 22:40:25.05452
NCT02626585|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-08|||August 2014||2014-08-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PRT||The Effect of Postrhinoplasty Taping on Postoperative Edema and Nasal Draping|The Effect of Postrhinoplasty Taping on Postoperative Edema and Nasal Draping|Completed||N/A|57|Actual|Bezmialem Vakif University||3|||f||||f||||||||No||2017-10-10 22:40:25.146068|2017-10-10 22:40:25.146068
NCT02626572|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-03-22|||February 2015||2015-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms|Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms. A 24-week International, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase II Study in Monotherapy Followed by an Optional 28-week Extension Period in Co-administration With Donepezil.|Active, not recruiting||Phase 2|500|Anticipated|Servier||4|||f||||t||||||||||2017-10-10 22:40:25.261307|2017-10-10 22:40:25.261307
NCT02626559|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-12-08|||November 2015||2015-11-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Serum Bupivacaine Concentration Levels After Injection of Liposomal Bupivacaine Into the Knee|Serum Bupivacaine Concentration Levels After Injection of the Knee Joint With a Mixture of Liposomal Bupivacaine and Free Bupivacaine During Total Knee Arthroplasty|Completed||N/A|40|Actual|University of Utah|||1||f||||f||||||||No||2017-10-10 22:40:27.184307|2017-10-10 22:40:27.184307
NCT02626546|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-11-28|||November 2015||2015-11-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|PROFS||Predictors, Risk Factors and Outcome Following Major Surgery|Predictors, Risk Factors and Outcome Following Major Surgery|Active, not recruiting||N/A|1061|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 22:40:27.263361|2017-10-10 22:40:27.263361
NCT02626533|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-04-27|||December 2015||2015-12-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|Pain+Stiffness||Persistent Postoperative Pain and Joint Stiffness After Total Knee Arthroplasty Performed for Osteoarthritis|Persistent Postoperative Pain and Joint Stiffness After Total Knee Arthroplasty Performed for Osteoarthritis|Recruiting||N/A|186|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, and joint fluid aspirate samples will be collected and stored for     analysis.   "|No||2017-10-10 22:40:27.379973|2017-10-10 22:40:27.379973
NCT02626520|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-02-09|||January 2016||2016-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla|Phase 2 Evaluation of a Community-Based Multi-modality Management Algorithm for Clinically Non-metastatic Ductal Adenocarcinoma of the Exocrine Pancreas or Ampulla|Active, not recruiting||Phase 2|10|Actual|Essentia Health||2|||f||||f||||||||Yes|We will make unidentified dataset available for electronic download.|2017-10-10 22:40:27.487282|2017-10-10 22:40:27.487282
NCT02626507|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-05-02|||January 2016||2016-01-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer|Phase I Dose-Escalation Study of Combination of Gedatolisib (a Dual Inhibitor of PI3-K and mTOR) With Palbociclib and Faslodex in the Neoadjuvant Setting in Previously Untreated Patients With ER+/HER2- Breast Cancer|Recruiting||Phase 1|18|Anticipated|Eastchester Center for Cancer Care||1|||f||||f||||||||Undecided||2017-10-10 22:40:27.611344|2017-10-10 22:40:27.611344
NCT02626494|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-04-28|||March 2015||2015-03-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|CoGlu||Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction|Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction: The Role of Glutamate|Completed||Phase 4|71|Actual|Psychiatric University Hospital, Zurich||2|||f||||t||||||||||2017-10-10 22:40:27.73887|2017-10-10 22:40:27.73887
NCT02626481|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-07-20|||December 2015||2015-12-01|July 2016|2016-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|IFM2014-04||Study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple Myeloma|A Multicenter Open Label Phase II Study of Daratumumab in Combination With Dexamethasone in Multiple Myeloma Resistant or Refractory to Bortezomib and Lenalidomide and Pomalidomide - an IFM 2014-04 Study|Recruiting||Phase 2|64|Anticipated|University Hospital, Lille||1|||f||||t||||||||||2017-10-10 22:40:27.856776|2017-10-10 22:40:27.856776
NCT02626468|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-07|||March 2013||2013-03-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|SLP-RespDis||Validation of Structured Light Plethysmography - Health and Disease|Validation in Healthy Subjects and Different Diagnostic States|Recruiting||N/A|100|Anticipated|Pneumacare Ltd|||2||f||||f||||||||No||2017-10-10 22:40:28.391426|2017-10-10 22:40:28.391426
NCT02626442|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-10-28|||July 2013||2013-07-01|October 2016|2016-10-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01||Interventional|EBH||Exercise and Brain Health|Exercise and Brain Health|Recruiting||N/A|300|Anticipated|Baltimore VA Medical Center||2|||f||||t||||||||||2017-10-10 22:40:29.220021|2017-10-10 22:40:29.220021
NCT02626429|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-05-01|||May 2015|Actual|2015-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Protein Requirements In Active Female Populations|Evaluation of Protein Requirements in Active, Young Adult Females|Active, not recruiting||N/A|7|Anticipated|University of Toronto||1|||f||||f||||||||||2017-10-10 22:40:29.334703|2017-10-10 22:40:29.334703
NCT02626416|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-07|||January 2016||2016-01-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Monitoring of Visual Axis Opacification Under Non-clinical Settings|Self-monitoring of Visual Axis Opacification (VAO) Under Non-clinical Settings in China|Not yet recruiting||N/A|1400|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:40:29.507103|2017-10-10 22:40:29.507103
NCT02626403|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-03-29|||January 2015||2015-01-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|June 2016|Actual|2016-06-01||Interventional|||Fronto-parietal tDCS in Severely Brain Injured Patients With Disorders of Consciousness|Effect of Fronto-parietal Transcranial Direct Stimulation on the Level of Consciousness in Patients With Disorders of Consciousness|Recruiting||N/A|35|Anticipated|University Hospital of Liege||2|||f|||||f|f||||||||2017-10-10 22:40:29.640873|2017-10-10 22:40:29.640873
NCT02626390|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-15|||April 2012||2012-04-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Information Provision During Early Gait Training Post Stroke|How do Different Styles of Information Provision Affect Learning During Early Gait Training Post Stroke? A Feasibility Study|Completed||Phase 1/Phase 2|18|Actual|University of Southampton||2|||f||||f||||||||No||2017-10-10 22:40:29.760967|2017-10-10 22:40:29.760967
NCT02613117|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-07-19|||November 2015||2015-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity||Completed||N/A|105|Actual|Procter and Gamble||2|||f||||||||||||||2017-10-10 22:43:02.620027|2017-10-10 22:43:02.620027
NCT02626364|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-06-14|||April 2016||2016-04-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification|Phase II Study of Single-agent Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification|Recruiting||Phase 2|33|Anticipated|Arog Pharmaceuticals, Inc.||1|||f||||f||||||||No||2017-10-10 22:40:30.053398|2017-10-10 22:40:30.053398
NCT02626351|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-08-14|||July 15, 2015|Actual|2015-07-15|December 2015|2015-12-01|January 30, 2017|Actual|2017-01-30|January 26, 2017|Actual|2017-01-26||Interventional|MONARCH||Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health & HIV Care|Optimizing the Delivery of Maternal and Child Health Services to Strengthen the Primary Health Care System in Rural South Africa|Completed||N/A|3172|Actual|University of KwaZulu||2|||f||||t||||||||||2017-10-10 22:40:30.207858|2017-10-10 22:40:30.207858
NCT02626338|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-01-23|||February 2016||2016-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML|Pilot Study of Crenolanib Combined With Standard Salvage Chmetherapy in Subjects With Relapsed/Refractory Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|72|Anticipated|Arog Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:40:30.402123|2017-10-10 22:40:30.402123
NCT02626325|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-07-04|||November 2015||2015-11-01|July 2016|2016-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|CHO-MUFA||Effect of High-carbohydrate or High-monounsaturated Fat on Blood Pressure: Meta-analysis of Randomized Clinical Trials|Effect of High-carbohydrate or High-monounsaturated Fatty Acids on Blood Pressure: a Meta-analysis of Randomized Clinical Trials|Active, not recruiting||N/A|1000|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-10 22:40:30.587752|2017-10-10 22:40:30.587752
NCT02626312|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-07-13|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||Phase I Trial of Radiation Therapy in Patients With Liver Cancers and Impaired Liver Function|Phase I Trial of Radiation Therapy in Patients With Liver Cancers and Impaired Liver Function|Recruiting||Phase 1|88|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 22:40:30.668633|2017-10-10 22:40:30.668633
NCT02626286|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-08-10|||June 2015||2015-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CohMSM||Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa|Prevention of HIV Infection in Men Who Have Sex With Men in Sub-Saharan Africa: Feasibility and Interest of a Quarterly Preventive Global Care (CohMSM)|Recruiting||N/A|700|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-10 22:40:30.951409|2017-10-10 22:40:30.951409
NCT02626273|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-07-28|||September 2015||2015-09-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|ADIBOX||ADIposity and Bone Metabolism: Effects of eXercise-induced Weight Loss in Obese Adolescents|ADIposity and Bone Metabolism: Effects of eXercise-induced Weight Loss in Obese Adolescents|Recruiting||N/A|50|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:40:31.115305|2017-10-10 22:40:31.115305
NCT02626260|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-08-04|||November 2015||2015-11-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Pilot Evaluation of Adhesives and How They Are Impacted by Output|A Pilot Evaluation of Adhesives and How They Are Impacted by Output|Completed||N/A|4|Actual|Coloplast A/S||1|||f||||f||||||||||2017-10-10 22:40:31.262264|2017-10-10 22:40:31.262264
NCT02626247|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-12-10|||September 2013||2013-09-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|NUTRIMEMO||Effect of Lipidic Nutrients on Memory and Well Being in Healthy Aging Adults|Effect of Lipidic Nutrients on Memory and Well Being in Healthy Aging Adults|Recruiting||N/A|400|Anticipated|Nutrimemo Consortium||2|||f||||t||||||||||2017-10-10 22:40:31.356844|2017-10-10 22:40:31.356844
NCT02626234|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-31|||December 9, 2015|Actual|2015-12-09|July 2017|2017-07-01|April 29, 2017|Actual|2017-04-29|April 29, 2017|Actual|2017-04-29||Interventional|||A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors|A Phase I, Multicenter, Open-label, Single-sequence Drug-drug Interaction Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors|Completed||Phase 1|32|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-10 22:40:31.542173|2017-10-10 22:40:31.542173
NCT02626221|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01|24 Months|Observational [Patient Registry]|AWARE-LACan||A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan)|A Prospective Non-interventional Study to Collect Real Life Clinical Data on the Impact of Therapy, the Diagnosis and Management of Chronic Urticaria in Patients Refractory to at Least One Course of H1 Antihistamine Therapy|Active, not recruiting||N/A|494|Actual|Novartis|||1||f||||f||||||||||2017-10-10 22:40:31.697721|2017-10-10 22:40:31.697721
NCT02626208|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-08-11|||January 2016||2016-01-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Dose Finding Study of Contraceptive Vaginal Ring With Different Estradiol Levels in Combination With Nestorone|A Dose Finding Study to Evaluate Serum Estradiol Levels With Use of Contraceptive Vaginal Rings Releasing Nestorone® and Escalating Doses of Estradiol in Normal Cycling Women|Completed||Phase 2|65|Actual|Health Decisions||3|||f||||f||||||||||2017-10-10 22:40:31.89861|2017-10-10 22:40:31.89861
NCT02626195|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-09-20|||October 2013||2013-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preoperative Nutritional Support in Malnutritional Cancer Patients|Prospective Study of Preoperative Nutritional Support in Malnutritional Pancreatobiliary Cancer Patients|Recruiting||Phase 2|50|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||No||2017-10-10 22:40:32.196302|2017-10-10 22:40:32.196302
NCT02626182|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-08-29|||December 2015||2015-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF|Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe Cystic Fibrosis Lung Disease|Recruiting||Phase 1/Phase 2|12|Anticipated|National Jewish Health||2|||f||||t||||||||||2017-10-10 22:40:32.352093|2017-10-10 22:40:32.352093
NCT02626169|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-08|2017-03-20|||December 2015||2015-12-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation|The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation|Recruiting||Phase 4|30|Anticipated|Baylor College of Medicine||2|||f||||f||||||||No||2017-10-10 22:40:32.551163|2017-10-10 22:40:32.551163
NCT02626156|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-03-22|||June 2015||2015-06-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|MUSTCOOL||Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence|Monitoring and Managing Newly Healed Chronic Leg and Foot Ulcer Skin Temperature: A Cooling Intervention (MUSTCOOL) to Prevent Ulcer Recurrence|Recruiting||Phase 2|240|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 22:40:32.694535|2017-10-10 22:40:32.694535
NCT02626143|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-03-24|||February 2016||2016-02-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Feeding Mode on Infant Growth and Cognitive Function|Effect of Feeding Mode on Infant Growth and Cognitive Function|Recruiting||N/A|540|Anticipated|Mead Johnson Nutrition||3|||f||||f||||||||||2017-10-10 22:40:32.875302|2017-10-10 22:40:32.875302
NCT02626130|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-07|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Pilot Study of Presurgical Tremelimumab With or Without Cryoablation in Patients With Metastatic Renal Cell Carcinoma (RCC)|A Pilot Study of Tremelimumab With or Without Tissue Cryoablation in Patients With Metastatic Renal Cell Carcinoma|Recruiting||Early Phase 1|30|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 22:40:33.015105|2017-10-10 22:40:33.015105
NCT02626104|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-10-06|||December 2015||2015-12-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|BLAAD||Bovine Lactoferrin and Antibiotic-associated Diarrhoea.|Bovine Lactoferrin in the Prevention of Antibiotic-associated Diarrhoea in Children - a Randomized Clinical Trial.|Recruiting||Phase 2|156|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-10 22:40:33.288866|2017-10-10 22:40:33.288866
NCT02626091|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-08-31|||January 2016||2016-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PERFECT||Perfusion Evaluation by Real-time Fluorescence-based Enhanced Reality of Anastomosis|Perfusion Evaluation by Real-time Fluorescence-based Enhanced Reality of Anastomosis|Recruiting||N/A|40|Anticipated|IHU Strasbourg||1|||f||||f||||||||No||2017-10-10 22:40:33.42269|2017-10-10 22:40:33.42269
NCT02626078|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-08-18|||April 16, 2015|Actual|2015-04-16|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|ARC2||Assessment of Food Practices by Residents in Nursing Homes|Assessment of Food Practices by Residents in Nursing Homes, Study of Relationship Between Food Intake and Nutritional Status.|Completed||N/A|46|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:40:33.56132|2017-10-10 22:40:33.56132
NCT02626065|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-08-18|||April 23, 2015|Actual|2015-04-23|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PAIR||Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies|Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies|Active, not recruiting||Phase 4|32|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:40:33.686507|2017-10-10 22:40:33.686507
NCT02626052|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-05-25|||December 2015||2015-12-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Observational|||Helpfulness of the Vibration Test Performed in Room Light on Clients With Inner Ear Problems|Diagnostic Accuracy of the Vibration Induced Nystagmus Test in Room Light.|Enrolling by invitation||N/A|400|Anticipated|Aultman Health Foundation|||1||f||||f||||||||||2017-10-10 22:40:33.806411|2017-10-10 22:40:33.806411
NCT02626039|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-03-08|||November 2013||2013-11-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Observational|MIRROR||Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients|Characterization and Comparison of Drugable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells and Cell-Free Circulating DNA in Metastatic Breast Cancer Patients|Recruiting||N/A|40|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||||||||Samples With DNA|"     Primary and Metastatic tumoral tissue (FFPE samples) and Blood samples   "|||2017-10-10 22:40:33.911919|2017-10-10 22:40:33.911919
NCT02626026|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-09-28|||January 2016||2016-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Safety and Pharmacokinetics of GS-4059 in Healthy Volunteers and Subjects With Rheumatoid Arthritis (RA)|A Phase 1, Placebo-Controlled, Randomized Study Evaluating the Safety and Pharmacokinetics of GS-4059 in Healthy Volunteers and Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 1|42|Actual|Gilead Sciences||5|||f||||f||||||||||2017-10-10 22:40:34.042802|2017-10-10 22:40:34.042802
NCT02625844|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-02-04|2016-02-04||September 2011||2011-09-01|February 2016|2016-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia|Croatian Time and Motion Survey for Anaemia Management With Erythropoietin Stimulating Agents in Haemodialysis Units|Completed||N/A|110|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-10 22:40:36.057155|2017-10-10 22:40:36.057155
NCT02626013|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-01-17|||December 2015||2015-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|ABReast||A Multicenter, Prospective Cohort Study to Provide Real-world Evidence on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and Health-related Quality of Life in Patients With MBC in Greece|A Multicenter, Prospective Cohort Study to Provide Real-world Evidence on the Effect of Nab-paclitaxel (ABRAXANE®) Treatment on the Clinical Outcomes and Health-related Quality of Life in Patients With Metastatic Breast Cancer in Greece. The 'ABReast' Study.|Recruiting||N/A|245|Anticipated|Genesis Pharma S.A.|||1||f||||f||||||||||2017-10-10 22:40:34.191732|2017-10-10 22:40:34.191732
NCT02626000|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-07-19|||April 6, 2016|Actual|2016-04-06|July 2017|2017-07-01|December 4, 2022|Anticipated|2022-12-04|August 23, 2021|Anticipated|2021-08-23||Interventional|MASTERKEY232||Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)|A Phase 1b/3 Multicenter, Randomized, Trial of Talimogene Laherparepvec in Combination With Pembrolizumab for the Treatment of Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1|40|Anticipated|Amgen||1|||f||||t|t|f||||||||2017-10-10 22:40:34.274|2017-10-10 22:40:34.274
NCT02625987|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-05-25|||April 2015||2015-04-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|ASC||Appendicectomy Skin Closure Technique: Changing Paradigms (ASC)|Comparison Between Intradermic vs Habitual Skin Closure Technique in Open Appendicectomy.|Completed||Phase 4|200|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||||2017-10-10 22:40:34.465297|2017-10-10 22:40:34.465297
NCT02625961|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-10-04|||February 10, 2016|Actual|2016-02-10|October 2017|2017-10-01|December 27, 2021|Anticipated|2021-12-27|February 15, 2019|Anticipated|2019-02-15||Interventional|||Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)|A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects With High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy|Recruiting||Phase 2|260|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-10-10 22:40:34.755142|2017-10-10 22:40:34.755142
NCT02625948|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-09-12|||September 2015||2015-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|TRAIGE||Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign||Recruiting||Phase 2|240|Anticipated|Ministry of Science and Technology of the People´s Republic of China||3|||f||||t||||||||||2017-10-10 22:40:34.965071|2017-10-10 22:40:34.965071
NCT02625922|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-06-22|||February 5, 2016|Actual|2016-02-05|June 2017|2017-06-01|January 11, 2017|Actual|2017-01-11|January 11, 2017|Actual|2017-01-11||Interventional|RELAX-Cardio||Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure|A Multicenter, Randomized, Double-blind, Crossover Placebo-controlled Phase II Study to Assess the Effect of Serelaxin Versus Placebo on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure After Exercise When Used in Addition to Standard of Care|Terminated||Phase 2|24|Actual|Novartis||2||Study was terminated based on results from pivotal adult AHF study CRLX030A2301|f||||t|f|f||||||||2017-10-10 22:40:35.199378|2017-10-10 22:40:35.199378
NCT02625909|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-09-01|||March 9, 2017|Actual|2017-03-09|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|REACT||Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.|A Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in People Who Inject Drugs and People With HIV Coinfection.|Recruiting||Phase 3|250|Anticipated|Kirby Institute||2|||f||||t|t|f|||f|||||2017-10-10 22:40:35.319402|2017-10-10 22:40:35.319402
NCT02625896|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-06-26|||June 17, 2017|Actual|2017-06-17|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|ACROPOSE||Free Fall Acrobatics to Reduce Neck Loads During Parachute Opening Shock: Evaluation of an Intervention.|Free Fall Acrobatics to Reduce Neck Loads During Parachute Opening Shock: Evaluation of an Intervention.|Enrolling by invitation||N/A|20|Anticipated|Karolinska Institutet||2|||f||||f|f|f||||||||2017-10-10 22:40:35.680832|2017-10-10 22:40:35.680832
NCT02625883|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-08-29|||December 2015||2015-12-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||Out-of-Hospital Resuscitation in Winterthur - an Outcome Study|Out-of-Hospital Resuscitation in an Urban Setting in Switzerland - an Outcome Study and Cost Effectiveness Analysis|Enrolling by invitation||N/A|151|Actual|Kantonsspital Winterthur KSW|||1||f||||f||||||||||2017-10-10 22:40:35.78224|2017-10-10 22:40:35.78224
NCT02625870|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2015-12-07|||December 2015||2015-12-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Interventional|OMEELVHT||Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides|A 12-Week, Randomized, Double-Blind, Corn Oil-Controlled Phase 3 Study to Assess the Efficacy and Safety of Omega-3-Acid Ethyl Esters 90 Soft Capsules in Subjects With Severe Hypertriglyceridemia|Not yet recruiting||Phase 3|240|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:40:35.862383|2017-10-10 22:40:35.862383
NCT02625857|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-10-04|||December 10, 2015|Actual|2015-12-10|September 2017|2017-09-01|January 30, 2018|Anticipated|2018-01-30|July 7, 2017|Actual|2017-07-07||Interventional|||Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer|An Open-Label, Phase 1 Study of the Safety and Immunogenicity of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Subjects With Metastatic Castration-resistant Prostate Cancer|Active, not recruiting||Phase 1|26|Actual|Janssen Research & Development, LLC||2|||f||||f|t|f||||||||2017-10-10 22:40:35.94252|2017-10-10 22:40:35.94252
NCT02625831|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-02-24|||November 2012||2012-11-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Observational|ficolupus||Anti-ficolin-3 Autoantibodies in Lupus Nephritis|Association Between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients With Systemic Lupus Erythematosus|Completed||N/A|213|Actual|University Hospital, Grenoble|||2||f||||f||||||Samples Without DNA|"     one serum sample per patient.   "|Undecided|sub-study still in progress. Further analysis is needed before sponsor can decide his Policy of sharing individual data for this research.|2017-10-10 22:40:36.250985|2017-10-10 22:40:36.250985
NCT02625818|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-10|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|GAP||The Genetic and Affective Prediction Study|The Genetic and Affective Prediction Study|Recruiting||N/A|400|Anticipated|St. Olavs Hospital|||1||f||||f||||||Samples With DNA|"     blood samples (plasma and serum)   "|||2017-10-10 22:40:36.373023|2017-10-10 22:40:36.373023
NCT02625805|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2017-06-15|||April 2016|Actual|2016-04-01|July 2016|2016-07-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|||Evaluation of Use of Brain Activity Monitoring Dynamics in ADHD|Evaluation of the Ability for Monitoring Dynamics in ADD/ADHD With an Easy to Use EEG|Completed||N/A|30|Actual|Brainmarc Ltd.||2|||f||||f||||||||||2017-10-10 22:40:36.482752|2017-10-10 22:40:36.482752
NCT02625792|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-06|2017-01-05|||December 2015||2015-12-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Role of Hemostatic Powder (Endo-clotTM) in Prevention of Bleeding Within High Risk Patients After ESD||Completed||Phase 3|45|Actual|Yonsei University||1|||f||||f||||||||No|Individual participant data will be not shared and used only for this study|2017-10-10 22:40:36.593361|2017-10-10 22:40:36.593361
NCT02625779|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-01-24|||March 2016||2016-03-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression|A Double-Blind, Placebo-Controlled Trial of Combined Cytidine- and Creatine-containing Drug and Dietary Supplement in the Treatment of the Bipolar Depression|Not yet recruiting||Phase 2|75|Anticipated|Ewha Womans University Mokdong Hospital||3|||f||||t||||||||||2017-10-10 22:40:36.700283|2017-10-10 22:40:36.700283
NCT02625766|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-03-31|||December 2014||2014-12-01|March 2017|2017-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Pelvis RCT: Impact of Surgery on Pain in Lateral Compression Type Pelvic Fractures|Impact of Surgery on Pain in Lateral Compression Type Pelvic Fractures: a Prospective Trial|Recruiting||N/A|130|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-10 22:40:36.823903|2017-10-10 22:40:36.823903
NCT02625753|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2015-12-09|||November 2014||2014-11-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Codeine Plus Paracetamol Versus Placebo for PRK Post-operative Pain|A Randomized Study of Codeine Plus Paracetamol Versus Placebo for PRK Post-operative Pain|Completed||Phase 3|40|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 22:40:36.981481|2017-10-10 22:40:36.981481
NCT02625740|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-08|||November 2013||2013-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2014|Actual|2014-11-01||Interventional|PACUS||Ultrasound to Enhance Paclitaxel Uptake in Critical Limb Ischemia: the PACUS Trial|Use of Local Ultrasound to Enhance Local Paclitaxel Delivery Effect After Femoro-popliteal Percutaneous Transluminal Angioplasty in Patients With Critical Limb Ischemia: the PACUS Trial|Completed||N/A|56|Actual|University of Rome Tor Vergata||2|||f||||f||||||||||2017-10-10 22:40:37.096136|2017-10-10 22:40:37.096136
NCT02625727|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-08|||August 2015||2015-08-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of Hyaluronic Acid vs. Hyaluronic Acid on Knee Osteoarthritis|Comparison of Therapeutic Effects of Hyaluronic Acid vs. Hyaluronic Acid Combined Corticosteroid on Knee Osteoarthritis: A Double Blind, Randomized-controlled Clinical Trial|Active, not recruiting||Phase 4|76|Anticipated|Taipei Medical University||2|||f||||f||||||||||2017-10-10 22:40:37.203825|2017-10-10 22:40:37.203825
NCT02625714|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-10|||June 2015||2015-06-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Safety/Tolerability and Pharmacokinetic Study of SID142|A Randomized, Open-label, Oral Multiple Dosing, Two-way Crossover Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetic Profiles of SID142 in Healthy Volunteers|Completed||Phase 1|41|Actual|SK Chemicals Co.,Ltd.||2|||f||||f||||||||||2017-10-10 22:40:37.305595|2017-10-10 22:40:37.305595
NCT02625701|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-12-08|||January 2012||2012-01-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy|Perioperative Fluid Management: Goal-Directed Therapy vs. Restrictive Approach, a Randomized Controlled Trial|Recruiting||Phase 3|400|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 22:40:37.407741|2017-10-10 22:40:37.407741
NCT02625688|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-03-27|||August 2013||2013-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||The Risk of Hyperbilirubinemia in Term Newborns After Placental Transfusion|The Risk of Hyperbilirubinemia in Term Newborns After Placental Transfusion: A Randomized-blinded Controlled Trial|Completed||N/A|400|Actual|Princess Anna Mazowiecka Hospital, Warsaw, Poland||3|||f||||f||||||||||2017-10-10 22:40:37.542022|2017-10-10 22:40:37.542022
NCT02625675|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-06-23|||March 2015||2015-03-01|June 2016|2016-06-01||||October 2016|Anticipated|2016-10-01||Observational|||Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot Study|Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot Study|Recruiting||N/A|25|Anticipated|University of Oxford|||1||f||||f||||||||||2017-10-10 22:40:37.653319|2017-10-10 22:40:37.653319
NCT02625662|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-10-25|||November 2015||2015-11-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Observational|iFocus||Facioscapulohumeral Dystrophy in Children|Facioscapulohumeral Dystrophy in Children: a Prospective, Observational Study on the Natural History, Predictors and Clinical Impact (iFocus)|Recruiting||N/A|30|Anticipated|University Medical Center Nijmegen|||1||f||||t||||||Samples With DNA|"     DNA and RNA samples   "|||2017-10-10 22:40:37.740947|2017-10-10 22:40:37.740947
NCT02625649|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-06-23|||January 2016||2016-01-01|October 2016|2016-10-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Observational|||Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients|Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients: Register-based and Clinical Follow-up Studies|Completed||N/A|148|Actual|University of Aarhus|||2||f||||f||||||Samples Without DNA|"     blood samples urine samples stool samples   "|||2017-10-10 22:40:37.845438|2017-10-10 22:40:37.845438
NCT02625636|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-07|2016-08-22|||December 2015||2015-12-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients|A Randomized, Double-blind, Glucagon and Placebo-controlled Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Single Escalating Doses of SAR438544 Administered by Subcutaneous Route in Healthy Subjects and Patients With Type 1diabetes Mellitus|Completed||Phase 1|20|Actual|Sanofi||6|||f||||f||||||||||2017-10-10 22:40:37.937528|2017-10-10 22:40:37.937528
NCT02625623|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-26|||December 28, 2015|Actual|2015-12-28|September 2017|2017-09-01|September 20, 2022|Anticipated|2022-09-20|March 31, 2018|Anticipated|2018-03-31||Interventional|||Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)|A Phase III Open-label, Multicenter Trial of Avelumab (MSB0010718C) as a Third-line Treatment of Unresectable, Recurrent, or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 3|376|Actual|EMD Serono||2|||f||||t||||||||||2017-10-10 22:40:38.053227|2017-10-10 22:40:38.053227
NCT02625610|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-05|||December 24, 2015|Actual|2015-12-24|August 2017|2017-08-01|March 11, 2024|Anticipated|2024-03-11|March 13, 2019|Anticipated|2019-03-13||Interventional|||Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)|A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction|Recruiting||Phase 3|466|Anticipated|EMD Serono||2|||f||||t||||||||||2017-10-10 22:40:38.378851|2017-10-10 22:40:38.378851
NCT02625597|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2015-12-07|||November 2013||2013-11-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Assessment of the Effects of Different Implant Abutment Occluding Materials on Dental Implant Health Parameters and Microbiology|An In Vivo Assessment of the Effects of Using Different Implant Abutment Occluding Materials on Implant Microleakage and the Peri-Implant Microbiome|Completed||N/A|8|Actual|Stony Brook University||1|||f||||f||||||||||2017-10-10 22:40:39.700238|2017-10-10 22:40:39.700238
NCT02625584|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-10-26|||January 2016||2016-01-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Reading Together: How to Promote Children's Language Development Using Family-based Shared Book Reading|Reading Together: How to Promote Children's Language Development Using Family-based Shared Book Reading|Recruiting||N/A|225|Anticipated|University of Liverpool||3|||f||||f||||||||||2017-10-10 22:40:39.84336|2017-10-10 22:40:39.84336
NCT02625571|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-28|||December 2015||2015-12-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Tx for Child Sexual Behavior Problems|Development and Pilot Testing of a Treatment for Children With Sexual Behavior Problems|Completed||N/A|15|Actual|Milton S. Hershey Medical Center||1|||f||||f||||||||||2017-10-10 22:40:39.960697|2017-10-10 22:40:39.960697
NCT02625558|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-12-04|||April 2015||2015-04-01|December 2015|2015-12-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|RioSAPH||Riociguat for Sarcoidosis Associated Pulmonary Hypertension|A Double Blind, Placebo Controlled Trial of Oral Riociguat for Sarcoidosis Associated Pulmonary Hypertension|Recruiting||Phase 4|60|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-10-10 22:40:40.043763|2017-10-10 22:40:40.043763
NCT02625545|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2017-06-22|||February 17, 2016|Actual|2016-02-17|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|May 30, 2017|Actual|2017-05-30||Interventional|MedLift||Study of Median Lobe Prostatic UroLift Procedure|Study of Median Lobe Prostatic UroLift Procedure|Active, not recruiting||N/A|45|Actual|NeoTract, Inc.||1|||f||||f||||||||No||2017-10-10 22:40:40.143369|2017-10-10 22:40:40.143369
NCT02625532|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-03-01|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|December 2016|Actual|2016-12-01||Interventional|LUTEAL||Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)|Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles: A Randomized Comparative Single Center Trial. LUTEAL Trial|Recruiting||N/A|60|Anticipated|Instituto Bernabeu||2|||f||||t||||||||||2017-10-10 22:40:40.246134|2017-10-10 22:40:40.246134
NCT02625519|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-03-01|||December 2015||2015-12-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|GENODON||Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)|Prospective, Randomized Open Trial to Evaluate the Efficacy of Highly Purified Urinary FSH Versus Recombinant FSH in Oocyte Donors Undergoing Controlled Ovarian Stimulation Based on Receptor N680S FSH Gene Polymorphism. Genodon Trial|Recruiting||Phase 4|180|Anticipated|Instituto Bernabeu||2|||f||||t||||||||||2017-10-10 22:40:40.346126|2017-10-10 22:40:40.346126
NCT02625506|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2015-12-05|||June 2015||2015-06-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy of Tramadol With Levobupivacaine for Modified Pectoral Nerve Block|Efficacy of Adding Tramadol as Adjunctive Analgesic With Levobupivacaine in Modified Pectoral Nerve Block for Modified Radical Mastectomy Surgery|Enrolling by invitation||N/A|60|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 22:40:40.448278|2017-10-10 22:40:40.448278
NCT02625493|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-02-02|||June 2014||2014-06-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|August 2014|Actual|2014-08-01||Observational|PREVAS||Patient Preference for Radial Versus Femoral Vascular Access|Patient Preferences for Radial Versus Femoral Vascular Access Options by Coronary Angiography and Intervention|Completed||N/A|198|Actual|Thorax Centrum Twente|||1||f||||f||||||||||2017-10-10 22:40:40.526295|2017-10-10 22:40:40.526295
NCT02625480|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2017-07-25|||December 2015||2015-12-01|July 2017|2017-07-01||||June 2019|Anticipated|2019-06-01||Interventional|ZUMA-4||A Multi-Center Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia|A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-4)|Recruiting||Phase 1/Phase 2|75|Anticipated|Kite Pharma, Inc.||1|||f||||||||||||||2017-10-10 22:40:40.6183|2017-10-10 22:40:40.6183
NCT02625467|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-05|||June 2013||2013-06-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|June 2014|Actual|2014-06-01||Interventional|||Treatment of Keratoconus With PALK Versus PK|Treatment of Keratoconus With Pachymetry Assisted Laser Keratoplasty (PALK) Versus Penetrating Keratoplasty (PK)|Completed||Phase 1|28|Actual|Instituto de Oftalmología Fundación Conde de Valenciana||2|||f||||f||||||||||2017-10-10 22:40:40.742519|2017-10-10 22:40:40.742519
NCT02625454|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-12-14|||December 2016||2016-12-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|RIFIVA||Reduction of Intrapartum Fever With Intravenous Acetaminophen|Randomized Control Trial of Intravenous Acetaminophen (OFIRMEV) for the Reduction of Intrapartum Maternal Fever and Fetal Tachycardia|Recruiting||Phase 2|168|Anticipated|Richmond University Medical Center||2|||f||||f||||||||||2017-10-10 22:40:40.872042|2017-10-10 22:40:40.872042
NCT02625441|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2017-08-09|||December 2015||2015-12-01|August 2017|2017-08-01|June 2023|Anticipated|2023-06-01|December 2022|Anticipated|2022-12-01||Interventional|BOLD-1||Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer|A Randomized Phase III Study Comparing Trastuzumab, Pertuzumab Plus Docetaxel (TPD) Followed by 3 Cycles of Chemotherapy to the Current Standard Regimen as the Treatments of Early Breast Cancer|Recruiting||Phase 3|1366|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-10 22:40:40.979373|2017-10-10 22:40:40.979373
NCT02625428|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-09-12|||November 2015||2015-11-01|September 2016|2016-09-01||||April 2018|Anticipated|2018-04-01||Interventional|||IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?|Does Contrast-Enhanced Ultrasound Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?|Recruiting||Phase 4|40|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:40:41.079171|2017-10-10 22:40:41.079171
NCT02625415|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-05|2017-02-09|||July 2016||2016-07-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|HFSB6||The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia|A Double Blind Placebo Control Randomised Trial to Test the Effectiveness of Vitamin B6 in Hand Foot Syndrome|Recruiting||N/A|100|Anticipated|Cyprus University of Technology||2|||f||||t||||||||||2017-10-10 22:40:41.157091|2017-10-10 22:40:41.157091
NCT02625389|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-03-02|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|In-Live||Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization.|Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. A Phase IV Study.|Not yet recruiting||Phase 4|125|Anticipated|Guerbet||1|||f||||f|f|f||||||||2017-10-10 22:40:41.333848|2017-10-10 22:40:41.333848
NCT02625376|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-05-23|||August 2015||2015-08-01|May 2016|2016-05-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Interventional|AGED||Resveratrol for Exudative Age-Related Macular Degeneration|Influence of Resveratrol and Resvega Versus Placebo on Incidence of Bilateralisation of Exudative AMD: a Double Masked Prospective Study.|Recruiting||N/A|489|Anticipated|Poitiers University Hospital||3|||f||||f||||||||||2017-10-10 22:40:41.414662|2017-10-10 22:40:41.414662
NCT02625363|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-12-04|||November 2015||2015-11-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Water Intake and Glycemic Response : Preliminary Study|Water Intake and Glycemic Response : Preliminary Study|Recruiting||N/A|10|Anticipated|Nutrifood Research Center, Jakarta, Indonesia||5|||f||||f||||||||||2017-10-10 22:40:41.499008|2017-10-10 22:40:41.499008
NCT02625350|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-04|||December 2015||2015-12-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Glycemic Index of Instant Noodle With and Without Soup: Does Serving Method Have an Effect?|Glycemic Index of Instant Noodle With and Without Soup: Does Serving Method Have an Effect?|Enrolling by invitation||N/A|10|Anticipated|Nutrifood Research Center, Jakarta, Indonesia||3|||f||||f||||||||||2017-10-10 22:40:41.589459|2017-10-10 22:40:41.589459
NCT02625337|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-09-14|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|IMPemBra||Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients|Phase 2 Study Comparing Pembrolizumab With Intermittent/Short-term Dual MAPK Pathway Inhibition Plus Pembrolizumab in Patients Harboring the BRAFV600 Mutation|Recruiting||Phase 2|32|Anticipated|The Netherlands Cancer Institute||4|||f||||f||||||||||2017-10-10 22:40:41.663721|2017-10-10 22:40:41.663721
NCT02625324|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-09-19|||May 2016|Actual|2016-05-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Valiant Evo International Clinical Trial|Valiant Evo International Clinical Trial|Recruiting||N/A|47|Anticipated|Medtronic Endovascular||1|||f||||t||||||||||2017-10-10 22:40:43.320389|2017-10-10 22:40:43.320389
NCT02625311|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-08|||December 2004||2004-12-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|February 2011|Actual|2011-02-01||Interventional|MIS||Comparing Minimal Invasive Surgery en Conventional Total Knee Arthroplasty|A Prospective Comparative Randomized International Multicenter Study Comparing MIS Computer Navigated Total Knee Arthroplasty vs Conventional Computer Navigated Total Knee Arthroplasty|Completed||Phase 4|69|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 22:40:43.438005|2017-10-10 22:40:43.438005
NCT02625298|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-08-30|2017-02-20||September 2010||2010-09-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Use of Mineral Trioxide Aggregate in the Treatment of Traumatized Teeth|Use of Mineral Trioxide Aggregate in the Treatment of Traumatized Permanent Teeth With Necrotic Pulps and Chronic Periapical Lesions|Completed||Phase 2|24|Actual|Association of Paediatric and Preventive Dentists of Serbia||2|||f||||t||||||||||2017-10-10 22:40:43.518325|2017-10-10 22:40:43.518325
NCT02625285|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-10-05|||January 24, 2017|Actual|2017-01-24|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Biosensors||Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative|Validation of New G6PD Point of Care Tests (Biosensors) Against Gold Standard Quantitative Spectrophotometry and Genotyping|Recruiting||N/A|150|Anticipated|University of Oxford|||3||f||||f||||||Samples With DNA|"     Two blood samples will be withdrawn from participants; one sample will be taken by     finger-stick (200 µl) and one sample (0.5 ml) will be taken by arm venipuncture. The blood     from capillary sample will be used to assess G6PD activity using the POC tests, CBC and     laboratory based quantitative tests. The venous blood will be used for reference standard     quantitative G6PD assays, Hb typing analysis, CBC and buffy-coat will be stored for DNA     extraction for G6PD genotyping only; leftover blood will be discarded.   "|||2017-10-10 22:40:43.821335|2017-10-10 22:40:43.821335
NCT02625272|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-08|||June 2015||2015-06-01|December 2015|2015-12-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Randomized Controlled Trial of a Novel HALS Technique Versus Laparoscopic Technique for Right Hemicolectomy|A Randomized Controlled Trial of a Novel HALS Technique Versus Laparoscopic Technique for Complete Mesocolic Excision and no Touch Isolation in Right Hemicolectomy|Recruiting||Phase 2|60|Anticipated|West China Hospital||3|||f||||t||||||||||2017-10-10 22:40:43.89861|2017-10-10 22:40:43.89861
NCT02625246|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-04-24|||December 2015||2015-12-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|CELEB||Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non‐Cystic Fibrosis Bronchiectasis|A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell (hMSC) Infusion in Patients With Non-Cystic Fibrosis Bronchiectasis|Recruiting||Phase 1|6|Anticipated|University of Miami||2|||f||||t||||||||Undecided||2017-10-10 22:40:44.106433|2017-10-10 22:40:44.106433
NCT02625233|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-19|2017-04-04||October 1, 2015|Actual|2015-10-01|May 2017|2017-05-01|February 1, 2016|Actual|2016-02-01|February 1, 2016|Actual|2016-02-01||Interventional||All subjects that were enrolled into the study.|Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses||Completed||N/A|105|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||t||||||||||2017-10-10 22:40:44.375267|2017-10-10 22:40:44.375267
NCT02625220|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-05|2016-08-11||October 2015||2015-10-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||All subjects that were dispensed a study lens.|Dispensing Evaluation of Investigational Contact Lenses||Completed||N/A|177|Actual|Johnson & Johnson Vision Care, Inc.||1|||f||||t||||||||||2017-10-10 22:40:44.697285|2017-10-10 22:40:44.697285
NCT02625207|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-03-01|2017-03-01||November 6, 2015|Actual|2015-11-06|March 2017|2017-03-01|March 26, 2016|Actual|2016-03-26|March 26, 2016|Actual|2016-03-26||Interventional||Safety analysis set included all participants who received at least 1 dose of study drug.|THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC|A Phase 1, Open-label, Parallel-group Study To Assess The Effect Of Cyp3a5 Genotype On The Pharmacokinetics Of Maraviroc And Cyp3a5-derived Metabolites With And Without Darunavir/Cobicistat In African-american And Caucasian Healthy Volunteers|Completed||Phase 1|47|Actual|ViiV Healthcare|As per change in planned analysis, calculation of metabolite PK parameters and statistical analyses were not conducted in Part 2, since substantial number of PK samples were below limit of quantitation, considered as non-reliable by investigator.|4|||f||||f||||||||||2017-10-10 22:40:45.019702|2017-10-10 22:40:45.019702
NCT02625194|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-06|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Utility of Oxygen Insufflation During Flexible Fiberoptic Bronchoscope-guided Intubation|The Utility of Oxygen Insufflation During Flexible Fiberoptic Bronchoscope-guided Intubation|Not yet recruiting||N/A|36|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 22:40:46.743085|2017-10-10 22:40:46.743085
NCT02625181|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-03-23|||July 2016||2016-07-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis|Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis|Recruiting||N/A|32000|Anticipated|Vanderbilt University Medical Center||1|||f||||f||||||||No||2017-10-10 22:40:46.836409|2017-10-10 22:40:46.836409
NCT02625168|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-06|||January 2013||2013-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Afatinib vs Erlotinib as 2nd TKI After Failure to 1st TKI and Chemotherapy for Metastatic NSCLC|Efficacy and Safety of Afatinib in Patients With EGFR-mutated Metastatic Non-small-cell Lung Cancer Previously Responsive to First-generation Tyrosine-kinase Inhibitors and Chemotherapy|Completed||Phase 2|25|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:40:47.087052|2017-10-10 22:40:47.087052
NCT02625155|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-03-29|||December 2015||2015-12-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|SPHERE||Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens|Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens: SPHERE|Recruiting||Phase 4|14000|Anticipated|InSource Diagnostics||2|||f||||f||||||||||2017-10-10 22:40:47.186126|2017-10-10 22:40:47.186126
NCT02625142|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-12-04|||February 2010||2010-02-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Family-Centered Rounds Checklist Implementation|Engaging Families in Bedside Rounds to Promote Pediatric Patient Safety|Completed||N/A|340|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 22:40:47.313285|2017-10-10 22:40:47.313285
NCT02625129|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-04-19|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Effectiveness of and Satisfaction With a Pharmacist-managed Travel Medicine Clinic|Determining the Clinical Effectiveness and Patient Satisfaction of a Pharmacist-managed Travel Medicine Clinic Under an Expanded Scope of Practice|Completed||N/A|103|Actual|University of Waterloo|||1||f||||f||||||||||2017-10-10 22:40:47.419397|2017-10-10 22:40:47.419397
NCT02625116|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-04-26|||September 2012||2012-09-01|April 2016|2016-04-01|October 2025|Anticipated|2025-10-01|September 2024|Anticipated|2024-09-01||Observational|ELENA||ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders|ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders|Recruiting||N/A|900|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||No||2017-10-10 22:40:47.494025|2017-10-10 22:40:47.494025
NCT02625103|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-02-24|||September 2015||2015-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.|The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring|Completed||Phase 4|48|Actual|Psychiatric Centre Rigshospitalet||1|||f||||t||||||||No||2017-10-10 22:40:47.577481|2017-10-10 22:40:47.577481
NCT02613104|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-07-11|||October 2014||2014-10-01|July 2016|2016-07-01||||June 2017|Anticipated|2017-06-01||Interventional|||Emotion Recognition Modification for Bipolar Disorder|Emotion Recognition Modification for Bipolar Disorder|Recruiting||N/A|80|Anticipated|Yeshiva University||4|||f||||f||||||||||2017-10-10 22:43:02.708267|2017-10-10 22:43:02.708267
NCT02625090|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-08-31|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy|An Open-label, Multicenter, Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of UCB0942 When Used as Adjunctive Therapy for Partial-onset Seizures in Adult Subjects With Highly Drug-resistant Focal Epilepsy|Active, not recruiting||Phase 2|42|Actual|UCB Pharma||1|||f||||t||||||||||2017-10-10 22:40:47.670527|2017-10-10 22:40:47.670527
NCT02625077|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2017-03-23|||January 2016||2016-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|VANTAGE||Valvuloplasty as Alternative to Toupet Fundoplication for GERD|Valvuloplasty as Alternative to Toupet Fundoplication for the Minimal Invasive Treatment of Gastroesophageal Reflux Disease: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Meander Medical Center||2||Ethical concerns with efficacy of technique.|f||||f||||||||||2017-10-10 22:40:47.800085|2017-10-10 22:40:47.800085
NCT02625064|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-05|||January 2016||2016-01-01|December 2015|2015-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|ARDS||Discovery of New Early Detection Biomarkers of Acute Respiratory Distress Syndrome|Discovery of New Early Detection Biomarkers of Acute Respiratory Distress Syndrome|Not yet recruiting||N/A|500|Anticipated|Xiangya Hospital of Central South University|||5||f||||f||||||Samples With DNA|"     blood   "|||2017-10-10 22:40:47.897523|2017-10-10 22:40:47.897523
NCT02625051|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-25|||July 2016||2016-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Quality of Life in Kidney Stone Patients Undergoing Surgery|Randomized Controlled Clinical Trial Comparing Ureteroscopic to Percutaneous Removal for the 1-2 cm Calculus Measuring Quality of Life as the Primary Outcome|Recruiting||N/A|100|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:40:48.014072|2017-10-10 22:40:48.014072
NCT02625038|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-02-17|||September 2014||2014-09-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|CARDFOREARM||Evaluation of the Intraoperative Accuracy of 3D-planned and Guided Osteotomies of the Hand and Forearm|CT-based Evaluation of the Intraoperative Implementation Accuracy of 3D-planned Osteotomies of the Hand and Forearm Performed With Patient-specific Instruments|Recruiting||N/A|110|Anticipated|Balgrist University Hospital||1|||f||||t||||||||||2017-10-10 22:40:48.123818|2017-10-10 22:40:48.123818
NCT02625025|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-08|||January 2016||2016-01-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Low vs Standard Pneumoperitoneum Pressure During Single Port Access Laparoscopic for Adnexal Pathology||Not yet recruiting||N/A|40|Anticipated|University of Cagliari||2|||f||||||||||||||2017-10-10 22:40:48.212744|2017-10-10 22:40:48.212744
NCT02625012|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-08|||January 2014||2014-01-01|December 2015|2015-12-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Observational|UVBVIT||Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Migration in Vitiligo|Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Dynamics in Vitiligo|Enrolling by invitation||N/A|30|Anticipated|Universidad Autonoma de San Luis Potosí|||1||f||||f||||||Samples With DNA|"     Skin biopsies   "|No||2017-10-10 22:40:48.280035|2017-10-10 22:40:48.280035
NCT02624999|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-07-10|||December 2016||2016-12-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck|An Individualized Cancer Vaccine for Recurrent/Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Not yet recruiting||Phase 2|100|Anticipated|Immunovative Therapies, Ltd.||2|||f||||f||||||||||2017-10-10 22:40:48.351558|2017-10-10 22:40:48.351558
NCT02624973|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-06-23|||April 2016||2016-04-01|June 2017|2017-06-01|June 2030|Anticipated|2030-06-01|June 2020|Anticipated|2020-06-01||Interventional|PETREMAC||PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial|PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial|Recruiting||Phase 2|200|Anticipated|Haukeland University Hospital||8|||f||||t||||||||Yes|Tumor genomic data will be made available after publication.|2017-10-10 22:40:48.611977|2017-10-10 22:40:48.611977
NCT02624960|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-06-07|||September 2016||2016-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Safety and Performance of the AccuCinch® System|Safety and Performance of the AccuCinch® Ventriculoplasty System|Withdrawn||N/A|0|Actual|Ancora Heart, Inc.||1||Sponsor re-evaluating study design prior to obtaining regulatory approval|f||||f||||||||No||2017-10-10 22:40:48.92553|2017-10-10 22:40:48.92553
NCT02624947|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-08-17|||December 2015||2015-12-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization|A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Their Infants|Recruiting||Phase 3|8618|Anticipated|Novavax||2|||f||||t||||||||||2017-10-10 22:40:49.015182|2017-10-10 22:40:49.015182
NCT02624934|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-02-01|||October 2015||2015-10-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Observational|||Podocan and Wnt Pathway in Left Ventricular Remodeling of Aortic Stenosis|Clinical Predictive Value of Podocan and Wnt Pathway Regulatory Molecules on Maladaptive Left Ventricular Response in Aortic Stenosis|Recruiting||N/A|100|Anticipated|Bassett Healthcare|||1||f||||f||||||||||2017-10-10 22:40:49.262977|2017-10-10 22:40:49.262977
NCT02613091|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-11-02|||April 2016||2016-04-01|November 2016|2016-11-01||||September 2016|Actual|2016-09-01||Interventional|||Effect of Clemastine Fumarate on Color Vision in Healthy Controls||Completed||Phase 1|23|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 22:43:02.818074|2017-10-10 22:43:02.818074
NCT02624921|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-09|||October 2013||2013-10-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||PHENOTYPE. Therapeutic Study in Barcelona|Positive Health Effects of the Natural Outdoor Environment in Typical Populations in Different Regions in Europe. Work Package 4: Therapeutic Study in Barcelona|Completed||N/A|26|Actual|Centre for Research in Environmental Epidemiology, Spain|||1||f||||||||||||||2017-10-10 22:40:49.351409|2017-10-10 22:40:49.351409
NCT02624908|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-07-21|||April 2016||2016-04-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Canagliflozin-Mealtime Insulin Rescue|Canagliflozin-Mealtime Insulin Rescue|Recruiting||Phase 4|40|Anticipated|Atlanta Research and Education Foundation||2|||f||||t||||||||||2017-10-10 22:40:49.447592|2017-10-10 22:40:49.447592
NCT02624895|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-07-26|||December 30, 2015|Actual|2015-12-30|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|SILQ||ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX -1st Line|ProSpective multIcenter observationaL Study on the Quality of Life of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX as 1st Line of Treatment|Recruiting||N/A|300|Anticipated|Amgen|||1||f||||f||||||None Retained|"     not collected   "|||2017-10-10 22:40:49.553767|2017-10-10 22:40:49.553767
NCT02624882|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-07-31|||November 2015||2015-11-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|May 2018|Anticipated|2018-05-01||Interventional|TAPPS||Impact of Antibiotic Treatment of Group A Streptococcal Blistering Distal Dactylitis in Children|Impact of Antibiotic Treatment of Group A Streptococcal Blistering Distal Dactylitis in Children|Recruiting||N/A|250|Anticipated|Centre Hospitalier Intercommunal Creteil||2|||f||||f||||||||||2017-10-10 22:40:49.698339|2017-10-10 22:40:49.698339
NCT02624869|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-10-05|||September 10, 2016|Actual|2016-09-10|October 2017|2017-10-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2021|Anticipated|2021-01-01||Interventional|HAUSER-OLE||Open Label Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Pediatric Subjects (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH).|Open-label, Single-Arm, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of Evolocumab for LDL-C Reduction, as Add-on to Diet and Lipid-lowering Therapy, in Pediatric Subjects From 10 to 17 Years of Age With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH)|Recruiting||Phase 3|115|Anticipated|Amgen||1|||f||||t||||||||||2017-10-10 22:40:49.799059|2017-10-10 22:40:49.799059
NCT02624856|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-08-18|||November 2015||2015-11-01|August 2016|2016-08-01||||November 2017|Anticipated|2017-11-01||Interventional|||Liposomal Bupivacaine Versus Standard Bupivacaine Plus Dexamethasone in Quadriceps Sparing Femoral Nerve Block and Wound Infiltration for Total Knee Arthroplasty|Prospective, Randomized, Double-Blinded, Allocation Concealed Study Comparing the Efficacy of Liposomal Bupivacaine Over Standard Bupivacaine Plus Dexamethasone in Quadriceps Sparing Femoral Nerve Block and Wound Infiltration for Primary Total Knee Arthroplasty|Recruiting||Phase 4|120|Anticipated|Albany Medical College||2|||f||||f||||||||||2017-10-10 22:40:49.946171|2017-10-10 22:40:49.946171
NCT02624843|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-04|||August 2015||2015-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Bioequivalence Study for Benzyl Alcohol Lotion 5%.|Bioequivalence Study for Benzyl Alcohol Lotion 5% (Hi-Tech Pharmacal Co. LTD) and Ulesfia (Benzyl Alcohol Lotion 5%) (Shionogi Inc.) in the Treatment of Head Lice and Their Ova.|Completed||Phase 3|225|Actual|Akorn, Inc.||3|||f||||f||||||||||2017-10-10 22:40:50.085304|2017-10-10 22:40:50.085304
NCT02624830|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-07|||November 2015||2015-11-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|SuResponsSUR||Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)|Long-term Sulfonylurea Response and Glucose Control After Switching From Insulin in Children With Diabetes Due to ABCC8 (SUR1) Mutations|Enrolling by invitation||Phase 4|30|Anticipated|Haukeland University Hospital||1|||f||||f||||||||||2017-10-10 22:40:50.213834|2017-10-10 22:40:50.213834
NCT02624817|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-29|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|SuResponsKIR||Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes|Long-term Sulfonylurea Response and Glucose Control After Switching From Insulin in Children With Diabetes Due to KCNJ11 (KIR6.2) Mutations|Completed||Phase 4|90|Actual|Haukeland University Hospital||1|||f||||f||||||||||2017-10-10 22:40:50.321531|2017-10-10 22:40:50.321531
NCT02624804|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-07-17|||June 27, 2017|Actual|2017-06-27|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes|A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes|Recruiting||Phase 1|10|Anticipated|Hackensack University Medical Center||1|||f||||t|t|f||||||||2017-10-10 22:40:50.469081|2017-10-10 22:40:50.469081
NCT02624791|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-04-20|2016-10-26||September 2012||2012-09-01|April 2017|2017-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||11 participants completed the operational tests 9 participants completed the tactical tests|Evaluating and Improving Functional Driving Vision of Patients With Astigmatism|Evaluating and Improving Functional Driving Vision of Patients With Astigmatism|Completed||N/A|11|Actual|University of Virginia|small number of subjects analyzed|6|||f||||f||||||||Undecided||2017-10-10 22:40:50.60993|2017-10-10 22:40:50.60993
NCT02624778|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-21|||December 2015||2015-12-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD|A Single- and Multiple-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Intravenous Doses of LY3002813 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease|Recruiting||Phase 1|150|Anticipated|Eli Lilly and Company||10|||f||||f||||||||||2017-10-10 22:40:50.869389|2017-10-10 22:40:50.869389
NCT02624765|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-03-21|||December 2015||2015-12-01|March 2016|2016-03-01||||November 2020|Anticipated|2020-11-01||Interventional|||FAST Therapy Trial of Fetal Tachyarrhythmia|Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial|Enrolling by invitation||Phase 3|600|Anticipated|The Hospital for Sick Children||6|||f||||t||||||||||2017-10-10 22:40:51.016495|2017-10-10 22:40:51.016495
NCT02624752|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-03-21|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|NutriSup Oral||Oral Nutrition Supplementation in Hospitalized Patients|Nutrition Supplementation in Hospitalized Patients (NutriSup Oral)|Recruiting||Phase 2|60|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||No||2017-10-10 22:40:51.159974|2017-10-10 22:40:51.159974
NCT02623647|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-10-06|||November 2015||2015-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|eHYPO||A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer|A Phase I-II Study on the Tolerance and Efficacy of SBRT in 3 Fractions for Low/Int Risk Prostate Cancer|Recruiting||Phase 1/Phase 2|59|Anticipated|Regina Elena Cancer Institute||1|||f||||f||||||||No||2017-10-10 22:40:51.24472|2017-10-10 22:40:51.24472
NCT02623634|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-12-03|||October 2015||2015-10-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01|2 Years|Observational [Patient Registry]|||The Association Between Factors and the Results of the Cuff Leak Test|The Association Between Factors and the Results of the Cuff Leak Test:a Cohort Study|Recruiting||N/A|300|Anticipated|Beijing Chao Yang Hospital|||1||f||||t||||||||||2017-10-10 22:40:51.312468|2017-10-10 22:40:51.312468
NCT02623621|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-03|||November 2015||2015-11-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|CIRCUS||Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer|A Single-arm Phase II Study of Circulating Soluble Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Predictor of Benefit From Bevacizumab (Bev) Beyond Progression in Metastatic Colorectal Cancer (mCRC) - the CIRCUS Study|Recruiting||N/A|97|Anticipated|Azienda Ospedaliero, Universitaria Pisana|||1||f||||f||||||Samples With DNA|"     Paired plasma and blood samples will be collected at baseline, at the time of every disease     assessment and at the time of disease progression   "|||2017-10-10 22:40:51.398578|2017-10-10 22:40:51.398578
NCT02623608|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-09-06|||August 2015||2015-08-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Effects of Functional Ingredients in an Acute Metabolic Challenge Context|Acute Metabolic Challenge for the Assessment of Cardiometabolic Protective Effects of Foods|Completed||N/A|15|Anticipated|Lund University||5|||f||||f||||||||||2017-10-10 22:40:51.469975|2017-10-10 22:40:51.469975
NCT02623595|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-05-30|||May 2016||2016-05-01|May 2016|2016-05-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy|A Prospective Single-arm Multi-center Phase II Study: Assessment of the Safety and Abscopal Effects of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy|Recruiting||Phase 2|60|Anticipated|Wuhan University||1|||f||||t||||||||Yes|Data of tumor response, abscopal effect rate and survival time will be available within 4 months of study completion|2017-10-10 22:40:51.71834|2017-10-10 22:40:51.71834
NCT02623582|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-06-08|||December 2015||2015-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CD123 Redirected Autologous T Cells for AML|Pilot Study of RNA-Redirected Autologous T Cells Engineered to Contain Anti-CD123 Linked to TCR and 4-1BB Signaling Domains in Patients With Refractory or Relapsed Acute Myeloid Leukemia|Terminated||Early Phase 1|7|Actual|University of Pennsylvania||2||This study was terminated due to lack of funding.|f||||t||||||||Yes||2017-10-10 22:40:51.870478|2017-10-10 22:40:51.870478
NCT02623569|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2015-12-04|||October 2014||2014-10-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina|Evaluation of the Anti-anginal Efficacy and Safety of Ivabradine Used in Patients With Stable Effort Angina Pectoris. A 12 Weeks Randomised, Double-blind Controlled, Parallel-group, Multicentre Study|Recruiting||Phase 2|336|Anticipated|Xintong Pharmacy Company||2|||f||||t||||||||||2017-10-10 22:40:51.984601|2017-10-10 22:40:51.984601
NCT02624739|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-06-09|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:40:52.141306|2017-10-10 22:40:52.141306
NCT02624726|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-10-03|||January 2016||2016-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|MINOAS||Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment|A Open Label, Non Randomized, Phase Two Trial in Metastatic Colorectal Cancer (mCRC) With the Combination of m FOLFIRI Plus Aflibercept as First Line Treatment: MINOAS Trial|Recruiting||Phase 2|89|Anticipated|Hellenic Oncology Research Group||1|||f||||f||||||||Undecided||2017-10-10 22:40:52.224064|2017-10-10 22:40:52.224064
NCT02624700|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-10-03|||January 28, 2016||2016-01-28|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer|Phase 2 Study of Pemetrexed and Sorafenib for Treatment of Recurrent or Metastatic Triple Negative Breast Cancer|Recruiting||Phase 2|35|Anticipated|Virginia Commonwealth University||1|||f||||t|t|f|||f|||||2017-10-10 22:40:52.514894|2017-10-10 22:40:52.514894
NCT02624687|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-05-01|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|StandBack||Reducing Sedentary Behavior to Decrease Low Back Pain: Stand Back Study|Reducing Sedentary Behavior to Decrease Low Back Pain: Stand Back Study|Completed||N/A|27|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:40:52.664522|2017-10-10 22:40:52.664522
NCT02624674|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-12-07|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Multi-spectral Imaging to Assess Wounds in Peripheral Vascular Disease Patients|Multi-spectral Imaging to Assess Wounds in Peripheral Vascular Disease Patients|Not yet recruiting||Phase 3|20|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-10 22:40:52.7767|2017-10-10 22:40:52.7767
NCT02624661|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-02-10|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique|Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique|Recruiting||Phase 1/Phase 2|10|Anticipated|Norwegian University of Science and Technology||1|||f||||t||||||||||2017-10-10 22:40:52.922935|2017-10-10 22:40:52.922935
NCT02624648|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-06-19|||October 2015||2015-10-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|maca||Effects of Lepidium Meyenii Walp on Sexual Function in Postmenopausal Women|Effects of Lepidium Meyenii Walp (Peruvian Maca) on Sexual Function in Postmenopausal|Recruiting||Phase 1|144|Anticipated|Universidade do Vale do Sapucai||2|||f||||t||||||||||2017-10-10 22:40:53.068|2017-10-10 22:40:53.068
NCT02624635|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-08|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Hip Strengthening and Manual Therapy for Heel Pain Patients|Effects of Adding Hip Strengthening to Manual Therapy for Heel Pain Patients|Recruiting||N/A|40|Anticipated|Centro Universitário Augusto Motta||2|||f||||f||||||||||2017-10-10 22:40:53.25751|2017-10-10 22:40:53.25751
NCT02624622|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-11-23|||March 2015||2015-03-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Chlorhexidine Cord Care for Newborn Infants in Kenya|A Comparison Between Mothers and Community Health Workers on Use of Chlorhexidine for Umbilical Cord Care: A Randomized Noninferiority Trial|Terminated||N/A|576|Actual|University of New Mexico||2||Lack of funds|f||||f||||||||||2017-10-10 22:40:53.391103|2017-10-10 22:40:53.391103
NCT02624609|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-06-02|||November 2015||2015-11-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Polyphenols Found in Pomegranate Juice on Postprandial Blood Glucose in Vivo|Effects of Polyphenols Found in Pomegranate Juice on Postprandial Blood Glucose in Vivo|Completed||N/A|16|Actual|University of Leeds||2|||f||||t||||||||No||2017-10-10 22:40:53.514159|2017-10-10 22:40:53.514159
NCT02624596|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-06-14|||June 2016||2016-06-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Understanding How Ketamine Brings About Rapid Improvement in OCD|NMDAR Modulation As a Therapeutic Target and Probe of Neural Dysfunction in OCD|Recruiting||Phase 2|120|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:40:53.631533|2017-10-10 22:40:53.631533
NCT02624583|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-07|||June 2010||2010-06-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|RFeCloR||Effects of RF on Clopidogrel Resistance in Patients at High Cardiovascular Risk|Effects of Ramadan Fasting on Clopidogrel Resistance in Patients at High Cardiovascular Risk. An Observational Study|Active, not recruiting||N/A|98|Actual|University of Monastir|||1||f||||f||||||Samples Without DNA|"     Venous blood samples were collected from the enrolled participants. Blood samples were     analyzed for hemoglobin, hematocrit, platelet cell count, Prothrombin time, activated partial     thromboplastin time, and clopidogrel effect on P2Y12 receptor by optical turbidimetry     (expressed as P2Y12 reaction units (PRU)).   "|||2017-10-10 22:40:53.778941|2017-10-10 22:40:53.778941
NCT02624570|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-08-02||||||August 2017|2017-08-01||||||||Expanded Access|AMLFLT3||Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy.|An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy|Available||N/A|||Novartis||||||||t|||||||||||2017-10-10 22:40:53.875866|2017-10-10 22:40:53.875866
NCT02624557|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-09-12|||December 21, 2015|Actual|2015-12-21|September 2017|2017-09-01|September 25, 2017|Anticipated|2017-09-25|September 25, 2017|Anticipated|2017-09-25||Interventional|||Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.|A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.|Recruiting||Phase 1|24|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 22:40:54.229293|2017-10-10 22:40:54.229293
NCT02624544|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-12-07|||January 2016||2016-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Proton Pump Inhibitors Use in Patients With Psoriasis|Proton Pump Inhibitors Use in Patients With Psoriasis|Not yet recruiting||Phase 4|30|Anticipated|EMS||2|||f||||t||||||||||2017-10-10 22:40:54.370111|2017-10-10 22:40:54.370111
NCT02624531|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-04-01|||November 2015||2015-11-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|SYSUGO-005||Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)|Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)|Recruiting||N/A|60|Anticipated|Sun Yat-sen University||1|||f||||f||||||||No||2017-10-10 22:40:54.469446|2017-10-10 22:40:54.469446
NCT02624518|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-02-21|||November 2015||2015-11-01|February 2017|2017-02-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer|68Ga-RM2 PET/MRI in the Evaluation of Patients With Biochemical Recurrence of Prostate Cancer and Non-contributory CT Scans|Recruiting||Phase 2/Phase 3|100|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:40:54.601487|2017-10-10 22:40:54.601487
NCT02624505|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-03-14|||December 2015||2015-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma|To Compare the Bronchoprotective Effects of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate Using Methacholine Bronchoprovocation Challenge Testing in Stable Mild Asthma Patients.|Recruiting||Phase 3|115|Anticipated|Cipla Ltd.||4|||f||||f||||||||No|Undecided|2017-10-10 22:40:54.728348|2017-10-10 22:40:54.728348
NCT02624492|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-10-02|||January 28, 2016|Actual|2016-01-28|October 2017|2017-10-01|November 15, 2019|Anticipated|2019-11-15|November 15, 2019|Anticipated|2019-11-15||Interventional|||To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL|An Open Label Multicenter Phase Ib/II Trial to Determine the Dose of BI 836826 in Combination With Gemcitabine and Oxaliplatin (GemOx) and the Efficacy of BI 836826-GemOx Versus Rituximab (R)- GemOx (R-GemOx) in Patients With Relapsed/ Refractory Diffuse Large B-cell Lymphoma (DLBCL) Who Are Not Eligible for, or Have Relapsed/Progressed After Autologous/Allogeneic Stem Cell Transplant|Recruiting||Phase 2|153|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:40:54.856569|2017-10-10 22:40:54.856569
NCT02624297|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-05-15|||January 2014||2014-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Chemoreflex Control of Sympathetic Activity in Patients With Coronary Artery Disease|Effect of Exercise Training on Chemoreflex Control of Sympathetic Activity in Patients With Coronary Artery Disease and Obstructive Sleep Apnea|Recruiting||N/A|50|Anticipated|University of Sao Paulo General Hospital||5|||f||||t||||||||||2017-10-10 22:40:56.709479|2017-10-10 22:40:56.709479
NCT02624479|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-09-25|||December 2018|Anticipated|2018-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|TSTS||Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate|Phase I Pharmacokinetic Pilot Study to Investigate the Bioavailability and Tolerability of Three Different Oral Formulations of Sodium Thiosulfate|Not yet recruiting||Phase 1|12|Anticipated|University Hospital Inselspital, Berne||3|||f||||f|f|f|||f|||||2017-10-10 22:40:54.986096|2017-10-10 22:40:54.986096
NCT02624466|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-12-07|||October 2015||2015-10-01|December 2015|2015-12-01|September 2019|Anticipated|2019-09-01|October 2017|Anticipated|2017-10-01||Observational|UToPaed_1||Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Observational Study|Part 1 of: 'Conceptualisation and Validation of a Paradigm Based on Uraemic Toxins for Management of Chronic Kidney Disease in Paediatric Patients (UToPaed)'|Recruiting||N/A|120|Anticipated|University Hospital, Ghent|||3||f||||f||||||||||2017-10-10 22:40:55.088496|2017-10-10 22:40:55.088496
NCT02624453|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2016-07-11|||July 2015||2015-07-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|PreCASA||Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS|Implementation and Evaluation of a Screening Strategy to Reduce Morbidity and Mortality Due to Cryptoccocal Meningo-encephalitis in ART Naive AIDS Patients With <100 CD4 Count at the Day Hospital of the Yaounde Central Hospital, Cameroon|Recruiting||N/A|400|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||f||||||||||2017-10-10 22:40:55.202809|2017-10-10 22:40:55.202809
NCT02624440|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2015-12-04|||January 2013||2013-01-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|SUTRICA||Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma|A Randomized, Open-label Phase III Study of Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Combination With Standard Therapy in Patients With Newly Diagnosed Multiple Myeloma|Recruiting||Phase 2|300|Anticipated|Aalborg Universitetshospital||3|||f||||t||||||||||2017-10-10 22:40:55.324446|2017-10-10 22:40:55.324446
NCT02624427|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-06-20|||December 2015||2015-12-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Goldmann Applanation Tonometry, Dynamic Contour Tonometry, and Corvis ST Tonometer|Comparison of Intraocular Pressure Measured by Goldmann Applanation Tonometry and Dynamic Contour Tonometry vs. Corvis ST Tonometer|Completed||N/A|109|Actual|University of Zurich||2|||f||||f||||||||No||2017-10-10 22:40:55.450463|2017-10-10 22:40:55.450463
NCT02624414|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-04-12|||February 6, 2015|Actual|2015-02-06|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|||Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin|A Prospective Study of the Feasibility of Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin|Recruiting||N/A|34|Anticipated|Melbourne Health||1|||f||||f||||||||||2017-10-10 22:40:55.516832|2017-10-10 22:40:55.516832
NCT02624401|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-03-22|||January 2016||2016-01-01|March 2017|2017-03-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|||The Neural Mechanisms of Anesthesia and Human Consciousness (Part 6)|The Neural Mechanisms of Anesthesia and Human Consciousness (Part 6)|Completed||Phase 4|160|Actual|University of Turku||5|||f||||f||||||||No||2017-10-10 22:40:55.596375|2017-10-10 22:40:55.596375
NCT02624388|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-06-20|||August 2016||2016-08-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|August 2018|Anticipated|2018-08-01||Interventional|UVA-Gen001||Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)|A Randomized, Placebo-Controlled Pilot Study of Genistein Supplementation in Pediatric Cancer Patients Receiving Myelosuppressive Chemotherapy|Recruiting||Phase 2|50|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-10 22:40:55.698934|2017-10-10 22:40:55.698934
NCT02624375|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-10-26|||February 2016||2016-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Immune Response to Shingles Vaccination|Immune Response to Shingles Vaccination|Recruiting||Phase 4|50|Anticipated|University of Washington||1|||f||||t||||||||No||2017-10-10 22:40:55.821048|2017-10-10 22:40:55.821048
NCT02624362|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-07|||August 2015||2015-08-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Odors on Asthma Symptoms|The Effect of Suggestion of Harmful/Beneficial Effects of Odors on Asthma Symptoms|Enrolling by invitation||N/A|48|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 22:40:55.895377|2017-10-10 22:40:55.895377
NCT02624349|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-12-05|||October 2013||2013-10-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|April 2016|Actual|2016-04-01||Interventional|||Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients|Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients|Active, not recruiting||Phase 4|130|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||No||2017-10-10 22:40:55.99637|2017-10-10 22:40:55.99637
NCT02624336|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-07|||February 2015||2015-02-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ESAA||Evaluation of Synergistic Anti-plaque Activity of Salvadora Persica L. and Green Tea: A Clinical Comparative Study|Evaluation of Synergistic Anti-plaque Activity of Salvadora Persica L. and Green Tea: A Clinical Comparative Study|Completed||Phase 2|14|Actual|University of Malaya||3|||f||||t||||||||No||2017-10-10 22:40:56.240798|2017-10-10 22:40:56.240798
NCT02624323|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2017-07-09|||August 2016||2016-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ultrasound Guided Axillary Versus Jugular Central Venous Catheterization|Real-time Ultrasound-guided Axillary and Jugular Vein Catheterization: A Prospective Comparison in Mechanically Ventilated Critically Ill Patients. A Randomized Study|Recruiting||N/A|550|Anticipated|Publiczny Samodzielny Zaklad Opieki Zdrowotnej Wojewodzkie Centrum Medyczne||2|||f||||t||||||||||2017-10-10 22:40:56.384698|2017-10-10 22:40:56.384698
NCT02624310|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-09-09|||January 2016||2016-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis|A Phase II, Randomized, Double Blind, Cross-over, Placebo-controlled Study on Norepinephrine Replenishment Therapy Using L-DOPS in Congenital Insensitivity to Pain With Anhidrosis Patients|Withdrawn||Phase 2|0|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:40:56.532811|2017-10-10 22:40:56.532811
NCT02624271|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-03|||April 2016||2016-04-01|December 2015|2015-12-01|April 2018|Anticipated|2018-04-01|April 2016|Anticipated|2016-04-01||Interventional|GASTRO-PRA||Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk|Non Invasive Diagnosis of Gastric Precancerous Lesions by GastroPanel Blood Test in Patients With Increased Gastric Cancer Risk : a French Multicenter Study|Not yet recruiting||N/A|2000|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 22:40:57.030979|2017-10-10 22:40:57.030979
NCT02624258|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-08-03|||November 2015||2015-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma|Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells Engineered to Contain Anti-CD19 Linked to TCR and 4-1BB Signaling Domains in Patients With Refractory or Relapsed Hodgkin Lymphoma|Recruiting||Early Phase 1|10|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:40:57.151247|2017-10-10 22:40:57.151247
NCT02624245|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-03|||May 2013||2013-05-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|August 2014|Actual|2014-08-01||Interventional|MCTACPTMECPTA||The Movement Control Training Associated With Conventional Physical Therapy is More Effective Than Conventional Physical Therapy Alone in Pain and Functional Performance?||Completed||N/A|34|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 22:40:57.291106|2017-10-10 22:40:57.291106
NCT02624232|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-12-04|||January 2016||2016-01-01|December 2015|2015-12-01|October 2020|Anticipated|2020-10-01|October 2016|Anticipated|2016-10-01||Observational|LOPAM||Long-term Outcome in Patients With Anorectal Malformations|Long-term Outcome in Patients Operated for Congenital Anorectal Malformations|Not yet recruiting||N/A|60|Anticipated|Odense University Hospital|||1||f||||t||||||||||2017-10-10 22:40:57.427354|2017-10-10 22:40:57.427354
NCT02624219|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-09-14|||August 23, 2016|Actual|2016-08-23|April 5, 2017|2017-04-05|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults|A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants|Active, not recruiting||Phase 1|276|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f|||||t|f|||f|||||2017-10-10 22:40:57.585252|2017-10-10 22:40:57.585252
NCT02624206|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-04-27|||August 2014||2014-08-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Specificity of Flavor-Nutrient Learning: An fMRI Experiment|Specificity of Flavor-Nutrient Learning: An fMRI Experiment|Completed||N/A|23|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 22:40:57.764644|2017-10-10 22:40:57.764644
NCT02624193|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-12-03|||April 2013||2013-04-01|October 2015|2015-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Health Improvement for Baltimore Youth|Improving Treatment Adherence in HIV-Positive Youth Through Mindfulness Training|Enrolling by invitation||N/A|255|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-10-10 22:40:57.892|2017-10-10 22:40:57.892
NCT02624180|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-05-01|||November 2015||2015-11-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV|Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV|Recruiting||Phase 2|102|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-10 22:40:58.056046|2017-10-10 22:40:58.056046
NCT02624167|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-03-13|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia|A Phase IIA, Prospective, Randomized, Double-blind, Multiple-dose Study of NW-3509A in Chronic Schizoprhenia Patients Not Responding to Their Current Anti-psychotic Medication|Completed||Phase 2|90|Actual|Newron||2|||f||||t||||||||No||2017-10-10 22:40:58.179203|2017-10-10 22:40:58.179203
NCT02624154|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-04|||December 2015||2015-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival|Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival|Not yet recruiting||N/A|2|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||||||2017-10-10 22:40:58.297096|2017-10-10 22:40:58.297096
NCT02624141|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-11-01|||April 2006||2006-04-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy|Open Multicentric Study to Assess the Hematopoyetic Response in Terms of Increase of Hemoglobin Levels, of Patients With Anemia Reklated to Malignant Tumors, Treated With Erythropoietin B (Recormon) Using the Pre-Filled Syringe With 30,000 IU, as Well as to Quantify Teh Risk Factors of Anemia and Its Impact on Quality of Life Related to Treatment|Terminated||Phase 4|10|Actual|Hoffmann-La Roche||1||The study was terminated due to low recruitment|f||||||||||||||2017-10-10 22:40:58.368662|2017-10-10 22:40:58.368662
NCT02624128|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-03-28|||February 2015||2015-02-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|February 2019|Anticipated|2019-02-01||Interventional|V-CHANCE||Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck|Preclinical and Clinical Study of Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck|Recruiting||Phase 2|39|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-10-10 22:40:58.509531|2017-10-10 22:40:58.509531
NCT02624115|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01|1 Month|Observational [Patient Registry]|||FAZA PET as Biomarker for Hypoxia in Rectal Cancer|18F-Fluoroazomycin Arabinoside (FAZA) Positron Emission Tomography/Magnetic Imaging Resonance (PET/MRI) as a Biomarker of Hypoxia in Rectal Cancer: A Pilot Study|Recruiting||N/A|10|Anticipated|University Health Network, Toronto|||1||f||||f||||||||Undecided||2017-10-10 22:40:58.625225|2017-10-10 22:40:58.625225
NCT02624102|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-15|||September 2015||2015-09-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression|Efficacy of Trial-based Cognitive Therapy and Behavioral Activation in Treatment of Depression: a Randomized Clinical Trial|Recruiting||Phase 3|96|Anticipated|Hemanny, Curt, M.D.||3|||f||||t||||||||||2017-10-10 22:40:58.732345|2017-10-10 22:40:58.732345
NCT02624089|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-03-21|||January 2016||2016-01-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|NALA||Nebulized Analgesia for Laparoscopic Appendectomy Trial|Evaluation of the Effect of Intraperitoneal Nebulized Ropivacaine on Morphine Consumption After Laparoscopic Appendectomy in Children. A Prospective, Randomized Double Blind Clinical Trial|Recruiting||Phase 1/Phase 2|200|Anticipated|McGill University Health Center||3|||f||||t||||||||No||2017-10-10 22:40:58.839679|2017-10-10 22:40:58.839679
NCT02624076|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-17|||December 2015||2015-12-01|December 2015|2015-12-01||||January 2018|Anticipated|2018-01-01||Interventional|AURIS||Acupuncture for Unexplained Subfertiliy|A Randomized Controlled Trial of Acupuncture Versus Expectant Management in Women With Unexplained Infertility|Not yet recruiting||N/A|1423|Anticipated|Heilongjiang University of Chinese Medicine||2|||f||||f||||||||||2017-10-10 22:40:58.933528|2017-10-10 22:40:58.933528
NCT02624063|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-07-28|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)|Randomized Clinical Trial to Assess the Effectiveness of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 1 (TNT-1 Study)|Completed||Phase 4|121|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 22:40:59.051028|2017-10-10 22:40:59.051028
NCT02624050|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-08-01|||August 1, 2016|Actual|2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs|Comparison of Methohexital With Propofol for Anesthetic Induction in Patients Treated With an Antagonist of the Renin-Angiotensin System.|Recruiting||N/A|120|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-10 22:40:59.135936|2017-10-10 22:40:59.135936
NCT02624037|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-11-04|||January 2015||2015-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Precision IFX: Using a Dashboard to Individualize Infliximab Dosage|Precision IFX: Using a Pharmacokinetic Dashboard to Optimize and Individualize Infliximab Dosage for Pediatric Inflammatory Bowel Disease Patients|Recruiting||N/A|50|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-10 22:40:59.252851|2017-10-10 22:40:59.252851
NCT02624024|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-06-30|||January 2016||2016-01-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Clinical Performance Evaluation of AQT90 FLEX TnI and TnT|AQT90 FLEX TnI and TnT - Clinical Sensitivity and Specificity Study|Completed||N/A|1743|Actual|Radiometer Medical ApS|||1||f||||||||||Samples Without DNA|"     Frozen plasma samples are retained for this study and possible future studies.   "|||2017-10-10 22:40:59.37916|2017-10-10 22:40:59.37916
NCT02624011|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Influence of Sedentary Time on Skeletal Muscle Protein Metabolism|Influence of Increased Sedentary Time on Long-term Rates of Skeletal Muscle Protein Synthesis in Young Adults|Recruiting||N/A|10|Anticipated|University of Birmingham||1|||f||||f||||||||||2017-10-10 22:40:59.470265|2017-10-10 22:40:59.470265
NCT02623998|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-09-18|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)|An Open-label, Randomized, Parallel Design Trial to Compare the Efficacy of a Sitagliptin-based Metabolic Intervention Versus Standard Diabetes Therapy in Inducing Remission of Type 2 Diabetes|Recruiting||Phase 3|100|Anticipated|Population Health Research Institute||2|||f||||f||||||||||2017-10-10 22:40:59.561075|2017-10-10 22:40:59.561075
NCT02623985|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-03|||December 2015||2015-12-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of Accuracy of Rapid Tests for Group A Beta Hemolytic Streptococci in Out-patients With Sore Throat|Evaluation of Accuracy of Rapid Tests for Group A Beta Hemolytic Streptococci in Out-patients With Sore Throat From Acute Pharyngitis at Siriraj Hospital|Not yet recruiting||Phase 3|400|Anticipated|Mahidol University||3|||f||||f||||||||||2017-10-10 22:40:59.753323|2017-10-10 22:40:59.753323
NCT02623972|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-06-30|||December 2015||2015-12-01|June 2017|2017-06-01|February 2023|Anticipated|2023-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer|A Phase 2 Study of Eribulin Followed by Doxorubicin and Cyclophosphamide as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer|Recruiting||Phase 2|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 22:40:59.835222|2017-10-10 22:40:59.835222
NCT02623959|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-04|2017-06-14|||April 27, 2016|Actual|2016-04-27|June 2017|2017-06-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|||Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis|A Double Blind Randomized Controlled Trial of Indwelling Pleural Catheters Versus Indwelling Pleural Catheters Plus Doxycycline Pleurodesis for Treatment of Malignant Pleural Effusions|Terminated||N/A|3|Actual|M.D. Anderson Cancer Center||2||Slow Accrual|f||||t|t|f||||||||2017-10-10 22:40:59.940814|2017-10-10 22:40:59.940814
NCT02623946|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-07-26|||November 2015||2015-11-01|July 2016|2016-07-01|February 2021|Anticipated|2021-02-01|December 2020|Anticipated|2020-12-01||Observational|||Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients|Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients|Recruiting||N/A|10|Anticipated|Clinique Neuro-Outaouais|||1||f||||f||||||||||2017-10-10 22:41:00.055582|2017-10-10 22:41:00.055582
NCT02623933|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2016|Actual|2016-12-01||Interventional|MARS||MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients|MRI Assisted Focal Boost Integrated With HDR Monotherapy Study in Low and Intermediate Risk Prostate Cancer Patients (MARS)|Active, not recruiting||N/A|60|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||Undecided||2017-10-10 22:41:00.136228|2017-10-10 22:41:00.136228
NCT02623920|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-05-18|||December 16, 2015|Actual|2015-12-16|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|S-BR||Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma|Phase II Study of Brentuximab Vedotin in Combination With Bendamustine and Rituximab, in Patients With CD30 Positive, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (NHL)|Withdrawn||Phase 2|0|Actual|University of Arizona||1||"Pharmaceutical company supplying the drug withdraw financial support. PI has decided to close   study prior to enrollment of any patients."|f||||t||||||||||2017-10-10 22:41:00.229732|2017-10-10 22:41:00.229732
NCT02623907|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-07|||May 2016||2016-05-01|December 2015|2015-12-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01|3 Years|Observational [Patient Registry]|CHIVAS-1||China Valve Registry Study-1|Registry Study of Aortic Valve Diseases in Chinese Elderly|Not yet recruiting||N/A|2000|Anticipated|Shanghai Zhongshan Hospital|||2||f||||t||||||||Undecided||2017-10-10 22:41:00.335042|2017-10-10 22:41:00.335042
NCT02623894|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-07|||October 2015||2015-10-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01|1 Year|Observational [Patient Registry]|||Influence of Different Risk Factors in Vascular Accelerated Aging (EVA Study)|Influence of Different Risk Factors in Vascular Accelerated Aging. A Cross-sectional, Descriptive Observational Study (EVA Study)|Recruiting||N/A|500|Anticipated|Fundacion para la Investigacion y Formacion en Ciencias de la Salud|||1||f||||f||||||Samples Without DNA|"     Fasting plasma glucose, creatinine, uric acid, Ca, P, serum total cholesterol, high-density     lipoprotein cholesterol and triglyceride levels will be measured using standard enzymatic     automated methods. Low-density lipoprotein cholesterol will be estimated by the Friedewald     equation when the direct parameter is not available. Glycated haemoglobin will be measured     with an immune-turbidimetric assay. Cytokines concentrations in plasma will be determined by     ELISA using commercial kits and following the manufacturer's recommendations. Oxidative     stress will be determined by measuring lipid peroxides and nucleic acid derivatives by ELISA     using commercial kits and following the manufacturer's recommendations.   "|||2017-10-10 22:41:00.404471|2017-10-10 22:41:00.404471
NCT02623881|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-08-24|||December 2015||2015-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Cervical Pessary vs. Vaginal Progesterone for Preventing Premature Birth in IVF Twin Pregnancies|The Effectiveness of Cervical Pessary Versus Vaginal Progesterone for Preventing Premature Birth in IVF Twin Pregnancies: a Randomized Controlled Trial.|Recruiting||N/A|290|Anticipated|Vietnam National University||2|||f||||f||||||||||2017-10-10 22:41:00.501578|2017-10-10 22:41:00.501578
NCT02623868|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-01-17|||October 2015||2015-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.|Clinical Trial to Assess the Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subjects|Completed||Phase 1|30|Actual|Chong Kun Dang Pharmaceutical||6|||f||||f||||||||||2017-10-10 22:41:02.371094|2017-10-10 22:41:02.371094
NCT02623855|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-02-14|||July 2015||2015-07-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|SHINE||Stay Healthy In Nature Everyday: Family Nature Outings in a Low Income Population|Stay Healthy In Nature Everyday: a Randomized Controlled Trial of the Effect of Family Nature Outings on Stress and Physical Inactivity in a Low Income Population|Completed||N/A|156|Actual|Children's Hospital & Research Center Oakland||2|||f||||f||||||||No||2017-10-10 22:41:02.490398|2017-10-10 22:41:02.490398
NCT02623842|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-07|||July 2013||2013-07-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Radiofrequency Non-ablation in the Treatment of Women With Urinary Stress Incontinence: Study Pilot||Completed||Phase 1|10|Actual|Centro de Atenção ao Assoalho Pélvico||1|||f||||f||||||||||2017-10-10 22:41:02.582253|2017-10-10 22:41:02.582253
NCT02623829|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-09-27|||December 2015||2015-12-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)|Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring: A Double Blinded, Randomized Controlled Trial|Enrolling by invitation||Phase 2|40|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 22:41:02.657178|2017-10-10 22:41:02.657178
NCT02623816|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2015-12-03|||August 2014||2014-08-01|December 2015|2015-12-01||||July 2016|Anticipated|2016-07-01||Interventional|||Prospective Study Assessing Patient Satisfaction of Symptom Control With Proton Pump Inhibitor Dosing Regimen||Recruiting||Phase 4|150|Anticipated|MetroHealth Medical Center||3|||f||||f||||||||||2017-10-10 22:41:02.746148|2017-10-10 22:41:02.746148
NCT02623803|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-08-29|||January 2016||2016-01-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies|Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies|Recruiting||Phase 4|50|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:41:02.829434|2017-10-10 22:41:02.829434
NCT02623790|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-23|||January 2016||2016-01-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|FROMAGE||Study of the Impact of Cheese Matrix on Postprandial Lipemia: a Clinical Study|Study of the Impact of Cheese Matrix on Postprandial Lipemia: a Clinical Study|Completed||N/A|40|Actual|Laval University||3|||f||||f||||||||||2017-10-10 22:41:02.921553|2017-10-10 22:41:02.921553
NCT02623777|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2015-12-03|||March 2015||2015-03-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome|Evaluation of the Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome and the Contribution of Short-chain Fatty Acids Production|Completed||N/A|9|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-10 22:41:03.017925|2017-10-10 22:41:03.017925
NCT02623764|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-12-03|||December 2015||2015-12-01|December 2015|2015-12-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|Cholindex||EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors|EEG-cholinergic Index and Its Validation of Clinical Response to Treatment With Cholinesterase Inhibitors|Not yet recruiting||N/A|200|Anticipated|Landspitali University Hospital|||3||f||||t||||||||||2017-10-10 22:41:03.091009|2017-10-10 22:41:03.091009
NCT02623088|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-08-30|||April 2015||2015-04-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|VNI-SOH2||CPAP Effect on Vascular Function in Obstructive Sleep Apnea|Long Term Effects of Positive Airway Pressure Therapies on Vascular Function in Obstructive Sleep Apnea|Completed||N/A|107|Actual|University Hospital, Grenoble|||1||f||||f||||||Samples Without DNA|"     Serum Bank   "|||2017-10-10 22:41:08.127155|2017-10-10 22:41:08.127155
NCT02623738|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-04-08|||November 2015||2015-11-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-|A Phase II/III Randomized, Double-masked, Controlled, Parallel Group, Multicenter Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-|Recruiting||Phase 2/Phase 3|304|Anticipated|Santen Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-10 22:41:03.401434|2017-10-10 22:41:03.401434
NCT02623725|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-06-28|||April 14, 2016|Actual|2016-04-14|June 2017|2017-06-01|January 2, 2019|Anticipated|2019-01-02|January 2, 2019|Anticipated|2019-01-02||Interventional|||Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule|Immunogenicity and Safety of a Tetravalent Dengue Vaccine Given as a Booster Injection in Adolescents and Adults Who Previously Completed the 3-dose Schedule in a Study Conducted in Latin America|Active, not recruiting||Phase 2|252|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:41:03.500425|2017-10-10 22:41:03.500425
NCT02623712|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-04|||March 6, 2017|Actual|2017-03-06|May 2017|2017-05-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|WTS||The Watch the Spot Trial|The Watch the Spot Trial: A Pragmatic Trial of More Versus Less Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules|Enrolling by invitation||N/A|39981|Anticipated|Kaiser Permanente||2|||f||||t|f|f||||||Undecided||2017-10-10 22:41:03.614122|2017-10-10 22:41:03.614122
NCT02623699|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-10-03|||January 31, 2016|Actual|2016-01-31|October 2017|2017-10-01|July 10, 2018|Anticipated|2018-07-10|July 10, 2018|Anticipated|2018-07-10||Interventional|||Single and Multiple Dose Study of BIIB067 in Adults With Amyotrophic Lateral Sclerosis (ALS)|A Phase 1, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB067 Administered to Adult Subjects With Amyotrophic Lateral Sclerosis|Recruiting||Phase 1|72|Anticipated|Biogen||2|||f||||t||||||||||2017-10-10 22:41:03.732035|2017-10-10 22:41:03.732035
NCT02623686|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-07|||January 2016||2016-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||The Effect of an Aromatherapy Intervention on Sleep in the ICU|What is the Effect of an Aromatherapy Intervention on Sleep in the ICU? An Exploratory Study|Not yet recruiting||N/A|50|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:41:03.86346|2017-10-10 22:41:03.86346
NCT02623673|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-02-14|||September 2015||2015-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema|Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema|Completed||N/A|20|Actual|Retina Clinic, Sao Paulo, Brazil|||1||f||||t||||||||Yes||2017-10-10 22:41:03.947149|2017-10-10 22:41:03.947149
NCT02623660|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-01-08|||January 2016||2016-01-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery|Accelerated Reduction of Post-operative Edema and Early Return to Function Following Total Knee Arthroplasty (TKA)|Enrolling by invitation||N/A|40|Anticipated|Bioelectric Research Corporation||2|||f||||t||||||||||2017-10-10 22:41:04.029739|2017-10-10 22:41:04.029739
NCT02623556|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-01-18|||December 2015||2015-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen|For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase III Clinical Research|Recruiting||Phase 3|1080|Anticipated|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.||2|||f||||f||||||||No||2017-10-10 22:41:04.157732|2017-10-10 22:41:04.157732
NCT02623543|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-03|||November 2013||2013-11-01|December 2015|2015-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Orthokeratology in Decreasing Myopic Progression in a Young Adult Population Enrolled in a Professional Optometric Curriculum|Effectiveness of Orthokeratology in Decreasing Myopic Progression in a Young Adult Population Enrolled in a Professional Optometric Curriculum|Recruiting||Phase 2|80|Anticipated|Illinois College of Optometry||2|||f||||t||||||||||2017-10-10 22:41:04.269305|2017-10-10 22:41:04.269305
NCT02623530|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-05|||October 2015||2015-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Critical Thinking in Nursing Students|The Teaching of Critical Thinking for Nursing Students: A Randomized Controlled Pilot Study|Completed||N/A|102|Actual|University of Sao Paulo||2|||f||||t||||||||Undecided|Data will be analyzed until June 2016, and subsequently arranged for publication.|2017-10-10 22:41:04.337225|2017-10-10 22:41:04.337225
NCT02623517|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-24|||May 2016||2016-05-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|AFCare||A Novel Healthcare Information Technology Tool to Improve Care in Patients With Atrial Fibrillation|A Novel Healthcare Information Technology Tool to Improve Care in Patients|Recruiting||N/A|75|Anticipated|University of California, San Diego|||2||f||||f||||||||No||2017-10-10 22:41:04.413604|2017-10-10 22:41:04.413604
NCT02623504|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-10-31|||January 2016||2016-01-01|October 2016|2016-10-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|||DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder|A Double Blind Study To Evaluate the Dose Tolerance and Safety of Equetro (Carbamazepine) Versus Placebo Followed by a Long-Term Maintenance in Children and Adolescents Aged 10-17 Years With Acute Manic or Mixed Bipolar I Disorder|Recruiting||Phase 4|150|Anticipated|Validus Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:41:04.504592|2017-10-10 22:41:04.504592
NCT02623491|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-12-05|||November 2015||2015-11-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy Participants|A Double-Blind, Placebo-Controlled, Randomized, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy Subjects|Completed||Phase 1|175|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 22:41:04.617436|2017-10-10 22:41:04.617436
NCT02623296|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-02-21|||October 2015||2015-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects|A Phase I, Drug-drug Interaction Study Between Oral Doses of GLPG1205 and a Cocktail of CYP2C9, CYP2C19 and CYP1A2 Substrates in Healthy Male Subjects|Completed||Phase 1|14|Actual|Galapagos NV||2|||f||||f||||||||||2017-10-10 22:41:06.558224|2017-10-10 22:41:06.558224
NCT02623478|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-07-12|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps|Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel Insulin Lispro Formulation in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy|Withdrawn||Phase 1|0|Actual|Eli Lilly and Company||2||Change in clinical strategy|f||||f|f|f|||f|||||2017-10-10 22:41:04.706376|2017-10-10 22:41:04.706376
NCT02623465|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-07-12|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy|Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel Insulin Lispro Formulation in Patients With Type 2 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy|Withdrawn||Phase 1|0|Actual|Eli Lilly and Company||4||Change in clinical strategy|f||||f|t|f||||||||2017-10-10 22:41:04.777876|2017-10-10 22:41:04.777876
NCT02623452|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-07-12|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy|Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel Insulin Lispro Formulation in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injection Therapy|Withdrawn||Phase 1|0|Actual|Eli Lilly and Company||4||Change in clinical strategy|f||||f|f|f|||f|||||2017-10-10 22:41:04.851029|2017-10-10 22:41:04.851029
NCT02623439|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-12-04|||July 2012||2012-07-01|December 2015|2015-12-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies|A Phase 2 Study of Nonmyeloablative Conditioning With Transplantation of Partially Human Leukocyte Antigen (HLA)-Mismatched Bone Marrow and Post-transplant Cyclophosphamide for Patients With Hematologic Malignancies|Suspended||Phase 2|20|Anticipated|University of California, San Diego||1||On hold for toxicitiy|f||||t||||||||||2017-10-10 22:41:04.923702|2017-10-10 22:41:04.923702
NCT02623426|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-07-25|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|MERIT||Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial|Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial|Recruiting||Phase 3|240|Anticipated|JHSPH Center for Clinical Trials||3|||f||||t||||||||||2017-10-10 22:41:05.137373|2017-10-10 22:41:05.137373
NCT02623413|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-04|||January 2016||2016-01-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|CONTROL||Cohort Study of German Hematological / Oncological Wards to Assess the Effect of Contact Precautions on Nosocomial Colonization With Vancomycin Resistant Enterococci|Cohort Study of German Hematological / Oncological Wards to Assess the Effect of Contact Precautions on Nosocomial Colonization With Vancomycin Resistant Enterococci|Enrolling by invitation||N/A|950|Anticipated|University of Cologne|||2||f||||f||||||Samples Without DNA|"     Cultured VRE strains from rectal swabs, stool samples and infection sites.   "|||2017-10-10 22:41:05.395512|2017-10-10 22:41:05.395512
NCT02623400|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-10-25|||July 2016||2016-07-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|July 2018|Anticipated|2018-07-01||Observational|RESILIENCE||The Effect of Perinatal Stress on the Development of Preterm Infants|The Effect of Perinatal Stress on the Development of Preterm Infants|Recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     saliva samples of both parents and the child, blood sample of mother and child, cord blood     sample,   "|No||2017-10-10 22:41:05.475258|2017-10-10 22:41:05.475258
NCT02623387|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-04|||June 2015||2015-06-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Ultrasound Guided Versus Standard Paravertebral Blockade in Breast Surgery|A Prospective Randomized Controlled Trial of Ultrasound Guided Versus Standard Paravertebral Blockade in Breast Surgery|Recruiting||N/A|100|Anticipated|University College Hospital Galway||2|||f||||f||||||||||2017-10-10 22:41:05.610984|2017-10-10 22:41:05.610984
NCT02623374|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-03-02|||October 2015||2015-10-01|December 2015|2015-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||MENOS@Work Trial: A Self-help CBT Intervention for Working Women|Menopause at Work: Improving the Experience of Menopause for Working Women|Completed||N/A|124|Actual|King's College London||2|||f||||t||||||||||2017-10-10 22:41:05.705533|2017-10-10 22:41:05.705533
NCT02623348|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-02|||December 2015||2015-12-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PED||Use of Pedometers to Measure and Increase Walking Among Patients With ESRD|Use of Pedometers to Measure and Increase Walking Among Patients With ESRD|Not yet recruiting||N/A|60|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:41:05.922513|2017-10-10 22:41:05.922513
NCT02623335|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-05-17|||February 2016||2016-02-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||PCORI-1502-27462 Navigating High Risk Surgery: Empowering Older Adults to Ask Questions That Inform Decisions About Surgical Treatment|Navigating High Risk Surgery: Empowering Older Adults to Ask Questions That Inform Decisions About Surgical Treatment|Enrolling by invitation||N/A|480|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-10 22:41:06.018942|2017-10-10 22:41:06.018942
NCT02623322|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-10-02|||March 4, 2016|Actual|2016-03-04|October 2017|2017-10-01|November 20, 2017|Anticipated|2017-11-20|November 20, 2017|Anticipated|2017-11-20||Interventional|||A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, Administered as Monotherapy for the Treatment of Acute Uncomplicated Seasonal Influenza A Infection in Otherwise Healthy Adults|Active, not recruiting||Phase 2|141|Anticipated|Genentech, Inc.||3|||f|||||t|f||||||||2017-10-10 22:41:06.119427|2017-10-10 22:41:06.119427
NCT02623309|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-03-27|||February 2016||2016-02-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients||Recruiting||Phase 3|108|Anticipated|Institut Paoli-Calmettes||2|||f||||t||||||||||2017-10-10 22:41:06.393296|2017-10-10 22:41:06.393296
NCT02623283|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-04-12|||December 2015||2015-12-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Observational|||The Tayside Brushing Study - Adult Follow up|Assessing the Long-term Effects of a School-to-home Childhood Supervised Brushing Programme in Young Adults From High Caries Risk Groups - The Tayside Brushing Study Adult Follow up|Recruiting||N/A|534|Anticipated|NHS Tayside|||1||f||||f||||||||||2017-10-10 22:41:06.643088|2017-10-10 22:41:06.643088
NCT02623270|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-08-08|||July 2015||2015-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||A Comparison of Controlled Ventilation With the V60 Non-Invasive Ventilator vs. Traditional Mask Ventilation|A Comparison of Controlled Ventilation With the V60 Non-Invasive Ventilator vs. Traditional Mask Ventilation|Completed||Phase 1|20|Actual|University of Utah||1|||f||||f||||||||No|We do not plan to share individual participant data.|2017-10-10 22:41:06.71236|2017-10-10 22:41:06.71236
NCT02623257|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2017-01-19|||January 2016||2016-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Observational|||EGFR Mutations on ctDNA in Patients With Advanced NSCLC|A Diagnostic Study to Determine the Prevalence of Epidermal Growth Factor Receptor Mutations Assessed With Circulating Tumor DNA Samples in Advanced Non-small Cell Lung Cancer|Recruiting||N/A|1000|Anticipated|First People's Hospital of Hangzhou|||1||f||||t||||||||||2017-10-10 22:41:06.775949|2017-10-10 22:41:06.775949
NCT02623244|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2016-09-05|||November 2015||2015-11-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|||The Association Between Ovarian Endometrioma and Lower Urinary Tract Symptoms||Recruiting||N/A|90|Anticipated|Far Eastern Memorial Hospital|||2||f||||t||||||||||2017-10-10 22:41:06.845563|2017-10-10 22:41:06.845563
NCT02623231|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2015-12-02|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Cipralex&GBM||The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients|The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 22:41:06.922389|2017-10-10 22:41:06.922389
NCT02623205|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-04-17|||May 2015||2015-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Advancing Personalized Antidepressant Treatment Using PET/MRI|Advancing Personalized Antidepressant Treatment Using PET/MRI|Recruiting||Phase 4|150|Anticipated|Stony Brook University||2|||f||||t||||||||||2017-10-10 22:41:07.092788|2017-10-10 22:41:07.092788
NCT02623192|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-07-24|||August 2014||2014-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01|3 Months|Observational [Patient Registry]|||Respiratory Mechanics Registry for ARDS Patients|Respiratory Mechanics in Acute Respiratory Distress Syndrome: A Quality Improvement-based Registry|Recruiting||N/A|200|Anticipated|St. Michael's Hospital, Toronto|||1||f||||t||||||||||2017-10-10 22:41:07.175504|2017-10-10 22:41:07.175504
NCT02623179|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-10-03|||January 15, 2016|Actual|2016-01-15|October 2017|2017-10-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Conventional and Molecular Diagnostic Method for Patients With Suspected UTI|Conventional and Molecular Diagnostic Method for Patients With Suspected Urinary Tract Infections: Clinical, Economic, and Quality of Life Outcomes|Completed||N/A|50|Actual|Southwest Regional PCR, LLC||2|||f||||f||||||||||2017-10-10 22:41:07.370143|2017-10-10 22:41:07.370143
NCT02623166|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-04|||November 2015||2015-11-01|July 2015|2015-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Treatment of Pneumonia, Diarrhoea and Fever in Children by Community Health Workers|To Operationalise the Policy of Treating Uncomplicated Pneumonia, Diarrhoea and Fever in Children Aged 2-59 Months by Community Health Workers(CHW)|Unknown status|Recruiting|N/A|24000|Anticipated|Society for Applied Studies|||1||f||||f||||||||||2017-10-10 22:41:07.442013|2017-10-10 22:41:07.442013
NCT02623153|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2015-12-04|||January 2016||2016-01-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer|Phase 2 Study of Comparison Between XELOX (Capecitabine and Oxaliplatin) and Docetaxel, Oxaliplatin and S1 Regimen as Neoadjuvant Chemotherapy for Patients With Locally Advanced Gastric Cancer|Not yet recruiting||Phase 2|200|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-10 22:41:07.5444|2017-10-10 22:41:07.5444
NCT02623140|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-04-23|||December 2015||2015-12-01|April 2017|2017-04-01|October 2021|Anticipated|2021-10-01|October 2017|Anticipated|2017-10-01||Interventional|SORT OUT IX||BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX|Randomized Comparison of a Polymer-Free Biolimus-eluting BIOFREEDOM Stent With a Biodegradable-Polymer Sirolimus-eluting ORSIRO Stent in Patients Treated With Percutaneous Coronary Intervention|Active, not recruiting||Phase 4|3150|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-10 22:41:07.640894|2017-10-10 22:41:07.640894
NCT02623127|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-04-25|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|KOSMIC||A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma|A Phase II, Non-comparative, Open Label, Multi-center Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma|Active, not recruiting||Phase 2|25|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 22:41:07.754382|2017-10-10 22:41:07.754382
NCT02623114|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2015-12-04|||May 2012||2012-05-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|August 2016|Anticipated|2016-08-01||Interventional|||Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers|Comprehensive Pathophysiological Study Based on the Core Neurocognitive Deficits and Development of Biological Markers of Treatment Response in Attention Deficit Hyperactivity Disorder|Recruiting||Phase 4|400|Anticipated|Seoul National University Childrens Hospital||2|||f||||t||||||||||2017-10-10 22:41:07.854393|2017-10-10 22:41:07.854393
NCT02623101|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Reflectance Confocal Microscopy in Basal Cell Carcinoma|In Vivo Reflectance Confocal Microscopy, a Novel Non-invasive Tool for Diagnosing Skin Cancer - A Randomized Controlled Trial|Recruiting||N/A|329|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-10 22:41:07.969819|2017-10-10 22:41:07.969819
NCT02623075|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-11-29|||October 2015||2015-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients|Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients|Enrolling by invitation||Phase 1/Phase 2|45|Anticipated|Northwestern University||3|||f||||t||||||||||2017-10-10 22:41:08.244146|2017-10-10 22:41:08.244146
NCT02623062|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-06-02|||December 2013||2013-12-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study|A Multi-centred, Randomised, Double-blind, Two Arms, Parallel Group, Placebo-controlled Study to Assess the Effect of Compound Sodium Alginate Oral Suspension Sachet in Patients With Reflux Disease|Completed||Phase 3|644|Actual|Reckitt Benckiser Healthcare (UK) Limited||2|||f||||f||||||||||2017-10-10 22:41:08.356582|2017-10-10 22:41:08.356582
NCT02623049|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-11-18|||November 2015||2015-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation|Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation|Recruiting||N/A|120|Anticipated|Rabin Medical Center|||6||f||||||||||Samples Without DNA|"     Blood sample   "|||2017-10-10 22:41:08.476445|2017-10-10 22:41:08.476445
NCT02623036|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-23|||November 2015||2015-11-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors|The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors in Resistant Hypertension|Recruiting||Phase 1|20|Anticipated|Memorial Health University Medical Center||2|||f||||f||||||||||2017-10-10 22:41:08.681512|2017-10-10 22:41:08.681512
NCT02623023|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-12-04|||January 2016||2016-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Prophylaxis for Anti-VEGF-induced IOP Elevation|Brimonidine/Timolol Fixed Combination Prophylaxis for Intraocular Pressure Elevation Following Intravitreal Injection of Antivascular Endothelial Growth Factor|Not yet recruiting||N/A|107|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 22:41:08.854653|2017-10-10 22:41:08.854653
NCT02623010|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|August 2018|Anticipated|2018-08-01||Interventional|||Bruton's Tyrosine Kinase Inhibitor Ibrutinib as Maintenance Treatment in Elderly Patients With Primary CNS Lymphoma|Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib as Maintenance Treatment in Elderly Patients With Primary CNS Lymphoma Following First Line Chemotherapy Treatment|Recruiting||Phase 2|30|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-10 22:41:08.953858|2017-10-10 22:41:08.953858
NCT02622984|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-09-26|||March 2016||2016-03-01|November 2015|2015-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|RBIRT||Remote Brief Intervention and Referrals to Treatment Service for Alcohol|Remote Brief Intervention and Referrals to Treatment Service for Alcohol|Not yet recruiting||Phase 2|356|Anticipated|Polaris Health Directions||2|||f||||f||||||||||2017-10-10 22:41:09.18306|2017-10-10 22:41:09.18306
NCT02622971|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-02-02|||June 2014||2014-06-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Phototherapy and Cryotherapy in Post-exercise Skeletal Muscle Recovery|Isolated and Combined Effects of Phototherapy and Cryotherapy in Post-exercise Skeletal Muscle Recovery|Completed||N/A|50|Actual|University of Nove de Julho||5|||f||||t||||||||Yes|all data is stored and saved in electronic devices to clarify any possible doubt regarding to methodological procedures and results.|2017-10-10 22:41:09.29639|2017-10-10 22:41:09.29639
NCT02622945|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-03-06|||February 2014||2014-02-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia|Transcranial Direct Current Stimulation in Acute and Chronic Post-stroke Aphasia|Recruiting||Phase 2|80|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 22:41:09.532953|2017-10-10 22:41:09.532953
NCT02622932|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-04-23|||December 2, 2015|Actual|2015-12-02|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients|A Phase 1, Open-label Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients|Active, not recruiting||Phase 1|6|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f||||||||Undecided||2017-10-10 22:41:09.680978|2017-10-10 22:41:09.680978
NCT02622919|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-12-04|||October 2015||2015-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:41:09.777376|2017-10-10 22:41:09.777376
NCT02622906|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-03|2015-12-04|||March 2012||2012-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|March 2012|Actual|2012-03-01||Interventional|ANGIOPAS||Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment Failure|Randomized Phase II Trial Evaluating the Efficiency of Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment Failure|Completed||Phase 2|24|Actual|Hospital Avicenne||2|||f||||f||||||||||2017-10-10 22:41:09.820024|2017-10-10 22:41:09.820024
NCT02622347|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-05-15|||August 2015||2015-08-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01|1 Day|Observational [Patient Registry]|||Spiking-and-Recovery Experiment DOREMI Study|Spiking-and-Recovery Experiment DOREMI Study|Completed||N/A|30|Actual|UMC Utrecht|||1||f||||f||||||Samples Without DNA|"     Bloodserum   "|||2017-10-10 22:41:16.015171|2017-10-10 22:41:16.015171
NCT02622893|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2016-02-14|||January 2010||2010-01-01|February 2016|2016-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Surgical Approach Affect on Post-operative Analgesic Requirement Following Laparoscopic Nephrectomy|Can Surgical Approach Affect Post-operative Analgesic Requirements Following Laparoscopic Nephrectomy: Transperitoneal Versus Retroperitoneal? A Prospective Clinical Study|Completed||Phase 4|40|Actual|Istanbul University||2|||f||||f||||||||No||2017-10-10 22:41:09.922885|2017-10-10 22:41:09.922885
NCT02622880|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-02|||February 2013||2013-02-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients|Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Oropharyngeal and Maxillofacial Cancer Patients Eligible Surgery|Completed||Phase 4|68|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-10 22:41:10.045961|2017-10-10 22:41:10.045961
NCT02622867|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-12-02|||February 2013||2013-02-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Lactobacillus Plantarum 3547 Effects Over Inflammatory and Immunologic Markers|Nutritional Intervention Clinical Trial to Evaluate the Lactobacillus Plantarum 3547 Probiotic Effects Over Different Inflammation and Immune System Markers in a Group of Healthy Middle-aged People|Completed||Phase 4|84|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-10 22:41:10.148573|2017-10-10 22:41:10.148573
NCT02622854|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2016-10-05|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis|Comparison of Plasma Exchange and Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis With Mildly Elevated Triglycerides|Recruiting||N/A|20|Anticipated|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-10 22:41:10.265143|2017-10-10 22:41:10.265143
NCT02622841|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-05-05|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|BLEND||Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases|Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases: First-in-Man Study According to the IDEAL Recommendations|Completed||Phase 1/Phase 2|13|Actual|UMC Utrecht||1|||f||||t||||||||||2017-10-10 22:41:10.398762|2017-10-10 22:41:10.398762
NCT02622828|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-04|||December 2015||2015-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Increasing the Winter Community Participation of Older Adult Wheelchair Users|Increasing the Winter Community Participation of Older Adult Wheelchair Users|Recruiting||N/A|5|Anticipated|University of Manitoba||1|||f||||f||||||||No||2017-10-10 22:41:10.512987|2017-10-10 22:41:10.512987
NCT02622815|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-04|||April 2012||2012-04-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|HYPERCAN||Hypercoagulation Screening in Cancer|Hypercoagulation Screening as Innovative Tool for Risk Assessment, Early Diagnosis and Prognosis in Cancer|Recruiting||N/A|16000|Anticipated|A.O. Ospedale Papa Giovanni XXIII|||3||f||||t||||||Samples With DNA|"     whole blood, plasma, serum and tissue   "|||2017-10-10 22:41:10.619683|2017-10-10 22:41:10.619683
NCT02622802|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-05-02|||November 2012|Actual|2012-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||Transplacental Transfer of Drugs Used in Pregnant Women|Transplacental Transfer of Drugs Used in Pregnant Women|Completed||N/A|250|Actual|University Hospital, Gasthuisberg||1|||f||||f||||||||||2017-10-10 22:41:10.743959|2017-10-10 22:41:10.743959
NCT02622789|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-07-26|||November 2015||2015-11-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Efficacy and Influence of Pilates Based Physical Therapy Exercises for Low Back Pain|Efficacy and Influence of Pilates Based Physical Therapy Exercises on Spinal Radiographic Kinematics and Functional Status in Patients With Low Back Pain|Recruiting||N/A|100|Anticipated|China Medical University Hospital|||3||f||||t||||||||||2017-10-10 22:41:10.854959|2017-10-10 22:41:10.854959
NCT02622776|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-06|||February 2016||2016-02-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ADVISE||Advanced Methods for Cancer Detection by Vaginal Screening|Advanced Methods for Cancer Detection by Vaginal Screening (ADVISE): A Pilot Study of Using Vaginal Cell Sampling for Ovarian or Endometrial Cancer Detection|Recruiting||N/A|120|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-10 22:41:10.950781|2017-10-10 22:41:10.950781
NCT02622763|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-06-21|||November 2015|Actual|2015-11-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|TolDecCDintra||Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment|Safety and Clinical Efficacy Evaluation of Intralesional Administration of Tolerogenic Dendritic Cells in Patients With Refractory Crohn's Disease|Recruiting||Phase 1|20|Anticipated|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-10 22:41:11.545713|2017-10-10 22:41:11.545713
NCT02622750|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-12-02|||November 2016||2016-11-01|December 2015|2015-12-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|TBSGPATART||Triple-branch Stent Graft Placement and Total-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection|Triple-branch Stent Graft Placement and Total-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection: A Prospective, Multi-center, Randomized, Open-label, Parallel-group, Non-inferiority Clinical Trial|Not yet recruiting||Early Phase 1|90|Anticipated|Fujian Medical University||2|||f||||t||||||||||2017-10-10 22:41:11.647035|2017-10-10 22:41:11.647035
NCT02622737|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-03-01|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|STEP||Study of the Effects of Three Exercise Programs in Parkinson's Disease|Comparison of the Effects of Exercise by Functional Training, Stationary Bicycle and Exergame in Parkinson Disease|Recruiting||Phase 2|210|Anticipated|Federal University of Bahia||3|||f||||f||||||||||2017-10-10 22:41:11.921329|2017-10-10 22:41:11.921329
NCT02622724|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-06-14|||November 2015||2015-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|INTEREST||Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS)|A Phase III Double-blind, Randomised, Parallel-Group Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human IFN Beta-1a) and Placebo in the Treatment of Patients With Moderate or Severe Acute Respiratory Distress Syndrome|Recruiting||Phase 3|300|Anticipated|Faron Pharmaceuticals Ltd||2|||f||||t||||||||No||2017-10-10 22:41:12.087339|2017-10-10 22:41:12.087339
NCT02622711|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-08-09|||November 2015||2015-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|InForma||Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast Cancer|Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast Cancer: A Four-arm Randomized Trial|Recruiting||N/A|260|Anticipated|European Institute of Oncology||4|||f||||f||||||||||2017-10-10 22:41:12.402815|2017-10-10 22:41:12.402815
NCT02622698|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-02|||August 2011||2011-08-01|December 2015|2015-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Oral Protein Supplementation Following Non-bariatric Surgery|A Randomized Trial of Oral Protein Supplementation Following Non-bariatric Abdominal Surgery|Completed||N/A|62|Actual|Eisenhower Army Medical Center||2|||f||||||||||||||2017-10-10 22:41:12.568183|2017-10-10 22:41:12.568183
NCT02622685|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-06-01|||May 2015||2015-05-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects|A Dose Block-randomized, Double-blind, Placebo Controlled, Multiple Dosing, Dose-escalation Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of DWP10292 and Ursodeoxycholic Acid in Healthy Male Subjects|Completed||Phase 1|58|Actual|Daewoong Pharmaceutical Co. LTD.||4|||f||||t||||||||||2017-10-10 22:41:12.691657|2017-10-10 22:41:12.691657
NCT02622672|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-03-13|||January 4, 2016|Actual|2016-01-04|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|October 25, 2016|Actual|2016-10-25||Interventional|||Water-soluble Ubiquinol Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Diabetes|Water-soluble Ubiquinol (a Reduced Form of Coenzyme Q10) Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Patients With Type 2 Diabetes|Completed||Phase 2/Phase 3|50|Actual|Chung Shan Medical University||2|||f||||f||||||||||2017-10-10 22:41:12.799717|2017-10-10 22:41:12.799717
NCT02622659|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-05-18|||March 2012||2012-03-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)|The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)|Completed||Phase 4|468|Actual|Guangzhou Yipinhong Pharmaceutical CO.,LTD||2|||f||||t||||||||Undecided||2017-10-10 22:41:12.904955|2017-10-10 22:41:12.904955
NCT02622646|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-08-16|||August 2016||2016-08-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients|Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients|Recruiting||N/A|25|Anticipated|Hospital Universitario La Fe|||2||f||||f||||||Samples With DNA|"     FVIII is measured by the one-stage assay in a central laboratory in complete blood samples   "|||2017-10-10 22:41:13.006147|2017-10-10 22:41:13.006147
NCT02622633|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-05-21|||April 2016||2016-04-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Epidural Stimulation for Resistant Depression Treatment|Epidural Stimulation for Resistant Depression Treatment: A Randomized Double Blind Clinical Trial|Active, not recruiting||Phase 2|10|Anticipated|University of Brasilia||2|||f||||f||||||||Undecided|The data will be available in the institution - Brasilia University.|2017-10-10 22:41:13.148893|2017-10-10 22:41:13.148893
NCT02622620|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-03-28|||July 2016||2016-07-01|March 2016|2016-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Study on Neuroepithelial Tumor Grading and Pseudoprogression After Glioma Therapy Using Advanced Functional MRI Techniques||Not yet recruiting||N/A|86|Anticipated|Tang-Du Hospital|||1||f||||f||||||||||2017-10-10 22:41:13.240695|2017-10-10 22:41:13.240695
NCT02622607|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-07-19|||January 2013||2013-01-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer|Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer|Recruiting||Phase 3|200|Anticipated|Tang-Du Hospital||2|||f||||t||||||||||2017-10-10 22:41:13.316827|2017-10-10 22:41:13.316827
NCT02622594|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-18|||October 2015||2015-10-01|July 2017|2017-07-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|||Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times|A Randomized, Evaluator-blinded, Bilateral Comparison of the Treatment of Facial Actinic Keratoses Using Combination Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Different Incubation Times|Completed||Phase 4|10|Actual|Dermatology, Laser & Vein Specialists of the Carolinas||4|||f||||f||||||||||2017-10-10 22:41:13.456024|2017-10-10 22:41:13.456024
NCT02622581|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-07-14|||December 2015||2015-12-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|September 2021|Anticipated|2021-09-01|3 Years|Observational [Patient Registry]|CRISP||Clinical Research Platform Into Molecular Testing, Treatment and Outcome of Non-Small Cell Lung Carcinoma Patients|Clinical Research Platform Into Molecular Testing, Treatment and Outcome of Non-Small Cell Lung Carcinoma Patients|Recruiting||N/A|5000|Anticipated|AIO-Studien-gGmbH|||3||f||||f||||||Samples With DNA|"     All patients will be asked to give consent for their tumor samples to be used for future     investigational translational research. If the patient agrees, contact details of the local     pathology where the tumor sample is stored as well as the sample's identification number will     be documented in the eCRF, creating the CRISP decentralized clinically annotated tissue     repository. Study sites will inform the local pathologists about the patient's consent and     ask for the tissue sample to be reserved for future CRISP analyses.   "|||2017-10-10 22:41:13.605925|2017-10-10 22:41:13.605925
NCT02622568|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-07|2017-05-16||July 2015||2015-07-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study|Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study|Completed||Phase 4|28|Actual|University of Texas Southwestern Medical Center|Attrition rate acceptable for pilot study. Some participants were lost at the first measurement follow-up, others at the second (6 and 12 weeks respectively).|2|||f||||f||||||||||2017-10-10 22:41:13.751953|2017-10-10 22:41:13.751953
NCT02621593|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-02-01|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD|Feasibility of Intense Pulsed Light (IPL) for Reducing Dry Eye Symptoms Caused by Meibomian Gland Dysfunction (MGD)|Completed||N/A|44|Actual|Lumenis Ltd.||1|||f||||f||||||||||2017-10-10 22:41:25.464224|2017-10-10 22:41:25.464224
NCT02622555|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-12-03|||August 2013||2013-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Cardiovascular Morbidity During Treatment of Overactive Bladder With B3 Agonists|Phase 4 Study of Cardiovascular Morbidity and Safety in Women Treated With Mirabegron for Overactive Bladder|Completed||Phase 4|221|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 22:41:14.078848|2017-10-10 22:41:14.078848
NCT02622542|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-10-20|||January 2017||2017-01-01|October 2016|2016-10-01|December 2025|Anticipated|2025-12-01|July 2020|Anticipated|2020-07-01||Interventional|ACUTE-B||ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy|A Randomized Controlled Comparative Study on Effectiveness of Endovascular Repair Versus Best Medical Therapy for Acute Uncomplicated Type B Aortic Dissection|Not yet recruiting||Phase 4|436|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Yes|Deidentified data will be made available following IRB approval|2017-10-10 22:41:14.201165|2017-10-10 22:41:14.201165
NCT02622516|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-29|||August 2015||2015-08-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Cervical Mobility and Vestibular Rehabilitation|Effectiveness of Additional Protocol Exercises for Cervical Mobility and Proprioception in Vestibular Rehabilitation: a Randomized Controlled Trial|Completed||N/A|28|Actual|Universidade Norte do Paraná||2|||f||||t||||||||||2017-10-10 22:41:14.488786|2017-10-10 22:41:14.488786
NCT02622503|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-12-12|||April 2008||2008-04-01|December 2016|2016-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||A Study on Rheumatoid Arthritis Patients Treated With Rituximab|Retrospective Data Collection on Rheumatoid Arthritis (RA) Patients Treated With Rituximab in Finland.|Completed||N/A|81|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:41:14.617165|2017-10-10 22:41:14.617165
NCT02622490|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-05-02|||September 2015||2015-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DIT2||Acute Effects of Different Macronutrient Compositions and Meal Distributions of the Food|Diet-induced Thermogenesis 2|Active, not recruiting||N/A|28|Actual|University Hospital, Linkoeping||4|||f||||f||||||||||2017-10-10 22:41:14.72598|2017-10-10 22:41:14.72598
NCT02622477|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-02-26|||June 2014||2014-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)|Clinical Course of Treatment With ESBRIET in Patients With Mild to Moderate IPF|Completed||N/A|12|Actual|Hoffmann-La Roche|||1||f||||||||||||Undecided||2017-10-10 22:41:14.842861|2017-10-10 22:41:14.842861
NCT02622464|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-07-26|||December 2015||2015-12-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction|Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction|Recruiting||N/A|8|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:41:14.98633|2017-10-10 22:41:14.98633
NCT02622451|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-13|||December 2015||2015-12-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Differential Sensitivity Markers in Youth Drug Abuse Prevention|Differential Sensitivity Markers in Youth Drug Abuse Prevention|Recruiting||N/A|200|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 22:41:15.09659|2017-10-10 22:41:15.09659
NCT02622438|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-08-03|||April 2015||2015-04-01|August 2016|2016-08-01||||April 2018|Anticipated|2018-04-01||Interventional|FSHD||Routine Health Care of Patients With FSHD|Course and Follow up of Patients Affected by Facioscapulohumeral Dystrophy|Recruiting||N/A|40|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 22:41:15.219443|2017-10-10 22:41:15.219443
NCT02622425|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-12-09|||June 2015||2015-06-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of PD01 on Cardiovascular Health and Microbial Environment|The Effect of the Carotenoid-producing Bacillus Strain PD01 on Cardiovascular Health and Microbial Environment|Completed||Phase 2|62|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 22:41:15.328916|2017-10-10 22:41:15.328916
NCT02622412|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2016-09-06|||March 2015||2015-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|BreathEase||Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease|Randomised Controlled Trial Testing the Effectiveness of a New Multi-professional Breathlessness sErvice for Patients With Any Advanced diSease Against Usual Care (BreathEase)|Recruiting||N/A|160|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-10 22:41:15.453713|2017-10-10 22:41:15.453713
NCT02622399|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-08-25|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|NOW||Mobilizing Community Networks to Optimize Child Well-being|Mobilizing Community Networks to Optimize Child Well-being|Completed||N/A|98|Actual|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-10 22:41:15.59445|2017-10-10 22:41:15.59445
NCT02622386|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-09-15|||August 11, 2016|Actual|2016-08-11|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis|The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis|Recruiting||Phase 2|50|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 22:41:15.692459|2017-10-10 22:41:15.692459
NCT02622373|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-07-18|||June 2015||2015-06-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Impact of Currently Recommended Postnatal Nutrition on Neonatal Body Composition|Impact of Currently Recommended Postnatal Nutrition on Neonatal Body Composition|Completed||N/A|40|Actual|University of Kansas Medical Center|||3||f||||f||||||||||2017-10-10 22:41:15.802033|2017-10-10 22:41:15.802033
NCT02622360|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-03-02|||July 2015||2015-07-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|SMeDy||Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study|Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study|Enrolling by invitation||N/A|200|Anticipated|Helsinki University|||2||f||||f||||||Samples With DNA|"     extraction of DNA from whole blood samples or saliva   "|||2017-10-10 22:41:15.899739|2017-10-10 22:41:15.899739
NCT02622334|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-03-17|||December 31, 2015|Actual|2015-12-31|March 2017|2017-03-01|July 31, 2016|Actual|2016-07-31|July 31, 2016|Actual|2016-07-31||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).|A MULTIPLE-CENTER, INVESTIGATOR/SUBJECT MASKED, ADAPTIVE, MULTIPLE ASCENDING DOSE, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO5093151 FOLLOWING 7 DAYS ADMINISTRATION IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION|Completed||Phase 1|45|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:41:16.091227|2017-10-10 22:41:16.091227
NCT02622321|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-18|||November 19, 2015|Actual|2015-11-19|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|October 25, 2016|Actual|2016-10-25||Interventional|HAVEN 1||A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors|A Randomized, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Patients With Inhibitors|Active, not recruiting||Phase 3|113|Actual|Hoffmann-La Roche||4|||t||||t|t|f||||||||2017-10-10 22:41:16.242554|2017-10-10 22:41:16.242554
NCT02622308|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-04-04|||March 11, 2016|Actual|2016-03-11|August 2016|2016-08-01|December 7, 2016|Actual|2016-12-07|April 11, 2016|Actual|2016-04-11||Interventional|||The Effects of INP on Peripheral Circulation in Dialysis Patients and Patients With PAD and Leg Ulcers|The Effects of Intermittent Negative Pressure on Peripheral Circulation in Dialysis Patients and Patients With Lower Limb Ischemia and Leg Ulcers|Terminated||N/A|4|Actual|Oslo University Hospital||1||Terminated due to lack of recruitment|f||||f|f|f||||||Undecided||2017-10-10 22:41:16.708586|2017-10-10 22:41:16.708586
NCT02622295|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Musculoskeletal Plasticity After Spinal Cord Injury|Musculoskeletal Plasticity After Spinal Cord Injury|Recruiting||N/A|80|Anticipated|University of Iowa||2|||f||||f||||||||No||2017-10-10 22:41:16.845347|2017-10-10 22:41:16.845347
NCT02622282|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-02-01|||May 2016||2016-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Text Messaging to Promote Walking Among Latino Adults at Risk for Peripheral Arterial Disease|Text Messaging to Promote Walking Among Latino Adults at Risk for PAD|Completed||N/A|69|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 22:41:17.033107|2017-10-10 22:41:17.033107
NCT02622269|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-02-24|||April 2015||2015-04-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Patient-driven Compression in Urography|Patient-driven Compression in Urography|Completed||N/A|50|Actual|Örebro University, Sweden||2|||f||||f||||||||No||2017-10-10 22:41:17.189862|2017-10-10 22:41:17.189862
NCT02622256|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-09-27|||June 2016||2016-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Twitter and CV Health|Twitter & Cardiovascular Health|Enrolling by invitation||N/A|600|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:41:17.314953|2017-10-10 22:41:17.314953
NCT02622243|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-04-19|||November 2015||2015-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge|Duration of Bronchoprotection of the Long Acting Muscarinic Antagonists Tiotropium and Glycopyrronium Against Methacholine Induced Bronchoconstriction|Completed||Phase 4|13|Actual|University of Saskatchewan||2|||f||||f||||||||Yes|journal publication|2017-10-10 22:41:17.436732|2017-10-10 22:41:17.436732
NCT02622230|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-10|||December 2015||2015-12-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Tolerability, Safety and Pharmacokinetic Study Of Mianhuahua Flavonoids Tablets in Healthy Adult Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single/ Multiple Dose Study to Assess the Safety , Tolerability, Pharmacokinetics of Mianhuahua Flavonoids Tablets After Oral Administration In Healthy Adult Subjects|Not yet recruiting||Phase 1|60|Anticipated|Xinjiang Uygur Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:41:17.556053|2017-10-10 22:41:17.556053
NCT02622217|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Impact of Sleep Deprivation on Anesthesiology Residents' Non-technical Skills|Impact of Sleep Deprivation on Anesthesiology Residents' Non-technical Skills: a Simulation Based Randomised Study.|Completed||N/A|20|Actual|University of Paris 5 - Rene Descartes||2|||f||||f||||||||Undecided||2017-10-10 22:41:17.662609|2017-10-10 22:41:17.662609
NCT02622204|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-12-12|||December 2015||2015-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|Osteotomy||The Effect of High Tibial Osteotomy on in Vivo Cartilage Mechanobiology in Patients With Knee Osteoarthritis|The Effect of High Tibial Osteotomy on in Vivo Cartilage Mechanobiology in Patients With Knee Osteoarthritis: Cross-sectional Observational Single-centre Study|Recruiting||N/A|40|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     serum, synovium biopsies   "|Undecided||2017-10-10 22:41:17.753538|2017-10-10 22:41:17.753538
NCT02622191|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-11-02|||July 2012||2012-07-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Analysis of the Eye in Patients With Primary Open-Angle Glaucoma and a Visual Field Defect in One Eye|Segmental Analysis of Retinal Layers and Measurement of Lamina Cribrosa Thickness in Patients With Asymmetric Primary Open-Angle Glaucoma|Completed||N/A|100|Actual|Wills Eye||2|||f||||f||||||||Yes|A manuscript is currently under development.|2017-10-10 22:41:17.859254|2017-10-10 22:41:17.859254
NCT02622178|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-05-02|||September 2011||2011-09-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||How Accurately Does the Diopsys Visual Evoked Potential (VEP) Vision Testing System Detect Glaucoma?|Sensitivity and Specificity of the NOVA-DN VEP Protocol and a Novel Analysis of Optical Coherence Tomography Images for Glaucoma Diagnosis|Completed||N/A|50|Actual|Wills Eye||3|||f||||f||||||||Yes|A manuscript is currently under development.|2017-10-10 22:41:17.959442|2017-10-10 22:41:17.959442
NCT02622165|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-05-25|||January 2016||2016-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|REWARD||Rewarding Healthy Food Choices: a Mobile Serious Game Intervention in Adolescents|Rewarding Healthy Food Choices: a Mobile Serious Game Intervention Targeting Snacking Behaviours in Adolescents|Completed||N/A|1463|Actual|University Ghent||2|||f||||t||||||||||2017-10-10 22:41:18.065255|2017-10-10 22:41:18.065255
NCT02622152|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2017-05-19|||January 2016||2016-01-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Right Lateral Positioning of Postoperative Pediatric Cardiac Surgery|Right Lateral Positioning of Postoperative Pediatric Cardiac Surgery: Effect on Arterial Oxygenation, Respiratory Mechanics, Hemodynamics, and Adverse Events|Recruiting||N/A|60|Anticipated|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:41:18.182752|2017-10-10 22:41:18.182752
NCT02622139|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-01-11|||November 2015||2015-11-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|MSOT_IBD||Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)|Monocentric, Prospective Interventional Study to Assess the Degree of Disease Activity With a Multispectral Optoacoustic Tomography (MSOT) Handheld Scanner in Patients With Crohn's Disease or Ulcerative Colitis|Recruiting||N/A|344|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||No||2017-10-10 22:41:18.350535|2017-10-10 22:41:18.350535
NCT02622126|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-11-04|||January 2016||2016-01-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia|The Effects of Colloid Pre-Loading on D-Dimer of the Mother and Her Baby During Cesarean Section Under Spinal Anesthesia for Mild Preeclampsia|Completed||Phase 2|60|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 22:41:18.525935|2017-10-10 22:41:18.525935
NCT02622113|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-07-03|||December 2014||2014-12-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus|An Open-Label, Multicenter Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Canagliflozin (TA-7284) as add-on to Insulin in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|139|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-10 22:41:18.723396|2017-10-10 22:41:18.723396
NCT02622100|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2017-06-18|||February 2016||2016-02-01|June 2017|2017-06-01|June 2023|Anticipated|2023-06-01|January 2019|Anticipated|2019-01-01||Observational|IRIS BVS||Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice|Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Recruiting||N/A|1000|Anticipated|Asan Medical Center|||1||f||||t||||||||No|This is not a publicly funded trial.|2017-10-10 22:41:18.860828|2017-10-10 22:41:18.860828
NCT02622087|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-09-20|||November 2015||2015-11-01|September 2017|2017-09-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||The Impact of Sex Hormones on One-session Treatment for Spider Phobia in Women|Sex Hormones and Fear Inhibition: a Novel Exploration of Why Women Are so Vulnerable to Anxiety Disorders|Completed||N/A|90|Actual|The University of New South Wales||3|||f||||f||||||||||2017-10-10 22:41:19.072893|2017-10-10 22:41:19.072893
NCT02622061|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-11|||May 2016||2016-05-01|May 2017|2017-05-01|April 28, 2017|Actual|2017-04-28|October 2016|Actual|2016-10-01||Observational|||NIOX VERO Nasal Application in Primary Ciliary Dyskinesia|A Clinical Investigation Determining the Discriminative Ability of the NIOX VERO NASAL to Differentiate Subjects With Primary Ciliary Dyskinesia From Healthy Controls|Completed||N/A|163|Actual|Aerocrine AB|||2||f||||f||||||||No||2017-10-10 22:41:19.358784|2017-10-10 22:41:19.358784
NCT02622048|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-06-07|||September 2015||2015-09-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Understanding and Helping Families: Parents With Psychosis|STAGE 1: Investigating Attributions and Expressed Emotion in Parents With and Without Psychosis STAGE 2: Investigating the Use of a Self-directed Parenting Programme With Parents Experiencing Psychosis|Recruiting||N/A|60|Anticipated|University of Manchester||1|||f||||f||||||||||2017-10-10 22:41:19.434221|2017-10-10 22:41:19.434221
NCT02622022|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-10-31|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MORPHILD||Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease|Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease|Recruiting||Phase 4|36|Anticipated|University of Aarhus||2|||f||||t||||||||No||2017-10-10 22:41:19.62174|2017-10-10 22:41:19.62174
NCT02622009|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-04|||November 2010||2010-11-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Viral Infections in BAL and Bronchial Biopsies of Stable COPD Patients|Human Rhinovirus and Respiratory Syncytial Virus From Bronchoalveolar Lavage and Bronchial Biopsies of Selected Patients With Stable Chronic Obstructive Pulmonary Disease.|Completed||N/A|53|Actual|University of Athens|||5||f||||f||||||Samples With DNA|"     BAL and bronchial biopsies   "|No||2017-10-10 22:41:19.706536|2017-10-10 22:41:19.706536
NCT02621996|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-01|||December 2015||2015-12-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Hammock Positioning's Influence on the Electromyographic Activity in the Flexor Muscles in Newborn Preterm|Hammock Positioning's Influence on the Electromyographic Activity in the Flexor Muscles in Newborn Preterm|Not yet recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:41:19.805786|2017-10-10 22:41:19.805786
NCT02621983|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-25|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Aerobic Exercise for Cognition in Schizophrenia|Aerobic Exercise for Cognition in Schizophrenia|Recruiting||N/A|40|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:41:19.916557|2017-10-10 22:41:19.916557
NCT02621970|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-02|||January 2016||2016-01-01|December 2015|2015-12-01|January 2024|Anticipated|2024-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma|Randomized Phase 3 Trial of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy Versus Concurrent Chemotherapy Alone in High Risk Nasopharyngeal Carcinoma Patients Treated With Intensity-modulated Radiotherapy|Not yet recruiting||Phase 3|534|Anticipated|Sun Yat-sen University||2|||f||||f||||||||No||2017-10-10 22:41:20.026787|2017-10-10 22:41:20.026787
NCT02621957|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-11-01|||December 2015||2015-12-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential|A Phase 1, Open-Label Study to Evaluate the Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential|Completed||Phase 1|15|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-10 22:41:20.174333|2017-10-10 22:41:20.174333
NCT02621944|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-19|||November 2016||2016-11-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia|Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia|Recruiting||Early Phase 1|30|Anticipated|University of Florida||3|||f||||t|t|f||||||||2017-10-10 22:41:20.331607|2017-10-10 22:41:20.331607
NCT02621931|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-23|||January 31, 2016|Actual|2016-01-31|August 2017|2017-08-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|||Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine|Completed||Phase 3|1134|Actual|Teva Pharmaceutical Industries||3|||f||||f|t|f||||||||2017-10-10 22:41:20.527259|2017-10-10 22:41:20.527259
NCT02621918|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-07-25|||March 2013||2013-03-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|EESRDS||The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis|The Effects of an Intradialytic Progressive Resistance and Aerobic Training in End-stage Renal Disease Patients Undergoing Hemodialysis|Completed||N/A|61|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||t||||||||||2017-10-10 22:41:22.581762|2017-10-10 22:41:22.581762
NCT02621905|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-07-19|||November 2015||2015-11-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg|Steady-State Comparative Bioavailability Study in Patients Requiring Anti-Fungal Prophylaxis Comparing Twice a Day Dosing of Lozanoc® (Mayne) Regardless of Food With Sporanox® (Janssen) Under Fed Conditions|Recruiting||Phase 4|40|Anticipated|Mayne Pharma International Pty Ltd||2|||f||||f||||||||No|Individual patient data will not be made available|2017-10-10 22:41:22.663529|2017-10-10 22:41:22.663529
NCT02621892|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-02-07|||October 2015||2015-10-01|April 2016|2016-04-01||||June 2017|Anticipated|2017-06-01||Interventional|T3MPO-1||A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C|A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)|Active, not recruiting||Phase 3|629|Actual|Ardelyx||2|||f||||f||||||||||2017-10-10 22:41:22.759997|2017-10-10 22:41:22.759997
NCT02621879|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-03-14|||March 2012||2012-03-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Interventional|||Bilateral Gluteal Fascio-myo-cutaneous Flap in Treatment of Recurrent Pilonidal Disease|Bilateral Gluteal Fascio-myo-cutaneous Advancement Flap in Treatment of Recurrent Sacrococcygeal Pilonidal Disease|Completed||N/A|40|Actual|Mansoura University||1|||f||||t||||||||Undecided||2017-10-10 22:41:23.131001|2017-10-10 22:41:23.131001
NCT02621866|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-07-12|||May 2, 2017|Actual|2017-05-02|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Trial of Daily Ultraviolet Therapy to Reduce Cardiovascular Risk Factors|A Trial of Daily Ultraviolet Therapy to Reduce Cardiovascular Risk Factors|Recruiting||N/A|100|Anticipated|University of Edinburgh||2|||f||||f|f|f||||||||2017-10-10 22:41:23.213001|2017-10-10 22:41:23.213001
NCT02621853|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-02|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Validation of a Raman Spectroscope to Determine Hepatic Fat Content|Clinical Validation of High Throughput Raman Fiber Optic Probe to Determine Hepatic Fat Content|Not yet recruiting||Phase 2|25|Anticipated|Nova Scotia Health Authority||1|||f||||t||||||||||2017-10-10 22:41:23.337032|2017-10-10 22:41:23.337032
NCT02621840|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-05-08|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation|A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation|Completed||N/A|442|Actual|Wills Eye||2|||f||||f||||||||Yes|A manuscript is under development.|2017-10-10 22:41:23.441045|2017-10-10 22:41:23.441045
NCT02621827|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-01|||November 2011||2011-11-01|December 2015|2015-12-01|May 2013|Actual|2013-05-01|October 2012|Actual|2012-10-01||Interventional|||Vitamin D Half-life in Pregnancy and Lactation|Vitamin D Half-life in Pregnancy and Lactation|Completed||N/A|49|Actual|Medical Research Council||2|||f||||f||||||||||2017-10-10 22:41:23.531935|2017-10-10 22:41:23.531935
NCT02621814|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2015-12-02|||March 2016||2016-03-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|||Clinical Trial of Friso Formula-fed With Low Glycation and Aggregation Protein About Infant's Growth Rate|A Randomized Controlled Clinical Trial of Friso Formula-fed With Low Glycation and Aggregation Protein About Infant's Growth Rate|Not yet recruiting||N/A|240|Anticipated|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 22:41:23.607206|2017-10-10 22:41:23.607206
NCT02621801|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-01|||August 2015||2015-08-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Evaluation of a Mind-body Education Program to Enhance Resiliency and Reduce Burnout in Residents|Evaluation of a Mind-body Education Program to Enhance Resiliency and Reduce Burnout in Residents|Active, not recruiting||N/A|173|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 22:41:23.719008|2017-10-10 22:41:23.719008
NCT02621788|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-12-01|||April 2014||2014-04-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Mind-body Educational Program to Enhance Resiliency and Reduce Burnout in First Year Residents|Evaluation of Mind-body Educational Program to Enhance Resiliency and Reduce Burnout in First Year Residents|Completed||N/A|85|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:41:23.788545|2017-10-10 22:41:23.788545
NCT02621775|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-05-18|||September 14, 2015|Actual|2015-09-14|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Seren@ctif||Effectiveness of Two Stress Management Programs in Adaptation Disorder With Anxiety (ADA)|Effectiveness of Two Stress Management Programs in the Adaptation Disorder With Anxiety (ADA) : Computer-based or Face- to -Face to Face Versus Control Group.Open Multicenter Prospective Randomized Controlled Therapeutic 3 Parallel Groups|Recruiting||N/A|120|Anticipated|University Hospital, Lille||3|||f||||f||||||||No||2017-10-10 22:41:23.869413|2017-10-10 22:41:23.869413
NCT02621762|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-09-25|||December 2015||2015-12-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|BicMag||Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum|Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum|Completed||N/A|12|Actual|University Hospital Inselspital, Berne||2|||f||||f|f|f||||||||2017-10-10 22:41:23.975731|2017-10-10 22:41:23.975731
NCT02621749|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-01-12|||January 2017||2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|COMET-AKI||Cerebral Microembolism in the Critically Ill With Acute Kidney Injury|Cerebral Microembolism in the Critically Ill With Acute Kidney Injury: A Prospective Multi-Center Randomized Controlled Trial Comparing Continuous With Intermittent Renal Replacement Therapy.|Recruiting||N/A|66|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 22:41:24.058667|2017-10-10 22:41:24.058667
NCT02621736|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-12-12|||January 2016||2016-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|COMEN||Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).|Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).|Recruiting||N/A|100|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||||No||2017-10-10 22:41:24.13675|2017-10-10 22:41:24.13675
NCT02621723|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-01|||January 2016||2016-01-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01|6 Months|Observational [Patient Registry]|CURIOS@||Capturing Readmission Internationally to Prevent Readmission by Safer@Home Group|Capturing Readmission Internationally to Prevent Readmission by Safer@Home|Not yet recruiting||N/A|1000|Anticipated|VU University Medical Center|||1||f||||f||||||||||2017-10-10 22:41:24.210279|2017-10-10 22:41:24.210279
NCT02621710|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2015-12-01|||December 2015||2015-12-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Observational|||Goal Achievement and Patient Satisfaction in Benign Hysterectomy|Goal Achievement and Patient Satisfaction in Benign Hysterectomy|Not yet recruiting||N/A|160|Anticipated|University Hospitals Cleveland Medical Center|||2||f||||||||||||||2017-10-10 22:41:24.336134|2017-10-10 22:41:24.336134
NCT02621697|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-12-02|||February 2014||2014-02-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Dual Task in Institutionalized Elderly|Dual Task in Institutionalized Elderly: Positive Impact on the Risk of Falls and Functionality|Completed||N/A|6|Actual|Universidade Federal do Triangulo Mineiro||2|||f||||t||||||||||2017-10-10 22:41:24.533498|2017-10-10 22:41:24.533498
NCT02621684|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-01-28|||November 2014||2014-11-01|January 2016|2016-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Physical Activity Intervention in African American Men After Radical Prostatectomy|A Pilot Study of Physical Activity Intervention in African American Men After Radical Prostatectomy|Withdrawn||N/A|0|Actual|Washington University School of Medicine||3||Not able to enroll any participants due to disinterest|f||||f||||||||||2017-10-10 22:41:24.623493|2017-10-10 22:41:24.623493
NCT02621671|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-06-29|||April 1, 2015|Actual|2015-04-01|June 2017|2017-06-01|June 27, 2017|Actual|2017-06-27|June 27, 2017|Actual|2017-06-27||Interventional|||Communicating Multiple Disease Risks|Communicating Multiple Disease Risks: A Translation of Risk Prediction Science|Completed||Phase 1|1191|Actual|Washington University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:41:24.724032|2017-10-10 22:41:24.724032
NCT02621658|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-01|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Clear Liquid vs Liberalized Diet in Preparation for Colonoscopy|Clear Liquid vs Liberalized Diet in Preparation for Colonoscopy|Not yet recruiting||N/A|1000|Anticipated|San Antonio Military Medical Center||2|||f||||f||||||||||2017-10-10 22:41:24.808098|2017-10-10 22:41:24.808098
NCT02621645|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-09-19|||May 2016||2016-05-01|January 2017|2017-01-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|TRAPIST||TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence|Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence: an Open-label Randomized Controlled Trial: TRAPIST - TRAP Intervention STudy|Recruiting||Phase 4|126|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-10 22:41:24.929847|2017-10-10 22:41:24.929847
NCT02621632|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-12-01|||March 2013||2013-03-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Socknleg||SocknLeg - a User Friendly Medical Compression Study of a Modified Application of a Medical Device|SocknLeg - a User Friendly Medical Compression Study of a Modified Application of a Medical Device|Completed||Phase 4|40|Actual|University of Zurich||1|||f||||t||||||||||2017-10-10 22:41:25.135126|2017-10-10 22:41:25.135126
NCT02621619|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2017-04-24|||January 2016||2016-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||IV Acetaminophen as an Analgesic Adjunct|Randomized Clinical Trial of IV Acetaminophen as an Analgesic Adjunct to IV Hydromorphone in the Treatment of Acute Severe Pain in Elderly ED Patients|Recruiting||Phase 4|162|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 22:41:25.239668|2017-10-10 22:41:25.239668
NCT02621606|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-09-28|||January 8, 2016|Actual|2016-01-08|September 2017|2017-09-01|December 18, 2017|Anticipated|2017-12-18|December 18, 2017|Anticipated|2017-12-18||Interventional|||[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)|A Three-Part Trial to Qualify [11C]MK-6884 Positron Emission Tomography for Use as a Biomarker for Regional M4 PAM Receptor Density Quantification in the Human Brain|Recruiting||Phase 1|26|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-10 22:41:25.351114|2017-10-10 22:41:25.351114
NCT02621580|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-01|||September 2012||2012-09-01|December 2015|2015-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Investigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy Patients|A 24-Month Cohort Study Assessing the Nature and the Time Course of Structural and Functional Changes to the Retina Following PASCAL Photocoagulation in Proliferative Diabetic Retinopathy Patients|Active, not recruiting||N/A|42|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 22:41:25.57846|2017-10-10 22:41:25.57846
NCT02621567|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-09-14|||January 2016||2016-01-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|BEAM-P||Bright Light Therapy Efficacy for Depressive Symptoms Following Cardiac Surgery or Acute Coronary Syndrome: Pilot Trial|Bright Light Therapy Efficacy for Depressive Symptoms Following Cardiac Surgery or Acute Coronary Syndrome: Pilot Trial|Recruiting||Phase 4|38|Anticipated|McGill University||2|||f||||f||||||||||2017-10-10 22:41:25.670508|2017-10-10 22:41:25.670508
NCT02621554|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-02-06|||April 2016||2016-04-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Impact of Resveratrol on Brain Function and Structure|Impact of Resveratrol on Brain Function and Structure|Completed||N/A|60|Actual|Max Planck Institute for Human Cognitive and Brain Sciences||2|||f||||t||||||||||2017-10-10 22:41:25.811511|2017-10-10 22:41:25.811511
NCT02621541|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-01-05|||December 2015||2015-12-01|January 2016|2016-01-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Nonfunctional Pancreatic NET and PET Imaging|Dual Tracer Functional Imaging of Nonfunctional Pancreatic Neuroendocrine Tumors Using 68Ga-DOTA-NOC and 18F-FDG PET/CT|Recruiting||Phase 4|20|Anticipated|Turku University Hospital||1|||f||||t||||||||||2017-10-10 22:41:25.908989|2017-10-10 22:41:25.908989
NCT02621528|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-27|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|November 2018|Anticipated|2018-11-01||Interventional|||Lifetech CeraFlex™ Post-Market Surveillance Study|Multi-center, Prospective, Post-market Study|Recruiting||N/A|120|Anticipated|Lifetech Scientific (Shenzhen) Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:41:26.008752|2017-10-10 22:41:26.008752
NCT02621515|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-05-04|||August 2016||2016-08-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CA209-322||Nivo/Ipi Combination Therapy in Symptomatic Brain Metastases|An Open-label, Single-arm, Phase II, Multicenter Study to Evaluate the Efficacy of Nivolumab/Ipilimumab Combination Therapy in Metastatic Melanoma Patients With Symptomatic Brain Metastases.|Recruiting||Phase 2|70|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-10-10 22:41:26.130039|2017-10-10 22:41:26.130039
NCT02621502|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-12-01|||September 2014||2014-09-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Quinoa Effects on Glycemic Index and Satiety|Pilot Study to Evaluate the Glycemic Index, and the Satiating Effect Using Different Quinoa Varieties in a Group of Healthy Overweight Subjects|Completed||N/A|8|Actual|Instituto de Investigación Hospital Universitario La Paz||5|||f||||t||||||||||2017-10-10 22:41:26.253279|2017-10-10 22:41:26.253279
NCT02621489|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2016-08-31|||December 2015||2015-12-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|Rebuild||Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects|Effects on Re-endothelialisation With Bydureon Treatment Add on to Insulin Versus Insulin Alone, Both in Combination With Metformin in Type 2 Diabetic Subjects|Recruiting||Phase 4|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 22:41:26.365406|2017-10-10 22:41:26.365406
NCT02621476|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-01-12|||February 2017||2017-02-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities|Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities|Not yet recruiting||N/A|80000|Anticipated|Kaiser Permanente||3|||f||||t||||||||||2017-10-10 22:41:26.488681|2017-10-10 22:41:26.488681
NCT02621463|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-03-15|||December 2015||2015-12-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Electric Blower Based Ventilator Used During Procedural Sedation|Electric Blower Based Ventilator Used During Procedural Sedation|Enrolling by invitation||N/A|100|Anticipated|University of Utah||1|||f||||f||||||||||2017-10-10 22:41:26.565198|2017-10-10 22:41:26.565198
NCT02621450|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2015-12-08|||December 2015||2015-12-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Low Sodium Dialysate and Ambulatory Blood Pressure Measurement Parameters|The Effect of Low Sodium Dialysate on Ambulatory Blood Pressure Measurement Parameters in Patients Undergoing Hemodialysis|Enrolling by invitation||N/A|50|Anticipated|Yuzuncu Yıl University||2|||f||||f||||||||||2017-10-10 22:41:26.629036|2017-10-10 22:41:26.629036
NCT02621437|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-03-24|||February 2016||2016-02-01|November 2015|2015-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|IPOD||Impact of Osteopathy on Pain After Breast Cancer Surgery|Study of the Impact of Osteopathic Care, Complementary Therapy to Standard Care, on Pain in Patients With Breast Cancer Surgery|Recruiting||N/A|170|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:41:26.705145|2017-10-10 22:41:26.705145
NCT02621424|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-05-05|||January 1, 2016|Actual|2016-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|rTMS for demen||Repetitive Transcranial Magnetic Stimulation for Dementia|Repetitive Transcranial Magnetic Stimulation for Dementia|Recruiting||N/A|62|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|f|||Yes|"Each participant will be informed of their treatment arm (sham versus actual RTMS) at the end of study.
The participant is then given the option of receiving actual treatment if a sham treatment was used for this participant during the study."|2017-10-10 22:41:26.826061|2017-10-10 22:41:26.826061
NCT02621411|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-04-01|||November 2015||2015-11-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Observational Study of Preoperative Screen for Substance Abuse|Preoperative Screen for Substance Abuse in Trauma Patients Undergoing Emergency Operation: a Prospective Observational Study|Completed||N/A|1031|Actual|West China Hospital|||2||f||||t||||||||||2017-10-10 22:41:26.932273|2017-10-10 22:41:26.932273
NCT02621398|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-09-21|||April 2016||2016-04-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer|Moving PD-1 Blockade With Pembrolizumab Into Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer|Suspended||Phase 1|30|Anticipated|Rutgers, The State University of New Jersey||1||no slots available to enroll|f||||t||||||||||2017-10-10 22:41:27.160186|2017-10-10 22:41:27.160186
NCT02621385|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-04-26|||November 2015||2015-11-01|November 2015|2015-11-01||||February 2016|Actual|2016-02-01||Interventional|||Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects|An Open-label, Single-sequence Study to Assess the Effect of Multiple Doses of Tradipitant on Cytochrome P450 3A4 Using Midazolam as a Substrate in Healthy Subjects.|Completed||Phase 1|24|Actual|Vanda Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:41:27.318056|2017-10-10 22:41:27.318056
NCT02621372|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-06-17|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Observational|||Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver Cirrhosis|Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver Cirrhosis|Recruiting||N/A|100|Anticipated|Tanta University|||1||f||||t||||||||Undecided||2017-10-10 22:41:27.438637|2017-10-10 22:41:27.438637
NCT02621359|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Two Week Nitazoxanidebased Quadruple Regimen|A Two Week Nitazoxanidebased Quadruple Regimen for Helicobacter Pylori Therapy After Failure of Standard Triple Therapy: A Single Center Experience|Recruiting||Phase 3|100|Anticipated|Tanta University||1|||f||||t||||||||||2017-10-10 22:41:27.529502|2017-10-10 22:41:27.529502
NCT02621346|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Maintaining Muscle Mass Gains|Maintaining Muscle Mass Gains|Not yet recruiting||Phase 2|60|Anticipated|Western University, Canada||3|||f||||f||||||||Yes|Individual participant data will provided to each participant at the end of the study.|2017-10-10 22:41:27.639891|2017-10-10 22:41:27.639891
NCT02621333|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-02|||October 2015||2015-10-01|December 2015|2015-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma|Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma: A Prospective, Randomised, Open, Multicenter Phase Ⅱ Study|Recruiting||Phase 2|280|Anticipated|Henan Cancer Hospital||2|||f||||f||||||||||2017-10-10 22:41:27.73823|2017-10-10 22:41:27.73823
NCT02621320|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-11-21|||November 2015||2015-11-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|VitD_SCI||Vitamin D Supplementation in Wheelchair Indoor Athletes|Effect of Vitamin D3 Supplementation on Exercise Performance in Wheelchair Athletes.|Completed||N/A|20|Actual|Swiss Paraplegic Centre Nottwil||2|||f||||f||||||||||2017-10-10 22:41:27.860042|2017-10-10 22:41:27.860042
NCT02621307|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-01|||July 2010||2010-07-01|November 2015|2015-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Salba & Flax on Postprandial Glycemia and Subjective Satiety|The Effect of Salba (Salvia Hispanica L) Versus Flax on Postprandial Blood Glucose Response and Subjective Appetite in Healthy Individuals|Completed||Phase 1|15|Actual|St. Michael's Hospital, Toronto||3|||f||||f||||||||||2017-10-10 22:41:27.94701|2017-10-10 22:41:27.94701
NCT02621294|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-11-30|||November 2015||2015-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Measuring Protein Requirement Using Amino Acid Oxidation in Strength and Endurance Athletes|Measuring Protein Requirement Using the Indicator Amino Acid Oxidation Method in Healthy Young Strength and Endurance Exercise Trained Individuals|Recruiting||N/A|16|Anticipated|University of Western Ontario, Canada||1|||f||||t||||||||||2017-10-10 22:41:28.040987|2017-10-10 22:41:28.040987
NCT02621281|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2017-05-12|||December 2015||2015-12-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|CIHMP||Clinical Impact of Hypothermic Machine Perfusion in Renal Transplant Recipients|Clinical Impact of Hypothermic Machine Perfusion in Renal Transplant Recipients|Recruiting||N/A|400|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||2|||f||||t||||||||||2017-10-10 22:41:28.135947|2017-10-10 22:41:28.135947
NCT02621268|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-06-11|||November 2014||2014-11-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|ICG||Minimally Invasive Imagery With Indocyanine Green|A Pilot & Feasibility Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Minimally Invasive Thoracic Surgery Presenting With Thoracic Nodules|Recruiting||Phase 1|48|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:41:28.254801|2017-10-10 22:41:28.254801
NCT02621255|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-07-19|||November 2015||2015-11-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Anesthesia in Fracture Healing|Effect of General and Regional Anesthesia on Fracture Healing|Recruiting||Phase 4|40|Anticipated|Cukurova University||2|||f||||f||||||||||2017-10-10 22:41:28.345114|2017-10-10 22:41:28.345114
NCT02621242|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-05-25|||December 2015||2015-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals|Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals|Recruiting||N/A|20|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 22:41:28.449998|2017-10-10 22:41:28.449998
NCT02621229|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-10-13|||December 2015||2015-12-01|October 2016|2016-10-01||||December 2020|Anticipated|2020-12-01||Interventional|||Refeeding Syndrome in Anorexia Nervosa|Multi Site Randomized Controlled Trial on Refeeding Syndrome in Anorexia Nervosa|Recruiting||N/A|120|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:41:28.530514|2017-10-10 22:41:28.530514
NCT02621216|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-01|||December 2013||2013-12-01|December 2015|2015-12-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01|10 Years|Observational [Patient Registry]|THORESCI||Tilburg Health Outcomes Registry of Emotional Stress in Coronary Intervention|Tilburg Health Outcomes Registry of Emotional Stress in Coronary Intervention|Recruiting||N/A|3000|Anticipated|University of Tilburg|||1||f||||t||||||Samples Without DNA|"     Blood serum is stored for biomarker analysis   "|||2017-10-10 22:41:28.626933|2017-10-10 22:41:28.626933
NCT02621203|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-12-02|||September 2015||2015-09-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Observational|JourneyHF-TR||Patient Journey in Hospital With Acute Heart Failure|Investigate to Medications, Re-hospitalization and Mortality of Patients With Hospitalized Acute Heart Failure Patients|Recruiting||N/A|1000|Anticipated|Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital|||1||f||||t||||||||||2017-10-10 22:41:28.710399|2017-10-10 22:41:28.710399
NCT02621190|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-08-16|||February 2016||2016-02-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|CARVE||Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs|Non-randomized Phase 2 Open-label Multicenter Study Determining the Response to Cabazitaxel in Metastatic Prostate Cancer (mCRPC) Patients With AR-V7 Positive Circulating Tumor Cells (CTCs): CARVE|Withdrawn||Phase 2|0|Actual|Erasmus Medical Center||2||no approval|f||||f||||||||||2017-10-10 22:41:28.777899|2017-10-10 22:41:28.777899
NCT02621177|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-01|||November 2013||2013-11-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents|A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess the Immunogenicity and Safety of 'NBP607(Trivalent Inactivated Cell Culture-derived Influenza Vaccine)' in Healthy Children and Adolescents Aged 6 Month ~ 18 Years)|Completed||Phase 3|385|Actual|SK Chemicals Co.,Ltd.||2|||f||||f||||||||||2017-10-10 22:41:28.87278|2017-10-10 22:41:28.87278
NCT02621164|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-01|||September 2014||2014-09-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents|A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess the Immunogenicity and Safety of 'NBP607-QIV(Quadrivalent Inactivated Cell Culture-derived Influenza Vaccine)' in Children and Adolescents Aged 6 Months ~ 18 Years|Completed||Phase 3|454|Actual|SK Chemicals Co.,Ltd.||2|||f||||t||||||||||2017-10-10 22:41:28.954862|2017-10-10 22:41:28.954862
NCT02621151|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-12-30|||October 2014||2014-10-01|December 2016|2016-12-01|May 2024|Anticipated|2024-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder|A Phase II Trial of MK3475 in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder Sparing Treatment for Muscle-Invasive Urothelial Cancer of the Bladder|Recruiting||Phase 2|54|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 22:41:29.041072|2017-10-10 22:41:29.041072
NCT02621138|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2016-04-07|||April 2016||2016-04-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Observational|||The Influence of Muscle Contraction on the Cardiac Autonomic System|The Influence of Muscle Contraction on the Cardiac Autonomic System at Rest and Activity|Not yet recruiting||N/A|32|Anticipated|Alyn Pediatric & Adolecent Rehabilitation Center|||2||f||||f||||||||Undecided||2017-10-10 22:41:29.141079|2017-10-10 22:41:29.141079
NCT02621125|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-01|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Fertilix Supplements and Assisted Reproductive Technology||Withdrawn||N/A|0|Actual|University Reproductive Associates||2|||f||||f||||||||||2017-10-10 22:41:29.208814|2017-10-10 22:41:29.208814
NCT02621112|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-27|||January 2016||2016-01-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||HBV Vaccine in Renal Failure Patients|Efficacy of Intradermal Hepatitis B Vaccine in Renal Failure Patients|Recruiting||Phase 2/Phase 3|120|Anticipated|The University of Hong Kong||3|||f||||t||||||||||2017-10-10 22:41:29.277891|2017-10-10 22:41:29.277891
NCT02621099|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-02|||March 2016||2016-03-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Observational|HICAM||Hybrid Gamma Camera in Breast Surgery|First Use of a Hybrid Gamma Camera for Sentinel Lymph Node Localisation in Patients Undergoing Surgery for Primary Breast Cancer|Withdrawn||N/A|0|Actual|University of Nottingham|||1|"The study was withdrawn due to the CE mark of the device was not yet granted during the   specified period."|f||||f||||||||||2017-10-10 22:41:29.376281|2017-10-10 22:41:29.376281
NCT02621086|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-03-06|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|CELLDEX||Cellodextrin Tolerability Study|A Pilot Study to Assess the Tolerability of a Single, Ascending Dose of a Non-digestible Carbohydrate in Healthy Volunteers|Not yet recruiting||N/A|12|Anticipated|University of Nottingham||4|||f||||f|f|f||||||No||2017-10-10 22:41:29.453204|2017-10-10 22:41:29.453204
NCT02621073|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-09-05|||November 2015||2015-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||VeraFlo With Prontosan® and Wound and Fracture Healing.|Does VeraFlo With Prontosan® Decrease Time to Wound and Fracture Healing in Patients With Infected Lower Extremity Fractures With Indwelling Hardware?|Recruiting||N/A|30|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 22:41:29.534068|2017-10-10 22:41:29.534068
NCT02621060|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-03-27|||September 2015||2015-09-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance|Effect of the Administration of Chlorogenic Acid on Glucemic Control, Insulin Secretion and Insulin Sensitivity in Patients With Impaired Glucose Tolerance|Recruiting||Phase 2|30|Anticipated|University of Guadalajara||2|||f||||t||||||||||2017-10-10 22:41:29.612866|2017-10-10 22:41:29.612866
NCT02621047|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-06-27|||December 4, 2015|Actual|2015-12-04|June 2017|2017-06-01|December 8, 2016|Actual|2016-12-08|December 8, 2016|Actual|2016-12-08||Interventional|||Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib|The Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib: A Multiple-Center, Open-Label Study Following Single Oral Dosing of Alectinib to Subjects With Hepatic Impairment and Matched Healthy Subjects With Normal Hepatic Function|Completed||Phase 1|28|Actual|Hoffmann-La Roche||2|||f||||f|t|f||||||||2017-10-10 22:41:29.713793|2017-10-10 22:41:29.713793
NCT02621034|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-04-29|2016-03-18||December 2015||2015-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Comparative Evaluation of Post-endodontic Pain Using Two Rotary Instrumentation Systems|Comparison of Post-endodontic Pain Using Reciproc and Oneshape Rotary Instrumentation Systems: A Randomized Clinical Trial|Completed||N/A|150|Actual|Zahedan University of Medical Sciences||3|||f||||t||||||||||2017-10-10 22:41:29.812076|2017-10-10 22:41:29.812076
NCT02621021|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-02|2017-08-24|||November 25, 2015||2015-11-25|August 3, 2017|2017-08-03|September 1, 2021|Anticipated|2021-09-01|September 1, 2020|Anticipated|2020-09-01||Interventional|||A Prospective Randomized and Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab|A Prospective Randomized and Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab|Recruiting||Phase 2|170|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 22:41:30.111489|2017-10-10 22:41:30.111489
NCT02621008|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-31|||November 2015||2015-11-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Mobile Phone-based Intervention for Promoting Healthy Habits and Weight Loss|A Self-Administered Mobile Phone-based Holistic Intervention for Promoting Healthy Habits and Weight Loss in People Who Are Overweight or Obese|Recruiting||N/A|500|Anticipated|Eco Fusion||1|||f||||f||||||||||2017-10-10 22:41:30.223561|2017-10-10 22:41:30.223561
NCT02620995|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-27|||October 2014||2014-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Sildenafil on Penile Vascular Function in Hypertensive Men With Erectile Dysfunction|Evaluation of Systemic and Penile Microvascular Endothelial Function and Arterial Pressure After Chronic Administration of Sildenafil in Hypertensive Men With Erectile Dysfunction|Recruiting||Phase 4|75|Anticipated|National Institute of Cardiology, Laranjeiras, Brazil||2|||f||||t||||||||||2017-10-10 22:41:30.320198|2017-10-10 22:41:30.320198
NCT02620982|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-09-28|||December 2015||2015-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|AriesIDE#1||ARIES for Vasculogenic Erectile Dysfunction|Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Vasculogenic Erectile Dysfunction|Completed||Phase 1|23|Actual|Dornier MedTech Systems||1|||f||||t||||||||||2017-10-10 22:41:30.530992|2017-10-10 22:41:30.530992
NCT02620969|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Observational|UToPaed_2||Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Kinetic Analysis|Part 2 of: 'Conceptualisation and Validation of a Paradigm Based on Uraemic Toxins for Management of Chronic Kidney Disease in Paediatric Patients (UToPaed)'|Recruiting||N/A|20|Anticipated|University Hospital, Ghent|||1||f||||f||||||||||2017-10-10 22:41:30.617667|2017-10-10 22:41:30.617667
NCT02620956|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-09-14|||November 2015||2015-11-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Aerosol Deposition in Asthmatic Obese Women Using Heliox|Aerosol Deposition in Asthmatic Obese Women Using Heliox: A Randomized, Crossover, Controlled Clinical Trial Study|Completed||Phase 2|20|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:41:30.70733|2017-10-10 22:41:30.70733
NCT02620943|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-02|||August 2014||2014-08-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Dietary Diversity is Associated With Maternal Anemia and Key Prenatal Outcomes in Ethiopia|Dietary Diversity is Associated With Maternal Anemia and Key Prenatal Outcomes in a Prospective Cohort Study of Rural Ethiopia|Completed||N/A|374|Actual|Dilla University|||2||f||||f||||||||||2017-10-10 22:41:30.794349|2017-10-10 22:41:30.794349
NCT02620930|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-02-22|||March 2014|Actual|2014-03-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|September 2016|Actual|2016-09-01||Observational|DASAP-HF||Diagnosis And Treatment of Sleep Apnea in Patient With Heart Failure|Diagnosis And Treatment of Sleep Apnea in Patient With Heart Failure DASAP-HF Study|Active, not recruiting||N/A|265|Actual|University of Florence|||1||f||||||||||||No||2017-10-10 22:41:30.884906|2017-10-10 22:41:30.884906
NCT02620917|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-10-03|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|IMITA2||Continuos Subcutaneous Insulin Infusion in Italy|Survey on Continuos Subcutaneous Insulin Infusion in Italy|Active, not recruiting||N/A|10000|Anticipated|University of Padova|||1||f||||f||||||||||2017-10-10 22:41:30.95207|2017-10-10 22:41:30.95207
NCT02620904|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-10-14|||February 2016||2016-02-01|December 2015|2015-12-01|January 2019||2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|MIFD||Mifepristone Induction for Fetal Demise|Mifepristone Induction for Fetal Demise, a Randomized Control Trial|Recruiting||Phase 4|74|Anticipated|Montefiore Medical Center||2|||f||||t||||||||Yes||2017-10-10 22:41:31.016421|2017-10-10 22:41:31.016421
NCT02620891|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-12-02|||February 2015||2015-02-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Helium Oxygen Mixture in the Treatment of Meconium Aspiration Syndrome|Study on the Effect of Helium Oxygen Mixture in the Treatment of Meconium Aspiration Syndrome Parallel Synchronized Intermittent Mandatory Ventilation; Synchronous Maudatory Ventilation|Recruiting||N/A|60|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-10 22:41:31.102015|2017-10-10 22:41:31.102015
NCT02620865|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-03-09|||December 2015||2015-12-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Bispecific Antibody Armed Activated T-cells With Aldesleukin and Sargramostim in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|Phase Ib/II Treatment of Advanced Pancreatic Cancer With Anti-CD3 x Anti-EGFR-Bispecific Antibody Armed Activated T-Cells (BATs) in Combination With Low Dose IL-2 and GM-CSF|Suspended||Phase 1/Phase 2|43|Anticipated|Barbara Ann Karmanos Cancer Institute||1||Pending administrative documentation|f||||f||||||||||2017-10-10 22:41:31.264766|2017-10-10 22:41:31.264766
NCT02620852|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-08-04|||August 31, 2016|Actual|2016-08-31|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|WISDOM||Women Informed to Screen Depending on Measures of Risk|Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer|Recruiting||N/A|100000|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:41:31.460632|2017-10-10 22:41:31.460632
NCT02620839|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-05-02|||December 1, 2016|Actual|2016-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies|A Phase Ib, Open-label Study of Alpelisib (BYL719) in Combination With Cisplatin in Patients With HPV+ Solid Tumor Malignancies|Recruiting||Phase 1|41|Anticipated|University of California, San Francisco||7|||f||||t||||||||||2017-10-10 22:41:31.615645|2017-10-10 22:41:31.615645
NCT02620826|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-12-01|||December 2013||2013-12-01|December 2016|2016-12-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Prospective Comparison of Indirect Pulp Therapy and Mineral Trioxide Aggregate Pulpotomy in Decayed Primary Molars|Prospective Comparison of Indirect Pulp Therapy and Mineral Trioxide Aggregate Pulpotomy in Decayed Primary Molars|Active, not recruiting||N/A|400|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 22:41:31.71905|2017-10-10 22:41:31.71905
NCT02620800|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-05-10|||January 18, 2016|Actual|2016-01-18|May 2017|2017-05-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|FABLOx||Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer|An Open Label, Multicenter, Single Arm, Phase 1/2 Trial of Metronomic 5-fluorouracil in Combination With Nab-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Adenocarcinoma.|Recruiting||Phase 1/Phase 2|11|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 22:41:31.914639|2017-10-10 22:41:31.914639
NCT02620774|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-02-23|||February 19, 2016|Actual|2016-02-19|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections||Recruiting||Phase 1|16|Anticipated|Hartford Hospital||2|||f||||f|t|f|||f|||No||2017-10-10 22:41:32.159682|2017-10-10 22:41:32.159682
NCT02620761|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-02-15|||December 2017|Anticipated|2017-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|Fenaki||Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants|Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|University of Iowa||2|||f||||t|t|f||||||||2017-10-10 22:41:32.285662|2017-10-10 22:41:32.285662
NCT02620748|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-02-22|||March 2015||2015-03-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|TA||Use of Intravenous Tranexamic Acid During Myomectomy|Use of Intravenous Tranexamic Acid During Myomectomy: A Randomized Double-Blind Placebo Controlled Trial|Recruiting||Phase 1|60|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-10 22:41:32.412084|2017-10-10 22:41:32.412084
NCT02620735|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-08-08|||December 2014||2014-12-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|iMOVE||Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:Protocol|Innovative Smart-phone-enabled Health Coaching Intervention (iMOVE) to Promote Long-term Maintenance of Physical Activity Behavior in Breast Cancer Survivors: Study Protocol for a Feasibility Pilot Randomized Controlled Trial|Recruiting||N/A|107|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:41:32.514073|2017-10-10 22:41:32.514073
NCT02620722|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2016-12-13|||September 2014||2014-09-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A New Technique for Determining Limb Occlusion Pressure|A New Technique for Determining Limb Occlusion Pressure|Recruiting||N/A|250|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-10 22:41:32.648769|2017-10-10 22:41:32.648769
NCT02620709|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-03-30|||January 2016||2016-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|KaHOLO||The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians|The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians|Recruiting||N/A|250|Anticipated|University of Hawaii||2|||f||||t||||||||||2017-10-10 22:41:32.781313|2017-10-10 22:41:32.781313
NCT02620696|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2015-12-02|||November 2009||2009-11-01|December 2015|2015-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin|Effect of Netazepide, a Gastrin/CCK2 Receptor Antagonist, on Esomeprazole-induced Increases in Circulating Gastrin and Chromogranin A, and on Esomeprazole Withdrawal in Healthy Subjects|Completed||Phase 1|48|Actual|Trio Medicines Ltd.||6|||f||||f||||||||No||2017-10-10 22:41:32.909181|2017-10-10 22:41:32.909181
NCT02620670|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-03-27|||April 2015||2015-04-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Evaluation of the Effect of Moderate-intensity Physical Activity on Glycemic Variability|Evaluation of the Effect of Moderate-intensity Physical Activity on Glycemic Variability in Individuals With Visceral Obesity and Normal Weight Without Changes in Glucose Tolerance|Recruiting||N/A|22|Anticipated|University of Guadalajara||2|||f||||f||||||||Undecided||2017-10-10 22:41:33.114595|2017-10-10 22:41:33.114595
NCT02620657|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-03-01|||December 2015||2015-12-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluate EGFR Mutation Status and Impact Factors in North China|A Retrospective Study on Real-world EGFR Mutation Testing Practice Status and Impact Factors in Patients With Advanced NSCLC in North China|Active, not recruiting||N/A|3000|Anticipated|Guangdong Association of Clinical Trials|||1||f||||f|f|f||||||No||2017-10-10 22:41:33.222811|2017-10-10 22:41:33.222811
NCT02620644|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-01|||January 2013||2013-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|RGCC||Retinal Ganglion Cell Complex Changes by Optical Coherence Tomography in Diabetic Patients Without Retinopathy|Retinal Ganglion Cell Complex Changes Using Spectral Domain Optical Coherence Tomography in Diabetic Patients Without Retinopathy|Completed||N/A|35|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 22:41:33.293205|2017-10-10 22:41:33.293205
NCT02612532|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-05-31|||October 2015||2015-10-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|LuCID||Lung Cancer Indicator Detection|Lung Cancer Indicator Detection|Recruiting||N/A|520|Anticipated|Owlstone Ltd||1|||f||||f||||||||||2017-10-10 22:43:10.581518|2017-10-10 22:43:10.581518
NCT02620618|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-01|||January 2013||2013-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study|Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study|Completed||Phase 1/Phase 2|20|Actual|Cairo University||1|||f||||t||||||||||2017-10-10 22:41:33.494163|2017-10-10 22:41:33.494163
NCT02620605|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-02-21|||December 2015||2015-12-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|OHSS||The Influence of Timing of Cabergoline Initiation on Prevention of OHSS|The Influence of Timing of Cabergoline Initiation on Prevention of Ovarian Hyper Stimulation Syndrome in Patients Undergoing Intra Cytoplasmic Sperm Injection .|Recruiting||Phase 3|75|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 22:41:33.605794|2017-10-10 22:41:33.605794
NCT02620592|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-01|||October 2014||2014-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZYDPLA1, a Novel DPP- IV Inhibitor, Following Oral Administration in Healthy Volunteers|Completed||Phase 1|84|Actual|Cadila Healthcare Limited||2|||f||||t||||||||||2017-10-10 22:41:33.740666|2017-10-10 22:41:33.740666
NCT02620579|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-05-03|||January 2016||2016-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|BISP||Biopsychosocial Influence on Shoulder Pain|Biopsychosocial Influence on Shoulder Pain: a Randomized, Pre-clinical Trial|Recruiting||Phase 2|448|Anticipated|Duke University||4|||f||||f||||||||||2017-10-10 22:41:33.854997|2017-10-10 22:41:33.854997
NCT02620553|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-04-19||2015-12-18|September 2007||2007-09-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional|Pre-POINT||Primary Intervention With Mucosal Insulin|Primary Intervention With Mucosal Insulin for Prevention of Type 1 Diabetes in Infants at High Genetic Risk to Develop Diabetes POINT (Primary Oral Insulin Trial) A Dose Finding and Safety Study ( Pre-POINT )|Completed||Phase 1/Phase 2|25|Actual|University of Colorado, Denver||2|||f||||t||||||||Yes||2017-10-10 22:41:34.080304|2017-10-10 22:41:34.080304
NCT02620540|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-09-28|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|February 2017|Actual|2017-02-01||Observational|||Evaluation of an Algorithm for Length Based Weight Estimation in Comparison to Known Devices|Evaluation of an Algorithm for Length Based Weight Estimation in Comparison to Already Known Devices Like the Broselow Tape (BT)|Active, not recruiting||N/A|500|Anticipated|University Children's Hospital, Zurich|||1||f||||t||||||||||2017-10-10 22:41:34.181186|2017-10-10 22:41:34.181186
NCT02620527|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-02-21|||November 2014||2014-11-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Concordance Between ctDNA Assay and FoundationOne|Study of Concordance Between Circulating Tumor DNA Assay and Foundation One Tissue Analysis For Genomic Alterations|Recruiting||N/A|2000|Anticipated|Foundation Medicine|||1||f||||f||||||||||2017-10-10 22:41:34.252677|2017-10-10 22:41:34.252677
NCT02620514|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-01-23|||June 2015|Actual|2015-06-01|January 2017|2017-01-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional|||Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)|Assessment of Health Literacy, Medication Adherence, and a Pilot Multi-component Intervention to Improve Medication Adherence in Patients With Inflammatory Bowel Disease|Completed||N/A|77|Actual|Emory University||5|||f||||f||||||||||2017-10-10 22:41:34.355518|2017-10-10 22:41:34.355518
NCT02620501|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-12-02|||July 2015||2015-07-01|December 2015|2015-12-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Does Use of Topical Lidocaine in EGD Reduce Amount of IV Midazolam and Fentanyl Required and Shorten Recovery Time|Does Topical Lidocaine Reduce The Amount of Intravenous Conscious Sedation Required To Complete Diagnostic Upper Endoscopy and Shorten Recovery Time? A Double Blinded, Randomized, Placebo Controlled Study.|Recruiting||N/A|106|Anticipated|Brooke Army Medical Center||2|||f||||t||||||||||2017-10-10 22:41:34.456426|2017-10-10 22:41:34.456426
NCT02620488|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-05-01|||September 2015||2015-09-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease|A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease|Completed||N/A|28|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-10-10 22:41:34.546705|2017-10-10 22:41:34.546705
NCT02620475|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-30|||January 2016||2016-01-01|November 2015|2015-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Randomized Split Scar Study of Suture Safe Treatment of Surgical Wounds to Minimize Scaring|A Randomized Split Scar Study of Suture Safe (South Medic) Treatment of Surgical Wounds to Minimize Scaring|Not yet recruiting||N/A|40|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:41:34.633381|2017-10-10 22:41:34.633381
NCT02620462|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-05-16|||February 2015||2015-02-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Wearable Sensor-based Balance Training for Patients With Knee Osteoarthritis|Explore the Effectiveness of a Sensor-based Interactive Exercise Training on Functional Performance in Patients With Knee Osteoarthritis|Active, not recruiting||N/A|24|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-10 22:41:34.71843|2017-10-10 22:41:34.71843
NCT02620449|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-01-05|||August 2015||2015-08-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living Adults|Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living Adults (Phosphate and Fibroblast Growth Factor 23 [FGF23]: Dietary and Molecular Mediators of Health and Disparities in Cardiovascular and Kidney Diseases)|Recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-10 22:41:34.96015|2017-10-10 22:41:34.96015
NCT02620436|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-06-02|||March 2016||2016-03-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MAHMAZ||Impact Evaluation of Maternity Homes Access in Zambia|Increasing Equitable Access to Safe Deliveries in Zambia|Recruiting||N/A|4900|Anticipated|Boston University||2|||f||||f|f|f||||||Yes|We will first ensure data are fully deidentified, then share them with academic partners at the University of Michigan and, once finalized, on a an open access site.|2017-10-10 22:41:35.104669|2017-10-10 22:41:35.104669
NCT02620410|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-07-17|||June 2016||2016-06-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|June 2017|Actual|2017-06-01||Interventional|RELAX-OAB||Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System|Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System: RELAX-OAB|Active, not recruiting||N/A|51|Actual|Axonics Modulation Technologies, Inc.||1|||f||||t||||||||||2017-10-10 22:41:35.364865|2017-10-10 22:41:35.364865
NCT02620397|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-14|||March 2015||2015-03-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|October 2015|Actual|2015-10-01||Observational|||Clinical Study to Validate the Use of a New Point of Care Troponin I Test|Clinical Study to Validate the Use of a New Point of Care Troponin I Test as an Aid in the Diagnosis of Myocardial Infarction and Prognosis of Subjects Presenting With Symptoms of Acute Coronary Syndrome|Active, not recruiting||N/A|1500|Anticipated|Trinity Biotech|||1||f||||f||||||Samples Without DNA|"     EDTA Whole Blood   "|||2017-10-10 22:41:35.508016|2017-10-10 22:41:35.508016
NCT02620384|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-06-26|||July 2015||2015-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||MELT Heart Failure|Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.|Recruiting||Phase 2|200|Anticipated|Aultman Health Foundation||2|||f||||f||||||||||2017-10-10 22:41:35.664479|2017-10-10 22:41:35.664479
NCT02620371|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-04-15|||September 2015||2015-09-01|September 2015|2015-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy of Ketamine Added to Local Anesthetic in Modified Pectoral Block for Management of Postoperative Pain|Efficacy and Safety of Ketamine Added to Local Anesthetic in Modified Pectoral Block for Management of Postoperative Pain in Patients Undergoing Modified Radical Mastectomy|Completed||Phase 3|60|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 22:41:35.831596|2017-10-10 22:41:35.831596
NCT02620358|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-03-30|||January 11, 2016|Actual|2016-01-11|March 2017|2017-03-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|||Two Opposite Strategies of Weaning From Mechanical Ventilation|Two Opposite Strategies of Weaning From Mechanical Ventilation: High Work of Breathing Versus Low Work of Breathing|Completed||N/A|1190|Actual|Althaia Xarxa Assistencial Universitària de Manresa||2|||f||||f||||||||Undecided||2017-10-10 22:41:35.990594|2017-10-10 22:41:35.990594
NCT02620345|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2015-11-30|||January 2010||2010-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|Fibroids||Fibroids in Women of Reproductive Age and Women Pregnancy|Uterine Fibroids Are a Very Common Finding in Women of Reproductive Age. Ready Safety Study Dydrogesterone + Multivitamin Nature in Women of Reproductive Age and Women Pregnancy|Completed||Phase 4|22|Actual|Triệu, Nguyễn Thị, M.D.||2|||f||||t||||||||||2017-10-10 22:41:36.156182|2017-10-10 22:41:36.156182
NCT02620332|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-12-01|||August 2015||2015-08-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|MultiPepT1De||Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)|Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)|Recruiting||Phase 1|24|Anticipated|King's College London||4|||f||||t||||||||||2017-10-10 22:41:36.279264|2017-10-10 22:41:36.279264
NCT02620319|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-06-15|||May 2013||2013-05-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Biodegradable Stents in the Management of Stenoses of the Large Airways|Biodegradable Stents in the Management of Stenoses of the Large Airways|Active, not recruiting||N/A|30|Anticipated|Thomayerova Teaching Hospital||1|||f||||t||||||||||2017-10-10 22:41:36.424919|2017-10-10 22:41:36.424919
NCT02620306|ClinicalTrials.gov processed this data on October 10, 2017|2015-12-01|2017-04-04|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan||Recruiting||Phase 3|468|Anticipated|Boryung Pharmaceutical Co., Ltd||4|||f||||||||||||||2017-10-10 22:41:36.579062|2017-10-10 22:41:36.579062
NCT02620293|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-06-02|||April 2016||2016-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin|A 47 Hour, Single Application, Occlusive Forearm Skin Patch Test to Assess, Under Dermatological Control, the Acute Cutaneous Tolerance of Project Storm on the Forearm of Adult Subjects With Dry/Atopic and Very Dry/Atopic Skin|Completed||Phase 1|33|Actual|Reckitt Benckiser Healthcare (UK) Limited||1|||f||||f||||||||||2017-10-10 22:41:36.712766|2017-10-10 22:41:36.712766
NCT02620280|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-07-12|||April 2016||2016-04-01|July 2016|2016-07-01|October 2022|Anticipated|2022-10-01|May 2022|Anticipated|2022-05-01||Interventional|NeoTRIPaPDL1||Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1|Neo-Adjuvant Study With the PDL1-directed Antibody in Triple Negative Locally Advanced Breast Cancer Undergoing Treatment With Nab-paclitaxel and Carboplatin|Recruiting||Phase 3|272|Anticipated|Fondazione Michelangelo||2|||f||||t||||||||||2017-10-10 22:41:36.857207|2017-10-10 22:41:36.857207
NCT02620267|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-05-30|||December 15, 2015|Actual|2015-12-15|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Target Engagement of the Early Auditory Processing Network by Transcranial Direct Current Stimulation (tDCS)|Target Engagement of the Early Auditory Processing Network by Transcranial Direct Current Stimulation (tDCS): A Pilot Study|Active, not recruiting||N/A|14|Actual|VA Greater Los Angeles Healthcare System||1|||f||||f||||||||||2017-10-10 22:41:37.114883|2017-10-10 22:41:37.114883
NCT02605538|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-09-06|||October 2015||2015-10-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively|Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively|Recruiting||N/A|250|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-10 22:44:32.991045|2017-10-10 22:44:32.991045
NCT02620254|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-19|||November 2015||2015-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Mast Cell Connect: A Registry for Patients With Mastocytosis|Mast Cell Connect: A Registry for Patients With Mastocytosis|Recruiting||N/A|200|Anticipated|Blueprint Medicines Corporation|||1||f||||||||||||||2017-10-10 22:41:37.2094|2017-10-10 22:41:37.2094
NCT02620241|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-11-03|||October 2015||2015-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR).|Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR) in Infants|Recruiting||N/A|50|Anticipated|Vrije Universiteit Brussel||1|||f||||||||||||||2017-10-10 22:41:37.317873|2017-10-10 22:41:37.317873
NCT02620228|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-06-05|||May 2016||2016-05-01|June 2017|2017-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Identification of Liver Tumours Using BIP - Biopsy System|INJ-LIVERB-01 Identification of Liver Tumours Using BIP - Biopsy System|Recruiting||N/A|60|Anticipated|Injeq Ltd||1|||f||||||||||||||2017-10-10 22:41:37.441187|2017-10-10 22:41:37.441187
NCT02620215|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-08-15|||November 2015||2015-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CRBII||Cervical Ripening Balloon in Induction of Labour at Term|Cervical Ripening Balloon in Induction of Labour at Term (CRBII) - A Prospective Randomized Controlled Trial|Recruiting||Phase 4|420|Anticipated|KK Women's and Children's Hospital||2|||f||||f||||||||||2017-10-10 22:41:37.572032|2017-10-10 22:41:37.572032
NCT02620202|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-03-06|||September 2015||2015-09-01|March 2017|2017-03-01|December 2036|Anticipated|2036-12-01|December 2018|Anticipated|2018-12-01||Observational|WESTCOR||Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting With Chest Pain|Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting With Chest Pain (WESTCOR Study)|Recruiting||N/A|3000|Anticipated|Haukeland University Hospital|||1||f||||f||||||Samples With DNA|"     Full blood, Serum samples, EDTA plasma, Urine   "|||2017-10-10 22:41:37.707|2017-10-10 22:41:37.707
NCT02620189|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-11-30|||March 2015||2015-03-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|August 2016|Anticipated|2016-08-01||Observational|THERAPIST||Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα|A Study to Investigate the Role of IL-17 and Th17 Pathway Activation in RA Patients With Inadequate Response to Anti-TNFα Therapies|Recruiting||N/A|50|Anticipated|Queen Mary University of London|||1||f||||t||||||Samples With DNA|"     -  Synovial tissue        -  RNA extraction on peripheral blood mononuclear cells   "|||2017-10-10 22:41:37.828457|2017-10-10 22:41:37.828457
NCT02620163|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2017-02-14|||December 2015|Actual|2015-12-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment|A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Trial to Evaluate the Safety and Efficacy of YH22162 in Subjects With Essential Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment|Completed||Phase 3|381|Actual|Yuhan Corporation||2|||f||||f||||||||||2017-10-10 22:41:38.082824|2017-10-10 22:41:38.082824
NCT02620150|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-05-24|||January 2016||2016-01-01|September 2016|2016-09-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||SSRI Effects on Depression and Immunity in HIV/AIDS|SSRI Effects on Depression and Immunity in HIV/AIDS|Recruiting||N/A|180|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:41:38.202424|2017-10-10 22:41:38.202424
NCT02620137|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-11-28|||January 2013||2013-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Maintenance of Multivitamin Supplements After Sleeve Gastrectomy|Maintenance of Multivitamin Supplements After Sleeve Gastrectomy|Completed||Phase 3|80|Actual|Hospital General Universitario Elche||2|||f||||t||||||||||2017-10-10 22:41:38.321261|2017-10-10 22:41:38.321261
NCT02620124|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-11-22|||May 2013||2013-05-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||GnRH Agonist as Luteal Support in FET Cycles|GnRH Anonist as Luteal Support in Frozen-thawed Embryo Transfer Cycles|Completed||Phase 4|100|Actual|Turku University Hospital||4|||f||||f||||||||No||2017-10-10 22:41:38.433537|2017-10-10 22:41:38.433537
NCT02620111|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-10-24|||June 2015||2015-06-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Protein Balance in Protein Supplemented Elderly Patients: Acute Study With Protein-tracer-techniques|Effect of Protein High in Leucine on Muscle Protein Balance in Elderly Patients: Acute Study With Protein-tracer-techniques|Withdrawn||N/A|0|Actual|University of Aarhus||2||Due to difficulties in recruiting frail subjects.|f||||f||||||||No||2017-10-10 22:41:38.554187|2017-10-10 22:41:38.554187
NCT02620098|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-30|||September 2014||2014-09-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||Effectiveness of a Handwriting Intervention|Effectiveness of a Handwriting Intervention With At-Risk Kindergarteners|Completed||N/A|35|Actual|Temple University||2|||f||||f||||||||||2017-10-10 22:41:38.661905|2017-10-10 22:41:38.661905
NCT02620085|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-12-01|||July 2011||2011-07-01|November 2015|2015-11-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|TPS||Thyroid Disease and Personality Study|Bio-psycho-social Correlates of Psychological Distress in Patients With Graves' Disease in Euthyroid Status|Recruiting||N/A|500|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-10 22:41:38.781332|2017-10-10 22:41:38.781332
NCT02620072|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-11-09|||December 2015||2015-12-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Fr1da Insulin Intervention|Mechanistic Study Using Oral Insulin for Immune Efficacy in Secondary Prevention of Type 1 Diabetes|Recruiting||Phase 2|220|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-10-10 22:41:38.908355|2017-10-10 22:41:38.908355
NCT02620059|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-12-04|||March 2016||2016-03-01|December 2015|2015-12-01|March 2019|Anticipated|2019-03-01|October 2017|Anticipated|2017-10-01||Interventional|||A Lifestyle Program on Healthy Weight in Postpartum Period|Development and Evaluation of a Lifestyle Intervention Program for Women' Weight Reduction After Childbirth|Not yet recruiting||N/A|100|Anticipated|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:41:39.037171|2017-10-10 22:41:39.037171
NCT02620033|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-01-22|||September 2015||2015-09-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy|Impact of Yoga As Complementary Therapy on Quality of Life, Pro-inflammatory, and Cellular Immune Biomarkers in Patients Undergoing Radical Prostatectomy: A Pilot Randomized-Controlled Trial|Terminated||N/A|6|Actual|The University of Texas Health Science Center at San Antonio||2||Lack of staffing|f||||f||||||||||2017-10-10 22:41:41.757795|2017-10-10 22:41:41.757795
NCT02620020|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-11-16|||February 2016||2016-02-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain|A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate to Severe Chronic Low Back Pain|Active, not recruiting||Phase 2/Phase 3|563|Actual|Regeneron Pharmaceuticals||4|||f||||t||||||||||2017-10-10 22:41:41.869569|2017-10-10 22:41:41.869569
NCT02620007|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-06-23|||December 2015||2015-12-01|June 2016|2016-06-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Interventional|TEOREM||Evaluation of Adherent Invasive E. Coli Eradication in Adult Crohn Disease|Multicenter Double Blind Randomized Clinical Trial Assessing the Benefit of Adherent Invasive E. Coli Eradication in Adult Ileal and Ileo-colonic Crohn Disease|Recruiting||Phase 2|62|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:41:42.103964|2017-10-10 22:41:42.103964
NCT02619994|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-05-02|||January 2016||2016-01-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|MDR-END||Treatment Shortening of MDR-TB Using Existing and New Drugs|Delamanid, Linezolid, Levofloxacin, and Pyrazinamide for Treatment of Patients With Fluoroquinolone-sensitive MDR-TB: A Phase 2, Multicenter, Randomized, Open-label, Clinical Trial|Recruiting||Phase 2|238|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:41:42.219119|2017-10-10 22:41:42.219119
NCT02619981|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-11-30|||November 2012||2012-11-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||The Effect of Parental Presence on Dental Fear|An Objective Assessment of Dental Fear, and the Influence of the Parental Presence on the Behavior of Anxious Children on Their First Restorative Dental Visit|Completed||Phase 4|150|Actual|Riyadh Colleges of Dentistry and Pharmacy||3|||f||||f||||||||||2017-10-10 22:41:42.3262|2017-10-10 22:41:42.3262
NCT02619968|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-11-30|||January 2016||2016-01-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Physical Exercise With Flow Restriction of the Forearm in Chronic Kidney Disease|Effectiveness of Physical Exercise With Flow Restriction on the Diameter and the Flow of the Blood Vessels of the Forearm in Chronic Kidney Disease: a Randomized Clinical Trial|Not yet recruiting||N/A|20|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:41:42.565327|2017-10-10 22:41:42.565327
NCT02619955|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-09-09|||March 2016||2016-03-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|HEPCICOR||Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity|Hepcicor Cohort : Clinical, Biological, Genetic and Fonctional charactérization of Rare Iron Overlaod phénotypes Associated With Hepcidin Deficiency Excluding C282Y Homozygosity|Recruiting||N/A|60|Anticipated|Rennes University Hospital|||1||f||||f||||||||||2017-10-10 22:41:42.690172|2017-10-10 22:41:42.690172
NCT02619942|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-10-24|||December 2015||2015-12-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|RELARC||Investigate the Radical Extent of Lymphadenectomy of LAparoscopic Right Colectomy for Colon Cancer(RELARC).|A Multicenter, Prospective, Randomized Clinical Trial to Investigate the Radical Extent of Lymphadenectomy: D2 Dissection vs. Complete Mesocolic Excision, of LAparoscopic Right Colectomy for Right-sided Colon Cancer.|Recruiting||N/A|1072|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 22:41:42.82735|2017-10-10 22:41:42.82735
NCT02619929|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-09-26|||February 2016||2016-02-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|StepUp||Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany|Assessment of Initial Oral Vinorelbine Dosing Schedules Used for the Treatment of Advanced Non-small-cell Lung Cancer and Metastatic Breast Cancer in Clinical Routine in Germany (StepUp)|Recruiting||N/A|100|Anticipated|Pierre Fabre Pharma GmbH|||1||f||||f||||||||||2017-10-10 22:41:42.96063|2017-10-10 22:41:42.96063
NCT02619916|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-05-17|||May 2015||2015-05-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||MBCT and CBT for Depression in Patients After Cancer: a Randomized Controlled Trial|Individual Mindfulness-Based Cognitive Therapy (MBCT) and Individual Cognitive Behavioral Therapy (CBT) for Depression in Patients After Cancer: a Randomized Controlled Trial|Recruiting||N/A|192|Anticipated|University Medical Center Groningen||3|||f||||f||||||||||2017-10-10 22:41:43.163715|2017-10-10 22:41:43.163715
NCT02619903|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2015-12-02|||February 2016||2016-02-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Oral Microbiota as Reservoir for Systemic Opportunistic Pathogens|The Oral Microbiota as Reservoir for Systemic Opportunistic Pathogens|Not yet recruiting||N/A|400|Anticipated|Malmö University||4|||f||||t||||||||||2017-10-10 22:41:43.308514|2017-10-10 22:41:43.308514
NCT02619890|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-01|||September 2015||2015-09-01|December 2015|2015-12-01||||December 2040|Anticipated|2040-12-01|5 Years|Observational [Patient Registry]|||Brain Glioma Registry Combining Clinical and Imaging Information|Registry Describing Clinical Information, Conventional, and Advanced Magnetic Resonance Imaging Information of Patients With Brain Glioma|Recruiting||N/A|9999|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-10 22:41:43.40866|2017-10-10 22:41:43.40866
NCT02619877|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-08-30|||October 2015||2015-10-01|November 2015|2015-11-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers|Phase 2 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers: A Randomized, Comparator-controlled, Single-blind, Parallel-group, Multi-center Study|Completed||Phase 2|59|Actual|Anterogen Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:41:43.512941|2017-10-10 22:41:43.512941
NCT02619864|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-03-13|||November 2015||2015-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme|A Phase I/II Study of the mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Patients With Previously Treated Glioblastoma Multiforme|Recruiting||Phase 1/Phase 2|52|Anticipated|Canadian Cancer Trials Group||1|||f||||t||||||||Yes||2017-10-10 22:41:43.615701|2017-10-10 22:41:43.615701
NCT02619851|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-04-21|||December 2015||2015-12-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Interventional|||A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects|A Phase II Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects: Controlled, Parallel, Multicenter|Not yet recruiting||Phase 2|22|Anticipated|Anterogen Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:41:43.761273|2017-10-10 22:41:43.761273
NCT02619838|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-07-27|||October 2015||2015-10-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Prospective Subtalar, Double, or Triple Arthrodesis Study With CCS Screws|Prospective Subtalar, Double, or Triple Arthrodesis Study With CCS Screws|Recruiting||N/A|50|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 22:41:43.876745|2017-10-10 22:41:43.876745
NCT02619825|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-06-03|||November 2015||2015-11-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie)|Non-Invasive Evaluation of Myocardial Stiffness by Elastography Pediatric Cardiology Under|Recruiting||N/A|120|Anticipated|French Cardiology Society||3|||f||||f||||||||||2017-10-10 22:41:43.98892|2017-10-10 22:41:43.98892
NCT02619812|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-17|2017-01-27||April 2016|Actual|2016-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT|A Randomized, Placebo-Controlled, Pilot Study of Colesevelam and Serum-Derived Bovine Immunoglobulin/Protein Isolate to Manage Diarrhea in Patients With Multiple Myeloma Receiving Conditioning Chemotherapy for Autologous Stem Cell Transplantation (SCT)|Terminated||Phase 2|4|Actual|Mayo Clinic|This study was terminated early due to difficulty recruiting subjects; pill burden and nausea were barriers to study continuation for subjects accrued. Data were not collected.|4||Difficulty recruiting; pill burden and nausea were barriers|f||||f|t|f||||||No||2017-10-10 22:41:44.102763|2017-10-10 22:41:44.102763
NCT02619799|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-02-12|2016-01-08||January 2015||2015-01-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Comparative Study of Intrathecal Magnesium Sulphate & Midazolam With Epidural Ropivacaine for Caesarean Patients|A Comparative Study Between Intrathecal Magnesium Sulphate Versus Midazolam Along With Epidural 0.75% Ropivacaine in Combined Spinal Epidural Technique for Preeclampsia Parturients Undergiong Elective Caesarean Section|Completed||Phase 2/Phase 3|50|Actual|Rangaraya Medical College||2|||f||||t||||||||No||2017-10-10 22:41:44.49673|2017-10-10 22:41:44.49673
NCT02619786|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-12-01|||December 2015||2015-12-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin|Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin|Not yet recruiting||Phase 3|62|Anticipated|Mahidol University||1|||f||||f||||||||||2017-10-10 22:41:45.076356|2017-10-10 22:41:45.076356
NCT02619773|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-12-19|||November 2015||2015-11-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Mupirocin Dressings Versus Island Dressings on Surgical Site Infections in Elective Colorectal Surgery|The Use of Mupirocin Dressings and Its Effect on Surgical Site Infections in Elective Colorectal Surgery: A Prospective, Randomized Controlled Trial|Enrolling by invitation||N/A|150|Anticipated|Gundersen Lutheran Medical Foundation||2|||f||||f||||||||||2017-10-10 22:41:45.19185|2017-10-10 22:41:45.19185
NCT02619760|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2016-07-11|||December 2015||2015-12-01|July 2016|2016-07-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Interventional|STOPDAPT-2||ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study|ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study|Recruiting||Phase 4|3000|Anticipated|Kyoto University, Graduate School of Medicine||2|||f||||t||||||||||2017-10-10 22:41:45.322762|2017-10-10 22:41:45.322762
NCT02619747|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-10-04|||April 2014|Actual|2014-04-01|October 2017|2017-10-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients|A Multi-centre, Randomised, Open Label, Placebo-controlled, Two-period Crossover Study to Evaluate 4-hour Esophageal pH Change in GERD Patients After Administration of Compound Sodium Alginate Oral Suspension Sachets or Placebo Sachets|Terminated||Phase 3|16|Actual|Reckitt Benckiser Healthcare (UK) Limited||2||Problems with recruitment|f||||f||||||||||2017-10-10 22:41:45.512028|2017-10-10 22:41:45.512028
NCT02619734|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-01|||August 2006||2006-08-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease|Efficacy and Safety of Autologous Bone Marrow Stem Cells Infusion for Treatment of Chronic Leg Ulcer in Sickle Cell Disease Patients|Enrolling by invitation||Phase 1|40|Anticipated|Federal University of Bahia||2|||f||||f||||||||||2017-10-10 22:41:45.656013|2017-10-10 22:41:45.656013
NCT02619721|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-10-08|||October 2015||2015-10-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)||Active, not recruiting||Early Phase 1|7|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||||||||||||2017-10-10 22:41:45.752956|2017-10-10 22:41:45.752956
NCT02619708|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2016-05-24|||December 2015||2015-12-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Preoperative Immersive Patient Quality Experience|Preoperative Immersive Patient Quality Experience|Completed||N/A|127|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-10 22:41:45.858699|2017-10-10 22:41:45.858699
NCT02619695|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-12-01|||June 2015||2015-06-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Comparison of Ketoprofen Gel to Placebo in Mechanical Low Back Pain|Comparison of Ketoprofen Gel to Placebo in Patients Presented With Mechanical Low Back Pain to the Emergency Department: A Randomized Placebo Controlled Trial|Recruiting||Phase 4|160|Anticipated|Akdeniz University||2|||f||||f||||||||||2017-10-10 22:41:45.959205|2017-10-10 22:41:45.959205
NCT02619682|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-02-27|||December 30, 2015|Actual|2015-12-30|February 2017|2017-02-01||||December 2020|Anticipated|2020-12-01||Interventional|||Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma|Alternating the Administration of Ixazomib and Lenalidomide as Maintenance Therapy After Autologous Transplant for Treating Multiple Myeloma|Recruiting||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-10 22:41:46.071892|2017-10-10 22:41:46.071892
NCT02619669|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-05-08|||April 20, 2017|Actual|2017-04-20|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer|Phase 1b Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer|Recruiting||Phase 1|13|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t|t|f||||||||2017-10-10 22:41:46.219154|2017-10-10 22:41:46.219154
NCT02619656|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2015-11-30|||April 2012||2012-04-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Trial of Supplemental CO2 Versus Room Air in Percutaneous Endoscopic Gastrostomy|Insufflation With Carbon Dioxide Reduces Pneumoperitoneum After Percutaneous Endoscopic Gastrostomy (PEG): A Randomized Controlled Trial|Completed||N/A|35|Actual|University of Utah||2|||f||||f||||||||||2017-10-10 22:41:46.341393|2017-10-10 22:41:46.341393
NCT02619643|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-05-09|||December 2015||2015-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Primed vs Unprimed Facilitatory and Depressive Paired Associative Stimulation|Primed vs Unprimed Facilitatory and Depressive Paired Associative Stimulation|Active, not recruiting||N/A|40|Anticipated|University of Minnesota - Clinical and Translational Science Institute||7|||f||||f||||||||||2017-10-10 22:41:46.439764|2017-10-10 22:41:46.439764
NCT02619630|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-06-23|||December 2015||2015-12-01|June 2016|2016-06-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|GRAALL-2014/T||Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old)|Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old): Evaluating the Efficacy of a Nelarabine Based Consolidation and Maintenance in High-risk Patients|Recruiting||Phase 2|275|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 22:41:46.530707|2017-10-10 22:41:46.530707
NCT02619617|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-09-19|||October 31, 2016|Actual|2016-10-31|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Safety and Efficacy Study of SOM230 s.c. in Cluster Headache|A Multicenter, Placebo-Controlled, Single Dose Study in Acute Episodic and Chronic Cluster Headache to Evaluate the Safety and Efficacy of SOM230 Subcutaneous (s.c.)|Recruiting||Phase 2|60|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 22:41:46.634392|2017-10-10 22:41:46.634392
NCT02619604|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-02-14|||May 2016||2016-05-01|January 2017|2017-01-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|Med-IQ CLL||A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia|A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia|Completed||N/A|50|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 22:41:46.771197|2017-10-10 22:41:46.771197
NCT02619591|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-09-19|2015-12-07||September 2011||2011-09-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Comparison Of Chest Ultrasound Techniques To Identify Clinically Significant Pneumothorax|Comparison Of Chest Ultrasound Techniques To Identify Clinically Significant Pneumothorax|Completed||N/A|260|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-10 22:41:46.860513|2017-10-10 22:41:46.860513
NCT02619578|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-28|||November 2013||2013-11-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||The Effect of TEAS on the Quality of Early Recovery|The Effect of Transcutaneous Electric Acupoint Stimulation on the Quality of Early Recovery in Patients Undergoing Gynecological Laparoscopic Surgery: a Prospective, Randomized, Placebo-controlled Trial|Completed||N/A|60|Actual|Guizhou Provincial People's Hospital||2|||f||||f||||||||||2017-10-10 22:41:47.167705|2017-10-10 22:41:47.167705
NCT02619565|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-12-01|||April 2010||2010-04-01|November 2015|2015-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|MDS04||Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes|Prognostic Value of Recurrent Mutations in a Prospective Cohort of Myelodysplasia and Secondary Acute Myeloid Leukemias|Active, not recruiting||N/A|323|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:41:47.32494|2017-10-10 22:41:47.32494
NCT02619552|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-11-30|||August 2011||2011-08-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|||Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease|Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease|Unknown status|Recruiting|N/A|90|Anticipated|University of Maryland|||3||f||||f||||||||||2017-10-10 22:41:47.504712|2017-10-10 22:41:47.504712
NCT02619539|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-03-22|||January 2016||2016-01-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28|1 Day|Observational [Patient Registry]|SIDE||Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE)|Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE)|Completed||N/A|280|Actual|Masaryk Hospital Krajská zdravotní a.s.|||1||f||||f||||||||Undecided||2017-10-10 22:41:47.652099|2017-10-10 22:41:47.652099
NCT02619526|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-30|||November 2015||2015-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Comparative Effects of Nebivolol and Carvedilol on Diastolic Function in the Elderly Heart Failure Patients|Comparative Effects of Nebivolol and Carvedilol on Diastolic Function of the Left Ventricle in the Elderly Heart Failure Patients With Preserved Ejection Fraction: Study Protocol for a Randomized Controlled Trial|Active, not recruiting||N/A|62|Anticipated|Dong-A University||2|||f||||t||||||||||2017-10-10 22:41:47.758357|2017-10-10 22:41:47.758357
NCT02619513|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-11-28|||December 2014||2014-12-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Dexmedetomidine Used in Continuous Thoracic Paravertebral Blocks|Effects of Dexmedetomidine as an Adjunctive Analgesic Used in Continuous Thoracic Paravertebral Blocks for Post-thoracotomy Pain Syndrome|Completed||Phase 4|60|Actual|Guangzhou General Hospital of Guangzhou Military Command||4|||f||||f||||||||||2017-10-10 22:41:47.90009|2017-10-10 22:41:47.90009
NCT02619500|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-02-11|||February 2016||2016-02-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Thrust Manipulation vs. Non-thrust Mobilizations for Mechanical Neck Pain|A Pragmatically Applied Cervical and Thoracic Non-thrust Mobilizations Versus Thrust Manipulation for Patients With Mechanical Neck Pain: A Multicenter Randomized Clinical Trial|Recruiting||N/A|136|Anticipated|Youngstown State University||2|||f||||f||||||||||2017-10-10 22:41:48.014551|2017-10-10 22:41:48.014551
NCT02619487|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-03-31|||August 2017|Anticipated|2017-08-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|November 2018|Anticipated|2018-11-01||Interventional|Edu4U||The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes|The Impact of Mobile Technology on Clinical Outcomes in Children and Adolescents With Type 1 Diabetes|Not yet recruiting||N/A|178|Anticipated|University of Louisville||4|||f||||f|f|f||||||No||2017-10-10 22:41:48.130213|2017-10-10 22:41:48.130213
NCT02619474|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-19|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Whiteboards on Patient Satisfaction|The Effect of Whiteboards on Patient Satisfaction: A Prospective Controlled Study in BC's Children's Hospital|Completed||N/A|266|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:41:48.239438|2017-10-10 22:41:48.239438
NCT02619461|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-11-29|||August 2014||2014-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||The Acute Effect of Exercise on Appetite Appetite-regulating Hormones and Inflammation in Children|The Acute Effect of High Intensity Exercise on Appetite, Appetite-regulating Hormones, and Bio-markers of Inflammation and Stress in Lean and Obese Boys|Completed||N/A|22|Actual|University of Toronto||2|||f||||f||||||||||2017-10-10 22:41:48.309301|2017-10-10 22:41:48.309301
NCT02619448|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-11-30|||December 2014||2014-12-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Concurrent Chemotherapy and Accelerated Hypofractionated Radiation in Medically Inoperable Non-small Cell Lung Cancer|Pilot Study of the Safety and Feasibility of Administering Concurrent Systemic Chemotherapy With Accelerated Hypofractionated Radiation Therapy in the Treatment of Medically Inoperable T1b and T2 Non-Small Cell Lung Cancer|Recruiting||Early Phase 1|12|Anticipated|State University of New York - Upstate Medical University||1|||f||||f||||||||||2017-10-10 22:41:48.517662|2017-10-10 22:41:48.517662
NCT02619435|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-03-28|||November 2015||2015-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|STREAM||Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer|Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer: a Multicentre, Single-arm, Two-stage, Phase 2 Study|Recruiting||Phase 2|46|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-10-10 22:41:48.655941|2017-10-10 22:41:48.655941
NCT02619422|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2017-04-24|||October 2015||2015-10-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|másPORmenos||More Intensive Cardiac Rehabilitation Programs in Less Time|Multicenter, Prospective, Randomized, Open, Blinded for the End Point Evaluator to Compare Compliance to Secondary Prevention Measures After Acute Coronary Syndrome and Intensive Cardiac Rehabilitation Program vs Standard Program|Active, not recruiting||N/A|509|Actual|Spanish Society of Cardiology||2|||f||||f|f|f||||||||2017-10-10 22:41:48.797722|2017-10-10 22:41:48.797722
NCT02619409|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-11-16|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of the Duration of Bupivacaine Spinal Block in Orthopedic Procedures With and Without Epinephrine Wash|Evaluation of the Duration of Bupivacaine Spinal Block as the Primary Anesthetic for Orthopedic Procedures With and Without Epinephrine Wash|Completed||N/A|30|Actual|Medical University of South Carolina||5|||f||||t||||||||||2017-10-10 22:41:48.914582|2017-10-10 22:41:48.914582
NCT02619396|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-03-22|||January 2016||2016-01-01|March 2017|2017-03-01|March 11, 2017|Actual|2017-03-11|March 11, 2017|Actual|2017-03-11||Interventional|PiLOT-AF||RF Power, LSI and Oesophageal Temperature Alerts During AF Ablation (PiLOT-AF Study)|Radiofrequency Power, Lesion Size Index and Oesophageal Temperature Alerts During Atrial Fibrillation Ablation: A Pilot Study|Completed||N/A|80|Actual|Oxford University Hospitals NHS Trust||4|||f||||f||||||||No||2017-10-10 22:41:49.021737|2017-10-10 22:41:49.021737
NCT02619383|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-29|2015-12-02|||June 2013||2013-06-01|December 2015|2015-12-01||||May 2015|Actual|2015-05-01||Interventional|HBOTED||HBOT Application in Erectile Dysfunction|Hyperbaric Oxygen Can Improve Erectile Dysfunction and Induce Penile Angiogenesis|Completed||Phase 1|37|Actual|Assaf-Harofeh Medical Center||1|||f||||f||||||||||2017-10-10 22:41:49.153408|2017-10-10 22:41:49.153408
NCT02619370|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-03-21|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of an Advance Care Planning Activity: Feasibility Testing for a Randomized Controlled Trial|Evaluation of an Advance Care Planning Activity: Feasibility Testing for a Randomized Controlled Trial|Completed||N/A|34|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-10 22:41:49.26998|2017-10-10 22:41:49.26998
NCT02619357|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-05-12|||September 21, 2015|Actual|2015-09-21|May 2017|2017-05-01|March 16, 2016|Actual|2016-03-16|March 16, 2016|Actual|2016-03-16||Interventional|||Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma|A Method Validation, Single-period, Open-label Evaluation Study to Explore the Sensitivity of a Novel Biosensor Device (SenseWear Armband Gecko) for Measuring Physical Activity in Subjects With COPD & Asthma|Completed||Phase 1|22|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:41:49.37311|2017-10-10 22:41:49.37311
NCT02619331|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-11-28|||February 2008||2008-02-01|November 2015|2015-11-01|September 2011|Actual|2011-09-01|December 2010|Actual|2010-12-01||Interventional|HSL-DI||Evaluation of High Speed Laser Doppler Imaging Technology|Evaluation of High Speed Laser Doppler Imaging Technology to Quantify Skin Prick Tests in Allergic Volunteers|Completed||N/A|50|Actual|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||||2017-10-10 22:41:49.60387|2017-10-10 22:41:49.60387
NCT02619318|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-08-29|||November 2013||2013-11-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2016|Actual|2016-04-01||Interventional|||Balancing Everyday Life - A Lifestyle Intervention for People With Psychiatric Disorders|Balancing Everyday Life - A Lifestyle Intervention for People With Psychiatric Disorders|Active, not recruiting||N/A|240|Anticipated|Lund University||2|||f||||||||||||||2017-10-10 22:41:49.686048|2017-10-10 22:41:49.686048
NCT02619305|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2015-12-01|||November 2015||2015-11-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Social Network Outcomes of a Livelihood Intervention for Impoverished Women in Rural Uganda|Social Network Outcomes of a Livelihood Intervention for Impoverished Women in Rural Uganda: Randomized Controlled Trial|Recruiting||N/A|600|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:41:49.795425|2017-10-10 22:41:49.795425
NCT02619292|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-07-12|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Mindful Movement for Breast Cancer Survivors|Mindful Movement for Breast Cancer Survivors|Completed||N/A|24|Anticipated|John Wayne Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 22:41:49.923184|2017-10-10 22:41:49.923184
NCT02619279|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2015-12-01|||November 2015||2015-11-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Livelihood Intervention for Impoverished Women and Children in Rural Uganda|A Livelihood Intervention for Impoverished Women and Children in Rural Uganda: Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:41:50.040556|2017-10-10 22:41:50.040556
NCT02619266|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-02|||December 2015||2015-12-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cancers|The Traditional Chinese Medicine Department of Xin Qiao Hospital|Recruiting||Phase 2/Phase 3|160|Anticipated|Xinqiao Hospital of Chongqing||3|||f||||t||||||||||2017-10-10 22:41:50.184675|2017-10-10 22:41:50.184675
NCT02619253|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-09-28|||January 14, 2016|Actual|2016-01-14|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma|A Phase I/Ib, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab (MK-3475) in Combination With Vorinostat in Patients With Advanced Renal or Urothelial Cell Carcinoma|Recruiting||Phase 1|42|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 22:41:50.387637|2017-10-10 22:41:50.387637
NCT02619240|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-02-03|||October 2015||2015-10-01|February 2017|2017-02-01||||April 2017|Anticipated|2017-04-01||Observational|||Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB|Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB|Recruiting||N/A|200|Anticipated|Chinese University of Hong Kong|||1||f||||||||||Samples Without DNA|"     bronchoscopic alveolar lavage   "|||2017-10-10 22:41:50.532645|2017-10-10 22:41:50.532645
NCT02619227|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2015-12-01|||November 2015||2015-11-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Livelihood Intervention for Impoverished Women in Rural Uganda|A Livelihood Intervention for Impoverished Women in Rural Uganda: Randomized Controlled Trial|Recruiting||N/A|92|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:41:50.629185|2017-10-10 22:41:50.629185
NCT02619214|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-30|||May 2013||2013-05-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|OSGA||Oxidative Stress Related to 2 Different Oxygen Concentrations During General Anesthesia. Clinical Trial.|Oxidative Stress Related to 2 Different Oxygen Concentrations During General Anesthesia. Clinical Trial.|Recruiting||Phase 4|60|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 22:41:50.730657|2017-10-10 22:41:50.730657
NCT02619201|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-30|||November 2015||2015-11-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Interventional|||Antiemetic Efficacy of Ondansetron Versus Metoclopramide|Comparison of Efficacy of Ondansetron Versus Metoclopramide for Vomiting in Children With Acute Gastroenteritis: Randomized Controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 3|250|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||2|||f||||f||||||||||2017-10-10 22:41:50.868222|2017-10-10 22:41:50.868222
NCT02619188|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-10-04|||September 2015||2015-09-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|May 2017|Anticipated|2017-05-01||Observational|PUQE-M||Nutritional Markers in Normal and Hyperemesis Pregnancies|Pregnancy Unique Questionnaire of Emesis (PUQE) Methode Evaluation; Relation Between Rate of Nausea/Vomiting in Pregnancy (PUQE-score), Self-reported Nutritional Intake and Biochemical Nutritional Markers|Recruiting||N/A|60|Anticipated|Haukeland University Hospital|||2||f||||f||||||||||2017-10-10 22:41:51.006156|2017-10-10 22:41:51.006156
NCT02619175|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-02-10|||November 2015||2015-11-01|February 2017|2017-02-01||||November 2017|Anticipated|2017-11-01||Interventional|||Characteristics of Balance Control to Unexpected Loss of Balance During Standing and Walking in Post-stroke Individuals|Characteristics of Balance Control to Unexpected Loss of Balance During Standing and Walking in Post-stroke Individuals|Recruiting||N/A|60|Anticipated|Loewenstein Hospital||2|||f||||||||||||||2017-10-10 22:41:51.148523|2017-10-10 22:41:51.148523
NCT02619162|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-09-13|||July 2015|Actual|2015-07-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics|Nintedanib Plus Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Phase 0/1 Safety and Pharmacodynamics|Recruiting||Phase 1|22|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III||1|||f||||f||||||||||2017-10-10 22:41:51.255715|2017-10-10 22:41:51.255715
NCT02619149|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-01-03|||March 2009||2009-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AVAC||Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis|Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis|Recruiting||Phase 3|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:41:51.384609|2017-10-10 22:41:51.384609
NCT02619136|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2015-11-30|||February 2016||2016-02-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|MINT||Myocardial Ischemia and Transfusion|Myocardial Ischemia and Transfusion: A Pilot, Multi-centre, Open-label Randomized Controlled Trial of Two Commonly Used Transfusion Strategies in Patients With Myocardial Infarction.|Not yet recruiting||N/A|60|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-10 22:41:51.500727|2017-10-10 22:41:51.500727
NCT02619123|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-02-09|||January 2013||2013-01-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|TBST||Tailored Screening for Breast Cancer in Premenopausal Women|Tailored Screening for Breast Cancer in Premenopausal Women. A Translational, Randomized Population-based Trial|Recruiting||N/A|33200|Anticipated|Cancer Prevention and Research Institute, Italy||2|||f||||f||||||||||2017-10-10 22:41:51.599832|2017-10-10 22:41:51.599832
NCT02619110|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-29|||February 2014||2014-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Backward Walking Treadmill Training on Balance in Patient With Chronic Stroke|The Purpose of This Study Was to Discuss on the Effects of Backward Walking Treadmill Training on Balance Ability, Speed of Walking and Cardiopulmonary Fitness for Patient With Chronic Stroke|Completed||N/A|30|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:41:51.706947|2017-10-10 22:41:51.706947
NCT02619097|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-29|||June 2014||2014-06-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes|Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes|Recruiting||Phase 1|24|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||5|||f||||f||||||||||2017-10-10 22:41:51.806715|2017-10-10 22:41:51.806715
NCT02619084|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-02-22|||December 2011||2011-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|STN-DBSinTS||Subthalamic Stimulation in Tourette's Syndrome|Subthalamic Nucleus Deep Brain Stimulation in Tourette's Syndrome|Completed||Phase 2|10|Actual|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta||2|||f||||f||||||||||2017-10-10 22:41:51.922537|2017-10-10 22:41:51.922537
NCT02619071|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2016-06-27|||August 2015||2015-08-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CeGAL||ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia|ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia- CeGAL-IPC 2014-012|Recruiting||N/A|87|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 22:41:52.073473|2017-10-10 22:41:52.073473
NCT02619058|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-12-02|||October 2015||2015-10-01|December 2015|2015-12-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients|An Open Label, Dose Escalation, Phase I Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients|Recruiting||Phase 1|20|Anticipated|Beijing Cancer Hospital||3|||f||||t||||||||||2017-10-10 22:41:52.178259|2017-10-10 22:41:52.178259
NCT02619045|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-30|2017-08-07|||November 9, 2015|Actual|2015-11-09|August 2017|2017-08-01|January 30, 2019|Anticipated|2019-01-30|January 30, 2019|Anticipated|2019-01-30||Interventional|EVAL'COACH||Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment|Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment, in Their Quality of Life and Medico-economic Analysis of This Follow-up Program Device|Active, not recruiting||N/A|200|Actual|Institut Claudius Regaud||1|||f||||f||||||||||2017-10-10 22:41:52.275362|2017-10-10 22:41:52.275362
NCT02619032|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-30|||October 2005||2005-10-01|November 2015|2015-11-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|REFEDS||Remifentanil and Fentanyl in Dental Surgery (REFEDS)|Remifentanil vs Fentanyl During Day Case Dental Surgery in Persons With Special Needs: a Comparative Study of Their Effect on Stress Response and Postoperative Pain|Completed||N/A|46|Actual|Attikon Hospital||2|||f||||f||||||||||2017-10-10 22:41:52.348287|2017-10-10 22:41:52.348287
NCT02619019|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-09-13|||November 2015||2015-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Spinal Dexamethasone During Transuretheral Prostatectomy|Intrathecal Dexamethasone in Patients Undergoing Transuretheral Prostatectomy.|Completed||Phase 2|90|Actual|Assiut University||3|||f||||f||||||||||2017-10-10 22:41:52.447004|2017-10-10 22:41:52.447004
NCT02619006|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-05-02|||November 2015||2015-11-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Observational|||Infant Brain Study Follow-Up at 3 and 4 Years of Age|Effects of Placental Transfusion on Early Brain Development in Infants Born at Term: Follow-Up at 3 & 4 Years of Age|Enrolling by invitation||N/A|100|Anticipated|University of Rhode Island|||2||f||||f||||||||Undecided||2017-10-10 22:41:52.566536|2017-10-10 22:41:52.566536
NCT02618993|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-11-17|||December 2015||2015-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of the Bilateral Mandibular Nerve Block (V3) in Mandibular Osteotomy|Effects of the Bilateral Mandibular Nerve Block (V3) in Mandibular Osteotomy: a Prospective, Randomized, Double-blind Versus Placebo Study|Recruiting||Phase 3|104|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 22:41:52.656815|2017-10-10 22:41:52.656815
NCT02618980|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2017-08-07|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Early Endoscopy for Acute Upper Gastrointestinal Bleeding in Acute Coronary Syndrome Patients|Management of Acute Upper Gastrointestinal Bleeding in Recent Acute Coronary Syndrome Patients by Early Endoscopy and Non-Endoscopy Treatment: A Randomized Controlled Trial to Evaluate Efficacy and Safety|Recruiting||N/A|70|Anticipated|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:41:52.959804|2017-10-10 22:41:52.959804
NCT02618967|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-08-24|||March 28, 2016|Actual|2016-03-28|August 2017|2017-08-01|November 3, 2017|Anticipated|2017-11-03|November 3, 2017|Anticipated|2017-11-03||Interventional|||Single Ascending Dose Study of AMG 570 in Healthy Subjects|A Randomized, Double Blind Placebo Controlled, First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Subcutaneous Doses of AMG 570 in Healthy Subjects|Active, not recruiting||Phase 1|48|Actual|Amgen||2|||f||||f||||||||||2017-10-10 22:41:53.066411|2017-10-10 22:41:53.066411
NCT02618954|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-27|||October 2013||2013-10-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|SONORE||Role of Ultrasound for Evaluating Rheumatoid Arthritis in Remission|Value of Ultrasound for Evaluating Rheumatoid Arthritis in Remission: Longitudinal Study|Recruiting||N/A|110|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 22:41:53.200536|2017-10-10 22:41:53.200536
NCT02618590|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2016-03-15|||June 2015||2015-06-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure|Which Treatment Strategy is Best in Non-small Cell Lung Cancer Patients Harboring EGFR Mutant Type After First/Second Line EGFR-TKI Failure, a Retrospective Study|Recruiting||N/A|800|Anticipated|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 22:41:57.042475|2017-10-10 22:41:57.042475
NCT02618941|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-06-02|||February 2, 2016|Actual|2016-02-02|June 2017|2017-06-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA)|Phase IB Follow-up, Controlled, Parallel Group, Single-center Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety/Tolerability, Immunological and Clinical Activity in Patients Who Have Participated in the AFF008 Program|Completed||Phase 1|26|Actual|Affiris AG||2|||f||||t||||||||||2017-10-10 22:41:53.307968|2017-10-10 22:41:53.307968
NCT02618928|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-07-07|||December 15, 2015||2015-12-15|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|OPALE||The Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in France|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in France|Active, not recruiting||N/A|700|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:41:53.411324|2017-10-10 22:41:53.411324
NCT02618915|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-05-10|||November 2015||2015-11-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B|Phase I/II Open-Label Safety and Dose Finding Study of Adeno-Associated Virus (AAV) rh10-Mediated Gene Transfer of Human Factor IX in Adults With Moderate/Severe to Severe Hemophilia B|Active, not recruiting||Phase 1/Phase 2|12|Anticipated|Dimension Therapeutics||4|||f||||t||||||||||2017-10-10 22:41:53.652379|2017-10-10 22:41:53.652379
NCT02618902|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-12-01|||February 2016||2016-02-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MS tolDC||"A NegativeDendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial"|"A NegativeDendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial"|Not yet recruiting||Phase 1|9|Anticipated|University Hospital, Antwerp||1|||f||||t||||||||||2017-10-10 22:41:53.779883|2017-10-10 22:41:53.779883
NCT02618889|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-05-19|||January 2016||2016-01-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||OnabotulinumtoxinA in the Management of Psychogenic Dystonia|OnabotulinumtoxinA in the Management of Psychogenic Dystonia|Recruiting||Phase 4|18|Anticipated|University of Cincinnati||2|||f||||f||||||||No||2017-10-10 22:41:53.869259|2017-10-10 22:41:53.869259
NCT02618876|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-01-24|||November 2015||2015-11-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Caudal Nalbuphine on Postoperative Analgesia in Children|Nalbuphine as an Adjuvant to Caudal Bupivacaine for Postoperative Analgesia in Children Undergoing Inguinal Hernia Repair|Recruiting||N/A|60|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 22:41:53.97357|2017-10-10 22:41:53.97357
NCT02618863|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-02-15|||December 2015||2015-12-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||The Cricoid Force Necessary to Occlude the Esophageal Entrance: Is There a Gender Difference?|The Cricoid Force Necessary to Occlude the Esophageal Entrance: Is There a Gender Difference?|Enrolling by invitation||N/A|60|Anticipated|Procare Riaya Hospital||2|||f||||f||||||||||2017-10-10 22:41:54.082607|2017-10-10 22:41:54.082607
NCT02618850|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-03-28|||April 2014||2014-04-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|PETRA2 - CRC||PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment|Study of the Role of Metabolic Response Measured by PET/CT Scan After 1 Cycle of First-line Therapy in Patients With Advanced Colorectal Cancer (CRC)|Recruiting||N/A|260|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-10-10 22:41:54.172861|2017-10-10 22:41:54.172861
NCT02618837|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-01-18|||December 2015||2015-12-01|January 2016|2016-01-01|November 2018|Anticipated|2018-11-01|March 2017|Anticipated|2017-03-01||Interventional|DUBIUS||Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers|Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers In Non ST Elevated acUte Coronary Syndromes With Initial Invasive Indication|Recruiting||Phase 4|2520|Anticipated|University of Padova||2|||f||||||||||||||2017-10-10 22:41:54.273856|2017-10-10 22:41:54.273856
NCT02618824|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-02-17|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Role of Terminal Warm Blood Cardioplegia as Myocardial Protection in the Use of Histidine-Tryptophan-Ketoglutarate Cardioplegia in Complex Congenital Heart Surgery|Role of Terminal Warm Blood Cardioplegia as Myocardial Protection in the Use of Histidine-Tryptophan-Ketoglutarate Cardioplegia in Complex Congenital Heart Surgery|Recruiting||Phase 2|110|Anticipated|National Cardiovascular Center Harapan Kita Hospital Indonesia||2|||f||||t||||||||||2017-10-10 22:41:54.393118|2017-10-10 22:41:54.393118
NCT02618811|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2015-11-28|||January 2014||2014-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|||ERAS in Colorectal Surgery Diminishes the Negative Impact of Sarcopenia on Short Term Outcomes|Enhanced Recovery After Surgery Protocol (ERAS) in Colorectal Surgery Diminishes the Negative Impact of Sarcopenia on Short Term Outcomes|Completed||N/A|171|Actual|Jagiellonian University|||4||f||||f||||||||||2017-10-10 22:41:54.506275|2017-10-10 22:41:54.506275
NCT02618798|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-30|||January 2014||2014-01-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Hepatic Venous Pressure Gradient and Platelet Activation in Chronic Liver Disease|Association of Hepatic Venous Pressure Gradient With Platelet Activation in Chronic Liver Disease|Recruiting||N/A|100|Anticipated|Medical University of Vienna|||1||f||||f||||||Samples With DNA|"     Serum Plasma Platelet pellet   "|||2017-10-10 22:41:54.606139|2017-10-10 22:41:54.606139
NCT02618785|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2017-04-16|||June 2016||2016-06-01|November 2016|2016-11-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Antispasmodic Drug for Diagnosis Proximal Tubal Occlusion on Hysterosalpingography|The Effect of Premedication Hyoscine-N-butylbromide Before Hysterosalpingography for Diagnosis of Proximal Tubal Obstruction in Infertile Women : A Randomized Double-Blind Controlled Trial|Completed||N/A|146|Actual|Mahidol University||2|||f||||t||||||||No||2017-10-10 22:41:54.709194|2017-10-10 22:41:54.709194
NCT02618382|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-12-12|||November 2015||2015-11-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population||Recruiting||Phase 4|50|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||1|||f||||t||||||||||2017-10-10 22:41:59.171469|2017-10-10 22:41:59.171469
NCT02618772|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-09-05|2016-06-19||January 2010||2010-01-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional||Study Population: Children 2-12 years old who presented to the Montreal Children's Hospital Emergency Department with a laceration requiring repair with sutures under local analgesia (local injection of lidocaine).|Intranasal Midazolam for Treatment of Anxiety in Children Undergoing Suturing in the Pediatric Emergency Department|Atomized Intranasal Midazolam for Anxiolysis and Facilitation of Laceration Repair in the Pediatric Emergency Department: A Randomized Controlled Trial|Completed||Phase 4|79|Actual|McGill University Health Center||2|||f||||t||||||||||2017-10-10 22:41:54.839797|2017-10-10 22:41:54.839797
NCT02618759|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-05-03|||August 28, 2015|Actual|2015-08-28|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis|Active, not recruiting||Phase 3|120|Actual|Taro Pharmaceuticals USA||2|||f||||f||||||||No||2017-10-10 22:41:55.833741|2017-10-10 22:41:55.833741
NCT02618746|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2016-10-18|||December 2013||2013-12-01|March 2016|2016-03-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|TELECARE||Home Rehabilitation Via Telemonitoring in Patients With COPD|Home Rehabilitation Via Telemonitoring of Vital Signs to Prevent Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|150|Actual|Thorax Research Foundation||3|||f||||f||||||||||2017-10-10 22:41:55.920315|2017-10-10 22:41:55.920315
NCT02618733|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-27|||December 2014||2014-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|PLEIO||Comparing Ticagrelor Versus Clopidogrel on Microcirculation|A Prospective Randomized Controlled Clinical Trial of Comparing ticagreLor Versus clopidogrEl on mIcrocirculation in Patients With Acute cOronary Syndrome Study|Recruiting||N/A|120|Anticipated|Dong-A University||2|||f||||t||||||||||2017-10-10 22:41:56.005991|2017-10-10 22:41:56.005991
NCT02618720|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-07-25|||May 2016||2016-05-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|COMBINE||Intravenous Versus Combined Oral and Intravenous Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Elective Colorectal Surgery|Intravenous Versus Combined Oral and Intravenous Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Elective Colorectal Surgery: A Double-blinded Multicenter Prospective Randomized Controlled Trial|Recruiting||Phase 3|920|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:41:56.101336|2017-10-10 22:41:56.101336
NCT02618707|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2016-03-04|||December 2015||2015-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|4 Days|Observational [Patient Registry]|||Lactate Levels During Cardiopulmonary Bypass in Pediatric Patients|Changes of Lactate Levels During Cardiopulmonary Bypass in Pediatric Undergoing Cardiac Surgery: Possible Early Marker of Morbidity and Mortality|Completed||N/A|40|Actual|Assiut University|||1||f||||t||||||||||2017-10-10 22:41:56.198948|2017-10-10 22:41:56.198948
NCT02618694|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2017-03-01|||April 2015||2015-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|PostLapAdrnl||Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study|Posterior Retroperitoneoscopic Approach Versus Transperitoneal Laparoscopic Approach in Management of Adrenal Tumors: A Randomized Comparative Study|Completed||N/A|13|Actual|Suez Canal University||2|||f||||f||||||||Undecided||2017-10-10 22:41:56.275747|2017-10-10 22:41:56.275747
NCT02618681|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-07|||June 2015||2015-06-01|December 2015|2015-12-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|ELC-CHN||Earlobe Creases Predict Prognosis in Chinese Patients With Acute Myocardial Infarction|Earlobe Creases Predict Prognosis in Chinese Patients With Acute Myocardial Infarction|Recruiting||N/A|902|Anticipated|Liaoning University of Traditional Chinese Medicine|||2||f||||f||||||||||2017-10-10 22:41:56.393281|2017-10-10 22:41:56.393281
NCT02618668|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-07-31|||November 2015||2015-11-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|Assiutu||"Haemodynamic Stability of Ketamine/Propofol Admixture Ketofol in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography"|"Haemodynamic Stability of Ketamine / Propofol Admixture Ketofol in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography"|Recruiting||Phase 2|90|Anticipated|Assiut University||2|||f||||||||||||||2017-10-10 22:41:56.475503|2017-10-10 22:41:56.475503
NCT02618655|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-28|2016-07-23|||March 2015||2015-03-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|2 Weeks|Observational [Patient Registry]|||Clinical Research for the Diagnosis of Tick-borne Diseases in Patients With Unexplained Acute Fever|Clinical Research for the Diagnosis of Tick-borne Diseases in Patients With Unexplained Acute Fever|Recruiting||N/A|200|Anticipated|Beijing Friendship Hospital|||1||f||||t||||||Samples With DNA|"     whole blood, serum   "|Yes||2017-10-10 22:41:56.566819|2017-10-10 22:41:56.566819
NCT02618642|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-12-29|||February 2016||2016-02-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||The Use of i/t Curve in Assessment of Phototherapy Effects|The Use of i/t Curve in Assessment of Effects of Biceps Brachi Phototherapy With PILER Light|Not yet recruiting||N/A|50|Anticipated|University of Rzeszow||3|||f||||f||||||||||2017-10-10 22:41:56.66091|2017-10-10 22:41:56.66091
NCT02618629|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-09-21|||January 2016||2016-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Mass Balance and Metabolism Study of 14C-Z-215|A Phase I Mass Balance and Metabolism Study of 14C-Z-215 in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Zeria Pharmaceutical||1|||f||||f||||||||||2017-10-10 22:41:56.740649|2017-10-10 22:41:56.740649
NCT02618616|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-07-14|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis|Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Determine the Efficacy, Safety and Tolerability of Once Daily Oral ZPL-3893787 (30mg) Administered for 12 Weeks in Adults With Moderate to Severe Plaque Psoriasis.|Completed||Phase 2|129|Actual|Ziarco Pharma Ltd||2|||f||||f||||||||||2017-10-10 22:41:56.820084|2017-10-10 22:41:56.820084
NCT02618603|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-11-27|||February 2016||2016-02-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Botulinum Toxin A for Shoulder Pain After Stroke|The Effectiveness of Ultrasound Guided Sub-acromial Bursa Injection With Botulinum Toxin A in for Refractory Shoulder Pain After Stroke.|Not yet recruiting||Phase 4|50|Anticipated|Sir Run Run Shaw Hospital||2|||f||||f||||||||||2017-10-10 22:41:56.946101|2017-10-10 22:41:56.946101
NCT02618577|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-09-01|||February 2016||2016-02-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|NOAH||Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes|Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes - An Investigator-driven, Prospective, Randomised, Double-blind, Multi-centre Trial Initiated by the European Society of Cardiology and AFNET|Recruiting||Phase 3|3400|Anticipated|German Atrial Fibrillation Network||2|||f||||t||||||||||2017-10-10 22:41:57.110592|2017-10-10 22:41:57.110592
NCT02618564|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2017-02-14|||December 2015||2015-12-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Use of Sennosides With Pico Salax in Bowel Preparation for Colonoscopy: a Study of Optimal Dose and Timing|The Use of Sennosides With Pico Salax in Bowel Preparation for Colonoscopy: a Study of Optimal Dose and Timing|Active, not recruiting||N/A|100|Actual|Queen's University||5|||f||||t||||||||No||2017-10-10 22:41:57.205653|2017-10-10 22:41:57.205653
NCT02618551|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2015-11-26|||November 2015||2015-11-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|HEAT-SA||Bronchial Thermoplasty for Severe Asthma With Dynamic Hyperinflation|Evaluation of the Efficiency of Bronchial Thermoplasty on Dynamic Hyperinflation in Uncontrolled Severe Asthma|Recruiting||N/A|15|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-10 22:41:57.439011|2017-10-10 22:41:57.439011
NCT02618538|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-01-30|||July 2015||2015-07-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.|Predictive Value of Combined Criteria to Tailor Breast Cancer Screening and New Opportunities From Circulating Markers. The Andromeda Study.|Enrolling by invitation||N/A|22000|Anticipated|Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-10 22:41:57.579355|2017-10-10 22:41:57.579355
NCT02618525|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-28|||June 2014||2014-06-01|December 2015|2015-12-01||||July 2015|Actual|2015-07-01||Interventional|||Supraorbital Pressure Versus Jaw Thrust for Assessing the Adequate Depth of Anesthesia for LMA Insertion in Children|Comparison of the Supraorbital Pressure and Jaw Thrust as Indicators for Depth of Anesthesia for Laryngeal Mask Airway Insertion in Children|Completed||N/A|50|Actual|B.P. Koirala Institute of Health Sciences||2|||f||||t||||||||||2017-10-10 22:41:57.731878|2017-10-10 22:41:57.731878
NCT02618499|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-11-22|||May 2016||2016-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Delayed Cord Clamping and Use of Oxytocin|Is Placental Transfusion Influenced by the Early Administration of Oxytocin?|Terminated||Phase 3|180|Actual|Fundacion para la Salud Materno Infantil||2||Futility suggested by DSMC|f||||t||||||||No||2017-10-10 22:41:57.931686|2017-10-10 22:41:57.931686
NCT02618486|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-26|||September 2014||2014-09-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|EONSPT||The Effects of Obesity on Non Surgical Periodontal Therapy|The Effects of Obesity on Non Surgical Periodontal Therapy|Completed||N/A|60|Actual|University of Malaya||2|||f||||t||||||||||2017-10-10 22:41:58.078498|2017-10-10 22:41:58.078498
NCT02618473|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-12-03|||January 2013||2013-01-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Snapshot Freeze on Cardiac CT Image Quality|Impact of a Motion Correction Algorithm on Image Quality and Diagnostic Utility in Patients Undergoing CT Angiography: A Randomized Controlled Trial|Completed||N/A|140|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-10 22:41:58.203861|2017-10-10 22:41:58.203861
NCT02618460|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-01-27|||January 2015||2015-01-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Renal NCE-MRI in Healthy Volunteers|Non-contrast Enhanced MR Imaging of the Kidney in Healthy Volunteers|Completed||N/A|16|Actual|Mario Negri Institute for Pharmacological Research||1|||f||||f||||||||||2017-10-10 22:41:58.309332|2017-10-10 22:41:58.309332
NCT02618447|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-04-05|||August 5, 2014|Actual|2014-08-05|April 2017|2017-04-01|February 4, 2016|Actual|2016-02-04|February 4, 2016|Actual|2016-02-04||Interventional|||4D Phase Contrast MR: Hypertrophy in Liver Cancer|4D Phase Contrast MR: Validation and Evaluation of Hypertrophy in Liver Cancer|Terminated||N/A|10|Actual|Washington University School of Medicine||1||Insufficient funding|f||||t|f|t|f|f|f|||No||2017-10-10 22:41:58.40976|2017-10-10 22:41:58.40976
NCT02618434|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-07-13|||March 2015||2015-03-01|July 2017|2017-07-01||||May 2018|Anticipated|2018-05-01||Interventional|||Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)||Recruiting||Phase 3|291|Anticipated|Supernus Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:41:58.538336|2017-10-10 22:41:58.538336
NCT02618421|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-08-22|||June 2015||2015-06-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|July 2015|Actual|2015-07-01||Observational|||A Cross-sectional Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS)|A Cross-sectional Population Representative Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS) in China, Taiwan and South Korea|Completed||N/A|8284|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 22:41:58.776047|2017-10-10 22:41:58.776047
NCT02618408|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-07-13|||January 2016||2016-01-01|July 2017|2017-07-01||||March 2018|Anticipated|2018-03-01||Interventional|||Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)||Recruiting||Phase 3|291|Anticipated|Supernus Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:41:58.86207|2017-10-10 22:41:58.86207
NCT02618395|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-10-20|||December 2015||2015-12-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Bioavailability Study of SPARC001 in Healthy Adult Volunteers||Completed||Phase 1|18|Actual|Sun Pharma Advanced Research Company Limited||3|||f||||f||||||||||2017-10-10 22:41:59.071575|2017-10-10 22:41:59.071575
NCT02618369|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-10-13|||April 2014||2014-04-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||MR-Guided High Intensity Focused Ultrasound for Pain Management Of Osteoid Osteoma & Benign Bone Tumors in Children and Adults|Magnetic Resonance-Guided High Intensity Focused Ultrasound for Pain Management of Osteoid Osteoma and Benign Bone Tumors in Children and Young Adults|Recruiting||N/A|10|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||No||2017-10-10 22:41:59.291365|2017-10-10 22:41:59.291365
NCT02618356|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-09-29|||December 25, 2015||2015-12-25|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer|A Phase II Clinical Study of Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer Failed of Standard Chemotherapy|Recruiting||Phase 2|82|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-10 22:41:59.392215|2017-10-10 22:41:59.392215
NCT02618343|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-03-27|||July 2016||2016-07-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron|A Randomized Control Equivalence Study of Emergency Medical Services Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron for Treatment of Pre-hospital Nausea|Recruiting||N/A|400|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 22:41:59.492715|2017-10-10 22:41:59.492715
NCT02618330|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-30|||July 2013||2013-07-01|November 2015|2015-11-01||||June 2015|Actual|2015-06-01||Interventional|||The Clinical Evaluation of Two Different Film Thicknesses of Clear Overlay Retainer.||Completed||N/A|80|Actual|Sichuan University||2|||f||||||||||||||2017-10-10 22:41:59.590739|2017-10-10 22:41:59.590739
NCT02618317|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-11-30|||July 2013||2013-07-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|CLOCK||Comparison of Effectiveness and Safety of Three Lock Solutions for Long-Term Central Venous Catheter for Hemodialysis|Comparison of Effectiveness and Safety of Three Lock Solutions for Long-Term Central Venous Catheter for Hemodialysis|Completed||Phase 4|75|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 22:41:59.665095|2017-10-10 22:41:59.665095
NCT02618304|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-27|||November 2015||2015-11-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction||Recruiting||N/A|50|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 22:41:59.775118|2017-10-10 22:41:59.775118
NCT02618291|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-07-17|||June 2016||2016-06-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|AGE3||Efficacy of an Active Geriatric Evaluation for Geriatric Syndromes to Prevent Functional Decline in Family Medicine|Efficacy of a an Active Geriatric Evaluation (AGE Tool) for Geriatric Syndromes to Prevent Functional Decline in Elderly Patients in Family Medicine: a Pragmatic Cluster Randomized Trial|Recruiting||Phase 3|792|Anticipated|University of Lausanne||2|||f||||f||||||||||2017-10-10 22:41:59.878041|2017-10-10 22:41:59.878041
NCT02618278|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-11-09|||February 2016||2016-02-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|POLAR||Physiotherapy for Sciatica; Is Earlier Better?|Physiotherapy Management of Lumbar Radicular Syndrome; Does Early Intervention Improve Outcomes?|Completed||Phase 3|80|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:41:59.992895|2017-10-10 22:41:59.992895
NCT02618265|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-11-27|||January 2016||2016-01-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Mobile Terminal Based Management of Stroke Secondary Prevention Adminstration Effect Research|Mobile Terminal Based Management and Platelet Reactivity Modified Drug Regulation of Stroke Secondary Prevention|Not yet recruiting||N/A|400|Anticipated|Peking University Third Hospital||3|||f||||f||||||||||2017-10-10 22:42:00.099706|2017-10-10 22:42:00.099706
NCT02618252|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-10-24|||August 2016||2016-08-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Ultrasound vs Veinviewer in Patients With Difficulty IV Access|Preventing Delay of Care in Patient With Difficult IV Access: A Randomized Trial of ED Intervention|Recruiting||N/A|216|Anticipated|University of Maryland||2|||f||||f||||||||||2017-10-10 22:42:00.219639|2017-10-10 22:42:00.219639
NCT02618239|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-26|||November 2013||2013-11-01|November 2013|2013-11-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Prebiotics on Intestinal Gas Production, Microbiota and Digestive Symptoms|Effect of Prebiotics on Intestinal Gas Production, Microbiota and Digestive Symptoms|Completed||N/A|20|Actual|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||f||||||||||2017-10-10 22:42:00.342144|2017-10-10 22:42:00.342144
NCT02618226|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-06-02|||January 2016||2016-01-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|ONUS-TBI||Optic Nerve Ultrasound in Severe Traumatic Injury|Diagnostic Accuracy of Optic Nerve Ultrasound for the Detection of Intracranial Hypertension and Prediction of Therapeutic Intensity Level and Mortality Following Severe Traumatic Brain Injury (ONUS-TBI): a Prospective Blinded Study|Recruiting||N/A|250|Anticipated|University of Michigan||1|||f||||t||||||||Undecided||2017-10-10 22:42:00.417999|2017-10-10 22:42:00.417999
NCT02618213|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-08-23|||December 2015||2015-12-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.|Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.|Recruiting||Phase 4|48|Anticipated|Hospital of South West Denmark||2|||f||||f||||||||||2017-10-10 22:42:00.534655|2017-10-10 22:42:00.534655
NCT02618200|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2017-08-08|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Echo-CAD||Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer|Creation of a Multimodality Image Database (MRI + Ultrasound) for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:42:00.642302|2017-10-10 22:42:00.642302
NCT02618187|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-09-02|||December 2015||2015-12-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Ulcerative Colitis|A Phase 1B Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis|Recruiting||Phase 1|55|Anticipated|Seres Therapeutics, Inc.||4|||f||||t||||||||||2017-10-10 22:42:00.724566|2017-10-10 22:42:00.724566
NCT02618174|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-27|||October 2013||2013-10-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Enhanced Broccoli Consumption After a Liking Norm and Vegetable Variety Message: Effects After a 24 Hour Delay.|Enhanced Broccoli Consumption After a Liking Norm and Vegetable Variety Message: Effects After a 24 Hour Delay.|Completed||N/A|400|Actual|University of Birmingham||5|||f||||f||||||||||2017-10-10 22:42:00.955803|2017-10-10 22:42:00.955803
NCT02618161|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-04-25|||September 2014||2014-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|THEPCA||Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment|A Randomised Feasibility Trial to Investigate the Timing of HDR Brachytherapy With EBRT in Intermediate and High Risk Localised Prostate CAncer Patients and Its Effects on Toxicity and Quality of Life|Recruiting||N/A|100|Anticipated|Southend University Hospital Foundation NHS Trust||2|||f||||t||||||||||2017-10-10 22:42:01.054151|2017-10-10 22:42:01.054151
NCT02618148|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2015-12-01|||January 2009||2009-01-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|WH||Hormone Estradiol Replacement Therapy Additional Herbals|The Natural Ingredients and Artificial Made Ready, a Good Combination Reduced the Risk of Thrombosis, Concerns With Their Use of HRT|Completed||Phase 4|2|Actual|Triệu, Nguyễn Thị, M.D.||2|||f||||t||||||||||2017-10-10 22:42:01.197287|2017-10-10 22:42:01.197287
NCT02618135|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-31|||May 2016||2016-05-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|August 2017|Anticipated|2017-08-01||Interventional|ASDBCI||Brain-Computer Interface-based Programme for the Treatment of ASD/ADHD|Effectiveness of a Brain-Computer Interface-based Programme for the Treatment of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder in Children: A Pilot Study|Recruiting||N/A|20|Anticipated|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-10 22:42:01.317199|2017-10-10 22:42:01.317199
NCT02618122|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-01-17|||December 2015||2015-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|beYOND-STS||A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece|A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and the Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in Advanced Soft Tissue Sarcomas in a Real World Setting in Greece. The 'beYOND-STS' Study|Recruiting||N/A|100|Anticipated|Genesis Pharma S.A.|||1||f||||f||||||||||2017-10-10 22:42:01.45174|2017-10-10 22:42:01.45174
NCT02618109|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-04-12|||January 2016||2016-01-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|LABMI||Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia|Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia|Recruiting||Phase 4|120|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 22:42:01.522051|2017-10-10 22:42:01.522051
NCT02618096|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-10-12|||October 2015||2015-10-01|October 2016|2016-10-01||||November 2018|Anticipated|2018-11-01||Interventional|||Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Multiparous Women at Term||Recruiting||N/A|154|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:42:01.652983|2017-10-10 22:42:01.652983
NCT02618083|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-07-26|||December 28, 2015|Actual|2015-12-28|November 2016|2016-11-01|January 28, 2019|Anticipated|2019-01-28|January 28, 2019|Anticipated|2019-01-28||Interventional|CRADO-RED||Prognostic Value of Hemodynamic Disturbances in Rhegmatogenous Retinal Detachment (CRADO-RED)|Prognostic Value of Hemodynamic Disturbances of the Central Retinal Artery in Color Doppler Ultrasound in Rhegmatogenous Retinal Detachment|Recruiting||N/A|150|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||f||||||||||2017-10-10 22:42:01.780314|2017-10-10 22:42:01.780314
NCT02618070|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-04-05|||March 2016||2016-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Cognitive Modulation of Dyspeptic Symptom During Food Ingestion in Functional Dyspepsia Patients Cognitive Modulation||Completed||N/A|30|Anticipated|University Hospital Tuebingen||2|||f||||||||||||||2017-10-10 22:42:01.864948|2017-10-10 22:42:01.864948
NCT02618057|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-10-12|||June 2016||2016-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia|Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia With Lobar Consolidation or Pleural Effusion in Children|Recruiting||Phase 4|80|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:42:03.572656|2017-10-10 22:42:03.572656
NCT02618044|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-12-02|||May 2006||2006-05-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Observational|||Laparoscopic Roux-en-Y Gastric Bypass and Gastro-esophageal Reflux|Long Term Effects of Laparoscopic Roux-en-Y Gastric Bypass on Gastro-esophageal Reflux: Clinical Impact of Weakly Acidic Reflux|Completed||N/A|86|Actual|University of Turin, Italy|||2||f||||f||||||||||2017-10-10 22:42:03.674361|2017-10-10 22:42:03.674361
NCT02618031|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-08-09|||March 2016||2016-03-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|||The Capillary Index Score Trial|The Capillary Index Score Trial: Phase I|Enrolling by invitation||N/A|54|Anticipated|Akron General Medical Center|||2||f||||t||||||||||2017-10-10 22:42:03.770014|2017-10-10 22:42:03.770014
NCT02618018|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-11-25|||September 2015||2015-09-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Evaluation of Efficacy and Stability of AT TORBI 709M 4-haptic Toric IOL in Cataract Surgery|An Investigator-Initiated Trials on the Efficacy and Stability of AT TORBI 709M 4-haptic Toric IOL in Cataract Surgery|Recruiting||N/A|20|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 22:42:03.902262|2017-10-10 22:42:03.902262
NCT02618005|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2016-07-21|||October 2015||2015-10-01|July 2016|2016-07-01||||March 2020|Anticipated|2020-03-01||Interventional|||Probiotics on Immune Function and Intestinal Microbiota in Astronauts Under Closed Microgravity Environment|Study for Evaluating the Impact of Continuous Consumption of Probiotics on Immune Function and Intestinal Microbiota in Astronauts Under Closed Microgravity Environment|Recruiting||N/A|10|Anticipated|Yakult Honsha Co., LTD||2|||f||||f||||||||||2017-10-10 22:42:04.029421|2017-10-10 22:42:04.029421
NCT02617992|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2017-07-09|||September 2013||2013-09-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|SANT||Systematic Wide-Field EMR Scar Assessment and Therapy Audit|Systematic Wide-Field EMR Scar Assessment and Therapy Audit|Completed||N/A|200|Actual|Western Sydney Local Health District|||1||f||||t||||||||||2017-10-10 22:42:04.140003|2017-10-10 22:42:04.140003
NCT02617979|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-02-22|||July 20, 2016|Actual|2016-07-20|February 2017|2017-02-01|January 31, 2019|Anticipated|2019-01-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement|Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement|Recruiting||N/A|225|Anticipated|Washington University School of Medicine||2|||f||||f|f|f||||||No||2017-10-10 22:42:04.228642|2017-10-10 22:42:04.228642
NCT02617953|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-16|||September 2015||2015-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus|Variable Changes in Continuous Resting EEG(Electroencephalography) and Auditory ERP(Event-related Potential) Before and After Transcranial Magnetic Stimulation Treatment; Double Blind Randomized Controll Trails|Enrolling by invitation||N/A|80|Anticipated|Seoul National University Hospital||3|||f||||t||||||||No||2017-10-10 22:42:04.430849|2017-10-10 22:42:04.430849
NCT02617940|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-05-03|||May 2015||2015-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|SLM1661||Efficacy of Sealants in Cavitated Enamel Lesions on Occlusal Surfaces in Children|Effectiveness of Sealants in Cavitated Enamel Lesions on Occlusal Surfaces of Primary and Permanent Molars in Children|Completed||N/A|546|Actual|Faculty Sao Leopoldo Mandic Campinas||2|||f||||f||||||||||2017-10-10 22:42:04.553977|2017-10-10 22:42:04.553977
NCT02617927|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-10-13|||October 2015||2015-10-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|March 2021|Anticipated|2021-03-01|1 Year|Observational [Patient Registry]|||The Safety Assessment of Vedolizumab During Pregnancy in IBD Patient|The Safety Assessment of Vedolizumab During Pregnancy in IBD Patient|Recruiting||N/A|200|Anticipated|Shaare Zedek Medical Center|||3||f||||f||||||Samples Without DNA|"     Blood, Stool, Urine & Spit   "|||2017-10-10 22:42:04.848721|2017-10-10 22:42:04.848721
NCT02617914|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-04-24|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|ENCODE||Hemodynamic and Cardiac Effects of Individualized PEEP Titration Using Esophageal Pressure Measurements in ARDS Patients|Hemodynamic and Cardiac Effects of Individualized PEEP Titration Using Esophageal Pressure Measurements in ARDS Patients|Withdrawn||N/A|0|Actual|RWTH Aachen University|||1|No approval from EC obtained. More details for study were required by EC.|f||||f||||||||||2017-10-10 22:42:05.015427|2017-10-10 22:42:05.015427
NCT02617888|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-06-12|2016-11-18||March 2011||2011-03-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells|The HEART BREAK Study: Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells|Completed||N/A|228|Actual|Walter Reed National Military Medical Center|Participants were enrolled at one center and using one CT scanner, variable shield types and shield sizes were not studied, and further work is needed to examine tissue-specific responses to radiation and shielding.|3|||f||||f||||||||No||2017-10-10 22:42:05.338784|2017-10-10 22:42:05.338784
NCT02617875|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-04-10|||July 2017|Anticipated|2017-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|TEMS||Telemedical Support for Prehospital Emergency Medical Service|Telemedical Support for Prehospital Emergency Medical Service - a Prospective Randomized Controlled Trial|Not yet recruiting||N/A|3010|Anticipated|RWTH Aachen University||2|||f||||t|f|f||||||||2017-10-10 22:42:05.909041|2017-10-10 22:42:05.909041
NCT02617862|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-10-13|||October 2015||2015-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||PCI Imaging System in Pediatric Ophthalmology|The Use of the PCI Wide Field Imaging System for Pediatric Ophthalmic Photography of the Posterior and Peripheral Retina|Recruiting||N/A|40|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-10 22:42:06.093863|2017-10-10 22:42:06.093863
NCT02617849|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-07-05|||March 2016||2016-03-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma|A Phase II Study of Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma|Recruiting||Phase 2|44|Anticipated|Jewish General Hospital||1|||f||||f||||||||||2017-10-10 22:42:06.229342|2017-10-10 22:42:06.229342
NCT02617823|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-11-20|||January 2016||2016-01-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Influence of Maternal Postioning on Spread of Local Anesthetic After Epidural Analgesia|Influence of Maternal Postioning on Spread of Local Anesthetic After Epidural Analgesia|Recruiting||N/A|1110|Anticipated|Region Skane||2|||f||||f||||||||No||2017-10-10 22:42:06.334443|2017-10-10 22:42:06.334443
NCT02617810|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-02-19|||November 2015||2015-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants|An Open-Label Drug Interaction Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on the Single-Dose Pharmacokinetics of Midazolam and the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects|Completed||Phase 1|18|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 22:42:06.442949|2017-10-10 22:42:06.442949
NCT02617797|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2015-11-26|||September 2015||2015-09-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|February 2016|Anticipated|2016-02-01||Interventional|||Radiofrequency in the Female Stress Urinary Incontinence|Radiofrequency in the Female Stress Urinary Incontinence: A Randomized Clinical Trial|Recruiting||Phase 2/Phase 3|42|Anticipated|Centro de Atenção ao Assoalho Pélvico||2|||f||||f||||||||||2017-10-10 22:42:06.625082|2017-10-10 22:42:06.625082
NCT02617784|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2016-01-17|2016-01-17||October 2001||2001-10-01|January 2016|2016-01-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional||All Enrolled: All participants enrolled into the study regardless of treatment received.|A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)|A Single Center, Open Label, Multiple-Dose Oral Oseltamivir Suspension Study in End-Stage-Renal Disease (ESRD) Patients on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)|Completed||Phase 1|24|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:42:06.824462|2017-10-10 22:42:06.824462
NCT02617771|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-25|||October 2014||2014-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|||Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric Primary Care.|Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric|Completed||Phase 4|84|Actual|Policlinico Hospital||2|||f||||f||||||||||2017-10-10 22:42:08.42459|2017-10-10 22:42:08.42459
NCT02617758|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-09-14|||November 2015||2015-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Bioequivalence Study of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Participants|An Open-Label, Randomized, Single Application, Two-Period Crossover, Pivotal Bioequivalence Study to Evaluate the Bioequivalence of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Subjects|Completed||Phase 1|56|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 22:42:08.556597|2017-10-10 22:42:08.556597
NCT02617745|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-07-19|||November 2015||2015-11-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01||Interventional|GLIOPLAK||Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid|Impact of the Platelet Level During Radiotherapy Associated With Temozolomide in Patients Treated for Glioblastoma|Recruiting||Phase 2|150|Anticipated|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 22:42:08.691068|2017-10-10 22:42:08.691068
NCT02617732|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2015-11-25|||January 2016||2016-01-01|November 2015|2015-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Tianqi Capsule on Glucose Variability in Patients With Type 2 Diabetes.||Not yet recruiting||N/A|100|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-10 22:42:08.825506|2017-10-10 22:42:08.825506
NCT02617719|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-03-01|||November 2015||2015-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|||Comprehensive Geriatric Assessment in Primary Care: The Fit for Late Life Project|Comprehensive Geriatric Assessment in Primary Care: The Fit for Late Life|Enrolling by invitation||N/A|50|Anticipated|University of Southampton|||1||f||||t||||||||Undecided||2017-10-10 22:42:08.956942|2017-10-10 22:42:08.956942
NCT02617706|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-08-10|||January 2017||2017-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery|A Prospective, Randomized, Parallel Study Comparing Transdermal, Continuous Oxygen Delivery to Standard of Care to Assess Postoperative Wound Infection Rate in Colon and Rectal Resections|Withdrawn||Phase 2|0|Actual|Neogenix, LLC dba Ogenix||2||financial reasons|f||||t||||||||||2017-10-10 22:42:09.048014|2017-10-10 22:42:09.048014
NCT02617693|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-10-02|||November 23, 2015|Actual|2015-11-23|October 2017|2017-10-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|Jom Mama||Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes|Jom Mama Project - Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes|Active, not recruiting||Phase 4|660|Anticipated|Novo Nordisk A/S||2|||f||||f|f|f||||||||2017-10-10 22:42:09.155|2017-10-10 22:42:09.155
NCT02617680|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2016-10-15|||February 2015||2015-02-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Factors Affecting the Effective End-tidal Concentration of Desflurane Anaesthesia|Factors Affecting the Effective End-tidal Concentration of Desflurane Anaesthesia|Completed||N/A|80|Actual|University Hospital Hradec Kralove||2|||f||||f||||||||||2017-10-10 22:42:09.278014|2017-10-10 22:42:09.278014
NCT02617667|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-03-28|||January 2016||2016-01-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)|A Phase 2, Multi-center, Randomized, Double-masked, Placebo (Vehicle)-Controlled Clinical Study With an Open Label Comparator Arm to Assess the Efficacy, Safety and Tolerability of Topical CyclASol® for Treatment of Dry Eye Disease|Completed||Phase 2|207|Actual|Novaliq GmbH||4|||f||||f||||||||Undecided||2017-10-10 22:42:09.422082|2017-10-10 22:42:09.422082
NCT02617654|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-05-12|||November 2015||2015-11-01|May 2016|2016-05-01||||September 2018|Anticipated|2018-09-01||Interventional|||Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes|A Randomized, Double-blinded Placebo-controlled, Paralleled Designed, Investigator Sponsored Study of the Effect of the GLP-1 Receptor Agonist Liraglutide on Beta-cell Function in C-peptide Positive Type 1 Diabetic Patients|Recruiting||Phase 2|50|Anticipated|Uppsala University Hospital||2|||f||||f||||||||||2017-10-10 22:42:09.548252|2017-10-10 22:42:09.548252
NCT02617641|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-10-01|||February 2016||2016-02-01|October 2016|2016-10-01||||August 2018|Anticipated|2018-08-01||Interventional|||A Web-Based Tailored Nursing Intervention to Increase Walking in Patients After an Acute Coronary Syndrome|Evaluation of a Web-Based Tailored Nursing Intervention (TAVIEenM@RCHE) Aimed at Increasing Walking in Patients After an Acute Coronary Syndrome: A Multicenter Randomized Controlled Trial|Recruiting||N/A|148|Anticipated|Montreal Heart Institute||2|||f||||f||||||||||2017-10-10 22:42:09.67565|2017-10-10 22:42:09.67565
NCT02617628|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|OAPXRNTX||Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone|Improving Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone (Vivitrol) Before vs. After Reentry|Active, not recruiting||Phase 2/Phase 3|200|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:42:09.804858|2017-10-10 22:42:09.804858
NCT02617615|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-04-04|||December 1, 2017|Anticipated|2017-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Trial to Evaluate Safety, Tolerability, PK and Antiviral Activity of MB-110 in Hepatitis C Virus Infected Patients|A Phase 1, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Single Ascending and Multiple Oral Doses of MB-110 and to Evaluate the Antiviral Activity in Hepatitis C Virus Infected Patients|Not yet recruiting||Phase 1|40|Anticipated|Microbio Co Ltd||2|||f||||f|t|f||||||||2017-10-10 22:42:09.908416|2017-10-10 22:42:09.908416
NCT02617602|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-17|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Goal Directed Hemodynamic Management of Acute Heart Failure After Cardiac Surgery in Children|Goal Directed Hemodynamic Management of Acute Heart Failure After Cardiac Surgery in Children: a Prospective Randomised Trial|Recruiting||Phase 3|40|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 22:42:10.096606|2017-10-10 22:42:10.096606
NCT02617589|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-09-26|||February 29, 2016|Actual|2016-02-29|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|March 10, 2019|Anticipated|2019-03-10||Interventional|CheckMate 498||An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)|A Randomized Phase 3 Open Label Study of Nivolumab vs Temozolomide Each in Combination With Radiation Therapy in Newly Diagnosed Adult Subjects With Unmethylated MGMT (Tumor O-6-methylguanine DNA Methyltransferase) Glioblastoma (CheckMate 498: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation 498)|Recruiting||Phase 3|550|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:42:10.339197|2017-10-10 22:42:10.339197
NCT02617576|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-01-24|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Flavoring Oral Contrast for MR Enterography|Flavoring Oral Contrast for MR Enterography|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-10 22:42:10.835733|2017-10-10 22:42:10.835733
NCT02617563|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-08-04|||December 2015||2015-12-01|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|November 2018|Anticipated|2018-11-01|5 Years|Observational [Patient Registry]|MASTERS-D2||A Prospective, 5-Year Global Study on MAST™ Minimally Invasive Fusion Procedures for the Treatment of the Degenerative Lumbar Spine|A Prospective, 5-Year Global Study on MAST™ Minimally Invasive Fusion Procedures for the Treatment of the Degenerative Lumbar Spine|Recruiting||N/A|560|Anticipated|Medtronic Spinal and Biologics|||1||f||||f||||||||||2017-10-10 22:42:10.924609|2017-10-10 22:42:10.924609
NCT02617550|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-08-23|||November 2015||2015-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|VENICE||Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients|Evaluation of the Effect of 0.4 mg Nitroglycerin Spray After Pretreatment With Multiple Once Daily Oral Doses of 2.5 mg, 5 mg and 10 mg Vericiguat (BAY 1021189) Each Given Over 14 ± 3 Days on Safety, Tolerability and Blood Pressure in a Multi-center, Randomized, Placebo-controlled, Double-blind Group Comparison Study in Stable Coronary Artery Disease (CAD) Patients Aged 30 to 80 Years|Completed||Phase 1|36|Actual|Bayer||2|||f||||t||||||||||2017-10-10 22:42:11.149335|2017-10-10 22:42:11.149335
NCT02617537|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-02-15|||January 2016||2016-01-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea|A Multinational, Double-blind, Randomized, Placebo-controlled, Parallel-group Clinical Study to Investigate the Efficacy and Safety of the Oral Hormonal Contraceptive BAY 86-5300 (0.02 mg Ethinyl Estradiol as Betadex Clathrate and 3 mg Drospirenone) Over 16 Weeks for the Treatment of Women With Dysmenorrhea|Withdrawn||Phase 3|0|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:42:11.27549|2017-10-10 22:42:11.27549
NCT02617524|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-01-17|||January 2016||2016-01-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|BAV||Dedicated Sheath Feasibility Study|A Prospective, Open-label Study to Evaluate the Feasibility and Safety of the Valve Medical Dedicated Sheath During Balloon Aortic Valvuloplasty|Not yet recruiting||N/A|15|Anticipated|Valve Medical||1|||f||||f||||||||||2017-10-10 22:42:11.819554|2017-10-10 22:42:11.819554
NCT02617511|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-11-30|||October 2015||2015-10-01|November 2015|2015-11-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Omega-3 Supplementation and Resistance Training|Omega-3 Fatty Acid Supplementation and Resistance Training on Inflammation and Body Composition in Older Men|Completed||N/A|24|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-10 22:42:11.929752|2017-10-10 22:42:11.929752
NCT02617498|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-03-21|||April 2013||2013-04-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|LDLT||Spray Diathermy Versus Harmonic Scalpel Technique for Hepatic Parenchymal Transection|Spray Diathermy Versus Harmonic Scalpel Technique for Hepatic Parenchymal Transection of Living Donor.|Completed||Early Phase 1|80|Actual|Mansoura University||2|||f||||t||||||||No||2017-10-10 22:42:12.055077|2017-10-10 22:42:12.055077
NCT02617485|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-06-01|||December 2015||2015-12-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||MabionCD20® Compared to MabThera® in Lymphoma Patients|Randomized, Parallel-group, Double-blind, Comparative Bioequivalence Trial of MabionCD20 (Mabion SA) Compared to MabThera (Rituximab by Hoffman-La Roche) in Patients With Diffuse Large B-cell Lymphoma|Recruiting||Phase 3|140|Anticipated|Mabion SA||2|||f||||t||||||||||2017-10-10 22:42:12.204824|2017-10-10 22:42:12.204824
NCT02617472|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-08-10|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI)|Assessment of the Effectiveness of a Pelvic Exercise Device in Strengthening Pelvic Floor Muscles and Treating Urinary Incontinence|Completed||N/A|93|Actual|Lelo Inc.||1|||f||||f||||||||||2017-10-10 22:42:12.428267|2017-10-10 22:42:12.428267
NCT02617459|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-30|||November 2015||2015-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma|a Multi-centers, Randomization, Single-blind, Positive-controlled, Parallel Clinical Trial to Evaluate the Efficacy and Safety of Levobetaxolol Hydrochloride Eye Drops in Patients With Primary Open-angle Glaucoma|Recruiting||Phase 3|240|Anticipated|Lee's Pharmaceutical Limited||2|||f||||f||||||||||2017-10-10 22:42:12.520743|2017-10-10 22:42:12.520743
NCT02617446|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-31|||December 2015||2015-12-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure|The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure - A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel Group Clinical Study|Recruiting||Phase 2|120|Anticipated|Lee's Pharmaceutical Limited||2|||f||||t||||||||||2017-10-10 22:42:12.627922|2017-10-10 22:42:12.627922
NCT02617433|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-05-02|||December 2015||2015-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Relationship Between Muscle Mass and Muscle Relaxation Time|Relationship Between Muscle Mass Measured by Bioelectrical Impedance Analysis and Muscle Relaxation|Completed||N/A|42|Actual|Korea University Anam Hospital||1|||f||||t||||||||Undecided||2017-10-10 22:42:12.731589|2017-10-10 22:42:12.731589
NCT02617420|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-09-14|||December 2015||2015-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Monitoring Adherence Using Mobile Technology|Monitoring Adherence Using Mobile Technology|Completed||N/A|25|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 22:42:12.815204|2017-10-10 22:42:12.815204
NCT02617407|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-11-28|||June 2016||2016-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients|Pilot Study -- Oral Microbiome and Dental Plaque Control With Livionex(R) in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT)|Recruiting||N/A|30|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:42:12.892391|2017-10-10 22:42:12.892391
NCT02617394|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Novel vs. Traditional US Diaphragm Scanning|Comparing Two Ultrasound-based Methods to Assess Diaphragm Movement|Recruiting||N/A|200|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 22:42:13.041386|2017-10-10 22:42:13.041386
NCT02617381|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-23|||January 25, 2016|Actual|2016-01-25|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|October 2018|Anticipated|2018-10-01||Interventional|HEMORISQ||Pre-operative Haemorrhagic Risk Screening, Using a Standardized Questionnaire Before Scheduled Surgeries|Pre-operative Haemorrhagic Risk Screening, Using a Standardized Questionnaire Before Scheduled Surgeries.|Recruiting||N/A|1500|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||Undecided||2017-10-10 22:42:13.141689|2017-10-10 22:42:13.141689
NCT02617368|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-25|||November 2014||2014-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|FFTKC||Fourier Transform of Videokeratography Data: Clinical Usefulness in Moderate and Frome Fruste Keratoconus|Fourier Transform of Videokeratography Data: Clinical Usefulness in Moderate and Frome Fruste Keratoconus|Completed||N/A|185|Actual|Democritus University of Thrace|||3||f||||||||||||||2017-10-10 22:42:13.24626|2017-10-10 22:42:13.24626
NCT02617355|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-27|||October 2011||2011-10-01|November 2015|2015-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Interference Between Surgical Magnetic Drapes and Pacemakers|Interference Between Surgical Magnetic Drapes and Pacemakers: An Observational Study Comparing Commercially Available Devices and a New Magnetically Isolated Drape|Completed||N/A|47|Actual|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-10 22:42:13.371853|2017-10-10 22:42:13.371853
NCT02617342|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-05-12|||November 2015||2015-11-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Robot-Mediated Intervention for Children With Autism Spectrum Disorders|Robot-Mediated Social Skills Intervention for Children With Autism Spectrum Disorders|Recruiting||N/A|40|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||||2017-10-10 22:42:13.450602|2017-10-10 22:42:13.450602
NCT02617329|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-25|||September 2014||2014-09-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Extracorporeal Therapy on Shoulder and Neck Pain|Effects of Extracorporeal Shock Wave Therapy on Shoulder and Neck Pain|Completed||N/A|40|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-10 22:42:13.552729|2017-10-10 22:42:13.552729
NCT02617316|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-27|||December 2013||2013-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Different Running Speeds of Strike Patterns|Analysis of the Different Running Speeds of Strike Patterns: The Efficiency of Shoes|Completed||N/A|20|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-10 22:42:13.801311|2017-10-10 22:42:13.801311
NCT02617303|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-01-15|||September 2015||2015-09-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|February 2016|Anticipated|2016-02-01||Interventional|PRECIOSA||Prevention of Falls and Its Consequences in Elderly People|Effectiveness of an Intervention Through Physical Exercise for the Prevention of Falls and Its Consequences in Elderly People (75-89 Years) Performed in Primary Care: Study Protocol for a Randomized Controlled Trial|Recruiting||N/A|402|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-10-10 22:42:13.902003|2017-10-10 22:42:13.902003
NCT02617290|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-07-31|||January 9, 2017|Actual|2017-01-09|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|ALPHEUS||Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting|Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting: The ALPHEUS Study|Recruiting||Phase 3|1900|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:42:14.090441|2017-10-10 22:42:14.090441
NCT02617264|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-12-01|||January 2016||2016-01-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Spot tm Tattooing of Biopsied Axillary Lymph Nodes With Ultrasound Guided in Breast Cancer Patients Prior to Surgery|Spot tm Tattooing of Biopsied Axillary Lymph Nodes With Ultrasound Guided in Breast Cancer Patients Prior to Surgery|Not yet recruiting||N/A|50|Anticipated|Kaplan Medical Center||1|||f||||f||||||||||2017-10-10 22:42:14.38356|2017-10-10 22:42:14.38356
NCT02617251|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-08-12|||April 2015||2015-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PRECAPED||Impact of Deprivation on Hospital Care Efficiency in Paediatrics|Impact of Deprivation on Hospital Care Efficiency in Paediatrics|Recruiting||N/A|3500000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 22:42:14.51987|2017-10-10 22:42:14.51987
NCT02617238|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-02-27|||July 2013||2013-07-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|SPARTE||Strategy for Preventing Cardiovascular and Renal Events Based on ARTErial Stiffness|Strategy for Preventing Cardiovascular and Renal Events Based on ARTErial Stiffness|Active, not recruiting||N/A|3000|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:42:14.611097|2017-10-10 22:42:14.611097
NCT02617225|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-27|2015-11-27|||November 2015||2015-11-01|November 2015|2015-11-01||||December 2015|Anticipated|2015-12-01||Observational|||Effect of a Pilot Group Hand-washing Program on Handwashing Behaviors Among Elementary School Children in Assam|Evaluation of DHaAL Intervention of Group Handwashing With Soap Before Mid-day Meals in Rural Elementary School of Assam|Recruiting||N/A|900|Anticipated|Network for Engineering and Economics Research and Management|||3||f||||f||||||||||2017-10-10 22:42:14.724991|2017-10-10 22:42:14.724991
NCT02617212|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-01-15|||November 2015||2015-11-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Implant Abutment Dis-/Reconnection and Peri-Implant Marginal Bone Loss.|Impact of Implant Abutment Dis-/Reconnection on Peri-Implant Marginal Bone Loss - Randomized Clinical Trial.|Active, not recruiting||N/A|24|Anticipated|Fortaleza University||2|||f||||t||||||||Undecided||2017-10-10 22:42:14.82978|2017-10-10 22:42:14.82978
NCT02617199|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2016-01-07|||November 2015||2015-11-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Epidural Anesthesia in Acute Pancreatitis|Epidural Anesthesia as an Alternative for Management in Acute Pancreatitis, a Randomised Clinical Trial|Recruiting||Phase 2/Phase 3|60|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||2|||f||||f||||||||||2017-10-10 22:42:14.953702|2017-10-10 22:42:14.953702
NCT02617186|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-01-09|||January 2016||2016-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer|Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: A Randomized Controlled Trial|Recruiting||N/A|186|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||No||2017-10-10 22:42:15.096492|2017-10-10 22:42:15.096492
NCT02617173|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2015-11-26|||November 2015||2015-11-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of Low Electrical Current on Testicular Spermatocyte Count|The Effect of Low Electrical Current on Testicular Spermatocyte Count|Not yet recruiting||N/A|10|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 22:42:15.219755|2017-10-10 22:42:15.219755
NCT02617160|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-04-27|||May 2016||2016-05-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluation of Automated Insulin Pump Settings Using the MD-Logic Advise4U|Evaluation of Automated Insulin Pump Settings Using the MD-Logic Pump Advisor- The MD-Logic Advise 4 U- Open Label, Parallel , Randomized, Controlled Study|Recruiting||N/A|34|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 22:42:15.354772|2017-10-10 22:42:15.354772
NCT02617147|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-26|||June 2014||2014-06-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Observational|||Choroidal Thickness Vitrectomy|Influence of Vitrectomy and Membrane Peeling on Choroidal Thickness|Recruiting||N/A|40|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 22:42:15.489643|2017-10-10 22:42:15.489643
NCT02617134|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2016-12-04|||November 2015||2015-11-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor|Immunotherapy With Chimeric Antigen Receptor-Modified T Cells for MUC1 Positive Advanced Refractory Solid Tumor|Recruiting||Phase 1/Phase 2|20|Anticipated|PersonGen BioTherapeutics (Suzhou) Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:42:15.597786|2017-10-10 22:42:15.597786
NCT02617121|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-25|||November 2015||2015-11-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|PONV||The Effects of Gabapentin and Ramosetron on Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgery|Comparison of the Prophylactic Anti-emetic Efficacy of Gabapentin and Ramosetron in Patients Undergoing Laparoscopic Gynecological Surgery|Not yet recruiting||N/A|120|Anticipated|Hallym University Medical Center||3|||f||||f||||||||||2017-10-10 22:42:15.709035|2017-10-10 22:42:15.709035
NCT02617108|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-28|||January 2016||2016-01-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Foley Balloon Therapy for Preventing Post-operative Adhesion Following Transection of Uterine Septum|A Prospective and Randomized Trial on the Effect of Foley Balloon Therapy for Preventing Post-operative Adhesion Following Transection of Uterine Septum|Not yet recruiting||N/A|210|Anticipated|Fu Xing Hospital, Capital Medical University||2|||f||||t||||||||||2017-10-10 22:42:15.831284|2017-10-10 22:42:15.831284
NCT02617095|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-26|2017-03-06|||February 2015||2015-02-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome|Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome|Terminated||N/A|64|Actual|Laboratoires Thea||2||recruitment rate too slow|f||||f||||||||||2017-10-10 22:42:15.923744|2017-10-10 22:42:15.923744
NCT02617082|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2015-11-27|||October 2015||2015-10-01|November 2015|2015-11-01||||October 2019|Anticipated|2019-10-01|5 Years|Observational [Patient Registry]|||Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery|Phase II Study of Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery|Recruiting||Phase 2|828|Anticipated|Fudan University|||1||f||||t||||||Samples Without DNA|"     blood   "|||2017-10-10 22:42:16.019598|2017-10-10 22:42:16.019598
NCT02617069|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-09-07|||September 2015||2015-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2016|Actual|2016-03-01||Interventional|||Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery|Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Randomized Study|Recruiting||Phase 2/Phase 3|170|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 22:42:16.13021|2017-10-10 22:42:16.13021
NCT02617056|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-09-06|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Observational|||Objective Assessment of Behavioral Associations of Patients With Dementia|Objective Assessment of Behavioral Associations of Patients With Dementia|Recruiting||N/A|60|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|||||2017-10-10 22:42:16.262331|2017-10-10 22:42:16.262331
NCT02617043|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HF-WBI-SIB||Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery|Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery|Recruiting||Phase 2|200|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-10 22:42:16.368155|2017-10-10 22:42:16.368155
NCT02617030|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-08-12|||September 2014||2014-09-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|TRANSAD||Developing a Program for Transition to Adult Care for Youth With Chronic Conditions : a Mixed Method Study|Developing a Program for Transition to Adult Care for Youth With Chronic Conditions : a Mixed Method Study|Recruiting||N/A|390|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 22:42:16.477606|2017-10-10 22:42:16.477606
NCT02617017|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-27|||January 2016||2016-01-01|November 2015|2015-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|BUSPARK||Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease|Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease. Multicenter, International, Placebo-controlled, Randomised, Double Blind Trial|Not yet recruiting||Phase 3|100|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:42:16.559142|2017-10-10 22:42:16.559142
NCT02617004|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-11-18|||February 2016||2016-02-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Observational|GRAALL-2014/B||Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults|Multicenter Trial Treatment of Philadelphia Chromosome Negative (Ph-) B-lineage Acute Lymphoblastic Leukemia (ALL) of Young Adults (18-59 Years).|Recruiting||N/A|500|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"     leukemic cells, nucleic acids, serum   "|||2017-10-10 22:42:16.652146|2017-10-10 22:42:16.652146
NCT02616991|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-05-02|||June 2016||2016-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|CTVENPOSTPART||Computed Tomography CT Venography During Postpartum Venous Thromboembolism|Contribution of CT Venography for Diagnosing Venous Thromboembolism During Postpartum|Recruiting||N/A|130|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 22:42:16.749987|2017-10-10 22:42:16.749987
NCT02616978|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-05|||November 2015||2015-11-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Retrospective Study on the Use of CEFALY® Device During Migraine Attacks|Retrospective Study on the Use of CEFALY® Device During Migraine Attacks|Completed||N/A|807|Actual|Cefaly Technology|||1||f||||f||||||||||2017-10-10 22:42:16.845042|2017-10-10 22:42:16.845042
NCT02616965|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-05-30|||February 22, 2017|Actual|2017-02-22|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma|A Phase I Trial Assessing the Feasibility of Romidepsin Combined With Brentuximab Vedotin for Patients With Requiring Systemic Therapy for Cutaneous T-cell Lymphoma|Recruiting||Phase 1|27|Anticipated|Fox Chase Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 22:42:16.917096|2017-10-10 22:42:16.917096
NCT02616952|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-12-04|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Chinese Herbal Decoction for Stress Urinary Incontinence|Effect of Yiqi Suoquan Tang, a Chinese Herbal Decoction, on Stress Urinary Incontinence|Recruiting||Phase 2|72|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||||2017-10-10 22:42:17.060307|2017-10-10 22:42:17.060307
NCT02616939|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-03-23|||January 2016||2016-01-01|March 2016|2016-03-01|November 2022|Anticipated|2022-11-01|November 2020|Anticipated|2020-11-01||Observational|Arineta||Clinical In-hospital Evaluation of the Usefulness of a New Multi-detector Computed Tomography Scanner From Arineta Ltd|Clinical In-hospital Evaluation of the Usefulness of a New Multi-detector Computed Tomography Scanner From Arineta Ltd|Recruiting||N/A|400|Anticipated|Carmel Medical Center|||1||f||||t||||||||No||2017-10-10 22:42:17.183587|2017-10-10 22:42:17.183587
NCT02616926|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2015-12-04|||December 2015||2015-12-01|December 2015|2015-12-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma|Hepatic Resection Versus Transarterial Chemoembolization Plus Radiofrequency Ablation for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma|Recruiting||N/A|538|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 22:42:17.299947|2017-10-10 22:42:17.299947
NCT02616913|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-25|||March 2013||2013-03-01|November 2015|2015-11-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Evaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects|A Single Dose, Double Blind, Randomized, Crossover Placebo- and Moxifloxacin (Open Label)-Controlled Study to Evaluate the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects|Completed||N/A|48|Actual|Cargill||3|||f||||t||||||||||2017-10-10 22:42:17.426665|2017-10-10 22:42:17.426665
NCT02616900|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-25|||December 16, 2015|Actual|2015-12-16|July 2017|2017-07-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|eQUEST||eSight Eyewear Quality of Life and Efficacy Study|eQUEST -- ESIGHT QUALITY OF LIFE AND EFFICACY STUDY A Multi-center, Prospective Cohort Study to Assess the Impact of eSight Eyewear on Functional Vision Improvement and Quality of Life in a Low Vision Population|Completed||N/A|50|Actual|eSight Corporation||1|||f||||f||||||||||2017-10-10 22:42:17.506077|2017-10-10 22:42:17.506077
NCT02616887|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-27|||November 2015||2015-11-01|November 2015|2015-11-01|November 2023|Anticipated|2023-11-01|February 2016|Anticipated|2016-02-01||Observational|||Study of Image-Guided SBRT for Vertebral Metastases|Phase II Study of Image-Guided Single Fraction SBRT With VMAT-FFF Technique for Vertebral Metastases|Recruiting||N/A|59|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||||||2017-10-10 22:42:17.598718|2017-10-10 22:42:17.598718
NCT02616874|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-09-19|||February 2016||2016-02-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|September 2016|Actual|2016-09-01||Interventional|||Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals|An Open Label Phase I Trial to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals (BCN02-Romi)|Active, not recruiting||Phase 1|15|Anticipated|IrsiCaixa||1|||f||||f||||||||||2017-10-10 22:42:17.679756|2017-10-10 22:42:17.679756
NCT02616861|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-08-25|||November 2015||2015-11-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers|A 2-stage Phase 1 Study of Safety, Tolerability, PK, and PD of IW-1973 Tablet in Healthy Volunteers in an Open-label, Single-dose Stage, and a Randomized, Double Blind, Placebo-controlled, Multiple-ascending-dose Stage|Completed||Phase 1|54|Actual|Ironwood Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:42:17.779981|2017-10-10 22:42:17.779981
NCT02616848|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2015-11-25|||November 2015||2015-11-01|November 2015|2015-11-01||||November 2015|Actual|2015-11-01||Interventional|||Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers||Recruiting||Phase 1|1|Anticipated|Istituti Ospitalieri di Cremona||1|||f||||f||||||||||2017-10-10 22:42:17.859828|2017-10-10 22:42:17.859828
NCT02616835|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-25|||August 2014||2014-08-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Investigating the Physiology of Targeted Theta-burst Neuromodulation|Investigating the Physiology of Targeted Theta-burst Neuromodulation|Completed||N/A|28|Actual|Institute of Mental Health Nottingham||2|||f||||||||||||||2017-10-10 22:42:17.958517|2017-10-10 22:42:17.958517
NCT02616822|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-11-27|||January 2013||2013-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Trans-Resveratrol in Endothelial Function in Hypertensive Patients|Acute Effects Of Trans-Resveratrol in Endothelial Function in Treated Hypertensive Patients|Completed||Phase 1|24|Actual|Hospital Universitario Pedro Ernesto||2|||f||||t||||||||||2017-10-10 22:42:18.043205|2017-10-10 22:42:18.043205
NCT02616809|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-27|||July 2014||2014-07-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Standing and Light-intensity Activity on Ambulatory Blood Pressure and Blood Glucose|Effects of Standing and Light-intensity Activity on Ambulatory Blood Pressure and Blood Glucose|Completed||Phase 3|10|Actual|Arizona State University||4|||f||||f||||||||||2017-10-10 22:42:18.272567|2017-10-10 22:42:18.272567
NCT02616796|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-29|||April 2015||2015-04-01|November 2015|2015-11-01||||December 2020|Anticipated|2020-12-01||Interventional|||Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome|Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome|Recruiting||Phase 1/Phase 2|60|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 22:42:18.408572|2017-10-10 22:42:18.408572
NCT02616783|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-10-04|||December 22, 2015|Actual|2015-12-22|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|pts > 60 yrs||Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years|A Phase 3b, Randomized, Open-Label Study to Evaluate Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Subjects Aged ≥ 60 Years|Active, not recruiting||Phase 3|166|Actual|Gilead Sciences||2|||f||||f|t|f||||||||2017-10-10 22:42:18.550009|2017-10-10 22:42:18.550009
NCT02616770|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-27|||March 2014||2014-03-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects.|Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study to Evaluate the Safety and Tolerability of S-1226 Administered by Nebulization in Normal Health Volunteers|Completed||Phase 1|36|Actual|SolAeroMed Inc.||6|||f||||t||||||||||2017-10-10 22:42:18.858385|2017-10-10 22:42:18.858385
NCT02616757|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2016-10-12|||October 2016||2016-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Quantitative Ultrasound for the Evaluation of Simple Bone Cyst Healing|Quantitative Ultrasound for the Evaluation of Simple Bone Cyst Healing|Recruiting||N/A|30|Anticipated|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-10 22:42:19.005821|2017-10-10 22:42:19.005821
NCT02616744|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-05-29|||January 2011||2011-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|BONADIUV||Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors|A Single--blind, Randomized, Placebo--controlled Phase II Study to Evaluate the Impact of Oral Bisphosphonate Treatment on Bone Mineral Density in Osteopenic Women Receiving Adjuvant Aromatase Inhibitors - BONADIUV Trial|Completed||Phase 2|171|Actual|Azienda Ospedaliero-Universitaria Careggi||2|||f||||f||||||||Undecided||2017-10-10 22:42:19.166852|2017-10-10 22:42:19.166852
NCT02616731|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2015-11-25|||September 2015||2015-09-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD|Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD: Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|100|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:42:19.325544|2017-10-10 22:42:19.325544
NCT02616718|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2016-07-28|||September 2015||2015-09-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|INPRO||Incisional Hernia Progression Over Time|Incisional Hernia Progression Over Time|Recruiting||N/A|50|Anticipated|Bispebjerg Hospital||1|||f||||t||||||||||2017-10-10 22:42:19.45624|2017-10-10 22:42:19.45624
NCT02616705|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-27|||November 2015||2015-11-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis|Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis|Recruiting||N/A|300|Anticipated|Mayo Clinic|||2||f||||f||||||None Retained|"     Bile   "|||2017-10-10 22:42:19.584896|2017-10-10 22:42:19.584896
NCT02616692|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-26|||May 9, 2016|Actual|2016-05-09|September 2017|2017-09-01|October 7, 2016|Actual|2016-10-07|October 7, 2016|Actual|2016-10-07||Observational|||HCC Patient Preferences in Japan|Patient Preferences for Treatments for Hepatocellular Cancer (HCC) in Japan|Completed||N/A|120|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:42:19.714125|2017-10-10 22:42:19.714125
NCT02616523|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2016-08-18|2016-05-28||July 2014||2014-07-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|June 2015|Actual|2015-06-01||Interventional|||Influence of Dexmedetomidine and Lidocaine on Opioid Consumption in Laparoscopic Intestine Resection|Influence of Dexmedetomidine and Lidocaine on Opioid Consumption, Cognitive Function and Incidence of Neuropathic Pain in Laparoscopic Intestine Resection|Completed||Phase 4|60|Actual|University Medical Centre Ljubljana|Limitations of our study is that we have not evaluated inflammatory response on the cellular level. This should be investigated in the future studies to establish if dexmedetomidine and lidocaine have clinically important anti-inflammatory effect.|3|||f||||f||||||||||2017-10-10 22:42:21.73098|2017-10-10 22:42:21.73098
NCT02616679|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-10-05|||January 2016||2016-01-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Cognitive Detection of Preclinical AD: Validation Using Biomarkers|Cognitive Detection of Preclinical AD: Validation Using Biomarkers|Recruiting||N/A|80|Anticipated|New York University School of Medicine|||2||f||||f|f|f||||Samples With DNA|"     Any remaining blood specimens will be retained indefinitely for future use by the Center for     Cognitive Neurology (CCN) at NYU Langone Medical Center. Some samples may also be sent to     Janssen Research & Development, LLC for potential future research use. Potential future     research use by study investigators or collaborators will include possible discovery of novel     biomarkers associated with increased AD risk, and study of validity of the use of such     markers in preclinical AD. True genetic testing will not be done on these samples.      Subjects may decline to have their samples stored for future use by checking the applicable     box on the informed consent form. Subjects who agreed to have their samples stored for future     use may revoke this permission.   "|||2017-10-10 22:42:19.860194|2017-10-10 22:42:19.860194
NCT02616653|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-02-28|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Identification of the L3-L4 Intervertebral Space in Obese Parturients|Identification of the L3-L4 Intervertebral Space in Obese Parturients at Term in the Sitting and Lateral Positions: Manual Palpation (Tuffier's Line Method) Versus Ultrasound Imaging|Completed||N/A|120|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f|f|f||||||No||2017-10-10 22:42:20.350265|2017-10-10 22:42:20.350265
NCT02616640|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-09-27|||January 11, 2016|Actual|2016-01-11|September 2017|2017-09-01|August 16, 2018|Anticipated|2018-08-16|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma|A Phase IB Multicenter, Open-label Study To Determine The Recommended Dose And Regimen Of Durvalumab (MEDI4736) Either As Monotherapy or In Combination With Pomalidomide (POM) With Or Without Low-Dose Dexamethasone (DEX) In Subjects With Relapsed And Refractory Multiple Myeloma (RRMM)|Active, not recruiting||Phase 1|121|Anticipated|Celgene||3|||f||||f||||||||||2017-10-10 22:42:20.476593|2017-10-10 22:42:20.476593
NCT02616627|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-27|||September 2015||2015-09-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Observational|||Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients|Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:42:20.687085|2017-10-10 22:42:20.687085
NCT02616614|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-25|||May 2015||2015-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris|Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Clindamycin 1.2% and Benzoyl Peroxide 3.75% Gel to Onexton® Gel in Subjects With Acne Vulgaris|Completed||Phase 3|818|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-10 22:42:20.81136|2017-10-10 22:42:20.81136
NCT02616601|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-06-14|||February 2015||2015-02-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis|Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Bioequivalence of a Generic Fluorouracil 0.5% Cream to Carac Cream in Subjects With Actinic Keratoses|Completed||Phase 3|410|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-10 22:42:20.944361|2017-10-10 22:42:20.944361
NCT02616588|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-05-09|||February 2016||2016-02-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|VHV||Vets Helping Vets Pilot Study|Vets Helping Vets Pilot Study|Completed||N/A|17|Actual|VA Eastern Colorado Health Care System||1|||f||||t||||||||||2017-10-10 22:42:21.058117|2017-10-10 22:42:21.058117
NCT02616575|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-27|||December 2015||2015-12-01|November 2015|2015-11-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||The Application of Smart Health Management System on Home-Care for Elderly Patients|The Application of Smart Health Management System on Home-Care for Elderly Patients|Not yet recruiting||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:42:21.174682|2017-10-10 22:42:21.174682
NCT02616562|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-09-20|||March 23, 2016|Actual|2016-03-23|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|April 17, 2020|Anticipated|2020-04-17||Interventional|||Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency|A Trial Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency naïve Pre-pubertal Children With Growth Hormone Deficiency|Active, not recruiting||Phase 2|60|Anticipated|Novo Nordisk A/S||4|||f||||t||||||||||2017-10-10 22:42:21.28942|2017-10-10 22:42:21.28942
NCT02616549|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-07|||October 2014||2014-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Multicomponent Yoga Intervention for Major Depressive Disorder|A Randomized Study of a Comprehensive Yoga Intervention for Patients With Major Depressive Disorder With Incomplete Response to Antidepressants|Completed||Phase 2|25|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:42:21.547098|2017-10-10 22:42:21.547098
NCT02616536|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-01-04|||November 2015||2015-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Comparison Between Teaching Methods on Knowledge Gain of Physiotherapy Students|Comparison Between Traditional Classroom Teaching Verses Flipped Classroom Teaching on Knowledge Gain of Physiotherapy Students|Completed||N/A|54|Actual|Universiti Tunku Abdul Rahman||2|||f||||f||||||||||2017-10-10 22:42:21.624559|2017-10-10 22:42:21.624559
NCT02616510|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-05-15|||July 2013||2013-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|POPCORn||Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile|Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile|Recruiting||N/A|125|Anticipated|UMC Utrecht|||2||f||||t||||||Samples Without DNA|"     plasma, serum, urine   "|||2017-10-10 22:42:22.076266|2017-10-10 22:42:22.076266
NCT02616497|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-05-30|||September 2015||2015-09-01|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|February 28, 2017|Actual|2017-02-28||Interventional|ASTERIAS||ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)|Comparison of Triflusal With Aspirin in the Secondary Prevention of Atherothrombotic Events|Active, not recruiting||Phase 4|1400|Actual|University of Ioannina||2|||f||||f||||||||||2017-10-10 22:42:22.174824|2017-10-10 22:42:22.174824
NCT02616484|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-10-04|||October 1, 2017|Actual|2017-10-01|October 2017|2017-10-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|DCA/PDCD||Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:|Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:|Recruiting||Phase 3|9|Anticipated|University of Florida||2|||f||||t|t|f||||||||2017-10-10 22:42:22.286291|2017-10-10 22:42:22.286291
NCT02616471|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-11-24|||March 2014||2014-03-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Osterix||Effect of High Cheese Consumption on Metabolic Syndrome Risk Factors|Effect of High Cheese Consumption on Metabolic Syndrome Risk Factors in a Metabolically Vulnerable Population|Completed||N/A|168|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-10 22:42:24.396711|2017-10-10 22:42:24.396711
NCT02616458|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-30|||November 2010||2010-11-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|October 2011|Actual|2011-10-01||Interventional|||The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population|The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population|Completed||N/A|310|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:42:24.515892|2017-10-10 22:42:24.515892
NCT02616445|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-05-01|||February 2015||2015-02-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects|A Phase I Double-Blind, Randomised, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of UE2343 in Healthy Subjects|Completed||Phase 1|40|Actual|Actinogen Medical||3|||f||||f||||||||No||2017-10-10 22:42:24.608382|2017-10-10 22:42:24.608382
NCT02616432|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-08-01|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|TMISTLead-in||Tomosynthesis Mammograpic Imaging Screening Trial|Tomosynthesis Mammography Imaging Screening Trial Lead-in|Active, not recruiting||N/A|2300|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-10 22:42:24.732252|2017-10-10 22:42:24.732252
NCT02616419|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-08-09|||May 15, 2017|Actual|2017-05-15|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||External Cold and Vibration Stimulation (Buzzy®) for Procedural Pain Management in Children Undergoing Needle-Related Procedures|External Cold and Vibration Stimulation (Buzzy® Device) VS Topical Anesthetic Cream for Procedural Pain Management in Children Undergoing Needle-Related Procedures in the Emergency Department : A Randomized Controlled Non-Inferiority Trial|Recruiting||N/A|380|Anticipated|St. Justine's Hospital||2|||f||||f|f|t|f|f|t|||||2017-10-10 22:42:24.834021|2017-10-10 22:42:24.834021
NCT02616406|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-09-13|||November 2015||2015-11-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Observational|||Objective Measure of Recovery After Outpatient Surgery|Assessment of Physical Activity to Determine When Patients Return to Baseline Levels of Activity Following Outpatient Inguinal Hernia Surgery|Recruiting||N/A|40|Anticipated|Mayo Clinic|||2||f||||f||||||||||2017-10-10 22:42:24.94456|2017-10-10 22:42:24.94456
NCT02616393|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-03-01|||November 2015||2015-11-01|March 2017|2017-03-01||||June 2017|Anticipated|2017-06-01||Interventional|||Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases|A Phase 2, Multicenter Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases|Recruiting||Phase 2|60|Anticipated|Kadmon Corporation, LLC||3|||f||||t||||||||||2017-10-10 22:42:25.051252|2017-10-10 22:42:25.051252
NCT02616380|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-07-11|||November 5, 2015||2015-11-05|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan|Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan|Active, not recruiting||N/A|100|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:42:25.372178|2017-10-10 22:42:25.372178
NCT02616367|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-25|||December 2015||2015-12-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Comparison of Ropivacaine and Liposomal Bupivacaine for Total Knee Arthroplasty|Comparison Between Ropivacaine and Liposomal Bupivacaine Periarticular Injections for Pain Relief After Total Knee Arthroplasty|Not yet recruiting||Phase 2|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:42:25.540186|2017-10-10 22:42:25.540186
NCT02616354|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-24|||January 2015||2015-01-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|PROTDOI||Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin|Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin|Recruiting||Phase 4|24|Anticipated|Southeast University, China||2|||f||||t||||||||||2017-10-10 22:42:25.658598|2017-10-10 22:42:25.658598
NCT02616341|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-08-09|||November 2012||2012-11-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder|Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder|Completed||N/A|51|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-10 22:42:25.798977|2017-10-10 22:42:25.798977
NCT02616328|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2017-07-12|||January 26, 2017|Actual|2017-01-26|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice|A Multicenter, Prospective, Observational, Non-Interventional Study Evaluating the Efficacy and Safety of Using Tocilizumab (TCZ) for Confirmed Rheumatoid Arthritis (RA) Patients In Clinical Practice|Recruiting||N/A|413|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:42:25.906081|2017-10-10 22:42:25.906081
NCT02616315|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-04-07|||February 2016||2016-02-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery|A Randomized, Double-Blind, Phase 4 Study to Evaluate the Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Patients Post Bariatric Surgery|Withdrawn||Phase 4|0|Actual|Takeda||2|||f||||f||||||||||2017-10-10 22:42:26.03729|2017-10-10 22:42:26.03729
NCT02616302|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-03-10|||November 2015||2015-11-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years|A Phase 2, Double-Blind, 12 Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 1 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease|Suspended||Phase 2|80|Anticipated|Takeda||4|||f||||f||||||||||2017-10-10 22:42:26.178353|2017-10-10 22:42:26.178353
NCT02616289|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Emollient Therapy for Severe Acute Malnutrition|Topical Emollient Therapy in the Management of Severe Acute Malnutrition: A Randomized Controlled Clinical Trial in Bangladesh|Not yet recruiting||N/A|200|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 22:42:26.464209|2017-10-10 22:42:26.464209
NCT02616276|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-03-16|||December 2015||2015-12-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|June 2016|Actual|2016-06-01||Interventional|BGI||Postprandial Effect of Breakfast Glycemic Index on Vascular Function, Insulinemia and Cognitive Performance (BGI Study)|Postprandial Effect of Breakfast Glycemic Index on Vascular Function, Insulinemia and Cognitive Performance, a Crossover Clinical Trial (BGI Study)|Completed||N/A|40|Actual|Fundacion para la Investigacion y Formacion en Ciencias de la Salud||3|||f||||f||||||||||2017-10-10 22:42:26.574418|2017-10-10 22:42:26.574418
NCT02616263|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-11-02|||March 2016||2016-03-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|September 2020|Anticipated|2020-09-01||Interventional|||Metatarsal Phalangeal Joint Deformity Progression - R01|Muscle, Joint and Movement Deterioration Contributing to Neuropathic Forefoot Deformity|Recruiting||N/A|62|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 22:42:26.681996|2017-10-10 22:42:26.681996
NCT02616237|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-08-22|||April 2014||2014-04-01|August 2016|2016-08-01||||October 2015|Actual|2015-10-01||Interventional|||A Facebook-based Weight Loss Programme for Obese Adults in Hong Kong|Effects of a Facebook-based Weight Loss Programme for Obese Adults in Hong Kong|Completed||N/A|59|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||No||2017-10-10 22:42:26.925314|2017-10-10 22:42:26.925314
NCT02616224|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-02-22|||September 2016|Anticipated|2016-09-01|February 2017|2017-02-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer||Withdrawn||N/A|0|Actual|Hoffmann-La Roche|||1|Resource constraints|f||||||||||||||2017-10-10 22:42:27.049993|2017-10-10 22:42:27.049993
NCT02616211|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-03-01|||October 2014||2014-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors|An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors|Active, not recruiting||N/A|15|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     At the time of recurrence, a minimum of two (2) and a maximum of four (4) tissue cores will     be taken through interventional biopsy, ultra sound guided biopsy, surgical resection, or     bronchoscopy. Investigators may also collect waste pleural fluid in patients who have a     pleurx catheter in place. These biopsies will be collected and individually processed for     pathology, gene mutation screening, transcriptome profiling and tumor xenografts.   "|||2017-10-10 22:42:27.14602|2017-10-10 22:42:27.14602
NCT02616198|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-24|||January 2009||2009-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2009|Actual|2009-09-01||Interventional|GIS||6-year Clinical Evaluation of Glass Ionomer Cements (GIS) With Resin Coating on Posterior Teeth|A Prospective 6-year Clinical Study Evaluating Reinforced Glass Ionomer Cements With Resin Coating on Posterior Teeth|Completed||N/A|54|Actual|Ege University||4|||f||||t||||||||||2017-10-10 22:42:27.235834|2017-10-10 22:42:27.235834
NCT02616185|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-10-05|||December 30, 2015|Actual|2015-12-30|October 2017|2017-10-01|April 20, 2019|Anticipated|2019-04-20|April 20, 2019|Anticipated|2019-04-20||Interventional|||A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)|A Phase 1 Study To Evaluate The Safety, Pharmacokinetics And Pharmacodynamics Of Escalating Doses Of A Vaccine-based Immunotherapy Regimen (Vbir) For Prostate Cancer (Pf-06753512)|Recruiting||Phase 1|133|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 22:42:27.500599|2017-10-10 22:42:27.500599
NCT02616172|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-08-10|||October 2015||2015-10-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss|Safety of Infusion of Autologous Human Bone Marrow Mononuclear Fraction in Children With Sensorineural Hearing Loss|Suspended||Phase 1/Phase 2|10|Anticipated|Florida Hospital||1||Restructuring Cell Lab|f||||t||||||||Undecided||2017-10-10 22:42:27.702555|2017-10-10 22:42:27.702555
NCT02616159|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-06-20|||November 2015||2015-11-01|November 2015|2015-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Oatmeal Varieties on Glycemic and Insulinemic Responses in Healthy Individuals|A Randomized, Controlled, Double-Blind Crossover Trial to Assess Effect of Oatmeal Varieties on Glycemic and Insulinemic Responses in Healthy Individuals|Completed||N/A|30|Actual|PepsiCo Global R&D||5|||f||||f||||||||||2017-10-10 22:42:27.821426|2017-10-10 22:42:27.821426
NCT02602730|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-11-10|||February 2012||2012-02-01|November 2015|2015-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|PostPartum_2||Internet-Based Nonsmoking Program for Postpartum Women|Internet-Based Nonsmoking Program for Postpartum Women|Completed||Phase 2|307|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 22:45:05.731634|2017-10-10 22:45:05.731634
NCT02616133|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-06-30|||January 2016||2016-01-01|February 2017|2017-02-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|CECity||HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program|HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program|Completed||N/A|30|Actual|Duke University|||1||f||||f||||||||||2017-10-10 22:42:28.08212|2017-10-10 22:42:28.08212
NCT02616120|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-12-08|||May 2015||2015-05-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|ESNMS||Effect of SQJZ Herbal Mixtures on Non-motor Symptoms of Parkinson's Disease|Efficacy and Safety of SQJZ Herbal Mixtures on Non-motor Symptoms With Parkinson's Disease Patients|Recruiting||Phase 2|240|Anticipated|Dongzhimen Hospital, Beijing||2|||f||||f||||||||||2017-10-10 22:42:28.177455|2017-10-10 22:42:28.177455
NCT02616107|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-03-06|||July 2014||2014-07-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|November 9, 2016|Actual|2016-11-09||Interventional|||Improving Cancer Family Caregivers' Knowledge and Communication About Care Options|Improving Cancer Family Caregivers' Knowledge and Communication About Care Options|Completed||N/A|35|Actual|Yale University||2|||f||||f||||||||No||2017-10-10 22:42:28.31142|2017-10-10 22:42:28.31142
NCT02616094|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-08-23|||November 2015||2015-11-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|||Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse|Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse|Recruiting||N/A|210|Anticipated|Yale University||3|||f||||f||||||||||2017-10-10 22:42:28.452105|2017-10-10 22:42:28.452105
NCT02616081|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-08-03|||January 2016||2016-01-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|NBRG-PCORI||Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury|Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury|Active, not recruiting||N/A|1500|Anticipated|University of Utah|||3||f||||f|f|f||||||||2017-10-10 22:42:28.58373|2017-10-10 22:42:28.58373
NCT02616068|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-02-13|||October 2015||2015-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma|A Phase III, Randomized, Double Blind, Non-inferiority, Comparative Study of the New Transdermal Patch Dosage Form Containing Loxoprofen Sodium (100 mg) and Loxonin® (60 mg Tablet) for the Treatment of Acute Traumatic Injuries|Completed||Phase 3|242|Actual|Daiichi Sankyo Brasil Farmacêutica LTDA||2|||f||||f||||||||||2017-10-10 22:42:28.726082|2017-10-10 22:42:28.726082
NCT02616055|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-08-28|||December 2015||2015-12-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101|Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101 in Subjects With Autosomal Dominant Polycystic Kidney Disease|Terminated||Phase 2|15|Actual|Kadmon Corporation, LLC||4||Sponsor opened Phase 2 Study.|f||||t||||||||||2017-10-10 22:42:28.899233|2017-10-10 22:42:28.899233
NCT02616042|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-26|||March 2009||2009-03-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||The Effect of New Dentifrices Containing Centella Asiatica and Bamboo Salt on Reducing Plaque and Gingivitis|The Effect of New Dentifrices Containing Centella Asiatica and Bamboo Salt on Reducing Plaque and Gingivitis: a Randomized Clinical Trial|Completed||Phase 3|33|Actual|LG Household & Health Care Ltd.||3|||f||||t||||||||||2017-10-10 22:42:29.069479|2017-10-10 22:42:29.069479
NCT02616029|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-10-02|||December 17, 2015|Actual|2015-12-17|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 16, 2017|Actual|2017-06-16||Interventional|||Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I|A Phase 3b Open-Label Pilot Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adult Subjects Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I|Recruiting||Phase 3|100|Anticipated|Gilead Sciences||1|||f||||t|t|f||||||||2017-10-10 22:42:29.193638|2017-10-10 22:42:29.193638
NCT02616016|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-10-13|||April 2014||2014-04-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||MRI Guided HIFU for Palliation of Painful Skeletal Metastases in Children|Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases in Children - A Pilot Study|Recruiting||N/A|10|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||||2017-10-10 22:42:29.42026|2017-10-10 22:42:29.42026
NCT02616003|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-04-24|||August 2015||2015-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||Preoperative Condition in Giant Obese Patients|A Novel Preoperative Conditioning Therapy in Giant Obese Patients With the Combination of Liraglutide and a Leucine-Based Amino-Acid Infusion and Caloric Restriction|Recruiting||Phase 4|50|Anticipated|Sana Klinikum Offenbach||1|||f||||f||||||||||2017-10-10 22:42:29.544742|2017-10-10 22:42:29.544742
NCT02615990|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-03-14|||November 2016||2016-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|Mobility||Impact of the Erigo Machine on Functional Recovery in ICU Patients|Impact of the Erigo Machine on Functional Recovery in ICU|Terminated||N/A|2|Actual|University of Kentucky||2||Vendor equipment agreement expired|f||||f|f|t|f|f||||No|This study did not gather data beyond one intervention before closing. This is not applicable.|2017-10-10 22:42:29.709558|2017-10-10 22:42:29.709558
NCT02615977|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-08-10|||April 2015||2015-04-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|LeAD_FP2||Learning and Relapse Risk in Alcohol Dependence (FP2)|Learning and Decision Making as Predictors of Treatment Outcome in Alcohol Use Disorder (Funding Period 2)|Recruiting||N/A|170|Anticipated|Technische Universität Dresden||2|||f||||f||||||||||2017-10-10 22:42:29.832593|2017-10-10 22:42:29.832593
NCT02615964|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-05-10|||May 2015||2015-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|||Nova Cold Hands Raynaud's Disorder, a Disease Which Results in Decreased Blood Flow to the Hands and Feet.|'Defining the Gold Standard in Diagnosis and Stratification of Raynaud's Disorder', Nova Cold Hands Raynaud's Disorder. Raynaud's Disease is a Vascular Disorder Which Results in Decreased Blood Flow to the Hands and Feet.|Completed||N/A|5|Actual|University of Illinois at Chicago|||1||f||||f||||||||||2017-10-10 22:42:29.970032|2017-10-10 22:42:29.970032
NCT02615951|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-11-23|||October 2015||2015-10-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|Breg||Characterization of Breg Cells|Characterization of B Regulatory (Breg) Cells in Healthy Subjects and in Rheumatoid Arthritis (RA)|Recruiting||N/A|100|Anticipated|University Hospital, Montpellier||5|||f||||f||||||||||2017-10-10 22:42:30.056069|2017-10-10 22:42:30.056069
NCT02615938|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2017-03-19|||April 2015||2015-04-01|March 2017|2017-03-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Interventional|chILD-EU_HCQ||Hydroxychloroquin (HCQ) in Pediatric Interstitial Lung Disease (ILD)|Hydroxychloroquine in Pediatric ILD: START Randomized Controlled in Parallel-group, Then Switch Placebo to Active Drug, and STOP Randomized Controlled in Parallel-Group to Evaluate the Efficacy and Safety of Hydroxychloroquine (HCQ)|Recruiting||Phase 2|80|Anticipated|Ludwig-Maximilians - University of Munich||4|||f||||t||||||||||2017-10-10 22:42:30.17733|2017-10-10 22:42:30.17733
NCT02615925|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-04-06|||November 4, 2014|Actual|2014-11-04|March 2017|2017-03-01|April 11, 2016|Actual|2016-04-11|April 11, 2016|Actual|2016-04-11||Interventional|URGPSYMAY||Descriptive Study of Mental Activity|Descriptive Study of Mental Activity in the Emergency Department of the Centre Hospitalier de Mayotte|Completed||N/A|564|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 22:42:30.352695|2017-10-10 22:42:30.352695
NCT02615912|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-09-26|||November 2015||2015-11-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants|A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants|Completed||N/A|24|Actual|Kimberly-Clark Corporation||1|||f||||f||||||||Undecided||2017-10-10 22:42:30.446842|2017-10-10 22:42:30.446842
NCT02615899|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-25|||November 2013||2013-11-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effectiveness of Impairment Specific Exercises for Balance and Fall Risk in Community-Living Older Adults at Risk: A Randomized Controlled Trial||Completed||N/A|40|Actual|Drexel University||2|||f||||f||||||||||2017-10-10 22:42:30.553288|2017-10-10 22:42:30.553288
NCT02615886|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-07-18|||November 2014||2014-11-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Pilot Feasibility of Rice Bran Supplementation in Nicaraguan Children|Pilot Feasibility of Dietary Heat-Stabilized Rice Bran Supplementation for Diarrheal Disease Prevention in Nicaraguan Children|Completed||N/A|47|Actual|Colorado State University||2|||f||||f||||||||||2017-10-10 22:42:30.830711|2017-10-10 22:42:30.830711
NCT02615873|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-14|||July 2016||2016-07-01|October 2015|2015-10-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004|An Open-Label,Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of AP-CD/LD in Fluctuating Parkinson's Disease Subjects Who Completed Study IN 11 004|Not yet recruiting||Phase 3|460|Anticipated|Intec Pharma Ltd.||1|||f||||t||||||||||2017-10-10 22:42:30.946709|2017-10-10 22:42:30.946709
NCT02615860|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-23|||November 2015||2015-11-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|TECAIN||Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive Patients|Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial|Recruiting||N/A|560|Anticipated|University Hospital, Essen||2|||f||||t||||||||||2017-10-10 22:42:31.068163|2017-10-10 22:42:31.068163
NCT02615847|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-08-04|||August 2015||2015-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 31, 2017|Actual|2017-03-31||Interventional|MemSID||Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease Patients|A Phase II, Open Label, Single Center Trial to Study the Safety and Tolerability of Memantin Mepha® as Supportive Long Term Treatment in Symptomatic Sickle Cell Disease|Completed||Phase 2|9|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 22:42:31.251504|2017-10-10 22:42:31.251504
NCT02615834|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-10-24|||May 2017||2017-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Chest Pressure for Intubated Peds Patients|Testing the Ability of Gentle Chest Pressure to Maintain Peripheral Oxygenation in Intubated Pediatric Patients|Not yet recruiting||N/A|80|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 22:42:31.37892|2017-10-10 22:42:31.37892
NCT02615821|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-23|||January 2015||2015-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Mental Contrasting Physical Activity Study|Mental Contrasting Physical Activity Study|Completed||N/A|105|Actual|University of British Columbia||3|||f||||||||||||||2017-10-10 22:42:31.496002|2017-10-10 22:42:31.496002
NCT02615808|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-07-25||||||July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Developing and Evaluating User-Designed Data Displays|Developing and Evaluating User-Designed Data Displays|Withdrawn||N/A|0|Actual|Children's Hospital Medical Center, Cincinnati||2||Change to study design.|f||||f||||||||||2017-10-10 22:42:31.622906|2017-10-10 22:42:31.622906
NCT02615795|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-23|||March 2011||2011-03-01|October 2010|2010-10-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease|Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease. A Clinical, Randomized, Controlled Study for Evaluation of Clinical and Economic Consequences of Monitoring Service|Recruiting||N/A|250|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 22:42:31.714785|2017-10-10 22:42:31.714785
NCT02615782|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-08-08|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects|A Randomized, Open-label, Oral Single Dosing, Two-way Crossover Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 After a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|16|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:42:31.850646|2017-10-10 22:42:31.850646
NCT02615769|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-12-06|||November 2015||2015-11-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect on Attendance if Including Focused Information of Spirometry in Preventive Health Checks|Effect on Attendance if Including Focused Information of Spirometry in Preventive Health Checks - a Randomized Controlled Trial in Primary Health Care|Recruiting||N/A|4356|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 22:42:31.97611|2017-10-10 22:42:31.97611
NCT02615756|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-11-23|||April 2013||2013-04-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|EXEBRAIN||Molecular and Functional Neurobiology of Physical Exercise|Molecular and Functional Neurobiology of Physical Exercise|Recruiting||N/A|50|Anticipated|Turku University Hospital||1|||f||||f||||||||||2017-10-10 22:42:32.123008|2017-10-10 22:42:32.123008
NCT02615730|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-07-12|||February 2016||2016-02-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma|A Phase Ib/IIa, Open-Label, Dose Finding Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of PI3Kβ Selective Inhibitor (GSK2636771) Administered in Combination With Paclitaxel in Advanced Gastric Adenocarcinoma Having Alterations in PI3K Pathway Genes|Recruiting||Phase 1/Phase 2|66|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-10 22:42:32.32564|2017-10-10 22:42:32.32564
NCT02615717|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-12-08|2016-10-17||November 2015||2015-11-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Using Attentional Bias Modification to Address Trauma Symptoms|Using Attentional Bias Modification to Address Trauma Symptoms|Completed||N/A|6|Actual|University of Nebraska Lincoln||2|||f||||f||||||||No||2017-10-10 22:42:32.436062|2017-10-10 22:42:32.436062
NCT02615704|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-09-20|||February 11, 2016|Actual|2016-02-11|September 2017|2017-09-01|December 17, 2018|Anticipated|2018-12-17|December 17, 2018|Anticipated|2018-12-17||Observational|eMocial||"Me and My Heart Study"|Evaluation of an Electronic Device Based Support Tool for ACS Patients: Brilique (Ticagrelor) Treatment Adherence (eMocial)|Recruiting||N/A|920|Anticipated|AstraZeneca|||4||f||||f||||||||||2017-10-10 22:42:32.880605|2017-10-10 22:42:32.880605
NCT02615691|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-04-24|||November 1, 2015||2015-11-01|April 2017|2017-04-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||BAX 855 Previously Untreated Patient (PUP)|Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity, and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) and Minimally Treated Patients (MTPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)|Recruiting||Phase 3|125|Anticipated|Baxalta US Inc.||1|||f||||t||||||||||2017-10-10 22:42:33.093161|2017-10-10 22:42:33.093161
NCT02615678|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2016-10-12|||October 2015||2015-10-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|January 2017|Anticipated|2017-01-01||Interventional|||Acupuncture for CIPN in Breast Cancer Patients|Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients- A Case Series|Recruiting||N/A|10|Anticipated|Southern California University of Health Sciences||1|||f||||f||||||||||2017-10-10 22:42:33.324391|2017-10-10 22:42:33.324391
NCT02615665|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-24|||January 2013||2013-01-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases|Role of CD3+ and NKp46+ Cells in Resected Colorectal Liver Metastases.|Completed||N/A|121|Actual|University of Milan|||1||f||||f||||||Samples Without DNA|"     We use the surgical specimens.   "|||2017-10-10 22:42:33.413917|2017-10-10 22:42:33.413917
NCT02615652|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-05-10|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Observational|||The Impact of Lifestyle on Mental Health Among Young Men in the Gilgel Gibe Field Research Center, Ethiopia: Pilot Study||Completed||N/A|865|Actual|University of Konstanz|||1||f||||f||||||Samples Without DNA|"     Immunoassay test for the screening of khat alkaloids in urine.   "|||2017-10-10 22:42:33.490033|2017-10-10 22:42:33.490033
NCT02615639|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-24|||November 2015||2015-11-01|November 2015|2015-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|CTHBVACADCHB||A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB|A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in Chronic Hepatitis B|Not yet recruiting||Phase 1/Phase 2|450|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||6|||f||||t||||||||||2017-10-10 22:42:33.549769|2017-10-10 22:42:33.549769
NCT02615626|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-24|||May 2012||2012-05-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Observational|VL||Visfatin Levels Before and After Periodontal Treatment|Gingival Crevicular Fluid and Serum Levels of Visfatin in Periodontal Diseases Before and After Non-surgical Periodontal Treatment|Completed||N/A|45|Actual|Bulent Ecevit University|||3||f||||f||||||Samples Without DNA|"     Gingival crevicular fluid and Serum   "|||2017-10-10 22:42:33.654032|2017-10-10 22:42:33.654032
NCT02615613|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-25|2015-11-26|||January 2014||2014-01-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Food Hedonics on Appetite Hormones Levels|Effect of Food Acceptability on Appetite Hormones' Response in Normal Weight Male Subjects|Completed||N/A|11|Actual|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-10 22:42:33.720598|2017-10-10 22:42:33.720598
NCT02615600|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-10-25|||November 2015||2015-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Daily Bitemporal Low-frequency Transcranial Random Noise Stimulation in Tinnitus (tRNS2-tin)|Effectiveness of Daily Bitemporal Low-frequency Transcranial Random Noise Stimulation in Patients With Chronic Tinnitus|Recruiting||N/A|30|Anticipated|University of Regensburg||1|||f||||t||||||||No||2017-10-10 22:42:33.787566|2017-10-10 22:42:33.787566
NCT02615587|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-02-04|||October 2015||2015-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Burden of Illness in Atrial Fibrillation|Burden of Illness in Atrial Fibrillation in Denmark|Completed||N/A|107532|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:42:33.893958|2017-10-10 22:42:33.893958
NCT02599571|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-06-06|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|ADHDenic||Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers|Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers|Recruiting||N/A|350|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:45:38.875057|2017-10-10 22:45:38.875057
NCT02615574|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-09-25|||March 2016||2016-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer|A Phase 2 Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer|Withdrawn||Phase 2|0|Actual|University of Pittsburgh||1||Due to inadequate supply of drug|f||||t||||||||||2017-10-10 22:42:34.025348|2017-10-10 22:42:34.025348
NCT02615561|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-09-14|||December 15, 2015|Actual|2015-12-15|September 2017|2017-09-01|September 7, 2016|Actual|2016-09-07|September 7, 2016|Actual|2016-09-07||Interventional|||Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product|Multicenter, Two-phase Exploratory Clinical Trial to Examine Efficacy and Safety After Open-label Topical Administration of a Medical Device (Bepanthen Itch Relief Cream) for Treatment of Acute Flare-ups Followed by Topical Administration of a New Cosmetic Bepanthen Product or a Cosmetic Comparator in a Parallel-group, Randomized, Investigator-blinded Care Phase for Skin Care in the Remission Phase in Infants With Mild Atopic Dermatitis|Completed||N/A|136|Actual|Bayer||3|||f||||f||||||||||2017-10-10 22:42:34.139824|2017-10-10 22:42:34.139824
NCT02615548|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-11-18|||March 2016||2016-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Exercise for Adults With Parkinson Disease|Investigating the Effect of Specific, Long- Term, Community-based Exercises on Walking, Balance, and Quality of Life in Adults With Parkinson Disease.|Active, not recruiting||N/A|30|Actual|University of British Columbia||2|||f||||t||||||||Undecided||2017-10-10 22:42:35.039236|2017-10-10 22:42:35.039236
NCT02615535|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-09-12|||December 2015||2015-12-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury|Neurofeedback-enhanced Mindfulness Meditation for the Treatment of Affective and Attentional Disturbances in Patients With Traumatic Brain Injury|Active, not recruiting||N/A|20|Actual|Spaulding Rehabilitation Hospital||2|||f||||f||||||||||2017-10-10 22:42:35.168696|2017-10-10 22:42:35.168696
NCT02615522|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|January 2028|Anticipated|2028-01-01|August 2027|Anticipated|2027-08-01||Observational|||Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration|Prospektive, Klinische Verlaufsuntersuchung (Post Market Follow-Up) Der primären Knieendoprothese BPK-S Integration|Recruiting||N/A|200|Anticipated|Peter Brehm GmbH|||1||f||||f||||||||||2017-10-10 22:42:35.306187|2017-10-10 22:42:35.306187
NCT02615509|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-05-19|||January 2016||2016-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:42:35.400577|2017-10-10 22:42:35.400577
NCT02615496|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-14|||December 7, 2015|Actual|2015-12-07|September 2017|2017-09-01|January 31, 2017|Actual|2017-01-31|September 30, 2016|Actual|2016-09-30||Observational|||Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept|Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: An Observational Postauthorisation Study|Completed||N/A|716|Actual|Bayer|||2||f||||f|f|f||||||||2017-10-10 22:42:35.451124|2017-10-10 22:42:35.451124
NCT02615483|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-03-27|||November 2015||2015-11-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|May 2017|Anticipated|2017-05-01||Interventional|||Lumbar Spinal Fusion - Web-based Platform Targeting Anxiety and Depression|Lumbar Spinal Fusion - Web-based Platform Targeting Anxiety and Depression|Recruiting||N/A|114|Anticipated|Central Jutland Regional Hospital||2|||f||||t||||||||No|We do not plan to share data|2017-10-10 22:42:35.574154|2017-10-10 22:42:35.574154
NCT02615470|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-30|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Enhancing a Sustainable Pharmacy-based Immunization Program in Two States|Impact of a Multicomponent Immunization Intervention on Pneumococcal and Herpes Zoster Vaccinations: A Randomized Controlled Trial of Community Pharmacies in 2 States|Active, not recruiting||N/A|64|Actual|Auburn University||2|||f||||f||||||||||2017-10-10 22:42:35.688173|2017-10-10 22:42:35.688173
NCT02615457|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-24|||October 2015||2015-10-01|November 2015|2015-11-01||||October 2025|Anticipated|2025-10-01||Interventional|||Huaier Granule in Treating Women With Triple Negative Breast Cancer||Recruiting||Phase 4|300|Anticipated|Shandong University||2|||f||||f||||||||||2017-10-10 22:42:35.799443|2017-10-10 22:42:35.799443
NCT02615444|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-09-26|||October 2015||2015-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effects of Beta-glucan Enriched Oatcake Consumption on Metabolic Disease Risk Factors|An Investigation of the Effects of Consuming Oatcakes Containing 4g of Oat Beta-glucan on Physiological Parameters in Individuals at Risk of Developing Metabolic Syndrome|Enrolling by invitation||N/A|90|Anticipated|Queen Margaret University||2|||f||||f||||||||||2017-10-10 22:42:35.902844|2017-10-10 22:42:35.902844
NCT02615431|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-06-09|||November 2015||2015-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|MiClAS||The Influence of MitraClip on Apnoea Asleep|the Influence of MitraClip on Apnoea Asleep|Active, not recruiting||N/A|34|Anticipated|RWTH Aachen University|||1||f||||f||||||||||2017-10-10 22:42:36.020844|2017-10-10 22:42:36.020844
NCT02615418|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-26|||January 2016||2016-01-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|NIBSTCLBP||Non Invasive Brain Stimulation Treatment for CLBP|A Novel Non Invasive Brain Stimulation,tDCS Based Treatment for Chronic Low Back Pain (CLBP)-Sourasky Medical Center-Tel Aviv|Not yet recruiting||N/A|60|Anticipated|NIBS NeuroScience Technologies||2|||f||||f||||||||||2017-10-10 22:42:36.100366|2017-10-10 22:42:36.100366
NCT02615405|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-25|||August 2012||2012-08-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour||Completed||N/A|240|Actual|National Science Council, Taiwan||3|||f||||t||||||||||2017-10-10 22:42:36.195419|2017-10-10 22:42:36.195419
NCT02615392|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-06-27|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Park Prescription Trial|Park Prescription Trial|Completed||N/A|160|Actual|National University, Singapore||2|||f||||f||||||||||2017-10-10 22:42:36.300258|2017-10-10 22:42:36.300258
NCT02615379|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-08-10|||July 1, 2017|Anticipated|2017-07-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion|A Prospective, Randomized, Parallel Pilot Study of Transdermal, Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion|Withdrawn||N/A|0|Actual|Neogenix, LLC dba Ogenix||2||Administrative reasons|f||||t|f|t|f|f||||||2017-10-10 22:42:36.817301|2017-10-10 22:42:36.817301
NCT02615366|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-01-11|||February 2016||2016-02-01|January 2016|2016-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|TABBS||Tranexamic Acid for Bleeding in Breast Surgery|Minimization of Bleeding Complications Through Utilization of Perioperative Tranexamic Acid in Breast Surgery: A Randomized Double-blinded Placebo-controlled Trial|Not yet recruiting||Phase 4|800|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:42:36.932876|2017-10-10 22:42:36.932876
NCT02615353|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-06-27|||January 2016||2016-01-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Preventing Diabetes in Latino Youth|Preventing Diabetes in Latino Youth|Recruiting||Early Phase 1|120|Anticipated|Arizona State University||2|||f||||t||||||||Yes||2017-10-10 22:42:37.041549|2017-10-10 22:42:37.041549
NCT02615340|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-03-15|||April 2016||2016-04-01|November 2015|2015-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|MELLOW-1||Melatonin for Prevention of Delirium in Critically Ill Patients|Efficacy and Safety of Melatonin for Prevention of Delirium in Critically Ill Patients: A Multi-centre, Randomized, Triple-blind, Placebo-controlled Feasibility Study|Not yet recruiting||Phase 2|69|Anticipated|Mount Sinai Hospital, Canada||3|||f||||f||||||||||2017-10-10 22:42:37.161631|2017-10-10 22:42:37.161631
NCT02615327|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-02-06|||November 2015||2015-11-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|Fiber2||Effect of Fiber on Glycemic Index|Verifying Fibers Meet Regulatory Definitions for Nutrition Facts Labeling: A Randomized, Controlled Trial Evaluating Polydextrose|Active, not recruiting||N/A|40|Anticipated|Institute for Food Safety and Health, United States||4|||f||||f||||||||||2017-10-10 22:42:37.33025|2017-10-10 22:42:37.33025
NCT02615314|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2015-11-25|||January 2015||2015-01-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and Migraine|Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and Migraine|Completed||N/A|232|Actual|Anadolu Medical Center|||2||f||||f||||||||||2017-10-10 22:42:37.423044|2017-10-10 22:42:37.423044
NCT02615301|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-24|||January 2009||2009-01-01|November 2015|2015-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Dietary Intake of Salmon and Bone Health|Intake of Dietary Vitamin D and K From Tailor-made Atlantic Salmon and Bone Health - A Randomized Intervention Study|Completed||N/A|122|Actual|National Institute of Nutrition and Seafood Research, Norway||4|||f||||t||||||||||2017-10-10 22:42:37.519923|2017-10-10 22:42:37.519923
NCT02615288|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-24|||January 2014||2014-01-01|November 2015|2015-11-01||||March 2015|Actual|2015-03-01||Interventional|||High Dose Vitamin D3 in Crohn's Disease|Impact of High Dose Vitamin D3 Supplementation in Treatment of Crohn's Disease in Remission: A Randomized Double-blind Controlled Study|Completed||N/A|40|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 22:42:37.61615|2017-10-10 22:42:37.61615
NCT02615275|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-09-14|||November 24, 2015|Actual|2015-11-24|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Multifrequency Bioelectrical Impedance Analysis to Estimate Body Composition|Validation of Eight-Electrode Multifrequency Bioelectrical Impedance Analysis to Estimate Body Composition in a Head and Neck Cancer Population Undergoing Radiation Therapy|Active, not recruiting||N/A|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:42:37.699478|2017-10-10 22:42:37.699478
NCT02615262|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-12-17|||December 2015||2015-12-01|December 2015|2015-12-01||||May 2017|Anticipated|2017-05-01||Interventional|||Intraoperative Dexamethasone in Pediatric Cardiac Surgery|Intraoperative Dexamethasone in Pediatric Cardiac Surgery: a Prospective Double-blind Randomised Clinical Trial|Recruiting||Phase 3|384|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 22:42:37.838879|2017-10-10 22:42:37.838879
NCT02615249|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-25|||April 2016||2016-04-01|November 2015|2015-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Clinical Evaluation of Metal Panel Allergens: Dose Response Study|Clinical Evaluation of Metal Panel Allergens: Aluminum, Copper, Manganese, Molybdenum, Tin, Titanium, Vanadium and Zinc Dose Response Study|Not yet recruiting||Phase 2|400|Anticipated|Allerderm||1|||f||||f||||||||||2017-10-10 22:42:37.959274|2017-10-10 22:42:37.959274
NCT02615236|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-07-07|||June 2016||2016-06-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Prospective Evaluation of Perineal Ultrasound in Thr Delivery Room to Improve the Diagnosis of OASIS|Prospective Evaluation of Perineal Ultrasound in Thr Delivery Room to Improve the Diagnosis of OASIS|Enrolling by invitation||N/A|300|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:42:38.108596|2017-10-10 22:42:38.108596
NCT02615223|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-06-09|||November 2015||2015-11-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CRYO-PCA-IV||Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer|A Prospective Multi-center Study to Compare the QOL and Efficacy of Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer.|Recruiting||N/A|120|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-10 22:42:38.200137|2017-10-10 22:42:38.200137
NCT02615210|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-07-26|||November 2015||2015-11-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|SOCABS||Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures|Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures|Not yet recruiting||N/A|60|Anticipated|Temple University||2|||f||||t||||||||||2017-10-10 22:42:38.307463|2017-10-10 22:42:38.307463
NCT02615197|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-03-23|||February 2016|Actual|2016-02-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients|Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients|Recruiting||Phase 2/Phase 3|75|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 22:42:38.405686|2017-10-10 22:42:38.405686
NCT02615184|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-03-10|||November 2015||2015-11-01|March 2016|2016-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants|A Phase 2, Double Blind, Up to 40 Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 1 to 11 Years With EE|Suspended||Phase 2|80|Anticipated|Takeda||5|||f||||f||||||||||2017-10-10 22:42:38.522816|2017-10-10 22:42:38.522816
NCT02615171|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-01|||October 1, 2017|Anticipated|2017-10-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||RELAX: A Mobile Application Suite Targeting Obesity and Stress|RELAX: A Mobile Application Suite Targeting Obesity and Stress|Not yet recruiting||N/A|60|Anticipated|University of Massachusetts, Worcester||3|||f||||t|f|f||||||||2017-10-10 22:42:38.707927|2017-10-10 22:42:38.707927
NCT02615158|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-11-23|||April 2006||2006-04-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Interventional|TOPS||Toddler Overweight Prevention Study Among Low-Income Families|Toddler Overweight Prevention: Comparison of Maternal and Toddler Intervention|Completed||N/A|277|Actual|University of Maryland||3|||f||||t||||||||||2017-10-10 22:42:38.824554|2017-10-10 22:42:38.824554
NCT02615145|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-08-21|||December 3, 2015||2015-12-03|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|LIFE-C||Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)|Active, not recruiting||N/A|1000|Anticipated|AbbVie|||4||f||||f||||||||||2017-10-10 22:42:38.931359|2017-10-10 22:42:38.931359
NCT02615132|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-09-20|||December 2015||2015-12-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||TeleRehab for Stroke Patients Using Mobile Technology|TeleRehab for Patients With Post-Stroke Communication Deficits Using Mobile Technology|Completed||N/A|20|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 22:42:39.101506|2017-10-10 22:42:39.101506
NCT02615119|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-05-15|||October 2015||2015-10-01|May 2017|2017-05-01|December 2027|Anticipated|2027-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa|Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa|Recruiting||N/A|310|Anticipated|Laureate Institute for Brain Research, Inc.||6|||f||||t||||||||No||2017-10-10 22:42:39.216303|2017-10-10 22:42:39.216303
NCT02615106|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2016-06-12|||November 2015||2015-11-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma|Phase 2 Study of Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma|Recruiting||Phase 2|60|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||Undecided||2017-10-10 22:42:39.376148|2017-10-10 22:42:39.376148
NCT02615080|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-02-24|||November 30, 2015|Actual|2015-11-30|February 2017|2017-02-01|February 24, 2017|Actual|2017-02-24|February 21, 2017|Actual|2017-02-21||Interventional|||Safety and Efficacy of CRD007 in Adult Asthma Subjects|A Double-Blind, Randomised, Placebo-controlled, Parallel Group, International, Multi-centre Phase 2 Trial Investigating the Safety and Efficacy of CRD007 in Adult Subjects With Asthma|Completed||Phase 2|168|Actual|RSPR Pharma AB||2|||f||||f||||||||||2017-10-10 22:42:39.493524|2017-10-10 22:42:39.493524
NCT02615067|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-09-21|||December 2015||2015-12-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|proSPECT-AS||Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer|A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)|Recruiting||Phase 3|600|Anticipated|Molecular Insight Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-10 22:42:39.88901|2017-10-10 22:42:39.88901
NCT02615054|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-08-14|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors|Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors|Recruiting||N/A|55|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-10-10 22:42:40.472263|2017-10-10 22:42:40.472263
NCT02615041|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-24|||January 2004||2004-01-01|November 2015|2015-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||The Pharmacodynamics of Meropenem in Patient With Ventilator-associated Pneumonia|The Pharmacodynamics of Meropenem in Patient With Ventilator-associated Pneumonia|Completed||Phase 4|9|Actual|Prince of Songkla University||3|||f||||f||||||||||2017-10-10 22:42:40.628884|2017-10-10 22:42:40.628884
NCT02615028|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-23|||December 2012||2012-12-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Development of Novel Designed Force Plate for Measuring the Balance Ability for the Elders|Kaohsiung Medical University Chung-Ho Memorial Hospital Institutional Review Board|Completed||N/A|40|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||||2017-10-10 22:42:40.791407|2017-10-10 22:42:40.791407
NCT02615015|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-03-21|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||SNPs in the DNase 1 Gene Impair Its Activity and Are Increased in a STE-ACS Patient Cohort Compared to Healthy Controls|Single Nucleotide Polymorphisms in the Deoxyribonuclease 1 Gene Impair Its Activity and Are Increased in a ST-elevation Acute Coronary Syndrome Patient Cohort Compared to Healthy Controls|Enrolling by invitation||N/A|800|Anticipated|Medical University of Vienna|||2||f||||f||||||Samples With DNA|"     Whole blood draw, DNA isolation, plasma isolation   "|||2017-10-10 22:42:40.892928|2017-10-10 22:42:40.892928
NCT02615002|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-03-12|||November 2015||2015-11-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)|Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease|Recruiting||Phase 2|500|Anticipated|Neurim Pharmaceuticals Ltd.||4|||f||||t||||||||||2017-10-10 22:42:41.041357|2017-10-10 22:42:41.041357
NCT02614989|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-24|||January 2016||2016-01-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||MRI Guided Focused Ultrasound for Tremor in Multiple Sclerosis|MRI Guided Focused Ultrasound for Tremor in Multiple Sclerosis|Not yet recruiting||N/A|15|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-10 22:42:41.485816|2017-10-10 22:42:41.485816
NCT02614976|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-10-12|||April 2013||2013-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Incidences of Cuff-related Trauma After Noninvasive Blood Pressure Measurement Between With and Without Padding|Incidences of Cuff-related Trauma After Noninvasive Blood Pressure Measurement Between With and Without Padding|Recruiting||N/A|300|Anticipated|Siriraj Hospital||2|||f||||t||||||||||2017-10-10 22:42:41.583056|2017-10-10 22:42:41.583056
NCT02614963|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-05-15|||December 2015||2015-12-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome|Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome: A Randomized, Double-blinded,Placebo- Controlled Multicenter Study|Recruiting||Phase 4|300|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 22:42:41.68464|2017-10-10 22:42:41.68464
NCT02614950|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-01-25|||February 2016||2016-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection|Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection|Completed||N/A|8|Actual|South East Asia Research Collaboration with Hawaii||1|||f||||t||||||||||2017-10-10 22:42:41.810418|2017-10-10 22:42:41.810418
NCT02614937|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-24|||April 2013||2013-04-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion|Open Label Squalamine Lactate Ophthalmic Solution for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)|Completed||Phase 1/Phase 2|20|Actual|Ohr Pharmaceutical Inc.||3|||f||||f||||||||||2017-10-10 22:42:41.924184|2017-10-10 22:42:41.924184
NCT02614924|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-07-12|2016-03-16||November 2012||2012-11-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Comparison of Flexible Fibreoptic Scope With Pentax AWS Videolaryngoscope for Ease of Intubation During Awake Intubation|Comparison of Flexible Fibreoptic Scope With Pentax AWS Videolaryngoscope for Ease of Intubation During Awake Intubation|Completed||N/A|40|Actual|University Hospitals Coventry and Warwickshire NHS Trust||2|||f||||f||||||||No||2017-10-10 22:42:42.036017|2017-10-10 22:42:42.036017
NCT02614911|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-08-24|||June 2014||2014-06-01|August 2017|2017-08-01|June 2029|Anticipated|2029-06-01|June 2029|Anticipated|2029-06-01||Observational|IMMUNOBIOTA||Characterization of Phenotype and Genotype of Early Onset Enteropathies|Host-Microbiota Interactions Across the Gut Immune System: Characterization of Phenotype and Genotype of Early Onset Enteropathies|Recruiting||N/A|346|Anticipated|Imagine Institute|||2||f||||f||||||Samples With DNA|"     Collection of:        -  blood samples        -  feces        -  biopsies (intestine / skin)        -  saliva        -  urina   "|||2017-10-10 22:42:42.317903|2017-10-10 22:42:42.317903
NCT02614898|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-06-02|||November 2015||2015-11-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|EVIDENCE||Eval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and Treatment|Evaluation of Potential Predictors of Disease Progression in Patients With aHUS, Including Genetics, Biomarkers and Treatment|Enrolling by invitation||Phase 4|330|Anticipated|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-10-10 22:42:42.435844|2017-10-10 22:42:42.435844
NCT02614885|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-23|||January 2016||2016-01-01|November 2015|2015-11-01||||January 2017|Anticipated|2017-01-01||Observational|||Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue|Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue|Not yet recruiting||N/A|10|Anticipated|Innoblative Designs, Inc.|||1||f||||f||||||||||2017-10-10 22:42:42.566326|2017-10-10 22:42:42.566326
NCT02614872|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2016-06-08|||March 2016||2016-03-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|||Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation|A Proof of Concept (POC) Study, Phase II, Open Label, Randomized, Standard Care - Controlled, Single Center Study Evaluating the Safety and Efficacy of Human, Alpha-1 Antitrypsin (AAT) [GLASSIA®] Treatment in First Lung Transplantation|Recruiting||Phase 2|30|Anticipated|Kamada, Ltd.||2|||f||||f||||||||No||2017-10-10 22:42:42.656977|2017-10-10 22:42:42.656977
NCT02614859|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-01-25|||December 2015|Actual|2015-12-01|January 2017|2017-01-01|April 2022|Anticipated|2022-04-01|April 2020|Anticipated|2020-04-01||Interventional|BIMET-1||Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients|Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients (BIMET-1)|Recruiting||Phase 2|66|Anticipated|Fox Chase Cancer Center||2|||f||||t||||||||||2017-10-10 22:42:42.769546|2017-10-10 22:42:42.769546
NCT02614846|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-22|||August 2015||2015-08-01|November 2015|2015-11-01||||March 2016|Anticipated|2016-03-01||Interventional|||Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients|A Safety, Pharmacokinetics and Pharmacodynamics Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura|Recruiting||Phase 1|29|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||||||||||||2017-10-10 22:42:42.864206|2017-10-10 22:42:42.864206
NCT02614820|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-22|||November 2015||2015-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD||Recruiting||N/A|100|Anticipated|General Hospital of Chinese Armed Police Forces||2|||f||||||||||||||2017-10-10 22:42:43.161115|2017-10-10 22:42:43.161115
NCT02614807|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Protein Supplementation in Thiazide-induced Hyponatremia|Thiazide Diuretic-caused Hyponatremia in the Elderly Hypertensive: Will a Bottle of Nepro a Day Keep Hyponatremia and the Doctor Away? A Proof-of-Concept Trial|Recruiting||N/A|40|Anticipated|Ottawa Hospital Research Institute||1|||f||||f||||||||Undecided||2017-10-10 22:42:43.275909|2017-10-10 22:42:43.275909
NCT02614781|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-07-06|||November 2015||2015-11-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea|Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea|Completed||N/A|892|Actual|Nordic Pharma SAS|||1||f||||f||||||||||2017-10-10 22:42:45.858825|2017-10-10 22:42:45.858825
NCT02614768|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2016-03-02|||July 2015||2015-07-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Standardized Evaluation of Subcutaneous Glucose Monitoring Systems Under Routine Environmental Conditions|Standardized Evaluation of Subcutaneous Glucose Monitoring Systems Under Routine Environmental Conditions|Completed||N/A|12|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-10 22:42:45.92847|2017-10-10 22:42:45.92847
NCT02614755|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-05-23|||November 2015||2015-11-01|May 2017|2017-05-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Observational|||An Observational Study of Lumosity in Seniors|An Observational Study of Lumosity in Seniors|Completed||N/A|68|Actual|Lumos Labs, Inc.|||1||f||||f||||||||||2017-10-10 22:42:46.002869|2017-10-10 22:42:46.002869
NCT02614742|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-04-27|||April 2016||2016-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|SAS||SFX01 After Subarachnoid Haemorrhage|SFX-01 After Subarachnoid Haemorrhage|Recruiting||Phase 2|90|Anticipated|Evgen Pharma||2|||f||||t||||||||||2017-10-10 22:42:46.079835|2017-10-10 22:42:46.079835
NCT02614716|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-08-04|||December 2015||2015-12-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)|A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3090106 in Subjects With Sjögren's Syndrome|Recruiting||Phase 1|32|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:42:46.453994|2017-10-10 22:42:46.453994
NCT02614703|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-03-10|||March 10, 2017|Actual|2017-03-10|March 2017|2017-03-01|December 13, 2018|Anticipated|2018-12-13|September 13, 2018|Anticipated|2018-09-13||Interventional|||"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance"|"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance is Superior to the Standardized Random Biopsy Protocol in Detecting Neoplasia: A Prospective Randomized Study"|Recruiting||Phase 2/Phase 3|185|Anticipated|Doctors Hospital at Renaissance||2|||f||||t|t|f||||||No|There is no plan to make individual data available unless otherwise asked for safety reason.|2017-10-10 22:42:46.632208|2017-10-10 22:42:46.632208
NCT02614677|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-11-22|||August 2014||2014-08-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||To Advance the New Disability Evaluation System in Taiwan||Completed||N/A|250|Actual|Changhua Christian Hospital|||1||f||||||||||||||2017-10-10 22:42:46.847063|2017-10-10 22:42:46.847063
NCT02614664|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-07-24|||November 2015||2015-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Changes in Cerebral Oxygenation During Laparoscopy in Patients With Single Ventricle Anatomy||Enrolling by invitation||N/A|50|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 22:42:46.918645|2017-10-10 22:42:46.918645
NCT02614651|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-07-18|||May 2016||2016-05-01|May 2016|2016-05-01|May 29, 2017|Actual|2017-05-29|April 20, 2017|Actual|2017-04-20||Interventional|AUREVI 1||AUgmented REality for the Visually Impaired - Part 1|Prospective Pilot Study on the Quantitative Evaluation of Vision Parameters Needed by Virtual Reality Goggle Displays for Subjects With Concentric Visual Field Constriction. AUgmented REality for the Visually Impaired - Part 1|Completed||N/A|15|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 22:42:47.01268|2017-10-10 22:42:47.01268
NCT02614638|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-01-31|||September 2016||2016-09-01|January 2017|2017-01-01|December 16, 2016|Actual|2016-12-16|December 16, 2016|Actual|2016-12-16||Interventional|OPTI-PP||Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy|Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy in the Hepato-Gastroenterology Department of the Nîmes University Hospital|Completed||N/A|129|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 22:42:47.136378|2017-10-10 22:42:47.136378
NCT02614625|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-11-22|||December 2014||2014-12-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Spectral-domain Optical Coherence Tomography of the Eye|A Prospective, Comparative, Observational Study on Spectral-domain Optical Coherence Tomography of the Eye|Recruiting||N/A|100|Anticipated|Augenabteilung Allgemeines Krankenhaus Linz|||4||f||||||||||||||2017-10-10 22:42:47.267222|2017-10-10 22:42:47.267222
NCT02614612|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-07-17|||December 2015||2015-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD|A Randomized, Parallel-Cohort Phase 1 Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute Graft Versus Host Disease|Active, not recruiting||Phase 1|31|Actual|Incyte Corporation||2|||f||||t||||||||||2017-10-10 22:42:47.342987|2017-10-10 22:42:47.342987
NCT02614599|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-11-21|||June 2015||2015-06-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|BrainProtein||Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet|Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein|Completed||Early Phase 1|100|Anticipated|Spanish Foundation for Neurometrics Development||2|||f||||t||||||||||2017-10-10 22:42:47.478246|2017-10-10 22:42:47.478246
NCT02614586|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-03-21|2017-03-21||December 2015||2015-12-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Schizophrenia Set included all participants who were enrolled and completed the Screening Phase (Part-1) of the study.|Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia|A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of TAK-058 and Ondansetron on P50 Auditory Gating in Subjects With Stable Schizophrenia|Terminated||Phase 1|11|Actual|Takeda||6|||f||||f||||||||||2017-10-10 22:42:47.570962|2017-10-10 22:42:47.570962
NCT02614573|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-08-24|||February 2016||2016-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|INR-Cap pilote||International Normalised Ratio Evaluation by Generalist Practitioners in Full-time Care Establishments for the Elderly|International Normalised Ratio Evaluation by Generalist Practitioners in Full-time Care Establishments for the Elderly: a Pilot Study|Completed||N/A|31|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||No||2017-10-10 22:42:47.7974|2017-10-10 22:42:47.7974
NCT02614560|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-08-03|||November 2015||2015-11-01|August 2017|2017-08-01|March 2023|Anticipated|2023-03-01|February 10, 2017|Actual|2017-02-10||Interventional|||A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients|A Phase 1/2 Study of Vadastuximab Talirine Administered in Sequence With Allogeneic Hematopoietic Stem Cell Transplant in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 1/Phase 2|14|Actual|Seattle Genetics, Inc.||2|||f||||t||||||||||2017-10-10 22:42:47.883044|2017-10-10 22:42:47.883044
NCT02614547|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-04||2017-08-04|November 2015||2015-11-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating The Efficacy, Safety, And Pharmacokinetics Of SAGE-547 Injection In The Treatment Of Adult Female Subjects With Severe Postpartum Depression|Completed||Phase 2|21|Actual|Sage Therapeutics||2|||f||||f||||||||||2017-10-10 22:42:48.130959|2017-10-10 22:42:48.130959
NCT02614534|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-09-05|||November 2015||2015-11-01|September 2016|2016-09-01||||October 2020|Anticipated|2020-10-01||Interventional|||Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma|Multicentre, Randomized Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma|Recruiting||Phase 3|||Maimónides Biomedical Research Institute of Córdoba|||||f||||f||||||||||2017-10-10 22:42:48.245285|2017-10-10 22:42:48.245285
NCT02614521|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-04-28|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation|A Single-center, Observational, 12-months Study to Examine the Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Patients With Paroxysmal Atrial Fibrillation.|Recruiting||N/A|150|Anticipated|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||No||2017-10-10 22:42:48.333495|2017-10-10 22:42:48.333495
NCT02614508|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-09-29|||January 2016||2016-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|A Phase I Study of Buparlisib (BKM120) and Ofatumumab or Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|1|Actual|Emory University||2|||f||||t||||||||||2017-10-10 22:42:48.432025|2017-10-10 22:42:48.432025
NCT02614495|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2017-06-19|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma|A Multi-center , Opened, Phase II Study of Safety and Efficacy of Sulfatinib in Advanced Medullary Thyroid Carcinoma ( MTC) and Iodine-refractory Differentiated Thyroid Carcinoma (DTC)|Recruiting||Phase 2|50|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||||2017-10-10 22:42:48.539409|2017-10-10 22:42:48.539409
NCT02614482|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2016-11-27|||October 2015||2015-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|FOXY2015||Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.|Efficacy and Tolerability of Fesoterodine for Overactive Bladder Syndrome in Children: an Extension Study.|Recruiting||Phase 3|30|Anticipated|CHU de Quebec-Universite Laval||1|||f||||t||||||||Yes|Publication to be submitted in 2017|2017-10-10 22:42:48.650339|2017-10-10 22:42:48.650339
NCT02614469|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-02-27|2016-10-31||March 2015||2015-03-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||A Food-Drug Interaction Study of Serum Urate After Oral Inosine|A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effects of Food on the Pharmacokinetics of Urate After a Single Dose of Inosine in Healthy Male Subjects|Completed||Phase 1|18|Actual|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-10 22:42:48.76854|2017-10-10 22:42:48.76854
NCT02614456|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-11-22|||December 2015||2015-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors|Combination Immunotherapy With Interferon-gamma and Nivolumab for Patients With Advanced Solid Tumors: A Phase 1 Study|Recruiting||Phase 1|15|Anticipated|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-10 22:42:49.279415|2017-10-10 22:42:49.279415
NCT02614443|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-08-17|||October 2015||2015-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|EAITDAS||Effectiveness and Acceptability of Internet-delivered Treatment for Depression, Anxiety and Stress|Effectiveness and Acceptability of Internet-delivered Treatment for Depression, Anxiety and Stress in University Students: Protocol for an Open Feasibility Trial|Recruiting||N/A|100|Anticipated|Silver Cloud Health||3|||f||||t||||||||||2017-10-10 22:42:49.380328|2017-10-10 22:42:49.380328
NCT02614430|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-09-05|||September 2015||2015-09-01|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|May 1, 2017|Actual|2017-05-01||Interventional|||Recover Working Life - Back on the Job After Acute Illness|Recover Working Life - Back on the Job After Acute Illness. A Study of the Effect on Functional Capacity and Self-rated Health and Working Capacity of a Vocational Training Course After Discharge From an Acute Hospitalisation|Completed||N/A|38|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 22:42:49.516647|2017-10-10 22:42:49.516647
NCT02614417|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-11-23|||June 2013||2013-06-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Sleep-disordered Breathing in Eisenmenger Syndrome|Sleep-disordered Breathing in Eisenmenger Syndrome|Completed||N/A|20|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-10 22:42:49.607043|2017-10-10 22:42:49.607043
NCT02614404|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-02-27|||November 2015||2015-11-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|MIM||Imatinib's Effect on the Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria|Imatinib's Effect on the Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria|Recruiting||Phase 1/Phase 2|20|Anticipated|HuLow||1|||f||||f||||||||||2017-10-10 22:42:49.671733|2017-10-10 22:42:49.671733
NCT02614391|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-27|||March 2013||2013-03-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Tablet Distraction for Pain Control During Venipuncture|Randomized Controlled Trial to Evaluate Tablet Distraction for Pain Control in Children Underwent Venipuncture|Completed||Phase 3|200|Actual|IRCCS Burlo Garofolo||2|||f||||f||||||||||2017-10-10 22:42:49.76155|2017-10-10 22:42:49.76155
NCT02614378|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2016-12-13|||November 2015||2015-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Abortive Effect of an Ear Insufflator on Migraine|Abortive Effect of an Ear Insufflator on Migraine|Completed||N/A|58|Actual|Carrick Institute for Graduate Studies||2|||f||||f||||||||No||2017-10-10 22:42:49.838028|2017-10-10 22:42:49.838028
NCT02614365|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-10-05|||July 2014||2014-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|GEMSII||Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach|Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach|Recruiting||N/A|80|Anticipated|Howard University||2|||f||||t||||||||||2017-10-10 22:42:49.92444|2017-10-10 22:42:49.92444
NCT02614352|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-24|2015-11-24||||||November 2015|2015-11-01||||February 2016|Anticipated|2016-02-01||Interventional|||Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects||Not yet recruiting||Phase 1|60|Anticipated|Ahn-Gook Pharmaceuticals Co.,Ltd||2|||f||||||||||||||2017-10-10 22:42:50.029817|2017-10-10 22:42:50.029817
NCT02614339|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-23|||December 2015||2015-12-01|November 2015|2015-11-01|November 2021|Anticipated|2021-11-01|July 2021|Anticipated|2021-07-01||Interventional|||Effect of Adjunctive Metformin on Recurrence of Non-DM Stage III Colorectal Cancer: Open-label Randomized Controlled Study||Not yet recruiting||Phase 3|593|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-10 22:42:50.124189|2017-10-10 22:42:50.124189
NCT02614326|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-02-21|||January 2016||2016-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||MemFlex to Prevent Depressive Relapse|A Randomised Controlled Trial of the Efficacy of Autobiographical Memory Flexibility (MemFlex) Training in Preventing Relapse of Recurrent Depression|Recruiting||Phase 2|70|Anticipated|Medical Research Council Cognition and Brain Sciences Unit||2|||f||||f||||||||||2017-10-10 22:42:50.200243|2017-10-10 22:42:50.200243
NCT02614313|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-05-09|||June 2016||2016-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Fructose Breath-testing in Irritable Bowel Syndrome (IBS)|Assessment of Psychological and Metabolic Responses During Fructose Intolerance Breath Tests in Patients With Functional GI Disorders: Placebo-controlled Breath Testing|Not yet recruiting||N/A|30|Anticipated|Brain-Gut Research Group||4|||f||||f||||||||||2017-10-10 22:42:50.317815|2017-10-10 22:42:50.317815
NCT02614300|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-23|||November 2015||2015-11-01|November 2015|2015-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||The Role of Pulmonary Rehabilitation and Airways Clearance Techniques in the Multidisciplinary Management of Non CF Bronchiectasis||Not yet recruiting||N/A|120|Anticipated|Hospital Clinic of Barcelona||4|||f||||t||||||||||2017-10-10 22:42:50.528236|2017-10-10 22:42:50.528236
NCT02614287|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-05-18|||November 2015||2015-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|May 2017|Actual|2017-05-01||Interventional|||A Safety Study of LY2951742 in Participants With Migraine, With or Without Aura|A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 in Patients With Migraine|Active, not recruiting||Phase 3|250|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 22:42:50.641894|2017-10-10 22:42:50.641894
NCT02614261|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-04-19|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|March 2017|Actual|2017-03-01||Interventional|REGAIN||Evaluation of LY2951742 in the Prevention of Chronic Migraine|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study|Active, not recruiting||Phase 3|825|Anticipated|Eli Lilly and Company||3|||f||||t||||||||||2017-10-10 22:42:50.93084|2017-10-10 22:42:50.93084
NCT02614248|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-05-06|||January 2016||2016-01-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population|The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population|Recruiting||N/A|150|Anticipated|Genesis Health System||2|||f||||t||||||||||2017-10-10 22:42:51.295318|2017-10-10 22:42:51.295318
NCT02614235|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-16|||February 2016||2016-02-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|SINPocket||Diagnosis of Arrhythmias in Syncope by Pocket-ECG III® or Conventional Holter|Diagnosis of Arrhythmias in Patients With Syncope by Continuous Cardiac Telemetry (Pocket-ECG III® System) or Conventional Holter|Completed||N/A|40|Actual|Complexo Hospitalario Universitario de A Coruña||2|||f||||f||||||||||2017-10-10 22:42:51.382072|2017-10-10 22:42:51.382072
NCT02614222|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-06-12|2017-01-30||October 26, 2015||2015-10-26|June 2017|2017-06-01|May 25, 2016|Actual|2016-05-25|May 25, 2016|Actual|2016-05-25||Interventional|||Computer Assisted Instrument Guidance (CAIG) for Orthopedic Peripheral Nerve Blocks|Computer Assisted Instrument Guidance (CAIG) For Orthopedic Peripheral Nerve Blocks|Completed||N/A|27|Actual|Clear Guide Medical||2|||f||||f||||||||||2017-10-10 22:42:51.472504|2017-10-10 22:42:51.472504
NCT02614209|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-08-09|||May 2015||2015-05-01|November 2015|2015-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|BNP||Blood Collection of Patient Presenting in the ED and Prescribed a BNP|A Blood Collection From Patients Presenting in the Emergency Department and Prescribed a Brain Natriuretic Peptide (BNP) Laboratory Test|Completed||N/A|400|Actual|Fujirebio Diagnostics, Inc.|||1||f||||f||||||Samples Without DNA|"     Blood sample   "|||2017-10-10 22:42:51.89429|2017-10-10 22:42:51.89429
NCT02614196|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-04-19|||December 2015||2015-12-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|March 2017|Actual|2017-03-01||Interventional|EVOLVE-2||Evaluation of LY2951742 in the Prevention of Episodic Migraine- the EVOLVE-2 Study|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study|Active, not recruiting||Phase 3|825|Anticipated|Eli Lilly and Company||3|||f||||t||||||||||2017-10-10 22:42:52.00218|2017-10-10 22:42:52.00218
NCT02614183|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-04-19|||November 2015||2015-11-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|March 2017|Actual|2017-03-01||Interventional|EVOLVE-1||Evaluation of LY2951742 in the Prevention of Episodic Migraine- the EVOLVE-1 Study|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study|Active, not recruiting||Phase 3|825|Anticipated|Eli Lilly and Company||3|||f||||t||||||||||2017-10-10 22:42:52.35861|2017-10-10 22:42:52.35861
NCT02614170|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-08-09|||March 2015||2015-03-01|November 2015|2015-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Insulin in Healthy Individuals|A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Insulin in Healthy Individuals|Completed||N/A|328|Actual|Fujirebio Diagnostics, Inc.|||1||f||||f||||||Samples Without DNA|"     Serum, Plasma, Random Urine and 24 hour Urine   "|||2017-10-10 22:42:52.785128|2017-10-10 22:42:52.785128
NCT02614157|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-06-11|||May 2016||2016-05-01|June 2016|2016-06-01|May 2022|Anticipated|2022-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer|Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemo-radiation for Preoperative Enlarged Lateral Nodes in Advanced Low Rectal Cancer: a Phase III Randomized Controlled Trial|Recruiting||Phase 3|212|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-10 22:42:52.867387|2017-10-10 22:42:52.867387
NCT02614144|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-24|||January 2013||2013-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01|30 Days|Observational [Patient Registry]|HAP||Epidemiology of Hospital Acquired Pneumonia|Identifying Agents of Early-onset and Late-onset Nosocomial Pneumonia in Patients in Intensive Care Through Genetic Analysis of Bacterial DNA and Determination of Their Distribution.|Completed||N/A|214|Actual|University Hospital Olomouc|||1||f||||t||||||Samples With DNA|"     In intubated patients, secretion samples for microbiology culture tests are obtained by     aspiration from the lower airway.   "|||2017-10-10 22:42:53.005516|2017-10-10 22:42:53.005516
NCT02614131|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-01-06|||December 2015||2015-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)|Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease|Terminated||Phase 1|130|Actual|Eli Lilly and Company||6||New data suggests that insufficient target engagement would be achieved for efficacy.|f||||f||||||||||2017-10-10 22:42:53.085021|2017-10-10 22:42:53.085021
NCT02614118|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-09-17|||September 2015||2015-09-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Premedication Efficacy of Oral Ketorolac and Ketorolac/ Acetaminophen on Post Treatment Pain|Premedication Efficacy of Oral Ketorolac and Ketorolac/ Acetaminophen on Post Endodontic Treatment Pain|Completed||Phase 2|66|Actual|Azad University of Medical Sciences||3|||f||||t||||||||||2017-10-10 22:42:53.211396|2017-10-10 22:42:53.211396
NCT02614105|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-09-28|||November 2015||2015-11-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|UriCO||Urinary Incontinence Amongst Women With Chronic Obstructive Pulmonary Disease|UriCO - Effect of Pelvic Floor Muscle Training and Cough-suppression Therapy on Urinary Incontinence Amongst Women With Chronic Obstructive Pulmonary Disease; a Randomised Controlled Trial|Recruiting||N/A|96|Anticipated|Ostfold Hospital Trust||3|||f||||t||||||||||2017-10-10 22:42:53.337312|2017-10-10 22:42:53.337312
NCT02614092|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-08-24|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|WATER-VET||Water-based Activity to Enhance Recall in Veterans|Water-based Activities to Enhance Recall in Veterans (WATER-VET)|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-10 22:42:53.471851|2017-10-10 22:42:53.471851
NCT02614079|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-09-21|||October 2015||2015-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing|Evaluation of the Percutaneous Spinal Cord Stimulation Trial Using the Dermatomal Somatosensory Evoked Potentials Collision Testing|Active, not recruiting||N/A|20|Anticipated|University of Toledo Health Science Campus||1|||f||||f||||||||||2017-10-10 22:42:53.578491|2017-10-10 22:42:53.578491
NCT02614066|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-25|||November 2015||2015-11-01|September 2016|2016-09-01||||March 2019|Anticipated|2019-03-01||Interventional|ZUMA-3||A Study Evaluating KTE-C19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3)|A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3)|Recruiting||Phase 1/Phase 2|75|Anticipated|Kite Pharma, Inc.||1|||f||||||||||||||2017-10-10 22:42:53.672887|2017-10-10 22:42:53.672887
NCT02614053|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-25|||March 2015||2015-03-01|November 2015|2015-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Plethysmography Variability Index Monitoring for Parturients With Antepartum Hemorrhage|Continuous Non Invasive Monitoring of Both Plethysmography Variability Index and Total Hemoglobin During Cesarean Section for Antepartum Hemorrhage As a Method For Early Detection of Bleeding|Active, not recruiting||N/A|124|Actual|Kasr El Aini Hospital|||1||f||||f||||||||||2017-10-10 22:42:53.847555|2017-10-10 22:42:53.847555
NCT02614040|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-09-14|||January 1, 2016|Actual|2016-01-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|SaLt-ED||Saline Against Lactated Ringers or Plasmalyte in the Emergency Department|Saline Against Lactated Ringers or Plasmalyte in the Emergency Department (SaLt-ED)|Completed||N/A|14000|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 22:42:53.925734|2017-10-10 22:42:53.925734
NCT02614027|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2017-01-26|||February 2016||2016-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|METALIP||Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances|Prevalence of Lipodystrophy Syndrome and Secondary Metabolic Syndrome in HIV-infected Patients|Recruiting||N/A|250|Anticipated|Asociacion para el Estudio de las Enfermedades Infecciosas|||1||f||||f||||||||Undecided||2017-10-10 22:42:54.065106|2017-10-10 22:42:54.065106
NCT02614014|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-12-01|||June 2014||2014-06-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Stress and Personality Profiles in IBD|Effect of the Stress and Personality Profiles in the Development, Evolution and Treatment of Inflammatory Bowel Disease.|Recruiting||N/A|220|Anticipated|Asociación Española de Gastroenterología||2|||f||||||||||||||2017-10-10 22:42:54.191485|2017-10-10 22:42:54.191485
NCT02614001|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-23|||May 2011||2011-05-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|May 2012|Actual|2012-05-01||Interventional|||Inspiratory Muscle Training in Stroke Patients With Stable Congestive Heart Failure: a Prospective RCT.|Inspiratory Muscle Training in Stroke Patients With Stable Congestive Heart Failure: a Prospective Randomized Controlled Trial.|Completed||N/A|48|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:42:54.297286|2017-10-10 22:42:54.297286
NCT02613988|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-12-02|||December 2015||2015-12-01|December 2015|2015-12-01||||February 2017|Anticipated|2017-02-01||Interventional|||Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas|Early Response Assessment Using on 3T Advanced MR Imaging as Predictor of Long-term Treatment Response in Newly Diagnosed Glioblastomas|Recruiting||N/A|100|Anticipated|Asan Medical Center||1|||f||||||||||||||2017-10-10 22:42:54.402123|2017-10-10 22:42:54.402123
NCT02613975|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-02-03|||April 2015||2015-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Cross Over Case Control Study of a Vibration Positional Device for Treatment of OSA|A Cross Over Case Control Study Using a Vibration Positional Device for Treatment of Position Dependent Obstructive Sleep Apnea|Active, not recruiting||N/A|40|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:42:54.550922|2017-10-10 22:42:54.550922
NCT02613962|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-06|||December 2015||2015-12-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|MAPPYACTS||Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling|A Prospective, Multicentric Clinical Proof-of-concept Study to Stratify Targeted Therapies Adapted to Molecular Profiling of Relapsed or Refractory Pediatric Tumors|Recruiting||N/A|300|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 22:42:54.65385|2017-10-10 22:42:54.65385
NCT02613949|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-02-02|||November 2015||2015-11-01|February 2017|2017-02-01|July 29, 2016|Actual|2016-07-29|July 8, 2016|Actual|2016-07-08||Interventional|PERRFECT-202||Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202|A Double-Blinded, Randomized, Sham-Controlled, Phase 2 Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia|Completed||N/A|45|Actual|Cerephex Corporation||3|||f||||f||||||||||2017-10-10 22:42:54.779644|2017-10-10 22:42:54.779644
NCT02613936|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-10-24|||September 2015||2015-09-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury|Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury|Recruiting||N/A|80|Anticipated|University of New Mexico||2|||f||||t||||||||Yes|Individual patient data on task performance may be requested from the researchers after study completion.|2017-10-10 22:42:54.893132|2017-10-10 22:42:54.893132
NCT02613923|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2016-09-29|||November 2015||2015-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer|A Pilot Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer|Recruiting||N/A|75|Anticipated|Case Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 22:42:55.017938|2017-10-10 22:42:55.017938
NCT02613910|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-05-12|2017-03-16||December 23, 2015|Actual|2015-12-23|April 2017|2017-04-01|March 23, 2016|Actual|2016-03-23|March 23, 2016|Actual|2016-03-23||Interventional||Ofatumumab|Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris|OPV117059: A Long-Term Extension Study of Ofatumumab Injection for Subcutaneous Use in Subjects With Pemphigus Vulgaris|Terminated||Phase 3|1|Actual|GlaxoSmithKline||1||"Novartis has acquired the rights to ofatumumab and terminated the OPV116910 and OPV117059   studies. This decision is not linked to any safety consideration."|f||||t|t|f||||||||2017-10-10 22:42:55.170104|2017-10-10 22:42:55.170104
NCT02613897|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-01-11|||January 2016||2016-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study|A 16-wk, Uni-center, Randomized, Double-blind, Parallel, Phase 3b Trial to Evaluate Efficacy of Saxagliptin + Dapagliflozin vs.Dapagliflozin With Regard to EGP in T2DM With Insufficient Glycemic Control on Metformin+/-Sulfonylurea Therapy|Recruiting||N/A|177|Anticipated|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-10-10 22:42:55.85045|2017-10-10 22:42:55.85045
NCT02613884|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-12-06|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis|Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis|Recruiting||Phase 2|30|Anticipated|Johns Hopkins All Children's Hospital||1|||f||||t||||||||No||2017-10-10 22:42:56.001996|2017-10-10 22:42:56.001996
NCT02613871|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-07-20|||December 2015||2015-12-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|January 2017|Actual|2017-01-01||Interventional|||Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection|A Phase 3b Open-Label Study of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 2 Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Coinfection|Active, not recruiting||Phase 3|111|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-10 22:42:56.088397|2017-10-10 22:42:56.088397
NCT02613858|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-05-10|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Observational|Preempt||Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan||Completed||N/A|550|Actual|Abbott|||1||f||||f||||||||||2017-10-10 22:42:56.195589|2017-10-10 22:42:56.195589
NCT02613845|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-02-22|||January 1, 2013|Actual|2013-01-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|December 31, 2013|Actual|2013-12-31||Observational|PODCAS||Predictors for Postoperative Delirium After Cardiac Surgery in Adults: a One-year, Single Center, Observational Cohort Study|Predictors for Postoperative Delirium After Cardiac Surgery in Adults: a One-year, Single Center, Observational Cohort Study|Completed||N/A|656|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||No||2017-10-10 22:42:56.277867|2017-10-10 22:42:56.277867
NCT02613832|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-11-22|||August 2014||2014-08-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Applicability of Techniques of Lung Expansion|Immediate Effect of Expiratory Positive Airway Pressure and Breath Stacking in Non-cooperative Patients Detected by Electrical Impedance Tomography|Completed||N/A|10|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:42:56.495955|2017-10-10 22:42:56.495955
NCT02613819|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-07-10|||July 2016||2016-07-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|FASTRACK II||Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney|Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial (FASTRACK II)|Recruiting||Phase 2|70|Anticipated|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||t||||||||||2017-10-10 22:42:56.604037|2017-10-10 22:42:56.604037
NCT02613806|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2015-11-23|||December 2015||2015-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Effects of Dexmedetomidine on Cough Response and Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery With General Anesthesia|Effects of Dexmedetomidine on Cough Response and Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery With General anesthesia---a Randomized Control Double-Blind Clinical Trial|Not yet recruiting||Phase 4|118|Anticipated|First Affiliated Hospital of Chongqing Medical University||2|||f||||f||||||||||2017-10-10 22:42:56.710273|2017-10-10 22:42:56.710273
NCT02613793|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-04-03|||January 2016||2016-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Saccadic Reaction Time and Preterm Pre-eclampsia|A Prospective Case Control Feasibility Study to Investigate the Utility of Saccadometry in the Diagnosis and Monitoring of Preterm Pre-eclampsia|Recruiting||N/A|30|Anticipated|Oxford University Hospitals NHS Trust|||2||f||||f|f|f||||||||2017-10-10 22:42:56.854802|2017-10-10 22:42:56.854802
NCT02613780|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-12-11|||January 2016||2016-01-01|December 2015|2015-12-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Refractive Treatment of Early Keratoconus|iDesign Aberrometer for the Refractive Treatment of Early Keratoconus|Not yet recruiting||Phase 3|24|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:42:56.966096|2017-10-10 22:42:56.966096
NCT02613767|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|September 2015|Actual|2015-09-01||Observational|||Muscle Protein Synthesis Rates After Protein Consumption in Lean, Overweight, and Obese Adults|Muscle Protein Synthesis Rates After Protein Consumption in Lean, Overweight, and Obese Adults|Completed||N/A|32|Actual|University of Illinois at Urbana-Champaign|||3||f||||f||||||Samples Without DNA|"     Plasma samples and Skeletal muscle tissue   "|||2017-10-10 22:42:57.053347|2017-10-10 22:42:57.053347
NCT02613754|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-10-17|||March 2015||2015-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Adding Contingency Management to Treatment as Usual for Disordered Gambling.|The Impact of Adding Contingency Management to Treatment as Usual for Disordered Gambling|Recruiting||N/A|54|Anticipated|University of Lethbridge||2|||f||||f||||||||||2017-10-10 22:42:57.132884|2017-10-10 22:42:57.132884
NCT02613741|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-23|||January 2001||2001-01-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|January 2004|Actual|2004-01-01||Interventional|||Metabolism of Fibrinogen and Apolipoprotein B-100 in Childhood Obesity and Cardiovascular Disease|Metabolism of Fibrinogen and Apolipoprotein B-100 in Childhood Obesity and Cardiovascular Disease|Active, not recruiting||N/A|21|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-10-10 22:42:57.235281|2017-10-10 22:42:57.235281
NCT02613728|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-23|2017-09-22|||May 13, 2016|Actual|2016-05-13|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)|Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)|Recruiting||N/A|32|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 22:42:57.325858|2017-10-10 22:42:57.325858
NCT02613715|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-20|||March 2015||2015-03-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Bioavailability of Blackberry Juice Anthocyanins|Influence of Ethanol in the Bioavailability of Blackberry Juice Anthocyanins in Normal Weight and Overweight/Obese Adults|Completed||Phase 1|18|Actual|Universidade do Porto||2|||f||||f||||||||||2017-10-10 22:42:57.436904|2017-10-10 22:42:57.436904
NCT02613702|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-07-28|||December 2015||2015-12-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|EFFECT||Efficacy of a Modified Technique of Free Gingival Graft in Volumetric Changes of the Graft: Randomized Clinical Trial|Efficacy of a Modified Technique of Free Gingival Graft in Volumetric Changes of the Graft: Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:42:57.53704|2017-10-10 22:42:57.53704
NCT02613689|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-04-20|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention|Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention: The Text to Forgo Smokeless Tobacco|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||||||||||||2017-10-10 22:42:57.642247|2017-10-10 22:42:57.642247
NCT02613676|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-10-24|||August 2015||2015-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns|Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns|Completed||N/A|1858|Actual|University of Stellenbosch||2|||f||||t||||||||||2017-10-10 22:42:57.740656|2017-10-10 22:42:57.740656
NCT02613663|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-01-13|||July 2016||2016-07-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Interventional|||"Immediate Implant Using Nanobone Versus Autogenous Bone for Treatment of Patients With Unrestorable Single Tooth."|"Evaluation of Surgical Time, Post-operative Pain and Marginal Bone Loss in Immediate Implant Using Nanobone Versus Autogenous Bone for Treatment of Patients With Unrestorable Single Tooth: Randomized Controlled Trials."|Recruiting||N/A|18|Anticipated|Cairo University||2|||f||||t||||||||No||2017-10-10 22:42:57.837457|2017-10-10 22:42:57.837457
NCT02613650|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-02-15|||May 12, 2016|Actual|2016-05-12|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers|A Phase 1b Trial of a Combination of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers|Recruiting||Phase 1|30|Anticipated|University of Utah||1|||f||||t|t|f||||||||2017-10-10 22:42:57.941868|2017-10-10 22:42:57.941868
NCT02613637|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-02-22|||May 2014||2014-05-01|February 2017|2017-02-01||||December 2024|Anticipated|2024-12-01|15 Years|Observational [Patient Registry]|||Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project|Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project|Recruiting||N/A|2000|Anticipated|University of Ulm|||1||f||||f||||||Samples With DNA|"     -  Tumor tissue        -  20-40 mL of peripheral blood in a heparinized (1:10) tube        -  10 ml EDTA-anticoagulated blood sample   "|||2017-10-10 22:42:58.029803|2017-10-10 22:42:58.029803
NCT02613624|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-01-11|||April 2015||2015-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|CKMC||Formative Research to Develop an Intervention Package to Promote Practice of Kangaroo Mother Care for Low Birth Weight and Preterm Infants in a Community (CKMC)|Formative Research to Develop an Intervention Package for Promotion of Kangaroo Mother Care for Low Birth Weight and Preterm Infants in a Community: In Preparation for a Randomized Controlled Trial to Examine Impact of Community Kangaroo Mother Care on Neonatal and Early Infant Mortality|Completed||N/A|28|Actual|Society for Applied Studies|||1||f||||f||||||||||2017-10-10 22:42:58.134301|2017-10-10 22:42:58.134301
NCT02613611|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2015-11-21|||November 2015||2015-11-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|HPV||HPV Screening (Human Papilloma Virus)|Screening for Human Papilloma Virus in Urine and Pap Smear.A Comparative Study.|Not yet recruiting||N/A|500|Anticipated|Kasr El Aini Hospital|||1||f||||f||||||||||2017-10-10 22:42:58.217407|2017-10-10 22:42:58.217407
NCT02613598|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-12-15|||January 2016||2016-01-01|December 2016|2016-12-01||||October 2020|Anticipated|2020-10-01||Interventional|||Dose Escalation Study to Determine the Maximum Tolerated Dose of the Combination of Ruxolitinib and Bortezomib in Patients With Relapsed or Refractory Lymphoma|Phase I Dose Escalation Study to Determine the Maximum Tolerated Dose of the Combination of Ruxolitinib and Bortezomib in Patients With Relapsed or Refractory Lymphoma|Recruiting||Phase 1|24|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 22:42:58.272893|2017-10-10 22:42:58.272893
NCT02613585|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-09-23|||February 2016||2016-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tick-borne Illness and Clothing Study of Rhode Island|Tick-borne Illness and Clothing Study of Rhode Island|Recruiting||N/A|250|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-10 22:42:58.371721|2017-10-10 22:42:58.371721
NCT02613572|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-06-26|||November 2015||2015-11-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ALA||Alpha Lipoic Acid in Geographic Atrophy|Evaluation of Lipoic Acid as a Treatment for Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD): Phase I- Tolerability Study and Phase II Pilot- Determine the Effects of ALA on the Progression of Geographic Atrophy (GA) in Patients With Age-related Macular Degeneration (AMD).|Recruiting||Phase 1/Phase 2|65|Anticipated|University of Pennsylvania||7|||f||||t||||||||||2017-10-10 22:42:58.485394|2017-10-10 22:42:58.485394
NCT02613559|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-21|2017-08-15|||November 2015||2015-11-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration|A Single-center, Open-label, Single Ascending Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Tolerability of Intravitreal TK001(Recombinant Humanized Anti-VEGF Monoclonal Antibody) in Subjects With Neovascular Age-Related Macular Degeneration|Recruiting||Phase 1|27|Anticipated|Jiangsu T-Mab Biopharma Co.,Ltd||6|||f||||||||||||||2017-10-10 22:42:58.612774|2017-10-10 22:42:58.612774
NCT02613546|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2015-12-01|||September 2015||2015-09-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|March 2016|Anticipated|2016-03-01||Interventional|||THE INFLUENCE OF COGNITIVE BEHAVIORAL THERAPY IN SEXUAL DYSFUNCTION FEMALE: Randomized Clinical Trial||Recruiting||Phase 2/Phase 3|34|Anticipated|Centro de Atenção ao Assoalho Pélvico||2|||f||||f||||||||||2017-10-10 22:42:58.721972|2017-10-10 22:42:58.721972
NCT02613533|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-08|||February 2010||2010-02-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Water Drinking Test in Patients With Occludable Angle|"What is the Effect of the Water Drinking Test on Patients With Narrow Angles on the Day of Their Scheduled Laser Iridotomy?"|Completed||N/A|20|Actual|Wills Eye||1|||f||||f||||||||Yes|A manuscript has been accepted for publication in Patient Preference and Adherence.|2017-10-10 22:42:58.806357|2017-10-10 22:42:58.806357
NCT02613520|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-04-24|||December 2015|Actual|2015-12-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|February 2017|Actual|2017-02-01||Interventional|||Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants|Clinical Trial to Evaluate the Safety and Immunogenicity in Age De-Escalation of Direct Venous Inoculation of a Plasmodium Falciparum Sporozoite Vaccine in Tanzanian Adults, Children, and Infants|Active, not recruiting||Phase 1|99|Anticipated|Sanaria Inc.||23|||f||||t||||||||||2017-10-10 22:42:58.895043|2017-10-10 22:42:58.895043
NCT02613507|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-22|2017-04-17|||December 2015||2015-12-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|CheckMate 078||Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer|An Open-label Randomized Multinational Phase 3 Trial of Nivolumab Versus Docetaxel in Previously Treated Subjects With Advanced or Metastatic Non-small Cell Lung Cancer (CheckMate 078: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 078)|Active, not recruiting||Phase 3|500|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 22:42:59.046139|2017-10-10 22:42:59.046139
NCT02613494|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-11-23|||February 2016||2016-02-01|November 2015|2015-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|GOTHIC1||Clozapine-induced Hypersalivation - Feasibility Trial|A Feasibility Study of Glycopyrrolate in Comparison to Hyoscine Hydrobromide and Placebo in the Treatment of Hypersalivation Induced by Clozapine|Not yet recruiting||Phase 1/Phase 2|42|Anticipated|Mersey Care NHS Trust||3|||f||||t||||||||||2017-10-10 22:42:59.210904|2017-10-10 22:42:59.210904
NCT02613481|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-08-03|||November 2015||2015-11-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|June 1, 2017|Actual|2017-06-01||Interventional|||The Emotional and Functional Benefits of Poly-L-Lactic Acid|The Emotional and Functional Benefits of Poly-L-Lactic Acid|Completed||N/A|50|Actual|Yardley Dermatology Associates||1|||f||||f||||||||||2017-10-10 22:42:59.307265|2017-10-10 22:42:59.307265
NCT02613468|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-23|||January 2004||2004-01-01|November 2015|2015-11-01|August 2005|Actual|2005-08-01|December 2004|Actual|2004-12-01||Interventional|||Periodontal Condition in Pregnancy and Low Birth Delivery Incidence|A Comparative Evaluation in Pregnant Women of the Periodontal Condition and Low Birth Delivery Incidence|Completed||N/A|269|Actual|Ondokuz Mayıs University||3|||f||||t||||||||||2017-10-10 22:42:59.387095|2017-10-10 22:42:59.387095
NCT02613455|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-11-23|||July 2015||2015-07-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Corticosteroid Injection Verses High Energy Extracorporeal Shock Wave Therapy for Lateral Epicondylitis|Prospective Randomize Trial Comparing Corticosteroid Injection to High Energy Extracorporeal Shock Wave Therapy for Lateral Epicondylitis|Recruiting||Phase 4|80|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||||2017-10-10 22:42:59.474435|2017-10-10 22:42:59.474435
NCT02613442|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-09-22|||April 2017|Anticipated|2017-04-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Factors Affecting Aqueous Humor Outflow Facility in Patients With Uveitis|Factors Affecting Aqueous Humor Outflow Facility in Patients With Uveitis|Withdrawn||N/A|0|Actual|University of Nebraska|||1|Due to uveitis specialist leaving our University|f||||f||||||||||2017-10-10 22:42:59.577506|2017-10-10 22:42:59.577506
NCT02613429|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-01-03|||November 2015||2015-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Identification of Airway Structures Necessary for Airway Access Via the Skin|Identification of Airway Structures Necessary for Airway Access Via the Skin to be Used in Case of Failure to Maintain Oxygenation With Non-invasive Methods|Completed||N/A|42|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 22:42:59.64632|2017-10-10 22:42:59.64632
NCT02613416|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-10-13|||November 2015||2015-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|Dmab||Denosumab and MRI Breast Imaging|Phase II Correlative Study of Denosumab Effects on Tissue and Imaging Breast Biomarkers|Recruiting||Phase 2|44|Anticipated|Stony Brook University||1|||f||||t||||||||No||2017-10-10 22:42:59.729024|2017-10-10 22:42:59.729024
NCT02613403|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-04-20|||December 10, 2015|Actual|2015-12-10|April 2017|2017-04-01|September 5, 2018|Anticipated|2018-09-05|August 14, 2018|Anticipated|2018-08-14||Interventional|||Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)|A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (MK-5172 + MK-3682 + MK-8408 Fixed Dose Combination (FDC)) in Subjects With Chronic HCV GT1 or GT3 Infection Who Have Failed a Direct Acting Antiviral Regimen|Recruiting||Phase 2|200|Anticipated|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-10 22:42:59.832219|2017-10-10 22:42:59.832219
NCT02613390|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-07-17|||December 18, 2015|Actual|2015-12-18|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety Evaluation of Intra-Operative MRI-Based Guidance for Laser Ablation of Epidural Metastasis|A Pilot Study to Evaluate Safety of Intraoperative MRI-Based Image Guidance for Laser Ablation of Epidural Metastasis|Active, not recruiting||N/A|11|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:43:00.016263|2017-10-10 22:43:00.016263
NCT02613377|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-04-27|||January 2016||2016-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01|28 Days|Observational [Patient Registry]|TRALI||Transfusion-related Acute Lung Injury: a Prospective Cohort Study in Critically Ill Children|Transfusion-related Acute Lung Injury: a Prospective Cohort Study in Critically Ill Children|Recruiting||N/A|1476|Anticipated|St. Justine's Hospital|||2||f||||f||||||Samples With DNA|"     Blood samples will be collected from patients with suspected TRALI in order to generate some     hypotheses regarding underlying mechanisms associated with the different types of TRALI     (objective #2.e), the plasma level of IL-1beta, IL-6, IL8, and IL-10 will be measured.   "|||2017-10-10 22:43:00.105703|2017-10-10 22:43:00.105703
NCT02613364|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-09-26|||May 6, 2016|Actual|2016-05-06|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|November 2020|Anticipated|2020-11-01||Interventional|YOCAS-II||Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors|A Randomized Clinical Trial Comparing the Effectiveness of Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy for Treating Insomnia in Cancer Survivors|Recruiting||N/A|630|Anticipated|University of Rochester||3|||f||||t||||||||||2017-10-10 22:43:00.220841|2017-10-10 22:43:00.220841
NCT02613351|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-05-14|||December 2015||2015-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|MAPLE||Muscle Activity and Sensation During Upright Partitioned Leg Exercise in COPD|Leg Muscle Activity and Sensation During Upright Partitioned Exercise Compared to Walking: Propulsion of a 3-wheeled Scooter by Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|15|Anticipated|West Park Healthcare Centre||1|||f||||f||||||||||2017-10-10 22:43:00.393745|2017-10-10 22:43:00.393745
NCT02613156|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-01-02|||June 2014||2014-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma|Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma|Completed||N/A|25|Actual|Sun Yat-sen University|||2||f||||f||||||||||2017-10-10 22:43:02.371996|2017-10-10 22:43:02.371996
NCT02613338|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-01-11|||November 2015||2015-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System - Phase 2|Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System - Phase 2|Recruiting||N/A|30|Anticipated|The University of Tennessee, Knoxville|||1||f||||f||||||||||2017-10-10 22:43:00.470861|2017-10-10 22:43:00.470861
NCT02613325|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-08-02|||June 8, 2015|Actual|2015-06-08|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||fPAM for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth|Pilot Study to Determine the Feasibility and Functionality of fPAM Imaging for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth|Recruiting||Phase 1|25|Anticipated|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||||2017-10-10 22:43:00.679115|2017-10-10 22:43:00.679115
NCT02613312|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-12-19|||November 2015||2015-11-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Observational|||Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma|Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma|Recruiting||N/A|200|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 22:43:00.822699|2017-10-10 22:43:00.822699
NCT02613299|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-12-19|||November 2015||2015-11-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Observational|||"Surgery for Mesothelioma After Radiation Therapy SMART for Resectable Malignant Pleural Mesothelioma"|"Surgery for Mesothelioma After Radiation Therapy SMART for Resectable Malignant Pleural Mesothelioma"|Recruiting||N/A|200|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 22:43:00.913995|2017-10-10 22:43:00.913995
NCT02613286|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-24|||May 2015||2015-05-01|November 2015|2015-11-01|June 2018|Anticipated|2018-06-01|November 2016|Anticipated|2016-11-01||Interventional|LESSER||LESs Surgical Radicality for EaRly Stage Cervical Cancer|A Proof of Concept Phase II Non-inferiority Trial Evaluating the Safety and Efficacy of Extrafascial Hysterectomy Plus Pelvic Lymph-node Dissection in Patients With Stage IA2-IB1 Cervical Cancer ≤ 2cm|Enrolling by invitation||Phase 2|40|Anticipated|Hospital de Câncer de Pernambuco||2|||f||||t||||||||||2017-10-10 22:43:01.011294|2017-10-10 22:43:01.011294
NCT02613260|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-05-02|||November 2015||2015-11-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System|Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System|Enrolling by invitation||N/A|9500|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:43:01.239219|2017-10-10 22:43:01.239219
NCT02613247|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-11-06|||March 2016||2016-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intra-articular Hyaluronic Acid Injection for Therapy-resistant Patellofemoral Pain Syndrome|Intra-articular Hyaluronic Acid Injection for Therapy-resistant Patellofemoral Pain Syndrome: an Open-label, Randomized, Delayed-start Clinical Trial|Recruiting||Phase 2|50|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 22:43:01.33954|2017-10-10 22:43:01.33954
NCT02613234|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2016-03-23|||November 2015||2015-11-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of 128-channel EEG Combined With BESA Dipole Localization and Intervention on Brain Waves for Epilepsy|Efficacy of 128-channel Electroencephalograph Combined With BESA Dipole Localization Method and Intervention on Brain Waves for Epilepsy: A Single-blinded Randomized Controlled and Open-label Extension Trial|Recruiting||N/A|80|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 22:43:01.523563|2017-10-10 22:43:01.523563
NCT02613221|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-04-13|||November 1, 2015|Actual|2015-11-01|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|September 1, 2017|Anticipated|2017-09-01||Interventional|APOLLON||A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer|A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With RAS Wild-type Metastatic Colorectal Cancer Refractory to Standard Chemotherapy|Active, not recruiting||Phase 1/Phase 2|56|Actual|Takeda||1|||f||||f||||||||||2017-10-10 22:43:01.651162|2017-10-10 22:43:01.651162
NCT02613208|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-10-02|||December 9, 2015|Actual|2015-12-09|October 2017|2017-10-01|September 28, 2018|Anticipated|2018-09-28|September 28, 2018|Anticipated|2018-09-28||Observational|Argo||A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer|Observational and Prospective Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Patients With Metastatic HER 2-Negative and Aggressive Disease Criteria|Active, not recruiting||N/A|110|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:43:01.833692|2017-10-10 22:43:01.833692
NCT02613195|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-24|2015-11-20|||January 2016||2016-01-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|HRCSDBD||Clinical Trial of Hydrogen-Rich Celsior Solution Applied in Aging DBD Liver/Kidney Transplantation|Hydrogen-Rich Celsior Solution Improve the Quality of Aging DBD Grafts in Liver/Kidney Transplantation: Prospective, Randomized Clinical Trial|Unknown status|Not yet recruiting|Phase 3|20|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-10 22:43:02.019803|2017-10-10 22:43:02.019803
NCT02613182|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-09-07|||February 2016||2016-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OLE||Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis|Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of NEOD001 in Subjects With Light Chain (AL) Amyloidosis|Active, not recruiting||Phase 2|40|Actual|Prothena Therapeutics Ltd.||1|||f||||f||||||||||2017-10-10 22:43:02.15523|2017-10-10 22:43:02.15523
NCT02613169|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-05-01|||August 2016||2016-08-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|iTIPS||Infant TB Infection Prevention Study|Preventing Mycobacterium Tuberculosis Infection in HIV-Exposed Infants|Recruiting||Phase 2|300|Anticipated|University of Washington||2|||f||||t||||||||Undecided||2017-10-10 22:43:02.252683|2017-10-10 22:43:02.252683
NCT02613078|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-02|||March 2016||2016-03-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Hypnotherapy vs. Probiotics in Children With IBS and Functional Abdominal Pain|Gut-Directed Hypnotherapy vs. Probiotics in Children and Adolescents With Irritable Bowel Syndrome and Functional Abdominal Pain - A Pilot Study|Recruiting||N/A|60|Anticipated|University Hospital Tuebingen||3|||f||||f||||||||||2017-10-10 22:43:02.906645|2017-10-10 22:43:02.906645
NCT02613065|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-08-18|||May 2015||2015-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Role of Protein in Regulating Ad Libitum Energy Intake in Humans|The Role of Protein in Regulating Ad Libitum Energy Intake in Humans|Completed||N/A|48|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 22:43:03.041198|2017-10-10 22:43:03.041198
NCT02613052|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-09-16|||January 2016||2016-01-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations|The Use of Agitated Saline, Albumin, or a Propofol-albumin Mixture for Enhanced Contrast in Bubble Studies During Transesophageal Echocardiographic Examinations|Recruiting||N/A|20|Anticipated|University of California, San Diego||3|||f||||f||||||||||2017-10-10 22:43:03.116976|2017-10-10 22:43:03.116976
NCT02613039|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-20|||October 2015||2015-10-01|November 2015|2015-11-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|COSEX||Oral Contraceptive Therapy and Sexuality|Study on the Effect of Combined Oral Contraceptive Therapy on Female Sexuality, Body Image and Mental Health|Recruiting||Phase 4|60|Anticipated|University of Florence||1|||f||||f||||||||||2017-10-10 22:43:03.209599|2017-10-10 22:43:03.209599
NCT02613026|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-22|||July 2009||2009-07-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|March 2013|Actual|2013-03-01||Interventional|||Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer|Comparative Analysis of the Efficacies of AT and AC-T Regimens in Neoadjuvant Chemotherapy of Breast Cancer|Completed||Phase 3|104|Actual|307 Hospital of PLA||2|||f||||f||||||||||2017-10-10 22:43:03.31651|2017-10-10 22:43:03.31651
NCT02613013|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-11-17|||October 2015||2015-10-01|November 2016|2016-11-01|April 2022|Anticipated|2022-04-01|March 2020|Anticipated|2020-03-01||Interventional|||Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure|Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure With Multi-mechanism Based on UBM: A Randomized Controlled Trial|Recruiting||N/A|240|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:43:03.408145|2017-10-10 22:43:03.408145
NCT02613000|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|iSOFA||Intestinal-Specific Organ Function Assessment (iSOFA Study)|Prospective, Multicenter Cohort Study on Prognostic Value of Gastrointestinal Symptoms and Intestinal-specific Biomarkers in Prediction of Outcome of Intensive Care Patients|Recruiting||N/A|500|Anticipated|University of Tartu|||2||f||||t||||||Samples With DNA|"     In patients included in Part B, approx. 7 ml of arterial or venous blood will be drawn each     morning during the study period. Standard EDTA containing vacutainers are used for blood     sampling and placed into ice until centrifugation. Blood will be centrifuged at 4 degrees by     study nurse or central laboratory of the study site, after which plasma will be separated and     stored at -80 degrees in eppendorf vials containing 1 ml of plasma, marked and labelled with     study code numbers.      10 ml of urine will be sampled each morning Timing of admission day sample at time of plasma     sampling (6 AM) from the collection bag and stored at -80 degrees. 2 eppendorf test-tubes     containing 1 ml are used for urine sampling.      Samples for citrulline measurements will be shipped to University of East Anglia, Norwich,     United Kingdom and other samples to Maastricht University Medical Center, Netherland, for     biochemical analyses to be performed.   "|||2017-10-10 22:43:03.507008|2017-10-10 22:43:03.507008
NCT02612987|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2017-05-31|||October 2015||2015-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||iCBT for Adolescents With Co-morbid Insomnia|Internet-delivered Cognitive Behaviour Therapy for Adolescents With Co-morbid Insomnia Attending Children and Youth Psychiatry: An Open Trial|Active, not recruiting||N/A|21|Actual|Uppsala University Hospital||1|||f||||f||||||||||2017-10-10 22:43:03.582785|2017-10-10 22:43:03.582785
NCT02612974|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-23|||January 2010||2010-01-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|Leech Therapy||Clinical Evaluation of Leech Therapy in the Treatment of Knee Osteoarthritis|Randomized Controlled Clinical Evaluation of Leech Therapy in the Treatment of Knee Osteoarthritis|Completed||Phase 2|60|Actual|Hamdard University||2|||f||||f||||||||||2017-10-10 22:43:03.654415|2017-10-10 22:43:03.654415
NCT02612961|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-11-21|||January 2016||2016-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Normal Saline Use With Suctioning|Normal Saline Use With Suctioning: A Randomized-Controlled Trial - Pilot Study|Recruiting||N/A|100|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 22:43:03.728245|2017-10-10 22:43:03.728245
NCT02612948|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-21|||November 2013||2013-11-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients|Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients|Completed||Phase 4|82|Actual|University of Tennessee Graduate School of Medicine||2|||f||||f||||||||||2017-10-10 22:43:03.828572|2017-10-10 22:43:03.828572
NCT02612935|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-23|||March 2015||2015-03-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis|An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis|Completed||N/A|88|Actual|Lumos Labs, Inc.|||1||f||||f||||||||||2017-10-10 22:43:03.952272|2017-10-10 22:43:03.952272
NCT02612922|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2016-08-24|||December 2015||2015-12-01|August 2016|2016-08-01||||August 2016|Actual|2016-08-01||Interventional|||Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza|A Phase III Randomized Double-Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza|Completed||Phase 3|325|Actual|Romark Laboratories L.C.||2|||f||||f||||||||||2017-10-10 22:43:04.023338|2017-10-10 22:43:04.023338
NCT02612142|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-21|||June 2011||2011-06-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PEXAT||Physical EXercise as an Adjunct Treatment for Depression|Efficacy of Exercise as an Adjunct Treatment for Clinically Depressed Inpatients During the Initial Stages of Antidepressant Therapy.|Completed||N/A|48|Actual|Université de Reims Champagne-Ardenne||3|||f||||f||||||||||2017-10-10 22:43:15.799077|2017-10-10 22:43:15.799077
NCT02612909|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-11-20|||February 2016||2016-02-01|October 2015|2015-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Safety and Immunogenicity Study of IVACFLU-A/H5N1|A Phase 2/3 Double Blinded, Randomized, Placebo-controlled Study in Healthy Adult Volunteers in Vietnam to Examine the Safety and Immunogenicity of an Inactivated A/H5N1 Influenza Vaccine (IVACFLU-A/H5N1) Produced by IVAC|Unknown status|Not yet recruiting|Phase 2/Phase 3|1800|Anticipated|Institute of Vaccines and Medical Biologicals, Vietnam||3|||f||||t||||||||||2017-10-10 22:43:04.177974|2017-10-10 22:43:04.177974
NCT02612896|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-07-26|||March 2016||2016-03-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|September 2020|Anticipated|2020-09-01||Interventional|CYSTISTOP||Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?|Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?|Recruiting||N/A|2900|Anticipated|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||||2017-10-10 22:43:04.291944|2017-10-10 22:43:04.291944
NCT02612883|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-01-06|||November 2015||2015-11-01|January 2017|2017-01-01|April 2021|Anticipated|2021-04-01|October 2020|Anticipated|2020-10-01||Observational|FLUX||Flux Measurement and Outcome in Major Abdominal Surgery|Flux Measurement and Outcome in Major Abdominal Surgery|Recruiting||N/A|875|Anticipated|Technische Universität Dresden|||5||f||||f||||||||||2017-10-10 22:43:04.399293|2017-10-10 22:43:04.399293
NCT02612870|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-23|||February 2016||2016-02-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|Sentimag02||Sienna+® Injection Time Study 4 Arms|Sienna+® Injection Time Study: A Prospective Multicentre, Controlled Clinical Trial to Evaluate the Performance of Superparamagnetic Iron Oxide vs. Standard Technique as Tracer in Sentinel Node Biopsy|Not yet recruiting||Phase 4|40|Anticipated|Kantonsspital Baden||4|||f||||f||||||||||2017-10-10 22:43:04.492814|2017-10-10 22:43:04.492814
NCT02612844|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-08-04|||November 2015||2015-11-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes|A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes|Completed||Phase 1|48|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 22:43:06.785012|2017-10-10 22:43:06.785012
NCT02612831|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-04-22|||January 2016||2016-01-01|November 2015|2015-11-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|BOKID||Bariatric Surgery for Obese Patients With Chronic Renal Insufficiency|Bariatric Surgery for Obese Patients With Chronic Renal Insufficiency|Recruiting||N/A|84|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||t||||||||||2017-10-10 22:43:06.890268|2017-10-10 22:43:06.890268
NCT02612818|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-07-19|||November 24, 2015|Actual|2015-11-24|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|ENDHY||Prevention of Adhesions During Celioscopy for Endometriosis. Impact of the Use of Anti-adhesion Treatment on Clinical Signs and Fertility at One Year|Prevention of Adhesions During Celioscopy for Endometriosis. Impact of the Use of Anti-adhesion Treatment on Clinical Signs and Fertility at One Year|Active, not recruiting||N/A|364|Actual|Nordic Pharma SAS|||1||f||||f||||||||||2017-10-10 22:43:07.011569|2017-10-10 22:43:07.011569
NCT02612805|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-08-15|||November 2015||2015-11-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|DATS||The Diabetes and Aquatic Training Study (DATS)|Effects of Two Models of Physical Training in Aquatic Environment in Control of Type 2 Diabetes - A Controled Randomized Clinical Trial: The Diabetes and Aquatic Training Study (DATS)|Completed||N/A|60|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||Undecided||2017-10-10 22:43:07.107975|2017-10-10 22:43:07.107975
NCT02612792|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-23|||December 2014||2014-12-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Platelet Rich Fibrin+1.2% Atorvastatin in Treatment of Mandibular Degree II Furcation Defects|Platelet Rich Fibrin Combined With 1.2% Atorvastatin Gel in Treatment of Mandibular Degree II Furcation Defects: a Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|82|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||f||||||||||2017-10-10 22:43:07.244718|2017-10-10 22:43:07.244718
NCT02612779|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-10-03|||December 18, 2015|Actual|2015-12-18|October 2017|2017-10-01|January 15, 2020|Anticipated|2020-01-15|October 27, 2019|Anticipated|2019-10-27||Interventional|||A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.|A Phase 2, Multiple Cohort Study of Elotuzumab in Combination With Pomalidomide and Low-Dose Dexamethasone (EPd), and in Combination With Nivolumab (EN), in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.|Active, not recruiting||Phase 2|60|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 22:43:07.3662|2017-10-10 22:43:07.3662
NCT02612766|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-08-02|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SafeOatDiet||Safety and Tolerability of Oat Containing Gluten-free Diet|SAFETY AND TOLERABILITY OF OAT CONTAINING GLUTEN-FREE DIET|Completed||N/A|25|Actual|Alfred Rusescu Institute for Mother and Child Care||1|||f||||||||||||||2017-10-10 22:43:07.555516|2017-10-10 22:43:07.555516
NCT02612753|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-07-25|||November 2015||2015-11-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|November 2017|Anticipated|2017-11-01||Interventional|Taph||Interest of Combining Speech Therapy With a Non-invasive Brain Stimulation (tDCS) for the Aphasic Patient|Interest of Combining Speech Therapy With a Non-invasive Brain Stimulation (tDCS) for the Aphasic Patient|Recruiting||N/A|24|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||f||||||||||2017-10-10 22:43:07.837436|2017-10-10 22:43:07.837436
NCT02612740|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-11-23|||April 2010||2010-04-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|December 2014|Actual|2014-12-01||Interventional|||Deproteinized Bovine Bone in Alveolar Bone Critical Size Defect (>2cm) Secondary to Cyst Removal|Deproteinized Bovine Bone for the Treatment of Alveolar Bone Critical Size Defect in Humans: A Randomized Clinical Pilot Study|Active, not recruiting||Phase 2/Phase 3|20|Actual|University of Padova, School of Dental Medicine||2|||f||||t||||||||||2017-10-10 22:43:08.022392|2017-10-10 22:43:08.022392
NCT02612727|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-04-19|||November 2012||2012-11-01|April 2017|2017-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|FSPT||Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in Neonates|Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in Neonates|Completed||Phase 1/Phase 2|447|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f|||f|||No||2017-10-10 22:43:08.143758|2017-10-10 22:43:08.143758
NCT02612714|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2015-11-20|||July 2013||2013-07-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Statin Lowering Testosterone and Sexual Function|Statin Therapy is Associated With Low Testosterone and Sexual Function in Men With Type 2 Diabetes|Completed||Phase 4|151|Actual|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-10-10 22:43:08.278052|2017-10-10 22:43:08.278052
NCT02612701|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-20|||October 2015||2015-10-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||E-Cigarette Aerosol, Conventional Cigarette Smoke, and Myocardial Perfusion|E-Cigarette Aerosol, Conventional Cigarette Smoke, and Myocardial Perfusion|Recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center||4|||f||||f||||||||||2017-10-10 22:43:08.403698|2017-10-10 22:43:08.403698
NCT02612688|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-07-14|||January 2016||2016-01-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|November 2017|Anticipated|2017-11-01||Interventional|PROVEN||Pragmatic Trial of Video Education in Nursing Homes|PROVEN: Pragmatic Trial of Video Education in Nursing Homes|Recruiting||N/A|152160|Anticipated|Brown University||2|||f||||t||||||||||2017-10-10 22:43:08.57776|2017-10-10 22:43:08.57776
NCT02612675|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2015-11-20|||January 2013||2013-01-01|November 2015|2015-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Glycemic Response to Oral Nutrition Supplements|Plasma Glucose and Insulin Response to Two Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus|Completed||N/A|13|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 22:43:08.752402|2017-10-10 22:43:08.752402
NCT02612662|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-01-19|||November 2015||2015-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects|A Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4076 Tetracosasodium Following Single-ascending Dose Administration to Healthy Male Subjects|Completed||Phase 1|80|Actual|AstraZeneca||6|||f||||f||||||||||2017-10-10 22:43:08.893032|2017-10-10 22:43:08.893032
NCT02612649|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-04-24|||October 1, 2015|Actual|2015-10-01|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Special Drug Use Surveillance of Irribow in Female Patients|Special Drug Use Surveillance of Irribow® Tablets and Irribow® OD Tablets in Female Patients|Active, not recruiting||N/A|793|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 22:43:09.061647|2017-10-10 22:43:09.061647
NCT02612636|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-06-06|||November 2015||2015-11-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|sayed||The Effect of Ear Plug and Eye Mask on Sleeping Quality in Critically Ill Patients|The Effect of Ear Plug and Eye Mask on Sleeping Quality in Critically Ill Patients|Completed||N/A|60|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 22:43:09.228835|2017-10-10 22:43:09.228835
NCT02612623|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-04-17|||December 17, 2015|Actual|2015-12-17|April 2017|2017-04-01|May 18, 2016|Actual|2016-05-18|May 4, 2016|Actual|2016-05-04||Interventional|||An 8-Week Refractory Chronic Cough Study|A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough|Completed||Phase 2|24|Actual|Afferent Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-10 22:43:09.340091|2017-10-10 22:43:09.340091
NCT02612610|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-04-17|||December 15, 2015|Actual|2015-12-15|April 2017|2017-04-01|November 4, 2016|Actual|2016-11-04|October 31, 2016|Actual|2016-10-31||Interventional|||A 12-Week Study in Subjects With Refractory Chronic Cough|A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough|Completed||Phase 2|253|Actual|Afferent Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-10 22:43:09.475799|2017-10-10 22:43:09.475799
NCT02612597|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-19|||January 2015||2015-01-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|BV-GT||The Effect of Blood Volume Changes on the Glucose Tolerance|The Effect of Blood Volume Changes After Bed Rest and Aerobic Exercise Training on the Glucose Tolerance|Recruiting||N/A|20|Anticipated|Zurich Center for Integrative Human Physiology||2|||f||||||||||||||2017-10-10 22:43:09.608711|2017-10-10 22:43:09.608711
NCT02612584|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-19|||November 2015||2015-11-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Clinical Efficacy of the Pinhole Soft Contact Lenses for Correcting Presbyopia||Recruiting||N/A|30|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 22:43:09.749744|2017-10-10 22:43:09.749744
NCT02612571|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-20|||July 2015||2015-07-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players|Comparing Rates of Glaucomatous Optic Neuropathy in Professional Wind Versus Non-wind Instrument Players in the Philadelphia Orchestra|Completed||N/A|51|Actual|Wills Eye|||2||f||||t||||||||Yes|Manuscript has been written and submitted to American Journal of Ophthalmology.|2017-10-10 22:43:09.970422|2017-10-10 22:43:09.970422
NCT02612558|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-10-05|||April 2016||2016-04-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SOAR||A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)|A Phase 2, Multi-Center, Open Label, Simon Two-Stage Study to Evaluate the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia|Recruiting||Phase 2|37|Anticipated|Rigel Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 22:43:10.187515|2017-10-10 22:43:10.187515
NCT02612545|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-20|2017-08-08|||November 12, 2015||2015-11-12|August 3, 2017|2017-08-03|April 30, 2020|Anticipated|2020-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia|A Multi-Site, Open-Label, Randomized Trial to Assess the Efficacy, Safety, and Tolerability of Dihydroartemisinin-Piperaquine Plus Mefloquine Compared to Dihydroartemisinin-Piperaquine or Artesunate-Mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia|Recruiting||Phase 1|384|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 22:43:10.451457|2017-10-10 22:43:10.451457
NCT02612519|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-06-14|||November 2015||2015-11-01|June 2016|2016-06-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites|Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites. A Multicentre Randomised Controlled Study|Recruiting||N/A|260|Anticipated|University of Leipzig||4|||f||||t||||||||||2017-10-10 22:43:10.792467|2017-10-10 22:43:10.792467
NCT02612506|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-02-13|||October 2015||2015-10-01|July 2016|2016-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers|A Randomized, Double-Blinded, Safety and Pharmacokinetic Study of Escalating Single Doses of Hepalatide in Healthy Volunteers|Completed||Phase 1|48|Actual|Shanghai HEP Pharmaceatical Co., Ltd.||2|||f||||||||||||No||2017-10-10 22:43:10.932008|2017-10-10 22:43:10.932008
NCT02612493|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-20|||January 2006||2006-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Obesity and Metabolic Surgery in Patients With Type I Diabetes|Obesity and Metabolic Surgery in Patients With Type I Diabetes|Completed||N/A|16|Actual|Sana Klinikum Offenbach|||1||f||||f||||||||||2017-10-10 22:43:11.040701|2017-10-10 22:43:11.040701
NCT02612480|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-12-14|||October 2015||2015-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Ticagrelor in Human Endotoxemia Response to Human Endotoxemia|The Effect of Ticagrelor on the Inflammatory Response to Human Endotoxemia|Completed||N/A|40|Actual|Radboud University||4|||f||||t||||||||||2017-10-10 22:43:11.153144|2017-10-10 22:43:11.153144
NCT02612467|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-04-18|||November 2015||2015-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Low Back Pain - What's Next? Stratified Care Compared to Current Practice|The Effectiveness of a Stratified Care Model for Non-specific Low Back Pain in Danish Primary Care Compared to Current Practice in a Randomised Controlled Trial|Recruiting||N/A|700|Anticipated|Region of Southern Denmark||2|||f||||t||||||||||2017-10-10 22:43:11.357699|2017-10-10 22:43:11.357699
NCT02612454|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study to Assess the Long-term Safety of Dupilumab (REGN668/SAR231893) Administered in Patients 6 to <18 Year of Age With Atopic Dermatitis (AD)|An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Dupilumab in Patients ≥6 to <18 Years of Age With Atopic Dermatitis|Enrolling by invitation||Phase 3|69|Anticipated|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:43:12.222213|2017-10-10 22:43:12.222213
NCT02612441|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-09-26|||November 2016||2016-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||The Efficacy of Acupuncture on Patients With First Acute Ischemic Stroke, With Signs of Hemiplegia and Hemiparesis|The Efficacy of Acupuncture on Patients With First Acute Ischemic Stroke, With Signs of Hemiplegia and Hemiparesis|Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-10 22:43:12.410317|2017-10-10 22:43:12.410317
NCT02612428|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-08-03|||January 2016||2016-01-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD|A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)|Recruiting||Phase 3|150|Anticipated|Vital Therapies, Inc.||2|||f||||t||||||||||2017-10-10 22:43:12.549861|2017-10-10 22:43:12.549861
NCT02612415|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-12-15|||November 2015||2015-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|FIRST-ABC||FIRST-line Support for Assistance in Breathing in Children (FIRST-ABC) Feasibility Study|FIRST-ABC Feasibility Study: Feasibility Study for a Randomised Trial of High Flow Nasal Cannula (HFNC) Versus Continuous Positive Airway Pressure (CPAP) for Non-invasive Respiratory Support in Critically Ill Children|Completed||Phase 2/Phase 3|121|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:43:12.959325|2017-10-10 22:43:12.959325
NCT02612402|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-20|||July 2014||2014-07-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Smartphone App on Activity|The Effect of a Smartphone Application for Encouraging Physical Activity on the Amount of Activity Performed by Patients With Diabetes or Hematological Malignancies|Recruiting||N/A|270|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-10 22:43:13.06003|2017-10-10 22:43:13.06003
NCT02612389|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-08-01|||March 2015||2015-03-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Interventional|MMforFA||Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants|Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants|Recruiting||N/A|120|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-10 22:43:13.176071|2017-10-10 22:43:13.176071
NCT02612376|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-11-14|||February 2016||2016-02-01|November 2016|2016-11-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|25 Years|Observational [Patient Registry]|||Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study|Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study|Recruiting||N/A|800|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples With DNA|"     Biospecimens of blood and cerebral spinal fluid   "|No||2017-10-10 22:43:13.338056|2017-10-10 22:43:13.338056
NCT02612363|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-04-19|||November 2015||2015-11-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Early Goal Directed Sedation on Microcirculation in Septic Shock|The Effect of Early Goal Directed Sedation on Microcirculation in Septic Shock Patients With Mechanical Ventilation|Recruiting||Phase 4|25|Anticipated|Southeast University, China||2|||f||||t||||||||Undecided||2017-10-10 22:43:13.437134|2017-10-10 22:43:13.437134
NCT02612350|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-04-03|||November 2015||2015-11-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|H1000||Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease|Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease|Active, not recruiting||N/A|1000|Anticipated|Pathway Genomics|||1||f||||f||||||Samples With DNA|"     Whole blood will be obtained, the plasma sample separated for the isolation of cell-free DNA,     and the sample that may be stored will be excess plasma as well as potentially DNA from the     buffy coat.   "|No||2017-10-10 22:43:13.731063|2017-10-10 22:43:13.731063
NCT02612337|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-08-16|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|AVERTS-1||Study of OTO-104 in Subjects With Unilateral Meniere's Disease|A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease|Completed||Phase 3|165|Actual|Otonomy, Inc.||2|||f||||f||||||||||2017-10-10 22:43:13.88647|2017-10-10 22:43:13.88647
NCT02612324|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-02-23|||January 2012||2012-01-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||An Evaluation of Pono Choices: A Culturally Responsive Teen Pregnancy and STI Prevention Program||Completed||N/A|1783|Actual|University of Hawaii||2|||f||||f||||||||||2017-10-10 22:43:14.002257|2017-10-10 22:43:14.002257
NCT02612311|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-05-12|||January 2016||2016-01-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|UNITY-CLL||Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Patients With Untreated and Previously Treated Chronic Lymphocytic Leukemia|A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With TGR-1202 Compared to Obinutuzumab in Combination With Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)|Recruiting||Phase 3|450|Anticipated|TG Therapeutics, Inc.||4|||f||||t||||||||||2017-10-10 22:43:14.1604|2017-10-10 22:43:14.1604
NCT02612298|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-10-13|||August 2015||2015-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|ESAHOM||Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate|Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate in Patients With Essential Hypertension|Recruiting||Phase 4|200|Anticipated|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:43:14.583558|2017-10-10 22:43:14.583558
NCT02612285|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-11-03|||March 2016||2016-03-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study of SNX-5422 in TP53 Null Cancers|A Single Arm Study of SNX-5422 in Subjects With TP53 Null Cancers|Terminated||Phase 2|1|Actual|Esanex Inc.||1||Recruitment very slow - study could not be enrolled|f||||f||||||||||2017-10-10 22:43:14.701985|2017-10-10 22:43:14.701985
NCT02612272|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-10-12|||November 2015||2015-11-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparing Intra-articular Corticosteroid to Intra-articular Ketorolac Knee Injections|A Double-blind, Randomized, Controlled, Equivalence Study Comparing Intra-articular Corticosteroid to Intra-articular Ketorolac Knee Injections|Recruiting||Phase 4|448|Anticipated|St. Luke's Hospital, Pennsylvania||2|||f||||f||||||||Yes|Will plan to submit to orthopaedic journals for publication|2017-10-10 22:43:14.791342|2017-10-10 22:43:14.791342
NCT02612246|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-07-28|||November 2015||2015-11-01|March 2016|2016-03-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||First-in-Human Single and Multiple Dose of GLPG1972|Randomized, Double-blind, Placebo-controlled, Dose-escalation Study for the Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of GLPG1972 in Healthy Male Subjects|Completed||Phase 1|41|Actual|Galapagos NV||4|||f||||f||||||||||2017-10-10 22:43:15.020579|2017-10-10 22:43:15.020579
NCT02612233|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-07-19|||September 2013||2013-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|DUPRO||Pain Management in Osteoarthritis Using the Centrally Acting Analgesics Duloxetine and Pregabalin|Pain Management in Osteoarthritis Using the Centrally Acting Analgesics Duloxetine and Pregabalin|Completed||Phase 4|81|Actual|St George's, University of London||3|||f||||t||||||||||2017-10-10 22:43:15.134074|2017-10-10 22:43:15.134074
NCT02612220|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-01-06|||December 2015||2015-12-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|BioFoam||Effectiveness of BioFoam® Surgical Matrix to Improve Hemostasis During Liver Resection|Effectiveness of BioFoam® Surgical Matrix to Improve Hemostasis During Liver Resection - A Randomized Controlled Trial|Recruiting||N/A|110|Anticipated|Technische Universität Dresden||2|||f||||f||||||||||2017-10-10 22:43:15.222899|2017-10-10 22:43:15.222899
NCT02612207|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-04-13|||August 2015||2015-08-01|April 2017|2017-04-01||||December 2017|Anticipated|2017-12-01||Observational|||Point-of-Care System for Determination of Bilirubin Capacity in Neonates||Recruiting||N/A|500|Anticipated|Stanford University|||1||f||||t||||||||||2017-10-10 22:43:15.314245|2017-10-10 22:43:15.314245
NCT02612194|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-08-11|||February 2016||2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer|LCI-GU-URO-CRI-001: A Phase II Study of Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer|Recruiting||Phase 2|46|Anticipated|Carolinas Healthcare System||3|||f||||t||||||||||2017-10-10 22:43:15.405564|2017-10-10 22:43:15.405564
NCT02612181|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-06-14|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dex on Microcirculation in SS—A Double-blinded Study|The Effect of Dexmedetomidine on Microcirculation in Septic Shock- A Double-blinded Study|Recruiting||Phase 4|44|Anticipated|Southeast University, China||2|||f||||t||||||||Undecided||2017-10-10 22:43:15.490516|2017-10-10 22:43:15.490516
NCT02612168|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-10-03|||January 11, 2017|Actual|2017-01-11|April 2017|2017-04-01|June 14, 2018|Anticipated|2018-06-14|June 1, 2018|Anticipated|2018-06-01||Interventional|||Melanoma Image Analysis Algorithm (MIAA) Validation Study|Effectiveness of an Image Analysing Algorithm to Diagnose Melanoma Compared to Gold Standard Histological Determination|Recruiting||N/A|1250|Anticipated|Skin Analytics Limited||1|||f||||f|f|f||||||||2017-10-10 22:43:15.580681|2017-10-10 22:43:15.580681
NCT02612155|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-06-27|||March 30, 2017|Actual|2017-03-30|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|(HIE)||A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy|A Phase II Multi-site Study of Autologous Cord Blood Cells for Hypoxic (HIE)|Recruiting||Phase 2|160|Anticipated|Duke University||2|||f||||t|t|f||||||||2017-10-10 22:43:15.703687|2017-10-10 22:43:15.703687
NCT02612129|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-07-07|||June 2016|Actual|2016-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Arimoclomol Prospective Study in Patients Diagnosed With NiemannPick Disease Type C|Arimoclomol Prospective Doubleblind, Randomised, Placebo-controlled Study in Patients Diagnosed With NiemannPick Disease Type C|Active, not recruiting||Phase 2/Phase 3|50|Actual|Orphazyme||2|||f||||t||||||||||2017-10-10 22:43:15.873744|2017-10-10 22:43:15.873744
NCT02612116|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-10-18|||September 2015||2015-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study|The Impact of Administration Strategy of Ticagrelor on Its Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris - a Randomized, Single-center, Open-label Pilot Study|Completed||Phase 4|49|Actual|Collegium Medicum w Bydgoszczy||3|||f||||f||||||||||2017-10-10 22:43:16.009471|2017-10-10 22:43:16.009471
NCT02612103|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-10-11|||November 2015||2015-11-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01|1 Year|Observational [Patient Registry]|||Biomarkers in Inflammatory Bowel Diseases|Evaluation of Markers of the Extracellular Matrix Turnover as Biomarkers in Inflammatory Bowel Diseases and Establishment of an Inflammatory Bowel Diseases (IBD) Biobank|Recruiting||N/A|300|Anticipated|Odense University Hospital|||6||f||||f||||||||||2017-10-10 22:43:16.11919|2017-10-10 22:43:16.11919
NCT02612090|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-02-06|||January 2016||2016-01-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|STR4||The Cholesterol Lowering Effects of Strawberry|The Cholesterol Lowering Effects of Strawberry: A Randomized Controlled Trial Establishing Strawberry's Role in Cardiovascular Health|Recruiting||N/A|50|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||No||2017-10-10 22:43:16.211255|2017-10-10 22:43:16.211255
NCT02612077|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-02-12|2016-01-15||May 2008||2008-05-01|February 2016|2016-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|CONCERT|Efficacy Analysis Set. Note: 29 participants dd not continue after enrollment.|Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)|A Cohort Survey of Patients With Metastatic Colorectal Cancer Starting a Chemotherapy in Combination With Avastin®|Completed||N/A|765|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:43:16.361875|2017-10-10 22:43:16.361875
NCT02612064|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-04-19|2017-02-02||November 1, 2015||2015-11-01|April 2017|2017-04-01|June 3, 2016|Actual|2016-06-03|June 3, 2016|Actual|2016-06-03||Interventional|||The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity|Completed||N/A|488|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:43:16.852417|2017-10-10 22:43:16.852417
NCT02612051|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-04-28|||December 4, 2015|Actual|2015-12-04|April 2017|2017-04-01|June 2, 2016|Actual|2016-06-02|June 2, 2016|Actual|2016-06-02||Interventional|||First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients|A FTIH Study With GSK3008348 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 1|40|Actual|GlaxoSmithKline||8|||f||||f||||||||||2017-10-10 22:43:17.601271|2017-10-10 22:43:17.601271
NCT02612038|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-20|||January 2016||2016-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ExpFLOSA||Nasal Expiratory Resistance in Patients With Sleep Apnea and Expiratory Flow Limitation|Nasal Expiratory Resistance in Patients With Sleep Apnea and Expiratory Flow Limitation|Not yet recruiting||N/A|30|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 22:43:17.839974|2017-10-10 22:43:17.839974
NCT02612025|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-09-01|||November 2015||2015-11-01|September 2016|2016-09-01||||November 2017|Anticipated|2017-11-01||Interventional|MUCKI||Effects of Resistance and Endurance Training in Pediatric Cancer Patients During Intensive Treatment Phase|Effects of Combined Resistance and Endurance Training in Pediatric Cancer Patients During Intensive Treatment Phase|Recruiting||N/A|40|Anticipated|Johannes Gutenberg University Mainz||2|||f||||||||||||||2017-10-10 22:43:17.962312|2017-10-10 22:43:17.962312
NCT02612012|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-20|||October 2015||2015-10-01|November 2015|2015-11-01||||October 2019|Anticipated|2019-10-01||Observational|||Axillary Radiotherapy for Early Stage Breast Cancer With Limited Positive Sentinel Lymph Nodes|Phase II Study of Axillary Level I-II Areas Radiotherapy for Early Stage Breast Cancer With Limited Positive Sentinel Lymph Nodes|Recruiting||N/A|475|Anticipated|Fudan University|||1||f||||t||||||||||2017-10-10 22:43:18.076856|2017-10-10 22:43:18.076856
NCT02611999|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-01-30|||January 2014||2014-01-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|December 2014|Actual|2014-12-01||Interventional|||Paid Price Information on Image and Procedure Ordering Rates|The Effect of Paid Price Information on Image and Procedure Ordering Rates|Completed||N/A|1205|Actual|Boston Children’s Hospital||3|||f||||||||||||||2017-10-10 22:43:18.217902|2017-10-10 22:43:18.217902
NCT02611986|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2016-10-26|||November 2015||2015-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|EMMA||Evaluation of Video Laryngoscopy (Video Macintosh-blade) and Direct Laryngoscopy (EMMA-Study)|Evaluation of Video Laryngoscopy (Video Macintosh-blade) and Direct Laryngoscopy (EMMA-Study): A Prospective, Randomized Trial|Recruiting||N/A|2000|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f||||||||No||2017-10-10 22:43:18.349711|2017-10-10 22:43:18.349711
NCT02611973|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-24|||March 10, 2016|Actual|2016-03-10|July 2017|2017-07-01|November 2022|Anticipated|2022-11-01|November 2019|Anticipated|2019-11-01||Interventional|FAST||Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia|French Aspirin Study in Essential Thrombocythemia: an Open and Randomized Study|Recruiting||Phase 3|2250|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-10-10 22:43:18.497743|2017-10-10 22:43:18.497743
NCT02611960|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-28|||April 18, 2016|Actual|2016-04-18|September 2017|2017-09-01|March 5, 2020|Anticipated|2020-03-05|March 5, 2020|Anticipated|2020-03-05||Interventional|||Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122)|A Two-arm, Open-label, Randomized Phase III Study of Pembrolizumab (MK-3475) Monotherapy Versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122)|Recruiting||Phase 3|230|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t|t|f||||||||2017-10-10 22:43:18.663927|2017-10-10 22:43:18.663927
NCT02610829|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-04-07|||November 2015||2015-11-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|Gammadose||Evaluation of a Short Course of Gamma Tocopherol Supplementation in Adult Subjects|Evaluation of a Short Course of Gamma Tocopherol Supplementation in Adult Subjects|Completed||N/A|10|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-10 22:43:33.251514|2017-10-10 22:43:33.251514
NCT02611947|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-19|||October 2010||2010-10-01|November 2015|2015-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||CT Indexes of Emphysema and Airways in Healthy Volunteers: Normal Values; Relations With Gender, Height and Weight|CT Indexes of Emphysema and Airways in Healthy Volunteers: Normal Values; Relations With Gender, Height and Weight|Completed||N/A|87|Actual|Erasme University Hospital|||1||f||||f||||||||||2017-10-10 22:43:18.845075|2017-10-10 22:43:18.845075
NCT02611934|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|UNICORN||Mild Therapeutic Hypothermia for Patients With Acute Coronary Syndrome and Cardiac Arrest Treated With PCI|Mild Therapeutic Hypothermia for Patients With Acute Coronary Syndrome and Cardiac Arrest Treated With Percutaneous Coronary Intervention|Not yet recruiting||N/A|500|Anticipated|Collegium Medicum w Bydgoszczy||2|||f||||f|f|f||||||||2017-10-10 22:43:18.973855|2017-10-10 22:43:18.973855
NCT02611921|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-08-29|||December 2015||2015-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder|Intranasal Ketamine Use in Autism Spectrum Disorder: A Placebo-Controlled Crossover Pilot Study|Recruiting||Phase 1|24|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 22:43:19.116537|2017-10-10 22:43:19.116537
NCT02611908|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-04-26|||June 2016||2016-06-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Obinutuzumab With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib.|A Phase 1 Clinical Trial to Evaluate Obinutuzumab With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib.|Recruiting||Phase 1|30|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-10 22:43:19.253237|2017-10-10 22:43:19.253237
NCT02611895|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-04-04|||March 2015||2015-03-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|RALNOVO||Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy|Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy ( RALNOVO )|Recruiting||N/A|60|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 22:43:19.410949|2017-10-10 22:43:19.410949
NCT02611882|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-09-26|||September 2015||2015-09-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|PSMA PET||Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients|Evaluation of Gallium-68 HBED-CC-PSMA Imaging in Prostate Cancer Patients|Active, not recruiting||Phase 1/Phase 2|225|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 22:43:19.522101|2017-10-10 22:43:19.522101
NCT02611869|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2015-11-19|||October 2015||2015-10-01|November 2015|2015-11-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|CryoLAEF||Effect of Cryoballoon and RF Ablation on Left Atrial Function|Effect of Cryoballoon Versus Radiofrequency Ablation for Pulmonary Vein Isolation on Left Atrial Function in Patients With Non-valvular Paroxysmal Atrial Fibrillation|Recruiting||N/A|120|Anticipated|G.Gennimatas General Hospital||2|||f||||f||||||||||2017-10-10 22:43:19.615569|2017-10-10 22:43:19.615569
NCT02611856|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-08-23|||April 2008||2008-04-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Observational|STT||Monochorial-diamniotic Pregnancies Complicated With a Twin-to-twin Syndrome|STT Study : Pediatric Follow-up of Children's From Monochorial-diamniotic Pregnancies Complicated With a Twin-to-twin Syndrome|Active, not recruiting||N/A|179|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     sera, urine   "|||2017-10-10 22:43:19.738092|2017-10-10 22:43:19.738092
NCT02611843|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-04-24|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Peer Supported Web-based CBT for OEF/OIF Veterans With PTSD and Substance Misuse|Peer Supported Web-based CBT for OEF/OIF Veterans With PTSD and Substance Misuse|Completed||N/A|30|Actual|Syracuse VA Medical Center||2|||f||||f||||||||||2017-10-10 22:43:19.843071|2017-10-10 22:43:19.843071
NCT02611817|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-20|||January 4, 2016|Actual|2016-01-04|September 2017|2017-09-01|September 3, 2020|Anticipated|2020-09-03|March 3, 2020|Anticipated|2020-03-03||Interventional|||Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy|Recruiting||Phase 3|824|Anticipated|Takeda||2|||f||||t||||||||||2017-10-10 22:43:20.539967|2017-10-10 22:43:20.539967
NCT02611804|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-03|||October 2015||2015-10-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp|A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp|Completed||Phase 3|492|Actual|Teva Pharmaceuticals USA||3|||f||||f||||||||||2017-10-10 22:43:21.517723|2017-10-10 22:43:21.517723
NCT02610270|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-19|||June 2014||2014-06-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|O3Sport||Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes|Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response|Completed||Early Phase 1|24|Actual|Centre d'Alt Rendiment||3|||f||||t||||||||||2017-10-10 22:43:39.776176|2017-10-10 22:43:39.776176
NCT02611778|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-04-27|||February 2016||2016-02-01|April 2017|2017-04-01||||March 2020|Anticipated|2020-03-01||Interventional|COLUMBUS-AMD||Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration|Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration|Recruiting||Phase 3|||Bioeq GmbH||2|||f||||t||||||||||2017-10-10 22:43:21.763223|2017-10-10 22:43:21.763223
NCT02611765|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-04-15|2016-03-10||September 2008||2008-09-01|April 2016|2016-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Syphilis Response to Higher Penicillin Dosage: The 2.4 Versus 7.2 Study|Syphilis Response to Higher Penicillin Dosage in HIV Co-Infected Patients|Completed||Phase 4|64|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 22:43:21.880247|2017-10-10 22:43:21.880247
NCT02611752|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-05-09|||October 2015||2015-10-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Multiple Dose Opioid Challenge Study|A Multiple Dose Opioid Challenge Study to Assess Blockade of Subjective Opioid Effects of CAM2038 q1w (Buprenorphine FluidCrystal® Subcutaneous Injection Depots) In Adults With Opioid Use Disorder|Completed||Phase 2|47|Actual|Braeburn Pharmaceuticals||5|||f||||f||||||||||2017-10-10 22:43:22.14904|2017-10-10 22:43:22.14904
NCT02611739|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-10-13|||January 2016||2016-01-01|October 2016|2016-10-01||||September 2016|Actual|2016-09-01||Interventional|||Medi-Port Pilot Randomized Controlled Trial|Using a Humanoid Robot to Reduce Procedural Pain and Distress in Children With Cancer: A Pilot Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-10 22:43:22.272353|2017-10-10 22:43:22.272353
NCT02611726|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-22|||December 2015||2015-12-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Acupuncture for Symptom Control During Assisted Reproductive Treatments Procedures|Effectiveness of Acupuncture Added to Standard Care Vs Standard Care Alone During In-Vitro-Fertilization: A Randomized Controlled Trial|Not yet recruiting||Phase 3|400|Anticipated|Bnai Zion Medical Center||2|||f||||t||||||||||2017-10-10 22:43:22.399497|2017-10-10 22:43:22.399497
NCT02611713|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-08|||January 4, 2016||2016-01-04|September 2017|2017-09-01|March 27, 2021|Anticipated|2021-03-27|March 27, 2021|Anticipated|2021-03-27||Observational|DUOGLOBE||Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease|DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)|Recruiting||N/A|200|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:43:22.55133|2017-10-10 22:43:22.55133
NCT02611700|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-01-29|||November 2015||2015-11-01|January 2016|2016-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma|An Prospective, Multicenter, Double-blind, Randomized, Controlled Clinical Study of Nimotuzumab Combined With Paclitaxel and Cisplatin as First-line Treatment of Metastatic Esophageal Squamous Cell Carcinomas|Recruiting||Phase 3|504|Anticipated|Biotech Pharmaceutical Co., Ltd.||2|||f||||f||||||||Undecided||2017-10-10 22:43:22.817514|2017-10-10 22:43:22.817514
NCT02611687|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-04-13|||April 2016||2016-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period|Double Blind, Multicentre, Randomized, Placebo-controlled Trial to Evaluate Safety and Efficacy of Pitolisant in Children From 6 to Less Than 18 Years With Narcolepsy With/Without Cataplexy, Followed by a Prolonged Open-label Period|Recruiting||Phase 2|60|Anticipated|Bioprojet||2|||f||||t||||||||||2017-10-10 22:43:23.080334|2017-10-10 22:43:23.080334
NCT02611674|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-09-01|||January 6, 2016|Actual|2016-01-06|September 2017|2017-09-01|September 9, 2019|Anticipated|2019-09-09|May 7, 2018|Anticipated|2018-05-07||Observational|||Methodology Study of Novel Outcome Measures to Assess Progression of ALS|Methodology Study of Novel Electrophysiological, Physical, and Imaging Outcome Measures to Assess the Progression of Amyotrophic Lateral Sclerosis|Active, not recruiting||N/A|100|Anticipated|Biogen|||1||f||||f||||||||||2017-10-10 22:43:23.211074|2017-10-10 22:43:23.211074
NCT02611661|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-02-21|||January 19, 2016|Actual|2016-01-19|February 2017|2017-02-01|July 31, 2019|Anticipated|2019-07-31|February 28, 2019|Anticipated|2019-02-28||Interventional|LASER||Local Ablative Strategies After Endovascular Radioembolization|Local Ablative Strategies After Endovascular Radioembolization (LASER)|Recruiting||Phase 1|40|Anticipated|Washington University School of Medicine||5|||f||||t|f|t|f|f|f|||No||2017-10-10 22:43:23.337301|2017-10-10 22:43:23.337301
NCT02611648|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-03-11|||November 2015||2015-11-01|March 2017|2017-03-01||||March 2016|Actual|2016-03-01||Interventional|||Duodenoscope Disinfect Study|Prospective Randomized Double-blinded Trial Comparing Three Duodenoscope High- Level Disinfection and Sterilization Procedures|Completed||N/A|541|Actual|Beth Israel Deaconess Medical Center||3|||f||||||||||||||2017-10-10 22:43:23.480342|2017-10-10 22:43:23.480342
NCT02611635|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-04-17|||February 2, 2016|Actual|2016-02-02|April 2017|2017-04-01|February 15, 2017|Actual|2017-02-15|January 26, 2017|Actual|2017-01-26||Observational|PRiSMA-AF||AF Patient Preference Study|AF Patient Preferences Towards NOAC Versus VKA Treatment: a Patient Preference Study.|Completed||N/A|382|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:43:23.562841|2017-10-10 22:43:23.562841
NCT02611622|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-02-16|||August 7, 2013|Actual|2013-08-07|February 2017|2017-02-01|October 21, 2015|Actual|2015-10-21|October 21, 2015|Actual|2015-10-21||Interventional|||LumaENT and Patient Satisfaction|Impact of Multimedia-based Patient Education on Patient Satisfaction Scores in an Otolaryngology Practice Setting|Completed||N/A|35|Actual|Washington University School of Medicine||2|||f||||f|f|f||||||No||2017-10-10 22:43:23.678481|2017-10-10 22:43:23.678481
NCT02611609|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-01-31|||January 2016||2016-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|MUST-ARDS||A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome|A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome|Recruiting||Phase 1/Phase 2|36|Anticipated|Athersys, Inc||3|||f||||t||||||||||2017-10-10 22:43:23.769023|2017-10-10 22:43:23.769023
NCT02611596|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-05-16|||November 2016||2016-11-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics|Does Ranolazine Decrease Biomarkers That Indicate Evidence of Myocardial Damage in Diabetics With Stable Ischemic Heart Disease? A Double-blinded, Randomized, Placebo Controlled Trial|Withdrawn||N/A|0|Actual|Walter Reed National Military Medical Center||2|||f||||f||||||||||2017-10-10 22:43:23.934047|2017-10-10 22:43:23.934047
NCT02611583|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-08|||June 24, 2016|Actual|2016-06-24|March 2017|2017-03-01|June 24, 2016|Actual|2016-06-24|June 24, 2016|Actual|2016-06-24||Interventional|||TENS Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the ED|Double-blind, Randomized, Placebo Controlled Trial of Transcutaneous Electrical Nerve Stimulation (TENS) Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the Emergency Department|Withdrawn||N/A|0|Actual|Albert Einstein Healthcare Network||2||Never initiated due to lack of funding and IRB Approval|f||||f||||||||||2017-10-10 22:43:26.099894|2017-10-10 22:43:26.099894
NCT02611570|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-07-30|||October 2014||2014-10-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Observational|||LDCT Screening in Non-smokers in Taiwan|Low Dose Computed Tomography Screening Study in Non-smokers With Risk Factors for Lung Cancer in Taiwan|Recruiting||N/A|12000|Anticipated|Academia Sinica, Taiwan|||1||f||||t||||||Samples With DNA|"     blood samples Urine samples   "|||2017-10-10 22:43:26.211787|2017-10-10 22:43:26.211787
NCT02611557|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-02-16|||February 2015||2015-02-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|INFORM||Lymphedema Progression Screening Using MRI|Imaging Noninvasively With Functional-MRI for Onset, Response and Management of Lymphatic Impairment|Recruiting||N/A|90|Anticipated|Vanderbilt University Medical Center||1|||f||||f||||||||||2017-10-10 22:43:26.403883|2017-10-10 22:43:26.403883
NCT02611544|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-08-16|||December 2015||2015-12-01|August 2017|2017-08-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors|Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors: A Randomized Clinical Pilot Trial|Completed||N/A|91|Actual|Indiana University||3|||f||||t|f|f||||||||2017-10-10 22:43:26.524417|2017-10-10 22:43:26.524417
NCT02611531|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-07-18|||November 2015||2015-11-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Video vs. TTG Respiratory Inhaler Technique Assessment and InstructioN (V-TRaIN)|Video vs. TTG Respiratory Inhaler Technique Assessment and InstructioN (V-TRaIN)|Recruiting||N/A|142|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 22:43:26.643836|2017-10-10 22:43:26.643836
NCT02611518|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-08-18|||April 5, 2016|Actual|2016-04-05|August 2017|2017-08-01|June 14, 2016|Actual|2016-06-14|June 14, 2016|Actual|2016-06-14||Interventional|||A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants|A Phase 1, 2-Panel, Open-Label, Fixed-Sequence Study in Healthy Adult Subjects to Investigate the Pharmacokinetic Interaction Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin|Completed||Phase 1|32|Actual|Janssen Research & Development, LLC||2|||f||||f||f||||||||2017-10-10 22:43:26.72836|2017-10-10 22:43:26.72836
NCT02611505|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-05-12|||November 30, 2015|Actual|2015-11-30|May 2017|2017-05-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||A Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine|An Open-Label, Single-Dose, Parallel-Group Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine|Completed||Phase 1|24|Actual|Janssen Research & Development, LLC||3|||f||||f||f||||||||2017-10-10 22:43:26.814392|2017-10-10 22:43:26.814392
NCT02611492|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2016-11-18|||April 2016||2016-04-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|GRAAPH2014||A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults|A Phase III Study, Randomized, to Evaluate the Reduction of Chemotherapy Intensity in Association With Nilotinib (Tasigna®) in Philadelphia Chromosome-positive (Ph+) ALL of Young Adults (18-59 Years Old) (GRAAPH-2014)|Recruiting||Phase 3|265|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:43:26.908806|2017-10-10 22:43:26.908806
NCT02611479|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-05-16|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|August 2017|Anticipated|2017-08-01||Observational|||Understanding Non-Response in Spine Fusion Surgery|Understanding Non-Response in Spine Fusion Surgery|Recruiting||N/A|200|Anticipated|University of Washington|||1||f||||f||||||||||2017-10-10 22:43:27.148917|2017-10-10 22:43:27.148917
NCT02611453|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP|CO2 Cholangiography as an Alternative to Iodinated Contrast in Endoscopic Retrograde Cholangiopancreatography|Recruiting||N/A|40|Anticipated|University of Virginia||1|||f||||f||||||||No||2017-10-10 22:43:27.449509|2017-10-10 22:43:27.449509
NCT02611440|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-11-18|||July 2015||2015-07-01|September 2015|2015-09-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|ADMED-AVC||Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients After Ischemic Stroke|Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients After Ischemic Stroke (ADMED-AVC)|Recruiting||N/A|182|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:43:27.551169|2017-10-10 22:43:27.551169
NCT02611427|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-09-09|||November 2015||2015-11-01|September 2016|2016-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Increasing Long-Term Physical Activity After Lumbar Spine Surgery|Increasing Long-Term Physical Activity After Lumbar Spine Surgery|Recruiting||N/A|350|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-10 22:43:27.67941|2017-10-10 22:43:27.67941
NCT02611414|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-05-17|||January 2016||2016-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effectiveness of tDCS for the Treatment of Functional Dyspepsia|Effectiveness of Transcranial Direct Current Stimulation for the Treatment of Functional Dyspepsia: a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|70|Anticipated|Hospital Ernesto Dornelles||2|||f||||t||||||||||2017-10-10 22:43:27.776343|2017-10-10 22:43:27.776343
NCT02611401|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-12-01|||May 2014||2014-05-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of MBI for Depressive Symptoms in Patients With MS|The Efficacy of a Mindfulness Based Intervention for Depressive Symptoms in Patients With Multiple Sclerosis and Their Caregivers. A Randomized Controlled Clinical Trial.|Recruiting||Phase 4|88|Anticipated|University of Turin, Italy||2|||f||||f||||||||||2017-10-10 22:43:27.877484|2017-10-10 22:43:27.877484
NCT02611388|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2015-11-19|||December 2015||2015-12-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||Neurohumoral Mechanism of Deferent Frequency Transcutaneous Electrical Acupoint Stimulation(TEAS)|Neurohumor Mechanism of Deferent Frequency Transcutaneous Electrical Acupoint Stimulation(TEAS): A Prospective, Randomized Controlled Trial|Not yet recruiting||N/A|81|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-10 22:43:27.961307|2017-10-10 22:43:27.961307
NCT02611375|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-07-20|||January 2017||2017-01-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Conditioning Neural Circuits to Improve Upper Extremity Function|Conditioning Neural Circuits to Improve Upper Extremity Function|Recruiting||N/A|70|Anticipated|Shepherd Center, Atlanta GA||3|||f||||t||||||||||2017-10-10 22:43:28.045666|2017-10-10 22:43:28.045666
NCT02611362|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-19|||April 2015||2015-04-01|November 2015|2015-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Multilevel Gaming Intervention for Persons on PrEP|A Multilevel Gaming Intervention for Persons on PrEP|Recruiting||N/A|90|Anticipated|Rhode Island Hospital||2|||f||||f||||||||||2017-10-10 22:43:28.155388|2017-10-10 22:43:28.155388
NCT02611336|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-18|||November 2015||2015-11-01|November 2015|2015-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|SUM||Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy|Study on New Insights in Remodeling of Endocrine Cardiomyopathies: ASsessmentt of Intramyocardial, Molecular and NeUroendocrine Parameters in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in AcroMegaly|Not yet recruiting||Phase 2|15|Anticipated|University of Roma La Sapienza||1|||f||||||||||||||2017-10-10 22:43:28.337636|2017-10-10 22:43:28.337636
NCT02611323|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-21|||March 9, 2016|Actual|2016-03-09|September 2017|2017-09-01|June 18, 2021|Anticipated|2021-06-18|June 18, 2021|Anticipated|2021-06-18||Interventional|||A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)|A Phase Ib/II Study Evaluating the Safety and Efficacy of Obinutuzumab in Combination With Polatuzumab Vedotin and Venetoclax in Patients With Relapsed or Refractory Follicular Lymphoma and Rituximab in Combination With Polatuzumab Vedotin and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Recruiting||Phase 1|134|Anticipated|Hoffmann-La Roche||4|||f|||||t|f||||||||2017-10-10 22:43:28.422501|2017-10-10 22:43:28.422501
NCT02611310|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-10-02|||January 19, 2017|Actual|2017-01-19|October 2017|2017-10-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Observational|||A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)|Saudi Arabia - A Disease Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer|Recruiting||N/A|200|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:43:28.769891|2017-10-10 22:43:28.769891
NCT02611297|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-11-19|||November 2013||2013-11-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Cryoprobe Transbronchial Lung Biospy in Patients With Mechanical Ventilation||Unknown status|Recruiting|N/A|15|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||t||||||||||2017-10-10 22:43:28.862054|2017-10-10 22:43:28.862054
NCT02611284|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-18|||October 2013||2013-10-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Less Invasive Beractant Administration in Preterm Infants|Less Invasive Beractant Administration in Preterm Infants: a Pilot Study.|Completed||N/A|60|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||||||||||||2017-10-10 22:43:28.981402|2017-10-10 22:43:28.981402
NCT02611271|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-09-19|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Observational|||Elimination of Antibiotics During Renal Replacement Therapy and Cytosorb Adsorptive Therapy|Elimination of Antibiotics During Combined Continuous Renal Replacement Therapy and Cytosorb Adsorptive Therapy in Patients With Sepsis and Acute Kidney Injury|Not yet recruiting||N/A|30|Anticipated|Heinrich-Heine University, Duesseldorf|||2||f||||f||||||||||2017-10-10 22:43:29.066176|2017-10-10 22:43:29.066176
NCT02611258|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-20|||November 2015||2015-11-01|November 2015|2015-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|ERGO||Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs|Study on New Insights in Remodeling of Endocrine Cardiomyopathies: Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in Cushing's Syndrome|Not yet recruiting||Phase 2|18|Anticipated|University of Roma La Sapienza||1|||f||||||||||||||2017-10-10 22:43:29.141443|2017-10-10 22:43:29.141443
NCT02611245|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-08-29|||November 2015||2015-11-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG|Phase 1 Study of NIR Fluorescence Guided Thoracic Surgery Using ICG|Enrolling by invitation||Phase 1|200|Anticipated|Chinese Academy of Sciences||1|||f||||t||||||||||2017-10-10 22:43:29.256428|2017-10-10 22:43:29.256428
NCT02611232|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-09-15|||December 2015||2015-12-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults|Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults|Enrolling by invitation||Phase 2|42|Anticipated|University of Oulu||2|||f||||t||||||||||2017-10-10 22:43:29.353053|2017-10-10 22:43:29.353053
NCT02611219|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-05-26|||March 2015||2015-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Deconditioning in Transplant|Effect of Increased Activity on Deconditioning in Pediatric Stem Cell Transplant Recipients: A Feasibility Study|Completed||Early Phase 1|30|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 22:43:29.471856|2017-10-10 22:43:29.471856
NCT02611206|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-09-13|||October 2015||2015-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for Adolescent Depression: Efficacy, Predictive Biomarkers, and Mechanisms|Repetitive Transcranial Magnetic Stimulation for Adolescent Depression: Efficacy, Predictive Biomarkers, and Mechanisms|Recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-10 22:43:29.594441|2017-10-10 22:43:29.594441
NCT02611193|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-11-18|||May 2016||2016-05-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy of Manipulative Treatment for Carpal Tunnel Syndrome|Efficacy of Manipulative Treatment for Carpal Tunnel Syndrome: a Randomized Clinical Trial|Not yet recruiting||N/A|66|Anticipated|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||f||||||||||2017-10-10 22:43:29.699224|2017-10-10 22:43:29.699224
NCT02611180|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-02-16|||April 30, 2015|Actual|2015-04-30|February 2017|2017-02-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Observational|||Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease|Analysis of Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease|Recruiting||N/A|50|Anticipated|Washington University School of Medicine|||2||f||||f|f|f||||Samples With DNA|"     Skin samples and blood samples   "|No||2017-10-10 22:43:29.780967|2017-10-10 22:43:29.780967
NCT02611167|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-04-19|||November 1, 2017|Anticipated|2017-11-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease|Pilot Phase I Study of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t|t|f||||||No||2017-10-10 22:43:29.936015|2017-10-10 22:43:29.936015
NCT02611154|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-03-09|2016-10-06||November 18, 2015|Actual|2015-11-18|March 2017|2017-03-01|January 19, 2016|Actual|2016-01-19|January 19, 2016|Actual|2016-01-19||Interventional|Intranasal||Intranasal Delivery of Testosterone and Its Effect on Doping Markers|Intranasal Delivery of Testosterone and Its Effect on Doping Markers|Completed||Phase 4|5|Actual|University of Utah||1|||f||||t||||||||Yes|Data will be published in the scientific literature.|2017-10-10 22:43:30.076828|2017-10-10 22:43:30.076828
NCT02611141|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2016-09-12|||November 2015||2015-11-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Retromolar Route Access With and Without A Retromolar Gap|Retromolar Route Access With and Without A Retromolar Gap - A Visualization Study Of The Vocal Cords|Recruiting||N/A|40|Anticipated|Medical University of Vienna||2|||f||||||||||||||2017-10-10 22:43:30.471182|2017-10-10 22:43:30.471182
NCT02611128|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-02-21|||August 2014||2014-08-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|DENND1A||Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia|Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia|Recruiting||N/A|65|Anticipated|University of Virginia|||1||f||||t|f|f||||Samples With DNA|"     Optional sample banking for later genetic analysis: At the time of study, the investigators     will request consent/assent to bank saliva samples for later genetic analysis (e.g., if     additional highly-promising gene candidates for adolescent hyperandrogenemia/PCOS are     identified). If subjects and parents do not provide assent/consent that would allow specimens     to be banked for later genetic analysis, the samples and the means of linking specimens to     data will be destroyed (once analysis for all participants is completed).   "|Undecided|We do not have current plans to share IPD|2017-10-10 22:43:30.581713|2017-10-10 22:43:30.581713
NCT02611115|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-10-04|||September 2015||2015-09-01|October 2017|2017-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|OptIPeCT||Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography.|Optimizing Tube Voltage Settings and Injection Parameters for the Individual Patient in CT Pulmonary Angiography.|Completed||N/A|235|Actual|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-10 22:43:30.719853|2017-10-10 22:43:30.719853
NCT02611102|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-09-23|||March 2016||2016-03-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Butter & MCT Oil on Lipoproteins - A RCT|Effects of Daily Butter & Medium-Chain Triglyceride Oil on Lipoproteins When Added to Baseline Diet a Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||||2017-10-10 22:43:30.78187|2017-10-10 22:43:30.78187
NCT02611089|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-03-08|||February 2016||2016-02-01|March 2016|2016-03-01|August 2036|Anticipated|2036-08-01|August 2018|Anticipated|2018-08-01||Observational|||Muscle Connective Tissue in Limb Development and Disease|Muscle Connective Tissue in Limb Development and Disease|Recruiting||N/A|30|Anticipated|King's College London|||2||f||||f||||||Samples With DNA|"     Tissue biopsies measuring no more than 5 x 10 mm, consisting of muscle, muscle connective     tissue, tendon, fat and skin, or a combination of the above, and / or; Tissue normally     discarded during the patient's routine reconstructive hand surgery.   "|No||2017-10-10 22:43:30.882637|2017-10-10 22:43:30.882637
NCT02611076|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-08-18|||October 15, 2015|Actual|2015-10-15|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|October 11, 2016|Actual|2016-10-11||Interventional|||Smoking-cessation: A Spanish-Language Clinical Trial|Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-Language Clinical Trial|Active, not recruiting||N/A|42|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|f|f||||||||2017-10-10 22:43:31.001928|2017-10-10 22:43:31.001928
NCT02611063|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-10-25|||January 2016||2016-01-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant|A Phase I Trial of Fostamatinib and Chronic Graft vs. Host Disease Development After Allogeneic Stem Cell Transplantation|Recruiting||Phase 1|18|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 22:43:31.090972|2017-10-10 22:43:31.090972
NCT02611050|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2015-11-18|||December 2015||2015-12-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment Decisions for Multi-vessel CAD|Treatment Decisions for Multi-vessel Coronary Artery Disease Patients|Enrolling by invitation||N/A|160|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-10 22:43:31.190058|2017-10-10 22:43:31.190058
NCT02609880|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-07-03|||July 2009||2009-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer|Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer|Recruiting||N/A|150|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 22:43:45.774516|2017-10-10 22:43:45.774516
NCT02611037|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-07-28|||January 4, 2016|Actual|2016-01-04|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma|A Phase 2 Study of Transarterial Chemoperfusion Treatment With Cisplatin, Methotrexate and Gemcitabine in Patients With Unresectable Pleural Mesothelioma|Recruiting||Phase 2|36|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-10 22:43:31.302455|2017-10-10 22:43:31.302455
NCT02611024|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-28|||May 6, 2016||2016-05-06|September 2016|2016-09-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Patients With Selected Solid Tumors|Phase I, Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Pretreated Patients With Selected Advanced Solid Tumors|Recruiting||Phase 1|100|Anticipated|PharmaMar||2|||f||||f||||||||||2017-10-10 22:43:31.539723|2017-10-10 22:43:31.539723
NCT02611011|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-07-15|||October 2016||2016-10-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey|Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey|Not yet recruiting||N/A|198|Anticipated|Gynuity Health Projects|||1||f||||f||||||Samples Without DNA|"     urine samples collected   "|Undecided||2017-10-10 22:43:31.648138|2017-10-10 22:43:31.648138
NCT02610985|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||2-D and 3-D Laparoscopic Hysterectomy|3-dimensional Versus Conventional Laparoscopy in Patients Undergoing Total Hysterectomy for Benign Disease - A Randomised Clinical Trial|Recruiting||N/A|400|Anticipated|University Hospital Roskilde||2|||f||||t||||||||||2017-10-10 22:43:31.753609|2017-10-10 22:43:31.753609
NCT02610972|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-03-22|||June 2017|Anticipated|2017-06-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study|Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study|Not yet recruiting||N/A|150|Anticipated|Gynuity Health Projects|||2||f||||f||||||Samples Without DNA|"     urine samples collected   "|Undecided||2017-10-10 22:43:31.857019|2017-10-10 22:43:31.857019
NCT02610959|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-05-12|||December 2015||2015-12-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|Mommy'sFood||Iodine Status During Pregnancy and Its Effect on Infant Development.|Iodine Status During Pregnancy and Its Effect on Infant Development; a Randomized Intervention Study With Cod|Active, not recruiting||N/A|142|Anticipated|National Institute of Nutrition and Seafood Research, Norway||2|||f||||t||||||||||2017-10-10 22:43:31.9495|2017-10-10 22:43:31.9495
NCT02610946|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-19|||April 2015||2015-04-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Do Technology Apps Improve Compliance in Adolescent Renal Transplant Recipients?|Do Technology Apps Improve Compliance in Adolescent Renal Transplant Recipients?|Recruiting||N/A|30|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:43:32.027714|2017-10-10 22:43:32.027714
NCT02610933|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-09-26|||November 2015||2015-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients|The Effect of Replacement of Vitamin K Antagonist by Rivaroxaban With or Without Vitamin K2 Supplementation on Vascular Calcifications in Chronic Hemodialysis Patients: A Randomized Controlled Trial|Recruiting||Phase 4|117|Anticipated|Onze Lieve Vrouw Hospital||3|||f||||||||||||||2017-10-10 22:43:32.126714|2017-10-10 22:43:32.126714
NCT02610920|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2016-07-27|||December 2015||2015-12-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection|Identification of Sentinel Lymph Nodes by Ultrasound Utilizing Iron Tracer Injection and Preoperative Biopsy in Women With Breast Cancer|Recruiting||N/A|20|Anticipated|Columbia University||1|||f||||f||||||||||2017-10-10 22:43:32.250914|2017-10-10 22:43:32.250914
NCT02610907|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-01-19|||November 2015||2015-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Pilot Evaluation of Adhesives and How They Are Impacted by Out-put||Completed||N/A|4|Actual|Coloplast A/S||1|||f||||f||||||||||2017-10-10 22:43:32.379353|2017-10-10 22:43:32.379353
NCT02610894|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-01-24|||September 2015||2015-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||An mHealth Self-Management Program to Decrease Postoperative Symptom Distress|A mHealth Self-Management Program to Decrease Postoperative Symptom Distress in Orthopaedic Patients|Active, not recruiting||N/A|40|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 22:43:32.500577|2017-10-10 22:43:32.500577
NCT02610881|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-04-22|||December 2015||2015-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children|Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children|Completed||N/A|110|Actual|Emory University||2|||f||||f||||||||||2017-10-10 22:43:32.6155|2017-10-10 22:43:32.6155
NCT02610868|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-25|||October 2015||2015-10-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|OPTIMYST||Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults|A Phase 3, Long-Term, Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects|Completed||Phase 3|187|Actual|US WorldMeds LLC||1|||f||||f||||||||||2017-10-10 22:43:32.753241|2017-10-10 22:43:32.753241
NCT02610855|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-09-11|||November 2015||2015-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|SAMUS SCOLI||Effect of Treatment on Activity and Muscle Function in Pediatric Patients With Scoliosis|Effect of Treatment on Activity and Muscle Function in Pediatric Patients With Scoliosis (SAMUS SCOLI)|Enrolling by invitation||N/A|36|Anticipated|Mayo Clinic||3|||f||||f||||||||||2017-10-10 22:43:32.989011|2017-10-10 22:43:32.989011
NCT02610816|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-06-06|||January 2016||2016-01-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|||Eosinophilic Esophagitis (EoE) Intervention Trial-Randomized 1 Food Elimination vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids|Eosinophilic Esophagitis (EoE) Intervention Trial-Randomized 1 Food Elimination vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids|Recruiting||Phase 2/Phase 3|292|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 22:43:33.372431|2017-10-10 22:43:33.372431
NCT02610803|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-19|||September 2014||2014-09-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke|Paroxysmal Atrial Fibrillation and Brief Runs of Premature Atrial Complexes in Patients With Acute Ischemic Stroke: A Historical Cohort Study|Completed||N/A|863|Actual|Odense University Hospital|||1||f||||f||||||||||2017-10-10 22:43:33.504956|2017-10-10 22:43:33.504956
NCT02610790|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-11-18|||December 2015||2015-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|BRAVE||BRacelet And Physical actiVity Evaluation (BRAVE)|Evaluation of Pre- and Post-operative Physical Activity on Postoperative Rehabilitation After Colorectal Surgery With a Connected Device|Not yet recruiting||N/A|50|Anticipated|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-10 22:43:33.614678|2017-10-10 22:43:33.614678
NCT02610764|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2017-04-12|||November 2015||2015-11-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ESO-CTC||Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC|Resectable Esophageal Adenocarcinoma: The Influence of Multimodal Therapy on the Prevalence and Enumeration of Circulating Tumor Cells in Comparison With Conventional Response Evaluation in a Feasibility Study|Completed||N/A|19|Actual|University Hospital Freiburg||1|||f||||f||||||||||2017-10-10 22:43:33.999073|2017-10-10 22:43:33.999073
NCT02610751|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-06-14|||January 2016||2016-01-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels|Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels|Recruiting||N/A|58|Anticipated|TriHealth Inc.|||2||f||||f||||||||No||2017-10-10 22:43:34.110189|2017-10-10 22:43:34.110189
NCT02610738|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-11-24|||January 2015||2015-01-01|November 2015|2015-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Junior KICkOFF: Diabetes Education for Children Under 11 Years|Junior KICk-OFF. Development and Pilot Evaluation of Structured Self-management Education Packages for Children 11 Years of Age and Under With Type 1 Diabetes, Their Parents and Carers.|Enrolling by invitation||N/A|24|Anticipated|Sheffield Children's NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 22:43:34.242824|2017-10-10 22:43:34.242824
NCT02610725|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-02-28|||November 2015||2015-11-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Online Yoga for Individuals With Mood Disorders|Online Yoga for Individuals With Mood Disorders|Recruiting||N/A|300|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 22:43:34.356073|2017-10-10 22:43:34.356073
NCT02610712|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-09-20|||May 2014||2014-05-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial of the Use of Ketamine in Treatment Resistant Depression|Clinical Trial of the Use of Ketamine in Treatment Resistant Depression|Recruiting||Phase 4|20|Anticipated|National Institute of Neurology and Neurosurgery, Mexico||1|||f||||||||||||||2017-10-10 22:43:34.460854|2017-10-10 22:43:34.460854
NCT02610699|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-01-22|||November 2014||2014-11-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CPAS||Community Pediatric Acceptability Study (CPAS)|CellScope Oto - Community Pediatric Acceptability Study (CPAS)|Completed||N/A|75|Actual|Emory University||2|||f||||f||||||||||2017-10-10 22:43:34.579651|2017-10-10 22:43:34.579651
NCT02610686|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-22|||March 2015||2015-03-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam|Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam|Unknown status|Recruiting|Phase 4|100|Anticipated|National Institute of Malariology, Parasitology and Entomology, Vietnam||1|||f||||f||||||||||2017-10-10 22:43:34.685688|2017-10-10 22:43:34.685688
NCT02610673|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-07-25|||February 8, 2016|Actual|2016-02-08|September 2016|2016-09-01|November 2021|Anticipated|2021-11-01|March 2018|Anticipated|2018-03-01|5 Years|Observational [Patient Registry]|||WiCS-LV Post Market Surveillance Registry|WiCS-LV Post Market Surveillance Registry|Enrolling by invitation||N/A|100|Anticipated|EBR Systems, Inc.|||1||f||||f||||||||||2017-10-10 22:43:34.822499|2017-10-10 22:43:34.822499
NCT02610660|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-04-28|||August 2015||2015-08-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|3 Years|Observational [Patient Registry]|TOPP-2||Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension|Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension|Recruiting||N/A|200|Anticipated|Association for Pediatric Pulmonary Hypertension|||1||f||||f||||||||||2017-10-10 22:43:34.927368|2017-10-10 22:43:34.927368
NCT02610647|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-06-16|||June 6, 2017|Actual|2017-06-06|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|NEURO COMP||Functional Significance of Complexity Measures in the Sensory-motor Behavior|Functional Significance of Complexity Measures in the Sensory-motor Behavior: Are There Potential Clinical Applications?|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nīmes||5|||f||||f|f|f||||||||2017-10-10 22:43:35.415527|2017-10-10 22:43:35.415527
NCT02610634|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-12-05|2016-12-05||July 2013||2013-07-01|December 2016|2016-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Visual Function During Gait in Parkinson's Disease: Impact of Cognition and Response to Visual Cues|Visual Function During Gait in Parkinson's Disease: Impact of Cognition and Response to Visual Cues|Completed||N/A|100|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||2||f||||f||||||||||2017-10-10 22:43:35.61619|2017-10-10 22:43:35.61619
NCT02610621|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-10-11|||December 2015||2015-12-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy|IIT2015-11-Giuliano: Safety and Efficacy of Omission of Sentinel Node Biopsy for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy|Withdrawn||Phase 2|0|Actual|Cedars-Sinai Medical Center||1||Study may not be clinically relevant at this time.|f||||f||||||||||2017-10-10 22:43:36.112607|2017-10-10 22:43:36.112607
NCT02610608|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-02-13|||February 2016||2016-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|AMPERT||Medical Assistance for the Procreation and Risk of Thrombosis.|Assistance Médicale à la Procréation et Risque Thrombotique|Recruiting||N/A|10000|Anticipated|University Hospital, Brest|||1||f||||f||||||Samples With DNA|"     One blood sample for each women particpating in the study   "|||2017-10-10 22:43:36.225251|2017-10-10 22:43:36.225251
NCT02610595|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-19|||December 2015||2015-12-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Study on the Therapeutic Effect of TCM Treatment for MDR MN|A Prospective, Multi-center Study of the Chinese Medicine for the Treatment of MDR Membranous Nephropathy in the Traditional Chinese Medicine (a Herbal Formula for Invigorating Spleen and Benefiting qi and Promoting Blood Circulation)|Unknown status|Not yet recruiting|N/A|220|Anticipated|Shanghai University of Traditional Chinese Medicine||1|||f||||f||||||||||2017-10-10 22:43:36.386579|2017-10-10 22:43:36.386579
NCT02610582|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-05-03|||November 2015||2015-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia|Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked Achromatopsia Investigated in an Exploratory, Dose-escalation Trial|Active, not recruiting||Phase 1/Phase 2|9|Anticipated|STZ eyetrial||1|||f||||t||||||||No||2017-10-10 22:43:36.527181|2017-10-10 22:43:36.527181
NCT02610569|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-10-12|||April 2014||2014-04-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|VCC2-RCH||Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative Colitis|Comparison of the PillCamCOLON (C2) Capsule With Standard Endoscopy for the Evaluation of the Severity and the Endoscopic Healing of Patients With Ulcerative Colitis (UC)|Recruiting||N/A|50|Anticipated|Société Française d'Endoscopie Digestive||2|||f||||f||||||||||2017-10-10 22:43:36.641655|2017-10-10 22:43:36.641655
NCT02610556|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-05-25|||January 2016||2016-01-01|May 2016|2016-05-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma|Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With Intensity-modulated Radiotherapy in High Risk Locregionally Advanced Nasopharyngeal Carcinoma: a Phase 2 Randomized Controlled Trial|Recruiting||Phase 2|130|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:43:36.791846|2017-10-10 22:43:36.791846
NCT02610543|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-08-17|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome|A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study to Evaluate the Efficacy of UCB5857 Over 12 Weeks in Subjects With Primary Sjögren's Syndrome|Recruiting||Phase 2|58|Anticipated|UCB Pharma||2|||f||||t||||||||||2017-10-10 22:43:37.017179|2017-10-10 22:43:37.017179
NCT02610530|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-07-29|||December 2015||2015-12-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|July 2016|Actual|2016-07-01||Observational|SIT-DOWN-1||Surgical Intervention for the Treatment of Diabetes in Overweight Non-responders-1|Efficacy of Surgical Intervention for the Treatment of Diabetes Mellitus Type 2 in Overweight Non-responders in Comparison With Conventional Nonsurgical Medical Treatment|Enrolling by invitation||N/A|90|Anticipated|Turkish Metabolic Surgery Foundation|||3||f||||f||||||||||2017-10-10 22:43:37.222217|2017-10-10 22:43:37.222217
NCT02610517|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2016-04-07|||June 2013||2013-06-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ARCH||ARCH Research Protocol for Provider Alcohol Pharmacotherapy Training and Assessment|Integration of Evidence-based Alcohol Interventions Into HIV Care (ARCH-IRA) (Phases 1- Provider Training and 2- Patient Intervention)|Completed||N/A|236|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 22:43:37.3491|2017-10-10 22:43:37.3491
NCT02610504|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-09-20|||April 2015||2015-04-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prospective Single Center Open Label Study of Shoulder OA Pain|A 26 Week Prospective Open Label Clinical Study Evaluating A Single Intra-Articular Injection of Durolane 3ml for Treatment of Osteoarthritis Pain of the Shoulder|Recruiting||N/A|36|Anticipated|Bioventus LLC||1|||f||||f||||||||Yes|possible publication|2017-10-10 22:43:37.496595|2017-10-10 22:43:37.496595
NCT02610491|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-19|||February 2015||2015-02-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Hesperidin on Glucose / Insulin Metabolism|The Effect of Hesperidin Administration on Glucose / Insulin Metabolism|Completed||Phase 2|53|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 22:43:37.612811|2017-10-10 22:43:37.612811
NCT02610478|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-10-03|||November 10, 2015||2015-11-10|September 26, 2017|2017-09-26|November 29, 2019|Anticipated|2019-11-29|November 30, 2018|Anticipated|2018-11-30||Interventional|||Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A|A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Teatment of Severe Influenza A|Enrolling by invitation||Phase 3|300|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 22:43:37.708801|2017-10-10 22:43:37.708801
NCT02610465|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-10-03|||November 5, 2015||2015-11-05|September 28, 2017|2017-09-28|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||High Image Matrix CT Reconstruction|High Image Matrix CT Reconstruction|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:43:37.811899|2017-10-10 22:43:37.811899
NCT02610452|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-07-27|||March 31, 2016|Actual|2016-03-31|July 2017|2017-07-01|November 12, 2016|Actual|2016-11-12|November 12, 2016|Actual|2016-11-12||Interventional|OUPS||Assessing the Impact of Clown Therapy in a Palliative Care Unit: A Prospective, Descriptive Study|Assessing the Impact of Clown Therapy in a Palliative Care Unit: A Prospective, Descriptive Study|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 22:43:37.90451|2017-10-10 22:43:37.90451
NCT02610439|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-28|||March 25, 2014|Actual|2014-03-25|September 2017|2017-09-01||||January 1, 2100|Anticipated|2100-01-01||Observational|||Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer|Exploratory Next Generation Sequencing to Identify Causative Variants for Taxane-Induced Peripheral Neuropathy From Breast Cancer Study E5103 Germline DNA Samples|Recruiting||N/A|575|Anticipated|National Cancer Institute (NCI)|||1||f||||||||||||||2017-10-10 22:43:37.983913|2017-10-10 22:43:37.983913
NCT02610426|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-28|||March 25, 2014|Actual|2014-03-25|September 2017|2017-09-01||||January 1, 2100|Anticipated|2100-01-01||Observational|||Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer|Exploratory Next Generation Sequencing to Identify Causative Variants for Therapy-Induced Congestive Heart Failure From Breast Cancer Study E5103 Germline DNA Samples|Recruiting||N/A|162|Anticipated|National Cancer Institute (NCI)|||1||f||||||||||Samples With DNA|"     Blood   "|||2017-10-10 22:43:38.069051|2017-10-10 22:43:38.069051
NCT02610413|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-19|2017-09-28|||March 25, 2014|Actual|2014-03-25|September 2017|2017-09-01||||January 1, 2100|Anticipated|2100-01-01||Observational|||Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer|Exploratory Next Generation Sequencing to Identify Causative Variants for Bevacizumab-Induced Hypertension From Breast Cancer Study E5103 Germline DNA Samples|Recruiting||N/A|354|Anticipated|National Cancer Institute (NCI)|||1||f||||||||||||||2017-10-10 22:43:38.148296|2017-10-10 22:43:38.148296
NCT02610400|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-04-14|||February 2016||2016-02-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of Targeted Parasite Elimination (TPE) in Namibia|Effectiveness and Feasibility of Targeted Parasite Elimination vs. Reactive Case Detection, With/Without Reactive Vector Control, as a Community Intervention in Response to Confirmed Passively Identified Index Cases, Zambezi Region, Namibia|Recruiting||Phase 3|6579|Anticipated|University of California, San Francisco||4|||f||||t||||||||Undecided||2017-10-10 22:43:38.236796|2017-10-10 22:43:38.236796
NCT02610387|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-07-22|||September 12, 2016||2016-09-12|July 2017|2017-07-01|December 20, 2017|Anticipated|2017-12-20|December 20, 2017|Anticipated|2017-12-20||Interventional|||The Effects of tDCS Combined With Balance Training on Lower Limbs Spasticity in Chronic Stroke Patients|The Effects of tDCS Combined With Balance Training on Lower Limbs Spasticity in Chronic Stroke Patients ( A Randomized Controlled Trial)|Recruiting||N/A|40|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:43:38.344767|2017-10-10 22:43:38.344767
NCT02610374|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-08-29|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Diet / Gut Microbiome Interaction and Influence on Inflammatory Disease in HIV Patients|Diet / Gut Microbiome Interaction and Influence on Inflammatory Disease in HIV Patients|Recruiting||N/A|98|Anticipated|University of Colorado, Denver||3|||f||||f||||||||||2017-10-10 22:43:38.440715|2017-10-10 22:43:38.440715
NCT02610361|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-02-07|||November 2013||2013-11-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors|A Phase 1A/1B, Open-Label, Multiple-Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics and Preliminary Antitumor Activities of the B RAF Inhibitor BGB 283 in Subjects With Solid Tumors|Active, not recruiting||Phase 1|131|Actual|BeiGene||1|||f||||f||||||||||2017-10-10 22:43:38.523937|2017-10-10 22:43:38.523937
NCT02610348|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-03-24|||November 2015||2015-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age|Persistence of Anti-Hep B Antibodies at 12 to 18 Months of Age in Children Having Received Hep B Vaccine at Birth and a DTaP-IPV-HB-Hib Hexavalent Vaccine (Hexaxim® or Infanrix Hexa®) Concomitantly With Prevnar® at 2, 4 and 6 Months of Age|Completed||N/A|124|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:43:38.605539|2017-10-10 22:43:38.605539
NCT02610335|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-05-16|||January 2016||2016-01-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|CLEMOB||Evaluation of Spinal Mobility Reeducation in Patients Treated for a Lumbar Spinal Stenosis After Epidural Infiltration|Evaluation of Spinal Mobility Reeducation in Patients Treated for a Lumbar Spinal Stenosis After Epidural Infiltration. Randomized and Comparative Study: Kyphosis Reeducation Versus Spinal Mobility Reeducation|Recruiting||N/A|300|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 22:43:38.695495|2017-10-10 22:43:38.695495
NCT02610322|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-19|||June 2016||2016-06-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Whole Soy Replacement Diet on Metabolic Features|A Randomized Controlled Trial of Whole Soy Diet in Place of Red/Processed Meat and High Fat Dairy Products on Metabolic Features in Postmenopausal Women|Not yet recruiting||N/A|208|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:43:38.818492|2017-10-10 22:43:38.818492
NCT02610309|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-18|||January 2012||2012-01-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|FBCI||Family-based Crisis Intervention With Suicidal Adolescents in the ED|Family-based Crisis Intervention With Suicidal Adolescents in the Emergency Department: A Randomized Clinical Trial|Completed||N/A|143|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-10 22:43:38.884299|2017-10-10 22:43:38.884299
NCT02610296|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-06-27|||December 2015||2015-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|ReGIFT||QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant|A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant|Recruiting||Phase 3|634|Anticipated|Quark Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:43:39.004386|2017-10-10 22:43:39.004386
NCT02610283|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-06-27|||December 2015||2015-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery|A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery|Active, not recruiting||Phase 2|341|Actual|Quark Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:43:39.559197|2017-10-10 22:43:39.559197
NCT02610257|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-08-05|||January 2016||2016-01-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|||Somatosensory Dysfunction as the Underlying Mechanism of Upper Limbs Motor Blocks in People With Parkinson's Disease|The Role of Somatosensory Dysfunction as the Underlying Mechanism of Upper Limbs Motor Blocks in People With Parkinson's Disease With and Without Freezing of Gait|Completed||N/A|45|Actual|Katholieke Universiteit Leuven||5|||f||||t||||||||||2017-10-10 22:43:39.933019|2017-10-10 22:43:39.933019
NCT02610244|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-12-29|||November 2015||2015-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CMH||Examining Benefits of Modified Cogmed Training With ADHD at Cambridge Memorial Hospital(CMH)|Examining Benefits of Modified Cogmed Training With ADHD Youth at Cambridge Memorial Hospital (CMH)|Recruiting||N/A|70|Anticipated|Cambridge Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:43:40.084559|2017-10-10 22:43:40.084559
NCT02610231|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-03-13|||December 2015||2015-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 16, 2017|Anticipated|2017-11-16||Interventional|||Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease|A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease|Active, not recruiting||Phase 3|300|Anticipated|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||f||||||||||2017-10-10 22:43:40.225955|2017-10-10 22:43:40.225955
NCT02610218|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-04-17|||April 2016||2016-04-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer||Recruiting||N/A|100|Anticipated|Peking University|||1||f||||f||||||Samples With DNA|"     Peripheral blood samples of 12.5 mL were collected from the patients for cfDNA and CTCs     analysis   "|||2017-10-10 22:43:40.515947|2017-10-10 22:43:40.515947
NCT02610205|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-11-20|||September 2012||2012-09-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Observational|||Caring Touch as a Bodily Anchor for Patients After Sustaining a Motor Vehicle Accident|Integrative Care at the Emergency Department|Completed||N/A|41|Actual|Karolinska University Hospital|||1||f||||f||||||||||2017-10-10 22:43:40.636|2017-10-10 22:43:40.636
NCT02610192|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-07-21|||March 2016||2016-03-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis|A Prospective Study of a Single Intra-Articular Injection of Autologous Protein Solution in Females With Primary Patellofemoral Osteoarthritis|Active, not recruiting||N/A|50|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-10 22:43:40.744206|2017-10-10 22:43:40.744206
NCT02610179|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-08-08|||April 2015||2015-04-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial|Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial|Recruiting||N/A|617|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 22:43:40.849777|2017-10-10 22:43:40.849777
NCT02610166|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-04-24|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With JIA and Their Parents|Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With Juvenile Idiopathic Arthritis (JIA) and Their Parents|Recruiting||N/A|120|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 22:43:40.999771|2017-10-10 22:43:40.999771
NCT02610140|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-08-16|||December 3, 2015|Actual|2015-12-03|August 2017|2017-08-01|July 29, 2019|Anticipated|2019-07-29|May 31, 2017|Actual|2017-05-31||Interventional|||Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)|A Randomized, Open-label, Active-controlled, Phase II Study of Intravenous Anetumab Ravtansine (BAY 94-9343) or Vinorelbine in Patients With Advanced or Metastatic Malignant Pleural Mesothelioma Overexpressing Mesothelin and Progressed on First Line Platinum/Pemetrexed-based Chemotherapy|Active, not recruiting||Phase 2|248|Actual|Bayer||2|||f||||t|t|f||||||||2017-10-10 22:43:41.345325|2017-10-10 22:43:41.345325
NCT02610127|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-08-16|||December 2015||2015-12-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A|Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A|Recruiting||N/A|60|Anticipated|Baxalta US Inc.|||2||f||||f||||||||||2017-10-10 22:43:41.729359|2017-10-10 22:43:41.729359
NCT02610114|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-03-20|||December 2015||2015-12-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||Improvement of Cell Selection in Reproductive Techniques|A New Method to Improve the Selection of Zygotes in the Context of Assisted Reproductive Medicine. A Randomized Controlled Blinded Monocenter Study|Recruiting||N/A|220|Anticipated|Luzerner Kantonsspital||2|||f||||f||||||||||2017-10-10 22:43:41.852835|2017-10-10 22:43:41.852835
NCT02610101|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-04-18|||November 2015||2015-11-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Nutritional Therapy Study in Pediatric Crohn's Disease|A Blinded, Nutritional Therapy Study, Using a Modified Specific Carbohydrate Diet in Pediatric Crohn's Disease|Recruiting||N/A|21|Anticipated|Seattle Children's Hospital||3|||f||||t||||||||||2017-10-10 22:43:41.967691|2017-10-10 22:43:41.967691
NCT02610075|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-09-11|||December 1, 2015|Actual|2015-12-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.|A Phase Ib Study to Determine the Maximum Tolerated Dose (MTD) of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.|Recruiting||Phase 1|78|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-10-10 22:43:42.216744|2017-10-10 22:43:42.216744
NCT02610062|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-05-02|||April 4, 2016|Actual|2016-04-04|May 2017|2017-05-01|September 11, 2018|Anticipated|2018-09-11|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)|A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|110|Anticipated|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-10 22:43:42.330586|2017-10-10 22:43:42.330586
NCT02610049|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-08-08|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|February 13, 2017|Actual|2017-02-13|February 3, 2017|Actual|2017-02-03||Interventional|Art_Tx_PTSD||Trial of Art Therapy During Cognitive Processing Therapy for PTSD|Randomized, Controlled Trial of Art Therapy During Cognitive Processing Therapy for PTSD|Terminated||N/A|31|Actual|Hampton VA Medical Center||3||Investigator has retired.|f||||f|f|f||||||||2017-10-10 22:43:42.463521|2017-10-10 22:43:42.463521
NCT02610036|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-11-19|||March 2012||2012-03-01|March 2012|2012-03-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Observational|||Obliterating Diabetic Microangiopathy of the Diabetic Foot|Pilot Study on the Presence of Microangiopathy in Diabetic Foot Ulcer|Completed||N/A|60|Actual|IRCCS Multimedica|||2||f||||f||||||||||2017-10-10 22:43:42.563065|2017-10-10 22:43:42.563065
NCT02610023|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-09-20|||January 2015||2015-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|July 2015|Actual|2015-07-01||Observational|||Food Frequency Questionnaires in Estimating Food Nutrient Intake in Healthy Young Adults|Comparative Assessment of Food Frequency Questionnaires|Active, not recruiting||N/A|100|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-10 22:43:42.641132|2017-10-10 22:43:42.641132
NCT02610010|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-18|||November 2015||2015-11-01|November 2015|2015-11-01|November 2025|Anticipated|2025-11-01|November 2022|Anticipated|2022-11-01||Interventional|||Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma|Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma: a Phase 3 Non-inferior Multicenter Randomized Controlled Trial|Recruiting||Phase 3|462|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:43:42.808977|2017-10-10 22:43:42.808977
NCT02609997|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2015-11-18|||September 2012||2012-09-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of In-the-bag Stability Between Single-piece and Three-piece Intraocular Lens|Comparison of In-the-bag Stability Between Single-piece and Three-piece Intraocular Lens Via Scheimpflug Imaging System|Completed||N/A|65|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:43:42.958007|2017-10-10 22:43:42.958007
NCT02609984|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2017-06-29|||October 2015||2015-10-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|May 26, 2017|Actual|2017-05-26||Interventional|IMDZ-C232||Trial of CMB305 and Atezolizumab in Patients With Sarcoma|A Randomized, Open-Label, Phase 2 Trial of CMB305 (Sequentially Administered LV305 and G305) and Atezolizumab in Patients With Locally Advanced, Relapsed, or Metastatic Sarcoma Expressing NY-ESO-1|Active, not recruiting||Phase 2|88|Actual|Immune Design||2|||f||||t||||||||||2017-10-10 22:43:43.100137|2017-10-10 22:43:43.100137
NCT02609971|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-07-14|||February 2015||2015-02-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Whole Body Vibration in Individuals Submitted to ACL|Immediate Effects of Whole Body Vibration on Neuromuscular Performance of Quadriceps Femoris in Individuals Submitted to Anterior Cruciate Ligament Reconstruction: A Randomized Clinical Trial|Completed||N/A|46|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||||2017-10-10 22:43:43.233547|2017-10-10 22:43:43.233547
NCT02609958|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-10-31|||October 2015||2015-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy|A Phase 2A, Single Arm, Multicentre, Study of ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy|Recruiting||Phase 2|25|Anticipated|Aslan Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:43:43.305881|2017-10-10 22:43:43.305881
NCT02609945|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-06-03|||November 2015||2015-11-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults|A Phase 1 First in Human Open-Label Study of the Safety and Pharmacokinetics of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults|Completed||Phase 1|21|Actual|Acorda Therapeutics||1|||f||||t||||||||||2017-10-10 22:43:43.408161|2017-10-10 22:43:43.408161
NCT02609932|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-09-18|||July 2016||2016-07-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of IFN-γ on Innate Immune Cells|Effect of Interferon-gamma 1-b on Innate Immune Cells|Active, not recruiting||Phase 1|20|Actual|University of Colorado, Denver||1|||f||||f||||||||||2017-10-10 22:43:43.518559|2017-10-10 22:43:43.518559
NCT02609919|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-09-01|||January 2016||2016-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age|Assessment of Immediate Adverse Reactions in Children Under 2 Years of Age Following Administration of Gadoteric Acid (Gd-DOTA or Dotarem)|Recruiting||N/A|200|Anticipated|St. Louis University|||1||f||||t||||||||||2017-10-10 22:43:43.613847|2017-10-10 22:43:43.613847
NCT02609906|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-19|||November 2015||2015-11-01|November 2015|2015-11-01||||November 2016|Anticipated|2016-11-01||Interventional|||Operative Treatment of 2-fragment-fractures (AO 11-A3) of the Proximal Humerus in the Elderly: Cement Augmented Locking Plate Philos vs. Proximal Humerus Nail MultiLoc||Recruiting||N/A|40|Anticipated|Klinikum der Universitaet Muenchen||2|||f||||t||||||||||2017-10-10 22:43:43.722481|2017-10-10 22:43:43.722481
NCT02609893|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-22|||December 2015||2015-12-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|BYE-C||Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs|Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs|Active, not recruiting||Phase 4|31|Actual|San Francisco Department of Public Health||2|||f||||t||||||||||2017-10-10 22:43:45.680782|2017-10-10 22:43:45.680782
NCT02609854|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-01-29|||November 2015||2015-11-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Sustained Acoustic Medicine for Chronic Low Back Pain Secondary to Herniated Nucleus Pulposus or Other Conditions|Sustained Acoustic Medicine for Chronic Low Back Pain Secondary to Herniated Nucleus Pulposus or Other Conditions|Completed||N/A|65|Actual|ZetrOZ, Inc.||2|||f||||f||||||||||2017-10-10 22:43:45.978409|2017-10-10 22:43:45.978409
NCT02609841|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-06-23|2017-05-30||September 30, 2015|Actual|2015-09-30|June 2017|2017-06-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Observational|PORTEND|Baseline data was summarized only for those patients who received all 6 hemodialysis (HD) treatments over 12 days; 28 patients did not complete all treatments and are excluded from baseline population.|POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study|POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis (PORTEND): A Multicenter, Prospective, Observational Study|Completed||N/A|240|Actual|ZS Pharma, Inc.|||1||f||||f|f|t|f|f||||||2017-10-10 22:43:46.073575|2017-10-10 22:43:46.073575
NCT02609828|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-10-02|||October 28, 2015|Actual|2015-10-28|October 2017|2017-10-01|July 21, 2020|Anticipated|2020-07-21|September 29, 2019|Anticipated|2019-09-29||Interventional|||Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy.|A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study Of The Analgesic Efficacy And Safety Of The Subcutaneous Administration Of Tanezumab (Pf-04383119) In Subjects With Cancer Pain Predominantly Due To Bone Metastasis Receiving Background Opioid Therapy|Recruiting||Phase 3|255|Anticipated|Pfizer||2|||f||||t|f|f||||||||2017-10-10 22:43:46.394217|2017-10-10 22:43:46.394217
NCT02609802|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-02-01|||November 2015||2015-11-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Different Analgesic Potency of Volatile Anesthetics at Equi-MAC|The Different Analgesic Potency of Sevoflurane and Desflurane at Equi-minimum Alveolar Concentration|Recruiting||Phase 3|89|Anticipated|Kangbuk Samsung Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:43:47.153502|2017-10-10 22:43:47.153502
NCT02609789|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-10-05|||December 10, 2015|Actual|2015-12-10|October 2017|2017-10-01|September 19, 2018|Anticipated|2018-09-19|December 22, 2017|Anticipated|2017-12-22||Interventional|||A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Subjects and Multiple Dose Study of JNJ-55920839 in Subjects With Mild to Moderate Systemic Lupus Erythematosus|Suspended||Phase 1|80|Anticipated|Janssen Research & Development, LLC||7|||f||||t|t|f||||||||2017-10-10 22:43:47.253245|2017-10-10 22:43:47.253245
NCT02609763|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-29|||November 2015||2015-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS) Scale|Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS) Scale|Completed||N/A|100|Actual|Topokine Therapeutics, Inc.|||1||f||||f||||||||||2017-10-10 22:43:47.483049|2017-10-10 22:43:47.483049
NCT02609750|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-03-07|||January 2013||2013-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|WorkUp||WorkUp. Structured Care With Workplace Interventions to Improve Work Ability in Patients With Neck and/or Low Back Pain|WorkUp. Early Structured Care Including Workplace Interventions to Improve Work Ability in Patients With Neck and/or Back Pain. A Prospective Pare Wise Cluster Randomized Controlled Trial in Primary Care With One Year Follow up|Active, not recruiting||N/A|364|Actual|Lund University||2|||f||||f||||||||||2017-10-10 22:43:47.540582|2017-10-10 22:43:47.540582
NCT02609737|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-06-16|||November 13, 2015||2015-11-13|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors|Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors|Recruiting||N/A|20|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:43:47.622992|2017-10-10 22:43:47.622992
NCT02609724|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-05-02|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|EFforT-BCRL||Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRL|Effectiveness of Fluoroscopy-guided Manual Lymph Drainage (MLD) Versus Traditional MLD or Placebo MLD, as Part of Decongestive Lymphatic Therapy, for the Treatment of Breast Cancer-related Lymphoedema (BCRL): a Randomised Controlled Trial|Recruiting||N/A|201|Anticipated|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||No||2017-10-10 22:43:47.745174|2017-10-10 22:43:47.745174
NCT02609711|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-18|||November 2015||2015-11-01|November 2015|2015-11-01||||March 2016|Anticipated|2016-03-01||Interventional|||Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects||Active, not recruiting||Phase 1|90|Anticipated|Ahn-Gook Pharmaceuticals Co.,Ltd|||||f||||||||||||||2017-10-10 22:43:47.878351|2017-10-10 22:43:47.878351
NCT02609698|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2015-11-18|||August 2015||2015-08-01|November 2015|2015-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)|A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial|Recruiting||Phase 4|906|Anticipated|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 22:43:47.974908|2017-10-10 22:43:47.974908
NCT02609685|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-09-21|||December 2015||2015-12-01|September 2016|2016-09-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Interventional|PMCAS||Active Surveillance of Papillary Thyroid Microcarcinoma|Active Surveillance of Papillary Thyroid Microcarcinoma|Recruiting||N/A|216|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-10 22:43:48.26632|2017-10-10 22:43:48.26632
NCT02609672|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-01-18|2016-09-27||August 2015||2015-08-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Resilience for Older Workers With OA Through Exercise|Resilience and Longevity for Older Workers With Arthritis Through Exercise|Completed||N/A|24|Actual|McMaster University|"Sample size in this trial was limited
Adherence to the exercise classes in the exercise group was poor"|2|||f||||t||||||||No||2017-10-10 22:43:48.446715|2017-10-10 22:43:48.446715
NCT02609646|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2016-07-28|||January 2016||2016-01-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||AbioKin - Antibiotic Kinetics|Antibiotic Pharmacokinetics in Critically Ill Patients|Recruiting||N/A|1500|Anticipated|Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva|||4||f||||f||||||Samples Without DNA|"     Blood samples to measure antibiotic plasma concentration   "|||2017-10-10 22:43:49.358781|2017-10-10 22:43:49.358781
NCT02609633|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-18|2017-07-28|||December 28, 2015|Actual|2015-12-28|July 2017|2017-07-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|CATS||Accu-Chek Connect at School (CATS) Pediatric Study|Accu-Chek Connect at School (CATS) Pediatric Study|Completed||N/A|200|Actual|Hoffmann-La Roche||2|||f|||||f|t|f|f||||||2017-10-10 22:43:49.555347|2017-10-10 22:43:49.555347
NCT02609620|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-12-30|||December 2015||2015-12-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|PFT||Safety & Initial Efficacy of the LunGuard PFT Sys. on Enteral-Fed, Sedated and Mechanically Ventilated Patients Peristaltic Feeding Tube|A Single-Center, Open Label, Randomized, Controlled Study to Evaluate the Safety & Initial Efficacy of the LunGuard PFT System, and Its Impact on GER in Enteral-Fed, Sedated and Mechanically Ventilated Critically Ill Patients|Not yet recruiting||N/A|20|Anticipated|LunGuard Ltd.||2|||f||||f||||||||||2017-10-10 22:43:49.684542|2017-10-10 22:43:49.684542
NCT02609607|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-10-25|||June 2016||2016-06-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Treating Anorectal Dysfunction in MS|Treating Anorectal Dysfunction Associated With Multiple Sclerosis|Recruiting||Phase 2|70|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-10 22:43:49.773661|2017-10-10 22:43:49.773661
NCT02609594|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-05-16|||November 2015||2015-11-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers|A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Amnioband Dehydrated Human Amniotic Membrane and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers|Recruiting||N/A|240|Anticipated|SerenaGroup, Inc.||3|||f||||f||||||||||2017-10-10 22:43:49.900969|2017-10-10 22:43:49.900969
NCT02609581|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-03-30|||November 2015||2015-11-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Tolerability of SLIT With LAIS® Mites Allergoid Tablets|Non-Interventional Study (NIS) on the Tolerability of Sublingual Immunotherapy With LAIS® Mites Tablets in Consideration of the Chosen Titration Schedule in Everyday Practice|Active, not recruiting||N/A|1000|Anticipated|University Hospital of Cologne|||1||f||||f||||||||No||2017-10-10 22:43:50.042284|2017-10-10 22:43:50.042284
NCT02609568|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-09-12|||April 16, 2014|Actual|2014-04-16|September 2017|2017-09-01|March 30, 2017|Actual|2017-03-30|March 17, 2017|Actual|2017-03-17||Observational|||Salivary Biomarkers in Pediatric Traumatic Brain Injury|Studying the Significance of Salivary Biomarkers in Pediatric Traumatic Brain Injury|Completed||N/A|77|Actual|Maricopa Integrated Health System|||3||f||||f||||||Samples Without DNA|"     Salivary biomarkers: S100B, neuron-specific enolase, GFAP   "|||2017-10-10 22:43:50.101176|2017-10-10 22:43:50.101176
NCT02609555|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-03-21|||October 2014||2014-10-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||TEM Assisted Perineal Rectopexy in Treatment of Rectal Prolapse|Trans-anal Endoscopic Microsurgery (TEM) Assisted Perineal Rectopexy With Postanal Repair and Anal Cerclage In Treatment of Rectal Prolapse (Novel Technique)|Completed||N/A|7|Actual|Mansoura University||1|||f||||t||||||||||2017-10-10 22:43:50.176334|2017-10-10 22:43:50.176334
NCT02609542|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-03-07|||March 2014||2014-03-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Observational|MEMENTO||Memorisation of Phonologic Information Among Children With Oral Language Developement Disorder|Coding and Memorisation of Phonologic Information Among Preschool and School Children With Oral Language Developement Disorder.|Recruiting||N/A|264|Anticipated|Lille Catholic University|||2||f||||f||||||||||2017-10-10 22:43:50.244008|2017-10-10 22:43:50.244008
NCT02609529|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-03-08|||November 2015||2015-11-01|March 2017|2017-03-01|March 2, 2017|Actual|2017-03-02|March 2017|Actual|2017-03-01||Interventional|||SBI in Children With d-IBS|Double-Blind, Randomized Pilot Study Evaluating Oral Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) on Nutritional Status in Children With Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)|Completed||N/A|20|Actual|Louisiana State University Health Sciences Center in New Orleans||2|||f||||f||||||||||2017-10-10 22:43:50.329334|2017-10-10 22:43:50.329334
NCT02609516|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-17|||January 2015||2015-01-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|September 2015|Actual|2015-09-01||Observational|||Impact of Socioeconomic Inequalities in Transition Between Health, Multimorbidity and Death Amongst Older People|What is the Impact of Socioeconomic Inequalities in the Rates of Transition Between Health, Multimorbidity and Death Amongst Older People in England?|Active, not recruiting||N/A|1300000|Anticipated|University College, London|||2||f||||t||||||||||2017-10-10 22:43:50.424214|2017-10-10 22:43:50.424214
NCT02609503|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-08-24|||February 2016||2016-02-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin|Pembrolizumab and Radiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Not Eligible for Cisplatin Therapy|Recruiting||Phase 2|29|Anticipated|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 22:43:50.500079|2017-10-10 22:43:50.500079
NCT02609490|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-17|||July 2015||2015-07-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Azilsartan in Chinese Patients With Mild and Moderate Hypertension|A Multi-center, Randomized, Double-blind, Double-dummy, With Olmesartan Medoxomil as Positive Control Parallel Clinical Study to Evaluate the the Safety and Efficacy of Azilsartan in Chinese Patients With Primary Mild and Moderate Hypertension|Recruiting||Phase 3|304|Anticipated|Lee's Pharmaceutical Limited||2|||f||||f||||||||||2017-10-10 22:43:50.597162|2017-10-10 22:43:50.597162
NCT02609477|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-08-17|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study to Evaluate Abuse Potential of Istradefylline|A Double-Blind, Randomized, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Istradefylline in Recreational Drug Users|Completed||Phase 1|42|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||6|||f||||f||||||||||2017-10-10 22:43:50.68566|2017-10-10 22:43:50.68566
NCT02609464|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-05-16|||December 2015||2015-12-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||The Use of Barbed Sutures in Total Hip Arthroplasty|The Use of Barbed Sutures in Total Hip Arthroplasty: A Prospective, Randomized, and Controlled Clinical Trial|Enrolling by invitation||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-10 22:43:50.933387|2017-10-10 22:43:50.933387
NCT02609451|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-08-29|||November 2007||2007-11-01|January 2017|2017-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Closure2vs12||Closure of Protective Ileostomy 2 vs. 12 Weeks After TME|Closure of Protective Ileostomy 2 vs. 12 Weeks Following Total Mesorectal Excision (TME) for Rectal Surgery: Interim Analysis of a Multicentre, Randomized, Controlled Study|Terminated||N/A|71|Actual|Kantonsspital Liestal||2||Evidence of bad outcome after interims analysis|f||||f||||||||||2017-10-10 22:43:51.00597|2017-10-10 22:43:51.00597
NCT02609438|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-17|||March 2014||2014-03-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Up4Health||An Intervention to Reduce Sitting Time at Work: Effects on Metabolic Health and Inactivity|The Effects of Short, Frequent Breaks in Sitting Versus Longer, Planned Breaks in Sitting on Sedentary Behavior and Metabolic Health Among Inactive Females Working Sedentary Jobs|Completed||N/A|49|Actual|Kansas State University||2|||f||||f||||||||||2017-10-10 22:43:51.105502|2017-10-10 22:43:51.105502
NCT02609425|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-12-05|||December 2015||2015-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Intrathoracic Esophagogastric Anastomosis After Robot Assisted Minimally Invasive Esophagectomy Using STRATAFIX|Intrathoracic Esophagogastric Anastomosis After Robot Assisted Minimally Invasive Esophagectomy Using STRATAFIX|Recruiting||Phase 4|30|Anticipated|Henry Ford Health System||1|||f||||t||||||||||2017-10-10 22:43:51.214392|2017-10-10 22:43:51.214392
NCT02609412|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-05-10|||May 2015||2015-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Immediate Effects of Self-myofascial Release on Latent Trigger Point Sensitivity||Completed||N/A|48|Actual|Goethe University||3|||f||||f||||||||||2017-10-10 22:43:51.324413|2017-10-10 22:43:51.324413
NCT02609399|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-09-21|||November 1, 2015|Actual|2015-11-01|September 2017|2017-09-01|May 28, 2017|Actual|2017-05-28|April 30, 2017|Actual|2017-04-30||Interventional|||ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir|Influenza Therapeutic Trial: A Pilot Randomized Controlled Trial for Feasibility of Enrolling Subjects for Influenza Therapeutic Trials and Administering Influenza Antivirals in the Emergency Department to High Risk Subjects|Completed||Phase 4|121|Actual|Johns Hopkins University||2|||f||||f|t|f||||||||2017-10-10 22:43:51.410647|2017-10-10 22:43:51.410647
NCT02609386|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-02-17|||December 2015||2015-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|INSPIRE||IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity|A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy With the IRX 2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity|Recruiting||Phase 2|200|Anticipated|IRX Therapeutics||2|||f||||t||||||||||2017-10-10 22:43:51.553237|2017-10-10 22:43:51.553237
NCT02609373|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|April 2015|Actual|2015-04-01||Interventional|ICOS||Improving Cancer-Related Outcomes in Shift Workers|Improving Cancer-Related Outcomes in Shift Workers|Completed||N/A|47|Actual|University of British Columbia||1|||f||||f||||||||No||2017-10-10 22:43:51.767833|2017-10-10 22:43:51.767833
NCT02609360|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2015-11-17|||May 2013||2013-05-01|November 2015|2015-11-01||||July 2016|Anticipated|2016-07-01||Interventional|||Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming|Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming|Recruiting||N/A|45|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||3|||f||||f||||||||||2017-10-10 22:43:51.904418|2017-10-10 22:43:51.904418
NCT02609347|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-08-29|||November 2015||2015-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Manual Therapy After Ankle/Hindfoot Fractures|Immediate Effects of Manual Therapy for Patients After Ankle/Hindfoot Fractures|Recruiting||N/A|76|Anticipated|Intermountain Health Care, Inc.||2|||f||||f||||||||No|Not planning on sharing data|2017-10-10 22:43:52.016742|2017-10-10 22:43:52.016742
NCT02609334|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-11-15|||March 2015||2015-03-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||RSPR-007 Mannitol Challenge Trial|A Double-Blind, Randomised, Placebo-controlled, Cross-over, Phase 2 Mannitol Challenge Trial, Investigating the Efficacy of CRD007 in Adult Subjects With Asthma|Completed||Phase 2|24|Actual|RSPR Pharma AB||3|||f||||f||||||||||2017-10-10 22:43:52.177693|2017-10-10 22:43:52.177693
NCT02609321|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-12-23|||November 2015||2015-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer|Efficacy of Thoracic Paravertebral Block vs Local Anesthesia of the Surgical Wound in Reduction of Acute Post-surgical Pain in Patients With Breast Cancer. Controlled Phase III, Randomized, Single-blind, Superiority Clinical Trial.|Completed||Phase 3|60|Actual|Instituto de Cancerología S.A.||2|||f||||f||||||||||2017-10-10 22:43:52.296421|2017-10-10 22:43:52.296421
NCT02609295|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-01-21|||February 2015||2015-02-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects|Effects of α-linolenic Acid Supplementation in the Form of Perilla Oil on Collagen-epinephrine Closure Time, Activated Partial Thromboplastin Time and Lp-PLA2 Activities in Nondiabetic and Hypercholesterolemic Subjects|Completed||Phase 3|86|Actual|Yonsei University||2|||f||||t||||||||||2017-10-10 22:43:52.549606|2017-10-10 22:43:52.549606
NCT02609282|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-11-17|||February 2015||2015-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||The Impact of Hourly Prompts on Reducing Prolonged Sitting at Work|Pilot Study to Assess the Impact of Hourly Prompts, Delivered by Microsoft Outlook, on Reducing Prolonged Sitting at Work|Completed||N/A|21|Actual|Glasgow Caledonian University||2|||f||||f||||||||||2017-10-10 22:43:52.66577|2017-10-10 22:43:52.66577
NCT02609269|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-06-09|||October 2015||2015-10-01|June 2017|2017-06-01||||December 2020|Anticipated|2020-12-01|1 Year|Observational [Patient Registry]|GRID®||Decipher Genomics Resource Information Database|Prospective Expression Analysis Using The Decipher Genomics Resource Information Database (GRID)® and Data Sharing Program|Recruiting||N/A|10000|Anticipated|GenomeDx Biosciences Corp|||1||f||||f||||||||||2017-10-10 22:43:52.775009|2017-10-10 22:43:52.775009
NCT02609256|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-07-29|||December 2015||2015-12-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|SMART||Stereotactic Infarct Tissue Aspiration for Malignant Infarction of Middle Cerebral Artery|Stereotactic Infarct Tissue Aspiration (SITA) for Malignant Infarction of Middle Cerebral Artery|Recruiting||N/A|40|Anticipated|General Hospital of Shenyang Military Region||2|||f||||f||||||||||2017-10-10 22:43:52.93155|2017-10-10 22:43:52.93155
NCT02609243|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-21|||July 2013||2013-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|DiNA-P||Diabetes Nutrition Algorithm - Prediabetes|Diabetes Nutrition Algorithm - Prediabetes (Dietary Strategies in the Prevention of Diabetes Mellitus Type 2 in a High-risk Cohort)|Recruiting||N/A|250|Anticipated|German Institute of Human Nutrition||4|||f||||t||||||||||2017-10-10 22:43:53.052041|2017-10-10 22:43:53.052041
NCT02609230|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-06-14|||November 5, 2015|Actual|2015-11-05|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma|A Phase I Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma|Recruiting||Phase 1|54|Anticipated|Fox Chase Cancer Center||2|||f||||t||||||||||2017-10-10 22:43:53.158292|2017-10-10 22:43:53.158292
NCT02609217|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-04-07|||November 2015||2015-11-01|April 2016|2016-04-01||||May 2016|Anticipated|2016-05-01||Observational|||Parents' Expectations and Experiences Around Cesarean Section in Belgium|Parents' Expectations and Experiences Around Cesarean Section in Belgium|Active, not recruiting||N/A|24|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-10 22:43:53.236222|2017-10-10 22:43:53.236222
NCT02609204|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-11-02|||November 2014||2014-11-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|DIOPSYS-ND||Normative Database for Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG)|NOVA™ PERG and FERG: Establishment of Reference Values for PERG and FERG Measurements|Completed||N/A|50|Actual|Wills Eye||1|||f||||f||||||||No||2017-10-10 22:43:53.312586|2017-10-10 22:43:53.312586
NCT02609191|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-06-02|||June 2016||2016-06-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|STRATOS||Assessment of Body Composition Via Dual-energy X-ray Absorptiometry Bone Densitometry|"Assessment of Body Composition Via Dual-energy X-ray Absorptiometry Bone Densitometry: Cross Calibration and Reproducibility Between the Stratos DR and Discovery A Bone Densitometers"|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 22:43:53.386938|2017-10-10 22:43:53.386938
NCT02609178|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-06-21|2016-04-05||December 2015||2015-12-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Basic Study of Fabricating Biomorphic Crowns|Comparative Evaluation of Different Occlusal Surface Designs of Artificial Crown|Completed||N/A|12|Actual|Fourth Military Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:43:53.504607|2017-10-10 22:43:53.504607
NCT02609165|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-09-02|||May 2015||2015-05-01|September 2017|2017-09-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|NEMO||Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema|Nerve Growth Factor Eye Drops as a Novel Treatment for Vision Loss in Patients With Retinitis Pigmentosa: From Preclinical to Clinical Phase II Trial|Completed||Phase 2|45|Actual|Ospedale San Raffaele||2|||f||||f||||||||||2017-10-10 22:43:53.964833|2017-10-10 22:43:53.964833
NCT02609152|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-04-06|||July 2016||2016-07-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|BétaSep||Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock|Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock: a Multicentre, Randomized, Double-blind Trial|Not yet recruiting||Phase 3|50|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||||2017-10-10 22:43:54.061885|2017-10-10 22:43:54.061885
NCT02609139|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-05-06|||November 2015||2015-11-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects|A Phase 1, Open Label, Single‑Dose, Within Cohort Randomized, 2‑Way Crossover Study To Evaluate The Pharmacokinetics Of A Modified Release Formulation Of Pf‑06650833 Under Fasting And Fed Conditions In Healthy Adult Subjects|Completed||Phase 1|18|Actual|Pfizer||6|||f||||f||||||||||2017-10-10 22:43:54.175659|2017-10-10 22:43:54.175659
NCT02609126|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-03-20|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|STEPUP||Safety Study of a Long-Acting Injectable Steroid to Treat Knee Osteoarthritis|A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial Evaluating the Pharmacokinetics, Safety and Preliminary Efficacy of EP-104IAR (Long-Acting Fluticasone Propionate) in Patients With Osteoarthritis of the Knee|Active, not recruiting||Phase 1|32|Actual|Eupraxia Pharmaceuticals Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:43:54.404091|2017-10-10 22:43:54.404091
NCT02609113|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-02-01|||August 2015||2015-08-01|February 2017|2017-02-01|October 21, 2016|Actual|2016-10-21|October 21, 2016|Actual|2016-10-21||Interventional|ATTRACT||Static Magnetic Therapy for Carpal Tunnel Syndrome|A Double Blinded, Prospective, Randomized Trial of Static Magnetic Therapy for Carpal Tunnel Syndrome (CTS)|Completed||N/A|22|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-10 22:43:54.500253|2017-10-10 22:43:54.500253
NCT02609100|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-05-10|||November 2015||2015-11-01|May 2017|2017-05-01|December 6, 2016|Actual|2016-12-06|December 6, 2016|Actual|2016-12-06||Interventional|||Video Capsule Endoscopy Versus Colonoscopy in Patients With Melena and Negative Upper Endoscopy|Video Capsule Endoscopy Versus Colonoscopy in Patients With Melena and Negative Upper Endoscopy: A Randomized Controlled Trial|Terminated||N/A|5|Actual|Washington University School of Medicine||2||Poor enrollment|f||||f||||||||||2017-10-10 22:43:54.589341|2017-10-10 22:43:54.589341
NCT02609087|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-01-09|||August 2015||2015-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect on Cerebral Oxygenation by Sevoflurane or Propofol Using Near-infrared Spectroscopy in Carotid Endarterectomy|Comparison the Effect on Cerebral Oxygenation by Sevoflurane-remifentanil or Propofol-remifentanil Anesthesia Using Near-infrared Spectroscopy in Patients Undergoing Carotid Endarterectomy)|Completed||Phase 4|69|Actual|Chonnam National University Hospital||2|||f||||t||||||||||2017-10-10 22:43:54.683982|2017-10-10 22:43:54.683982
NCT02609074|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-18|||March 2013||2013-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Pilot Clinical Trial of CPC/rhBMP-2 Microffolds as Bone Substitute for Bone Regeneration|Pilot Clinical Trial of CPC/rhBMP-2 Microffolds as Bone Substitute for Bone Regeneration|Completed||Phase 4|81|Actual|East China University of Science and Technology||2|||f||||f||||||||||2017-10-10 22:43:54.769459|2017-10-10 22:43:54.769459
NCT02609061|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2015-11-17|||January 2015||2015-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects|Platelet Rich Fibrin Combined With 1% Alendronate Gel in Treatment of Mandibular Degree II Furcation Defects: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|72|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||||||||||||2017-10-10 22:43:54.850863|2017-10-10 22:43:54.850863
NCT02609048|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-01-30|||November 2015|Actual|2015-11-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)|A 12-week, Double-blind, Randomized, Placebo-controlled, Phase 2 Study, to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC) and an Inadequate Response to Ursodeoxycholic Acid (UDCA)|Terminated||Phase 2|41|Actual|CymaBay Therapeutics, Inc.||3||"Study stopped early after review of safety and efficacy demonstrated efficacy proof-of-concept   and need for dose reduction."|f||||t||||||||||2017-10-10 22:43:54.947885|2017-10-10 22:43:54.947885
NCT02609035|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-04-25|||March 31, 2016|Actual|2016-03-31|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|ImmuSMART||Immunization Services Model for Adult Rate Improvement|Immunization Services Model for Adult Rate Improvement|Completed||N/A|22301|Actual|Pharmacy Quality Alliance||2|||f||||f||||||||||2017-10-10 22:43:55.189409|2017-10-10 22:43:55.189409
NCT02609022|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-05-11|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis|A First-in-human and Proof-of-concept Study to Assess the Safety, Tolerability and Immunogenic Response of CV-MG01, Acetylcholine Receptor Mimetic Peptides, as Potential Therapeutic Vaccine, in Patients With Myasthenia Gravis|Active, not recruiting||Phase 1/Phase 2|24|Actual|CuraVac||2|||f||||t||||||||No||2017-10-10 22:43:55.267466|2017-10-10 22:43:55.267466
NCT02609009|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-09-10|||September 2014||2014-09-01|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|April 5, 2017|Actual|2017-04-05||Interventional|||Back Pain and Spinal Manipulation in Adolescent Scoliosis|Back Pain Management With Spinal Manipulation Therapy Compared to Usual Medical Care in Adolescent Idiopathic Scoliosis Patients: A Pilot Study|Completed||N/A|20|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-10 22:43:55.367356|2017-10-10 22:43:55.367356
NCT02608996|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-08-25|||December 2015||2015-12-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|TENSE1||Nesiritide in Uncontrolled Hypertension|Therapeutic Effects of BNP in Uncontrolled Hypertensive Patients|Recruiting||Phase 1/Phase 2|15|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 22:43:55.464595|2017-10-10 22:43:55.464595
NCT02608983|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-11-18|||April 2010||2010-04-01|November 2015|2015-11-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|HYFFI||Hydrocolloids as Functional Food Ingredients for Gut Health|Hydrocolloids as Functional Food Ingredients for Gut Health|Completed||N/A|60|Actual|University of Ulster||3|||f||||f||||||||||2017-10-10 22:43:55.574274|2017-10-10 22:43:55.574274
NCT02608970|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-07-27|||December 31, 2015|Actual|2015-12-31|July 2017|2017-07-01|July 23, 2017|Actual|2017-07-23|July 23, 2017|Actual|2017-07-23||Interventional|||Safety and Tolerability Study of BMS-986177 in Healthy Subjects|A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BMS-986177 in Healthy Subjects|Completed||Phase 1|104|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:43:55.667549|2017-10-10 22:43:55.667549
NCT02608957|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-03-30|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|May 2016|Actual|2016-05-01||Interventional|Latella-US||Evaluation of the Latella™ Knee Implant System for Medial Osteoarthritis Pain Reduction|Evaluation of the Latella™ Knee Implant System for Medial Osteoarthritis Pain Reduction (Latella-US Study)|Terminated||N/A|1|Actual|Cotera, Inc.||1||Sponsor elected to terminate the study prior to subject treatment.|f||||f||||||||||2017-10-10 22:43:55.756769|2017-10-10 22:43:55.756769
NCT02608944|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-12-07|||September 2012||2012-09-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging|Comparison of New MRI Methods for Quantitative Assessment of Myocardial Perfusion With Quantitative PET Perfusion Imaging|Recruiting||N/A|20|Anticipated|University of Utah||1|||f||||f||||||||||2017-10-10 22:43:55.842174|2017-10-10 22:43:55.842174
NCT02608931|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-12-07|||November 2015||2015-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia|The Safety , Tolerability and Efficacy of Dronabinol, a Synthetic Endocannabinoid Receptor Agonist, for the Treatment of Nausea and Vomiting in Patients With Familial Dysautonomia|Recruiting||Phase 2|25|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 22:43:55.970573|2017-10-10 22:43:55.970573
NCT02608918|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-05-11|||November 2015||2015-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Taste Properties of HIV Inhibitor|An Open-Label Taste Assessment of BMS-955176 in Healthy Subjects|Terminated||Phase 1|6|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 22:43:56.104399|2017-10-10 22:43:56.104399
NCT02608905|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-05-31|||November 2015||2015-11-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Dapagliflozin on Inflammation and Endothelial Function|The Effect of Dapagliflozin on Inflammation and Endothelial Function|Recruiting||Phase 4|40|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 22:43:56.191906|2017-10-10 22:43:56.191906
NCT02608892|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-08-04|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Caring for Babies During the Newborn Screening Blood Test|Caring for Babies During the Newborn Screening Blood Test: How do Parents Help? A Pilot RCT|Completed||N/A|100|Actual|Children's Hospital of Eastern Ontario||2|||f||||f||||||||||2017-10-10 22:43:56.296939|2017-10-10 22:43:56.296939
NCT02608866|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-05-24|||November 2015||2015-11-01|May 2016|2016-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Single Versus Multiple Fractionated SSRS for Spinal Metastases|A Prospective Randomized Clinical Trial of Single Versus Multiple Fractionated Stereotactic Spine Radiosurgery for Patients With Spinal Metastases|Recruiting||Phase 2|64|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-10 22:43:56.484428|2017-10-10 22:43:56.484428
NCT02608853|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-11-17|||January 2015||2015-01-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants|Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants|Completed||N/A|9999|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-10-10 22:43:56.573818|2017-10-10 22:43:56.573818
NCT02608840|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-09-20|||July 2015||2015-07-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Auditory Stimulation of Slow Wave Sleep and Memory in Mild Cognitive Impairment and Older Adults|Auditory Stimulation of Slow Wave Sleep and Memory in Mild Cognitive Impairment and Older Adults|Recruiting||N/A|30|Anticipated|Northwestern University||4|||f||||f||||||||Undecided||2017-10-10 22:43:56.658516|2017-10-10 22:43:56.658516
NCT02608827|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-10-25|||January 2011||2011-01-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|March 2013|Actual|2013-03-01||Interventional|||Sympathetic and Blood Pressure Responses to Aerobic Exercise and Guided Respiration in Hypertensives|Sympathetic and Blood Pressure Responses to Aerobic Exercise and Guided Respiration in Hypertensives|Completed||N/A|29|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:43:56.768801|2017-10-10 22:43:56.768801
NCT02608814|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-05-15|||May 2015||2015-05-01|May 2017|2017-05-01|March 14, 2017|Actual|2017-03-14|March 14, 2017|Actual|2017-03-14||Interventional|AUDIO||Advanced Ultrasound in Pleural Infection|Advanced Ultrasound in Pleural Infection|Completed||N/A|20|Actual|University of Oxford||1|||f||||f||||||||||2017-10-10 22:43:56.841753|2017-10-10 22:43:56.841753
NCT02608801|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-07-10|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|NOFRACTsub||Prediction and Secondary Prevention of Fractures|Prediction and Secondary Preventing of Fractures in a Norwegian Population. A Substudy of Norwegian Capture the Fracture Initiative|Recruiting||N/A|1000|Anticipated|Oslo University Hospital|||1||f||||||||||||||2017-10-10 22:43:56.913604|2017-10-10 22:43:56.913604
NCT02608788|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-11-18|||September 2014||2014-09-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||S.L. Spray Solution® and Difflam® and Acular®Spray for the Prevention of Postoperative Sore Throat|Comparing the Efficacies Between the Spray of S.L. Spray Solution and Difflam and Acular to Release Postoperative Sore Throat|Completed||Phase 4|380|Actual|Chang Gung Memorial Hospital||4|||f||||t||||||||||2017-10-10 22:43:57.020598|2017-10-10 22:43:57.020598
NCT02608775|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-08-16|||January 2016||2016-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Usefulness and Predictive Capacity of ANI and SPI of the Hemodynamic Response|Usefulness and Predictive Capacity of ANI and SPI of the Hemodynamic Response to Standardized Stimuli During Neuro- and Urologic Surgery Under Standard Target Controlled Infusion of Propofol and Sufentanil.|Completed||N/A|20|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-10 22:43:57.112609|2017-10-10 22:43:57.112609
NCT02606890|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-12-07|||August 2015||2015-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|SLPAF||Stroke Lesion Pattern on MRI and Atrial Fibrillation|Is the Lesion Pattern on Magnetic Resonance Imaging in Acute Ischemic Stroke Patients Associated With Atrial Fibrillation?|Completed||N/A|1000|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 22:44:18.921943|2017-10-10 22:44:18.921943
NCT02608749|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-19|||May 2014||2014-05-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Osteoporosis and Fall Prevention High Risk Population Intervention and Follow up in the Metropolitan Area|Osteoporosis and Fall Prevention High Risk Population Intervention and Follow up in the Metropolitan Area|Completed||N/A|151|Actual|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-10 22:43:57.278531|2017-10-10 22:43:57.278531
NCT02608736|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-06-29|||December 2015||2015-12-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|December 2016|Actual|2016-12-01||Interventional|GAMA||Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid|Phase 0 Clinical Trial With Valproic Acid as a Chemopreventive Agent in Patients With Head and Neck Squamous Cell Carcinoma Previously Treated|Active, not recruiting||Early Phase 1|42|Actual|Barretos Cancer Hospital||2|||f||||t||||||||||2017-10-10 22:43:57.368293|2017-10-10 22:43:57.368293
NCT02608723|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-17|||June 2014||2014-06-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes?|Chronic Plantar Fasciitis Treated With Shock Wave Therapy: Do the External Appearance of the Device Influence Clinical Outcomes? A Randomized Controlled Clinical Trial.|Completed||Phase 4|135|Actual|Asociacion Colaboracion Cochrane Iberoamericana||3|||f||||f||||||||||2017-10-10 22:43:57.516645|2017-10-10 22:43:57.516645
NCT02608697|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-06-14||2017-06-14|October 2015||2015-10-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia|Completed||Phase 2|153|Actual|Catabasis Pharmaceuticals||4|||f||||f||||||||||2017-10-10 22:43:58.137523|2017-10-10 22:43:58.137523
NCT02608684|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-01-31|||February 2016||2016-02-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|PemCiGem||A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer|A Phase II Study of Pembrolizumab With Cisplatin and Gemcitabine Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer|Recruiting||Phase 2|25|Anticipated|Cedars-Sinai Medical Center||1|||f||||t||||||||No||2017-10-10 22:43:58.290677|2017-10-10 22:43:58.290677
NCT02608671|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-01-02|||December 2015||2015-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Adhesive Tape in Episiotomy Repair|SKIN ADHESIVE TAPE COMPARED WITH CONTINUOUS SUTURE IN PERINEAL SKIN REPAIR AFTER EPISIOTOMY: RANDOMIZED TRIAL|Active, not recruiting||Phase 4|320|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:43:58.420911|2017-10-10 22:43:58.420911
NCT02608658|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-07-25|||March 2016||2016-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 20, 2017|Actual|2017-06-20||Interventional|||Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites|Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites|Active, not recruiting||N/A|12|Anticipated|St. Louis University||1|||f||||f||||||||||2017-10-10 22:43:58.512884|2017-10-10 22:43:58.512884
NCT02608645|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-18|||November 2015||2015-11-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|EPHESUS||A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)|Evaluation of Perceptions, Knowledge and Compliance With tHE Guidelines for Secondary Prevention in Real Life Practice: A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)|Not yet recruiting||N/A|6000|Anticipated|Muğla Sıtkı Koçman University|||1||f||||f||||||||||2017-10-10 22:43:58.603378|2017-10-10 22:43:58.603378
NCT02608632|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2015-11-19|||February 2013||2013-02-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure|High Frequency Guided Renal Artery Denervation for Improving Outcome of Renal Ablation Procedure|Active, not recruiting||Phase 2|170|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 22:43:58.824518|2017-10-10 22:43:58.824518
NCT02608619|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-08-21|||November 2015||2015-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement|Pilot Study to Determine Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement|Recruiting||N/A|5|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"     tissue   "|||2017-10-10 22:43:58.922279|2017-10-10 22:43:58.922279
NCT02608606|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-10-10|||March 2015||2015-03-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|FKosl||Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors|Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors|Completed||N/A|20|Actual|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||Yes|The preliminary data from this trial will be presented at the AASLD Liver meeting in San Francisco in November 2015|2017-10-10 22:43:59.036076|2017-10-10 22:43:59.036076
NCT02608593|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-05-10|||February 2016||2016-02-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BROWSE||Breast Reconstruction Outcomes With and Without StratticE|Breast Reconstruction Outcomes With and Without StratticE (BROWSE)|Not yet recruiting||N/A|400|Anticipated|University Hospital of South Manchester NHS Foundation Trust|||2||f||||t||||||||||2017-10-10 22:43:59.128925|2017-10-10 22:43:59.128925
NCT02608580|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-02-01|||December 2013||2013-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.|Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.|Recruiting||N/A|50|Anticipated|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 22:43:59.241579|2017-10-10 22:43:59.241579
NCT02608567|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-02-06|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||Prognostic Impact of Myocardial Longitudinal Strain in Asymptomatic Aortic Stenosis: a Meta-Analysis|Prognostic Impact of Myocardial Longitudinal Strain in Asymptomatic Aortic Stenosis: a Meta-Analysis|Active, not recruiting||N/A|1000|Actual|European Association of Cardiovascular Imaging|||2||f||||f||||||||||2017-10-10 22:43:59.337388|2017-10-10 22:43:59.337388
NCT02608541|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-10-13|||October 2015||2015-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|SMuRFS||Sheffield Multiple Rib Fractures Study:|Sheffield Multiple Rib Fractures Study: Evolution of Classification, Management and Outcomes|Recruiting||N/A|300|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 22:43:59.55958|2017-10-10 22:43:59.55958
NCT02608528|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2016-06-07|||September 2015||2015-09-01|June 2016|2016-06-01||||September 2017|Anticipated|2017-09-01||Interventional|||Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy|Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy|Recruiting||Early Phase 1|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:43:59.687309|2017-10-10 22:43:59.687309
NCT02608515|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-01-17|||December 2015||2015-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|LEGEND||A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease|"A Retrospective Chart Review Study of the Outcomes of Second Line Therapy With LEnalidomide/Dexamethasone in Greek Patients With Relapsed/Refractory Multiple MyEloma and the Treatment PatterNs Following Progressive Disease, The LEGEND Study"|Completed||N/A|207|Actual|Genesis Pharma S.A.|||1||f||||||||||||||2017-10-10 22:43:59.794282|2017-10-10 22:43:59.794282
NCT02608502|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-09-12||2017-09-12|November 2015|Actual|2015-11-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults|A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults|Completed||Phase 3|11850|Actual|Novavax||2|||f||||f||||||||||2017-10-10 22:43:59.911218|2017-10-10 22:43:59.911218
NCT02608489|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2016-08-22|2016-04-14||January 2014||2014-01-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery|Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial|Completed||N/A|86|Actual|Soonchunhyang University Hospital||2|||f||||t||||||||||2017-10-10 22:44:00.195695|2017-10-10 22:44:00.195695
NCT02608476|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-09-06|||November 2015||2015-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)|A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris|Recruiting||Phase 3|700|Anticipated|Cassiopea SpA||2|||f||||f||||||||||2017-10-10 22:44:00.970403|2017-10-10 22:44:00.970403
NCT02608463|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-02-13|||January 2016||2016-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Neuropathic Pain in Pregnancy|Neuropathic Pain in Pregnancy|Recruiting||N/A|130|Anticipated|University of Arkansas||3|||f||||t||||||||No||2017-10-10 22:44:01.119579|2017-10-10 22:44:01.119579
NCT02608450|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-09-06|||November 2015||2015-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)|A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris|Recruiting||Phase 3|700|Anticipated|Cassiopea SpA||2|||f||||f||||||||||2017-10-10 22:44:01.20979|2017-10-10 22:44:01.20979
NCT02608437|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-16|||October 2015||2015-10-01|November 2015|2015-11-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Interventional|NIBIT-M4||A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients|A Phase 1b, Open-label, Dose Escalation Study Investigating Different Doses of SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients|Recruiting||Phase 1|19|Anticipated|Italian Network for Tumor Biotherapy Foundation||1|||f||||t||||||||||2017-10-10 22:44:01.480519|2017-10-10 22:44:01.480519
NCT02608424|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-11-16|||March 2015||2015-03-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|parkgo-1||Effects of Feet Mechanical Stimulation on Cardiovascular Autonomic Profile and Inflammation in Parkinson's Disease|Effects of Feet Mechanical Stimulation on the Inflammatory State and Cardiovascular Autonomic Profile in Patients With Parkinson's Disease|Recruiting||N/A|50|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-10-10 22:44:01.598026|2017-10-10 22:44:01.598026
NCT02608411|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-06-09|||October 2015||2015-10-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|October 2017|Anticipated|2017-10-01||Interventional|TIMES||TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)|TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES). Phase II Clinical Trial, Single Arm, Two Stage|Terminated||Phase 2|5|Actual|Istituto Oncologico Veneto IRCCS||1||Safety results (applied in METIV-HCC trial) have led early termination|f||||f||||||||||2017-10-10 22:44:01.851111|2017-10-10 22:44:01.851111
NCT02608398|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-09-28|||July 2015||2015-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||The Effect of a Structured Weight-loss Programme on the Metabolic Profiles of Obese and Overweight Children|The Effect of a Structured Weight-loss Programme on the Metabolic Profiles of Obese and Overweight Children|Completed||N/A|36|Actual|Imperial College London|||1||f||||t||||||Samples With DNA|"     urine and stool samples will be collected from those who consent   "|||2017-10-10 22:44:01.942637|2017-10-10 22:44:01.942637
NCT02608385|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-05-10|||December 2015||2015-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors|Phase I Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors|Active, not recruiting||Phase 1|35|Actual|University of Chicago||1|||f||||t||||||||||2017-10-10 22:44:02.027537|2017-10-10 22:44:02.027537
NCT02608372|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2015-11-16|||May 2015||2015-05-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Brown Seaweeds Effect on Glucose Tolerance and Appetite Response|Effect of Brown Seaweeds on Glycaemia, Gastric Emptying, and Appetite: A Randomized, Controlled Crossover Meal Study|Completed||N/A|20|Actual|University of Copenhagen||6|||f||||t||||||||||2017-10-10 22:44:02.108569|2017-10-10 22:44:02.108569
NCT02608359|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-07-27|||May 31, 2016|Actual|2016-05-31|July 2017|2017-07-01|August 29, 2019|Anticipated|2019-08-29|June 20, 2018|Anticipated|2018-06-20||Observational|||A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer|A Prospective, Multicenter, Post-marketing Surveillance to Assess Safety of Zytiga (Abiraterone Acetate Tablets 250 mg) in Indian Patients With Metastatic, Castration Resistant Prostate Cancer as Per Locally Approved Prescribing Information|Recruiting||N/A|103|Anticipated|Johnson & Johnson Private Limited|||1||f||||f|f|||||||||2017-10-10 22:44:02.211156|2017-10-10 22:44:02.211156
NCT02608346|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-03-20|||November 2014|Actual|2014-11-01|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)|Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)|Recruiting||N/A|200|Anticipated|Institut Curie||1|||f||||t||||||||||2017-10-10 22:44:02.296535|2017-10-10 22:44:02.296535
NCT02608333|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-08-16|||September 2015||2015-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|IDEA||Efficiency of Early Intervention for Autism Spectrum Disorder|Impact of Early Intervention on the Global Development of Children With Autism Spectrum Disorder in a European French-speaking Population Dr Marie-Maude GEOFFRAY Le Vinatier Hospital|Recruiting||N/A|180|Anticipated|Hôpital le Vinatier||2|||f||||f||||||||||2017-10-10 22:44:02.3876|2017-10-10 22:44:02.3876
NCT02608320|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-17|2017-06-29|||November 17, 2015|Actual|2015-11-17|June 2017|2017-06-01|April 13, 2016|Actual|2016-04-13|April 13, 2016|Actual|2016-04-13||Interventional|||A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants|A Randomized, Partially-blinded, Two-arm, Single-application, 3-way Crossover Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Subjects|Completed||Phase 1|52|Actual|Janssen Research & Development, LLC||24|||f||||||f||||||||2017-10-10 22:44:02.477746|2017-10-10 22:44:02.477746
NCT02608307|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-09-27|||February 9, 2016|Actual|2016-02-09|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2019|Anticipated|2019-06-01||Observational|||Medical Treatment Decision Making Using Adaptive Conjoint Analysis|Adolescent and Young Adult, Parental, and Health Care Provider Decision Making Using Conjoint Analysis|Recruiting||N/A|150|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-10 22:44:04.246499|2017-10-10 22:44:04.246499
NCT02608294|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2015-11-17|||July 2014||2014-07-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Influence of Kinesio Taping® in Paretic Tibialis Anterior Muscle During Patient Gait and Balance After Stroke|Influence of Kinesio Taping® in Paretic Tibialis Anterior Muscle at Joint Dynamics During Patient Gait and Balance After Stroke: A Pilot Study|Completed||N/A|14|Actual|Universidade Federal de Pernambuco||2|||f||||f||||||||||2017-10-10 22:44:04.368821|2017-10-10 22:44:04.368821
NCT02608281|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-08-09|||November 2015||2015-11-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|CEDEM||Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE-MRI|Clinical Study to Evaluate Diagnostic Accuracy of Low Dose Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE-MRI|Completed||N/A|110|Actual|Siemens Healthcare QT||1|||f||||f||||||||||2017-10-10 22:44:04.450428|2017-10-10 22:44:04.450428
NCT02608268|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-09-29|||November 24, 2015|Actual|2015-11-24|September 2017|2017-09-01|October 8, 2019|Anticipated|2019-10-08|October 8, 2018|Anticipated|2018-10-08||Interventional|||Safety and Efficacy of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.|Phase I-Ib/II Open-label Multi-center Study of the Safety and Efficacy of MBG453 as Single Agent and in Combination With PDR001 in Adult Patients With Advanced Malignancies|Recruiting||Phase 1/Phase 2|250|Anticipated|Novartis||5|||f||||f|t|f||||||||2017-10-10 22:44:04.538413|2017-10-10 22:44:04.538413
NCT02608255|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-01-03|||January 2016||2016-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||A Prospective Pilot Study to Evaluate a New Marker of Ischemia in Chest Pain Triage|A Prospective Pilot Study to Evaluate a New Marker of Ischemia in Chest Pain Triage|Completed||N/A|100|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:44:04.698215|2017-10-10 22:44:04.698215
NCT02608242|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-01-31|||November 2015|Actual|2015-11-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin|A Randomized, Open-label, Single Dose, Crossover Clinical Trial to Compare the Safety and Pharmacokinetics of YH22189 in Comparison to Telmisartan/Amlodipine and Rosuvastatin in Healthy Volunteers|Terminated||Phase 1|123|Actual|Yuhan Corporation||3||sponsor decision|f||||f||||||||No||2017-10-10 22:44:04.77924|2017-10-10 22:44:04.77924
NCT02608229|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-03-16|||June 6, 2016|Actual|2016-06-06|March 2017|2017-03-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer|Phase Ib Study of BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer|Recruiting||Phase 1|25|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||No||2017-10-10 22:44:04.864857|2017-10-10 22:44:04.864857
NCT02608216|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer|[18F]Fluorothymidine (FLT) PET/CT Imaging in Rb+ Metastatic Breast Cancer Patients Undergoing LEE011 and Weekly Paclitaxel Therapy|Recruiting||Phase 1|20|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:44:04.975999|2017-10-10 22:44:04.975999
NCT02608203|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2015-11-16|||December 2015||2015-12-01|November 2015|2015-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|GEP-NOC||[68 Ga]-DOTANOC PET/CT in GEP-NETs|Impact of [68 Ga]-DOTANOC PET-CT on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Prospective, Multicentric Study.|Not yet recruiting||Phase 2/Phase 3|110|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-10 22:44:05.073727|2017-10-10 22:44:05.073727
NCT02608190|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-08-29|||November 2015||2015-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Rehabilitating Unilateral Neglect Using Spatial Working Memory Training|Using Working Memory Training to Rehabilitate Unilateral Visual Neglect|Recruiting||N/A|40|Anticipated|University of Waterloo||2|||f||||f||||||||||2017-10-10 22:44:05.251716|2017-10-10 22:44:05.251716
NCT02608177|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-10-04|||November 2015||2015-11-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CANDY-CANE||Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management|Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management|Recruiting||N/A|24|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 22:44:05.353668|2017-10-10 22:44:05.353668
NCT02608164|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-05-24|||August 2015||2015-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|SCD3||A Comparison of Capsules and Oral Spray Solution as Methods of Delivering Vitamin D3 and Raising Status|A Comparison of Capsules and Oral Spray Solution as Methods of Delivering Vitamin D3 and Raising Status: a Randomised Crossover Study|Completed||N/A|22|Actual|University of Ulster||2|||f||||f||||||||||2017-10-10 22:44:05.487209|2017-10-10 22:44:05.487209
NCT02608151|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-11-16|||September 2011||2011-09-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect in the Short and Medium Term of Different Techniques of Tactile Stimulations on Neurological Development in a Population of Very Preterm Infants|Effect in the Short and Medium Term of Different Techniques of Tactile Stimulations on Neurological Development in a Population of Very Preterm Infants|Unknown status|Active, not recruiting|N/A|36|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||||||||||||2017-10-10 22:44:05.595325|2017-10-10 22:44:05.595325
NCT02608138|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-10-24|||April 2015||2015-04-01|January 2016|2016-01-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Observational|IoGeneration||Iodine Status in Portuguese Children and the Role of Salt Fortification in School Canteens|Iodine Status in Portuguese Children and the Role of Salt Fortification in School Canteens|Completed||N/A|2018|Actual|Universidade do Porto|||1||f||||||||||Samples Without DNA|"     Urine   "|||2017-10-10 22:44:05.707889|2017-10-10 22:44:05.707889
NCT02608125|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Dose Escalation and Dose Expansion Study of PRN1371 in Adult Patients With Advanced Solid Tumors|A Phase I Open-Label, Multicenter, Dose-Escalation Study of PRN1371, a FGFR 1-4 Kinase Inhibitor, in Adult Patients With Advanced Solid Tumors, Followed by an Expansion Cohort in Patients With FGFR 1, 2, 3, or 4 Genetic Alterations|Recruiting||Phase 1|50|Anticipated|Principia Biopharma, Inc.||1|||f||||f||||||||||2017-10-10 22:44:05.823768|2017-10-10 22:44:05.823768
NCT02608112|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-08-02|||December 31, 2015|Actual|2015-12-31|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year|Subcutaneous Tocilizumab in Monotherapy or in Combination With csDMARD in Patients With Moderate to Severe Active Rheumatoid Arthritis and Followed by Hospital and Office Based Rheumatologists: Non Interventional Study to Describe Real-World Drug Retention Rate of the Biotherapy at 1 Year|Active, not recruiting||N/A|410|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:44:06.007859|2017-10-10 22:44:06.007859
NCT02608099|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-05-09|||November 2015||2015-11-01|September 2016|2016-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|AEIOU||Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation|Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation|Completed||Phase 4|300|Actual|Baim Institute for Clinical Research||2|||f||||f||||||||||2017-10-10 22:44:06.320743|2017-10-10 22:44:06.320743
NCT02608086|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-05-22|||November 2015||2015-11-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PFA||Psychological First Aid (PFA): RCT Adults Non-intentional Trauma Emergency Room|Psychological First Aid: A Randomized-controlled Trial of Adults Affected by Non-intentional Trauma in the Emergency Room|Completed||N/A|220|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-10 22:44:06.450906|2017-10-10 22:44:06.450906
NCT02608073|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-03-01|||November 2004||2004-11-01|March 2016|2016-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer|A Multi-Center Phase II Trial of Capecitabine (Xeloda) in Combination With Cisplatin as First Line Chemotherapy in Patients With Metastatic Nasopharyngeal Carcinoma|Completed||Phase 2|45|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:44:06.581579|2017-10-10 22:44:06.581579
NCT02608060|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-11-01|||September 2006||2006-09-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B|Open Multicentric Study to Assess the Hematopoyetic Response in Terms of Increase of Hemoglobin Levels of Patients With Anemia Related to Non- Hodgkin Lymphoma, Chronic Lymphocytic Leukemia or Multiple Myeloma, Treated With Erythropoietin B (Recormon) Using Pre-filled Syringe With 30000 IU, as Well as to Quantify the Risk Factors of Anemia and Its Impact on Quality of Life Related to Treatment|Terminated||Phase 4|4|Actual|Hoffmann-La Roche||1||Due to poor enrollment this study was terminated prematurely.|f||||||||||||||2017-10-10 22:44:06.7035|2017-10-10 22:44:06.7035
NCT02608047|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2015-11-17|||October 2014||2014-10-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou|Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou|Recruiting||N/A|2000|Anticipated|Guangzhou 8th People's Hospital|||2||f||||f||||||Samples With DNA|"     Peripheral blood   "|||2017-10-10 22:44:06.94284|2017-10-10 22:44:06.94284
NCT02599558|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-14|||November 2015||2015-11-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Cytosponge and Dietary Therapy in EoE|A Pilot Trial of Dietary Therapy Directed by the Esophageal Sponge in the Management of Eosinophilic Esophagitis.|Recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:45:38.996692|2017-10-10 22:45:38.996692
NCT02608021|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-07-12|||October 1, 2015|Actual|2015-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Neurotrack Test Validation Protocol|Neurotrack Test Validation Protocol|Recruiting||N/A|80|Anticipated|New York University School of Medicine|||2||f||||f|f|f||||||||2017-10-10 22:44:07.136737|2017-10-10 22:44:07.136737
NCT02608008|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-02-17|||September 2014||2014-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|EchoNav||Safety and Efficacy of EchoNavigator System Release II During Structural Heart Interventions|Safety and Efficacy of EchoNavigator System Release II (Philips, Andover, MA) During Structural Heart Interventions|Recruiting||N/A|200|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-10 22:44:07.231329|2017-10-10 22:44:07.231329
NCT02607995|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-21|||May 28, 2015|Actual|2015-05-28|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|STEREOplus||Structured Psychoeducation for Unemployed Adolescents With Extreme Obesity in a Multicenter Observational Study Focusing on Feasibility|Structured Psychoeducation for Unemployed Adolescents With Extreme Obesity in a Multicenter Observational Study Focusing on Feasibility|Active, not recruiting||N/A|49|Actual|University of Ulm|||1||f||||t||||||||||2017-10-10 22:44:07.347427|2017-10-10 22:44:07.347427
NCT02607969|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-16|||November 2015||2015-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|March 2016|Anticipated|2016-03-01||Interventional|||Investigating the Effectiveness of Control Frequency on and Deformational Plagiocephaly|Comparison the Effectiveness Control Frequency of Physiotherapy Home Program on Deformational Plagiocephaly|Not yet recruiting||N/A|30|Anticipated|Hacettepe University||2|||f||||t||||||||||2017-10-10 22:44:07.563951|2017-10-10 22:44:07.563951
NCT02607956|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-05-22|||November 11, 2015|Actual|2015-11-11|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|May 12, 2017|Actual|2017-05-12||Interventional|||Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults|Active, not recruiting||Phase 3|645|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 22:44:07.692157|2017-10-10 22:44:07.692157
NCT02607943|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-08-17|||December 2015||2015-12-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|ICAS||Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke|Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke: A Multi-center, Randomized Control Study|Recruiting||Phase 3|120|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-10 22:44:08.06743|2017-10-10 22:44:08.06743
NCT02607930|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-05-22|||November 13, 2015|Actual|2015-11-13|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|May 9, 2017|Actual|2017-05-09||Interventional|||Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults|Active, not recruiting||Phase 3|629|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 22:44:08.227937|2017-10-10 22:44:08.227937
NCT02607917|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-06-23|||December 2014||2014-12-01|June 2016|2016-06-01|November 2019|Anticipated|2019-11-01|July 2019|Anticipated|2019-07-01||Interventional|||Testing a Community Intervention to Increase Aspirin Use|Testing a Community Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease|Recruiting||Phase 4|10800|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-10 22:44:08.601312|2017-10-10 22:44:08.601312
NCT02607904|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-11-01|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy|A Phase 2, Double-blind, Randomized, Placebo-controlled Pharmacokinetic Trial in 2 Parallel Groups to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and GWP42003-P in Patients With Epilepsy|Enrolling by invitation||Phase 2|40|Anticipated|GW Research Ltd||1|||f||||f||||||||No||2017-10-10 22:44:08.694598|2017-10-10 22:44:08.694598
NCT02607891|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-03-14|||October 2016||2016-10-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy|A Phase 2, Double-blind, Randomized, Placebo-controlled Pharmacokinetic Trial in 2 Parallel Groups to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and GWP42003-P in Patients With Epilepsy|Recruiting||Phase 2|40|Anticipated|GW Research Ltd||4|||f||||f||||||||No||2017-10-10 22:44:08.97571|2017-10-10 22:44:08.97571
NCT02607878|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-12-05|||January 2015||2015-01-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Automated Pupillometry for Coma Prognostication After Cardiac Arrest|Automated Pupillometry for Coma Prognostication After Cardiac Arrest|Recruiting||N/A|500|Anticipated|Centre Hospitalier Universitaire Vaudois|||1||f||||t||||||||No||2017-10-10 22:44:09.190366|2017-10-10 22:44:09.190366
NCT02606682|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-02-12|||July 2015||2015-07-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Phase 1 Study of NPT200-11 in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Single Ascending Dose Trial of the Safety, Tolerability and Pharmacokinetics of NPT200-11 in Healthy Subjects|Completed||Phase 1|55|Actual|Neuropore Therapies Inc.||7|||f||||f||||||||||2017-10-10 22:44:22.342454|2017-10-10 22:44:22.342454
NCT02607865|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-10-04|||February 15, 2016|Actual|2016-02-15|October 2017|2017-10-01|March 26, 2018|Anticipated|2018-03-26|March 10, 2017|Actual|2017-03-10||Interventional|PIONEER 3||Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes|Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes|Active, not recruiting||Phase 3|1860|Anticipated|Novo Nordisk A/S||4|||f||||f|t|f||||||||2017-10-10 22:44:09.373793|2017-10-10 22:44:09.373793
NCT02607852|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-06-21|||April 8, 2015|Actual|2015-04-08|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Feedback System of PROMS in Children With Burns|System for Feedback of Patient Reported Outcomes in Children With Burns|Active, not recruiting||N/A|35|Actual|Shriners Hospitals for Children||2|||f||||f|f|f||||||No||2017-10-10 22:44:10.067796|2017-10-10 22:44:10.067796
NCT02607839|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-17|||February 2013||2013-02-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|||Regulation of Intestinal and Hepatic Lipoprotein Particle Production by Blood Glucose in Humans|Regulation of Intestinal and Hepatic Lipoprotein Particle Production by Blood Glucose in Humans|Completed||Phase 2|10|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:44:10.197323|2017-10-10 22:44:10.197323
NCT02607826|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-10-27|||November 2016||2016-11-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors|Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors|Not yet recruiting||N/A|298|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 22:44:10.303934|2017-10-10 22:44:10.303934
NCT02607813|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-07|||January 18, 2016|Actual|2016-01-18|August 2017|2017-08-01|March 14, 2019|Anticipated|2019-03-14|March 14, 2019|Anticipated|2019-03-14||Interventional|||Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations|A Phase I Dose Finding Study of Oral LXH254 in Adult Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations|Recruiting||Phase 1|174|Anticipated|Novartis||6|||f||||f|t|f||||||||2017-10-10 22:44:10.388807|2017-10-10 22:44:10.388807
NCT02607787|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-11-17|||April 2015||2015-04-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|EXACT||EXercise And Colo-Rectal Cancer Trial|The Feasibility and Effects of a Home-based Walking and Strengthening Intervention on Physiological, Biochemical and Psychological Outcomes in Colo-rectal Cancer Survivors|Recruiting||N/A|60|Anticipated|University of Ulster||2|||f||||f||||||||||2017-10-10 22:44:10.866975|2017-10-10 22:44:10.866975
NCT02607774|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-10-02|||December 17, 2015|Actual|2015-12-17|October 2017|2017-10-01|January 11, 2017|Actual|2017-01-11|January 11, 2017|Actual|2017-01-11||Interventional|||Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis|An Open-label, Single Sequence Crossover, Study Investigating the Influence of Secukinumab Treatment on the Pharmacokinetics of Midazolam as a CYP3A4 Substrate in Patients With Moderate to Severe Plaque Psoriasis|Completed||Phase 1|25|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-10 22:44:10.983872|2017-10-10 22:44:10.983872
NCT02607761|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-06-16|||October 2014||2014-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|FAST||Fertility Awareness in University Students|Fertility Awareness in University Students|Completed||N/A|323|Actual|Universidade do Porto||3|||f||||f||||||||||2017-10-10 22:44:11.116335|2017-10-10 22:44:11.116335
NCT02607748|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-17|||November 2015||2015-11-01|November 2015|2015-11-01||||October 2017|Anticipated|2017-10-01||Interventional|||18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques|18F-fluoride (18F-NaF) Positron Emission Tomography (PET) for Identification of Ruptured and High-Risk Coronary Atherosclerotic Plaques|Recruiting||Phase 4|120|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-10 22:44:11.215692|2017-10-10 22:44:11.215692
NCT02607722|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-09-21|||August 31, 2015|Actual|2015-08-31|September 2017|2017-09-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Observational|||All-Case Surveillance of Ofev in Patients With IPF in Japan|The Special Drug Use-results Survey (All-Case Surveillance) of Ofev® Capsules in Patients With Idiopathic Pulmonary Fibrosis (IPF) in Japan|Recruiting||N/A|6000|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 22:44:11.759354|2017-10-10 22:44:11.759354
NCT02607709|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2016-12-26|||June 2016||2016-06-01|December 2016|2016-12-01|January 2032|Anticipated|2032-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Lymphadenectomy in Urothelial Carcinoma|Lymphadenectomy in Urothelial Carcinoma in the Renal Pelvis and Ureter|Recruiting||N/A|366|Anticipated|University Hospital Roskilde||2|||f||||t||||||||||2017-10-10 22:44:12.405064|2017-10-10 22:44:12.405064
NCT02607696|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-01-31|||May 2016||2016-05-01|January 2017|2017-01-01||||October 2016|Anticipated|2016-10-01||Interventional|||Pharmacokinetics of Zolpidem Orodispersible Tablet|Phase I Randomized Clinical Trial of Evaluation of Zolpidem Hemitartarate Pharmacokinetics (Orodispersible Tablet 1.75 mg and 3.50 mg) After Single Dose Oral Administration in Male and Female Healthy Subjects|Withdrawn||Phase 1|0|Actual|Biolab Sanus Farmaceutica||2|||f||||f||||||||||2017-10-10 22:44:12.520674|2017-10-10 22:44:12.520674
NCT02606097|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-19|||April 2014||2014-04-01|November 2015|2015-11-01||||May 2017|Anticipated|2017-05-01||Interventional|||Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation|A Phase 2 Study of Regorafenib in Metastatic Gastrointestinal Stromal Tumours With C-KIT exon17 Mutation|Recruiting||Phase 2|21|Anticipated|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-10-10 22:44:27.638067|2017-10-10 22:44:27.638067
NCT02607683|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-06-28|||January 1, 2016|Actual|2016-01-01|June 2017|2017-06-01|October 31, 2016|Actual|2016-10-31|September 19, 2016|Actual|2016-09-19||Interventional|||Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)|A Phase 2b/3, Multicenter, Dose-ranging, Randomized, Double-masked, Placebo-controlled Study of XAF5 Ointment for Reduction of Lower Lid Steatoblepharon|Completed||Phase 2/Phase 3|300|Actual|Topokine Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 22:44:12.612046|2017-10-10 22:44:12.612046
NCT02607670|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-01-02|||January 2016||2016-01-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds|A Phase 2, Randomized, Double-blind, Placebo-controlled Study of TAT4 Gel for the Reduction of Nasolabial Folds|Recruiting||Phase 2|111|Anticipated|Topokine Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:44:12.722503|2017-10-10 22:44:12.722503
NCT02607657|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-01-31|||May 2016||2016-05-01|January 2017|2017-01-01||||October 2016|Anticipated|2016-10-01||Interventional|||Pharmacokinetics of Eplerenone Tablet|Phase I Trial Comparing Eplerenone Pharmacokinetics (Tablet) in Different Dosages: 25mg, 50mg,100 mg Per Day and 100 mg (One 50 mg Tablet Every 12 Hours).|Withdrawn||Phase 1|0|Actual|Biolab Sanus Farmaceutica||5|||f||||f||||||||||2017-10-10 22:44:12.816483|2017-10-10 22:44:12.816483
NCT02607644|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-02-12|||November 2015||2015-11-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Laryngeal Tube vs Laryngeal Mask Airway|Clinical Evaluation of Laryngeal Tube and Laryngeal Mask Airway for Cardiac Arrest Treatment in Emergency Ambulances in Singapore|Recruiting||N/A|875|Anticipated|Singapore General Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:44:12.931729|2017-10-10 22:44:12.931729
NCT02607631|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-11-17|||November 2015||2015-11-01|November 2015|2015-11-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor|A Phase II Study of Pembrolizumab for Patients With Thymic Epithelial Tumor Who Progressed After at Least One Previous Regimen of Cisplatin-Containing Chemotherapy|Not yet recruiting||Phase 2|30|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 22:44:13.041115|2017-10-10 22:44:13.041115
NCT02607618|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-08-09|||November 2015||2015-11-01|August 2017|2017-08-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Interventional|REVIVE-2||Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2|A Phase 3, Randomized, Double-blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of ABSSSI: REVIVE-2|Completed||Phase 3|613|Actual|Motif Bio||2|||f||||f||||||||||2017-10-10 22:44:13.129092|2017-10-10 22:44:13.129092
NCT02607605|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2015-11-17|||August 2015||2015-08-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|ctDNA||A Prospective, Observational Trial on the Diagnostic and Prognostic of LM|A Prospective, Observational Trial on the Diagnostic and Prognostic Value of Cell-free DNA in Advanced Lung Cancer With Leptomeningeal Metastases|Recruiting||N/A|10|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     patient's cerebrospinal fluid   "|||2017-10-10 22:44:13.325063|2017-10-10 22:44:13.325063
NCT02607592|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-02-17|||August 2015||2015-08-01|February 2016|2016-02-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|NACA||A Prospective Multi-center Phase III Randomized Controlled Trial|Nadaplatin or Cisplatin Combined With Pemetrexed in the First Line Treatment of Advanced Adenocarcinoma：A Prospective Multi-center Phase III Randomized Controlled Trial|Recruiting||Phase 3|293|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:44:13.407718|2017-10-10 22:44:13.407718
NCT02607579|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-04-26|||January 2015||2015-01-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|June 2016|Actual|2016-06-01||Interventional|||Comparing Exparel & Ropivacaine for Pain Relief in Total Knee Arthroplasty|A Randomized, Blinded Study to Compare Exparel and Ropivacaine for Pain Relief Following Total Knee Arthroplasty|Active, not recruiting||N/A|200|Anticipated|Monmouth Medical Center||2|||f||||||||||||||2017-10-10 22:44:13.506084|2017-10-10 22:44:13.506084
NCT02607566|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-17|||September 2015||2015-09-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Yoga for Type 2 Diabetes|Yoga as a Complementary Therapy for Type 2 Diabetes: An Initial Investigation|Recruiting||N/A|60|Anticipated|The Miriam Hospital||2|||f||||f||||||||||2017-10-10 22:44:13.598349|2017-10-10 22:44:13.598349
NCT02607553|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-02-22|||June 2016||2016-06-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA|G-202-006: An Open-Label, Single-Arm, Phase II Study to Evaluate the Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA|Completed||Phase 2|2|Actual|GenSpera, Inc.||1|||f||||f||||||||No||2017-10-10 22:44:13.701375|2017-10-10 22:44:13.701375
NCT02607540|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-01-10|||October 2014||2014-10-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|PFCRTESC||Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer|Two-arm Phase III Trial Comparing Radiotherapy With Differentcycles of Cisplatin-5-fluorouracil for Esophageal Cancer|Recruiting||Phase 3|210|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology||2|||f||||t||||||||||2017-10-10 22:44:13.780304|2017-10-10 22:44:13.780304
NCT02607527|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-08-10|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Annular Reshaping of the Mitral Valve for MR Using the Millipede IRIS System|Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System|Recruiting||N/A|10|Anticipated|Millipede Inc.||1|||f||||f||||||||||2017-10-10 22:44:13.905659|2017-10-10 22:44:13.905659
NCT02607514|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-02-22|||February 20, 2017|Actual|2017-02-20|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Hyperthermic Yoga for Depressive Symptoms|Mechanisms of Hyperthermic Yoga for the Treatment of Depression|Recruiting||N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||t|f|f||||||||2017-10-10 22:44:13.992115|2017-10-10 22:44:13.992115
NCT02607501|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-02-06|||April 2016||2016-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|EESIS||European eCLIPS™ Safety, Feasibility and Efficacy Study|A Multi-center Post Marketing Study Evaluating the Safety, Technical Feasibility, and Efficacy of the eCLIPs™ Family of Products for the Treatment of Bifurcation Intracranial Aneurysms.|Recruiting||N/A|60|Anticipated|Evasc Medical Systems Corp.||1|||f||||t||||||||No||2017-10-10 22:44:14.079062|2017-10-10 22:44:14.079062
NCT02607488|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2015-11-17|||November 2015||2015-11-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery|Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Laparoscopic Bariatric Surgery: A Dose Dependent Study|Recruiting||Phase 1/Phase 2|180|Anticipated|Mansoura University||4|||f||||t||||||||||2017-10-10 22:44:14.20933|2017-10-10 22:44:14.20933
NCT02607475|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-06-26|||November 2015||2015-11-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluation of Robotic Telesonography|Evaluation of Robotic Telesonography for Obstetric and Adult and Pediatric Abdominal Imaging|Recruiting||N/A|90|Anticipated|University of Saskatchewan||1|||f||||f||||||||||2017-10-10 22:44:14.333126|2017-10-10 22:44:14.333126
NCT02607462|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-04-15|||November 2015||2015-11-01|April 2016|2016-04-01||||October 2017|Anticipated|2017-10-01||Interventional|||PRP Therapy to m. Gluteus Medius During THA|Single Injection of Platelet-rich Plasma (PRP) to m. Gluteus Medius During Total Hip Arthroplasty Using Direct Lateral (Hardinge) Approach|Recruiting||N/A|80|Anticipated|Satakunta Central Hospital||2|||f||||f||||||||||2017-10-10 22:44:14.446387|2017-10-10 22:44:14.446387
NCT02607449|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-04-25|||December 2013||2013-12-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|FS-1||FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis|Randomized, Placebo-controlled Study of Safety and Therapeutic Efficacy of the Drug FS-1 in the Oral Dosage Form in Drug-resistant Pulmonary Tuberculosis|Recruiting||Phase 3|480|Anticipated|Scientific Center for Anti-infectious Drugs, Kazakhstan||2|||f||||f||||||||||2017-10-10 22:44:14.533372|2017-10-10 22:44:14.533372
NCT02607436|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-05-02|||July 2015||2015-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|SAGE-CAD||Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease|Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Progression of Coronary Artery Disease|Completed||Phase 4|40|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||No||2017-10-10 22:44:14.626082|2017-10-10 22:44:14.626082
NCT02607423|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-01-22|||November 2015||2015-11-01|January 2016|2016-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery|Role of Early 18F-FDG-PET/CT Scan in Predicting Mediastinal Downstaging With Neoadjuvant Chemotherapy in Resectable Stage III A NSCLC|Recruiting||Phase 2|68|Anticipated|Eastern Cooperative Oncology Group||1|||f||||||||||||||2017-10-10 22:44:14.715837|2017-10-10 22:44:14.715837
NCT02607410|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-11-17|||January 2010||2010-01-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|January 2012|Actual|2012-01-01||Interventional|||Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D|Short and Long Term Effects of a Dypeptidil-peptidase-4 Versus Bedtime NPH Insulin as add-on Therapy in Patients With Type 2 Diabetes|Completed||Phase 4|40|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 22:44:14.848299|2017-10-10 22:44:14.848299
NCT02607397|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-03-27|||May 2015||2015-05-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|ROCOCO LGG||ROCOCO - Low Grade Glioma - Planning Study|In Silico Clinical Trial on Irradiation Low Grade Glioma, Comparing Photon and Proton Therapy: A Multicentric Planning Study Based on a Reference Dataset of Patients|Completed||N/A|25|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-10 22:44:14.940654|2017-10-10 22:44:14.940654
NCT02607384|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-03-02|||November 2014|Actual|2014-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|BREDS||The Baltimore Reading and Eye Disease Study|A School-based Intervention to Diagnose and Treat Vision Problems in Elementary School Children With Reading Difficulty|Active, not recruiting||N/A|400|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 22:44:15.007358|2017-10-10 22:44:15.007358
NCT02607371|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-13|||August 27, 2015|Actual|2015-08-27|September 2017|2017-09-01|October 15, 2016|Actual|2016-10-15|October 15, 2016|Actual|2016-10-15||Observational|PRiSMA-AF||Anticoagulation Preference by AF Patients Study|AF Patient Preferences Towards NOAC Versus VKA Treatment: a Patient Preference Study|Completed||N/A|198|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:44:15.093536|2017-10-10 22:44:15.093536
NCT02607358|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-10-12|||January 2015||2015-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|NATIS||Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke)|NATIS: Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke|Completed||N/A|496|Actual|Zealand University Hospital|||2||f||||t||||||||||2017-10-10 22:44:15.200195|2017-10-10 22:44:15.200195
NCT02607345|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-11-16|||February 2015||2015-02-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||25gr. Glucomedics vs 25gr. Zusto|25gr. Glucomedics vs 25gr. Zusto|Completed||N/A|10|Actual|AZ-VUB||2|||f||||f||||||||||2017-10-10 22:44:15.381065|2017-10-10 22:44:15.381065
NCT02607332|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-07-13|||November 2015||2015-11-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Trial of Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib||Recruiting||Phase 2|25|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-10 22:44:15.490558|2017-10-10 22:44:15.490558
NCT02607319|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-05-25|||November 2015||2015-11-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|BRIF||Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure|Effect of Low Molecular Weight Heparin (Bemiparin) on Implantation Rate in Patients With Recurrent Implantation Failure Undergoing IVF/ICSI - A Prospective Randomized Clinical Trial|Recruiting||Phase 4|200|Anticipated|American University of Beirut Medical Center||2|||f||||f||f||||||Undecided||2017-10-10 22:44:15.589602|2017-10-10 22:44:15.589602
NCT02607293|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-05-23|||December 31, 2015|Actual|2015-12-31|May 2017|2017-05-01|March 16, 2017|Actual|2017-03-16|January 15, 2017|Actual|2017-01-15||Observational|ARTIST||A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation|An Exploratory Study to Explore the Correlation Between the Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response Using New Gonal-f® Pen in Assisted Reproductive Technology (ART) Treatment in China|Completed||N/A|1064|Actual|Merck KGaA|||1||f||||t||||||||||2017-10-10 22:44:16.003508|2017-10-10 22:44:16.003508
NCT02607280|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-04-17|||December 2015|Actual|2015-12-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||DS-5565 Phase III Study for Renal Impairment in Japanese Subjects|A JAPANESE, PHASE 3, OPEN-LABEL, 14-WEEK STUDY OF DS-5565 IN PATIENTS WITH PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY WITH RENAL IMPAIRMENT OR POST-HERPETIC NEURALGIA WITH RENAL IMPAIRMENT|Completed||Phase 3|35|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-10 22:44:16.148998|2017-10-10 22:44:16.148998
NCT02607267|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-02-07|||October 2014||2014-10-01|November 2015|2015-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Edmonton Obesity Staging System: Post-operative Outcome and 30-day Mortality|The Importance of the Edmonton Obesity Score System in Predicting Postoperative Outcome and 30 Day Mortality After Metabolic Surgery|Completed||N/A|534|Actual|Sana Klinikum Offenbach|||2||f||||f||||||||||2017-10-10 22:44:16.248697|2017-10-10 22:44:16.248697
NCT02607254|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-03-06|||September 2015||2015-09-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy|Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy|Recruiting||Phase 2|20|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 22:44:16.345422|2017-10-10 22:44:16.345422
NCT02607241|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2017-05-01|||November 2015||2015-11-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|OCTOPUS-3||Comparison of Paclitaxel-Coated Balloons Against Drug-Eluting Bioresorbable Scaffolds for Elective PCI Using OCT|Comparison of a Paclitaxel-Coated Balloon Without Stent Implantation Against a Drug-Eluting Bioresorbable Scaffold for Treatment of Stable Coronary Artery Disease: A Prospective Randomized Study Using Optical Coherence Tomography|Suspended||Phase 4|240|Anticipated|University of Jena||2||"The product used in the comparator arm (BRS) has become unavailable in April 2017. The   recruitment will go on, as soon as the use of another BRS is approved."|f||||t||||||||||2017-10-10 22:44:16.447931|2017-10-10 22:44:16.447931
NCT02607215|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-01-03|||November 2015||2015-11-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Platinum Rechallenge in Patients With Platinum-sensitive mTNBC|Platinum Retreated in Second- or Third-line Patients With Platinum Sensitive Metastatic Triple Negative Breast Cancer (Randomised, Phase II, NPN Trial)|Recruiting||Phase 2|84|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 22:44:16.656727|2017-10-10 22:44:16.656727
NCT02607202|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-09-01|||March 2015||2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|AGNOSTOS||A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP)|A Phase II, Randomized, Multicenter Study to Assess the Efficacy of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP): The AGNOSTOS Trial|Recruiting||Phase 2|120|Anticipated|Fondazione del Piemonte per l'Oncologia||2|||f||||f||||||||||2017-10-10 22:44:16.759906|2017-10-10 22:44:16.759906
NCT02607176|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2017-05-20|||October 2015||2015-10-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Heweizhixie capsuleTherapy on Patients With Diarrhea|A Post -Marketing Drug Evaluation(Phase IV Clinical Trial) to Study the Safety and Efficacy of Heweizhixie Capsule in Patients With Diarrhea|Recruiting||Phase 4|2400|Anticipated|Shanghai University of Traditional Chinese Medicine||1|||f||||f||||||||No||2017-10-10 22:44:16.920598|2017-10-10 22:44:16.920598
NCT02607163|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2015-11-16|||September 2015||2015-09-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Dexmedetomidine on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery||Recruiting||Phase 4|108|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 22:44:17.011491|2017-10-10 22:44:17.011491
NCT02607150|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-04-06|||December 2014||2014-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|||Changes in Cerebral Oxygenation During the Administration of Cell Saver Blood and Allogeneic Blood|Changes in Cerebral Oxygenation During the Administration of Cell Saver Blood and Allogeneic Blood|Completed||N/A|50|Actual|Nationwide Children's Hospital|||1||f||||f||||||||No||2017-10-10 22:44:17.104262|2017-10-10 22:44:17.104262
NCT02607137|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2017-03-15|||October 2014||2014-10-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation of Training Program on Promoting Family Holistic Health|Evaluation of Training Program on Promoting Family Holistic Health|Recruiting||N/A|100|Anticipated|The University of Hong Kong||1|||f||||t||||||||||2017-10-10 22:44:17.183567|2017-10-10 22:44:17.183567
NCT02607124|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-04-13|||April 2016||2016-04-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy|A Phase I/II Study of Ribociclib, a CDK4/6 Inhibitor, Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)|Recruiting||Phase 1/Phase 2|24|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 22:44:17.318217|2017-10-10 22:44:17.318217
NCT02595749|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-04-18|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effects of Intranasal Oxytocin on Cigarette Smoking|Effects of Intranasal Oxytocin on Cigarette Smoking|Recruiting||Phase 4|30|Anticipated|University of Southern California||2|||f||||f|t|f||||||No||2017-10-10 22:46:34.335421|2017-10-10 22:46:34.335421
NCT02607111|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-09-08|||August 2016||2016-08-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients|A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients: A Prospective Study|Recruiting||Phase 4|15|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-10 22:44:17.430499|2017-10-10 22:44:17.430499
NCT02607098|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-02-28|||November 2015||2015-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Understanding Adaptive Challenges Associated With Male-factor Infertility|Understanding Adaptive Challenges Associated With Male-factor Infertility|Completed||N/A|24|Actual|Duke University|||2||f||||f||||||||||2017-10-10 22:44:17.530374|2017-10-10 22:44:17.530374
NCT02607085|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-06-06|||October 31, 2015|Actual|2015-10-31|June 2017|2017-06-01|May 31, 2016|Actual|2016-05-31|April 30, 2016|Actual|2016-04-30||Observational|REVEAL-ED||REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study|REal World EVidence for TrEAtment of HyperkaLemia in the Emergency Department (REVEAL - ED): a Multicenter, Prospective, Observational Study|Completed||N/A|203|Actual|ZS Pharma, Inc.|||1||f||||f||||||||||2017-10-10 22:44:17.60429|2017-10-10 22:44:17.60429
NCT02607072|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-15|2015-11-16|||October 2015||2015-10-01|November 2015|2015-11-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Interventional|APREMEC||Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial|Enteric-coated Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients (the APREMEC Trial): a Large-scale Multicenter Randomized Double-blind Placebo-controlled Trial|Recruiting||Phase 3|3000|Anticipated|The Fourth Affiliated Hospital of Anhui Medical University||3|||f||||t||||||||||2017-10-10 22:44:17.68314|2017-10-10 22:44:17.68314
NCT02607059|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-09|||May 2015||2015-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01|3 Years|Observational [Patient Registry]|||Epidemiologic Registry PETHEMA LMA 2015|Epidemiologic Registry of Patients Diagnosed With Acute Myeloid Leukemia (PETHEMA LMA 2015)|Recruiting||N/A|500|Anticipated|PETHEMA Foundation|||1||f||||f||||||||||2017-10-10 22:44:17.771631|2017-10-10 22:44:17.771631
NCT02607046|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-09-01|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Exercise Rehabilitation in Veterans With PAD|Post-revascularization Rehabilitation to Improve Function in Veterans With PAD|Recruiting||N/A|52|Anticipated|VA Office of Research and Development||4|||f||||f|f|f|||f|||||2017-10-10 22:44:17.839455|2017-10-10 22:44:17.839455
NCT02607033|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-08-29|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|Action3||Exercise and Weight Loss in PAD|Exercise and Weight Loss to Improve Mobility Function in Veterans With PAD|Recruiting||N/A|76|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:44:17.9443|2017-10-10 22:44:17.9443
NCT02607020|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-12-07|||December 2015||2015-12-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|December 2018|Anticipated|2018-12-01||Interventional|AUTOMOVEMS||Self-Management Program Based on Physical Exercises in People With Multiple Sclerosis|Self-Management Program Based on Physical Exercises for People With Multiple Sclerosis With Mild Neurological Impairment: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 22:44:18.053585|2017-10-10 22:44:18.053585
NCT02607007|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Dairy and Non-dairy Breakfasts on Satiety and Post-meal Glycemia in Healthy Older Adults|The Effect of Dairy and Non-dairy Breakfasts on Subjective Appetite Ratings, Food Intake, and Post-meal Glycemia in Healthy Older Adults|Completed||Phase 1/Phase 2|29|Actual|University of Toronto||5|||f||||f||||||||||2017-10-10 22:44:18.225848|2017-10-10 22:44:18.225848
NCT02606994|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-08-30|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|TPvsM||Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositis|Comparison of the Healing of Chemotherapy-Induced Oral Mucositis Using Oral Defense Toothpaste Versus Crest Toothpaste and Magic Mouth Rinse|Not yet recruiting||Phase 2|82|Anticipated|Oral Defense, LLC||2|||f||||f|f|f||||||||2017-10-10 22:44:18.346144|2017-10-10 22:44:18.346144
NCT02606981|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-05-10|||July 2015||2015-07-01|May 2017|2017-05-01|December 20, 2016|Actual|2016-12-20|December 20, 2016|Actual|2016-12-20||Interventional|||Automatic Chlorination and Child Health in Urban Bangladesh|Evaluating Low-cost Automatic Water Disinfection Systems to Improve Water Quality and Child Health in Urban Bangladesh|Completed||N/A|1549|Actual|Stanford University||2|||f||||t||||||||||2017-10-10 22:44:18.426359|2017-10-10 22:44:18.426359
NCT02606955|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-11-15|||February 2015||2015-02-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Probing the Dry Weight by Bioimpedance: The Resistance Stabilization Test|Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW?|Recruiting||N/A|60|Anticipated|Miulli General Hospital||1|||f||||t||||||||||2017-10-10 22:44:18.527789|2017-10-10 22:44:18.527789
NCT02606942|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-01-21|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|July 2016|Anticipated|2016-07-01||Observational|||Prevalence of Chondromalacia Patella Among Adolescent Dancers - Correlation Between Symptoms and Sonography Findings|Prevalence of Chondromalacia Patella Among Adolescent Dancers - Correlation Between Symptoms and Sonography Findings|Not yet recruiting||N/A|90|Anticipated|Sheba Medical Center|||3||f||||f||||||||||2017-10-10 22:44:18.632115|2017-10-10 22:44:18.632115
NCT02606916|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2017-10-03|||July 2015||2015-07-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.|A Prospective, Single-arm Study of Simultaneous Modulated Accelerated Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Carcinoma.|Recruiting||Phase 2|44|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 22:44:18.736552|2017-10-10 22:44:18.736552
NCT02606877|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-04-26|||April 19, 2016|Actual|2016-04-19|April 2017|2017-04-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|||A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination|Investigation of Drug-drug Interaction Between Nintedanib and Pirfenidone in Patients With IPF (an Open Label, Multiple-dose, Two Group Study)|Completed||Phase 4|38|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:44:18.99318|2017-10-10 22:44:18.99318
NCT02606864|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2016-11-11|||December 2015||2015-12-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients|Non-blinded, Randomized, Single Center, Single Dose, Cross-over Study to Assess the Effect of a High Calorie/High Fat Meal on the Pharmacokinetics of Four 30 mg Nifurtimox Tablets Taken Orally by Adult Male and Female Patients Suffering From Chronic Chagas' Disease|Completed||Phase 1|36|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:44:19.076327|2017-10-10 22:44:19.076327
NCT02606851|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-16|2017-03-03|||December 4, 2015|Actual|2015-12-04|March 2017|2017-03-01|December 28, 2016|Actual|2016-12-28|December 28, 2016|Actual|2016-12-28||Observational|||Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.|China Survey of Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease|Completed||N/A|1000|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-10 22:44:20.758475|2017-10-10 22:44:20.758475
NCT02606838|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-04-04|2016-12-12||November 2015||2015-11-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of an Ascensia Lancing System|User Performance of the Styx Lancing System|Completed||N/A|119|Actual|Ascensia Diabetes Care||1|||f||||f||||||||No||2017-10-10 22:44:20.856678|2017-10-10 22:44:20.856678
NCT02606825|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-09-14|||July 2015||2015-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years|VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years or Not Candidates for Intensive Chemotherapy|Recruiting||N/A|2000|Anticipated|PETHEMA Foundation|||1||f||||f||||||||||2017-10-10 22:44:21.125894|2017-10-10 22:44:21.125894
NCT02606812|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-25|||March 2017||2017-03-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|EFCMRNAMS||Effect of Food Consumption on microRNA Related to Metabolic Syndrome|Effect of Food Consumption on microRNA Related to Metabolic Syndrome. A Randomized Clinical Trial|Not yet recruiting||N/A|50|Anticipated|Universidad Juárez Autónoma de Tabasco||2|||f||||t||||||||||2017-10-10 22:44:21.220384|2017-10-10 22:44:21.220384
NCT02606799|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-11-30|||December 2015||2015-12-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|EXCESS||Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy|Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy - a Randomized Study (EXCESS)|Not yet recruiting||Phase 2|24|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 22:44:21.291375|2017-10-10 22:44:21.291375
NCT02606786|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-09-06|||March 2015||2015-03-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effectiveness of Lumbopelvic Stabilization Exercises for Pregnancy-related Low Back Pain|Effectiveness of Lumbopelvic Stabilization Exercises for Pregnancy-related Low Back Pain|Withdrawn||N/A|0|Actual|Texas Woman's University||1||Difficulty with participant recruitment and retainment|f||||f||||||||||2017-10-10 22:44:21.388582|2017-10-10 22:44:21.388582
NCT02606773|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-16|||June 2015||2015-06-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||"Novo C Plus Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects"|"Open-label, Randomized Comparator Study for Evaluation the Bioavailability of Novo C Plus Vitamin C Containing Dietary Supplement in Healthy Subjects"|Completed||Phase 1|32|Actual|Semmelweis University||4|||f||||f||||||||||2017-10-10 22:44:21.472773|2017-10-10 22:44:21.472773
NCT02606760|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-09-18|||November 23, 2015|Actual|2015-11-23|September 2017|2017-09-01|February 8, 2017|Actual|2017-02-08|February 8, 2017|Actual|2017-02-08||Interventional|||Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis|A Randomized, Double-blind, Vehicle-controlled, Parallel Group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis|Completed||Phase 3|378|Actual|Polichem S.A.||2|||f||||f||||||||||2017-10-10 22:44:21.555075|2017-10-10 22:44:21.555075
NCT02606747|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-11-16|||March 2015||2015-03-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||The Balance Control Mechanism of DPN Patients|The Balance Control Mechanism of Diabetic Peripheral Neuropathy Patients|Recruiting||N/A|200|Anticipated|Peking University|||2||f||||t||||||||||2017-10-10 22:44:21.784026|2017-10-10 22:44:21.784026
NCT02606734|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-09-19|2016-05-18||October 2015||2015-10-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||DyeVert Pilot Trial|DyeVert Pilot Trial|Completed||N/A|44|Actual|Osprey Medical, Inc||1|||f||||f||||||||||2017-10-10 22:44:21.878316|2017-10-10 22:44:21.878316
NCT02606721|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-05-11|||March 2016||2016-03-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Observational|||Food Allergy Challenge Diagnostic Study|An Exploratory Pilot Study Evaluating Various Diagnostic Measurements Taken During an Escalating Dose Oral Food Challenge to Patient Response|Recruiting||N/A|60|Anticipated|ORA, Inc.|||1||f||||f||||||||No||2017-10-10 22:44:22.067801|2017-10-10 22:44:22.067801
NCT02606695|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-03-22|||November 2015||2015-11-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Comprehensive Spinal Alignment Planning Study|A Prospective Multicenter Study Evaluating the Clinical and Radiographic Outcomes of Thoracolumbar Spine Surgery When Comprehensive Sagittal Alignment Surgical Planning is Used|Enrolling by invitation||N/A|300|Anticipated|NuVasive|||1||f||||f||||||||No||2017-10-10 22:44:22.23097|2017-10-10 22:44:22.23097
NCT02606669|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-08-17|||December 2015||2015-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||The Effect of Intermittent Energy Restriction Using Meal Replacements in Overweight Chinese Subjects|The Effect of Intermittent Energy Restriction Using Meal Replacements in Overweight Chinese Subjects: a Pilot Randomized Control Trial|Completed||N/A|19|Actual|Khoo Teck Puat Hospital||2|||f||||f||||||||||2017-10-10 22:44:22.444583|2017-10-10 22:44:22.444583
NCT02606630|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-02-06|||October 2015||2015-10-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis|A [C-11]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT-555 on Central Nervous System Inflammation in Subjects With Relapsing Forms of Multiple Sclerosis|Terminated||Phase 1|4|Actual|AbbVie||1||Company decision|f||||f||||||||||2017-10-10 22:44:23.068963|2017-10-10 22:44:23.068963
NCT02606617|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2015-11-15|||December 2015||2015-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes|What is the Effects of Prokinetic Drug on the Blood Glucose in Type 2 Diabetes Patients: Mosapride Comparing Placebo|Not yet recruiting||Phase 4|200|Anticipated|Third Military Medical University||2|||f||||||||||||||2017-10-10 22:44:23.143596|2017-10-10 22:44:23.143596
NCT02606604|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|July 2017|Actual|2017-07-01||Interventional|MSCycling||Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS|Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking Performance and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study|Active, not recruiting||N/A|20|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-10-10 22:44:23.235581|2017-10-10 22:44:23.235581
NCT02606591|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-10-03|||March 2016||2016-03-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Houston Independent School District (HISD) Yoga Evaluation|Houston Independent School District (HISD) Yoga and Wellness Program Evaluation|Recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:44:23.32136|2017-10-10 22:44:23.32136
NCT02606578|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-12-20|||October 2015||2015-10-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Observational|||Achalasia Patient Reported Outcomes|Achalasia Patient Reported Outcomes|Recruiting||N/A|100|Anticipated|Mayo Clinic|||1||f||||t||||||||||2017-10-10 22:44:23.415661|2017-10-10 22:44:23.415661
NCT02606565|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-01-04|||July 2016||2016-07-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Efficacy of Umbilical Cord Cleansing With a Single Application of 4% Chlorhexidine for the Prevention of Newborn Infections in Uganda: a Randomized Controlled Trial|Acceptability and Efficacy of Umbilical Cord Cleansing With 4% Chlorhexidine for the Prevention of Newborn Infections in Lira District, Northern Uganda: A Randomised Controlled Trial|Recruiting||Phase 4|4760|Anticipated|Makerere University||2|||f||||t||||||||||2017-10-10 22:44:23.500177|2017-10-10 22:44:23.500177
NCT02606552|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-16|||November 2015||2015-11-01|November 2015|2015-11-01|November 2022|Anticipated|2022-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease||Not yet recruiting||Phase 4|670|Anticipated|Yonsei University||3|||f||||t||||||||||2017-10-10 22:44:23.609414|2017-10-10 22:44:23.609414
NCT02606539|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-08|2017-03-21|||September 2015||2015-09-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|SVCGTN||Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms|Primary Surgery Plus Single Course Methotrexate Versus Primary Methotrexate for Treatment of Gestational Trophoblastic Neoplasms in Low Risk Cases Above 40y: a Randomized Controled Trial|Recruiting||Phase 2/Phase 3|20|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 22:44:23.704134|2017-10-10 22:44:23.704134
NCT02606526|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-11-25|||July 2016||2016-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda|A Randomised Controlled Trial in HIV-1 Exposed Ugandan Infants to Estimate Additional Benefits (Non-specific Effects) of BCG|Recruiting||Phase 3|2200|Anticipated|Makerere University||2|||f||||t||||||||||2017-10-10 22:44:23.909824|2017-10-10 22:44:23.909824
NCT02606513|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-03-13|||January 2014||2014-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||MR Urography vs CT Urography|Opacification of the Upper Urinary Tract With MR Urography Compared to CT Urography|Completed||N/A|20|Actual|Kuopio University Hospital||1|||f||||t||||||||Undecided|Data will be shared after manuscript submission|2017-10-10 22:44:24.049226|2017-10-10 22:44:24.049226
NCT02606474|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2015-11-13|||November 2015||2015-11-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Placenta Accreta&Its Complications in Placenta Previa Cases|Incidence of Placenta Accreta & it's Complications in Cases of Previous Cesarean With Placenta Previa Anterior|Not yet recruiting||N/A|100|Anticipated|Kasr El Aini Hospital|||1||f||||f||||||||||2017-10-10 22:44:24.347366|2017-10-10 22:44:24.347366
NCT02606461|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-05-25|||December 2015||2015-12-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|SEAL||Selinexor in Advanced Liposarcoma|A Phase 2-3, Multicenter, Randomized, Double-blind Study of Selinexor (KPT-330) Versus Placebo in Patients With Advanced Unresectable Dedifferentiated Liposarcoma (DDLS)|Recruiting||Phase 2/Phase 3|245|Anticipated|Karyopharm Therapeutics Inc||2|||f||||t||||||||Yes||2017-10-10 22:44:24.414166|2017-10-10 22:44:24.414166
NCT02606448|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-02-20|||August 2014||2014-08-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Exparel Infiltration in Anterior Cruciate Ligament Reconstruction|Liposomal Bupivacaine Versus Femoral Nerve Block for Pain Control After Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Trial|Completed||Phase 4|84|Actual|Henry Ford Health System||2|||f||||t||||||||||2017-10-10 22:44:24.607269|2017-10-10 22:44:24.607269
NCT02606435|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-12|||November 2015||2015-11-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Thrombus Aspiration in Patients With STEMI|Safety and Efficacy of Thrombus Aspiration in Patients With ST-segment Elevation Myocardial Infarction (STEMI)|Recruiting||Phase 4|300|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-10 22:44:24.688245|2017-10-10 22:44:24.688245
NCT02606422|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-05-04|||April 2013||2013-04-01|May 2016|2016-05-01|May 2020|Anticipated|2020-05-01|April 2020|Anticipated|2020-04-01||Interventional|||tDCS Intervention in Primary Progressive Aphasia|Effects of Transcranial Direct Current Stimulation (tDCS) in Spoken and Written Production in Primary Progressive Aphasia (PPA)|Recruiting||N/A|70|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 22:44:24.79143|2017-10-10 22:44:24.79143
NCT02606409|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-08-20|||November 2015||2015-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|DEXsedation||Dexmedetomidine Versus Propofol for Prolonged Sedation in Poly Traumatized Mechanically Ventilated Patients|Dexmedetomidine Versus Propofol for Prolonged Sedation in Poly Traumatized Mechanically Ventilated Patients|Completed||Phase 2/Phase 3|60|Actual|Assiut University||2|||f||||t||||||||No||2017-10-10 22:44:24.900728|2017-10-10 22:44:24.900728
NCT02606396|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-07-17|||November 2015||2015-11-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer|Palliation of Malignant Dysphagia With Spray Cryotherapy in Patients With Advanced Esophageal Cancer: A Pilot Study|Recruiting||N/A|15|Anticipated|Hunter Holmes Mcguire Veteran Affairs Medical Center||1|||f||||t||||||||||2017-10-10 22:44:24.99644|2017-10-10 22:44:24.99644
NCT02606383|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-01-31|||June 2016||2016-06-01|January 2017|2017-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis|Non-inferiority, Phase III Clinical Trial Comparing Dapaconazole Cream 2% (Biolab Sanus Farmacêutica Ltda.) Versus Ketoconazole Cream 2% (Nizoral® Janssen-Cilag) in Patients With Tinea Pedis|Withdrawn||Phase 3|0|Actual|Biolab Sanus Farmaceutica||2|||f||||f||||||||||2017-10-10 22:44:25.124859|2017-10-10 22:44:25.124859
NCT02606370|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-09-20|||January 2016||2016-01-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Unstable Shoes on Trunk Muscle Activity, Lumbar Spine Kinematics and Pain in Patients With Low Back Pain|Effects of Unstable Shoes on Trunk Muscle Activity, Lumbar Spine Kinematics and Pain in Patients With Low Back Pain|Completed||N/A|40|Actual|Cardenal Herrera University||2|||f||||t||||||||||2017-10-10 22:44:25.222926|2017-10-10 22:44:25.222926
NCT02606357|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-07-05|||November 22, 2015|Actual|2015-11-22|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NEWLAN||Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan|Treatment Initiation With Basal Insulin in Uncontrolled Type 2 Diabetes Patients on Oral Anti-Diabetic Agent (OAD) in Jordan|Active, not recruiting||Phase 4|290|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-10 22:44:25.30812|2017-10-10 22:44:25.30812
NCT02606344|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2015-11-13|||September 2014||2014-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV|Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV: a Multi-centric Randomized Trial|Completed||N/A|561|Actual|NMP Medical Research Institute||2|||f||||t||||||||||2017-10-10 22:44:25.414182|2017-10-10 22:44:25.414182
NCT02606331|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-06-08|||April 2015||2015-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy of Minimally Invasive Surgical Technique in Accelerating Orthodontic Treatment|Evaluation the Efficacy of Flapless Corticotomy Accomplished by Either Hard-laser or Piezosurgey in Accelerating Upper Canine Retraction and Evaluation of the Dento-alveolar Changes and the Levels of Acceptance and Discomfort.|Completed||N/A|36|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 22:44:25.497001|2017-10-10 22:44:25.497001
NCT02606318|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2015-11-19|||December 2013||2013-12-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Adjusting Challenge-Skill Balance to Improve the Elderly's Quality of Life|Adjusting Challenge-Skill Balance to Improve the Elderly's Quality of Life: A Randomized Controlled Trial|Completed||N/A|56|Actual|Harue Hospital||2|||f||||f||||||||||2017-10-10 22:44:25.588049|2017-10-10 22:44:25.588049
NCT02606305|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-06-13|||December 2015||2015-12-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of Mirvetuximab Soravtansine in Comb. With Bevacizumab, Carboplatin, PLD or Pembrolizumab in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer|A Phase 1b Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Mirvetuximab Soravtansine (IMGN853) in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin or Pembrolizumab in Adults With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer, or Endometrial Cancer|Recruiting||Phase 1|200|Anticipated|ImmunoGen, Inc.||4|||f||||f||||||||||2017-10-10 22:44:25.682906|2017-10-10 22:44:25.682906
NCT02606292|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-09-27|||August 2014||2014-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Photoacoustic Endoscopy of Barrett's Esophagus|Photoacoustic Endoscopy of Barrett's Esophagus|Completed||Early Phase 1|8|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 22:44:25.811549|2017-10-10 22:44:25.811549
NCT02605551|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2015-11-11|||November 2015||2015-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|HOT||Hypertension and Osteopathic Treatment|The Utilization of Osteopathic Manipulation (OMT) as an Adjunct Therapy in the Treatment of Hypertension|Enrolling by invitation||N/A|200|Anticipated|Larkin Community Hospital||2|||f||||f||||||||||2017-10-10 22:44:32.906911|2017-10-10 22:44:32.906911
NCT02606279|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-01-24|||July 2014||2014-07-01|January 2017|2017-01-01|August 4, 2016|Actual|2016-08-04|August 4, 2016|Actual|2016-08-04||Interventional|RAS-HIV||Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients|Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients|Terminated||Phase 2|1|Actual|Wake Forest University Health Sciences||2||Change in study design and inability to recruit participants|f||||f||||||||||2017-10-10 22:44:25.885352|2017-10-10 22:44:25.885352
NCT02606266|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-08-12|||October 2016||2016-10-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|GANCIMVEAR||Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance|Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance|Not yet recruiting||Phase 2/Phase 3|52|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:44:25.972865|2017-10-10 22:44:25.972865
NCT02606253|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-10-31|||February 2016||2016-02-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure|Comparison of Oral Thiazides vs Intravenous Thiazides vs Tolvaptan in Combination With Loop Diuretics for Diuretic Resistant Decompensated Heart Failure|Enrolling by invitation||Phase 4|60|Anticipated|Vanderbilt University||3|||f||||f||||||||||2017-10-10 22:44:26.075724|2017-10-10 22:44:26.075724
NCT02606240|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-08-05|||March 2016||2016-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Low-Flow CO2 Removal for Mild to Moderate ARDS With PRISMALUNG|Extracorporeal CO2 Removal (ECCO2R) With a Renal Replacement Platform (PRISMALUNG) to Enhance Lung Protective Ventilation in Patients With Mild to Moderate Acute Respiratory Distress Syndrome (ARDS)|Completed||N/A|20|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||f||||||||||2017-10-10 22:44:26.188404|2017-10-10 22:44:26.188404
NCT02606227|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-01-03|||April 2016||2016-04-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|FISCP||Financial Incentive for Smoking Cessation in Pregnancy|Financial Incentive for Smoking Cessation in Pregnancy|Recruiting||N/A|480|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:44:26.286444|2017-10-10 22:44:26.286444
NCT02606214|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-04-05|||November 2015||2015-11-01|April 2016|2016-04-01||||December 2015|Actual|2015-12-01||Interventional|||A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects|A Phase I, Double-Blind, Placebo Controlled, Randomized, Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects|Terminated||Phase 1|18|Actual|Global Alliance for TB Drug Development||7||Clinical Hold from FDA|f||||f||||||||||2017-10-10 22:44:26.395314|2017-10-10 22:44:26.395314
NCT02606201|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-06-19|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|IPSMA||Peri-sphincter Injection of Autologous Myofibres to Treat of Urinary Incontinence by Sphincter Deficiency|Peri-sphincter Injection of Autologous Myofibres to Treat of Urinary Incontinence by Sphincter Deficiency|Recruiting||N/A|42|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 22:44:26.495345|2017-10-10 22:44:26.495345
NCT02606188|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-14|2015-11-14|||November 2015||2015-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Modified HFNC Oxygen in Patients Undergoing Bronchoscopy.|Modified High-flow Nasal Cannula Oxygen in Patients Undergoing Bronchoscopy.|Not yet recruiting||N/A|136|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-10 22:44:26.739911|2017-10-10 22:44:26.739911
NCT02606175|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-11-22|||February 2016||2016-02-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|February 2019|Anticipated|2019-02-01||Interventional|||Medication Knowledge, Medication Adherence and Health Literacy in Patients Who Underwent a Kidney Transplantation.|Medication Knowledge, Medication Adherence and Health Literacy in Patients Who Underwent a Kidney Transplantation.|Recruiting||N/A|60|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||Undecided||2017-10-10 22:44:26.847592|2017-10-10 22:44:26.847592
NCT02606162|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-07-05|||June 2016||2016-06-01|July 2016|2016-07-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Observational|CROSS||Outcomes of Severe Osteoporotic Fractures Hospitalized in France: the CROSS Cohort|Outcomes of Severe Osteoporotic Fractures Hospitalized in France: the CROSS Cohort|Recruiting||N/A|2200|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Whole blood   "|No||2017-10-10 22:44:27.004106|2017-10-10 22:44:27.004106
NCT02606149|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-06-23|||July 2016||2016-07-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|HIPPOCRATE||Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life|Impact of a Truthful Information Concerning Chemotherapy on Chemotherapy Prescription at the End of Life : a Randomized Controlled Study in Non-curable Lung Cancer Patients|Not yet recruiting||N/A|210|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:44:27.110831|2017-10-10 22:44:27.110831
NCT02606136|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-09-11|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|DMD||Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)|Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy|Recruiting||Phase 2|22|Anticipated|FibroGen||1|||f||||t|t|||||||||2017-10-10 22:44:27.225295|2017-10-10 22:44:27.225295
NCT02606123|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-10-02|||October 2015||2015-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer|A Phase 1/2 Open-Label Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral EPI-506 in Patients With Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|166|Anticipated|ESSA Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:44:27.413081|2017-10-10 22:44:27.413081
NCT02606110|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-07-10|||June 2014||2014-06-01|July 2017|2017-07-01||||December 2015|Anticipated|2015-12-01||Observational|||Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer||Withdrawn||N/A|0|Actual|Eastern Regional Medical Center|||1|PI decided no longer to pursue|f||||||||||||||2017-10-10 22:44:27.559808|2017-10-10 22:44:27.559808
NCT02606084|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-09-25|||December 4, 2015|Actual|2015-12-04|September 2017|2017-09-01|November 17, 2017|Anticipated|2017-11-17|November 17, 2017|Anticipated|2017-11-17||Interventional|||A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine|An Open-Label, Single-Dose, Parallel-Group Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine|Recruiting||Phase 1|32|Anticipated|Janssen Research & Development, LLC||4|||f||||f||f||||||||2017-10-10 22:44:27.760741|2017-10-10 22:44:27.760741
NCT02606071|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-09-25|||August 2013||2013-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2016|Actual|2016-09-01|12 Months|Observational [Patient Registry]|IRON-MPP||Italian Registry On Multipoint Left Ventricular Pacing|Italian Registry On Multipoint Left Ventricular|Active, not recruiting||N/A|436|Actual|University of Rome Tor Vergata|||1||f||||f||||||||||2017-10-10 22:44:27.87717|2017-10-10 22:44:27.87717
NCT02606058|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-03-07|||September 2010|Actual|2010-09-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|APTS||The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?|A Randomised Two Arm Open Label Controlled Trial Comparing Standard Immediate Cord Clamping Versus Deferring Cord Clamping for 60 Seconds or More in Babies Born Less Than 30 Weeks of Gestation to Determine Which Cord Clamping Method Results in Improved Survival and Less Disability.|Active, not recruiting||N/A|1637|Actual|University of Sydney||2|||f||||t||||||||||2017-10-10 22:44:27.96383|2017-10-10 22:44:27.96383
NCT02606045|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-21|||August 15, 2018|Anticipated|2018-08-15|August 2017|2017-08-01|August 15, 2022|Anticipated|2022-08-15|August 15, 2022|Anticipated|2022-08-15||Interventional|VWDMin||Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease|Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease: The VWD Minimize Study|Not yet recruiting||Phase 3|60|Anticipated|University of Pittsburgh||2|||f||||t|t|f||||||||2017-10-10 22:44:28.123849|2017-10-10 22:44:28.123849
NCT02606032|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-04-26|||May 2016||2016-05-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|FMT||Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis|Randomized Trial of Antimicrobials Versus Placebo in Addition to Fecal Microbiota Therapy in for the Induction of Remission in Active Ulcerative Colitis|Recruiting||Phase 2|80|Anticipated|Hamilton Health Sciences Corporation||2|||f||||t||||||||No||2017-10-10 22:44:28.218371|2017-10-10 22:44:28.218371
NCT02606019|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||The Use of Biomarkers in Predicting Dengue Outcome|The Use of Biomarkers in Predicting Dengue Outcome|Recruiting||N/A|108|Anticipated|Universiti Tunku Abdul Rahman|||1||f||||f||||||Samples Without DNA|"     Serum/plasma samples   "|||2017-10-10 22:44:28.344673|2017-10-10 22:44:28.344673
NCT02606006|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-12-27|||November 2015||2015-11-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Inpatient Physical Activity Function Through Enhanced Participation Levels in Animal-Assisted Therapy Programs|Inpatient Physical Activity Function Through Enhanced Participation Levels in Animal-Assisted Therapy Programs|Withdrawn||N/A|0|Actual|Aurora Health Care||2||Removing from ClinicalTrials.gov as this is not really a clinical trial.|f||||f||||||||No||2017-10-10 22:44:28.442973|2017-10-10 22:44:28.442973
NCT02605993|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-03-17|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|February 2017|Actual|2017-02-01||Interventional|||A Open-label, Multiple Ascending Dose Study to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria|A Phase 2, Open-label, Multiple Ascending Dose Study to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria|Active, not recruiting||Phase 2|26|Actual|Alexion Pharmaceuticals||4|||f||||t||||||||||2017-10-10 22:44:28.574443|2017-10-10 22:44:28.574443
NCT02605980|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-05-13|||March 2016||2016-03-01|March 2016|2016-03-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Observational|ACUSIT||Acute Effects of Sitting Time in Older Adults|The Acute Effects of Sitting Time on Physiological and Psychological Function in Older Adults|Recruiting||N/A|130|Anticipated|University of Birmingham|||2||f||||f||||||Samples With DNA|"     Saliva and serum from living donors   "|||2017-10-10 22:44:28.723759|2017-10-10 22:44:28.723759
NCT02605967|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-08-21|||April 20, 2016|Actual|2016-04-20|August 2017|2017-08-01|June 28, 2018|Anticipated|2018-06-28|May 1, 2018|Anticipated|2018-05-01||Interventional|||Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma|A Phase II, Open-label, Randomized Controlled Study of PDR001 in Patients With Moderately Differentiated/Undifferentiated Locally Advanced Recurrent or Metastatic Nasopharyngeal Carcinoma Who Progressed on Standard Treatment|Recruiting||Phase 2|114|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 22:44:28.832935|2017-10-10 22:44:28.832935
NCT02605954|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-06-29|||November 18, 2015|Actual|2015-11-18|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 14, 2017|Actual|2017-06-14||Interventional|||Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults|A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Abacavir/Lamivudine (ABC/3TC) Plus a Third Antiretroviral Agent to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adult Subjects|Active, not recruiting||Phase 3|275|Actual|Gilead Sciences||2|||f||||f|t|f||||||||2017-10-10 22:44:28.987143|2017-10-10 22:44:28.987143
NCT02605941|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-11-12|||February 2014||2014-02-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|December 2015|Anticipated|2015-12-01||Observational|||DNA Methylation Biomarkers for Cervical Cancer Screening|DNA Methylation Biomarkers for Cervical Cancer Screening|Recruiting||N/A|5000|Anticipated|iStat Biomedical CO., Ltd.|||1||f||||t||||||Samples With DNA|"     cervical cells   "|||2017-10-10 22:44:29.173067|2017-10-10 22:44:29.173067
NCT02605928|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-02-17|2016-12-23||October 2014||2014-10-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Interventional||Same patient achieved intra-articular injection to one one or to multiple joints|Use of BIP-Needles in Rheumatologic Injections|INJ-INAR-01 Use of BIP-Needles in Rheumatologic Injections|Completed||N/A|79|Actual|Injeq Ltd||1|||f||||||||||||||2017-10-10 22:44:29.260474|2017-10-10 22:44:29.260474
NCT02605915|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-08-01|||December 31, 2015|Actual|2015-12-31|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer|A Phase Ib, Open-Label Study Evaluating the Safety and Pharmacokinetics of Atezolizumab (Anti−PD-L1 Antibody) in Combination With Trastuzumab Emtansine or With Trastuzumab and Pertuzumab (With and Without Docetaxel) in Patients With HER2-Positive Breast Cancer and Atezolizumab With Doxorubicin and Cyclophosphamide in HER2-Negative Breast Cancer|Recruiting||Phase 1|98|Anticipated|Hoffmann-La Roche||10|||f||||f||||||||||2017-10-10 22:44:29.428788|2017-10-10 22:44:29.428788
NCT02605902|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-01-16|||September 2016||2016-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|ONLINE-TICS||Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders|Randomized Observer Blind Clinical Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders|Recruiting||N/A|160|Anticipated|Hannover Medical School||3|||f||||f||||||||No||2017-10-10 22:44:29.604547|2017-10-10 22:44:29.604547
NCT02605889|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2015-11-12|||October 2014||2014-10-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|ACT-DM||Acupuncture in the Complementary Treatment of Diabetes Mellitus Type II|Acupuncture in the Treatment of Diabetes Mellitus Supplemental Type II : Applied Clinical Intervention by Nurses Acupuncturists|Recruiting||N/A|132|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-10 22:44:29.866376|2017-10-10 22:44:29.866376
NCT02605876|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-09-13|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Vibratory Stimuli, A Novel Rehabilitation Method for Preventing Post - Traumatic Knee Osteoarthritis||Recruiting||N/A|75|Anticipated|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-10 22:44:29.964551|2017-10-10 22:44:29.964551
NCT02605863|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-07-18|||January 2016||2016-01-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Enzalutamide for Bladder Cancer Chemoprevention|The Effect of Androgen Deprivation Therapy With Enzalutamide on Bladder Cancer Chemoprevention|Recruiting||Phase 2|50|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 22:44:30.070887|2017-10-10 22:44:30.070887
NCT02605850|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-02-27|||January 2016||2016-01-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|PomPAT||Effects of Phytonutrients on Vascular Health|Effects of Phytonutrients on Vascular Health|Completed||N/A|32|Actual|University of California, Los Angeles||3|||f||||f||||||||No|IPD will not be shared with other researchers.|2017-10-10 22:44:30.171048|2017-10-10 22:44:30.171048
NCT02605837|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-06-27|||November 1, 2015||2015-11-01|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||A Placebo- Controlled Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved|Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study|Recruiting||Phase 3|300|Anticipated|Shire||2|||f||||f||||||||||2017-10-10 22:44:30.291436|2017-10-10 22:44:30.291436
NCT02605824|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-03-10|||March 2016||2016-03-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|CONA||Clinical Trial of NAC in Asthma|Clinical Trial of NAC in Asthma|Recruiting||Phase 4|20|Anticipated|University of California, San Francisco||2|||f||||t|t|f||||||||2017-10-10 22:44:30.740042|2017-10-10 22:44:30.740042
NCT02605811|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-03-01|||September 2015||2015-09-01|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer|Radiation Versus Temozolomide in Preventing Brain Metastases in Limited Stage Small Cell Lung Cancer|Enrolling by invitation||Phase 2|426|Anticipated|Guangzhou Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:44:30.865362|2017-10-10 22:44:30.865362
NCT02605798|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-12|||August 2015||2015-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom)|Comparative Open-label,Randomized, Fasting, Three Way Three Sequence Two Treatment Partial Replicate Crossover Bioequivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom)|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||3|||f||||f||||||||||2017-10-10 22:44:30.970417|2017-10-10 22:44:30.970417
NCT02605772|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-16|||December 2015||2015-12-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes|A Randomized, Non-inferiority, Open-label Clinical Trial to Evaluate the Safety and Efficacy of GAcarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes in Chinese|Not yet recruiting||Phase 4|100|Anticipated|Fifth Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 22:44:31.162799|2017-10-10 22:44:31.162799
NCT02605759|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-13|2017-02-02|||March 2016||2016-03-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Coldplay Cryoablation of Dysplastic Squamous Tissue in Patients With Esophageal Squamous Cell Dysplasia|Clinical Study to Evaluate the Safety, Feasibility and Efficacy of the Coldplay CryoBalloon Focal Ablation System for the Cryoablation of Dysplastic Squamous Tissue in Patients With Esophageal Squamous Cell Dysplasia|Recruiting||N/A|100|Anticipated|C2 Therapeutics, Inc.||1|||f||||f||||||||No||2017-10-10 22:44:31.249135|2017-10-10 22:44:31.249135
NCT02605746|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-12-12|||November 2015||2015-11-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis|A Phase 0/II Study of Ceritinib (LDK378) in Preoperative Glioblastoma Multiforme (GBM) and CNS Metastasis Patients Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration|Recruiting||Early Phase 1|48|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||3|||f||||f||||||||||2017-10-10 22:44:31.334898|2017-10-10 22:44:31.334898
NCT02605720|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-03-02|||September 2015||2015-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|ECG-Lihir||Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns|Electrocardiographic Safety Evaluation of Monthly Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns to Block Malaria Transmission|Completed||Phase 3|78|Actual|Lihir Medical Centre||1|||f||||t||||||||||2017-10-10 22:44:31.5428|2017-10-10 22:44:31.5428
NCT02605707|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-12|||November 2014||2014-11-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke|Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke|Recruiting||Phase 1/Phase 2|30|Anticipated|Southern Medical University, China||2|||f||||f||||||||||2017-10-10 22:44:31.63381|2017-10-10 22:44:31.63381
NCT02605694|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-07-28|||December 2015||2015-12-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO)|A Phase 2, Randomized Study of Duvelisib Administered in Combination With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO)|Withdrawn||Phase 2|0|Actual|Verastem, Inc.||2||Sponsor is focusing on studies which can enable registration of duvelisib|f||||t||||||||||2017-10-10 22:44:31.733248|2017-10-10 22:44:31.733248
NCT02605681|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-17|||December 2015||2015-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|28 Days|Observational [Patient Registry]|||Midkine and ACE-Ang II Induced Endothelial Injury in Sepsis|Relationship of Midkine and ACE-Ang II Induced Endothelial Injury in Sepsis|Enrolling by invitation||N/A|120|Anticipated|Southeast University, China|||2||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 22:44:31.844837|2017-10-10 22:44:31.844837
NCT02605668|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-08-02|||January 2016||2016-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Interventional|PROTECT-AD||Providing Tools for Effective Care and Treatment of Anxiety Disorders|Providing Tools for Effective Care and Treatment of Anxiety Disorders (AD): Outcomes, Mediators and Moderators of Enhanced Extinction|Recruiting||N/A|620|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-10 22:44:31.919739|2017-10-10 22:44:31.919739
NCT02605655|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-01-05|||June 2014||2014-06-01|November 2014|2014-11-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome|Phase 0 Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome|Completed||Early Phase 1|60|Actual|Shanghai University of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-10 22:44:32.047566|2017-10-10 22:44:32.047566
NCT02605642|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-03|||September 10, 2015|Actual|2015-09-10|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|PERSIST||Post-Marketing Use Of Inflectra (Infliximab) For Standard Of Care Treatment Of Rheumatoid Disease Who Are Naïve To Biologics Or Switched From Remicade™|Persist: Prospective Observational Cohort Study To Assess Persistence Of Inflectra(tm) (Infliximab) In Patients With Rheumatoid Diseases Who Are Either Naive To Biologics Or Switched From Stable Remicade(tm) (Infliximab)|Active, not recruiting||N/A|337|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 22:44:32.139502|2017-10-10 22:44:32.139502
NCT02605629|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-12-06|||January 2016||2016-01-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|VOLUME||EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors|EValuation of the Impact of a TOpical Lotion, CG428, on Permanent Chemotherapy Induced Hair and Scalp Disorders in Cancer SUrvivors: A randoMized, Single-center, Double-blind placEbo Controlled Trial (a Pilot Study)|Active, not recruiting||N/A|32|Anticipated|Samsung Medical Center||2|||f||||f||||||||Undecided||2017-10-10 22:44:32.346052|2017-10-10 22:44:32.346052
NCT02605616|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-01-05|||November 2015||2015-11-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)|A Randomized, Double-Blinded, Placebo-controlled Phase IIa Study to Assess the Efficacy and Safety of a Novel AstraZeneca Compound in Subjects With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)|Recruiting||Phase 2|100|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 22:44:32.449586|2017-10-10 22:44:32.449586
NCT02605603|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-09-28|||May 2015||2015-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|||SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease|Effect of Two Different Therapeutic Interventions: SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease|Recruiting||N/A|30|Anticipated|Lysosomal and Rare Disorders Research and Treatment Center, Inc.|||1||f||||f||||||||Undecided||2017-10-10 22:44:32.545566|2017-10-10 22:44:32.545566
NCT02605590|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-05-16|||December 2015||2015-12-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety, Tolerability and Pharmacokinetics Study of AIR DNAse Administered by Inhalation to Healthy Adult Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose and Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AIR-DNase When Administered by Inhalation to Healthy Adult Subjects|Completed||Phase 1|18|Actual|Protalix||4|||f||||f||||||||||2017-10-10 22:44:32.63617|2017-10-10 22:44:32.63617
NCT02605577|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-12-30|||January 2016||2016-01-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|NLP||Research of Systemic Management for Late Preterm Infants Nutrition in China|Research of Systemic Management for Late Preterm Infants Nutrition in China|Enrolling by invitation||N/A|2000|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 22:44:32.731378|2017-10-10 22:44:32.731378
NCT02605564|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-02-22|||March 2015||2015-03-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Effects of Gluten Free Diet on Type 1 Diabetes Mellitus in Children|Effect of a Gluten Free Diet on Ameliorating New Onset Type 1 Diabetes Mellitus in Children and Adolescents|Enrolling by invitation||N/A|60|Anticipated|Loma Linda University||2|||f||||f||||||||||2017-10-10 22:44:32.830849|2017-10-10 22:44:32.830849
NCT02605525|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-02-02|||December 2015||2015-12-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Efficacy and Safety of SM101 in the Treatment of IgA Nephropathy|A Phase 2 Study to Assess the Efficacy and Safety of Intravenous Infusion With Human Soluble Recombinant Fc-gamma Receptor IIB (SM101/BAX 1810) in Subjects With Immunoglobulin A Nephropathy (IgAN)|Withdrawn||Phase 2|0|Actual|Baxalta US Inc.||3|||f||||t||||||||||2017-10-10 22:44:33.094323|2017-10-10 22:44:33.094323
NCT02605512|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-03-01|||October 2015||2015-10-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|BACCARAT||BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study|Early Detection and Prediction of Cardiotoxicity in Radiotherapy-treated Breast Cancer Patients|Recruiting||N/A|120|Anticipated|Institut de Radioprotection et de Surete Nucleaire||1|||f||||f||||||||||2017-10-10 22:44:33.178077|2017-10-10 22:44:33.178077
NCT02605499|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-12|||November 2015||2015-11-01|November 2015|2015-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|UVCLEAR-MDRO||Ultra Violet-C Light Evaluation as an Adjunct to Removing Multi-Drug Resistant Organisms (UVCLEAR-MDRO)|Ultra Violet-C Light Evaluation as an Adjunct to Removing Multi-Drug Resistant Organisms (UVCLEAR-MDRO)|Enrolling by invitation||N/A|11000|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 22:44:33.27212|2017-10-10 22:44:33.27212
NCT02605473|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-13|||September 2008||2008-09-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Parallel Trial of Decitabine and Peg-Interferon in Melanoma: Phase II Portion|A Parallel Phase I/II Study of Low Dose Decitabine (5-Aza-Deoxycytidine) With Peginterferon Alfa-2b in Advanced Melanoma|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||"Study terminated following Phase I NCT00791271, no progression to Phase II due to toxicity and   lack of efficacy."|f||||t||||||||||2017-10-10 22:44:33.459323|2017-10-10 22:44:33.459323
NCT02605460|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-09-13|||February 2014||2014-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission|Chemo Sensitization Before Hematopoietic Stem Cell Transplantation With a CXCR4 Antagonist in Patients With Acute Leukemia in Complete Remission: Pilot Study|Recruiting||Phase 2|20|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||1|||f||||f||||||||||2017-10-10 22:44:33.561561|2017-10-10 22:44:33.561561
NCT02605447|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-10-01|||January 2016||2016-01-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||EVOLVE Short DAPT Study|A Prospective, Multicenter, Single-arm Study Designed to Assess the Safety of 3-month Dual Antiplatelet Therapy (DAPT) in Subjects at High Risk for Bleeding Undergoing Percutaneous Coronary Intervention (PCI) With the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System|Recruiting||Phase 4|2000|Anticipated|Boston Scientific Corporation||1|||f||||t||||||||||2017-10-10 22:44:33.888325|2017-10-10 22:44:33.888325
NCT02605434|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-15|||March 2016||2016-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Accordance||A Study to Assess the Efficacy and Safety of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients|Phase 3 Multicenter Randomized Double-Blind, Double-dummy, Active-Controlled Study Comparing Efficacy/Safety of Gastric-retentive, Controlled-release Accordion Pill Carbidopa/Levodopa to Immediate Release in Fluctuating Parkinson's Patients|Recruiting||Phase 3|328|Anticipated|Intec Pharma Ltd.||2|||f||||t||||||||||2017-10-10 22:44:34.509652|2017-10-10 22:44:34.509652
NCT02605421|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-10-04|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma|Tandem Myeloablative Consolidation Therapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma|Recruiting||Phase 2|12|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f|||f|||||2017-10-10 22:44:34.990506|2017-10-10 22:44:34.990506
NCT02605408|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-04-26|||April 2016||2016-04-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Cataract Surgery in Indian Patients With or Without LenSx® Laser|A Phaco ± LenSx® Procedure Patients Registry in Indian Tertiary Medical Centers|Withdrawn||N/A|0|Actual|Alcon Research|||1|Management Decision|f||||f||||||||||2017-10-10 22:44:35.118845|2017-10-10 22:44:35.118845
NCT02605382|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-11-12|||October 2012||2012-10-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis|Efficacy of 0.12% Chlorhexidine Gluconate for Non-surgical Treatment of Peri-implant Mucositis|Completed||Phase 2|37|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||||2017-10-10 22:44:35.338156|2017-10-10 22:44:35.338156
NCT02605369|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-15|||June 2016||2016-06-01|November 2015|2015-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||SURVIVAL PLUSS: Increasing Capacity for Mama-baby Survival in Post-conflict Uganda and South Sudan|SURVIVAL PLUSS: Increasing Capacity for Mama-baby Survival in Post-conflict Uganda and South Sudan|Not yet recruiting||Phase 4|1800|Anticipated|Makerere University||2|||f||||t||||||||||2017-10-10 22:44:35.435937|2017-10-10 22:44:35.435937
NCT02605356|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-10-06|||October 2016||2016-10-01|September 2016|2016-09-01|July 2021|Anticipated|2021-07-01|November 2019|Anticipated|2019-11-01||Interventional|||Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma|A Phase 1b/2 Trial to Evaluate the Safety and Efficacy of Radium-223 Dichloride (BAY88-8223) in Combination With Bortezomib and Dexamethasone in Early Relapsed Multiple Myeloma|Withdrawn||Phase 1/Phase 2|0|Actual|Bayer||5||Study restarted under new study number 18987|f||||t||||||||||2017-10-10 22:44:35.534854|2017-10-10 22:44:35.534854
NCT02605343|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-06-02|||August 2015||2015-08-01|November 2015|2015-11-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Observational|||Prospective Observational Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Patients Undergoing Elective Surgical Procedures|Prospective Observational Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Patients Undergoing Elective Surgical Procedures Compared to Historical Data|Completed||N/A|110|Actual|AltheaDx|||2||f||||f||||||||No||2017-10-10 22:44:35.765689|2017-10-10 22:44:35.765689
NCT02605330|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-09-15|||November 2015||2015-11-01|September 2017|2017-09-01|September 14, 2017|Actual|2017-09-14|November 2016|Actual|2016-11-01||Observational|||Kinetics of Plasma Fibrinogen in Cardiac Surgery|Kinetics of Plasma Fibrinogen During Cardiac and Thoracic Aortic Surgery|Completed||N/A|26|Actual|University Hospital Inselspital, Berne|||3||f||||f||||||Samples With DNA|"     Whole blood containing all components   "|||2017-10-10 22:44:35.854911|2017-10-10 22:44:35.854911
NCT02605317|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-01-13|||January 2014||2014-01-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|whatsapp||Use of WhatsApp for Communication Between Consulting Physicians and the Emergency Physicians|Use of whatsApp Messenger (a Messaging Program for Smart Phones) in Communication Between Consulting Physicians and the Emergency Physicians: A Retrospective Observational Study|Completed||N/A|500|Actual|Adiyaman University Research Hospital|||1||f||||f||||||||||2017-10-10 22:44:35.924682|2017-10-10 22:44:35.924682
NCT02605291|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-10-25|||January 2016||2016-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Dietary Macronutrient Manipulation and Substrate Oxidation During Exercise|The Effect of Dietary Macronutrient Manipulation and Glycogen Depleting Exercise on Substrate Oxidation at Rest and During Exercise|Active, not recruiting||N/A|13|Actual|University of Birmingham||3|||f||||f||||||||||2017-10-10 22:44:36.107535|2017-10-10 22:44:36.107535
NCT02605278|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-11-13|||January 2015||2015-01-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|DROP||Multicomponent Program for the Integrated Management of Chronic Pain and Depression in Primary Care|Assessment of a Multicomponent Program for the Integrated Management of Chronic Pain and Depression in Primary Care. Cluster Randomized Clinical Trial|Recruiting||N/A|330|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-10 22:44:36.213745|2017-10-10 22:44:36.213745
NCT02605265|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-12-05|||October 2015||2015-10-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|CinClare||Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1|A Randomized Phase III Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer|Recruiting||Phase 3|360|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 22:44:36.321008|2017-10-10 22:44:36.321008
NCT02605252|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-09-19|||March 2016||2016-03-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||New Strategy Study of Functional Cure of Chronic Hepatitis B|A Study on Optimizing HBsAg Clearance in CHB Patients With Sequential Treatment of Pegylated Interferon Alpha-2b and Nucleoside Analogues|Recruiting||N/A|120|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||1|||f||||f||||||||No||2017-10-10 22:44:36.425284|2017-10-10 22:44:36.425284
NCT02605239|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-12|||March 2013||2013-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|December 2013|Actual|2013-12-01||Interventional|PSYBLE||Phycosocial Impact of Bleaching Teeth|Effect on Oral Health, Phycosocial Impact and Esthetics Perception of Bleaching Teeth|Completed||N/A|58|Actual|University of Chile||1|||f||||t||||||||||2017-10-10 22:44:36.505142|2017-10-10 22:44:36.505142
NCT02605226|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-06-09|||November 2015||2015-11-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CRYO-PCA-III||Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer|A Prospective Multi-center Study to Compare the QOL and Efficacy of External Beam Radiation Therapy or Cryoablation Therapy for Stage III Prostate Cancer|Recruiting||N/A|240|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||No||2017-10-10 22:44:36.618367|2017-10-10 22:44:36.618367
NCT02605213|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2015-11-11|||September 2015||2015-09-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients|Evaluation of Effectiveness and Safety of Oral Vancomycin in Treatment of Primary Sclerosing Cholangitis.|Recruiting||Phase 4|30|Anticipated|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:44:36.735186|2017-10-10 22:44:36.735186
NCT02605200|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-11-14|||August 2015||2015-08-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Identification and Treatment of Diabetes In Solid Organ Transplant Recipients|Identification and Treatment of Diabetes In Solid Organ Transplant Recipients|Enrolling by invitation||N/A|500|Anticipated|Emory University||1|||f||||f||||||||||2017-10-10 22:44:36.84326|2017-10-10 22:44:36.84326
NCT02605187|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-10-03|||November 2015|Actual|2015-11-01|October 2017|2017-10-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Interventional|||Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management|Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management|Completed||N/A|160|Actual|Stanford University||4|||f||||t||||||||||2017-10-10 22:44:36.956274|2017-10-10 22:44:36.956274
NCT02605174|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-04-10|||May 2016||2016-05-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|SPARTAN||Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine|A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)|Active, not recruiting||Phase 3|3007|Actual|CoLucid Pharmaceuticals||4|||f||||f||||||||||2017-10-10 22:44:37.131044|2017-10-10 22:44:37.131044
NCT02605161|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-12|||November 2015||2015-11-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Observational|||Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease|Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease|Not yet recruiting||N/A|10|Anticipated|Ottawa Hospital Research Institute|||2||f||||f||||||||||2017-10-10 22:44:39.155763|2017-10-10 22:44:39.155763
NCT02605148|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-03-07|||December 2015||2015-12-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|TEFA||TEFA Family Prevention: Glutenfree Diet to Preserve Beta-cell Function|TEFA TEDDY Family Prevention - Gluten Free Diet to Preserve Beta-cell Function in Subjects With Islet Autoimmunity.|Enrolling by invitation||N/A|60|Anticipated|Lund University||2|||f||||f||||||||Undecided||2017-10-10 22:44:39.244822|2017-10-10 22:44:39.244822
NCT02605135|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-07-21|||April 2016||2016-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Host Response to Pessaries in Microbial Communities of the Postmenopausal Vagina|Host Response to Pessaries in Microbial Communities of the Postmenopausal|Recruiting||N/A|75|Anticipated|Loyola University|||2||f||||f||||||Samples Without DNA|"     Testing will consists of a vaginal swab (AIM 1) and 10 mL of vaginal lavage at each study     visit.   "|||2017-10-10 22:44:39.346305|2017-10-10 22:44:39.346305
NCT02605122|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-09-06|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial Pneumonia|A Phase 2/3, Randomized, Open-Label, Multi-center Study to Determine the Safety and Efficacy of Solithromycin in Adolescents (12 to 17 Years of Age, Inclusive) and Children (≥2 Months to <12 Years of Age) With Suspected or Confirmed Community-Acquired Bacterial Pneumonia|Recruiting||Phase 2/Phase 3|400|Anticipated|Cempra Inc||2|||f||||t|t|f||||||||2017-10-10 22:44:39.451231|2017-10-10 22:44:39.451231
NCT02605109|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-08-30|||June 2015||2015-06-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|MKU||Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)|Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV) and Infection Control Experiences in a Medical Institution of South Korea|Completed||N/A|200|Actual|Konkuk University Medical Center|||1||f||||t||||||||Undecided||2017-10-10 22:44:39.65452|2017-10-10 22:44:39.65452
NCT02605096|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-07|||November 1, 2015|Actual|2015-11-01|August 2017|2017-08-01|April 1, 2016|Actual|2016-04-01|April 1, 2016|Actual|2016-04-01||Interventional|||Pilot Study to Test the Feasibility of the Use of MRI in Suspected Scaphoid Fractures|A Single Centre Randomised, Non-blinded, Prospective Pilot to Test the Feasibility Associated With the Use of MRI as the Initial Imaging Modality in the Investigation of Patients Presenting With Suspected Scaphoid Fracture|Terminated||Phase 3|10|Actual|Guy's and St Thomas' NHS Foundation Trust||2||"Recruitment strategy not working. This information was really useful to design a randomised   controlled trial."|f||||f||||||||||2017-10-10 22:44:39.861374|2017-10-10 22:44:39.861374
NCT02605083|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-06-26|||November 2015||2015-11-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors|A Phase 1-2 Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|120|Anticipated|Effector Therapeutics||1|||f||||f||||||||||2017-10-10 22:44:39.961146|2017-10-10 22:44:39.961146
NCT02605070|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-06-09|||November 2015||2015-11-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia|Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia|Terminated||Phase 3|30|Actual|Instituto de Investigacion Sanitaria La Fe||2||UNDER RECRUITMENT|f||||f||||||||||2017-10-10 22:44:40.137859|2017-10-10 22:44:40.137859
NCT02605057|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-05-08|||November 2015||2015-11-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Dermatopharmacokinetic Trial of LEO 80185 Gel|Dermatopharmacokinetic Trial of LEO 80185 Gel|Completed||Phase 1|32|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:44:40.253075|2017-10-10 22:44:40.253075
NCT02605044|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-13|||January 2014||2014-01-01|November 2015|2015-11-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Study to Compare the Efficacy and Safety of Masitinib in Combination With FOLFIRI to Placebo in Combination With FOLFIRI in Second Line Treatment of Patients With Metastatic Colorectal Cancer|A Prospective, Multicenter, Randomized, Double Blind, Placebo-controlled, 2-parallel Groups, Phase 3 Study to Compare the Efficacy and Safety of Masitinib in Combination With FOLFIRI (Irinotecan, 5-fluorouracil and Folinic Acid) to Placebo in Combination With FOLFIRI in Second Line Treatment of Patients With Metastatic Colorectal Cancer|Recruiting||Phase 3|550|Anticipated|AB Science||2|||f||||||||||||||2017-10-10 22:44:40.338699|2017-10-10 22:44:40.338699
NCT02605005|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-11-11|||December 2013||2013-12-01|November 2015|2015-11-01||||January 2015|Actual|2015-01-01||Observational|||The Impact of a Beach Chair Position During Shoulder Arthroscopy on Regional Cerebral Oxygen Saturation : Comparison of Interscalene Block and General Anesthesia||Completed||N/A|60|Actual|Osijek University Hospital|||2||f||||f||||||||||2017-10-10 22:44:40.44957|2017-10-10 22:44:40.44957
NCT02604992|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2016-01-18|||November 2015||2015-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers|An Open-Label, Randomized, Single-Dose, Two-Period, Two-Way Crossover Comparative Bioavailability Study of Dronabinol Oral Solution, 4.25 mg to Marinol Capsule, 5 mg in Healthy Volunteers Under Fed Conditions|Completed||N/A|54|Actual|INSYS Therapeutics Inc||6|||f||||t||||||||||2017-10-10 22:44:40.540135|2017-10-10 22:44:40.540135
NCT02604979|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-01-24|||September 23, 2015|Actual|2015-09-23|January 2017|2017-01-01|February 6, 2016|Actual|2016-02-06|February 6, 2016|Actual|2016-02-06||Observational|||The Influences of Long Periods of Pneumoperitoneum and Head up Position on the Variation of Heart-rate Corrected QT Interval During Robotic-assisted Laparoscopic Gastrectomy - Observational Study||Completed||N/A|30|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 22:44:40.655981|2017-10-10 22:44:40.655981
NCT02604966|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-24|2015-12-18|||April 2015||2015-04-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||P. Falciparum Resistance to Artemisinin in Vietnam|Efficacy of Artesunate Monotherapy and Dihydroartemisinin - Piperaquine in Patients With Uncomplicated Falciparum Malaria in Central Vietnam|Unknown status|Recruiting|Phase 4|120|Anticipated|National Institute of Malariology, Parasitology and Entomology, Vietnam||2|||f||||f||||||||||2017-10-10 22:44:40.746586|2017-10-10 22:44:40.746586
NCT02604953|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-11-02|||July 2014||2014-07-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||"Comparing SD-tVEP and PERG Tests Between Patients With Glaucoma, Patients With High Eye Pressure and Normal Patients"|1-Year Prospective Study: SD-tVEP and PERG for Early Detection of Retinal Ganglion Cell Dysfunction in Ocular Hypertension Patients|Completed||Phase 4|90|Actual|Wills Eye||3|||f||||f||||||||Yes|Data has been presented at the American Glaucoma Society in March 2015 and manuscript will be submitted for publication in 2017.|2017-10-10 22:44:40.870675|2017-10-10 22:44:40.870675
NCT02604940|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-11-11|||August 2014||2014-08-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Evaluation of Dexmedetomidine on Post-operative Narcotic Requirements and Pain Scores in Bariatric Patients|Evaluation of a Single Intra-operative Dose of Dexmedetomidine on Post-operative Narcotic Requirements and Pain Scores in Bariatric Surgery Patients|Recruiting||Phase 4|100|Anticipated|West Virginia University||2|||f||||t||||||||||2017-10-10 22:44:40.974335|2017-10-10 22:44:40.974335
NCT02604927|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-11-11|||February 2016||2016-02-01|November 2015|2015-11-01|September 2017|Anticipated|2017-09-01|November 2016|Anticipated|2016-11-01||Interventional|||Beta-alanine Supplementation and Its Effects on Performance, Muscle Carnosine Content and Safety in Athletes With Spinal-cord Injury||Not yet recruiting||N/A|20|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:44:41.090389|2017-10-10 22:44:41.090389
NCT02604914|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-05-24|||June 2015||2015-06-01|September 2015|2015-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects|1) To Identify the Concentration of CD That Provides Optimal Bioavailability of a Concomitant Fixed Concentration of LD Infused SC Continuously; 2) To Compare the Bioavailability of the Optimal LD/CD Solution to That of LD/CD Intestinal Gel|Completed||Phase 1|36|Actual|NeuroDerm Ltd.||3|||f||||f||||||||||2017-10-10 22:44:41.16978|2017-10-10 22:44:41.16978
NCT02604901|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-11|||June 2012||2012-06-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ECO-PHIL||Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications|Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications|Completed||N/A|1091|Actual|University of Pittsburgh||4|||f||||f||||||||||2017-10-10 22:44:41.254049|2017-10-10 22:44:41.254049
NCT02604888|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-01-03|||October 2015||2015-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|MEXISAREATA||Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females||Recruiting||N/A|20|Anticipated|Mexis George||1|||f||||t||||||||Yes||2017-10-10 22:44:41.364196|2017-10-10 22:44:41.364196
NCT02604875|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-08-12|||November 2015||2015-11-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|Co-Rhythm||The Circadian Rhythm of Copeptin|The Circadian Rhythm of Copeptin|Completed||N/A|18|Actual|University Hospital, Basel, Switzerland|||1||f||||t||||||||No||2017-10-10 22:44:41.446688|2017-10-10 22:44:41.446688
NCT02604862|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-05-02|||May 2016||2016-05-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|FIB ONE||Imaging FIB ONE in the Human Lung Using Endomicroscopy|Exploratory Clinical Study to Image the Intrapulmonary Microdosing of FIBroproliferation ONE (FIB ONE) Using Endomicroscopy|Recruiting||Early Phase 1|18|Anticipated|University of Edinburgh||1|||f||||t||||||||No||2017-10-10 22:44:41.522234|2017-10-10 22:44:41.522234
NCT02604849|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2015-11-12|||July 2012||2012-07-01|November 2015|2015-11-01|November 2015||2015-11-01|July 2015|Actual|2015-07-01||Observational|||Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin||Completed||N/A|44|Actual|Maimónides Biomedical Research Institute of Córdoba|||2||f||||f||||||||||2017-10-10 22:44:41.744531|2017-10-10 22:44:41.744531
NCT02604836|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-11-01|||June 2004||2004-06-01|November 2016|2016-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia|A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate|Completed||Phase 4|1711|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:44:41.841301|2017-10-10 22:44:41.841301
NCT02604823|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-11-01|||November 2003||2003-11-01|November 2016|2016-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)|Efficacy and Safety of Peginterferon Alfa-2a (40 KD) (Pegasys®) in Patients With HBeAg-Positive Chronic Hepatitis B|Completed||Phase 4|307|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:44:42.235957|2017-10-10 22:44:42.235957
NCT02604810|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-07-10|||December 2015||2015-12-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency|An Open-label, Multi-center Study to Evaluate the Safety and Pharmacokinetics of IGSC 20% Administered for 6 Months in Subjects With Primary Immunodeficiency|Recruiting||Phase 3|50|Anticipated|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-10-10 22:44:42.326718|2017-10-10 22:44:42.326718
NCT02604797|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-11-11|||January 2016||2016-01-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Analgesia Effects of Nalbuphine vs Sulfentanil|Analgesia Effects of Nalbuphine vs Sulfentanil in Patient-controlled Intravenous Analgesia After Cesarean Section|Not yet recruiting||N/A|80|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 22:44:42.465732|2017-10-10 22:44:42.465732
NCT02604784|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-09-01|||October 2015||2015-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PI-CaP||Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors|Feasibility, Efficacy and Safety of Pressurized IntraPeritoneal Air-flow Chemotherapy (PIPAC) With Oxaliplatin, Cisplatin and Doxorubicin in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancers and Primary Tumors of the Peritoneum: An Open-label, Single-arm, Phase II Clinical Trial PI-CaP|Recruiting||Phase 2|63|Anticipated|Fondazione del Piemonte per l'Oncologia||1|||f||||f||||||||||2017-10-10 22:44:42.547314|2017-10-10 22:44:42.547314
NCT02604745|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-09-22|||March 2016||2016-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|DMR||Degenerative Mitral Regurgitation in Intermediate Risk Patients|Degenerative Mitral Regurgitation in Intermediate Risk Patients 65 or Older: Exercise Echocardiogram and HRQOL Post Surgery Preliminary Analysis|Recruiting||N/A|20|Anticipated|Northwestern University|||1||f||||f||||||||||2017-10-10 22:44:42.793481|2017-10-10 22:44:42.793481
NCT02604732|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2015-11-10|||December 2015||2015-12-01|November 2015|2015-11-01||||August 2016|Anticipated|2016-08-01||Interventional|||Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair|Randomized Controlled Trial on Pre-operative Withdrawal Versus no Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair|Not yet recruiting||N/A|100|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-10 22:44:42.871105|2017-10-10 22:44:42.871105
NCT02604719|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2015-11-27|||November 2015||2015-11-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH|Tranexamic Acid and Ethamsylate For Preventing Post Partum Hemorrhage in Patient Undergoing LSCS at High Risk For Post PartumHemorrhage : A Randomized Controlled Trial|Not yet recruiting||Phase 1/Phase 2|64|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:44:42.946173|2017-10-10 22:44:42.946173
NCT02604706|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2015-11-13|||October 2010||2010-10-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Auricular Acupuncture in Substance Abuse: Effects on Anxiety, Sleep, Drug Use.|RCT of Auricular Acupuncture in Substance Abuse: Effects on Anxiety, Sleep, Drug Use and Use of Addiction Treatment Services. A Randomized Controlled Study|Completed||Phase 2|280|Actual|Örebro Läns Landsting||3|||f||||f||||||||||2017-10-10 22:44:43.015323|2017-10-10 22:44:43.015323
NCT02604693|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-09-20|||December 2014||2014-12-01|September 2016|2016-09-01||||January 2019|Anticipated|2019-01-01||Observational|||Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)||Recruiting||N/A|150|Anticipated|National Jewish Health|||3||f||||f||||||||||2017-10-10 22:44:43.091163|2017-10-10 22:44:43.091163
NCT02604680|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-12|2017-07-27||2017-07-25|October 2015||2015-10-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris|A Randomized, Controlled Evaluation of the Safety and Efficacy of Topical Treatments for Moderate-Severe Facial Acne Vulgaris|Completed||Phase 2|509|Actual|Braintree Laboratories||5|||f||||f||||||||||2017-10-10 22:44:43.172203|2017-10-10 22:44:43.172203
NCT02604667|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-01-18|||November 2015||2015-11-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|MOST-CA||Mechanisms of Ischemic Stroke in Cancer Patients|Mechanisms of Ischemic Stroke in Cancer Patients|Recruiting||N/A|165|Anticipated|Weill Medical College of Cornell University|||3||f||||f||||||Samples Without DNA|"     Blood samples   "|No||2017-10-10 22:44:43.335317|2017-10-10 22:44:43.335317
NCT02604654|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-20|||November 2015||2015-11-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Effectiveness and Safety of Yiqitongluo Granule for Stroke|Phase IV Clinical Trial of Yiqitongluo Granule in the Treatment of Stroke With Qi-deficiency and Blood-stasis Syndrome|Enrolling by invitation||Phase 4|2400|Anticipated|First Hospital of Jilin University||1|||f||||t||||||||||2017-10-10 22:44:43.536992|2017-10-10 22:44:43.536992
NCT02604641|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-03-07|||October 2014||2014-10-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Assessment of the Impact of a Coenzyme Q10 Supplementation on the Skin|Assessment of the Impact of a Coenzyme Q10 Supplementation on the Skin: Randomised, Double-blind, Placebo-controlled Pilot Study|Completed||N/A|33|Actual|Higher School of Applied Sciences (VIST)||3|||f||||f||||||||||2017-10-10 22:44:43.61308|2017-10-10 22:44:43.61308
NCT02604628|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-02-07|||November 2015||2015-11-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CAP-PACT||Increasing Community-acquired Pneumonia Protocol Adherence by Antibiotic Stewardship|Community-acquired Pneumonia: Increasing Protocol Adherence by Antibiotic Stewardship in a Stepped Wedge Cluster- Randomized Trial|Recruiting||N/A|5400|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-10 22:44:43.714335|2017-10-10 22:44:43.714335
NCT02604615|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-07-02|||October 2014||2014-10-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|DCOECRT||The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy|Two Cycles Versus Four Cycles of Capecitabine Combined Oxaliplatin Concurrent Radiotherapy as First-line Therapy for Chinese Locally Advanced Esophageal Squamous Cell Carcinomas, an Open Randomised Phase III Cilinical Trial|Recruiting||Phase 3|60|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology||2|||f||||t||||||||Undecided||2017-10-10 22:44:43.869633|2017-10-10 22:44:43.869633
NCT02604602|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01|2 Weeks|Observational [Patient Registry]|||Coagulation Factors and Postpartum Hemorrhage|Peripartal Concentration of Coagulation Factors and Postpartum Hemorrhage|Recruiting||N/A|1100|Anticipated|University of Zurich|||2||f||||f||||||||||2017-10-10 22:44:44.007513|2017-10-10 22:44:44.007513
NCT02604589|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-04-03|2017-01-19||March 2016||2016-03-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Continuous Intercostal Nerve Blockade for Traumatic Rib Fractures|"Prime Rib Time: Randomized Control Trial Evaluating the Use of Continuous Intercostal Nerve Blockade for Traumatic Rib Fractures"|Terminated||N/A|10|Actual|William Beaumont Hospitals|Study terminated early due to lack of enrollment.|3||resource reallocation|f||||t||||||||No||2017-10-10 22:44:44.086419|2017-10-10 22:44:44.086419
NCT02604576|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-07-27|||December 2016||2016-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia|Efficacy of Fixed-dose Combination of Bromopride and Simethicone Versus Isolated Bromopride in Participants With Functional Dyspepsia.|Recruiting||Phase 3|330|Anticipated|EMS||2|||f||||f||||||||||2017-10-10 22:44:44.603115|2017-10-10 22:44:44.603115
NCT02604563|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-06-22|||March 10, 2016|Actual|2016-03-10|June 2017|2017-06-01|November 30, 2025|Anticipated|2025-11-30|November 30, 2025|Anticipated|2025-11-30||Observational|||Aging, Geriatric Syndromes and Clonal Hematopoiesis|Aging, Geriatric Syndromes and Clonal Hematopoiesis|Recruiting||N/A|175|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||Samples With DNA|"     -  Peripheral blood        -  Buccal swab or tongue brushing   "|No||2017-10-10 22:44:44.744885|2017-10-10 22:44:44.744885
NCT02604550|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-04-21|2017-04-21||November 2015||2015-11-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||All participants who consented to take part in the trial and received the intervention of the study arm they were randomized to.|Anterior Cruciate Ligament Pain Study|Comparison Between Femoral Nerve Block and Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial|Completed||Phase 4|115|Actual|Emory University|Data collection with a paper journal was low, resulting in the study switching to a smartphone application for participant record keeping. The data analyses include participants who enrolled after the smartphone application became available.|2|||f||||f||||||||||2017-10-10 22:44:44.862162|2017-10-10 22:44:44.862162
NCT02604524|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-07-15|||January 2016||2016-01-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp|Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp|Completed||N/A|32|Actual|University of Virginia||2|||f||||f||||||||Yes|undetermined|2017-10-10 22:44:45.562296|2017-10-10 22:44:45.562296
NCT02604511|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-06-22|||January 2016||2016-01-01|June 2017|2017-06-01|February 2023|Anticipated|2023-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing|Phase II Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing|Active, not recruiting||Phase 2|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 22:44:45.644187|2017-10-10 22:44:45.644187
NCT02604498|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-07-19|||December 2015||2015-12-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function|Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function|Recruiting||Phase 1|24|Anticipated|Zhejiang Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:44:45.719438|2017-10-10 22:44:45.719438
NCT02604485|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-02-02|||October 2015||2015-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism|A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism (HI)|Completed||Phase 2|10|Actual|XOMA (US) LLC||1|||f||||f||||||||||2017-10-10 22:44:45.806305|2017-10-10 22:44:45.806305
NCT02604472|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-12|||January 1998||1998-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|June 2013|Actual|2013-06-01||Observational|||Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients|Stage-specified Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Locoregionally-advanced Nasopharyngeal Carcinoma - A Retrospective, Population-based Study|Completed||N/A|12206|Actual|Sun Yat-sen University|||2||f||||t||||||||||2017-10-10 22:44:45.875518|2017-10-10 22:44:45.875518
NCT02604459|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-05-31|||June 2015||2015-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|OPCare||Does Optimized General Anesthesia Care Reduce Postoperative Delirium?|Does Optimized General Anesthesia Care Reduce Postoperative Delirium In Older Patients Undergoing Hip Fracture Repair?|Recruiting||Phase 4|160|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||No||2017-10-10 22:44:45.938021|2017-10-10 22:44:45.938021
NCT02604446|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-11-18|||September 2015||2015-09-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo|Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty. A Double Blinded Randomized Controlled Study. Tapentadol vs Oxycodone vs Placebo|Recruiting||Phase 3|150|Anticipated|St. Olavs Hospital||3|||f||||f||||||||||2017-10-10 22:44:46.039094|2017-10-10 22:44:46.039094
NCT02604433|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-07-21|||May 2, 2016|Actual|2016-05-02|July 2017|2017-07-01|April 30, 2019|Anticipated|2019-04-30|September 30, 2018|Anticipated|2018-09-30||Interventional|BELIEVE||An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia|A Phase 3, Double-Blind, Placebo Controlled Multicenter Study to Determine the Efficacy and Safety of Luspatercept (ACE-536) in Adults With Transfusion Dependent Beta (B)-Thalassemia|Active, not recruiting||Phase 3|335|Actual|Celgene||2|||f||||t||||||||||2017-10-10 22:44:46.259684|2017-10-10 22:44:46.259684
NCT02604420|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-03-08|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|||Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants|Identification of the Pathogenesis of Thrombotic Microangiopathy in the Allo Stem Cell Transplant Setting in Adults|Recruiting||N/A|200|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||Samples With DNA|"     Peripheral blood mononuclear cells Plasma Bone marrow core biopsies   "|No|No plan to share IPD.|2017-10-10 22:44:46.562709|2017-10-10 22:44:46.562709
NCT02604407|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-05-16|2017-02-01||November 2015||2015-11-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||Safety set consisted of all participants in the randomized set (participants who signed informed consent for whom a randomization number had been assigned) who had taken at least 1 dose of investigational product.|Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)|A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)|Completed||Phase 3|275|Actual|Shire||3|||f||||||||||||||2017-10-10 22:44:46.714366|2017-10-10 22:44:46.714366
NCT02604394|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2015-11-14|||November 2015||2015-11-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|Rheo-STEMI||Rheolytic Thrombectomy in Patients With Acute STEMI and Large Thrombus Burden|Rheolytic Thrombectomy in Patients With Acute STEMI and Large Thrombus Burden|Recruiting||N/A|200|Anticipated|Magdi Yacoub Heart Foundation||2|||f||||t||||||||||2017-10-10 22:44:47.243115|2017-10-10 22:44:47.243115
NCT02604381|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-08-09|||November 2015||2015-11-01|August 2017|2017-08-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|13GOHJ||A Study on the Efficacy of Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Leaf Extract in Adults With Osteoarthritis of the Knee.|A Double Blind, Placebo Controlled Parallel Study on the Efficacy of Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Leaf Extract in Adults With Osteoarthritis of the Knee.|Completed||Phase 2|200|Actual|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-10 22:44:47.351491|2017-10-10 22:44:47.351491
NCT02604368|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-10-03|||January 2018|Anticipated|2018-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|SCOT||Sickle Cell Omega-3 Treatment Trial (SCOT Trial)|A Phase 3, Prospective, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multi-center Study of SC411 for Sickle Cell Disease|Not yet recruiting||Phase 3|213|Anticipated|Sancilio and Company, Inc.||2|||f||||t|t|f||||||||2017-10-10 22:44:47.448111|2017-10-10 22:44:47.448111
NCT02604355|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-05-23|||November 28, 2015|Actual|2015-11-28|May 2017|2017-05-01|May 9, 2016|Actual|2016-05-09|May 9, 2016|Actual|2016-05-09||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients|A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose and Multiple-Ascending Dose, Adaptive Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Subjects and Chronic Hepatitis B Patients|Terminated||Phase 1|49|Actual|Hoffmann-La Roche||4||Molecule Development was Terminated|f|||||f|f||||||||2017-10-10 22:44:47.555441|2017-10-10 22:44:47.555441
NCT02604342|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-09-18|||November 3, 2015|Actual|2015-11-03|September 2017|2017-09-01|April 3, 2019|Anticipated|2019-04-03|January 26, 2017|Actual|2017-01-26||Interventional|||Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib|Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase-Positive Advanced Non Small Cell Lung Cancer Patients Previously Treated With Platinum-Based Chemotherapy and Crizotinib|Active, not recruiting||Phase 3|119|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 22:44:47.687071|2017-10-10 22:44:47.687071
NCT02604329|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-21|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|February 14, 2017|Actual|2017-02-14|February 14, 2017|Actual|2017-02-14||Interventional|PEDIALASE||Feasibility Study of a Protocol to Treat Pediatric Oral Mucositis by Low-level Laser Therapy|Feasibility Study of a Treatment Protocol of Pediatric Chemo- and Radiotherapy-induced Oral Mucositis by Low-level Laser Therapy|Completed||N/A|22|Actual|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-10 22:44:47.995382|2017-10-10 22:44:47.995382
NCT02604316|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-05-03|||January 2014|Actual|2014-01-01|September 2016|2016-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SATIN||SATIN: Satiety Innovation. Study 2- University of Aberdeen|SATIN: Satiety Innovation, Study 2. Effect of Novel Fibres (Arabinoxylan and Beta-glucan) in Appetite, Metabolic and Gut Health.|Completed||N/A|40|Actual|University of Aberdeen||4|||f||||t||||||||||2017-10-10 22:44:48.119885|2017-10-10 22:44:48.119885
NCT02604303|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-04-18|||September 2015||2015-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms|A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms|Enrolling by invitation||N/A|200|Anticipated|VA Northern California Health Care System|||1||f||||f||||||Samples With DNA|"     Patient monocytes from peripheral blood   "|||2017-10-10 22:44:48.268913|2017-10-10 22:44:48.268913
NCT02604290|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-10-03|||January 2015||2015-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|KITALO||Kinesio Taping Efficacy in Chronic Low Back Pain Treatment (KITALO)|Kinesio Taping Method for Chronic Mechanical Low Back Pain: a Randomised Controlled Trial|Completed||N/A|61|Actual|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||f||||||||||2017-10-10 22:44:48.385575|2017-10-10 22:44:48.385575
NCT02604277|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-11-14|||January 2016||2016-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Suicidal Behavior in Patients Diagnosed With Bipolar Disorder|Suicidal Behavior in Patients Diagnosed With Bipolar Disorder: The Roles of Biological and Childhood and Adult Environmental Risk Factors|Recruiting||N/A|130|Anticipated|Emory University||1|||f||||f||||||||||2017-10-10 22:44:48.51776|2017-10-10 22:44:48.51776
NCT02604264|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-03-21|2017-03-21||December 2014|Actual|2014-12-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap|Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap|Completed||Phase 4|3500|Actual|Pursuit Vascular, Inc.|There were no device-related adverse events during the study. Adverse events that were not device-related were not collected during this post-market study.|2|||f||||f|f|t|f|f|f|||No||2017-10-10 22:44:48.665122|2017-10-10 22:44:48.665122
NCT02604251|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-08-15|||October 2015||2015-10-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|April 2017|Actual|2017-04-01||Interventional|||Evaluation of the KLOX BioPhotonic WoundGel System in the Treatment of Surgical Wounds|A Prospective Randomized Clinical Study Evaluating the Safety and Efficacy of the KLOX BioPhotonic WoundGel System When Compared With Silicone Sheets in the Treatment of Surgical Wounds|Active, not recruiting||N/A|42|Actual|KLOX Technologies Inc.||2|||f||||f||||||||||2017-10-10 22:44:49.083898|2017-10-10 22:44:49.083898
NCT02604238|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-13|||March 2016||2016-03-01|November 2015|2015-11-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|MONALYSE||Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism|Efficacy and Safety of Thrombolytic Therapy With Half Dose Alteplase, Added to Standard Anticoagulation Therapy With Heparine, in Patients With Moderate Pulmonary Embolism: a Prospective, Randomized, Open Label,Controlled Trial|Not yet recruiting||Phase 3|130|Anticipated|Azienda U.S.L. 1 di Massa e Carrara||2|||f||||t||||||||||2017-10-10 22:44:49.195217|2017-10-10 22:44:49.195217
NCT02604225|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-11-14|||December 2015||2015-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|TRUSB||Trial of Methoxyflurane With Periprostatic Local Anaesthesia to Reduce the Discomfort of TRUS B|A Phase 3 Double-blind Placebo-controlled Randomized Trial of Methoxyflurane With Periprostatic Local Anaesthesia to Reduce the Discomfort of Transrectal Ultrasound-guided Prostate Biopsy|Recruiting||Phase 3|420|Anticipated|University of Sydney||2|||f||||f||||||||||2017-10-10 22:44:49.274076|2017-10-10 22:44:49.274076
NCT02604212|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-06-26|||October 2015||2015-10-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic HBV Infection|A Multicenter, Randomized, Double-blind, Placebo-controlled Multi-dose Study to Determine the Depth of Hepatitis B Surface Antigen (HBsAg) Reduction Following Intravenous ARC-520 in Combination With Entecavir or Tenofovir in Patients With HBeAg Positive, Chronic Hepatitis B Virus (HBV) Infection|Terminated||Phase 2|32|Actual|Arrowhead Pharmaceuticals||3||Company decision to discontinue trial|f||||t||||||||||2017-10-10 22:44:49.396118|2017-10-10 22:44:49.396118
NCT02604199|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-06-26|||October 2015||2015-10-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic HBV Infection|A Multicenter, Randomized, Double-blind, Placebo-controlled, Multi-dose Study to Determine the Depth of Hepatitis B Surface Antigen (HBsAg) Reduction Following Intravenous ARC-520 in Combination With Entecavir or Tenofovir in Patients With HBeAg Negative, Chronic Hepatitis B Virus (HBV) Infection|Terminated||Phase 2|58|Actual|Arrowhead Pharmaceuticals||3||Company decision to discontinue trial|f||||t||||||||||2017-10-10 22:44:49.498855|2017-10-10 22:44:49.498855
NCT02604186|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-09-10|||July 2016||2016-07-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|SPASTOX||Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia|Botulinum Toxin in Patients With Hereditary Spastic Paraplegia: a Randomized, Double-blind, Placebo-controlled, Crossover Study|Active, not recruiting||Phase 2/Phase 3|55|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-10 22:44:49.733028|2017-10-10 22:44:49.733028
NCT02604160|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-01-25|||November 17, 2015|Actual|2015-11-17|January 2017|2017-01-01|June 22, 2016|Actual|2016-06-22|June 22, 2016|Actual|2016-06-22||Interventional|||A Study of LY3113593 in Participants With Chronic Kidney Disease|A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis|Completed||Phase 1|80|Actual|Eli Lilly and Company||2|||f||||f|t|f||||||||2017-10-10 22:44:49.956812|2017-10-10 22:44:49.956812
NCT02604147|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-05-12|||January 2014||2014-01-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Inspiratory Muscle Training in Wheelchair Basketball Players|Inspiratory Muscle Training in Wheelchair Basketball Players: Effects on Physical Performance and Cardiopulmonary Variables|Completed||N/A|24|Actual|Universidade Metodista de Piracicaba||2|||f||||t||||||||||2017-10-10 22:44:50.058501|2017-10-10 22:44:50.058501
NCT02604134|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-03-23|||July 2014||2014-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Medical Management of Caries in the Primary Dentition Using Silver Nitrate|Medical Management of Caries in the Primary Dentition Using Silver Nitrate: A Pilot Study|Enrolling by invitation||Early Phase 1|200|Anticipated|University of Iowa||2|||f||||f||||||||No||2017-10-10 22:44:50.135399|2017-10-10 22:44:50.135399
NCT02604121|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-03-12|||February 2013||2013-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|Cytobuccale||Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity|Interest of Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity by Transepithelial Brushing in Liquid-based|Recruiting||N/A|200|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 22:44:50.25135|2017-10-10 22:44:50.25135
NCT02604108|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-10|||January 2015||2015-01-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Training Program for Happy Family Kitchen Movement Project|Training Program for Happy Family Kitchen Movement, A Community-based Research to Enhance Family Health, Happiness and Harmony in Hong Kong|Recruiting||N/A|400|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:44:50.335791|2017-10-10 22:44:50.335791
NCT02604095|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-13|||May 2014||2014-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism|Effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism|Completed||N/A|16|Actual|Shanghai 10th People's Hospital||1|||f||||t||||||||||2017-10-10 22:44:50.454971|2017-10-10 22:44:50.454971
NCT02604082|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-11-11|||September 2011||2011-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|ClearanceMV||Comparison of Three Technical Airway Clearance in Mechanical Ventilated Patients|Comparison of Three Technical Airway Clearance in Mechanical Ventilated Patients|Completed||N/A|93|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||||2017-10-10 22:44:50.560809|2017-10-10 22:44:50.560809
NCT02604069|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2015-11-12|||November 2015||2015-11-01|November 2015|2015-11-01||||February 2016|Anticipated|2016-02-01||Interventional|||Detection of Flap Ischemia Using Interstitial Glucose Monitor|Postoperative Monitoring of Tissue Perfusion in Microvascular Free Flaps Using Continuous Interstitial Glucose Monitoring Device: A Pilot Study|Not yet recruiting||Early Phase 1|30|Anticipated|Hamilton Health Sciences Corporation||1|||f||||||||||||||2017-10-10 22:44:50.671147|2017-10-10 22:44:50.671147
NCT02604056|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-06-13|||September 2015||2015-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||Pragmatic Cluster Trial for Nursing Home Antipsychotic Prescribing|Ontario Appropriate Prescribing Demonstration Project: Pragmatic, Cluster-Randomized Clinical Trial to Reduce Antipsychotic Medication Prescribing in Long-Term Care Homes|Active, not recruiting||N/A|60|Actual|Women's College Hospital||2|||f||||f||||||||No||2017-10-10 22:44:50.769541|2017-10-10 22:44:50.769541
NCT02604043|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-08-16|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Continuous Supraglottic pH Monitoring in Prolonged Intubated Intensive Care Patients and High Risk Aspiration Intraoperative Patients|Continuous Supraglottic pH Monitoring in Prolonged Intubated Intensive Care Patients and High Risk Aspiration Intraoperative Patients|Recruiting||N/A|15|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-10-10 22:44:50.85702|2017-10-10 22:44:50.85702
NCT02604030|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-02-28|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|December 2016|Actual|2016-12-01||Interventional|||Surgical Intervention and Physiotherapy in Breast Cancer: Effects in Scapular Kinematics, Pain and Upper Limb Function|Scapular Kinematics and Upper Limb Function in Women Who Had Undergone Breast Cancer Surgery Subjected to Upper Limb Stretching and Strengthening Exercises Program|Completed||N/A|9|Actual|Universidade Federal de Sao Carlos||1|||f||||f||||||||||2017-10-10 22:44:50.972092|2017-10-10 22:44:50.972092
NCT02604017|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2017-08-17|2017-08-17|2017-01-31|October 2015||2015-10-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional||All participants who received at least 1 dose of study drug (ITT population).|A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection|A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)|Completed||Phase 3|703|Actual|AbbVie||2|||f||||f||||||||||2017-10-10 22:44:51.085267|2017-10-10 22:44:51.085267
NCT02604004|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-10|||April 2013||2013-04-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers|Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet 150 mg (Test) and EPIVIR of Glaxosmithkline in Healthy Volunteers of Both Genders in Fasting Condition|Completed||Phase 1|28|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:44:51.636363|2017-10-10 22:44:51.636363
NCT02603991|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-10-12|||June 2016||2016-06-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Observational|||Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)|Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)|Recruiting||N/A|1|Anticipated|Beijing Pins Medical Co., Ltd|||1||f||||t||||||||||2017-10-10 22:44:51.746789|2017-10-10 22:44:51.746789
NCT02603978|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-09-18|||August 2015||2015-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Interventions for Sanctioned Ohio University Students|Examining the Efficacy of Interventions for Sexual Assault: A Preliminary Randomized Controlled Trial|Enrolling by invitation||Phase 2|240|Anticipated|Ohio University||4|||f||||f||||||||||2017-10-10 22:44:51.832197|2017-10-10 22:44:51.832197
NCT02603965|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-10-19|||August 2013||2013-08-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery|A Pilot Phase I Open Label Study of Cu-64-TP3805 PET Imaging for Detection of Prostate Cancer in Men Undergoing Radical Prostatectomy|Completed||Phase 1|25|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 22:44:51.905387|2017-10-10 22:44:51.905387
NCT02603952|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-12-16|||December 2015||2015-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|MEDI8852||A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza|A Phase 2a, Randomized, Partial Double-blind, Single Dose, Active-controlled, Dose Ranging Study to Evaluate the Safety of MEDI8852 in Adults With Acute, Uncomplicated Influenza|Completed||Phase 1/Phase 2|375|Actual|MedImmune LLC||4|||f||||f||||||||||2017-10-10 22:44:52.017958|2017-10-10 22:44:52.017958
NCT02603939|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-04-10|||June 2013||2013-06-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|PAPO||Understanding Pain Perception in Osteoarthritis|Understanding Pain Perception in Osteoarthritis: a Mechanistic Study in People With Knee Osteoarthritis|Recruiting||N/A|250|Anticipated|St George's, University of London|||2||f||||f||||||Samples With DNA|"     Blood collected   "|||2017-10-10 22:44:52.143767|2017-10-10 22:44:52.143767
NCT02603926|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-06-06|||October 2015||2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone|Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone|Enrolling by invitation||Phase 2|15|Anticipated|University of California, Davis||1|||f||||t|t|||||||||2017-10-10 22:44:52.223003|2017-10-10 22:44:52.223003
NCT02603913|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2016-10-28|||November 2015||2015-11-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|ENDOPREG||Oxidative Stress and Endothelial Function in Pregnancy Complications|Oxidative Stress and Endothelial Function in Pregnancy Complications: Development of a New Screening Algorithm|Recruiting||N/A|330|Anticipated|Universiteit Antwerpen|||5||f||||f||||||Samples Without DNA|"     Blood and placenta samples   "|||2017-10-10 22:44:52.30174|2017-10-10 22:44:52.30174
NCT02603900|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-11-25|||October 2015||2015-10-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Adductor Canal Catheter vs Local Infiltration of Analgesia for Total Knee Arthroplasty|A Double-Blinded Randomized Controlled Trial Comparing the Adductor Canal Catheter (ACC) and Local Infiltration of Analgesia (LIA) Following Primary Total Knee Arthroplasty|Recruiting||Phase 4|110|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-10 22:44:52.400522|2017-10-10 22:44:52.400522
NCT02603874|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-10|||January 2016||2016-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||The Development of a Vertebra Localizing Aid Medical Device|The Development of a Vertebra Localizing Aid Medical Device|Not yet recruiting||N/A|100|Anticipated|Target Tape||2|||f||||f||||||||||2017-10-10 22:44:52.597558|2017-10-10 22:44:52.597558
NCT02603861|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-11|2016-04-04|||November 2015||2015-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study of LY3154207 on Sleep in Healthy Male Participants|An Evaluation of the Impact of Single Doses of LY3154207 on Sleep Latency in Sleep-Deprived Healthy Subjects|Completed||Phase 1|16|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-10 22:44:52.683728|2017-10-10 22:44:52.683728
NCT02603848|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-08-28|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ibuprofen Compared to Morphine as a Pediatric Postoperative Pain Management Tool Following Inguinal Surgery|Assessing the Effectiveness of Ibuprofen Compared to Morphine as a Pediatric Postoperative Pain Management Tool Following Inguinal Surgery|Not yet recruiting||N/A|100|Anticipated|McMaster University||2|||f||||t|f|f||||||||2017-10-10 22:44:52.766155|2017-10-10 22:44:52.766155
NCT02603835|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-09-22|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|August 2017|Actual|2017-08-01||Interventional|IC-HOT||Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT)|A Multi-Center Evaluation of the Delivery of Intracoronary Hyperoxemic Supersaturated Oxygen Therapy for 60 Minutes in Anterior Acute Myocardial Infarction Patients With Successful Reperfusion (Via PCI) ≤ Six Hours After Symptom Onset|Active, not recruiting||N/A|100|Actual|TherOx||1|||f||||t||t|t|||||||2017-10-10 22:44:52.858547|2017-10-10 22:44:52.858547
NCT02603822|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-09-14|||August 2015||2015-08-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability|Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability|Recruiting||Phase 1|24|Anticipated|Mayo Clinic||1|||f||||f||||||||Undecided||2017-10-10 22:44:52.965567|2017-10-10 22:44:52.965567
NCT02603809|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-07-26|||January 25, 2016|Actual|2016-01-25|July 2017|2017-07-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Clinical Study to Explore the Effects of Actelion's Latest Endothelin Receptor Antagonist (ERA) - at Different Dose Strengths - on the Efficacy, Safety and Tolerability in Subjects With Essential Hypertension|Multi-center, Double-blind, Double-dummy, Randomized, Placebo- and Active-reference, Parallel Group, Phase 2 Dose-finding Study With Actelion's Latest Endothelin Receptor Antagonist (ERA) in Subjects With Essential Hypertension (Grade 1 and 2)|Completed||Phase 2|1000|Actual|Actelion||6|||f||||t||||||||||2017-10-10 22:44:53.061371|2017-10-10 22:44:53.061371
NCT02603796|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-07-22|||October 2015||2015-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||3D Imaging of Neonatal Faces|3D Imaging of Neonatal Subjects|Completed||N/A|18|Actual|Sharp HealthCare|||1||f||||f||||||||||2017-10-10 22:44:53.455182|2017-10-10 22:44:53.455182
NCT02603783|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-05-16|||November 2015||2015-11-01|October 2015|2015-10-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Esophageal capsaïcin Infusion and Mucosal Integrity|"Effect of capsaïcin Infusion on Esophageal Mucosal Integrity - a Role for TRPV1-mediated Neuropeptides?"|Completed||N/A|13|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 22:44:53.545058|2017-10-10 22:44:53.545058
NCT02603770|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-12-02|||November 2015||2015-11-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers|A Single Site, Randomized Open Label Cross-Over Study to Compare Pharmacokinetic Profiles (PK) of XueZhiKang (XZK) Capsules Versus Lovastatin Tablets in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Luye Pharma Group Ltd.||2|||f||||f||||||||||2017-10-10 22:44:53.627509|2017-10-10 22:44:53.627509
NCT02603757|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-05-05|||March 2016||2016-03-01|May 2016|2016-05-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer|Prospective Pilot Study to Assess the Effectiveness of Vitamin D Supplementation for Patients Requiring Chemotherapy for Stage III Colorectal Cancer|Recruiting||N/A|70|Anticipated|Legacy Health System||2|||f||||f||||||||||2017-10-10 22:44:53.738267|2017-10-10 22:44:53.738267
NCT02603744|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2017-04-26|||June 2015||2015-06-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|||Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF)|Evaluate the Safety and Feasibility of Intra-ovarian Injection of Autologous Adipose Derived Mesenchymal Stromal Cells (ADMSC) in Women With Premature Ovarian Failure(POF)|Recruiting||Phase 1/Phase 2|9|Anticipated|Royan Institute||3|||f||||t||||||||||2017-10-10 22:44:53.858193|2017-10-10 22:44:53.858193
NCT02603731|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-05-22|||August 2015||2015-08-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Delirium at the Intensive Care Unit - a Retrospective Cohort Study|Delirium at the Intensive Care Unit - a Retrospective Cohort Study|Completed||N/A|183|Actual|Zealand University Hospital|||1||f||||f||||||||No||2017-10-10 22:44:53.967278|2017-10-10 22:44:53.967278
NCT02603718|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-11-10|||March 2014||2014-03-01|November 2015|2015-11-01|March 2018|Anticipated|2018-03-01|March 2016|Anticipated|2016-03-01||Interventional|||An Applicative On-line EEG Tool for Enhancing Treatment Efficacy|An Applicative On-line EEG Tool for Enhancing Treatment Efficacy|Recruiting||N/A|80|Anticipated|Reuth Medical Center||2|||f||||t||||||||||2017-10-10 22:44:54.05619|2017-10-10 22:44:54.05619
NCT02603705|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-08-01|||March 7, 2016|Actual|2016-03-07|August 2017|2017-08-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain|An Open-label Phase 3 Trial to Evaluate the Safety and Tolerability of Egalet ADER Oxycodone Tablet, Egalet-002, in Patients With Moderate-to-Severe Chronic Noncancer Pain|Completed||Phase 3|281|Actual|Egalet Ltd||1|||f||||f||||||||||2017-10-10 22:44:54.178242|2017-10-10 22:44:54.178242
NCT02603692|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-01-19|||November 2014||2014-11-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|PROMIS-QOL||Health Related Quality of Life in Pediatric Central Nervous System (CNS) Tumors: A Feasibility Study Utilizing PROMIS|Health Related Quality of Life in Pediatric Central Nervous System (CNS) Tumors: A Feasibility Study Utilizing PROMIS|Active, not recruiting||N/A|20|Actual|Children's Hospital Medical Center, Cincinnati|||3||f||||f||||||||||2017-10-10 22:44:54.33725|2017-10-10 22:44:54.33725
NCT02603497|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-01-03|||November 2015||2015-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function|Pharmacokinetic (PK) Study of ASP015K -Evaluation of Pharmacokinetics in Patients With Impaired Renal Function and Subjects With Normal Renal Function-|Completed||Phase 1|31|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-10 22:44:55.793509|2017-10-10 22:44:55.793509
NCT02603679|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-09-06|||February 2015||2015-02-01|September 2016|2016-09-01|June 2024|Anticipated|2024-06-01|June 2018|Anticipated|2018-06-01||Interventional|PREDIX LumB||Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases|PREDIX Luminal B - Neoadjuvant Response-guided Treatment of ER Positive Tumors With High Proliferation or Low Proliferation With Metastatic Nodes. Part of a Platform of Translational Phase II Trials Based on Molecular Subtypes|Recruiting||Phase 2|200|Anticipated|Karolinska University Hospital||4|||f||||f||||||||||2017-10-10 22:44:54.432478|2017-10-10 22:44:54.432478
NCT02603666|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-11-01|2016-09-06||January 2012||2012-01-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects|Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects|Completed||N/A|130|Actual|Karolinska University Hospital||1|||f||||f||||||||Yes||2017-10-10 22:44:54.567451|2017-10-10 22:44:54.567451
NCT02603653|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-10|||November 2015||2015-11-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|MEMOCUSH||Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease|Cognitive Sequels of Cushing Syndrome|Not yet recruiting||N/A|30|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-10 22:44:54.73252|2017-10-10 22:44:54.73252
NCT02603640|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-06-19|||October 2015||2015-10-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|VIBRATIONS||" Virtual Brain -Based Interpretation of Electrophysiological Signals in Epilepsy"|" Virtual Brain -Based Interpretation of Electrophysiological Signals in Epilepsy"|Recruiting||N/A|20|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:44:54.819319|2017-10-10 22:44:54.819319
NCT02603627|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-11-10|||December 2015||2015-12-01|October 2015|2015-10-01||||August 2016|Anticipated|2016-08-01||Observational|||Prevalence of COPD in Our Lung Cancer Population, Compared to Controls|Cross-sectional Study to Compare the Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Patients Newly Diagnosed With Lung Cancer, Compared to Controls|Unknown status|Not yet recruiting|N/A|200|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 22:44:54.898936|2017-10-10 22:44:54.898936
NCT02603614|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-01-31|||December 2015||2015-12-01|January 2017|2017-01-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Interventional|||Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment|A Randomized, Double Blind, Placebo-Controlled, Dose Escalating, Cross Over Designed Study to Assess the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Open-Label, Continuous Subcutaneous Infusion of Cenderitide Via the Insulet Drug Delivery System in Chronic Stable Heart Failure Subjects With Moderate Renal Impairment|Completed||Phase 1/Phase 2|8|Actual|Capricor Inc.||2|||f||||f||||||||No||2017-10-10 22:44:54.983724|2017-10-10 22:44:54.983724
NCT02603601|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-05-02|||March 2014||2014-03-01|May 2017|2017-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Trial of Lifestyle Interventions to Control Weight After Bariatric Surgery|A Randomized Controlled Trial of Lifestyle Interventions to Control Weight After Bariatric Surgery|Completed||N/A|18|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-10 22:44:55.086524|2017-10-10 22:44:55.086524
NCT02603588|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2015-11-10|||February 2014||2014-02-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||The Effects of Sphenopalatine Ganglion Acupuncture on Nasal Function|Effects of Sphenopalatine Ganglion Acupuncture on Nasal Ventilation and Autonomic Nervous Activity in Healthy Volunteers|Completed||N/A|44|Actual|Beijing Tongren Hospital||2|||f||||t||||||||||2017-10-10 22:44:55.189823|2017-10-10 22:44:55.189823
NCT02603575|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-11-10|||November 2015||2015-11-01|November 2015|2015-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients||Recruiting||N/A|200|Anticipated|Beijing Chao Yang Hospital||4|||f||||||||||||||2017-10-10 22:44:55.284583|2017-10-10 22:44:55.284583
NCT02603562|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-05-15|||March 30, 2016|Actual|2016-03-30|May 2017|2017-05-01|February 14, 2017|Actual|2017-02-14|December 13, 2016|Actual|2016-12-13||Interventional|FSHD||Evaluate Safety and Biological Activity of ATYR1940 in Patients With Early Onset Facioscapulohumeral Muscular Dystrophy|An Open-Label, Intrapatient Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Early Onset and Other Pediatric Onset Facioscapulohumeral Muscular Dystrophy|Completed||Phase 1/Phase 2|8|Actual|aTyr Pharma, Inc.||2|||f||||t||||||||||2017-10-10 22:44:55.377912|2017-10-10 22:44:55.377912
NCT02603549|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-01-30|||July 2015||2015-07-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||Pituitary Function and Spontaneous Intracranial Hypotension|Spontaneous Spinal Cerebrospinal Fluid Leaks and Intracranial Hypotension|Active, not recruiting||N/A|100|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 22:44:55.473403|2017-10-10 22:44:55.473403
NCT02603536|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-01-31|||April 2013|Actual|2013-04-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|WelTelOAKTREE||WelTelOAKTREE: Text Messaging to Support Patients With HIV/AIDS in British Columbia|WelTelOAKTREE: Text Messaging to Support Patients With HIV/AIDS in British Columbia|Completed||N/A|85|Actual|BC Women's Hospital & Health Centre||1|||f||||f||||||||Undecided||2017-10-10 22:44:55.540162|2017-10-10 22:44:55.540162
NCT02603523|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-01-29|||January 2016||2016-01-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|DanSE||Effects of Senior Dance on Risk Factors for Falls|Effects of Senior Dance on Risk Factors for Falls in Older Adults: A Randomized Controlled Trial|Recruiting||N/A|82|Anticipated|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||||2017-10-10 22:44:55.619381|2017-10-10 22:44:55.619381
NCT02603510|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-05-18|||November 2015||2015-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion|A Randomized, 2X4 Week, Active-Controlled, Open-Label, 2-Treatment Arm, 2-Period Cross-Over Study Assessing the Safety of SAR342434 and Humalog® Used in Continuous Subcutaneous Insulin Infusion (CSII) in Adult Patients With Type 1 Diabetes Mellitus (T1DM)|Completed||Phase 1|27|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:44:55.702532|2017-10-10 22:44:55.702532
NCT02602938|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2015-11-12|||November 2015||2015-11-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|ACABC||Aspirin on CTCs of Advanced Breast and Colorectal Cancer||Recruiting||Phase 2|40|Anticipated|Zhejiang Provincial People’s Hospital||1|||f||||t||||||||||2017-10-10 22:45:04.046355|2017-10-10 22:45:04.046355
NCT02603471|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-11-10|||July 2014||2014-07-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ALCTXT||Cell Phone Technology Targeting ART and Naltrexone Adherence and Alcohol Use|Cell Phone Technology Targeting ART and Naltrexone Adherence and Alcohol Use|Recruiting||N/A|50|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 22:44:55.88957|2017-10-10 22:44:55.88957
NCT02603458|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-02-04||||||February 2016|2016-02-01||||August 2020|Anticipated|2020-08-01||Interventional|||NRX-1074 in Early Course Schizophrenia|A Placebo-controlled Two-dose Trial of NRX-1074 Early in the Course of Schizophrenia|Withdrawn||Phase 2|0|Actual|New York University School of Medicine||2||The study was withdrawn by the sponsor.|f||||t||||||||Undecided|The study has been withdrawn by the sponsor, so the plan to share data has not been discussed and is undecided.|2017-10-10 22:44:55.987194|2017-10-10 22:44:55.987194
NCT02603406|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2015-11-10|||December 2015||2015-12-01|September 2015|2015-09-01||||June 2016|Anticipated|2016-06-01||Interventional|NIMBUS||Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits|Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits (NIMBUS Trial)|Unknown status|Not yet recruiting|Phase 2|22|Anticipated|Ajou University School of Medicine||2|||f||||f||||||||||2017-10-10 22:44:58.98007|2017-10-10 22:44:58.98007
NCT02603393|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-09-26|||November 20, 2015|Actual|2015-11-20|September 2017|2017-09-01|July 18, 2017|Actual|2017-07-18|July 18, 2017|Actual|2017-07-18||Interventional|||Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD|A 26-week, Randomized, Double Blind, Parallel-group Multicenter Study to Assess the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD|Completed||Phase 4|1053|Actual|Novartis||2|||f||||f||||||||||2017-10-10 22:44:59.092355|2017-10-10 22:44:59.092355
NCT02603380|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-11-09|||March 2015||2015-03-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Feasibility of a Software App for Testing Inattention in Delirium|Feasibility Study of a Software Application for Detection and Monitoring of Attentional Deficits in Delirium|Completed||N/A|48|Actual|University of Edinburgh|||2||f||||f||||||||||2017-10-10 22:44:59.691895|2017-10-10 22:44:59.691895
NCT02603367|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-08-11|||November 24, 2015|Actual|2015-11-24|August 2017|2017-08-01|August 10, 2017|Actual|2017-08-10|August 10, 2017|Actual|2017-08-10||Interventional|COMFORT||COMFORT Caregiver Intervention in Improving Communication and Reducing Distress in Caregivers of Patients With Lung Cancer|The COMFORT Caregiver Intervention (CCI)|Completed||N/A|50|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 22:44:59.772458|2017-10-10 22:44:59.772458
NCT02603354|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-11-10|||March 2015||2015-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|Brief6%||Efectiveness of a Brief Protocol by a Low (6%) Concentration Gel Peroxide Hydrogen of Teeth Bleaching|Efectiveness of a Brief Protocol by a Low (6%) Concentration Gel Peroxide Hydrogen of Teeth Bleaching|Completed||N/A|31|Actual|University of Chile||2|||f||||t||||||||||2017-10-10 22:44:59.864441|2017-10-10 22:44:59.864441
NCT02603341|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-09-01|||February 2016||2016-02-01|September 2017|2017-09-01|November 2030|Anticipated|2030-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial|Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial|Recruiting||N/A|1720|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:44:59.9514|2017-10-10 22:44:59.9514
NCT02603328|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-09-21|||July 2018|Anticipated|2018-07-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|AT CASH EPOC||Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial|Phase I-II Randomized, Placebo-Controlled, Single-Blinded, Single-Site Clinical Trial of Atorvastatin in the Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC)|Not yet recruiting||Phase 1/Phase 2|80|Anticipated|University of Chicago||2|||f||||t|t|f|||f|||||2017-10-10 22:45:00.231335|2017-10-10 22:45:00.231335
NCT02603315|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-05-29|||October 2015||2015-10-01|October 2015|2015-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|VITMPM||Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)|To Assess the Correlation Between the Predictive Factor of Vascularity (CD74) in Malignant Pleural Mesothelioma and Treatment Results (Response Rate, and Overall Survival )|Completed||N/A|50|Actual|Ain Shams University|||1||f||||f||||||||||2017-10-10 22:45:00.338261|2017-10-10 22:45:00.338261
NCT02603302|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-06-11|||January 2016||2016-01-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RaDE||Radiation Dose Escalation in Locally Advanced Rectal Cancer|Phase II Study of Neoadjuvant Radiotherapy Dose Escalation in Association With Chemotherapy for the Treatment of Locally Advanced Rectal Cancer|Recruiting||Phase 2|48|Anticipated|University of Brasilia||1|||f||||f||||||||Yes|We may share data in requested by metanalists|2017-10-10 22:45:00.403491|2017-10-10 22:45:00.403491
NCT02603289|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-01-30|||September 2015|Actual|2015-09-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Observational|||One Week Aligner Evaluation|One Week Aligner Evaluation|Active, not recruiting||N/A|287|Actual|Align Technology, Inc.|||3||f||||f||||||||||2017-10-10 22:45:00.488122|2017-10-10 22:45:00.488122
NCT02603276|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-02-07|||April 2015||2015-04-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Lipid-lowering Effect of Phytosterols, Red Yeast Rice and Their Combination|Lipid-lowering Effect of Phytosterols, Red Yeast Rice and Their Combination in Moderately Hypercholesterolemic Subjects in Primary Prevention for Cardiovascular Diseases: a Randomized, Double Blind, Clinical Trial|Completed||N/A|60|Anticipated|University of Bologna||3|||f||||f||||||||||2017-10-10 22:45:00.552782|2017-10-10 22:45:00.552782
NCT02603263|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-11-09|||February 2015||2015-02-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||The Effect of a Descriptive Norm Promoting Vegetable Selection in a Workplace Restaurant Setting: an Observational Study|The Effect of a Descriptive Norm Promoting Vegetable Selection in a Workplace|Completed||N/A|9445|Actual|University of Birmingham|||1||f||||f||||||||||2017-10-10 22:45:00.632326|2017-10-10 22:45:00.632326
NCT02603250|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-01-06|||September 2015||2015-09-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda|Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda|Completed||N/A|132|Actual|PATH|||2||f||||f||||||||||2017-10-10 22:45:00.703672|2017-10-10 22:45:00.703672
NCT02603237|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-01-20|||March 2016||2016-03-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Metabolic Response to Fat and Glucose|Metabolic Response to Fat and Glucose|Not yet recruiting||N/A|111|Anticipated|Saarland University||2|||f||||f||||||||Undecided|will be decided at a later stage|2017-10-10 22:45:00.772954|2017-10-10 22:45:00.772954
NCT02603224|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-07-05|||November 2015||2015-11-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers|A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of MRG-201 Following Local Intradermal Injection in Normal Healthy Volunteers|Completed||Phase 1|54|Actual|miRagen Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:45:00.855571|2017-10-10 22:45:00.855571
NCT02603198|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|June 2015|Actual|2015-06-01||Interventional|||2%-Mepivacaine With Two Different Vasoconstrictors Solutions in Third Molar Surgery a Comparative Study|2%-Mepivacaine With Two Different Vasoconstrictors; 1:20.000 Levonordefrin or 1:100.000 Epinephrin for Local Anesthesia in Third Molar Surgery: A Comparative Randomized Clinical Trial|Active, not recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 22:45:00.990861|2017-10-10 22:45:00.990861
NCT02603185|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-04-25|||January 9, 2017|Actual|2017-01-09|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers|A First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Hemay007|Recruiting||Phase 1|82|Anticipated|Hemay Pharmaceutical PTY. LTD.||2|||f||||f||||||||||2017-10-10 22:45:01.079196|2017-10-10 22:45:01.079196
NCT02603172|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-05-18|||May 12, 2016||2016-05-12|May 2017|2017-05-01|October 17, 2017|Anticipated|2017-10-17|October 17, 2017|Anticipated|2017-10-17||Interventional|||A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis|A Three-part Open-label, Non-randomised, Dose-escalation Study to Investigate the Safety and Tolerability of GSK3039294 Administered as a Single Dose to Healthy Volunteers, and as Repeat Dose to Healthy Volunteers and Patients With Systemic Amyloidosis|Recruiting||Phase 1|30|Anticipated|GlaxoSmithKline||5|||f||||f||||||||||2017-10-10 22:45:01.317119|2017-10-10 22:45:01.317119
NCT02603159|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2015-11-09|||October 2014||2014-10-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|DCECRT||Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy||Recruiting||Phase 3|200|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology||2|||f||||t||||||||||2017-10-10 22:45:01.485059|2017-10-10 22:45:01.485059
NCT02603146|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-09-21|||March 2016||2016-03-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|StopRA||Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis|Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis|Recruiting||Phase 2|200|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:45:01.677937|2017-10-10 22:45:01.677937
NCT02603133|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-04-26|||July 2016||2016-07-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|WISER||Web-based Implementation for the Science of Enhancing Resilience Study|Web-based Implementation for the Science of Enhancing Resilience Study|Active, not recruiting||N/A|1100|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:45:01.968117|2017-10-10 22:45:01.968117
NCT02603120|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-05-19|||November 11, 2015|Actual|2015-11-11|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|May 9, 2017|Actual|2017-05-09||Interventional|||Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching From a Regimen of Dolutegravir and ABC/3TC, or a Fixed Dose Combination (FDC) of ABC/DTG/3TC to a FDC of GS-9883/F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed|Active, not recruiting||Phase 3|567|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-10 22:45:02.180155|2017-10-10 22:45:02.180155
NCT02603107|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-05-22|||November 20, 2015|Actual|2015-11-20|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|May 15, 2017|Actual|2017-05-15||Interventional|||Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults|A Phase 3, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to GS-9883/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults|Active, not recruiting||Phase 3|520|Anticipated|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 22:45:02.49255|2017-10-10 22:45:02.49255
NCT02603094|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-09-16|||December 2015||2015-12-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Gastric pH in Intubated Children - Part Two|Untersuchung Des Magen-pH in lntubationsanästhesie Bei Kindern - Teil Zwei|Completed||N/A|180|Actual|University Children's Hospital, Zurich||2|||f||||t||||||||||2017-10-10 22:45:02.809048|2017-10-10 22:45:02.809048
NCT02603081|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-09-28|||December 2015||2015-12-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Study to Evaluate SPI-1005 in Adults With Meniere's Disease|Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease|Completed||Phase 1/Phase 2|40|Actual|Sound Pharmaceuticals, Incorporated||4|||f||||f||||||||||2017-10-10 22:45:02.880863|2017-10-10 22:45:02.880863
NCT02603068|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-02-05|||February 2016||2016-02-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis|Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis|Withdrawn||Phase 2|0|Actual|United Therapeutics||2||Study design was inadequate and would not achieve study endpoints|f||||f||||||||No|Study is withdrawn. There is no data to share.|2017-10-10 22:45:02.977811|2017-10-10 22:45:02.977811
NCT02603055|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-08-30|||July 2015||2015-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults|A Phase Ib Single Center, Randomized, Blinding, Parallel-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Hepatitis E Vaccine in Healthy Adults Aged 16 to 65 Years Old in China|Completed||Phase 1|60|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 22:45:03.076878|2017-10-10 22:45:03.076878
NCT02603042|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-04-26|||November 2015||2015-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|BioHypophos||Biomarker for Hypophosphatasia Disease|Biomarker for Hypophosphatasia Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectrometry 7, 5 ml     EDTA blood and a dry blood spot filter card are taken. To proof the correct diagnosis of     Hypophosphatasia in those patients where up to the enrollment in the study no genetic testing     has been done, sequencing of Hypophosphatasia disease will be done.      The analyses are done in the Centogene AG Schillingallee 68 D-18057 Rostock Germany   "|Undecided||2017-10-10 22:45:03.157579|2017-10-10 22:45:03.157579
NCT02603029|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-03-07|||March 2015||2015-03-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Influence of of Cream With the Silver Fir Wood Extract (Belinal) on Skin|Placebo Controlled Study of Influence of Cream With the Silver Fir (Abies Alba) Wood Extract on the Skin|Completed||N/A|10|Actual|Higher School of Applied Sciences (VIST)||2|||f||||f||||||||||2017-10-10 22:45:03.343269|2017-10-10 22:45:03.343269
NCT02603016|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-03-11|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma|Phase 1 Study of Clinical Nutrition That Research Safty and Efficacy in Lung Neoplasms And Breast Carcinoma|Completed||N/A|480|Actual|Chinese PLA General Hospital||4|||f||||t||||||||||2017-10-10 22:45:03.431969|2017-10-10 22:45:03.431969
NCT02603003|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-04-24|||June 2015||2015-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|CTC-TCM-FZ||"theFuzzing Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs"|"A Study on theFuzzingTherapy Promoted Immune Reconstitution to Improve the Survival of Early-stage Lung Cancer After Surgical Operation"|Active, not recruiting||Phase 1|200|Anticipated|Shanghai University of Traditional Chinese Medicine||3|||f||||f||||||||||2017-10-10 22:45:03.529166|2017-10-10 22:45:03.529166
NCT02602990|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-07-05|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01|6 Months|Observational [Patient Registry]|||Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic Agent|Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic Agent|Active, not recruiting||N/A|50|Anticipated|Emboflu|||1||f||||f||||||||||2017-10-10 22:45:03.623394|2017-10-10 22:45:03.623394
NCT02602977|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-04-01|||October 2015||2015-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|RISPENDO||the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia|the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia, a Pilot Proof-of-principle Study|Completed||Early Phase 1|30|Actual|Radboud University||3|||f||||f||||||||||2017-10-10 22:45:03.710947|2017-10-10 22:45:03.710947
NCT02602964|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-04-01|||April 2015||2015-04-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|LEOPARD-3||A Trial Comparing Deep Versus Moderate Neuromuscular Block - in Low Pressure Pneumoperitoneum|A Randomized Controlled Trial Comparing Deep Versus Moderate Neuromuscular Block - in Low Pressure Pneumoperitoneum - to Optimize the Surgical Conditions During Laparoscopic Donor Nephrectomy|Completed||Phase 4|34|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 22:45:03.85482|2017-10-10 22:45:03.85482
NCT02602951|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-02-11|||November 2015||2015-11-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|4D-FLOW||4D FLOW: Feasibility Study of a Sequence 4D of Flow Applied to the Cervico-encephalic Vascular Pathologies|4D FLOW: Feasibility Study of a Sequence 4D of Flow Applied to the Cervico-encephalic Vascular Pathologies|Recruiting||N/A|30|Anticipated|Centre Hospitalier St Anne||2|||f||||f||||||||||2017-10-10 22:45:03.944941|2017-10-10 22:45:03.944941
NCT02602925|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-05-17|||March 2016|Actual|2016-03-01|November 2016|2016-11-01|April 20, 2018|Anticipated|2018-04-20|April 20, 2018|Anticipated|2018-04-20||Interventional|||Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity|Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity: A Randomized Pragmatic Trial|Active, not recruiting||Phase 4|120|Actual|Radboud University||2|||f||||f||||||||Undecided||2017-10-10 22:45:04.154724|2017-10-10 22:45:04.154724
NCT02602912|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-06-05|||May 2015||2015-05-01|June 2017|2017-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Identification of Spine Structures by Using BIP-Needles|INJ-SPINE-01 Identification of Spine Structures by Using BIP-Needles|Recruiting||N/A|100|Anticipated|Injeq Ltd||1|||f||||f||||||||||2017-10-10 22:45:04.26522|2017-10-10 22:45:04.26522
NCT02602899|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2016-12-08|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|ANT-DBS-RE||Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Refractory Epilepsy|Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Refractory Epilepsy|Recruiting||N/A|30|Anticipated|Beijing Pins Medical Co., Ltd||1|||f||||t||||||||||2017-10-10 22:45:04.355964|2017-10-10 22:45:04.355964
NCT02602886|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-11-27|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder|Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder|Recruiting||N/A|48|Anticipated|Ruijin Hospital||1|||f||||f||||||||No||2017-10-10 22:45:04.498073|2017-10-10 22:45:04.498073
NCT02602873|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-08-11|||August 2015||2015-08-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|July 2017|Anticipated|2017-07-01||Observational|||Study of Tacrolimus Used for Pediatric Patients With Nephrotic Syndrome Based on Pharmacogenomics and Metabonomics|Guangzhou Women and Children's Medical Center|Enrolling by invitation||N/A|150|Anticipated|Guangzhou Women and Children's Medical Center|||2||f||||f||||||Samples With DNA|"     DNAs extracted from whole blood are stored in freezer with -80 centigrade.   "|No|we are carrying out experiment now. Data is not ready to publish for not completing the study. We will share data when we complete our study.|2017-10-10 22:45:04.67069|2017-10-10 22:45:04.67069
NCT02602860|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-05-11|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers|A Single-center, Open-label Positron Emission Tomography Study to Evaluate the Time-course of Displacement of [11C]UCB-J by Brivaracetam and Levetiracetam in Healthy Volunteers|Recruiting||Phase 1|16|Anticipated|UCB Pharma||2|||f||||f||||||||||2017-10-10 22:45:04.804346|2017-10-10 22:45:04.804346
NCT02602847|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-12-27|||November 2012||2012-11-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|ECOGREFFE-B||Study of Covalently Closed Circular DNA (cccDNA) in Liver Transplant Patients With B Virus Markers|Study of cccDNA in Liver Transplant Patients With B Virus Markers|Recruiting||N/A|42|Anticipated|Hospices Civils de Lyon|||3||f||||f||||||||||2017-10-10 22:45:04.952252|2017-10-10 22:45:04.952252
NCT02602834|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-11-09|||May 2015||2015-05-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Imminently Effect of Interval Training With High Intensity (HIT) After Heart Transplantation|Changes in Blood Measured Before, During and After Exercise in Heart Transplant Recipients. Imminently Effect of Interval Training With High Intensity Compared With Continuous Moderate Intensity|Completed||N/A|19|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 22:45:05.115692|2017-10-10 22:45:05.115692
NCT02602808|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-06-02|||January 2014||2014-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Observational|||Study of Peripheral Blood Non-coding RNAs as Diagnosis and Prognosis Biomarker for Acute Pancreatitis|Study of Peripheral Blood Non-coding RNAs as Diagnosis and Prognosis Biomarker for Acute Pancreatitis|Recruiting||N/A|600|Anticipated|Changhai Hospital|||3||f||||t||||||Samples Without DNA|"     Peripheral blood samples were collected from patients within the first 24 h after hospital     admission. Serum, plasma and blood cells was isolated after blood collection by     centrifugation at room temperature.   "|||2017-10-10 22:45:05.201995|2017-10-10 22:45:05.201995
NCT02602795|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-04-10|||December 2015||2015-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence|Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence|Recruiting||N/A|95|Anticipated|Rhode Island Hospital||3|||f||||t||||||||||2017-10-10 22:45:05.303703|2017-10-10 22:45:05.303703
NCT02602782|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-06-27|||December 2015||2015-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|PRESCIENT||Physiologic Signals and Signatures With the Accuryn™ Monitoring System in Intensive Care Patients|Physiologic Signals and Signatures With the Accuryn™ Monitoring System in Intensive Care Patients|Enrolling by invitation||N/A|100|Anticipated|Potrero Medical|||1||f||||||f||||||||2017-10-10 22:45:05.393855|2017-10-10 22:45:05.393855
NCT02602769|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2016-09-09|||November 2015||2015-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Observational|||Metabolic Phenotyping in Children With ROHHAD Syndrome|Metabolic Phenotyping in Children With ROHHAD Syndrome|Recruiting||N/A|12|Anticipated|Boston Children’s Hospital|||2||f||||f||||||Samples Without DNA|"     The investigators will retain blood samples for future measurement of hormones involved in     regulation of weight, appetite and satiety.   "|||2017-10-10 22:45:05.447684|2017-10-10 22:45:05.447684
NCT02602756|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-07-25|||November 2015||2015-11-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|January 2019|Anticipated|2019-01-01||Interventional|HYGROMEL||Study Assessing Two Models of Hypofractionated Protontherapy on Large Choroidal Melanomas|Phase II Trial, Randomized, Under Single-blind Conditions, Assessing Two Models of Modified Hypofractionated Proton-therapy on Patients With Large Choroidal Melanomas|Recruiting||Phase 2|82|Anticipated|Centre Antoine Lacassagne||2|||f||||t||||||||||2017-10-10 22:45:05.546537|2017-10-10 22:45:05.546537
NCT02602743|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-02-03|||August 2016|Actual|2016-08-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Propofol-Ketamine vs Remifentanyl-Ketamine for Sedation in Pediatric Patients Undergoing Colonoscopy|Propofol-Ketamine vs Remifentanyl-Ketamine for Sedation in Pediatric Patients Undergoing Colonoscopy|Completed||Phase 4|70|Actual|Cukurova University||2|||f||||f||||||||No||2017-10-10 22:45:05.642393|2017-10-10 22:45:05.642393
NCT02602717|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-11-10|||February 2013||2013-02-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|Tgcyto||The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study.||Unknown status|Recruiting|N/A|110|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-10 22:45:05.815412|2017-10-10 22:45:05.815412
NCT02602704|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-11-06|||December 2015||2015-12-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients|Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients|Recruiting||Phase 4|114|Anticipated|Hanyang University||2|||f||||f||||||||No||2017-10-10 22:45:05.898011|2017-10-10 22:45:05.898011
NCT02602691|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-09-30|||April 2016||2016-04-01|September 2016|2016-09-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|CUPIDON||Cost-utility Analysis of the AlloMap® Test|Cost-utility Analysis of the AlloMap® Test for the Monitoring of Patients After Heart Transplantation|Recruiting||N/A|216|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:45:05.998096|2017-10-10 22:45:05.998096
NCT02602678|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-01-27|||November 2015||2015-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|BRONCHIO-DV||Prone Position Effects on Work of Breathing and Intrinsic PEEP in Children With Severe Acute Viral Bronchiolitis|Prone Position Effects on Work of Breathing and Intrinsic PEEP in Children With Severe Acute Viral Bronchiolitis|Completed||N/A|16|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:45:06.084395|2017-10-10 22:45:06.084395
NCT02602665|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Central Line Placement-EVALUATION OF LINE DEPTH AS A FACTOR IN NEED FOR LINE REPLACEMENT SECONDARY TO MALPOSITION|Central Line Placement Study -EVALUATION OF LINE DEPTH AS A FACTOR IN NEED FOR LINE REPLACEMENT SECONDARY TO MALPOSITION|Not yet recruiting||N/A|130|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 22:45:06.156833|2017-10-10 22:45:06.156833
NCT02602639|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-10|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|FES||Functional Electrical Stimulation With Rowing as Exercise After Spinal Cord Injury|Development of a Spinal Cord Injury-specific Exercise-based Capacity|Enrolling by invitation||N/A|6|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-10-10 22:45:06.309756|2017-10-10 22:45:06.309756
NCT02602626|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-04-21|||November 2015||2015-11-01|November 2015|2015-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||The Acceptability of the HPV Vaccine Postpartum and With Pediatric Well-child Visits: A Pilot Study|The Acceptability of the HPV Vaccine Postpartum and With Pediatric Well-child Visits: A Pilot Study|Completed||N/A|600|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 22:45:06.377714|2017-10-10 22:45:06.377714
NCT02602613|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-06-19|||December 2015||2015-12-01|June 2016|2016-06-01||||December 2018|Anticipated|2018-12-01||Interventional|||AMENDTM Mitral Valve Repair System, Annuloplasty Ring Applied in a Transcatheter Method||Recruiting||N/A|40|Anticipated|Valcare Medical Ltd.||1|||f||||||||||||||2017-10-10 22:45:06.439864|2017-10-10 22:45:06.439864
NCT02602600|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-12-20|||November 2015||2015-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GAP||Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis|Effect of Glucagon-like Peptide-1 Stimulation on Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Obstructive Stenosis of Major Coronary Vessels|Recruiting||Phase 4|33|Anticipated|Bispebjerg Hospital||1|||f||||t||||||||||2017-10-10 22:45:06.531203|2017-10-10 22:45:06.531203
NCT02602587|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-21|||September 2014||2014-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|OXYLAM||Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients|Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients. Modulations of the Balance During Cytarabine/Anthracycline Treatment - OxyLAM|Active, not recruiting||N/A|37|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 22:45:06.764303|2017-10-10 22:45:06.764303
NCT02602574|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-05-02|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Observational|||ERCP-induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?|Endoscopic Retrograde Cholangiopancreatography (ERCP)-Induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?|Enrolling by invitation||N/A|66|Anticipated|University Hospital Rijeka|||3||f||||t||||||Samples With DNA|"     plasma, mononuclear cell suspension   "|||2017-10-10 22:45:06.861946|2017-10-10 22:45:06.861946
NCT02602561|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-08-28|||November 2015||2015-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of HMB Supplementation on Recovery Following ACL Surgery|Effects of HMB Supplementation on Muscle Mass Following ACL Reconstructive Surgery|Recruiting||N/A|30|Anticipated|Metabolic Technologies Inc.||2|||f||||f||||||||||2017-10-10 22:45:06.990316|2017-10-10 22:45:06.990316
NCT02602548|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2016-09-28|||May 2015||2015-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||The Incidence and Incubation Period of False Positive Cultures in Shoulder Surgery|The Incidence and Incubation Period of False Positive Cultures in Shoulder Surgery Study Protocol: A Pilot Study|Enrolling by invitation||N/A|100|Anticipated|Methodist Sports Medicine|||2||f||||f||||||||Yes||2017-10-10 22:45:07.099713|2017-10-10 22:45:07.099713
NCT02602535|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-09-13|||January 2016||2016-01-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Mindfulness-Oriented Recovery Enhancement For Chronic Pain and Prescription Opioid Misuse in Primary Care|Mindfulness-Oriented Recovery Enhancement For Chronic Pain and Prescription Opioid Misuse in Primary Care|Recruiting||N/A|260|Anticipated|University of Utah||2|||f||||||||||||||2017-10-10 22:45:07.180686|2017-10-10 22:45:07.180686
NCT02602522|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2016-10-09|||November 2015||2015-11-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Interventional|||Danshen-Jiang-Fu Granule Prepared by Danshen From Different Producing Areas for Primary Dysmenorrhea|The Comparison of the Effect on Danshen-Jiang-Fu Granule Prepared by Danshen (Salvia Miltiorrhiza) From Different Producing Areas (Shandong and Sichuan) for Primary Dysmenorrhea: a Cross-over, Randomized, Double-blind Controlled Trials|Recruiting||Early Phase 1|100|Anticipated|China Academy of Chinese Medical Sciences||2|||f||||f||||||||||2017-10-10 22:45:07.276917|2017-10-10 22:45:07.276917
NCT02602509|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-04-12|||November 2015||2015-11-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers|Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers|Completed||Phase 1|18|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-10 22:45:07.367321|2017-10-10 22:45:07.367321
NCT02602496|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-02-15|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals|Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals Through Intake of Whole Wheat Products in Comparison With Fruits and Vegetables|Recruiting||N/A|100|Anticipated|University of Nebraska Lincoln||4|||f||||t||||||||||2017-10-10 22:45:07.47846|2017-10-10 22:45:07.47846
NCT02602483|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-01-18|||December 2015||2015-12-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).|Randomized, Double Blind, Placebo Controlled Exploratory Study To Assess the Efficacy and Safety of a Triple Combination of Ibuprofen+Mg+Ascorbic Acid for Acute Pain Treatment in Temporomandibular Join Disorder (TMJD) Patients|Completed||Phase 1/Phase 2|96|Actual|Spherium Biomed||4|||f||||t||||||||Undecided||2017-10-10 22:45:07.605103|2017-10-10 22:45:07.605103
NCT02602470|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-05-10|||January 8, 2015|Actual|2015-01-08|April 2017|2017-04-01|March 10, 2016|Actual|2016-03-10|March 10, 2016|Actual|2016-03-10||Observational|||Preferences & Treatment Satisfaction Drivers in Rosacea Patients|A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea|Completed||N/A|206|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:45:07.752454|2017-10-10 22:45:07.752454
NCT02602457|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-06-19|||November 2015||2015-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)|Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)|Recruiting||N/A|108|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-10 22:45:07.858603|2017-10-10 22:45:07.858603
NCT02602444|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-04-26|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|PINPOINT||Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients|Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction Patients|Completed||N/A|73|Actual|Collegium Medicum w Bydgoszczy|||2||f||||f||||||||||2017-10-10 22:45:07.963386|2017-10-10 22:45:07.963386
NCT02602431|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-05-10|||March 2014||2014-03-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Low Laser Light Therapy After Impacted Third Molar Removal|A Unique Application of Low Laser Therapy After Third Molar Surgery: A Randomized Controlled Clinical Trial|Recruiting||N/A|30|Anticipated|University of Sao Paulo||4|||f||||f||||||||||2017-10-10 22:45:08.056466|2017-10-10 22:45:08.056466
NCT02602418|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-05-24|||September 2012|Actual|2012-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Neural Correlates of Working Memory Training for HIV Patients|Neural Correlates of Working Memory Training for HIV Patients: A Randomized Control Clinical Trial|Recruiting||N/A|180|Anticipated|University of Hawaii||2|||f||||t||||||||No||2017-10-10 22:45:08.179237|2017-10-10 22:45:08.179237
NCT02602405|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-11-28|||December 2015||2015-12-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Return to Work After Potential Severe Injury|Return to Work After Potential Severe Injury; a Population Based Observational Study|Completed||N/A|1741|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-10 22:45:08.287217|2017-10-10 22:45:08.287217
NCT02602392|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2015-11-09|||January 2011||2011-01-01|November 2015|2015-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ChildAsthma||Online Asthma Self-Management for Children Aged 5-10 and Their Parents|Online Asthma Self-Management for Children Aged 5-10 and Their Parents|Completed||Phase 2|622|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 22:45:08.366996|2017-10-10 22:45:08.366996
NCT02602379|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2016-11-16|||February 2015||2015-02-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Evaluation of NoL Index and ANI After Nociceptive Stimulation at Different Infusion Rates of Remifentanil Infusion|Evaluation of NoL Index and ANI Variations After Nociceptive Stimulation Under Different Rates of Infusion of Intravenous Remifentanil in Patients Undergoing Laparotomies With Intraoperative Epidural Analgesia|Completed||N/A|40|Actual|Maisonneuve-Rosemont Hospital|||1||f||||t||||||||||2017-10-10 22:45:08.449928|2017-10-10 22:45:08.449928
NCT02602366|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-07-29|||November 2015||2015-11-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy|The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy Among Young Women in Zimbabwe and South Africa|Recruiting||N/A|400|Anticipated|CONRAD||4|||f||||f||||||||||2017-10-10 22:45:08.549201|2017-10-10 22:45:08.549201
NCT02602353|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-10-26||2016-10-25|October 2015||2015-10-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)|A Phase 2, Randomized, Double-Blind, Parallel-Group and Placebo-Controlled Pilot Study to Assess the Safety and Efficacy of a New Pain Patch Versus Placebo and No Treatment for the Treatment of Delayed Onset Muscle Soreness (DOMS)|Completed||Phase 2|42|Actual|Lead Chemical Co.,Ltd.||3|||f||||f||||||||||2017-10-10 22:45:08.666814|2017-10-10 22:45:08.666814
NCT02602340|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-02-02|||October 2015||2015-10-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Neurocognitive Predictors of Behavioral Therapy Response in Depression|Neurocognitive Predictors of Behavioral Therapy Response in Depression|Recruiting||N/A|100|Anticipated|Laureate Institute for Brain Research, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:45:08.759229|2017-10-10 22:45:08.759229
NCT02602327|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-12-02|||October 2016||2016-10-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases|Phase I Study of Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases|Recruiting||Phase 1|24|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 22:45:08.854218|2017-10-10 22:45:08.854218
NCT02602314|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01|February 2024|Anticipated|2024-02-01|February 2023|Anticipated|2023-02-01||Interventional|SUSTRENIM||Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia|Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia: a Prospective Study Comparing Nilotinib Versus Imatinib With Switch to Nilotinib in Absence of Optimal Response. SUSTRENIM Study - GIMEMA CLM1415|Not yet recruiting||Phase 4|600|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||2|||f||||t||||||||No||2017-10-10 22:45:08.976024|2017-10-10 22:45:08.976024
NCT02602301|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-11-10|||November 2015||2015-11-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels|The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels .A Prospective Randomized Controlled Trial.|Active, not recruiting||Phase 4|327|Anticipated|Kasr El Aini Hospital||3|||f||||f||||||||||2017-10-10 22:45:09.240236|2017-10-10 22:45:09.240236
NCT02602275|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-01-27|||August 2015||2015-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|NEURIM||Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands|Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands - A Randomized, Placebo-controlled, Double-blind, Cross-over Trial of Mode of Action and Response Prediction by Functional Magnetic Resonance Imaging MRI|Completed||Phase 2|53|Actual|Biologische Heilmittel Heel GmbH||2|||f||||f||||||||Undecided||2017-10-10 22:45:09.422969|2017-10-10 22:45:09.422969
NCT02602262|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-08-25|||November 2015||2015-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients|Observational Study of HIV+ Deceased Donor Solid Organ Transplant for HIV+ Recipients|Active, not recruiting||N/A|425|Anticipated|Johns Hopkins University|||2||f||||f|f|f||||Samples With DNA|"     Plasma, serum, peripheral blood mononuclear cells, tissue   "|||2017-10-10 22:45:09.506705|2017-10-10 22:45:09.506705
NCT02602249|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-10|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.|Phase 1 Study of Antigen-specific Cytotoxic T Lymphocytes Induced by Dendritic Cells Infected by Recombinant Adeno-associated Virus With MUC1 Gene(MUC1-gene-DC-CTL) or Directly Pulsed by MUC1 Peptide(MUC1-peptide-DC-CTL) in Gastric Cancer.|Not yet recruiting||Phase 1|24|Anticipated|Beijing Doing Biomedical Co., Ltd.||3|||f||||f|f|f||||||||2017-10-10 22:45:09.610161|2017-10-10 22:45:09.610161
NCT02602236|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-02-03|||November 2015||2015-11-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Multicenter Pilot Study to Describe the Performance of a New Device in Patients With Colostomy|Multicenter Pilot Study to Describe the Performance of a New Device in Patients With Colostomy|Terminated||N/A|31|Actual|BBraun Medical SAS||1||Investigational product needs improvements|f||||f||||||||||2017-10-10 22:45:09.69193|2017-10-10 22:45:09.69193
NCT02602223|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-08-26|2016-04-15||September 2012||2012-09-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Comparison of Amnion Chorion Membrane vs. Dense Polytetrafluoroethylene Membrane in Ridge Preservation Procedures|A Randomized Split-mouth Clinical Trial on Effectiveness of Amnion-Chorion Membranes in Alveolar Ridge Preservation: a Clinical, Radiological, & Morphometric Study|Completed||Phase 2|9|Actual|Indiana University|Small Sample size, but expanding study not justified through post hoc analysis. Crossover effects due to split mouth study design potentially indirect and possibly only minimal due to biological infeasibility of cross over effects.|2|||f||||f||||||||||2017-10-10 22:45:09.78577|2017-10-10 22:45:09.78577
NCT02602210|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-11-09|||January 2015||2015-01-01|September 2015|2015-09-01||||May 2017|Anticipated|2017-05-01||Interventional|SCOTCH||Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis|Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis|Unknown status|Recruiting|Phase 3|356|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-10 22:45:10.115042|2017-10-10 22:45:10.115042
NCT02602197|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-11-10|||August 2013||2013-08-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Intravenous Paracetamol Compared Dexketoprofen for Postoperative Analgesia After Septoplasty|The Efficacy of Intravenous Paracetamol Versus Dexketoprofen for Postoperative Pain Management After Septoplasty: A Prospective Randomized Double Blind Study|Active, not recruiting||Phase 3|2|Actual|Baskent University||2|||f||||t||||||||||2017-10-10 22:45:10.283353|2017-10-10 22:45:10.283353
NCT02602184|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2016-07-18|||November 2015||2015-11-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds|Prospective, Placebo-controlled, Double Blind, Randomized Intra-individual Comparative Clinical Study to Assess the Safety and Efficacy of AR/101 Compared to Placebo in Accelerating Re-epithelialization of Split Thickness Wounds|Recruiting||Phase 2|18|Anticipated|Arava Bio Tech Ltd.||2|||f||||f||||||||||2017-10-10 22:45:10.351645|2017-10-10 22:45:10.351645
NCT02602171|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-09|||April 2015||2015-04-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|VALEEvE||Virtual Acoustic Localization Experiment|Virtual Acoustic Localization Experiment for the Evaluation of a Dereverberation Algorithm in Terms of Speech Intelligibility & Localization Performance of Normal Hearing & Hearing Impaired Subjects|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 22:45:10.624411|2017-10-10 22:45:10.624411
NCT02602158|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-07-21|||October 2015||2015-10-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|13CTriOBT||13C Trioctanoate Breath Test as a Measurement of Gastric Fat Volume Emptying|The13C Trioctanoate Breath Test as a Measurement Method for the Gastric Emptying of Fat; a Randomised, Single Blinded, Cross Over Study|Completed||Early Phase 1|32|Actual|University of Zurich||2|||f||||t||||||||No||2017-10-10 22:45:10.72968|2017-10-10 22:45:10.72968
NCT02602145|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-09-21|||December 2014||2014-12-01|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Observational|SFA stent||Optimal Stent Selection for the Femoropopliteal Artery|Optimal Stent Selection for the Femoropopliteal Artery|Recruiting||N/A|40|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-10-10 22:45:10.852483|2017-10-10 22:45:10.852483
NCT02602132|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-08-21|||March 2016||2016-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||Clamping vs. Free Drainage Before the Removal of Short-term Indwelling Urethral Catheters in Internal Medicine Patients.|Clamping vs. Free Drainage Before the Removal of Short-term Indwelling Urethral Catheters in Internal Medicine Patients.|Suspended||N/A|242|Anticipated|Hospital Universitario Fundación Alcorcón||2||Not enough participants. very slow and poor recruitment|f||||f||||||||||2017-10-10 22:45:10.961186|2017-10-10 22:45:10.961186
NCT02602119|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-09-21|||May 2015||2015-05-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Intraoperative Imaging of Pulmonary Nodules by OTL38|Intraoperative Imaging of Pulmonary Nodules by OTL38|Recruiting||Phase 1|48|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:45:11.051746|2017-10-10 22:45:11.051746
NCT02602106|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-09|||June 2011||2011-06-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|September 2012|Actual|2012-09-01||Interventional|aquapreg||Regular Aquatic Activities and Pregnancy Outcomes|Effects of Regular Aquatic Activities on Pregnancy Outcomes|Unknown status|Recruiting|N/A|200|Anticipated|Universidad Politecnica de Madrid||2|||f||||t||||||||||2017-10-10 22:45:11.175401|2017-10-10 22:45:11.175401
NCT02602093|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-06-07|||January 2016||2016-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Percutaneous Transforaminal Endoscopic Discectomy vs. Open Microdiscectomy for Lumbar Disc Herniation (PTED-study)|(Cost) Effectiveness of Percutaneous Transforaminal Endoscopic Discectomy vs. Open Microdiscectomy for Patients With Symptomatic Lumbar Disc Herniation|Recruiting||N/A|682|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-10-10 22:45:11.297902|2017-10-10 22:45:11.297902
NCT02602080|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-05-23|||December 2015||2015-12-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Patient Recovery After Orthopedic Surgery Under Nerve Blocks With Sedation vs. Nerve Block With Either Sedation or General Anesthesia|Patient Recovery After Orthopedic Surgery Under Nerve Blocks With Sedation in Foot and Ankle Patients (FA) and Nerve Block With Either Sedation or General Anesthesia (GA) in Total Shoulder Arthroplasty (TSA) Patients. A Pilot Study|Completed||N/A|55|Actual|Hospital for Special Surgery, New York|||3||f||||f||||||||||2017-10-10 22:45:11.456751|2017-10-10 22:45:11.456751
NCT02602067|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-11-04|||November 2015||2015-11-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|Tenatumomab||131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients|A Dose Escalation Study to Evaluate Safety, Tolerability Dosimetry, Pharmacokinetics and Preliminary Efficacy of 131I-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients|Suspended||Phase 1|36|Anticipated|sigma-tau i.f.r. S.p.A.||1||An amendment has to be submitted in order to change drug infusion modality|f||||t||||||||||2017-10-10 22:45:11.545595|2017-10-10 22:45:11.545595
NCT02602054|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-11-16|||October 2015||2015-10-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|April 2016|Anticipated|2016-04-01||Interventional|||The Best Treatment Strategy: Surgical vs Pharmacological to Close the Ductus Arteriosus Persistent in Preterm Infants|The Best Treatment Strategy: Surgical Versus Pharmacological, to Close the Ductus Arteriosus Persistent in Preterm Infants. A Randomized Controlled Trial|Recruiting||Phase 2|40|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||2|||f||||f||||||||||2017-10-10 22:45:11.697863|2017-10-10 22:45:11.697863
NCT02602041|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-04-20|||November 2015||2015-11-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study|Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners|Recruiting||N/A|40|Anticipated|University Medical Center Groningen|||2||f||||f||||||||||2017-10-10 22:45:11.867787|2017-10-10 22:45:11.867787
NCT02602028|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-09|||April 2011||2011-04-01|November 2015|2015-11-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF|The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With Familial Mediterranean Fever: A Randomized Trial|Completed||Phase 4|79|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||2|||f||||f||||||||||2017-10-10 22:45:12.775775|2017-10-10 22:45:12.775775
NCT02602002|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-11-09|||April 2008||2008-04-01|November 2015|2015-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Experimental Medicine Study to Validate Pharmacodynamic Pain Assessments in Healthy Volunteers With an Opioid Analgesic (Remifentanil)|Experimental Medicine Study to Validate Pharmacodynamic Pain Assessments in Healthy Volunteers in a Randomised, Double Blind, Placebo Controlled, 2 Way Cross-over Design With an Opioid Analgesic (Remifentanil)|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:45:12.924386|2017-10-10 22:45:12.924386
NCT02601989|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-06-20|||November 2015||2015-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MAKROTAD||Effects on Insulin Resistance With Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study|Effects on Insulin Resistance With the Phosphodiesterase-5 Inhibitor Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study|Recruiting||Phase 2|25|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 22:45:13.060199|2017-10-10 22:45:13.060199
NCT02601976|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-09|||August 2010||2010-08-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2012|Actual|2012-09-01||Interventional|EUROP||Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population|Response Evaluation of Peginterferon Alfa-2a 180µg 20kDa (Unipeg®) Plus Ribavirin (Ribazole®) in Treatment naïve Pakistani Population With Chronic Hepatitis C Infection|Completed||Phase 4|64|Actual|Getz Pharma||1|||f||||t||||||||||2017-10-10 22:45:13.213193|2017-10-10 22:45:13.213193
NCT02601963|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-02-14|||September 2015||2015-09-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|EMIRA||Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea|A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Two Different Doses of a Topical Minocycline Foam Compared to Vehicle in the Treatment of Papulopustular Rosacea - Study FX2015-10|Completed||Phase 2|233|Actual|Foamix Ltd.||3|||f||||f||||||||||2017-10-10 22:45:13.375467|2017-10-10 22:45:13.375467
NCT02601950|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-14|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma|A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma|Recruiting||Phase 2|250|Anticipated|Epizyme, Inc.||1|||f||||t||||||||||2017-10-10 22:45:13.605234|2017-10-10 22:45:13.605234
NCT02601937|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-08-02|||December 2015||2015-12-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma|A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma|Recruiting||Phase 1|108|Anticipated|Epizyme, Inc.||1|||f||||f||||||||||2017-10-10 22:45:13.983407|2017-10-10 22:45:13.983407
NCT02601924|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2017-01-27|||November 2015||2015-11-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of Pressure Massage and Topical Gel on Pain During Intra Oral Injections|Efficacy of Pressure Massage and Topical Gel on Pain During Inferior Alveolar Nerve Block and Maxillary Anterior Injections: A Single-Blind Randomized Clinical Trial|Enrolling by invitation||Phase 2|80|Actual|Azad University of Medical Sciences||4|||f||||t||||||||||2017-10-10 22:45:14.204933|2017-10-10 22:45:14.204933
NCT02601911|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-09-17|||September 2015||2015-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Premedication on Success of Inferior Alveolar Nerve Block Injection|Comparison of Ketorolac and Ketorolac/Acetaminophen on Success of Inferior Alveolar Nerve Block Injection|Completed||Phase 2|60|Actual|Azad University of Medical Sciences||3|||f||||t||||||||||2017-10-10 22:45:14.280872|2017-10-10 22:45:14.280872
NCT02601898|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-01-07|||January 2015||2015-01-01|January 2016|2016-01-01||||November 2015|Actual|2015-11-01||Interventional|||Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment|Vaginal Administration of Alpha Lipoic Acid vs Progesterone for the Subchorionic Hematoma Treatment|Completed||Phase 4|54|Actual|Azienda USL Ferrara||2|||f||||||||||||||2017-10-10 22:45:14.367411|2017-10-10 22:45:14.367411
NCT02601885|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-16|||October 18, 2016||2016-10-18|August 2017|2017-08-01|May 14, 2019|Anticipated|2019-05-14|July 13, 2018|Anticipated|2018-07-13||Interventional|||A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis|An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis|Recruiting||Phase 1|35|Anticipated|AbbVie||3|||f||||f||||||||||2017-10-10 22:45:14.452435|2017-10-10 22:45:14.452435
NCT02601859|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-05-18|||June 2016||2016-06-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment|Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment|Not yet recruiting||N/A|20|Anticipated|University of Dundee||1|||f||||f||||||||||2017-10-10 22:45:14.551848|2017-10-10 22:45:14.551848
NCT02601846|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|RELAX-PE||Age-adjusted D-dimer Cut-off to Rule Out Pulmonary Embolism in the Emergency Department : A Real Life Impact Study|Age-adjusted D-dimer Cut-off to Rule Out Pulmonary Embolism in the Emergency Department : A Real Life Impact Study|Recruiting||N/A|1100|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 22:45:14.637294|2017-10-10 22:45:14.637294
NCT02601833|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-02-27|||January 2016||2016-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of Silver Diamine Fluoride as a Treatment for Caries in Comparison to Traditional Restorative Techniques|The Effectiveness of Silver Diamine Fluoride as a Treatment for Caries in Comparison to Traditional Restorative Techniques: A 12 Month Randomized Controlled Trial|Recruiting||Phase 3|98|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 22:45:14.826102|2017-10-10 22:45:14.826102
NCT02601820|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-09-14|||November 2015||2015-11-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Observational|PROP-UP||The Patient-Reported Outcomes Project of HCV-TARGET|The Patient-Reported Outcomes Project of HCV-TARGET (PROP UP)|Recruiting||N/A|1600|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 22:45:14.969153|2017-10-10 22:45:14.969153
NCT02601807|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-05-10|||August 2015||2015-08-01|May 2016|2016-05-01||||October 2016|Anticipated|2016-10-01||Interventional|||ActiPatch Therapy for Back Pain|A Randomised Controlled Trial to Assess the Benefits of ActiPatch-Pulsed Shortwave Therapy for Chronic Lower Back Pain|Recruiting||N/A|30|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 22:45:15.113048|2017-10-10 22:45:15.113048
NCT02601794|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-06-20|||August 2015||2015-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|DIVAS||A Study of Delivering a Mindfulness App Intervention to Accompany Supportive Care Among Women With Breast Cancer|Delivering an Intervention to Accompany Supportive Care|Completed||N/A|112|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 22:45:15.215779|2017-10-10 22:45:15.215779
NCT02600676|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-10-24|||September 2015||2015-09-01|September 2015|2015-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis|Randomized, Double Blind, Placebo Controlled Trial of Sacral Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis|Completed||N/A|52|Actual|University of Aarhus||2|||f||||t||||||||Yes|Publication|2017-10-10 22:45:28.811258|2017-10-10 22:45:28.811258
NCT02601781|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-12-28|||October 2015||2015-10-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2016|Actual|2016-12-01||Interventional|STRATEGY-IT||Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry|A Prospective Evaluation of a Standardized Strategy for the Use of Bioresorbable Vascular Scaffold in ST-segment Elevation Myocardial Infarction: the BVS STEMI STRATEGY-IT Registry|Active, not recruiting||Phase 4|500|Actual|Azienda Ospedaliera Bolognini di Seriate Bergamo||1|||f||||t||||||||||2017-10-10 22:45:15.331841|2017-10-10 22:45:15.331841
NCT02601768|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2015-11-09|||January 2015||2015-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Occluder Size Determination in Transcatheter ASD II Closure Based on 3D TEE Assessment|Occluder Size Determination in Transcatheter Closure of Ostium Secundum Atrial Septal Defect Based on Three-Dimensional Echocardiography Assessment|Recruiting||N/A|50|Anticipated|Institute of Cardiology, Warsaw, Poland|||1||f||||t||||||||||2017-10-10 22:45:15.426043|2017-10-10 22:45:15.426043
NCT02601755|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-04-24|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||iCanCope With Pain: A Smartphone and Web Self-management Program for Adolescents and Young Adults With Chronic Pain|iCanCope With Pain: An Integrated Smartphone and Web Self-management Program for Adolescents and Young Adults With Chronic Pain|Recruiting||N/A|120|Anticipated|The Hospital for Sick Children||2|||f||||f|f|f||||||||2017-10-10 22:45:15.515462|2017-10-10 22:45:15.515462
NCT02601742|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2015-11-09|||November 2015||2015-11-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|January 2016|Anticipated|2016-01-01||Interventional|||Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute|Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute in Mexican Children: Randomized Double-blind Study|Unknown status|Not yet recruiting|Phase 3|350|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||2|||f||||f||||||||||2017-10-10 22:45:17.299639|2017-10-10 22:45:17.299639
NCT02601729|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-04-03|||September 2014||2014-09-01|April 2017|2017-04-01||||April 2018|Anticipated|2018-04-01||Observational|RESCUE||Reimbursement Study of Continuous Glucose Monitoring in Belgium|Clinical Impact of RT-CGM Reimbursement in Belgium: a Multicenter Real-life Observational Study|Active, not recruiting||N/A|500|Anticipated|Katholieke Universiteit Leuven|||2||f||||f||||||||||2017-10-10 22:45:17.449361|2017-10-10 22:45:17.449361
NCT02601716|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-08-25|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults|Clinical Trial of PfSPZ Vaccine Administered by Direct Venous Inoculation: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults|Active, not recruiting||Phase 2|92|Actual|Sanaria Inc.||6|||f||||t||||||||||2017-10-10 22:45:17.527971|2017-10-10 22:45:17.527971
NCT02601703|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-11-16|||August 2015||2015-08-01|July 2016|2016-07-01||||October 2016|Actual|2016-10-01||Interventional|||To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Tacrolimus Ointment, 0.1% (Glenmark Pharmaceuticals, Ltd) to the Marketed Product Protopic® (Tacrolimus) Ointment, 0.1% (Astellas Pharma US, Inc.) in the Treatment of Moderate to Severe Atopic Dermatitis (AD)|Completed||Phase 3|1110|Actual|Glenmark Pharmaceuticals Ltd. India||3|||f||||f||||||||||2017-10-10 22:45:17.666024|2017-10-10 22:45:17.666024
NCT02601690|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-07-07|||October 2015||2015-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America|Observational, Cross-sectional Analysis of T Cell Responses to Synthetic Peptide Immuno-Regulatory Epitopes (SPIREs) for Multiple Allergens in Subjects With Allergy in North America|Active, not recruiting||N/A|199|Actual|Adiga Life Sciences, Inc.|||1||f||||f||||||Samples With DNA|"     Blood samples for Peripheral Blood Mononuclear Cells (from whole blood), Immunoglobulin E     (from serum), and potential tissue typing (from whole blood).   "|||2017-10-10 22:45:17.882385|2017-10-10 22:45:17.882385
NCT02601677|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-08|2015-11-09|||November 2015||2015-11-01|November 2015|2015-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder|Deep Brain Stimulation of Nucleus Accumbens/Anterior Limb of Internal Capsule to Prevent Treatment-Refractory Obsessive Compulsive Disorder|Not yet recruiting||N/A|10|Anticipated|Tang-Du Hospital||2|||f||||t||||||||||2017-10-10 22:45:17.960242|2017-10-10 22:45:17.960242
NCT02601664|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-06-27|||November 2015||2015-11-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|CONCERTO||Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions|Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions|Terminated||Phase 4|3|Actual|North Texas Veterans Healthcare System||2||Due to lack of eligible patients.|f||||t||||||||||2017-10-10 22:45:18.053281|2017-10-10 22:45:18.053281
NCT02601651|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-11-04|||December 2015||2015-12-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect of Perioperative Intravenous Lidocaine on Opioid Consumption and Pain After Laparoscopic Totally Extraperitoneal Inguinal Hernioplasty|Effect of Perioperative Intravenous Lidocaine on Opioid Consumption and Pain After Laparoscopic Totally Extraperitoneal Inguinal Hernioplasty|Active, not recruiting||Phase 4|64|Anticipated|B.P. Koirala Institute of Health Sciences||2|||f||||t||||||||||2017-10-10 22:45:18.312147|2017-10-10 22:45:18.312147
NCT02601638|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-12-12|||November 2014||2014-11-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Laryngectomy Education|Effect of Total Laryngectomy Preoperative Education on Postoperative Complications and Unplanned Hospital Readmission|Completed||N/A|55|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 22:45:18.447673|2017-10-10 22:45:18.447673
NCT02601612|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-09-21|||October 2015||2015-10-01|September 2016|2016-09-01||||May 2017|Anticipated|2017-05-01||Interventional|||Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children|A Phase I Study of the Safety and Immunogenicity of a Single Dose of the Live Recombinant RSV D46cpΔM2-2 Vero Grown Virus Vaccine (Lot RSV #008A), Delivered as Nose Drops to RSV-Seropositive Children 12 to 59 Months of Age and RSV-Seronegative Infants and Children 6 to 24 Months of Age|Recruiting||Phase 1|45|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-10 22:45:18.733093|2017-10-10 22:45:18.733093
NCT02601599|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-03-09|||November 2015|Actual|2015-11-01|April 2016|2016-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|MIND-THE-GAP||Medical Student INtervention to Promote Effective Nicotine Dependence and Tobacco HEalthcare|Medical Student INtervention to Promote Effective Nicotine Dependence and Tobacco HEalthcare: GrAduate Entry Programme (MIND-THE-GAP) Feasibility Randomised Trial|Completed||N/A|67|Actual|Royal College of Surgeons, Ireland||2|||f||||f||||||||||2017-10-10 22:45:18.865756|2017-10-10 22:45:18.865756
NCT02601586|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-07-11|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|OXYDOPA||Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease|Evaluation of the Analgesic Effects of Prolonged-release Oxycodone and of Levodopa, Versus Placebo, on Central Neuropathic Pain in Parkinson's Disease: OXYDOPA Trial|Recruiting||Phase 2/Phase 3|75|Anticipated|University Hospital, Toulouse||3|||f||||f|f|f||||||||2017-10-10 22:45:19.013006|2017-10-10 22:45:19.013006
NCT02601560|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-08-16||2017-08-01|December 3, 2015|Actual|2015-12-03|August 2017|2017-08-01|November 3, 2016|Actual|2016-11-03|August 20, 2016|Actual|2016-08-20||Interventional|||Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics, of MEDI6012 in Subjects With Stable Coronary Artery Disease|A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single- Ascending Doses of MEDI6012 in Subjects With Stable Coronary Artery Disease|Completed||Phase 2|48|Actual|MedImmune LLC||7|||f||||f||||||||||2017-10-10 22:45:19.399815|2017-10-10 22:45:19.399815
NCT02601547|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-11-09|||September 2010||2010-09-01|November 2015|2015-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|LYMCOTEP||PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma|PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma Patients -Implication in the Evaluation of Neuro-cognitive Function Alteration (LYMCOTEP)|Completed||N/A|18|Actual|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-10 22:45:19.530766|2017-10-10 22:45:19.530766
NCT02601534|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-08|||July 2015||2015-07-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Be Healthy, So Easy: FAMILY Education Project|Be Healthy, So Easy: FAMILY Education Project|Recruiting||N/A|600|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:45:19.635774|2017-10-10 22:45:19.635774
NCT02601521|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-11-19|||November 2015||2015-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PiHQ||Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.|Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.|Recruiting||N/A|400|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 22:45:19.756709|2017-10-10 22:45:19.756709
NCT02601508|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-08|||November 2015||2015-11-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|MISPCNUHH||Compare of Surgical Condition and Complications With Moderate and Deep NM Block|A Randomized, Parallel Design, Single-center Study to Compare of Surgical Condition and Postoperative Complications With Moderate and Deep Neuromuscular Blockade in Laparoscopic Gastrectomy|Not yet recruiting||N/A|80|Anticipated|Chonnam National University Hospital||2|||f||||f||||||||||2017-10-10 22:45:19.887173|2017-10-10 22:45:19.887173
NCT02601495|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2017-03-06|||November 2015||2015-11-01|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery|Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery|Enrolling by invitation||N/A|100|Anticipated|Laureate Institute for Brain Research, Inc.|||1||f||||f||||||Samples With DNA|"     Whole Blood, Serum, Plasma, Microbiome   "|||2017-10-10 22:45:20.035597|2017-10-10 22:45:20.035597
NCT02601482|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-06-21|||October 2015||2015-10-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Optimization of Interval-training in Patients With Type 2 Diabetes|Optimization of Interval-training in Patients With Type 2 Diabetes|Active, not recruiting||N/A|14|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-10 22:45:20.161254|2017-10-10 22:45:20.161254
NCT02601469|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-05-03|||September 4, 2015|Actual|2015-09-04|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis|An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS (Taro Pharmaceuticals U.S.A., Inc.) in Patients With Plaque Psoriasis.|Recruiting||Phase 2|60|Anticipated|Taro Pharmaceuticals USA||1|||f||||f||||||||No||2017-10-10 22:45:20.368053|2017-10-10 22:45:20.368053
NCT02601456|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-01-23|||May 2016||2016-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|||Changes in Trans Tibial Amputee Running Asymmetry During Prolonged Effort|The Effect of Prolonged Effort on the Bilateral Asymmetry in Trans Tibial Amputee Running With Running Specific Prosthesis|Enrolling by invitation||N/A|10|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-10-10 22:45:20.48316|2017-10-10 22:45:20.48316
NCT02601443|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-09|2016-11-09|||November 2015||2015-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prevention of Preterm Birth With a Pessary in Triplet||Recruiting||Phase 2|50|Anticipated|Federico II University||2|||f||||t||||||||||2017-10-10 22:45:20.600445|2017-10-10 22:45:20.600445
NCT02601417|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-05|||August 27, 2015|Actual|2015-08-27|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||The Necessity of Bile Cultures in Patients With Acute Cholangitis|The Necessity of Bile Cultures in Patients With Acute Cholangitis|Recruiting||N/A|440|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 22:45:20.857352|2017-10-10 22:45:20.857352
NCT02601404|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-03-01|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01|5 Years|Observational [Patient Registry]|||REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD)|REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD)|Recruiting||N/A|1000|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:45:20.973908|2017-10-10 22:45:20.973908
NCT02601391|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-04-07|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|STEPPS-HI||An Evaluation of an Adapted STEPPS Group Within Forensic Services|Adapting the Systems Training and Emotional Predictability and Problem Solving Group (STEPPS) for Service Users With Complex Needs. A Pilot Evaluation of STEPPS High Intensity (STEPPS HI) Within Forensic Inpatient Services|Not yet recruiting||N/A|15|Anticipated|Sussex Partnership NHS Foundation Trust||1|||f||||f|f|f||||||No||2017-10-10 22:45:21.071986|2017-10-10 22:45:21.071986
NCT02601378|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-04-24|||February 1, 2016|Actual|2016-02-01|April 2017|2017-04-01|March 24, 2019|Anticipated|2019-03-24|October 2, 2017|Anticipated|2017-10-02||Interventional|||A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.|A Phase I, Multi-center, Open-label, Study of LXS196, an Oral Protein Kinase C Inhibitor, in Patients With Metastatic Uveal Melanoma|Recruiting||Phase 1|100|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 22:45:21.18936|2017-10-10 22:45:21.18936
NCT02601365|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-09-18|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|iGRASP||Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia|A Phase I Study of Inhaled GM-CSF in the Treatment of Respiratory Virus-associated Severe Pneumonia|Not yet recruiting||Phase 1|12|Anticipated|Milton S. Hershey Medical Center||4|||f||||f||||||||||2017-10-10 22:45:21.284235|2017-10-10 22:45:21.284235
NCT02601352|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-07-18|||September 2015||2015-09-01|November 2015|2015-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Air Pollution and Cardiometabolic Study|Characterization and Health Risk Assessment of Exposure to Source-Specific PM2.5 in Subjects With Hypertension in Beijing|Completed||N/A|59|Actual|Peking University|||1||f||||t||||||Samples Without DNA|"     Whole blood and urine   "|||2017-10-10 22:45:21.374938|2017-10-10 22:45:21.374938
NCT02601339|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-11-06|||April 2015||2015-04-01|November 2015|2015-11-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Observational|||NIRS Monitoring in Premature Infants|Beside Monitor of Cerebral Metabolism in Premature Infants With Intraventricular Hemorrhage and Post-Hemorrhagic Hydrocephalus|Recruiting||N/A|170|Anticipated|Massachusetts General Hospital|||4||f||||f||||||||||2017-10-10 22:45:21.452555|2017-10-10 22:45:21.452555
NCT02601326|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-03-14|||January 2012||2012-01-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|||Laparoscopic Ventral Mesh Rectopexy Versus Delorme's Operation in Management of Complete Rectal Prolapse|Laparoscopic Ventral Mesh Rectopexy Versus Delorme's Operation in Management of Complete Rectal Prolapse|Completed||N/A|50|Actual|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:45:21.586227|2017-10-10 22:45:21.586227
NCT02601313|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01||||July 2018|Anticipated|2018-07-01||Interventional|ZUMA-2||A Phase 2 Multicenter Study Evaluating Subjects With Relapsed/Refractory Mantle Cell Lymphoma|A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-C19 in Subjects With Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) (ZUMA-2)|Recruiting||Phase 2|70|Anticipated|Kite Pharma, Inc.||1|||f||||t||||||||||2017-10-10 22:45:21.681897|2017-10-10 22:45:21.681897
NCT02601300|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-09-06||2017-09-06|December 14, 2015|Actual|2015-12-14|September 2017|2017-09-01|August 8, 2017|Actual|2017-08-08|September 6, 2016|Actual|2016-09-06||Interventional|||An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis|A Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.|Completed||Phase 2|40|Actual|Celgene||1|||f||||f||||||||||2017-10-10 22:45:21.923905|2017-10-10 22:45:21.923905
NCT02601287|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-07-19|||November 2015||2015-11-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients||Completed||Phase 4|168|Actual|Allergan||2|||f||||f||||||||||2017-10-10 22:45:22.165632|2017-10-10 22:45:22.165632
NCT02601274|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-01-13|||April 2015||2015-04-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|HMPL-309||Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor|Open-label, Dose Escalation Phase I Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumors|Recruiting||Phase 1|66|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||No||2017-10-10 22:45:22.279123|2017-10-10 22:45:22.279123
NCT02601261|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-11-05|||November 2015||2015-11-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Observational|HAWAII||How Anxiety in Pregnant Hospitalized Women Change wIth Internet Use|How Anxiety in Pregnant Hospitalized Women Change wIth Internet Use|Not yet recruiting||N/A|109|Anticipated|University of Padova|||2||f||||f||||||||||2017-10-10 22:45:22.356498|2017-10-10 22:45:22.356498
NCT02601248|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-05-31|||October 2012||2012-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor|Single Site, Open-label, Dose Escalation Phase I Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumors|Completed||Phase 1|24|Actual|Hutchison Medipharma Limited||1|||f||||f||||||||No||2017-10-10 22:45:22.439847|2017-10-10 22:45:22.439847
NCT02601235|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-09|||March 2016||2016-03-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|||Clinical Study Evaluating the Efficacy and Safety of Pediatric Drugs in Improving Nasal Congestion.|Clinical Study Evaluating the Efficacy and Safety of Pediatric Naridrin® (Naphazoline Hydrochloride + Mepyramine Maleate + Dexpanthenol) Compared to 0.05 % Oxymetazoline Hydrochloride in Improving Nasal Congestion.|Not yet recruiting||Phase 3|238|Anticipated|EMS||2|||f||||f||||||||||2017-10-10 22:45:22.514472|2017-10-10 22:45:22.514472
NCT02601222|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-09-19|||March 2016||2016-03-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema|A Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trials to Evaluate the Efficacy and Safety of Runzao Zhiyang Capsule in Treating Chronic Eczema|Recruiting||Phase 4|240|Anticipated|Guizhou Tongjitang Pharmaceutical Co.,Ltd||2|||f||||f||||||||||2017-10-10 22:45:22.599783|2017-10-10 22:45:22.599783
NCT02601196|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-07-10|||September 2016||2016-09-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure|IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure|Not yet recruiting||Phase 4|20|Anticipated|Sheba Medical Center||1|||f||||||||||||||2017-10-10 22:45:23.880562|2017-10-10 22:45:23.880562
NCT02601183|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2016-06-19|||May 2016||2016-05-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|CTedHI||Cranial Temperature Early Diagnose Hemorrhagic and Ischemic Stroke|Cranial Temperature, as an Early Diagnosis Marker for Hemorrhagic and Ischemic Stroke|Recruiting||N/A|60|Anticipated|Third Military Medical University|||2||f||||t||||||||Yes||2017-10-10 22:45:23.965857|2017-10-10 22:45:23.965857
NCT02601157|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-07|2017-05-26|||December 2015||2015-12-01|May 2017|2017-05-01||||November 2022|Anticipated|2022-11-01||Interventional|HOST-IDEA||Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial|Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial|Recruiting||Phase 4|2152|Anticipated|Seoul National University Hospital||4|||f||||t||||||||||2017-10-10 22:45:24.12673|2017-10-10 22:45:24.12673
NCT02601144|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-03-18|||October 2015||2015-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Variable Frequency Stimulation of Subthalamic Nucleus for Freezing of Gait in Parkinson's Disease|Double-Blind Trial of Variable Frequency Stimulation for Freezing of Gait in Parkinson's Disease|Completed||Phase 1|28|Actual|Beijing Pins Medical Co., Ltd||4|||f||||t||||||||||2017-10-10 22:45:24.296929|2017-10-10 22:45:24.296929
NCT02601131|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-11-28|||February 2016||2016-02-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Post-transfusion Platelet Count|Post-transfusion Platelet Count|Completed||N/A|80|Actual|Region Skane|||5||f||||f||||||Samples With DNA|"     Pending the analyses of complement factors and endothelial markers plasma is stored in -80     degrees Celcius. All samples are destroyed after analyses.   "|||2017-10-10 22:45:24.381875|2017-10-10 22:45:24.381875
NCT02601118|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-06|||March 2014||2014-03-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Micro-expression Reading Skill Training in Medical Students|Effects of Micro- and Subtle-expression Reading Skill Training in Medical Students|Completed||N/A|82|Actual|Pusan National University Hospital||2|||f||||t||||||||||2017-10-10 22:45:24.531321|2017-10-10 22:45:24.531321
NCT02601092|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-02-23|||October 2016||2016-10-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|November 2017|Anticipated|2017-11-01||Interventional|MGB||Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Mini Gastric Bypass|Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Mini Gastric Bypass: A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Spital Limmattal Schlieren||2|||f||||t||||||||||2017-10-10 22:45:24.735631|2017-10-10 22:45:24.735631
NCT02601079|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-02-07|||September 2016||2016-09-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Endodrill vs. Conventional Biopsy. Diagnostics and Genetic Analysis|Endodrill vs. Conventional Biopsy. Diagnostics and Genetic Analysis in Tumors of the Distal Esophagus and Cardia|Recruiting||N/A|20|Anticipated|Region Skane||2|||f||||t||||||||No||2017-10-10 22:45:24.860629|2017-10-10 22:45:24.860629
NCT02601066|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-04-05|||September 2015||2015-09-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|||Cardiac Arrhythmias and Sudden Death in Patients Affected With Laminopathies|Identification of Predictors of Cardiac Arrhythmias and Sudden Death in Pediatric Patients Affected With Laminopathies|Recruiting||N/A|40|Anticipated|Hospital Sant Joan de Deu||1|||f||||t||||||||||2017-10-10 22:45:24.961199|2017-10-10 22:45:24.961199
NCT02601053|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-06|||June 2015||2015-06-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|FF8||The Fear F8ctor Study - Does Fear Induce a Blood Curdling State?|The Fear F8ctor Study - Does Fear Induce a Blood Curdling State? The Origin Behind the Phrase Unravelled|Completed||N/A|24|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 22:45:25.07084|2017-10-10 22:45:25.07084
NCT02601040|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2015-11-06|||November 2011||2011-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|June 2014|Actual|2014-06-01||Interventional|||Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines|Phase IV Clinical Trial to Assess the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) and Live Attenuated HAV Vaccine in Health Chinese Children and Adult|Completed||Phase 4|13500|Actual|Jiangsu Province Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-10 22:45:25.163898|2017-10-10 22:45:25.163898
NCT02601027|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-07-12|||November 2015||2015-11-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA|A Phase III Study of Pre-operative Transversus Abdominis Plane Blocks Using the Nimbus Ambulatory Infusion System in Patients Undergoing Abdominal Free Flap-based Breast Reconstruction|Recruiting||Phase 3|128|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 22:45:25.262514|2017-10-10 22:45:25.262514
NCT02601014|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-09-21|||February 2016||2016-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|STARVE-PC||Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7|Biomarker-Driven Phase-2 Study of Combined Immune Checkpoint Blockade for AR-V7-Expressing Metastatic Castration-Resistant Prostate Cancer (STARVE-PC)|Recruiting||Phase 2|15|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:45:25.398935|2017-10-10 22:45:25.398935
NCT02601001|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-01-27|||November 2015||2015-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety Study of Omecamtiv Mecarbil in Healthy Japanese Subjects|A Phase 1, Single Center Double-blind, Randomized, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Omecamtiv Mecarbil in Healthy Japanese Subjects|Completed||Phase 1|50|Actual|Amgen||3|||f||||f||||||||||2017-10-10 22:45:25.507321|2017-10-10 22:45:25.507321
NCT02600988|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-11-05|||July 2011||2011-07-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Alovita-1||Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant|Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant|Completed||Phase 1/Phase 2|150|Actual|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||3|||f||||f||||||||||2017-10-10 22:45:25.588951|2017-10-10 22:45:25.588951
NCT02600975|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-06-19|||December 8, 2015|Actual|2015-12-08|June 2017|2017-06-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|||A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B|A Phase I Study to Assess the Safety and Immunogenicity of a Protein Particle Malaria Vaccine Candidate, R21, Administered With AS01B in Healthy UK Volunteers|Completed||Phase 1|20|Actual|University of Oxford||2|||f||||t||||||||Undecided|Yes when manuscript is published|2017-10-10 22:45:25.702719|2017-10-10 22:45:25.702719
NCT02600962|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-11-06|||January 2003||2003-01-01|November 2015|2015-11-01||||April 2013|Actual|2013-04-01||Observational|||Impact of Initial Diagnosis on Mortality for Patients Hospitalised With Acute Myocardial Infarction|Impact of Initial Diagnosis on Mortality for Patients Hospitalised With Acute Myocardial Infarction: A National Cohort Study|Completed||N/A|564412|Actual|University of Leeds|||2||f||||f||||||||||2017-10-10 22:45:25.773559|2017-10-10 22:45:25.773559
NCT02600949|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-08-16|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Peptide Vaccine in Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma|Pilot Study of the Feasibility and Safety of a Personalized Peptide Vaccine in Patients With Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma|Enrolling by invitation||Phase 1|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 22:45:25.844135|2017-10-10 22:45:25.844135
NCT02600936|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-08-30|||June 22, 2017|Actual|2017-06-22|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||Sinai Vein Stent Registry|Sinai Vein Stent Registry|Recruiting||N/A|400|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||t|f|t|f|||||||2017-10-10 22:45:25.958986|2017-10-10 22:45:25.958986
NCT02600923|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-09-11|||April 15, 2016|Actual|2016-04-15|September 2017|2017-09-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate|Study Of Palbociclib In Combination With Letrozole As Treatment Of Postmenopausal Women With Hormone Receptor Positive, Her2-negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate|Recruiting||Phase 3|130|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 22:45:26.079181|2017-10-10 22:45:26.079181
NCT02600910|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-02-20|||November 2015||2015-11-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|NHSSI||Natural History of Shoulder Pathology in Manual Wheelchair Users|Natural History of Shoulder Pathology in Manual Wheelchair Users|Recruiting||N/A|75|Anticipated|Mayo Clinic|||2||f||||f||||||||Undecided|This will be decided further into the study.|2017-10-10 22:45:26.460121|2017-10-10 22:45:26.460121
NCT02600897|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-09-21|||March 23, 2016|Actual|2016-03-23|September 2017|2017-09-01|March 9, 2022|Anticipated|2022-03-09|March 9, 2022|Anticipated|2022-03-09||Interventional|||A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|A Phase Ib/II Study Evaluating the Safety and Efficacy of Obinutuzumab in Combination With Polatuzumab Vedotin and Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Recruiting||Phase 1/Phase 2|128|Anticipated|Hoffmann-La Roche||4|||f||||t|t|f||||||||2017-10-10 22:45:26.566187|2017-10-10 22:45:26.566187
NCT02600884|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-05-10|||September 2015||2015-09-01|May 2016|2016-05-01||||November 2018|Anticipated|2018-11-01||Interventional|||Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention|Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention|Recruiting||N/A|1060|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 22:45:26.741859|2017-10-10 22:45:26.741859
NCT02600871|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-06-15|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|April 30, 2017|Actual|2017-04-30||Interventional|||Skin and Soft Tissue Infection (SSTI) Study|Skin and Soft Tissue Infection (SSTI) Study|Completed||Phase 4|103|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 22:45:26.865153|2017-10-10 22:45:26.865153
NCT02600858|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-07-19|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Exogenous Effects of Standard Medical Care (Dopamine) on Motor Learning of an Upper Limb Task in Parkinson Disease|Exogenous Effects of Standard Medical Care (Dopamine) on Motor Learning of an Upper Limb Task in Parkinson Disease|Terminated||N/A|23|Actual|University of Utah||2||Lack of progress with recruitment and funding expired prior to reaching target sample size|f||||f||||||||||2017-10-10 22:45:27.005381|2017-10-10 22:45:27.005381
NCT02600832|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-12-02|||January 2016||2016-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|AABM||AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study|Alcohol Approach Bias Modification to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study|Recruiting||N/A|32|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:45:27.236394|2017-10-10 22:45:27.236394
NCT02600806|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-05|||May 2005||2005-05-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients|Evaluation of a Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients|Recruiting||Phase 4|500|Anticipated|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||1|||f||||t||||||||||2017-10-10 22:45:27.54576|2017-10-10 22:45:27.54576
NCT02600793|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-10-31|||August 2016||2016-08-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Ceftaroline Diffusion Into Cerebrospinal Fluid of Children|Ceftaroline Diffusion Into Cerebrospinal Fluid of Children With Ventriculitis Due to Ventriculoperitoneal Shunt (VPS) Infection|Recruiting||Phase 1|12|Anticipated|Wayne State University||1|||f||||f||||||||||2017-10-10 22:45:27.656825|2017-10-10 22:45:27.656825
NCT02600780|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-06|||November 2013||2013-11-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|ZEST||Zurig (Febuxostat) 40mg Efficacy and Safety Trial|Febuxostat (Zurig) Efficacy & Safety Trial in Comparison With Allopurinol in Hyperuricemic Subjects With or Without Gout|Completed||Phase 4|50|Actual|Getz Pharma||2|||f||||t||||||||||2017-10-10 22:45:27.740702|2017-10-10 22:45:27.740702
NCT02600754|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-05-10|||February 2016||2016-02-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Telehealth Depression Treatments for Older Adults|Telehealth Treatments for Depression With Low-Income Homebound Seniors|Recruiting||N/A|276|Anticipated|University of Texas at Austin||3|||f||||f||||||||||2017-10-10 22:45:28.028281|2017-10-10 22:45:28.028281
NCT02600741|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-08-25|||July 24, 2015|Actual|2015-07-24|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|September 7, 2017|Anticipated|2017-09-07||Observational|FIRST||Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)|A 12-Month Randomized, Open-Label Study of Caregiver Psycho-education and Skills Training in Patients Recently Diagnosed With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder and Receiving Paliperidone Palmitate or Oral Antipsychotic Treatment|Recruiting||N/A|150|Anticipated|Janssen Scientific Affairs, LLC|||2||f||||f||||||||||2017-10-10 22:45:28.132542|2017-10-10 22:45:28.132542
NCT02600728|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-06|||March 2014||2014-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Training Based On Declarative Memory Cues Improved Gait In Patients With Parkinson's Disease|Improvement In Gait Performance After Training Based On Declarative Memory Cues In Patients With Parkinson's Disease: A Randomized Clinical Trial|Completed||N/A|50|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 22:45:28.406786|2017-10-10 22:45:28.406786
NCT02600715|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-06-13|||November 2015||2015-11-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|June 15, 2017|Anticipated|2017-06-15||Interventional|ROBIN||Reduction of Bladder Injection Pain With Belladonna Opiate Suppository|Reduction of Bladder Injection Pain With Belladonna Opiate Suppository: A Randomized, Double-Blind, Placebo-Controlled Trial (ROBIN Trial)|Enrolling by invitation||Phase 4|26|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||No||2017-10-10 22:45:28.506043|2017-10-10 22:45:28.506043
NCT02600702|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2016-12-01|||October 2014||2014-10-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||A Study of Siriraj Home Exercises Protocol for Primary Osteoarthritis of the Knee|A Randomized Control Study of Siriraj Home Exercises Protocol for Primary Knee Osteoarthritis Patients Versus Usual Orthopedic Outpatient Consultation in Primary Knee Osteoarthritis Patients|Completed||N/A|135|Actual|Mahidol University||3|||f||||t||||||||||2017-10-10 22:45:28.619212|2017-10-10 22:45:28.619212
NCT02600689|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-11|||August 2015||2015-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EXPLORE-IPF||Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis|Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis|Recruiting||N/A|20|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 22:45:28.69474|2017-10-10 22:45:28.69474
NCT02600663|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-11-18|||April 2016||2016-04-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|chron_pain||Identification of Patients at Risk of Chronic Back Pain Using Questionnaires|Identification of Patients at Risk of Chronic Back Pain Using Questionnaires|Recruiting||N/A|250|Anticipated|Swiss Paraplegic Centre Nottwil|||1||f||||t||||||||No||2017-10-10 22:45:28.917012|2017-10-10 22:45:28.917012
NCT02600650|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-11-06|||November 2015||2015-11-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||EndogenousTestosterone Response to a Testosterone Boosting Supplement|EndogenousTestosterone Response to a Testosterone Boosting Supplement|Not yet recruiting||N/A|60|Anticipated|Canadian Memorial Chiropractic College||2|||f||||f||||||||||2017-10-10 22:45:28.997023|2017-10-10 22:45:28.997023
NCT02600637|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-08-04|||November 1, 2015|Actual|2015-11-01|August 2017|2017-08-01|May 30, 2018|Anticipated|2018-05-30|April 30, 2018|Anticipated|2018-04-30||Interventional|WPBI||Wellness Programs for Brain-Injured Individuals|Evaluation of Wellness Programs for Brain-Injured Individuals|Recruiting||N/A|40|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:45:29.09427|2017-10-10 22:45:29.09427
NCT02600624|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-05|||August 18, 2016|Actual|2016-08-18|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Prenatal Alcohol Biomarker Study in Uruguay|Newborn Phosphatidylethanol Screening to Detect Fetal Alcohol Exposure in Uruguay|Recruiting||N/A|1800|Anticipated|Northwestern University|||1||f||||f||||||Samples With DNA|"     Maternal alcohol biomarker assays will include ethylglucuronide (EtG) in hair and nails and     PEth in blood obtained at the time of delivery. Newborn umbilical cord and routine 48 hour     heel stick blood will be collected to assess newborn PEth levels   "|No||2017-10-10 22:45:29.202648|2017-10-10 22:45:29.202648
NCT02600611|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-03-21|||November 1, 2015|Actual|2015-11-01|January 2017|2017-01-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|REVIVE-1||Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1|A Phase 3, Randomized, Double-blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of ABSSSI: REVIVE-1|Completed||Phase 3|600|Actual|Motif Bio||2|||f||||f||||||||Undecided||2017-10-10 22:45:29.298945|2017-10-10 22:45:29.298945
NCT02600598|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-03-02|||July 2016||2016-07-01|March 2017|2017-03-01|January 16, 2017|Actual|2017-01-16|December 27, 2016|Actual|2016-12-27||Interventional|||Biological Effects of LEO 43204 in Actinic Keratosis|Biological Effects of LEO 43204 in Actinic Keratosis Assessed by Histopathology|Completed||Phase 1|24|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:45:29.484944|2017-10-10 22:45:29.484944
NCT02600572|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-02-16|||January 2016||2016-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Changes in Attention Level Due to Isometric Exercises and Level Three Progression Eccentric Movements|Changes in Attention Level Due to Isometric Exercises and Level Three Progression Eccentric Movements|Withdrawn||N/A|0|Actual|Carrick Institute for Graduate Studies||2||Logistics reason at the data collection site|f||||f||||||||||2017-10-10 22:45:29.808724|2017-10-10 22:45:29.808724
NCT02600559|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-07-26|||October 2015||2015-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes|An 8-Week, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes|Completed||Phase 3|501|Actual|Otonomy, Inc.||1|||f||||f||||||||||2017-10-10 22:45:29.896004|2017-10-10 22:45:29.896004
NCT02600546|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-03-28|||October 2015||2015-10-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT||Completed||N/A|62|Actual|Optovue|||1||f||||||||||||||2017-10-10 22:45:29.979486|2017-10-10 22:45:29.979486
NCT02600533|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-07|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|June 28, 2017|Actual|2017-06-28|June 28, 2017|Actual|2017-06-28||Interventional|||Increasing Minority Participation in Clinical Trials|Increasing Minority Group Participation in Clinical Trials a Randomized Controlled Study of an Office-based Educational Video|Completed||N/A|63|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 22:45:30.038035|2017-10-10 22:45:30.038035
NCT02600520|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2015-11-11|||November 2014||2014-11-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis|1.2% Rosuvastatin Versus 1.2% Atorvastatin Local Drug Delivery in Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|45|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||t||||||||||2017-10-10 22:45:30.146428|2017-10-10 22:45:30.146428
NCT02600507|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-14|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression|Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder|Recruiting||Phase 3|550|Anticipated|Intra-Cellular Therapies, Inc.||3|||f||||f|t|f||||||||2017-10-10 22:45:30.23294|2017-10-10 22:45:30.23294
NCT02600494|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-14|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression|Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder|Recruiting||Phase 3|550|Anticipated|Intra-Cellular Therapies, Inc.||3|||f||||f|t|f||||||||2017-10-10 22:45:30.406083|2017-10-10 22:45:30.406083
NCT02600481|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-08|||January 2016||2016-01-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery|Comparison of the Impacts of Prolonged Low-pressure and Standard-pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery in the Trendelenburg Position: a Bi-center, Randomized Controlled Trial|Not yet recruiting||N/A|280|Anticipated|Huadong Hospital||2|||f||||f||||||||||2017-10-10 22:45:30.711008|2017-10-10 22:45:30.711008
NCT02600468|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-01-13|||September 2013||2013-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg|Outline of Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg|Completed||N/A|671|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:45:30.877992|2017-10-10 22:45:30.877992
NCT02600455|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-01-12|||September 2013||2013-09-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL|Outline of Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL|Completed||N/A|505|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:45:30.97091|2017-10-10 22:45:30.97091
NCT02600442|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-09-28|||July 2013||2013-07-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Observational|||Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers|Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) and Molecular Markers|Recruiting||N/A|168|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     somatic molecular analyses   "|||2017-10-10 22:45:31.053174|2017-10-10 22:45:31.053174
NCT02600429|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-08-28|||September 2015||2015-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1|Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy: SEER-1|Recruiting||Phase 3|46|Anticipated|ReGenTree, LLC||2|||f||||f||||||||||2017-10-10 22:45:31.177032|2017-10-10 22:45:31.177032
NCT02600416|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-07-12|||December 2015||2015-12-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|CIRE||The CIRE Study (CItrate REcirculation Study)|Effects of AV Port Reversal in Citrate CVVH - The CIRE Study (CItrate REcirculation Study)|Recruiting||N/A|12|Anticipated|Ziekenhuis Oost-Limburg||1|||f||||f||||||||||2017-10-10 22:45:31.322174|2017-10-10 22:45:31.322174
NCT02600390|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-02-24|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|LU||SANGUINATE™ in Sickle Cell Disease Associated Leg Ulcer|An Open-label, Repeated-dose, Dose Escalation Study of the Safety and Effectiveness of SANGUINATE™ for the Treatment of Leg Ulcers in Adult Patients With Sickle Cell Disease|Completed||Phase 2|10|Actual|Prolong Pharmaceuticals||2|||f||||t||||||||No||2017-10-10 22:45:31.507996|2017-10-10 22:45:31.507996
NCT02600377|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-05|||November 2015||2015-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||A Series of Systematic Reviews and Meta-analyses of the Effect of Vegetarian/Vegan Diets on Cardiometabolic Risk|Effect of Vegetarian/Vegan Diets on Cardiometabolic Risk: Systematic Reviews and Meta-analyses of Randomized Controlled Dietary Trials to Provide Evidence-based Guidance for Nutrition Guidelines Development|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:45:31.617944|2017-10-10 22:45:31.617944
NCT02600364|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-07-19|||December 2015||2015-12-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device|Prospective, Multicenter, Single Arm Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device|Recruiting||N/A|400|Anticipated|Phenox GmbH|||1||f||||t|f|f||||||||2017-10-10 22:45:31.710734|2017-10-10 22:45:31.710734
NCT02600351|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-06-27|||November 11, 2015|Actual|2015-11-11|June 2017|2017-06-01|May 29, 2017|Actual|2017-05-29|March 23, 2017|Actual|2017-03-23||Interventional|||Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies|A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies|Completed||Phase 3|87|Actual|Gilead Sciences||4|||f||||f|t|||||||||2017-10-10 22:45:31.947561|2017-10-10 22:45:31.947561
NCT02600338|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-06|||September 2014||2014-09-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Meta-analyses of the Effect of Legumes on Blood Pressure|Effect of Legumes on Blood Pressure in Humans: A Systematic Review and Meta-analysis of Randomized Controlled Trials|Active, not recruiting||N/A|1|Actual|University of Toronto|||1||f||||f||||||||||2017-10-10 22:45:32.146183|2017-10-10 22:45:32.146183
NCT02600325|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-11-18|||February 2016||2016-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|DAHHS-2||Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV|Grazoprevir (MK-5172)+ Elbasvir (MK-8742) for the Treatment of Acute Hepatitis C Genotype 1/4. The Dutch Acute HCV in HIV Study (DAHHS-2)|Recruiting||Phase 3|80|Anticipated|Erasmus Medical Center||1|||f||||f||||||||||2017-10-10 22:45:32.252054|2017-10-10 22:45:32.252054
NCT02600312|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-06|||October 2015||2015-10-01|November 2015|2015-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|oXiris||Comparing Cytokines, Toxins Adsorbing oXiris Filter to ST150 Filter During CRRT in Patients With Septic Shock|Comparing Cytokines, Toxins Adsorbing oXiris Filter to ST150 Filter During CRRT in Patients With Septic Shock|Recruiting||Phase 4|16|Anticipated|Skane University Hospital||2|||f||||f||||||||||2017-10-10 22:45:32.359342|2017-10-10 22:45:32.359342
NCT02600299|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-09-20|||July 2015||2015-07-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Effectiveness of a Psycho-educational Group (PEG) Intervention on Supportive Care and Survivorship Issues in Early-stage Breast Cancer Survivors Who Have Received Systemic Treatment||Completed||Phase 2|80|Actual|National University, Singapore||2|||f||||f||||||||||2017-10-10 22:45:32.456768|2017-10-10 22:45:32.456768
NCT02600286|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-05-15|||October 23, 2015|Actual|2015-10-23|May 2017|2017-05-01|October 23, 2018|Anticipated|2018-10-23|October 23, 2018|Anticipated|2018-10-23||Interventional|UPACOMT||Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A|LONG-TERM EFFECTS TOLERANCE AND THE Ulipristal Acetate IN DISEASE Charcot-MARIE-TOOTH TYPE OF 1A|Recruiting||Phase 2|45|Anticipated|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-10-10 22:45:32.575277|2017-10-10 22:45:32.575277
NCT02600273|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-06-02|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Novel Approaches to Reducing Tobacco Related Harm|Novel Approaches to Reducing Tobacco Related Harm Among HIV-Infected Smokers|Recruiting||N/A|24|Anticipated|Duke University||4|||f||||f||||||||||2017-10-10 22:45:32.695172|2017-10-10 22:45:32.695172
NCT02600260|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-05-10|||December 2013||2013-12-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial|Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial|Recruiting||N/A|9000|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-10 22:45:32.795246|2017-10-10 22:45:32.795246
NCT02600247|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-11-06|||November 2015||2015-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effects of Duloxetine on Pain Relief After Total Knee Arthroplasty in Central Sensitization Patient|Effects of Duloxetine on Pain Relief After Total Knee Arthroplasty in Central Sensitization Patient : A Randomized, Controlled, Double-Blind Trial|Not yet recruiting||N/A|100|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 22:45:32.9229|2017-10-10 22:45:32.9229
NCT02600234|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-08-21|||December 2015||2015-12-01|August 2016|2016-08-01|December 2022|Anticipated|2022-12-01|December 2016|Actual|2016-12-01||Interventional|||REDUCE LAP-HF RANDOMIZED TRIAL I|REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure|Active, not recruiting||N/A|44|Actual|Corvia Medical||2|||f||||t||||||||||2017-10-10 22:45:33.004147|2017-10-10 22:45:33.004147
NCT02600221|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-11-16|||October 2015||2015-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China|A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China|Completed||N/A|2180|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 22:45:33.146269|2017-10-10 22:45:33.146269
NCT02600208|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-18|||October 2015||2015-10-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device|BT13BTθ51 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha Beta T Cell and B Cell Depletion For Patients With Hematologic Malignancies|Recruiting||Phase 2/Phase 3|60|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-10 22:45:33.24619|2017-10-10 22:45:33.24619
NCT02600195|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-10-27|||May 2015||2015-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Reduction of Infection in Neonatal Intensive Care Units Using the Evidence-based Practice for Improving Quality|Reduction of Infection in Neonatal Intensive Care Units Using the Evidence-based Practice for Improving Quality: A Cluster Randomised Trial|Recruiting||N/A|15600|Anticipated|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 22:45:33.341981|2017-10-10 22:45:33.341981
NCT02600182|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-11-01|||December 2015||2015-12-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Bilevel Positive Airway Pressure in Cardiac Surgery|Effects of Bilevel Positive Airway Pressure in Postoperative Cardiac Surgery: A Randomized Clinical Trial|Completed||N/A|36|Actual|Universidade Federal de Santa Maria||2|||f||||t||||||||Undecided||2017-10-10 22:45:33.710293|2017-10-10 22:45:33.710293
NCT02600169|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-04-20|||July 2015||2015-07-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab|Retrospective Analysis of Response Markers and Adverse Events in a Nationwide Cohort of Advanced Melanoma Patients Treated With Pembrolizumab|Recruiting||N/A|150|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 22:45:33.810216|2017-10-10 22:45:33.810216
NCT02600156|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-04-04|||September 2015||2015-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Focal Laser Ablation of Prostate Cancer Tumors|A Pilot Study to Evaluate Magnetic Resonance Thermal Image-Guided Focal Laser Ablation of Prostate Cancer Tumors|Recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:45:33.915607|2017-10-10 22:45:33.915607
NCT02600143|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-04-20|||August 2013||2013-08-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|COLIPI||Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.|Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.|Recruiting||N/A|300|Anticipated|University Medical Center Groningen|||1||f||||f||||||Samples With DNA|"     Intestinal biopsies, whole blood samples, stool samples   "|||2017-10-10 22:45:33.999937|2017-10-10 22:45:33.999937
NCT02600130|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-03-16|||August 2016||2016-08-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Alzheimer's Disease|A Phase, I Prospective, Randomized, Double-Blinded, Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Longeveron Allogeneic Human Mesenchymal Stem Cell (LMSCs) Infusion Versus Placebo in Patients With Alzheimer's Disease|Recruiting||Phase 1|30|Anticipated|Longeveron LLC||3|||f||||t||||||||No||2017-10-10 22:45:34.082307|2017-10-10 22:45:34.082307
NCT02600117|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-23|||November 2015||2015-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Use of TDF in Patients With Inactive Chronic Hepatitis B Infection|The Use of Tenofovir Disoproxil Fumarate (TDF) in the Management of Patients With Inactive Chronic Hepatitis B (CHB) Infection|Enrolling by invitation||Phase 3|100|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:45:34.180947|2017-10-10 22:45:34.180947
NCT02600104|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-04-03|||June 10, 2015|Actual|2015-06-10|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluate the Performance of the PicoWayTM Picosecond Fractional Laser for Wrinkles Reduction|Clinical Study to Evaluate the Performance of the PicoWayTM Picosecond Fractional Laser for Wrinkles Reduction|Active, not recruiting||N/A|74|Actual|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 22:45:34.267482|2017-10-10 22:45:34.267482
NCT02600091|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-04-20|||January 2016||2016-01-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|MILESTONE||Mindfulness-based Cognitive Therapy to Improve Emotional Wellbeing and Glycaemic Control in Diabetes|Exploring the Effectiveness of Mindfulness-based Cognitive Therapy to Improve Emotional Wellbeing and Glycaemic Control Among Adults With Diabetes|Recruiting||N/A|40|Anticipated|University of Aberdeen||2|||f||||f||||||||||2017-10-10 22:45:34.34927|2017-10-10 22:45:34.34927
NCT02600078|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-16|||November 2015||2015-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||The Evaluation of a Mobile Device to Measure Ataxia With High Altitude Exposure|The Evaluation of a Mobile Device to Measure Ataxia With High Altitude Exposure|Recruiting||N/A|16|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-10-10 22:45:34.439852|2017-10-10 22:45:34.439852
NCT02600065|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-11-24|||November 2014||2014-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2016|Anticipated|2016-11-01||Observational|GLIO-CMV-01||Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy|Analysis of CMV Infections in Patients Suffering From Brain Tumors and Brain Metastases During and After Radio(Chemo)Therapy|Recruiting||N/A|250|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||Samples Without DNA|"     blood for CMV status analysis blood for immunophenotyping serum plasma   "|Undecided||2017-10-10 22:45:34.649539|2017-10-10 22:45:34.649539
NCT02600052|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-06-22|||May 2016||2016-05-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Pattern Respiratory PNF Associated Aerobic Training on Lung Volumes and 6MWT Test in Parkinson Individuals|Efficacy of Pattern Respiratory Proprioceptive Neuromuscular Facilitation Associated With Aerobic Training on the Volumes, Lung Capacity and Six-minute Walking Test in Individuals With Parkinson: Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:45:34.771069|2017-10-10 22:45:34.771069
NCT02600039|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-11-06|||October 2015||2015-10-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||The Short-term Effect of ELTGOL on Pulmonary Ventilation Valued Through Electrical Impedance Tomography in Cystic Fibrosis Patients|The Short-term Effect of ELTGOL on Pulmonary Ventilation Valued Through Electrical Impedance Tomography in Cystic Fibrosis Patients: Randomized Crossover Study|Recruiting||N/A|10|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:45:34.877893|2017-10-10 22:45:34.877893
NCT02600026|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-10-04|||November 2015||2015-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Video Feedback Intervention for Cognitively Impaired Older Drivers|Video Feedback Intervention for Cognitively Impaired Older Drivers|Recruiting||Phase 1/Phase 2|60|Anticipated|Rhode Island Hospital||2|||f||||t||||||||||2017-10-10 22:45:34.975952|2017-10-10 22:45:34.975952
NCT02600013|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-07-03|||December 2015||2015-12-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|||Locomotor Training With Exoskeleton EKSO-GT in Patients With Incomplete Motor Spinal Cord Injury in a Hospital Setting|Locomotor Training With the Exoskeleton EKSO-GT in Patients With Incomplete Motor Spinal Cord Injury in a Hospital Setting: an Observational Study|Recruiting||N/A|40|Anticipated|Montecatone Rehabilitation Institute S.p.A.|||1||f||||f||||||||||2017-10-10 22:45:35.094126|2017-10-10 22:45:35.094126
NCT02600000|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-10-23|||February 2015||2015-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Inspiratory Muscle Training Effectiveness in Sympathetic Activity and Functional Capacity in Patients With Heart Failure|Effectiveness of Inspiratory Muscle Training Associated With a Cardiac Rehabilitation Program in Sympathetic Activity and Functional Capacity in Patients With Heart Failure: a Randomized Clinical Trial|Recruiting||Phase 4|20|Anticipated|Universidade Federal de Pernambuco||5|||f||||t||||||||||2017-10-10 22:45:35.223045|2017-10-10 22:45:35.223045
NCT02599987|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-01-10|||November 2015||2015-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Inspiratory Muscle Training in Patients With End-stage Renal Disease|Effectiveness of Inspiratory Muscle Training in Respiratory Muscle Strength, Chest Wall Volume, Diaphragm Thickness and Mobility in Patients With End-stage Renal Disease: Randomized Clinical Trial|Completed||N/A|24|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||Undecided||2017-10-10 22:45:35.330086|2017-10-10 22:45:35.330086
NCT02599974|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-09-28|||January 2006||2006-01-01|September 2016|2016-09-01||||December 2020|Anticipated|2020-12-01||Observational|ASAINT||PET-CT in the Initial Staging of Breast Cancer and in the Early Assessment of Response to Neoadjuvant Chemotherapy|Role of Fluorodeoxyglucose (FDG) PET-CT in the Initial Staging of Breast Cancer (ASAINT 1) and in the Early Assessment of Response to Neoadjuvant Chemotherapy (ASAINT 2)|Recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 22:45:35.420857|2017-10-10 22:45:35.420857
NCT02599961|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-04-18|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study to Assess the Long Term Safety and Efficacy of UX007 in Subjects With Glucose Type 1 DS|An Open-label Extension Study to Assess the Long-term Safety and Efficacy of UX007 in Subjects With Glucose Transporter Type 1 Deficiency Syndrome|Enrolling by invitation||Phase 2|40|Anticipated|Ultragenyx Pharmaceutical Inc||1|||f||||f||||||||||2017-10-10 22:45:35.515926|2017-10-10 22:45:35.515926
NCT02599948|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-05|||March 2015||2015-03-01|August 2014|2014-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|FRANS||FRench-speAking Icu (Intensive Care Unit) Nutritional Survey|FRench-speAking Icu (Intensive Care Unit) Nutritional Survey|Completed||N/A|1215|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 22:45:35.621538|2017-10-10 22:45:35.621538
NCT02599935|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-11-05|||September 2011||2011-09-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|VAINICA||Nutritional Improvement in Chronic Heart Failure Patients|Impact on Nutrition and Quality of Life of Patients With Heart Failure After a Nurse Intervention on Nutrition Improvement|Completed||N/A|76|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-10 22:45:35.695264|2017-10-10 22:45:35.695264
NCT02599909|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-10-03|||October 26, 2015||2015-10-26|September 27, 2017|2017-09-27|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Gut Microbiota in People With Hepatocellular Carcinoma (HCC)|Gut Microbiota in Patients With HCC|Not yet recruiting||N/A|88|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:45:35.898189|2017-10-10 22:45:35.898189
NCT02599896|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-06|2017-10-05|||October 30, 2015||2015-10-30|September 12, 2017|2017-09-12|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults|VRC 606: A Phase 1, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS) and VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults|Active, not recruiting||Phase 1|45|Actual|National Institutes of Health Clinical Center (CC)||8|||f||||||||||||||2017-10-10 22:45:35.986157|2017-10-10 22:45:35.986157
NCT02599883|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-05|||September 2012||2012-09-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evidence-based Analysis of Low-dose CT in Management of COPD|Impact of Low-dose Computed Tomography on the Management of Chronic Obstructive Pulmonary Disease Patients: an Evidence-based Study|Completed||N/A|195|Actual|Azienda Ospedaliero-Universitaria di Parma||1|||f||||f||||||||||2017-10-10 22:45:36.108878|2017-10-10 22:45:36.108878
NCT02599870|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-06-02|||September 2015||2015-09-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures|Prospective Randomized Clinical Study to Evaluate the Clinical Impact of Pharmacogenetics-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures|Active, not recruiting||N/A|56|Actual|AltheaDx||2|||f||||f||||||||||2017-10-10 22:45:36.191419|2017-10-10 22:45:36.191419
NCT02599857|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-05-23|||January 1, 2017|Anticipated|2017-01-01|November 2015|2015-11-01|May 1, 2017|Anticipated|2017-05-01|May 1, 2017|Anticipated|2017-05-01||Interventional|||The Effects of a CONCOR Smartphone Application|The Effects of a CONCOR Smartphone Application on Arrhythmia, Heart Failure Events and Quality of Life in Patients With Congenital Heart Disease: a Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2||never started|f||||f||||||||||2017-10-10 22:45:36.289635|2017-10-10 22:45:36.289635
NCT02599844|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-11-16|||December 2015||2015-12-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|IMPRESS-YA||Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults|Long Term Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults - IMPRESS YA|Recruiting||N/A|55|Anticipated|University of Florida|||2||f||||f||||||Samples Without DNA|"     serum and urine   "|||2017-10-10 22:45:36.370833|2017-10-10 22:45:36.370833
NCT02599831|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-27|||October 2014||2014-10-01|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|September 2016|Actual|2016-09-01||Interventional|||Efficacy of Electrical Pudendal Nerve Stimulation for Patients With Post Prostatectomy Incontinence|Efficacy of Electrical Pudendal Nerve Stimulation for Patients With Post Prostatectomy Incontinence|Completed||N/A|96|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-10 22:45:36.491895|2017-10-10 22:45:36.491895
NCT02599818|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-08-30|||March 15, 2016|Actual|2016-03-15|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|NavSTAR||Navigation Services to Avoid Rehospitalization (NavSTAR)|Navigation Services to Avoid Rehospitalization (NavSTAR) Among Substance Users|Enrolling by invitation||N/A|420|Anticipated|Friends Research Institute, Inc.||2|||f||||t||||||||||2017-10-10 22:45:36.595944|2017-10-10 22:45:36.595944
NCT02599805|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-11-05|||December 2015||2015-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Can Topical Oxygen Therapy (Natrox™) Improve Wound Healing in Diabetic Foot Ulcers?|Can Topical Oxygen Therapy (Natrox™) Improve Wound Healing in Diabetic Foot Ulcers?|Not yet recruiting||Phase 3|20|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 22:45:36.732113|2017-10-10 22:45:36.732113
NCT02599792|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-04-29|||November 2015||2015-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656|A Two-Part Phase 1 Healthy Volunteer Study: A Crossover Comparison of CTP-656 Solid Dose Formulation vs. Kalydeco® and a Double-Blind, Placebo-Controlled, Ascending Multiple Dose Evaluation of CTP-656|Completed||Phase 1|37|Actual|Concert Pharmaceuticals||5|||f||||f||||||||||2017-10-10 22:45:36.821723|2017-10-10 22:45:36.821723
NCT02599779|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|OZM-065||A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients|A Phase II Proof of Principle Study of the Activity of Pembrolizumab (MK-3475) in Combination With SBRT in Primary Tyrosine Kinase Inhibitor (TKI) Refractory Metastatic Kidney Cancer (mRCC) Patients|Recruiting||Phase 2|35|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 22:45:36.928307|2017-10-10 22:45:36.928307
NCT02599766|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-10-06|||February 2014||2014-02-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Animal-assisted Therapy on Brain-injured Patients|Short-term Effects of Animal-assisted Therapy on the Rehabilitation Process of Brain-injured Patients at REHAB Basel|Completed||N/A|25|Actual|Swiss Tropical & Public Health Institute||2|||f||||f||||||||||2017-10-10 22:45:37.056056|2017-10-10 22:45:37.056056
NCT02599753|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-07-21|||August 2015||2015-08-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients|Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients With Neuropsychiatric Disorders by Multimodal Neuroimaging|Recruiting||Phase 2|140|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-10 22:45:37.176925|2017-10-10 22:45:37.176925
NCT02599740|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-01-14|||October 2015||2015-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Natural Fruit Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Level|The Bioequivalence of a Natural Extract Versus the Assumed Key Active Compound in Reducing the Post-prandial Blood Glucose Levels|Completed||N/A|84|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-10 22:45:37.474305|2017-10-10 22:45:37.474305
NCT02599727|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-02-16|||November 2015||2015-11-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effects of Isometric Exercises on Balance, Heart Rate, Pulse Ox and Blood Pressure|Effects of Isometric Exercises on Balance, Heart Rate, Pulse Ox and Blood Pressure|Withdrawn||N/A|0|Actual|Carrick Institute for Graduate Studies||2||Logistics reason at the data collection site|f||||f||||||||||2017-10-10 22:45:37.592991|2017-10-10 22:45:37.592991
NCT02599714|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-15|||December 7, 2015|Actual|2015-12-07|September 2017|2017-09-01|August 7, 2019|Anticipated|2019-08-07|August 7, 2019|Anticipated|2019-08-07||Interventional|PASTOR||Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer|A Phase I/II Multicenter Study of the Combination of AZD2014 and Palbociclib on a Background of Hormonal Therapy in Patients With Locally Advanced/Metastatic Estrogen Receptor Positive Breast Cancer Comprising a Safety, Pharmacokinetic and Preliminary Efficacy Evaluation Followed by a Randomised, Double-Blind, Placebo-controlled, Parallel Group Extension|Recruiting||Phase 1/Phase 2|241|Anticipated|AstraZeneca||2|||f||||t|t|f||||||||2017-10-10 22:45:37.69153|2017-10-10 22:45:37.69153
NCT02599701|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-07-12|||September 2015||2015-09-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Acute Effects of Gabapentin in Sleep Parameters and Hormonal Release During Sleep in Older Men|Acute Effects of Gabapentin on Polysomnography Parameters and on Hypothalamic-pituitary-adrenal, Hypothalamic-pituitary-gonadal and Somatotropic Axes During Sleep in Older Men: a Randomized, Double-blind, Placebo-controlled Trial|Terminated||Phase 4|8|Actual|Associação Fundo de Incentivo à Pesquisa||2||Gabapentin increased hypopnea-apnea index in the first 8 recruited subjects.|f||||f||||||||||2017-10-10 22:45:37.828691|2017-10-10 22:45:37.828691
NCT02599688|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-06-16|||November 2015||2015-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Open Label Extension of LipoLat-CS202|An Open-label Extension Study of the Safety and Efficacy of Subconjunctival Liposomal Latanoprost (POLAT-001) in Patients With Ocular Hypertension and Primary Open Angle Glaucoma|Completed||N/A|17|Actual|Peregrine Ophthalmic|||1||f||||f||||||||||2017-10-10 22:45:37.916329|2017-10-10 22:45:37.916329
NCT02599675|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-07|||November 2015||2015-11-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Vitamin D Supplementation and Muscle Characteristics in Trained Subjects|Effects of 12 Weeks of Vitamin D Supplementation on Muscle Characteristics in Trained Subjects|Completed||N/A|71|Actual|Inland Norway University of Applied Sciences||2|||f||||t||||||||||2017-10-10 22:45:37.985676|2017-10-10 22:45:37.985676
NCT02599662|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-04-19|||January 2015||2015-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|IORT||Intraoperative Radiation Therapy for Resectable Pancreas Cancer|Phase I Study of Low Kilovoltage Intraoperative Radiation for Patients With Resectable Pancreatic Adenocarcinoma|Recruiting||Phase 1|12|Anticipated|Loyola University||3|||f||||t||||||||||2017-10-10 22:45:38.083187|2017-10-10 22:45:38.083187
NCT02599649|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-06-07|||March 21, 2016|Actual|2016-03-21|June 2017|2017-06-01|March 2025|Anticipated|2025-03-01|March 2025|Anticipated|2025-03-01||Interventional|||Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)|Phase II Combination of Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)|Recruiting||Phase 2|80|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 22:45:38.192252|2017-10-10 22:45:38.192252
NCT02599636|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-07-13|||October 2015||2015-10-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||To Survive After ICU Discharge|Multicenter Prospective Study: To Survive After ICU Discharge|Active, not recruiting||N/A|1200|Anticipated|Althaia Xarxa Assistencial Universitària de Manresa|||1||f||||f||||||||||2017-10-10 22:45:38.352522|2017-10-10 22:45:38.352522
NCT02599623|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-06-17|||January 2016||2016-01-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy of Local Anesthesia in Emergency Inguinal Hernia Surgery|Safety and Efficacy of Local Anesthesia in Emergency Inguinal Hernia Surgery, a Prospective Randomized Trial|Recruiting||N/A|80|Anticipated|RenJi Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:45:38.452475|2017-10-10 22:45:38.452475
NCT02599610|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-02-14|||October 2015||2015-10-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Effects of Digital Vaginal Examination During Labor on Pain and Anxiety Levels|Effects of Digital Vaginal Examination During Labor on Pain and Anxiety : a Randomised Controlled Trial|Recruiting||N/A|40|Anticipated|Ankara University||2|||f||||f||||||||||2017-10-10 22:45:38.583366|2017-10-10 22:45:38.583366
NCT02599597|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-06-29|||February 2016||2016-02-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Prevention of Depressive Relapse by Means of Physical Exercise and Lifestyle|Prevention of Depressive Relapse by Means of Physical Exercise and Lifestyle|Recruiting||N/A|150|Anticipated|Lund University||3|||f||||f||||||||||2017-10-10 22:45:38.696282|2017-10-10 22:45:38.696282
NCT02599584|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-09-30|||November 2015||2015-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|Simstaf&perf||Performance and Team Pre-critical Staff Before Critical Event in High Fidelity Simulation for Anesthesiology Residents|Improvement of Team Performance With a Pre-critical Staff Within the Team Prior to Admission of Critical Simulated Patient in High Fidelity Simulation Session for Anesthesiology Resident During Their Education Curriculum|Completed||N/A|44|Actual|Claude Bernard University||2|||f||||f||||||||Undecided||2017-10-10 22:45:38.798728|2017-10-10 22:45:38.798728
NCT02599545|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-21|||October 2015||2015-10-01|July 2017|2017-07-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Observational|||Testosterone and Cortisol Levels in Infants|Testosterone and Cortisol Levels in Infant Health and Development|Terminated||N/A|300|Anticipated|Duke University|||1||f||||||||||Samples Without DNA|"     A blood sample will be obtained only from the infant by collecting the leftover cord blood     from the hospital lab. If no remnant blood is available, a blood specimen will not be     collected. Mothers will be asked to provide a saliva sample within 72 hours of delivery, then     mother and infant saliva sampling will be collected in the morning on the same day when the     infant reaches 40 weeks postmenstrual age (PMA) or discharge from the Duke Intensive Care     Nursery (ICN) (whichever comes first), 12 months, and 24 months corrected age (CA)(+/- 1     month).   "|||2017-10-10 22:45:39.09752|2017-10-10 22:45:39.09752
NCT02599532|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-05-03|||April 30, 2017|Actual|2017-04-30|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome|Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome|Recruiting||Phase 1|30|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f|t|f||||||||2017-10-10 22:45:39.173549|2017-10-10 22:45:39.173549
NCT02599519|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-12-12|||January 2015||2015-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:45:39.276107|2017-10-10 22:45:39.276107
NCT02599506|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-05|||December 2015||2015-12-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|FORECAST||Fear of Cancer Recurrence (FoR) Trajectory During Radiation Treatment|Fear of Cancer Recurrence (FoR) Trajectory During Radiation Treatment and Follow-up Into Survivorship of 100 Breast Cancer patients-a Pilot Study|Not yet recruiting||N/A|100|Anticipated|University of St Andrews|||1||f||||f||||||||||2017-10-10 22:45:39.313881|2017-10-10 22:45:39.313881
NCT02599493|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-01-16|||January 2016||2016-01-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|EVRIOS||EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin|EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin in the Treatment of Staphylococcal Bone and Joint Infections|Recruiting||Phase 4|460|Anticipated|Rennes University Hospital||2|||f||||t||||||||||2017-10-10 22:45:41.480353|2017-10-10 22:45:41.480353
NCT02599480|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-12-12|||April 2016||2016-04-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|Beta3_LVH||Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure|A Multi-centre Randomized, Placebo-controlled Trial of Mirabegron, a New beta3-adrenergic Receptor Agonist on Left Ventricular Mass and Diastolic Function in Patients With Structural Heart Disease|Enrolling by invitation||Phase 2|297|Anticipated|Université Catholique de Louvain||2|||f||||t||||||||||2017-10-10 22:45:41.679714|2017-10-10 22:45:41.679714
NCT02599467|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-11-05|||January 2015||2015-01-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||EMG at Performing ULTN 1 in Breast Cancer Patients|Evoked EMG Muscle Activity at Performing ULTN 1 in Breast Cancer Patients|Completed||N/A|124|Actual|University of Alcala||3|||f||||t||||||||||2017-10-10 22:45:41.816779|2017-10-10 22:45:41.816779
NCT02599454|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-09-13|||February 2016||2016-02-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer|A Phase I Trial of an Immune Checkpoint Inhibitor Plus Stereotactic Ablative Radiotherapy in Patients With Inoperable Stage I Non-Small Cell Lung Cancer|Recruiting||Phase 1|33|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 22:45:41.882059|2017-10-10 22:45:41.882059
NCT02599441|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-04-26|||February 2016||2016-02-01|April 2017|2017-04-01||||February 2018|Anticipated|2018-02-01||Observational|||Computed Tomography for Evaluating Supination-external Rotation Type Ankle Fractures|Comparison of a Novel Weight Bearing Cone-beam Computed Tomography (CT) Scan to Gravity Stress X-ray for Determining Instability of Supination-external Rotation Type Ankle Fractures|Recruiting||N/A|20|Anticipated|State University of New York at Buffalo|||1||f||||f||||||||||2017-10-10 22:45:41.977455|2017-10-10 22:45:41.977455
NCT02599428|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-04-03|||February 2016||2016-02-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|||Recovery After ICU Treatment: A Prospective Cohort Study|Recovery After ICU Treatment: A Prospective Cohort Study|Recruiting||N/A|200|Anticipated|Zealand University Hospital|||1||f||||t||||||||No||2017-10-10 22:45:42.058127|2017-10-10 22:45:42.058127
NCT02599415|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-03-24|||September 2014||2014-09-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Anti-psoriatic Effect of TL01 Light Therapy|Studying the Effect of Narrow Band Ultraviolet B Phototherapy on Skin Dendritic (DCs) Cells in Psoriasis Patients|Completed||N/A|6|Actual|University of Aberdeen||1|||f||||f||||||||No||2017-10-10 22:45:42.138479|2017-10-10 22:45:42.138479
NCT02599402|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-14|||December 8, 2015|Actual|2015-12-08|September 2017|2017-09-01|December 20, 2021|Anticipated|2021-12-20|December 19, 2021|Anticipated|2021-12-19||Interventional|CheckMate 401||Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma|Clinical Trial of Nivolumab (BMS-936558) Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Therapy of Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma CheckMate 401: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 401|Active, not recruiting||Phase 3|615|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:45:42.31992|2017-10-10 22:45:42.31992
NCT02599389|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-11-25|||December 2015||2015-12-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|INTACT||Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis|Economic Evaluation Comparing Standard Balloon Angioplasty Versus Drug-eluted Balloon or Laser-Excimer in Association With Drug-eluted Balloon in the Treatment of Femoropopliteal Artery In-stent Restenosis.|Recruiting||Phase 4|252|Anticipated|University Hospital, Bordeaux||3|||f||||t||||||||||2017-10-10 22:45:42.661585|2017-10-10 22:45:42.661585
NCT02599376|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-09-07|||December 2014||2014-12-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Comparative Study of Haemodynamic Changes After Spinal Anaesthesia in Non-obese and Pregnant Women|Comparative Study of Haemodynamic Changes After Spinal Anaesthesia in Non-obese and Pregnant Women|Completed||N/A|60|Actual|University of Aberdeen||2|||f||||f||||||||No||2017-10-10 22:45:42.806054|2017-10-10 22:45:42.806054
NCT02599363|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-09-23|||January 2016||2016-01-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer|A Phase I Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer|Recruiting||Phase 1|28|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 22:45:42.891153|2017-10-10 22:45:42.891153
NCT02599350|ClinicalTrials.gov processed this data on October 10, 2017|2009-04-30|2015-11-05|||May 2009||2009-05-01|November 2015|2015-11-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Observational|||Assessing Gas Exchange in Intensive Care Patients on a Ventilator|Evaluation of a New Computer Slide Rule Method for Assessing Gas Exchange in Intensive Care Patients on a Ventilator|Completed||N/A|30|Actual|University of Aberdeen|||1||f||||f||||||||||2017-10-10 22:45:42.971717|2017-10-10 22:45:42.971717
NCT02599337|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-11-04|||July 2015||2015-07-01|July 2015|2015-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Bioequivalence Study of Sorafenib Tablet and Nexavar|Randomized, Open-label, 3-way Reference Replicated Crossover Bioequivalence Study of Sorafenib 200 mg Tablet and Nexavar (Reference) Following a 200 mg Dose in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|36|Actual|Yabao Pharmaceutical Group||2|||f||||f||||||||||2017-10-10 22:45:43.035841|2017-10-10 22:45:43.035841
NCT02599324|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-08-22|||November 2015||2015-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors|A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors|Recruiting||Phase 1/Phase 2|261|Anticipated|Pharmacyclics LLC.||4|||f||||||||||||||2017-10-10 22:45:43.130734|2017-10-10 22:45:43.130734
NCT02599311|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-05-21|||August 2015||2015-08-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||the Indications and Clinical Efficacy of Pelvic Organ Prolapse Surgery|The Clinical Efficacy of Pelvic Organ Prolapse Surgery|Recruiting||Phase 3|1000|Anticipated|Peking University People's Hospital||4|||f||||t||||||||||2017-10-10 22:45:43.513587|2017-10-10 22:45:43.513587
NCT02599298|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-10-28|||July 2016||2016-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SGMT||Sleep Study-Guided Multidisciplinary Therapy for Patients Presenting With Acute Coronary Syndrome|Sleep Study-Guided Multidisciplinary Therapy for Patients Presenting With Acute Coronary Syndrome|Recruiting||N/A|180|Anticipated|National University, Singapore||2|||f||||f||||||||||2017-10-10 22:45:43.613369|2017-10-10 22:45:43.613369
NCT02599285|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-09-12|||November 2015||2015-11-01|September 2016|2016-09-01||||December 2022|Anticipated|2022-12-01||Observational|POSTFIX-C||Fixation of the Posterior Malleolus in Trimalleolar AO Weber C Fractures.|Operative Treatment of AO Weber C Fibular Fractures With Additional Medium-sized Posterior Malleolar Fragment: Syndesmotic Reduction and Functional Outcome After Syndesmotic Positioning Screws or Posterior Fragment Fixation. POSTFIX-C Trial: a Prospective Comparative Observational Study.|Recruiting||N/A|54|Anticipated|Medical Center Haaglanden|||2||f||||f||||||||||2017-10-10 22:45:43.717072|2017-10-10 22:45:43.717072
NCT02599272|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-08-01|||October 7, 2015|Actual|2015-10-07|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|PSP||Effects of Mixed Spices on Cardiometabolic Function - the PolySPice (PSP) Study|Effects of Mixed Spices on Cardiometabolic Function - the PolySPice (PSP) Study|Recruiting||N/A|24|Anticipated|Clinical Nutrition Research Centre, Singapore||3|||f||||f||||||||||2017-10-10 22:45:43.821061|2017-10-10 22:45:43.821061
NCT02599259|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-07-11|||March 2015||2015-03-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.|Using Artificial Intelligence on Mobile Devices to Automate Directly Observed Therapy (DOT), Confirm Medication Ingestion, and Optimize Treatment in Patients on Anticoagulation Therapy.|Completed||N/A|28|Actual|AiCure||2|||f||||f||||||||||2017-10-10 22:45:43.931645|2017-10-10 22:45:43.931645
NCT02599246|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-01-31|||November 17, 2015|Actual|2015-11-17|January 2017|2017-01-01|February 24, 2016|Actual|2016-02-24|February 22, 2016|Actual|2016-02-22|1 Day|Observational [Patient Registry]|NIVLEAKS||FiO2 in Chronic Obstructive Pulmonary Disease (COPD) Patient Normobaric O2 Versus NIV|Measured FiO2 With Nasal Canula O2 Versus Noninvasive Ventilation (NIV) With the Same O2 Flow, in COPD Patients the NIV LEAKS Study|Completed||N/A|14|Actual|Breas Medical S.A.R.L.|||1||f||||f|f|f||||||Undecided||2017-10-10 22:45:44.023683|2017-10-10 22:45:44.023683
NCT02599233|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-01-31|||March 2016|Actual|2016-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Observational|PATCH||Characterization of Post-operative Pain Trajectories Over Seven Days and Links With Chronicity|Characterization of Post-operative Pain Trajectories Over Seven Days and Their Potential Links With Chronicity After 3 Months: a Single-center, Prospective, Pilot Cohort Study at the Nîmes University Hospital|Completed||N/A|392|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 22:45:44.097805|2017-10-10 22:45:44.097805
NCT02599220|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-11-05|||January 2002||2002-01-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Clinical Outcomes and Cost of Gram Negative Bacteremia|Epidemiology, Outcomes, and Costs Associated With Gram Negative Bacteremia|Completed||N/A|2000|Actual|Duke University|||1||f||||f||||||Samples With DNA|"     Human DNA from patients with gram negative bacteremia   "|||2017-10-10 22:45:44.193506|2017-10-10 22:45:44.193506
NCT02599207|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-06-27|||November 2015||2015-11-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|October 2016|Actual|2016-10-01||Interventional|||Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy|Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy|Active, not recruiting||Phase 1|15|Actual|Duke University||2|||f||||t||||||||||2017-10-10 22:45:44.257516|2017-10-10 22:45:44.257516
NCT02599194|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-02-15|||July 2015||2015-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||18F-FSPG PET/CT for Cancer Patients on Therapy|An Exploratory Study of the Role of 18F-FSPG PET/CT Imaging for Cancer Patients Receiving Therapy|Suspended||Phase 2|50|Anticipated|Stanford University||1||business decision|f|||||t|f||||||||2017-10-10 22:45:44.335826|2017-10-10 22:45:44.335826
NCT02599181|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2017-05-29|||January 2013||2013-01-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Local Inflammation Does Not Correlate With Bacterial Colonization and Contamination of Perineural Catheters|Local Inflammation Does Not Correlate With Bacterial Colonization and Contamination of Perineural Catheters|Completed||N/A|200|Actual|Balgrist University Hospital||2|||f||||f||||||||||2017-10-10 22:45:44.455357|2017-10-10 22:45:44.455357
NCT02599168|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-10-03|||December 5, 2015|Actual|2015-12-05|October 2017|2017-10-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Interventional|||Effect of Dexmedetomidine on Propofol Requirement During Anesthesia|The Effect of Dexmedetomidine on Propofol Requirements During Anesthesia Administered by Bispectral Index-Guided Closed-Loop Anesthesia Delivery System: A Randomized Controlled Study|Completed||Phase 4|80|Actual|Sir Ganga Ram Hospital||2|||f||||t||||||||||2017-10-10 22:45:44.541416|2017-10-10 22:45:44.541416
NCT02599155|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-06-22|||November 2015||2015-11-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of the Hydroxyethyl Starch on Kidney Injury in Pediatric Cardiac Surgery|The Effect of the Hydroxyethyl Starch on Kidney Injury in Pediatric Cardiac Surgery|Completed||N/A|200|Actual|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-10 22:45:44.644323|2017-10-10 22:45:44.644323
NCT02599142|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-06-23|||November 2015||2015-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|CORIOLIS||Comparing Immobilisation Shells in Cranial Radiotherapy|A Randomised Controlled Trial Comparing the Accuracy and Acceptability of Closed-face and Open-face Thermoplastic Immobilisation Shells in Cranial Radiotherapy|Enrolling by invitation||N/A|40|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||Undecided||2017-10-10 22:45:44.735977|2017-10-10 22:45:44.735977
NCT02599129|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-01-30|||November 2015||2015-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of Secukinumab for the Treatment of Alopecia Areata|An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata|Terminated||Phase 2|11|Actual|Icahn School of Medicine at Mount Sinai||2||low enrollment|f||||t||||||||||2017-10-10 22:45:44.8212|2017-10-10 22:45:44.8212
NCT02599116|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-10-03|||December 2015||2015-12-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gastrointestinal Microbiome Study of Appendiceal Cancer|A Cohort Study of the Gastrointestinal Microbiome in Appendiceal Cancer With Peritoneal Spread|Recruiting||N/A|24|Anticipated|Mercy Medical Center||1|||f||||f||||||||||2017-10-10 22:45:44.93878|2017-10-10 22:45:44.93878
NCT02599103|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-11-05|||September 2013||2013-09-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects||Completed||N/A|17|Actual|Academia Sinica, Taiwan||10|||f||||t||||||||||2017-10-10 22:45:45.030494|2017-10-10 22:45:45.030494
NCT02599090|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-04|||December 2008||2008-12-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma|Phase II Portion of Multi Phase Study of Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||4||Multi phase study did not progress to Phase II. Phase I registered as NCT00734526.|f||||f||||||||||2017-10-10 22:45:45.116137|2017-10-10 22:45:45.116137
NCT02599077|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-11-21|||November 2015||2015-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas|Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas in Women With Diameters Smaller Than 4 Centimeters Thereof, at University Hospital Fundación Santa Fe de Bogota, Between the Years 2015-2017|Suspended||Phase 2/Phase 3|50|Anticipated|Fundación Santa Fe de Bogota||2|||f||||t||||||||||2017-10-10 22:45:45.216178|2017-10-10 22:45:45.216178
NCT02599064|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-08-03|||November 2015||2015-11-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD|A Phase 1/2 Multicenter, Multidose, Dose Escalation Study to Evaluate the Safety, Tolerability and Clinical Activity of RXI-109 Administered by Intravitreal Injection to Reduce the Progression of Subretinal Fibrosis in Subjects With Advanced Neovascular Age-related Macular Degeneration|Recruiting||Phase 1/Phase 2|9|Anticipated|RXi Pharmaceuticals, Corp.||1|||f||||t||||||||||2017-10-10 22:45:45.302262|2017-10-10 22:45:45.302262
NCT02599051|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-04-18|||November 2008||2008-11-01|April 2017|2017-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Transobturator Verus Single Incision Slings|Transobturator Versus Single Incision Slings: 1 Year Results of a Randomized Control Trial|Completed||N/A|89|Actual|The Cleveland Clinic||2|||f||||t||||||||No||2017-10-10 22:45:45.384336|2017-10-10 22:45:45.384336
NCT02599038|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-10-15|||October 2015||2015-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Serine Supplementation for Obese Subjects With Fatty Liver Disease|Serine Supplementation in Nonalcoholic Fatty Liver Disease|Completed||Phase 1/Phase 2|10|Actual|Sahlgrenska University Hospital, Sweden||1|||f||||f||||||||No||2017-10-10 22:45:45.468561|2017-10-10 22:45:45.468561
NCT02599025|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-05|||February 2016||2016-02-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Posture and Passive Cycling on Cardiac Autonomic Control System in Children With Severe Cerebral Palsy|Effect of Posture and Passive Cycling on Cardiac Autonomic Control System in Children With Severe Cerebral Palsy|Not yet recruiting||N/A|24|Anticipated|Ziv Hospital||4|||f||||f||||||||||2017-10-10 22:45:45.544477|2017-10-10 22:45:45.544477
NCT02599012|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-02-07|||September 12, 2015|Actual|2015-09-12|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients||Recruiting||Phase 2|100|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-10 22:45:45.62016|2017-10-10 22:45:45.62016
NCT02598999|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-05-11|||November 2015||2015-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||First-in-man Dose Escalation Study of ALX-009 and Its Components in Healthy Men and Cystic Fibrosis Suffering Patients|Randomized, Double Blind, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics After Single Ascending Doses or Multiple Ascending Doses of OSCN-, bLF or ALX-009 in Healthy Male Volunteers and Cystic Fibrosis Patients|Recruiting||Phase 1|124|Anticipated|Alaxia SAS||4|||f||||f||||||||||2017-10-10 22:45:45.802991|2017-10-10 22:45:45.802991
NCT02598986|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-05|||June 2013||2013-06-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Macronutrient Supplementation on Glycemic Index of Pita Bread|Glycemic Index of Bread: Fiber or Minerals? This is the Question.|Completed||N/A|96|Actual|American University of Beirut Medical Center||4|||f||||f||||||||||2017-10-10 22:45:45.941513|2017-10-10 22:45:45.941513
NCT02598973|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-09-11|||February 1, 2016|Actual|2016-02-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Effect of Exercise in Parkinsonism|Effect of Exercise on Recovery in Drug-Induced Parkinsonism and Parkinson Disease|Recruiting||Phase 1/Phase 2|120|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:45:46.027361|2017-10-10 22:45:46.027361
NCT02598960|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-10-02|||October 9, 2015|Actual|2015-10-09|September 2017|2017-09-01|February 1, 2019|Anticipated|2019-02-01|January 30, 2019|Anticipated|2019-01-30||Interventional|||An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.|A Phase 1/2a Dose Escalation and Cohort Expansion Study for Safety, Tolerability, and Efficacy of BMS-986156 Administered Alone and in Combination With Nivolumab (BMS-936558, Anti PD-1 Monoclonal Antibody) in Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|310|Anticipated|Bristol-Myers Squibb||4|||f||||f|t|f||||||||2017-10-10 22:45:46.129217|2017-10-10 22:45:46.129217
NCT02598947|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-11-07|||September 2016||2016-09-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||The Effectiveness of a Treatment for Posterior Shoulder Tightness: A Feasibility Study|The Effectiveness of Treatment for Posterior Shoulder Tightness in Combination With 'Best Care' Compared With 'Best Care' Alone in Individuals With Shoulder Impingement Syndrome: A Feasibility Study|Recruiting||N/A|60|Anticipated|Western Sussex Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 22:45:46.340277|2017-10-10 22:45:46.340277
NCT02598934|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-02-10|2016-02-10||August 2004||2004-08-01|February 2016|2016-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional||Intent-to-Treat (ITT) Population: All enrolled participants who received at least 1 dose of study medication.|A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis|A Prospective Open-Label, Multicenter Study to Evaluate the Change in Bone Turnover Markers After Once Monthly Oral Ibandronate Therapy in Treatment Naive Postmenopausal Osteoporosis Patients|Completed||Phase 4|308|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:45:46.451429|2017-10-10 22:45:46.451429
NCT02598921|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2015-12-16|||July 2014||2014-07-01|October 2013|2013-10-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Screening for Uterine Cavity Abnormalities in Women Scheduled for IVF|Determining an Accurate and Cost-effective Strategy for Screening for Uterine Cavity Abnormalities in Women Scheduled for IVF|Completed||Phase 2|120|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:45:47.003941|2017-10-10 22:45:47.003941
NCT02598908|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-04-24|||February 24, 2017|Actual|2017-02-24|April 2017|2017-04-01|February 24, 2022|Anticipated|2022-02-24|February 24, 2022|Anticipated|2022-02-24||Observational|||An EQA Scheme for TPMT Activity and Thiopurine Metabolites|Collection of Blood Samples for Use in an External Quality Assurance (EQA) Scheme for Thiopurine S-methyl Transferase (TPMT) Activity and Thiopurine Metabolites, 6-thioguanine Nucleotides (6TGN) and 6-methyl Mercaptopurine Nucleotides (6MMPN).|Recruiting||N/A|40|Anticipated|Sandwell & West Birmingham Hospitals NHS Trust|||2||f||||f|t|f|||f|Samples Without DNA|"     Up to 60 mL of EDTA blood will be collected from each of the selected volunteers by trained     phlebotomy staff at Sandwell or City hospitals and virology tested just prior to the sample     distribution.      Surplus blood from routine specimens analysed for 6TGN and 6MMPN will be selected on the     basis of thiopurine metabolite concentrations of interest and volume of blood remaining.   "|No|Not applicable. Results will be analysed anonymised.|2017-10-10 22:45:47.077141|2017-10-10 22:45:47.077141
NCT02598895|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-06-12|||January 2016|Actual|2016-01-01|June 2017|2017-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Docetaxel and Carboplatin in Treating Patients With Metastatic, Hormone Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway|A Pilot Study of Docetaxel and Carboplatin for Treatment of Patients With Metastatic, Castration Resistant Prostate Cancer Containing Biallelic Inactivation of Genes in the BRCA1/2 Pathway|Recruiting||N/A|14|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 22:45:47.164438|2017-10-10 22:45:47.164438
NCT02598882|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-11-04|||September 2014||2014-09-01|November 2015|2015-11-01|November 2015|Anticipated|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Virtual Reality as a Tool for Rehabilitation on Elderly People|Physical Activity With an Active Video Game Provides Bigger Energy Expenditure and Less Muscle Fatigue|Active, not recruiting||N/A|13|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 22:45:47.29431|2017-10-10 22:45:47.29431
NCT02598869|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-11-04|||November 2015||2015-11-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema|Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema (CME)|Not yet recruiting||Phase 4|30|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-10 22:45:47.375745|2017-10-10 22:45:47.375745
NCT02598856|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-02-02|||March 2016||2016-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|OPI-15-002||Bioavailability of Nasal Naloxone and Injected Naloxone Compared|Bioavailability of Nasal Naloxone and Injected Naloxone Compared. A Randomized, Open Label, 4-way Cross-over Study|Completed||Phase 1|22|Actual|Norwegian University of Science and Technology||4|||f||||t||||||||||2017-10-10 22:45:47.461835|2017-10-10 22:45:47.461835
NCT02598843|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-11-04|||November 2013||2013-11-01|November 2015|2015-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Standard Non Operative Treatment Versus Accelerated Rehabilitation of Achilles Tendon Ruptures|Functional Outcomes After Conservative Management of the Acutely Ruptured Achilles Tendon in the Under 60 Age Group. A Randomised Controlled Trial Comparing Standard Conservative Management With Accelerated Rehabilitation Using a Moon Boot|Recruiting||N/A|160|Anticipated|NHS Lothian||2|||f||||t||||||||||2017-10-10 22:45:47.596253|2017-10-10 22:45:47.596253
NCT02598830|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-07|||November 2015||2015-11-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Granheim COPD Study - Vitamin D and Strength Training|The Granheim COPD Study: Effects of Vitamin D3-supplementation on the Efficacy of Strength Training in COPD Patients and Healthy Controls - a Double-blinded RCT|Recruiting||N/A|100|Anticipated|Inland Norway University of Applied Sciences||2|||f||||t||||||||||2017-10-10 22:45:47.712858|2017-10-10 22:45:47.712858
NCT02598817|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-07-19|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|August 2018|Anticipated|2018-08-01||Observational|||Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula|"Acceptability of High Sn-2 Infant Formula in Non-Breast Fed Healthy Term Infants Regarding Gastrointestinal Tolerability by Both Parents and Pediatrician. An Open Label Pilot Study Evaluation in the Gulf Cooperation Council (GCC) Countries."|Not yet recruiting||N/A|500|Anticipated|Nestlé|||1||f||||f||||||||||2017-10-10 22:45:47.848337|2017-10-10 22:45:47.848337
NCT02598804|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|GEET One||Evaluation of the Effectiveness of Self Management Program on Changes in Physical Activity Level of Knee Osteoarthritis Patients in Spa Therapy|Evaluation of the Effectiveness of Self Management Program on Changes in Physical Activity Level of Knee Osteoarthritis Patients in Spa Therapy|Recruiting||N/A|142|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:45:47.933559|2017-10-10 22:45:47.933559
NCT02598791|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2015-11-07|||October 2015||2015-10-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|GASOLIN||GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake|GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake|Recruiting||N/A|18|Anticipated|University Hospital, Gentofte, Copenhagen||4|||f||||t||||||||||2017-10-10 22:45:48.031232|2017-10-10 22:45:48.031232
NCT02598778|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-05|||November 2015||2015-11-01|November 2015|2015-11-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Comparing Mouth Rinses in Regard to Streptococcus Mutans Reduction|Comparing Chlorhexidine Gluconate, Sodium Fluoride, Coconut Oil and Water Mouth Rinses in Regard to Streptococcus Mutan Reduction|Not yet recruiting||N/A|40|Anticipated|Montefiore Medical Center||4|||f||||f||||||||||2017-10-10 22:45:48.134644|2017-10-10 22:45:48.134644
NCT02598765|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-04-16|||March 2016||2016-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Micro vs. Standard Trabeculectomy Study|Micro vs. Standard Trabeculectomy Study|Recruiting||N/A|240|Anticipated|Francis I. Proctor Foundation||2|||f||||f||||||||||2017-10-10 22:45:48.238228|2017-10-10 22:45:48.238228
NCT02598752|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-09-11|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation|Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation|Recruiting||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:45:48.324846|2017-10-10 22:45:48.324846
NCT02598739|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-11-05|||May 2014||2014-05-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|PSA||Evaluation of the Effectiveness of Resistance Training in Patients With Psoriatic Arthritis|Resistance Training in Patients With Psoriatic Arthritis Improves Function, Disease Activity and Quality of Life|Completed||N/A|41|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 22:45:48.416571|2017-10-10 22:45:48.416571
NCT02598726|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-06-27|||March 2016||2016-03-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer|Phase 1 Pilot Study of Curcumin and Piperine to Derive a Safe, Optimal Biologic Dose for Ureteral Stent-Induced Symptoms in Cancer Patients|Recruiting||Phase 1|40|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:45:48.491523|2017-10-10 22:45:48.491523
NCT02598713|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-09-15|||December 2015||2015-12-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Validation of Aspiration Markers in Intubated Patients|Validation of Markers for Aspiration for Endotracheal Tube Cuff Leak|Recruiting||Phase 1|20|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 22:45:48.587313|2017-10-10 22:45:48.587313
NCT02598700|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-07-18|||February 2016||2016-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Correlation of Spinopelvic Parameters and Acetabular Cup Orientation|Measurement and Quantitative Correlation of Spinopelvic Parameters and Acetabular Cup Orientation Between Standing and Sitting to Define a Better Functional Anteversion Safe Zone in Total Hip Arthroplasty|Recruiting||N/A|84|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 22:45:48.702857|2017-10-10 22:45:48.702857
NCT02598687|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-04-20|||December 2015||2015-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.|A Phase I Trial Testing TH-302, a Tumor-selective Hypoxia-Activated Cytotoxic Prodrug, in Combination With Preoperative Chemoradiotherapy in Patients With Distal Esophageal and Esophago-gastric Junction Adenocarcinoma|Withdrawn||Phase 1|0|Actual|Maastricht Radiation Oncology||1||"2 Phase 3 trials didn't meet their primary endpoint, so further development and testing of   TH-302 is uncertain"|f||||t||||||||Undecided||2017-10-10 22:45:48.955312|2017-10-10 22:45:48.955312
NCT02598674|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-06-16|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|IMPRESS-C||Severe Sepsis in Children - IMPRESS-C|Long Term Impact of Pediatric Acute Renal Injury in Severe Sepsis in in Children - IMPRESS-C|Not yet recruiting||N/A|55|Anticipated|University of Florida|||2||f||||f||||||Samples Without DNA|"     serum and urine   "|||2017-10-10 22:45:49.092605|2017-10-10 22:45:49.092605
NCT02598661|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-09-29|||November 24, 2015|Actual|2015-11-24|September 2017|2017-09-01|February 28, 2022|Anticipated|2022-02-28|April 17, 2019|Anticipated|2019-04-17||Interventional|||Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)|A Study to Evaluate Imetelstat (JNJ-63935937) in Transfusion-Dependent Subjects With IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) That is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment|Recruiting||Phase 3|200|Anticipated|Janssen Research & Development, LLC||3|||f||||t||f||||||||2017-10-10 22:45:49.305476|2017-10-10 22:45:49.305476
NCT02598648|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-24|||September 2015||2015-09-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Role and Molecular Mechanism of Farnesoid X Receptor(FXR) and RIPK3 in the Formation of Acute Respiratory Distress Syndrome in Neonates|Daping Hospital of the Third Military Medical University|Recruiting||N/A|40|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||3|||f||||f||||||||||2017-10-10 22:45:49.649371|2017-10-10 22:45:49.649371
NCT02598635|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2017-03-22|||October 2015||2015-10-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|October 2016|Actual|2016-10-01||Interventional|||Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis|Effects of Cholecalciferol on Osteoprotegerin Levels and Other Clinical Outcomes in Chronic Kidney Disease Patients on Peritoneal Dialysis: a Randomized Controlled Trial|Active, not recruiting||Phase 4|58|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-10 22:45:49.756418|2017-10-10 22:45:49.756418
NCT02598622|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-02-28|2016-02-22||September 2009||2009-09-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|May 2012|Actual|2012-05-01||Interventional|ALC||A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL|A Phase II Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL|Terminated||Phase 2|8|Actual|Indiana University|Early termination leading to small numbers of subjects analyzed. Unable to meet enrollment goals. Drug expired prior to being able to enroll total subjects.|2||Drug availability|f||||t||||||||||2017-10-10 22:45:49.901262|2017-10-10 22:45:49.901262
NCT02598609|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-10-20|||November 2015||2015-11-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|June 2017|Anticipated|2017-06-01||Interventional|SEPREVEN||An Educational Program to Prevent Adverse Events in Neonates : a Randomised Trial.|An Multifaceted Educational Program for Caregivers to Prevent Adverse Events in Neonatal Intensive Care Unit Patients, a Stepped Wedge Cluster Randomised Trial.|Recruiting||N/A|8000|Anticipated|Centre Hospitalier Intercommunal Creteil||3|||f||||f||||||||Undecided||2017-10-10 22:45:50.256269|2017-10-10 22:45:50.256269
NCT02598596|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-09-14|||December 2015||2015-12-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|TRIPLE||Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect|Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect|Recruiting||Phase 2|87|Anticipated|Ampel BioSolutions, LLC||6|||f||||f||||||||||2017-10-10 22:45:50.458943|2017-10-10 22:45:50.458943
NCT02598583|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-03-14|||November 2015||2015-11-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|July 2016|Actual|2016-07-01||Interventional|||An Open-Label, Intrapatient, Dose-Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria|An Open-Label, Intrapatient, Dose-Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria|Active, not recruiting||Phase 1/Phase 2|13|Actual|Alexion Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:45:50.588197|2017-10-10 22:45:50.588197
NCT02598570|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-02-03|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma|An Open-Label, Single-Arm, Multicenter Phase 1 Study Evaluating the Safety and Pharmacokinetics of Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma|Completed||Phase 1|7|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 22:45:50.695431|2017-10-10 22:45:50.695431
NCT02598557|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-05|2017-09-22|||December 6, 2016|Actual|2016-12-06|May 2017|2017-05-01||||January 31, 2019|Anticipated|2019-01-31||Interventional|||Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer|Alternative Dosing of Exemestane in Postmenopausal Women With Stage 0-II ER-Positive Breast Cancer: A Randomized Presurgical Trial|Recruiting||Phase 2|300|Anticipated|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-10-10 22:45:50.79181|2017-10-10 22:45:50.79181
NCT02598544|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-11-16|||May 2013||2013-05-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ERLO||Endocrine Regulation of Lipolysis in Obesity and Diabetes|Atrial Natriuretic Peptide (ANP)-Induced Lipid Mobilization Regulation in Different Adipose Tissue Depots of Obese Subjects|Completed||N/A|55|Actual|Hasselt University||3|||f||||f||||||||||2017-10-10 22:45:50.947095|2017-10-10 22:45:50.947095
NCT02598531|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-06-23|||January 2016||2016-01-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|SWIFT||Surgical Weight-Loss to Improve Functional Status Trajectories Following Total Knee Arthroplasty (SWIFT Trial)|Surgical Weight-Loss to Improve Functional Status Trajectories Following Total Knee Arthroplasty (SWIFT Trial)|Recruiting||N/A|500|Anticipated|Geisinger Clinic|||2||f||||t||||||Samples With DNA|"     Blood Samples Synovial Fluid   "|No||2017-10-10 22:45:51.062858|2017-10-10 22:45:51.062858
NCT02598518|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-10-04|||July 2015||2015-07-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ICT||Integrating Combined Therapies for Persons With Co-occurring Disorders|Integrating Combined Therapies for Persons With Co-occurring Disorders|Enrolling by invitation||N/A|38|Actual|Stanford University||2|||f||||t||||||||||2017-10-10 22:45:51.173087|2017-10-10 22:45:51.173087
NCT02598505|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-11-04|||September 2015||2015-09-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Indacaterol in Heart Failure Patients: Any Role on Lung Fluid Regulation|Indacaterol in Heart Failure Patients: Any Role on Lung Fluid Regulation|Recruiting||Phase 3|60|Anticipated|Centro Cardiologico Monzino||2|||f||||f||||||||||2017-10-10 22:45:51.283902|2017-10-10 22:45:51.283902
NCT02598492|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-07-13|||September 2015||2015-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|1 Year|Observational [Patient Registry]|||Imputation of PaO2 From SaO2|Imputation of PaO2 From SaO2 in the Respiratory Component of the Sequential Organ Failure Assessment (SOFA) Score|Recruiting||N/A|1000|Anticipated|Brigham and Women's Hospital|||1||f||||t||||||||||2017-10-10 22:45:51.380844|2017-10-10 22:45:51.380844
NCT02598479|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-04|||November 2015||2015-11-01|November 2015|2015-11-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|IPTLDAZCAM||A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer|The IPTLD QoL Broad Study A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer|Recruiting||N/A|100|Anticipated|Best Answer for Cancer Foundation|||1||f||||t||||||||||2017-10-10 22:45:51.584676|2017-10-10 22:45:51.584676
NCT02598466|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-02-05|||July 2015||2015-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa|Patient-Reported Efficacy of Subcutaneous Abatacept in Rheumatoid Arthritis: An Evaluation Of Patients In a Compassionate Use Programme in South Africa|Completed||N/A|69|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:45:51.669837|2017-10-10 22:45:51.669837
NCT02598453|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-11-01|||January 2005||2005-01-01|November 2016|2016-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia|An Open-Label, Multi-Center Study to Determine Level of Adherence to Monthly Oral or Every Three Month Intravenous Ibandronate Treatment in Post-Menopausal Women With Osteoporosis or Osteopenia, Who Are GI Intolerant of Daily or Weekly Alendronate or Risendronate|Completed||Phase 4|545|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:45:51.76583|2017-10-10 22:45:51.76583
NCT02598440|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-11-01|||March 2004||2004-03-01|November 2016|2016-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis|A Randomized, Open-Label, Muti-Center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once-Monthly Ibandronate and Once-Weekly Alendronate. A Six Month, Two-Sequence, and Two-Period Crossover Study|Completed||Phase 4|341|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:45:51.968872|2017-10-10 22:45:51.968872
NCT02598427|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-12-23|||May 2016||2016-05-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer|Phase I Dose Escalation Trial of Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis|Recruiting||Phase 1|36|Anticipated|Duke University||1|||f||||t||||||||||2017-10-10 22:45:52.152926|2017-10-10 22:45:52.152926
NCT02598414|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-22|||November 2015||2015-11-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery|The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak and Short-term Outcomes in Robotic Colorectal Surgery: A Prospective Randomized Trial|Recruiting||Phase 2/Phase 3|102|Anticipated|Acibadem University||2|||f||||t||||||||||2017-10-10 22:45:52.490903|2017-10-10 22:45:52.490903
NCT02598401|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-08-29|||August 21, 2017|Actual|2017-08-21|August 2017|2017-08-01|October 10, 2022|Anticipated|2022-10-10|April 10, 2022|Anticipated|2022-04-10||Observational|BONES||The British Osteonecrosis Study|The British Osteonecrosis Study: A Prospective Multi-centre Study to Examine the Natural History of Osteonecrosis in Older Children, Teenagers and Young Adults With Acute Lymphoblastic Leukaemia and Lymphoblastic Lymphoma|Recruiting||N/A|50|Anticipated|University of Leeds|||1||f||||f||||||Samples With DNA|"     Samples will be obtained for future genetic analysis.   "|||2017-10-10 22:45:52.659002|2017-10-10 22:45:52.659002
NCT02598388|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-09-11|||December 10, 2015|Actual|2015-12-10|September 2017|2017-09-01|December 28, 2018|Anticipated|2018-12-28|August 3, 2018|Anticipated|2018-08-03||Interventional|||Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo|A Randomized, Observer-blind, Placebo-controlled, Two-part, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo|Recruiting||Phase 2|575|Anticipated|Janssen Vaccines & Prevention B.V.||3|||f||||t||f||||||||2017-10-10 22:45:52.799564|2017-10-10 22:45:52.799564
NCT02598375|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-12-27|||January 2015||2015-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|10 Days|Observational [Patient Registry]|ERTENIFABPICU||Evaluation of Status of Early Reached Target Enteral Nutrition and IFABP as Biomarker of Feeding Intolerance in Critically Ill Children|Stage 1Evaluation of Status of Early Reached Target Enteral Nutrition in Critically Ill Children in the PICU (ERTEN in PICU) Stage 2 IFABP as Biomarker of Feeding Intolerance in Critically Ill Children in the PICU(IFABP in PICU)|Recruiting||N/A|150|Anticipated|Gazi University|||2||f||||t||||||Samples Without DNA|"     Urine and blood will be collected from critically ill children in PICU   "|Yes|It is concluded the first phase of ERTEN-IFABP IN PICU.95 patients date were evaluated and the statistically significant results were obtained in the first observational phase of the study We conduct the second phase of our study.|2017-10-10 22:45:52.954265|2017-10-10 22:45:52.954265
NCT02598362|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-04|||April 2015||2015-04-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|||Pharmacokinetics of Ciprofloxacin in Pediatric Patients|Pharmacokinetics of Ciprofloxacin in Pediatric Patients With Emphasis on Renal Excretion|Recruiting||Phase 4|20|Anticipated|University Hospital, Ghent||2|||f||||t||||||||||2017-10-10 22:45:53.098353|2017-10-10 22:45:53.098353
NCT02598349|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-07-18|||April 2016||2016-04-01|July 2017|2017-07-01|October 2040|Anticipated|2040-10-01|October 2039|Anticipated|2039-10-01||Interventional|PC04||Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas (PC04)|A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma|Recruiting||Phase 2|60|Anticipated|University of Florida||1|||f||||t|f|f||||||||2017-10-10 22:45:53.223187|2017-10-10 22:45:53.223187
NCT02598336|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-08-30|||January 2011||2011-01-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|SLPvsPNT||Validation of Structured Light Plethysmography|Validation of Structured Light Plethysmography Against Spirometry in Children and Adults|Recruiting||N/A|110|Anticipated|Pneumacare Ltd||2|||f||||f||||||||||2017-10-10 22:45:53.376098|2017-10-10 22:45:53.376098
NCT02598323|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-04|||November 2015||2015-11-01|November 2015|2015-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|Echo-col||Prevention and Treatment of Premature Labour for Asymptomatic Pregnant Women|Premature Labour Screening by Cervical Ultrasound for Asymptomatic Pregnant Women in the PACA Region. Various Treatment Strategies : 1. Progesterone 200mg (Vaginal Way) 2. Pessary 3. Vaginal Stitching 4. Rest|Not yet recruiting||N/A|3500|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:45:53.531268|2017-10-10 22:45:53.531268
NCT02598310|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-09-26|||November 2015||2015-11-01|September 2016|2016-09-01||||October 2020|Anticipated|2020-10-01||Interventional|||Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer|Phase II Study of Neoadjuvant Nab-paclitaxel (PTX) and Trastuzumab for ER Negative and HER2 Positive Breast Cancer|Recruiting||Phase 2|30|Anticipated|Osaka Medical College||1|||f||||t||||||||||2017-10-10 22:45:53.625836|2017-10-10 22:45:53.625836
NCT02598297|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-05-26|||February 3, 2016|Actual|2016-02-03|May 2017|2017-05-01|March 24, 2021|Anticipated|2021-03-24|October 15, 2017|Anticipated|2017-10-15||Interventional|||Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.|A Randomized, Double Blind, Placebo-controlled, Multicenter, Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations|Terminated||Phase 3|53|Actual|Novartis||2||Unresolvable inability to recruit the patients.|f||||t|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:45:53.746399|2017-10-10 22:45:53.746399
NCT02598284|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-10-17|||January 2016||2016-01-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|H3||Healthy Hearts in the Heartland|Midwest Small Practice Care Transformation Research Alliance (MSPCTRA)|Recruiting||N/A|1000|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 22:45:54.147943|2017-10-10 22:45:54.147943
NCT02598271|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-03-21|||November 2015||2015-11-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|InCreAS||Influence of Elevated Baseline Serum Creatinine and Body Composition on Acute Kidney Injury in Cardiac Surgery|Influence of Elevated Baseline Serum Creatinine and Body Composition on Acute Kidney Injury in Cardiac Surgery - The InCreAS Trial|Recruiting||N/A|200|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-10-10 22:45:54.297581|2017-10-10 22:45:54.297581
NCT02598258|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-11-04|||October 2015||2015-10-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hemodynamic Effects of Dry Sauna Followed by Cold Water Immersion in Healthy Subjects|Hemodynamic Effects of Dry Sauna Followed by Cold Water Immersion in Healthy Subjects|Recruiting||N/A|30|Anticipated|Montreal Heart Institute||1|||f||||f||||||||||2017-10-10 22:45:54.443006|2017-10-10 22:45:54.443006
NCT02598245|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-04|||January 2015||2015-01-01|November 2015|2015-11-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|URGE-III||Comparison of TOT 8/4 Versus TOT 6/3|Comparison of the Distance Between the Transobturator Tape (TOT) and the Urethra According to Two Different Placement Techniques of the Tape (TOT 8/4 vs TOT 6/3)|Recruiting||N/A|120|Anticipated|Klinikum der Universität Köln||2|||f||||f||||||||||2017-10-10 22:45:54.524889|2017-10-10 22:45:54.524889
NCT02598232|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-03-07|||October 2014||2014-10-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Efficacy and Safety of the 1,414 nm Nd:YAG Laser System for Alleviating Back Pain in a Lumbar Disc Patient|A 24-week, Single-center, Open-label, Clinical Study to Evaluate the Efficacy and Safety of the 1,414nm Nd:YAG Laser System Added to PEN to Further Alleviate Back Pain in a Lumbar Herniated Intervertebral Disc Patient|Completed||Phase 2/Phase 3|30|Actual|LUTRONIC Corporation||1|||f||||f||||||||No||2017-10-10 22:45:54.619149|2017-10-10 22:45:54.619149
NCT02598219|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-07-19|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|SENTIRAD||Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.|Randomized Study Comparing Sentinel Node (SN) Policy to Current French Initial Staging Protocols in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence|Recruiting||Phase 3|240|Anticipated|Centre Oscar Lambret||2|||f||||t|f|f||||||||2017-10-10 22:45:54.708088|2017-10-10 22:45:54.708088
NCT02598206|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-05-25|||December 2015||2015-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Food Effect Study PF-04136309|A Phase I Randomized Open Label, Single Dose, 2-period Crossover Study To Evaluate Food Effect On The Pharmacokinetics Of Pf-04136309 In Healthy Volunteers.|Completed||Phase 1|18|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 22:45:54.874475|2017-10-10 22:45:54.874475
NCT02598193|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-08-30|||January 14, 2016|Actual|2016-01-14|August 2017|2017-08-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|||Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)|An Exploratory Multicenter, Open-Label, Single Arm Study of the Safety and Tolerability of Pirfenidone (Esbriet®) in Combination With Nintedanib (Ofev®) in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 4|89|Actual|Hoffmann-La Roche||1|||f||||t|t|f||||||||2017-10-10 22:45:54.966412|2017-10-10 22:45:54.966412
NCT02598180|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-11-04|||November 2014||2014-11-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|May 2016|Anticipated|2016-05-01||Interventional|CP-FG-001||VergenixTM Flowable Gel in Patients With Lower Limb Ulcers|Single Arm,Open Label Study, to Evaluate the Safety and Performance of VergenixTM Flowable Gel in Patients With Lower Limb Ulcers (CP-FG-001)|Unknown status|Recruiting|N/A|40|Anticipated|Collplant||1|||f||||t||||||||||2017-10-10 22:45:55.132979|2017-10-10 22:45:55.132979
NCT02598167|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-11-01|||December 2015||2015-12-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition|Assessing Patients Preferences Towards Disease-modifying Therapeutic Options in Relapsing Remitting Multiple Sclerosis|Completed||N/A|223|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:45:55.276254|2017-10-10 22:45:55.276254
NCT02598154|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-08-18|||May 20, 2016|Actual|2016-05-20|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|MASEA 2||"Metrological Characteristics of the Inertial Unit FOX HiKoB© in Comparison With the Reference System for the Adaptive Trigger System Functional Electrical Stimulation of Foot Elevators in Hemiplegic Post-stroke Patients"|"Evaluation of the Metrological Characteristics of the Inertial Unit FOX HiKoB© in Comparison With the Reference System for the Adaptive Trigger System Functional Electrical Stimulation of Foot Elevators in Hemiplegic Post-stroke Patients"|Completed||N/A|29|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 22:45:55.378275|2017-10-10 22:45:55.378275
NCT02597972|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-09-21|||September 2015||2015-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Reverse Total Shoulder Arthroplasty Versus Open Reduction Internal Fixation of 3&4 Part Proximal Humerus Fractures|Reverse Total Shoulder Arthroplasty Versus Open Reduction Internal Fixation of 3 &Amp; 4-Part Proximal Humerus Fractures: A Randomized Prospective Study|Recruiting||N/A|100|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 22:45:58.511038|2017-10-10 22:45:58.511038
NCT02598141|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-05-23|||May 2016||2016-05-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|IOAP Turrax||Grinding Versus Standard Methods for the Treatment of Per-operative Bacteriological Samples Associated With Osteo-articular Sepsis|Comparative Evaluation of Two Techniques for the Treatment of Per-operative Bacteriological Samples Associated With Osteo-articular Sepsis: Grinding (Ultra Turrax) Versus Standard Methods|Recruiting||N/A|122|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 22:45:55.450111|2017-10-10 22:45:55.450111
NCT02598128|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-01-24|2016-11-14||November 2015||2015-11-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional||Safety Population|Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)|Study to Evaluate Safety, Tolerability and Fat Absorption Using a Novel Enteral Feeding In-line Digestive Enzyme Cartridge (RELIZORB) in Patients With Cystic Fibrosis Receiving Enteral Feeding|Completed||N/A|34|Actual|Alcresta Therapeutics, Inc.||2|||f||||t||||||||Undecided||2017-10-10 22:45:55.554924|2017-10-10 22:45:55.554924
NCT02598115|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-08-18|||September 19, 2016|Actual|2016-09-19|August 2017|2017-08-01|December 25, 2016|Actual|2016-12-25|December 25, 2016|Actual|2016-12-25||Interventional|MEDREV||Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older|Impact of the Implementation of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older|Completed||N/A|622|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 22:45:55.991789|2017-10-10 22:45:55.991789
NCT02598102|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-11-23|||April 2015||2015-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of Preprocedural Diclofenac in Males Undergoing Double J Stent Removal Under Local Anesthesia|Efficacy of Preprocedural Diclofenac in Males Undergoing Double J Stent Removal Under Local Anesthesia|Completed||Phase 2|150|Actual|Institute of Nephro Urology, Bangalore||2|||f||||f||||||||||2017-10-10 22:45:57.557385|2017-10-10 22:45:57.557385
NCT02598089|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-02-22|||November 2015||2015-11-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|IVACFLU-S||Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S)|A Phase 1 Double Blinded, Randomized, Placebo-Controlled Study In Healthy Adult Volunteers In Vietnam To Examine The Safety And Immunogenicity Of A Seasonal Trivalent Inactivated Split Virion Influenza Vaccine (IVACFLU-S) Produced By IVAC|Completed||Phase 1|60|Actual|Institute of Vaccines and Medical Biologicals, Vietnam||2|||f||||t||||||||||2017-10-10 22:45:57.63968|2017-10-10 22:45:57.63968
NCT02598076|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-07-18|||August 2015||2015-08-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures|Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures: A Model of Patient Engagement in Functional Neurological Symptom Disorders|Recruiting||N/A|36|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 22:45:57.728609|2017-10-10 22:45:57.728609
NCT02598063|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-02-01|||October 2005||2005-10-01|February 2016|2016-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B|A Randomized, Open-label Study Evaluating the Efficacy and Safety of Peginterferon Alfa-2a (40KD) (PEGASYS®) or Adefovir Dipivoxil (ADV) in Patients With Lamivudine-resistant HBeAg Positive Chronic Hepatitis B|Completed||Phase 4|255|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:45:57.813671|2017-10-10 22:45:57.813671
NCT02598050|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-10-01|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||Preoperative Cognitive Screening in Older Surgical Patients Utility for Predicting Morbidity|NIH Explanatory/Developmental Research Grant Program: Preoperative Cognitive Screening in Older Surgical Patients: Feasibility and Utility for Predicting Morbidity|Recruiting||N/A|250|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"     White blood cells and plasma   "|Undecided||2017-10-10 22:45:57.914607|2017-10-10 22:45:57.914607
NCT02598024|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-07|||March 2016||2016-03-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|TENT2016||Treating Earthquake in Nepal Trauma (TENT) Trial 2016|The Effectiveness of 4-session Narrative Exposure Therapy and 2-session Group Control-focused Behavioural Treatment on PTSD in Nepal Earthquake Survivors After 12 Months: Study Protocol for the Randomised Waiting-list Controlled Trial|Not yet recruiting||N/A|240|Anticipated|Nepalese Psychological Association||3|||f||||t||||||||||2017-10-10 22:45:58.097118|2017-10-10 22:45:58.097118
NCT02598011|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-12-28|||March 2016||2016-03-01|December 2015|2015-12-01||||November 2022|Anticipated|2022-11-01||Interventional|Toca7||A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care|The Toca 7 Study: A Phase 1b Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care|Not yet recruiting||Phase 1|18|Anticipated|Tocagen Inc.||2|||f||||||||||||||2017-10-10 22:45:58.177637|2017-10-10 22:45:58.177637
NCT02597998|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-03-08|||September 2015||2015-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Metabolism and Pharmacokinetics of [14C]-BI 409306 After Administration as Oral Solution in Healthy Male Volunteers|Metabolism and Pharmacokinetics of [14C]-BI 409306 After Administration of 25 mg [14C]-BI 409306 as Oral Solution in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:45:58.250319|2017-10-10 22:45:58.250319
NCT02597985|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-06-17|||October 2015||2015-10-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|TAVR-FRAILTY||Prehabilitation to Improve Functional and Clinical Outcomes in Patients With Aortic Stenosis|Prehabilitation to Improve Functional and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: TAVR-FRAILTY Trial|Recruiting||N/A|40|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:45:58.362077|2017-10-10 22:45:58.362077
NCT02597959|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-09-12|||September 2015||2015-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|||Reducing Musculoskeletal Stresses and Work-related Injuries Among Allied Health Professionals in Surgical Care|Exposure Assessment and Intervention for Reducing Musculoskeletal Stresses and Work-related Injuries Among Allied Health Professionals in Surgical Care|Completed||N/A|21|Actual|Mayo Clinic|||2||f||||f||||||||||2017-10-10 22:45:58.594714|2017-10-10 22:45:58.594714
NCT02597946|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-10-03|||March 18, 2016|Actual|2016-03-18|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Afatinib in NSCLC With HER2 Mutation|A Phase II Study of Afatinib in Patients With Advanced NSCLC Harboring HER2 Mutations, Previously Treated With Chemotherapy|Recruiting||Phase 2|40|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:45:58.673707|2017-10-10 22:45:58.673707
NCT02597933|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-10-03|||November 12, 2015|Actual|2015-11-12|October 2017|2017-10-01|December 28, 2018|Anticipated|2018-12-28|November 30, 2018|Anticipated|2018-11-30||Interventional|||A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis|A Double Blind, Randomised, Placebo-controlled Trial Evaluating Efficacy and Safety of Oral Nintedanib Treatment for at Least 52 Weeks in Patients With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)|Recruiting||Phase 3|520|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:45:58.798044|2017-10-10 22:45:58.798044
NCT02597920|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2017-02-21|||November 2015||2015-11-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Patient Convenience Study|Non-interventional Study Describing Patients' Perception on Anticoagulant Treatment and Treatment Convenience When Treated With Pradaxa or Vitamin K Antagonist for Stroke Prophylaxis in Atrial Fibrillation|Completed||N/A|1852|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-10 22:45:59.300923|2017-10-10 22:45:59.300923
NCT02597907|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2017-04-20|2017-03-08||July 2014||2014-07-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant|Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant|Completed||N/A|88|Actual|Kyungpook National University||2|||f||||f||||||||No||2017-10-10 22:45:59.701738|2017-10-10 22:45:59.701738
NCT02597894|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-04-25|||March 1, 2018|Anticipated|2018-03-01|April 2017|2017-04-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy|Feasibility of Repeat Targeted Biopsies in Patients Undergoing High-Dose-Rate Prostate Brachytherapy|Withdrawn||N/A|0|Actual|Jonsson Comprehensive Cancer Center||1||P. I. left the Institution. Study never opened|f||||t|f|f|||f|||||2017-10-10 22:45:59.991996|2017-10-10 22:45:59.991996
NCT02597881|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-04-11|||April 2016||2016-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Achondroplasia Natural History Multicenter Clinical Study|Achondroplasia Natural History Multicenter Clinical Study|Enrolling by invitation||N/A|1500|Anticipated|Johns Hopkins University|||1||f||||f||||||||No||2017-10-10 22:46:00.089419|2017-10-10 22:46:00.089419
NCT02597868|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2016-03-26|||January 2013||2013-01-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)|A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)|Recruiting||N/A|132|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-10 22:46:00.204749|2017-10-10 22:46:00.204749
NCT02597855|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-07-18|2016-03-22||September 2015||2015-09-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|December 2015|Actual|2015-12-01|6 Months|Observational [Patient Registry]|||Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy||Active, not recruiting||N/A|29|Actual|Yeungnam University College of Medicine|||2||f||||f||||||||||2017-10-10 22:46:00.335783|2017-10-10 22:46:00.335783
NCT02597842|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-04|||December 2015||2015-12-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Transcutaneous Electrical Acupoint Stimulation(TEAS) for Postoperative Nausea and Vomiting in Laparoscopic Operation|Efficiency of Transcutaneous Electrical Acupoint Stimulation(TEAS) With Single Acupoint or Two Acupoints for Postoperative Nausea and Vomiting in Laparoscopic Operation: A Single Center, Randomized, Double-blinded, Controlled Clinical Trial|Not yet recruiting||N/A|180|Anticipated|Xijing Hospital||4|||f||||t||||||||||2017-10-10 22:46:00.608663|2017-10-10 22:46:00.608663
NCT02597829|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-11-04|||November 2015||2015-11-01|November 2015|2015-11-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|APOLLO||Does Clinical Response Correlate With Serum Certolizumab Levels?|Does Clinical Response Correlate With Serum Certolizumab Levels? A Prospective Open Label Trial of Adult Patients With Active Crohn's Disease (APOLLO)|Not yet recruiting||Phase 4|20|Anticipated|Shafran Gastroenterology Center||1|||f||||f||||||||||2017-10-10 22:46:00.719327|2017-10-10 22:46:00.719327
NCT02597816|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2015-12-17|||October 2013||2013-10-01|October 2013|2013-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Role of Three Dimensional Ultrasound in the Diagnosis of Septate Uterus|Three Dimensional Trans-vaginal Ultrasound to Reevaluate Arcuate Uteri Diagnosed by Hystro-salpingography|Completed||Phase 2|38|Actual|Assiut University||1|||f||||f||||||||||2017-10-10 22:46:00.806079|2017-10-10 22:46:00.806079
NCT02597803|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-09-26|||September 2015||2015-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1|A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of RGN-259 Ophthalmic Solutions for the Treatment of Dry Eye: ARISE-1|Completed||Phase 2/Phase 3|317|Actual|ReGenTree, LLC||3|||f||||f||||||||||2017-10-10 22:46:00.869397|2017-10-10 22:46:00.869397
NCT02597595|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-04-26|||November 2014||2014-11-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major|Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major|Active, not recruiting||N/A|60|Anticipated|Tanta University||2|||f||||t||||||||||2017-10-10 22:46:02.641211|2017-10-10 22:46:02.641211
NCT02597790|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-05-10|||October 2013||2013-10-01|May 2016|2016-05-01||||October 2017|Anticipated|2017-10-01||Observational|CTSI-PLACE||A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects|Clinical and Translational Science Institute Prospective Longitudinal Assessment of Coinfected Subjects With HIV/Hepatitis C for Endothelial Function Study|Recruiting||N/A|120|Anticipated|University of California, Los Angeles|||2||f||||f||||||Samples With DNA|"     Plasma and serum   "|||2017-10-10 22:46:00.961119|2017-10-10 22:46:00.961119
NCT02597777|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2017-04-03|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin|Pilot Randomized Double-Blind Controlled Trial of Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin|Completed||N/A|14|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 22:46:01.047511|2017-10-10 22:46:01.047511
NCT02597764|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-02-19|||February 2015||2015-02-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Diaphragmatic Breathing as an Adjunctive Therapy in the Management of Children With Bladder and Bowel Disorders|Use of Diaphragmatic Breathing (DB) in the Management of Bladder and Bowel Disorders in Children: A Pilot Randomized Trial|Completed||N/A|23|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:46:01.167525|2017-10-10 22:46:01.167525
NCT02597751|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-05-24|||September 2014||2014-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||DCD Imaging-Intervention Study|Developmental Coordination Disorder: Integrating Brain Imaging and Rehabilitation to Improve Outcomes|Recruiting||N/A|90|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:46:01.268449|2017-10-10 22:46:01.268449
NCT02597738|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-01-17|||January 2016||2016-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine|Scientific and Methodological Advancements in Human Specimens to Further the Development of Lung Cancer-based Precision Medicine - A Feasibility Study|Recruiting||N/A|90|Anticipated|University of Arkansas||3|||f||||f||||||||No||2017-10-10 22:46:01.366499|2017-10-10 22:46:01.366499
NCT02597725|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-11-04|||November 2015||2015-11-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|SRT||Salvage Radiotherapy After Radical Prostatectomy|Changes in Bladder Function After Surgery and Radiation Therapy for Prostate Cancer|Unknown status|Not yet recruiting|N/A|70|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-10 22:46:01.462091|2017-10-10 22:46:01.462091
NCT02597712|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-04-20|||June 2013||2013-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||YF476 in Barrett's Esophagus|Randomized, Placebo-controlled Trial of YF476, a Gastrin Receptor Antagonist, in Barrett's Esophagus|Enrolling by invitation||Phase 2|22|Anticipated|Trio Medicines Ltd.||2|||f||||f||||||||||2017-10-10 22:46:01.575544|2017-10-10 22:46:01.575544
NCT02597699|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-11-03|||October 2015||2015-10-01|October 2015|2015-10-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|FOETIVA2||Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide|Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide: A Phase III Randomized Trial|Active, not recruiting||Phase 3|66|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 22:46:01.754204|2017-10-10 22:46:01.754204
NCT02597686|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-02-05|||October 2015||2015-10-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|||The STAGE Study for Bipolar Disorder|A Pilot Study of a Brief Self-distancing and Perspective Broadening Training Package for Bipolar Disorder|Recruiting||N/A|12|Anticipated|University of East Anglia||1|||f||||f||||||||||2017-10-10 22:46:01.858605|2017-10-10 22:46:01.858605
NCT02597673|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty|Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty|Recruiting||N/A|136|Anticipated|University of Tennessee||4|||f||||t||||||||||2017-10-10 22:46:01.949255|2017-10-10 22:46:01.949255
NCT02597660|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-06-02|||January 1, 2018|Anticipated|2018-01-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|October 2019|Anticipated|2019-10-01||Interventional|||A Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy|A Double-Blind Placebo-Controlled Study to Evaluate the Efficacy of Somatropin in the Treatment of Patellar Tendinopathy|Not yet recruiting||Phase 2|50|Anticipated|University of Michigan||2|||f||||t|t|f||||||||2017-10-10 22:46:02.078198|2017-10-10 22:46:02.078198
NCT02597647|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-07-01|||February 2011||2011-02-01|July 2016|2016-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection|Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection|Completed||Phase 1|17|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 22:46:02.190439|2017-10-10 22:46:02.190439
NCT02597634|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-10-12||2016-10-12|November 2015||2015-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|DOMS||Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)|A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy, and Safety of SST-0225, a Topical Ibuprofen Cream, in the Treatment of Delayed Onset Muscle Soreness (DOMS)|Completed||Phase 3|156|Actual|Strategic Science & Technologies, LLC||2|||f||||f||||||||Undecided||2017-10-10 22:46:02.273789|2017-10-10 22:46:02.273789
NCT02597621|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-10-05|||March 2013||2013-03-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||Biomarkers for Therapy Response in Drug-resistant Tuberculosis|Biomarkers for Therapy Response in Drug-resistant Tuberculosis|Recruiting||N/A|40|Anticipated|Research Center Borstel|||3||f||||f||||||Samples With DNA|"     Urine, blood   "|||2017-10-10 22:46:02.378136|2017-10-10 22:46:02.378136
NCT02597608|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-09-13|||July 2013||2013-07-01|November 2015|2015-11-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Impact Evaluation of the DFID Programme to Accelerate Improved Nutrition of the Extreme Poor in Bangladesh|Impact Evaluation of the DFID Programme to Accelerate Improved Nutrition of the Extreme Poor in Bangladesh|Completed||N/A|11340|Actual|International Food Policy Research Institute||7|||f||||f||||||||||2017-10-10 22:46:02.483488|2017-10-10 22:46:02.483488
NCT02597582|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-08-24|2015-11-10||January 2014||2014-01-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients|A Prospective Randomized Study of LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients|Completed||Phase 4|41|Actual|Taichung Veterans General Hospital||2|||f||||f||||||||No||2017-10-10 22:46:02.736297|2017-10-10 22:46:02.736297
NCT02597569|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-11-09|||December 2015||2015-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|CO-OP_KT||Building Capacity in the System to Support Persons With Stroke and Cognitive Impairment|Building Capacity in the System to Support Persons With Stroke and Cognitive Impairment: An Evidence-based, Multi-faceted, Knowledge Translation Approach|Recruiting||N/A|34|Anticipated|Sunnybrook Health Sciences Centre|||2||f||||f||||||||Undecided||2017-10-10 22:46:03.289708|2017-10-10 22:46:03.289708
NCT02597556|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-12-14|||February 2016||2016-02-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in Vietnamese School Children|A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in School Children in Southern Vietnam|Withdrawn||Phase 4|0|Actual|Oxford University Clinical Research Unit, Vietnam||2||The prevalence of worm infections in the site is significantly lower than expected|f||||t||||||||||2017-10-10 22:46:03.424116|2017-10-10 22:46:03.424116
NCT02597543|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-07-24|2017-06-06||November 2015||2015-11-01|July 2017|2017-07-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction|Stress Cardiac MRI Using Regadenoson for Evaluation of Nonspecific Allograft Dysfunction|Completed||Phase 4|14|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 22:46:03.55524|2017-10-10 22:46:03.55524
NCT02597530|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-12-10|||November 2015||2015-11-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|TEAS||Different Stimuli of Transcutaneous Electric Acupoint Stimulation(TEAS) on Acupuncture Anesthesia|Effect of Different Time of Transcutaneous Electric Acupoint Stimulation(TEAS) on Acupuncture Anesthesia|Not yet recruiting||N/A|60|Anticipated|Xijing Hospital||3|||f||||f||||||||||2017-10-10 22:46:04.040384|2017-10-10 22:46:04.040384
NCT02597517|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-05-01|||November 2015||2015-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|||New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy|Optical Enhancement System ™ Plus Optical Magnification Utility in the Identification of Normal Gastric Mucosa, Helicobacter Pylori Associated Gastritis, and Gastric Atrophy|Completed||N/A|72|Actual|Instituto Ecuatoriano de Enfermedades Digestivas|||2||f||||t||||||Samples Without DNA|"     Histological biopsies from gastric mucosal   "|||2017-10-10 22:46:04.123816|2017-10-10 22:46:04.123816
NCT02597504|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-08-22|||October 2015||2015-10-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Development of a Neurocognitive Screening Test|Development of a Neurocognitive Screening Test|Recruiting||N/A|1600|Anticipated|ImPACT Applications, Inc.||2|||f||||f||||||||||2017-10-10 22:46:04.240812|2017-10-10 22:46:04.240812
NCT02597491|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-06-08|||December 2015||2015-12-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||SMART for Smoking Cessation in Lung Cancer Screening|Adaptive Interventions for Smoking Cessation in Lung Cancer Screening Programs|Enrolling by invitation||N/A|1000|Anticipated|University of Minnesota - Clinical and Translational Science Institute||6|||f||||f||||||||||2017-10-10 22:46:04.369494|2017-10-10 22:46:04.369494
NCT02597478|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-08-24|||January 4, 2016|Actual|2016-01-04|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea|A Preliminary Study of Prophylactic Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea|Recruiting||Phase 2/Phase 3|30|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 22:46:04.463184|2017-10-10 22:46:04.463184
NCT02597465|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-10-20|||December 2016||2016-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of SPARC1507||Not yet recruiting||Phase 3|198|Anticipated|Sun Pharma Advanced Research Company Limited||2|||f||||f||||||||||2017-10-10 22:46:04.580885|2017-10-10 22:46:04.580885
NCT02597452|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-08-22|||March 2014||2014-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|iBE||Clinical Utility Study of a Low-Cost Hand-Held Breast Scanner|Clinical Utility Study of a Low-Cost Hand-Held Breast Scanner|Active, not recruiting||Phase 4|1000|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:46:04.673242|2017-10-10 22:46:04.673242
NCT02597439|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-09-12|||September 2016||2016-09-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|PURPOSE||Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe|Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe|Recruiting||N/A|220|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-10 22:46:04.756098|2017-10-10 22:46:04.756098
NCT02597426|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-09-20|||June 2015||2015-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|October 2016|Actual|2016-10-01||Observational|||Nasopharyngeal Carcinoma Post IMRT|A Comprehensive Prospective Cross Sectional Study on the Late Effects of Radical Chemoradiotherapy in Nasopharyngeal Carcinoma Patients Treated in the Intensity-Modulated Radiotherapy Era|Active, not recruiting||N/A|108|Actual|University Health Network, Toronto|||2||f||||f||||||||||2017-10-10 22:46:05.079209|2017-10-10 22:46:05.079209
NCT02597413|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-04|2016-05-23|||September 2015||2015-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|RPM-Eval||Evaluation of Post-voiding Residual Urine: a Before-after, Post-partum Study|Evaluation of Post-voiding Residual Urine: a Before-after, Post-partum Study|Completed||N/A|88|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-10 22:46:05.22676|2017-10-10 22:46:05.22676
NCT02597400|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2016-02-16|||October 2015||2015-10-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM|A Phase 1, Open-Label, Sequential, Multiple-Dose, Drug-Drug Interaction Study of Glucokinase (GK) Activator HMS5552 and Metformin in Patients With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 1|12|Actual|Hua Medicine Limited||1|||f||||f||||||||No||2017-10-10 22:46:05.321996|2017-10-10 22:46:05.321996
NCT02597387|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-22|||August 2015||2015-08-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs|A Single-arm, Open, Multi-center Phase II Clinical Trial of Mitoxantrone HCL Liposome Injection in Subjects With Relapsed Diffuse Large B-cell Lymphoma and and Peripheral T/NK Lymphomas|Recruiting||Phase 2|50|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:46:05.455211|2017-10-10 22:46:05.455211
NCT02597374|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-12-04|||October 2015||2015-10-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|AOE||EEG in Children With Unilateral Cerebral Injury During Action and Action Observation(AOE)|"Exploration du système Des Neurones-miroirs Par Enregistrement EEG du Rythme mu Chez l'Enfant Atteint de lésion cérébrale unilatérale Lors d'Action, d'Observation et d'Imagination d'Action du Membre supérieur.  Action-Observation-EEG "|Recruiting||N/A|15|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 22:46:05.55925|2017-10-10 22:46:05.55925
NCT02597361|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-09-01|||January 2016||2016-01-01|August 2016|2016-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|ARCADE||Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)|Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome: a Double Blind, Randomized, Placebo Controlled, Multicenter Trial.|Recruiting||Phase 3|108|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 22:46:05.651331|2017-10-10 22:46:05.651331
NCT02597348|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-09-28|||September 2015||2015-09-01|September 2016|2016-09-01|February 2027|Anticipated|2027-02-01|February 2027|Anticipated|2027-02-01||Interventional|TRANSMET||Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy|Curative Potential of Liver Transplantation in Patients With Definitively Unresectable Colorectal Liver Metastases (CLM) Treated by Chemotherapy: a Prospective Multicentric Randomized Trial|Recruiting||Phase 3|90|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:46:05.819873|2017-10-10 22:46:05.819873
NCT02597335|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-09-19|||April 2015||2015-04-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|IDASPE||Non Invasive Detection of IDH1/2 Mutation in Gliomas|Non Invasive IDentification of Gliomas With IDH1/2 Mutation by Analysis of Circulating Plasmatic DNA, D-2-hydroxyglutarate Dosage in Biological Liquids and Detection by Brain SPEctro-MRI: Impact for Diagnosis and Follow-up|Recruiting||N/A|40|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:46:05.939359|2017-10-10 22:46:05.939359
NCT02597322|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-07-24|||February 2012||2012-02-01|March 2017|2017-03-01|June 2017|Actual|2017-06-01|November 2015|Actual|2015-11-01||Interventional|AXIPAN||Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN)|An Open-label, Non-randomized, Multicenter, Two Stage Designed Phase II Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN)|Completed||Phase 2|21|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:46:06.043416|2017-10-10 22:46:06.043416
NCT02597309|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-02-28|||November 2015||2015-11-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|I-Can||The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin|The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With ≥200 Units Per Day of U-500 Insulin|Withdrawn||Phase 4|0|Actual|Joslin Diabetes Center||2|||f||||||||||||||2017-10-10 22:46:06.137282|2017-10-10 22:46:06.137282
NCT02597296|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-03-22|||October 2015||2015-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:46:06.212976|2017-10-10 22:46:06.212976
NCT02597283|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-02-11|||December 2015||2015-12-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|BIGUARD||Coronary Bifurcation Lesions Treated With Biguard Stent System|A Prospective, Multi-center, Randomized Trial Comparing Biguard Stent With Regular Sirolimus-eluting Stent System for Patients With Coronary Bifurcation Lesions|Terminated||N/A|400|Actual|Nanjing First Hospital, Nanjing Medical University||2||Funding issues|f||||t|f|f||||||No||2017-10-10 22:46:06.254584|2017-10-10 22:46:06.254584
NCT02597270|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-02-03|||March 2016||2016-03-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|MAPPING||An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection|Mapping Natural Polymorphisms of Hepatitis C Virus NS3/4A Protease and NS5A Region Among Brazilian Chronic Patients (MAPPING)|Completed||N/A|239|Actual|Janssen-Cilag Ltd.|||1||f||||f||||||Samples With DNA|"     The total blood volume to be collected will be approximately 15 milliliters (mL) (3 tubes,     5mL each). Fasting is not required. The blood sample collection scheme was designed to     collect the minimum number of blood samples that is necessary to accomplish the study     objective. Blood samples will be frozen and incinerated 30 days after blood collection at the     national central laboratory.   "|||2017-10-10 22:46:06.36935|2017-10-10 22:46:06.36935
NCT02597257|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-11-03|||August 2015||2015-08-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain|Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain: Randomized, Controlled, Comparative Study|Recruiting||Phase 2|44|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:46:06.471193|2017-10-10 22:46:06.471193
NCT02597244|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-11-03|||June 2014||2014-06-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Effectiveness of Percutaneous Foraminotomy|Effectiveness of Percutaneous Foraminotomy in Patients With Lumbar Foraminal Stenosis: A Prospective, Pilot Study|Recruiting||N/A|20|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 22:46:06.593819|2017-10-10 22:46:06.593819
NCT02597231|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-10-03|||November 2015|Actual|2015-11-01|October 2017|2017-10-01|December 31, 2016|Actual|2016-12-31|December 2016|Actual|2016-12-01||Interventional|MELO||Melatonin and Sleep in Preventing Delirium in the Hospital|Melatonin and Sleep in Preventing Delirium in the Hospital: A Randomized Placebo-controlled Trial|Completed||Phase 1/Phase 2|94|Actual|Scripps Health||2|||f||||f||||||||||2017-10-10 22:46:06.690298|2017-10-10 22:46:06.690298
NCT02596659|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-11-03|||September 2013||2013-09-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effectiveness of Radial Extracorporeal Shockwave Therapy on Tennis Elbow|Effectiveness of Radial Extracorporeal Shockwave Therapy on Tennis Elbow|Completed||N/A|30|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:46:15.650359|2017-10-10 22:46:15.650359
NCT02597218|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-04|||October 2015||2015-10-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.|Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy in a High-volume Center. A Cohort Study.|Recruiting||N/A|350|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||t||||||||||2017-10-10 22:46:06.783041|2017-10-10 22:46:06.783041
NCT02597205|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-08-11|||May 2015||2015-05-01|November 2015|2015-11-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|TAKEmeds||The Adherence and Knowledge Exchange Heart and Stroke Medicines Study|TAKEmeds Program: The Adherence and Knowledge Exchange Heart and Stroke Medicines Study|Completed||Early Phase 1|190|Actual|Duke Kunshan University||1|||f||||f||||||||||2017-10-10 22:46:06.892945|2017-10-10 22:46:06.892945
NCT02597192|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-03|||June 2014||2014-06-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Effects of Bacillus Containing Oral Hygiene Products on Gingivitis: a Randomized Controlled Trial|Professor Doctor, Cukurova University Faculty of Dentistry|Completed||N/A|40|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 22:46:06.992369|2017-10-10 22:46:06.992369
NCT02597179|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-04-27|||September 2012||2012-09-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer|Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer|Recruiting||N/A|350|Anticipated|Samsung Medical Center|||1||f||||f|f|f||||Samples With DNA|"     Blood, tumor samples   "|||2017-10-10 22:46:07.069368|2017-10-10 22:46:07.069368
NCT02597166|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-11-01|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection|The Effects of Anti-Viral Therapy on the Clinical Status, Quality of Life, and Survival of Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection|Enrolling by invitation||Phase 3|30|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:46:07.135878|2017-10-10 22:46:07.135878
NCT02597153|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-23|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas|A Single-arm, Open, Multi-center Phase II Clinical Trial of Mitoxantrone HCL Liposome Injection in Subjects With Relapsed Cutaneous T Cell Lymphomas|Terminated||Phase 2|1|Actual|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||1||Just one subject enrolled in this trial during one and a half years.|f||||f||||||||||2017-10-10 22:46:07.220643|2017-10-10 22:46:07.220643
NCT02597140|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-05|||August 2015||2015-08-01|November 2015|2015-11-01||||May 2016|Anticipated|2016-05-01||Interventional|||Pilot Study of Effect of Intravenous Lidocaine on Propofol Requirement in Facial Plastic Surgery|Pilot Study of Effect of Intravenous Lidocaine on Propofol Requirement During Monitored Anesthesia Care in Facial Plastic Surgery|Recruiting||Phase 4|40|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||2|||f||||t||||||||||2017-10-10 22:46:07.291329|2017-10-10 22:46:07.291329
NCT02597127|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-05|||January 2016||2016-01-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|November 2016|Actual|2016-11-01||Interventional|ORION||Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)|A Placebo-controlled, Double-blind, Randomized Trial to Compare the Effect of Different Doses of ALN-PCSSC Given as Single or Multiple Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C|Active, not recruiting||Phase 2|501|Actual|The Medicines Company||8|||f||||t||||||||||2017-10-10 22:46:07.396415|2017-10-10 22:46:07.396415
NCT02597114|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-02-27|||November 2015|Actual|2015-11-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|February 2019|Anticipated|2019-02-01||Interventional|||Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181|An Extension Study of AGT-181-102 Evaluating Safety and Glycosaminoglycans (GAGs) in Adult Patients With Hurler-Scheie or Scheie Syndrome Who Have Completed 8-Weeks of Dosing With AGT-181 in Study AGT-181-102|Enrolling by invitation||Phase 1|3|Anticipated|ArmaGen, Inc||1|||f||||t||||||||||2017-10-10 22:46:07.617989|2017-10-10 22:46:07.617989
NCT02597101|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-08-15|||November 2015||2015-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes|Neutrophil Elastase Inhibition as Adjunctive Therapy to Improve Glucometabolic Variables in Overweight and Obese, Insulin-Resistant Type 2 Diabetic Patients|Recruiting||Phase 2|42|Anticipated|Allegheny Singer Research Institute||2|||f||||t||||||||||2017-10-10 22:46:07.694011|2017-10-10 22:46:07.694011
NCT02597088|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-11-03|||November 2015||2015-11-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Observational|||Development of Methods for Enhance Human Milk Presentation During Storage and Warming|Development of Methods for Enhance Human Milk Presentation During Storage and Warming|Unknown status|Not yet recruiting|N/A|20|Anticipated|Sharron Bransburg-Zabary Consulting services|||1||f||||t||||||||||2017-10-10 22:46:07.79942|2017-10-10 22:46:07.79942
NCT02597075|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-10-05|||January 2016||2016-01-01|October 2017|2017-10-01|December 2026|Anticipated|2026-12-01|September 2021|Anticipated|2021-09-01||Interventional|||Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy|Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy. A Multicenter Open Label Randomized Controlled Phase III Trial|Recruiting||Phase 3|524|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||||2017-10-10 22:46:07.867442|2017-10-10 22:46:07.867442
NCT02597062|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-07-10|||March 29, 2016||2016-03-29|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|February 2019|Anticipated|2019-02-01||Interventional|||High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma|A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma After 1-3 Prior Therapies|Recruiting||Phase 2|76|Anticipated|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-10 22:46:08.059674|2017-10-10 22:46:08.059674
NCT02597049|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-02-15|||November 2015||2015-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|AWARD-10||A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus|A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|424|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:46:08.174982|2017-10-10 22:46:08.174982
NCT02597036|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors|A Phase 1 Study of LY3127804 as Monotherapy and in Combination With Ramucirumab in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|105|Anticipated|Eli Lilly and Company||5|||f||||f||||||||||2017-10-10 22:46:08.565148|2017-10-10 22:46:08.565148
NCT02597023|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-06-01|||September 2015||2015-09-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults|The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults|Recruiting||N/A|55|Anticipated|University of Colorado, Boulder||2|||f||||t||||||||||2017-10-10 22:46:08.686761|2017-10-10 22:46:08.686761
NCT02597010|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-11-03|||January 2015||2015-01-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A 2 Week, Crossover Trial of Dietary Nitrate in HTN|Dietary Nitrate for Resistant Hypertension: A Randomized, Placebo-controlled, Crossover Trial|Completed||N/A|20|Actual|Royal College of Surgeons, Ireland||2|||f||||f||||||||||2017-10-10 22:46:08.810172|2017-10-10 22:46:08.810172
NCT02596984|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-11-09|||March 2015||2015-03-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|CaspoKin||Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients|Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 22:46:09.165538|2017-10-10 22:46:09.165538
NCT02596971|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-07-06|||December 22, 2015|Actual|2015-12-22|July 2017|2017-07-01|January 15, 2020|Anticipated|2020-01-15|January 15, 2020|Anticipated|2020-01-15||Interventional|||A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)|A Phase IB/II Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus CHOP in Patients With Follicular Lymphoma or Rituximab Plus CHOP in Patients With Diffuse Large B-Cell Lymphoma|Recruiting||Phase 1|92|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 22:46:09.297265|2017-10-10 22:46:09.297265
NCT02596958|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-03-07|2016-02-05||September 2007||2007-09-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational||Analysis population was defined as all participants included in the observational study, regardless of whether they finished it or not. Nine hundred and ninety six (996) participants were documented but only 987 participants were included in the analysis population as 9 participants were excluded due to documented second line treatment.|Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants|Available - Avastin in Addition to Platinum-based Chemotherapy is Indicated for First-lime Treatment of Patients With Locally Advanced, Metastatic or Recurrent Non-small Lung Cancer Other Than Predominantly Squamous Cell Histology|Completed||N/A|996|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:46:09.498673|2017-10-10 22:46:09.498673
NCT02596945|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-06-13|2015-12-07||July 31, 2009|Actual|2009-07-31|May 2017|2017-05-01|February 28, 2011|Actual|2011-02-28|February 28, 2011|Actual|2011-02-28||Observational||Safety Set (SS) population: Participants who received at least 1 dose of study drug were included.|Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis|Non-Interventional Observation Trial to Investigate the Efficacy, Safety and Usability of Mircera in PD Patients in Daily Use|Completed||N/A|223|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:46:09.983353|2017-10-10 22:46:09.983353
NCT02596932|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2017-01-05|||February 2016||2016-02-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus|Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus and Its Impact on Neonatal Blood Glucose Levels|Recruiting||N/A|100|Anticipated|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||Undecided||2017-10-10 22:46:10.180635|2017-10-10 22:46:10.180635
NCT02596919|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-05-08|||September 2015||2015-09-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Fast Infrared Meibography (Photography)|Fast Infrared Meibography (Photography)|Terminated||N/A|15|Actual|Queen Victoria Hospital NHS Foundation Trust||1||"After review, recruitment was halted as the images obtained needed improvement. To be presented   at the British Oculoplastic Surgery Society in Jun 17"|f||||f||||||||||2017-10-10 22:46:10.276096|2017-10-10 22:46:10.276096
NCT02596906|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brain and Cognitive Changes After Reasoning Training in Individuals With Mild Cognitive Impairment|Brain and Cognitive Changes After Reasoning Training in Individuals With Cognitive Complaints|Recruiting||N/A|50|Anticipated|The University of Texas at Dallas||3|||f||||f||||||||||2017-10-10 22:46:10.340366|2017-10-10 22:46:10.340366
NCT02596893|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-09-27|||December 8, 2015|Actual|2015-12-08|September 2017|2017-09-01|December 28, 2018|Anticipated|2018-12-28|September 28, 2018|Anticipated|2018-09-28||Interventional|||Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease|A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease|Recruiting||Phase 3|1064|Anticipated|Celgene||4|||f||||t||||||||||2017-10-10 22:46:10.519883|2017-10-10 22:46:10.519883
NCT02596880|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-10-16|||September 2015||2015-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|SD100||Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics|Sustained Viral Response Rate in 100 Subjects With Cirrhosis Due to Hepatitis C Treated With 12 Weeks of Sofosbuvir, Daclatasvir and Ribavirin|Completed||Phase 3|100|Actual|Tehran University of Medical Sciences||1|||f||||f||||||||No||2017-10-10 22:46:13.51086|2017-10-10 22:46:13.51086
NCT02596841|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-11-02|||February 2013||2013-02-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Observational|Dm&Vc||Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias|Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias|Completed||N/A|60|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|||1||f||||f||||||||||2017-10-10 22:46:13.765828|2017-10-10 22:46:13.765828
NCT02596828|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-12-29|||April 2016||2016-04-01|December 2016|2016-12-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma|Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma|Recruiting||Phase 2|4|Anticipated|University of Regensburg||1|||f||||f||||||||||2017-10-10 22:46:13.825221|2017-10-10 22:46:13.825221
NCT02596815|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-03|||July 2015||2015-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Hypoalgesic Effect of Median Nerve Neural Mobilization Compared to a Controlled Group|Hypoalgesic Effect of Median Nerve Neural Mobilization in Cervicobrachial Pain Compared to a Controlled Group|Completed||Phase 2|51|Actual|Universidad Europea de Madrid||2|||f||||t||||||||||2017-10-10 22:46:13.933137|2017-10-10 22:46:13.933137
NCT02596802|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-05-03|||December 2015||2015-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FETO||Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia|Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)|Recruiting||N/A|10|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 22:46:14.219832|2017-10-10 22:46:14.219832
NCT02596789|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-05-03|||June 2012||2012-06-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|RC-TMS||Cortical Excitability Using Transcranial Magnetic Stimulation and Neuronavigation Device|Study of Cortical Excitability in Healthy Subjects With Transcranial Magnetic Stimulation (TMS) and a Neuronavigation Device|Completed||N/A|75|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-10 22:46:14.343074|2017-10-10 22:46:14.343074
NCT02596776|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-05-03|||March 2016||2016-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Cold Induced Changes in White Adipose|Cold Induced Changes in Human Subcutaneous White Adipose|Recruiting||Early Phase 1|90|Anticipated|University of Kentucky||3|||f||||t||||||||||2017-10-10 22:46:14.444721|2017-10-10 22:46:14.444721
NCT02596763|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-30|||December 2015||2015-12-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|BACLOPHONE||Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder|Phone-based Safety Monitoring of the First Year of Baclofen Treatment for Alcohol Use Disorder: the BACLOPHONE Cohort Study|Recruiting||Phase 4|792|Anticipated|University Hospital, Lille||1|||f||||t||||||||No||2017-10-10 22:46:14.567804|2017-10-10 22:46:14.567804
NCT02596737|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-11-03|||May 2015||2015-05-01|November 2015|2015-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|WittyFit||WittyFit - Live Your Work Differently|WittyFit - Live Your Work Differently|Recruiting||N/A|100|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 22:46:14.918956|2017-10-10 22:46:14.918956
NCT02596724|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-04|||July 2015||2015-07-01|November 2015|2015-11-01|July 2022|Anticipated|2022-07-01|July 2018|Anticipated|2018-07-01|5 Years|Observational [Patient Registry]|||TME Neoadjuvant Breast Registry|TME Neoadjuvant Breast Registry (The NEAT Registry)|Enrolling by invitation||N/A|1000|Anticipated|Targeted Medical Education|||1||f||||f||||||||||2017-10-10 22:46:15.058484|2017-10-10 22:46:15.058484
NCT02596711|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-24|||November 2, 2015|Actual|2015-11-02|August 2017|2017-08-01|August 22, 2017|Actual|2017-08-22|August 22, 2017|Actual|2017-08-22||Interventional|||Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers|Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers|Completed||Phase 1/Phase 2|26|Actual|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 22:46:15.152335|2017-10-10 22:46:15.152335
NCT02596698|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-10-10|||October 2015||2015-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders|Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders|Recruiting||N/A|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||Samples Without DNA|"     We will keep de-identified saliva and blood samples for analysis until the completion of the     study. Samples will then be destroyed.   "|||2017-10-10 22:46:15.284384|2017-10-10 22:46:15.284384
NCT02596685|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-03-31|||December 2015||2015-12-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Effects of Electronic Cigarette Use on the Lungs|Effects of Electronic Cigarette Use on the Human Lung|Recruiting||N/A|60|Anticipated|Ohio State University Comprehensive Cancer Center||4|||f||||t||||||||||2017-10-10 22:46:15.422214|2017-10-10 22:46:15.422214
NCT02596672|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-09-18|||September 2015||2015-09-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Promoting Walking in Older Adults Living in Independent Living Communities in Northern Ireland: A Feasibility Study.|Promoting Walking in Older Adults Living in Independent Living Communities in Northern Ireland: A Feasibility Study.|Completed||N/A|60|Anticipated|Queen's University, Belfast||2|||f||||f||||||||||2017-10-10 22:46:15.556755|2017-10-10 22:46:15.556755
NCT02596646|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-11-05|||January 2012||2012-01-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Early Precut in Difficult Biliary Cannulation|Early Precut Sphincterotomy During ERCP With Difficult Biliary Access (Italian: Esecuzione Del Pre-cut Precoce in Corso di ERCP Con Difficoltosa Incannulazione Della Via Biliare)|Terminated||N/A|375|Actual|Università Vita-Salute San Raffaele||2||Interim analysis recommended terminating the study|f||||t||||||||||2017-10-10 22:46:15.75479|2017-10-10 22:46:15.75479
NCT02596633|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-02-17|||January 2015||2015-01-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||A RCT of Telephone-supported ACT in MS|A Feasibility Randomized Control Trial (RCT) of Telephone-supported Acceptance and Commitment Therapy (ACT) for Low Mood in Multiple Sclerosis (MS)|Active, not recruiting||Phase 3|30|Actual|University of Nottingham||2|||f||||f||||||||No||2017-10-10 22:46:15.85205|2017-10-10 22:46:15.85205
NCT02596620|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-01-15|2016-05-03||October 2013||2013-10-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication|The Efficacy of 10-day Metronidazole and Levofloxacin Containing Sequential Therapy and 10-day Levofloxacin-containing Triple Therapy In Second Line Helicobacter Pylori Eradication Therapies|Completed||N/A|164|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||Yes|mmmm|2017-10-10 22:46:15.94848|2017-10-10 22:46:15.94848
NCT02596607|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-08-08|||November 6, 2015|Actual|2015-11-06|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|STROKE 69||Study of the Performance of Stroke Management in the Rhône Area|Study of the Performance of Acute Stroke Management in the Rhône Area After Implementation of a Multi-action Program|Recruiting||N/A|1300|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:46:16.191804|2017-10-10 22:46:16.191804
NCT02596594|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-03-31|||January 2010||2010-01-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|port-IUGR||Intraumbilical Amino Acids and Glucose Supplementation Via Port by Severe IUGR in Human Fetuses|Intraumbilical Amino Acids and Glucose Supplementation Via Subcutaneously Implanted Port System by Severe IUGR Human Fetuses|Completed||Early Phase 1|14|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||t||||||||||2017-10-10 22:46:16.266868|2017-10-10 22:46:16.266868
NCT02596581|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-03|||July 2014||2014-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||Chemerin and IL-6 Levels in Diabetes and Periodontitis|Association of Gingival Crevicular Fluid Chemerin and IL-6 Levels in Chronic Periodontitis With and Without Type 2 Diabetes Mellitus After Non-Surgical Periodontal Therapy|Completed||N/A|80|Actual|Bulent Ecevit University||4|||f||||f||||||||||2017-10-10 22:46:16.340755|2017-10-10 22:46:16.340755
NCT02596568|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-11-02|||January 2013||2013-01-01|January 2013|2013-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Effect of tDCS Applied During Sleep on Memory Consolidation|The Use of Transcranial Direct Current Stimulation During Slow Wave Sleep in Healthy Students and Older Adults|Completed||N/A|14|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-10 22:46:16.413444|2017-10-10 22:46:16.413444
NCT02596555|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-04-26|||January 2016||2016-01-01|April 2016|2016-04-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|PEITHO-2||Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.|Safety and Efficacy of Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Intermediate-Risk Pulmonary Embolism|Recruiting||Phase 4|700|Anticipated|Johannes Gutenberg University Mainz||1|||f||||t||||||||||2017-10-10 22:46:16.58201|2017-10-10 22:46:16.58201
NCT02596542|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-08-01|||November 2015||2015-11-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CWI||Cold Water Immersion and Recovery|Cold Water Immersion as a Strategy to Promote Post-exercise Recovery in Healthy Young Men|Completed||N/A|12|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-10 22:46:16.677759|2017-10-10 22:46:16.677759
NCT02596529|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2016-09-12|||January 2014||2014-01-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|POSTFIX||Fixation of the Posterior Malleolus in Medium-sized Trimalleolar AO Weber-B Fractures.|Medium-sized Posterior Fragments in AO-Weber B Fractures, Does Open Reduction and Internal Fixation Improve Outcome? A Multicenter Randomized Controlled Trial. The POSTFIX-trial.|Recruiting||N/A|84|Anticipated|Medical Center Haaglanden||2|||f||||f||||||||||2017-10-10 22:46:16.755658|2017-10-10 22:46:16.755658
NCT02596516|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-05|||December 2015||2015-12-01|November 2015|2015-11-01|December 2020|Anticipated|2020-12-01|January 2017|Anticipated|2017-01-01||Observational|||A Comparison of Colonic Bile Acid Content Following Right and Left Colectomies|A Comparison of Colonic Bile Acid Content Following Right and Left Colectomies|Not yet recruiting||N/A|100|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-10 22:46:16.850629|2017-10-10 22:46:16.850629
NCT02596503|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-15|||October 2015||2015-10-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors|A Phase I/II Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors|Recruiting||Phase 1|21|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-10 22:46:16.902726|2017-10-10 22:46:16.902726
NCT02596477|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01||||October 2016|Actual|2016-10-01||Interventional|||Evaluation of Vepoloxamer in Chronic Heart Failure|A Phase 2 Randomized, Double-Blind, Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vepoloxamer Injection, 22.5% (Sodium-Free) in Ambulatory Subjects With Chronic Heart Failure|Terminated||Phase 2|10|Actual|Mast Therapeutics, Inc.||3||Terminated for administrative reasons not related to safety or efficacy|f||||t||||||||||2017-10-10 22:46:17.142331|2017-10-10 22:46:17.142331
NCT02596464|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-11-02|||February 2015||2015-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:46:17.247051|2017-10-10 22:46:17.247051
NCT02596451|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-05-26|2017-04-18||August 2015||2015-08-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||A total of 1164 subjects were randomized in the study; however there were 21 subjects excluded from the safety population randomized who did not received dose. (Test=2, Reference=10, Placebo=9). Therefore the subject numbers are not consistent with any of the rows in the Participant Flow module.|To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel, 1% (Glenmark Pharmaceuticals Ltd) to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis Consumer Health, Inc) in Patients With Osteoarthritis (OA) of the Knee|Completed||Phase 3|1164|Actual|Glenmark Pharmaceuticals Ltd. India||3|||f||||f||||||||||2017-10-10 22:46:17.304189|2017-10-10 22:46:17.304189
NCT02596438|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-05-08|||October 1, 2012|Actual|2012-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 30, 2017|Anticipated|2017-09-30|6 Months|Observational [Patient Registry]|TAAS||Thousand Asian American Study|Thousand Asian American Study (TAAS)|Recruiting||N/A|2000|Anticipated|University of California, Davis|||1||f||||t||||||||||2017-10-10 22:46:17.716102|2017-10-10 22:46:17.716102
NCT02596425|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-11-29|||November 2015||2015-11-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Pulmonary Recruitment Maneuver for Postlaparoscopic Shoulder Pain|Pulmonary Recruitment Maneuver to Reduce Postlaparoscopic Shoulder Pain: Randomized Controlled Trial|Completed||Phase 3|90|Actual|Kangbuk Samsung Hospital||3|||f||||f||||||||||2017-10-10 22:46:17.813503|2017-10-10 22:46:17.813503
NCT02596412|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-08-22|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|April 2018|Anticipated|2018-04-01||Interventional|MINIDOCS||Augmented Reality to Reduce Pain During Botulinum Toxin Injections in Cerebral-palsied Children|MINIDOCS : Contribution of Augmented Reality to Reduce Pain During of Botulinum Toxin Injections in Cerebral-palsied Children. A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:46:17.905168|2017-10-10 22:46:17.905168
NCT02596399|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-03-09|||November 30, 2015|Actual|2015-11-30|March 2017|2017-03-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Interventional|||A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers|A PHASE I, RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED, SINGLE-ASCENDING DOSE STUDY TO INVESTIGATE THE SAFETY,TOLERABILITY, AND PHARMACOKINETICS OF DSTA4637S IN HEALTHY VOLUNTEERS|Completed||Phase 1|30|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-10 22:46:18.015758|2017-10-10 22:46:18.015758
NCT02596386|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-03|||November 2015||2015-11-01|October 2015|2015-10-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Observational|||Examination of Potassium Levels in Saliva in ESRD Patients|Examination of Potassium Levels in Saliva in ESRD Patients|Not yet recruiting||N/A|50|Anticipated|Hadassah Medical Organization|||2||f||||f||||||||||2017-10-10 22:46:18.114697|2017-10-10 22:46:18.114697
NCT02596373|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-02|||June 2015||2015-06-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|June 2016|Anticipated|2016-06-01||Interventional|||A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer|A Randomized, Open-label, Positive-controlled, Single-institutional, Phase Ⅱ of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer|Recruiting||Phase 2|60|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:46:18.191459|2017-10-10 22:46:18.191459
NCT02596360|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-03-31|||November 2015||2015-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Hydex||Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers|Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers|Completed||Phase 1|20|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:46:18.272246|2017-10-10 22:46:18.272246
NCT02596347|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-09-20|||April 2015||2015-04-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Observational|||The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)|The Role of JAK2 in Alveolar Macrophages in Chronic Beryllium Disease|Recruiting||N/A|12|Anticipated|National Jewish Health|||2||f||||f||||||Samples With DNA|"     Bronchoalveolar lavage fluid 4 heparin tubes for PBMC   "|||2017-10-10 22:46:18.379009|2017-10-10 22:46:18.379009
NCT02596334|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-24|||December 23, 2015|Actual|2015-12-23|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|MONCAY||Study to Evaluate the Efficacy of MONotherapy of TiviCAY® Versus a Triple Therapy in HIV-1-infected Patients|Randomized Clinical Trial to Evaluate the Efficacy of a Dolutegravir Monotherapy (Tivicay®) Versus the Maintenance of a Successful Triple Therapy Using Abacavir + Lamivudine + Dolutegravir (Triumeq®) in HIV-1- Infected Patients|Recruiting||Phase 3|160|Anticipated|Centre Hospitalier Régional d'Orléans||2|||f||||t||||||||||2017-10-10 22:46:18.494521|2017-10-10 22:46:18.494521
NCT02596308|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-02|||October 2014||2014-10-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Immunogenicity and Safety of Subunit Plague Vaccine|Immunogenicity and Safety of Subunit Plague Vaccine Comprised by Fraction 1 Capsule (F1) and Virulence-Associated (V) Antigens: A Random Phase 2a Clinical Trial|Completed||Phase 2|240|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 22:46:18.749358|2017-10-10 22:46:18.749358
NCT02596295|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2015-11-03|||October 2015||2015-10-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Observational|||Human Milk Sample Composition in Israeli Mothers and Correlation With Their Diet|Human Milk Sample Collection From Israeli Mothers and Its Analysis and Correlation Between Composition, Demographics and Diet|Recruiting||N/A|150|Anticipated|Enzymotec|||2||f||||f||||||Samples Without DNA|"     Human milk   "|||2017-10-10 22:46:18.83781|2017-10-10 22:46:18.83781
NCT02596282|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-11-02|||October 2014||2014-10-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Enhanced Provision of Male Circumcision (MC) for HIV Prevention, Rakai, Uganda|A Randomized Trial of the Acceptability and Safety of Early Infant Male Circumcision (EIMC) Conducted by Nurse Midwives and Clinical Offices Using the Mogen Clamp|Completed||Phase 2/Phase 3|501|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-10 22:46:18.919368|2017-10-10 22:46:18.919368
NCT02596269|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-11-03|||October 2012||2012-10-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Nefopam/Fentanyl Postoperative Intravenous Patient-Controlled-Analgesia|A Randomized Controlled Trial on the Effect and Safety of Intravenous Nefopam/Fentanyl Postoperative Patient-Controlled-Analgesia in Patients Undergoing Laparotomy|Completed||Phase 2/Phase 3|73|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:46:18.998705|2017-10-10 22:46:18.998705
NCT02596256|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-04-26|||April 2016||2016-04-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)|Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer Stage II Randomized Controlled Clinical Studies|Not yet recruiting||Phase 2|80|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-10 22:46:19.070051|2017-10-10 22:46:19.070051
NCT02596243|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-07-11|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)|A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 Clinical Trial to Evaluate the Efficacy and the Safety of GX-188E, a DNA-based Therapeutic Vaccine, Administered Intramuscularly by Electroporation(EP) in HPV Type 16 and/or 18 Positive Patients With Biopsy-proven Cervical Intraepithelial Neoplasia Grade 2(CIN2), Grade 2/3 (CIN2/3), Grade 3(CIN3)|Active, not recruiting||Phase 2|134|Actual|Genexine, Inc.||2|||f||||t||||||||||2017-10-10 22:46:19.177254|2017-10-10 22:46:19.177254
NCT02596230|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-10-03|||November 5, 2015|Actual|2015-11-05|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism|Characterization of Patients Following Acute Venous Thromboembolism (VTE) and Safety and Effectiveness of Dabigatran Etexilate (DE) in the Treatment and Secondary Prevention of Acute Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in Comparison to Vitamin K Antagonist (VKA) in Routine Clinical Practice - RE-COVERY DVT/PE|Recruiting||N/A|14000|Anticipated|Boehringer Ingelheim|||3||f||||||||||||||2017-10-10 22:46:19.355366|2017-10-10 22:46:19.355366
NCT02596217|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-07-05|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers|Safety, Tolerability, and Pharmacokinetics of Single Rising s.c. (Stage 1) and i.v. (Stage 2) Doses of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers (Double-blind, Randomized, Placebo-controlled Within Dose Groups)|Completed||Phase 1|80|Actual|AbbVie||8|||f||||f||||||||||2017-10-10 22:46:19.630965|2017-10-10 22:46:19.630965
NCT02596204|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-07-28|||September 2015||2015-09-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|DCT1A||Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote Monitoring|Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote Monitoring|Completed||N/A|113|Actual|Children's Hospitals and Clinics of Minnesota||2|||f||||f||||||||||2017-10-10 22:46:19.750369|2017-10-10 22:46:19.750369
NCT02596191|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-03|||November 2015||2015-11-01|November 2015|2015-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|CMT-TOOLS||Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers|Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers|Not yet recruiting||N/A|80|Anticipated|Assistance Publique Hopitaux De Marseille||4|||f||||f||||||||||2017-10-10 22:46:19.840489|2017-10-10 22:46:19.840489
NCT02596178|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-08-01|||March 2016||2016-03-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Titration of PEEP During Mechanical Ventilation in Patients With ARDS Using Electrical Impedance Tomography.||Recruiting||Phase 2/Phase 3|25|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-10 22:46:19.979727|2017-10-10 22:46:19.979727
NCT02596165|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-11-02|||November 2015||2015-11-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|BR-102||Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics|Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics|Not yet recruiting||N/A|75|Anticipated|University of Basel||1|||f||||f||||||||||2017-10-10 22:46:20.127474|2017-10-10 22:46:20.127474
NCT02596152|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-18|||August 2015||2015-08-01|November 2015|2015-11-01||||May 2016|Anticipated|2016-05-01||Interventional|TraWaFit||Mini-trampoline Intervention vs. Nordic Walking: Balance, Fitness and Neuropsychological Effects|Comparison of 12-week Mini-trampoline Intervention With a Nordic Walking Intervention: Balance, Fitness and Neuropsychological Effects|Recruiting||N/A|54|Anticipated|University of Basel||2|||f||||f||||||||||2017-10-10 22:46:20.240333|2017-10-10 22:46:20.240333
NCT02596139|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-02|||March 2015||2015-03-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Reliability and Validity of the Taiwan-version of Multidimensional Fatigue Inventory and Fatigue Severity Scale||Completed||N/A|123|Actual|Chang Gung University|||1||f||||t||||||||||2017-10-10 22:46:20.349101|2017-10-10 22:46:20.349101
NCT02596126|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-02-03|||July 2016||2016-07-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|SECURE||Secondary Prevention of Cardiovascular Disease in the Elderly Trial|Secondary Prevention of Cardiovascular Disease in the Elderly Trial|Recruiting||Phase 3|3206|Anticipated|Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III||2|||f||||t||||||||||2017-10-10 22:46:20.43959|2017-10-10 22:46:20.43959
NCT02596113|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2015-11-03|||July 2015||2015-07-01|November 2015|2015-11-01|May 2019|Anticipated|2019-05-01|June 2016|Anticipated|2016-06-01||Observational|||Νew Molecular Biomarkers for the Prevention and Early Detection of Precancerous or Cancerous Colorectal Lesions During Screening for Colorectal Cancer|Νew Molecular Biomarkers for the Prevention and Early Detection of Precancerous or Cancerous Colorectal Lesions During Screening for Colorectal Cancer|Recruiting||N/A|90|Anticipated|Evangelismos Hospital|||3||f||||t||||||Samples With DNA|"     whole blood serum and colonic polyps tissue samples   "|||2017-10-10 22:46:20.682392|2017-10-10 22:46:20.682392
NCT02596100|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-10-06|||September 2015||2015-09-01|October 2015|2015-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations|A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations|Completed||Phase 1|52|Actual|Portola Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:46:20.781322|2017-10-10 22:46:20.781322
NCT02596087|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-12-05|||April 2016||2016-04-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|IQ-MAPLE||Improving Quality by Maintaining Accurate Problems in the EHR|Improving Quality by Maintaining Accurate Problems in the Electronic Health Record|Active, not recruiting||N/A|2386|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 22:46:20.857978|2017-10-10 22:46:20.857978
NCT02596074|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-08-01|||November 2015||2015-11-01|August 2017|2017-08-01|July 4, 2017|Actual|2017-07-04|March 7, 2017|Actual|2017-03-07||Interventional|||Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN|A Phase 2, Randomized, Double-Blind, Parallel-Group Study to Assess the Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With Usual Type Vulvar Intraepithelial Neoplasia|Completed||Phase 2|12|Actual|Cutanea Life Sciences, Inc.||2|||f||||f||||||||||2017-10-10 22:46:20.972411|2017-10-10 22:46:20.972411
NCT02596061|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-04-24|||November 2015||2015-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|I2Q||In It To Quit: Commitment Contracts for Smoking Cessation|In It To Quit: Commitment Contracts for Smoking Cessation|Active, not recruiting||N/A|311|Actual|Community Health Center, Inc.||4|||f||||f||||||||||2017-10-10 22:46:21.076597|2017-10-10 22:46:21.076597
NCT02596048|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-05-31|||December 2015||2015-12-01|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|Iomeron®-400||A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA)|A Phase IV Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA) of the Thoraco-Abdominal Aorta, and the Carotid, Pulmonary, and Peripheral Arteries|Completed||Phase 4|224|Actual|Bracco Diagnostics, Inc||1|||f||||t||||||||||2017-10-10 22:46:21.180528|2017-10-10 22:46:21.180528
NCT02596035|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-09-26|||November 30, 2015|Actual|2015-11-30|September 2017|2017-09-01|December 1, 2021|Anticipated|2021-12-01|October 31, 2021|Anticipated|2021-10-31||Interventional|CheckMate 374||An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma|A Phase 3b/4 Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Renal Cell Carcinoma (CheckMate 374: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation 374)|Active, not recruiting||Phase 4|150|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 22:46:21.322217|2017-10-10 22:46:21.322217
NCT02595996|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-07-18|||June 7, 2017|Actual|2017-06-07|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Propranolol Dose Escalation in Lymphedema in Patients|An Intra-patient Dose Escalation Study of Propranolol in Patients With Lymphedema|Recruiting||Phase 2|20|Anticipated|Columbia University||1|||f||||t|t|f|||f|||||2017-10-10 22:46:21.853038|2017-10-10 22:46:21.853038
NCT02595983|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-05-23|||October 2015||2015-10-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant|An Open-label Study to Evaluate the Efficacy and Safety of Revusiran in Patients With Transthyretin-mediated Familial Amyloidotic Polyneuropathy With Disease Progression Post-Orthotopic Liver Transplant|Completed||Phase 2|12|Actual|Alnylam Pharmaceuticals||1|||f||||t||||||||||2017-10-10 22:46:21.974701|2017-10-10 22:46:21.974701
NCT02595970|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-04-19|||May 20, 2015|Actual|2015-05-20|April 2017|2017-04-01|February 9, 2017|Actual|2017-02-09|February 9, 2017|Actual|2017-02-09||Interventional|IPSI-PSO||Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis|A 52-week (Plus Extension Until Commercialization), Single-arm Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI) at 16 Weeks, as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Participants Suffering From Moderate to Severe Psoriasis|Completed||Phase 3|120|Actual|Novartis||1|||f||||f||||||||||2017-10-10 22:46:22.109702|2017-10-10 22:46:22.109702
NCT02595957|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-06-30|||October 29, 2015||2015-10-29|February 28, 2017|2017-02-28|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Clinical Center Genomics Opportunity Secondary Findings Analysis and Return|Clinical Center Genomics Opportunity Secondary Findings Analysis and Return|Enrolling by invitation||N/A|111|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:46:22.270356|2017-10-10 22:46:22.270356
NCT02595931|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-09-12|||June 8, 2016|Actual|2016-06-08|September 2017|2017-09-01||||April 30, 2018|Anticipated|2018-04-30||Interventional|||ATR Kinase Inhibitor VX-970 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|Phase I Clinical Trial of VX-970 in Combination With the Topoisomerase I Inhibitor Irinotecan in Patients With Advanced Solid Tumors|Recruiting||Phase 1|51|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 22:46:27.446521|2017-10-10 22:46:27.446521
NCT02595892|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-09-04|||August 25, 2016|Actual|2016-08-25|July 2017|2017-07-01|September 2, 2019|Anticipated|2019-09-02|September 2, 2019|Anticipated|2019-09-02||Interventional|||Gemcitabine Hydrochloride Alone or With VX-970 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Phase 2 Study of VX-970 (NSC# 780162) in Combination With Gemcitabine Versus Gemcitabine Alone in Subjects With Platinum-Resistant Recurrent Ovarian or Primary Peritoneal Fallopian Tube Cancer|Recruiting||Phase 2|70|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 22:46:32.305599|2017-10-10 22:46:32.305599
NCT02595879|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-09-12|||May 27, 2016|Actual|2016-05-27|September 2017|2017-09-01||||December 31, 2018|Anticipated|2018-12-31||Interventional|||Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar Cancer|Phase I Dose-Escalation Bioavailability Study of Oral Triapine in Combination With Concurrent Chemoradiation for Locally Advanced Cervical Cancer (LACC) and Vulvar Cancer|Suspended||Phase 1|64|Anticipated|National Cancer Institute (NCI)||1||Drug Supply Issues|f||||||||||||||2017-10-10 22:46:32.544137|2017-10-10 22:46:32.544137
NCT02595866|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-03|2017-10-02|||February 3, 2016|Actual|2016-02-03|September 2017|2017-09-01||||April 1, 2018|Anticipated|2018-04-01||Interventional|||Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms|Phase I Study of MK-3475 (Pembrolizumab) in Patients With Human Immunodeficiency Virus (HIV) and Relapsed/Refractory or Disseminated Malignant Neoplasm|Recruiting||Phase 1|39|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-10 22:46:32.691203|2017-10-10 22:46:32.691203
NCT02595853|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-11-02|||October 2014||2014-10-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|GRAPHE||Efficacy of a Novel Hemostatic Powder in GI Bleeding|A Novel Hemostatic Powder for the Endoscopic Treatment of Gastrointestinal Bleeding: Evaluation of Efficacy, Feasibility and Rebleeding Predictive Factors Results From a Multicenter Prospective Study Performed in Routine Practice|Completed||N/A|200|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 22:46:32.843144|2017-10-10 22:46:32.843144
NCT02595840|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-11-02||||||November 2015|2015-11-01||||||||Expanded Access|||A Prospective, Multiparametric Biomarker Study to Identify Predictors of Treatment Response and Resistance in Patients With EGFR-mutated Non-small-cell Lung Cancer Receiving Maintenance Therapy With Either Afatinib or Pemetrexed With the AIO-TRK-0114 Study (MARBLE)|A Prospective, Multiparametric Biomarker Study to Identify Predictors of Treatment Response and Resistance in Patients With EGFR-mutated Non-small-cell Lung Cancer Receiving Maintenance Therapy With Either Afatinib or Pemetrexed With the AIO-TRK-0114 Study (MARBLE)|No longer available||N/A|||AIO-Studien-gGmbH|||||f||||||||||||||2017-10-10 22:46:32.948919|2017-10-10 22:46:32.948919
NCT02595827|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-02-20|||October 9, 2015|Actual|2015-10-09|February 2017|2017-02-01|December 5, 2016|Actual|2016-12-05|December 5, 2016|Actual|2016-12-05||Interventional|||Non-inferiority Trial of Conditional vs Universal Follow up for Children With Fever in Democratic Republic of Congo|Universal Versus Conditional Follow Up for Children With Unclassified Fever at the Community Level: A Cluster-Randomized, Community-based, Non-Inferiority Trial in Kalemie, Democratic Republic of Congo (DRC)|Completed||Phase 3|4451|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 22:46:33.00629|2017-10-10 22:46:33.00629
NCT02595814|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-03-20|||July 23, 2014|Actual|2014-07-23|March 2017|2017-03-01|July 23, 2020|Anticipated|2020-07-23|July 23, 2020|Anticipated|2020-07-23|3 Years|Observational [Patient Registry]|REPORT-HF||Global Non-interventional Heart Failure Disease Registry|International Registry to Assess mEdical Practice With lOngitudinal obseRvation for Treatment of Heart Failure|Recruiting||N/A|18700|Anticipated|Novartis|||1||f||||f||||||||||2017-10-10 22:46:33.261351|2017-10-10 22:46:33.261351
NCT02595801|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-16|||August 2014||2014-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Surgery in Early Life and Child Development at School-entry: A Population-based Study|Surgery in Early Life and Child Development at School-entry: A Population-based Study|Completed||N/A|188628|Actual|The Hospital for Sick Children|||2||f||||||||||||||2017-10-10 22:46:34.016647|2017-10-10 22:46:34.016647
NCT02595788|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-02|||March 2014||2014-03-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|||Haemodynamic Changes During Anaesthesia in the Prone Position, Evaluated Using Transoesophageal Ultrasound|Haemodynamic Changes During Anaesthesia in the Prone Position, Evaluated Using Transoesophageal Ultrasound|Recruiting||N/A|20|Anticipated|Odense University Hospital|||2||f||||f||||||||||2017-10-10 22:46:34.080394|2017-10-10 22:46:34.080394
NCT02595775|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-05-03|||September 2015||2015-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Trial of an Audit and Feedback Report to Improve Colonoscopy Performance|A Randomized Controlled Trial of an Audit and Feedback Report to Improve Colonoscopy Performance|Enrolling by invitation||N/A|900|Anticipated|Sunnybrook Health Sciences Centre||4|||f||||f||||||||||2017-10-10 22:46:34.162843|2017-10-10 22:46:34.162843
NCT02595762|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-07-06|||October 30, 2016|Actual|2016-10-30|July 2017|2017-07-01|October 30, 2024|Anticipated|2024-10-30|October 30, 2024|Anticipated|2024-10-30||Observational|||A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer|A Disease Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer|Recruiting||N/A|300|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:46:34.239224|2017-10-10 22:46:34.239224
NCT02595736|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-09-09|||November 2015||2015-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study of LY3200327 in Healthy Participants|A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3200327 in Healthy Subjects|Completed||Phase 1|52|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:46:34.419887|2017-10-10 22:46:34.419887
NCT02595723|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-12-28|||July 2015||2015-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Phenytoin for Memory Impairment Secondary to Megestrol|Phenytoin for Memory Impairment Secondary to Megestrol|Completed||Early Phase 1|22|Actual|University of Texas Southwestern Medical Center||3|||f||||f||||||||||2017-10-10 22:46:34.658789|2017-10-10 22:46:34.658789
NCT02595710|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-01-25|||December 2013||2013-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Bartonella in Liver Transplant Patients|Undetected Bartonella Spp. Infection Puts Liver Transplant Patients at Great Risk|Recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples With DNA|"     Alpha Proteobacterium Growth Medium (BAPGM) multi-platform testing, including liquid culture,     enriched agar plating and molecular techniques. Four-mm skin biopsies from non-lesional skin     will be acquired from the same patients, processed using our published techniques, and imaged     using confocal microscopy and compared to BAPGM test results. Urine samples will be collected     and analyzed for microRNAs. Blood smears will be analyzed for intra-erythrocytic Bartonella     spp.   "|Yes|We will share individual patient data (IPD) with other researchers upon requet.|2017-10-10 22:46:34.741721|2017-10-10 22:46:34.741721
NCT02595697|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-04-10|||July 2015||2015-07-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|J-EMT||Communication Intervention for Toddlers With Autism|An Efficacy Trail of Enhanced Milieu Teaching Language Intervention Plus Joint Attention, Engagement, Regulation Intervention for Toddlers With Autism|Recruiting||N/A|120|Anticipated|Vanderbilt University||2|||f||||f||||||||Undecided||2017-10-10 22:46:34.832041|2017-10-10 22:46:34.832041
NCT02595684|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-11-02|||August 2015||2015-08-01|October 2015|2015-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.|Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.|Completed||Phase 4|18|Actual|University of Guadalajara||2|||f||||f||||||||||2017-10-10 22:46:34.919888|2017-10-10 22:46:34.919888
NCT02595671|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-05-02|||September 2015||2015-09-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||B-slim, a Multi-source Digital Super Coach for Sustainable Weight Loss|B-slim, a Multi-source Digital Super Coach for Sustainable Weight Loss|Completed||N/A|120|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||t||||||||Undecided|IPD will be discussed in the next steering committee|2017-10-10 22:46:35.041198|2017-10-10 22:46:35.041198
NCT02595658|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2015-11-02|||November 2014||2014-11-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Insulin Dose Adjustments for Meals Differing in Fat Content in T1DM||Completed||N/A|10|Actual|Northumbria University||4|||f||||t||||||||||2017-10-10 22:46:35.162502|2017-10-10 22:46:35.162502
NCT02595645|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-11-02|||August 2015||2015-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|GENESIS||GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps|GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps|Completed||N/A|101|Actual|University of Ulm||1|||f||||f||||||||||2017-10-10 22:46:35.231827|2017-10-10 22:46:35.231827
NCT02595632|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-09|||November 2015||2015-11-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|October 2022|Anticipated|2022-10-01||Observational|||Breath Analysis in Healthy Controls|Exhaled Breath Analysis by Secondary Electrospray Ionization (SESI-MS) in Healthy Controls|Recruiting||N/A|500|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 22:46:35.309512|2017-10-10 22:46:35.309512
NCT02595619|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-02|||July 2015||2015-07-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Renal Replacement Therapy Plus Extracorporeal Carbon Dioxide Removal|Combined Strategy of Renal Replacement Therapy Plus Extracorporeal Carbon Dioxide Removal in Patients With Acute Kidney Injury|Recruiting||Phase 1|10|Anticipated|University of Turin, Italy||1|||f||||f||||||||||2017-10-10 22:46:35.37995|2017-10-10 22:46:35.37995
NCT02595606|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-01-11|||September 2015||2015-09-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients|0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients|Recruiting||Phase 4|60|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:46:35.454352|2017-10-10 22:46:35.454352
NCT02595593|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-05-02|||April 2015||2015-04-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Rib Fixation for Clinically Severe Rib Fractures From Trauma|A Multicenter Prospective Randomized Trial on the Intervention of Rib Fixation for Clinically Severe Rib Fractures From Trauma|Recruiting||N/A|300|Anticipated|SCRI Development Innovations, LLC||2|||f||||t||||||||||2017-10-10 22:46:35.637881|2017-10-10 22:46:35.637881
NCT02595580|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-11-21|||January 2016||2016-01-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|GPI-II||The GlucoPred Investigation II|An Open, Controlled Investigation of Measurement Precision, System Accuracy and User Performance Evaluation in Subjects With Diabetes Mellitus Type 1 Using GlucoPred, a Non-invasive Continuous Blood Glucose Measurement Device|Terminated||N/A|16|Actual|Norwegian University of Science and Technology||1||skin irritation caused by device|f||||t||||||||||2017-10-10 22:46:35.822403|2017-10-10 22:46:35.822403
NCT02595567|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-11-02|||October 2010||2010-10-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|December 2015|Anticipated|2015-12-01||Interventional|||Catheter Placement for Hepatic Hydrothorax|Indwelling Tunneled Catheter Placement for Treatment of Hepatic Hydrothorax|Recruiting||N/A|40|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-10 22:46:35.938005|2017-10-10 22:46:35.938005
NCT02595554|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-02-02|||November 2015||2015-11-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|SYSGO002||Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer|Neoadjuvant Chemotherapy and Radical Surgery Versus Concurrent Chemoirradiation in FIGO Stage IIB Cervical Cancer|Recruiting||Phase 3|220|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:46:36.047066|2017-10-10 22:46:36.047066
NCT02595541|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-10|||June 2015||2015-06-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension|Effects of Adding Oral Sildenafil to Intravenous Milrinone on Postoperative Pulmonary Hypertension in Pediatric Undergoing Repair of Ventricular Septal Defect|Completed||Phase 1/Phase 2|30|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 22:46:36.17252|2017-10-10 22:46:36.17252
NCT02595528|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-10-03|||April 29, 2016|Actual|2016-04-29|October 2017|2017-10-01|October 22, 2017|Anticipated|2017-10-22|October 22, 2017|Anticipated|2017-10-22||Interventional|||A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia|A Phase 2, Multicenter, Double-masked, Randomized, Vehicle-Controlled, Study of the Concurrent Use of AGN-190584 and AGN-199201 in Patients With Presbyopia|Active, not recruiting||Phase 2|163|Actual|Allergan||4|||f||||f|t|f||||||||2017-10-10 22:46:36.269782|2017-10-10 22:46:36.269782
NCT02595515|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-14|||November 2015||2015-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Chiropractic Treatment of Infantile Colic|The Effect of Chiropractic Treatment of Infantile Colic. A Randomized, Controlled Trial|Recruiting||N/A|186|Anticipated|Nordic Institute of Chiropractic and Clinical Biomechanics||2|||f||||f||||||||||2017-10-10 22:46:36.411451|2017-10-10 22:46:36.411451
NCT02595502|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-06-13|2016-06-10||September 1, 2015|Actual|2015-09-01|June 2017|2017-06-01|November 1, 2015|Actual|2015-11-01|November 1, 2015|Actual|2015-11-01||Interventional||All subjects that were dispensed at least one study lens.|Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses||Completed||N/A|286|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||t||||||||||2017-10-10 22:46:36.521299|2017-10-10 22:46:36.521299
NCT02595489|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-10-12|||March 2016||2016-03-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy|A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy|Recruiting||Phase 1/Phase 2|20|Anticipated|Stanford University||1|||f||||t||||||||Undecided||2017-10-10 22:46:36.773718|2017-10-10 22:46:36.773718
NCT02595476|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-03-31|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Influence of Depth of Anesthesia on Pupillary Reactivity to a Standardized Stimulus|The Influence of Depth of Anesthesia on Pupillary Reactivity to a Standardized Stimulus Under Steady-state Remifentanil Analgesia|Completed||N/A|12|Actual|Hôpital Armand Trousseau||2|||f||||f||||||||||2017-10-10 22:46:36.871102|2017-10-10 22:46:36.871102
NCT02595463|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-08-18|||November 2015||2015-11-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients|Intravenous Lidocaine to Decrease Postoperative Pain in Pediatric Patients Undergoing Tonsillectomy: A Randomized, Double Blind, Placebo Controlled Trial|Recruiting||Phase 2/Phase 3|90|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-10 22:46:36.947002|2017-10-10 22:46:36.947002
NCT02595450|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-12-17|2015-12-01||September 2008||2008-09-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational||Analysis population included participants who received at least 1 documented treatment cycle.|A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer|A Non Interventional Trial of Tarceva Metastatic Non Small Lung Cancer.|Completed||N/A|299|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:46:37.043228|2017-10-10 22:46:37.043228
NCT02595437|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-01-18|||November 1, 2015||2015-11-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Triferic Pediatric Pharmacokinetic Protocol|Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis|Completed||Phase 1/Phase 2|22|Actual|Rockwell Medical Technologies, Inc.||2|||f||||f||||||||||2017-10-10 22:46:37.261161|2017-10-10 22:46:37.261161
NCT02595424|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-08-17|||November 6, 2015|Actual|2015-11-06|January 2017|2017-01-01||||January 31, 2018|Anticipated|2018-01-31||Interventional|||Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery|Randomized Phase II Study of Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced G3 Non-small Cell Gastroenteropancreatic Neuroendocrine Carcinomas|Recruiting||Phase 2|126|Anticipated|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-10-10 22:46:37.656176|2017-10-10 22:46:37.656176
NCT02595411|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-02-06|||July 2015||2015-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Observational|||Reliability of the Melbourne Assessment|Reliability of the Melbourne Assessment|Completed||N/A|30|Actual|University Children's Hospital, Zurich|||1||f||||f||||||||No||2017-10-10 22:46:41.661462|2017-10-10 22:46:41.661462
NCT02595398|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-08-07|||November 2015||2015-11-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PEACHTREE||Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis|A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects With Macular Edema Associated With Non-infectious Uveitis|Active, not recruiting||Phase 3|160|Actual|Clearside Biomedical, Inc.||2|||f||||f||||||||||2017-10-10 22:46:41.739961|2017-10-10 22:46:41.739961
NCT02595385|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-11-02|||February 2015||2015-02-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|February 2016|Anticipated|2016-02-01||Interventional|CONSERVE||Blood Conservation in Adult Cardiac Surgery, What is the Way Forward in Today's Practice?||Recruiting||N/A|240|Anticipated|Belfast Health and Social Care Trust||4|||f||||f||||||||||2017-10-10 22:46:42.165021|2017-10-10 22:46:42.165021
NCT02595372|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-06-26|||November 12, 2015|Actual|2015-11-12|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy|Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy|Recruiting||Phase 2|42|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 22:46:42.27118|2017-10-10 22:46:42.27118
NCT02595359|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-05-01|||January 2013||2013-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis|Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis|Recruiting||Phase 2|1000|Anticipated|Universidade Federal de Pernambuco||1|||f||||f||||||||Undecided|undecided|2017-10-10 22:46:42.39679|2017-10-10 22:46:42.39679
NCT02595346|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-12-06|||June 2016||2016-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|APLAQUINE||Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome|Efficiency of Hydroxychloroquine on the Endothelial Dysfunction in Antiphospholipid Syndrome (APLAQUINE)|Recruiting||Phase 2|30|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 22:46:42.516168|2017-10-10 22:46:42.516168
NCT02595333|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-11-02|||November 2015||2015-11-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Incision Pain and Uterine Contraction Pain After Cesarean Section|Differences in Incision Pain and Uterine Contraction Pain After Cesarean Section Between Primary Section and Repeat Section|Not yet recruiting||N/A|80|Anticipated|Fudan University||4|||f||||t||||||||||2017-10-10 22:46:42.61325|2017-10-10 22:46:42.61325
NCT02595320|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-04-12|||October 2015||2015-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|X7-7||Capecitabine in Metastatic Breast and GI Cancers|Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.|Recruiting||Phase 2|200|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||Undecided|Plan to share data is undecided.|2017-10-10 22:46:42.707047|2017-10-10 22:46:42.707047
NCT02595307|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-03-07|||May 2014||2014-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Improving Informed Consent for Cleft Palate Repair|Role of a Written Summary on Risk Recall During Consent Process for Cleft Palate Repair|Recruiting||N/A|40|Anticipated|IWK Health Centre||2|||f||||||||||||No|Aggregate results only will be shared.|2017-10-10 22:46:42.876672|2017-10-10 22:46:42.876672
NCT02595294|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-04|||July 2015||2015-07-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Hypoalgesic Effect of Neural Mobilization|Hypoalgesic Effect of Neural Mobilization in Cervicobrachial Pain Compared to a Controlled Group|Completed||Phase 2|52|Actual|Universidad Europea de Madrid||2|||f||||t||||||||||2017-10-10 22:46:42.976822|2017-10-10 22:46:42.976822
NCT02595281|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-12-05|||April 2016||2016-04-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|PRONOV4IR||HE4 as a Relapse Biomarker in Ovarian Cancers|Determination of the Interest of HE4 as a Relapse Biomarker in Ovarian Cancers Stages IIIb, IIIc and IV After Neo-adjuvant Chemotherapy and Surgery.|Recruiting||N/A|90|Anticipated|Institut de Cancérologie de Lorraine||1|||f||||t||||||||||2017-10-10 22:46:43.142014|2017-10-10 22:46:43.142014
NCT02595268|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-01-26|||November 2015||2015-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy Participants|A Phase 1, Open-label, Sequential Study to Investigate the Effect of JNJ 63623872 on Pitavastatin in Healthy Subjects|Completed||Phase 1|14|Actual|Janssen Research & Development, LLC||1|||f||||||||||||||2017-10-10 22:46:43.241398|2017-10-10 22:46:43.241398
NCT02595255|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-03-09|||April 2014||2014-04-01|November 2015|2015-11-01|April 2031|Anticipated|2031-04-01|April 2017|Anticipated|2017-04-01||Observational|CHANCE||AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)|Antimüllerian Hormone as a Predictor of Future Infertility Risk in Prepubertal/Pubertal Cancer Patients|Recruiting||N/A|275|Anticipated|Erasme University Hospital|||3||f||||f||||||Samples Without DNA|"     serum for hormonal assessment   "|||2017-10-10 22:46:43.33269|2017-10-10 22:46:43.33269
NCT02595242|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-05-22|||June 2015||2015-06-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma|Safety and Efficacy Study of Mitoxantrone Hydrochloride Liposome Injection Plus Cyclophosphamide,Vincristine and Prednison (CNOP)in Diffuse Large B Cell Lymphoma|Withdrawn||Phase 1|0|Actual|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||3|||f||||f||||||||||2017-10-10 22:46:43.482132|2017-10-10 22:46:43.482132
NCT02595229|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2015-11-01|||May 2010||2010-05-01|November 2015|2015-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Pronator Quadratus Repair After Volar Plating of Distal Radius Fractures|Pronator Quadratus Repair After Volar Plating of Distal Radius Fractures or Not? - Results of a Prospective Randomized Trial|Completed||N/A|60|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-10 22:46:43.642738|2017-10-10 22:46:43.642738
NCT02595216|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-04-05|||September 2015||2015-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment With the Profound System for Submental Laxity|Clinical Study to Evaluate the Performance of Profound System With Nominal Angle of 75° to the Skin's Surface for Submental Laxity|Active, not recruiting||N/A|60|Anticipated|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 22:46:43.712799|2017-10-10 22:46:43.712799
NCT02595203|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-01-14|||November 2015||2015-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Mass Balance Recovery and Metabolic Profile of 14C Debio 1450 Following Single Oral and Intravenous Doses in Healthy Male Subjects|A Phase I, Two-part, Open-label, Non-randomised Study to Investigate the Mass Balance Recovery and Metabolic Profile of 14C Debio 1450 Following Single Oral and Intravenous Doses in Healthy Male Subjects|Completed||Phase 1|18|Actual|Debiopharm International SA||3|||f||||f||||||||||2017-10-10 22:46:43.799471|2017-10-10 22:46:43.799471
NCT02595190|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-11-01|||March 2015||2015-03-01|November 2015|2015-11-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|TSSPC||Treatment of the Symptomatic Sacral Perineurial Cysts|A Randomized Controlled Trial to Compare the Efficacy of Medicine Conservative Treatment and Surgical Treatment for Symptomatic Sacral Perineurial Cysts (Tarlov Cysts) and the Applied Value of Resting State Functional Magnetic Resonance Imaging (rfMRI).|Recruiting||Phase 4|96|Anticipated|Southwest Hospital, China||3|||f||||t||||||||||2017-10-10 22:46:43.876992|2017-10-10 22:46:43.876992
NCT02595177|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-11-01|||July 2014||2014-07-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Multifocal Intraocular Lens x Monovision x Hybrid Monovision After Bilateral Cataract Surgery|Multifocal Intraocular Lens vs. Monovision vs. Hybrid Monovision After Bilateral Cataract Surgery|Completed||N/A|30|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-10-10 22:46:44.045787|2017-10-10 22:46:44.045787
NCT02595164|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-11-01|||November 2015||2015-11-01|November 2015|2015-11-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Observational|||Common Decision Making Deficits in Suicidal Behaviors and Eating Disorders|Common Decision Making Deficits in Suicidal Behaviors and Eating Disorders|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-10 22:46:44.131282|2017-10-10 22:46:44.131282
NCT02595151|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-11-01|||March 2015||2015-03-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Real-time Observation of Microcirculatory Hemodynamics in Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy|Real-time Observation of Microcirculatory Hemodynamics in Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy: a Feasibility Study|Unknown status|Recruiting|N/A|94|Anticipated|Shandong University|||2||f||||t||||||Samples Without DNA|"     Targeted fresh biopsy samples from each examined site were fixed in 10% pH neutral formalin,     and embedded in paraffin. Slides of 4-um sections were deparaffinized and hydrated. After     antigen retrieval and blocking procedures, Immunology and Histology Chemistry (IHC) staining     for CD34 was performed by mouse anti-CD34 monoclonal antibody (ZM-0046, ZSGB-BIO, Beijjing,     China) as per the manufacturers' instructions.   "|||2017-10-10 22:46:44.207274|2017-10-10 22:46:44.207274
NCT02595138|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2015-11-02|||October 2015||2015-10-01|November 2015|2015-11-01|December 2023|Anticipated|2023-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer||Active, not recruiting||Phase 3|430|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:46:44.300067|2017-10-10 22:46:44.300067
NCT02595125|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2017-07-04|||February 24, 2016|Actual|2016-02-24|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|DIRECTE||Study Assessing the Reduction of Pain Felt During Installation Intra- Uterine Device by Direct Technique|Comparative Study, Prospective, Randomized , Assessing the Reduction of Pain Felt During Installation Intra- Uterine Device by Direct Technique. A Monocentric Study|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 22:46:44.377695|2017-10-10 22:46:44.377695
NCT02595112|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-02|2016-12-22|||December 2015||2015-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|SREENSTAPH2||Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery|Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery. A Monocentric Study|Recruiting||N/A|160|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||No||2017-10-10 22:46:44.479608|2017-10-10 22:46:44.479608
NCT02595099|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-02|||February 2016||2016-02-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Mindfulness for Osteoarthritis-related Knee Pain|Feasibility and Acceptability of a Mindfulness-based Intervention for People With Osteoarthritis (OA) Related Knee Pain.|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of Nottingham||1|||f||||f||||||||||2017-10-10 22:46:44.577639|2017-10-10 22:46:44.577639
NCT02595086|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-11-01|||July 2015||2015-07-01|June 2015|2015-06-01|June 2023|Anticipated|2023-06-01|June 2020|Anticipated|2020-06-01||Interventional|KLASS-04||Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy|Multicenter Randomized Controlled Trial Comparing Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy for the Middle Third Early Gastric Cancer (KLASS-04)|Recruiting||Phase 3|256|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:46:44.674364|2017-10-10 22:46:44.674364
NCT02595073|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-08-17|||September 4, 2015|Actual|2015-09-04|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of DSXS With Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Moderate to Severe Atopic Dermatitis.|Active, not recruiting||Phase 3|124|Anticipated|Taro Pharmaceuticals USA||2|||f||||f||||||||||2017-10-10 22:46:44.795311|2017-10-10 22:46:44.795311
NCT02595060|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-02-20|||January 2016||2016-01-01|January 2016|2016-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|GI-HOPE||Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Inhalation to Improve Host Defense and Pulmonary Barrier Restoration|GM-CSF Inhalation to Improve Host Defense and Pulmonary Barrier Restoration (GI-HOPE). A Randomized, Double-blind, Parallel Group, Multicenter, Phase II Study|Recruiting||Phase 2|45|Anticipated|Savara Inc.||3|||f||||t||||||||||2017-10-10 22:46:44.882564|2017-10-10 22:46:44.882564
NCT02595047|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2015-10-30|||January 2013||2013-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)|Phase 1/2 Study of Autologous Tissues/Body Surface Organs Prefabrication in Tissue Reconstruction|Unknown status|Active, not recruiting|N/A|1|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||||2017-10-10 22:46:45.018325|2017-10-10 22:46:45.018325
NCT02595034|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-05-03|||January 2015||2015-01-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris|A Randomized Double Blind Multiple Center Placebo Controlled Study Comparing CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® (Clindamycin 1%/Benzoyl Peroxide 5%) Topical Gel in the Treatment of Acne Vulgaris|Completed||Phase 1|1000|Actual|Taro Pharmaceuticals USA||3|||f||||f|f|f|||f|||No||2017-10-10 22:46:45.116516|2017-10-10 22:46:45.116516
NCT02595021|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-07-23|||July 2015||2015-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Total/Subtotal Colectomy in Ovarian Cancer|A Phase II Study of Total or Subtotal Colectomy in Stage IIIC and Stage IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (EOC, FTC, PPC)|Recruiting||Phase 2|80|Anticipated|Shanghai Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-10 22:46:45.207357|2017-10-10 22:46:45.207357
NCT02595008|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2017-05-03|||August 28, 2015|Actual|2015-08-28|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis|An Open Label, Safety Study to Assess the Potential for Adrenal Suppression and Pharmacokinetics Following Maximal Use Treatment With DSXS in Patients With Atopic Dermatitis.|Recruiting||Phase 2|70|Anticipated|Taro Pharmaceuticals USA||1|||f||||f||||||||No||2017-10-10 22:46:45.314206|2017-10-10 22:46:45.314206
NCT02594995|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-04-17|||July 2015||2015-07-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|INCIMO||The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion|The Impact of NBP on the Collateral Circulation in Acute Acute Internal Carotid Artery(ICA)/Middle Cerebral Artery(M1) Occlusion|Enrolling by invitation||Phase 4|568|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||4|||f||||t||||||||||2017-10-10 22:46:45.417309|2017-10-10 22:46:45.417309
NCT02594982|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-10-02|||August 2015||2015-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|DANDELION||DANish DELIrium Study On Neurointensive Care Patients|DANish DELIrium Study On Neurointensive Care Patients. A Two Phase Intervention Study|Completed||N/A|100|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 22:46:45.518801|2017-10-10 22:46:45.518801
NCT02594969|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-05-25|||January 2014||2014-01-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|AD||The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis|The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis|Completed||N/A|20|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 22:46:45.64131|2017-10-10 22:46:45.64131
NCT02594956|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-09-09|||December 2015||2015-12-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|IPOD||Impact of the Absence of Nasogastric Decompression After Pancreaticoduodenectomy|Impact of the Absence of Nasogastric Decompression After Pancreaticoduodenectomy : A Prospective and Randomized Study|Recruiting||N/A|100|Anticipated|Rennes University Hospital||2|||f||||t||||||||||2017-10-10 22:46:45.756589|2017-10-10 22:46:45.756589
NCT02594943|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-09-04|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer|Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer|Not yet recruiting||N/A|20|Anticipated|Region Skane||2|||f||||f|f|f||||||||2017-10-10 22:46:45.865308|2017-10-10 22:46:45.865308
NCT02594930|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2016-10-17|||September 2015||2015-09-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|COSPI||Comparison of Two Different Techniques of Synovial Biopsy and Resistances of Cutaneous Smears in Suspected PPI|Comparison of Directed Versus Undirected Synovial Biopsy in Culture-negative Periprosthetic Joint Infections (With Preoperative Smears From the Skin) of the Knee and Evaluation of Outcome After Revision Joint Arthroplasty|Recruiting||N/A|30|Anticipated|Technische Universität München||1|||f||||f||||||||No||2017-10-10 22:46:45.977007|2017-10-10 22:46:45.977007
NCT02594917|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-05-01|||October 2015||2015-10-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension|Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension|Recruiting||N/A|20|Anticipated|University of Pittsburgh|||2||f||||t||||||Samples With DNA|"     We are generating inducible pluripotent stem cells from blood and skin biopsies from     participants.   "|Undecided||2017-10-10 22:46:46.091927|2017-10-10 22:46:46.091927
NCT02594904|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-31|||July 2015||2015-07-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency|A Multicenter Study to Evaluate the Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency|Unknown status|Recruiting|Phase 4|300|Anticipated|Southern Medical University, China||4|||f||||f||||||||||2017-10-10 22:46:46.187642|2017-10-10 22:46:46.187642
NCT02594891|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2016-05-21|||November 2015||2015-11-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis|Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis on Patients With choledocholithiasis--a Prospective Randomized Trial|Completed||N/A|85|Actual|First People's Hospital of Hangzhou||2|||f||||t||||||||Undecided||2017-10-10 22:46:46.288927|2017-10-10 22:46:46.288927
NCT02594878|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-11-15|||October 2015||2015-10-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|CNOPAM||Chronic Non-bacterial Osteomyelitis Treated With Pamidronate|Chronic Non-bacterial Osteomyelitis Treated With Pamidronate in a Randomised Placebo Controlled Trial|Recruiting||Phase 2|32|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 22:46:46.405743|2017-10-10 22:46:46.405743
NCT02594865|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-06-24|||September 2015||2015-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|GluCip||The Glycaemic Effects of Glucerna® in Critically Ill Patients.|Glucerna in Critically Ill Patients (GluCip Trial): Investigating the Glycaemic Effects of a Reduced-carbohydrate, Modified-fat, Fiber-containing Enteral Formula (Glucerna®) in Critically Ill Patients.|Completed||N/A|100|Actual|Onze Lieve Vrouwe Gasthuis||2|||f||||f||||||||||2017-10-10 22:46:46.528028|2017-10-10 22:46:46.528028
NCT02594852|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-10-02|||March 2015||2015-03-01|October 2017|2017-10-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Laser - a New Possibility in Fertility Treatment - a Pilot Study|Laser - a New Possibility in Fertility Treatment - a Pilot Study|Terminated||N/A|20|Actual|Regionshospitalet Viborg, Skive||2||Too few patients enrolling + laser no longer available|f||||t||||||||||2017-10-10 22:46:46.633608|2017-10-10 22:46:46.633608
NCT02594839|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2016-08-08|||February 2013||2013-02-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|||Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease|A Phase I-II Study to Evaluate Safety and Efficacy of Allogeneic Bone-Marrow Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease|Recruiting||Phase 1/Phase 2|20|Anticipated|Federal Research Clinical Center of Federal Medical & Biological Agency, Russia||2|||f||||t||||||||||2017-10-10 22:46:46.853029|2017-10-10 22:46:46.853029
NCT02594826|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2016-10-12|2016-08-22||February 2009||2009-02-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|September 2013|Actual|2013-09-01||Interventional|||Cervical Cancer Screening Intervention Among Korean American Women|Facilitating Cervical Cancer Screening Among Underserved Korean American Women|Completed||N/A|744|Actual|Fox Chase Cancer Center||2|||f||||f||||||||||2017-10-10 22:46:46.965863|2017-10-10 22:46:46.965863
NCT02594813|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-11-24|||November 2015||2015-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|EGD||Bleeding Rate After EGD and Colonoscopy in Patients Who Continue to Take Antithrombotic Agents||Enrolling by invitation||N/A|1000|Anticipated|Showa Inan General Hospital|||1||f||||f||||||Samples Without DNA|"     Excised specimens after taking biopsy or doing polypectomy   "|||2017-10-10 22:46:47.321369|2017-10-10 22:46:47.321369
NCT02594800|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-04-25|||December 15, 2015||2015-12-15|September 2015|2015-09-01|March 28, 2018|Anticipated|2018-03-28|March 28, 2018|Anticipated|2018-03-28||Interventional|||Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis|The Impact of Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis Evaluated by Computed Tomography Perfusion (CTP)|Recruiting||Phase 4|44|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||t||||||||||2017-10-10 22:46:47.485477|2017-10-10 22:46:47.485477
NCT02594787|ClinicalTrials.gov processed this data on October 10, 2017|2015-11-01|2015-11-02|||March 2011||2011-03-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Phosphorus on Diet Induced Thermogenesis||Completed||N/A|23|Actual|Lebanese American University||2|||f||||t||||||||||2017-10-10 22:46:47.624346|2017-10-10 22:46:47.624346
NCT02594774|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-11-02|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy of Osteopathic Treatment in Function Abdominal Pain in Children and Adolescents|Efficacy of Osteopathic Treatment in Function Abdominal Pain in Children and Adolescents|Unknown status|Recruiting|N/A|60|Anticipated|Parc de Salut Mar||2|||f||||f||||||||||2017-10-10 22:46:47.727309|2017-10-10 22:46:47.727309
NCT02594761|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-30|||August 2013||2013-08-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion|Pharmacokinetic Study Comparing Hercules, EU-approved Herceptin® and US-Licensed Herceptin® Administered as a Single Intravenous Infusion to Healthy Male Volunteers|Completed||Phase 1|132|Actual|Mylan Pharmaceuticals||3|||f||||f||||||||||2017-10-10 22:46:47.853751|2017-10-10 22:46:47.853751
NCT02594748|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effects of Self-management Education Based on Theory of Planned Behavior on Patients With Type 2 Diabetes|The Effects of Self-management Education Based on Theory of Planned Behavior on Self-management and Quality of Life of Patients With Type 2 Diabetes and the Other Influencing Factors of Quality of Life|Suspended||N/A|280|Anticipated|University of Turku||2||The voluntary attendance rate for intervention is low.|f||||t||||||||No||2017-10-10 22:46:47.966867|2017-10-10 22:46:47.966867
NCT02594735|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-02-23|||November 2015||2015-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AID||Abatacept in Juvenile Dermatomyositis|Abatacept for the Treatment of Refractory Juvenile Dermatomyositis|Recruiting||Phase 4|10|Anticipated|George Washington University||1|||f||||f||||||||||2017-10-10 22:46:48.094981|2017-10-10 22:46:48.094981
NCT02594722|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-04-17|||April 2016||2016-04-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Metabolism and Oxygen Consumption During Functional Electrical Stimulation Cycling in COPD||Completed||Phase 3|25|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 22:46:48.284606|2017-10-10 22:46:48.284606
NCT02594709|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-11-02|||January 2011||2011-01-01|November 2015|2015-11-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|ONSMsmSRS||Multisession Radiosurgery for Optic Nerve Sheath Meningiomas|Observational Study on Multisession Radiosurgery for Optic Nerve Sheath Meningiomas|Recruiting||Phase 2|50|Anticipated|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta||1|||f||||f||||||||||2017-10-10 22:46:48.39164|2017-10-10 22:46:48.39164
NCT02594696|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-09-15|||October 2015||2015-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness|Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness|Active, not recruiting||N/A|30|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 22:46:48.518917|2017-10-10 22:46:48.518917
NCT02594683|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-31|||August 2015||2015-08-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|July 2019|Anticipated|2019-07-01||Observational|VenusFU||A Follow-up Study to Investigate the Effects of a New Infant Formula on Growth and Body Composition|A Follow-up Study of a Randomised, Controlled, Study to Investigate the Effects of a New Infant Formula Given in the First 12 Months of Life on Growth and Body Composition up to 5 Years of Age|Recruiting||N/A|540|Anticipated|Danone Asia Pacific Holdings Pte, Ltd.|||3||f||||f||||||Samples Without DNA|"     Stools, saliva and blood (optional)   "|||2017-10-10 22:46:48.657846|2017-10-10 22:46:48.657846
NCT02594670|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-11-02|||October 2015||2015-10-01|March 2015|2015-03-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|AI-RCT||Acupuncture for Insomnia: a Randomized Controlled Trial|Acupuncture Based on Different Acupoints Combination for Insomnia: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|333|Anticipated|The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-10 22:46:48.785125|2017-10-10 22:46:48.785125
NCT02594657|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-07-28|||August 2015||2015-08-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|PRIOx||Pedal Rate Influence on Oxygen Consumption in Eccentric|Pedal Rate Influence on Oxygen Consumption in Eccentric|Recruiting||N/A|15|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:46:48.928213|2017-10-10 22:46:48.928213
NCT02594644|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2017-04-04|||November 6, 2014|Actual|2014-11-06|March 2017|2017-03-01|June 22, 2016|Actual|2016-06-22|June 22, 2016|Actual|2016-06-22||Interventional|||The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy|The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy|Completed||N/A|33|Actual|University of California, Davis||4|||f||||f||||||||||2017-10-10 22:46:49.050116|2017-10-10 22:46:49.050116
NCT02594631|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-10-30|||March 2015||2015-03-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial.|Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial.|Unknown status|Recruiting|Phase 4|100|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 22:46:49.16938|2017-10-10 22:46:49.16938
NCT02594618|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-08-01|||August 2014||2014-08-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Energy Metabolism and Cost of Physical Activities Using Whole Body Calorimeter|Energy Metabolism and Cost of Physical Activities Using Whole Body Calorimeter|Completed||N/A|20|Actual|Clinical Nutrition Research Centre, Singapore|||1||f||||f||||||||||2017-10-10 22:46:49.294321|2017-10-10 22:46:49.294321
NCT02594605|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-08-26|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Applied The Platelet Rich Fibrin in Chronic Periodontitis|Investigation of the Contributions of Platelet Rich Fibrin Combined With Conventional Periodontal Flap on Periodontal Healing|Completed||Phase 2|16|Actual|Ataturk University||2|||f||||t||||||||||2017-10-10 22:46:49.376974|2017-10-10 22:46:49.376974
NCT02594592|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-30|||January 2015||2015-01-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Clinical Value of Self-assessment Risk of Osteoporosis in Chinese|Combined Assessment of the Osteoporosis Self-assessment Tool for Asians and the One-Minute Osteoporosis Risk Test in a Wuhan Population|Completed||N/A|389|Actual|Wuhan Integrated Traditional Chinese and Western Medicine Hospital|||4||f||||f||||||||||2017-10-10 22:46:49.499525|2017-10-10 22:46:49.499525
NCT02594579|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-30|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Vitamin D3 Supplementation on Muscle Mass in ICU Patient|Effect of High Dose Vitamin D3 Supplementation on Skeletal Muscle Mass and Body Compositions in Critically Ill Patients With Vitamin D Deficiency|Unknown status|Not yet recruiting|Phase 3|40|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-10 22:46:49.610655|2017-10-10 22:46:49.610655
NCT02594566|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-09-19|||November 2015||2015-11-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Interventional|CM04-101||Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine|A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Prophylactic Cytomegalovirus Plasmid DNA Vaccine in Healthy Adults|Withdrawn||Phase 1|0|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-10-10 22:46:49.751438|2017-10-10 22:46:49.751438
NCT02594553|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-09-15|||November 2015||2015-11-01|October 2015|2015-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CHILI||Optimizing Management and Medication of Febrile Children in Out-of-hours Primary Care: CHILI Cluster RCT|Optimizing Management and Medication of Febrile Children in Out-of-hours Primary Care: the CHILI Cluster Randomised Trial|Completed||N/A|1262|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 22:46:49.877107|2017-10-10 22:46:49.877107
NCT02594540|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-01-11|||December 2015||2015-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation|Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation - A Randomized Clinical Trial|Completed||N/A|28|Actual|Federal University of Health Science of Porto Alegre||2|||f||||f||||||||||2017-10-10 22:46:49.986403|2017-10-10 22:46:49.986403
NCT02594527|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|SoMoVe||Southampton Mobility Volunteer Programme|The Southampton Mobility Volunteer Programme to Increase Physical Activity Levels of Older Inpatients: A Feasibility Study|Recruiting||N/A|50|Anticipated|University of Southampton||1|||f||||t||||||||Undecided||2017-10-10 22:46:50.130529|2017-10-10 22:46:50.130529
NCT02594514|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-30|||January 2007||2007-01-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Laparoscopic Sleeve Gastrectomy in Severely Obese Adolescents: Effects on Metabolism|Laparoscopic Sleeve Gastrectomy in Severely Obese Adolescents: Effective for Resolution of Cardiovascular Comorbidities|Completed||N/A|22|Actual|University of Sao Paulo General Hospital|||1||f||||||||||||||2017-10-10 22:46:50.280798|2017-10-10 22:46:50.280798
NCT02594501|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-06-06|||February 2016||2016-02-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|COBRA-REDUCE||Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy|COBRA PzF Stenting to Reduce the Duration of Triple Therapy in Patients Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention|Recruiting||N/A|844|Anticipated|CeloNova BioSciences, Inc.||2|||f||||t|f|t|f|f||||No||2017-10-10 22:46:50.375885|2017-10-10 22:46:50.375885
NCT02594462|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Interventional|||Contraception in Women With Sickle Cell Disease|Use of Etonogestrel-releasing Contraceptive Implant in Women With Sickle Cell Disease|Active, not recruiting||Phase 4|19|Actual|University of Sao Paulo||1|||f||||f||||||||No||2017-10-10 22:46:50.906579|2017-10-10 22:46:50.906579
NCT02594449|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-11-02|||October 2015||2015-10-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers|A Pharmacodynamic and Safety Study of Benzalkonium Chloride Solution Clearing the Oral Colonized Bacterium in Healthy Volunteers|Unknown status|Enrolling by invitation|Phase 4|20|Anticipated|Lustre Pharmaceutical Lab Co., Ltd||3|||f||||f||||||||||2017-10-10 22:46:51.002119|2017-10-10 22:46:51.002119
NCT02594436|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-01-03|||December 2015||2015-12-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|PrAKtice||The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice|The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice: A Prospective Phase IV, Multicentre, Pan-Hellenic Observational Cohort Study|Active, not recruiting||N/A|440|Actual|LEO Pharma|||2||f||||f||||||||||2017-10-10 22:46:51.10846|2017-10-10 22:46:51.10846
NCT02594423|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-12-01|||December 2015||2015-12-01|December 2015|2015-12-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Strategies for Management of Corneal Neovascularisation|Management of Active and Established Corneal Neovascularisation to Prevent Visual Impairment|Not yet recruiting||Phase 4|40|Anticipated|University of Nottingham||2|||f||||t||||||||||2017-10-10 22:46:51.201125|2017-10-10 22:46:51.201125
NCT02594410|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-30|||September 2011||2011-09-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Zainidip in Renal Artery Stenosis|The Efficacy of Renal Artery Stent Combined With Standardized Medical Therapy in Patients With Atherosclerotic Renal Artery Stenosis|Completed||Phase 4|149|Actual|Lee's Pharmaceutical Limited||1|||f||||f||||||||||2017-10-10 22:46:51.290072|2017-10-10 22:46:51.290072
NCT02594397|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2015-10-31|||December 2015||2015-12-01|September 2015|2015-09-01||||December 2016|Anticipated|2016-12-01||Interventional|ADG-RCT||Acupuncture for Diabetic Gastroparalysis: a Randomized Controlled Trial||Unknown status|Not yet recruiting|N/A|210|Anticipated|The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine||3|||f||||||||||||||2017-10-10 22:46:51.37713|2017-10-10 22:46:51.37713
NCT02594384|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-06-15|||October 2015||2015-10-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|March 2018|Anticipated|2018-03-01||Interventional|LAM-002A/NHL||A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma|A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A (Apilimod Dimeyslate Capsules) Administered Orally in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma|Recruiting||Phase 1|75|Anticipated|Lam Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 22:46:51.475307|2017-10-10 22:46:51.475307
NCT02594371|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-11-14|||December 2015||2015-12-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer|An Open-Label, Randomized, Multicenter, Phase 3 Study to Determine the Safety, Tolerability, and Tumor Response of Oraxol and Its Comparability to IV Taxol or Generic IV Paclitaxel in Subjects With Metastatic Breast Cancer|Recruiting||Phase 3|360|Anticipated|Kinex Pharmaceuticals Inc||2|||f||||t||||||||Undecided||2017-10-10 22:46:51.741506|2017-10-10 22:46:51.741506
NCT02594358|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-03-06|||October 2014||2014-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CAS||Caffeine in Amblyopia Study||Withdrawn||Phase 1/Phase 2|0|Actual|Johns Hopkins University||2||Could not recruit|f||||f||||||||||2017-10-10 22:46:52.048514|2017-10-10 22:46:52.048514
NCT02594345|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-02-22|||October 2015||2015-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation|In Vitro Study of the Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation in Healthy Volunteers' Blood|Completed||N/A|18|Actual|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||||2017-10-10 22:46:52.169968|2017-10-10 22:46:52.169968
NCT02594332|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-11|||November 17, 2015|Actual|2015-11-17|July 2017|2017-07-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Interventional|MEMORY||Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study|A Randomized, Double-blind, Placebo-controlled, Mono-center Study to Evaluate the Effects of Mepolizumab on Airway Physiology in Patients With Eosinophilic Asthma: the MEMORY Study|Terminated||Phase 3|29|Actual|Johannes Gutenberg University Mainz||2||recruitment problems|f||||f||||||||||2017-10-10 22:46:52.309539|2017-10-10 22:46:52.309539
NCT02594319|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-10-30|||February 2015||2015-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Understanding Mechanisms of Health Behavior||Completed||N/A|61|Actual|University of Colorado, Boulder||3|||f||||f||||||||||2017-10-10 22:46:52.497701|2017-10-10 22:46:52.497701
NCT02594306|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-02-17|||October 2015||2015-10-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Brain Electrophysiological Study(EEG/ERP) on Opiate Addicts Treating by Bilateral NAc/ALIC Deep Brain Stimulation|Brain Electrophysiological Study(EEG/ERP) on Opiate Addicts Treating by Bilateral NAc/ALIC Deep Brain Stimulation|Recruiting||N/A|20|Anticipated|Tang-Du Hospital||3|||f||||t||||||||||2017-10-10 22:46:52.632329|2017-10-10 22:46:52.632329
NCT02594293|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2017-04-11|||October 2015||2015-10-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy|A Prospective, Randomized, Controlled Clinical Trial to Evaluate the Role of Peg-IFN Alfa-2a in Reducing RelapSe Rate in Patients With Hepatitis B e Antigen(HBeAg)-nEgative Chronic Hepatitis B After Discontinuation of NUC Therapy|Recruiting||Phase 4|354|Anticipated|Huashan Hospital||3|||f||||f||||||||||2017-10-10 22:46:52.855147|2017-10-10 22:46:52.855147
NCT02594280|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-10-30|||December 2015||2015-12-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Benchmarking Management of Glaucoma Using the Diopsys VEP/PERG Protocols.|Observational/Prospective Study for Benchmarking the Management of Glaucoma With Selective Laser Trabeculoplasty (SLT) or Trabecular Stent Bypass Microsurgery, Using the Diopsys Visual Evoked Potential/Pattern ERG Protocols|Unknown status|Not yet recruiting|N/A|60|Anticipated|Diopsys, Inc.|||2||f||||f||||||||||2017-10-10 22:46:53.116254|2017-10-10 22:46:53.116254
NCT02594267|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-03-10|||October 2015||2015-10-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)|A Phase 1, Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Patients With Peripheral T-Cell Lymphoma (PTCL)|Recruiting||Phase 1|30|Anticipated|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-10 22:46:53.246311|2017-10-10 22:46:53.246311
NCT02594254|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-07-17||2017-07-17|November 2015||2015-11-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects|A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects|Completed||Phase 2|135|Actual|C3 Jian, LLC||7|||f||||f||||||||||2017-10-10 22:46:53.417128|2017-10-10 22:46:53.417128
NCT02594241|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-07-28|||March 2016||2016-03-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|POSAR||PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial|PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-10 22:46:53.590522|2017-10-10 22:46:53.590522
NCT02594228|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-30|||December 2010||2010-12-01|October 2015|2015-10-01|August 2013|Actual|2013-08-01|June 2011|Actual|2011-06-01||Interventional|||Protein Intake and Physical Performance|Effects of Increased Protein Intake and Exercise Training on Body Composition, Cardiovascular Health and Physical Performance|Completed||N/A|25|Actual|Skidmore College||2|||f||||f||||||||||2017-10-10 22:46:53.744645|2017-10-10 22:46:53.744645
NCT02594189|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-31|2017-07-13|||October 19, 2015||2015-10-19|July 12, 2017|2017-07-12|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers|Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers|Recruiting||Phase 1|200|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:46:54.137903|2017-10-10 22:46:54.137903
NCT02594176|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-02-02|||October 2015||2015-10-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|March 2016|Anticipated|2016-03-01||Interventional|OANIT||Study of FLEXISEQ® for Treatment of Osteoarthritis of the Knee in NSAID-compromised Patients|A Randomised, Double-blind, Placebo Controlled Study of Topical FLEXISEQ® for the Treatment of Osteoarthritis of the Knee in Patients Contraindicated for or With Clinical Intolerance to NSAIDs|Recruiting||N/A|600|Anticipated|Pro Bono Bio||2|||f||||f||||||||Undecided||2017-10-10 22:46:54.256461|2017-10-10 22:46:54.256461
NCT02594163|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-05-30|||October 2015||2015-10-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma|A Randomized, Open Label, Phase 2 Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for Relapsed or Refractory CD30-Positive Diffuse Large B-Cell Lymphoma|Active, not recruiting||Phase 2|110|Anticipated|Seattle Genetics, Inc.||2|||f||||t||||||||||2017-10-10 22:46:54.400675|2017-10-10 22:46:54.400675
NCT02594150|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-06-07|||December 2015||2015-12-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|CRCSO||Single Center Randomized Pilot Study Of Colorectal Cancer Screening Outreach|Single Center Randomized Pilot Study Of Colorectal Cancer Screening Outreach|Enrolling by invitation||N/A|1080|Anticipated|University of Pennsylvania||4|||f||||f||||||||||2017-10-10 22:46:54.615701|2017-10-10 22:46:54.615701
NCT02594137|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-30|||January 2012||2012-01-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||A Comparison Between Two Techniques for Performing Decompressive Craniectomy|A Randomized Controlled Study Comparing 2 Surgical Techniques for Decompressive Craniectomy: With Watertight Duraplasty Versus Without Watertight Duraplasty.|Completed||N/A|58|Actual|Hospital of the Restoration, Recife||2|||f||||t||||||||||2017-10-10 22:46:54.698441|2017-10-10 22:46:54.698441
NCT02594124|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-08-16|||November 4, 2015|Actual|2015-11-04|August 2017|2017-08-01|August 1, 2022|Anticipated|2022-08-01|August 1, 2022|Anticipated|2022-08-01||Interventional|SHINE||A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies.|An Open-Label Extension Study for Patients With Spinal Muscular Atrophy Who Previously Participated in Investigational Studies of ISIS 396443|Enrolling by invitation||Phase 3|289|Anticipated|Biogen||4|||t||||t||||||||||2017-10-10 22:46:54.781|2017-10-10 22:46:54.781
NCT02594111|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-07-19|||June 3, 2013|Actual|2013-06-03|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Colchicine in Percutaneous Coronary Intervention|Anti-inflammatory Therapy During Percutaneous Coronary Intervention|Recruiting||Phase 4|800|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||t|||||2017-10-10 22:46:55.103272|2017-10-10 22:46:55.103272
NCT02594098|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-04-11|||November 2015||2015-11-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Secukinumab for Treatment of Atopic Dermatitis|A Pilot Study to Evaluate the Efficacy and Safety of Secukinumab in the Treatment of Moderate to Severe Atopic Dermatitis|Recruiting||Phase 2|44|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|t||||f|||No||2017-10-10 22:46:55.210335|2017-10-10 22:46:55.210335
NCT02594085|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-01-19|||October 2015||2015-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||An Exploratory Study Investigating Adhesive Reaction to Output||Completed||N/A|15|Actual|Coloplast A/S||6|||f||||f||||||||||2017-10-10 22:46:55.32723|2017-10-10 22:46:55.32723
NCT02594072|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-06-06|||April 2016||2016-04-01|June 2016|2016-06-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|ASSERT||Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)|Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT): A Phase II Randomized Trial for Intermediate and High Risk Prostate Cancer|Recruiting||N/A|80|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 22:46:55.435051|2017-10-10 22:46:55.435051
NCT02594059|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-09-11|||December 2012||2012-12-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|Endoth-FPI||Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis|Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis|Recruiting||N/A|40|Anticipated|Hopital Foch||1|||f||||f||||||||||2017-10-10 22:46:55.538787|2017-10-10 22:46:55.538787
NCT02594046|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-04-03|||July 1, 2015||2015-07-01|April 2017|2017-04-01|May 28, 2016|Actual|2016-05-28|February 28, 2016|Actual|2016-02-28||Interventional|||The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia|The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia|Completed||N/A|38|Actual|Pusan National University Hospital||2|||f||||t||||||||No||2017-10-10 22:46:55.630474|2017-10-10 22:46:55.630474
NCT02594033|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-07-31|||October 27, 2015|Actual|2015-10-27|July 2017|2017-07-01|January 28, 2016|Actual|2016-01-28|January 28, 2016|Actual|2016-01-28||Interventional|||A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles|A Single Centre, Randomised, 3-period Cross-over Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles|Completed||Phase 1|46|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-10 22:46:55.698006|2017-10-10 22:46:55.698006
NCT02594020|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-04-22|||June 2008||2008-06-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of Different Methods of Enamel Preparation Before Pit and Fissure Sealants||Completed||N/A|400|Actual|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-10 22:46:55.780491|2017-10-10 22:46:55.780491
NCT02594007|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-05|||November 2015||2015-11-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|December 31, 2016|Actual|2016-12-31||Interventional|||Mobile Health Monitoring Solution for Heart Failure Patients|Mobile Health Monitoring Solution for Heart Failure Patients|Completed||N/A|31|Actual|Atlantic Health System||2|||f||||f||||||||||2017-10-10 22:46:55.86599|2017-10-10 22:46:55.86599
NCT02593994|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-08-31|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|October 31, 2022|Anticipated|2022-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|IRIS-Onyx||IRIS-Onyx Cohort in the IRIS-DES Registry|Evaluation of Effectiveness and Safety of Resolute Onyx™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Recruiting||N/A|4000|Anticipated|Asan Medical Center|||1||f||||t||||||||||2017-10-10 22:46:55.95742|2017-10-10 22:46:55.95742
NCT02593981|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-03-23|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Addressing Sleep Problems in Older Adults|To Sleep, Perchance to Dream: A Randomized, Placebo-Controlled Study to Test a Fruit/Honey-Based Foodstuff for Sleep Problems in Older Adults|Recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:46:58.178596|2017-10-10 22:46:58.178596
NCT02593968|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-10-30|||September 2015||2015-09-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Yallaferon in Chinese Population|a Multi-sites, Randomized, Parallel, Placebo-Controlled Clinical, Pilot Study to Evaluated the Efficacy and Safety of Recombinant Human Interferon Alpha-2b Gel (Yallaferon®) in HPV Infection|Unknown status|Recruiting|Phase 2|100|Anticipated|Lee's Pharmaceutical Limited||2|||f||||f||||||||||2017-10-10 22:46:58.265564|2017-10-10 22:46:58.265564
NCT02593955|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-04-05|||September 2015||2015-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effects of a High Intensity Exercise Training Program in Patients With Parkinson's Disease|The Effects of a High Intensity Exercise Training Program on Sleep and Vigilance in Patients With Parkinson's Disease (The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients)|Recruiting||N/A|75|Anticipated|University of Alabama at Birmingham||3|||f||||t||||||||||2017-10-10 22:46:58.351984|2017-10-10 22:46:58.351984
NCT02593942|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2015-10-29|||January 2015||2015-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy|Effect of Remifentanil Infusion Alone During the Closure Period for Early Emergence and Hemodynamic Stability in Patients Undergoing Supratentorial Craniotomy|Completed||Phase 4|80|Actual|Yeditepe University Hospital||2|||f||||f||||||||||2017-10-10 22:46:58.455956|2017-10-10 22:46:58.455956
NCT02593929|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-06-06|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer|Pharmacodynamic Effects and Predictive Biomarkers of JAK/STAT Inhibition With Ruxolitinib in Operable Head and Neck Cancer: a Window Trial|Withdrawn||Early Phase 1|0|Actual|University of Pittsburgh||1|||f||||||||||||||2017-10-10 22:46:58.562161|2017-10-10 22:46:58.562161
NCT02593916|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-12-09|||March 2007||2007-03-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01|5 Years|Observational [Patient Registry]|||Response to Medication Registry|Response to Medication Registry|Active, not recruiting||N/A|196|Actual|Intermountain Health Care, Inc.|||1||f||||f||||||Samples With DNA|"     -  blood samples        -  buccal samples   "|||2017-10-10 22:46:58.654347|2017-10-10 22:46:58.654347
NCT02593903|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-11-21|||February 2014||2014-02-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Antibiotic Use Following Distal and Mid-shaft Hypospadias Repair|Prophylactic Antibiotics Following Distal/Mid-shaft Hypospadias Repair: Are They Necessary?|Recruiting||N/A|160|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-10 22:46:58.738265|2017-10-10 22:46:58.738265
NCT02593890|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-30|||November 2015||2015-11-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Breast Surgery Recovery: The Clinical and Psychosocial Impact of THEYA Recovery Range|Breast Surgery Recovery: The Clinical and Psychosocial Impact of THEYA Recovery Range|Unknown status|Not yet recruiting|N/A|100|Anticipated|Theya||2|||f||||f||||||||||2017-10-10 22:46:58.863681|2017-10-10 22:46:58.863681
NCT02593877|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-09-18|||June 1, 2016|Actual|2016-06-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|iTACTIC||Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy|A Multi-centre, Prospective, Randomized Controlled Study to Compare Outcomes of Viscoelastic Haemostatic Assay (VHA)-Guided Resuscitation Versus Conventional Resuscitation Support in Haemorrhaging Trauma Patients|Recruiting||Phase 2|392|Anticipated|Queen Mary University of London||2|||f||||t||||||||||2017-10-10 22:46:58.975884|2017-10-10 22:46:58.975884
NCT02593864|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-08-24|||February 2016||2016-02-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Biomarker Stress Test for Detection of Early Osteoarthritis|A Novel Serum Biomarker Stress Test for Detection of Early Osteoarthritis|Recruiting||N/A|50|Anticipated|VA Palo Alto Health Care System||1|||f||||f||||||||||2017-10-10 22:46:59.2689|2017-10-10 22:46:59.2689
NCT02593851|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-04-12|||December 4, 2015|Actual|2015-12-04|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection|A Phase 1b, Randomized, Partially Double-blind, Placebo-controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With RSV Infection|Suspended||Phase 1|96|Anticipated|Janssen Sciences Ireland UC||16||Trial is suspended following HA feedback regarding the drug formulation.|f||||f|t|||||||||2017-10-10 22:46:59.395069|2017-10-10 22:46:59.395069
NCT02593838|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-05-10|||September 2015||2015-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Dynamic CT Myocardial Perfusion Imaging|Diagnostic Value and Practicability of Dynamic CT Stress and Rest Myocardial Perfusion Imaging in Daily Clinical Practice - A Monocentric Prospective Diagnostic Study|Recruiting||N/A|50|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 22:46:59.710119|2017-10-10 22:46:59.710119
NCT02593825|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-08-02|||January 2016||2016-01-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|START-Play||Efficacy of the START-Play Program for Infants With Neuromotor Disorders|Efficacy of the START-Play Program for Infants With Neuromotor Disorders|Recruiting||N/A|140|Anticipated|Duquesne University||2|||f||||f||||||||Undecided||2017-10-10 22:46:59.848569|2017-10-10 22:46:59.848569
NCT02593812|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-19|||July 2016|Actual|2016-07-01|July 2017|2017-07-01|May 11, 2017|Actual|2017-05-11|May 11, 2017|Actual|2017-05-11||Interventional|||The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease|The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease|Terminated||N/A|27|Actual|University of Utah||2||Lack of progress with recruitment and funding period expired|f||||||||||||||2017-10-10 22:47:00.008904|2017-10-10 22:47:00.008904
NCT02593799|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2016-08-08|||December 2015||2015-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study|Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study|Recruiting||N/A|1000|Anticipated|General Hospital of Shenyang Military Region|||2||f||||f||||||||||2017-10-10 22:47:00.151234|2017-10-10 22:47:00.151234
NCT02593786|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-09-26|||December 25, 2015|Actual|2015-12-25|September 2017|2017-09-01|July 30, 2019|Anticipated|2019-07-30|April 7, 2019|Anticipated|2019-04-07||Interventional|CheckMate 077||A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors|A Phase 1/2, Open-Label Study of Nivolumab (BMS-936558) in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors (CheckMate 077: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 077)|Recruiting||Phase 1/Phase 2|56|Anticipated|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:47:00.394893|2017-10-10 22:47:00.394893
NCT02593773|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-04-19|||December 2015||2015-12-01|April 2017|2017-04-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|STEADFAST||Safety, Tolerability and Efficacy of ACTIMMUNE Dose Escalation in Friedreich's Ataxia Study|Multicenter, Safety and Efficacy, Open-Label Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia|Completed||Phase 3|86|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||1|||f||||t||||||||||2017-10-10 22:47:00.504309|2017-10-10 22:47:00.504309
NCT02593760|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-08-21|||January 25, 2016|Actual|2016-01-25|August 2017|2017-08-01|December 13, 2019|Anticipated|2019-12-13|December 13, 2019|Anticipated|2019-12-13||Interventional|||A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)|A Phase IB/III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib Versus Placebo and Ruxolitinib in Patients With Intermediate- or High-Risk Myelofibrosis|Recruiting||Phase 1/Phase 2|104|Anticipated|Hoffmann-La Roche||2|||f||||t|t|f||||||||2017-10-10 22:47:00.635896|2017-10-10 22:47:00.635896
NCT02593747|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2017-02-10|||December 2015||2015-12-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|Bordeaux||To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup|A Single-dose, Single-center, Randomized, Open-label, Two-way Crossover Study in Healthy Adults to Assess the Bioequivalence of Loratadine Oral Solution/Syrup 1mg/mL (GPLA Formula) Versus Claritin Peach Syrup 1mg/mL (ANNA Formula)|Completed||Phase 1|54|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:47:00.79479|2017-10-10 22:47:00.79479
NCT02593734|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-10-30|||July 2013||2013-07-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|JFR||Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana|Joining Forces: Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana|Completed||Phase 4|139|Actual|University of Ghana Medical School||2|||f||||t||||||||||2017-10-10 22:47:00.916219|2017-10-10 22:47:00.916219
NCT02593721|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-01|||July 2015||2015-07-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Hypoalgesic Effect of Neural Mobilization Versus Ibuprofen Pharmacologic Treatment|Hypoalgesic Effect of Median Nerve Neural Mobilization Versus Ibuprofen Pharmacologic Treatment in Patients With Cervicobrachial Pain|Completed||Phase 2/Phase 3|50|Actual|Universidad Europea de Madrid||2|||f||||t||||||||||2017-10-10 22:47:01.054629|2017-10-10 22:47:01.054629
NCT02593708|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-30|2015-10-30|||October 2015||2015-10-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+|Phase I Study to Evaluate the Safety of Neratinib in Combination With Paclitaxel, Trastuzumab and Pertuzumab in Women and Men With Advanced or Metastatic HER2+ Solid Tumors|Unknown status|Recruiting|Phase 1|40|Anticipated|University of California, San Francisco||4|||f||||t||||||||||2017-10-10 22:47:01.389729|2017-10-10 22:47:01.389729
NCT02593695|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-11-09|||October 2015||2015-10-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Deep Brain Stimulation of Nucleus Accumbens to Treat Severe Anorexia Nervosa|Deep Brain Stimulation of Nucleus Accumbens as a New Treatment to Treat Severe Anorexia Nervosa|Active, not recruiting||N/A|10|Anticipated|Tang-Du Hospital||2|||f||||t||||||||||2017-10-10 22:47:01.541002|2017-10-10 22:47:01.541002
NCT02593682|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Role of Orexin in Human Panic Disorder|The Role of Orexin in Human Panic Disorder|Recruiting||Early Phase 1|12|Anticipated|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 22:47:01.656716|2017-10-10 22:47:01.656716
NCT02593669|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-30|||January 2016||2016-01-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Cataract Surgery on Sleep Quality|The Effect of Cataract Surgery for Age-related Cataract Patients on Circadian Rhythm and Sleep Quality|Not yet recruiting||N/A|10000|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:47:01.8372|2017-10-10 22:47:01.8372
NCT02593656|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-29|||January 2015||2015-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Protein Ingestion and Exercise Training on Muscular Performance|Effects of Frequent, High Quality, Multi-Ingredient Protein Meals and Exercise Training on Hormones, Body Composition, Muscular Performance, and Energy Metabolism in Active Healthy Men and Women|Completed||N/A|60|Actual|Skidmore College||2|||f||||f||||||||||2017-10-10 22:47:02.000169|2017-10-10 22:47:02.000169
NCT02593643|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-25|||January 2016||2016-01-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.|A Double-blind Pilot Trial of the Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.|Completed||Early Phase 1|9|Actual|Sunnybrook Health Sciences Centre||4|||f||||t||||||||||2017-10-10 22:47:02.135901|2017-10-10 22:47:02.135901
NCT02593617|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-30|||December 2012||2012-12-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Effect of Energy Drink Consumption on Alcohol-Substance Use and It's Relationship With Impulsivity In University Students|The Effect of Energy Drink Consumption on Alcohol-Substance Use and It's Relationship With Impulsivity In University Students|Completed||N/A|2623|Actual|Mustafakemalpasa State Hospital||6|||f||||t||||||||||2017-10-10 22:47:02.37923|2017-10-10 22:47:02.37923
NCT02593591|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-02-15|||November 6, 2015|Actual|2015-11-06|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.|Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.|Recruiting||N/A|130|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:47:02.661643|2017-10-10 22:47:02.661643
NCT02593578|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-02-15|||October 28, 2015|Actual|2015-10-28|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.|Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.|Recruiting||N/A|87|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 22:47:02.75983|2017-10-10 22:47:02.75983
NCT02593565|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-04-27|||November 2015||2015-11-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|12 Months|Observational [Patient Registry]|V-PREG||Vasculitis Pregnancy Registry|The Vasculitis Pregnancy Registry (V-PREG)|Recruiting||N/A|100|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 22:47:02.874227|2017-10-10 22:47:02.874227
NCT02593539|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-04-27|||July 22, 2016||2016-07-22|April 2017|2017-04-01|December 7, 2018|Anticipated|2018-12-07|September 7, 2018|Anticipated|2018-09-07||Interventional|||Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled GSK2269557 in Patients With APDS/PASLI|An Open-label, Single Arm Study to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Repeat Doses of Inhaled GSK2269557 in Patients With APDS/PASLI|Recruiting||Phase 2|5|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:47:03.092495|2017-10-10 22:47:03.092495
NCT02593526|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-08-21|||August 2016||2016-08-01|August 2016|2016-08-01||||November 2017|Anticipated|2017-11-01||Interventional|DIDIT||Diuretic/Cool Dialysate Trial|Diuretic/Cool Dialysate Trial|Recruiting||N/A|20|Anticipated|University of New Mexico||4|||f||||f||||||||||2017-10-10 22:47:03.228639|2017-10-10 22:47:03.228639
NCT02593513|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-28|||October 26, 2015|Actual|2015-10-26|July 2017|2017-07-01|April 7, 2017|Actual|2017-04-07|February 22, 2017|Actual|2017-02-22||Interventional|DESTINy||Diafert for Embryo Selection and Fertility Improvement (DESTINy)|A Prospective, Single-center, Randomized, Two-arm, Interventional Study to Evaluate the Implantation Rate of Embryos Selected on the Basis of Morphology and Granulocyte-Colony Stimulating Factor (G-CSF) Concentration in the Ovarian Follicular Fluid (FF) - FF G-CSF - Compared to the Implantation Rate of Embryos Selected on the Basis of Morphology Alone When Elective Single Embryo Transfer (SET) of a Fresh Embryo is Performed on Day 2/3 After Oocyte Retrieval|Completed||Phase 3|108|Actual|Forest Laboratories||2|||f||||f|f|f||||||||2017-10-10 22:47:03.372569|2017-10-10 22:47:03.372569
NCT02593500|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-29|||April 2014||2014-04-01|April 2014|2014-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µg|A Single Center, Single Dose, Open-label, Randomized, Two Period Crossover Study to Determine the Bioequivalence of Two Inhalation Formulations Containing Budesonide 200 µg Administered as 3 Puffs (Total Dose of 600 µg) in at Least 52 Healthy Males and Females Under Fasting Conditions|Completed||Phase 1|57|Actual|Reig Jofre Group||2|||f||||f||||||||||2017-10-10 22:47:03.48483|2017-10-10 22:47:03.48483
NCT02593487|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-31|||November 2015||2015-11-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Rosuvastatin Therapy on HDL2 Level|Effect of Rosuvastatin Therapy on HDL2 Level and Antiatherosclerotic Reverse Cholesterol Transport Process in Chinses CAD Patients With Hyperlipidemia|Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-10 22:47:03.59328|2017-10-10 22:47:03.59328
NCT02593474|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-04-13|||September 2015||2015-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Medication-Assisted Treatment for Youth With Substance Use Disorders|Medication-Assisted Treatment for Youth With Substance Use Disorders|Recruiting||Phase 1|50|Anticipated|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-10 22:47:03.723342|2017-10-10 22:47:03.723342
NCT02593461|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-28|||October 22, 2015|Actual|2015-10-22|July 2017|2017-07-01|April 7, 2017|Actual|2017-04-07|December 15, 2016|Actual|2016-12-15||Interventional|DESTINy||Diafert® for Embryo Selection and Fertility Improvement|A Prospective, Single-center, Randomized, Two-arm, Interventional Study to Evaluate the Implantation Rate of Embryos Selected on the Basis of Morphology and Granulocyte-Colony Stimulating Factor (G-CSF) Concentration in the Ovarian Follicular Fluid (FF) - FF G-CSF - Compared to the Implantation Rate of Embryos Selected on the Basis of Morphology Alone When Elective Single Embryo Transfer (SET) of a Fresh Embryo is Performed on Day 2/3 After Oocyte Retrieval|Completed||Phase 3|14|Actual|Forest Laboratories||2|||f||||f|f|f||||||||2017-10-10 22:47:03.84443|2017-10-10 22:47:03.84443
NCT02593448|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-29|||March 2012||2012-03-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|April 2013|Actual|2013-04-01||Interventional|||Influence of Cardiopulmonary Bypass, and Sevoflurane or Propofol Anesthesia, on Tissue Oxygen Saturation.|Influence of Cardiopulmonary Bypass and Sevoflurane or Propofol Anesthesia on Tissue Oxygen Saturation of Thenar Muscle in Adults.|Completed||Phase 4|64|Actual|Medical University of Gdansk||2|||f||||f||||||||||2017-10-10 22:47:03.955486|2017-10-10 22:47:03.955486
NCT02593435|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-03-22|||October 2015||2015-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01|3 Months|Observational [Patient Registry]|RCA||The Registration Program of BRCA1/2 Gene|The Registration Program of BRCA1/2 Gene in Chinese Breast Cancer Group|Recruiting||N/A|8000|Anticipated|Chinese Anti-Cancer Association|||1||f||||f||||||Samples With DNA|"     The samples, both tissue(s) and blood of patients should be provided for NGS test after ICF     being signed   "|Undecided|The data-sharing of the volunteers' genetic information need be discussed more.|2017-10-10 22:47:04.077769|2017-10-10 22:47:04.077769
NCT02593422|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-06-12|||April 2015||2015-04-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Writing About Experiences With Ovarian Cancer|Writing About Experiences With Ovarian Cancer|Completed||N/A|73|Actual|University of Maryland||2|||f||||f||||||||||2017-10-10 22:47:04.17771|2017-10-10 22:47:04.17771
NCT02593409|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-18|||May 25, 2017|Actual|2017-05-25|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|PREPPIE||HIV PrEP Priming of Immune Effectors|HIV Pre-Exposure Prophylaxis Priming of Immune Effectors|Recruiting||Phase 4|220|Anticipated|MRC/UVRI Uganda Research Unit on Aids||1|||f||||t|t|f|||t|||||2017-10-10 22:47:04.262367|2017-10-10 22:47:04.262367
NCT02593396|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-10-25|||August 2015||2015-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial Of Bupropion Hydrochloride Sustained-Release In The Treatment Of Sexual Dysfunction In Men On Methadone Maintenance Therapy|Recruiting||Phase 2|70|Anticipated|University of Malaya||2|||f||||t||||||||||2017-10-10 22:47:04.37052|2017-10-10 22:47:04.37052
NCT02593383|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-10-30|||March 2015||2015-03-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne|A Placebo Control, Multicenter, Randomized, Double Blind, Multi-formula Groups, and Parallel Phase Ⅰb+Ⅱa Study Evaluating the Safety and Efficacy of Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne|Unknown status|Recruiting|Phase 1/Phase 2|240|Anticipated|Lee's Pharmaceutical Limited||5|||f||||t||||||||||2017-10-10 22:47:04.466413|2017-10-10 22:47:04.466413
NCT02593370|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-02-11|||October 2015||2015-10-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Suprasacral Parallel Shift - Ultrasound/MR Image Fusion Guided Lumbosacral Plexus Block||Completed||Phase 1|26|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-10 22:47:04.560019|2017-10-10 22:47:04.560019
NCT02593357|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-09-19|||December 2012||2012-12-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|endothBPCO||Peripheral Endothelial Function in COPD Patients|Assessment of a Peripheral Endothelial Dysfunction in COPD (Chronic Obstructive Pulmonary Disease)|Recruiting||N/A|170|Anticipated|Hopital Foch||1|||f||||f||||||||||2017-10-10 22:47:04.778312|2017-10-10 22:47:04.778312
NCT02593344|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-05-02|||December 2012||2012-12-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Endothasthm||Peripheral Endothelial Function in Asthmatic Patients|Peripheral Endothelial Function in Asthmatic Patients|Completed||N/A|113|Actual|Hopital Foch||1|||f||||f||||||||||2017-10-10 22:47:04.896|2017-10-10 22:47:04.896
NCT02593331|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-05-03|||October 29, 2015|Actual|2015-10-29|May 2017|2017-05-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|||Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance|A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance|Completed||Phase 1|79|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-10 22:47:05.002775|2017-10-10 22:47:05.002775
NCT02593318|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-11-23|||October 2015||2015-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|TOAD||Trial of Oxaloacetate in Alzheimer's Disease (TOAD)|Trial of Oxaloacetate in Alzheimer's Disease (TOAD)|Recruiting||Phase 1|30|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-10 22:47:05.114206|2017-10-10 22:47:05.114206
NCT02593292|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-08-09|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PROSPERO||Program of Research for the Optimization of a Supervised Patient Pathway for Expectant According to Risk in Obstetrics|Program of Research for the Optimization of a Supervised Patient Pathway for Expectant According to Risk in Obstetrics|Recruiting||N/A|1500|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:47:05.315539|2017-10-10 22:47:05.315539
NCT02593279|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-02-17|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|AVAD||AVAD: Asthma With Small Airways Dysfunction|AVAD: Asthma With Small Airways Dysfunction. Clinical, Immunobiological, Tomodensitometric Description, Genetic Signature Compared With Asthmatic Population With Proximal Airways Obstruction|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:47:05.446333|2017-10-10 22:47:05.446333
NCT02593266|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-11-18|||November 2013||2013-11-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|FamilyTalkCL||A Trial of a Preventive Intervention Program for Chilean Families With Depressed Parents|A Pilot Randomized Controlled Trial of a Preventive Intervention Program for Chilean Families With Depressed Parents|Recruiting||N/A|64|Anticipated|University of Chile||2|||f||||f||||||||||2017-10-10 22:47:05.593671|2017-10-10 22:47:05.593671
NCT02593253|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-05-05|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of a Novel Audit and Feedback Bundle on Inpatient Performance|The Effect of a Novel Electronic Physician Audit and Feedback Bundle on Inpatient Performance Metrics|Completed||N/A|200|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:47:05.694215|2017-10-10 22:47:05.694215
NCT02593240|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-04-25|||October 2015||2015-10-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Worksite Wellness Randomized Controlled Trial||Active, not recruiting||N/A|554|Actual|Tufts University||4|||f||||f||||||||||2017-10-10 22:47:05.786658|2017-10-10 22:47:05.786658
NCT02593227|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-09-20|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer|A Randomized Multicenter Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of Vaccination With Folate Receptor Alpha Peptides With GM-CSF in Patients With Triple Negative Breast Cancer Defined as Primary Tumor That is Her2-neu and Low (< 10%) ER/PR Nuclear Staining|Recruiting||Phase 2|80|Anticipated|Tapimmune Inc.||4|||f||||t||||||||||2017-10-10 22:47:05.913076|2017-10-10 22:47:05.913076
NCT02593214|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-03-20|||August 2015||2015-08-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Performance and Safety Trial of an Innovative Female Condom (Wondaleaf®)|A Clinical Trial to Asses the Performance and Safety of an Innovative Female Condom (Wondaleaf®) Among Healthy Married Couples|Completed||N/A|21|Actual|Clinical Research Centre, Malaysia||1|||f||||f||||||||||2017-10-10 22:47:06.093189|2017-10-10 22:47:06.093189
NCT02593201|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-31|||February 26, 2016|Actual|2016-02-26|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels||Recruiting||Phase 4|360|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:47:06.20368|2017-10-10 22:47:06.20368
NCT02593188|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-21|||November 12, 2015|Actual|2015-11-12|July 2017|2017-07-01|June 12, 2021|Anticipated|2021-06-12|June 12, 2021|Anticipated|2021-06-12||Observational|||Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)|Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)|Recruiting||N/A|250|Anticipated|Baxalta US Inc.|||2||f||||f||||||Samples Without DNA|"     Blood samples (plasma) for antibodies against recombinant human hyaluronidase (rHuPH20) that     remain after study testing will be stored at the Central Laboratory to confirm implausible or     critical test results, if required. Samples will be stored in a coded form and according to     local requirements for a maximum of 2 years after the final study report has been completed     and subsequently will be destroyed.   "|||2017-10-10 22:47:06.320519|2017-10-10 22:47:06.320519
NCT02593175|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-10-02|||August 2016|Actual|2016-08-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Women's Triple-Negative First-Line Study: A Phase II Trial of Panitumumab, Carboplatin and Paclitaxel (PaCT) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy|Women's Triple-Negative First-Line Study: A Phase II Trial of Panitumumab, Carboplatin and Paclitaxel (PaCT) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy|Recruiting||Phase 2|37|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:47:06.49965|2017-10-10 22:47:06.49965
NCT02593162|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-01-27|||October 2015|Actual|2015-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection|Phase 2a, Randomized, Double-Blind Study to Investigate the Safety and Efficacy of Faldaprevir in Combination With Ribavirin and TD-6450 for 12 Weeks in Treatment-Naive Patients Chronically Infected With Genotype 4 Hepatitis C Virus|Completed||Phase 2|16|Actual|Trek Therapeutics, PBC||2|||f||||f||||||||No||2017-10-10 22:47:06.598607|2017-10-10 22:47:06.598607
NCT02593149|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-02-15|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap|Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap|Completed||Phase 4|1671|Actual|Pursuit Vascular, Inc.||2|||f||||f|f|t|f|f|f|||No||2017-10-10 22:47:06.699211|2017-10-10 22:47:06.699211
NCT02593136|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-03-10|||June 2014||2014-06-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Home Fortification of Complementary Foods in Bihar India|Assessing Feasibility and Program Effectiveness of Home Fortification of Complementary Foods in Bihar: A Cluster Randomized Community Pilot|Completed||N/A|11861|Actual|Emory University||2|||f||||t|f|f||||||No||2017-10-10 22:47:06.775495|2017-10-10 22:47:06.775495
NCT02593123|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-09-14|||November 4, 2015||2015-11-04|September 2017|2017-09-01|December 31, 2025|Anticipated|2025-12-31|December 31, 2025|Anticipated|2025-12-31||Interventional|||Allogeneic Stem Cell Transplantationin Relapsed Hematological Malignancy: Early GVHD Prophylaxis|Adoptive Immunotherapy in Patients With Relapsed Hematological Malignancy: Effect of Duration and Intensity of Early GVHD Prophylaxis on Long-Term Clinical Outcomes|Recruiting||Phase 2|60|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f|||t|||||2017-10-10 22:47:06.87678|2017-10-10 22:47:06.87678
NCT02593110|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-09-12|||October 2015||2015-10-01|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|September 2020|Anticipated|2020-09-01||Interventional|TELEX||Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease|Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease|Recruiting||N/A|240|Anticipated|Northwestern University||4|||f||||t||||||||||2017-10-10 22:47:07.007868|2017-10-10 22:47:07.007868
NCT02593097|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-09-14|||February 2016||2016-02-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|MPEM||Metformin for the Prevention of Episodic Migraine (MPEM)|Metformin for the Prevention of Episodic Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Study|Recruiting||Phase 3|40|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:47:07.131702|2017-10-10 22:47:07.131702
NCT02593084|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-02-21|||January 2016||2016-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|||Resistance Training to Optimize Health in Pre-frail Older Adults|Resistance Training to Optimize Health in Pre-frail Older Adults|Recruiting||N/A|60|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 22:47:07.220932|2017-10-10 22:47:07.220932
NCT02593071|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-05-30||2017-05-30|October 2015||2015-10-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.|A Phase II Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) Recombinant F Nanoparticle Vaccine in Healthy Older Adult Subjects Previously Treated With the Same Vaccine, or Placebo, in the Prior Year; and to Estimate the Incidence Rate of RSV Disease and Vaccine Efficacy in Subjects Based on Their RSV F Vaccine Experience Over Two Consecutive Years.|Completed||Phase 2|1330|Actual|Novavax||2|||f||||f||||||||||2017-10-10 22:47:07.356207|2017-10-10 22:47:07.356207
NCT02593058|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-08-18|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|November 30, 2018|Anticipated|2018-11-30|December 15, 2017|Anticipated|2017-12-15||Interventional|PEPS-RCT||Positive Emotions Program for Schizophrenia (PEPS)|Positive Emotions Program for Schizophrenia (PEPS): A Randomized Controlled Study on Improving Pleasure and Motivation in Schizophrenia|Recruiting||N/A|60|Anticipated|Institut et Haute Ecole de la Santé la Source||2|||f||||t||||||||||2017-10-10 22:47:07.469054|2017-10-10 22:47:07.469054
NCT02593045|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-03-02|||October 2015||2015-10-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)|Open Label, Multicenter Phase I Study of IPH4102, a Humanized Anti-KIR3DL2 Monoclonal Antibody, in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)|Recruiting||Phase 1|60|Anticipated|Innate Pharma||1|||f||||f||||||||||2017-10-10 22:47:07.574493|2017-10-10 22:47:07.574493
NCT02593019|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-02-16|||December 2015||2015-12-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients|Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients|Recruiting||Phase 2|45|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:47:07.754278|2017-10-10 22:47:07.754278
NCT02593006|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-05-12|||November 2015||2015-11-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|STOP-JIA||Start Time Optimization of Biologics in Polyarticular JIA|Start Time Optimization of Biologics in Polyarticular JIA|Recruiting||N/A|400|Anticipated|Hackensack University Medical Center|||1||f||||f||||||||||2017-10-10 22:47:07.871258|2017-10-10 22:47:07.871258
NCT02592993|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-02-22|||May 23, 2015|Actual|2015-05-23|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Performance of PicoWayTM Picosecond Fractional Laser for Acne Scars|Clinical Study to Evaluate the Performance of the PicoWayTM Picosecond Fractional Laser for Treatment of Acne Scars|Active, not recruiting||N/A|53|Actual|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 22:47:08.285829|2017-10-10 22:47:08.285829
NCT02592980|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-09-05|||January 2016||2016-01-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients|Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients With Low Time in Therapeutic Range - Study Design|Recruiting||Phase 4|300|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:47:08.371593|2017-10-10 22:47:08.371593
NCT02592954|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-29|||September 2015||2015-09-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin|Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin|Unknown status|Recruiting|Phase 1|10|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 22:47:08.609475|2017-10-10 22:47:08.609475
NCT02592941|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-08-15||||||August 2017|2017-08-01||||||||Expanded Access|||Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy|An Open Label, Expanded Access Protocol Intended to Provide Treatment With MP-104 (Deflazacort) to U.S. Children, Adolescents, and/or Adults With Duchenne Muscular Dystrophy|Available||N/A|||PTC Therapeutics|||||||||||||||||||2017-10-10 22:47:08.714339|2017-10-10 22:47:08.714339
NCT02592928|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-08-08|||July 6, 2017|Actual|2017-07-06|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|e-Spiro-HC3||Regional Implementation of Collaborative Lung Function Testing|Regional Implementation of Collaborative Lung Function Testing|Recruiting||N/A|300|Anticipated|Hospital Clinic of Barcelona|||3||f||||f||||||||||2017-10-10 22:47:08.913542|2017-10-10 22:47:08.913542
NCT02592915|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-02-21|||October 2015||2015-10-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|EXCICLON||Effect of a Bolus of Clonidine Systemically Administered on the Excitability of the Spinal Motoneurons of the Lower Extremity|Monocentric, Prospective Randomized Controlled Clinical Trial Assessing the Effect on the Lower Limb Spinal Motoneuron Excitability, the Efficacy in Term of Morphinic Sparing and Safety of of Early Clonidine Bolus Intravenous Administration During General Anesthesia in Children and Adolescent 6-18 Years Old Requesting Reconstructive Tympanic Surgery|Recruiting||Phase 3|40|Anticipated|Queen Fabiola Children's University Hospital||2|||f||||f||||||||||2017-10-10 22:47:09.028278|2017-10-10 22:47:09.028278
NCT02592902|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-05-02|||April 2014||2014-04-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Recurrent Respiratory Papillomatosis and Extraesophageal Reflux|Recurrent Respiratory Papillomatosis and Extraesophageal Reflux|Recruiting||N/A|60|Anticipated|University Hospital Ostrava||2|||f||||f||||||||||2017-10-10 22:47:09.126558|2017-10-10 22:47:09.126558
NCT02592889|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-02-22|||September 2015||2015-09-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|MITRA-CRT||(MitraClip in Non-Responders to Cardiac Resynchronization Therapy)|(MitraClip in Non-Responders to Cardiac Resynchronization Therapy)|Recruiting||Phase 4|30|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-10 22:47:09.233849|2017-10-10 22:47:09.233849
NCT02592876|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-09-28|||October 2015||2015-10-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma|A Randomized, Open-Label Phase 2 Study of Denintuzumab Mafodotin (SGN-CD19A) Plus Rituximab, Ifosfamide, Carboplatin, and Etoposide (19A+RICE) Chemotherapy vs. RICE in the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Who Are Candidates for Autologous Stem Cell Transplant|Recruiting||Phase 2|150|Anticipated|Seattle Genetics, Inc.||2|||f||||f||||||||||2017-10-10 22:47:09.334861|2017-10-10 22:47:09.334861
NCT02592863|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-01-18|||January 2015||2015-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Trental for the Treatment of Vertigo/Dizziness/Imbalance|A Double-Blind, Placebo-Controlled, Randomized Trial of Pentoxifylline for Imbalance Secondary to Insufficient Microvascular Perfusion|Enrolling by invitation||N/A|30|Anticipated|University of Missouri-Columbia||2|||f||||||||||||||2017-10-10 22:47:09.607151|2017-10-10 22:47:09.607151
NCT02592850|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-29|||January 2016||2016-01-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|EBOTTH||Evidence-Based Osteopathy for Tension-Type Headache (EBOTTH)|Osteopathic Manipulative Treatment in Frequent Episodic Tension-type Headache: the EBOTTH Multicentric Study|Unknown status|Not yet recruiting|N/A|264|Anticipated|University of Milano Bicocca||2|||f||||f||||||||||2017-10-10 22:47:09.68842|2017-10-10 22:47:09.68842
NCT02592837|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-11-24|||May 2016||2016-05-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||EBUS-TBNA vs Flex 19G EBUS-TBNA|Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) Versus Flexible 19G Endobronchial Ultrasound Transbronchial Needle (Flex 19G EBUS-TBNA) in the Assessment of Mediastinal and Hilar Lymphadenopathy: a Randomised Trial|Recruiting||N/A|250|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||Undecided||2017-10-10 22:47:09.815026|2017-10-10 22:47:09.815026
NCT02592824|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-09-13|||November 2015||2015-11-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|GLUTAMICSII||Glutamate for Metabolic Intervention in Coronary Surgery II|Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II|Recruiting||Phase 3|310|Anticipated|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-10 22:47:09.921387|2017-10-10 22:47:09.921387
NCT02592811|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-28|||July 2010||2010-07-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones|Endoscopic Sphincterotomy Plus Large-Balloon Dilatation (ESLBD) Versus Conventional Endoscopic Treatment for Removal of Large Common Bile Duct Stones : A Prospective Comparative Multi Center Randomized Study|Completed||Phase 3|150|Actual|Société Française d'Endoscopie Digestive||2|||f||||t||||||||||2017-10-10 22:47:10.096973|2017-10-10 22:47:10.096973
NCT02592798|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-09-13|||March 1, 2016|Actual|2016-03-01|September 2017|2017-09-01|June 12, 2020|Anticipated|2020-06-12|July 11, 2019|Anticipated|2019-07-11||Interventional|||Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)|A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms With Switchover, Pilot Study to Evaluate the Efficacy and Safety of Intravenous Abatacept in Treatment Resistant Nephrotic Syndrome (Focal Segmental Glomerulosclerosis/ Minimal Change Disease)|Recruiting||Phase 2|90|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-10 22:47:10.197128|2017-10-10 22:47:10.197128
NCT02592785|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-09-19|||December 15, 2015|Actual|2015-12-15|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|February 5, 2017|Actual|2017-02-05||Interventional|||Phase I Dose Escalation Study of BAY 1163877 in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors|An Open Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BAY 1163877 in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors|Active, not recruiting||Phase 1|9|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:47:10.379869|2017-10-10 22:47:10.379869
NCT02592772|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-10|||December 2015||2015-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Manipulating Tobacco Constituents in Male Menthol Smokers|Manipulating Tobacco Constituents in Male Menthol Smokers|Recruiting||N/A|57|Anticipated|UConn Health||3|||f||||t||||||||||2017-10-10 22:47:10.487747|2017-10-10 22:47:10.487747
NCT02592759|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-06-15|||October 2015||2015-10-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke Patients|Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke|Recruiting||Phase 2|48|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:47:10.612687|2017-10-10 22:47:10.612687
NCT02592746|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-01-01|||June 2016||2016-06-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC|A Phase II Randomized Study of Palbociclib in Combination With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer|Recruiting||Phase 2|122|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-10 22:47:10.734791|2017-10-10 22:47:10.734791
NCT02592733|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-29|||November 2015||2015-11-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|CYDAR-IRAAA||A Case Control Observational Study to Assess CYDAR Automated Overlay Guidance During EVAR|A Case Control Observational Study to Assess CYDAR Automated Overlay Guidance During EVAR|Unknown status|Not yet recruiting|N/A|300|Anticipated|Royal Free Hospital NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 22:47:10.835962|2017-10-10 22:47:10.835962
NCT02592720|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-29|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CocktailII||Cocktail Injection Improves Outcomes of FFR Guided PCI|Intracoronary Cocktail Injection Improves Outcomes of Fractional Flow Reserve Guided Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrom (ACS)|Unknown status|Recruiting|Phase 4|500|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-10 22:47:10.906644|2017-10-10 22:47:10.906644
NCT02592707|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-09-29|||March 6, 2017|Actual|2017-03-06|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPSC001 in NETs|An International, Multicenter, Open-label Study to Evaluate Safety, Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)|Recruiting||Phase 1/Phase 2|45|Anticipated|Ipsen||1|||f||||f|f|f||||||||2017-10-10 22:47:11.011443|2017-10-10 22:47:11.011443
NCT02592694|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-28|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty|Intracoronary Cocktail Injection Combined With Thrombus Aspiration in ST-elevation Myocardial Infarction Patients Treated With Primary Angioplasty|Unknown status|Recruiting|Phase 4|1000|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-10 22:47:11.11525|2017-10-10 22:47:11.11525
NCT02592681|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-28|||November 2015||2015-11-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine|Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine|Unknown status|Not yet recruiting|N/A|120|Anticipated|Western University, Canada||3|||f||||f||||||||||2017-10-10 22:47:11.195188|2017-10-10 22:47:11.195188
NCT02592668|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-09-05|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Spinal Cord Injury Epidural Stimulation|A Feasibility Study: Epidural Stimulation to Enable Volitional Movement After Chronic Complete Paralysis in Humans.|Active, not recruiting||N/A|2|Actual|Mayo Clinic||1|||f||||f|f|t|f|f||||||2017-10-10 22:47:11.281389|2017-10-10 22:47:11.281389
NCT02592655|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-08-22|2017-01-10||December 2015||2015-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||"One Windlass indicates the participants received only one windlass tourniquet because it appeared to be effective. Two Windlass describes the participants that received two windlass tourniquets because one did not appear to be effective. The total describes all participants. All participants received both the pneumatic and tape tourniquet."|A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet|Randomized Sequence, Assessor-Blind, Cross-Over Study of a Windlass Tourniquet, a Pneumatic Tourniquet and an Elastic Adhesive Bandage for Use as a Tourniquet|Completed||N/A|19|Actual|Migura, Marcus|"Tourniquet tape 5 cm ended early due to excessive narrowing, resulting in data loss.
The pressure mapping system proved subjective in use and software bugs resulted corrupt data files.
Small sample size, therefore only large individuals enrolled."|4|||f||||f||||||||||2017-10-10 22:47:11.380564|2017-10-10 22:47:11.380564
NCT02592642|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-08-29|||September 2014||2014-09-01|August 2017|2017-08-01|March 1, 2017|Actual|2017-03-01|February 15, 2017|Actual|2017-02-15||Interventional|||the Evaluation of Four Non-operative Treatments for Degenerative Lumbar Spinal Stenosis|Self-Management to Improve Walking Ability in Degenerative Lumbar Spinal Stenosis: the Evaluation of Four Novel Strategies.|Completed||N/A|104|Actual|Mount Sinai Hospital, Canada||6|||f||||f||||||||||2017-10-10 22:47:11.896769|2017-10-10 22:47:11.896769
NCT02592629|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-11-03|||February 2016||2016-02-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Efficacy of Local Anesthetics to Reduce Shoulder Pain Post-Steroid Injections|The Efficacy of Local Anesthetics to Reduce Shoulder Pain Post-Steroid Injections|Recruiting||Phase 4|150|Anticipated|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-10-10 22:47:12.195677|2017-10-10 22:47:12.195677
NCT02592616|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-06-21|||October 2015||2015-10-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Interval-training and Appetite Regulation in Patients With Type 2 Diabetes|Interval-training and Appetite Regulation in Patients With Type 2 Diabetes|Active, not recruiting||N/A|14|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-10 22:47:12.333672|2017-10-10 22:47:12.333672
NCT02592603|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-08-03|||October 2015||2015-10-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Endocuff for Surveillance of Serrated Polyposis Syndrome|Endocuff-assisted vs. Standard Colonoscopy for Surveillance of Serrated Polyposis Syndrome: A Randomized Controlled Trial|Completed||N/A|125|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-10 22:47:12.466556|2017-10-10 22:47:12.466556
NCT02592590|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-28|||November 2015||2015-11-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|MAPS||Multiphase Activity Promotion Study|A Social-Cognitive Smartphone Application for Improving Physical Activity in Adults|Completed||N/A|118|Actual|University of Illinois at Urbana-Champaign||4|||f||||f||||||||No||2017-10-10 22:47:13.093855|2017-10-10 22:47:13.093855
NCT02592577|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-06-26|||November 2015||2015-11-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC|A Phase I/ II Dose Escalation Open Label Clinical Trial Evaluating the Safety and Efficacy of MAGE A10ᶜ⁷⁹⁶T in Subjects With Stage IIIb or Stage IV Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|28|Anticipated|Adaptimmune||1|||f||||f||||||||||2017-10-10 22:47:13.236954|2017-10-10 22:47:13.236954
NCT02592564|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-08-31|||October 2015||2015-10-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|April 2017|Actual|2017-04-01||Interventional|UMEII||Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder|The Brain´s Plasticity and Change in Cellular Aging After Internet-delivered Cognitive Behavior Therapy for Social Anxiety Disorder|Active, not recruiting||N/A|50|Actual|Linkoeping University||1|||f||||f||||||||||2017-10-10 22:47:13.434682|2017-10-10 22:47:13.434682
NCT02592551|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-12-06|||May 2016||2016-05-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma|Window Of Opportunity Phase II Study Of MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma|Recruiting||Phase 2|20|Anticipated|Baylor College of Medicine||3|||f||||||||||||||2017-10-10 22:47:13.594305|2017-10-10 22:47:13.594305
NCT02592538|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-05-21|||February 2013||2013-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma|Endobiliary Radiofrequency Ablation With S-1 in Patients With Unresectable Cholangiocarcinoma: A Prospective Randomized Trial With Open Label Control|Active, not recruiting||N/A|66|Actual|First People's Hospital of Hangzhou||2|||f||||t||||||||Undecided||2017-10-10 22:47:13.709095|2017-10-10 22:47:13.709095
NCT02592525|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-08-24|||November 2015||2015-11-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|IPSDM-SW||Implementing Shared Decision Making in Interprofessional Home Care Teams|Implementing Shared Decision Making in Interprofessional Home Care Teams : a Stepped Wedge Cluster Randomized Trial|Recruiting||N/A|640|Anticipated|CHU de Quebec-Universite Laval||4|||f||||t||||||||||2017-10-10 22:47:13.813491|2017-10-10 22:47:13.813491
NCT02592512|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-07-11|||October 2015||2015-10-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||NIV-NAVA vs NIV-PS/PC in Respiratory Insufficiency|Non-Invasive Ventilation With Neurally Adjusted Ventilatory Assist vs NIV Pressure Support or Pressure Control in Treatment of Patients With Acute Respiratory Insufficiency. A Prospective, Randomised, Single Blinded, Crossover Pilot Study|Completed||N/A|30|Actual|Vejle Hospital|||2||f||||t||||||||||2017-10-10 22:47:13.926496|2017-10-10 22:47:13.926496
NCT02592499|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-07-06|||June 2016||2016-06-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|SweVAD||Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure|Swedish Evaluation of Left Ventricular Assist Device|Recruiting||N/A|140|Anticipated|Vastra Gotaland Region||2|||f||||t||||||||||2017-10-10 22:47:14.023389|2017-10-10 22:47:14.023389
NCT02592473|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia|Prostate Artery Embolization Safety and Efficacy: A Pilot Study|Recruiting||Phase 1|50|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-10 22:47:14.273348|2017-10-10 22:47:14.273348
NCT02592447|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-09-28|||September 29, 2015|Actual|2015-09-29|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention|Preliminary Evaluation of an Internet-Assisted Cognitive Behavioral Intervention for Targeted Therapy Fatigue|Active, not recruiting||N/A|48|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-10 22:47:14.480466|2017-10-10 22:47:14.480466
NCT02592434|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-09-25|||June 10, 2016|Actual|2016-06-10|September 2017|2017-09-01|April 29, 2019|Anticipated|2019-04-29|April 29, 2019|Anticipated|2019-04-29||Interventional|||Efficacy Study Of Tofacitinib In Pediatric JIA Population|Efficacy, Safety And Tolerability Of Tofacitinib For Treatment Of Polyarticular Course Juvenile Idiopathic Arthritis (Jia) In Children And Adolescent Subjects|Recruiting||Phase 3|265|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 22:47:14.590504|2017-10-10 22:47:14.590504
NCT02592421|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-07-14|||October 2015||2015-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2|Protocol 2: Elucidation of Mechanisms Responsible for the Increase in EGP Following SGLT2 Inhibition: Decrease in Plasma Glucose Conc or Change in Islet Hormone (Glucagon/Insulin) Secretion|Recruiting||Phase 3|45|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 22:47:14.921813|2017-10-10 22:47:14.921813
NCT02592408|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-31|||November 2015||2015-11-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|MalTreSu||A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan|A Study to Assess Current Standard Malaria Treatment Guidelines and Evaluate Recently Developed G6PD Diagnostic Tools in the Republic of the Sudan|Completed||Phase 4|320|Actual|Menzies School of Health Research||4|||f||||f||||||||||2017-10-10 22:47:15.022241|2017-10-10 22:47:15.022241
NCT02592395|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-28|||October 2015||2015-10-01|October 2015|2015-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma|Phase I Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma|Unknown status|Recruiting|Phase 1|24|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||||||||||||2017-10-10 22:47:15.123151|2017-10-10 22:47:15.123151
NCT02592382|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-11-19|||January 2016||2016-01-01|November 2015|2015-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Nasal Xylitol in the Prevention of Otitis Media|Nasal Xylitol for Recurrent Otitis Media|Not yet recruiting||N/A|50|Anticipated|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-10 22:47:15.231786|2017-10-10 22:47:15.231786
NCT02592369|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-04-17|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|February 2017|Actual|2017-02-01||Observational|FORWARD||CoreValve™ Evolut R™ FORWARD Study|The Medtronic CoreValve™ Evolut R™ FORWARD Study|Active, not recruiting||N/A|1061|Actual|Medtronic Cardiovascular|||1||f||||f||||||||Undecided||2017-10-10 22:47:15.315041|2017-10-10 22:47:15.315041
NCT02592356|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-02-24|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Tyrosine Kinase Inhibitors (TKI) and Body Composition|Effects of Tyrosine Kinase Inhibitors on Body Composition in Endocrine Tumors -- A Pilot Study|Recruiting||N/A|25|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:47:15.52723|2017-10-10 22:47:15.52723
NCT02592343|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-09-08|||January 2016||2016-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||A Prospective Trial of Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection|Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. Difficile Infection|Recruiting||Phase 2|100|Anticipated|McMaster University||1|||f||||t||||||||||2017-10-10 22:47:15.624474|2017-10-10 22:47:15.624474
NCT02592330|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-08-18|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|CALEC||Safety and Feasibility of CALEC for LSCD|Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell Transplantation in the Treatment of Limbal Stem Cell Deficiency|Recruiting||Phase 1|24|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||||2017-10-10 22:47:15.72679|2017-10-10 22:47:15.72679
NCT02592317|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-07-20|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|November 2016|Actual|2016-11-01||Interventional|||A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer|Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Subjects With Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1|25|Actual|Aragon Pharmaceuticals, Inc.||1|||f||||f|t|||||||||2017-10-10 22:47:15.831434|2017-10-10 22:47:15.831434
NCT02592304|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-29|||September 2014||2014-09-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Preoperative Assessment of Mesorectal Lymph Nodes by Dual Energy CT. PUMK-DECT|Preoperative Assessment of Mesorectal Lymph Nodes by Dual Energy CT. PUMK-DECT|Unknown status|Recruiting|N/A|70|Anticipated|Odense University Hospital||1|||f||||t||||||||||2017-10-10 22:47:15.940235|2017-10-10 22:47:15.940235
NCT02592291|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-05-01|||October 2015||2015-10-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions|Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions (Component 3)|Recruiting||N/A|160|Anticipated|University of Pittsburgh||2|||f||||f||||||||Undecided||2017-10-10 22:47:16.012223|2017-10-10 22:47:16.012223
NCT02592278|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-11-02|||March 2015||2015-03-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Prevention of Dental Caries Lesions With Fluoride Varnish in Erupting First Permanent Molars|Prevention of Dental Caries Lesions With Fluoride Varnish in Erupting First Permanent Molars|Completed||Phase 4|180|Actual|Universidad Iberoamericana||3|||f||||f||||||||||2017-10-10 22:47:16.113001|2017-10-10 22:47:16.113001
NCT02592265|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2016-09-19|||October 2012||2012-10-01|October 2015|2015-10-01|June 2016|Actual|2016-06-01|August 2015|Actual|2015-08-01||Observational|ECOPASEP||Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden|Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden and Social Participation.|Completed||N/A|233|Actual|Lille Catholic University|||1||f||||f||||||||||2017-10-10 22:47:17.860163|2017-10-10 22:47:17.860163
NCT02592252|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-09-14|||September 2014||2014-09-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|January 2017|Anticipated|2017-01-01||Interventional|MAISHA||Impact of Microfinance and Participatory Gender Training for Women in Reducing Intimate Partner Violence|Cluster Randomised Controlled Trial to Assess the Impact of Combined Microfinance and Gender Training for Women and Gender Training for Women and Their Male Partners in Reducing Intimate Partner Violence|Recruiting||N/A|2640|Anticipated|London School of Hygiene and Tropical Medicine||4|||f||||f||||||||||2017-10-10 22:47:17.946047|2017-10-10 22:47:17.946047
NCT02592239|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-07-26|||November 2014||2014-11-01|September 2016|2016-09-01|June 30, 2017|Actual|2017-06-30|June 2017|Actual|2017-06-01||Interventional|||Hedonic Perception and Brain Activity Response to Meal|Hedonic Perception and Brain Activity Response to Meal in Health and Functional Dyspepsia|Completed||N/A|80|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-10 22:47:18.035672|2017-10-10 22:47:18.035672
NCT02592226|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-04-18|||November 2015||2015-11-01|October 2015|2015-10-01||||December 2016|Actual|2016-12-01||Interventional|||Clinical Significance of Alveolar Recruitment Maneuver During Bariatric Surgery||Completed||N/A|230|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 22:47:18.120791|2017-10-10 22:47:18.120791
NCT02592213|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-09-26|||October 2015||2015-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Breast Cancer Related Lymphedema With Cell-assisted Lipotransfer|Treatment of Breast Cancer Related Lymphedema With Cell-assisted Lipotransfer|Active, not recruiting||Phase 2|10|Anticipated|Odense University Hospital||1|||f||||t||||||||||2017-10-10 22:47:18.197774|2017-10-10 22:47:18.197774
NCT02592200|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-09-12|||October 2015||2015-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women|A Double Blind Placebo-Controlled Study on the Effect of the Probiotic Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women - Proof of Concept|Completed||N/A|40|Actual|BioGaia AB||2|||f||||f||||||||||2017-10-10 22:47:18.280006|2017-10-10 22:47:18.280006
NCT02592187|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-07-08|||October 2015||2015-10-01|July 2016|2016-07-01||||September 2018|Anticipated|2018-09-01||Interventional|ReMemory-MCI||A Cognitive Training Tool Based on Life-logging in Mild Cognitive Impairment (ReMemory-MCI)|A Cognitive Training Tool Based on Life-logging in Mild Cognitive Impairment (ReMemory-MCI)|Not yet recruiting||N/A|30|Anticipated|Consorci Sanitari de Terrassa||2|||f||||||||||||||2017-10-10 22:47:18.363343|2017-10-10 22:47:18.363343
NCT02592174|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-10-27|||January 2016||2016-01-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|HAND55-70||Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study|Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study|Recruiting||N/A|210|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-10 22:47:18.467791|2017-10-10 22:47:18.467791
NCT02592161|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2015-10-29|||April 2012||2012-04-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis|A Randomized, Single Center, Double Blind, Parallel, Placebo-controlled Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis|Completed||Phase 2|166|Actual|Korea Health Industry Development Institute||2|||f||||f||||||||||2017-10-10 22:47:18.609992|2017-10-10 22:47:18.609992
NCT02592148|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-02-29|||November 2015||2015-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|SaliVit||Occurrence of Selected Vitamins in Saliva and Blood|Collection of Saliva and Blood Samples From Voluntary Donors to Establish the Occurrence of Selected Vitamins in Saliva and to Investigate Their Concentration Relative to Blood Levels|Completed||N/A|50|Actual|DSM Nutritional Products, Inc.|||1||f||||f||||||||||2017-10-10 22:47:18.678084|2017-10-10 22:47:18.678084
NCT02592135|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-23|||December 2015||2015-12-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|TACIT||High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)|High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)|Recruiting||N/A|500|Anticipated|Indiana University|||1||f||||f||||||Samples Without DNA|"     Plasma and serum specimens for bio marker analysis   "|Undecided||2017-10-10 22:47:18.861608|2017-10-10 22:47:18.861608
NCT02592122|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2015-10-29|||October 2013||2013-10-01|October 2015|2015-10-01||||October 2016|Anticipated|2016-10-01||Interventional|||Airway Responsiveness in Patients With AECOPD Mechanical Ventilation by Inspiratory and Bronchial Dilation Testchronic Obstructive Pulmonary Disease||Unknown status|Recruiting|N/A|120|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-10 22:47:18.966198|2017-10-10 22:47:18.966198
NCT02592109|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2016-06-21|||November 2015||2015-11-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Enhanced Counseling Using Complementary Feeding Recommendation Based on Linear Programming on Nutritional Status,Omega-3 Fatty Acids, Malondialdehyde, and Alpha-Tocopherol in Overweight Children in East Jakarta|Effect of Enhanced Counseling Using Complementary Feeding Recommendation Based on Linear Programming on Nutritional Status, Omega-3 Fatty Acid, Malondialdehyde, and Alpha-Tocopherol in Children With Risk of Overweight in East Jakarta|Completed||Phase 2|38|Actual|Indonesia University||2|||f||||f||||||||||2017-10-10 22:47:19.112098|2017-10-10 22:47:19.112098
NCT02592096|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-10-28|||July 2015||2015-07-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol|A Single Dose Phase I Clinical Study of Pazufloxacin Mesilate Ear Drops for the Patients With Otitis Media|Unknown status|Recruiting|Phase 1|32|Anticipated|Lee's Pharmaceutical Limited||4|||f||||f||||||||||2017-10-10 22:47:19.222475|2017-10-10 22:47:19.222475
NCT02592083|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-09-07|||October 2015||2015-10-01|September 2016|2016-09-01|December 2024|Anticipated|2024-12-01|December 2018|Anticipated|2018-12-01||Interventional|PREDIX LumA||Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors|PREDIX Luminal A - Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors. Part of a Platform of Translational Phase II Trials Based on Molecular Subtypes|Recruiting||Phase 2|200|Anticipated|Karolinska University Hospital||3|||f||||f||||||||||2017-10-10 22:47:19.328717|2017-10-10 22:47:19.328717
NCT02592070|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-02-22|||July 2015||2015-07-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ACT||Activity & Cognition After Treatment for Breast Cancer|Activity & Cognition After Treatment (ACT) for Breast Cancer|Completed||N/A|31|Actual|University of Illinois at Urbana-Champaign||1|||f||||f|f|f||||||No||2017-10-10 22:47:19.453416|2017-10-10 22:47:19.453416
NCT02592057|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-29|2017-08-25|||November 30, 2015|Actual|2015-11-30|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India|A Multicenter, Prospective, Observational, Post Marketing Surveillance Study to Evaluate the Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Patients With Chronic Hepatitis C Virus Infection in India|Active, not recruiting||N/A|532|Actual|Gilead Sciences|||1||f||||f||||||||||2017-10-10 22:47:19.558925|2017-10-10 22:47:19.558925
NCT02592044|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-03-18|||November 2015||2015-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Aromatherapy on Venopuncture Pain and Anxiety|Evaluation of the Effect of Aromatherapy With Lavender Essential Oil on Pain and Anxiety During Peripheral Venous Cannulation|Completed||Phase 4|106|Actual|Tokat Gaziosmanpasa University||2|||f||||t||||||||||2017-10-10 22:47:19.700444|2017-10-10 22:47:19.700444
NCT02592031|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-29|||February 2009||2009-02-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women|An Open, Randomized, Two-way Cross-over Phase I Study to Compare the Bioavailability, Safety and Tolerability of Single s.c. Doses of 300 IU XM17 With 300 IU Gonal-f® in 36 Healthy, Down-regulated Young Women|Completed||Phase 1|49|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-10-10 22:47:19.789367|2017-10-10 22:47:19.789367
NCT02592018|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-05-02|||October 2016|Actual|2016-10-01|May 2017|2017-05-01||||October 2018|Anticipated|2018-10-01||Interventional|||Immunologic Response to Secukinumab in Plaque Psoriasis|Characterization of the Response to Secukinumab in Plaque Psoriasis Using Novel Immunologic and Genetic Profiling|Recruiting||Phase 4|15|Anticipated|University of California, San Francisco||1|||f||||f||||||||No||2017-10-10 22:47:19.87946|2017-10-10 22:47:19.87946
NCT02591823|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-01-13|||October 2015||2015-10-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||Hair Fall in Patients on Low Dose Methotrexate|Observational Study of Hair Fall in Rheumatoid Arthritis Patients Treated With Low Dose Methotrexate|Recruiting||N/A|80|Anticipated|Columbia Asia|||2||f||||t||||||||||2017-10-10 22:47:21.451606|2017-10-10 22:47:21.451606
NCT02592005|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-11-30|||May 2015||2015-05-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|IPANEMA||Impact of Particulate Matter on Mothers and Babies in Antwerp (IPANEMA)|Impact of Particulate Matter on Mothers and Babies in Antwerp (IPANEMA), a Prospective Cohort Study on the Impact of Pollutants and Particulate Matter in Pregnancy: Methodology and Design|Recruiting||N/A|200|Anticipated|Universiteit Antwerpen|||1||f||||f||||||Samples With DNA|"     maternal blood maternal hair maternal urine umbilical cord blood   "|||2017-10-10 22:47:19.974607|2017-10-10 22:47:19.974607
NCT02591992|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-02-17|||October 2015||2015-10-01|February 2016|2016-02-01|May 2018|Anticipated|2018-05-01|November 2016|Anticipated|2016-11-01||Interventional|CAT-CAD||Computed Tomography as the First-Choice Diagnostics in High Pre-Test Probability of Coronary Artery Disease|Coronary Artery Computed Tomography as the First-Choice Imaging Diagnostics in Patients With High Pre-Test Probability of Coronary Artery Disease|Recruiting||N/A|120|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||f||||||||||2017-10-10 22:47:20.078719|2017-10-10 22:47:20.078719
NCT02591979|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-29|||May 2014||2014-05-01|October 2015|2015-10-01||||October 2016|Anticipated|2016-10-01|3 Months|Observational [Patient Registry]|||PASHOS Project: Advanced Platform for Sleep Apnea Syndrome Assessment|PASHOS Project: Advanced Platform for Sleep Apnea Syndrome Assessment. A Multi-Centre Study to Validate a Sleep Apnea Screening Model in Primary Health Care|Unknown status|Recruiting|N/A|198|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||||2017-10-10 22:47:20.171703|2017-10-10 22:47:20.171703
NCT02591966|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-11-29|||January 2015||2015-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Genetic Alteration After Systemic Treatment in Breast Cancer|Genetic Alteration After Systemic Treatment in Breast Cancer|Recruiting||N/A|350|Anticipated|Samsung Medical Center|||1||f||||f||||||Samples With DNA|"     1. Blood sample : whole blood        2. Tissue : Fresh tissue, Fixed tissue (5ea of 5-10µm unstained sections),   "|||2017-10-10 22:47:20.259951|2017-10-10 22:47:20.259951
NCT02591953|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-11-20|||November 2015||2015-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections||Recruiting||N/A|60|Anticipated|Rush University Medical Center||2|||f||||||||||||||2017-10-10 22:47:20.3292|2017-10-10 22:47:20.3292
NCT02591940|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-29|||November 2013||2013-11-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|||Proof of Concept of Model Based Cardiovascular Prediction|Proof of Concept of Model Based Cardiovascular Prediction|Unknown status|Enrolling by invitation|N/A|140|Anticipated|German Heart Institute|||2||f||||f||||||||||2017-10-10 22:47:20.436601|2017-10-10 22:47:20.436601
NCT02591927|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-29|||February 2016||2016-02-01|October 2015|2015-10-01||||February 2019|Anticipated|2019-02-01||Interventional|REAGIK-STEMI||Reappraisal of GIK in Acute STEMI by Pre-hospital Administration|Reappraisal of Glucose-insulin-potassium Therapy in Acute St-segment Elevation Myocardial Infarction by Pre-hospital Administration|Not yet recruiting||Phase 3|334|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 22:47:20.516206|2017-10-10 22:47:20.516206
NCT02591914|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-10-28|||February 2014||2014-02-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration||Unknown status|Active, not recruiting|Phase 1|25|Anticipated|Retinal Consultants of Arizona||1|||f||||f||||||||||2017-10-10 22:47:20.750811|2017-10-10 22:47:20.750811
NCT02591901|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-29|||January 2016||2016-01-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PReSuTINeB||Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)|Prevention of Recurrent Symptomatic Urinary Tract Infections in Participants With Chronic Neurogenic Bladder Dysfunction: A Mixed Method Study|Unknown status|Not yet recruiting|Phase 2|48|Anticipated|Buckinghamshire Healthcare NHS Trust||2|||f||||t||||||||||2017-10-10 22:47:20.842018|2017-10-10 22:47:20.842018
NCT02591888|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-06-06|||February 2015||2015-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||Impact of Liposomal Bupivacaine Administered Following Placement of a Transobturator Suburethral Sling|The Impact of Liposomal Bupivacaine Administered Following Placement of a Transobturator Suburethral Sling for Stress Urinary Incontinence: A Randomized Placebo-controlled Trial|Terminated||Phase 4|18|Actual|TriHealth Inc.||2||"Difficult to enroll; since a similar research project on a different population showed no   significance the study has been closed."|f||||t||||||||No||2017-10-10 22:47:20.965968|2017-10-10 22:47:20.965968
NCT02591875|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-10-18|||October 2015||2015-10-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||Atrial Flutter Ablation in a Real World Population|Atrial Flutter Ablation in a Real World Population: A Multicenter Italian Registry (The LEONARDO Study)|Recruiting||N/A|1000|Anticipated|Azienda Ospedaliera Pugliese Ciaccio|||1||f||||f||||||||||2017-10-10 22:47:21.05439|2017-10-10 22:47:21.05439
NCT02591862|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-01-23|||February 2016|Actual|2016-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)|Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms|Recruiting||Phase 2|6|Anticipated|AKARI Therapeutics||1|||f||||t||||||||||2017-10-10 22:47:21.144686|2017-10-10 22:47:21.144686
NCT02591849|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-03-30|||October 2014||2014-10-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||GLP-1 Effects on Insulin and Glucagon in PTDM|GLP-1 Restores Altered Insulin and Glucagon Secretion in Post-transplantation Diabetes Mellitus|Completed||N/A|24|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 22:47:21.246066|2017-10-10 22:47:21.246066
NCT02591836|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-28|||January 2003||2003-01-01|October 2015|2015-10-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin|An 8‐Week, Double‐Blind, Randomized, Placebo‐Controlled, Dose‐Ranging Study of the Efficacy and Safety of Gemcabene Administered as Monotherapy or in Combination With Atorvastatin in the Treatment of Hypercholesterolemic Patients|Completed||Phase 2|277|Actual|Gemphire Therapeutics, Inc.||16|||f||||f||||||||||2017-10-10 22:47:21.334239|2017-10-10 22:47:21.334239
NCT02591810|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-29|||November 5, 2015|Actual|2015-11-05|September 2017|2017-09-01|November 9, 2016|Actual|2016-11-09|November 5, 2016|Actual|2016-11-05||Interventional|DRUJ||Treatment Options for Acute Distal Radioulnar Joint Instability|Comparison of Treatment Options for Acute Distal Radioulnar Joint Instability: A Prospective Randomized Control Trial|Withdrawn||N/A|0|Actual|Orlando Health, Inc.||3|||f||||f||||||||||2017-10-10 22:47:21.53596|2017-10-10 22:47:21.53596
NCT02591797|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-07-17|||October 2015||2015-10-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Effectiveness of Hand/Eyes/Mouth Behavior Management Technique During Local Anesthesia in Preschool Children|Effectiveness of Hand/Eyes/Mouth Behavior Management Technique in Anxiety, Pain and Behavior Levels During an Inferior Alveolar and Lingual Nerve Block Procedure in Preschool Children: a Randomized Clinical Trial|Completed||N/A|52|Actual|Cardenal Herrera University||2|||f||||f||||||||||2017-10-10 22:47:21.610251|2017-10-10 22:47:21.610251
NCT02591784|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-10-28|||November 2008||2008-11-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer|The Phase II of Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer|Completed||Phase 2|42|Actual|Biotech Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:47:21.695885|2017-10-10 22:47:21.695885
NCT02591771|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2017-09-03|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock|Phase II Clinical Trial for a Stepwise Progression in the Treatment of Cardiogenic Shock|Recruiting||Phase 2|24|Anticipated|Niguarda Hospital||1|||f||||f||||||||||2017-10-10 22:47:21.791241|2017-10-10 22:47:21.791241
NCT02591758|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-09-02|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|February 1, 2018|Anticipated|2018-02-01|December 1, 2017|Anticipated|2017-12-01||Observational|NOVA-SKIN||Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy|Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy (NOVA-SKIN Study)|Recruiting||N/A|30|Anticipated|Montreal Heart Institute|||1||f||||f||||||||||2017-10-10 22:47:21.892082|2017-10-10 22:47:21.892082
NCT02591745|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-06-28|||January 2015||2015-01-01|June 2017|2017-06-01|January 2030|Anticipated|2030-01-01|January 2027|Anticipated|2027-01-01|18 Years|Observational [Patient Registry]|iFAD||International Fetal Anesthesia Database|International Fetal Anesthesia Database|Recruiting||N/A|2000|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-10-10 22:47:22.023975|2017-10-10 22:47:22.023975
NCT02591732|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-05-17|||August 2014||2014-08-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark|A Nation-wide Registry Study of Patients With Non-valvular Atrial Fibrillation Initiating Anticoagulation Therapies in the Early Period Follow Apixaban Marketing in Denmark: Patient Characteristics, Treatment Patterns, and Early Bleeding Events|Completed||N/A|52178|Actual|Bristol-Myers Squibb|||4||f||||f||||||||||2017-10-10 22:47:22.116365|2017-10-10 22:47:22.116365
NCT02591719|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-06-26|||November 2015||2015-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of rTMS Based on Hemodynamic Activity for Language Recovery in Early Poststroke Aphasia|Effects of Repetitive Transcranial Magnetic Stimulation Based on Hemodynamic Activity for Language Recovery in Early Poststroke Aphasia: Randomized Controlled Trial|Recruiting||N/A|36|Anticipated|Seoul National University Bundang Hospital||3|||f||||f||||||||||2017-10-10 22:47:22.195002|2017-10-10 22:47:22.195002
NCT02591706|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-04-13|||January 2015||2015-01-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|March 2016|Actual|2016-03-01||Interventional|H2015-1||Clinical Assessment of Dental Implant|Clinical and Radiographic Assessment of V3 Implant: A Randomized Controlled Trial|Active, not recruiting||N/A|34|Actual|University Hospital of Liege||2|||f||||f||||||||||2017-10-10 22:47:22.299599|2017-10-10 22:47:22.299599
NCT02591693|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-06-01|||August 2015||2015-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Individualised Informal Caregiver Training for Palliative Care at Home|Feasibility Study: Improving Caregiver Confidence in Their Ability to Look After Patients With Palliative Care Needs, Using Focused One to One Training in the Home|Terminated||N/A|14|Actual|University of Oxford||2||"Trial OT left post due to significant personal circumstances. Study team unable to recruit new   OT to post in time frame available."|f||||f||||||||||2017-10-10 22:47:22.374252|2017-10-10 22:47:22.374252
NCT02591680|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-28|||March 2015||2015-03-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||The Effect of Muscle Strengthening Associated With Neuromuscular Stimulus in Patients With Patellofemoral Pain During Negotiating Stairs|The Effect of Muscle Strengthening Associated With Neuromuscular Stimulus in Patients With Patellofemoral Pain During Negotiating Stairs: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|34|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 22:47:22.453031|2017-10-10 22:47:22.453031
NCT02591667|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-04-02|||March 2016||2016-03-01|April 2016|2016-04-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|CARCINOSIS||Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer|Assessment of Histopathological Response to Combination Chemotherapy With Oxaliplatin, Irinotecan, Fluorouracil and Bevacizumab in Patients With Peritoneal Metastasis From Colorectal Cancer|Recruiting||Phase 2|30|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 22:47:22.530125|2017-10-10 22:47:22.530125
NCT02591654|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-07-25|||October 2015||2015-10-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|MPAK||MRI and PET to Assess Pembrolizumab Response|A Feasibility Study of MRI and PET Imaging to Assess Response to MK-3475 (Pembrolizumab) in Patients With Metastatic Melanoma|Recruiting||Early Phase 1|20|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-10 22:47:22.639847|2017-10-10 22:47:22.639847
NCT02591641|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-03-01|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Use of a Shear Reduction Surface in Pre-hospital Transport|Use of a Shear Reduction Surface in Pre-hospital Transport|Completed||N/A|30|Actual|Mayo Clinic||2|||f||||f|f|f||||||No||2017-10-10 22:47:22.728356|2017-10-10 22:47:22.728356
NCT02591615|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-05-18|||March 2016||2016-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC|Randomized Phase II Trial Evaluating the Optimal Sequencing of PD-1 Inhibition With Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in Patients With Chemotherapy Naive Stage IV Non-small Cell Lung Cancer|Recruiting||Phase 2|90|Anticipated|Alliance Foundation Trials, LLC.||2|||f||||t||||||||No||2017-10-10 22:47:22.891359|2017-10-10 22:47:22.891359
NCT02591602|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-10-28|||November 2011||2011-11-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|RADHOME||Teleradiology Program for Frail Patients Living at Home or in Nursing-homes|Teleradiology Program for Frail Patients Living at Home or in Nursing-homes|Completed||N/A|162|Actual|Azienda Ospedaliera Città della Salute e della Scienza di Torino||2|||f||||f||||||||||2017-10-10 22:47:23.014286|2017-10-10 22:47:23.014286
NCT02591589|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-03-15|||July 2015||2015-07-01|March 2017|2017-03-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Intraoperative Oxygen Concentration and Neurocognition After Cardiac Surgery|The Relationship Between Administered Oxygen Levels and Arterial Partial Oxygen Pressure to Neurocognition in Post-operative Mechanically Ventilated Cardiac Surgical Patients|Recruiting||N/A|100|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-10 22:47:23.19861|2017-10-10 22:47:23.19861
NCT02591576|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-28|||January 2003||2003-01-01|October 2015|2015-10-01||||July 2013|Actual|2013-07-01||Observational|||Long Term Excess Mortality of Acute Myocardial Infarction in Patients With and Without Diabetes: A Population-based Cohort Study||Completed||N/A|700000|Actual|University of Leeds|||2||f||||t||||||||||2017-10-10 22:47:23.322257|2017-10-10 22:47:23.322257
NCT02591563|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-05|||October 2015||2015-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Acute Otitis Media and Nasopharyngeal Colonization Caused by Vaccine Serotypes of Strep Pneumoniae in Healthy Children|A Study Evaluating Acute Otitis Media and Nasopharyngeal Colonization Caused by Vaccine Serotypes of Streptococcus Pneumoniae in Healthy Children|Recruiting||N/A|240|Anticipated|Rochester General Hospital|||1||f||||t||||||Samples Without DNA|"     middle ear fluid, throat swabs, and nasal swabs   "|||2017-10-10 22:47:23.390491|2017-10-10 22:47:23.390491
NCT02591550|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-28|||March 2015||2015-03-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Study on the Mechanism of Cough Hypersensitivity||Recruiting||N/A|300|Anticipated|The First Affiliated Hospital of Guangzhou Medical University|||3||f||||t||||||Samples Without DNA|"     mucosa of upper trachea   "|||2017-10-10 22:47:23.47238|2017-10-10 22:47:23.47238
NCT02591537|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-09-07|2017-03-28||October 2015|Actual|2015-10-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional||Each participant was assigned to both study groups (acted as her own control), as four wounds on one side of each participant were treated with OxyGenesys dressing, and four wounds on the opposite side of each participant were treated with the Tegaderm control dressing. In some instances, not all of the participants contributed data to outcomes.|OxyGenesys Dissolved Oxygen Dressing; Abdominoplasty at Northwestern University|Prospective, Randomized, Single Center, Controlled Evaluation of the Effectiveness of OxyGenesys Topical Dissolved Oxygen Dressing in Accelerating the Healing of Split Thickness Skin Graft Donor Sites Using the NWU Abdominoplasty Scar Model|Completed||N/A|8|Actual|Halyard Health||2|||f||||f||||||||||2017-10-10 22:47:23.564251|2017-10-10 22:47:23.564251
NCT02591524|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-28|||November 2015||2015-11-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation|Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hannover Medical School||1|||f||||f||||||||||2017-10-10 22:47:24.084148|2017-10-10 22:47:24.084148
NCT02591511|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-28|||April 2015||2015-04-01|October 2015|2015-10-01||||February 2016|Anticipated|2016-02-01||Interventional|||Effects of Patient-centered Stroke Educating System: a Randomized Controlled Trial||Unknown status|Recruiting|N/A|80|Anticipated|Taipei Medical University||2|||f||||||||||||||2017-10-10 22:47:24.172576|2017-10-10 22:47:24.172576
NCT02591498|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-10-28|||January 2014||2014-01-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CCTSB||Computerized Cognitive Training for Schizophrenia in Brazil|Computerized Cognitive Training for Schizophrenia in Brazil|Recruiting||Phase 3|100|Anticipated|Universidade Federal do Rio de Janeiro||3|||f||||f||||||||||2017-10-10 22:47:24.260327|2017-10-10 22:47:24.260327
NCT02591485|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-04-09|||February 2016||2016-02-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||Prevention of Post Traumatic Stress Disorder Following Trauma by Attention Control Training|Prevention of Post Traumatic Stress Disorder Following Trauma by Attention Control Training|Recruiting||N/A|100|Anticipated|Tel Aviv University||2|||f||||t||||||||No||2017-10-10 22:47:24.378566|2017-10-10 22:47:24.378566
NCT02591472|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-09-26|||January 2016||2016-01-01|September 2017|2017-09-01|December 14, 2017|Anticipated|2017-12-14|December 14, 2017|Anticipated|2017-12-14||Interventional|||An Integrated-Delivery-of-Care Approach to Improve Patient Outcomes, Safety, Well-Being After Orthopaedic Trauma|An Integrated-Delivery-of-Care Approach to Improve Patient Outcomes, Safety, Well-Being After Orthopaedic Trauma|Active, not recruiting||N/A|111|Actual|University of Florida||2|||f||||t||||||||||2017-10-10 22:47:24.496253|2017-10-10 22:47:24.496253
NCT02591459|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-28|||October 2015||2015-10-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Android Mobile Devices to Assist Routine Anticipation for Autistic Children|Android Mobile Devices to Assist Routine Anticipation for Autistic Children|Unknown status|Active, not recruiting|N/A|10|Anticipated|University of Mogi das Cruzes||1|||f||||t||||||||||2017-10-10 22:47:24.627359|2017-10-10 22:47:24.627359
NCT02591446|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-08-08|||October 2014||2014-10-01|April 2017|2017-04-01|August 7, 2017|Actual|2017-08-07|August 7, 2017|Actual|2017-08-07||Observational|||Transcranial Magnetic Stimulation Studies in Autism Spectrum Disorders|Transcranial Magnetic Stimulation Studies in Autism Spectrum Disorders|Completed||N/A|48|Actual|Rhode Island Hospital|||1||f||||t||||||||||2017-10-10 22:47:24.725932|2017-10-10 22:47:24.725932
NCT02591433|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-18|||August 2013||2013-08-01|October 2016|2016-10-01||||November 2014|Actual|2014-11-01||Interventional|||JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer|Pilot Study of the Effectiveness of the JeffQuit Smoking Cessation Program|Withdrawn||N/A|0|Actual|Thomas Jefferson University||1||Slow Accrual|f||||f||||||||||2017-10-10 22:47:24.80422|2017-10-10 22:47:24.80422
NCT02591420|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-09-30|||April 2016||2016-04-01|September 2016|2016-09-01||||April 2018|Anticipated|2018-04-01||Interventional|||Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection|Safety and Virologic Effect of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously to Adults During Early Acute HIV Infection|Recruiting||Phase 1|24|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-10 22:47:24.909002|2017-10-10 22:47:24.909002
NCT02591407|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-05-08|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|TAP||Trial Comparing Transversus Abdominis Plane Block Versus Epidural Anesthesia for Pain Management in Colorectal Surgery|A Prospective Randomized Clinical Trial Comparing the Transversus Abdominis Plane Block (TAP) Versus Epidural Anesthesia For Enhanced Recovery Pathway Perioperative Management of Pain in Elective Colorectal Surgery|Enrolling by invitation||N/A|176|Anticipated|Saint Joseph Mercy Health System||2|||f||||f||||||||No||2017-10-10 22:47:25.042423|2017-10-10 22:47:25.042423
NCT02591394|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-01-02|||November 2015||2015-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|STEPS||STEPs to Blood Pressure Reduction.|STEPs to Blood Pressure Reduction. A Randomized Clinical Trial of the Stroke Transitions, Education, and Prevention Clinic Versus Usual Care for Post-Stroke Blood Pressure Reduction|Recruiting||N/A|200|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 22:47:25.13985|2017-10-10 22:47:25.13985
NCT02591381|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-07-05|||October 2015||2015-10-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TC vs ST AUS||Transcorporal Versus Standard Artificial Urinary Sphincter Placement|A Randomized Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement|Recruiting||N/A|400|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:47:25.233114|2017-10-10 22:47:25.233114
NCT02591368|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-09-29|||October 2015||2015-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||MiniTightRope Suspensionplasty Compared With LRTI for the Treatment of Basilar Thumb Arthritis|MiniTightRope Suspensionplasty Compared With Ligamentous Reconstruction Tendon Interposition for the Treatment of Basilar Thumb Arthritis. A Randomized Clinical Trial|Recruiting||N/A|90|Anticipated|Orlando Health, Inc.||3|||f||||f||||||||||2017-10-10 22:47:25.344066|2017-10-10 22:47:25.344066
NCT02591355|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-06-14|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment|A Monocentric, Double-blind, Randomized, Active- and Placebo-controlled Split-scalp Study to Evaluate the Clinical Effectiveness of Platelet-rich Plasma (PRP) in the Treatment of Androgenetic Alopecia|Not yet recruiting||N/A|50|Anticipated|Regen Lab SA||2|||f||||f|f|f||||||Undecided||2017-10-10 22:47:25.440374|2017-10-10 22:47:25.440374
NCT02591342|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-05-11|||September 2009||2009-09-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Comparison of a Cemented, Polished Tapered Stem and an Anatomic Stem for Femoral Neck Fracture||Completed||N/A|1014|Actual|Sundsvall Hospital|||2||f||||f||||||||||2017-10-10 22:47:25.518826|2017-10-10 22:47:25.518826
NCT02591329|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-03-15|||August 2015||2015-08-01|March 2017|2017-03-01|March 31, 2017|Anticipated|2017-03-31|March 2017|Anticipated|2017-03-01||Interventional|||Increasing Household Purchase and Child Consumption of Calcium Products|Increasing Household Purchase and Child Consumption of Calcium Products: A Randomised Controlled Trial|Active, not recruiting||N/A|189|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:47:25.598089|2017-10-10 22:47:25.598089
NCT02591316|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-07-17|||February 2015||2015-02-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Nutrition, Physical Activity, and Cognition in Breast Cancer Survivors|Lifestyle Factors, Inflammation, and Cognition in Breast Cancer Survivors|Completed||N/A|68|Actual|Texas State University, San Marcos|||2||f||||f||||||Samples With DNA|"     Serum and plasma   "|||2017-10-10 22:47:25.674363|2017-10-10 22:47:25.674363
NCT02591303|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-08-22|||November 3, 2015|Actual|2015-11-03|August 2017|2017-08-01|September 15, 2016|Actual|2016-09-15|September 15, 2016|Actual|2016-09-15||Interventional|StresSleep||Stress and Insomnia|Stress and Insomnia: Investigating a Bidirectional Relation|Completed||N/A|15|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 22:47:25.764406|2017-10-10 22:47:25.764406
NCT02591277|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-09-14|||November 30, 2015|Actual|2015-11-30|September 2017|2017-09-01|August 14, 2017|Actual|2017-08-14|August 14, 2017|Actual|2017-08-14||Observational|||Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection|A Prospective Observational Post-Marketing Study of Harvoni in Japanese Patients With Genotype 1 Chronic Hepatitis C Infection|Completed||N/A|3294|Actual|Gilead Sciences|||1||f||||f|t|f||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:47:25.941995|2017-10-10 22:47:25.941995
NCT02591264|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-28|||November 2015||2015-11-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3||Unknown status|Not yet recruiting|N/A|120|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-10 22:47:26.42239|2017-10-10 22:47:26.42239
NCT02591251|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-07-30|||October 2015||2015-10-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Povidone-iodine Versus Normal Saline Solution in Vaginal Cleansing in Laparoscopy|A Comparison Between Povidone-iodine and Normal Saline Solution in Preoperative Vaginal Cleansing in Laparoscopic Surgery: a Randomized Clinical Study|Completed||Phase 2|100|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:47:26.516074|2017-10-10 22:47:26.516074
NCT02591238|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-02-03|2015-11-23||June 2015||2015-06-01|June 2015|2015-06-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional||According to the requirements of the randomized controlled trials and statistical methods to determine a total of 63 participants, and signed the informed consent.|Melatonin in Smoke-induced Vascular Injury|The Protective Effect of Melatonin on Smoke-induced Vascular Injury in Human|Completed||Phase 4|68|Actual|Peking Union Medical College Hospital|Limitations. First, the dose-dependent manner of melatonin should be considered. Second, the duration of smoke exposure and melatonin administration time should be prolonged. Lastly,the levels of melatonin at different time points should be examined.|4|||f||||t||||||||Undecided|The cycle of the experiment is long, and it is a part of the experiment.|2017-10-10 22:47:26.635817|2017-10-10 22:47:26.635817
NCT02591225|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-11-12|||October 2015||2015-10-01|November 2015|2015-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon|Phenprocoumon Versus Dabigatran in Subjects With Atrial Fibrillation and Left Atrial Thrombus - a Prospective, Randomized, Controlled, Open-label One Year Follow-up Pilot Study|Recruiting||Phase 4|40|Anticipated|University of Ulm||2|||f||||f||||||||||2017-10-10 22:47:27.103891|2017-10-10 22:47:27.103891
NCT02591212|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-10-25|||November 2015||2015-11-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|P_ConnectED||A Pilot of Bystander Training Programming in Sexual Violence and Subtance Abuse|Connecting Through Educational Training: A Pilot of Bystander Training Programming in Sexual Violence and Subtance Abuse|Completed||N/A|427|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 22:47:27.22009|2017-10-10 22:47:27.22009
NCT02591199|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-05-01|||September 2015||2015-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome|A Phase 2a, Biphasic Adaptive Design Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome|Recruiting||Phase 2|348|Anticipated|Urigen||4|||f||||t||||||||||2017-10-10 22:47:27.316215|2017-10-10 22:47:27.316215
NCT02591173|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-07-27|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure|Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure|Recruiting||Early Phase 1|22|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 22:47:27.6198|2017-10-10 22:47:27.6198
NCT02591160|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-01-19|||May 2015||2015-05-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism|Optimal Hydrochlorothiazide Cessation in Diagnosis of Hyperparathyroidism|Recruiting||N/A|15|Anticipated|University of Missouri-Columbia||1|||f||||f||||||||No|Individual participant data will not be shared.|2017-10-10 22:47:27.767337|2017-10-10 22:47:27.767337
NCT02591147|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-06-13|||October 2016||2016-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SDF||Silver Diamine Fluoride Pilot Study (SDF)|Effectiveness of Silver Diamine Fluoride in Arresting Early Approximal Carious Lesion Progression: A Pilot Study|Recruiting||Early Phase 1|144|Anticipated|University of Iowa||2|||f||||f||||||||Undecided||2017-10-10 22:47:27.871213|2017-10-10 22:47:27.871213
NCT02591134|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-09-14|||July 2016||2016-07-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|SWITCH||EffectS of Non-nutritive sWeetened Beverages on appetITe During aCtive weigHt Loss|SWITCH: EffectS of Non-nutritive sWeetened Beverages on appetITe During aCtive weigHt Loss|Recruiting||N/A|432|Anticipated|University of Liverpool||2|||f||||f||||||||||2017-10-10 22:47:27.983199|2017-10-10 22:47:27.983199
NCT02591121|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-11-13|||October 2015||2015-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|PRO-H||Procalcitonin Test Reference Range Determination|Clinical Evaluation To Determine The Expected Values Distribution Of Procalcitonin For The RAMP® Procalcitonin Test In A Healthy Reference Population (PRO-H)|Completed||N/A|125|Actual|Response Biomedical Corp.|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 22:47:28.105002|2017-10-10 22:47:28.105002
NCT02591108|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-09-08|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Train of Four Motor Point Stimulation and Monitoring|Quantitative Assessment of Train of Four Device for Patients Receiving Neuromuscular Blockade|Not yet recruiting||N/A|400|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|f|||f|||||2017-10-10 22:47:28.174642|2017-10-10 22:47:28.174642
NCT02591095|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-07-13|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2017|Actual|2017-04-01||Interventional|MONAVI-1||A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer|A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer|Active, not recruiting||Phase 2|46|Anticipated|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-10 22:47:28.267504|2017-10-10 22:47:28.267504
NCT02591082|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-11-16|||December 2015||2015-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter|A Multi-Center, Post-Marketing, Prospective, Observational Study Following Treatment With Intra-Arterial Delivery of Chemotherapeutic Agents Using the RenovoCath™ RC120 Catheter|Recruiting||N/A|100|Anticipated|RenovoRx|||1||f||||f||||||||No||2017-10-10 22:47:28.378596|2017-10-10 22:47:28.378596
NCT02591069|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-10-04|||October 2015||2015-10-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2016|Actual|2016-01-01||Interventional|SNV||Vagal Nerve Stimulation in Coma Patients|Vagus Nerve Stimulation in Patients With Chronic Consciousness Disorders|Recruiting||N/A|20|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-10 22:47:28.495725|2017-10-10 22:47:28.495725
NCT02591056|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2016-10-24|2016-07-25||January 2016||2016-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study of the Combined Effect of Low Level Laser Therapy and Manual Lymph Drainage on Reducing Body Circumference|An Evaluation of the Combined Effect of the Erchonia® Verju™ Laser With the Green PRESS 8 Lymph Drainage System on the Reduction of Body Circumference|Terminated||N/A|27|Actual|Erchonia Corporation||1||Sponsor decision|f||||f||||||||No||2017-10-10 22:47:28.600922|2017-10-10 22:47:28.600922
NCT02591043|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-09-28|||October 2015||2015-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|PelvicRetro||Surgical Treatment of Low Energy Pelvic Fractures in the Elderly|Surgical Treatment of Low Energy Pelvic Ring Fractures in the Elderly: Cross-sectional Single-centre Study From Basel, Switzerland|Completed||N/A|79|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-10-10 22:47:28.795386|2017-10-10 22:47:28.795386
NCT02591030|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-06-26|||December 15, 2015|Actual|2015-12-15|June 2017|2017-06-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Interventional|AMEBICA||Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours|Randomised Phase II/III Study, Assessing the Safety and Efficacy of Modified Folfirinox Versus Gemcis in Locally Advanced, Unresectable and/or Metastatic Bile Duct Tumours|Recruiting||Phase 2/Phase 3|316|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 22:47:28.890299|2017-10-10 22:47:28.890299
NCT02591017|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-11-02|||February 2015||2015-02-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ONKEMI||Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients|Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients|Recruiting||Phase 3|34|Anticipated|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-10 22:47:29.177054|2017-10-10 22:47:29.177054
NCT02591004|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-10-22|||December 2015||2015-12-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Calcium Channel Blockers Compared to Magnesium Sulfate in Fetal Cerebral Blood Flow|Comparing Fetal Cerebral Blood Flow Between Magnesium Sulfate & Calcium Channel Blockers in Patients With Preterm Labor; a Randomized Controlled Trial.|Recruiting||Phase 2/Phase 3|130|Anticipated|Kasr El Aini Hospital||2|||f||||f||||||||||2017-10-10 22:47:29.281164|2017-10-10 22:47:29.281164
NCT02590991|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-09-04|||November 2015||2015-11-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Follow-up Study to Investigate Long Term Effect of Supplementing Pre- and Probiotics in Children Born by C-Section|A Follow-up Clinical Study to Investigate the Long Term Effect of Supplementation of Pre- and Probiotics in Early Life in Children Born by Caesarean Section (Julius SN Follow-up 1)|Recruiting||N/A|155|Anticipated|Danone Asia Pacific Holdings Pte, Ltd.|||3||f||||f||||||Samples Without DNA|"     Stool samples will be collected from subjects at least once during study visits.      Voluntary blood sample will be collected from subjects.   "|||2017-10-10 22:47:29.378156|2017-10-10 22:47:29.378156
NCT02590978|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-12-30|||December 2015||2015-12-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|CPPAL-2015||Early Cholecystectomy in Patients With Mild Gallstone Acute Pancreatitis|Early Cholecystectomy in Patients With Mild Gallstone Acute Pancreatitis: A Randomized Prospective Study|Recruiting||N/A|100|Anticipated|Hospital del Salvador||2|||f||||t||||||||||2017-10-10 22:47:29.459942|2017-10-10 22:47:29.459942
NCT02590965|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-02-20|||April 2014||2014-04-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|February 2017|Actual|2017-02-01||Interventional|||A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer|A Randomized, Double-blind, Placebo-controlled, Multi-center Phase II Clinical Trial to Evaluate the Efficacy and Safety of Fruquintinib Plus Best Supportive Care in Patients With Advanced Non-squamous Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|91|Actual|Hutchison Medipharma Limited||2|||f||||f||||||||||2017-10-10 22:47:29.555854|2017-10-10 22:47:29.555854
NCT02590952|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-07-24|||October 2011||2011-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I Study of Epitinib(HMPL-813) in Patients With Advanced Solid Tumors|An Open-label, Multi-Centered, Dose Escalation Phase Ib Study (Expansion Stage) of Epitinib (HMPL-813) in Patients With Advanced Solid Tumors|Recruiting||Phase 1|60|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||||2017-10-10 22:47:29.651822|2017-10-10 22:47:29.651822
NCT02590939|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-09-12|||February 1, 2016|Actual|2016-02-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|ACME||Acute Treatment of Migraine With e-TNS|Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device|Completed||N/A|106|Actual|Cefaly Technology||2|||f||||f||||||||||2017-10-10 22:47:29.73831|2017-10-10 22:47:29.73831
NCT02590926|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2017-06-01|||September 26, 2014||2014-09-26|June 2017|2017-06-01|January 1, 2017|Actual|2017-01-01|September 5, 2016|Actual|2016-09-05|5 Years|Observational [Patient Registry]|FACE||Safety of Negative FrActional Flow Reserve in Patients With ChallEnging Lesions|Safety of Negative FrActional Flow Reserve in Patients With ChallEnging Lesions|Completed||N/A|285|Actual|Azienda Ospedaliera Città della Salute e della Scienza di Torino|||1||f||||t||||||||||2017-10-10 22:47:29.817961|2017-10-10 22:47:29.817961
NCT02590913|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2015-10-28|||March 2015||2015-03-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Acute Metabolic and Endocrine Responses of Glucose and Fructose in Healthy Young Subjects|Acute Metabolic and Endocrine Responses of Glucose and Fructose in Healthy Young Subjects: A Double-blinded, Randomized, Crossover Trial|Completed||N/A|20|Actual|Zhejiang University||2|||f||||t||||||||||2017-10-10 22:47:29.89768|2017-10-10 22:47:29.89768
NCT02590900|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-27|||June 2010||2010-06-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|December 2010|Actual|2010-12-01||Observational|||Disposition of Intravenous Paracetamol in Young Women|Disposition of Intravenous Paracetamol in Young Women, Including During Pregnancy, in Postpartum or When on Oral Contraceptives|Completed||N/A|69|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||||||2017-10-10 22:47:29.984276|2017-10-10 22:47:29.984276
NCT02590887|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01||||December 2015|Anticipated|2015-12-01||Interventional|||Immunomodulatory and Antioxidant Effects of a Drink Manufactured From Lupine Protein Hydrolysates|Clinical Study to Assess the Immunomodulatory and Antioxidant Effects of a Drink Manufactured From Lupine Protein Hydrolysates in Healthy Volunteers|Unknown status|Enrolling by invitation|Phase 1/Phase 2|34|Anticipated|University of Seville||1|||f||||||||||||||2017-10-10 22:47:30.080263|2017-10-10 22:47:30.080263
NCT02590874|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-06-08|||January 2016||2016-01-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|DEMO||The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment|The Depression and Memory Trial|Active, not recruiting||Phase 4|19|Actual|University of North Texas Health Science Center||2|||f||||t||||||||No||2017-10-10 22:47:30.33852|2017-10-10 22:47:30.33852
NCT02590861|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-06-22|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Oral Health Function With Implant Supported Partial Dentures|Improving Oral Health Function With Implant Supported Partial Dentures|Not yet recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 22:47:30.461871|2017-10-10 22:47:30.461871
NCT02590848|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-05|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|July 30, 2017|Actual|2017-07-30||Interventional|WALNUTs||Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development|Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development: A Dietary Intervention|Active, not recruiting||N/A|650|Actual|Centre for Research in Environmental Epidemiology, Spain||2|||f||||t||||||||||2017-10-10 22:47:30.573291|2017-10-10 22:47:30.573291
NCT02590835|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-28|||February 2013||2013-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|February 2013|Actual|2013-02-01||Interventional|||Efficiency of Piezocision-assisted Orthodontic Treatment in Adult Patients|Efficiency of Piezocision-assisted Orthodontic Treatment in Adult Patients|Completed||N/A|24|Actual|University Hospital of Liege||2|||f||||f||||||||||2017-10-10 22:47:30.681249|2017-10-10 22:47:30.681249
NCT02590822|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-11-21|||November 2015||2015-11-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|Diastolic||Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction|Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction. The Diastolic Study|Recruiting||Phase 4|120|Anticipated|University of Leicester||3|||f||||f||||||||||2017-10-10 22:47:30.777281|2017-10-10 22:47:30.777281
NCT02590809|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-02-08|||October 7, 2015|Actual|2015-10-07|February 2017|2017-02-01|July 6, 2016|Actual|2016-07-06|July 6, 2016|Actual|2016-07-06||Interventional|Light-CARMIDO||Hypertrophic Cardiomyopathy Symptom Release by BX1514M||Completed||Phase 2|38|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 22:47:30.985829|2017-10-10 22:47:30.985829
NCT02590796|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-28|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Validating Studies to Assess the Diagnostic Accuracy of a Software Application for Detection and Monitoring of Attentional Deficits in Delirium|MICA: Development of a Software Application for Detection and Monitoring of Attentional Deficits in Delirium|Unknown status|Recruiting|N/A|1110|Anticipated|University of Edinburgh|||7||f||||f||||||||||2017-10-10 22:47:31.108509|2017-10-10 22:47:31.108509
NCT02590783|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-04-27|||September 2015||2015-09-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Treatment of Pelvic Ring Fractures in the Elderly|Treatment of Pelvic Ring Fractures in the Elderly: A Randomized Controlled Trial Comparing Surgical vs. Conservative Therapy|Recruiting||N/A|140|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 22:47:31.259755|2017-10-10 22:47:31.259755
NCT02590770|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-07-27|||October 2015||2015-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Gaze Contingent Feedback in Social Anxiety Disorder|Gaze Contingent Feedback in Treatment of SAD|Completed||N/A|40|Actual|Tel Aviv University||2|||f||||f||||||||||2017-10-10 22:47:31.368296|2017-10-10 22:47:31.368296
NCT02590744|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-06-13|||October 2015||2015-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery|Effects of Preoperative Using of Eye Patches on Prevention of Preschool Children Emergence Agitation After Cataract Surgery: A Single Center, Prospective, Randomized, Controlled Study.|Recruiting||N/A|180|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:47:31.569336|2017-10-10 22:47:31.569336
NCT02590731|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-02-28|||February 2012||2012-02-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||The Influence of Cognitive Status on Walking Abilities After Femoral Neck Fracture|The Influence of Cognitive Status on Walking Abilities After Hemiarthroplasty for Femoral Neck Fracture: a Prospective Cohort Study|Completed||N/A|188|Actual|Sundsvall Hospital|||2||f||||f||||||||||2017-10-10 22:47:31.685807|2017-10-10 22:47:31.685807
NCT02590718|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-28|||October 2015||2015-10-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|MFLPIC||Management Following Lumbar Puncture In Children|Management Following Lumbar Puncture In Children|Unknown status|Not yet recruiting|N/A|200|Anticipated|Beijing Children's Hospital||2|||f||||f||||||||||2017-10-10 22:47:31.767176|2017-10-10 22:47:31.767176
NCT02590705|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-28|2015-10-28|||October 2015||2015-10-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|ALPIC||Anesthesia Lumbar Puncture In Children|Anesthesia Lumbar Puncture In Children (ALPIC)|Unknown status|Not yet recruiting|N/A|200|Anticipated|Beijing Children's Hospital||2|||f||||f||||||||||2017-10-10 22:47:31.844525|2017-10-10 22:47:31.844525
NCT02590692|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-03-29|||October 2015||2015-10-01|March 2017|2017-03-01|September 2022|Anticipated|2022-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD|A Phase I/IIa Safety Study of Subretinal Implantation of CPCB-RPE1 (Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Seeded on a Polymeric Substrate) in Subjects With Advanced, Dry Age-Related Macular Degeneration (AMD)|Recruiting||Phase 1/Phase 2|20|Anticipated|Regenerative Patch Technologies, LLC||1|||f||||t||||||||||2017-10-10 22:47:31.940487|2017-10-10 22:47:31.940487
NCT02590679|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-28|||May 2013||2013-05-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|July 2016|Anticipated|2016-07-01||Interventional|Venus-P||Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p|Multi-center Trial of Percutaneous Pulmonary Valve Implantation Using Venus-P Valve for Patients With Severe Pulmonary Regurgitation and Native Right Ventricular Outflow Tract After Previous Surgical Repair|Unknown status|Recruiting|Phase 2/Phase 3|44|Anticipated|Shanghai Zhongshan Hospital||1|||f||||t||||||||||2017-10-10 22:47:32.069206|2017-10-10 22:47:32.069206
NCT02590666|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2016-03-08|||June 2016||2016-06-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Endometrial Polypectomy Performed With Bipolar Electrode Versapoint vs Microscissors or Graspers|Comparative Study of Endometrial Polypectomy Performed With Bipolar Electrode Versapoint vs Microscissors or Graspers|Not yet recruiting||N/A|40|Anticipated|University of Cagliari||2|||f||||f||||||||||2017-10-10 22:47:32.199097|2017-10-10 22:47:32.199097
NCT02590653|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-09-20|||October 2014||2014-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|CONTRAST||Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI|Assessment of the Effects of Aggressive Atorvastatin Therapy on Myocardial Deformation Characteristics, Vascular Rigidity, 24 Hour ECG Monitoring Parameters and Quality of Life in Patients With STEMI|Recruiting||Phase 4|200|Anticipated|Penza State University||2|||f||||f||||||||||2017-10-10 22:47:32.277341|2017-10-10 22:47:32.277341
NCT02590640|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-10-13|||November 2015||2015-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers|Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers|Recruiting||N/A|40|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:47:32.39713|2017-10-10 22:47:32.39713
NCT02590627|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2015-10-28|||May 2014||2014-05-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|WB-Malaria||In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure|In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure|Unknown status|Active, not recruiting|Phase 4|600|Anticipated|National Institute for Medical Research, Tanzania||2|||f||||f||||||||||2017-10-10 22:47:32.479423|2017-10-10 22:47:32.479423
NCT02590614|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-09-12|||November 2013||2013-11-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Genetic, Dietary and Environmental Influences on Vitamin D Metabolism|Genetic, Dietary and Environmental Influences on Vitamin D Metabolism|Active, not recruiting||N/A|412|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 22:47:32.572968|2017-10-10 22:47:32.572968
NCT02590601|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-09-02|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|January 1, 2023|Anticipated|2023-01-01|January 1, 2023|Anticipated|2023-01-01||Interventional|BRO-HF||Bromocriptine in the Treatment of Peripartum Cardiomyopathy|Bromocriptine in the Treatment of Peripartum Cardiomyopathy, A Bayesian Randomized Registry Trial|Recruiting||Phase 3|80|Anticipated|Montreal Heart Institute||2|||f||||t||||||||||2017-10-10 22:47:32.710545|2017-10-10 22:47:32.710545
NCT02590588|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-23|2017-03-30||January 2016|Actual|2016-01-01|August 2017|2017-08-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional||'There was only one patient enrolled|Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis|Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor, Idelalisib (GS-1101), in IgM-Associated AL Amyloid|Terminated||Phase 2|1|Actual|Boston Medical Center|Early termination leading to small numbers of subjects analyzed.|1||Poor accrual|f||||t|t|f||||||||2017-10-10 22:47:32.843722|2017-10-10 22:47:32.843722
NCT02590575|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-05-11|||October 2015||2015-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|Prismalung||"Low Flow CO2 Removal on RRT"|"Low Flow CO2 Removal Via a Membrane Gas Exchange Device (Prismalung®) on a Renal Replacement Platform (Prismaflex®) in Hypercapnic, Ventilated Patients Requiring Renal Replacement"|Completed||N/A|20|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-10-10 22:47:33.067365|2017-10-10 22:47:33.067365
NCT02590562|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-06-27|2015-12-03||December 31, 2013|Actual|2013-12-31|June 2017|2017-06-01|August 31, 2014|Actual|2014-08-31|August 31, 2014|Actual|2014-08-31||Observational||Overall Population: Participants who met all inclusion criteria, diagnosed with RA according to ACR 1987 criteria and were using biological DMARDs approved in China for RA treatment.|An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.|A Multi-center Cross-sectional Study on Treatment Patterns and Patient Characteristics in Rheumatoid Arthritis (RA) Patients Treated by Biological DMARDs in China|Completed||N/A|808|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:47:33.1894|2017-10-10 22:47:33.1894
NCT02590549|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2015-10-28|||January 2011||2011-01-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||MyoRing Implantation With Corneal Collagen Crosslinking for Keratoconus|Complete Corneal Ring (MyoRing) Implantation Combined With Corneal Collagen Crosslinking for Keratoconus|Completed||N/A|16|Actual|Ufa Eye Research Institute||1|||f||||||||||||||2017-10-10 22:47:36.05387|2017-10-10 22:47:36.05387
NCT02590536|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-08-13|||October 2015||2015-10-01|August 2017|2017-08-01|June 2, 2017|Actual|2017-06-02|June 2017|Actual|2017-06-01||Interventional|||A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction|A Randomized Controlled Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction|Completed||Phase 3|90|Actual|Ain Shams University||2|||f||||||||||||||2017-10-10 22:47:36.137294|2017-10-10 22:47:36.137294
NCT02590523|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-09-30|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Intracameral Antibiotic Safety Study|Intracameral Antibiotic Safety Study|Not yet recruiting||Phase 3|500|Anticipated|Panhandle Eye Group, LLP||3|||f||||f|t|f||||||||2017-10-10 22:47:36.237569|2017-10-10 22:47:36.237569
NCT02590510|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-10-27|||October 2015||2015-10-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis||Not yet recruiting||Phase 4|50|Anticipated|Hebei Medical University||2|||f||||||||||||||2017-10-10 22:47:36.323332|2017-10-10 22:47:36.323332
NCT02590497|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2017-02-09|||March 2016||2016-03-01|February 2017|2017-02-01||||December 2018|Anticipated|2018-12-01||Interventional|||Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery|The Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center||1||PI made decision|f||||t||||||||||2017-10-10 22:47:36.848143|2017-10-10 22:47:36.848143
NCT02590484|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-28|||June 2012||2012-06-01|October 2015|2015-10-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta|The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta: a Prospective Study|Recruiting||N/A|||Minia University|||||f||||||||||||||2017-10-10 22:47:36.979402|2017-10-10 22:47:36.979402
NCT02590471|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-09-25|||October 2015||2015-10-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Prospective Study of Two Methods of Revascularization of the Femoral Artery (SFA): Stenting in the SFA, and Stenting of the SFA, Supplemented by Fasciotomy in Hunter Channel.|Pilot Prospective Study of Two Methods of Revascularization of the Superficial Femoral Artery: Stenting in the Superficial Femoral Artery, and Stenting of the Superficial Femoral Artery, Supplemented by Fasciotomy in Hunter Channel in Patients With Steno-occlusive Lesions of Femoral-popliteal Segment TASC C, D|Active, not recruiting||Phase 4|50|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 22:47:37.185091|2017-10-10 22:47:37.185091
NCT02590458|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-06-20|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer|Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer|Recruiting||Early Phase 1|200|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:47:37.300173|2017-10-10 22:47:37.300173
NCT02590445|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-12-04|||October 2015||2015-10-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Novel Deep Brain Stimulation in Ventral Capsule and Stratum for Refractory Obsessive-Compulsive Disorder|Novel Deep Brain Stimulation in Ventral Capsule and Stratum for Refractory Obsessive-Compulsive Disorder: A Pilot Study|Recruiting||Phase 2/Phase 3|8|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-10 22:47:37.41691|2017-10-10 22:47:37.41691
NCT02590432|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-11-11|||November 2015||2015-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation|An Open-label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.|Active, not recruiting||Phase 4|829|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-10 22:47:37.541709|2017-10-10 22:47:37.541709
NCT02590419|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-10-28|||November 2015||2015-11-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Application of Diffusion Tensor Imaging and Tractography in Epilepsy Surgery|Application of Diffusion Tensor Imaging and Tractography in Epilepsy Surgery|Unknown status|Not yet recruiting|N/A|40|Anticipated|London Health Sciences Centre||2|||f||||f||||||||||2017-10-10 22:47:37.809048|2017-10-10 22:47:37.809048
NCT02590393|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-10-02|||February 1, 2018|Anticipated|2018-02-01|October 2017|2017-10-01|September 1, 2019|Anticipated|2019-09-01|February 1, 2019|Anticipated|2019-02-01||Interventional|Ecig1||The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence|The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence|Not yet recruiting||Phase 3|375|Anticipated|Duke University||3|||f||||f|f|f|||t|||||2017-10-10 22:47:38.027337|2017-10-10 22:47:38.027337
NCT02590380|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-03-10|||June 2016||2016-06-01|October 2015|2015-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Comparing Pedicle Screw Systems for the Treatment of Adolescent Paediatric Spine Deformity|A Randomized Controlled Trial: Comparison of a Top Loading MESA® Spinal System With MESA Rail™ and a Side Locking Pedicle Screw System for the Treatment of Adolescent Paediatric Spine Deformity|Not yet recruiting||N/A|60|Anticipated|K2M, Inc.||2|||f||||f||||||||||2017-10-10 22:47:38.129457|2017-10-10 22:47:38.129457
NCT02590367|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-11-30|||August 2015||2015-08-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy|Huo JieGe, Doctor of Medicine,Professor of Medicine,Professor of Medical Science.|Recruiting||Phase 2/Phase 3|64|Anticipated|Jiangsu Province Hospital of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 22:47:38.248959|2017-10-10 22:47:38.248959
NCT02590354|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-07-12|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|ISALA||Analytical Treatment Interruption in HIV Positive Patients|Analytical Treatment Interruption in HIV Positive Patients With Low Viral Reservoir to Evaluate the Potential of a Functional Cure|Recruiting||N/A|45|Anticipated|Institute of Tropical Medicine, Belgium||1|||f||||t||||||||||2017-10-10 22:47:38.355919|2017-10-10 22:47:38.355919
NCT02590341|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-27|||June 2014||2014-06-01|October 2015|2015-10-01|May 2024|Anticipated|2024-05-01|May 2024|Anticipated|2024-05-01|10 Years|Observational [Patient Registry]|MYKKE||Myocarditis Registry for Children and Adolescents - MYKKE|Myocarditis Registry for Children and Adolescents - MYKKE|Recruiting||N/A|1500|Anticipated|German Heart Institute|||1||f||||f||||||||||2017-10-10 22:47:38.468817|2017-10-10 22:47:38.468817
NCT02590159|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-08-16|||November 2015||2015-11-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Clinical Study for the BONGO NASAL Expiratory Positive Airway Pressure (EPAP) Device in the Treatment of Obstructive Sleep Apnea (OSA)|Clinical Study for the BONGO NASAL EPAP Device in the Treatment of Obstructive Sleep Apnea (OSA)|Terminated||N/A|9|Actual|InnoMed Healthscience Inc.||1||delay in enrollment|f||||f||||||||||2017-10-10 22:47:40.165945|2017-10-10 22:47:40.165945
NCT02590328|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-02-27|||December 2015||2015-12-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Neonatal Screening of Severe Combined Immunodeficiencies|Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs|Recruiting||N/A|200000|Anticipated|Children's Hospital of Fudan University|||1||f||||t||||||Samples With DNA|"     Some drops of blood stored on the neonatal screening card (Guthrie card) as a source of DNA     to screening. Samples is performed after parents' information and consent. The card drawn for     the protocol will follow the usual network except that the test for quantifying TRECs will be     realized to determine the presence of SCID.   "|No||2017-10-10 22:47:38.580027|2017-10-10 22:47:38.580027
NCT02590315|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-07-27|||December 2014||2014-12-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|ProteusDonna||Tomosynthesis Versus Digital Mammography in a Population-based Screening Program|Digital Breast Tomosynthesis Versus Digital Mammography in a Population-based Screening Program. A Controlled Randomized Multicenter Trial|Recruiting||Phase 4|92000|Anticipated|Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte||2|||f||||t||||||||||2017-10-10 22:47:38.654877|2017-10-10 22:47:38.654877
NCT02590302|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-27|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Improving Transitions in Care for Children and Youth With Mental Health Concerns|Improving Transitions in Care for Children and Youth With Mental Health Concerns: Implementation and Evaluation of an Emergency Department Mental Health Clinical Pathway|Not yet recruiting||N/A|3095|Anticipated|Children's Hospital of Eastern Ontario||1|||f||||f|f|f||||||||2017-10-10 22:47:38.883174|2017-10-10 22:47:38.883174
NCT02590289|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-12-01|||October 2015||2015-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects|An Open-Label, Single-Dose, 4-Way Crossover, Bioavailability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Food Effect of BBI-5000 Capsules in Healthy Adult Subjects|Completed||Phase 1|20|Actual|Brickell Biotech, Inc.||4|||f||||f||||||||||2017-10-10 22:47:39.023268|2017-10-10 22:47:39.023268
NCT02590276|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-09-14|||September 2015||2015-09-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|PREV-DEMALS||Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)|Predict to Prevent Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:47:39.118771|2017-10-10 22:47:39.118771
NCT02590263|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-18|||September 3, 2015||2015-09-03|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|July 22, 2018|Anticipated|2018-07-22||Interventional|||Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma|A Non-Randomized, Open-Label, Multi-Center Phase 1/2 Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-414 in Japanese Subjects With Malignant Glioma|Recruiting||Phase 1|50|Anticipated|AbbVie||4|||f||||f||||||||||2017-10-10 22:47:39.213431|2017-10-10 22:47:39.213431
NCT02590250|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-08-21|||December 16, 2015|Actual|2015-12-16|August 2017|2017-08-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Observational|||A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India|Evaluation of the Safety and Effectiveness of BOTOX® (Botulinum Toxin Type A) in the Treatment of Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder: A Phase IV Non-interventional Post-marketing Surveillance Study in India|Completed||N/A|250|Actual|Allergan|||1||f||||f|f|f||||||||2017-10-10 22:47:39.381687|2017-10-10 22:47:39.381687
NCT02590237|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-09-29|||October 2015||2015-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||KingVision Video Laryngoscopy vs Direct Laryngoscopy - Equivalence Trial|A Clinical Evaluation of the King Vision Video Laryngoscope aBlade System in Children|Completed||N/A|200|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-10 22:47:39.490873|2017-10-10 22:47:39.490873
NCT02590224|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-08-05|||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of Iron Deficiency Anemia During Pregnancy|Ferrous Bis-glycinate Versus Ferrous Glycine Sulfate for the Treatment of Iron Deficiency Anemia During Pregnancy|Completed||Phase 2|126|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:47:39.580211|2017-10-10 22:47:39.580211
NCT02590211|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-05-31|||July 2016||2016-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PERHAPS||Poker, Skills and Associated Problems|Poker, Skills and Associated Problems (PERHAPS). Controlled Experimental Single Centre Study of Poker Players: Study of the Cognitive Mechanisms Underlying Poker Skills and of the Specificity of Poker-related Problems|Recruiting||N/A|150|Anticipated|Nantes University Hospital||3|||f||||f||||||||No||2017-10-10 22:47:39.672784|2017-10-10 22:47:39.672784
NCT02590198|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-07-06|||May 3, 2016|Actual|2016-05-03|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|DIACORD||Diagnostic Performance Comparison Between Procalcitonin-based vs. ANAES-based Guidelines|Diagnostic Performance Comparison Between Procalcitonin-based vs. ANAES-based Guidelines; Impact on Antibiotic Use in Newborns With Suspected Early-onset Neonatal Infection (EONI)|Recruiting||N/A|8928|Anticipated|Nantes University Hospital|||2||f||||f||||||||||2017-10-10 22:47:39.781888|2017-10-10 22:47:39.781888
NCT02590185|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-09-28|||December 2015||2015-12-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|MARVEL||MetAbolism vaRiability of VEnLafaxine|Xploring Venlafaxine Pharmacokinetic Variability by a Phenotyping Approach|Recruiting||N/A|205|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:47:39.938477|2017-10-10 22:47:39.938477
NCT02590172|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-08-12|||December 2016||2016-12-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Observational|UNISURC||Evaluation of the Methods and Effectiveness of Care for Eligible Medical and Surgical Patients on Admission in Continuous Monitoring Units|Evaluation of the Methods and Effectiveness of Care for Eligible Medical and Surgical Patients on Admission in Continuous Monitoring Units|Not yet recruiting||N/A|4600|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 22:47:40.073844|2017-10-10 22:47:40.073844
NCT02590146|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-09-28|||November 2015||2015-11-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Non-Pharmacologic Patient Centered Pain Control Adjuncts During First Trimester Abortion|Non-Pharmacologic Patient Centered Pain Control Adjuncts During First Trimester Abortion|Completed||N/A|74|Actual|University of Hawaii||2|||f||||f||||||||No||2017-10-10 22:47:40.262596|2017-10-10 22:47:40.262596
NCT02590133|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-04-14|||July 2015||2015-07-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC|A Multi-institutional, Randomized Controlled, Phase II Clinical Trial on Comparison of Efficacy and Safety of Nedaplatin Plus 5-Fu Combined With and Without Endostar® Continuous Intravenous Infusion in Refractory Nasopharyngeal Carcinoma|Recruiting||Phase 2|328|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:47:40.351934|2017-10-10 22:47:40.351934
NCT02590120|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-08-31|||February 2015||2015-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PEPS||Enteral Nutrition and Amino Acid Absorption|Comparaison du Profil d'Absorption Des Acides aminés Entre Une Nutrition entérale Semi-élémentaire et Une Nutrition entérale polymérique|Recruiting||N/A|12|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-10 22:47:40.528397|2017-10-10 22:47:40.528397
NCT02590107|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-04-24|||April 1, 2016|Actual|2016-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant|The Effect of Oral Supplementation and Improved Nutritional Status on Hematopoietic Stem Cell Transplant Patients|Recruiting||N/A|98|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-10 22:47:40.622881|2017-10-10 22:47:40.622881
NCT02590094|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-03-31|||October 2015||2015-10-01|March 2017|2017-03-01||||October 2018|Anticipated|2018-10-01||Interventional|||Comparison of Interval Variation and Dosage in Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy|Comparison of Interval Variation and Dosage in Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy|Recruiting||N/A|300|Anticipated|Panhandle Eye Group, LLP||6|||f||||t||||||||||2017-10-10 22:47:40.737393|2017-10-10 22:47:40.737393
NCT02590081|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01||||October 2016|Anticipated|2016-10-01||Interventional|NSD5||Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients|A Prospective Randomized, Double-Blind Parallel Group Trial To Assess The Efficacy And Safety Of Intravenous Dextrose 5% Solution Compare With Normal Saline (Standard Care) In Rinsing During Haemodialysis In Subjects With End Stage Renal Failure (ESRF) With Respect To Systolic Blood Pressure Control Over 3 Months Period.|Unknown status|Not yet recruiting|Phase 4|434|Anticipated|Penang Hospital, Malaysia||2|||f||||f||||||||||2017-10-10 22:47:40.836329|2017-10-10 22:47:40.836329
NCT02590068|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-10-12|||December 2015||2015-12-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination|Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination|Recruiting||N/A|20|Anticipated|Rockefeller University||2|||f||||f||||||||No||2017-10-10 22:47:40.987226|2017-10-10 22:47:40.987226
NCT02590055|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary|Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary|Recruiting||Phase 2|29|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:47:41.10569|2017-10-10 22:47:41.10569
NCT02590042|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-07-17|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|October 2020|Anticipated|2020-10-01||Interventional|||Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction|A Phase I Open-labeled, Single-arm, Single-centred Study to Test the Safety of ADSC-SVF-002 in Subjects With Soft Tissue Defects or Abnormal Wound Healing|Not yet recruiting||Phase 1|10|Anticipated|AdiSave Inc.||1|||f||||f|f|f||||||||2017-10-10 22:47:41.19183|2017-10-10 22:47:41.19183
NCT02590029|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-12-05|||November 2015||2015-11-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Psychosocial Support for Acute Hospital Pain and Distress|Psychosocial Support for Acute Hospital Pain and Distress|Recruiting||N/A|240|Anticipated|University of Utah||3|||f||||||||||||||2017-10-10 22:47:41.367828|2017-10-10 22:47:41.367828
NCT02590016|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-27|||September 2015||2015-09-01|October 2015|2015-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial|Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: Insulin-Glucose-Infusion Versus Observational Approach - Is There a Difference in Neonatal Hypoglycemia Rate?|Unknown status|Recruiting|Phase 4|50|Anticipated|Tampere University Hospital||2|||f||||t||||||||||2017-10-10 22:47:41.565018|2017-10-10 22:47:41.565018
NCT02590003|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-08-23|||November 2015||2015-11-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer|A Randomized Phase II Trial of Combination Versus Single Agent Chemotherapy in High-risk Elderly Patients With Advanced Non-small Cell Lung Cancer|Recruiting||Phase 2|72|Anticipated|Yale University||2|||f||||t||||||||||2017-10-10 22:47:41.69474|2017-10-10 22:47:41.69474
NCT02589990|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-03-07|||January 2016||2016-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|STAGE||Strength Training Adaptations, Age and Genes|Effect of Maximal Strength Training in Relation to Age and Genes|Recruiting||N/A|90|Anticipated|Telemark University College||1|||f||||f||||||||No||2017-10-10 22:47:41.816869|2017-10-10 22:47:41.816869
NCT02589977|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-01-27|||November 2015||2015-11-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|HFpEF-PRoF||Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF|Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF|Recruiting||Phase 4|60|Anticipated|Vanderbilt University Medical Center||3|||f||||f||||||||||2017-10-10 22:47:41.940259|2017-10-10 22:47:41.940259
NCT02589964|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-10-27|||March 2015||2015-03-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Probiotics||Probiotics in the Reduction of Antibiotic Associated Diarrhea|Probiotics in the Reduction of Antibiotic Associated Diarrhea and Clostridium Difficile in Pneumonia Patients Within a Community Teaching Hospital|Terminated||Phase 1|1|Actual|TriHealth Inc.||2||Low Recruitment|f||||f||||||||No|The study was closed due to poor recruitment, so there is no data to share.|2017-10-10 22:47:42.066669|2017-10-10 22:47:42.066669
NCT02589951|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-26|||October 2014||2014-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Missed Serious Medical Illness in Psychiatric Patients Seen in an Academic Emergency Department|Missed Serious Medical Illness in Psychiatric Patients Seen in an Academic Emergency Department|Completed||N/A|2200|Actual|Lawson Health Research Institute|||1||f||||t||||||||||2017-10-10 22:47:42.203719|2017-10-10 22:47:42.203719
NCT02589938|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-05-25|||February 2016||2016-02-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|ACUPUNCTURE||Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer|A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients With Head and Neck Cancer|Recruiting||N/A|240|Anticipated|Wake Forest University Health Sciences||3|||f||||t|f|f||||||No||2017-10-10 22:47:42.288572|2017-10-10 22:47:42.288572
NCT02589925|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-02-07|||November 2016||2016-11-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|Dempark-DBS||Combined Subthalamic and Nucleus Basalis Meynert Deep Brain Stimulation for Parkinson's Disease With Dementia|Kombinierte Tiefe Hirnstimulation Des Nucleus Subthalamicus Und Nucleus Basalis Meynert Zur Behandlung Der Parkinson-Krankheit Mit Demenz|Not yet recruiting||Phase 1|12|Anticipated|Wuerzburg University Hospital||2|||f||||f||||||||||2017-10-10 22:47:42.417004|2017-10-10 22:47:42.417004
NCT02589912|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-12-05||||||November 2016|2016-11-01||||||||Expanded Access|||Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients|Compassionate Use Arm - ABI541 Auditory Brainstem Implant for Neurofibromatosis Type 2 Patients With Deafness|No longer available||N/A|||Massachusetts Eye and Ear Infirmary|||||||||||||||||||2017-10-10 22:47:42.544501|2017-10-10 22:47:42.544501
NCT02589899|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-06-07|||October 2015||2015-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Monitoring of Needle-placement With Multiple Frequency Bioimpedance Monitoring|Monitoring of Needle-placement With Multiple Frequency Bioimpedance Monitoring|Recruiting||N/A|32|Anticipated|Oslo University Hospital|||1||f||||||||||||||2017-10-10 22:47:42.629155|2017-10-10 22:47:42.629155
NCT02589886|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|SHIFT||Self-help and Education on the Internet for Functional Motor Disorders|Self-Help and Education on the Internet for Functional Motor Disorders, a Randomised Controlled Trial (SHIFT)|Recruiting||N/A|200|Anticipated|University Medical Center Groningen||2|||f||||f||||||||Undecided||2017-10-10 22:47:42.739414|2017-10-10 22:47:42.739414
NCT02589873|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-09-18|||September 2015||2015-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2017|Actual|2017-08-01||Interventional|GIBW||Getting in Balance: A Workplace Diabetes Prevention Intervention Trial|A Workplace Intervention Trial Comparing Two Diabetes Prevention Programs - In-person and Online - Delivered in a Large Urban Workplace Environment.|Active, not recruiting||N/A|157|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-10 22:47:42.869053|2017-10-10 22:47:42.869053
NCT02589860|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-09-07|||January 2016||2016-01-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|||Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant|A Pilot Study: Gene Expression and Bacterial Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant|Active, not recruiting||N/A|50|Anticipated|Indiana University|||1||f||||t||||||Samples With DNA|"     Cells collected from oral mucosal samples   "|||2017-10-10 22:47:42.986213|2017-10-10 22:47:42.986213
NCT02589847|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-03-22|||October 2015||2015-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2016|Actual|2016-12-01||Interventional|||Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection|An Open-label Efficacy and Safety Assessment of Rebiotix RBX2660 (Microbiota Suspension) for the Treatment of Recurrent Clostridium Difficile Infection|Active, not recruiting||Phase 2|150|Actual|Rebiotix Inc.||1|||f||||f||||||||||2017-10-10 22:47:43.115845|2017-10-10 22:47:43.115845
NCT02589834|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-27|||April 2015||2015-04-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Quran of Post Operative Pain|The Effect of Listening to Quran During Cesarean Section on Postoperative Pain|Completed||Phase 2|118|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:47:43.274479|2017-10-10 22:47:43.274479
NCT02589821|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-06-19|||December 7, 2015|Actual|2015-12-07|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase III Study of Sulfatinib in Treating Advanced Pancreatic Neuroendocrine Tumors|A Randomized, Double-blind, Multi-center Phase III Clinical Study to Assess the Efficacy and Safety of Sulfatinib Compared to Placebo in Patients With Advanced Pancreatic Neuroendocrine Tumors|Recruiting||Phase 3|195|Anticipated|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-10 22:47:43.356396|2017-10-10 22:47:43.356396
NCT02589808|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-02-19|||July 2015||2015-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|POPPET||Preoperative Pocket Echocardiography Trial|Preoperative Pocket Echocardiography Trial|Completed||N/A|76|Actual|Imperial College London||1|||f||||f||||||||||2017-10-10 22:47:43.473777|2017-10-10 22:47:43.473777
NCT02589795|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-03-08|||November 2015||2015-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers|A Phase I Clinical Trial to Assess the Safety and Immunogenicity of HIV DNA-C CN54ENV Immunisations Administered Via the Intramuscular and Intradermal Methods With and Without Electroporation Followed by Boosting With Recombinant HIV CN54gp140 in Healthy Male and Female Volunteers|Recruiting||Phase 1|24|Anticipated|Imperial College London||3|||f||||f||||||||||2017-10-10 22:47:43.562481|2017-10-10 22:47:43.562481
NCT02589600|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-05-23|||January 2016||2016-01-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|ZEST II||Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)|ZEST II for Osteoporotic Fracture Prevention|Recruiting||Phase 4|514|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 22:47:45.821292|2017-10-10 22:47:45.821292
NCT02589782|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-01-16|||January 2017||2017-01-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|June 2020|Anticipated|2020-06-01||Interventional|TB-PRACTECAL||Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)|A Randomised, Controlled, Open-Label, Phase II-III Trial to Evaluate the Safety and Efficacy of Regimens Containing Bedaquiline and Pretomanid for the Treatment of Adult Patients With Pulmonary Multidrug Resistant Tuberculosis|Recruiting||Phase 2/Phase 3|630|Anticipated|Medecins Sans Frontieres, Netherlands||4|||f||||t||||||||No||2017-10-10 22:47:43.660928|2017-10-10 22:47:43.660928
NCT02589769|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons|Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons|Recruiting||N/A|84|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 22:47:43.823988|2017-10-10 22:47:43.823988
NCT02589756|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-04-19|||September 2015||2015-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Fish or Nuts? Dietary Effects on Cardiometabolic Risk Factors and Persistent Organic Pollutants|Fish or Nuts? Dietary Effects on Cardiometabolic Risk Factors and Persistent Organic Pollutants|Recruiting||N/A|120|Anticipated|Oslo University Hospital||3|||f||||t||||||||||2017-10-10 22:47:43.915922|2017-10-10 22:47:43.915922
NCT02589743|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2015-10-27|||April 2003||2003-04-01|October 2015|2015-10-01|June 2005|Actual|2005-06-01|June 2003|Actual|2003-06-01||Interventional|||Randomized Clinical Trial of Occlusal Sealant|Impact of the Intermediary Layer on Sealant Retention: A Randomized 24-month Clinical Trial|Completed||Phase 2|65|Actual|University of Campinas, Brazil||4|||f||||t||||||||||2017-10-10 22:47:44.019238|2017-10-10 22:47:44.019238
NCT02589730|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Effect of Smart Phone Application on the Individualized Management of Chinese Diabetic Patients|Individualized Management Based on Mobile Phone Platform in Diabetic Patients|Unknown status|Recruiting|N/A|234|Anticipated|Shanghai Geping Information Technology Company||3|||f||||f||||||||||2017-10-10 22:47:44.090559|2017-10-10 22:47:44.090559
NCT02589717|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-11-01|||November 2015||2015-11-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Expanded Access|||An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy|An Open-Label, Multicenter, Expanded Access Program for Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy.|Approved for marketing||N/A|||Genentech, Inc.|||||||||||||||||||2017-10-10 22:47:44.172636|2017-10-10 22:47:44.172636
NCT02589704|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-07-29|||November 2015||2015-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Nutritional Status of Cerebral Palsy Patients in Turkey|A Prospective, Cross Sectional Study to Evaluate the Etiology and Nutritional Status of Cerebral Palsy Patients in Turkey|Completed||N/A|1123|Actual|Abbott Nutrition|||1||f||||f||||||||||2017-10-10 22:47:44.306381|2017-10-10 22:47:44.306381
NCT02589691|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-07-26|||December 23, 2015|Actual|2015-12-23|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ROC-HYPOX||Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX)|Addition of Neuromuscular-Blocking Agents During Sevoflurane Induction in Infants : Potential Interest in Reducing Hypoxemia Episodes|Recruiting||Phase 4|412|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||||||||||||2017-10-10 22:47:44.40451|2017-10-10 22:47:44.40451
NCT02589678|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-12-01|||August 2015||2015-08-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SiVET||Zambia SiVET MMR Tdap-IPV|A Simulated Vaccine Efficacy Trial Using MMR and Tdap-IPV Vaccines in Healthy, HIV Negative Women at High Risk of HIV Infection in Lusaka and Ndola, Zambia.|Active, not recruiting||Phase 1/Phase 2|160|Actual|Emory University||2|||f||||f||||||||||2017-10-10 22:47:44.480968|2017-10-10 22:47:44.480968
NCT02589665|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-10-03|||December 2015||2015-12-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis|A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis|Recruiting||Phase 2|240|Anticipated|Eli Lilly and Company||7|||f||||f||||||||||2017-10-10 22:47:44.593181|2017-10-10 22:47:44.593181
NCT02589652|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy|Efficacy of Switch or Sequential Combination Therapy of Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Low HBsAg and HBeAg Titers After Long-term Entecavir Therapy: A Multicenter, Prospective Cohort Study|Unknown status|Not yet recruiting|N/A|294|Anticipated|Huashan Hospital|||3||f||||t||||||||||2017-10-10 22:47:45.262811|2017-10-10 22:47:45.262811
NCT02589639|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-08-25|||October 28, 2015|Actual|2015-10-28|August 2017|2017-08-01|January 16, 2018|Anticipated|2018-01-16|September 2, 2017|Anticipated|2017-09-02||Interventional|||Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus|A 52-week Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Empagliflozin Once Daily, as an add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control|Active, not recruiting||Phase 4|269|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 22:47:45.435229|2017-10-10 22:47:45.435229
NCT02589626|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-06-29|||October 29, 2015|Actual|2015-10-29|June 2017|2017-06-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|||Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA|A 52-week Randomised, Double-blind, Parallel Group, Safety and Efficacy Study of Empagliflozin Once Daily as add-on Therapy to Glucagon-like Peptide-1 Receptor Agonist in Japanese Type 2 Diabetes Mellitus Patients With Insufficient Glycaemic Control|Completed||Phase 4|65|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:47:45.623844|2017-10-10 22:47:45.623844
NCT02589613|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-26|||October 2013||2013-10-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Glucose and Fructose Stimulated Brain Activity in Obese Subjects|Effects of Acute Glucose and Fructose Ingestion on Brain Activity in Obese Volunteers|Completed||N/A|12|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-10 22:47:45.736818|2017-10-10 22:47:45.736818
NCT02589587|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-04-11|||October 2013||2013-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Enteroendocrine Cells Before and After Sleeve Gastrectomy|Enteroendocrine Cells in Lean Controls and Healthy Subjects Before and After Sleeve Gastrectomy|Completed||N/A|40|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||Undecided||2017-10-10 22:47:45.941747|2017-10-10 22:47:45.941747
NCT02589574|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-07-26|||November 2015||2015-11-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Improving Influenza Vaccination Rates in Nurses Through Text Message Reminders : a RCT|Improving Influenza Vaccination Rates in Nurses Through Electronic Text Message Reminders : a Randomised Controlled Trial|Recruiting||N/A|537|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:47:46.023822|2017-10-10 22:47:46.023822
NCT02589561|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-07-27|||October 2015||2015-10-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|May 2016|Actual|2016-05-01||Interventional|REFITHEARING||REFIT Hearing: Remote Fitting of Hearing Aids|REFIT Hearing: Remote Fitting of Hearing Aids|Active, not recruiting||N/A|60|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||No||2017-10-10 22:47:46.116802|2017-10-10 22:47:46.116802
NCT02589548|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-05-10|||October 2009||2009-10-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Brazilian Prospective Hodgkin Lymphoma Registry|Brazilian Prospective Hodgkin Lymphoma Registry|Recruiting||N/A|1000|Anticipated|Universidade Federal do Rio de Janeiro|||1||f||||f||||||Samples With DNA|"     Formalin-fixed tissue for central diagnostic pathology review   "|||2017-10-10 22:47:46.208746|2017-10-10 22:47:46.208746
NCT02589535|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-24|2016-11-14|||November 2015||2015-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01|2 Weeks|Observational [Patient Registry]|||Circulating Stem Cells, SDF-1, HIF-1 and Sepsis's Indices in Emergency Abdominal Surgical Patients|Circulating Stem Cells, SDF-1, HIF-1 and Sepsis: Relationship Between Indices of Sepsis and Emergency Abdominal Surgical Patients|Recruiting||N/A|1000|Anticipated|University of Foggia|||2||f||||f||||||Samples Without DNA|"     blood samples   "|||2017-10-10 22:47:46.300737|2017-10-10 22:47:46.300737
NCT02589522|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-09-12|||July 21, 2016|Actual|2016-07-21|September 2017|2017-09-01||||September 30, 2018|Anticipated|2018-09-30||Interventional|||VX-970 and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer|Phase 1 Trial to Determine the Recommended Phase 2 Dose (RP2D) of VX-970 When Combined With Whole Brain Radiotherapy (WBRT) in Patients With Brain Metastases From Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|46|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 22:47:46.382523|2017-10-10 22:47:46.382523
NCT02589509|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-10-06|||December 2015||2015-12-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Cognitive Rehabilitation and Brain Activity of Attention Control in TBI|Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI|Recruiting||N/A|36|Anticipated|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-10 22:47:46.527419|2017-10-10 22:47:46.527419
NCT02589496|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-02-10|||March 26, 2016|Actual|2016-03-26|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis|Phase II Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis|Recruiting||Phase 2|40|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:47:46.670678|2017-10-10 22:47:46.670678
NCT02589483|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-04-12|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Reinforcement of Rectal Anastomosis-RORA|RORA (Reinforcement of Rectal Anastomosis(<10cm) With HemoPatch - Pilot Study|Recruiting||N/A|10|Anticipated|Capio Sankt Görans Hospital||1|||f||||f||||||||No||2017-10-10 22:47:46.753915|2017-10-10 22:47:46.753915
NCT02589470|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-27|||January 2016||2016-01-01|October 2015|2015-10-01|January 2019|Anticipated|2019-01-01|February 2016|Anticipated|2016-02-01||Interventional|COMETE||COMETE Study : COgnitive Rehabilitation of MEmory in Temporal Epilepsy|COMET Study Effectiveness of a Cognitive Remediation Program of Memory in Patients With Temporal Lobe Epilepsy|Not yet recruiting||N/A|120|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 22:47:46.848085|2017-10-10 22:47:46.848085
NCT02589457|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-01-11|||October 2015||2015-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet|A Randomized, Open-label, Single-dosing, 2x2 Crossover Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet (Tenofovir Disoproxil Aspartate) With Viread® Tablet (Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers|Completed||Phase 1|40|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:47:46.93028|2017-10-10 22:47:46.93028
NCT02589444|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-06-10|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Vitamin D and Microbiota in Cystic Fibrosis|Pilot Study Evaluating the Role of Vitamin D Repletion on Gut and Lung Microbiota in Cystic Fibrosis|Completed||N/A|41|Actual|Emory University||3|||f||||f||||||||||2017-10-10 22:47:47.016563|2017-10-10 22:47:47.016563
NCT02589431|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-27|||June 2009||2009-06-01|October 2015|2015-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Comparison of Total, Salivary and Calculated Free Cortisol Levels in Patients With Severe Sepsis|Comparison of Total, Salivary and Calculated Free Cortisol Levels in Patients With Severe Sepsis|Completed||N/A|46|Actual|TC Erciyes University|||2||f||||f||||||||||2017-10-10 22:47:47.130851|2017-10-10 22:47:47.130851
NCT02589418|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-14|||October 2015||2015-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|MAC-DENT1||Mechanisms of Acupuncture Analgesia on Experimental Dental Pain - A Psychophysical Study (Phase1)|Mechanisms of Acupuncture Analgesia on Experimental Dental Pain - A Randomized, Single Blinded, Sham-controlled Psychophysical Study (Phase1)|Completed||N/A|35|Actual|University of Zurich||1|||f||||t||||||||||2017-10-10 22:47:47.206337|2017-10-10 22:47:47.206337
NCT02589054|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-03-29|||November 2015||2015-11-01|October 2015|2015-10-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Observational|RAFFAB||Regional Changes in Upper Limb Perfusion Following Brachial Plexus Block: A Pilot Study|Regional Changes in Upper Limb Perfusion Following Brachial Plexus Block: A Pilot Study|Completed||N/A|18|Actual|Lawson Health Research Institute|||1||f||||||||||||||2017-10-10 22:47:50.783074|2017-10-10 22:47:50.783074
NCT02589392|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-01|||May 2015||2015-05-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis|Effect of Cetaphil® Restoraderm® Moisturizer on Very Dry Skin in Children With a Controlled Atopic Dermatitis:a Randomised, Parallel Group Study|Completed||Phase 4|120|Actual|Galderma||2|||f||||f||||||||||2017-10-10 22:47:47.4164|2017-10-10 22:47:47.4164
NCT02589379|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-01-16|||July 2015||2015-07-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|PMPPOPF||Ultrasound Elastography for Prediction of Postoperative Pancreatic Fistula|The Value of Endoscopic Ultrasound Elastography for Prediction of Pancreatic Fistula in Patients Undergoing Pancreatic Resection for Benign or Malignant Disease|Recruiting||N/A|90|Anticipated|University of Zurich|||1||f||||t||||||Samples Without DNA|"     Non-tumorous pancreatic tissue   "|||2017-10-10 22:47:47.519412|2017-10-10 22:47:47.519412
NCT02589366|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-06-06|||November 2015||2015-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium|A Phase I, Prospective, Open-Label, Comparison Study of Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Cancer of the the Endometrium Who Are Undergoing Lymph Node Dissection|Recruiting||Phase 1|10|Anticipated|University of California, San Diego||1|||f||||t||||||||No||2017-10-10 22:47:47.63301|2017-10-10 22:47:47.63301
NCT02589353|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-18|||May 1, 2016|Actual|2016-05-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Human Oral Detection of Glucose Olygomers|The Role of Salivary Contents in Taste Perception of Starch and Its Hydrolysis Products|Recruiting||Phase 4|300|Anticipated|Oregon State University||1|||f||||||||||||||2017-10-10 22:47:47.729449|2017-10-10 22:47:47.729449
NCT02589340|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-09-29|||January 2016||2016-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BUS-PD||Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia|Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia|Recruiting||Phase 1|15|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 22:47:47.802082|2017-10-10 22:47:47.802082
NCT02589327|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-05-09|||October 2015||2015-10-01|September 2015|2015-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Exercise on Cardiac Fat in Women With Obesity: a Pilot Study|Effects of Exercise on Cardiac Fat in Women With Obesity: a Pilot Study|Completed||N/A|15|Actual|Texas Tech University||2|||f||||t||||||||||2017-10-10 22:47:47.89296|2017-10-10 22:47:47.89296
NCT02589314|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-05-01|||November 2015||2015-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Periodontal Therapy in the Systemic Status of Individuals With Chronic Periodontitis and Diabetes Type 2|Effect of Mechanical Periodontal Therapy in the Microbiological, Immunocellular and Immunoglobulin Profiles and in the Dosage of Pro and Anti-inflammatory Cytokines From Peripheral Blood and Saliva of Subjects With Chronic Periodontitis and Diabetes Type 2|Active, not recruiting||N/A|90|Anticipated|University of Brasilia||1|||f||||||||||||||2017-10-10 22:47:47.969422|2017-10-10 22:47:47.969422
NCT02589301|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-02-06|||November 2015|Actual|2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|||Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations|A Single-center, Open-label, Parallel Study With Single Subcutaneous Injection for Pharmacokinetics and Pharmacodynamics Comparison of Two Pegfilgrastim Formulations in Both Male and Female Healthy Volunteers, Test Formulation is an Injectable Solution Containing 6 mg of Pegfilgrastim, Manufactured by Eurofarma Laboratórios S/A, and Reference Formulation (Neulastim® Injectable Solution Containing 6 mg) Marketed by Produtos Roche Químicos e Farmacêuticos S/A|Completed||Phase 1|100|Actual|Eurofarma Laboratorios S.A.||2|||f||||f||||||||||2017-10-10 22:47:48.040992|2017-10-10 22:47:48.040992
NCT02589288|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-08-11|||November 2015||2015-11-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus|Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus For Postoperative Analgesia After Day-Case Anterior Cruciate Ligament Reconstruction|Completed||N/A|80|Actual|ASST Gaetano Pini-CTO||2|||f||||f||||||||||2017-10-10 22:47:48.161753|2017-10-10 22:47:48.161753
NCT02589275|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-09-19|||August 2015||2015-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients|A 3-Month, Multicenter, Open-Label Extension to Evaluate Safety and Efficacy of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia|Terminated||Phase 3|375|Actual|Tonix Pharmaceuticals, Inc.||1||"For business reason unrelated to safety or tolerability,Tonix has discontinued the Fibromyalgia   development with TNX102 SL."|f||||f||||||||||2017-10-10 22:47:48.335771|2017-10-10 22:47:48.335771
NCT02589262|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-10-13|||September 2015||2015-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Safety, Blood Levels and Effects of AUT00206|A Randomised, Double-blind, Placebo-controlled, Single and Repeated Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AUT00206 in Healthy Volunteers.|Completed||Phase 1|||Autifony Therapeutics Limited|||||f||||f||||||||||2017-10-10 22:47:48.547396|2017-10-10 22:47:48.547396
NCT02589249|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-04-16|||November 2015||2015-11-01|April 2017|2017-04-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Interventional|||The Effect of AyuFlex® Supplementation on Joint Health|The Effect of AyuFlex® Dietary Supplementation on Joint Mobility, Comfort and Functional Capacity in Healthy Overweight Subjects|Completed||N/A|105|Actual|The Center for Applied Health Sciences, LLC||3|||f||||t||||||||Undecided||2017-10-10 22:47:48.618224|2017-10-10 22:47:48.618224
NCT02589041|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-08-11|||November 2015||2015-11-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|October 2016|Actual|2016-10-01||Interventional|||US-guided Sciatic Nerve Block: Evaluation of the Intraneural Ropivacaine Minimal Effective Volume (MEV90)|Ultrasound-guided Popliteal Sciatic Nerve Block: an Evaluation of the Intraneural|Completed||N/A|45|Actual|ASST Gaetano Pini-CTO||1|||f||||f||||||||||2017-10-10 22:47:50.857018|2017-10-10 22:47:50.857018
NCT02589236|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-06|||November 2015||2015-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SNO-6||Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation Treated With Lumacaftor/Ivacaftor|Completed||Phase 2|138|Actual|Nivalis Therapeutics, Inc.||3|||f||||t||||||||||2017-10-10 22:47:48.725233|2017-10-10 22:47:48.725233
NCT02589223|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-04-25|||February 16, 2017|Actual|2017-02-16|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Trial to Determine the Feasibility and Effectiveness of Early Multisensory Stimulation Intervention in Patients in the Trauma-Neurosurgical Intensive Care Unit (TNICU) Following Severe Acquired Brain Injury|A Pilot Randomized Controlled Trial to Determine the Feasibility and Effectiveness of Early Multisensory Stimulation Intervention in Patients in the Trauma-Neurosurgical Intensive Care Unit (TNICU) Following Severe Acquired Brain Injury|Recruiting||N/A|20|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||No||2017-10-10 22:47:48.974719|2017-10-10 22:47:48.974719
NCT02589210|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-08-23|||May 2015||2015-05-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||dHACM Mesh In the Treatment of Diabetic Foot Ulcers|A Single Center, Prospective, Single-Blinded, Non-Randomized, Historical Controlled Trial of dHACM Mesh In the Treatment of Diabetic Foot Ulcers|Completed||N/A|10|Actual|MiMedx Group, Inc.||1|||f||||t||||||||||2017-10-10 22:47:49.104034|2017-10-10 22:47:49.104034
NCT02589197|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-06-02|||July 13, 2016|Actual|2016-07-13|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Observational|GOLD||Gait and Functional Outcomes Study Following Total Knee Arthroplasty With Medial-pivot or Posterior-stabilized Implants|Muscle Activation and Biomechanical Function of the Lower-limb Joints Following Total Knee Arthroplasty With Medial-pivot or Posterior-stabilized Implants: an Electromyography Study|Recruiting||N/A|60|Anticipated|MicroPort Orthopedics Inc.|||3||f||||f||||||||No||2017-10-10 22:47:49.200775|2017-10-10 22:47:49.200775
NCT02589184|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-02-16|||October 2015||2015-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effects on Shoulder Pain of Simulated Hyper-gravity During Rehabilitation Exercises|Effects on Shoulder Pain of Simulated Hyper-gravity During Rehabilitation Exercises|Withdrawn||N/A|0|Actual|Carrick Institute for Graduate Studies||4||Logistics reason at the data collection site|f||||f||||||||||2017-10-10 22:47:49.3292|2017-10-10 22:47:49.3292
NCT02589171|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-10-24|||February 2016||2016-02-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The neoClose Abdominal Closure vs Carter-Thomason Trial|Randomized Trial Evaluating Effectiveness of neoClose Abdominal Closure Device Versus Carter-Thomason Needle Passer|Recruiting||N/A|70|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||Yes||2017-10-10 22:47:49.436303|2017-10-10 22:47:49.436303
NCT02589158|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-03-21|||November 2015||2015-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat|Steady-state Pharmacokinetics of Atazanavir/Cobicistat and Darunavir/Cobicistat Once Daily Over 72 Hours in Healthy Volunteers|Completed||Phase 1|16|Actual|St Stephens Aids Trust||1|||f||||||||||||||2017-10-10 22:47:49.55522|2017-10-10 22:47:49.55522
NCT02589145|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-08-02|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype|Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype|Recruiting||Phase 1/Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:47:49.66069|2017-10-10 22:47:49.66069
NCT02589132|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-10-26|||August 2015||2015-08-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Mobile-Thrive - A Family Self-Management Approach to Failure to Thrive|Mobile-Thrive - A Family Self-Management Approach to Failure to Thrive|Recruiting||N/A|40|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-10 22:47:49.824799|2017-10-10 22:47:49.824799
NCT02589106|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-08-17|||January 2017||2017-01-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Anisotropic Textile Braces for Adolescent Idiopathic Scoliosis|Safety and Efficacy of Anisotropic Textile Braces for Adolescent Idiopathic Scoliosis|Active, not recruiting||Early Phase 1|15|Anticipated|The Hong Kong Polytechnic University||1|||f||||t||||||||||2017-10-10 22:47:50.398021|2017-10-10 22:47:50.398021
NCT02589080|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2016-09-07|||January 2015||2015-01-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|EPIONE||Phantom Limb Pain: Efficacy of Non-invasive Sensory Feedback Through the Prosthesis|Phantom Limb Pain: Efficacy of Non-invasive Sensory Feedback Through the Prosthesis|Recruiting||N/A|10|Anticipated|Lund University Hospital||1|||f||||f||||||||||2017-10-10 22:47:50.599262|2017-10-10 22:47:50.599262
NCT02589067|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-07|||October 2015||2015-10-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Decolonization of the Oropharynx, an Important and Neglected Reservoir of S. Aureus Colonization|Decolonization of the Oropharynx, an Important and Neglected Reservoir of S. Aureus Colonization.|Recruiting||Phase 2|240|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-10-10 22:47:50.688189|2017-10-10 22:47:50.688189
NCT02589028|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||The Effects of Premeal Consumption of Protein-enriched Bar on Blood Glucose Level and Secretion of Hormones|The Effects of Premeal Consumption of Protein-enriched Bar on Blood Glucose Level and Secretion of Hormones in Healthy Adults and Patients With Type 2 Diabetes|Unknown status|Recruiting|N/A|30|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:47:50.928886|2017-10-10 22:47:50.928886
NCT02589015|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-02-10|||March 2015||2015-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Correlation of Neck Circumference With Difficult Mask Ventilation and Difficult Laryngoscopy in Morbidly Obese Patients|Correlation of Neck Circumference With Difficult Mask Ventilation and Difficult Laryngoscopy in Morbidly Obese Turkish Patients: A Prospective Clinical Trial|Completed||N/A|120|Actual|Istanbul University|||1||f||||t||||||||Undecided||2017-10-10 22:47:51.038118|2017-10-10 22:47:51.038118
NCT02589002|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-08-29|||July 2015||2015-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|Sucralose||Effects of Sucralose on Glucose Metabolism|Effects of Sucralose on Insulin Sensitivity, Pancreatic Response and Appetite Regulating Hormones|Recruiting||N/A|66|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-10 22:47:51.129302|2017-10-10 22:47:51.129302
NCT02588989|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-05-11|||October 2015||2015-10-01|May 2016|2016-05-01|December 2026|Anticipated|2026-12-01|December 2016|Anticipated|2016-12-01||Observational|||Fibrosis, Valvular and Ventricular Function in Patients With TGA|Fibrosis, Valvular and Ventricular Function in Patients With Transposition of the Great Arteries|Recruiting||N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     Intracellular RNA collection from whole blood   "|||2017-10-10 22:47:51.220382|2017-10-10 22:47:51.220382
NCT02588976|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-11-14|||July 2009||2009-07-01|November 2016|2016-11-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|SONEW||Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery|Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery|Completed||N/A|30|Actual|Triemli Hospital||1|||f||||f||||||||No||2017-10-10 22:47:51.326294|2017-10-10 22:47:51.326294
NCT02588963|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-28|||January 2015||2015-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2015|Actual|2015-09-01||Interventional|PRICAD||Prevention of Respiratory Infections Among Children Under 3 Years of Age Attending Daycare Centres|Prevention of Respiratory Infections Among Children Under 3 Years of Age Attending|Active, not recruiting||N/A|200|Actual|Polytechnic Institute of Porto||4|||f||||t||||||||Undecided||2017-10-10 22:47:51.400258|2017-10-10 22:47:51.400258
NCT02588950|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-06-06|||January 12, 2016|Actual|2016-01-12|June 2017|2017-06-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes|Comparative Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered Subcutaneously as a Bolus Via Syringe Versus Continuous Subcutaneous Insulin Infusion and Characterization of TID and BID Dosing at Steady State in High-Dose Insulin-Treated Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 1|32|Actual|Eli Lilly and Company||4||Slow enrollment|f||||f||||||||||2017-10-10 22:47:51.485324|2017-10-10 22:47:51.485324
NCT02588937|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-12-12|||October 2015||2015-10-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients||Unknown status|Active, not recruiting|Phase 4|76|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||||||||||||2017-10-10 22:47:51.599277|2017-10-10 22:47:51.599277
NCT02588924|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-10-26|||September 2015||2015-09-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Observational|||Study on the Relationship Between Environmental and Occupational Exposure to Metals and Parkinson's Disease|Study on the Relationship Between Environmental and Occupational Exposure to Metals and Parkinson's Disease|Unknown status|Enrolling by invitation|Phase 1|100|Anticipated|"University of Campania Luigi Vanvitelli"|||2||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-10 22:47:51.698297|2017-10-10 22:47:51.698297
NCT02588911|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-26|||November 2013||2013-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency|Randomised Trial of Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency: if You Don't Tell, They Won't Know|Completed||N/A|18|Actual|Hospital Israelita Albert Einstein||2|||f||||f||||||||||2017-10-10 22:47:51.782559|2017-10-10 22:47:51.782559
NCT02588898|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-27|||September 2009||2009-09-01|October 2015|2015-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes|B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes|Completed||N/A|212|Actual|Saarland University|||2||f||||f||||||Samples Without DNA|"     Fasting blood samples (serum, whole blood and EDTA-plasma)   "|||2017-10-10 22:47:51.889352|2017-10-10 22:47:51.889352
NCT02588885|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|RESPECT||Restoring Emotional, Sexual, and Physical Empowerment Through CBT & Trauma-sensitive Care: A Chronic Pelvic Pain Intervention|Restoring Emotional, Sexual, and Physical Empowerment Through CBT & Trauma-sensitive Care: A Chronic Pelvic Pain Intervention|Unknown status|Recruiting|N/A|50|Anticipated|Rush University Medical Center||1|||f||||f||||||||||2017-10-10 22:47:51.97881|2017-10-10 22:47:51.97881
NCT02588872|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2017-05-20|2017-04-12||August 2011||2011-08-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|HA vs PRP||Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis|Hyaluronic Acid vs Platelet Rich Plasma: Prospective Double-blind Randomized Controlled Trial Comparing Clinical Outcomes and the Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis|Completed||N/A|111|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-10 22:47:52.088955|2017-10-10 22:47:52.088955
NCT02588859|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-02-22|||October 2015||2015-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|ONTARGET-INDIA||Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients|A Non-Interventional, Multicentre, Prospective, Observational Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Patients. (ONTARGET-India)|Completed||N/A|1200|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 22:47:52.349554|2017-10-10 22:47:52.349554
NCT02588846|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-05-01|||January 2018|Anticipated|2018-01-01|August 2016|2016-08-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Multi-target Tracking in Prostate Radiotherapy Using MLC and KIM|Phase I Feasibility Study of Accounting for Relative Motion of Multiple Targets in Prostate Cancer Radiotherapy Using Realtime Multi-leaf Collimator Adaptation and Kilovoltage (kV) Intrafraction Monitoring|Not yet recruiting||N/A|30|Anticipated|Royal North Shore Hospital||2|||f||||t|f|f||||||Yes|Share for research purposes with interested parties.|2017-10-10 22:47:54.263028|2017-10-10 22:47:54.263028
NCT02588833|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-01-26|||November 2015||2015-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PADDOCK||Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. APL-2 in PNH Subjects|A Phase Ib, Open Label, Multiple Ascending Dose, Pilot Study to Assess the Safety, Preliminary Efficacy and Pharmacokinetics of Subcutaneously Administered APL-2 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)|Recruiting||Phase 1|6|Anticipated|Apellis Pharmaceuticals, Inc.||3|||f||||||||||||||2017-10-10 22:47:54.368065|2017-10-10 22:47:54.368065
NCT02588820|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-08-16|||April 2016||2016-04-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|VIRECURE||Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection|Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection: A Pilot Comparative Study|Recruiting||Phase 3|15|Anticipated|Hospital Clinic of Barcelona||1|||f||||t||||||||||2017-10-10 22:47:54.448198|2017-10-10 22:47:54.448198
NCT02588807|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-07-14|||July 2017|Anticipated|2017-07-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|ALS-PHL||Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis|The Combination of Phospholipids and Medical Herbs for the Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS); A Pilot Study|Not yet recruiting||Phase 1|10|Anticipated|Herb Spirit||1|||f||||f|f|f||||||||2017-10-10 22:47:54.52704|2017-10-10 22:47:54.52704
NCT02588794|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|CASAKI||Cytokine Adsorption in Sepsis and Acute Kidney Injury|Cytokine Adsorption in Sepsis and Acute Kidney Injury|Recruiting||N/A|124|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-10 22:47:54.597923|2017-10-10 22:47:54.597923
NCT02588781|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2017-04-25|||October 2015||2015-10-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study|Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study|Recruiting||Phase 2|29|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:47:54.711712|2017-10-10 22:47:54.711712
NCT02588768|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-24|2016-02-02|||February 2015||2015-02-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Photobiomodulation Therapy in a Field Test With High-level Rugby Players|Phototherapy (With a Combination of Super-pulsed Laser and LEDs) in a Field Test With High-level Rugby Players|Completed||N/A|12|Actual|University of Nove de Julho||2|||f||||t||||||||Yes|all data is properly stored in electronic devices and available for possible doubts regarding to methodological procedures or results.|2017-10-10 22:47:54.80158|2017-10-10 22:47:54.80158
NCT02588755|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-27|2016-03-30|||December 2015||2015-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection|Anti-tumor Recurrence With Transarterial Chemoembolization (TACE) Plus Tegafur Versus TACE on Patients With Intrahepatic Cholangiocarcinoma After Curative Resection：A Randomized Controlled Study|Recruiting||N/A|180|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 22:47:54.904045|2017-10-10 22:47:54.904045
NCT02588742|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Melatonin on Postoperative Delirium in Elderly ICU Patients|The Effect of Melatonin on Postoperative Delirium in Elderly ICU Patients : Randomized, Placebo-controlled, Double Blind Study|Unknown status|Not yet recruiting|N/A|114|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 22:47:54.98935|2017-10-10 22:47:54.98935
NCT02588729|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-03-06|||October 2015||2015-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|May 2017|Anticipated|2017-05-01||Interventional|||A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCT|A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With Gestational Diabetes Mellitus - RCT|Recruiting||N/A|230|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-10 22:47:55.199242|2017-10-10 22:47:55.199242
NCT02588716|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-07-19|||September 2015||2015-09-01|July 2016|2016-07-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Terlipressin on Blood Loss and Transfusion Requirements During Major Liver Resection.|Effects of Terlipressin on Blood Loss and Transfusion Requirements During Major Liver Resection.|Completed||Phase 2|40|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:47:55.322522|2017-10-10 22:47:55.322522
NCT02588703|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-04-13|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Delivering Treatment in DUI Programs to Reduce Alcohol-Related Disparities|Delivering Treatment in DUI Programs to Reduce Alcohol-Related Disparities|Enrolling by invitation||Phase 2|300|Anticipated|RAND||2|||f||||t||||||||||2017-10-10 22:47:55.4194|2017-10-10 22:47:55.4194
NCT02588690|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-07-19|||November 2015||2015-11-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|BFW||Beauty From Within Community Screening Project|Beauty From Within Community Screening Project|Active, not recruiting||N/A|400|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 22:47:55.495519|2017-10-10 22:47:55.495519
NCT02588677|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-04-20|||April 2013||2013-04-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 5, 2016|Actual|2016-12-05||Interventional|||The Objective is to Compare the Efficacy and Safety of Masitinib in Combination With Riluzole in the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)|Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel Group, Phase 2/3 Study to Compare the Efficacy and Safety of Masitinib|Completed||Phase 2/Phase 3|394|Actual|AB Science||3|||f||||t||||||||||2017-10-10 22:47:55.583147|2017-10-10 22:47:55.583147
NCT02588664|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-01-05|||July 2016||2016-07-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|October 2018|Anticipated|2018-10-01||Interventional|COMPASS||Comprehensive Post-Acute Stroke Services|Early Supported Discharge for Improving Functional Outcomes After Stroke|Recruiting||N/A|6000|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||Undecided|TBD|2017-10-10 22:47:55.682055|2017-10-10 22:47:55.682055
NCT02588651|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-23|||June 2016||2016-06-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)|A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)|Recruiting||Phase 2|31|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:47:55.918915|2017-10-10 22:47:55.918915
NCT02588638|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-10-26|||December 2015||2015-12-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01|1 Day|Observational [Patient Registry]|NextGen-SE||Next Generation Sequencing Diagnostics - On the Road to Rapid Diagnostics for Rare Diseases|Next Generation Sequencing Diagnostics - On the Road to Rapid Diagnostics for Rare Diseases|Recruiting||N/A|100|Anticipated|University Hospital Tuebingen|||2||f||||f||||||Samples With DNA|"     Blood sample   "|||2017-10-10 22:47:56.017912|2017-10-10 22:47:56.017912
NCT02588625|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-07-20|||February 2016||2016-02-01|July 2016|2016-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)|A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)|Withdrawn||Phase 2|0|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 22:47:56.111194|2017-10-10 22:47:56.111194
NCT02588599|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2016-08-20|2016-06-09||October 2015||2015-10-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis|A Retrospective Evaluation of the Effect of the Erchonia LUNULA™ on the Increase of Clear Nail in Patients With Toenail Onychomycosis|Completed||N/A|54|Actual|Erchonia Corporation||1|||f||||f||||||||No||2017-10-10 22:47:56.451392|2017-10-10 22:47:56.451392
NCT02588586|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-12-20|||October 2015||2015-10-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of the Safety and Antiretroviral Activity of 3BNC117|An Open Label, Phase 2 Study of the Safety and Antiretroviral Activity of 3BNC117 in HIV-Infected Individuals on Combination Antiretroviral Therapy|Active, not recruiting||Phase 1/Phase 2|17|Actual|Rockefeller University||1|||f||||t||||||||No||2017-10-10 22:47:56.63738|2017-10-10 22:47:56.63738
NCT02588560|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-26|||September 2015||2015-09-01|August 2015|2015-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy|Serial Viral Load Changes and Hepatotoxicity in Lymphoma Patients With Hepatitis C Antibody After Chemotherapy Treatment: A Prospective Multicenter Observational Study and Long-term Retrospective Analysis|Enrolling by invitation||N/A|38|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||Samples With DNA|"     Peripheral blood mononuclear cells   "|||2017-10-10 22:47:57.091022|2017-10-10 22:47:57.091022
NCT02588547|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-24|2017-06-23|||November 2015|Actual|2015-11-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Prevention of Spinal Induced Shivering During CS|Prophylactic Granisetron for the Prevention of Spinal Induced Shivering During Cesarean Section: a Prospective Double Blind Dose Ranging Clinical Study|Recruiting||Phase 2|120|Anticipated|Assiut University||4|||f||||f||||||||||2017-10-10 22:47:57.201157|2017-10-10 22:47:57.201157
NCT02588534|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-10-26|||August 2004||2004-08-01|October 2015|2015-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects|An Open-label, Randomized, 2-period Crossover Bioequivalence Study Comparing a 50-mg Dose of Liquid Etanercept Administered to Healthy Subjects by Subcutaneous Injection in the Thigh Using an Auto-injector Device and Manual Injection|Completed||Phase 1|36|Actual|Amgen||2|||f||||f||||||||||2017-10-10 22:47:57.360551|2017-10-10 22:47:57.360551
NCT02588508|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-11-18|||April 2015||2015-04-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Effectiveness of Warm Packs, Perineal Massage and Hands Off During Labour in the Perineal Outcomes.|Effectiveness of Warm Packs, Perineal Massage and Hands Off During Labour in the Perineal Outcomes.|Recruiting||N/A|201|Anticipated|Universidade Federal de Pernambuco||3|||f||||f||||||||||2017-10-10 22:47:57.661016|2017-10-10 22:47:57.661016
NCT02588495|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-11-06|||August 2014||2014-08-01|November 2015|2015-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||"Accuracy of Gastric Ultrasound to Diagnose a Full Stomach. A Bayesian Framework"|"Accuracy of Gastric Ultrasound to Diagnose a Full Stomach. A Bayesian Framework"|Recruiting||N/A|80|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 22:47:57.856196|2017-10-10 22:47:57.856196
NCT02588482|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-26|||November 2014||2014-11-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Interventional|COMETIQUE||Comparison Between High-density Electroencephalography and Conventional Electroencephalography for Comatose Patients|Comparison Between High-density Electroencephalography and Conventional Electroencephalography to Diagnose the Presence of Consciousness in Post-anoxic Comatose Patients|Unknown status|Recruiting|N/A|66|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-10 22:47:57.966548|2017-10-10 22:47:57.966548
NCT02588469|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-08-04|||August 2015||2015-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|OBESOMAC||Exercise and Venous Compression on Upper Airway Resistance in Obese Teenagers With OSA|Effects of Exercise and Venous Compression on Upper Airway Resistance in Obese Teenagers With Obstructive Sleep Apnea Syndrome|Recruiting||N/A|90|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-10 22:47:58.07623|2017-10-10 22:47:58.07623
NCT02588456|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-06-08|||October 2015||2015-10-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia|Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia|Terminated||Phase 1|15|Anticipated|University of Pennsylvania||1||This study was terminated due to lack of efficacy|f||||t||||||||||2017-10-10 22:47:58.216492|2017-10-10 22:47:58.216492
NCT02588443|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-03-29|||October 2015||2015-10-01|March 2016|2016-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma|Phase I Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma|Recruiting||Phase 1|10|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:47:58.315583|2017-10-10 22:47:58.315583
NCT02588430|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-07-26|||January 2016||2016-01-01|July 2016|2016-07-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01|3 Years|Observational [Patient Registry]|||Post-Marketing Surveillance of Patients Using the Subretinal Retina Implant Alpha|Post-Marketing Surveillance of Patients Using the Subretinal Retina Implant Alpha|Enrolling by invitation||N/A|100|Anticipated|Retina Implant AG|||1||f||||f||||||||||2017-10-10 22:47:58.419279|2017-10-10 22:47:58.419279
NCT02588417|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-27|||July 2015||2015-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Intrathecal Dexamethasone and Labor Analgesia|Intrathecal Levobupivacaine Versus A Combination of Levobupivacaine and Dexamethasone in Parturients Receiving Combined Spinal Epidural for Vaginal Delivery Analgesia: A Comparative Study.|Completed||Phase 2|80|Actual|Kasr El Aini Hospital||2|||f||||f||||||||||2017-10-10 22:47:58.507516|2017-10-10 22:47:58.507516
NCT02588404|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-07-27|||December 2016||2016-12-01|July 2016|2016-07-01||||January 2030|Anticipated|2030-01-01||Observational|||The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient|The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient|Not yet recruiting||N/A|65|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital|||1||f||||f||||||Samples With DNA|"     Areas of prostate tumor will be identified by the pathologist of the study. This will then be     excised from the paraffin block using a tissue microarray punch. Two punches will be     acquired: one for RNA extraction and one for DNA extraction. RNA and DNA will be extracted     using the RecoverAll Nucleic Acid Isolation Kit (Ambion). Standard protocol for the isolation     of nucleic acids will be used differing only in the time of protease digestion such that RNA     is isolated after a short incubation (30 minutes), while DNA is isolated after a longer     incubation (overnight).   "|||2017-10-10 22:47:58.629872|2017-10-10 22:47:58.629872
NCT02588391|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brain Training in Preterm Children at Risk for Inattention, Hyperactivity, and Executive Function Impairment|Randomized Controlled Trial of Executive Function Training in Preterm Children at Risk for Inattention, Hyperactivity and Executive Function Impairment|Recruiting||N/A|40|Anticipated|Stanford University||3|||f||||t||||||||||2017-10-10 22:47:58.727298|2017-10-10 22:47:58.727298
NCT02588378|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-08-09|||April 2015||2015-04-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||The Role of Inflammation in AMD and Related Disorders|In Vivo Visualization of Active Macrophages and Retinal Pigment Epithelium (RPE) Damage in Age Related Macular Degeneration (AMD) & Related Conditions|Recruiting||N/A|200|Anticipated|St. Michael's Hospital, Toronto|||9||f||||f||||||||||2017-10-10 22:47:58.845294|2017-10-10 22:47:58.845294
NCT02588365|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brain Training in Children With/At-risk for Attention-Deficit/Hyperactivity Disorder and Executive Function Impairment|Randomized Controlled Trial of Executive Function Training in Children With or At-risk for Attention-Deficit/Hyperactivity Disorder (ADHD) and Executive Function (EF) Impairment|Recruiting||N/A|40|Anticipated|Stanford University||3|||f||||t||||||||||2017-10-10 22:47:58.939264|2017-10-10 22:47:58.939264
NCT02588352|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-05-18|||May 2012||2012-05-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of Salt Sensitivity in Young Adults|Evaluation of Salt Sensitivity in Young Adults|Completed||N/A|40|Actual|New York University School of Medicine||1|||f||||f||||||||Yes|De-identified data will be kept on a local server and will be available for sharing based on evaluation of requests from investigators. The transfer of data outside of NYU will be conducted via signed DTA signed by both institutions.|2017-10-10 22:47:59.052631|2017-10-10 22:47:59.052631
NCT02588339|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-05-18|||February 23, 2016|Actual|2016-02-23|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention|A Phase II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat for Graft Versus Host Disease (GVHD) Prevention|Recruiting||Phase 2|64|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 22:47:59.137834|2017-10-10 22:47:59.137834
NCT02588326|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-09-01|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays|Evaluation of the Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution of Two Different Formulations of a Locally-acting Mometasone Furoate Suspension-based Nasal Spray|Not yet recruiting||Phase 1|50|Anticipated|University of Florida||2|||f||||t|t|f|||f|||||2017-10-10 22:47:59.259954|2017-10-10 22:47:59.259954
NCT02588313|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-09-22|||October 2015||2015-10-01|October 2015|2015-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Investigation of Long-term Effects of CarelessTM on Microcirculation|Investigation of Long-term Effects of CarelessTM on Microcirculation in Healthy Volunteers - a Randomized, Double-blind, Placebo-controlled Study With Parallel Design|Completed||N/A|75|Actual|Vital Solutions Swiss AG||3|||f||||f||||||||||2017-10-10 22:47:59.368931|2017-10-10 22:47:59.368931
NCT02588300|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2016-04-21|||July 2013||2013-07-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Upper Airway Collapse in Patients With Obstructive Sleep Apnea Syndrome by Drug Induced Sleep Endoscopy|Evaluation of the Upper Airway Collapse in Patients With Obstructive Sleep Apnea Syndrome by Drug Induced Sleep Endoscopy According to the Munich Sleep Video Protocol|Completed||N/A|43|Actual|Technische Universität München||1|||f||||f||||||||||2017-10-10 22:47:59.452848|2017-10-10 22:47:59.452848
NCT02588287|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-09-14|||November 2015||2015-11-01|September 2016|2016-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir|Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir|Recruiting||N/A|15|Anticipated|University of Colorado, Denver||1|||f||||f||||||||||2017-10-10 22:47:59.527429|2017-10-10 22:47:59.527429
NCT02588274|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-12-04|||March 2016||2016-03-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndromes|Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndromes: Study Protocol for a Randomized, Placebo-controlled Trial|Recruiting||N/A|68|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-10 22:47:59.628854|2017-10-10 22:47:59.628854
NCT02588261|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-09-15|||February 10, 2016|Actual|2016-02-10|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SOLAR||A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations|An Open-label, Randomized Phase 3 Efficacy Study of ASP8273 vs Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations|Active, not recruiting||Phase 3|530|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-10 22:47:59.756433|2017-10-10 22:47:59.756433
NCT02588248|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-11-29|||June 2016||2016-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MINT-C||L-Menthol Infusion as a Novel Technique During Colonoscopy|L-Menthol Infusion as a Novel Technique During Colonoscopy: The MINT-C Study|Recruiting||Phase 3|300|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-10 22:48:00.40885|2017-10-10 22:48:00.40885
NCT02588235|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Ezetimibe and Atorvastatin Therapy on TCFA|Impact of Combined Ezetimibe and Atorvastatin Therapy on Coronary Thin-cap Fibroatheroma As Assessed by Optical Coherence Tomography|Recruiting||Phase 4|100|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-10 22:48:00.519179|2017-10-10 22:48:00.519179
NCT02588222|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-05-11|||June 2015||2015-06-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|GRINCH||GRINCH: Groningen Initiative on Reference Intervals in Children|GRINCH: Groningen Initiative on Reference Intervals in Children|Completed||N/A|120|Actual|University Medical Center Groningen|||1||f||||f||||||Samples Without DNA|"     feces samples   "|||2017-10-10 22:48:00.627374|2017-10-10 22:48:00.627374
NCT02588209|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-26|||January 2012||2012-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||Cognitive Screening and Cognitive Training in Seniors|Cognitive Screening and Cognitive Training in Seniors|Unknown status|Active, not recruiting|N/A|71|Actual|The University of Texas at Dallas||2|||f||||f||||||||||2017-10-10 22:48:00.705096|2017-10-10 22:48:00.705096
NCT02588196|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-27|||November 2015||2015-11-01|October 2015|2015-10-01||||October 2018|Anticipated|2018-10-01||Interventional|||The Relationships Between Gene Polymorphisms of LTA4H and Dexamethasone Treatment for Tuberculous Meningitis||Not yet recruiting||Phase 4|200|Anticipated|Hebei Medical University||1|||f||||||||||||||2017-10-10 22:48:00.787537|2017-10-10 22:48:00.787537
NCT02588183|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-09-22|||August 2015||2015-08-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|March 2017|Anticipated|2017-03-01||Interventional|COR-ADVANCE||PV Cryoablation Efficacy (COR ADVANCE Study)|PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study)|Recruiting||N/A|25|Anticipated|Hospital San Carlos, Madrid||1|||f||||f||||||||||2017-10-10 22:48:00.858349|2017-10-10 22:48:00.858349
NCT02588170|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-06-19|||December 7, 2015|Actual|2015-12-07|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase III Study of Sulfatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors|A Randomized, Double-blind, Multi-center Phase III Clinical Study to Assess the Efficacy and Safety of Sulfatinib Compared to Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors|Recruiting||Phase 3|273|Anticipated|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-10 22:48:00.948232|2017-10-10 22:48:00.948232
NCT02588157|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-07-19|||October 2015||2015-10-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Cricoid Pressure on Macintosh, McGrath X-Blade and Glidescope Videolaryngoscopes in Rapid Sequence Induction Intubation|Videolaryngoscopes for Rapid Sequence Intubation|Completed||Phase 4|120|Actual|Kocaeli University||2|||f||||f||||||||||2017-10-10 22:48:01.071573|2017-10-10 22:48:01.071573
NCT02588144|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-24|2017-06-16|||October 2015||2015-10-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|STN+SNr||Combined Stimulation of STN and SNr for Resistant Freezing of Gait in Parkinson's Disease|Combined Stimulation of Subthalamic Nucleus and Substantia Nigra Pars Reticulata for Resistant Freezing of Gait in Parkinson's Disease: A Randomized Controlled Multicenter Trial|Recruiting||N/A|54|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-10 22:48:01.18371|2017-10-10 22:48:01.18371
NCT02588131|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01|March 2018|Anticipated|2018-03-01|June 2016|Anticipated|2016-06-01||Interventional|||A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)|A Single Arm, Phase II Clinical Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Monoclonal Antibody in Unresectable Malignant Mesothelioma Subjects: The NIBIT-MESO-1|Recruiting||Phase 2|40|Anticipated|Italian Network for Tumor Biotherapy Foundation||1|||f||||t||||||||||2017-10-10 22:48:01.3432|2017-10-10 22:48:01.3432
NCT02588118|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-24|||January 2010||2010-01-01|October 2015|2015-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|BIS5||Gender and PK-PD of Propofol and Cisatracurium|Effect of Gender on the Pharmacokinetics-pharmacodynamics of Propofol and Cisatracurium Besylate|Completed||N/A|120|Actual|Medical University of Graz|||2||f||||f||||||||||2017-10-10 22:48:01.459727|2017-10-10 22:48:01.459727
NCT02588105|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-08-04|||November 10, 2015|Actual|2015-11-10|August 2017|2017-08-01|June 2, 2020|Anticipated|2020-06-02|June 2, 2020|Anticipated|2020-06-02||Interventional|AToM||Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer|A Phase I, Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD0156 Monotherapy or in Combination With Either Cytotoxic Chemotherapies or Novel Anti-Cancer Agents in Patients With Advanced Malignancies|Recruiting||Phase 1|225|Anticipated|AstraZeneca||1|||t||||f||||||||||2017-10-10 22:48:01.555471|2017-10-10 22:48:01.555471
NCT02588092|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-06-26|||December 2015||2015-12-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)|A Phase 1, Open-label, Dose-escalation, Multicenter Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Activity of ADCT 301 in Patients With Relapsed or Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia|Recruiting||Phase 1|80|Anticipated|ADC Therapeutics SARL||1|||f||||f||||||||||2017-10-10 22:48:01.689534|2017-10-10 22:48:01.689534
NCT02588079|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Internet-Based Cognitive Behavioral Therapy for Children With Dental Anxiety|Internet-Based Cognitive Behavioral Therapy for Children With Dental Anxiety- A Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:48:01.845023|2017-10-10 22:48:01.845023
NCT02588066|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-06|||November 2015||2015-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Pancreatoduodenectomy With or Without Ligamentum Teres Wrap Around Gastroduodenal Artery Stump for Prevention of Pancreatic Hemorrhage|Pancreatoduodenectomy With or Without Prophylactic Ligamentum Teres Hepatic Wrap Around the Gastroduodenal Artery Stump for Prevention of Pancreatic Hemorrhage - Panda - Multicentric Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-10 22:48:01.940519|2017-10-10 22:48:01.940519
NCT02588053|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-08-29|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|||Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?|Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)? A Longitudinal Study Using Whole Brain, Neocortical and Subcortical Atrophy Rates and Patient Reported Outcomes (PROs).|Recruiting||N/A|146|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 22:48:02.024988|2017-10-10 22:48:02.024988
NCT02588040|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-01-25|||May 2016||2016-05-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|October 2017|Anticipated|2017-10-01|36 Months|Observational [Patient Registry]|||Recover L-PRP in Lateral Epicondylitis (REGP-11-00)|Post-Market Data Collection for Chronic Lateral Epicondylitis Patients Treated With Leukocyte- and Platelet-Rich Plasma (L-PRP) Prepared With the Recover Mini Platelet Separation Kit|Recruiting||N/A|100|Anticipated|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-10-10 22:48:02.11274|2017-10-10 22:48:02.11274
NCT02588027|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder|Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder|Recruiting||N/A|85|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:48:02.214292|2017-10-10 22:48:02.214292
NCT02588014|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-26|||November 2015||2015-11-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Observational|||The Neural Bases of Early Visual and Auditory Processing and Emotion Recognition Deficits in Schizophrenia|Examining the Neural Bases of Early Visual and Auditory Processing and Emotion Recognition Deficits in Schizophrenia Using Magnetoencephalography|Not yet recruiting||N/A|60|Anticipated|Shalvata Mental Health Center|||2||f||||t||||||||||2017-10-10 22:48:02.352806|2017-10-10 22:48:02.352806
NCT02588001|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-09-25|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Interventional|JCASTRE-Zero||Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide|Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide|Recruiting||N/A|60|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||t||||||||||2017-10-10 22:48:02.455537|2017-10-10 22:48:02.455537
NCT02587988|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2016-10-31|||September 2014||2014-09-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Trial to Evaluate the Efficacy and Safety of HCP1302|A Randomized, Double-blind, Multicenter, Phase Ⅲ Study to Evaluate the Efficacy and Safety of HCP1302 in Both Erectile Dysfunction and Hypertension Patients Being Treated With HGP0904|Completed||Phase 3|232|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 22:48:02.562486|2017-10-10 22:48:02.562486
NCT02587975|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-07-21|||June 2016||2016-06-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of Evogliptin on Bone Metabolism in Human|Pharmacodynamics Study to Investigate the Effect of Evogliptin on Bone Metabolism in Healthy Volunteers|Recruiting||Phase 4|20|Anticipated|DongGuk University||1|||f||||f||||||||||2017-10-10 22:48:02.639448|2017-10-10 22:48:02.639448
NCT02587962|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-08-29|||August 4, 2017|Actual|2017-08-04|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors|A Phase 1/2 Multicenter, Single-Arm, Open-Label, Dose-Escalation Study of Birinapant in Combination With Pembrolizumab (KEYTRUDA®) in Patients With Relapsed or Refractory Solid Tumors|Recruiting||Phase 1/Phase 2|104|Anticipated|Medivir||1|||f||||t|t|f||||||||2017-10-10 22:48:02.719733|2017-10-10 22:48:02.719733
NCT02587949|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-02-09|||November 2015||2015-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||The Correlation Between Hair Cortisol Level of Acute Stroke or Its Long Term Disability.|The Correlation Between Hair Cortisol Level of Acute Stroke or Its Long Term Disability.|Recruiting||N/A|30|Anticipated|Bnai Zion Medical Center|||1||f||||f||||||||Undecided||2017-10-10 22:48:02.827517|2017-10-10 22:48:02.827517
NCT02587936|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-07-28|||April 2016|Actual|2016-04-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|ICD-Pieces||Improving Chronic Disease Management With Pieces|Improving Chronic Disease Management With Pieces (ICD-Pieces)|Recruiting||N/A|10991|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t|f|f||||||||2017-10-10 22:48:03.031894|2017-10-10 22:48:03.031894
NCT02587923|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Endoscopic Unroofing for Small Gastric SETs|A Retrospective Study on Safety, Diagnostic Yield and Therapeutic Effects of Endoscopic Unroofing for Small Gastric Subepithelial Tumors|Unknown status|Not yet recruiting|N/A|20|Anticipated|Medical University of Vienna|||1||f||||||||||||||2017-10-10 22:48:03.192039|2017-10-10 22:48:03.192039
NCT02587910|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Interventional|GERDMeDS||Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease|Melanole, a Nigella Sativa (Black Seed) Extract for the Treatment of Gastroesophageal Reflux Disease|Unknown status|Recruiting|Phase 2/Phase 3|170|Anticipated|Lebanese American University||2|||f||||t||||||||||2017-10-10 22:48:03.281733|2017-10-10 22:48:03.281733
NCT02587897|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-03-07|||July 1, 2016|Actual|2016-07-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Observational|||Musculoskeletal Health of the Upper Extremity in Emerging Health Professionals|Sonographic Tissue Morphology in Early Stage Work-related Median Nerve Pathology|Enrolling by invitation||N/A|180|Anticipated|University of Southern California|||2||f||||f||||||||Yes|Once manuscripts from the project become available, datasets used to produce manuscripts will be shared with individual peers under the auspices of the PI. Only de-identified data in final databases, will be shared; raw data will not be shared. Data from secondary analyses beyond the specific aims will only be shared under the auspices of the investigators involved. When authorized, data will be made available to requestors under a data-sharing agreement that provides for: (1) using the data for research only, (2) securing the data using appropriate techniques, (3) destroying or returning the data after analyses are completed, and (4) providing the PI with a summary of how the data were used. Requestors agree to protect the intellectual property rights of the PI, or other investigators as indicted, by appropriately acknowledging the source of the data in any document or presentation, which may include oversight or authorship on work that is based substantially on the shared data.|2017-10-10 22:48:03.402126|2017-10-10 22:48:03.402126
NCT02587884|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-03-30||||||March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH|Anti-recurrence Treatment of Postresection on Hepatocellular Carcinoma Patients With Microvascular Invasion Presence and Over-expression of Aspartate Beta-hydroxylase: A Randomized Controlled Study|Not yet recruiting||Phase 1|180|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 22:48:03.496224|2017-10-10 22:48:03.496224
NCT02587871|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-09-12|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|November 20, 2021|Anticipated|2021-11-20|November 20, 2019|Anticipated|2019-11-20||Interventional|||Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission|HLA-Mismatched Allogeneic Cellular Therapy (Microtransplantation) After Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia &lt; 60 Years|Not yet recruiting||Phase 2|34|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 22:48:03.581263|2017-10-10 22:48:03.581263
NCT02587858|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-09-27|||April 2015||2015-04-01|September 2016|2016-09-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01||Observational|||NBIAready: Online Collection of Natural History Patient-reported Outcome Measures|NBIAready: Online Collection of Natural History Patient-reported Outcome Measures|Recruiting||N/A|300|Anticipated|Oregon Health and Science University|||1||f||||f||||||||||2017-10-10 22:48:03.739417|2017-10-10 22:48:03.739417
NCT02587845|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of Transexamic Acid in Hip Replacement|Use of Tranexamic Acid(TNA) in Preventing Blood Loss During and After Total Hip Arthroplasty|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-10 22:48:03.825219|2017-10-10 22:48:03.825219
NCT02587832|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-25|||July 2009||2009-07-01|October 2015|2015-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||High Flow Nasal Cannula in Comparison With Nasal Continuous Positive Airway Pressure in the Management of Respiratory Distress Syndrome|Randomized Control Trial: Heated Humidity High Flow Nasal Cannula in Comparison With Nasal Continuous Positive Airway Pressure in the Management of Respiratory Distress Syndrome in Extreme Low Birth Infants in Immediate Post Extubation Period|Completed||N/A|60|Actual|Sidra Medical and Research Center||2|||f||||f||||||||||2017-10-10 22:48:03.923393|2017-10-10 22:48:03.923393
NCT02587819|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-03-15|2016-01-20||May 2013||2013-05-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|||Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment|An Open-Label Phase 1 Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment When Applied Twice Daily for 28 Days in Male and Female Patients With Basal Cell Carcinoma|Completed||Phase 1|21|Actual|Biosceptre||1|||f||||f||||||||||2017-10-10 22:48:04.019788|2017-10-10 22:48:04.019788
NCT02587455|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PEAR||Pembrolizumab and Palliative Radiotherapy in Lung|Phase I Dose Escalation of pAlliative Radiotherapy With Anti-PD1 Antibody Pembrolizumab in Thoracic Tumours|Recruiting||Phase 1|48|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:48:07.386738|2017-10-10 22:48:07.386738
NCT02587806|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-27|||February 2015||2015-02-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS|An Open-label, Non-randomized, Phase I/II Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS|Unknown status|Recruiting|Phase 1/Phase 2|69|Anticipated|Novo Cellular Medicine Institute LLP||1|||f||||t||||||||||2017-10-10 22:48:04.280135|2017-10-10 22:48:04.280135
NCT02587793|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-24|2017-08-20|||October 2014||2014-10-01|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients|Kaohsiung Medical University Chung-Ho Memorial Hospital|Recruiting||N/A|150|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||Samples With DNA|"     If the cultured cells can become cell lines, these cell lines will be stored.   "|||2017-10-10 22:48:04.425135|2017-10-10 22:48:04.425135
NCT02587780|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-26|||November 2015||2015-11-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|||Blood Sugar Responses by Physical Activity Level and Intensity|An Observational Study of Incremental Area Under the Curve Values in Similar, Non-diabetic, Subjects- Undertaking Different Amounts and Intensities of Physical Activity|Unknown status|Not yet recruiting|N/A|45|Anticipated|Small Changes|||3||f||||f||||||||||2017-10-10 22:48:04.537382|2017-10-10 22:48:04.537382
NCT02587767|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2016-12-01|||September 2016||2016-09-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||577nm Micropulse Laser vs Half-dose Photodynamic Therapy on Acute Central Serous Chorioretinopathy|Prospective Randomized Controlled Clinical Trial to Evaluate the Effects of 577nm Micropulse Laser vs Half-dose Photodynamic Therapy on Acute Central Serous Chorioretinopathy|Enrolling by invitation||N/A|64|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided|it is undecided to make individual participant data available when the study is going on|2017-10-10 22:48:04.613136|2017-10-10 22:48:04.613136
NCT02587754|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-07-06|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|April 27, 2017|Actual|2017-04-27|March 2017|Actual|2017-03-01||Interventional|||Acupuncture in the Treatment of Fatigue in Parkinson's Disease|Acupuncture in the Treatment of Fatigue in Parkinson's Disease: a Pilot Randomized Controlled Study|Completed||N/A|40|Actual|Tan Tock Seng Hospital||2|||f||||t||||||||||2017-10-10 22:48:04.694885|2017-10-10 22:48:04.694885
NCT02587741|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2015-10-25|||July 2015||2015-07-01|October 2015|2015-10-01|July 2025|Anticipated|2025-07-01|July 2023|Anticipated|2023-07-01||Interventional|CORRECT||Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens|Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens: a Multicentre Randomized Parallel-group Clinical Trial|Recruiting||Early Phase 1|600|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||3|||f||||f||||||||||2017-10-10 22:48:04.789324|2017-10-10 22:48:04.789324
NCT02587728|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-08-22|||February 24, 2016|Actual|2016-02-24|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Carpal Tunnel/Amyloidosis Blood Sample Study|Collection of Peripheral Blood Samples From Patients With Carpal Tunnel Syndrome for Laboratory Screening of Amyloidosis|Recruiting||N/A|500|Anticipated|University of Miami|||1||f||||f|f|f||||Samples With DNA|"     Genome DNA extracted peripheral blood mononuclear cells (PBMCs)   "|||2017-10-10 22:48:04.911019|2017-10-10 22:48:04.911019
NCT02587715|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-27|||February 2015||2015-02-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS|An Open-label, Non-randomized, Phase I/II Study of Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and Liberation Therapy (When Associated With Chronic Cerebrovascular Venous Insufficiency) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)|Unknown status|Recruiting|Phase 1/Phase 2|69|Anticipated|Novo Cellular Medicine Institute LLP||1|||f||||t||||||||||2017-10-10 22:48:04.995438|2017-10-10 22:48:04.995438
NCT02587702|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-29|||June 2013||2013-06-01|October 2015|2015-10-01||||December 2015|Anticipated|2015-12-01||Interventional|||Influence of Improved Formula on Fatty Acids and Mineral Metabolism in Infants||Unknown status|Recruiting|N/A|90|Anticipated|Beingmate Baby & Child Food Co Ltd .||3|||f||||f||||||||||2017-10-10 22:48:05.156255|2017-10-10 22:48:05.156255
NCT02587689|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-25|2016-12-01|||October 2015||2015-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor|Phase I/II Study of Anti-MUC1 CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor|Recruiting||Phase 1/Phase 2|20|Anticipated|PersonGen BioTherapeutics (Suzhou) Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:48:05.247536|2017-10-10 22:48:05.247536
NCT02587676|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2016-12-26|||June 2013||2013-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|July 2015|Actual|2015-07-01||Observational|||Deterioration of Resilient Denture Liners and Patient Characteristics|Changes in the Hardness of Resilient Denture Liners Embedded in Maxillary Complete Dentures and Their Association With Patient Characteristics|Completed||N/A|100|Actual|Nihon University|||1||f||||f||||||||||2017-10-10 22:48:05.359208|2017-10-10 22:48:05.359208
NCT02587663|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-04-08|||November 20, 2005|Actual|2005-11-20|April 2017|2017-04-01|November 20, 2017|Anticipated|2017-11-20|November 20, 2011|Actual|2011-11-20||Interventional|||Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI|Sonography Compared With MRI in Pre-Operative Evaluation of Patients With Breast Cancer to Determine Extent of Breast Disease|Active, not recruiting||N/A|300|Actual|University of Southern California||3|||f||||t|f|f||||||||2017-10-10 22:48:05.453949|2017-10-10 22:48:05.453949
NCT02587650|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|kinase-fusion||Trial of TKF Inhibition in Unresectable Stage III/IV BRAF/NRAS WT Melanoma|Phase II Trial Of Targeted Kinase Fusion Inhibition in Unresectable Stage III/IV BRAF/NRAS Wild-Type Melanoma|Active, not recruiting||Phase 2|44|Anticipated|University of California, San Francisco||4|||f||||t||||||||||2017-10-10 22:48:05.57406|2017-10-10 22:48:05.57406
NCT02587442|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01||||March 2016|Anticipated|2016-03-01||Interventional|||A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers|A Phase I Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers|Unknown status|Recruiting|Phase 1|27|Anticipated|Original BioMedicals Co. Ltd.||1|||f||||f||||||||||2017-10-10 22:48:07.522708|2017-10-10 22:48:07.522708
NCT02587637|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-01-16|||October 2015||2015-10-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back Pain|A Prospective Post Market Observational Pilot Study to Evaluate the Effectiveness of DRG Stimulation in the Treatment of Discogenic Low Back Pain|Active, not recruiting||N/A|15|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-10 22:48:05.661991|2017-10-10 22:48:05.661991
NCT02587624|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2016-10-13|||March 2011||2011-03-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|MAGNA-AF||Remote MAGNetic Catheter Ablation for Atrial Fibrillation|Safety, Radiation Exposure and Efficacy of Remote MAGNetic Catheter Ablation for Atrial Fibrillation|Recruiting||N/A|1000|Anticipated|Paracelsus Medical University|||1||f||||f||||||||||2017-10-10 22:48:05.727069|2017-10-10 22:48:05.727069
NCT02587611|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-04-28|||November 2015||2015-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Randomized Comparison of Elemental Liquid Diet and Standard Semi-solid Diet on Gastric Emptying|Randomized Comparison of Elemental Liquid Diet and Standard Semi-solid Diet on Gastric Emptying in Healthy Subjects and Bedridden Gastrostomy-fed Patients|Completed||N/A|8|Actual|Showa Inan General Hospital||2|||f||||f||||||||||2017-10-10 22:48:05.83966|2017-10-10 22:48:05.83966
NCT02587598|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-26|2017-09-15|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of INCB053914 in Subjects With Advanced Malignancies|A Phase 1/2 Study of INCB053914 in Subjects With Advanced Malignancies|Recruiting||Phase 1/Phase 2|270|Anticipated|Incyte Corporation||4|||t||||f||||||||||2017-10-10 22:48:05.934451|2017-10-10 22:48:05.934451
NCT02587585|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-04-20|||September 2015||2015-09-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Activity Feedback Enabled by Smart Watches During In-patient Stroke Rehabilitation|An International Randomized Clinical Trial of Activity Feedback During In-patient Stroke Rehabilitation Enabled by Smart Watches|Recruiting||N/A|200|Anticipated|The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine||2|||f||||t|f|f||||||Undecided|In the unlikely event that someone asks, it will probably be shared but so far (March 2017) there is no plan|2017-10-10 22:48:06.132372|2017-10-10 22:48:06.132372
NCT02587572|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-03-31|||December 2017|Anticipated|2017-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Interventional|SIRONA||Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial|A Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Efficacy of Allogeneic Human Mesenchymal Stem Cells in Patients With Metabolic Syndrome.|Not yet recruiting||Phase 2|40|Anticipated|Longeveron LLC||4|||f||||t|t|f||||||||2017-10-10 22:48:06.224991|2017-10-10 22:48:06.224991
NCT02587559|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-05-13|||May 2016||2016-05-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effectiveness of Manual Therapy and Exercise in Shoulder OA|Effectiveness of Manual Therapy and Exercise in the Management of Glenohumeral Osteoarthritis: A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-10 22:48:06.320818|2017-10-10 22:48:06.320818
NCT02587546|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-09-07|||October 2015||2015-10-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Thulium Contact Laser of Laryngotracheal Stenosis|Thulium Contact Laser in the Treatment of Tumorous and Non-tumorous Laryngotracheal Stenosis|Recruiting||N/A|45|Anticipated|University Hospital Ostrava||3|||f||||f||||||||||2017-10-10 22:48:06.411216|2017-10-10 22:48:06.411216
NCT02587533|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-02-23|||November 2015||2015-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ChemoBar||Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation|Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation|Recruiting||N/A|15|Anticipated|Hannover Medical School||4|||f||||t||||||||||2017-10-10 22:48:06.520177|2017-10-10 22:48:06.520177
NCT02587520|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-06-28|||April 22, 2016|Actual|2016-04-22|June 2017|2017-06-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Interventional|||Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects|Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults|Completed||Phase 1/Phase 2|1365|Actual|Sanofi||6|||f||||t||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available the company continue to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 22:48:06.671106|2017-10-10 22:48:06.671106
NCT02587507|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-07-27|||June 2015||2015-06-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Proteomic Analysis of Mononuclear Cells After a High-Fat, High-Carbohydrate Meal With or Without Orange Juice|Proteomic Analysis of the Peripheral-Blood Mononuclear Cells Response After a High-Fat, High-Carbohydrate Meal With or Without Orange Juice in Healthy Subjects|Completed||N/A|12|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 22:48:06.948585|2017-10-10 22:48:06.948585
NCT02587494|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-22|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cardiac Catheterization in Cardiac Arrest|Role of Early Cardiac Catheterization in Cardiac Arrest|Not yet recruiting||N/A|75|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||||2017-10-10 22:48:07.061581|2017-10-10 22:48:07.061581
NCT02587481|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-02-16|||November 2015||2015-11-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|PAPA||Pneumological Acute Coronary Syndrom (ACS) Phenotyping Aachen|Pneumological Phenotyping of Acute Coronary Syndrom (ACS) Patients Concerning Concomitant Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|500|Anticipated|RWTH Aachen University|||1||f||||f||||||Samples Without DNA|"     Serum, Blood plasm   "|||2017-10-10 22:48:07.204212|2017-10-10 22:48:07.204212
NCT02587468|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-29|||October 2015||2015-10-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Bioavailability and Absorption Kinetics of Phenolic Compounds and Specific Vitamins|Bioavailability and Absorption Kinetics of Phenolic Compounds and Specific Vitamins of a Commercially Available, Encapsulated Nutraceutical (Juice Plus+®)|Completed||N/A|20|Actual|Green Beat||1|||f||||f||||||||||2017-10-10 22:48:07.28774|2017-10-10 22:48:07.28774
NCT02587429|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-10-04|||October 2015||2015-10-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of a Patient Education in Pain Coping for Patients Scheduled for Total Knee Arthroplasty|Effect of a Patient Education in Pain Coping for Patients With High Levels of Pain Catastrophizing Before Total Knee Arthroplasty|Recruiting||N/A|84|Anticipated|Regional Hospital West Jutland||3|||f||||t||||||||||2017-10-10 22:48:07.636944|2017-10-10 22:48:07.636944
NCT02587416|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-23|||November 2002||2002-11-01|October 2015|2015-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers|A Study of the Effect of Oral, Multiple‐Dose 300 mg and 900 mg Gemcabene (CI‐1027) Administration on the Steady‐State Pharmacokinetics of Atorvastatin 80 mg|Completed||Phase 1|20|Actual|Gemphire Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 22:48:07.752573|2017-10-10 22:48:07.752573
NCT02587390|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-23|||May 2000||2000-05-01|October 2015|2015-10-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers|A Study to Evaluate the Effects of Gemcabene on the Steady-State Pharmacokinetics and Pharmacodynamics of Simvastatin in Healthy Volunteers|Completed||Phase 1|20|Actual|Gemphire Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:48:07.984431|2017-10-10 22:48:07.984431
NCT02587377|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-10-26|||June 2013||2013-06-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||New Biomarkers for Invasive Fungal Infections in Paediatric Haemato-oncology|New Biomarkers for Invasive Fungal Infections in Paediatric Haemato-oncology. A National Belgian Study|Terminated||N/A|20|Actual|Queen Fabiola Children's University Hospital||1||The current rate of recruitment is insufficient.|f||||f||||||||||2017-10-10 22:48:08.087031|2017-10-10 22:48:08.087031
NCT02587364|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-23|||April 1999||1999-04-01|October 2015|2015-10-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers|An Oral, Rising, Multiple‐Dose Tolerance, Pharmacokinetic and Pharmacodynamic Study of Gemcabene Capsules in Healthy Volunteers|Completed||Phase 1|50|Actual|Gemphire Therapeutics, Inc.||6|||f||||f||||||||||2017-10-10 22:48:08.170796|2017-10-10 22:48:08.170796
NCT02587351|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-08-16|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Beta-Blockers for the Prevention of Acute Exacerbations of COPD|Recruiting||Phase 3|1028|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 22:48:08.285101|2017-10-10 22:48:08.285101
NCT02587338|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-04-27|||May 2015||2015-05-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|April 2016|Actual|2016-04-01||Interventional|CATS||Cognitive Ability Training in Seniors|Verbesserung Kognitiver Fähigkeiten im Alter|Active, not recruiting||N/A|50|Actual|Wuerzburg University Hospital||2|||f||||f||||||||||2017-10-10 22:48:08.514987|2017-10-10 22:48:08.514987
NCT02587325|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-07-19|||April 1, 2017|Actual|2017-04-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|August 2019|Anticipated|2019-08-01||Interventional|||ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension|A Phase 1 Clinical Trial of ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension (PAH)|Recruiting||Phase 1|25|Anticipated|Aadi, LLC||1|||f|||||t|f||||||||2017-10-10 22:48:08.614196|2017-10-10 22:48:08.614196
NCT02587312|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-01-30|||November 2016|Actual|2016-11-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers|Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers|Recruiting||N/A|90|Anticipated|Brown University||2|||f||||||||||||||2017-10-10 22:48:08.711338|2017-10-10 22:48:08.711338
NCT02587286|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-01-20|||March 2015||2015-03-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Gather mHealth India RCT for Behavior and Health Outcomes|Investigation of the Gather mHealth Platform on Diabetics' Behavior and Health Outcomes.|Completed||N/A|91|Actual|Gather Health India||2|||f||||f||||||||Yes|posted to clinicaltrials.gov|2017-10-10 22:48:08.802068|2017-10-10 22:48:08.802068
NCT02587273|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-10-28|||October 2015||2015-10-01|October 2015|2015-10-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|FENTANYL06||The Pharmacokinetics of Fentanyl in Intensive Care Patients|The Pharmacokinetics of Fentanyl in Intensive Care Patients|Recruiting||Phase 4|150|Anticipated|Oslo University Hospital||1|||f||||t||||||||||2017-10-10 22:48:08.913533|2017-10-10 22:48:08.913533
NCT02587260|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-02-10|||December 17, 2015|Actual|2015-12-17|February 2017|2017-02-01|February 10, 2017|Actual|2017-02-10|February 10, 2017|Actual|2017-02-10||Interventional|HI-TECH||Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)|Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function and Other Circulating Biomarkers in Humans|Completed||Phase 4|54|Actual|Erasmus Medical Center||6|||f||||f||||||||Undecided||2017-10-10 22:48:09.06709|2017-10-10 22:48:09.06709
NCT02587247|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-01-17|||March 2016||2016-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|iTEP Colon||ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer|Apport de l'Immuno-TEP préciblée Avec l'Anticorps bispécifique Anti-ACE x Anti-HSG TF2 et le Peptide IMP-288 marqué au Gallium-68 Pour l'Imagerie Des Patients Potentiellement Candidats à Une Chirurgie d'exérèse et/ou Thermoablation Locale d'Une ou Plusieurs métastases, au Diagnostic ou Lors de la Rechute de Cancers Colo-rectaux (CCR) Exprimant l'antigène Carcino-embryonnaire (ACE): Comparaison au Bilan Conventionnel|Completed||Phase 2|11|Actual|Nantes University Hospital||1|||f||||f||||||||No||2017-10-10 22:48:09.194496|2017-10-10 22:48:09.194496
NCT02587234|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-07-13|2017-06-16||November 2006||2006-11-01|July 2017|2017-07-01|April 2012|Actual|2012-04-01|February 2010|Actual|2010-02-01||Interventional|||Driving Neuroplasticity With Nerve Stimulation and Modified CIT|Driving Neuroplasticity With Nerve Stimulation and Modified Constraint-Induced Therapy|Completed||Phase 1/Phase 2|21|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 22:48:09.270705|2017-10-10 22:48:09.270705
NCT02587221|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-10-03|||September 2016||2016-09-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age|A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age|Active, not recruiting||Phase 3|6798|Actual|Seqirus||2|||f||||t||||||||||2017-10-10 22:48:09.549572|2017-10-10 22:48:09.549572
NCT02587208|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2015-10-24|||January 2015||2015-01-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Plastibell Versus Conventional Dissection Techniques for Circumcision in Infants and Children|Plastibell Versus Conventional Dissection Techniques for Circumcision in Infants|Unknown status|Recruiting|N/A|100|Anticipated|King Saud University||2|||f||||t||||||||||2017-10-10 22:48:09.845279|2017-10-10 22:48:09.845279
NCT02587195|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-10-23|||October 2015||2015-10-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|TERICIS||A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period|A National, Multi-center Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period|Not yet recruiting||Phase 3|11|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 22:48:09.926847|2017-10-10 22:48:09.926847
NCT02587182|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-06-02|||June 2015||2015-06-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Dry Needling in Patients With Sleep Bruxism and Temporomandibular Disorders: a Prospective Case Series||Completed||N/A|17|Actual|CEU San Pablo University||1|||f||||f||||||||||2017-10-10 22:48:10.040653|2017-10-10 22:48:10.040653
NCT02587169|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-10-23|||January 2012||2012-01-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|GEIS-27||Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum|GEIS-27: Phase I/II Multicenter and Prospective Trial of Nilotinib and Adriamycin as Neoadjuvant Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Broto, Javier Martín, M.D.||1|||f||||t||||||||||2017-10-10 22:48:10.101671|2017-10-10 22:48:10.101671
NCT02587156|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-10-03|||October 2015|Actual|2015-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|FONDAA||Fate of Nutrient-Derived Amino Acids, FONDAA|Fate of Nutrient-Derived Amino Acids: Influence of Habituated Levels of Daily Dietary Protein Intake on Protein Utilization|Recruiting||N/A|12|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-10 22:48:10.273383|2017-10-10 22:48:10.273383
NCT02587130|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-05-02|||May 2016||2016-05-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|KETAREF||Ketamine and Refractory Painful Care in a Palliative Unit|The Effect and Tolerance of a Ketamine Subcutaneous Bolus, During Painful Care of Refractory Bed Sores, Ulcers and Vascular Wounds in a Palliative Care Unit|Not yet recruiting||Phase 4|40|Anticipated|Lille Catholic University||1|||f||||f||||||||||2017-10-10 22:48:10.450299|2017-10-10 22:48:10.450299
NCT02587117|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-01-26|2015-10-27||February 2013||2013-02-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|OLP||A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus|Comparative Study of the Efficacy of Lycopene Versus Prednisolone in the Management of Oral Lichen Planus: A Randomized, Double Blind Clinical Trial|Completed||Phase 4|28|Actual|B.P. Koirala Institute of Health Sciences|Due to limitation of time, there were small numbers of subjects enrollment; not possible to follow-up the cases after the treatments were over and to determine the relapse rate of the patients; performed at a single medical center.|2|||f||||t||||||||||2017-10-10 22:48:10.527856|2017-10-10 22:48:10.527856
NCT02587104|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-08-23|||June 2015||2015-06-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||dHACM In the Treatment of Diabetic Foot Ulcers|A Single Center, Prospective, Non-Randomized, Historical Controlled Trial of dHACM In the Treatment of Diabetic Foot Ulcers|Completed||N/A|16|Actual|MiMedx Group, Inc.||1|||f||||t||||||||||2017-10-10 22:48:12.448344|2017-10-10 22:48:12.448344
NCT02587091|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-26|||February 2014||2014-02-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effectiveness of Advertising Availability of Prenatal Ultrasound on Uptake of Antenatal Care in Rural Uganda|Effectiveness of Advertising Availability of Prenatal Ultrasound on Uptake of Antenatal Care in Rural Uganda: a Randomized Trial|Completed||N/A|157|Actual|Bridge to Health Medical and Dental||2|||f||||||||||||||2017-10-10 22:48:12.537272|2017-10-10 22:48:12.537272
NCT02587078|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-11-29|||March 2013||2013-03-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|VOMOSEP||Volume Therapy With Crystalloids and Colloids and Hemodynamic Monitoring in Patients With Severe Sepsis|Volume Therapy With Crystalloids and Colloids|Withdrawn||Phase 4|0|Actual|Wuerzburg University Hospital||2||treatment substance not labled for sepsis anymore|f||||f||||||||Undecided||2017-10-10 22:48:12.633225|2017-10-10 22:48:12.633225
NCT02587065|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-09-17|||October 19, 2016|Actual|2016-10-19|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|PLATINUM||Plegridy Satisfaction Study in Participants|Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Plegridy (Pre-filled Pen) in Subjects With Relapsing-remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM)|Active, not recruiting||Phase 4|199|Actual|Biogen||1|||||||f|t|f||||||||2017-10-10 22:48:13.262866|2017-10-10 22:48:13.262866
NCT02587052|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-11-22|||October 2015||2015-10-01|November 2016|2016-11-01||||September 2016|Actual|2016-09-01||Observational|GenTac||A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis, GenTac|A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis|Completed||N/A|200|Anticipated|Vastra Gotaland Region|||2||f||||f||||||||||2017-10-10 22:48:13.42072|2017-10-10 22:48:13.42072
NCT02587026|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-09-29|||August 27, 2015|Actual|2015-08-27|September 2017|2017-09-01|May 31, 2021|Anticipated|2021-05-31|May 31, 2020|Anticipated|2020-05-31|80 Years|Observational [Patient Registry]|||Biorepository for Precision Genomics|Collection of Specimens and Clinical Data to Create a Biorepository for Precision Genomics|Recruiting||N/A|500|Anticipated|Indiana University|||1||f||||f||||||Samples With DNA|"     Prospective blood and tumor tissue samples will be collected. Retrospective review of patient     charts for clinical information will also be done.   "|||2017-10-10 22:48:13.617958|2017-10-10 22:48:13.617958
NCT02587013|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-09-21|||November 2015||2015-11-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Uterine Repair Methods for Cesarean Delivery|Randomized Controlled Trial of Uterine Exteriorization Versus in Situ Repair for Elective Cesarean Delivery|Recruiting||N/A|180|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-10 22:48:13.893893|2017-10-10 22:48:13.893893
NCT02587000|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-09-11|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FRA-IIT-UPA||Adenomyosis and Ulipristal Acetate|Pilot Phase II, Randomized , and Control in Double Blind Placebo Effectiveness a 3 Months on Bleeding Fibroids Treatment With ULIPRISTAL ACETATE 10 mg/Day in Patients Suffering From Symptomatic Endometriosis|Recruiting||Phase 2|48|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:48:14.042006|2017-10-10 22:48:14.042006
NCT02586987|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-08-31|||December 28, 2015|Actual|2015-12-28|August 2017|2017-08-01|August 10, 2018|Anticipated|2018-08-10|August 10, 2018|Anticipated|2018-08-10||Interventional|||A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours|A Phase I, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability and Preliminary Anti-tumour Activity of Ascending Doses of Selumetinib (AZD6244 Hyd-sulfate) in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours|Recruiting||Phase 1|60|Anticipated|AstraZeneca||4|||f||||f|t|f||||||||2017-10-10 22:48:14.172972|2017-10-10 22:48:14.172972
NCT02586974|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-10-23|||September 2015||2015-09-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response|Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response: Head-to-head Randomized Comparison Versus Standard Insufflation During Robot Assisted Radical Prostatectomy|Unknown status|Recruiting|N/A|64|Anticipated|Azienda Ospedaliera Città della Salute e della Scienza di Torino||2|||f||||f||||||||||2017-10-10 22:48:14.401022|2017-10-10 22:48:14.401022
NCT02586961|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-09-11|||October 2015||2015-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Actual|2017-09-01||Interventional|EPIDEX||Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.|Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies : a Multicentre Randomized Controlled Trial|Terminated||Phase 2/Phase 3|195|Actual|Assistance Publique - Hôpitaux de Paris||2||Removal of Adrénaline lots for safety reasons.|f||||f||||||||||2017-10-10 22:48:14.52115|2017-10-10 22:48:14.52115
NCT02586948|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-08-25|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|EPHEBE||Physiological Study of Minimally Invasive ECCO2R in Exacerbations of COPD Requiring Invasive Mechanical Ventilation|Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation|Recruiting||N/A|12|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:48:14.63659|2017-10-10 22:48:14.63659
NCT02586935|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-17|||December 2015||2015-12-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|TIDE||Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders|A Randomized Placebo-controlled Trial of Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders (ASD)|Recruiting||Phase 2|90|Anticipated|Anagnostou, Evdokia, M.D.||2|||f||||t||||||||No||2017-10-10 22:48:14.774283|2017-10-10 22:48:14.774283
NCT02586922|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-16|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Observational|||Fetal Lung Volume and Pulmonary Artery Resistance Index Measurement in Term Diabetic Pregnancy|Fetal Lung Volume and Pulmonary Artery Resistance Index Measurement in Term Diabetic Pregnancy and Their Correlation With Neonatal Outcome: a Pilot Study|Completed||N/A|70|Actual|Ain Shams University|||1||f||||t||||||||||2017-10-10 22:48:14.900313|2017-10-10 22:48:14.900313
NCT02586909|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-09-20|||April 2016||2016-04-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension|A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Alzheimer's Disease|Enrolling by invitation||Phase 3|1150|Anticipated|Axovant Sciences Ltd.||1|||f||||t||||||||||2017-10-10 22:48:14.991999|2017-10-10 22:48:14.991999
NCT02586896|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-10-24|||March 2016||2016-03-01|October 2016|2016-10-01||||September 2020|Anticipated|2020-09-01||Interventional|||Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments|Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments|Recruiting||N/A|300|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 22:48:15.600177|2017-10-10 22:48:15.600177
NCT02586883|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-12-02|||April 2016||2016-04-01|December 2016|2016-12-01|April 2020|Anticipated|2020-04-01|November 2019|Anticipated|2019-11-01||Interventional|EPITRANS||Bronchial Trans-epithelial Transport in Patients With Idiopathic Multiple Dilations of the Bronchi|Study of the Bronchial Trans-epithelial Transport in Patients With Idiopathic Multiple Dilations of the Bronchi|Recruiting||N/A|75|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 22:48:15.727339|2017-10-10 22:48:15.727339
NCT02586870|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-07-06|||November 2015||2015-11-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|DysArt||Assessment of Renal Artery Fibromuscular Dysplasia: From Diagnosis to Treatment|Assessment of Renal Artery Fibromuscular Dysplasia: From Diagnosis to Treatment|Recruiting||N/A|55|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:48:15.844167|2017-10-10 22:48:15.844167
NCT02586857|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2017-07-19|||January 2016||2016-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)|A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)|Recruiting||Phase 1/Phase 2|72|Anticipated|Acerta Pharma BV||1|||f||||t||||||||||2017-10-10 22:48:15.929995|2017-10-10 22:48:15.929995
NCT02586844|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-04-11|||October 2013||2013-10-01|April 2016|2016-04-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Observational|NET-SEQ||Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors|Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors|Recruiting||N/A|30|Anticipated|University Health Network, Toronto|||2||f||||f||||||Samples With DNA|"     Fresh tumor tissue, 3 tubes of whole blood, archival tumor tissue   "|||2017-10-10 22:48:16.021873|2017-10-10 22:48:16.021873
NCT02586831|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-08-22|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|DIPIT||Diabetes Islet Preservation Immune Treatment|A Pilot, Safety and Feasibility Trial of Anti-Thymocyte Globulin (ATG), Pegylated Granulocyte Colony Stimulating Factor (GCSF), Low Dose Interleukin-2 (IL-2), Etanercept and Exenatide in the Treatment of New Onset Type 1 Diabetes|Not yet recruiting||Phase 1/Phase 2|42|Anticipated|University of Miami||2|||f||||t|t|f||||||||2017-10-10 22:48:16.126862|2017-10-10 22:48:16.126862
NCT02586818|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-19||||||July 2017|2017-07-01||||July 2017|Anticipated|2017-07-01||Observational|||Clinical Performance of Investigational InRhythm PT/INR System in a Professional Use Setting|Clinical Performance of the Investigational InRhythm PT/INR System in a Professional Use Setting|Withdrawn||N/A|0|Actual|Accriva Diagnostics|||2|Product was discontinued.|f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:48:16.259822|2017-10-10 22:48:16.259822
NCT02586805|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-05-23|||March 3, 2016|Actual|2016-03-03|May 2017|2017-05-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|||Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE|HELP Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX-2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)|Completed||Phase 3|120|Actual|Shire||4|||f||||t||||||||||2017-10-10 22:48:16.360502|2017-10-10 22:48:16.360502
NCT02586792|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-01-26|||January 12, 2016|Actual|2016-01-12|December 7, 2016|2016-12-07|December 29, 2016|Actual|2016-12-29|December 29, 2016|Actual|2016-12-29||Interventional|||H7N9 Boost in Healthy Adults|Phase II, Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of a Single Intramuscular Dose of Inactivated Influenza A/H7N9 Vaccine After Priming With Inactivated Influenza A/H7N7 Vaccine|Completed||Phase 2|27|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-10 22:48:16.569331|2017-10-10 22:48:16.569331
NCT02586779|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-03|||October 2015||2015-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Effectiveness of WhatsApp (a Messenger Program) Usage in Emergency Department (ED)|Effectiveness of WhatsApp Messenger Usage and Other Technologises on Communication Between Consulting Physicians and the Emergency Department Staff: Randomised Double-blind Controlled Trial|Completed||N/A|300|Actual|Adiyaman University Research Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:48:16.668982|2017-10-10 22:48:16.668982
NCT02586766|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-22|||October 2011||2011-10-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||University of Michigan Youth Violence Prevention Emergency Department Brief Intervention (Project Sync)|University of Michigan Youth Violence Prevention Emergency Department Brief Intervention|Completed||N/A|409|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 22:48:16.746215|2017-10-10 22:48:16.746215
NCT02586753|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-23|||December 2015||2015-12-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus|A Phase II Study to Compare Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus|Unknown status|Not yet recruiting|Phase 2|2|Anticipated|Mianyang Central Hospital||2|||f||||t||||||||||2017-10-10 22:48:16.809057|2017-10-10 22:48:16.809057
NCT02586740|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-06-15|||November 2015||2015-11-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation||Completed||N/A|120|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 22:48:16.887859|2017-10-10 22:48:16.887859
NCT02586727|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-10-22|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy|Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|Larkin Community Hospital||2|||f||||f||||||||||2017-10-10 22:48:16.951536|2017-10-10 22:48:16.951536
NCT02586714|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-23|||July 2012||2012-07-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational|MBC||Maternal Body Composition Regulates Placental Function|Maternal Body Composition Regulates Placental Function|Completed||N/A|41|Actual|National Center for Research Resources (NCRR)|||3||f||||f||||||||||2017-10-10 22:48:17.024698|2017-10-10 22:48:17.024698
NCT02586701|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-10-17|||September 2013||2013-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Supervised Versus Non-supervised Exercise on Adherence and Functional Outcomes in Colorectal Patients|Effects of a Supervised Versus Non-supervised Exercise Program on Adherence and Functional Outcomes in Colorectal Cancer Patients|Active, not recruiting||Phase 3|50|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 22:48:17.091488|2017-10-10 22:48:17.091488
NCT02586688|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-09-25|||October 2015||2015-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents|A Randomized, Sham-Controlled Trial Evaluating the Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents|Recruiting||N/A|100|Anticipated|Neuronetics||4|||f||||t||||||||||2017-10-10 22:48:17.170136|2017-10-10 22:48:17.170136
NCT02585453|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-12-02|||April 2015||2015-04-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome||Completed||Phase 4|60|Actual|Medical University of Vienna||3|||f||||f||||||||||2017-10-10 22:48:33.058665|2017-10-10 22:48:33.058665
NCT02586675|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-05-16|||February 15, 2016|Actual|2016-02-15|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer|The TEEL Study: A Phase I Trial of Tamoxifen With Ribociclib (LEE011) in Adult Patients With Advanced ER+ (HER2 Negative) Breast Cancer|Active, not recruiting||Phase 1|7|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-10 22:48:17.329225|2017-10-10 22:48:17.329225
NCT02586662|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-22|||March 2012||2012-03-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Observational|||Prediction of Functional Disability in Subjects With Scapular Dyskinesis|Prediction of Functional Disability in Subjects With Scapular Dyskinesis: Shoulder Tightness, Forward Shoulder Posture, Joint Range of Motion, Scapular Kinematics and Associated Muscular Activity|Completed||N/A|51|Actual|National Taiwan University Hospital|||1||f||||||||||||||2017-10-10 22:48:17.422798|2017-10-10 22:48:17.422798
NCT02586649|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-02-28|||July 2014||2014-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||24hr Effects of Tiotropium Bromide in Tetraplegia|A Randomized, Double-blind, Placebo-controlled Trial to Determine the Effects and Duration of Action of Tiotropium Bromide on Pulmonary Function in Persons With SCI|Active, not recruiting||Phase 2|10|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-10 22:48:17.581764|2017-10-10 22:48:17.581764
NCT02586636|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-25|||March 2016||2016-03-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ImpOCT||Impact of OCT1 on Metformin Tolerance|Impact of OCT1 Genotype and OCT1 Inhibiting Drugs on an Individual's Tolerance of Metformin|Recruiting||Phase 4|60|Anticipated|NHS Tayside||2|||f||||f||||||||||2017-10-10 22:48:17.691603|2017-10-10 22:48:17.691603
NCT02586623|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-09-14|||February 2016||2016-02-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|RESTORE||Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension|RESTORE: A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy|Recruiting||Phase 4|482|Anticipated|Lundbeck Northera Ltd.||2|||f||||f||||||||||2017-10-10 22:48:17.819054|2017-10-10 22:48:17.819054
NCT02586610|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-01-18|||October 2016|Actual|2016-10-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer|A Phase II Trial of Neoadjuvant Chemoradiation (CRT) and Pembrolizumab in Patients With Rectal Cancer: Hoosier Cancer Research Network GI15-213|Withdrawn||Phase 2|0|Actual|Hoosier Cancer Research Network||1||Dr. Rahma decided to run the study through a different group|f||||t||||||||||2017-10-10 22:48:18.225797|2017-10-10 22:48:18.225797
NCT02586597|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-10-23|||February 2015||2015-02-01|October 2015|2015-10-01||||February 2016|Anticipated|2016-02-01||Interventional|||Paired Associative Stimulation in Stroke|Paired Associative Stimulation Modulates Motor Excitability and Plasticity in Chronic Stroke Patients|Unknown status|Recruiting|Phase 1|20|Anticipated|Medical University of South Carolina||3|||f||||f||||||||||2017-10-10 22:48:18.33265|2017-10-10 22:48:18.33265
NCT02586584|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-09-20|||April 2016||2016-04-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Observational|||The I-Score Study: Developing a New Patient-Reported Tool for the Routine HIV Care of Patients on Antiretroviral Therapy|The I-Score Study: The Development and Validation of a Patient-Reported Measure of Antiretroviral Therapy's Interference With Life: A Clinical Patient-management Tool for Healthcare Providers|Recruiting||N/A|160|Anticipated|McGill University Health Center|||1||f||||t||||||||||2017-10-10 22:48:18.450578|2017-10-10 22:48:18.450578
NCT02586571|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2017-05-01|||December 2014||2014-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|IceAge2||Growth and Body Composition in Breastfed Infants - Study on Age of Introduction of Complementary Foods in Iceland|Growth and Body Composition in Breastfed Infants - Study on Age of Introduction of Complementary Foods in Iceland|Enrolling by invitation||N/A|100|Anticipated|University of Iceland|||3||f||||f||||||Samples With DNA|"     Urine samples will be obtained from all infants at 5.5 and 12 months of age. Breast milk     samples will be obtained from all mothers when the child is 5.5 months of age.   "|||2017-10-10 22:48:18.543869|2017-10-10 22:48:18.543869
NCT02586558|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-23|||January 2016||2016-01-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CRI||Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants|Effect of Prebiotic on Colic and Crying and Fussing Behaviour in Infants CRI Study: Colic Relief Initiative Study|Unknown status|Not yet recruiting|Phase 3|120|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 22:48:18.650938|2017-10-10 22:48:18.650938
NCT02586545|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-01-06|||August 2015||2015-08-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Shared Care for Patients With Type 2 Diabetes Across the Primary and Secondary Health Care Sector||Active, not recruiting||N/A|140|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-10 22:48:18.736428|2017-10-10 22:48:18.736428
NCT02586519|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-04-13|||June 2016||2016-06-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|PINUP||Pressure-Sensing Insoles in the Neuropathic Ulcer Treatment Pathway|Pressure-Sensing Insoles in the Neuropathic Ulcer Treatment Pathway (PINUP): A Randomized Controlled Trial for Active Neuropathic Ulcer Treatment|Recruiting||N/A|75|Anticipated|University of Calgary||3|||f||||t||||||||Undecided||2017-10-10 22:48:18.896073|2017-10-10 22:48:18.896073
NCT02586493|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-12-19|2016-10-03||October 2015||2015-10-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects|An Open-label Study of the Correct Use and Ease of Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|278|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:48:19.292089|2017-10-10 22:48:19.292089
NCT02586480|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-23|||April 2012||2012-04-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01|12 Months|Observational [Patient Registry]|PRECISE||Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode|Evolution of the PR Interval in Patients Implanted With a Dual Chamber Pacemaker With Algorithm for Spontaneous AV Conduction Preservation|Unknown status|Active, not recruiting|N/A|848|Actual|LivaNova|||1||f||||f||||||||||2017-10-10 22:48:19.540322|2017-10-10 22:48:19.540322
NCT02586467|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-22|||August 2013||2013-08-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|MilkMessage||Messages for Increasing Dairy Consumption|Testing the Effectiveness of Targeted, Framed, -Efficacy Enhancing Messages for Increasing Milk and Milk Product Consumption in Adults Aged 30--50 Years.|Completed||N/A|732|Actual|University of British Columbia||5|||f||||f||||||||||2017-10-10 22:48:19.721456|2017-10-10 22:48:19.721456
NCT02586454|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-06-18|||November 2015||2015-11-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Analgesic Efficacy of Transmuscular Quadratus Lumborum in Patients Undergoing Total Abdominal Hysterectomy|Transmuscular Quadratus Lumborum Block for Postoperative Pain After Total Abdominal Hysterectomy|Completed||N/A|64|Actual|Kuala Lumpur General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:48:19.805745|2017-10-10 22:48:19.805745
NCT02586441|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-11-02|||November 2015||2015-11-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Evaluation of EEG With Respect to the Change of Depth of Anesthesia During General Anesthesia|Evaluation of EEG With Respect to the Change of Depth of Anesthesia|Not yet recruiting||Phase 4|40|Anticipated|Korea University Anam Hospital||1|||f||||t||||||||||2017-10-10 22:48:19.908333|2017-10-10 22:48:19.908333
NCT02586428|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-10-13|||September 2015||2015-09-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Noninvasive Prenatal Testing|Decision-Making in Patients Regarding Noninvasive Prenatal Testing|Terminated||N/A|33|Actual|St. Louis University|||1|difficult to enroll, Pi decision to closed|f||||f||||||||||2017-10-10 22:48:20.002594|2017-10-10 22:48:20.002594
NCT02586415|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-08-04|||April 2016||2016-04-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|DEFUSE 3||Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3|Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3|Terminated||N/A|182|Actual|Stanford University||2||Interim analysis showed a high likelihood of benefit in the endovascular group|f||||t|f|||||||||2017-10-10 22:48:20.309197|2017-10-10 22:48:20.309197
NCT02586402|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-10-23|||October 2015||2015-10-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis|A Phase 2, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Pegolsihematide for the Correction of Anemia in Patients With CRF Undergoing Dialysis and Previously Treated With ESAs|Unknown status|Recruiting|Phase 2|60|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:48:20.677318|2017-10-10 22:48:20.677318
NCT02586389|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-05-18|||October 2015||2015-10-01|May 2016|2016-05-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|||Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay|Collection of Whole Blood and Tissue Specimens From Patients Diagnosed With Non-Hematologic Cancer for Use in Development of a Noninvasive Liquid Biopsy Assay to Determine the Tumor Genomic Profile in Circulating Cell-Free Tumor DNA|Recruiting||N/A|3000|Anticipated|Sequenom, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood samples and tissue samples will be collected for DNA extraction.   "|||2017-10-10 22:48:20.825806|2017-10-10 22:48:20.825806
NCT02586376|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-02-02|||October 2015||2015-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|LLLTMSKF||Effects of the Low-level Laser Therapy (LLLT) on Muscle Strength (MS) of the Patients With Kidneys Failure (KF)|Effects of the Different Intensities of the Low-level Laser Therapy on Handgrip Test on Patients With Kidneys Failure: A Randomized, Controlled Clinical Trail|Completed||N/A|16|Actual|Federal University of Health Science of Porto Alegre||4|||f||||f||||||||||2017-10-10 22:48:20.941418|2017-10-10 22:48:20.941418
NCT02586363|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-12-01|||November 2015||2015-11-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety|A Randomized, Open-label, 3-way Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics and Safety of Single-dose Cavir Tab. 0.5mg With Baraclude Tab. 0.5mg in Healthy Male Volunteers|Active, not recruiting||Phase 1|30|Anticipated|Seoul St. Mary's Hospital||3|||f||||f||||||||||2017-10-10 22:48:21.086864|2017-10-10 22:48:21.086864
NCT02586350|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)|A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Compare the Efficacy and Safety of Anlotinib Versus Placebo in Patients With Medullary Thyroid Carcinoma(ALTER01031)|Recruiting||Phase 2/Phase 3|90|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||f||||||||||2017-10-10 22:48:21.207822|2017-10-10 22:48:21.207822
NCT02586337|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)|A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Compare the Efficacy and Safety of Anlotinib Versus Placebo in Patients With 131I-Refractory Differentiated Thyroid Cancer(ALTER01032)|Recruiting||Phase 2/Phase 3|120|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||f||||||||||2017-10-10 22:48:21.361205|2017-10-10 22:48:21.361205
NCT02586324|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-09|||January 2008||2008-01-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Comparison of Two Embryo Culture Media for IVF and ICSI|Comparison of Two Embryo Culture Media for IVF (in Vitro Fertilization) and ICSI ( Intracytoplasmic Sperm Injection ): Randomized Prospective Study|Completed||N/A|1000|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:48:21.505716|2017-10-10 22:48:21.505716
NCT02586311|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-10-04|||January 2016||2016-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||CKD-330 Phase 3 Trial in Amlodipine Non-responder|A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a CKD-330 Versus Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by Amlodipine Monotherapy|Completed||Phase 3|160|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||No||2017-10-10 22:48:21.570851|2017-10-10 22:48:21.570851
NCT02586298|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-08-22|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Autologous Mitochondrial Transfer in ICSI to Improve Oocyte and Embryo Quality in IVF Patients. Pilot Study|Autologous Mitochondrial Transfer as a Complementary Technique to ICSI to Improve Oocyte and Embryo Quality in IVF Patients. Pilot Study|Completed||N/A|59|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-10-10 22:48:21.666445|2017-10-10 22:48:21.666445
NCT02586285|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-03-30|||June 2015||2015-06-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma|A Randomized Controlled Study on the Effect of S-Adenosyl Methionine Treatment on Anti-tumor Recurrence After Curative Resection of Hepatocellular Carcinoma|Recruiting||Phase 1|300|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 22:48:21.753339|2017-10-10 22:48:21.753339
NCT02586272|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-07-28|||November 25, 2014|Actual|2014-11-25|July 2017|2017-07-01|April 7, 2017|Actual|2017-04-07|February 22, 2017|Actual|2017-02-22||Interventional|DESTINy||Diafert for Embryo Selection and Fertility Improvement|A Prospective, Single-center, Randomized, Two-arm, Interventional Study to Evaluate the Implantation Rate of Embryos Selected on the Basis of Morphology and Granulocyte-Colony Stimulating Factor (G-CSF) Concentration in the Ovarian Follicular Fluid (FF) - FF G-CSF - Compared to the Implantation Rate of Embryos Selected on the Basis of Morphology Alone When Elective Single Embryo Transfer (SET) of a Fresh Embryo is Performed on Day 2/3 After Oocyte Retrieval.|Completed||Phase 3|61|Actual|Forest Laboratories||2|||f||||f|f|f||||||||2017-10-10 22:48:21.863321|2017-10-10 22:48:21.863321
NCT02586259|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2017-05-08|||December 2015||2015-12-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|CORE Practice||Effectiveness of Cortiment® in Patients With Ulcerative Colitis|A Prospective Multi-centre Observational Cohort Study Assessing the Effectiveness of Cortiment® for the Treatment of Mild-to-moderate Active Ulcerative Colitis in Routine Clinical Practice|Recruiting||N/A|300|Anticipated|Ferring Pharmaceuticals|||1||f||||||||||||||2017-10-10 22:48:21.983115|2017-10-10 22:48:21.983115
NCT02586246|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2015-11-13|||January 2011||2011-01-01|November 2015|2015-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870|Long-term Treatment Study of CDP870 Self-injection. A Multicenter, Open-label, Long-term Safety Study to Evaluate the Safety and Efficacy of CDP870 Self-injection Administered at a Dose of 200 mg Biweekly for 24 Weeks or Longer in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870 Administered Concomitantly With or Without Methotrexate (MTX)|Completed||Phase 3|86|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 22:48:22.102443|2017-10-10 22:48:22.102443
NCT02586233|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-08-28|||September 2015||2015-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ASSENT||Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke|A Phase 1b/2, Multi-Center, Double-Blind (Principal Investigators and Study Subjects Blinded, Sponsor Unblinded), Placebo-Controlled, Randomized, Single-Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke|Recruiting||Phase 1/Phase 2|96|Anticipated|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-10 22:48:22.236055|2017-10-10 22:48:22.236055
NCT02586220|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-04-02|||August 2015||2015-08-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Iodine Nutrition During Pregnancy and Related Neonatal Physical Development|Iodine Nutrition During Pregnancy and Related Neonatal Physical Development|Recruiting||N/A|250|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||Samples Without DNA|"     spot urine sample of pregnant women   "|No||2017-10-10 22:48:22.486821|2017-10-10 22:48:22.486821
NCT02586207|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-10-05|||November 2015||2015-11-01|October 2017|2017-10-01|September 2021|Anticipated|2021-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Pembrolizumab in Combination With CRT for LA-SCCHN|Phase Ib Study of Pembrolizumab in Combination With Chemo Radiotherapy (CRT) for Locally-advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 1|39|Anticipated|Sanford Health||1|||f||||t||||||||||2017-10-10 22:48:22.60125|2017-10-10 22:48:22.60125
NCT02586194|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-23|2016-10-05|||November 2015||2015-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Pharmacokinetics Study in Patients With Impaired Hepatic Function|Pharmacokinetic Study of ASP015K - Evaluation of Pharmacokinetics in Patients With Impaired Hepatic Function and Subjects With Normal Hepatic Function|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||Undecided||2017-10-10 22:48:22.750896|2017-10-10 22:48:22.750896
NCT02586181|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-22|||August 2009||2009-08-01|October 2015|2015-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|KnoVIB||Effect of 1 Year Vitamin D or D Plus B-vitamins on Bone Markers in Elderly People (KnoVIB)|Effect of 1 Year Vitamin D or D Plus B-vitamins on Bone Markers in Elderly People|Completed||N/A|93|Actual|Saarland University||2|||f||||f||||||||||2017-10-10 22:48:22.85074|2017-10-10 22:48:22.85074
NCT02586168|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-22|||July 2001||2001-07-01|October 2015|2015-10-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects|The Effect of Gemcabene (CI‐1027) on Insulin Sensitivity in Nondiabetic Subjects|Completed||Phase 2|53|Actual|Gemphire Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:48:22.950169|2017-10-10 22:48:22.950169
NCT02585986|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-09-11|||January 2016||2016-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young Patients|Randomized, Double Blind, Placebo-controlled Intervention Study to Evaluate Safety and Efficiency of a Probiotic in Symptoms Reduction and Use of Topic Corticoids in Mild Atopic Dermatitis Patients Aged 4 to 17 Years|Completed||N/A|51|Actual|Biopolis S.L.||2|||f||||f||||||||Undecided||2017-10-10 22:48:24.943954|2017-10-10 22:48:24.943954
NCT02586155|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-26|||October 2015||2015-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|BETonMACE||Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD|A Phase III Multi-Center, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Clinical Trial in High-Risk Type 2 Diabetes Mellitus (T2DM) Subjects With Coronary Artery Disease (CAD) to Determine Whether Bromodomain Extraterminal Domain (BET) Inhibition Treatment With RVX000222 Increases the Time to Major Adverse Cardiovascular Events (MACE)|Recruiting||Phase 3|2400|Anticipated|Resverlogix Corp||2|||f||||t||||||||||2017-10-10 22:48:23.026482|2017-10-10 22:48:23.026482
NCT02586142|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-23|||August 2010||2010-08-01|August 2010|2010-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Botulinum Toxin Injections by Ultrasounds Guidance and Stretching Exercise in Spastic Toe Clawing|Botulinum Toxin Injections by Ultrasounds Guidance and Stretching Exercise in Spastic Toe Clawing|Completed||Phase 3|30|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 22:48:23.174483|2017-10-10 22:48:23.174483
NCT02586129|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-08-22|||October 2015||2015-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 7, 2017|Actual|2017-07-07||Interventional|||Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes|Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Trial to Evaluate the Safety and Efficacy of YH14755 in Subjects With Dyslipidemia and Type II Diabetes|Active, not recruiting||Phase 3|264|Anticipated|Yuhan Corporation||3|||f||||f||||||||||2017-10-10 22:48:23.306643|2017-10-10 22:48:23.306643
NCT02586103|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-06-18|||November 2015||2015-11-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Prospective Study Assessing the Validity of Y-PAS (Yale Preoperative Anxiety Scale) to Predict Patients Undergoing Magnetic Resonance Imaging Without the Use of Sedation/General Anesthesia||Completed||N/A|80|Actual|Nationwide Children's Hospital|||1||f||||f|f|f||||||||2017-10-10 22:48:23.510073|2017-10-10 22:48:23.510073
NCT02586090|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-06-09|||January 2016||2016-01-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|TEENS+||The Role of Parents in Adolescent Obesity Treatment|Innovative Approaches to Adolescent Obesity Treatment: Exploring the Role of Parents|Recruiting||N/A|192|Anticipated|Virginia Commonwealth University||2|||f||||t||||||||No||2017-10-10 22:48:23.578217|2017-10-10 22:48:23.578217
NCT02586077|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-02-08|||February 1, 2014||2014-02-01|February 2017|2017-02-01|November 15, 2016|Actual|2016-11-15|June 30, 2016|Actual|2016-06-30||Interventional|||Foot and Ankle Clinic Application for Liposomal Related Anesthetic|Foot and Ankle Clinic Application for Liposomal Related Anesthetic|Completed||Phase 4|36|Actual|OrthoCarolina Research Institute, Inc.||1|||f||||t||||||||||2017-10-10 22:48:23.679514|2017-10-10 22:48:23.679514
NCT02586064|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-22|||September 1, 2016|Actual|2016-09-01|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Comparative Effectiveness of Two Treatments for Veterans With PTSD|Interpersonal Therapy for Veterans With PTSD|Recruiting||N/A|176|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:48:23.75389|2017-10-10 22:48:23.75389
NCT02586038|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-05|||October 2015||2015-10-01|September 2017|2017-09-01|October 2022|Anticipated|2022-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study of MLN9708 Plus Oral Dexamethasone or Plus Oral Cyclophosphamide and Dexamethasone or Plus Bendamustine and Dexamethasone or Plus Oral Thalidomide and Dexamethasone Followed by Maintenance With MLN9708 in Newly Diagnosed Elderly Multiple Myeloma Patients||Recruiting||Phase 2|260|Anticipated|University of Turin, Italy||4|||f||||f||||||||||2017-10-10 22:48:24.111435|2017-10-10 22:48:24.111435
NCT02586012|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-05-30|||September 2015||2015-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Weight-based Dosing in Hemophilia A|Weight-based Dosing in Hemophilia A: A Randomized, Controlled, Open-label, Crossover Trial to Measure Factor VIII Recovery Following Factor VIII Concentrate Dosing Based on Total Body Weight, Ideal Body Weight, and Lean Body Mass|Recruiting||Phase 2|24|Anticipated|University of Pittsburgh||6|||f||||t||||||||No||2017-10-10 22:48:24.43579|2017-10-10 22:48:24.43579
NCT02585999|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-04-17|2016-06-30||October 2015||2015-10-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional||30 participants completed the baseline questionnaire, but 2 withdrew prior to starting the study.|The Pharmacokinetics of 12 Week Continuous Patch Use|The Pharmacokinetics of 12 Week Continuous Patch Use|Completed||N/A|30|Actual|Boston Medical Center|It is difficult to compare our findings with those of previous studies, as previous studies have used other instrumentation and techniques in analysis of EE2. Serum analysis was also performed after all samples were collected from participants.|1|||f||||f|f|t|f|f||||No||2017-10-10 22:48:24.555314|2017-10-10 22:48:24.555314
NCT02585973|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-07-01|||February 2016||2016-02-01|July 2016|2016-07-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC|Phase Ib Trial of Dose-escalating AZD1775 in Combination With Concurrent Radiation and Cisplatin for Intermediate and High Risk Head and Neck Squamous Cell Carcinoma (HNSCC)|Recruiting||Phase 1|24|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:48:25.11885|2017-10-10 22:48:25.11885
NCT02585960|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-04-24|||November 21, 2015|Actual|2015-11-21|April 2017|2017-04-01|November 1, 2018|Anticipated|2018-11-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||BAX 855 PK-Guided Dosing|Phase 3, Prospective, Randomized, Multi-center Clinical Study Comparing the Safety and Efficacy of BAX 855 Following PK-guided Prophylaxis Targeting Two Different FVIII Trough Levels in Subjects With Severe Hemophilia A|Active, not recruiting||Phase 3|116|Anticipated|Baxalta US Inc.||3|||f||||f||||||||||2017-10-10 22:48:25.275042|2017-10-10 22:48:25.275042
NCT02585947|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-12-20|||November 2015||2015-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma|A Multicenter Study to Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma Patients With Isolated Anti-HBc-positivity Who Will be Treated With Rituximab Based Chemotherapy|Recruiting||Phase 4|90|Anticipated|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:48:25.602848|2017-10-10 22:48:25.602848
NCT02585934|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-09-22|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study|A Phase 3, Double-blind, Randomized Study of RVT-101 Versus Placebo When Added to Existing Stable Donepezil Treatment in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 3|1315|Actual|Axovant Sciences Ltd.||2|||f||||t|t|f||||||||2017-10-10 22:48:25.721032|2017-10-10 22:48:25.721032
NCT02585921|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-23|||October 2015||2015-10-01|October 2015|2015-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Organ Donation Interventions Among High Students|Combining, Expanding, and Evaluating Multiple Evidence-based Organ Donation Interventions|Recruiting||N/A|1800|Anticipated|Case Western Reserve University||4|||f||||f||||||||||2017-10-10 22:48:26.21111|2017-10-10 22:48:26.21111
NCT02585908|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Safety and Efficacy of γδ T Cell Against Gastric Cancer|γδ T Cell Immunotherapy for Treatment of Gastric Cancer|Not yet recruiting||Phase 1/Phase 2|120|Anticipated|Beijing Doing Biomedical Co., Ltd.||4|||f||||f|f|f||||||||2017-10-10 22:48:26.302883|2017-10-10 22:48:26.302883
NCT02585895|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-08-21|2017-08-21||December 21, 2015|Actual|2015-12-21|August 2017|2017-08-01|January 20, 2017|Actual|2017-01-20|September 1, 2016|Actual|2016-09-01||Interventional|||Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment|A Randomized, Actively Controlled, Open-label, Multicenter Study of Efficacy and Safety of Evolocumab Compared With Low Density Lipoprotein Cholesterol (LDL-C) Apheresis, Followed by Single-Arm Evolocumab Administration in Subjects Receiving LDL-C Apheresis Prior to Study Enrollment|Completed||Phase 3|39|Actual|Amgen||2|||f||||f|t|f||||||||2017-10-10 22:48:26.44277|2017-10-10 22:48:26.44277
NCT02585882|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-23|||March 2012||2012-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|August 2013|Actual|2013-08-01||Interventional|||Preventive Effect of Salt Fluoridation|Caries Preventive Effect of Salt Fluoridation in Preschool Children in The Gambia|Completed||N/A|441|Actual|University of Witten/Herdecke||2|||f||||f||||||||||2017-10-10 22:48:28.872484|2017-10-10 22:48:28.872484
NCT02585869|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-22|||December 1999||1999-12-01|October 2015|2015-10-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Efficacy and Safety of Gemcabene in Patients With Low HDL‐C and Either Normal or Elevated Triglycerides|A 12‐Week, Double‐Blind, Placebo‐Controlled, Randomized, Multicenter Study to Determine the Efficacy and Safety of CI‐1027 in Patients With Low HDL‐C and Either Normal or Elevated Triglycerides|Completed||Phase 2|161|Actual|Gemphire Therapeutics, Inc.||5|||f||||f||||||||||2017-10-10 22:48:28.943318|2017-10-10 22:48:28.943318
NCT02585856|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-02-11|||February 2013||2013-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma|Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma|Active, not recruiting||N/A|39|Actual|First People's Hospital of Hangzhou||2|||f||||f||||||||Yes|publication|2017-10-10 22:48:29.031238|2017-10-10 22:48:29.031238
NCT02585843|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2016-06-06|||November 2015||2015-11-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance|Pilot Study of Natriuretic Versus Standard Doses of Mineralocorticoid Receptor Antagonists in Heart Failure and Loop Diuretic Resistance in Outpatients|Recruiting||Phase 2/Phase 3|40|Anticipated|Columbia University||2|||f||||t||||||||Undecided||2017-10-10 22:48:29.108955|2017-10-10 22:48:29.108955
NCT02585830|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-06-06|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Sleep Timing and Insulin Resistance in Adolescents With Obesity|Investigating the Relationship Between Circadian Phase and Insulin Resistance in Obese Adolescents|Recruiting||N/A|30|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 22:48:29.191446|2017-10-10 22:48:29.191446
NCT02585817|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-05-18|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|RPM-CIED||Remote Patient Management for Cardiac Implantable Electronic Devices|Remote Patient Management for Cardiac Implantable Electronic Devices|Recruiting||N/A|400|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||No||2017-10-10 22:48:29.251431|2017-10-10 22:48:29.251431
NCT02585804|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-05-20|||September 2015||2015-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TRANSLATE||Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects|"Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects: The TRANSLATE Study"|Recruiting||Phase 4|12|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:48:29.336199|2017-10-10 22:48:29.336199
NCT02585791|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-09-06|||February 22, 2017|Actual|2017-02-22|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|February 2019|Anticipated|2019-02-01||Interventional|||Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors|"EVALUATION OF ACUTE AND SUBACUTE EFFECTS OF NICOTINE FREE ELECTRONIC CIGARETTE (NFEC) VAPORS -Aim 2.1 of Adverse Effects of Inhaled Nicotine From Tobacco and E-cigarettes."|Recruiting||N/A|30|Anticipated|University of Miami||3|||f||||f|f|f||||||||2017-10-10 22:48:29.428306|2017-10-10 22:48:29.428306
NCT02585778|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-04-27|||October 23, 2015||2015-10-23|April 2017|2017-04-01|April 3, 2017|Actual|2017-04-03|April 3, 2017|Actual|2017-04-03||Interventional|||Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab in Insulin Treated Patients With Type 1 or Type 2 Diabetes and With Hypercholesterolemia at High Cardiovascular Risk Not Adequately Controlled on Maximally Tolerated LDL-C Lowering Therapy|Completed||Phase 3|517|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:48:29.530191|2017-10-10 22:48:29.530191
NCT02585765|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-02-28|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCI|Insulin Sensitivity in the Peri-Wound Microcirculation of Pressure Ulcers in SCI|Recruiting||Phase 2|30|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f|t|f||||||No||2017-10-10 22:48:29.966691|2017-10-10 22:48:29.966691
NCT02584660|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-04-28|||October 15, 2015|Actual|2015-10-15|April 2017|2017-04-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|MERCURY PE||A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department|MulticEnter Trial of Rivaroxaban for Early disCharge of pUlmonaRY Embolism From the Emergency Department|Completed||Phase 4|114|Actual|Janssen Scientific Affairs, LLC||2|||f||||t||||||||||2017-10-10 22:48:30.065121|2017-10-10 22:48:30.065121
NCT02584647|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-19|||November 4, 2015|Actual|2015-11-04|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PLX3397||PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors|Phase I Study Evaluating Combination Therapy With the Receptor Tyrosine Kinase Inhibitor PLX3397 and Sirolimus in Patients With Unresectable Sarcoma and Phase II Study in Malignant Peripheral Nerve Sheath Tumors|Recruiting||Phase 1/Phase 2|49|Anticipated|Columbia University||2|||f||||t|t|f||||||||2017-10-10 22:48:30.254962|2017-10-10 22:48:30.254962
NCT02584634|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-28|||December 18, 2015|Actual|2015-12-18|September 2017|2017-09-01|January 14, 2018|Anticipated|2018-01-14|January 14, 2018|Anticipated|2018-01-14||Interventional|||Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)|A Phase 1b/2, Open-label, Dose-finding Study To Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab (msb0010718c) In Combination With Either Crizotinib Or Pf-06463922 In Patients With Advanced Or Metastatic Non-small Cell Lung Cancer|Recruiting||Phase 2|130|Anticipated|Pfizer||2|||f||||f|t|f||||||||2017-10-10 22:48:30.392738|2017-10-10 22:48:30.392738
NCT02584621|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-10-04|||November 2015||2015-11-01|October 2017|2017-10-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|Web-AME||Web-Based Adolescent Motivational Enhancement Study|Web-Supported Adolescent Motivational Enhancement to Reduce Alcohol Use|Completed||N/A|148|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-10 22:48:30.587767|2017-10-10 22:48:30.587767
NCT02585752|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-03-22|||October 2015||2015-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:48:30.657782|2017-10-10 22:48:30.657782
NCT02585739|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2015-10-22|||October 2011||2011-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|November 2013|Actual|2013-11-01||Interventional|||Cluster Headache and SPINK-1 Gene|Cluster Headache and SPINK-1 Gene|Completed||N/A|42|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||||||||||||2017-10-10 22:48:30.701634|2017-10-10 22:48:30.701634
NCT02585726|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-08-22|||October 2015||2015-10-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|WAVES||Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES)|Lake Washington Vascular VenaSeal™ Post-Market Evaluation: WAVES|Completed||Phase 4|50|Actual|Lake Washington Vascular||1|||f||||||||||||||2017-10-10 22:48:30.889579|2017-10-10 22:48:30.889579
NCT02585687|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-08-31|||July 2012|Actual|2012-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ETAFIRM||Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma|Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma|Terminated||N/A|28|Actual|Hospices Civils de Lyon||1||problems with enrollment|f||||f||||||||||2017-10-10 22:48:31.276162|2017-10-10 22:48:31.276162
NCT02585674|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2016-12-05|||December 2015||2015-12-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|AUTOMATIX||Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo|A 21-Week, Open-label, Randomized, Controlled, Parallel-group, Multi-center Study Evaluating the Efficacy and Safety of HOE901-U300 Administered According to a Device-Supported Treat-to-target Regimen Versus Routine Titration in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|151|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:48:31.365279|2017-10-10 22:48:31.365279
NCT02585648|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2017-03-22|||February 2016||2016-02-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome|Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome|Completed||N/A|45|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 22:48:31.607825|2017-10-10 22:48:31.607825
NCT02585635|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-05-08|||March 2016||2016-03-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|MOrPH||Risk Models to Optimise Prophylaxis Schedules in Children With Haemophilia|Risk Models to Optimise Prophylaxis Schedules in Children With Haemophilia|Enrolling by invitation||N/A|20|Anticipated|Neuroscience Research Australia|||2||f||||f||||||||No||2017-10-10 22:48:31.720778|2017-10-10 22:48:31.720778
NCT02585622|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-05-09|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|April 2019|Anticipated|2019-04-01||Interventional|NEPHSTROM||NEPHSTROM for Diabetic Kidney Disease|Novel Stromal Cell Therapy for Diabetic Kidney Disease (NEPHSTROM Study)|Not yet recruiting||Phase 1/Phase 2|48|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||t|f|f||||||||2017-10-10 22:48:31.793594|2017-10-10 22:48:31.793594
NCT02585609|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-04-20|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Observational|||Sleep Quality in Patients With Advanced Cancer|Sleep Quality in Patients With Advanced Cancer. A Comparison of Objective Assessments and Self-reports of Sleep Quality|Completed||N/A|41|Actual|Norwegian University of Science and Technology|||1||f||||f|f|f||||||||2017-10-10 22:48:31.93445|2017-10-10 22:48:31.93445
NCT02585596|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-11-08|||October 2015||2015-10-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Phase II Clinical Trial of YH23537 in Patients With Chronic Periodontal Disease.|A Double-blind, Randomized, Parallel, Placebo-active Controlled, Multi-center Phase II Clinical Trial to Investigate the Efficacy and Safety of YH23537 Following 12-week Oral Administration in Patients With Chronic Periodontal Disease|Active, not recruiting||Phase 2|275|Anticipated|Yuhan Corporation||5|||f||||f||||||||No||2017-10-10 22:48:32.009351|2017-10-10 22:48:32.009351
NCT02585583|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-22|||May 2015||2015-05-01|October 2015|2015-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|PRDBRS2||Deep Brain Frameless Radiosurgery for Drug Resistant Invalidating Tremor. Dose Escalation Pilot Study|Deep Brain Frameless Radiosurgery for Drug Resistant Invalidating Tremor. Dose Escalation Pilot Study|Recruiting||Phase 2|8|Anticipated|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta||1|||f||||f||||||||||2017-10-10 22:48:32.113718|2017-10-10 22:48:32.113718
NCT02585570|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-10-30|||October 2015||2015-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Phenylephrine During Shoulder Arthroscopic Surgery|Effect of Phenylephrine Infusion for Preventing Hypotension During Shoulder Arthroscopic Surgery in the Beach Chair Position|Completed||N/A|66|Actual|Inje University||3|||f||||f||||||||No||2017-10-10 22:48:32.219168|2017-10-10 22:48:32.219168
NCT02585557|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-13|||November 2015||2015-11-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|HHN||Heart Health NOW (Previously Known as Facilitation, Spread, and Translation of Patient-Centered Evidence in North Carolina Practices)|Heart Health NOW (Previously Known as Facilitation, Spread, and Translation of Patient-Centered Evidence in North Carolina Practices)|Enrolling by invitation||N/A|300|Anticipated|University of North Carolina, Chapel Hill||5|||f||||f||||||||||2017-10-10 22:48:32.30084|2017-10-10 22:48:32.30084
NCT02585544|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-08-08|||October 15, 2015|Actual|2015-10-15|August 2017|2017-08-01|April 15, 2019|Anticipated|2019-04-15|April 15, 2019|Anticipated|2019-04-15||Interventional|PROLAMBU||Ambulatory Prolapse Surgery|Ambulatory Prolapse Surgery: Feasibility Study|Recruiting||N/A|72|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:48:32.374467|2017-10-10 22:48:32.374467
NCT02585531|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-11-10|||November 2015||2015-11-01|October 2015|2015-10-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Epinephrine, Dexamethasone and Hypertonic Saline in Bronchiolitis|Epinephrine, Dexamethasone, and Hypertonic Saline in Children With Bronchiolitis in the Hospital General Naval de Alta Especialidad. A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||2|||f||||f||||||||||2017-10-10 22:48:32.487883|2017-10-10 22:48:32.487883
NCT02585518|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-05-01|||February 2015||2015-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Ecological Momentary Assessment of Eating Behavior in Overweight Youth|Ecological Momentary Assessment of Eating Behavior in Overweight Youth|Recruiting||N/A|40|Anticipated|University of Chicago|||2||f||||f||||||||||2017-10-10 22:48:32.601464|2017-10-10 22:48:32.601464
NCT02585505|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-22|||December 2010||2010-12-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Tissue Distribution of F18-FDG Labeled ABMSCT in Patients With Type2 Diabetes Mellitus|Tissue Distribution of F18-FDG Labeled Autologous Bone Marrow Derived Stem Cells in Patients With Type2 Diabetes Mellitus|Completed||Phase 1/Phase 2|21|Actual|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||||2017-10-10 22:48:32.673646|2017-10-10 22:48:32.673646
NCT02585492|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-10-05|||November 2015||2015-11-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Mother Position in Skin-to-skin Contact Newborn on Oxygen Saturation Levels.|Episodes of Decreased Oxygen Saturation in Newborns in Skin-to-skin Contact: Role of Maternal Position After Delivery. A Randomized Clinical Study.|Recruiting||N/A|5866|Anticipated|Red Salud Materno Infantil y del Desarrollo||2|||f||||f||||||||||2017-10-10 22:48:32.754532|2017-10-10 22:48:32.754532
NCT02585479|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-22|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma|Systemic Chemotherapy VersusTranscatheter Arterial Chemoembolization As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma(HCC)|Unknown status|Not yet recruiting|Phase 2/Phase 3|164|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-10 22:48:32.878067|2017-10-10 22:48:32.878067
NCT02585466|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-23|||April 2008||2008-04-01|October 2015|2015-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|BIS4||BIS and Entropy Nociception Monitoring|"Precise Quantification of Surrogate Nociception Measures Bispectral Index (sBIS)-Electromyography (sEMG) Variabilities and Response Entropy-State Entropy (RE-SE) Difference. A Practice Alignment Study."|Completed||Phase 4|50|Actual|Medical University of Graz|||2||f||||f||||||||||2017-10-10 22:48:32.992452|2017-10-10 22:48:32.992452
NCT02585440|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-01-31|||April 2016||2016-04-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects|A Phase 1, Randomized, Partial-Blind, Placebo-controlled, Sequential Dose Group, Ascending, Multiple Dose Study of the Safety, Tolerability and Pharmacokinetics, With Food Effect, of CMX157 in Healthy Subjects|Completed||Phase 1|50|Actual|ContraVir Pharmaceuticals, Inc.||5|||f||||t||||||||Yes||2017-10-10 22:48:33.260046|2017-10-10 22:48:33.260046
NCT02585427|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-08-01|||November 2014||2014-11-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Co-ingesting a Low/High GI Meal With Different Fat Saturation on Postprandial Glucose, Insulin, and Triacylglycerol Responses in Healthy Participants|Effects of Co-ingesting a Low/High GI Meal With Different Fat Saturation on Postprandial Glucose, Insulin, and Triacylglycerol Responses in Healthy Participants|Completed||N/A|25|Actual|Clinical Nutrition Research Centre, Singapore||6|||f||||f||||||||||2017-10-10 22:48:33.399415|2017-10-10 22:48:33.399415
NCT02585414|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-11-30|||November 2016||2016-11-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Assessment of TFT by OCT in Healthy Subjects and Subjects With DES|Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease|Recruiting||N/A|340|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-10-10 22:48:33.532802|2017-10-10 22:48:33.532802
NCT02585401|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-03-20|||February 18, 2016|Actual|2016-02-18|March 2017|2017-03-01|May 19, 2016|Actual|2016-05-19|March 31, 2016|Actual|2016-03-31||Observational|||Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada|Evaluation of Physician Knowledge of Key Safety Information for Eylea in Canada: An Observational Postauthorization Safety Study|Completed||N/A|99|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:48:33.63301|2017-10-10 22:48:33.63301
NCT02585388|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-22|2017-08-23|||October 23, 2015|Actual|2015-10-23|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Interventional|CHEOPS||Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.|A Randomized Phase II, Multicenter Study Evaluating the Benefit of Adding a Non Steroidal Aromatase Inhibitor to Oral Vinorelbine in Patients With Pretreated Metastatic Breast Cancer|Active, not recruiting||Phase 2|120|Actual|ARCAGY/ GINECO GROUP||2|||f||||t||||||||||2017-10-10 22:48:33.731108|2017-10-10 22:48:33.731108
NCT02585375|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2017-05-19|||April 2015||2015-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT|Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT|Recruiting||Phase 4|70|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 22:48:33.981945|2017-10-10 22:48:33.981945
NCT02585362|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-05-11|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program|Influence of a Specially Formulated Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program on Physical Performance in Cancer Outpatients|Recruiting||N/A|88|Anticipated|Kantonsspital Winterthur KSW||2|||f||||f||||||||No||2017-10-10 22:48:34.092982|2017-10-10 22:48:34.092982
NCT02585349|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-10-30|||June 2013||2013-06-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01|12 Months|Observational [Patient Registry]|CASPER||Cognition and Affect After Stroke: a Prospective Evaluation of Risks|Cognition and Affect After Stroke: a Prospective Evaluation of Risks|Unknown status|Recruiting|N/A|250|Anticipated|Maastricht University Medical Center|||1||f||||f||||||Samples With DNA|"     Buffycoats from EDTA tubes are taken for DNA extraction (ApoE, CLU, PICALM, CR1, ACE, MTHFR).     One PAXgene tube is collected to ensure long-term stability of RNA. Extraction of RNA and     subsequent analysis of expression of inflammatory and stroke-related genes at the mRNA level     will be done.   "|||2017-10-10 22:48:34.233684|2017-10-10 22:48:34.233684
NCT02585336|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-22|||July 2015||2015-07-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|IMPROVE||Changes in Sugar-sweetened Beverage Intake and Metabolic Health: Improving Metabolic Profile Very Effortlessly|Effects of Sugar-sweetened Beverage Consumption Changes on Metabolic Health: Improving Metabolic Profile Very Effortlessly (IMPROVE)|Unknown status|Active, not recruiting|N/A|200|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:48:34.333289|2017-10-10 22:48:34.333289
NCT02585323|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-06-27|||April 1, 2017|Actual|2017-04-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||SuPRA: Using Wearable Activity Trackers With a New Application to Improve Physical Activity in Knee Osteoarthritis|Supporting Physical Activity and Reducing Sedentary Behavior in Arthritis|Recruiting||N/A|60|Anticipated|University of British Columbia||2|||f|||||f|f||||||No||2017-10-10 22:48:34.425799|2017-10-10 22:48:34.425799
NCT02585310|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-21|||November 2011||2011-11-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Packed Red Blood Cell Transfusion in Elective Coronary Artery Bypass Graft Surgery in A University Hospital|Packed Red Blood Cell Transfusion in Elective Coronary Artery Bypass Graft Surgery in A University Hospital|Completed||N/A|300|Actual|Mahidol University|||1||f||||f||||||||||2017-10-10 22:48:34.533492|2017-10-10 22:48:34.533492
NCT02585297|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-22|||October 2015||2015-10-01|October 2015|2015-10-01||||October 2017|Anticipated|2017-10-01||Observational|||The Presence of Microbes in the Sperm and Their Impact on Sperm Capacitation and IVF Treatment|The Presence of Microbes in the Sperm and Their Impact on Sperm Capacitation and IVF Treatment|Unknown status|Not yet recruiting|N/A|200|Anticipated|Meir Medical Center|||4||f||||t||||||Samples Without DNA|"     Semen and vaginal discharge   "|||2017-10-10 22:48:34.602754|2017-10-10 22:48:34.602754
NCT02585284|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-22|||September 2011||2011-09-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|BIS3||Effect of Age on Propofol-BIS Response|Effect of Age on Propofol-Bispectral Index Response Relationship Among Different Age Groups From Vicenarians to Nonagenarians. A New Logistic Model Compared With Traditional Sigmoid Emax Model|Completed||N/A|80|Actual|Medical University of Graz|||8||f||||f||||||||||2017-10-10 22:48:34.686885|2017-10-10 22:48:34.686885
NCT02584712|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-21|||January 2014||2014-01-01|October 2015|2015-10-01||||December 2014|Actual|2014-12-01||Interventional|||Effect of Exercise Training in Autonomic Modulation in Breast Cancer Patients|Effect of Exercise Training in Autonomic Modulation in Breast Cancer Patients Treated With Doxorubicin|Completed||N/A|18|Actual|Federal University of Maranhao||2|||f||||f||||||||||2017-10-10 22:48:39.713485|2017-10-10 22:48:39.713485
NCT02585271|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-11-02|||October 2015||2015-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Transanal Decompression Tube Versus Stent for Acute Malignant Left-sided Colonic and Rectal Obstruction|Transanal Decompression Tube Versus Stent as a Bridge to Surgery for Acute Malignant Left-sided Colonic and Rectal Obstruction|Terminated||Phase 2|8|Actual|Xuzhou Central Hospital||2||We can not get enough sample size.|f||||f||||||||Yes|We plan to share data by publishing articles.|2017-10-10 22:48:34.76864|2017-10-10 22:48:34.76864
NCT02585258|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-07-20|||March 2016||2016-03-01|July 2016|2016-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|Gloria||The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study|The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study Comparing the Cost-effectiveness and Safety of Additional Low-dose Glucocorticoid in Treatment Strategies for Elderly Patients With Rheumatoid Arthritis|Recruiting||Phase 4|800|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-10-10 22:48:34.862071|2017-10-10 22:48:34.862071
NCT02585232|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-06|||October 1, 2016|Actual|2016-10-01|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|December 31, 2019|Anticipated|2019-12-31||Interventional|ODeC||Optimizing Dementia Care|Optimizing Dementia Care Through Collaborative Recovery Interventions|Recruiting||N/A|68|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 22:48:35.189024|2017-10-10 22:48:35.189024
NCT02585219|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-22|||January 2016||2016-01-01|October 2015|2015-10-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|||Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas|Pilot Feasibility of 11C-MET-PET as a Post-surgery Baseline Scan in the Follow-up of High-grade Gliomas for the Detection of Tumor Recurrence.|Unknown status|Not yet recruiting|N/A|10|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 22:48:35.310527|2017-10-10 22:48:35.310527
NCT02585193|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-08-22|||August 2015||2015-08-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of a Commercial Program on Weight Loss and Health Outcomes|Evaluation of a Commercial Program on Weight Loss and Health Outcomes|Completed||N/A|150|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 22:48:35.498735|2017-10-10 22:48:35.498735
NCT02585180|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-18|||November 2015||2015-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Subglottic Secretions Surveillance to Predict Bacterial Pathogens Involved in Ventilator-associated Pneumonia|Subglottic Secretions Surveillance to Predict Bacterial Pathogens Involved in Ventilator-associated Pneumonia (VAP): an Ancillary Study of the DEMETER Trial (NCT02515617)|Recruiting||N/A|1000|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||t||||||||||2017-10-10 22:48:35.580797|2017-10-10 22:48:35.580797
NCT02585167|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-18|||May 2016||2016-05-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|VAAFT||Endoscopic Treatment of Complex Anal Fistulas|Endoscopic or Surgical Treatment of Complex Perianal Fistula. A Randomized Controlled Clinical Study|Recruiting||N/A|66|Anticipated|University of Southern Denmark||2|||f||||t||||||||||2017-10-10 22:48:35.74205|2017-10-10 22:48:35.74205
NCT02585154|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-10-25||||||October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|||Studying Movement Control in PD Using Closed Loop DBS|Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation|Recruiting||N/A|||University of Oxford|||||f||||||||||||||2017-10-10 22:48:35.850997|2017-10-10 22:48:35.850997
NCT02585141|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-08-18|||October 2015||2015-10-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Aspiration Treatment of Perianal Abscess|Aspiration or Surgical Drainage of Perianal Abscess. A Randomized Controlled Clinical Study|Recruiting||N/A|98|Anticipated|University of Southern Denmark||2|||f||||t||||||||||2017-10-10 22:48:35.947243|2017-10-10 22:48:35.947243
NCT02585128|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-22|||September 2015||2015-09-01|October 2015|2015-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Predictors of Postoperative Delirium After Transcatheter Aortic Valve Implantation|Incidence and Risk Factors of Acute Postoperative Confusion State After Trans-catheter Aortic Valve Implantation (TAVI)|Recruiting||N/A|97|Anticipated|Cardiocentro Ticino||1|||f||||f||||||||||2017-10-10 22:48:36.064654|2017-10-10 22:48:36.064654
NCT02585115|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-10-05|||October 2015||2015-10-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Diagnostic Accuracy of Point of Care Test of First Voided Urine Compared to Midstream Voided Urine in Primary Care|Is a First Void Urine Sample as Accurate as a Midstream Urine Sample in Diagnosing Urinary Tract Infections With a Point-Of-Care-Test Method in Adult, Symptomatic, Non-pregnant Women in General Practice?|Completed||N/A|117|Actual|University of Copenhagen|||1||f||||f||||||||||2017-10-10 22:48:36.171844|2017-10-10 22:48:36.171844
NCT02585102|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-22|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|VegUp||Motivating Value of Vegetables Study|Increasing the Relative Reinforcing Values of Vegetables by Incentive Sensitization|Active, not recruiting||N/A|103|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 22:48:36.242665|2017-10-10 22:48:36.242665
NCT02585089|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-07-25|||October 2015||2015-10-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|April 2016|Actual|2016-04-01||Interventional|PocPep-CVD||Effects of Cured Pork Peptides on Blood Pressure & Cardiovascular Risk Factors|Beneficial Effects of Pork Bioactive Peptides on Cardiovascular Health in Humans|Active, not recruiting||N/A|50|Anticipated|Universidad Católica San Antonio de Murcia||2|||f||||t||||||||||2017-10-10 22:48:36.460903|2017-10-10 22:48:36.460903
NCT02583347|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-08-25|||December 2015||2015-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Sleep Disturbance in Patients With End-Stage Renal Disease|Sleep Disturbance in Patients With End-Stage Renal Disease|Recruiting||N/A|60|Anticipated|Beaumont Hospital|||1||f||||f||||||||||2017-10-10 22:48:52.960346|2017-10-10 22:48:52.960346
NCT02585076|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-05-18|||November 4, 2015|Actual|2015-11-04|May 2017|2017-05-01|May 30, 2016|Actual|2016-05-30|February 29, 2016|Actual|2016-02-29||Observational|REFINE HT||A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With Hypertension|A National, Multicenter, Non-interventional, Crosssectional Study for the Determination of the pREvalence of Non-valvular Atrial FIbrillation Among patieNts Diagnosed With Hypertension Attending HEllenic Hypertension Centers|Completed||N/A|1119|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:48:36.570036|2017-10-10 22:48:36.570036
NCT02585063|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-09-14|||November 2015||2015-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Independent Prescribing Optometrists in Acute Ophthalmic Services|Independent Prescribing Optometrists in Acute Ophthalmic Services|Recruiting||N/A|500|Anticipated|Aston University|||1||f||||f||||||||||2017-10-10 22:48:36.680575|2017-10-10 22:48:36.680575
NCT02585050|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-22|||January 2010||2010-01-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|December 2012|Actual|2012-12-01||Observational|||Influences of DNAR Order Prohibition on Hospital Discharged Ratios and Neurological Outcomes at Discharge|Influences of DNAR Order Prohibition on Hospital Discharged Ratios and Neurological Outcomes at Discharge|Completed||N/A|266|Actual|Adiyaman University Research Hospital|||1||f||||t||||||||||2017-10-10 22:48:36.775084|2017-10-10 22:48:36.775084
NCT02585037|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-26|||August 2015||2015-08-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Changes in Grip Strength by Using Bandage Kinesio Taping|Changes in Grip Strength by Using Bandage Kinesio Taping|Completed||N/A|45|Actual|University of Mogi das Cruzes||3|||f||||t||||||||||2017-10-10 22:48:36.851885|2017-10-10 22:48:36.851885
NCT02585024|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-05-16|||February 2016||2016-02-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)|Cytisine as a Smoking Cessation Agent: Improving Adherence Through a Better Understanding of Pharmacokinetics and Dose Response|Recruiting||Phase 1|48|Anticipated|University of Auckland, New Zealand||6|||f||||f||||||||No||2017-10-10 22:48:36.927494|2017-10-10 22:48:36.927494
NCT02585011|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-11-03|||December 2015||2015-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Local Infiltration Anesthesia With Ropivacaine on Postoperative Pain After Hip Hemiarthroplasty|Effect of Local Infiltration Anesthesia With Ropivacaine on Postoperative Pain After Hip Hemiarthroplasty|Recruiting||N/A|120|Anticipated|St. Olavs Hospital||2|||f||||f||||||||||2017-10-10 22:48:37.048922|2017-10-10 22:48:37.048922
NCT02584998|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-06-06|||January 1, 2017|Actual|2017-01-01|June 2017|2017-06-01|December 30, 2017|Anticipated|2017-12-30|June 12, 2017|Anticipated|2017-06-12||Interventional|||Reducing Colorectal Cancer Death Through Mailed Outreach Screening|Reducing Colorectal Cancer Death Through Mailed Outreach Screening|Recruiting||N/A|783|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||No||2017-10-10 22:48:37.171953|2017-10-10 22:48:37.171953
NCT02584985|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-09-15|||January 2016||2016-01-01|April 2016|2016-04-01|January 2022|Anticipated|2022-01-01|January 2019|Anticipated|2019-01-01||Interventional|ETAP||Evaluate Efficacy, Morbidity and Functional Outcome of Endoscopic TranAnal Proctectomy vs Standard Transabdominal Laparoscopic Proctectomy for Rectal Cancer|A Multicentric Randomised Trial to Evaluate Efficacy, Morbidity and Functional Outcome of Endoscopic TranAnal Proctectomy Versus Standard Transabdominal Laparoscopic Proctectomy for Low Lying Rectal Cancer (ETAP-GRECCAR 11)|Recruiting||Phase 3|226|Anticipated|Institut Paoli-Calmettes||2|||f||||t||||||||||2017-10-10 22:48:37.288033|2017-10-10 22:48:37.288033
NCT02584972|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2015-11-02|||November 2015||2015-11-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|PCASD||Postural Control During Walking and Standing Among Children With Autism Spectrum Disorder|Postural Control During Walking and Standing Among Children With Autism Spectrum Disorder|Not yet recruiting||N/A|40|Anticipated|Soroka University Medical Center|||2||f||||t||||||||||2017-10-10 22:48:37.40178|2017-10-10 22:48:37.40178
NCT02584959|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-01|||November 1, 2015|Actual|2015-11-01|September 2017|2017-09-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|||Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema|A Phase 3, Randomized, Double-blind, Placebo-controlled, Two-period, Three-sequence, Partial Crossover Study to Evaluate the Efficacy and Safety of Subcutaneous Administration of 2000 IU of C1 Esterase Inhibitor [Human] Liquid for Injection for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema|Completed||Phase 3|66|Actual|Shire||3|||f||||||||||||||2017-10-10 22:48:37.514008|2017-10-10 22:48:37.514008
NCT02584946|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-22|||November 2015||2015-11-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Avenanthramides and Exercise|Effect of Avenanthramides Supplement on Exercise-induced Physiological and Psychological Changes|Unknown status|Not yet recruiting|N/A|36|Anticipated|PepsiCo Global R&D||2|||f||||||||||||||2017-10-10 22:48:37.688683|2017-10-10 22:48:37.688683
NCT02584933|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-09-12|||December 11, 2015|Actual|2015-12-11|September 2017|2017-09-01|December 14, 2020|Anticipated|2020-12-14|December 14, 2020|Anticipated|2020-12-14||Interventional|||Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study|An Open-label, Multi-center, Phase IV Roll-over Study in Patients With ALK Positive Malignancies Who Have Completed a Novartis-sponsored Ceritinib (LDK378) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Ceritinib|Recruiting||Phase 4|150|Anticipated|Novartis||1|||t||||f||||||||||2017-10-10 22:48:37.763762|2017-10-10 22:48:37.763762
NCT02584920|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-21|||October 2014||2014-10-01|October 2015|2015-10-01||||August 2015|Actual|2015-08-01||Interventional|||A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 And Rituximab in Patients With CD20-Positive, B-cell Lymphoma||Completed||Phase 1/Phase 2|87|Actual|Shanghai Henlius Biotech||2|||f||||t||||||||||2017-10-10 22:48:37.933467|2017-10-10 22:48:37.933467
NCT02584907|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-04-13|||October 2015||2015-10-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Fat Based Enteral Nutrition for Blood Glucose Control in ICU|Effect of Fat Based Versus Glucose Based Enteral Nutrition on Serum Glucose Levels and Clinical Outcome in Hyperglycemic Patients in ICU|Completed||N/A|88|Actual|Shahid Beheshti University||2|||f||||t||||||||No||2017-10-10 22:48:38.018737|2017-10-10 22:48:38.018737
NCT02582788|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-01-05|||October 2015||2015-10-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Bathing Additives in Pediatric Atopic Dermatitis|Bathing Additives in Management of Pediatric Atopic Dermatitis|Recruiting||N/A|120|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:49:00.009733|2017-10-10 22:49:00.009733
NCT02584894|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-22|||November 2015||2015-11-01|October 2015|2015-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|TETT-STIM||Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation|Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation : A Control Randomized Study|Unknown status|Not yet recruiting|N/A|60|Anticipated|University Hospital, Tours||2|||f||||f||||||||||2017-10-10 22:48:38.113966|2017-10-10 22:48:38.113966
NCT02584881|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-10-21|||December 2014||2014-12-01|October 2014|2014-10-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|SOPP||Safe Opioid Prescription Practice for Patients Discharged From Trauma Services|Safe Opioid Prescription Practice for Patients Discharged From Trauma Services With a Prescription for Opioids|Unknown status|Not yet recruiting|N/A|300|Anticipated|Rhode Island Hospital||2|||f||||f||||||||||2017-10-10 22:48:38.232825|2017-10-10 22:48:38.232825
NCT02584868|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-02-21|||May 2012||2012-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|COLCHIRCARD||Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced Colloid||Recruiting||Phase 3|140|Anticipated|Queen Fabiola Children's University Hospital||2|||f||||f||||||||||2017-10-10 22:48:38.306833|2017-10-10 22:48:38.306833
NCT02584855|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-07-26|||November 2015||2015-11-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|SPIRIT P3||A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis|A Phase 3, Multicenter Study With a 36-Week Open-Label Period Followed by a Randomized Double-Blind Withdrawal Period From Week 36 to Week 104 to Evaluate the Long-Term Efficacy and Safety of Ixekizumab (LY2439821) 80 mg Every 2 Weeks in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Active Psoriatic Arthritis|Active, not recruiting||Phase 3|400|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:48:38.416262|2017-10-10 22:48:38.416262
NCT02584842|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-10-22|||January 2012||2012-01-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|RITE||Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy|Rivaroxaban for Thrombosis Prophylaxis in Endovenous Laser Ablation With and Without Miniphlebectomy: A Multicenter Experience|Completed||N/A|400|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-10 22:48:38.713447|2017-10-10 22:48:38.713447
NCT02584829|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-09-25|||November 6, 2015|Actual|2015-11-06|September 2017|2017-09-01||||July 15, 2019|Anticipated|2019-07-15||Interventional|||Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma|Study to Evaluate Cellular Adoptive Immunotherapy Using Polyclonal Autologous CD8+ Antigen-Specific T Cells for Metastatic Merkel Cell Carcinoma in Combination With MHC Class I Up-Regulation and the Anti-PD-L1 Antibody Avelumab|Suspended||Phase 1/Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center||2||Temporarily closed to accrual|f||||t||||||||||2017-10-10 22:48:38.785948|2017-10-10 22:48:38.785948
NCT02584816|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization|A Phase III, Multicenter, Open Label, Randomized Study of Bovine Rotavirus Pentavalent Vaccine (BRV-PV) to Evaluate Lot-To-Lot Consistency and to Investigate Potential Interference With Routine UIP Vaccinations in Healthy Infants in India.|Completed||Phase 3|1500|Actual|Serum Institute of India Pvt. Ltd.||4|||f||||t||||||||||2017-10-10 22:48:38.935099|2017-10-10 22:48:38.935099
NCT02584803|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-07-07|||May 2016||2016-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Inferior Vena Cava Assessment in Term Pregnancy Using Ultrasound: a Feasibility Study of Subxiphoid and RUQ Views|Inferior Vena Cava Assessment in Term Pregnancy Using Ultrasound: a Feasibility Study of Subxiphoid and RUQ Views|Recruiting||N/A|30|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||Undecided||2017-10-10 22:48:39.04903|2017-10-10 22:48:39.04903
NCT02584777|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-07-08|||November 2015||2015-11-01|July 2016|2016-07-01|August 2020|Anticipated|2020-08-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis|A Phase II, Prospective, Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Asian Subjects With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis or Post- Essential Thrombocythemia Myelofibrosis|Withdrawn||Phase 2|0|Actual|Baxalta US Inc.||1|||f||||t||||||||||2017-10-10 22:48:39.212013|2017-10-10 22:48:39.212013
NCT02584764|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-08-15|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Internet Supported Group Cognitive Behavior Therapy (CBT) for Hoarding Disorder (HD)|Internet Supported Group Cognitive Behavior Therapy for Hoarding Disorder - A Pilot Study|Completed||N/A|20|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 22:48:39.293707|2017-10-10 22:48:39.293707
NCT02584751|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-11-14|||August 2016||2016-08-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals|Comparison of GERD and the Effects of Anti-Reflux Therapy on Pulmonary Function Between Able-Bodied and SCI Individuals|Recruiting||Phase 1|110|Anticipated|James J. Peters Veterans Affairs Medical Center||4|||f||||f||||||||||2017-10-10 22:48:39.385508|2017-10-10 22:48:39.385508
NCT02584738|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-11-30|||September 2015||2015-09-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation|Efficacy of Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation. A Randomized Controlled Trial|Recruiting||Phase 4|152|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||2|||f||||f||||||||||2017-10-10 22:48:39.504084|2017-10-10 22:48:39.504084
NCT02584725|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-21|||December 2014||2014-12-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Tranexamic Acid Dosing for Total Joint Arthroplasty|Determining the Optimal Dose of Tranexamic Acid in Decreasing Blood Loss During Lower Extremity Total Joint Arthroplasty|Completed||Phase 4|84|Actual|Columbia University||3|||f||||f||||||||||2017-10-10 22:48:39.631855|2017-10-10 22:48:39.631855
NCT02584699|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-10-21|||July 2015||2015-07-01|October 2015|2015-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC|Phase II Study of Stereotactic Ablative Radiotherapy in Elderly Patients With Stage I Non-Small Cell Lung Cancer|Recruiting||Phase 2|40|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-10 22:48:39.779583|2017-10-10 22:48:39.779583
NCT02584686|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-11-18|2016-06-10||October 2015||2015-10-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction|Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction Not Responding to Oral and Intracavernous Therapy|Completed||Phase 1|24|Actual|Cairo University|Small sample size (24 total). Several questions need answering: Would a higher BTX-A give a better result? Would the results be maintained for the expected duration of BTX-A effectiveness period of 3 to 6 months?|2|||f||||t||||||||||2017-10-10 22:48:39.885879|2017-10-10 22:48:39.885879
NCT02584673|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-05-16|2017-04-04||October 2015||2015-10-01|May 2017|2017-05-01|December 9, 2016|Actual|2016-12-09|December 9, 2016|Actual|2016-12-09||Interventional|||Computer Assisted Instrument Guidance (CAIG) For Arterial Line Placement|Computer Assisted Instrument Guidance (CAIG) For Arterial Line Placement|Completed||N/A|30|Actual|Clear Guide Medical||2|||f||||f|f|t|f|||||||2017-10-10 22:48:40.581099|2017-10-10 22:48:40.581099
NCT02584608|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-10|||January 2016||2016-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Use of ACTIMMUNE in Patients With ADO2|Phase 2a Study of Interferon Gamma-1b for the Treatment of Autosomal Dominant Type 2 Osteopetrosis|Recruiting||Phase 2|12|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 22:48:40.923118|2017-10-10 22:48:40.923118
NCT02584595|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-21|||September 2015||2015-09-01|October 2015|2015-10-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Observational|EPIC||Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients With St. Jude Medical Implantable Cardioverter Defibrillator (ICD) Systems or Cardiac Resynchronization Therapy Defibrillation (CRT-D) Systems.|An Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients With St. Jude Medical Implantable Cardioverter Defibrillator (ICD) Systems or Cardiac Resynchronization Therapy Defibrillation (CRT-D) Systems.|Withdrawn||N/A|0|Actual|St. Jude Medical|||1|Business decision|f||||f||||||||||2017-10-10 22:48:41.037096|2017-10-10 22:48:41.037096
NCT02584582|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-10-21|||July 2015||2015-07-01|October 2015|2015-10-01||||November 2015|Anticipated|2015-11-01||Interventional|ALFA-1||The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate|The Effect of GLP-1 on Postprandial Glucagon Secretion During Prolonged and Intermittent Stimulation of the GLP-1 Receptor Independent of The Gastric Emptying Rate. A Randomized, Open-label Study in People With Type 1 Diabetes|Unknown status|Enrolling by invitation|Phase 2/Phase 3|10|Anticipated|Hvidovre University Hospital||3|||f||||f||||||||||2017-10-10 22:48:41.110652|2017-10-10 22:48:41.110652
NCT02584556|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-21|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma|A Randomized Controlled Trial of Radical Hepatectomy With Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma|Unknown status|Not yet recruiting|Phase 2/Phase 3|122|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-10 22:48:41.30561|2017-10-10 22:48:41.30561
NCT02584543|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-05-14|||October 2015||2015-10-01|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)|Safety and Immunogenicity Study of the Recombinant Hepatitis E Vaccine(Escherichia Coli) Coadministration With Recombinant Hepatitis B Vaccine|Active, not recruiting||Phase 4|600|Anticipated|Xiamen Innovax Biotech Co., Ltd||3|||f||||f||||||||||2017-10-10 22:48:41.404117|2017-10-10 22:48:41.404117
NCT02584530|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-08-02|||July 2016||2016-07-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparing Ultrasound Guided PICC Line Insertion in Neonates With Standard Procedure|A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion in Neonates With Standard Procedure|Recruiting||N/A|60|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||f||||||||||2017-10-10 22:48:41.4968|2017-10-10 22:48:41.4968
NCT02584517|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-21|||January 2016||2016-01-01|October 2015|2015-10-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Observational|ATLAS||Aetiology of TemporaL Arteritis Study|Understanding the Aetiology and Pathogenesis of Giant Cell Arteritis|Not yet recruiting||N/A|200|Anticipated|University of Oxford|||2||f||||f||||||Samples With DNA|"     Serum Plasma Peripheral Blood Mononuclear Cells Whole blood   "|||2017-10-10 22:48:41.603228|2017-10-10 22:48:41.603228
NCT02584504|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-07-12|||November 30, 2015||2015-11-30|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|April 6, 2017|Actual|2017-04-06||Interventional|ODYSSEY-NIPPON||Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin|Active, not recruiting||Phase 3|159|Anticipated|Sanofi||3|||f||||t||||||||||2017-10-10 22:48:41.695853|2017-10-10 22:48:41.695853
NCT02584491|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-30|||July 2015||2015-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|BeFAST||Brain Change After Fun, Athletic, Sports-skill Training (BeFAST)|Linking Neuroplasticity With the Outcomes of Motor Learning Based Interventions: Multi-modal Evaluation of Walking-based Training in Children and Youth With Cerebral Palsy|Active, not recruiting||N/A|30|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||1|||f||||f||||||||||2017-10-10 22:48:41.892155|2017-10-10 22:48:41.892155
NCT02584478|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-06-15|||December 2015||2015-12-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|AL3818||Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)|A Phase 1/2a Evaluation of the Safety and Efficacy of Adding AL3818, a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy, in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)|Recruiting||Phase 1/Phase 2|48|Anticipated|Advenchen Laboratories, LLC||1|||f||||t||||||||||2017-10-10 22:48:42.000811|2017-10-10 22:48:42.000811
NCT02584465|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-08-23|||August 28, 2015|Actual|2015-08-28|April 2016|2016-04-01|May 2022|Anticipated|2022-05-01|June 2018|Anticipated|2018-06-01||Interventional|REGOVAR||REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression|A Randomized, Open-label, Comparative, Multicenter, Phase II Study of the Efficacy and Safety of REGorafenib Versus Tamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression|Recruiting||Phase 2|116|Anticipated|ARCAGY/ GINECO GROUP||2|||f||||t||||||||||2017-10-10 22:48:42.156996|2017-10-10 22:48:42.156996
NCT02584452|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-10-11|||October 2015||2015-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction|Randomized Controlled Trial Evaluating Postoperative Analgesia and Muscle Strength Between Single Versus Continuous Adductor Canal Block for Ambulatory ACL Reconstruction.|Recruiting||N/A|50|Anticipated|Vanderbilt University||2|||f||||f||||||||No||2017-10-10 22:48:42.306378|2017-10-10 22:48:42.306378
NCT02584439|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-12-06|||October 2015||2015-10-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|BRADYVASC||Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)|Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)|Recruiting||Phase 3|30|Anticipated|University Hospital, Rouen||2|||f||||t||||||||||2017-10-10 22:48:42.440908|2017-10-10 22:48:42.440908
NCT02584426|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-02-28|||January 2017|Actual|2017-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Subcutaneous Injection and Ultrasonic Dispersion of Cefazolin Into Chronic Pelvic-Region Pressure Ulcers in Persons With Spinal Cord Injury||Recruiting||N/A|20|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||||||||||Undecided||2017-10-10 22:48:42.568338|2017-10-10 22:48:42.568338
NCT02584413|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-03-16|||April 16, 2013|Actual|2013-04-16|March 2017|2017-03-01|April 30, 2023|Anticipated|2023-04-30|April 30, 2023|Anticipated|2023-04-30||Observational|||Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma|Hypotonia as a Clinical Predictor of Optic Pathway Glioma in Children With Neurofibromatosis Type 1|Recruiting||N/A|80|Anticipated|Washington University School of Medicine|||1||f||||t|f|t|f|f|f|||No||2017-10-10 22:48:42.652884|2017-10-10 22:48:42.652884
NCT02584400|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-05-23|||May 2016||2016-05-01|May 2016|2016-05-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|HX4 SD||Tumor Hypoxia With HX4 PET in Several Diseases|Non-invasive Imaging of Tumor Hypoxia With [18F]HX4 Positron-Emission-Tomography (PET): A Phase II Trial|Recruiting||Phase 2|120|Anticipated|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-10-10 22:48:42.750527|2017-10-10 22:48:42.750527
NCT02584387|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-05-05|||September 2016||2016-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|3D-VVRET||3D Video Virtual Reality Exposure Therapy Study|3D Video Virtual Reality Exposure Therapy (3D-VVRET) Study|Enrolling by invitation||N/A|40|Anticipated|University of Texas at Austin||2|||f||||||||||||||2017-10-10 22:48:42.853925|2017-10-10 22:48:42.853925
NCT02584374|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-01-21|||January 2016||2016-01-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Balloon Test for Iliac Vein Compression|Balloon Test for Iliac Vein Compression|Unknown status|Recruiting|N/A|20|Anticipated|Maastricht University Medical Center|||2||f||||f||||||||||2017-10-10 22:48:42.923607|2017-10-10 22:48:42.923607
NCT02584348|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-08-26|||November 2013||2013-11-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ECHOGASTRO||Gastric Ultrasound in Paediatric Anaesthesia|Ultrasound Assessment of Gastric Contents : the Way to Best Induce Children for Emergency Surgery|Completed||N/A|146|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:48:43.142981|2017-10-10 22:48:43.142981
NCT02584335|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-08-24|||July 2015||2015-07-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|May 2016|Actual|2016-05-01||Interventional|||To Evaluate Reduction of Pain in Wounds Treatment Previously Applying Lidocaine Topical Solution vs Placebo|Randomised, Double-blind Clinical Trial to Evaluate the Reduction of Pain in the Wounds Treatment Previously Applying Lidocaine Topical Solution vs Placebo|Suspended||Phase 4|26|Anticipated|Hospital Universitari de Bellvitge||2||Difficulties with the recruitment|f||||t||||||||||2017-10-10 22:48:43.223376|2017-10-10 22:48:43.223376
NCT02584322|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-08-31|||November 2015||2015-11-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|November 2016|Actual|2016-11-01||Interventional|||Fast Tracking in VATS Lobectomy: A Prospective, Historically Controlled, Propensity-Matched Clinical Trial|Fast Tracking in VATS Lobectomy: A Prospective, Historically Controlled, Propensity-Matched Clinical Trial|Completed||N/A|100|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t||||||||||2017-10-10 22:48:43.317396|2017-10-10 22:48:43.317396
NCT02584309|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-08-29|||February 22, 2016|Actual|2016-02-22|August 2017|2017-08-01|October 31, 2023|Anticipated|2023-10-31|October 31, 2023|Anticipated|2023-10-31||Interventional|||Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma|A Non-Inferiority Study of Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma|Recruiting||Phase 2|75|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 22:48:43.418247|2017-10-10 22:48:43.418247
NCT02584296|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-01-05|||March 2015||2015-03-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Physical Activity as Self-Management Approach to Improve Health Outcomes in AML|Physical Activity as a Self-Management Approach to Improve Health Outcomes in Acute Myeloid Leukemia|Completed||N/A|23|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-10 22:48:43.526194|2017-10-10 22:48:43.526194
NCT02584283|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-07-16|||October 2015||2015-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|DHOPE-DCD||Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation|A Multicenter Randomized Controlled Trial to Compare the Efficacy of End-ischemic Dual Hypothermic Oxygenated Perfusion With Standard Static Cold Storage of Liver Grafts Donated After Circulatory Death in Preventing Biliary Complications|Recruiting||Phase 3|156|Anticipated|University Medical Center Groningen||2|||f||||t||||||||||2017-10-10 22:48:43.59698|2017-10-10 22:48:43.59698
NCT02584270|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-12-16|||January 2017||2017-01-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|PGSRT||Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue|Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue (PGSRT): a Randomized Clinical Trial|Not yet recruiting||N/A|40|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 22:48:43.743051|2017-10-10 22:48:43.743051
NCT02584257|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-03-10|||April 2016||2016-04-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma|Comparison of the Pharmacodynamic Profile of Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate Using Bronchoprovocation in Adult Patients With Stable Mild Asthma|Completed||Phase 3|91|Actual|Lupin Ltd.||5|||f||||f||||||||No||2017-10-10 22:48:45.30173|2017-10-10 22:48:45.30173
NCT02584244|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-08-22|||May 2016||2016-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers|Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers|Recruiting||N/A|21|Anticipated|Lumicell, Inc.||1|||f||||t||||||||||2017-10-10 22:48:45.476861|2017-10-10 22:48:45.476861
NCT02584231|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-10-20|||September 2015||2015-09-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population|Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population|Unknown status|Recruiting|Phase 4|24|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-10 22:48:45.594504|2017-10-10 22:48:45.594504
NCT02584218|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-20|||January 2015||2015-01-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|June 2015|Actual|2015-06-01||Interventional|||Effectiveness of Sealing Dental Caries|Effectiveness of Sealing Dental Caries: a Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|100|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-10 22:48:45.729444|2017-10-10 22:48:45.729444
NCT02584205|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-10-20|||April 2015||2015-04-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Does Inspiratory Muscle Training Improve Functional Capacity in Subjects With Obstructive Sleep Apnea?|Does Inspiratory Muscle Training Improve Functional Capacity in Subjects With Obstructive Sleep Apnea? Randomized Clinical Trial|Unknown status|Recruiting|N/A|10|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:48:45.804532|2017-10-10 22:48:45.804532
NCT02584192|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-21|||October 2014||2014-10-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of Early Home-based Cardiac Rehabilitation Program for Patients After Acute Myocardial Infarction|Efficacy of Early Home-based Cardiac Rehabilitation Program for Patients After Acute Myocardial Infarction|Completed||N/A|52|Actual|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||t||||||||||2017-10-10 22:48:45.895501|2017-10-10 22:48:45.895501
NCT02584179|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2017-02-23|||December 2015|Actual|2015-12-01|February 2017|2017-02-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Can Significant Prostate Cancer Be Detected With a Biparametric MRI?|Can Significant Prostate Cancer Be Detected With a Short Non-Contrast Enhanced Biparametric MRI (Bp-MRI)?|Recruiting||N/A|600|Anticipated|Herlev Hospital||1|||f||||t||||||||Yes|as a publication|2017-10-10 22:48:45.963448|2017-10-10 22:48:45.963448
NCT02584166|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-27|||October 2009||2009-10-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|OPERA||Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences (OPERA)|Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences|Completed||N/A|4929|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:48:46.058235|2017-10-10 22:48:46.058235
NCT02584153|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-10-24|||July 2017||2017-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HiP_1||A Study of Fibrin Sealant Plus Silver Microparticles to Prevent Incisional Hernias Following Abdominal Surgery|An Open-label, Single-arm, Phase 1 Study Examining the Safety and Efficacy of Fibrin Sealant Plus Silver Microparticles to Prevent Incisional Hernias (HiP_1 Trial) Following Abdominal Surgery|Not yet recruiting||Phase 1|15|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 22:48:46.133061|2017-10-10 22:48:46.133061
NCT02584140|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-09-22|||May 2016||2016-05-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|AEGiS||PrEP Adherence Enhancement Guided by iTAB and Drug Levels for Women|Multimodal Interventions to Improve Adherence to Oral Tenofovir/Emtricitabine as Pre-Exposure Prophylaxis in Women in Southern California|Recruiting||Phase 4|100|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-10 22:48:46.22126|2017-10-10 22:48:46.22126
NCT02584127|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-05-11|||September 2009||2009-09-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|September 2013|Actual|2013-09-01||Interventional|CFCHKA||Tobacco-Related Disease Prevention Among Korean Americans|Tobacco-Related Disease Prevention Among Korean Americans|Completed||N/A|405|Actual|University of California, Berkeley||2|||f||||f||||||||||2017-10-10 22:48:46.446798|2017-10-10 22:48:46.446798
NCT02584114|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-20|||January 2016||2016-01-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Brain Effects of Memory Training in Early Psychosis|Brain Effects of Memory Training in Early Psychosis|Not yet recruiting||N/A|46|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 22:48:46.548756|2017-10-10 22:48:46.548756
NCT02584101|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-05-25|||January 2016||2016-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Acceptance and Commitment Therapy (ACT) and Carers|The Use of Acceptance and Commitment Therapy to Promote WellBeing and Psychological Flexibility in Carers: A Randomized Controlled Feasibility Trial|Completed||N/A|18|Actual|University of Glasgow||2|||f||||f||||||||||2017-10-10 22:48:46.62673|2017-10-10 22:48:46.62673
NCT02584088|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-26|||October 11, 2016|Actual|2016-10-11|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation|Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation|Recruiting||N/A|80|Anticipated|TriHealth Inc.|||1||f||||f||||||||||2017-10-10 22:48:46.710101|2017-10-10 22:48:46.710101
NCT02584075|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-21|||November 2015||2015-11-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function||Not yet recruiting||Phase 4|100|Anticipated|Beijing Chao Yang Hospital||1|||f||||||||||||||2017-10-10 22:48:46.796751|2017-10-10 22:48:46.796751
NCT02584062|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-03-21|||December 2015||2015-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Observation of Technologic Application of No-touch Fluid-air Exchange in Surgery of Idiopathic Macula Hole|The Eye Hospital of Tianjin Medical University|Recruiting||N/A|2|Anticipated|Tianjin Medical University Eye Hospital||2|||f||||f||||||||||2017-10-10 22:48:46.872332|2017-10-10 22:48:46.872332
NCT02584049|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-02-10|||December 2015||2015-12-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|OGéDIS||Osteopathic Medicine in the Management of Care-induced Pain in Elderly Care (OGéDIS)|Effects of Osteopathic Treatment in the Management of Care-induced Pain in Elderly Care, in Follow-up Care and Rehabilitation Geriatric|Recruiting||N/A|76|Anticipated|Centre Hospitalier René Dubos||2|||f||||f||||||||No||2017-10-10 22:48:46.95292|2017-10-10 22:48:46.95292
NCT02584036|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-07-11|||October 2015||2015-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Observational|||Project IMPACT Immunizations (IMProving America's Communities Together)|Project IMPACT Immunizations (IMProving America's Communities Together)|Completed||N/A|1080|Actual|American Pharmacists Association Foundation|||1||f||||f||||||||||2017-10-10 22:48:47.040402|2017-10-10 22:48:47.040402
NCT02584023|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-06-21|||October 2015||2015-10-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Lung Ultrasound and Alveolar Recruitment in Mechanically Ventilated Infants|Preventive Effect of Lung Ultrasound and Alveolar Recruitment on Atelectasis in Mechanically Ventilated Infants|Completed||N/A|40|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 22:48:47.137776|2017-10-10 22:48:47.137776
NCT02584010|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-02-14|||January 2016||2016-01-01|February 2017|2017-02-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|Kelofin||Efficacy Study of Two Silicon-based Products to Treat Scars|Comparative, Open, Randomized Trial Between Two Silicon-based Products to Treat Postoperative Scars|Withdrawn||N/A|0|Actual|Ache Laboratorios Farmaceuticos S.A.||3|||f||||f||||||||||2017-10-10 22:48:47.219774|2017-10-10 22:48:47.219774
NCT02583997|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-06-02|||June 2016||2016-06-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|AlvéCare||Non-closure of Alveoli After Avulsion of Wisdom Teeth|Non-closure of Alveoli After Avulsion of Wisdom Teeth: a Randomized, Open, Multicenter Trial|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 22:48:47.293076|2017-10-10 22:48:47.293076
NCT02583984|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-05-24|||March 2017||2017-03-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Metabolomic Study in Exhaled Breath Condensate of Thoracic Surgical Patients|Metabolomic Study in Exhaled Breath Condensate of Thoracic Surgical Patients|Not yet recruiting||N/A|40|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples Without DNA|"     Exhaled breath condensate   "|||2017-10-10 22:48:47.399725|2017-10-10 22:48:47.399725
NCT02583971|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-08-01|||November 2016||2016-11-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|||Assessment of Thrombotic Status in Patients With Atrial Fibrillation|Assessment of Thrombotic Status in Patients With Atrial Fibrillation|Not yet recruiting||N/A|500|Anticipated|East and North Hertfordshire NHS Trust|||1||f||||f||||||Samples Without DNA|"     Whole blood Plasma store   "|||2017-10-10 22:48:47.478574|2017-10-10 22:48:47.478574
NCT02583958|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-20|||October 2014||2014-10-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers|Assessment of Efficacy and Safety for a New Wound Dressing URGO 310 3166 in the Local Treatment of Venous or Mixed Leg Ulcers: A European, Randomised Clinical Trial|Unknown status|Recruiting|N/A|||Laboratoires URGO||2|||f||||f||||||||||2017-10-10 22:48:47.543018|2017-10-10 22:48:47.543018
NCT02583945|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-21|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|PrevenAKI||Prevention of Postoperative Acute Kidney Injury|Effect of a Kidney Bundle on the Occurence of Postoperative Acute Kidney Injury in Patients at Risk|Unknown status|Not yet recruiting|N/A|500|Anticipated|Wuerzburg University Hospital||1|||f||||f||||||||||2017-10-10 22:48:47.623577|2017-10-10 22:48:47.623577
NCT02583932|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-06|||October 2015||2015-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer|Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In People Newly Diagnosed With Advanced Cancer: Full Trial|Recruiting||Phase 3|471|Anticipated|Jewish General Hospital||3|||f||||f||||||||No||2017-10-10 22:48:47.70678|2017-10-10 22:48:47.70678
NCT02583919|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-03-08|||September 2015||2015-09-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes|Double Blind, Randomized, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Efficacy of ISIS 449884 Administered Once Weekly for 26 Weeks in Patients With Type 2 Diabetes Being Treated With Metformin|Active, not recruiting||Phase 2|80|Anticipated|Ionis Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:48:47.809439|2017-10-10 22:48:47.809439
NCT02581514|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-06-23|||October 2015||2015-10-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|EOSINOPHILIM||Eosinophilia Diagnosis|Algorithm for the Early Diagnosis and Treatment of Patients With Eosinophilia|Recruiting||N/A|53|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-10-10 22:49:14.521864|2017-10-10 22:49:14.521864
NCT02583906|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-10-20|||April 2014||2014-04-01|October 2015|2015-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment|Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment|Recruiting||N/A|44|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 22:48:47.921267|2017-10-10 22:48:47.921267
NCT02583893|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-06-09|||October 7, 2015|Actual|2015-10-07|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|October 2020|Anticipated|2020-10-01||Interventional|||Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia|A Biomarker Validation Study to Establish Whether Serial Flow Cytometric Measurements Predict Clinical Response to Sirolimus and MEC (Mitoxantrone Etoposide Cytarabine) Treatment in Patients With High-Risk Acute Myelogenous Leukemia|Recruiting||Phase 2|65|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 22:48:48.159752|2017-10-10 22:48:48.159752
NCT02583880|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2016-12-19|||October 2015||2015-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Screening Day Latin America|Screening Day Latin America to Assess Disease-related Malnutrition and Clinical Nutrition Practice in ICU Patients|Completed||N/A|1162|Actual|Fresenius Kabi|||1||f||||f||||||||||2017-10-10 22:48:48.36016|2017-10-10 22:48:48.36016
NCT02583867|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-05-03|||December 2015||2015-12-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Predictors of Depression Treatment Response to Exercise|Predictors of Depression Treatment Response to Exercise|Recruiting||Phase 3|50|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-10 22:48:48.740034|2017-10-10 22:48:48.740034
NCT02583854|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2015-10-24|||September 2015||2015-09-01|October 2015|2015-10-01|April 2017|Anticipated|2017-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison Study of Compression Devices Used in Transradial Coronary Angiography||Unknown status|Recruiting|N/A|500|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 22:48:48.839429|2017-10-10 22:48:48.839429
NCT02583841|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2015-10-21|||February 2015||2015-02-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||"Effect of Scaling and Root Planing on Liver Function Test (Alanine Aminotransferase and Aspartate Aminotransferase) in Systemically Healthy - Chronic Periodontitis Subjects: a Clinical Trial."||Completed||Phase 4|50|Actual|Tatyasaheb Kore Dental College||2|||f||||||||||||||2017-10-10 22:48:48.959203|2017-10-10 22:48:48.959203
NCT02583828|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-02-03|||June 2015||2015-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients||Recruiting||N/A|200|Anticipated|Capital Medical University||4|||f||||f||||||||||2017-10-10 22:48:49.072321|2017-10-10 22:48:49.072321
NCT02583815|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-05-31|||August 2015||2015-08-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|PAMCap||Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)|Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCap)|Recruiting||N/A|40|Anticipated|University of Texas Southwestern Medical Center|||1||f||||t||||||Samples With DNA|"     Blood samples will be collected at each study visit (Baseline, then every weeks until week 12     (+/-14 days). Prior to storage, complete the sample inventory logs for each subject so that     specimen chain of custody can be established. Samples will be frozen at −80°C until the time     of analysis.      Include in each shipment batch copies of: 1) the blood collection source documents for each     patient; and 2) copies of each subjects specimen inventory form      Keep originals of these documents in the subject's chart      Samples will be analyzed using a multiplexed ELISA method (Meso Scale Discovery) for     IL-1beta, IL-6, IL-10 and TNF-alpha      With explicit participant consent, samples will also be processed for DNA and stored for     future analysis.   "|||2017-10-10 22:48:49.179525|2017-10-10 22:48:49.179525
NCT02583802|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-21|||September 2013||2013-09-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients|The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients by Ear Pills Combined With Shengmai Capsule|Unknown status|Recruiting|Phase 2/Phase 3|150|Anticipated|Beijing University of Chinese Medicine||2|||f||||f||||||||||2017-10-10 22:48:49.292922|2017-10-10 22:48:49.292922
NCT02583789|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-07-31|||May 2016||2016-05-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon|A Double-blinded, Placebo-controlled, Crossover Study to Assess Efficacy of Oral Treprostinil Titrated to Highest Tolerable Dose in 20 Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Resistant to Vasodilatory Therapy|Recruiting||Early Phase 1|20|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 22:48:49.431539|2017-10-10 22:48:49.431539
NCT02583776|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-08-09|||October 2015||2015-10-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CGM&VLBWI||Continuous Glucose Monitoring and Preterm Infants|NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS|Completed||Phase 4|50|Actual|University Hospital Padova||2|||f||||t||||||||||2017-10-10 22:48:49.559679|2017-10-10 22:48:49.559679
NCT02583763|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-05-10|||January 2013||2013-01-01|May 2016|2016-05-01|December 2023|Anticipated|2023-12-01|December 2017|Anticipated|2017-12-01|7 Years|Observational [Patient Registry]|CADETTE||Cardiac Displacement From Third Trimester to Early Childhood|Cardiac Displacement From Third Trimester to Early Childhood|Recruiting||N/A|90|Anticipated|University Hospital, Linkoeping|||2||f||||f||||||Samples With DNA|"     The investigators will take a blood sample from the umbilical cord at birth and again at 7     years of age. The sample will be analyzed for growth factors and cardiac markers.      2015-05-20 an additional ethical approval was accepted for analyzing epigenetic factors in     the children's DNA.   "|||2017-10-10 22:48:49.674034|2017-10-10 22:48:49.674034
NCT02583750|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-20|||January 2014||2014-01-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Snooze Control: Sleep Duration & Glucose Metabolism|Snooze Control: The Effect of Sleep Deprivation on Glucose Metabolism|Completed||N/A|16|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-10 22:48:49.78332|2017-10-10 22:48:49.78332
NCT02583737|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-05-10|||June 2014||2014-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparative Study Between Lyophilized or Frozen Bone Allografts for Sinus-lifting|Histological and Microtomographic Comparative Study Between Lyophilized or Frozen Bone Allografts for Sinus-lifting: A Randomized Clinical Trial|Active, not recruiting||N/A|15|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:48:49.86224|2017-10-10 22:48:49.86224
NCT02583711|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-03-08|||October 2015||2015-10-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||The Step Home Trial: Utilising Physical Activity Data in the Acute Post-operative Setting|The Step Home Trial: Utilising Physical Activity Data in the Acute Post-operative Setting|Recruiting||N/A|60|Anticipated|Imperial College London|||1||f||||f||||||||||2017-10-10 22:48:49.929931|2017-10-10 22:48:49.929931
NCT02583698|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-06-08|||October 2015||2015-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices|Efficacy of Nonselective Beta Blockers vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices|Recruiting||N/A|250|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 22:48:50.001522|2017-10-10 22:48:50.001522
NCT02583685|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-15|||May 2015||2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SWITCH-1||Switching Regimen in Treating Cirrhotic HCV GT1b Subjects|Efficacy and Safety of Switching From Pegylated Interferon/Ribavirin (PR) to Direct-acting Antiviral Agents (DAAs) for Chinese With CHC Genotype 1b Infection (SWITCH-1)|Recruiting||Phase 2|160|Anticipated|Humanity and Health Research Centre||8|||f||||t||||||||||2017-10-10 22:48:50.101994|2017-10-10 22:48:50.101994
NCT02583672|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-08-30|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)|Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-inflammatory Medications|Recruiting||Phase 2|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t|t|f||||||||2017-10-10 22:48:50.264491|2017-10-10 22:48:50.264491
NCT02583659|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-11-10|||January 2013||2013-01-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|June 2016|Anticipated|2016-06-01||Observational|||The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study|The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study|Recruiting||N/A|250|Anticipated|Huazhong University of Science and Technology|||1||f||||f||||||Samples With DNA|"     DNA extracted from peripheral blood sample   "|||2017-10-10 22:48:50.40152|2017-10-10 22:48:50.40152
NCT02583646|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-21|2017-07-29|||October 15, 2015||2015-10-15|July 28, 2017|2017-07-28|September 30, 2018|Anticipated|2018-09-30|June 29, 2018|Anticipated|2018-06-29||Observational|||Investigating the Impact of Obesity on Pubertal Development in Girls|Investigating the Impact of Obesity on Pubertal Development in Girls|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:48:50.491731|2017-10-10 22:48:50.491731
NCT02583620|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-10-20|||September 2009||2009-09-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ASSOMYP||Identification of Genomic Loci Determining Susceptibility to the Development of High Myopia|Identification of Genomic Loci Determining Susceptibility to the Development of High Myopia|Completed||N/A|553|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 22:48:50.759766|2017-10-10 22:48:50.759766
NCT02583607|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-20|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|Brava||Brava and Fat Transfer for Breast Reconstruction|Brava and Fat Transfer for Breast Reconstruction|Unknown status|Not yet recruiting|Phase 1/Phase 2|50|Anticipated|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-10-10 22:48:50.856742|2017-10-10 22:48:50.856742
NCT02583594|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-06-22|||December 6, 2015|Actual|2015-12-06|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2016|Actual|2016-03-01||Interventional|SCALA||A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis|A Phase 1, Exploratory, Randomized, Open-label, 2-Arm Study to Characterize the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Alemtuzumab 12mg Administered Subcutaneously or Intravenously in Patients With Progressive Multiple Sclerosis|Active, not recruiting||Phase 1|24|Anticipated|Sanofi||2|||f||||f||||||||||2017-10-10 22:48:50.949782|2017-10-10 22:48:50.949782
NCT02583581|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-06-15|||October 2015||2015-10-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks|A Feasibility Study for Examination the Use of Brain Prefrontal Activity Monitoring, for Early Detection of Migraine Attack|Recruiting||N/A|50|Anticipated|Brainmarc Ltd.||1|||f||||f||||||||||2017-10-10 22:48:51.081667|2017-10-10 22:48:51.081667
NCT02583568|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-02-10|||October 2015||2015-10-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|MARGIN||Fluorescence Guided Surgery in Breast Cancer|Phase II, Open-Label Study to Evaluate Safety and Explore Efficacy of Escalating Doses of Bevacizumab-IRDye800CW as an Optical Imaging Agent to Detect Cancer Tissue Delineation During Tumor Resection Surgery in Patients With Breast Cancer|Completed||Phase 1/Phase 2|26|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-10-10 22:48:51.169206|2017-10-10 22:48:51.169206
NCT02583555|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-21|||November 2015||2015-11-01|October 2015|2015-10-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Case Management Study to Reduce Health Care Utilization for Frequent Hospital Care Users|Randomised Case Management Study to Reduce Health Care Utilization for Frequent Hospital Care Users|Unknown status|Not yet recruiting|N/A|400|Anticipated|Region Sjælland||2|||f||||f||||||||||2017-10-10 22:48:51.268579|2017-10-10 22:48:51.268579
NCT02583542|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-09-18|||June 2015||2015-06-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|August 2016|Actual|2016-08-01||Interventional|TORCMEK||A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers|A Phase Ib/IIa Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers|Recruiting||Phase 1/Phase 2|118|Anticipated|Queen Mary University of London||2|||f||||f||||||||||2017-10-10 22:48:51.356136|2017-10-10 22:48:51.356136
NCT02583529|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2015-10-20|||July 2014||2014-07-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|NOVTPD||Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation|Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation|Recruiting||Early Phase 1|30|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-10 22:48:51.487654|2017-10-10 22:48:51.487654
NCT02583516|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-08-22|||June 2015||2015-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma|A Randomized Phase II Study of Vemurafenib Plus Cobimetinib Continuous Versus Intermittent, in Previously Untreated BRAFV600- Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma|Recruiting||Phase 2|116|Anticipated|Grupo Español Multidisciplinar de Melanoma||2|||f||||f||||||||||2017-10-10 22:48:51.597181|2017-10-10 22:48:51.597181
NCT02583503|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-02-28|||December 7, 2015|Actual|2015-12-07|October 2015|2015-10-01|June 28, 2016|Actual|2016-06-28|June 28, 2016|Actual|2016-06-28||Observational|||Hindfoot Alignment in Total Knee Replacement|Hindfoot Alignment in TKR - Validation of a Novel Radiographic Study|Completed||N/A|65|Actual|Golden Jubilee National Hospital|||1||f||||t|f|f||||||No||2017-10-10 22:48:51.777881|2017-10-10 22:48:51.777881
NCT02583490|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-09-29|||March 2015||2015-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Low Pulse Amplitude Focal ECT (LAP Study)|Low Pulse Amplitude Focal Electroconvulsive Therapy|Recruiting||N/A|10|Anticipated|Augusta University||2|||f||||t||||||||||2017-10-10 22:48:51.864795|2017-10-10 22:48:51.864795
NCT02583477|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-12|||March 25, 2016|Actual|2016-03-25|September 2017|2017-09-01|February 14, 2018|Anticipated|2018-02-14|February 14, 2018|Anticipated|2018-02-14||Interventional|||Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma|A Phase Ib and II Open-Label, Multi-Center Study of MEDI4736 Evaluated in Different Combinations in Patients With Metastatic Pancreatic Ductal Adenocarcinoma|Recruiting||Phase 1/Phase 2|19|Anticipated|AstraZeneca||2|||f||||f|t|f||||||||2017-10-10 22:48:51.984131|2017-10-10 22:48:51.984131
NCT02583464|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-20|||September 2014||2014-09-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.|Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.|Completed||Phase 1|24|Actual|Laboratorio Elea S.A.C.I.F. y A.||2|||f||||f||||||||||2017-10-10 22:48:52.106234|2017-10-10 22:48:52.106234
NCT02583451|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-27|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects|A Randomized, Double-Blind, Placebo- and Active-Controlled, 4-Period Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects|Completed||Phase 1|48|Actual|Eisai Inc.||5|||f||||f||||||||||2017-10-10 22:48:52.188301|2017-10-10 22:48:52.188301
NCT02583438|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-21|||October 2015||2015-10-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes|Beijing Chao-yang Hospital, Capital Medical University|Not yet recruiting||Phase 4|100|Anticipated|Beijing Chao Yang Hospital||1|||f||||t||||||||||2017-10-10 22:48:52.28841|2017-10-10 22:48:52.28841
NCT02583412|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-04-08|||September 2015||2015-09-01|April 2017|2017-04-01|June 30, 2017|Anticipated|2017-06-30|September 2016|Actual|2016-09-01||Interventional|||Pilot Study of the Immunogenicity, Reactogenicity and Tolerability of Two Schedules of a 4CmenB Vaccine in Adolescents and Young Adults|Preparedness for and Response to Meningococcal Outbreaks: a Pilot Study of the Immunogenicity, Reactogenicity and Tolerability of Two Schedules of a 4CmenB Vaccine in Adolescents and Young Adults|Active, not recruiting||Phase 4|120|Actual|Dalhousie University||2|||f||||t||||||||||2017-10-10 22:48:52.430265|2017-10-10 22:48:52.430265
NCT02583399|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-12|||July 17, 2017|Actual|2017-07-17|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients|A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months|Recruiting||Phase 4|24|Anticipated|Cumberland Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 22:48:52.513841|2017-10-10 22:48:52.513841
NCT02583386|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-11-29|||April 2016||2016-04-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|FFF||Comprehensive Fall Prevention and Detection in Multiple Sclerosis|Comprehensive Fall Prevention and Detection in Multiple Sclerosis|Recruiting||N/A|94|Anticipated|Portland VA Medical Center||4|||f||||f||||||||Undecided||2017-10-10 22:48:52.615096|2017-10-10 22:48:52.615096
NCT02583373|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-07-20|||March 2016||2016-03-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae|Randomised, Multicentre, Double-blind, Placebo-controlled Study to Assess the Safety, Efficacy and Pharmacodynamics After the Intravenous Administration of CAL02 in Severe Community-acquired Pneumonia Due to Streptococcus Pneumoniae|Recruiting||Phase 1|24|Anticipated|Combioxin SA||3|||f||||t||||||||||2017-10-10 22:48:52.720043|2017-10-10 22:48:52.720043
NCT02583360|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-24|||March 2015||2015-03-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Mechanisms and Management of Infant Dysphagia|Neonatal Esophagus and Airway Interactions in Health and Disease|Recruiting||N/A|145|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-10 22:48:52.856231|2017-10-10 22:48:52.856231
NCT02583334|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-10-20|||January 2015||2015-01-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||Acupuncture for Fibromyalgia|Clinical Efficacy of Acupuncture in Patients With Fibromyalgia: A Multi-center, Randomized, Assessor and Participant-blinded, Controlled, and Parallel-design Clinical Trial|Unknown status|Recruiting|N/A|158|Anticipated|China Medical University Hospital||2|||f||||f||||||||||2017-10-10 22:48:53.051134|2017-10-10 22:48:53.051134
NCT02583321|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-18|||November 2015||2015-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate|Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate: an Ancillary Study of the DEMETER Trial (NCT02515617)|Recruiting||N/A|60|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||t||||||||||2017-10-10 22:48:53.150208|2017-10-10 22:48:53.150208
NCT02583308|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-18|||November 2015||2015-11-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Impact of the Subglottic Secretions Drainage on the Tracheal Secretions Colonisation|Impact of the Subglottic Secretions Drainage on the Tracheal Secretions Colonisation: an Ancillary Study of the DEMETER Trial (NCT02515617)|Recruiting||N/A|1000|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||t||||||||||2017-10-10 22:48:53.253044|2017-10-10 22:48:53.253044
NCT02583295|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2017-08-13|||June 15, 2016|Actual|2016-06-15|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Impact of Maternal Sound on Awareness for Pediatric Patients Undergoing Cardiac Surgery|The Impact of Maternal Sound on Awareness for Pediatric Patients Undergoing Cardiac Surgery|Recruiting||N/A|300|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 22:48:53.427944|2017-10-10 22:48:53.427944
NCT02583282|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-08-19|||August 2015||2015-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion|A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion|Recruiting||Phase 3|100|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 22:48:53.512201|2017-10-10 22:48:53.512201
NCT02583269|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-05-25|||March 2016||2016-03-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery|Phase I Study of Muscadine Grape Extract (MGE) in Advanced Malignancy|Recruiting||N/A|30|Anticipated|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-10 22:48:53.594408|2017-10-10 22:48:53.594408
NCT02583256|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-07-04|||January 2016||2016-01-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)|Phase III, Randomized, Observer Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Repeated Exposure to Either the Same or Alternate Type of Vaccine, Adjuvanted or Non-adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV or QIV), Administered to Subjects Previously Vaccinated in Trial V118_05 (NCT01964989)|Completed||Phase 3|1601|Actual|Seqirus||4|||f||||f||||||||||2017-10-10 22:48:53.817675|2017-10-10 22:48:53.817675
NCT02583243|ClinicalTrials.gov processed this data on October 10, 2017|2008-06-05|2015-10-21|||May 2005||2005-05-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Project BEST: Buprenorphine Entry Into Substance Abuse Treatment|Project BEST: Buprenorphine Entry Into Substance Abuse Treatment|Completed||N/A|209|Actual|Yale University|||1||f||||f||||||||||2017-10-10 22:48:53.948326|2017-10-10 22:48:53.948326
NCT02583217|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-05-05|||April 2015||2015-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01|1 Day|Observational [Patient Registry]|||Effect of Ketamine+Propofol vs Remifentanyl+Propofol on Laryngeal Mask Insertion Conditions|Effect of Ketamine+Propofol vs Remifentanyl+Propofol on Laryngeal Mask Insertion Conditions|Completed||N/A|50|Actual|Ankara University|||2||f||||f||||||||||2017-10-10 22:48:54.112963|2017-10-10 22:48:54.112963
NCT02583204|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-10-21|||October 2015||2015-10-01|October 2015|2015-10-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|||Taxane Chemotherapy and Nail Toxicity in Women With Breast Cancer; Stage Two: Evaluation of Interventions|Taxane Chemotherapy and Nail Toxicity in Women With Breast Cancer; Stage Two: Evaluation of Interventions|Unknown status|Not yet recruiting|N/A|105|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f||||||||||2017-10-10 22:48:54.217355|2017-10-10 22:48:54.217355
NCT02583191|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-05-31|||March 2016||2016-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients|CONKO_011/ AIO-SUP-0115/Ass.: Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients - a Randomized Phase III Study|Recruiting||Phase 3|450|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-10-10 22:48:54.33647|2017-10-10 22:48:54.33647
NCT02583165|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-07-13|||November 9, 2015|Actual|2015-11-09|July 2017|2017-07-01|February 25, 2021|Anticipated|2021-02-25|January 1, 2019|Anticipated|2019-01-01||Interventional|||A Study in Adult Subjects With Select Advanced Solid Tumors|A Phase 1 Study of MEDI1873 (GITR Agonist) in Adult Subjects With Select Advanced Solid Tumors|Recruiting||Phase 1|51|Anticipated|MedImmune LLC||1|||f||||f||||||||||2017-10-10 22:48:54.619224|2017-10-10 22:48:54.619224
NCT02583152|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-04-03|||November 2015||2015-11-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis|Use of New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis|Recruiting||N/A|40|Anticipated|Manchester Royal Eye Hospital|||1||f||||f||||||||No||2017-10-10 22:48:54.75807|2017-10-10 22:48:54.75807
NCT02583139|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-05-11|||August 2014||2014-08-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Designed Music Narratives for the Reduction of Side Effects of Chemotherapy in Children (7-12 Years) With Cancer|The Effect and Meaning of Designed Music Narratives on Anticipatory, Acute, and Delayed Side Effect of Chemotherapy in Children (7-12 Years) With Cancer: a Randomized Controlled Multisite Study|Recruiting||N/A|68|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 22:48:54.850171|2017-10-10 22:48:54.850171
NCT02583126|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-11-30|||August 2014||2014-08-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Guided Imagery and Music for the Reduction of Side Effects of Chemotherapy in Teenagers|The Effect and Meaning of a Designed Guided Imagery and Music Intervention on Anticipatory, Acute, and Delayed Side Effect of Chemotherapy in Teenagers With Cancer: a Randomized Controlled Multisite Study|Recruiting||N/A|68|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 22:48:54.985786|2017-10-10 22:48:54.985786
NCT02583113|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-04-17|||February 2016||2016-02-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Bilateral Total Knee Arthroplasty vs Unicompartment Arthroplasty Retrospective and Clinical Outcome Study|A Retrospective Consecutive Series Patient Preference and Clinical Outcomes Study in Bilateral Knee Osteoarthritis Patients With Both Total Knee Arthroplasty and Unicompartment Knee Arthroplasty Prostheses.|Recruiting||N/A|200|Anticipated|Medacta USA|||1||f||||f||||||||||2017-10-10 22:48:55.136113|2017-10-10 22:48:55.136113
NCT02583100|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-21|||October 2015||2015-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Outcomes in Cleft Palate Surgery|Improving Outcomes in Cleft Palate Surgery Through an Audit and Feedback Intervention Directed at Surgeons|Active, not recruiting||N/A|7|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 22:48:55.259808|2017-10-10 22:48:55.259808
NCT02583087|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-25|||January 2, 2016|Actual|2016-01-02|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01|3 Years|Observational [Patient Registry]|ESTEBAN||ESD for the Treatment of Early Barrett's Neoplasia|Endoscopic Submucosal Dissection for the Treatment of Early Barrett's Neoplasia|Recruiting||N/A|150|Anticipated|Hôpital Cochin|||1||f||||f||||||||||2017-10-10 22:48:55.368389|2017-10-10 22:48:55.368389
NCT02583074|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-20|||September 2015||2015-09-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Trial of STN-DBS for Primary Cranial-Cervical Dystonia|Subthalamic Deep Brain Stimulation in Patients With Medication-Refractory Primary Cranial-Cervical Dystonia: A Randomised, Sham-controlled Trial|Recruiting||N/A|40|Anticipated|Beijing Tiantan Hospital||2|||f||||t||||||||||2017-10-10 22:48:55.489672|2017-10-10 22:48:55.489672
NCT02583061|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-09-12|||September 2003||2003-09-01|September 2016|2016-09-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|||Toronto Gestational Glucose Tolerance Cohort|Toronto Gestational Glucose Tolerance Cohort|Recruiting||N/A|350|Anticipated|Mount Sinai Hospital, Canada|||1||f||||f||||||Samples Without DNA|"     Serum and plasma   "|||2017-10-10 22:48:55.596906|2017-10-10 22:48:55.596906
NCT02583048|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-01|||August 2016||2016-08-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis|A Trial of the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, Among Participants Taking Multidrug Treatment for Drug-Resistant Pulmonary Tuberculosis|Recruiting||Phase 2|84|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-10 22:48:55.684326|2017-10-10 22:48:55.684326
NCT02583035|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-03-20|||February 2015||2015-02-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|TelOG||Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy|Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy|Recruiting||N/A|131|Anticipated|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-10 22:48:55.799461|2017-10-10 22:48:55.799461
NCT02583022|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-20|||June 2013||2013-06-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis|A Randomized, Open-label, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Atopic Dermatitis|Completed||Phase 2|74|Actual|Amorepacific Corporation||3|||f||||t||||||||||2017-10-10 22:48:55.910991|2017-10-10 22:48:55.910991
NCT02583009|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-09-19|||October 2014||2014-10-01|September 2016|2016-09-01||||August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea|Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group, Dose Finding Phase II Clinical Trial to Evaluate Anti Rosacea Effect and Safety of PAC-14028 Cream (0.1%, 0.3%, 1.0%) in Rosacea Patients|Completed||Phase 2|216|Actual|Amorepacific Corporation||4|||f||||t||||||||||2017-10-10 22:48:56.003649|2017-10-10 22:48:56.003649
NCT02582996|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-02-14|||April 2018|Anticipated|2018-04-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks|National, Phase III, Multicenter, Randomized, Open, Parallel, to Evaluate the Efficacy, Safety and Superiority of Cefalium® Compared to the Tylenol® in the Treatment of Migraine Attacks|Not yet recruiting||Phase 3|336|Anticipated|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f|f|f||||||||2017-10-10 22:48:56.117593|2017-10-10 22:48:56.117593
NCT02582983|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-05-25|2016-05-25||February 2004||2004-02-01|May 2016|2016-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection|An Open-Label Safety Trial of Enfuvirtide (T-20/RO 29-9800, HIV-1 Fusion Inhibitor) in Combination With Free Choice Antiviral Regimen in Thai Patients With Advanced HIV Infection|Completed||Phase 4|23|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:48:56.261659|2017-10-10 22:48:56.261659
NCT02582970|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-18|2017-01-18||May 2005||2005-05-01|January 2017|2017-01-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01||Interventional||Intent-to-treat (ITT) population included all participants receiving at least one dose of study drug.|A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum|An Expanded Access Program of AvastinTM (Bevacizumab) in Patients With Metastatic Cancer of the Colon or Rectum|Completed||Phase 4|40|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:48:56.562905|2017-10-10 22:48:56.562905
NCT02582957|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-04-21|||April 2016||2016-04-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|SiVent||Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome|Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome|Recruiting||N/A|916|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 22:48:57.365071|2017-10-10 22:48:57.365071
NCT02582944|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-02-23|||March 25, 2015|Actual|2015-03-25|February 2017|2017-02-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Electromagnetic Navigation for Peripheral Pulmonary Lesions|Electromagnetic Navigation for Peripheral Pulmonary Lesions Using a Tip Tracked Steerable Catheter and Optical Guidance|Recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||No||2017-10-10 22:48:57.546653|2017-10-10 22:48:57.546653
NCT02582931|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-18|||December 2, 2015|Actual|2015-12-02|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer|Pilot Study of MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer|Recruiting||Phase 1|10|Anticipated|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||||2017-10-10 22:48:57.652234|2017-10-10 22:48:57.652234
NCT02582918|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-12-28|||January 2017||2017-01-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5|Comparative Effectiveness Trial of Care Delivery Strategies for HCC Screening Process Completion|Not yet recruiting||N/A|3000|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-10 22:48:57.800722|2017-10-10 22:48:57.800722
NCT02582905|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-03-17|||May 2016||2016-05-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|January 2020|Anticipated|2020-01-01||Interventional|||Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders|Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders|Recruiting||Phase 4|199|Anticipated|University of Texas Southwestern Medical Center||3|||f||||t||||||||No||2017-10-10 22:48:57.888589|2017-10-10 22:48:57.888589
NCT02582892|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-21|||October 2012||2012-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2013|Actual|2013-10-01||Interventional|VitaminD||Systemic Vitamin D Supplementation in Dental Implants Patients|Systemic Vitamin D Supplementation in Menopausal Women With Dental Implants|Completed||Phase 4|135|Actual|University Potiguar||1|||f||||t||||||||||2017-10-10 22:48:58.004484|2017-10-10 22:48:58.004484
NCT02582879|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-06-20|||September 2015||2015-09-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01|2 Years|Observational [Patient Registry]|informCLL||informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia|informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia|Recruiting||N/A|1500|Anticipated|Pharmacyclics LLC.|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-10 22:48:58.147701|2017-10-10 22:48:58.147701
NCT02582866|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-28|||January 2016||2016-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994|A Multicenter, Open-label, Follow-up Study to Assess the Long-term Use of Lacosamide (Flexible Dose From 200 to 600 mg/Day) Used as Monotherapy in Subjects Who Completed SP0994 and Received Lacosamide Monotherapy Treatment|Active, not recruiting||Phase 3|150|Anticipated|UCB Pharma||1|||f||||f||||||||||2017-10-10 22:48:59.17652|2017-10-10 22:48:59.17652
NCT02582853|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-21|||September 2015||2015-09-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|November 2016|Anticipated|2016-11-01||Observational|GBS||sCD163 as a Potential Biomarker in Guillain- Barré Syndrome|sCD163 as a Potential Biomarker in Guillain- Barré Syndrome|Recruiting||N/A|60|Anticipated|University of Aarhus|||2||f||||t||||||Samples Without DNA|"     Spinal fluid and blood sample for identification of different factors   "|||2017-10-10 22:48:59.377325|2017-10-10 22:48:59.377325
NCT02582827|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-05-23|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas|A Phase I Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas|Not yet recruiting||Phase 1|60|Anticipated|NantBioScience, Inc.||1|||f||||f|t|f||||||No||2017-10-10 22:48:59.597137|2017-10-10 22:48:59.597137
NCT02582814|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-07|||October 26, 2015|Actual|2015-10-26|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With Type 1 Diabetes Mellitus (T1DM)|A Clinical Pharmacology and Long Term Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With Type 1 Diabetes Who Have Inadequate Glycemic Control|Completed||Phase 3|170|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:48:59.707355|2017-10-10 22:48:59.707355
NCT02582801|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-15|||October 2015||2015-10-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer|18F-Alfatide Ⅱ PET/CT in the Diagnosis and Treatment Response Evaluation of Breast Cancer Patients|Recruiting||Phase 1|200|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 22:48:59.909831|2017-10-10 22:48:59.909831
NCT02582775|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-10-04|||March 2016||2016-03-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|||MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs|MT2015-20: Biochemical Correction of Severe Epidermolysis Bullosa by Allogeneic Cell Transplantation and Serial Donor Mesenchymal Cell Infusions|Recruiting||Phase 2|60|Anticipated|Masonic Cancer Center, University of Minnesota||5|||f||||t|t|f||||||||2017-10-10 22:49:00.121734|2017-10-10 22:49:00.121734
NCT02582762|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2015-10-19|||September 2015||2015-09-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Pilot Study of Efficacy of Nail Gel in Finger Nail Surface Abnormality|Pilot Study of Efficacy of Nail Gel Containing Artemisia Abrotanum Extract and Glycerin in Finger Nail Surface Abnormality|Unknown status|Recruiting|Phase 3|20|Anticipated|Mahidol University||1|||f||||t||||||||||2017-10-10 22:49:00.290942|2017-10-10 22:49:00.290942
NCT02582749|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-09-13|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases|Androgen Deprivation Therapy With or Without Radium-223 Dichloride in Patients With Newly Diagnosed Metastatic Prostate Cancer With Bone Metastases: Hoosier Cancer Research Network GU13-170|Recruiting||Phase 2|204|Anticipated|Hoosier Cancer Research Network||2|||f||||t||||||||||2017-10-10 22:49:00.388204|2017-10-10 22:49:00.388204
NCT02582736|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-20|||April 2012||2012-04-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Antipsychotics and Risk of Hyperglycemic Emergencies|Atypical Antipsychotics and Hyperglycemic Emergencies: Multicentre, Retrospective Cohort Study of Administrative Data|Completed||N/A|725489|Actual|Canadian Network for Observational Drug Effect Studies, CNODES|||4||f||||f||||||||||2017-10-10 22:49:00.565178|2017-10-10 22:49:00.565178
NCT02582723|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-02-17|||September 2015||2015-09-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|STABLE||Acute Effect of Cheeses With Different Energy Content on Appetite|Acute Effect of Cheeses With Different Energy Content on Appetite|Completed||N/A|40|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-10 22:49:00.706746|2017-10-10 22:49:00.706746
NCT02582710|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-20|||May 2015||2015-05-01|September 2015|2015-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|POMEGA||Impact of an Optimized Formulation of Omega 3 on the Composition of Atheromatous Plaques in Patients Requiring Carotid Endarterectomy||Recruiting||Phase 3|96|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 22:49:00.786683|2017-10-10 22:49:00.786683
NCT02582697|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-07-06|||February 2014||2014-02-01|July 2017|2017-07-01|July 2023|Anticipated|2023-07-01|February 2022|Anticipated|2022-02-01||Interventional|P3BEP||Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours|Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours|Recruiting||Phase 3|500|Anticipated|University of Sydney||2|||f||||t||||||||||2017-10-10 22:49:00.865968|2017-10-10 22:49:00.865968
NCT02582684|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-04-04|||December 2015||2015-12-01|April 2017|2017-04-01|October 9, 2017|Anticipated|2017-10-09|February 28, 2017|Actual|2017-02-28||Interventional|||Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients|A Study to Evaluate Dolutegravir Plus Lamivudine Dual Therapy for the Treatment of Naïve HIV-1-infected Participants|Active, not recruiting||Phase 2|122|Actual|AIDS Clinical Trials Group||1|||f||||t||||||||||2017-10-10 22:49:01.150443|2017-10-10 22:49:01.150443
NCT02582671|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-11|||November 5, 2015||2015-11-05|September 2017|2017-09-01|December 25, 2017|Anticipated|2017-12-25|December 25, 2017|Anticipated|2017-12-25||Observational|REACH||The Effectiveness of ABT-450/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland|Real World Evidence of the Effectiveness of ABT-450/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland|Active, not recruiting||N/A|150|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:49:01.292196|2017-10-10 22:49:01.292196
NCT02582658|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-11|||October 6, 2015||2015-10-06|September 2017|2017-09-01|January 23, 2017|Actual|2017-01-23|January 23, 2017|Actual|2017-01-23||Observational|REAL||Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)|Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Austria (REAL)|Completed||N/A|172|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 22:49:01.395882|2017-10-10 22:49:01.395882
NCT02582645|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-20|||October 2015||2015-10-01|October 2015|2015-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Closed Window vs. Open Window Technique in Management of Palatally Impacted Canines|Closed Window Technique Versus Open Window Technique in Management of Palatally Impacted Canines. A Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|University Hospital Olomouc||2|||f||||f||||||||||2017-10-10 22:49:01.498082|2017-10-10 22:49:01.498082
NCT02582632|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-05-01|||November 2015||2015-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|GARNET||A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults|An Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Adults With Genotype 1b Hepatitis C Virus (HCV) Without Cirrhosis (GARNET)|Completed||Phase 3|166|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 22:49:01.59644|2017-10-10 22:49:01.59644
NCT02582619|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-01-10|||October 2015||2015-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Multidisciplinary Model to Guide Employment Amongst PLWSCI|Development of a Multidisciplinary Model to Guide Employment Outcomes in People Living With Spinal Cord Injuries in South Africa.|Active, not recruiting||N/A|500|Anticipated|University of KwaZulu|||4||f||||f||||||||||2017-10-10 22:49:03.365518|2017-10-10 22:49:03.365518
NCT02582606|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-19|||February 2014||2014-02-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||Meal Pattern and Metabolic Parameters|Effects of the Constancy of Daily Meal Pattern on Energy Balance, Glucose Profiles and Plasma Lipoproteins in Obese Women|Completed||N/A|9|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-10 22:49:03.545235|2017-10-10 22:49:03.545235
NCT02582580|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-19|||October 2015||2015-10-01|October 2015|2015-10-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|EAPFPTC||Effects of Antenatal Pelvic Floor Preparation Techniques for Childbirth|Effects of Perineal Massage, Vaginal Dilator and Pelvic Floor Muscles Training on the Perineal Integrity Primiparous: A Randomized Controlled Trial Protocol|Unknown status|Not yet recruiting|N/A|63|Anticipated|Universidade Federal de Sao Carlos||3|||f||||f||||||||||2017-10-10 22:49:03.787731|2017-10-10 22:49:03.787731
NCT02582567|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|GESTAFIT||Effects of Exercise During Gestation on Maternal and Foetal Health|Effects of Supervised Exercise During Gestation on Maternal and Foetal Health Markers. The GESTAFIT Project|Active, not recruiting||N/A|140|Actual|Universidad de Granada||2|||f||||f||||||||||2017-10-10 22:49:03.939806|2017-10-10 22:49:03.939806
NCT02582554|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|NutriSTEP||Efficacy of Nutrition Risk Screening With NutriSTEP® in Toddlers and Preschoolers|Efficacy of Nutrition Risk Screening With NutriSTEP® in Toddlers and Preschoolers|Completed||N/A|166|Actual|University of Guelph||2|||f||||f||||||||||2017-10-10 22:49:04.069116|2017-10-10 22:49:04.069116
NCT02582541|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-19|||February 2014||2014-02-01|October 2015|2015-10-01|November 2018|Anticipated|2018-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Endoscopic Biliary RFA of Malignant Bile Duct Obstruction|Endoscopic Biliary Radiofrequency Ablation of Malignant Bile Duct Obstruction|Recruiting||N/A|100|Anticipated|The Second Hospital of Nanjing Medical University||2|||f||||t||||||||||2017-10-10 22:49:04.142953|2017-10-10 22:49:04.142953
NCT02582528|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-30|||February 2016||2016-02-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Cognitive Remediation in Youth at Risk of Serious Mental Illness|Pilot Study of Cognitive Remediation and Motivational Interviewing on Cognition and Functioning in Young People at Risk of Serious Mental Illness|Terminated||N/A|12|Actual|University of Calgary||2||recruitment difficulties|f||||f||||||||Undecided||2017-10-10 22:49:04.236585|2017-10-10 22:49:04.236585
NCT02582515|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-05-01|||October 2015||2015-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|DCS+HRT||Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo|Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo|Recruiting||N/A|22|Anticipated|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 22:49:04.49913|2017-10-10 22:49:04.49913
NCT02582502|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-07-24|||October 2015||2015-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|HOPES||Hyperbaric Oxygen Post Established Stroke|Hyperbaric Oxygen Post Established Stroke - HOPES - Study|Recruiting||N/A|140|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:49:04.650216|2017-10-10 22:49:04.650216
NCT02582489|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-04-12|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy|Prospective, Randomized, Double-blind Clinical Trial to Investigate the Efficacy of Autologous Bone Marrow Aspirate Concentrate Post-Meniscectomy|Not yet recruiting||N/A|100|Anticipated|Rush University Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:49:04.813078|2017-10-10 22:49:04.813078
NCT02582476|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-05-11|||January 2015||2015-01-01|October 2016|2016-10-01|July 30, 2017|Anticipated|2017-07-30|May 9, 2017|Actual|2017-05-09||Interventional|||Bumetanide in Hypokalaemic Periodic Paralysis|A Randomised, Double-blind, Placebo-controlled, Phase II Clinical Trial With a Cross-over Design Assessing Efficacy of a Single Dose of Bumetanide in Reducing Focal Attack Severity in Hypokalaemic Periodic Paralysis Assessed Using the McManis Protocol|Active, not recruiting||Phase 2|12|Anticipated|University College, London|||||f||||t||||||||||2017-10-10 22:49:04.958378|2017-10-10 22:49:04.958378
NCT02582463|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-04-27|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|June 2017|Anticipated|2017-06-01||Observational|MOAT||Development of the Medicines Optimisation Assessment Tool|Development of the Medicines Optimisation Assessment Tool (MOAT) - Targeting Hospital Pharmacists' Input to Reduce Risks and Improve Patient Outcomes|Recruiting||N/A|2000|Anticipated|University College, London|||1||f||||f||||||||No||2017-10-10 22:49:05.07832|2017-10-10 22:49:05.07832
NCT02582437|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-19|||June 2015||2015-06-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||MAC Bipsectral Index Below 50 for Chronic Opioid User|The Effect of Chronic Opioid Use on Minimum Alveolar Concentration of Sevoflurane for Maintaining Bispectral(BIS) Index Below 50 ; Prospective, Blind Study|Unknown status|Recruiting|N/A|20|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-10 22:49:05.270032|2017-10-10 22:49:05.270032
NCT02582424|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-01-25|||July 2012||2012-07-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study.|Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study|Completed||N/A|103|Actual|Primus Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:49:05.353044|2017-10-10 22:49:05.353044
NCT02582411|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-02-24|||August 2015||2015-08-01|February 2016|2016-02-01||||January 2016|Actual|2016-01-01||Observational|||Laser Speckle Flowgraphy in Caucasians: Age Dependence and Comparison With Doppler Optical Coherence Tomography|Laser Speckle Flowgraphy in Caucasians: Age Dependence and Comparison With Doppler Optical Coherence Tomography|Completed||N/A|80|Actual|Medical University of Vienna|||4||f||||||||||||||2017-10-10 22:49:05.446546|2017-10-10 22:49:05.446546
NCT02582398|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-02-10|||November 2013||2013-11-01|February 2017|2017-02-01||||July 2017|Anticipated|2017-07-01||Interventional|||Influence of Light Exposure on Cerebral MAO-A in Seasonal Affective Disorder and Healthy Controls Measured by PET|Influence of Light Exposure on Cerebral Monoamine Oxidase A in Seasonal Affective Disorder and Healthy Controls Measured by PET|Recruiting||N/A|48|Anticipated|Medical University of Vienna||2|||f||||||||||||||2017-10-10 22:49:05.544029|2017-10-10 22:49:05.544029
NCT02582385|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2015-10-20|||October 2012||2012-10-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)|In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis|Completed||N/A|5|Actual|Brugmann University Hospital|||2||f||||f||||||Samples Without DNA|"     Archived/residual histopathology sections and paraffin blocks entirely from residual autopsy     material. Archived material involves old cases (autopsied between 2000 and 2005). All     autopsies were conducted within the legal frame of the then applicable laws. There is no     reference whatsoever to names or identifications of the deceased patients (anonymous     samples).   "|||2017-10-10 22:49:05.656648|2017-10-10 22:49:05.656648
NCT02582359|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-02-28|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|February 2022|Anticipated|2022-02-01|February 2019|Anticipated|2019-02-01||Interventional|||MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age|Phase I Dose Escalation Study of Millennium 9708 in Combination With Induction and Consolidation Chemotherapy in Adults >= 60 Years With Acute Myeloid Leukemia|Recruiting||Phase 1|54|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:49:05.839699|2017-10-10 22:49:05.839699
NCT02582346|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-03-17|||November 2015||2015-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Neuro-Tracto||Assessment of Magnetic Resonance Imaging Neurography and Tractography for Preoperative Mapping of Pelvic Nerves|Assessment of Magnetic Resonance Imaging Neurography and Tractography for Preoperative Mapping of Pelvic Nerves|Completed||N/A|20|Actual|IHU Strasbourg||1|||f||||f||||||||||2017-10-10 22:49:05.956958|2017-10-10 22:49:05.956958
NCT02582333|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-05|||October 2015||2015-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy|Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy|Recruiting||N/A|400|Anticipated|Taichung Veterans General Hospital|||2||f||||f||||||Samples With DNA|"     HBV DNA and genotype   "|||2017-10-10 22:49:06.049384|2017-10-10 22:49:06.049384
NCT02582320|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-02-16|||March 2016||2016-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program|A Retrospective Study to Evaluate the Clinical-Biologic Characteristics and Outcome of Patients Treated in Italy According to the Ibrutinib-Named Patient Program for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Recruiting||N/A|215|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||No||2017-10-10 22:49:06.177725|2017-10-10 22:49:06.177725
NCT02582307|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-05-08|||March 20, 2017|Actual|2017-03-20|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Buscopan Versus Acetaminophen for Acute Abdominal Pain in Children|Hyoscine Hydrobromide (Buscopan) Versus Acetaminophen for Acute Abdominal Pain in Children: A Randomized Controlled Trial|Recruiting||Phase 3|230|Anticipated|Lawson Health Research Institute||2|||f||||f|f|f||||||No||2017-10-10 22:49:06.627665|2017-10-10 22:49:06.627665
NCT02582281|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-19|||October 2015||2015-10-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Non Touch Technique for IUD Insertion|The Non Touch Technique for Intrauterine Device Insertion, a Single Blinded Randomized Control Trial|Unknown status|Recruiting|N/A|100|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-10 22:49:06.825697|2017-10-10 22:49:06.825697
NCT02582268|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-19|||October 2015||2015-10-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||A Novel IUD Insertion Technique|Introducing Trans- Abdominal Guided Intrauterine Device Insertion, a Single Blinded Randomized Control Trial|Unknown status|Recruiting|N/A|100|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-10 22:49:06.929277|2017-10-10 22:49:06.929277
NCT02582255|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-07-10|||November 2015||2015-11-01|July 2017|2017-07-01|December 22, 2016|Actual|2016-12-22|July 2016|Actual|2016-07-01||Interventional|M3-ABMG||A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania|A Phase 4 Study to Evaluate the Safety and Immunogenicity of Monovalent Oral Polio Vaccine Type 2 in Healthy IPV-vaccinated Children Aged 1 to 5 Years in Lithuania|Completed||Phase 4|100|Actual|Fidec Corporation||1|||f||||t||||||||||2017-10-10 22:49:07.061198|2017-10-10 22:49:07.061198
NCT02582242|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-09-20|||October 19, 2015|Actual|2015-10-19|September 2017|2017-09-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|||Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin|A 24-week, Multinational, Multicentre, Randomised, Open Label, Parallel-group Treat-to-target Trial to Compare Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin|Completed||Phase 4|437|Actual|Novo Nordisk A/S||2|||f||||f|f|f||||||||2017-10-10 22:49:07.160447|2017-10-10 22:49:07.160447
NCT02578381|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-05-16|||March 16, 2016|Actual|2016-03-16|May 2017|2017-05-01|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Interventional|COMET||Boston Scientific COMET Wire Validation Study|Boston Scientific COMET Wire Validation Study|Completed||N/A|106|Actual|University Hospital Southampton NHS Foundation Trust||3|||f||||f||||||||No||2017-10-10 22:49:55.762757|2017-10-10 22:49:55.762757
NCT02582229|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-09-12|||November 2015||2015-11-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Endomina||A Prospective Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina TM) as an Aid for Endoscopic Gastric Reduction.|A Prospective Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina TM) as an Aid for Endoscopic Gastric Reduction.|Completed||N/A|40|Actual|Erasme University Hospital||1|||f||||f||||||||||2017-10-10 22:49:07.367442|2017-10-10 22:49:07.367442
NCT02582203|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-10-31|||February 2012||2012-02-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA|Clinical and Economic Outcomes of Ceftaroline Fosamil for the Treatment of Acute Bacterial Skin and Skin Structure Infections Documented or at Risk of Methicillin-Resistant S. Aureus|Completed||Phase 4|174|Actual|Wayne State University||2|||f||||||||||||||2017-10-10 22:49:07.554222|2017-10-10 22:49:07.554222
NCT02582190|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-05-02|||December 2, 2017|Anticipated|2017-12-02|May 2017|2017-05-01|September 2, 2018|Anticipated|2018-09-02|September 2, 2018|Anticipated|2018-09-02||Interventional|COPPER-AF||COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF|Colchicine for the Prevention of Atrial Fibrillation Recurrence After Electrical Cardioversion of Persistent Atrial Fibrillation.|Not yet recruiting||Phase 3|160|Anticipated|Elpen Pharmaceutical Co. Inc.||1|||f||||f|f|f||||||No||2017-10-10 22:49:07.655424|2017-10-10 22:49:07.655424
NCT02582177|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-25|||February 1, 2018|Anticipated|2018-02-01|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|July 1, 2018|Anticipated|2018-07-01||Interventional|DaVinci||Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis|Phase 3 Study, Randomized, Open, Parallel to Evaluate Ketoconazole and Betamethasone Dipropionate(Candicort®) Compared to Clotrimazole and Dexamethasone Acetate(Baycuten N®) in Relief of Fungal Infections/Dermatophytosis Symptoms.|Not yet recruiting||Phase 3|160|Anticipated|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f|f|f||||||||2017-10-10 22:49:07.765572|2017-10-10 22:49:07.765572
NCT02582164|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-08-22|||June 2015||2015-06-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|LWDOCT||Long-Working Distance OCT for Children|Long-Working Distance OCT System With Fixation Alignment for Pediatric Imaging|Recruiting||N/A|250|Anticipated|Duke University||4|||f||||t||||||||||2017-10-10 22:49:07.867445|2017-10-10 22:49:07.867445
NCT02582151|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-03-21|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder|A Randomized Trial of Transcutaneous Nerve Stimulation for Neurogenic Bladder|Enrolling by invitation||Phase 2|60|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 22:49:07.988141|2017-10-10 22:49:07.988141
NCT02582138|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-02-01|||January 2016||2016-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SPRINTT||Multicomponent Intervention for Physical Frailty and Sarcopenia|Sarcopenia and Physical fRailty IN Older People: Multi-componenT Treatment Strategies (SPRINTT)|Recruiting||N/A|1500|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||Undecided||2017-10-10 22:49:08.05921|2017-10-10 22:49:08.05921
NCT02582125|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-03-03|||November 2015||2015-11-01|April 2016|2016-04-01||||July 2017|Anticipated|2017-07-01||Interventional|||ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer|ONO-4538 Multicenter, Open-label, Single-arm, Phase II Study in Advanced Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|50|Anticipated|Ono Pharmaceutical Co. Ltd||1|||f||||f||||||||||2017-10-10 22:49:08.158867|2017-10-10 22:49:08.158867
NCT02582112|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-02-04|||September 2010||2010-09-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Warming IV Fluids and Incidence of Hypotension|Do Warming iv Fluids During the Management of Spinal- Induced Hypotension Decrease the Incidence of Hypotension and Reduce the Requirement of Fluid, Blood and Ephedrine?|Completed||Phase 1|60|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 22:49:08.252643|2017-10-10 22:49:08.252643
NCT02582099|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2016-05-02|||December 2013||2013-12-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis and Recurrent Sinusitis|Comparison of the Efficacy and Complication of Gentamicin and Normal Saline Nasal Irrigation in Chronic Rhinosinusitis and Recurrent Sinusitis : a Double Blind Randomized Control Trial|Recruiting||Phase 4|40|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-10 22:49:08.324104|2017-10-10 22:49:08.324104
NCT02582086|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-07|||January 2016||2016-01-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Topical Natural Health Product for the Treatment of Herpes Labialis|Recruiting||N/A|40|Anticipated|Laboratoire Boreaderme Inc.||2|||f||||f||||||||||2017-10-10 22:49:08.421179|2017-10-10 22:49:08.421179
NCT02582073|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-03-08|||November 7, 2015|Actual|2015-11-07|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|May 5, 2016|Actual|2016-05-05||Interventional|G204||A Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using Mobile EECs|A Double-blind Randomized Parallel Group Study of Three Cumulative Doses of Grass MATA MPL Compared to Placebo and Grass MATA in Patients With Seasonal Allergic Rhinoconjunctivitis Exposed to Grass Pollen in Mobile Environmental Exposure Chambers (mEECs™) Out of the Grass Pollen Season|Active, not recruiting||Phase 2|265|Actual|Allergy Therapeutics||6|||f||||t||||||||||2017-10-10 22:49:08.493931|2017-10-10 22:49:08.493931
NCT02582060|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-07-19|||March 2014||2014-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Individualizing Hemophilia Prophylaxis Using Thromboelastography|Individualizing Hemophilia Prophylaxis Using Thromboelastography|Recruiting||N/A|60|Anticipated|Children's Hospital Los Angeles||1|||f||||t||||||||||2017-10-10 22:49:08.592139|2017-10-10 22:49:08.592139
NCT02582047|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-19|||October 2012||2012-10-01|October 2015|2015-10-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Influenza Vaccine and Pneumococcal Vaccine|Immunogenicity and Safety of an Influenza Vaccine Administered Concomitantly With a 13-Valent Pneumococcal Conjugate Vaccine or 23-Valent Polysaccharide Pneumococcal Vaccine in Elderly Patients|Completed||Phase 4|224|Actual|Korea University Guro Hospital||2|||f||||t||||||||||2017-10-10 22:49:08.669995|2017-10-10 22:49:08.669995
NCT02582034|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-12-02|||December 2015||2015-12-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry|Selective Internal Radiation Therapy for Hepatocellular Carcinomas With Yttrium-90 Loaded Microspheres: Optimized Dosimetry Versus Standard Dosimetry|Recruiting||Phase 2|210|Anticipated|Center Eugene Marquis||2|||f||||f||||||||||2017-10-10 22:49:08.763411|2017-10-10 22:49:08.763411
NCT02582021|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-06-12|||November 2015||2015-11-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||WISE CVD - Continuation (WISE HFpEF)|Women's Ischemia Syndrome Evaluation (WISE) - Coronary Microvascular Dysfunction (CMD) and Heart Failure With Preserved Ejection Fraction (HFpEF)|Recruiting||N/A|220|Anticipated|Cedars-Sinai Medical Center|||2||f||||f||||||Samples With DNA|"     A maximum of 45 mL of whole blood will be collected, which will be processed and stored as     serum, plasma, and DNA for biomarkers and for genetic testing.   "|Yes||2017-10-10 22:49:08.992718|2017-10-10 22:49:08.992718
NCT02582008|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-05-30|||January 2016||2016-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy|Smoking Cessation in Patients With Squamous Cell Cancer of the Head and Neck Undergoing Radiation Therapy With or Without Chemotherapy|Recruiting||N/A|60|Anticipated|Wake Forest University Health Sciences||2|||f||||f|t|f||||||||2017-10-10 22:49:09.121267|2017-10-10 22:49:09.121267
NCT02581995|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-11|||November 19, 2015|Actual|2015-11-19|September 2017|2017-09-01|August 9, 2017|Actual|2017-08-09|August 9, 2017|Actual|2017-08-09||Interventional|AQUA||Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.|Open-label Phase-4 Study to Examine the Change of Vision-related Quality of Life in Subjects With Diabetic Macular Edema (DME) During Treatment With Intravitreal Injections of 2 mg Aflibercept According to EU Label for the First Year of Treatment|Completed||Phase 4|477|Actual|Bayer||1|||f||||f|t|f|||t|||||2017-10-10 22:49:09.272884|2017-10-10 22:49:09.272884
NCT02581982|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-31|||March 2016|Actual|2016-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer|Single-Arm Phase II Combination Study of Low-Dose Paclitaxel With Pembrolizumab in Platinum-Refractory Urothelial Carcinoma|Recruiting||Phase 2|27|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-10 22:49:09.572208|2017-10-10 22:49:09.572208
NCT02581969|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-07-24|||April 14, 2016|Actual|2016-04-14|July 2017|2017-07-01|July 30, 2017|Anticipated|2017-07-30|March 20, 2017|Actual|2017-03-20||Observational|POTTER 10||"Extension at 10 Years of the: Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."|"Extension at 10 Years of the: Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A. POTTER-10"|Active, not recruiting||N/A|43|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:49:09.689844|2017-10-10 22:49:09.689844
NCT02581956|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-20|||November 2008||2008-11-01|October 2015|2015-10-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Walking Affecting Immunology and Quality of Life of Breast Cancer Patients|Walking Affecting Immunology and Quality of Life of Breast Cancer Patients|Completed||N/A|30|Actual|Kaohsiung Veterans General Hospital.||2|||f||||||||||||||2017-10-10 22:49:09.795609|2017-10-10 22:49:09.795609
NCT02581943|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-05|||May 2016||2016-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer|Immune Response in Patients With Recurrent or Metastatic Non-small Cell Lung Cancer and Performance Status of 2 Treated With a Combination of Pembrolizumab and Low Dose Weekly Carboplatin/Paclitaxel|Suspended||Phase 2|20|Anticipated|Wake Forest University Health Sciences||2||Pending amendment to increase accrual goal|f||||f|t|f||||||||2017-10-10 22:49:09.873516|2017-10-10 22:49:09.873516
NCT02581930|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-06-19|||August 2016||2016-08-01|December 2016|2016-12-01||||August 2018|Anticipated|2018-08-01||Interventional|||Ibrutinib in Treating Patients With Refractory Stage IV Cutaneous Melanoma|A Phase 2 Study of Ibrutinib (PCI-32765) in Refractory Distant Metastatic Cutaneous Melanoma: Correlation of Biomarkers With Response and Resistance|Recruiting||Phase 2|32|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 22:49:10.031555|2017-10-10 22:49:10.031555
NCT02581904|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-20|||January 2015||2015-01-01|October 2015|2015-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Prevena Vascular Groin Wound Study|Evaluation of Closed Incision Negative Pressure Device (Prevena) to Prevent Vascular Wound Complications|Enrolling by invitation||Phase 4|150|Anticipated|Thomas Jefferson University||3|||f||||f||||||||||2017-10-10 22:49:10.383047|2017-10-10 22:49:10.383047
NCT02581891|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-08-15|||November 19, 2015|Actual|2015-11-19|August 2017|2017-08-01|April 28, 2019|Anticipated|2019-04-28|April 28, 2019|Anticipated|2019-04-28||Interventional|||"Managing Neovascular (Known as Wet) Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye"|Managing Neovascular Age-related Macular Degeneration (nAMD) Over 2 Years With a Treat and Extend (T&E) Regimen of 2 mg Intravitreal Aflibercept - a Randomized, Open-label, Active-controlled, Parallel-group Phase IV/IIIb Study (ARIES)|Recruiting||Phase 4|268|Anticipated|Bayer||2|||f||||f|t|f|||t|||||2017-10-10 22:49:10.517605|2017-10-10 22:49:10.517605
NCT02581878|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-20|2017-09-29|||November 20, 2015|Actual|2015-11-20|September 2017|2017-09-01|March 30, 2020|Anticipated|2020-03-30|March 30, 2020|Anticipated|2020-03-30||Interventional|||Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma|An Open-label Phase I, Dose-escalation Study to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Biodistribution, Radiation Dosimetry and Pharmacokinetics of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma|Recruiting||Phase 1|60|Anticipated|Bayer||2|||f||||t|f|f||||||||2017-10-10 22:49:10.759376|2017-10-10 22:49:10.759376
NCT02581865|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-03-14|||October 2015||2015-10-01|March 2017|2017-03-01||||December 2016|Actual|2016-12-01||Interventional|||Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome|Active, not recruiting||Phase 2|124|Actual|Neurocrine Biosciences||3|||f||||||||||||||2017-10-10 22:49:10.917996|2017-10-10 22:49:10.917996
NCT02581852|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-03-03|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Workability in Patients With Seropositive Rheumatoid Arthritis||Completed||N/A|100|Actual|Kaiser Franz Josef Hospital||1|||f||||f||||||||||2017-10-10 22:49:11.076142|2017-10-10 22:49:11.076142
NCT02581839|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-04-07|||November 17, 2015|Actual|2015-11-17|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|September 15, 2017|Anticipated|2017-09-15||Interventional|||Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate|Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate|Recruiting||Phase 2|20|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 22:49:11.167552|2017-10-10 22:49:11.167552
NCT02581826|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-01-03|||October 2013||2013-10-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Recruiting||Phase 2|40|Anticipated|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation||2|||f||||f||||||||||2017-10-10 22:49:11.275722|2017-10-10 22:49:11.275722
NCT02581813|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-06-13|||May 2016||2016-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Does Dairy Benefit Bone & Body Composition in Overweight Girls Undergoing a Weight Management Program?|Effects of a Weight Management Intervention With Increased Dairy Intake on Body Composition and Bone Health in Overweight and Obese Girls.|Recruiting||N/A|75|Anticipated|Brock University||3|||f||||f||||||||Undecided||2017-10-10 22:49:11.378084|2017-10-10 22:49:11.378084
NCT02581800|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-12|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect and Experience of PreHomeCare of Preterm Infants Using Telecommunication and Smartphone Application|Effect and Experience of PreHomeCare of Preterm Infants Using Telecommunication and Smartphone Application: A Randomized Intervention Study.|Recruiting||N/A|160|Anticipated|Naestved Hospital||2|||f||||f||||||||||2017-10-10 22:49:11.49819|2017-10-10 22:49:11.49819
NCT02581787|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-09-13|||August 2016||2016-08-01|September 2016|2016-09-01||||January 2020|Anticipated|2020-01-01||Interventional|||SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer|Fresolimumab and Stereotactic Ablative Radiotherapy in Early Stage Non-small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|60|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:49:11.579205|2017-10-10 22:49:11.579205
NCT02581774|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-19|||January 2013||2013-01-01|January 2013|2013-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at Term|Management of Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at Term; the Mode of Delivery and the Neonatal Outcomes|Completed||Phase 4|324|Actual|Sisli Etfal Training & Research Hospital|||2||f||||f||||||||||2017-10-10 22:49:11.700916|2017-10-10 22:49:11.700916
NCT02581761|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-10-20|||November 2015||2015-11-01|October 2015|2015-10-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|amalis||A Prospective Study of Misoprostol Administration in Asymptomatic Patients With Pregnancies of Unknown Location|A Randomized Prospective Double Blind Study of Misoprostol Administration in Asymptomatic Patients With Pregnancies of Unknown Location|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 22:49:11.779025|2017-10-10 22:49:11.779025
NCT02581748|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-05-31|||September 2015||2015-09-01|April 2016|2016-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German) in Healthy Chinese Male Subjects||Recruiting||Phase 1|123|Anticipated|Shanghai Henlius Biotech||2|||f||||t||||||||||2017-10-10 22:49:11.845812|2017-10-10 22:49:11.845812
NCT02581722|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-19|||August 2015||2015-08-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Efficacy Study of Non-Surgical MC Device for Adolescent Male Population Including Contraindicated Subjects|A Safety and Efficacy Study of Non-surgical MC Device on PrePex Adolescent Male Population, Including Contraindicated Subjects Scheduled to Undergo Circumcision in an Effort to Prevent the Spread of HIV in Resource Limited Settings|Unknown status|Active, not recruiting|N/A|300|Anticipated|Ministry of Health, Rwanda||1|||f||||f||||||||||2017-10-10 22:49:12.110676|2017-10-10 22:49:12.110676
NCT02581709|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-04-03|||May 2016||2016-05-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||An Intervention Programme to Reduce Cognitive Impairment Due to Cancer|The Development and Feasibility Testing of an Intervention Programme to Reduce Cognitive Impairment Due to Cancer Treatment|Active, not recruiting||N/A|15|Actual|Queen's University, Belfast||1|||f||||f||||||||||2017-10-10 22:49:12.226192|2017-10-10 22:49:12.226192
NCT02581696|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-02-03|||August 2015||2015-08-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers|An Open-label, Multiple-dose, Single-arm, Phase 1 Study to Evaluate the Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Boryung Pharmaceutical Co., Ltd||1|||f||||f||||||||No||2017-10-10 22:49:12.322648|2017-10-10 22:49:12.322648
NCT02581683|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-09-29|||September 2015||2015-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Magnesium Sulfate in Adductor Canal Blocks|Does Magnesium Sulfate as a Supplement in Adductor Canal Blocks Improve Pain Control After Total Knee Arthroplasty?|Recruiting||Phase 4|120|Anticipated|Queen's University||3|||f||||f||||||||||2017-10-10 22:49:12.42584|2017-10-10 22:49:12.42584
NCT02581670|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-20|||July 2015||2015-07-01|October 2015|2015-10-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer|Prospective Non-randomized Phase II Study on Stereotactic Body Radiation Therapy for Medically Inoperable Lung and Liver Oligometastases From Breast Cancer|Recruiting||Phase 2|40|Anticipated|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-10 22:49:12.560412|2017-10-10 22:49:12.560412
NCT02581657|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-03-10|||October 2015||2015-10-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM|Phase 2a Multicenter, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|37|Actual|PhaseBio Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-10 22:49:12.696943|2017-10-10 22:49:12.696943
NCT02581644|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-06-14|||November 29, 2016|Actual|2016-11-29|June 2017|2017-06-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Observational|||Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries|Evaluation of the Effectiveness of the Belatacept (Nulojix®) Patient Alert Cards in Patients Following Renal Transplantation in European Economic Area Countries|Completed||N/A|63|Actual|Bristol-Myers Squibb|||3||f||||f||||||||||2017-10-10 22:49:13.266118|2017-10-10 22:49:13.266118
NCT02581631|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-26|||December 18, 2015|Actual|2015-12-18|September 2017|2017-09-01|February 13, 2020|Anticipated|2020-02-13|June 9, 2019|Anticipated|2019-06-09||Interventional|CheckMate 436||An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas|A Phase I/ II Study to Evaluate the Safety and Preliminary Efficacy of Nivolumab in Combination With Brentuximab Vedotin in Subjects With Relapsed Refractory Non Hodgkin Lymphomas With CD30 Expression (CheckMate 436: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation 436)|Recruiting||Phase 1/Phase 2|146|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 22:49:13.406565|2017-10-10 22:49:13.406565
NCT02581618|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-03-07|||May 2015||2015-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Remote Ischemic Preconditioning in Elective Percutaneous Interventions|Effect of One Cycle Remote Ischemic Preconditioning on Myocardial Injury After Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease|Completed||N/A|102|Actual|Trakya University||2|||f||||f||||||||||2017-10-10 22:49:13.688657|2017-10-10 22:49:13.688657
NCT02581605|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-10-20|||November 2014||2014-11-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Correction of Angular Deformities in Knee Arthrosis|Patient Matched Osteotomy to Correct Angular Deformities in Knee Arthrosis|Unknown status|Recruiting|N/A|84|Anticipated|Imperial College London|||2||f||||f||||||||||2017-10-10 22:49:13.788887|2017-10-10 22:49:13.788887
NCT02581592|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-07-29|||November 2015||2015-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment|The Effect of Moderate Hepatic Impairment on the Pharmacokinetics Following Single-Dose Inhaled Administration of TD-4208|Completed||Phase 1/Phase 2|16|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||No||2017-10-10 22:49:13.884088|2017-10-10 22:49:13.884088
NCT02581579|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-13|||November 2015||2015-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection|Pilot Phase I Clinical Trial, Double-blind, Randomized, Placebo Controlled and Masked to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection|Recruiting||N/A|24|Anticipated|Manresana de Micobacteriologia, SL||2|||f||||f||||||||||2017-10-10 22:49:13.984779|2017-10-10 22:49:13.984779
NCT02581566|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2016-05-06|||July 2015||2015-07-01|May 2016|2016-05-01||||April 2016|Actual|2016-04-01||Interventional|||Effect of Intrathecal vs Intraarticular Dexmedetomidine on Postoperative Pain Following Arthroscopy||Completed||N/A|90|Actual|Assiut University||3|||f||||||||||||||2017-10-10 22:49:14.088677|2017-10-10 22:49:14.088677
NCT02581540|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-01-27|||June 2011||2011-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|MACROS||Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin|Mersey Acute Coronary Syndrome Rule-Out Using High Sensitive Troponin (MACROS) : A Comparison of Risk Scores in Consecutive, Unselected Chest Pain Presentations With Suspected Acute Coronary Syndrome in the Era of High Sensitive Troponin|Completed||N/A|3054|Actual|Aintree University Hospitals NHS Foundation Trust|||1||f||||f||||||||No|All data anonymised and will be analysed accordingly. Results of the study will be published once analysis completed|2017-10-10 22:49:14.289544|2017-10-10 22:49:14.289544
NCT02581527|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-11|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|RIFASHORT||A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis|An International Multicentre Controlled Clinical Trial to Evaluate 1200mg and 1800mg Rifampicin Daily for Four Months in the Reduction of the Duration of Standard Treatment of Pulmonary Tuberculosis|Recruiting||Phase 3|654|Anticipated|St George's, University of London||3|||f||||t|f|f|||f|||||2017-10-10 22:49:14.387371|2017-10-10 22:49:14.387371
NCT02581501|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-12-05|||February 2016||2016-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer|Prospective Phase I Study of Gax (Gemcitabine, ABRAXANE, and Xeloda) for Metastatic Pancreatic Cancer Protocol # TSH - APG - 2015-01|Withdrawn||Phase 1|0|Actual|Stamford Hospital||1||Due to no enrollment, Celgene (sponsor) withdrew funding|f||||t||||||||||2017-10-10 22:49:14.630494|2017-10-10 22:49:14.630494
NCT02581488|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-02-08|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|January 27, 2017|Actual|2017-01-27|January 2017|Actual|2017-01-01||Interventional|||Use of Santyl in Diabetic Foot Ulcers|Clinical Outcomes for Diabetic Foot Ulcers Treated With Clostridial Collagenase (SANTYL®) Ointment or With a Comparator Product Containing Silver|Completed||Phase 4|102|Actual|Smith & Nephew, Inc.||2|||f||||f||||||||||2017-10-10 22:49:14.72225|2017-10-10 22:49:14.72225
NCT02581475|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-08-26|2016-05-27||November 2015||2015-11-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy of Segmental Examination Twice of the Proximal Colon on Adenoma Detection|Efficacy of Segmental Examination Twice of Proximal Colon on Adenoma Detection: a Prospective, Randomized, Controlled Study|Completed||N/A|386|Actual|Shandong University||2|||f||||t||||||||||2017-10-10 22:49:14.837393|2017-10-10 22:49:14.837393
NCT02581462|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-06-01|||May 2016||2016-05-01|June 2016|2016-06-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|PETRARCA||FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer|FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of Adenocarcinoma of the Stomach and Gastroesophageal Junction Expressing HER-2. A Phase II/III Trial of the AIO.|Recruiting||Phase 2/Phase 3|404|Anticipated|Krankenhaus Nordwest||2|||f||||t||||||||||2017-10-10 22:49:15.104325|2017-10-10 22:49:15.104325
NCT02581449|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2015-10-20|||September 2015||2015-09-01|October 2015|2015-10-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Effect of Omega-3 Fatty Acids on Oxidative Stress and Dyslipidemia in Pediatric Patients Undergoing Hemodialysis|Evaluation of the Effect of Omega-3 Fatty Acids Supplementation on Pediatric Patients Undergoing Hemodialysis|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Ain Shams University||2|||f||||f||||||||||2017-10-10 22:49:15.216415|2017-10-10 22:49:15.216415
NCT02581436|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-08-29|||September 2014||2014-09-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|TITRATE||Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR|Addition of kSORT Assay in the Follow-up of Patients After Kidney Transplantation|Active, not recruiting||N/A|70|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||No|At this moment there is no plan to make individual participant data available|2017-10-10 22:49:15.324726|2017-10-10 22:49:15.324726
NCT02581423|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-11-01|||August 2005||2005-08-01|November 2016|2016-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer|Phase IV Clinical Study of Safety and Tolerability of Oral Xeloda (Capecitabine) in Adjuvant Treatment of Resected Cancer of the Colon|Completed||Phase 4|63|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:49:15.45368|2017-10-10 22:49:15.45368
NCT02581410|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-08-29|2017-08-29||December 15, 2015|Actual|2015-12-15|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 30, 2016|Actual|2016-08-30||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier|Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier|Completed||Phase 3|431|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-10 22:49:15.588301|2017-10-10 22:49:15.588301
NCT02581397|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-11|||May 2015||2015-05-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|Transpulmin||Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough|Randomized Clinical Trial Evaluating the Non-clinical Inferiority of Suppository Transpulmin and Suppository Guaiacol Compared to Transpulmin Syrup in Frames of Productive Cough of Infectious Origin in Pediatric Participants.|Recruiting||Phase 3|270|Anticipated|Ache Laboratorios Farmaceuticos S.A.||3|||f||||f||||||||||2017-10-10 22:49:16.40414|2017-10-10 22:49:16.40414
NCT02581384|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-08-03|||May 2016||2016-05-01|August 2016|2016-08-01|February 2023|Anticipated|2023-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors|Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors|Recruiting||Phase 1/Phase 2|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||Undecided||2017-10-10 22:49:16.492896|2017-10-10 22:49:16.492896
NCT02581371|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-19|||February 2015||2015-02-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm|Randomized, Double-blind, Placebo-controlled Study of the Effect of Cerebrolysin® (EVER Neuro Pharma GmbH, Austria) at the Level of Paresis of the Upper Limb When Used in Complex Therapy of Acute Ischemic Stroke|Unknown status|Recruiting|Phase 4|30|Anticipated|Clinical Institute of the Brain, Russia||2|||f||||t||||||||||2017-10-10 22:49:16.590981|2017-10-10 22:49:16.590981
NCT02581358|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-07-18|||October 2015||2015-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Use of the Scolioscan for Quantitative Evaluation of Spinal Deformity - A Validity Study on Patients With Scoliosis|Use of the Scolioscan for Quantitative Evaluation of Spinal Deformity - A Validity Study on Patients With Scoliosis|Recruiting||N/A|1000|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-10 22:49:16.951797|2017-10-10 22:49:16.951797
NCT02581345|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-07-11|||September 2015||2015-09-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|September 2016|Actual|2016-09-01||Interventional|||Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis|A Phase 3 Randomized, Double-blind, Multicenter Study to Evaluate Efficacy, Safety, and Immunogenicity of an Adalimumab Biosimilar (M923) and Humira® in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis|Completed||Phase 3|827|Actual|Momenta Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:49:17.084883|2017-10-10 22:49:17.084883
NCT02579538|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-09|||September 2015||2015-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|FlexCAPP||Flexibility of Cognition And Persistent Pain|Cognitive Predictors of Persistent Post-surgical Pain (PPSP)|Active, not recruiting||N/A|300|Anticipated|Washington University School of Medicine|||2||f||||f||||||||||2017-10-10 22:49:43.010684|2017-10-10 22:49:43.010684
NCT02581332|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-01-24|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The Effects of Mindfulness Meditation on Fibromyalgia-Related Pain|The Effects of Mindfulness Meditation on Fibromyalgia-Related Pain|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||1||Due to insufficient interest in the study and enrollment has been closed|f||||t||||||||No||2017-10-10 22:49:17.462232|2017-10-10 22:49:17.462232
NCT02581319|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-20|||July 2015||2015-07-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||Clinical Conditions and Prevalence of Periodontopathogens in Smokers and Non-smokers After Periodontal Therapy|Clinical Conditions and Prevalence of Periodontopathogens in Smokers and Non-smokers After Periodontal Therapy|Unknown status|Recruiting|N/A|60|Anticipated|University of Sao Paulo||1|||f||||t||||||||||2017-10-10 22:49:17.614319|2017-10-10 22:49:17.614319
NCT02581306|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-11-22|||October 2015||2015-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|BC||Exercise Induced Changes in Fat Metabolism|Exercise-mediated Changes in Adipocyte Differentiation and Metabolic Function|Active, not recruiting||N/A|30|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 22:49:17.722004|2017-10-10 22:49:17.722004
NCT02581293|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-10-19|||March 2015||2015-03-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Visceral and Parietal Peritoneum Suturation on Postoperative Vital Signs|Effect of Visceral and Parietal Peritoneum Suturation on Postoperative Vital Signs|Unknown status|Recruiting|Phase 1|132|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||4|||f||||f||||||||||2017-10-10 22:49:17.818492|2017-10-10 22:49:17.818492
NCT02581280|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-12-09|||December 2014||2014-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Remifentanil, Sufentanil, Clopidogrel, Ticagrelor During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)|Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Remifentanil, Sufentanil, Clopidogrel, Ticagrelor During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)|Recruiting||N/A|70|Anticipated|Yonsei University|||2||f||||f||||||Samples Without DNA|"     Residual blood samples(1~2 cc) at each sampling time are collected from all subjects while     using ECMO for drug concentration assays(LC-MS/MS etc.). After ECMO device is removed,     residual arterial blood samples(1~2 mls) at each sampling time are collected and drug     concentrations are assayed.   "|||2017-10-10 22:49:17.930963|2017-10-10 22:49:17.930963
NCT02581267|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-08|2015-10-19|||October 2015||2015-10-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Missed Serious Medical Illness in Psychiatric Patients Seen in an Academic Emergency Department|Missed Serious Medical Illness in Psychiatric Patients Seen in an Academic Emergency Department|Unknown status|Active, not recruiting|N/A|800|Anticipated|Western University, Canada|||1||f||||||||||||||2017-10-10 22:49:18.032184|2017-10-10 22:49:18.032184
NCT02581254|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-04-20|||July 2015||2015-07-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Thin Wire Versus Thick Wire Snare for Cold Snare Polypectomy of Diminutive Polyps|Thin Wire Versus Thick Wire Snare for Cold Snare Polypectomy of Diminutive Polyps- A Randomised Controlled Trial|Recruiting||N/A|600|Anticipated|Western Sydney Local Health District||2|||f||||t||||||||No||2017-10-10 22:49:18.113477|2017-10-10 22:49:18.113477
NCT02581241|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-07-06|||January 2016||2016-01-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Abnormal QT-Response to the Sudden Tachycardia Provoked by Standing in Individuals With Drug-induced Long QT Syndrome|Abnormal QT-Response to the Sudden Tachycardia Provoked by Standing in Individuals With Drug-induced Long QT Syndrome|Recruiting||N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 22:49:18.231012|2017-10-10 22:49:18.231012
NCT02581228|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-09-26|||October 2015||2015-10-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Observational|||Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy|Multi-centre, Retrospective, Open Label Study, to Establish and Validate ML-PrediCare for Patients of Advanced Melanoma Undergoing Immunotherapy, as a 1st, 2nd and Later Lines|Recruiting||N/A|500|Anticipated|Optimata Ltd.|||2||f||||f||||||Samples Without DNA|"     Tumor tissue from an unresectable or metastatic site of disease will be collected for     biomarker analyses. Paraffin-embedded tissue samples from patients treated with the     immunotherapy drugs (with the previously obtained inform consent form) will be collected from     the tissue bank of the hospital and according to the European Commission regulations.   "|||2017-10-10 22:49:18.334263|2017-10-10 22:49:18.334263
NCT02581215|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-08-16|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer|Phase II Randomized, Double-Blind Study of mFOLFIRINOX Plus Ramucirumab Versus mFOLFIRINOX Plus Placebo in Advanced Pancreatic Cancer Patients: Hoosier Cancer Research Network GI14-198|Recruiting||Phase 2|95|Anticipated|Hoosier Cancer Research Network||2|||f||||t||||||||||2017-10-10 22:49:18.441609|2017-10-10 22:49:18.441609
NCT02581202|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-06-01|||December 21, 2015||2015-12-21|June 2017|2017-06-01|May 27, 2017|Actual|2017-05-27|May 27, 2017|Actual|2017-05-27||Observational|SIMPLE||The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation|ProSpective, MultI-Center, Observational PrograM to Assess the Effectiveness of Dual TheraPy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Routine Clinical Settings of the Russian Federation|Completed||N/A|216|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 22:49:18.621371|2017-10-10 22:49:18.621371
NCT02578004|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-14|||January 2013||2013-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|April 2014|Actual|2014-04-01||Observational|||Risk Factors for Pressure Ulcers|Case Control Study of the Risk Factors for Pressure Ulcers in Tunisian Patients|Completed||N/A|313|Actual|Centre Hôpital Universitaire Farhat Hached|||2||f||||t||||||||||2017-10-10 22:50:01.361361|2017-10-10 22:50:01.361361
NCT02581176|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-03-10|||April 2016||2016-04-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|December 2018|Anticipated|2018-12-01||Interventional|CAP||Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study|Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study|Recruiting||Phase 4|300|Anticipated|University Hospital, Akershus||1|||f||||t||||||||||2017-10-10 22:49:18.912586|2017-10-10 22:49:18.912586
NCT02581163|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-07-06|||October 7, 2015||2015-10-07|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Observational|||Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, +/- Dasabuvir, +/- Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium|Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, +/- Dasabuvir, +/- Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium|Active, not recruiting||N/A|300|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 22:49:19.049971|2017-10-10 22:49:19.049971
NCT02581150|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-05-30|||February 2016||2016-02-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|AMBUVASC||Cost-utility Analysis of the Outpatient Versus Conventional Hospitalization in Treatment of Occlusive Arterial Disease|Cost-utility Analysis of the Outpatient Hospitalization Versus Conventional Hospitalization in Endovascular Treatment of Occlusive Arterial Disease|Active, not recruiting||N/A|160|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-10-10 22:49:19.171904|2017-10-10 22:49:19.171904
NCT02581137|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-09-12|||June 10, 2016|Actual|2016-06-10|September 2017|2017-09-01||||October 31, 2017|Anticipated|2017-10-31||Interventional|||Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion|M4OC-Prevent: Metformin for Oral Cancer Prevention|Active, not recruiting||Phase 2|26|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-10 22:49:19.270933|2017-10-10 22:49:19.270933
NCT02581124|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-04-27|||October 2015||2015-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease|A Phase 1, Open-label Study to Evaluate the Effect of Lapatinib, a BCRP Inhibitor, on the Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease Receiving Hemodialysis|Completed||Phase 1|10|Actual|Akros Pharma Inc.||1|||f||||f||||||||||2017-10-10 22:49:19.38399|2017-10-10 22:49:19.38399
NCT02581111|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-09-25|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|September 25, 2017|Actual|2017-09-25|September 22, 2017|Actual|2017-09-22||Interventional|NO-HOLDS||Naloxone for Optimizing Hypoxemia Of Lung Donors|Randomized Placebo-controlled Trial of Intravenous Naloxone to Improve Oxygenation in Hypoxemic Lung-Eligible Brain-Dead Organ Donors|Completed||Phase 2/Phase 3|199|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 22:49:19.472089|2017-10-10 22:49:19.472089
NCT02581098|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-01-23|||August 2015||2015-08-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|miR-200b||Effect of miR-200b on Diabetic Wounds|Novel Regulators of Wound Angiogenesis|Recruiting||N/A|124|Anticipated|Ohio State University|||2||f||||t||||||Samples With DNA|"     Tissue, wound fluid   "|||2017-10-10 22:49:19.553342|2017-10-10 22:49:19.553342
NCT02581085|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-01-23|||February 2016||2016-02-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Liver Trial on Oral Tocotrienol|Tocotrienol Against the Progression of End Stage Liver Disease|Recruiting||Early Phase 1|70|Anticipated|Ohio State University||2|||f||||t||||||||||2017-10-10 22:49:19.666244|2017-10-10 22:49:19.666244
NCT02581072|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-06-09|||October 2015||2015-10-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204|A Double-blind, Double-dummy, Randomized, 4-period Crossover Study to Define the ECG Effects of SB204 Using a Clinical and Supratherapeutic Dose Compared With Placebo and Moxifloxacin in Subjects With Acne Vulgaris: A Thorough ECG STudy|Completed||Phase 1|56|Actual|Novan, Inc.||4|||f||||f||||||||No||2017-10-10 22:49:19.767396|2017-10-10 22:49:19.767396
NCT02581059|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-09-13|||April 2016||2016-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Ginseng for Patients on Regorafenib|A Randomized Phase II Trial to Evaluate the Efficacy of Supportive Therapy With Ginseng for Patients on Treatment With Regorafenib|Recruiting||Phase 2|90|Anticipated|Hoosier Cancer Research Network||2|||f||||t||||||||||2017-10-10 22:49:19.941705|2017-10-10 22:49:19.941705
NCT02581046|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-18|||January 2011||2011-01-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of the Timing of Cataract Surgery on Complications in Patients With Bilateral Congenital Cataracts|Effect of the Timing of Lens-removal Cataract Surgery on Postoperative Complications Rate Among Patients With Bilateral Congenital Cataracts|Completed||N/A|61|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:49:20.145717|2017-10-10 22:49:20.145717
NCT02581033|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-10-12|||May 2014||2014-05-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|STOP||Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients|Determinants of Sustained Virological Response After Discontinuation of Long-term Nucleoside Analogue Therapy in Chronic Hepatitis B Patients|Recruiting||N/A|200|Anticipated|St Vincent's Hospital Melbourne||1|||f||||t||||||||Undecided||2017-10-10 22:49:20.282407|2017-10-10 22:49:20.282407
NCT02581020|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-07-11|||January 14, 2016||2016-01-14|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Observational|||The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects|A Follow-up Study to Assess the Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatment of Chronic Hepatitis C Virus (HCV) Infection|Active, not recruiting||N/A|436|Anticipated|AbbVie|||1||f||||||||||||||2017-10-10 22:49:20.43606|2017-10-10 22:49:20.43606
NCT02581007|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-06-08|||November 2015||2015-11-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||RIC Transplant Using Haplo Donors|Reduced Intensity Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients With Hematologic Malignancies|Recruiting||Phase 2|30|Anticipated|Northside Hospital, Inc.||1|||f||||f||||||||No||2017-10-10 22:49:20.675309|2017-10-10 22:49:20.675309
NCT02580994|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-10-11|||January 2017||2017-01-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|October 2019|Anticipated|2019-10-01||Interventional|REACTION||Pembrolizumab in Untreated Extensive SCLC|REACTION: A Phase II Study of Etoposide and Cis/Carboplatin With or Without Pembrolizumab (MK-3475) in Untreated Extensive Small Cell Lung Cancer|Not yet recruiting||Phase 2|118|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-10 22:49:20.849029|2017-10-10 22:49:20.849029
NCT02580981|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-15|||July 2016||2016-07-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|July 2020|Anticipated|2020-07-01||Interventional|||Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses|Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses|Recruiting||N/A|60|Anticipated|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-10 22:49:22.691289|2017-10-10 22:49:22.691289
NCT02580968|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-03|||March 2015||2015-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Key Electro-acupuncture Technique on Migraine|Study of Key Electro-acupuncture Technique on Migraine|Recruiting||N/A|2|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 22:49:22.852689|2017-10-10 22:49:22.852689
NCT02580955|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-08-10|||October 2015||2015-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions|ReFlow Study, a Physician-initiated Trial Investigating the Efficacy of the LegFlow Paclitaxel-Eluting Peripheral Balloon Dilatation Catheter for the Treatment of Femoropopliteal Lesions Longer Than 15cm (TASC C&D Lesions).|Recruiting||Phase 3|120|Anticipated|Flanders Medical Research Program||1|||f||||f||||||||||2017-10-10 22:49:22.990249|2017-10-10 22:49:22.990249
NCT02580942|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-10-14|||July 2015||2015-07-01|July 2015|2015-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Efficacy Study of Acupoint Sticking in Summer to Treat Asthma|Efficacy Study of Acupoint Sticking in Treating Winter Diseases in Summer to Treat Asthma of Kidney Yang Deficiency Type|Suspended||N/A|72|Anticipated|Shanghai University of Traditional Chinese Medicine||2||Statistical analysis of existing data|f||||f||||||||Undecided||2017-10-10 22:49:23.126956|2017-10-10 22:49:23.126956
NCT02580929|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-10-21|||October 2014||2014-10-01|October 2015|2015-10-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer Patients|Effectiveness of Radiotherapy Before Surgery in Patients With High-risk Relapse Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|50|Anticipated|Peking Union Medical College||2|||f||||t||||||||||2017-10-10 22:49:23.229906|2017-10-10 22:49:23.229906
NCT02580916|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-08-15|||July 2015||2015-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|August 2017|Actual|2017-08-01||Interventional|SCQOLIT||Utility of the Skin Cancer Quality of Life Impact Tool|Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a Feasibility Study in Non-melanoma Skin Cancer|Enrolling by invitation||Phase 1|300|Anticipated|Oxford University Hospitals NHS Trust||4|||f||||f||||||||||2017-10-10 22:49:23.319301|2017-10-10 22:49:23.319301
NCT02580903|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2015-10-19|||February 2015||2015-02-01|October 2015|2015-10-01|February 2021|Anticipated|2021-02-01|February 2016|Anticipated|2016-02-01||Observational|MPNPH||Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms|Pulmonary Hypertension in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms; an Observational Prospective Study|Recruiting||N/A|250|Anticipated|Odense University Hospital|||1||f||||f||||||Samples Without DNA|"     All patients will submit a blood sample for later analysis   "|||2017-10-10 22:49:23.409185|2017-10-10 22:49:23.409185
NCT02580890|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-02-24|||September 2014||2014-09-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD)|Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|16|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:49:23.496014|2017-10-10 22:49:23.496014
NCT02580877|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-03-02|||January 2016||2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)|Exploring Immunologic Effects of Oral Insulin in Relatives at Risk for Type 1|Active, not recruiting||Phase 2|92|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-10 22:49:23.594945|2017-10-10 22:49:23.594945
NCT02580864|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-11-29|||October 2015||2015-10-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Observational|||Bologna IBD Markers|Predictive Factors of Anti-TNFalfa-induced Deep Remission in Crohn's Disease|Recruiting||N/A|150|Anticipated|Nestlé|||2||f||||f||||||Samples With DNA|"     Blood, stool, biopsy and urine   "|||2017-10-10 22:49:23.875815|2017-10-10 22:49:23.875815
NCT02580851|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-05-11|||December 2011||2011-12-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|MAGnet||Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention|Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention|Active, not recruiting||N/A|200|Actual|University of Ulm||2|||f||||f||||||||||2017-10-10 22:49:23.974072|2017-10-10 22:49:23.974072
NCT02580838|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2015-10-18|||August 2015||2015-08-01|October 2015|2015-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke|The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke|Recruiting||Phase 3|150|Anticipated|National Cheng-Kung University Hospital||3|||f||||t||||||||||2017-10-10 22:49:24.118677|2017-10-10 22:49:24.118677
NCT02580825|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-19|||October 2015||2015-10-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Biofeedback Gait Retraining to Reduce Lower Extremity Impact in Obese Children|Biofeedback Gait Retraining to Reduce Lower Extremity Impact in Obese Children|Unknown status|Not yet recruiting|N/A|50|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-10 22:49:24.257771|2017-10-10 22:49:24.257771
NCT02580812|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-07-31|||October 2015||2015-10-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|MONALISABABY||Neurological Consequences of Perinatal Listeriosis Infection|Multicentric Observational National Analysis of Listeriosis and Listeria : Evaluation of the Neurological Consequences of Perinatal Listeriosis Infection|Recruiting||N/A|360|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:49:24.371001|2017-10-10 22:49:24.371001
NCT02580799|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-01-26|2015-12-01||February 2014||2014-02-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational||Full analysis set (FAS): All enrolled participants.|Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples|Immunohistochemical HER2 Status Evaluation In Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study|Completed||N/A|30|Actual|Hoffmann-La Roche|||1||f||||f||||||||No||2017-10-10 22:49:24.567194|2017-10-10 22:49:24.567194
NCT02580786|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-21|||June 2011||2011-06-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Breastfeeding Preterm Infants - The Efficacy of Internet-based Peer Support||Completed||N/A|124|Actual|University of Turku||2|||f||||f||||||||||2017-10-10 22:49:25.997184|2017-10-10 22:49:25.997184
NCT02580773|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-18|||November 2015||2015-11-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TASC||Therapeutic Anticoagulation Strategy for Acute Chest Syndrome|A Prospective, Randomized, Double-blind, Placebo Controlled, Multi-national Study of Therapeutic Anticoagulation Strategy for Acute Chest Syndrome in Adults|Not yet recruiting||Phase 3|200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:49:26.087531|2017-10-10 22:49:26.087531
NCT02580760|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-01-22|||July 2015||2015-07-01|September 2015|2015-09-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|TSBS||Transgender, Silicone and Blood Smear|Circulating Silicone After Cosmetic Silicone Injection in Transgender Patients|Completed||N/A|66|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 22:49:26.228971|2017-10-10 22:49:26.228971
NCT02580747|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2015-10-19|||October 2015||2015-10-01|October 2015|2015-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso|Clinical Study of Chimeric Mesothelin Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Malignancies|Recruiting||Phase 1|20|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 22:49:26.341935|2017-10-10 22:49:26.341935
NCT02580734|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-10-25|||March 2014||2014-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|BMS2013||Efficacy of Melatonin in Burning Mouth Syndrome (BMS)|Melatonin to Treat Burning Mouth Syndrome (BMS): A Randomized, Cross-over, Placebo-controlled, Triple-blind Clinical Trial|Completed||N/A|20|Actual|University of Milan||2|||f||||f||||||||||2017-10-10 22:49:26.474504|2017-10-10 22:49:26.474504
NCT02580721|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2015-10-18|||September 2015||2015-09-01|October 2015|2015-10-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||The Influence of Mucosal Tissue Thickness on Soft and Hard Tissue Changes Around Implants|The Influence of Mucosal Tissue Thickness on Soft and Hard Tissue Changes Around Implants. A Randomized Controlled Clinical Study|Recruiting||N/A|140|Anticipated|Cukurova University||4|||f||||f||||||||||2017-10-10 22:49:26.57963|2017-10-10 22:49:26.57963
NCT02580708|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-07-25|||September 2015||2015-09-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 1/2 Study of the Safety and Efficacy of Rociletinib When Administered in Combination With Trametinib in Patients With Activating EGFR Mutation-positive Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|A Phase 1/2 Study of the Safety and Efficacy of Rociletinib When Administered in Combination With Trametinib in Patients With Activating EGFR Mutation-positive Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|7|Actual|Clovis Oncology, Inc.||1|||f||||f||||||||||2017-10-10 22:49:26.70125|2017-10-10 22:49:26.70125
NCT02580695|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-09-26|||December 2015||2015-12-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis|A Phase I/II, Randomized, Double-blind, Controlled Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UC-MSCs) in Patients With Knee Osteoarthritis|Active, not recruiting||Phase 1/Phase 2|30|Actual|Universidad Los Andes, Chile||2|||f||||t||||||||||2017-10-10 22:49:26.847846|2017-10-10 22:49:26.847846
NCT02580682|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-07-23|||July 2016|Actual|2016-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Treatment of Sanfu Herbal Patch for Allergic Rhinitis: a Controlled Clinical Trial|Treatment of Sanfu Herbal Patch for Allergic Rhinitis: a Randomized Controlled Clinical Trial|Recruiting||Phase 2|200|Anticipated|Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust||3|||f||||t||||||||||2017-10-10 22:49:26.961333|2017-10-10 22:49:26.961333
NCT02580669|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-04-26|||June 2014||2014-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|VASOSEP||Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis|Study by Magnetic Resonance Imaging of the Modifications of the Vasoreactivity and Cerebral Connectivity in the Progressive Forms of Multiple Sclerosis|Recruiting||N/A|66|Anticipated|University Hospital, Montpellier||3|||f||||f||||||||||2017-10-10 22:49:27.07583|2017-10-10 22:49:27.07583
NCT02580656|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2017-09-29|||January 2016||2016-01-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||An Open Trial of Metacognitive Therapy for Anxiety and Depression in Cancer|An Open Trial of Metacognitive Therapy for Anxiety and Depression in Cancer (OMAC Study)|Completed||N/A|28|Actual|University of Liverpool||1|||f||||f||||||||||2017-10-10 22:49:27.226657|2017-10-10 22:49:27.226657
NCT02580643|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-10-03|||December 2015||2015-12-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01|5 Years|Observational [Patient Registry]|PROGRESS III||Prospective Post-Market Data Collection on Patients With Knee OA and Treated With nSTRIDE APS|Prospective Post-Market Data Collection on Patients With Knee Osteoarthritis and Treated With nSTRIDE Autologous Protein Solution (REGP-22-00)|Active, not recruiting||N/A|78|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-10-10 22:49:27.329502|2017-10-10 22:49:27.329502
NCT02580630|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2016-10-29|||April 2016||2016-04-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|||Achilles Tendinopathy Treated With Training and Injections|Achilles Tendinopathy Treated With Heavy Slow Resistance Training Supplemented With Injection of Glucocorticosteroid or Local Anaesthetic.|Recruiting||Phase 4|100|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||Undecided||2017-10-10 22:49:27.428583|2017-10-10 22:49:27.428583
NCT02579161|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-09-28|||September 2014||2014-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy|Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy|Recruiting||Phase 3|290|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-10 22:49:46.7198|2017-10-10 22:49:46.7198
NCT02580617|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-19|||April 2015||2015-04-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease|A Phase 1 Clinical Study to Evaluate the Safety of Allogeneic Adipose-derived Stem Cells in the Subjects With Crohn's Disease|Unknown status|Recruiting|Phase 1|9|Anticipated|Anterogen Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:49:27.570446|2017-10-10 22:49:27.570446
NCT02580604|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-08-29|||November 2015||2015-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||PTH And Calcium Responses to Exercise in Older Adults Experiment 2 (PACE Sr. 2)|PTH And Calcium Responses to Exercise in Older Adults Experiment 2 (PACE Sr. 2)|Recruiting||Early Phase 1|28|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:49:27.667878|2017-10-10 22:49:27.667878
NCT02580591|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-08-24|||October 12, 2015|Actual|2015-10-12|August 2017|2017-08-01|September 22, 2017|Anticipated|2017-09-22|September 1, 2017|Anticipated|2017-09-01||Interventional|||Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)|A Phase III, Randomised, Double Blind, Placebo-controlled, Parallel Group, Efficacy, Safety and Tolerability Trial of Once Daily, Oral Doses of Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-3)|Active, not recruiting||Phase 3|960|Anticipated|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 22:49:27.826662|2017-10-10 22:49:27.826662
NCT02580578|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-19|2017-07-25|||July 31, 2015|Actual|2015-07-31|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids||Recruiting||N/A|1000|Anticipated|Allergan|||1||f||||f|f|f||||||||2017-10-10 22:49:28.515034|2017-10-10 22:49:28.515034
NCT02580565|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-10-16|||November 2015||2015-11-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|PHEDRE||Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease|PHEDRE Trial Protocol - Observational Study of the Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and Analgesics in the French Sickle-cell Disease Population|Not yet recruiting||N/A|2000|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 22:49:28.69007|2017-10-10 22:49:28.69007
NCT02580552|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-02-23|||November 2015||2015-11-01|December 2016|2016-12-01||||July 2017|Anticipated|2017-07-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of MRG-106 in Patients With Cutaneous T Cell Lymphoma (CTCL), MF Subtype|A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Injection in Patients With Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Sub-type|Recruiting||Phase 1|50|Anticipated|miRagen Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:49:28.82968|2017-10-10 22:49:28.82968
NCT02580539|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-09-12|||November 2015||2015-11-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|EBV-TCL-01||A Study of the Safety and Efficacy of EBV Specific T-cell Lines|A Phase I/II Open-label Study of the Safety and Efficacy of Epstein-Barr Virus Specific T-cell Lines for the Treatment of EBV Infection or EBV-related Lymphoproliferative Diseases|Recruiting||Phase 1/Phase 2|12|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||t||||||||||2017-10-10 22:49:29.048911|2017-10-10 22:49:29.048911
NCT02580526|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-07-05|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|November 17, 2015|Actual|2015-11-17|November 17, 2015|Actual|2015-11-17||Interventional|||Comparison of Mask Ventilation Techniques in Patients Requiring General Anesthesia|Comparison of Mask Ventilation Techniques in Patients Requiring General Anesthesia|Completed||N/A|104|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 22:49:29.204305|2017-10-10 22:49:29.204305
NCT02580513|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-06-08|||January 2016||2016-01-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Circadian Misalignment and Insulin Sensitivity|Impact of Circadian Misalignment on Insulin Sensitivity|Completed||N/A|14|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 22:49:29.318688|2017-10-10 22:49:29.318688
NCT02580500|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-01-01|||October 2015||2015-10-01|January 2016|2016-01-01|January 2016|Anticipated|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Epidural and Spinal Anesthesia Techniques in Pilonidal Dermoid Sinus Surgeries|Epidural and Spinal Anesthesia Techniques in Pilonidal Dermoid Sinus Surgeries: Prospective Randomized Trials|Recruiting||N/A|100|Anticipated|Lütfiye Nuri Burat Government Hospital||2|||f||||f||||||||||2017-10-10 22:49:29.468468|2017-10-10 22:49:29.468468
NCT02580487|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-19|||January 2012||2012-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|umpikipu||Perioperative Pain Management of Pediatric Appendectomy Patients|Perioperative Pain Management of Pediatric Appendectomy Patients in Kuopio University Hospital During the Years 2010-2012|Completed||N/A|178|Actual|Kuopio University Hospital|||2||f||||f||||||||||2017-10-10 22:49:29.598786|2017-10-10 22:49:29.598786
NCT02580474|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-07-21|||February 2016||2016-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure|The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure|Recruiting||Phase 4|90|Anticipated|The Catholic University of Korea||1|||f||||f||||||||||2017-10-10 22:49:29.693122|2017-10-10 22:49:29.693122
NCT02580461|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|RECHARGE||Renewing Caregiver Health and Well-being Through Exercise|Renewing Caregiver Health and Well-being Through Exercise: A Randomized Controlled Trial|Completed||N/A|80|Actual|University of Calgary||2|||f||||f||||||||||2017-10-10 22:49:29.816584|2017-10-10 22:49:29.816584
NCT02580448|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-09-20|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|CLARITY-01||CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)|A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer|Recruiting||Phase 1/Phase 2|175|Anticipated|Innocrin Pharmaceutical||3|||f||||f||||||||||2017-10-10 22:49:29.93149|2017-10-10 22:49:29.93149
NCT02578966|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-02-24|||January 2014||2014-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Interventional|CZC||Cohort Zero Caries|Impact of Preventive Child Oral Health Programs in Primary Health Care.|Enrolling by invitation||N/A|650|Anticipated|Hospital Nossa Senhora da Conceicao||2|||f||||f||||||||||2017-10-10 22:49:48.993526|2017-10-10 22:49:48.993526
NCT02580435|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2015-10-28|||December 2015||2015-12-01|October 2015|2015-10-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||Deciphering the Role of the Gut Microbiota in Multiple Sclerosis|Deciphering the Role of the Gut Microbiota in Multiple Sclerosis|Not yet recruiting||N/A|520|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples Without DNA|"     From each patient, the investigarors will obtain        1. Clinical metadata, including: Consent form; Medications; annual relapse rate;        2. Blood tests, including a complete blood count, complete biochemistry, lipid profile,          cholesterol profile;        3. Gut microbiota profile obtained from stool samples will be processed for shotgun          metagenomic sequencing and 16S rRNA profiling. Gut microbiota profiling will be done          from stool samples that will be immediately flash-frozen in liquid nitrogen and          preserved at a minimum of -80oC until further processing.   "|||2017-10-10 22:49:30.348641|2017-10-10 22:49:30.348641
NCT02580422|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-09-21|||October 1, 2015||2015-10-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia|Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia|Terminated||N/A|8|Actual|Indiana University|||1|Low accrual|f||||t||||||Samples With DNA|"     Blood samples will be collected: one sample for cytokine analysis, one sample for future     research.   "|||2017-10-10 22:49:30.472028|2017-10-10 22:49:30.472028
NCT02580409|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-19|||January 2015||2015-01-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|REACH||REACH Pilot Study (Rehabilitation Enhancing Aging Through Connected Health)|Maintaining Physical Independence in Older Adults|Unknown status|Recruiting|N/A|76|Anticipated|Spaulding Rehabilitation Hospital||1|||f||||f||||||||||2017-10-10 22:49:30.574354|2017-10-10 22:49:30.574354
NCT02580396|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-08-15|||March 2016||2016-03-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine|Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine|Recruiting||N/A|25|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 22:49:30.688923|2017-10-10 22:49:30.688923
NCT02580383|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2016-06-21|||September 2015||2015-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Multifidus Muscle Twitch on the Prognosis of Lumbar Medial Branch RF|Effect of the Multifidus Muscle Twitch on the Long Term Effect of Radiofrequency Lumbar Medial Branch Neurotomy|Completed||N/A|68|Actual|Severance Hospital|||3||f||||t||||||||||2017-10-10 22:49:30.790891|2017-10-10 22:49:30.790891
NCT02580370|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-09-07||2016-09-07|September 2015||2015-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|REALISE 1||Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines||Completed||Phase 3|450|Actual|Revance Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:49:30.889228|2017-10-10 22:49:30.889228
NCT02580357|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-03-27|2016-12-11||February 2014||2014-02-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Comparison of Two Different Low-level Laser Intensity Protocols on the Healing of Palatal Wounds|Comparison of Two Different Low-level Laser Intensity Protocols on the Healing of Palatal Wounds After Connective Tissue Graft Removal: Randomized Clinical Trial|Completed||N/A|54|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||f||||||||Undecided||2017-10-10 22:49:30.97926|2017-10-10 22:49:30.97926
NCT02580344|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-03-20|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||The Effect of Ibuprofen on Intrauterine Contraceptive Device Associated Uterine Bleeding|Action of Ibuprofen on IUD-associated Heavy Menstrual Bleeding|Completed||Phase 2|128|Actual|Assiut University||1|||f||||f|f|f||||||Yes||2017-10-10 22:49:31.430504|2017-10-10 22:49:31.430504
NCT02580331|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2015-10-18|||November 2014||2014-11-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||1% Metformin Gel in the Treatment of Class II Furcation Defects|1% Metformin Gel as Local Drug Delivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|64|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||f||||||||||2017-10-10 22:49:31.524482|2017-10-10 22:49:31.524482
NCT02580318|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-09-11|2017-07-01||August 2015||2015-08-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?|Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?|Completed||N/A|54|Actual|St. Luke's Hospital and Health Network, Pennsylvania||1|||f||||f||||||||||2017-10-10 22:49:31.660737|2017-10-10 22:49:31.660737
NCT02580292|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2016-11-07|||October 2015||2015-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Observational|||Diagnostic Accuracy of Doppler Resistive Indices for Early Diagnosis of Acute Kidney Injury .|Diagnostic Accuracy of Renal, Carotid, and Aortic Doppler Resistive Indices for Early Diagnosis of Acute Kidney Injury Following Cardiopulmonary Bypass Surgery.|Recruiting||N/A|125|Anticipated|University of Michigan|||1||f||||f||||||||||2017-10-10 22:49:32.715406|2017-10-10 22:49:32.715406
NCT02580279|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2017-05-01|||February 2015||2015-02-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy|Phase II Study of Topical Epigallocatechin-3-gallate (EGCG) in Patients With Breast Cancer Receiving Adjuvant Radiotherapy|Enrolling by invitation||Phase 2|68|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||f||||||||||2017-10-10 22:49:32.811668|2017-10-10 22:49:32.811668
NCT02578576|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-16|||December 2015||2015-12-01|October 2015|2015-10-01||||December 2017|Anticipated|2017-12-01||Observational|||The Diagnostic Methods of Early Postoperative Flare-up of Crohn's Disease|The Diagnostic Methods of Crohn's Disease Flare-up Within One Month After Resection|Not yet recruiting||N/A|300|Anticipated|Jinling Hospital, China|||2||f||||||||||||||2017-10-10 22:49:53.321865|2017-10-10 22:49:53.321865
NCT02580266|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-07-31|||September 2015||2015-09-01|July 2017|2017-07-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Observational|DDRD||Blood/Urine Markers for Drug Discovery for Renal Disease in Diabetes|Blood/Urine Markers for Drug Discovery for Renal Disease in Diabetes|Recruiting||N/A|600|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||Samples Without DNA|"     Plasma, serum, urine   "|||2017-10-10 22:49:32.922096|2017-10-10 22:49:32.922096
NCT02580253|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2017-06-29|||November 1, 2017|Anticipated|2017-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation|Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity|Not yet recruiting||Phase 2|300|Anticipated|Zhejiang University||2|||f||||f|f|f||||||||2017-10-10 22:49:33.02012|2017-10-10 22:49:33.02012
NCT02580240|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-18|2017-04-30|2017-01-24||September 2015||2015-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Initiation of Hydrocortisone for the Treatment of Septic Shock|Early Initiation of Low-dose Hydrocortisone Treatment for Septic Shock in Adults: a Randomized Clinical Trial|Completed||N/A|118|Actual|Northern Jiangsu Province People's Hospital||2|||f||||f||||||||No||2017-10-10 22:49:33.125684|2017-10-10 22:49:33.125684
NCT02580227|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-27|||June 2015||2015-06-01|October 2015|2015-10-01|March 2017|Anticipated|2017-03-01|August 2016|Anticipated|2016-08-01||Interventional|||Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures|The Effect of Preoperative Tranexamic Acid on Blood Loss and Transfusion Rates in Intertrochanteric and Subtrochanteric Femur Fractures.|Unknown status|Recruiting|Phase 4|100|Anticipated|Good Samaritan Regional Medical Center, Oregon||2|||f||||f||||||||||2017-10-10 22:49:33.505407|2017-10-10 22:49:33.505407
NCT02580214|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-19|||May 2013||2013-05-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01||Interventional|Immunehip||Immunonutrition in Total Hip Arthroplasty|A Protocol Of Perioperative Care Plus Immunonutrition Enhances Recovery After Total Hip Arthroplasty. A Randomized Pilot Study|Completed||Phase 2/Phase 3|32|Actual|Federal University of Mato Grosso do Sul||2|||f||||f||||||||||2017-10-10 22:49:33.6391|2017-10-10 22:49:33.6391
NCT02580201|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-07-10|||November 2015||2015-11-01|July 2017|2017-07-01|August 11, 2016|Actual|2016-08-11|July 2016|Actual|2016-07-01||Interventional|T2-ABMG||A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age|A Phase 4 Study to Evaluate the Safety and Immunogenicity of Trivalent Oral Polio Vaccine in Healthy Polio Vaccinated Children 1 to 5 Years of Age and in Healthy Unvaccinated Infants at 6 Weeks of Age in the Dominican Republic|Completed||Phase 4|154|Actual|Fidec Corporation||1|||f||||t||||||||||2017-10-10 22:49:33.736708|2017-10-10 22:49:33.736708
NCT02580188|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-04-24|||March 2015||2015-03-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|December 2015|Actual|2015-12-01||Interventional|DEEPCOL||The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery|The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery|Enrolling by invitation||Phase 4|70|Anticipated|Seoul National University Bundang Hospital||2|||f||||f||||||||Yes||2017-10-10 22:49:33.828264|2017-10-10 22:49:33.828264
NCT02580175|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-17|2015-10-17|||May 2014||2014-05-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Surgical Evacuation of Abortion Under Ultrasonographic Guide|Surgical Evacuation of First Trimester Missed Miscarriage With or Without Use of Transabdominal Ultrasound|Completed||Phase 2|200|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:49:33.941742|2017-10-10 22:49:33.941742
NCT02580162|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-10-13|||December 2015||2015-12-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|SHIFT||Success in Health: Impacting Families Together|Parents as Peer Interventionists in Treatment for Pediatric Weight Management|Recruiting||N/A|304|Anticipated|Seattle Children's Hospital||4|||f||||t||||||||||2017-10-10 22:49:34.0368|2017-10-10 22:49:34.0368
NCT02580149|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-09-19|||October 2015||2015-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment|The Effect of an Acute Dose of Ticagrelor or Clopidogrel and of Treatment for 14 Days on Ischemia-reperfusion Induced Endothelial Dysfunction of the Forearm Vasculature in Healthy Male Subjects.|Completed||Phase 4|24|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 22:49:34.170908|2017-10-10 22:49:34.170908
NCT02580136|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-03-31|||September 2015||2015-09-01|March 2017|2017-03-01|September 2026|Anticipated|2026-09-01|September 2025|Anticipated|2025-09-01|120 Months|Observational [Patient Registry]|ENB||Esthesioneuroblastoma: Outcomes After Treatment|Esthesioneuroblastoma: Outcomes After Treatment|Recruiting||N/A|100|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-10 22:49:34.286117|2017-10-10 22:49:34.286117
NCT02580123|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-10-17|||May 2012||2012-05-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Smile-Kids: Study on Complementary Feeding Transition||Completed||N/A|53|Actual|University of Minho||2|||f||||||||||||||2017-10-10 22:49:34.380037|2017-10-10 22:49:34.380037
NCT02580110|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-06-22|||October 2015||2015-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota|On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota|Completed||N/A|39|Actual|Lund University||3|||f||||||||||||||2017-10-10 22:49:34.462395|2017-10-10 22:49:34.462395
NCT02580097|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-02-01|||August 2015||2015-08-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|||Predictive Value of Magnetic Resonance Perfusion Imaging in Acute and Subacute Stroke Patients|Predictive Value of Magnetic Resonance Perfusion Imaging in Acute and Subacute Stroke Patients|Recruiting||N/A|300|Anticipated|Chinese PLA General Hospital|||1||f||||t||||||||||2017-10-10 22:49:34.566046|2017-10-10 22:49:34.566046
NCT02580084|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-11-30|||August 2015||2015-08-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|August 2015|Actual|2015-08-01||Interventional|||Clinical Study of the Aorta-femoral Bypass and Hybrid Intervention and the Iliac Arteries With Stenting and Plasty of the Common Femoral Artery Effectiveness in Patients With the Iliac Segment and Femoral Artery Occlusive Disease (TASC C, D)|Prospective Randomized Clinical Study of the Aorta-femoral Bypass and Hybrid Intervention and the Iliac Arteries With Stenting and Plasty of the Common Femoral Artery Effectiveness in Patients With the Iliac Segment and Femoral Artery Occlusive Disease (TASC C, D)|Active, not recruiting||Phase 4|84|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 22:49:34.688668|2017-10-10 22:49:34.688668
NCT02580071|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-19|||October 2015||2015-10-01|October 2015|2015-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients|An Open Label, Non-randomized, Clinical Study of Chinese Medicine, Sheng-Yu-Tang, for Immune Reconstitution Following Peripheral Blood Stem Cell Transplantation in >CR1 (Complete Remission) and Refractory Acute Leukemia Patients|Recruiting||N/A|50|Anticipated|China Medical University Hospital||2|||f||||f||||||||||2017-10-10 22:49:34.813262|2017-10-10 22:49:34.813262
NCT02580058|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-09-12|||December 23, 2015|Actual|2015-12-23|September 2017|2017-09-01|March 12, 2018|Anticipated|2018-03-12|March 12, 2018|Anticipated|2018-03-12||Interventional|||A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)|A Phase 3, Multicenter, Randomized, Open-label Study Of Avelumab (msb0010718c) Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum-resistant/Refractory Ovarian Cancer|Active, not recruiting||Phase 3|546|Actual|Pfizer||3|||f||||||||||||||2017-10-10 22:49:34.962632|2017-10-10 22:49:34.962632
NCT02580045|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-11-25|||October 2015||2015-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer|CSF Pharmacokinetics of Systemic Anti-Cancer Therapies in Patients With Advanced Cancer|Recruiting||N/A|20|Anticipated|Duke University|||1||f||||t||||||Samples With DNA|"     Blood samples and cerebrospinal fluid samples are to be collected for pharmacokinetic     analysis by blood draw and lumbar puncture, respectively.   "|||2017-10-10 22:49:35.844027|2017-10-10 22:49:35.844027
NCT02580032|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-09-21|||October 5, 2015|Actual|2015-10-05|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)|Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)|Enrolling by invitation||N/A|320|Anticipated|Novo Nordisk A/S|||4||f||||f||||||||||2017-10-10 22:49:35.985467|2017-10-10 22:49:35.985467
NCT02580019|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-11-30|||February 2016||2016-02-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|Recruiting||Umbilical Cord Derived Mesenchymal Stem Cells Treatment in Ischemic Stroke|Cell Therapy by Intravenous Injection of Umbilical Cord Derived Mesenchymal Stem Cells After Stroke|Not yet recruiting||Phase 2|2|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-10 22:49:36.188989|2017-10-10 22:49:36.188989
NCT02580006|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-16|||November 2015||2015-11-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers|A Randomized, Double-blind, Active Control, Single Dosing, Crossover Clinical Trial to Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers|Unknown status|Not yet recruiting|Phase 1|42|Anticipated|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:49:36.313058|2017-10-10 22:49:36.313058
NCT02579993|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2016-08-30|||March 2015||2015-03-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation|ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation Expanded in Vitro on Amniotic Membrane in Patients With Limbal Stem Cell Deficiency.|Recruiting||N/A|10|Anticipated|Instituto de Oftalmología Fundación Conde de Valenciana||1|||f||||f||||||||||2017-10-10 22:49:36.44508|2017-10-10 22:49:36.44508
NCT02579980|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-19|||October 2015||2015-10-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Quantitative Imaging Biomarkers for Sarcoma|Development of Quantitative Imaging Biomarkers for Evaluating Sarcoma Patients|Recruiting||N/A|60|Anticipated|Columbia University||1|||f||||t||||||||||2017-10-10 22:49:36.568298|2017-10-10 22:49:36.568298
NCT02579954|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-06-26|||August 6, 2015|Actual|2015-08-06|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FONCE-HTAP||Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension|Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t||||||||||2017-10-10 22:49:36.939929|2017-10-10 22:49:36.939929
NCT02579941|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-06-06|||November 2015||2015-11-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.|Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.|Completed||N/A|40|Actual|Brugmann University Hospital||3|||f||||f||||||||||2017-10-10 22:49:37.088772|2017-10-10 22:49:37.088772
NCT02579928|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-02-20|||October 2015||2015-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Ketamine Infusion for Adolescent Depression and Anxiety|Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders|Recruiting||Phase 4|36|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 22:49:37.18322|2017-10-10 22:49:37.18322
NCT02579915|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-07-19|||September 2015||2015-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)|Phase 2 Randomized Controlled Trial of Attention and Interpretation Modification (AIM) for Anxiety Disorders in Primary Care|Recruiting||N/A|42|Anticipated|Brown University||2|||f||||t||||||||||2017-10-10 22:49:37.304065|2017-10-10 22:49:37.304065
NCT02579902|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2015-11-27|||February 2015||2015-02-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Vitamin D3 Supplementation in Treatment of Irritable Bowel Syndrome|Effect of Vitamin D3 Supplementation on Clinical Signs, Oxidative Stress and Inflammatory Biomarkers in Patients With Irritable Bowel Syndrome|Completed||Phase 1|90|Actual|Ahvaz Jundishapur University of Medical Sciences||2|||f||||||||||||||2017-10-10 22:49:37.399647|2017-10-10 22:49:37.399647
NCT02579889|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-03-08|||September 2015||2015-09-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|B3||Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease|Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease - B3 Study|Recruiting||N/A|1308|Anticipated|Biotronik SE & Co. KG||2|||f||||t||||||||||2017-10-10 22:49:37.534425|2017-10-10 22:49:37.534425
NCT02579876|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-19|||October 2015||2015-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|SMILEE||Milk Patch for Eosinophilic Esophagitis|A Double, Blind Placebo-controlled, Randomized Trial to Study Efficacy and Safety of the Viaskin Milk for Treating Milk Induced Eosinophilic Esophagitis in Children|Active, not recruiting||Phase 2|20|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-10 22:49:37.752968|2017-10-10 22:49:37.752968
NCT02579863|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-07-28|||October 19, 2015|Actual|2015-10-19|July 2017|2017-07-01|July 31, 2021|Anticipated|2021-07-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185)|A Phase III Study of Lenalidomide and Low-dose Dexamethasone With or Without Pembrolizumab (MK3475) in Newly Diagnosed and Treatment naïve Multiple Myeloma (KEYNOTE 185).|Suspended||Phase 3|640|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 22:49:37.953366|2017-10-10 22:49:37.953366
NCT02579850|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-07-19|||May 29, 2015|Actual|2015-05-29|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|TRIBUTE||2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients|52-week, Double Blind, Randomized, 2 Active Parallel Arms Study of Fixed Combination CHF 5993 Administered vs Ultibro® in COPD Patients|Completed||Phase 3|1532|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-10 22:49:38.2157|2017-10-10 22:49:38.2157
NCT02579837|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-11-30|||March 2016||2016-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease|CLEAR SIGHT: A Randomized Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease|Recruiting||N/A|740|Anticipated|Western University, Canada||2|||f||||f||||||||No||2017-10-10 22:49:38.332755|2017-10-10 22:49:38.332755
NCT02579824|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-09-14|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma|A Phase I Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1|28|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:49:38.424385|2017-10-10 22:49:38.424385
NCT02579811|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-04-07|||December 30, 2015|Actual|2015-12-30|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer|A Phase II Study of the Efficacy and Safety of Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer After Treatment With Pd-1 or Pd-L1 Inhibitors|Recruiting||Phase 2|50|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-10 22:49:38.514202|2017-10-10 22:49:38.514202
NCT02579798|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-07-25|||July 2013||2013-07-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Does Pulmonary Compliance Optimization Through PEEP Manipulations Reduces the Incidence of Postoperative Hypoxaemia in Bariatric Surgery?|Does Pulmonary Compliance Optimization Through PEEP Manipulations Reduces the Incidence of Postoperative Hypoxaemia in Bariatric Surgery?|Completed||N/A|100|Actual|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:49:40.325208|2017-10-10 22:49:40.325208
NCT02579785|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-05-09|||December 2015||2015-12-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|March 2016|Actual|2016-03-01||Interventional|||Using mHealth to Promote Post-Menstrual Regulation Contraceptive Uptake and Continuation in Bangladesh|Using mHealth to Promote Post-Menstrual Regulation Contraceptive Uptake and Continuation in the Sylhet, Chittagong and Dhaka Regions of Bangladesh|Active, not recruiting||N/A|969|Actual|Marie Stopes International||2|||f||||f||||||||||2017-10-10 22:49:40.502023|2017-10-10 22:49:40.502023
NCT02579772|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-06-17|||July 2015||2015-07-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction|Systemic Vascular Dysfunction in COPD Patients With Mild-to-moderate Airflow Obstruction: Pharmacological Treatment With N-acetylcysteine|Completed||Phase 4|13|Actual|Queen's University||2|||f||||f||||||||||2017-10-10 22:49:40.679059|2017-10-10 22:49:40.679059
NCT02579759|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-01-04|||December 2015||2015-12-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PLEO-CMT||Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)|International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months|Active, not recruiting||Phase 3|323|Actual|Pharnext SA||3|||f||||t||||||||||2017-10-10 22:49:40.769263|2017-10-10 22:49:40.769263
NCT02579746|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2015-10-19|||August 2014||2014-08-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|DASHNa-CC||Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians|Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians|Completed||N/A|60|Actual|University of Toronto||2|||f||||t||||||||||2017-10-10 22:49:41.018993|2017-10-10 22:49:41.018993
NCT02579733|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-12-26|||February 2016||2016-02-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|ACE||Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis||Recruiting||Phase 4|52|Anticipated|Kyungpook National University||2|||f||||||||||||||2017-10-10 22:49:41.095124|2017-10-10 22:49:41.095124
NCT02579720|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Revaccination With Pollinex® Quattro|Non-interventional Study A Multicentre Observational Study for Revaccination With Pollinex® Quattro in Patients With a Recurrent Grass Pollen Allergy|Completed||N/A|108|Actual|University Hospital of Cologne|||2||f||||t||||||||No||2017-10-10 22:49:41.190677|2017-10-10 22:49:41.190677
NCT02579707|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-11-28|||October 2015||2015-10-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Food Effect Study of AG120 in Healthy Subjects|A Phase 1, Open-Label, Randomized, 2-Period Crossover Study To Evaluate The Effect Of Food On AG-120 Pharmacokinetics Following Single Oral Dose Administration To Healthy Subjects|Completed||Phase 1|36|Actual|Agios Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:49:41.272391|2017-10-10 22:49:41.272391
NCT02579694|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-07-17|||September 2015||2015-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Short Term Evaluation of SLIC Screw in Treatment of Scapholunate Injury|Multicenter Retrospective-prospective Short-term Evaluation of the SLIC Screw System in Subjects Requiring Treatment for Acute Scapholunate Injury|Terminated||N/A|9|Actual|Acumed, LLC|||1|Difficulties finding subjects meeting enrollment criteria|f||||f||||||||||2017-10-10 22:49:41.365886|2017-10-10 22:49:41.365886
NCT02579681|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-04-26|||April 30, 2014|Actual|2014-04-30|April 2017|2017-04-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|StarTec||Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012|Single Country Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis Patients Treated With BG00012|Completed||Phase 3|221|Actual|Biogen||1|||f||||f||||||||||2017-10-10 22:49:41.45823|2017-10-10 22:49:41.45823
NCT02579668|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-05-27|||September 2014||2014-09-01|October 2015|2015-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Language Therapy in British Sign Language|Language Therapy in British Sign Language - a Pilot Study to Explore the Use of Therapeutic Strategies and Resources by Deaf Adults With Young People Who Have Language Difficulties in BSL.|Completed||N/A|29|Actual|University College, London||1|||f||||t||||||||||2017-10-10 22:49:41.605312|2017-10-10 22:49:41.605312
NCT02579655|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-08-30|||November 2015||2015-11-01|August 2016|2016-08-01|January 2021|Anticipated|2021-01-01|October 2020|Anticipated|2020-10-01||Interventional|ACCESS||Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study|Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study|Recruiting||N/A|4714|Anticipated|University of Calgary||4|||f||||f||||||||No||2017-10-10 22:49:41.68322|2017-10-10 22:49:41.68322
NCT02579642|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy|Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy|Enrolling by invitation||Phase 4|44|Anticipated|University of Alberta||2|||f||||t||||||||||2017-10-10 22:49:41.830507|2017-10-10 22:49:41.830507
NCT02579629|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-06-15|||July 2015||2015-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Use of On-Q Pump for Pain Post C-Section|Multimodal Post-Cesarean Analgesia With Spinal Morphine and Continuous Wound Infiltration of Ropivacaine Using the OnQ® Elastomeric Pump: A Dose-Ranging Study Using a High-Volume, Low-Dose Protocol|Enrolling by invitation||Phase 4|60|Anticipated|Emory University||3|||f||||f||||||||Undecided||2017-10-10 22:49:41.945112|2017-10-10 22:49:41.945112
NCT02579616|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-11-08|||October 2015||2015-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer Who Failed Gemcitabine-based Combination Chemotherapy|An Open-Label, Multicenter Phase 2 Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy|Active, not recruiting||Phase 2|26|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-10 22:49:42.099575|2017-10-10 22:49:42.099575
NCT02579603|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-05-16|||October 16, 2015|Actual|2015-10-16|May 2017|2017-05-01|January 31, 2017|Actual|2017-01-31|January 3, 2017|Actual|2017-01-03||Interventional|||Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF|A Twelve Week, Open-label, Randomised, Parallel-group Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Oral Nintedanib in Combination With Oral Pirfenidone, Compared to Treatment With Nintedanib Alone, in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 4|105|Actual|Boehringer Ingelheim||2|||t||||||||||||||2017-10-10 22:49:42.219148|2017-10-10 22:49:42.219148
NCT02579590|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-05-04|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|||The Female Sexual Functions With Progestogen-only Contraception|Evaluation of Female Sexual Functions in Progestogen-only Contraceptive Users|Recruiting||N/A|430|Anticipated|Assiut University|||4||f||||f|f|f||||||Yes||2017-10-10 22:49:42.383556|2017-10-10 22:49:42.383556
NCT02579577|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-02|||October 2015||2015-10-01|May 2016|2016-05-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Observational|||Decision Making and Future Planning for Children With Complex Illness|Decision Making and Future Planning for Children With Complex Illnesses: a Qualitative Multi-stakeholder, Longitudinal Study.|Completed||N/A|32|Actual|University of Nottingham|||1||f||||f||||||||||2017-10-10 22:49:42.486052|2017-10-10 22:49:42.486052
NCT02579564|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-10-20|||October 2016||2016-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients|Systemic Chemotherapy Combined With Thoracic Cavity Perfusion of Recombinant Human Adenovirus Type 5 and Endostatin Injections Versus Cisplatin for Treatment Malignant Hydrothorax in Non Small Cell Lung Cancer (NSCLC) Patients: A Multi-center, Randomized, Controlled Clinical Trial|Not yet recruiting||Phase 3|134|Anticipated|Xinqiao Hospital of Chongqing||2|||f||||f||||||||||2017-10-10 22:49:42.576026|2017-10-10 22:49:42.576026
NCT02579551|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-05-15|||December 7, 2011|Actual|2011-12-07|May 2017|2017-05-01|May 4, 2017|Actual|2017-05-04|February 1, 2014|Actual|2014-02-01||Interventional|||Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery|Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Facial Basal Cell Carcinomas|Completed||N/A|179|Actual|Thomas Jefferson University||1|||f||||f||||||||||2017-10-10 22:49:42.870262|2017-10-10 22:49:42.870262
NCT02579525|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-09-29|||May 2016||2016-05-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|TARTARE-2S||Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock|Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock [TARTARE-2S]- A Multicentre Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Helsinki University Central Hospital||2|||f||||t||||||||||2017-10-10 22:49:43.149075|2017-10-10 22:49:43.149075
NCT02579512|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-10-15|||June 2015||2015-06-01|September 2015|2015-09-01||||May 2016|Anticipated|2016-05-01||Observational|||Non Invasive Extra-corporeal ECG Signal Analysis Algorithm( NID Algorithm) for Myocardial Ischemia|Non Invasive Extra-corporeal ECG Signal Analysis Algorithm( NID Algorithm) for Myocardial Ischemia|Unknown status|Recruiting|N/A|500|Anticipated|Taichung Veterans General Hospital|||1||f||||||||||||||2017-10-10 22:49:43.316284|2017-10-10 22:49:43.316284
NCT02579499|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-16|||October 2015||2015-10-01|October 2015|2015-10-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparing the Intensity-based Statin Therapy With Attained Low-density Lipoprotein Cholesterol Based Statin Therapy in Patients With Coronary Artery Disease: Statin Strategy Proposal Trial||Not yet recruiting||Phase 4|4400|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-10 22:49:43.453192|2017-10-10 22:49:43.453192
NCT02579486|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-12-17|||September 2012||2012-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:49:43.580455|2017-10-10 22:49:43.580455
NCT02579473|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-10-03|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214|A Multi-center, Open-label, Multiple Ascending Dosage-ranging Cohort (MAD) Study in Early, Untreated or Stably Treated Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetics (PK) of Injections of SER-214 Administered Subcutaneously Once a Week for Two Weeks After 0-2 Weeks of Dose Titration|Active, not recruiting||Phase 1|20|Anticipated|Serina Therapeutics||4|||f||||t||||||||||2017-10-10 22:49:43.644902|2017-10-10 22:49:43.644902
NCT02579460|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-02-09|||November 2015||2015-11-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition|Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition|Enrolling by invitation||N/A|53|Anticipated|Dallas VA Medical Center||1|||f||||f||||||||||2017-10-10 22:49:43.783599|2017-10-10 22:49:43.783599
NCT02579434|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-04-15|||December 2014||2014-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Interventional|CYP3A_basal||Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics|Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics|Completed||Phase 1|102|Actual|Seoul National University Hospital||4|||f||||||||||||||2017-10-10 22:49:43.868423|2017-10-10 22:49:43.868423
NCT02579421|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-27|||November 2015||2015-11-01|July 2017|2017-07-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Interventional|||Hormones and Reduction in Co-users of Marijuana and Nicotine|Sex Differences and Progesterone: Association With Impulsivity and Marijuana Reduction in Co-Users of Marijuana and Nicotine Cigarettes|Completed||N/A|100|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 22:49:43.951343|2017-10-10 22:49:43.951343
NCT02579408|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Observational|||Quantifying Steatosis in Liver Transplant Donors|Controlled Attenuation Parameter for the Evaluation of Donor Steatosis in Living Donor Liver Transplantation|Recruiting||N/A|100|Anticipated|The University of Hong Kong|||1||f||||f||||||Samples Without DNA|"     Serum and plasma for storage in anticipation of future biomarkers for the prediction of     improved post-transplant outcomes   "|||2017-10-10 22:49:44.050101|2017-10-10 22:49:44.050101
NCT02579395|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-08-29|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Couples-based Approach for Increasing Physical Activity Among Adults With Type 2 Diabetes|A Couples-based Approach for Increasing Physical Activity Among Adults With Type 2 Diabetes|Recruiting||N/A|90|Anticipated|University of Colorado, Denver||3|||f||||f||||||||||2017-10-10 22:49:44.150467|2017-10-10 22:49:44.150467
NCT02579382|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-08-14|||November 10, 2015|Actual|2015-11-10|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|January 16, 2017|Actual|2017-01-16||Interventional|||A Study of the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of GS-9620 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Subjects With Chronic Hepatitis B and Who Are Currently Not on Treatment|Active, not recruiting||Phase 2|192|Actual|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-10 22:49:44.261106|2017-10-10 22:49:44.261106
NCT02579369|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-01-01|||October 2015||2015-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa|A Phase 1/2 Clinical Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa|Recruiting||Phase 1/Phase 2|5|Anticipated|Anterogen Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:49:44.430174|2017-10-10 22:49:44.430174
NCT02579356|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-15|||May 2014||2014-05-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers|A Randomized, Open-label, Multiple-dose, Crossover Study to Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers|Completed||Phase 1|48|Actual|Samil Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-10 22:49:44.537555|2017-10-10 22:49:44.537555
NCT02579343|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-16|||August 2015||2015-08-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture|Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture|Unknown status|Recruiting|N/A|40|Anticipated|Florida Gulf Coast University||2|||f||||f||||||||||2017-10-10 22:49:44.663893|2017-10-10 22:49:44.663893
NCT02579330|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-15|||December 2015||2015-12-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Trial on Use of Coloshield in Transanal and Anal Surgery|Randomized Controlled Trial on Practicability of Coloshield in Transanal and Anal Surgery|Unknown status|Not yet recruiting|N/A|22|Anticipated|Cantonal Hosptal, Baselland||2|||f||||f||||||||||2017-10-10 22:49:44.763533|2017-10-10 22:49:44.763533
NCT02579317|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-11|||November 2015||2015-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger|Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger|Recruiting||N/A|170|Anticipated|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-10 22:49:44.841351|2017-10-10 22:49:44.841351
NCT02579304|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-12-29|||January 2017||2017-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Diagnostic Value of Transbronchial Lung Cryobiopsy|Feasibility, Safety and Diagnostic Value of Transbronchial Lung Cryobiopsy in the Work-up of Diffuse Interstitial Lung Diseases.|Not yet recruiting||N/A|20|Anticipated|Katholieke Universiteit Leuven|||1||f||||f||||||Samples Without DNA|"     transbronchial lung biopsies   "|||2017-10-10 22:49:44.934697|2017-10-10 22:49:44.934697
NCT02579291|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Dry Needling in Patients Who Had Experience Stroke|Changes in Spasticity, Motor Function and Stabilometry After Dry Needling of the Tibialis Posterior Muscle in Post-stroke Patients|Completed||N/A|30|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-10 22:49:45.003649|2017-10-10 22:49:45.003649
NCT02579278|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-03-08|||November 2015||2015-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|ctDNA||Circulating Tumour DNA (ctDNA) Rectal Cancer and the Relationship to Extramural Venous Invasion|Circulating Tumour DNA (ctDNA) Rectal Cancer and the Relationship to Extramural Venous Invasion (ctDNA Trial)|Recruiting||N/A|40|Anticipated|Royal Marsden NHS Foundation Trust|||2||f||||t||||||Samples Without DNA|"     20 patients with mrEMVI positive and 20 patients with mrEMVI negative tumours, that were both     mrEMVI positive at baseline, are selected for the trial.      Each patient will have two blood samples taken that will be analysed for ctDNA. One blood     sample will be taken at the time of preoperative assessment, after chemoradiotherapy, and a     further sample will be taken intraoperatively, from the peripheral vein of the patient's arm.     For each of the blood samples the presence or absence of ctDNA mutations (kras and p53) will     be identified.   "|||2017-10-10 22:49:45.155311|2017-10-10 22:49:45.155311
NCT02579265|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-07-31|||December 2015||2015-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants|A Prospective, Randomized, Controlled, Double-Blind, Parallel-Group, Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants Requiring 28 Days of Parenteral Nutrition|Recruiting||Phase 3|400|Anticipated|Fresenius Kabi||2|||f||||t||||||||||2017-10-10 22:49:45.259438|2017-10-10 22:49:45.259438
NCT02579252|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ADAMANT||24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease|A 24 Months Randomised, Placebo-controlled, Parallel Group, Double Blinded, Multi Centre, Phase 2 Study to Assess Safety and Efficacy of AADvac1 Applied to Patients With Mild Alzheimer's Disease|Active, not recruiting||Phase 2|208|Actual|Axon Neuroscience SE||2|||f||||t||||||||||2017-10-10 22:49:45.431966|2017-10-10 22:49:45.431966
NCT02579239|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-05-15|||November 5, 2015|Actual|2015-11-05|May 2017|2017-05-01|October 5, 2016|Actual|2016-10-05|October 5, 2016|Actual|2016-10-05||Interventional|FSHD||The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies|An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophies|Completed||Phase 1/Phase 2|18|Actual|aTyr Pharma, Inc.||2|||f||||f||||||||||2017-10-10 22:49:45.830948|2017-10-10 22:49:45.830948
NCT02579226|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-20|||October 28, 2015|Actual|2015-10-28|September 2017|2017-09-01|June 3, 2019|Anticipated|2019-06-03|January 5, 2018|Anticipated|2018-01-05||Interventional|||A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.|A Phase I, Open-Label, Multicentre Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD2811 in Patients With Advanced Solid Tumours.|Recruiting||Phase 1|72|Anticipated|AstraZeneca||4|||f||||f|t|f||||||||2017-10-10 22:49:45.972805|2017-10-10 22:49:45.972805
NCT02579213|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-10-16|||October 2015||2015-10-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Electronic Nose and Fetal Chromosomal Disorders|Examining the Ability of Electronic Nose in Detecting Fetal Chromosomal Disorders|Unknown status|Not yet recruiting|N/A|500|Anticipated|Rambam Health Care Campus|||1||f||||||||||Samples With DNA|"     .33 ml of amniotic fluid are drawn from the uterine cavity, when 30 cc are part of routine     tests and the rest of the amount (3 ml) is intended for research   "|||2017-10-10 22:49:46.120469|2017-10-10 22:49:46.120469
NCT02579200|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-10-14|||November 2015||2015-11-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Inspiratory Muscle Training for Breathless Patients With Chronic Obstructive Pulmonary Disease and Heart Failure|Inspiratory Muscle Training for Dyspneic Patients With COPD-HF Overlap: a Multicenter, Randomized Controlled Trial|Recruiting||Phase 4|50|Anticipated|Queen's University||2|||f||||f||||||||No||2017-10-10 22:49:46.211095|2017-10-10 22:49:46.211095
NCT02579187|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-06-30|||April 2018|Anticipated|2018-04-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||MicroRNA and MicroRNA Inhibitors Socket Study, Pilot Clinical Trial|Efficacy of Local Delivery of MicroRNAs and MicroRNA Inhibitors in Promoting Osteogenesis and Modulating Local Inflammation: A Pilot Clinical Trial Using the Tooth Socket Model|Not yet recruiting||Phase 1|24|Anticipated|University of Iowa||4|||f||||t|t|f|||f|||||2017-10-10 22:49:46.380848|2017-10-10 22:49:46.380848
NCT02579174|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-01-05|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Total Knee Replacement Component Alignment Using Manual Versus Custom Instrumentation|Total Knee Replacement Component Alignment Using Manual Versus Custom Instrumentation|Recruiting||N/A|80|Anticipated|Northwestern University||4|||f||||f||||||||||2017-10-10 22:49:46.596379|2017-10-10 22:49:46.596379
NCT02579148|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-04-07|||September 2015||2015-09-01|October 2015|2015-10-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes|Collagen Scaffolds Loaded With Human Umbilical Cord Mesenchymal Stem Cells for the Improvement of Erectile Function in Men With Diabetes|Withdrawn||Phase 1|0|Actual|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||f||||||||||2017-10-10 22:49:46.893649|2017-10-10 22:49:46.893649
NCT02579135|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2017-09-15|||September 7, 2015|Actual|2015-09-07|September 2017|2017-09-01|April 6, 2017|Actual|2017-04-06|May 4, 2016|Actual|2016-05-04||Interventional|||Reducing HIV Risk Among Adolescents: Evaluating Project HEART|Reducing HIV Risk Among Adolescents: Evaluating Project HEART|Completed||N/A|222|Actual|North Carolina State University||2|||f||||f||||||||||2017-10-10 22:49:47.036591|2017-10-10 22:49:47.036591
NCT02579122|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-08-15|||October 2015||2015-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|REVIBRIDGE||REVIparin-BRIDging-in a General Practice Setting in GErmany|REVIparin-BRIDging-in a General Practice Setting in GErmany (REVIBRIDGE). Non-interventional Study to Evaluate Reviparin for Prevention of Thrombosis and Thromboembolism in General and Orthopedic Surgery (Here: for Perioperative Bridging of Oral Anticoagulation in Interventional Procedures) in General Practices|Terminated||N/A|77|Actual|Mylan Inc.|||1|Poor recruitment|f||||f||||||||||2017-10-10 22:49:47.15382|2017-10-10 22:49:47.15382
NCT02579109|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-16|||February 2014||2014-02-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||Multisensorial Information's Treatment in Autism Spectrum Disorder|Exploring Social Cognition in Autism Spectrum Disorder With Long Time Memory Task. Controlled Study on 8-13 Years Childs|Completed||N/A|38|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 22:49:47.278213|2017-10-10 22:49:47.278213
NCT02579096|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-06-15|||March 6, 2017|Actual|2017-03-06|June 2017|2017-06-01|September 30, 2021|Anticipated|2021-09-30|February 26, 2021|Anticipated|2021-02-26||Interventional|||Gout: Allopurinol vs. Febuxostat|CSP #594 - Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat|Recruiting||Phase 4|950|Anticipated|VA Office of Research and Development||4|||f||||f|t|f|||f|||No||2017-10-10 22:49:47.391335|2017-10-10 22:49:47.391335
NCT02579083|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-09-07|||January 2016||2016-01-01|September 2016|2016-09-01||||April 2017|Anticipated|2017-04-01||Interventional|VAST||Vaginal Antibody Safety Trial: Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV)|A Phase 1, Single Center Study to Assess the Safety of MB66, a Combined Anti-HIV (VRC01-N) and Anti-HSV (HSV8-N) Monoclonal Antibody Film for Vaginal Application as Microbicide|Recruiting||Phase 1|43|Anticipated|LeafBio, Inc.||3|||f||||t||||||||||2017-10-10 22:49:47.599661|2017-10-10 22:49:47.599661
NCT02579070|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-10-12|||March 2016||2016-03-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|DFUPS||Diabetic Foot Ulcer Prevention System (DFUPS) - Part 2|Efficacy and Safety of Diabetic Foot Ulcer Prevention System (DFUPS) - a Single Blind Randomised Clinical Trial in Diabetic Foot Patients at High Risk of Foot Ulceration|Active, not recruiting||N/A|110|Actual|King's College Hospital NHS Trust||2|||f||||f||||||||||2017-10-10 22:49:47.734984|2017-10-10 22:49:47.734984
NCT02579044|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-06-01|||December 2015||2015-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria|Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria|Recruiting||Phase 1/Phase 2|80|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-10 22:49:47.979541|2017-10-10 22:49:47.979541
NCT02579031|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2017-02-15|||April 2016||2016-04-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|May 2018|Anticipated|2018-05-01||Interventional|BIOSTEMI||A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Recruiting||N/A|1250|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 22:49:48.119686|2017-10-10 22:49:48.119686
NCT02579018|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-12-30|||March 2016||2016-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Heart Rate Sensing and Response in Persons With Anorexia Nervosa|Heart Rate Sensing and Response in Persons With Anorexia Nervosa|Completed||N/A|18|Actual|Duke University||3|||f||||||||||||||2017-10-10 22:49:48.286479|2017-10-10 22:49:48.286479
NCT02579005|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-08-30|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Interventional|RIM||Radio-Immuno-Modulation in Lung Cancer|Radio-Immuno-Modulation for Advanced Lung Cancer: a Pilot Study Evaluating Tolerance and Immune Responses|Not yet recruiting||Phase 1|24|Anticipated|Hopital du Sacre-Coeur de Montreal||2|||f||||t|f|f|||f|||||2017-10-10 22:49:48.36787|2017-10-10 22:49:48.36787
NCT02578992|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-10-17|2016-05-12||December 2014||2014-12-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||age from 20-80|"Neutral Head Position and Head-lift Position for Orotracheal Intubation With Trachway Intubating Stylet in Adults"|"Neutral Head Position and Head-lift Position for Orotrachwal Intubation With Trachway Intubating Stylet in Adults"|Completed||N/A|130|Actual|Tri-Service General Hospital|Tracheal intubation with Trachway was performed by an novice anesthesiologist.|2|||f||||f||||||||||2017-10-10 22:49:48.46774|2017-10-10 22:49:48.46774
NCT02578979|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-15|||August 2015||2015-08-01|October 2015|2015-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Serial ECG Versus Holter to Detect Atrial Fibrillation in Elderly Ischemic Stroke Patients|Serial Electrocardiogram Versus Holter to Detect Atrial Fibrillation in Elderly Patients With Acute Ischemic Stroke: Study Protocol of a Randomized Controlled Trial|Recruiting||N/A|600|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 22:49:48.855968|2017-10-10 22:49:48.855968
NCT02578953|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-05-05|||September 9, 2015|Actual|2015-09-09|May 2017|2017-05-01|December 15, 2015|Actual|2015-12-15|December 15, 2015|Actual|2015-12-15||Interventional|||Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects|Bioequivalence Study of Dutasteride Capsules-An Evaluation of the Bioequivalence of Dutasteride Capsule Manufactured at GSK Compared to Dutasteride Capsule Manufactured at Catalent in Healthy Japanese Male Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 22:49:49.108983|2017-10-10 22:49:49.108983
NCT02578940|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-07-03|||November 2015||2015-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Interventional|FALCON||Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer|A Phase 3, Open-label Study to Assess the Clinical Utility of Fluciclovine (18F) PET/CT in Patients With Prostate Cancer With Biochemical Recurrence After Radical Treatment|Active, not recruiting||Phase 3|180|Anticipated|Blue Earth Diagnostics||1|||f||||f||||||||||2017-10-10 22:49:49.267403|2017-10-10 22:49:49.267403
NCT02578927|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-10-16|||January 2013||2013-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Green Tea Attenuates Pressure Reduction Induced by a Session of Physical Exercise|Green Tea Attenuates Pressure Reduction Induced by a Session of Physical Exercise|Completed||N/A|15|Actual|Federal University of Paraíba||3|||f||||t||||||||||2017-10-10 22:49:49.390947|2017-10-10 22:49:49.390947
NCT02578914|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-05-25|||August 2015||2015-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis|A Randomized, Parallel, Single-Center, Double-Masked, Vehicle-Controlled Phase II Study to Evaluate the Activity of NS2 Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Provocation Test (CAPT)|Completed||Phase 2|100|Actual|Aldeyra Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:49:49.476923|2017-10-10 22:49:49.476923
NCT02578901|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-09-21|||June 2016||2016-06-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|A-TREAT||American Trial Using Tranexamic Acid in Thrombocytopenia|American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)|Active, not recruiting||Phase 3|360|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-10 22:49:49.589998|2017-10-10 22:49:49.589998
NCT02578888|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-15|||April 2015||2015-04-01|October 2015|2015-10-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies|Early Palliative Medicine Intervention Using Idiographic Assessment for Women With High Risk Gynecologic Malignancies|Recruiting||N/A|180|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-10 22:49:49.877171|2017-10-10 22:49:49.877171
NCT02578875|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-09-12|||October 1, 2015||2015-10-01|August 30, 2017|2017-08-30|January 1, 2030|Anticipated|2030-01-01|October 1, 2020|Anticipated|2020-10-01||Observational|||Evaluation of MiSeq for Microbial Identification in Specimens|Evaluation of MiSeq for Microbial Identification in Specimens|Enrolling by invitation||N/A|57|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:49:50.031531|2017-10-10 22:49:50.031531
NCT02578862|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-28|||July 2015|Actual|2015-07-01|September 2017|2017-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||Total Intravenous Anesthesia in Sinus Surgery|Total Intravenous Versus Inhaled Anesthesia in Endoscopic Sinus Surgery for Advanced Paranasal Disease|Recruiting||Phase 4|110|Anticipated|Ochsner Health System||2|||f||||t||||||||||2017-10-10 22:49:50.142189|2017-10-10 22:49:50.142189
NCT02578849|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-15|||January 2012||2012-01-01|October 2015|2015-10-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|NORAPARK||Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia|Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia and Healthy Age Matched Controls; [11C]Yohimbine and [11C]MeNER PET|Unknown status|Recruiting|N/A|45|Anticipated|Aarhus University Hospital|||3||f||||t||||||||||2017-10-10 22:49:50.288115|2017-10-10 22:49:50.288115
NCT02578836|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-08-29|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||Transoral Gastric Volume Reduction as an Intervention for Weight Management|Transoral Gastric Volume Reduction as an Intervention for Weight Management|Withdrawn||N/A|0|Actual|University of Miami||1||Study was withdrawn due to PI decision|f||||f|f|f||||||||2017-10-10 22:49:50.451693|2017-10-10 22:49:50.451693
NCT02578823|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-06-28|||January 2016||2016-01-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|TTM36-IHCA||Targeted Temperature Management After In-Hospital Cardiac Arrest|Targeted Temperature Management at 36℃ After In-Hospital Cardiac Arrest Trial(TTM36-IHCA Trial): An Investigator-Initiated, Single-Center, Randomized, Controlled, Assessor-Blinded, Pilot Clinical Trial|Recruiting||N/A|60|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-10 22:49:50.587262|2017-10-10 22:49:50.587262
NCT02578810|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-08-30|||October 2016||2016-10-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|BIS2||PIERS and BIS, sFIT:PIGF, Adrenomedullin|Sensitivity and Specificity of Bispectral Index (BIS) EEG Parameter, sFIT (Soluble FMS Tyrosine Kinase): PIGF (Placental Growth Factor) Ratio, Adrenomedullin for Grading Preeclampsia Integrated Estimate Risk Score (PIERS)|Recruiting||N/A|48|Anticipated|Medical University of Graz|||2||f||||f||||||||||2017-10-10 22:49:50.728063|2017-10-10 22:49:50.728063
NCT02578797|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-05-26|||December 18, 2015|Actual|2015-12-18|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|September 20, 2016|Actual|2016-09-20||Interventional|||A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study|An Open-Label Phase 1b QT/QTc Study of JNJ-56021927 (ARN-509) in Subjects With Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1|45|Actual|Aragon Pharmaceuticals, Inc.||1|||f||||f||f||||||||2017-10-10 22:49:50.834833|2017-10-10 22:49:50.834833
NCT02578784|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-16|||October 2015||2015-10-01|October 2015|2015-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|DEB-after-CB||DEB-after-Cutting Balloon-PTA in Dialysis Fistula Stenosis|Prospective, Randomized Trial on the Clinical Utility of Drug-coated Balloons After Angioplasty of Plain Old Balloon-resistent Dialysis Fistula Stenosis Using Cutting Ballons|Recruiting||N/A|40|Anticipated|Cantonal Hospital of St. Gallen||2|||f||||f||||||||||2017-10-10 22:49:50.980228|2017-10-10 22:49:50.980228
NCT02578771|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-07-13||2017-07-12|October 2015||2015-10-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle|Pilot Clinical Evaluation to Characterize the in Vivo Effects of Topically Applied ZuraPrep and ZuraPrep Vehicle|Completed||Phase 3|123|Actual|Zurex Pharma, Inc.||4|||f||||f||||||||||2017-10-10 22:49:51.10671|2017-10-10 22:49:51.10671
NCT02578758|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-05-30|||September 2014||2014-09-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of a Transdiagnostic Internet-based Protocol in Community Sample|The Differential Efficacy of a Specific Positive Psychology Components in a Transdiagnostic Internet-based Protocol for the Treatment of Emotional Disorders|Recruiting||N/A|252|Anticipated|Universitat Jaume I||3|||f||||t||||||||||2017-10-10 22:49:51.240154|2017-10-10 22:49:51.240154
NCT02578745|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-06-02|||October 2015||2015-10-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PICO-C||Prophylactic Incisional Care in Obese Women at Cesarean|Prophylactic Negative Pressure Wound Therapy in Obese Women After Cesarean: a Pilot Randomized Trial|Completed||N/A|120|Actual|Washington University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:49:51.389207|2017-10-10 22:49:51.389207
NCT02578732|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-07-11|||June 2016||2016-06-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial|BrUOG 318: FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial|Recruiting||Phase 2|60|Anticipated|Brown University||1|||f||||t||||||||||2017-10-10 22:49:51.543235|2017-10-10 22:49:51.543235
NCT02578719|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|GON||Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up|Placebo-Controlled Randomized Double Blind Trial of Blocking Greater Occipital Nerve Block With Bupivacaine Versus Saline in the Treatment of Chronic Migraine|Not yet recruiting||Phase 4|250|Anticipated|Bozok University||2|||f||||t||||||||||2017-10-10 22:49:51.667904|2017-10-10 22:49:51.667904
NCT02578706|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-08-28|||October 2015||2015-10-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Targeting Platelets in Chronic HIV Infection|Targeting Platelets in Chronic HIV Infection|Completed||Phase 2|41|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||t|t|f||||||||2017-10-10 22:49:51.811006|2017-10-10 22:49:51.811006
NCT02578693|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-16|2016-09-21|||May 2015||2015-05-01|September 2016|2016-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)|Long Term Follow-up for Subjects With Chronic Hepatitis C Infection Who Received Interferon-based Therapy or Direct-acting Antiviral Agents (DAAs)-Based Therapy|Recruiting||N/A|1500|Anticipated|Humanity and Health Research Centre|||1||f||||t||||||Samples Without DNA|"     Serum/Plasma   "|||2017-10-10 22:49:51.987269|2017-10-10 22:49:51.987269
NCT02578680|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-06-05|||January 15, 2016|Actual|2016-01-15|June 2017|2017-06-01|April 26, 2019|Anticipated|2019-04-26|September 11, 2017|Anticipated|2017-09-11||Interventional|||Study of Platinum+Pemetrexed Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Non-squamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)|A Randomized, Double-Blind, Phase III Study of Platinum+ Pemetrexed Chemotherapy With or Without Pembrolizumab (MK-3475) in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects (KEYNOTE-189)|Active, not recruiting||Phase 3|570|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 22:49:52.131836|2017-10-10 22:49:52.131836
NCT02578667|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-05-13|||December 2015||2015-12-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Gorbly Compression Device for Use in Image-guided Procedures|Gorbly Compression Device for Use in Image-guided Procedures|Withdrawn||N/A|0|Actual|University of Miami||2||study cancelled|f||||f||||||||||2017-10-10 22:49:52.44426|2017-10-10 22:49:52.44426
NCT02578654|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-04-22|||November 2012||2012-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Interventions to Improve HIV Care Engagement After Hospital Discharge|Interventions to Improve HIV Care Engagement Within 30 Days After Hospital Discharge Among HIV-infected Patients|Completed||N/A|240|Actual|Thammasat University||1|||f||||f||||||||||2017-10-10 22:49:52.559707|2017-10-10 22:49:52.559707
NCT02578641|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-10-04|||July 2014||2014-07-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Multicentre, Randomized, Open-Label, Phase III Clinical Trial for Advanced Nasopharyngeal Carcinoma Patients|A Multicentre, Randomized, Open-Label, Phase III Clinical Trial Of Gemcitabine And Carboplatin Followed By Epstein-Barr Virus-Specific Autologous Cytotoxic T Lymphocytes Versus Gemcitabine And Carboplatin As First Line Treatment For Advanced Nasopharyngeal Carcinoma Patients|Recruiting||Phase 3|330|Anticipated|Tessa Therapeutics||2|||f||||t||||||||||2017-10-10 22:49:52.654833|2017-10-10 22:49:52.654833
NCT02578628|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2016-10-30|||October 2015||2015-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Discontinuation of Automated Engagement Support|Discontinuation of Automated Engagement Support|Enrolling by invitation||N/A|1700|Anticipated|University of Vermont||2|||f||||f||||||||||2017-10-10 22:49:52.907128|2017-10-10 22:49:52.907128
NCT02578615|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-15|||December 2013||2013-12-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Physiotherapy for Chronic Metatarsalgia|Physiotherapie Bei Chronischer Metatarsalgie - Ein Vergleich Klinischer Parameter Vor Und Nach Therapie gemäß Spiraldynamik®- Konzept|Completed||N/A|28|Actual|Spiraldynamik AG|||1||f||||f||||||||||2017-10-10 22:49:52.996388|2017-10-10 22:49:52.996388
NCT02578602|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2015-10-14|||October 2010||2010-10-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|November 2014|Actual|2014-11-01||Interventional|||MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer|MR Techniques in the Evaluation of Hepatocellular Carcinoma: Gadoxetate|Completed||Phase 1|26|Actual|University of Southern California||1|||f||||f||||||||||2017-10-10 22:49:53.075914|2017-10-10 22:49:53.075914
NCT02578550|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-03-31|||November 2015||2015-11-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy Participants|A Single-Dose, Open-Label, Randomized, Crossover Study to Assess the Bioequivalence of Darunavir 800 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 10 mg, in the Presence of Cobicistat 150 mg, Administered as Either a Fixed-Dose Combination Tablet or as Separate Agents in Healthy Subjects|Completed||Phase 1|126|Actual|Janssen Sciences Ireland UC||2|||f||||f||||||||||2017-10-10 22:49:53.557514|2017-10-10 22:49:53.557514
NCT02578524|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-22|||January 2015||2015-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Satisfaction With Multifocal vs Accommodating Lens Implants 2 Years After Surgery|Satisfaction With Multifocal vs Accommodating Lens Implants 2 Years After Surgery|Completed||N/A|117|Actual|MDbackline, LLC|||2||f||||f||||||||||2017-10-10 22:49:53.958138|2017-10-10 22:49:53.958138
NCT02578511|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-03|||June 29, 2017|Actual|2017-06-29|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)|Standard Maintenance [POMP/D (Methotrexate, 6 - Mercaptopurine, Vincristine, Prednisone/Dexamethasone)] Plus Ixazomib Maintenance Therapy in Adults With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)|Recruiting||Phase 1|18|Anticipated|Medical College of Wisconsin||1|||||||t|t|f||||||||2017-10-10 22:49:54.073363|2017-10-10 22:49:54.073363
NCT02578498|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-08-15|||October 2015||2015-10-01|October 2015|2015-10-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|HiLoCarb||Glucagon Efficiency After High and Low Carbohydrate Diet|Glucagon Efficiency After High and Low Carbohydrate Diet|Completed||Phase 4|10|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-10 22:49:54.214108|2017-10-10 22:49:54.214108
NCT02578485|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-10-15|||July 2013||2013-07-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Single Session of Active Video Game Promotes Post Exercise Hypotension in Middle-aged Hypertensive|Single Session of Active Video Game Promotes Post Exercise Hypotension in Middle-aged Hypertensive|Completed||N/A|15|Actual|Federal University of Paraíba||5|||f||||f||||||||||2017-10-10 22:49:54.348213|2017-10-10 22:49:54.348213
NCT02578472|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-03-23|||November 2015||2015-11-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants|A Double-blind, Randomized, Controlled, 3-way Crossover, Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Subjects|Completed||Phase 1|36|Actual|Janssen-Cilag International NV||6|||f||||f||||||||||2017-10-10 22:49:54.462144|2017-10-10 22:49:54.462144
NCT02578459|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-03-30|||April 2016||2016-04-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|December 2016|Anticipated|2016-12-01||Interventional|||A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain|A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain|Recruiting||N/A|30|Anticipated|Flowonix Medical||2|||f||||f||||||||Undecided||2017-10-10 22:49:54.650065|2017-10-10 22:49:54.650065
NCT02578446|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-07-05|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|March 2026|Anticipated|2026-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Uncemented Tritanium Compared With Cemented Metal-backed Tibia Components in Total Knee Replacement|Migration and Survival of the Uncemented Tritanium Tibia Compared With the Cemented Metal-backed Tibia Using the Triathlon Cruciate Retaining (CR) Total Knee System. A Single Centre RSA Study|Active, not recruiting||N/A|72|Actual|Region Skane||2|||f||||f||||||||||2017-10-10 22:49:54.83932|2017-10-10 22:49:54.83932
NCT02578433|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-01-09|||December 2015||2015-12-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Mindful Self Compassion in Rehabilitation Inpatients|Mindful Self Compassion in Rehabilitation Inpatients: a Randomized Controlled Trial|Completed||N/A|200|Actual|Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin||2|||f||||f||||||||No||2017-10-10 22:49:54.973263|2017-10-10 22:49:54.973263
NCT02578420|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-07-25|||January 2016||2016-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|July 2016|Actual|2016-07-01||Interventional|||Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo|Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo|Completed||N/A|160|Actual|University Hospital, Basel, Switzerland||4|||f||||f||||||||||2017-10-10 22:49:55.096505|2017-10-10 22:49:55.096505
NCT02578407|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-10-14|||September 2015||2015-09-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|ACC||Pilot Study of Accommodative/Vergence Therapy to Modify Accommodative Function in Children With Myopia|Pilot Study of Accommodative/Vergence Therapy to Modify Accommodative Function in Children With Myopia|Unknown status|Recruiting|N/A|30|Anticipated|Sun Yat-sen University||1|||f||||f||||||||||2017-10-10 22:49:55.463114|2017-10-10 22:49:55.463114
NCT02578394|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-04-08|||April 2016||2016-04-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|ASGARD||Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study|A Feasibility Study to Undertake a Definitive Randomised Multi-centre, Double-blind, Double-dummy Controlled Study of a Novel Agent Anakinra vs. Depo-Medrone for Acute Gout Attacks in Patients With Moderate Chronic Kidney Disease|Recruiting||Phase 2/Phase 3|32|Anticipated|Southend University Hospital Foundation NHS Trust||2|||f||||f||||||||No||2017-10-10 22:49:55.580559|2017-10-10 22:49:55.580559
NCT02578368|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-04-06|||February 2016||2016-02-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|FLOT5||Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction|Effect of Chemotherapy Alone vs. Chemotherapy Followed by Surgical Resection on Survival and Quality of Life in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction - A Phase III Trial of Arbeitsgemeinschaft Internistische Onkologie/Chirurgische Arbeitsgemeinschaft Onkologie/Chirurgische Arbeitsgemeinschaft für Den Oberen Gastrointestinaltrakt (AIO/CAO-V/CAOGI)|Recruiting||Phase 3|271|Anticipated|Krankenhaus Nordwest||2|||f||||t||||||||Undecided||2017-10-10 22:49:55.877481|2017-10-10 22:49:55.877481
NCT02578355|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-04-24|||September 2016||2016-09-01|April 2017|2017-04-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|5 Years|Observational [Patient Registry]|OPeRA||National Plaque Registry and Database|National Plaque Registry and Database|Not yet recruiting||N/A|20000|Anticipated|Semmelweis University Heart and Vascular Center|||1||f||||f||||||||||2017-10-10 22:49:56.063221|2017-10-10 22:49:56.063221
NCT02578342|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-10-15|||August 2015||2015-08-01|October 2015|2015-10-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Brain Activity in Adults With ADHD During Neuropsychological Tasks|Brain Activity and Functional Connectivity in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) During Tasks of Motor Inhibition and Cognitive Switching|Unknown status|Recruiting|N/A|45|Anticipated|Kantonsspital Aarau|||3||f||||t||||||||||2017-10-10 22:49:56.215994|2017-10-10 22:49:56.215994
NCT02578329|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-06-06|||July 2015||2015-07-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|RISMED||An Intervention Study to Assess the Effect of the Mediterranean Diet on the Plasma Fatty Acid Profile|A Randomized Intervention Study to Assess the Effect of the Mediterranean Diet on the Plasma Fatty Acid Profile|Recruiting||N/A|150|Anticipated|Centro Cardiologico Monzino||2|||f||||f||||||||||2017-10-10 22:49:56.32426|2017-10-10 22:49:56.32426
NCT02578316|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-04-05|2017-02-07||June 2009||2009-06-01|April 2017|2017-04-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional||Safety analysis set included all participants who received at least a partial dose of study drug and had at least one postdose safety assessment.|A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies.|An Open-Label, Non-Randomized, Single-Center Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies.|Completed||Phase 1|6|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-10 22:49:56.485012|2017-10-10 22:49:56.485012
NCT02578303|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-07-27|||May 2015||2015-05-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|VAAPS||Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations|Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations|Recruiting||N/A|139|Anticipated|Central Hospital Saint Quentin||2|||f||||f||||||||||2017-10-10 22:49:57.010326|2017-10-10 22:49:57.010326
NCT02578290|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-01-23|||October 2015||2015-10-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Clinical Decision Support (CDS) for Outpatient Radiology Imaging|The Impact of Clinical Decision Support (CDS) for Outpatient Radiology Imaging: A Randomized Control Trial|Terminated||N/A|2033|Actual|Abdul Latif Jameel Poverty Action Lab||2||"Due to an error in the implementation of the project, CDS was provided to all providers, rather   than to the intended random sample of providers."|f||||f||||||||||2017-10-10 22:49:57.128147|2017-10-10 22:49:57.128147
NCT02578277|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-04-29|||November 2015||2015-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates|Effects of BMS-955176 on the Single-dose Pharmacokinetics of Probe Substrates (Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin) in Healthy Subjects|Completed||Phase 1|20|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 22:49:57.237452|2017-10-10 22:49:57.237452
NCT02578264|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-05|||June 2015||2015-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|February 2017|Actual|2017-02-01||Observational|||Molecular Stethoscope|Molecular Stethoscope for Colon Cancer Detection|Active, not recruiting||N/A|26|Actual|Scripps Translational Science Institute|||1||f||||f||||||||||2017-10-10 22:49:57.321811|2017-10-10 22:49:57.321811
NCT02578251|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-15|||October 2015||2015-10-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Paracetamol for Intrapartum Analgesia|Efficacy of Intravenous Paracetamol as an Analgesic During the First Stage of Labor: A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 2|104|Anticipated|Ain Shams Maternity Hospital||2|||f||||||||||||||2017-10-10 22:49:57.406152|2017-10-10 22:49:57.406152
NCT02578238|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-06-01|||September 24, 2015||2015-09-24|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|||"Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the New-Drug Re-examination"|"Post-Marketing Surveillance of Humira in Korean Pediatric CD Patients Under the New-Drug Re-examination"|Completed||N/A|147|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 22:49:57.502805|2017-10-10 22:49:57.502805
NCT02578212|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-04-07|||January 2015||2015-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Trust Game and Placebo Response|Trust Game and Placebo Response|Completed||N/A|106|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 22:49:57.769701|2017-10-10 22:49:57.769701
NCT02578199|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-08-07|2017-06-13||December 2015||2015-12-01|November 2016|2016-11-01|March 10, 2017|Actual|2017-03-10|December 2, 2016|Actual|2016-12-02||Interventional|||Novel and Scalable Internet Supplemented Weight Loss Treatment in Primary Care|Novel and Scalable Internet Supplemented Weight Loss Treatment in Primary Care|Completed||N/A|31|Actual|Yale University||1|||f||||t||||||||||2017-10-10 22:49:57.854106|2017-10-10 22:49:57.854106
NCT02578186|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-01-25|2016-08-30||November 2013||2013-11-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluation of Diphenhydramine Hydrochloride Effects in Subjects With Occasional Sleeplessness|Randomized, Double-Blind, Placebo-Controlled, Crossover, In-home Study to Assess the Efficacy of Diphenhydramine Hydrochloride in Subjects With Occasional Sleeplessness|Completed||Phase 4|33|Actual|Procter and Gamble||2|||f||||f||||||||||2017-10-10 22:49:58.063993|2017-10-10 22:49:58.063993
NCT02578173|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2016-06-19|||October 2015||2015-10-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS 2.0|Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS 2.0|Completed||N/A|20|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||f||||||||||2017-10-10 22:49:58.338741|2017-10-10 22:49:58.338741
NCT02578160|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-10-22|||November 2015||2015-11-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy of Tell-Show-Do Behavior-Management Technique During Local Anesthesia in Preschool Children|Efficacy of Tell-Show-Do Behavior-Management Technique in Anxiety, Pain and Behavior Levels During an Inferior Alveolar and Lingual Nerve Block Procedure in Preschool Children: A Randomized Clinical Trial|Active, not recruiting||N/A|52|Actual|University of Sao Paulo||2|||f||||f||||||||Yes|July 2016|2017-10-10 22:49:58.408551|2017-10-10 22:49:58.408551
NCT02578147|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-19|||September 2015||2015-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||JUEGA: A Fun Study for Hispanic/Latino Adolescent Girls|JUEGA: A Fun Study for Hispanic/Latino Adolescent Girls|Recruiting||N/A|1200|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 22:49:58.505974|2017-10-10 22:49:58.505974
NCT02578134|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-03-14|||October 2015||2015-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||US-guided Percutaneous Electrolysis (EPE®) in Plantar Fasciosis|Effectiveness of US-guided Percutaneous Electrolysis (EPE®) Versus Placebo in Individuals With Plantar Fasciosis|Withdrawn||N/A|0|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-10 22:49:58.624174|2017-10-10 22:49:58.624174
NCT02578121|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-01-20|||December 2015||2015-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination|A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Patients|Withdrawn||Phase 2|0|Actual|University of Arkansas||1||Investigator decided to close study without enrollment|f||||t||||||||||2017-10-10 22:49:58.688231|2017-10-10 22:49:58.688231
NCT02578108|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-12|||October 2015||2015-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|September 1, 2017|Actual|2017-09-01||Interventional|||Diagnostic Genicular Nerve Block Prior to Radiofrequency Ablation for Knee Osteoarthritis Pain|A Prospective Trial of Zero Versus One Diagnostic Genicular Nerve Blocks to Determine Clinical Outcomes After Radiofrequency Ablation for the Treatment of Chronic Painful Knee Osteoarthritis|Active, not recruiting||N/A|60|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 22:49:58.767721|2017-10-10 22:49:58.767721
NCT02578095|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-08-09|||October 2015||2015-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Acute Hip Fracture Study in Patients 65 Years or Greater|A Phase II, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Multi-Center Study to Explore the Efficacy, Safety and Tolerability of VK5211 in Subjects With Acute Hip Fracture|Active, not recruiting||Phase 2|108|Actual|Viking Therapeutics, Inc.||4|||f||||t||||||||||2017-10-10 22:49:58.868257|2017-10-10 22:49:58.868257
NCT02578082|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-07-29|||December 2015||2015-12-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment|The Effect of Severe Renal Impairment on the Pharmacokinetics Following Single-Dose Inhaled Administration of TD 4208|Completed||Phase 1/Phase 2|16|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||No||2017-10-10 22:49:58.996299|2017-10-10 22:49:58.996299
NCT02578069|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-14|||August 2015||2015-08-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent|A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Efficacy of the NOVA Sirolimus Eluting Stent Versus the Apollo Stent|Unknown status|Active, not recruiting|Phase 2/Phase 3|264|Anticipated|Sino Medical Sciences Technology Inc.||2|||f||||t||||||||||2017-10-10 22:49:59.082143|2017-10-10 22:49:59.082143
NCT02578056|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-15|||February 2014||2014-02-01|October 2015|2015-10-01|September 2024|Anticipated|2024-09-01|July 2020|Anticipated|2020-07-01||Interventional|||Advanced Genital Prolapse Surgery With and Without Mid Urethral Sling to Prevent Stress Urinary Incontinence|Advanced Genital Prolapse Surgery With and Without Mid Urethral Sling to Prevent Stress Urinary Incontinence. A Multicenter, Randomized, Double-blind, Controlled Study|Enrolling by invitation||N/A|374|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 22:49:59.164222|2017-10-10 22:49:59.164222
NCT02578043|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-05-04|||April 2015||2015-04-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris|A Multi Center Double Blind Randomized Placebo Controlled Parallel Group Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris|Completed||Phase 1|844|Actual|Taro Pharmaceuticals USA||3|||f||||f|f|f|||f|||No||2017-10-10 22:49:59.269323|2017-10-10 22:49:59.269323
NCT02578030|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-10-20|||October 2015||2015-10-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD|A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 1|27|Actual|Shire||2|||f||||f||||||||No||2017-10-10 22:49:59.347146|2017-10-10 22:49:59.347146
NCT02578017|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-11-08|||July 2014||2014-07-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ENHANCE||ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease|ENHANCE Study (ElectroNic Hydroxyurea AdhereNCE): A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease|Recruiting||N/A|72|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-10 22:50:01.243903|2017-10-10 22:50:01.243903
NCT02577991|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-12-19|||February 2014||2014-02-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Local Steroid Application on a Cervical Plate Versus Intravenous Steroids on Dysphagia Following Anterior Cervical Discectomy and Fusion (ACDF)|A Prospective, Randomized Controlled Trial on the Effect of Local Steroid Application on a Cervical Plate Versus Intravenous Steroids on Dysphagia Following Anterior Cervical Discectomy and Fusion (ACDF)|Active, not recruiting||N/A|75|Actual|Northwestern University||3|||f||||f||||||||||2017-10-10 22:50:01.452466|2017-10-10 22:50:01.452466
NCT02577978|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-12|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Stability of the Medial Pivot Total Knee Prosthesis|Stability of the Medial Pivot Total Knee Prosthesis|Completed||N/A|50|Actual|Northwestern University||2|||f||||f||||||||||2017-10-10 22:50:01.552081|2017-10-10 22:50:01.552081
NCT02577965|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-10-14|||March 2011||2011-03-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|June 2012|Actual|2012-06-01||Interventional|OCTAVIA||Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial|Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial|Completed||Phase 4|140|Actual|A.O. Ospedale Papa Giovanni XXIII||2|||f||||t||||||||||2017-10-10 22:50:01.637082|2017-10-10 22:50:01.637082
NCT02577952|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-11-07|||January 2014||2014-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||Lipodystrophy Connect Patient Registry|Lipodystrophy Connect Patient Registry|Recruiting||N/A|300|Anticipated|PatientCrossroads|||1||f||||f||||||||No|De-identified aggregate participant data is shared via a professional portal.|2017-10-10 22:50:01.737102|2017-10-10 22:50:01.737102
NCT02577939|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-10-13|||June 2013||2013-06-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of Cardiorespiratory Performance After Interval Exercise Training Prior to Hematopoietic Cell Transplantation|Evaluation of Cardiorespiratory Performance After Interval Exercise Training (IET) Prior to Hematopoietic Cell Transplantation|Completed||N/A|40|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:50:01.836266|2017-10-10 22:50:01.836266
NCT02577926|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-05-18|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|Ruxo-BEAT||The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia|Ruxolitinib Versus Best Available Therapy in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia - The Ruxo-BEAT Trial|Recruiting||Phase 3|380|Anticipated|RWTH Aachen University||2|||f||||t||||||||No||2017-10-10 22:50:01.972582|2017-10-10 22:50:01.972582
NCT02577913|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2017-05-18|||November 2015||2015-11-01|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|November 2021|Anticipated|2021-11-01||Observational|EURAS-CORA||European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception|European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception|Suspended||N/A|101000|Anticipated|Center for Epidemiology and Health Research, Germany|||2|Product temporarily not available on market|f||||t||||||||||2017-10-10 22:50:02.354171|2017-10-10 22:50:02.354171
NCT02577900|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2015-10-15|||February 2013||2013-02-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|DFU||Diabetic Foot Ulcer Study on Topical Interventions|Randomized, Controlled Study of Nanocrystalline Silver, Manuka Honey and Conventional Dressing in Healing Diabetic Foot Ulcer|Completed||Phase 4|31|Actual|Queen Elizabeth Hospital, Hong Kong||3|||f||||f||||||||||2017-10-10 22:50:02.472073|2017-10-10 22:50:02.472073
NCT02577887|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-05-18|||July 2015||2015-07-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01|1 Year|Observational [Patient Registry]|BRADYCARE II||Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II|Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II|Recruiting||N/A|2016|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-10 22:50:02.594458|2017-10-10 22:50:02.594458
NCT02577874|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-10-15|||June 2015||2015-06-01|October 2015|2015-10-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Observational|||A Comparison of European and Chinese Blood Sugar Responses|A Comparison of European and Chinese Blood Sugar Responses|Unknown status|Recruiting|N/A|100|Anticipated|Small Changes|||2||f||||t||||||||||2017-10-10 22:50:02.743835|2017-10-10 22:50:02.743835
NCT02577861|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2016-09-29|||October 2015||2015-10-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|HOLOCORE||Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency|Multinational, Multicentre, Prospective, Open-label, Uncontrolled Clinical Trial to Assess the Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency Due to Ocular Burns (HOLOCORE)|Recruiting||Phase 4|70|Anticipated|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-10 22:50:02.865158|2017-10-10 22:50:02.865158
NCT02577848|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-15|2015-10-16|||October 2015||2015-10-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||GLP-1 on Non-ST-Segment Elevation Myocardial Infarction|Effects of Liraglutide on Left Ventricular Function in Patients With Non-ST-Segment Elevation Myocardial Infarction|Unknown status|Recruiting|N/A|90|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 22:50:03.047897|2017-10-10 22:50:03.047897
NCT02577835|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-12-23|||November 2015||2015-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|VASOTENS||International Registry for Ambulatory Blood Pressure and Arterial Stiffness Telemonitoring|International Registry for Ambulatory Blood Pressure and Arterial Stiffness Telemonitoring|Recruiting||N/A|2000|Anticipated|Italian Institute of Telemedicine|||1||f||||f||||||||Undecided||2017-10-10 22:50:03.227779|2017-10-10 22:50:03.227779
NCT02577822|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-12|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||The Viability of Short Stems in Total Hip Arthroplasty|The Viability of Short Stems in Total Hip Arthroplasty|Completed||N/A|59|Actual|Northwestern University||2|||f||||f||||||||||2017-10-10 22:50:03.503339|2017-10-10 22:50:03.503339
NCT02577809|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-10-14|||July 2015||2015-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Intrathecal Opioid Study|An Investigation of the Influence of Different Intrathecal Opioids on the Post-operative Pain Experiences of Woman at Rahima Moosa Mother and Child Hospital|Completed||Phase 4|100|Actual|University of Witwatersrand, South Africa||3|||f||||f||||||||||2017-10-10 22:50:03.60664|2017-10-10 22:50:03.60664
NCT02577796|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-15|||December 2014||2014-12-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|30 Days|Observational [Patient Registry]|||Radial Artery Spasm Leading to Occlusion in Patients Undergoing Coronary Angiogram Via Radial Access|Association of Radial Artery Spasm With Development of Radial Arterial Occlusion in Patients Undergoing Diagnostic Angiogram and/or Percutaneous Coronary Intervention (PCI) Via Radial Access|Unknown status|Recruiting|N/A|800|Anticipated|Maimonides Medical Center|||1||f||||t||||||||||2017-10-10 22:50:03.748072|2017-10-10 22:50:03.748072
NCT02577783|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-14|||October 2015||2015-10-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||PDD vs PAD to Treat Initially Diagnosed MM|Doxorubicin Hydrochloride Liposome vs Doxorubicin Combined With Bortizomib and Dexamethasone to Treat Initially Diagnosed Multiple Myeloma: A Randomized Prospective Clinical Study|Recruiting||Phase 4|64|Anticipated|The First Affiliated Hospital of Soochow University||2|||f||||f||||||||||2017-10-10 22:50:03.850906|2017-10-10 22:50:03.850906
NCT02577770|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-12|2016-05-10|||May 2015||2015-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of Caffeine on Acupuncture Analgesia With the Human Pain Model|A Single Center, Double Blind, Randomized, Parallel-group Study to Assess the Effect of 200mg Caffeine,400mg Caffeine and Decaffeinated on Acupuncture Analgesia With the Human Pain Model|Recruiting||Phase 1/Phase 2|200|Anticipated|Chengdu University of Traditional Chinese Medicine||3|||f||||f||||||||||2017-10-10 22:50:03.983642|2017-10-10 22:50:03.983642
NCT02577757|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-10-13|||November 2012||2012-11-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|ICA Langage||Establishing the Language Network With Independent Component Analysis of Resting State MRI||Unknown status|Recruiting|N/A|120|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 22:50:04.11853|2017-10-10 22:50:04.11853
NCT02577744|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Acute Effect of EPAP and Noninvasive Ventilation on Pulmonary Function and Lung Regional Ventilation on Bariatric Surgery|Acute Effect of EPAP and Noninvasive Ventilation on Pulmonary Function, Regional Lung Ventilation and Respiratory Mechanics on Patients Submitted Bariatric Surgery Evaluated by Spirometry and Electric Impedance Tomography: A Clinical Trial Controlled Randomized|Recruiting||Phase 4|30|Anticipated|Universidade Federal de Pernambuco||2|||f||||||||||||||2017-10-10 22:50:04.249263|2017-10-10 22:50:04.249263
NCT02577731|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-11-14|||January 2014||2014-01-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|||Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury|Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury|Recruiting||N/A|110|Anticipated|University of Florida||3|||f||||f||||||||||2017-10-10 22:50:04.385221|2017-10-10 22:50:04.385221
NCT02577705|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-01-30|||June 16, 2014|Actual|2014-06-16|October 2015|2015-10-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Building Wealth and Health Network: A Microfinance/TANF Demonstration Project|Building Wealth and Health Network: A Microfinance/TANF Demonstration Project|Completed||N/A|145|Actual|Center for Hunger-Free Communities||3|||f||||f||||||||||2017-10-10 22:50:04.783894|2017-10-10 22:50:04.783894
NCT02577692|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-07-12|||May 2016||2016-05-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|November 2016|Anticipated|2016-11-01||Interventional|||Inspired Oxygen on Oxidative Stress and Breath Volatile Organic Compound Composition in Healthy Volunteers|Impact of Inspired Oxygen on Oxidative Stress and Breath Volatile Organic Compound Composition in Healthy Volunteers: A Randomized Controlled Cross-over Trial|Recruiting||N/A|20|Anticipated|Klinikum der Universitaet Muenchen, Grosshadern||2|||f||||f||||||||||2017-10-10 22:50:04.973994|2017-10-10 22:50:04.973994
NCT02577679|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-14|||June 2015||2015-06-01|October 2015|2015-10-01|November 2015|Anticipated|2015-11-01|September 2015|Actual|2015-09-01||Observational|||Associations Between Periodontitis and Autoimmune Antibodies in Rheumatoid Arthritis Disease|Associations Between Periodontitis and Autoimmune Antibodies in Rheumatoid Arthritis Disease|Unknown status|Active, not recruiting|N/A|47|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:50:05.097054|2017-10-10 22:50:05.097054
NCT02577666|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2016-09-27|||February 2015||2015-02-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluation of EBT With Young, Substance Abusing Homeless Mothers|Evaluation of EBT With Young, Substance Abusing Homeless Mothers|Recruiting||Phase 2|240|Anticipated|Ohio State University||3|||f||||f||||||||No||2017-10-10 22:50:05.20191|2017-10-10 22:50:05.20191
NCT02577653|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-02-16|||October 2015||2015-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Posturographic Characteristics of Eccentric, Isometric and Concentric Movements|Posturographic Characteristics of Eccentric, Isometric and Concentric Movements|Withdrawn||N/A|0|Actual|Carrick Institute for Graduate Studies||1||Logistics reason at the data collection site|f||||f||||||||||2017-10-10 22:50:05.324136|2017-10-10 22:50:05.324136
NCT02577640|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Dietary Soy Isoflavones In Chronic Pancreatitis|Dietary Soy Isoflavones In Chronic Pancreatitis|Completed||N/A|11|Actual|Ohio State University||2|||f||||f||||||||||2017-10-10 22:50:05.459312|2017-10-10 22:50:05.459312
NCT02577627|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-04-03|||September 2015||2015-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|January 2018|Anticipated|2018-01-01||Observational|||Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC|Multi-Centre, Multi-Indication, Two-Stage, Oncological Study to Retrospectively Assess and Prospectively Validate the Predictive Accuracy of PrediCare - a Standalone, Treatment Decision Support Software Device for Predicting Time-to-Progression in Individual Patients Under Standard of Care Treatments|Recruiting||N/A|5000|Anticipated|Optimata Ltd.|||2||f||||f||||||||||2017-10-10 22:50:05.563584|2017-10-10 22:50:05.563584
NCT02577614|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-04-21|||February 2016||2016-02-01|April 2016|2016-04-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|FEIBA||FEIBA and Use of Blood Products in Cardiac Surgery|Factor VIII Inhibitor Bypass Activity (FEIBA) for the Reduction of Transfusion in Cardiac Surgery: A Randomized Double Blind Placebo Controlled Pilot Trial|Recruiting||Phase 1|12|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-10 22:50:05.720045|2017-10-10 22:50:05.720045
NCT02577601|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-08-29|||September 8, 2015|Actual|2015-09-08|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|June 17, 2017|Actual|2017-06-17||Interventional|||Impact of Combined Hormonal Contraceptives on UPA|Determining the Impact of Combined Hormonal Contraceptives on Ulipristal Acetate|Recruiting||Phase 4|60|Anticipated|Oregon Health and Science University||3|||f||||t||||||||||2017-10-10 22:50:05.875875|2017-10-10 22:50:05.875875
NCT02577588|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-10-13|||May 2016||2016-05-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ATACC||Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer|Phase I Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer|Recruiting||Phase 1|10|Anticipated|National Center for Tumor Diseases, Heidelberg||1|||f||||t||||||||||2017-10-10 22:50:05.992426|2017-10-10 22:50:05.992426
NCT02577575|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-05-10|||August 2010||2010-08-01|May 2016|2016-05-01||||September 2014|Actual|2014-09-01||Interventional|OT||Adult Oxytocin Study|The Effects of Oxytocin on Social Cognition in Patients With Schizophrenia|Active, not recruiting||Early Phase 1|200|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:50:06.099392|2017-10-10 22:50:06.099392
NCT02577562|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-11-16|||May 2010||2010-05-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|November 2012|Actual|2012-11-01||Expanded Access|||Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study|Zenith® Fenestrated AAA Endovascular Graft Clinical Study|Available||N/A|||Cook Group Incorporated|||||||||||||||||||2017-10-10 22:50:06.223514|2017-10-10 22:50:06.223514
NCT02577549|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-24|||January 2016||2016-01-01|July 2016|2016-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|WE-CAN||Weight Loss and Exercise for Communities With Arthritis in North Carolina|Weight Loss and Exercise for Communities With Arthritis in North Carolina|Recruiting||N/A|820|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-10 22:50:06.371391|2017-10-10 22:50:06.371391
NCT02577536|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-08-04|||September 15, 2017|Anticipated|2017-09-15|August 2017|2017-08-01|September 15, 2021|Anticipated|2021-09-15|September 15, 2021|Anticipated|2021-09-15|3 Years|Observational [Patient Registry]|PregSource||PregSource: Crowdsourcing to Understand Pregnancy|PregSource: Crowdsourcing to Understand Pregnancy, Observations of Daily Living From Pregnant Women|Not yet recruiting||N/A|100000|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||||||2017-10-10 22:50:06.540478|2017-10-10 22:50:06.540478
NCT02577523|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-01-04|||November 2015||2015-11-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||A Clinical Study Investigating the Efficacy, Safety, Tolerability and Pharmacokinetics of ND0612H, a Solution of Levodopa/Carbidopa Administered as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease|A Multicenter, Parallel-group, Rater-blinded, Randomized Clinical Study Investigating the Efficacy, Safety, Tolerability and Pharmacokinetics of 2 Dosing Regimens of ND0612H, a Solution of Levodopa/Carbidopa Delivered Via a Pump System as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease|Active, not recruiting||Phase 2|38|Actual|NeuroDerm Ltd.||2|||f||||t||||||||||2017-10-10 22:50:06.692273|2017-10-10 22:50:06.692273
NCT02577510|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-14|2017-07-18||November 2015||2015-11-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Comparing Ways to Freeze the Nerve That Provides Thigh Sensation|A Comparison Between Ultrasound- and Neurostimulation-Guided Lateral Femoral Cutaneous Nerve Block|Completed||Phase 3|21|Actual|Canadian Forces Health Services Centre Ottawa||2|||f||||f||||||||||2017-10-10 22:50:06.870699|2017-10-10 22:50:06.870699
NCT02577497|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-05-09|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|EXPAND||Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma|Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma|Enrolling by invitation||Phase 4|30|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-10 22:50:07.213039|2017-10-10 22:50:07.213039
NCT02577484|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-12-05|||November 2015||2015-11-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|ACIST-FFR||Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement|Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement: the ACIST-FFR Study|Active, not recruiting||N/A|240|Anticipated|Acist Medical Systems|||1||f||||f||||||||||2017-10-10 22:50:07.310267|2017-10-10 22:50:07.310267
NCT02577471|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-15|||July 2012||2012-07-01|October 2015|2015-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|umpiraskaus||The Function of Gastrointestinal Tract During Pregnancy|The Function of Gastrointestinal Tract During Pregnancy and After Delivery|Completed||N/A|1000|Actual|Kuopio University Hospital|||3||f||||f||||||||||2017-10-10 22:50:07.464876|2017-10-10 22:50:07.464876
NCT02577458|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-07-13|||September 2015||2015-09-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of the Combination of CM082 With Everolimus in Patients With mRCC|Phase 1 Study of the Combination of CM082 With Everolimus in Patients With Metastatic Renal Cell Carcinoma (RCC): Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy|Recruiting||Phase 1|18|Anticipated|AnewPharma||1|||f||||f||||||||||2017-10-10 22:50:07.550807|2017-10-10 22:50:07.550807
NCT02577445|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-04-05|2017-01-10||February 2016||2016-02-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|TREAT-CSA||The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice|The remedē® System (Respiratory Rhythm Management™ Device) for the Treatment of Central Sleep Apnea in Daily Practice|Terminated||N/A|31|Actual|LivaNova|Due to the early study termination, the amount of collected data was inconclusive at the time of early study termination to draw any conclusion on the study objectives.||2|Commercial distribution of the remedē System stopped by LivaNova.|f||||t||||||||||2017-10-10 22:50:07.677456|2017-10-10 22:50:07.677456
NCT02577432|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-10-19|||May 2013||2013-05-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Two Syringe Spinal Anesthesia Technique for Cesarean Section: A Simple Way to Achieve More Satisfactory Block and Less Hypotension|Two Syringe Spinal Anesthesia Technique for Cesarean Section: A Controlled Randomized Study of a Simple Way to Achieve More Satisfactory Block and Less Hypotension|Completed||N/A|124|Actual|Dr. Soliman Fakeeh Hospital||2|||f||||t||||||||||2017-10-10 22:50:08.247958|2017-10-10 22:50:08.247958
NCT02577419|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-10-03|||October 2015||2015-10-01|October 2017|2017-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||Optimizing Growth in Infants Receiving Modified Fat Breast Milk for the Treatment of Chylothorax|Optimizing Growth in Infants Receiving Modified Fat Breast Milk for the Treatment of Chylothorax Following Cardiothoracic Surgery|Recruiting||N/A|21|Anticipated|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-10 22:50:08.348772|2017-10-10 22:50:08.348772
NCT02577406|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-27|||December 30, 2015|Actual|2015-12-30|September 2017|2017-09-01|November 27, 2019|Anticipated|2019-11-27|April 1, 2019|Anticipated|2019-04-01||Interventional|IDHENTIFY||An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation|A Phase 3, Multicenter, Open-label, Randomized Study Comparing the Efficacy and Safety of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation|Recruiting||Phase 3|280|Anticipated|Celgene||2|||f||||t||||||||||2017-10-10 22:50:08.487693|2017-10-10 22:50:08.487693
NCT02577393|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-10-27|||June 2015||2015-06-01|October 2016|2016-10-01||||June 2019|Anticipated|2019-06-01||Interventional|||Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy||Enrolling by invitation||Phase 2|53|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||f||||||||||2017-10-10 22:50:08.939057|2017-10-10 22:50:08.939057
NCT02577380|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-08-11|||June 2014||2014-06-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Addressing Gender Based Violence in HIV Testing and Counseling|Addressing Gender Based Violence in HIV Testing and Counseling|Completed||N/A|500|Actual|Population Council||2|||f||||f||||||||||2017-10-10 22:50:09.049999|2017-10-10 22:50:09.049999
NCT02577367|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-09-05|||October 2015||2015-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding|The Effect of Holding Tube Feeding When Administering Levothyroxine on the Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding|Recruiting||Phase 4|24|Anticipated|Maimonides Medical Center||2|||f||||f||||||||||2017-10-10 22:50:09.166558|2017-10-10 22:50:09.166558
NCT02577354|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-08-04|||August 2016||2016-08-01|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2018|Anticipated|2018-04-01||Interventional|ReActiv8-B||ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain|ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)|Recruiting||N/A|128|Anticipated|Mainstay Medical||2|||f||||t||||||||||2017-10-10 22:50:09.286569|2017-10-10 22:50:09.286569
NCT02577341|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-04-15|||August 2015||2015-08-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer|A Prospective, Double-blinded, Randomized Phase Ⅱ Study of Nimotuzumab Combined With Chemoradiotherapy for Unresectable, Locally Advanced Squamous Cell Lung Cancer|Recruiting||Phase 2|150|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:50:09.479443|2017-10-10 22:50:09.479443
NCT02577328|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-14|||November 2015||2015-11-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Observational|||Pain Management in Internal Medicine Department|Pain Management in Internal Medicine Department|Unknown status|Not yet recruiting|N/A|300|Anticipated|Bnai Zion Medical Center|||1||f||||t||||||||||2017-10-10 22:50:09.626349|2017-10-10 22:50:09.626349
NCT02577315|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-10-07|2016-10-07||September 2015||2015-09-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||Treated set (TS): all subjects who were randomised to study medication and were documented to have received at least 1 dose of study drug.|Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions|An Open-label, Randomised, Single-dose, Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Two Fixed Dose Combination Tablets of Empagliflozin 12.5 mg and Metformin 500 mg Compared With the Free Combination of Empagliflozin 25 mg and Metformin 1000 mg Tablets Under Fed Conditions|Completed||Phase 1|25|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:50:09.734755|2017-10-10 22:50:09.734755
NCT02577302|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-03|||December 2016||2016-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|PROTECT||CAN-Stim Compared to PTNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology|Clinical Trial Study of Chronic Afferent Nerve Stimulation in the Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology as Compared to Peripheral Tibial Nerve Stimulation|Enrolling by invitation||Phase 3|300|Anticipated|StimGuard, LLC.||2|||f||||t||||||||Yes|upon study completion|2017-10-10 22:50:10.138923|2017-10-10 22:50:10.138923
NCT02577289|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-14|||July 2015||2015-07-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite|Evaluation of Bone Quantity in Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite as Sole Grafting Material in Patients With Atrophied Posterior Maxillary Ridge|Recruiting||N/A|18|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 22:50:10.271293|2017-10-10 22:50:10.271293
NCT02577276|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-08-28|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of a Tele-Rehabilitation Service Program|Joint Gertner ReAbility Online and Mayo Clinic Feasibility Study: Evaluation of a Tele-Rehabilitation Service Program|Recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-10 22:50:10.441823|2017-10-10 22:50:10.441823
NCT02577263|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2017-03-06|||April 2015||2015-04-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|January 2017|Actual|2017-01-01||Observational|||Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer|Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer|Active, not recruiting||N/A|64|Actual|Pontificia Universidad Catolica de Chile|||1||f||||f||||||||Undecided||2017-10-10 22:50:10.576357|2017-10-10 22:50:10.576357
NCT02577250|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-14|||May 2015||2015-05-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Ketamine Infusions for PTSD and Treatment-Resistant Depression|Efficacy and Safety of Repeated Intravenous Subanesthetic Ketamine Infusions Among Veterans With Treatment Resistant Depression Comorbid With Chronic Post-Traumatic Stress Disorder: A Proof-of-concept Study|Unknown status|Recruiting|Phase 1|20|Anticipated|Minneapolis Veterans Affairs Medical Center||1|||f||||t||||||||||2017-10-10 22:50:10.715034|2017-10-10 22:50:10.715034
NCT02577237|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-04-07|||August 1, 2015|Actual|2015-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer|Building Family Caregiver Skills Using a Simulation-based Intervention for Care of Patients With Head and Neck Cancer|Active, not recruiting||N/A|18|Actual|Case Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 22:50:10.89386|2017-10-10 22:50:10.89386
NCT02577224|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-03-21|||August 2015|Actual|2015-08-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||An RCT of a Patient-initiated Treatment Service for BEB and HFS|A Randomised Controlled Trial to Explore the Effectiveness and Cost-effectiveness of a Patient-initiated Botulinum Toxin Treatment Model for Blepharospasm and Hemifacial Spasm Compared to Treatment as Usual|Active, not recruiting||N/A|130|Actual|Moorfields Eye Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:50:11.101203|2017-10-10 22:50:11.101203
NCT02577211|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-11-07|||December 2013||2013-12-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|hipoentnut||Hypocaloric Enteral Nutrition in the Critically Ill Patient|Randomized Controlled Trial of Hypocaloric Hyperproteic Enteral Nutrition in the Critically Ill Patient|Completed||Phase 3|120|Actual|Lafrancol S.A.||2|||f||||t||||||||||2017-10-10 22:50:11.261346|2017-10-10 22:50:11.261346
NCT02577198|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-01-27|||November 2015|Actual|2015-11-01|October 2016|2016-10-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|CODES||Computerized Decision Support System Linked to Electronic Health Records to Improve Patient Care in a General Hospital|Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Patient Care in a General Hospital|Completed||N/A|6479|Actual|Istituto Ortopedico Galeazzi||2|||f||||f||||||||||2017-10-10 22:50:11.356857|2017-10-10 22:50:11.356857
NCT02577185|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-05-08|||November 2015||2015-11-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A|An Exploratory Psoriasis Plaque Test Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A as Tool Compound|Completed||Phase 1|10|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:50:11.451375|2017-10-10 22:50:11.451375
NCT02577172|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-01-25|||November 2015|Actual|2015-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|TAST||Testicular Cancer and Aerobic and Strength Training|Testicular Cancer and Aerobic and Strength Training - a Randomized Controlled National Phase II Study|Terminated||N/A|19|Actual|Oslo University Hospital||2||Unexpected events|f|||||f|f||||||||2017-10-10 22:50:11.568755|2017-10-10 22:50:11.568755
NCT02577159|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-09-28|||July 2015||2015-07-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|DAPHNIS||Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)|Effects of Dapagliflozin on Hyperlipidemia, Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)|Recruiting||Phase 4|50|Anticipated|Osaka University||1|||f||||t||||||||||2017-10-10 22:50:11.672104|2017-10-10 22:50:11.672104
NCT02577146|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-10-02|||October 2015||2015-10-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic|The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic|Recruiting||N/A|100|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 22:50:11.821148|2017-10-10 22:50:11.821148
NCT02577133|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2015-10-15|||October 2015||2015-10-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|January 2016|Anticipated|2016-01-01||Interventional|||Prevention of Colic With the Probiotic Lactobacillus Reuteri|Prevention of Colic With the Probiotic Lactobacillus Reuteri in Mexican Infants: Randomized, Double-blind Study|Unknown status|Not yet recruiting|Phase 2/Phase 3|478|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||2|||f||||f||||||||||2017-10-10 22:50:12.139094|2017-10-10 22:50:12.139094
NCT02577120|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-04-03|||May 2015||2015-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Wound Healing Endpoint and Recurrence|Wound Healing Endpoint and Recurrence|Recruiting||N/A|265|Anticipated|Ohio State University|||5||f||||t||||||Samples With DNA|"     Tissue   "|||2017-10-10 22:50:12.288003|2017-10-10 22:50:12.288003
NCT02577094|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-01-17||||||January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|EPRALLO||Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia||Withdrawn||Phase 1/Phase 2|0|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 22:50:12.599686|2017-10-10 22:50:12.599686
NCT02573909|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-04-11|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|epioksipanu||The Safety and Efficacy of Epidural Oxycodone|The Safety and Efficacy of Epidural Oxycodone|Recruiting||Phase 4|100|Anticipated|Kuopio University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:50:55.533389|2017-10-10 22:50:55.533389
NCT02577081|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-09-17|||January 2016||2016-01-01|September 2016|2016-09-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Assessment of the Risk of Contralateral Non Simultaneous Neck of Femur Fracture in the Elderly.|Assessment of the Risk of Contralateral Non Simultaneous Neck of Femur Fracture in the Elderly. CT Based Study.|Recruiting||N/A|100|Anticipated|Meir Medical Center||1|||f||||t||||||||No||2017-10-10 22:50:12.748422|2017-10-10 22:50:12.748422
NCT02577068|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-13|||October 2015||2015-10-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||Combination Effect of Nefopam With Propacetamol for Postoperative Pain After Thyroidectomy||Unknown status|Not yet recruiting|N/A|84|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-10 22:50:12.869984|2017-10-10 22:50:12.869984
NCT02577055|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-02-02|||April 2016|Actual|2016-04-01|January 2017|2017-01-01|April 2021|Anticipated|2021-04-01|October 2020|Anticipated|2020-10-01||Interventional|Lune2||Fertility After Poly-myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids|Fertility After Poly-myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids|Recruiting||N/A|294|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 22:50:13.421792|2017-10-10 22:50:13.421792
NCT02577042|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-10-04|||October 2015||2015-10-01|October 2017|2017-10-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen|"Study of the Effect of Atorvastatin for Reducing Inflamaging (Aging-related Complication) in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen"|Active, not recruiting||Phase 4|42|Actual|Fundacio Lluita Contra la SIDA||2|||f||||f||||||||||2017-10-10 22:50:13.579553|2017-10-10 22:50:13.579553
NCT02577029|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-01-17|||December 2015||2015-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Monarch||Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic HBV|A Multicenter, Open-Label Study to Evaluate ARC-520 Administered Alone and in Combination With Other Therapeutics in Patients With Chronic Hepatitis B Virus (HBV) Infection (MONARCH)|Terminated||Phase 2|80|Actual|Arrowhead Pharmaceuticals||3||Company decision to discontinue trial|f||||f||||||||||2017-10-10 22:50:13.731223|2017-10-10 22:50:13.731223
NCT02577016|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-01-02|||November 2015||2015-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)|A Phase III, Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Trial to Assess the Safety and Efficacy of Addition of Sitagliptin in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin Monotherapy in Addition to Diet and Exercise Therapy|Completed||Phase 3|141|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:50:13.991155|2017-10-10 22:50:13.991155
NCT02577003|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-01-02|||November 2015||2015-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)|A Phase III, Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Trial to Assess the Safety and Efficacy of Addition of Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin Monotherapy in Addition to Diet and Exercise Therapy|Completed||Phase 3|143|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:50:14.111001|2017-10-10 22:50:14.111001
NCT02576990|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-21|||December 2, 2015|Actual|2015-12-02|September 2017|2017-09-01|September 19, 2018|Anticipated|2018-09-19|September 19, 2018|Anticipated|2018-09-19||Interventional|||Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)|A Phase II Study of Pembrolizumab (MK-3475) in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) or Relapsed or Refractory Richter Syndrome (rrRS)|Recruiting||Phase 2|106|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f|t|f||||||||2017-10-10 22:50:14.222499|2017-10-10 22:50:14.222499
NCT02576977|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-09-06|||October 19, 2015|Actual|2015-10-19|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183)|A Phase III Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (KEYNOTE 183)|Suspended||Phase 3|300|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 22:50:14.459795|2017-10-10 22:50:14.459795
NCT02576964|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2016-11-01|||January 2005||2005-01-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer|An Open-Label Phase II Study of Capecitabine in Combination With Pegylated Interferon Alfa-2a in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 2|16|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:50:14.700916|2017-10-10 22:50:14.700916
NCT02576951|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-03-08|||October 19, 2015|Actual|2015-10-19|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|September 3, 2016|Actual|2016-09-03||Interventional|||A Study of LY2951742 in Healthy Participants|Tolerability, Pharmacokinetics and Pharmacodynamics of LY2951742 in Healthy Subjects Following a Subcutaneous Administration of a Lyophilized Formulation or a Solution Formulation|Active, not recruiting||Phase 1|178|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:50:14.824793|2017-10-10 22:50:14.824793
NCT02576938|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-14|2017-03-14|||February 2016||2016-02-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis|Completed||Phase 2|124|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 22:50:14.919843|2017-10-10 22:50:14.919843
NCT02576925|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-02-03|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Observational|VASCO-DIP||A Predictive Score for the Ischemic Etiology of a Transient Diplopia (VASCO-DIP)|Development and Validation of a Predictive Score for the Ischemic Etiology of a Transient Diplopia|Enrolling by invitation||N/A|175|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 22:50:15.117002|2017-10-10 22:50:15.117002
NCT02576912|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-06-21|||February 2015||2015-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|THC-Preg||Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone|Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone|Recruiting||Phase 1|19|Anticipated|Yale University||4|||f||||f||||||||||2017-10-10 22:50:15.205522|2017-10-10 22:50:15.205522
NCT02576899|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-09-26|||September 1, 2015|Actual|2015-09-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|ACT-PT||Improving Functional Outcomes of Veterans With PTSD and Tobacco Dependence|Improving Functional Outcomes of Veterans With PTSD and Tobacco Dependence|Recruiting||Phase 1|50|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:50:15.327308|2017-10-10 22:50:15.327308
NCT02576886|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-01-14|||September 2015||2015-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SFSO-MPI||Combined Supine/Prone Acquisitions in Stress-First/Stress-Only Myocardial Perfusion Imaging to Reduce Equivocal Results|Combined Supine/Prone Acquisitions in Stress-First/Stress-Only Myocardial Perfusion Imaging to Reduce Equivocal Results in Patients Undergoing Testing in a Tertiary Care Facility|Completed||N/A|490|Actual|Hamilton Health Sciences Corporation||1|||f||||f||||||||||2017-10-10 22:50:15.442997|2017-10-10 22:50:15.442997
NCT02576873|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-07-26|||March 2014||2014-03-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Observational|||Long-term Outcome of End-stage Renal Disease Patients Treated With Hig-efficiency Hemodiafiltration|Long-term Outcome of End-stage Renal Disease Patients Treated With High-efficiency Hemodiafiltration: a Historical Cohort of a Single-center in South East Asia|Completed||N/A|66|Actual|Chulalongkorn University|||1||f||||f||||||||No||2017-10-10 22:50:15.522219|2017-10-10 22:50:15.522219
NCT02576860|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-20|||October 2015||2015-10-01|September 2017|2017-09-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle|A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period|Completed||Phase 3|263|Actual|Cutanea Life Sciences, Inc.||2|||f||||f||||||||||2017-10-10 22:50:15.612253|2017-10-10 22:50:15.612253
NCT02576847|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-20|||September 2015||2015-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|July 14, 2017|Actual|2017-07-14||Interventional|||Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel|A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety of Omiganan Topical Gel in Subjects With Rosacea|Active, not recruiting||Phase 3|307|Actual|Cutanea Life Sciences, Inc.||1|||f||||f||||||||||2017-10-10 22:50:15.777778|2017-10-10 22:50:15.777778
NCT02576834|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2016-09-27|||April 2015||2015-04-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Suicide Prevention Among Substance Abusing Homeless Youth|Suicide Prevention Among Substance Abusing Homeless Youth|Recruiting||Phase 1/Phase 2|150|Anticipated|Ohio State University||2|||f||||t||||||||No||2017-10-10 22:50:15.889126|2017-10-10 22:50:15.889126
NCT02576821|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-02-11|||January 2016||2016-01-01|February 2016|2016-02-01|October 2020|Anticipated|2020-10-01|January 2020|Anticipated|2020-01-01||Interventional|ShaTau7||Hippocampal Sclerosis and Amnesia Not Due to Alzheimer's Disease|Hippocampal Sclerosis and Amnesia Not Due to Alzheimer's Disease|Recruiting||N/A|140|Anticipated|Centre Hospitalier St Anne||5|||f||||f||||||||||2017-10-10 22:50:15.993992|2017-10-10 22:50:15.993992
NCT02576795|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-06-09|||August 2015||2015-08-01|June 2017|2017-06-01||||February 2022|Anticipated|2022-02-01||Interventional|||Gene Therapy Study in Severe Haemophilia A Patients|A Phase 1/2, Dose-Escalation Safety, Tolerability and Efficacy Study of BMN 270, an Adenovirus-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Patients With Severe Haemophilia A|Active, not recruiting||Phase 1/Phase 2|15|Actual|BioMarin Pharmaceutical||1|||f||||||||||||||2017-10-10 22:50:16.253977|2017-10-10 22:50:16.253977
NCT02576782|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-13|||June 2013||2013-06-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Dexamethasone & Bupivacaine vs Bupivacaine Alone in Combined Femoral and Sciatic Nerve Block for Perioperative Analgesia in Patients Undergoing Lower Limb Surgeries|Combination of Dexamethasone and Bupivacaine Versus Bupivacaine Alone in Combined Femoral and Sciatic Nerve Block for Intraoperative and Postoperative Analgesia in Patients Undergoing Lower Limb Vascular Surgeries|Completed||Phase 4|63|Actual|Cairo University||3|||f||||f||||||||||2017-10-10 22:50:16.357723|2017-10-10 22:50:16.357723
NCT02576769|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-13|||November 2015||2015-11-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||The Role of Melanocyte in Basal Cell Carcinoma|Melanocyte Features and Its Influence in Pigmentation in Basal Cell Carcinoma in the Mexican Population|Unknown status|Not yet recruiting|N/A|30|Anticipated|Universidad Autonoma de San Luis Potosí|||1||f||||f||||||||||2017-10-10 22:50:16.615452|2017-10-10 22:50:16.615452
NCT02576756|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-08-16|||October 2015||2015-10-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Retrospective Study in Patients Who Have Had a Difficult Intubation.|Retrospective Study of the Risk of Aspiration and Postoperative Pulmonary Problems in Patients Who Have Had a Difficult Intubation.|Completed||N/A|1000|Anticipated|Universitair Ziekenhuis Brussel|||2||f||||f||||||||No||2017-10-10 22:50:16.780653|2017-10-10 22:50:16.780653
NCT02573376|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-09-14|||November 2015||2015-11-01|September 2016|2016-09-01|March 2021|Anticipated|2021-03-01|September 2020|Anticipated|2020-09-01||Interventional|||Antiviral Pharmacology and Adherence in Drug Users|Antiviral Pharmacology and Adherence in Drug Users|Recruiting||N/A|60|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:51:00.805258|2017-10-10 22:51:00.805258
NCT02576743|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-04-11|||November 2015||2015-11-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Pushing Spatiotemporal Limits for 4D Flow MRI and Dynamic MRA in the Brain at Ultra-High Field|Pushing Spatiotemporal Limits for 4D Flow MRI and Dynamic MRA in the Brain at Ultra-High Field|Not yet recruiting||N/A|90|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||||||2017-10-10 22:50:16.879964|2017-10-10 22:50:16.879964
NCT02576730|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-13|||October 2011||2011-10-01|December 2010|2010-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|FACTS||Functional Outcome Assessment After (Calcaneal) Trauma Surgey|Functional Outcome Assessment After (Calcaneal) Trauma Surgey|Completed||N/A|20|Actual|Maastricht University Medical Center|||2||f||||f||||||||||2017-10-10 22:50:16.990259|2017-10-10 22:50:16.990259
NCT02576717|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-21|||October 16, 2015|Actual|2015-10-16|July 2017|2017-07-01|June 30, 2020|Anticipated|2020-06-30|May 31, 2020|Anticipated|2020-05-31||Interventional|||A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis|A Phase 3, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of RPC1063 Administered Orally To Relapsing Multiple Sclerosis Patients|Enrolling by invitation||Phase 3|2350|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 22:50:17.162311|2017-10-10 22:50:17.162311
NCT02576704|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-01-02|||May 2011||2011-05-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|PROMETHE||Prognostic Value of Myocardial Perfusion Heterogeneity in Normal SPECT Studies|Prognostic Value of Myocardial Perfusion Heterogeneity in Normal Dual Isotope High Speed Myocardial Perfusion Imaging With a Semi Conductor Gamma Camera.|Completed||N/A|1119|Actual|University Hospital, Grenoble|||1||f||||t||||||||||2017-10-10 22:50:17.838934|2017-10-10 22:50:17.838934
NCT02576691|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-14|||January 2005||2005-01-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2013|Actual|2013-04-01||Observational|||Effects of Percutaneous Coronary Intervention in Patients With Cardiac Arrest After Acute Myocardial Infarction: a 2-Year Study||Completed||N/A|2363|Actual|Wenzhou Medical University|||2||f||||||||||||||2017-10-10 22:50:17.955801|2017-10-10 22:50:17.955801
NCT02576678|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-08-25|||October 13, 2015|Actual|2015-10-13|August 2017|2017-08-01|November 15, 2019|Anticipated|2019-11-15|December 14, 2017|Anticipated|2017-12-14||Interventional|||A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis|A Phase 2, Multicenter, Open-Label Study to Assess the Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis|Recruiting||Phase 2|43|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 22:50:18.064645|2017-10-10 22:50:18.064645
NCT02576665|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-09-05|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)|A Phase 1b Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma|Recruiting||Phase 1|30|Anticipated|Tocagen Inc.||1|||f||||f||||||||||2017-10-10 22:50:18.280358|2017-10-10 22:50:18.280358
NCT02576652|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-06-01|||December 22, 2015|Actual|2015-12-22|May 2017|2017-05-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Bone Histomorphometry in Subjects Undergoing Total Hip Replacement|Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement|Recruiting||Phase 4|15|Anticipated|Amgen||1|||f||||f||||||||||2017-10-10 22:50:18.417291|2017-10-10 22:50:18.417291
NCT02576639|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-08-07|2017-03-09||August 10, 2015|Actual|2015-08-10|August 2017|2017-08-01|March 11, 2016|Actual|2016-03-11|March 11, 2016|Actual|2016-03-11||Interventional|||Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of CNP520 in Healthy Elderly Subjects|Completed||Phase 2|124|Actual|Novartis||5|||f||||||||||||||2017-10-10 22:50:18.611203|2017-10-10 22:50:18.611203
NCT02576613|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-01-31|||October 2015||2015-10-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|MPP-S||Modified Psychodynamic Psychotherapy for Patients With Schizophrenia|Modified Psychodynamic Psychotherapy for Patients With Schizophrenia - a Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 22:50:21.022214|2017-10-10 22:50:21.022214
NCT02576600|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-16|||October 2010||2010-10-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Pupillometry Guided Remifentanil Administration and Total Opioid Consumption During Propofol - Remifentanil TCI|Pupillometry Guided Versus Standard Practice Remifentanil Administration and Total Opioid Consumption|Completed||N/A|65|Actual|Hôpital Armand Trousseau||2|||f||||t||||||||||2017-10-10 22:50:21.151769|2017-10-10 22:50:21.151769
NCT02576587|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-04-13|||January 1, 2012|Actual|2012-01-01|April 2017|2017-04-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Observational|Safebeat||Influence of Sleep Apnea on Risk of Atrial Fibrillation|Elucidation of the Influence of Sleep Apnea on Risk of Atrial Fibrillation|Completed||N/A|317|Actual|The Cleveland Clinic|||2||f||||t||||||Samples With DNA|"     PAXgene RNA, Serum, Citrate, Citrate Plasma, EDTA, EDTA Plasma, SCAT- 1, Plain urine, Urine     in Acetic Acid   "|Yes||2017-10-10 22:50:21.234735|2017-10-10 22:50:21.234735
NCT02576574|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-14|||October 29, 2015|Actual|2015-10-29|September 2017|2017-09-01|July 26, 2024|Anticipated|2024-07-26|July 25, 2019|Anticipated|2019-07-25||Interventional|||Avelumab in First-line Non-Small Cell Lung Cancer (JAVELIN Lung 100)|A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+ Non-small Cell Lung Cancer|Recruiting||Phase 3|1095|Anticipated|EMD Serono||3|||f||||t||||||||||2017-10-10 22:50:21.378911|2017-10-10 22:50:21.378911
NCT02576561|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-07-11|||November 2015||2015-11-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL|Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL|Active, not recruiting||Phase 2|10|Actual|THEVAX Genetics Vaccine||9|||f||||t||||||||||2017-10-10 22:50:24.074485|2017-10-10 22:50:24.074485
NCT02576535|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-01-21|2015-10-19||February 2000||2000-02-01|January 2016|2016-01-01||||June 2011|Actual|2011-06-01||Interventional|||Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations|Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations|Completed||N/A|18|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 22:50:24.340376|2017-10-10 22:50:24.340376
NCT02576522|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-12|||June 2015||2015-06-01|October 2015|2015-10-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Tumor Bed Hypofractionated IMRT After Surgery for Patients With Single,Large Brain Metastases From Solid Tumor|Tumor Bed Hypofractionated IMRT (VMAT-RA) After Surgical Resection for Patients With Single, Large (≥2.1 cm) Brain Metastases From Solid Tumor|Recruiting||Phase 2|55|Anticipated|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-10 22:50:24.579001|2017-10-10 22:50:24.579001
NCT02576509|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-21|||November 25, 2015|Actual|2015-11-25|September 2017|2017-09-01|June 22, 2019|Anticipated|2019-06-22|October 1, 2018|Anticipated|2018-10-01||Interventional|||An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma|A Randomized, Multi-center Phase III Study of Nivolumab Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (CheckMate 459: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 459)|Recruiting||Phase 3|726|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 22:50:24.711006|2017-10-10 22:50:24.711006
NCT02576496|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-06-23|||March 2016||2016-03-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of EDO-S101, A First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies|A Phase 1 Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of EDO-S101, a First-in-Class Alkylating Histone Deacetylase Inhibition (HDACi) Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies|Recruiting||Phase 1|84|Anticipated|Mundipharma-EDO GmbH||1|||f||||t||||||||Yes|relevant patient listing data of de-identified patients may be reviewed|2017-10-10 22:50:25.31489|2017-10-10 22:50:25.31489
NCT02576483|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-10-26|||July 2015||2015-07-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||An Evaluation of LASIK and PRK Surgery in Physicians|An Evaluation of Quality of Vision and Quality of Life With LASIK and PRK Surgery in Physicians|Recruiting||N/A|700|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-10 22:50:25.471592|2017-10-10 22:50:25.471592
NCT02576457|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-14|||December 2, 2015|Actual|2015-12-02|September 2017|2017-09-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis|A Phase 1b/2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Subjects With Severe Sepsis|Terminated||Phase 1|35|Actual|Bristol-Myers Squibb||2||Business Objectives Have Changed|f||||t|t|f||||||||2017-10-10 22:50:25.756252|2017-10-10 22:50:25.756252
NCT02576444|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-08-08|||November 2015||2015-11-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|OLAPCO||OLAParib COmbinations|A Phase II Study of the PARP Inhibitor Olaparib (AZD2281) Alone and in Combination With AZD1775, AZD5363, or AZD2014 in Advanced Solid Tumors|Recruiting||Phase 2|64|Anticipated|Yale University||4|||f||||t||||||||||2017-10-10 22:50:25.888196|2017-10-10 22:50:25.888196
NCT02576431|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-09-05|||October 2015||2015-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of LOXO-101 (Larotrectinib) in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)|A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 (Larotrectinib) in Subjects With NTRK Fusion-Positive Tumors|Recruiting||Phase 2|151|Anticipated|Loxo Oncology, Inc.||8|||t||||f||||||||||2017-10-10 22:50:26.020323|2017-10-10 22:50:26.020323
NCT02576418|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-09-07|||October 2015||2015-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||PartoSure to Predict Spontaneous Preterm Delivery in Pregnancies After Assisted Reproductive Technology (ART)|Evaluation of the PartoSure Time to Delivery (TTD) Test to Predict Spontaneous Preterm Delivery in Pregnancies After Assisted Reproductive Technology (ART)|Recruiting||N/A|100|Anticipated|Vietnam National University||1|||f||||f||||||||||2017-10-10 22:50:26.24373|2017-10-10 22:50:26.24373
NCT02576405|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-14|||October 2015||2015-10-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Observational|||Psychiatric Disorder and Postoperative Morbidity in Hip and Knee Artroplasty|Characterization of Preoperative Psychiatric Disorder in Relation to Postoperative Morbidity in Elective Fast-Track Total Hip and Knee Arthroplasty|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-10 22:50:26.320515|2017-10-10 22:50:26.320515
NCT02576392|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-06-02|||July 1, 2015||2015-07-01|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|FLOOD||FDA: Lowering Orthopedic Opioid Dosing (FLOOD)|Reducing the Use of Opioid Therapy Following Orthopedic Surgery: A Randomized Controlled Trial|Completed||N/A|561|Actual|Kaiser Permanente||2|||f||||f||||||||No||2017-10-10 22:50:26.378298|2017-10-10 22:50:26.378298
NCT02576379|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-07-08|||January 2010||2010-01-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|2 Years|Observational [Patient Registry]|||The Impact of a Helicopter Emergency Medical System on Prognosis in Stroke Patients|The Impact of a Helicopter Emergency Medical System on Prognosis in Stroke Patients|Completed||N/A|1068|Actual|Rigshospitalet, Denmark|||2||f||||t||||||||||2017-10-10 22:50:26.449382|2017-10-10 22:50:26.449382
NCT02576366|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-05-25|||June 2016||2016-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus|Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus|Not yet recruiting||Phase 4|24|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 22:50:26.629712|2017-10-10 22:50:26.629712
NCT02576353|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-11-30|||October 2015||2015-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects|A Phase 1, Open-label, Randomized, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects|Completed||Phase 1|50|Actual|INSYS Therapeutics Inc||5|||f||||f||||||||||2017-10-10 22:50:26.731703|2017-10-10 22:50:26.731703
NCT02576340|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-14|||January 2013||2013-01-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Spasmolytic in Upper Gastrointestinal Endoscopy|Spasmolytic (Otilonium Bromide) Use in Upper Gastrointestinal Endoscopy: Randomized Prospective Trial|Completed||Phase 4|400|Actual|Konya Training and Research Hospital||2|||f||||f||||||||||2017-10-10 22:50:26.858016|2017-10-10 22:50:26.858016
NCT02576327|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-12-28|||October 2015||2015-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation|A Multi-central Perspective Randomized Controlled Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation|Active, not recruiting||Phase 4|130|Anticipated|Peking University||2|||f||||f||||||||||2017-10-10 22:50:26.944545|2017-10-10 22:50:26.944545
NCT02576314|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-15|||May 2015||2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients|Efficacy and Safety Study of Sofosbuvir Containing Regimens in Subjects With Chronic Hepatitis C Virus Genotype 3 Infection|Recruiting||Phase 3|60|Anticipated|Humanity and Health Research Centre||2|||f||||t||||||||||2017-10-10 22:50:27.055509|2017-10-10 22:50:27.055509
NCT02576301|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-21|||October 2015||2015-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|AML||Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS|Ph 1b Dose Escalation Study of OXi4503 as a Single Agent and in Combination With Cytarabine With Subsequent Phase 2 Cohorts for Subjects With Relapsed/Refractory Acute AML and MDS|Recruiting||Phase 1/Phase 2|105|Anticipated|Mateon Therapeutics||4|||f||||f||||||||||2017-10-10 22:50:27.165856|2017-10-10 22:50:27.165856
NCT02576288|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-03-21|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|SAVORO||Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity|Effects of Sitagliptin on Arterial Vasoreactivity and Proatherogenic Mediators in Obesity|Recruiting||Phase 2|20|Anticipated|University of Southern California||2|||f||||f|f|f||||||||2017-10-10 22:50:27.302158|2017-10-10 22:50:27.302158
NCT02576275|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-07-28|||December 2015||2015-12-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)|A Phase 3, Randomized, Double-blind Study of Duvelisib Administered in Combination With Rituximab and Bendamustine vs Placebo Administered in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma|Withdrawn||Phase 3|0|Actual|Verastem, Inc.||2||"The scope of the program has been reduced to focus resources on studies which can potentially   enable the registration of duvelisib."|f||||t||||||||||2017-10-10 22:50:27.419252|2017-10-10 22:50:27.419252
NCT02576262|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-06-24|||September 2015||2015-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Observational|||HPV Integration Testing for Human Papillomavirus-Positive Women||Recruiting||N/A|1200|Anticipated|Huazhong University of Science and Technology|||1||f||||||||||||||2017-10-10 22:50:27.569259|2017-10-10 22:50:27.569259
NCT02576249|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-07-19|2017-06-20||October 2015||2015-10-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis|Does Anesthetic Contribute to Symptomatic Relief in Corticosteroid Injections for Knee Osteoarthritis? A Double-Blind Randomized Trial Comparing Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections|Completed||Phase 4|29|Actual|Mayo Clinic|Lack of power due to lower than expected enrollment; follow-up was limited to 3 months.|2|||f||||f|t|f|||t|||||2017-10-10 22:50:27.654085|2017-10-10 22:50:27.654085
NCT02576236|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-07-03|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|February 2019|Anticipated|2019-02-01||Interventional|Hepysé||Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection|Comparison of the Efficacy and Tolerance of Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance WITH Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection: a Randomised Multicentre Trial|Recruiting||N/A|2500|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:50:28.12106|2017-10-10 22:50:28.12106
NCT02576223|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-14|||October 2015||2015-10-01|October 2015|2015-10-01||||May 2016|Anticipated|2016-05-01||Interventional|||Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery|Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery - a Randomized, Blinded, Placebo Controlled Study|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-10-10 22:50:28.261922|2017-10-10 22:50:28.261922
NCT02576210|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-14|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:50:28.352913|2017-10-10 22:50:28.352913
NCT02576197|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-10-17|||May 2015||2015-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients|A Double Blind, Randomized, Placebo-Controlled Intervention Study to Evaluate the Effectiveness and Safety of a Treatment With a Probiotic in Adult Patients Diagnosed With Mild to Moderate Plaque Psoriasis|Completed||N/A|98|Actual|Biopolis S.L.||2|||f||||f||||||||No||2017-10-10 22:50:28.413729|2017-10-10 22:50:28.413729
NCT02576184|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-04-21|||December 2015||2015-12-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MEMBO||Mesh Reinforcement During Temporary Stoma Closure After Sphincter-Saving Rectal Cancer Surgery|Mesh Reinforcement During Temporary Stoma Closure After Sphincter-Saving Rectal Cancer Surgery: A Randomized-controlled Trial|Recruiting||Phase 3|381|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 22:50:28.534863|2017-10-10 22:50:28.534863
NCT02576171|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-06-21|||October 15, 2015|Actual|2015-10-15|June 2017|2017-06-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|SoFT||Group Therapy Supported Internet-based CBT for Adolescents With Social Anxiety Disorder - A Feasibility Trial|Group Therapy Supported Internet-based Cognitive Behavioral Therapy for Adolescents With Social Anxiety Disorder - A Feasibility Trial|Completed||N/A|30|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 22:50:28.670311|2017-10-10 22:50:28.670311
NCT02576158|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-06-24|||April 2015||2015-04-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|September 2018|Anticipated|2018-09-01||Observational|||HPV Integration Testing for Cervical Cancer Screening|HPV（Human Papillomavirus） Integration Testing for Cervical Cancer Screening|Recruiting||N/A|12000|Anticipated|Huazhong University of Science and Technology|||1||f||||||||||||||2017-10-10 22:50:28.791378|2017-10-10 22:50:28.791378
NCT02576145|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-12-09|2015-12-09||April 2003||2003-04-01|December 2015|2015-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax)|Immune Response to Neoantigen and Recall Antigen in Pediatric Renal Transplant Recipients Treated With the IL-2R Alfa Monoclonal Antibody, Daclizumab (Zenapax®)|Completed||Phase 4|11|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-10 22:50:28.904589|2017-10-10 22:50:28.904589
NCT02576132|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-13|||November 2011||2011-11-01|October 2015|2015-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Pupillometry for Pain Assessment in Critically Ill Patients|Pupillometry for Pain Assessment in Critically Ill Patients|Completed||N/A|80|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 22:50:29.697004|2017-10-10 22:50:29.697004
NCT02576119|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-08-07|||October 19, 2015|Actual|2015-10-19|August 2017|2017-08-01|October 14, 2016|Actual|2016-10-14|February 26, 2016|Actual|2016-02-26||Interventional|||A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects|A Randomized, Double-Blind, Double-Dummy, Positive-Controlled, Crossover Study to Determine Electrocardiographic Effects of BMS-955176 in Healthy Subjects|Terminated||Phase 1|315|Actual|ViiV Healthcare||2||"This study was terminated early due to neuropsychiatric serious adverse events reported by 2   participants."|f||||f|t|f||||||||2017-10-10 22:50:30.061263|2017-10-10 22:50:30.061263
NCT02576106|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-31|||February 2016|Actual|2016-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|CRYOSE01||Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy|Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy|Recruiting||N/A|20|Anticipated|Centre Leon Berard||1|||f||||f||||||||||2017-10-10 22:50:30.159803|2017-10-10 22:50:30.159803
NCT02576093|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-10-15|||March 2014||2014-03-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients|First-in-human, Single Center, Combined SAD/MAD, Double-blind, Placebo-controlled, Half-side Comparison Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of 0.1%, 0.3% and 1% WOL071-007-containing Formulations in Atopic Dermatitis Patients|Completed||Phase 1|58|Actual|Dr. August Wolff GmbH & Co. KG Arzneimittel||4|||f||||t||||||||||2017-10-10 22:50:30.264564|2017-10-10 22:50:30.264564
NCT02576080|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-14|||October 2015||2015-10-01|October 2015|2015-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|GIGIST||Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index|Efficacy of Adjuvant Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index. Multicenter, Prospective, Randomized Study. Etude Multicentrique, Prospective, randomisée|Not yet recruiting||Phase 3|80|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:50:30.368317|2017-10-10 22:50:30.368317
NCT02576067|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-09-26|||December 2015||2015-12-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|CIRT||Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study|Cardiovascular Inflammation Reduction Trial (CIRT) - Inflammation Imaging Study|Recruiting||Phase 3|216|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 22:50:30.476178|2017-10-10 22:50:30.476178
NCT02576041|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-03-21|2016-09-22||October 2015||2015-10-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|F1||Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria|Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria|Completed||Phase 4|19|Actual|Menarini International Operations Luxembourg SA||1|||f||||f||||||||Undecided||2017-10-10 22:50:30.69181|2017-10-10 22:50:30.69181
NCT02576028|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-20|||October 2011||2011-10-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Fascial Manipulation® Associated With Standard Care Versus Standard Post-surgical Care for Total Hip Arthroplasty|Fascial Manipulation® Associated With Standard Care Versus Standard Post-surgical Care for Total Hip Arthroplasty: a Randomized Controlled Trial.|Completed||N/A|51|Actual|Azienda Ospedaliera Bolognini di Seriate Bergamo||2|||f||||f||||||||||2017-10-10 22:50:30.991282|2017-10-10 22:50:30.991282
NCT02576015|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-14|||March 2016||2016-03-01|October 2015|2015-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Continuous Femoral Nerve Block With Modulation of Depth of Anesthesia on Prognosis of Patients Receiving Total Knee Arthroplasty|The Effect of Continuous Femoral Nerve Block With Modulation of Depth of Anesthesia on Prognosis of Patients Receiving Total Knee Arthroplasty|Not yet recruiting||N/A|380|Anticipated|First Affiliated Hospital of Chongqing Medical University||2|||f||||f||||||||||2017-10-10 22:50:31.067172|2017-10-10 22:50:31.067172
NCT02576002|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2016-02-25|||October 2015||2015-10-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)|Study to Estimate the Incidence and Prevalence and Treatment Patterns of Pediatric Pulmonary Hypertension in the US|Completed||N/A|2691|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:50:31.231872|2017-10-10 22:50:31.231872
NCT02575989|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-01-03|||January 2016||2016-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|HYPOTRAUM 2||Prevention of HYPOthermia in TRAUMa Patients|Prevention of HYPOthermia Before Admission in TRAUMa Patients - Hypotraum 2 Study|Recruiting||N/A|1200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:50:31.312018|2017-10-10 22:50:31.312018
NCT02575976|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-05-03|||March 2015||2015-03-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Cardiac Rehabilitation on Functional Capacity and Cardiovascular Risk Factors|Effects of Cardiac Rehabilitation on Functional Capacity and Cardiovascular Risk Factors in Brazilian Patients Assisted by Public Health Care: A Randomized Controlled Trial|Active, not recruiting||N/A|115|Actual|Federal University of Minas Gerais||3|||f||||f||||||||No||2017-10-10 22:50:31.411005|2017-10-10 22:50:31.411005
NCT02575963|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-10-03|||October 2012||2012-10-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|May 2018|Anticipated|2018-05-01||Interventional|||Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients|A Phase I/II Study of Lintuzumab-Ac225 in Older Patients With Untreated Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|72|Anticipated|Actinium Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:50:31.516816|2017-10-10 22:50:31.516816
NCT02575950|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-05-04|||June 2016||2016-06-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne|Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 Applied in a Split-face (Left/Right) Topical Design in Adults With Moderate to Severe Acne|Completed||Phase 2|40|Actual|LEO Pharma||2|||f||||f||||||||Undecided||2017-10-10 22:50:31.694384|2017-10-10 22:50:31.694384
NCT02575937|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-05-03|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Low Glycemic Diet Intervention and Community Diabetic Patients|The Efficiency of Nutrition Education-based Low Glycemic Diet Intervention on Community Diabetic Patients|Not yet recruiting||N/A|1000|Anticipated|Sun Yat-sen University||3|||f||||t||||||||||2017-10-10 22:50:31.808212|2017-10-10 22:50:31.808212
NCT02575924|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-01-14|||June 2015||2015-06-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Influence of Culture Media on Clinical Outcomes in Poor Responders or Severe Male Infertility|Employing a Single Step Media Can Improve the Clinical Outcomes in Those Patient Who Usually Show an High Cycle Cancellation Rate?|Recruiting||Phase 1|24|Anticipated|European Hospital||6|||f||||t||||||||||2017-10-10 22:50:31.898855|2017-10-10 22:50:31.898855
NCT02575911|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2017-04-25|2017-03-09||October 28, 2015|Actual|2015-10-28|April 2017|2017-04-01|April 9, 2016|Actual|2016-04-09|April 9, 2016|Actual|2016-04-09||Interventional||This analysis population includes all participants/eyes exposed to the device during the study (Safety Analysis Set).|Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study|Accuracy of LASIK Flaps Created With the LenSx® Femtosecond Laser - A Pilot Study|Completed||N/A|34|Actual|Alcon Research||1|||f||||f|f|t|f|||||||2017-10-10 22:50:32.040471|2017-10-10 22:50:32.040471
NCT02575898|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-05-23|||October 2015||2015-10-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study|Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study|Recruiting||N/A|20|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-10 22:50:32.459101|2017-10-10 22:50:32.459101
NCT02575885|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-08|||March 16, 2016|Actual|2016-03-16|July 2017|2017-07-01|September 18, 2019|Anticipated|2019-09-18|September 18, 2018|Anticipated|2018-09-18||Interventional|ENDS||Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers|Nicotine Delivery From Novel Non-tobacco Electronic Systems (ENDS)|Recruiting||N/A|36|Anticipated|Roswell Park Cancer Institute||2|||f||||f||||||||||2017-10-10 22:50:32.566671|2017-10-10 22:50:32.566671
NCT02575872|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-13|2015-10-14|||October 2013||2013-10-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors|The Effectiveness of a Comprehensive Physical Activity Behavioral Intervention on Underserved Diverse Obese Endometrial Cancer Survivors|Unknown status|Active, not recruiting|N/A|30|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-10 22:50:32.687875|2017-10-10 22:50:32.687875
NCT02575859|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-10-13|||January 2006||2006-01-01|September 2015|2015-09-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Interventional|||Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients|Pilot Study of Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Colorectal Cancer at High Risk for the Development of Metachronous Peritoneal Metastases|Completed||Phase 1/Phase 2|20|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-10 22:50:32.822433|2017-10-10 22:50:32.822433
NCT02575846|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-06-27|||November 26, 2015|Actual|2015-11-26|June 2017|2017-06-01|November 11, 2016|Actual|2016-11-11|November 11, 2016|Actual|2016-11-11||Interventional|||Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair|Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair|Completed||N/A|4|Actual|Duke University||2|||f||||||||||||||2017-10-10 22:50:32.90777|2017-10-10 22:50:32.90777
NCT02575833|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-05-09|||November 23, 2015|Actual|2015-11-23|May 2017|2017-05-01|April 13, 2017|Actual|2017-04-13|January 23, 2017|Actual|2017-01-23||Interventional|||Treadmill CV Safety Study|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of AMG 334 on Exercise Time During a Treadmill Test in Subjects With Stable Angina|Completed||Phase 2|89|Actual|Amgen||2|||f||||t||||||||||2017-10-10 22:50:32.994217|2017-10-10 22:50:32.994217
NCT02575820|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2016-05-12|||November 2015||2015-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Old Blood and Postoperative Complications|The Effects of Old Red Blood Cell Transfusion on Morbidity in Patients Undergoing Revision Total Hip Arthroplasty: Retrospective Study|Withdrawn||N/A|0|Actual|Seoul National University Hospital|||2|Sample size was too small to evaluate the clinical implications.|f||||f||||||||||2017-10-10 22:50:33.179945|2017-10-10 22:50:33.179945
NCT02575807|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-05-04|||January 2016||2016-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SEASCAPE||Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer|A Phase 1/2, Open-Label Safety and Efficacy Evaluation of CRS-207 in Combination With Epacadostat in Adults With Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer|Recruiting||Phase 1/Phase 2|126|Anticipated|Aduro Biotech, Inc.||4|||f||||t|t|f||||||No||2017-10-10 22:50:33.292551|2017-10-10 22:50:33.292551
NCT02575794|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-06-12|||November 15, 2017|Anticipated|2017-11-15|June 2017|2017-06-01|December 15, 2022|Anticipated|2022-12-15|December 15, 2021|Anticipated|2021-12-15||Interventional|||Terameprocol in Treating Patients With Recurrent High Grade Glioma|Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients With Recurrent High Grade Glioma|Suspended||Phase 1|23|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1||Drug production issues|f||||t|t|f||||||No||2017-10-10 22:50:33.420433|2017-10-10 22:50:33.420433
NCT02575768|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-10-14|||June 2012||2012-06-01|June 2012|2012-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Myocardial Flow Reserve in Severe AS Without Obstructive Coronary Artery Disease|Reduced Myocardial Flow Reserve in Exertional Angina With Severe Aortic Stenosis and Normal Coronary Arteries: Insight From Prospective Observational Adenosine-stress Cardiac Magnetic Resonance Imaging Study|Completed||N/A|104|Actual|Samsung Medical Center|||3||f||||t||||||||||2017-10-10 22:50:33.863184|2017-10-10 22:50:33.863184
NCT02575755|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-14|||October 2012||2012-10-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women|A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant Papua New Guinean Women|Unknown status|Recruiting|Phase 4|150|Anticipated|Papua New Guinea Institute of Medical Research||3|||f||||f||||||||||2017-10-10 22:50:33.952535|2017-10-10 22:50:33.952535
NCT02575742|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Colonic Motility in Constipation and Ageing|Colonic Motility And Gut Microbiota Composition In Constipation And Ageing|Unknown status|Recruiting|N/A|60|Anticipated|Queen Mary University of London|||4||f||||||||||||||2017-10-10 22:50:34.068633|2017-10-10 22:50:34.068633
NCT02575729|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-10-12|||August 2011||2011-08-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Sonography-guided Steroid Injection for Carpal Tunnel Syndrome|Sonography-guided Steroid Injection for Carpal Tunnel Syndrome|Completed||Phase 3|39|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 22:50:34.151982|2017-10-10 22:50:34.151982
NCT02575716|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-12|||March 2013||2013-03-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of Intubating Condition of the Mcgrath Videolaryngoscope With and Without Muscle Relaxant|Comparison of Intubating Condition of the Mcgrath Videolaryngoscope With and Without Muscle Relaxant|Completed||Phase 1|34|Actual|Prince of Songkla University||2|||f||||f||||||||||2017-10-10 22:50:34.281591|2017-10-10 22:50:34.281591
NCT02575703|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-11-20|||October 2015||2015-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of [¹⁴C]-LY3023414 in Healthy Participants|Disposition of [¹⁴C]-LY3023414 Following Oral Administration in Healthy Subjects|Completed||Phase 1|8|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 22:50:34.375967|2017-10-10 22:50:34.375967
NCT02575690|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-09-27|||January 2013||2013-01-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|May 2015|Actual|2015-05-01||Interventional|||Spirulina Supplementation and Cardiovascular Risk in Obese Caucasians With Treated Hypertension|Effect of Spirulina Maxima Supplementation on Cardiovascular Risk in Obese Caucasians With Treated Hypertension:a Randomized Double-blind Placebo-controlled Study|Active, not recruiting||N/A|150|Anticipated|Poznan University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:50:34.475461|2017-10-10 22:50:34.475461
NCT02575677|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-04-11|||October 2012||2012-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|oksisynnytys||Oxycodone in Treatment of Early Labour Pain Efficacy and Safety|Oxycodone in Treatment of Early Labour Pain Efficacy and Safety|Recruiting||N/A|90|Anticipated|Kuopio University Hospital|||1||f||||f|f|f||||Samples Without DNA|"     venous blood for the analysis of oxycodone   "|No||2017-10-10 22:50:34.563178|2017-10-10 22:50:34.563178
NCT02575664|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-12-25|||August 2012||2012-08-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|lonkkalaasta||Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty|Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty|Completed||Phase 4|160|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-10-10 22:50:34.644674|2017-10-10 22:50:34.644674
NCT02575651|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-02-09|||April 2015||2015-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies|A Phase I, Open-label, Dose Escalation Study to Assess the Safety and Tolerability of Fluzoparib Following Single and Multiple Oral Doses in Patients With Advanced Solid Malignancies|Recruiting||Phase 1|42|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:50:34.740109|2017-10-10 22:50:34.740109
NCT02575638|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-10-02|||July 2008||2008-07-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)|Phase I Clinical Trial of Camptothecin-20-O-Propionate Hydrate (CZ48)|Recruiting||Phase 1|65|Anticipated|Cao Pharmaceuticals Inc.||1|||f||||t||||||||||2017-10-10 22:50:34.833088|2017-10-10 22:50:34.833088
NCT02575625|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-14|||April 2013||2013-04-01|October 2015|2015-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|TRANSTEATOSE||Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis|Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis|Unknown status|Recruiting|N/A|85|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 22:50:34.956833|2017-10-10 22:50:34.956833
NCT02575612|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-15|||July 2014||2014-07-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer|Can a Pathological Complete Response in the Breast be Diagnosed by Vacuum-assisted, Ultrasound Guided Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients? A Proof of Concept From a Prospective Cohort Study|Completed||N/A|50|Actual|Heidelberg University||1|||f||||f||||||||||2017-10-10 22:50:35.066562|2017-10-10 22:50:35.066562
NCT02575599|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-06-01|||September 1, 2018|Anticipated|2018-09-01|November 2016|2016-11-01|January 1, 2020|Anticipated|2020-01-01|September 1, 2019|Anticipated|2019-09-01||Interventional|DiaWeb||Web-based Guided Self-Determination Intervention for Adults With Type 2 Diabetes in General Practice|Assessment of a Web-based Guided Self-Determination Intervention for Adults With Type 2 Diabetes in General Practice|Not yet recruiting||N/A|172|Anticipated|University of Stavanger||2|||f||||t|f|f||||||||2017-10-10 22:50:35.166407|2017-10-10 22:50:35.166407
NCT02575586|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-02-29|||October 2015||2015-10-01|October 2015|2015-10-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness of Deep Dry Needling on Muscle Tone in Healthy Subjects|Effectiveness of Deep Dry Needling on Muscle Tone in Healthy Subjects|Completed||N/A|35|Actual|University of Castilla-La Mancha||2|||f||||t||||||||Yes||2017-10-10 22:50:35.25665|2017-10-10 22:50:35.25665
NCT02575573|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-01-09|||October 2015||2015-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|REDEED||Resuscitation Decisions in the Emergency Department (ED)|Influencing Factors on Resuscitation Decisions in the ED|Recruiting||N/A|50000|Anticipated|University Hospital, Basel, Switzerland|||1||f||||t||||||||||2017-10-10 22:50:35.342967|2017-10-10 22:50:35.342967
NCT02575560|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-09|||October 2015||2015-10-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)|High Dose Weekly Use First-generation EGFR-TKI Instead of Daily Regular Dose in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 3|30|Anticipated|Qingdao Central Hospital|||1||f||||t||||||||||2017-10-10 22:50:35.44614|2017-10-10 22:50:35.44614
NCT02575547|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2017-07-27|||May 2015||2015-05-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|October 2016|Actual|2016-10-01||Observational|||Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients|Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemo-radiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: Prospective Observational Study|Recruiting||N/A|186|Anticipated|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 22:50:35.560197|2017-10-10 22:50:35.560197
NCT02575534|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-07-26|||October 2015||2015-10-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|AAD and CRT||Acute Mechanical Response to Anti-arrhythmic Drug Therapy|Acute Mechanical Response to Anti-arrhythmic Drug Therapy|Recruiting||N/A|50|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 22:50:35.674171|2017-10-10 22:50:35.674171
NCT02575521|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-11|||August 2015||2015-08-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Effect of Propofol-Dexmedetomidine on Cerebral Oxygenation and Metabolism During Brain Tumor Resection|Effect of Propofol-Dexmedetomidine Total Intravenous Anaesthesia on Cerebral Oxygenation and Metabolism During Brain Tumor Resection Compared to Sevoflurane Anaesthesia|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 22:50:35.782124|2017-10-10 22:50:35.782124
NCT02575508|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-05-19||||||May 2016|2016-05-01||||May 2020|Anticipated|2020-05-01||Interventional|||Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer|A Phase Ib/II Study of BGJ398 in Combination Modified FOLFIRINOX in Treatment-Naïve Metastatic Pancreatic Cancer Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Roswell Park Cancer Institute||1||drug supply issues|f||||t||||||||||2017-10-10 22:50:35.900567|2017-10-10 22:50:35.900567
NCT02575495|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-03-15|||February 2015||2015-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||A Randomized Control Trial of Antibiotic Treatment Duration For Asymptomatic Bacteriuria After Kidney Transplantation|A Pilot Randomized Control Study of Shortening Antibiotic Treatment Duration For Asymptomatic Bacteriuria Within A Month After Kidney Transplantation|Completed||Phase 2|20|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 22:50:36.039808|2017-10-10 22:50:36.039808
NCT02575482|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-06-03|||July 2015||2015-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects|A Single-center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SUVN-D4010 After Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects|Completed||Phase 1|64|Actual|Suven Life Sciences Limited||2|||f||||t||||||||||2017-10-10 22:50:36.120081|2017-10-10 22:50:36.120081
NCT02575469|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-23|||October 1, 2017|Anticipated|2017-10-01|January 2017|2017-01-01|January 1, 2036|Anticipated|2036-01-01|October 1, 2035|Anticipated|2035-10-01||Observational|||Exercise Capacity in Diseases and Health|Exercise Capacity in Diseases and Health|Not yet recruiting||N/A|500|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-10 22:50:36.208748|2017-10-10 22:50:36.208748
NCT02575456|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-11|2016-08-30|||October 2015||2015-10-01|December 2015|2015-12-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine|A Single-Center, Randomized, Blind, Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of the Adenovirus Type 5 Vector Based Ebola Virus Disease Vaccine (Ad5-EBOV) in Healthy Adults in Sierra Leone|Completed||Phase 2|500|Actual|Jiangsu Province Centers for Disease Control and Prevention||3|||f||||t||||||||||2017-10-10 22:50:36.266721|2017-10-10 22:50:36.266721
NCT02575443|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-08-20|||September 2015||2015-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neuromuscular Block and Anesthetic Depth Monitoring||Recruiting||N/A|40|Anticipated|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-10 22:50:36.360272|2017-10-10 22:50:36.360272
NCT02575430|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-04-28|||December 2015||2015-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT|Retrospective, Uncontrolled, Multicenter, Case History Study to Determine the Natural History of Visual Function in Subjects With Inherited Retinal Disease (IRD) Caused by Inherited Mutation of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)|Completed||N/A|59|Actual|QLT Inc.|||1||f||||f||||||||||2017-10-10 22:50:36.44231|2017-10-10 22:50:36.44231
NCT02575417|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-04-10|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|CERC||Development of a Community Engagement Activity for Advance Care Planning|Development of a Community Engagement Activity for Advance Care Planning|Completed||N/A|93|Actual|Milton S. Hershey Medical Center||3|||f||||t||||||||||2017-10-10 22:50:36.549425|2017-10-10 22:50:36.549425
NCT02575404|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-09-18|||October 2015||2015-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients|Phase IB Study of a Galectin Inhibitor (GR-MD-02) and Pembrolizumab in Patients With Metastatic Melanoma, Non-Small Cell Lung Cancer, and Head and Neck Squamous Cell Carcinoma.|Recruiting||Phase 1|22|Anticipated|Providence Health & Services||3|||f||||f||||||||||2017-10-10 22:50:36.629878|2017-10-10 22:50:36.629878
NCT02575391|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-10-09|||October 2009||2009-10-01|October 2015|2015-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Effects of Whole Food Intervention on Mucositis in Patients Treated for Thoracic Cancer|The Effects of Whole Food Intervention on Mucositis in Patients Treated for Thoracic Cancer With Radiation With or Without Chemotherapy|Terminated||Phase 1/Phase 2|7|Actual|Providence Health & Services||1||Lack of participant recruitment.|f||||f||||||||||2017-10-10 22:50:36.753528|2017-10-10 22:50:36.753528
NCT02575378|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-10-13|||September 2015||2015-09-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer||Active, not recruiting||Phase 4|159|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-10 22:50:36.830152|2017-10-10 22:50:36.830152
NCT02575365|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-09-26|||February 16, 2016|Actual|2016-02-16|September 2017|2017-09-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|||Effect of Fingolimod on Neurodegeneration|Effect of Fingolimod on Neurodegeneration, Brain Atrophy and Cognitive Impairment in Relapsing Remitting Multiple Sclerosis Patients|Terminated||Phase 4|4|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-10 22:50:36.900903|2017-10-10 22:50:36.900903
NCT02575352|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-08-09|||May 2015||2015-05-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01|24 Months|Observational [Patient Registry]|CPC||Calcium Phosphate Cement Registry (CPC Registry)|Observational Prospective Multi-center International Study on the Use of Injectable Calcium Phosphate Cements for the Treatment of Bone Defects in Adults.|Recruiting||N/A|500|Anticipated|Graftys SA|||1||f||||f||||||||||2017-10-10 22:50:37.006001|2017-10-10 22:50:37.006001
NCT02575339|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-08-30|||July 2016||2016-07-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2018|Anticipated|2018-12-01||Interventional|||MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma|An Open Label Randomized Phase I/II Trial of MLN0128 Compared to Sorafenib in Patients With Advanced or Metastatic Hepatocellular Carcinoma: Big Ten Cancer Research Consortium BTCRC-GI13-002|Recruiting||Phase 1/Phase 2|118|Anticipated|Big Ten Cancer Research Consortium||3|||||||t|t|f||||||||2017-10-10 22:50:37.171714|2017-10-10 22:50:37.171714
NCT02575326|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-13|||August 2015||2015-08-01|October 2015|2015-10-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|TAC||Teen Asthma Control Encouraging a Healthier Lifestyle|Developing Patient-Centered Approaches to Asthma Management in Obese Adolescents|Unknown status|Recruiting|N/A|166|Anticipated|Henry Ford Health System||2|||f||||f||||||||||2017-10-10 22:50:37.311844|2017-10-10 22:50:37.311844
NCT02575313|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-10-09|||October 2009||2009-10-01|October 2015|2015-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer|The Effects of Whole Food Intervention on Mucositis in Patients Being Treated for Head and Neck Cancer With Radiation With or Without Chemotherapy|Terminated||Phase 1/Phase 2|10|Actual|Providence Health & Services||1||Lack of participant recruitment.|f||||f||||||||||2017-10-10 22:50:37.403307|2017-10-10 22:50:37.403307
NCT02575300|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-06-30|||October 9, 2015|Actual|2015-10-09|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors|Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors|Recruiting||Phase 2|51|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 22:50:37.488861|2017-10-10 22:50:37.488861
NCT02575287|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-01-07|||September 2015||2015-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Minimal Injuries From Esophagus Detected by Optical Enhancement System™ Associated to Optical Magnification HD Scopes|Mucosal and Minimal Injuries Detected Through Digital Chromoendoscopy Using Optical Enhancement System™ Associated to High Definition Plus Optical Magnification in Non Erosive Gastroesophageal Reflux Disease|Completed||N/A|100|Actual|Instituto Ecuatoriano de Enfermedades Digestivas|||2||f||||t||||||Samples Without DNA|"     histological biopsies from esophagus   "|||2017-10-10 22:50:37.589207|2017-10-10 22:50:37.589207
NCT02575274|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-10-11|||September 2013||2013-09-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Peri-Implantitis Surgical Treatment an RCT Study|Regenerative Treatment of Peri-Implantitis: Double Blind Randomized Controlled Clinical Trial|Unknown status|Enrolling by invitation|Phase 2/Phase 3|30|Anticipated|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-10 22:50:37.71406|2017-10-10 22:50:37.71406
NCT02575261|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-08-14|||September 2015|Actual|2015-09-01|October 2015|2015-10-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients|Chimeric Antigen Receptor-Modified T Cells for EphA2 Positive Recurrent and Metastatic Malignant Glioma|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 22:50:37.842175|2017-10-10 22:50:37.842175
NCT02575248|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-06-20|||October 2014||2014-10-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Induction of Ovulation by Clomiphene Citrate Following Laparoscopic Surgery for Endometriosis Stage 1 and Stage 2 With and Without Suppression by Dienogest|Induction of Ovulation by Clomiphene Citrate Following Laparoscopic Surgery for Endometriosis Stage 1 and Stage 11 With and Without Suppression by Dienogest|Recruiting||Phase 4|310|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:50:37.956905|2017-10-10 22:50:37.956905
NCT02575235|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2015-10-13|||October 2015||2015-10-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|CPC2||Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia|Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia|Unknown status|Not yet recruiting|Early Phase 1|75|Anticipated|Seoul National University Hospital||3|||f||||f||||||||||2017-10-10 22:50:38.127338|2017-10-10 22:50:38.127338
NCT02575222|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-07-06|||February 2016||2016-02-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma|Phase I Study of Neoadjuvant Nivolumab in Patients With Non-metastatic High-risk Clear Cell Renal Cell Carcinoma|Recruiting||Phase 1|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:50:38.40102|2017-10-10 22:50:38.40102
NCT02575209|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-07-26|||September 2015||2015-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects|Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects|Completed||N/A|80|Actual|Corporacion Parc Tauli|||4||f||||||||||||||2017-10-10 22:50:38.633062|2017-10-10 22:50:38.633062
NCT02575196|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-04-18|||October 2015||2015-10-01|April 2017|2017-04-01|March 21, 2016|Actual|2016-03-21|March 21, 2016|Actual|2016-03-21||Observational|NINCA||Non Invasive Neuromonitoring After Cardiac Arrest|Phase 2 Prospective, Observational, Pilot Study of Noninvasive Monitoring of Regional Cerebral Blood Flow for the Evaluation of Brain Tissue Perfusion During and After Resuscitation for Cardiac Arrest|Completed||N/A|21|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f|f|f||||||||2017-10-10 22:50:38.816866|2017-10-10 22:50:38.816866
NCT02575183|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-01-24|||August 31, 2016|Actual|2016-08-31|January 2017|2017-01-01|December 1, 2018|Anticipated|2018-12-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation|Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation|Recruiting||Phase 4|152|Anticipated|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-10 22:50:38.996881|2017-10-10 22:50:38.996881
NCT02575170|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2016-07-31|||June 2013||2013-06-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Amino Acid Infusion in Mothers Before and During Cesarean Delivery|Intravenous Amino Acid Infusion in Mothers Before and During Cesarean Delivery: Effects on Maternal and Neonatal Temperature|Completed||N/A|76|Actual|B.P. Koirala Institute of Health Sciences||2|||f||||f||||||||||2017-10-10 22:50:39.240593|2017-10-10 22:50:39.240593
NCT02575157|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-10-13|||June 2015||2015-06-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|||"Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a Drug Holiday From Bisphosphonates"|"Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a Drug Holiday From Bisphosphonates"|Recruiting||N/A|120|Anticipated|National Bone Health Alliance||1|||f||||f||||||||||2017-10-10 22:50:39.444701|2017-10-10 22:50:39.444701
NCT02575144|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-12-08|||September 2015||2015-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|GEM-CLARIDEX||GEM-CLARIDEX: Ld vs BiRd|GEM-CLARIDEX: Lenalidomide and Dexamethasone (Ld) Versus Clarithromycin / Lenalidomide [Revlimid®] / Dexamethasone (BiRd) as Initial Therapy in Multiple Myeloma|Recruiting||Phase 3|338|Anticipated|PETHEMA Foundation||2|||f||||t||||||||||2017-10-10 22:50:39.589841|2017-10-10 22:50:39.589841
NCT02575131|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-10-18|||October 2015||2015-10-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Breakfast Test Products and Acute Satiety Scores|The Effect of Breakfast Test Products on Acute Satiety Scores in Different Test Conditions|Completed||Phase 2|32|Actual|TNO||10|||f||||f||||||||||2017-10-10 22:50:39.885728|2017-10-10 22:50:39.885728
NCT02575118|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-05-24|||October 2015||2015-10-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Bisphenol A in Saliva and Urine Related to Placement of Dental Composites|Concentration of Bisphenol A in Saliva and Urine Before and After Treatment With Polymer-based Dental Filling Materials|Recruiting||N/A|20|Anticipated|Uni Research|||1||f||||f||||||Samples Without DNA|"     Saliva Urine   "|||2017-10-10 22:50:40.064347|2017-10-10 22:50:40.064347
NCT02575105|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-10|2015-10-14|||May 2008||2008-05-01|October 2015|2015-10-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Observational|BIS1||BIS Monitoring of Patients With Hydrocephalus|Bispectral Index Monitoring of Propofol Anesthesia in Patients With Hydrocephalus. A Prospective Observational Study|Completed||N/A|60|Actual|Medical University of Graz|||4||f||||f||||||||||2017-10-10 22:50:40.16972|2017-10-10 22:50:40.16972
NCT02575092|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-09-24|||November 2015||2015-11-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|August 2017|Anticipated|2017-08-01||Interventional|CONTRAST-CADT||The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment|Department of Geriatrics|Recruiting||Phase 2/Phase 3|4000|Anticipated|Fuling Central Hospital of Chongqing City||3|||f||||t||||||||||2017-10-10 22:50:40.265124|2017-10-10 22:50:40.265124
NCT02575079|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-07-19|||March 2015||2015-03-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT|Parafilm Application to Prevent Central Line Associated Bloodstream Infections in Pediatric Patients Undergoing Hematopoietic Cell Transplantation|Active, not recruiting||N/A|51|Actual|Emory University||1|||f||||t||||||||||2017-10-10 22:50:40.41108|2017-10-10 22:50:40.41108
NCT02575066|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-09-26|||January 2016||2016-01-01|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|January 2021|Anticipated|2021-01-01||Interventional|PASART-2||Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients|Phase II Clinical Study of Concurrent Pazopanib for Non-metastatic Sarcoma Patients to be Treated With Radiotherapy, Localized in the Extremities, Trunk and Chest Wall or the Head and Neck Region (PASART-2)|Recruiting||Phase 2|35|Anticipated|The Netherlands Cancer Institute||1|||f||||t|f|f||||||||2017-10-10 22:50:40.5251|2017-10-10 22:50:40.5251
NCT02575053|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-12-06|||October 2015||2015-10-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|||Safety of a Powder-free Latex Allergy Protocol in the Operating Theatre: A Prospective, Observational Cohort Study|Switching to Powder Free Latex Gloves in the Entire OR as Part of a New ' Latex Safe' Protocol: a Safe Alternative? A Prospective, Observational Cohort Study|Completed||N/A|221|Actual|Jessa Hospital|||1||f||||f||||||||||2017-10-10 22:50:40.694607|2017-10-10 22:50:40.694607
NCT02575040|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-12|||May 2015||2015-05-01|October 2015|2015-10-01|May 2020|Anticipated|2020-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease|Efficacy of Fecal Microbiota Transplantation for Refractory Inflammatory Bowel Disease|Recruiting||Phase 3|60|Anticipated|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||1|||f||||t||||||||||2017-10-10 22:50:40.850555|2017-10-10 22:50:40.850555
NCT02575027|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2017-01-04|||November 2014||2014-11-01|January 2017|2017-01-01||||November 2017|Anticipated|2017-11-01||Interventional|||Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme|4π Radiotherapy for Recurrent Glioblastoma Multiforme: A Feasibility Trial|Recruiting||N/A|10|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:50:40.953169|2017-10-10 22:50:40.953169
NCT02575014|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-07-26|||October 2013||2013-10-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|HBOT||Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy|Preoperative Hyperbaric Oxygen Therapy (HBOT) vs. Non Preoperative HBOT in Patients Undergoing Pancreaticoduodenectomy for Premalignant, and Malignant Tumors of the Common Bile Duct, Periampullary and Duodenum|Enrolling by invitation||N/A|50|Anticipated|Florida Hospital Tampa Bay Division||2|||f||||t||||||||||2017-10-10 22:50:41.091514|2017-10-10 22:50:41.091514
NCT02575001|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-10-13|||July 2015||2015-07-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|||The Influence of Psychobiological Adversity to Children and Adolescents With Type 1 Diabetes|The Influence of Psychobiological Adversity to Children and Adolescents With Type 1 Diabetes|Unknown status|Recruiting|N/A|200|Anticipated|University of Ljubljana, Faculty of Medicine|||3||f||||f||||||Samples With DNA|"     The genes with expected influence to stress reactivity and mental disorders will be tested.   "|||2017-10-10 22:50:41.206203|2017-10-10 22:50:41.206203
NCT02574988|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-07-25|||January 2014||2014-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|ThaiSCAR||Severe Cutaneous Adverse Reactions in Thailand|The Multicenter Registry of Patients With Severe Cutaneous Adverse Reactions Among Tertiary Medical Institutes in Thailand|Recruiting||N/A|200|Anticipated|Chulalongkorn University|||1||f||||t||||||Samples With DNA|"     cryopreserved peripheral blood mononuclear cells, buffy coat, serum   "|No||2017-10-10 22:50:41.422463|2017-10-10 22:50:41.422463
NCT02574975|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-15|||April 2015||2015-04-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics|Comparison of Different Methodologies Assessing Airway Responsiveness and Investigation of Treatment Efficacy of Budesonide /Formoterol in Asthmatics|Unknown status|Recruiting|Phase 4|80|Anticipated|Zhujiang Hospital||5|||f||||t||||||||||2017-10-10 22:50:41.546297|2017-10-10 22:50:41.546297
NCT02574962|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2016-07-15|||August 2015||2015-08-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy|Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy|Withdrawn||Phase 2|0|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-10 22:50:41.663494|2017-10-10 22:50:41.663494
NCT02574949|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-10-13|||July 2015||2015-07-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Impact of Low Frame Rate Fluoroscopy and Cine-angiography on Reducing Operator and Patient Dose|Impact of Low Frame Rate Fluoroscopy and Cine-angiography on Reducing Operator and Patient Radiation Dose and Impact on Image Quality During Cardiac Catheterization|Unknown status|Not yet recruiting|N/A|600|Anticipated|University Health Network, Toronto||3|||f||||f||||||||||2017-10-10 22:50:41.780859|2017-10-10 22:50:41.780859
NCT02574936|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-13|||January 2014||2014-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Reduction Dead Space Volume With Karydakis Modification|Effects of Reduction Dead Space Volume With Karydakis Modification|Completed||N/A|80|Actual|Siverek Devlet Hastanesi||1|||f||||t||||||||||2017-10-10 22:50:41.877287|2017-10-10 22:50:41.877287
NCT02574923|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-12-04|||November 2015||2015-11-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Outcomes of Stem Cells for Cerebral Palsy|Outcomes of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy: A Self-Controlled Clinical Trial|Recruiting||Phase 2|30|Anticipated|Vinmec International Hospital||1|||f||||f||||||||||2017-10-10 22:50:41.956132|2017-10-10 22:50:41.956132
NCT02574910|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-08-03|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1|A Phase 1 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children With Classic 21-Hydroxylase Deficiency|Recruiting||Phase 1|36|Anticipated|University of Texas Southwestern Medical Center||3|||f||||t|t|f||||||||2017-10-10 22:50:42.046847|2017-10-10 22:50:42.046847
NCT02574897|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-07-14|||July 2014||2014-07-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||The Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for Chemotherapy|Evaluating the Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for Intensive Chemotherapy|Recruiting||N/A|120|Anticipated|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-10 22:50:42.165217|2017-10-10 22:50:42.165217
NCT02574884|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-12|||August 2011||2011-08-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|VINTAGE VHC||Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins||Completed||N/A|8|Actual|University Hospital, Tours||3|||f||||f||||||||||2017-10-10 22:50:42.254346|2017-10-10 22:50:42.254346
NCT02574871|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-13|||August 2014||2014-08-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Data Collection for Stress Identification|Data Collection for Identification of the Chronic Stress Presence in Healthy Adult Subjects|Completed||N/A|120|Actual|University of Mogi das Cruzes|||1||f||||t||||||||||2017-10-10 22:50:42.32797|2017-10-10 22:50:42.32797
NCT02574845|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-12|2016-12-20|2016-12-08||October 2015||2015-10-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||The randomised set (RS) includes all randomised subjects, whether treated or not.|DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)|The Effect of Different Doses of Metformin or Furosemide on Rosuvastatin Pharmacokinetics Following Oral Administration in Healthy Male Subjects (an Open-label, Randomised, Single-dose, Six-way Crossover Study)|Completed||Phase 1|18|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 22:50:42.497233|2017-10-10 22:50:42.497233
NCT02574819|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-10|||April 2015||2015-04-01|October 2015|2015-10-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Methylnaltrexone in Opioid-Induced Constipation Patients|Methylnaltrexone (MNTX) for Treatment of Opioid-induced Constipation in Advanced Illness Patients : a Multicenter, Randomized, Double-blind , Placebo-controlled Trail|Unknown status|Recruiting|Phase 2/Phase 3|198|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||f||||||||||2017-10-10 22:50:43.336389|2017-10-10 22:50:43.336389
NCT02574806|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-08-15|||April 2014||2014-04-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Normal Values of Brain Natriuretic Peptide in Healthy Newborn|Normal Values of Brain Natriuretic Peptide in Healthy Newborn|Completed||N/A|167|Actual|Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud|||2||f||||||||||||||2017-10-10 22:50:43.46125|2017-10-10 22:50:43.46125
NCT02574793|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-10|||December 2014||2014-12-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Observational|||Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects|Characteristics of Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects|Unknown status|Recruiting|N/A|60|Anticipated|Huashan Hospital|||1||f||||t||||||||||2017-10-10 22:50:43.536113|2017-10-10 22:50:43.536113
NCT02574780|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-10-07|||April 2014||2014-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|LTP||Lymphedema Upper Limb of Breast Cancer Through Muscle Strengthening Associated With Complex Physical Therapy|Lymphedema Treatment of Post-surgical Upper Limb of Breast Cancer Through Muscle Strengthening Associated With Complex Physical Therapy|Completed||Phase 2/Phase 3|42|Actual|Federal University of São Paulo||2|||f||||t||||||||No||2017-10-10 22:50:43.622288|2017-10-10 22:50:43.622288
NCT02574767|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-09|||August 2015||2015-08-01|October 2015|2015-10-01|March 2018|Anticipated|2018-03-01|September 2016|Anticipated|2016-09-01||Interventional|MIGHT||Diet and Physical Activity Counseling and n3-long Chain (PUFA) Supplementation in Obese Pregnant Women|Effectiveness on Maternal and Offspring Metabolic Control of a Home-based Dietary and Physical Activity Counseling and n3-long Chain Polyunsaturated Fatty Acids (PUFA) Supplementation in Obese Pregnant Women.|Recruiting||N/A|1000|Anticipated|University of Chile||4|||f||||f||||||||||2017-10-10 22:50:43.718087|2017-10-10 22:50:43.718087
NCT02574754|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-04-12|||May 2016||2016-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Assessment of 2012 Bioequivalence Standards for Warfarin|Assessment of 2012 Bioequivalence Standards for Narrow Therapeutic Index Drugs: a Study With Warfarin|Not yet recruiting||Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 22:50:45.909847|2017-10-10 22:50:45.909847
NCT02574741|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-04-28|||June 2012||2012-06-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PIII||Combination Treatment for Augmenting Language in Children With ASD|Augmenting Language Interventions in ASD: A Translational Approach (ACE Project 3)|Recruiting||Phase 2|72|Anticipated|University of California, Los Angeles||3|||f||||t||||||||||2017-10-10 22:50:46.021197|2017-10-10 22:50:46.021197
NCT02574728|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-07-15|||June 2015||2015-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|AflacST1502||Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors|AflacST1502: A Phase II Study of Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors|Recruiting||Phase 2|60|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 22:50:46.133762|2017-10-10 22:50:46.133762
NCT02574715|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-06-28|||September 18, 2015|Actual|2015-09-18|June 2017|2017-06-01|September 28, 2016|Actual|2016-09-28|July 1, 2016|Actual|2016-07-01||Observational|JULIA||An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive Method|A Cross-sectional, Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess® as Their Contraceptive Method - The JULIA Study.|Completed||N/A|1039|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:50:46.24696|2017-10-10 22:50:46.24696
NCT02574702|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-10-12|||February 2013||2013-02-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Trial to Reduce Wound Infection With Contralateral Drainage in Loop Ileostomy Closure|Prospective Randomized Controlled Trial to Reduce the Superficial Surgical Site Infection Due to a Contralateral Drainage Application in Loop Ileostomy Closure|Unknown status|Recruiting|Phase 4|78|Anticipated|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-10 22:50:46.331651|2017-10-10 22:50:46.331651
NCT02574689|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-04-28|||September 2014||2014-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|HIPP||Home-based, Individually-tailored Physical Activity Print Intervention for African American Women in the Deep South|Home-based, Individually-tailored Physical Activity Print Intervention for African American Women in the Deep South|Active, not recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 22:50:46.427442|2017-10-10 22:50:46.427442
NCT02574676|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-09-26|||October 2015||2015-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|12 Months|Observational [Patient Registry]|||Quality of Life (QOL) Registry for Patients With AL Amyloidosis|Prospective Observational Study Measuring the Short-Form36 ( SF-36v2) and Other QOL Tools in an AL Amyloidosis Population|Active, not recruiting||N/A|343|Actual|Prothena Therapeutics Ltd.|||1||f||||f||||||||||2017-10-10 22:50:46.518835|2017-10-10 22:50:46.518835
NCT02574663|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-06-28|||October 2015||2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors|A Phase I Study Evaluating the Safety and Efficacy of TGR 1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors|Active, not recruiting||Phase 1|65|Actual|TG Therapeutics, Inc.||4|||f||||t||||||||||2017-10-10 22:50:46.604582|2017-10-10 22:50:46.604582
NCT02574650|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-07-26|||November 2015||2015-11-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|SCOUT||Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.|Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) for Symptomatic Chronic Functional Tricuspid Regurgitation|Recruiting||N/A|30|Anticipated|Mitralign, Inc.||1|||f||||t||||||||||2017-10-10 22:50:46.756951|2017-10-10 22:50:46.756951
NCT02574637|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-03-31|||January 5, 2016|Actual|2016-01-05|March 2017|2017-03-01|June 18, 2019|Anticipated|2019-06-18|January 1, 2019|Anticipated|2019-01-01||Interventional|||Evaluation of Efficacy and Safety of MEDI2070 in Subjects With Active, Moderate to Severe Crohn's Disease|A Phase 2b Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti Tumor Necrosis Factor-Alpha Therapy|Recruiting||Phase 2|342|Anticipated|Allergan||5|||f||||t|t|f||||||||2017-10-10 22:50:47.073333|2017-10-10 22:50:47.073333
NCT02574624|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-09-25|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|VISIA||Vitreous Surgery With Intraocular Assistance|Vitreous Surgery With Intraocular Assistance (VISIA)|Terminated||N/A|5|Actual|Johns Hopkins University||1||Difficulty in finding patients with complex retinal pathology to enroll in this study.|f||||f||||||||||2017-10-10 22:50:47.546098|2017-10-10 22:50:47.546098
NCT02574611|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-11-14|||October 2015||2015-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of High Resolution Colonic Manometry in Studying Motility|Safety and Efficacy of High Resolution Manometry in Studying Colonic Motility and Iontophoretic Administration of Prokinetic Agents|Recruiting||Phase 1|16|Anticipated|James J. Peters Veterans Affairs Medical Center||4|||f||||f||||||||||2017-10-10 22:50:47.635989|2017-10-10 22:50:47.635989
NCT02574598|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-04-07|||June 2016||2016-06-01|April 2016|2016-04-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|||MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients|A Randomized Crossover, Phase II Clinical Trial of MK-3475 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Non-Small Cell Lung Cancer (NSCLC) Previously Treated.|Not yet recruiting||Phase 2|70|Anticipated|Instituto Nacional de Cancerologia de Mexico||2|||f||||f||||||||Yes||2017-10-10 22:50:47.758095|2017-10-10 22:50:47.758095
NCT02574585|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-10-09|||December 2015||2015-12-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury|Randomized Clinical Trial for the Evaluation of Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury|Not yet recruiting||Phase 2|40|Anticipated|Hospital Sao Rafael||2|||f||||t||||||||||2017-10-10 22:50:47.868776|2017-10-10 22:50:47.868776
NCT02574572|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-10-09|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury|Evaluation of the Safety and Potential Effectiveness of Autologous Mesenchymal Stem Cells Transplantation in Subjects With Cervical Chronic and Complete Spinal Cord Injury|Unknown status|Recruiting|Phase 1|10|Anticipated|Hospital Sao Rafael||1|||f||||t||||||||||2017-10-10 22:50:47.947205|2017-10-10 22:50:47.947205
NCT02574546|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-05-02|||January 2017||2017-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Markers for Predicting Risk of Breast Cancer in Women of Different Races|Molecular Markers for Predicting Risk of Developing Breast Cancer in Different Ethnicities|Recruiting||N/A|150|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||Samples With DNA|"     Blood and breast tissue (normal and tumor cells) samples will be collected.   "|||2017-10-10 22:50:48.227504|2017-10-10 22:50:48.227504
NCT02574533|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-09-26|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma|A Pilot Study of Vigil™ Augmented Autologous Tumor Cell Immunotherapy in Combination With Pembrolizumab PD-1 Inhibitor for Patients With Advanced Melanoma|Completed||Phase 1|2|Actual|Gradalis, Inc.||1|||f||||t||||||||||2017-10-10 22:50:48.494495|2017-10-10 22:50:48.494495
NCT02574520|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-06-14|||November 2015|Actual|2015-11-01|June 2017|2017-06-01||||August 2017|Anticipated|2017-08-01||Interventional|PERSIST||Trial of Extended Release Bupivacaine for Pain Relief After Surgery|A Placebo-controlled Trial (Part 1) or Active-controlled (Part 2) of SABER® Bupivacaine for the Management of Postoperative Pain Following Laparoscopic Cholecystectomy|Active, not recruiting||Phase 3|264|Anticipated|Durect||2|||f||||f||||||||||2017-10-10 22:50:48.642814|2017-10-10 22:50:48.642814
NCT02574507|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-07-13|||October 2015||2015-10-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners|Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners|Recruiting||N/A|100|Anticipated|Duke University||1|||f||||t||||||||||2017-10-10 22:50:48.871426|2017-10-10 22:50:48.871426
NCT02574494|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2017-02-02|||October 2015||2015-10-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Does Breastfeeding Lower Blood Pressure in Postpartum Hypertensive Patients?||Recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 22:50:49.060108|2017-10-10 22:50:49.060108
NCT02574481|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-02-21|||December 2015|Actual|2015-12-01|February 2017|2017-02-01|March 2022|Anticipated|2022-03-01|March 2018|Anticipated|2018-03-01||Interventional|IMPERIAL||ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent|A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries|Active, not recruiting||Phase 3|524|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-10 22:50:49.166021|2017-10-10 22:50:49.166021
NCT02574468|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2015-10-10|||January 2013||2013-01-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Topical Dexamethasone on Histologic Response of Human Dental Pulp|Effect of Topical Dexamethasone on Histologic Response of Human Dental Pulp|Completed||Phase 4|10|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:50:49.490922|2017-10-10 22:50:49.490922
NCT02574455|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-03-27|||March 31, 2017|Anticipated|2017-03-31|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer|Phase III Study of Sacituzumab Govitecan (IMMU-132) in Refractory/Relapsed Triple-Negative Breast Cancer|Not yet recruiting||Phase 3|328|Anticipated|Immunomedics, Inc.||2|||f||||t|t|f||||||Undecided||2017-10-10 22:50:49.600068|2017-10-10 22:50:49.600068
NCT02574442|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-01-30|||September 2017|Anticipated|2017-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|Confocal||Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer|Pilot Study of the Hand-held In Vivo Confocal Microscopy Probe for Detection of Cervical Intraepithelial Neoplasia|Suspended||N/A|60|Anticipated|British Columbia Cancer Agency|||1|Funding has run out but we are trying to secure more funding.|f||||f||||||Samples Without DNA|"     Cervical biopsies   "|||2017-10-10 22:50:49.727454|2017-10-10 22:50:49.727454
NCT02574429|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-10-13|||November 2015||2015-11-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|CPTDBT||CPT Group for DBT Clients With Co-Occurring Borderline Personality Disorder and PTSD|Pilot Study Examining the Impact of a Cognitive Processing Therapy (CPT) Group for Patients With Co-Occurring Borderline Personality Disorder and Posttraumatic Stress Disorder|Unknown status|Not yet recruiting|N/A|45|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||t||||||||||2017-10-10 22:50:49.846186|2017-10-10 22:50:49.846186
NCT02574416|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-09-13|||February 2015||2015-02-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|June 2016|Actual|2016-06-01||Observational|LiLL||An Evaluation of the Determinants of Lifestyle and Health Behaviors in Later Life|An Evaluation of the Determinants of Lifestyle and Health Behaviours in Later Life, and to Investigate Their Relationship With Health Outcomes|Active, not recruiting||N/A|84|Actual|National Health Service, United Kingdom|||1||f||||f||||||||||2017-10-10 22:50:49.947203|2017-10-10 22:50:49.947203
NCT02574403|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-09-20|||November 2015||2015-11-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|STOPECU||Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS|Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)|Recruiting||Phase 4|60|Anticipated|Nantes University Hospital||1|||f||||t||||||||||2017-10-10 22:50:50.052577|2017-10-10 22:50:50.052577
NCT02574390|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-04-20|||December 2015||2015-12-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01|1 Year|Observational [Patient Registry]|AnswerALS||Answer ALS: Individualized Initiative for ALS Discovery|Answer ALS -Creation of a Large Bio-repository of iPS Cells, Cell Lines, and Bio-fluid Samples, Combined With Clinical Information to Rapidly Advance Therapeutics That Could Treat ALS|Recruiting||N/A|1000|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"     plasma, serum, DNA, Cerebrospinal fluid, induced pluripotent stem cells,   "|||2017-10-10 22:50:50.292282|2017-10-10 22:50:50.292282
NCT02574364|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-09|||July 2013||2013-07-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|ACAOA||Abdomen CT and Open Appendicectomy：New Diagnostic and Surgical Procedures|Abdomen CT and Open Appendicectomy：New Diagnostic and Surgical Procedures|Completed||N/A|730|Actual|Ningbo Municipal No.4 Hospital||2|||f||||t||||||||||2017-10-10 22:50:50.548216|2017-10-10 22:50:50.548216
NCT02574351|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-01-28|||May 2011||2011-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Study of T-Regulatory Cells in Asthma|Study of T-Regulatory Cells in Asthma|Completed||N/A|66|Actual|Northwell Health|||4||f||||f||||||Samples Without DNA|"     T regulatory cells are isolated in the blood specimens   "|||2017-10-10 22:50:50.64903|2017-10-10 22:50:50.64903
NCT02574338|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-02-17|||September 2015||2015-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Cervical Ripening: A Comparison Between Intravaginal Misoprostol Tablet and Intracervical Foley's Catheter in a Low Resource Setting||Recruiting||N/A|126|Anticipated|Federal Teaching Hospital Abakaliki||2|||f||||t||||||||||2017-10-10 22:50:50.740955|2017-10-10 22:50:50.740955
NCT02574325|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-08-05|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis||Unknown status|Active, not recruiting|Phase 2|11|Actual|Arisaph Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-10 22:50:51.027287|2017-10-10 22:50:51.027287
NCT02574312|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-14|||October 2015||2015-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SOLO||ATTUNE Single-Use Instrumentation vs. ATTUNE Reusable Instrumentation in Primary Total Knee Arthroplasty|Comparison of Alignment Achieved Using Single-Use Versus Reusable Instrumentation in Total Knee Arthroplasty (TKA): A Prospective, Non-Randomized Multi-center Investigation|Recruiting||N/A|88|Anticipated|DePuy Orthopaedics||2|||f||||f||||||||||2017-10-10 22:50:51.151835|2017-10-10 22:50:51.151835
NCT02573922|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-09|||May 2012||2012-05-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|oksineukir||Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery|Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery|Completed||Phase 4|180|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-10-10 22:50:55.450333|2017-10-10 22:50:55.450333
NCT02574299|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-08-26|||October 2014||2014-10-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PRODIPRICIDE||Characterization of Auditory Processing Involved in the Encoding of Speech Sounds|Characterization of Ascending and Descending Auditory Processing Involved in the Encoding of Speech Sounds in Adult and Children: Variability Related to Changes in Sensory Input or a Neurodevelopmental Disorder or Targeted Remediation|Recruiting||N/A|165|Anticipated|Hospices Civils de Lyon||6|||f||||f||||||||||2017-10-10 22:50:51.296148|2017-10-10 22:50:51.296148
NCT02574286|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-08-08|||May 1, 2016|Actual|2016-05-01|August 2017|2017-08-01|March 31, 2021|Anticipated|2021-03-31|February 26, 2021|Anticipated|2021-02-26||Interventional|||Phase 4 Study to Evaluate the Effect of Velaglucerase Alfa (VPRIV®) on Patients With Type 1 Gaucher Disease Through the IV Administration of VPRIV® Over 2 Years|An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment With Velaglucerase Alfa on Bone-related Pathology in Treatment-naïve Patients With Type 1 Gaucher Disease|Recruiting||Phase 4|40|Anticipated|Shire||1|||f||||f|t|f||||||||2017-10-10 22:50:51.41087|2017-10-10 22:50:51.41087
NCT02574273|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-06-02|||October 2015||2015-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)|Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program) for Youth With Anxiety, ADHD, or Autistic Disorder|Recruiting||N/A|160|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||No||2017-10-10 22:50:51.572854|2017-10-10 22:50:51.572854
NCT02574260|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-11-13|2015-11-13||August 2008||2008-08-01|November 2015|2015-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)|Phase 2 Extension Protocol for Extended Use of OncoVEX^GM-CSF for Eligible Patients Participating in Study 002/03: Study of the Efficacy, Safety and Immunogenicity of OncoVEX^GM-CSF in Patients With Stage IIIc and Stage IV Malignant Melanoma|Completed||Phase 2|3|Actual|BioVex Limited||1|||f||||f||||||||||2017-10-10 22:50:51.690433|2017-10-10 22:50:51.690433
NCT02574247|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-05-19|||March 29, 2016|Actual|2016-03-29|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|||Role of the Auditory Efferent System in Auditory Perceptual Learning|Role of the Auditory Efferent System in Auditory Perceptual Learning|Terminated||N/A|28|Actual|VA Loma Linda Health Care System||3||PI change of institution|f||||f||||||||No||2017-10-10 22:50:52.049459|2017-10-10 22:50:52.049459
NCT02574234|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-04-24|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|APOCOGNIT||Influence of Apelin Levels on Postoperative Cognitive Disorders After Orthopedic Surgery in Elderlies (APOCOGNIT)|Influence of Apelin Levels on Postoperative Cognitive Disorders After Orthopedic Surgery in Elderlies|Recruiting||N/A|105|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 22:50:52.188695|2017-10-10 22:50:52.188695
NCT02574221|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-10-04|||August 2015||2015-08-01|October 2017|2017-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Pilot Study to Evaluate a Molecular Method for Plaque|A Pilot Study to Evaluate the Sensitivity of a Novel Molecular Method for Plaque Toxicity|Completed||N/A|60|Actual|Procter and Gamble||2|||f|||||f|f||||||||2017-10-10 22:50:52.318755|2017-10-10 22:50:52.318755
NCT02574208|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-11-21|||October 2015||2015-10-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Acceptability/Feasibility of HIV Testing by ELISA or Rapid Test to Adult Patients in Paris, France|Acceptability and Feasibility of HIV Testing by ELISA or Rapid Test to Adult Patients Consulting Their General Practitioner in Paris, France: A Multi-center Prospective Randomized Study|Completed||N/A|260|Actual|Hopital Lariboisière||2|||f||||f||||||||No||2017-10-10 22:50:52.406231|2017-10-10 22:50:52.406231
NCT02574195|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-04-05|||August 2015||2015-08-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Evolution of Effectiveness of Diabetes Medical Care in Russia|Evolution of Effectiveness of Diabetes Medical Care in Russia|Completed||N/A|599|Actual|Endocrinology Research Centre, Moscow|||1||f||||f||||||||Undecided||2017-10-10 22:50:52.50491|2017-10-10 22:50:52.50491
NCT02574182|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-10-08|||February 2015||2015-02-01|September 2015|2015-09-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Observational|IRMARCHE||Study of Motor Representations in Healthy Subjects and Amnestic MCI|Walking, Brain and Functional Magnetic Resonance Imaging Study of Motor Representations in Healthy Subjects and Amnestic MCI|Unknown status|Recruiting|N/A|70|Anticipated|University Hospital, Angers|||3||f||||f||||||||||2017-10-10 22:50:52.58961|2017-10-10 22:50:52.58961
NCT02574169|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2016-05-27|||June 2016||2016-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|M'RHICO||Alveolar Recruitment Maneuvers, Intracerebral Hemodynamic and Oxygenation|Alveolar Recruitment Maneuvers, Intracerebral Hemodynamic and Oxygenation|Not yet recruiting||N/A|62|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-10 22:50:52.707848|2017-10-10 22:50:52.707848
NCT02574156|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-05-05|||January 1, 2017|Actual|2017-01-01|May 2017|2017-05-01|December 20, 2018|Anticipated|2018-12-20|August 1, 2018|Anticipated|2018-08-01||Interventional|CHyCS||Control of Hyperglycemia After Cardiac Surgery: CHyCS Trial|Control of Hyperglycemia After Cardiac Surgery: CHyCS Trial|Recruiting||Phase 3|500|Anticipated|University of Sao Paulo||2|||f||||t||||||||Yes||2017-10-10 22:50:52.830012|2017-10-10 22:50:52.830012
NCT02574143|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-05-02|||July 2015||2015-07-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01|3 Years|Observational [Patient Registry]|PROGNOSIS||The PROspective German NOn-CF bronchiectaSIS Patient Registry|The PROspective German NOn-CF bronchiectaSIS Patient Registry|Recruiting||N/A|750|Anticipated|Hannover Medical School|||1||f||||f||||||||||2017-10-10 22:50:52.954111|2017-10-10 22:50:52.954111
NCT02574130|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2016-10-11|||July 2015||2015-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria|Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria|Recruiting||Phase 4|84|Anticipated|Thammasat University||2|||f||||t||||||||||2017-10-10 22:50:53.122175|2017-10-10 22:50:53.122175
NCT02574117|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-04-06|||April 2010||2010-04-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Cone Beam Computed Tomography for Evaluating Corticotomy-assisted Maxillary Expansion|Corticotomy-assisted Slow Maxillary Expansion With Bone Allograft Assessed With Cone Beam Computed Tomography in Young Adults|Completed||N/A|4|Actual|Cairo University||1|||f||||f||||||||||2017-10-10 22:50:53.274113|2017-10-10 22:50:53.274113
NCT02574104|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-11-04|||September 2014||2014-09-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Observational|TESTPILOT||Generalizing TESTPILOT to New Single Family Room NICUs|Generalizing TESTPILOT-NICU: Transportable Enhanced Simulation Technologies for Pre-Implementation Limited Operations Testing in Neonatal Intensive Care Units|Recruiting||N/A|1200|Anticipated|Women and Infants Hospital of Rhode Island|||15||f||||t||||||||No|Summary level data will be made available to other researchers|2017-10-10 22:50:53.382492|2017-10-10 22:50:53.382492
NCT02574091|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-12|||November 26, 2015|Actual|2015-11-26|July 2017|2017-07-01|February 19, 2017|Actual|2017-02-19|February 19, 2017|Actual|2017-02-19||Interventional|||Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients|A Single-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Icotinib Hydrochloride Cream in Healthy Adult Participants, Followed by Patients With Mild to Moderate Psoriasis|Completed||Phase 1|28|Actual|Betta Pharmaceuticals Co.,Ltd.||8|||f||||f||||||||||2017-10-10 22:50:53.550388|2017-10-10 22:50:53.550388
NCT02574078|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-09-14|||November 13, 2015|Actual|2015-11-13|September 2017|2017-09-01|August 4, 2022|Anticipated|2022-08-04|April 3, 2022|Anticipated|2022-04-03||Interventional|CheckMate370||A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)|A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance After Induction Chemotherapy or as First-line Treatment Alone or in Combination With Standard of Care Therapies (CheckMate 370: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 370)|Recruiting||Phase 1/Phase 2|555|Anticipated|Bristol-Myers Squibb||10|||f||||t||||||||||2017-10-10 22:50:53.69396|2017-10-10 22:50:53.69396
NCT02574065|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-10-27|||March 2016||2016-03-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|||Effects on Crying Time in Colicky Infants With the Supplementation of Lactobacillus Reuteri DSM 17938|Effects on Crying Time in Colicky Infants With the Supplementation of Lactobacillus Reuteri DSM 17938: A Randomized, Double Blind, Placebo-controlled Study|Recruiting||N/A|116|Anticipated|Shanghai Children's Hospital||2|||f||||||||||||||2017-10-10 22:50:54.38206|2017-10-10 22:50:54.38206
NCT02574052|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-09|||October 2014||2014-10-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Medical College Students' Responds to Menu Labeling|Medical College Students' Responds to Menu Labeling With or Without Nutrition|Completed||Phase 3|120|Actual|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||||2017-10-10 22:50:54.501061|2017-10-10 22:50:54.501061
NCT02574039|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-10-09|||July 2015||2015-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Oat Phenolics Bioavailability|Absorption, Metabolism and Excretion of Oat Phenolic Acids in Healthy Men.|Completed||N/A|7|Actual|University of Reading||2|||f||||f||||||||||2017-10-10 22:50:54.591019|2017-10-10 22:50:54.591019
NCT02574026|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-10-24|||August 2010||2010-08-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|TAPFINGER||Tapfinger Psychomotor Target|MagnetoEncephaloGraphy Study of Cerebral Activations Induced by Psychomotor Tasks for Target Localisation in View of BCI Clinical Trial|Recruiting||Phase 1|30|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 22:50:54.661529|2017-10-10 22:50:54.661529
NCT02574013|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2016-02-23|||November 2015||2015-11-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|SPONGE||Randomized Controlled Trial for Retractor SPONGE Evaluation in Laparoscopic Colorectal Surgery|The Impact of Use of a Retractor Sponge on Duration of Hospital Stay and Perioperative Complications in Patients With Colorectal Cancer Undergoing Laparoscopic Colorectal Surgery: the SPONGE Trial|Recruiting||N/A|188|Anticipated|St. Antonius Hospital||2|||f||||f||||||||||2017-10-10 22:50:54.765407|2017-10-10 22:50:54.765407
NCT02574000|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-08-16|||November 2015||2015-11-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|SPARS||Observational Study of Hemiplegic Shoulder Pain After Recent Stroke|Observational Study to Investigate Proportion of Patients With Hemiplegic Shoulder Pain Within 72 Hours Post-stroke and at Follow-up 8-10 Weeks Later.|Completed||N/A|163|Actual|St George's, University of London|||1||f||||f||||||||||2017-10-10 22:50:54.868309|2017-10-10 22:50:54.868309
NCT02573987|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-10-09|||March 2013||2013-03-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|April 2015|Actual|2015-04-01||Interventional|MELIBIO||MEOPA Versus Local Anesthesia for Analgesia During Chorionic Villus Sampling.|MEOPA (Equimolar Mix of Oxygen and Nitrogen Monoxide) Versus Local Anesthesia for Analgesia During Chorionic Villus Sampling.|Unknown status|Active, not recruiting|Phase 4|192|Anticipated|Hospital St. Joseph, Marseille, France||2|||f||||f||||||||||2017-10-10 22:50:54.953003|2017-10-10 22:50:54.953003
NCT02573974|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-10-14|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|METERMUCADIG||Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer|Study of Alterations in Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer|Recruiting||N/A|45|Anticipated|University Hospital, Tours||2|||f||||f||||||||No||2017-10-10 22:50:55.056178|2017-10-10 22:50:55.056178
NCT02573961|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-08|||October 2015||2015-10-01|October 2015|2015-10-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Laser Acupuncture Versus High Protein/Low Carbohydrate Diet on Endothelial Markers in Obese Females|Laser Acupuncture Versus High Protein/Low Carbohydrate Diet on Endothelial Markers in Obese Females. A Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|National Research Center, Egypt||3|||f||||t||||||||||2017-10-10 22:50:55.160162|2017-10-10 22:50:55.160162
NCT02573935|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-09-19|||January 2015||2015-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|CLAIM||Clarithromycin in Multiple Myeloma Induction Therapy|A Randomized Placebo-controlled Phase II Study of Clarithromycin or Placebo Combined With VCD Induction Therapy Prior to High-dose Melphalan With Stem Cell Support in Patients With Newly Diagnosed Multiple Myeloma|Terminated||Phase 2|58|Actual|Aalborg Universitetshospital||2||"Suspected side effects to the combination of clarithromycin and VCD (bortezomib,   cyclophosphamide and dexamethasone)"|f||||t||||||||||2017-10-10 22:50:55.338329|2017-10-10 22:50:55.338329
NCT02573896|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-08-11|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01||Interventional|||Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells|Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells, ch14.18 and Lenalidomide|Not yet recruiting||Phase 1|24|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t|t|f||||||||2017-10-10 22:50:55.626433|2017-10-10 22:50:55.626433
NCT02573883|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-04-24|||October 2015||2015-10-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|July 2018|Anticipated|2018-07-01||Interventional|CuRLS||Clobetasol Proprionate Versus Fractionated CO2 Laser for the Treatment of Lichen Sclerosus|A Randomized Trial of Clobetasol Proprionate Versus Fractionated CO2 Laser for the Treatment of Lichen Sclerosus (CuRLS)|Recruiting||Phase 3|56|Anticipated|Medstar Health Research Institute||2|||f||||t||||||||||2017-10-10 22:50:55.772961|2017-10-10 22:50:55.772961
NCT02573870|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-02-08|2017-02-08||December 2015||2015-12-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease|201546, A Repeat-dose Study of Batefenterol/FF (GSK961081/GW685698) Compared With Placebo in the Treatment of COPD|Completed||Phase 2|63|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:50:55.916072|2017-10-10 22:50:55.916072
NCT02573857|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-03-21|||October 2015||2015-10-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|DSMOZ-2||A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection|A Phase Ib Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection|Terminated||Phase 1/Phase 2|16|Actual|Medicines for Malaria Venture||3|||f||||f||||||||||2017-10-10 22:50:56.336924|2017-10-10 22:50:56.336924
NCT02573844|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-08|||January 2015||2015-01-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|PRITON||Pain Relief In Irritable Bowel Syndrome|Efficacy of Proklama on Patients' Symptoms With Irritable Bowel Syndrome: Clinical Trial, Double- Blind, Crossover, Controlled Study vs. Placebo|Unknown status|Recruiting|Phase 4|30|Anticipated|Geophyt S.r.l.s.||2|||f||||t||||||||||2017-10-10 22:50:56.441373|2017-10-10 22:50:56.441373
NCT02573831|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-04-11|||February 2015||2015-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|oksisynnII||The Effect of Oxycodone to the Placental Circulation at Early Labour|The Effect of Oxycodone to the Placental Circulation at Early Labour|Recruiting||Phase 4|20|Anticipated|Kuopio University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:50:56.536101|2017-10-10 22:50:56.536101
NCT02573818|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-03-22|||September 1, 2015|Actual|2015-09-01|March 2017|2017-03-01|June 15, 2016|Actual|2016-06-15|June 15, 2016|Actual|2016-06-15||Observational|||Sedasys Post Approval Study Users Response to System Alarms|Open-Label Post Approval Study of the SEDASYS System User Response to System Alarms|Terminated||N/A|51|Actual|Ethicon Endo-Surgery|||1|franchise closed; no safety concerns|f||||f|f|t|f|f|f|||No||2017-10-10 22:50:56.615317|2017-10-10 22:50:56.615317
NCT02573805|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2015-10-10|||September 2015||2015-09-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01|12 Months|Observational [Patient Registry]|NPTR||the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males|the Evaluation of Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males|Unknown status|Recruiting|N/A|1000|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|||2||f||||f||||||None Retained|"     Rigiscan parameters analyzed by Rigiscan plus software   "|||2017-10-10 22:50:56.680191|2017-10-10 22:50:56.680191
NCT02573792|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-09|2017-02-06|||October 5, 2015|Actual|2015-10-05|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|OCTON||Optical Coherence Tomography and Optic Neuritis (OCTON)|Optical Coherence Tomography for the Etiological Diagnosis of Inflammatory Optic Neuritis|Recruiting||N/A|120|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 22:50:56.766856|2017-10-10 22:50:56.766856
NCT02573779|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-10-31|||August 2015||2015-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|||Growth and Microbiome Development in Very Low Birth Weight Infants Fed Primarily Mother's Own Milk vs. Donor Human Milk|Intestinal Microbiota and Short Term Outcomes in Very Low Birth Weight Infants Fed Primarily Donor Human Milk Compared to Infants Fed Primarily Mother's Own Milk|Active, not recruiting||N/A|125|Actual|Baylor College of Medicine|||2||f||||f||||||||||2017-10-10 22:50:56.832849|2017-10-10 22:50:56.832849
NCT02573766|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-03-20|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy|Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy|Recruiting||N/A|90|Anticipated|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-10-10 22:50:56.929639|2017-10-10 22:50:56.929639
NCT02573753|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-03-21|||October 2015||2015-10-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effects of Sleep on Human Microbiota: Implications for Health and Disease|The Effects of Sleep on Human Microbiota: Implications for Health and Disease|Enrolling by invitation||N/A|200|Anticipated|Mayo Clinic||3|||f||||f||||||||||2017-10-10 22:50:57.05392|2017-10-10 22:50:57.05392
NCT02573740|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-06-30|||December 2015||2015-12-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment|A Study to Evaluate the Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of Multiple Doses of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment Due to Alzheimer's Disease|Terminated||Phase 1|8|Actual|AbbVie||2||Insufficient target engagement of ABT-957 (preclinical data)|f||||f||||||||||2017-10-10 22:50:57.108439|2017-10-10 22:50:57.108439
NCT02573727|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-01-28|||October 2015||2015-10-01|July 2016|2016-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure|''To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure'|Completed||N/A|120|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 22:50:57.190893|2017-10-10 22:50:57.190893
NCT02573714|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-07-18|||December 2015||2015-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises|Comparison of Sub-dissociative Intranasal Ketamine Plus Standard Pain Therapy Versus Standard Pain Therapy in the Treatment of Pediatric Sickle Cell Disease Vasoocclusive Crises in Resource-limited Settings: a Multi-centered, Randomized, Controlled Trial|Recruiting||N/A|160|Anticipated|Cameroon Baptist Convention Health||2|||f||||t||||||||||2017-10-10 22:50:57.395561|2017-10-10 22:50:57.395561
NCT02573688|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-08|||January 2016||2016-01-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Interdisciplinary Intervention in Patients With Obesity and Other Metabolic Diseases|Interdisciplinary Intervention Project - Promotion and Rehabilitation in Patients With Obesity and Other Metabolic Diseases|Not yet recruiting||N/A|150|Anticipated|Federal University of São Paulo||1|||f||||f||||||||||2017-10-10 22:50:57.708852|2017-10-10 22:50:57.708852
NCT02573675|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-08|||November 2015||2015-11-01|October 2015|2015-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|PDKOREA||An Assessment on Current Outcomes of Peritoneal Dialysis in Korea|An Assessment on Current Outcomes of Peritoneal Dialysis in Korea|Not yet recruiting||N/A|30000|Anticipated|Ewha Womans University|||1||f||||f||||||||||2017-10-10 22:50:57.820897|2017-10-10 22:50:57.820897
NCT02573662|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-11-08|||April 2015||2015-04-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Observational|OrthoMetKnee||Metabolic Complications Following Knee Injury in Young and Middle Aged Patients|Metabolic Complications Following Knee Injury in Young and Middle Aged Patients|Recruiting||N/A|16|Anticipated|Haugaard, Steen Bendix, M.D., DMSc|||2||f||||t||||||Samples With DNA|"     Blood and Urine sampling   "|||2017-10-10 22:50:57.888724|2017-10-10 22:50:57.888724
NCT02573649|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2016-04-01|||April 2015||2015-04-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|TIRECS||The Tilt Test-Induced REsponse in Closed-loop Stimulation (TIRECS) Study|Effects of Closed-loop Stimulation vs. DDD Pacing on Prevalence and Timing of Haemodynamic Variations and Clinical Prodromes Induced by Head-up Tilt Test in Patients With Refractory Cardioinhibitory Vasovagal Syncope. The TIRECS Study|Completed||N/A|30|Actual|Azienda Ospedaliera Cardinale G. Panico||2|||f||||f||||||||||2017-10-10 22:50:58.023408|2017-10-10 22:50:58.023408
NCT02573636|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-03-16|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|March 2041|Anticipated|2041-03-01|January 2030|Anticipated|2030-01-01||Observational|||The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation Therapy|The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation Therapy|Recruiting||N/A|208|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital|||1||f||||f||||||Samples With DNA|"     Areas of prostate tumor will be identified by the pathologist of the study. This will then be     excised from the paraffin block using a tissue microarray punch. Two punches will be     acquired: one for RNA extraction and one for DNA extraction. RNA and DNA will be extracted     using the RecoverAll Nucleic Acid Isolation Kit (Ambion). Standard protocol for the isolation     of nucleic acids will be used differing only in the time of protease digestion such that RNA     is isolated after a short incubation (30 minutes), while DNA is isolated after a longer     incubation (overnight). DNA will be used to assess copy number variation at the PTEN locus     (10q23) using quantitative PCR and appropriate Taqman chemistry.   "|||2017-10-10 22:50:58.131532|2017-10-10 22:50:58.131532
NCT02573623|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-10-09|||July 2013||2013-07-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Observational|PROMISE-TB||Evaluation of an Innovative Tuberculosis Diagnostic Test|Evaluation, of Innovative Tuberculosis Diagnostic Tests - Promoting Infant Health and Nutrition in Sub-Saharian Africa (PROMISE Consortium)|Unknown status|Recruiting|N/A|300|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||6||f||||f||||||Samples Without DNA|"     Urine Serum Cell culture supernatant   "|||2017-10-10 22:50:58.24839|2017-10-10 22:50:58.24839
NCT02573597|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-05-02|||October 2015||2015-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PIEB vs CEI for Labor Analgesia: An MLAC Study|Programmed Intermittent Epidural Bolus (PIEB) Compared to Continuous Epidural Infusion (CEI) Relative Efficacy and Mechanism of Efficacy For Labor Anlagesia: A Minimal Local Analgesic Concentration (MLAC) Study|Recruiting||Phase 4|160|Anticipated|Stanford University||4|||f||||t||||||||||2017-10-10 22:50:58.463297|2017-10-10 22:50:58.463297
NCT02573584|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-06-01|||October 2015||2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Vascular Fingerprint Validation Study|Vascular Fingerprint to Identify Patients at Risk for Arterial Cardiovascular Events Within the First Year After Start of Cisplatin-based Chemotherapy for Testicular Cancer: a Validation Study|Recruiting||N/A|178|Anticipated|University Medical Center Groningen|||1||f||||f||||||||No||2017-10-10 22:50:58.581976|2017-10-10 22:50:58.581976
NCT02573571|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-10-03|||October 2015|Actual|2015-10-01|October 2017|2017-10-01|October 2017|Actual|2017-10-01|December 2016|Actual|2016-12-01||Observational|SPECIFY||Personalized Needs in Clostridium Difficile Infections|Scoring Personalized Needs in Clostridium Difficile Infections for Fidaxomixin Therapy|Completed||N/A|150|Actual|University of Athens|||1||f||||t||||||Samples With DNA|"     Whole blood for human DNA extraction and human stool for whole bacterial DNA extraction.     Sampling is done on the first day and on disease recurrence   "|||2017-10-10 22:50:58.693265|2017-10-10 22:50:58.693265
NCT02573558|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-04-05|||October 2015||2015-10-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Intraoperative Sedation and Postoperative Delirium|Prevalence of Postoperative Delirium According to the Use of Dexmedetomidine or Propofol in Elderly Patients Undergoing Orthopedic Surgery: Retrospective Study|Completed||N/A|855|Actual|Seoul National University Bundang Hospital|||2||f||||f||||||||||2017-10-10 22:50:58.844189|2017-10-10 22:50:58.844189
NCT02573545|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-08|||January 2013||2013-01-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|IFE||Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case|Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case|Unknown status|Recruiting|N/A|148|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 22:50:58.928603|2017-10-10 22:50:58.928603
NCT02573532|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-07-26|||October 2015||2015-10-01|July 2017|2017-07-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Observational|BASEL-PMI||Incidence and Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery|Basel Incidence, Patient Characteristics, Outcome and Possible Strategies to Improve Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery: 1-Year Follow-up|Recruiting||N/A|2000|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f|f|f||||||||2017-10-10 22:50:59.020566|2017-10-10 22:50:59.020566
NCT02573519|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-11-10|||October 2015||2015-10-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Interventional|||Gastrointestinal Motility Among Diabetes Patients|Gastrointestinal Motility Among Diabetes Patients|Recruiting||N/A|45|Anticipated|University of Aarhus||2|||f||||t||||||||No||2017-10-10 22:50:59.133398|2017-10-10 22:50:59.133398
NCT02573506|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2017-10-03|||August 2015||2015-08-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer|A Prospective, Randomized, Phase Ⅱ Study of Consolidation Chemotherapy or Observation After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer|Recruiting||Phase 2|204|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:50:59.289793|2017-10-10 22:50:59.289793
NCT02573493|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-06-30|||April 13, 2016|Actual|2016-04-13|June 2017|2017-06-01|October 31, 2028|Anticipated|2028-10-31|May 31, 2018|Anticipated|2018-05-31||Interventional|APA||Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)|"Phase II Non-Randomized Two Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arm 1) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial."|Recruiting||Phase 2|80|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 22:50:59.457021|2017-10-10 22:50:59.457021
NCT02573480|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-06-01|||November 2015||2015-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Optimization Study of the Wraparound Care for Youth Injured by Violence Program|Optimization Study of the Wraparound Care for Youth Injured by Violence Program|Recruiting||N/A|120|Anticipated|University of Manitoba||1|||f||||t||||||||||2017-10-10 22:50:59.642435|2017-10-10 22:50:59.642435
NCT02573467|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-15|||November 2, 2015|Actual|2015-11-02|August 2017|2017-08-01|February 13, 2017|Actual|2017-02-13|February 13, 2017|Actual|2017-02-13||Interventional|||An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203|Extension of the CBYM338B2203 Phase IIb/III Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Intravenous BYM338 in Patients With Sporadic Inclusion Body Myositis|Completed||Phase 3|211|Actual|Novartis||4|||f||||t|t|f||||||||2017-10-10 22:50:59.750835|2017-10-10 22:50:59.750835
NCT02573454|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-05-04|||February 2015||2015-02-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Prosocial Exercise: Does Exercising for Charity Result in Greater Well-Being and Physical Activity?|Prosocial Exercise: Does Exercising for Charity Result in Greater Well-Being and Physical Activity?|Completed||N/A|117|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:50:59.926385|2017-10-10 22:50:59.926385
NCT02573441|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-10-27|||October 2015||2015-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||KEYS to Succeed: Cognitive and Academic Intervention Program for Children and Adolescents Surviving Cancer|KEYS to Succeed: Cognitive and Academic Intervention Program for Children and Adolescents Surviving Cancer|Recruiting||N/A|45|Anticipated|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-10 22:51:00.040158|2017-10-10 22:51:00.040158
NCT02573428|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-03-10|||June 2015||2015-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|EYE||Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder|Evaluating the Validity of an Eye Gaze Tracking Assessment Tool in Identifying Autism Spectrum Disorder|Completed||N/A|389|Actual|The Cleveland Clinic|||3||f||||t||||||||Undecided||2017-10-10 22:51:00.17609|2017-10-10 22:51:00.17609
NCT02573415|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-07-26|||October 2015||2015-10-01|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Uterine Transplantation for the Treatment of Uterine Factor Infertility|Uterine Transplantation for the Treatment of Uterine Factor Infertility|Enrolling by invitation||N/A|10|Anticipated|The Cleveland Clinic||1|||f||||t||||||||||2017-10-10 22:51:00.43386|2017-10-10 22:51:00.43386
NCT02573402|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-04-07|||July 12, 2016|Actual|2016-07-12|April 2017|2017-04-01||||April 2017|Anticipated|2017-04-01||Interventional|||The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury|The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury|Recruiting||N/A|40|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 22:51:00.572954|2017-10-10 22:51:00.572954
NCT02573389|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-07|||September 2015||2015-09-01|August 2015|2015-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Pancreatic Duct Stenting to Prevent Postoperative Pancreatic Fistula (POPF) After Distal Pancreatectomy|A Pilot Study on the Effect of Transampullary Pancreatic Duct Stenting on Postoperative Pancreatic Fistula Rate After Distal Pancreatectomy|Not yet recruiting||Phase 3|120|Anticipated|Kaiser Permanente||2|||f||||t||||||||||2017-10-10 22:51:00.689538|2017-10-10 22:51:00.689538
NCT02573363|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-07-24|||October 7, 2015|Actual|2015-10-07|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia|Phase I Investigator Sponsored Study to Assess the Tolerability and Efficacy of Selinexor in Combination With High Dose Cytarabine (HiDAC) and Mitoxantrone Chemotherapy for Remission Induction in Acute Myelogenous Leukemia (AML)|Recruiting||Phase 1|27|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-10 22:51:00.932554|2017-10-10 22:51:00.932554
NCT02573350|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-13||2015-10-13|March 2009||2009-03-01|October 2015|2015-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Phase 2, Multi-center, Uncontrolled, Open-label Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683|A Phase 2, Multi-center, Uncontrolled, Open-label Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683 as 100 mg BID With Optional Titration to 200 mg BID for up to Six Months Exposure in Patients With Pulmonary Multi-drug Resistant Tuberculosis|Completed||Phase 2|213|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t||||||||||2017-10-10 22:51:01.074756|2017-10-10 22:51:01.074756
NCT02573337|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-10-02|||October 2015||2015-10-01|January 2016|2016-01-01|January 2017|Actual|2017-01-01|March 2016|Actual|2016-03-01||Interventional|||Perception of Facial Expressions Following Correction of Wrinkles and Folds|A Multi-center, Non-comparative Study to Evaluate the Perception of Facial Expressions Following Correction of Wrinkles and Folds in the Lower Face Using Emervel Classic Lidocaine and Emervel Deep Lidocaine|Completed||Phase 4|63|Actual|Q-Med AB||1|||f||||f||||||||||2017-10-10 22:51:01.190058|2017-10-10 22:51:01.190058
NCT02573324|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-01|||December 22, 2015||2015-12-22|September 2017|2017-09-01|April 17, 2020|Anticipated|2020-04-17|March 18, 2020|Anticipated|2020-03-18||Interventional|Intellance1||A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification|A Randomized, Placebo Controlled Phase 2b/3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)|Recruiting||Phase 2|720|Anticipated|AbbVie||2|||f||||t||||||||||2017-10-10 22:51:01.308229|2017-10-10 22:51:01.308229
NCT02573311|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-02-07|||September 2015||2015-09-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Actual Use Study of Tamsulosin in Men|A 6-month OTC-simulated, Open Label, Uncontrolled Study of Tamsulosin 0.4 mg in Men|Completed||Phase 3|1120|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 22:51:02.371764|2017-10-10 22:51:02.371764
NCT02573298|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-03-17|||February 2013||2013-02-01|July 2016|2016-07-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|CDRI||Cryotherapy and Doppler in Inflammatory Rheumatic Diseases|Cryotherapy and Doppler in Inflammatory Rheumatic Diseases|Completed||N/A|50|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-10 22:51:02.596708|2017-10-10 22:51:02.596708
NCT02573285|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-05-01|||September 2015||2015-09-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|September 2018|Anticipated|2018-09-01||Interventional|||Spontaneous Pneumothorax in Children|Simple Aspiration for Initial Management of Primary Spontaneous Pneumothorax in Children: A Multi-Center Pilot Study|Recruiting||N/A|80|Anticipated|University of Wisconsin, Madison||2|||f||||t|f|f||||||No|No sharing|2017-10-10 22:51:02.714673|2017-10-10 22:51:02.714673
NCT02573272|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-08|||June 2015||2015-06-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Observational|||Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors|Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors|Unknown status|Recruiting|N/A|204|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||||||2017-10-10 22:51:02.841729|2017-10-10 22:51:02.841729
NCT02573259|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-09-28|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors|A Phase 1, Open-label, Dose Escalation And Expansion Study Of Pf-06801591 In Patients With Locally Advanced Or Metastatic Melanoma, Squamous Cell Head And Neck Cancer, Ovarian Cancer, Sarcoma, Non-small Cell Lung Cancer, Urothelial Carcinoma Or Other Solid Tumors.|Recruiting||Phase 1|150|Anticipated|Pfizer||5|||f||||f||||||||||2017-10-10 22:51:02.934303|2017-10-10 22:51:02.934303
NCT02573246|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-05-22|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study|Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study|Recruiting||N/A|65|Anticipated|Duke University||3|||f||||f||||||||No||2017-10-10 22:51:03.104477|2017-10-10 22:51:03.104477
NCT02573220|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-12-08|||June 2015||2015-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer|A UGT1A1 Genotype-Guided Dosing Study of Irinotecan Administered in Combination With 5-Fluorouracil/Leucovorin (FOLFIRI) and Cetuximab as First-Line Therapy in RAS Wild-Type Metastatic Colorectal Cancer Patients|Withdrawn||Phase 1|0|Actual|University of Chicago||1||Study terminated by PI due to inability to accrue.|f||||f||||||||||2017-10-10 22:51:03.44699|2017-10-10 22:51:03.44699
NCT02573207|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-08-24|||March 2016||2016-03-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|RHIMES-HF||Recovery of Hibernating Myocardium in End Stage Heart Failure||Recruiting||N/A|94|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-10-10 22:51:03.556834|2017-10-10 22:51:03.556834
NCT02573194|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-03-02|||August 2015||2015-08-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Effect of Breakfasts Varying in Protein Source on Appetite and Energy Intake|The Acute Effect of Breakfasts Varying in Protein Source Content on Subjective Appetite Ratings and Voluntary Energy Intake in Healthy Subjects|Completed||N/A|28|Actual|Lund University||4|||f||||f||||||||||2017-10-10 22:51:03.653823|2017-10-10 22:51:03.653823
NCT02573181|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-03-18|||October 2015||2015-10-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study of the Safety, Tolerability, and Immunogenicity of V114 Compared With Prevnar 13™ in Healthy Adults 65 Years of Age or Older Previously Vaccinated With 23-valent Pneumococcal Polysaccharide Vaccine (V114-007)|A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Adults 65 Years of Age or Older Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine|Completed||Phase 2|253|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 22:51:03.738005|2017-10-10 22:51:03.738005
NCT02573168|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Schizophrenia/Schizoaffective Disorder|A Three-arm, Parallel Group, Multicentre, Double-blind, Randomized Controlled Trial Evaluating the Impact of GeneSight Psychotropic and Enhanced-GeneSight Psychotropic, on Response to Psychotropic Treatment in Patients Suffering From Schizophrenia/Schizoaffective Disorder|Recruiting||Phase 4|531|Anticipated|St. Joseph's Healthcare Hamilton||3|||f||||t||||||||||2017-10-10 22:51:03.808996|2017-10-10 22:51:03.808996
NCT02573142|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-04-07|||October 2015||2015-10-01|April 2017|2017-04-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|BCHF||Integrated Child Obesity Treatment Study: Bull City Healthy and Fit|A Novel Healthcare-Community Partnership for Childhood Obesity Treatment: A Randomized Pilot Study|Completed||N/A|97|Actual|Duke University||2|||f||||f||||||||||2017-10-10 22:51:04.121892|2017-10-10 22:51:04.121892
NCT02573129|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-09-08|||May 2015||2015-05-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Lean Meats Mediterranean Diet Study|Effects of Incorporating Red Meat Into a Mediterranean-style Dietary Pattern on Cardiometabolic and Emotional Well-being|Active, not recruiting||N/A|45|Anticipated|Purdue University||2|||f||||f||||||||||2017-10-10 22:51:04.230461|2017-10-10 22:51:04.230461
NCT02573116|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-12-06|||December 2013||2013-12-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|EndothSAS||Impact of Treatment of Periodontis on Endothelial Function in Patients With Obstructive Sleep Apnea|Impact of Treatment of Periodontis on Endothelial Function in Patients With Obstructive Sleep Apnea|Recruiting||N/A|120|Anticipated|Hopital Foch||2|||f||||f||||||||||2017-10-10 22:51:04.364794|2017-10-10 22:51:04.364794
NCT02573103|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-05-21|||November 2014||2014-11-01|October 2015|2015-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Air Pollution and Lipids Metabolic Disorder|Air Pollution and Lipids Metabolic Disorder|Completed||N/A|75|Actual|Peking University|||1||f||||t||||||Samples Without DNA|"     plasma and urine   "|||2017-10-10 22:51:04.454411|2017-10-10 22:51:04.454411
NCT02573090|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-10-27|||November 2006||2006-11-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|October 2017|Anticipated|2017-10-01||Interventional|SEAL-DK||Sealing Manifest Occlusal Caries Lesions in the Permanent Dentition|SEAL-DK: Sealing Manifest Occlusal Caries Lesions in the Permanent Dentition in Children and Adolescents. RCT|Active, not recruiting||N/A|521|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-10 22:51:04.518578|2017-10-10 22:51:04.518578
NCT02573077|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-07-14|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ASSERT||An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy|A Prospective, Observational Study Measuring Sodium Improvement and Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia Secondary to SIADH in Italy|Recruiting||N/A|100|Anticipated|Otsuka Pharmaceutical Europe Ltd|||1||f||||f||||||||||2017-10-10 22:51:04.621425|2017-10-10 22:51:04.621425
NCT02573064|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-10-08|||January 2010||2010-01-01|October 2015|2015-10-01||||December 2012|Actual|2012-12-01||Observational|||Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical||Completed||N/A|113|Actual|Maimónides Biomedical Research Institute of Córdoba|||1||f||||f||||||||||2017-10-10 22:51:04.817849|2017-10-10 22:51:04.817849
NCT02573051|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2015-10-08|||June 2015||2015-06-01|October 2015|2015-10-01||||October 2015|Anticipated|2015-10-01||Interventional|||Termination Of Anembryonic Pregnancy|Misoprostol Plus Isosorbide Mononitrate Versus Misoprostol For Termination Of Anembryonic Pregnancy|Unknown status|Recruiting|Phase 2|108|Anticipated|Assiut University||2|||f||||f||||||||||2017-10-10 22:51:04.884103|2017-10-10 22:51:04.884103
NCT02573038|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-01-05|||February 2016||2016-02-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ASTRID||Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).|Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients.|Withdrawn||Phase 2|0|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-10 22:51:04.980245|2017-10-10 22:51:04.980245
NCT02573025|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-03-10|||September 17, 2015|Actual|2015-09-17|March 2017|2017-03-01|April 11, 2016|Actual|2016-04-11|April 11, 2016|Actual|2016-04-11||Interventional|||A Bioequivalence Study of Pegylated Interferon Alfa-2a (PEG-IFN Alfa-2a) Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys) Following Subcutaneous Administration|An Open-Label, Randomized, Multi-Center, Single Dose, Two-Period, Two Sequence Crossover Study to Investigate the Bioequivalence of Peginterferon (PEG-IFN) Alfa-2a Benzyl Alcohol-Free Formulation Versus the Reference Market Formulation Following Subcutaneous Administration Via Prefilled Syringe in Healthy Chinese Subjects|Completed||Phase 1|277|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:51:05.069118|2017-10-10 22:51:05.069118
NCT02572830|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reconsolidation and EMDR|Blocking Memory Reconsolidation by Eye Movement Desensitization and Reprocessing (EMDR)|Recruiting||N/A|120|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 22:51:09.116986|2017-10-10 22:51:09.116986
NCT02573012|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-09-27|||March 31, 2016|Actual|2016-03-31|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants|Prospective, Multicentre, Placebo-controlled, Double-blind Interventional Study to Compare the Efficacy of Maintenance Treatment With Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Patients|Recruiting||Phase 4|225|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:51:05.173875|2017-10-10 22:51:05.173875
NCT02572999|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-04-10|||October 2015||2015-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Observational|||Incidence and Risk Factors for Hospitalization-Associated Disability|Incidence and Risk Factors for Hospitalization-Associated Disability (HAD) and Its Association With Hospital and Care Processes in Patients With Valvular Heart Disease|Completed||N/A|80|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||||||||||||2017-10-10 22:51:07.466919|2017-10-10 22:51:07.466919
NCT02572986|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-10-13|||September 2015||2015-09-01|October 2015|2015-10-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies|A Randomized, Double-Blind, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% to Elimite™ Cream 5% in the Treatment of Scabies|Completed||Phase 3|250|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-10 22:51:07.552877|2017-10-10 22:51:07.552877
NCT02572973|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-06-02|||July 2014||2014-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|April 2016|Actual|2016-04-01||Interventional|ANM||Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders|Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders: A Pilot Study|Active, not recruiting||N/A|6|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||No||2017-10-10 22:51:07.652496|2017-10-10 22:51:07.652496
NCT02572960|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-10-25|||October 2015||2015-10-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|AldOst||Physiologic Interactions Between the Adrenal- and the Parathyroid Glands|Physiologic Interactions Between the Adrenal- and the Parathyroid Glands|Recruiting||Phase 4|80|Anticipated|University of Aarhus||4|||f||||t||||||||No||2017-10-10 22:51:07.753087|2017-10-10 22:51:07.753087
NCT02572947|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-12-23|||June 2016||2016-06-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|MONODO||A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients|An Interventional, One-arm, Open Label Pilot Study to Assess the Feasibility of Dolutegravir Monotherapy in Virologically Suppressed Patients on Conventional Triple Antiretroviral Therapy of Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors|Active, not recruiting||Phase 2|8|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-10-10 22:51:07.882772|2017-10-10 22:51:07.882772
NCT02572934|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-06-01|||August 2015||2015-08-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|STANDBY||Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)|Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)|Recruiting||N/A|280|Anticipated|University Medical Center Groningen|||4||f||||f||||||||No||2017-10-10 22:51:07.97817|2017-10-10 22:51:07.97817
NCT02572921|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-10-08|||May 2014||2014-05-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Positive Psychotherapy and Cognitive-Behavioral Psychotherapy for Depression|Evaluation of the Positive Psychotherapy to Reduce Symptoms and to Promote Happiness With Depressive Patients Compared to Cognitive-Behavioral Psychotherapy|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Salzburg||2|||f||||t||||||||||2017-10-10 22:51:08.090005|2017-10-10 22:51:08.090005
NCT02572908|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-08-04|||August 2015||2015-08-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Wheat-IBS||Effects of Wheat Breads on Symptoms of IBS, a Pilot Study|Effects of Wheat Breads on Symptoms of IBS, a Pilot Study|Completed||N/A|26|Anticipated|Oy Karl Fazer Ab||3|||f||||||||||||||2017-10-10 22:51:08.1843|2017-10-10 22:51:08.1843
NCT02572895|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-09-07|||August 2015||2015-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|PACCANN||Cranberry Extract and Urinary Infection Prevention: a Clinical Trial|Recurrent Urinary Tract Infection Prevention With Biologic Cranberry Extract Intake Standardized in Proanthocyanidins: A Double-blind Clinical Trial|Recruiting||Phase 1|140|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 22:51:08.412023|2017-10-10 22:51:08.412023
NCT02572882|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-06-07|||October 2015||2015-10-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|January 2017|Actual|2017-01-01||Interventional|||Gut Microbiome and p-Inulin in Hemodialysis|A Multi-center Study to Characterize the Gut Microbiome of Individuals With End-stage Renal Disease Treated With Maintenance Hemodialysis, and to Explore Effects of P-inulin on the Gut Microbiome|Active, not recruiting||Phase 1|13|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-10-10 22:51:08.524291|2017-10-10 22:51:08.524291
NCT02572869|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-08-30|||September 30, 2015|Actual|2015-09-30|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps|Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps|Active, not recruiting||N/A|26|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:51:08.654149|2017-10-10 22:51:08.654149
NCT02572856|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-02-15|||December 25, 2015|Actual|2015-12-25|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|CGM||Continuous Glucose Monitoring During and After Surgery|Continuous Glucose Monitoring During and After Surgery|Recruiting||N/A|20|Anticipated|University of Washington||1|||f||||f||||||||No||2017-10-10 22:51:08.776516|2017-10-10 22:51:08.776516
NCT02572843|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-09-19|||April 11, 2016|Actual|2016-04-11|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|March 2021|Anticipated|2021-03-01||Interventional|||Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)|Anti-PD-L1 Antibody MEDI4736 in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC). A Multicenter Single-arm Phase II Trial.|Recruiting||Phase 2|68|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||||2017-10-10 22:51:08.889835|2017-10-10 22:51:08.889835
NCT02572817|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-05-16|||November 2015||2015-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A|A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A|Recruiting||Phase 3|300|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:51:09.211705|2017-10-10 22:51:09.211705
NCT02572804|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-10-31|||September 2015||2015-09-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparing Rectus Sheath Catheter to Epidural Post Cystectomy|A Randomised Controlled Trial of Thoracic Epidural Analgesia Versus Surgically Placed Rectus Sheath Catheters for Open Radical Cystectomy: Is There a Difference in Patient Outcomes?|Recruiting||N/A|160|Anticipated|Vancouver Coastal Health||2|||f||||f||||||||||2017-10-10 22:51:09.423256|2017-10-10 22:51:09.423256
NCT02572791|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-10-31|||October 2015||2015-10-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|SHINE||Staph Household Intervention for Eradication (SHINE)|Integrating Personal and Household Environmental Hygiene Measures to Prevent Methicillin-Resistant Staphylococcus Aureus Infection|Recruiting||Phase 4|207|Anticipated|Washington University School of Medicine||3|||f||||t||||||||||2017-10-10 22:51:09.552628|2017-10-10 22:51:09.552628
NCT02572778|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-10-13|||September 2015||2015-09-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|UCL-Xenog||Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer|Establishment of Primary Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer for Preclinical Evaluation of Targeted Therapies.|Recruiting||N/A|40|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||Samples With DNA|"     Biopsies of the tumor of the patients with squamous cell carcinoma of the head and neck   "|||2017-10-10 22:51:09.6621|2017-10-10 22:51:09.6621
NCT02572765|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-03-13|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Observational|||Evaluation of Splenic Metabolic Activity With 18FDG-PET in Hypertension|Evaluation of Splenic Metabolic Activity With 18FDG-PET in Hypertension|Not yet recruiting||N/A|120|Anticipated|Neuromed IRCCS|||2||f||||||||||Samples Without DNA|"     Total blood and serum   "|||2017-10-10 22:51:09.748893|2017-10-10 22:51:09.748893
NCT02572752|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2016-11-08|2016-11-08||August 2015||2015-08-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Treated Set (TS): This analysis set included all 70 subjects (that is, all subjects who received at least 1 dose of study medication).|Relative Bioavailability of 2 Oral Formulations of Nintedanib|Bioequivalence of 1 Soft Gelatine Capsule Containing 200 mg Nintedanib Compared to 2 Soft Gelatine Capsules Containing 100 mg Nintedanib Following Oral Administration in Healthy Male Subjects|Completed||Phase 1|70|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 22:51:09.845359|2017-10-10 22:51:09.845359
NCT02572739|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-03-21|||May 2014||2014-05-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Observational|||Cardiac Output Measurement With NICCOMO and PiCCO Devices at Different PEEP Levels|Assessment of Reliability of Cardiac Output Measurement Based on Impedance (NICCOMO) - Method of Noninvasive Cardiac Output Measurement, Compared to Transthoracic Thermodilution (PiCCO) at Different PEEP Levels|Recruiting||N/A|50|Anticipated|Medical University of Gdansk|||1||f||||f||||||||||2017-10-10 22:51:10.376203|2017-10-10 22:51:10.376203
NCT02572726|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-09-26|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Exploration of the Neuroplasticity of Endogenous Analgesia in Health and Chronic Pain|Integration of Neuroimaging and Transcranial Magnetic Stimulation: an Exploration of the Neuroplasticity of Endogenous Analgesia in Health and Chronic Pain|Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-10 22:51:10.475957|2017-10-10 22:51:10.475957
NCT02572713|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-08-14|||October 2015||2015-10-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Observational|S4||Systemic Synuclein Sampling Study (S4)|Systemic Synuclein Sampling Study (S4)|Completed||N/A|80|Actual|Michael J. Fox Foundation for Parkinson's Research|||4||f||||f||||||Samples With DNA|"     Biofluid samplings [blood, saliva, and cerebrospinal fluid (CSF)] Tissue samplings (skin,     colon, submandibular gland)   "|||2017-10-10 22:51:10.582102|2017-10-10 22:51:10.582102
NCT02572700|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-08-09|||September 2015||2015-09-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis|Pain Mechanisms and Ultrasonographic Inflammatory Changes as Prognostic Factors in Patients With Psoriatic Arthritis: a Prospective, Exploratory Cohort Study|Recruiting||N/A|100|Anticipated|Frederiksberg University Hospital|||1||f||||t||||||||||2017-10-10 22:51:10.701383|2017-10-10 22:51:10.701383
NCT02572687|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-10-05|||February 2016||2016-02-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies|An Open-Label, Multicenter, Phase 1 Study of Ramucirumab Plus MEDI4736 in Patients With Locally Advanced and Unresectable or Metastatic Gastrointestinal or Thoracic Malignancies|Recruiting||Phase 1|114|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 22:51:10.831991|2017-10-10 22:51:10.831991
NCT02572674|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-06-19|||May 2010||2010-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|RechuteBP||Study of Predictor of Mood Relapse in Bipolar Disorders|Study of Predictor of Mood Relapse in Bipolar Disorders : Prospective, Clinical, Neuropsychological, Biological and Genetic Study|Active, not recruiting||N/A|274|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:51:11.074405|2017-10-10 22:51:11.074405
NCT02572661|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-09-26|||July 2015||2015-07-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|SUSPECT||Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT)|Mapping of Sentinel Lymph Node Drainage Using SPECT to Tailor Highly‐Selective Elective Nodal Irradiation in Node‐Negative Neck of Patients With Head and Neck Cancer (SUSPECT)|Recruiting||N/A|40|Anticipated|The Netherlands Cancer Institute||1|||f||||t||||||||||2017-10-10 22:51:11.155971|2017-10-10 22:51:11.155971
NCT02572648|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-09-20|||October 2015||2015-10-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Observational|MIND-HF||A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls|A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls (MIND-HF)|Completed||N/A|30|Actual|Emory University|||2||f||||t||||||||||2017-10-10 22:51:11.26649|2017-10-10 22:51:11.26649
NCT02572635|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-10-04|||October 2015||2015-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax|A Randomised, Placebo Controlled, Double-blind, Dose Escalation, Single Centre Trial to Evaluate the Safety and Immunogenicity of PnuBioVax Administered on Three Occasions 28 Days Apart at Three Dose Levels in Healthy Adult Subjects.|Completed||Phase 1|36|Actual|ImmunoBiology Limited||4|||f||||f||||||||||2017-10-10 22:51:11.371165|2017-10-10 22:51:11.371165
NCT02572622|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-02-23|||February 2014||2014-02-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Comparison of Different Treatment Methods in Lumbal Disc Herniation Treatment|Lumbal Disk Herniasyonunda Farklı Tedavi Yöntemlerinin Karşılaştırılması|Completed||N/A|30|Actual|Hacettepe University||3|||f||||f||||||||||2017-10-10 22:51:11.486022|2017-10-10 22:51:11.486022
NCT02572609|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-11-26|2015-11-26||November 2011||2011-11-01|November 2015|2015-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Treated set (TS): 36 subjects took 1 dose of reference product and 1 dose of test product.|Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride|Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride|Completed||Phase 1|||Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 22:51:11.584898|2017-10-10 22:51:11.584898
NCT02572596|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-02-08|||January 1, 2013||2013-01-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients|A Prospective Control Study of Comparing Intermediate-dose Cyclophosphamide(ID-CTX) and G-CSF Plus or Not Recombinant Human Thrombopoietin (rhTPO) for PBSC Mobilization in Patients With Multiple Myeloma|Recruiting||N/A|200|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-10 22:51:11.833484|2017-10-10 22:51:11.833484
NCT02572583|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2015-10-08|||November 2014||2014-11-01|April 2015|2015-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||A Clinical Study of Treating Influenza With Liugan Shuangjie Heji||Unknown status|Recruiting|Phase 1/Phase 2|300|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||3|||f||||f||||||||||2017-10-10 22:51:11.942573|2017-10-10 22:51:11.942573
NCT02572570|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-09-14|||December 2015||2015-12-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth|Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth|Recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 22:51:12.037643|2017-10-10 22:51:12.037643
NCT02572557|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-06-26|||December 2016|Actual|2016-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TruFreeze Cryotherapy Central Airway Disease|A Prospective Evaluation of Spray Cryotherapy in Patients With Malignant and Benign Central Airway Disease|Enrolling by invitation||N/A|25|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-10-10 22:51:12.126669|2017-10-10 22:51:12.126669
NCT02572544|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-08|||October 2015||2015-10-01|October 2015|2015-10-01||||October 2015|Anticipated|2015-10-01||Interventional|||Comparison of Objective and Subjective Changes Induced by Multiple Pinhole Glasses and Single Pinhole Glasses||Unknown status|Recruiting|N/A|30|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||1|||f||||f||||||||||2017-10-10 22:51:12.201862|2017-10-10 22:51:12.201862
NCT02572531|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-07-04|||September 1, 2016|Actual|2016-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|PROVIS||Effect of Probiotics on Pain and Oral Wound Healing After Third Molar Surgery|Effect of Probiotic Supplements on Pain and Oral Wound Healing After Third Molar Surgery|Enrolling by invitation||N/A|60|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-10 22:51:12.293399|2017-10-10 22:51:12.293399
NCT02572518|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-10-09|||May 2014||2014-05-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01|45 Days|Observational [Patient Registry]|IATDYFV||Immunity After Two Doses of Yellow Fever Vaccine|Duration of Immunity After Two Doses of Vaccine Against Yellow Fever in Adults|Completed||N/A|440|Actual|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)|||1||f||||t||||||Samples With DNA|"     whole blood, serum   "|||2017-10-10 22:51:12.372095|2017-10-10 22:51:12.372095
NCT02572505|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-10-05|||November 2015|Actual|2015-11-01|October 2017|2017-10-01|September 20, 2017|Actual|2017-09-20|September 20, 2017|Actual|2017-09-20||Interventional|PrEP-HIVD||Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples|Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples|Withdrawn||N/A|0|Actual|University of Missouri-Columbia||1|||f||||f||||||||||2017-10-10 22:51:12.444121|2017-10-10 22:51:12.444121
NCT02572492|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-07|||January 2015||2015-01-01|October 2015|2015-10-01|April 2019|Anticipated|2019-04-01|December 2017|Anticipated|2017-12-01||Interventional|CARFI||Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support|Phase II Study of Carfilzomib-cyclophosphamide-dexamethasone and High-dose Melphalan (HDT) Followed by Randomization Between Observation or Maintenance With Carfilzomib and Dexamethasone in Patients With Relapsed Multiple Myeloma After HDT|Recruiting||Phase 2|200|Anticipated|Aalborg Universitetshospital||2|||f||||t||||||||||2017-10-10 22:51:12.540748|2017-10-10 22:51:12.540748
NCT02572479|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-05-02|||October 2015||2015-10-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|JERN_ALS||Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS)|Observational Study for Evaluating the Potential of Diet and Food Components as Disease Modifiers in Amyotrophic Lateral Sclerosis (JERN_ALS)|Enrolling by invitation||N/A|50|Anticipated|University of Jena|||1||f||||f||||||Samples Without DNA|"     Blood sampling every six months (1x 9mL Sarstedt monovette)   "|||2017-10-10 22:51:12.662642|2017-10-10 22:51:12.662642
NCT02570971|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-06|||October 2015||2015-10-01|October 2015|2015-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||Mannitol Versus Supportive Care in Ciguatera Fish Poisoning|Mannitol Versus Supportive Care in Ciguatera Fish Poisoning: A Randomized Control Trial|Not yet recruiting||Phase 3|200|Anticipated|University of South Florida||2|||f||||||||||||||2017-10-10 22:51:29.804306|2017-10-10 22:51:29.804306
NCT02572466|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-01-27|||February 2015||2015-02-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Study of High Sensitive Troponin-I Level in End-stage Renal Disease Patients Receiving Hemodialysis|Study of High Sensitive Troponin-I Level in End-stage Renal Disease Patients Receiving Hemodialysis|Completed||N/A|207|Actual|Chulalongkorn University|||2||f||||f||||||Samples Without DNA|"     blood sample   "|No||2017-10-10 22:51:12.7341|2017-10-10 22:51:12.7341
NCT02572453|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-08|2017-10-02|||April 4, 2016|Actual|2016-04-04|September 2017|2017-09-01||||August 31, 2019|Anticipated|2019-08-31||Interventional|||Onalespib in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Diffuse Large B-Cell Lymphoma|Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL|Recruiting||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 22:51:12.945711|2017-10-10 22:51:12.945711
NCT02572440|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-07|||October 2014||2014-10-01|October 2015|2015-10-01||||June 2015|Actual|2015-06-01||Expanded Access|||Autologous Platelet-rich Plasma (aPRP) for Complex Aortic Arch Surgerymacrovascular Operation|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Temporarily not available||N/A|||Beijing Anzhen Hospital|||||f||||||||||||||2017-10-10 22:51:13.135495|2017-10-10 22:51:13.135495
NCT02572427|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-07-25|2015-10-09||September 2013||2013-09-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Resident Training Enhanced by New Innovations: Teleintubation|Video Laryngoscopy for Enhancing and Maintaining Intubation Skills|Completed||N/A|82|Actual|University of Arkansas||2|||f||||f||||||||||2017-10-10 22:51:13.226446|2017-10-10 22:51:13.226446
NCT02572414|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-08-19|||January 2015||2015-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Men Together Making a Difference: Health Promotion for Black Men|Health Promotion for HIV Positives: A Randomized Trial With HIV Positive Black Men|Recruiting||N/A|384|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:51:14.082574|2017-10-10 22:51:14.082574
NCT02572401|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-10-07|||October 2011||2011-10-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2013|Actual|2013-06-01||Interventional|STAND||Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men|Reducing the Risk of HIV/STD Infection Among African American Men|Completed||N/A|391|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-10 22:51:14.187167|2017-10-10 22:51:14.187167
NCT02572388|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-08-08|||October 15, 2015|Actual|2015-10-15|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1|Safety and Immunogenicity of a Protein Particle Malaria Vaccine Candidate, R21, Administered With and Without Matrix-M1 in Healthy UK Volunteers|Active, not recruiting||Phase 1|24|Anticipated|University of Oxford||4|||f||||||||||||||2017-10-10 22:51:14.29578|2017-10-10 22:51:14.29578
NCT02572375|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-03-27|||October 2014||2014-10-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|COGUSS||Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study|An Open-Label, Randomized, Multiple-Dose, 2-Way Crossover Comparative Bioavailability Steady State Study of Codeine Phosphate/Guaifenesin Extended-Release Tablet in Healthy Subjects|Completed||Phase 1|38|Actual|Nexgen Pharma, Inc||2|||f||||t||||||||||2017-10-10 22:51:14.39051|2017-10-10 22:51:14.39051
NCT02572362|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2016-12-11|||August 2015||2015-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Secondary Cancer Risk After Radiation Therapy for Rectal Cancer|Estimation of Second Cancer Risk in Patients Planned With Different Radiotherapy Regimes for Rectal Cancer - A Planning Study and Model-based Analysis|Completed||N/A|25|Actual|Kantonsspital Graubuenden|||1||f||||f||||||||||2017-10-10 22:51:14.484825|2017-10-10 22:51:14.484825
NCT02572349|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-04-23|||October 2015||2015-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IW-1701 Administered Orally as Single Doses to Healthy Subjects|Completed||Phase 1|24|Actual|Ironwood Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 22:51:14.560751|2017-10-10 22:51:14.560751
NCT02572336|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2015-11-16|||October 2015||2015-10-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA|Phase II Study to Assess the Safety, Imaging, Pharmacodynamic and Clinical Outcomes of Acute Ischemic Stroke Subjects Treated With tPA and THR-18|Unknown status|Recruiting|Phase 2|40|Anticipated|D-Pharm Ltd.||2|||f||||f||||||||||2017-10-10 22:51:14.647278|2017-10-10 22:51:14.647278
NCT02572323|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-02-16|||February 15, 2017|Actual|2017-02-15|February 2017|2017-02-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons|Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons|Recruiting||Phase 2|100|Anticipated|University of California, San Diego||2|||f||||t|t|f|||f|||No||2017-10-10 22:51:14.755237|2017-10-10 22:51:14.755237
NCT02572310|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-06-22|||March 2016||2016-03-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Simplex High Viscosity Bone Cement in Primary Total Knee Arthroplasty|A Prospective Radiostereometric Analysis (RSA) Study of Implant Stability and Clinical Evaluation of Simplex High Viscosity Bone Cement in Primary Total Knee Arthroplasty|Active, not recruiting||N/A|25|Actual|Nova Scotia Health Authority||1|||f||||f||||||||Undecided||2017-10-10 22:51:14.871293|2017-10-10 22:51:14.871293
NCT02572297|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-06-19|||May 18, 2010|Actual|2010-05-18|June 2017|2017-06-01|August 23, 2015|Actual|2015-08-23|February 2015|Actual|2015-02-01|10 Years|Observational [Patient Registry]|REPOMSE||National Network for the Study of Predictors and Prevention of Sudden Unexpected Death in Drug-resistant Partial Epilepsies|National Network for the Study of Predictors and Prevention of Sudden Unexpected Death in Drug-resistant Partial Epilepsies|Completed||N/A|1072|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 22:51:14.955207|2017-10-10 22:51:14.955207
NCT02572284|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-10-04|||October 7, 2015|Actual|2015-10-07|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer|A Phase I Dose Escalation Study of Preoperative Stereotactic Body Radiation Therapy (SBRT) for High Risk Prostate Cancer|Recruiting||N/A|9|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-10 22:51:15.041872|2017-10-10 22:51:15.041872
NCT02572271|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2015-10-07|||September 2015||2015-09-01|October 2015|2015-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study|Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study|Recruiting||N/A|22|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-10 22:51:15.16023|2017-10-10 22:51:15.16023
NCT02572258|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-07|||September 2015||2015-09-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Supplementary Food on Prevention of Moderate Malnutrition in Children|The Effect of Supplementary Food Cookies on Prevention of Moderate Malnutrition in Preschool Children in Rural Mexico|Unknown status|Recruiting|N/A|1048|Anticipated|PepsiCo Global R&D||2|||f||||||||||||||2017-10-10 22:51:15.264212|2017-10-10 22:51:15.264212
NCT02572245|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-06-03|||January 2016||2016-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|B538-05||A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects|A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Pharmacokinetics Of Pf-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects|Completed||Phase 1|164|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 22:51:15.345165|2017-10-10 22:51:15.345165
NCT02572232|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-08-28|||September 1, 2017|Anticipated|2017-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Supraglottic Airway Devices in Pediatric Difficult Airway Situations|Comparison of Three Different Supraglottic Airway Devices and Endotracheal Intubation in Pediatric Difficult Airway Situations in a Manikin|Not yet recruiting||N/A|40|Anticipated|Medical University of Vienna||1|||f||||t|f|f||||||||2017-10-10 22:51:15.437188|2017-10-10 22:51:15.437188
NCT02572219|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-03-13|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effects of a Nutraceutical Preparation on Cognitive Impairment in Hypertensive Patients|Effects of a Nutraceutical Preparation on Cognitive Impairment in Hypertensive Patients|Completed||Phase 3|12|Actual|Neuromed IRCCS||2|||f||||||||||||||2017-10-10 22:51:15.502111|2017-10-10 22:51:15.502111
NCT02572206|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-09-26|||September 2015||2015-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations|Demonstration of mGluR5 Overexpression in Amish and Mennonite CNTNAP2 Mutation Carriers|Terminated||Phase 1|4|Actual|New York State Psychiatric Institute||1||NIMH terminated study|f||||t||||||||||2017-10-10 22:51:15.566789|2017-10-10 22:51:15.566789
NCT02572193|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-12-15|||October 2015||2015-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|POEM2||To Assess the Feasibility of Same Day Discharge Following a POEM Procedure|To Assess the Feasibility of Same Day Discharge Following a POEM Procedure|Recruiting||N/A|100|Anticipated|McMaster University||1|||f||||f||||||||||2017-10-10 22:51:15.640669|2017-10-10 22:51:15.640669
NCT02572180|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-06-23|||September 2015||2015-09-01|June 2016|2016-06-01||||September 2017|Anticipated|2017-09-01||Interventional|||A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD)|A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD): Differential Effects of Training in a 2D or 3D Environment|Recruiting||N/A|90|Anticipated|University Hospital Tuebingen||3|||f||||f||||||||No||2017-10-10 22:51:15.724507|2017-10-10 22:51:15.724507
NCT02572167|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-09-28|||October 2015||2015-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma|A Phase 1/2 Study Evaluating Brentuximab Vedotin in Combination With Nivolumab in Patients With Relapsed or Refractory Hodgkin Lymphoma After Failure of Frontline Therapy|Active, not recruiting||Phase 1/Phase 2|93|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-10-10 22:51:15.846875|2017-10-10 22:51:15.846875
NCT02572154|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-10-24|||September 2012||2012-09-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PARTHOM||Sperm DNA Fragmentation in Recurrent Pregnancy Loss|Male Factor in Early Recurrent Pregnancy Loss : Study of Sperm DNA Fragmentation in Patients With Unexplained Recurrent Pregnancy Loss.|Completed||N/A|64|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 22:51:15.973831|2017-10-10 22:51:15.973831
NCT02572141|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-12-29|||October 2015||2015-10-01|October 2015|2015-10-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Interventional|OPTICAL||FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL)|A Phase III Study to Evaluate the 3-year Disease-free Survival in Patients With Locally Advanced Colon Cancer Receiving Either Perioperative or Postoperative Chemotherapy With FOLFOX or CAPOX Regimens|Recruiting||Phase 3|738|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:51:16.055378|2017-10-10 22:51:16.055378
NCT02572128|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-07-11|||June 2015||2015-06-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Mineral Absorption From Fortified Rice Produced With Different Fortification Techniques|Comparative Evaluations of Micronutrient Absorption From Mineral Fortified Rice Produced With Different Fortification Techniques: An Evaluation of Hot and Cold Extrusion (Study 1) and Coating Technologies (Study 2)|Completed||N/A|44|Actual|Swiss Federal Institute of Technology||2|||f||||f||||||||||2017-10-10 22:51:16.152979|2017-10-10 22:51:16.152979
NCT02572115|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-06|||September 4, 2017|Actual|2017-09-04|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|December 4, 2017|Anticipated|2017-12-04||Interventional|Akutknappen||Differentiated Access to Out-of-hours Primary Care Through Emergency Access|Differentiated Access to Out-of-hours Primary Care Through Emergency Access|Enrolling by invitation||N/A|6000|Anticipated|University of Aarhus||3|||f||||t|f|f||||||||2017-10-10 22:51:16.237004|2017-10-10 22:51:16.237004
NCT02572102|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-07|||June 2015||2015-06-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Impact of Energy Drinks and Panax Ginseng on Heart Rhythm|Impact of Energy Drinks and Panax Ginseng on Heart Rhythm in Healthy Volunteers|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of the Pacific||3|||f||||f||||||||||2017-10-10 22:51:16.337296|2017-10-10 22:51:16.337296
NCT02571179|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-04-11|||January 2011||2011-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|fentaobs||Intranasal Fentanyl in Treatment of Labour Pain|Intranasal Fentanyl in Treatment of Labour Pain - Efficacy and Safety|Recruiting||Phase 4|20|Anticipated|Kuopio University Hospital||1|||f||||f||||||||Undecided||2017-10-10 22:51:27.410664|2017-10-10 22:51:27.410664
NCT02572089|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-01-11|||October 2014||2014-10-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers|Phase 1, Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers|Completed||Phase 1|30|Actual|National Institute on Drug Abuse (NIDA)||5|||f||||t||||||||||2017-10-10 22:51:16.417325|2017-10-10 22:51:16.417325
NCT02572076|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-12-26|||February 2016||2016-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Investigational Plan: Evaluation of the Performance of the Motus Cleansing System|Clinical Investigational Plan: Evaluation of the Performance of the Motus Cleansing System|Recruiting||N/A|40|Anticipated|Motus GI Medical Technologies Ltd||1|||f||||f||||||||No||2017-10-10 22:51:16.501149|2017-10-10 22:51:16.501149
NCT02572063|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-04-27|||November 15, 2015|Actual|2015-11-15|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Observational|ProAge||Omics4Aging: Stratification of Frailty Population|Omics4Aging: Stratification of Frailty Population Based on Nutrients Profiling and Metabolic Profiling at Baseline|Recruiting||N/A|60|Anticipated|Nestlé|||1||f||||f||||||Samples With DNA|"     Blood and urine samples and feces   "|||2017-10-10 22:51:16.570229|2017-10-10 22:51:16.570229
NCT02572050|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-04-18|||October 2015||2015-10-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|AaRon||Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection|Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection for Clinical Stage II or III Gastric Cancer|Recruiting||Phase 2|87|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-10 22:51:16.781028|2017-10-10 22:51:16.781028
NCT02572037|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2017-09-12|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|July 30, 2017|Actual|2017-07-30|July 1, 2017|Actual|2017-07-01||Observational|||Research and Clinical Value of New Classification for Premature Ejaculation: Multi-Center Research|Research and Clinical Value of New Classification for Premature Ejaculation:Multi-Center Research|Completed||N/A|584|Actual|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|||4||f||||t||||||||||2017-10-10 22:51:16.904911|2017-10-10 22:51:16.904911
NCT02572024|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-04-26|||November 2015||2015-11-01|August 2016|2016-08-01||||November 2020|Anticipated|2020-11-01||Interventional|The Nordic BAT||The Effect of Baroreflex Activation Therapy (BAT) on Blood Pressure and Sympathetic Function in Patients With Resistant Hypertension (The Nordic BAT Study)||Recruiting||N/A|100|Anticipated|Helsinki University Central Hospital||2|||f||||||||||||||2017-10-10 22:51:17.008333|2017-10-10 22:51:17.008333
NCT02572011|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-09-20|||December 2015||2015-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Transtibial Amputee Balance Training: A Randomised Controlled Trial|A Games-console Based Balance Training Intervention for Transtibial Amputees: A Randomised Controlled Trial|Recruiting||N/A|32|Anticipated|Nottingham Trent University||2|||f||||f||||||||No||2017-10-10 22:51:17.126754|2017-10-10 22:51:17.126754
NCT02571998|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-03-24||2017-03-24|October 2015||2015-10-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris|A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Multicenter Study to Evaluate the Safety and Efficacy of CLS001 Topical Gel Versus Vehicle Applied Once Daily for 12 Weeks to Female Subjects With Moderate to Severe Acne Vulgaris|Completed||Phase 2|320|Actual|Cutanea Life Sciences, Inc.||2|||f||||f||||||||||2017-10-10 22:51:17.226505|2017-10-10 22:51:17.226505
NCT02571985|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-03-03|||May 2012||2012-05-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|April 2013|Actual|2013-04-01||Expanded Access|||PRESERVE-Zenith® Iliac Branch System Clinical Extended Study|Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™|No longer available||N/A|||Cook Group Incorporated|||||f||||||||||||||2017-10-10 22:51:17.381297|2017-10-10 22:51:17.381297
NCT02571972|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-02-17|||October 2014||2014-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dorzolamide-timolol Drops With Injections to Treat AMD,RVO or DME.|Effect of Topical Aqueous Suppressant on Anatomic and Functional Response to Intravitreal Anti-vascular Endothelial Growth Factor Injections in Age-related Macular Degeneration, Retinal Vein Occlusions or Diabetic Macular Edema.|Recruiting||Phase 2|15|Anticipated|Wills Eye||1|||f||||f||||||||Yes|"Manuscript is under development. Age-related macular degeneration data published JAMA Ophthalmol. 2016 Apr;134(4):437-43. doi: 10.1001/jamaophthalmol.2016.0045. Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration.
Sridhar J1, Hsu J1, Shahlaee A1, Garg SJ1, Spirn MJ1, Fineman MS1, Vander J1. PMID: 26914218 DOI: 10.1001/jamaophthalmol.2016.0045"|2017-10-10 22:51:17.489538|2017-10-10 22:51:17.489538
NCT02571959|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-10-10|||October 2015||2015-10-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|PHACO||Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults|Pharmacokinetic Study of the Amoxicillin / Clavulanic Acid Association to Optimize Dosage Among Obese Adults (PHACO)|Recruiting||Phase 1/Phase 2|25|Anticipated|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba||1|||f||||t||||||||||2017-10-10 22:51:17.601089|2017-10-10 22:51:17.601089
NCT02571946|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-08-19|||November 2016||2016-11-01|August 2016|2016-08-01|September 2022|Anticipated|2022-09-01|September 2018|Anticipated|2018-09-01||Interventional|PTHP||Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis|Feasibility of High Dose Proton Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: Prospective Phase II Trial|Not yet recruiting||Phase 2|53|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:51:17.692152|2017-10-10 22:51:17.692152
NCT02571933|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-12-22|||October 2015||2015-10-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|FPS-RCam||Face Validity and Cross-Cultural Acceptability of the FPS-R in Cameroon|Face Validity and Cross-Cultural Acceptability of the FPS-R in Cameroon|Completed||N/A|36|Actual|Cameroon Baptist Convention Health|||3||f||||f||||||||||2017-10-10 22:51:17.785982|2017-10-10 22:51:17.785982
NCT02571920|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-11-03|||November 2015||2015-11-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Observational|EMOA||Hemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA)|Hemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA Study)|Recruiting||N/A|2000|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 22:51:17.902279|2017-10-10 22:51:17.902279
NCT02571907|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-03-03||2016-12-02|April 2015||2015-04-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|November 2015|Actual|2015-11-01||Interventional|||PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study|Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation|Active, not recruiting||N/A|40|Actual|Cook Group Incorporated||1|||t||||||||||||||2017-10-10 22:51:18.015737|2017-10-10 22:51:18.015737
NCT02571894|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2016-09-04|||July 2014||2014-07-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|COBC||The Cardio-Oncology Breast Cancer Study|Effects of Identifying and Treating Early, Subclinical Cardiotoxicity on the Long-Term Incidence of Clinical Cardiotoxicity in Women With Breast Cancer, A Prospective Randomized Study: The Cardio-Oncology Breast Cancer Study (COBC)|Recruiting||N/A|320|Anticipated|Karolinska University Hospital||2|||f||||t||||||||||2017-10-10 22:51:18.196379|2017-10-10 22:51:18.196379
NCT02571881|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-04-11|||October 2012||2012-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|oksisektio||Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section|Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section|Recruiting||Phase 4|90|Anticipated|Kuopio University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:51:18.383376|2017-10-10 22:51:18.383376
NCT02571868|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-07|||January 2011||2011-01-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|QuickSept||Acute and Cronic Evaluation of AV/PV and VV Delay IEGM Based Optimisation Algorithm-QuickSept Study|Acute and Cronic Evaluation of AV/PV and VV Delay IEGM Based Optimisation Algorithm (QuickOpt™) Compared With Echocardiographic Method for Cardiac Resincronization Therapy in CRT Implants With Right Interventricular Basal-Mid Septum Placement of Leads (QuickSept Study)|Completed||N/A|53|Actual|Maria Vittoria Hospital|||1||f||||f||||||||||2017-10-10 22:51:18.515042|2017-10-10 22:51:18.515042
NCT02571855|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-07-25|||October 1, 2015|Actual|2015-10-01|July 2017|2017-07-01|February 1, 2016|Actual|2016-02-01|February 1, 2016|Actual|2016-02-01||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects|Double-blind, Placebo-controlled, Randomized Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-541468: Part A: Multiple-ascending Doses in Healthy Young Adults After Morning Administration Part B: Single-ascending Doses in Healthy Elderly Subjects After Morning Administration Part C: Repeated Doses in Both Healthy Young Adults and Elderly Subjects After Evening Administration|Completed||Phase 1|85|Actual|Actelion||6|||f||||f||||||||||2017-10-10 22:51:18.614575|2017-10-10 22:51:18.614575
NCT02571842|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-07|||January 2012||2012-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Rituximab in Recurrent IgA Nephropathy|A Randomized, Prospective, Open-Label Study of Rituximab in the Treatment of Recurrent IgA Nephropathy With Active Endocapillary Proliferation Pathology|Unknown status|Recruiting|Phase 4|30|Anticipated|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 22:51:18.755498|2017-10-10 22:51:18.755498
NCT02571829|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-11-22|||May 2016||2016-05-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma|A Phase II Single Arm Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well-Differentiated or Dedifferentiated Liposarcoma|Active, not recruiting||Phase 2|30|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-10 22:51:18.876663|2017-10-10 22:51:18.876663
NCT02571816|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-03-17|||October 2015||2015-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215|A Phase 1 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||Undecided||2017-10-10 22:51:18.987049|2017-10-10 22:51:18.987049
NCT02571803|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-11-13|||October 2015||2015-10-01|November 2015|2015-11-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|DISCO-CT||Dietary Intervention to Stop COronary Atherosclerosis in Computed Tomography|The Effect of Strict Dietary Intervention on Atherosclerotic Lesions in Patients Diagnosed With Coronary Artery Disease, Assessed by Coronary Computed Tomography Angiography (CCTA).|Recruiting||N/A|180|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||t||||||||||2017-10-10 22:51:19.097233|2017-10-10 22:51:19.097233
NCT02571790|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2015-10-07|||October 2015||2015-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|Relax-TAG||Virtual Reality and Relaxation for the Treatment of Generalized Anxiety Disorders: a Comparative Study With Standard Relaxation|Virtual Reality and Relaxation for the Treatment of Generalized Anxiety Disorders: a Comparative Study With Standard Relaxation|Unknown status|Recruiting|N/A|58|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:51:19.190727|2017-10-10 22:51:19.190727
NCT02571777|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-05-02|||December 8, 2015|Actual|2015-12-08|May 2017|2017-05-01|April 7, 2019|Anticipated|2019-04-07|April 7, 2019|Anticipated|2019-04-07||Interventional|||Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma|A Multicenter, Randomized, 52-week, Double-blind, Parallelgroup, Active Controlled Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma|Recruiting||Phase 3|2980|Anticipated|Novartis||5|||f||||t||||||||||2017-10-10 22:51:19.338164|2017-10-10 22:51:19.338164
NCT02571764|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-07|||September 2015||2015-09-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Supplementary Food for Moderate Acute Malnutrition in Children|The Effect of Supplementary Food on Recovery From Moderate Acute Malnutrition in Pre-school Children in Rural Mexico|Unknown status|Recruiting|N/A|248|Anticipated|PepsiCo Global R&D||1|||f||||f||||||||||2017-10-10 22:51:20.733773|2017-10-10 22:51:20.733773
NCT02571751|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-04-24|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Open-label, Multi-center Trial to Evaluate Safety and Efficacy of Cohesive Silicone Gel-Filled Breast Implants UNIGEL®||Recruiting||N/A|166|Anticipated|Sewoon Medical Co., Ltd||1|||f||||||||||||||2017-10-10 22:51:20.839796|2017-10-10 22:51:20.839796
NCT02571166|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-02-28|||November 2015||2015-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||HSV529 Vaccine in HSV-2 Seropositive Adults|Phase I Study of the Genital Immune Response to Live, Attenuated HSV529 Vaccine in HSV-2 Seropositive Adults|Active, not recruiting||Phase 1|10|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-10 22:51:27.486588|2017-10-10 22:51:27.486588
NCT02571738|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-10-05|||October 2015|Actual|2015-10-01|October 2017|2017-10-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|*OTI-15-01||Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers|A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers|Terminated||Phase 3|108|Actual|Osiris Therapeutics||2||"Company's desire to allocate more research and development resources to other clinical   programs. Decision not driven by any safety concerns."|f||||t||||||||||2017-10-10 22:51:20.930289|2017-10-10 22:51:20.930289
NCT02571725|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-09-15|||February 2016||2016-02-01|September 2017|2017-09-01|February 2022|Anticipated|2022-02-01|February 2018|Anticipated|2018-02-01||Interventional|||PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer|A Phase 1-2 Study of the Combination of Olaparib and Tremelimumab, in BRCA1 and BRCA2 Mutation Carriers With Recurrent Ovarian Cancer|Recruiting||Phase 1/Phase 2|50|Anticipated|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-10 22:51:21.082372|2017-10-10 22:51:21.082372
NCT02571712|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-07-16|||November 15, 2015|Actual|2015-11-15|July 2017|2017-07-01|March 15, 2018|Anticipated|2018-03-15|March 15, 2018|Anticipated|2018-03-15||Interventional|||Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension|Evaluation of the Safety of GANFORT® (Bimatoprost 0.03% Plus Timolol 0.5%) Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension|Recruiting||Phase 4|750|Anticipated|Allergan||1|||f||||f||||||||||2017-10-10 22:51:21.236207|2017-10-10 22:51:21.236207
NCT02571699|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-06-09|||March 2016||2016-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Minimum Effective Volume of Lidocaine-Bupivacaine for Subgluteal Block|Minimum Effective Volume of Lidocaine-Bupivacaine for Ultrasound-Guided Subgluteal Sciatic Nerve Block|Recruiting||N/A|60|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 22:51:21.376411|2017-10-10 22:51:21.376411
NCT02571673|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-03-28|||October 5, 2015||2015-10-05|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)|Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)|Active, not recruiting||N/A|63|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 22:51:21.535141|2017-10-10 22:51:21.535141
NCT02571660|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-11-24|||November 2015||2015-11-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|November 2016|Anticipated|2016-11-01||Interventional|||Efficacy of Vitamin D on the Clinical Management of Pediatric Patients With Asthma|Efficacy of Vitamin D on the Clinical Management of Pediatric Patients With Asthma in the Hospital General Naval de Alta Especialidad|Not yet recruiting||Phase 3|100|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||2|||f||||f||||||||||2017-10-10 22:51:21.607188|2017-10-10 22:51:21.607188
NCT02571647|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-08-09|||January 11, 2016|Actual|2016-01-11|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|April 24, 2017|Actual|2017-04-24||Observational|EVAM||Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory|Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory|Active, not recruiting||N/A|300|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 22:51:21.722645|2017-10-10 22:51:21.722645
NCT02571634|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-08-30|2016-04-04||May 2015||2015-05-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|RFA||Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints|Open Label Feasibility Pilot Study to Assess the Efficacy and Safety of the Use of Lazanda for Anxiolysis During Radiofrequency Nerve Ablation of Lumbar Facet Joints|Completed||Phase 4|23|Actual|Defense and Veterans Center for Integrative Pain Management|This was a pilot study with a small number enrolled without comparison to any other groups. Future studies indicated with larger numbers and comparison to other forms of sedation.|1|||f||||f||||||||||2017-10-10 22:51:21.792405|2017-10-10 22:51:21.792405
NCT02571621|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-06|||January 1989||1989-01-01|October 2015|2015-10-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Observational|Combitube||Serial Usage of Combitube in Anesthesiology|Evaluation of Serial Usage of Combitube in Anesthesiology|Completed||N/A|745|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 22:51:22.033687|2017-10-10 22:51:22.033687
NCT02571608|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-09-12|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|November 2017|Anticipated|2017-11-01||Interventional|CANTAKE||Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control|ContinuAtioN of meTformin to Improve And KEep Peri-operative Glycemic Control: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.|Not yet recruiting||Phase 4|76|Anticipated|McMaster University||2|||f||||f|f|f||||||||2017-10-10 22:51:22.111197|2017-10-10 22:51:22.111197
NCT02571595|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-09-19|||May 2015||2015-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Sleep Program to Improve Sleep Quality in People With HIV|Efficacy Potential of an Internet-based Sleep Program to Improve Sleep Quality in People With HIV|Enrolling by invitation||N/A|60|Anticipated|McGill University||2|||f||||f||||||||||2017-10-10 22:51:22.225627|2017-10-10 22:51:22.225627
NCT02571582|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-06|||January 2009||2009-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Predictors of Mortality in Patients With Advanced Lung Disease in Home Oxygen Therapy|Predictors of Mortality in Patients With Advanced Lung Disease in Home Oxygen Therapy|Completed||N/A|553|Actual|Federal University of Uberlandia|||2||f||||f||||||||||2017-10-10 22:51:22.330423|2017-10-10 22:51:22.330423
NCT02571569|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-09-18|||October 28, 2015|Actual|2015-10-28|September 2017|2017-09-01|June 15, 2018|Anticipated|2018-06-15|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Single Escalating Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors|A Phase 1, First in Man, Multicenter, Open Label, Single Escalating Dose Study of BAY1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors|Recruiting||Phase 1|38|Anticipated|Bayer||2|||f||||t|t|f|||t|||||2017-10-10 22:51:22.404386|2017-10-10 22:51:22.404386
NCT02571556|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-11-29|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)|OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)|Completed||Phase 1/Phase 2|80|Actual|Eyegate Pharmaceuticals, Inc.||1|||f||||f||||||||Undecided||2017-10-10 22:51:22.510783|2017-10-10 22:51:22.510783
NCT02571543|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2017-06-12|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|Ibudelay||Can Ibuprofen Delay Ovulation in Natural Cycle-IVF?|Investigation of Ibuprofen in the Delay of Ovulation in NC-IVF (Natural Cycle in Vitro Fertilisation) Therapy With the Objective of Reducing Premature Ovulation and Thus Improving Effectivity (Off Label Use)|Recruiting||Phase 2|68|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 22:51:22.588014|2017-10-10 22:51:22.588014
NCT02571530|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-11-03|||September 2015||2015-09-01|November 2016|2016-11-01||||September 2018|Anticipated|2018-09-01||Interventional|||Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer|Phase 1 Trial of Super-selective Intra-arterial Cerebral Infusion of Trastuzumab After Blood-Brain Barrier Disruption for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer|Recruiting||Phase 1|48|Anticipated|Northwell Health||1|||f||||f||||||||||2017-10-10 22:51:22.690329|2017-10-10 22:51:22.690329
NCT02571517|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-07|||November 2011||2011-11-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis|Impact of the Administration of Systemic Glucocorticoids on Inflammatory Response and Clinical Evolution of Patients Diagnosed With Moderate- Severe Bronchiolitis|Completed||Phase 4|94|Actual|Fundació Sant Joan de Déu||2|||f||||f||||||||||2017-10-10 22:51:22.771075|2017-10-10 22:51:22.771075
NCT02571504|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-09-19|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Cognitive Training for the Remediation of Functional Brain Health in HIV|Brain Imaging to Understand HIV-associated Neurocognitive Disorder and Predict Response to Cognitive Training|Completed||N/A|81|Actual|McGill University||2|||f||||f||||||||||2017-10-10 22:51:22.861092|2017-10-10 22:51:22.861092
NCT02571478|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2016-11-01|||February 2016||2016-02-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluation of a Brief Marriage Intervention for Internal Behavioral Health Consultants in Military Primary Care|Evaluation of a Brief Marriage Intervention for Internal Behavioral Health Consultants in Military Primary Care|Recruiting||N/A|500|Anticipated|Wright State University||2|||f||||f||||||||||2017-10-10 22:51:23.073882|2017-10-10 22:51:23.073882
NCT02571465|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-07|2016-11-14|||April 2015||2015-04-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|POP||Assessment of Fluid Responsiveness in Patients After Cardiac Surgery|Assessment of Fluid Responsiveness in Patients After Cardiac Surgery Comparison of Different Functional Hemodynamic Parameters and Tests|Completed||N/A|40|Actual|Triemli Hospital|||1||f||||f||||||||||2017-10-10 22:51:23.196249|2017-10-10 22:51:23.196249
NCT02571452|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-08-09|||January 12, 2016|Actual|2016-01-12|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|BBTI||Brief Behavioral Insomnia Treatment Study|Telephone-Facilitated Insomnia Treatment in Primary Care for OEF/OIF/OND Veterans|Recruiting||N/A|110|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:51:23.26097|2017-10-10 22:51:23.26097
NCT02571439|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2017-07-22|||October 2014||2014-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|March 2016|Actual|2016-03-01||Interventional|Surgical-TAP||Comparative Study of Two Different Techniques to Perform TAP-blocks|A Randomized Controlled Trial of Surgical TAP-block After Cesarean Delivery: a Cost-effective Alternative to the Conventional TAP-block|Active, not recruiting||Phase 4|84|Actual|Maimonides Medical Center||2|||f||||f||||||||||2017-10-10 22:51:25.234743|2017-10-10 22:51:25.234743
NCT02571426|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-22|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Renal Function During Pediatric Anesthesia|The Influence of Propofol and Sevoflurane Anesthesia on Water and Sodium Retention in Children|Unknown status|Recruiting|Phase 1|32|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-10 22:51:25.339385|2017-10-10 22:51:25.339385
NCT02571413|ClinicalTrials.gov processed this data on October 10, 2017|2010-01-11|2016-05-02|||May 2009||2009-05-01|May 2016|2016-05-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Evaluation of the Animated Cartoon-aided Teaching of Intranasal Corticosteroid Allergic Rhinitis|Evaluation of the Animated Cartoon-aided Teaching of Intranasal Corticosteroid Administration Technique Among Thai Children With Allergic Rhinitis|Completed||N/A|80|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 22:51:25.446011|2017-10-10 22:51:25.446011
NCT02571400|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-05-09|||October 2015||2015-10-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study|Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study|Completed||N/A|1013|Actual|University of Notre Dame Australia|||1||f||||f||||||||No||2017-10-10 22:51:25.557426|2017-10-10 22:51:25.557426
NCT02571387|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-11-18|||May 2016||2016-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MindOb||MindOb: A 12-month Computerized Mindfulness-based Intervention for Obese Individuals|Study of the Effects of Mindfulness on Impulsive Eating, Motivation Toward Exercise, and Weight Loss in Obese Patients: Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|University of Paris 5 - Rene Descartes||3|||f||||f||||||||No||2017-10-10 22:51:25.664218|2017-10-10 22:51:25.664218
NCT02571374|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2015-10-07|||October 2013||2013-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Symbiotics to Prevent Postoperative Infection in Colorectal Cancer|Change in Incidence of Surgical Site Infection After Resection of Colorectal Cancer Between Patients Receiving a Symbiotic Compound and Patients Receiving a Placebo.|Unknown status|Recruiting|N/A|92|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-10 22:51:25.79031|2017-10-10 22:51:25.79031
NCT02571348|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-12-28|||September 2015||2015-09-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Optimum Micro-osteoperforations Accelerated Tooth Movement Interval|Optimum Micro-osteoperforations Accelerated Tooth Movement Interval, Related Pain Perception and Impact to Daily Functions - A Randomized Controlled Trial|Active, not recruiting||N/A|36|Anticipated|University of Malaya||3|||f||||f||||||||||2017-10-10 22:51:26.054566|2017-10-10 22:51:26.054566
NCT02571322|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-03-02|||January 19, 2016|Actual|2016-01-19|March 2017|2017-03-01|January 12, 2017|Actual|2017-01-12|January 12, 2017|Actual|2017-01-12||Interventional|||Whole Body Vibration Training on Body Composition|The Effect of Whole Body Vibration Training on Body Composition, Physical Fitness, and Quality of Life|Withdrawn||N/A|0|Actual|University of Miami||2||Lack of funding; logistics of conducting study were very complex.|f||||f||||||||No||2017-10-10 22:51:26.351817|2017-10-10 22:51:26.351817
NCT02571309|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2017-03-01|||August 2016||2016-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Asthmatuner||Asthmatuner a Self-management App for Asthma: A Randomized Controlled Multicentre Trial|Asthmatuner a Self-management App for Asthma|Recruiting||N/A|43|Anticipated|Karolinska Institutet||2|||f||||t||||||||No||2017-10-10 22:51:26.485535|2017-10-10 22:51:26.485535
NCT02571296|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-07|||July 2015||2015-07-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth|The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth|Unknown status|Recruiting|Phase 4|212|Anticipated|Ghamra Military Hospital||2|||f||||f||||||||||2017-10-10 22:51:26.597516|2017-10-10 22:51:26.597516
NCT02571283|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-04-05|||October 2015||2015-10-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel|A Randomized, Prospective Trial Comparing Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel|Withdrawn||Phase 4|0|Actual|University of Louisville||3||PI decided to focus on more current topics of interest.|f||||t||||||||||2017-10-10 22:51:26.704992|2017-10-10 22:51:26.704992
NCT02571270|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-06|||March 2015||2015-03-01|October 2015|2015-10-01||||August 2015|Actual|2015-08-01||Interventional|||12-Week-Combined Physical Training In Heart Failure Patients|Impact Of Supervised 12-Week-Combined Physical Training In Heart Failure Patients: A Randomized Trial|Completed||N/A|28|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||4|||f||||||||||||||2017-10-10 22:51:26.802112|2017-10-10 22:51:26.802112
NCT02571257|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-10|||August 2000||2000-08-01|October 2015|2015-10-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy|An 8-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study in Hypercholesterolemic Patients to Determine the Efficacy and Safety of Combination Therapy With CI-1027 and a Statin|Completed||Phase 2|66|Actual|Gemphire Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 22:51:26.892294|2017-10-10 22:51:26.892294
NCT02571231|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-10-07|||November 2015||2015-11-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||High Flow Ventilation With Volume Guarantee|Pilot Study: High Flow Ventilation With Volume Guarantee|Unknown status|Not yet recruiting|N/A|15|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 22:51:27.079468|2017-10-10 22:51:27.079468
NCT02571218|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-03-02|||July 2015||2015-07-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||AF Substrate Mapping and Guided Ablation|Substrate-Targeted Catheter Ablation to Treat Persistent Atrial Fibrillation|Completed||N/A|80|Actual|St. Jude Medical||2|||f||||f||||||||||2017-10-10 22:51:27.167339|2017-10-10 22:51:27.167339
NCT02571205|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-03-29|||November 2015||2015-11-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|February 2019|Anticipated|2019-02-01||Observational|||Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy|Observational Study of Clinical Outcomes for Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy|Active, not recruiting||N/A|15|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||t||||||Samples With DNA|"     Samples to be collected as part of Biobank   "|No|Data available on request|2017-10-10 22:51:27.244453|2017-10-10 22:51:27.244453
NCT02571153|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-01-12|2016-09-28||September 2015||2015-09-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Low Doses of Ketamine and Postoperative Quality of Recovery|Effects of Low Doses of Ketamine on Postoperative Quality of Recovery After Total Intravenous Anesthesia|Completed||Phase 4|135|Actual|Pontificia Universidade Catolica de Sao Paulo||3|||f||||f||||||||||2017-10-10 22:51:27.576326|2017-10-10 22:51:27.576326
NCT02571140|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-02-07|||October 2013||2013-10-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects|A Phase Ib Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects|Enrolling by invitation||Phase 1|30|Anticipated|Entera Bio Ltd.||2|||f||||t||||||||||2017-10-10 22:51:28.026324|2017-10-10 22:51:28.026324
NCT02571127|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-10-06|||October 2015||2015-10-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness.|Ph IV , Longitudinal, Prospective, Open Label, Non-comparative, to Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness.|Unknown status|Not yet recruiting|Phase 4|46|Anticipated|Farmoquimica S.A.||1|||f||||t||||||||||2017-10-10 22:51:28.0928|2017-10-10 22:51:28.0928
NCT02571114|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-09-27|||October 2015||2015-10-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Glycemic and Metabolic Responses of Frozen Yogurt Containing Saskatoon Berry Powder in Healthy Males and Females|A Randomized, Controlled Study to Examine the Glycemic and Metabolic Responses of Frozen Yogurt Containing Saskatoon Berry Powder in Healthy Males and Females|Completed||N/A|13|Actual|University of Manitoba||4|||f||||f||||||||||2017-10-10 22:51:28.335585|2017-10-10 22:51:28.335585
NCT02571101|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-12-16|||November 2015||2015-11-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation|A Prospective, Randomized, Double-blinded, Active-control, 3-Treatment Arm, Parallel, Multi-center, Phase 2 Trial to Evaluate Safety and Efficacy With CDFR0812-15/25mg and CDFR0812-15/50mg Compared to Clomipramine HCl 15mg in Male Patients Diagnosed With Premature Ejaculation|Recruiting||Phase 2|297|Anticipated|CTC Bio, Inc.||3|||f||||f||||||||||2017-10-10 22:51:28.469452|2017-10-10 22:51:28.469452
NCT02571088|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-04-08|||September 2014||2014-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|EXDRE||Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients|Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients: Benefits on Physical Ability and Skeletal Muscle. An Interventional Pilot, Multicentric, Prospective, Longitudinal Study|Completed||N/A|40|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 22:51:28.653922|2017-10-10 22:51:28.653922
NCT02571062|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-10-07|||March 2015||2015-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation|A Bioequivalence Study of the Reference Clinical Fexinidazole Tablet vs Proposed Market Formulation in Healthy Male Volunteers of African Sub-Saharan Origin:an Open-label,Randomized,Two-treatment,Single Dose,Replicate Design,Fed Condition|Completed||Phase 1|30|Actual|Drugs for Neglected Diseases||2|||f||||f||||||||||2017-10-10 22:51:28.935336|2017-10-10 22:51:28.935336
NCT02571049|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-02-07|||September 2015||2015-09-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine|Randomized, Double-Blind, Crossover, Comparator Pilot Study of DFN-11 Injection (Strength A vs. Strength B) for Rapidly Escalating Migraine|Completed||Phase 2|20|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-10 22:51:29.035488|2017-10-10 22:51:29.035488
NCT02571036|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-27|||October 2015||2015-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies|A Multicenter Phase 1, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Malignancies|Recruiting||Phase 1|250|Anticipated|Deciphera Pharmaceuticals LLC||7|||f||||f|t|||||||||2017-10-10 22:51:29.133842|2017-10-10 22:51:29.133842
NCT02571023|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-07|||January 2016||2016-01-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Multicenter Clinical Study on Diagnosis and Treatment of Skull Base Trauma|Multicenter Clinical Study on Diagnosis and Treatment of Skull Base Trauma|Not yet recruiting||N/A|300|Anticipated|Shanghai Changzheng Hospital|||1||f||||f||||||||||2017-10-10 22:51:29.294801|2017-10-10 22:51:29.294801
NCT02571010|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-04-14|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|March 17, 2020|Anticipated|2020-03-17|March 17, 2020|Anticipated|2020-03-17||Interventional|RESISTAL||Evaluation of the Efficacy of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia|Pilot Study to Evaluate the Effectiveness of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia of Less Than Three Months Duration|Recruiting||N/A|45|Anticipated|CRRF La Châtaigneraie||3|||f||||f||||||||||2017-10-10 22:51:29.409142|2017-10-10 22:51:29.409142
NCT02570997|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-09-05|||September 2015||2015-09-01|October 2015|2015-10-01||||May 2016|Actual|2016-05-01||Interventional|||Ascending Dose Study of CT1812 in Healthy Volunteers|A Two-Part, Double-Blind, Placebo-Controlled, Phase I Study of the Safety Pharmacokinetics of Single and Multiple Ascending Doses of CT1812 in Healthy Volunteers|Completed||Phase 1|80|Actual|Cognition Therapeutics||2|||f||||t||||||||||2017-10-10 22:51:29.562318|2017-10-10 22:51:29.562318
NCT02570984|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-08-08|||September 2016||2016-09-01|August 2016|2016-08-01|September 2024|Anticipated|2024-09-01|September 2023|Anticipated|2023-09-01||Interventional|CASK||Controlling and Preventing Asthma Progression and Severity in Kids|Controlling and Preventing Asthma Progression and Severity in Kids|Not yet recruiting||Phase 3|250|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-10 22:51:29.679977|2017-10-10 22:51:29.679977
NCT02570958|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-06-01|||October 2017|Anticipated|2017-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ENB-RIGGS||ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors|Robotic ICG Guided Surgery (RIGGS) Using Electromagnetic Navigational Bronchoscopy (ENB): A Novel Technique for Targeting Small Lung Tumors|Withdrawn||Phase 1|0|Actual|St. Joseph's Healthcare Hamilton||1||Funding was not received|f||||f|f|f||||||No||2017-10-10 22:51:29.893426|2017-10-10 22:51:29.893426
NCT02570945|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-02-01|||September 2015||2015-09-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Trial of a Pharmacist-physician Intervention Model to Reduce High-risk Drug Use by Hospitalised Elderly Patients|Randomized Controlled Trial of a Pharmacist-physician Intervention Model to Reduce High-risk Drug Use by Elderly Inpatients|Completed||Phase 4|321|Actual|Centre de recherche du Centre hospitalier universitaire de Sherbrooke||2|||f||||f||||||||||2017-10-10 22:51:29.997882|2017-10-10 22:51:29.997882
NCT02570932|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-08-25|||July 2015||2015-07-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries|Intrathecal Administration (Pattern 100/3) of Expanded Autologous Adult Bone Marrow Mesenchymal Stem Cells in Established Chronic Spinal Cord Injuries|Active, not recruiting||Phase 2|10|Actual|Puerta de Hierro University Hospital||1|||f||||f||||||||||2017-10-10 22:51:30.084284|2017-10-10 22:51:30.084284
NCT02570919|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-10-06|||September 2015||2015-09-01|October 2015|2015-10-01|September 2021|Anticipated|2021-09-01|September 2016|Anticipated|2016-09-01||Interventional|PROSINT||Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer|Phase II Randomized Study Comparing Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy (IGRT) With Urethral Sparing for Intermediate Risk Prostate Cancer|Recruiting||Phase 2|30|Anticipated|Fundacao Champalimaud||2|||f||||f||||||||||2017-10-10 22:51:30.178866|2017-10-10 22:51:30.178866
NCT02570906|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-02-25|||December 2015||2015-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Performance Assessment of a Remote Patient Monitoring Device|A Performance Assessment of a Remote Patient Monitoring Device in Measuring Heart Rate, Respiration Rate, Posture, and Activity Level|Completed||N/A|12|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-10 22:51:30.285764|2017-10-10 22:51:30.285764
NCT02570893|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2015-10-06|||May 2015||2015-05-01|October 2015|2015-10-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma|A Multicenter, Randomized, Open-label, Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Patients Undergoing Radical Esophagectomy for Pathologic Lymph Node Positive Esophageal Squamous Cell Carcinoma|Recruiting||Phase 3|366|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-10 22:51:30.37586|2017-10-10 22:51:30.37586
NCT02570880|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-07|||October 2015||2015-10-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SLOWBREAD||Effect of Dough Fermentation Time of Bread on the Glycaemic Index|Effect of Dough Fermentation Time of Bread on the Glycaemic Index|Unknown status|Enrolling by invitation|N/A|15|Anticipated|Zurich University of Applied Sciences||1|||f||||f||||||||||2017-10-10 22:51:30.502342|2017-10-10 22:51:30.502342
NCT02570867|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-07|||June 2015||2015-06-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Functional Brain Changes of Primary Open-angle Glaucoma Patients|Study on the Changes of Brain Function in Primary Open-angle Glaucoma Patients With fMRI|Unknown status|Recruiting|N/A|40|Anticipated|First Affiliated Hospital of Jinan University|||2||f||||f||||||||||2017-10-10 22:51:30.572481|2017-10-10 22:51:30.572481
NCT02570854|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-07-28|||September 22, 2015|Actual|2015-09-22|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients|A First-in-human, Two-part (Open Label, and Randomized/Double Blind/Placebo Controlled), Single- and Repeat-dose Study of CSJ137 in Erythropoietin-treated Chronic Hemodialysis Patients With Functional Iron-deficiency Anemia|Recruiting||Phase 1/Phase 2|88|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 22:51:30.670837|2017-10-10 22:51:30.670837
NCT02570841|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-10-05|||February 2015||2015-02-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Pain Thresholds Under High-dose Topical Capsaicin|Heat-, Cold-, and Mechanical Pain Thresholds Under Exposition of High Dose Topical Capsaicin|Completed||Phase 4|20|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 22:51:30.775282|2017-10-10 22:51:30.775282
NCT02570828|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-01-12|||October 2015||2015-10-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Thermal Imaging in Neonates: A Feasibility Study in Healthy Babies and Babies With Suspected TTN|Thermal Imaging in Neonates: a Feasibility Study in Healthy Babies and Babies With Suspected Transient Tachypnea of the Newborn (TTN)|Completed||Phase 1|25|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 22:51:30.875451|2017-10-10 22:51:30.875451
NCT02570815|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-01-09|||October 2016||2016-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer|Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer: Analysis of Accuracy and Added Value|Recruiting||Phase 1|30|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||No||2017-10-10 22:51:30.966275|2017-10-10 22:51:30.966275
NCT02570802|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-10-25|||October 2015||2015-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ultrasonographic Reference Values for Peripheral Nerves in Children|Ultrasonographic Reference Values for Peripheral Nerves and Nerve Roots in the Normal Population of Children and Adolescents|Recruiting||N/A|255|Anticipated|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-10-10 22:51:31.106228|2017-10-10 22:51:31.106228
NCT02570789|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-10-13|||December 2012||2012-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|METASUN||Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy|A Proof of Concept Study to Evaluate the Use of Metabonomics and Lipidomics in Predicting Toxicity and Efficacy of Anti-VEGF Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma|Recruiting||Phase 4|90|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-10-10 22:51:31.201908|2017-10-10 22:51:31.201908
NCT02570776|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-10-05|||December 2013||2013-12-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Observational|||UBT as a Diagnostic Tool for HP Prevalance|Prevalence of Helicobacter Pylori Infection in Dyspeptic Adults and Validation of C14 Urea Breath Test (UBT) as a Diagnostic Tool for Helicobacter Pylori Infection in Pakistani Population|Unknown status|Recruiting|N/A|200|Anticipated|National Institute of Liver & GI Diseases, Pakistan|||1||f||||f||||||||||2017-10-10 22:51:31.545236|2017-10-10 22:51:31.545236
NCT02570763|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-06-23|||August 2016||2016-08-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder||Not yet recruiting||N/A|12|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:51:31.655225|2017-10-10 22:51:31.655225
NCT02570750|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-03-01|||May 7, 2015|Actual|2015-05-07|March 2017|2017-03-01|December 5, 2016|Actual|2016-12-05|December 5, 2016|Actual|2016-12-05||Observational|||The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis|Non-interventional Study Of The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis|Completed||N/A|183|Actual|Pfizer|||2||f||||f||||||||||2017-10-10 22:51:31.743901|2017-10-10 22:51:31.743901
NCT02570737|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-01-23|||April 2014||2014-04-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|July 2018|Anticipated|2018-07-01|5 Years|Observational [Patient Registry]|RELAHP||Latin American Pulmonary Hypertension Registry|Latin American Pulmonary Hypertension Registry|Enrolling by invitation||N/A|500|Anticipated|Asociacion Latinoamericana de Torax|||2||f||||f|f|f||||||Undecided||2017-10-10 22:51:31.921677|2017-10-10 22:51:31.921677
NCT02570724|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-09-07|||June 2013||2013-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||HES Patch Versus Blood Patch|Clinical Effect and Cerebral Vasoconstriction Induced After Epidural Blood Patch Versus Epidural Hydroxyethyl Starch Patch in Patients With Headache Due to Intracranial Hypotension|Recruiting||N/A|20|Anticipated|University Hospital, Strasbourg, France||2|||f||||t||||||||||2017-10-10 22:51:32.021911|2017-10-10 22:51:32.021911
NCT02570711|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-06-23|||October 2015||2015-10-01|March 2016|2016-03-01||||May 2017|Anticipated|2017-05-01||Interventional|||Study of Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Previously Untreated Metastatic Pancreatic Cancer||Terminated||Phase 2|3|Actual|Acerta Pharma BV||2||Sponsor Decision|f||||||||||||||2017-10-10 22:51:32.127029|2017-10-10 22:51:32.127029
NCT02570698|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-15|||October 2015||2015-10-01|August 2017|2017-08-01|January 23, 2017|Actual|2017-01-23|December 7, 2016|Actual|2016-12-07||Observational|||BM Collection From NICU Infants for Composition|Collection and Characterization of Premature Infants Feces for Identification of Factors Contributing to Skin Irritation|Completed||N/A|25|Actual|Kimberly-Clark Corporation|||1||f||||f||||||||||2017-10-10 22:51:32.216791|2017-10-10 22:51:32.216791
NCT02570685|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-03-01|||October 2015||2015-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Psychosocial Benefits of Gratitude Journals|Psychosocial Benefits of Gratitude Journals: A Randomized Controlled Intervention Trial|Completed||N/A|192|Actual|University of Limerick||3|||f||||f||||||||||2017-10-10 22:51:32.300179|2017-10-10 22:51:32.300179
NCT02570672|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-12-07|||April 2016||2016-04-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Metformin for Preventing Frailty in High-risk Older Adults||Recruiting||Phase 2|120|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 22:51:32.396421|2017-10-10 22:51:32.396421
NCT02570659|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-06|||October 2015||2015-10-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Investigating the Effect of an Information Video for Neck Injuries in a Emergency Department Setting|A Randomized Controlled Trial Evaluating the Effect of an Information Video in a Acute Whiplash Population|Unknown status|Not yet recruiting|N/A|240|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:51:32.484591|2017-10-10 22:51:32.484591
NCT02570646|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2016-11-29|||October 2015||2015-10-01|May 2016|2016-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|QA-DDS||QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings|QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings|Completed||N/A|248|Actual|University of Kentucky||1|||f||||t||||||||||2017-10-10 22:51:32.561805|2017-10-10 22:51:32.561805
NCT02570633|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-03-24|||July 2014||2014-07-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|||Ginger Capsules for the Prophylactic Treatment of Migraine|Double-blind Placebo-controlled Clinical Trial of Ginger (Zingiber Officinale) in Prophylactic Migraine Treatment|Recruiting||N/A|104|Anticipated|Federal University of Minas Gerais||2|||f||||t||||||||||2017-10-10 22:51:32.6454|2017-10-10 22:51:32.6454
NCT02570620|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-05|||September 2010||2010-09-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ECOLDIA||Contribution of Ultrasonography in the Evaluation of Cervical Induction-delivery Time|Apport de l'échographie du Col Dans l'évaluation du Délai Induction Accouchement (DIA) Chez Des Patientes à Score de Bishop défavorable après déclenchement Par Dinoprostone Intravaginal|Completed||N/A|342|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 22:51:32.740584|2017-10-10 22:51:32.740584
NCT02570607|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-06|||November 2015||2015-11-01|October 2015|2015-10-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Observational|BNP||Preoperative BNP as Biomarker of Postoperative Cardiovascular Complications|Relevance of Preoperative BNP as a Biomarker of Postoperative Cardiovascular Complications in Major Non-cardiac Adult Surgery|Unknown status|Not yet recruiting|N/A|200|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||||2017-10-10 22:51:32.81956|2017-10-10 22:51:32.81956
NCT02570594|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-09-07|||January 2014|Actual|2014-01-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|AMOrSchiz||Autobiographical Memory Organization in Schizophrenia|Autobiographical Memory Organization in Schizophrenia|Completed||N/A|80|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 22:51:32.874221|2017-10-10 22:51:32.874221
NCT02570581|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-06|||June 2014||2014-06-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|MELA||MELA Study - Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers|MELA Study - Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers|Completed||Phase 1|16|Actual|Centre Hospitalier Universitaire de Nice||24|||f||||f||||||||||2017-10-10 22:51:32.97103|2017-10-10 22:51:32.97103
NCT02570568|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-04-12|||October 2015||2015-10-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Pen Torch Transillumination: Shedding Light on Difficult Venepuncture|Pen Torch Transillumination: Shedding Light on Difficult Venepuncture|Completed||N/A|69|Actual|National University Hospital, Singapore||3|||f||||t||||||||||2017-10-10 22:51:33.508996|2017-10-10 22:51:33.508996
NCT02570555|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-09-07|||April 2013|Actual|2013-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Strabismus Surgery and Driving Ability|Strabismus Surgery and Driving Ability|Recruiting||N/A|40|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 22:51:33.608512|2017-10-10 22:51:33.608512
NCT02570542|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-08|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)|A Multi-center Randomized Phase II Study of the Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)|Recruiting||Phase 2|150|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 22:51:33.694359|2017-10-10 22:51:33.694359
NCT02570529|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-06|||October 2015||2015-10-01|October 2015|2015-10-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy||Not yet recruiting||Phase 4|78|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 22:51:33.872431|2017-10-10 22:51:33.872431
NCT02570516|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-04-13|||November 2015||2015-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|LYNCH-CHROMO||NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome|Comparison of Colonoscopy With Virtual Chromoendoscopy Using 3rd Generation NBI System to Chromoendoscopy With Indigo Carmine in Lynch Patients.|Recruiting||N/A|140|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:51:33.945953|2017-10-10 22:51:33.945953
NCT02570503|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-12-14|||October 2015||2015-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty|Do Intraoperative Periarticular Injections Improve Postoperative Pain Control in Patients Receiving Duramorph (Preservative Free) During Total Knee Arthroplasty? A Prospective, Double-Blind, Randomized Controlled Trial|Enrolling by invitation||Phase 4|128|Anticipated|Virginia Commonwealth University||2|||f||||t||||||||No||2017-10-10 22:51:34.094661|2017-10-10 22:51:34.094661
NCT02570490|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-06-07||2017-02-20|November 2015||2015-11-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections|A Randomized, Double-blind, Multi-center Study to Evaluate the Safety and Efficacy of Oral Sodium Fusidate (CEM-102) Compared to Oral Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infections|Completed||Phase 3|716|Actual|Cempra Inc||2|||f||||f|t|f||||||||2017-10-10 22:51:34.204262|2017-10-10 22:51:34.204262
NCT02570477|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-04-23|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment|Fecal Microbiota Transplantation (FMT) for Moderate to Severe Clostridium Difficile Infection (CDI): A Randomised Study With Concurrent Stool Microbiota Assessment (FMT-CDI-RCT Study)|Active, not recruiting||N/A|30|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||No||2017-10-10 22:51:34.393946|2017-10-10 22:51:34.393946
NCT02570464|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-05-10|||March 2012||2012-03-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CLARIS||Aortic Cross-Clamping and Systemic Inflammatory Response in Humans: Effect of Ischemic Preconditioning|Aortic Cross-Clamping and Systemic Inflammatory Response in Humans: Effect of Ischemic Preconditioning|Completed||N/A|68|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 22:51:34.479518|2017-10-10 22:51:34.479518
NCT02570451|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-01-05|||September 2014||2014-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Preoperative Cognitive Screening of Surgical Patients 65 Years of Age or Older|Preoperative Cognitive Screening of Surgical Patients 65 Years of Age or Older: Feasibility of Routine Screening and Utility for Predicting Morbidity|Active, not recruiting||N/A|711|Anticipated|Brigham and Women's Hospital|||2||f||||f||||||||||2017-10-10 22:51:34.714358|2017-10-10 22:51:34.714358
NCT02570438|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-10-01|||July 2015||2015-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Observational|||Improving Surgical Safety of Seniors Through Preoperative Cognitive Screening|Improving Surgical Safety of Seniors Through Preoperative Cognitive Screening|Recruiting||N/A|500|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||No||2017-10-10 22:51:34.841137|2017-10-10 22:51:34.841137
NCT02570425|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-04-27|2015-10-13||July 2014||2014-07-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional|HCP-ELIOT||Comparing Maintenance of Device Mastery With Turbohaler© vs. Spiromax© in Healthcare Professionals naïve to Both Devices|THE HCP ELIOT STUDY: Comparing Maintenance of Device Mastery With TURBOHALER© vs. SPIROMAX© in Healthcare Professionals naïve to Both Devices (The Easy Low Instruction Over Time [ELIOT] Study)|Completed||N/A|516|Actual|Research in Real-Life Ltd||2|||f||||t||||||||Undecided|Decision has not been made|2017-10-10 22:51:34.971785|2017-10-10 22:51:34.971785
NCT02570412|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-21||||||October 2015|2015-10-01||||||||Expanded Access|||Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy|Compassionate Use of Aldoxorubicin in Sarcoma Patients Who Have Failed Prior Chemotherapy|No longer available||N/A|||CytRx|||||||||||||||||||2017-10-10 22:51:35.981147|2017-10-10 22:51:35.981147
NCT02570399|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-10-05|||April 2015||2015-04-01|October 2015|2015-10-01|April 2022|Anticipated|2022-04-01|April 2018|Anticipated|2018-04-01||Interventional|||High Dose SBRT for Abdominal-Pelvic Lymph Nodal Lesions in Oligometastatic Patients|Feasibility Study of High Dose Stereotactic Body Radiation Therapy (SBRT) for Lymph Nodal Lesions in Oligometastatic Patients for Genito-urinary, Gastro-intestinal and Gynaecological Cancer|Recruiting||N/A|39|Anticipated|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-10 22:51:36.071888|2017-10-10 22:51:36.071888
NCT02570386|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-05-12|||October 2015||2015-10-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer|A Randomized Controlled Trial of Clinical Effectiveness of Freezing All Embryos Followed by Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer, in Women Undergoing In-vitro Fertilization Treatment|Recruiting||N/A|800|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:51:36.19692|2017-10-10 22:51:36.19692
NCT02570373|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-04-11|||September 2015||2015-09-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants|Phase 1, Open-label, Single-dose Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Subjects|Completed||Phase 1|8|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 22:51:36.312531|2017-10-10 22:51:36.312531
NCT02570360|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Exercise and Treatment-as-usual in Substance Use Treatment Outcomes|Comparative Effects of Exercise and Treatment-as-usual on Abstinence, Craving, and the Endocannabinoid System in Substance Users|Completed||N/A|21|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 22:51:36.394077|2017-10-10 22:51:36.394077
NCT02570347|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-08-16|||April 2016|Actual|2016-04-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|RADIANS||Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite|Routine vs. Clinically-Directed Antibiotic Treatment in Snake Bite With Local Envenomation: a Randomised Controlled Trial|Recruiting||Phase 4|130|Anticipated|Jawaharlal Institute of Postgraduate Medical Education & Research||2|||f||||f||||||||||2017-10-10 22:51:36.494648|2017-10-10 22:51:36.494648
NCT02570334|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2016-07-11|||December 2015||2015-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|PediacamDEV||A Cross Sectional Evaluation of the Development in Children Age 4 to 7 Infected or Exposed to HIV From the ANRS 12140 Cohort (Pediacam)|A Cross Sectional Evaluation of the Development in Children Age 4 to 7 Infected or Exposed to HIV From the ANRS 12140 Cohort (Pediacam)|Recruiting||N/A|400|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||3|||f||||f||||||||||2017-10-10 22:51:36.648673|2017-10-10 22:51:36.648673
NCT02570321|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-04-25|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|CLAIR||Cross-linking for Corneal Ulcers Treatment Trial|Cross-linking for Corneal Ulcers Treatment Trial|Recruiting||Phase 4|266|Anticipated|University of California, San Francisco||6|||f||||f||||||||||2017-10-10 22:51:36.774222|2017-10-10 22:51:36.774222
NCT02570295|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-01-30|2016-09-29||July 2015||2015-07-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|SAFT||Swiss Army Physical Fitness Training|Swiss Army Physical Fitness Training - An Intervention Study Investigating the Influence of the Swiss Armed Forces' New Sport Concept on Physical and Psychological Parameters of the Recruits|Completed||N/A|722|Actual|Swiss Federal Institute of Sport Magglingen|It is possible that people who are interested in health or fitness issues were more likely to sign the informed consent, which could have had an influence on the injuries and fitness outcomes.|2|||f||||f||||||||No||2017-10-10 22:51:37.037495|2017-10-10 22:51:37.037495
NCT02570282|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2017-09-27||2016-12-07|September 2015|Actual|2015-09-01|January 2017|2017-01-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Interventional|||Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder|A Phase 2A, Single-Dose, Double-Blind Placebo-Controlled, 2-Way Crossover Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder|Completed||Phase 2|31|Actual|Strategic Science & Technologies, LLC||2|||f||||f||||||||||2017-10-10 22:51:37.506228|2017-10-10 22:51:37.506228
NCT02570269|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-10-03|||December 2015||2015-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Prospective Comparison of Oral Intubation Via - Ambu® Aura Gain™ vs Slotted Guedel Tubus|Prospective Randomized Comparison Between a Flexible Fiberoptic Intubation Via the Ambu® Aura Gain™ Airway and the Slotted Guedel Tubus in Terms of Time to a Completed Airway Management and Patient Safety.|Completed||Phase 4|94|Actual|Schulthess Klinik||2|||f||||f||||||||||2017-10-10 22:51:37.621005|2017-10-10 22:51:37.621005
NCT02570256|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-02-01|||May 2013||2013-05-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Deficit Fields for Stroke Recovery|Error-enhanced Learning & Recovery in 2 & 3 Dimensions|Recruiting||N/A|100|Anticipated|Shirley Ryan AbilityLab||3|||f||||||||||||||2017-10-10 22:51:37.714069|2017-10-10 22:51:37.714069
NCT02570243|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-17|||February 2015||2015-02-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion|High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion Forearm Artery Occlusion|Completed||Phase 4|1800|Actual|University of Patras||2|||f||||f||||||||||2017-10-10 22:51:37.816421|2017-10-10 22:51:37.816421
NCT02570230|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-27|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Ketamine Combination With Spinal Morphine for Post Thoracic Surgery Pain : A Randomized Control Study|Low Dose Intraoperative Intravenous Ketamine Combination With Spinal Morphine for Post Thoracic Surgery Pain : A Randomized Control Study|Recruiting||Phase 4|40|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-10 22:51:37.917711|2017-10-10 22:51:37.917711
NCT02570035|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-06|||December 2012||2012-12-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease|Protocol for Specified Drug Use-results Survey of Betanis Tablets (for Patients With Coexisting Cardiovascular Disease)|Completed||N/A|316|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 22:51:40.709128|2017-10-10 22:51:40.709128
NCT02570217|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2015-10-06|||January 2012||2012-01-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||HHHFNC (Heated Humidified High-Flow Nasal Cannula) Versus NCPAP for Respiratory Distress Syndrome of Prematurity|HHHFNC (Heated Humidified High-Flow Nasal Cannula) Versus NCPAP (Nasal Continuous Positive Airway Pressure) in Preterm Infants With Mild to Moderate Respiratory Distress Syndrome (RDS): a Randomized Clinical Trial.|Completed||N/A|316|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||||2017-10-10 22:51:38.029673|2017-10-10 22:51:38.029673
NCT02570204|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-04-28|||September 2015||2015-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests|Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests|Completed||N/A|343|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-10-10 22:51:38.138572|2017-10-10 22:51:38.138572
NCT02570191|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-11-01|||November 2004||2004-11-01|November 2016|2016-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV)|An Open-label, Multicenter, National, Not-randomized Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (40 KD) (PEGASYS) in Patients With HBeAg-negative Chronic Hepatitis B|Completed||Phase 4|60|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:51:38.225429|2017-10-10 22:51:38.225429
NCT02570178|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-03-21|||September 2012||2012-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|EWii||Effectiveness of an Intervention to Improve Balance and Decrease Falls in the Elderly (EWii)|Randomized Clinical Trial Evaluating the Effectiveness of a Primary Care Intervention Using the NintendoTM Wii Console to Improve Balance and Decrease Falls in the Elderly (EWii)|Completed||N/A|1037|Actual|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-10-10 22:51:38.333201|2017-10-10 22:51:38.333201
NCT02570165|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-02-03|2017-02-03||November 2015||2015-11-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Study 201012: A Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With COPD|Completed||Phase 2|325|Actual|GlaxoSmithKline||7|||f||||f||||||||||2017-10-10 22:51:38.442574|2017-10-10 22:51:38.442574
NCT02570152|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-07-25|||May 7, 2016|Actual|2016-05-07|July 2017|2017-07-01|July 29, 2019|Anticipated|2019-07-29|July 29, 2019|Anticipated|2019-07-29||Interventional|||A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia|A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia|Active, not recruiting||N/A|2000|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 22:51:39.479209|2017-10-10 22:51:39.479209
NCT02570139|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-05-15|||October 2015||2015-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing|Multi-Center, Randomized Trial Comparing the Efficacy of 3M™ Cavilon™ Advanced Barrier Film for the Treatment of Incontinence-associated Dermatitis to a Commercially Available Moisture Barrier|Recruiting||N/A|102|Anticipated|3M||2|||f||||f||||||||No||2017-10-10 22:51:39.617007|2017-10-10 22:51:39.617007
NCT02570113|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-03-16|||November 2015||2015-11-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||The Peregrine Post-Market Study for the Treatment of Hypertension|A Post-Market Study of Transcatheter Perivascular Renal Denervation for the Treatment of Hypertension Using the Ablative Solutions Inc. Peregrine System™ Infusion Catheter|Recruiting||N/A|120|Anticipated|Ablative Solutions, Inc.||1|||f||||t||||||||No||2017-10-10 22:51:39.997645|2017-10-10 22:51:39.997645
NCT02570100|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-07-27|||April 2015||2015-04-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|October 2017|Anticipated|2017-10-01||Interventional|||Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM)|Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells|Recruiting||N/A|100|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||No||2017-10-10 22:51:40.183857|2017-10-10 22:51:40.183857
NCT02570087|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-10-05|||July 2011||2011-07-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|CTOHFrEF||Benefits of CTO-PCI in Selected Cases With HFrEF (CTOHFrEF)|Benefits of Chronic Total Coronary Occlusion Percutaneous Intervention in Patients With Chronic Heart Failure and Reduced Ejection Fraction.|Completed||N/A|39|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-10 22:51:40.298662|2017-10-10 22:51:40.298662
NCT02570074|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-08-03|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|PROOF||PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults|Phase I Study to Evaluate Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants|Completed||Phase 1|19|Actual|Duke University||2|||f||||t||||||||||2017-10-10 22:51:40.386626|2017-10-10 22:51:40.386626
NCT02570061|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-06|||July 2013||2013-07-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Recruiting to Clinical Trials on the Telephone|Recruiting to Clinical Trials on the Telephone|Completed||Phase 3|125|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 22:51:40.486137|2017-10-10 22:51:40.486137
NCT02570048|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-10-06|||June 2012||2012-06-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Observational|||1 Tinnitus Alleviation Via Sensory Substitution|Tinnitus Alleviation Via Sensory Substitution (Modulation of Tinnitus Through Simultaneous Auditory and Transcutaneous Tactile Stimulation of the Tongue).|Completed||N/A|60|Actual|MuteButton|||1||f||||f||||||||||2017-10-10 22:51:40.603665|2017-10-10 22:51:40.603665
NCT02570022|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-08-17|2016-06-08||October 2014||2014-10-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|EXP-TSA|Sixty patients were recruited for the study. Three patients declined to participate and were excluded before randomization. The remaining 57 patients were randomized with 31 patients in the INB group and 26 patients in the LB group. No patients were lost to follow-up. There were no statistical differences in any demographics between the 2 groups|Liposomal Bupivacaine in Total Shoulder Arthroplasty|Liposomal Bupivacaine Versus Interscalene Nerve Block for Pain Control After Shoulder Arthroplasty: A Prospective Randomized Trial|Completed||Phase 4|57|Actual|Henry Ford Health System|Use of the VAS, which is a simple one-dimensional analog rating scale, to assess the patients subjective pain level. Patient compliance is a limitation, with maintenance of pain dairies decreasing as time from surgery progressed.|2|||f||||t||||||||||2017-10-10 22:51:40.877132|2017-10-10 22:51:40.877132
NCT02570009|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-10-01|||June 2015||2015-06-01|October 2016|2016-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Weight Loss for Couples||Active, not recruiting||N/A|128|Actual|University of Connecticut||2|||f||||||||||||||2017-10-10 22:51:41.244046|2017-10-10 22:51:41.244046
NCT02569996|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-11-05|2015-11-05||July 2005||2005-07-01|November 2015|2015-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study of Long-Term Rituximab (MabThera) Maintenance Therapy in Participants With Advanced Follicular Lymphoma|A Multicenter, Phase III, Open-label Study Evaluating the Benefit of a Long-term Effect of MabThera (Rituximab) Maintenance Therapy in Patients With Advanced Follicular Lymphoma After Induction of Response (CR[u] or PR) With MabThera (Rituximab) Containing First-line Regimen|Completed||Phase 3|124|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:51:41.342959|2017-10-10 22:51:41.342959
NCT02569983|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-05-23|||September 2015||2015-09-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|SOCQER-2||The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research|A Multi-centre Prospective Pilot Observational Cohort Study to Assess Quality of Life and Survival After Surgery for Advanced Ovarian Cancer|Recruiting||N/A|120|Anticipated|University of Birmingham|||1||f||||f||||||||||2017-10-10 22:51:41.751768|2017-10-10 22:51:41.751768
NCT02569970|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-10-04|||November 2010||2010-11-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|December 2010|Actual|2010-12-01||Interventional|FLUOXETINE||Efficacy of Fluoxetine Against Seizure-induced Central Apneas|Efficacy of Fluoxetine Against Seizure-induced Central Apneas : a Randomized Placebo-controled Double-blind Trial.|Completed||Phase 3|70|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:51:41.884257|2017-10-10 22:51:41.884257
NCT02569957|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-08-22|||October 2, 2015|Actual|2015-10-02|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|June 10, 2017|Actual|2017-06-10||Interventional|||Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Evaluation of the Addition of N-Acetylcysteine to Topotecan in the Tumor Microenvironment of Persistent or Recurrent High Grade Endometrioid or Serous Ovarian Carcinoma|Active, not recruiting||Phase 2|1|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-10-10 22:51:41.984559|2017-10-10 22:51:41.984559
NCT02569944|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-05|||June 2013||2013-06-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Feasibility of Bladder Stimulation in Infants|Evaluation of Feasibility of Urine Collection Using Perineal Bag Versus Bladder Stimulation in Infants Less Than 12 Months Old|Completed||N/A|58|Actual|Hospital del Río Hortega||2|||f||||f||||||||||2017-10-10 22:51:42.09031|2017-10-10 22:51:42.09031
NCT02569931|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-10-31|||December 2015||2015-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SPRING||The Unstable Kneecap - the Impact of Anatomy on Function|Surgery for Patellofemoral Instability, is There Normal Gait|Recruiting||N/A|72|Anticipated|St George's, University of London||2|||f||||t||||||||||2017-10-10 22:51:42.165334|2017-10-10 22:51:42.165334
NCT02569918|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-01-09|||February 2015||2015-02-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|EPIONE||Use of Hand Prosthesis With Surface Electrical Stimulation for Treatment of Phantom Limb Pain|Natural Sensory Feedback for Phantom Limb Modulation and Therapy|Recruiting||N/A|20|Anticipated|University of Lausanne Hospitals||1|||f||||f||||||||||2017-10-10 22:51:42.285642|2017-10-10 22:51:42.285642
NCT02569905|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-23|||April 2014||2014-04-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering|Tumor Hospital of Guangxi Medical University, China|Completed||Phase 4|166|Actual|Guangxi Medical University||3|||f||||t||||||||||2017-10-10 22:51:42.403689|2017-10-10 22:51:42.403689
NCT02569892|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration|Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration|Recruiting||N/A|56|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 22:51:42.508331|2017-10-10 22:51:42.508331
NCT02569879|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-07-06|||October 1, 2015||2015-10-01|July 2017|2017-07-01|April 16, 2018|Anticipated|2018-04-16|April 16, 2018|Anticipated|2018-04-16||Observational|||Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.|Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.|Recruiting||N/A|1|Anticipated|GlaxoSmithKline|||2||f||||||||||||||2017-10-10 22:51:42.610537|2017-10-10 22:51:42.610537
NCT02569866|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2016-08-10|||November 2014||2014-11-01|March 2016|2016-03-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Antibiotics After Breast Reduction:Clinical Trial With Randomization|Antibiotics After Breast Reduction:Clinical Trial With Randomization|Completed||Phase 2|124|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 22:51:42.719568|2017-10-10 22:51:42.719568
NCT02569853|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-07-20|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|May 30, 2017|Actual|2017-05-30||Interventional|RESTOR||DFN-11 Injection in Episodic Migraine With or Without Aura||Active, not recruiting||Phase 3|268|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-10 22:51:42.82419|2017-10-10 22:51:42.82419
NCT02569840|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-05-22|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|||Amino Acid Feed Children's Study|An Evaluation of the Tolerance and Acceptability of Neocate Junior an Amino Acid Based Formula for Children|Active, not recruiting||N/A|20|Anticipated|Nutricia UK Ltd||1|||f||||f||||||||No||2017-10-10 22:51:42.933687|2017-10-10 22:51:42.933687
NCT02569827|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-10-04|||July 2018|Anticipated|2018-07-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore|A Phase Ib/IIa Single Centre, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Dose Ranging Trial in Adult Participants With Uncomplicated Dengue Fever in Singapore|Not yet recruiting||Phase 1/Phase 2|72|Anticipated|Singapore General Hospital||4|||f||||t|f|f||||||||2017-10-10 22:51:43.018997|2017-10-10 22:51:43.018997
NCT02569814|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-02-23|||September 2015||2015-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin||Completed||Phase 1|100|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-10 22:51:43.123739|2017-10-10 22:51:43.123739
NCT02569801|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2017-08-18|||December 6, 2015|Actual|2015-12-06|August 2017|2017-08-01|January 4, 2018|Anticipated|2018-01-04|January 4, 2018|Anticipated|2018-01-04||Interventional|HydranGea||A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy|A Phase II, Open-Label, Randomized Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic ER+ /HER2- Breast Cancer Resistant to Aromatase Inhibitor Therapy|Active, not recruiting||Phase 2|71|Actual|Genentech, Inc.||2|||f|||||t|f||||||||2017-10-10 22:51:43.231684|2017-10-10 22:51:43.231684
NCT02569788|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-06-06|||September 2015||2015-09-01|June 2016|2016-06-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma|Phase I/II Trail Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma|Recruiting||Phase 1/Phase 2|62|Anticipated|Shanghai Proton and Heavy Ion Center||1|||f||||t||||||||||2017-10-10 22:51:43.411509|2017-10-10 22:51:43.411509
NCT02569775|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-15|||April 2014||2014-04-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Outcomes of Stem Cells for Cerebral Palsy|Outcomes of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy: A Self-Controlled Clinical Trial|Completed||Phase 2|40|Actual|Vinmec International Hospital||1|||f||||f||||||||||2017-10-10 22:51:43.669424|2017-10-10 22:51:43.669424
NCT02569762|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-10-05|||July 2016|Actual|2016-07-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Artificial Sweeteners on Gut Microbiota and Glucose Metabolism|Assessment of the Effect of Artificial Sweeteners on Gut Microbiota and Glucose Metabolism|Recruiting||N/A|24|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-10 22:51:43.780287|2017-10-10 22:51:43.780287
NCT02569749|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-11-02|||June 2015||2015-06-01|November 2015|2015-11-01||||March 2016|Anticipated|2016-03-01|1 Month|Observational [Patient Registry]|||Sleep Apnea Screening|Sleep Apnea-Hypopnea Syndrome Screening|Terminated||N/A|15|Actual|Arrhythmia Network Technology S.L.|||4|Administrative reasons|f||||t||||||||||2017-10-10 22:51:43.905765|2017-10-10 22:51:43.905765
NCT02569736|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-07|||September 2014||2014-09-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|Tocihelper||Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation|Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation|Unknown status|Recruiting|N/A|60|Anticipated|Association Aquitaine de Recherche Clinique en Rhumatologie|||3||f||||f||||||||||2017-10-10 22:51:44.067226|2017-10-10 22:51:44.067226
NCT02569723|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-12-20|||October 2015||2015-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy|Pilot Study of a Carbon 14 Oxaliplatin Microdosing Assay to Predict Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer|Recruiting||N/A|6|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 22:51:44.196004|2017-10-10 22:51:44.196004
NCT02569697|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-09-01|||October 2015||2015-10-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms|Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms|Completed||Phase 1|50|Actual|CONRAD||4|||f||||f||||||||||2017-10-10 22:51:44.540325|2017-10-10 22:51:44.540325
NCT02569684|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-04-07|||October 2015||2015-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Effects of Prebiotics on GLP-1 in Type 2 Diabetes|Effects of Prebiotics on GLP-1 in Type 2 Diabetes|Recruiting||N/A|35|Anticipated|Oslo University Hospital||2|||f||||||||||||No||2017-10-10 22:51:44.684838|2017-10-10 22:51:44.684838
NCT02569671|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-08-15|||October 2015||2015-10-01|August 2016|2016-08-01|May 2022|Anticipated|2022-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Bone Level Tapered Multi-Center Study|Immediate Placement of the Straumann® Bone Level Tapered Implant With Early Loading in Single Tooth Gaps in the Maxilla and Mandible Compared to Delayed Placement|Recruiting||N/A|52|Anticipated|Institut Straumann AG||2|||f||||f||||||||No||2017-10-10 22:51:44.817016|2017-10-10 22:51:44.817016
NCT02569658|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2017-05-20|2017-04-14||September 2015||2015-09-01|April 2016|2016-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty|Investigation of the Blood Sparing Properties of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty|Completed||N/A|110|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-10 22:51:44.998481|2017-10-10 22:51:44.998481
NCT02568891|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-11-29|||January 2017||2017-01-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|MGM-dialysis||Modulation of Gut Microbiota in End-stage Renal Disease|Modulation of Gut Microbiota in End-stage Renal Disease: A Pilot Study|Not yet recruiting||Phase 2|60|Anticipated|Medical University of Graz||2|||f||||f||||||||||2017-10-10 22:51:54.50038|2017-10-10 22:51:54.50038
NCT02569645|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-09-19|||November 2015||2015-11-01|August 2016|2016-08-01|May 2021|Anticipated|2021-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Rosuvastatin in the Treatment of Rectal Cancer|Phase 2 Trial of Rosuvastatin (Crestor®) Combined With Standard Chemoradiation Therapy in the Treatment of High-Risk Locally Advanced Rectal Cancer|Recruiting||Phase 2|48|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||Undecided||2017-10-10 22:51:45.478702|2017-10-10 22:51:45.478702
NCT02569619|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-03-09|||April 2014||2014-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|GAF||Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders|Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders: Motivational Determinants of Adherence, Effect on Cognitive Determinants of Physical Activity, Physical Activity, Sitting Time and Clinical Symptoms|Completed||Phase 2|86|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 22:51:45.712293|2017-10-10 22:51:45.712293
NCT02569606|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-05-08|||September 2015||2015-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Transfusion and Coagulation Management in Trauma Patients After the Introduction of a Coagulation Algorithm|Transfusion and Coagulation Management in Trauma Patients After the Introduction of a Coagulation Algorithm|Active, not recruiting||N/A|1800|Actual|University of Zurich|||2||f||||f||||||||||2017-10-10 22:51:45.830328|2017-10-10 22:51:45.830328
NCT02569593|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-05-17|||October 2015||2015-10-01|May 2017|2017-05-01|August 2018||2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of the Absorption Rate From Different Oral Fe-supplements in Obese Volunteers Pre- and Post-RYGB|Evaluation of the Absorption Rate From Different Oral Fe-supplements in Obese Volunteers Pre- and Post-RYGB: an Interventional Study|Recruiting||N/A|15|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-10 22:51:45.924232|2017-10-10 22:51:45.924232
NCT02569580|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-06|2015-10-06|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||"Effectiveness of No More Anti-lice Medical Device to Kill Lice and Lice Eggs"|"Clinical Trial of Anti-Lice Treatment Using the Medical Device No More Which is Designed to Kill Lice and Lice Eggs on the Head."|Unknown status|Recruiting|N/A|50|Anticipated|Pharmayeda||1|||f||||t||||||||||2017-10-10 22:51:46.033174|2017-10-10 22:51:46.033174
NCT02569567|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-11-14|||November 2015||2015-11-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|SMART||Comparison of Smart-Shear Wave Elastography and Transient Elastography|Applicability, Reliability and Accuracy for Staging Hepatic Fibrosis: Comparison of Smart-Shear Wave Elastography and Transient Elastography|Unknown status|Recruiting|N/A|105|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-10 22:51:46.124013|2017-10-10 22:51:46.124013
NCT02569554|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-05-13|||December 2015||2015-12-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||PPI And Food Effect Study For PF-06463922 In Healthy Volunteers|A Phase 1, Randomized, Crossover, Open-Label, 4 Period Study In Healthy Volunteers To Demonstrate The Lack Of Effect Of Rabeprazole And Food On The Pharmacokinetics Of PF-06463922 And To Assess The Relative Bioavailability Of Oral Solution To The Tablet Formulation Of PF-06463922|Completed||Phase 1|27|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 22:51:46.231824|2017-10-10 22:51:46.231824
NCT02569541|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-06-19|||December 2015||2015-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections in Subjects for Whom Chronic Antibiotic Suppressive Therapy is Indicated|An Open-Label, Non-Randomized, Single-Arm, Multi-Center Study to Evaluate Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections in Subjects for Whom Chronic Antibiotic Suppressive Therapy is Indicated|Active, not recruiting||Phase 2/Phase 3|30|Actual|Cempra Inc||1|||f||||f|t|f||||||No||2017-10-10 22:51:46.334688|2017-10-10 22:51:46.334688
NCT02569528|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-05-03|||October 2015||2015-10-01|August 2016|2016-08-01|March 2, 2017|Actual|2017-03-02|March 2, 2017|Actual|2017-03-02||Observational|INFORM-AF||ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1|ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1|Completed||N/A|52|Actual|Duke University|||2||f||||f||||||||||2017-10-10 22:51:46.480758|2017-10-10 22:51:46.480758
NCT02569515|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-11-01|||October 2004||2004-10-01|November 2016|2016-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia|An Open-Label Study of the Tolerability and Flexibility of Multi-Dose NeoRecormon Administered by Reco-Pen in Pre-Dialysis Patients With Chronic Renal Anemia.|Completed||Phase 4|58|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:51:46.571563|2017-10-10 22:51:46.571563
NCT02569502|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-11-01|||April 2005||2005-04-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection|Open Label, Nonrandomized Clinical Trial of Safety and Tolerability of Enfuviritide (Fuzeon®, HIV Fusion Inhibitor) in Patients With Advanced HIV1 Infection|Completed||Phase 4|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:51:46.663085|2017-10-10 22:51:46.663085
NCT02569489|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-06-08|||December 2015||2015-12-01|June 2016|2016-06-01||||December 2015|Actual|2015-12-01||Interventional|||Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast Cancer|Phase I Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast Cancer|Withdrawn||Phase 1|0|Actual|HUYA Bioscience International||1||Reconsideration of Study Design; plan for alternative protocol|f||||f||||||||||2017-10-10 22:51:46.745461|2017-10-10 22:51:46.745461
NCT02569476|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-08-30|||December 2015||2015-12-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||BGB 3111 in Combination With Obinutuzumab in Subjects With B-Cell Lymphoid Malignancies|A Phase 1b Study to Assess Safety, Tolerability and Antitumor Activity of the Combination of BGB 3111 With Obinutuzumab in Subjects With B-Cell Lymphoid Malignancies|Recruiting||Phase 1|86|Anticipated|BeiGene||1|||f||||t||||||||||2017-10-10 22:51:46.834498|2017-10-10 22:51:46.834498
NCT02569463|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-04|||June 2014||2014-06-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Low-dose IL-2 ( Interleukin-2) Treatment in Macrophage Activation Syndrome（MAS）|Safety and Efficiency Study of Low-dose IL-2 Treatment in Macrophage Activation Syndrome|Recruiting||Phase 1/Phase 2|6|Anticipated|Peking University People's Hospital||1|||f||||t||||||||||2017-10-10 22:51:46.949789|2017-10-10 22:51:46.949789
NCT02569450|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-08-17|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|SHEWHART||Evaluation of Control Chart Impact on Surgical Outcomes|The Impact of Surgical Outcomes Monitoring Using Control Chart on Surgical Performance: A Cluster Randomized Trial|Recruiting||N/A|48000|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:51:47.047131|2017-10-10 22:51:47.047131
NCT02569437|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2016-09-12|||September 2014||2014-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps|The Role of Doxycycline in Management of Moderate to Severe Chronic Rhinosinusitis With Nasal Polyps|Completed||N/A|48|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||Undecided||2017-10-10 22:51:47.124245|2017-10-10 22:51:47.124245
NCT02569424|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-12-02|||September 2015||2015-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PEEPUS||Effect of PEEP and Trendelenburg on Ultrasound Size of Internal Jugular and Subclavian Veins|Effect of PEEP and Trendelenburg on Ultrasound Size of Internal Jugular and Subclavian Veins: A Cross-over Randomized Controlled Study|Completed||N/A|42|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 22:51:47.259046|2017-10-10 22:51:47.259046
NCT02569411|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-02|||August 2015||2015-08-01|October 2015|2015-10-01||||August 2016|Anticipated|2016-08-01||Interventional|||Contacting Authors to Retrieve Individual Patient Data|Contacting Authors to Retrieve Individual Patient Data: Protocol for a Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|116|Anticipated|St. Michael's Hospital, Toronto||2|||f||||||||||||||2017-10-10 22:51:47.327885|2017-10-10 22:51:47.327885
NCT02569398|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-22|||November 23, 2015|Actual|2015-11-23|September 2017|2017-09-01|April 10, 2024|Anticipated|2024-04-10|April 10, 2024|Anticipated|2024-04-10||Interventional|EARLY||An Efficacy and Safety Study of JNJ-54861911 in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia|A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer's Dementia|Recruiting||Phase 2/Phase 3|1650|Anticipated|Janssen Research & Development, LLC||3|||f||||t||f||||||||2017-10-10 22:51:47.410738|2017-10-10 22:51:47.410738
NCT02569385|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-02|||August 2015||2015-08-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|Weaning TTE||Examination of Cardiovascular Function/ Cardio Respiratory Interaction on Spontaneous Breathing Trials in Patients in the Prolonged Weaning|Examination of Cardiovascular Function/ Cardio Respiratory Interaction on Spontaneous Breathing Trials in Patients in the Prolonged Weaning|Unknown status|Recruiting|N/A|20|Anticipated|RWTH Aachen University|||1||f||||f||||||||||2017-10-10 22:51:49.748959|2017-10-10 22:51:49.748959
NCT02569359|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-11-09|||April 2016||2016-04-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of Shea Nut Oil in Hemophilic Arthropathy||Recruiting||N/A|40|Anticipated|Tri-Service General Hospital||2|||f||||t||||||||||2017-10-10 22:51:50.001669|2017-10-10 22:51:50.001669
NCT02569346|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-05-15|||March 2016||2016-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|SCRUM||Bioequivalence Study of CRushed TriUMeq With or Without Drip Feed Compared to the Whole Tablet|Bioequivalence Study of CRushed TriUMeq With or Without Drip Feed Compared to the Whole Tablet (SCRUM)|Completed||Phase 1|22|Actual|Radboud University||3|||f||||f||||||||||2017-10-10 22:51:50.111318|2017-10-10 22:51:50.111318
NCT02569333|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-09-13|||January 2016||2016-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PATIENT-UC||Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis|Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis: PATIENT-UC|Recruiting||N/A|200|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||Yes||2017-10-10 22:51:50.21268|2017-10-10 22:51:50.21268
NCT02569320|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2017-07-03|||May 9, 2016|Actual|2016-05-09|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma|A Phase 1b Trial of AR-42 With Pomalidomide in Relapsed Multiple Myeloma|Suspended||Phase 1|72|Anticipated|Ohio State University Comprehensive Cancer Center||1||Internal data analysis|f||||t||||||||||2017-10-10 22:51:50.425198|2017-10-10 22:51:50.425198
NCT02569307|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-03|2016-09-02|||October 2015||2015-10-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|NAYAB||Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States|A Randomised Double Blind Placebo Controlled Pilot Study of Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States|Recruiting||Phase 2|320|Anticipated|Pakistan Institute of Learning and Living||4|||f||||t||||||||||2017-10-10 22:51:50.619573|2017-10-10 22:51:50.619573
NCT02569294|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-07-11|||January 2013||2013-01-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|GIBC||Feasibility and Impact of Group Interventions on Breast Cancer Patients Well-being|Feasibility and Impact of Yoga, Self-hypnosis and Cognitive-behavioral Group Interventions in Improving Well-being of Breast Cancer Patients|Completed||N/A|114|Actual|University Hospital of Liege||4|||f||||f||||||||||2017-10-10 22:51:50.802468|2017-10-10 22:51:50.802468
NCT02569268|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-05-07|||January 2012||2012-01-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|3 Years|Observational [Patient Registry]|BEST||Beijing Vascular Disease Patients Evaluation STudy|Early Vascular Disease Detection System for High Risk Patients in Beijing|Completed||N/A|2000|Anticipated|Peking University Shougang Hospital|||1||f||||t||||||Samples With DNA|"     Blood sample for DNA examination   "|||2017-10-10 22:51:51.032341|2017-10-10 22:51:51.032341
NCT02569255|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-02|||November 2011||2011-11-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|||Safe Use of New Oral Anticoagulants in Ablation for Atrial Fibrillation|Safe Use of New Oral Anticoagulants in Patients Treated by Catheter Ablation for Atrial Fibrillation|Completed||N/A|234|Actual|Private Hospital Heart Center Varde|||1||f||||f||||||||||2017-10-10 22:51:51.148123|2017-10-10 22:51:51.148123
NCT02569242|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-09-21|||December 2015||2015-12-01|September 2016|2016-09-01||||September 2019|Anticipated|2019-09-01||Interventional|||Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer|ONO-4538 Phase III Study A Multicenter, Randomized, Open-label Study in Patients With Unresectable Advanced or Recurrent Esophageal Cancer|Active, not recruiting||Phase 3|390|Anticipated|Ono Pharmaceutical Co. Ltd||2|||f||||t||||||||||2017-10-10 22:51:51.252023|2017-10-10 22:51:51.252023
NCT02569229|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-07-18|||June 2015||2015-06-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|GluTolCF||Glucose Tolerance in Children With Cystic Fibrosis|Glucose Tolerance and Its Clinical Impact in Children and Adolescents With Cystic Fibrosis|Active, not recruiting||N/A|14|Actual|University Hospital, Basel, Switzerland|||1||f||||t||||||Samples Without DNA|"     Glucose, C-Peptide, Insulin, HbA1c in blood specimen.   "|||2017-10-10 22:51:51.50975|2017-10-10 22:51:51.50975
NCT02569216|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-10-11|||October 2016||2016-10-01|October 2016|2016-10-01||||October 2016|Actual|2016-10-01||Interventional|EI||Electrical Inhibition (EI): A Preliminary Study To Inhibit Preterm Labor And Preterm Birth|Electrical Inhibition (EI): A Preliminary Study To Prevent The Uterine Contractions Of Human Preterm Labor And Preterm Birth|Withdrawn||Phase 1|0|Actual|New York University Langone Medical Center||1||"FDA/IRB approved but hospital administration vetoed the study fearing litigation of a preterm   birth though the electrical uterine pacemaker/EI is not the cause."|f||||t||||||||||2017-10-10 22:51:51.609548|2017-10-10 22:51:51.609548
NCT02569203|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-10-05|||April 2014||2014-04-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Immune-enhancing Enteral Nutrition on Immunomodulation in Critically Ill Patients|Effects of Enteral Formula Including Immune-modulating Nutrients on Clinical Course and Immune Function in Critically Ill Patients|Completed||N/A|30|Actual|Yonsei University||3|||f||||f||||||||||2017-10-10 22:51:51.714645|2017-10-10 22:51:51.714645
NCT02569177|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-11-24|||November 2015||2015-11-01|November 2015|2015-11-01||||November 2015|Actual|2015-11-01||Observational|||Biomarkers for Postoperative Myocardial Infarction in Cardiac Surgery.|Evaluation of the Association Between Heart Type Fatty-acid Binding Proteins and High Sensitive Troponin and Postoperative Myocardial Infarction in Patients Undergoing Cardiac Surgery.|Withdrawn||N/A|0|Actual|UMC Utrecht|||1|Due to lack of funding|f||||f||||||Samples Without DNA|"     Blood samples will be drawn before incision (baseline), during cardiopulmonary bypass and     after release of the aortic cross clamp. Subsequently, blood samples will be drawn on arrival     at the intensive care unit and three and six hours after arrival. On post-operative day 1 and     2 blood samples will be drawn on the ICU or the medium care. All samples will be stored     according the hospital blood banking protocol and analyzed at once at the end of the study.     Left over material will be discarded after all necessary analysis has been conducted.   "|||2017-10-10 22:51:51.95293|2017-10-10 22:51:51.95293
NCT02569164|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-10-05|||October 2015||2015-10-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|||Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)|Urinary Albumin Excretion in Women With Polycyclic Ovary Syndrome and it's Relation to Cardiovascular Risk Factors|Unknown status|Not yet recruiting|N/A|50|Anticipated|Kasr El Aini Hospital|||1||f||||f||||||||||2017-10-10 22:51:52.141408|2017-10-10 22:51:52.141408
NCT02569151|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2015-10-05|||April 2016||2016-04-01|October 2015|2015-10-01|April 2027|Anticipated|2027-04-01|March 2027|Anticipated|2027-03-01||Observational|||20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up|USEFULNESS OF MORNING HOME BLOOD PRESSURE MEASUREMENTS IN JAPANESE PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF A 20-YEARS, PROSPECTIVE, LONGITUDINAL STUDY|Not yet recruiting||N/A|600|Anticipated|Nagaoka Red Cross Hospital|||1||f||||f||||||||||2017-10-10 22:51:52.217425|2017-10-10 22:51:52.217425
NCT02569138|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-12-06|||October 2015||2015-10-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Balance-Enhancing Effects of Insole Hardness and Thickness for Older Adult Footwear|Investigating Long Term Balance-Enhancing Effects of Insole Hardness and Thickness for Older Adult Footwear|Completed||N/A|13|Actual|Wilfrid Laurier University||2|||f||||f||||||||||2017-10-10 22:51:52.311559|2017-10-10 22:51:52.311559
NCT02569125|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-09-26|||January 2016||2016-01-01|September 2017|2017-09-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|EPASOS||Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome|Open Label Phase II Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome|Withdrawn||Phase 2|0|Actual|University Hospital Freiburg||1||Change in supply of study medication|f||||f||||||||||2017-10-10 22:51:52.417083|2017-10-10 22:51:52.417083
NCT02569112|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-10-27|||August 2015||2015-08-01|October 2015|2015-10-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of CoolSculpt Combining Venus Legacy Technology for Enhanced Results in Fat Reduction and Laxity of the Flanks|Prospective Internally Controlled Blind Reviewed Clinical Evaluation of Cryolipolysis Combined With MP2 Technology for Enhanced Subject Results in Circumferential Fat Reduction and Skin Laxity of the Flanks|Completed||N/A|10|Actual|Venus Concept||2|||f||||t||||||||||2017-10-10 22:51:52.529464|2017-10-10 22:51:52.529464
NCT02569099|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-05-29|||October 2014||2014-10-01|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|April 30, 2017|Actual|2017-04-30||Interventional|||Effects of Training Caregivers on the Outcomes of Stroke Survivors and Caregivers in Zimbabwe|A Randomised Controlled Study to Compare the Effects of Standardised Care Plus Conventional Care Versus Conventional Care Only on the Outcomes of Stroke Survivors (HIV+ and HIV-) and Their Family Caregivers in Harare and Chitungwiza|Completed||N/A|376|Actual|University of Zimbabwe||2|||f||||t||||||||Yes|through publication of results and conference presentations.|2017-10-10 22:51:52.647452|2017-10-10 22:51:52.647452
NCT02569073|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-07-26|||June 21, 2017|Actual|2017-06-21|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|ICAMP||Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain|Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain|Recruiting||Phase 4|40|Anticipated|Temple University||2|||f||||t|t|f||||||||2017-10-10 22:51:52.857908|2017-10-10 22:51:52.857908
NCT02569060|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-09-08|||October 2015||2015-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|FAITH-DM||Feeding America Intervention Trial for Health--Diabetes Mellitus|Feeding America Intervention Trial for Health--Diabetes Mellitus|Active, not recruiting||N/A|572|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:51:52.989418|2017-10-10 22:51:52.989418
NCT02569047|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-06-14|||October 2015||2015-10-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2016|Anticipated|2016-06-01||Interventional|||ART and Hall Technique for Management of Occlusal-proximal Caries in Primary Molars|ART and Hall Technique for the Management of Occlusal-proximal Caries in Primary Molars: A Randomized Clinical Trial|Active, not recruiting||N/A|120|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 22:51:53.116874|2017-10-10 22:51:53.116874
NCT02569034|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-09-22|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Dissociating Components of Anhedonia: A Pilot fMRI Study|Dissociating Components of Anhedonia: Pilot Behavioral and fMRI Data for the Effort Expenditure for Rewards Task|Recruiting||N/A|90|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 22:51:53.259812|2017-10-10 22:51:53.259812
NCT02569021|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-10-21|||May 2014||2014-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Observational|||Battery-preserving Stimulation Patterns for Deep Brain Stimulation|Battery-preserving Stimulation Patterns to Improve Symptoms in Parkinson's Disease and Essential Tremor|Completed||N/A|30|Actual|University of Florida|||1||f||||t||||||||||2017-10-10 22:51:53.37514|2017-10-10 22:51:53.37514
NCT02569008|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-08|||January 2014||2014-01-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Minimal Volume for Fluid Challenge in Post-operative Patients|Study of Changes on Mean Systemic Filling Pressure (Pmsf) in Post-surgical Patients After a Fluid Challenge: Looking for the Minimal Dose of Fluids|Completed||N/A|80|Actual|St George's, University of London||4|||f||||f||||||||||2017-10-10 22:51:53.48548|2017-10-10 22:51:53.48548
NCT02568995|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-09-25|||May 2014||2014-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|FEMORALIA||Pain Management Following Total Hip Arthroplasty|Postoperative Pain Management Following Total Hip Arthroplasty. A Comparison Between Local Infiltration Analgesia and Ultrasound Guided 3-in-1 Block|Completed||Phase 3|55|Actual|Örebro University, Sweden||2|||f||||f||||||||||2017-10-10 22:51:53.595781|2017-10-10 22:51:53.595781
NCT02568982|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-07-05|||September 2015||2015-09-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Observational|COMPLICUSHING||Cushing's Disease Complications|Evolution of the Metabolic, Cardiovascular, Bone Complications and of the Quality of Life in Cushing's Disease|Recruiting||N/A|150|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     blood Urinary salivary   "|||2017-10-10 22:51:53.694833|2017-10-10 22:51:53.694833
NCT02568969|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-03-23|||March 2015||2015-03-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|CLM-CARD||Lactate in High-risk Cardiac Surgery|Continuous Monitoring of Lactate in High-risk Cardiac Surgery|Completed||N/A|21|Actual|Northern State Medical University||1|||f||||f||||||||||2017-10-10 22:51:53.776315|2017-10-10 22:51:53.776315
NCT02568943|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-10-03||||||October 2017|2017-10-01||||||||Expanded Access|||An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma|An Open-label, Multi-center, Expanded Treatment Protocol of Oral Panobinostat in Combination With Bortezomib and Dexamethasone in Patients With Relapsed, and Relapsed and Refractory Multiple Myeloma|Available||N/A|||Novartis|||||f||||||||||||||2017-10-10 22:51:53.875499|2017-10-10 22:51:53.875499
NCT02568930|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-08-07|||July 2015||2015-07-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Observational|SUSTAIN-IT||SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support?|SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support?|Recruiting||N/A|800|Anticipated|Northwestern University|||2||f||||f||||||||||2017-10-10 22:51:54.028218|2017-10-10 22:51:54.028218
NCT02568917|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-03-16|||January 2016||2016-01-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Effectiveness of ART and Conventional Treatment - Practice-based Clinical Trial|Effectiveness of Atraumatic Restorative Treatment and Conventional Restorations in Primary and Permanent Dentition: A Practice-based Clinical Trial|Recruiting||N/A|800|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 22:51:54.175453|2017-10-10 22:51:54.175453
NCT02568904|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-08-16|||December 2016|Actual|2016-12-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Observational|||Alcohol and Innate Immunity|The Effects of Binge Drinking on Innate Host Defence Mechanisms|Enrolling by invitation||N/A|32|Anticipated|Medical University of Graz|||1||f||||f||||||Samples Without DNA|"     Serum, Plasma, Urine, Stool   "|||2017-10-10 22:51:54.264293|2017-10-10 22:51:54.264293
NCT02568878|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-12-10|||November 2015||2015-11-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|October 2016|Anticipated|2016-10-01||Interventional|||Creatine for Depressed Male and Female Methamphetamine Users|An Open-Label Pilot Study of Creatine for Depressed Male and Female Methamphetamine Users|Recruiting||Phase 3|29|Anticipated|Montana State University||1|||f||||f||||||||||2017-10-10 22:51:54.594658|2017-10-10 22:51:54.594658
NCT02568865|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-08-28|||January 15, 2016|Actual|2016-01-15|August 2017|2017-08-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Noninvasive Physiologic Sensors to Assess Depression|Non-Invasive Physiologic Sensors to Assess Depression|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital|||2||f||||||||||||||2017-10-10 22:51:54.696779|2017-10-10 22:51:54.696779
NCT02568852|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-05-23|2016-02-18||October 2015||2015-10-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of Coagulation Factors During Laparoscopic Cholecystectomy|Comparison of Coagulation Factors During Laparoscopic Cholecystectomy With General Anesthesia and Spinal-epidural Anesthesia:Prospective Randomized Trials|Completed||N/A|50|Actual|Lütfiye Nuri Burat Government Hospital||2|||f||||t||||||||Yes|yes|2017-10-10 22:51:54.810858|2017-10-10 22:51:54.810858
NCT02568839|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-09-06|||November 2014||2014-11-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|PREDIX HER2||Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer|PREDIX HER2 - Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer. Part of a Platform of Translational Phase II Trials Based on Molecular Subtypes|Recruiting||Phase 2/Phase 3|200|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-10 22:51:55.381716|2017-10-10 22:51:55.381716
NCT02568826|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-08-31|||December 2016||2016-12-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|IDN5243inLBP||Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain|Tolerability, Safety and Activity of IDN5243, 4 mg Bid Intramuscularly in the Treatment of Low Back Pain. A Prospective, Open Label, Single-center, Uncontrolled Study|Not yet recruiting||Phase 2|50|Anticipated|Indena S.p.A||1|||f||||f||||||||||2017-10-10 22:51:55.530184|2017-10-10 22:51:55.530184
NCT02568813|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-08|||March 30, 2015|Actual|2015-03-30|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|EPILETRE||Epilepsy and Mood Regulation Disorder in Children|Epilepsy and Mood Regulation Disorders: a Prospective and Longitudinal Study in Children With Newly Diagnosed Epilepsy|Recruiting||N/A|300|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:51:55.647548|2017-10-10 22:51:55.647548
NCT02568800|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-15|||October 2015||2015-10-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|PICNIC||Prolonged Infusion Cefepime and Nosocomial Infections|Prolonged Infusion Cefepime and Nosocomial Infections|Unknown status|Recruiting|Phase 3|134|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:51:55.768575|2017-10-10 22:51:55.768575
NCT02568787|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-06-10|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|June 10, 2017|Actual|2017-06-10|June 10, 2017|Actual|2017-06-10||Interventional|||The Effect of an RBAC Supplement (BRM4) on NAFLD|The Effect of an Enhanced Rice Bran Nutritional Supplement on Non-Alcoholic Fatty Liver Disease (NAFLD)|Completed||N/A|23|Actual|University of Miami||2|||f||||f||||||||No||2017-10-10 22:51:55.888795|2017-10-10 22:51:55.888795
NCT02568774|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2017-06-28|||August 2015||2015-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Acupuncture on Post-Stroke Overactive Bladder|Acupuncture on Post-Stroke Overactive Bladder: A Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:51:56.002006|2017-10-10 22:51:56.002006
NCT02568761|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-08-15|||August 2015||2015-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Injection Snoreplasty and Oropharyngeal Exercises|Injection Snoreplasty and Oropharyngeal Exercises: Two Therapeutic Options in the Management of Snoring and Obstructive Sleep Apnea Syndrome.|Recruiting||N/A|34|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:51:56.113551|2017-10-10 22:51:56.113551
NCT02568748|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2017-04-26|||October 2015||2015-10-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC|Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Patients With Advanced Hepatocelluler Carcinoma|Recruiting||Phase 3|20|Anticipated|Tanta University||4|||f||||t||||||||Undecided||2017-10-10 22:51:56.248529|2017-10-10 22:51:56.248529
NCT02568722|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-04-25|||October 2015||2015-10-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)|STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)|Recruiting||Phase 3|2866|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-10-10 22:51:56.436815|2017-10-10 22:51:56.436815
NCT02568709|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-05-20|||February 2012||2012-02-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Interventional|MEG||Oxytocin MEG Study|Effects of Oxytocin on Neural Activation Patterns During Social Cognitive Tasks in Patients With Schizophrenia|Active, not recruiting||Early Phase 1|40|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:51:56.781016|2017-10-10 22:51:56.781016
NCT02568540|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-03-16|||October 2015||2015-10-01|March 2017|2017-03-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Observational|CTracker||C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study|preSmartphone App for Monitoring and Reporting of Hepatitis C Related Health Information: C Tracker Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study|Recruiting||N/A|500|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-10 22:51:58.228778|2017-10-10 22:51:58.228778
NCT02568696|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-02-23|||June 2015||2015-06-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|KTX||Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function|Activation of Coagulation Pathways in Clinical Renal Allotransplantation and Delayed Graft Function and Acute Rejection of the Graft|Active, not recruiting||N/A|100|Actual|Helsinki University Central Hospital|||1||f||||f||||||Samples Without DNA|"     Three 4.5 ml citrated blood samples are taken during kidney transplantation surgery.      Sample 1: taken after induction of anesthesia but before beginning of surgery from central     venous catheter or by peripheral venous puncture.      Sample 2 and 3: taken at 2 minutes after start of the reperfusion from the blood going into     the transplant and the blood coming out of the transplant (iliac artery and renal vein     respectively) by vessel puncture with a 24G needle. These samples are drawn into 5-ml     syringes and transferred immediately into pyrogen free citrated vacuum tubes.      Samples are centrifuged, plasma separated and divided into aliquots and stored at -80C.   "|||2017-10-10 22:51:56.887483|2017-10-10 22:51:56.887483
NCT02568683|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-02||2017-01-13|February 11, 2016|Actual|2016-02-11|August 2017|2017-08-01|June 22, 2017|Actual|2017-06-22|October 3, 2016|Actual|2016-10-03||Interventional|||Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)|A Phase 1b-2, Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)|Completed||Phase 1/Phase 2|10|Actual|Gilead Sciences||3|||f||||f|t|f||||||||2017-10-10 22:51:56.987842|2017-10-10 22:51:56.987842
NCT02568670|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-09-14|||November 2015||2015-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|ResPeCt||Removal Peripheral Intravenous Catheters According to Clinical Signs or Every 96 Hours: A Non Inferiority Study|Removal Peripheral Intravenous Catheters According to Clinical Signs or Every 96 Hours: A Non Inferiority Study (ResPeCt)|Completed||N/A|1305|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-10 22:51:57.102592|2017-10-10 22:51:57.102592
NCT02568657|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-04|2015-10-04|||February 2015||2015-02-01|February 2015|2015-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Uterine Tamponade for Treatment of Primary Postpartum Hemorrhage|Comparison Between Celox Versus Bakri Balloon for Treatment of Primary Atonic Postpartum Hemorrhage|Completed||Phase 2|66|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:51:57.172683|2017-10-10 22:51:57.172683
NCT02568644|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-02|||July 2014||2014-07-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Ginger Capsules for the Acute Treatment of Migraine Attacks|Double-blind Placebo-controlled Clinical Trial of Ginger (Zingiber Officinale) Addition to Ketoprofen for the Acute Treatment of Migraine Attacks|Completed||N/A|60|Actual|Federal University of Minas Gerais||2|||f||||t||||||||||2017-10-10 22:51:57.243266|2017-10-10 22:51:57.243266
NCT02568631|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-02|||September 2015||2015-09-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Improving Social Cognition for Adults With ASD by the Serious Game JeStiMulE Versus Controls|Improving Social Cognition for Adults With Autism Spectrum Disorder by the Serious Game JeStiMulE Versus Classic Video Game Stimulation Not Improving Social Cognition|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|Fondation Lenval||2|||f||||f||||||||||2017-10-10 22:51:57.48087|2017-10-10 22:51:57.48087
NCT02568618|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-05-09|||July 2015||2015-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|Genomics||Patient and Provider Confidence and Satisfaction With the Clinical Use of CYP Genetic Variability|Patient and Provider Confidence and Satisfaction With the Clinical Use of CYP Genetic Variability Analysis to Guide Analgesic Treatment: A Randomized, Controlled Pilot Study Using the Pain Medication and Mental Health DNA InsightTM Test.|Terminated||N/A|27|Actual|Defense and Veterans Center for Integrative Pain Management||2||Sponsor pulled funding related to enrollment pace.|f||||f||||||||||2017-10-10 22:51:57.597178|2017-10-10 22:51:57.597178
NCT02568605|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-06-08|||May 2015||2015-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease|Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease|Recruiting||N/A|60|Anticipated|University of Calgary||3|||f||||f||||||||Undecided||2017-10-10 22:51:57.694076|2017-10-10 22:51:57.694076
NCT02568592|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-05-11|||March 2015||2015-03-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake|Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake in Women|Active, not recruiting||N/A|16|Actual|University of Birmingham||3|||f||||f||||||||No||2017-10-10 22:51:57.805827|2017-10-10 22:51:57.805827
NCT02568579|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-06-28|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Infant Immunity Comparison of Breastfed and Bottlefed Infants|Effects of Breastfeeding in Immunologic Priming in Young Infants|Active, not recruiting||N/A|85|Actual|Duke University|||2||f||||f||||||Samples With DNA|"     Four 2.6 ml ACD tubes will be collected . All blood will be processed for pyrosequencing,     TBNK, CBC and differential, platelets, sera plasman and PBMC's. Stool samples   "|||2017-10-10 22:51:57.88622|2017-10-10 22:51:57.88622
NCT02568566|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-04|||March 30, 2016|Actual|2016-03-30|July 2017|2017-07-01||||February 29, 2020|Anticipated|2020-02-29||Interventional|||Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants|A Prospective, Single-Arm, Open-label, Non-randomized, Phase IIA Trial of a Nonavalent Prophylactic HPV Vaccine to Assess Immunogenicity of a Prime and Deferred-Booster Dosing Schedule Among 9-11 Year-Old Girls and Boys|Active, not recruiting||Phase 2|200|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-10 22:51:57.967329|2017-10-10 22:51:57.967329
NCT02568553|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-05|2017-09-12|||June 14, 2016|Actual|2016-06-14|September 2017|2017-09-01||||December 31, 2018|Anticipated|2018-12-31||Interventional|||Lenalidomide and Blinatumomab in Treating Patients With Relapsed Non-Hodgkin Lymphoma|A Phase I Trial of the Combination of Lenalidomide and Blinatumomab in Patients With Relapsed or Refractory Non-Hodgkins Lymphoma (NHL)|Recruiting||Phase 1|36|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 22:51:58.064989|2017-10-10 22:51:58.064989
NCT02568527|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-10-03|||October 2015||2015-10-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Biodegradable Synthetic Scaffold as a Substitute for hAM in Limbal Epithelial Cells Transplant in LSCD Patients|Study to Evaluate Safety & Efficacy of PLGA Scaffold to Regenerate Limbal Epithelial Cells Using Autologous Limbal Grafts by SLET (Simple Limbal Epithelial Transplant) Procedure in Patients Having Total Unilateral LSCD|Not yet recruiting||Phase 1|10|Anticipated|L.V. Prasad Eye Institute||1|||f||||f||||||||||2017-10-10 22:51:58.322593|2017-10-10 22:51:58.322593
NCT02568514|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-04-06|||August 2016||2016-08-01|April 2017|2017-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Study of the Effect on Clinical Outcomes Using Secure Text Messaging|Study of the Effect on Clinical Outcomes Using Secure Text Messaging|Withdrawn||N/A|0|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:51:58.420357|2017-10-10 22:51:58.420357
NCT02568501|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-11-10|||January 2016||2016-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults|Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults|Completed||Phase 3|90|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:51:58.533955|2017-10-10 22:51:58.533955
NCT02568488|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-03-19|||March 2014||2014-03-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Effect of Metformin on Different Hormones in PCOS Patients|The Effect of Metformin on Serum Insulin, Androgens and AMH in PCOS Patients|Completed||Phase 4|48|Actual|Cairo University||1|||f||||t||||||||||2017-10-10 22:51:58.625137|2017-10-10 22:51:58.625137
NCT02568462|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-06-06|||November 2015||2015-11-01|June 2016|2016-06-01|July 2021|Anticipated|2021-07-01|April 2017|Anticipated|2017-04-01||Interventional|RENASCENT II||Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent|Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial II|Active, not recruiting||Phase 2|60|Actual|Amaranth Medical Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:51:58.804374|2017-10-10 22:51:58.804374
NCT02568449|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-03-28|||October 2015||2015-10-01|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent|A Phase II Trial of BIBF 1120 (Nintedanib) in Recurrent Malignant Pleural Mesothelioma|Recruiting||Phase 2|55|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-10 22:51:58.941963|2017-10-10 22:51:58.941963
NCT02568436|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2016-07-08|||July 2015||2015-07-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Low Level Laser Therapy in Accelerating Tooth Movement For Dental Crowding Cases|Evaluation of Low-Level Laser Therapy (LLLT) Effectiveness in Accelerating Orthodontic Tooth Movement For Dental Crowding Cases: A Randomized Controlled Clinial Trial|Completed||N/A|26|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 22:51:59.06382|2017-10-10 22:51:59.06382
NCT02568423|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-09-07|||November 4, 2015|Actual|2015-11-04|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 13, 2016|Actual|2016-05-13||Interventional|||A Study of Mirikizumab (LY3074828) in Healthy Participants|A Single-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of LY3074828 in Japanese and Caucasian Healthy Subjects|Recruiting||Phase 1|42|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 22:51:59.160794|2017-10-10 22:51:59.160794
NCT02568410|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-05-22|||October 2015||2015-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|PRICS||Platelets as Regulators of Inflammation in Cardiac Surgery|Platelets as Regulators of Inflammation and Tissue Injury After Cardiac Surgery|Recruiting||N/A|100|Anticipated|Duke University|||1||f||||f||||||Samples With DNA|"     Plasma, DNA, Platelet RNA   "|||2017-10-10 22:51:59.266987|2017-10-10 22:51:59.266987
NCT02568397|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-05-25|||October 2015||2015-10-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants|Effect of LY3314814 on the Pharmacokinetics of Dabigatran in Healthy Subjects|Completed||Phase 1|60|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:51:59.356469|2017-10-10 22:51:59.356469
NCT02568384|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-08-24|2016-12-30||October 2015||2015-10-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Evaluation of an Ascensia Blood Glucose Meter and App System|Open Label, Single-center Study of the Onyx Meter and App System for Blood Glucose Monitoring in Insulin-Dependent and Insulin-using, Non-Insulin-Dependent Diabetes Mellitus Patients to Demonstrate Usability in a Clinical Setting.|Completed||N/A|45|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-10 22:51:59.451706|2017-10-10 22:51:59.451706
NCT02568371|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-11-05|||October 2015||2015-10-01|October 2015|2015-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|bio-Share||Biobank Based on the i-Share Student Cohort|Biobank Based on the i-Share Student Cohort|Recruiting||N/A|2000|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||Samples With DNA|"     buffy coat ; plasma ; serum ; whole blood ; red blood cells ; DNA ; RNA   "|||2017-10-10 22:51:59.745167|2017-10-10 22:51:59.745167
NCT02568358|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-10-02|||October 2015||2015-10-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Observational|||DNA-based Testing in BAL of Lung Transplant Recipients With Suspected Non-viral Lower Respiratory Tract Infection|DNA-based Testing in BAL of Lung Transplant Recipients With Suspected Non-viral Lower Respiratory Tract Infection|Unknown status|Not yet recruiting|N/A|48|Anticipated|Hannover Medical School|||1||f||||f||||||Samples With DNA|"     Bronchoalveolar lavage   "|||2017-10-10 22:51:59.842864|2017-10-10 22:51:59.842864
NCT02568345|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-01-22|2015-10-06||January 2013||2013-01-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Sugammadex ED90 Dose in the Obese Patients|Sugammadex ED90 Dose to Reverse the Rocuronium Blockade in the Obese Patients|Completed||Phase 4|31|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||1|||f||||f||||||||Yes||2017-10-10 22:51:59.912845|2017-10-10 22:51:59.912845
NCT02568332|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-05-02|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|February 2017|Actual|2017-02-01||Interventional|||A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals|A Phase I Study to Assess the Safety and Immunogenicity of Prime-boost Immunisations With Vaccine Candidates AdCh3NSmut1 and MVA-NSmut in HIV-1 Seropositive HCV-uninfected Adults on Antiretroviral Therapy (ART)|Active, not recruiting||Phase 1|20|Actual|University of Oxford||1|||f||||t||||||||||2017-10-10 22:52:00.131482|2017-10-10 22:52:00.131482
NCT02568319|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2015-12-23|||September 2015||2015-09-01|October 2015|2015-10-01||||December 2015|Actual|2015-12-01||Interventional|||Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects|A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging in a Defined Special Population - Obese Subjects (BMI > or Equal to 30 kg/m2)|Completed||Phase 2|120|Anticipated|Neothetics, Inc||2|||f||||f||||||||||2017-10-10 22:52:00.221525|2017-10-10 22:52:00.221525
NCT02568306|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-08-02|||October 5, 2015|Actual|2015-10-05|August 2017|2017-08-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Interventional|||A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects|A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects.|Completed||Phase 1|93|Actual|Novo Nordisk A/S||2|||f||||f|t|f|||t|||||2017-10-10 22:52:00.306101|2017-10-10 22:52:00.306101
NCT02568293|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-02-08|||October 2015||2015-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|SHIELD||Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis|A Multicenter, Parallel, Blinded, Randomized Comparison of the Safety and Efficacy of Balloon Angioplasty Plus Intraluminal SBCV To Balloon Angioplasty Alone for Treatment of Stenosis or Occlusion Within the Femoropopliteal Artery|Active, not recruiting||N/A|66|Anticipated|Symic Vascular||2|||f||||f||||||||||2017-10-10 22:52:00.380518|2017-10-10 22:52:00.380518
NCT02568280|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-08-30|||October 2015||2015-10-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes|A Randomised Trial Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes|Completed||Phase 1|42|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 22:52:00.470577|2017-10-10 22:52:00.470577
NCT02568254|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-07-14|2017-06-12||September 3, 2015|Actual|2015-09-03|July 2017|2017-07-01|January 18, 2016|Actual|2016-01-18|January 18, 2016|Actual|2016-01-18||Interventional||All subjects that were dispensed at least 1 study lens.|Evaluation of Three Daily Disposable Contact Lenses||Completed||N/A|78|Actual|Johnson & Johnson Vision Care, Inc.|Caution of interpretation of results: A significant first-order carryover effect was noted in the study analysis.|6|||f|||||f|t|f|f|t|||||2017-10-10 22:52:01.479706|2017-10-10 22:52:01.479706
NCT02568241|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-09-28|||December 2015||2015-12-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|IDPR-HSCT||Interferon-α After DLI for the Prevention of Relapse|Interferon α After Prophylactic Donor Lymphocyte Infusion for the Relapse Prevention After Hematopoietic Stem Cell Transplantation|Recruiting||Phase 1/Phase 2|42|Anticipated|Peking University People's Hospital||1|||f||||t||||||||||2017-10-10 22:52:01.902565|2017-10-10 22:52:01.902565
NCT02568228|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-11-21|||August 2015||2015-08-01|November 2016|2016-11-01||||November 2016|Actual|2016-11-01||Interventional|||Health Beneficial Effects of Krill Oil and Lean and Fatty Fish|Health Beneficial Effects of Krill Oil and Lean and Fatty Fish|Completed||N/A|40|Actual|Oslo and Akershus University College of Applied Sciences||3|||f||||f||||||||||2017-10-10 22:52:02.020544|2017-10-10 22:52:02.020544
NCT02568215|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-09-05|||May 2016||2016-05-01|September 2017|2017-09-01||||July 2020|Anticipated|2020-07-01||Interventional|||Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women|A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa|Recruiting||Phase 2|1500|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-10 22:52:02.139706|2017-10-10 22:52:02.139706
NCT02568202|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-01-11|||September 2015||2015-09-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)|Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)|Completed||N/A|449|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 22:52:02.330096|2017-10-10 22:52:02.330096
NCT02568189|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-09-13|||November 2015||2015-11-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and Dehydration|Randomized Controlled Trial of Inferior Vena Cava Ultrasonography in the Management and Disposition of Pediatric Patients Undergoing Evaluation for Sepsis and Dehydration|Recruiting||N/A|564|Anticipated|Icahn School of Medicine at Mount Sinai||4|||f||||t||||||||||2017-10-10 22:52:02.428384|2017-10-10 22:52:02.428384
NCT02568176|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-02-16|||October 2015||2015-10-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Participants|An Open-Label Study to Evaluate the Pharmacokinetics of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Subjects|Completed||Phase 1|71|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 22:52:02.623758|2017-10-10 22:52:02.623758
NCT02568163|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-09-07|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Influence of Stress on Non Surgical Periodontal Treatment|Influence of Stress on Non Surgical Periodontal Treatment|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 22:52:02.74612|2017-10-10 22:52:02.74612
NCT02568150|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-01|||February 2014||2014-02-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines|Single Arm, Open, Single Institute, Domestic Phase 4 Clinical Study to Evaluate the Onset Time of Improvement of Glabellar Frown Lines and Safety of DWP450-004 Injection for Adults With Worse Than Moderate Glabellar Frown Lines|Completed||Phase 4|45|Actual|Daewoong Pharmaceutical Co. LTD.||1|||f||||f||||||||||2017-10-10 22:52:02.874132|2017-10-10 22:52:02.874132
NCT02568137|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-09-29|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|PINGS||Phone-based Intervention Under Nurse Guidance After Stroke|Phone-based Intervention Under Nurse Guidance After Stroke|Completed||N/A|60|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-10 22:52:02.939089|2017-10-10 22:52:02.939089
NCT02568124|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-07-18|||November 2015||2015-11-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|TRACS||Tranexamic Acid in Chronic Subdural Hematomas|Tranexamic Acid in Chronic Subdural Hematomas|Recruiting||Phase 2/Phase 3|130|Anticipated|Centre de recherche du Centre hospitalier universitaire de Sherbrooke||2|||f||||f||||||||||2017-10-10 22:52:03.029201|2017-10-10 22:52:03.029201
NCT02568111|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-04-21|||February 2016||2016-02-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|BRITE||Brimonidine Tartrate for the Treatment of Injection Related Erythema|Brimonidine Tartrate for the Treatment of Injection Related Erythema Associated With Sub-cutaneous Administration of Peginterferon Beta-1a (BRITE)|Withdrawn||Phase 4|0|Actual|Biogen||2|||f||||||||||||||2017-10-10 22:52:03.160737|2017-10-10 22:52:03.160737
NCT02568098|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-05-30|||October 2015||2015-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Pharmacokinetic and Mosquito-Lethal Effects of Ivermectin (IVM), Primaquine (PQ), Dihydroartemisinin-Piperaquine (DHA-PQP) and Albendazole (ABZ) in Healthy Subjects|Open-Label Study to Evaluate Safety, Tolerability, Potential Pharmacokinetic Interactions and Mosquito-Lethal Effects of Orally Administered Ivermectin, Primaquine, Dihydroartemisinin-Piperaquine, and Albendazole in Healthy Adult Subjects|Completed||Phase 1|16|Actual|University of Oxford||3|||f||||f||||||||||2017-10-10 22:52:03.260965|2017-10-10 22:52:03.260965
NCT02568085|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-02|||November 2015||2015-11-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Trial Evaluating Use of Arista in Total Thyroidectomy|Randomized Controlled Trial Evaluating Use of Arista Absorbable Surgical Hemostatic Powder in Total Thyroidectomy With and Without Neck Dissections|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|University of California, San Francisco||4|||f||||f||||||||||2017-10-10 22:52:03.374896|2017-10-10 22:52:03.374896
NCT02568072|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-08|||October 2015||2015-10-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|MARATHON||Training-induced Increased Left Ventricular Trabeculation|Increased Left Ventricular Trabeculation in Athletes - a Marker of Left Ventricular Non-compaction or a Physiological Epiphenomenon of Increased Cardiac Preload?|Completed||N/A|120|Actual|St George's, University of London|||1||f||||f||||||Samples With DNA|"     Blood samples. Urine samples.   "|||2017-10-10 22:52:03.45474|2017-10-10 22:52:03.45474
NCT02568059|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-10-17|||December 2015||2015-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers|The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers (Clinical Trial Phase I)|Completed||Phase 1|25|Actual|Thammasat University||2|||f||||t||||||||||2017-10-10 22:52:03.538473|2017-10-10 22:52:03.538473
NCT02568046|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-08|||March 2016||2016-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients|An Open Label, Multi-Center Phase 1b/2a Trial Investigating Different Doses of Sym004 in Combination With FOLFIRI in Patients With Metastatic Colorectal Cancer Progressing After First Line Therapy|Active, not recruiting||Phase 1/Phase 2|10|Actual|Symphogen A/S||2|||f||||f||||||||||2017-10-10 22:52:03.634847|2017-10-10 22:52:03.634847
NCT02568033|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-01-30|||October 2013||2013-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer|Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer (Protocol Number GK001)|Recruiting||Early Phase 1|22|Anticipated|The Cooper Health System||1|||f||||f||||||||||2017-10-10 22:52:03.74942|2017-10-10 22:52:03.74942
NCT02568020|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-10-31|||November 2016||2016-11-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||LPD+α-ketoacids on Autophagy and Improving Muscle Wasting in CKD|Mechanisms of Low Protein Diet Supplemented With α-ketoacids on Autophagy and Improving Muscle Wasting in Chronic Kidney Disease: the Role of Autophagy in Muscle Wasting|Not yet recruiting||Phase 4|60|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||No||2017-10-10 22:52:03.932683|2017-10-10 22:52:03.932683
NCT02568007|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-12-07|||December 2015||2015-12-01|December 2015|2015-12-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding Disorders|Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding Disorders|Not yet recruiting||Phase 4|75|Anticipated|Medical College of Wisconsin||3|||f||||f||||||||||2017-10-10 22:52:04.018179|2017-10-10 22:52:04.018179
NCT02567994|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|TETRIS||Tenelia Triple Combination Study|Efficacy and Safety of Teneligliptin Versus Sitagliptin as add-on Therapy to Metformin Plus Glimepiride in T2DM Patinets With Inadequate Glycemic Control|Recruiting||Phase 3|200|Anticipated|Handok Pharmaceuticals Co., Ltd.||2|||f||||f||||||||Yes||2017-10-10 22:52:04.119555|2017-10-10 22:52:04.119555
NCT02567227|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-06-26|||February 2016||2016-02-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|CREM||Cognitive Remediation to Improve Mobility in Sedentary Seniors|Cognitive Intervention to Improve Simple and Complex Walking|Recruiting||N/A|420|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-10 22:52:13.004847|2017-10-10 22:52:13.004847
NCT02567981|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-11-03|||September 2015||2015-09-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Comparison of Two Nutrition Interventions in Young Children in El Salvador|Impact of the Consumption of an M+ Fortified Premix (Chapuditos®) in 4 Rural Municipalities in the Department of La Libertad, El Salvador in Children From 6 to 59 Months.|Recruiting||N/A|4000|Anticipated|The Mathile Institute for the Advancement of Human Nutrition||2|||f||||t||||||||||2017-10-10 22:52:04.231142|2017-10-10 22:52:04.231142
NCT02567968|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-01-03|||August 2016||2016-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Determine if Caffeine Accelerates Emergence From Anesthesia|A Randomized, Double-Blinded, Placebo-Controlled Pilot Study to Determine if Caffeine and Sodium Benzoate Accelerates Emergence From Anesthesia|Recruiting||Phase 4|8|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-10 22:52:04.35586|2017-10-10 22:52:04.35586
NCT02567955|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-01|||September 2015||2015-09-01|October 2015|2015-10-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Immunogenicity and Safety of Gardasil-9 and Cervarix|Immunogenicity and Safety of Gardasil-9 and Cervarix When Administered to 9-10-year-old Subjects According to 0-6 Month Schedule|Recruiting||Phase 3|370|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 22:52:04.457598|2017-10-10 22:52:04.457598
NCT02567942|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-02-26|||July 2015||2015-07-01|February 2016|2016-02-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Colon Cancer|Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Colon Cancer|Recruiting||N/A|300|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:52:04.551118|2017-10-10 22:52:04.551118
NCT02567929|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-02-26|||July 2015||2015-07-01|February 2016|2016-02-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer|Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer|Recruiting||N/A|300|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||No||2017-10-10 22:52:04.637393|2017-10-10 22:52:04.637393
NCT02567916|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-07-23|||April 2015||2015-04-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Comparison of Injection Pain of Propofol During Endoscopy : LCT Propofol vs MCT/LCT Propofol|A Comparison of Injection Pain of Propofol During Endoscopy : LCT Propofol vs MCT/LCT Propofol|Completed||Phase 4|129|Actual|Kyungpook National University||2|||f||||||||||||||2017-10-10 22:52:04.719269|2017-10-10 22:52:04.719269
NCT02567903|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-10-02|||September 2015||2015-09-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Interventional|||Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System|Tourniquet Study: Is the High Thrombosis Risk After Knee Arthroscopy Caused by Limb-tourniquet Application? A Randomized Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System|Unknown status|Recruiting|N/A|50|Anticipated|Groene Hart Ziekenhuis||2|||f||||f||||||||||2017-10-10 22:52:06.599685|2017-10-10 22:52:06.599685
NCT02567890|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-01|||September 2015||2015-09-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|October 2016|Anticipated|2016-10-01||Interventional|sBodyProject||Swedish Body Project for Prevention of Eating Disorders|An Interactive Internet-based Program for Prevention of Eating Disorders on a Broad Basis|Recruiting||N/A|400|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-10 22:52:06.73583|2017-10-10 22:52:06.73583
NCT02567877|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-07-10|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|||Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?|Is Levothyroxine Alone Adequate Thyroid Hormone Replacement for All Patients?|Recruiting||N/A|190|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-10 22:52:06.850198|2017-10-10 22:52:06.850198
NCT02567864|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-05-10|||July 12, 2014|Actual|2014-07-12|May 2017|2017-05-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|HBA||Development and Evaluation of the Healthy Beat Accupunch (HBA) Exercise Program for the Community Older Adults|Development and Evaluation of an Evidence-based Intervention Guideline of the Healthy Beat Accupunch (HBA) Exercise Program for the Community Older Adults|Completed||N/A|232|Actual|Kaohsiung Medical University||2|||f||||f||||||||||2017-10-10 22:52:06.969748|2017-10-10 22:52:06.969748
NCT02567851|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-04-18|||February 2014||2014-02-01|October 2015|2015-10-01|February 2018|Anticipated|2018-02-01|February 2016|Actual|2016-02-01||Interventional|BREVITY||A Study of Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity|BREVITY: A Phase II Study of Brentuximab Vedotin Using a Response Adapted Design in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity|Active, not recruiting||Phase 2|38|Actual|University of Birmingham||1|||f||||f||||||||||2017-10-10 22:52:07.053373|2017-10-10 22:52:07.053373
NCT02567838|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-03-24|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Lidocaine Gel During Transrectal Sonography|LIdocaine Gel Versus Plain Lubricating Gel for Pain Reduction During Transrectal Sonography (LIPS)|Completed||Phase 3|80|Actual|Kangbuk Samsung Hospital||2|||f||||f||||||||No||2017-10-10 22:52:07.184731|2017-10-10 22:52:07.184731
NCT02567825|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-08-24|||November 2015||2015-11-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|December 2020|Anticipated|2020-12-01||Interventional|||Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media|Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media|Recruiting||Phase 3|240|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 22:52:07.292834|2017-10-10 22:52:07.292834
NCT02567812|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-02|||October 2015||2015-10-01|October 2015|2015-10-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01|1 Year|Observational [Patient Registry]|||Database of Pelvic Inflammatory Disease|Prospective Data Collection of Patients With Pelvic Inflammatory Disease|Recruiting||N/A|200|Anticipated|Kangbuk Samsung Hospital|||1||f||||f||||||||||2017-10-10 22:52:07.432482|2017-10-10 22:52:07.432482
NCT02567799|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-24|||November 2015||2015-11-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Interventional|NSCLC||BIO 300 Non-Small Cell Lung Cancer Study|A Phase I/II Clinical Study Evaluating the Safety and Effectiveness of BIO 300 Oral Suspension in Patients Receiving Chemoradiation Therapy for Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|36|Anticipated|Humanetics Corporation||1|||f||||f||||||||||2017-10-10 22:52:07.606636|2017-10-10 22:52:07.606636
NCT02567786|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-07-21|||October 2015||2015-10-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Fresh Frozen Plasma and Plasmalyte ® for Priming Cardiopulmonary Bypass in Infants and Children|Comparison of Fresh Frozen Plasma and Plasmalyte ® for Priming Cardiopulmonary Bypass in Infants and Children Undergoing Open-heart Surgery: A Double-blind Randomized Controlled Study|Recruiting||N/A|60|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 22:52:07.746422|2017-10-10 22:52:07.746422
NCT02567773|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-03-02|||September 2015||2015-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078|A Randomized Double-blind (Sponsor Unblind) Placebo Controlled Study in Healthy Subjects to Evaluate: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Repeat Doses of GSK2881078, the Selective Androgen Receptor Modulator With an Open Label Dosing Arm to Evaluate the Effect of CYP3A4 Inhibition on Pharmacokinetics of GSK2881078|Completed||Phase 1|108|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:52:07.840437|2017-10-10 22:52:07.840437
NCT02567760|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-02-27|||April 2015||2015-04-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Development and Evaluation of a Cognitive Enhancement Product Made From Selected Thai Herbs for Menopausal Women|Development and Evaluation of a Cognitive Enhancement Product Made From Selected Thai Herbs for Menopausal Women|Completed||Phase 1|30|Actual|Khon Kaen University||2|||f||||f||||||||||2017-10-10 22:52:07.941705|2017-10-10 22:52:07.941705
NCT02567747|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-02-03|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Observational|||Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age|Impact of Vaccination Against Pneumococcal Disease on the Morbidity of Acute Otitis Media in Colombian Children < 5 Years of Age|Active, not recruiting||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-10 22:52:08.023087|2017-10-10 22:52:08.023087
NCT02567734|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-12-24|||October 2015||2015-10-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trials of CT-guided Percutaneous Irreversible Electroporation（IRE）in the Treatment of Patients With Locally Advanced Tumors|Clinical Trials of CT-guided Percutaneous Irreversible Electroporation（IRE）in the Treatment of Patients With Locally Advanced Tumors：The Safety and Efficacy Assessment|Unknown status|Active, not recruiting|N/A|20|Anticipated|Chinese PLA General Hospital||1|||f||||f||||||||||2017-10-10 22:52:08.110084|2017-10-10 22:52:08.110084
NCT02567721|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-02-11|||October 2015||2015-10-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)|European Medicines Agency (EMA) Post-authorisation Safety Study of Influenza Vaccine|Completed||N/A|11530|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-10 22:52:08.194606|2017-10-10 22:52:08.194606
NCT02567695|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-04-10|||September 2015|Actual|2015-09-01|September 2015|2015-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects|A Phase 1, Single-Dose, Open-Label, Randomized, Two-Period Crossover Study to Evaluate the Relative Bioavailability of GBT440 300 mg Administered as Capsule Formulations in Healthy Subjects|Completed||Phase 1|26|Actual|Global Blood Therapeutics||2|||f||||f||||||||||2017-10-10 22:52:08.454553|2017-10-10 22:52:08.454553
NCT02567682|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-04-10|||September 2015||2015-09-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects|A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Doses of GBT440 on the Pharmacokinetics of Probe Substrates for CYP1A2, CYP2C9, CYP2C19, and CYP3A4 in Healthy Subjects|Completed||Phase 1|24|Actual|Global Blood Therapeutics||1|||f||||f||||||||||2017-10-10 22:52:08.538689|2017-10-10 22:52:08.538689
NCT02567669|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-10-04|||January 2016||2016-01-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Observational|MUSFAT||Muscle Loss and Fatigue as a Consequence of Radiotherapy|Muscle Loss and Fatigue as a Consequence of Radiotherapy|Enrolling by invitation||N/A|20|Anticipated|Essentia Health|||1||f||||f||||||||Yes|meeting presentation and publication|2017-10-10 22:52:08.67643|2017-10-10 22:52:08.67643
NCT02567656|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-04-07|||September 2015||2015-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma|A Phase I/Ib, Dose Escalation Study to Evaluate Safety and Efficacy of RP6530, a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed or Refractory T-cell Lymphoma|Recruiting||Phase 1|58|Anticipated|Rhizen Pharmaceuticals SA||1|||f||||f||||||||No||2017-10-10 22:52:08.768109|2017-10-10 22:52:08.768109
NCT02567643|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-03-27|||May 2013||2013-05-01|March 2017|2017-03-01||||March 2017|Anticipated|2017-03-01||Interventional|||Stereotactic Radiosurgery (SRS) for Multiple CNS Mets|Stereotactic Radiosurgery for Multiple (5+) CNS Metastases|Active, not recruiting||N/A|33|Actual|The Cooper Health System||1|||f||||f||||||||||2017-10-10 22:52:08.903329|2017-10-10 22:52:08.903329
NCT02567630|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-01-26|||October 1, 2015|Actual|2015-10-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 31, 2019|Anticipated|2019-08-31||Interventional|||Early Childhood Constraint Therapy in Cerebral Palsy|Early Childhood Constraint Therapy for Sensory/Motor Impairment in Cerebral Palsy|Recruiting||N/A|216|Anticipated|Nationwide Children's Hospital||3|||f||||t||||||||||2017-10-10 22:52:08.993015|2017-10-10 22:52:08.993015
NCT02567617|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-01|||May 2014||2014-05-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||Polyphenols Supplementation on Prostaglandin E2 in Women - Randomized Clinical Trial|Polyphenol Supplementation Inhibits Physiological Increase of Prostaglandin E2 During Reproductive Period - A Randomized Clinical Trial|Completed||Phase 2|26|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||t||||||||||2017-10-10 22:52:09.101518|2017-10-10 22:52:09.101518
NCT02567604|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-10-01|||October 2015||2015-10-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective|Development of Core Outcomes for Age-related Macular Degeneration (AMD)|Unknown status|Not yet recruiting|N/A|24|Anticipated|Queen's University, Belfast|||1||f||||f||||||||||2017-10-10 22:52:09.177187|2017-10-10 22:52:09.177187
NCT02567591|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-08-12|||July 2016||2016-07-01|June 2016|2016-06-01|March 2021|Anticipated|2021-03-01|November 2020|Anticipated|2020-11-01||Interventional|FAPA||Adapted Physical Activity Effect on Aerobic Function and in Patients in Pre Liver Transplantation|Adapted Physical Activity Effect on Aerobic Function and in Patients in Pre Liver Transplantation|Recruiting||N/A|30|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-10 22:52:09.262069|2017-10-10 22:52:09.262069
NCT02567578|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-10-27|||October 2015||2015-10-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia|A Multicenter, Randomized, Double-blind, Placebo-controlled Dose-finding Phase 2 Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia|Active, not recruiting||Phase 2|420|Anticipated|Yuhan Corporation||4|||f||||f||||||||||2017-10-10 22:52:09.495375|2017-10-10 22:52:09.495375
NCT02567565|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-01|||May 2015||2015-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|3 Months|Observational [Patient Registry]|||Evaluation of Tear Film Lipid Layer Thickness Change After Cataract Surgery|Evaluation of Tear Film Lipid Layer Thickness Change After Cataract Surgery|Completed||N/A|60|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 22:52:09.599756|2017-10-10 22:52:09.599756
NCT02567539|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-02-26|||April 2015||2015-04-01|October 2015|2015-10-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma|Phase II Study of Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma|Recruiting||N/A|54|Anticipated|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-10 22:52:09.849904|2017-10-10 22:52:09.849904
NCT02567526|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-10-31|||August 2011||2011-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Cost Effectiveness of Nutrition Intervention in Long Term Care|Cost Effectiveness of Nutrition Intervention in Long Term Care|Completed||N/A|148|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-10 22:52:09.985677|2017-10-10 22:52:09.985677
NCT02567513|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-05|||October 2009||2009-10-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Cost-Effectiveness of Weight Loss Prevention in Nursing Homes: A Controlled Trial|Cost-Effectiveness of Weight Loss Prevention in Nursing Homes: A Controlled Trial|Completed||N/A|154|Actual|Vanderbilt University||3|||f||||f||||||||||2017-10-10 22:52:10.075589|2017-10-10 22:52:10.075589
NCT02567500|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-10-02|||July 2015||2015-07-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Physalis Child : Identification of Cognitive and Emotional Factors|Identification of Cognitive and Emotional Factors in Relation to Auditory Hallucinations in Non-psychotic Children|Unknown status|Recruiting|Phase 2|40|Anticipated|Fondation Lenval||2|||f||||f||||||||||2017-10-10 22:52:10.174115|2017-10-10 22:52:10.174115
NCT02567487|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-10-02|||July 2015||2015-07-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||TAP Block With Two Different Doses of Levobupivacaine|Comparison of TAP Block With Two Different Doses of Levobupivacaine for Postoperative Pain Management in Pediatric Patients|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Ankara University||2|||f||||f||||||||||2017-10-10 22:52:10.285821|2017-10-10 22:52:10.285821
NCT02567474|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2015-10-02|||November 2012||2012-11-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Self Management Program on Clinical Status of COPD Patients|Effect of Self Management Program Based on 5A Model on Clinical Status of Chronic Obstructive Pulmonary Disease|Completed||N/A|50|Actual|Ahvaz Jundishapur University of Medical Sciences||2|||f||||f||||||||||2017-10-10 22:52:10.37456|2017-10-10 22:52:10.37456
NCT02567461|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-03-15|||March 2016||2016-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|EDOX-APT||Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel|Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel (EDOX-APT): A Prospective Randomized Study|Recruiting||Phase 4|75|Anticipated|University of Florida||3|||f||||t|f|f||||||No||2017-10-10 22:52:10.467872|2017-10-10 22:52:10.467872
NCT02567448|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2017-02-16|||July 2015||2015-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Pathophysiology of the Upper Airway in Patients With COPD and Concomitant OSA|Pathophysiology of the Upper Airway in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Concomitant Obstructive Sleep Apnea (OSA)|Recruiting||N/A|100|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 22:52:10.588746|2017-10-10 22:52:10.588746
NCT02567435|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-09-28|||May 23, 2016|Actual|2016-05-23|May 2017|2017-05-01||||November 1, 2022|Anticipated|2022-11-01||Interventional|||Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma|A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND#122782) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)|Suspended||Phase 3|387|Anticipated|National Cancer Institute (NCI)||3||Other - Feasibility Assessment|f||||t||||||||||2017-10-10 22:52:10.73118|2017-10-10 22:52:10.73118
NCT02567240|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2015-10-01|||January 2015||2015-01-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Carbon Monoxide-Saturated Medium for Islet Isolation|A Novel Approach to Harvest Islets for Autologous Islet Transplantation|Unknown status|Recruiting|Phase 1|24|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 22:52:12.906636|2017-10-10 22:52:12.906636
NCT02567422|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-09-25|||September 2, 2016|Actual|2016-09-02|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||VX-970, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced HPV-Negative Head and Neck Squamous Cell Carcinoma|A Phase I Study of VX-970 in Combination With Cisplatin and XRT in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121)|Recruiting||Phase 1|45|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 22:52:11.18569|2017-10-10 22:52:11.18569
NCT02567409|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-09-28|||August 19, 2016|Actual|2016-08-19|September 2017|2017-09-01||||August 31, 2018|Anticipated|2018-08-31||Interventional|||Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Metastatic Urothelial Cancer|A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without VX-970 in Metastatic Urothelial Carcinoma|Recruiting||Phase 2|90|Anticipated|National Cancer Institute (NCI)||2|||||||f||||||||||2017-10-10 22:52:11.360563|2017-10-10 22:52:11.360563
NCT02567396|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-02|2017-04-20|||June 2016||2016-06-01|April 2017|2017-04-01||||October 2018|Anticipated|2018-10-01||Interventional|||Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction|A Phase I Study of Single Agent Talazoparib (BMN 673) in Advanced Cancer Patients With Hepatic and Renal Dysfunction|Withdrawn||Phase 1|0|Actual|National Cancer Institute (NCI)||1||Other- Protocol moved to Disapproved|f||||||||||||||2017-10-10 22:52:11.605907|2017-10-10 22:52:11.605907
NCT02567383|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-10-05|||September 2015||2015-09-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer|A Phase II Clinical Trial Evaluating the Safety and Efficacy of Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer|Recruiting||Phase 2|45|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital||1|||f||||f||||||||||2017-10-10 22:52:11.696374|2017-10-10 22:52:11.696374
NCT02567370|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-10-22|||August 2015||2015-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|FIH||Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-ascending Dose Study With a Food-Effect Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects and Subjects With Schizophrenia|Completed||Phase 1|70|Actual|Amgen||2|||f||||f||||||||||2017-10-10 22:52:11.777116|2017-10-10 22:52:11.777116
NCT02567357|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-09-26|||January 2015||2015-01-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|PREDICTORS||Parents Resources for Decreasing the Incidence of Change Triggered Temper Outbursts|PREDICTORS (Parents Resources for Decreasing the Incidence of Change Triggered Temper Outbursts)|Active, not recruiting||Phase 1|80|Anticipated|Queen's University, Belfast||2|||f||||f||||||||Undecided||2017-10-10 22:52:11.981277|2017-10-10 22:52:11.981277
NCT02567344|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-05-04|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Excitatory rTMS to the Left Dorsolateral Pre-Frontal Cortex to Reduce Cannabis-Cue Induced Craving|A Double Blind, Sham Controlled Trial of Excitatory rTMS to the Left Dorsolateral Pre-Frontal Cortex to Reduce Cannabis-Cue Induced Craving and Impulsive Decision Making in Cannabis Use Disordered Participants.|Completed||N/A|18|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-10 22:52:12.087971|2017-10-10 22:52:12.087971
NCT02567331|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-11-01|||October 2004||2004-10-01|November 2016|2016-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer|An Open-label Study of the Safety, Tolerability, and Response Rate of Xeloda in Treatment-naïve Patients With Metastatic Colorectal Cancer|Completed||Phase 4|28|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:52:12.165478|2017-10-10 22:52:12.165478
NCT02567318|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-12-15|||October 2015||2015-10-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Is the Volume of the Caudate Nuclei Associated With Area of Secondary Hyperalgesia?|Is the Volume of the Caudate Nuclei Associated With Area of Secondary Hyperalgesia? - A Study of Healthy Volunteers|Completed||N/A|120|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-10 22:52:12.255122|2017-10-10 22:52:12.255122
NCT02567305|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-06-22|||September 2015||2015-09-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063)|Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063)|Recruiting||N/A|200|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f||||||Samples With DNA|"     50ul Blood during routine blood sampling   "|||2017-10-10 22:52:12.342939|2017-10-10 22:52:12.342939
NCT02567292|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-10-12|||May 2015||2015-05-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Breast Milk and Congenital Gastrointestinal Disorders|Effects of an All Breast Milk Diet on Enteral Feeding Outcomes of Neonates With Congenital Gastrointestinal Disorders|Recruiting||N/A|100|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 22:52:12.441018|2017-10-10 22:52:12.441018
NCT02567279|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-12-06|||June 2016||2016-06-01|December 2016|2016-12-01|October 2020|Anticipated|2020-10-01|August 2018|Anticipated|2018-08-01||Interventional|DIBLAN||Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa|Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa|Recruiting||Phase 3|84|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||No||2017-10-10 22:52:12.540019|2017-10-10 22:52:12.540019
NCT02567266|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-06-05|||January 2016||2016-01-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|COMET||Community Study of Outcome Monitoring for Emotional Disorders in Teens|Community Study of Outcome Monitoring for Emotional Disorders in Teens|Recruiting||N/A|222|Anticipated|University of Miami||3|||f||||t||||||||||2017-10-10 22:52:12.651859|2017-10-10 22:52:12.651859
NCT02567253|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-04-14|||March 2016||2016-03-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|OvIP1||Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer|Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer: A Randomized Phase II Trial|Recruiting||Phase 2|48|Anticipated|University Hospital, Ghent||4|||f||||t||||||||||2017-10-10 22:52:12.753896|2017-10-10 22:52:12.753896
NCT02567214|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-08-29|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|RED||Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD|Indacaterol 110µg/ Glycopyrronium 50µg (Ultibro®) Versus Tiotropium (Spiriva®) Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD|Recruiting||Phase 4|40|Anticipated|Laval University||2|||f||||f||||||||Undecided||2017-10-10 22:52:13.131999|2017-10-10 22:52:13.131999
NCT02567201|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-12-23|||October 2015||2015-10-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|EVA||Electrophysiological Evaluation of Voluntary Attention||Recruiting||N/A|360|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:52:13.288867|2017-10-10 22:52:13.288867
NCT02567188|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-01-14|2015-11-02||April 2009||2009-04-01|January 2016|2016-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational||All enrolled participants with available data for baseline characteristics.|A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis||Completed||N/A|144|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:52:13.868933|2017-10-10 22:52:13.868933
NCT02567175|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2016-10-18||||||October 2016|2016-10-01||||||||Expanded Access|||Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders|Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders|Available||N/A|||Children's Hospital of Philadelphia|||||||||||||||||||2017-10-10 22:52:14.56188|2017-10-10 22:52:14.56188
NCT02567162|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-12-08|||November 2015||2015-11-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01|90 Days|Observational [Patient Registry]|MNEMONICH||Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage|Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage (MNEMONICH)|Completed||N/A|40|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-10-10 22:52:14.642582|2017-10-10 22:52:14.642582
NCT02567149|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-06-28|||June 2016||2016-06-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.|Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.|Withdrawn||Phase 2|0|Actual|University of Minnesota - Clinical and Translational Science Institute||1||No funding|f||||t|t|f||||||No||2017-10-10 22:52:14.748123|2017-10-10 22:52:14.748123
NCT02567136|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-06-15|||September 2015||2015-09-01|June 2017|2017-06-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Observational|||Imaging Biomarkers in ALS|A Longitudinal Study of Imaging Biomarkers in Amyotrophic Lateral Sclerosis (ALS)|Active, not recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-10 22:52:14.854861|2017-10-10 22:52:14.854861
NCT02567123|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-09-30|||November 2014||2014-11-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Running Study for Runners With Chronic Knee Pain|The Effects of Gait Retraining in Runners With Patellofemoral Pain: A Randomized Trial|Completed||N/A|21|Actual|University of New Mexico||2|||f||||||||||||||2017-10-10 22:52:14.939532|2017-10-10 22:52:14.939532
NCT02567110|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-08-22|||July 2016||2016-07-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Magnetic Resonance Spectroscopy (MRS) in Midlife Depression|Inflammation-Induced Central Nervous System (CNS) Glutamate as a Function of Depression in Middle Age|Recruiting||N/A|145|Anticipated|Emory University|||2||f||||t||||||Samples With DNA|"     inflammatory gene expression studies, APOE4 genotyping   "|||2017-10-10 22:52:15.051135|2017-10-10 22:52:15.051135
NCT02567097|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-11-16|||January 2016||2016-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating Specific Plans to Increase Smoking Quit Attempts in Prison|The Role of Self-Incentives in Smoking Cessation: A Randomised Controlled Trial Within a Local Prison|Recruiting||N/A|159|Anticipated|University of Manchester||4|||f||||f||||||||||2017-10-10 22:52:15.172116|2017-10-10 22:52:15.172116
NCT02567084|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-01|||February 2011||2011-02-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|BRBBT||Complete Twelve Month Bone Remodeling With a Bi-phasic Injectable Bone Substitute in Benign Bone Tumors|"A Prospective, Longitudinal Patient Study on CERAMENT™|BONE VOID FILLER in Benign Bone Tumors"|Completed||N/A|14|Actual|Poznan University of Medical Sciences||1|||f||||t||||||||||2017-10-10 22:52:15.271657|2017-10-10 22:52:15.271657
NCT02567071|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-30|||September 2015||2015-09-01|September 2015|2015-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|RESTORE||Natural Microbiota Restoration After C-section Birth|Retablissement Du Microbiote Naturel Apres Naissance Par Cesarienne|Not yet recruiting||N/A|225|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||f||||||||||2017-10-10 22:52:15.384827|2017-10-10 22:52:15.384827
NCT02567058|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-09-30|||December 2012||2012-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|MEDUSAA||Biomechanical and Ultrasonic Assessment of the Achilles Tendon in Vivo (MEDUSAA)|Biomechanical and Ultrasonic Assessment of the Achilles Tendon in Vivo (MEDUSAA)|Completed||N/A|62|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 22:52:15.49909|2017-10-10 22:52:15.49909
NCT02567045|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-03-06|||February 25, 2016|Actual|2016-02-25|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Uptake to Colorectal Cancer Screening in Familial-risk Population|Uptake to Colorectal Cancer Screening in Familiar-risk Population: A Randomized Controlled Trial Comparing Immunochemical Fecal Occult Blood Test With Colonoscopy|Recruiting||N/A|1076|Anticipated|Hospital Universitario de Canarias||2|||f||||f||||||||||2017-10-10 22:52:15.591941|2017-10-10 22:52:15.591941
NCT02567032|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-05-20|||October 2010||2010-10-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Interventional|ASO-Behavioral||Adult Study Oxytocin - Behavioral|Mechanisms and Effects of Oxytocin on Social Cognition in Schizophrenia - Behavioral|Recruiting||Early Phase 1|200|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:52:15.925673|2017-10-10 22:52:15.925673
NCT02567019|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-07-06|||December 2015||2015-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Immunoregulation of Periodontal Diseases|Immunoregulation of Periodontal Diseases|Recruiting||N/A|50|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:52:16.054677|2017-10-10 22:52:16.054677
NCT02567006|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-07-17|||March 2016||2016-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|SMSVaxGuate||SMS Mobile Technology to Improve Early Childhood Vaccine Coverage in Guatemala|SMS Mobile Technology to Improve Early Childhood Vaccine Coverage in Guatemala|Active, not recruiting||N/A|720|Actual|University of Colorado, Denver||2|||f||||f|f|f||||||||2017-10-10 22:52:16.16998|2017-10-10 22:52:16.16998
NCT02566993|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-10-05|||July 2016||2016-07-01|January 2017|2017-01-01||||June 2019|Anticipated|2019-06-01||Interventional|ATLANTIS||Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) Versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer|Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) Versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS Trial)|Recruiting||Phase 3|600|Anticipated|PharmaMar||3|||f||||||||||||||2017-10-10 22:52:16.328196|2017-10-10 22:52:16.328196
NCT02566980|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-04-05|||August 2014||2014-08-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Biological Triggers of Depression in Pregnancy|The Role of Kynurenine Pathway Metabolites in Perinatal Depression and Suicidality|Active, not recruiting||N/A|200|Anticipated|Michigan State University|||2||f||||t||||||Samples With DNA|"     Adult Blood Cord Blood Placenta   "|No||2017-10-10 22:52:16.926713|2017-10-10 22:52:16.926713
NCT02566967|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-01-23|||May 2015|Actual|2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective|An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve LDA or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective When Treating to Target|Active, not recruiting||Phase 3|20|Anticipated|Arthritis & Rheumatic Disease Specialties Research||1|||f||||f||||||||||2017-10-10 22:52:17.11027|2017-10-10 22:52:17.11027
NCT02566954|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-09-30|||May 2014||2014-05-01|September 2015|2015-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|MI3DEOS||3 Dimensional Study of Lower Limbs and Feet of Children in Standing Position|3 Dimensional Study of Lower Limbs and Feet of Children in Standing Position|Unknown status|Recruiting|Phase 1/Phase 2|300|Anticipated|Fondation Lenval||1|||f||||f||||||||||2017-10-10 22:52:17.226652|2017-10-10 22:52:17.226652
NCT02566941|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-11-15|||October 2015||2015-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Neuromuscular Electrical Stimulation in the Critically Ill|Neuromuscular Electrical Stimulation in the Critically Ill|Recruiting||N/A|100|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:52:17.35987|2017-10-10 22:52:17.35987
NCT02566928|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-07-18|||October 2015||2015-10-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|November 2018|Anticipated|2018-11-01||Interventional|CAMP-2||Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence|Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence|Recruiting||Phase 4|278|Anticipated|Clinical Directors Network||2|||f||||t|t|f||||||||2017-10-10 22:52:17.493396|2017-10-10 22:52:17.493396
NCT02566915|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-02-22|||August 2015||2015-08-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of Exhalation Valve on the Lack of Air and Exercise Tolerance in Patients With COPD|Effects of Expiratory Positive Airway Pressure on Dyspnea and Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease|Enrolling by invitation||N/A|19|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:52:17.639317|2017-10-10 22:52:17.639317
NCT02566902|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-04-25|||October 2015||2015-10-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma|Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma|Recruiting||N/A|213|Anticipated|Seton Healthcare Family||2|||f||||f||||||||No||2017-10-10 22:52:17.735598|2017-10-10 22:52:17.735598
NCT02566889|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-09-21|||November 12, 2015|Actual|2015-11-12|September 2017|2017-09-01|August 6, 2030|Anticipated|2030-08-06|August 6, 2019|Anticipated|2019-08-06||Interventional|ADAPT||An Efficacy and Safety Study of Infliximab in Pediatric Participants With Inflammatory Bowel Disease|A Phase 4, Multicenter, Open-label Study of Serum Infliximab Concentrations and Efficacy and Safety of Dose Escalation in Pediatric Patients With Inflammatory Bowel Disease|Recruiting||Phase 4|130|Anticipated|Janssen Scientific Affairs, LLC||2|||f||||t||f||||||||2017-10-10 22:52:17.896323|2017-10-10 22:52:17.896323
NCT02566876|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-10-01|||December 2013||2013-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Bifidobacteria In Children With Abdominal Pain-Associated Functional Gastrointestinal Disorders|A Multicentre, Randomised, Double-Blind, Placebo Controlled, Crossover Trial On The Efficacy Of A Mixture Of Three Bifidobacteria In Children With Abdominal Pain-Associated Functional Gastrointestinal Disorders|Completed||Phase 4|73|Actual|Federico II University||2|||f||||t||||||||||2017-10-10 22:52:18.124202|2017-10-10 22:52:18.124202
NCT02566863|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-03-21|||June 2015||2015-06-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Haemodynamic Effect of Dexmedetomidine|Haemodynamic Effect of Dexmedetomidine in Relation to Autonomic System Activity|Recruiting||Phase 4|50|Anticipated|Medical University of Gdansk||1|||f||||f||||||||||2017-10-10 22:52:18.215989|2017-10-10 22:52:18.215989
NCT02566850|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-06-09|||January 2014||2014-01-01|September 2015|2015-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Investigational Study of the Ekso Bionics Powered Exoskeleton for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment|Investigational Study of the Ekso Bionics Powered Exoskeleton for High-Dosage Use by Individuals With Spinal Cord Injury in a Non-Clinical Environment|Enrolling by invitation||N/A|12|Anticipated|Ekso Bionics||1|||f||||f||||||||||2017-10-10 22:52:18.319939|2017-10-10 22:52:18.319939
NCT02566837|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-09-30|||February 2012||2012-02-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TOXINECHO||Use of Ultrasound in Injections of Botulinum Toxin|Ultrasound Guidance to Alleviate the Pain Associated With Intramuscular Injections of Botulinum Toxin in Spastic Patients|Completed||N/A|124|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 22:52:18.424291|2017-10-10 22:52:18.424291
NCT02566824|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-09-18|||October 2010||2010-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|August 2020|Anticipated|2020-08-01||Interventional|||Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder|A Cognitive Behavioral Therapy Group Intervention for Adolescents With Attention-Deficit / Hyperactivity Disorder|Recruiting||Phase 4|216|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-10-10 22:52:18.526835|2017-10-10 22:52:18.526835
NCT02566811|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-04-27|||April 12, 2017|Actual|2017-04-12|April 2017|2017-04-01|April 12, 2026|Anticipated|2026-04-12|April 12, 2026|Anticipated|2026-04-12||Interventional|STATEC||Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)|A Randomised Trial of Non-selective Versus Selective Adjuvant Therapy in High Risk Apparent Stage 1 Endometrial Cancer|Recruiting||N/A|2000|Anticipated|University College, London||2|||f||||t|f|f||||||No||2017-10-10 22:52:18.65869|2017-10-10 22:52:18.65869
NCT02566798|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-05-19|||December 2015||2015-12-01|September 2015|2015-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|OléograpeSEED||Anti-inflammatory Effect of Serum of Osteoarthritis Patients After Administration of the Oléogrape®SEED, an Extract of Grape and Olive|Anti-inflammatory Effect of Serum of Osteoarthritis Patients After Administration of the Oléogrape®SEED, an Extract of Grape and Olive|Completed||N/A|12|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-10 22:52:18.75174|2017-10-10 22:52:18.75174
NCT02566772|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-08-01|||March 2016||2016-03-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer|A Phase 1, Open-Label, Non-Randomized, Safety, Tolerability and Pharmacokinetic Study of TAS3681 in Patients With Metastatic Castration Resistant Prostate Cancer|Recruiting||Phase 1|130|Anticipated|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-10-10 22:52:18.885928|2017-10-10 22:52:18.885928
NCT02566746|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-03-31|||June 20, 2016|Actual|2016-06-20|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|ConstiCAPE||Contribution of Percutaneous Endoscopic Caecostomie in the Management of Severe Constipation Refractory to Medical Treatment||Recruiting||N/A|60|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-10 22:52:19.088517|2017-10-10 22:52:19.088517
NCT02566733|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-10-18|||October 2015||2015-10-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass|Performance of the Minto Model in Effect Site Mode for Target Controlled Infusion of Remifentanil During Cardiopulmonary Bypass|Completed||Phase 4|56|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:52:19.185139|2017-10-10 22:52:19.185139
NCT02566720|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-12-10|||January 2016||2016-01-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study|Mechanism of Amantadine and Functional Improvement Following Acquired Brain Injury as Measured by MRI Tractography; A Pilot Study|Not yet recruiting||N/A|10|Anticipated|Hamilton Health Sciences Corporation||1|||f||||f||||||||||2017-10-10 22:52:19.263637|2017-10-10 22:52:19.263637
NCT02566707|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-03-30|||August 2015||2015-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PRADAII||Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance Regimen|Pharmacokinetics, Safety and Efficacy of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance Regimen in Patients With Intolerance and/or Resistance to NRTIs, NNRTIs and RTV: A Pilot Study|Terminated||Phase 2|9|Actual|Radboud University||1||due to introduction of another integrase inhibitor, recruitement was not feasible anymore.|f||||f||||||||||2017-10-10 22:52:19.353484|2017-10-10 22:52:19.353484
NCT02566694|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-04-11|||March 2015||2015-03-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Observational|||Analysis of Specimens From Patients With Orthopaedic Implants|Analysis of Specimens From Patients With Orthopaedic Implants|Recruiting||N/A|200|Anticipated|Royal National Orthopaedic Hospital NHS Trust|||2||f||||f||||||Samples Without DNA|"     Periprosthetic tissue samples   "|||2017-10-10 22:52:19.438997|2017-10-10 22:52:19.438997
NCT02566681|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-03-29|||September 2015||2015-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MSC/ONM||Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis|Phase I Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis (MSC/ONM)|Recruiting||Phase 1|10|Anticipated|Red de Terapia Celular||1|||f||||t||||||||||2017-10-10 22:52:19.64649|2017-10-10 22:52:19.64649
NCT02566668|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-02-27|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Observational|||Immune Interactions in Severe Asthma|Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma|Recruiting||N/A|120|Anticipated|University of Pittsburgh|||2||f||||f||||||Samples With DNA|"     Blood - total and specific Immunoglobulin E (IgE); complete blood count; plasma and serum;     Deoxyribonucleic Acid (DNA); peripheral blood mononuclear cells (PBMC) Endobronchial biopsy     Endobronchial brushings Pulmonary Lavage Exhaled Breath Condensate (EBC)   "|||2017-10-10 22:52:19.7817|2017-10-10 22:52:19.7817
NCT02566655|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-06-01|||September 2015||2015-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CSM/OP/2011||Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis|Phase I Clinical Trial To Evaluate The Intravenous Infusion Of Autologous Fucosylated Bone Marrow Mesenchymal Cells Therapy In Patients With Established Osteoporosis and Low Impact Fractures|Recruiting||Phase 1|10|Anticipated|Red de Terapia Celular||1|||f||||t||||||||||2017-10-10 22:52:19.895586|2017-10-10 22:52:19.895586
NCT02566642|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-08-10|||October 2014||2014-10-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Understanding the Role of the Anesthesiologist|Patients Preoperative Understanding of the Role of the Anesthesiologist|Completed||N/A|200|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||No||2017-10-10 22:52:20.067483|2017-10-10 22:52:20.067483
NCT02566629|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-01|||July 2015||2015-07-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase|Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase|Unknown status|Recruiting|N/A|30|Anticipated|Shandong University|||3||f||||t||||||Samples With DNA|"     extract 16S rDNA from fecal microflora   "|||2017-10-10 22:52:20.145975|2017-10-10 22:52:20.145975
NCT02566616|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-04-03|||November 2015||2015-11-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|ESTIM||Electrical Nerve Stimulation of the Ulnar Nerve|Electrical Nerve Stimulation of the Ulnar Nerve During Cubital Tunnel Decompression Surgery: Does it Improve Long Term Functional Outcomes?|Withdrawn||N/A|0|Actual|University of Chicago||2||No participants enrolled|f||||t||||||||||2017-10-10 22:52:20.242529|2017-10-10 22:52:20.242529
NCT02566603|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-26|||November 2015||2015-11-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP|A Phase 1b Open-Label, Dose Escalation Study of PRTX-100 in Adult Patients With Persistent/Chronic Immune Thrombocytopenia|Recruiting||Phase 1/Phase 2|30|Anticipated|Protalex, Inc.||1|||f||||t||||||||||2017-10-10 22:52:20.339283|2017-10-10 22:52:20.339283
NCT02566590|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-05-01|||January 2015||2015-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Preventing the Loss of Muscle and Function in Hospitalized Older Adults|Preventing the Loss of Muscle and Function in Hospitalized Older Adults|Completed||N/A|20|Actual|University of Utah||2|||f||||t||||||||No||2017-10-10 22:52:20.539413|2017-10-10 22:52:20.539413
NCT02566577|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-04-10|||July 2013||2013-07-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Physiologic Effects of RBC Transfusion|Physiologic Effects of RBC Storage in Chronic Transfusion Recipients: Vasoreactivity, Exercise Capacity, and Oxygen Consumption|Enrolling by invitation||Phase 4|30|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 22:52:20.632946|2017-10-10 22:52:20.632946
NCT02566564|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-08-28|||April 2016||2016-04-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Intra-articular Lopain (MTX-071) Phase I/IIa Study in Chronic Osteoarthritic Knee Joint Pain|An Open Label, Single Dose, Dose-escalating Phase I/IIa Study to Determine the Safety and Clinical Effects of Intra-articular Injections of Lopain (MTX-071) in Patients With Chronic Osteoarthritic Knee Joint Pain|Completed||Phase 1|23|Actual|Mestex AG||1|||f||||t||||||||||2017-10-10 22:52:20.738722|2017-10-10 22:52:20.738722
NCT02566551|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-02|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment.|Prospective Controlled Randomized Study of Prostatic Arteries Embolization (PAE) vs Transurethral Resection of the Prostate (TURP) for Benign Prostatic Hyperplasia (BPH) Treatment.|Recruiting||N/A|100|Anticipated|Group of Research in Minimally Invasive Techniques||2|||f||||t||||||||||2017-10-10 22:52:20.877602|2017-10-10 22:52:20.877602
NCT02566538|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-08-16|||May 2013||2013-05-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Observational|MLP||Prospective Population Based Cohort Study on Cognitive and Cardiovascular Aging (MonaLisaPredor)|Prospective Population Based Cohort Study on Cognitive and Cardiovascular Aging|Recruiting||N/A|1500|Anticipated|University Hospital, Toulouse|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 22:52:20.997885|2017-10-10 22:52:20.997885
NCT02566525|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-05|||November 2015||2015-11-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|REFRESH||CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery|CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery|Completed||N/A|52|Actual|CytoSorbents, Inc||2|||f||||t||||||||||2017-10-10 22:52:21.108796|2017-10-10 22:52:21.108796
NCT02566512|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-05-01|||September 2015||2015-09-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Assessment of Cough Strength in Patients With Tracheostomies|Assessment of Cough Strength in Patients With Tracheostomies|Recruiting||N/A|20|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-10 22:52:21.21875|2017-10-10 22:52:21.21875
NCT02566499|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-05-02|||October 1, 2017|Anticipated|2017-10-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Performance Assessment of a First Generation Breast Microwave Imaging System: Study of Breast Abnormalities Detection|Performance Assessment of a First Generation Breast Microwave Imaging System: Study of Breast Abnormalities Detection|Not yet recruiting||N/A|14|Anticipated|University of Manitoba||1|||f||||f|f|f||||||No||2017-10-10 22:52:21.329602|2017-10-10 22:52:21.329602
NCT02566486|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-10-01|||November 2013||2013-11-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|||Postoperative Pain Intensity After Using Different Instrumentation Techniques: a Randomized Clinical Study|Postoperative Pain Intensity After Using Different Instrumentation Techniques: a Randomized Clinical Study|Completed||N/A|90|Actual|Bulent Ecevit University||2|||f||||t||||||||||2017-10-10 22:52:21.412298|2017-10-10 22:52:21.412298
NCT02566473|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-10-26|||April 2011||2011-04-01|October 2016|2016-10-01|April 2031|Anticipated|2031-04-01|April 2031|Anticipated|2031-04-01|20 Years|Observational [Patient Registry]|FORCE-TJR||FORCE-TJR: Improving Orthopedic Outcomes Through a National TJR Registry|Improving Orthopedic Outcomes Through a National TJR Registry|Recruiting||N/A|30000|Anticipated|University of Massachusetts, Worcester|||1||f||||f||||||||||2017-10-10 22:52:21.511292|2017-10-10 22:52:21.511292
NCT02566460|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2016-04-30|||January 2013||2013-01-01|February 2016|2016-02-01||||December 2014|Actual|2014-12-01||Interventional|||The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock||Completed||N/A|360|Actual|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 22:52:21.636494|2017-10-10 22:52:21.636494
NCT02566447|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-09-30|||October 2015||2015-10-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||"Solana™ Trichomonas Assay Field Study"|"Solana™ Trichomonas Assay Field Study"|Unknown status|Not yet recruiting|N/A|1000|Anticipated|Quidel Corporation|||1||f||||f||||||Samples With DNA|"     Trichomonas vaginalis in vaginal swabs and urine samples   "|||2017-10-10 22:52:21.713962|2017-10-10 22:52:21.713962
NCT02566421|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-05-25|||October 2015||2015-10-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery|Precision Medicine for Patients With Malignancy at the Comprehensive Cancer Center of Wake Forest University|Suspended||N/A|300|Anticipated|Wake Forest University Health Sciences||1||Assessing Feasibility|f||||f|f|f||||||||2017-10-10 22:52:21.896023|2017-10-10 22:52:21.896023
NCT02566408|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-02-23|||October 2015||2015-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity|Attitudes, Beliefs and Preferences of Older Breast Cancer Survivors Towards Physical Activity|Active, not recruiting||N/A|61|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 22:52:22.00819|2017-10-10 22:52:22.00819
NCT02566395|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-01-03|||December 2014||2014-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies|A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies|Recruiting||Phase 3|10|Anticipated|Northwell Health||1|||f||||f||||||||||2017-10-10 22:52:22.096195|2017-10-10 22:52:22.096195
NCT02566382|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-10-01|||September 2015||2015-09-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|DESEP||Preliminary Study of Feasibility of Arthrodesis Scapula-humeral Under Arthroscopy|Arthrodesis Gleno Humeral Under Arthroscopy in the Sequelae of Plexus Brachial Evaluation of the Technical Feasibility|Recruiting||N/A|15|Anticipated|University Hospital, Brest||1|||f||||f||||||||||2017-10-10 22:52:22.216845|2017-10-10 22:52:22.216845
NCT02566369|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-08-31|||November 30, 2015|Actual|2015-11-30|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy and Safety of CD5789 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris|A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris|Active, not recruiting||Phase 3|1200|Anticipated|Galderma R&D||2|||f||||f||||||||||2017-10-10 22:52:22.308809|2017-10-10 22:52:22.308809
NCT02566356|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-05-20|||September 2012||2012-09-01|May 2016|2016-05-01||||August 2016|Anticipated|2016-08-01||Interventional|ASO-fMRI||Adult Study Oxytocin - fMRI|Mechanisms and Effects of Oxytocin on Social Cognition in Schizophrenia - fMRI|Recruiting||Early Phase 1|72|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:52:22.640657|2017-10-10 22:52:22.640657
NCT02566343|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-11-16|||November 2014||2014-11-01|June 2016|2016-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|PredicT||Preoperative Diagnostic Tests for Pulmonary Risk Assessment in COPD|Preoperative Diagnostic Tests for Pulmonary Risk Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Undergoing Major Surgery|Completed||N/A|365|Actual|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f||||||||No||2017-10-10 22:52:22.748693|2017-10-10 22:52:22.748693
NCT02566330|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-07-07|||October 2015||2015-10-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||The EndoBarrier Device: A 3-year Follow up Study|The Effect of the EndoBarrier Device: A 3-year Follow up of a Randomized Clinical Trial|Completed||Phase 2|10|Actual|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-10 22:52:22.824651|2017-10-10 22:52:22.824651
NCT02566317|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-01-24|||January 15, 2016|Actual|2016-01-15|January 2017|2017-01-01|December 15, 2018|Anticipated|2018-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Stand & Move at Work|Stand & Move at Work: A Group Randomized Trial|Recruiting||N/A|720|Anticipated|Arizona State University||2|||f||||t|f|f||||||Undecided||2017-10-10 22:52:22.912503|2017-10-10 22:52:22.912503
NCT02566304|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-10-18|||November 2015||2015-11-01|October 2016|2016-10-01||||September 2020|Anticipated|2020-09-01||Interventional|||Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies|A Two Step Approach to Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies|Recruiting||Phase 2|30|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 22:52:24.822586|2017-10-10 22:52:24.822586
NCT02566291|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-01-22|||January 2015||2015-01-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|OSSGA||Observational Study With Investigation of Two Second Generation Laryngeal Masks|Supraglottic Airways LMA Supreme and Ambu AuraGain in Clinical Practice: a Prospective Observational Study|Completed||N/A|364|Actual|Johannes Gutenberg University Mainz|||2||f||||f||||||||No||2017-10-10 22:52:25.007376|2017-10-10 22:52:25.007376
NCT02566278|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2017-08-16|||October 20, 2015|Actual|2015-10-20|August 2017|2017-08-01|July 25, 2016|Actual|2016-07-25|July 25, 2016|Actual|2016-07-25||Interventional|||Determination of Upper Airway Collapsibility During Routine CPAP Titration|Determination of Upper Airway Collapsibility During Routine CPAP Titration|Terminated||N/A|20|Anticipated|University of California, San Diego||1||Data collection has been completed for the study. We are not recruiting any more subjects.|f||||f||||||||||2017-10-10 22:52:25.144628|2017-10-10 22:52:25.144628
NCT02566265|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-09-07|||September 2015||2015-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SHIVERING 2||Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients|Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients (SHIVERING 2)|Active, not recruiting||Phase 2|123|Actual|Yale University||2|||f||||f||||||||||2017-10-10 22:52:25.24088|2017-10-10 22:52:25.24088
NCT02566252|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-08-08|||July 2015||2015-07-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)|A Randomized, Open-label, Crossover Study to Assess the Safety, Tolerability, and Pharmacodynamics of PUL-042 Inhalation Solution in Healthy Subjects and the Effect of Pretreatment With Cromolyn Sodium or Albuterol Sulfate|Completed||Phase 1|16|Actual|Pulmotect, Inc.||3|||f||||f||||||||||2017-10-10 22:52:25.337263|2017-10-10 22:52:25.337263
NCT02566239|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-09-20|||March 2014||2014-03-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|AIMs||Ambient Independence Measures for Guiding Care Transitions|Ambient Independence Measures for Guiding Care Transitions|Active, not recruiting||N/A|96|Actual|Oregon Health and Science University||2|||f||||f||||||||Yes||2017-10-10 22:52:25.46825|2017-10-10 22:52:25.46825
NCT02566226|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-06-23|||November 2015||2015-11-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Impact of Intrathecal Morphine on Sleep Apnea Syndrome|Impact of Intrathecal Morphine on Sleep Apnea Syndrome After Hip Arthroplasty Performed Under Spinal Anaesthesia|Recruiting||Phase 4|60|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 22:52:25.573797|2017-10-10 22:52:25.573797
NCT02566213|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-09-30|||October 2010||2010-10-01|September 2015|2015-09-01||||December 2016|Anticipated|2016-12-01||Interventional|FINESKILL||Human Fine-motor-skills in Weightlessness: Comparison of a Laboratory and an Everyday-like Context|Human Fine-motor-skills in Weightlessness: Comparison of a Laboratory and an Everyday-like Context|Unknown status|Recruiting|N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 22:52:25.727854|2017-10-10 22:52:25.727854
NCT02566200|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-02-23|||October 2015||2015-10-01|February 2016|2016-02-01|October 2027|Anticipated|2027-10-01|May 2017|Anticipated|2017-05-01|10 Years|Observational [Patient Registry]|FASTMI2015||French Registry of Acute ST-elevation or Non-ST-elevation Myocardial Infarction 2015|French Registry of Acute ST-elevation or Non-ST-elevation Myocardial Infarction 2015|Active, not recruiting||N/A|5000|Actual|French Cardiology Society|||1||f||||f||||||Samples With DNA|"     -  blood samples for genotyping and serum banking        -  faeces samples for genetic analysis of microbiota   "|||2017-10-10 22:52:25.859549|2017-10-10 22:52:25.859549
NCT02566187|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-02-23|||August 2015||2015-08-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet||Completed||Phase 1|99|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-10 22:52:25.97348|2017-10-10 22:52:25.97348
NCT02566174|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-08-25|||September 25, 2015||2015-09-25|August 24, 2017|2017-08-24|August 24, 2017|Actual|2017-08-24|August 24, 2017|Actual|2017-08-24||Observational|||Family Caregiving Role Adjustment and Dyadic Mutuality|Family Caregiving Role Adjustment and Dyadic Mutuality: A Mixed Methods Study|Completed||N/A|240|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:52:26.198734|2017-10-10 22:52:26.198734
NCT02566161|ClinicalTrials.gov processed this data on October 10, 2017|2015-10-01|2017-09-12|||September 15, 2015||2015-09-15|August 21, 2017|2017-08-21|March 1, 2019|Anticipated|2019-03-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Parental Irradiation of Ukrainian Cleanup Workers and Evacuees and Germline Mutations in Their Offspring (Trio Study)|Parental Irradiation of Ukrainian Cleanup Workers and Evacuees and Germline Mutations in Their Offspring (Trio Study)|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:52:26.319926|2017-10-10 22:52:26.319926
NCT02566148|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-05-12|||February 2012||2012-02-01|May 2017|2017-05-01|May 2013|Actual|2013-05-01|February 2012|Actual|2012-02-01||Observational|PARCOURS||Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France|Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France|Completed||N/A|2468|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||3||f||||f||||||||||2017-10-10 22:52:26.413731|2017-10-10 22:52:26.413731
NCT02566122|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-09-07|||January 2014||2014-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Establishment of Normal Muscle Strength for French Population|Establishment of Normal Muscle Strength Measured by Hand-held Dynamometer and Muscle Mass Assessed by Ultrasonography for French Population|Recruiting||N/A|320|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 22:52:26.70352|2017-10-10 22:52:26.70352
NCT02566109|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-11|||March 2016||2016-03-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|CHI||Community Hospital Identification of High CV Risk Patients During Cancer Treatment|Community Hospital Identification of High CV Risk Patients During Cancer|Active, not recruiting||N/A|30|Anticipated|Wake Forest University Health Sciences||1|||f||||t|f|f||||||||2017-10-10 22:52:26.831737|2017-10-10 22:52:26.831737
NCT02566096|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-07-14|||September 2015||2015-09-01|March 2016|2016-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine Postoperatively|Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine in Patients Undergoing Major Abdominal Cancer Surgery|Completed||Phase 4|60|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 22:52:26.933575|2017-10-10 22:52:26.933575
NCT02566083|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-06-26|||October 2015||2015-10-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Post-Approval Study of the Tecnis® Toric IOL|Post-Approval Study of the Tecnis® Toric IOL, Models ZCT300 and ZCT400|Recruiting||N/A|435|Anticipated|Abbott Medical Optics||2|||f||||f||||||||||2017-10-10 22:52:27.097184|2017-10-10 22:52:27.097184
NCT02566070|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-10-14|||November 2015||2015-11-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|COBO2||COntinuous vs BOlus Nasogastric Feeding in Mechanically Ventilated Pediatric Patients 2|COntinuous vs BOlus Nasogastric Feeding in Mechanically Ventilated Pediatric Patients 2|Recruiting||N/A|860|Anticipated|Akron Children's Hospital||2|||f||||t||||||||||2017-10-10 22:52:27.225864|2017-10-10 22:52:27.225864
NCT02566057|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-07-31|||July 10, 2014|Actual|2014-07-10|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis|Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis|Active, not recruiting||N/A|100|Anticipated|Northwell Health||2|||f||||f||||||||||2017-10-10 22:52:27.38149|2017-10-10 22:52:27.38149
NCT02566044|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-05-12|||July 25, 2017|Anticipated|2017-07-25|May 2017|2017-05-01|July 11, 2019|Anticipated|2019-07-11|July 11, 2019|Anticipated|2019-07-11||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Inhaled QBW276 in Patients With Cystic Fibrosis|Not yet recruiting||Phase 1/Phase 2|56|Anticipated|Novartis||2|||f||||t|f|f||||||||2017-10-10 22:52:27.485904|2017-10-10 22:52:27.485904
NCT02566031|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-04-27|||January 23, 2016|Actual|2016-01-23|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients|A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients|Recruiting||Phase 4|404|Anticipated|Novartis||2|||f|||||f|f||||||||2017-10-10 22:52:27.607958|2017-10-10 22:52:27.607958
NCT02566018|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-01-23|||May 2015||2015-05-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|prox_hum||Treatment of Proximal Humerus Fractures in the Elderly|Treatment Options for Proximal Humerus Fractures in the Elderly and Their Implication on Personal Independence|Recruiting||N/A|166|Anticipated|University Hospital, Basel, Switzerland|||2||f||||f||||||||||2017-10-10 22:52:27.758441|2017-10-10 22:52:27.758441
NCT02566005|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-08-31|||September 2015||2015-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor|A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor|Completed||N/A|200|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||t||||||||||2017-10-10 22:52:27.860284|2017-10-10 22:52:27.860284
NCT02565992|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-18|||October 2015||2015-10-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|CAPRA||CAVATAK and PembRolizumab in Advanced Melanoma|Phase I Study of Intratumoral CAVATAK® (Coxsackievirus A21) and Pembrolizumab in Subjects With Advanced Melanoma|Recruiting||Phase 1|30|Anticipated|Viralytics||1|||f||||||||||||||2017-10-10 22:52:27.956294|2017-10-10 22:52:27.956294
NCT02565979|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-07|||April 2016||2016-04-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Long-term Resveratrol and Metabolism|Effects of Long-term Resveratrol Supplementation on Metabolic Health|Recruiting||N/A|58|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 22:52:28.052643|2017-10-10 22:52:28.052643
NCT02565966|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-07-12|||June 2014||2014-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Understanding the Mechanism(s) of Action on the Modified Atkins Diet for Epilepsy: Human Brain Tissues|Understanding the Mechanism(s) of Action on the Modified Atkins Diet for Epilepsy: Human Brain Tissues|Recruiting||N/A|30|Anticipated|New York University School of Medicine||2|||f||||||||||||||2017-10-10 22:52:28.153839|2017-10-10 22:52:28.153839
NCT02565953|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-09-20|||October 2015||2015-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|FISBAL||Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon||Recruiting||Phase 3|134|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||f||||||||||2017-10-10 22:52:28.260246|2017-10-10 22:52:28.260246
NCT02565940|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-09-30|||December 2014||2014-12-01|September 2015|2015-09-01||||December 2017|Anticipated|2017-12-01||Observational|||Study by Metagenomics and Culturomicsapproaches of Bacterial and Viral Flora of Diabetic Foot Infection||Recruiting||N/A|150||Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 22:52:28.534823|2017-10-10 22:52:28.534823
NCT02565927|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2015-09-29|||May 2015||2015-05-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||A Trail of a Novel Tracheal Radioactive Stent for the Malignant Airway Obstruction|A Novel Tracheal Radioactive Stent Loaded With 125I Seeds for the Malignant Airway Obstruction Versus a Conventional Stent: A Prospective Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|60|Anticipated|Zhongda Hospital||2|||f||||f||||||||||2017-10-10 22:52:28.685201|2017-10-10 22:52:28.685201
NCT02565914|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-09-11|||August 2015||2015-08-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation|A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation|Enrolling by invitation||Phase 3|1116|Anticipated|Vertex Pharmaceuticals Incorporated||3|||t||||t||||||||||2017-10-10 22:52:28.847012|2017-10-10 22:52:28.847012
NCT02565901|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-11-10|||February 2016||2016-02-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer|A Phase 1-2 Study of Sirolimus, Docetaxel and Carboplatin for Treatment of Patients With Metastatic, Castration Resistant Prostate Cancer: (Rapamycin Inhibition of DDSP [RID])|Recruiting||Phase 1/Phase 2|58|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 22:52:29.260069|2017-10-10 22:52:29.260069
NCT02565888|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-01-25|||November 2015||2015-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|DATE-4||A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat|A Drug-drug Interaction Study Between the Novel Anti-HCV Agent Daclatasvir and the Antiretroviral Agents Atazanavir/Ritonavir or Atazanavir/Cobicistat in Healthy Volunteers|Completed||Phase 1|16|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 22:52:29.415429|2017-10-10 22:52:29.415429
NCT02565875|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-02-09|||March 2016||2016-03-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|SLL||Standardizing Language in Laparoscopic Surgery|Does Standardizing Language in Laparoscopic Surgery Improve Efficiency? A Randomized Controlled Trial|Not yet recruiting||N/A|40|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||No|IPD will not be shared, but will be available upon request as it will not contain any identifying data on the participant as determined through our institution's IRB.|2017-10-10 22:52:29.554367|2017-10-10 22:52:29.554367
NCT02565862|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-04-06|||January 2016||2016-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|DATE-3||A Drug-drug Interaction Study Between Daclatasvir and Metformin|A Drug-drug Interaction Study Between the Novel Anti-hepatitis c Virus (HCV) Agent Daclatasvir and The Antidiabetic Agent Metformin in Healthy Volunteers|Completed||Phase 1|20|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 22:52:29.699485|2017-10-10 22:52:29.699485
NCT02565849|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2015-09-30|||February 2013||2013-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|SCA||Study of Ventilatory Mechanics in Patients With Sickle Cell Anemia|Early Detection of Changes in Ventilatory Mechanics in Patients With Sickle Cell Anemia|Completed||N/A|80|Actual|Rio de Janeiro State University|||3||f||||t||||||||||2017-10-10 22:52:29.821355|2017-10-10 22:52:29.821355
NCT02565836|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-10-11|||October 2015||2015-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|||Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed|Reversal of Warfarin-associated Major Hemorrhage: a Multicenter, Retrospective Cohort Study of Fixed-dose Activated (FEIBA VH) Versus Variable-dose Inactivated (Kcentra) Prothrombin Complex Concentrate|Enrolling by invitation||N/A|564|Anticipated|Rush University Medical Center|||2||f||||f||||||||||2017-10-10 22:52:29.912539|2017-10-10 22:52:29.912539
NCT02565823|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-04-19|||October 2015||2015-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue|Investigation of Exercise-Induced Myokines and Adipokines|Completed||N/A|12|Actual|Joslin Diabetes Center||1|||f||||f||||||||||2017-10-10 22:52:30.007319|2017-10-10 22:52:30.007319
NCT02565810|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-07-10|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis|An Open-labelled, Single-arm, Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis|Completed||Phase 2|49|Actual|Samsung Bioepis Co., Ltd.||1|||f||||f||||||||||2017-10-10 22:52:30.092359|2017-10-10 22:52:30.092359
NCT02565797|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-04-20|||November 2015||2015-11-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparative Prevention-effectiveness Trial of DabirAIR Overlay System|A Point-of-care, Pragmatic Comparative Prevention-effectiveness Trial of DabirAIR Alternating Pressure Overlay System to Reduce Hospital-acquired Pressure Ulcers in the Peri-operative Setting.|Recruiting||N/A|800|Anticipated|Dabir Surfaces Inc||3|||f||||f||||||||No|Aggregate data|2017-10-10 22:52:30.180482|2017-10-10 22:52:30.180482
NCT02565784|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-05-12|||December 2015||2015-12-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 29, 2016|Actual|2016-12-29||Interventional|||Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population|An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population|Active, not recruiting||Phase 4|100|Actual|Q-Med AB||1|||f||||f||||||||||2017-10-10 22:52:30.289064|2017-10-10 22:52:30.289064
NCT02565771|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-07-11|||March 2013||2013-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|SALTO_GyV||Evaluation of the Improvement of Autonomic Nervous System by a Physical Rehabilitation Program Adapted to Adulthood After Chemotherapy or Radiotherapy in Childhood|Evaluation of the Improvement of Autonomic Nervous System by a Physical Rehabilitation Program Adapted to Adulthood After Chemotherapy or Radiotherapy in Childhood|Completed||N/A|6|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 22:52:30.36109|2017-10-10 22:52:30.36109
NCT02565758|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-25|||September 23, 2015||2015-09-23|August 2017|2017-08-01|June 25, 2020|Anticipated|2020-06-25|December 24, 2018|Anticipated|2018-12-24||Interventional|||ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Cancer Tumors|A Multicenter, Phase 1, Open-Label, Dose-Escalation Study of ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|220|Anticipated|AbbVie||3|||f||||f||||||||||2017-10-10 22:52:30.462215|2017-10-10 22:52:30.462215
NCT02565745|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-06-20|||December 2015||2015-12-01|June 2017|2017-06-01|December 12, 2017|Anticipated|2017-12-12|August 31, 2017|Anticipated|2017-08-31||Interventional|PENFUP||Skin Dressings Versus Lubrication to Prevent Pressure Ulcers: A Randomized Trial|Impact of Skin Dressings Compared With Cream for Skin Lubrication in the Prevention of Pressure Ulcers in Patients at High or Very High Risk: A Multicenter Randomized Trial|Recruiting||Phase 3|1000|Anticipated|Fundación Cardioinfantil Instituto de Cardiología||2|||f||||t|f|f||||||No||2017-10-10 22:52:30.592708|2017-10-10 22:52:30.592708
NCT02565732|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-08-02||2016-08-02|September 2015||2015-09-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis||Completed||Phase 2|67|Actual|Revance Therapeutics, Inc.||3|||f||||||||||||||2017-10-10 22:52:30.71354|2017-10-10 22:52:30.71354
NCT02565719|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-09-26|||March 2016||2016-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection|An Open-label, Randomized, Active Controlled, Parallel Comparison Study of the Safety and Efficacy of REP 2139-Mg in Combination With Pegasys® and Viread® and REP 2165-Mg in Combination With Pegasys® and Viread® in Patients With HBeAg Negative Chronic Hepatitis B|Active, not recruiting||Phase 2|40|Actual|Replicor Inc.||4|||f||||f||||||||||2017-10-10 22:52:30.827068|2017-10-10 22:52:30.827068
NCT02565706|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-30|||July 2014||2014-07-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Online WIC Nutrition Education to Promote Farmers' Market Fruit and Vegetable Purchases and Consumption|Online WIC Nutrition Education to Promote Farmers' Market Fruit and Vegetable Purchases and Consumption|Unknown status|Active, not recruiting|N/A|744|Actual|William Paterson University of New Jersey||4|||f||||f||||||||||2017-10-10 22:52:31.115297|2017-10-10 22:52:31.115297
NCT02565693|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-29|||September 2014||2014-09-01|September 2015|2015-09-01||||March 2018|Anticipated|2018-03-01||Interventional|APACHE-AF||Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation|Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation: A Randomised Phase II Clinical Trial|Recruiting||Phase 2|100|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-10 22:52:31.27|2017-10-10 22:52:31.27
NCT02565680|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-05-10|||February 2012||2012-02-01|May 2017|2017-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|CAHISU||Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency|Glucocorticoids Associated With Antihistamines Versus Antihistamines Randomized Double Blinded for the Management of Acute Urticaria in Emergency|Completed||Phase 2/Phase 3|100|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 22:52:31.482554|2017-10-10 22:52:31.482554
NCT02565667|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-03-24|||September 2015||2015-09-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Prospective Clinical Study for Transanal Double Purse-string Rectal Anastomosis Preformed With KOL Stapler|A Prospective Randomized Clinical Study for Transanal Double Purse-string Rectal Anastomosis Preformed With KOL Stapler|Recruiting||N/A|100|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 22:52:31.594591|2017-10-10 22:52:31.594591
NCT02565654|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-30|||October 2015||2015-10-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome|Efficacy of Rifaximin for Diarrhea-predominant Irritable Bowel Syndrome With Positive Lactulose Hydrogen Breath Test|Not yet recruiting||N/A|120|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||Samples With DNA|"     Faeces   "|||2017-10-10 22:52:31.726415|2017-10-10 22:52:31.726415
NCT02565641|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-11-01|||March 2003||2003-03-01|November 2016|2016-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer|An Open-label, Phase II Study of Capecitabine Plus Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|63|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:52:31.819422|2017-10-10 22:52:31.819422
NCT02565628|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-04-25|2017-04-25||November 16, 2015|Actual|2015-11-16|April 2017|2017-04-01|May 13, 2016|Actual|2016-05-13|May 13, 2016|Actual|2016-05-13||Interventional|||PF-06669571 In Subjects With Idiopathic Parkinson's Disease|A Phase 1b, Double Blind, Sponsor Open, Randomized, Parallel, Group Multiple Dose Study Examining The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06669571 In Subjects With Idiopathic Parkinson's Disease.|Completed||Phase 1|20|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 22:52:31.930656|2017-10-10 22:52:31.930656
NCT02565615|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-10-02|||June 22, 2016|Actual|2016-06-22|October 2017|2017-10-01|October 10, 2018|Anticipated|2018-10-10|October 10, 2018|Anticipated|2018-10-10|12 Weeks|Observational [Patient Registry]|ATTENTION||Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting|Atorvastatin Effectiveness And Safety In Cardiology Patients In Real World Setting: A Registry Study In China|Recruiting||N/A|10000|Anticipated|Pfizer|||1||f||||f||f||||||||2017-10-10 22:52:32.558537|2017-10-10 22:52:32.558537
NCT02565602|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-10-13|||February 2014||2014-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Comparison of Calcium Metabolism in Caucasian and Asian Postmenopausal Women of Chinese Descent and the Use of Strontium as a Qualitative Marker of Calcium Metabolism|A Comparative Study of Calcium Metabolism in Caucasian and Asian Postmenopausal Women of Chinese Descent and the Use of Strontium as a Qualitative Marker of Calcium Metabolism in Humans|Completed||N/A|10|Actual|National University, Singapore||1|||f||||t||||||||||2017-10-10 22:52:32.736844|2017-10-10 22:52:32.736844
NCT02565589|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-03|||April 2014||2014-04-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Observational|||Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients|Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients|Completed||N/A|48|Actual|Yonsei University|||2||f||||f||||||||||2017-10-10 22:52:32.83664|2017-10-10 22:52:32.83664
NCT02565576|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-04-10|||September 29, 2015|Actual|2015-09-29|April 2017|2017-04-01|December 27, 2017|Anticipated|2017-12-27|July 31, 2017|Anticipated|2017-07-31||Interventional|||Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Preliminarily Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of CFZ533 in Patients With Moderate to Severe Myasthenia Gravis|Recruiting||Phase 2|44|Anticipated|Novartis||2|||f||||t||||||||||2017-10-10 22:52:32.902148|2017-10-10 22:52:32.902148
NCT02565563|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-04-07|||October 2015||2015-10-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|EMDR;PTSD||Recording Heart Rate Variability During Eye Movement Desensitisation Reprocessing With or Without Eye Movement|Digitally Recording Heart Rate Variability Via the Patient's Finger: Is There a Difference Between Eye Movements and no Eye Movements During Eye Movement Desensitisation Reprocessing Treatment for Post Traumatic Stress Disorder?|Withdrawn||N/A|0|Actual|University of Edinburgh||2||No participants recruited|f||||f||||||||||2017-10-10 22:52:33.026103|2017-10-10 22:52:33.026103
NCT02565550|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-09-30|||July 2015||2015-07-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome|Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome|Unknown status|Recruiting|Phase 4|90|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 22:52:33.105318|2017-10-10 22:52:33.105318
NCT02565537|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-12-01|||October 2015||2015-10-01|December 2015|2015-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||High Resolution Wavefront-guided vs. Wavefront Optimized LASIK|A Prospective Randomized Comparison of the AMO CustomVue to the Alcon Wavelight in Patients Undergoing LASIK|Recruiting||Phase 4|100|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 22:52:33.189605|2017-10-10 22:52:33.189605
NCT02565524|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-09-29|||April 2014||2014-04-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|GenAuDiss||"Exploration and Characterization of Genetic and Phenotypic Profile of theSchizotiste"|"Exploration and Characterization of Genetic and Phenotypic Profile of the Early Dissociative Disorder Associated With Autism Spectrum Disorder: a Pilot Study"|Unknown status|Recruiting|N/A|60|Anticipated|Fondation Lenval||1|||f||||f||||||||||2017-10-10 22:52:33.271837|2017-10-10 22:52:33.271837
NCT02565511|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-27|||November 30, 2015|Actual|2015-11-30|September 2017|2017-09-01|May 6, 2024|Anticipated|2024-05-06|May 6, 2024|Anticipated|2024-05-06||Interventional|Generation S1||A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease|A Randomized, Double-blind, Placebo-controlled, Two-cohort, Parallel Group Study to Evaluate the Efficacy of CAD106 and CNP520 in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease.|Recruiting||Phase 2/Phase 3|1340|Anticipated|Novartis||4|||f||||t|t|f||||||||2017-10-10 22:52:33.367842|2017-10-10 22:52:33.367842
NCT02565498|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-06-28|||June 2016||2016-06-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||Preoperative vs Postoperative IMRT for Extremity/Truncal STS|Phase III Study of Preoperative vs Postoperative Intensity Modulated Radiation Therapy For Truncal/Extremity Soft Tissue Sarcoma|Recruiting||Phase 3|206|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||No||2017-10-10 22:52:33.59178|2017-10-10 22:52:33.59178
NCT02565485|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-09-14|||September 2015||2015-09-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Pulse Pressure and Post-epidural Fetal Heart Rate Changes|Pulse Pressure-guided IV Fluid Preload to Prevent Post-epidural Fetal Heart Rate (FHR) Changes: a Randomized Controlled Trial|Recruiting||N/A|276|Anticipated|MetroHealth Medical Center||2|||f||||f||||||||||2017-10-10 22:52:33.706637|2017-10-10 22:52:33.706637
NCT02565472|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-02-23|||October 2015||2015-10-01|February 2016|2016-02-01||||December 2015|Actual|2015-12-01||Interventional|||Effects of Juice on Gastrointestinal Tolerance and Breath Hydrogen Response in Human Subjects|Effect of a White Grape Juice Compared to Apple Juice on Gastrointestinal Tolerance and Breath Hydrogen Response in Human Subjects|Completed||N/A|40|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||||||||||||2017-10-10 22:52:33.818943|2017-10-10 22:52:33.818943
NCT02565459|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-07-19|||September 2015||2015-09-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|||MSC and Kidney Transplant Tolerance (Phase A)|Third-party Bone Marrow-derived Mesenchymal Stromal Cells to Induce Tolerance in Recipients of Kidney Transplants From Deceased Donors (Phase A)|Recruiting||Phase 1|22|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||f||||||||||2017-10-10 22:52:34.005839|2017-10-10 22:52:34.005839
NCT02565433|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-09-29|||November 2013||2013-11-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|PRAMECE-1302||Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)|Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases|Unknown status|Recruiting|N/A|130|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||||2017-10-10 22:52:34.209697|2017-10-10 22:52:34.209697
NCT02565420|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-01-04|||September 2015||2015-09-01|January 2017|2017-01-01|September 2022|Anticipated|2022-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Saline Versus Lactated Ringer's Solution: The SOLAR Fluid Trial|Saline Versus Lactated Ringer's Solution: The SOLAR Fluid Trial|Recruiting||N/A|8548|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 22:52:34.320968|2017-10-10 22:52:34.320968
NCT02565407|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-05-01|||October 2015||2015-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Robot-aided Proprioceptive Rehabilitation Training|Robot-aided Proprioceptive Rehabilitation Training With Additional Vibro-tactile Feedback|Recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 22:52:34.438997|2017-10-10 22:52:34.438997
NCT02565394|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-09-12|||November 2016||2016-11-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|OR-STRETCH||Microbreaks in the OR to Mitigate High Physical and Mental Demands|OR-STRETCH: Microbreaks in the Operating Room With the Incorporation of Stretches to Mitigate High Physical and Mental Demands While Enhancing Performance During Surgical Procedures|Enrolling by invitation||N/A|70|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:52:34.597121|2017-10-10 22:52:34.597121
NCT02565381|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-06-15|2017-05-20||October 2015|Actual|2015-10-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|QUIT||A Pilot Randomized Controlled Trial of Financial Incentives, Text Messaging, and Usual Care for Homeless Smokers|The QUIT Smoking Study: A Pilot Randomized Controlled Trial of Financial Incentives, Text Messaging, and Usual Care to Help Homeless Smokers Quit Smoking|Completed||N/A|83|Actual|Massachusetts General Hospital|Small sample size; short duration of follow-up; primary outcome based exclusively on exhaled carbon monoxide measurement.|3|||f||||f||||||||||2017-10-10 22:52:34.701813|2017-10-10 22:52:34.701813
NCT02565368|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-30|||July 2015||2015-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, 2-way Crossover Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers|Completed||Phase 1|26|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:52:35.843498|2017-10-10 22:52:35.843498
NCT02565355|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-29|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|FGID||Targeted Food Elimination for Treatment of Functional Gastrointestinal Diseases in Children|Randomized Controlled Trial of Food Elimination Based on IgG Antibodies for Treatment of Functional Gastrointestinal Diseases (FGIDs) in Children|Completed||N/A|60|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 22:52:35.967685|2017-10-10 22:52:35.967685
NCT02565342|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-09-26|||September 2015||2015-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery|Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery|Completed||Phase 4|50|Actual|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||||2017-10-10 22:52:36.073688|2017-10-10 22:52:36.073688
NCT02565329|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-29|||January 2014||2014-01-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Serum Lactate Trend in Liver Resection|"Serum Lactate Trend in Liver Resection With Intermittent Pringle Maneuver: The Square-Root Shape"|Completed||N/A|133|Actual|University of Milan|||1||f||||f||||||||||2017-10-10 22:52:36.156943|2017-10-10 22:52:36.156943
NCT02565316|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-30|||November 2014||2014-11-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy of Nepeta Menthoides Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial|Efficacy of Nepeta Menthoides Boiss & Bohse Freeze Dried Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|70|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:52:36.239743|2017-10-10 22:52:36.239743
NCT02565303|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2017-04-24|||June 2015||2015-06-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Minimum Effective Dose of Ropivacaine for Spinal Anesthesia in Cesarean Section|Minimum Effective Dose of Ropivacaine for Different Intervertebral Space of Spinal Anesthesia in Cesarean Section|Completed||N/A|40|Actual|Shanghai 6th People's Hospital||2|||f||||f||||||||||2017-10-10 22:52:36.344308|2017-10-10 22:52:36.344308
NCT02565290|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2015-09-30|||May 2015||2015-05-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Effect of Mother's Supplementation Omega-3 in the Dynamics of Fetal Ductus Arteriosus: a Randomized Clinical Trial.|Effect of Mother's Supplementation Omega-3 in the Dynamics of Fetal Ductus Arteriosus: a Randomized Clinical Trial.|Unknown status|Recruiting|N/A|74|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 22:52:37.059197|2017-10-10 22:52:37.059197
NCT02565277|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-10-27|||September 2015||2015-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial|The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial|Recruiting||Phase 4|150|Anticipated|Health Sciences North Research Institute||2|||f||||f||||||||||2017-10-10 22:52:37.194677|2017-10-10 22:52:37.194677
NCT02565264|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-08-22|||September 2015||2015-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Plasma Derived Exosomes on Cutaneous Wound Healing|Effect of Plasma Derived Exosomes on Intractable Cutaneous Wound Healing: Prospective Trial|Enrolling by invitation||Early Phase 1|5|Anticipated|Kumamoto University||1|||f||||f||||||||||2017-10-10 22:52:37.323526|2017-10-10 22:52:37.323526
NCT02565251|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-12-13|||September 2015||2015-09-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Volemic Resuscitation in Sepsis and Septic Shock|Volemic Resuscitation in Sepsis and Septic Shock|Recruiting||N/A|100|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy||4|||f||||f||||||||||2017-10-10 22:52:37.42531|2017-10-10 22:52:37.42531
NCT02565238|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-05-05|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01|3 Months|Observational [Patient Registry]|||BIO.MASTER.BioMonitor 2 Study|Master Study of the Insertable Cardiac Monitor BioMonitor 2.|Completed||N/A|92|Actual|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-10 22:52:37.571734|2017-10-10 22:52:37.571734
NCT02565225|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-08-23|||November 2014||2014-11-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|MiDEAR||Mobile Medically Supervised Patient Management in Rheumatoid Arthritis|Mobile Medically Supervised Patient Management in Rheumatoid Arthritis Patients Using DocuMed.rh and RheumaLive App|Completed||N/A|60|Actual|Heinrich-Heine University, Duesseldorf|||2||f||||||||||||||2017-10-10 22:52:37.661989|2017-10-10 22:52:37.661989
NCT02565212|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-09-29|||May 2014||2014-05-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis|Istanbul Gaziosmanpasa Taksim Research and Training Hospital,|Completed||Phase 4|30|Actual|Istanbul Training and Research Hospital||3|||f||||f||||||||||2017-10-10 22:52:37.761906|2017-10-10 22:52:37.761906
NCT02565199|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-08-24|||September 2015||2015-09-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Premotor Cortex: A New Target for Stroke Motor Rehabilitation|Premotor Cortex: A New Target for Stroke Motor Rehabilitation Using Transcranial Magnetic Stimulation|Recruiting||N/A|50|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 22:52:37.844946|2017-10-10 22:52:37.844946
NCT02565186|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-08-01|||October 2015||2015-10-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|GLADIATOR||An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine|An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)|Enrolling by invitation||Phase 3|2580|Anticipated|CoLucid Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:52:37.99028|2017-10-10 22:52:37.99028
NCT02565173|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-12-02|||September 2015||2015-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|MATrX-1||Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma|Phase III Multi-center, Randomized, Double-masked, Active- and Placebo-controlled Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma|Completed||Phase 3|303|Actual|Inotek Pharmaceuticals Corporation||5|||f||||f||||||||||2017-10-10 22:52:38.52655|2017-10-10 22:52:38.52655
NCT02565160|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-08-26|||October 2015||2015-10-01|August 2016|2016-08-01||||October 2016|Anticipated|2016-10-01||Observational|||Analysis of Human Knee Joint Fluid Using Metabonomic, Genomic and Tribology Techniques|Looking for Biomarkers in Human Joint Fluid Using Metabonomic, Microbiomic and Tribological Analysis|Recruiting||N/A|150|Anticipated|Imperial College London|||3||f||||f||||||Samples With DNA|"     Blood, Urine and Joint Fluid   "|Yes|Publication in peer review journal|2017-10-10 22:52:38.675473|2017-10-10 22:52:38.675473
NCT02565134|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2016-07-14|||October 2014||2014-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus|Multi Center, Double-blind, Randomized, Placebo-controlled Parallel-group, Dose Finding Phase II Clinical Trial to Evaluate Antipruritic Effect and Safety of PAC-14028 Cream (0.1%, 0.3%, 1.0%) in Skin Pruritus Patients|Completed||Phase 2|296|Actual|Amorepacific Corporation||4|||f||||t||||||||||2017-10-10 22:52:38.941502|2017-10-10 22:52:38.941502
NCT02565121|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-30|||June 2013||2013-06-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Olfaction Disorders in Patients Included in The Trauma Brain Injury (TBI) Database at Trondheim University Hospital|Olfaction Disorders in Patients Included in The Trauma Brain Injury (TBI) Database at Trondheim University Hospital: Prevalence and Treatment|Completed||N/A|20|Actual|St. Olavs Hospital||1|||f||||f||||||||||2017-10-10 22:52:39.075867|2017-10-10 22:52:39.075867
NCT02565108|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-09-18||2017-09-18|January 20, 2016|Actual|2016-01-20|September 2017|2017-09-01|July 21, 2016|Actual|2016-07-21|July 21, 2016|Actual|2016-07-21||Interventional|||A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol|A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol (GWP42003-P)|Completed||Phase 2|20|Actual|GW Research Ltd||2|||f||||f||||||||||2017-10-10 22:52:39.203952|2017-10-10 22:52:39.203952
NCT02565095|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-09-30|||March 2009||2009-03-01|September 2015|2015-09-01||||December 2016|Anticipated|2016-12-01||Interventional|OTOBAR||Interaction of Otolith Stimulation and Carotid Baroreflex in Humans|Interaction of Otolith Stimulation and Carotid Baroreflex in Humans|Unknown status|Recruiting|N/A|54|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 22:52:39.353741|2017-10-10 22:52:39.353741
NCT02565082|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-07-25|||September 2015||2015-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients|Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients|Completed||N/A|64|Actual|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 22:52:39.444085|2017-10-10 22:52:39.444085
NCT02565069|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-02-24|||July 2015||2015-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Identification for the Treatment of Complex Arrhythmias|"Identification for the Treatment of Complex Arrhythmias (CartoFinder™ Algorithm Trial: CF163 EU)"|Active, not recruiting||Phase 4|70|Anticipated|Biosense Webster, Inc.||1|||f||||f||||||||||2017-10-10 22:52:39.58681|2017-10-10 22:52:39.58681
NCT02565056|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Feasibility RCT of ACT Self-help for Depression in Haemodialysis|Acceptance and Commitment Therapy Self-help Intervention for Depression in Haemodialysis Patients: A Feasibility Randomised Controlled Trial|Completed||N/A|9|Actual|University of Lincoln||2|||f||||f||||||||||2017-10-10 22:52:39.678078|2017-10-10 22:52:39.678078
NCT02565043|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-29|||April 2015||2015-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:52:39.792679|2017-10-10 22:52:39.792679
NCT02565030|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-04-24|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|||Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome|Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome|Active, not recruiting||N/A|1200|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||4||f||||f||||||||||2017-10-10 22:52:39.845734|2017-10-10 22:52:39.845734
NCT02565017|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-08-22|||September 15, 2015|Actual|2015-09-15|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System|Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System|Active, not recruiting||N/A|70|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-10-10 22:52:39.960839|2017-10-10 22:52:39.960839
NCT02565004|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-09-12|||September 23, 2015||2015-09-23|August 31, 2017|2017-08-31|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Observational|||Clinical and Laboratory Analysis of Familial Cancer|Clinical and Laboratory Analysis of Familial Cancer|Enrolling by invitation||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:52:40.071107|2017-10-10 22:52:40.071107
NCT02564991|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-30|2017-10-05|||September 17, 2015||2015-09-17|June 30, 2017|2017-06-30|September 30, 2020|Anticipated|2020-09-30|June 22, 2020|Anticipated|2020-06-22||Observational|||Study of Structural Imaging|Cross-Sectional and Longitudinal Study of Structural Imaging|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:52:40.164983|2017-10-10 22:52:40.164983
NCT02564965|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-30|||May 2014||2014-05-01|September 2015|2015-09-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Endoscopic Large Caliber Drainage vs. Complete Necrosectomy for Treatment of Walled-off Pancreatic Necrosis|Endoscopic Large Caliber Drainage vs. Complete Necrosectomy for Treatment of Walled-off Pancreatic Necrosis: A Prospective, Randomized Noninferiority Trial.|Enrolling by invitation||N/A|56|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:52:40.383129|2017-10-10 22:52:40.383129
NCT02564952|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-07-31|||March 9, 2016|Actual|2016-03-09|July 2017|2017-07-01|June 7, 2017|Actual|2017-06-07|June 7, 2017|Actual|2017-06-07||Interventional|||An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol|A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol (GWP42003-P)|Completed||Phase 2|20|Actual|GW Research Ltd||1|||f||||f||||||||||2017-10-10 22:52:40.491553|2017-10-10 22:52:40.491553
NCT02564939|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-03-28|||February 23, 2017|Actual|2017-02-23|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Ramelteon Prevention of Delirium - RCT|Randomized, Double Blind, Placebo-Controlled Clinical Trial Evaluating Ramelteon in the Prevention of Delirium|Recruiting||Phase 4|240|Anticipated|Hartford Hospital||2|||f||||f|t|f||||||||2017-10-10 22:52:40.589555|2017-10-10 22:52:40.589555
NCT02564926|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-07-24|||January 5, 2016|Actual|2016-01-05|July 2017|2017-07-01|January 23, 2018|Anticipated|2018-01-23|January 23, 2018|Anticipated|2018-01-23||Interventional|BEYOND||Foxiga Korea Local Phase 4 Study|Effects of Dapagliflozin Compared With Glimepiride on Body Composition in Patients With Type 2 Diabetes Inadequately Controlled With Metformin|Active, not recruiting||Phase 4|125|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:52:40.704668|2017-10-10 22:52:40.704668
NCT02564913|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-29|||December 2011||2011-12-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Integrated Clinical Evaluation of Traditional Chinese Medicine (TCM) and Conventional Medicine on Diabetic Patients||Completed||N/A|250|Actual|Changhua Christian Hospital|||3||f||||||||||||||2017-10-10 22:52:40.873376|2017-10-10 22:52:40.873376
NCT02564900|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-04-27|||August 2015||2015-08-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors|Phase 1, Two-Part, Multicenter, Non-randomized, Open-label, Multiple Dose First-In-Human Study of DS-8201A, in Subjects With Advanced Solid Malignant Tumors|Recruiting||Phase 1|198|Anticipated|Daiichi Sankyo, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:52:40.990513|2017-10-10 22:52:40.990513
NCT02564887|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-11-09|||January 2016||2016-01-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy|Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy|Recruiting||N/A|100|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 22:52:41.133155|2017-10-10 22:52:41.133155
NCT02564874|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-04-21|||June 2015||2015-06-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect on Dietary Compensation and Weight Gain in Adults by Savory Solid and Sugary Liquid Discretionary Food Sources|Effect on Dietary Compensation and Weight Gain in Adults by Savory Solid and Sugary Liquid Discretionary Food Sources|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Lack of funding|f||||||||||||||2017-10-10 22:52:41.710322|2017-10-10 22:52:41.710322
NCT02564861|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-04-27|||September 2015||2015-09-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Multiple Dose Study of D1971a in Healthy Volunteers|A Phase I, Double-Blind, Randomised, Placebo Controlled, Multiple-Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DS-1971a in Healthy Male and Female Subjects|Completed||Phase 1|25|Actual|Daiichi Sankyo, Inc.||4|||f||||f||||||||||2017-10-10 22:52:41.806114|2017-10-10 22:52:41.806114
NCT02564848|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-05-22|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|January 2025|Anticipated|2025-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65|IIT2015-06-Chung: Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Clinical T1-2 Estrogen-Positive Breast Cancer Over Age 65|Recruiting||N/A|200|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-10 22:52:41.911822|2017-10-10 22:52:41.911822
NCT02564835|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-06-22|||September 2015||2015-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer|Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer|Active, not recruiting||N/A|27|Actual|University of Michigan||3|||f||||t||||||||No||2017-10-10 22:52:42.029803|2017-10-10 22:52:42.029803
NCT02564822|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-04-07|||July 2015||2015-07-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Observational|||Effects of the Visual Stimulation on the Motor and Visual Cortex in Migraneurs With and Without Aura|Effects of the Visual Stimulation on the Motor and Visual Cortex in Migraneurs With and Without Aura|Recruiting||N/A|30|Anticipated|Universidade Federal de Pernambuco|||2||f||||t||||||||||2017-10-10 22:52:42.140371|2017-10-10 22:52:42.140371
NCT02564809|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-08-21|||January 2016||2016-01-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Cognitive Brain Training in Older Adults|The Effect of Fit Brains Training on Cognitive Performance in Older Adults|Active, not recruiting||N/A|123|Actual|University of British Columbia||3|||f||||t||||||||||2017-10-10 22:52:42.245343|2017-10-10 22:52:42.245343
NCT02564796|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-02-02|||February 2, 2017|Actual|2017-02-02|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic Congenital Heart Disease - A Prospective Control Trial|Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic Congenital Heart Disease - A Prospective Randomized Control Trial|Recruiting||Phase 2|40|Anticipated|University of California, San Diego||2|||f||||t|t|f||||||No||2017-10-10 22:52:42.354602|2017-10-10 22:52:42.354602
NCT02564783|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-10-26|||October 2015||2015-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||The Burden of Pediatric Surgical Conditions in Rural Kenya|The Burden of Pediatric Surgical Conditions in Rural Kenya - a Prospective Cohort Study|Completed||N/A|800|Actual|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 22:52:42.48118|2017-10-10 22:52:42.48118
NCT02564770|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-11-01|||January 2012||2012-01-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia|A Retrospective Chart Review of the Use of MabThera (Rituximab) for the Treatment of Rheumatoid Arthritis (RA) in Australian Rheumatology Practice|Completed||N/A|167|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:52:42.578857|2017-10-10 22:52:42.578857
NCT02564757|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Observational|||Does Pregnancy Increase Risk of Ventral Hernia Recurrence?|Does Pregnancy Increase Risk of Ventral Hernia Recurrence?|Completed||N/A|3578|Actual|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-10 22:52:42.699108|2017-10-10 22:52:42.699108
NCT02564744|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-09-22|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||Study to Evaluate the Efficacy and Tolerability Debio 1562 in Combination With Rituximab in Patients With Relapsed and/or Refractory DLBCL and Other Forms of NHL|A Phase 2 Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Patients With Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma and Other Forms of Non-Hodgkin's Lymphoma|Recruiting||Phase 2|75|Anticipated|Debiopharm International SA||3|||f||||f||||||||||2017-10-10 22:52:42.800069|2017-10-10 22:52:42.800069
NCT02564731|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-01-05|||June 2016||2016-06-01|January 2017|2017-01-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study|Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study|Recruiting||N/A|300|Anticipated|Beijing Children's Hospital|||1||f||||t||||||||||2017-10-10 22:52:43.02132|2017-10-10 22:52:43.02132
NCT02564718|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-09-08|||November 19, 2015|Actual|2015-11-19|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|Einstein Jr||Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates|7-day Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Children From Birth to Less Than 6 Months With Arterial or Venous Thrombosis|Recruiting||Phase 1/Phase 2|8|Anticipated|Bayer||1|||f||||t|t|f||||||||2017-10-10 22:52:43.169587|2017-10-10 22:52:43.169587
NCT02564705|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-05-26|||February 2016||2016-02-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|I-Spondy||Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis|A Multi-Center, Prospective, Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis|Recruiting||N/A|180|Anticipated|AOSpine North America Research Network|||2||f||||f||||||||||2017-10-10 22:52:43.423329|2017-10-10 22:52:43.423329
NCT02564692|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-11-18|||November 2015||2015-11-01|November 2016|2016-11-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|15 Years|Observational [Patient Registry]|||GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype|Alzheimer's Prevention Registry GeneMatch Program|Recruiting||N/A|500000|Anticipated|Banner Health|||1||f||||f||||||||||2017-10-10 22:52:43.568633|2017-10-10 22:52:43.568633
NCT02564679|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-29|||July 2014||2014-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Sleeve Gastrectomy in Adolescents With Complicated Morbid Obesity and NAFLD|Effects of Sleeve Gastrectomy on Hepatic and Metabolic Abnormalities in Adolescents With Complicated Morbid Obesity and NAFLD|Completed||N/A|40|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||f||||||||||2017-10-10 22:52:43.872578|2017-10-10 22:52:43.872578
NCT02564666|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-09-29|||October 2015||2015-10-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|SORATEL||The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib|The Effect of Telephone Counseling on the Compliance and the Level of Satisfaction for Patients Receiving Sorafenib Due to Advanced Hepatocellular Carcinoma|Not yet recruiting||N/A|64|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-10 22:52:43.968408|2017-10-10 22:52:43.968408
NCT02564640|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-12-08|||June 2015||2015-06-01|June 2015|2015-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparison of Hemodynamic Changes by Using the Videolaryngoscope and the Macintosh Laryngoscope|Comparison of Hemodynamic Changes After Endotracheal Intubation by Using the Videolaryngoscope and the Macintosh Direct Laryngoscope in Elderly Hypertensive Patients|Completed||N/A|100|Actual|Antalya Training and Research Hospital||2|||f||||f||||||||||2017-10-10 22:52:44.208321|2017-10-10 22:52:44.208321
NCT02564627|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-09-30|||July 2015||2015-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||PENS T6 With Ambulatory Self-applied Patch vs Conventional Procedure|Percutaneous Electrical Neurostimulation (PENS) of Dermatome T6 With an Ambulatory Self-applied Patch vs PENS of Dermatome T6 With Conventional Procedure: Effect on Appetite and Weight Loss in Moderately Obese Patients|Completed||Phase 3|90|Actual|Abdel Kadar Clinic||3|||f||||t||||||||||2017-10-10 22:52:44.317209|2017-10-10 22:52:44.317209
NCT02564614|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-10-03|||May 2, 2016||2016-05-02|October 2017|2017-10-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Interventional|||A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)|A Phase 1b, Proof of Mechanism, Open-label Study of RO7070179, a Hypoxia-inducible Factor 1a (HIF1A) mRNA Antagonist in Adult Subjects With Hepatocellular Carcinoma (HCC)|Active, not recruiting||Phase 1|9|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:52:44.417735|2017-10-10 22:52:44.417735
NCT02564601|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-09-28|||June 2015||2015-06-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||The Impact of Piano Training on Cognitive Performance and Psychosocial Well-Being in Older Adults|The Impact of Piano Training on Cognitive Performance and Psychosocial Well-Being in Older Adults|Unknown status|Recruiting|N/A|90|Anticipated|University of South Florida||3|||f||||t||||||||||2017-10-10 22:52:44.553833|2017-10-10 22:52:44.553833
NCT02564588|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-09-20||2017-09-20|October 2015||2015-10-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Dasotraline Binge Eating Disorder Study|A 12-week, Randomized, Double-blind, Parallel-group, Placebo Controlled, Flexibly Dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder|Completed||Phase 2/Phase 3|319|Actual|Sunovion||2|||f||||t||||||||||2017-10-10 22:52:44.697142|2017-10-10 22:52:44.697142
NCT02564575|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-01-31|||August 2015||2015-08-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults|Phase 1 Evaluation of a Live Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein|Completed||Phase 1|30|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:52:44.951583|2017-10-10 22:52:44.951583
NCT02564562|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-12-03|||October 2015||2015-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers|A Phase 1 Open-Label, Radiolabeled, Single-Dose Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers|Completed||Phase 1|6|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 22:52:45.076291|2017-10-10 22:52:45.076291
NCT02564549|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-03-03|||October 5, 2015|Actual|2015-10-05|March 2017|2017-03-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca|Multiparametric MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Cancer (MAVERICK)|Suspended||N/A|192|Anticipated|Virginia Commonwealth University||2||Pending revisions|f||||t|f|f||||||||2017-10-10 22:52:45.179513|2017-10-10 22:52:45.179513
NCT02564536|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-05-03|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)|A Pilot Study of Pacritinib in Combination With Low Dose Decitabine in Patients With Intermediate-High Risk Myelofibrosis or MPN/MDS Syndromes|Withdrawn||Phase 1|0|Actual|Washington University School of Medicine||1||Lack of funding following full FDA clinical hold|f||||t|t|f||||||No||2017-10-10 22:52:45.28308|2017-10-10 22:52:45.28308
NCT02564523|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-06-20|||November 6, 2015|Actual|2015-11-06|June 2017|2017-06-01|July 21, 2019|Anticipated|2019-07-21|January 21, 2019|Anticipated|2019-01-21||Interventional|||Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults|A Randomized, Observer-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Different Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo in Healthy Adults, Including Elderly Subjects, HIV-infected Subjects, and Healthy Children in Two Age Strata in Africa|Recruiting||Phase 2|1056|Anticipated|Janssen Vaccines & Prevention B.V.||3|||f||||t||f||||||||2017-10-10 22:52:45.389893|2017-10-10 22:52:45.389893
NCT02564497|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-02-24|||October 2015||2015-10-01|February 2017|2017-02-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|||A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C|A Randomized, Open-label, Parallel-group, Single-dose, Biocomparability Study of the Pharmacokinetics of Belatacept Drug Products Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Active Pharmaceutical Ingredient Manufactured by Process C in Healthy Subjects|Completed||Phase 1|176|Actual|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 22:52:45.566841|2017-10-10 22:52:45.566841
NCT02564484|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-09-12|||February 8, 2016|Actual|2016-02-08|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01||Observational|||iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy|Collection of PBMC's From Patients With Unusually Severe Vincristine-Induced Neuropathy for the Creation of Neuronal-Like Cells|Recruiting||N/A|130|Anticipated|St. Jude Children's Research Hospital|||2||f||||f|f|f||||Samples With DNA|"     Blood samples will be obtained from each cohort.   "|||2017-10-10 22:52:45.674918|2017-10-10 22:52:45.674918
NCT02564471|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-05-01|||April 2016||2016-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MALRAB||Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.|Effect of Antimalarial Drugs on the Immune Response to Rabies Vaccine for Post-exposure Prophylaxis. A Randomized, Open Label, Trial in Healthy US Adults Age 18-60 Years|Recruiting||Phase 4|100|Anticipated|State University of New York - Upstate Medical University||4|||f||||f||||||||||2017-10-10 22:52:45.774702|2017-10-10 22:52:45.774702
NCT02564458|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-05-30|||September 2015||2015-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|FAST||Fitness in Allogeneic Stem Cell Transplantation|Fitness in Allogeneic Stem Cell Transplantation|Active, not recruiting||N/A|35|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-10 22:52:45.894889|2017-10-10 22:52:45.894889
NCT02564445|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-12-19|||January 2016||2016-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Using Social Incentives and Gamification for Weight Loss Promotion|Using Social Incentives and Gamification for Weight Loss Promotion|Completed||Phase 3|196|Actual|University of Pennsylvania||3|||f||||f||||||||No||2017-10-10 22:52:46.003104|2017-10-10 22:52:46.003104
NCT02564432|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-05-15|||October 1, 2015|Actual|2015-10-01|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|April 18, 2018|Anticipated|2018-04-18||Observational|MMPOP||Microbiome and Metagenome in Percutaneous Osseointegrated Prostheses (MMPOP)|Microbiome and Innate Immunity With Percutaneous Osseointegrated Prostheses|Active, not recruiting||N/A|10|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|Samples With DNA|"     Stomal and skin swab samples for bacterial 16S ribosomal RNA and fungal 18S ribosomal RNA.     Blood samples to detect mRNA of genes regulating production of immune proteins. Serous     drainage from the stoma to determine wound healing cytokine expression.   "|No||2017-10-10 22:52:46.088417|2017-10-10 22:52:46.088417
NCT02564419|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-07-19|||November 2015||2015-11-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|BMI||Brain Machine Interface (BMI) in Subjects Living With Quadriplegia|Early Feasibility Study of a Medtronic Activa PC+S System for Persons Living With Spinal Cord Injury|Recruiting||N/A|3|Anticipated|University of Miami||1|||f||||t||||||||||2017-10-10 22:52:46.152513|2017-10-10 22:52:46.152513
NCT02564406|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2016-07-21|||January 2013||2013-01-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Extracorporeal CO2 Removal in Hypercapnic Patients|Extracorporeal CO2 Removal in Hypercapnic Patients Who Failed Noninvasive Ventilation and Refuse Endotracheal Intubation: a Case Series|Completed||N/A|35|Actual|University of Roma La Sapienza||1|||f||||f||||||||||2017-10-10 22:52:46.235189|2017-10-10 22:52:46.235189
NCT02564393|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-29|||May 2011||2011-05-01|September 2015|2015-09-01||||May 2013|Actual|2013-05-01||Observational|MucoNETs||Induction of Neutrophilic Traps ( NETs ) by the Environment and Infectious Inflammatory Lung Cystic Fibrosis|Secretion Induction of Neutrophil Extracellular Traps (NETs)in Inflammatory and Infectious Environment of Mucoviscidose|Completed||Phase 3|55|Actual|University Hospital, Tours|||2||f||||f||||||||||2017-10-10 22:52:46.323112|2017-10-10 22:52:46.323112
NCT02564380|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-07-28|||March 2016||2016-03-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|PRIMUS||Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)|A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)|Recruiting||Phase 2|130|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-10-10 22:52:46.382257|2017-10-10 22:52:46.382257
NCT02564367|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-08-16|||October 2015||2015-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|S-1 adjuvant||Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction|Multicenter Phase I/II Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction|Recruiting||Phase 1/Phase 2|60|Anticipated|AIO-Studien-gGmbH||1|||f||||f||||||||||2017-10-10 22:52:46.477788|2017-10-10 22:52:46.477788
NCT02564354|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-11-08|||September 2015||2015-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation|Open-Label, Exploratory Study to Evaluate the Effects of QR-010 on Nasal Potential Difference in Subjects With CF With the ΔF508 CFTR Mutation|Completed||Phase 1|18|Actual|ProQR Therapeutics||2|||f||||t||||||||||2017-10-10 22:52:46.572738|2017-10-10 22:52:46.572738
NCT02564341|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-19|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|TEACH||Targeting Effective Analgesia in Clinics for HIV - Intervention|Collaborative Care Intervention to Improve Providers' Opioid Prescribing for HIV-infected Patients - Intervention Component|Active, not recruiting||N/A|41|Actual|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 22:52:46.669186|2017-10-10 22:52:46.669186
NCT02564328|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-29|||November 2014||2014-11-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke|Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke|Recruiting||Phase 1|40|Anticipated|Southern Medical University, China||2|||f||||t||||||||||2017-10-10 22:52:46.765704|2017-10-10 22:52:46.765704
NCT02564315|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-12-05|||October 2015||2015-10-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||The Long-Term Quitting (Smoking Cessation) Study|The Long-Term Quitting Study: Testing Relapse Recovery Intervention Components|Recruiting||Phase 4|1000|Anticipated|University of Wisconsin, Madison||9|||f||||t||||||||Yes||2017-10-10 22:52:46.91593|2017-10-10 22:52:46.91593
NCT02564302|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-09-20|||August 2015||2015-08-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Mindfulness on Atrial Fibrillation|Effects of Monitored Mindfulness Training on Quality-of-life, Anxiety, and Depression in Patients Awaiting Ablation of Atrial Fibrillation|Recruiting||N/A|60|Anticipated|Newmarket Electrophysiology Research Group Inc||2|||f||||f||||||||||2017-10-10 22:52:47.049098|2017-10-10 22:52:47.049098
NCT02564289|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-03-18|||September 2015||2015-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|CHROS||Cardiovascular Effects of Chronic Snus Use|Cardiovascular Effects of Chronic Snus Use|Completed||N/A|50|Actual|Umeå University|||2||f||||f||||||Samples With DNA|"     Blood samples, Urine samples   "|No||2017-10-10 22:52:47.144587|2017-10-10 22:52:47.144587
NCT02564276|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-06-27|||February 2016||2016-02-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer|Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer|Recruiting||Phase 3|114|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-10 22:52:47.231732|2017-10-10 22:52:47.231732
NCT02564250|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-29|||September 2015||2015-09-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women|Healthy Mother - Lifelong Health: A Longitudinal Study on Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women|Recruiting||N/A|150|Anticipated|Vestre Viken Hospital Trust|||1||f||||f||||||||||2017-10-10 22:52:49.407024|2017-10-10 22:52:49.407024
NCT02564237|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-01-17|||August 2015||2015-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||A Controlled Study to Evaluate the Safety and Immunogenicity of StreptAnova™ in Healthy Adults|A Phase I, Randomized, Observer-blind, Comparator-controlled, Study of the Safety and Immunogenicity of StreptAnova™ Vaccine in Healthy Adults Age ≥ 18 - 50 Years|Active, not recruiting||Phase 1|39|Actual|Dalhousie University||2|||f||||t||||||||||2017-10-10 22:52:49.492033|2017-10-10 22:52:49.492033
NCT02564224|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-04-04|||September 2015||2015-09-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Expanded Access|PURSE||Study Comparing Pursestring Wound Closure vs Conventional Closure to Reverse Stoma of Colorectal Cancer Patients|Randomized Clinical Trial of Stoma Reversal Comparing Pursestring Wound Closure vs Conventional Closure to Eliminate the VSS Score of the Scar for Colorectal Cancer Patients|Available||N/A|||Zhejiang University|||||f|||t|||||||||||2017-10-10 22:52:49.585451|2017-10-10 22:52:49.585451
NCT02564211|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-03-23|||October 2015||2015-10-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)|A Phase III, Multicenter, Open-label Long-term Treatment Trial to Assess the Safety and Efficacy of Addition of Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin Monotherapy in Addition to Diet and Exercise Therapy|Completed||Phase 3|77|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 22:52:49.653394|2017-10-10 22:52:49.653394
NCT02564198|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-05-18|||December 2015||2015-12-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors|A Phase 1 Study Of Ramucirumab, a Human Monoclonal Antibody Against the Vascular Endothelial Growth Factor-2 (VEGFR-2) Receptor in Children With Refractory Solid Tumors, Including CNS Tumors|Recruiting||Phase 1|36|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 22:52:49.722494|2017-10-10 22:52:49.722494
NCT02564185|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-01-31|||September 2010||2010-09-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|TENS||Prospective, Randomized Study of the Impact of a Education Program for Patients Suffering From Low Back Pain|Prospective, Randomized Study of the Impact of a Education Program for Patients Suffering From Low Back Pain|Completed||N/A|98|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-10 22:52:49.899731|2017-10-10 22:52:49.899731
NCT02564172|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-12-20|||September 2015||2015-09-01|December 2016|2016-12-01|October 2020|Anticipated|2020-10-01|September 2020|Anticipated|2020-09-01||Interventional|STIMCONE||Conus Medullaris Stimulation With 5 Columns Lead Versus Medical Treatment in Refractory Pudendal Neuralgia|Conus Medullaris Stimulation With 5 Columns Lead Versus Medical Treatment in Refractory Pudendal Neuralgia: a Randomized, Open, Controlled, Multicenter Trial.|Recruiting||N/A|42|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-10 22:52:49.975794|2017-10-10 22:52:49.975794
NCT02564159|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-01-20|||October 2015||2015-10-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|MALICUS||Malnutrition Screening by Muscle Ultrasound in Patients Requiring Mechanical Ventilation in Intensive Care Unit|Ultrasound Measurement of the Quadriceps Muscle Diameter for the Detection and the Follow-up of Malnutrition in Patients Receiving Mechanical Ventilation in Intensive Care Unit|Unknown status|Recruiting|N/A|226|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 22:52:50.108185|2017-10-10 22:52:50.108185
NCT02564146|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-06-26|||December 2016||2016-12-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|ALPACA||First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine|Induction Treatment With Nab-paclitaxel/Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer Followed by Either Alternating Application of Gemcitabine Monotherapy and Nab-paclitaxel/Gemcitabine or Continuing Application of Nab-paclitaxel/Gemcitabine: A Randomized Phase II Study|Recruiting||Phase 2|325|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||No||2017-10-10 22:52:50.324259|2017-10-10 22:52:50.324259
NCT02564133|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2017-08-08|||June 2013||2013-06-01|August 2017|2017-08-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|COL-FOP||Hip Fracture and Patent Foramen Ovale|Are Postoperative Complications More Frequent When Patients Having a Hip Fracture Have a Patent Foramen Ovale ?|Terminated||N/A|41|Actual|Hopital Foch||1||"We have discovered a too low prevalence of Patent Foramen Ovale compared to the theoretical %   of around 20-25%."|f||||f||||||||||2017-10-10 22:52:50.439705|2017-10-10 22:52:50.439705
NCT02564120|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-11-22|||January 2011||2011-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)||Active, not recruiting||N/A|1656|Actual|UNC Lineberger Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-10 22:52:50.525021|2017-10-10 22:52:50.525021
NCT02564107|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-11-01|||November 2004||2004-11-01|November 2016|2016-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease|An Open Label Study of the Efficacy, Safety, and Pharmacoeconomics of Oral Ibandronate (Bondronat 50 mg) in Treatment of Metastatic Bone Disease|Completed||Phase 4|48|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:52:50.589765|2017-10-10 22:52:50.589765
NCT02564094|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-11-01|||February 2005||2005-02-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies|Optimizing Treatment of the Anaemia in Onco-Hematological Diseases With NeoRecormon 30,000 IU Once Weekly|Completed||Phase 4|54|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:52:50.693074|2017-10-10 22:52:50.693074
NCT02564081|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-02-01|||August 2015||2015-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Remote Effects of Lower Limb Stretching||Completed||N/A|63|Actual|Goethe University||3|||f||||||||||||||2017-10-10 22:52:50.793523|2017-10-10 22:52:50.793523
NCT02564068|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-08-11|||March 2015||2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Oxytocin on HR in Sleep Apnea Patient|Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep|Recruiting||N/A|20|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-10 22:52:50.879646|2017-10-10 22:52:50.879646
NCT02564029|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-04-17|||December 16, 2015|Actual|2015-12-16|April 2017|2017-04-01|February 7, 2017|Actual|2017-02-07|January 10, 2017|Actual|2017-01-10||Interventional|||PF-06372865 in Subjects With Photosensitive Epilepsy|A Double Blind, Randomized, Cross- Over Study Examining Efficacy Of Pf-06372865 In A Photosensitivity Epilepsy Study Using Lorazepam As A Positive Control|Completed||Phase 2|7|Actual|Pfizer||4|||f||||f||||||||||2017-10-10 22:52:51.445448|2017-10-10 22:52:51.445448
NCT02564016|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-12-01|||October 2014||2014-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Efficacy of Labor Epidurals for Postpartum Tubal Ligation|Efficacy of Labor Epidurals for Postpartum Tubal Ligation: Effect of Postpartum Epidural Saline Infusion on the Reactivation of Labor Epidurals for Postpartum Tubal Ligation Following Vaginal Delivery|Terminated||N/A|36|Actual|Medical University of South Carolina||2||"Of 36 participants only 8 participants able to fully complete the study procedures. At this   time, the study will be closed due to poor enrollment numbers."|f||||t||||||||||2017-10-10 22:52:51.665031|2017-10-10 22:52:51.665031
NCT02564003|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-09-29|||June 2012||2012-06-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|oksineoinfa||Oxycodone Pharmacokinetics in Preterm Infants|Oxycodone Pharmacokinetics in Preterms, Infants and Children|Completed||Phase 4|79|Actual|Kuopio University Hospital|||1||f||||t||||||Samples Without DNA|"     Plasma and urine samples for oxycodone concentration measurement   "|||2017-10-10 22:52:51.753605|2017-10-10 22:52:51.753605
NCT02563990|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-07-20|||February 2016||2016-02-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Injection Pressure & Adductor Canal Block|The Impact of Injection Pressure During Adductor Canal Nerve Block|Recruiting||N/A|60|Anticipated|University of Miami||2|||f||||||||||||||2017-10-10 22:52:51.833446|2017-10-10 22:52:51.833446
NCT02563977|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2015-09-29|||July 2015||2015-07-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Observational|||Changes To The Abdominal Wall After DIEP Flap Breast Reconstruction|Structural Changes In The Abdominal Wall After Deep Inferior Epigastric Perforator Flap Breast Reconstruction|Unknown status|Recruiting|N/A|15|Anticipated|Oslo University Hospital|||1||f||||||||||||||2017-10-10 22:52:51.970082|2017-10-10 22:52:51.970082
NCT02563964|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-09-01|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2019|Anticipated|2019-08-01|1 Year|Observational [Patient Registry]|CULPRIT||Vulnerable Plaque Imaging in NSTEMI|Characterizing Vulnerable Plaques in Non-ST-Elevation Myocardial Infarction Using 18F-NaF Positron Emission Tomography - Cardiac Magnetic Resonance Imaging: A Feasibility Study|Recruiting||N/A|33|Anticipated|Maastricht University Medical Center|||1||f||||t||||||Samples Without DNA|"     Biomarkers   "|||2017-10-10 22:52:52.060398|2017-10-10 22:52:52.060398
NCT02563951|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-01-07|||September 2015||2015-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers|A Phase I Pharmacokinetic Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers|Completed||Phase 1|50|Actual|Maxinase Life Sciences Ltd.||5|||f||||t||||||||||2017-10-10 22:52:52.176848|2017-10-10 22:52:52.176848
NCT02563938|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-06-27|||September 2015||2015-09-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001|A Phase 1, Randomized, Double-Blind, Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001 in Subjects With Atopic Disease|Completed||Phase 1|34|Actual|Allakos, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:52:52.307872|2017-10-10 22:52:52.307872
NCT02563925|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-12-21|||September 2015||2015-09-01|December 2016|2016-12-01||||September 2017|Anticipated|2017-09-01||Interventional|||Brain Irradiation and Tremelimumab in Metastatic Breast Cancer|A Pilot Study of Brain Irradiation and Tremelimumab in Metastatic Breast Cancer|Active, not recruiting||N/A|28|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:52:52.396606|2017-10-10 22:52:52.396606
NCT02563912|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2016-04-05|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Pre-calculated Doses of Medication for Pediatric Resuscitation, a Simulation Experimental Trial|Pre-calculated Doses of Medication for Pediatric Resuscitation, a Simulation Cross-over Randomized Experimental Trial|Completed||N/A|40|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-10 22:52:52.503154|2017-10-10 22:52:52.503154
NCT02563886|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-02-23|||September 2015||2015-09-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|EAMT||Electrically Assisted Movement Therapy|Electrically Assisted Movement Therapy (EAMT) for Upper Limb Stroke Rehabilitation|Active, not recruiting||N/A|12|Anticipated|Swiss Federal Institute of Technology||2|||f||||f||||||||No||2017-10-10 22:52:52.721919|2017-10-10 22:52:52.721919
NCT02563873|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Bowditch Revisited: Defining the Optimum Heart Rate Range in Chronic Heart Failure|Bowditch Revisited: Defining the Optimum Heart Rate Range in Chronic Heart Failure|Recruiting||N/A|110|Anticipated|University of Leeds||2|||f||||f||||||||||2017-10-10 22:52:52.844913|2017-10-10 22:52:52.844913
NCT02563860|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-10-01|||July 2015||2015-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Statins||Pharmacological Treatment of Rett Syndrome With Statins|Pharmacological Treatment of Rett Syndrome With 3-Hydroxy-3 Methylglutaryl-coenzyme A Reductase Inhibitor-Lovastatin (Mevacor)|Completed||Phase 2|20|Actual|Montefiore Medical Center||1|||f||||f||||||||||2017-10-10 22:52:52.949385|2017-10-10 22:52:52.949385
NCT02563847|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-09-28|||May 2014||2014-05-01|September 2015|2015-09-01||||March 2015|Actual|2015-03-01||Interventional|||Effect of Amino Acids and Sugar Alcohols on Gastric Emptying and Release of Satiation Peptides in Humans|Effect of Amino Acids and Sugar Alcohols on Gastric Emptying and Release of Satiation Peptides in Normal Weight and Obese Subjects|Completed||N/A|20|Actual|University Hospital, Basel, Switzerland||7|||f||||f||||||||||2017-10-10 22:52:53.045497|2017-10-10 22:52:53.045497
NCT02563834|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-08-30|2016-02-29||January 2007||2007-01-01|August 2016|2016-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism|A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism|Completed||N/A|18|Actual|Indiana University||2|||f||||f||||||||No||2017-10-10 22:52:53.177372|2017-10-10 22:52:53.177372
NCT02563821|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-29|2016-09-02|||November 2015||2015-11-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PCEA-IMG||Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Third Trimester Medical Termination of Pregnancy Analgesia : a Randomized Study. (PCEA-IMG)|Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Third Trimester Medical Termination of Pregnancy Analgesia : a Randomized Study.|Recruiting||Phase 3|34|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-10 22:52:53.538353|2017-10-10 22:52:53.538353
NCT02563808|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-29|||March 2013||2013-03-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Impact of Anticipated Regret Incorporation Into Patient Decision Aids|Impact of Anticipated Regret on Decision-Making in Preference Sensitive Care for Breast and Prostate Cancer|Completed||N/A|189|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:52:53.646647|2017-10-10 22:52:53.646647
NCT02563795|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-03-14|||May 2015||2015-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01|1 Day|Observational [Patient Registry]|||Low Dose Spinal Anesthesia in Cesarean Surgery|Does the Reduction of Local Anesthetic Dose Provide Surgical Anesthesia While Avoiding Maternal Hypotension in Obese Pregnant for C/S by Single Shot Spinal Anesthesia?|Completed||N/A|100|Actual|Ankara University|||4||f||||f||||||||||2017-10-10 22:52:53.716372|2017-10-10 22:52:53.716372
NCT02563782|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-07-25|||August 24, 2015|Actual|2015-08-24|July 2017|2017-07-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|PORTRAY||Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD|Ph 2, Double-Masked, Randomized, Parallel, Sham Surgery/Placebo Control, Multi-Center Study to Evaluate Systemic IMT Regimens as Graft Rejection Prophylaxis Following Transplantation of hESC Derived RPE Cells in Patients With AMD|Withdrawn||Phase 2|0|Actual|Astellas Pharma Inc||2||Changes to the study design and the cell line|f||||t||||||||||2017-10-10 22:52:53.79756|2017-10-10 22:52:53.79756
NCT02563769|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-13|||February 2016||2016-02-01|July 2017|2017-07-01||||February 2018|Anticipated|2018-02-01||Interventional|||Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study|Phase 1, Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Cocaine and Clavulanic Acid|Recruiting||Phase 1|12|Anticipated|Temple University||3|||f||||t||||||||||2017-10-10 22:52:53.879847|2017-10-10 22:52:53.879847
NCT02563756|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-02-27|||September 2015||2015-09-01|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|UKA or TKA?||Unicondylar- or Total Knee Replacement? Patient Satisfaction, Function and Muscle Mass|Unicondylar - or Total Knee Replacement in Medial Gonarthritis? A Randomized Study of Patient Related Outcome Measures, Function and Muscle Mass|Recruiting||N/A|80|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:52:53.993746|2017-10-10 22:52:53.993746
NCT02563743|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-12-02|||September 2015||2015-09-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Stress and Mental Ill-health in the Workplace: Evaluation of an Intervention for the Prevention of Sick Leave|Preventing Sickness Absenteeism Among Employees With Common Mental Disorders and Stress-related Symptoms: a Cluster Randomized Trial of a Problem-solving Based Intervention Versus Care-as-usual Conducted at the Occupational Health Services|Recruiting||N/A|150|Anticipated|Karolinska Institutet||2|||f||||||||||||||2017-10-10 22:52:54.088378|2017-10-10 22:52:54.088378
NCT02563730|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2016-10-25|||November 2014||2014-11-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Open Label Trial of Utility of Cryobiopsy in the Multidisciplinary Diagnosis of Idiopathic Interstitial Lung Disease|Open Label Trial of Utility of Cryobiopsy in the Multidisciplinary Diagnosis of Idiopathic Interstitial Lung Disease|Recruiting||N/A|100|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-10 22:52:54.2117|2017-10-10 22:52:54.2117
NCT02563704|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2015-09-30|||September 2013||2013-09-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Trial of the Efficacy of Artesunate and Three Quinine Regimens in the Treatment of Severe Malaria in Children at the Ebolowa Regional Hospital - Cameroon|A Randomized Trial of the Efficacy of Artesunate and Three Quinine Regimens in the Treatment of Severe Malaria in Children at the Ebolowa Regional Hospital - Cameroon|Completed||Phase 3|238|Actual|University of Yaounde 1||4|||f||||f||||||||||2017-10-10 22:52:54.662376|2017-10-10 22:52:54.662376
NCT02563691|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-09-28|||November 2014||2014-11-01|September 2015|2015-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|CROP||Stereotactic Radiotherapy for Oligometastatic Prostate Cancer|Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer: A Phase I/II Study|Recruiting||Phase 1/Phase 2|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 22:52:54.787002|2017-10-10 22:52:54.787002
NCT02563678|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-10-04|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|O2B||Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines|Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines: a Pilot Study|Recruiting||Phase 1|40|Anticipated|Intermountain Health Care, Inc.||9|||f||||f||||||||||2017-10-10 22:52:54.900507|2017-10-10 22:52:54.900507
NCT02563665|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2016-10-27|||September 2015||2015-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy|A Prospective Study on Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy|Recruiting||N/A|50|Anticipated|Institute of Liver and Biliary Sciences, India|||2||f||||f||||||||||2017-10-10 22:52:55.062423|2017-10-10 22:52:55.062423
NCT02563652|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-10-20|||September 2015||2015-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Can Biomarkers Aid in the Prediction of Postoperative Pain and Circulatory Instability After Major Abdominal Surgery?|Can Biomarkers Aid in the Prediction of Postoperative Pain and Circulatory Instability After Major Abdominal Surgery? A Prospective Observational Study|Recruiting||N/A|100|Anticipated|St. Olavs Hospital|||1||f||||f||||||Samples With DNA|"     Full blood, serum, plasma and urine will be stored in cryotubes at -81 degrees celcius for     later analysis   "|||2017-10-10 22:52:55.150225|2017-10-10 22:52:55.150225
NCT02563639|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-09-13|||September 2015||2015-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01|12 Months|Observational [Patient Registry]|APAF||Apixaban in Atrial Fibrillation Registry|APAF Apixaban in Atrial Fibrillation Registry|Recruiting||N/A|5000|Anticipated|IHF GmbH - Institut für Herzinfarktforschung|||1||f||||f||||||||||2017-10-10 22:52:55.25655|2017-10-10 22:52:55.25655
NCT02563626|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2017-08-23|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|12 Months|Observational [Patient Registry]|CAAR||Coronary Artery Aneurysm Registry|Coronary Artery Aneurysms: Incidence, Management and Long Term Prognosis|Completed||N/A|1565|Actual|St Carlos Hospital, Madrid, Spain|||1||f||||f||||||||||2017-10-10 22:52:55.358395|2017-10-10 22:52:55.358395
NCT02563613|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|HFKM||Happy Family Kitchen Movement Project|Happy Family Kitchen Movement, A Community-based Research to Enhance Family Health, Happiness and Harmony in Hong Kong: A Cluster Randomized Controlled Trial|Recruiting||N/A|4000|Anticipated|The University of Hong Kong||3|||f||||f||||||||||2017-10-10 22:52:55.472079|2017-10-10 22:52:55.472079
NCT02563600|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Brief-tele Support on Attendance at Physiotherapy Sessions|Effect of Brief-tele Support on Attendance at Physiotherapy Sessions for Pelvic Floor Dysfunctions|Recruiting||N/A|500|Anticipated|Swansea University||3|||f||||f||||||||||2017-10-10 22:52:55.630516|2017-10-10 22:52:55.630516
NCT02563587|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-28|||September 2015||2015-09-01|September 2015|2015-09-01|January 2018|Anticipated|2018-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Efficacy of Spontaneous Laughter in the Postoperative Treatment of Children|Efficacy of the Spontaneous Laughter on Postoperative Pain and Anxiety in Children. A Randomized Controlled Trial|Recruiting||N/A|210|Anticipated|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||3|||f||||f||||||||||2017-10-10 22:52:55.745113|2017-10-10 22:52:55.745113
NCT02563574|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-18|||December 2016||2016-12-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||ARCH II Study (Alcohol Research Center on HIV Study II)|Alcohol and HIV: Biobehavioral Interactions and Intervention|Recruiting||N/A|140|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 22:52:55.927944|2017-10-10 22:52:55.927944
NCT02563561|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-12-02|||September 2015||2015-09-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|November 2020|Anticipated|2020-11-01||Interventional|||A Study of Intravesical Apaziquone as a Surgical Adjuvant in Patient Undergoing TURBT|A Multicenter, Multi-Arm, Randomized, Multi-Dose, Placebo-Controlled, Double-Blind, Phase 3 Study of Intravesical Apaziquone (EOquin®) as a Surgical Adjuvant in the Immediate Postoperative Period in Patients Undergoing TURBT|Active, not recruiting||Phase 3|1869|Anticipated|Spectrum Pharmaceuticals, Inc||3|||f||||t||||||||||2017-10-10 22:52:56.12159|2017-10-10 22:52:56.12159
NCT02563548|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-05-16|||October 2015||2015-10-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Phase 1b Open-Label Study of PEGPH20 With Pembrolizumab|A Phase 1b Open-Label Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Pembrolizumab in Subjects With Selected Hyaluronan High Solid Tumors|Recruiting||Phase 1|81|Anticipated|Halozyme Therapeutics||1|||f||||t||||||||No||2017-10-10 22:52:56.251759|2017-10-10 22:52:56.251759
NCT02563535|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2015-09-28|||September 2015||2015-09-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|ACOART-BTK||Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos ® in Below-The-Knee Arteries to Treat Critical Limb Ischemia||Recruiting||Phase 4|140|Anticipated|Ospedale San Donato||2|||f||||f||||||||||2017-10-10 22:52:56.397194|2017-10-10 22:52:56.397194
NCT02563522|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-26|||January 2017|Actual|2017-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers|A Phase III, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Asses the Safety and Efficacy of VM202 to Treat Chronic Nonhealing Foot Ulcers in Diabetic Patients With Concomitant Peripheral Arterial Disease (PAD)|Recruiting||Phase 3|300|Anticipated|ViroMed Co., Ltd. dba VM BioPharma||2|||f||||t|t|f||||||||2017-10-10 22:52:56.507269|2017-10-10 22:52:56.507269
NCT02563509|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-05-21|||January 2013||2013-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Reconstitution of HIV-specific Immunity Against HIV|Reconstitution of HIV-specific Immunity Against HIV|Recruiting||Phase 1|40|Anticipated|Guangzhou 8th People's Hospital||2|||f||||f|f|f||||||Undecided||2017-10-10 22:52:56.716064|2017-10-10 22:52:56.716064
NCT02563483|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-29|||September 2007||2007-09-01|September 2015|2015-09-01|November 2009|Actual|2009-11-01|February 2008|Actual|2008-02-01||Interventional|||Yoga for Family Caregivers of Alzheimers Disease Patient|A Yoga and Compassion Meditation Program Improve Quality of Life and Self-compassion in Family Caregivers of Alzheimer's Disease Patients: a Randomized Controlled Trial|Completed||N/A|46|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 22:52:56.943509|2017-10-10 22:52:56.943509
NCT02563470|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-29|||April 2014||2014-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Bleeding, Cardio- and Cerebrovascular Complications in Head and Neck Surgery|A Retrospective Registry of Bleeding, Cardio- and Cerebrovascular Complications in Patients Treated for Head and Neck Cancer|Completed||N/A|456|Actual|University of Turku|||1||f||||f||||||||||2017-10-10 22:52:57.031531|2017-10-10 22:52:57.031531
NCT02563457|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-10-04|||February 2009||2009-02-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|DIAPERIO||Efficacy of Periodontal Treatment on Glycaemic Control in Diabetic Patients|Efficacy of Periodontal Treatment on Glycaemic Control in Diabetic Patients|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 22:52:57.10026|2017-10-10 22:52:57.10026
NCT02563444|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-10-20|||June 2014||2014-06-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|ECHOFUSION||Interest in Using Ultrasound Fusion in Percutaneous Interventional Radiology|Interest in Using Ultrasound Fusion in Percutaneous Interventional Radiology|Completed||N/A|25|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||No||2017-10-10 22:52:57.203901|2017-10-10 22:52:57.203901
NCT02563431|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-09-29|||July 2012||2012-07-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|4P-ED||Multi-disciplinary Prevention Program|Early Phase of Multi-disciplinary Prevention Program of Shoulder Pain Post-stroke|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 22:52:57.276849|2017-10-10 22:52:57.276849
NCT02563418|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-29|||May 2014||2014-05-01|September 2015|2015-09-01||||May 2017|Anticipated|2017-05-01||Interventional|VOG-HD||Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study|Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Angers||1|||f||||||||||||||2017-10-10 22:52:57.37179|2017-10-10 22:52:57.37179
NCT02563405|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-07-26|||September 2015||2015-09-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients|The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients|Recruiting||Phase 2/Phase 3|30|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||||2017-10-10 22:52:57.449874|2017-10-10 22:52:57.449874
NCT02563392|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-02-21|||April 2015||2015-04-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|ORAM||Does Preventive Uterine Artery Occlusion During Laparoscopic Myomectomy Impact on Ovarian Reserve Markers?|Does Preventive Uterine Artery Occlusion During Laparoscopic Myomectomy Impact on Ovarian Reserve Markers? A Randomized Control Trial|Recruiting||N/A|60|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 22:52:57.55187|2017-10-10 22:52:57.55187
NCT02563379|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-30|||September 2015||2015-09-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01|12 Months|Observational [Patient Registry]|DIMOSPAF||Association of Dipping Pattern or Early Morning Surge of BP With Asymptomatic Episodes of Paroxysmal Atrial Fibrillation in Subjects With Hypertension (DIMOSPAF)|Association Between Circadian Blood Pressure Patterns With Asymptomatic Episodes of Paroxysmal Atrial Fibrillation in Hypertensive Subjects|Unknown status|Not yet recruiting|N/A|200|Anticipated|Evangelismos Hospital|||3||f||||f||||||||||2017-10-10 22:52:57.69428|2017-10-10 22:52:57.69428
NCT02563366|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2015-09-28|||November 2015||2015-11-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.|Effect of Bone Marrow-derived Mesenchymal Stem Cells (BM-MSCs) on Recovery of Poor Early Graft Function Post Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Multi-center Randomized Controlled Trial|Not yet recruiting||Phase 1/Phase 2|120|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 22:52:57.847033|2017-10-10 22:52:57.847033
NCT02563353|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-09-21|||November 2015||2015-11-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|PaVOS||PTH and Vibration in OSteoporosis Study|PTH and Vibration in OSteoporosis (PaVOS) Study|Recruiting||N/A|40|Anticipated|Odense University Hospital||3|||f||||t||||||||||2017-10-10 22:52:58.180859|2017-10-10 22:52:58.180859
NCT02563340|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2015-09-28|||November 2015||2015-11-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of BM-MSCs on Chronic AMR After Kidney Transplantation|Efficacy and Safety of Bone Marrow-derived Mesenchymal Stem Cells (BM-MSCs) on Chronic Antibody-mediated Rejection (cAMR) After Kidney Transplantation: A Multi-center Perspective Study|Not yet recruiting||Phase 1/Phase 2|60|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 22:52:58.39146|2017-10-10 22:52:58.39146
NCT02563327|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-02-27|||May 30, 2016|Actual|2016-05-30|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|S31PK/PD||Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis|TBTC Study 31 PK/PD: Population Pharmacokinetic and Pharmacodynamic Study of Efficacy and Safety of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis in the Study 31 Treatment Trial: Intensive PK Sampling|Recruiting||Phase 3|60|Anticipated|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-10 22:52:58.562738|2017-10-10 22:52:58.562738
NCT02563314|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-04-07|||March 22, 2017|Actual|2017-03-22|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|OXYSET||Comparison of Two Oxygen Setting During Non-invasive Mechanical Ventilation of Chronic Obstructive Pulmonary Disease|Comparison of Two Oxygen Setting During Non-invasive Mechanical Ventilation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial|Recruiting||N/A|88|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||No||2017-10-10 22:52:58.734002|2017-10-10 22:52:58.734002
NCT02563301|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-09-28|||August 2009||2009-08-01|September 2015|2015-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Videolaryngoscopy in Patients With Cervical Spine Immobilisation|A Randomised Crossover Trial Comparing the McGrath Series 5 Videolaryngoscope With the Macintosh Laryngoscope in Patients With Cervical Spine Immobilisation|Completed||N/A|49|Actual|NHS Tayside||2|||f||||f||||||||||2017-10-10 22:52:58.883863|2017-10-10 22:52:58.883863
NCT02563288|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2017-07-25|||August 2016||2016-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Esmolol Versus Dexmedetomidine During Intracranial Procedures|Comparison of Esmolol and Dexmedetomidine on Sympathetic Control During Intracranial Procedures|Recruiting||Phase 3|60|Anticipated|George Papanicolaou Hospital||2|||f||||f||||||||||2017-10-10 22:52:58.964507|2017-10-10 22:52:58.964507
NCT02563275|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-09-28|||March 2013||2013-03-01|September 2015|2015-09-01||||October 2015|Anticipated|2015-10-01||Interventional|Grafism||The Operation of Control Devices During Parabolic Flights: Influence of Weightlessness, Stress and Motivation|The Operation of Control Devices During Parabolic Flights: Influence of Weightlessness, Stress and Motivation|Unknown status|Recruiting|N/A|15|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 22:52:59.083009|2017-10-10 22:52:59.083009
NCT02563262|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-09-28|||September 2012||2012-09-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|HYDRONAUT||Human Neutral Body Posture in Weightlessness||Completed||N/A|8|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 22:52:59.180504|2017-10-10 22:52:59.180504
NCT02563249|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-09-28|||May 2012||2012-05-01|September 2015|2015-09-01||||December 2015|Anticipated|2015-12-01||Interventional|DEXTER0g||Influence of Gravity on Dexterity, Hand-eye Coordination and Perception of Orientation and Distances||Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 22:52:59.259123|2017-10-10 22:52:59.259123
NCT02563236|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-09-28|||March 2012||2012-03-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|June 2013|Actual|2013-06-01||Interventional|3DPICK||Evaluation of 3D Selection Tasks in Parabolic Flight Conditions: Pointing Task in Augmented Reality User Interfaces|Evaluation of 3D Selection Tasks in Parabolic Flight Conditions: Pointing Task in Augmented Reality User Interfaces|Completed||N/A|9|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 22:52:59.345585|2017-10-10 22:52:59.345585
NCT02563223|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-09-28|||November 2011||2011-11-01|September 2015|2015-09-01||||October 2015|Anticipated|2015-10-01||Interventional|SLS-JUMP||The Effect of Gravity on the Muscular Control of Landing From a Jump|The Effect of Gravity on the Muscular Control of Landing From a Jump|Unknown status|Recruiting|N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 22:52:59.432853|2017-10-10 22:52:59.432853
NCT02563210|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-06-12|||October 19, 2015|Actual|2015-10-19|June 2017|2017-06-01|May 29, 2017|Actual|2017-05-29|May 29, 2017|Actual|2017-05-29||Interventional|ARC36||Airway Resistance Measurement in Children 3 to 6 Years of Age|Interrupter Technique and Plethysmography Airway Resistance Measurement: Comparison of These Two Techniques for the Diagnosis of Airway Obstruction Diagnosis and Bronchodilation Response in Children 3 to 6 Years of Age|Completed||N/A|130|Actual|University Hospital, Brest||1|||f||||f||||||||||2017-10-10 22:52:59.523638|2017-10-10 22:52:59.523638
NCT02563197|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-04-25|||November 23, 2015|Actual|2015-11-23|April 2017|2017-04-01|April 29, 2016|Actual|2016-04-29|February 17, 2016|Actual|2016-02-17||Interventional|||Inhalation Flow Rate-study|An Open, Multi-center Study to Measure Inhaled Flow Rates Generated by Non-CF Bronchiectasis Patients for the T-326 Inhaler|Completed||Phase 1|33|Actual|Bayer||1|||f||||f||||||||||2017-10-10 22:52:59.627475|2017-10-10 22:52:59.627475
NCT02563184|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-29|||September 2015||2015-09-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease|Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|Phase 4|100|Anticipated|Banner Health||2|||f||||f||||||||||2017-10-10 22:52:59.763879|2017-10-10 22:52:59.763879
NCT02563171|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-29|||July 2014||2014-07-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Gingival Crevicular Fluid Vaspin and Omentin Levels in Obese Patients With Chronic Periodontitis|Effects of Non-Surgical Periodontal Treatment on the Gingival Crevicular Fluid Levels of Vaspin and Omentin-1 in Obese Patients With Chronic Periodontitis|Completed||Early Phase 1|76|Actual|Bulent Ecevit University||4|||f||||f||||||||||2017-10-10 22:52:59.870439|2017-10-10 22:52:59.870439
NCT02563158|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2016-05-10|||January 2016||2016-01-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|OHx-NOHx||Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC|Short- and Long-term Outcomes of Liver Resection With Versus Without Hepatic Inflow Occlusion for the Hepatitis B Virus-related Hepatocellular Carcinoma: a Prospective Randomized Controlled Trial|Recruiting||N/A|114|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 22:52:59.990754|2017-10-10 22:52:59.990754
NCT02563145|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-06-26|||October 2015||2015-10-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents|Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents (Part of EU-MATRICS: Multidisciplinary Approaches to Translational Research)|Recruiting||N/A|40|Anticipated|Central Institute of Mental Health, Mannheim||3|||f||||t||||||||||2017-10-10 22:53:00.168982|2017-10-10 22:53:00.168982
NCT02563132|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-05-28|||October 2015||2015-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Carbon Dioxide Insufflation Colonoscopy in IBD Patients|Carbon Dioxide Insufflation Colonoscopy in Inflammatory Bowel Disease Patients|Completed||N/A|64|Actual|Vitkovice Hospital||2|||f||||f||||||||||2017-10-10 22:53:00.31035|2017-10-10 22:53:00.31035
NCT02563119|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-28|||October 2013||2013-10-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Intestinal Microbiota in Patients Before and After Bariatric Surgery and Healthy Controls|Characterization of Intestinal Microbiota in Healthy Subjects and Patients Before and After Bariatric Surgery Using Next Generation Sequencing Methods|Completed||N/A|70|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-10 22:53:01.004667|2017-10-10 22:53:01.004667
NCT02563106|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-11-10|||October 2015||2015-10-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI|A Double-Blind, Placebo-Controlled, Multicenter Study of SYN-004 Compared to Placebo for the Prevention of C.Diff in Patients With a Diagnosis of a Lower Respiratory Tract Infection|Completed||Phase 2|413|Actual|Synthetic Biologics Inc.||2|||f||||f||||||||||2017-10-10 22:53:01.110715|2017-10-10 22:53:01.110715
NCT02563093|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-10-20|2016-08-26||September 2015||2015-09-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults|Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations|Completed||Phase 4|208|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 22:53:01.225456|2017-10-10 22:53:01.225456
NCT02563080|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2017-01-13|||September 2015||2015-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|APPEI||Pancreatic Exocrine Insufficiency in Acute Pancreatitis|Development of Pancreatic Exocrine Insufficiency After Moderately Severe or Severe Acute Pancreatitis|Recruiting||N/A|50|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||None Retained|"     Fecal samples.   "|No||2017-10-10 22:53:02.223856|2017-10-10 22:53:02.223856
NCT02563067|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-02-20|||December 3, 2015|Actual|2015-12-03|February 2017|2017-02-01|March 27, 2019|Anticipated|2019-03-27|March 27, 2019|Anticipated|2019-03-27||Interventional|||Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.|A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Existing Asthma Therapy in Patients With Uncontrolled Severe Asthma.|Recruiting||Phase 3|846|Anticipated|Novartis||3|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 22:53:02.358233|2017-10-10 22:53:02.358233
NCT02563054|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-11-01|||April 2003||2003-04-01|November 2016|2016-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer|An Open-Label Randomized International Multi-Center Phase III Study of Capecitabine (Xeloda) in Combination With Cisplatin Versus FU/Cisplatin in Patients With Advanced and/or Metastatic Gastric Cancer|Completed||Phase 3|316|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:53:02.981307|2017-10-10 22:53:02.981307
NCT02563041|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-25|||July 2012||2012-07-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|CITRIM||Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis Catheters|Comparative Effectiveness of 30% Trisodium Citrate and Heparin Lock Solutions in Preventing Infection and Dysfunction of Hemodialysis Catheters: a Randomized Controlled Trial (CITRIM Trial)|Completed||Phase 4|179|Actual|Catholic University of Pelotas||2|||f||||f||||||||||2017-10-10 22:53:03.154559|2017-10-10 22:53:03.154559
NCT02563028|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-11-11|||October 2015||2015-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|VEP||A Novel Method for Capturing the Visual Evoked Potential During Spine Surgery Under Total Intravenous Anesthesia|A Novel Method for Capturing the Visual Evoked Potential (VEP) During Single-Level Lumbar Spine Decompression/Fusion Under Total Intravenous Anesthesia (TIVA)|Completed||N/A|20|Actual|Hospital for Special Surgery, New York||1|||f||||f||||||||||2017-10-10 22:53:03.244712|2017-10-10 22:53:03.244712
NCT02563015|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-18|||March 7, 2016|Actual|2016-03-07|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Can Correction of Low Vitamin D Status in Infancy Program for a Leaner Body Composition?|Novel Functional Outcomes of Vitamin D in Infancy; Can Correction of Low Vitamin D Status Program for a Leaner Body Composition Phenotype?|Recruiting||N/A|198|Anticipated|McGill University||3|||f||||f||||||||||2017-10-10 22:53:03.331885|2017-10-10 22:53:03.331885
NCT02563002|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-10-04|||November 30, 2015|Actual|2015-11-30|October 2017|2017-10-01|September 18, 2019|Anticipated|2019-09-18|August 15, 2019|Anticipated|2019-08-15||Interventional|||Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)|A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177)|Recruiting||Phase 3|270|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 22:53:03.453432|2017-10-10 22:53:03.453432
NCT02562989|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-27|||October 19, 2015|Actual|2015-10-19|July 2017|2017-07-01|December 27, 2016|Actual|2016-12-27|December 27, 2016|Actual|2016-12-27||Interventional|||[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)|A Study to Qualify [18F]MK-6240 Positron Emission Tomography (PET) for Use as a Biomarker of Neurofibrillary Tangle Pathology in Alzheimer's Disease|Completed||Phase 1|13|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:53:03.816361|2017-10-10 22:53:03.816361
NCT02562976|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-27|||May 2013||2013-05-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||OLGA Stage is More Appropriate in Predicting Early Gastric Cancer|OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Than Endoscopic Gastric Atrophy Classification and OLGIM Stage: A Prospective Study|Completed||N/A|227|Actual|Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||||||2017-10-10 22:53:03.904644|2017-10-10 22:53:03.904644
NCT02562963|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-05-02|||November 2015||2015-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor|Phase 1/2 Study of Natural Killer T Cell Infusion in Patients With Advanced Solid Tumor|Recruiting||Phase 1/Phase 2|120|Anticipated|Tsinghua University||1|||f||||f||||||||No||2017-10-10 22:53:03.980055|2017-10-10 22:53:03.980055
NCT02562950|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-21|||September 2015||2015-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects|A Phase I, Open Interaction Study Between Oral Doses of GLPG1837 and Single Doses of Midazolam in Healthy Male Subjects|Completed||Phase 1|24|Actual|Galapagos NV||2|||f||||f||||||||||2017-10-10 22:53:04.087737|2017-10-10 22:53:04.087737
NCT02562937|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-09-28|||January 2015||2015-01-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Reducing Sedentary Behaviour in University Students Using Text Messages|Reducing Sedentary Behaviour In University Students Using A Text Message-Based Intervention|Completed||N/A|82|Actual|Western University, Canada||2|||f||||t||||||||||2017-10-10 22:53:04.180912|2017-10-10 22:53:04.180912
NCT02562924|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-05-23|||November 2015||2015-11-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery|An Open-label, Prospective, Randomized, Pilot Clinical Study to Study the Efficacy of MEDIHONEY® Rinses Compared to Intranasal Corticosteroid Rinses in Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery|Recruiting||N/A|36|Anticipated|University of Vermont Medical Center||3|||f||||t||||||||||2017-10-10 22:53:04.25527|2017-10-10 22:53:04.25527
NCT02562911|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-03-12|||January 2013||2013-01-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|EPIMUCO||Puberty in Girls Followed for Cystic Fibrosis|Epidemiological Study of the Progress of Puberty in Girls Followed for Cystic Fibrosis|Completed||N/A|166|Actual|University Hospital, Toulouse|||1||f||||f||||||||||2017-10-10 22:53:04.3852|2017-10-10 22:53:04.3852
NCT02562898|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-07-17|||October 2015||2015-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|144525||Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer|A Study of the Safety, Immunopharmacodynamics and Anti-tumor Activity of Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 1/Phase 2|35|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 22:53:04.467802|2017-10-10 22:53:04.467802
NCT02562885|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-01-12|||October 2015||2015-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ECLASS||Effect of Auditory Stimulation on Spike Waves in Sleep|Effect of Closed-loop Auditory Stimulation on Spike Waves During Slow Wave Sleep, an Open Label Pilot Study|Completed||N/A|6|Actual|University Children's Hospital, Zurich||1|||f||||f||||||||||2017-10-10 22:53:04.571784|2017-10-10 22:53:04.571784
NCT02562872|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-10|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||DSM265 Prophylaxis of Plasmodium Falciparum Malaria|Proof-of-concept, Single Center Study in Healthy Adult Volunteers to Investigate Safety, Tolerability, Pharmacokinetics and Prophylactic Activity of Single Dose DSM265 in a Controlled Human Malarial Infection Challenge Either by Direct Venous Inoculation of Plasmodium Falciparum Sporozoites or Mosquito-borne Plasmodium Falciparum|Completed||Phase 1|24|Actual|Medicines for Malaria Venture||6|||f||||t||||||||||2017-10-10 22:53:04.655551|2017-10-10 22:53:04.655551
NCT02562859|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-21|||September 2015||2015-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food|An Open-label Study to Compare the Oral Bioavailability of an Oral Tablet of GLPG1837 Relative to an Oral Suspension After Single-dose Intake in Healthy Subjects and to Evaluate the Effect of Food on the Oral Tablet|Completed||Phase 1|12|Actual|Galapagos NV||3|||f||||f||||||||||2017-10-10 22:53:04.767872|2017-10-10 22:53:04.767872
NCT02562846|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-05-11|||June 2015||2015-06-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01|9 Months|Observational [Patient Registry]|PROTECT||PRediction Of Treatment Response to ECT in Depression and Cognitive Side effecTs|Prediction of ECT Treatment Response in Depression and Early Detection of ECT-related Memory Problems|Recruiting||N/A|70|Anticipated|Universiteit Antwerpen|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:53:04.853088|2017-10-10 22:53:04.853088
NCT02562833|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-04-20|||February 2015||2015-02-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|||The PLE²NO Self-management and Exercise Program for Knee Osteoarthritis|The PLE²NO Self-management and Exercise Program for Knee Osteoarthritis: A Randomized Controlled Trial|Completed||N/A|80|Actual|Technical University of Lisbon||2|||f||||f||||||||Yes||2017-10-10 22:53:04.931059|2017-10-10 22:53:04.931059
NCT02562820|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-08-28|||November 2015||2015-11-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome|Ketamine for the Treatment of Rett Syndrome: An Exploratory Trial|Terminated||Phase 1|4|Actual|The Cleveland Clinic||2||Funding withdrawn|f||||t||||||||||2017-10-10 22:53:05.039168|2017-10-10 22:53:05.039168
NCT02562807|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-08-09|||October 2015||2015-10-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||A Study of TAS-303 in Female Patients With Stress Urinary Incontinence|A Phase I Study of TAS-303 in Female Patients With Stress Urinary Incontinence|Completed||Phase 1|16|Actual|Taiho Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-10 22:53:05.129148|2017-10-10 22:53:05.129148
NCT02562794|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-12-16|||August 2016||2016-08-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Addressing Mental Health Disparities in Refugee Children: A Community-based Participatory Research (CBPR) Collaboration|Addressing Mental Health Disparities in Refugee Children: A CBPR Collaboration|Enrolling by invitation||N/A|400|Anticipated|Harvard School of Public Health||2|||f||||f||||||||||2017-10-10 22:53:05.231803|2017-10-10 22:53:05.231803
NCT02562781|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2016-10-05|||November 2014||2014-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|HYPEROXIA||Is Peri-operative Hyperoxemia a Risk Factor for Postoperative Complications?|Is Peri-operative Hyperoxemia a Risk Factor for Postoperative Complications? A Randomised, Prospective Study in Patients Undergoing Vascular Surgery|Recruiting||Phase 3|184|Anticipated|Örebro University, Sweden||2|||f||||t||||||||||2017-10-10 22:53:05.311848|2017-10-10 22:53:05.311848
NCT02562768|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-03-20|||September 30, 2015|Actual|2015-09-30|March 2017|2017-03-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease|Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease|Completed||Phase 1|80|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:53:05.408328|2017-10-10 22:53:05.408328
NCT02562755|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-09-05|||October 2015||2015-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|PHOCUS||Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone|A Phase 3 Randomized, Open-Label Study Comparing Pexa Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy|Recruiting||Phase 3|600|Anticipated|SillaJen, Inc.||2|||f||||t||||||||||2017-10-10 22:53:05.507252|2017-10-10 22:53:05.507252
NCT02562742|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-28|||November 12, 2015|Actual|2015-11-12|July 2017|2017-07-01|June 12, 2017|Actual|2017-06-12|June 12, 2017|Actual|2017-06-12||Observational|||Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection|A Prospective Observational Post-Marketing Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection|Completed||N/A|554|Actual|Gilead Sciences|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:53:05.841982|2017-10-10 22:53:05.841982
NCT02562729|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-10-12|||September 2015||2015-09-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer|A Simplified Approach of Complete Nerve-sparing Type C1 Radical Hysterectomy for Cervical Cancer, a Phase II Study|Completed||Phase 2|62|Actual|Shanghai Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-10 22:53:06.201164|2017-10-10 22:53:06.201164
NCT02562716|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-07-12|||October 2015||2015-10-01|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|||S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery|A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma|Recruiting||Phase 2|112|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-10 22:53:06.528169|2017-10-10 22:53:06.528169
NCT02562703|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-09-25|||November 2015||2015-11-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|February 2016|Anticipated|2016-02-01||Interventional|||tVNS for Depression|Transcutaneous Vagus Nerve Stimulation for Treating Major Depressive Disorder: a Phase II, Randomized, Double-blind Clinical Trial|Unknown status|Not yet recruiting|Phase 1/Phase 2|40|Anticipated|Santa Casa Medical School||2|||f||||f||||||||||2017-10-10 22:53:13.16008|2017-10-10 22:53:13.16008
NCT02562690|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2016-05-10|||March 2015||2015-03-01|May 2016|2016-05-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome|Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome|Recruiting||N/A|500|Anticipated|University of Hertfordshire|||1||f||||t||||||Samples Without DNA|"     Plasma   "|||2017-10-10 22:53:13.249683|2017-10-10 22:53:13.249683
NCT02562677|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-09-25|||October 2015||2015-10-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||TNS for Treating Major Depressive Disorder in the Elderly|Effect of TNS for Major Depressive Disorder in the Elderly: a Phase II Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 1/Phase 2|10|Anticipated|Santa Casa Medical School||1|||f||||f||||||||||2017-10-10 22:53:13.795056|2017-10-10 22:53:13.795056
NCT02562664|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-29|||January 2014||2014-01-01|January 2014|2014-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients|Insulin Sensitizing Agent (Metformin) Improves Clinical Pregnancy Rate and Insulin Parameters in Polycystic Ovarian Syndrome Patients With Acanthosis Nigricans|Completed||Phase 2|66|Actual|Assiut University||2|||f||||||||||||||2017-10-10 22:53:13.86671|2017-10-10 22:53:13.86671
NCT02562638|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-10-07|||October 2015||2015-10-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Pre-Procedural Fasting in Cardiac Intervention|Do Patients Need Pre-Procedural Fasting for Coronary Artery Procedures?|Unknown status|Not yet recruiting|N/A|240|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 22:53:14.199187|2017-10-10 22:53:14.199187
NCT02562625|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-01-06|||February 2016||2016-02-01|September 2015|2015-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|PERM||Trial of Pembrolizumab and Radiotherapy in Melanoma|Randomised Phase II Trial of Pembrolizumab and Radiotherapy in Melanoma|Not yet recruiting||Phase 2|234|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:53:14.326841|2017-10-10 22:53:14.326841
NCT02562612|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2016-06-01|||October 2016||2016-10-01|June 2016|2016-06-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of SM-88 in Advanced Cancers|Ascending Multi-Dose Clinical Trial to Assess the Pharmacokinetics Efficacy of SM-88 Oral Administration in Breast Cancer Subjects|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Tyme, Inc||1|||f||||f||||||||||2017-10-10 22:53:14.422546|2017-10-10 22:53:14.422546
NCT02562599|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-28|||August 2015||2015-08-01|September 2015|2015-09-01|August 2018|Anticipated|2018-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin|Study Of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy With Raltitrexed-Cisplatin for Patients With Locally Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 2|60|Anticipated|Hubei Cancer Hospital||1|||f||||f||||||||||2017-10-10 22:53:14.494641|2017-10-10 22:53:14.494641
NCT02562586|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-09-28|||May 2014||2014-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Is Drainage Necessary After Total Hip Replacement?|Is Drainage Necessary After Total Hip Replacement? A Randomized Controlled Trial|Completed||N/A|92|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:53:14.61475|2017-10-10 22:53:14.61475
NCT02562573|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-04-10|||May 2015||2015-05-01|October 2016|2016-10-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome|A Phase 2, Single-Arm, Open-Label Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome|Completed||Phase 2|24|Actual|ProMetic BioSciences Inc.||1|||f||||t||||||||||2017-10-10 22:53:14.711203|2017-10-10 22:53:14.711203
NCT02562560|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-11-02|||September 2008||2008-09-01|November 2015|2015-11-01||||July 2015|Actual|2015-07-01||Interventional|2NIA||Neuropsycholgy and Neuroimaging in Transient Global Amnesia|Neuropsycholgy and Neuroimaging in Transient Global Amnesia|Terminated||N/A|60|Actual|University Hospital, Caen||2|||f||||||||||||||2017-10-10 22:53:14.792696|2017-10-10 22:53:14.792696
NCT02562547|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-27|||April 2015||2015-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Observational|||Evaluation of the Hem-Avert® Perianal Stabilizer Into Routine Clinical Practice|Evaluation of the Hem-Avert® Perianal Stabilizer Into Routine Clinical Practice|Completed||N/A|799|Actual|Desert Perinatal Associates|||1||f||||f||||||||||2017-10-10 22:53:14.870684|2017-10-10 22:53:14.870684
NCT02562534|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2015-09-28|||January 2014||2014-01-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|DB-ECG-3T||Creation of an ECG Database in 3T MRI With Healthy Heart and Several Kind of Cardiac Disease.|Use of a New ElectroCardioGraph to Create an ECG Database in 3T MRI With Healthy Heart and Several Kind of Cardiac Disease in Order to Let go of Artifacts.|Unknown status|Recruiting|N/A|30|Anticipated|Central Hospital, Nancy, France||3|||f||||f||||||||||2017-10-10 22:53:14.949817|2017-10-10 22:53:14.949817
NCT02562521|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-08-24|||September 2015||2015-09-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Smoking Cessation Intervention for Yale Dining Employees|A Smoking Cessation Intervention for Yale Dining Employees|Recruiting||Phase 4|60|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 22:53:15.069686|2017-10-10 22:53:15.069686
NCT02562508|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-12-29|||December 2015||2015-12-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls|Immunogenicity and Safety Study of a Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Female Subjects Aged 9 to 17 Years|Unknown status|Active, not recruiting|Phase 3|979|Actual|Xiamen University||3|||f||||f||||||||||2017-10-10 22:53:15.217366|2017-10-10 22:53:15.217366
NCT02562495|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-04|||January 21, 2016|Actual|2016-01-21|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|ECHOSCAN||Ultrasound to Evaluate the Quadriceps Muscle Wasting|Interest of the Ultrasound to Evaluate the Quadriceps Muscle Wasting in Critical Ill Patients.|Completed||N/A|42|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 22:53:15.325041|2017-10-10 22:53:15.325041
NCT02562482|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-10-21|||October 2015||2015-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults|Phase 2 Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Chikungunya Virus-Like Particle Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults|Active, not recruiting||Phase 2|400|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 22:53:15.420369|2017-10-10 22:53:15.420369
NCT02562469|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-09-25|||September 2015||2015-09-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||ACTIVATE: A Computerized Training Program for Children With ADHD|ACTIVATE: A Computerized Training Program for Children With ADHD|Unknown status|Recruiting|N/A|40|Anticipated|New York University||1|||f||||f||||||||||2017-10-10 22:53:15.725519|2017-10-10 22:53:15.725519
NCT02562456|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-06-14|||October 2015||2015-10-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Cost-efficacy Between ART and Composite Resin Restorations in Primary Molars|Difference of Cost-efficacy Between Atraumatic Restoration Treatment (ART) and Composite Resin Restorations in Primary Molars: A Randomized Clinical Trial|Recruiting||Phase 4|428|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:53:15.812494|2017-10-10 22:53:15.812494
NCT02562430|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-12-22|||August 2016||2016-08-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Neurobiological Underpinnings of Placebo Response in Depression|Neurobiological Underpinnings of Placebo Response in Depression|Recruiting||Phase 4|80|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 22:53:16.767391|2017-10-10 22:53:16.767391
NCT02562417|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex|Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex|Withdrawn||Phase 4|0|Actual|Centre Hospitalier Universitaire Vaudois||2||Change of practice in the department|f||||f||||||||||2017-10-10 22:53:16.89027|2017-10-10 22:53:16.89027
NCT02562404|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-03-02|||April 2015|Actual|2015-04-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Observational|||Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation|Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation (Vagus Nerve Study)|Completed||N/A|100|Actual|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-10-10 22:53:16.991545|2017-10-10 22:53:16.991545
NCT02562391|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-09-25|||May 2011||2011-05-01|September 2015|2015-09-01|May 2017|Anticipated|2017-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Left Atrial Appendage Excision on Procedure Outcome in Patients With Persistent and Long-standing Persistent Atrial Fibrillation Undergoing Surgical Ablation||Unknown status|Active, not recruiting|Phase 2|180|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 22:53:17.064252|2017-10-10 22:53:17.064252
NCT02562378|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-07|||October 2015||2015-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|July 2017|Anticipated|2017-07-01||Interventional|||T-DM1 and Non-pegylated Liposomal Doxorubicin in HER2-positive Metastatic Breast Cancer|Phase I Multicenter Clinical Trial Evaluating the Combination of Trastuzumab Emtansine (T-DM1) and Non-pegylated Liposomal Doxorubicin in HER2-positive Metastatic Breast Cancer|Recruiting||Phase 1|21|Anticipated|MedSIR||1|||f||||f||||||||||2017-10-10 22:53:17.170868|2017-10-10 22:53:17.170868
NCT02562365|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2016-12-02|||November 2015||2015-11-01|December 2016|2016-12-01|November 2023|Anticipated|2023-11-01|November 2021|Anticipated|2021-11-01||Interventional|ACTS||Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer|A Phase II,Randomized Study of Adjuvant Chemotherapy of Three-step Regimens (ACTS) in Stage IIIc and Stage IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (EOC, FTC, PPC)|Recruiting||Phase 2|130|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 22:53:17.293102|2017-10-10 22:53:17.293102
NCT02562352|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-08-28|||October 2015||2015-10-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|TAPER||Team Approach to Polypharmacy Evaluation and Reduction|Team Approach to Polypharmacy Evaluation and Reduction: Feasibility Study|Recruiting||N/A|75|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 22:53:17.404802|2017-10-10 22:53:17.404802
NCT02562339|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-06-24|||May 2015||2015-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Resiliency Training for Adolescents With Craniofacial Conditions and Their Caregivers|Examining the Psychosocial Effects of Resiliency Training for Adolescents With Craniofacial Conditions and Their Caregivers|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||2||"Due to the departure of study staff and lack of interest by potential subjects and the sponsor,   the investigators decided to end the study."|f||||f||||||||||2017-10-10 22:53:17.522842|2017-10-10 22:53:17.522842
NCT02562326|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-04-28|||September 2015||2015-09-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus|A Randomised, Monocentric, Double-blind, Multiple Daily Dose, Two-period 14 Day Cross-over Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of Individualised Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|51|Actual|Adocia||2|||f||||f||||||||||2017-10-10 22:53:17.624312|2017-10-10 22:53:17.624312
NCT02562313|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2016-11-21|||September 2015||2015-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®|A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®|Completed||Phase 1|80|Actual|Adocia||2|||f||||f||||||||||2017-10-10 22:53:17.723993|2017-10-10 22:53:17.723993
NCT02562300|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-27|2015-09-27|||January 2014||2014-01-01|January 2014|2014-01-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Uterotonics Using to Reduce Bleeding at Cesarean Section|Comparative Study of Sublingual Misoprostol Versus Oxytocin in Reducing Bleeding at Cesarean Section|Completed||Phase 2|120|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 22:53:17.820875|2017-10-10 22:53:17.820875
NCT02562287|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-08-17|||October 2015||2015-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder|A Randomized Controlled Trial to Evaluate the Effectiveness of Clozapine Versus Olanzapine, Quetiapine or Risperidone in Treatment Resistant Bipolar Disorder|Recruiting||Phase 4|54|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:53:17.90218|2017-10-10 22:53:17.90218
NCT02562274|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-02-27|||September 2014||2014-09-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Evaluation of Consumption Safety and Effect of Mulberry Leaves and Vietnamese Coriander Based Instant Polyherbal Porridge on Working Memory and Bone Formation Markers|Evaluation of Consumption Safety and Effect of Mulberry Leaves and Vietnamese Coriander Based Instant Polyherbal Porridge on Working Memory and Bone Formation Markers|Completed||Phase 1|45|Actual|Khon Kaen University||3|||f||||t||||||||||2017-10-10 22:53:18.195826|2017-10-10 22:53:18.195826
NCT02562261|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-05-24|||January 2015||2015-01-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Observational|PRESS||Platelet REactivity in Sepsis Syndrome (PRESS)|Platelet Reactivity During Different Stages of Sepsis|Active, not recruiting||N/A|140|Actual|University Hospital of Patras|||4||f||||t||||||||||2017-10-10 22:53:18.292603|2017-10-10 22:53:18.292603
NCT02562248|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-04-24|||September 1, 2015|Actual|2015-09-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Improving Anxiety Detection in Pediatrics Using Health Information Technology|Improving Anxiety Detection in Pediatrics Using Health Information Technology|Active, not recruiting||N/A|70|Anticipated|Indiana University||2|||f||||t||||||||Undecided||2017-10-10 22:53:18.380649|2017-10-10 22:53:18.380649
NCT02562235|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-28|2017-09-12|||October 29, 2015|Actual|2015-10-29|September 2017|2017-09-01|December 28, 2020|Anticipated|2020-12-28|December 28, 2018|Anticipated|2018-12-28||Interventional|PATENT-CHILD||Riociguat in Children With Pulmonary Arterial Hypertension (PAH)|Open-label, Individual Dose Titration Study to Evaluate Safety, Tolerability and Pharmacokinetics of Riociguat in Children From 6 to Less Than 18 Years of Age With Pulmonary Arterial Hypertension (PAH)|Recruiting||Phase 3|20|Anticipated|Bayer||1|||f||||t|t|f||||||||2017-10-10 22:53:18.508946|2017-10-10 22:53:18.508946
NCT02562222|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|August 2016|Anticipated|2016-08-01||Interventional|||Optimized tDCS for the Treatment of Migraine|Optimizing the Effect of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Migraine|Recruiting||Phase 2|14|Anticipated|Universidade Federal de Pernambuco||7|||f||||t||||||||||2017-10-10 22:53:18.873379|2017-10-10 22:53:18.873379
NCT02562209|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-26|2015-09-28|||January 2012||2012-01-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|PACER||High Protein Atkin's Complete (Lacto) VEgetaRian Diet (PACER) and Weight Loss|To Determine the Effect of PACER Diet (High Protein Atkin's Complete VEgetaRian Diet) in Obese Subjects|Completed||N/A|104|Actual|Diabetes Foundation, India||2|||f||||t||||||||||2017-10-10 22:53:19.031016|2017-10-10 22:53:19.031016
NCT02562196|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-05-10|||March 2016||2016-03-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|August 2016|Anticipated|2016-08-01||Interventional|||tDCS for the Treatment of Migraine|Effect of Transcranial Direct Current Stimulation (tDCS) Optimized Protocol for the Treatment of Migraine|Recruiting||Phase 2|14|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:53:19.177959|2017-10-10 22:53:19.177959
NCT02562183|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-06-18|||August 2015||2015-08-01|June 2017|2017-06-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein|The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein|Enrolling by invitation||Phase 4|2186|Anticipated|Techpool Bio-Pharma Co., Ltd.||1|||f||||f||||||||Undecided||2017-10-10 22:53:19.296265|2017-10-10 22:53:19.296265
NCT02562170|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-26|||July 2013||2013-07-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study|Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study|Completed||Phase 4|50|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 22:53:19.425066|2017-10-10 22:53:19.425066
NCT02562157|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-07-28|||February 2016||2016-02-01|July 2016|2016-07-01||||September 2018|Anticipated|2018-09-01||Interventional|||Endoscopic Gastroenteric Anastomosis With New Tissue Apposing Stent in the Management of Antro-pyloroduodenal Obstruction : Evaluation of Feasibility, Efficacy and Tolerance.|Gastroenteric Anastomosis With Natural Orifice Translumenal Endoscopic Surgery (NOTES) Using the New Fashionned Tissue Apposing Stent Axios® for the Treatment of Antro-pyloric or Duodenal Obstructions : Prospective Evaluation of Feasibility, Efficacy and Tolerance.|Recruiting||N/A|10|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-10 22:53:19.511291|2017-10-10 22:53:19.511291
NCT02562144|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-05-24|||April 5, 2016|Actual|2016-04-05|May 2017|2017-05-01|April 7, 2016|Actual|2016-04-07|April 6, 2016|Actual|2016-04-06||Interventional|Xylocaine||A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults|A Randomized Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults|Completed||Phase 4|17|Actual|Isala||2|||f||||f|f|f||||||No||2017-10-10 22:53:19.609493|2017-10-10 22:53:19.609493
NCT02562118|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-05-29|||September 2015||2015-09-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer|Phase Ib Followed by Phase II Study of Pre-operative Treatment With Lenvatinib Combined With Letrozole in Post-menopausal Women With Newly Diagnosed Hormone Receptor Positive Breast Cancer With Measurable Primary Breast Tumor|Recruiting||Phase 1/Phase 2|40|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-10 22:53:19.807896|2017-10-10 22:53:19.807896
NCT02562105|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-27|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Prognosis of Hematological Cancer Patient Underwent Mechanical Ventillation|In a Developing Country; What is the Fate of Hematologic Cancer Patients Requiring Mechanical Ventilation for More Than One Day? A Prospective Cohort Study|Completed||N/A|50|Actual|Mansoura University|||1||f||||t||||||||||2017-10-10 22:53:19.915872|2017-10-10 22:53:19.915872
NCT02562092|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-09-12|||August 2015||2015-08-01|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|GLADLY||The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project|The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project|Active, not recruiting||N/A|112|Actual|Emory University||3|||f||||f||||||||||2017-10-10 22:53:20.041942|2017-10-10 22:53:20.041942
NCT02562079|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-04-05|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|VISS||Vasculopathy, Inflammation and Systemic Sclerosis|Vasculopathy, Inflammation and Systemic Sclerosis: The Role of Endothelial Cell Activation and OX40/OX40L in Modulation of T Lymphocyte Activation|Completed||N/A|350|Actual|University Hospital, Bordeaux||3|||f||||f||||||||||2017-10-10 22:53:20.14147|2017-10-10 22:53:20.14147
NCT02562066|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-06-02|||January 2016||2016-01-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes|A Phase 3, Double-blind, Outpatient Crossover Study to Evaluate the Efficacy and Safety of Amifampridine Phosphate (3,4 Diaminopyridine Phosphate) in Patients With Congenital Myasthenic Syndromes (CMS)|Recruiting||Phase 3|20|Anticipated|Catalyst Pharmaceuticals, Inc.||2|||t||||f||||||||||2017-10-10 22:53:20.255164|2017-10-10 22:53:20.255164
NCT02562053|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-07-03|||October 2015||2015-10-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?|Does Adding Combined Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? A Double Blind Placebo Controlled Study.|Recruiting||Phase 3|300|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 22:53:20.386464|2017-10-10 22:53:20.386464
NCT02562040|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-02-02|||June 2016||2016-06-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|PATS||Pediatric Adenotonsillectomy for Snoring|Impact of Treatment of Mild Sleep-Disordered Breathing on Children's Health|Recruiting||N/A|460|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 22:53:20.533971|2017-10-10 22:53:20.533971
NCT02562027|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-02-21|||September 11, 2015|Actual|2015-09-11|February 2017|2017-02-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer|Objective Treatment Allocation With SBRT vs. Surgery in High Risk Patients With Early Stage Lung Cancer Within an Accountable Care Collaborative Effort Between Surgery and Radiation Oncology|Recruiting||N/A|400|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 22:53:20.684965|2017-10-10 22:53:20.684965
NCT02562014|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-09-28|||February 2012||2012-02-01|September 2015|2015-09-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Interventional|||Role of Colonic Short Chain Fatty Acids in Obesity|Effect of Inulin and Resistant Starch on Postprandial Short Chain Fatty Acid, Glucose, Insulin and Gut Hormone Responses in Lean and Overweight Subjects.|Completed||N/A|25|Actual|University of Toronto||2|||f||||f||||||||||2017-10-10 22:53:20.835668|2017-10-10 22:53:20.835668
NCT02562001|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-09-24|||November 2015||2015-11-01|September 2015|2015-09-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Association Between tDCS and Lokomat Training in Patients With Incomplete Spinal Cord Injury|Association of Transcranial Direct Current Stimulation (tDCS) With Gait Training With Partial Body Weight Support on the Robotic Device (Lokomat) for Treatment of Patients With Incomplete Spinal Cord Injury|Not yet recruiting||N/A|20|Anticipated|University of Sao Paulo General Hospital||4|||f||||f||||||||||2017-10-10 22:53:20.94361|2017-10-10 22:53:20.94361
NCT02561988|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-07-07|||December 2015||2015-12-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies|A Phase 1 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies|Recruiting||Phase 1|60|Anticipated|Blueprint Medicines Corporation||1|||f||||f||||||||||2017-10-10 22:53:21.042402|2017-10-10 22:53:21.042402
NCT02561975|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-08-25|||December 2014||2014-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CAR-DIFF||Adaptation of Alveolar-capillary Diffusion at Effort of Subjects Suffering From Complex Congenital Heart Disease||Recruiting||N/A|56|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 22:53:21.131863|2017-10-10 22:53:21.131863
NCT02561962|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-09-13|||November 20, 2015|Actual|2015-11-20|September 2017|2017-09-01|March 13, 2020|Anticipated|2020-03-13|August 20, 2018|Anticipated|2018-08-20||Interventional|||A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma|A Phase 1 First in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 224 in Subjects With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1|60|Anticipated|Amgen||1|||f||||f||||||||||2017-10-10 22:53:21.221198|2017-10-10 22:53:21.221198
NCT02561949|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Adapting Mental Health Interventions for War-Affected Youth Through Employment Programs|Adapting Mental Health Interventions for War-Affected Youth Through Employment Programs in Sierra Leone|Active, not recruiting||N/A|80|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-10 22:53:21.31535|2017-10-10 22:53:21.31535
NCT02561936|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-06-09|||October 2015||2015-10-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Relative Bioavailability of Three Oral Formulations Candidates of Rilpivirine for Potential Pediatric Use Compared to Oral Tablet|A Phase 1, Open-label, Randomized, 2-panel, 4-way Crossover Study in Healthy Adult Subjects to Assess the Rilpivirine Relative Bioavailability Compared to the 25-mg Oral Tablet and the Food Effect Following Single Dose Administration of Oral Pediatric Formulation Candidates|Completed||Phase 1|32|Actual|Janssen Sciences Ireland UC||8|||f||||f||||||||||2017-10-10 22:53:21.398566|2017-10-10 22:53:21.398566
NCT02561923|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-06-12|||August 27, 2015|Actual|2015-08-27|June 2017|2017-06-01|June 17, 2016|Actual|2016-06-17|June 17, 2016|Actual|2016-06-17||Interventional|||A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants|Randomized, Parallel-Group, 2-Part Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding Parameters and Pharmacodynamics After a Punch Biopsy Procedure in Healthy Subjects Treated With Rivaroxaban|Completed||Phase 1|158|Actual|Janssen Scientific Affairs, LLC||4|||f||||t|t|f||||||||2017-10-10 22:53:21.503647|2017-10-10 22:53:21.503647
NCT02561897|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-03-08|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ENTICED-AF||EdoxabaN or Warfarin Therapy In Cardiovascular Implantable Electrical Device Procedures in Patients With Non-Valvular Atrial Fibrillation|A Phase 4, Randomized, Open Label, Multicenter, Prospective Comparative Study to Evaluate the Efficacy and Safety of Edoxaban or Warfarin Therapy In Cardiovascular Implantable Electrical Device Procedures in Patients With Non-valvular Atrial Fibrillation|Terminated||Phase 4|5|Actual|Electrophysiology Research Foundation||2||Did not meet enrolment target for phase 1|f||||t|f|f||||||No||2017-10-10 22:53:21.794702|2017-10-10 22:53:21.794702
NCT02561884|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-09-25|||October 2015||2015-10-01|September 2015|2015-09-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers||Unknown status|Enrolling by invitation|Phase 1|58|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||||2017-10-10 22:53:21.869781|2017-10-10 22:53:21.869781
NCT02561871|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-10-31|||September 2015||2015-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers|Phase 1, First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers|Completed||Phase 1|34|Actual|Crucell Holland BV||3|||f||||f||||||||||2017-10-10 22:53:21.933444|2017-10-10 22:53:21.933444
NCT02561858|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-25|||October 2015||2015-10-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Toxicity of Perirenal Fat in Overweight or Obese Subjects: A Pathophysiological Link Between Uric Acid Stones and Renal Ammonium Formation|Toxicity of Perirenal Fat in Overweight or Obese Subjects: A Pathophysiological Link Between Uric Acid Stones and Renal Ammonium Formation|Unknown status|Not yet recruiting|N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 22:53:22.021147|2017-10-10 22:53:22.021147
NCT02561845|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-05-10|||October 2015||2015-10-01|April 2016|2016-04-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients|Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in Percutaneous Coronary Intervention Patients|Withdrawn||N/A|0|Actual|AstraZeneca|||1||f||||f||||||Samples Without DNA|"     whole blood   "|||2017-10-10 22:53:22.163956|2017-10-10 22:53:22.163956
NCT02561832|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-02-14|||November 2015||2015-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer|A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety, Tolerability and Efficacy of Olaparib in Combination With Carboplatin: Part A: Dose Escalation of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer; Followed by Part B: an Expansion Phase of Olaparib in Combination With Carboplatin in the Neoadjuvant Treatment of HER-2 Negative Breast Cancer Patients With Germline BRCA1/2 Mutations|Completed||Phase 1|20|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 22:53:22.249492|2017-10-10 22:53:22.249492
NCT02561819|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-10-03|||November 2015||2015-11-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients|Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients|Recruiting||N/A|25|Anticipated|Boston Children’s Hospital|||1||f||||f||||||Samples With DNA|"     Urine samples   "|No||2017-10-10 22:53:22.386192|2017-10-10 22:53:22.386192
NCT02561793|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-07-03|||October 2015||2015-10-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|DHEA||DHEA Versus Placebo in Women With Poor Ovarian Response|Does DHEA Improve Pregnancy Rate in Women Undergoing IVF/Intracytoplasmatic Sperm Injection(ICSI) With Expected Poor Ovarian Response According to the Bologna Criteria? A Double Blind Randomized Placebo Controlled Study|Recruiting||Phase 3|440|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 22:53:22.704224|2017-10-10 22:53:22.704224
NCT02561780|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-24|||October 2011||2011-10-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Impact of a Mental Health Curriculum for High School Students on Knowledge and Stigma|Youth Mental Health Awareness Study and Early Intervention Research Project|Completed||N/A|534|Actual|University of Ottawa||3|||f||||f||||||||||2017-10-10 22:53:22.807769|2017-10-10 22:53:22.807769
NCT02561767|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2015-09-25|||October 2015||2015-10-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Effect of BM-MSCs in DCD Kidney Transplantation|The Efficacy and Safety of Bone Marrow-derived Mesenchymal Stem Cells in Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Multi-center Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 1/Phase 2|120|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-10 22:53:22.885251|2017-10-10 22:53:22.885251
NCT02561754|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-03-08|||March 2015||2015-03-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|September 2019|Anticipated|2019-09-01||Interventional|IDDAdol||Weight Management for Adolescents With IDD|Weight Management for Adolescents With IDD|Recruiting||N/A|123|Anticipated|University of Kansas Medical Center||3|||f||||f|f|f||||||||2017-10-10 22:53:22.994552|2017-10-10 22:53:22.994552
NCT02561741|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-10-18|||December 2012||2012-12-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions|An Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Pharmacokinetics, Bioavailability, and Safety of 3 Tablets of COV155 Administered in Normal, Healthy Subjects Under Fed (High- and Low-Fat Meal) and Fasted Conditions|Completed||Phase 1|30|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-10 22:53:23.112974|2017-10-10 22:53:23.112974
NCT02561728|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-06-27|||July 2016||2016-07-01|June 2016|2016-06-01|October 2023|Anticipated|2023-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Hanger Helmet Study|Prospective Study to Evaluate Effectiveness of the Hanger Helmet vs the P Pod Helmet in Improving the Head and Face Symmetry|Withdrawn||N/A|0|Actual|Children's Hospital Medical Center, Cincinnati||2||No Participants Enrolled|f||||f||||||||||2017-10-10 22:53:23.172771|2017-10-10 22:53:23.172771
NCT02561715|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-10-24|||August 2015||2015-08-01|September 2015|2015-09-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|||Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson's|Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study to Examine the Effects of Anosognosia on Self-Reported Quality of Life for People With Parkinson's|Recruiting||N/A|20|Anticipated|University of Birmingham|||1||f||||f||||||||||2017-10-10 22:53:23.248176|2017-10-10 22:53:23.248176
NCT02561702|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-03-29|||September 2015||2015-09-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease|Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease|Completed||Phase 2|4|Actual|University of Rochester||2|||f||||f||||||||||2017-10-10 22:53:23.337629|2017-10-10 22:53:23.337629
NCT02561689|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-05-13|||January 2014||2014-01-01|May 2016|2016-05-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|SEALANT-DK||SEALANT-DK: Longevity and Efficacy of 6 Resin Sealants Used for Sealing Permanent Teeth in Children and Adolescents|SEALANT-DK: Longevity and Efficacy of 6 Resin Sealants Used for Sealing Permanent Teeth in Children and Adolescents|Active, not recruiting||N/A|248|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-10 22:53:23.427814|2017-10-10 22:53:23.427814
NCT02561676|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-09-25|||March 2015||2015-03-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Improving Functioning in Persons With Chronic Pain Post-SCI Through Virtual Classroom Education|Improving Functioning in Persons With Chronic Pain Post-SCI Through Virtual Classroom Education|Unknown status|Recruiting|Phase 1/Phase 2|80|Anticipated|Kessler Foundation||2|||f||||f||||||||||2017-10-10 22:53:23.502389|2017-10-10 22:53:23.502389
NCT02561663|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-09-25|||September 2015||2015-09-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||NWT03 and Arterial Stiffness|A Randomized, Double-blind, Placebo Controlled, Crossover Study to Determine the Effect of 5g Egg Protein Hydrolysate (NWT-03) on Arterial Stiffness, Microcirculation and Blood Pressure in Otherwise Healthy Subjects With Metabolic Syndrome|Unknown status|Recruiting|Phase 3|80|Anticipated|Newtricious R&D BV||2|||f||||f||||||||||2017-10-10 22:53:23.596506|2017-10-10 22:53:23.596506
NCT02561650|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-10-18|||December 2011||2011-12-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions|An Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Pharmacokinetics, Bioavailability, and Safety of COV155 Administered in Normal, Healthy Subjects Under Fed (High- and Low-Fat Meal) and Fasted Conditions|Completed||Phase 1|48|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-10 22:53:23.682392|2017-10-10 22:53:23.682392
NCT02561637|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-25|||August 2014||2014-08-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SICAM||The Effect of Spouses' Involvement Through Case Management in Older Patients' Fast-track Program|The SICAM-trial: Studying the Effect of Spouses' Involvement Through Case Management in Older Patients' Fast-track Program During and After Total Hip Replacement - A Quasi-experimental Study With a Complex Intervention|Completed||N/A|58|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-10 22:53:23.737634|2017-10-10 22:53:23.737634
NCT02561624|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-04-12|||July 2015||2015-07-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Hati Salama (Secure Voucher)|Expanding the Successful E-voucher System to Improve Malaria Prevention and Fight New Global Health Threats Through Innovative Health Partnerships and Mobile Phone Technology in Tanzania|Completed||N/A|5219|Actual|Queen's University||2|||f||||f||||||||||2017-10-10 22:53:23.810602|2017-10-10 22:53:23.810602
NCT02561611|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-09-22|||June 2016||2016-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|WorkACTIVE-P||Multi-component Workplace Energy Balance Intervention|Multi-component Workplace Energy Balance Intervention|Recruiting||N/A|40|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-10 22:53:23.88626|2017-10-10 22:53:23.88626
NCT02561598|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-07-28|||May 2014||2014-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia|A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia|Recruiting||N/A|350|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples With DNA|"     Samples from other approved projects will be used from both malignant hyperthermia cases and     controls.   "|||2017-10-10 22:53:23.978228|2017-10-10 22:53:23.978228
NCT02561585|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-05-08|||January 2016||2016-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||LEO 124249 Ointment in the Treatment of Alopecia Areata|Efficacy of Twice Daily Applications of LEO 124249 Ointment 30mg/g for 12 Weeks to Subjects With Alopecia Areata|Completed||Phase 2|31|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:53:24.068568|2017-10-10 22:53:24.068568
NCT02561572|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-02-01|2016-10-12||October 2015||2015-10-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Effect of Acupuncture on Pre-operative Anxiety Levels in Neurosurgical Patients: a Randomised, Controlled Trail|The Effect of Acupuncture on Pre-operative Anxiety Levels in Neurosurgical Patients: a Randomised, Controlled Trail|Completed||N/A|128|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 22:53:24.164707|2017-10-10 22:53:24.164707
NCT02561559|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2016-02-26|||April 2015||2015-04-01|September 2015|2015-09-01|April 2020|Anticipated|2020-04-01|April 2016|Anticipated|2016-04-01||Observational|||SBRT Treatment for Lung Metastasis From Soft Tissue Sarcoma|Phase II Study to Evaluate Feasibility and Safety of Stereotactic Body Radiation Radiotherapy (SBRT) for Lung Metastases From Soft Tissue Sarcoma|Recruiting||N/A|44|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||||||2017-10-10 22:53:24.439139|2017-10-10 22:53:24.439139
NCT02561351|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-05-02|||September 2013||2013-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation|Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation|Completed||N/A|70|Actual|Mahidol University|||1||f||||f||||||||||2017-10-10 22:53:26.32241|2017-10-10 22:53:26.32241
NCT02561546|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-25|||December 2015||2015-12-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma|A Phase II Study to Investigate Preliminary Efficacy Using p53 Gene Therapy for Treatment of Diabetes Concurrent With Hepatocellular Carcinoma|Not yet recruiting||Phase 2|40|Anticipated|Shenzhen SiBiono GeneTech Co.,Ltd||2|||f||||f||||||||||2017-10-10 22:53:24.521032|2017-10-10 22:53:24.521032
NCT02561533|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-07-13|||December 2014||2014-12-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma|Immunohistochemical Detection of the BRAFV600E Mutation on Cytological Specimen in PTC|Completed||N/A|53|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-10 22:53:24.608861|2017-10-10 22:53:24.608861
NCT02561520|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-08-24|||December 2016||2016-12-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD|Safety and Efficacy of Autologous Platelet Rich Plasma and Platelet Poor Plasma Eye Drops in the Treatment of Ocular Graft-Versus-Host Disease|Withdrawn||Phase 1|0|Actual|University of Pittsburgh||1||Study did not enroll participants is being withdrawn from the system.|f||||t||||||||||2017-10-10 22:53:24.699035|2017-10-10 22:53:24.699035
NCT02561507|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|||Perioperative Aspirin Usage Survey|Use of Aspirin in the Perioperative Setting: A Surgeon's Survey|Completed||N/A|150|Actual|University of New Mexico|||1||f||||f||||||||||2017-10-10 22:53:24.797764|2017-10-10 22:53:24.797764
NCT02561494|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-10-27|||June 2015||2015-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Postoperative Analgesic Effect of Nefopam||Completed||N/A|78|Actual|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-10 22:53:24.93399|2017-10-10 22:53:24.93399
NCT02561481|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-09-15|||December 2015||2015-12-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)|Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)|Recruiting||Phase 1/Phase 2|60|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-10 22:53:25.068868|2017-10-10 22:53:25.068868
NCT02561468|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-04-05|||April 2015||2015-04-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Preemptive Analgesic Efficacy of Nefopam||Completed||N/A|94|Actual|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-10 22:53:25.218209|2017-10-10 22:53:25.218209
NCT02561455|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-25|2017-09-21|||April 28, 2016|Actual|2016-04-28|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial|A Phase 1/2 Open-label Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial|Active, not recruiting||Phase 1/Phase 2|130|Anticipated|Astellas Pharma Inc||1|||t||||f||||||||||2017-10-10 22:53:25.298768|2017-10-10 22:53:25.298768
NCT02561442|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-04-24||2017-04-24|October 2015||2015-10-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration|A Single-Dose, Randomized, Three-way, Partially Blinded Crossover Study to Compare the Pharmacokinetics and Bioavailability of Ceftriaxone Administered as a 1 Gram Intravenous Infusion, a 1 Gram Subcutaneous Infusion and a 2 Gram Subcutaneous Infusion in Healthy Adult Subjects|Completed||Phase 2/Phase 3|18|Actual|scPharmaceuticals, Inc.||3|||f||||f|t|f||||||No||2017-10-10 22:53:25.387557|2017-10-10 22:53:25.387557
NCT02561429|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-05-02|||July 2013||2013-07-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Difference Histamine Concentration (1, 5 and 10 mg/ml) for Skin Prick Test Positive Control|Comparison of Difference Histamine Concentration (1, 5 and 10 mg/ml) for Positive Control of Skin Prick Test|Completed||N/A|180|Actual|Mahidol University||1|||f||||t||||||||||2017-10-10 22:53:25.472219|2017-10-10 22:53:25.472219
NCT02561416|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-04-24|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|EUDAIMON||Cost-utility and Biological Underpinnings of MBSR in Fibromyalgia Syndrome|Cost-utility and Biological Underpinnings of Mindfulness-Based Stress Reduction (MBSR) in Fibromyalgia Syndrome: A Three-arm Randomized, Controlled Trial (EUDAIMON Project)|Active, not recruiting||Phase 3|225|Actual|Fundació Sant Joan de Déu||3|||f||||f||||||||No||2017-10-10 22:53:25.697816|2017-10-10 22:53:25.697816
NCT02561403|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-10-03|||March 2016||2016-03-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Brain Aging in Veterans (BRAVE) Training: A Cognitive Training Pilot Trial in Older Veterans With Traumatic Brain Injury|Cognitive Reserve and Training in Older Veterans With Traumatic Brain Injury: Study 2|Recruiting||N/A|90|Anticipated|San Francisco Veterans Affairs Medical Center||3|||f||||||||||||||2017-10-10 22:53:25.808905|2017-10-10 22:53:25.808905
NCT02561390|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-05-02|||November 2013||2013-11-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Comparison Between spIgE and Skin Prick Test of Local and Imported Aeroallergens|In-vivo Potency Evaluation of American Cockroach, Dog, Cat, Dust Mites and Mold Allergen Extracts Produced by Siriraj Hospital Comparing With Imported Extracts by Using Skin Prick Test.|Completed||N/A|84|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 22:53:25.92347|2017-10-10 22:53:25.92347
NCT02561377|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-09-28|||September 2015||2015-09-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of Resistance Training on Metabolic Control and Outcome in Prediabetes (NMR-based Metabonomics)|Effect of Resistance Training on Metabolic Control and Outcome in Prediabetes (NMR-based Metabonomics)|Unknown status|Recruiting|N/A|276|Anticipated|Nanjing University of Traditional Chinese Medicine||3|||f||||f||||||||||2017-10-10 22:53:26.013207|2017-10-10 22:53:26.013207
NCT02561364|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-09-28|||October 2015||2015-10-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01|4 Weeks|Observational [Patient Registry]|BPP||Biophysical Profile in Preterm Pregnancies|Pattern of Human Fetal Biophysical Profile Scoring in Relationship to Gestational Age.|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Tennessee|||1||f||||f||||||||||2017-10-10 22:53:26.128363|2017-10-10 22:53:26.128363
NCT02561338|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-09-25|||September 2015||2015-09-01|September 2015|2015-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Multi-center 12-week Study of HMS5552 in T2DM|A Multi-center, Randomized, Double-blind, Placebo-controlled, 12-week Phase II Study to Evaluate the Safety, Tolerability, Efficacy and Population PK of HMS5552 in Type 2 Diabetic Adult Subjects|Completed||Phase 2|258|Actual|Hua Medicine Limited||5|||f||||f||||||||No||2017-10-10 22:53:26.413521|2017-10-10 22:53:26.413521
NCT02561325|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-07-25|||September 2015||2015-09-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|SODIVASC||"Comparative Evaluation of the Effect on Blood Pressure of an Equivalent Content of Sodium in the Form of Bicarbonate of Sodium and in the Form of Sodium Chloride, on Sensitive Sodium Subjects"|"Comparative Evaluation of the Effect on Blood Pressure of an Equivalent Content of Sodium in the Form of Bicarbonate of Sodium and in the Form of Sodium Chloride, on Sensitive Sodium Subjects"|Recruiting||N/A|192|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:53:26.542486|2017-10-10 22:53:26.542486
NCT02561312|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-24|||August 2015||2015-08-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|||Comparison of Two Methods of Transfusion for Stroke Prevention in Sickle Cell|Comparison of Two Methods of Transfusion for Stroke Prevention in Sickle Cell|Unknown status|Recruiting|N/A|8|Anticipated|Chattanooga-Hamilton County Hospital Authority|||2||f||||f||||||||||2017-10-10 22:53:26.691345|2017-10-10 22:53:26.691345
NCT02561299|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-06-08|||September 2015||2015-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|OPTIMIZE BTK||Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study|Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study|Recruiting||N/A|50|Anticipated|Cardiovascular Systems Inc||2|||f||||f||||||||||2017-10-10 22:53:26.820127|2017-10-10 22:53:26.820127
NCT02561286|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-09-28|||April 2008||2008-04-01|September 2015|2015-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|BRO||Being Responsible for Ourselves HIV Risk Reduction for Black MSM|Help Us, Save Us! HIV/STI Risk Reduction for Black Men Who Have Sex With Men|Completed||N/A|595|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:53:27.000343|2017-10-10 22:53:27.000343
NCT02561273|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-07-07|||October 2015||2015-10-01|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma|A Phase I/II Trial of CHOEP Chemotherapy Plus Lenalidomide as Front Line Therapy for Patients With Stage II, III and IV Peripheral T-Cell Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|54|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-10 22:53:27.1314|2017-10-10 22:53:27.1314
NCT02561260|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-09-27|||May 2015||2015-05-01|September 2015|2015-09-01||||May 2017|Anticipated|2017-05-01||Observational|||Multicenter and Prospective Clinical Registry Study of Autoimmune Encephalitis in China||Unknown status|Active, not recruiting|N/A|400|Anticipated|Beijing Tongren Hospital|||3||f||||||||||||||2017-10-10 22:53:27.413638|2017-10-10 22:53:27.413638
NCT02561247|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-09-07|||November 10, 2015|Actual|2015-11-10|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Prismaflex HF20 Set and Prismaflex® System 7.10 for Acute CRRT in Children|Clinical Evaluation of the Prismaflex HF20 Set and Prismaflex® System 7.10 for Acute Continuous Renal Replacement Therapy (CRRT) in Children|Recruiting||N/A|30|Anticipated|Baxter Healthcare Corporation||1|||f||||f||||||||||2017-10-10 22:53:27.481582|2017-10-10 22:53:27.481582
NCT02561234|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-06-23|||October 2015||2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors|A Phase I Multiple Dose, Dose Escalation Trial of AEB1102 (Co-ArgI-PEG) in Patients With Advanced Solid Tumors|Recruiting||Phase 1|100|Anticipated|Aeglea Biotherapeutics||1|||f||||f||||||||||2017-10-10 22:53:27.616987|2017-10-10 22:53:27.616987
NCT02561221|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-09-29|||April 2016||2016-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|PROPEL||Promoting Successful Weight Loss in Primary Care in Louisiana|Promoting Successful Weight Loss in Primary Care in Louisiana|Active, not recruiting||N/A|800|Anticipated|Pennington Biomedical Research Center||2|||f||||t||||||||||2017-10-10 22:53:27.776983|2017-10-10 22:53:27.776983
NCT02561208|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-02-23||||||February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of an Mhealth Intervention to Increase Adherence to Triage of HPV+ Women|Evaluation of an Mhealth Intervention to Increase Adherence to Triage of HPV+ Women Who Have Performed HPV-Test Self-collection|Withdrawn||N/A|0|Actual|Centro de Estudio de Estado y Sociedad||2||Because lack of funding|f||||f||||||||||2017-10-10 22:53:27.90132|2017-10-10 22:53:27.90132
NCT02561195|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-09-06|||July 16, 2015|Actual|2015-07-16|August 2017|2017-08-01|April 1, 2020|Anticipated|2020-04-01|March 7, 2017|Actual|2017-03-07||Interventional|||A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years|A Phase 2, Placebo-controlled, Randomized, Observer-blinded Study To Evaluate The Safety, Tolerability, And Immunogenicity Of Two 3-dose Regimens Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 To 85 Years|Active, not recruiting||Phase 2|855|Actual|Pfizer||6|||f||||t|t|f||||||||2017-10-10 22:53:27.990155|2017-10-10 22:53:27.990155
NCT02561182|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-10-25|||September 2015||2015-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Bone Health in Patients With Overgrowth|Bone Health in Patients With Overgrowth|Recruiting||N/A|15|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-10 22:53:28.132089|2017-10-10 22:53:28.132089
NCT02561169|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-08-03|||December 2015||2015-12-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza|A Randomized Controlled Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza|Terminated||Phase 4|1|Actual|McMaster University||2|||f||||||||||||||2017-10-10 22:53:28.20018|2017-10-10 22:53:28.20018
NCT02561156|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-05-25|||September 14, 2015|Actual|2015-09-14|May 2017|2017-05-01|July 23, 2017|Anticipated|2017-07-23|July 13, 2017|Anticipated|2017-07-13||Interventional|||TAK-653 Escalating Single and Multiple Dose Study in Healthy Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of TAK-653 in Healthy Subjects|Recruiting||Phase 1|112|Anticipated|Takeda||13|||f||||f|f|f||||||||2017-10-10 22:53:28.293508|2017-10-10 22:53:28.293508
NCT02561143|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-06-21|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Interventional|||"Effectiveness of Nutritional Counselling and Improved Atta Supplementation in Cachexic Adult Indian Cancer Patients"|"To Evaluate the Effectiveness of Nutritional Counselling and Improved Atta Supplementation in Delaying Progression of Cachexia to Refractory Cachexia in Adult Cancer Patients in Indian Population"|Completed||N/A|150|Actual|University of Westminster||2|||f||||t||||||||||2017-10-10 22:53:28.413439|2017-10-10 22:53:28.413439
NCT02561130|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-09-18|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|July 2017|Actual|2017-07-01||Interventional|||Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga|Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga|Active, not recruiting||Phase 4|154|Actual|Population Health Research Institute||2|||f||||f||||||||||2017-10-10 22:53:28.531769|2017-10-10 22:53:28.531769
NCT02561117|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-07-18|||January 2019|Anticipated|2019-01-01|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|January 2021|Anticipated|2021-01-01||Interventional|METRO||Once Daily Metronidazole for Perforated Appendicitis|Metronidazole Every 24 Hours as Part of Triple Antibiotic Therapy for Ruptured Appendicitis in Children Managed Operatively (METRO): a Noninferiority Randomized Controlled Trial|Withdrawn||Phase 4|0|Actual|Children's Hospital of Eastern Ontario||2||Lack of funding|f||||t|t|f|||t|||||2017-10-10 22:53:28.667105|2017-10-10 22:53:28.667105
NCT02561104|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-04-11|||December 2015||2015-12-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|August 2016|Anticipated|2016-08-01||Interventional|||Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification Cataract Surgery|Outcomes of Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification|Recruiting||N/A|180|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-10 22:53:28.752679|2017-10-10 22:53:28.752679
NCT02561078|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-09-12|||October 2015||2015-10-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|VIVID||An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus|Safety and Efficacy of Human Regular U-500 Insulin Administered by Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Subjects With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Parallel Clinical Trial|Completed||Phase 3|420|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 22:53:28.994356|2017-10-10 22:53:28.994356
NCT02561065|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-02-03|||May 2015||2015-05-01|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|TANSNIP-PESA||Long-term Impact Evaluation of a Worksite-based Lifestyle Intervention to Reduce Cardiovascular Risk in Office Workers|Long-term Impact Evaluation of a Worksite-based Lifestyle Intervention to Reduce Cardiovascular Risk in Office Workers|Enrolling by invitation||N/A|850|Anticipated|Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III||4|||f||||t||||||||||2017-10-10 22:53:29.305223|2017-10-10 22:53:29.305223
NCT02561052|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-05-09|||September 2, 2015||2015-09-02||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:53:29.442174|2017-10-10 22:53:29.442174
NCT02561039|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-11-01|||December 2006||2006-12-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease|Randomized, Open Label Study to Assess the Efficacy and Safety of the Intravenous and Oral Ibandronic Acid for Improving the Performance Status of Patients With Malignant Bone Disease Secondary to Solid Tumors and Hematological Malignancies|Completed||Phase 3|97|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:53:29.504429|2017-10-10 22:53:29.504429
NCT02561026|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-09-13|||January 2016||2016-01-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|TOPPIT||Transfusion of Plasma Prior to Invasive Procedures Pilot Trial (TOPPIT)|Transfusion of Plasma Prior to Invasive Procedures Pilot Trial (TOPPIT)|Recruiting||Phase 3|80|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:53:29.649854|2017-10-10 22:53:29.649854
NCT02561013|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-11-23|||September 2015||2015-09-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers|A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers|Withdrawn||N/A|0|Actual|3M||2||Business reasons|f||||f||||||||||2017-10-10 22:53:29.778472|2017-10-10 22:53:29.778472
NCT02561000|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-06-23|||April 2016||2016-04-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|TRIP-PCI||Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention- Thrombin Receptor Inhibitory Pepducin in PCI (TRIP-PCI)|Recruiting||Phase 2|600|Anticipated|Tufts Medical Center||3|||f||||t||||||||||2017-10-10 22:53:29.913995|2017-10-10 22:53:29.913995
NCT02560974|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-11-01|||June 2006||2006-06-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer|A Phase III Study Comparing Adjuvant Chemotherapy Consisting of Capecitabine/Oxaliplatin Versus Surgery Alone in Patients With Stage II (T1N2, T2N1, T3N0), IIIa (T2N2, T3N1, T4N0) and IIIb (T3N2) Gastric Adenocarcinoma|Completed||Phase 3|1035|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 22:53:30.059409|2017-10-10 22:53:30.059409
NCT02560961|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-09-23|||September 2015||2015-09-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Is Kinesio Taping Better Than Placebo Taping for Improving Performance During Unilateral Vertical Jump and Hop Tests?|Is Kinesio Taping Better Than Placebo Taping for Improving Performance During Unilateral Vertical Jump and Hop Tests? Protocol Study for a Randomized, Placebo-controlled, Double-blind, Clinical Trials.|Unknown status|Not yet recruiting|Phase 1|100|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 22:53:30.200375|2017-10-10 22:53:30.200375
NCT02560948|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-01-26|||December 2015||2015-12-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis|A Multicenter, International, Randomised, Double-blind, Placebo Controlled Study to Demonstrate the Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis|Unknown status|Recruiting|Phase 3|654|Anticipated|BioTech Tools S.A.||2|||f||||t||||||||||2017-10-10 22:53:30.286552|2017-10-10 22:53:30.286552
NCT02560935|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-03-20|||July 2016||2016-07-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|SPRING||Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II|Primary Prevention of Stroke in Children With Sickle Cell Disease in Sub-Saharan Africa II|Recruiting||Phase 3|440|Anticipated|Vanderbilt University Medical Center||2|||f||||t|f|f||||||No||2017-10-10 22:53:32.463444|2017-10-10 22:53:32.463444
NCT02560922|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-09-12|||April 2016||2016-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|STAART||Pain Coping Skills Training for African Americans With Osteoarthritis|Pain Coping Skills Training for African Americans With Osteoarthritis|Active, not recruiting||N/A|248|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 22:53:32.634163|2017-10-10 22:53:32.634163
NCT02560909|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-04-06|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|||Adjuvanted Influenza Vaccine in Stem Cell Transplant|A Randomized Controlled Trial Comparing Adjuvanted vs. Nonadjuvanted Influenza Vaccine in Adult Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients.|Completed||Phase 4|73|Actual|University Health Network, Toronto||2|||f||||f|f|f||||||No||2017-10-10 22:53:32.748973|2017-10-10 22:53:32.748973
NCT02560883|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-10-13|||January 2013||2013-01-01|October 2016|2016-10-01||||December 2025|Anticipated|2025-12-01||Observational|||Clinical Research in Hairy Cell Leukemia:Surveillance and Documentation of Clinical Outcomes|Clinical Research in Hairy Cell Leukemia: Surveillance and Documentation of Clinical Outcomes in a Rare Form of Adult Leukemia|Recruiting||N/A|1000|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-10 22:53:32.93563|2017-10-10 22:53:32.93563
NCT02560870|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-06-03|||March 2014||2014-03-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Compare the Efficacy of Aloe Vera Mouthwash With Non- Alcoholic Chlorhexidine Mouthwash on Periodontal Diseases|Randomized, Clinical Trial to Evaluate the Effects of Aloe Vera Mouthwash in Comparison With Non-alcoholic Chlorhexidine on Periodontal Disease|Completed||Phase 2/Phase 3|32|Actual|Islamic Azad University, Tehran||2|||f||||t||||||||||2017-10-10 22:53:32.998636|2017-10-10 22:53:32.998636
NCT02560857|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-04-06|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Observational|QTF-Monitor||Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients|Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients|Active, not recruiting||N/A|151|Actual|University Health Network, Toronto|||1||f||||f||||||Samples Without DNA|"     Whole blood samples (plasma will be extracted to perform Quantiferon-Monitor test)   "|||2017-10-10 22:53:33.060708|2017-10-10 22:53:33.060708
NCT02560844|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-05-24|||July 2015||2015-07-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|CARE||Cardiomyopathy Arrhythmia Risk Evaluation|Cardiomyopathy Arrhythmia Risk Evaluation|Recruiting||N/A|400|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 22:53:33.128313|2017-10-10 22:53:33.128313
NCT02560831|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-24|||March 2013||2013-03-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|TherExercOA||Effects of Therapeutic Exercises in Elderly Women With Knee Osteoarthritis|Assessment of the Effects of Therapeutic Exercises Associated With Pompage Technique on Pain, Muscle Strength and Postural Balance in Older Women With Knee Osteoarthritis: a Randomized Clinical Trial|Completed||N/A|22|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 22:53:33.189352|2017-10-10 22:53:33.189352
NCT02560818|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-11-10|||September 2015||2015-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CASOHAR||Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer|Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer|Recruiting||N/A|10|Anticipated|Centre Francois Baclesse||2|||f||||f||||||||||2017-10-10 22:53:33.251259|2017-10-10 22:53:33.251259
NCT02560805|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-12-20|||October 2015||2015-10-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ANG-P||Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV|Post-Traumatic Stress Disorder and Cardiovascular Disease Risk: Role of Sympathetic Overactivity and Angiotensin II|Recruiting||Phase 2|134|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 22:53:33.45303|2017-10-10 22:53:33.45303
NCT02560792|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-09-24|||September 2009||2009-09-01|September 2015|2015-09-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|TAG||Tailored Activity Goals - an Exercise Prescription Study||Completed||N/A|101|Actual|University of Colorado, Boulder||3|||f||||f||||||||||2017-10-10 22:53:33.609546|2017-10-10 22:53:33.609546
NCT02560597|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-24|||February 2015||2015-02-01|September 2015|2015-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy|Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy - Case Study in Patients With Epilepsia Partialis Continua (EPC) and Refractory Status Epilepticus (SE)|Enrolling by invitation||N/A|10|Anticipated|University Hospital, Ghent||1|||f||||t||||||||||2017-10-10 22:53:35.452765|2017-10-10 22:53:35.452765
NCT02560766|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-03-02|||January 2016||2016-01-01|March 2016|2016-03-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|RLS||An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS|A Multicenter, Double-Blind, Placebo Controlled, Parallel Group, Efficacy and Safety Evaluation of HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) in Adolescents Aged 13 to 17 Years Old With Moderate-to-Severe Primary Restless Legs Syndrome|Recruiting||Phase 4|132|Anticipated|XenoPort, Inc.||3|||f||||f||||||||||2017-10-10 22:53:33.852634|2017-10-10 22:53:33.852634
NCT02560753|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-06-06|||July 2015||2015-07-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|May 2016|Actual|2016-05-01||Interventional|||Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease|Phase 2a Feasibility Study of T3D-959 in Subjects With Mild to Moderate Alzheimer's Disease|Active, not recruiting||Phase 1/Phase 2|36|Anticipated|T3D Therapeutics, Inc.||4|||f||||f||||||||Undecided||2017-10-10 22:53:33.978642|2017-10-10 22:53:33.978642
NCT02560740|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2016-12-13|||March 2016||2016-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of the Efficacy and Safety of PerOx Quench on the Prevention of Oxaliplatin Treatment Induced Neuropathy|A Randomised, Double-blinded, Placebo Controlled Study to Assess the Efficacy and Safety of PerOx Quench or Placebo for 35 Days on the Prevention of Oxaliplatin Treatment Induced Sensory Neuropathy|Terminated||N/A|9|Actual|SMR Biotech Co., Ltd.||2||"Subjects' not-well compliance due to diarrhea and softening stool after taking PerOx Quench 4   sachets a day."|f||||f||||||||No||2017-10-10 22:53:34.123082|2017-10-10 22:53:34.123082
NCT02560727|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-24|||October 2014||2014-10-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|September 2015|Actual|2015-09-01||Observational|TET||To Evaluate the Feasibility, Safety, and Efficacy of TET for FMT Via Colonic Approach|Feasibility, Safety, and Efficacy of Transendoscopic Enteral Tubing in Fecal Microbiota Transplantation|Unknown status|Recruiting|Phase 2/Phase 3|200|Anticipated|The Second Hospital of Nanjing Medical University|||2||f||||t||||||||||2017-10-10 22:53:34.255957|2017-10-10 22:53:34.255957
NCT02560714|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-06-29|||August 2015||2015-08-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Observational|||SI Joint Fusion and Decortication Using the SImmetry System|SI Joint Fusion and Decortication Using the SImmetry System|Recruiting||N/A|25|Anticipated|Zyga Technology, Inc.|||1||f||||f||||||||||2017-10-10 22:53:34.389212|2017-10-10 22:53:34.389212
NCT02560701|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-10-15|||September 2015||2015-09-01|September 2015|2015-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Observational|||High Deductible Health Plans and Bipolar Disorder|Impact of High Deductible Health Plans on Patients With Bipolar Disorder|Active, not recruiting||N/A|109000|Anticipated|Harvard Pilgrim Health Care|||1||f||||t||||||||||2017-10-10 22:53:34.503516|2017-10-10 22:53:34.503516
NCT02560688|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-06-16|||December 2015||2015-12-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects|A Phase 1, Open-label, 2-period, Fixed-sequence Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion Coadministered With Clopidogrel in Healthy Subjects|Completed||Phase 1|22|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||||2017-10-10 22:53:34.590018|2017-10-10 22:53:34.590018
NCT02560675|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-09-26|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Observational|||Why Does Acute Post Whiplash Injury Pain Transform Into Chronic Pain?|Why Does Acute Post Whiplash Injury Pain Transform Into Chronic Pain? Multi-modal Assessment of Risk Factors and Predictors of Pain Chronification|Recruiting||N/A|870|Anticipated|Rambam Health Care Campus|||2||f||||f||||||Samples With DNA|"     Blood collection for genetics. Whole blood sample (10cc) will be collected from each subject     and placed in EDTA-coated tubes. Genomic DNA will be isolated using DNA Extraction Kit .     Quality and quantity of the DNA sample will be measured using a NanoDrop Machine.   "|||2017-10-10 22:53:34.721582|2017-10-10 22:53:34.721582
NCT02560662|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-03-25|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PhysSurg-B||PhysSurg-B : Physical Activity in Relation to Surgical Operations - Breast Cancer|PhysSurg-B : Physical Activity in Relation to Surgical Operations, a Prospective Open-label Randomized Controlled Multicenter Study of the Effect of Physical Activity on Recovery After Breast Cancer Surgery|Recruiting||N/A|340|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t|f|f||||||No||2017-10-10 22:53:34.84149|2017-10-10 22:53:34.84149
NCT02560649|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-23|||May 2015||2015-05-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Interventional|||An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients|"A Prospective, Randomized, Multicenter, Open-label, Exploratory Study of Utilizing of Response-Guided-Therapy (RGT) Strategy on Optimal Nucleoside Analogue (NUC)-Experienced Patients"|Unknown status|Active, not recruiting|Phase 4|324|Anticipated|Ruijin Hospital||3|||f||||||||||||||2017-10-10 22:53:34.953941|2017-10-10 22:53:34.953941
NCT02560636|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|PLUMMB||Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer|Phase I Study of Hypofractionated Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) in the Treatment of Advanced Bladder Cancer|Recruiting||Phase 1|34|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:53:35.092548|2017-10-10 22:53:35.092548
NCT02560623|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-02-08|||October 2015||2015-10-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|||Minimally-Invasive Detection of Barrett's Esophagus and Barrett's Esophagus Related Dysplasia/Carcinoma|Minimally-Invasive Detection of Barrett's Esophagus and Barrett's Esophagus Related Dysplasia/Carcinoma by a Sponge on String Device|Recruiting||N/A|320|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 22:53:35.2112|2017-10-10 22:53:35.2112
NCT02560610|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma|The Effect of OC000459 on Eosinophilic Airway Inflammation and Asthma Control in Subjects With Refractory Eosinophilic Asthma: a Randomised, Double-blind, Placebo Controlled Trial|Recruiting||Phase 2|40|Anticipated|Atopix Therapeutics, Ltd.||2|||f||||t||||||||||2017-10-10 22:53:35.351473|2017-10-10 22:53:35.351473
NCT02560389|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-07-05|||March 2016||2016-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)|Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)|Recruiting||Phase 4|105|Anticipated|University of Arkansas||3|||f||||t||||||||||2017-10-10 22:53:37.651605|2017-10-10 22:53:37.651605
NCT02560584|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-06-13|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|||A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting|A Prospective, Open, Comparative, Within Patient Controlled Multicenter Phase 3 Study of Blue Light Cystoscopy With Cysview and White Light Cystoscopy Using KARL STORZ D-Light C PDD Flexible Videoscope System in Detection of Bladder Cancer in Patients With Bladder Cancer|Completed||Phase 3|304|Actual|Photocure||1|||f||||f||||||||No|IPD will not be shared with other researchers|2017-10-10 22:53:35.564727|2017-10-10 22:53:35.564727
NCT02560571|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-09-18|||October 2015||2015-10-01|September 2016|2016-09-01||||October 2020|Anticipated|2020-10-01||Interventional|||Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients|Preoperative Evaluation of Endometrial Cancer|Recruiting||Phase 2|200|Anticipated|Meir Medical Center||1|||f||||||||||||||2017-10-10 22:53:35.887325|2017-10-10 22:53:35.887325
NCT02560558|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-09-01|||September 2015||2015-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Bela 8 Week Dosing|Belatacept Immunosuppression Therapy in Post-Transplant Kidney Recipients: Comparison of 4-Week and 8-Week Dosing Intervals|Recruiting||Phase 4|150|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 22:53:35.994214|2017-10-10 22:53:35.994214
NCT02560545|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-03-29|||September 2015||2015-09-01|March 2016|2016-03-01||||September 2016|Anticipated|2016-09-01||Interventional|||Cannabinoids Effects on the Pain Modulation System|Cannabinoids Effects on the Pain Modulation System|Recruiting||N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 22:53:36.183042|2017-10-10 22:53:36.183042
NCT02560532|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-07-10|||March 1, 2016||2016-03-01|July 2017|2017-07-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|REVERSE||Evaluation of the Efficacy and Safety of Clazosentan in Reversing Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage|A Prospective, Multi-center, Open-label, Single-arm, Phase 2 Study to Assess the Efficacy and Safety of Clazosentan in Reversing Angiographically-confirmed Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage (aSAH) Treated by Surgical Clipping or Endovascular Coiling|Completed||Phase 2|25|Actual|Actelion||1|||f||||f||||||||||2017-10-10 22:53:36.31355|2017-10-10 22:53:36.31355
NCT02560519|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-10-19|||January 2017||2017-01-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|ALBICS||Albumin in Cardiac Surgery|Albumin vs Ringer Solution for Cardiac Surgery|Not yet recruiting||Phase 4|1250|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-10 22:53:36.469374|2017-10-10 22:53:36.469374
NCT02560506|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-12-26|||January 2008||2008-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Development of Low Cost Devices to Increase Access to Treadmill Training|Development of Low Cost Devices to Increase Access to Treadmill Training|Completed||N/A|19|Actual|Shirley Ryan AbilityLab||1|||f||||f||||||||||2017-10-10 22:53:36.584082|2017-10-10 22:53:36.584082
NCT02560493|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-09-26|||October 2015||2015-10-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|GameSquad||Gaming Technology to Encourage Healthy Weight and Activity in Youth|Gaming Technology to Encourage Healthy Weight and Activity in Youth|Completed||N/A|46|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-10 22:53:36.689119|2017-10-10 22:53:36.689119
NCT02560480|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-08-30|||August 2015||2015-08-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Finngroin||Groin Injuries in Finnish Contact Sports|Groin Injuries in Finnish Contact Sports: Prospective 2-year Clinical and Magnetic Resonance Imaging Study|Recruiting||N/A|200|Anticipated|Kuopio University Hospital|||2||f||||t||||||||||2017-10-10 22:53:36.792527|2017-10-10 22:53:36.792527
NCT02560467|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-06-16|||December 1, 2015|Actual|2015-12-01|June 2017|2017-06-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Perfusion Imaging With Myocardial Contrast Echocardiography in HCM||Completed||N/A|10|Actual|Oregon Health and Science University||1|||f||||t||||||||||2017-10-10 22:53:36.909119|2017-10-10 22:53:36.909119
NCT02560454|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-08-12|||January 2016||2016-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|TDAHEC2||Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD)|Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD)|Recruiting||N/A|90|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 22:53:37.034037|2017-10-10 22:53:37.034037
NCT02560441|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-24|||September 2015||2015-09-01|September 2015|2015-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type|A Multicenter Phase II Trial to Evaluate the Safety and Efficacy of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|Chinese Academy of Medical Sciences||3|||f||||f||||||||||2017-10-10 22:53:37.203246|2017-10-10 22:53:37.203246
NCT02560428|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-09-14|||April 2015||2015-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|ESCALATES||Evaluating System Change to Advance Learning and Take Evidence to Scale (ESCALATES)|Evaluating System Change to Advance Learning and Take Evidence to Scale (ESCALATES)|Active, not recruiting||N/A|7|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-10-10 22:53:37.3114|2017-10-10 22:53:37.3114
NCT02560415|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-24|||September 2014||2014-09-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MICHELANGELO||Gaming Open Library for Intervention in Autism at Home (GOLIAH /MICHELANGELO)|Patient-centric Model for Remote Management, Treatment and Rehabilitation of Children With Autism - Michelangelo / GOLIAH (Gaming Open Library for Intervention in Autism at Home) Project|Completed||N/A|24|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:53:37.429752|2017-10-10 22:53:37.429752
NCT02560402|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-05-09|||August 2015||2015-08-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||The Relation Between the Renal Resistive Index and Glomerular Hyper Filtration|Relation Between Renal Resistive Index, Glomerular Hyperfiltration and Hyperdynamic Circulation in Critically Ill Patients With Trauma or Sepsis.|Completed||N/A|40|Actual|VU University Medical Center|||1||f||||f||||||||No||2017-10-10 22:53:37.536425|2017-10-10 22:53:37.536425
NCT02560376|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2015-09-24|||February 2014||2014-02-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis|68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis|Unknown status|Recruiting|Early Phase 1|100|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||||2017-10-10 22:53:37.796148|2017-10-10 22:53:37.796148
NCT02560363|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-01-08|||November 2015||2015-11-01|January 2016|2016-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects|An Open-label, Randomized, Cross Over Single Oral Dose Study Comparing the Pharmacokinetics of Different Formulations of AZD9977 (Part A) and Influence of Food (Part B) in Healthy Male Subjects|Withdrawn||Phase 1|0|Actual|AstraZeneca||4||Has been terminated before FSFV.|f||||f||||||||||2017-10-10 22:53:37.947296|2017-10-10 22:53:37.947296
NCT02560350|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-24|||August 2015||2015-08-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Small Intestinal Submucosa Scaffold Combined With Adipose-derived Stem Cells to Form an Adipocyte-containing Hypodermis|Implantation of a Small Intestinal Submucosa Scaffold Combined With Adipose-derived Stem Cells to Evaluate Its Potential to Form an Adipocyte-containing Hypodermis|Unknown status|Recruiting|N/A|5|Anticipated|Nanfang Hospital of Southern Medical University|||1||f||||f||||||||||2017-10-10 22:53:38.091967|2017-10-10 22:53:38.091967
NCT02560337|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-05-26|||September 2015||2015-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|CaTo-ROC||Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.|Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy - A Phase 2 Randomized, Open-label Study|Recruiting||Phase 2|34|Anticipated|Vejle Hospital||2|||f||||t||||||||||2017-10-10 22:53:38.192415|2017-10-10 22:53:38.192415
NCT02560324|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-09-14|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|RAP||Effect of Ramelteon on Smoking Abstinence|Repurposing Melatonin Receptor Agonists as Adjunct Treatments for Smoking Cessation|Recruiting||Phase 2|50|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 22:53:38.30682|2017-10-10 22:53:38.30682
NCT02560311|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-24|||December 2014||2014-12-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|September 2015|Anticipated|2015-09-01||Observational|||Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis|Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis|Unknown status|Recruiting|N/A|100|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-10 22:53:38.430348|2017-10-10 22:53:38.430348
NCT02560298|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-03-22|||January 2016||2016-01-01|March 2016|2016-03-01||||August 2018|Anticipated|2018-08-01||Interventional|InterAACT||Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer|InterAACT - An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin Plus 5-Fluorouracil Versus Carboplatin Plus Weekly Paclitaxel in Patients With Inoperable Locally Recurrent or Metastatic Disease|Recruiting||Phase 2|80|Anticipated|Eastern Cooperative Oncology Group||2|||f||||||||||||||2017-10-10 22:53:38.531652|2017-10-10 22:53:38.531652
NCT02560285|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-07-29|||January 2016||2016-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|February 2017|Anticipated|2017-02-01|30 Days|Observational [Patient Registry]|HiriSCORE||High-risk Patients in Cardiac Surgery Procedures: HiriSCORE|An International Multicenter Prospective Study for Identify High-risk Patients in Cardiac Surgery Procedures: HiriSCORE|Recruiting||N/A|3000|Anticipated|University of Sao Paulo General Hospital|||2||f||||t||||||||Yes|All data can be used by centers coparticipants after approval by the HiriSCORE group.|2017-10-10 22:53:38.701229|2017-10-10 22:53:38.701229
NCT02560272|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2015-09-24|||September 2014||2014-09-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried|A Phase III, Double Blind, Parallel-controlled, Randomised Study to Evaluate the Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine in Healthy Children 2 Months to 5 Years of Age|Unknown status|Recruiting|Phase 3|1560|Anticipated|Beijing Minhai Biotechnology Co., Ltd||2|||f||||f||||||||||2017-10-10 22:53:38.822328|2017-10-10 22:53:38.822328
NCT02560259|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-09-24|||October 2015||2015-10-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Role of Referred Pain From the Retro Trochanteric Region in Patients With Knee Pain|The Role of Referred Pain From the Retro Trochanteric Region in Patients With Knee Pain. Prevalence, Interpretation and Management: A Randomized Controlled Study|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-10-10 22:53:38.900269|2017-10-10 22:53:38.900269
NCT02560246|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-06-21|||April 2015||2015-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|MGM||Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth|Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth|Recruiting||N/A|400|Anticipated|University of Pennsylvania|||2||f||||f||||||Samples With DNA|"     1. Collect stool, maternal blood, cord blood, and placenta from women with preterm and term     labor in order to investigate whether diet and gut microbiome play a role in preterm birth.   "|||2017-10-10 22:53:38.99433|2017-10-10 22:53:38.99433
NCT02560233|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-04|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Modulating Stress-Reactivity by Real-Time Multimodal Functional Neuroimaging Based Neurofeedback|Modulating Stress-Reactivity by Real-Time Multimodal Functional Neuroimaging Based Neurofeedback|Not yet recruiting||N/A|60|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f|f|f||||||||2017-10-10 22:53:39.19388|2017-10-10 22:53:39.19388
NCT02560220|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-09-24|||August 2015||2015-08-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|TOL-1||MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients|A Single-arm Phase-I Trial for the Determination of Safety and Feasibility of the Intravenous Administration of Mitomycin C-treated Donor Peripheral Blood Mononuclear Cells (MICs) for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients (TOL-1 Study)|Unknown status|Recruiting|Phase 1|10|Anticipated|Heidelberg University||1|||f||||t||||||||||2017-10-10 22:53:39.3135|2017-10-10 22:53:39.3135
NCT02560207|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-10-26|||November 2015||2015-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU.|Does Continuous Cefotaxime Administration Improve Time to Attainment and Maintenance of Target Drug Levels in Critically Ill Patients?|Completed||Phase 4|60|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-10 22:53:39.414401|2017-10-10 22:53:39.414401
NCT02560194|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-24|||June 2014||2014-06-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Evaluation of Flexible Sigmoidoscopy Screening as an Adjunct to the National FOBT Screening Programme in Scotland|Evaluation of Flexible Sigmoidoscopy Screening as an Adjunct to the National FOBT Screening Programme in Scotland - A Random Evaluation|Unknown status|Recruiting|Phase 3|6000|Anticipated|University of Dundee||2|||f||||f||||||||||2017-10-10 22:53:39.499214|2017-10-10 22:53:39.499214
NCT02560181|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-10-12|||August 2014||2014-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer|Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer|Recruiting||Phase 1/Phase 2|15|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-10 22:53:39.608631|2017-10-10 22:53:39.608631
NCT02560168|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-07-25|||October 2015||2015-10-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease|Multidimensional Wavelet Analysis of Surface Electrocardiogram for Identifying Subclinical Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease|Recruiting||Phase 2/Phase 3|200|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-10 22:53:39.716858|2017-10-10 22:53:39.716858
NCT02560142|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-02-28|||August 2015||2015-08-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||A Non-interventional Functional Magnetic Resonance Imaging (fMRI) Study and Behavioral Assessment in Healthy Participants|Non-Drug, Single Site, fMRI and Behavior Assessment Optimization Study in Healthy Volunteers|Completed||N/A|31|Actual|Hoffmann-La Roche|||1||f||||||||||Samples With DNA|"     Whole blood for DNA extraction   "|||2017-10-10 22:53:39.990559|2017-10-10 22:53:39.990559
NCT02560129|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-06-05|||July 2015||2015-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||MICU Recovery Clinic|Evaluation of Outcomes Following Critical Illness Through a MICU Recovery Clinic|Recruiting||N/A|250|Anticipated|Wake Forest University Health Sciences|||1||f||||f|f|f||||||Undecided||2017-10-10 22:53:40.091423|2017-10-10 22:53:40.091423
NCT02560116|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-01-20|||June 2015||2015-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler Signals|The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler Signals to Assess Pulmonary Artery Systolic Pressures. Correlation With Invasive Measurements Obtained by Right Heart Catheterization|Withdrawn||N/A|0|Actual|Northwell Health|||1||f||||t||||||||||2017-10-10 22:53:40.229804|2017-10-10 22:53:40.229804
NCT02560103|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-05-10|||September 2015||2015-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||An Observational Study to Investigate the Effects of Rapid Transmeridian Travel|An Observational Study to Investigate the Effects of Rapid Travel|Recruiting||N/A|25|Anticipated|Vanda Pharmaceuticals|||1||f||||f||||||||||2017-10-10 22:53:40.315991|2017-10-10 22:53:40.315991
NCT02560090|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-01-03|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Bamberg Diabetes Transitional Care Pilot Study|Transforming Patient-Centered Medical Homes Into Medical Communities for Underserved Rural Patients|Active, not recruiting||N/A|58|Actual|Medical University of South Carolina||3|||f||||f||||||||||2017-10-10 22:53:40.424417|2017-10-10 22:53:40.424417
NCT02560077|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2016-03-21|||December 2010||2010-12-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Cashew Apple Juice on the Physiological and Psychological Fitness in the Middle Aged and Elderly Volunteers|Study the Effect of Cashew Apple Juice on the Physiological and Psychological Fitness in the Middle Aged and Elderly Volunteers|Completed||Phase 1|45|Actual|Khon Kaen University||3|||f||||t||||||||||2017-10-10 22:53:40.543435|2017-10-10 22:53:40.543435
NCT02560064|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-10-02|||November 2015||2015-11-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Observational|||Length of Small Bowel. How Can Standardise Measurement and Why?|Length of Small Bowel. How Can Standardise Measurement and Why?|Unknown status|Not yet recruiting|N/A|45|Anticipated|İnonu University|||1||f||||f||||||||||2017-10-10 22:53:40.637166|2017-10-10 22:53:40.637166
NCT02560051|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-23|||November 2015||2015-11-01|November 2016|2016-11-01|November 2023|Anticipated|2023-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer|Phase 2 Study of Androgen Deprivation Therapy (ADT) Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer|Recruiting||Phase 2|224|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||t||||||||No||2017-10-10 22:53:40.720001|2017-10-10 22:53:40.720001
NCT02560038|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-23|||October 2015||2015-10-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer|Phase II Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Urothelial Cancer|Recruiting||Phase 2|37|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||No||2017-10-10 22:53:40.849263|2017-10-10 22:53:40.849263
NCT02560025|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-08-15|||December 2015||2015-12-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML|A Phase II Study of the Aurora A Kinase Inhibitor Alisertib in Combination With 7+3 Induction Chemotherapy in Patients With High-risk Acute Myeloid Leukemia|Active, not recruiting||Phase 2|42|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 22:53:40.983916|2017-10-10 22:53:40.983916
NCT02560012|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-08-02|||January 4, 2016|Actual|2016-01-04|August 2017|2017-08-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Interventional|||Personalized Targeted Inhibitors Treatment in Renal Cell Cancer|Targeting of Renal Cell Cancer With Specific Inhibitors: A Model for Selective Adaptive Medicine Based on Molecular Alterations|Terminated||Phase 2|4|Actual|The University of Texas Health Science Center, Houston||1||Loss of laboratory performing molecular analysis|f||||t||||||||||2017-10-10 22:53:41.122262|2017-10-10 22:53:41.122262
NCT02559999|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2017-03-17|||June 4, 2014|Actual|2014-06-04|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Objective Markers of Pain Perception in Humans|Objective Markers of Pain Perception in Humans: a Study in Healthy Subjects|Recruiting||N/A|44|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||No||2017-10-10 22:53:41.224312|2017-10-10 22:53:41.224312
NCT02559986|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-23|||January 2012||2012-01-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Follow up of Mothers Suspected of Postpartum Depression|Follow-up of Postpartum Depression After Referral From Pediatric Clinics|Completed||N/A|73|Actual|Indiana University|||1||f||||f||||||||||2017-10-10 22:53:41.319586|2017-10-10 22:53:41.319586
NCT02559973|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder|A Single-Center, Randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine (RBP-6000) Using Poly (DL-lactide-co-glycolide) Polymer of Two Different Molecular Weights (Low and High Molecular Weights as Test Treatments) in Comparison to Intermediate Molecular Weight (Reference Treatment) in Treatment-Seeking Subjects With Opioid Use Disorder|Completed||Phase 1|47|Actual|Indivior Inc.||3|||f||||f||||||||No||2017-10-10 22:53:41.392294|2017-10-10 22:53:41.392294
NCT02559960|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-24|2016-11-30|||September 2015||2015-09-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Observational|||Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study|Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study|Recruiting||N/A|20000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t||||||||||2017-10-10 22:53:41.505781|2017-10-10 22:53:41.505781
NCT02559934|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-07-31|||November 2015||2015-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis|An Open-label, Multiple-dose, Pharmacokinetic Study of SR-T100 Gel (Containing 2.3% Solamargine in Solanum Undatum Plant Extract) in Patients With Actinic Keratosis|Recruiting||Phase 1|10|Anticipated|G&E Herbal Biotechnology Co., LTD||1|||f||||f||||||||||2017-10-10 22:53:41.686344|2017-10-10 22:53:41.686344
NCT02559921|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-01-19|||December 2014||2014-12-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.||Completed||Phase 2|300|Actual|Beijing Chaoyang District Centre for Disease Control and Prevention||7|||f||||||||||||||2017-10-10 22:53:41.786226|2017-10-10 22:53:41.786226
NCT02559908|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-06-15|||February 27, 2015|Actual|2015-02-27|June 2017|2017-06-01|December 30, 2017|Anticipated|2017-12-30|February 12, 2016|Actual|2016-02-12||Interventional|||A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw|A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of VYC-25L Hyaluronic Acid Injectable Gel for Restoration and Creation of Facial Volume in the Chin and Jaw|Active, not recruiting||N/A|120|Actual|Allergan||2|||f||||f|f|f||||||||2017-10-10 22:53:41.868935|2017-10-10 22:53:41.868935
NCT02559895|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-04-11|||September 2015||2015-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|PROMISE 1||A Multicenter Assessment of ALD403 in Frequent Episodic Migraine|A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines|Active, not recruiting||Phase 3|900|Actual|Alder Biopharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-10 22:53:42.001267|2017-10-10 22:53:42.001267
NCT02559882|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-09-24|||August 2015||2015-08-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||How to Test Success of a Renal Denervation|Testing Effectiveness of Renal Denervation in Patients With Therapy-resistant Hypertension|Unknown status|Recruiting|N/A|20|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 22:53:42.27972|2017-10-10 22:53:42.27972
NCT02559869|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-09-27|||November 2015||2015-11-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|TRACK-ALS||Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis|Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples With DNA|"     iPSC Line Generation, DNA, Inflammatory Markers, Plasma, CSF   "|||2017-10-10 22:53:42.35668|2017-10-10 22:53:42.35668
NCT02559856|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-08-10|||May 2016|Actual|2016-05-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|COBRRA||Comparison of Bleeding Risk Between Rivaroxaban and Apixaban|Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: The Pilot Study|Active, not recruiting||Phase 4|72|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:53:42.477514|2017-10-10 22:53:42.477514
NCT02559843|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-23|||November 2014||2014-11-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Pomegranate Juice on Oxidative Stress in Patients With type2 Diabetes|Effects of Pomegranate Juice Consumption on Glycemic Control, Lipid Profile, Oxidative Stress and Blood Pressure in Patients With Type 2 Diabetes|Completed||Phase 4|60|Actual|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-10 22:53:42.588015|2017-10-10 22:53:42.588015
NCT02559830|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-09-23|||January 2015||2015-01-01|September 2015|2015-09-01|October 2025|Anticipated|2025-10-01|October 2025|Anticipated|2025-10-01||Interventional|||Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy|A Phase I/II Clinical Trial of Lentiviral Hematopoietic Stem Cell Gene Therapy for Treatment of Developed Metachromatic Leukodystrophy and Adrenoleukodystrophy|Recruiting||Phase 1/Phase 2|50|Anticipated|Shenzhen Second People's Hospital||1|||f||||t||||||||||2017-10-10 22:53:42.837531|2017-10-10 22:53:42.837531
NCT02559817|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-07-18|||November 1, 2015|Actual|2015-11-01|July 2017|2017-07-01|May 5, 2018|Anticipated|2018-05-05|May 5, 2018|Anticipated|2018-05-05||Interventional|LIN-MD-63||A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, A Multicenter, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation (IBS-C) (ie, Fulfill Rome III Criteria for Child/Adolescent IBS and Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation|Recruiting||Phase 2|260|Anticipated|Forest Laboratories||5|||f||||t|t|f||||||||2017-10-10 22:53:42.985|2017-10-10 22:53:42.985
NCT02559804|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-01-25|||May 2014||2014-05-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|NB-SCI||Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)|Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)|Recruiting||N/A|150|Anticipated|Associazione Italiana Ematologia Oncologia Pediatrica|||1||f||||f||||||||||2017-10-10 22:53:43.244351|2017-10-10 22:53:43.244351
NCT02559791|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-02-09|||October 2015||2015-10-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma|Route of Administration of Anti-IL5 Monoclonal Antibody in Prednisone-dependent Eosinophilic Asthma|Enrolling by invitation||Phase 2/Phase 3|15|Anticipated|McMaster University||1|||f||||f||||||||||2017-10-10 22:53:43.364465|2017-10-10 22:53:43.364465
NCT02559778|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-04-25|||September 2015||2015-09-01|April 2017|2017-04-01|September 2025|Anticipated|2025-09-01|September 2020|Anticipated|2020-09-01||Interventional|PEDS-PLAN||Pediatric Precision Laboratory Advanced Neuroblastoma Therapy|PEDS-PLAN - Pediatric Precision Laboratory Advanced Neuroblastoma Therapy- A Pilot Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by Maintenance With DFMO for Subjects With Newly Diagnosed High-Risk Neuroblastoma|Recruiting||Phase 1|24|Anticipated|Spectrum Health Hospitals||1|||f||||t||||||||||2017-10-10 22:53:43.506819|2017-10-10 22:53:43.506819
NCT02559765|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-05-11|||August 2015||2015-08-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.|Current Access to, Use and Perceived Efficacy of Physiotherapy and Rehabilitation Services by People With Progressive Multiple Sclerosis: a Survey of People With Progressive Multiple Sclerosis Via the UK MS Register.|Completed||N/A|1298|Actual|University of Glasgow|||1||f||||f||||||||||2017-10-10 22:53:43.708273|2017-10-10 22:53:43.708273
NCT02559752|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-09-27|||October 13, 2015|Actual|2015-10-13|September 2017|2017-09-01|October 30, 2021|Anticipated|2021-10-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy|Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy|Recruiting||N/A|80|Anticipated|Washington University School of Medicine||1|||f||||f|f|f||||||||2017-10-10 22:53:43.842553|2017-10-10 22:53:43.842553
NCT02559739|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-05-08|||July 2015||2015-07-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Sleep Deficiency and Stroke Outcome|Sleep Deficiency and Sleep Fragmentation and Their Impact on the Short- and Long-term Outcome of Ischemic Stroke and Transient Ischemic Attacks - a Two-center Prospective Observational Cohort Study|Recruiting||N/A|520|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-10 22:53:43.964824|2017-10-10 22:53:43.964824
NCT02559726|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-06-24|||June 2015||2015-06-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|HSYNC||Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response|Identification and Quantification of a Mechanical Hyper-synchronicity State in Hypertrophic Cardiomyopathy (HCM) With Left Outflow-tract Obstruction and Description of Its Electrical and Electro-mechanical Characteristics Thanks to an Innovative Multi-imaging Approach to Predict a Positive Response to Dual Chamber Pacing. The Hsync Study.|Recruiting||N/A|60|Anticipated|University Hospital, Bordeaux||3|||f||||f||||||||||2017-10-10 22:53:44.105838|2017-10-10 22:53:44.105838
NCT02559713|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-09-11|||November 15, 2015|Actual|2015-11-15|September 2017|2017-09-01|February 23, 2018|Anticipated|2018-02-23|February 23, 2018|Anticipated|2018-02-23||Interventional|||Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease|An Open-Label, Multicenter and Open Enrollment Model, Postmarketing, Milk-Only Lactation Study to Assess Concentration of Vedolizumab in Breast Milk of Lactating Women With Active Ulcerative Colitis or Crohn's Disease Who Are Receiving Vedolizumab Therapeutically|Recruiting||Phase 4|12|Anticipated|Takeda||1|||f||||f|t|f||||||||2017-10-10 22:53:44.245641|2017-10-10 22:53:44.245641
NCT02559700|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-23|||November 2015||2015-11-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Online Brain Training Intervention for Over 50s|Optimising Engagement in an Online Brain Training Intervention for Adults Over 50|Not yet recruiting||N/A|10000|Anticipated|King's College London||1|||f||||f||||||||||2017-10-10 22:53:44.348847|2017-10-10 22:53:44.348847
NCT02559687|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-09-06|||December 2, 2015|Actual|2015-12-02|September 2017|2017-09-01|March 18, 2019|Anticipated|2019-03-18|September 26, 2017|Anticipated|2017-09-26||Interventional|||Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)|A Phase II Study of Pembrolizumab Monotherapy in Third-line Previously Treated Subjects With Advanced/Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus or Advanced/Metastatic Siewert Type I Adenocarcinoma of the Esophagogastric Junction (KEYNOTE -180)|Active, not recruiting||Phase 2|100|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 22:53:44.437226|2017-10-10 22:53:44.437226
NCT02559674|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-10-26|||July 2016||2016-07-01|October 2016|2016-10-01|July 2022|Anticipated|2022-07-01|July 2019|Anticipated|2019-07-01||Interventional|||QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel|Phase Ib/II Study of ALT-803 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Advanced Pancreatic Cancer|Recruiting||Phase 1/Phase 2|66|Anticipated|Altor BioScience||1|||f||||t||||||||No||2017-10-10 22:53:44.570051|2017-10-10 22:53:44.570051
NCT02559661|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-23|||October 2015||2015-10-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|April 2016|Anticipated|2016-04-01||Observational|||Virtual Surgery: Construction of a Training Program and Analysis of Significant Factors for Operating Performance|Virtual Vitreoretinal Surgery: Construction of a Training Program and Analysis of Significant Factors for Operating Performance|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Odense University Hospital|||3||f||||f||||||||||2017-10-10 22:53:44.681954|2017-10-10 22:53:44.681954
NCT02559648|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-04-18|||September 2014||2014-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis|Evaluation of Efficacy of Denosumab in Patients With Thalassemia Major and Osteoporosis: A Randomized, Placebo-controlled, Single-site, Double Blind Phase 2b Clinical Trial|Active, not recruiting||Phase 2|63|Actual|Laikon General District Hospital, Athens||2|||f||||f||||||||Undecided||2017-10-10 22:53:44.762305|2017-10-10 22:53:44.762305
NCT02559635|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-04-06|||December 2016||2016-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Does Bowel Stimulation Before Loop Ileostomy Closure Reduce Postoperative Ileus?|Does Bowel Stimulation Before Loop Ileostomy Closure Reduce Postoperative Ileus? A Multicenter Randomized Controlled Trial|Recruiting||N/A|166|Anticipated|Jewish General Hospital||2|||f||||f||||||||||2017-10-10 22:53:44.853755|2017-10-10 22:53:44.853755
NCT02559622|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-04-19|2017-04-19||April 2014||2014-04-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CARIMA||Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab|A Randomized, Double-blind, Placebo-controlled, Multicenter, Exploratory Evaluation of Surrogate Markers of Cardiovascular Risk in Patients With Active Chronic Plaque-type Psoriasis Treated for up to 52 Weeks With Subcutaneous (s.c.) Secukinumab (300 mg or 150 mg).|Completed||Phase 3|151|Actual|Novartis||4|||f||||f||||||||||2017-10-10 22:53:45.029144|2017-10-10 22:53:45.029144
NCT02559609|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-06-23|||January 2016||2016-01-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Interventions for Unemployed Hazardous Drinkers|Interventions for Unemployed Hazardous Drinkers|Recruiting||N/A|280|Anticipated|UConn Health||4|||f||||t||||||||||2017-10-10 22:53:47.659759|2017-10-10 22:53:47.659759
NCT02559596|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-05-03|||June 2015||2015-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Reactivation of Varicella Zoster Virus and Risk of Vascular Disease|Reactivation of Varicella Zoster Virus and Risk of Vascular Disease in the Health Survey for England: a Nested Case Control Study|Active, not recruiting||N/A|2000|Anticipated|University College, London|||2||f||||f||||||||||2017-10-10 22:53:48.003413|2017-10-10 22:53:48.003413
NCT02559583|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-07-19|||July 2014||2014-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|HOLA||Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America|Hemato-Oncology Latin America Observational Registry in CLL, Multiple Myeloma, Non-Hodgkin Lymphoma|Completed||Phase 4|5443|Actual|Janssen-Cilag Ltd.|||3||f||||f||||||||||2017-10-10 22:53:48.118007|2017-10-10 22:53:48.118007
NCT02559570|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-07-18|||November 30, 2015|Actual|2015-11-30|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|LIN-MD-62||A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)|Recruiting||Phase 2|160|Anticipated|Forest Laboratories||5|||f||||t|t|f||||||||2017-10-10 22:53:48.382071|2017-10-10 22:53:48.382071
NCT02559557|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-08-30|||October 22, 2015|Actual|2015-10-22|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects|Adaptation and Pilot-Testing a Parenting Intervention for Spanish-Speaking Parents of Children at Risk for Neurocognitive Late Effects|Active, not recruiting||N/A|50|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 22:53:48.665431|2017-10-10 22:53:48.665431
NCT02559544|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-07-28|||May 2015||2015-05-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||[18F]Fluoroestradiol (FES) PET/CT Imaging to Evaluate in Vivo Estrogen Receptor Activity in Endocrine Refractory Recurrent or Metastatic Breast Cancer|[18F]Fluoroestradiol (FES) PET/CT Imaging to Evaluate in Vivo Estrogen Receptor Activity in Endocrine Refractory Recurrent or Metastatic Breast Cancer|Recruiting||N/A|50|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:53:48.787043|2017-10-10 22:53:48.787043
NCT02559531|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-12-24|||September 2015||2015-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Reliability of the Swiss Emergency Triage Scale (SETS®) Used by Emergency Medical Service (EMS) Providers|Reliability of the Swiss Emergency Triage Scale (SETS®) Used by Emergency Medical Service (EMS) Providers|Completed||N/A|23|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-10-10 22:53:48.88229|2017-10-10 22:53:48.88229
NCT02559518|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-07-03|||September 2015||2015-09-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Non-invasive Cerebellar Stimulation on Motor Learning|Effects of Non-invasive Cerebellar Stimulation on Motor Learning and Cortical Electrical Activity of Healthy Individuals|Unknown status|Active, not recruiting|N/A|18|Anticipated|Universidade Federal de Pernambuco||6|||f||||t||||||||||2017-10-10 22:53:48.969468|2017-10-10 22:53:48.969468
NCT02559492|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-07-11|||November 2015||2015-11-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors|A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors|Active, not recruiting||Phase 1|114|Anticipated|Incyte Corporation||2|||f||||f||||||||||2017-10-10 22:53:49.22882|2017-10-10 22:53:49.22882
NCT02559479|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-12-01|||September 2015||2015-09-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes|A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes|Recruiting||N/A|100|Anticipated|Instituto Aragones de Ciencias de la Salud||2|||f||||f||||||||Yes||2017-10-10 22:53:49.346353|2017-10-10 22:53:49.346353
NCT02559466|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-06|||September 2015||2015-09-01|September 2015|2015-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of Deep Transcranial Magnetic Stimulation (TMS) for Treatment-resistant Depression and Neuroanatomical Correlates: a Clinical Study Coupled With Positon Emission Tomography (PET)|Efficacy of Deep Transcranial Magnetic Stimulation (TMS) for Treatment-resistant Depression and Neuroanatomical Correlates: a Randomized Clinical Study Coupled With Positon Emission Tomography (PET)|Unknown status|Recruiting|N/A|36|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:53:49.438856|2017-10-10 22:53:49.438856
NCT02559453|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-07-07|||September 2015||2015-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds|A Randomized Trial Comparing the Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds Requiring Hospitalization|Enrolling by invitation||N/A|250|Anticipated|Georgetown University||2|||f||||f||||||||||2017-10-10 22:53:49.530045|2017-10-10 22:53:49.530045
NCT02559427|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-07-04|||October 2016||2016-10-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|THERMA-SAS||SPA Therapy in the Treatment of Sleep Apnea Syndrome|Impact of 3-week SPA Therapy on Sleep Apnea in Patients With Obstructive Sleep Apnea Syndrome and Chronic Venous Insufficiency: A Randomized, Controlled Study|Recruiting||N/A|100|Anticipated|Association Francaise pour la Recherche Thermale||2|||f||||f||||||||||2017-10-10 22:53:49.699712|2017-10-10 22:53:49.699712
NCT02559414|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-08-08|2017-08-08||February 2015|Actual|2015-02-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|April 2016|Actual|2016-04-01||Interventional|||Antiplatelet Therapy in HIV|Antiplatelet Therapy in HIV - Antiplatelet and Immune Modulating Effects of Aspirin or Clopidogrel in Subjects With HIV|Completed||Phase 2|55|Actual|New York University School of Medicine||3|||f||||f||||||||||2017-10-10 22:53:49.883898|2017-10-10 22:53:49.883898
NCT02559401|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-04-11|||June 2014||2014-06-01|April 2016|2016-04-01||||June 2017|Anticipated|2017-06-01||Observational|||Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation|Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation|Recruiting||N/A|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:53:50.364239|2017-10-10 22:53:50.364239
NCT02559375|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-02-23|||September 2014||2014-09-01|February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Observational|||PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals|PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals|Active, not recruiting||N/A|466|Actual|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:53:50.529152|2017-10-10 22:53:50.529152
NCT02559362|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-09-23|||April 2015||2015-04-01|September 2016|2016-09-01||||June 2016|Actual|2016-06-01||Observational|||Study on Breast Cancer Patient Perspectives of Exercise|Study on Breast Cancer Patient Perspectives of Exercise|Active, not recruiting||N/A|26|Actual|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:53:50.597938|2017-10-10 22:53:50.597938
NCT02559349|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-04-11|||September 2015||2015-09-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Observational|||Gut Microbiota And Radiotherapy|Gut Microbiota And Radiotherapy|Recruiting||N/A|10|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||Samples Without DNA|"     Stool Sample   "|||2017-10-10 22:53:50.661794|2017-10-10 22:53:50.661794
NCT02559336|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-03-27|||November 22, 2015|Actual|2015-11-22|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|November 30, 2016|Actual|2016-11-30||Interventional|SPaRK||Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General Hospital|Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General Hospital|Active, not recruiting||N/A|865|Actual|National Cancer Centre, Singapore||2|||f||||f||||||||||2017-10-10 22:53:50.733793|2017-10-10 22:53:50.733793
NCT02559323|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-04-11|||May 2010||2010-05-01|April 2016|2016-04-01||||May 2017|Anticipated|2017-05-01||Observational|||LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey|LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey|Recruiting||N/A|2000|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:53:50.82211|2017-10-10 22:53:50.82211
NCT02559310|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-05-30|||September 2015||2015-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|LEAP||Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia|A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Lefamulin (BC 3781) Versus Moxifloxacin (With or Without Adjunctive Linezolid) in Adults With Community-Acquired Bacterial Pneumonia|Completed||Phase 3|551|Actual|Nabriva Therapeutics AG||2|||f||||t||||||||||2017-10-10 22:53:50.904044|2017-10-10 22:53:50.904044
NCT02559297|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-06-14|||August 10, 2015|Actual|2015-08-10|June 2017|2017-06-01|June 3, 2017|Actual|2017-06-03|June 3, 2017|Actual|2017-06-03||Interventional|||Effects of Sevoflurane and Desflurane on Treg|Effects of Sevoflurane and Desflurane Anesthesia on Regulatory T Cells in Patients Undergoing Living Donor Kidney Transplantation|Completed||Phase 2|40|Actual|Mahidol University||2|||f||||f||||||||Yes|Data is obtained by flow cytometry and multiplex immunoassay. The data includes percentages of regulatory T cells and the measured cytokines. The data will be available in the end of study period, 05/2017.|2017-10-10 22:53:51.19849|2017-10-10 22:53:51.19849
NCT02559284|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-08-31|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|NETIFLOW||RESPIMER® Netiflow® vs. Saline Solutions During Nasal Irrigation Following Bilateral Ethmoidectomy (Nasal Polyposis)|A Comparative, Multicenter and Randomized Study Evaluating the Safety and Efficacy of RESPIMER® Netiflow® Versus Saline Solutions During Nasal Irrigation Following Bilateral Ethmoidectomy in the Treatment of Nasal Polyposis.|Completed||N/A|189|Actual|Laboratoire de la Mer||2|||f||||f||||||||||2017-10-10 22:53:51.288937|2017-10-10 22:53:51.288937
NCT02559271|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-22|||August 2015||2015-08-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Pediatric Refraction With SVOne Autorefractor|Pediatric Refraction With SVOne Autorefractor|Unknown status|Recruiting|N/A|40|Anticipated|Smart Vision Labs|||1||f||||||||||||||2017-10-10 22:53:51.439358|2017-10-10 22:53:51.439358
NCT02559258|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-06-15|||August 2015||2015-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Escalating Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Epsi- Gam in Healthy, Cat-, Dust Mite-, or Bermuda Grass-Allergic Subjects|Terminated||Phase 1|5|Actual|Tunitas Therapeutics, Inc.||5||Sponsor Decision|f||||f||||||||||2017-10-10 22:53:51.503394|2017-10-10 22:53:51.503394
NCT02559245|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-08-11|||September 2015||2015-09-01|August 2017|2017-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Flixweed and Fig on Irritable Bowel Syndrome With Predominant Constipation: a Single Blind Randomized Clinical Trial.||Completed||N/A|150|Actual|Isfahan University of Medical Sciences||3|||f||||||||||||||2017-10-10 22:53:51.573969|2017-10-10 22:53:51.573969
NCT02559232|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-02-15|||September 2015||2015-09-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|BRONCE-AP||An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers|An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers|Completed||N/A|247|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:53:53.558066|2017-10-10 22:53:53.558066
NCT02559219|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-04-11|||December 2014||2014-12-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Observational|||Smart Adult Living After Childhood Cancer (SmartALACC) Online Care Plans: Feasibility and Patient Satisfaction|Smart Adult Living After Childhood Cancer (SmartALACC) Online Care Plans: Feasibility and Patient Satisfaction|Recruiting||N/A|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 22:53:53.663871|2017-10-10 22:53:53.663871
NCT02559206|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-01-19|||October 2015||2015-10-01|January 2017|2017-01-01||||September 2016|Actual|2016-09-01||Interventional|||Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|A Phase 2b, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group, Dose-range-finding Study of Two Delayed Release Formulations of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation|Completed||Phase 2|532|Actual|Ironwood Pharmaceuticals, Inc.||8|||f||||f||||||||||2017-10-10 22:53:53.743424|2017-10-10 22:53:53.743424
NCT02559180|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-04-12|||October 2015||2015-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|SwapTwo||Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab|Investigator Initiated Observational Study of Intravitreal Aflibercept Injection in Subjects With Diabetic Macular Edema Previously Treated With Ranibizumab or Bevacizumab|Recruiting||Phase 4|20|Anticipated|The Cleveland Clinic||1|||f||||t||||||||Undecided||2017-10-10 22:53:54.039721|2017-10-10 22:53:54.039721
NCT02559167|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-06-13|||February 2016||2016-02-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CBD||Cannabidiol and Cocaine Craving/Dependence|Cannabidiol as a New Treatment for Cocaine Addiction|Recruiting||Phase 2|110|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-10 22:53:54.270062|2017-10-10 22:53:54.270062
NCT02559154|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-10-03|||July 2010||2010-07-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Modified Bortezomib-based Combination Therapy for Multiple Myeloma|An Open-Label Phase IV Study of the Efficacy of Bortezomib-based Combination Therapy the Treatment of Subjects With Multiple Myeloma|Active, not recruiting||Phase 4|80|Actual|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-10 22:53:54.397337|2017-10-10 22:53:54.397337
NCT02559141|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-27|||March 2014||2014-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Non-invasive Early Goal Directed Therapy in Colorectal Surgery: a Feasibility Study||Completed||N/A|80|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-10 22:53:54.521847|2017-10-10 22:53:54.521847
NCT02559128|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-24|||December 2013||2013-12-01|September 2015|2015-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|CARMET2||The Role of Insulin Resistance in Patients With Heart Failure and Type 2 Diabetes|The Role of Insulin Resistance in Patients With Heart Failure and Type 2 Diabetes|Recruiting||N/A|100|Anticipated|Institute for Clinical and Experimental Medicine|||4||f||||t||||||||||2017-10-10 22:53:54.637924|2017-10-10 22:53:54.637924
NCT02559115|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-10-03|||September 2015||2015-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer|A Phase II Study of 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer|Recruiting||Phase 2|20|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:53:54.766276|2017-10-10 22:53:54.766276
NCT02559102|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-03-09|||July 2015||2015-07-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|DEGA||Dexmedetomidine Sedation Versus General Anaesthesia for Inguinal Hernia Surgery in Infants|Dexmedetomidine Sedation Versus General Anaesthesia for Inguinal Hernia Surgery on Peri-operative Outcomes and Neurocognitive Development in Infants: A Randomized Controlled Trial|Recruiting||Phase 3|100|Anticipated|KK Women's and Children's Hospital||2|||f||||t||||||||||2017-10-10 22:53:54.876179|2017-10-10 22:53:54.876179
NCT02559089|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-27|||May 2015||2015-05-01|September 2015|2015-09-01||||May 2017|Anticipated|2017-05-01||Observational|||Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China||Unknown status|Active, not recruiting|N/A|400|Anticipated|Beijing Tongren Hospital|||3||f||||||||||||||2017-10-10 22:53:54.993455|2017-10-10 22:53:54.993455
NCT02559076|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-24|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|ERERCT||The Eat Right Emirates Healthy Lifestyle Study|Preschool Obesity in the United Arab Emirates: Determinants and the Effectiveness of the 10-step Healthy Lifestyle Tool for Toddlers- Eat Right Emirates|Completed||N/A|150|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 22:53:55.055042|2017-10-10 22:53:55.055042
NCT02559063|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-08-14|||October 2015||2015-10-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Vision-based Speed of Processing Cognitive Training and Mild Cognitive Impairment|Neurophysiological Aspects of Vision-based Speed of Processing Cognitive Training in Older Adults With Mild Cognitive Impairment|Recruiting||N/A|84|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 22:53:55.123302|2017-10-10 22:53:55.123302
NCT02559050|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-09-23|||May 2013||2013-05-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Nasal Reconstruction Using a Customized 3D-printed Nasal Stent for Congenital Arhinia|Nasal Reconstruction Using a Customized 3D-printed Nasal Stent for Congenital Arhinia|Completed||N/A|1|Actual|Seoul St. Mary's Hospital|||1||f||||f||||||||||2017-10-10 22:53:55.205377|2017-10-10 22:53:55.205377
NCT02559037|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-07-27|||April 2015||2015-04-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Acupuncture and Moxibustion Treatment for Crohn's Disease|Study on the Mechanism of Moxibustion Effect on Maintaining Crohn's Disease Intestinal Homeostasis Via Intestinal Microbiota and Intestinal Mucosal Immunity|Recruiting||Phase 2|80|Anticipated|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-10 22:53:55.256887|2017-10-10 22:53:55.256887
NCT02559024|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-09-18|||September 2015||2015-09-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer|Phase I/Ib Study of Surgical Resection or Radiofrequency Ablation (RFA) of Metastatic Lesions in the Liver in Combination With Monoclonal Antibody to OX40 (MEDI6469) in Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 1|4|Actual|Providence Health & Services||3|||f||||f||||||||||2017-10-10 22:53:55.348566|2017-10-10 22:53:55.348566
NCT02559011|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-04-12|||March 2016||2016-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|Reveal||Assessment of Arrhythmias in Patients Undergoing Transcatheter Aortic Valve Implantation Using a Small Insertable Cardiac Monitoring Device|Assessment of Arrhythmias in Patients Undergoing Transcatheter Aortic Valve Implantation Using a Small Insertable Cardiac Monitoring Device|Recruiting||N/A|100|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 22:53:55.426509|2017-10-10 22:53:55.426509
NCT02558998|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-04-11|||March 2015||2015-03-01|April 2016|2016-04-01||||March 2018|Anticipated|2018-03-01||Interventional|||Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care|Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care|Recruiting||Early Phase 1|120|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 22:53:55.511969|2017-10-10 22:53:55.511969
NCT02558985|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2016-10-19|||September 2015||2015-09-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Observational|||Pulmonary Compliance Changes During Manipulation of Early Onset Scoliosis and Cast Application|Pulmonary Compliance Changes During Manipulation of Early Onset Scoliosis and Cast|Recruiting||N/A|50|Anticipated|Indiana University|||1||f||||f||||||||||2017-10-10 22:53:55.574075|2017-10-10 22:53:55.574075
NCT02558972|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-07-26|||September 2015||2015-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)|Northera Improves Postural Tachycardia Syndrome (POTS) and Postural|Recruiting||Phase 2|30|Anticipated|New York Medical College||2|||f||||t||||||||||2017-10-10 22:53:55.646195|2017-10-10 22:53:55.646195
NCT02558959|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-07-01|||September 2015||2015-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer|Effect of Second-line Irinotecan and Capecitabine Versus Irinotecan Alone in Advanced Biliary Tract Cancer Patients Progressed After First-line Gemcitabine and Cisplatin: A Randomized Controlled Study|Recruiting||Phase 2|74|Anticipated|Zhejiang University||2|||f||||||||||||||2017-10-10 22:53:55.754582|2017-10-10 22:53:55.754582
NCT02558946|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-02-10|||May 2015||2015-05-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||Physical Therapy for Men Undergoing Prostatectomy|Perioperative Pelvic Floor Muscle Training May Improve Recovery of Continence in Men With Localized Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy|Recruiting||N/A|160|Anticipated|Indiana University||2|||f||||f||||||||||2017-10-10 22:53:55.977188|2017-10-10 22:53:55.977188
NCT02558751|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-09-23|||July 2013||2013-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Pneumonia Vaccine in Aging HIV Positive Individuals|Immune Response to Pneumococcal Vaccination in Aging HIV Positive Individuals|Completed||Early Phase 1|51|Actual|University of Toledo Health Science Campus||3|||f||||f||||||||||2017-10-10 22:53:58.485573|2017-10-10 22:53:58.485573
NCT02558933|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-23|||June 2015||2015-06-01|September 2015|2015-09-01|April 2017|Anticipated|2017-04-01|March 2016|Anticipated|2016-03-01||Interventional|Neuro-SAF||Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children|Epigallocatechin Gallate (EGCG) as Therapeutic Tool to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Parc de Salut Mar||1|||f||||f||||||||||2017-10-10 22:53:56.09631|2017-10-10 22:53:56.09631
NCT02558920|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-08-23|||March 2015||2015-03-01|May 2015|2015-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Meta-analyses of the Relation of Fructose-Containing Sugars and Their Food Sources With Risk of Obesity|Relation of Fructose-Containing Sugars and Important Food Sources of These Sugars With Markers of Adiposity and Risk of Obesity: A Series of Systematic Reviews and Meta-Analyses of Controlled Trials and Prospective Cohort Studies|Unknown status|Active, not recruiting|N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:53:56.219112|2017-10-10 22:53:56.219112
NCT02558907|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-03-31|||September 2015|Actual|2015-09-01|June 2016|2016-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|MoCA||Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology|Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology|Completed||N/A|66|Actual|Centre Francois Baclesse|||1||f||||f||||||||||2017-10-10 22:53:56.319714|2017-10-10 22:53:56.319714
NCT02558894|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-04|||November 16, 2015|Actual|2015-11-16|August 2017|2017-08-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma|A Phase II Open-Label, Multi-Center Study of MEDI4736 Evaluated as Single Agent or in Combination With Tremelimumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma|Completed||Phase 2|65|Actual|AstraZeneca||2|||f||||f|t|f||||||||2017-10-10 22:53:56.408406|2017-10-10 22:53:56.408406
NCT02558881|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-23|||June 2014||2014-06-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|COCAGI||Colon Capsule Versus Virtual Colonoscopy for Colorectal Cancer Screening|Evaluation of a Complementary Action of Recruitment of Patients With a Positive Screening Test and Not Realizing Optical Colonoscopy as Part of Organized Colorectal Cancer Screening|Completed||N/A|664|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 22:53:56.559815|2017-10-10 22:53:56.559815
NCT02558868|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-11-29|||September 2015||2015-09-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer|Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer|Not yet recruiting||Phase 2|80|Anticipated|Zhejiang University||2|||f||||f||||||||||2017-10-10 22:53:56.659077|2017-10-10 22:53:56.659077
NCT02558855|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-04-10|||January 2015||2015-01-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Effects of Thrust Joint Manipulation on the Resting and Contracting Thickness of Transversus Abdominis in Subjects With Low Back Pain|The Effects of Thrust Joint Manipulation on the Resting and Contracting Thickness of Transversus Abdominis in Subjects With Low Back Pain|Completed||N/A|67|Actual|Nova Southeastern University||2|||f||||f||||||||||2017-10-10 22:53:56.75528|2017-10-10 22:53:56.75528
NCT02558842|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-08-01|||March 2013||2013-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight Distance|Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight Distance in a Region With High Prevalence of the Disease: Randomized Clinical Trial|Completed||N/A|160|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||Yes||2017-10-10 22:53:56.889|2017-10-10 22:53:56.889
NCT02558829|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-02-09|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|November 29, 2016|Actual|2016-11-29|November 29, 2016|Actual|2016-11-29||Interventional|||Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency|Confirmatory Validation of Oral Macimorelin as a Growth Hormone (GH) Stimulation Test (ST) for the Diagnosis of Adult Growth Hormone Deficiency (AGHD) in Comparison With the Insulin Tolerance Test (ITT)|Completed||Phase 3|157|Actual|AEterna Zentaris||2|||f||||f||||||||Undecided||2017-10-10 22:53:57.584723|2017-10-10 22:53:57.584723
NCT02558816|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-10|||October 14, 2015|Actual|2015-10-14|August 2017|2017-08-01|October 2023|Anticipated|2023-10-01|April 2018|Anticipated|2018-04-01||Interventional|OAsIs||A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients|A Phase I/II Trial of Obinutuzumab, ABT-199 (GDC-0199) Plus Ibrutinib in Relapsed / Refractory Mantle Cell Lymphoma Patients|Recruiting||Phase 1/Phase 2|48|Anticipated|Nantes University Hospital||1|||f||||t||||||||||2017-10-10 22:53:57.791758|2017-10-10 22:53:57.791758
NCT02558803|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-05-24|||February 2015||2015-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3|HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3|Completed||N/A|1305|Actual|Regenstrief Institute, Inc.||2|||f||||f||||||||No|Individual provider data will not be made available.|2017-10-10 22:53:57.965833|2017-10-10 22:53:57.965833
NCT02558790|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2017-08-23|||March 2016||2016-03-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD|L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD: An Open-label Pilot Study of Cognitive and Functional Effects|Active, not recruiting||Phase 2|15|Anticipated|Massachusetts General Hospital||1|||f||||||||||||||2017-10-10 22:53:58.141786|2017-10-10 22:53:58.141786
NCT02558777|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-09-23|||October 2013||2013-10-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|MID-Nurse-P||Pilot Study of a Multicomponent Nurse Intervention to Reduce Delirium in Hospitalized Older Adults|Pilot Study of a Multicomponent Nurse Intervention to Reduce the Incidence and Severity of Delirium in Hospitalized Older Adults: MID-Nurse-P|Completed||N/A|50|Actual|Complejo Hospitalario Universitario de Albacete||2|||f||||f||||||||||2017-10-10 22:53:58.26997|2017-10-10 22:53:58.26997
NCT02558764|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-23|||November 2015||2015-11-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Effects of Preventive Negative Pressure Wound Therapy With PICO on Surgical Wounds of Kidney Transplant Patients|Effects of Preventive Negative Pressure Wound Therapy With PICO on Surgical Wounds of Kidney Transplant Patients: A Pilot Trial|Unknown status|Not yet recruiting|N/A|60|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-10 22:53:58.399534|2017-10-10 22:53:58.399534
NCT02558738|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-23|||June 2015||2015-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations|Non Interventional Study (NIS): Clinical Investigation for Evaluation of the Safety and Efficacy of Ectoin Ear Spray and Normison Ear Spray in Skin Treatment of Outer Ear Canal Irritations: A Mulitcenter Non Interventional Study|Completed||N/A|60|Actual|Bitop AG|||2||f||||t||||||||||2017-10-10 22:53:58.624666|2017-10-10 22:53:58.624666
NCT02558725|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-12-28|||April 2015||2015-04-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Iron Supplementation During Pregnancy - One Versus Two Ferrous Sulfate Capsules for Iron Deficient Pregnant Women|Iron Supplementation During Pregnancy - One Versus Two Ferrous Sulfate Capsules for Iron Deficient Pregnant Women|Recruiting||N/A|100|Anticipated|Assuta Hospital Systems||2|||f||||f||||||||||2017-10-10 22:53:58.72047|2017-10-10 22:53:58.72047
NCT02558699|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-09-23|||September 2015||2015-09-01|September 2015|2015-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|CUVIA-AF II||Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation||Not yet recruiting||N/A|110|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 22:53:58.933414|2017-10-10 22:53:58.933414
NCT02558686|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-01-20|||October 2015||2015-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Exercise and Post-dry Needling Soreness|Effects of Eccentric Exercise, Sham or Placebo on Post-Needling Soreness by Dry Needling on Active Trigger Points|Completed||N/A|90|Actual|Universidad Rey Juan Carlos||3|||f||||t||||||||||2017-10-10 22:53:59.027104|2017-10-10 22:53:59.027104
NCT02558673|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-11-01|||May 2014||2014-05-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2014|Actual|2014-07-01||Interventional|||Trimethylamine-N-oxide Production and Metabolism|Impact of Diet and Gut Microbiota on Trimethylamine-N-oxide Production and Fate in Humans|Completed||N/A|40|Actual|Cornell University||4|||f||||f||||||||||2017-10-10 22:53:59.135264|2017-10-10 22:53:59.135264
NCT02558660|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-12-24|||August 2014||2014-08-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluating Use of a Farmers Market Incentive Program Among Low-Income Health Center Patients|Evaluating Use of a Farmers Market Incentive Program Among Low-Income Health Center Patients|Completed||N/A|177|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 22:53:59.392037|2017-10-10 22:53:59.392037
NCT02558647|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-08-29|||February 2016||2016-02-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|HUNT-SHUTi||Overcoming Insomnia. From Genes to Long-term Impact on Health and Work.|Overcoming Insomnia. From Genes to Long-term Impact on Health and Work. A Large RCT of Online Cognitive-behavioral Therapy for Insomnia.|Recruiting||N/A|1500|Anticipated|Norwegian Institute of Public Health||2|||f||||f||||||||||2017-10-10 22:53:59.491955|2017-10-10 22:53:59.491955
NCT02558634|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-01-13|||January 2016||2016-01-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY Trial|Thalamic Deep Brain Stimulation for Spasmodic Dysphonia: A Prospective, Randomized, Double-Blinded, Sham-Controlled Trial|Recruiting||Phase 1|6|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 22:53:59.607588|2017-10-10 22:53:59.607588
NCT02558621|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2016-05-09|||September 2015||2015-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|AQrate||New Robotic Assistance System for Spinal Fusion Surgery|Clinical Trial on Performance and Acceptance of a New Robotic Assistance System During Spinal Fusion Surgery|Completed||N/A|24|Actual|KB Medical SA||1|||f||||f||||||||Undecided||2017-10-10 22:53:59.717721|2017-10-10 22:53:59.717721
NCT02558608|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2015-10-14|||June 2015||2015-06-01|October 2015|2015-10-01|April 2020|Anticipated|2020-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Dissecting of The Inferior Pulmonary Ligament on Postoperative Pulmonary Reexpansion and Recurrence|Effect of Dissecting of The Inferior Pulmonary Ligament on Postoperative Pulmonary Reexpansion and Recurrence After Operation by Video-assisted Thoracic Surgery in the Treatment of Primary Spontaneous Pneumothorax(PSP)|Recruiting||Phase 3|260|Anticipated|Chinese Medical Association||2|||f||||t||||||||||2017-10-10 22:53:59.829242|2017-10-10 22:53:59.829242
NCT02558595|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-11-30|||September 2015||2015-09-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)|Randomized, Controlled Pilot Study of Niacinamide in Polycystic Kidney Disease|Recruiting||Phase 2|36|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-10 22:53:59.948688|2017-10-10 22:53:59.948688
NCT02558582|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-05-04|||September 2015||2015-09-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Effect of Exercise Training in Patients With Pulmonary Hypertension|Effect of Exercise Training in Arterial and Chronic Thromboembolic Pulmonary Hypertension in Switzerland and Standardization With European Countries|Recruiting||N/A|32|Anticipated|University of Zurich||4|||f||||f||||||||||2017-10-10 22:54:00.071354|2017-10-10 22:54:00.071354
NCT02558569|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-09-13|||September 2015||2015-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Use of Fentanyl in General Anesthesia for Craniotomy With or Without 0.5% Levobupivacaine Scalp Block|The Use of Fentanyl in General Anesthesia for Craniotomy With or Without 0.5% Levobupivacaine Scalp Block: A Randomized Controlled Trial|Completed||Phase 4|128|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 22:54:00.199693|2017-10-10 22:54:00.199693
NCT02558556|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-12-16|||January 2016||2016-01-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||FALCON: a Multicenter Randomized Controlled Trial|Near-infrared Fluorescence Cholangiography Assisted Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy (FALCON): a Multicenter Randomized Controlled Trial|Recruiting||N/A|308|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 22:54:00.301868|2017-10-10 22:54:00.301868
NCT02558543|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-07-06|||September 2015||2015-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|scleradec2||Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis|Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis : Controlled Clinical Trial With Efficacy Assessment|Recruiting||Phase 2|40|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-10-10 22:54:00.449961|2017-10-10 22:54:00.449961
NCT02558530|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-02-28|||January 2015||2015-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|November 2015|Actual|2015-11-01||Interventional|||Resolution of Liver Fat in Non-alcoholic Fatty Liver Disease|Rapid Resolution of Human Fatty Liver Disease, the Key to Obesity-related Morbidity and Mortality|Active, not recruiting||N/A|20|Anticipated|Helsinki University Central Hospital||1|||f||||f||||||||No||2017-10-10 22:54:00.585565|2017-10-10 22:54:00.585565
NCT02558517|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-08-10|||January 2014||2014-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|CORTICOLUP||Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus|Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment (Prednisone 5 Milligram Per Day) in Quiescent Systemic Lupus|Recruiting||Phase 3|136|Anticipated|Groupe Hospitalier Pitie-Salpetriere||2|||f||||f||||||||||2017-10-10 22:54:00.680555|2017-10-10 22:54:00.680555
NCT02558504|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-23|2015-10-06|||January 2013||2013-01-01|October 2015|2015-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|HARMONI||Radiofrequency in the Treatment of Barrett's Oesophagus|Clinical and Medico-economic Evaluation of Radiofrequency Ablation Versus Oesophagectomy in the Treatment of High Grade Dysplasia in Barrett's Oesophagus|Recruiting||Phase 4|250|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:54:00.792731|2017-10-10 22:54:00.792731
NCT02558491|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-05-01|||September 2015||2015-09-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM|Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM|Completed||N/A|52|Actual|University of Virginia||2|||f||||f||||||||Yes|To be determined|2017-10-10 22:54:00.900337|2017-10-10 22:54:00.900337
NCT02558478|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-12-06|||September 2015||2015-09-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|GEN-NEUROSENS||Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing|Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing|Recruiting||N/A|39|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||Samples With DNA|"     DNA Fibroblasts   "|||2017-10-10 22:54:01.014482|2017-10-10 22:54:01.014482
NCT02558452|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2016-08-11|||December 2016||2016-12-01|August 2016|2016-08-01|January 2028|Anticipated|2028-01-01|January 2027|Anticipated|2027-01-01|10 Years|Observational [Patient Registry]|SENIOR||European Transplant Registry of Senior Renal Transplant Recipients on Advagraf|European Transplant Registry of Senior Renal Transplant Recipients Receiving Initial Immunosuppression With Tacrolimus Once Daily, Mycophenolate and Steroids|Not yet recruiting||N/A|1000|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples Without DNA|"     HLA antibodies, Non HLA antibodies   "|Yes|aggregated data are available through the Steering committee of DESCARTES and EKITA|2017-10-10 22:54:01.223547|2017-10-10 22:54:01.223547
NCT02558439|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2017-08-03||2017-08-03|August 2015||2015-08-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging 24-Week Study to Evaluate the Safety and Efficacy of a Single Injection of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain|Completed||Phase 2|175|Actual|Centrexion Therapeutics||3|||f||||||||||||||2017-10-10 22:54:01.335633|2017-10-10 22:54:01.335633
NCT02558426|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-23|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ERCVD||Estrogen Receptors and Chronic Venous Disease|Molecular Analysis of Estrogen Receptors in Patients With Chronic Venous Disease|Completed||N/A|40|Actual|University of Cantanzaro|||1||f||||t||||||||||2017-10-10 22:54:01.468398|2017-10-10 22:54:01.468398
NCT02558413|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-07-14|||August 2015||2015-08-01|July 2016|2016-07-01||||December 2015|Actual|2015-12-01||Interventional|||Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers|A Double-Blind, Placebo-Controlled, Single Ascending Oral Dose Study of the Safety and Pharmacokinetics of BTA-C585 in Healthy Volunteers|Completed||Phase 1|60|Actual|Aviragen Therapeutics||2|||f||||f||||||||||2017-10-10 22:54:01.54507|2017-10-10 22:54:01.54507
NCT02558400|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-01-12|||September 2015||2015-09-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension||Active, not recruiting||Phase 3|690|Actual|Aerie Pharmaceuticals||3|||f||||||||||||||2017-10-10 22:54:01.633829|2017-10-10 22:54:01.633829
NCT02558387|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-11-18|||November 2014||2014-11-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Interventional|||Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck|Phase II Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck : a Multicentre Phase II Study|Active, not recruiting||Phase 2|20|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:54:01.727383|2017-10-10 22:54:01.727383
NCT02558374|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension||Completed||Phase 3|708|Actual|Aerie Pharmaceuticals||2|||f||||||||||||||2017-10-10 22:54:01.804697|2017-10-10 22:54:01.804697
NCT02555566|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-12-06|||March 2014||2014-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TRANSPLANTEETs||Role of Epoxyeicosatrienoic Acids in Chronic Allograft Nephropathy - The TRANSPLANT-EETs Study|Role of Epoxyeicosatrienoic Acids in Chronic Allograft Nephropathy|Completed||N/A|80|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 22:54:42.413756|2017-10-10 22:54:42.413756
NCT02558361|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-10-20|||April 2016||2016-04-01|June 2016|2016-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Treatment With Apremilast in Patients With Psoriatic Arthritis|A Skin and Synovial Tissue Assessment of Overlapping Genes and Their Response After 3 Months Treatment With Apremilast in Patients With Psoriatic Arthritis|Withdrawn||Phase 4|0|Actual|University of South Florida||1||FDA approved synovial biopsy device unavailable|f||||f||||||||No||2017-10-10 22:54:01.8827|2017-10-10 22:54:01.8827
NCT02558348|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-06-15|||November 2015||2015-11-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|AL3818||Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)|A Phase 1/2a Evaluation of the Safety, Pharmacokinetics and Efficacy of AL3818, a Dual Receptor Tyrosine Kinase Inhibitor, in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)|Recruiting||Phase 1/Phase 2|63|Anticipated|Advenchen Laboratories, LLC||1|||f||||t||||||||||2017-10-10 22:54:01.973565|2017-10-10 22:54:01.973565
NCT02558335|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-04-11|||April 2013||2013-04-01|April 2016|2016-04-01||||April 2017|Anticipated|2017-04-01||Observational|||CTCs for High Grade Glioma|Circulating Tumor Markers for High Grade Glioma|Recruiting||N/A|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     22 cc of blood   "|||2017-10-10 22:54:02.092881|2017-10-10 22:54:02.092881
NCT02558322|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-02|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Observational|AVFN||Regional Variation in the Primary Medical Care of Northern Germany|Regional Variation of Patient Population and Reasons for Consultation in the Primary Medical Care of Northern Germany|Completed||N/A|1022|Actual|Universitätsklinikum Hamburg-Eppendorf|||3||f||||f||||||||||2017-10-10 22:54:02.162128|2017-10-10 22:54:02.162128
NCT02558309|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-01-11|||October 2015||2015-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Observational|||Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure|Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure|Withdrawn||N/A|0|Actual|New York University School of Medicine|||1|The Primary Investigator is no longer with UPMC. No patients have been enrolled.|f||||t||||||||||2017-10-10 22:54:02.251969|2017-10-10 22:54:02.251969
NCT02558296|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-07-05|||October 2015||2015-10-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|BEST||Bexagliflozin Efficacy and Safety Trial (BEST)|A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events|Recruiting||Phase 3|1650|Anticipated|Theracos||2|||f||||t||||||||||2017-10-10 22:54:02.343574|2017-10-10 22:54:02.343574
NCT02558283|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-08-28|||January 25, 2016|Actual|2016-01-25|August 2017|2017-08-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese Adults|A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese Adults|Completed||N/A|175|Actual|Allergan||4|||f||||f|f|f||||||||2017-10-10 22:54:02.934918|2017-10-10 22:54:02.934918
NCT02558270|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-09-26|||June 2016||2016-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of SGLT-2 Inhibition on Hepatic Glucose and Energy Metabolism|Acute Effects of Sodium GlucOse Co-Transporter 2 (SGLT2) Inhibition on Hepatic Glucose and Energy Metabolism|Recruiting||Phase 2|20|Anticipated|Medical University of Vienna||4|||f||||t||||||||||2017-10-10 22:54:03.027309|2017-10-10 22:54:03.027309
NCT02558257|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-08-15|||October 16, 2015|Actual|2015-10-16|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Perception of Palliative Care Encounter|Perception of the Palliative Care Encounter by Patients Who Are Referred to Outpatient Supportive/ Palliative Care|Active, not recruiting||N/A|209|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-10 22:54:03.128192|2017-10-10 22:54:03.128192
NCT02558244|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-02-24|||January 2016||2016-01-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study|Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study|Recruiting||N/A|100|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:54:03.216303|2017-10-10 22:54:03.216303
NCT02558231|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-09-08|||May 1, 2016||2016-05-01|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|TRITON||The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension|The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Placebo-controlled, Phase 3b Study|Recruiting||Phase 3|238|Anticipated|Actelion||2|||f||||t||||||||||2017-10-10 22:54:03.32228|2017-10-10 22:54:03.32228
NCT02558218|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-22|||January 2015||2015-01-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery|Postoperative Discomfort and Ocular Redness Following Phacoemulsification and Intraocular Lens Implantation|Completed||N/A|80|Actual|Democritus University of Thrace||2|||f||||f||||||||||2017-10-10 22:54:03.572421|2017-10-10 22:54:03.572421
NCT02558205|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry|Establishing a Correlation Between Pre-treatment CT Perfusion Parameter Values and Post-treatment PET/CT Dosimetry to Aid in Tumor-specific Y-90 Radioembolization Treatment Planning for Hepatocellular Carcinoma|Recruiting||N/A|15|Anticipated|Rush University Medical Center|||1||f||||f||||||||||2017-10-10 22:54:03.673897|2017-10-10 22:54:03.673897
NCT02558192|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-09-22|||January 2014||2014-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|||Administration of a Lactobacillus GG and Vitamins Containing Mixture is Effective in Preventing Nosocomial Infection in Children||Completed||Phase 3|90|Actual|Federico II University||2|||f||||f||||||||||2017-10-10 22:54:03.81558|2017-10-10 22:54:03.81558
NCT02557997|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-22|||April 2014||2014-04-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation|Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation|Unknown status|Recruiting|N/A|202|Anticipated|University Hospital, Strasbourg, France|||4||f||||f||||||||||2017-10-10 22:54:05.652969|2017-10-10 22:54:05.652969
NCT02558179|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-07-12|||September 2015||2015-09-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|March 2017|Anticipated|2017-03-01|6 Weeks|Observational [Patient Registry]|SAGE||Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method|Prospective Multicenter Cross Sectional Study of the American International Biotechnology (AIBiotech) Gynecologene Test for the Evaluation of Bacterial Vaginosis/Vaginitis in Symptomatic Women|Enrolling by invitation||N/A|300|Anticipated|American International Biotechnology|||2||f||||f||||||Samples With DNA|"     Extracted DNA from vaginal swab(s) will be maintained after evaluation for a time period up     to 1 year.   "|Undecided||2017-10-10 22:54:03.939576|2017-10-10 22:54:03.939576
NCT02558166|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-05-09|||August 2015||2015-08-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Renal Resistive Index in Patients With Shock|Relation Between the Renal Resistive Index and Markers of the Systemic Circulation, the Microcirculation, Fluid Status and of Renal Function.|Completed||N/A|92|Actual|VU University Medical Center|||2||f||||f||||||||||2017-10-10 22:54:04.042901|2017-10-10 22:54:04.042901
NCT02558153|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2017-09-28|||June 2015||2015-06-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|APERTO||RCT of Paclitaxel DEB Compared to Standard PTA in Dialysis Fistula|A Randomized Trial of Aperto Paclitaxel Eluting Dilatation Catheter Compared to POBA in Dialysis Fistula|Recruiting||N/A|150|Anticipated|Groene Hart Ziekenhuis||2|||f||||f||||||||||2017-10-10 22:54:04.14976|2017-10-10 22:54:04.14976
NCT02558140|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-09-20|||October 11, 2015|Actual|2015-10-11|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors|An Open-Label, Multicenter, Dose-Escalation Phase I Study of RO6874813, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|120|Anticipated|Hoffmann-La Roche||3|||f|||||t|f||||||||2017-10-10 22:54:04.362406|2017-10-10 22:54:04.362406
NCT02558127|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-10-18|||May 2015||2015-05-01|February 2016|2016-02-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Observational|CF-asthma||Asthma With Hypersecretion-associated Gene for Cystic Fibrosis|Asthma With Hypersecretion-associated Gene for Cystic Fibrosis Clinical, Inflammatory and Genetics Characterization|Completed||N/A|100|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||f||||||Samples With DNA|"     From peripheral blood samples, the DNA extraction following the protocol saline method. From     the DNA samples obtained CFTR gene analysis to detect genetic variants by sequencing or mass     Next Generation Sequencing (NGS) in Miseq team Illumina platform (available in the Hospital     de la Santa Creu i Sant be held Pau).   "|No||2017-10-10 22:54:04.496918|2017-10-10 22:54:04.496918
NCT02558114|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-06-13|||December 2015||2015-12-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.|Randomized Study of Two Treatment Strategies With Ribavirin for Chronic Hepatitis E and Severe Acute Forms|Recruiting||Phase 4|56|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-10 22:54:04.58646|2017-10-10 22:54:04.58646
NCT02558101|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-07-25|||November 2, 2015|Actual|2015-11-02|July 2017|2017-07-01|July 21, 2018|Anticipated|2018-07-21|July 7, 2017|Actual|2017-07-07||Interventional|Lung-SCREEN||Lung Screen Uptake Trial|Randomised Controlled Trial to Test Novel Invitation Methods and Materials Targeted to Increase Informed Uptake of Lung Cancer Screening in Individuals at High Risk of Lung Cancer|Active, not recruiting||N/A|1997|Actual|University College, London||2|||f||||t||||||||||2017-10-10 22:54:04.687939|2017-10-10 22:54:04.687939
NCT02558088|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-12|2017-01-29|||September 2014||2014-09-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Pharmacological Properties of Salmeterol|Pharmacological Properties of Inhaled Salmeterol in Healthy Trained Males|Completed||Phase 4|11|Actual|University of Copenhagen||1|||f||||t||||||||||2017-10-10 22:54:04.811076|2017-10-10 22:54:04.811076
NCT02558075|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-05-03|||May 1, 2017|Actual|2017-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Mood Lifters: A Self Help Program|Mood Lifters: A Self Help Program to Improve One's Psychological and Behavioral Well Being|Recruiting||N/A|50|Anticipated|University of Michigan||1|||f||||f|f|f||||||No||2017-10-10 22:54:04.929912|2017-10-10 22:54:04.929912
NCT02558062|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-05-02|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BAC ONE||Microdosing of BAC ONE to the Distal Lung|Exploratory Clinical Study of Intrapulmonary Microdosing of the BACterial Detection Probe (BAC ONE) in Ventilator Associated Pneumonia|Recruiting||Early Phase 1|12|Anticipated|University of Edinburgh||1|||f||||t||||||||No||2017-10-10 22:54:05.040902|2017-10-10 22:54:05.040902
NCT02558049|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-05-01|||November 2015||2015-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid|Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid|Completed||N/A|12|Actual|University of Ottawa||1|||f||||f||||||||||2017-10-10 22:54:05.150984|2017-10-10 22:54:05.150984
NCT02558036|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-08-10|||January 2016||2016-01-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Optimal Head and Neck Position During Videolaryngoscopy|"Optimal Head and Neck Position for Intubation During Videolaryngoscopy: Comparison Between Sniffing and Neutral Position Using Channelled and Non-channelled Videolaryngoscopes"|Recruiting||N/A|200|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust||4|||f||||f||||||||||2017-10-10 22:54:05.286374|2017-10-10 22:54:05.286374
NCT02558023|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-09-07|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|Uranic||The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine|The Treatment of Hypertension Associated With Severe Preeclampsia. A Randomize Controlled Trial of Urapidil Versus Nicardipine. The Uranic Trial|Recruiting||Phase 3|366|Anticipated|University Hospital, Strasbourg, France||2|||f||||t||||||||||2017-10-10 22:54:05.401597|2017-10-10 22:54:05.401597
NCT02558010|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-07-18|||May 1, 2016|Actual|2016-05-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Perioperative Methadone Use to Decrease Opioid Requirement in Pediatric Spinal Fusion Patients|Perioperative Methadone Use to Decrease Opioid Requirement in Pediatric Spinal Fusion Patients|Recruiting||Phase 3|44|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-10 22:54:05.525899|2017-10-10 22:54:05.525899
NCT02557984|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-22|||February 2014||2014-02-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity|Dopamine D2/3- and μ-opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity in Healthy Volunteers|Completed||N/A|121|Actual|University of Zurich||3|||f||||f||||||||||2017-10-10 22:54:05.758435|2017-10-10 22:54:05.758435
NCT02557971|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-08-31|||August 2015||2015-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder||Completed||Phase 4|315|Actual|Allergan|||1||f||||f||||||||||2017-10-10 22:54:05.897002|2017-10-10 22:54:05.897002
NCT02557958|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-01-24|||January 2009||2009-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study|Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study|Active, not recruiting||N/A|19|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 22:54:06.005668|2017-10-10 22:54:06.005668
NCT02557945|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-12-22|||August 2015||2015-08-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Gabapentin in Patients at Clinical Risk for Psychosis|Gabapentin in Patients at Clinical Risk for Psychosis|Recruiting||Phase 1/Phase 2|48|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-10 22:54:06.100562|2017-10-10 22:54:06.100562
NCT02557932|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-05-30|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication|Comparison of 7-day Proton Pump Inhibitor (PPI)-Clarithromycin Containing Triple Therapy and 10-day Bismuth Quadruple Therapy for Helicobacter Eradication as First-line Regimen: Randomized Controlled Trial|Active, not recruiting||Phase 3|350|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-10 22:54:06.199567|2017-10-10 22:54:06.199567
NCT02557919|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-22|||September 2013||2013-09-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|FRESH||Families Reduce Exposure to Smoke at Home|Evaluation of the Smoking Cessation and Tobacco Use Exposure Patterns of Head Start Parents in Boston|Completed||N/A|225|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-10 22:54:06.315588|2017-10-10 22:54:06.315588
NCT02557906|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-03-21|||July 2014||2014-07-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|POBRAD-M||Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)|Prospective, Multi-centre, Observational Trial Evaluating Outcomes of Immediate Breast Reconstruction Using an Implant and Acellular Dermal Matrix (SurgiMend) or Autologous Tissue|Active, not recruiting||N/A|209|Actual|King's College London||3|||f||||f||||||||||2017-10-10 22:54:06.398738|2017-10-10 22:54:06.398738
NCT02557893|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-22|||April 2006||2006-04-01|September 2015|2015-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effects of Resistance Exercise During Pregnancy|Effects of Exercise on Back Pain in Pregnancy|Completed||N/A|134|Actual|University of Georgia||3|||f||||f||||||||||2017-10-10 22:54:06.512926|2017-10-10 22:54:06.512926
NCT02557880|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-03-24|||September 2016||2016-09-01|March 2017|2017-03-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Sleep Application Diary and Sleep Hygiene in Adolescents|Does the Utilization of a Sleep Application Diary Improve Sleep Hygiene in Adolescents?|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center||2||Could not get teenagers to enroll|f||||f||||||||||2017-10-10 22:54:06.58719|2017-10-10 22:54:06.58719
NCT02557867|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-10-10|||August 2015||2015-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|||The Effect of Obesity in Dexmedetomidine Metabolic Clearance|The Effect of Obesity in Dexmedetomidine Metabolic Clearance|Active, not recruiting||Phase 4|40|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||Undecided||2017-10-10 22:54:06.83952|2017-10-10 22:54:06.83952
NCT02557854|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-02-06|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors||Recruiting||Phase 1|14|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 22:54:07.030685|2017-10-10 22:54:07.030685
NCT02557841|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-07-03|||September 2015||2015-09-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Cerebellar tDCS on Motor Learning of Healthy Individuals|Effects of Cerebellar Transcranial Direct Current Stimulation (ctDCS) on Motor Learning of Healthy Individuals|Unknown status|Active, not recruiting|N/A|12|Actual|Universidade Federal de Pernambuco||3|||f||||t||||||||||2017-10-10 22:54:07.15316|2017-10-10 22:54:07.15316
NCT02557828|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-06-01|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|April 2016|Actual|2016-04-01||Interventional|||Target Sign vs Palpation for Radial Arterial Line Placement|Dynamic Need Tip Positioning With Ultrasound Versus Palpation Technique for Radial Artery Cannulation: A Prospective Randomized Controlled Trial|Terminated||N/A|260|Actual|University of Iowa||2||Principal Investigator retired|f||||f||||||||||2017-10-10 22:54:07.283745|2017-10-10 22:54:07.283745
NCT02557815|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2015-09-22|||February 2012||2012-02-01|September 2015|2015-09-01||||October 2014|Actual|2014-10-01||Interventional|||Changing the Vulnerable Brain: A Neuromodulation Study in Alcohol Dependence|Changing the Vulnerable Brain: A Neuromodulation Study in Alcohol Dependence|Completed||Phase 3|80|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 22:54:07.398413|2017-10-10 22:54:07.398413
NCT02557802|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-01-25|||October 2015||2015-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||T-cell Diversity Following Intranasal and Intramuscular Vaccines|Breadth of T-cell Responses After Heterologous Route Immunological Prime-boost Using Influenza Antigens as a Model System|Completed||N/A|30|Anticipated|University of Surrey||2|||f||||f||||||||||2017-10-10 22:54:07.524356|2017-10-10 22:54:07.524356
NCT02557789|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-09-22|||June 2015||2015-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects|A Study to Assess the Bioavailability and Pharmacokinetics of an Immediate Release Tablet Formulation of Lefamulin When Administered to Fed and Fasted Healthy Subjects in Comparison to an Intravenous Formulation and a Capsule Formulation|Completed||Phase 1|20|Actual|Nabriva Therapeutics AG||4|||f||||t||||||||||2017-10-10 22:54:07.663532|2017-10-10 22:54:07.663532
NCT02557763|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-09-22|||January 2011||2011-01-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||To Compare Anterior Knee Pain Between Non Severe and Severe Patellofemoral Arthritis After Oxford UKA|Study of Oxford Unicompartmental Knee Arthroplasty to Determine Anterior Knee Pain, Pain Score, Knee Score and Functional Score Between Patients Without Severe Patellofemoral Arthritis and Patients With Severe Patellofemoral Arthritis|Completed||N/A|104|Actual|Thammasat University||1|||f||||t||||||||||2017-10-10 22:54:07.933768|2017-10-10 22:54:07.933768
NCT02557750|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-06-26|||January 2016||2016-01-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience|Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience|Recruiting||N/A|35|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:54:08.062576|2017-10-10 22:54:08.062576
NCT02557737|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-03-28|||September 2012||2012-09-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities|Comparison of Surface Landmark, Ultrasonography and Electric Stimulation Guidance for Botulinum Toxin Injections in Stroke Patients With Spasticity on Upper Extremities.|Recruiting||Phase 3|40|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||No||2017-10-10 22:54:08.166192|2017-10-10 22:54:08.166192
NCT02557724|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-09-29|||September 2015||2015-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Mobilization of Mesenchymal Stem Cells During Liver Transplantation|Mobilization of Mesenchymal Stem Cells During Liver Transplantation|Recruiting||N/A|150|Anticipated|Rutgers, The State University of New Jersey|||2||f||||f||||||||||2017-10-10 22:54:08.332411|2017-10-10 22:54:08.332411
NCT02557711|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-03-28|||June 2016||2016-06-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|||The Findings of Ultrasound Elastography and ARFI in Strokes Patients With Spastic Elbow Flexor|The Correlation Between Clinical Examination and Ultrasound Elastography Acoustic Radiation Force Impulse Findings in Hemiplegic Patients With Elbow Flexor Spasticity After Stroke|Not yet recruiting||N/A|50|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||No||2017-10-10 22:54:08.465026|2017-10-10 22:54:08.465026
NCT02557698|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-03-07|2017-01-18||November 2014||2014-11-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|||Effectiveness of Using an Oil Bath Additive|Prospective, Randomized Study on the Skin Functional Parameters to Assess Skin Barrier Improvement After the Use of a Commercially Available Oil Bath Containing 84.75% Soybean Oil Compared to no Bath Additive|Completed||N/A|60|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 22:54:08.608703|2017-10-10 22:54:08.608703
NCT02557685|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-21|||June 2015||2015-06-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Gut Microbiota Changes After Fecal Microbiota Transplantation|Alterations in Gut Microbiota and Metabolism Following FMT for Recurrent C. Difficile Infection|Unknown status|Recruiting|Phase 2|6|Anticipated|The Miriam Hospital||1|||f||||t||||||||||2017-10-10 22:54:09.728075|2017-10-10 22:54:09.728075
NCT02557672|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-05-03|||August 2016||2016-08-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding|Prothrombin Complex Concentrate (PCC) Compared to Fresh Frozen Plasma (FFP) for Post-cardiopulmonary Bypass Coagulopathy and Bleeding, a Prospective Randomized Trial at Large US Medical Center.|Enrolling by invitation||Phase 4|100|Anticipated|Mayo Clinic||2|||f||||f|t|f||||||Undecided||2017-10-10 22:54:09.814764|2017-10-10 22:54:09.814764
NCT02557659|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-03-06|||March 2011||2011-03-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|June 2014|Actual|2014-06-01||Expanded Access|||Zenith® Low Profile AAA Endovascular Graft|Clinical Investigation Plan for the Zenith® Low Profile AAA Endovascular Graft|Available||N/A|||Cook Group Incorporated|||||||||||||||||||2017-10-10 22:54:09.907274|2017-10-10 22:54:09.907274
NCT02557646|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-02-29|2016-01-12||May 2009||2009-05-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||Intention-to-treat (ITT) population included all enrolled participants who provided evaluable data for the study.|An Observational Study to Assess the Effect of Cumulative Ribavirin Dose in Participants With Chronic Hepatitis C||Completed||N/A|697|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:54:10.039209|2017-10-10 22:54:10.039209
NCT02557633|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-03-02|||August 2015||2015-08-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL|A Pre-season, Single Site, Single-blind, Parallel Group, Randomized Study to Determine the Tolerability and Safety of Two New Cumulative Doses of Modified Grass Allergens Adsorbed to L-tyrosine With Monophosphoryl Lipid A Adjuvant (Corixa), Phenol Preserved (Grass MATA MPL); Allergy Therapeutics, (UK) Ltd., Compared With Placebo in Patients With Seasonal Allergic Rhinoconjunctivitis Due to Grass Pollen Allergy.|Completed||Phase 1|29|Actual|Allergy Therapeutics||3|||f||||t||||||||||2017-10-10 22:54:12.899179|2017-10-10 22:54:12.899179
NCT02557620|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-01-02|||September 2015||2015-09-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly|A Randomised, Double-blind, Placebo Controlled, Double Dummy, Single-centre Trial in Healthy Subjects Comparing the Steady-state Exposure of Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly|Completed||Phase 1|113|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-10 22:54:13.013394|2017-10-10 22:54:13.013394
NCT02557607|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-22|||December 2014||2014-12-01|September 2015|2015-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|ASL-HSA||Quantification of Cerebral Blood Flow by Arterial Spin Labeling in Vasospasm in Subarachnoid Haemorrhage|Quantification of Cerebral Blood Flow by Arterial Spin Labeling in the Screening and Monitoring of Vasospasm in Subarachnoid Haemorrhage|Recruiting||N/A|50|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 22:54:13.109837|2017-10-10 22:54:13.109837
NCT02557594|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2017-04-10|||October 6, 2015|Actual|2015-10-06|April 2017|2017-04-01|March 8, 2016|Actual|2016-03-08|November 17, 2015|Actual|2015-11-17||Interventional|||Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers|A Randomized, Open-label, Two-way Crossover Study to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg After a Single Oral Dose in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:54:13.227745|2017-10-10 22:54:13.227745
NCT02557581|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-07-29|||July 2015||2015-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|June 30, 2017|Actual|2017-06-30||Interventional|||cAMP Signaling and Muscle Adaptations||Recruiting||N/A|72|Anticipated|University of Copenhagen||3|||f||||f||||||||||2017-10-10 22:54:13.323476|2017-10-10 22:54:13.323476
NCT02557568|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-23|||October 2011||2011-10-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|ScreenStaph||Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne|Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne|Completed||N/A|160|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 22:54:14.00955|2017-10-10 22:54:14.00955
NCT02557555|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-06-28|2017-04-06||September 2015|Actual|2015-09-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Patient Education on Labor Analgesia Options|Effects of Antenatal and Perinatal Education of Labor Analgesia Options on Maternal Anxiety, Labor Analgesia and Maternal Satisfaction With Labor Analgesia|Completed||N/A|100|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-10-10 22:54:14.10436|2017-10-10 22:54:14.10436
NCT02557542|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-07-04|||October 2015||2015-10-01|March 2017|2017-03-01|December 2017||2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|OSVeC||Pilot RCT Evaluating a One Stop Vein Clinic|Pilot Randomised Controlled Trial Evaluating the Potential Benefit of a One Stop Vein Clinic (OSVeC)|Recruiting||N/A|416|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-10 22:54:14.36936|2017-10-10 22:54:14.36936
NCT02557529|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-05-16|||August 2015||2015-08-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy|Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy - The DAHANCA 31 Study|Recruiting||Phase 2|72|Anticipated|Herlev Hospital||2|||f||||f||||||||||2017-10-10 22:54:14.649431|2017-10-10 22:54:14.649431
NCT02557516|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2016-11-24|||November 2015||2015-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Combination Study of IPH2201 With Ibrutinib in Patients With Relapsed, Refractory or Previously Untreated Chronic Lymphocytic Leukemia|Open Label 1b/2a Trial of a Combination of IPH2201 and Ibrutinib in Patients With Relapsed, Refractory or Previously Untreated Chronic Lymphocytic Leukemia|Recruiting||Phase 1/Phase 2|45|Anticipated|Innate Pharma||1|||f||||f||||||||||2017-10-10 22:54:14.810203|2017-10-10 22:54:14.810203
NCT02557503|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-22|||January 2015||2015-01-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE|An Randomized and Controlled Study of Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE|Recruiting||Phase 4|110|Anticipated|Beijing Cancer Hospital||2|||f||||f||||||||||2017-10-10 22:54:14.956519|2017-10-10 22:54:14.956519
NCT02557490|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-22|2015-09-22|||January 2015||2015-01-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases|A Randomized Controlled Trial of TACE Hepatic Artery Infusion of Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases|Recruiting||Phase 4|100|Anticipated|Beijing Cancer Hospital||2|||f||||f||||||||||2017-10-10 22:54:15.099407|2017-10-10 22:54:15.099407
NCT02557477|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2015-09-22|||March 2010||2010-03-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Omega 3/6 Fatty Acids for Reading in Children|Omega 3/6 Fatty Acids for Reading in Children: A Randomised, Double-blind, Placebo-controlled Trial in 9-year-old Mainstream Schoolchildren in Sweden|Completed||Phase 4|154|Actual|Göteborg University||2|||f||||f||||||||||2017-10-10 22:54:15.212827|2017-10-10 22:54:15.212827
NCT02557464|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-08-22|||November 10, 2015|Actual|2015-11-10|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|December 10, 2015|Actual|2015-12-10||Interventional|ADAL||Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading.|Identification of Early Semantic Markers of Alzheimer's Disease by Using Eye Tracking in Reading Neutral and Predictable Sentences|Recruiting||N/A|48|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 22:54:15.303603|2017-10-10 22:54:15.303603
NCT02557451|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-09-22||||||August 2015|2015-08-01||||January 2020|Anticipated|2020-01-01||Interventional|STAR||Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications|Subretinal Haematoma in AMD: Randomized Controlled Study of 2 Therapeutic Approaches in the Antiangiogenic Era|Not yet recruiting||N/A|90|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:54:15.418478|2017-10-10 22:54:15.418478
NCT02557438|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-09-28|||June 2015||2015-06-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Observational|||Effects of Weight Loss Surgery on Bone Health in Adolescents|Bone Metabolism in Adolescents Undergoing Bariatric Surgery|Recruiting||N/A|240|Anticipated|Massachusetts General Hospital|||3||f||||t||||||Samples With DNA|"     Blood samples, fecal samples   "|||2017-10-10 22:54:15.563423|2017-10-10 22:54:15.563423
NCT02557425|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-05-04|||October 2015||2015-10-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|PROTECT||Prophylaxis Against Malaria to Enhance Child Development (PROTECT Study)|Prophylaxis Against Malaria to Enhance Child Development|Active, not recruiting||N/A|272|Actual|Indiana University|||5||f||||f||||||||||2017-10-10 22:54:15.670117|2017-10-10 22:54:15.670117
NCT02557412|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-06-24|||May 2015||2015-05-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea|Long-term Effect of Nasal Continuous Positive Airway Pressure on Lipid Profile in Patients With Dyslipidaemia and Mild-moderate Obstructive Sleep Apnea|Recruiting||Phase 4|114|Anticipated|Hospital Universitario La Paz||3|||f||||f||||||||||2017-10-10 22:54:15.789508|2017-10-10 22:54:15.789508
NCT02557386|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-10-10|||January 2016||2016-01-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Optimal Volume of Bupivacaine in Adductor Canal Nerve Block|Optimal Volume of Bupivacaine in Adductor Canal Nerve Block in Patients Undergoing Unilateral Cruciate Ligament Reconstruction Surgery|Recruiting||Phase 4|60|Anticipated|Pontificia Universidad Catolica de Chile||6|||f||||t||||||||Undecided||2017-10-10 22:54:16.067566|2017-10-10 22:54:16.067566
NCT02557373|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-07-18|||August 2015||2015-08-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Pilot Feasibility of Rice Bran Supplementation in Children|Pilot Feasibility of Rice Bran Supplementation for Diarrheal Disease Prevention in Malian Children|Completed||N/A|48|Actual|Colorado State University||2|||f||||f||||||||||2017-10-10 22:54:16.216992|2017-10-10 22:54:16.216992
NCT02557360|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-03-27|||November 2015||2015-11-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis|Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis|Completed||Phase 4|24|Actual|Pomeranian Medical University Szczecin||1|||f||||f||||||||||2017-10-10 22:54:16.305435|2017-10-10 22:54:16.305435
NCT02557347|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-07-27|||June 2013||2013-06-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Fluid Overload in Peritoneal Dialysis|The Efficacy of Managing Fluid Overload in Peritoneal Dialysis Patient by a Structured Nurse-lead Intervention Protocol|Completed||Phase 4|102|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-10 22:54:16.393541|2017-10-10 22:54:16.393541
NCT02557334|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-01-03|||October 2015||2015-10-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effects of Freeze Dried Strawberry Powder Supplementation on Vascular Function and Blood Markers of Cardiovascular Risk|Effects of Freeze Dried Strawberry Powder Supplementation on Vascular Function and Blood Markers of Cardiovascular Risk|Recruiting||N/A|50|Anticipated|Penn State University||3|||f||||f||||||||||2017-10-10 22:54:16.470562|2017-10-10 22:54:16.470562
NCT02557321|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2017-04-27|||October 2015||2015-10-01|April 2017|2017-04-01|November 2023|Anticipated|2023-11-01|November 2018|Anticipated|2018-11-01||Interventional|||PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma|A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination With Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma|Recruiting||Phase 1/Phase 2|144|Anticipated|Provectus Pharmaceuticals||3|||f||||f||||||||||2017-10-10 22:54:16.604837|2017-10-10 22:54:16.604837
NCT02557308|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-06-12|||August 2014||2014-08-01|June 2017|2017-06-01|June 2026|Anticipated|2026-06-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis|An Observational, Prospective, Cohort Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis|Recruiting||N/A|1000|Anticipated|Celltrion|||2||f||||t||||||Samples Without DNA|"     Blood samples for immunogenicity should be retained at the central laboratory up to the End     of the Study, in case additional analysis is required. If additional analysis is not required     during the study or after the End of the Study, blood samples will be stored in a CELLTRION,     Inc. or designated biobank for a further 5 years (from the date the sample is transferred to     the CELLTRION, Inc. or biobank) unless a specific authorization is given by CELLTRION, Inc.   "|||2017-10-10 22:54:16.942639|2017-10-10 22:54:16.942639
NCT02557295|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-06-12|||December 2013||2013-12-01|June 2017|2017-06-01|June 2026|Anticipated|2026-06-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA|An Observational, Prospective Cohort Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Rheumatoid Arthritis|Recruiting||N/A|950|Anticipated|Celltrion|||3||f||||t||||||Samples Without DNA|"     Blood samples for immunogenicity should be retained at the central laboratory up to the End     of the Study, in case additional analysis is required. If additional analysis is not required     during the study or after the End of the Study, blood samples will be stored in a CELLTRION,     Inc. or designated biobank for a further 5 years (from the date the sample is transferred to     the CELLTRION, Inc. or biobank) unless a specific authorization is given by CELLTRION, Inc.   "|||2017-10-10 22:54:17.049335|2017-10-10 22:54:17.049335
NCT02557269|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-09-21|||May 2015||2015-05-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|"4S"||"4S - Seasonal Symptoms Suppression Study"|"Real Life Proof-of-Concept Study to Assess the Effect of Methylcellulose as add-on Seal to the In-season Pharmacologic Rescue Treatment in Subjects With Allergic Rhinitis"|Unknown status|Active, not recruiting|Phase 4|60|Actual|Association Asthma, Bulgaria||3|||f||||t||||||||||2017-10-10 22:54:17.213234|2017-10-10 22:54:17.213234
NCT02557256|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-02-24|||January 2016||2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Malignant Pediatric Pelvic Tumors: A Retrospective Study|Malignant Pediatric Pelvi-abdominal Tumors: A Retrospective Study|Recruiting||N/A|90|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:54:17.365589|2017-10-10 22:54:17.365589
NCT02557243|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-06-26|||January 2016||2016-01-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study|Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study|Recruiting||N/A|260|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:54:17.48158|2017-10-10 22:54:17.48158
NCT02557230|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-02-24|||January 2016||2016-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Observational|||Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience|Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience|Recruiting||N/A|250|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:54:17.586054|2017-10-10 22:54:17.586054
NCT02557217|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-06-26|||October 2015||2015-10-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction|A Phase II Randomised, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Oral NP202 in Adults Who Have Left Ventricular Systolic Dysfunction Following Myocardial Infarction|Recruiting||Phase 2|120|Anticipated|Armaron Bio Pty Ltd||2|||f||||t||||||||||2017-10-10 22:54:17.682347|2017-10-10 22:54:17.682347
NCT02557204|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-12-06|||September 2015||2015-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Comparison of Different Methods of Nasogastric Tube Insertion in Anesthetized and Intubated Patients|Comparison of Different Methods of Nasogastric Tube Insertion in Anesthetized and Intubated Patients: A Prospective Randomized Controlled Trial|Completed||N/A|200|Actual|Antalya Training and Research Hospital||4|||f||||f||||||||||2017-10-10 22:54:17.797426|2017-10-10 22:54:17.797426
NCT02557191|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-09-21|||April 2015||2015-04-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Biomarkers, Neurodevelopment and Preterm Infants|Biomarkers to Predict Neurodevelopmental Outcomes in Very Preterm Infants|Recruiting||N/A|50|Anticipated|Montefiore Medical Center|||1||f||||f||||||Samples With DNA|"     Cord blood, buccal swab and urine samples will be collected from enrolled patients.   "|||2017-10-10 22:54:17.900964|2017-10-10 22:54:17.900964
NCT02557178|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-10-07|||September 2016||2016-09-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Home-Based Health Management of COPD Patients|Home-Based Health Management of COPD Patients|Recruiting||Phase 2|115|Anticipated|Minnesota HealthSolutions||2|||f||||t||||||||No||2017-10-10 22:54:18.009932|2017-10-10 22:54:18.009932
NCT02557165|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-21|||January 2011||2011-01-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|June 2015|Actual|2015-06-01||Observational|||Impact of COPD on Muscle Regeneration|Impact of Chronic Obstructive Pulmonary Disease on Peripheral and Respiratory Muscle Regeneration|Unknown status|Active, not recruiting|N/A|27|Actual|Laval University|||2||f||||f||||||Samples Without DNA|"     Muscle biopsies from the quadriceps and diaphragm muscles   "|||2017-10-10 22:54:18.141485|2017-10-10 22:54:18.141485
NCT02557139|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-01-13|||September 2015||2015-09-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Bioavailability of KD025 in Healthy Male Subjects Completed in the UK|A Three Way Crossover, Randomised, Open-Label Study in Healthy Subjects, Designed to Compare the Bioavailability of a KD025 Tablet Formulation Administered in the Fed and Fasted States and to Assess the Relative Bioavailability of a Tablet and Capsule Formulation in the Fed State|Completed||Phase 1|24|Actual|Kadmon Corporation, LLC||3|||f||||f||||||||||2017-10-10 22:54:18.350515|2017-10-10 22:54:18.350515
NCT02557126|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-01-09|||October 2015||2015-10-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study of URC102 to Assess the Safety and Efficacy in Gout Patients|A Placebo-controlled, Randomized, Double-blind, Multicenter Phase 2 Study to Assess the Efficacy and Safety of URC102 in Gout Patients|Completed||Phase 2|76|Actual|JW Pharmaceutical||2|||f||||||||||||||2017-10-10 22:54:18.478277|2017-10-10 22:54:18.478277
NCT02557113|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2015-09-21|||January 2011||2011-01-01|September 2015|2015-09-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Creation of a Small Cavity Reduces the Rate of Cement Leakage During Vertebral Body Augmentation|Creation of a Small Cavity in Vertebral Body Reduces the Rate of Cement Leakage During Vertebral Body Augmentation: A Prospective Randomized Controlled Study|Completed||N/A|36|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-10 22:54:18.576389|2017-10-10 22:54:18.576389
NCT02557100|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-09-27|||November 19, 2015|Actual|2015-11-19|September 2017|2017-09-01|February 8, 2019|Anticipated|2019-02-08|May 30, 2018|Anticipated|2018-05-30||Interventional|||Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis|A Randomized, Head-to-Head, Single-Blinded Study to Assess Changes in the Immune Profile in Response to Treatment With Subcutaneous Abatacept in Combination With Methotrexate Versus Subcutaneous Adalimumab in Combination With Methotrexate in Adults With Early Rheumatoid Arthritis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drugs|Recruiting||Phase 4|50|Anticipated|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:54:18.669258|2017-10-10 22:54:18.669258
NCT02557087|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-21|||September 2015||2015-09-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Hyoscine ButylBromide for Intrapartum Analgesia|Efficacy of Intravenous Hyoscine ButylBromide as an Analgesic During the First Stage of Labor: A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 2|104|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 22:54:18.921906|2017-10-10 22:54:18.921906
NCT02557074|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-04-14|||December 2015||2015-12-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|TreatPelade||TREg Activation in the Treatment of the PELADE (Alopecia Areata)|TREg Activation in the Treatment of the PELADE (Alopecia Areata). Double Blind Randomized Placebo Controlled Comparative Study Using Low Doses of IL2|Recruiting||Phase 3|56|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 22:54:18.998303|2017-10-10 22:54:18.998303
NCT02557061|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-10-07|||April 2009||2009-04-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|TIL||Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers|Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers|Completed||N/A|56|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 22:54:19.12335|2017-10-10 22:54:19.12335
NCT02557048|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-02-24|||November 2017|Anticipated|2017-11-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|||Head and Neck Cancer in Children: A Retrospective Study|Malignant Head and Neck Tumors in Children: A Retrospective Study|Not yet recruiting||N/A|120|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:54:19.208345|2017-10-10 22:54:19.208345
NCT02556489|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-29|||September 2015||2015-09-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Transcriptomics Signature of Anti Vaccinia Memory B Cells|Transcriptomics Signature of Anti Vaccinia Memory B Cells in Healthy Individuals at a Short Time After Vaccination|Unknown status|Enrolling by invitation|N/A|12|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-10-10 22:54:25.21553|2017-10-10 22:54:25.21553
NCT02557022|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-08-22|||September 2014||2014-09-01|November 2014|2014-11-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Meta Analysis of the Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight|The Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight: A Systematic Review and Meta-analyses of Randomized Controlled Trials|Unknown status|Active, not recruiting|N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-10 22:54:19.774873|2017-10-10 22:54:19.774873
NCT02557009|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-07-24|||October 1, 2013|Actual|2013-10-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Changes in Hemodynamic Values With Posture|Changes in Hemodynamic Values With Posture|Completed||N/A|60|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-10-10 22:54:19.885852|2017-10-10 22:54:19.885852
NCT02556996|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-10-07|||October 1998||1998-10-01|October 2015|2015-10-01|April 2002|Actual|2002-04-01|March 2001|Actual|2001-03-01||Interventional|||Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children|Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children|Completed||Phase 3|356|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-10-10 22:54:19.979788|2017-10-10 22:54:19.979788
NCT02556983|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-04-11|||August 2015||2015-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Observational|||CT Dose Simulation Study for Appendicitis|Optimizing the Radiation Dose for CT Imaging With Iterative Reconstruction in Diagnosing Acute Appendicitis: Dose Simulation Study|Completed||N/A|30|Anticipated|Seoul National University Bundang Hospital|||1||f||||f||||||||||2017-10-10 22:54:20.099867|2017-10-10 22:54:20.099867
NCT02556970|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-11-14||||||November 2016|2016-11-01||||September 2015|Actual|2015-09-01||Interventional|SiMuPort||A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery|A Randomised Multi-centre Feasibility Study Investigating Post-operative Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgical (VATS) Procedures|Withdrawn||N/A|0|Actual|University Hospitals Bristol NHS Foundation Trust||2||Study never started and was abandoned.|f||||f||||||||||2017-10-10 22:54:20.24083|2017-10-10 22:54:20.24083
NCT02556957|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2016-08-29|||September 2015||2015-09-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|mLAKE||CHWs, mHealth, and Combination HIV Prevention|CHWs, mHealth, and Combination HIV Prevention: An Implementation Science Cluster-Randomized Trial (mLAKE)|Recruiting||N/A|2500|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 22:54:20.401118|2017-10-10 22:54:20.401118
NCT02556944|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-21|||April 2015||2015-04-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Mix and Match Study of Two Multifocal Intraocular Lens With Different Add Power|Mix and Match Study of Two Multifocal Intraocular Lens With Different Add Power|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:54:20.520651|2017-10-10 22:54:20.520651
NCT02556931|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-07-12|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies|Phase II Study of Shortened-duration Tacrolimus Following Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Malignancies That Are Challenging to Engraft|Recruiting||Phase 2|120|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 22:54:20.607628|2017-10-10 22:54:20.607628
NCT02556918|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-07-31|||January 2016||2016-01-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|SITA-CABGDM||Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery|Sitagliptin for the Prevention and Treatment of Hyperglycemia in Patients With Type 2 Diabetes Undergoing Cardiac Surgery|Recruiting||Phase 4|200|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 22:54:20.776924|2017-10-10 22:54:20.776924
NCT02556905|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-01-24|||March 2011||2011-03-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea|REVLIMID® Drug Use Examination|Active, not recruiting||N/A|624|Actual|Celgene|||1||f||||f||||||||||2017-10-10 22:54:20.958668|2017-10-10 22:54:20.958668
NCT02556892|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-07-20|||July 3, 2015|Actual|2015-07-03|July 2017|2017-07-01|November 30, 2018|Anticipated|2018-11-30|July 28, 2018|Anticipated|2018-07-28||Interventional|||A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Phase 1 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Subjects With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Active, not recruiting||Phase 1|8|Actual|Janssen Pharmaceutical K.K.||1|||f||||f|f|||||||||2017-10-10 22:54:21.144153|2017-10-10 22:54:21.144153
NCT02556879|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-04-13|||March 9, 2016|Actual|2016-03-09|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|DSATH||Immunization Anti HLA in the Liver Transplant Recipients (DSATH)|Immunization Anti HLA in the Liver Transplant Recipients (DSATH)|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:54:21.251726|2017-10-10 22:54:21.251726
NCT02556866|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|ESBAM||Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis|Multicenter Randomized Double-blind Study Comparing the Efficacy and Safety of Rituximab in Combination With Corticosteroids to Corticosteroids Plus Placebo in the Treatment of Non-infectious Active Mixed Cryoglobulinemia Vasculitis|Recruiting||Phase 2|158|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 22:54:21.363178|2017-10-10 22:54:21.363178
NCT02556853|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2017-01-24|||September 2015||2015-09-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultrasound for Double Lumen Endotracheal Tube|Comparison Between Ultrasound and Clinical Assessment of the Correct Positioning of Left Double Lumen Endotracheal Tube|Terminated||N/A|5|Actual|424 General Military Hospital||2||"The Thoracic Surgery Department has almost stopped completely its surgical activities and the   completion of the study doesn't seem to be feasible."|f||||f||||||||||2017-10-10 22:54:21.473517|2017-10-10 22:54:21.473517
NCT02556840|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-06-23|||May 2016||2016-05-01|June 2016|2016-06-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|MODY2||Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes|Impact of Two Standardized Clinical Care Protocols on Pregnancy Outcomes in Women With Monogenic Diabetes MODY2|Recruiting||N/A|80|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:54:21.554979|2017-10-10 22:54:21.554979
NCT02556827|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2015-09-22|||July 2015||2015-07-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|||Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients|Investigation of Relation Between Demodex Density With Immune Response and Oxidative Stress in Rosacea Patients|Unknown status|Recruiting|N/A|80|Anticipated|Istanbul Training and Research Hospital|||2||f||||f||||||||||2017-10-10 22:54:21.69061|2017-10-10 22:54:21.69061
NCT02556814|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-04-18|||September 2015||2015-09-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Caffeic Acid Combining High-dose Dexamethasone in Management of ITP|A Prospective, Multicenter, Placebo Controlled Study on Caffeic Acid Tablet Combining High-dose Dexamethasone in Management of Adult Primary Immune Thrombocytopenia (ITP)|Recruiting||Phase 4|240|Anticipated|Shandong University||2|||f||||t||||||||No||2017-10-10 22:54:21.847281|2017-10-10 22:54:21.847281
NCT02556801|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-10-25|||September 2015||2015-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||SUBLIVAC Phleum Study|A Single-center, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Investigate the Relative Efficacy and Safety of Immunotherapy With SUBLIVAC FIX Phleum Pratense (SP) Compared to Placebo in Grass Pollen-Allergic Subjects With IgE-Mediated Seasonal Allergic Rhinoconjunctivitis|Completed||Phase 2|168|Actual|HAL Allergy||4|||f||||t||||||||||2017-10-10 22:54:21.990993|2017-10-10 22:54:21.990993
NCT02556788|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-08-31|||November 2015||2015-11-01|August 2017|2017-08-01|May 12, 2017|Actual|2017-05-12|February 7, 2017|Actual|2017-02-07||Interventional|||Double-Blind Efficacy and Safety of CD5789 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris|A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50µg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris|Completed||Phase 3|1212|Actual|Galderma R&D||2|||f||||f||||||||||2017-10-10 22:54:22.106192|2017-10-10 22:54:22.106192
NCT02556775|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-10-06|||December 2015||2015-12-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|33 Months|Observational [Patient Registry]|||Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia (Immune Globulin (Human) 10% With rHuPH20)|Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia (Immune Globulin (Human) 10% With rHuPH20)|Recruiting||N/A|30|Anticipated|Baxalta US Inc.|||2||f||||f||||||Samples Without DNA|"     Blood samples (plasma) for antibodies against recombinant human hyaluronidase (rHuPH20) that     remain after study testing is done may be stored and used for additional testing (eg, further     evaluation of an abnormal test or an adverse event). Samples will be stored in a coded form     for a maximum of 2 years after the final study report has been completed and, subsequently,     will be destroyed.   "|||2017-10-10 22:54:22.396192|2017-10-10 22:54:22.396192
NCT02556762|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-04-19|||August 2015||2015-08-01|April 2016|2016-04-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|SUMC-EC-002||Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer|Phase III Randomized Controlled Trial of Definite Chemoradiotherapy in Patients With Esophageal Cancer: Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy|Recruiting||Phase 3|202|Anticipated|Shantou University Medical College||2|||f||||f||||||||||2017-10-10 22:54:22.521511|2017-10-10 22:54:22.521511
NCT02556749|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-01-03|||October 2015||2015-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Cranberry Juice on Cardiovascular Risk Factors|Effects of Cranberry Juice on Cardiovascular Risk Factors in a Placebo-controlled Crossover Trial|Recruiting||N/A|50|Anticipated|Penn State University||2|||f||||f||||||||||2017-10-10 22:54:22.635207|2017-10-10 22:54:22.635207
NCT02556736|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-07-07|||December 14, 2015|Actual|2015-12-14|July 2017|2017-07-01|February 28, 2021|Anticipated|2021-02-28|August 28, 2019|Anticipated|2019-08-28||Interventional|||RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa|Phase I/IIa, Open-Label, Dose-Escalation Study of Safety and Tolerability of Intravitreal RST-001 in Patients With Advanced Retinitis Pigmentosa (RP)|Recruiting||Phase 1/Phase 2|15|Anticipated|Allergan||1|||f||||t||||||||||2017-10-10 22:54:22.757973|2017-10-10 22:54:22.757973
NCT02556723|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-10-01|||September 2014||2014-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Intravitreal Injections of Ziv-aflibercept for Macular Diseases|Intravitreal Injections of Ziv-aflibercept for Macular Diseases: Diabetic Macular Edema, Wet AMD and Macular Edema Secondary to Vein Occlusons|Completed||N/A|60|Anticipated|Retina Clinic, Sao Paulo, Brazil||1|||f||||f||||||||Undecided||2017-10-10 22:54:22.859078|2017-10-10 22:54:22.859078
NCT02556710|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-07-27|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||AP-003-B Study to Evaluate the Efficacy And Safety Of An Intra-Articular Injection Of Ampion™ In Adults With Pain With Osteoarthritis Of The Knee|A Randomized, Placebo-Controlled, Double-Blind Study to Evaluated the Efficacy and Safety of an Intra-Articular Injection of AMPION™ in Adults With Pain Due to Osteoarthritis of the Knee|Completed||Phase 3|480|Actual|Ampio Pharmaceuticals. Inc.||2|||f||||t||||||||||2017-10-10 22:54:22.981895|2017-10-10 22:54:22.981895
NCT02556697|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-12-06|||December 2014||2014-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MiPECSE||In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients|In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients|Recruiting||N/A|60|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 22:54:23.267671|2017-10-10 22:54:23.267671
NCT02556684|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-01-12|||September 2015||2015-09-01|January 2016|2016-01-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|BSGILAB||Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy|A Prospective Study to Evaluate Dynamic Breast-Specific Gamma Imaging in Monitoring Tumor Responses in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy|Recruiting||N/A|200|Anticipated|Zhejiang University|||1||f||||t||||||||||2017-10-10 22:54:23.387934|2017-10-10 22:54:23.387934
NCT02556658|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-06-15|||February 2015||2015-02-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|NAPfem||Predicted Level of General Anaesthesia in Hip Fracture Surgery|Predicted Level of General Anaesthesia in Hip Fracture Surgery|Completed||Phase 4|100|Actual|University Hospital, Angers||2|||f||||||||||||||2017-10-10 22:54:23.614314|2017-10-10 22:54:23.614314
NCT02556645|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-09-18|||May 2016||2016-05-01|September 2017|2017-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel||Recruiting||N/A|120|Anticipated|University of Pennsylvania||2|||f||||||||||||||2017-10-10 22:54:23.754223|2017-10-10 22:54:23.754223
NCT02556619|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-05-22|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Randomized Control Trial (RCT) of Early Palliative Care for HCC|Early Symptom Control and Palliative Care Referral for Advanced Hepatocellular Carcinoma; a Randomized Control Trial|Not yet recruiting||N/A|72|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f|f|f||||||No||2017-10-10 22:54:24.06372|2017-10-10 22:54:24.06372
NCT02556606|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-08-07|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|September 30, 2020|Anticipated|2020-09-30|March 31, 2020|Anticipated|2020-03-31||Interventional|||Ketamine for Treatment Resistant Late-Life Depression|Ketamine for Treatment Resistant Late-Life Depression|Recruiting||Phase 3|72|Anticipated|VA Office of Research and Development||4|||f||||t|t|f|||f|||||2017-10-10 22:54:24.163138|2017-10-10 22:54:24.163138
NCT02556593|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-19|2017-10-03|||September 2015||2015-09-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases|IMRT Combined With Erlotinib Compared With Whole-brain Radiotherapy for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases|Enrolling by invitation||Phase 2|116|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:54:24.298366|2017-10-10 22:54:24.298366
NCT02556580|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2016-10-13|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Albumin||Volume Kinetics for 20% Albumin in Different Clinical Situations|Volume Kinetics for 20% Albumin in Conscious and Anesthetized Humans With and Without Inflammation|Recruiting||Phase 4|45|Anticipated|Sodertalje Hospital||3|||f||||f||||||||Yes|When the study is completed.|2017-10-10 22:54:24.430881|2017-10-10 22:54:24.430881
NCT02556567|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-11|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Exploring the Effects of Sleep Patterns and Physical Activity on Asthma in Adolescents With Wrist-worn Smart Devices|Exploring the Effects of Sleep Patterns and Physical Activity on Asthma in Adolescents With Wrist-worn Smart Devices|Completed||N/A|23|Actual|Arkansas Children's Hospital Research Institute||1|||f||||f||||||||||2017-10-10 22:54:24.568907|2017-10-10 22:54:24.568907
NCT02556554|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-11-14|||September 2015||2015-09-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy|A Single-center, Prospective, 'Open-label,' Investigator-initiated Pilot Study Evaluating the Role of Continuous Glucose Monitor (CGM) Use Either Alone or With Remote Monitoring Capabilities in Pregnancy Associated With Type 1 Diabetes|Active, not recruiting||N/A|40|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-10-10 22:54:24.685915|2017-10-10 22:54:24.685915
NCT02556541|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-03-04|||September 2015||2015-09-01|April 2015|2015-04-01||||August 2016|Anticipated|2016-08-01||Interventional|||Ultrasound-guided Peripheral Vascular Access in Children|Ultrasound-guided Peripheral Vascular Access in Children - a Single- Blind, Randomized, Cross-over Trial|Unknown status|Recruiting|N/A|50|Anticipated|University of Aarhus|||||f||||||||||||||2017-10-10 22:54:24.801269|2017-10-10 22:54:24.801269
NCT02556528|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-18|||November 2015||2015-11-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Feasibility of Health Coaching in Cancer Patients|A Study to Assess the Feasibility of Using Health Coaching Sessions in Cancer Patients|Unknown status|Not yet recruiting|N/A|10|Anticipated|Oxford University Hospitals NHS Trust||1|||f||||f||||||||||2017-10-10 22:54:24.900155|2017-10-10 22:54:24.900155
NCT02556515|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-06-28|||November 2008||2008-11-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Joint Replacement or Interpositional Arthroplasty for CMC1 Arthritis, a Prospective Trial|Total Joint Replacement or Interpositional Arthroplasty for the Treatment of Arthritis in the Carpometacarpal Joint of the Thumb|Active, not recruiting||N/A|40|Anticipated|Oslo University Hospital||2|||f||||t||||||||No||2017-10-10 22:54:24.983445|2017-10-10 22:54:24.983445
NCT02556502|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-08-10|||November 2015||2015-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|MAF||18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study|18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study|Recruiting||N/A|40|Anticipated|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-10 22:54:25.112885|2017-10-10 22:54:25.112885
NCT02556476|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-21|||June 2011||2011-06-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Observational|CEACCLR||Cost Effectiveness Analysis of Critical Care in Resource Limited Setting|Cost Effectiveness of Intensive Care in a Low Resource Setting: Prospective Cohort of Medical Critically Ill Patients|Completed||N/A|148|Actual|University of Sarajevo|||1||f||||f||||||||||2017-10-10 22:54:25.284562|2017-10-10 22:54:25.284562
NCT02556463|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-07-31|||November 4, 2015|Actual|2015-11-04|July 2017|2017-07-01|June 24, 2020|Anticipated|2020-06-24|June 24, 2020|Anticipated|2020-06-24||Interventional|||A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors|A Phase I, First-Time-in-Human Study of MEDI9197, a TLR 7/8 Agonist, Administered Intratumorally as a Single Agent in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors|Recruiting||Phase 1|135|Anticipated|MedImmune LLC||4|||f||||f||||||||||2017-10-10 22:54:25.428671|2017-10-10 22:54:25.428671
NCT02556450|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-05-10|||January 2016||2016-01-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|Homage||Bioprofiling Response to Mineralocorticoid Receptor Antagonists for the Prevention of Heart Failure|"Bioprofiling Response to Mineralocorticoid Receptor Antagonists for the Prevention of Heart Failure. A Proof of Concept Clinical Trial Within the EU FP 7 (European Union FP7) HOMAGE Programme  Heart OMics in AGing "|Recruiting||Phase 2|800|Anticipated|ACS Biomarker||2|||f||||t||||||||||2017-10-10 22:54:25.610633|2017-10-10 22:54:25.610633
NCT02556437|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-10-24|||June 2016||2016-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)|Randomized, Single-blind, Cross-over Study Investigating the Non-inferiority of Efficacy and Safety of HyQvia in Comparison With Conventional Subcutaneous Ig Therapy in Multifocal Motor Neuropathy|Enrolling by invitation||Phase 2|20|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 22:54:25.766911|2017-10-10 22:54:25.766911
NCT02556424|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-09-13|||January 2016||2016-01-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|TRIOZ||Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema|Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema|Recruiting||Phase 3|142|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-10 22:54:25.916419|2017-10-10 22:54:25.916419
NCT02556411|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2016-03-08|||June 2016||2016-06-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)||Not yet recruiting||N/A|50|Anticipated|University of Cagliari||2|||f||||f||||||||||2017-10-10 22:54:26.105862|2017-10-10 22:54:26.105862
NCT02556398|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-08-22|||September 2015||2015-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 31, 2017|Anticipated|2017-08-31||Interventional|||Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control|Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control|Recruiting||N/A|30|Anticipated|Joslin Diabetes Center||1|||f||||f||||||||||2017-10-10 22:54:26.200333|2017-10-10 22:54:26.200333
NCT02556385|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-01-31|||October 2015||2015-10-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of rTMS Based on Brain Activation During Language Performance in Stroke Patients With Non-fluent Aphasia|Effects of Repetitive Transcranial Magnetic Stimulation Based on Brain Activation During Language Performance in Stroke Patients With Non-fluent Aphasia: A Pilot Study|Recruiting||N/A|4|Anticipated|Seoul National University Bundang Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:54:26.298083|2017-10-10 22:54:26.298083
NCT02556372|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2017-03-07|||February 2016||2016-02-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|JKB-122AIH||Liver Test Study of Using JKB-122 in AIH Patients|A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies|Recruiting||Phase 2|20|Anticipated|TaiwanJ Pharmaceuticals Co., Ltd||1|||f||||f||||||||||2017-10-10 22:54:26.461972|2017-10-10 22:54:26.461972
NCT02556359|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-04-15|||July 2015||2015-07-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Observational|IMMUNEREP||Consequences of DNA Repair and Telomere Defects on the Function of the Immune System: Application to CVID and Immune Deficiencies With Dysmorphic Syndromes|Consequences of DNA Repair and Telomere Defects on the Function of the Immune System: Application to CVID and Immune Deficiencies With Dysmorphic Syndromes|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Blood samples will be obtained as a source of DNA and viable lymphocytes for functional     studies. Blood will be sent to the laboratory of Dr JP de Villartay, INSERM UMR1163, Genome     Dynamics in the Immune System, Université Paris Descartes - Sorbonne Paris Cité, Institut     Imagine, 24 boulevard du Montparnasse, 75015 PARIS. Functional studies will be performed     immediately.      A portion of the blood sample taken as part of the research will be included in a biological     collection: B-EBV cell lines will be derived from patients and their parents. EBV-B cell     lines will be established by Centre de Ressource Biologique (CRB, Hôpital Necker - Enfants     Malades, Bâtiment IMAGINE 1er étage, 149, rue de Sèvres - 75 743 PARIS CEDEX 15, under the     supervision of Dr Marie-Alexandra Alyanakian & Anne Esling & Christine Gouarin). Skin     biopsies will be obtained from patients to derive fibroblast lines at CRB.   "|||2017-10-10 22:54:26.694114|2017-10-10 22:54:26.694114
NCT02556346|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-02-29|||November 2015||2015-11-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Withdrawn||Phase 1|0|Actual|Molecular Templates, Inc.||5||"The patient population (CLL & SLL) was included in another ongoing study involving NHL   patients."|f||||t||||||||||2017-10-10 22:54:26.803072|2017-10-10 22:54:26.803072
NCT02556320|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-01-22|||May 2013||2013-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|VIRIDAE||Immunological and Viral Parameters in Patients Receiving Anti-epileptic Drugs|Immunological and Viral Parameters in Patients Receiving Anti-epileptic Drugs|Completed||N/A|30|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 22:54:27.055019|2017-10-10 22:54:27.055019
NCT02556307|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2016-01-18|2016-01-18||March 2009||2009-03-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational||All treated participants were included in the analysis.|A Study of the Effectiveness of Peginterferon Alfa-2a (Pegasys) and Ribavirin Treatment in Slovenian Hepatitis C (HCV) Patients||Completed||N/A|270|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:54:27.150689|2017-10-10 22:54:27.150689
NCT02556294|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-04-11|||June 2015||2015-06-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Fostering Resilience to Psychosocial and HIV Risk in Indian MSM|Fostering Resilience to Psychosocial and HIV Risk in Indian MSM|Recruiting||N/A|608|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 22:54:27.494023|2017-10-10 22:54:27.494023
NCT02556281|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-12-06|||October 2012||2012-10-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|CTC||Prognostic Value of Circulating Tumoral Free DNA Versus Circulating Tumoral Cells in Patients With Colorectal Cancer Stage II-III|PROGNOSTIC VALUE OF CIRCULATING TUMORAL FREE DNA Versus CIRCULATING TUMORAL CELLS IN PATIENTS WITH COLORECTAL CANCER STAGE II-III|Recruiting||N/A|216|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 22:54:27.60356|2017-10-10 22:54:27.60356
NCT02556268|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-21|2017-08-02|||February 23, 2016|Actual|2016-02-23|July 2017|2017-07-01|December 7, 2016|Actual|2016-12-07|December 7, 2016|Actual|2016-12-07||Interventional|||Interaction With HIV Antiretroviral Agents|Potential Pharmacokinetic Interaction of Human Immunodeficiency Virus (HIV) Antiretroviral Agents as Fixed-dose Combinations and Riociguat in HIV Patients|Completed||Phase 1|40|Actual|Bayer||5|||f||||f|t|f||||||||2017-10-10 22:54:27.680559|2017-10-10 22:54:27.680559
NCT02556255|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-21|||October 2015||2015-10-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Safety and Effectiveness Study of Eximo's CathiTM Atherectomy Device for PAD Treatment|Safety and Effectiveness Evaluation of Eximo's CathiTM, a Hybrid Atherectomy Device, in Subjects Affected With PAD|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Eximo Medical Ltd.||1|||f||||f||||||||||2017-10-10 22:54:27.769213|2017-10-10 22:54:27.769213
NCT02556242|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-18|||October 2015||2015-10-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|TIRS||Targeted Indoor Residual Spraying Against Malaria|From Malaria Control to Sustainable Elimination: Cluster Randomised Trial Comparing Targeted Versus Generalised Vector Control in South Africa|Unknown status|Enrolling by invitation|Phase 4|500000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-10 22:54:27.850081|2017-10-10 22:54:27.850081
NCT02556229|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-06-26|||June 2016||2016-06-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|ALINEA||Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA).|Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory Choroidal Neovascularization (CNV) in Young Patients.|Recruiting||Phase 2|20|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-10 22:54:27.955905|2017-10-10 22:54:27.955905
NCT02556216|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-08-19|||February 2015||2015-02-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Observational|BoneX||Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)|Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)|Recruiting||N/A|100|Anticipated|Hannover Medical School|||1||f||||f||||||Samples Without DNA|"     blood; urine, bone tissue   "|Undecided||2017-10-10 22:54:28.181566|2017-10-10 22:54:28.181566
NCT02556203|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-09-19|||December 16, 2015|Actual|2015-12-16|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|GALILEO||Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes|Global Multicenter, Open-label, Randomized, Event-driven, Active-controlled Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement (TAVR) to Optimize Clinical Outcomes|Recruiting||Phase 3|1520|Anticipated|Bayer||2|||f||||t|t|f||||||||2017-10-10 22:54:28.304994|2017-10-10 22:54:28.304994
NCT02556190|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-08-23|||June 2013||2013-06-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Colistin Pharmacokinetics in Critically Ill Patients During Extended Dialysis|Colistin Pharmacokinetics in Critically Ill Patients With Acute Kidney Injury AKIN III During Extended Dialysis Using the GENIUS Dialysis System|Completed||N/A|8|Actual|Hannover Medical School|||1||f||||f||||||Samples With DNA|"     -  blood samples        -  dialysate samples   "|||2017-10-10 22:54:28.816368|2017-10-10 22:54:28.816368
NCT02556177|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-05-03|||November 2015||2015-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|mTBI-phase2||Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2|Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2|Recruiting||N/A|525|Anticipated|GE Healthcare||2|||f||||f||||||||||2017-10-10 22:54:28.888054|2017-10-10 22:54:28.888054
NCT02556164|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-21|||May 2013||2013-05-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Electro-acupuncture for Gait and Balance in Parkinson's Disease|Objective Assessment of Electro-acupuncture Efficacy for Gait and Balance in Patients With Parkinson's Disease|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Arizona||2|||f||||t||||||||||2017-10-10 22:54:29.031637|2017-10-10 22:54:29.031637
NCT02556138|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-03-30|||September 2015||2015-09-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist Candidates|Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist Candidates|Suspended||N/A|10|Anticipated|Mayo Clinic||1||awaiting IRB continuing review|f||||f||||||||||2017-10-10 22:54:29.256782|2017-10-10 22:54:29.256782
NCT02556125|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-09-07|||December 2015||2015-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Diaphragm Pacing After Spinal Cord Injury|Intramuscular Pacing to Enhance Voluntary Diaphragm Activation|Recruiting||N/A|40|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-10 22:54:29.355097|2017-10-10 22:54:29.355097
NCT02556112|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-05-05|||August 2015||2015-08-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Effectiveness of a Group Lifestyle Balance Class in a Military Population|Effectiveness of a Group Lifestyle Balance Class in a Military Population|Enrolling by invitation||N/A|107|Anticipated|David Grant U.S. Air Force Medical Center||3|||f||||f||||||||No||2017-10-10 22:54:29.470973|2017-10-10 22:54:29.470973
NCT02556099|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-09-21|||August 2014||2014-08-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||EXTEND EXpanding Treatment for Existing Neurological Disease|EXpanding Treatment for Existing Neurological Disease (EXTEND)|Recruiting||Phase 2|100|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-10 22:54:29.595553|2017-10-10 22:54:29.595553
NCT02556086|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-01-19|||December 2015||2015-12-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|June 2016|Anticipated|2016-06-01||Interventional|||A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)|A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)|Withdrawn||Phase 2|0|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 22:54:29.714342|2017-10-10 22:54:29.714342
NCT02556073|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-09-20|||August 2014||2014-08-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||ICS/LABA Combination With Integrated Dose Counter and Smartphone APP to Improve Asthma Control|The Use of ﬂuticasone Propionate/Salmeterol Inhaler With Integrated Dose Counter and Smartphone Self Management to Improve Airway Inflammation and Asthma Control|Unknown status|Enrolling by invitation|N/A|112|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-10 22:54:29.865454|2017-10-10 22:54:29.865454
NCT02556060|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-11-23|||September 2015||2015-09-01|November 2015|2015-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Lamotrigine for Ketamine Dependence Trial|Lamotrigine for Ketamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial|Recruiting||Phase 2/Phase 3|80|Anticipated|Taipei City Hospital||2|||f||||t||||||||||2017-10-10 22:54:29.98432|2017-10-10 22:54:29.98432
NCT02556047|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-10-12|||September 2015||2015-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of the Safety & Performance of 2 Intradermal Safety Devices|A Clinical Investigation to Evaluate the Safety and Performance of Two Star Intradermal Safety Device (IDSD) Syringes in Healthy Adult Volunteers|Completed||N/A|20|Actual|University of Surrey||1|||f||||f||||||||||2017-10-10 22:54:30.119407|2017-10-10 22:54:30.119407
NCT02556034|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-09-08|||September 2015||2015-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|APRAN||Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.|Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)|Recruiting||N/A|100|Anticipated|Centre de Rhumatologie de l'Est du Québec|||1||f||||f||||||||||2017-10-10 22:54:30.250349|2017-10-10 22:54:30.250349
NCT02556021|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-12-28|||September 2015||2015-09-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease|A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of CJ-12420 in Patients With Non-erosive Reflux Disease|Recruiting||Phase 3|324|Anticipated|CJ HealthCare Corporation||3|||f||||f||||||||No||2017-10-10 22:54:30.455249|2017-10-10 22:54:30.455249
NCT02556008|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-05-01||||||May 2017|2017-05-01||||||||Expanded Access|||Cannabidiol for Pediatric Epilepsy (Compassionate Use)|Cannabidiol for the Treatment of Pediatric Epilepsy (Expanded Access/Compassionate Use Protocol)|No longer available||N/A|||University of California, Los Angeles|||||||||||||||||||2017-10-10 22:54:30.572661|2017-10-10 22:54:30.572661
NCT02555995|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-02-23|||November 2015||2015-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Assessment of Scan Quality of Sparse OCT Retina Scanner (MimoStudy01)|Assessment of Scan Quality of Sparse OCT Retina Scanner (MimoStudy01)|Completed||N/A|30|Actual|University of Bern||1|||f||||t||||||||||2017-10-10 22:54:30.677903|2017-10-10 22:54:30.677903
NCT02555982|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-07-25|||June 2016||2016-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|Btx-HT||Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor|Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study|Recruiting||Phase 3|120|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 22:54:30.772955|2017-10-10 22:54:30.772955
NCT02555969|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-01-09|||August 2015||2015-08-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis|Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis|Recruiting||N/A|50|Anticipated|Tufts Medical Center|||1||f||||f||||||||||2017-10-10 22:54:30.915022|2017-10-10 22:54:30.915022
NCT02555956|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-09-20|||April 2012||2012-04-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|MMG||Grid Laser for Diffuse Diabetic Maculopathy|Subthreshold Double Frequency Nd. YAG Grid Laser for Diffuse Diabetic Maculopathy|Completed||N/A|50|Actual|Dow University of Health Sciences|||1||f||||t||||||||||2017-10-10 22:54:31.013522|2017-10-10 22:54:31.013522
NCT02555943|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-20|2017-07-03|||February 2015||2015-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DASCO||DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)|Direct Antiviral Agents for the Treatment of Chronic HCV/HBV Co-infection Patients|Recruiting||Phase 2/Phase 3|32|Anticipated|Humanity and Health Research Centre||2|||f||||t||||||||||2017-10-10 22:54:31.092183|2017-10-10 22:54:31.092183
NCT02555930|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-03-08|||December 2014||2014-12-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Observational|HIV-POGO||Clinical Phenotyping and Genotyping of HIV-Associated Sensory Neuropathy: The HIV-POGO Study|Clinical Phenotyping and Genotyping of HIV-Associated Sensory Neuropathy: The HIV-POGO Study|Recruiting||N/A|200|Anticipated|Imperial College London|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 22:54:31.224494|2017-10-10 22:54:31.224494
NCT02555917|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2015-09-19|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Comparison of Remnant Preserving Versus Remnant Resecting Anterior Cruciate Ligament Reconstruction|Tibia and Femoral Tunnel Location Comparison of Remnant Preserving Versus Remnant Resecting Anterior Cruciate Ligament Reconstruction|Unknown status|Not yet recruiting|N/A|40|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 22:54:31.364561|2017-10-10 22:54:31.364561
NCT02555904|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-18|||October 2015||2015-10-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||VoIce Changes and Heart Failure|Do VoIce Changes Predict Heart Failure|Unknown status|Not yet recruiting|N/A|12|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-10 22:54:31.439922|2017-10-10 22:54:31.439922
NCT02555891|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-09-21|||September 2014||2014-09-01|September 2015|2015-09-01||||March 2017|Anticipated|2017-03-01||Observational|PIP-STOPP||The PIP-STOPP Study|Assessing Potentially Inappropriate Prescribing (PIP) and Predicting Patient Outcomes in Ontario's Elderly Population Using the Modified STOPP Criteria in Large Administrative Health Databases (the PIP-STOPP Study)|Unknown status|Active, not recruiting|N/A|2000000|Anticipated|Bruyere Research Institute|||1||f||||f||||||||||2017-10-10 22:54:31.505845|2017-10-10 22:54:31.505845
NCT02555878|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-09-22|||September 11, 2015|Actual|2015-09-11|September 2017|2017-09-01|July 13, 2018|Anticipated|2018-07-13|July 13, 2018|Anticipated|2018-07-13||Interventional|||A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants|Efficacy and Safety of Rivaroxaban Prophylaxis Compared With Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism|Recruiting||Phase 3|700|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 22:54:31.594829|2017-10-10 22:54:31.594829
NCT02555865|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-01-06|||June 2016||2016-06-01|January 2017|2017-01-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||Aetiology of Children With Bronchiectasis in China|Aetiology of Children With Bronchiectasis in China--A Multicenter Retrospective Study|Recruiting||N/A|300|Anticipated|Beijing Children's Hospital|||1||f||||t||||||||||2017-10-10 22:54:33.69705|2017-10-10 22:54:33.69705
NCT02555839|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-03-02|||March 1, 2015|Actual|2015-03-01|March 2017|2017-03-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|||Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice|Multicenter Non-interventional Study to Investigate Drug Utilization of Pomalidomide in Clinical Practice for the Treatment of Relapsed/Refractory Multiple Myeloma (rrMM)|Recruiting||N/A|70|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 22:54:33.916242|2017-10-10 22:54:33.916242
NCT02555813|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-11-01|||May 2015||2015-05-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Treatment of Pancreatic Cancer With Abraxane|Multicenter Non-interventional Study to Investigate Safety, Tolerability and Efficacy of Nab-paclitaxel in Clinical Routine Treatment of First-line Pancreatic Cancer Patients|Recruiting||N/A|75|Anticipated|Celgene Corporation|||1||f||||f||||||||||2017-10-10 22:54:34.036159|2017-10-10 22:54:34.036159
NCT02555800|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-07-25|||December 2014||2014-12-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis|Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial|Recruiting||Phase 2|36|Anticipated|Centro de Investigación en. Enfermedades Infecciosas, Mexico||3|||f||||f||||||||||2017-10-10 22:54:34.294581|2017-10-10 22:54:34.294581
NCT02555787|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-10-05|||March 5, 2015|Actual|2015-03-05|October 2017|2017-10-01|March 2023|Anticipated|2023-03-01|December 2022|Anticipated|2022-12-01||Observational|CHORUS||Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients|Global Multicentre Kidney Transplant Advagraf Conversion Registry. A Non-interventional Post-authorisation Study (PAS)|Recruiting||N/A|4500|Anticipated|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 22:54:34.469906|2017-10-10 22:54:34.469906
NCT02555774|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2016-07-15|||May 2014||2014-05-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy of Cognitive Training in Subjective Memory Impairment|One Center, Randomized Trial to Assess Efficacy of Cognitive Training in Subjective Memory Impairment|Completed||N/A|65|Actual|Asan Medical Center||3|||f||||f||||||||||2017-10-10 22:54:34.900657|2017-10-10 22:54:34.900657
NCT02555761|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-08-25|||October 19, 2015|Actual|2015-10-19|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea|Evaluation of the Safety and Effectiveness of Lastacaft® Ophthalmic Solution 0.25% (Alcaftadine) for the Prevention of Itching Associated With Allergic Conjunctivitis: A Postmarketing Surveillance Study in Korea|Recruiting||N/A|3000|Anticipated|Allergan|||1||f||||f|f|f||||||||2017-10-10 22:54:35.003063|2017-10-10 22:54:35.003063
NCT02555553|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-15|||April 2016||2016-04-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Noom Monitor for Binge Eating|Noom Monitor for Binge Eating|Recruiting||Phase 2|200|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 22:54:42.501735|2017-10-10 22:54:42.501735
NCT02555748|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-08-07|||November 17, 2015|Actual|2015-11-17|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|SUP-R||Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma|Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma|Recruiting||Phase 4|214|Anticipated|Institut Claudius Regaud||2|||f||||t||||||||||2017-10-10 22:54:35.39219|2017-10-10 22:54:35.39219
NCT02555735|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2015-10-17|||October 2015||2015-10-01|October 2015|2015-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Exceptional Responders With Pancreatic Cancer to Chemotherapy|Evaluation of Exceptional Responders With Pancreatic Cancer to Standard of Care Chemotherapy|Recruiting||N/A|30|Anticipated|Adera Labs, LLC|||1||f||||f||||||||||2017-10-10 22:54:35.5221|2017-10-10 22:54:35.5221
NCT02555722|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-01-16|2017-01-16||September 2015||2015-09-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional||Baseline characteristics are collected for all completed subjects.|Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear|Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear|Completed||N/A|90|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 22:54:35.687097|2017-10-10 22:54:35.687097
NCT02555709|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-12-22|||August 2015||2015-08-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients|A Randomized, Double-Blind, Placebo-Controlled Ascending Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTP-43742 in Healthy Volunteers and Psoriatic Patients and Clinical Proof-of-Concept in Psoriatic Patients|Completed||Phase 1/Phase 2|74|Actual|Vitae Pharmaceuticals, Inc.||13|||f||||f||||||||||2017-10-10 22:54:38.788417|2017-10-10 22:54:38.788417
NCT02555696|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-02-22|||May 31, 2012|Actual|2012-05-31|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|February 28, 2016|Actual|2016-02-28||Observational|||Abraxane in Treatment of Metastatic Breast Cancer|Assessment of Abraxane in Metastatic Breast Cancer in a Real-life Setting|Completed||N/A|203|Actual|Celgene|||1||f||||f||||||||||2017-10-10 22:54:38.981911|2017-10-10 22:54:38.981911
NCT02555683|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-02-20|||December 11, 2015|Actual|2015-12-11|February 2017|2017-02-01|November 16, 2018|Anticipated|2018-11-16|November 16, 2018|Anticipated|2018-11-16||Interventional|||Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.|A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of QAW039 When Added to Existing Asthma Therapy in Patients With Uncontrolled Severe Asthma.|Recruiting||Phase 3|846|Anticipated|Novartis||3|||f||||t||||||||||2017-10-10 22:54:39.149244|2017-10-10 22:54:39.149244
NCT02555670|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-05-09|||May 2014||2014-05-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Observational|ICUBIACT||Relation Between Bioelectrical Impedance Analysis (BIA) and CT-scan Analysis in the ICU|Relation Between Bioelectrical Impedance-derived Muscle Mass and CT-derived Muscle Area in Critically Ill Patients|Completed||N/A|222|Actual|VU University Medical Center|||1||f||||f||||||||No||2017-10-10 22:54:39.855826|2017-10-10 22:54:39.855826
NCT02555657|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-09-22|||October 13, 2015|Actual|2015-10-13|September 2017|2017-09-01|May 30, 2019|Anticipated|2019-05-30|December 11, 2018|Anticipated|2018-12-11||Interventional|||Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)|A Randomized Open-Label Phase III Study of Single Agent Pembrolizumab Versus Single Agent Chemotherapy Per Physician's Choice for Metastatic Triple Negative Breast Cancer (mTNBC) - (KEYNOTE-119)|Active, not recruiting||Phase 3|600|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t|t|f||||||||2017-10-10 22:54:39.96539|2017-10-10 22:54:39.96539
NCT02555644|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-10-03|||February 2016||2016-02-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer|A Phase 1b Trial of LY2606368 in Combination With Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Cancer|Recruiting||Phase 1|70|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:54:40.135732|2017-10-10 22:54:40.135732
NCT02555631|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-18|||September 2015||2015-09-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||PowerUp for Health: A Diabetes Prevention Program for Men|Translating the Diabetes Prevention Program to Engage Men From Disadvantaged Areas|Unknown status|Recruiting|N/A|120|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||f||||||||||2017-10-10 22:54:40.390145|2017-10-10 22:54:40.390145
NCT02555618|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-02|2016-11-02||September 2015||2015-09-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Randomized Set included all randomized participants.|Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants|A Randomized Double-Blind Parallel-Group Comparative Phase 2 Study to Evaluate the Immunogenicity and Safety of a Single Subcutaneous Injection of TAK-850 in Comparison With Influenza HA Vaccine in Healthy Adult Subjects|Completed||Phase 2|400|Actual|Takeda||2|||f||||f||||||||||2017-10-10 22:54:40.587803|2017-10-10 22:54:40.587803
NCT02555605|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-09-17|||November 2013||2013-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Dexmedetomidine Sedation in Children With Respiratory Morbidities|Feasibility of Dexmedetomidine in Children With Respiratory Morbidities Undergoing Deep Sedation for Magnetic Resonance Imaging|Completed||N/A|19|Actual|Universitair Ziekenhuis Brussel|||1||f||||f||||||||||2017-10-10 22:54:42.1327|2017-10-10 22:54:42.1327
NCT02555592|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-10-05|||October 2015||2015-10-01|October 2015|2015-10-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level|Treatment Strategy of Surgical Resection With Sequential Adjuvant Chemotherapy and Radiotherapy for Patients With Stage IIIA Non-small Cell Lung Cancer and N2 Disease Only in the Subaortic or Paraaortic Level, or Both|Recruiting||N/A|25|Anticipated|Pusan National University Hospital|||1||f||||f||||||||||2017-10-10 22:54:42.23636|2017-10-10 22:54:42.23636
NCT02555579|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-09-20|||October 26, 2015|Actual|2015-10-26|September 2015|2015-09-01|September 20, 2017|Actual|2017-09-20|September 20, 2017|Actual|2017-09-20||Interventional|||Simplified Diet Approach in Phenylketonuria|Use of Dietary Protein and Free Fruits and Vegetables to Improve Metabolic Control Among Teens and Adults With Phenylketonuria: A Mixed Methods Approach|Completed||N/A|33|Actual|University of Nebraska||1|||f||||f||||||||||2017-10-10 22:54:42.350153|2017-10-10 22:54:42.350153
NCT02555540|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-06-06|||August 2015||2015-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses|Clinical Study to Generate a Set of Data Characterising Clinical Events, Physiological Responses, and Innate and Adaptive Immune Responses Following a Single IM Immunisation With Boostrix® or Placebo in Healthy Adults|Active, not recruiting||Phase 4|240|Actual|University Hospital, Ghent||16|||f||||f||||||||||2017-10-10 22:54:42.615978|2017-10-10 22:54:42.615978
NCT02555527|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-05-03|||September 2015|Actual|2015-09-01|September 2016|2016-09-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|||Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment|Cost-effectiveness and Financial Impact of Contrast Echocardiography for the Assessment of Left Ventricular Thrombus|Completed||N/A|500000|Actual|Duke University|||1||f||||f||||||||||2017-10-10 22:54:42.738324|2017-10-10 22:54:42.738324
NCT02555514|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-17|||October 2015||2015-10-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|IBBM-CKJ||Identification of Biochemical and Biomechanical Markers for Cartilage Degeneration in the Knee Joint (IBBM-CKJ)|Identification of Biochemical and Biomechanical Markers for Cartilage Degeneration in the Knee Joint (IBBM-CKJ)|Not yet recruiting||N/A|100|Anticipated|University of Cologne|||1||f||||f||||||Samples With DNA|"     In order to investigate cartilage degeneration/turnover (COMP, collagen II, GAGs), miRNA and     cytokine profiles 4 blood draws will be carried out   "|||2017-10-10 22:54:42.813407|2017-10-10 22:54:42.813407
NCT02555501|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-18|||October 2014||2014-10-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|OMLTPT||Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy|Laser Therapy Associated With Photodynamic Therapy in the Treatment of Oral Mucositis Induced by Chemotherapy in Young Patients: Randomized Blind Clinical Trial|Completed||Phase 3|18|Actual|Universidade Ceuma||2|||f||||t||||||||||2017-10-10 22:54:42.890534|2017-10-10 22:54:42.890534
NCT02555488|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-18|||January 2015||2015-01-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Comparing the Antibacterial Effect of 810 nm Diode Laser and Photodynamic Therapy|Comparing the Antibacterial Effect of 810 nm Diode Laser and Photodynamic Therapy in Reducing the Microbial Flora of the Canal While Root Retreatment in Patients With Periradicular Lesions|Unknown status|Recruiting|Phase 2|20|Anticipated|Shahid Beheshti University||2|||f||||f||||||||||2017-10-10 22:54:43.021101|2017-10-10 22:54:43.021101
NCT02555475|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-07-23|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital|The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital: a Randomised Trial|Recruiting||N/A|300|Anticipated|Macfarlane Burnet Institute for Medical Research and Public Health Ltd||2|||f||||f||||||||||2017-10-10 22:54:43.119897|2017-10-10 22:54:43.119897
NCT02555462|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-04-03|||September 2015||2015-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||Real-Ear Measurement (REM) and Test Box System Integration Into Fitting Software||Completed||N/A|205|Anticipated|Phonak AG, Switzerland||1|||f||||||||||||||2017-10-10 22:54:43.258205|2017-10-10 22:54:43.258205
NCT02555449|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-12-15|||September 2015||2015-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of [¹⁴C]-LY3202626 in Healthy Male Participants|Disposition of [¹⁴C]-LY3202626 Following Oral Administration in Healthy Male Subjects|Completed||Phase 1|8|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 22:54:43.332881|2017-10-10 22:54:43.332881
NCT02555423|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-18|||October 2015||2015-10-01|September 2015|2015-09-01||||April 2017|Anticipated|2017-04-01||Interventional|||The Effects of Serratus Plane Block Performed Under Direct Vision on Post-operative Pain in Breast Surgery||Unknown status|Not yet recruiting|N/A|||Kingston Hospital NHS Trust|||||f||||||||||||||2017-10-10 22:54:43.553735|2017-10-10 22:54:43.553735
NCT02555410|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-07-10|||January 2013||2013-01-01|July 2017|2017-07-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Observational|||Seizure Detection and Warning System in Epilepsy Patients|A Pivotal, Phase II Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients|Completed||N/A|11|Actual|Brain Sentinel|||1||f||||f||||||||||2017-10-10 22:54:43.622341|2017-10-10 22:54:43.622341
NCT02555397|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-08-17|||August 2015||2015-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer|Phase 1 Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer After Definitive Radiotherapy|Recruiting||Phase 1|15|Anticipated|Henry Ford Health System||1|||f||||t||||||||||2017-10-10 22:54:43.703989|2017-10-10 22:54:43.703989
NCT02555384|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-05-05|||January 2018|Anticipated|2018-01-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|AMPEL||AMblyopia Treatment Through PErceptual Training in Children (AMPEL)|Improving Visual Functions in Young Children With Amblyopia Through Perceptual Learning|Not yet recruiting||N/A|60|Anticipated|University of Basel||2|||f||||f|f|f||||||||2017-10-10 22:54:43.801535|2017-10-10 22:54:43.801535
NCT02555345|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-17|||October 2014||2014-10-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Gene Expression Profile and Inflammation Profile of Classic Asthma, Cough Variant Asthma and Eosinophilic Bronchitis|Difference in Gene Expression Profile in Peripheral Blood Mononuclear Cells and Inflammation Profile in Patients With Classic Asthma, Cough Variant Asthma, and Eosinophilic Bronchitis Compared With Healthy Controls|Unknown status|Recruiting|N/A|250|Anticipated|State Key Laboratory of Respiratory Disease|||4||f||||f||||||Samples With DNA|"     Blood sample collection for future analysis (including genetic tests on DNA) on the     pathobiology of diseases.   "|||2017-10-10 22:54:44.610458|2017-10-10 22:54:44.610458
NCT02555332|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-17|||December 2012||2012-12-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Maternal Thyroid Function in Early Pregnancy and Their Relationship With Gestational Diabetes Mellitus|Maternal TSH Level and TPOAb Status in Early Pregnancy and Their Relationship to the Risk of Gestational Diabetes Mellitus|Completed||N/A|7729|Actual|Shanghai First Maternity and Infant Hospital|||1||f||||f||||||||||2017-10-10 22:54:44.73076|2017-10-10 22:54:44.73076
NCT02555306|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-09-11|||September 16, 2015|Actual|2015-09-16|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration|A Phase I/II, Open-label, Dose-escalating, Sequential-cohort Study Assessing the Safety, Tolerability, Immunogenicity, and Bioactivity of a Single Intravitreal Injection of DE-122 Injectable Solution for the Treatment of Refractory Exudative Age-related Macular Degeneration|Completed||Phase 1/Phase 2|12|Actual|Santen Inc.||4|||f||||f||||||||||2017-10-10 22:54:44.943784|2017-10-10 22:54:44.943784
NCT02555293|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-10-13|||February 2016||2016-02-01|October 2016|2016-10-01||||April 2018|Anticipated|2018-04-01||Interventional|ARROW||Administration of Rifaximin to Improve Liver Regeneration and Outcome Following Major Liver Resection|Administration of Rifaximin to Improve Liver Regeneration and Outcome Following Major Liver Resection|Recruiting||Phase 2|96|Anticipated|RWTH Aachen University||2|||f||||||||||||||2017-10-10 22:54:45.066232|2017-10-10 22:54:45.066232
NCT02555280|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-03-30|||September 2016||2016-09-01|March 2017|2017-03-01|June 2022|Anticipated|2022-06-01|July 2019|Anticipated|2019-07-01||Interventional|PAS003||Post-Approval 'Real Conditions of Use' Study|A 2 and 5 Year Comparative Evaluation of Clinical Outcomes in the Treatment of Degenerative Spinal Stenosis With Concomitant Low Back Pain by Decompression With and Without Additional Stabilization Using the Coflex® Interlaminar Technology for FDA Real Conditions of Use Study|Recruiting||N/A|345|Anticipated|Paradigm Spine||2|||f||||f||||||||No||2017-10-10 22:54:45.179829|2017-10-10 22:54:45.179829
NCT02555267|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-08-27|||September 2015||2015-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma|Multi-center, Prospective Cohort Study to Investigate the Impact of Comprehensive Geriatric Assessments on Survival and Toxicities in Elderly Diffuse Large B-cell Lymphoma Patients Treated With R-CHOP|Active, not recruiting||N/A|148|Actual|Chonbuk National University Hospital|||1||f||||f||||||||||2017-10-10 22:54:45.334257|2017-10-10 22:54:45.334257
NCT02555254|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-08-25|||February 2016||2016-02-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|ISOCRATE||Impact of Speed Of Rewarming After CaRdiac Arrest and ThErapeutic Hypothermia|Impact of Speed Of Rewarming After CaRdiac Arrest and ThErapeutic Hypothermia. A Randomized Controlled Pilot Study|Recruiting||N/A|60|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-10 22:54:45.442707|2017-10-10 22:54:45.442707
NCT02555241|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-12-02|||September 2015||2015-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Emergence of Generative Language|Instructional Programming to Promote the Emergence of Generative Language in Children With Autism Spectrum Disorder|Completed||N/A|9|Actual|Emory University||3|||f||||f||||||||||2017-10-10 22:54:45.560169|2017-10-10 22:54:45.560169
NCT02555228|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2016-02-15|2016-02-15||August 2015||2015-08-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Small Volume Simethicone Before Gastroscopy: Any Benefit?|Benefits of Premedication With Small Volume Simethicone Solution Before Diagnostic Gastroscopy: A Randomized Endoscopist-blinded Prospective Study|Completed||Phase 2/Phase 3|54|Actual|Changi General Hospital||2|||f||||t||||||||Yes|Data send to Singapore Health Sciences Authority|2017-10-10 22:54:45.662423|2017-10-10 22:54:45.662423
NCT02555215|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-09-17|||February 22, 2016|Actual|2016-02-22|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)|A Multicenter Extension Study to Determine the Long-Term Safety and Efficacy of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis|Active, not recruiting||Phase 3|20|Actual|Biogen||1|||f||||t||||||||||2017-10-10 22:54:46.033032|2017-10-10 22:54:46.033032
NCT02555202|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-03-30|||October 15, 2015|Actual|2015-10-15|September 2016|2016-09-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Observational|LCADL||Validation of French Version of LCADL and Dyspnea-12|Validation of the French Version of the London Chest Activity of Daily Living Scale (LCADL) and the Dyspnea-12 Questionnaire|Completed||N/A|50|Actual|University Hospital, Brest|||1||f||||t||||||||||2017-10-10 22:54:46.189063|2017-10-10 22:54:46.189063
NCT02555189|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-06-22|||December 2015||2015-12-01|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|September 2020|Anticipated|2020-09-01||Interventional|||Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression|Randomized Phase IB/II Study of Enzalutamide With and Without Ribociclib in Patients With Metastatic Castrate Resistant, Chemotherapy Naïve Prostate Cancer That Retains RB Expression|Recruiting||Phase 1/Phase 2|117|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-10 22:54:46.293726|2017-10-10 22:54:46.293726
NCT02555176|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-06-05|||December 14, 2016|Actual|2016-12-14|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)|A Pilot Trial of a Low-Carbohydrate Normocaloric Diet, in Patients With Head and Neck Carcinoma (HNC) and Its Effect on Stromal-Epithelial Metabolic Uncoupling|Active, not recruiting||N/A|7|Actual|Thomas Jefferson University||1|||f||||t|f|f||||||||2017-10-10 22:54:46.458749|2017-10-10 22:54:46.458749
NCT02555163|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-02-03|||September 2015||2015-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|HoLERBT||Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT)|Holmium (Ho: YAG) Laser En Bloc Resection Of Bladder Tumor (HoLERBT) Versus Conventional Transurethral Resection Of Bladder Tumors (cTURBT): A Prospective Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Mansoura University||2|||f||||t||||||||Undecided||2017-10-10 22:54:46.569526|2017-10-10 22:54:46.569526
NCT02555150|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-01-17|||September 2015||2015-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD|A Randomized, Phase 3, Double-Blind, Crossover Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD|Completed||Phase 3|40|Anticipated|Rhodes Pharmaceuticals, L.P.||3|||f||||f||||||||No||2017-10-10 22:54:46.678559|2017-10-10 22:54:46.678559
NCT02555137|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-09-06|||February 2016||2016-02-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01|2 Years|Observational [Patient Registry]|InShape2||Early Non-invasive Detection of CTEPH After Pulmonary Embolism|Early Non-invasive Detection of CTEPH After Pulmonary Embolism - The InShape-2 Study|Recruiting||N/A|336|Anticipated|Leiden University Medical Center|||1||f||||f||||||||No||2017-10-10 22:54:46.776557|2017-10-10 22:54:46.776557
NCT02555124|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-03-09|||September 12, 2015|Actual|2015-09-12|March 2017|2017-03-01|October 31, 2015|Actual|2015-10-31|October 31, 2015|Actual|2015-10-31||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Participants|A Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Subjects|Completed||Phase 1|24|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-10-10 22:54:46.934951|2017-10-10 22:54:46.934951
NCT02555111|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-05-31|||September 2015||2015-09-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|RIPORT||Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.|Multicentric Randomized Study of Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.|Recruiting||Phase 3|296|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-10 22:54:47.061858|2017-10-10 22:54:47.061858
NCT02555098|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-05-19|||September 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:54:47.194011|2017-10-10 22:54:47.194011
NCT02555085|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-04-17|||September 30, 2015|Actual|2015-09-30|April 2017|2017-04-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||Single Ascending Doses of BIIB063 in Healthy Volunteers|Phase 1 Randomized, Blinded, Placebo-Controlled Study of Single Ascending Doses of BIIB063 in Healthy Volunteers|Terminated||Phase 1|29|Actual|Biogen||8||Clinical study terminated due to preclinical safety findings in non-human primates.|f||||f||||||||||2017-10-10 22:54:47.247496|2017-10-10 22:54:47.247496
NCT02555072|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-07-07|||July 2016||2016-07-01|July 2016|2016-07-01|December 2027|Anticipated|2027-12-01|June 2026|Anticipated|2026-06-01||Interventional|||Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)|Yellow Fever Vaccine Immunity After 1 Dose of Vaccine in Children and Adults: a Cohort Study in Non-endemic Area|Recruiting||Phase 4|4761|Anticipated|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||1|||f||||t||||||||||2017-10-10 22:54:47.37572|2017-10-10 22:54:47.37572
NCT02555059|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-18|2017-09-19|||July 15, 2016|Actual|2016-07-15|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Special Drug Use Investigation of Ciproxan Injection in Pediatrics|Special Drug Use Investigation of Ciproxan® Injection in Pediatrics|Recruiting||N/A|45|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 22:54:47.492474|2017-10-10 22:54:47.492474
NCT02555046|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-09-18|||October 2015||2015-10-01|August 2015|2015-08-01|July 2018|Anticipated|2018-07-01|August 2017|Anticipated|2017-08-01||Interventional|||Muscle and Cerebral Oxygenation Under EVAR of AAA: GA vs LA|Muscle and Cerebral Oxygenation Under Endovascular Aortic Repair (EVAR) of Abdominal Aortic Aneurysm: General Versus Local Anesthesia - an Randomised Controlled Trial Study|Not yet recruiting||N/A|26|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 22:54:47.609798|2017-10-10 22:54:47.609798
NCT02555033|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-18|||February 2014||2014-02-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Simultaneous Balance and Resistance Training in Older Adults|Effects of Simultaneous Balance and Resistance Training on Strength, Power and Balance in Older Adults: A Stratified and Randomised Trial|Completed||N/A|75|Actual|University of Kassel||3|||f||||f||||||||||2017-10-10 22:54:47.851899|2017-10-10 22:54:47.851899
NCT02555020|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-09-15|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|December 23, 2016|Actual|2016-12-23|December 22, 2016|Actual|2016-12-22||Interventional|laparoscopy||Effect of Preoperative Oral Carbohydrates on Quality of Recovery|Effect of Preoperative Oral Carbohydrates on Quality of Recovery: Randomized Controlled Trial|Completed||Phase 3|153|Anticipated|Yonsei University||3|||f||||t||||||||||2017-10-10 22:54:47.996076|2017-10-10 22:54:47.996076
NCT02555007|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-18|||August 2015||2015-08-01|September 2015|2015-09-01||||August 2018|Anticipated|2018-08-01||Interventional|NVB Metro||Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM|Phase IA/IB of Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With Non Small Cell Lung Cancer or Malignant Pleural Mesothelioma|Recruiting||Phase 1|32|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:54:48.080959|2017-10-10 22:54:48.080959
NCT02554825|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-17|||August 2011||2011-08-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Healthy Futures Evaluation|Healthy Futures Longitudinal School-Cluster Randomized Controlled Trial|Completed||N/A|1344|Actual|JSI Research & Training Institute, Inc.||2|||f||||||||||||||2017-10-10 22:54:54.595349|2017-10-10 22:54:54.595349
NCT02554994|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-02-20|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ASPRA-IS||Multifactorial Intervention on Frailty in Vulnerable Older Adults|The Effect of Multifactorial Intervention on Frailty in Vulnerable Older Adults Living in Rural Communities: A Designed Delay Trial|Completed||N/A|187|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-10 22:54:48.20669|2017-10-10 22:54:48.20669
NCT02554981|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-05-25|2017-03-24||July 21, 2015|Actual|2015-07-21|May 2017|2017-05-01|March 24, 2016|Actual|2016-03-24|March 24, 2016|Actual|2016-03-24||Interventional|EMPOWER|51 participants were initially enrolled in the study, 1 participant discontinued before dosing and is not included in the Intent-to-treat (ITT) population.|Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®|Evaluation of Maintaining Visual Performance Of Subjects Who Engage in Electronic Visual Tasking While Using Restasis (EMPOWER)|Completed||Phase 4|51|Actual|Allergan||1|||f||||f||||||||||2017-10-10 22:54:48.460838|2017-10-10 22:54:48.460838
NCT02554968|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-11-20|||September 2015||2015-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer|Reliability and Validity of Five Shoulder-Specific Patient Reported Outcome Measures for Use in Patients With Head and Neck Cancer|Recruiting||N/A|250|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 22:54:49.133359|2017-10-10 22:54:49.133359
NCT02554955|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-01|||February 2004||2004-02-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants|Pilot, Single-arm, Non-comparative, Open-label Study of Daclizumab in Combination With Mycophenolate Mofetil and Sirolimus in the Prevention of Acute Rejection in Cardiac Allografts Recipients in Risk of Deteriorated Renal Function|Completed||Phase 4|36|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:54:49.256831|2017-10-10 22:54:49.256831
NCT02554942|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-01|||June 2004||2004-06-01|November 2016|2016-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors|An Open-Label Study of the Safety Of NeoRecormon in Patients With Solid Tumors Being Treated With Platinum Capable of Inducing Anemia|Completed||Phase 4|28|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:54:49.404535|2017-10-10 22:54:49.404535
NCT02554929|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-07-17|||September 2015||2015-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SAD & SM TRMT||Treatment of Social Anxiety Disorder and Selective Mutism|Efficacy of a Group Cognitive Behavioral Therapy Program in the Treatment of Young Children With Social Anxiety Disorder and/or Selective Mutism: A Randomized Controlled Trial|Active, not recruiting||N/A|88|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 22:54:49.541308|2017-10-10 22:54:49.541308
NCT02554916|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-12-14|||July 2010||2010-07-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|||Locomotor Adaptation Training to Prevent Mobility Disability|Locomotor Adaptation Training to Prevent Mobility Disability|Recruiting||N/A|48|Anticipated|University of Florida|||3||f||||t||||||||||2017-10-10 22:54:49.672085|2017-10-10 22:54:49.672085
NCT02554903|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-10-06|||December 2015||2015-12-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|Soprano||Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation|A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation|Recruiting||Phase 2|64|Anticipated|Actelion||2|||f||||t||||||||Undecided||2017-10-10 22:54:49.878655|2017-10-10 22:54:49.878655
NCT02554890|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-10-05|||April 29, 2016|Actual|2016-04-29|October 2017|2017-10-01|April 5, 2018|Anticipated|2018-04-05|April 5, 2018|Anticipated|2018-04-05||Interventional|PIONEER-HF||comParIson Of Sacubitril/valsartaN Versus Enalapril on Effect on ntpRo-bnp in Patients Stabilized From an Acute Heart Failure Episode|A Multicenter, Randomized, Double-blind, Double Dummy, Parallel Group, Active-controlled 8-week Study to Evaluate the Effect of Sacubitril/Valsartan (LCZ696) Versus Enalapril on Changes in NT-proBNP and Safety and Tolerability of In-hospital Initiation of LCZ696 Compared to Enalapril in HFrEF Patients Who Have Been Stabilized Following Hospitalization for Acute Decompensated Heart Failure (ADHF).|Recruiting||Phase 4|736|Anticipated|Novartis||2|||f||||t||||||||||2017-10-10 22:54:50.346418|2017-10-10 22:54:50.346418
NCT02554877|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-07-05|2017-07-05||October 2015||2015-10-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin|A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin|Completed||Phase 2|206|Actual|Pfizer||4|||f||||f||||||||||2017-10-10 22:54:50.556137|2017-10-10 22:54:50.556137
NCT02554864|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-16|||March 2016||2016-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|LILAC||Location of Injection of Local Anesthetics in the Adductor Canal Block|Location of Injection of Local Anesthetics in the Adductor Canal Block: A Randomized Controlled Trial of the Effect on Postoperative Analgesia and Motor Power|Recruiting||N/A|108|Anticipated|Women's College Hospital||3|||f||||f||||||||||2017-10-10 22:54:54.311067|2017-10-10 22:54:54.311067
NCT02554851|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-06-21|||January 2017||2017-01-01|June 2016|2016-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.|Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer. Multicenter, Randomized, Double-blind, Placebo-controlled Study.|Not yet recruiting||Phase 3|204|Anticipated|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||2|||f||||f||||||||||2017-10-10 22:54:54.432328|2017-10-10 22:54:54.432328
NCT02554838|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-06-13|||November 2015||2015-11-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|PACTE||How to Act on the Mobility Restriction Linked to Senior's Phobia of Falling|How to Act on the Mobility Restriction Linked to Senior's Phobia of Falling|Recruiting||N/A|48|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-10 22:54:54.494719|2017-10-10 22:54:54.494719
NCT02554812|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-09-28|||November 9, 2015|Actual|2015-11-09|September 2017|2017-09-01|February 13, 2020|Anticipated|2020-02-13|December 2, 2019|Anticipated|2019-12-02||Interventional|||A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)|A Phase 1b/2 Open-label Study To Evaluate Safety, Clinical Activity, Pharmacokinetics And Pharmacodynamics Of Avelumab (msb0010718c) In Combination With Other Cancer Immunotherapies In Patients With Advanced Malignancies|Recruiting||Phase 2|671|Anticipated|Pfizer||14|||f||||f||||||||||2017-10-10 22:54:54.677767|2017-10-10 22:54:54.677767
NCT02554799|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-04-18|||September 2015||2015-09-01|September 2015|2015-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers|A Phase 1 Exploratory Study to Evaluate the Pharmacokinetics of Selected Oral Formulations of MMV390048 Administered in the Fasted State to Healthy Volunteers|Completed||Phase 1|18|Actual|Medicines for Malaria Venture||3|||f||||f||||||||||2017-10-10 22:54:55.109286|2017-10-10 22:54:55.109286
NCT02554786|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-09-30|||December 2015||2015-12-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma|A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma|Recruiting||Phase 3|2800|Anticipated|Novartis||5|||f||||t||||||||||2017-10-10 22:54:55.235345|2017-10-10 22:54:55.235345
NCT02554773|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-09-29|||September 2015||2015-09-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|July 2021|Anticipated|2021-07-01||Interventional|||An Open-label Extension Study of an Investigational Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B|An Open-label Extension Study of Subcutaneously Administered ALN-AT3SC in Patients With Moderate or Severe Hemophilia A or B Who Have Participated in a Previous Clinical Study With ALN-AT3SC|Active, not recruiting||Phase 1/Phase 2|37|Anticipated|Alnylam Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:54:55.838651|2017-10-10 22:54:55.838651
NCT02554760|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-06-20|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|CCI||Flank Study With Crown Cooling Insert|CoolSculpting the Flank Using an Applicator With a Crown Cooling Insert|Completed||N/A|19|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-10 22:54:56.132755|2017-10-10 22:54:56.132755
NCT02554747|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-09-27|||October 2015||2015-10-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|ADDENDUM||Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa|Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa|Recruiting||Phase 4|60|Anticipated|Odense University Hospital||2|||f||||t||||||||Yes|A minimum of 3 pier reviewed articles. All results will be published wether positive or negative.|2017-10-10 22:54:56.221368|2017-10-10 22:54:56.221368
NCT02554734|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-01-13|||August 2015||2015-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|NOCOFPK2||Pharmacokinetic Study in Healthy Volunteers|Pharmacokinetics of Levodopa After Repeated Doses of Carbidopa, ODM-104 and Levodopa: an Open, Randomised Study With Crossover Design in Healthy Males and Females|Completed||Phase 1|15|Actual|Orion Corporation, Orion Pharma||3|||f||||f||||||||||2017-10-10 22:54:56.362328|2017-10-10 22:54:56.362328
NCT02554721|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-07-24|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CiloMecT||Pharmacodynamic Study of Cilostazol in Healthy Volunteers|Effect of Cilostazol as an add-on Treatment to a Single Antiplatelet Agent (Acetylsalicylic Acid or Clopidogrel) on Platelet Function Testing and Bleeding Time in Healthy Volunteers|Recruiting||Phase 1|68|Anticipated|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-10 22:54:56.457227|2017-10-10 22:54:56.457227
NCT02554708|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-07-21|||August 2015||2015-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|pToWin||pCONus Treatment of Wide Neck Intracranial Aneurysms|pToWin pCONus Treatment of Wide Neck Intracranial Aneurysms|Recruiting||N/A|100|Anticipated|Phenox GmbH|||1||f||||t|f|f||||||||2017-10-10 22:54:56.573489|2017-10-10 22:54:56.573489
NCT02554695|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-03-21|||October 20, 2015|Actual|2015-10-20|March 2017|2017-03-01|October 25, 2016|Actual|2016-10-25|October 25, 2016|Actual|2016-10-25||Interventional|||Osteoclast Inhibition and Bone Formation|Effects of Age and Osteoclast Inhibition on Bone Formation|Completed||N/A|81|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-10 22:54:56.758183|2017-10-10 22:54:56.758183
NCT02554682|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-07-03|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||The P4 Intervention Study to Improve Adolescent Health|A Pilot Efficacy and Implementation Study of the Patients, Parents and Professionals Partnering to Improve Adolescent Health (P4) Intervention|Active, not recruiting||N/A|344|Actual|Children's Hospital of Philadelphia||5|||f||||f||||||||||2017-10-10 22:54:56.875927|2017-10-10 22:54:56.875927
NCT02554669|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-23|2015-09-17|||January 2013||2013-01-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Acute Effects of Postabsorptive and Postprandial Physical Activity|Acute Effects of Postabsorptive and Postprandial Physical Activity on Glycemia and Inflammation|Completed||N/A|12|Actual|Inland Norway University of Applied Sciences||3|||f||||f||||||||||2017-10-10 22:54:57.010656|2017-10-10 22:54:57.010656
NCT02554656|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-09-29|||October 27, 2015|Actual|2015-10-27|September 2017|2017-09-01|September 25, 2018|Anticipated|2018-09-25|September 25, 2018|Anticipated|2018-09-25||Observational|||Vfend Special Investigation For Pediatric - Observational|Vfend Special Investigation For Pediatric|Recruiting||N/A|100|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 22:54:57.102134|2017-10-10 22:54:57.102134
NCT02554643|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-22|||November 2012||2012-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Soccer and Health: Diet and Exercise on Type 2 Diabetes Mellitus|Soccer and Health: Impact of Nutritional Intervention and Recreational Soccer Training in Patients With Type 2 Diabetes Mellitus|Completed||N/A|60|Actual|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-10 22:54:57.175241|2017-10-10 22:54:57.175241
NCT02554617|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-18|2016-05-02|||October 2010||2010-10-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Observational|FeNO_nor||Measurements of Exhaled Nitric Oxide in Healthy Subjects in Thailand|Measurements of Exhaled Nitric Oxide in Healthy Subjects in Thailand|Completed||N/A|100|Actual|Mahidol University|||1||f||||f||||||||||2017-10-10 22:54:57.392464|2017-10-10 22:54:57.392464
NCT02554604|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-03-26|||September 2015||2015-09-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|||Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies|Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies and Volatile Organic Compounds in Maternal Saliva Characteristic of Preeclampsia|Enrolling by invitation||N/A|100|Anticipated|Meir Medical Center|||1||f||||f|f|f||||||No||2017-10-10 22:54:57.462456|2017-10-10 22:54:57.462456
NCT02554591|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-02-16|||September 16, 2015|Actual|2015-09-16|February 2017|2017-02-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|||Genomic Landscape of Ceritinib|Retrospective Analysis of Genomic Landscape of ALK Positive NSCLC Prior to Ceritinib, and at Disease Progression Following Ceritinib|Recruiting||N/A|10|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 22:54:57.53447|2017-10-10 22:54:57.53447
NCT02554578|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-08-22|||October 2015||2015-10-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|mHeart||Impact of mHealth in Heart Transplant Management|Effectiveness Improving Medication Adherence in Heart Transplant Management|Active, not recruiting||N/A|158|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 22:54:57.627916|2017-10-10 22:54:57.627916
NCT02554565|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-12-08|||July 2014||2014-07-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|PAIRHPV||Nnovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology|Innovation for Standard Identification for Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cance: Towards Development of Personalized Biomarkers in Clinical Oncology (PAIR HPV : Human PapillomaVirus)|Terminated||Phase 2|26|Actual|Institut Curie||1||Study in competition with another so it was decided to stop recruitment|f||||f||||||||No||2017-10-10 22:54:57.698129|2017-10-10 22:54:57.698129
NCT02554552|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-11-15|||September 2015||2015-09-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee|A Multicenter, Randomized, Double-blinded, Parallel, Placebo-controlled, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular YY1201 Once in the Treatment of Patients With Osteoarthritis of the Knee|Withdrawn||Phase 1/Phase 2|0|Actual|Yooyoung Pharmaceutical Co.,Ltd.||4||This study has been withdrawn prior to enrollment.|f||||t||||||||Undecided||2017-10-10 22:54:57.777852|2017-10-10 22:54:57.777852
NCT02554539|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-10-12|||July 2015||2015-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|miRNA_EF||Transciptomic Modification Induced by miRNAs in Endometrial Fluid|Human Embryonic Transciptomic Modification Induced by miRNAs Secreted by Human Endometrium to Endometrial Fluid|Recruiting||N/A|20|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 22:54:57.875174|2017-10-10 22:54:57.875174
NCT02554526|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-17|||September 2015||2015-09-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|||Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors|Basic Study on Novel Therapeutic Strategy With Bypassing Agent Therapy in Hemophilia A Patients With Inhibitors|Not yet recruiting||N/A|10|Anticipated|Nara Medical University|||1||f||||f||||||||||2017-10-10 22:54:57.950908|2017-10-10 22:54:57.950908
NCT02554513|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-07-05|||November 2, 2015|Actual|2015-11-02|July 2017|2017-07-01|December 29, 2017|Anticipated|2017-12-29|November 30, 2017|Anticipated|2017-11-30||Interventional|EPG&SPT||Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT)|Apraxia of Speech: A Comparison of EPG Treatment & Sound Production Treatment|Recruiting||N/A|10|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 22:54:58.03453|2017-10-10 22:54:58.03453
NCT02554500|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-01-28|||September 2015||2015-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bone Microcirculation After Remote Ischemic Preconditioning|Effects of Remote Ischemic Preconditioning in Bone Microcirculation|Recruiting||N/A|80|Anticipated|University of Schleswig-Holstein||5|||f||||f||||||||||2017-10-10 22:54:58.124036|2017-10-10 22:54:58.124036
NCT02554487|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-05-08|||August 2015||2015-08-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|October 2020|Anticipated|2020-10-01||Interventional|eSATIS||Early Sleep Apnea Treatment in Stroke|Early Sleep Apnea Treatment in Stroke: A Multicenter, Randomized, Rater-Blinded, Clinical Trial of Adaptive Servo-Ventilation|Recruiting||N/A|200|Anticipated|University Hospital Inselspital, Berne||3|||f||||f||||||||||2017-10-10 22:54:58.346553|2017-10-10 22:54:58.346553
NCT02554474|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-08-01|||January 2017|Actual|2017-01-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis|Effective of Online Physical Activity Monitoring in Inflammatory Arthritis (OPAM-IA): A New Model of Care|Recruiting||N/A|130|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-10 22:54:58.487608|2017-10-10 22:54:58.487608
NCT02554461|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-05-01|||August 2015||2015-08-01|October 2016|2016-10-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Optimization of Movement Patterns in Elite Volleyball Players|Optimaliseren Van Lichaams- en Bewegingsspecifieke Kenmerken Bij Volleybalspelers Met Het Oog op Het Reduceren Van Blessures|Completed||N/A|37|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||No||2017-10-10 22:54:58.613435|2017-10-10 22:54:58.613435
NCT02554448|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-05-28|||January 2016||2016-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy|Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy|Recruiting||N/A|80|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||1|||f||||t||||||||No|not ready to share the data|2017-10-10 22:54:58.700112|2017-10-10 22:54:58.700112
NCT02554435|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-09-12|||January 2016||2016-01-01|June 2016|2016-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||TAME Health: Testing Activity Monitors' Effect on Health|TAME Health: Testing Activity Monitors' Effect on Health|Completed||N/A|40|Actual|The University of Texas Medical Branch, Galveston||2|||f||||||||||||||2017-10-10 22:54:58.795952|2017-10-10 22:54:58.795952
NCT02554422|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-16|||December 2013||2013-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|PalpEar||Objective Measurement of Ossicular Chain Mobility Using a Palpating Instrument Intraoperatively|"Messung Der Beweglichkeit Der Gehörknöchelchenkette während Einer Ohroperation. (Objective Measurements of Ossicular Chain Mobility Using a Palpating Instrument Intraoperatively)"|Completed||N/A|32|Actual|Sensoptic SA||1|||f||||f||||||||||2017-10-10 22:54:58.919109|2017-10-10 22:54:58.919109
NCT02554409|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-06-28|||June 30, 2015|Actual|2015-06-30|June 2017|2017-06-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Observational|||Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry|Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol|Active, not recruiting||N/A|300|Anticipated|Sanofi|||1||f||||f||||||||||2017-10-10 22:54:59.006527|2017-10-10 22:54:59.006527
NCT02554396|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-02-18|||September 2015||2015-09-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia|A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 (Aceclidine/Tropicamide) Ophthalmic Topical Formulation in the Treatment of Early to Moderate Presbyopia|Completed||Phase 2|20|Actual|Presbyopia Therapies, LLC||2|||f||||||||||||||2017-10-10 22:54:59.110514|2017-10-10 22:54:59.110514
NCT02554383|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-28|||February 2016||2016-02-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?|Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?|Recruiting||Phase 3|688|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 22:54:59.197932|2017-10-10 22:54:59.197932
NCT02554370|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-17|||February 2008||2008-02-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|September 2013|Actual|2013-09-01||Interventional|PSYCHE||Psychoeducational Programme for PD Patients With STN-DBS|Psychoeducational Programme for Patients With Parkinson's Disease Undergoing Subthalamic Deep Brain Stimulation|Completed||N/A|19|Actual|Groupe Hospitalier Pitie-Salpetriere||2|||f||||f||||||||||2017-10-10 22:54:59.33689|2017-10-10 22:54:59.33689
NCT02554357|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2016-09-07|||July 2015||2015-07-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery|Quality of Analgesia After Interscalene Block With Bupivacaine and Exparel® vs. Bupivacaine Alone After Arthroscopic Shoulder Surgery|Completed||N/A|50|Actual|North American Institute for Continuing Medical Education (NAICE)||2|||f||||f||||||||||2017-10-10 22:54:59.421875|2017-10-10 22:54:59.421875
NCT02554344|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)|Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)|Recruiting||Early Phase 1|14|Anticipated|Baylor Research Institute||1|||f||||t||||||||||2017-10-10 22:54:59.527267|2017-10-10 22:54:59.527267
NCT02554331|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-09-17|||April 2014||2014-04-01|September 2015|2015-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|RBD-M2H||Gait and REM Sleep Behavior Disorder|Recherche et Mesure d'Anomalies précoces de la Marche au Cours Des Troubles du Comportement en Sommeil Paradoxal Idiopathiques|Unknown status|Recruiting|N/A|63|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 22:54:59.631202|2017-10-10 22:54:59.631202
NCT02554318|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-17|||October 2013||2013-10-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|FSS||Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia|The Effect of Fermented Soybean Supplementation on the Body Weight and Physical Function of Tuberculosis Patients With Standard Therapy in Indonesia|Completed||N/A|129|Actual|University of Giessen||2|||f||||f||||||||||2017-10-10 22:54:59.735021|2017-10-10 22:54:59.735021
NCT02554305|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2015-09-17|||October 2015||2015-10-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Fusion Versus The Affinity Oxygenation Systems|The Fusion Versus The Affinity Oxygenation Systems - A Prospective Randomized Trial In Patients Undergoing Coronary Artery Bypass Grafting (CABG)|Not yet recruiting||N/A|60|Anticipated|Hadassah Medical Organization||4|||f||||f||||||||||2017-10-10 22:54:59.854014|2017-10-10 22:54:59.854014
NCT02554292|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-09-02|||October 2015||2015-10-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01|9 Months|Observational [Patient Registry]|PASSWORD||Post Market Surveillance of SeQuent Please Neo With Scoring Balloon|Post MArket Surveillance of SeQuent Please Neo With ScORing Balloon Lesion Preparation in Real WorlD Patients|Recruiting||N/A|400|Anticipated|B. Braun Melsungen AG|||1||f||||f||||||||No||2017-10-10 22:54:59.940243|2017-10-10 22:54:59.940243
NCT02554266|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-05-22|||September 2015||2015-09-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|April 2018|Anticipated|2018-04-01|24 Months|Observational [Patient Registry]|BTKRegistry||Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries|A Prospective, Multicenter, Single Arm Real-World Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon Percutaneous Transluminal Angioplasty (PTA) Catheter for Treatment of Below-the-Knee (BTK) Arteries|Recruiting||N/A|500|Anticipated|C. R. Bard|||1||f||||t||||||||No||2017-10-10 22:55:00.23808|2017-10-10 22:55:00.23808
NCT02554253|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-03-21|||September 2015||2015-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction|The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction in Patients 75 Years of Age or Older and Undergoing Cardiac Surgery|Recruiting||N/A|52|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:55:00.406257|2017-10-10 22:55:00.406257
NCT02554240|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-09-17|||December 2014||2014-12-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee|Active-controlled, Dose-Response, Randomized, Double-blind, Therapeutic Exploratory Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee|Unknown status|Recruiting|Phase 2|120|Anticipated|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-10 22:55:00.509346|2017-10-10 22:55:00.509346
NCT02554227|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-02-16|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Cytokine Profiles in Spondylodiscitis|Verification and Progress of Cytokine Profiles for the Discrimination of Infectious and Non-infectious, Degenerative Diseases of the Spine|Recruiting||N/A|30|Anticipated|University of Cologne|||1||f||||f||||||Samples With DNA|"     Bio-Plex Pro Human Cytokine Group I 27-plex Assay (IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6,     IL-7, IL-8, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17, FGF basic, Eotaxin, G-CSF, GM-CSF,     IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α, VEGF)   "|||2017-10-10 22:55:00.606723|2017-10-10 22:55:00.606723
NCT02554214|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-17|||September 2015||2015-09-01|September 2015|2015-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device||Unknown status|Recruiting|N/A|30|Anticipated|Rheon Medical SA||1|||f||||||||||||||2017-10-10 22:55:00.690384|2017-10-10 22:55:00.690384
NCT02554201|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-07-27|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction|Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction|Completed||N/A|30|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-10 22:55:00.784503|2017-10-10 22:55:00.784503
NCT02554188|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-03-29|||May 1, 2018|Anticipated|2018-05-01|March 2017|2017-03-01|December 1, 2019|Anticipated|2019-12-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Fasting-mimicking Diet and Immunosenescence|Effect of Fasting-mimicking Diet on Immunosenescence and Vaccination in Older Adults: A Randomized Clinical Trial|Not yet recruiting||Phase 2|320|Anticipated|University of Southern California||2|||f||||t|f|f||||||No||2017-10-10 22:55:00.875702|2017-10-10 22:55:00.875702
NCT02554175|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-09-17|||October 2015||2015-10-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effective Effect-Site Propofol Concentration for Induction and Intubation for Schnider Model in Parturients|The Effective Effect-Site Propofol Concentration for Induction and Intubation for Schnider Model in Parturients|Not yet recruiting||N/A|36|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-10 22:55:00.981851|2017-10-10 22:55:00.981851
NCT02554162|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-11-24|||October 2015||2015-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Chewy Satiety - the Interplay Between Food Structure, Oral Processing and Satiety|Chewy Satiety - the Interplay Between Food Structure, Oral Processing and Satiety|Completed||N/A|20|Actual|VTT Technical Research Centre of Finland||5|||f||||||||||||||2017-10-10 22:55:01.063295|2017-10-10 22:55:01.063295
NCT02554149|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-03-28|||September 2015||2015-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|1 Year|Observational [Patient Registry]|||Radiological Measurement of Femoral Stem Version Using Lateral Decubitus Method: A Prospective Study||Completed||N/A|40|Actual|Seoul National University Bundang Hospital|||1||f||||t||||||||||2017-10-10 22:55:01.348824|2017-10-10 22:55:01.348824
NCT02554136|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-17|||July 2015||2015-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816|An Open-labeled, Randomized Crossover Study to Evaluate the Pharmacokinetic Interaction and Safety After Single Oral Administration of HGP0918 and HGP0816 in Healthy Adult Subjects|Completed||Phase 1|36|Actual|Hanmi Pharmaceutical Company Limited||6|||f||||f||||||||||2017-10-10 22:55:01.46731|2017-10-10 22:55:01.46731
NCT02554123|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2015-09-17|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Reduction of Postoperative Pain After Milligan-Morgan Haemorrhoidectomy With Application of Vitamin E Ointment|Reduction of Postoperative Pain and Improvement of Patients´Comfort After Milligan-Morgan Haemorrhoidectomy With Application of Vitamin E Ointment|Completed||Phase 3|60|Actual|Hospital General Universitario Elche||2|||f||||t||||||||||2017-10-10 22:55:01.643798|2017-10-10 22:55:01.643798
NCT02554110|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-03-21|||October 12, 2015|Actual|2015-10-12|March 2017|2017-03-01|January 12, 2017|Actual|2017-01-12|January 12, 2017|Actual|2017-01-12||Interventional|||Peripheral Nerve Stimulation to Reduce Hypoxic Events|A Randomized Control Trial of the Oxistimulator as an Adjunct to Standard Practice to Decrease Extent and Duration of Oxygen Desaturation in Adult Patients Who Have Received Anesthetics or Are Receiving Sedating Medications|Completed||N/A|80|Actual|Mayo Clinic||2|||f||||f|f|f||||||No||2017-10-10 22:55:01.753051|2017-10-10 22:55:01.753051
NCT02554097|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-08-17|||August 2015||2015-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01|3 Years|Observational [Patient Registry]|||Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements|Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements - A Multicenter, Prospective and Retrospective Cohort Study Based on Case Register System|Enrolling by invitation||N/A|2700|Anticipated|Beijing Friendship Hospital|||3||f||||t||||||||||2017-10-10 22:55:01.902289|2017-10-10 22:55:01.902289
NCT02554084|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-01-06|||November 2014||2014-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Optical Coherence Tomography of Tear Film Dynamics In-Vivo|Optical Coherence Tomography of Tear Film Dynamics In-Vivo|Recruiting||N/A|60|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-10 22:55:02.064486|2017-10-10 22:55:02.064486
NCT02554071|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-09-16|||January 2014||2014-01-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Manitoba Pharmacist Initiated Smoking Cessation Pilot Project|Manitoba Pharmacist Initiated Smoking Cessation Pilot Project|Completed||Phase 4|119|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-10 22:55:02.205581|2017-10-10 22:55:02.205581
NCT02554058|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-05-08|||May 2015||2015-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Combined Tactile and Proprioception Training After Spinal Cord Injury|Phase 1 Effects of Training With a Novel Rehabilitation Bike on the Functional Recovery and Corticospinal Plasticity in Individuals With Incomplete Spinal Cord Injuries|Completed||N/A|10|Actual|University of Manitoba||1|||f||||t||||||||||2017-10-10 22:55:02.323365|2017-10-10 22:55:02.323365
NCT02554032|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-06-09|||June 2015||2015-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||The Aortic Surgery Cerebral Protection Evaluation (ACE) Randomized CardioLink-3 Trial|A Randomized Controlled Trial of Axillary vs. Innominate Artery Cannulation for Antegrade Cerebral Protection in Aortic Surgery: The ACE Randomized Trial|Recruiting||N/A|110|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 22:55:02.559221|2017-10-10 22:55:02.559221
NCT02554019|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-07-11|||August 2015||2015-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|BT063 in SLE||Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus|A Prospective, Double-blind, Randomized, Placebo-controlled, Repeated Dose, Multicentre Phase IIa Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus|Active, not recruiting||Phase 2|36|Anticipated|Biotest||2|||f||||t||||||||||2017-10-10 22:55:02.685057|2017-10-10 22:55:02.685057
NCT02554006|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2017-09-12|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|BATMAN||Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings|Predischarge Bundle for Patients in Dual Antiplatelet Therapy to Minimize the Negative Impact of Nuisance Bleedings on Quality of Life: a Randomized Controlled Trial.|Completed||N/A|448|Actual|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-10 22:55:02.813585|2017-10-10 22:55:02.813585
NCT02553993|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-01-06|||September 2013||2013-09-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Comparing the Cognitive Effects of Two Exergame Training and Traditional Training in Patients With Chronic Stroke|Comparing the Cognitive Effects of Two Exergame Balance Training Systems and Traditional Weight Shifting Training in Patients With Chronic Stroke|Completed||N/A|43|Actual|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-10 22:55:02.919728|2017-10-10 22:55:02.919728
NCT02553980|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-02-03|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Virtual Trainer System (3rd Version) for Physical Activity Promotion in Middle-aged Hong Kong Adults|Development and Dissemination of an Online Exercise and Health Promotion Program for Hong Kong Middle-aged Chinese: The Virtual Trainer System 3rd Version|Recruiting||N/A|200|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:55:03.0682|2017-10-10 22:55:03.0682
NCT02553967|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-03-01|||November 2015||2015-11-01|March 2016|2016-03-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|REMASCO||Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)|Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)|Recruiting||N/A|40|Anticipated|Centre Oscar Lambret||2|||f||||f||||||||No||2017-10-10 22:55:03.194203|2017-10-10 22:55:03.194203
NCT02553954|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-17|2016-07-20|||October 2014||2014-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Molecular Mechanisms of Senescence Predisposing to Cancer : Exploratory Analysis on Healthy Tissues (SkinAge).|Molecular Mechanisms of Senescence Predisposing to Cancer : Exploratory Analysis on Healthy Tissues Collected for Two Age Groups.|Recruiting||N/A|60|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||No||2017-10-10 22:55:03.298462|2017-10-10 22:55:03.298462
NCT02553941|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-09-13|||April 2016||2016-04-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome|Phase 1b Trial of the Combination of Ibrutinib and Azacitidine for the Treatment of Higher Risk Myelodysplastic Syndromes in Previously Treated Patients or in Untreated Patients Unfit for or Who Refuse Intense Therapy|Recruiting||Phase 1|24|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 22:55:03.419522|2017-10-10 22:55:03.419522
NCT02553915|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-08-28|||December 2015||2015-12-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach|Omega-3 Fatty Acids for MDD With High Inflammation: A Personalized Approach|Recruiting||Phase 2/Phase 3|100|Anticipated|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-10 22:55:03.687081|2017-10-10 22:55:03.687081
NCT02553902|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-06-15|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Economic Evaluation of Treatment Modalities for Position Dependent Obstructive Sleep Apnea|Economic Evaluation of Treatment Modalities for Position Dependent Obstructive Sleep Apnea Patients|Recruiting||N/A|200|Anticipated|Onze Lieve Vrouwe Gasthuis||2|||f||||f||||||||No||2017-10-10 22:55:03.840649|2017-10-10 22:55:03.840649
NCT02553889|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-12-12|||October 2015||2015-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis|A Phase 2, Randomized, Double Blind, Placebo Controlled Study of the Safety, PK, and PD of Multiple Doses of ISIS 416858 (ISIS-FXI RX), Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis|Completed||Phase 2|49|Actual|Ionis Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 22:55:03.972219|2017-10-10 22:55:03.972219
NCT02553876|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-17|||September 2015||2015-09-01|September 2015|2015-09-01|June 2022|Anticipated|2022-06-01|September 2021|Anticipated|2021-09-01||Observational|||Dorsal Root Ganglion Stimulation for Hand and Upper Limb Pain|An Observational Cohort Study to Assess the Long Term Effectiveness of Dorsal Root Ganglion Stimulation for Chronic Pain in the Upper Limb(s)|Recruiting||N/A|20|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-10 22:55:04.113228|2017-10-10 22:55:04.113228
NCT02553863|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-11-18|||September 2015||2015-09-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effectiveness and Cost-effectiveness of Acupuncture in Managing Chemotherapy-induced Peripheral Neuropathy|A Randomised Controlled Trial to Assess the Effectiveness and Cost-effectiveness of Acupuncture in the Management of Chemotherapy-induced Peripheral Neuropathy|Recruiting||N/A|98|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||||2017-10-10 22:55:04.229413|2017-10-10 22:55:04.229413
NCT02553850|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-10-29|||April 2007||2007-04-01|October 2016|2016-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)|A SURVEY TO STUDY THE CORRELATION BETWEEN THE SERUM LEVELS OF BONE TURNOVER MARKERS AND THE CLINICAL PICTURE IN PATIENTS WITH BREAST CANCER AND BONE METASTASES RECEIVING IBRADONIC ACID TREATMENT|Completed||N/A|442|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:55:04.331403|2017-10-10 22:55:04.331403
NCT02553837|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2016-01-31|||November 2015||2015-11-01|September 2015|2015-09-01|July 2022|Anticipated|2022-07-01|August 2017|Anticipated|2017-08-01||Interventional|||Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult|Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult|Active, not recruiting||Phase 3|317|Anticipated|Green Cross Corporation||1|||f||||t||||||||||2017-10-10 22:55:04.437313|2017-10-10 22:55:04.437313
NCT02553824|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-04-25|||July 2015||2015-07-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|April 15, 2017|Actual|2017-04-15||Interventional|||FDA Approved Medication to Reduce Binge Eating and/or Purging|Qsymia (Phentermine-topiramate) to Reduce Binge Eating/Purging in Patients With Bulimia Nervosa and Binge Eating Disorder|Active, not recruiting||Phase 1|30|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:55:04.5116|2017-10-10 22:55:04.5116
NCT02553811|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-07-13|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|DCTS||Diagnosis of Carpal Tunnel Syndrome: Effectiveness of Diagnostic Tests. Clinical Trial of Accuracy|Accuracy of Ultrasonography and Electromyography in the Diagnosis of Carpal Tunnel Syndrome|Completed||N/A|115|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-10-10 22:55:04.602741|2017-10-10 22:55:04.602741
NCT02553798|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-01-12|||August 2015||2015-08-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Long-term Safety Study of DRM04 in Subjects With Primary Axillary Hyperhidrosis|An Open-label Study Assessing Long-term Safety of DRM04 in Subjects With Primary Axillary Hyperhidrosis|Completed||Phase 3|564|Actual|Dermira, Inc.||1|||f||||f||||||||||2017-10-10 22:55:04.687124|2017-10-10 22:55:04.687124
NCT02553785|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-16|||June 2015||2015-06-01|September 2015|2015-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|ReviventTC1||Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy|Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy|Recruiting||Phase 1|50|Anticipated|BioVentrix||1|||f||||t||||||||||2017-10-10 22:55:04.841095|2017-10-10 22:55:04.841095
NCT02553759|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-09-17|||October 2013||2013-10-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|June 2014|Actual|2014-06-01||Interventional|ObACNPain||Observed Actions in Chronic Neck Pain|Influence of the Actions Observed on Cervical Motion in Patients With Chronic Neck Pain. Randomized Controlled Trial|Completed||N/A|28|Actual|AG Clinic||2|||f||||t||||||||||2017-10-10 22:55:05.058601|2017-10-10 22:55:05.058601
NCT02553746|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-10-14|||September 2015||2015-09-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Ultrasound for Neuraxial Anesthesia|Study of the Use of Ultrasound Scan for Lumbar Regional Anesthesia|Recruiting||N/A|80|Anticipated|424 General Military Hospital||2|||f||||f||||||||||2017-10-10 22:55:05.129944|2017-10-10 22:55:05.129944
NCT02553733|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-09-27|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HeartBeet||Effect of Beetroot Juice on Coronary Blood Flow and Walking Performance in PAD|Effects of Dietary Nitrate Supplementation on Coronary Blood Flow and Walking Performance in Peripheral Arterial Disease|Recruiting||Phase 2|24|Anticipated|Penn State University||2|||f||||f||||||||||2017-10-10 22:55:05.522403|2017-10-10 22:55:05.522403
NCT02553720|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-17|||September 2015||2015-09-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|July 2016|Anticipated|2016-07-01||Interventional|ATLANTIS||Aqua Therapy in Deep Venous Thrombosis and Insufficiency|Aqua Therapy to Lower Adverse and Negative Effects of Deep Vein ThrombosIs and Post Thrombotic Syndrome|Recruiting||N/A|100|Anticipated|Arizona Cardiovascular Consultants||2|||f||||f||||||||||2017-10-10 22:55:05.695544|2017-10-10 22:55:05.695544
NCT02553707|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-09-16|||July 2006||2006-07-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer|Open-Label Study to Establish the Short Term Efficacy of Intravenous Loading-Doses of Bondronat 6 mg in Patients With Breast Cancer and Skeletal Metastases Experiencing Moderate to Severe Pain, Within 7 Days After Initiation of Treatment|Completed||Phase 4|182|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:55:05.863728|2017-10-10 22:55:05.863728
NCT02553694|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-03-02|||July 2014||2014-07-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|SAVE-CPAP||Sleep Apnea Video Education for CPAP (SAVE-CPAP)|Impact of a Short Educational Video on OSA Patient Satisfaction, Knowledge and Outcomes|Completed||N/A|212|Actual|University of Chicago||4|||f||||f||||||||No||2017-10-10 22:55:06.03451|2017-10-10 22:55:06.03451
NCT02553681|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-02-16|||July 2015||2015-07-01|February 2017|2017-02-01|February 16, 2017|Actual|2017-02-16|February 2017|Actual|2017-02-01||Interventional|||Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Roflufocon D|Clinical Evaluation of Hydra-PEG (Polyethylene Glycol) Treatment (HPT) Treated Rigid Contact Lenses Made From Roflufocon D|Completed||Phase 4|45|Actual|Contamac Ltd||2|||f||||f||||||||||2017-10-10 22:55:06.190566|2017-10-10 22:55:06.190566
NCT02553668|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-09-16|||October 2015||2015-10-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Proteomics for Identification of Hyperoxia-induced Changes in Protein Expression|Proteomics for Identification of Hyperoxia-induced Changes in Protein Expression|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Hospital of Cologne||1|||f||||f||||||||||2017-10-10 22:55:06.303342|2017-10-10 22:55:06.303342
NCT02553655|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-08-29|||October 2015||2015-10-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Remote Ischemic Limb Preconditioning In Healthy Volunteers|Does Remote Ischemic Limb Preconditioning Improve Cerebral Vasomotor Reactivity in Healthy Volunteers?|Recruiting||N/A|30|Anticipated|University of Miami||3|||f||||f||||||||||2017-10-10 22:55:06.417391|2017-10-10 22:55:06.417391
NCT02553642|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-02-28|||September 14, 2015|Actual|2015-09-14|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)|A Prospectively Designed Study to Assess the Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)|Recruiting||Phase 2|70|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:55:06.535437|2017-10-10 22:55:06.535437
NCT02553629|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-12-11|2016-07-14||September 2015||2015-09-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|BLISS3||Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients|Effect of Depth of Neuromuscular Block on Intraoperative Surgical Conditions as Determined by the Leiden Surgical Rating Scale in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery|Completed||Phase 4|109|Actual|Leiden University Medical Center||2|||f||||||||||||||2017-10-10 22:55:06.674753|2017-10-10 22:55:06.674753
NCT02553616|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-08-25|||January 2016||2016-01-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||An Intervention to Promote Healthy Behaviors in Homeless Youth|An Intervention to Promote Healthy Behaviors in Homeless Youth|Recruiting||N/A|600|Anticipated|University of Texas at Austin||1|||f||||t||||||||||2017-10-10 22:55:07.053985|2017-10-10 22:55:07.053985
NCT02553603|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-08-15|||July 18, 2017|Actual|2017-07-18|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment|The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment|Recruiting||Phase 1|40|Anticipated|The University of Texas Medical Branch, Galveston||4|||f||||f|t|f|||f|||||2017-10-10 22:55:07.170516|2017-10-10 22:55:07.170516
NCT02553590|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-11-10|||January 2015||2015-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Tolerability of SLIT With LAIS® 2-Tree Allergoid Tablets|Non-Interventional Study (NIS) on the Tolerability of Sublingual Immunotherapy With LAIS® 2-Tree Tablets in Consideration of the Chosen Titration Schedule in Everyday Practice|Completed||N/A|160|Actual|University Hospital of Cologne|||1||f||||f||||||||||2017-10-10 22:55:07.300993|2017-10-10 22:55:07.300993
NCT02553577|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-06-21|||September 2015||2015-09-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Impact of Electronic Cigarettes on Perinatal Immune Responsiveness and Birth Outcomes|The Impact of Electronic Cigarettes on Perinatal Immune Responsiveness and Birth Outcomes in Appalachia|Recruiting||N/A|360|Anticipated|University of Kentucky|||3||f||||t|f|f||||Samples With DNA|"     Serum cytokines: interleukin (IL) IL-1α, IL1β, IL-6, IL-8, IL-10, CRP, TNFα and MMP-8 Urinary     Cotinine Urinary ( NNAL) 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its     metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol Expired Carbon Monoxide   "|||2017-10-10 22:55:07.373296|2017-10-10 22:55:07.373296
NCT02553564|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-05-05|||September 2015||2015-09-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||30 Day Rehospitalization Risk in Hemodialysis Patients|A Randomized Controlled Trial of a Checklist Intervention to Reduce 30 Day Rehospitalization Risk in Hemodialysis Patients|Active, not recruiting||N/A|320|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-10 22:55:07.473254|2017-10-10 22:55:07.473254
NCT02553551|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2016-10-17|||July 2015||2015-07-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of Vitamin C on Postoperative Pain After Laparoscopic Cholecystectomy|Effect of Vitamin C on Postoperative Pain After Laparoscopic Cholecystectomy; a A Prospective Randomized Controlled Trial|Recruiting||N/A|320|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-10 22:55:07.553213|2017-10-10 22:55:07.553213
NCT02553525|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-06-23|||May 2016||2016-05-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Effects of Stimulation Patterns of Deep Brain Stimulation|Effects of Stimulation Patterns of Deep Brain Stimulation|Enrolling by invitation||N/A|180|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:55:07.73925|2017-10-10 22:55:07.73925
NCT02553512|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-04-03|2017-04-03||September 2013||2013-09-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01|2 Weeks|Observational [Patient Registry]|||Helius in Hypertension-I: The UK Hypertension Registry|Helius in Hypertension-I: The UK Hypertension Registry|Completed||N/A|151|Actual|Proteus Digital Health, Inc.|This was an open-label registry. Patients may have increased their adherence due to a Hawthorne effect. Patients may have been selective in the medications that they actually ingested.||1||f||||f||||||||||2017-10-10 22:55:07.873762|2017-10-10 22:55:07.873762
NCT02553499|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-08-18|||November 12, 2015|Actual|2015-11-12|August 2017|2017-08-01|March 23, 2019|Anticipated|2019-03-23|March 23, 2019|Anticipated|2019-03-23||Interventional|||Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001)|A Phase 1 Trial of MK-1248 as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors.|Active, not recruiting||Phase 1|96|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f|t|f||||||||2017-10-10 22:55:08.27549|2017-10-10 22:55:08.27549
NCT02553486|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-05-04|||September 2015||2015-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|QUADOP||Internationally Adopted Children Quality of Life|Internationally Adopted Children Quality of Life Study (QUADOP)|Completed||N/A|756|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 22:55:08.352875|2017-10-10 22:55:08.352875
NCT02553447|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-05-25|||October 19, 2015|Actual|2015-10-19|May 2017|2017-05-01|August 28, 2020|Anticipated|2020-08-28|August 28, 2019|Anticipated|2019-08-28||Interventional|||Cholecalciferol in Treating Patients With Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency|A Pilot Study of Vitamin D Replacement in Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia With Low Vitamin D Levels|Recruiting||Early Phase 1|312|Anticipated|University of Nebraska||3|||f||||t||||||||||2017-10-10 22:55:08.777882|2017-10-10 22:55:08.777882
NCT02553434|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-09-16|||September 2015||2015-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparing 14 F Pigtail Catheter to Traditional 28-32F Chest Tube in the Management of Traumatic Hemothorax and Hemopneumothorax|Prospective and Randomized Study Comparing 14 F Pigtail Catheter to Traditional 32-36F Chest Tube in the Management of Traumatic Hemothorax and Hemopneumothorax|Unknown status|Not yet recruiting|Phase 3|40|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-10 22:55:08.887846|2017-10-10 22:55:08.887846
NCT02553421|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-03-09|2016-11-04||August 2015||2015-08-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Optical Detection of Intravenous Infiltration:A Pilot Study||Completed||N/A|243|Actual|ivWatch, LLC||3|||f||||f||||||||||2017-10-10 22:55:08.989057|2017-10-10 22:55:08.989057
NCT02553408|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-09-09|||September 2015||2015-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Patients and Care Providers Perspectives and Experience With Decision Aid Tool for Self-monitoring of Blood Glucose|Patients and Care Providers Perspectives and Experience With Decision Aid Tool for Self-monitoring of Blood Glucose|Completed||N/A|16|Actual|Lawson Health Research Institute||1|||f||||f||||||||No||2017-10-10 22:55:09.300127|2017-10-10 22:55:09.300127
NCT02553395|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-10-13|||September 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:55:09.370118|2017-10-10 22:55:09.370118
NCT02553382|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-11-11|||November 2015||2015-11-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Interventional|FIGHT||Fibre Grain Herb Trial in Type 2 Diabetes|Co-administration of Three Complimentary Therapies (Viscous Dietary Fiber, Whole Grain and Ginseng) for Comprehensive Risk Reduction in Type 2 Diabetes Mellitus|Recruiting||Phase 3|84|Anticipated|St. Michael's Hospital, Toronto||2|||f||||||||||||||2017-10-10 22:55:09.408118|2017-10-10 22:55:09.408118
NCT02553369|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-07-25|||February 2015||2015-02-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Observational|ChikVIH||Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection|Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection|Completed||N/A|388|Actual|University Hospital Center of Martinique|||1||f||||f||||||||||2017-10-10 22:55:09.48287|2017-10-10 22:55:09.48287
NCT02553356|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-12-08|||September 2015||2015-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers|A Single-Dose, Open-Label, Randomized, Food Effect Study in Healthy Volunteers With PT2385 Tablets|Completed||Phase 1|16|Actual|Peloton Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:55:09.566348|2017-10-10 22:55:09.566348
NCT02553343|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-04-25||2017-04-25|September 2015||2015-09-01|April 2017|2017-04-01|April 4, 2016|Actual|2016-04-04|April 4, 2016|Actual|2016-04-04||Interventional|||A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older|Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older|Completed||Phase 2|802|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 22:55:11.792597|2017-10-10 22:55:11.792597
NCT02553330|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-04-17|||October 2015||2015-10-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study With INCB018424 Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)|An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of INCB018424 Phosphate Cream Applied Topically to Subjects With Alopecia Areata|Active, not recruiting||Phase 2|90|Actual|Incyte Corporation||2|||f||||f||||||||||2017-10-10 22:55:11.918748|2017-10-10 22:55:11.918748
NCT02553317|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-09-14|||September 2015||2015-09-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|HERCULES||Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura|A Phase III Double-blind, Randomized, Parallel Group, Multicenter Placebo-controlled Trial to Study the Efficacy and Safety of Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura|Completed||Phase 3|145|Actual|Ablynx||2|||f||||t||||||||||2017-10-10 22:55:12.049861|2017-10-10 22:55:12.049861
NCT02553304|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-01-13|||September 2015||2015-09-01|July 2015|2015-07-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01|2 Years|Observational [Patient Registry]|||Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients|Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients|Enrolling by invitation||N/A|250|Anticipated|National Health Research Institutes, Taiwan|||1||f||||t||||||Samples With DNA|"     The molecular markers to be tested in this project include (but not limited to) cytogenetic     abnormalities by fluorescent-in-situ hybridization (FISH), immunoglobulin heavy chain     variable region (IGHV) hypermutation status, gene mutations for Notch1, SF3B1, p53, MyD88,     and BIRC3, and the expressions for ZAP70 and stem cell factor (SCF).   "|||2017-10-10 22:55:12.473183|2017-10-10 22:55:12.473183
NCT02553291|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-07-18|||November 2014||2014-11-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Clinical Trial of SystemCHANGE to Improve Exercise, Diet and Health in HIV-Infected Adults||Completed||N/A|109|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-10-10 22:55:12.541036|2017-10-10 22:55:12.541036
NCT02553278|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-04-06|||January 10, 2016|Actual|2016-01-10|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||VelaShape and Contour I V3 for Abdominal Fat Reduction vs. Control|Clinical Study to Evaluate the Performances of Modified VelaShape and the Performance of Contour I V3 Devices for Abdominal Fat Reduction vs. Control|Recruiting||N/A|24|Anticipated|Syneron Medical||2|||f||||f||||||||||2017-10-10 22:55:12.632748|2017-10-10 22:55:12.632748
NCT02553265|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-09-20|||September 2015||2015-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CarbiFD||Carbidopa for the Treatment of Excessive Blood Pressure Variability|Carbidopa in Familial Dysautonomia: Phase-II Study, Investigational New Drug (IND) 117435, Date: 01/07/13|Recruiting||Phase 2|30|Anticipated|New York University School of Medicine||3|||f||||t||||||||||2017-10-10 22:55:12.728123|2017-10-10 22:55:12.728123
NCT02553252|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-03-07|||November 2015||2015-11-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||SKY Versus WLC in PTSD|Sudarshan Kriya Yoga (SKY) Versus Wait List Control (WLC) in Post Traumatic Stress Disorder: A Randomised Controlled Study|Suspended||N/A|52|Actual|Lawson Health Research Institute||2||A pilot study is currently in progress.|f||||f||||||||||2017-10-10 22:55:12.890403|2017-10-10 22:55:12.890403
NCT02553239|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-07-05|||July 2014||2014-07-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|CoolLoop PAF||CoolLoop Paroxysmal Atrial Fibrillation|CoolLoop Paroxysmal Atrial Fibrillation|Recruiting||N/A|112|Anticipated|AFreeze GmbH||1|||f||||f||||||||||2017-10-10 22:55:12.972201|2017-10-10 22:55:12.972201
NCT02553226|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2017-04-21|||April 2016||2016-04-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|January 2019|Anticipated|2019-01-01||Interventional|CONDISOX||Continued Versus Discontinued Oxytocin Stimulation of Labour|Continued Versus Discontinued Oxytocin Stimulation of Labour in a Double-blind Randomised Controlled Trial|Recruiting||Phase 4|1200|Anticipated|University of Aarhus||2|||f||||t||||||||No|"The trial is GCP monitored by the GCP unit of Aarhus University Hospital and Odense University Hospital
Members of the Data Monitoring Committee:
Chair: Lone Krebs (Obstetrician) Member: Gorm Greisen (Pediatrician) Member: Martin Johansen (Statistician)
Members of the Trial Steering Committee:
Chair: Jim Thornton Member: Thomas bergholt Member: Inger Stornes"|2017-10-10 22:55:13.07195|2017-10-10 22:55:13.07195
NCT02553213|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-10-25|||July 2015||2015-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|ECODO||Early Changes of Diabetes Parameters After Obesity Therapy|Early Changes of Diabetes Parameters After Obesity Therapy|Recruiting||N/A|30|Anticipated|University of Hohenheim||3|||f||||f||||||||||2017-10-10 22:55:13.208751|2017-10-10 22:55:13.208751
NCT02553200|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-07-24|||January 2016||2016-01-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|BMACPF||The Efficacy of Breathing Exercise With BreatheMAX Device on Airway Secretion Clearance and Lung Function|Study of Breathing Exercise With Oscillated Inspiratory Loading (OIS) and Oscillated Positive Expiratory Pressure (OPEP) for Airway Secretion Clearance and Lung Function in Intubated Patients, Both With and Without Mechanical Ventilation Dependence|Recruiting||N/A|30|Anticipated|Khon Kaen University||3|||f||||f||||||||||2017-10-10 22:55:13.30892|2017-10-10 22:55:13.30892
NCT02553187|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-02-14|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia|A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia|Recruiting||Phase 4|160|Anticipated|Zhejiang Kanglaite Pharmaceutical Co.Ltd||2|||f||||t||||||||||2017-10-10 22:55:13.420217|2017-10-10 22:55:13.420217
NCT02553174|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-08-01|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||AKI in Thoracic and Abdominal Surgery|Acute Kidney Injury and Nonsteroidal Anti-inflammatory Drugs in Patients Undergoing High-risk Abdominal or Thoracic Surgery|Active, not recruiting||N/A|500|Anticipated|Milton S. Hershey Medical Center|||3||f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-10 22:55:13.538597|2017-10-10 22:55:13.538597
NCT02553161|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-01-17|||December 2015||2015-12-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth|Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth|Recruiting||N/A|210|Anticipated|University of Cincinnati||3|||f||||t||||||||No||2017-10-10 22:55:14.232659|2017-10-10 22:55:14.232659
NCT02553148|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-02-22|||June 2014||2014-06-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Estimating the Global Need for Palliative Care for Children|Estimating the Global Need for Palliative Care for Children: A Cross Sectional Analysis|Completed||N/A|18837613|Actual|International Children's Palliative Care Network|||23||f||||f||||||||Yes|A manuscript reporting results has been prepared and is being reviewed for journal publication.|2017-10-10 22:55:14.482295|2017-10-10 22:55:14.482295
NCT02553135|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-04-26|||September 2015||2015-09-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Choroideremia Gene Therapy Clinical Trial|An Open Label Phase 2 Clinical Trial of Retinal Gene Therapy for Choroideremia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1)|Active, not recruiting||Phase 2|6|Actual|University of Miami||1|||f||||t||||||||||2017-10-10 22:55:14.635832|2017-10-10 22:55:14.635832
NCT02553122|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-15|||October 2015||2015-10-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||The Combined Efficacy of Evicel and Tranexamic Acid on Total Knee Arthroplasty|The Combined Efficacy of Evicel and Tranexamic Acid on Total Knee Arthroplasty During the Early Perioperative Period|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 22:55:14.733937|2017-10-10 22:55:14.733937
NCT02552927|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-03-30|||August 2015||2015-08-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|SLIGHT||Chest Shielding in Premature Infants During Phototherapy|Effect of Chest Shielding on the Incidence of Patent Ductus Arteriosus in Premature Infants Undergoing Phototherapy|Recruiting||Phase 2|140|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 22:55:16.413256|2017-10-10 22:55:16.413256
NCT02553109|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-01-14|||January 2015||2015-01-01|January 2017|2017-01-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01|5 Years|Observational [Patient Registry]|PANDORA||Paraclinoid ANeurysm Prospectively Driven ObseRvational Analysis (PANDORA) Study|The Risk of Rupture or Growth in Patients With Small Unruptured Paraclinoid Aneurysm: Paraclinoid ANeurysm Prospectively Driven ObseRvational Analysis (PANDORA) Study|Recruiting||N/A|645|Anticipated|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 22:55:14.84412|2017-10-10 22:55:14.84412
NCT02553096|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-08-29|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Actual|2017-08-01||Interventional|ACCESS||Exacerbation Self-management in COPD: The ACCESS Study|Adaptive Computerized COPD Exacerbation Self-management Support (ACCESS): A Randomized Controlled Trial|Active, not recruiting||N/A|87|Actual|Radboud University||2|||f||||t||||||||||2017-10-10 22:55:15.041757|2017-10-10 22:55:15.041757
NCT02553083|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2016-10-05|||December 2016||2016-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|HDDT||High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection|High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection|Not yet recruiting||Phase 4|300|Anticipated|Rabin Medical Center||3|||f||||f||||||||||2017-10-10 22:55:15.151139|2017-10-10 22:55:15.151139
NCT02553070|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-11-12|||September 2015||2015-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|||Health Professions Students and Faculty Perceptions of Poisoning Severity|Health Professions Students and Facutly Perceptions of Poisoning Severity|Completed||N/A|1000|Actual|University of Florida|||1||f||||f||||||||||2017-10-10 22:55:15.261019|2017-10-10 22:55:15.261019
NCT02553057|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-16|||October 2015||2015-10-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|lapVent||Low Tidal Volume for Lung Protection During Anesthesia of Laparoscopic Surgery in Trendlenburg Position||Unknown status|Not yet recruiting|N/A|90|Anticipated|Mansoura University||3|||f||||t||||||||||2017-10-10 22:55:15.353792|2017-10-10 22:55:15.353792
NCT02553044|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-05-04|||October 2015||2015-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Change in Free 25(OH)D After High Dose in Vitamin D Deficient Postmenopausal Women|Change in Free 25(OH)D After High Dose in Vitamin D Deficient Postmenopausal Women|Active, not recruiting||N/A|112|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||4|||f||||f||||||||||2017-10-10 22:55:15.453184|2017-10-10 22:55:15.453184
NCT02553031|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-05-14|||July 2014||2014-07-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Application of MR-PET in Colorectal Cancer|Application of MR-PET in Colorectal Cancer|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:55:15.592952|2017-10-10 22:55:15.592952
NCT02553018|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-10-05|||September 2015|Actual|2015-09-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|Self-i||Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe|A National, Randomized, Open-label Study Comparing Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated With Methotrexate Administered by Auto-injector Versus Administration by Conventional Subcutaneous Injection.|Completed||Phase 3|278|Actual|Nordic Pharma SAS||2|||f||||f||||||||||2017-10-10 22:55:15.680985|2017-10-10 22:55:15.680985
NCT02553005|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-12|2015-09-25|||May 2015||2015-05-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|October 2015|Anticipated|2015-10-01||Interventional|||Evaluation of the Effect of Acupuncture on Hand Pain, Functional Deficits and Health Related Quality of Life in Patients With Rheumatoid Arthritis|Evaluation of the Effect of Acupuncture on Hand Pain, Functional Deficits and Health Related Quality of Life in Patients With Rheumatoid Arthritis - A Multicenter, Double-blinded, Randomised Clinical Trial|Unknown status|Recruiting|Early Phase 1|90|Anticipated|University of Coimbra||3|||f||||f||||||||||2017-10-10 22:55:15.778068|2017-10-10 22:55:15.778068
NCT02552992|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-09-15|||January 2015||2015-01-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Yoga for Chronic Low Back Pain and Its Mechanism of Action: Impact of Strength and Stretch (YoMA II)|Yoga for Chronic Low Back Pain and Its Mechanism of Action: Impact of Strength and Stretch (YoMA II)|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 22:55:15.888531|2017-10-10 22:55:15.888531
NCT02552979|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-05-02|||January 2012||2012-01-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Observational|||Atopy Patch Test in Children With Atopic Dermatitis|Atopy Patch Test in Children With Atopic Dermatitis|Completed||N/A|56|Actual|Mahidol University|||1||f||||f||||||||||2017-10-10 22:55:15.989144|2017-10-10 22:55:15.989144
NCT02552966|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-09-22|||September 1, 2015|Actual|2015-09-01|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin|Assessing the Impacts of an Upper Esophageal Sphincter Assist Device on Laryngeal Symptoms and Salivary Pepsin: A Pilot Study|Enrolling by invitation||Phase 2|25|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-10 22:55:16.067071|2017-10-10 22:55:16.067071
NCT02552953|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-24|||September 2015||2015-09-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers|A Phase I Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers|Unknown status|Recruiting|Phase 1|35|Anticipated|Cyclacel Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:55:16.155039|2017-10-10 22:55:16.155039
NCT02552940|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-06-02|||October 31, 2015|Actual|2015-10-31|June 2017|2017-06-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|||An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice|A PROSPECTIVE, NON-INTERVENTIONAL STUDY TO EVALUATE THE CLINICAL EFFECTIVENESS, THE CONSISTENCY OF EVALUATION SCORES, QUALITY OF LIFE, SAFETY AND TOLERABILITY OF TOCILIZUMAB SUBCUTANEOUS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY CLINICAL PRACTICE|Active, not recruiting||N/A|120|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:55:16.262951|2017-10-10 22:55:16.262951
NCT02535195|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-08-26|||March 2013||2013-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|February 2014|Actual|2014-02-01||Interventional|||Effect of Ginger Supplement on Non-alcoholic Fatty Liver||Completed||Phase 2/Phase 3|60|Actual|National Nutrition and Food Technology Institute||2|||f||||||||||||||2017-10-10 22:58:55.946525|2017-10-10 22:58:55.946525
NCT02552914|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-03-01|||September 2015||2015-09-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|Colli-Pee||Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs|Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of Several Sexual Transmitted Infections, Including Reproducibility of the Test Results and Acceptability by MSM Participating in a PrEP Study|Active, not recruiting||N/A|186|Actual|Institute of Tropical Medicine, Belgium|||1||f||||f||||||Samples Without DNA|"     First-void urine   "|||2017-10-10 22:55:16.533957|2017-10-10 22:55:16.533957
NCT02552901|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-01-14|||November 2015||2015-11-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|LFT-0002||Cardiox Liver Function Test Pivotal Trial|A Pivotal, Within Subject, Comparison of the LFT™ Dye Monitor System to the Indocyanine Green Dye (ICG) Serial Blood Plasma Disappearance Rate in Patients With Impaired and Non-Impaired Hepatic Function|Withdrawn||Phase 3|0|Actual|Cardiox Corporation||2|||f||||f||||||||||2017-10-10 22:55:16.618036|2017-10-10 22:55:16.618036
NCT02552888|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-08-11|||March 2016||2016-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|NICE||Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial|Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial|Completed||Phase 2|70|Actual|Tulane University||2|||f||||t||||||||||2017-10-10 22:55:16.724492|2017-10-10 22:55:16.724492
NCT02552875|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-09-16|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|STSTS||Shortening of the Twitch Stabilization Period by Tetanic Stimulation in Acceleromyography in Children and Young Adults|Shortening of the Twitch Stabilization Period by Tetanic Stimulation in Acceleromyography in Children and Young Adults|Completed||Phase 4|80|Actual|University of Regensburg||2|||f||||t||||||||||2017-10-10 22:55:16.832994|2017-10-10 22:55:16.832994
NCT02552862|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-12-14|||September 2016||2016-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)|Study of the Effect of Adjunctive Vivomixx® in Addition to Antibiotics on Systemic and Cerebral Inflammatory Response in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)|Withdrawn||Phase 3|0|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2||No candidates during recruiting time. There were no candidates meeting the inclusion criteria|f||||t||||||||||2017-10-10 22:55:16.925104|2017-10-10 22:55:16.925104
NCT02552849|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2017-10-02|||April 25, 2013|Actual|2013-04-25|October 2017|2017-10-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Observational|||Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada||Active, not recruiting||N/A|305|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:55:17.222866|2017-10-10 22:55:17.222866
NCT02552836|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-04-13|||March 2016||2016-03-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Efficacy of Psychotherapy for Depressed Parkinson`s Disease Patients|Evaluation of Two Psychotherapies for Depressed Patients With Parkinson`s Disease|Recruiting||N/A|80|Anticipated|Hopital Montfort||2|||f||||f||||||||No|No plan to share data|2017-10-10 22:55:17.385908|2017-10-10 22:55:17.385908
NCT02552823|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-10-02|||October 2015||2015-10-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|August 2017|Actual|2017-08-01||Interventional|||Effects of Peas on Blood Glucose Control|A Randomized, Controlled, Cross-over Trial Examining the Effect of Peas on Post-prandial Glucose Response in Healthy Adults|Active, not recruiting||N/A|64|Actual|St. Boniface General Hospital Research Centre||10|||f||||f||||||||||2017-10-10 22:55:17.499924|2017-10-10 22:55:17.499924
NCT02552810|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-05-10|2015-12-07||January 2010||2010-01-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2010|Actual|2010-09-01||Interventional|||Plasma of Argon Cleaning on Implant Abutments: 5-year Results of a Randomized Clinical Trial|Effect of Plasma of Argon Cleaning on Implant Abutments in Patients With a History of Periodontal Disease and Thin Biotype: Five Years Post-loading Results of a Randomized Controlled Trial|Completed||N/A|30|Actual|University of Valencia||2|||f||||t||||||||No||2017-10-10 22:55:17.657224|2017-10-10 22:55:17.657224
NCT02552797|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-16|||September 2015||2015-09-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|Power Up||The Development and Piloting of 'Power Up': A Tool for Young People With Internalising/Emotional Disorders to Make Shared Decisions in Child and Adolescent Mental Health Services (CAMHS)|The Development and Piloting of 'Power Up': A Tool for Young People With Internalising/Emotional Disorders to Make Shared Decisions in Child and Adolescent Mental Health Services (CAMHS)|Unknown status|Not yet recruiting|N/A|105|Anticipated|University College, London||2|||f||||f||||||||||2017-10-10 22:55:18.135212|2017-10-10 22:55:18.135212
NCT02552784|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-09-15|||June 2015||2015-06-01|July 2015|2015-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|MHMRS Qol||Quality of Life of Patients and Theirs Parents With Inherited Metabolic Diseases With Restricted Diet|Determinants of Health Status and Quality of Life of Patients and Their Parents With Inherited Metabolic Diseases Diagnosed During Childhood and Requiring Restrictive and Specific Diet|Recruiting||N/A|763|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 22:55:18.242869|2017-10-10 22:55:18.242869
NCT02552771|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-02-03|||January 2016||2016-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CAMRA||The Canadian Mitral Research Alliance (CAMRA) Trial CardioLink-2|A Randomized Trial of Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis: The Canadian Mitral Research Alliance (CAMRA-1) Trial|Recruiting||N/A|88|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-10-10 22:55:18.359562|2017-10-10 22:55:18.359562
NCT02552758|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-16|||May 2015||2015-05-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism|The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism|Unknown status|Recruiting|N/A|100|Anticipated|Shanghai Mental Health Center||2|||f||||f||||||||||2017-10-10 22:55:18.522242|2017-10-10 22:55:18.522242
NCT02552745|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-01-02|||October 2014||2014-10-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|||Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization|Sun Yat-sen University Cancer Center|Completed||N/A|200|Actual|Sun Yat-sen University|||2||f||||f||||||||||2017-10-10 22:55:18.627971|2017-10-10 22:55:18.627971
NCT02552732|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-08-08|||November 2015||2015-11-01|August 2016|2016-08-01||||March 2017|Anticipated|2017-03-01||Interventional|N3ADS||Nasal High Flow Therapy 30 Day Readmission Study|Nasal High Flow (NHF) Therapy Use Following Hospitalization for an Exacerbation of COPD: A Feasibility Study|Recruiting||N/A|100|Anticipated|Fisher and Paykel Healthcare||2|||f||||t||||||||||2017-10-10 22:55:18.720229|2017-10-10 22:55:18.720229
NCT02552706|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-12|2016-03-26|||September 2014||2014-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|||The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis|The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis Among Very Low Birth Weight Infants With Formula-feeding|Unknown status|Recruiting|N/A|270|Anticipated|Shenzhen Bao'an Maternal and Child Health Hospital||2|||f||||t||||||||||2017-10-10 22:55:18.940756|2017-10-10 22:55:18.940756
NCT02552693|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-01-12|||March 2015||2015-03-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|TracTOR||The TracTOR (Tracking and Tracing Operations Research) Study -- Zimbabwe|Enhancing Retention in Care for HIV-positive Mothers and Their Infants by Improving Facility Tracking and Community Health Worker Tracing in Zimbabwe|Completed||N/A|946|Actual|Elizabeth Glaser Pediatric AIDS Foundation||2|||f||||f||||||||Yes|Dataset has been shared with the USAID study sponsor who will make data available in 2018|2017-10-10 22:55:19.071894|2017-10-10 22:55:19.071894
NCT02552680|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-07-08|||October 2010||2010-10-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Preventive Program for Work-Related Musculoskeletal Disorders|Influence of a Preventive Program (Educational and Gymnastics) for Work-Related Musculoskeletal Disorders in Surgeons|Completed||N/A|54|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 22:55:19.152506|2017-10-10 22:55:19.152506
NCT02552667|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-16|||September 2014||2014-09-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy and Safety of HCP1102 Capsule|Efficacy and Safety of HCP1102 Capsule : A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Clinical Trial|Completed||Phase 3|228|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-10 22:55:19.229706|2017-10-10 22:55:19.229706
NCT02552654|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2016-09-30|||September 2015||2015-09-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Cortisol and the Formation of Intrusive Memories|Cortisol and the Formation of Intrusive Memories: An Experimental Approach With a Trauma Film Paradigm|Completed||N/A|60|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 22:55:19.305689|2017-10-10 22:55:19.305689
NCT02552641|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-16|||September 2015||2015-09-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|February 2016|Anticipated|2016-02-01||Interventional|||Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole|Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole|Unknown status|Recruiting|Phase 4|363|Anticipated|EMS||3|||f||||t||||||||||2017-10-10 22:55:19.37928|2017-10-10 22:55:19.37928
NCT02552628|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-09-30|||January 2016||2016-01-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|WILSTIM DBS||WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)|DEEP BRAIN STIMULATION FOR SEVERE DYSTONIA ASSOCIATED WITH WILSON'S DISEASE. A Prospective Multicenter Meta-analysis of Nof1 Trials|Recruiting||Phase 3|5|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:55:19.481072|2017-10-10 22:55:19.481072
NCT02552602|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-16|||May 2015||2015-05-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||The Role of Multivitamins in Pediatric HIV Management in Nigeria|The Role of Multivitamins in Pediatric HIV Management in Nigeria: A Randomized Controlled Study|Unknown status|Active, not recruiting|N/A|190|Actual|University of the West of Scotland||3|||f||||t||||||||||2017-10-10 22:55:19.676517|2017-10-10 22:55:19.676517
NCT02552589|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-02-05|||September 2015||2015-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Toothpaste on the Reduction of Plaque and Inflammation|Clinical Evaluation of the Effect of an Experimental Toothpaste on the Reduction of Dental Plaque and Gingival Inflammation|Completed||N/A|241|Actual|Technische Universität Dresden||2|||f||||t||||||||||2017-10-10 22:55:19.781743|2017-10-10 22:55:19.781743
NCT02552576|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-10-02|||October 5, 2015|Actual|2015-10-05|October 2017|2017-10-01|February 15, 2018|Anticipated|2018-02-15|February 15, 2018|Anticipated|2018-02-15||Interventional|||Study of Voncento® in Subjects With Von Willebrand Disease|An Open-label, Multi-centre Post-marketing Study to Assess the Efficacy and Safety of Voncento® in Subjects With Von Willebrand Disease|Recruiting||Phase 4|30|Anticipated|CSL Behring||1|||f||||f||||||||||2017-10-10 22:55:19.869969|2017-10-10 22:55:19.869969
NCT02552563|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-15|||February 2011||2011-02-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Engaging Caregivers in Dementia Care|Engaging Caregivers in the Care of Veterans With Dementia|Completed||N/A|75|Actual|Corporal Michael J. Crescenz VA Medical Center||2|||f||||f||||||||||2017-10-10 22:55:19.997514|2017-10-10 22:55:19.997514
NCT02552550|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-08-10|||July 2013||2013-07-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx|Analysis of Swallowing, Speech and Quality of Life of Patients With Stage T3-T4 Squamous Cell Carcinoma of the Oropharynx Before and After Multimodal Treatment With Curative Intent|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-10 22:55:20.092407|2017-10-10 22:55:20.092407
NCT02510326|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2016-07-23|||October 2015||2015-10-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Evaluation of Motion in the Arthritic Wrist Joint||Recruiting||N/A|10|Anticipated|Clalit Health Services|||1||f||||f||||||||||2017-10-10 23:05:21.682153|2017-10-10 23:05:21.682153
NCT02552537|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-05-10|||September 2015||2015-09-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|iFAAM-PPI||iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions|Integrated Approaches to Food Allergen and Allergy Risk Management: iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions|Completed||Phase 4|44|Actual|University of Zurich||2|||f||||t||||||||||2017-10-10 22:55:20.214266|2017-10-10 22:55:20.214266
NCT02552524|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-06-03|||December 2013||2013-12-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of rTMS in Pathological Gamblers|Study of the Effect of an Active rTMS Session in Pathological Gamblers: Impact on Craving and Severity of These Behaviors|Completed||N/A|22|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:55:20.336915|2017-10-10 22:55:20.336915
NCT02552511|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-12-15|||September 2015||2015-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Epidemiology Study on Neonatal Seizure|A Multi-Centre Epidemiology Study on Neonatal Seizure in China|Recruiting||N/A|1400|Anticipated|Children's Hospital of Fudan University|||1||f||||t||||||||||2017-10-10 22:55:20.427579|2017-10-10 22:55:20.427579
NCT02552498|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-10-03|||October 2015||2015-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|February 2016|Actual|2016-02-01||Interventional|||Post Occlusive Reactive Hyperemia on Gingiva Assessed by Laser Speckle Contrast Imaging||Completed||N/A|17|Actual|Semmelweis University||3|||f||||f||||||||||2017-10-10 22:55:20.674671|2017-10-10 22:55:20.674671
NCT02552485|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-12-30|||January 2015||2015-01-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions|Prospective, Monocentric Study for the Evaluation of Latent Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions Lost to Follow-up.|Completed||N/A|93|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 22:55:20.78024|2017-10-10 22:55:20.78024
NCT02552472|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-01-11|||August 2012||2012-08-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||A Study of Inhaler Use in the Community|Haphazard and Careless Use of Inhalers, an Observational Study|Completed||N/A|150|Actual|Beaumont Hospital|||1||f||||f||||||||||2017-10-10 22:55:20.888704|2017-10-10 22:55:20.888704
NCT02552459|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-10-16|||September 2015||2015-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery|Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery: A Randomized Controlled Study|Recruiting||Phase 4|120|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||4|||f||||t||||||||||2017-10-10 22:55:20.99021|2017-10-10 22:55:20.99021
NCT02552446|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-09-16|||April 2014||2014-04-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Energy Expenditure in ICU Patients Using Predictive Formulas and Various Body Weights Versus Indirect Calorimetry|Indirect Calorimetry an Essential Tool in the Intensive Care: Comparison of the Energy Expenditure Calculated With Different Body Weights Used in Several Predictive Equations and Indirect Calorimetry Measurements|Completed||N/A|87|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 22:55:21.119869|2017-10-10 22:55:21.119869
NCT02552433|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-10-28|||September 2015||2015-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|30 Days|Observational [Patient Registry]|CONTOUR||Complications in Body Contouring Surgery|Complications in Post-bariatric Body Contouring Surgery; Prevalence With hands-on Treatment Regimen|Recruiting||N/A|160|Anticipated|St. Antonius Hospital|||1||f||||f||||||Samples Without DNA|"     Bloodsamples, asessing:        -  albumin        -  hemoglobin        -  vitamin D (25-hydroxy vitamin D)        -  ferritin        -  folic acid        -  vitamin B12   "|||2017-10-10 22:55:21.215255|2017-10-10 22:55:21.215255
NCT02552420|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-09-15|||September 2007||2007-09-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2012|Actual|2012-07-01||Observational|||The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism|The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism|Completed||Phase 2/Phase 3|128|Actual|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||f||||||||||2017-10-10 22:55:21.315336|2017-10-10 22:55:21.315336
NCT02552407|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-10-04|||September 2015||2015-09-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis|Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis|Active, not recruiting||N/A|18000|Anticipated|Population Health Research Institute|||2||f||||f||||||||Undecided||2017-10-10 22:55:21.39073|2017-10-10 22:55:21.39073
NCT02552394|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-02-01|||July 2015|Actual|2015-07-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts|Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts|Recruiting||Phase 1|24|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-10 22:55:21.486212|2017-10-10 22:55:21.486212
NCT02552381|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-04-21|||August 2015||2015-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|FICT||Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH|Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH|Recruiting||N/A|300|Anticipated|Diagnostica Stago R&D|||3||f||||f||||||Samples Without DNA|"     Frozen citrated Poor Platelets Plasma   "|Undecided||2017-10-10 22:55:21.595343|2017-10-10 22:55:21.595343
NCT02552368|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2015-11-02|||August 2012||2012-08-01|November 2015|2015-11-01||||December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Chronic Stroke With IpsiHand|A Brain Computer Interface and Brain-Controlled Stroke Rehabilitation Method Utilizing Electroencephalography in Hemiparetic and Hemiplegic Stroke Patients to Achieve Thought Control of Machines and a Better Understanding of Brain Function|Recruiting||Phase 1/Phase 2|20|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-10 22:55:21.735978|2017-10-10 22:55:21.735978
NCT02552355|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-09-26|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin|Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin|Completed||Phase 2|101|Actual|Colorado State University||4|||f||||f||||||||||2017-10-10 22:55:21.870967|2017-10-10 22:55:21.870967
NCT02552342|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-16|2015-09-16|||May 2015||2015-05-01|September 2015|2015-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Corticosteroid Therapy for Severe Community-Acquired Pneumonia|Efficacy of Methylprednisolone in Severe Community-acquired Pneumonia，A Multi-center Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|610|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 22:55:22.001572|2017-10-10 22:55:22.001572
NCT02552329|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-07-27|||December 2013||2013-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|MCI-TaiChi||Effects of Tai Chi Exercise on Cognition and Serum Biomarkers of Individuals With MCI|A Randomized Controlled Trial of Mind-body Exercise: Effects of a 6-month Tai Chi Exercise on Cognition and Serum Biomarkers of Individuals With Mild Cognitive Impairment (MCI)|Completed||N/A|66|Actual|Chiang Mai University||2|||f||||f||||||||No||2017-10-10 22:55:22.140334|2017-10-10 22:55:22.140334
NCT02552316|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-11-10|||December 2014||2014-12-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Psoriasis Microbiome and Phototherapy|The Cutaneous Microbiota of Psoriasis: Lesional Variation and a Phase IV, Interventional Study of Its Response to Phototherapy|Completed||Phase 4|34|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 22:55:22.28547|2017-10-10 22:55:22.28547
NCT02552303|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-06-30|2016-12-21||April 2014||2014-04-01|June 2017|2017-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia|The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia|Completed||N/A|39|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-10 22:55:22.394567|2017-10-10 22:55:22.394567
NCT02552290|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-16|||November 2013||2013-11-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Immediate Effects Cervicothoracic Manipulation Versus Passive Upper Trapezius Stretch|Effects of Cervicothoracic Manipulation and Passive Stretching to the Upper Trapezius Muscle on Pressure Pain Thresholds and Cervical Range of Motion on Healthy Individuals|Completed||N/A|90|Actual|University of Nevada, Las Vegas||3|||f||||f||||||||||2017-10-10 22:55:22.830757|2017-10-10 22:55:22.830757
NCT02552277|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-05-23|||October 27, 2015|Actual|2015-10-27|May 2017|2017-05-01|November 6, 2017|Anticipated|2017-11-06|March 7, 2017|Actual|2017-03-07||Interventional|||A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy|A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Range Finding Study to Access the Efficacy and Safety of Intramuscular Injection of Human Placenta- Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy.|Active, not recruiting||Phase 2|26|Actual|Celgene||3|||f||||t||||||||||2017-10-10 22:55:22.945902|2017-10-10 22:55:22.945902
NCT02552264|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-04-14|||November 2015||2015-11-01|April 2016|2016-04-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Testing a Training Program to Enhance Emotional Management Skills and Professional Resiliency in Healthcare Providers|Implementing and Evaluating an Empirically Supported Training Program to Enhance Emotional Management Skills and Professional Resiliency in Healthcare Providers|Recruiting||N/A|240|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-10 22:55:23.073512|2017-10-10 22:55:23.073512
NCT02552251|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-09-15|||August 2012||2012-08-01|September 2015|2015-09-01||||December 2015|Anticipated|2015-12-01||Interventional|COCA||COrticosteroid in Congenital Adrenal Hyperplasia|Comparative Study of the Use of Glucocorticoids in the Treatment of Congenital Adrenal Hyperplasia in Its Classical Form|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|University Hospital, Caen||3|||f||||f||||||||||2017-10-10 22:55:23.184709|2017-10-10 22:55:23.184709
NCT02552238|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-04-27|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|April 14, 2017|Actual|2017-04-14||Interventional|||Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142|A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease|Active, not recruiting||Phase 3|174|Actual|Bracco Diagnostics, Inc||1|||f||||f||||||||No||2017-10-10 22:55:23.29979|2017-10-10 22:55:23.29979
NCT02552225|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-10-07|||April 2016||2016-04-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Treatment of Chronic Laryngitis With Amitriptyline|Double-blind Placebo Controlled Trial of the Treatment of Chronic Laryngitis With Amitriptyline|Recruiting||Phase 2/Phase 3|80|Anticipated|Boston Medical Center||2|||f||||t||||||||Yes||2017-10-10 22:55:23.41073|2017-10-10 22:55:23.41073
NCT02552212|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-09-27|||September 2015||2015-09-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|May 2018|Anticipated|2018-05-01||Interventional|C-axSpAnd||Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS|Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate Efficacy and Safety of Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis (axSpA) Without X-ray Evidence of Ankylosing Spondylitis (AS) and Objective Signs of Inflammation|Active, not recruiting||Phase 3|317|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-10 22:55:23.547587|2017-10-10 22:55:23.547587
NCT02552199|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-10-23|||September 2015||2015-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||A Non-Interventional Study To Assess Sweating|A Non-Interventional Study To Assess Sweating, As Measured By Gravimetry, In Subjects With Primary Hyperhidrosis And In Healthy Individuals|Completed||N/A|28|Actual|Brickell Biotech, Inc.|||2||f||||f||||||||||2017-10-10 22:55:23.888898|2017-10-10 22:55:23.888898
NCT02552186|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-12-01|||September 2015||2015-09-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Non-invasive Clinical Pectus Index as a Measurement of Severity in Pectus|Non-invasive Clinical Pectus Index as a Measurement of Severity in Pectus|Recruiting||N/A|230|Anticipated|Johns Hopkins All Children's Hospital||2|||f||||f||||||||||2017-10-10 22:55:23.965808|2017-10-10 22:55:23.965808
NCT02552173|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-03-28|||October 2015||2015-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||The Relationship Between Operative and Radiologic Stem Version|The Relationship Between Operative and Radiologic Stem Version : Which Factors Influence Resultant Stem Version in Primary Total Hip Arthroplasty|Completed||N/A|40|Actual|Seoul National University Bundang Hospital|||1||f||||t||||||||||2017-10-10 22:55:24.065524|2017-10-10 22:55:24.065524
NCT02552147|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-10-03|||September 2015||2015-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism|Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism|Recruiting||Phase 1|16|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 22:55:24.834532|2017-10-10 22:55:24.834532
NCT02552134|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-10-23|||October 2016||2016-10-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|SRS||Standardised Regional Sport-club Based Exercise Programmes|HEPA Steiermark: Standardised Regional Sport-club Based Exercise Programmes|Recruiting||N/A|194|Anticipated|Sportunion Österreich||4|||f||||f||||||||||2017-10-10 22:55:24.982548|2017-10-10 22:55:24.982548
NCT02552121|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-08-18|||October 2015||2015-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors|Dose-escalating and Cohort Expansion Safety Trial of Tissue Factor Specific Antibody Drug Conjugate Tisotumab Vedotin (HuMax®-TF-ADC) in Patients With Locally Advanced and/or Metastatic Solid Tumors Known to Express Tissue Factor|Active, not recruiting||Phase 1/Phase 2|44|Anticipated|Genmab||1|||f||||t||||||||||2017-10-10 22:55:25.105495|2017-10-10 22:55:25.105495
NCT02552108|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-05-11|||October 2015||2015-10-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Single-Component CBT for GAD|Behavioural Experiments for Intolerance of Uncertainty: A Single-Component Treatment for Generalized Anxiety Disorder|Recruiting||N/A|50|Anticipated|Universite du Quebec en Outaouais||2|||f||||f||||||||||2017-10-10 22:55:25.261729|2017-10-10 22:55:25.261729
NCT02552095|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-07|||June 2013||2013-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Triathlon PKR Study in Japan|A Prospective, Single Arm, Multi Center Study on the Compatibility of Triathlon PKR and the Motion Analysis for Japanese|Active, not recruiting||N/A|63|Actual|Stryker Japan K.K.||1|||f||||f||||||||||2017-10-10 22:55:25.373923|2017-10-10 22:55:25.373923
NCT02552082|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-07|||June 2015||2015-06-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Scorpio Non Restricted Geometry (NRG) Study in Japan|The Verification Study on the Effectiveness of Rotational Tolerance of Scorpio NRG Study in TKA|Recruiting||N/A|300|Anticipated|Stryker Japan K.K.||1|||f||||f||||||||No||2017-10-10 22:55:25.477756|2017-10-10 22:55:25.477756
NCT02552069|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-07|||June 2015||2015-06-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Tritanium® Study in Japan|The Verification Study on the Early Fixation/ Stability of Tritanium Cup|Recruiting||N/A|50|Anticipated|Stryker Japan K.K.||1|||f||||f||||||||||2017-10-10 22:55:25.571513|2017-10-10 22:55:25.571513
NCT02552056|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-05-12|||October 2015||2015-10-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of Integrating CAMH Into PHC and Traditional Healers' Practice in Uganda: a Randomized Controlled Trial|The Effect of Integrating Child and Adolescent Mental Health Into Primary Health Care and Traditional Healers' Practice: a Randomized Controlled Trial in Eastern Uganda|Completed||N/A|36|Actual|University of Bergen||2|||f||||f||||||||||2017-10-10 22:55:25.674178|2017-10-10 22:55:25.674178
NCT02552043|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-08-20|||July 2015||2015-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Video Game Exercise Effectiveness of a Domiciliary Pulmonary Rehabilitation Program in Cystic Fibrosis Patients|Video Game Exercise Effectiveness of a Domiciliary Pulmonary Rehabilitation Program in Cystic Fibrosis Patients|Completed||N/A|41|Actual|Universidad Autonoma de Madrid||2|||f||||t||||||||||2017-10-10 22:55:25.759595|2017-10-10 22:55:25.759595
NCT02552030|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-02-13|||October 1, 2015|Actual|2015-10-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|April 25, 2016|Actual|2016-04-25||Interventional|iPARR||iPhone App Compared to Standard RR-measurement|iPhone App Compared to Standard RR-measurement - iPARR Trial|Completed||N/A|1019|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||No||2017-10-10 22:55:25.861251|2017-10-10 22:55:25.861251
NCT02552017|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-15|||November 2014||2014-11-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|ADENOMA||Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities|Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities|Unknown status|Recruiting|N/A|1772|Anticipated|South Tyneside NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 22:55:25.961199|2017-10-10 22:55:25.961199
NCT02552004|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-08-31|||October 2015||2015-10-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|Pilot pCLE||Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study|Assessment of the Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery - a Pilot Study|Recruiting||N/A|30|Anticipated|IHU Strasbourg||1|||f||||f||||||||||2017-10-10 22:55:26.107706|2017-10-10 22:55:26.107706
NCT02551991|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-09-29|||September 2015||2015-09-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|October 31, 2018|Anticipated|2018-10-31||Interventional|||Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma|A Randomized, Open-label Phase 2 Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-Paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 2|168|Anticipated|Ipsen||3|||f||||t||||||||||2017-10-10 22:55:26.214059|2017-10-10 22:55:26.214059
NCT02551978|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-11-26|||September 2015||2015-09-01|September 2015|2015-09-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|KOP||Kids Obesity Prevention Program - Study (KOP)|Kids Obesity Prevention Program - Study (KOP). A Serious Game to Address Barriers to Prevention and Treatment of Obesity in Primary School Children|Completed||N/A|60|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 22:55:26.329733|2017-10-10 22:55:26.329733
NCT02551965|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-04-07|||January 2016||2016-01-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|TANGO||Nursing Follow up in Geriatric Oncology : Tracking Time of Caregiver Exhaustion Risk|Nursing Follow up in Geriatric Oncology : Tracking Time of Caregiver Exhaustion Risk|Recruiting||N/A|200|Anticipated|University Hospital, Strasbourg, France||1|||f||||t||||||||||2017-10-10 22:55:26.40292|2017-10-10 22:55:26.40292
NCT02551952|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-15|||November 2015||2015-11-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Interventional|MentalPlus®||Digital Game: A Scale to Evaluate the Perioperative Cognitive Function|Digital Game MentalPlus®: A Scale to Evaluate on Perioperative Cognitive Function: Content Analysis, Internal Consistency, Convergent Validity and Clinical Validation of the Diagnostic Test|Not yet recruiting||N/A|100|Anticipated|University of Sao Paulo||4|||f||||t||||||||||2017-10-10 22:55:26.489636|2017-10-10 22:55:26.489636
NCT02551939|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2015-09-15|||October 2013||2013-10-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Breast Fat Grafting Augmentation in Chinese Women|Magnetic Resonance Imaging and Breast-Q Evaluation After Breast Autologous Fat Grafting Augmentation in Chinese Women|Completed||N/A|38|Actual|Nanjing Medical University||1|||f||||t||||||||||2017-10-10 22:55:26.614997|2017-10-10 22:55:26.614997
NCT02551926|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-15|||August 2015||2015-08-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Health Education Using Text Messaging Prevents Hypertension in High Risk People|Health Education Using Text Messaging Prevents Hypertension in High Risk People: a Comparison Between Effectiveness of Electronic Text Messaging and Printed Material|Unknown status|Recruiting|N/A|600|Anticipated|Qazvin University Of Medical Sciences||4|||f||||||||||||||2017-10-10 22:55:26.6746|2017-10-10 22:55:26.6746
NCT02551913|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-15|||September 2015||2015-09-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||A Theory-based Sleep Intervention in Improving Sleep Quality in Adolescents|Effectiveness of Theory-based Sleep Hygiene Intervention in Improving Sleep Quality in Adolescents: a Cluster Randomized Controlled Trial|Unknown status|Recruiting|N/A|2715|Anticipated|Qazvin University Of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:55:26.763414|2017-10-10 22:55:26.763414
NCT02551900|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-15|||September 2015||2015-09-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Comparison of the Effect of Warm and Cold Water Exercise Training on Vascular Function in Type 2 Diabetic Patients|A Comparison of the Effect of Warm and Cold Water Exercise Training on Vascular Function in Type 2 Diabetic Patients|Unknown status|Enrolling by invitation|N/A|48|Anticipated|Chulalongkorn University||2|||f||||||||||||||2017-10-10 22:55:26.847573|2017-10-10 22:55:26.847573
NCT02551887|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-02-09|2015-09-23||February 2014||2014-02-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional||These were eligible patients males and females 11-14 years of age with no prior HPV vaccine doses administered. Additionally, they also had to be eligible for Tdap and/or MCV4 vaccination at the visit.|HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts|HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts|Completed||N/A|647|Actual|Regenstrief Institute, Inc.||3|||f||||f||||||||No||2017-10-10 22:55:26.949337|2017-10-10 22:55:26.949337
NCT02551874|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-09-06|||October 20, 2015|Actual|2015-10-20|September 2017|2017-09-01|November 16, 2017|Anticipated|2017-11-16|May 8, 2017|Actual|2017-05-08||Interventional|||A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin|A 24-week International, Multicenter, Randomized, Open-Label, Active-Controlled, Parallel Group, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin With or Without Sulfonylurea Therapy|Active, not recruiting||Phase 3|650|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:55:27.377939|2017-10-10 22:55:27.377939
NCT02551861|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-01-14|||December 2015||2015-12-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3|A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-Cirrhotic Subjects Infected With Chronic HCV Genotype 3|Withdrawn||Phase 2|0|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 22:55:27.561231|2017-10-10 22:55:27.561231
NCT02551848|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-10-31|||August 2014||2014-08-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Botulinum Toxin Type A for Injection of Bilateral Upper Extremity Tremor in Patients With Essential Tremor Using Kinematic Assessment|Botulinum Toxin Type A for Injection of Bilateral Upper Extremity Tremor in Patients With Essential Tremor Using Kinematic Assessment|Recruiting||Phase 2|25|Anticipated|Western University, Canada||1|||f||||f||||||||||2017-10-10 22:55:27.692285|2017-10-10 22:55:27.692285
NCT02551835|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-03-01|||April 2015||2015-04-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Vitamin D Supplements on Markers for Cardiovascular Disease and Diabetes: an Individual Participant Data Meta-analysis|The Effect of Vitamin D Supplementation on Markers for Cardiovascular Disease and Diabetes: an Individual Participant Data Meta-analysis of Randomized Controlled Trials|Active, not recruiting||N/A|2945|Actual|VU University Medical Center|||12||f||||f||||||||||2017-10-10 22:55:27.791731|2017-10-10 22:55:27.791731
NCT02551809|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-07-24|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients|A Randomized, Double-blind, Placebo-controlled, 3-arm Parallel-group, Multicenter, Phase IIa Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UBITh® AD Immunotherapeutic Vaccine (UB-311) in Patients With Mild Alzheimer's Disease|Active, not recruiting||Phase 2|43|Actual|United Neuroscience Ltd.||3|||f||||||||||||||2017-10-10 22:55:27.948531|2017-10-10 22:55:27.948531
NCT02551796|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2016-06-13|||September 2015||2015-09-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Early Changes Among FLEx, LASIK and FS-LASIK|Comparison of Early Changes in Ocular Surface and Inflammatory Mediators Among Lenticule Extraction, Laser in Situ Keratomileusis and Femtosecond Laser-assisted Laser in Situ Keratomileusis|Completed||N/A|75|Actual|Sun Yat-sen University||3|||f||||f||||||||||2017-10-10 22:55:29.765286|2017-10-10 22:55:29.765286
NCT02551783|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-09-15|||September 2015||2015-09-01|September 2015|2015-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|DoVeBuG||Dorsal vs. Ventral Buccal Graft Dorsal vs. Ventral Buccal Graft|A Randomized Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty|Not yet recruiting||Phase 3|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:55:29.901509|2017-10-10 22:55:29.901509
NCT02551770|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-12-21|||October 2015||2015-10-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Emdogain Minimally Invasive Surgical Technique|Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study|Recruiting||N/A|50|Anticipated|Institut Straumann AG||2|||f||||f||||||||No||2017-10-10 22:55:30.003199|2017-10-10 22:55:30.003199
NCT02551757|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-15|||June 2013||2013-06-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|November 2014|Actual|2014-11-01||Interventional|SCOUTS||Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients|Randomized Trial of Continuous Positive Airway Pressure in Patients Undergoing Intensive Inpatient Rehabilitation After Acute Stroke|Completed||Phase 1/Phase 2|40|Actual|University of Washington||2|||f||||f||||||||||2017-10-10 22:55:30.095795|2017-10-10 22:55:30.095795
NCT02551744|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-09-28|||July 2012||2012-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers|Pantoprazole Versus Famotidine for the Prevention of Recurrent Peptic Ulcers in Thienopyridine Users — a Double-blind Randomized Controlled Trial|Recruiting||N/A|334|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-10 22:55:30.162942|2017-10-10 22:55:30.162942
NCT02551731|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-10-04|||January 2016|Actual|2016-01-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms|A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms|Active, not recruiting||Phase 2|9|Actual|INSYS Therapeutics Inc||1|||f||||f|t|f||||||||2017-10-10 22:55:30.258292|2017-10-10 22:55:30.258292
NCT02551718|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-07-14|||September 11, 2015|Actual|2015-09-11|July 2017|2017-07-01||||July 1, 2019|Anticipated|2019-07-01||Interventional|||High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia|Individualized Treatment for Relapsed/Refractory Acute Leukemia Based on Chemosensitivity and Genomics/Gene Expression Data|Recruiting||N/A|25|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 22:55:30.331902|2017-10-10 22:55:30.331902
NCT02551705|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-14|||October 2015||2015-10-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|FISCIP||Functional Imaging of Social Cognition in Premanifest Huntington's Disease|Functional Imaging of Social Cognition in Premanifest Huntington's Disease|Unknown status|Not yet recruiting|N/A|40|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 22:55:30.422209|2017-10-10 22:55:30.422209
NCT02551692|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-06-01|||January 2016||2016-01-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)|Effects of Smoking Environments on Craving and Smoking|Recruiting||N/A|120|Anticipated|Duke University||3|||f||||f||||||||||2017-10-10 22:55:30.592208|2017-10-10 22:55:30.592208
NCT02551679|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-14|||August 2014||2014-08-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|ACP-CLI||Blood Derived Autologous Angiogenic Cell Precursor Therapy in Patients With Critical Limb Ischemia (ACP-CLI)|A Randomized Double Blind Placebo Controlled Clinical Study to Assess Blood-Derived Autologous Angiogenic Cell Precursor Therapy in Patients With Critical Limb Ischemia (ACP-CLI)|Unknown status|Recruiting|Phase 2|95|Anticipated|Hemostemix||2|||f||||t||||||||||2017-10-10 22:55:30.681632|2017-10-10 22:55:30.681632
NCT02551666|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-09-15|||September 2015||2015-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Balance Recovery Training for Fall Prevention in Retirement Communities|Balance Recovery Training for Fall Prevention in Retirement Communities|Unknown status|Not yet recruiting|N/A|60|Anticipated|Texas A&M University||2|||f||||||||||||||2017-10-10 22:55:30.779592|2017-10-10 22:55:30.779592
NCT02551653|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-09-14|||November 17, 2015|Actual|2015-11-17|September 2017|2017-09-01|March 14, 2017|Actual|2017-03-14|March 14, 2017|Actual|2017-03-14||Interventional|||Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients|A Microdose Study to Evaluate the Biodistribution of [11C]-GSK2256098 in the Lungs and Heart of Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients Using Positron Emission Tomography (PET)|Completed||Phase 1|10|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:55:30.858116|2017-10-10 22:55:30.858116
NCT02551640|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-02-27|||September 2015||2015-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients|Improving Physical Activity Behavior in Patients With High Cardio-metabolic Risk Using a Multi-modal mHealth Intervention: a 2-arm Randomized Controlled Trial|Enrolling by invitation||N/A|300|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:55:30.941279|2017-10-10 22:55:30.941279
NCT02551627|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-04-21|||June 2016||2016-06-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Investigate the Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children|Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children (7-10yrs; Inclusive) in Bangladesh: a Randomised, Double Blind Controlled Trial|Not yet recruiting||N/A|396|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:55:31.036495|2017-10-10 22:55:31.036495
NCT02108483|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-07-16|||April 2014||2014-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phototoxicity Test of Dapsone Gel in Healthy Volunteers||Completed||Phase 1|33|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:34:36.934261|2017-10-11 00:34:36.934261
NCT02551614|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-05-12|||March 17, 2015|Actual|2015-03-17|May 2017|2017-05-01|May 24, 2016|Actual|2016-05-24|May 24, 2016|Actual|2016-05-24||Interventional|||Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease|Measurement of Neutrophil Retention in the Lung in Vivo, Using Autologous Labelled Neutrophils, in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|46|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:55:31.118553|2017-10-10 22:55:31.118553
NCT02551601|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-02-28|||August 2015||2015-08-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Subfoveal Choroidal Thickness in Thai Population|Subfoveal Choroidal Thickness in Thai Population|Recruiting||N/A|300|Anticipated|Khon Kaen University|||1||f||||t||||||||No||2017-10-10 22:55:31.22591|2017-10-10 22:55:31.22591
NCT02551588|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-01-22|||December 2012||2012-12-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|RACINE||Valvular Aortic Stenosis: Study of Myocardiac Fibrosis by Magnetic Resonance Imagery|Calcified Aortic Valve Stenosis (AVS). Markers of Fibrosis Using Cardiac Magnetic Resonance|Completed||N/A|70|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||t||||||Samples Without DNA|"     Plasma and serum   "|||2017-10-10 22:55:31.318897|2017-10-10 22:55:31.318897
NCT02551575|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-06-17|||November 2014||2014-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of Traditional Chinese Medicine (TCM) Comprehensive Therapy in Patients With Rheumatoid Arthritis|Efficacy and Safety of Qingre Huoxue Comprehensive Therapy in the Treatment of Rheumatoid Arthritis (RA): A Randomized, Double-blind, Double-dummy, Multi-center Trial|Active, not recruiting||Phase 2/Phase 3|468|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||3|||f||||t||||||||||2017-10-10 22:55:31.399883|2017-10-10 22:55:31.399883
NCT02551562|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-03-29|||October 2015||2015-10-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||A Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments|A Post-market, Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments|Recruiting||N/A|20|Anticipated|DeNova Research||2|||f||||f||||||||||2017-10-10 22:55:31.495063|2017-10-10 22:55:31.495063
NCT02551549|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-06-22|||September 2015||2015-09-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Multiple-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of CD101 Injection in Healthy Subjects|Completed||Phase 1|24|Actual|Cidara Therapeutics Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:55:31.58041|2017-10-10 22:55:31.58041
NCT02551536|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-09-15|||April 2014||2014-04-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis|Comparison of Efficacy, Safety and Cost Effectiveness of Montelukast and Levocetirizine Versus Montelukast and Fexofenadine in Patients of Allergic Rhinitis: a Randomized, Double-blind Clinical Trial|Completed||Phase 4|70|Actual|Indira Gandhi Medical College||2|||f||||t||||||||||2017-10-10 22:55:31.673307|2017-10-10 22:55:31.673307
NCT02551510|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-09-26|||August 2015||2015-08-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|PWC||Comparison of Skin Adhesive to Subcuticular Suture Wound Closure After Port Placement|Open, Randomized, Controlled Non-inferiority Trial to Compare Synthetic Tissue Adhesive and Skin Suture After Port Catheter Implantation With Reference to Cosmetic Result and Economy of Time at Equal Risk for Wound Infection|Recruiting||Phase 4|158|Anticipated|Jena University Hospital||2|||f||||f||||||||||2017-10-10 22:55:31.834951|2017-10-10 22:55:31.834951
NCT02551484|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-09-14||||||November 2012|2012-11-01||||January 2016|Anticipated|2016-01-01||Interventional|NIRS||Contribution of Near-InfraRed Spectroscopy (NIRS) to the Evaluation of Healing After Amputation of the Leg|Contribution of Near-InfraRed Spectroscopy (NIRS) to the Evaluation of Microcirculation Following Trans-tibial Amputation for Peripheral Artery Disease|Unknown status|Recruiting|N/A|||Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:55:32.017963|2017-10-10 22:55:32.017963
NCT02551471|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-25|||May 1, 2015|Actual|2015-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|PELVICARE||Benchmarking Trial Between France and Australia Comparing Management of Primary Rectal Cancer Beyond TME (Total Mesorectum Excision) and Locally Recurrent Rectal Cancer||Active, not recruiting||N/A|240|Anticipated|University Hospital, Bordeaux|||2||f||||f||||||||||2017-10-10 22:55:32.104553|2017-10-10 22:55:32.104553
NCT02551458|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-09-14||||||March 2015|2015-03-01||||March 2023|Anticipated|2023-03-01||Interventional|Esostrate||Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy|SYSTEMATIC SURGERY VERSUS SURVEILLANCE AND RESCUE SURGERY IN OPERABLE CANCER OF THE OESOPHAGUS WITH A COMPLETE CLINICAL RESPONSE TO RADIOCHEMOTHERAPY|Recruiting||Phase 2/Phase 3|||Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 22:55:32.254003|2017-10-10 22:55:32.254003
NCT02452450|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-05-22|||January 2014||2014-01-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Ibuprofen and Paracetamol Pharmacokinetic Study||Completed||Phase 1|43|Actual|Reckitt Benckiser Healthcare (UK) Limited||5|||f||||f||||||||||2017-10-10 23:16:43.195731|2017-10-10 23:16:43.195731
NCT02551445|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-15|||September 2011||2011-09-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2011|Actual|2011-09-01||Interventional|ET4AN||A fMRI Pilot Study of the Effects of Meal-support in Eating Disorders.|A fMRI Pilot Study of the Effects of Cognitive Behavioural Therapy (Meal-support) in Eating Disorders.|Completed||N/A|37|Actual|King's College London||1|||f||||f||||||||||2017-10-10 22:55:32.554493|2017-10-10 22:55:32.554493
NCT02551432|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-10|||September 2015||2015-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MISP-MK3475||Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer|Phase II Study of Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer|Active, not recruiting||Phase 2|26|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 22:55:32.6572|2017-10-10 22:55:32.6572
NCT02551419|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-03-27|||June 2015||2015-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|BENEFIC||Proof of Mechanism of a New Ketogenic Supplement Using Dual Tracer PET (Positron Emission Tomography)|Effect of a Ketogenic Supplement on Brain Energy Metabolism Measured by Neuroimaging in Mild Cognitive Impairment|Recruiting||N/A|50|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-10 22:55:32.750629|2017-10-10 22:55:32.750629
NCT02551406|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-02-25|||September 2015||2015-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|TcCO2-VAD||Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients|Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients|Completed||N/A|55|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-10 22:55:32.881542|2017-10-10 22:55:32.881542
NCT02551393|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-14|||January 2016||2016-01-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Enhance Drug Compliance in Response to Home Blood Pressure(BP) Monitoring in Older People|Enhance Drug Compliance in Response to Home Blood Pressure(BP) Monitoring in Older People With Uncontrolled Hypertension: a Randomized Controlled Trial|Not yet recruiting||N/A|270|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:55:32.969086|2017-10-10 22:55:32.969086
NCT02551380|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-04-06|||October 2015||2015-10-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|EFFET||Folinic Acid in Children With Autism Spectrum Disorders|"Evaluation of the Efficiency of Folinic Acid in Children With Autism Spectrum Disorders: a Pilot Study EFFET"|Recruiting||Phase 2|40|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||Undecided|To be completed after discussions with the different research teams participating in the study|2017-10-10 22:55:33.078332|2017-10-10 22:55:33.078332
NCT02551367|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2015-09-15|||October 2015||2015-10-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|LVCCFOROI||Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )|Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome|Unknown status|Not yet recruiting|Phase 2|110|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 22:55:33.216634|2017-10-10 22:55:33.216634
NCT02551354|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-15|||November 2012||2012-11-01|September 2015|2015-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|PERIDANS||Estimation of Pain During Epidural Analgesia During Labor|Estimation of Pain During Epidural Analgesia During Labor - a Monocentric Study|Completed||N/A|40|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 22:55:33.355934|2017-10-10 22:55:33.355934
NCT02551341|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-02-10|||September 2015||2015-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Lung Protective Ventilation During Robotic Assisted Prostatectomy|Randomized Study To Study the Effect of Lung Protective Ventilation (PEEP) Compared With Normal Ventilation (ZEEP) on Lung Function, Kidney Treatment of Sodium and Water, Vasoactive Hormones, Biomarkers of Nephrotoxicity and Haemodynamics in Patients Undergoing Robot-assisted Radical Prostatectomy|Completed||Phase 3|24|Anticipated|Aarhus University Hospital||2|||f||||t||||||||||2017-10-10 22:55:33.468023|2017-10-10 22:55:33.468023
NCT02551328|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-15|||June 2015||2015-06-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Observational|MINI-SEVO||Preconditioning With Sevoflurane and Propofol in Patients Undergoing Minimally Invasive Mitral Valve Surgery|A Single-center Observational Study Investigating the Effect of Volatile Conditioning (VC) With Sevoflurane on Myocardial Biomarkers and Platelets Function in Patients Having Minimally Invasive Mitral Valve Surgery (MIMV)|Unknown status|Recruiting|N/A|48|Anticipated|Fondazione Toscana Gabriele Monasterio|||2||f||||f||||||||||2017-10-10 22:55:33.557907|2017-10-10 22:55:33.557907
NCT02551315|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-06-16|||June 2016||2016-06-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|DiabOS||Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes|Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes: the DiabOS Study|Recruiting||N/A|440|Anticipated|University Hospital, Basel, Switzerland|||4||f||||t||||||Samples Without DNA|"     Bone trunover markers, parameters re calcium metabolism, HbA1c, Insulin, pentosidine, markers     of inflammation   "|||2017-10-10 22:55:33.65218|2017-10-10 22:55:33.65218
NCT02551302|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2015-09-15|||October 2015||2015-10-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BalanC||"Efficacy of Hybrid Systems (Topping Off) Versus Rigid Spinal Fusion in Lumbar Fusion Surgery: A Dual-center, Prospective, Randomized Pilot Study (CD Horizon BalanC)"||Not yet recruiting||N/A|60|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-10 22:55:33.778892|2017-10-10 22:55:33.778892
NCT02551289|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-05-18|||January 2016||2016-01-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|MARCO||MAgnetic Resonance Imaging in COeliac Disease|MRI Assessment in Newly Diagnosed Coeliac Disease and Following Gluten-free Diet Treatment|Recruiting||N/A|72|Anticipated|University of Nottingham|||2||f||||f||||||Samples Without DNA|"     Stool sample   "|||2017-10-10 22:55:33.863529|2017-10-10 22:55:33.863529
NCT02551276|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-12|2016-03-14|||November 2013||2013-11-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2014|Actual|2014-11-01||Interventional|||Chronic Beta2-adrenergic Stimulation and Cardiac and Skeletal Muscle Hypertrophy|Role of 11 Weeks of Beta2-adrenergic Signaling and Resistance Training for Cardiac and Skeletal Muscle Hypertrophy in Men|Completed||N/A|42|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 22:55:34.0149|2017-10-10 22:55:34.0149
NCT01946386|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-07-17|||September 2013||2013-09-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Vasoconstriction Study With LEO 90100||Completed||Phase 1|35|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-11 01:17:08.846794|2017-10-11 01:17:08.846794
NCT02551263|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2016-07-14|||July 2015||2015-07-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|E-SPEC||Eribulin Treatment as 1st-line or 2nd-line Chemotherapy for HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast Cancer|Prospective Observational Study to Explore the Efficacy of Eribulin as 1st-line or 2nd-line Chemotherapy in Patients With HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast Cancer|Recruiting||N/A|120|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||f||||||||||2017-10-10 22:55:34.104296|2017-10-10 22:55:34.104296
NCT02551250|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-15|2017-06-17|||September 2015||2015-09-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01|3 Years|Observational [Patient Registry]|MAGNUS-HCC||Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis|Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging as a Surveillance Test for Hepatocellular Carcinoma in Patients With Liver Cirrhosis|Recruiting||N/A|211|Anticipated|Seoul St. Mary's Hospital|||1||f||||f||||||||Undecided||2017-10-10 22:55:34.235092|2017-10-10 22:55:34.235092
NCT02551237|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-03-17|||December 2015||2015-12-01|March 2016|2016-03-01|March 2030|Anticipated|2030-03-01|March 2020|Anticipated|2020-03-01||Interventional|NACRE||Neoadjuvant Treatment for Advanced Rectal Carcinoma|A Phase III Study Evaluating Two Neoadjuvant Treatments Radiochemotherapy (5 Weeks - 50Gy+Capecitabine) and Radiotherapy (1week - 25Gy) in Patient Over 75 With Locally Advanced Rectal Carcinoma|Recruiting||Phase 3|420|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-10 22:55:34.383392|2017-10-10 22:55:34.383392
NCT02551211|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-12-06|||December 2016||2016-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|LYMPHOLUNG||Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer|Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer|Not yet recruiting||N/A|58|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 22:55:34.873232|2017-10-10 22:55:34.873232
NCT02551198|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-11-25|||November 2015||2015-11-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation|Comparative Evaluation the Efficacy of 2L Polyethylene Glycol With Ascorbic Acid (PEG-Asc) and Oral Sulfate Solution (OSS) in Split Method for Bowel Preparation (The Phase III Prospective Randomized Clinical Trial)|Recruiting||Phase 3|184|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-10 22:55:34.983278|2017-10-10 22:55:34.983278
NCT02551185|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-09-28|||December 22, 2015|Actual|2015-12-22|September 2017|2017-09-01|March 8, 2018|Anticipated|2018-03-08|March 8, 2018|Anticipated|2018-03-08||Interventional|||ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors|A Phase 1b Study of the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors|Recruiting||Phase 1|41|Anticipated|Celgene||1|||f||||||||||||||2017-10-10 22:55:35.105107|2017-10-10 22:55:35.105107
NCT02551172|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-15|||October 2014||2014-10-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD|An Efficacy and Safety Study of HCP1105 Capsule in Combined Hyperlipidemic Patients With High Risk for Coronary Heart Disease (CHD): A Randomized,Double-blind, Multicenter, Phase 3 Study|Unknown status|Recruiting|Phase 3|270|Anticipated|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-10 22:55:35.231196|2017-10-10 22:55:35.231196
NCT02551159|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-18|||October 15, 2015|Actual|2015-10-15|August 2017|2017-08-01|October 2, 2018|Anticipated|2018-10-02|March 1, 2018|Anticipated|2018-03-01||Interventional|KESTREL||Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer|A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 Alone or in Combination With Tremelimumab Versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squamous Cell Head and Neck Cancer Patients|Active, not recruiting||Phase 3|823|Actual|AstraZeneca||3|||f||||t|t|f||||||||2017-10-10 22:55:35.51633|2017-10-10 22:55:35.51633
NCT02551146|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-10-05|||September 7, 2015|Actual|2015-09-07|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GC||Influence of Implants and Locators for Improved Retention|Influence of Implants and Locators for Improved Retention of Mandibular Full Dentures on Patient's Quality of Life and Oral Function. A Controlled, Randomized and Prospective Study|Recruiting||N/A|52|Anticipated|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-10-10 22:55:36.29954|2017-10-10 22:55:36.29954
NCT02551133|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-15|||November 2014||2014-11-01|September 2015|2015-09-01||||November 2015|Anticipated|2015-11-01||Interventional|||Comparison of Dexamethasone Doses on Persistent Postmastectomy Pain|Comparison of the Two Different Doses of Dexamethasone on Persistent Mastectomy Pain|Unknown status|Active, not recruiting|Phase 4|144|Anticipated|Mustafa Kemal University||2|||f||||f||||||||||2017-10-10 22:55:36.420552|2017-10-10 22:55:36.420552
NCT02551120|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-05-26|||June 2014||2014-06-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism|Characterization of Patients With Idiopathic Hypoparathyroidism, Autosomal Dominant Hypocalcaemia and Pseudohypoparathyroidism|Recruiting||N/A|100|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Blood samples (whole blood, serum and plasma), urine collection (24h) and bone biopsies   "|Undecided||2017-10-10 22:55:36.522583|2017-10-10 22:55:36.522583
NCT02551107|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-05-08|||December 2015||2015-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Infant Nasal Nitric Oxide Levels in Congenital Heart Disease|Nasal Nitric Oxide Levels in Infants With and Without Congenital Heart Disease|Recruiting||N/A|120|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-10 22:55:36.64575|2017-10-10 22:55:36.64575
NCT02551094|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-06|||September 2015||2015-09-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|COLCOT||Colchicine Cardiovascular Outcomes Trial (COLCOT)|Colchicine Cardiovascular Outcomes Trial (COLCOT)|Recruiting||Phase 3|4500|Anticipated|Montreal Heart Institute||2|||f||||t||||||||||2017-10-10 22:55:36.748555|2017-10-10 22:55:36.748555
NCT02551081|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-12-15|||October 2015||2015-10-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units|Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units|Recruiting||N/A|2000|Anticipated|Children's Hospital of Fudan University|||1||f||||t||||||||||2017-10-10 22:55:36.870451|2017-10-10 22:55:36.870451
NCT02551068|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-05-15|||December 2015||2015-12-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|HOPE-IPF||High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib|High Oxygen Delivery to Preserve Exercise Capacity in IPF Patients Treated With Nintedanib: The HOPE-IPF Study|Recruiting||N/A|88|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 22:55:36.97887|2017-10-10 22:55:36.97887
NCT02551055|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-14|||September 30, 2015|Actual|2015-09-30|August 2017|2017-08-01|February 17, 2017|Actual|2017-02-17|February 17, 2017|Actual|2017-02-17||Interventional|||MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma|An Umbrella Study to Evaluate MLN1117 in Combination With Taxanes (Docetaxel or Paclitaxel) and Other Investigational Anticancer Agents for the Treatment of Patients With Previously Treated Advanced and Metastatic Gastric and Gastroesophageal Adenocarcinoma|Terminated||Phase 1|32|Actual|Takeda||4||Business Decision; No Safety Or Efficacy Concerns.|f||||f|t|f||||||||2017-10-10 22:55:37.106466|2017-10-10 22:55:37.106466
NCT02551042|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-05-27|||September 2015||2015-09-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Interventional|||CSL Behring Sclero XIII|A Phase II, Double-blind, Randomized, Placebo-controlled Study to Investigate Pharmacokinetics (PK), Safety and Efficacy of Intravenous Factor XIII Treatment in Patients With Systemic Sclerosis|Recruiting||Phase 2|26|Anticipated|University College, London||2|||f||||t||||||||No||2017-10-10 22:55:37.260178|2017-10-10 22:55:37.260178
NCT02551029|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-03-17|||February 2016||2016-02-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||fMRI and Visceral Perception Upon Capsaicin Infusion|Brain and Brainstem Activation Following Duodenal Nociceptive Stimulation With Capsaicin, an Exploratory High-resolution fMRI Study in Healthy Volunteers|Recruiting||N/A|21|Anticipated|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-10 22:55:37.403209|2017-10-10 22:55:37.403209
NCT02551016|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-09-14|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Heart Failure Recorded in Primary Care, Hospital Admissions and National Mortality Registry|Capture and Concordance of Heart Failure Recorded in Primary Care, Hospital Admissions and National Mortality Registry: A Cohort Study In 2.1 Million People|Unknown status|Active, not recruiting|N/A|100000|Anticipated|University College, London|||3||f||||t||||||||||2017-10-10 22:55:37.515386|2017-10-10 22:55:37.515386
NCT02551003|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-12-15|||September 2015||2015-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy|A Multi-Centre Safety and Efficacy Study of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonates Encephalopathy in China|Recruiting||Phase 1/Phase 2|60|Anticipated|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 22:55:37.593888|2017-10-10 22:55:37.593888
NCT02550990|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-12-19|||September 2015||2015-09-01|December 2016|2016-12-01||||August 2018|Anticipated|2018-08-01||Interventional|||Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline|Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition, Physiological Markers, Daily Function and Quality of Life in Stroke Patients With Cognitive Decline|Recruiting||N/A|75|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-10 22:55:37.712482|2017-10-10 22:55:37.712482
NCT02550977|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-04|||September 18, 2015|Actual|2015-09-18|July 2017|2017-07-01|August 15, 2016|Actual|2016-08-15|July 15, 2016|Actual|2016-07-15||Interventional|||Russia/Ukraine Suppression of Ovarian Activity Study|Multicenter, Open-label, Uncontrolled Study to Investigate Suppression of Ovarian Activity of a Transdermal Contraceptive Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene in 80 Young Female Volunteers Over 3 Treatment Cycles|Completed||Phase 2|91|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 22:55:37.83318|2017-10-10 22:55:37.83318
NCT02550964|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-17|||January 2014||2014-01-01|September 2015|2015-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Incidence and Risk Factor of Hydroxychloroquine and Chloroquine Retinopathy|Incidence and Risk Factor Evaluation for Toxic Maculopathy Associated With Hydroxychloroquine and Chloroquine|Recruiting||N/A|124|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-10 22:55:37.937138|2017-10-10 22:55:37.937138
NCT02550951|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-15|||October 2014||2014-10-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Utility of MR Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy|Utility of Magnetic Resonance Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy|Unknown status|Enrolling by invitation|N/A|7|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:55:38.0312|2017-10-10 22:55:38.0312
NCT02550925|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-05-16|||September 2015||2015-09-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors|A Novel Acceptance-Based Intervention for Anxious Cancer Survivors|Recruiting||N/A|100|Anticipated|University of Colorado, Boulder||2|||f||||f||||||||||2017-10-10 22:55:38.219505|2017-10-10 22:55:38.219505
NCT02550912|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-12|2016-07-11|||August 2015||2015-08-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||A Study Evaluating the Effect of Vitamin D on Clinical Outcome in Autistic Children|A Pilot Study Evaluating the Effect of Vitamin D on Clinical Outcome in Autistic Children|Completed||Phase 2|42|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 22:55:38.316286|2017-10-10 22:55:38.316286
NCT02550899|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-12|2016-01-09|||January 2013||2013-01-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence|Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence|Completed||Phase 4|30|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-10 22:55:38.413606|2017-10-10 22:55:38.413606
NCT02550886|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-08-31|||December 2015||2015-12-01|August 2016|2016-08-01||||March 2016|Actual|2016-03-01||Observational|Work Burden||Anticipated Versus Actual Patient and Caregiver Burden Following Ambulatory Orthopedic Surgery|Anticipated Versus Actual Patient and Caregiver Burden Following Ambulatory Orthopedic Surgery|Terminated||N/A|28|Actual|Hospital for Special Surgery, New York|||1|Lost many participants to follow-up.|f||||f||||||||No||2017-10-10 22:55:38.61716|2017-10-10 22:55:38.61716
NCT02550873|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-10-26|||August 2015||2015-08-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|A Phase 2 Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Active, not recruiting||Phase 2|117|Actual|Promedior, Inc.||2|||f||||t||||||||||2017-10-10 22:55:38.717283|2017-10-10 22:55:38.717283
NCT02550860|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-01-30|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|Tewlip||Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function|Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function|Recruiting||Phase 3|40|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:55:38.918981|2017-10-10 22:55:38.918981
NCT02550847|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-04-12|||August 2014||2014-08-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|April 2016|Anticipated|2016-04-01||Observational|||Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer|Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:55:39.067786|2017-10-10 22:55:39.067786
NCT02550834|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-02-23|||August 2015||2015-08-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|SCI-RCT||Wheelchair Indoors Curling With SCI patients_RCT|The Effects of Indoors Curling Exercise in Persons With Chronic Spinal Cord Injury on Control Capabilities of Trunk Movements: a Randomized-controlled Trial.|Completed||Phase 1/Phase 2|32|Actual|HES-SO Valais-Wallis||2|||f||||f||||||||||2017-10-10 22:55:39.183187|2017-10-10 22:55:39.183187
NCT02550821|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2016-08-15|||September 2015||2015-09-01|August 2016|2016-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects|Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects|Recruiting||N/A|70|Anticipated|Hacettepe University||2|||f||||f||||||||||2017-10-10 22:55:39.290027|2017-10-10 22:55:39.290027
NCT02550808|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-15|||March 2012||2012-03-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|July 2016|Anticipated|2016-07-01||Observational|||Metabolic Changes in Patients With Chronic Cardiopulmonary Disease|Metabolic and Histological Changes in Skeletal Muscle and Fat Tissue in Patients With Chronic Cardiopulmonary Disease|Recruiting||N/A|400|Anticipated|General and Teaching Hospital Celje|||5||f||||f||||||Samples With DNA|"     Serum; plasma; Skeletal muscle; fat tissue; urine; full blood   "|||2017-10-10 22:55:39.388776|2017-10-10 22:55:39.388776
NCT02550795|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2016-12-05|||September 2015||2015-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer|Effects of Single Dose Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer|Completed||N/A|150|Actual|Gachon University Gil Medical Center||3|||f||||t||||||||||2017-10-10 22:55:39.481853|2017-10-10 22:55:39.481853
NCT02550782|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-02-26|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Infraclavicular Perineural Dexmedetomidine|Does Patient-Controlled Infraclavicular Perineural Dexmedetomidine Improve Postoperative Analgesia Deadline?|Completed||N/A|60|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 22:55:39.569485|2017-10-10 22:55:39.569485
NCT02550769|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-14|||April 2015||2015-04-01|September 2015|2015-09-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|NOTESvsL-LAR||Study of NOTES-TME Versus L-LAR in Rectal Cancer|Multicenter Prospective Randomized Controlled Study of the Transanal Total Mesorectal Excision Versus Laparoscopic Low Anterior Resection in Rectal Cancer|Recruiting||Phase 4|116|Anticipated|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-10 22:55:39.657949|2017-10-10 22:55:39.657949
NCT02550756|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-14|||February 2014||2014-02-01|September 2015|2015-09-01||||November 2014|Actual|2014-11-01||Interventional|||Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)|An Open Label, Ascending Dose Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)|Completed||Phase 1|11|Actual|Centrexion Therapeutics||2|||f||||||||||||||2017-10-10 22:55:39.7695|2017-10-10 22:55:39.7695
NCT02550743|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-12-20|||June 2016||2016-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study|BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Phase I Study|Recruiting||Phase 1|24|Anticipated|Brown University||4|||f||||t||||||||||2017-10-10 22:55:39.851473|2017-10-10 22:55:39.851473
NCT02550730|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-01-09|||July 2015||2015-07-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|BBB||Best Beginnings for Babies Birth Sister Program Evaluation|Birth Sisters Best Beginnings Evaluation|Recruiting||N/A|594|Anticipated|Boston Medical Center||2|||f||||f||||||||||2017-10-10 22:55:39.961496|2017-10-10 22:55:39.961496
NCT02550717|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-04-11|||September 1, 2015|Actual|2015-09-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|EPISAT||Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)|A Pharmacoepidemiologitcal Study on the Risk of Bleeding in New Users of Low-dose Aspirin (ASA) in The Health Improvement Network (THIN), UK|Completed||N/A|398158|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:55:40.07001|2017-10-10 22:55:40.07001
NCT02357355|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-03-07|||November 1, 2014|Actual|2014-11-01|March 2017|2017-03-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|||Driving Ability in Patients With CMT 1A|Driving Ability in Patients With CMT 1A|Completed||N/A|32|Actual|University of Iowa||2|||f||||f|f|f||||||||2017-10-10 23:36:24.017521|2017-10-10 23:36:24.017521
NCT02550704|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-11-18|||May 2016||2016-05-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|SIIMPA||Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in IBS-D Patients|Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in Patients Suffering From Irritable Bowel Syndrome With Diarrhoea|Recruiting||N/A|68|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 22:55:40.181701|2017-10-10 22:55:40.181701
NCT02550691|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-08-29|||December 2015||2015-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BADGES||Identification of a Biomarker Associated With Cis-duplication of the SMN1 Gene|Identification of a Biomarker Associated With Cis-duplication of the SMN1 Gene Aiming at Improving the Genetic Counseling in Spinal Muscular Atrophy Families|Recruiting||N/A|311|Anticipated|University Hospital, Rouen||3|||f||||f||||||||||2017-10-10 22:55:40.28497|2017-10-10 22:55:40.28497
NCT02550678|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-04-09|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|ASN-002-001||A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma|A Phase 1/2a Study of the Efficacy and Safety of ASN-002 Alone or in Combination With 5-FU in Adult Patients With Low-risk Nodular Basal Cell Carcinoma|Recruiting||Phase 1/Phase 2|36|Anticipated|Ascend Biopharmaceuticals Ltd||5|||f||||f|f|f||||||Undecided||2017-10-10 22:55:40.38667|2017-10-10 22:55:40.38667
NCT02550665|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-07-15|||December 2014||2014-12-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|ODESA||Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg|A Multicenter, Randomized, Open-label, Prospective Trial to Evaluate the Safety and Tolerability of Donepezil 23 mg With or Without Intermediate Dose Titration in Patients With Alzheimer's Disease Taking Donepezil Hydrochloride 10 mg|Active, not recruiting||Phase 3|176|Actual|Asan Medical Center||3|||f||||f||||||||||2017-10-10 22:55:40.523968|2017-10-10 22:55:40.523968
NCT02550639|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-11-08|||February 2014||2014-02-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|RESPECT||Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant|A Prospective Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection According to Baseline hCMV-specific T-cell Response in Kidney Transplant Patients (RESPECT)|Recruiting||Phase 4|160|Anticipated|Hospital Universitari de Bellvitge||4|||f||||f||||||||||2017-10-10 22:55:40.915004|2017-10-10 22:55:40.915004
NCT02550626|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-09-14|||July 2015||2015-07-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Exploring the Relationship Between Alpha-synucleinopathy Related Non-motor Symptom and Post-op. Delirium in Elderly Patients With Spine Surgery||Unknown status|Recruiting|N/A|129|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-10 22:55:41.036869|2017-10-10 22:55:41.036869
NCT02550613|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-05-14|||May 2014||2014-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma|Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:55:41.131608|2017-10-10 22:55:41.131608
NCT02550600|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-09-11|||November 2015||2015-11-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|EXODUS||Extracorporeal Lung Assist Device in Acute Lung Impairment|EXODUS: Extracorporeal Lung Assist Device in Acute Lung Impairment: A Randomized Controlled Study|Not yet recruiting||N/A|300|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-10-10 22:55:41.221258|2017-10-10 22:55:41.221258
NCT02550587|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-02-29|||September 2015||2015-09-01|February 2016|2016-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|||Patient Satisfaction With Anesthesia Care|Satisfaction Rate of Patients Receiving Anesthesia in the First Half of 2015, in Erzincan|Active, not recruiting||N/A|8000|Anticipated|Cukurova University|||1||f||||f||||||||||2017-10-10 22:55:41.360922|2017-10-10 22:55:41.360922
NCT02550574|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-06-19|||August 2015||2015-08-01|December 2016|2016-12-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||Use of 2-octylcyanoacrylate With Full-thickness Skin Grafts|Use of 2-octylcyanoacrylate (Dermabond) During Cutaneous Wound Closure With Full-thickness Skin Grafts: a Randomized Split Wound Comparative Effectiveness Trial|Completed||N/A|50|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 22:55:41.439703|2017-10-10 22:55:41.439703
NCT02550561|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-10-26|||June 2015||2015-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS|Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome|Recruiting||Phase 1|32|Anticipated|University of California, Irvine||1|||f||||t||||||||No||2017-10-10 22:55:41.513154|2017-10-10 22:55:41.513154
NCT02550548|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-06-26|||April 21, 2016|Actual|2016-04-21|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Incretin Action in Physiology and Diabetes|Incretin Action in Physiology and Diabetes|Recruiting||Phase 1|25|Anticipated|Duke University||4|||f||||t||||||||||2017-10-10 22:55:41.605273|2017-10-10 22:55:41.605273
NCT02550535|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-07-19|||September 2015||2015-09-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients|A Single Arm Phase I/II Study of the Safety and Efficacy of Gene-modified WT1 TCR Therapy in Patients With Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukaemia (AML) Who Have Failed to Achieve or Maintain an IWG Defined Response Following Hypomethylating Agent Therapy.|Suspended||Phase 1/Phase 2|25|Anticipated|Cell Therapy Catapult||1||Change on Sponsorship|f||||t||||||||||2017-10-10 22:55:41.691415|2017-10-10 22:55:41.691415
NCT02550522|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-06-26|||September 2015||2015-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|BCI||Brain Computer Interface: Neuroprosthetic Control of a Motorized Exoskeleton|Brain Computer Interface: Neuroprosthetic Control of a Motorized Exoskeleton|Recruiting||N/A|5|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-10 22:55:41.802893|2017-10-10 22:55:41.802893
NCT02550509|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-09-19|||November 2013||2013-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Changes in Echogenicity and Muscle Stiffness in Elastography After Botulinum Toxin Injection a Spastic Muscle|Changes in Echogenicity and Muscle Stiffness in Elastography After Botulinum Toxin Injection a Spastic Muscle - A Monocentric Study|Terminated||N/A|6|Actual|Centre Hospitalier Universitaire de Saint Etienne||1||Difficulties to include patients|f||||f||||||||||2017-10-10 22:55:41.88667|2017-10-10 22:55:41.88667
NCT02550496|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-11-21|||May 2016||2016-05-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|ETDT||Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis|Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis. Prospective, Multicenter Study (ETDT)|Recruiting||Phase 3|100|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-10 22:55:41.960847|2017-10-10 22:55:41.960847
NCT02550483|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-12-11|||September 2015||2015-09-01|September 2015|2015-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Novel Metabolites of Beta-Carotene and Lycopene||Completed||N/A|36|Actual|USDA Beltsville Human Nutrition Research Center||3|||f||||f||||||||||2017-10-10 22:55:42.059026|2017-10-10 22:55:42.059026
NCT02550470|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-12-21|||July 2015||2015-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||"Evaluation of Micropores SpiraLith Absorbents"|Evaluation of Micropore's SpiraLith TM Absorbents Into Anesthesia Breathing Circuits|Completed||N/A|230|Actual|Rutgers, The State University of New Jersey||3|||f||||f||||||||||2017-10-10 22:55:42.13764|2017-10-10 22:55:42.13764
NCT02550457|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-09-18|||September 2015||2015-09-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Kinesio Taping on Chronic Nonspecific Low Back Pain|Effects of Kinesio Taping on Chronic Nonspecific Low Back Pain: a Randomized Controlled Trial|Recruiting||N/A|108|Anticipated|Universidade Federal do Rio Grande do Norte||4|||f||||f||||||||||2017-10-10 22:55:42.386508|2017-10-10 22:55:42.386508
NCT02550444|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-08-01|||April 2013||2013-04-01|September 2015|2015-09-01|June 2016|Actual|2016-06-01|May 2015|Actual|2015-05-01||Interventional|||Intrathecal Clonidine in Cesarean Section May Lead to Worse Blood Gas Results in the Newborns|Comparison Between Intravenous and Intrathecal Clonidine in Post-cesarean Analgesia|Completed||N/A|64|Actual|University of Sao Paulo General Hospital||3|||f||||f||||||||||2017-10-10 22:55:42.532175|2017-10-10 22:55:42.532175
NCT02550431|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-10-25|||January 2016||2016-01-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth|Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth|Recruiting||N/A|100|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 22:55:42.670392|2017-10-10 22:55:42.670392
NCT02550418|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-07-25|||October 2015||2015-10-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|TOPICAL-1||Budesonide 9 mg Capsules in Active UC|Open-label, Multi-centre, Proof of Concept Phase IIa Clinical Trial on the Efficacy and Tolerability of an 8 Week Oral Treatment With Once Daily 9 mg Budesonide in Patients With Active Ulcerative Colitis|Completed||Phase 2|60|Actual|Dr. Falk Pharma GmbH||1|||f||||f||||||||||2017-10-10 22:55:42.77911|2017-10-10 22:55:42.77911
NCT02550405|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-07-21|||March 2012||2012-03-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||The Behavioral and Brain Mechanism of IGD|The Behavioral and Brain Mechanism of Internet Gaming Disorder|Completed||N/A|204|Actual|Beijing Normal University||2|||f||||t||||||||||2017-10-10 22:55:42.887438|2017-10-10 22:55:42.887438
NCT02550392|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-11-30|||March 2016||2016-03-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|OPTIMISM||Psychoeducation for Transient Ischaemic Attack and Minor Stroke|Optimising Psychoeducation for Transient Ischaemic Attack and Minor Stroke Management (OPTIMISM)|Recruiting||N/A|56|Anticipated|University of Nottingham||2|||f||||f||||||||No||2017-10-10 22:55:43.012187|2017-10-10 22:55:43.012187
NCT02550379|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-11-08|||September 2015||2015-09-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Emotion Recognition Training for Young People|Emotion Recognition Training for Socially Anxious Adolescents: A Randomized Controlled Trial|Completed||N/A|115|Actual|University College Dublin||2|||f||||f||||||||Undecided||2017-10-10 22:55:43.15618|2017-10-10 22:55:43.15618
NCT02550366|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-05-02|||October 2016|Actual|2016-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI|Novel Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MR for Non-Invasive Evaluation of Coronary Artery Disease|Recruiting||Phase 1/Phase 2|110|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t|t|f||||||No||2017-10-10 22:55:43.328142|2017-10-10 22:55:43.328142
NCT02550353|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2016-06-13|||September 2015||2015-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Changes Between Lenticule Extraction and Femtosecond Laser-assisted Laser in Situ Keratomileusis|Comparison of Early Changes in Ocular Surface and Inflammatory Mediators Between Lenticule Extraction and Femtosecond Laser-assisted Laser in Situ Keratomileusis|Completed||N/A|75|Actual|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:55:43.468847|2017-10-10 22:55:43.468847
NCT02550340|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2016-04-25|||September 2015||2015-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|1 Day|Observational [Patient Registry]|Munich BREW||Munich Study for Beer Related ECG Change Workup|Munich Study for Beer Related ECG Change Workup|Completed||N/A|3029|Anticipated|Klinikum der Universitaet Muenchen|||1||f||||f||||||||||2017-10-10 22:55:43.6202|2017-10-10 22:55:43.6202
NCT02550327|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2016-03-16|||January 2016||2016-01-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer|A Pilot Study of Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Resectable or Potentially Resectable Pancreatic Adenocarcinoma (PDAC)|Recruiting||Early Phase 1|16|Anticipated|Baylor Research Institute||1|||f||||t||||||||||2017-10-10 22:55:43.733176|2017-10-10 22:55:43.733176
NCT02550314|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-12-20|||March 2015||2015-03-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18|A Phase III Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18-multicenter,Investigator Initiated Clinical Trial|Completed||Phase 3|20|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||t||||||||Undecided||2017-10-10 22:55:43.893812|2017-10-10 22:55:43.893812
NCT02550301|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2015-09-17|||September 2015||2015-09-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Does Mean Platelet Volume Change With Clopidogrel|Prospective Pilot Study- Does Mean Platelet Volume Change With Clopidogrel in Patients With Stable Angina Undergoing Percutaneous Coronary Intervention?|Unknown status|Not yet recruiting|N/A|100|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples Without DNA|"     Whole blood in EDTA collection tubes to measure Mean Platelet Volume   "|||2017-10-10 22:55:44.01094|2017-10-10 22:55:44.01094
NCT02550288|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-14|2017-05-24|2017-05-24||September 29, 2015|Actual|2015-09-29|May 2017|2017-05-01|May 30, 2016|Actual|2016-05-30|May 30, 2016|Actual|2016-05-30||Interventional|||A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)|A Phase III, Randomized, Active Comparator-controlled Clinical Trial to Study the Efficacy and Safety of MK-0653C in Japanese Patients With Hypercholesterolemia|Completed||Phase 3|309|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-10 22:55:44.16083|2017-10-10 22:55:44.16083
NCT02550275|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-14|||January 2015||2015-01-01|September 2015|2015-09-01||||February 2018|Anticipated|2018-02-01||Interventional|COSIMH||Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging||Recruiting||N/A|80|Anticipated|University Hospital, Angers||3|||f||||||||||||||2017-10-10 22:55:45.532917|2017-10-10 22:55:45.532917
NCT02550262|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-05-02|||September 2015||2015-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor|Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 10 ml of Bupivacaine 0.0625% Plus Fentanyl 2 mcg/ml.|Completed||N/A|40|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||4|||f||||f||||||||No||2017-10-10 22:55:45.619922|2017-10-10 22:55:45.619922
NCT02550249|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-04-10|||June 2015||2015-06-01|July 2015|2015-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|Neo-nivo||Neoadjuvant Nivolumab in Glioblastoma|Phase II Study of Neoadjuvant Nivolumab in Patients With Glioblastoma Multiforme|Completed||Phase 2|29|Actual|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||||2017-10-10 22:55:45.719006|2017-10-10 22:55:45.719006
NCT02550236|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-01-31|||October 2010||2010-10-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|LIFE-Child||LIFE Leipzig Research Centre for Civilization Diseases|Prospective Population-based Childhood Cohort Study in the Leipzig Area Investigating Genetic, Environmental, and Metabolic Factors and Their Association With the Development of Civilization Diseases|Recruiting||N/A|12000|Anticipated|University of Leipzig|||3||f||||t||||||Samples With DNA|"     -  blood samples for mRNA and DNA analysis        -  serum samples        -  plasma samples        -  serum samples from oral glucose tolerance testing        -  urine samples        -  hair samples        -  mother's milk   "|||2017-10-10 22:55:45.830066|2017-10-10 22:55:45.830066
NCT02550223|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-14|||January 2015||2015-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|US radial||Ultrasound Guided Radial Artery Catheterization|Ultrasound Guided Radial Artery Cathetrization, A Novel Technique.|Completed||N/A|90|Actual|Mansoura University||3|||f||||t||||||||||2017-10-10 22:55:45.961778|2017-10-10 22:55:45.961778
NCT02550210|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-03-25|||August 2015||2015-08-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers|A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable|Recruiting||N/A|20|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-10 22:55:46.048941|2017-10-10 22:55:46.048941
NCT02550197|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-09-16|2016-09-16||September 2015||2015-09-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 Years|Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Subjects Aged 18 to 60 Years in the Republic of Korea|Completed||Phase 3|300|Actual|Sanofi||2|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-10 22:55:46.183186|2017-10-10 22:55:46.183186
NCT02550184|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-10-27|||October 2015||2015-10-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|February 2016|Anticipated|2016-02-01||Interventional|||Ultrasonography in the Emergency Department|Ultrasonography in the Emergency Department. A Randomised Controlled Multicenter Study.|Unknown status|Not yet recruiting|N/A|288|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-10 22:55:46.981482|2017-10-10 22:55:46.981482
NCT02550171|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-09-16|||March 2009||2009-03-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01|10 Years|Observational [Patient Registry]|BGB||BioGene Bank Cohort Study for Approved Research Requests|The BioGene Bank Cohort Study is a Collection of Human Blood Samples (DNA and Plasma) Along With De-identified (Coded) Health Information, Questionnaire Responses on Environment and History of Family Disease to be Used for Research|Completed||N/A|7056|Actual|Northwell Health|||1||f||||f||||||Samples With DNA|"     DNA   "|No||2017-10-10 22:55:47.108414|2017-10-10 22:55:47.108414
NCT02550158|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-14|||June 2011||2011-06-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|ECIPE||A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease|"A Randomized Controlled Study Evaluating the Impact of an Educational Program EDU-MICI on Patients With Inflammatory Bowel Disease"|Completed||N/A|263|Actual|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||2|||f||||t||||||||||2017-10-10 22:55:47.177379|2017-10-10 22:55:47.177379
NCT02550145|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-07-01|||February 2014||2014-02-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery|The Role of GLP-1 in Mediating Glucose Reductions After Bariatric Surgery|Recruiting||Phase 1|30|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 22:55:47.289449|2017-10-10 22:55:47.289449
NCT02550132|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-01-06|2015-12-02||June 2013||2013-06-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Role of the Rate of Force Application in Responses to Spinal Manipulation Therapy|Neuromechanical Response to Spinal Manipulation Therapy: Effects of a Constant Rate of Force Application|Completed||N/A|25|Actual|Université du Québec à Trois-Rivières||1|||f||||f||||||||||2017-10-10 22:55:49.400128|2017-10-10 22:55:49.400128
NCT02550119|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-03-24|||April 19, 2006|Actual|2006-04-19|March 2017|2017-03-01|April 1, 2010|Actual|2010-04-01|April 1, 2010|Actual|2010-04-01||Interventional|||Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy|A Pilot Study to Evaluate the Safety and Efficacy of Aprepitant in Combination With Dolasetron and Dexamethasone for the Prevention of Nausea and Vomiting Following Oxaliplatin-containing Regimen Which Includes 5-FU.|Terminated||N/A|19|Actual|University of Southern California||2||Insufficient accrual|f||||t|f|f||||||||2017-10-10 22:55:49.811919|2017-10-10 22:55:49.811919
NCT02550080|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-03-01|||July 2015||2015-07-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome|A Phase IV, Randomised, Multicentre, Double-blind, Study to Evaluate the Clinical Utility of Prospective Genetic Screening (HLA-B*1301) for Susceptibility to Dapsone Hypersensitivity Syndrome|Recruiting||Phase 4|3130|Anticipated|Shandong Provincial Institute of Dermatology and Venereology||2|||f||||f|f|f||||||||2017-10-10 22:55:50.315253|2017-10-10 22:55:50.315253
NCT02550067|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-12|2017-09-19|||November 2015||2015-11-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|ECHO||The Evidence for Contraceptive Options and HIV Outcomes Trial|A Multi Center, Open-Label, Randomised Clinical Trial Comparing HIV Incidence and Contraceptive Benefits in Women Using Depot Medroxyprogesterone Acetate (DMPA), Levonorgestrel (LNG) Implant, and Copper Intrauterine Devices (IUDs)|Active, not recruiting||N/A|7800|Anticipated|FHI 360||3|||f||||t||||||||||2017-10-10 22:55:50.423063|2017-10-10 22:55:50.423063
NCT02550054|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-12-15|||September 2015||2015-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Erythropoietin in Premature Infants to Prevent Encephalopathy|Erythropoietin in Premature Infants to Prevent Encephalopathy: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Erythropoietin in China|Recruiting||Phase 2|312|Anticipated|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 22:55:50.551885|2017-10-10 22:55:50.551885
NCT02550041|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-12-21|||August 2015||2015-08-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients||Terminated||N/A|68|Actual|University Hospital, Montpellier||1||Difficulties for inclusions|f||||f||||||||||2017-10-10 22:55:50.671792|2017-10-10 22:55:50.671792
NCT02550028|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-12-15|||September 2015||2015-09-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Levetiracetam Treatment of Neonatal Seizures|Levetiracetam Treatment of Neonatal Seizures: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Oral Levetiracetam as First Line Treatment for Neonatal Seizures in China|Recruiting||Phase 4|100|Anticipated|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 22:55:50.761304|2017-10-10 22:55:50.761304
NCT02550015|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-01-09|||September 2015||2015-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||High Intensity Interval Training After Stroke|The Effect of High Intensity Interval Training on Maximal Oxygen Uptake and Risk Factors for Recurrent Stroke|Recruiting||N/A|70|Anticipated|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 22:55:50.903067|2017-10-10 22:55:50.903067
NCT02550002|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-02-27|||December 2015||2015-12-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Observational|||Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen|Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen (TOLERANT Study)|Recruiting||N/A|175|Anticipated|University Hospital Inselspital, Berne|||2||f||||t||||||None Retained|"     blood   "|||2017-10-10 22:55:51.013109|2017-10-10 22:55:51.013109
NCT02549989|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-06-02|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer|Single-Arm, Open-Label, Phase II Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer|Recruiting||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:55:51.109869|2017-10-10 22:55:51.109869
NCT02549976|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-14|||September 2015||2015-09-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|DESTIN||Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis|Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis|Unknown status|Not yet recruiting|N/A|101|Anticipated|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||1|||f||||f||||||||||2017-10-10 22:55:51.204246|2017-10-10 22:55:51.204246
NCT02549963|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-23|||October 2015||2015-10-01|September 2015|2015-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban|A Prospective, Multi-Center, Pilot Study to Compare the Safety and Effectiveness of WATCHMAN Left Atrial Appendage Occlusion Device With Rivaroxaban for Stroke Prevention in Patients With Atrial Fibrillation|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-10-10 22:55:51.359496|2017-10-10 22:55:51.359496
NCT02549950|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-14|||September 2015||2015-09-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficiency of Piezo-Corticision in Accelerating Orthodontic Tooth Movement|Efficiency and Efficacy of Peizo-Coticision in Reducing Orthodontic Treatment Time: Randomized Clinical Trial|Unknown status|Recruiting|N/A|60|Anticipated|King Abdullah International Medical Research Center||2|||f||||t||||||||||2017-10-10 22:55:51.481995|2017-10-10 22:55:51.481995
NCT02549937|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-02-23|||November 2015|Actual|2015-11-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multi-Center, Open-Label Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors|A Multi-Center, Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics of Sulfatinib in Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||Undecided||2017-10-10 22:55:51.579125|2017-10-10 22:55:51.579125
NCT02549924|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-11-30|||September 2015||2015-09-01|November 2015|2015-11-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus|Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus Inadequately Controlled With Metfomin|Recruiting||Phase 2|22|Anticipated|University of Guadalajara||2|||f||||f||||||||||2017-10-10 22:55:51.77957|2017-10-10 22:55:51.77957
NCT02549911|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-14|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis|Hyperthermic Intraperitoneal Chemotherapy, Intravenous Chemotherapy Combined With Surgery for the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis|Unknown status|Recruiting|Phase 2|40|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-10 22:55:51.905469|2017-10-10 22:55:51.905469
NCT02549898|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-01-16|||August 2015||2015-08-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI|Investigation of Vascular Inflammation in Migraine Without Aura Using Molecular Nano-imaging and Black Blood Imaging MRI|Recruiting||N/A|42|Anticipated|Danish Headache Center||3|||f||||t||||||||||2017-10-10 22:55:52.011849|2017-10-10 22:55:52.011849
NCT02549885|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-09-15|||April 2016||2016-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|August 2017|Actual|2017-08-01||Interventional|PNF||Efficacy of Proprioceptive Neuromuscular Facilitation in Pain Relief|Efficacy of Proprioceptive Neuromuscular Facilitation in Pain Relief in Women With Migraine|Active, not recruiting||N/A|30|Actual|Universidade Federal de Pernambuco||2|||f||||f||||||||||2017-10-10 22:55:52.117383|2017-10-10 22:55:52.117383
NCT02549872|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-11|||September 2015||2015-09-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Observational|||Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries|Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries: a Cohort Study in Linked Electronic Health Records|Unknown status|Active, not recruiting|N/A|51000|Anticipated|University College, London|||2||f||||t||||||||||2017-10-10 22:55:52.2264|2017-10-10 22:55:52.2264
NCT02549859|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-06-05|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS|Long-term Effect of Low Frequency 60Hz Stimulation on Aspiration, Freezing of Gait and Other Axial and Motor Symptoms in PD Patients With Bilateral STN DBS|Completed||Phase 2/Phase 3|11|Actual|University of Chicago||3|||f||||f||||||||||2017-10-10 22:55:52.329449|2017-10-10 22:55:52.329449
NCT02549846|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-01-02|||September 2015||2015-09-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Interventional|ASSORT||AdminiStration of Statin On Acute Ischemic stRoke patienT Trial|Randomized Controlled Trial of Early Versus Late Statin Therapy in Patients With Ischemic Stroke|Active, not recruiting||Phase 4|270|Actual|Hyogo College of Medicine||2|||f||||t||||||||||2017-10-10 22:55:52.420502|2017-10-10 22:55:52.420502
NCT02549833|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-01-20|||September 2016||2016-09-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma|Pilot Randomized Neo-adjuvant Evaluation of Poly-ICLC-Assisted Tumor Lysate Vaccines in Adult Patients With WHO Grade II Glioma|Recruiting||Phase 1|30|Anticipated|University of California, San Francisco||2|||f||||t||||||||No||2017-10-10 22:55:52.522484|2017-10-10 22:55:52.522484
NCT02549820|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-05-25|||July 2015||2015-07-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|CHOP_FETO||Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia|Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)|Recruiting||N/A|10|Anticipated|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-10-10 22:55:52.662516|2017-10-10 22:55:52.662516
NCT02549807|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-14|||July 2014||2014-07-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Measurement by 2D Ultrasound of the Pennation Angle and Elasticity of Gastrocnemius Muscle|Evaluation of the Reproducibility of the Measurement by 2D Ultrasound and Sonoelastometry of the Pennation Angle and Elasticity of the Medial Gastrocnemius Muscle in Children/Adolescent/Adult Cerebral Hemiplegia After Stroke|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Saint Etienne|||3||f||||f||||||||||2017-10-10 22:55:52.785128|2017-10-10 22:55:52.785128
NCT02549794|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2015-09-14|||April 2015||2015-04-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Image Quality of Coronary Computed Tomography Angiography bEtweeN High concenTRATion and Low concEntration Contrast Agents(CONCENTRATE Trial)||Unknown status|Recruiting|N/A|318|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-10 22:55:52.906866|2017-10-10 22:55:52.906866
NCT02549781|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-01-20|||November 2014||2014-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Environmental Influence on Gambling Behavior|Influence of Sensorimotor Environment on Gambling Behavior in Pathological Gambling.|Recruiting||N/A|90|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||||2017-10-10 22:55:53.018322|2017-10-10 22:55:53.018322
NCT02549768|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-10-10|||September 2015||2015-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery|Effect of Dexmedetomidine as Anesthetic Coadjuvant on Plasmatic Cortisol Response in Transsphenoidal Surgery for Pituitary Tumors|Recruiting||Phase 4|40|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||Undecided||2017-10-10 22:55:53.140115|2017-10-10 22:55:53.140115
NCT02549755|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-14|||September 2015||2015-09-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||11C-acetate for Treatment Response After Radiotherapy for HCC|Feasibility of 11C-acetate in the Monitoring of Treatment Response Following Radiotherapy in Patients With Hepatocellular Carcinoma|Unknown status|Not yet recruiting|Phase 2|18|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 22:55:53.270045|2017-10-10 22:55:53.270045
NCT02549742|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2017-01-17|||February 2014||2014-02-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Electrochemotherapy on Head and Neck Cancer|Electrochemotherapy on Head and Neck Cancer|Recruiting||Phase 2|25|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||Undecided||2017-10-10 22:55:53.409593|2017-10-10 22:55:53.409593
NCT02549729|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-03-15|||September 2015||2015-09-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy|Effect of the Pelvic Floor Training on Pelvic Floor Muscle Strength in Postmenopausal Women With or Without Hormonal Therapy: A Randomized Controlled Trial|Completed||N/A|88|Actual|University of Sao Paulo||4|||f||||t||||||||||2017-10-10 22:55:53.531182|2017-10-10 22:55:53.531182
NCT02549716|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-08-02|||January 5, 2017|Actual|2017-01-05|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|aSAH||Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH|Clinical, Pharmacological and Molecular Effects of Intravenous and Oral Acetaminophen in Adults With Aneurysmal Sub-Arachnoid Hemorrhage|Recruiting||Phase 4|50|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-10 22:55:53.618431|2017-10-10 22:55:53.618431
NCT02549703|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-06-30|||September 2015||2015-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Mitochondrial Dysfunction and Disease Progression|Mitochondrial Dysfunction and Disease Progression|Active, not recruiting||N/A|49|Actual|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||Samples With DNA|"     Blood and CSF samples will be stored indefinitely at the Casaccia lab. Skin samples will be     stored indefinitely at the New York Stem Cell Foundation.   "|||2017-10-10 22:55:53.712828|2017-10-10 22:55:53.712828
NCT02549690|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-13|2017-04-17|||September 2015||2015-09-01|April 2017|2017-04-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Testosterone Gel in Poor Responders Undergoing IVF|Effectiveness of Testosterone Gel Pretreatment in Poor Responders Undergoing IVF Treatment: a Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Vietnam National University||2|||f||||f||||||||||2017-10-10 22:55:53.779179|2017-10-10 22:55:53.779179
NCT02549677|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2017-04-10|||October 2015||2015-10-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|ELEGANT||Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer|Comparison the Safety and Efficacy of Epirubicin Plus Cyclophosphamide (EC)Versus Docetaxel Plus Cyclophosphamide (TC) in Lymph Node Negative, ER Positive, Her2 Negative Breast Cancer Patients as Adjuvant Chemotherapy|Recruiting||Phase 4|264|Anticipated|Ruijin Hospital||2|||f||||f||||||||No|There is no plan to share IPD|2017-10-10 22:55:53.863379|2017-10-10 22:55:53.863379
NCT02549664|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-12-15|||May 2015||2015-05-01|December 2016|2016-12-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01|3 Years|Observational [Patient Registry]|LIVE-HCM/LQT||Exercise in Genetic Cardiovascular Conditions|"Exercise in Genetic Cardiovascular Conditions (Lifestyle and Exercise in Hypertrophic Cardiomyopathy LIVE-HCM/Lifestyle and Exercise in the Long QT Syndrome LIVE-LQTS"|Recruiting||N/A|4286|Anticipated|Yale University|||2||f||||t||||||||||2017-10-10 22:55:53.961152|2017-10-10 22:55:53.961152
NCT02549651|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-10-05|||July 13, 2016|Actual|2016-07-13|October 2017|2017-10-01|November 30, 2022|Anticipated|2022-11-30|November 30, 2022|Anticipated|2022-11-30||Interventional|||MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)|A Phase 1b Study to Evaluate the Safety and Efficacy of MEDI4736 as Monotherapy and in Combination With Tremelimumab or AZD9150 in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma|Recruiting||Phase 1|207|Anticipated|MedImmune LLC||3|||f||||f|t|f||||||||2017-10-10 22:55:54.231919|2017-10-10 22:55:54.231919
NCT02549625|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-09-22|||August 2015||2015-08-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells|Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells for Systemic, Single Right Ventricular Failure Due to Congenital Heart Disease|Recruiting||Phase 1|10|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:55:54.616447|2017-10-10 22:55:54.616447
NCT02549612|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-11-27|||March 2017||2017-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Early Non-Surgical Treatment of Children With Middle Ear Effusion on the Hearing|The Effect of Early Non-Surgical Treatment of Children With Middle Ear Effusion on the Hearing Level and the Health Economics|Not yet recruiting||N/A|80|Anticipated|Vastra Gotaland Region||2|||f||||f||||||||||2017-10-10 22:55:54.710051|2017-10-10 22:55:54.710051
NCT02549599|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-09-14|||February 2015||2015-02-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|Chat/Text||Evaluating a Digital Health Information Tool|Chat/Text Program: Digital Health Information Efficacy Trial|Completed||N/A|5220|Actual|New York University||3|||f||||f||||||||||2017-10-10 22:55:54.802123|2017-10-10 22:55:54.802123
NCT02549586|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-10-27|||December 2015||2015-12-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|ASCOTT||Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance|Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance|Enrolling by invitation||Phase 2/Phase 3|10|Anticipated|University of Toronto||1|||f||||t||||||||||2017-10-10 22:55:54.895141|2017-10-10 22:55:54.895141
NCT02549560|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2015-09-12|||October 2015||2015-10-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|tDCS||Effects of the Transcranial Stimulation on Prevention of Cognitive Dysfunction in Cardiac Surgery|Effects of the Transcranial Direct Current Stimulation on Prevention of Cognitive Dysfunction in Elderly Patients Submitted to Cardiac Surgeries: Prospective, Randomized and Double-blind Study|Unknown status|Not yet recruiting|N/A|138|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:55:55.150506|2017-10-10 22:55:55.150506
NCT02549547|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-14|||August 2015||2015-08-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|January 2016|Anticipated|2016-01-01||Interventional|JumpStep||Jump Step - A Participatory Approach to Physical Activity & Mental Wellness|Jump Step - A Participatory Approach to Physical Activity & Mental Wellness|Unknown status|Recruiting|N/A|80|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-10 22:55:55.270603|2017-10-10 22:55:55.270603
NCT02549534|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-08-24|||September 2015||2015-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer|Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer|Completed||N/A|29|Actual|Indiana University|||2||f||||t||||||||||2017-10-10 22:55:55.407927|2017-10-10 22:55:55.407927
NCT02549521|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2015-09-14|||November 2006||2006-11-01|September 2015|2015-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|parathormon||Mg Induced Changes From Day 0 to Day 28 on Serum and Urine Bone Metabolic Parameters in 70 y Old Females (no 50).|Magnesium Supplementation in Elderly Females|Completed||Phase 1|50|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 22:55:55.602826|2017-10-10 22:55:55.602826
NCT02549508|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-07-04|||September 2015||2015-09-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|June 2017|Actual|2017-06-01||Interventional|||Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD|Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD|Active, not recruiting||N/A|87|Actual|Fisher and Paykel Healthcare||2|||f||||t|f|t|f|f||||||2017-10-10 22:55:55.695786|2017-10-10 22:55:55.695786
NCT02549495|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-08-28|||March 2013||2013-03-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Observational|||Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico|Evaluation of a Community Health Worker Intervention on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico|Active, not recruiting||N/A|121|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||No||2017-10-10 22:55:55.784589|2017-10-10 22:55:55.784589
NCT02549482|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-12|||August 2011||2011-08-01|September 2015|2015-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Detecting a Volume Deficit During Spontaneous Breathing|Detecting a Central Volume Deficit in Spontaneous Breathing Healthy Volunteers by Systolic Blood Pressure Variation|Completed||N/A|13|Actual|Aalborg Universitetshospital||1|||f||||f||||||||||2017-10-10 22:55:55.871687|2017-10-10 22:55:55.871687
NCT02549469|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-09-11|||March 2007||2007-03-01|September 2015|2015-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily|A Pilot Four-Way Crossover Bioequivalence Trial of Sustained Release Forms of Naproxen Versus Aleve Tablets in Healthy Adult Subjects in a Fasted State|Completed||Phase 1|32|Actual|Bayer||4|||f||||f||||||||||2017-10-10 22:55:55.941902|2017-10-10 22:55:55.941902
NCT02549456|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2017-03-22|||December 2015||2015-12-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|NOTES||Natural Orifice Transluminal Endoscopic Surgery for Colorectal Cancer|Natural Orifice Transluminal Endoscopic Surgery for Colorectal Cancer|Recruiting||N/A|30|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 22:55:56.049191|2017-10-10 22:55:56.049191
NCT02549443|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-09-14|||August 2013||2013-08-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||The Anabolic Effect Of Perioperative Nutrition With Insulin In Patients Undergoing CABG|The Anabolic Effect Of Perioperative Nutrition With Insulin In Patients Undergoing CABG|Completed||N/A|30|Actual|McGill University Health Center||3|||f||||t||||||||||2017-10-10 22:55:56.168218|2017-10-10 22:55:56.168218
NCT02549430|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-31|||October 2012||2012-10-01|July 2017|2017-07-01|February 9, 2017|Actual|2017-02-09|February 9, 2017|Actual|2017-02-09||Interventional|TREnd||To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy|Phase 2,Open-label,Multicenter,Randomized Study of PD0332991 (Oral CDK4/6 Inhibitor) Monotherapy and in Combination With the HT to Which the pt Has Progressed in the Previous Line for ER+,Her2- Post-menopausal Advanced Breast Cancer Pts|Completed||Phase 2|115|Actual|Fondazione Sandro Pitigliani||2|||f||||f||||||||||2017-10-10 22:55:56.261242|2017-10-10 22:55:56.261242
NCT02549417|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-07-02|||September 29, 2015|Actual|2015-09-29|July 2017|2017-07-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Interventional|||Phase 3 Study of KHK7580|Phase 3 Study of KHK7580 (A Clinical Study of KHK7580 in Subjects With Secondary Hyperparathyroidism Receiving Peritoneal Dialysis)|Completed||Phase 3|39|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-10 22:55:56.365954|2017-10-10 22:55:56.365954
NCT02549404|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-07-02|||September 28, 2015||2015-09-28|July 2017|2017-07-01|December 28, 2016|Actual|2016-12-28|December 6, 2016|Actual|2016-12-06||Interventional|||Phase 3 Study of KHK7580|Phase 3 Study of KHK7580 (A Long-term Study of KHK7580 in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis)|Completed||Phase 3|137|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-10 22:55:56.437866|2017-10-10 22:55:56.437866
NCT02549391|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-03-23|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Phase 3 Study of KHK7580|Phase 3 Study of KHK7580 (A Randomized, Double-Blind, Intra-Subject Dose-Adjustment, Parallel-Group Study of KHK7580 and Cinacalcet Hydrochloride in Subjects With Secondary Hyperparathyroidism Receiving Hemodialysis)|Completed||Phase 2/Phase 3|634|Actual|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||||2017-10-10 22:55:56.511578|2017-10-10 22:55:56.511578
NCT02549378|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-14|||May 2013||2013-05-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study of the Impact of Changes in Carbonemia on Microcirculation in Patients Achieving a Test Hypercapnia|Study of the Impact of Changes in Carbonemia on Microcirculation in Patients - A Monocentric Study|Completed||N/A|10|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 22:55:56.592447|2017-10-10 22:55:56.592447
NCT02549365|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-08-10|||October 2015||2015-10-01|July 2015|2015-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SNIFFLE-3||Efficacy & Safety of Nasal Influenza Immunisation in Children|Efficacy & Safety of Nasal Influenza Immunisation in Children - The SNIFFLE-3 Study|Completed||Phase 4|176|Actual|Imperial College London||2|||f||||t||||||||||2017-10-10 22:55:56.661209|2017-10-10 22:55:56.661209
NCT02549352|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-01||2017-09-01|November 2015||2015-11-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|September 22, 2016|Actual|2016-09-22||Interventional|||Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up|Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up|Completed||Phase 3|306|Anticipated|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:55:56.740209|2017-10-10 22:55:56.740209
NCT02549339|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-01||2017-09-01|November 13, 2015|Actual|2015-11-13|September 2017|2017-09-01|August 10, 2017|Actual|2017-08-10|August 5, 2016|Actual|2016-08-05||Interventional|||Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up|Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up|Completed||Phase 3|309|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:55:56.808027|2017-10-10 22:55:56.808027
NCT02549326|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-11|||November 2012||2012-11-01|September 2015|2015-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Vitamin D Intervention in Young Adults With Severe Childhood-onset Obesity|Vitamin D Intervention in Young Adults With Severe Childhood-onset Obesity|Completed||N/A|42|Actual|Helsinki University Central Hospital||4|||f||||f||||||||||2017-10-10 22:55:56.874358|2017-10-10 22:55:56.874358
NCT02549313|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-11-02|||January 2012||2012-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Effect of the Position of the Patient's Head|Study of the Effect of the Position of the Patient's Head With Brain Lesions on Cerebral Blood Flow|Completed||N/A|16|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"     blood sample   "|||2017-10-10 22:55:56.951503|2017-10-10 22:55:56.951503
NCT02549300|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-09-11|||April 2015||2015-04-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Interventional|||The Effects of Connective Tissue Massage and Lifestyle Modifications in Adolescents Tension Type Headache|Konnektif Doku Masajı ve Yaşam Stili Modifikasyonlarının Adölesanlarda Gerilim Tipi Baş Ağrısına Etkisi|Unknown status|Recruiting|N/A|30|Anticipated|Hacettepe University||2|||f||||f||||||||||2017-10-10 22:55:57.023035|2017-10-10 22:55:57.023035
NCT02549287|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-31|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparative Effectiveness Trail to Reduce Child Maltreatment, Improve Client Outcomes and Examine Client Burden|Comparative Effectiveness Trail to Reduce Child Maltreatment, Improve Client Outcomes and Examine Client Burden|Recruiting||N/A|960|Anticipated|Georgia State University||2|||f||||f||||||||||2017-10-10 22:55:57.111162|2017-10-10 22:55:57.111162
NCT02549274|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-01-16|||March 2011||2011-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effectiveness of a Self-rehabilitation Program|Effectiveness of Active Home Exercises for Patients With Chronic Neck Pain: a Prospective Comparative Randomized Clinical Trial|Completed||N/A|106|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 22:55:57.209702|2017-10-10 22:55:57.209702
NCT02549261|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-09-11|||March 2011||2011-03-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|April 2012|Actual|2012-04-01||Interventional|||Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer|Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer|Unknown status|Active, not recruiting|N/A|150|Anticipated|Biotech Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-10 22:55:57.288322|2017-10-10 22:55:57.288322
NCT02549248|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-11|||December 2012||2012-12-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|NANOPI||Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology|Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology. A Monocentric Study|Completed||N/A|100|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||Samples Without DNA|"     Bronchoalveolar lavages (BAL), bronchial washings (BW), exhaled air condensates (EAC), blood     and urine   "|||2017-10-10 22:55:57.371364|2017-10-10 22:55:57.371364
NCT02549235|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-08-03|||April 2015||2015-04-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2016|Actual|2016-07-01||Observational|||Morphological Characteristics Of Uteri With Three-dimensional Ultrasound At The Time Of Embryo Transfer|Morphological Characteristics Of Uteri With Three-dimensional Ultrasound At The Time Of Embryo Transfer and Correlation to Clinical Outcomes|Active, not recruiting||N/A|530|Anticipated|Chinese University of Hong Kong|||1||f||||f||||||||||2017-10-10 22:55:57.450083|2017-10-10 22:55:57.450083
NCT02549209|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-09-06|||August 22, 2017|Actual|2017-08-22|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Pembro/Carbo/Taxol in Endometrial Cancer|Phase II Study of Pembrolizumab in Combination With Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma|Recruiting||Phase 2|46|Anticipated|Big Ten Cancer Research Consortium||1|||f||||t|t|f||||||||2017-10-10 22:55:57.769278|2017-10-10 22:55:57.769278
NCT02549196|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-01|||October 2015||2015-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CPC-12||A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type|A Phase II, Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type|Active, not recruiting||Phase 2|20|Anticipated|Chase Pharmaceuticals Corporation||2|||f||||f||||||||||2017-10-10 22:55:57.885251|2017-10-10 22:55:57.885251
NCT02549183|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-03-06|||June 1, 2015|Actual|2015-06-01|March 2017|2017-03-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|PROCO||Evaluation of Spinal Cord Stimulation Pulse Rate On Clinical Outcomes|Evaluation of Stimulation Pulse Rate on Clinical Outcomes in Patients Whose Pain is Controlled by 10KHz Frequency - a Feasibility Study|Active, not recruiting||N/A|22|Actual|Basildon and Thurrock University Hospitals NHS Foundation Trust||4|||f||||f||||||||No||2017-10-10 22:55:57.964409|2017-10-10 22:55:57.964409
NCT02549170|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-08-23|||December 2015||2015-12-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP|A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)|Recruiting||Phase 3|232|Anticipated|Baxalta US Inc.||3|||f||||t||||||||||2017-10-10 22:55:58.072212|2017-10-10 22:55:58.072212
NCT02549157|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Treatments for Urogynaecological Problems and Patient Selfreports|Relationship Between Treatments for Urogynecological Problems and Patient Reported Values, Psychological States, and Quality of Life|Recruiting||N/A|500|Anticipated|Swansea University|||1||f||||f||||||||||2017-10-10 22:55:58.255766|2017-10-10 22:55:58.255766
NCT02549144|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-11-16|||December 2015||2015-12-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|||Effects of a Large Increase in Dietary Fats and Cholesterol on HDL Composition and Function in Healthy Subjects|Effects of a Large Increase in Dietary Fats and Cholesterol on HDL Composition and Function in Healthy Subjects|Not yet recruiting||N/A|14|Anticipated|Azienda Ospedaliero, Universitaria Pisana||1|||f||||f||||||||||2017-10-10 22:55:58.330929|2017-10-10 22:55:58.330929
NCT02549131|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-03-21|||September 2015||2015-09-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Cesarean Wound Closure in Women With BMI 40 or Greater|Cesarean Wound Closure in Women With BMI 40 or Greater: A Randomized Controlled Trial Comparing Subcuticular Suture to Surgical Staples|Recruiting||N/A|420|Anticipated|Mednax Center for Research, Education and Quality||2|||f||||t||||||||No|no individual patient data will be shared|2017-10-10 22:55:58.420272|2017-10-10 22:55:58.420272
NCT02549118|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-11|||September 2015||2015-09-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Tenoxicam for Intrapartum Analgesia|Efficacy of Intravenous Tenoxicam as an Analgesic During the First Stage of Labor: A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 22:55:58.531187|2017-10-10 22:55:58.531187
NCT02549105|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-09-11|||October 2014||2014-10-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Lidocaine-Prilocaine Cream (EMLA) Topical Application Versus Wound Infiltration With Lidocaine After Cesarean Section|A Comparison Between Lidocaine-Prilocaine Cream (EMLA) Application And Wound Infiltration With Lidocaine For Post Caesarean Section Pain Relief : A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|80|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 22:55:58.627314|2017-10-10 22:55:58.627314
NCT02549079|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2015-09-14|||January 2004||2004-01-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Soluble Factors in the Serum of Severely Burned Patients|Soluble Factors in the Serum of Severely Burned Patients|Completed||N/A|23|Actual|RWTH Aachen University|||1||f||||t||||||Samples With DNA|"     blood samples   "|||2017-10-10 22:55:58.91886|2017-10-10 22:55:58.91886
NCT02549066|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-10-03|||January 2016||2016-01-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Interventional|ICAROX||Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation|Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation|Completed||N/A|18|Actual|Sahlgrenska University Hospital, Sweden||1|||f||||f||||||||||2017-10-10 22:55:58.988|2017-10-10 22:55:58.988
NCT02549053|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-09-14|||February 2012||2012-02-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Barrett||Prevalence of Human Papillomavirus in Barrett Esophagus Compared With Controls|Prevalence of Human Papillomavirus in Barrett Esophagus Compared With Controls|Completed||N/A|219|Actual|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 22:55:59.084058|2017-10-10 22:55:59.084058
NCT02549040|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2016-02-04|||September 2015||2015-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Bioavailability of MK-1439 Experimental Nano Formulations in Healthy Adults (MK-1439-046)|A Rapid Pharmacokinetic Trial of the Bioavailability of Four MK-1439 Nano Formulations in Healthy Adults|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 22:55:59.171524|2017-10-10 22:55:59.171524
NCT02549027|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-05-31|2015-11-04||November 6, 2009|Actual|2009-11-06|May 2017|2017-05-01|April 6, 2010|Actual|2010-04-06|April 6, 2010|Actual|2010-04-06||Interventional|||A Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG) (MK-1064-003)|A Crossover Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG)|Completed||Phase 1|20|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-10 22:55:59.272487|2017-10-10 22:55:59.272487
NCT02549014|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-11|2017-05-31|2015-10-30||July 6, 2009|Actual|2009-07-06|May 2017|2017-05-01|September 29, 2009|Actual|2009-09-29|September 29, 2009|Actual|2009-09-29||Interventional|||A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064 (MK-1064-001)|A Single Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||11|||f||||f||||||||||2017-10-10 22:55:59.996862|2017-10-10 22:55:59.996862
NCT02549001|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-11|||August 20, 2015|Actual|2015-08-20|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis|A Multicenter, Randomized, Double-blind, Parallel, Vehicle-controlled Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Onychomycosis|Active, not recruiting||Phase 3|953|Actual|Polichem S.A.||3|||f||||f||||||||||2017-10-10 22:56:01.204191|2017-10-10 22:56:01.204191
NCT02548988|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-11|||October 2015||2015-10-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Selective Neuromuscular Electrical Stimulation on VMO|Immediate Effect of Selective Neuromuscular Electrical Stimulation of Vastus Medialis Obliquus in Women With Patellofemoral Pain Syndrome|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||||2017-10-10 22:56:01.326889|2017-10-10 22:56:01.326889
NCT02548975|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-02-17|||November 2009||2009-11-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|||Risk Factors for Delirium Following Cardiac Surgery|Risk Factors for Delirium Following Cardiac Surgery|Completed||N/A|5600|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||||2017-10-10 22:56:01.396019|2017-10-10 22:56:01.396019
NCT02548962|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-07-06|||March 2016||2016-03-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma|A Randomized Multicenter Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|235|Anticipated|Pharmacyclics LLC.||3|||f||||t||||||||||2017-10-10 22:56:01.48534|2017-10-10 22:56:01.48534
NCT02548949|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-10-02|||April 2016|Actual|2016-04-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PMS||Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQ|Korean Post Marketing Surveillance To Observe Effectiveness And Safety Of Pristiq (Registered) In Patients With Major Depressive Disorder.|Recruiting||N/A|600|Anticipated|Pfizer|||1||f||||f||||||None Retained|"     Retention of biospecimen is not needed necessarily. If the investigator check blood sample     under routine practice during the study, investigator record results of blood sampling, such     as CBC and blood chemistry.      Full lists of recordings are following : Hemoglobin, Hematocrit, RBC, WBC, Platelets, Sodium,     Potassium, BUN, Creatinine, Calcium, Total Bilirubin, SGOT/AST, SGPT/ALT, Cholesterol.   "|||2017-10-10 22:56:01.671868|2017-10-10 22:56:01.671868
NCT02548936|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-11|||April 2015||2015-04-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE|Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy in Reduction of Progression of Atherosclerosis Among Patients With Systemic Lupus Erythematosus: A Randomized Single-Blind Trial|Unknown status|Enrolling by invitation|Early Phase 1|30|Actual|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 22:56:01.937098|2017-10-10 22:56:01.937098
NCT02548923|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-09-11|||November 2014||2014-11-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients|Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients|Completed||Phase 4|57|Actual|University of Tennessee Graduate School of Medicine||2|||f||||f||||||||||2017-10-10 22:56:02.066921|2017-10-10 22:56:02.066921
NCT02548910|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-09-26|||April 2016||2016-04-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRICE||Phlebotomy to Prevent Blood Loss in Major Hepatic Resections|The PRICE Trial: Phlebotomy Resulting in Controlled Hypovolemia to Prevent Blood Loss in Major Hepatic Resections|Recruiting||N/A|62|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:56:02.166272|2017-10-10 22:56:02.166272
NCT02548897|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-09-20|||October 2015||2015-10-01|September 2017|2017-09-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease|Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease|Completed||N/A|5|Actual|University of Florida||1|||f||||t|f|t|f|||||||2017-10-10 22:56:02.302575|2017-10-10 22:56:02.302575
NCT02548884|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-01-13|||September 2015||2015-09-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Pancreatic Sphincterotomy Versus Double Wire Technique in Difficult Cannulation||Recruiting||N/A|1300|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-10 22:56:02.398952|2017-10-10 22:56:02.398952
NCT02548871|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-11|||September 2010||2010-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|June 2014|Actual|2014-06-01||Interventional|||Evaluation of the Teen Outreach Program in Chicago Public Schools|Evaluation of the Teen Outreach Program in Chicago Public Schools: Replication of an Evidence-Based Teen Pregnancy Prevention Program|Completed||N/A|12253|Actual|Chapin Hall Center for Children||2|||f||||f||||||||||2017-10-10 22:56:02.501089|2017-10-10 22:56:02.501089
NCT02548858|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-05-30|||August 2015||2015-08-01|May 2017|2017-05-01|July 1, 2017|Anticipated|2017-07-01|June 30, 2017|Anticipated|2017-06-30||Interventional|POETRY||Perineorrhaphy Outcomes Related to Body Imagery|Perineorrhaphy Outcomes Related to Body Imagery (POETRY)|Recruiting||N/A|46|Anticipated|University of New Mexico||2|||f||||f||||||||No||2017-10-10 22:56:02.591993|2017-10-10 22:56:02.591993
NCT02537665|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-08-31|||June 2015||2015-06-01|August 2015|2015-08-01||||September 2015|Anticipated|2015-09-01||Interventional|||Heating Precondition of Epidural Catheter Decrease the Incidence of Injury to Blood Vessel During Epidural Catheter Placement||Unknown status|Recruiting|N/A|200|Anticipated|Fudan University||2|||f||||||||||||||2017-10-10 22:58:27.583096|2017-10-10 22:58:27.583096
NCT02548832|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-10|||April 2013||2013-04-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Effect of Administration of the Combination Bezafibrate More Berberine on Lipid Profile in Patients With Dyslipidemia|Effect of Administration of the Combination Bezafibrate More Berberine on Lipid Profile in Patients With Mixed Dyslipidemia|Unknown status|Recruiting|Phase 2|60|Anticipated|University of Guadalajara||3|||f||||f||||||||||2017-10-10 22:56:02.816469|2017-10-10 22:56:02.816469
NCT02548819|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-05-30|||September 2015||2015-09-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01|6 Months|Observational [Patient Registry]|CDMR||University Hospital Cardiac Device MR Registry: The Safety of MR Imaging in Patients With Implanted Cardiac Devices|University Hospital Cardiac Device MR Registry: The Safety of MR Imaging in Patients With Implanted Cardiac Devices|Completed||N/A|220|Actual|University Health Care System, Augusta, Georgia|||1||f||||f||||||||No||2017-10-10 22:56:02.958605|2017-10-10 22:56:02.958605
NCT02548806|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-04-15|||September 2015||2015-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers|Randomised Single Dose 3 Way Crossover Single Blind Study to Evaluate the Pharmacokinetic Dose Proportionality, Compare the Bioavailability and Safety of Clonidine Mucoadhesive Buccal Tablets (MBT) With Catapres in Normal Healthy Volunteers|Completed||Phase 1|36|Actual|Onxeo||3|||f||||f||||||||Yes|presentation at ESMO congress|2017-10-10 22:56:03.047755|2017-10-10 22:56:03.047755
NCT02548793|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-05-25|||January 2016||2016-01-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||CPR Education Via a Mobile Application Compared to VSI Kit|CPR Education for Families of Cardiac Patients Before Hospital Discharge|Enrolling by invitation||N/A|3000|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:56:03.172387|2017-10-10 22:56:03.172387
NCT02548780|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-04-25|||April 2016||2016-04-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||LifePearl-Doxo Pharmacokinetic (PK) Study|Pharmacokinetic Study in Patients With Unresectable Hepatocellular Carcinoma (HCC) Receiving Treatment With LifePearl Microspheres Loaded With Doxorubicin|Recruiting||N/A|25|Anticipated|Terumo Europe N.V.||1|||f||||t||||||||||2017-10-10 22:56:03.359031|2017-10-10 22:56:03.359031
NCT02548767|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-07-13|||February 2016||2016-02-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Adverse Metabolic Effects of Dietary Sugar|Adverse Metabolic Effects of Dietary Sugar: Ad Libitum vs Energy-balanced Diets|Recruiting||N/A|72|Anticipated|University of California, Davis||4|||f||||f||||||||||2017-10-10 22:56:03.508744|2017-10-10 22:56:03.508744
NCT02548754|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-04-07|||May 2016||2016-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|TREAT-AF||Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation|TRanscutaneous Electrical vAgus Nerve sTimulation to Suppress Atrial Fibrillation|Recruiting||N/A|52|Anticipated|University of Oklahoma||2|||f||||t||||||||||2017-10-10 22:56:03.670319|2017-10-10 22:56:03.670319
NCT02548741|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-09-10|||September 2015||2015-09-01|August 2015|2015-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|MET||Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes|Evaluation of the Metformin Scavenging Mechanism on Methylglyoxal in Patients With Type 2 Diabetes Mellitus|Unknown status|Not yet recruiting|N/A|120|Anticipated|University of Arizona||3|||f||||||||||||||2017-10-10 22:56:03.770589|2017-10-10 22:56:03.770589
NCT02548728|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-05-07|||February 2016||2016-02-01|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Oxytocin Treatment of Opioid Dependence|Oxytocin Treatment of Opioid Dependence|Enrolling by invitation||Phase 1/Phase 2|25|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 22:56:03.885985|2017-10-10 22:56:03.885985
NCT02548715|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-11|||July 2015||2015-07-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|LSHT||Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery|Levothyroxine Treatment of Subclinical Hypothyroidism After Non-thyroid Head and Neck Surgery: A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 2/Phase 3|200|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 22:56:04.003867|2017-10-10 22:56:04.003867
NCT02548702|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-10|||October 2015||2015-10-01|September 2015|2015-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|Fit4Life||Community-based Sport Programme and Type 2 Diabetes|Effect of a Community-based Sport Programme on Disease Symptoms and Quality of Life in Men and Women With Type 2 Diabetes|Not yet recruiting||N/A|4032|Anticipated|Nottingham Trent University||2|||f||||f||||||||||2017-10-10 22:56:04.095083|2017-10-10 22:56:04.095083
NCT02548689|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-12-16|||July 2015||2015-07-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||PAI-1 Expression in Non-scarring Hair Loss|Evaluating PAI-1 Expression in the Hair Follicles of Patients With Non-scarring Hair Loss.|Recruiting||N/A|55|Anticipated|Northwestern University|||2||f||||f||||||Samples With DNA|"     Skin tissue will be formalin-fixed overnight at room temperature, processed and paraffin     embedded. Six micron thick sections will be prepared. Tissue blocks and slides will be stored     at room temperature. All samples will be de-identified.   "|||2017-10-10 22:56:04.215218|2017-10-10 22:56:04.215218
NCT02548676|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-11-30|||April 2015||2015-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Optical Angiography in Glaucoma|Optical Angiography in Glaucoma|Recruiting||N/A|60|Anticipated|Medical University of Vienna|||2||f||||||||||||||2017-10-10 22:56:04.34988|2017-10-10 22:56:04.34988
NCT02548663|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-14|||June 2014||2014-06-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|ME_E_SLA||Sport Therapy and Osteopathy Manipulative Treatment in ALS|Sport Therapy for Contrasting the Deterioration of Muscle Oxidative Metabolism in Patients Affected by Amyotrophic Lateral Sclerosis (ALS) - Project ME_E_SLA|Completed||N/A|30|Actual|University of Milano Bicocca||2|||f||||f||||||||||2017-10-10 22:56:04.464476|2017-10-10 22:56:04.464476
NCT02548650|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-03-23|||March 2016||2016-03-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|OPTIMUS-5||Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus|Pharmacodynamic Effects of Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus: The Optimizing Anti-Platelet Therapy In Diabetes MellitUS (OPTIMUS)-5 Study|Recruiting||Phase 4|64|Anticipated|University of Florida||2|||f||||f|f|f||||||No||2017-10-10 22:56:04.562952|2017-10-10 22:56:04.562952
NCT02548637|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-07-12|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Effects of Acupuncture on Aromatase Inhibitor-Induced Joint Pain|Effects of Acupuncture on Aromatase Inhibitor-Induced Joint Pain|Completed||N/A|20|Anticipated|John Wayne Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 22:56:04.675064|2017-10-10 22:56:04.675064
NCT02548624|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-04-04|||November 2016||2016-11-01|April 2017|2017-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position|An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position|Withdrawn||N/A|0|Actual|Medtronic - MITG|||1|Protocol is being reevaluated by sponsor|f||||f||||||||||2017-10-10 22:56:04.752385|2017-10-10 22:56:04.752385
NCT02548611|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-03-08|||September 2015||2015-09-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|SASSICAIA||Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention|Intensified Loading With Prasugrel Versus Standard Loading With Clopidogrel in Invasive-treated Patients With Biomarker-Negative Angina Pectoris|Recruiting||Phase 4|2240|Anticipated|Klinikum der Universitaet Muenchen||2|||f||||t||||||||No||2017-10-10 22:56:04.822771|2017-10-10 22:56:04.822771
NCT02548598|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-02-23|||January 2017||2017-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|AIMS||Analysis of Inflammation and Microbiome in Patients With Sinusitis and Asthma|Analysis of Inflammation and Microbiome in Patients With Sinusitis and Asthma|Recruiting||N/A|160|Anticipated|University of California, San Francisco|||3||f||||f||||||Samples Without DNA|"     Mucus collected from the airway, induced sputum, brushings from the airway epithelium, mucus     collected from the nasal passages, and blood.   "|||2017-10-10 22:56:04.921921|2017-10-10 22:56:04.921921
NCT02548585|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-07-11|||December 9, 2015|Actual|2015-12-09|July 2017|2017-07-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Interventional|||A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Subjects With Type 2 Diabetes|A Phase 1/2, Randomized, Double-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MEDI0382 in Overweight and Obese Subjects With a History of Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|113|Actual|MedImmune LLC||2|||f||||f|f|f||||||||2017-10-10 22:56:05.016179|2017-10-10 22:56:05.016179
NCT02548572|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-11-26|||March 2017||2017-03-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|TES/RP||Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study|Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy NSR Device Study - A Multicenter Study|Not yet recruiting||N/A|210|Anticipated|Wills Eye||2|||f||||t||||||||Yes||2017-10-10 22:56:05.131707|2017-10-10 22:56:05.131707
NCT02548559|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-09-12|||November 2016||2016-11-01|September 2016|2016-09-01||||November 2017|Anticipated|2017-11-01||Interventional|||Sublingual Cannabidiol for Anxiety|Sublingual Cannabidiol for Anxiety|Not yet recruiting||Phase 2|16|Anticipated|Mclean Hospital||1|||f||||f||||||||||2017-10-10 22:56:05.210721|2017-10-10 22:56:05.210721
NCT02548546|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-09-15|||August 2015||2015-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques|Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques|Recruiting||N/A|30|Anticipated|Mayo Clinic||3|||f||||f||||||||||2017-10-10 22:56:05.313698|2017-10-10 22:56:05.313698
NCT02548533|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-08-25|||June 2015||2015-06-01|September 2015|2015-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Fractional Laser Assisted Topical Anesthesia|Fractional CO2 Laser Assisted Topical Articaine Anesthesia vs. Topical EMLA Administration: a Randomized Controlled Study|Unknown status|Recruiting|Phase 4|10|Anticipated|Netherlands Institute for Pigment Disorders||2|||f||||f||||||||||2017-10-10 22:56:05.392869|2017-10-10 22:56:05.392869
NCT02548520|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-11|||October 2008||2008-10-01|September 2015|2015-09-01|March 2012|Actual|2012-03-01|July 2011|Actual|2011-07-01||Observational|||Maternal and Infant Vitamin Status During the First Nine Months of Infant Life|Vitamin D Status in the First 9 Months of Life|Completed||N/A|107|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-10 22:56:05.488173|2017-10-10 22:56:05.488173
NCT02548507|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-10|||March 2015||2015-03-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01|3 Weeks|Observational [Patient Registry]|CNMI||Nocturnal Leg Cramps in Geneva : an Observational Study|Prevalence, Main Features and Treatment of Nocturnal Leg Cramps in Geneva: A Primary Care Prospective Observational Study|Unknown status|Recruiting|N/A|600|Anticipated|University of Geneva, Switzerland|||1||f||||f||||||||||2017-10-10 22:56:05.561957|2017-10-10 22:56:05.561957
NCT02548494|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-31|||November 2015||2015-11-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes|Early Administration of Long-acting Insulin Glargine for the Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes: A Randomized Double Blind Trial|Recruiting||N/A|90|Anticipated|Chattanooga-Hamilton County Hospital Authority||2|||f||||f||||||||||2017-10-10 22:56:05.679573|2017-10-10 22:56:05.679573
NCT02548481|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-08-16|||November 2015||2015-11-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Observational|BESTA-AVC||Validation and Standardisation of a Pool of Simplified Evaluation Aimed to the Diagnoses of Aphasic Disorders and Adapted to the Patients Suffering an Acute Phase of Stroke|Validation and Standardisation of a Pool of Simplified Evaluation Aimed to the Diagnoses of Aphasic Disorders and Adapted to the Patients Suffering an Acute Phase of Stroke|Recruiting||N/A|395|Anticipated|University Hospital, Limoges|||1||f||||f||||||||||2017-10-10 22:56:05.792674|2017-10-10 22:56:05.792674
NCT02548468|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-04-17|||November 20, 2015|Actual|2015-11-20|April 2017|2017-04-01|March 16, 2017|Actual|2017-03-16|January 23, 2017|Actual|2017-01-23||Interventional|||Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma|A Two-Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Cutaneous T Cell Lymphoma|Withdrawn||Phase 1|0|Actual|Thomas Jefferson University||1||Slow accrual|f||||t||||||||||2017-10-10 22:56:05.868968|2017-10-10 22:56:05.868968
NCT02548455|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-08-03|||October 27, 2015|Actual|2015-10-27|August 2017|2017-08-01|March 21, 2017|Actual|2017-03-21|August 19, 2016|Actual|2016-08-19||Interventional|||St Jude Medical LV Lead - Quartet 1457Q IDE|A Clinical Evaluation of the Safety of the St. Jude Medical Quartet 1457Q Left Ventricular Lead, an Investigational Device Exemption (IDE) Study|Completed||N/A|496|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-10 22:56:05.994012|2017-10-10 22:56:05.994012
NCT02548442|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-10-03|||August 2015||2015-08-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|CAMP-01||Children's Autism Metabolome Project|Children's Autism Metabolome Project (CAMP): Development and Clinical Evaluation of the Stemina Metabolic Biomarker-Based Test to Diagnose Autism Spectrum Disorder in Early Childhood|Recruiting||N/A|1500|Anticipated|Stemina Biomarker Discovery, Inc.|||3||f||||f||||||Samples With DNA|"     Blood plasma for metabolite analysis and blood samples for DNA and RNA expression analysis     will be collected from all children as part of the study protocol. In addition, a urine     sample for metabolite analysis will also be obtained from children capable of providing the     sample while at the clinical site.   "|||2017-10-10 22:56:06.1173|2017-10-10 22:56:06.1173
NCT02548429|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-21|||June 2017||2017-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:56:06.23106|2017-10-10 22:56:06.23106
NCT02548416|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-11-20|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Peroperative Use of Positive End-expiratory Pressure Prevents Formation of Atelectasis as Studied by Computerised Tomography at End of Surgery|Peroperative Use of Positive End-expiratory Pressure Prevents Formation of Atelectasis as Studied by Computerised Tomography at End of Surgery|Completed||N/A|24|Actual|Landstinget Västmanland||2|||f||||f||||||||||2017-10-10 22:56:06.271186|2017-10-10 22:56:06.271186
NCT02548403|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-10|||July 2014||2014-07-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Simethicone on Bowel Preparation for Colonoscopy|Use of Simethicone to Improve the Bowel Cleansing Effects of Polyethylene Glycol With Ascorbic Acid for Colonoscopy|Completed||Phase 3|260|Actual|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-10 22:56:08.196733|2017-10-10 22:56:08.196733
NCT02548390|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-09-23|||September 2015||2015-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of Intravenous RXDX-107 in Patients With Solid Tumors|A Phase 1/1b, Multicenter, Open-Label Study of Intravenous RXDX-107 in Adult Patients With Locally Advanced or Metastatic Solid Cancer|Terminated||Phase 1|70|Anticipated|Ignyta, Inc.||1||Company decision|f||||f||||||||||2017-10-10 22:56:08.291116|2017-10-10 22:56:08.291116
NCT02548377|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-10-13|||September 2015||2015-09-01|October 2016|2016-10-01||||January 2020|Anticipated|2020-01-01||Interventional|RIPC-HNC||Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial|Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial|Enrolling by invitation||N/A|60|Anticipated|Aarhus University Hospital Skejby||2|||f||||f||||||||||2017-10-10 22:56:08.392264|2017-10-10 22:56:08.392264
NCT02548364|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-03-21|||October 2015||2015-10-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|VITDAMI||Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)|Multicentric, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction|Recruiting||Phase 3|144|Anticipated|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz||2|||f||||f||||||||||2017-10-10 22:56:08.495122|2017-10-10 22:56:08.495122
NCT02548351|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-08-14|||September 2015||2015-09-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|REGENERATE||Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment|A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis|Recruiting||Phase 3|2000|Anticipated|Intercept Pharmaceuticals||3|||f||||t||||||||||2017-10-10 22:56:08.853818|2017-10-10 22:56:08.853818
NCT02548338|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-09-11|||September 2014||2014-09-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|||Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast Cancer|Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast Cancer|Completed||Phase 2/Phase 3|60|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-10 22:56:11.286333|2017-10-10 22:56:11.286333
NCT02548325|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-10|||July 2015||2015-07-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study|Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study|Unknown status|Recruiting|N/A|450|Anticipated|Corporacion Parc Tauli|||1||f||||f||||||||||2017-10-10 22:56:11.359587|2017-10-10 22:56:11.359587
NCT02548312|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-02-14|||January 2016||2016-01-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Effect of Different Financial Competing Interest Statements on Readers' Perceptions of Clinical Educational Articles|Randomised Controlled Trial to Measure the Effect of Different Financial Competing Interest Statements on Readers' Perceptions of Clinical Educational Articles|Completed||N/A|1065|Actual|The BMJ||8|||f||||f||||||||||2017-10-10 22:56:11.445394|2017-10-10 22:56:11.445394
NCT02548299|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-03-31|||May 2015||2015-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Cooking and Nutrition Education for Health Among Adults With Diabetes|Cooking and Nutrition Education for Health Among Adults With Diabetes|Completed||N/A|45|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-10-10 22:56:11.547423|2017-10-10 22:56:11.547423
NCT02536209|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2016-01-04|||August 2015||2015-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects||Completed||Phase 1|20|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||f||||||||||2017-10-10 22:58:44.678646|2017-10-10 22:58:44.678646
NCT02548286|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-12-04|||August 2015||2015-08-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs|A Randomized, Open-label, Single-dosing, Crossover Study to Compare the Safety and Pharmacokinetics of CKD-330(Fixed-dose Combination of Candesartan Cilexetil 8 mg and Amlodipine 5 mg) With Coadministration of the Two Separate Drugs in Healthy Male Volunteers(B)|Completed||Phase 1|53|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 22:56:11.648594|2017-10-10 22:56:11.648594
NCT02548273|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-10|||January 2013||2013-01-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Observational|||Corneal Changes in Diabetics After Phacoemulsification|Corneal Changes in Diabetics After Phacoemulsification|Completed||N/A|160|Actual|Jawaharlal Institute of Postgraduate Medical Education & Research|||2||f||||t||||||||||2017-10-10 22:56:11.744869|2017-10-10 22:56:11.744869
NCT02548260|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-08-11|||March 2016||2016-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment of Proximal Interphalangeal Joint Injuries. Clinical Efficiency of Syndactyly Treatment and Digital Compression|Treatment of Proximal Interphalangeal Joint Injuries. Comparative Study of the Clinical Efficiency and Cost of Syndactyly Treatment Versus Immobilization and Compression Versus no Compression|Recruiting||N/A|180|Anticipated|Centre Hospitalier Universitaire Vaudois||4|||f||||t||||||||||2017-10-10 22:56:11.823019|2017-10-10 22:56:11.823019
NCT02548247|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-11|||March 2011||2011-03-01|September 2015|2015-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Consumption of Orafti® Inulin on Bowel Motor Function in Subjects With Constipation|Effect of Consumption of Inulin on Bowel Motor Function in Subjects With Constipation|Completed||N/A|54|Actual|Beneo GmbH||2|||f||||f||||||||||2017-10-10 22:56:11.950292|2017-10-10 22:56:11.950292
NCT02548234|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-13|||September 11, 2015|Actual|2015-09-11|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Effect of Mirror Therapy Versus Bilateral Arm Training for Rehabilitation After Chronic Stroke|Effect of Mirror Therapy Versus Bilateral Arm Training for Rehabilitation After Chronic Stroke: a Pilot Randomized-controlled Trial|Recruiting||N/A|60|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-10 22:56:12.210232|2017-10-10 22:56:12.210232
NCT02548221|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2015-09-11|||September 2015||2015-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|TTE||Impact of Large-Volume Pleural Effusions on Heart Function|The Assessment of Heart Function Using Transthoracic Echocardiogram (TTE) Following Thoracentesis on Large-volume Pleural Effusions|Unknown status|Recruiting|N/A|30|Anticipated|Beijing Chao Yang Hospital|||1||f||||f||||||||||2017-10-10 22:56:12.352175|2017-10-10 22:56:12.352175
NCT02548208|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-11|||January 2011||2011-01-01|September 2015|2015-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Single Focused Shock Wave in the Release od Delayed Onset Muscle Soreness (DOMS)|Effect of a Single Administration of Focused Extracorporeal Shock Wave in the Relief of Delayed-Onset Muscle Soreness|Completed||N/A|46|Actual|Goethe University||3|||f||||f||||||||||2017-10-10 22:56:12.475277|2017-10-10 22:56:12.475277
NCT02548195|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-09-11|||July 2015||2015-07-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma|Oxaliplatin Plus Gemcitabine Versus Capecitabine Alone as Adjuvant Treatment in the Prevention of Recurrence of Intrahepatic Cholangiocarcinoma|Recruiting||Phase 3|286|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 22:56:12.593882|2017-10-10 22:56:12.593882
NCT02548182|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-11|||March 2015||2015-03-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|EPAWROSFI||Enhancing Physical Activity and Weight Reduction Through Smartcare and Financial Incentives|Enhancing Physical Activity and Weight Reduction Through Smartcare and Financial Incentives: A Pilot Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|105|Anticipated|Seoul National University Hospital||3|||f||||f||||||||||2017-10-10 22:56:12.760636|2017-10-10 22:56:12.760636
NCT02548169|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-03-16|||August 2015||2015-08-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|PancVax||Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer|A Phase I, Safety Trial of Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer|Recruiting||Phase 1|20|Anticipated|Baylor Research Institute||2|||f||||t||||||||||2017-10-10 22:56:12.876006|2017-10-10 22:56:12.876006
NCT02548156|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-01-16|2016-06-16||September 2015||2015-09-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Intra Oral Kinetics of Fluoride Containing Dentifrices|Intra-oral Kinetics of Fluoride Containing Dentifrices in a Modified Saliva Clearance Study|Completed||N/A|29|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:56:13.021844|2017-10-10 22:56:13.021844
NCT02548143|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-01-24|||August 2016||2016-08-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|LR769||A Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) LR769 for the Prevention of Excessive Bleeding in Congenital Hemophilia A or B Patients With Inhibitors to Factor VIII or IX Undergoing Elective Surgery or Other Invasive Procedure|A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Congenital Hemophilia A or B Patients With Inhibitors to Factor VIII or IX Undergoing Elective Surgery or Other Invasive Procedures (PERSEPT 3)|Recruiting||Phase 3|12|Anticipated|LFB USA, Inc.||1|||f||||t||||||||Undecided||2017-10-10 22:56:13.596034|2017-10-10 22:56:13.596034
NCT02548130|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-10|||October 2002||2002-10-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Impact of MELD Score for 700 Consecutive Liver Transplantations|Impact of the Introduction of the MELD Score to Prioritize the Waiting List on Survival, Blood Losses, And Transfusion Requirement for 700 Consecutive Liver Transplantations, Observational Study|Completed||N/A|700|Actual|Centre hospitalier de l'Université de Montréal (CHUM)|||2||f||||f||||||||||2017-10-10 22:56:13.706318|2017-10-10 22:56:13.706318
NCT02548117|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-07-14|||February 2016||2016-02-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||H-36731: Finasteride in Management of Elevated Red Blood Cells|H-36371: Finasteride as a Method of Managing Testosterone-Induced Erythrocytosis|Withdrawn||Phase 3|0|Actual|Baylor College of Medicine||2||Funding was not available.|f||||f||||||||||2017-10-10 22:56:14.687235|2017-10-10 22:56:14.687235
NCT02548104|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-05|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block|Department of Anesthesiology of Cedars Sinai Medical Center|Not yet recruiting||N/A|144|Anticipated|Cedars-Sinai Medical Center||4|||f||||f|f|f||||||||2017-10-10 22:56:14.80576|2017-10-10 22:56:14.80576
NCT02548065|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-01-30|||April 1, 2015|Actual|2015-04-01|January 2017|2017-01-01|January 30, 2017|Actual|2017-01-30|October 31, 2016|Actual|2016-10-31||Interventional|VET||"Efficacy and Tolerability of Balneotherapy With Mineral Water Named Debole of Vetriolo in Fibromyalgia Syndrome"|"Efficacy and Tolerability of Balneotherapy With Mineral Water Named Debole of Vetriolo in Patients With Fibromyalgia Syndrome (FS): A Randomized Double Blind Controlled Clinical Trial"|Completed||N/A|100|Actual|Azienda Ospedaliera Universitaria Senese||2|||f||||t||||||||||2017-10-10 22:56:15.215126|2017-10-10 22:56:15.215126
NCT02548052|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-05-12|||October 22, 2015|Actual|2015-10-22|May 2017|2017-05-01|February 19, 2016|Actual|2016-02-19|February 19, 2016|Actual|2016-02-19||Interventional|||Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis|A Phase I Trial to Evaluate Safety and Efficacy of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test|Completed||Phase 1|15|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 22:56:15.368326|2017-10-10 22:56:15.368326
NCT02548039|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-06-14|||January 2015||2015-01-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Observational|||To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients.|To Study The Influence Of Pharmacogenomics Factors On Pharmacokinetics And Pharmacodynamics Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients.|Recruiting||Phase 4|300|Anticipated|KK Women's and Children's Hospital|||1||f||||f||||||Samples With DNA|"     Plasma, serum and Genomic DNA.   "|Undecided||2017-10-10 22:56:15.501735|2017-10-10 22:56:15.501735
NCT02548026|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-10|||January 2011||2011-01-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|MAGS||Meals and Grazing Study|Meals and Grazing Study|Completed||N/A|15|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-10 22:56:15.623727|2017-10-10 22:56:15.623727
NCT02548013|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-09-11|||August 2014||2014-08-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Preterm Premature Rupture of Membranes, Outpatient Management vs Inpatient Management|Is Outpatient Management of PPROM Equivalent to Hospital Management|Unknown status|Recruiting|N/A|560|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 22:56:15.746138|2017-10-10 22:56:15.746138
NCT02548000|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-08-02|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|December 2016|Actual|2016-12-01||Interventional|DRTAE||Diabetes Resistance Training Adaptations in Elderly|Muscle and Vascular Adaptations Induced by Resistance Training in Elderly Diabetic Type 2|Completed||N/A|40|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 22:56:15.873252|2017-10-10 22:56:15.873252
NCT02547987|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-10-23|||September 2015||2015-09-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|CADENCE||Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer|CADENCE: Carboplatin and Docetaxel in Neoadjuvant Treatment of ER-Negative, HER2-Negative Breast Cancer: A Co-Clinical Trial With Genoproteomic Discovery|Recruiting||Phase 2|44|Anticipated|Baylor Breast Care Center||1|||f||||t||||||||No||2017-10-10 22:56:16.000775|2017-10-10 22:56:16.000775
NCT02547974|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-04-06|||August 31, 2015|Actual|2015-08-31|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.|An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.|Completed||Phase 1|120|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-10-10 22:56:16.150897|2017-10-10 22:56:16.150897
NCT02547961|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-08-14|||September 2015|Actual|2015-09-01|September 2015|2015-09-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||Chimeric Antigen Receptor-Modified T Cells for Breast Cancer|Chimeric Antigen Receptor-Modified T Cells for HER-2 Positive Recurrent and Metastatic Breast Cancer|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 22:56:16.272083|2017-10-10 22:56:16.272083
NCT02547948|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-08-14|||September 2015|Actual|2015-09-01|September 2015|2015-09-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||CD19-targeting CAR T Cells for B Cell Lymphoma|CD19-targeting CAR T Cells for Refractory B Cell Lymphoma|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 22:56:16.393769|2017-10-10 22:56:16.393769
NCT02547935|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-09-25|||September 21, 2015|Actual|2015-09-21|September 2017|2017-09-01|March 28, 2018|Anticipated|2018-03-28|March 28, 2018|Anticipated|2018-03-28||Interventional|||A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD|An Exploratory Phase II/III, Randomized, Double-blind, Placebo Controlled, Parallel Design Study to Evaluate the Efficacy, Safety and Pharmacodynamics of Dapagliflozin and Dapagliflozin in Combination With Saxagliptin in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria Treated With ACEi or ARB|Active, not recruiting||Phase 2/Phase 3|458|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 22:56:16.523395|2017-10-10 22:56:16.523395
NCT02547922|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-09-19|||November 4, 2015|Actual|2015-11-04|September 2017|2017-09-01|July 20, 2020|Anticipated|2020-07-20|May 27, 2019|Anticipated|2019-05-27||Interventional|TULIP-LN1||Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis|A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects With Active Proliferative Lupus Nephritis|Recruiting||Phase 2|150|Anticipated|AstraZeneca||3|||f||||t|t|f||||||||2017-10-10 22:56:17.082208|2017-10-10 22:56:17.082208
NCT02547909|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-04-25|||May 2016||2016-05-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||The Application of Probe-based Confocal Laser Endomicroscopy in the Diagnosis of Deep Endometriosis|The Application of Probe-based Confocal Laser Endomicroscopy in the Diagnosis of Deep Endometriosis|Not yet recruiting||N/A|10|Anticipated|Sheba Medical Center||1|||f||||t||||||||||2017-10-10 22:56:17.48789|2017-10-10 22:56:17.48789
NCT02547896|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2015-09-10|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Effectiveness of Diclofenac and Its Association to Codeine After Lower Third Molar Extraction.|Effectiveness of Non-steroidal Anti-inflammatory Diclofenac and Its Association to the Opioid Codeine for Pain, Swelling and Trismus in the Bilateral Mandibular Third Molar Extraction With a High Degree of Difficulty Model.|Completed||Phase 4|50|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:56:17.606426|2017-10-10 22:56:17.606426
NCT02547883|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-06-16|||June 2016||2016-06-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|SITE||Statins In The Elderly|Mortality and Economic Impact of Stopping Statins in People Aged of 75 and Over: a Pragmatic Clinical Trial|Recruiting||N/A|2430|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 22:56:17.699674|2017-10-10 22:56:17.699674
NCT02547870|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-07-05|||August 2015||2015-08-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long‐Acting Nanosuspension of Rilpivirine on Pharmacokinetics|A Phase 1 Open‐Label, Randomized, Parallel‐Group Study in Healthy Subjects to Investigate the Effect of Different Storage Conditions of a Long‐Acting Nanosuspension of Rilpivirine on the Single‐Dose Plasma Pharmacokinetics of Rilpivirine After Intramuscular Injection|Completed||Phase 1|74|Actual|Janssen Infectious Diseases BVBA||2|||f||||f||||||||||2017-10-10 22:56:17.80236|2017-10-10 22:56:17.80236
NCT02547857|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-12-23|||September 2015||2015-09-01|December 2016|2016-12-01||||October 2016|Actual|2016-10-01||Observational|||Transvaginal Pelvic Ultrasound in the ED|Transvaginal Pelvic Ultrasound in the ED|Completed||N/A|114|Actual|Minneapolis Medical Research Foundation|||1||f||||f||||||||||2017-10-10 22:56:17.923724|2017-10-10 22:56:17.923724
NCT02547844|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-06-13|||September 2015||2015-09-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla|Open Randomized Study to Assess the Evolution of Plasma Lipid Profile by Lipidomic in Patients Infected With Human Immunodeficiency Virus (HIV-1) With Viral Suppression That Change Atripla® to Eviplera® Compared to Continue With Atripla®|Completed||Phase 4|30|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-10 22:56:18.059372|2017-10-10 22:56:18.059372
NCT02547831|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-09-10|||July 2013||2013-07-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|December 2015|Anticipated|2015-12-01||Observational|||Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients|Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients|Unknown status|Recruiting|N/A|100|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||1||f||||f||||||||||2017-10-10 22:56:18.167204|2017-10-10 22:56:18.167204
NCT02547818|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-06-23|||September 2015||2015-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|COGNITE||Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease|A Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease|Recruiting||Phase 3|600|Anticipated|AZTherapies, Inc.||4|||f||||t||||||||||2017-10-10 22:56:18.302976|2017-10-10 22:56:18.302976
NCT02547805|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-01-17|||September 2015||2015-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days|A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of ALLN-177 Treatment Over 28 Days in Patients With Secondary Hyperoxaluria and Kidney Stones|Completed||Phase 2|66|Actual|Allena Pharmaceuticals||2|||f||||t||||||||No||2017-10-10 22:56:18.765256|2017-10-10 22:56:18.765256
NCT02547792|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-05-08|||July 31, 2016|Actual|2016-07-31|May 2017|2017-05-01|October 4, 2018|Anticipated|2018-10-04|October 5, 2017|Anticipated|2017-10-05||Interventional|||Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults|Phase 1 , Placebo-Controlled, Dose-Ranging Trial to Determine Safety and Immunogenicity of an Oral Adenoviral-Vector Based Influenza B Vaccine|Active, not recruiting||Phase 1|54|Actual|Vaxart||3|||f||||t||||||||No||2017-10-10 22:56:18.927387|2017-10-10 22:56:18.927387
NCT02547779|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-13|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|SMART-SURG||Isotonic Solutions and Major Adverse Renal Events Trial in the Non-Medical Intensive Care Unit (SMART-SURG)|Isotonic Solutions and Major Adverse Renal Events Trial in Non-Medical Intensive Care Units|Completed||Phase 3|10000|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 22:56:19.057475|2017-10-10 22:56:19.057475
NCT02547766|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-05-09|||April 2015||2015-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices|Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices|Completed||Phase 1/Phase 2|10|Actual|University of Utah||1|||f||||t||||||||||2017-10-10 22:56:19.215643|2017-10-10 22:56:19.215643
NCT02547753|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-10-24|||October 2015||2015-10-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of Alveolar Wound Repair After Dental Extraction in Kidney Transplanted Recipients|Evaluation of Alveolar Wound Repair After Dental Extraction in Kidney Transplanted Recipients|Recruiting||N/A|60|Anticipated|University of Sao Paulo|||2||f||||t||||||Samples With DNA|"     blood and saliva - laboratorial tests   "|Yes|All the data will be available after the end of study|2017-10-10 22:56:19.318772|2017-10-10 22:56:19.318772
NCT02547727|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-11-23|||February 2016||2016-02-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults|Humoral and Cell-mediated Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in Previously Rabies Immunized HIV-infected Adults|Recruiting||N/A|40|Anticipated|Queen Saovabha Memorial Institute||2|||f||||f||||||||||2017-10-10 22:56:19.695887|2017-10-10 22:56:19.695887
NCT02547714|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2017-08-10|2017-04-11||June 16, 2015|Actual|2015-06-16|August 2017|2017-08-01|May 2, 2016|Actual|2016-05-02|May 2, 2016|Actual|2016-05-02||Interventional|||Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A|A Multi-center, Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety for 16 Weeks in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A|Completed||Phase 4|34|Actual|Novartis||1|||f||||f||||||||||2017-10-10 22:56:19.857202|2017-10-10 22:56:19.857202
NCT02547701|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-11|||August 2014|Actual|2014-08-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population|Multicentre, Open Label Study to Assess the Tolerability of P-3058 Nail Solution in Paediatric Patients Affected by Mild-to-moderate Onychomycosis|Completed||Phase 3|20|Actual|Polichem S.A.||1|||f||||f||||||||||2017-10-10 22:56:20.353926|2017-10-10 22:56:20.353926
NCT02547688|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-07|||January 2015||2015-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Assessment of the Tolerability of Dry Airflow in the Nasal Cavity During Sleep|Assessment of the Tolerability of Dry Airflow in the Nasal Cavity During Sleep|Withdrawn||N/A|0|Actual|Johns Hopkins University||1||Study sponsor discontinued|f||||f||||||||||2017-10-10 22:56:20.465109|2017-10-10 22:56:20.465109
NCT02547675|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-03-17||||||March 2016|2016-03-01||||||||Expanded Access|||Rociletinib (CO-1686) USA Expanded Access Program|An Expanded Access Protocol of Oral Rociletinib (CO-1686) as Epidermal Growth Factor Receptor (EGFR)-Directed Therapy for Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) With the T790M Resistance Mutation|No longer available||N/A|||Clovis Oncology, Inc.|||||||||||||||||||2017-10-10 22:56:20.543515|2017-10-10 22:56:20.543515
NCT02547662|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-07-12|||December 24, 2015|Actual|2015-12-24|April 2017|2017-04-01|December 15, 2020|Anticipated|2020-12-15|December 15, 2020|Anticipated|2020-12-15||Interventional|||Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia|Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients With Multiple Myeloma With Extramedullary Disease or Plasma Cell Leukemia|Recruiting||Phase 2|30|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 22:56:20.642923|2017-10-10 22:56:20.642923
NCT02547649|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-02-03|||October 2015||2015-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)|A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Pneumococcal Vaccine-Naïve Adults 50 Years of Age or Older|Completed||Phase 2|690|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-10 22:56:20.805983|2017-10-10 22:56:20.805983
NCT02547636|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2016-12-19|||December 2015||2015-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Prospective Clinical Evaluation of the FilmArray® NGDS Warrior Panel|Prospective Clinical Evaluation of the FilmArray® NGDS Warrior Panel|Completed||N/A|1822|Actual|BioFire Diagnostics, LLC|||1||f||||f||||||Samples With DNA|"     Residual specimens may be stored for use as negative clinical matrix in contrived testing     studies.   "|||2017-10-10 22:56:20.905018|2017-10-10 22:56:20.905018
NCT02547623|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-15|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|November 1, 2016|Actual|2016-11-01|October 1, 2016|Actual|2016-10-01||Interventional|||Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery|A Phase 3, Prospective, Randomized, Parallel-design, Multicenter Study to Evaluate the Safety of Icon Bioscience-10090 for the Treatment of Inflammation Associated With Cataract Surgery|Completed||Phase 3|180|Actual|ICON Bioscience Inc||2|||f||||f||||||||||2017-10-10 22:56:20.996043|2017-10-10 22:56:20.996043
NCT02547610|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-05-14|||May 2014||2014-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||MR/PET in the Evaluation of Patients With Esophageal Cancer|MR/PET in the Evaluation of Patients With Esophageal Cancer|Recruiting||N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:56:21.11338|2017-10-10 22:56:21.11338
NCT02547597|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-10|||April 2011||2011-04-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris|Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris|Completed||Phase 4|99|Actual|Gachon University Gil Medical Center||2|||f||||f||||||||||2017-10-10 22:56:21.213581|2017-10-10 22:56:21.213581
NCT02547584|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-04-19|||September 2015||2015-09-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|AWARE||Impact of Anxiety on Cardiac Substrate Modification in Women With Atrial Fibrillation Undergoing Catheter Ablation|Impact of Anxiety on Cardiac Substrate Modification in Women With Atrial Fibrillation Undergoing Catheter Ablation|Recruiting||N/A|152|Anticipated|Texas Cardiac Arrhythmia Research Foundation||2|||f||||f||||||||No||2017-10-10 22:56:21.328092|2017-10-10 22:56:21.328092
NCT02547571|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-11-21|||March 2016||2016-03-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|B-CLEAN||The Bowel CLEAnsing: A National Initiative|The Bowel CLEAnsing: A National Initiative|Recruiting||Phase 4|3500|Anticipated|McGill University Health Center||12|||f||||f||||||||Undecided||2017-10-10 22:56:21.454331|2017-10-10 22:56:21.454331
NCT02547181|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-10-21|||September 2014||2014-09-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparing Short-term Function and Pain After No Treatment or Splinting for Boxer's Fracture|Comparing Short-term Function and Pain After No Treatment or Splinting for Boxer's Fracture|Recruiting||N/A|40|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 22:56:26.082477|2017-10-10 22:56:26.082477
NCT02547558|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-10|||October 2015||2015-10-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Pulmonary Gas Exchange Response to Indacaterol in COPD|Pulmonary Gas Exchange Response to Indacaterol in Stable Symptomatic Chronic Obstructive Pulmonary Disease Patients|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-10 22:56:21.70588|2017-10-10 22:56:21.70588
NCT02547545|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-08-09|||September 2015||2015-09-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|BCCRPMM||Breast Cancer Chemotherapy Risk Prediction Mathematical Model|"Macro-microscopic Syndrome Differentiation and Combination，Based on the Chinese Medicine Clinical Phenotype to Construct Breast Cancer Chemotherapy Risk Prediction Mathematical Model"|Recruiting||N/A|795|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||1||f||||||||||||||2017-10-10 22:56:21.840667|2017-10-10 22:56:21.840667
NCT02547532|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-09|||September 2015||2015-09-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Observational|AATD||Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency|Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency|Unknown status|Not yet recruiting|N/A|100|Anticipated|Fondazione Salvatore Maugeri|||5||f||||f||||||||||2017-10-10 22:56:21.917662|2017-10-10 22:56:21.917662
NCT02547519|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2017-09-19|||August 2015||2015-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pre-POINT-Early Study|Pilot Study Using Oral Insulin at Early Age for Immune Efficacy in Primary Prevention of Type 1 Diabetes|Active, not recruiting||Phase 2|44|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-10-10 22:56:22.013282|2017-10-10 22:56:22.013282
NCT02547506|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-07-29|||September 2015||2015-09-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Observational|||Comparison of Cardiorespiratory Fitness Among Regular Exercisers With and Without Parkinson Disease and Across Different Modes of Group Exercise|Comparison of Cardiorespiratory Fitness Among Regular Exercisers With and Without Parkinson Disease and Across Different Modes of Group Exercise|Recruiting||N/A|45|Anticipated|University of Indianapolis|||3||f||||f||||||||||2017-10-10 22:56:22.121236|2017-10-10 22:56:22.121236
NCT02547493|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-04-26|||September 2015||2015-09-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|November 2016|Anticipated|2016-11-01||Interventional|VACINA||Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients|Comparison of Humoral Response to Conjugate Pneumococcal Vaccine and Polysaccharide Pneumococcal Vaccine in Rheumatoid Arthritis (RA) Patients Treated With Abatacept|Recruiting||N/A|80|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 22:56:22.217908|2017-10-10 22:56:22.217908
NCT02547480|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-10-17|||November 2015||2015-11-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||LifePearl-Iri Pharmacokinetic Study|Pharmacokinetic Study In Patients With Liver Predominant Unresectable mCRC Receiving Treatment With LifePearl Microspheres Loaded With Irinotecan|Recruiting||N/A|20|Anticipated|Terumo Europe N.V.||1|||f||||t||||||||||2017-10-10 22:56:22.378915|2017-10-10 22:56:22.378915
NCT02547467|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-09-09|||September 2015||2015-09-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|TOADS||TOADS Study: TO Assess Death From Septic Shock.|Epidemiological Survey of Death Modalities in Patients With Septic Shock Referred to French Intensive Care Units: TOADS Study.|Unknown status|Not yet recruiting|N/A|340|Anticipated|University Hospital, Angers|||1||f||||t||||||||||2017-10-10 22:56:22.487182|2017-10-10 22:56:22.487182
NCT02547454|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-05-09|2015-10-21||December 31, 2008|Actual|2008-12-31|May 2017|2017-05-01|November 30, 2014|Actual|2014-11-30|November 30, 2014|Actual|2014-11-30||Observational||Analysis population included all enrolled participants.|An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)|Investigating the Effectiveness of Renal Anaemia Treatment in Pre-Dialysis Patients With Mircera in Daily Clinical Practice - MIRVITA|Completed||N/A|393|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:56:22.714713|2017-10-10 22:56:22.714713
NCT02547441|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-07-20|||October 2015||2015-10-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|July 5, 2017|Actual|2017-07-05||Interventional|||Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle|A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With an Open-Label Safety Extension|Active, not recruiting||Phase 3|463|Actual|Cutanea Life Sciences, Inc.||2|||f||||f||||||||||2017-10-10 22:56:23.299677|2017-10-10 22:56:23.299677
NCT02547428|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-06-15|||August 2015||2015-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|A Phase IIb, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Crossover, Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2|85|Actual|Euthymics BioScience, Inc.||2|||f||||f||||||||||2017-10-10 22:56:23.605848|2017-10-10 22:56:23.605848
NCT02547415|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-25|||January 2015||2015-01-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|PEDOUL||Chronic Pain in Children and Adolescents.|Study of Characteristics of Medically Unexplained Chronic Pain in Children and Adolescents.|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f|f|f||||||||2017-10-10 22:56:23.763087|2017-10-10 22:56:23.763087
NCT02547402|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-05-02|||December 2015||2015-12-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|DDI||A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males|An Open-label Exploratory Study of the Pharmacokinetic Interaction of CXA-10 Administered to Steady State With Pravastatin and Vytorin® (Simvastatin and Ezetimibe) in Healthy Males|Completed||Phase 1|10|Actual|Complexa, Inc.||1|||f||||f||||||||No||2017-10-10 22:56:23.927726|2017-10-10 22:56:23.927726
NCT02547389|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-09|||January 2014||2014-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Enhancing Medical Compliance and Health-related Quality of Life of Patients With Epilepsy|Enhancing Medical Compliance and Health-related Quality of Life of Patients With Epilepsy: Randomized Controlled Trial|Completed||N/A|144|Actual|NMP Medical Research Institute||2|||f||||t||||||||||2017-10-10 22:56:24.077474|2017-10-10 22:56:24.077474
NCT02547376|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-09-29|||February 2015||2015-02-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Observational|||Genetic and Telomere Characteristics of High of Grade Soft Tissue Sarcomas|Genetic and Telomere Characteristics of High of Grade Soft Tissue Sarcomas|Recruiting||N/A|100|Anticipated|University Hospitals, Leicester|||1||f||||f||||||Samples With DNA|"     Soft tissue sarcoma tissue Blood (Plasma and Buffy coat) Saliva   "|||2017-10-10 22:56:24.175091|2017-10-10 22:56:24.175091
NCT02547363|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-04||2017-09-01|November 2015||2015-11-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 17, 2016|Actual|2016-08-17||Interventional|||Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up|Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up|Completed||Phase 3|316|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:56:24.287553|2017-10-10 22:56:24.287553
NCT02547350|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-09|||September 2015||2015-09-01|September 2015|2015-09-01||||December 2020|Anticipated|2020-12-01||Interventional|||Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas||Not yet recruiting||Phase 2|200|Anticipated|Peking University First Hospital||3|||f||||||||||||||2017-10-10 22:56:24.432724|2017-10-10 22:56:24.432724
NCT02547337|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-09|||September 2015||2015-09-01|September 2015|2015-09-01||||December 2016|Anticipated|2016-12-01||Observational|ISLET-PET||Glucose-stimulated Pancreatic Islet and Intestinal Blood Flow in Healthy Subjects and in Type 1 Diabetes|Glucose-stimulated Pancreatic Islet and Intestinal Blood Flow in Healthy Subjects and in Type 1 Diabetes Using Positron Emission Tomography and Diffusion Weighted Imaging|Unknown status|Not yet recruiting|N/A|20|Anticipated|Turku University Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma, serum, faeces   "|||2017-10-10 22:56:24.553161|2017-10-10 22:56:24.553161
NCT02547324|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-09-09|||May 2014||2014-05-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Slump Sitting X-ray of the Lumbar Spine Is Better Than Conventional Flexion View|Slump Sitting X-ray of the Lumbar Spine Is Better Than Conventional Flexion|Terminated||N/A|60|Actual|National University Hospital, Singapore||2||Study results were too significant|f||||f||||||||||2017-10-10 22:56:24.690595|2017-10-10 22:56:24.690595
NCT02547311|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-10|||July 2015||2015-07-01|September 2015|2015-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Shared Medical Appointments to Improve Outcomes in Adolescents With Type 1 Diabetes||Recruiting||N/A|320|Anticipated|University of Colorado Denver School of Medicine Barbara Davis Center||2|||f||||f||||||||||2017-10-10 22:56:24.806051|2017-10-10 22:56:24.806051
NCT02547298|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-09-21|||June 2015||2015-06-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Interstitial Cystitis (IC)-Like Findings With Hydrodistension|Correlation Between Urinary Symptoms and Interstitial Cystitis (IC)-Like Findings on Cystoscopy With Hydrodistension|Recruiting||N/A|990|Anticipated|St. Louis University||1|||f||||f||||||||||2017-10-10 22:56:24.927055|2017-10-10 22:56:24.927055
NCT02547285|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-10|||February 2013||2013-02-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Analysis of the Biomechanics of Walking|Analysis of the Biomechanics of Walking in the Senior Under the Terms of Footwear|Completed||N/A|120|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-10 22:56:25.131898|2017-10-10 22:56:25.131898
NCT02547272|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-03-22|||February 2013||2013-02-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|DigeSTAPH||Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus|Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus in a Cohort of Adult Patients Hospitalized in Intensive Care at the University Hospital of St Etienne.|Completed||N/A|400|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"     bacterial samples   "|No||2017-10-10 22:56:25.227902|2017-10-10 22:56:25.227902
NCT02547259|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-09|||September 2011||2011-09-01|September 2015|2015-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Influence of Emotion in a Test Run Forgetfulness|Influence of Negative or Painful Emotions in a Directed Forgetting Paradigm in Healthy Subjects and Patients With Schizophrenia|Completed||N/A|60|Actual|Centre Hospitalier Universitaire de Saint Etienne||4|||f||||f||||||||||2017-10-10 22:56:25.325588|2017-10-10 22:56:25.325588
NCT02547246|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-03-22|||January 2012||2012-01-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Transcranial Magnetic Stimulation and Bulimic Craving|Transcranial Magnetic Stimulation, Embodied Cognition and Bulimic Craving|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 22:56:25.426877|2017-10-10 22:56:25.426877
NCT02547233|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-03-22|||November 2015||2015-11-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up|Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up|Active, not recruiting||Phase 3|306|Anticipated|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:56:25.534244|2017-10-10 22:56:25.534244
NCT02547220|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-14|||October 1, 2015||2015-10-01|August 2017|2017-08-01|February 1, 2022|Anticipated|2022-02-01|February 1, 2022|Anticipated|2022-02-01||Interventional|||A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Patients With Kidney Transplant|A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinryze® (C1 Esterase Inhibitor [Human]) for the Treatment of Acute Antibody-mediated Rejection in Kidney Transplant Patients|Recruiting||Phase 3|112|Anticipated|Shire||2|||f||||t||||||||||2017-10-10 22:56:25.625377|2017-10-10 22:56:25.625377
NCT02547207|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-03-02|||December 2015||2015-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||MultiPoint Pacing Mapping Study|MultiPoint Pacing Mapping Study|Recruiting||N/A|40|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-10 22:56:25.925875|2017-10-10 22:56:25.925875
NCT02547194|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-03-29|||September 2015||2015-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Graft Patency as a Predictor of Health-related Quality of Life.|Graft Patency as a Predictor of Health-related Quality of Life in Coronary Artery Bypass Patients.|Completed||N/A|254|Actual|Örebro County Council|||2||f||||f||||||||||2017-10-10 22:56:25.999233|2017-10-10 22:56:25.999233
NCT02519179|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-21|||June 2015||2015-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OBS-II||Influence of Bottle-Type of Infant Feeding Behavior||Active, not recruiting||N/A|48|Actual|California Polytechnic State University-San Luis Obispo||1|||f||||t||||||||||2017-10-10 23:03:38.609282|2017-10-10 23:03:38.609282
NCT02547168|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-03-15|||March 2016||2016-03-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|Lung-AF||Determining the True Incidence of Atrial Fibrillation Before and After Lung Resection|Determining the True Incidence of Atrial Fibrillation Before and After Lung Resection|Recruiting||N/A|75|Anticipated|McMaster University||1|||f||||f||||||||No||2017-10-10 22:56:26.303912|2017-10-10 22:56:26.303912
NCT02547155|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-19|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Does Spinal Anesthesia for Prolapse Surgery With Lead to Urinary Retention?|Does Spinal Anesthesia for Prolapse Surgery With Concomitant Sling Procedures Lead to an Increase in Urinary Retention Compared to General Anesthesia?|Recruiting||N/A|68|Anticipated|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-10 22:56:26.40954|2017-10-10 22:56:26.40954
NCT02547142|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-03-15|||March 2016||2016-03-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Early Integration of Palliative Care in Esophageal Cancer Patients|Evaluation of the Implementation of an Early Integrated Palliative Care Program in the Esophageal Cancer Population|Recruiting||N/A|120|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 22:56:26.499749|2017-10-10 22:56:26.499749
NCT02547129|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-04-10|||September 2015||2015-09-01|April 2017|2017-04-01|January 23, 2017|Actual|2017-01-23|January 23, 2017|Actual|2017-01-23||Interventional|||Static vs. Articulating Antibiotic Spacer for PJI in TKA|A Randomized Clinical Trial of Static Versus Articulating Antibiotic Spacer for Treatment of Periprosthetic Joint Infection in Total Knee Arthroplasty|Completed||N/A|4|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:56:26.588752|2017-10-10 22:56:26.588752
NCT02547116|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-08-31|||November 2015||2015-11-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis|Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis|Not yet recruiting||Phase 4|16|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 22:56:26.660185|2017-10-10 22:56:26.660185
NCT02547103|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-09-07|||May 2016||2016-05-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|COSMO-PD||Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection|Efficacy and Safety of Local Application of Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection: A Pilot Study, Double- Blind, Stratified Randomized Controlled Trial|Recruiting||Phase 4|165|Anticipated|Chiang Mai University||3|||f||||t||||||||||2017-10-10 22:56:26.726556|2017-10-10 22:56:26.726556
NCT02547090|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2015-09-10|||February 2012||2012-02-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Observational|||Minimizing Complications in Scoliosis Surgery in Children With Cerebral Palsy|The Effect of Two Surgeons on Blood Loss and Operative Time in Cerebral Palsy (CP) Patients Undergoing Posterior Spinal Fusion|Completed||N/A|50|Actual|Phoenix Children's Hospital|||2||f||||f||||||||||2017-10-10 22:56:26.831405|2017-10-10 22:56:26.831405
NCT02547077|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-05-24|||July 2015||2015-07-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Use of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure|Use of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure: a Randomized Evaluator Blinded Split Wound Comparative Effectiveness Trial|Completed||N/A|50|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 22:56:26.896842|2017-10-10 22:56:26.896842
NCT02547064|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-06-07|2016-06-28||October 2015||2015-10-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|GlideMStylet||Effect of Modified Stylet Angulation on the Intubation With GlideScope®|Stylet Angulation of Seventy Degrees Reduced Time to Intubation With the GlideScope®: A Prospective Randomized Trial|Completed||N/A|162|Actual|Keimyung University Dongsan Medical Center||2|||f||||t||||||||||2017-10-10 22:56:26.976286|2017-10-10 22:56:26.976286
NCT02547038|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2017-09-28|||February 2015||2015-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy|Comparing the Efficacy and Impact on Gastrointestinal Microbiome of Reverse Hybrid Therapy and Bismuth Quadruple Therapy in Helicobacter Pylori Eradication|Recruiting||N/A|438|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-10 22:56:27.459646|2017-10-10 22:56:27.459646
NCT02547025|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-28|||December 2013||2013-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Personalized Treatment for Refractory H Pylori Infection|Personalized Treatment for Refractory H Pylori Infection|Recruiting||N/A|150|Anticipated|Kaohsiung Veterans General Hospital.||3|||f||||t||||||||||2017-10-10 22:56:27.592422|2017-10-10 22:56:27.592422
NCT02547012|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2015-09-09|||November 2013||2013-11-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Comparison of Two Rescue Therapies for Helicobacter Pylori Infection|Comparison of Two Rescue Therapies for Helicobacter Pylori Infection — A Multicenter Randomized Controlled Trial|Unknown status|Recruiting|N/A|160|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-10 22:56:27.720485|2017-10-10 22:56:27.720485
NCT02546999|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-29|||September 2015||2015-09-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|WE||Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?|Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?|Recruiting||Phase 4|96|Anticipated|St. Olavs Hospital||2|||f||||t|f|f||||||||2017-10-10 22:56:27.838369|2017-10-10 22:56:27.838369
NCT02546804|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-09-09|||June 2015||2015-06-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||A Clinical Trial to Study the Effects of Two Home Made Mouthwashes in Patients With Gum Diseases|Evaluate the Efficacy of Potassium Permanganate Mouthwash and Hot Salt Water Mouthwash and Their Comparison With Chlorhexidine Mouthwash on Plaque Index,Gingival Index and Periodontal Probing Depth|Unknown status|Recruiting|N/A|120|Anticipated|Government College of Dentistry, Indore||3|||f||||t||||||||||2017-10-10 22:56:31.629067|2017-10-10 22:56:31.629067
NCT02546986|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-09-01|||October 9, 2015|Actual|2015-10-09|September 2017|2017-09-01|January 26, 2018|Anticipated|2018-01-26|April 13, 2017|Actual|2017-04-13||Interventional|||Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer|A Phase 2 Multicenter, Randomized, Placebo Controlled, Double Blind Study to Assess the Safety and Efficacy of CC-486 (Oral Azacitidine) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Plus Placebo in Subjects With Previously Treated Locally Advanced or Metastatic Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|100|Actual|Celgene||2|||f||||t||||||||||2017-10-10 22:56:27.955298|2017-10-10 22:56:27.955298
NCT02546973|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-11-03|||September 2015||2015-09-01|November 2016|2016-11-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Observational|ANCA||Quality of Life in Patients With Anal Cancer|ANCA - A Registry Based Study of Clinical Results and Health Related Quality of Life in Patients After Treatment for Anal Cancer|Recruiting||N/A|300|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||No||2017-10-10 22:56:29.9564|2017-10-10 22:56:29.9564
NCT02546960|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-27||2017-09-08|November 12, 2015|Actual|2015-11-12|September 2017|2017-09-01|August 31, 2020|Anticipated|2020-08-31|September 12, 2016|Actual|2016-09-12||Interventional|||A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860|Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2 Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860|Active, not recruiting||Phase 2|848|Actual|Janssen Research & Development, LLC||6|||f||||t||f||||||||2017-10-10 22:56:30.076258|2017-10-10 22:56:30.076258
NCT02546947|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-02-24|||June 2015||2015-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CURAREA||Monitoring in Intensive Care Unit of Neuromuscular Blocking Agents Used for Acute Respiratory Distress Syndrome After Cardiothoracic Surgery|Monitoring in Intensive Care Unit of Neuromuscular Blocking Agents (NMBA) Used for Acute Respiratory Distress Syndrome (ARDS) After Cardiothoracic Surgery|Completed||N/A|82|Actual|Centre Chirurgical Marie Lannelongue||2|||f||||t||||||||No||2017-10-10 22:56:30.222949|2017-10-10 22:56:30.222949
NCT02546934|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-10|2017-01-03|||March 2016||2016-03-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|TNBC||ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)|A Phase II, Multicenter, Randomized Study of ABX Plus Cisplatin (AP) Versus Gemcitabine Plus Cisplatin (GP) as First-Line Treatment in Patients With Advanced Triple-Negative Breast Cancer|Recruiting||Phase 2|254|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 22:56:30.307773|2017-10-10 22:56:30.307773
NCT02546921|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-07-06|||September 2015||2015-09-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase I Study of MOv18 IgE, a First in Class Chimeric IgE Antibody in Patients With Advanced Solid Tumours|A Cancer Research UK Phase I Study of MOv18 IgE, a First in Class Chimeric IgE Antibody Against Folate Receptor-alpha, in Patients With Advanced Solid Tumours|Recruiting||Phase 1|25|Anticipated|Cancer Research UK|||||f||||f||||||||||2017-10-10 22:56:30.41327|2017-10-10 22:56:30.41327
NCT02546908|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-24|||September 9, 2015|Actual|2015-09-09|August 2017|2017-08-01|September 7, 2020|Anticipated|2020-09-07|September 7, 2020|Anticipated|2020-09-07|5 Years|Observational [Patient Registry]|||A Registry of Participants With Prostate Cancer in Asia|A Multicenter, Prospective, Longitudinal Registry of Patients With Prostate Cancer in Asia|Recruiting||N/A|3830|Anticipated|Janssen Research & Development, LLC|||3||f||||f||f||||||||2017-10-10 22:56:30.52058|2017-10-10 22:56:30.52058
NCT02546895|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Prospective Registration of Head and Neck Cancer|Prospective Registration of Head and Neck Cancer Patients for Clinical Data and Tissue Collection|Recruiting||N/A|2000|Anticipated|Samsung Medical Center|||1||f||||f||||||Samples With DNA|"     1. Serum        2. Tissue specimen   "|||2017-10-10 22:56:30.858811|2017-10-10 22:56:30.858811
NCT02546882|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-09-09|||February 2015||2015-02-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||The Improving Effect of Autologous Stromal Vascular Fraction (SVF) in Adipose Tissue on Skin Grafting|Phase 1/2 Study of Autologous Stromal Vascular Fraction in Adipose Tissue Transplantation in Improving Skin Grafting|Unknown status|Recruiting|Phase 1/Phase 2|75|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||||2017-10-10 22:56:30.978324|2017-10-10 22:56:30.978324
NCT02546869|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-06-01|||September 2015||2015-09-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting||Suspended||Phase 3|100|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:56:31.095324|2017-10-10 22:56:31.095324
NCT02546856|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-09-07|||March 2015||2015-03-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2017|Actual|2017-09-01||Interventional|ETIFIC||Safety and Effectiveness of Drug up Titration by Nurses Specialized in Heart Failure (HF) Patients|Safety and Effectiveness of Drug up Titration by Nurses Specialized in Heart Failure (HF) Patients|Recruiting||Phase 4|628|Anticipated|Hospital Galdakao-Usansolo||2|||f||||f||||||||||2017-10-10 22:56:31.185406|2017-10-10 22:56:31.185406
NCT02546843|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2016-10-24|||September 2015||2015-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PedLapBlock||Depth of Neuromuscular Blockade and the Perioperative Conditions in Laparoscopic Surgery in Pediatric Population|Deep Neuromuscular Blockade During Laparoscopic Surgery in Pediatric Patient and the Impact of the Depth of the Blockade on the Surgery Conditions, Perioperative Complications and Surgeon Satisfaction|Recruiting||N/A|200|Anticipated|Brno University Hospital||2|||f||||t||||||||||2017-10-10 22:56:31.31417|2017-10-10 22:56:31.31417
NCT02546830|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-04-25|||January 2016||2016-01-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|FreeO2PostOp||Automatic Oxygen Administration After Major Abdominal and Thoracic Surgery|Automatic Oxygen Administration in Early and Late Postoperative Hypoxaemia Prevention After Major Abdominal and Thoracic Surgery|Recruiting||N/A|180|Anticipated|University Hospital, Brest||2|||f||||t||||||||No||2017-10-10 22:56:31.441772|2017-10-10 22:56:31.441772
NCT02546817|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-09-26|||November 30, 2015|Actual|2015-11-30|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30|2 Years|Observational [Patient Registry]|||Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS|Eliquis (Apixaban) Regulatory Postmarketing Surveillance In Real World Practice (rPMS) For Venous Thromboembolism (VTE) Treatment And Prevention Of Recurrent VTE|Active, not recruiting||N/A|265|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:56:31.558247|2017-10-10 22:56:31.558247
NCT02546791|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-07-24|||July 22, 2015|Actual|2015-07-22|July 2017|2017-07-01|March 29, 2017|Actual|2017-03-29|November 30, 2016|Actual|2016-11-30||Observational|PASS||Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study|Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study|Completed||N/A|101|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 22:56:31.744712|2017-10-10 22:56:31.744712
NCT02546778|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-09|||May 2014||2014-05-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Radiofrequency on Located Adiposity|Effects of Radiofrequency on Located Adiposity: A Pilot Study|Completed||N/A|30|Actual|Federal University of Health Science of Porto Alegre||1|||f||||t||||||||||2017-10-10 22:56:31.815857|2017-10-10 22:56:31.815857
NCT02546765|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-11|||October 2015||2015-10-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Delirium||Dexmedetomidine and IV Acetaminophen for the Prevention of Postoperative Delirium Following Cardiac Surgery|Dexmedetomidine and IV Acetaminophen for the Prevention of Postoperative Delirium Following Cardiac Surgery in Adult Patients 60 Years of Age and Older|Recruiting||Phase 4|120|Anticipated|Beth Israel Deaconess Medical Center||4|||f||||t||||||||||2017-10-10 22:56:31.899543|2017-10-10 22:56:31.899543
NCT02546752|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-05-24|||September 2015||2015-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine|Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine|Completed||Early Phase 1|1306|Actual|Regenstrief Institute, Inc.||2|||f||||f||||||||No|Individual provider data will not be shared.|2017-10-10 22:56:32.017628|2017-10-10 22:56:32.017628
NCT02546739|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-01|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL|Phase I Study of T Cells Expressing an Anti-CD19 Chimeric Receptor in Children and Young Adults With B Cell Malignancies|Not yet recruiting||Phase 1|100|Anticipated|Beijing Doing Biomedical Co., Ltd.||3|||f||||f|f|f||||||||2017-10-10 22:56:32.124881|2017-10-10 22:56:32.124881
NCT02546726|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-12-09|||August 2015||2015-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|HEAT||Heat & Aerobic Training (HEAT) Study|Heat & Aerobic Training (HEAT) for Pre-Hypertensive Middle-Aged Adults|Recruiting||N/A|50|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||Undecided||2017-10-10 22:56:32.220688|2017-10-10 22:56:32.220688
NCT02546713|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-18|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Abutment Macro Design and Peri-implant Tissues|The Influence of Abutment Macro-design on Peri-implant Tissue Dimensions for Guided Placed and Restored Implants|Active, not recruiting||N/A|28|Anticipated|Nova Southeastern University||2|||f||||f||||||||||2017-10-10 22:56:32.466904|2017-10-10 22:56:32.466904
NCT02546700|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-09-05|||September 30, 2015|Actual|2015-09-30|September 2017|2017-09-01|November 25, 2016|Actual|2016-11-25|November 25, 2016|Actual|2016-11-25||Interventional|||A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Chronic Obstructive Pulmonary Disease and a History of Exacerbations|Completed||Phase 2|309|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-10 22:56:32.573329|2017-10-10 22:56:32.573329
NCT02546687|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2015-09-09|||August 2015||2015-08-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||Prediction of Anastomotic Leak/Stricture After Esophagectomy With Gastric Pull-up by Venous Blood Gas|Prediction of Anastomotic Leak/Stricture After Esophagectomy With Gastric Pull-up by Venous Blood Gas|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Rabin Medical Center|||1||f||||t||||||Samples Without DNA|"     Venous blood gas mesurment   "|||2017-10-10 22:56:32.818435|2017-10-10 22:56:32.818435
NCT02546674|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-10-03|||February 18, 2016|Actual|2016-02-18|October 2017|2017-10-01|February 18, 2020|Anticipated|2020-02-18|February 18, 2020|Anticipated|2020-02-18||Interventional|NILOdeepR||Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.|A Phase IV Single Arm, Multicenter, Open-label Study Assessing Deep Molecular Response in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive CML in Chronic Phase After Two Years of Treatment With Nilotinib 300mg BID|Recruiting||Phase 4|171|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 22:56:32.906383|2017-10-10 22:56:32.906383
NCT02546661|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-21|||October 3, 2016|Actual|2016-10-03|September 2017|2017-09-01|March 21, 2019|Anticipated|2019-03-21|March 21, 2019|Anticipated|2019-03-21||Interventional|BISCAY||Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer|An Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Multi-Centre, Multi-arm Phase 1b Study in Patients With Muscle Invasive Bladder Cancer (MIBC) Who Have Progressed on Prior Treatment (BISCAY).|Recruiting||Phase 1|110|Anticipated|AstraZeneca||7|||f||||f|t|f||||||||2017-10-10 22:56:33.143578|2017-10-10 22:56:33.143578
NCT02546648|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-24|||February 2015||2015-02-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|October 2015|Actual|2015-10-01||Interventional|POISE-3||PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study|PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study (POISE-3)|Completed||Phase 3|100|Anticipated|McMaster University||1|||f||||f||||||||||2017-10-10 22:56:33.364164|2017-10-10 22:56:33.364164
NCT02546635|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-02-08|||August 2015||2015-08-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Potential Food Effect And Repeated Dosing of AX-024.HCl In Healthy Subjects|A Safety, Tolerability, and Pharmacokinetic Clinical Trial of AX-024.HCl to Evaluate A) Potential Food Effect and B) Multi-dosing in Healthy Male Subjects|Completed||Phase 1|32|Actual|Artax Biopharma Inc||2|||f||||f||||||||||2017-10-10 22:56:33.472339|2017-10-10 22:56:33.472339
NCT02546440|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-05-10|||September 2015||2015-09-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|DMF-CTCL||Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)|Phase IIA Study on Therapy With the NF-κB Inhibiting and Apoptosis Inducing Drug Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)|Recruiting||Phase 2|25|Anticipated|Universitätsmedizin Mannheim||1|||f||||t||||||||||2017-10-10 22:56:35.551548|2017-10-10 22:56:35.551548
NCT02546609|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-09-12|||November 19, 2015||2015-11-19|January 2017|2017-01-01|January 31, 2017|Actual|2017-01-31|November 30, 2016|Actual|2016-11-30||Interventional|||The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease|A Randomized, Blinded, Placebo-Controlled Study To Evaluate The Effect Fixed-Dose Leucine, Metformin, Sildenafil Combinations(NS-0200) Versus Placebo On Hepatic Fat Assessed By MRI In Non Alcoholic Fatty Liver Disease Patients|Completed||Phase 2|91|Actual|NuSirt Biopharma||3|||f||||f||||||||||2017-10-10 22:56:33.911743|2017-10-10 22:56:33.911743
NCT02546596|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-07-11|||April 2014||2014-04-01|July 2016|2016-07-01|February 2022|Anticipated|2022-02-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effect of Electro-Hyperthermia in Preoperative Radiotherapy for Locally Advanced Rectal Cancer|The Effect of Electro-hyperthermia in Preoperative Radiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer: Phase II Single Institutional Study|Recruiting||Phase 2|72|Anticipated|Yonsei Hyperthermia Study Group||1|||f||||t||||||||||2017-10-10 22:56:34.052848|2017-10-10 22:56:34.052848
NCT02546583|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-08-23|||August 2015||2015-08-01|August 2016|2016-08-01|July 2025|Anticipated|2025-07-01|July 2025|Anticipated|2025-07-01||Interventional|||Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure|Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure|Recruiting||N/A|200|Anticipated|Yale University||3|||f||||t||||||||||2017-10-10 22:56:34.138106|2017-10-10 22:56:34.138106
NCT02546570|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-12-15|||August 2015||2015-08-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Oxytocin and Affect Processing in Posttraumatic Stress Disorder|Posttraumatic Stress Disorder and Affective Functioning: A Test of the Potentially Normalizing Effects of Oxytocin|Active, not recruiting||Phase 4|11|Actual|Yale University||3|||f||||f||||||||Undecided||2017-10-10 22:56:34.222974|2017-10-10 22:56:34.222974
NCT02546557|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-04-25|||October 2015||2015-10-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|OPTICABG||Optilene® Suture for Coronary Artery Bypass Graft Surgery|Assessment of the Performance of a New Suture Material (Optilene® Suture) for Coronary Artery Bypass Graft Surgery. An Observational Post CE-mark Study|Recruiting||N/A|200|Anticipated|Aesculap AG|||1||f||||f||||||||||2017-10-10 22:56:34.480525|2017-10-10 22:56:34.480525
NCT02546531|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-09-22|||February 3, 2016|Actual|2016-02-03|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer|Phase I Study of Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer|Recruiting||Phase 1|50|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||||2017-10-10 22:56:34.740705|2017-10-10 22:56:34.740705
NCT02546518|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-11-27|||September 2015||2015-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||A Comparison of Surgical and a New Non-Surgical Treatment Methods for Secretory Otitis Media in Children|A Comparison of Surgical and a New Non-Surgical Treatment Methods for Secretory Otitis Media in Children- Hearing and Socioeconomic Aspects|Recruiting||N/A|80|Anticipated|Vastra Gotaland Region||2|||f||||f||||||||||2017-10-10 22:56:34.88593|2017-10-10 22:56:34.88593
NCT02546505|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-12-01|||October 2015||2015-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Impact of Front-of-pack Nutrition Labelling on Consumer Purchases|Impact of Front-of-pack Nutrition Labelling on Consumer Purchases - Controlled Trial in Shopper Laboratory Stores|Completed||N/A|900|Actual|University of Paris 13||3|||f||||f||||||||||2017-10-10 22:56:34.999986|2017-10-10 22:56:34.999986
NCT02546492|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-07-08|||August 2016|Actual|2016-08-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|TGActhar||Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar|Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar|Recruiting||N/A|20|Anticipated|University of Maryland||1|||f||||t|t|f|||t|||||2017-10-10 22:56:35.131572|2017-10-10 22:56:35.131572
NCT02546479|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-04|||September 4, 2015||2015-09-04|July 28, 2017|2017-07-28|August 16, 2016|Actual|2016-08-16|August 16, 2016|Actual|2016-08-16||Observational|||Follow-Up Study of People Treated for Scoliosis|Breast and Other Cancers Following X-Rays for Scoliosis|Completed||N/A|5573|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:56:35.259931|2017-10-10 22:56:35.259931
NCT02546466|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-04-12|||September 2015||2015-09-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Functional Taping on Static Postural Control in Patients With Non-specific Chronic Low Back Pain|Effects of Functional Taping Compared to Sham and Minimal Intervention Strategy on Pain Intensity and Static Postural Control in Patients With Non-specific Chronic Low Back Pain: a Protocol for a Randomized Sham-controlled Trial|Recruiting||N/A|120|Anticipated|University of Sao Paulo||3|||f||||f||||||||||2017-10-10 22:56:35.351506|2017-10-10 22:56:35.351506
NCT02546453|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-07-07|||September 2014||2014-09-01|July 2016|2016-07-01||||September 2017|Anticipated|2017-09-01||Interventional|NGSKids||Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKids|Use of Specific Genetic Alteration s of Tumoral Cells Identified by NGS to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor -|Recruiting||N/A|30|Anticipated|Institut Curie||1|||f||||f||||||||||2017-10-10 22:56:35.456345|2017-10-10 22:56:35.456345
NCT02546427|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-11-01|||September 2015||2015-09-01|November 2016|2016-11-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Hypofractionated Whole Pelvic Radiotherapy of the Prostate|Phase I Feasibility Study of Accelerated Hypofractionated Whole Pelvic Radiotherapy for Patients With Intermediate-High Risk Prostate Cancer|Not yet recruiting||Phase 1|35|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 22:56:35.645829|2017-10-10 22:56:35.645829
NCT02546414|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-09-08|||January 2013||2013-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|||Platelet Count（PC）/Spleen Diameter(SD) Ratio to Predict the Variceal Haemorrhage in HBV Cirrhotic Patients in China||Completed||N/A|150|Actual|RenJi Hospital|||3||f||||t||||||||||2017-10-10 22:56:35.722064|2017-10-10 22:56:35.722064
NCT02546401|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2016-04-21|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|BOLUS||Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump|Comparison of Injection of an Analogue Bolus of Insulin Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump.|Completed||Phase 3|22|Actual|University Hospital, Brest||2|||f||||f||||||||No||2017-10-10 22:56:35.800933|2017-10-10 22:56:35.800933
NCT02546388|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-08-28|||October 2015||2015-10-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis|Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis|Recruiting||N/A|15|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 22:56:35.883267|2017-10-10 22:56:35.883267
NCT02546375|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-05|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands|A Retrospective Observational Research Study To Describe The Real World Use Of Bosutinib In The Uk And Netherlands|Completed||N/A|86|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 22:56:35.973024|2017-10-10 22:56:35.973024
NCT02546362|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-07-13|||October 2015||2015-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||CEFALY® Device in the Treatment of Patients With Fibromyalgia|A Single Center, Pilot, Open Trial of the CEFALY® Device in the Treatment of Patients With Fibromyalgia|Recruiting||N/A|50|Anticipated|Cefaly Technology||1|||f||||f||||||||||2017-10-10 22:56:36.077999|2017-10-10 22:56:36.077999
NCT02546349|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-09-09|||July 2014||2014-07-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA|The Treatment Effect of Inhaled Corticosteroid and Long-acting beta2 Agonist Combination Versus Long-acting Anti-cholinergic Agent on Stratified COPD Patients Based on the Levels of Exhaled Nitric Oxide|Unknown status|Active, not recruiting|Phase 4|143|Anticipated|Taipei Veterans General Hospital, Taiwan||4|||f||||f||||||||||2017-10-10 22:56:36.16574|2017-10-10 22:56:36.16574
NCT02546336|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-12-11|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Ultrasound-Guided Hip Joint Cooled Radiofrequency Denervation|Ultrasound-Guided Hip Joint Cooled Radiofrequency Denervation: A Prospective Pilot Study|Recruiting||N/A|15|Anticipated|Women's College Hospital||1|||f||||f||||||||||2017-10-10 22:56:36.269459|2017-10-10 22:56:36.269459
NCT02546323|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-08-09|||September 17, 2015|Actual|2015-09-17|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis|A Randomized, Double-blind, Placebo-controlled, Multicenter Parallel Group Phase 3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects|Active, not recruiting||Phase 3|543|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 22:56:36.393694|2017-10-10 22:56:36.393694
NCT02546310|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-02-02|||October 2015||2015-10-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects|Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Phase 1, Exploratory Study Investigating the Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects|Completed||Phase 1|54|Anticipated|Heptares Therapeutics Limited||3|||f||||f||||||||||2017-10-10 22:56:36.540173|2017-10-10 22:56:36.540173
NCT02546297|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-04-20|||January 2015||2015-01-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparisons of Inhaled LAMA or ICS+LABA for COPD With Bronchiectasis|The Comparisons of the Efficacy and Safety of Inhaled LAMA or ICS+LABA for Patients in COPD C Group With Bronchiectasis|Recruiting||Phase 4|80|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||t||||||||||2017-10-10 22:56:36.630773|2017-10-10 22:56:36.630773
NCT02546284|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-03-13|||July 2016||2016-07-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Lenzilumab (KB003) in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)|A Phase 1 Study of Lenzilumab (KB003) in Subjects With Previously Treated Chronic Myelomonocytic Leukemia (CMML)|Recruiting||Phase 1|18|Anticipated|KaloBios Pharmaceuticals||1|||f||||f|t|f||||||No||2017-10-10 22:56:36.74323|2017-10-10 22:56:36.74323
NCT02546271|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-11-18|||March 2009||2009-03-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|GPS||A Small-group Intervention to Reduce HIV Sexual Transmission Risk Behavior Among HIV-positive Men Who Have Sex With Men|A Small-group Intervention to Reduce HIV Sexual Transmission Risk Behavior Among HIV-positive Men Who Have Sex With Men|Completed||N/A|82|Actual|Ryerson University||1|||f||||f||||||||||2017-10-10 22:56:36.835539|2017-10-10 22:56:36.835539
NCT02546258|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-04-10|||August 25, 2014|Actual|2014-08-25|November 2015|2015-11-01|November 21, 2014|Actual|2014-11-21|November 21, 2014|Actual|2014-11-21||Interventional|||Evaluation of the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis|A Prospective, Open Label, Non-comparative Clinical Investigation to Evaluate the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis|Completed||N/A|60|Actual|Reckitt Benckiser Healthcare (UK) Limited||1|||f||||f||||||||||2017-10-10 22:56:36.894145|2017-10-10 22:56:36.894145
NCT02546245|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-12-19|||September 2015||2015-09-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Modification and Evaluation of the Educational Mobile Games Heroes of Knowledge in Children|Modification and Evaluation of the Educational Mobile Games Heroes of Knowledge in Children|Completed||N/A|133|Actual|Yale University||2|||f||||f||||||||||2017-10-10 22:56:36.963322|2017-10-10 22:56:36.963322
NCT02546232|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-05-31|||March 2015||2015-03-01|May 2016|2016-05-01|April 2028|Anticipated|2028-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting|Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting: A Phase 2 Clinical Trial Protocol Studying Biological Rationale for the Optimal Selection of Treatment Regimens|Recruiting||Phase 2|210|Anticipated|Oslo University Hospital||2|||f||||f||||||||No||2017-10-10 22:56:37.041591|2017-10-10 22:56:37.041591
NCT02546219|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-03-21|||March 2016||2016-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Observational|||a4b7 Integrin in Eosinophilic Esophagitis|Investigating the Role of a4b7 Integrin as a Therapeutic Target in Eosinophilic Esophagitis|Recruiting||N/A|16|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     Peripheral blood and esophageal eosinophils will be analyzed and may be stored for future     studies.   "|||2017-10-10 22:56:37.133082|2017-10-10 22:56:37.133082
NCT02546206|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2015-09-08|||November 2011||2011-11-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Probiotic Yoghurt Effect on Experimental Gingivitis|Influence of Probiotics on Clinical Parameters and GCF Levels of Interleukin-1β in Experimental Gingivitis: a Randomized Controlled Clinical Trial|Completed||Early Phase 1|51|Actual|Marmara University||2|||f||||f||||||||||2017-10-10 22:56:37.243327|2017-10-10 22:56:37.243327
NCT02546193|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-06-15|||September 2015||2015-09-01|June 2017|2017-06-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|||Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction|Outpatient Foley Catheter Compared to Usual Inpatient Care for Cervical Ripening: a Randomized Controlled Trial|Terminated||N/A|39|Actual|Mayo Clinic||2||Unable to recruit/accrue adequate numbers of participants within funding period.|f||||f||||||||||2017-10-10 22:56:37.323419|2017-10-10 22:56:37.323419
NCT02546180|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-09-08|||February 2014||2014-02-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Improving Patient Understanding of the Surgical Hospital Experience: Use of YouTube Video Playlist|Improving Patient Understanding of the Surgical Hospital Experience: Use of YouTube Video Playlist|Completed||N/A|65|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:56:37.424735|2017-10-10 22:56:37.424735
NCT02546167|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-09|2017-03-03|||September 2015||2015-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||CART-BCMA Cells for Multiple Myeloma|Pilot Study Of Redirected Autologous T Cells Engineered To Contain an Anti-BCMA scFv Coupled To TCRζ And 4-1BB Signaling Domains in Patients With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1|27|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-10-10 22:56:37.629295|2017-10-10 22:56:37.629295
NCT02546154|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-06-13|||January 22, 2016|Actual|2016-01-22|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)|A Non-interventional Study of the Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With the Intravenous Iron Monofer® (10% Iron Isomaltoside 1000)|Recruiting||N/A|350|Anticipated|Pharmacosmos A/S|||2||f||||f||||||||||2017-10-10 22:56:37.73883|2017-10-10 22:56:37.73883
NCT02546141|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-01-11|||October 2015||2015-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PARROT||Postprandial Plasma Amino Acid Concentrations After Dairy Consumption|Postprandial Plasma Amino Acid Concentrations After Dairy Consumption|Completed||N/A|10|Actual|NIZO Food Research||8|||f||||f||||||||||2017-10-10 22:56:37.851282|2017-10-10 22:56:37.851282
NCT02546128|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-09-07|||July 2015||2015-07-01|September 2015|2015-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|LEICSTES||LEICeSter Tendon Extracorporeal Shockwave Studies|LEICSTES = LEICeSter Tendon Extracorporeal Shockwave Studies Assessing the Benefits of the Addition of Extra-Corporeal Shockwave Treatment to a Structured Home-rehabilitation Programme for Patients With Tendinopathy.|Recruiting||N/A|300|Anticipated|University Hospitals, Leicester||2|||f||||f||||||||||2017-10-10 22:56:37.959563|2017-10-10 22:56:37.959563
NCT02546115|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-09-07|||September 2014||2014-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||RCT - Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis|Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis, a Single-blinded Randomised Controlled Trial|Unknown status|Recruiting|N/A|40|Anticipated|University Hospitals, Leicester||2|||f||||||||||||||2017-10-10 22:56:38.053416|2017-10-10 22:56:38.053416
NCT02546102|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-06-21|||December 2015||2015-12-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma|A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy|Suspended||Phase 3|414|Anticipated|ImmunoCellular Therapeutics, Ltd.||2||Company at this time unable to secure sufficient financial resources to complete|f||||t||||||||||2017-10-10 22:56:38.172137|2017-10-10 22:56:38.172137
NCT02546089|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-09-07|||September 2014||2014-09-01|September 2015|2015-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||ABI v Dry Needling for Plantar Fasciitis|Investigating the Effects of Ultrasound Guided Autologous Blood Injection for Chronic Plantar Fasciitis Versus Ultrasound Guided Dry-needling Alone, a Randomised Controlled Trial|Recruiting||N/A|60|Anticipated|University Hospitals, Leicester||2|||f||||t||||||||||2017-10-10 22:56:38.404572|2017-10-10 22:56:38.404572
NCT02546076|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-04-12|||May 2016|Actual|2016-05-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|KELOID||Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars|Within-subject Randomized Clinical Trial Comparing Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars|Withdrawn||Phase 2|0|Actual|University Hospital Inselspital, Berne||2||Lack of patients|f||||f||||||||||2017-10-10 22:56:38.491266|2017-10-10 22:56:38.491266
NCT02546063|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-08-09|||August 2015||2015-08-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Carbohydrate Estimation Supported by the GoCARB System|Carbohydrate Estimation Supported by the GoCARB System in Individuals With Type 1 Diabetes|Completed||N/A|20|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||No||2017-10-10 22:56:38.574885|2017-10-10 22:56:38.574885
NCT02546050|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-02-16|||June 2015||2015-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of Metformin on Composition of Human Gut Bacteria|Effects of Metformin on Human Gut Microbiota|Completed||Phase 1|26|Actual|University of Copenhagen||1|||f||||t||||||||||2017-10-10 22:56:38.662989|2017-10-10 22:56:38.662989
NCT02546037|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-05-16|||September 2015||2015-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|TAGPSOLACEA||Clotting With Different Dialyzer Membranes|Pilot Study to Determine the Effect of Different Dialyzer Membranes on Clotting During Haemodiafiltration Treatments in Patients With Chronic Kidney Disease|Unknown status|Active, not recruiting|N/A|10|Actual|University College, London|||2||f||||f||||||||||2017-10-10 22:56:38.751913|2017-10-10 22:56:38.751913
NCT02546024|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-08-30|||September 2015||2015-09-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Predictors of Treatment Response in Late-onset Major Depressive Disorder|Predictors of Treatment Response in Late-onset Major Depressive Disorder|Suspended||N/A|40|Anticipated|King's College London|||2|Revision of recruitment strategies due to difficulties in recruitment|f||||f||||||||||2017-10-10 22:56:38.839602|2017-10-10 22:56:38.839602
NCT02546011|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-08-04|||January 2014||2014-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|1 Week|Observational [Patient Registry]|||The Monica Fetal Heart Monitor|The Monica External Fetal Heart Rate Monitor Compared to the Standard Fetal Heart Rate Monitor|Completed||N/A|36|Actual|St. Louis University|||1||f||||f||||||||No||2017-10-10 22:56:38.936829|2017-10-10 22:56:38.936829
NCT02545998|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-08-17|||June 2015||2015-06-01|February 2016|2016-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Conducting Annual Asthma Reviews Using Telehealthcare: Comparison With Standard Care (Face-to-face Consultations)|Conducting Annual Asthma Reviews Using Telehealthcare: Comparison With Standard Care (Face-to-face Consultations)|Completed||N/A|90|Actual|Imperial College London||2|||f||||f||||||||||2017-10-10 22:56:39.015049|2017-10-10 22:56:39.015049
NCT02545985|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2015-09-12|||January 2013||2013-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||First-in-man Sirolimus-eluting Prolim® Stent Registry|Novel Sirolimus-eluting Stent Prolim® With a Biodegradable Polymer in the All-comers Population|Completed||N/A|204|Actual|Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland||1|||f||||f||||||||||2017-10-10 22:56:39.101194|2017-10-10 22:56:39.101194
NCT02545972|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-09-20|||February 2016||2016-02-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|OneTAC||Once-a-day Tacrolimus Conversion Study: The OneTAC Trial|A Prospective Non-randomized Trial of Conversion From Twice a Day Tacrolimus to Once Daily Modified Release Tacrolimus|Recruiting||Phase 4|100|Anticipated|Newark Beth Israel Medical Center||1|||f||||f||||||||No||2017-10-10 22:56:39.176373|2017-10-10 22:56:39.176373
NCT02545959|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-10-01|||September 2015||2015-09-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|EFFRITE||Intrathecal Rituximab in Progressive Multiple Sclerosis|Intrathecal Rituximab in Progressive Multiple Sclerosis|Unknown status|Recruiting|Phase 2|12|Anticipated|Centre Hospitalier de PAU||3|||f||||f||||||||||2017-10-10 22:56:39.27206|2017-10-10 22:56:39.27206
NCT02545946|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-03-20|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Trial of Abscess Drainage Techniques|Traditional Incision and Drainage of Cutaneous Abscess Vs. Minimally Invasive Incision and Drainage With Vessel Loop: A Randomized Control Trial.|Active, not recruiting||N/A|350|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||Undecided||2017-10-10 22:56:39.379844|2017-10-10 22:56:39.379844
NCT02545933|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-03-15|||February 2016||2016-02-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|VORA-PRATIC||Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor|Adjunctive Vorapaxar Therapy in Patients With Prior Myocardial Infarction Treated With New Generation P2Y12 Receptor Inhibitors Prasugrel and Ticagrelor (VORA-PRATIC): A Prospective, Randomized, Pharmacodynamic Study|Recruiting||Phase 4|126|Anticipated|University of Florida||3|||f||||f|f|f||||||||2017-10-10 22:56:39.460023|2017-10-10 22:56:39.460023
NCT02545920|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-09-07|||September 2015||2015-09-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Observational|||To Assess Ear Blood Flow During Dialysis|Pilot Study to Assess the Effects of Haemodialysis Treatments on Blood Flow to the Ear|Unknown status|Not yet recruiting|N/A|10|Anticipated|University College, London|||1||f||||f||||||||||2017-10-10 22:56:39.577809|2017-10-10 22:56:39.577809
NCT02545907|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-07|||October 2015||2015-10-01|September 2015|2015-09-01|April 2018|Anticipated|2018-04-01|October 2016|Anticipated|2016-10-01||Interventional|CATALYST||A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis|A Single Arm Open Labeled Multicentre Phase 1b Dose Escalation Study of Carfilzomib Taken in Combination With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|University College, London||1|||f||||f||||||||||2017-10-10 22:56:39.667912|2017-10-10 22:56:39.667912
NCT02545894|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-09-09|||September 2014||2014-09-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|November 2015|Anticipated|2015-11-01||Interventional|||An Evaluation of a New Nonverbal Treatment for Global Aphasia|An Investigation Into the Effect of a Novel, Non Verbal, Cognitive Treatment on Functional Communication in Global Aphasia|Unknown status|Recruiting|N/A|7|Anticipated|University College, London||3|||f||||||||||||||2017-10-10 22:56:39.901546|2017-10-10 22:56:39.901546
NCT02545881|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-10-18|||July 2015||2015-07-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Observational|PROAG||Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness|Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness|Recruiting||N/A|200|Anticipated|Turku University Hospital|||1||f||||||||||Samples Without DNA|"     Fixed tissue   "|||2017-10-10 22:56:40.007571|2017-10-10 22:56:40.007571
NCT02545868|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-09-18|||October 27, 2015|Actual|2015-10-27|September 2017|2017-09-01|December 10, 2022|Anticipated|2022-12-10|February 14, 2017|Actual|2017-02-14||Interventional|||A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis|A Phase IIIB, Multicenter, Randomized, Parallel-Group, Open-Label Study to Evaluate the Effects of Ocrelizumab on Immune Responses in Patients With Relapsing Forms of Multiple Sclerosis|Active, not recruiting||Phase 3|102|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 22:56:40.124376|2017-10-10 22:56:40.124376
NCT02545855|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-07-12|||July 2015||2015-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||High-flow Nasal Cannula Therapy for Stable Chronic Obstructive Pulmonary Disease (COPD)|Long-term High-flow Nasal Cannula Therapy in Patients With Stable COPD: a Prospective, Randomized Crossover Study|Active, not recruiting||N/A|30|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||f||||||||||2017-10-10 22:56:40.275758|2017-10-10 22:56:40.275758
NCT02545842|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-08-31|||September 12, 2015|Actual|2015-09-12|August 2017|2017-08-01|April 26, 2018|Anticipated|2018-04-26|April 26, 2018|Anticipated|2018-04-26||Interventional|||Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)|Titration Target for Chinese Type 2 Diabetes Mellitus Patients Using Insulin Glargine to Achieve Glycaemic Goals: An Assessment of Three Different Fasting Plasma Glucose Targets - BEYOND III/FPG GOAL Study|Recruiting||Phase 4|934|Anticipated|Sanofi||3|||f||||f||||||||||2017-10-10 22:56:40.380396|2017-10-10 22:56:40.380396
NCT02545829|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-10-12|||August 2015||2015-08-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluating the Bioequivalence of HIP1302, HGP1406|A Randomized, Open, 2-way Cross-over, Single Dose Study to Evaluate and Compare Safety and Pharmacokinetics of the HIP1302 and HGP1406 (Tenofovir) in Healthy Korean Male Volunteers|Completed||Phase 1|38|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 22:56:40.547328|2017-10-10 22:56:40.547328
NCT02545816|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-09-08|||May 2015||2015-05-01|September 2015|2015-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparing Simplified EEG Monitoring Tool With Standard EEG Monitoring in Patients With Acute Neurological Insult|A Validation Study to Compare Bispectral Index EEG Monitoring With Full EEG in Patients With an Acute Neurological Insult|Unknown status|Recruiting|N/A|80|Anticipated|Hasselt University||1|||f||||f||||||||||2017-10-10 22:56:40.624339|2017-10-10 22:56:40.624339
NCT02545803|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-09-08|||May 2015||2015-05-01|September 2015|2015-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effect of High Frequency Percussive Ventilation on Cerebral Tissue Oxygenation|The Effect of High Frequency Percussive Ventilation on Cerebral Tissue Oxygenation|Recruiting||N/A|50|Anticipated|Hasselt University||1|||f||||f||||||||||2017-10-10 22:56:40.707747|2017-10-10 22:56:40.707747
NCT02545790|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-10-27|||August 2015||2015-08-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|LVOTO||Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions|Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions|Recruiting||N/A|45|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples With DNA|"     Plasma and tissue samples from patients will be stored for the duration of the study.     Patients may choose to consent to have these samples stores beyond the completion of primary     analysis for testing in future studies.   "|||2017-10-10 22:56:40.788079|2017-10-10 22:56:40.788079
NCT02545777|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-10|||May 2014||2014-05-01|September 2015|2015-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||The Clinical Study on Treating Acute Gouty Arthritis Using Both Internal and External Therapy of Tonifying Spleen and Descending Turbid||Unknown status|Recruiting|Phase 2|120|Anticipated|Beijing University of Chinese Medicine||2|||f||||||||||||||2017-10-10 22:56:40.885349|2017-10-10 22:56:40.885349
NCT02545764|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-08-08|||September 2015||2015-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|June 2017|Actual|2017-06-01||Interventional|||Training Induced Reduction of Lower-limb Joint Loads During Locomotion in Obese Children|The Effects of a Strength and Neuromuscular Exercise Programme for the Lower Extremity on Knee Load, Pain and Function in Obese Children and Adolescents: a Randomised, Single-blinded Controlled Trial|Active, not recruiting||N/A|48|Anticipated|St. Pölten University of Applied Sciences||2|||f||||||||||||||2017-10-10 22:56:41.105006|2017-10-10 22:56:41.105006
NCT02545751|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-04-17|||January 2016||2016-01-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer|A Phase II Study of Stereotactic Body Radiation Therapy and ZADAXIN's® (Thymalfasin) Induced Tumor Effects in Patients With Heavily Pretreated, Metastatic Esophageal Cancer|Recruiting||Phase 2|29|Anticipated|Hangzhou Cancer Hospital||1|||f||||f||||||||||2017-10-10 22:56:41.213433|2017-10-10 22:56:41.213433
NCT02545738|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-08-09|||April 2015||2015-04-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|LIRALBU||Antiproteinuric Effects of Liraglutide Treatment|Antiproteinuric Effects of Liraglutide Treatment in Patients With Type 2 Diabetes and Albuminuria: A Randomised, Placebo-Controlled Trial|Completed||Phase 4|32|Actual|Steno Diabetes Center||2|||f||||t||||||||||2017-10-10 22:56:41.313312|2017-10-10 22:56:41.313312
NCT02545725|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-08|||April 2015||2015-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|QOLColorect||Quality of Life in Colorectal (ex-)Cancer Patients, Based on the Belgian Cancer Registry.|Quality of Life in (ex-)Cancer Patients, Based on the Belgian Cancer Registry. Pilot Study: Quality of Life in Colorectal (ex-)Cancer Patients.|Completed||N/A|1220|Actual|Belgian Cancer Registry|||1||f||||f||||||||||2017-10-10 22:56:41.422128|2017-10-10 22:56:41.422128
NCT02545712|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-02-04|||January 2016||2016-01-01|February 2017|2017-02-01||||April 2017|Anticipated|2017-04-01||Observational|SEEN||Safe Excipient Exposure in Neonates and Small ChildreN|Safe Excipient Exposure in Neonates and Small ChildreN - a Retrospective, Descriptive Study Off the Amount of Ethanol, Propylene Glycol, Benzyl Alcohol, Parabens, Acesulfam k, Aspartame, Glycerol, Sorbitol and Polysorbate-80 Exposed to Pediatric Patients|Active, not recruiting||N/A|630|Actual|Bispebjerg Hospital|||2||f||||t||||||||||2017-10-10 22:56:41.523314|2017-10-10 22:56:41.523314
NCT02545699|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-06-05|||September 2015||2015-09-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Prospective Trial to Compare ADR of G-EYE™ Colonoscopy With Standard Colonoscopy|Prospective Randomized Trial to Compare the Adenoma Detection Rate of G-EYE™ Colonoscopy With Standard Colonoscopy|Recruiting||N/A|350|Anticipated|Smart Medical Systems Ltd.||2|||f||||f||||||||||2017-10-10 22:56:41.700571|2017-10-10 22:56:41.700571
NCT02545686|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-09|||September 2015||2015-09-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|CPAP_normal||Effect of CPAP on Breath Hold and Chest Movement in Normal Volunteers|Use of the Real-time Position Management (RPM) to Measure the Effects of Continuous Positive Airway Pressure (CPAP) on Duration of Breath Hold and Diaphragm Motion in Normal Volunteers|Unknown status|Recruiting|N/A|10|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 22:56:41.821497|2017-10-10 22:56:41.821497
NCT02545673|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-04-24|||November 2015||2015-11-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|July 2019|Anticipated|2019-07-01||Interventional|||Enhanced Linkage to HIV Care Following Home-Based HIV Testing in Rural Uganda|Enhanced Linkage to HIV Care Following Home-Based HIV Testing in Rural Uganda|Enrolling by invitation||N/A|566|Anticipated|San Diego State University||2|||f||||f||||||||Undecided||2017-10-10 22:56:41.95294|2017-10-10 22:56:41.95294
NCT02545660|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-11-19|||November 2015||2015-11-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Use of Quantitative Light Induced Fluorescence Digital as an Oral Hygiene Evaluation Tool in Orthodontics|The Use of QLF-D (Quantitative Light-induced Fluorescence-DigitalTM) as an Oral Hygiene Evaluation Tool to Assess Plaque Accumulation and Enamel Demineralisation in Orthodontics|Unknown status|Recruiting|N/A|60|Anticipated|Royal Liverpool and Broadgreen University Hospitals NHS Trust||2|||f||||t||||||||||2017-10-10 22:56:42.088386|2017-10-10 22:56:42.088386
NCT02545647|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-06-30|||September 2015||2015-09-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|Bandolera||Banded Versus Non-banded Roux-en-y Gastric Bypass|Banded Versus Non-banded Roux-en-y Gastric Bypass, a Randomised Controlled Trial|Active, not recruiting||N/A|130|Actual|Rijnstate Hospital||2|||f||||f||||||||||2017-10-10 22:56:42.206224|2017-10-10 22:56:42.206224
NCT02545634|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-09-08|||June 2015||2015-06-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Effects of a Probiotic Supplement on Symptoms of Attention Deficit Hyperactivity Disorder and Anxiety in Children|Effects of a Probiotic Supplement on Symptoms of ADHD and Anxiety in Children|Unknown status|Recruiting|Phase 4|100|Anticipated|Acadia University||2|||f||||f||||||||||2017-10-10 22:56:42.325015|2017-10-10 22:56:42.325015
NCT02545621|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-07-28|||September 2015||2015-09-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Observational|||A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study|A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study|Recruiting||N/A|20|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-10 22:56:42.507849|2017-10-10 22:56:42.507849
NCT02545608|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-06-08||2017-06-08|October 2015||2015-10-01|June 2017|2017-06-01|March 15, 2017|Actual|2017-03-15|April 2016|Actual|2016-04-01||Interventional|||Safety and Efficacy of Restylane Vital for Skin Rejuvenation of Dorsal Hands|A Randomised, Multi-centre, Evaluator-blinded, Split-hand, no Treatment-controlled Study to Evaluate the Safety and Efficacy of Restylane Vital for Skin Rejuvenation of the Dorsal Hands in Chinese Subjects|Completed||N/A|109|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-10 22:56:42.650636|2017-10-10 22:56:42.650636
NCT02545595|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-10-10|||May 2012||2012-05-01|October 2016|2016-10-01||||December 2013|Actual|2013-12-01||Interventional|||Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients||Completed||Phase 2|||Poitiers University Hospital||3|||f||||||||||||||2017-10-10 22:56:42.764211|2017-10-10 22:56:42.764211
NCT02545582|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-01-30|||August 2015||2015-08-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01|12 Months|Observational [Patient Registry]|||VITARIA Registry Study|VITARIA Registry Study|Suspended||N/A|200|Anticipated|Cyberonics, Inc.|||1|Sponsor decision|f||||f||||||||||2017-10-10 22:56:42.874544|2017-10-10 22:56:42.874544
NCT02545569|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|CPS||Evaluation of New Custom Made Hearing Product Technology and Shell Modification|Evaluation of New Custom Made Hearing Product Technology and Shell Modification|Not yet recruiting||N/A|25|Anticipated|Phonak AG, Switzerland||2|||f||||f||||||||||2017-10-10 22:56:42.994929|2017-10-10 22:56:42.994929
NCT02545556|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2016-08-26|||August 2015||2015-08-01|October 2015|2015-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Liver Cancer HepaSphere Combined With Cryosurgery|HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）Combined With Cryosurgery for Liver Cancer: Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 22:56:43.097308|2017-10-10 22:56:43.097308
NCT02545543|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-04-16|2017-02-28|2017-02-10|September 2015||2015-09-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional||The Full Analysis Set (FAS) was used for analysis of subject characteristics and comprised all subjects who gave informed consent and who were randomized to treatment. Screening failures were not included in the FAS.|A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age|A Phase 3, Randomized, Multicenter, Observer-Blinded, Noninferiority Study to Evaluate the Immunogenicity and Safety of a Seqirus Quadrivalent Inactivated Influenza Virus Vaccine (Seqirus QIV) With a US-Licensed 2015-2016 Quadrivalent Inactivated Comparator Influenza Vaccine (Comparator QIV) in a Pediatric Population 5 Through 17 Years of Age|Completed||Phase 3|2278|Actual|Seqirus||2|||f||||t||||||||||2017-10-10 22:56:43.227858|2017-10-10 22:56:43.227858
NCT02545530|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-07|||May 2015||2015-05-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Transdermal Clonidine in Chronic Hemodialysis Patients|Transdermal Clonidine on Blood Pressure of Chronic Hemodialysis Patients: A Randomized Crossover Clinical Trial|Unknown status|Recruiting|N/A|45|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-10 22:56:44.080835|2017-10-10 22:56:44.080835
NCT02545517|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-03-31|||October 1, 2015||2015-10-01|March 2017|2017-03-01|December 3, 2022|Anticipated|2022-12-03|December 3, 2022|Anticipated|2022-12-03||Interventional|||A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.|A Phase 3, Open-label, Multicenter Study to Evaluate Long-term Immunogenicity and Boostability of Immune Responses in Adults Who Received Different Primary Vaccination Regimens of Pre-exposure Prophylaxis With Purified Chick-Embryo Cell Rabies Vaccine Administered Concomitantly or Separately From a Japanese Encephalitis Vaccine.|Active, not recruiting||Phase 3|578|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 22:56:44.192757|2017-10-10 22:56:44.192757
NCT02545504|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-06-07|||October 13, 2015|Actual|2015-10-13|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|January 2019|Anticipated|2019-01-01||Interventional|GAMMA-1||Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5745 Combined With mFOLFOX6 as First Line Treatment in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 3|432|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 22:56:44.386603|2017-10-10 22:56:44.386603
NCT02541734|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-05-29|||August 2015||2015-08-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|GLP1-EX-GELO||Effect of Gelofusine on GLP1-receptor Imaging|Effect of Gelofusine on 111In-DTPA-AHX-Lys40-Exendin 4 Uptake in the Kidney|Completed||Phase 1/Phase 2|12|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 22:57:31.867645|2017-10-10 22:57:31.867645
NCT02545491|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-07-25|||January 2015||2015-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Implementation and Adoption of Care for Child Development in Day Care Centers|Implementation of Care for Child Development and Implications on Early Childhood Development: A Pilot Study in Lebanon|Recruiting||N/A|456|Anticipated|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-10 22:56:44.733789|2017-10-10 22:56:44.733789
NCT02545465|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-05-23|||September 15, 2015|Actual|2015-09-15|May 2017|2017-05-01|August 31, 2016|Actual|2016-08-31|May 31, 2016|Actual|2016-05-31||Observational|CAPTURE||A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice|Retrospective Chart Review of Patients With PAH or Inoperable/Persistent/Recurrent CTEPH Who Transition Their PH Treatment to Adempas|Completed||N/A|125|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:56:46.832221|2017-10-10 22:56:46.832221
NCT02545452|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2017-07-21|||September 15, 2015|Actual|2015-09-15|July 2017|2017-07-01|July 29, 2016|Actual|2016-07-29|March 14, 2016|Actual|2016-03-14||Interventional|||Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring|A Parallel Group, Randomized, Open-label Study to Investigate the Effect of the Intravaginally Administered Antimycotic Miconazole, Antibiotic Clindamycin, Spermicide Nonoxynol-9, or Co-usage of Tampons on 3 Consecutive Days on the Pharmacokinetics of Anastrozole and Levonorgestrel Released From an Intra-vaginal Ring in Healthy Young Women|Completed||Phase 1|52|Actual|Bayer||4|||f||||f||||||||||2017-10-10 22:56:46.936263|2017-10-10 22:56:46.936263
NCT02545439|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-08|2015-11-09|||July 2015||2015-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers|A Phase 1 Study to Evaluate the Impact of CYP3A4 Induction on the Single Dose Pharmacokinetics of ALKS 5461|Completed||Phase 1|24|Actual|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 22:56:47.055394|2017-10-10 22:56:47.055394
NCT02545426|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2016-07-09|||July 2015||2015-07-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Myocardial Stunning During Hemodialysis: Role of Dialyste Calcium Concentration|Myocardial Stunning During Hemodialysis: Role of Dialyste Calcium Concentration|Completed||N/A|19|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 22:56:47.129281|2017-10-10 22:56:47.129281
NCT02545413|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-03-21|||May 2016||2016-05-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome|Randomized,Double-blind, Placebo Controlled Trial to Study the Efficacy and Safety of Probiotics in Adult Patients With Irritable Bowel Syndrome-diarrhea Predominant (IBS-D)|Withdrawn||Phase 3|0|Actual|Next Gen Pharma India Pvt. Ltd.||2||Investigator (Dr Amit) not interested to carry out the study|f||||f||||||||||2017-10-10 22:56:47.218975|2017-10-10 22:56:47.218975
NCT02545400|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-10-02|||November 2013||2013-11-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Observational|||Quantification of Side Effects During Hepatitis C Therapy|Quantification of Side Effects During Dual or Triple Therapy for Chronic Hepatitis C|Completed||N/A|108|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-10 22:56:47.318776|2017-10-10 22:56:47.318776
NCT02545387|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-11-29|||January 2015||2015-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells|Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells|Active, not recruiting||N/A|45|Anticipated|Medical University of Graz|||1||f||||f||||||Samples Without DNA|"     serum liver tissue bone marrow   "|||2017-10-10 22:56:47.396811|2017-10-10 22:56:47.396811
NCT02545374|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-04-11|||May 2014||2014-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|DOMOPLAIES||Medico-economic Evaluation of a Project of Wounds by a Remote Network|Medico-economic Evaluation of the DOMOPLAIES Project by the CICAT-LR Network|Completed||N/A|193|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 22:56:47.474402|2017-10-10 22:56:47.474402
NCT02545361|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-03-07|||April 2018|Anticipated|2018-04-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients|A Phase 1/2a, Multi-center, Dose Escalation, 2 Stages Study to Evaluate the Safety, Tolerability, and Anti-cancer Activity of Subcutaneously Administered KAHR-102 for the Treatment of Lymphoma Patients Who Express Both B7 and FasR|Suspended||Phase 1/Phase 2|40|Anticipated|Kahr Medical||1||Delay in IP production|f||||t||||||||||2017-10-10 22:56:47.721002|2017-10-10 22:56:47.721002
NCT02545348|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-04-25|||August 2015||2015-08-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|January 2020|Anticipated|2020-01-01||Observational|SNE||Use of the Sentinel Node Biopsy for Early Endometrial Cancer.|Evaluation (Good Medical Practice Evaluation) of the Use of the Sentinel Node Biopsy in Early Stage Endometrial Cancer and Its Implication on the Adjuvant Treatement and on the Outcomes of the Cancer|Recruiting||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-10-10 22:56:47.821172|2017-10-10 22:56:47.821172
NCT02545335|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-09-15|||November 2014||2014-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Neutrophil Function During Therapy With Protease Inhibitors in Chronic Hepatitis C|Neutrophil Function During Combination Therapy With Protease Inhibitors in Chronic Hepatitis C|Recruiting||N/A|150|Anticipated|Medical University of Graz|||1||f||||f||||||Samples Without DNA|"     Serum Plasma   "|||2017-10-10 22:56:47.989253|2017-10-10 22:56:47.989253
NCT02545322|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-02-17|2015-11-24||February 2012||2012-02-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|August 2012|Actual|2012-08-01||Interventional|BART||Image Guided Adaptive Radiotherapy in the Head-and-neck Region|Image Guided Adaptive Radiotherapy Based on Elastic Image Registration for Improved Tumor Coverage and Reduction of Side Effect in Normal Tissues|Completed||N/A|18|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-10 22:56:48.105265|2017-10-10 22:56:48.105265
NCT02545309|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-11-29|||January 2015||2015-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|SSC-CIP||Secondary Sclerosing Cholangitis in Critically Ill Patients|Secondary Sclerosing Cholangitis in Critically Ill Patients (SSC-CIP): A Pilot Study on the Possible Genetic Basis of the Disease|Recruiting||N/A|140|Anticipated|Medical University of Graz|||2||f||||f||||||Samples With DNA|"     Serum Stool Urine DNA   "|||2017-10-10 22:56:48.315716|2017-10-10 22:56:48.315716
NCT02545296|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-31|||July 2015||2015-07-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|October 2016|Actual|2016-10-01||Interventional|BABY||HIV Point-of-Care Test Evaluation in Infants|HIV Point-of-Care Tests in Babies Study (BABY) - Operational Evaluation of HIV Point-of-Care Tests for Very Early Infant HIV Diagnostics in Infants Born to HIV Infected Mothers in Mbeya, Tanzania|Completed||N/A|604|Actual|Ludwig-Maximilians - University of Munich||1|||f||||t||||||||||2017-10-10 22:56:48.443288|2017-10-10 22:56:48.443288
NCT02545270|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-08-15|||March 2016||2016-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Validation of a Subjective Rating Scale for Assessment of the Surgical Workspace in Laparoscopy|Validation of a Subjective Rating Scale for Assessment of the Surgical Workspace in Laparoscopy|Completed||N/A|16|Actual|Herlev Hospital||3|||f||||t||||||||||2017-10-10 22:56:48.901368|2017-10-10 22:56:48.901368
NCT02545257|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-02-24|||September 2015||2015-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care|Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care|Active, not recruiting||N/A|191|Actual|Helsinki University||2|||f||||f||||||||||2017-10-10 22:56:48.998141|2017-10-10 22:56:48.998141
NCT02545244|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-07|||February 2015||2015-02-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Blacktea||Effectiveness of Black Tea Mouthwash on Plaque Formation|"Effectiveness of Black Tea Mouthwash on Plaque Formation:A Randomized Controlled Clinical Trial"|Completed||Phase 3|45|Actual|Sri Hasanamba Dental College and Hospital||3|||f||||t||||||||||2017-10-10 22:56:49.107836|2017-10-10 22:56:49.107836
NCT02545231|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-16|||February 2013||2013-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ELEVATE||Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis|Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis, Endothelial Function, Circulating microRNAs, and Cardiovascular Events in Patients With Coronary Artery Disease Requiring Stent Implantation: OCT and NIRS Comparison|Active, not recruiting||Phase 4|1000|Actual|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-10 22:56:49.206715|2017-10-10 22:56:49.206715
NCT02545218|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-04-13|||September 2015||2015-09-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|||Perineorraphy Versus Pelvic Floor Exercise - a Randomized Trial|Perineorraphy Versus Pelvic Floor Exercise - a Randomized Trial|Recruiting||N/A|70|Anticipated|Stockholm South General Hospital||2|||f||||f||||||||||2017-10-10 22:56:49.292029|2017-10-10 22:56:49.292029
NCT02545205|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-03-22|||August 2016||2016-08-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|HAL-RCT-I||New Technology for Individualised, Intensive Training of Gait After Stroke|New Technology for Individualised, Intensive Training of Gait After Stroke- Phase III Trials, Study I|Not yet recruiting||Phase 3|108|Anticipated|Danderyd Hospital||2|||f||||f||||||||||2017-10-10 22:56:49.505707|2017-10-10 22:56:49.505707
NCT02545192|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-04-12|||September 2016||2016-09-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|LFMS in PTSD||A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments|A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments|Not yet recruiting||Phase 1|24|Anticipated|Mclean Hospital||2|||f||||f||||||||||2017-10-10 22:56:49.652982|2017-10-10 22:56:49.652982
NCT02545179|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-09|||September 2015||2015-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Web-based Daily Care Training of Children With Cerebral Palsy|Ethics Committee of the University of Social Welfare and Rehabilitation Science|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Social Welfare and Rehabilitation Science||2|||f||||t||||||||||2017-10-10 22:56:49.76075|2017-10-10 22:56:49.76075
NCT02545166|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-07-04|||July 2016||2016-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|CEMS||Validation of a Purine Biosensor in Detecting Acute Cerebral Ischaemia: Carotid Endarterectomy Model in SMARTChip|Validation of a Purine Biosensor in Detecting Acute Cerebral Ischaemia: Carotid Endarterectomy Model in SMARTChip|Active, not recruiting||N/A|153|Actual|University Hospitals Coventry and Warwickshire NHS Trust|||2||f||||f||||||||||2017-10-10 22:56:49.850851|2017-10-10 22:56:49.850851
NCT02545153|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-09-08|||January 2009||2009-01-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Fibrin Sealant for Cholangiotomy Closure Study|Randomised Controlled Trial of Fibrin Sealant to Prevent Bile Leakage After Cholangiotomy|Unknown status|Recruiting|Phase 2|200|Anticipated|Lasarettet i Enköping||2|||f||||f||||||||||2017-10-10 22:56:49.942132|2017-10-10 22:56:49.942132
NCT02545140|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-03-30|||October 2015||2015-10-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Observational|PRE-STARt||Prevention Strategies for Adolescents at Risk of Diabetes|Prevention Strategies for Adolescents at Risk of Diabetes - Validation of a Risk Tool for Young People Aged 12 - 14 Years|Recruiting||N/A|500|Anticipated|University Hospitals, Leicester|||1||f||||f||||||||||2017-10-10 22:56:50.057584|2017-10-10 22:56:50.057584
NCT02544958|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-05-31|||May 2015||2015-05-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Er:YAG Laser for Treatment of Enlarged Pores|The Efficacy and Safety of Erbium:Yttrium Aluminum Garnet Laser for Treatment of Enlarged Pores: A Pilot Study|Active, not recruiting||N/A|24|Anticipated|Mahidol University||1|||f||||t||||||||||2017-10-10 22:56:54.998528|2017-10-10 22:56:54.998528
NCT02545114|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-08|||August 2015||2015-08-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Tolvaptan for Patients With Acute Neurological Injuries|Use of Tolvaptan to Treat SIADH-induced Hyponatremia in Selected Patients With Acute Neurological Injuries|Unknown status|Recruiting|N/A|80|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 22:56:50.365266|2017-10-10 22:56:50.365266
NCT02545088|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-03-22|||October 2015||2015-10-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|HAL-RCT-II||New Technology for Individualised, Intensive Training of Gait After Stroke- Study II|New Technology for Individualised, Intensive Training of Gait After Stroke- Phase III Trials, Study II|Recruiting||Phase 3|162|Anticipated|Danderyd Hospital||3|||f||||f||||||||||2017-10-10 22:56:50.663061|2017-10-10 22:56:50.663061
NCT02545075|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-07-07|||October 31, 2015|Actual|2015-10-31|July 2017|2017-07-01|April 30, 2019|Anticipated|2019-04-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine|A Randomized, Open-Label, Two-arm, Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine|Active, not recruiting||Phase 3|180|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f|||t|||||2017-10-10 22:56:50.827282|2017-10-10 22:56:50.827282
NCT02545062|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2015-09-10|||May 2014||2014-05-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes|Early Detection of Mild Cognitive Impairment in Young Diabetes Patients Using the MoCa Test|Unknown status|Recruiting|N/A|170|Anticipated|Clalit Health Services||2|||f||||f||||||||||2017-10-10 22:56:50.965657|2017-10-10 22:56:50.965657
NCT02545049|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-09-19|||September 17, 2015|Actual|2015-09-17|September 2017|2017-09-01|February 27, 2020|Anticipated|2020-02-27|January 28, 2020|Anticipated|2020-01-28||Interventional|FIGARO-DKD||Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate Efficacy and Safety of Finerenone on the Reduction of Cardiovascular Morbidity and Mortality in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease in Addition to Standard of Care.|Recruiting||Phase 3|6400|Anticipated|Bayer||2|||f||||t|t|f||||||||2017-10-10 22:56:51.398595|2017-10-10 22:56:51.398595
NCT02545036|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-09-08|||June 2015||2015-06-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Combined Western and Traditional Chinese Medicine Daycare for CKD Patients|Clinical Study of Combined Western Medicine and Traditional Chinese Medicine Daycare Model for Chronic Kidney Disease Patients|Unknown status|Recruiting|Phase 3|60|Anticipated|China Medical University Hospital||2|||f||||f||||||||||2017-10-10 22:56:54.366271|2017-10-10 22:56:54.366271
NCT02545023|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2017-09-12|||August 10, 2015|Actual|2015-08-10|September 2017|2017-09-01|August 10, 2019|Anticipated|2019-08-10|August 10, 2018|Anticipated|2018-08-10||Observational|||Supportive Care Questionnaires in Gathering Data on Unmet Needs and Health-Related Quality of Life in Latina Breast Cancer Survivors After Surgery, Chemotherapy, or Radiation Therapy|Supportive Care Needs of Breast Cancer Survivors: A Needs Assessment|Active, not recruiting||N/A|100|Actual|University of Southern California|||1||f||||t|f|f||||||||2017-10-10 22:56:54.457509|2017-10-10 22:56:54.457509
NCT02545010|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-06-21|||September 2015||2015-09-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer|Phase I Study of Low Dose Whole Abdominal Radiation Therapy (LDWART) in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer With Predominant Non-visceral Abdominal Disease|Recruiting||Phase 1|24|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-10 22:56:54.541295|2017-10-10 22:56:54.541295
NCT02544997|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-11-30|||September 2015||2015-09-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway|A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway|Recruiting||Phase 2|30|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 22:56:54.62346|2017-10-10 22:56:54.62346
NCT02544984|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-05-03|||October 2015||2015-10-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|||The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease|The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease: a Double Blinded RCT|Active, not recruiting||N/A|92|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 22:56:54.70695|2017-10-10 22:56:54.70695
NCT02544971|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-03-20|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|NFTIP||Neurofeedback Therapeutic Intervention For Post-Traumatic Stress Disorder Patients Compared To Treatment As Usual|Neurofeedback Therapeutic Intervention For Post-Traumatic Stress Disorder Patients Compared To Treatment As Usual|Recruiting||N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||||2017-10-10 22:56:54.804316|2017-10-10 22:56:54.804316
NCT02544945|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-09-08|||September 2015||2015-09-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Comparing 3-D Printed vs Standard Bolus for Breast Cancer Chest Wall Radiotherapy|Comparing 3-D Printed vs Standard Bolus for Breast Cancer Chest Wall Radiotherapy: A Feasibility Study Measuring Bolus Spatial Accuracy, Dosimetric Accuracy and Treatment Set-up Time|Unknown status|Not yet recruiting|N/A|16|Anticipated|Nova Scotia Health Authority||2|||f||||t||||||||||2017-10-10 22:56:55.109639|2017-10-10 22:56:55.109639
NCT02544932|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-07|||October 2015||2015-10-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Pleotropic Effect of New Oral Anticoagulants|Prospective Randomized Study for Evaluating Vascular Protective Effects of New Oral Anticoagulants in High Risk Patients With Atrial Fibrillation|Unknown status|Not yet recruiting|Phase 3|55|Anticipated|Kyunghee University Medical Center||3|||f||||t||||||||||2017-10-10 22:56:55.218486|2017-10-10 22:56:55.218486
NCT02544919|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-03-24|||September 2015|Actual|2015-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|LNCLT||Lipids and Neurological Complications in Liver Transplantation|Impact of Pretreatment With Omega 3 Enriched Lipid Emulsion on Early Neurological Complications After Living Donor Liver Transplantation. A Randomized Controlled Trial>|Recruiting||Phase 4|80|Anticipated|Mansoura University||2|||f||||f||||||||||2017-10-10 22:56:55.355834|2017-10-10 22:56:55.355834
NCT02544906|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-08|||September 2015||2015-09-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|Agitation||Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation||Unknown status|Not yet recruiting|N/A|120|Anticipated|Mansoura University||3|||f||||t||||||||||2017-10-10 22:56:55.505949|2017-10-10 22:56:55.505949
NCT02544893|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-08-02|||September 2015||2015-09-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Postoperative Analgesic Effects of Using Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block|Postoperative Analgesic Effects of Using Bupivacaine Alone or Added Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block in Thoracotomy|Completed||Phase 4|93|Actual|TC Erciyes University||3|||f||||f||||||||||2017-10-10 22:56:55.602729|2017-10-10 22:56:55.602729
NCT02544880|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-08-22|||April 25, 2016|Actual|2016-04-25|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC|PDE5 Inhibition Via Tadalafil (Cialis®) to Enhance Anti-Tumor MUC1 Vaccine Efficacy in Patients With Resectable, and Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC): A Phase I/II Clinical Trial|Recruiting||Phase 1/Phase 2|104|Anticipated|University of Miami||5|||f||||t|t|f||||||||2017-10-10 22:56:55.704793|2017-10-10 22:56:55.704793
NCT02544867|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-04|||September 2013||2013-09-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Optimizing Sedentary Behavior Interventions to Affect Acute Physiological Changes|Optimizing Sedentary Behavior Interventions to Affect Acute Physiological|Completed||N/A|30|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-10 22:56:55.871838|2017-10-10 22:56:55.871838
NCT02544854|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-10-10|||September 2015||2015-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pharmacokinetic/Pharmacodynamic Model of Propofol in Children|Pharmacokinetic/Pharmacodynamic Model of Propofol in Children|Recruiting||Phase 4|40|Anticipated|Pontificia Universidad Catolica de Chile||3|||f||||t||||||||Undecided||2017-10-10 22:56:55.971851|2017-10-10 22:56:55.971851
NCT02544841|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-11-07|||February 2012||2012-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of Safer Sex Intervention (SSI)|Evaluation of Safer Sex Intervention (SSI)|Completed||N/A|319|Actual|The Policy & Research Group||2|||f||||f||||||||||2017-10-10 22:56:56.091743|2017-10-10 22:56:56.091743
NCT02544828|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2015-09-08|||November 2015||2015-11-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Intravenous Iron Sucrose in Arthroplasty|Does Intraoperative Intravenous Iron Sucrose Enhance Postoperative Oxygenation Profile in Total Arthroplasty Surgery?|Unknown status|Not yet recruiting|Phase 4|76|Anticipated|Konkuk University Medical Center||2|||f||||t||||||||||2017-10-10 22:56:56.183385|2017-10-10 22:56:56.183385
NCT02544815|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2016-04-01|||March 2016||2016-03-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|DIG-START-AHF||Digoxin Short Term Treatment Assessment Randomized Trial in AHF|Assessment of the Efficacy and Safety of a Short Term Treatment With Digoxin on Patients With Acute Heart Failure Syndromes. A Randomized Controlled Trial.|Recruiting||Phase 3|1500|Anticipated|University of Monastir||2|||f||||t||||||||Undecided||2017-10-10 22:56:56.296435|2017-10-10 22:56:56.296435
NCT02544802|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-04-18|||June 2015||2015-06-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|||Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee|Treatment of Primary Osteoarthritis of the Knee Joint With Autologous Mesenchymal Stem Cells|Active, not recruiting||Phase 1|4|Actual|Steminent Biotherapeutics Inc.||1|||f||||t||||||||||2017-10-10 22:56:56.445787|2017-10-10 22:56:56.445787
NCT02544789|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2015-09-08|||June 2009||2009-06-01|September 2015|2015-09-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Interventional|||Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia|Phase II, Multi-center, and Pharmacokinetic Study of Efficacy, Safety and Pharmacokinetic of Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia|Completed||Phase 2|44|Actual|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-10 22:56:56.533663|2017-10-10 22:56:56.533663
NCT02544776|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-03-24|||January 2015||2015-01-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients|Effect of Amlodipine and Clomid on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients|Completed||N/A|60|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 22:56:56.623484|2017-10-10 22:56:56.623484
NCT02544763|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-10-11|||April 2016||2016-04-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)|A Double-blind, Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P, CBD) as Add-on Therapy in Patients With Tuberous Sclerosis Complex Who Experience Inadequately-controlled Seizures|Recruiting||Phase 3|192|Anticipated|GW Research Ltd||3|||f||||t||||||||||2017-10-10 22:56:56.716894|2017-10-10 22:56:56.716894
NCT02544750|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-10-11|||August 2016||2016-08-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)|A Double-blind, Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P, CBD) as Add-on Therapy in Patients With Tuberous Sclerosis Complex Who Experience Inadequately-controlled Seizures|Enrolling by invitation||Phase 3|192|Anticipated|GW Research Ltd||1|||f||||t||||||||||2017-10-10 22:56:56.818384|2017-10-10 22:56:56.818384
NCT02544737|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-08-25|||September 2015||2015-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Apatinib for Metastatic Esophageal Cancer.|A Phase II Study of Apatinib for Patients With Heavily Pretreated, Metastatic Esophageal Cancer.|Recruiting||Phase 2|29|Anticipated|Hangzhou Cancer Hospital||1|||f||||||||||||||2017-10-10 22:56:56.911459|2017-10-10 22:56:56.911459
NCT02544724|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-08-02|||November 2016||2016-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||NM-IL-12 (rHuIL‐12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy|Single-Arm, Open-Label Study To Evaluate The Safety, Tolerability And Preliminary Efficacy Of NM-IL-12 (rHuIL‐12) In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy|Not yet recruiting||Phase 2|12|Anticipated|Neumedicines Inc.||1|||f||||t||||||||||2017-10-10 22:56:57.003251|2017-10-10 22:56:57.003251
NCT02544711|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-08-26|||December 2015||2015-12-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|MARGIC||Cost-effectiveness Evaluation of the Use of a Patient Specific Instrument for Surgical Resection of Malignant Bone Tumor Within the Pelvis Versus the Conventional Surgical Treatment|Cost-effectiveness Evaluation of the Use of a Patient Specific Instrument for Surgical Resection of Malignant Bone Tumor Within the Pelvis Versus the Conventional Surgical Treatment|Recruiting||N/A|90|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-10 22:56:57.094914|2017-10-10 22:56:57.094914
NCT02544698|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-06-15|||November 2015||2015-11-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older||Unknown status|Enrolling by invitation|Phase 1|120|Actual|Beijing Chaoyang District Centre for Disease Control and Prevention||4|||f||||||||||||||2017-10-10 22:56:57.217837|2017-10-10 22:56:57.217837
NCT02544685|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2015-09-08|||July 2010||2010-07-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|FENSY||Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients|Prevention of Febrile Neutropenia in Pediatric Cancer Patients by Lactobacillus Rhamnosus GG and Bifidobacterium Animalis Subspecies. Lactis BB-12 in Combination With Inulin and Oligofructose|Unknown status|Recruiting|Phase 2|120|Anticipated|S&D Pharma SK s.r.o.||2|||f||||f||||||||||2017-10-10 22:56:57.507118|2017-10-10 22:56:57.507118
NCT02544672|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-04|||July 2015||2015-07-01|September 2015|2015-09-01||||July 2016|Anticipated|2016-07-01||Interventional|||Function Benefits of a Myoelectric Elbow-Wrist-Hand Orthosis|Function Benefits of a Myoelectric Elbow-Wrist-Hand Orthosis|Unknown status|Recruiting|N/A|30|Anticipated|Myomo||1|||f||||||||||||||2017-10-10 22:56:57.657286|2017-10-10 22:56:57.657286
NCT02544659|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-10-12|||October 2015||2015-10-01|September 2015|2015-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome|Unrandomized, Open Label Single-center Study to Assess the Long Term Efficacy of Intravenous Bisphosphonates for Bone Marrow Edema in Patients With SAPHO Syndrome|Completed||Phase 1|30|Actual|Peking Union Medical College Hospital||1|||f||||||||||||||2017-10-10 22:56:57.753442|2017-10-10 22:56:57.753442
NCT02544646|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-12-01|||October 2011||2011-10-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Interventional|||Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG|Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG or PEX|Recruiting||N/A|50|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-10-10 22:56:57.835177|2017-10-10 22:56:57.835177
NCT02544633|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-06-28|||October 2015||2015-10-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET|Phase 2, Parallel-Arm Study of MGCD265 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor|Recruiting||Phase 2|200|Anticipated|Mirati Therapeutics Inc.||4|||f||||t||||||||Undecided||2017-10-10 22:56:57.933871|2017-10-10 22:56:57.933871
NCT02544620|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-08-17|||September 2015||2015-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Out Patient Surgery for Total Knee and Hip Replacement and Unicompartmental Knee Replacement - a Feasibility Study||Recruiting||N/A|1500|Anticipated|Hvidovre University Hospital|||3||f||||t||||||||||2017-10-10 22:56:58.308575|2017-10-10 22:56:58.308575
NCT02544607|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-06-20|||March 2016||2016-03-01|June 2017|2017-06-01|December 30, 2017|Anticipated|2017-12-30|October 31, 2017|Anticipated|2017-10-31||Interventional|||Ketamine for Depression: An MRI Study|Baseline Insular Dysfunction as a Predictor of Ketamine's Antidepressant Effects in Anxious Depression|Recruiting||Phase 4|28|Anticipated|Massachusetts General Hospital||1|||f||||t|t|f||||||No||2017-10-10 22:56:58.404595|2017-10-10 22:56:58.404595
NCT02544594|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-05-11|||November 2015||2015-11-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|October 2018|Anticipated|2018-10-01||Interventional|ECLS-SHOCK||Clinical Study of Extra-Corporal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction|Randomized Clinical Study of Extra-Corporal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction|Recruiting||Phase 4|42|Anticipated|Klinikum der Universitaet Muenchen||2|||f||||f||||||||||2017-10-10 22:56:58.506074|2017-10-10 22:56:58.506074
NCT02544581|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-06|||September 2015||2015-09-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare|Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare|Unknown status|Enrolling by invitation|N/A|300|Anticipated|SoberLink, LLC|||2||f||||t||||||||||2017-10-10 22:56:58.608879|2017-10-10 22:56:58.608879
NCT02540967|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-09-26|||October 27, 2015|Actual|2015-10-27|September 2017|2017-09-01|September 15, 2018|Anticipated|2018-09-15|September 15, 2018|Anticipated|2018-09-15||Observational|||Drug Use Investigation of Gadovist.|Drug Use Investigation of Gadovist|Recruiting||N/A|3300|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 22:57:42.284758|2017-10-10 22:57:42.284758
NCT02544568|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-09-07|||November 2009||2009-11-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Standardized Meals on the Metabolic, Hormonal and Inflammatory Responses in Human|Effects of Standardized Meals With Different Compositions of Fat, Protein and Carbohydrate on the Metabolic, Hormonal and Inflammatory Responses in Human|Completed||N/A|68|Actual|Karolinska University Hospital||4|||f||||t||||||||||2017-10-10 22:56:58.69654|2017-10-10 22:56:58.69654
NCT02544555|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-15|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|SCENARIO-FP||Efficacy of Subintimal vs Intraluminal Approach for Atherosclerotic Chronic Occlusive Femoropopliteal Arterial Disease|Safety and Efficacy of Subintimal Versus Intraluminal Approach for Atherosclerotic Chronic Occlusive Femoro-Popliteal Arterial Disease: Prospective, Multicenter, Randomized, Controlled Trial (SCENARIO-FP)|Recruiting||N/A|200|Anticipated|Korea University Guro Hospital||2|||f||||t||||||||||2017-10-10 22:56:58.784398|2017-10-10 22:56:58.784398
NCT02544542|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2017-02-01|||January 2014|Actual|2014-01-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Trial of a New Rectum Cooling System on Patients of Hypoxic-ischemic Brain Damage|A Comparative Clinical Trial of a New Rectum Cooling System Versus Temperature-adjusting Blanket on Patients of Hypoxic-ischemic Brain Damage|Completed||N/A|70|Actual|Children's Hospital of Chongqing Medical University||2|||f||||f||||||||||2017-10-10 22:56:58.930937|2017-10-10 22:56:58.930937
NCT02544529|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-07|||June 2016||2016-06-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Echothiophate Iodide for the Prevention of Progression of Myopia|Echothiophate Iodide for the Prevention of Progression of Myopia|Unknown status|Not yet recruiting|Phase 4|33|Anticipated|Danbury Eye Physicians & Surgeons, PC||2|||f||||f||||||||||2017-10-10 22:56:59.058656|2017-10-10 22:56:59.058656
NCT02544516|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2016-11-21|||April 2014||2014-04-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Upside Down, Give me the Handle|"Study on the Links Between Perception and Action in Schizophrenia, Upside Down, Give me the Handle"|Completed||N/A|60|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 22:56:59.179461|2017-10-10 22:56:59.179461
NCT02544490|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2017-09-14|||September 2013||2013-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|miRNA-Sepsis||Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis|Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis|Recruiting||N/A|450|Anticipated|National University Hospital, Singapore|||1||f||||f||||||Samples Without DNA|"     Whole blood extraction from subjects subsequently separated to plasma and serum that are     stored in the Tissue Repository.   "|||2017-10-10 22:56:59.428236|2017-10-10 22:56:59.428236
NCT02544477|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-09-10|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High-flow Nasal Cannula Oxygen Versus Conventional Oxygen Therapy After Pulmonary Lobectomy|High-flow Nasal Cannula Oxygen Versus Conventional Oxygen Therapy After Pulmonary Lobectomy|Recruiting||N/A|94|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-10 22:56:59.523716|2017-10-10 22:56:59.523716
NCT02544464|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-06-11|||August 2016||2016-08-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?|Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?|Not yet recruiting||Phase 4|76|Anticipated|Konkuk University Medical Center||2|||f||||t||||||||||2017-10-10 22:56:59.622464|2017-10-10 22:56:59.622464
NCT02544451|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-08-09|||August 2015||2015-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor|A Phase 3, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor in Subjects Aged 6 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|Active, not recruiting||Phase 3|240|Anticipated|Vertex Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-10-10 22:56:59.72805|2017-10-10 22:56:59.72805
NCT02544438|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2017-09-26|||September 2015||2015-09-01|September 2017|2017-09-01|September 20, 2017|Actual|2017-09-20|September 20, 2017|Actual|2017-09-20||Interventional|BSTPHASE1-01||Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|a Phase i/Iia, Open Label, Uncontrolled Study to Evaluate the Safety and Efficacy of Astarabine (BST-236) as Single Agent in Patients With Refractory or Relapsed Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) Disease|Completed||Phase 1/Phase 2|20|Anticipated|BioSight Ltd.||1|||f||||t||||||||||2017-10-10 22:56:59.962203|2017-10-10 22:56:59.962203
NCT02544425|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-06|2016-05-17|||September 2015||2015-09-01|May 2016|2016-05-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|VIDL+ASCT||VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)|Phase II Study of VIDL (VP-16, Ifosfamide, Dexamethasone, L-asparaginase) Chemotherapy Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Stage III/IV Extranodal NK-T-Cell Lymphoma|Recruiting||Phase 2|27|Anticipated|Samsung Medical Center||1|||f||||f||||||||Yes||2017-10-10 22:57:00.109727|2017-10-10 22:57:00.109727
NCT02544412|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-08-09|||September 2015||2015-09-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|May 2017|Anticipated|2017-05-01||Interventional|PST||A Well-being Training for Preservice Teachers|A Well-being Training for Preservice Teachers|Recruiting||N/A|100|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 22:57:00.227095|2017-10-10 22:57:00.227095
NCT02544399|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-08|||November 2009||2009-11-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Bone Microarchitecture in Women Practicing Golf|Is Golf a Sport Suited to the Female Skeleton After 60 Years? Pilot Study Evaluating the Microarchitecture 3D Carriers and Noncarriers Bones|Completed||N/A|67|Actual|Centre Hospitalier Universitaire de Saint Etienne|||3||f||||f||||||Samples Without DNA|"     Blood sample   "|||2017-10-10 22:57:00.343863|2017-10-10 22:57:00.343863
NCT02544386|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-09-08|||June 2009||2009-06-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Impact of Hemiplegia Due to Stroke on the Microarchitecture of the Bone|Impact of Hemiplegia Due to Stroke on the Microarchitecture of the Bone: Evaluation Using Micro CT 3D High Resolution and by Magnetic Resonance Imaging (MRI)|Terminated||N/A|10|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1|Inclusion rhythm too slow|f||||f||||||Samples With DNA|"     blood sample   "|||2017-10-10 22:57:00.420811|2017-10-10 22:57:00.420811
NCT02544373|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-08|||November 12, 2015|Actual|2015-11-12|September 2017|2017-09-01|April 30, 2021|Anticipated|2021-04-30|November 12, 2020|Anticipated|2020-11-12||Interventional|||CPAP to Treat Cognitive Dysfunction in MS|A Randomized Trial of Positive Airway Pressure Therapy to Treat Cognitive Dysfunction in MS Patients With Obstructive Sleep Apnea|Recruiting||N/A|175|Anticipated|University of Michigan||2|||f||||f|f|f||||||||2017-10-10 22:57:00.5029|2017-10-10 22:57:00.5029
NCT02544360|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-07-11|||September 2015||2015-09-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|Smokerface||A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools|Smokerface: A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools: Randomized Controlled Trial|Active, not recruiting||N/A|12000|Anticipated|University of Giessen||2|||f||||t||||||||||2017-10-10 22:57:00.620537|2017-10-10 22:57:00.620537
NCT02544347|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-07|2015-11-02|||July 2014||2014-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Gingival Crevicular Fluid Vaspin and Omentin Levels in Type 2 Diabetic Patients With Chronic Periodontitis|Effects of Non-Surgical Periodontal Treatment on the Gingival Crevicular Fluid Levels of Vaspin and Omentin-1 in Type 2 Diabetic Patients With Chronic Periodontitis|Completed||N/A|60|Actual|Bulent Ecevit University||4|||f||||f||||||||||2017-10-10 22:57:00.722711|2017-10-10 22:57:00.722711
NCT02544321|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-08-29|||September 2015||2015-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes|Bromocriptine Quick Release (QR) as Adjunct Therapy in Type 1 Diabetes|Recruiting||Phase 2|133|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:57:00.937462|2017-10-10 22:57:00.937462
NCT02544308|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-04-28|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|December 2025|Anticipated|2025-12-01|October 2021|Anticipated|2021-10-01||Interventional|IDRIS||Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma|Phase III Randomised Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma|Recruiting||Phase 3|140|Anticipated|University College, London||2|||f||||t|t|f|||t|||||2017-10-10 22:57:01.198509|2017-10-10 22:57:01.198509
NCT02544295|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-08|||January 2012||2012-01-01|September 2015|2015-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|PHENOVIRTPSY||Based-virtual Reality Diagnosis for Neuropsychiatric Diseases and Sleep/Wake Disorders|Based-virtual Reality Diagnosis for Neuropsychiatric Diseases and Sleep/Wake Disorders|Recruiting||N/A|590|Anticipated|University of Bordeaux||2|||f||||f||||||||||2017-10-10 22:57:01.33042|2017-10-10 22:57:01.33042
NCT02544282|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-07-12|||April 2014||2014-04-01|October 2015|2015-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Large-scale Prospective Double-blind Randomized Controlled Trial of Pecs II Block for Breast Surgery|Large-scale Prospective Double-blind Randomized Controlled Trial of Pecs II Block for Breast Surgery: Effect on Postoperative Pain and Opioid Consumption|Completed||Phase 4|140|Actual|GZA Ziekenhuizen Campus Sint-Augustinus||2|||f||||f||||||||||2017-10-10 22:57:01.460152|2017-10-10 22:57:01.460152
NCT02544269|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-05-02|||June 1, 2016|Actual|2016-06-01|March 2016|2016-03-01|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Interventional|||Hemodynamic Effect of Lumbosacral Plexus Blockade Versus Spinal Anesthesia|Surgical Anesthesia for Elective Hip Surgery - Hemodynamic Effect of Lumbosacral Plexus Blockade Compared to Spinal Anesthesia|Terminated||Phase 4|8|Actual|University of Aarhus||2||"After pilot study no difference in the primary end point was found between the two primary.   Non-inferiority trial not deemed feasible."|f||||t||||||||Yes|Anonymized data will be made available through Danish Data Archive.|2017-10-10 22:57:01.608722|2017-10-10 22:57:01.608722
NCT02544256|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-10-17|||December 2015||2015-12-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Mild Hypothermia During Intracranial Aneurysm Clipping|Mild Hypothermia During Intracranial Aneurysm Clipping: Effect on Brain Microcirculation and Postoperative Vasospasms in Patients With Ruptured Aneurysms|Withdrawn||N/A|0|Actual|University Hospital Hradec Kralove||2||higher mortality in another published study|f||||f||||||||||2017-10-10 22:57:01.727199|2017-10-10 22:57:01.727199
NCT02544243|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2015-09-05|||September 2015||2015-09-01|September 2015|2015-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer|Randomised, Multicenter Phase II Study in Patients With Metastatic Breast Cancer With Vinorelbine Plus Gemcitabine Versus Vinorelbine Plus Cisplatin|Unknown status|Not yet recruiting|Phase 2|200|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||||||||||||2017-10-10 22:57:01.818148|2017-10-10 22:57:01.818148
NCT02544230|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-05|||January 2004||2004-01-01|September 2015|2015-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia|Efficacy of Granulocyte Transfusions for the Treatment of Severe Infections in Hematological Patients With Febrile Neutropenia|Completed||N/A|101|Actual|Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne|||1||f||||f||||||||||2017-10-10 22:57:01.926533|2017-10-10 22:57:01.926533
NCT02544217|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2016-02-05|||May 2015||2015-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||A Dose-escalating Clinical Trial With KH176|A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176|Completed||Phase 1|30|Actual|Khondrion BV||2|||f||||f||||||||||2017-10-10 22:57:02.017097|2017-10-10 22:57:02.017097
NCT02544204|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-01|||November 2015||2015-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|STOP-PAD||SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease|A Phase 2B Randomized Double Blind Placebo Controlled Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection as Adjunct to Revascularization of Infrapopliteal Lesions in Subjects With Advanced Peripheral Artery Disease and Tissue Loss|Recruiting||Phase 2|120|Anticipated|Juventas Therapeutics, Inc.||4|||f||||t||||||||||2017-10-10 22:57:02.119203|2017-10-10 22:57:02.119203
NCT02544191|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2016-08-01|||December 2015||2015-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia|GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia: A Single-center Prospective Study in China|Recruiting||Phase 2|30|Anticipated|Jinling Hospital, China||1|||f||||t||||||||||2017-10-10 22:57:02.412652|2017-10-10 22:57:02.412652
NCT02544178|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-09-21|||April 2015||2015-04-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Observational|EPIBRAINRAD||Study of Neurological Complication After Radiotherapy for High Grade Glioblastoma|EPIBRAINRAD : Study of Neurological Complication After Radiotherapy for Glioblastoma High Grade|Recruiting||N/A|200|Anticipated|Institut de Radioprotection et de Surete Nucleaire|||1||f||||f||||||Samples Without DNA|"     -  protéin S-100B, 8,12-iso-iPF2α-VI level, homocystéine        -  micro RNAs (brain-miR-112, brain-miR-161, hsa-let-7d-3p, hsa-miR-5010-3p,          hsa-miR-26a-5p, hsamiR-1285-5p, hsa-miR-151a-3p, hsamiR-103a-3p, hsa-miR-107,          hsa-miR-532-5p, hsa-miR-26b-5p, hsa-let-7f-5p, …).        -  microparticules   "|||2017-10-10 22:57:02.566408|2017-10-10 22:57:02.566408
NCT02544165|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2015-09-04|||November 2012||2012-11-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|January 2013|Actual|2013-01-01||Interventional|NONINVASHEMO||Non Invasive Measurement of the Haemodynamic Parameters and of the Advanced Glycation End Products (AGEs) Levels|Non Invasive Measurement of the Haemodynamic Parameters and of the Advanced Glycation End Products (AGEs) Levels in Students Smokers and in Students Who Intake Caffeine (NONINVASHAEMOAGES)|Completed||N/A|178|Actual|Technological Education Institute of Sterea Ellada||4|||f||||t||||||||||2017-10-10 22:57:02.677654|2017-10-10 22:57:02.677654
NCT02544152|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-02-22|||February 2015||2015-02-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome|A Randomized, Double-blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Lubiprostone in Adult Subjects With Mixed or Unsubtyped Irritable Bowel Syndrome (IBS-M/IBS-U)|Active, not recruiting||Phase 2|71|Actual|Sucampo Pharma Americas, LLC||2|||f||||f||||||||No||2017-10-10 22:57:02.787686|2017-10-10 22:57:02.787686
NCT02544139|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-08-15|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Specificity Study of Diagnostic for Chagas Disease|Determination of Estimated Specificity of Chagas Detect Plus Rapid Tests|Completed||N/A|200|Actual|InBios International, Inc.|||1||f||||||||||Samples Without DNA|"     serum   "|||2017-10-10 22:57:02.963124|2017-10-10 22:57:02.963124
NCT02544126|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-01-20|||September 2015||2015-09-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Computer-Based Intervention in HIV-Positive Young Adults|Computer-Based Intervention in HIV-Positive Young Adults|Withdrawn||N/A|0|Actual|Emory University||2|||f||||t||||||||||2017-10-10 22:57:03.047878|2017-10-10 22:57:03.047878
NCT02544113|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-08-17|||December 2015||2015-12-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation|A Randomized Controlled Clinical Trial of Thymoglobulin® and Extended Delay of Calcineurin Inhibitor Therapy for Renal Protection After Liver Transplantation. A Multi-Center Study|Recruiting||Phase 2|110|Anticipated|The Cleveland Clinic||2|||f||||t|t|f|||f|||||2017-10-10 22:57:03.162413|2017-10-10 22:57:03.162413
NCT02544100|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-12-15|||September 2015||2015-09-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Neonatal Neurologic Intensive Care Network of China|Neonatal Neurologic Intensive Care Network of China|Recruiting||N/A|2000|Anticipated|Children's Hospital of Fudan University|||1||f||||t||||||Samples With DNA|"     Blood, Urine and CSF samples   "|||2017-10-10 22:57:03.287302|2017-10-10 22:57:03.287302
NCT02544087|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-07-27|||April 2015||2015-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction|Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction: Mechanisms of Multi-target Anti-inflammatory Action|Recruiting||N/A|120|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||4|||f||||t||||||||||2017-10-10 22:57:03.394197|2017-10-10 22:57:03.394197
NCT02544061|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-08-02|||December 2015||2015-12-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds|A Phase IIa Open-label, Randomized Study to Compare the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of NM-IL-12 (rHuIL-12) to Standard of Care in Subjects With Open Surgical Wounds Following Colostomy Takedown Allowed to Heal by Secondary Intention|Recruiting||Phase 2|30|Anticipated|Neumedicines Inc.||2|||f||||f||||||||||2017-10-10 22:57:03.666918|2017-10-10 22:57:03.666918
NCT02544048|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-08-12|||September 4, 2015||2015-09-04|August 11, 2017|2017-08-11|August 11, 2017|Actual|2017-08-11|September 4, 2015|Actual|2015-09-04||Observational|||Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults|Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults|Completed||N/A|75|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:57:03.797129|2017-10-10 22:57:03.797129
NCT02543840|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-04-05|||January 2016||2016-01-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|BHIP-CCM||Hybrid Collaborative Care Randomized Program Evaluation|Hybrid Controlled Trial to Implement Collaborative Care in General Mental Health|Recruiting||N/A|675|Anticipated|VA Boston Healthcare System||2|||f||||f||||||||No||2017-10-10 22:57:05.743278|2017-10-10 22:57:05.743278
NCT02544035|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-09-01|||September 4, 2015||2015-09-04|August 14, 2017|2017-08-14|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Determining Age Appropriateness of Children's Products and Toys: An Interagency Agreement With the Consumer Product Safety Commission|Determining Age Appropriateness of Children's Products and Toys: An Interagency Agreement With the Consumer Product Safety Commission|Completed||N/A|720|Anticipated|National Institutes of Health Clinical Center (CC)||12|||f||||||||||||||2017-10-10 22:57:03.881636|2017-10-10 22:57:03.881636
NCT02544022|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-08-04|||September 3, 2015||2015-09-03|July 31, 2017|2017-07-31|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Observational|||Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs)|Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs)|Recruiting||N/A|414|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:57:03.996122|2017-10-10 22:57:03.996122
NCT02544009|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-08-04|||September 2, 2015||2015-09-02|July 26, 2017|2017-07-26|May 19, 2016|Actual|2016-05-19|May 19, 2016|Actual|2016-05-19||Observational|||Quantifying the Persistence of Metabolic Adaptation and Weight Regain Following Extreme Weight Loss|Quantifying Weight Regain and the Persistence of Metabolic Adaptation Following Extreme Weight Loss|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:57:04.098072|2017-10-10 22:57:04.098072
NCT02543996|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-09-06|||August 31, 2015||2015-08-31|September 5, 2017|2017-09-05|May 22, 2050|Anticipated|2050-05-22|May 22, 2050|Anticipated|2050-05-22||Observational|||Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)|Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:57:04.179233|2017-10-10 22:57:04.179233
NCT02543983|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-05|2017-09-21|||September 1, 2015||2015-09-01|September 18, 2017|2017-09-18|July 21, 2021|Anticipated|2021-07-21|July 21, 2021|Anticipated|2021-07-21||Interventional|||Neurobiology of Suicide|The Neurobiology of Suicide|Recruiting||Phase 2|170|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:57:04.269626|2017-10-10 22:57:04.269626
NCT02543970|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-04|||February 2015||2015-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||A Confirmatory Study for Evaluation of the Treatment by the Celluma3 of Periorbital Wrinkles|A Confirmatory Study for Evaluation of the Treatment by the Celluma3 of Periorbital Wrinkles|Completed||N/A|42|Actual|BioPhotas|||1||f||||f||||||||||2017-10-10 22:57:04.35646|2017-10-10 22:57:04.35646
NCT02543957|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-02-04|||September 2015||2015-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy|A Prospective Study of the Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy|Recruiting||N/A|350|Anticipated|Baylor College of Medicine|||1||f||||t||||||||||2017-10-10 22:57:04.410947|2017-10-10 22:57:04.410947
NCT02543944|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-10-06|||February 2016||2016-02-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|GBN||Improving Treatment Outcomes for Prescription Opioid Dependence|Improving Treatment Outcomes for Prescription Opioid Dependence|Recruiting||Phase 2/Phase 3|200|Anticipated|University of Arkansas||2|||f||||t||||||||||2017-10-10 22:57:04.501066|2017-10-10 22:57:04.501066
NCT02543931|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-28|||November 2015||2015-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|CLaRA||Curcuma Longa L in Rheumatoid Arthritis|Phase Ib Randomized, Double-Blind, Placebo-Controlled Study of Meriva in Rheumatoid Arthritis|Terminated||Phase 1|3|Actual|University of Arizona||3||insufficient enrollment|f||||t||||||||||2017-10-10 22:57:04.596575|2017-10-10 22:57:04.596575
NCT02543918|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-11-09|2016-11-09||September 2015||2015-09-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants|Vaccination Response Following Administration of Ixekizumab to Healthy Subjects|Completed||Phase 1|84|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:57:04.690517|2017-10-10 22:57:04.690517
NCT02543905|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-09-12|||April 2015||2015-04-01|September 2017|2017-09-01|April 2025|Anticipated|2025-04-01|April 2020|Anticipated|2020-04-01||Observational|PROFILE||The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment|The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment|Recruiting||N/A|700|Anticipated|Institute of Cancer Research, United Kingdom|||2||f||||t||||||Samples With DNA|"     Serum, plasma, urine, DNA, RNA   "|||2017-10-10 22:57:05.251023|2017-10-10 22:57:05.251023
NCT02543892|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-08-30|||August 2016||2016-08-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study of a Vaccine for Pneumonia in Adults and Toddlers in Kenya|Phase 1-2 Safety and Immunogenicity Study of PATH-wSP in Kenyan Adults and Toddlers|Recruiting||Phase 1/Phase 2|147|Anticipated|PATH||8|||f||||t||||||||||2017-10-10 22:57:05.349195|2017-10-10 22:57:05.349195
NCT02543879|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-02-15|||September 2015||2015-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies|A Phase 1 Dose Escalation, Multicenter, Open-label, Safety, Pharmacokinetic and Pharmacodynamic Study of FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies|Recruiting||Phase 1|78|Anticipated|Forma Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 22:57:05.459926|2017-10-10 22:57:05.459926
NCT02543866|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-04-25|||February 17, 2017|Actual|2017-02-17|April 2017|2017-04-01|September 2022|Anticipated|2022-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms|Fecal Microbiota Transplantation as a Strategy to Eradicate Intestinal Carriage of Resistant Organisms|Recruiting||Phase 1|20|Anticipated|Seattle Children's Hospital||1|||f||||t|t|f||||||No||2017-10-10 22:57:05.569916|2017-10-10 22:57:05.569916
NCT02543853|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2015-09-04|||March 2015||2015-03-01|September 2015|2015-09-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||The Effect of Two Different Endoscopic Entry Techniques on Postoperative Gastrointestinal Function|The Effect of Two Different Endoscopic Entry Techniques on Postoperative Gastrointestinal Function|Unknown status|Recruiting|N/A|140|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t||||||||||2017-10-10 22:57:05.655224|2017-10-10 22:57:05.655224
NCT02543827|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-03-02|||November 2015||2015-11-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|MV140||Evaluation of the Efficacy and Safety of MV140|Prospective Randomized, Double-blind, Parallel-controlled Versus Placebo in a Polyvalent Sublingual Bacterial Vaccine to 3 Months and 6 Months in Women With RUTI for the Immunomodulatory Efficacy Evaluation, Safety and Clinical Impact|Recruiting||Phase 3|240|Anticipated|Inmunotek S.L.||3|||f||||f|f|f||||||No||2017-10-10 22:57:05.832263|2017-10-10 22:57:05.832263
NCT02543814|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-04-18|||August 2015||2015-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:57:05.966367|2017-10-10 22:57:05.966367
NCT02543801|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-06-12|||January 25, 2016|Actual|2016-01-25|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||A Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip Arthroplasty|A Prospective, Randomized Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip Arthroplasty|Enrolling by invitation||Phase 4|216|Anticipated|Kootenai Health||2|||f||||f||||||||No||2017-10-10 22:57:06.005391|2017-10-10 22:57:06.005391
NCT02543788|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-08-17|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||CHRONIC OPTIC NEUROPATHY IN MULTIPLE SCLEROSIS|CHRONIC OPTIC NEUROPATHY IN MULTIPLE SCLEROSIS: DEMYELINATING AND/OR PRIMARY DEGENERATIVE PATHOPHYSIOLOGY?|Completed||N/A|39|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 22:57:06.089823|2017-10-10 22:57:06.089823
NCT02543775|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-05-10|||July 2010||2010-07-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Sentinel Lymph Node Detection in Early Cervical Cancer|Sentinel Lymph Node Detection in Early Cervical Cancer|Suspended||N/A|75|Anticipated|University Health Network, Toronto||1||"On hold to determine next steps-considering a protocol amendment to investigate ICG instead of   blue dye/Tm99."|f||||t||||||||||2017-10-10 22:57:06.168835|2017-10-10 22:57:06.168835
NCT02543762|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-09-04|||February 2012||2012-02-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|June 2014|Actual|2014-06-01|2 Years|Observational [Patient Registry]|CE||Usefulness of Chromoendoscopy for the Early Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease|Usefulness of Chromoendoscopy for the Early Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease|Completed||N/A|350|Actual|Hospital Clinic of Barcelona|||1||f||||f||||||||||2017-10-10 22:57:06.240301|2017-10-10 22:57:06.240301
NCT02543749|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-09-21|||July 2014||2014-07-01|September 2015|2015-09-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||DC Vaccination in CML|Dendritic Cells as Autologous Vaccine in Patients With Chronic Myeloid Leukemia|Recruiting||Phase 1/Phase 2|30|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-10 22:57:06.342948|2017-10-10 22:57:06.342948
NCT02543736|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-04|||July 2015||2015-07-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Reliability and Validity of Gait and Postural Balance Parameters|Reliability and Validity of Gait and Postural Balance Parameters Using an Instrumented Treadmill in Patients With Knee Osteoarthritis|Unknown status|Recruiting|N/A|76|Anticipated|Schulthess Klinik||1|||f||||||||||||||2017-10-10 22:57:06.429013|2017-10-10 22:57:06.429013
NCT02543723|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-07-26|||June 1, 2017|Actual|2017-06-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence|A Randomized Longitudinal Intervention Study to Assess the Efficacy and Feasibility of Telehealth-based Strategies to Increase Oral Chemotherapeutic Agent Medication Adherence and Health Literacy Among Cancer Patients.|Recruiting||N/A|150|Anticipated|East Carolina University||2|||f||||f|f|f||||||||2017-10-10 22:57:06.528085|2017-10-10 22:57:06.528085
NCT02543710|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-03-24|||October 2015||2015-10-01|March 2017|2017-03-01|December 2033|Anticipated|2033-12-01|December 2020|Anticipated|2020-12-01||Interventional|Momatec2||Biomarker Guided Treatment in Gynaecological Cancer|Biomarker Guided Treatment in Gynaecological Cancer|Recruiting||Phase 4|1300|Anticipated|Haukeland University Hospital||2|||f||||f||||||||No||2017-10-10 22:57:08.538375|2017-10-10 22:57:08.538375
NCT02543697|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-09-07|||February 2015||2015-02-01|September 2016|2016-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|AVS||Adrenal Venous Sampling in Patients With Overt or Subclinical Cushings Syndrome, and Bilateral Adrenal Tumors|Adrenal Venous Sampling in Patients With Overt or Subclinical Cushings Syndrome, and Bilateral Adrenal Tumors|Recruiting||N/A|30|Anticipated|Haukeland University Hospital||1|||f||||t||||||||||2017-10-10 22:57:08.710877|2017-10-10 22:57:08.710877
NCT02543684|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-04|||November 2013||2013-11-01|September 2015|2015-09-01||||April 2015|Actual|2015-04-01||Interventional|||Post-prandial Glucose and Insulin Levels in Type 2 Diabetes Mellitus Patients After Consumption of Ready-to-eat Mixed Meals|Post-prandial Glucose and Insulin Levels in Type 2 Diabetes Mellitus Patients After Consumption of Ready-to-eat Mixed Meals|Completed||N/A|24|Actual|Harokopio University||4|||f||||||||||||||2017-10-10 22:57:08.806563|2017-10-10 22:57:08.806563
NCT02543671|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-04|||October 2014||2014-10-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Investigation of Vitamin D3 Enriched, Reduced-fat Yellow Cheese Efficacy to Prevent Vitamin D Deficiency|Investigation of Vitamin D3 Enriched, Reduced-fat Yellow Cheese Efficacy to Prevent Vitamin D Deficiency|Completed||N/A|80|Actual|Harokopio University||2|||f||||||||||||||2017-10-10 22:57:08.908529|2017-10-10 22:57:08.908529
NCT02543658|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-04|||September 2015||2015-09-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension|The Curative Effect and Security of Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension|Not yet recruiting||Phase 1|80|Anticipated|The First Affiliated Hospital of Nanchang University||2|||f||||f||||||||||2017-10-10 22:57:09.01769|2017-10-10 22:57:09.01769
NCT02543645|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-06-16|||October 2015||2015-10-01|June 2017|2017-06-01|May 22, 2017|Actual|2017-05-22|April 2017|Actual|2017-04-01||Interventional|||A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer|A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer|Terminated||Phase 1/Phase 2|18|Actual|Celldex Therapeutics||1||Portfolio re-prioritization|f||||f||||||||||2017-10-10 22:57:09.164669|2017-10-10 22:57:09.164669
NCT02519166|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-06|||May 2012||2012-05-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Biofilm Plaie||Characterisation of Biofilm of the Chronic Wounds||Completed||N/A|130|Actual|Institut Curie||1|||f||||f||||||||||2017-10-10 23:03:38.704481|2017-10-10 23:03:38.704481
NCT02543632|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-06-21|||August 2015||2015-08-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01|6 Months|Observational [Patient Registry]|P5||PARACHUTE V PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE.|PARACHUTE V: PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE. A German Trial to Evaluate the Improvement in Quality of Life and Cardiac Output Following Implanting of the Parachute Implant System|Terminated||N/A|85|Actual|CardioKinetix, Inc|||2|Company closed|f||||f||||||||||2017-10-10 22:57:09.2857|2017-10-10 22:57:09.2857
NCT02543619|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-04|||March 2015||2015-03-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy of Two Injection Techniques on Success Rate of Inferior Alveolar Nerve Anesthesia|Comparative Efficacy of Gow-Gates and Inferior Alveolar Nerve Block Injection Techniques on Success Rate of Anesthesia in Patients With Symptomatic Irreversible Pulpitis|Completed||Phase 2|40|Actual|Azad University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:57:09.422327|2017-10-10 22:57:09.422327
NCT02543606|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-09-04|||April 2015||2015-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Bioequivalence of Two Formulations of Esomeprazole|A Randomized, Two-way Crossover, Single-dose Pharmacokinetic Study to Evaluate the Bioequivalence of Esomelone for Injection/Infusion (Esomeprazole 40mg), Compared to Reference Drug (Nexium 40mg) in Healthy Adult Subjects|Completed||Phase 4|14|Actual|Yung Shin Pharm. Ind. Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:57:09.51707|2017-10-10 22:57:09.51707
NCT02543593|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|PVD/tDCS||Efficacy of Transcranial Direct-Current Stimulation (tDCS) for Provoked Vestibulodynia : a Triple Blind Randomized Controlled Trial||Completed||N/A|40|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-10 22:57:09.819731|2017-10-10 22:57:09.819731
NCT02543580|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-09-04|||July 2015||2015-07-01|September 2015|2015-09-01||||October 2015|Anticipated|2015-10-01||Interventional|||Acupuncture-assisted Anesthsia With Single or Dual Acupoints Affects Analgesics|Efficiency of Acupuncture-assisted Anesthsia With Single or Dual Acupoints in Patients Undergoing Radical Operation of Breast Cancer: A Single Center, Randomized, Double-blinded, Controlled Clinical Trial|Unknown status|Recruiting|N/A|204|Anticipated|Xijing Hospital||4|||f||||t||||||||||2017-10-10 22:57:09.941365|2017-10-10 22:57:09.941365
NCT02543567|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-06-06||2017-06-06|September 21, 2015|Actual|2015-09-21|June 2017|2017-06-01|November 29, 2016|Actual|2016-11-29|June 7, 2016|Actual|2016-06-07||Interventional|||A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants|A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate A Range of Dose Levels of a Heterologous Prime‐Boost Regimen of Ad26.ZEBOV and MVA‐BN®‐Filo in Healthy Adult Subjects|Completed||Phase 3|525|Actual|Janssen Vaccines & Prevention B.V.||4|||f||||t||f||||||||2017-10-10 22:57:10.06829|2017-10-10 22:57:10.06829
NCT02543554|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-12-26|||October 2014||2014-10-01|December 2015|2015-12-01||||March 2016|Anticipated|2016-03-01||Observational|||ED Lung Protective Ventilation to Reduce Complications|The Effect of Lung Protective Ventilation Initiated in the Emergency Department on the Incidence of Pulmonary Complications and Clinical Outcomes|Recruiting||N/A|513|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-10-10 22:57:10.207958|2017-10-10 22:57:10.207958
NCT02543541|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-08-22|||October 25, 2015||2015-10-25|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Pilot Study of Structured Palliative Care for Patients Enrolled on Phase I Clinical Trials|A Pilot Study of Structured Palliative Care for Patients Enrolled on Phase I Clinical Trials|Recruiting||N/A|80|Anticipated|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 22:57:10.301722|2017-10-10 22:57:10.301722
NCT02543528|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-05-26|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|November 8, 2016|Actual|2016-11-08|November 8, 2016|Actual|2016-11-08||Interventional|||A Clinical Trial to Evaluate Investigational Silicone Hydrogel Contact Lenses Worn Continuously for One Week|Echo Ionic Silicone Hydrogel 6-Month Extended Wear Investigation|Completed||N/A|171|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||t|f|t|f|f|t|||||2017-10-10 22:57:10.421408|2017-10-10 22:57:10.421408
NCT02543515|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2017-01-31|||March 2015||2015-03-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01|1 Day|Observational [Patient Registry]|||Psychosocial and Clinical Characteristics Predicting Women's Acceptance of Office Hysteroscopy|Psychosocial and Clinical Characteristics Predicting Women's Acceptance of Office Hysteroscopy: An Observational Study|Completed||N/A|100|Actual|Centro Hospitalar Tondela-Viseu|||1||f||||f||||||||||2017-10-10 22:57:10.539727|2017-10-10 22:57:10.539727
NCT02543502|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-04|||August 2012||2012-08-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TPAMI||Treatment of Periodontal Disease in Patients With Acute Myocardial Infarction|Treatment of Periodontal Disease in Patients With Acute Myocardial Infarction: Randomized Controlled Trial|Completed||N/A|54|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 22:57:10.666893|2017-10-10 22:57:10.666893
NCT02543489|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-07|||December 2012||2012-12-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Flex Intramedullary Rod Study|A Prospective, Post-market, Multi-center Comparative Study of the Efficacy of Flex Intramedullary(IM) Rod in Terms of Range of Motion (ROM) Improvement.|Active, not recruiting||N/A|100|Actual|Stryker Japan K.K.||1|||f||||f||||||||||2017-10-10 22:57:10.816133|2017-10-10 22:57:10.816133
NCT02543476|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|SUPREME-HN||SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)|SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)|Completed||N/A|513|Actual|AstraZeneca|||1||f||||f||||||Samples Without DNA|"     Archival tumor tissues samples   "|||2017-10-10 22:57:10.913092|2017-10-10 22:57:10.913092
NCT02543463|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-07|||April 2015||2015-04-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Navigation With X3 vs Non-Navigation With X3 Study|Comparison X3 Study Between Navi-THA and Non-navi-THA|Active, not recruiting||N/A|60|Anticipated|Stryker Japan K.K.||2|||f||||f||||||||||2017-10-10 22:57:11.050968|2017-10-10 22:57:11.050968
NCT02542527|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-10-19|||September 2015||2015-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|C88||Evaluation of the Functionality of a Fluid Filled Single Breast Pump|C88- Pilot Study A Prospective Case Series for Evaluation of the Functionality of a Fluid Filled Single Breast Pump Applied on a Lactating Breast|Completed||N/A|4|Actual|Medela AG||1|||f||||f||||||||||2017-10-10 22:57:21.01452|2017-10-10 22:57:21.01452
NCT02543450|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-04|||September 2014||2014-09-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Physiotherapy in Order to Improve Walking Capacity and Participation in Chronic Stroke Subjects|Two Different Physiotherapy Programs in Order to Improve Walking Capacity and Participation in Chronic Stroke Subjects|Unknown status|Recruiting|N/A|14|Anticipated|University of Valencia||2|||f||||f||||||||||2017-10-10 22:57:11.153105|2017-10-10 22:57:11.153105
NCT02543437|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-03-07|2015-09-25||July 2010||2010-07-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2011|Actual|2011-12-01||Interventional|||Large Head X3 Study|The Effect of Large Diameter Head to Prevent Dislocation, and of 3 rd Generation Highly Crosslinked Polyethylene to Reduce Wear in Computer Assisted Total Hip Arthroplasty.|Unknown status|Active, not recruiting|N/A|120|Actual|Stryker Japan K.K.||1|||f||||f||||||||||2017-10-10 22:57:11.297987|2017-10-10 22:57:11.297987
NCT02543411|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-12-14|||September 2015||2015-09-01|December 2015|2015-12-01||||November 2015|Actual|2015-11-01||Interventional|||Use of Lidocaine in Endoscopic Submucosal Dissection|Effect of Intravenous Lidocaine During Endoscopic Submucosal Dissection for Gastric Neoplasm|Completed||N/A|66|Actual|Severance Hospital||2|||f||||f||||||||||2017-10-10 22:57:11.645328|2017-10-10 22:57:11.645328
NCT02543385|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-04|||June 2014||2014-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SKET||S Ketamine Use in Total Abdominal Hysterectomy|The Use of S Ketamine Versus Placebo During Target Controlled Intravenous Anaesthesia to Reduce Morphine Consumption and Side-Effects After Abdominal Hysterectomy: A Randomized Control Trial|Withdrawn||N/A|0|Actual|KK Women's and Children's Hospital||2||Change of protocol title|f||||f||||||||||2017-10-10 22:57:11.866946|2017-10-10 22:57:11.866946
NCT02543372|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-08-30|||August 2015||2015-08-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||RCT of Internet-Delivered CBT Treatments for Pathological Gambling: Comparing the Effects of Added Involvement From CSOs|Internet-Delivered Treatments for Pathological Gambling: a Randomized Controlled Trial Comparing the Effects of Added Involvement By Concerned Significant Others|Recruiting||N/A|200|Anticipated|Karolinska Institutet||2|||f||||||||||||||2017-10-10 22:57:12.069943|2017-10-10 22:57:12.069943
NCT02543359|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-10-27|||September 2012||2012-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Statewide Trial to Compare Three Training Models for Implementing an Evidence-based Treatment (EBT)|A Statewide Trial to Compare Three Training Models for Implementing an EBT|Active, not recruiting||N/A|648|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-10 22:57:12.206869|2017-10-10 22:57:12.206869
NCT02543346|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-09-26|||October 2015||2015-10-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Comparability and Standardization of Controlled Allergen Challenge Facilities|Comparability and Standardization of Controlled Allergen Challenge Facilities|Completed||Phase 4|98|Actual|Queen's University||2|||f||||f||||||||||2017-10-10 22:57:12.317348|2017-10-10 22:57:12.317348
NCT02543333|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-03-29|||July 2013||2013-07-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|SLPBD||Validation of Structured Light Plethysmography: Asthma|Validation of Structured Light Plethysmography: Pre- and Post- Bronchodilator Challenge|Recruiting||N/A|300|Anticipated|Pneumacare Ltd|||3||f||||f||||||||||2017-10-10 22:57:12.448251|2017-10-10 22:57:12.448251
NCT02543320|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-04-04|||August 29, 2012|Actual|2012-08-29|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||LORETA (Low Resolution Electromagnetic Tomography) Neurofeedback|Neurofeedback for Acute Radiotherapy-Induced Pain in Head and Neck Cancer Patients|Active, not recruiting||N/A|17|Actual|M.D. Anderson Cancer Center||1|||f||||f|f|f||||||||2017-10-10 22:57:12.566|2017-10-10 22:57:12.566
NCT02543307|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-03|||February 2012||2012-02-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NPP||Effects of Nurse-led Patient Pathways|Quality and Process Improvement Using Nurse-led Patient Pathways in an Orthopedic Hospital|Completed||N/A|607|Actual|Zurich University of Applied Sciences||2|||f||||f||||||||||2017-10-10 22:57:12.687081|2017-10-10 22:57:12.687081
NCT02543294|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-09-15|||September 10, 2012|Actual|2012-09-10|September 2017|2017-09-01|September 10, 2017|Actual|2017-09-10|September 10, 2017|Actual|2017-09-10||Interventional|||REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)|REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)|Completed||N/A|20|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-10 22:57:12.813163|2017-10-10 22:57:12.813163
NCT02543281|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-05-12|||April 2015||2015-04-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|aCRT-ELSYNC||Adaptive CRT Effect on Electrical Dyssynchrony|Adaptive CRT Effect on Electrical Dyssynchrony|Enrolling by invitation||N/A|32|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-10 22:57:12.932371|2017-10-10 22:57:12.932371
NCT02543268|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-11-16||2016-09-09|September 2015||2015-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants|A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of a Heterologous Prime‐Boost Regimen Using Three Different Batches of Ad26.ZEBOV and a Single Batch of MVA‐BN®‐Filo in Healthy Adult Subjects|Completed||Phase 3|329|Actual|Crucell Holland BV||4|||f||||t||||||||||2017-10-10 22:57:13.044139|2017-10-10 22:57:13.044139
NCT02541747|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2016-07-09|||June 2014||2014-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Assessments in Stress and Quality of Sleep/Life in Night-shift Nurses and Doctors|Assessments in Stress and Quality of Sleep/Life in Night-shift Nurses and Doctors|Completed||Phase 4|77|Actual|Taichung Veterans General Hospital||2|||f||||f||||||||No||2017-10-10 22:57:31.740044|2017-10-10 22:57:31.740044
NCT02543255|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-12-01|||September 2016||2016-09-01|December 2016|2016-12-01||||October 2018|Anticipated|2018-10-01||Interventional|ACDC-RP||Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)|Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC-RP Trial): A Randomized, Open-label, Multi-centre Phase-2 Study Evaluating the Pathological Complete Response (pCR) Rate Following Neoadjuvant Therapy in Participants With High-risk Prostate Carcinoma for Whom Radical Prostatectomy is Indicated|Recruiting||Phase 2|76|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 22:57:13.164032|2017-10-10 22:57:13.164032
NCT02543242|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-04|||August 2015||2015-08-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||InTone for Urinary Incontinence|Effectiveness of the Intone Pelvic Floor Device for Urinary Incontinence|Unknown status|Recruiting|N/A|30|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:57:13.307111|2017-10-10 22:57:13.307111
NCT02543229|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-09-20|||July 2015||2015-07-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|February 7, 2017|Actual|2017-02-07||Interventional|||Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD|A Phase 1 Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 in Combination With Ranibizumab in Subjects With Wet AMD|Active, not recruiting||Phase 1|50|Anticipated|Opthea Pty Ltd.||6|||f||||t||||||||||2017-10-10 22:57:13.427016|2017-10-10 22:57:13.427016
NCT02543216|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-09|||January 2015||2015-01-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|FADSDIET||Gene - Diet Interactions in Fatty Acid Desaturase 1 Gene|Gene - Diet Interactions in Fatty Acid Desaturase 1 Gene (FADSDIET)|Completed||N/A|59|Actual|University of Eastern Finland||2|||f||||||||||||||2017-10-10 22:57:13.571422|2017-10-10 22:57:13.571422
NCT02543203|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-09-19|||July 2015||2015-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Essential Oils for Enhancing QOL in ASD|Essential Oils for Enhancing of Quality of Life in Autism Spectrum Disorder (ASD)|Recruiting||Phase 2|34|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-10 22:57:13.665195|2017-10-10 22:57:13.665195
NCT02543190|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-01-27|||October 2014||2014-10-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|SWIFT||System-Wide Improvement for Transitions After Surgery: The SWIFT Post op Program|System-Wide Improvement for Transitions After Surgery: The SWIFT Post op Program|Recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 22:57:13.794471|2017-10-10 22:57:13.794471
NCT02543177|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2016-10-04|||September 2015||2015-09-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|NSTEMI-CKD||Optimised Procedure in Patients With NSTEMI and CKD|Optimised Procedure in Patients With an Acute Non-ST-segment Elevation Myocardial Infarction and Acute or Chronic Kidney Disease|Terminated||N/A|1|Actual|RWTH Aachen University||4||not enough patients recruited|f||||f||||||||||2017-10-10 22:57:13.901154|2017-10-10 22:57:13.901154
NCT02543164|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-09-13|||February 2015||2015-02-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Influence of Beta-glucan Enriched Barley Flour in Bread on Glycemic Response|Comparison of the Glycemic Response of Consumption of Bread Enriched With Barley Beta-glucans With White Bread. Controlled Intervention Trial. A Pilot Study|Completed||N/A|10|Actual|Nutrition Institute, Slovenia||2|||f||||f||||||||||2017-10-10 22:57:14.006539|2017-10-10 22:57:14.006539
NCT02543151|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-08-08|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Interventional|||SpyGlass in Post Liver Transplant Biliary Complications.|Prospective Evaluation of SpyGlass Direct Visualization System in Post Liver Transplant Biliary Stricture.|Active, not recruiting||N/A|20|Actual|Hospital Israelita Albert Einstein||1|||f||||t||||||||||2017-10-10 22:57:14.098992|2017-10-10 22:57:14.098992
NCT02543138|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-09-03|||August 2015||2015-08-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|TDEANTT||The Development and Experimental Application of a New Thoracostomy Trocar|The Development and Experimental Application of a New Thoracostomy Trocar|Completed||N/A|16|Actual|Hanyang University||1|||f||||t||||||||||2017-10-10 22:57:14.229947|2017-10-10 22:57:14.229947
NCT02543125|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-02-22|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Nasal High Frequency Oscillatory Versus Nasal Intermittent Positive Pressure Ventilation in Neonate After Extubation|Nasal High Frequency Oscillatory Versus Nasal Intermittent Positive Pressure Ventilation in Neonate After Extubation|Active, not recruiting||N/A|75|Anticipated|Guangdong Women and Children Hospital||2|||f||||t||||||||Yes||2017-10-10 22:57:14.737766|2017-10-10 22:57:14.737766
NCT02543099|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2015-09-03|||June 2015||2015-06-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||Efficacy and Safety Study of Policosanol|The Effect of Policosanol on Elderly Patients With Endothelial Dysfunction|Unknown status|Recruiting|Phase 3|100|Anticipated|General Hospital of Chinese Armed Police Forces||2|||f||||t||||||||||2017-10-10 22:57:14.829868|2017-10-10 22:57:14.829868
NCT02543086|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-09-14|||July 2015||2015-07-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos|A Phase1 Interventional Sequential Single Site Study to Characterize the Effectiveness of Oral KAE609 in Reducing Asexual & Sexual Blood-stage P. Falciparum Following Inoculation in Healthy-volunteers & Subsequent Infectivity to Mosquitoes|Terminated||Phase 1|8|Actual|Novartis||1|||f||||f||||||||||2017-10-10 22:57:14.934095|2017-10-10 22:57:14.934095
NCT02543073|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-05-09|||September 2014||2014-09-01|September 2015|2015-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||MSC for Treatment of Interstitial Lung Disease After Allo-HSCT|Mesenchymal Stem Cell for Treatment of Interstitial Lung Disease After Allogenetic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 1/Phase 2|60|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-10 22:57:15.034041|2017-10-10 22:57:15.034041
NCT02543060|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-10-04|||June 2015||2015-06-01|October 2017|2017-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Pilot Study to Evaluate a Method for Plaque When Comparing Stannous Fluoride Toothpaste to a Regular Dentifrice|A Pilot Study to Evaluate the Sensitivity of a Novel Molecular Method for Plaque Toxicity When Comparing Two-step Toothpaste to a Regular Dentifrice|Completed||N/A|60|Actual|Procter and Gamble||2|||f|||||f|f||||||||2017-10-10 22:57:15.137674|2017-10-10 22:57:15.137674
NCT02543047|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-01-11|||November 2015||2015-11-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|April 2017|Anticipated|2017-04-01||Interventional|||The Angioshield Study Feasibility II|THE ANGIOSHIELD STUDY:Feasibility Study to Demonstrate the Safety of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery|Recruiting||Early Phase 1|15|Anticipated|Neograft Technologies, Incorporated||2|||f||||t||||||||||2017-10-10 22:57:15.212834|2017-10-10 22:57:15.212834
NCT02543034|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-05-11|||March 16, 2016|Actual|2016-03-16|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 14, 2017|Actual|2017-04-14||Interventional|||Compare of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site|Randomized, Controlled, Phase IV Study of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site|Completed||N/A|105|Actual|Mundipharma Korea Ltd||3|||f||||f||||||||No||2017-10-10 22:57:15.520629|2017-10-10 22:57:15.520629
NCT02543021|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-04|||November 2015||2015-11-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Virtual Chromoendoscopy for Colitis Surveillance: A Feasibility Study|A Study to Assess the Feasibility and Patient Acceptability of a Randomised, Crossover Design to Compare Virtual vs Conventional Chromoendoscopy for the Detection of Dysplasia in Colitis|Unknown status|Not yet recruiting|N/A|60|Anticipated|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-10 22:57:15.641198|2017-10-10 22:57:15.641198
NCT02543008|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-02-13|||September 2015||2015-09-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Physical Activity Following Thoracic Mobilization on Heart Rate Variability and Pressure Pain Threshold.|Effect of Physical Activity Following Thoracic Mobilization on Heart Rate Variability and Pressure Pain Threshold in Asymptomatic Subjects: a Randomized Clinical Trial.|Completed||N/A|34|Actual|Federal University of Health Science of Porto Alegre||3|||f||||||||||||||2017-10-10 22:57:15.760875|2017-10-10 22:57:15.760875
NCT02542995|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-03|||November 2009||2009-11-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|March 2013|Actual|2013-03-01||Interventional|HWP||Creating Healthy Work Places (HWP) Study|Creating Healthy Workplaces: Improving Outcomes for Providers and Patients|Completed||N/A|1296|Actual|Minneapolis Medical Research Foundation||2|||f||||f||||||||||2017-10-10 22:57:15.855155|2017-10-10 22:57:15.855155
NCT02542982|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-21|2015-09-03|||April 2013||2013-04-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||tDCS and Motor Training and Motor Deficit After Stroke|Effects of Anodal tDCS and Motor Training on Chronic Motor Deficit After Stroke|Completed||Phase 3|26|Actual|Military Medical Academy, Belgrade, Serbia||2|||f||||f||||||||||2017-10-10 22:57:15.950465|2017-10-10 22:57:15.950465
NCT02542969|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-10-07|||September 2015||2015-09-01|September 2015|2015-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin|A Single Center, Open-label, Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin in Healthy Subjects|Completed||Phase 1|25|Actual|Madrigal Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:57:16.058399|2017-10-10 22:57:16.058399
NCT02542956|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-08-15|||October 2014||2014-10-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine for Pain Management|Prospective, Randomized, Controlled Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine For Pain Management After Abdominoplasty and TRAM Flap Breast Reconstruction.|Recruiting||Phase 4|45|Anticipated|Henry Ford Health System||2|||f||||f||||||||||2017-10-10 22:57:16.161746|2017-10-10 22:57:16.161746
NCT02542943|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-01-16|2016-08-02||September 2015||2015-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity|Completed||N/A|240|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 22:57:16.288095|2017-10-10 22:57:16.288095
NCT02542930|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-10-09|||January 2016||2016-01-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Abscopal Effect for Metastatic Non-small Cell Lung Cancer.|A Phase II Study of Radiotherapy and ZADAXIN's® (Thymalfasin) Induced Abscopal Effect in Patients With Heavily Pretreated, Metastatic Non-small Cell Lung Cancer.|Not yet recruiting||Phase 2|29|Anticipated|Zhejiang Provincial People’s Hospital||1|||f||||f||||||||||2017-10-10 22:57:17.097811|2017-10-10 22:57:17.097811
NCT02542917|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-09-04|||September 2015||2015-09-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Observational|||Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study|Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study|Unknown status|Enrolling by invitation|N/A|50|Anticipated|King's College Hospital NHS Trust|||1||f||||f||||||||||2017-10-10 22:57:17.193577|2017-10-10 22:57:17.193577
NCT02542904|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-01-07|||August 2015||2015-08-01|September 2015|2015-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Extensive Mesenteric Excision (EME) Versus Local Mesenteric Excision (LME) for Crohn's Disease||Unknown status|Recruiting|N/A|104|Anticipated|Jinling Hospital, China||2|||f||||||||||||||2017-10-10 22:57:17.285218|2017-10-10 22:57:17.285218
NCT02542878|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-04|||October 2015||2015-10-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|FR-Lumbar||Effect of Myofascial Release by Foam Rolling on Back Muscles Endurance|Acute Effects of Foam Rolling Self-application on Isometric Back Extension Endurance on Basketball Players. A Pilot Study.|Unknown status|Not yet recruiting|N/A|150|Anticipated|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||||2017-10-10 22:57:17.5863|2017-10-10 22:57:17.5863
NCT02542865|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-08-04|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|October 9, 2018|Anticipated|2018-10-09|October 9, 2018|Anticipated|2018-10-09||Interventional|||A Study to Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School Children|Clinical Study to Measure the Impact of Fortified Malt Based Food on Immunity Outcomes in School Children|Recruiting||N/A|924|Anticipated|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 22:57:17.680653|2017-10-10 22:57:17.680653
NCT02542852|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-01-24|||September 2015||2015-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|Dolatav||A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia|A Pilot Phase II Study of a Nucleoside Sparing Regimen of Dolutegravir + Atazanavir/r in HIV-1 Infected Patients With Detectable Viremia (DOLATAV Study)|Recruiting||Phase 2|40|Anticipated|Ospedale San Raffaele||1|||f||||f||||||||||2017-10-10 22:57:17.777527|2017-10-10 22:57:17.777527
NCT02542839|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-21|||November 2015||2015-11-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||rTMS and Botulinum Toxin in Primary Cervical Dystonia|Combined Therapy With rTMS and Botulinum Toxin in Primary Cervical Dystonia|Recruiting||N/A|35|Anticipated|University of Florida||2|||f||||t|f|t|f|f||||||2017-10-10 22:57:17.883975|2017-10-10 22:57:17.883975
NCT02542826|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-02-10|||August 2015||2015-08-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Pulmonary Rehab, Dyspnea, Walk and Step Testing in COPD|Constant Rate Shuttle Walking and Stair Stepping Tests to Assess Exertional Dyspnea in COPD: Responsiveness to Pulmonary Rehabilitation and Minimal Clinically Important Difference|Recruiting||N/A|80|Anticipated|McGill University||1|||f||||f|f|f||||||No||2017-10-10 22:57:17.99874|2017-10-10 22:57:17.99874
NCT02542813|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-05-05|||September 14, 2015|Actual|2015-09-14|May 2017|2017-05-01|December 16, 2015|Actual|2015-12-16|December 16, 2015|Actual|2015-12-16||Interventional|||Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers|A Single Centre, Single Blind Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:57:18.102549|2017-10-10 22:57:18.102549
NCT02542800|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2015-09-04|||September 2015||2015-09-01|August 2015|2015-08-01||||March 2017|Anticipated|2017-03-01||Interventional|MULTIBRAIN_2||The Influence of Collective Schemas on Individual Memory|ETUDE D'IMAGERIE PAR RESONANCE MAGNETIQUE FONCTIONNELLE CHEZ LE SUJET SAIN DES RELATIONS ENTRE MEMOIRE COLLECTIVE ET INDIVIDUELLE|Unknown status|Recruiting|N/A|24|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-10 22:57:18.216057|2017-10-10 22:57:18.216057
NCT02542787|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-04|2017-01-30|||August 2015||2015-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis|A Phase II Proof of Concept (PoC), Double-Blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VSN16R for the Treatment of Spasticity in Subjects With Multiple Sclerosis|Recruiting||Phase 2|160|Anticipated|Canbex Therapeutics Ltd||2|||f||||t||||||||||2017-10-10 22:57:18.28945|2017-10-10 22:57:18.28945
NCT02542774|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-03|||August 2015||2015-08-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|October 2015|Anticipated|2015-10-01||Observational|||Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes|Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes: an Examination of Variation in Health Service Delivery|Unknown status|Active, not recruiting|N/A|80000|Anticipated|University College, London|||1||f||||t||||||||||2017-10-10 22:57:18.396659|2017-10-10 22:57:18.396659
NCT02542761|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-08-07|2017-08-07||June 2015|Actual|2015-06-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Comparative Performance of Dynamic Elastic Response Feet|Comparative Performance of Dynamic Elastic Response Feet|Completed||N/A|10|Actual|Mayo Clinic||2|||f||||f|f|t|f|f|t|||||2017-10-10 22:57:18.471436|2017-10-10 22:57:18.471436
NCT02542748|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-09-11|||May 2015||2015-05-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of Norepinephrine and Ephedrine on Hypotension After Spinal Anesthesia in Parturients|Comparison of Norepinephrine and Ephedrine on Hypotension After Spinal Anesthesia in Parturients Undergoing Cesarean Section: a Randomized Double Blinded Controlled Study|Completed||N/A|66|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-10 22:57:18.835902|2017-10-10 22:57:18.835902
NCT02542735|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-08-18|||November 2015||2015-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Incidence of Type 2 Diabetes in the di@Bet.es Study|Incidence of Type 2 Diabetes in the di@Bet.es Study: Role of Fatty Acid Transport System Regulated by VEGFB in the Development of Metabolic Diseases.|Recruiting||N/A|3000|Anticipated|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud|||1||f||||f||||||Samples With DNA|"     Blood Serum and DNA   "|||2017-10-10 22:57:18.933237|2017-10-10 22:57:18.933237
NCT02542722|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-09-07|||January 2009||2009-01-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|PIZARRA||Type 2 Diabetes Prevention|Prevention of Type 2 Diabetes Mellitus (Egabro-Pizarra Study)|Completed||N/A|390|Actual|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||2|||f||||f||||||||||2017-10-10 22:57:19.02184|2017-10-10 22:57:19.02184
NCT02542709|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-09-03|||March 2015||2015-03-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||The Use of Noninvasive Brain Stimulation in Post-traumatic Stress Disorder|The Use of Noninvasive Brain Stimulation in Post-traumatic Stress Disorder|Unknown status|Recruiting|N/A|28|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 22:57:19.096833|2017-10-10 22:57:19.096833
NCT02542696|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-06-08|||August 2015||2015-08-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||"An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease"|"An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients With Parkinson's Disease Complicated by Motor Fluctuations (OFF Episodes)"|Recruiting||Phase 3|226|Anticipated|Sunovion||1|||f||||t||||||||||2017-10-10 22:57:19.187145|2017-10-10 22:57:19.187145
NCT02542514|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-03-08|||September 2015||2015-09-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|August 2016|Actual|2016-08-01||Interventional|iLOC||Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma|Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma|Active, not recruiting||Phase 2|39|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-10 22:57:21.077209|2017-10-10 22:57:21.077209
NCT02352818|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-28|||January 2015||2015-01-01|January 2015|2015-01-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01|1 Year|Observational [Patient Registry]|||Chronic Total Occlusion Registry||Recruiting||N/A|600|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:37:09.739378|2017-10-10 23:37:09.739378
NCT02542683|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-07-25|||April 2016||2016-04-01|July 2016|2016-07-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Observational|||Physical Activity and Cognitive Development in Children|Physical Activity and Cognitive Development in Children|Recruiting||N/A|300|Anticipated|Columbia University|||2||f||||f||||||Samples Without DNA|"     Because the blood sampling will only be performed when the study subject will be having his     or her routine blood tests either as a part of preoperative testing, or as follow up for his     or her clinical condition, there will be no additional discomfort or problems associated with     the blood draw.      The amount of blood we will be asking for the study is approximately 5 ml, of about one     teaspoonful. We will test for the following: cytokine panel (Tumor necrosis     factor(TNF-alpha), Interleukins (IL-1ß, IL-6, IL-8), CRP and other relevant biomarkers as     indicated   "|No||2017-10-10 22:57:19.629671|2017-10-10 22:57:19.629671
NCT02542670|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-07-24|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.|Genetic Variants of Selected Genes Using Target Deep Sequencing in Colo-Rectal Cancer Patients.|Recruiting||N/A|50|Anticipated|Tanta University|||3||f||||t||||||Samples With DNA|"     At least 50 ng of tumor DNA will be extracted from FFPE samples and/or fresh tissue and used     for hybridization capture and NGS using the IlluminaMiSeqDx platform.   "|||2017-10-10 22:57:19.747311|2017-10-10 22:57:19.747311
NCT02542657|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-05-17|||October 2015||2015-10-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|May 2020|Anticipated|2020-05-01||Interventional|||Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma|Phase I/II Study of Ixazomib in Combination With Pomalidomide, Clarithromycin and Dexamethasone (PiC-D) in Patients With Double Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|52|Anticipated|University of California, Davis||1|||f||||t|t|f||||||||2017-10-10 22:57:19.852917|2017-10-10 22:57:19.852917
NCT02542644|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-05-19|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT|Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following Descemet's Membrane Endothelial Keratoplasty Using Ultra-high Resolution Optical Coherence Tomography|Not yet recruiting||N/A|80|Anticipated|Medical University of Vienna||1|||f||||t|f|f||||||||2017-10-10 22:57:19.96887|2017-10-10 22:57:19.96887
NCT02542631|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-05-30|||August 1, 2015|Actual|2015-08-01|May 2017|2017-05-01|October 1, 2017|Anticipated|2017-10-01|March 27, 2017|Actual|2017-03-27||Interventional|||Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents|Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents|Active, not recruiting||N/A|280|Anticipated|Calibra Medical, Inc.||2|||f||||f||||||||||2017-10-10 22:57:20.096422|2017-10-10 22:57:20.096422
NCT02542618|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-10-09|||October 2015||2015-10-01|October 2015|2015-10-01|March 2020|Anticipated|2020-03-01|October 2018|Anticipated|2018-10-01||Interventional|||The Efficacy of Inquiry Based Stress Reduction (IBSR) for Depression, a Clinical Trial|The Efficacy of Inquiry Based Stress Reduction (IBSR) for Depression, a Randomized Clinical Trial|Recruiting||N/A|88|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 22:57:20.338913|2017-10-10 22:57:20.338913
NCT02542605|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-06-02|||November 11, 2015|Actual|2015-11-11|June 2017|2017-06-01|May 9, 2018|Anticipated|2018-05-09|May 9, 2018|Anticipated|2018-05-09||Interventional|||To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients|Phase I, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Single Dose Study to Evaluate the Blockade of CGRP Receptor by AMG 334 in Preventing PACAP-38 Induced Migraine-like Attacks in Migraine Patients|Recruiting||Phase 1|42|Anticipated|Amgen||3|||f||||f||||||||||2017-10-10 22:57:20.450873|2017-10-10 22:57:20.450873
NCT02542592|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-01-17|||September 2015||2015-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Methylprednisolone on Immune Signaling in Hip-arthroplasty Patients|Effect of Preoperative Intravenous High Dose Methylprednisolone on Immune Signaling in Patients Scheduled for Total Hip-arthroplasty|Completed||Phase 2/Phase 3|64|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 22:57:20.553252|2017-10-10 22:57:20.553252
NCT02542579|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2016-08-29|||July 2015||2015-07-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|September 2015|Actual|2015-09-01||Observational|||Gastric Microbiota and Helicobacter Pylori Test Findings|Impact of the Composition of Gastric Microbiota on the Accuracy of Helicobacter Pylori Test|Completed||N/A|121|Actual|Konkuk University Medical Center|||1||f||||t||||||Samples With DNA|"     Microbiota on the gastric biopsied specimen   "|No||2017-10-10 22:57:20.657106|2017-10-10 22:57:20.657106
NCT02542566|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-04-04|||January 21, 2015|Actual|2015-01-21|September 2015|2015-09-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|||Protected Versus Early Weight Bearing Post Microfracture Surgery|Randomised Control Trial Comparing Conservative Rehabilitation and Protected Weight Bearing Versus Accelerated Rehabilitation and Early Weight Bearing Post Microfracture Knee Surgery.|Terminated||N/A|6|Actual|Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust||2||Study was stopped prematurely due to the lack of eligible participants.|f||||f||||||||||2017-10-10 22:57:20.737341|2017-10-10 22:57:20.737341
NCT02542553|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-09-03|||February 2013||2013-02-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Bilateral Bronchoalveolar Lavage in Ventilator-associated Pneumonia|Bilateral Bronchoalveolar Lavage Cultures for Diagnosing Ventilator-associated Pneumonia. Microbiologic Concordance and Impact on the Efficacy of Treatment Decisions.|Completed||N/A|79|Actual|Catholic University of the Sacred Heart||1|||f||||f||||||||||2017-10-10 22:57:20.818986|2017-10-10 22:57:20.818986
NCT02542540|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-01-19|||July 2013||2013-07-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of a Physical Rehabilitation Program Using the Nintendo Wii on Children With Osteogenesis Imperfecta (OI)|Effects of a Physical Rehabilitation Program Using the Nintendo Wii on Children With Osteogenesis Imperfecta (OI) Is Nintendo Wii an Effective Intervention for Children With Osteogenesis Imperfecta|Terminated||N/A|20|Actual|Centre Hospitalier Universitaire de Saint Etienne||2||difficulty to include patients|f||||f||||||||||2017-10-10 22:57:20.916078|2017-10-10 22:57:20.916078
NCT02542501|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-07-25|||July 2015||2015-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|ANALUTS||Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues|A Prospective Post Marketing Non Interventional Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive LHRH Analogues and to Evaluate the Effect of LHRH Analogues on Lower Urinary Tract Symptoms (ANALUTS Study)|Recruiting||N/A|458|Anticipated|Ipsen|||1||f||||f||||||||||2017-10-10 22:57:21.176202|2017-10-10 22:57:21.176202
NCT02542488|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-03|||February 2016||2016-02-01|September 2015|2015-09-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Observational|||STOPBANG As A Screening Tool for Obstructive Sleep Apnoea in Pregnancy|Use of the STOPBANG Questionnaire for Predicting Obstructive Sleep Apnoea in Pregnancy|Unknown status|Not yet recruiting|N/A|100|Anticipated|City Hospitals Sunderland NHS Foundation Trust|||1||f||||||||||||||2017-10-10 22:57:21.310299|2017-10-10 22:57:21.310299
NCT02542475|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-04-12|||September 2015||2015-09-01|April 2016|2016-04-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Low Field Magnetic Stimulation: Open Label Study.|Low Field Magnetic Stimulation: Open Label Study.|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Mclean Hospital||1|||f||||f||||||||||2017-10-10 22:57:21.375887|2017-10-10 22:57:21.375887
NCT02542462|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-09-19|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|May 2017|Actual|2017-05-01||Interventional|||Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study|Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study|Active, not recruiting||Phase 4|101|Actual|Children's Hospital Medical Center, Cincinnati||4|||f||||f||||||||||2017-10-10 22:57:21.454088|2017-10-10 22:57:21.454088
NCT02542449|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-04|||April 2013||2013-04-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Greenselect Phytosome® on Weight Maintenance After Weight Loss in Obese Women|Placebo Controlled, Randomized, Single Blinded Trial on the Effects of Greenselect Phytosome® on Weight Maintenance in Obese Women After a 3-month Weight Loss Intervention|Completed||Phase 4|40|Actual|Istituto Auxologico Italiano||2|||f||||f||||||||||2017-10-10 22:57:21.544606|2017-10-10 22:57:21.544606
NCT02542436|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-09-11|||September 1, 2015|Anticipated|2015-09-01|September 2017|2017-09-01|December 31, 2015|Anticipated|2015-12-31|December 31, 2015|Anticipated|2015-12-31||Observational|||Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical Use in the UK Population|An Observational Study to Investigate the Real World Effectiveness of Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in the UK|Withdrawn||N/A|0|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-10 22:57:21.654845|2017-10-10 22:57:21.654845
NCT02542423|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-03|||September 2015||2015-09-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure.|Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. The ENDOLUNG Study|Unknown status|Not yet recruiting|N/A|150|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 22:57:21.722116|2017-10-10 22:57:21.722116
NCT02542410|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-08-14|||May 2016||2016-05-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study|Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study|Recruiting||Phase 2|14|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-10 22:57:21.793806|2017-10-10 22:57:21.793806
NCT02542397|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-06-26|||September 2015||2015-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients|LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Pilot Study of Pain Management in Oncology Outpatients|Recruiting||Phase 2|78|Anticipated|Carolinas Healthcare System||1|||f||||t||||||||||2017-10-10 22:57:21.876107|2017-10-10 22:57:21.876107
NCT02542384|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-09-06|||September 2015||2015-09-01|September 2017|2017-09-01|February 2, 2018|Anticipated|2018-02-02|December 29, 2017|Anticipated|2017-12-29||Interventional|||A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating the Analgesic Efficacy and Safety of Intravenous CR845 in Patients Undergoing Abdominal Surgery|Recruiting||Phase 2/Phase 3|450|Anticipated|Cara Therapeutics, Inc.||3|||f||||t||||||||||2017-10-10 22:57:21.964841|2017-10-10 22:57:21.964841
NCT02542371|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-10|||September 2015||2015-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Use of 99mTc Tilmanocept for Imaging Arterial Inflammation|Use of 99mTc Tilmanocept for Imaging Arterial Inflammation|Enrolling by invitation||N/A|24|Anticipated|Massachusetts General Hospital|||4||f||||||||||Samples Without DNA|"     whole blood, plasma and serum   "|||2017-10-10 22:57:22.093155|2017-10-10 22:57:22.093155
NCT02542345|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-06-29|||May 2011|Actual|2011-05-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|IRCADO||Comparative Assessment of Coronary MR Angiography Vs Coronary Multislice CT After Coronary Artery Reimplantation in Children and Young Adults.|Comparative Assessment of Coronary MR Angiography Vs Coronary Multislice CT After Coronary Artery Reimplantation in Children and Young Adults.|Recruiting||N/A|180|Anticipated|Centre Chirurgical Marie Lannelongue||1|||f||||t||||||||||2017-10-10 22:57:22.177052|2017-10-10 22:57:22.177052
NCT02542332|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2015-09-04|||May 2015||2015-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Are Doctors Familiar With the Test Characteristics of Lung Cancer Screening?|Are Doctors Familiar With the Test Characteristics of Lung Cancer Screening?|Completed||N/A|556|Actual|Otto Wagner Hospital||2|||f||||f||||||||||2017-10-10 22:57:22.256058|2017-10-10 22:57:22.256058
NCT02542319|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-10-10|||November 2015||2015-11-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|MagiCal-CKD||Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease|The Effect of Oral Magnesium Supplementation on Vascular Calcification in Chronic Kidney Disease - A Randomized Clinical Trial|Recruiting||Phase 2/Phase 3|250|Anticipated|Nordsjaellands Hospital||2|||f||||t||||||||||2017-10-10 22:57:22.34009|2017-10-10 22:57:22.34009
NCT02345967|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-11-12|||January 2015||2015-01-01|November 2016|2016-11-01||||August 2017|Anticipated|2017-08-01||Interventional|FIGS-2||Function of Implanted Glucose Sensor 2|Function of Implanted Glucose Sensor 2|Active, not recruiting||N/A|20|Actual|GlySens Incorporated||1|||f||||||||||||||2017-10-10 23:38:23.559298|2017-10-10 23:38:23.559298
NCT02542306|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-09-04|||July 2013||2013-07-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|SEFC||Safety and Efficacy of Fibrinogen Concentrate in Aortic Arch Surgery Involving Moderate Hypothermic Circulatory Arrest|Safety and Efficacy of Fibrinogen Concentrate in Aortic Arch Surgery Involving Moderate Hypothermic Circulatory Arrest|Unknown status|Recruiting|Phase 2|150|Anticipated|Beijing Municipal Science & Technology Commission||2|||f||||t||||||||||2017-10-10 22:57:22.440169|2017-10-10 22:57:22.440169
NCT02542293|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-10-02|||November 3, 2015|Actual|2015-11-03|September 2017|2017-09-01|October 4, 2018|Anticipated|2018-10-04|October 4, 2018|Anticipated|2018-10-04||Interventional|NEPTUNE||Study of 1st Line Therapy Study of Durvalumab With Tremelimumab Versus SoC in Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE).|A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination With Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients With Advanced or Metastatic Non Small-Cell Lung Cancer (NSCLC)|Recruiting||Phase 3|960|Anticipated|AstraZeneca||2|||f||||t||||||||||2017-10-10 22:57:22.558009|2017-10-10 22:57:22.558009
NCT02542280|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-12-03|2015-10-02||July 2013||2013-07-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Does Endometrial Injury Improve Intrauterine Insemination Outcome?|Endometrial Injury May Increase the Pregnancy Rate in Patients Undergoing Intrauterine Insemination|Completed||Phase 3|360|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 22:57:23.494108|2017-10-10 22:57:23.494108
NCT02542267|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-04-10|||September 2015||2015-09-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||In-Stent Restenosis Post-Approval Study|Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)|Enrolling by invitation||N/A|108|Anticipated|W.L.Gore & Associates||1|||f||||t||||||||||2017-10-10 22:57:23.768336|2017-10-10 22:57:23.768336
NCT02542254|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2016-09-08|||October 2015||2015-10-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effects of RPL554 on Top of Standard COPD Reliever Medications|A Phase II, Randomised, Double Blind, Placebo Controlled, Six Way Crossover Study to Assess the Bronchodilator Effect of RPL554 Administered on Top of Salbutamol and Ipratropium in Patients With COPD.|Completed||Phase 2|36|Actual|Verona Pharma plc||6|||f||||f||||||||||2017-10-10 22:57:23.916585|2017-10-10 22:57:23.916585
NCT02542241|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-12-22|||December 2015||2015-12-01|December 2015|2015-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|CELTA||Hypertonic Saline Resuscitation in Trauma Patients After Hemorrhage Control|Hypertonic Saline Resuscitation for Early Closure of Open Abdomen in Trauma Patients|Recruiting||Phase 4|400|Anticipated|Fundacion Clinica Valle del Lili||2|||f||||t||||||||||2017-10-10 22:57:24.050512|2017-10-10 22:57:24.050512
NCT02542228|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-01-12|||March 2014||2014-03-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|January 2016|Actual|2016-01-01||Observational|HR-QOLPIDD||Construction of a Health-related Quality of Life (HR-QOL) Questionnaire for Patients With Primary Antibody Deficiency Disease|Construction and Validation of a Health-related Quality of Life (HR-QOL) Instrument for Patients With Primary Antibody Deficiency Disease|Completed||N/A|76|Actual|University of South Florida|||1||f||||f||||||||||2017-10-10 22:57:24.171979|2017-10-10 22:57:24.171979
NCT02542215|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-08-26|||June 2015||2015-06-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer|A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Cobiprostone for the Prevention of Severe Oral Mucositis in Subjects With Head and Neck Cancer (HNC)|Terminated||Phase 2|47|Actual|Sucampo Pharma Americas, LLC||2|||f||||t||||||||||2017-10-10 22:57:24.25589|2017-10-10 22:57:24.25589
NCT02542202|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-22|||May 2015||2015-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer|A Pilot Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Renal Cell Carcinoma|Recruiting||N/A|25|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 22:57:24.484008|2017-10-10 22:57:24.484008
NCT02542189|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-09-02|||June 2009||2009-06-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||High Sensitivity Cardiac Troponin T in Patients With Atrial Fibrillation Admitted to an Emergency Department (ED)|High Sensitivity Cardiac Troponin T in Patients With Atrial Fibrillation Admitted to an Emergency Department (ED)|Completed||N/A|3037|Actual|University Hospital Heidelberg|||1||f||||f||||||||||2017-10-10 22:57:24.59754|2017-10-10 22:57:24.59754
NCT02542176|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-07-06|||October 2015||2015-10-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome|Pilot Study: Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome|Active, not recruiting||N/A|20|Anticipated|University of Connecticut||2|||f||||f||||||||||2017-10-10 22:57:24.644841|2017-10-10 22:57:24.644841
NCT02542163|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-03-31|||September 2015||2015-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|||Pilot Evaluation of the NimbleHeart Harness System in Cardiac Rehabilitation (PEN-CR)|Pilot Evaluation of the NimbleHeart Harness System in Cardiac Rehabilitation (PEN-CR)|Completed||N/A|20|Actual|NimbleHeart Inc.|||1||f||||f||||||||||2017-10-10 22:57:24.714919|2017-10-10 22:57:24.714919
NCT02542150|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-08-30|||September 2015||2015-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of Acetate and Alcohol on Brain Function|Effects of Acetate and Alcohol on Brain Function|Enrolling by invitation||N/A|20|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:57:24.777933|2017-10-10 22:57:24.777933
NCT02542137|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-06|||January 2016||2016-01-01|September 2015|2015-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Abscopal Effect for Metastatic Small Cell Lung Cancer|A Phase II Study of Radiotherapy and ZADAXIN's® (Thymalfasin) Induced Abscopal Effect in Patients With Heavily Pretreated, Metastatic Small Cell Lung Cancer|Not yet recruiting||Phase 2|29|Anticipated|Zhejiang Provincial People’s Hospital||1|||f||||f||||||||||2017-10-10 22:57:24.850289|2017-10-10 22:57:24.850289
NCT02541760|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-02|||April 2014||2014-04-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children|Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children|Completed||Phase 3|143|Actual|Hormozgan University of Medical Sciences||3|||f||||t||||||||||2017-10-10 22:57:31.443661|2017-10-10 22:57:31.443661
NCT02542124|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-08-02|||December 2015||2015-12-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT)|A Single Arm, Open-Label Study To Evaluate The Safety, Tolerability And Preliminary Efficacy Of NM-IL-12 (rHuIL‐12) In Patients With Cutaneous T Cell Lymphoma (CTCL) Undergoing Low Dose Total Skin Electron Beam Therapy (TSEBT)|Recruiting||Phase 2|10|Anticipated|Neumedicines Inc.||1|||f||||f||||||||||2017-10-10 22:57:24.998052|2017-10-10 22:57:24.998052
NCT02542111|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-07-31|||May 2015||2015-05-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||A Study of Bortezomib Plus GDP in the Treatment of Refractory and Relapsed Non-GCB DLBCL|A Phase II Study of the Efficacy and Safety of Bortezomib Plus GDP in the Treatment of Refractory and Relapsed Non-GCB Diffuse Large B-cell Lymphoma|Recruiting||Phase 2|30|Anticipated|Ruijin Hospital||1|||f||||||||||||||2017-10-10 22:57:25.166149|2017-10-10 22:57:25.166149
NCT02542098|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-04-21|||January 2017|Anticipated|2017-01-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Safety, Pharmacokinetics (PK), and Effectiveness of Hydrocodone Bitartrate (HYD) Extended-Release Tablets in Children|A Phase 2B, Open-label, Multicenter Study Evaluating the Safety, Pharmacokinetics, and Effectiveness of Hydrocodone Bitartrate Extended-Release Tablets (HYD) in Children, Aged 12 to 17 Years Inclusive, With Moderate to Severe Malignant and/or Nonmalignant Pain Requiring Around-the-Clock Opioid Analgesics|Withdrawn||Phase 2|0|Actual|Purdue Pharma LP||1||Study has been updated with a new protocol number|f||||t||||||||||2017-10-10 22:57:25.267678|2017-10-10 22:57:25.267678
NCT02542085|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-04|||November 2012||2012-11-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of Hybrid and Laparoscopic Incisional Hernia Repair|Comparison of Hybrid and Laparoscopic Incisional Hernia Repair: A Prospective Randomized Multicentre Study|Unknown status|Active, not recruiting|N/A|160|Anticipated|Oulu University Hospital||2|||f||||t||||||||||2017-10-10 22:57:25.350479|2017-10-10 22:57:25.350479
NCT02542072|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-01-30|2017-01-30||August 2015||2015-08-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses|Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses|Completed||N/A|90|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 22:57:25.482286|2017-10-10 22:57:25.482286
NCT02542059|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-05-29|||August 2015||2015-08-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Observational|GLP1-bar||Visualizing Beta Cells After Bariatric Surgery|Visualizing Beta Cells in Patients With Remission of T2DM After Bariatric Surgery|Recruiting||N/A|24|Anticipated|Radboud University|||2||f||||f||||||||||2017-10-10 22:57:28.874768|2017-10-10 22:57:28.874768
NCT02542046|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-03|||January 2015||2015-01-01|September 2015|2015-09-01||||January 2017|Anticipated|2017-01-01||Interventional|||Uniformity of Oral Contrast Material in the Bowel|Uniformity of Oral Contrast Material in the Bowel|Unknown status|Recruiting|Phase 3|750|Anticipated|University of California, San Francisco||3|||f||||f||||||||||2017-10-10 22:57:29.007072|2017-10-10 22:57:29.007072
NCT02542033|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2016-10-19|||May 2015||2015-05-01|September 2015|2015-09-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||Glycemic Response to Low Sugar Apple Juice|Double-blind, Randomized, Controlled, Cross-over Trial on Glycemic Response to Low Sugar Apple Juice|Completed||N/A|30|Actual|Clinical Research Center Kiel GmbH||2|||f||||f||||||||||2017-10-10 22:57:29.103234|2017-10-10 22:57:29.103234
NCT02542020|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-12|||June 2015||2015-06-01|July 2017|2017-07-01|May 2022|Anticipated|2022-05-01|May 2018|Anticipated|2018-05-01||Observational|Prospec-HIV||Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis|Prospective Evaluation of HIV Infected Patients Followed at Evandro Chagas National Institute of Infectious Disease (INI) - Oswaldo Cruz Foundation (FIOCRUZ) Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis|Recruiting||N/A|2000|Anticipated|Oswaldo Cruz Foundation|||1||f||||t||||||Samples Without DNA|"     Blood samples   "|||2017-10-10 22:57:29.187996|2017-10-10 22:57:29.187996
NCT02542007|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-10-05|||May 2015||2015-05-01|October 2017|2017-10-01|July 2021|Anticipated|2021-07-01|November 2017|Anticipated|2017-11-01||Interventional|RECOVERY||Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions|RECOVERY: A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions of Native Coronary Artery|Active, not recruiting||N/A|440|Actual|OrbusNeich||2|||f||||t||||||||||2017-10-10 22:57:29.277424|2017-10-10 22:57:29.277424
NCT02541994|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-04-27|||September 2015||2015-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|November 2016|Actual|2016-11-01||Interventional|||Axial Length and Central Corneal Thickness in Benign Intracranial Hypertension|The Potential Value of Axial Length and Central Corneal Thickness in the Assessment for Risk of Permanent Optic Nerve Damage and Visual Field Loss in Benign Intracranial Hypertension|Suspended||N/A|5|Actual|Ochsner Health System||1||Disparate corneal thickness readings from two measurement techniques employed.|f||||f||||||||||2017-10-10 22:57:29.403325|2017-10-10 22:57:29.403325
NCT02541981|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-10|||September 2015||2015-09-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Natural Course for Renal Function After Heart Transplantation|Natural Course for Renal Function After Heart Transplantation|Unknown status|Active, not recruiting|N/A|500|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 22:57:29.590744|2017-10-10 22:57:29.590744
NCT02541968|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-08-25|||August 2015||2015-08-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder|Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder - a Randomized Controlled Non-inferiority Trial|Recruiting||N/A|120|Anticipated|Karolinska Institutet||3|||f||||||||||||||2017-10-10 22:57:29.661367|2017-10-10 22:57:29.661367
NCT02541955|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-06-03|||August 2016||2016-08-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Use of Acthar in Rheumatoid Arthritis (RA) Related Flares|Use of Acthar in Rheumatoid Arthritis Related Flares|Not yet recruiting||Phase 4|40|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 22:57:29.806377|2017-10-10 22:57:29.806377
NCT02541929|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-03-28|||June 2016||2016-06-01|March 2017|2017-03-01|October 30, 2019|Anticipated|2019-10-30|June 2018|Anticipated|2018-06-01||Interventional|||Fish Oil Brain Delivery Study|Fish Oil Brain Delivery Study|Recruiting||Phase 2/Phase 3|32|Anticipated|University of Southern California||2|||f||||f||||||||||2017-10-10 22:57:30.013262|2017-10-10 22:57:30.013262
NCT02541916|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-10-27|||April 2015||2015-04-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|April 2018|Anticipated|2018-04-01||Interventional|LITMUS||Liver Immune Tolerance Marker Utilization Study|Liver Immune Tolerance Marker Utilization Study|Active, not recruiting||N/A|102|Actual|University of Toronto||1|||f||||t||||||||||2017-10-10 22:57:30.11128|2017-10-10 22:57:30.11128
NCT02541903|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-06-19|||October 2015||2015-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma|A Phase 2 Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma Following Systemic Therapy|Recruiting||Phase 2|29|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||No||2017-10-10 22:57:30.196821|2017-10-10 22:57:30.196821
NCT02541890|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-10-02|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|July 2017|Actual|2017-07-01||Interventional|||Effects of Workplace Intervention in Occupational Rehabilitation on Return to Work|Effects of Workplace Intervention in Inpatient Occupational Rehabilitation on Return to Work for Persons With Somatic and/or Common Mental Health Problems. A Randomised Controlled Trial|Active, not recruiting||N/A|175|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 22:57:30.306839|2017-10-10 22:57:30.306839
NCT02541877|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-09-03|||September 2015||2015-09-01|September 2015|2015-09-01|September 2023|Anticipated|2023-09-01|September 2018|Anticipated|2018-09-01||Interventional|START||Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve|A Prospective, Multi-center,Randomized Controled Trial of Sizing-strategy of Bicuspid Aortic Valve Stenosis With Transcatheter Self-expandable Valve|Not yet recruiting||Phase 3|159|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||3|||f||||t||||||||||2017-10-10 22:57:30.416838|2017-10-10 22:57:30.416838
NCT02541864|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-12|2017-07-12||July 2013||2013-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication|Comparison of Hybrid and Bismuth Containing Quadruple Therapies for Helicobacter Pylori Eradication: a Randomized Controlled Trial|Completed||N/A|330|Actual|Kaohsiung Veterans General Hospital.|The trial was performed in a single country|2|||f||||t||||||||||2017-10-10 22:57:30.537725|2017-10-10 22:57:30.537725
NCT02541851|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2017-08-01|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|DOLOCHROREA||Chronic Pain After Surgical Intensive Care Admission: Incidence and Risk Factors: the DOLOCHROREA Study|Chronic Pain After Surgical Intensive Care Admission: Incidence and Risk Factors: the DOLOCHROREA Study|Terminated||N/A|100|Actual|Centre Hospitalier Universitaire de Besancon|||1|Insufficient recruitment leading to selection bias and insufficient data|f||||f||||||||||2017-10-10 22:57:30.858981|2017-10-10 22:57:30.858981
NCT02541838|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-08-09|||May 2016||2016-05-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|DPN||Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy|High Intensity Muscle Power and Balance Perturbation Training to Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy|Recruiting||N/A|20|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-10 22:57:30.934004|2017-10-10 22:57:30.934004
NCT02541825|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-03|2015-09-03|||August 2015||2015-08-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Using Covered Stent of Diameter of 7mm in TIPS|Using Covered Stent of Diameter of 7mm in a Prospective, Single Blind, Randomized, Controlled Study of TIPS(Transjugular Intrahepatic Portosystemic Stent Shunt )|Active, not recruiting||Phase 1|216|Anticipated|Beijing Shijitan Hospital||2|||f||||t||||||||||2017-10-10 22:57:31.032221|2017-10-10 22:57:31.032221
NCT02541812|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-02|||July 2011||2011-07-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Use of Magnetic Brain Stimulation to Treat Obsessive Compulsive Disorder, a Pilot Study|The Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Obsessive Compulsive Disorder (OCD), a Pilot Study|Completed||N/A|20|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-10 22:57:31.112053|2017-10-10 22:57:31.112053
NCT02541799|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-10-03|||June 2015||2015-06-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comprehension of Research Informed Consent When Applied Through a Telemedicine Medium|Comprehension of Research Informed Consent When Applied Through a Telemedicine Medium|Completed||Phase 2|130|Actual|University of Iowa||2|||f||||f||||||||||2017-10-10 22:57:31.176771|2017-10-10 22:57:31.176771
NCT02541786|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-01|||January 2015||2015-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection|Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection|Completed||Phase 4|177|Actual|Kaohsiung Medical University||2|||f||||t||||||||||2017-10-10 22:57:31.24533|2017-10-10 22:57:31.24533
NCT02541773|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-03-08|||November 2013||2013-11-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|COVERT-HF||Novel Vascular Biomarkers Behaviour and Clinical Value in Heart Failure and CRT|The Characterisation of Vascular Biomarkers Before and After Cardiac Resynchronization Therapy in Patients With Chronic Heart Failure and Their Role in Predicting Response|Unknown status|Active, not recruiting|N/A|58|Anticipated|University Hospitals Coventry and Warwickshire NHS Trust|||1||f||||f||||||Samples Without DNA|"     Participants with have peripheral and coronary sinus samples taken for plasma and serum.   "|||2017-10-10 22:57:31.331821|2017-10-10 22:57:31.331821
NCT02518776|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-07|||June 2010||2010-06-01|August 2015|2015-08-01||||July 2016|Anticipated|2016-07-01||Interventional|ITEMS||Influence of Emotional Disorders and Executive on the Components Retrograde and Anterograde Episodic Memory in MS||Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:41.866468|2017-10-10 23:03:41.866468
NCT02541721|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-03-01|||September 2015||2015-09-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Effectiveness and Tolerability of LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses|An Open-label Study to Investigate the Effectiveness in Clinical Symptomatic Control and Tolerability of Medical Device LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses|Recruiting||N/A|75|Anticipated|Health Products Research and Development Lda.||1|||f||||f||||||||||2017-10-10 22:57:32.00739|2017-10-10 22:57:32.00739
NCT02541708|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-04-22|||September 2015||2015-09-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|Ferinject||IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania|Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania|Active, not recruiting||Phase 3|230|Actual|Ifakara Health Institute||2|||f||||t||||||||||2017-10-10 22:57:32.160219|2017-10-10 22:57:32.160219
NCT02541695|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-01-12|||September 2015||2015-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|March 2016|Actual|2016-03-01||Interventional|CORAL||Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli|Characterization Of Resistance Against Live-attenuated Diarrhoeagenic E. Coli|Completed||N/A|44|Actual|NIZO Food Research||2|||f||||t||||||||||2017-10-10 22:57:32.309184|2017-10-10 22:57:32.309184
NCT02541682|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2015-11-20|||March 2013||2013-03-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||Assessment of the Relationship Between Affective Temperament and the Severity of Nausea and Vomiting in Early Pregnancy|Assessment of the Relationship Between Affective Temperament and the Severity of Nausea and Vomiting in Early Pregnancy|Completed||N/A|252|Actual|Mustafa Kemalpasa Government Hospital||4|||f||||f||||||||||2017-10-10 22:57:32.423045|2017-10-10 22:57:32.423045
NCT02541669|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-04-20|||November 20, 2015|Actual|2015-11-20|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|||A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Subjects|A Randomized, Open-Label and Double-Blind, Placebo-Controlled, Single- and Multiple-Dose, Phase 1 Study of the Pharmacokinetics of TAK-491 40 mg and 80 mg in Healthy Chinese Subjects|Completed||Phase 1|64|Anticipated|Takeda||5|||f||||f||||||||||2017-10-10 22:57:32.541955|2017-10-10 22:57:32.541955
NCT02541656|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-11-29|||January 2015||2015-01-01|July 2015|2015-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Dynamic Preload Dependence Indices in Laparoscopic Surgery|Dynamic Preload Dependence Indices in Laparoscopic Surgery|Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 22:57:32.652475|2017-10-10 22:57:32.652475
NCT02541643|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-02||||||September 2015|2015-09-01||||||||Expanded Access|||Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma|Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma|No longer available||N/A|||Icahn School of Medicine at Mount Sinai|||||||||||||||||||2017-10-10 22:57:32.742778|2017-10-10 22:57:32.742778
NCT02541630|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-04-26|||August 2015||2015-08-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Big Mind for Veterans With PTSD|A Pilot Study of Big Mind for Veterans With PTSD|Withdrawn||N/A|0|Actual|VA Salt Lake City Health Care System||1||"Attempts to recruit eligible subjects revealed that it would not be possible to enroll adequate   numbers. Thus- no subjects were enrolled."|f||||f||||||||||2017-10-10 22:57:32.821035|2017-10-10 22:57:32.821035
NCT02541617|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-04-26|||January 2016||2016-01-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|Hub&Spoke||Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation|Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation|Withdrawn||N/A|0|Actual|Vanderbilt University Medical Center||2||Lack of enrollment|f||||f||||||||||2017-10-10 22:57:32.900931|2017-10-10 22:57:32.900931
NCT02541604|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-08-01|||November 30, 2015|Actual|2015-11-30|August 2017|2017-08-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2022|Anticipated|2022-01-31||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors|An Early-Phase, Multicenter, Open-Label Study of the Safety and Pharmacokinetics of Atezolizumab (MPDL3280A) In Pediatric and Young Adult Patients With Previously Treated Solid Tumors|Recruiting||Phase 1/Phase 2|100|Anticipated|Hoffmann-La Roche||1|||f||||t||||||||||2017-10-10 22:57:33.007687|2017-10-10 22:57:33.007687
NCT02541591|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-05-10|||August 2015||2015-08-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|NEUROPROTECT||Neuroprotective Goal Directed Hemodynamic Optimization in Post-cardiac Arrest Patients|Neuroprotective Goal Directed Hemodynamic Optimization in Post-cardiac Arrest Patients: a Randomized Controlled Trial (the NEUROPROTECT Post-CA Trial)|Recruiting||N/A|90|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-10 22:57:33.279986|2017-10-10 22:57:33.279986
NCT02541578|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-07-29|||September 2015||2015-09-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Physiological Complexity of Gait Over the First Six Months Post Stroke|Physiological Complexity of Gait Over the First Six Months Post Stroke|Recruiting||N/A|60|Anticipated|University of Indianapolis|||1||f||||f||||||||||2017-10-10 22:57:33.429351|2017-10-10 22:57:33.429351
NCT02541565|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-20|||November 24, 2015|Actual|2015-11-24|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma|MK-3475 in Combination With Standard RCHOP Therapy for Previously Untreated Diffuse Large B-Cell Lymphoma|Recruiting||Phase 2|20|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 22:57:33.540851|2017-10-10 22:57:33.540851
NCT02541552|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-08-24|||April 2015||2015-04-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Volume of Local Anesthetic for Adductor Canal Block on Quadriceps Muscle Function: A Dose Finding Study|Effect of Volume of Local Anesthetic for Adductor Canal Block on Quadriceps Muscle Function: A Dose Finding Study|Completed||Phase 3|26|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-10 22:57:33.750693|2017-10-10 22:57:33.750693
NCT01874912|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-07|||November 2009||2009-11-01|June 2013|2013-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Human Irisin Concentration in Sarcopenia||Completed||N/A|406|Actual|Korea University|||1||f||||t||||||||||2017-10-11 01:36:00.477517|2017-10-11 01:36:00.477517
NCT02541539|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-10-25|||August 2015||2015-08-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effects of Lactobacillus Casei on Respiratory and Gastrointestinal Diseases in Adults|Effects of Lactobacillus Casei in the Prevention of Upper Respiratory and Diarrheal Diseases Among Adults|Active, not recruiting||Phase 2/Phase 3|150|Actual|University of Science Malaysia||2|||f||||t||||||||||2017-10-10 22:57:33.844558|2017-10-10 22:57:33.844558
NCT02541526|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-09-01|||May 2013||2013-05-01|September 2015|2015-09-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia|Mirtazapine as a Treatment for Co-Occurring Opioid and Amphetamine Type Stimulant Dependence (COATS) in Malaysia|Unknown status|Recruiting|Phase 3|80|Anticipated|University of Science Malaysia||2|||f||||f||||||||||2017-10-10 22:57:33.936783|2017-10-10 22:57:33.936783
NCT02541513|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-09-01|||May 2013||2013-05-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence|An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and Amphetamine-type Stimulant Dependence|Unknown status|Active, not recruiting|Phase 3|40|Anticipated|University of Science Malaysia||1|||f||||f||||||||||2017-10-10 22:57:34.073057|2017-10-10 22:57:34.073057
NCT02541500|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-09-01|||April 2013||2013-04-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence|An Open-label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and Amphetamine-type Stimulant Dependence (COATS)|Unknown status|Recruiting|Phase 3|40|Anticipated|University of Science Malaysia||1|||f||||f||||||||||2017-10-10 22:57:34.179008|2017-10-10 22:57:34.179008
NCT02541487|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-08-25|||March 2016||2016-03-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Fetal Effects of Pre-Pregnancy Lifestyle Interventions in Unexplained Infertility Patients|Fetal Effects of Pre-Pregnancy Lifestyle Interventions in Unexplained Infertility Patients|Enrolling by invitation||N/A|60|Anticipated|University of Oklahoma|||3||f||||f||||||Samples With DNA|"     A de-identified sample of blood will be collected at the time of the baseline visit.   "|||2017-10-10 22:57:34.845417|2017-10-10 22:57:34.845417
NCT02541474|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-02-23|||August 15, 2016||2016-08-15|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|PACT||The PAtient-Centred Team - Effectiveness and Cost-effectiveness Study|Effectiveness and Cost-effectiveness of Interdisciplinary Teamwork in Medical Emergencies: The PAtient-Centred Team (PACT) Service Model. Effect and Cost Effectiveness Evaluation|Recruiting||N/A|1200|Anticipated|University Hospital of North Norway||2|||f||||f||||||||No|Due to data privacy legislation regarding sensitive data in Norway we are not at liberty to share original data.|2017-10-10 22:57:34.932521|2017-10-10 22:57:34.932521
NCT02541461|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-11-10|||October 2015||2015-10-01|November 2015|2015-11-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Body Composition After Laparoscopic Gastrectomy for Gastric Cancer|Evaluation of Changes in Body Composition After Laparoscopic Gastrectomy for Stomach Cancer - Comparison Between Billoth I and Roux-en-Y Anastomosis|Recruiting||N/A|60|Anticipated|Hanyang University Seoul Hospital||2|||f||||f||||||||||2017-10-10 22:57:35.05143|2017-10-10 22:57:35.05143
NCT02541448|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-02|||July 2015||2015-07-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|PRESSURE||Pneumoperitoneum Management With SurgiQuest AirSeal at Low vs. Higher Pressure ( PRESSURE )|A Single Center, Prospective, Randomized, Controlled Study To Evaluate Physician Preference Related to the Use of the SURGIQUEST AIRSEAL® INSUFFLATION SYSTEM (AIS) at Low VS. Higher Pressure for the Management of Pneumoperitoneum.|Unknown status|Recruiting|N/A|102|Anticipated|SurgiQuest, Inc.||2|||f||||f||||||||||2017-10-10 22:57:35.166036|2017-10-10 22:57:35.166036
NCT02541435|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-11-03|||November 2016||2016-11-01|November 2016|2016-11-01|December 2033|Anticipated|2033-12-01|December 2033|Anticipated|2033-12-01||Observational|||Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer|Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer - a Prospective Longitudinal Study|Recruiting||N/A|1600|Anticipated|St. Olavs Hospital|||3||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 22:57:35.340219|2017-10-10 22:57:35.340219
NCT02541409|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-02-02|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|C-DOT||Directly Observed Therapy for HCV in Chennai, India|Directly Observed Therapy for the Delivery of HCV Therapy Among HCV-infected Individuals in Chennai, India|Completed||Phase 2|50|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 22:57:35.656323|2017-10-10 22:57:35.656323
NCT02541396|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-02-22|||October 2015||2015-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy|A Pilot Study Of The Efficacy Of WafermineTM Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy|Completed||Phase 2|72|Actual|iX Biopharma Ltd.||7|||f||||t||||||||||2017-10-10 22:57:35.768351|2017-10-10 22:57:35.768351
NCT02541383|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-05-31|||September 2015||2015-09-01|May 2016|2016-05-01|August 2024|Anticipated|2024-08-01|August 2022|Anticipated|2022-08-01||Interventional|Cassiopeia||A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma|Study of Daratumumab in Combination With Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD) in the First Line Treatment of Transplant Eligible Subjects With Newly Diagnosed Multiple Myeloma|Recruiting||Phase 3|1080|Anticipated|Intergroupe Francophone du Myelome||4|||f||||t||||||||||2017-10-10 22:57:35.900581|2017-10-10 22:57:35.900581
NCT02541370|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2015-09-02|||September 2015||2015-09-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133|Clinical Study of Chimeric CD(Cluster of Differentiation)133 Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Malignancies|Recruiting||Phase 1|20|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 22:57:36.285128|2017-10-10 22:57:36.285128
NCT02541357|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-05-23|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|MBM_Colo||Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery|Effects of Preoperative Relaxation and Intensified Surgery Education on Preoperative Wellbeing and Postoperative Complaints in Patients Undergoing Colorectal Surgery - a Randomized Controlled Trial|Terminated||N/A|4|Actual|Universität Duisburg-Essen||4||Recruitment insufficient|f||||t||||||||No|Study has been terminated|2017-10-10 22:57:36.402458|2017-10-10 22:57:36.402458
NCT02541344|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-11-09|||June 2014||2014-06-01|November 2015|2015-11-01||||October 2015|Actual|2015-10-01||Interventional|||Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects|Double-blind, Randomised, Placebo-controlled, Three-way Crossover Clinical Investigation to Evaluate the Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects|Completed||Phase 3|27|Anticipated|InQpharm Group||3|||f||||f||||||||||2017-10-10 22:57:36.535339|2017-10-10 22:57:36.535339
NCT02541331|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-03|||July 2014||2014-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|EOLIA||Efficacy Of Bacterial Lysate In Asthmatic Children|Influence of Polyvalent Mechanical Bacterial Lysate ISMIGEN® on Clinical Course of Asthma and Related Immunological Parameters in Asthmatic Children (EOLIA Study): Randomised Double-blind Placebo-controlled Multicentre Parallel-group Study|Completed||Phase 3|150|Actual|Lallemand Pharma International||2|||f||||f||||||||||2017-10-10 22:57:36.654357|2017-10-10 22:57:36.654357
NCT02541318|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-09-02|||August 2014||2014-08-01|September 2015|2015-09-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Study of Effects of Dao-In Exercise on the Perimenopausal Women With Sleep Disturbance|Study of Effects of Dao-In Exercise on the Perimenopausal Women With Sleep Disturbance|Unknown status|Recruiting|N/A|100|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-10 22:57:36.782302|2017-10-10 22:57:36.782302
NCT02541305|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-12-02|||July 2015||2015-07-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effectiveness of an Exercise Proprioceptive Program in Institutionalized Elderly|Effectiveness of an Exercise Proprioceptive Program on Predictors of Risk of Falls in Institutionalized Elderly|Unknown status|Recruiting|N/A|50|Anticipated|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||||2017-10-10 22:57:36.922603|2017-10-10 22:57:36.922603
NCT02541292|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-04-10|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD|Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD|Recruiting||N/A|15|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-10 22:57:37.075263|2017-10-10 22:57:37.075263
NCT02541279|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effectiveness of a Group Intervention for the Treatment of Shoulder Pathologies|Effectiveness of a Group Intervention for the Treatment of Shoulder Pathologies|Completed||N/A|76|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||Yes||2017-10-10 22:57:37.676019|2017-10-10 22:57:37.676019
NCT02541266|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-14|||November 2015||2015-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|ASK||Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation|Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation|Recruiting||N/A|200|Anticipated|Institute of Cancer Research, United Kingdom|||3||f||||f||||||||||2017-10-10 22:57:37.774493|2017-10-10 22:57:37.774493
NCT02541253|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-11-04|||September 2015||2015-09-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children|An Open-label(Part1), Single Arm(Part1), Randomized(Part2), Double-blind(Part2), Active-controlled(Part2), Phase III Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children|Completed||Phase 3|543|Actual|Green Cross Corporation||2|||f||||t||||||||Undecided||2017-10-10 22:57:37.882433|2017-10-10 22:57:37.882433
NCT02541240|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-05-10|||September 2015||2015-09-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of an Intervention to Enhance Resilience in Physical Therapy Students|Effects of an Intervention to Enhance Resilience in Physical Therapy Students|Completed||N/A|43|Actual|University of Indianapolis||2|||f||||f||||||||No|Individual data will not be shared.|2017-10-10 22:57:37.981271|2017-10-10 22:57:37.981271
NCT02541227|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-03|||May 2014||2014-05-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|90 Days|Observational [Patient Registry]|CREGS-S||Cerebrolysin REGistry Study in Stroke|Cerebrolysin REGistry Study in Stroke A Registry Study to Assess Practices, Safety and Effectiveness of Cerebrolysin in Routine Treatment of Acute Ischemic Stroke|Unknown status|Recruiting|N/A|2000|Anticipated|Ever Neuro Pharma GmbH|||2||f||||f||||||||||2017-10-10 22:57:38.09013|2017-10-10 22:57:38.09013
NCT02541214|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-01-11|||September 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:57:38.175712|2017-10-10 22:57:38.175712
NCT02541201|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-10-12|||August 2015||2015-08-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|COME-PASS||The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS)|The Effect of the Consumption of Low-Fat Milk Enriched With Plant Sterols on Serum Low-Density Lipoprotein Cholesterol in Healthy Southern Chinese (COME-PASS)|Completed||Phase 2|221|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 22:57:38.213385|2017-10-10 22:57:38.213385
NCT02541188|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-09-01|||October 2014||2014-10-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01||Observational|MediSein||Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean Sea||Unknown status|Recruiting|N/A|460|Anticipated|University Hospital, Montpellier|||2||f||||f||||||||||2017-10-10 22:57:38.296985|2017-10-10 22:57:38.296985
NCT02541175|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-01-12|||October 2015||2015-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|MC-EECG||Multi-Channel Esophageal ECG Signal Classification|Paroxysmal Atrial Fibrillation Detection and Heart Beat Classification in Multi-Channel Esophageal Long-Term ECG|Completed||N/A|20|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 22:57:38.399026|2017-10-10 22:57:38.399026
NCT02541162|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-02-20|||June 11, 2014|Actual|2014-06-11|February 2017|2017-02-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2015|Actual|2015-10-15||Interventional|COUPLE||Cancer and Sexual Health : Early Information and Sexual Satisfaction of Couples in Oncology|Cancer and Sexual Health : Early Information and Sexual Satisfaction of Couples in Oncology|Suspended||N/A|60|Actual|Groupe Hospitalier Paris Saint Joseph||2||The study was suspended because the oncology service decided to adopt the procedure in routine|f||||f|f|f||||||Undecided||2017-10-10 22:57:38.495227|2017-10-10 22:57:38.495227
NCT02541149|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-03|||June 2014||2014-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma|Evaluation of Annexin A2 as a Novel Diagnostic Marker for Hepatocellular Carcinoma in Egyptian Patients|Completed||N/A|90|Actual|Ain Shams University|||3||f||||f||||||||||2017-10-10 22:57:38.569452|2017-10-10 22:57:38.569452
NCT02541136|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-03|||October 2011||2011-10-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||Neural Changes of Exercise: a Functional MRI Study|Neural and Stress Correlates of Resilience in an Exercise-behavioural Programme|Completed||N/A|40|Actual|University of Dublin, Trinity College||2|||f||||t||||||||||2017-10-10 22:57:38.647554|2017-10-10 22:57:38.647554
NCT02541123|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-08-03|||January 2016||2016-01-01|August 2017|2017-08-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|VIGILANT||Evaluation of Biomarker Kinetics After Mild Brain Injury Trauma|A Prospective Evaluation of Uch-l1 and Gfap Biomarker Kinetics After Mild Brain Injury Trauma|Completed||N/A|194|Actual|Banyan Biomarkers, Inc|||5||f||||f||||||||||2017-10-10 22:57:38.732797|2017-10-10 22:57:38.732797
NCT02541110|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-03|||September 2015||2015-09-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Observational|||Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler|Second Trimester Maternal Serum Homocysteine Level & Uterine Artery Doppler for Prediction of Preeclampsia , Intra-Uterine Growth Retardation (IUGR) & Other Obstetric Complications|Unknown status|Not yet recruiting|N/A|200|Anticipated|Kasr El Aini Hospital|||1||f||||f||||||||||2017-10-10 22:57:38.829526|2017-10-10 22:57:38.829526
NCT02541097|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-06-22|||May 2016||2016-05-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Preventing Language Decline in Dementia|Preventing Language Decline in Dementia|Active, not recruiting||N/A|20|Actual|Baycrest||2|||f||||f||||||||No|Only de-identified group data will be published|2017-10-10 22:57:38.882027|2017-10-10 22:57:38.882027
NCT02541084|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-08-21|||August 18, 2015|Actual|2015-08-18|August 2017|2017-08-01|July 30, 2016|Actual|2016-07-30|March 30, 2016|Actual|2016-03-30||Observational|||Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan|Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) Treatment in Real-life Japanese Settings.|Completed||N/A|72|Actual|Bayer|||3||f||||f||||||||||2017-10-10 22:57:38.950886|2017-10-10 22:57:38.950886
NCT02541071|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-09-03|||November 2013||2013-11-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Influence of the Noradrenergic System on the Formation of Intrusive Memories|Influence of the Noradrenergic System on the Formation of Intrusive Memories: An Experimental Approach With a Trauma Film Paradigm|Completed||N/A|118|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-10 22:57:39.027979|2017-10-10 22:57:39.027979
NCT02541058|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2016-07-15|||June 2015||2015-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|22Q||Non-Invasive Chromosomal Evaluation of 22q11.2|Non-Invasive Chromosomal Evaluation of 22q11.2 Using Cell-free Fetal DNA From Maternal Plasma|Recruiting||N/A|1000|Anticipated|Roche Sequencing Solutions|||2||f||||f||||||Samples With DNA|"     Retained samples included extracted DNA and plasma   "|||2017-10-10 22:57:39.131567|2017-10-10 22:57:39.131567
NCT02541045|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-08-15|||August 2015||2015-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis|Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis|Recruiting||Phase 3|108|Anticipated|Hospital General de Mexico||2|||f||||t||||||||||2017-10-10 22:57:39.21248|2017-10-10 22:57:39.21248
NCT02541032|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-30|||December 2015||2015-12-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|PREMIERS||PeRiodontal Treatment to Eliminate Minority InEquality and Rural Disparities in Stroke|PeRiodontal Treatment to Eliminate Minority InEquality and Rural Disparities in Stroke|Recruiting||Phase 3|400|Anticipated|University of South Carolina||2|||f||||t||||||||||2017-10-10 22:57:39.452129|2017-10-10 22:57:39.452129
NCT02541006|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-03-10|||November 2014||2014-11-01|November 2013|2013-11-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|||Comparison 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPD|A Randomized, Parallel-group, Phase IV Study to Compare the Bronchodilator Efficacy of Tiotropium (18 µg Once Daily [od]) Delivered Via a DISCAIR With Tiotropium (18 µg od) Delivered Via a HandiHaler®, in Patients With Moderate-to-severe COPD|Completed||Phase 4|58|Actual|Neutec Ar-Ge San ve Tic A.Ş||2|||f||||f||||||||No||2017-10-10 22:57:39.709514|2017-10-10 22:57:39.709514
NCT02540993|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-09-13|||September 17, 2015|Actual|2015-09-17|September 2017|2017-09-01|October 28, 2019|Anticipated|2019-10-28|September 29, 2019|Anticipated|2019-09-29||Interventional|FIDELIO-DKD||Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate the Safety and Efficacy of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease|Recruiting||Phase 3|4800|Anticipated|Bayer||2|||f||||t|t|f||||||||2017-10-10 22:57:39.923678|2017-10-10 22:57:39.923678
NCT02540941|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-09-01|||October 2015||2015-10-01|June 2015|2015-06-01||||June 2018|Anticipated|2018-06-01||Observational|||Protocols Development for Single Cells Genomics and Their Implementation for Molecular Diversity Between Cells|Protocols Development for Single Cells Genomics and Their Implementation for Molecular Diversity Between Cells|Not yet recruiting||N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-10 22:57:42.818293|2017-10-10 22:57:42.818293
NCT02540928|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-11-01|||October 2015||2015-10-01|November 2016|2016-11-01||||October 2019|Anticipated|2019-10-01||Interventional|||AMG 319 in HPV Positive and Negative HNSCC|A Cancer Research UK Randomised, Double Blind, Placebo Controlled Phase IIa Trial of AMG 319 Given Orally as a Neoadjuvant Therapy in Patients With Human Papillomavirus (HPV) Positive and Negative Head and Neck Squamous Cell Carcinoma (HNSCC)|Recruiting||Phase 2|54|Anticipated|Cancer Research UK||2|||f||||f||||||||||2017-10-10 22:57:42.867748|2017-10-10 22:57:42.867748
NCT02540915|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-09-21|||November 2013||2013-11-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01|10 Years|Observational [Patient Registry]|||The Children's Spine Foundation and Study Group|The Children's Spine Foundation and Study Group|Recruiting||N/A|1000|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 22:57:43.072456|2017-10-10 22:57:43.072456
NCT02540902|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-02-28|||October 2015||2015-10-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of an All Polyethylene Tibial Component|A Prospective Study of an All Polyethylene Tibial Component Used in Total Knee Arthroplasty Surgery|Recruiting||N/A|30|Anticipated|Golden Jubilee National Hospital||1|||f||||f||||||||No||2017-10-10 22:57:43.217317|2017-10-10 22:57:43.217317
NCT02540889|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Listen-in||Listen in: Developing and Testing a Therapy Application for Patients With Speech Comprehension Deficits After Stroke.|Listen-In: the Development and Testing of a Web-based Therapy Application for Patients With Impaired Speech Comprehension Caused by Stroke|Recruiting||N/A|36|Anticipated|University College, London||2|||f||||t||||||||||2017-10-10 22:57:43.33577|2017-10-10 22:57:43.33577
NCT02540876|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-07|||September 8, 2015|Actual|2015-09-08|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery|A Pilot Study for Ilorasertib (ABT-348) in Patients With CDKN2A-deficient Advanced Solid Cancers: A Series of Individual Patient Cross-Over Studies With Growth Trajectory Assessment|Recruiting||Phase 1|12|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-10 22:57:43.453106|2017-10-10 22:57:43.453106
NCT02540863|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-09-15|||June 2015||2015-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Miofascial Release and Exercises Therapy in the Treatment of Temporomandibular Disorders|Effectiveness of Myofascial Release and Exercises Therapy in the Treatment of Temporomandibular Disorders: a Randomized Clinical Trial|Completed||N/A|64|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-10 22:57:43.580768|2017-10-10 22:57:43.580768
NCT02540850|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-01-07|2015-10-13||February 2014||2014-02-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|RESEPT||CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population|Screening of Colorectal Cancer Using Improved SEPT9 (Septin 9) Gene Methylation Assay in Chinese Population|Completed||N/A|1031|Actual|BioChain (Beijing) Science and Technology, Inc.|||3||f||||t||||||||||2017-10-10 22:57:43.693246|2017-10-10 22:57:43.693246
NCT02540837|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-05-13|||October 2015||2015-10-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Obturator and Femoral Nerve Block in Patients With Hip Fracture|Analgesic Effect of an Obturator Nerve Block Combined With a Femoral Nerve Block Compared With Femoral Nerve Block Alone in Patients With Hip Fracture|Recruiting||Phase 4|90|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 22:57:44.235597|2017-10-10 22:57:44.235597
NCT02540824|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2015-09-03|||January 2015||2015-01-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer|A Phase II Clinical Trial to Investigate Efficacy and Safety of Apatinib as a Single Agent in RET-fusion Gene Positive Non-small Cell Lung Cancer Who Failed to Previous Treatment.|Recruiting||Phase 2|40|Anticipated|Tongji University||1|||f||||t||||||||||2017-10-10 22:57:44.360024|2017-10-10 22:57:44.360024
NCT02540798|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-10-21|||July 2015||2015-07-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|November 2015|Actual|2015-11-01||Observational|||Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?|Do Increased Levels of Anxiety Decrease the Reproducibility of Symptoms During Urodynamic Studies in Women?|Completed||N/A|27|Actual|Sandwell & West Birmingham Hospitals NHS Trust|||1||f||||||||||||||2017-10-10 22:57:44.595856|2017-10-10 22:57:44.595856
NCT02540785|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-11-24|||April 2014||2014-04-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Early Changes Between Lenticule Extraction and Small-Incision Lenticule Extraction|Comparison of Early Changes in Ocular Surface and Inflammatory Mediators Between Lenticule Extraction and Small-Incision Lenticule Extraction|Completed||N/A|41|Actual|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 22:57:44.685137|2017-10-10 22:57:44.685137
NCT02299479|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-08-19|||July 2015||2015-07-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|AIDA||Adjusting Insulin Delivery to Activity|Adjusting Insulin Delivery to Activity (AIDA)|Recruiting||N/A|20|Anticipated|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-10 23:47:32.854942|2017-10-10 23:47:32.854942
NCT02540772|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2016-02-09|2015-09-05||April 2013||2013-04-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Minimum number for comparison of means|Neuropsychological Rehabilitation of Spontaneous Confabulation|Study of the Neuroanatomical Circuits, Predictors and Prognostic Factors of Spontaneous Confabulation: Designing an Assessment and Rehabilitation Program|Completed||N/A|20|Actual|San Rafael University Hospital, Granada, Spain||2|||f||||f||||||||||2017-10-10 22:57:44.797118|2017-10-10 22:57:44.797118
NCT02540759|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-03-10|||September 2015||2015-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response|Study of the Effect of Dose of Buglossoides Arvensis Oil on Eicosapentaenoic Acid Accrual and on the Inflammatory Response|Completed||Phase 1|88|Actual|Réseau de Santé Vitalité Health Network||4|||f||||f||||||||||2017-10-10 22:57:45.191071|2017-10-10 22:57:45.191071
NCT02540746|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-10-19|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transdiagnostic Treatment for Early Stage Mental Health Problems in Youth|Transdiagnostic Treatment for Early Stage Mental Health Problems in Youth: A Pilot Randomized Trial|Recruiting||N/A|80|Anticipated|St. Joseph's Healthcare Hamilton||4|||f||||f||||||||No||2017-10-10 22:57:45.327697|2017-10-10 22:57:45.327697
NCT02540733|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-06-10|||January 1, 2012||2012-01-01|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||MRI Study of the Structural and Functional Rehabilitation in the Cerebral Infarction Patients With Diabetes|MRI Study of the Structural and Functional Rehabilitation in the Cerebral Infarction Patients With Diabetes|Recruiting||N/A|80|Anticipated|Zhejiang University|||2||f||||t||||||||||2017-10-10 22:57:45.575843|2017-10-10 22:57:45.575843
NCT02540720|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-10-29|||August 2015||2015-08-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||The Research of Standard Diagnosis and Treatment for Severe HSP in Children|The Research of Standard Diagnosis and Treatment for Severe Henoch-Schonlein Purpura in Children|Recruiting||Phase 2|30|Anticipated|Nanjing Children's Hospital||3|||f||||f||||||||||2017-10-10 22:57:45.646474|2017-10-10 22:57:45.646474
NCT02540707|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-04-10|||September 2015||2015-09-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes|Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes: A Prospective Randomized Controlled Trial|Recruiting||Phase 4|150|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-10 22:57:45.739061|2017-10-10 22:57:45.739061
NCT02540694|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-03|||May 2015||2015-05-01|September 2015|2015-09-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||EBUS vs EUS-B for Diagnosing Sarcoidosis|Endobronchial vs. Esophageal Ultrasound for Diagnosing Sarcoidosis: A Randomized Clinical Trial; - A Standard vs. - ProCore Needle Comparison -|Recruiting||N/A|350|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||4|||f||||f||||||||||2017-10-10 22:57:45.814425|2017-10-10 22:57:45.814425
NCT02540681|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-04-25|||January 2015||2015-01-01|March 2016|2016-03-01|July 2022|Anticipated|2022-07-01|January 2021|Anticipated|2021-01-01||Observational|ProFit||Prosthetic Fit Assessment in Transtibial Amputees Secondary to Trauma|Prosthetic Fit Assessment in Transtibial Amputees Secondary to Trauma (ProFit)|Recruiting||N/A|60|Anticipated|Major Extremity Trauma Research Consortium|||1||f||||t||||||||||2017-10-10 22:57:45.905068|2017-10-10 22:57:45.905068
NCT02540668|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-05-25|||September 2015||2015-09-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants|Effect of LY3314814 on the Pharmacokinetics of Warfarin in Healthy Subjects|Completed||Phase 1|15|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:57:45.999981|2017-10-10 22:57:45.999981
NCT02540655|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-10-30|||September 2015||2015-09-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center Study to Evaluate the Safety and Efficacy of Stemchymal® Infusion for the Treatment of Polyglutamine Spinocerebellar Ataxia|Recruiting||Phase 2|60|Anticipated|Steminent Biotherapeutics Inc.||2|||f||||t||||||||||2017-10-10 22:57:46.075705|2017-10-10 22:57:46.075705
NCT02540642|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-11-16|||October 2010||2010-10-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients|Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients|Completed||N/A|38|Actual|Smt. Kashibai Navale Medical College and General Hospital||2|||f||||t||||||||||2017-10-10 22:57:46.150184|2017-10-10 22:57:46.150184
NCT02540629|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-02-14|||January 2016||2016-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|2% Project||Implementation of Gold Standard EMS CPR Programs for 2% Improvement in Survival Rates of Out-of-Hospital Cardiac Arrest in a Metropolitan City||Recruiting||N/A|8070|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 22:57:46.239008|2017-10-10 22:57:46.239008
NCT02540616|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-02|2017-03-06|||September 2013||2013-09-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Transcranial Electrical Stimulation for Mal de Debarquement Syndrome|Transcranial Electrical Stimulation for Mal de Debarquement Syndrome|Recruiting||N/A|300|Anticipated|Laureate Institute for Brain Research, Inc.||2|||f||||f||||||||No|Anonymized data will be shared once recruitment is sufficient to prevent the inadvertent identification of participants by demographic or clinical characteristics|2017-10-10 22:57:46.316007|2017-10-10 22:57:46.316007
NCT02540603|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-04-18|||September 2015||2015-09-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of a Full Face Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ|Evaluation of a Full Face Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ|Completed||N/A|15|Actual|Fisher and Paykel Healthcare||1|||f||||f|f|f||||||No|Data will be shared to any other parties.|2017-10-10 22:57:46.410029|2017-10-10 22:57:46.410029
NCT02540590|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-09-03|||November 2014||2014-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|LASCAM||Post-operative Blood Flow Measurements of the Oral Mucosa|Evaluation of Laser Speckle Contrast Imaging for Assessment of Oral Mucosal Blood Flow Following Periodontal Plastic Surgery: an Exploratory Observational Study|Completed||N/A|8|Actual|Semmelweis University|||2||f||||f||||||||||2017-10-10 22:57:46.482646|2017-10-10 22:57:46.482646
NCT02540577|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-03-13|||September 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:57:46.566844|2017-10-10 22:57:46.566844
NCT02540564|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-01|||January 2013||2013-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:57:46.606116|2017-10-10 22:57:46.606116
NCT02540551|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-03-30|||January 1, 2016||2016-01-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01||Interventional|SONAR-2||Sentinel Node Detection in Ovarian Cancer|Sentinel Node in Ovarian Cancer: SONAR-2|Recruiting||Phase 1|52|Anticipated|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-10 22:57:46.643197|2017-10-10 22:57:46.643197
NCT02540538|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-09-13|||September 2015||2015-09-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders|Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders|Completed||Phase 1|34|Actual|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-10 22:57:46.756145|2017-10-10 22:57:46.756145
NCT02540525|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2015-09-01|||January 2013||2013-01-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Transobturator Sling Compared With Single-incision Mini-sling for the Treatment of Stress Urinary Incontinence|Transobturator Sling Compared With Single-incision Mini-sling for the Treatment of Stress Urinary Incontinence: A Randomized Controlled Trial|Completed||N/A|100|Actual|Faculdade de Medicina do ABC||2|||f||||t||||||||||2017-10-10 22:57:46.84383|2017-10-10 22:57:46.84383
NCT02540512|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-07-26|||July 27, 2017|Anticipated|2017-07-27|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Acupuncture for Pain in the Emergency Department|Auricular Acupuncture for the Acute Management of Pain in the Emergency Department|Withdrawn||Early Phase 1|0|Actual|Loma Linda University||3||No participants enrolled|f||||t|f|f||||||||2017-10-10 22:57:46.925652|2017-10-10 22:57:46.925652
NCT02540499|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2016-06-28|||May 2015||2015-05-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|INHALE||Deep Inspiration Breath Hold as Primary Strategy for Locally Advanced Lung Cancer Radiotherapy|Deep Inspiration Breath Hold as Primary Strategy for Locally Advanced Lung Cancer Radiotherapy|Recruiting||N/A|80|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 22:57:47.043875|2017-10-10 22:57:47.043875
NCT02540473|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-08-28|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Fostering Resilience in Physician Moms|Fostering Resilience: An Intervention for Women Physicians at Risk for Burnout|Completed||N/A|44|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 22:57:48.989287|2017-10-10 22:57:48.989287
NCT02540460|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2015-09-01|||June 2014||2014-06-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371|A Phase I Clinical Study, Multiple Dose of LCB01-0371 in Healthy Male Subjects|Completed||Phase 1|30|Actual|LegoChem Biosciences, Inc||4|||f||||f||||||||||2017-10-10 22:57:49.091555|2017-10-10 22:57:49.091555
NCT02540447|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2017-03-24|2015-09-05||January 2013||2013-01-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|PNP||Purge Vs no Purge in Living Donor Liver Transplantation Recipients|Graft Portal Reperfusion Without Purging Graft Preservative Solution In Living Donor Liver Transplantation. A Prospective Randomized Controlled Trial|Completed||N/A|80|Actual|Mansoura University||2|||f||||f||||||||No||2017-10-10 22:57:49.187365|2017-10-10 22:57:49.187365
NCT02540434|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-03-31|2017-02-16||October 2015|Actual|2015-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|TOP-CLOT|only 1 subject received study intervention (Cryoprecipitate arm). 1 other subject was randomized to receive RiaSTAP, but did not necessitate this intervention so did not get the product. Therefore, the number of participants is marked as 0 for RiaSTAP arm.|Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions|Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions (TOP-CLOT)|Terminated||N/A|19|Actual|Weill Medical College of Cornell University||2||Feasibility issues prevent completion of recruitment.|f||||f||f||||||No|IPD will not be shared|2017-10-10 22:57:49.496157|2017-10-10 22:57:49.496157
NCT02540421|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-09-01|||January 2001||2001-01-01|September 2015|2015-09-01|December 2007|Actual|2007-12-01|January 2007|Actual|2007-01-01||Observational|||Recurrence in High-grade Lesions After Conization|Presence of Positive Resection Margins, Hypooestrogenism and Specimen Volume May Influence Risk of Disease Recurrence in Patients With High-grade Cervical Intra-epithelial Neoplasia Undergoing Large Loop Excision of the Transformation Zone|Completed||N/A|103|Actual|Faculdade de Medicina do ABC|||2||f||||t||||||||||2017-10-10 22:57:49.833762|2017-10-10 22:57:49.833762
NCT02540408|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-02-05|||November 2011||2011-11-01|September 2015|2015-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|BALISTIC||Detection and Characterization of COPD in Dairy Farmers|COPD in Dairy Farmers: Screening, Characterization and Constitution of a Cohort. The BALISTIC Study|Completed||N/A|400|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||t||||||Samples Without DNA|"     Serum for further analyses   "|||2017-10-10 22:57:50.070346|2017-10-10 22:57:50.070346
NCT02540395|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-09-01|||March 2015||2015-03-01|September 2015|2015-09-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation|Prospective Donor-specific Cellular Alloresponse Assessment for Immunosuppression Minimization in de Novo Renal Transplantation|Recruiting||N/A|669|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 22:57:50.202374|2017-10-10 22:57:50.202374
NCT02540382|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-01|||January 2006||2006-01-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Covered and Bare Stent in TIPS|Comparison of Covered and Bare Stent in TIPS|Completed||N/A|258|Actual|Beijing Shijitan Hospital||2|||f||||t||||||||||2017-10-10 22:57:50.39448|2017-10-10 22:57:50.39448
NCT02540356|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-06-30|2017-05-22||November 2, 2015|Actual|2015-11-02|May 2017|2017-05-01|May 26, 2016|Actual|2016-05-26|May 26, 2016|Actual|2016-05-26||Interventional|||Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer|A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects With Refractory Ovarian Cancer With Malignant Ascites|Terminated||Phase 1/Phase 2|2|Actual|Baxalta US Inc.|Study was terminated early with only 1 subject having been dosed. Therefore no statistical analysis was performed on the outcome measures. Only descriptive data for one subject are available.|2|||f||||f||||||||||2017-10-10 22:57:50.645922|2017-10-10 22:57:50.645922
NCT02540343|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-11-03|||November 2014||2014-11-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|Orebro-G||"Intercultural Adaptation and Validation of the Orebro Musculoskeletal Pain Questionnaire"|"Intercultural Adaptation and Validation of the Orebro Musculoskeletal Pain Questionnaire-Translation and Validation of a Questionnaire"|Completed||N/A|90|Actual|Balgrist University Hospital|||3||f||||f||||||||||2017-10-10 22:57:51.261592|2017-10-10 22:57:51.261592
NCT02540330|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-10-18|||March 2016||2016-03-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|007||A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant|An Open Label, Phase 2 Pharmacokinetic Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy or Lumpectomy|Recruiting||Phase 2|30|Anticipated|Atossa Genetics, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:57:51.390973|2017-10-10 22:57:51.390973
NCT02540317|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-02-07|||October 2015||2015-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Internet-based Cognitive Behavior Therapy for Stress Disorders: a Randomized Trial||Active, not recruiting||N/A|100|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:57:51.505179|2017-10-10 22:57:51.505179
NCT02540304|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-06-07|||September 2012|Actual|2012-09-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Teen Pregnancy Prevention Replication Study|Teen Pregnancy Prevention Replication Study|Completed||N/A|7620|Actual|Abt Associates||2|||f||||f||||||||||2017-10-10 22:57:51.606735|2017-10-10 22:57:51.606735
NCT02540291|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-11-14|||July 2015||2015-07-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Study of E7046 in Subjects With Selected Advanced Malignancies|An Open-Label Multicenter Phase 1 Study of E7046 in Subjects With Selected Advanced Malignancies|Recruiting||Phase 1|40|Anticipated|Eisai Inc.||1|||f||||||||||||||2017-10-10 22:57:51.692299|2017-10-10 22:57:51.692299
NCT02540278|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-09-01|||August 2013||2013-08-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|PP+||Evaluation of the Positive Prevention PLUS Program|Evaluation of the Positive Prevention PLUS Program Teen Pregnancy Prevention Program|Completed||N/A|4267|Actual|California State University, San Bernardino||2|||f||||f||||||||||2017-10-10 22:57:51.82396|2017-10-10 22:57:51.82396
NCT02540265|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-05-16|2017-01-16||August 2015||2015-08-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Analysis population includes all subjects randomized to treatment|Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery|A Phase 2, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety, Efficacy, and Pharmacokinetics of N1539 Following Bunionectomy|Completed||Phase 2|59|Actual|Recro Pharma, Inc.||3|||f||||f||||||||||2017-10-10 22:57:51.93081|2017-10-10 22:57:51.93081
NCT02540252|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-01-26|||August 19, 2015|Actual|2015-08-19|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|November 13, 2016|Actual|2016-11-13||Observational|Amp-Nu||Nutrition and Inflammation Among Patients With Lower Limb Amputation|Nutritional Status, Eating Pattern and Inflammation Among Patients With Amputation of the Lower Limb - a Longitudinal Cohort Study|Active, not recruiting||N/A|49|Actual|Hvidovre University Hospital|||1||f||||t||||||Samples With DNA|"     Serum and plasma samples; peripheral blood mononuclear cells (PBMCs); and muscle biopsies   "|Undecided||2017-10-10 22:57:52.88832|2017-10-10 22:57:52.88832
NCT02540239|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-04-18|||January 2015||2015-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Premedication Simethione Improves Visibility During Bowel Cleansing for Colonoscopy||Completed||N/A|590|Actual|Changhai Hospital||2|||f||||t||||||||||2017-10-10 22:57:52.98782|2017-10-10 22:57:52.98782
NCT02540226|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-05-23|||November 2015||2015-11-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TXA Knee||Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement|The Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Total Knee Replacement|Recruiting||Phase 4|76|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-10 22:57:53.084804|2017-10-10 22:57:53.084804
NCT02540213|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-11-18|2015-11-18||January 2009||2009-01-01|November 2015|2015-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational||Safety set included all participants who had at least one MIRCERA application.|Observational Study of MIRCERA in Users of Self-Application and Multidose Systems||Completed||N/A|240|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:57:53.238366|2017-10-10 22:57:53.238366
NCT02540200|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-07-24|||January 2017||2017-01-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy of BST-CarGel in Treating Chondral Lesions of the Hip|A Pilot Study for Efficacy of BST-CarGel as an Adjunct to Microfracture for the Treatment of Chondral Lesions of the Hip: a Case Control Study|Not yet recruiting||Phase 3|50|Anticipated|Nova Scotia Health Authority||2|||f||||t||||||||No||2017-10-10 22:57:53.970087|2017-10-10 22:57:53.970087
NCT02540187|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-03-09|||February 2012||2012-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients|Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients|Completed||N/A|164|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||Samples Without DNA|"     blood specimen   "|||2017-10-10 22:57:54.060547|2017-10-10 22:57:54.060547
NCT02540174|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-17|||May 2015||2015-05-01|September 2015|2015-09-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|ALTAKRA-1405||Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment|Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of Integrating the Addiction Treatment to the Initial Cancer Treatment Program|Recruiting||N/A|242|Anticipated|Centre Oscar Lambret||2|||f||||f||||||||||2017-10-10 22:57:54.164526|2017-10-10 22:57:54.164526
NCT02540161|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-09-07|||February 1, 2016|Actual|2016-02-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma|Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma|Recruiting||Phase 2|90|Anticipated|Duke University||2|||f||||f|t|f||||||||2017-10-10 22:57:54.274251|2017-10-10 22:57:54.274251
NCT02540148|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-02||||||September 2015|2015-09-01||||September 2016|Anticipated|2016-09-01||Interventional|||Transpalpebral Micro Current Electrical Stimulation for the Treatment of Dry Age-Related Macular Degeneration|Transpalpebral Micro Current Electrical Stimulation for the Treatment of Dry Age-Related Macular Degeneration|Unknown status|Not yet recruiting|N/A|30|Anticipated|The Eye Machine Canada Inc.||2|||f||||||||||||||2017-10-10 22:57:54.367793|2017-10-10 22:57:54.367793
NCT02540135|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-07-11|||December 2017|Anticipated|2017-12-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma|Fluorescein vs. Intraoperative MRI in the Resection of Malignant High Grade Glioma|Not yet recruiting||N/A|60|Anticipated|University of Colorado, Denver||2|||f||||f|f|f|||f|||||2017-10-10 22:57:54.432459|2017-10-10 22:57:54.432459
NCT02540122|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-06-16|||August 2015||2015-08-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pilot Clinical Evaluation of Approved Contact Lenses|Imaging of Conjunctival Microvasculature During Contact Lens Wear|Completed||Phase 1|30|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||t|f|t|f|f||||||2017-10-10 22:57:54.518905|2017-10-10 22:57:54.518905
NCT02540109|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-06-13|||July 2015||2015-07-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study|Targeted Transcranial Electrotherapy for Stroke Rehabilitation - Exploratory Trial on Aphasia|Recruiting||Phase 2|58|Anticipated|Soterix Medical||2|||f||||t||||||||||2017-10-10 22:57:54.609521|2017-10-10 22:57:54.609521
NCT02540096|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-08-09|||November 2015||2015-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Effects of Mental Practice for Mobility in Post-stroke Hemiparesis|Effects of Mental Practice for Mobility in Post-stroke Hemiparesis: Randomized Controlled Trial of Efficacy.|Recruiting||N/A|70|Anticipated|Federal University of Juiz de Fora||2|||f||||f||||||||||2017-10-10 22:57:54.713706|2017-10-10 22:57:54.713706
NCT02540083|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-06-19|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|ADAPT-ENRICH||Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography|Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT Trial) ADAPT-Enrich: Recruitment Plan for Initially Asymptomatic Women Referred for Breast Biopsy After Screening Digital Breast Tomosynthesis Exam|Terminated||N/A|94|Actual|GE Healthcare||2||Sponsor has obtained sufficient case load prematurely.|f||||f||||||||||2017-10-10 22:57:54.812374|2017-10-10 22:57:54.812374
NCT02540070|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-11-11|||August 2014||2014-08-01|August 2015|2015-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Motor Sparing Knee Block to Infiltration Analgesia for Pain Following Knee Arthroplasty|Ultrasound Guided Motor Sparing Knee Blocks With or Without Dexmedetomidine for Postoperative Analgesia Following Knee Arthroplasty: a Randomized Double Blinded Study|Recruiting||Phase 3|135|Anticipated|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-10 22:57:54.887424|2017-10-10 22:57:54.887424
NCT02540057|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-08-03|||August 2016||2016-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||FCR or APL in LRTI - A Single Surgeon Randomized Controlled Trial|Flexor Carpi Radialis or Abductor Pollicis Longus in Ligament Reconstruction and Tendon Interposition - A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Nova Scotia Health Authority||2||Abandoned following local ethics review.|f||||f||||||||||2017-10-10 22:57:55.014092|2017-10-10 22:57:55.014092
NCT02540044|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-06-27|||January 2016||2016-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SuPER||Supporting Patient Care With Electronic Resource (SuPER)|Supporting Patient Care With Electronic Resource (SuPER): Efficacy of an Online Decision Aid for Patients Considering Biologic Therapy for Rheumatoid Arthritis|Recruiting||N/A|148|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 22:57:55.092338|2017-10-10 22:57:55.092338
NCT02540031|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-08|2016-07-25|||September 2015||2015-09-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy|The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy in Patients Showing Brown Effluents|Recruiting||Phase 3|158|Anticipated|Kyungpook National University||2|||f||||t||||||||||2017-10-10 22:57:55.324727|2017-10-10 22:57:55.324727
NCT02539823|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-06-05|||September 2015||2015-09-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|May 24, 2017|Actual|2017-05-24||Interventional|||Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans|To Characterize the Acute and Short-term Effects of Cannabidiol (CBD) Administration on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans|Active, not recruiting||Phase 2|45|Actual|Hurd,Yasmin, Ph.D.||3|||f||||t||||||||||2017-10-10 22:57:58.143716|2017-10-10 22:57:58.143716
NCT02540018|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-05-17|||September 2015||2015-09-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|EffPac||Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis|Multicenter Randomized Controlled Trial to Assess the Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Superficial Femoral and Popliteal Arteries to Prevent Vessel Restenosis or Reocclusion|Active, not recruiting||N/A|172|Anticipated|Jena University Hospital||2|||f||||f||||||||||2017-10-10 22:57:55.435344|2017-10-10 22:57:55.435344
NCT02540005|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-06-27|||September 2015||2015-09-01|June 2016|2016-06-01||||June 2016|Actual|2016-06-01||Observational|||Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage|Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage|Completed||N/A|32|Actual|Tampere University Hospital|||2||f||||||||||||||2017-10-10 22:57:55.5455|2017-10-10 22:57:55.5455
NCT02539992|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-05-13|2015-09-29||May 2012||2012-05-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ShapeMatch|Forty-four (44) patients were enrolled over an 11 month period in a randomized manner in 4 centers.|ShapeMatch Cutting Guide Functional Outcomes Study|A Prospective, Randomized, Multi-centre Study of the Triathlon Cruciate Retaining Total Knee System Using ShapeMatch Cutting Guides|Terminated||N/A|44|Actual|Stryker European Operations BV|Due to early study termination, there was limited data available for analysis and therefore insufficient power to provide robust, meaningful results for our primary or secondary analysis.|3||Product discontinued in November 2014|f||||f||||||||||2017-10-10 22:57:55.649254|2017-10-10 22:57:55.649254
NCT02539979|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-04-13|||August 2015||2015-08-01|April 2016|2016-04-01||||October 2016|Anticipated|2016-10-01||Interventional|||A Trial of Intravenous Paracetamol vs. Placebo in Patients Receiving Radiofrequency Ablation of the Medial Branch Facet Nerve|A Double Blinded Randomized Control Trial of Intravenous Paracetamol vs. Placebo in Patients Receiving Radiofrequency Ablation of the Medial Branch Facet Nerve|Recruiting||N/A|50|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 22:57:56.451591|2017-10-10 22:57:56.451591
NCT02539966|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-05-02|||March 2015||2015-03-01|April 2017|2017-04-01|October 2022|Anticipated|2022-10-01|September 2017|Anticipated|2017-09-01||Interventional|FANTOM II||Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold|Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold|Recruiting||N/A|220|Anticipated|REVA Medical, Inc.||3|||f||||t||||||||||2017-10-10 22:57:56.59428|2017-10-10 22:57:56.59428
NCT02539953|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-02|||April 2015||2015-04-01|February 2015|2015-02-01||||September 2015|Anticipated|2015-09-01||Interventional|||Ambulatory Blood Pressure Monitoring in Rivaroxaban Therapy||Unknown status|Not yet recruiting|N/A|20|Anticipated|King's College Hospital NHS Trust||1|||f||||t||||||||||2017-10-10 22:57:56.807476|2017-10-10 22:57:56.807476
NCT02539940|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-05-17|||September 2015||2015-09-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2017|Anticipated|2017-09-01||Observational|Apollo||Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment|A Prospective Observational Study Using Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment|Recruiting||N/A|200|Anticipated|Jena University Hospital|||1||f||||t||||||||||2017-10-10 22:57:56.912118|2017-10-10 22:57:56.912118
NCT02539927|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-05-04|||July 2015||2015-07-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|SAGIT||Validation Study of the SAGIT® Instrument in Acromegaly|International Multicentre Validation Study of SAGIT® Instrument in Acromegaly|Active, not recruiting||N/A|200|Anticipated|Ipsen|||3||f||||f||||||||||2017-10-10 22:57:57.088368|2017-10-10 22:57:57.088368
NCT02539914|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-03-04|||June 2015||2015-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Feasibility Study of a Virtual Reality Cognitive-motor Task Based on Positive Stimuli for Stroke Rehabilitation|Interactive System for Diagnostics and Rehabilitation of Cognitive-motor Deficits: Controlled Longitudinal Clinical Study With Stroke Patients|Completed||N/A|18|Actual|Universidade da Madeira||2|||f||||f||||||||||2017-10-10 22:57:57.273996|2017-10-10 22:57:57.273996
NCT02539901|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-31|||October 2011||2011-10-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|DECCODES||Development of a Deaf Child With a Cochlear Implant.|Cognitive and Communicative Development Description of Deaf Child With a Cochlear Implant.|Completed||N/A|73|Actual|University Hospital, Toulouse|||4||f||||f||||||||||2017-10-10 22:57:57.415504|2017-10-10 22:57:57.415504
NCT02539875|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-11-10|||April 2015||2015-04-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|||Promoting Smoking Cessation in the Community Via QTW 2015|"Building Capacity and Promoting Smoking Cessation in the Community Via Quit to Win Contest 2015: a Randomized Controlled Trial on Brief Intervention (AWARD Model) and Active Referral to Smoking Cessation Services"|Active, not recruiting||N/A|1306|Actual|The University of Hong Kong||3|||f||||t||||||||Undecided||2017-10-10 22:57:57.547114|2017-10-10 22:57:57.547114
NCT02539862|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-08-31|||August 2015||2015-08-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|NEXPERTSANTE||Evaluating the Efficacy of the Management of an Online Program of Cognitive Behavioral Therapy for Primary Insomnia|Pilot Study Evaluating the Efficacy of the Management of an Online Program of Cognitive Behavioral Therapy for Primary Insomnia|Unknown status|Not yet recruiting|N/A|46|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 22:57:57.679264|2017-10-10 22:57:57.679264
NCT02539849|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-06-13|||December 2014||2014-12-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease|Effect of Prebiotic Fructo-oligosaccharides (FOS) on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease|Active, not recruiting||N/A|38|Actual|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||f||||||||||2017-10-10 22:57:57.847498|2017-10-10 22:57:57.847498
NCT02539836|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-07-25|||September 2015||2015-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study on Dietary Nutrition Intervention Techniques for Children Obesity|Study on Dietary Nutrition Intervention Techniques for Children Obesity|Recruiting||N/A|40|Anticipated|Chinese Academy of Sciences||1|||f||||f||||||||||2017-10-10 22:57:57.986937|2017-10-10 22:57:57.986937
NCT02539810|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-02-23|||September 2015||2015-09-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|ANDORRA||Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)|Optimum and Stepped Care Standardised Antihypertensive Treatment With or Without Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis. ANDORRA TRIAL|Recruiting||Phase 4|140|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:57:58.259176|2017-10-10 22:57:58.259176
NCT02539797|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-03-17|||October 2014||2014-10-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|ICDC||Improving Cognition in Schizophrenia Using tDCS|Improving Cognition in Schizophrenia Using Transcranial Direct Current Stimulation|Recruiting||N/A|40|Anticipated|University of California, Los Angeles||3|||f||||f||||||||||2017-10-10 22:57:58.456689|2017-10-10 22:57:58.456689
NCT02539784|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-07-31|||June 2015||2015-06-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|SpinalPark||Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease|Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease: A Phase I Safety and Efficacy Study|Recruiting||Phase 1/Phase 2|6|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:57:58.566081|2017-10-10 22:57:58.566081
NCT02539771|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-06-19|||September 2014||2014-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|DREPASOM||Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events|Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events|Recruiting||N/A|150|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 22:57:58.66605|2017-10-10 22:57:58.66605
NCT02539758|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-08|2015-08-31|||July 2013||2013-07-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Effect of Ocular Massage on the Management of Elevated Intraocular Pressure After Acute Angle Closure|The Effect of Ocular Massage on the Management of Elevated Intraocular Pressure After Acute Angle Closure|Completed||N/A|20|Actual|Tianjin Medical University Eye Hospital||1|||f||||t||||||||||2017-10-10 22:57:58.7723|2017-10-10 22:57:58.7723
NCT02539745|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-04-21|||July 2013||2013-07-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|||Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma|Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma|Completed||N/A|200|Actual|Tianjin Medical University Eye Hospital|||2||f||||t||||||Samples With DNA|"     Cdx-2, Fok I, Bsm I and Taq I polymorphisms   "|||2017-10-10 22:57:58.882217|2017-10-10 22:57:58.882217
NCT02539732|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-11|||September 2015||2015-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|OWED||Prediction of Outcome of Weaning From Mechanical Ventilation Using the Electrical Activity of the Diaphragm|Prediction of Outcome of Weaning From Mechanical Ventilation Using the Electrical Activity of the Diaphragm|Recruiting||N/A|110|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-10 22:57:58.99154|2017-10-10 22:57:58.99154
NCT02539719|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-07-27|||August 2015||2015-08-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer|A Phase 1a/1b Dose Escalation and Expansion Study of Single-Agent SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer|Recruiting||Phase 1|108|Anticipated|Stemcentrx||1|||f||||f||||||||||2017-10-10 22:57:59.434937|2017-10-10 22:57:59.434937
NCT02539706|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2015-09-15|||January 2014||2014-01-01|September 2015|2015-09-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|MENS||Menstrual Cycle on Injection Pain of Rocuronium|The Impact of the Menstrual Cycle on Injection Pain of Rocuronium|Unknown status|Recruiting|N/A|50|Anticipated|Adnan Menderes University||2|||f||||t||||||||||2017-10-10 22:57:59.623551|2017-10-10 22:57:59.623551
NCT02539693|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2017-01-07|||October 2016||2016-10-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Sacrococcygeal Local Anesthesia With Different Doses of Clonidine for Pilonidal Sinus Surgery|Sacrococcygeal Local Anesthesia With Different Doses of Clonidine for Pilonidal Sinus Surgery: A Prospective Randomized Trial|Recruiting||N/A|60|Anticipated|Makassed General Hospital||2|||f||||f||||||||||2017-10-10 22:57:59.752345|2017-10-10 22:57:59.752345
NCT02539680|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PeTRA||Intestinal Phosphate Transporter Expression in CKD Patients|Joint Study on Intestinal Phosphate-TRAnsporter Expression in CKD Patients|Recruiting||N/A|30|Anticipated|RWTH Aachen University||3|||f||||f||||||||No||2017-10-10 22:57:59.876126|2017-10-10 22:57:59.876126
NCT02539641|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-03-27|||April 2015||2015-04-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|September 2015|Actual|2015-09-01||Interventional|BIG||Bariatric Procedures and Changes in Incretins and Gastric Emptying|Bariatric Procedures and Changes in Incretins and Gastric Emptying|Completed||N/A|32|Actual|Rijnstate Hospital||5|||f||||f||||||||||2017-10-10 22:58:00.105688|2017-10-10 22:58:00.105688
NCT02539628|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-04-27|||March 2015||2015-03-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption|Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption: A Randomized, Triple-masked, Controlled Study|Completed||Phase 4|110|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 22:58:00.229544|2017-10-10 22:58:00.229544
NCT02539615|ClinicalTrials.gov processed this data on October 10, 2017|2015-09-01|2016-01-21|||September 2015||2015-09-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old|A Single-arm, Multi-center Trial of the ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years of Age|Withdrawn||Phase 3|0|Actual|Atossa Genetics, Inc.||1|||f||||f||||||||||2017-10-10 22:58:00.330389|2017-10-10 22:58:00.330389
NCT02539602|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-08-31|||September 2011||2011-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|N2K||Evaluation of a Need to Know (N2K): A New Sex Education Program for High School Students|Rigorous Evaluation of Need to Know (N2K): A Three-Year Quasi-Experimental Sex Education Program for High School Students in Texas|Completed||N/A|1616|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 22:58:00.995601|2017-10-10 22:58:00.995601
NCT02539589|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-11-07|||June 2012||2012-06-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of Becoming a Responsible Teen (BART)|Evaluation of Becoming a Responsible Teen (BART)|Completed||N/A|850|Actual|The Policy & Research Group||2|||f||||f||||||||||2017-10-10 22:58:01.095052|2017-10-10 22:58:01.095052
NCT02539576|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-12-17|||October 2015||2015-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects|A Phase I, Open-label, Single-dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Abacavir/Dolutegravir/Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects|Completed||Phase 1|12|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-10-10 22:58:01.181677|2017-10-10 22:58:01.181677
NCT02539563|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-03-10|||June 2015||2015-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Do Peanut Shaped Birthing Balls Reduce the Length of Labor in Patients With Epidural Analgesia?|Do Peanut Shaped Birthing Balls Reduce the Length of Labor in Patients With Epidural Analgesia?|Recruiting||N/A|240|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-10 22:58:01.316446|2017-10-10 22:58:01.316446
NCT02539550|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-06-22|||August 2015||2015-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects|A Phase 1, Placebo-controlled, Randomized, Subject- And Investigator-blind, Sponsor-open, Crossover Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Pf-06266047 After Administration Of Single Ascending Doses To Healthy Adult Subjects|Completed||Phase 1|25|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 22:58:01.480366|2017-10-10 22:58:01.480366
NCT02539537|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-01-24|||March 2015||2015-03-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|NEOPAN||A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma|A Randomized Phase III Trial Comparing Chemotherapy With Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma|Recruiting||Phase 3|170|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-10 22:58:01.625512|2017-10-10 22:58:01.625512
NCT02539524|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-09-12|||January 2015||2015-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Yoga on Clinical Impact and Psychosocial Aspects of COPD|Effects of Yoga Respiratory Exercises on Clinical Impact, and Psychosocial Aspects in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|18|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:58:01.831516|2017-10-10 22:58:01.831516
NCT02539511|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-10-25|||July 2015||2015-07-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Glutamatergic Modulation of Disordered Alcohol Use|The Effect of Brief Potent Glutamatergic Modulation on Disordered Alcohol Use|Recruiting||Phase 2/Phase 3|40|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-10 22:58:01.920999|2017-10-10 22:58:01.920999
NCT02539498|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-04-13|||April 2012||2012-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|MicrOs||Bone Architectural Parameters in Postmenopausal Women Affected With Primary Hyperparathyroidism|Characterization of Bone Architectural Parameters Assessed by High-Resolution Peripheral Quantitative Computed Tomography in Post-menopausal Women Affected With Primary Hyperparathyroidism|Completed||N/A|83|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 22:58:02.048717|2017-10-10 22:58:02.048717
NCT02539485|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-01|||June 2015||2015-06-01|August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Interventional|||Heating Precondition of Streamlined Liner of the Pharynx Airway Decrease the Incidence of Sore Throat||Unknown status|Recruiting|N/A|120|Anticipated|Fudan University||1|||f||||||||||||||2017-10-10 22:58:02.161785|2017-10-10 22:58:02.161785
NCT02539472|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-04-15|||November 2015||2015-11-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|DIAPREMYF||Early Diagnosis of Mycosis Fungoides|Evaluation of a Combination of Blood Biomarkers for the Early Diagnosis of Mycosis Fungoides|Recruiting||N/A|620|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 22:58:02.246008|2017-10-10 22:58:02.246008
NCT02539459|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-09-08|||September 2015||2015-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|SAGE||Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus|A Phase II Study of Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Therapy|Recruiting||Phase 2|43|Anticipated|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-10 22:58:02.322538|2017-10-10 22:58:02.322538
NCT02539446|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-17|||October 2014||2014-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|October 2014|Actual|2014-10-01||Interventional|||Suprapostural Attention Focus and Postural Difficulty on H-reflex and Brain Activity: Aging and Parkinson's Disease|The Effects of Suprapostural Attention Focus and Postural Difficulty on H-reflex and Brain Activity: Aging and Parkinson's Disease|Recruiting||N/A|30|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 22:58:02.406882|2017-10-10 22:58:02.406882
NCT02539433|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-08-31|||December 2003||2003-12-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)|Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)|Completed||N/A|22|Actual|Northwell Health||1|||f||||f||||||||||2017-10-10 22:58:02.497904|2017-10-10 22:58:02.497904
NCT02539420|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-04-25|||April 2016||2016-04-01|April 2016|2016-04-01||||April 2016|Anticipated|2016-04-01||Interventional|||A Prospective Trial of BiPAP Administration vs. Non-positive Pressure Therapy for Pediatric Status Asthmaticus|A Prospective, Randomized Trial of Early Versus Delayed BiPAP Administration or Non-positive Pressure Therapy in the Management of Pediatric Status Asthmaticus|Withdrawn||N/A|0|Actual|Northwell Health||3|||f||||t||||||||||2017-10-10 22:58:02.578039|2017-10-10 22:58:02.578039
NCT02189382|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-08-28|||June 2014||2014-06-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of the Safety and Efficacy of an Oxalate Gel or Negative Control on Dentinal Hypersensitivity||Completed||N/A|70|Actual|Procter and Gamble||2|||f||||t||||||||||2017-10-11 00:13:31.342305|2017-10-11 00:13:31.342305
NCT02539407|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-09-14|||September 2015||2015-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|OPTIMOME||Population Pharmacokinetics of Anti-infectives in Critically Ill Children|Population Pharmacokinetics and Rationalization of Anti-infectives Administration in Critically Ill Children|Recruiting||N/A|1850|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 22:58:02.655139|2017-10-10 22:58:02.655139
NCT02539394|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-03-15|||August 2015||2015-08-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Topical Corticosteroids on Dysphagia in Anterior Cervical Discectomy and Fusion|Do Intraoperative Topical Corticosteroids Aid in the Prevention of Postoperative Dysphagia Following Elective Anterior Cervical Discectomy and Fusion? A Randomized, Controlled, Double Blinded Clinical Trial|Enrolling by invitation||N/A|100|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-10 22:58:02.742381|2017-10-10 22:58:02.742381
NCT02539381|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-08-31|||July 2015||2015-07-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||The Stroke Vision App: A Screening Tool for Visual Stroke|Stroke Vision: A Screening Tool for the Assessment of Visual Impairments in Stroke Survivors|Unknown status|Recruiting|N/A|62|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f||||||||||2017-10-10 22:58:02.836866|2017-10-10 22:58:02.836866
NCT02539368|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-27|||April 22, 2015|Actual|2015-04-22|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|January 31, 2019|Anticipated|2019-01-31||Observational|CONNECT-IBD||Post-Marketing Use Of Inflectra (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease|Post-marketing Observational Cohort Study Of Patients With Inflammatory Bowel Disease (Ibd) Treated With Inflectra (Infliximab) In Usual Clinical Practice (Connect-ibd)|Recruiting||N/A|3300|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 22:58:02.98118|2017-10-10 22:58:02.98118
NCT02539355|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-10-20|||August 2015||2015-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Diet and Metabolic Inflammation|Diet and Metabolic Inflammation|Completed||N/A|16|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-10 22:58:03.402244|2017-10-10 22:58:03.402244
NCT02539342|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-05-05|||October 2016||2016-10-01|May 2017|2017-05-01|March 2, 2017|Actual|2017-03-02|March 2, 2017|Actual|2017-03-02||Interventional|||Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy|Caphosol Study: A Randomized Controlled Open-Labeled Trial Investigating Topical Caphosol for Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy|Terminated||Phase 3|1|Actual|Medical College of Wisconsin||2||Lack of funding|f||||t||||||||||2017-10-10 22:58:03.51261|2017-10-10 22:58:03.51261
NCT02539329|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-01-11|||February 2015||2015-02-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Characterization of Anti-FGFR3 Antibodies|Characterization of Sensory Neuropathies Associated With Anti-FGFR3 Antibodies|Recruiting||N/A|465|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||Samples Without DNA|"     blood sample for antibodies measure   "|||2017-10-10 22:58:03.634443|2017-10-10 22:58:03.634443
NCT02539316|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-04-12|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|SMOFPILOT||Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population|Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population|Completed||Phase 4|9|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 22:58:03.780727|2017-10-10 22:58:03.780727
NCT02539303|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-09-13|||August 2015||2015-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Delivery of Yamani-15/5 Chemical Solution for PAD|In-vivo Demineralization of Calcific Peripheral Arterial Disease (PAD) Using Local Delivery of Yamani-15/5 Chemical Solution|Recruiting||N/A|5|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 22:58:04.009|2017-10-10 22:58:04.009
NCT02539290|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-02|||August 2015||2015-08-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility|Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility: A Randomised Controlled Trial Protocol|Recruiting||N/A|192|Anticipated|CHU de Quebec-Universite Laval||2|||f||||t||||||||||2017-10-10 22:58:04.139839|2017-10-10 22:58:04.139839
NCT02539277|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2015-09-02|||December 2014||2014-12-01|August 2015|2015-08-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection|A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection: A Double Blind, Double Dummy, Randomized, Controlled Trial|Unknown status|Recruiting|Phase 4|600|Anticipated|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-10 22:58:04.298432|2017-10-10 22:58:04.298432
NCT02539264|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2016-01-05|||January 2014||2014-01-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA)|Impact of Smoking, BZD and Obesity on Severe Obstructive Sleep Apnea (sOSA)|Completed||N/A|920|Actual|Astes|||1||f||||f||||||||||2017-10-10 22:58:04.441847|2017-10-10 22:58:04.441847
NCT02539251|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-08-01|||September 2015||2015-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Arabic Ages and Stages Questionnaire-III|Adaptation and Validation of the Ages and Stages Questionnaires -3 (ASQ-3) in Arabic|Recruiting||N/A|575|Anticipated|American University of Beirut Medical Center|||1||f||||t||||||||||2017-10-10 22:58:04.521996|2017-10-10 22:58:04.521996
NCT02539238|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2015-09-02|||June 2015||2015-06-01|August 2015|2015-08-01||||September 2017|Anticipated|2017-09-01||Interventional|||Improving CPR Quality With Longitudinal Practice and Realtime Feedback - RCT With CEA|The Effect of a New Training Program on CPR Quality of Pediatric Healthcare Providers: A Randomized Control Trial With Economic Evaluation|Unknown status|Recruiting|N/A|110|Anticipated|Alberta Children's Hospital||2|||f||||t||||||||||2017-10-10 22:58:04.624508|2017-10-10 22:58:04.624508
NCT02539225|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-08-25|||October 2015||2015-10-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma|A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of S-1 and Oxaliplatin With or Without Ramucirumab as First-line Therapy Followed by Paclitaxel With Ramucirumab as Second-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|Recruiting||Phase 2|190|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 22:58:04.730317|2017-10-10 22:58:04.730317
NCT02539173|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-06|||June 1, 2014|Actual|2014-06-01|August 2015|2015-08-01|November 1, 2015|Actual|2015-11-01|October 1, 2015|Actual|2015-10-01||Interventional|BBDDIAPHRAGM||Diagnosis of Diaphragmatic Paralysis After Interscalene Block: Feasibility and Impact Observed|Diagnosis of Diaphragmatic Paralysis After Interscalene Block by Measuring the Inspiratory Diaphragmatic Thickening: Feasibility and Impact Observed|Completed||N/A|50|Actual|Groupe Hospitalier Paris Saint Joseph||1|||f||||t||||||||||2017-10-10 22:58:05.313082|2017-10-10 22:58:05.313082
NCT02539160|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-03-15|||February 2016||2016-02-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease|Impact of Chronic Kidney Disease on the Pharmacodynamic and Pharmacokinetic Effects of Ticagrelor in Patients With Diabetes Mellitus and Coronary Artery Disease|Recruiting||Phase 4|82|Anticipated|University of Florida||4|||f||||t|f|f||||||||2017-10-10 22:58:05.429831|2017-10-10 22:58:05.429831
NCT02539147|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-02-20|||September 2014||2014-09-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|CASPASEs||Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis|Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis|Completed||N/A|6|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||None Retained|"     arterial blood (20ml)   "|||2017-10-10 22:58:05.588589|2017-10-10 22:58:05.588589
NCT02539134|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-04-19|2017-04-19||September 2015||2015-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||The safety analysis set included all participants who were enrolled and received study drug.|TAK-935 Multiple Rising Dose Study in Healthy Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Multiple Doses of TAK-935 in Healthy Subjects|Completed||Phase 1|40|Actual|Takeda||7|||f||||f||||||||||2017-10-10 22:58:05.745068|2017-10-10 22:58:05.745068
NCT02539121|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-08-31|||October 2015||2015-10-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Influence of Acupuncture in the Postpartum Blood Loss|Influence of Acupuncture in the Postpartum Blood Loss|Not yet recruiting||N/A|300|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias||2|||f||||f||||||||||2017-10-10 22:58:07.470717|2017-10-10 22:58:07.470717
NCT02539108|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-10-19|2016-08-26||August 2015||2015-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy Children|Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy Children|Completed||Phase 4|60|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 22:58:07.605725|2017-10-10 22:58:07.605725
NCT02539095|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-08-31|||April 2014||2014-04-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of Intra-articular Collagen Injection in Patients With Knee Joint Pain Compared to Normal Saline Injection|A Double-blind, Randomized, Post-marketing Surveillance to Evaluate the Efficacy of Intra-articular Collagen Injection in Patients With Knee Joint Pain Compared to Normal Saline Injection|Unknown status|Active, not recruiting|Phase 4|200|Actual|Sewon Cellontech Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:58:08.307742|2017-10-10 22:58:08.307742
NCT02539082|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-09-01|||November 2013||2013-11-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis|A Post-marketing Surveillance to Evaluate the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis|Unknown status|Recruiting|Phase 4|60|Anticipated|Sewon Cellontech Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:58:08.436767|2017-10-10 22:58:08.436767
NCT02539069|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-01|||August 2012||2012-08-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|February 2015|Actual|2015-02-01||Interventional|||The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy|A Post-marketing Surveillance to Evaluate the Efficacy and Safety of CHONDRON (Autologous Cultured Chondrocyte) Through Arthroscopy in Patients With Knee Cartilage Defects|Unknown status|Active, not recruiting|Phase 4|10|Anticipated|Sewon Cellontech Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:58:08.557025|2017-10-10 22:58:08.557025
NCT02539056|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-01|||July 2012||2012-07-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|February 2015|Actual|2015-02-01||Interventional|||The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte)|This Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte) in Patients With Cartilage Defects in Their Knees.|Unknown status|Active, not recruiting|Phase 4|24|Anticipated|Sewon Cellontech Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:58:08.669025|2017-10-10 22:58:08.669025
NCT02539043|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-09-01|||January 2015||2015-01-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Ultrasound Cavitation Focused on Located Adiposity|Effects of Ultrasound Cavitation Focused on Located Adiposity: Pilot Study|Completed||N/A|28|Actual|Federal University of Health Science of Porto Alegre||2|||f||||f||||||||||2017-10-10 22:58:08.753429|2017-10-10 22:58:08.753429
NCT02539030|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-08-31|||February 2013||2013-02-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Comparison of Efficacy and Safety of Microfracture and Modified Microfracture|Random Clinical Trial for Comparison of Efficacy and Safety of Simple Microfracture and Modified Microfracture Using Collagen in the Patients With Knee Cartilage Defects|Unknown status|Active, not recruiting|Phase 4|100|Actual|Sewon Cellontech Co., Ltd.||2|||f||||t||||||||||2017-10-10 22:58:08.844753|2017-10-10 22:58:08.844753
NCT02539017|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-08-09|||November 2015||2015-11-01|August 2016|2016-08-01||||September 2017|Anticipated|2017-09-01||Interventional|||The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer||Withdrawn||Phase 2|0|Actual|First Affiliated Hospital Xi'an Jiaotong University||2||because of safety problem, this trial was stopped in the hospital|f||||||||||||||2017-10-10 22:58:08.969427|2017-10-10 22:58:08.969427
NCT02539004|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-07-31|||June 2015||2015-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||US-Non Contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up|Ultrasound Non-contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up|Recruiting||N/A|70|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-10 22:58:11.272985|2017-10-10 22:58:11.272985
NCT02538991|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-06-15|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|September 2018|Anticipated|2018-09-01||Interventional|||TVT Versus Bulkamid®-Injections in Treatment of Stress Urinary Incontinence|TVT Versus Bulkamid®-Injections in Treatment of Stress Urinary Incontinence - Patient Satisfaction and Complications of the Treatment|Active, not recruiting||N/A|224|Actual|Helsinki University Central Hospital||2|||f||||||||||||||2017-10-10 22:58:11.364009|2017-10-10 22:58:11.364009
NCT02538978|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-07-27|||January 2017||2017-01-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|CLIRST III||Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System|Safety and Effectiveness of the SurgWerksTM-CLI Kit and VXPTM System for the Rapid Intra-operative Aspiration, Preparation and Intramuscular Injection of Concentrated Autologous Bone Marrow Cells Into the Ischemic Index Limb of Rutherford Category 5 Non-Reconstructable Critical Limb Ischemia Patients|Not yet recruiting||Phase 3|224|Anticipated|Cesca Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 22:58:11.480097|2017-10-10 22:58:11.480097
NCT02538965|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-06-29|||November 19, 2015|Actual|2015-11-19|June 2017|2017-06-01|January 31, 2024|Anticipated|2024-01-31|May 14, 2019|Anticipated|2019-05-14||Interventional|||A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 2, Multicenter, Single-arm, Open-label Study to Evaluate the Activity, Safety and Pharmacokinetics of Lenalidomide (Revlimid®) in Pediatric Subjects From 1 to = 18 Years of Age With Relapsed or Refractory Acute Myeloid Leukemia.|Recruiting||Phase 2|43|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 22:58:11.5964|2017-10-10 22:58:11.5964
NCT02538952|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-07-26|||July 2012||2012-07-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|XPRES||Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons|Evaluating Performance, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons in Botswana During 2012-2013: The Xpert Package Rollout Evaluation Study (XPRES)|Active, not recruiting||Phase 4|18696|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-10 22:58:11.839206|2017-10-10 22:58:11.839206
NCT02538939|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-08-24|||December 2, 2015|Actual|2015-12-02|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|THIOCAL||Efficacy and Tolerance of Sodium Thiosulfate Injection After Ultrasound-guided Percutaneous Irrigation of Calcific Tendinopathy of the Rotator Cuff|Efficacy and Tolerance of Sodium Thiosulfate Injection After Ultrasound-guided Percutaneous Irrigation of Calcific Tendinopathy of the Rotator Cuff|Active, not recruiting||Phase 2|17|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 22:58:12.091592|2017-10-10 22:58:12.091592
NCT02538926|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-08-08|||October 1, 2017|Anticipated|2017-10-01|August 2017|2017-08-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|A Phase II Study of Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin Plus Asparaginase (DA-EPOCH-A) for Adults With Acute Lymphoblastic Leukemia/Lymphoma|Not yet recruiting||Phase 2|71|Anticipated|University of Washington||1|||f||||f|t|f||||||||2017-10-10 22:58:12.195149|2017-10-10 22:58:12.195149
NCT02538913|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-09-17|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|August 2023|Anticipated|2023-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Exercise Training for Rectal Cancer Patients|Exercise Training for Rectal Cancer Patients. A Randomized Controlled Trial.|Recruiting||N/A|150|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 22:58:12.460394|2017-10-10 22:58:12.460394
NCT02538900|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-02-13|||June 2015||2015-06-01|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|LITE||Low InTensity Exercise Intervention in PAD|Low InTensity Exercise Intervention in PAD|Recruiting||N/A|305|Anticipated|Northwestern University||3|||f||||t||||||||||2017-10-10 22:58:12.587147|2017-10-10 22:58:12.587147
NCT02538887|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-08-31|||November 2015||2015-11-01|August 2015|2015-08-01||||May 2016|Anticipated|2016-05-01||Observational|||Use of a Supplemental Radiofrequency Detection System Subsequent to Manual Counting of Vaginal Textiles Following Vaginal Birth|Use of a Supplemental Radiofrequency Detection System Subsequent to Manual Counting of Vaginal Textiles Following Vaginal Birth: A Prospective Effectiveness and Efficiency Study For Sponge Tracking|Unknown status|Not yet recruiting|N/A|2500|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||||||||||||2017-10-10 22:58:12.712444|2017-10-10 22:58:12.712444
NCT02538874|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-05-22|||October 31, 2015|Actual|2015-10-31|May 2017|2017-05-01|November 5, 2016|Actual|2016-11-05|November 4, 2016|Actual|2016-11-04||Interventional|||A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body|A Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986171 in Healthy Subjects|Completed||Phase 1|275|Actual|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-10 22:58:12.794876|2017-10-10 22:58:12.794876
NCT02538861|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-01-30|||September 2015|Actual|2015-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acute Chest Pain Imaging in the ED With the Combine CCTA and CT Perfusion|Acute Chest Pain Imaging in Emergency Department With Combined Approach of Coronary CT Angiography and CT Myocardial Perfusion|Recruiting||N/A|250|Anticipated|Baptist Health South Florida||3|||f||||f||||||||||2017-10-10 22:58:12.908371|2017-10-10 22:58:12.908371
NCT02538848|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-06-06|||October 2015||2015-10-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of HTD4010 in Healthy Volunteers|A First in Human, Randomized, Double-Blind Study to Assess Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Effects of HTD4010 in Healthy Participants|Completed||Phase 1|32|Actual|HighTide Biopharma Pty Ltd||4|||f||||t||||||||||2017-10-10 22:58:13.031533|2017-10-10 22:58:13.031533
NCT02538835|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-11-14|||August 2018||2018-08-01|November 2016|2016-11-01||||July 2020|Anticipated|2020-07-01||Interventional|||The Effect of Group Treatment for Depression: A Study of Metacognitive Therapy, Mindfulness and Support Groups|The Effect of Group Treatment for Depression: A Randomised Controlled Study of Metacognitive Therapy, Mindfulness and Support Groups|Not yet recruiting||N/A|165|Anticipated|University of Southern Denmark||3|||f||||||||||||||2017-10-10 22:58:13.121975|2017-10-10 22:58:13.121975
NCT02157194|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2016-10-24|||February 2013||2013-02-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|March 2014|Actual|2014-03-01||Observational|||Endobronchial Ultrasound-transbronchial Needle Aspiration (EBUS-TBNA) Sample Division||Completed||N/A|88|Actual|University Hospital, Essen|||1||f||||||||||||||2017-10-11 00:20:55.19626|2017-10-11 00:20:55.19626
NCT02538822|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-04|||September 1, 2014|Actual|2014-09-01|July 2017|2017-07-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Risk of Rupture of Aneurysms of the Thoracic Ascending Aorta (ATA) From the Dynamic Imaging|Assessment of the Risk of Rupture of Aneurysms of the Thoracic Ascending Aorta (ATA) From the Dynamic Imaging - A Monocentric Study|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 22:58:13.220777|2017-10-10 22:58:13.220777
NCT02538809|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-11-18|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|Cytokeratin||Quantitative Evaluation of Cytokeratin in the Urine of Spinal Cord Individuals With Suspicion of Bladder Cancer|Quantitative Evaluation of a Bladder Cancer Marker (Cytokeratin) in the Urine of Spinal Cord Individuals With Symptoms or Clinical Findings Suspicious for Bladder Cancer|Not yet recruiting||N/A|100|Anticipated|Swiss Paraplegic Centre Nottwil|||1||f||||f||||||||No||2017-10-10 22:58:13.336479|2017-10-10 22:58:13.336479
NCT02538796|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-03-09|||May 2011||2011-05-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Embodied Cognition: Exploratory Study of Automatic and Controlled Processes in Anorexia Nervosa.|The Embodied Cognition: Exploratory Study of Automatic and Controlled Processes in Anorexia Nervosa. A Monocentric Study|Completed||N/A|176|Actual|Centre Hospitalier Universitaire de Saint Etienne||8|||f||||f||||||||||2017-10-10 22:58:13.451822|2017-10-10 22:58:13.451822
NCT02538783|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-08-01|||May 2016||2016-05-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Weigh Forward, Financial Incentives for Maintenance of Weight Loss|A Randomized Trial of Financial Incentives for Maintenance of Weight Loss|Active, not recruiting||N/A|259|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 22:58:13.576675|2017-10-10 22:58:13.576675
NCT02538770|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-01-08|||September 2014||2014-09-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization|The Impact of Respiratory Pathogen PCR Assay on Treatment of Adult Patients: A Randomized Controlled Trial|Completed||N/A|900|Actual|University of Oulu||2|||f||||f||||||||||2017-10-10 22:58:13.69709|2017-10-10 22:58:13.69709
NCT02538744|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-10-10|||August 2015||2015-08-01|October 2016|2016-10-01||||August 2018|Anticipated|2018-08-01||Interventional|||Complementary Combination Therapy for Cocaine Dependence|Complementary Combination Therapy for Cocaine Dependence|Recruiting||Phase 1|45|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 22:58:13.796941|2017-10-10 22:58:13.796941
NCT02538731|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2015-09-01|||August 2015||2015-08-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Laser Lithotripsy for Difficult Large Bile Duct Stones|Randomized Trial of Spyglass Guided Laser Lithotripsy Versus Dilation-Assisted Stone Extraction for the Endoscopic Removal of Difficult Large Bile Duct Stones|Unknown status|Not yet recruiting|N/A|150|Anticipated|Shandong Provincial Hospital||2|||f||||f||||||||||2017-10-10 22:58:14.064784|2017-10-10 22:58:14.064784
NCT02538718|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-01|||July 2015||2015-07-01|August 2015|2015-08-01||||November 2016|Anticipated|2016-11-01||Interventional|||Efficacy and Safety of MgSO4 as Tocolytics Compared to Ritodrine in Preterm Labor|Efficacy and Safety of MgSO4 as Tocolytics Compared to Ritodrine in Preterm Labor|Unknown status|Recruiting|N/A|50|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 22:58:14.173334|2017-10-10 22:58:14.173334
NCT02538705|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2017-04-04|||August 2015|Actual|2015-08-01|August 2015|2015-08-01|January 1, 2016|Actual|2016-01-01|January 1, 2016|Actual|2016-01-01||Interventional|||Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot|Safety and Efficacy Study of Pl-vegf165 to Treat Diabetic Foot Syndrome|Completed||N/A|35|Actual|Human Stem Cell Institute, Russia||1|||f||||f||||||||||2017-10-10 22:58:14.281227|2017-10-10 22:58:14.281227
NCT02538692|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2017-04-17|||December 2015||2015-12-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome|Traditional Chinese Medicine Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome: a Randomized Placebo-controlled Trial and a Mechanistic Study|Completed||Phase 2/Phase 3|160|Actual|Chengdu University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 22:58:14.368077|2017-10-10 22:58:14.368077
NCT02538679|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-09-08|||August 7, 2015|Actual|2015-08-07|September 2017|2017-09-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques|A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Technique Versus Laparoscopic Transversus Abdominis Plane Nerve Block Technique Versus No Block on Postoperative Opioid Consumption After Major Colorectal Surgery|Completed||N/A|127|Actual|Cedars-Sinai Medical Center||3|||f||||||||||||||2017-10-10 22:58:14.453921|2017-10-10 22:58:14.453921
NCT02538666|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-09-26|||September 30, 2015|Actual|2015-09-30|September 2017|2017-09-01|November 20, 2019|Anticipated|2019-11-20|September 20, 2018|Anticipated|2018-09-20||Interventional|CheckMate 451||An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy|A Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination With Ipilimumab, or Placebo as Maintenance Therapy in Subjects With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based First Line Chemotherapy (CheckMate 451: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 451)|Recruiting||Phase 3|810|Anticipated|Bristol-Myers Squibb||3|||f||||t|t|f||||||||2017-10-10 22:58:14.601703|2017-10-10 22:58:14.601703
NCT02538653|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-09-13|||September 2015||2015-09-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content Consumed Alone.|Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content Consumed Alone.|Completed||N/A|20|Actual|Mondelēz International, Inc.||2|||f||||f||||||||||2017-10-10 22:58:15.792319|2017-10-10 22:58:15.792319
NCT02538640|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-10-30|||August 2015||2015-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content and GI Consumed Alone.|Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content and GI Consumed Alone.|Completed||N/A|20|Anticipated|Mondelēz International, Inc.||2|||f||||f||||||||||2017-10-10 22:58:15.905962|2017-10-10 22:58:15.905962
NCT02538627|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-08-31|||August 2015||2015-08-01|August 2017|2017-08-01|October 5, 2016|Actual|2016-10-05|October 5, 2016|Actual|2016-10-05||Interventional|||Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib|A Phase 1 Multi Arm Study Evaluating the Safety, Pharmacology and Preliminary Activity of the Co-Administration of MM-151 With Seribantumab (MM-121), Istiratumab (MM-141), or Trametinib in Biomarker-selected Cancer Patients|Terminated||Phase 1|5|Actual|Merrimack Pharmaceuticals||6||Sponsor decision|f||||||||||||||2017-10-10 22:58:16.035448|2017-10-10 22:58:16.035448
NCT02538614|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-28|||December 29, 2015|Actual|2015-12-29|July 2017|2017-07-01|July 5, 2017|Actual|2017-07-05|July 5, 2017|Actual|2017-07-05||Interventional|||Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia|A Phase 1b/2 Study of Idelalisib in Combination With BI 836826 in Subjects With Chronic Lymphocytic Leukemia|Terminated||Phase 1|2|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 22:58:16.178914|2017-10-10 22:58:16.178914
NCT02538601|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-09-01|||February 2012||2012-02-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Enhanced Smoking Cessation Intervention for Smokers Exposed to the World Trade Center (WTC) Disaster|Enhanced Smoking Cessation Intervention for Smokers Exposed to the WTC Disaster|Completed||N/A|90|Actual|Stony Brook University||2|||f||||f||||||||||2017-10-10 22:58:16.285162|2017-10-10 22:58:16.285162
NCT02538588|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-09-01|||August 2015||2015-08-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Comparison of Amikacin Lung Delivery With Two Nebulizers||Unknown status|Recruiting|N/A|12|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-10 22:58:16.380732|2017-10-10 22:58:16.380732
NCT02538575|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-07-31|||May 2016||2016-05-01|July 2016|2016-07-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|MUCO-TM6||6 Minute Walk Test in Cystic Fibrosis|Prognosis Contribution of the 6 Minute Walk Test in Cystic Fibrosis : Prospective Multicenter Study|Recruiting||N/A|250|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 22:58:16.483064|2017-10-10 22:58:16.483064
NCT02538562|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-06|||October 11, 2011|Actual|2011-10-11|July 2017|2017-07-01|April 19, 2013|Actual|2013-04-19|April 19, 2013|Actual|2013-04-19||Observational|||Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea|HER2 Advanced Gastric Epidemiology Study in Korea: An Assessment of HER2 Status in Tumor Tissue Samples of Gastric and Gastro-esophageal (GE) Junction Cancer|Completed||N/A|1695|Actual|Hoffmann-La Roche|||1||f||||||||||Samples With DNA|"     Approximately 2000 tumor tissue samples will be obtained from 17 local laboratories in Korea.     Because the study itself is noninterventional, samples must have been previously collected in     accordance with routine clinical practice.   "|||2017-10-10 22:58:16.780189|2017-10-10 22:58:16.780189
NCT02538549|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2015-08-29|||August 2015||2015-08-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Pilot RCT to Test Effectiveness of the ACE4 (Activity Challenge- 4 Areas) for Depression and Anxiety|A Pilot Randomized Controlled Trial to Test Effectiveness of the ACE4 (Activity Challenge - 4 Areas) for Depression and Anxiety: A Behavioural Activation Based Game.|Unknown status|Recruiting|N/A|120|Anticipated|Queen's University||2|||f||||t||||||||||2017-10-10 22:58:16.906459|2017-10-10 22:58:16.906459
NCT02538536|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-04-10|||July 2015||2015-07-01|October 2016|2016-10-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|A Phase 2, Open-label, Single Arm, Exploratory, Observational Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 2|41|Actual|ProMetic BioSciences Inc.||1|||f||||||||||||||2017-10-10 22:58:17.014239|2017-10-10 22:58:17.014239
NCT02537600|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-12-02|||December 2015||2015-12-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|CONVERCE||Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis|Evaluation of Cobimetinib + Vemurafenib Combination Treatment in Patients With Brain Metastasis BRAFV600 Mutated Cutaneous Melanoma|Recruiting||Phase 2|137|Anticipated|Center Eugene Marquis||1|||f||||t||||||||||2017-10-10 22:58:17.112998|2017-10-10 22:58:17.112998
NCT02537587|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-08-31|||January 2014||2014-01-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Solstice||Effect of Varying the Protein and Dietary Fiber Content of Energy Bars on Their Glycemic and Insulinemic Impact|Effect of Varying the Protein and Dietary Fiber Content of Energy Bars on Their Glycemic and Insulinemic Impact|Completed||N/A|12|Actual|Glycemic Index Laboratories, Inc||7|||f||||f||||||||||2017-10-10 22:58:17.3571|2017-10-10 22:58:17.3571
NCT02537574|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-02-13|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|January 9, 2017|Actual|2017-01-09|October 27, 2016|Actual|2016-10-27||Interventional|||Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)|A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL®|Completed||Phase 3|380|Actual|Alkermes, Inc.||3|||f||||f||||||||||2017-10-10 22:58:17.505461|2017-10-10 22:58:17.505461
NCT02537561|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-02-10|||December 2015||2015-12-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors|A Phase I Adaptive Design Trial of Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|Washington University School of Medicine||2||The pharmaceutical company did not want to follow through with support for the study.|f||||f||||||||||2017-10-10 22:58:17.682151|2017-10-10 22:58:17.682151
NCT02537548|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2017-06-14|||August 28, 2015|Actual|2015-08-28|June 2017|2017-06-01|August 28, 2020|Anticipated|2020-08-28|August 28, 2019|Anticipated|2019-08-28||Interventional|||Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma|Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)|Recruiting||N/A|46|Anticipated|University of Southern California||1|||f||||t|f|f||||||||2017-10-10 22:58:17.818649|2017-10-10 22:58:17.818649
NCT02537535|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-01-30|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|GOAL||Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada|Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada|Enrolling by invitation||N/A|3000|Anticipated|Canadian Heart Research Centre|||1||f||||f|f|f||||||No||2017-10-10 22:58:18.0164|2017-10-10 22:58:18.0164
NCT02537522|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-06-14|2016-11-11||July 1, 2015|Actual|2015-07-01|June 2017|2017-06-01|July 1, 2015|Actual|2015-07-01|July 1, 2015|Actual|2015-07-01||Interventional||All subjects that were dispensed at least one study lens.|Evaluation of 8.5 vs 9.0 Base Curve for 1-DAY ACUVUE(r) TruEye(r) Brand Contact Lenses||Completed||Phase 4|72|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||t|f|t|f|||||||2017-10-10 22:58:18.127939|2017-10-10 22:58:18.127939
NCT02537496|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-07-18|||August 2015||2015-08-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|rTMS-AD||Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS|Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Enhancement of Dorsolateral Prefrontal Cortex Neuroplasticity: A TMS-EEG Study|Recruiting||N/A|45|Anticipated|Centre for Addiction and Mental Health||3|||f||||t||||||||||2017-10-10 22:58:18.597779|2017-10-10 22:58:18.597779
NCT02537483|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-11|||October 2015||2015-10-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris|A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris|Unknown status|Not yet recruiting|Phase 2|350|Anticipated|Valeant Pharmaceuticals||4|||f||||f||||||||||2017-10-10 22:58:18.718988|2017-10-10 22:58:18.718988
NCT02537470|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-01-12|||July 2015||2015-07-01|January 2017|2017-01-01||||August 2016|Actual|2016-08-01||Interventional|BRID||Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes|A 12-week Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Determine the Efficacy and Safety of Biphasic Remogliflozin Etabonate When Administered to Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|191|Actual|BHV Pharma||2|||f||||f||||||||||2017-10-10 22:58:18.815508|2017-10-10 22:58:18.815508
NCT02537457|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-08-28|||January 2014||2014-01-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Bioequivalence Study of Rivaroxaban|Randomized, Non-blinded, Two-way Crossover Study to Establish the Bioequivalence Between a Rivaroxaban Tablet 15 mg and a Rivaroxaban Granule 15 mg in Japanese Healthy Adult Male Subjects|Completed||Phase 1|40|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:58:18.941215|2017-10-10 22:58:18.941215
NCT02538523|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-10-18|||April 2016||2016-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:58:19.027099|2017-10-10 22:58:19.027099
NCT02538510|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-08-23|||October 8, 2015|Actual|2015-10-08|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery|A Single Arm Phase I/II Study of MK-3475 Combined With Vorinostat for Recurrent Unresectable and/or Metastatic Squamous Cell Head and Neck Cancer and Recurrent Unresectable and/or Metastatic Salivary Gland Malignancies|Active, not recruiting||Phase 1/Phase 2|49|Actual|University of Washington||1|||f||||t||||||||||2017-10-10 22:58:19.068879|2017-10-10 22:58:19.068879
NCT02538497|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-05-12|||August 2015||2015-08-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Northern Babies: A Study of Predictors of Postpartum Depression and Parent-infant Interaction Difficulties|Predicting Postpartum Depression and Improving Parent-infant Interaction During the Perinatal Period: The Newborn Behavioral Observation Intervention|Recruiting||N/A|500|Anticipated|University of Tromso||2|||f||||f||||||||||2017-10-10 22:58:19.174841|2017-10-10 22:58:19.174841
NCT02538484|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects|A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Postmenopausal Women With Estrogen Receptor Positive Breast Cancer|Recruiting||Early Phase 1|60|Anticipated|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-10-10 22:58:19.276119|2017-10-10 22:58:19.276119
NCT02538471|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-18|||August 2015||2015-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer|LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer|Recruiting||Phase 2|28|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-10-10 22:58:19.370077|2017-10-10 22:58:19.370077
NCT02538458|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-09-01|||November 2014||2014-11-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|BRONDUSAL||Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants|Effects of Reduction of the Length of Treatment by Nebulized 3% Hypertonic Saline From 72 to 24 Hours on Clinical Remission, in Children Younger Than 12 Month Hospitalized for Acute Bronchiolitis. BRONDUSAL|Unknown status|Recruiting|Phase 4|160|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 22:58:19.453691|2017-10-10 22:58:19.453691
NCT02538445|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2016-03-22|||May 2011||2011-05-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Can we Forget? Directed Forgetting and Embodied Cognition in Schizophrenia|Can we Forget? Directed Forgetting and Embodied Cognition in Schizophrenia|Completed||N/A|96|Actual|Centre Hospitalier Universitaire de Saint Etienne||8|||f||||f||||||||No||2017-10-10 22:58:19.675361|2017-10-10 22:58:19.675361
NCT02538432|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-06-03|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors|15xxGCC: PHASE II TRIAL OF THE EP4 RECEPTOR ANTAGONIST, AAT-007 (RQ-07; CJ-023,423) IN ADVANCED SOLID TUMORS|Withdrawn||Phase 2|0|Actual|University of Maryland||2||PI No Longer at University of Maryland. Now at Fox Chase|f||||t|t|f||||||No||2017-10-10 22:58:19.783944|2017-10-10 22:58:19.783944
NCT02538406|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-28|||August 2015||2015-08-01|July 2017|2017-07-01|December 15, 2017|Anticipated|2017-12-15|October 15, 2017|Anticipated|2017-10-15||Observational|||The Utility of Time Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate.|The Utility of Time Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate. A Randomized Controlled Clinical Trial.|Recruiting||N/A|400|Anticipated|Baylor College of Medicine|||2||f||||t||||||||||2017-10-10 22:58:19.948944|2017-10-10 22:58:19.948944
NCT02538393|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-05-31|||November 20, 2015|Actual|2015-11-20|May 2017|2017-05-01|June 15, 2016|Actual|2016-06-15|March 15, 2016|Actual|2016-03-15||Interventional|||Relative Bioavailability of Sorafenib Tablet for Oral Suspension|An Open Label, Randomized, Four-way Crossover Study in Healthy Male Subjects to Assess the Relative Bioavailability of Sorafenib Tablet for Oral Suspension Compared to Marketed Tablet and to Investigate the Pharmacokinetics of Sorafenib Tablet for Oral Suspension Including Food Effect and Dose Proportionality|Completed||Phase 1|30|Actual|Bayer||4|||f||||f|t|f||||||||2017-10-10 22:58:20.053024|2017-10-10 22:58:20.053024
NCT02538380|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2015-08-31|||March 2015||2015-03-01|June 2015|2015-06-01||||September 2017|Anticipated|2017-09-01||Interventional|||EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients|EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer|Unknown status|Recruiting|N/A|40|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 22:58:20.150888|2017-10-10 22:58:20.150888
NCT02538367|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-10-27|||August 2015||2015-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation|A Randomized, Double-blind/Open-label, Placebo/Active-controlled, Single/Multiple Dose, Parallel, Phase 1/2a Trial to Evaluate the Safety, Tolerability, PK , PD of YH12852 in Healthy Subjects and Patients With Functional Constipation|Completed||Phase 1/Phase 2|120|Actual|Yuhan Corporation||14|||f||||f||||||||||2017-10-10 22:58:20.239365|2017-10-10 22:58:20.239365
NCT02538354|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-05-25|||March 2016||2016-03-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|RISE-UP||The Effect of Riboflavin in Crohn's Disease|The Effect of Riboflavin Supplementation on Faecalibacterium Prausnitzii in Crohn's Disease|Recruiting||N/A|84|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-10 22:58:20.364592|2017-10-10 22:58:20.364592
NCT02538341|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-07-16|||May 2016||2016-05-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)|Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)|Recruiting||Phase 2|1000|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 22:58:20.532374|2017-10-10 22:58:20.532374
NCT02538328|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-09-01|||July 2014||2014-07-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Harmonic Scalpel and Ligasure Devices in Laparoscopic Morbid Obesity Surgery|Comparison of Harmonic Scalpel and Ligasure Devices in Laparoscopic Morbid Obesity Surgery|Completed||N/A|90|Actual|Inonu University||2|||f||||t||||||||||2017-10-10 22:58:20.745897|2017-10-10 22:58:20.745897
NCT02538315|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-05-02|||October 2016||2016-10-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients|Using 3,4-dihydroxy-6-[18F]-Fluoro-l-phenylalanine ( [18F]FDOPA) PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients|Recruiting||N/A|30|Anticipated|University of Saskatchewan|||1||f||||f||||||||||2017-10-10 22:58:20.831827|2017-10-10 22:58:20.831827
NCT02538302|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-08-29|||July 2013||2013-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Minirin Versus Oxybutynin for Nocturnal Enuresis in Children|Minirin Versus Oxybutynin for Nocturnal Enuresis in Children|Completed||Phase 3|66|Actual|Hormozgan University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:58:20.925532|2017-10-10 22:58:20.925532
NCT02538289|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-02-23|||April 2016|Actual|2016-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Hospital Without Dyspnea. Rationale and Design of a Multidisciplinary Intervention|Hospital Without Dyspnea. Rationale and Design of a Multidisciplinary Intervention|Recruiting||N/A|100|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||t||||||||||2017-10-10 22:58:21.047406|2017-10-10 22:58:21.047406
NCT02538276|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-05-01|||July 2013||2013-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01|1 Year|Observational [Patient Registry]|||Carotid Endarterectomy and Carotid Artery Stenting in Brazil|Study of a Real-word Registry of Carotid Endarterectomy and Carotid Artery Stenting in Brazil. Analysis of Prospective Cases of the Registry of Vascular Diseases at University Hospitals of the State of São Paulo|Recruiting||N/A|500|Anticipated|University of Sao Paulo|||2||f||||t||||||||||2017-10-10 22:58:21.169444|2017-10-10 22:58:21.169444
NCT02538263|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-08-29|||January 2013||2013-01-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Volume-targeted Versus Pressure-limited Noninvasive Ventilation in Patients With Acute Hypercapnic Respiratory Failure||Completed||N/A|58|Actual|Beijing Chao Yang Hospital||2|||f||||||||||||||2017-10-10 22:58:21.283586|2017-10-10 22:58:21.283586
NCT02538250|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-10-12|||July 2015||2015-07-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Acceptability Study on Oral Nutrition Supplement (ONS)|Acceptability Study on Nutricomp Drink Plus in Adult Patients|Completed||Phase 4|23|Actual|B. Braun Melsungen AG||1|||f||||f||||||||||2017-10-10 22:58:21.379308|2017-10-10 22:58:21.379308
NCT02538237|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2015-09-01|||November 2013||2013-11-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|August 2014|Actual|2014-08-01||Interventional|ibuprofen||the Effect of Sub-gingival Irrigation With Ibuprofen 2% Mouthwash in Treatment of Periodontal Diseases.|A Randomized, Double-Blind, Split-mouth, Placebo-controlled, Clinical Trial of the Effect of Sub-gingival Irrigation With Ibuprofen Mouthwash in Treatment of Periodontal Diseases|Completed||Phase 2/Phase 3|20|Actual|Islamic Azad University, Tehran||2|||f||||t||||||||||2017-10-10 22:58:21.479544|2017-10-10 22:58:21.479544
NCT02538224|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-06-03|||July 2013||2013-07-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Efficacy of Subgingivally Delivered Doxycycline Plus Ketoprofen Gel as an Adjunct to Non-surgical Periodontal Treatment|Randomized, Double Blind, Placebo Controlled Clinical Trial of Compare With Doxycycline Plus Ketoprofen Gel in Chronic Periodontitis|Completed||Phase 2/Phase 3|20|Actual|Islamic Azad University, Tehran||2|||f||||t||||||||No||2017-10-10 22:58:21.587907|2017-10-10 22:58:21.587907
NCT02538211|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-24|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|Rota-biome||The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses|The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses|Completed||N/A|63|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||f||||||||||2017-10-10 22:58:21.692558|2017-10-10 22:58:21.692558
NCT02538198|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-31|2017-07-05|||August 31, 2015|Actual|2015-08-31|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Lenalidomide Maintenance in Plasma Cell Myeloma|Lenalidomide Maintenance in Plasma Cell Myeloma|Recruiting||Phase 2|100|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 22:58:21.805181|2017-10-10 22:58:21.805181
NCT02538185|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-08-28|||August 2013||2013-08-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Intradermal Rabies Immunization Using NanoJect: A Comparative Study|Intradermal Rabies Immunization Using NanoJect: A Comparative Study|Completed||Phase 1|66|Actual|University of Lausanne Hospitals||3|||f||||f||||||||||2017-10-10 22:58:21.923827|2017-10-10 22:58:21.923827
NCT02538172|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-11-16|||October 2015||2015-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Cell-mediated Immunity for Prevention of CMV Disease|Monitoring of Specific Cytomegalovirus Cell-mediated Immunity (CMV-CMI) for Optimization of Preventive Strategies Against CMV Infection in High-risk Solid-organ Transplant Recipients|Recruiting||N/A|200|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-10 22:58:22.033101|2017-10-10 22:58:22.033101
NCT02538159|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-09-25|||September 2014||2014-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|PYCBAC||Safety and Bacteraemia Between Peripherally Inserted and Central Inserted Catheters.|Randomized, Prospective, Single-center Study to Compare the Effectiveness and Safety in Terms of Catheter Bacteraemia, Between Peripherally Inserted Central Catheters and Non-tunneled Central Venous Catheter in Tertiary Hospital|Unknown status|Recruiting|N/A|516|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 22:58:22.173657|2017-10-10 22:58:22.173657
NCT02538146|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-07|||August 2015||2015-08-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Acetyl-L-carnitine on Chronic Pancreatitis|Acetyl-L-carnitine as Pain Therapy in Chronic Pancreatitis|Terminated||Early Phase 1|3|Actual|University of Kentucky||1||Older participants could not tolerate the acidity of the product and withdrew.|f||||t||||||||Yes|One young participant (>35) successfully completed the trial and provided a personal statement and data indicating the acetyl-L-carnatine had improved his pancreatitis. Two older individuals (>60) withdrew from the study within two months citing inability to tolerate the acidity of the product. Difficulties recruiting in this very ill population was also a consideration in termination. For additional information contact sabrina.mcilwrath@uky.edu|2017-10-10 22:58:22.283331|2017-10-10 22:58:22.283331
NCT02538133|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-05-02|||September 2015||2015-09-01|August 2015|2015-08-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|LEUCOPRO||Study Assessing Hybrid SPECT-CT With Labeled Leukocytes for Diagnosis of Vascular Prosthesis Infections|Tomoscintigraphie Hybride Aux Leucocytes Marqués Dans le Diagnostic Des Infections de Prothèses Vasculaires.|Recruiting||Phase 3|80|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 22:58:22.386595|2017-10-10 22:58:22.386595
NCT02538120|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-02-11|||May 2012||2012-05-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|NEURODIAB1||Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients|Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1|Completed||N/A|40|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-10 22:58:22.513149|2017-10-10 22:58:22.513149
NCT02538107|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-05-09|2015-10-05||September 30, 2007|Actual|2007-09-30|May 2017|2017-05-01|November 30, 2011|Actual|2011-11-30|November 30, 2011|Actual|2011-11-30||Observational||Safety analysis set included participants who received at least 1 dose of study treatment. Age was reported for N=278 participants since data for 1 participant was missing.|An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant|Non-interventional, Observational Study to Investigate the Efficiency and Safety of Mircera in Patients With a Kidney Transplant|Completed||N/A|290|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:58:22.6207|2017-10-10 22:58:22.6207
NCT02538094|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-03-24|||September 2014||2014-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis|Transcranial Direct Current Stimulation and Cognition in Adults With Multiple Sclerosis or Encephalitis|Recruiting||N/A|50|Anticipated|Johns Hopkins University||2|||f||||f||||||||No||2017-10-10 22:58:23.611143|2017-10-10 22:58:23.611143
NCT02538081|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-05-25|||August 2015|Actual|2015-08-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Nicotinic Receptors and Schizophrenia|Nicotinic Receptors and Schizophrenia|Withdrawn||Phase 1/Phase 2|0|Actual|VA Office of Research and Development||2||Withdrawn|f||||t||||||||No||2017-10-10 22:58:23.722316|2017-10-10 22:58:23.722316
NCT02538068|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-03-09|||January 2014||2014-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Psychology of Physical Activity|Meaning and Purpose as Predictors of Physical Activity Maintenance|Completed||N/A|160|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:58:23.87596|2017-10-10 22:58:23.87596
NCT02538055|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-04-26|||September 2011||2011-09-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|Living Healthy||Using CERS to Optimize Quality of Life for Persons With Diabetes and Chronic Pain|Using CERS to Optimize Quality of Life for Persons With Diabetes and Chronic Pain|Completed||N/A|230|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||No|The data will stay at UAB|2017-10-10 22:58:23.973701|2017-10-10 22:58:23.973701
NCT02538042|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-01-26|||September 2015||2015-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|VLNCCue||Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)|Strengthening Instrumental Extinction to Prevent Smoking Relapse|Recruiting||N/A|300|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 22:58:24.091885|2017-10-10 22:58:24.091885
NCT02538029|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-10-02|||August 2015||2015-08-01|October 2017|2017-10-01|August 16, 2017|Actual|2017-08-16|August 16, 2017|Actual|2017-08-16||Interventional|||The Effects of Dual Task Training in Individuals With Parkinson's Disease|The Effects of Dual Task Training on Motor and Non-Motor Function in Individuals With Parkinson's Disease|Completed||N/A|44|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 22:58:24.215162|2017-10-10 22:58:24.215162
NCT02538016|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-07-25|||October 2016||2016-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|TCUPS||TCUPS- Tolvaptan Use in Cyctinuria and Urolithiasis: A Pilot Study|Use of Tolvaptan, a Vasopressin Antagonist, to Increase Urine Dilution and Reduce Cystine Urolithiasis Among Patients With Homozygous Cystinuria: a Pilot Investigation|Not yet recruiting||N/A|8|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-10 22:58:24.320633|2017-10-10 22:58:24.320633
NCT02538003|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-03-22|||September 2015||2015-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||To Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371|A Randomized, Open-label, Single Dose, Crossover, Phase Ⅰ Trial to Evaluate the Effect of Food on the Pharmacokinetics of LCB01-0371 in Healthy Male Subjects|Completed||Phase 1|30|Actual|LegoChem Biosciences, Inc||2|||f||||f||||||||No||2017-10-10 22:58:24.444473|2017-10-10 22:58:24.444473
NCT02537990|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-11-15|||August 2005||2005-08-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01|6 Years|Observational [Patient Registry]|MDS||MDS-CAN: A Prospective National MDS Clinical Database and Local Tissue Bank|MDS-CAN: A Prospective National MDS Clinical Database and Local Tissue Bank|Recruiting||N/A|1200|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||Samples With DNA|"     Specimens of bone marrow will be collected by aspiration when bone marrows are done for     clinical purposes only. BM Plasma will be stored in aliquots, Mononuclear cells (MCs) will be     isolated by density gradient centrifugation of buffy coat cells. The remainder of MC     collected in this way will be used for immediate extraction of DNA by standard techniques.   "|Yes|Individual participant data can be available to other researchers for their own patients from that center but not other centers. Collective anonymized data of all registry patients is available to them however.|2017-10-10 22:58:24.575051|2017-10-10 22:58:24.575051
NCT02537977|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-11-09|||July 2015||2015-07-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy|CD19-directed Chimeric Antigen Receptor T Cells Therapy in Relapsed/Refractory B Cell Malignancy|Recruiting||Phase 1/Phase 2|40|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine||1|||f||||t||||||||No||2017-10-10 22:58:24.709823|2017-10-10 22:58:24.709823
NCT02537964|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-10-13|||September 2016||2016-09-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of Chlorhexidine Bathing in the Neonatal Intensive Care Unit|Evaluation of the Effectiveness of Chlorhexidine Bathing in Reducing Nosocomial Infections in the Neonatal Intensive Care Unit|Recruiting||N/A|1000|Anticipated|Shaare Zedek Medical Center||2|||f||||t||||||||No||2017-10-10 22:58:24.840135|2017-10-10 22:58:24.840135
NCT02537951|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2016-08-07|||September 2015||2015-09-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Autofluorescent Flavoprotein Imaging of Intraepidermal Nerve Fibers: a Pilot Study|Autofluorescent Flavoprotein Imaging of Intraepidermal Nerve Fibers: a Pilot Study|Enrolling by invitation||N/A|10|Anticipated|Erasmus Medical Center||3|||f||||t||||||||||2017-10-10 22:58:24.981771|2017-10-10 22:58:24.981771
NCT02537938|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-03-27|||January 2016||2016-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)|A Randomized, Placebo-Controlled, Double-blind, Parallel-Group, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally-administered NGP 555 in Healthy Subjects|Completed||Phase 1|24|Actual|NeuroGenetic Pharmaceuticals Inc||2|||f||||t||||||||||2017-10-10 22:58:25.120751|2017-10-10 22:58:25.120751
NCT02537925|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2015-08-28|||January 2014||2014-01-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma|The Effect of Celecoxib on Concurrent Chemoradiation With Weekly Nedaplatin in Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 3|120|Anticipated|Nanning Second People's Hospital||2|||f||||t||||||||||2017-10-10 22:58:25.215501|2017-10-10 22:58:25.215501
NCT02537912|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2015-08-30|||December 2013||2013-12-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|||Blood Glucose and Body Fat Regulatory Effect of Peanut Skin Extract|Effects of Peanut Skin Extract on Blood Glucose Regulation and Body Fat Reduction|Completed||N/A|30|Actual|Chung Shan Medical University||2|||f||||t||||||||||2017-10-10 22:58:25.360588|2017-10-10 22:58:25.360588
NCT02537899|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-08-28|||June 2015||2015-06-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|SATURN||Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD|A Case Series of Patients With Spinal Cord Injury Treated With Standard Therapies and NeuroAiD|Recruiting||Phase 4|30|Anticipated|Moleac Pte Ltd.||1|||f||||f||||||||||2017-10-10 22:58:25.486981|2017-10-10 22:58:25.486981
NCT02537886|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-06-29|||June 2016||2016-06-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|||Development of Patient Centered Virtual Multimedia Interactive Informed Consent Tool to Improve Patient Comprehension and Consent|Development of Patient Centered Virtual Multimedia Interactive Informed Consent Tool to Improve Patient Comprehension and Consent|Recruiting||N/A|6|Anticipated|Yale University|||1||f||||f||||||||||2017-10-10 22:58:25.657116|2017-10-10 22:58:25.657116
NCT02537873|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-06-06|||July 2015||2015-07-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder|Phase I Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder|Recruiting||Phase 1|18|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f||||||||2017-10-10 22:58:25.763458|2017-10-10 22:58:25.763458
NCT02537860|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-01-07|||December 2015||2015-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Paravertebral Block for Inguinal Hernia Repair in Elderly|Paravertebral Block for Inguinal Hernia Repair in Elderly: Randomized Double-blinded Clinical Trial|Recruiting||N/A|200|Anticipated|Makassed General Hospital||2|||f||||f||||||||||2017-10-10 22:58:25.865773|2017-10-10 22:58:25.865773
NCT02537847|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2015-08-28|||November 2012||2012-11-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|September 2015|Anticipated|2015-09-01||Interventional|SETAP||Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli|A Randomized Controlled Trial of Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Extended-Spectrum ß-lactamase-producing Escherichia Coli|Unknown status|Recruiting|Phase 2|96|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-10 22:58:25.971592|2017-10-10 22:58:25.971592
NCT02537834|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-06-28|||August 2015||2015-08-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Tofogliflozin GLP-1 Analogue Combination Trial|An Open-Label, Multicenter Study to Evaluate 52-Week Long-Term Safety, Tolerability and Efficacy of Tofogliflozin With Glucagon-like Peptide-1(GLP-1) Analogue Treatment In Type 2 Diabetes Mellitus|Active, not recruiting||Phase 4|65|Anticipated|Kowa Company, Ltd.||1|||f||||f||||||||||2017-10-10 22:58:26.070583|2017-10-10 22:58:26.070583
NCT02537821|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-05-10|||June 2015||2015-06-01|May 2016|2016-05-01||||December 2018|Anticipated|2018-12-01||Observational|||HLA Sensitization in Severely Burned Patients|HLA Sensitization in Severely Burned Patients|Recruiting||N/A|50|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-10 22:58:26.175774|2017-10-10 22:58:26.175774
NCT02537808|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-11-10|||June 2015||2015-06-01|November 2016|2016-11-01|May 2022|Anticipated|2022-05-01|May 2019|Anticipated|2019-05-01||Observational|FIRST-NIS||Non-interventional Study of Lenalidomide / Dexamethasone as First Line Therapy in Patients With Multiple Myeloma|A Non-interventional Study of Lenalidomide (Revlimid®) in Combination With Dexamethasone as First Line Therapy in Transplant-ineligible Patients With Multiple Myeloma|Recruiting||N/A|167|Anticipated|iOMEDICO AG|||1||f||||f||||||||No||2017-10-10 22:58:26.238018|2017-10-10 22:58:26.238018
NCT02537795|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-01-26|||August 2015||2015-08-01|August 2015|2015-08-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Psychiatric Neurosurgery (PNS) for Obsessive Compulsive Disorder (OCD): A Qualitative Analysis of Patient and Family Member Experiences|Psychiatric Neurosurgery (PNS) for Obsessive Compulsive Disorder (OCD): A Qualitative Analysis of Patient and Family Member Experiences|Unknown status|Recruiting|N/A|40|Anticipated|Universitaire Ziekenhuizen Leuven|||4||f||||f||||||||||2017-10-10 22:58:26.329171|2017-10-10 22:58:26.329171
NCT02537782|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-01-17|||September 2015||2015-09-01|January 2017|2017-01-01||||February 2018|Anticipated|2018-02-01||Interventional|WORK-CRT||Myocardial Work and Metabolism in CRT|Investigating Inhomogeneities of Regional Myocardial WORKload and Metabolism in a Cardiac Resynchronisation Therapy Patient Population|Recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-10 22:58:26.416093|2017-10-10 22:58:26.416093
NCT02537769|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-05-11|||August 2015||2015-08-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients|Randomized Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients|Recruiting||N/A|40|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-10 22:58:26.521295|2017-10-10 22:58:26.521295
NCT02537756|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-08-28|||August 2015||2015-08-01|August 2015|2015-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination|Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination|Not yet recruiting||N/A|168|Anticipated|University of Texas Southwestern Medical Center||4|||f||||t||||||||||2017-10-10 22:58:26.625496|2017-10-10 22:58:26.625496
NCT02537743|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-10-21|||August 2015||2015-08-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|October 2020|Anticipated|2020-10-01||Observational|PROKidney||Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma|Open-labeled, Multicenter, Non-interventional, Prospective PRO Registry for Patients With First Line Treatment for Advanced RCC Using a Tablet-technology Based Digital Device|Recruiting||N/A|550|Anticipated|iOMEDICO AG|||1||f||||f||||||||No||2017-10-10 22:58:26.704006|2017-10-10 22:58:26.704006
NCT02537730|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-09-06|2016-06-10||September 2015||2015-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Interventional|||BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover Study|BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover Study|Completed||Phase 4|33|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 22:58:26.77677|2017-10-10 22:58:26.77677
NCT02537717|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-10-13|||August 2015||2015-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:58:27.067336|2017-10-10 22:58:27.067336
NCT02537704|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-05-20|||September 2015||2015-09-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|GLBOMEX||"Translational Study for Obesity Management in Mexican Adults Using the Group Lifestyle Balance Program"|"Translational Study for Overweight and Obesity Management in Adults Using the Group Lifestyle Balance Program in Primary Care Clinics and Public Hospitals From Sonora, México"|Active, not recruiting||N/A|258|Actual|Universidad de Sonora||1|||f||||f||||||||||2017-10-10 22:58:27.10626|2017-10-10 22:58:27.10626
NCT02537691|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-12|||August 27, 2015|Actual|2015-08-27|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|||Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers|A Prospective, Single Arm, Longitudinal Cohort Study To Assess Biomarkers In Real World Patients With Severe Asthma|Completed||Phase 4|483|Actual|Hoffmann-La Roche||1|||f|||||t|f||||||||2017-10-10 22:58:27.20718|2017-10-10 22:58:27.20718
NCT02537678|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-09-19|||September 2015||2015-09-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Stepped Care for Children After Trauma: Optimizing Treatment|Stepped Care for Children After Trauma: Optimizing Treatment|Recruiting||N/A|216|Anticipated|University of South Florida||2|||f||||t||||||||Yes|The data dictionaries for the descriptive and analyzed data were uploaded for the NIMH Data Archive (Salloum C2318).|2017-10-10 22:58:27.482096|2017-10-10 22:58:27.482096
NCT02537652|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-08-30|||January 2016||2016-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Central and Peripheral Blood Pressure in Stroke|Effect of Posture and Fasting State on Central and Peripheral Blood Pressure in Patients With Stroke|Recruiting||N/A|75|Anticipated|Hampshire Hospitals NHS Foundation Trust|||3||f||||t||||||||Yes|Individual participant data will be anonymised before it is shared outside the clinical study team|2017-10-10 22:58:27.663949|2017-10-10 22:58:27.663949
NCT02537639|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-10-31|||May 2016||2016-05-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|ISITOE||Impact of Simulator-based Training in Transoesophageal Echocardiography|Impact of Simulator-based Training in Transoesophageal Echocardiography|Completed||N/A|45|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-10 22:58:27.890921|2017-10-10 22:58:27.890921
NCT02537626|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-05-21|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||An Evaluation of the Effects of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease|An Evaluation of the Effect of the Erchonia ALS on Alzheimer's Disease|Recruiting||N/A|60|Anticipated|Erchonia Corporation||2|||f||||f|f|f||||||No||2017-10-10 22:58:27.993433|2017-10-10 22:58:27.993433
NCT02537613|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-05|||December 2015||2015-12-01|July 2017|2017-07-01|August 2021|Anticipated|2021-08-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|A Phase Ib Study of Ibrutinib in Combination With Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Recruiting||Phase 1|40|Anticipated|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-10 22:58:28.109549|2017-10-10 22:58:28.109549
NCT02537444|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-11-30|||November 2015||2015-11-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)|A Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer|Active, not recruiting||Phase 2|76|Anticipated|Acerta Pharma BV||2|||f||||||||||||||2017-10-10 22:58:28.242928|2017-10-10 22:58:28.242928
NCT02537431|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-05-02|||December 2015||2015-12-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)|An Open-Label, Single-Arm, Phase 3 Study to Evaluate the Effects of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)|Active, not recruiting||Phase 3|14|Actual|Ultragenyx Pharmaceutical Inc||1|||f||||t||||||||||2017-10-10 22:58:28.348089|2017-10-10 22:58:28.348089
NCT02537418|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-07|||October 1, 2015|Actual|2015-10-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens|A Phase IB Study of Durvalumab (MEDI4736) With or Without Tremelimumab in Patients With Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens|Active, not recruiting||Phase 1|175|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-10 22:58:28.498902|2017-10-10 22:58:28.498902
NCT02537405|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-08-28|||February 2014||2014-02-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects|Randomized, Non-blinded, Two-way Crossover Study to Establish the Bioequivalence Between a Rivaroxaban Tablet 10 mg and a Rivaroxaban Granule 10 mg in Japanese Healthy Adult Male Subjects|Completed||Phase 1|40|Actual|Bayer||2|||f||||f||||||||||2017-10-10 22:58:28.628115|2017-10-10 22:58:28.628115
NCT02537392|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-01-11|||September 2015||2015-09-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease|Primary Prevention of Multi-micronutrient Supplementation During Peri-conception Against Congenital Heart Disease: A Community-based Randomised Controlled Trial in China|Recruiting||N/A|9374|Anticipated|Health Science Center of Xi’an Jiaotong University||3|||f||||t||||||||No||2017-10-10 22:58:28.720229|2017-10-10 22:58:28.720229
NCT02537379|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-06-23|||September 15, 2015|Actual|2015-09-15|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Observational|||Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection|A Prospective Observational Post-Marketing Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection|Completed||N/A|552|Actual|Gilead Sciences|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 22:58:28.836078|2017-10-10 22:58:28.836078
NCT02537366|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-03-08|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|VENDETTA||Dexmedetomidine for Non-invasive Ventilation After Chest Trauma|Dexmedetomidine for Non-invasive Ventilation After Chest Trauma (VENDETTA)|Completed||Phase 4|20|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 22:58:29.057313|2017-10-10 22:58:29.057313
NCT02537353|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-31|||September 2015||2015-09-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip|Prospective, Randomized Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip Plus Epinephrine Injection in Nonvariceal Upper Gastrointestinal Bleeding|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 22:58:29.160816|2017-10-10 22:58:29.160816
NCT02537340|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-30|2015-08-30|||August 2015||2015-08-01|August 2015|2015-08-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Observational|||PET/CT for Staging Rectal Cancer Patients With and Without EMVI-MR|The Use of PET/CT for Initial Staging of Rectal Cancer Patients With Extramural Vascular Invasion Detected by MR (EMVI-MR)|Active, not recruiting||N/A|106|Anticipated|Instituto do Cancer do Estado de São Paulo|||2||f||||t||||||||||2017-10-10 22:58:29.271822|2017-10-10 22:58:29.271822
NCT02537327|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-11-22|||August 2014||2014-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Incidence of Recurrent Caries Next to Tooth Restorations|Epidemiological Study on the Incidence and Characteristics of Secondary Caries Next to Tooth Restorations|Completed||N/A|450|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 22:58:29.364759|2017-10-10 22:58:29.364759
NCT02517957|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-06|||August 2015||2015-08-01|August 2015|2015-08-01||||August 2017|Anticipated|2017-08-01||Interventional|||Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research||Unknown status|Not yet recruiting|Phase 2|342|Anticipated|Shanghai Yueyang Integrated Medicine Hospital||3|||f||||t||||||||||2017-10-10 23:03:49.325455|2017-10-10 23:03:49.325455
NCT02537314|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-01-20|||September 2015||2015-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans|Role of the Foregut in Nutrient Metabolism in Lean and Obese Humans|Enrolling by invitation||Phase 1|34|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 22:58:29.43845|2017-10-10 22:58:29.43845
NCT02537301|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-01-09|||June 2015||2015-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by a Group of Doctors|Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by Trainees After Finishing ERCP Training|Completed||N/A|60|Anticipated|Fourth Military Medical University|||1||f||||t||||||||||2017-10-10 22:58:29.537833|2017-10-10 22:58:29.537833
NCT02537288|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-01-05|||October 2015||2015-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval|A Phase I Single Centre, Randomized, Double Blind (Except For Moxifloxacin), Placebo And Active Controlled, Four Way Cross Over Study Investigating The Effect Of Single Therapeutic And Supra Therapeutic Doses Of Fedovapagon On The QT/QTC Interval In Healthy Volunteers Using Oral Moxifloxacin To Confirm Assay Sensitivity|Completed||Phase 1|43|Actual|Vantia Ltd||4|||f||||f||||||||||2017-10-10 22:58:29.626095|2017-10-10 22:58:29.626095
NCT02537275|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-31|||June 2014||2014-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of the Pigment-free Optical Zone Diameter of Decorative Tinted Soft Contact Lenses on Visual Function||Completed||N/A|30|Actual|Yonsei University||1|||f||||f||||||||||2017-10-10 22:58:29.747525|2017-10-10 22:58:29.747525
NCT02537262|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-03-11|||August 2015||2015-08-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of Preoperative Oral Carbohydrates on Quality of Recovery in Laparoscopic Colorectal Surgery Patients||Recruiting||N/A|70|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 22:58:29.845862|2017-10-10 22:58:29.845862
NCT02537249|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-11-09|||August 2015||2015-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Dexmedetomidine on Quality of Recovery and Analgesia After Video-assisted Thoracoscopic Surgery||Completed||N/A|111|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 22:58:29.943447|2017-10-10 22:58:29.943447
NCT02537236|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-09-01|||January 2009||2009-01-01|August 2015|2015-08-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.|Efficacy and Safety of Fish Oil (Omega-3 Fatty Acid) Supplementation With Therapeutic Lifestyle Changes Diet Associated With Lipidic Profile in HIV-positive Patients With Antiretroviral Therapy.|Completed||Phase 3|200|Actual|Instituto Mexicano del Seguro Social||5|||f||||t||||||||||2017-10-10 22:58:30.048567|2017-10-10 22:58:30.048567
NCT02537223|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-06-21|||September 2015||2015-09-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer|Phase I Trial of BYL719 in Combination With Concurrent Cisplatin-based Chemoradiotherapy in Patients With Locoregionally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN)|Recruiting||Phase 1|36|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 22:58:30.214842|2017-10-10 22:58:30.214842
NCT02537210|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-04-25|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|August 2022|Anticipated|2022-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis|Oral 5-aminosalicylic Acid Withdrawal in Long Standing Inactive Ulcerative Colitis: A Double-blind, Randomized, Placebo-controlled Trial|Recruiting||N/A|194|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-10 22:58:30.325786|2017-10-10 22:58:30.325786
NCT02537197|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-11-21|||April 2016||2016-04-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Regular Naltrexone Dosing on Disordered Gamblers|The Effect of Regular Naltrexone Dosing on Disordered Gamblers: An Examination of Neural Activation, Gambling Urges, and Gambling Behaviour|Recruiting||Phase 1|55|Anticipated|University of Calgary||1|||f||||t||||||||No||2017-10-10 22:58:30.433953|2017-10-10 22:58:30.433953
NCT02537184|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-09-02|||September 2014||2014-09-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Impact of Two Recall Intervals on Dental Caries Incidence and Other Outcomes of Preschool Children|Impact of Two Recall Intervals Associated to Oral Health Counseling on Dental Caries Incidence, Anxiety and Quality of Life of Preschool Children With High Caries Risk: Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|224|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 22:58:30.556813|2017-10-10 22:58:30.556813
NCT02537171|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-08-01|||July 2015||2015-07-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer|Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer: A Randomized, Parallel, Controlled Study|Unknown status|Recruiting|Phase 3|40|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-10 22:58:30.66286|2017-10-10 22:58:30.66286
NCT02537158|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2016-03-13|||August 2015||2015-08-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection|Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection:a Non-randomized Controlled Trial|Recruiting||N/A|90|Anticipated|Chinese Academy of Medical Sciences||3|||f||||t||||||||||2017-10-10 22:58:30.770127|2017-10-10 22:58:30.770127
NCT02536963|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-09-26|||January 2016||2016-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Quality Vision Outcomes in Managed Care Setting While Reducing Cost by Use of Accurate, Automated Screening|Amblyopia and Strabismus Testing in Pediatrics|Recruiting||N/A|340|Anticipated|Rebiscan, Inc.||2|||f||||t||||||||||2017-10-10 22:58:34.542781|2017-10-10 22:58:34.542781
NCT02536950|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2017-02-09|||August 2015||2015-08-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas|An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas|Completed||N/A|16|Actual|Stanford University||3|||f||||t||||||||No||2017-10-10 22:58:34.62816|2017-10-10 22:58:34.62816
NCT02537132|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-02-07|||January 2015||2015-01-01|July 2016|2016-07-01||||April 2016|Actual|2016-04-01||Interventional|||"New Perspectives of Adaptation to NIV in ALS"|"New Perspectives of Adaptation to Non-Invasive Ventilation (NIV) in Amyotrophic Lateral Sclerosis (ALS)"|Recruiting||N/A|48|Anticipated|Fondazione Don Carlo Gnocchi Onlus||2|||f||||||||||||||2017-10-10 22:58:30.989422|2017-10-10 22:58:30.989422
NCT02537119|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-01-26|||May 2015||2015-05-01|September 2015|2015-09-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||Massage Therapy on Hamstrings in Patients With Nonspecific Low Back Pain|Massage Therapy on Hamstrings in Patients With Nonspecific Low Back Pain|Completed||N/A|20|Actual|Cardenal Herrera University||2|||f||||t||||||||Undecided||2017-10-10 22:58:31.10787|2017-10-10 22:58:31.10787
NCT02537106|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-06-01|||September 2015||2015-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation|A Comparison of the Effect of 1.5% Versus 3% NaCl on Brain Relaxation and Microcirculation During the Supratentorial Brain Tumor Surgery, and Natremia and Ssmolarity in Postoperative Period|Recruiting||N/A|200|Anticipated|University Hospital Hradec Kralove||2|||f||||f||||||||||2017-10-10 22:58:31.220781|2017-10-10 22:58:31.220781
NCT02537093|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-07-07|||August 2015||2015-08-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||﻿﻿Pilot Study of Asynchronous and Synchronous Telepsychiatry for Skilled Nursing Facilities|﻿﻿A Pilot Study Examining Use of Asynchronous and Synchronous Telepsychiatry Consultation for Skilled Nursing Facility Residents|Completed||N/A|40|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 22:58:31.323483|2017-10-10 22:58:31.323483
NCT02537080|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-10-15|||September 2015||2015-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Nimodipine on the Postoperative Cognitive Dysfunction|The Effect of Nimodipine in the Preoperative Period on the Onset of Postoperative Cognitive Dysfunction in Adults|Terminated||N/A|15|Actual|University Hospital Hradec Kralove||2||higher POCD in nimodipine Group|f||||f||||||||||2017-10-10 22:58:31.476713|2017-10-10 22:58:31.476713
NCT02537067|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-28|||January 2010||2010-01-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle|A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle for 18 Months|Unknown status|Active, not recruiting|Phase 3|28|Actual|Sewon Cellontech Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:58:31.579831|2017-10-10 22:58:31.579831
NCT02537054|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-09-18|||September 2015||2015-09-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|EyNeP||Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)|Intravitreal Aflibercept (Eylea) for Therapy of Choroidal Neovascularization (CNV) and Fibrovascular Proliferation (FVP) in Patients With Pseudoxanthoma Elasticum (PXE)|Recruiting||Phase 2|20|Anticipated|University Hospital, Bonn||1|||f||||f||||||||||2017-10-10 22:58:31.698657|2017-10-10 22:58:31.698657
NCT02537041|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-04-06|||September 2015||2015-09-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Interventional|Elasto-Cardio||Non-invasive Evaluation of Myocardial Stiffness by Elastography|Non-invasive Evaluation of Myocardial Stiffness by Elastography in the Elderly Suffering From Isolated Diastolic Heart Failure: New Diagnostic Tool?|Recruiting||N/A|100|Anticipated|French Cardiology Society||3|||f||||f||||||||||2017-10-10 22:58:31.816061|2017-10-10 22:58:31.816061
NCT02537015|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-02-15||2017-02-14|August 2015||2015-08-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|OLE2||An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert|An Open-label Extension (OLE 2) Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert in Subjects With Open-angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-004|Completed||Phase 1/Phase 2|81|Actual|ForSight Vision5, Inc.||1|||f||||f||||||||||2017-10-10 22:58:32.053561|2017-10-10 22:58:32.053561
NCT02537002|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-04-28|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Single Dose Study of PF-05230907 in Healthy Japanese Subjects|A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo-controlled, Single Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of An Intravenous Bolus Infusion Pf-05230907 In Healthy Japanese Subjects|Completed||Phase 1|17|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 22:58:32.163152|2017-10-10 22:58:32.163152
NCT02536989|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-06|2016-02-05|||March 2009||2009-03-01|August 2010|2010-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot|Comparison of High Dose Infusion and Low Dose Bolus Intravenous Omeprazole for Treatment of Bleeding Ulcer With Adherent Clot|Completed||Phase 4|40|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-10 22:58:32.268969|2017-10-10 22:58:32.268969
NCT02536976|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-10-25|||December 2015||2015-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|MICT-PD||Mirabegron in Parkinson Disease and Impaired Cognition|A Clinical Trial of Mirabegron for Overactive Bladder Symptoms in Patients With Parkinson Disease and Impaired Cognition|Recruiting||Phase 4|30|Anticipated|HealthPartners Institute||2|||f||||t||||||||No||2017-10-10 22:58:32.381887|2017-10-10 22:58:32.381887
NCT02536937|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-03-07|||September 2015||2015-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate|An Open-label Two-stage Pharmacokinetic and Tolerability Study of Eliglustat Tartrate Given as a Single Dose in Subjects With Mild, Moderate and Severe Renal Impairment, and in Matched Subjects With Normal Renal Function|Completed||Phase 1|32|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 22:58:34.733294|2017-10-10 22:58:34.733294
NCT02536924|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-29|2015-08-29|||August 2015||2015-08-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|RESOLVE||RCT of RESOLVE: A Waiting Room Intervention for Crisis Clients|Randomized Control Trial of RESOLVE (Relaxation Exercise, SOLving Problem and cognitiVe Errors): A Waiting Room Intervention for Crisis Clients|Unknown status|Recruiting|N/A|140|Anticipated|Queen's University||2|||f||||t||||||||||2017-10-10 22:58:34.837533|2017-10-10 22:58:34.837533
NCT02536911|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-02-09|||September 2015||2015-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study of the Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate|An Open-label Pharmacokinetic and Tolerability Study of Eliglustat Tartrate Given as a Single Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function|Completed||Phase 1|24|Actual|Sanofi||3|||f||||f||||||||||2017-10-10 22:58:34.944296|2017-10-10 22:58:34.944296
NCT02536898|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-08-31|||May 2015||2015-05-01|August 2015|2015-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|NoFRACT||Norwegian Capture the Fracture Initiative|Norwegian Capture the Fracture Initiative|Recruiting||N/A|87000|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 22:58:35.044864|2017-10-10 22:58:35.044864
NCT02536885|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-06-01|||September 2015||2015-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Blood Pressure on the Postoperative Cognitive Dysfunction|The Effect of the Perioperative Blood Pressure on the Onset of Postoperative Cognitive Dysfunction in Adults|Recruiting||N/A|100|Anticipated|University Hospital Hradec Kralove||2|||f||||f||||||||||2017-10-10 22:58:35.184806|2017-10-10 22:58:35.184806
NCT02536872|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-10-13|||October 2015||2015-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|||A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder|An Observational Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder|Completed||N/A|25|Actual|Medway NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 22:58:35.28183|2017-10-10 22:58:35.28183
NCT02536846|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-03-21|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|||The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals|The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals|Not yet recruiting||Phase 4|30|Anticipated|Mclean Hospital||1|||f||||f||||||||||2017-10-10 22:58:35.581707|2017-10-10 22:58:35.581707
NCT02536833|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-04-25|||August 2015||2015-08-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects|Active, not recruiting||Phase 2|445|Anticipated|Samumed LLC||4|||f||||f||||||||||2017-10-10 22:58:35.732913|2017-10-10 22:58:35.732913
NCT02536820|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-08-31|||September 2015||2015-09-01|August 2015|2015-08-01||||September 2016|Anticipated|2016-09-01||Interventional|PNIT||Psychoneuroimmunology Therapy in Uncontrolled Diabetic Patients: A Quasi-experimental Study||Unknown status|Not yet recruiting|Phase 3|500|Anticipated|Fundación Salutia||2|||f||||t||||||||||2017-10-10 22:58:35.901301|2017-10-10 22:58:35.901301
NCT02536807|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-09-17|||August 2014||2014-08-01|September 2015|2015-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Minimally Invasive Volume Augmentation of Papillae Around Implant Restorations With Hyaluronic Acid Injection|Minimally Invasive Volume Augmentation of Papillae Around Implant Restorations With Hyaluronic Acid Injection. A Randomized Controlled Clinical Trial With 6 Months Follow-up|Completed||N/A|22|Actual|Malmö University||2|||f||||f||||||||||2017-10-10 22:58:35.987523|2017-10-10 22:58:35.987523
NCT02536794|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-09-29|||December 2015||2015-12-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|||MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer|A Single Arm Phase II Study Evaluating the Efficacy and Safety of MEDI4736 in Combination With Tremelimumab in Patients With Metastatic Her2 Negative Breast Cancer|Suspended||Phase 2|30|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 22:58:36.082451|2017-10-10 22:58:36.082451
NCT02536781|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2017-04-20|2016-03-01||August 2015||2015-08-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment|Khon Kaen University Ethics Committee in Human Research|Completed||Phase 2/Phase 3|70|Actual|Khon Kaen University||2|||f||||t||||||||||2017-10-10 22:58:36.233042|2017-10-10 22:58:36.233042
NCT02536768|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-07-11|||September 2015||2015-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|ENHANCE||Evaluation of South Africa's National Adherence Strategy|Evaluation of the National Department of Health's National Adherence Guidelines for Chronic Diseases in South Africa Using Routinely Collected Data|Recruiting||N/A|8256|Anticipated|Boston University||2|||f||||t|f|f||||||||2017-10-10 22:58:36.617371|2017-10-10 22:58:36.617371
NCT02535611|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2015-08-28|||October 2015||2015-10-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|EMISO||Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome||Unknown status|Not yet recruiting|Phase 3|100|Anticipated|Mazandaran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:58:50.421539|2017-10-10 22:58:50.421539
NCT02536755|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-07-13|||October 28, 2015|Actual|2015-10-28|July 2017|2017-07-01|June 22, 2021|Anticipated|2021-06-22|June 22, 2021|Anticipated|2021-06-22||Interventional|EXOSKEL||Skeletal Response to Eliglustat in Patients With Gaucher Disease|Open Label Interventional Multicenter Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Successfully Completed the Phase 2 or Phase 3 Studies|Enrolling by invitation||Phase 3|40|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-10 22:58:36.755579|2017-10-10 22:58:36.755579
NCT02536742|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-04-21|||May 2016||2016-05-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|PYTHIA||Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer|A Phase II Study of Palbociclib Plus Fulvestrant for Pretreated Patients With ER+/HER2- Metastatic Breast Cancer|Recruiting||Phase 2|120|Anticipated|International Breast Cancer Study Group||1|||f||||t|f|f||||||No||2017-10-10 22:58:36.876261|2017-10-10 22:58:36.876261
NCT02536729|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-08-31|||September 2015||2015-09-01|August 2015|2015-08-01||||June 2016|Anticipated|2016-06-01||Observational|||Evaluation of the Quality of Life of Patients Requiring Intestinal Cleansing Using Oral Medications to Imaging Procedure by Patient Reported Outcome||Unknown status|Not yet recruiting|N/A|600|Anticipated|Fundación Salutia|||3||f||||f||||||||||2017-10-10 22:58:37.150723|2017-10-10 22:58:37.150723
NCT02536716|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2016-06-17|||August 2015||2015-08-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing|The Effect of Platform-Matching Versus Platform-Switching Using Standard Internal Versus Tapered Internal Plus Dental Implants on Peri-implant Hard and Soft Tissue Healing|Recruiting||Phase 4|30|Anticipated|University of Louisville||2|||f||||t||||||||||2017-10-10 22:58:37.250434|2017-10-10 22:58:37.250434
NCT02536703|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-08-27|||September 2015||2015-09-01|August 2015|2015-08-01|December 2020|Anticipated|2020-12-01|December 2015|Anticipated|2015-12-01||Interventional|LOTUS-CHINA||Safety and Efficacy of Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population|LOTUS-CHINA: Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation In Patients With Severe Aortic Stenosis In Chinese Population|Not yet recruiting||Phase 3|20|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||1|||f||||t||||||||||2017-10-10 22:58:37.363089|2017-10-10 22:58:37.363089
NCT02536690|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-05-31|||August 2015||2015-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Remifentanil and Midazolam on Propofol for Loss of Consciousness|The Effect of Remifentanil and Midazolam on Propofol for Loss of Consciousness During Induction of Anesthesia|Completed||N/A|120|Actual|Severance Hospital||3|||f||||t||||||||||2017-10-10 22:58:37.469032|2017-10-10 22:58:37.469032
NCT02536677|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-05-10|||January 2016||2016-01-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|1 Month|Observational [Patient Registry]|EMPACT||The Evaluation and Management of Patients With Acute Chest Pain in China|The Evaluation and Management of Patients With Acute Chest Pain in China|Recruiting||N/A|10000|Anticipated|Qilu Hospital of Shandong University|||1||f||||f||||||||||2017-10-10 22:58:37.796007|2017-10-10 22:58:37.796007
NCT02536664|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-10-07|2015-10-07||September 2009||2009-09-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational||Reduced Safety Set Overall (rSSO): Included participants who received at least 1 dose of study drug during the maintenance therapy with adequate completion of documentation (primary data lock).|Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants|RIM - Rituximab in Maintenance|Completed||N/A|505|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-10 22:58:37.961401|2017-10-10 22:58:37.961401
NCT02536651|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2017-08-14|||September 2014||2014-09-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Reliability and Validity of the Finnish Visual Analogue Scale Foot and Ankle and the Lower Extremity Functional Scale|Reliability and Validity of the Finnish Versions of the Visual Analogue Scale Foot and Ankle and the Lower Extremity Functional Scale|Completed||N/A|120|Actual|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 22:58:38.967527|2017-10-10 22:58:38.967527
NCT02536638|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2015-08-28|||July 2015||2015-07-01|August 2015|2015-08-01||||February 2017|Anticipated|2017-02-01||Observational|||Proteinuria During Acute Pyelonephritis In Pregnancy|Quantitating Proteinuria During Acute Pyelonephritis In Pregnancy|Unknown status|Recruiting|N/A|48|Anticipated|MemorialCare Health System|||2||f||||t||||||Samples With DNA|"     urine collection for 24 hour urine protein and creatinine analysis urine sample for     urinalysis with microscopy and culture blood for measurement of serum creatinine   "|||2017-10-10 22:58:39.069306|2017-10-10 22:58:39.069306
NCT02536625|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-08-17|||October 2015||2015-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|RAPANK||Study of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)|RAPANK: Study of the Impact of Everolimus Treatment on the Development and Functions of Lymphocytes NK (Natural Killer), for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)|Recruiting||N/A|36|Anticipated|Centre Leon Berard|||1||f||||f||||||||||2017-10-10 22:58:39.220555|2017-10-10 22:58:39.220555
NCT02536612|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-08-02|||May 2015||2015-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|EN||Empower, Nudge: Increasing Dual Protection in South Africa|Empower, Nudge: Increasing Dual Protection Among Young Women in South Africa|Completed||N/A|100|Actual|Brown University||2|||f||||f||||||||||2017-10-10 22:58:39.335338|2017-10-10 22:58:39.335338
NCT02536599|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-02-24|||October 2015||2015-10-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Observational|||Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia|Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia|Recruiting||N/A|360|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 22:58:39.469499|2017-10-10 22:58:39.469499
NCT02536586|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-08-18|||September 2015||2015-09-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Study of LY3023414 in Japanese Participants With Advanced Cancer|A Phase 1 Study of LY3023414 in Japanese Patients With Advanced Malignancies|Recruiting||Phase 1|12|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 22:58:39.571245|2017-10-10 22:58:39.571245
NCT02535598|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-05-12|||May 2014||2014-05-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||Therapy Labs: To Improve Adherence in Internet Based Psychotherapy|Therapy Labs: To Improve Adherence in Internet Based Psychotherapy|Completed||N/A|169|Actual|Uppsala University||4|||f||||f||||||||||2017-10-10 22:58:50.572004|2017-10-10 22:58:50.572004
NCT02536573|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-07-14|||December 2016||2016-12-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Total Hip Arthroplasty Using Radlink Surgical Positioning Software|Prospective, Randomized Study to Evaluate Total Hip Arthroplasty With and Without Radlink Surgical Positioning Software|Enrolling by invitation||N/A|200|Anticipated|Anderson Orthopaedic Research Institute||2|||f||||f||||||||||2017-10-10 22:58:39.707473|2017-10-10 22:58:39.707473
NCT02536560|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-28|||January 2012||2012-01-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Observational|INCA||Intestinal Microbiota Composition After Antibiotic Treatment in Early Life|"Intestinal Microbiota Composition After Antibiotic Treatment in Early Life. The INCA Study"|Unknown status|Recruiting|N/A|450|Anticipated|Agentschap NL|||2||f||||f||||||Samples With DNA|"     faecal samples   "|||2017-10-10 22:58:39.788592|2017-10-10 22:58:39.788592
NCT02536547|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-27|||June 2013||2013-06-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|PAVM||Diagnostic Value of Pulmonary Ultrasound in the Diagnosis of Ventilator-associated Pneumoniae|Diagnostic Value of Pulmonary Ultrasound in the Diagnosis of Ventilator-associated Pneumoniae|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||None Retained|"     biochemistry : procalcitonin, leukocytes, neutrophils      microbiology : bronchoalveolar lavage and tracheal aspiration   "|||2017-10-10 22:58:39.936047|2017-10-10 22:58:39.936047
NCT02536534|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-01-10|||June 2015||2015-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|e-MOTION PH||Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension|(e-MOTION PH) Electronic - Activity Level Monitoring Pilot in Pulmonary Hypertension|Completed||N/A|35|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:58:40.030944|2017-10-10 22:58:40.030944
NCT02536521|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-06-14|||August 2015||2015-08-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|Lapa-BP||Predictive Variables of the Hemodynamic Effect During the Laparoscopic Surgery in Children|Study on the Predictive Variables Able to Predict the Hemodynamic Effect of Intra-abdominal Pressure in the Children Undergoing Laparoscopic Surgery|Completed||N/A|123|Actual|Seoul National University Hospital|||2||f||||t||||||||||2017-10-10 22:58:40.131554|2017-10-10 22:58:40.131554
NCT02536508|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-06-14|||September 22, 2015|Actual|2015-09-22|May 2017|2017-05-01|September 6, 2017|Anticipated|2017-09-06|September 6, 2017|Anticipated|2017-09-06||Interventional|||Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease|A Randomized, Double-Blind, Parallel-Group, 52-Week, Chronic-Dosing, Multi-Center Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease|Recruiting||Phase 3|500|Anticipated|Pearl Therapeutics, Inc.||3|||f||||t|t|f|||f|||Yes||2017-10-10 22:58:40.220987|2017-10-10 22:58:40.220987
NCT02536495|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-10-28|||September 2015||2015-09-01|October 2015|2015-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer|An Investigator-Sponsored Phase 1/2 Study of Selinexor (KPT-330) and Docetaxel as Second Line Therapy in Patients With Relapsed Squamous Cell Lung Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|Ohio State University Comprehensive Cancer Center||1||PI decision due to funding support|f||||t||||||||||2017-10-10 22:58:40.473573|2017-10-10 22:58:40.473573
NCT02536482|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-28|||August 2013||2013-08-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||Free Amino Acid-based Formula to Treat Children Cow's Milk Protein Allergy|Tolerability to a New Free Amino Acid-based Formula in Children With Cow's Milk Protein Allergy|Completed||Phase 2|15|Actual|Edetec Indústria Alimentícia S.A.||1|||f||||t||||||||||2017-10-10 22:58:40.800023|2017-10-10 22:58:40.800023
NCT02536469|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2017-02-01|||August 2015||2015-08-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors|A Phase Ib, Dose Escalation, Multiple Dose Trial With HuMax-IL8 in Patients With Metastatic or Unresectable, Locally Advanced Malignant Solid Tumors|Completed||Phase 1|15|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 22:58:40.914328|2017-10-10 22:58:40.914328
NCT02536456|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-07-21|||July 2014||2014-07-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||China PEACE Millions Persons Project|China PEACE Millions Persons Project|Recruiting||N/A|4000000|Anticipated|China National Center for Cardiovascular Diseases|||1||f||||t||||||Samples With DNA|"     For each high-risk subject, a 6mL whole blood sample is collected in an EDTA vacuum tube.A     10mL urine sample is also collected.   "|||2017-10-10 22:58:41.015987|2017-10-10 22:58:41.015987
NCT02536443|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2017-04-24|||January 2009||2009-01-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01|1 Year|Observational [Patient Registry]|COMMIT-HF||Contemporary Modalities in Treatment of Heart Failure|Contemporary Modalities in Treatment of Heart Failure|Recruiting||N/A|4000|Anticipated|Silesian Centre for Heart Diseases|||1||f||||f||||||||||2017-10-10 22:58:41.1136|2017-10-10 22:58:41.1136
NCT02536430|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-09-01|||March 2015||2015-03-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy of Ketorolac Buccal Infiltration on Success Rate of Inferior Alveolar Nerve Block|Efficacy of Ketorolac Buccal Infiltration on Success Rate of Inferior Alveolar Nerve Block in Patients With Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial|Completed||Phase 2|40|Actual|Azad University of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:58:41.228513|2017-10-10 22:58:41.228513
NCT02536417|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-01|||June 29, 2016|Actual|2016-06-29|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients|Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients: A Randomized Double-blinded Placebo Controlled Pilot Study|Recruiting||Phase 3|50|Anticipated|Fraser Health||2|||f||||||||||||||2017-10-10 22:58:41.34379|2017-10-10 22:58:41.34379
NCT02536404|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-09-06|||November 2015||2015-11-01|September 2017|2017-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis||Recruiting||Phase 2|180|Anticipated|Arena Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:58:41.511478|2017-10-10 22:58:41.511478
NCT02536222|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-09-13|||September 2015||2015-09-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts|Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts|Completed||Phase 4|20379|Actual|PATH||2|||f||||f||||||||||2017-10-10 22:58:44.582311|2017-10-10 22:58:44.582311
NCT02536391|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-11-01|||October 2015||2015-10-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects|A Phase 1, Single-Dose, Randomized, Cross-Over, Relative Bioavailability, and Food Effect Study of Ipatasertib (GDC-0068) in Healthy Subjects|Completed||Phase 1|18|Actual|Genentech, Inc.||6|||f||||||||||||||2017-10-10 22:58:41.850152|2017-10-10 22:58:41.850152
NCT02536378|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-06-12|||September 2015||2015-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01|30 Days|Observational [Patient Registry]|||POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE|POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE. The ROADSTER 2 Study.|Recruiting||N/A|600|Anticipated|Silk Road Medical|||1||f||||f||||||||||2017-10-10 22:58:41.97544|2017-10-10 22:58:41.97544
NCT02536365|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-04-12|||September 2015||2015-09-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|December 2019|Anticipated|2019-12-01||Interventional|||Sensory Integration Therapy in Autism: Mechanisms and Effectiveness|Sensory Integration Therapy in Autism: Mechanisms and Effectiveness|Recruiting||N/A|180|Anticipated|Albert Einstein College of Medicine, Inc.||3|||f||||f||||||||No|We will not be sharing IPD|2017-10-10 22:58:42.32692|2017-10-10 22:58:42.32692
NCT02536352|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-07|||October 2015||2015-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being|Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being|Recruiting||Early Phase 1|1500|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||||2017-10-10 22:58:42.466883|2017-10-10 22:58:42.466883
NCT02536339|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-07-18|||December 16, 2015|Actual|2015-12-16|July 2017|2017-07-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|||Pertuzumab With High-Dose Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy|An Open-Label, Single-Arm, Phase II Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Central Nervous System Progression Post-Radiotherapy in Patients With HER2-Positive Metastatic Breast Cancer (PATRICIA)|Active, not recruiting||Phase 2|40|Actual|Genentech, Inc.||1|||f|||||t|f||||||||2017-10-10 22:58:42.605014|2017-10-10 22:58:42.605014
NCT02536326|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2015-08-31|||November 2012||2012-11-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|LEPU-RDN||LEPU Renal Denervation System for Resistant Hypertension|LEPU Renal Denervation System for Resistant Hypertension in Chinese Populations|Completed||Phase 3|50|Actual|Lepu Medical Technology (Beijing) Co., Ltd.||1|||f||||t||||||||||2017-10-10 22:58:42.768855|2017-10-10 22:58:42.768855
NCT02536313|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-08-16|2017-08-16|2016-05-23|July 29, 2015|Actual|2015-07-29|August 2017|2017-08-01|June 28, 2016|Actual|2016-06-28|March 28, 2016|Actual|2016-03-28||Interventional||Safety Analysis Set: participants who took at least 1 dose of study drug|Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen|A Phase 2, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/GS-5816/GS-9857 Fixed-Dose Combination With or Without Ribavirin in Subjects With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen|Completed||Phase 2|49|Actual|Gilead Sciences||2|||f||||f|t|f||||||||2017-10-10 22:58:42.875716|2017-10-10 22:58:42.875716
NCT02536300|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-28|||January 14, 2016|Actual|2016-01-14|September 2017|2017-09-01|May 2023|Anticipated|2023-05-01|August 2021|Anticipated|2021-08-01||Interventional|||Dose Optimization Study of Idelalisib in Follicular Lymphoma|Dose Optimization Study of Idelalisib in Follicular Lymphoma|Recruiting||Phase 3|240|Anticipated|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 22:58:43.48546|2017-10-10 22:58:43.48546
NCT02536287|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2015-08-26|||September 2015||2015-09-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Total Parathyroidectomy With and Without Autotransplantation|Comparison of Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Without Autotransplantation:A Randomized Clinical Trial|Not yet recruiting||Phase 3|96|Anticipated|The Second Hospital of Anhui Medical University||2|||f||||t||||||||||2017-10-10 22:58:43.876115|2017-10-10 22:58:43.876115
NCT02536274|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-26|||September 2015||2015-09-01|August 2015|2015-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||"Examination of the Impact of a Dynamic Flexion Orthosis (Dynaflex®Ottobock) or of a Back Bandage (Lumbo Sensa®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Back Pain"|"Examination of the Impact of a Dynamic Flexion Orthosis (Dynaflex®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Low Back Pain and Examination of the Impact of a Back Bandage (Lumbo Sensa®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Low Back Pain"|Unknown status|Not yet recruiting|N/A|80|Anticipated|RWTH Aachen University||4|||f||||f||||||||||2017-10-10 22:58:44.033024|2017-10-10 22:58:44.033024
NCT02536261|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2017-05-15|||June 2016|Actual|2016-06-01|May 2017|2017-05-01||||December 2019|Anticipated|2019-12-01|2 Years|Observational [Patient Registry]|||Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus|Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus|Recruiting||N/A|30|Anticipated|Ruijin Hospital|||2||f||||t||||||Samples With DNA|"     Whole blood; urine; tumor specimens (if possible)   "|Undecided|The individual patient Data would not be shared to the third facility, but the sponsor hasn't decided whether to share the individual patient date to the other related studies hold by himself in the future.|2017-10-10 22:58:44.219542|2017-10-10 22:58:44.219542
NCT02536248|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-05-03|||August 1, 2015|Actual|2015-08-01|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Sitagliptin Therapy and Kinetics of Inflammatory Markers|EFFECTS OF SITAGLIPTIN THERAPY ON THE KINETICS OF MARKERS OF LOW-GRADE INFLAMMATION AND CELL ADHESION MOLECULES IN PATIENTS WITH TYPE 2 DIABETES|Active, not recruiting||Phase 3|22|Actual|Laval University||2|||f||||t||||||||||2017-10-10 22:58:44.374813|2017-10-10 22:58:44.374813
NCT02536235|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-09-27|||July 2015||2015-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|HAPPE||Applied Topical Heat as an Adjunct for Pain Control in First-Trimester Surgical Abortionl|Applied Topical Heat as an Adjunct for Pain Control in First-Trimester Surgical Abortion: A Randomized Controlled Trial|Completed||N/A|120|Actual|Planned Parenthood of New York City, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:58:44.491186|2017-10-10 22:58:44.491186
NCT02536196|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-05-02|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation|A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation|Recruiting||N/A|285|Anticipated|Keystone Heart||2|||f||||f||||||||||2017-10-10 22:58:44.821733|2017-10-10 22:58:44.821733
NCT02536183|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-02-14|||October 2016||2016-10-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors|A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin (LTLD, ThermoDox®) and Magnetic Resonance-Guided High Intensity Focused Ultrasound (MR-HIFU) for Relapsed or Refractory Solid Tumors in Children, Adolescents, and Young Adults|Recruiting||Phase 1|34|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-10 22:58:45.121492|2017-10-10 22:58:45.121492
NCT02536170|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-04-21|||February 2016||2016-02-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Arginine Therapy for Sickle Cell Disease Pain|Phase 2 Randomized Control Trial of Arginine Therapy for Pediatric Sickle Cell Disease Pain|Recruiting||Phase 2|114|Anticipated|Emory University||3|||f||||t||||||||||2017-10-10 22:58:45.283212|2017-10-10 22:58:45.283212
NCT02536157|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-03-21|||July 2015||2015-07-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Volar Plate Injury: A Comparison of Two Splinting Methods|A Randomised Controlled Trial Investigating the Effectiveness of Two Splinting Methods in the Non-operative Management of Volar Plate Injuries at the Proximal Interphalangeal Joint|Recruiting||N/A|42|Anticipated|National Health Service, United Kingdom||2|||f||||f||||||||||2017-10-10 22:58:45.447941|2017-10-10 22:58:45.447941
NCT02536144|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-08-26|||August 2015||2015-08-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||The Clinical Application of MCCES in Examination of Human Colon|The Clinical Application of Magnetic-controlled Capsule Endoscopy System in Examination of Human Colon|Unknown status|Recruiting|N/A|80|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-10 22:58:45.555741|2017-10-10 22:58:45.555741
NCT02536131|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-10-04|||August 2014||2014-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Intestinal Microbiome and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease|Intestinal Microbiome and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease|Completed||N/A|80|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 22:58:45.671544|2017-10-10 22:58:45.671544
NCT02536118|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-07-21|||July 2015||2015-07-01|July 2017|2017-07-01|August 2026|Anticipated|2026-08-01|August 2026|Anticipated|2026-08-01|9 Years|Observational [Patient Registry]|||Micra Transcatheter Pacing System Post-Approval Registry|Micra Transcatheter Pacing System Post-Approval Registry|Recruiting||N/A|2450|Anticipated|Medtronic|||1||f||||f||||||||||2017-10-10 22:58:45.80649|2017-10-10 22:58:45.80649
NCT02536105|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-08-23|||May 2016||2016-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||PK/PD Pediatric ADHD Classroom Study|Pharmacokinetic Pharmacodynamic Studies of Methylphenidate Extended Release Products in Pediatric Attention Deficit Hyperactivity Disorder|Recruiting||N/A|150|Anticipated|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-10 22:58:46.250016|2017-10-10 22:58:46.250016
NCT02536092|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Prospective Multi-Center Study of a Novel Dual-Wavelength Laser for Hair Removal|A Prospective Multi-Center Study of a Novel Dual-Wavelength Laser for Hair Removal|Terminated||N/A|50|Actual|Cutera Inc.||1||Sponsor terminated study|f||||f||||||||No|Study terminated|2017-10-10 22:58:46.386491|2017-10-10 22:58:46.386491
NCT02536079|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-08-26|||June 2014||2014-06-01|August 2015|2015-08-01||||December 2017|Anticipated|2017-12-01|3 Months|Observational [Patient Registry]|NeST||NeuroAiD Safe Treatment Registry|NeuroAiD Safe Treatment Registry|Recruiting||N/A|2000|Anticipated|CHIMES Society|||1||f||||f||||||||||2017-10-10 22:58:46.479817|2017-10-10 22:58:46.479817
NCT02536066|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-08-26|||September 2010||2010-09-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Daily Physical Activity After Meals -Long Term Effects on Blood Glucose|Daily Physical Activity After Meals -Long Term Effects on Blood Glucose|Completed||N/A|40|Actual|Inland Norway University of Applied Sciences||2|||f||||f||||||||||2017-10-10 22:58:46.590814|2017-10-10 22:58:46.590814
NCT02536053|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-08-17|||December 2015||2015-12-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Observational|||Outcomes in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage|Functional Outcomes and Health Related Quality of Life in Lower Extremity Soft Tissue Sarcoma Patients After Limb Salvage: A Prospective Study|Recruiting||N/A|100|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 22:58:46.682109|2017-10-10 22:58:46.682109
NCT02536040|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2016-08-08|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Stopping Cavities Study: Diammine Silver Fluoride|Pragmatic Trial of Topical Diammine Silver Fluoride for Dental Caries Arrest|Completed||Phase 3|66|Actual|Advantage Dental Services, LLC||2|||f||||f||||||||||2017-10-10 22:58:46.769128|2017-10-10 22:58:46.769128
NCT02536027|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-26|||August 2014||2014-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of CVVH on NGAL in Septic AKI|Effect of Continuous Venovenous Hemofiltration on the Plasma Level of Neutrophil Gelatinase-associated Lipocalin in Critical Ill Patients With Septic Acute Kidney Injury|Completed||N/A|30|Actual|First People's Hospital of Chenzhou||1|||f||||t||||||||||2017-10-10 22:58:46.852368|2017-10-10 22:58:46.852368
NCT02536014|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-01-27|||August 2015||2015-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Dexmedetomidine on Heart-rate Corrected QT(QTc) Interval Prolongation During Robotic-assisted Laparoscopic Radical Prostatectomy -Randomized Blind Clinical Trial-||Completed||N/A|50|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 22:58:46.917948|2017-10-10 22:58:46.917948
NCT02535585|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-25|||November 2015||2015-11-01|August 2015|2015-08-01|November 2019|Anticipated|2019-11-01|May 2017|Anticipated|2017-05-01||Interventional|||Arthroscopic Treatment of Anterior Shoulder Dislocation Using Knotted and Knotless Anchors|Arthroscopic Treatment of Anterior Shoulder Dislocation Using Knotted and Knotless Anchors|Not yet recruiting||Phase 4|54|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:58:50.686973|2017-10-10 22:58:50.686973
NCT02536001|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-08-26|||September 2015||2015-09-01|May 2015|2015-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Prospective Randomized Study to Compare Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes|Prospective Randomized Study to Compare Anatomical, Functional and Sexual Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes While Preserving the Uterus|Not yet recruiting||N/A|100|Anticipated|Ziv Hospital||2|||f||||t||||||||||2017-10-10 22:58:46.993381|2017-10-10 22:58:46.993381
NCT02535988|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-08-28|||September 2015||2015-09-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Abscopal Effect for Metastatic Colorectal Cancer|A Phase II Study of Radiotherapy and ZADAXIN's® (Thymalfasin) Induced Abscopal Effect in Patients With Heavily Pretreated, Metastatic Colorectal Cancer|Not yet recruiting||Phase 2|29|Anticipated|Zhejiang Provincial People’s Hospital||1|||f||||t||||||||||2017-10-10 22:58:47.063654|2017-10-10 22:58:47.063654
NCT02535975|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-08-26|||December 2014||2014-12-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy||Unknown status|Recruiting|N/A|80|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 22:58:47.140888|2017-10-10 22:58:47.140888
NCT02535962|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-09-05|||October 2016||2016-10-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|PFAPA||Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA)|Effects of Probiotic Addition to Corticosteroid Treatment for PFAPA|Not yet recruiting||Phase 2|53|Anticipated|Connecticut Children's Medical Center||2|||f||||f||||||||||2017-10-10 22:58:47.228327|2017-10-10 22:58:47.228327
NCT02535949|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-07-03|||February 2016||2016-02-01|July 2017|2017-07-01||||January 2018|Anticipated|2018-01-01||Interventional|TAMPITI||Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury|Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury (TAMPITI TRIAL)|Active, not recruiting||Phase 2|150|Anticipated|Washington University School of Medicine||3|||f||||t||||||||||2017-10-10 22:58:47.323|2017-10-10 22:58:47.323
NCT02535936|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-09-28|||August 2015||2015-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy|Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy|Recruiting||N/A|15|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f||||||||||2017-10-10 22:58:47.562422|2017-10-10 22:58:47.562422
NCT02535923|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-06-07|||December 1, 2017|Anticipated|2017-12-01|June 2017|2017-06-01|November 1, 2020|Anticipated|2020-11-01|June 1, 2020|Anticipated|2020-06-01||Interventional|CBT-I||CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes|CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes|Not yet recruiting||N/A|60|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 22:58:47.697815|2017-10-10 22:58:47.697815
NCT02535910|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-09-23|||August 2015||2015-08-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of vitaminD3 or 25(OH)D3 Fortified Dairy on Vitmain D Status and CVD Risk Markers|Fortification of Milk and Butter With Either vitaminD3 or 25(OH)D3: The Effect on Vitamin D Status and Cardiovascular Disease Risk Markers in Humans|Unknown status|Enrolling by invitation|N/A|18|Anticipated|University of Reading||3|||f||||t||||||||||2017-10-10 22:58:47.825097|2017-10-10 22:58:47.825097
NCT02535897|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-08-28|||July 2013||2013-07-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|||Protein Ingestion and Muscle Carnitine Uptake|The Effects of an Insulinotropic Protein-carbohydrate Beverage on L- Carnitine Absorption and Muscle Carnitine Uptake|Completed||Phase 1|7|Actual|University of Nottingham||3|||f||||f||||||||||2017-10-10 22:58:47.934903|2017-10-10 22:58:47.934903
NCT02535884|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-20|||July 2014||2014-07-01|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|June 30, 2020|Anticipated|2020-06-30||Interventional|HD-DBS||Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)|Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD): A Prospective, Randomised, Controlled, International, Multi-centre Study|Recruiting||N/A|50|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-10-10 22:58:48.025083|2017-10-10 22:58:48.025083
NCT02535871|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-09-11|||September 2015||2015-09-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris|A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris|Unknown status|Not yet recruiting|Phase 3|800|Anticipated|Valeant Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:58:48.209707|2017-10-10 22:58:48.209707
NCT02535858|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-26|||November 2007||2007-11-01|August 2015|2015-08-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Interventional|||Virtual Environment With Biofeedback to Promote Awareness of Relapse Risk Among Chemically Dependent Individuals|Virtual Environment With Biofeedback to Promote Awareness of Relapse Risk Among Chemically Dependent Individuals|Completed||N/A|80|Actual|University of Mogi das Cruzes||2|||f||||t||||||||||2017-10-10 22:58:48.297417|2017-10-10 22:58:48.297417
NCT02535845|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-08-28|||May 2017||2017-05-01|August 2015|2015-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial|Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination|Not yet recruiting||N/A|95|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 22:58:48.383921|2017-10-10 22:58:48.383921
NCT02535832|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-05-09|||September 2015||2015-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)|Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)|Recruiting||Phase 1|36|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 22:58:48.487143|2017-10-10 22:58:48.487143
NCT02535819|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-09-18|||June 2015||2015-06-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PERCEPOLIS||Endothelial Cell Loss After Phacoemulsification Intra and Supracapsular|Endothelial Cell Loss After Phacoemulsification Intra and Supracapsular|Active, not recruiting||N/A|294|Actual|Centre Hospitalier Régional Metz-Thionville||2|||f||||f||||||||||2017-10-10 22:58:48.611917|2017-10-10 22:58:48.611917
NCT02535806|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-07-18|||July 2015||2015-07-01|July 2017|2017-07-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults|A Pilot Study of Mitoxantrone-Based Four Drug Reinduction in Combination With Bortezomib for Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma in Children and Young Adults|Terminated||Phase 2|2|Actual|Children's Mercy Hospital Kansas City||1||Funding source discontinued|f||||f|t|||||||||2017-10-10 22:58:48.706598|2017-10-10 22:58:48.706598
NCT02535793|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-04-11|||September 2014||2014-09-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|DROSOALLERG||Characterisation of Occupational Allergy to Drosophila||Completed||N/A|12|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 22:58:48.825036|2017-10-10 22:58:48.825036
NCT02535780|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-07-21|||August 2015||2015-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Transcranial Treatments in Eating Disorders|Novel Transcranial Treatments to Modulate Taste Reward and Body Perception Pathways in Eating Disorders|Terminated||N/A|1|Actual|University of Colorado, Denver||4||Study procedures and time not feasible due to patient schedule|f||||f||||||||No||2017-10-10 22:58:48.906867|2017-10-10 22:58:48.906867
NCT02535767|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-02-02|||August 2015||2015-08-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PQSAFETY||Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali|Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali|Completed||Phase 1/Phase 2|28|Actual|University of California, San Francisco||4|||f||||t||||||||||2017-10-10 22:58:48.994702|2017-10-10 22:58:48.994702
NCT02535754|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-08-26|||April 2010||2010-04-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|||Interventions to Increase Workplace Wellness|Interventions to Increase Workplace Wellness|Completed||N/A|682|Actual|University of British Columbia||3|||f||||t||||||||||2017-10-10 22:58:49.096414|2017-10-10 22:58:49.096414
NCT02535741|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-11-16|2015-09-29||October 2006||2006-10-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2013|Actual|2013-05-01||Interventional|TriathlonCR|168 cases have received the Triathlon CR total knee replacement|Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee|Clinical Outcome Study for the Triathlon CR Total Knee|Completed||N/A|168|Actual|Stryker European Operations BV||1|||f||||f||||||||||2017-10-10 22:58:49.197221|2017-10-10 22:58:49.197221
NCT02535728|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-07-01|||July 2015||2015-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|AGE||Anesthesia Geriatric Evaluation and Quality of Life After Cardiac Surgery|Anesthesia Geriatric Evaluation and the Prediction of Quality of Life in Elderly Cardiac Surgery Patients|Recruiting||N/A|560|Anticipated|St. Antonius Hospital|||1||f||||f||||||Samples Without DNA|"     Blood samples are taken directly after induction of anesthaesia.   "|||2017-10-10 22:58:49.443091|2017-10-10 22:58:49.443091
NCT02535715|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-06-15|||January 2015||2015-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)|A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)|Completed||Phase 2|10|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-10 22:58:49.523127|2017-10-10 22:58:49.523127
NCT02535689|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-28|2017-09-12|||August 25, 2015||2015-08-25|August 28, 2017|2017-08-28|May 20, 2020|Anticipated|2020-05-20|May 20, 2020|Anticipated|2020-05-20||Interventional|||Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus|Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus; a Phase Ib Clinical Trial and Associated Mechanistic Studies|Recruiting||Phase 1|38|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 22:58:49.719803|2017-10-10 22:58:49.719803
NCT02535676|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-05-10|||November 2014||2014-11-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|STARTS||Schizophrenia TreAtment With electRic Transcranial Stimulation|Treatment of Negative Symptoms of Schizophrenia With Transcranial Direct Current Stimulation (tDCS): A Randomized, Double-blinded, Sham-controlled, Clinical Trial|Recruiting||Phase 2/Phase 3|100|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:58:49.847199|2017-10-10 22:58:49.847199
NCT02535663|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-04-11|||June 2014||2014-06-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Consumption of Dairy Yogurt Enhanced Immune Function|Consumption of Dairy Yogurt With Rhamnogalacturonan in Korean Citrus Hallabong Peel Polysaccharide Enhanced Immune Function and Attenuated Inflammatory Response|Completed||Phase 2/Phase 3|120|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 22:58:49.977834|2017-10-10 22:58:49.977834
NCT02535650|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-02-20|||November 12, 2015||2015-11-12|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma|An Open Label Phase II Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma|Recruiting||Phase 2|18|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 22:58:50.0978|2017-10-10 22:58:50.0978
NCT02535637|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-08-25|||June 2010||2010-06-01|August 2015|2015-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Breastfeeding and Obesity on Offspring Body Composition|Impact of Breastfeeding and Obesity on Offspring Body Composition and Growth at Six Months of Age|Completed||N/A|37|Actual|University of Oklahoma|||1||f||||f||||||||||2017-10-10 22:58:50.235075|2017-10-10 22:58:50.235075
NCT02535624|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-25|||February 2003||2003-02-01|August 2015|2015-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures|Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures - Quasi-randomized Clinical Trial of 56 Hemodynamically Unstable Patients With Injury Severity Score ≥ 33|Completed||N/A|56|Actual|Uppsala University||2|||f||||f||||||||||2017-10-10 22:58:50.320187|2017-10-10 22:58:50.320187
NCT02535572|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-08-27|||August 2015||2015-08-01|August 2015|2015-08-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|FEAST||Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment|Focal Electrically-Administered Seizure Therapy (FEAST): Studies at Two Enrolling Sites to Further Test and Refine the Treatment|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-10 22:58:50.841057|2017-10-10 22:58:50.841057
NCT02535559|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-08-17|||September 2015||2015-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Longitudinal Evaluation of Teens Against Tobacco Use|Longitudinal Evaluation of Teens Against Tobacco Use|Completed||N/A|2290|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 22:58:50.948394|2017-10-10 22:58:50.948394
NCT02535546|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-01-31|||July 2014|Actual|2014-07-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|Helios||Seasonal Trends in Pneumococcal Carriage in COPD Patients|Characterisation of Isolates of Streptococcus Pneumoniae in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|150|Actual|Beaumont Hospital|||1||f||||f||||||Samples With DNA|"     Sputum   "|||2017-10-10 22:58:51.037555|2017-10-10 22:58:51.037555
NCT02535533|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-11-07|||January 2016||2016-01-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||SLM + Axitinib for Clear Cell RCC|A Therapeutic Trial for Safety and Preliminary Efficacy of the Combination of Axitinib and Seleniomethionine (SLM) for Adult Patients With Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)|Recruiting||Phase 1|30|Anticipated|University of Iowa||1|||f||||t||||||||||2017-10-10 22:58:51.142263|2017-10-10 22:58:51.142263
NCT02535520|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-03-28|||August 2015||2015-08-01|October 2015|2015-10-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|||Evaluation of RTVue XR With SSADA|Clinical Evaluation of RTVue XR With SSADA in Retinal Patients|Completed||N/A|155|Actual|Optovue|||1||f||||f||||||||||2017-10-10 22:58:51.260087|2017-10-10 22:58:51.260087
NCT02535507|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-08-27|||January 2015||2015-01-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer|Single Arm Phase II Clinical Trial to Investigate the Efficacy and Safety of Pyrotinib as a Single Agent in HER2 Mutation Advanced Non-small Cell Lung Cancer Patients Who Failed to Previous at Least 2nd Line Treatments|Recruiting||Phase 2|40|Anticipated|Tongji University||1|||f||||t||||||||||2017-10-10 22:58:51.305525|2017-10-10 22:58:51.305525
NCT02535494|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-10-11|||March 2014||2014-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Risks and Benefits of Naloxone Prescribing|Risks and Benefits of Overdose Education and Naloxone Prescribing to Heroin Users|Recruiting||Phase 1|700|Anticipated|New York State Psychiatric Institute||3|||f||||f||||||||||2017-10-10 22:58:51.413577|2017-10-10 22:58:51.413577
NCT02535481|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-03-10|||September 2015||2015-09-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|EPIGRAAFT||Epidermal Grafting in Wound Healing|A Multi-centre Randomised Controlled Trial to Compare Epidermal Grafting With Split Skin Grafting for Wound Healing|Recruiting||Phase 4|44|Anticipated|University College, London||2|||f||||t||||||||||2017-10-10 22:58:53.72059|2017-10-10 22:58:53.72059
NCT02535468|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-12-21|||December 2015||2015-12-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Observational|T2Bacteria||T2Bacteria Panel Pivotal Study||Recruiting||N/A|1850|Anticipated|T2 Biosystems|||2||f||||f||||||||||2017-10-10 22:58:53.855843|2017-10-10 22:58:53.855843
NCT02535455|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-27|||August 2015||2015-08-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|ACES Pilot||Acceptance and Compassion to Enhance Self-care Pilot|Development and Pilot of Positive Self-Reappraisal Emotion Regulation Intervention to Improve Self-Care Among HIV+ Substance Users|Unknown status|Not yet recruiting|Early Phase 1|20|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 22:58:53.936366|2017-10-10 22:58:53.936366
NCT02535442|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-07-01|||August 2015||2015-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Observational|||Nasal Swab Study to Explore the Nasal Microbia|An Exploratory Study to Evaluate the Microbial Consortia and the Host Inflammatory Factors Present in the Nasal Passages of Patients During Upper Respiratory Symptomology and When Healthy|Completed||N/A|42|Actual|Kimberly-Clark Corporation|||1||f||||f||||||None Retained|"     microbiota from nasal samples   "|||2017-10-10 22:58:54.032578|2017-10-10 22:58:54.032578
NCT02535429|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-08-11|||July 2015||2015-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Massage Therapy for HIV-positive People : Effects on Anxiety, Depression, Hyperventilation and Quality of Life||Completed||N/A|28|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-10 22:58:54.103589|2017-10-10 22:58:54.103589
NCT02535403|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-01-26|||August 2015||2015-08-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Internet-based Cognitive Behavioral Therapy (CBT) for Adolescents With Anxiety Disorders||Completed||N/A|70|Actual|University of Aarhus||2|||f||||||||||||||2017-10-10 22:58:54.273578|2017-10-10 22:58:54.273578
NCT02535390|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-10-27|||December 2014||2014-12-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ABCR||Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression|Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression|Recruiting||N/A|80|Anticipated|Queen's University||2|||f||||f||||||||||2017-10-10 22:58:54.350895|2017-10-10 22:58:54.350895
NCT02535377|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-09-01|||February 2015||2015-02-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Observational|||Human Sperm Markers of Cryodamage Resistance|Molecular Diagnostic of Sperm Cryoresistance of Semen Donors and Clinical Outcomes After Artificial Insemination. Optimization of Sperm Bank|Recruiting||N/A|40|Anticipated|Instituto Valenciano de Infertilidad, IVI Alicante|||2||f||||t||||||||||2017-10-10 22:58:54.43432|2017-10-10 22:58:54.43432
NCT02535364|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-06-05|||August 21, 2015|Actual|2015-08-21|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|April 26, 2017|Actual|2017-04-26||Interventional|ROCKET||Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL)|A Phase 2, Single-arm, Multicenter Trial to Determine the Efficacy and Safety of JCAR015 in Adult Subjects With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia|Terminated||Phase 2|82|Actual|Juno Therapeutics, Inc.||1||Safety reasons|f||||t||||||||||2017-10-10 22:58:54.523753|2017-10-10 22:58:54.523753
NCT02535351|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-03-21|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|TARIBO||Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery|Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery|Recruiting||Phase 3|270|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-10 22:58:54.777175|2017-10-10 22:58:54.777175
NCT02535338|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-12|||January 21, 2016|Actual|2016-01-21|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer|A Phase 1/2 Trial of Erlotinib and Onalespib Lactate in EGFR-Mutant Non-small Cell Lung Cancer|Suspended||Phase 1/Phase 2|46|Anticipated|National Cancer Institute (NCI)||1||Other - Phase I Portion Complete. Amendment pending to change study drugs|f||||f||||||||||2017-10-10 22:58:54.900255|2017-10-10 22:58:54.900255
NCT02535325|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-27|2017-09-12|||September 30, 2015|Actual|2015-09-30|September 2017|2017-09-01||||October 1, 2018|Anticipated|2018-10-01||Interventional|||Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer|A Phase I Study of Methoxyamine Combined With Chemo-radiation for Locally Advanced Non-squamous Non-small Cell Lung Cancer|Recruiting||Phase 1|15|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-10 22:58:55.007965|2017-10-10 22:58:55.007965
NCT02535299|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-09-10|||June 2016||2016-06-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Par-4；GLP-1||Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment|The Correlation Between Par-4 and Telomere-telomerase System in the New Dignosised Type 2 Diabetes Patients Who Received GLP-1 Analog or Metformin Treatment|Recruiting||Phase 4|200|Anticipated|Third Military Medical University||1|||f||||t||||||||Undecided||2017-10-10 22:58:55.326653|2017-10-10 22:58:55.326653
NCT02535286|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-04-07|||September 2015||2015-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL or Richter's Transformation|Phase I/II Study of Pembrolizumab in Combination With TG-1101 (Ublituximab) and TGR-1202 in Patients With Relapsed-refractory Chronic Lymphocytic Leukemia (CLL) or Richter's Transformation (RT)|Recruiting||Phase 1/Phase 2|12|Anticipated|TG Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 22:58:55.432121|2017-10-10 22:58:55.432121
NCT02535273|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-25|||September 2015||2015-09-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia|The Effect of Dexmedetomidine Subsidiary Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia：A Randomized, Double Blind Controlled Trial|Unknown status|Not yet recruiting|Phase 4|212|Anticipated|Tang-Du Hospital||4|||f||||f||||||||||2017-10-10 22:58:55.512451|2017-10-10 22:58:55.512451
NCT02535260|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|||Clearblue Advanced Fertility Monitor Consumer Three Cycle at Home Study|Clearblue Advanced Fertility Monitor Consumer Three Cycle at Home Study|Withdrawn||N/A|0|Actual|SPD Development Company Limited|||1|Study not started, no longer required|f||||f||||||Samples Without DNA|"     Urine samples collected throughout study   "|||2017-10-10 22:58:55.612967|2017-10-10 22:58:55.612967
NCT02535247|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-06-14|||January 5, 2016|Actual|2016-01-05|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of MK-3475 in Relapsed or Refractory Peripheral T-cell Non-Hodgkin Lymphoma|A Phase II Study to Determine Feasibility and Safety of Single Agent MK-3475 in Relapsed or Refractory Peripheral T-cell Non-Hodgkin Lymphoma|Suspended||Phase 2|24|Anticipated|Fox Chase Cancer Center||1||Study has been temporarily suspended for interim analyses|f||||t||||||||||2017-10-10 22:58:55.678272|2017-10-10 22:58:55.678272
NCT02535234|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-11-06|||April 2017||2017-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:58:55.752495|2017-10-10 22:58:55.752495
NCT02535221|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-02-24|||July 1, 2015|Actual|2015-07-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer|Randomized Trial of Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With Estrogen Receptor-Positive HER2 Negative Breast Cancer|Recruiting||Phase 3|234|Anticipated|Peking University||2|||f||||f||||||||||2017-10-10 22:58:55.791437|2017-10-10 22:58:55.791437
NCT02535208|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-10-06|||September 2016||2016-09-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|||Combining Restrictive Guidelines and a NIRS SCORE to Decrease RBC Transfusions|A Pilot Randomized Trial of Restrictive Red Blood Cell Transfusion Guidelines Used in Combination With Near-infrared Spectroscopy Splanchnic-cerebral Oxygenation Ratio Evaluations Versus Liberal Red Blood Cell Transfusion Guidelines in Preterm Infants|Recruiting||N/A|82|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 22:58:55.866899|2017-10-10 22:58:55.866899
NCT02535182|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-03-24|||August 2015||2015-08-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|May 2019|Anticipated|2019-05-01||Observational|||Pilot Study Using Propranolol To Promote Prenylation Of The Gtpase Rap1b In Hematopoietic Stem Cell Transplant Recipients|Pilot Study Using Propranolol To Promote Prenylation Of The Gtpase Rap1b In Hematopoietic Stem Cell Transplant Recipients|Recruiting||N/A|40|Anticipated|Medical College of Wisconsin|||2||f||||f||||||Samples With DNA|"     Peripheral blood mononuclear cells (PBMCs) will be isolated from the whole blood samples     collected from patients at the three designated time points (Baseline, Day -2, and Day +28).     Members of Dr. Carol Williams' laboratory (Professor, Pharmacology and Toxicology, MCW) will     conduct western blotting on the cytosolic and membrane fractions of isolated PBMCs to     determine the distribution of Rap1 in the different fractions, and the status of Rap1     prenylation in the cells.   "|||2017-10-10 22:58:56.012154|2017-10-10 22:58:56.012154
NCT02535169|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-04-27|||May 2014||2014-05-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Lifestyle-Related Health Outcomes in Prediabetes and Diabetes|Lifestyle-Related Health Outcomes in Prediabetes and Diabetes|Recruiting||N/A|200|Anticipated|Indiana University||2|||f||||f||||||||Yes|Data will be shared via presentations and publications.|2017-10-10 22:58:56.09846|2017-10-10 22:58:56.09846
NCT02535156|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2017-08-10|||January 2003||2003-01-01|August 2017|2017-08-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Schizotypal Personality Disorder Risperidone||Completed||Phase 1/Phase 2|21|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f|||||f|f||||||||2017-10-10 22:58:56.207404|2017-10-10 22:58:56.207404
NCT02535143|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-10-11|||September 2014||2014-09-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Impact of Energy Drinks on the Manual Dexterity of Final Year Dental Students|The Impact of Energy Drinks on the Manual Dexterity of Final Year Dental Students|Completed||Phase 4|60|Actual|Riyadh Colleges of Dentistry and Pharmacy||2|||f||||t||||||||No||2017-10-10 22:58:56.465658|2017-10-10 22:58:56.465658
NCT02535130|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-08-16|||August 2015||2015-08-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of Nebulization and Positive Expiratory Pressure Combination||Recruiting||N/A|15|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-10 22:58:56.592289|2017-10-10 22:58:56.592289
NCT02535117|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-08-25|||June 2015||2015-06-01|August 2015|2015-08-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC|Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Initial Partial Hepatectomy: A Multicenter Experience|Active, not recruiting||Phase 4|216|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 22:58:56.703191|2017-10-10 22:58:56.703191
NCT02535104|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2017-03-28|||February 2016||2016-02-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)|Phase II Clinical Study, Double Blinded, Multicentric, Controlled Against Placebo, in Parallel Groups, to Evaluate the Efficacy and Safety of a Topical Product Containing Ranpirnase in Genital Warts - HPV|Completed||Phase 1/Phase 2|70|Actual|Tamir Biotechnology, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:58:56.79449|2017-10-10 22:58:56.79449
NCT02535091|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-06-14|||July 2016||2016-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures|An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures|Recruiting||Phase 3|1200|Anticipated|SK Life Science||1|||f||||f||||||||||2017-10-10 22:58:56.936918|2017-10-10 22:58:56.936918
NCT02535078|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-04-12|||November 2015||2015-11-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Cutaneous Melanoma|A Phase Ib/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 in Combination With Durvalumab (MEDI4736) or Tremelimumab or the Combination of Durvalumab and Tremelimumab in Patients With Advanced Melanoma|Recruiting||Phase 1/Phase 2|225|Anticipated|Immunocore Ltd||4|||f||||t||||||||||2017-10-10 22:58:58.216702|2017-10-10 22:58:58.216702
NCT02535065|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-02-15|||August 2014||2014-08-01|February 2017|2017-02-01|January 2021|Anticipated|2021-01-01|January 23, 2017|Actual|2017-01-23||Interventional|||Zenith® Low Profile AAA Endovascular Graft|Clinical Study Plan for the Zenith® Low Profile AAA Endovascular Graft|Active, not recruiting||N/A|62|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-10 22:58:58.469952|2017-10-10 22:58:58.469952
NCT02535052|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-05-13|||July 2015||2015-07-01|May 2016|2016-05-01||||August 2017|Anticipated|2017-08-01||Observational|SONIC||Investigating the Immune System in chrONIC Kidney Disease.|Investigating the Immune System in chrONIC Kidney Disease - the SONIC Study.|Active, not recruiting||N/A|43|Actual|University of Birmingham|||2||f||||f||||||Samples With DNA|"     Serum, Plasma, Peripheral Blood Mononuclear Cells, Urine   "|||2017-10-10 22:58:58.683955|2017-10-10 22:58:58.683955
NCT02535039|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-12-19|||October 2015||2015-10-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Methylprednisolone Combined Electric-acupuncture on Cognitive Function|Methylprednisolone Combined Electric-acupuncture Treatment Effects on Cognitive Function After Surgery for Elderly Patients With General Anesthesia|Recruiting||Phase 1/Phase 2|80|Anticipated|Shengjing Hospital||2|||f||||t||||||||||2017-10-10 22:58:58.820941|2017-10-10 22:58:58.820941
NCT02535026|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-02-24|2017-02-24||July 2011||2011-07-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational||All participants were included.|An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants|Epidemiological, Prospective and Observational Study on the HER2 Status in Breast Invasive Carcinomas Assessed by Immunohistochemistry (IHC) and Silver In-situ Hybridization (SISH) in a Sample of Latin-American Patients|Completed||N/A|580|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:58:58.990646|2017-10-10 22:58:58.990646
NCT02535013|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-12-23|||August 2015||2015-08-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|LUS||Intraoperative Lung Ultrasound in Pediatric Patients|Benefit of Intraoperative Lung Ultrasound in Pediatric Patients Undergoing Cardiac Surgery|Completed||N/A|122|Actual|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 22:59:00.254631|2017-10-10 22:59:00.254631
NCT02535000|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2016-04-13|||January 2014||2014-01-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery|Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery|Active, not recruiting||Phase 4|60|Actual|Serviço de Anestesiologia de Joinville||2|||f||||t||||||||||2017-10-10 22:59:00.370713|2017-10-10 22:59:00.370713
NCT02534987|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-08-21|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|iCPR2||Integrated Clinical Prediction Rules: Bringing Evidence to Diverse Primary Care Settings|Integrated Clinical Prediction Rules: Bringing Evidence to Diverse Primary Care Settings|Enrolling by invitation||N/A|40|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 22:59:00.490774|2017-10-10 22:59:00.490774
NCT02534974|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-03-14|||July 2015||2015-07-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|AGATE||Impact of the Addition of a Device Providing Continuous Pneumatic Regulation of Tube Cuff Pressure to an Overall Strategy Aimed at Preventing Ventilator-associated Pneumonia in the Severe Trauma Patient. A Multicentre, Randomised, Controlled Study.||Recruiting||N/A|440|Anticipated|Poitiers University Hospital|||||f||||||||||||||2017-10-10 22:59:00.596919|2017-10-10 22:59:00.596919
NCT02534961|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-08-25|||January 2015||2015-01-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prophylactic Antibiotics Before RFA for HCC|Prophylactic Administration of Antibiotics Before Radiofrequency Ablation for Hepatocellular Carcinoma: A Randomized Trial|Recruiting||Phase 4|600|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-10 22:59:00.70857|2017-10-10 22:59:00.70857
NCT02534948|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2016-07-25|||October 2015||2015-10-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|MABT||Feasibility Study of Mindfulness and Acceptance Based Group Therapy for Social Anxiety|Feasibility Study of Mindfulness and Acceptance Based Group Therapy for Females With Social Anxiety|Active, not recruiting||Phase 1|32|Anticipated|Bahria University||2|||f||||t||||||||||2017-10-10 22:59:00.82157|2017-10-10 22:59:00.82157
NCT02534935|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-10-04|||August 31, 2015|Actual|2015-08-31|October 2017|2017-10-01|February 22, 2021|Anticipated|2021-02-22|August 21, 2017|Actual|2017-08-21||Interventional|||Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.|A Phase 2, Randomized, Controlled, Observer-blinded Study, Conducted To Describe The Immunogenicity, Safety And Tolerability Of A Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent Rlp2086) When Administered To Healthy Toddlers Aged 12 To <18 Months Or 18 To <24 Months.|Recruiting||Phase 2|396|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 22:59:00.929014|2017-10-10 22:59:00.929014
NCT02534922|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-04-03|||February 2016||2016-02-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|ProlantaOC||Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer|Phase I Open-Label, Dose-Escalation and Pharmacokinetic Study of Subcutaneous Prolanta™ in Subjects With Recurrent or Persistent Epithelial Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|Recruiting||Phase 1|18|Anticipated|Oncolix, Inc.||1|||f||||t||||||||||2017-10-10 22:59:01.134773|2017-10-10 22:59:01.134773
NCT02534909|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-09-12|||September 10, 2015|Actual|2015-09-10|September 2017|2017-09-01|December 20, 2023|Anticipated|2023-12-20|December 20, 2023|Anticipated|2023-12-20||Interventional|||Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria|An Open-label Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316, an Anti-C5 Monoclonal Antibody in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)|Recruiting||Phase 2|9|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 22:59:01.235858|2017-10-10 22:59:01.235858
NCT02534896|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-04-21|||November 2015||2015-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis|To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis|Recruiting||Phase 3|330|Anticipated|Sun Pharma Global FZE||3|||f||||f||||||||||2017-10-10 22:59:01.371454|2017-10-10 22:59:01.371454
NCT02534883|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-01-31|||August 2015||2015-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Cervical Ripening in Postmenopausal Women|Cervical Ripening in Postmenopausal Women: A Randomized, Double Blind, Placebo Controlled Trial|Terminated||N/A|7|Actual|St. Louis University||2||not able to meet enrollment|f||||f||||||||No||2017-10-10 22:59:01.533583|2017-10-10 22:59:01.533583
NCT02534870|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-10-15|||September 2015||2015-09-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects|Multiple-Dose Pharmacokinetics, Safety and Tolerability of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects|Completed||Phase 1|18|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 22:59:01.663097|2017-10-10 22:59:01.663097
NCT02534857|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-08-27|||September 2015||2015-09-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment|A Randomized Double Blinded Controlled Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment|Unknown status|Not yet recruiting|N/A|280|Anticipated|Shanghai First Maternity and Infant Hospital||2|||f||||t||||||||||2017-10-10 22:59:01.777812|2017-10-10 22:59:01.777812
NCT02534844|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-07-24|||September 2015||2015-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Interventional|||Study of VTS-270 (2-hydroxypropyl-β-cyclodextrin) to Treat Niemann-Pick Type C1 (NPC1) Disease|A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled 3-Part Trial of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Subjects With Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease|Active, not recruiting||Phase 2/Phase 3|51|Actual|Vtesse Inc.||2|||f||||t||||||||||2017-10-10 22:59:01.938106|2017-10-10 22:59:01.938106
NCT02534831|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2015-08-26|||March 2012||2012-03-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Manual Therapy in Chronic Obstructive Pulmonary Disease|The Effect of Soft Tissue Manual Therapy Intervention on Lung Function in Severe Chronic Obstructive Pulmonary Disease: a Proof of Concept Study|Completed||N/A|9|Actual|University of Chile||1|||f||||t||||||||||2017-10-10 22:59:02.105443|2017-10-10 22:59:02.105443
NCT02534818|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-11-07|||June 2015||2015-06-01|August 2015|2015-08-01||||November 2015|Anticipated|2015-11-01||Interventional|||Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia|Conventional Fluorescein Sodium Dosage o.1ml/kg Compared With a Lower Fluorescein Sodium Dosage o.02ml/kg for the Detection of Gastric Intestinal Metaplasia in a High Risk Population: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|180|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 22:59:02.205827|2017-10-10 22:59:02.205827
NCT02534805|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-01-05|||August 2015||2015-08-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis|Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis|Completed||N/A|38|Actual|Virginia Commonwealth University|||1||f||||f||||||||No||2017-10-10 22:59:02.309012|2017-10-10 22:59:02.309012
NCT02534792|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-10-26|||September 2015||2015-09-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Early Revalvulation After Fallot Repair Improves Clinical Outcome||Completed||N/A|320|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-10 22:59:02.373752|2017-10-10 22:59:02.373752
NCT02534779|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-06-01|||August 2015||2015-08-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products|Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products|Completed||N/A|49|Actual|CONRAD||1|||f||||f||||||||Undecided||2017-10-10 22:59:02.450539|2017-10-10 22:59:02.450539
NCT02534766|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-09-26|||September 2015||2015-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|MISSION-COPD||MISSION COPD - Modern Innovative SolutionS in Improving Outcomes iN COPD|MISSION COPD - Modern Innovative SolutionS in Improving Outcomes iN - COPD - A Comparison of Clinical Outcomes Before and After the MISSION Clinic.|Completed||N/A|114|Actual|Portsmouth Hospitals NHS Trust|||2||f||||f||||||||||2017-10-10 22:59:02.54529|2017-10-10 22:59:02.54529
NCT02534753|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-03-22|||September 2015||2015-09-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||A Pharmacokinetics Study of Intravenous Ascorbic Acid|A Phase 1, Single-Dose Study to Evaluate the Pharmacokinetics of Intravenous Ascorbic Acid in Healthy Male and Female Volunteers|Completed||Phase 1|8|Actual|McGuff Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 22:59:02.657069|2017-10-10 22:59:02.657069
NCT02534740|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-12-20|||September 2015||2015-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study Comparing Amounts of Tafamidis In The Blood With Or Without Food|A Phase 1, Open-Label, Randomized, Single Dose Study To Estimate The Relative Bioavailability And Food Effect Of PF‑06291826 (Tafamidis) Following Administration Of New Soft Gelatin Capsule Oral Formulations In Healthy Subjects|Completed||Phase 1|18|Actual|Pfizer||5|||f||||f||||||||||2017-10-10 22:59:02.743251|2017-10-10 22:59:02.743251
NCT02534727|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-08-12|||August 24, 2015||2015-08-24|July 12, 2017|2017-07-12|December 12, 2019|Anticipated|2019-12-12|August 8, 2018|Anticipated|2018-08-08||Observational|||Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance|Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:59:02.824398|2017-10-10 22:59:02.824398
NCT02534714|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-08-28|||July 2015||2015-07-01|August 2015|2015-08-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Observational|||Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016|Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016|Recruiting||N/A|580|Anticipated|OSF Healthcare System|||2||f||||f||||||||||2017-10-10 22:59:02.897945|2017-10-10 22:59:02.897945
NCT02534688|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-03-16|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients|Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients|Completed||Phase 4|50|Actual|King Chulalongkorn Memorial Hospital||2|||f||||||||||||||2017-10-10 22:59:03.197087|2017-10-10 22:59:03.197087
NCT02534675|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-10-24|||February 2015||2015-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|I-PREDICT||Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers|An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Malignancies and Poor Prognosis|Recruiting||N/A|225|Anticipated|University of California, San Diego|||1||f||||t||||||Samples With DNA|"     Primary tumor tissue or metastases   "|||2017-10-10 22:59:03.283243|2017-10-10 22:59:03.283243
NCT02534662|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-06-17|||May 2015||2015-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Feasibility of an Endoluminal-suturing Device (Endomina TM) for Gastric Reduction|A Prospective Study to Evaluate the Safety and Feasibility of an Endoluminal-suturing Device (Endomina TM) as an Aid for Endoscopic Gastric Reduction|Completed||N/A|11|Actual|Theodor Bilharz Research Institute||1|||f||||t||||||||Yes||2017-10-10 22:59:03.363317|2017-10-10 22:59:03.363317
NCT02534649|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-11-08|||December 2015||2015-12-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|BIP||Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials|Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials|Recruiting||N/A|2000|Anticipated|Institut Bergonié||1|||f||||f||||||||||2017-10-10 22:59:03.431713|2017-10-10 22:59:03.431713
NCT02534636|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2016-12-23|||October 2015||2015-10-01|October 2016|2016-10-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis|Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986165 in Healthy Subjects and to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of BMS-986165 in Subjects With Moderate to Severe Psoriasis|Completed||Phase 1|140|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-10 22:59:03.52808|2017-10-10 22:59:03.52808
NCT02534623|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2015-08-26|||September 2015||2015-09-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Postoperative Quality of Recovery After Transurethral Resection of the Bladder|Postoperative Quality of Recovery After Transurethral Resection of the Bladder: Spinal Versus General Anesthesia|Unknown status|Not yet recruiting|N/A|70|Anticipated|General Hospital Zadar||2|||f||||f||||||||||2017-10-10 22:59:03.634108|2017-10-10 22:59:03.634108
NCT02534610|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-26|||January 2014||2014-01-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Analgesic Benefit of Preoperative vs. Postoperative Etoricoxib in Total Knee Arthroplasty|Is There Any Analgesic Benefit From Preoperative vs. Postoperative Etoricoxib Administration in Total Knee Arthroplasty?|Completed||N/A|165|Actual|Foisor Orthopedics Clinical Hospital||3|||f||||f||||||||||2017-10-10 22:59:03.765058|2017-10-10 22:59:03.765058
NCT02534597|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-09-01|||August 2015||2015-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ENCCI||National Evaluation of Quality of Childcare|National Evaluation of Quality of Childcare (ENCCI)|Enrolling by invitation||N/A|1698|Actual|Duke University||10|||f||||f||||||||||2017-10-10 22:59:03.873991|2017-10-10 22:59:03.873991
NCT02534584|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2015-08-25|||August 2013||2013-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Observational|||Use of Care Bundle in Acute Kidney Injury|Impact of Compliance With a Care Bundle on Acute Kidney Injury Outcomes|Completed||N/A|944|Actual|Derby Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 22:59:03.988545|2017-10-10 22:59:03.988545
NCT02534571|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-12|||September 7, 2015|Actual|2015-09-07|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|TC325||To Compare a Hemostatic Powder TC-325 and Standard Treatment in the Control of Acute Upper Gastrointestinal Bleeding From Nonvariceal Causes|Endoscopic Application of a Hemostatic Powder TC-325 Versus Standard Treatment in the Control of Acute Upper Gastrointestinal Bleeding From Nonvariceal Causes; A Non-inferiority Randomized Trial|Recruiting||N/A|247|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 22:59:04.062459|2017-10-10 22:59:04.062459
NCT02534558|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-02-05|||August 1, 2014|Actual|2014-08-01|February 2017|2017-02-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Pathomechanism of MicroRNA-29 in Shoulder Stiffness|Pathomechanism of MicroRNA-29 in Shoulder Stiffness|Recruiting||N/A|50|Anticipated|Chang Gung Memorial Hospital||2|||f||||t|f|f||||||No||2017-10-10 22:59:04.203333|2017-10-10 22:59:04.203333
NCT02534545|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2016-02-24|||September 2015||2015-09-01|January 2016|2016-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS)|Remote Ischemic Conditioning for Avoiding Recurrence of Ischemic Stroke in Patients With Symptomatic Intracranial Atherosclerotic Stenosis|Recruiting||N/A|3000|Anticipated|Capital Medical University||2|||f||||t||||||||Undecided||2017-10-10 22:59:04.357995|2017-10-10 22:59:04.357995
NCT02534532|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-11-24|||October 2015||2015-10-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|AFScreenCol||Atrial Fibrillation Screening With a Smartphone Device and iECG Application|Atrial Fibrillation Screening With a Smartphone Device and iECG Application|Withdrawn||N/A|0|Actual|Bayer|||1||f||||f||||||||||2017-10-10 22:59:04.793223|2017-10-10 22:59:04.793223
NCT02534519|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-24|||July 2015||2015-07-01|August 2015|2015-08-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01|1 Day|Observational [Patient Registry]|Blood Genome||Whole Genome Sequencing for Blood Group Genotyping and Definition as Exemplified on U- and St(a)+.|Applicability of Whole Genome Sequencing for Human Blood Group Genotyping and Genetic Definition of New Alleles as Exemplified on References and the Two MNSs-variants: U- and Stones(a)+|Recruiting||N/A|8|Anticipated|Blood Donation Service Zurich, SRC|||2||f||||f||||||Samples With DNA|"     Two times 10 mL EDTA-anticoagulated whole blood and genomic DNA resulting from this amount.   "|||2017-10-10 22:59:04.896916|2017-10-10 22:59:04.896916
NCT02534506|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-09-15|||November 6, 2015|Actual|2015-11-06|September 2017|2017-09-01|June 18, 2018|Anticipated|2018-06-18|June 17, 2018|Anticipated|2018-06-17||Interventional|||Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors|A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Malignant Tumors|Recruiting||Phase 1|18|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f|||t|||||2017-10-10 22:59:05.036832|2017-10-10 22:59:05.036832
NCT02534467|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-24|||August 2015||2015-08-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?|Montelukast as Adjunct Treatment in Children With Atopic Dermatitis|Unknown status|Not yet recruiting|Phase 4|62|Anticipated|Murdoch Childrens Research Institute||2|||f||||f||||||||||2017-10-10 22:59:05.405477|2017-10-10 22:59:05.405477
NCT02534454|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-03-14|||August 2015||2015-08-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TDCSNIC||TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence|Transcranial Direct Current Stimulation (TDCS) and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence|Recruiting||N/A|100|Anticipated|The Mind Research Network||4|||f||||f||||||||||2017-10-10 22:59:05.488275|2017-10-10 22:59:05.488275
NCT02534441|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-09-22|||August 2015||2015-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Epidemiology and Co-Reactivity of Novel Surfactant Allergens|Epidemiology and Co-Reactivity of Novel Surfactant Allergens|Completed||N/A|48|Actual|Minneapolis Veterans Affairs Medical Center||1|||f||||||||||||||2017-10-10 22:59:05.627544|2017-10-10 22:59:05.627544
NCT02534428|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-24|||June 2014||2014-06-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Wool Clothing for the Management of Childhood Atopic Dermatitis|The Effects of Superfine Merino Wool in the Management of Childhood Atopic Dermatitis|Completed||N/A|39|Actual|Murdoch Childrens Research Institute||2|||f||||f||||||||||2017-10-10 22:59:05.712286|2017-10-10 22:59:05.712286
NCT02534415|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-25|||August 2013||2013-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Topically-Applied Hyaluronic-Acid on Palatal Epithelial Wound Closure|Effect of Topically-Applied Hyaluronic-Acid on Palatal Epithelial Wound Closure|Completed||Phase 4|36|Actual|Marmara University||3|||f||||f||||||||||2017-10-10 22:59:05.817414|2017-10-10 22:59:05.817414
NCT02534402|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-26|2017-05-26|||August 2015||2015-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Prednisone Administration in Quiescent COPD Patients to Determine the Effect on Gene Expression|Clinical Implementation and Outcomes Evaluation of Blood-Based Biomarkers for COPD Management: COPD Prednisone Sub-Study|Active, not recruiting||Phase 4|40|Actual|University of British Columbia||2|||f||||f||||||||Undecided||2017-10-10 22:59:05.919297|2017-10-10 22:59:05.919297
NCT02534389|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-02-08|||January 2015||2015-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|July 2016|Actual|2016-07-01||Interventional|||Fish Oil Supplement in Rectal Cancer|Fish Oil Supplement Combined With Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer|Completed||N/A|100|Actual|AC Camargo Cancer Center||2|||f||||t||||||||||2017-10-10 22:59:06.032651|2017-10-10 22:59:06.032651
NCT02534376|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-08-02|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal|Phase 0 Trial of Presurgical Cholesterol-lowering on Prostate Cancer Cell Growth|Recruiting||Early Phase 1|70|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-10 22:59:06.123056|2017-10-10 22:59:06.123056
NCT02534363|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-03-13|||October 2005|Actual|2005-10-01|March 2017|2017-03-01|January 2013|Actual|2013-01-01|January 2011|Actual|2011-01-01||Interventional|PAFIP2_nc1Y||Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up|Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: a Randomized Comparison of Aripiprazole, Quetiapine and Ziprasidone Over 1 Year|Completed||Phase 4|136|Actual|Fundación Marques de Valdecilla||3|||f||||f|f|f||||||No||2017-10-10 22:59:06.24108|2017-10-10 22:59:06.24108
NCT02534350|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-10-02|||December 31, 2015|Actual|2015-12-31|October 2017|2017-10-01|September 27, 2017|Actual|2017-09-27|February 20, 2017|Actual|2017-02-20||Interventional|RSVAdultLungTx||Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection|A Phase 2b, Randomized, Controlled Trial Evaluating GS-5806 in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection|Completed||Phase 2|61|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 22:59:06.363439|2017-10-10 22:59:06.363439
NCT02534337|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-03-17|||September 2015||2015-09-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma|Gemcitabine Plus Oxaliplatin (GEMOX) Versus Oxaliplatin Plus Fluorouracil/Leucovorin(FOLFOX4) As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma(HCC)|Active, not recruiting||Phase 2/Phase 3|134|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-10 22:59:06.492297|2017-10-10 22:59:06.492297
NCT02534324|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-03-13|2016-02-16||September 2015||2015-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|7 Days|Observational [Patient Registry]|||The Effect of Pre-discharge Blood Pressure of Patients With Asymptomatic Severe Hypertension in Emergency Department|The Effect of Pre-discharge Blood Pressure on the Follow-up Outcomes After Managing the Patients With Asymptomatic Severe Hypertension in Emergency Department|Completed||N/A|146|Actual|Chulalongkorn University|The results may not be generalizable to other centers with different treatment practices. We still had a considerable percentage of patients who were lost-to-follow-up that may have affected the results. The size of population was relatively small.||2||f||||f||||||||No||2017-10-10 22:59:06.593906|2017-10-10 22:59:06.593906
NCT02534311|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2015-08-27|||July 2015||2015-07-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28)|Prospective Evaluation of Rheumatoid Arthritis Activity Using DAS28 in Patients Treated With Subcutaneously Administered Tocilizumab on Local Level|Unknown status|Recruiting|N/A|60|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 22:59:06.901324|2017-10-10 22:59:06.901324
NCT02534298|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-08-24|||April 2015||2015-04-01|August 2015|2015-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|SSD||Functional Magnetic Resonance Imaging Study of the Central Auditory System After Single Sided Deafness|Reorganization of Central Auditory System After Single Sided Deafness: a Functional Magnetic Resonance Imaging Study|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-10 22:59:06.993246|2017-10-10 22:59:06.993246
NCT02534285|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-12-20|||August 2015||2015-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study to Investigate the Impact of Noise on Requirements of Anesthetics During General Anesthesia||Completed||N/A|100|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-10-10 22:59:07.088142|2017-10-10 22:59:07.088142
NCT02534272|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-06-03|||October 2015||2015-10-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota|Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota|Recruiting||N/A|320|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||Samples Without DNA|"     Stool   "|||2017-10-10 22:59:07.384048|2017-10-10 22:59:07.384048
NCT02534259|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-05-19|||August 2015||2015-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Observational|||Mobile Monitoring of Fracture Healing|Mobile Monitoring of Fracture Healing|Recruiting||N/A|8|Anticipated|Milton S. Hershey Medical Center|||1||f||||||||||||||2017-10-10 22:59:07.536866|2017-10-10 22:59:07.536866
NCT02534246|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-09-12|||August 2016||2016-08-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Head to Head Comparison of Two Needles EUS Guided FNB|A Paired Prospective, Single Blinded Study of the Diagnostic Accuracy and Specimen Adequacy of Two Endoscopic Tissue Biopsy Needles for Diagnosis Solid Pancreatic Mass|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-10 22:59:07.665815|2017-10-10 22:59:07.665815
NCT02534233|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-03-13|||April 2015||2015-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|ColdPlay2||Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium|Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium|Enrolling by invitation||N/A|60|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 22:59:07.795898|2017-10-10 22:59:07.795898
NCT02534220|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-26|||February 2014||2014-02-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Manual Versus Oscillating-rotating Toothbrushes After Root Coverage Procedure|Gingival Margin Stability After Mucogingival Plastic Surgery. The Effect of Manual Versus Powered Toothbrushing: a Randomized Clinical Trial|Completed||N/A|60|Actual|University of Milan||2|||f||||f||||||||||2017-10-10 22:59:07.936238|2017-10-10 22:59:07.936238
NCT02534207|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-01-24|||August 2015||2015-08-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Basmisanil Positron Emission Tomography Study in Japanese Volunteers|A Single-Centre, Non-Randomised, Open Label, Positron Emission Tomography Imaging Study to Assess Occupancy of α5-Containing GABAA Receptors by RO5186582 in Healthy Volunteers of Japanese Origin|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:59:08.05902|2017-10-10 22:59:08.05902
NCT02534194|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-09-11|||August 2015||2015-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Observational|GestATion||Gestational Age Assessment Tool|Gestational Age Assessment Tool for Newborn Babies|Recruiting||N/A|150|Anticipated|University of Nottingham|||1||f||||f||||||||||2017-10-10 22:59:08.201896|2017-10-10 22:59:08.201896
NCT02534181|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2015-08-24|||July 2015||2015-07-01|August 2015|2015-08-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|RESCUE||Refeeding Syndrome in Cancer Patients|Refeeding Syndrome in Cancer Patients Admitted to Adult Intensive Care Unit|Unknown status|Active, not recruiting|Phase 2|140|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 22:59:08.376276|2017-10-10 22:59:08.376276
NCT02534168|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-01-19|||September 2015|Actual|2015-09-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Post-surgical Pain Assessment in Children: Roles of Skin Conductance and Genomics|Post-surgical Pain Assessment in Children: Roles of Skin Conductance and Genomics|Recruiting||N/A|160|Anticipated|Milton S. Hershey Medical Center||1|||f||||f||||||||||2017-10-10 22:59:08.507728|2017-10-10 22:59:08.507728
NCT02534155|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-09-08|||April 2015||2015-04-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|HiRiDe||High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy|High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Randomized Controlled Trial Comparing MitraClip® to Surgical Therapy|Terminated||Phase 4|294|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-10 22:59:08.648312|2017-10-10 22:59:08.648312
NCT02534142|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-12-08|||October 2015||2015-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|February 2017|Anticipated|2017-02-01||Observational|||Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence|Colonoscopy Followup After Positive Fecal Occult Blood Test- Understanding Barriers to Adherence|Recruiting||N/A|2000|Anticipated|Meuhedet. Healthcare Organization|||2||f||||t||||||||||2017-10-10 22:59:08.830054|2017-10-10 22:59:08.830054
NCT02534129|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-10-04|2017-04-06||August 2015||2015-08-01|October 2017|2017-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||The analysis population consisted of 13 breast cancer patients receiving radiation to a breast. Each breast was divided into two radiation fields, one defined as the Difinsa53 arm and the other as the Aquaphor Arm. Thus each participant contributed data from two fields.|Topical Use of Difinsa53™ to Prevent Radiation Dermatitis|Topical Use of a Silibin-based Cream, Difinsa53™, to Prevent Radiation Dermatitis in Patients With Breast Cancer: A Prospective Study|Terminated||Phase 1/Phase 2|13|Actual|ProTechSure Scientific, Inc.|This trial was terminated early, based on minimal radiation dermatitis (scores of 0-1 only in most fields evaluated) that precluded any meaningful analysis of any differing effect in the two treatment arms.|1||"Insufficient dermatitis was seen in the controls to allow any determination of protection by   Difinsa53"|f||||f||||||||||2017-10-10 22:59:08.939431|2017-10-10 22:59:08.939431
NCT02534116|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-08-24|||December 2015||2015-12-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|||A Comparison of Incisional Negative-Pressure Wound Therapy Versus Conventional Dressings Following Abdominal Surgery|A Comparison of Incisional Negative-Pressure Wound Therapy Versus Conventional Dressings Following Abdominal Surgery: A Randomized-Controlled Trial|Not yet recruiting||N/A|36|Anticipated|Yale University||2|||f||||t||||||||||2017-10-10 22:59:09.199046|2017-10-10 22:59:09.199046
NCT02534103|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-24|||December 2014||2014-12-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|||Relationship Between a Combined Index of Diastolic and Systolic Performance and Intraoperative Hemodynamic Changes During Off-pump Coronary Bypass Surgery||Unknown status|Recruiting|N/A|120|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-10 22:59:09.315334|2017-10-10 22:59:09.315334
NCT02517216|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-08-05|||February 2014||2014-02-01|August 2015|2015-08-01||||April 2017|Anticipated|2017-04-01||Interventional|BrainDTI||Parabolic Flight Induced Neuroplasticity Studied With Advanced Magnetic Resonance Imaging Methods||Unknown status|Recruiting|N/A|27|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:59.45659|2017-10-10 23:03:59.45659
NCT02534090|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2015-08-26|||November 2015||2015-11-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Observational|NIRS/NICU2||Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy|Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy|Unknown status|Not yet recruiting|N/A|20|Anticipated|Brigham and Women's Hospital|||2||f||||f||||||||||2017-10-10 22:59:09.401702|2017-10-10 22:59:09.401702
NCT02534077|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-03-21|||August 2015|Actual|2015-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants|Compassionate Use of an Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants|Recruiting||Phase 3|40|Anticipated|Mednax Center for Research, Education and Quality||1|||f||||||||||||||2017-10-10 22:59:09.514371|2017-10-10 22:59:09.514371
NCT02534064|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-10-15|||October 2014||2014-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Consumption of Yogurt Fortified in Calcium and Vit. D on Circulating Levels of 25OHD in Postmenopausal Women|Effect of the Consumption of Yogurt Fortified in Calcium and Vitamin D on the Circulating Levels of 25OHD in Postmenopausal Women|Completed||N/A|140|Actual|Yoplait France SAS||3|||f||||f||||||||||2017-10-10 22:59:09.650669|2017-10-10 22:59:09.650669
NCT02534051|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-09-18|||October 2015||2015-10-01|September 2017|2017-09-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||A Clinical Care Pathway for Obese Pregnant Women: A Pilot Cluster RCT|A Clinical Care Pathway for Obese Pregnant Women: A Pilot Cluster Randomized Controlled Trial|Completed||N/A|189|Actual|McMaster University||2|||f||||f||||||||||2017-10-10 22:59:09.788483|2017-10-10 22:59:09.788483
NCT02534038|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-09-05|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of AVP-786 for the Treatment of Disinhibition in Patients With Neurodegenerative Disorders|Recruiting||Phase 2|12|Anticipated|Avanir Pharmaceuticals||2|||f||||f||||||||||2017-10-10 22:59:09.887878|2017-10-10 22:59:09.887878
NCT02534025|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2017-02-05|||January 2016||2016-01-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|RIRI||Remote Ischemic Preconditioning in Liver Transplantation||Recruiting||N/A|100|Anticipated|Mansoura University||2|||f||||f||||||||||2017-10-10 22:59:10.031752|2017-10-10 22:59:10.031752
NCT02534012|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-06-13|||May 2016||2016-05-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Paravertebral Block vs. General Anesthesia for Major Abdominal Surgery|Paravertebral Block Versus General Anesthesia for Major Abdominal Surgery in Elderly: a Prospective Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Makassed General Hospital||2|||f||||f||||||||||2017-10-10 22:59:10.162387|2017-10-10 22:59:10.162387
NCT02533999|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-03-27|||April 2013||2013-04-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|||Peak(R) vs. Electrocautery in Children Undergoing Tonsillectomy With Adenoidectomy|Assessment of 14-Day Outcomes With the Peak® Surgery System Versus the Traditional Electrocautery Method in Children Ages 3 to 18 Years Undergoing Tonsillectomy With Adenoidectomy for Sleep Disordered Breathing|Completed||N/A|75|Actual|Nemours Children's Clinic||2|||f||||f||||||||No||2017-10-10 22:59:10.297871|2017-10-10 22:59:10.297871
NCT02533986|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-02-10|||August 2015||2015-08-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Berry Peel Intake on Glucose Metabolism in Healthy Subjects|Effects of Berry Peel Intake on Glucose Metabolism in Healthy Subjects|Completed||Phase 1/Phase 2|23|Actual|Lund University||2|||f||||f||||||||||2017-10-10 22:59:10.427111|2017-10-10 22:59:10.427111
NCT02533973|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-08-18|||September 2015||2015-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population||Active, not recruiting||Phase 4|950|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 22:59:10.567916|2017-10-10 22:59:10.567916
NCT02533960|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2017-05-01|||June 2015||2015-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|RASUNOA-Prime||Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime|Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime|Recruiting||N/A|4000|Anticipated|University Hospital Heidelberg|||3||f||||f||||||||||2017-10-10 22:59:10.667939|2017-10-10 22:59:10.667939
NCT02533947|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-05-24|||June 2014||2014-06-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CaSpo||Cognition in Allogeneic Stem Cell Transplanted Patients and Sports|Effects of Physical Exercise on Cognitive Functions in Patients After Allogeneic Stem Cell Transplantation|Recruiting||N/A|80|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 22:59:10.776109|2017-10-10 22:59:10.776109
NCT02533934|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2016-12-02|||August 2016||2016-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|STOP-CO||Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre or Post Liver Transplant|A Pilot Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir and Ledipasvir for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant|Recruiting||Phase 4|50|Anticipated|University of California, San Francisco||1|||f||||f||||||||Undecided||2017-10-10 22:59:10.913971|2017-10-10 22:59:10.913971
NCT02533921|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-10-04|||October 2015||2015-10-01|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?|Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?|Active, not recruiting||N/A|210|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 22:59:11.115144|2017-10-10 22:59:11.115144
NCT02533908|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children|Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children: A Prospective, Randomized, Double-blind, Placebo-controlled, Monocentric Study|Recruiting||Phase 3|402|Anticipated|University Children's Hospital, Zurich||2|||f||||t||||||||No||2017-10-10 22:59:11.204099|2017-10-10 22:59:11.204099
NCT02533882|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-02-08|||December 2014||2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LEADERS||Lakeshore Examination of Activity and Disability Exercise Response Study|Dose-Response Effects of Transformative Exercise in Improving Health and Function in Adults With Spinal Cord Injury and Multiple Sclerosis|Recruiting||N/A|180|Anticipated|University of Alabama at Birmingham||3|||f||||f||||||||||2017-10-10 22:59:11.43537|2017-10-10 22:59:11.43537
NCT02533869|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-07-26|||July 2015||2015-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|OPTICAP||The Optimization of a Low-dose Computed Tomography Protocol in Patients With Suspected Uncomplicated Acute Appendicitis|The Optimization of a Low-dose Computed Tomography Protocol in Patients With Suspected Uncomplicated Acute Appendicitis (OPTICAP)|Active, not recruiting||N/A|60|Actual|Turku University Hospital||1|||f||||f||||||||||2017-10-10 22:59:11.55254|2017-10-10 22:59:11.55254
NCT02533856|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-10-19|||August 2015||2015-08-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ETOC||Trial of Emergency Department Discharge With Enhanced Transitions of Care Compared to Usual Care|Randomized Control Trial of Emergency Department Discharge With Enhanced Transitions of Care Compared to Usual Care|Completed||N/A|316|Actual|Thomas Jefferson University||2|||f||||f||||||||||2017-10-10 22:59:11.637665|2017-10-10 22:59:11.637665
NCT02533843|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-10-17|||April 2014||2014-04-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2016|Actual|2016-03-01||Interventional|OASIS||Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation|Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation|Active, not recruiting||Phase 3|120|Anticipated|Texas Cardiac Arrhythmia Research Foundation||3|||f||||f||||||||||2017-10-10 22:59:11.736206|2017-10-10 22:59:11.736206
NCT02533830|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-01-29|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|RCT||Gum Chewing And Bowel Motility in Patients Undergoing Cesarean Section. Kasr el Ainy Experience|Gum Chewing And Bowel Motility in Patients Undergoing Cesarean Section. Kasr el Ainy Experience.A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|162|Anticipated|Kasr El Aini Hospital||2|||f||||t||||||||||2017-10-10 22:59:11.857796|2017-10-10 22:59:11.857796
NCT02533817|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-05-11|||December 2012||2012-12-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|FED||Fructose and Ethnic Differences Study (FED Study)|Fructose and Ethnic Differences Study|Completed||N/A|20|Actual|King's College London||2|||f||||f||||||||||2017-10-10 22:59:11.981469|2017-10-10 22:59:11.981469
NCT02533804|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-08-14|||December 31, 2014|Actual|2014-12-31|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|||Lake Nona Life Project|A Community Epidemiology Study Evaluating the Factors Influencing Overall Health and Wellness|Recruiting||N/A|9000|Anticipated|Johnson & Johnson Health and Wellness Solutions, Inc.|||1||f||||f|f|f||||||||2017-10-10 22:59:12.073636|2017-10-10 22:59:12.073636
NCT02533791|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-10-11|||July 2015||2015-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization|Safety and Immunogenicity of a Booster Dose of the Recombinant Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults After Primary Immunization|Completed||Phase 1|110|Actual|Jiangsu Province Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-10 22:59:14.153374|2017-10-10 22:59:14.153374
NCT02533778|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-07-31|||July 2015||2015-07-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|ARISE||ARISE: After 8 Hours Reperfusion in Ischemic Stroke Embolization|ARISE: After 8 Hours Reperfusion in Ischemic Stroke Embolization|Suspended||N/A|25|Anticipated|Abington Memorial Hospital||1||"Similar large international competing trial with results of strong positive statistically   benefit"|f||||t||||||||||2017-10-10 22:59:14.269943|2017-10-10 22:59:14.269943
NCT02533765|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-09-28|||May 2015||2015-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor|Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor|Recruiting||Phase 2|29|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-10 22:59:14.376779|2017-10-10 22:59:14.376779
NCT02533752|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-08-24|||September 2014||2014-09-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01|24 Months|Observational [Patient Registry]|WATCHMAN||Canadian WATCHMAN Registry|Canadian WATCHMAN Registry|Unknown status|Recruiting|N/A|100|Anticipated|Cardiology Research UBC|||1||f||||f||||||||||2017-10-10 22:59:14.504185|2017-10-10 22:59:14.504185
NCT02533739|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-08-10|||September 2015||2015-09-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Vestibular Disorder and Visuo-spatial Functions|Impact Des déficits Vestibulaires Sur le développement Des Fonctions Visuo-spatiales.|Recruiting||N/A|500|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 22:59:14.62096|2017-10-10 22:59:14.62096
NCT02533713|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-07-18|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|December 1, 2021|Anticipated|2021-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of Life|Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of Life: A Randomized Clinical Trial|Recruiting||N/A|36|Anticipated|Craig Hospital||2|||f||||f|f|t|f|f|t|||||2017-10-10 22:59:14.873304|2017-10-10 22:59:14.873304
NCT02533700|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2016-04-18|||September 2015||2015-09-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL|CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With Peripheral T-cell Lymphoma (PTCL)|Recruiting||Phase 4|1|Anticipated|Shandong Provincial Hospital||2|||f||||t||||||||||2017-10-10 22:59:14.973897|2017-10-10 22:59:14.973897
NCT02533687|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2017-02-27|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparison of Different Energy Sources During TUR-P|Comparison of Two Different Bipolar and A Monopolar Energy Sources During Transurethral Resection of Prostate|Not yet recruiting||N/A|90|Anticipated|Selcuk University||3|||f||||f|f|f||||||Undecided||2017-10-10 22:59:15.077398|2017-10-10 22:59:15.077398
NCT02533674|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-07-03|||December 2014||2014-12-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors|Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|PharmaMar||1|||f||||f||||||||||2017-10-10 22:59:15.357074|2017-10-10 22:59:15.357074
NCT02533661|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-02-12|||August 2015||2015-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Family-Centered Intervention for Preterm Infants at Preschool Age|Effects of Family-Centered Intervention for Preterm Infants at Preschool Age|Recruiting||N/A|270|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||Undecided||2017-10-10 22:59:16.088536|2017-10-10 22:59:16.088536
NCT02533648|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-08-24|||September 2011||2011-09-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|DIAXO||Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients|Involvement of Reactive Oxygen Species Produced by the Xanthine Oxidase in Mitochondrial Alterations in Skeletal Muscle of Type 2 Diabetic Patients|Unknown status|Recruiting|Phase 3|39|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 22:59:16.226689|2017-10-10 22:59:16.226689
NCT02533635|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-24|||August 2015||2015-08-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Ganoderma Tea on Eczema Patient|Product Functional Study of Effect A Master Ganoderma Detox Tea on Eczema Patient|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Hong Kong Baptist University||2|||f||||f||||||||||2017-10-10 22:59:16.363581|2017-10-10 22:59:16.363581
NCT02533622|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-08-24|||January 2011||2011-01-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Observational|||Holy Name Progressive Mobility in the ICU|A Clinical Study Of The Impact Of Total Care® Bed System Combined With The Liko Lift to Facilitate Early Progressive Mobility Compliance and Associated Clinical and Financial Outcomes.|Completed||N/A|63|Actual|Hill-Rom|||2||f||||f||||||||||2017-10-10 22:59:16.479971|2017-10-10 22:59:16.479971
NCT02533609|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-04-13|||September 2015||2015-09-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|DIADSORB MAB||Elimination of Antibiotics During Citrate-anticoagulated Continuous-veno-venous-haemodialysis|Elimination of Antibiotics During Citrate-anticoagulated Continuous-veno-venous-haemodialysis|Active, not recruiting||N/A|30|Anticipated|Heinrich-Heine University, Duesseldorf|||2||f||||f||||||||||2017-10-10 22:59:16.570989|2017-10-10 22:59:16.570989
NCT02533596|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-08-24|||September 2010||2010-09-01|February 2015|2015-02-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Observational|||Elimination of Cardiac and Inflammatory Biomarkers and Adipokines by Therapeutic Plasma Exchange|Elimination of Cardiac and Inflammatory Biomarkers and Adipokines by Therapeutic Plasma Exchange|Completed||N/A|21|Actual|Hannover Medical School|||1||f||||f||||||Samples With DNA|"     -  blood samples        -  plasma samples from TPE waste bag   "|||2017-10-10 22:59:16.664947|2017-10-10 22:59:16.664947
NCT02533583|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-08-11|||November 2015||2015-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Pulse Oximetry With Clinical Observation to Screen for Lung Disease in Neonates|Pulse Oximetry With Clinical Observation to Screen for Lung Disease in Neonates|Active, not recruiting||N/A|15000|Anticipated|Guangdong Women and Children Hospital|||2||f||||f||||||||||2017-10-10 22:59:16.753014|2017-10-10 22:59:16.753014
NCT02533570|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-06-23|||July 2015||2015-07-01|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Interventional|||Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus|A Multi-center, Randomized, Double-blinded, Placebo-controlled, Multiple-ascending-dose Study of Brentuximab Vedotin in Adults With Active Systemic Lupus Erythematosus|Terminated||Phase 2|20|Actual|Seattle Genetics, Inc.||2||Sponsor decision based on portfolio prioritization|f||||f||||||||||2017-10-10 22:59:16.850503|2017-10-10 22:59:16.850503
NCT02533557|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-05-18|||August 2015||2015-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|US-SCBPB||Comparison 1 Plane-2 Injection and 2 Plane-2 Injection Ultrasound-guided Supraclavicular Brachial Plexus Block|A Randomized Comparison Between 1 Plane-2 Injection and 2 Plane-2 Injection Ultrasound-guided Supraclavicular Brachial Plexus Block (US-SCBPB) in Upper Extremity Surgery|Completed||N/A|70|Actual|Gachon University Gil Medical Center||2|||f||||f||||||||No||2017-10-10 22:59:17.025075|2017-10-10 22:59:17.025075
NCT02533544|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-07-21|||October 2015||2015-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B|Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B : a Real Life Multicenter Cohort Study in Korea|Recruiting||N/A|500|Anticipated|The Catholic University of Korea|||1||f||||f||||||||||2017-10-10 22:59:17.168237|2017-10-10 22:59:17.168237
NCT02533531|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-04-24|||April 16, 2014|Actual|2014-04-16|April 2017|2017-04-01|June 9, 2016|Actual|2016-06-09|June 9, 2016|Actual|2016-06-09||Interventional|||Proof of Concept Study for 1 Lead Patch Technology|Proof of Concept Study for 1 Lead Patch Technology|Completed||N/A|72|Actual|LifeWatch Services, Inc.||1|||f||||f|f|t|f|f|f|||||2017-10-10 22:59:17.293062|2017-10-10 22:59:17.293062
NCT02533518|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-24|||October 2010||2010-10-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|UVFBCL||Ultra-Violet Fluorescence Bronchial Cancer Location|Ultra-Violet Fluorescence Bronchial Cancer Location|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 22:59:17.387219|2017-10-10 22:59:17.387219
NCT02533492|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-24|||June 2011||2011-06-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|Vicryl-Plus||Compare Antimicrobial to Conventional Suture in Patients Receiving Primary Total Knee Replacement|Compare the Results of Antimicrobial to Conventional Suture Materials in Patients Receiving Primary Total Knee Replacement: A Prospective Double-blinded Randomized Controlled Trial|Completed||Phase 4|102|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 22:59:17.629203|2017-10-10 22:59:17.629203
NCT02533479|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-08-25|||January 2010||2010-01-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|January 2012|Actual|2012-01-01||Interventional|||Erythrocytes and Skeletal-muscle Fatty Acids Are Positively Correlated After Caloric Restriction and Exercise|Erythrocytes and Skeletal-muscle Unsaturated and Omega-6 Fatty Acids Are Positively Correlated After Caloric Restriction and Exercise|Completed||N/A|11|Actual|Centre d'Alt Rendiment||1|||f||||t||||||||||2017-10-10 22:59:17.745888|2017-10-10 22:59:17.745888
NCT02533466|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-06-28|2016-07-06||October 1, 2015||2015-10-01|March 2017|2017-03-01|November 6, 2015|Actual|2015-11-06|November 6, 2015|Actual|2015-11-06||Interventional||The Per Protocol (PP) population was the primary population.|In Vivo Investigation of Initial Stages of Enamel Erosion|Study to Investigate the Initial Stages of Enamel Erosion in Vivo|Completed||N/A|30|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 22:59:17.862951|2017-10-10 22:59:17.862951
NCT02533440|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-04-11|||August 2015||2015-08-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|FAST||Efficacy of EXPAREL in Comparison to Standard of Care for the Treatment of Post Operative Dental Implant Pain|A Prospective, Randomized, Open-Label Study Comparing Postsurgical Analgesia Using EXPAREL® To Standard Of Care For The Full Arch Surgical Therapy (FAST) Dental Implant Surgery Procedure|Completed||N/A|69|Actual|Bellaire Facial Surgery Center||2|||f||||f||||||||||2017-10-10 22:59:18.821714|2017-10-10 22:59:18.821714
NCT02533427|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-04-04|||October 2015||2015-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol|A Phase 1, Open-Label, Drug Interaction Study Evaluating the Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol|Completed||Phase 1|15|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-10 22:59:18.953052|2017-10-10 22:59:18.953052
NCT02533414|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2017-03-03|||August 2016|Actual|2016-08-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Use of Ureteral Access Sheath on Levels of Netrin-1 in Patients Undergoing RIRS|Effect of Use of Ureteral Access Sheath on Blood and Urine Levels of Netrin-1 in Patients Undergoing Retrograde Intrarenal Surgery|Recruiting||N/A|60|Anticipated|Selcuk University||2|||f||||f|f|f||||||Undecided||2017-10-10 22:59:19.118645|2017-10-10 22:59:19.118645
NCT02533401|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-03-30|2016-03-29||February 2006||2006-02-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All Participants Enrolled: All participants who complied with selection criteria at enrollment.|A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)|A Multicenter, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Rituximab Plus Fludarabine and Cyclophosphamide (FCR) as First-Line Treatment in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|34|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 22:59:19.269895|2017-10-10 22:59:19.269895
NCT02533388|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-03-10|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effects of TEAS on Stress Response During Extubation of General Anesthesia in Elderly Patients|Effects of Transcutaneous Electrical Acupoint Stimulation on the Stress Response During Extubation After General Anesthesia in Elderly Patients Undergoing Elective Supratentorial Craniotomy|Completed||N/A|100|Actual|Shengjing Hospital||2|||f||||t||||||||||2017-10-10 22:59:19.666458|2017-10-10 22:59:19.666458
NCT02533375|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-07-21|||September 28, 2015||2015-09-28|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)|A Multicenter, Open-Label Study of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis|Completed||Phase 3|10|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 22:59:19.792462|2017-10-10 22:59:19.792462
NCT02533362|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-25|||October 2015||2015-10-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||ANF-Rho in the Treatment of Chronic Neutropenia|A Phase 2, Open-Label, Single Center, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of ANF-Rho™ in Patients With Chronic Neutropenia|Unknown status|Not yet recruiting|Phase 1/Phase 2|5|Anticipated|Prolong Pharmaceuticals||1|||f||||t||||||||||2017-10-10 22:59:19.923999|2017-10-10 22:59:19.923999
NCT02533349|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-05-29|||May 2016||2016-05-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease|Randomized Controlled Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease|Recruiting||Phase 3|200|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-10 22:59:20.052274|2017-10-10 22:59:20.052274
NCT02532777|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-10-29|||August 2015||2015-08-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||The Research of Standard Diagnosis and Treatment for HSPN in Children|The Research of Standard Diagnosis and Treatment for Henoch-Schonlein Purpura Nephritis in Children|Recruiting||Phase 2|100|Anticipated|Nanjing Children's Hospital||3|||f||||f||||||||||2017-10-10 22:59:26.984495|2017-10-10 22:59:26.984495
NCT02533336|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2017-03-27|||November 9, 2015|Actual|2015-11-09|March 2017|2017-03-01|March 31, 2017|Anticipated|2017-03-31|August 31, 2016|Actual|2016-08-31||Interventional|DL||The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania|The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania: Cluster Randomized Trial|Terminated||Phase 3|4917|Actual|National Institute for Medical Research, Tanzania||2||futility ground|f||||t||||||||||2017-10-10 22:59:20.206244|2017-10-10 22:59:20.206244
NCT02533323|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-10-19|||January 2012||2012-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|September 2016|Actual|2016-09-01||Interventional|||P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens|Phase 2 Trial of Pegaspargase-Gemox Chemotherapy in Newly Diagnosed, Nasal Type, Extranodal Natural Killer/T-cell Lymphoma|Terminated||Phase 2|50|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 22:59:20.336829|2017-10-10 22:59:20.336829
NCT02533310|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-05-02|||August 1, 2015|Actual|2015-08-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|February 22, 2017|Actual|2017-02-22||Interventional|VIMSE||Virtual Reality Immersive Method for Spider (Phobia) Exposure Therapy (VIMSE)|Single-session Gamified Virtual Reality Exposure Therapy for Spider Phobia vs. Traditional Exposure Therapy: a Randomized Controlled Non-inferiority Trial|Active, not recruiting||N/A|100|Actual|Stockholm University||2|||f||||f||||||||||2017-10-10 22:59:20.457142|2017-10-10 22:59:20.457142
NCT02533297|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-25|||May 2009||2009-05-01|August 2015|2015-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Developing Standards Skill According to the Learning Curves|Developing Standards for Skill Performance Times in Nursing Clinical Education Program According to Learning Curve|Completed||N/A|57|Actual|Mashhad University of Medical Sciences||1|||f||||t||||||||||2017-10-10 22:59:20.594883|2017-10-10 22:59:20.594883
NCT02533271|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-22|||August 2015||2015-08-01|August 2015|2015-08-01|August 2025|Anticipated|2025-08-01|August 2023|Anticipated|2023-08-01||Interventional|STELLAR||Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer|Phase III Study of Short-term Radiotherapy Plus Neoadjuvant Chemotherapy Versus Preoperative Long-term Chemoradiotherapy in Locally Advanced Rectal Cancer|Recruiting||Phase 3|552|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 22:59:20.783971|2017-10-10 22:59:20.783971
NCT02533258|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-05-11|2017-05-11||December 2, 2015|Actual|2015-12-02|April 2017|2017-04-01|May 12, 2016|Actual|2016-05-12|May 12, 2016|Actual|2016-05-12||Observational||Safety population included all the enrolled participants who received at least one dose of the axitinib.|Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice|Post-marketing Surveillance Study To Observe Inlyta (Registered) Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice|Completed||N/A|13|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 22:59:20.929877|2017-10-10 22:59:20.929877
NCT02533245|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-27|||January 2015||2015-01-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|THES||Transplantoux Health Evaluation Study|Effect of an Exercise Training Intervention on Health-related Quality of Life and Psychosocial and Behavioral Variables in Adult Solid Organ Transplant Recipients: a Quasi-experimental Study Design|Unknown status|Recruiting|N/A|500|Anticipated|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||||2017-10-10 22:59:21.368809|2017-10-10 22:59:21.368809
NCT02533232|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-01-13|||August 2015||2015-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia|Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia: A Randomised Placebo-controlled Double-blind Trial|Recruiting||Phase 1|60|Anticipated|Pakistan Institute of Learning and Living||2|||f||||t||||||||||2017-10-10 22:59:21.478417|2017-10-10 22:59:21.478417
NCT02533219|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-10-10||||||October 2016|2016-10-01||||||||Expanded Access|[18F]-DOPA||Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia|Phase II Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia|Available||N/A|||Baylor College of Medicine|||||||||||||||||||2017-10-10 22:59:21.609495|2017-10-10 22:59:21.609495
NCT02533206|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-20|||August 2015||2015-08-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Pilot Study of The EPIC Trial|Endoscopic Polypectomy Performed In Clinic (EPIC) for Chronic Rhinosinusitis With Polyps: Pilot Study of The EPIC Randomised Controlled Trial|Active, not recruiting||N/A|20|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 22:59:21.851815|2017-10-10 22:59:21.851815
NCT02533193|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-09-13|||August 2015||2015-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Enhanced Recovery After Surgery Protocal Versus Traditional Care in Laparoscopic Hepatectomy|A Randomized Controlled Trial of Enhanced Recovery After Surgery Protocal Versus Traditional Care in Laparoscopic Hepatectomy|Completed||N/A|126|Actual|Sir Run Run Shaw Hospital||2|||f||||f||||||||||2017-10-10 22:59:21.96402|2017-10-10 22:59:21.96402
NCT02533180|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-08-21|||October 2015||2015-10-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|OPTIMAL||Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation|Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Operational Tolerance Following Liver Transplantation in Adults (ITN056ST)|Recruiting||Phase 2|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t|t|f|||f|||||2017-10-10 22:59:22.069404|2017-10-10 22:59:22.069404
NCT02530944|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-10-06|||April 2015||2015-04-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|April 2017|Anticipated|2017-04-01||Observational|||Web-based Genetic Research on Lupus||Active, not recruiting||N/A|5000|Actual|23andMe, Inc.|||1||f||||f||||||Samples With DNA|"     Saliva samples are collected for DNA analysis   "|||2017-10-10 22:59:49.582937|2017-10-10 22:59:49.582937
NCT02533154|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-05-19|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients|Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients|Not yet recruiting||Phase 4|40|Anticipated|Medical University of Vienna||2|||f||||f|f|f||||||||2017-10-10 22:59:22.304627|2017-10-10 22:59:22.304627
NCT02533141|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-05-19|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of Simvastatin Withdrawal on Ocular Endothelial Function|Effect of Simvastatin Withdrawal on Ocular Endothelial Function|Not yet recruiting||Phase 4|20|Anticipated|Medical University of Vienna||2|||f||||f|f|f||||||||2017-10-10 22:59:22.403296|2017-10-10 22:59:22.403296
NCT02533128|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-06-16|||September 2015||2015-09-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|March 2019|Anticipated|2019-03-01||Interventional|BBB||Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery|Biomarkers, Blood Pressure and BIS: Perioperative Risk Stratification and Management Optimization of Patients at Cardiac Risk Undergoing Major Noncardiac Surgery (The BBB Study)|Recruiting||N/A|458|Anticipated|Cantonal Hospital of St. Gallen||2|||f||||t||||||||||2017-10-10 22:59:22.4949|2017-10-10 22:59:22.4949
NCT02533115|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-08-17||||||August 2017|2017-08-01||||||||Expanded Access|401||EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML|Expanded Access Protocol of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection for Patients 60-75 Years of Age With Secondary AML|Approved for marketing||N/A|||Jazz Pharmaceuticals|||||||||||||||||||2017-10-10 22:59:22.608243|2017-10-10 22:59:22.608243
NCT02533089|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-07-26|||May 2016||2016-05-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|July 2017|Anticipated|2017-07-01||Interventional|||Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi|Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi|Recruiting||N/A|124|Anticipated|Dignitas International||2|||f||||f||||||||||2017-10-10 22:59:22.784466|2017-10-10 22:59:22.784466
NCT02533076|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-08-21|||November 2014||2014-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients|The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients|Completed||Early Phase 1|50|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 22:59:22.875321|2017-10-10 22:59:22.875321
NCT02533063|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-05-11|||November 2015||2015-11-01|May 2017|2017-05-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Semi-Recumbent Vibration Therapy in Older Adults|Semi-Recumbent Vibration Therapy in Older Adults|Completed||N/A|32|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 22:59:22.981407|2017-10-10 22:59:22.981407
NCT02533050|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2016-12-06|||August 2014||2014-08-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CAPCORSAS||Attentional Capacity and Working Memory in Coronary Artery Disease Patients: Impact of the Presence of a Sleep Apnea Syndrome and Chronic Effects of Treatment With CPAP|Attentional Capacity and Working Memory in Coronary Artery Disease Patients: Impact of the Presence of a Sleep Apnea Syndrome and Chronic Effects of Treatment With a Continuous Positive Airway Pressure System (CPAP). Etude CAPCORSAS|Recruiting||N/A|192|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||No||2017-10-10 22:59:23.084892|2017-10-10 22:59:23.084892
NCT02533037|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-21|||August 2013||2013-08-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effects Of Rehabilitation Incorporating Gait Training On Clinical Measures Associated With Chronic Ankle Instability|Effects Of Rehabilitation Incorporating Gait Training On Clinical Measures Associated With Chronic Ankle Instability|Completed||Phase 2/Phase 3|26|Actual|University of Virginia||2|||f||||f||||||||||2017-10-10 22:59:23.200103|2017-10-10 22:59:23.200103
NCT02533024|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-09-21|||August 2015||2015-08-01|September 2016|2016-09-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|||Preoperative Prevalence of Ulnar Neuropathy and Changes in Ulnar Nerve Latency During Surgery|Preoperative Prevalence of Ulnar Neuropathy and Changes in Ulnar Nerve Latency During Surgery|Completed||N/A|4|Actual|University of Toledo Health Science Campus||1|||f||||f||||||||||2017-10-10 22:59:23.288254|2017-10-10 22:59:23.288254
NCT02533011|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-22|||July 2015||2015-07-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|December 2016|Actual|2016-12-01||Observational|HBP||Evaluation of the Heparin Binding Protein Levels in Sepsis|Heparin Binding Protein (HBP) in Sepsis for the Prediction of Disease Progression|Completed||N/A|1055|Actual|Christiana Care Health Services|||3||f||||f||||||Samples With DNA|"     Blood sample   "|||2017-10-10 22:59:23.388466|2017-10-10 22:59:23.388466
NCT02532998|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-02-09|2016-12-01||September 2015||2015-09-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects|A Phase I, Randomized, Single-Blind, Crossover Study to Assess the Pharmacodynamics of AZD9977 Following Single-Dose Administration to Healthy Male Subjects|Completed||Phase 1|40|Actual|AstraZeneca||8|||f||||f||||||||||2017-10-10 22:59:23.553249|2017-10-10 22:59:23.553249
NCT02532985|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-24|||October 2014||2014-10-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary Fiber|A Randomized, Double-Blind, Crossover Study to Assess Gastrointestinal Tolerability of Cba-1, a Novel Dietary Fiber, Using Three Dose Levels at Multiple Eating Occasions in Healthy Men and Women|Completed||N/A|45|Actual|Cargill||5|||f||||t||||||||||2017-10-10 22:59:24.840809|2017-10-10 22:59:24.840809
NCT02532972|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-08-17|||September 2015||2015-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Cochlear Implantation for Treatment of Single-sided Deafness|Cochlear Implantation for Treatment of Single-sided Deafness|Recruiting||N/A|10|Anticipated|Massachusetts Eye and Ear Infirmary||1|||f||||f||||||||||2017-10-10 22:59:24.974493|2017-10-10 22:59:24.974493
NCT02532946|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-12|||August 2012||2012-08-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Bedsider||Bedsider.Org in Post-abortion Contraceptive Counseling: A Mixed Methods Study|Bedsider.Org in Post-abortion Contraceptive Counseling: A Mixed Methods Study|Completed||N/A|346|Actual|Boston Medical Center||2|||f||||f||||||||Yes|Publication in peer-reviewed journal|2017-10-10 22:59:25.208753|2017-10-10 22:59:25.208753
NCT02532933|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-21|||July 2015||2015-07-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Stereo Radiography of TKA Patella Mechanics|Influence of Patellar Geometry on Kinematics, Quadriceps Function, and Patient Outcome in Subjects With the Attune PS RP|Enrolling by invitation||N/A|44|Anticipated|University of Denver||2|||f||||f||||||||||2017-10-10 22:59:25.283166|2017-10-10 22:59:25.283166
NCT02532920|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-09-21|||January 2015||2015-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||The Natural History of Atopic Disease in Thai Children and Association With Atopic March|The Natural History of Atopic Disease in Thai Children and Association With Atopic March|Completed||N/A|102|Actual|Mahidol University|||1||f||||t||||||||No||2017-10-10 22:59:25.362888|2017-10-10 22:59:25.362888
NCT02532907|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-08-25|||August 2015||2015-08-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Observational|||Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs|Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs|Recruiting||N/A|20|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     Some of the data, blood and tissue that is taken during the study will be kept and used in     future research to learn more about _Hepatitis C.   "|||2017-10-10 22:59:25.463525|2017-10-10 22:59:25.463525
NCT02532894|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2015-08-25|||October 2014||2014-10-01|August 2015|2015-08-01||||October 2014|Actual|2014-10-01||Interventional|ESMOKE||Effects of E-smoke on Levels of Endothelial Progenitor Cells and Microparticles in Healthy Volunteers||Completed||N/A|16|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 22:59:25.560534|2017-10-10 22:59:25.560534
NCT02532881|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-11-11|||August 2015||2015-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|Reh@:Info||Evaluation of a Video-based Internet Intervention as Preparation for Inpatient Psychosomatic Rehabilitation|Evaluation of a Video-based Internet Intervention as Preparation for Inpatient Psychosomatic Rehabilitation: A Randomized Controlled Trial|Completed||Phase 2|492|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-10 22:59:25.792226|2017-10-10 22:59:25.792226
NCT02532868|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-08-25|||May 2005||2005-05-01|August 2015|2015-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)|A Phase I Dose Escalation Study of MK0457 Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a 24-Hour Continuous Infusion Given Every 21 Days in Patients With Advanced Cancer|Terminated||Phase 1|27|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 22:59:25.896914|2017-10-10 22:59:25.896914
NCT02532855|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-25|2017-03-16|||October 2015||2015-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)|A Phase III, Multicenter, Randomized, Double-Blind, Active-Comparator Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin Compared With the Addition of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea|Active, not recruiting||Phase 3|556|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 22:59:26.01113|2017-10-10 22:59:26.01113
NCT02532842|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-11-02|||July 2015||2015-07-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate|Paliperidone Palmitate in Early Schizophrenia - A Retrospective, Non-interventional Study of Patients With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate Over a 12-Month Period|Completed||Phase 4|90|Actual|Janssen Pharmaceutica N.V., Belgium|||1||f||||f||||||||||2017-10-10 22:59:26.355199|2017-10-10 22:59:26.355199
NCT02532829|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-10-24|||September 2015||2015-09-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|July 2016|Actual|2016-07-01||Observational|HIPER||Human Intestinal Peptides Evaluation and Research|Effects of Different Metabolic States and Surgical Models on Glucose Metabolism and Secretion of Ileal L-cell Peptides|Enrolling by invitation||N/A|240|Anticipated|Turkish Metabolic Surgery Foundation|||8||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 22:59:26.483231|2017-10-10 22:59:26.483231
NCT02532816|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-21|||October 2013||2013-10-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Interventional|||Nutrient-Dense Complementary Foods on Catch-up Growth and Nutritional Status of Stunting Children|The Effect of Higher Nutrient-Dense Complementary Foods on Catch-up Growth and Nutritional Status of Stunting Children in Dompu District, Indonesia|Unknown status|Active, not recruiting|N/A|217|Actual|SEAMEO Regional Centre for Food and Nutrition||3|||f||||t||||||||||2017-10-10 22:59:26.605395|2017-10-10 22:59:26.605395
NCT02532803|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-03-08|||August 2015||2015-08-01|March 2017|2017-03-01|August 2022|Anticipated|2022-08-01|August 2018|Anticipated|2018-08-01||Interventional|MINSTREL||Mri IN STaging REctal Polyp Planes|Mri IN STaging REctal Polyp Planes|Recruiting||N/A|55|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 22:59:26.709375|2017-10-10 22:59:26.709375
NCT02532790|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-10-29|||August 2015||2015-08-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children|The Research of Standard Diagnosis and Treatment for Henoch-Schonlein Purpura Nephritis With Mild Proteinuria in Children|Recruiting||Phase 2|100|Anticipated|Nanjing Children's Hospital||2|||f||||f||||||||||2017-10-10 22:59:26.867068|2017-10-10 22:59:26.867068
NCT02532764|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-08-15|||June 2015||2015-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients|Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis|Active, not recruiting||Phase 1/Phase 2|64|Anticipated|ProQR Therapeutics||2|||f||||t||||||||||2017-10-10 22:59:27.113018|2017-10-10 22:59:27.113018
NCT02532751|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-11-21|||December 2016||2016-12-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||Effects of Body Contouring Surgery in Obese Patients|Effects of Body Contouring Surgery in Obese Patients: a Prospective Study|Not yet recruiting||N/A|100|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 22:59:27.289663|2017-10-10 22:59:27.289663
NCT02532738|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2015-08-25|||January 2016||2016-01-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||The Efficiency of MSC in Refractory Crohn's Disease|A Stage II Clinical Trial Comparing the Efficiacy of Routine Treatment Combined With or Without MSC Therapy in Refractory Crohn's Disease|Not yet recruiting||Phase 2/Phase 3|3|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||3|||f||||f||||||||||2017-10-10 22:59:27.382194|2017-10-10 22:59:27.382194
NCT02532725|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-23|||June 1972||1972-06-01|August 2015|2015-08-01|December 1972|Actual|1972-12-01|December 1972|Actual|1972-12-01||Observational|||Work-Related Effects of Heat, Activity, and Fat in Middle Aged Men|Relationship of Occupational Heat Stress Endurance, Work, and Percentage of Body Fat in Middle Aged Men|Completed||N/A|12|Actual|Freeman-Sheldon Research Group, Inc.|||2||f||||f||||||||||2017-10-10 22:59:27.485544|2017-10-10 22:59:27.485544
NCT02532699|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-23|||June 2011||2011-06-01|August 2015|2015-08-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|||Anti-hypertensive Effect of Mycelia of Antrodia Cinnamomea|Anti-hypertensive Effect of Fermented Mycelia of Antrodia Cinnamomea Among Mild Hypertensive Subjects in a Double-blinded Randomized Trial|Completed||N/A|41|Actual|Chung Shan Medical University||2|||f||||t||||||||||2017-10-10 22:59:27.726547|2017-10-10 22:59:27.726547
NCT02532686|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-23|||October 2014||2014-10-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia|DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia|Unknown status|Recruiting|Phase 2|60|Anticipated|China Medical University Hospital||2|||f||||f||||||||||2017-10-10 22:59:27.812521|2017-10-10 22:59:27.812521
NCT02532673|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-23|||August 2014||2014-08-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir|Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir|Completed||N/A|1200|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 22:59:27.920635|2017-10-10 22:59:27.920635
NCT02532660|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2016-10-13|||November 2016||2016-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LABCATTCJUSS||Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode|Fase II/III Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode|Not yet recruiting||Phase 2/Phase 3|282|Anticipated|Laboratório Catarinense SA||3|||f||||f||||||||||2017-10-10 22:59:27.994971|2017-10-10 22:59:27.994971
NCT02532647|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-08-03|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy and Safety of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy|A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy|Completed||Phase 3|79|Actual|Paion UK Ltd.||3|||f||||||||||||||2017-10-10 22:59:28.096716|2017-10-10 22:59:28.096716
NCT02532634|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-23|2016-08-30|||August 2015||2015-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|RAPA||Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone|Comparison of Ramosetron, Aprepitant, and Dexamethasone (RAD) With Palonosetron, Aprepitant, and Dexamethasone (PAD) for Prevention of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy|Recruiting||Phase 4|292|Anticipated|Kangdong Sacred Heart Hospital||2|||f||||f||||||||||2017-10-10 22:59:28.199742|2017-10-10 22:59:28.199742
NCT02532621|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-06-26|||November 2015||2015-11-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Evaluation of a Vascular Anastomotic Connector System|Clinical Evaluation of a Vascular Anastomotic Connector System for Minimally Invasive Connection of an Arteriovenous Graft for Hemodialysis|Recruiting||N/A|104|Anticipated|Phraxis, Inc.||2|||f||||f||||||||No||2017-10-10 22:59:28.319111|2017-10-10 22:59:28.319111
NCT02532608|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-09-12|||October 2015||2015-10-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|SleepD-ISO||Infra-slow Oscillations During Sleep|Infra-slow Oscillations During Sleep, After Acute Sleep Deprivation and in Subjects With Restless Legs Syndrome/Periodic Leg Movements During Sleep (RLS/PLMS): an Explorative, Prospective, Monocentric, Observational Case-control and Interventional Study|Recruiting||N/A|20|Anticipated|Neurocenter of Southern Switzerland||1|||f||||f||||||||||2017-10-10 22:59:28.479734|2017-10-10 22:59:28.479734
NCT02532595|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-03-28|||May 2015||2015-05-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||TDN, Manual Therapy and Exercise For the Management of Achilles Tendinopathy|Trigger Point Dry Needling, Manual Therapy and Exercise vs Manual Therapy and Exercise For the Management of Achilles Tendinopathy|Recruiting||N/A|66|Anticipated|Nova Southeastern University||2|||f||||f||||||||||2017-10-10 22:59:28.566191|2017-10-10 22:59:28.566191
NCT02532582|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-09|||May 2015||2015-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Assessment of Patient Positioning|Effort to Reduce Postoperative Brachial Neuropraxia Through Nerve Compression|Enrolling by invitation||N/A|40|Anticipated|Northwestern University|||1||f||||f||||||||||2017-10-10 22:59:28.687222|2017-10-10 22:59:28.687222
NCT02532569|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-02-03|||August 2015||2015-08-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|BR-JELITE||Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj|A Multi-center, Open, phase4 Study to Assess the Long-term Immunogenicity and Safety of Fourth Administration of BR JEV and to Investigate on Vaccine Interchangeability in Children Aged 6 Years Who Received 3 Doses With ENCEVAC or JEV-GCC|Completed||Phase 4|94|Actual|Boryung Pharmaceutical Co., Ltd||1|||f||||f||||||||No||2017-10-10 22:59:28.745415|2017-10-10 22:59:28.745415
NCT02532556|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-12-05|||May 2015||2015-05-01|July 2015|2015-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|Muscle Pump||Electrical Stimulation of the Muscle Pumps of the Leg|Electrical Stimulation of the Muscle Pumps of the Leg|Completed||N/A|12|Actual|Imperial College London||7|||f||||f||||||||||2017-10-10 22:59:28.841507|2017-10-10 22:59:28.841507
NCT02532543|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-09-13|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials|Prospective, Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials (SYMBIOS CORTICAL-CANCELLOUS GRANULE MIX; SYMBIOS OSTEOGRAF LD-300; OSTEOGRAF/N-300) Following Tooth Extraction|Recruiting||N/A|80|Anticipated|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-10-10 22:59:28.913766|2017-10-10 22:59:28.913766
NCT02532530|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-09-08|||June 2015||2015-06-01|September 2015|2015-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ICARUS||Peri-operative Monitoring of Cerebral Oxygenation and the Onset of Delirium in Patients Undergoing Cardiac Surgery|Peri-operative Monitoring of Regional Cerebral Oxygen Saturation and Onset of Delirium in Cardiac Surgery Patients|Recruiting||N/A|200|Anticipated|Hasselt University||1|||f||||f||||||||||2017-10-10 22:59:29.028692|2017-10-10 22:59:29.028692
NCT02532517|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-24|2017-09-07|||September 1, 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 22:59:29.137754|2017-10-10 22:59:29.137754
NCT02532504|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2017-01-13|||August 2015||2015-08-01|August 2015|2015-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CREATOR||Change Your Life With Seven Sheets of Paper|Change Your Life With Seven Sheets of Paper: A Pilot Randomized Controlled Trial for Postnatal Depression: A Pilot Randomized Controlled Trial for Postnatal Depression|Completed||Phase 2|36|Actual|Pakistan Institute of Learning and Living||2|||f||||t||||||||||2017-10-10 22:59:29.189474|2017-10-10 22:59:29.189474
NCT02532491|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-03-13|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|May 2018|Anticipated|2018-05-01||Interventional|PAFIP3_1Y||Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up|Open Flexible-dose Randomized Study of the Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: A 1-year Follow-up|Enrolling by invitation||Phase 4|200|Anticipated|Fundación Marques de Valdecilla||2|||f||||f|f|f||||||No||2017-10-10 22:59:29.278733|2017-10-10 22:59:29.278733
NCT02532478|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-21|||February 2007||2007-02-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Fortune of Temporary Ileostomies in Patients After Rectal Cancer Surgery|Fortune of Temporary Ileostomies in Patients Treated With Laparoscopic Low Anterior Resection for Rectal Cancer|Completed||N/A|160|Actual|Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi|||2||f||||f||||||||||2017-10-10 22:59:29.377694|2017-10-10 22:59:29.377694
NCT02532465|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-07-14|||August 2015||2015-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Glottic View Using Supraglottic Devices in Pediatric Patients|Glottic View Using Supraglottic Devices in Pediatric Patients|Enrolling by invitation||N/A|100|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-10 22:59:29.433835|2017-10-10 22:59:29.433835
NCT02532452|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-05-09|||August 2015||2015-08-01|May 2017|2017-05-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Third Party Anti-Viral Cytotoxic T-Cells|Third Party Anti-viral Cytotoxic T-cells (CTLs) for Treatment of Viral Infections in Immunocompromised Patients|Recruiting||Phase 2|100|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-10 22:59:29.498543|2017-10-10 22:59:29.498543
NCT02532439|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-09-25|||August 2014|Actual|2014-08-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|DMPOs||Bone Microarchitectural Database Constitution From HR-pQCT Device in Clinical Situation Potentially Associated With Bone Loss|Bone Microarchitectural Database Constitution From High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Device in Clinical Situation Potentially Associated With Bone Loss|Recruiting||N/A|400|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 22:59:29.594481|2017-10-10 22:59:29.594481
NCT02532426|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-10-12|||May 2012||2012-05-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|OXYPHEN||Influence of Chronic Hypoxia on Oxidative Phenotype in Patients With Chronic Obstructive Pulmonary Disease|Influence of Chronic Hypoxia on Oxidative Phenotype in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|52|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||||No||2017-10-10 22:59:29.925022|2017-10-10 22:59:29.925022
NCT02532413|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-08-22|||July 2015||2015-07-01|August 2015|2015-08-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B|Comparison of Antiviral Efficacy of Entecavir Monotherapy and Combination Treatment With Poly IC for Chronic Hepatitis B|Unknown status|Recruiting|Phase 4|180|Anticipated|Wuhan Union Hospital, China||4|||f||||f||||||||||2017-10-10 22:59:30.083891|2017-10-10 22:59:30.083891
NCT02532400|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-04-10|||March 2016||2016-03-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|COMPETE||Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients|Comparison of Neoadjuvant Aromatase Inhibitors With Ovarian Suppression Versus Chemotherapy in Premenopausal Patients With Hormone Receptor-positive Breast Cancer (COMPETE): a Randomized Phase 3 Trial|Recruiting||Phase 3|252|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-10 22:59:30.219567|2017-10-10 22:59:30.219567
NCT02529033|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-10-24|||August 2015||2015-08-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Hemodynamic Survey Cardiac Surgical Scenarios|Comparative Hemodynamic Assessment Between Lidco Rapid and Pulmonary Artery Thermodilution|Completed||N/A|64|Actual|University of Iowa|||1||f||||t||||||||||2017-10-10 23:00:09.52106|2017-10-10 23:00:09.52106
NCT02532387|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-03-21|||August 2015||2015-08-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01|1 Month|Observational [Patient Registry]|||Outpatient Treatment of PE and DVT in the Emergency Department|Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis: Impact of a New Protocol on Emergency Department Efficiency and Patient Safety|Recruiting||N/A|400|Anticipated|Massachusetts General Hospital|||3||f||||f||||||||||2017-10-10 22:59:30.351875|2017-10-10 22:59:30.351875
NCT02532374|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-03-29|2017-03-29||September 2015||2015-09-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional||"PK population: all the subjects who have signed the informed consent, completed at least one P3L product use period and for whom at least one PK parameter can been derived. No subjects were excluded due to major protocol deviations impacting the evaluation of the results.
1 subject withdrew after the product test at the admission visit."|Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L|A Single-center, Open-label, Ascending Nicotine Levels Study to Investigate the Nicotine Pharmacokinetic and Pharmacodynamics Profiles, Safety and Tolerability of P3L in Smoking Healthy Subjects in Relation to Nicorette® Inhalator|Completed||N/A|16|Actual|Philip Morris Products S.A.||1|||f||||f|f|f||||||No||2017-10-10 22:59:30.523295|2017-10-10 22:59:30.523295
NCT02532361|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-12-22|||August 2015||2015-08-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Proportion of Hysterectomy After Female Sterilization|A Retrospective Analysis to Describe the Proportion of Hysterectomy After Female Sterilization With Hysteroscopic Device or Tubal Ligation Using Intermountain Healthcare Database in the US|Completed||N/A|10578|Actual|Bayer|||2||f||||f||||||||||2017-10-10 22:59:31.189467|2017-10-10 22:59:31.189467
NCT02532348|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-21|||August 2011||2011-08-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|PLAQUETTE||Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV Infection|Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV Infection|Completed||N/A|133|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||Samples Without DNA|"     blood specimen   "|||2017-10-10 22:59:31.334362|2017-10-10 22:59:31.334362
NCT02532335|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-10-15|||August 2015||2015-08-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|OCAPUSH||Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers|Study of the Effects of Obeticholic Acid on Farnesoid X Receptor Expression in Jejunum and on Gut Microbiota in Morbidly Obese Patients and Healthy Volunteers|Recruiting||Phase 1|40|Anticipated|Sahlgrenska University Hospital, Sweden||4|||f||||f||||||||No||2017-10-10 22:59:31.440204|2017-10-10 22:59:31.440204
NCT02532322|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-08-07|||November 2015||2015-11-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy of Acetaminophen in Posterior Fossa Surgery|Efficacy of Intravenous Acetaminophen as Analgesic Adjuvant Therapy in Children Undergoing Posterior Fossa Surgery|Recruiting||Phase 2|44|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-10 22:59:31.570232|2017-10-10 22:59:31.570232
NCT02532309|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-08-26|||April 2015||2015-04-01|August 2015|2015-08-01||||April 2018|Anticipated|2018-04-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques|A 2-year, Open-label, Randomized Study to Evaluate the Efficacy of Rosuvastatin Dosing Adjustment by LDL-C Level Compared to That of 5mg Maintenance Dose in Chinese Patients With Carotid Atherosclerotic Plaques|Recruiting||Phase 4|308|Anticipated|China-Japan Friendship Hospital||2|||f||||t||||||||||2017-10-10 22:59:31.727208|2017-10-10 22:59:31.727208
NCT02532296|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-08-04|||June 2015||2015-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Improving Hospital-to-Home Care Transitions for High-risk Younger Adult Patients|Improving Hospital-to-Home Care Transitions for High-risk Younger Adult Patients at a Safety Net Hospital: Activating Partnerships Among Patients, Families and Medical Staff|Completed||N/A|201|Actual|Cambridge Health Alliance||2|||f||||f||||||||||2017-10-10 22:59:31.874967|2017-10-10 22:59:31.874967
NCT02532283|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-06-26|||December 11, 2015|Actual|2015-12-11|June 2017|2017-06-01|March 15, 2017|Actual|2017-03-15|February 24, 2017|Actual|2017-02-24||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection|Completed||Phase 2|102|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 22:59:31.994749|2017-10-10 22:59:31.994749
NCT02532270|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-11-05|||September 2015||2015-09-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Detecting Hypotension By Continuous Non-invasive Arterial Pressure Monitoring|Detecting Hypotension By Continuous Non-invasive Arterial Pressure Monitoring During Spinal Anaesthesia for Cesarean Section:A Prospective,Randomized, Controlled Study|Recruiting||N/A|100|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 22:59:32.291158|2017-10-10 22:59:32.291158
NCT02532257|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-06-20|||April 2016|Actual|2016-04-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Ibrutinib in Combination With Rituximab and Lenalidomide in Previously Untreated Subjects With Follicular Lymphoma and Marginal Zone Lymphoma|An Open Label, Phase 2 Study of Ibrutinib in Combination With Rituximab and Lenalidomide in Previously Untreated Subjects With Follicular Lymphoma and Marginal Zone Lymphoma|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:59:32.38768|2017-10-10 22:59:32.38768
NCT02532244|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-24|||June 2015||2015-06-01|August 2015|2015-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|||Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases|Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases|Recruiting||N/A|300|Anticipated|Nemours Children's Clinic|||1||f||||f||||||Samples With DNA|"     serum, lymphoblastoid cell lines derived from peripheral blood mononuclear cells, saliva,     buccal cells   "|||2017-10-10 22:59:32.477084|2017-10-10 22:59:32.477084
NCT02532231|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-04-18|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Nivolumab in Acute Myeloid Leukemia (AML) in Remission at High Risk for Relapse|PD-1 Inhibition With Nivolumab for the Treatment of Patients With Acute Myeloid Leukemia in Remission at High Risk for Relapse|Recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:59:32.57615|2017-10-10 22:59:32.57615
NCT02532218|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-08-05|||August 2015||2015-08-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|REASCEND||Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia|Randomized Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia|Unknown status|Active, not recruiting|Phase 2|176|Anticipated|Arisaph Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-10 22:59:32.684946|2017-10-10 22:59:32.684946
NCT02532192|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-01-05|||December 2015||2015-12-01|January 2016|2016-01-01||||December 2019|Anticipated|2019-12-01||Interventional|||A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma|A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1||Withdrawal of study support.|f||||f||||||||||2017-10-10 22:59:32.795388|2017-10-10 22:59:32.795388
NCT02532179|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|SCITMO||Subcutaneous Immunotherapy for Mouse in Adults|A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)|Completed||Phase 1/Phase 2|50|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-10 22:59:32.924311|2017-10-10 22:59:32.924311
NCT02532166|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-24|||January 2012||2012-01-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus|Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus. Diagnostic Value of White Light Endoscopy, Narrow Band Imaging and Chromoendoscopy for Detection of Esophageal Manifestation in Patients With Oral Lichen.|Unknown status|Recruiting|N/A|50|Anticipated|Ruhr University of Bochum||1|||f||||f||||||||||2017-10-10 22:59:33.068127|2017-10-10 22:59:33.068127
NCT02532153|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-03-01|||February 2017|Anticipated|2017-02-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 2017|Anticipated|2017-02-01||Interventional|||The Impact of Ketamine on the Reward Circuitry of Suicidal Patients|The Impact of Ketamine on the Reward Circuitry of Suicidal Patients: An MRI Study|Withdrawn||Phase 3|0|Actual|Massachusetts General Hospital||1||No funding.|f||||f|t|f|||f|||||2017-10-10 22:59:33.158647|2017-10-10 22:59:33.158647
NCT02532140|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-05-02|||August 2015||2015-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime|Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime Administered as Single IV Doses in Healthy Human Volunteers|Completed||Phase 1|88|Actual|Wockhardt||3|||f||||f||||||||||2017-10-10 22:59:33.242504|2017-10-10 22:59:33.242504
NCT02532127|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-10-25|||December 2014||2014-12-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|DIMITRA||Dentomaxillofacial Paediatric Imaging: An Investigation Towards Low Dose Radiation Induced Risks|Dentomaxillofacial Paediatric Imaging: An Investigation Towards Low Dose Radiation Induced Risks|Active, not recruiting||N/A|50|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-10 22:59:33.316467|2017-10-10 22:59:33.316467
NCT02532114|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-06-08|||December 2015||2015-12-01|June 2017|2017-06-01||||June 2018|Anticipated|2018-06-01||Interventional|||Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer|A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer|Recruiting||Phase 1|12|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-10 22:59:33.399055|2017-10-10 22:59:33.399055
NCT02532101|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-05-01|||December 2014||2014-12-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|UNIDOPP||Modulating Effects of Oil Palm Phenolics in Uncontrolled Insulin-treated Type 2 Diabetes Mellitus|Modulating Effects of Oil Palm Phenolics in Uncontrolled Insulin-treated Type 2 Diabetes Mellitus|Terminated||N/A|8|Actual|University of Science Malaysia||1||Study was terminated due to futility.|f||||t||||||||No||2017-10-10 22:59:33.501711|2017-10-10 22:59:33.501711
NCT02532088|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-05-01|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|PREDOPP||Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes|Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes|Not yet recruiting||Phase 2|268|Anticipated|University of Science Malaysia||2|||f||||t|f|f||||||No||2017-10-10 22:59:33.585043|2017-10-10 22:59:33.585043
NCT02532075|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-10-26|||February 2016||2016-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of a Respiratory Muscle Warm-up Prior to Exercise in Patients With Chronic Obstructive Pulmonary Disease|The Effect of a Respiratory Muscle Warm-up Prior to Exercise in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Terminated||N/A|5|Actual|University of Portsmouth||4||Recruitment difficulties|f||||f||||||||No||2017-10-10 22:59:33.680678|2017-10-10 22:59:33.680678
NCT02532062|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-06-22|||January 2016||2016-01-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Interventional|||The Pittsburgh Vitamin D Study: Vitamin D Supplementation in Vitamin D-deficient Subjects at Risk of Lung Cancer|Efficacy of Vitamin D Supplementation in Vitamin D-deficient Subjects at Risk of Lung Cancer (The Pittsburgh Vitamin D Study)|Recruiting||Phase 2|120|Anticipated|University of Pittsburgh||2|||f||||t||||||||Undecided||2017-10-10 22:59:33.780052|2017-10-10 22:59:33.780052
NCT02532049|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-07-14|||October 12, 2015|Actual|2015-10-12|July 2017|2017-07-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313|A Phase Ia Clinical Trial to Assess the Safety, Immunogenicity and Ex-vivo Efficacy of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 Pfs-IMX313 Alone and With MVA Pfs25-IMX313|Completed||Phase 1|26|Actual|University of Oxford||4|||f||||||||||||||2017-10-10 22:59:35.880986|2017-10-10 22:59:35.880986
NCT02532036|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-03-08|||September 2015||2015-09-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection|A Phase I Trial to Compare the Safety and Immunogenicity of Candidate TB Vaccine MVA85A Administered by the Aerosol Inhaled Route and the Intramuscular Route in Healthy Adult Volunteers Who Are Latently Infected With Mycobacterium Tuberculosis|Recruiting||Phase 1|15|Anticipated|University of Oxford||3|||f||||f||||||||||2017-10-10 22:59:35.979118|2017-10-10 22:59:35.979118
NCT02532023|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-24|||September 2015||2015-09-01|August 2015|2015-08-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|||The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients|The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Gene Expression and Serum Levels of Some Inflammatory and Endothelial Factors in Migraine Patients|Unknown status|Enrolling by invitation|Phase 4|80|Anticipated|Tehran University of Medical Sciences||4|||f||||t||||||||||2017-10-10 22:59:36.111858|2017-10-10 22:59:36.111858
NCT02532010|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-02-17|||June 2015||2015-06-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|Pacritinib||Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML|Induction Therapy With Pacritinib Combined With Decitabine or Cytarabine in Older Patients With Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 2|60|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||Yes|data will be shared with the sponsor|2017-10-10 22:59:36.233582|2017-10-10 22:59:36.233582
NCT02531997|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-04-26|||August 2015||2015-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Mind-body Intervention to Improve Body and/or Self Image|A Mind-body Intervention to Improve Body and/or Self Image: a Phase II Randomized Trial|Recruiting||N/A|97|Anticipated|University of Michigan||2|||f||||t||||||||No|Small pilot study for feasibility and effect size. Data would not be helpful to others; too small for secondary analysis.|2017-10-10 22:59:36.356435|2017-10-10 22:59:36.356435
NCT02531984|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2015-08-24|||August 2015||2015-08-01|August 2015|2015-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|AZI-STOP||The Efficacy of Azithromycin in Treating Children With Non Cystic Fibrosis Bronchiectasis|Open Trial With Randomized Withdrawal of Treatment, to Evaluate the Efficacy of Azithromycin in the Treatment of Children With Non Cystic Fibrosis Bronchiectasis ( AZI-STOP Study )|Active, not recruiting||Phase 3|100|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 22:59:36.470895|2017-10-10 22:59:36.470895
NCT02531971|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-09-08|||January 2015||2015-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Fentanyl Patch Pharmacokinetics in Healthy Adults|Absolute Bioavailability/ Pharmacokinetic and Residual Drug Analysis of Duragesic ® Transdermal System and Generic Fentanyl Transdermal System in Healthy Adults|Recruiting||Phase 4|24|Anticipated|University of Maryland||2|||f||||f|t|f|||f|||||2017-10-10 22:59:36.535857|2017-10-10 22:59:36.535857
NCT02531958|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-06-23|||August 14, 2015|Actual|2015-08-14|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|December 18, 2015|Actual|2015-12-18||Interventional|||Assessment of Optimal Egg Intake in a Healthy Population|Assessment of Optimal Egg Intake in a Healthy Population|Completed||N/A|38|Actual|University of Connecticut||3|||f||||f||||||||||2017-10-10 22:59:36.657294|2017-10-10 22:59:36.657294
NCT02531945|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-10-13|||September 2015||2015-09-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SCOBIOMOD||Evaluation of the Surface Topography for Monitoring Scoliosis Patients Aged 10-13 Years|Scoliosis Patients Aged 10-13 Years: Monitoring of Scoliosis by the Surface Topography|Recruiting||N/A|125|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-10 22:59:36.748404|2017-10-10 22:59:36.748404
NCT02531932|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-04-19|||August 2015||2015-08-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer|A Multi-Centered Randomized Phase II Study Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer|Recruiting||Phase 2|72|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 22:59:37.012788|2017-10-10 22:59:37.012788
NCT02531919|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-04-12|||August 2013||2013-08-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Extended Use of Sodium Bicarbonate in Patients With Cancer|Chronic Oral Bicarbonate Feasibility Study|Completed||Phase 1|15|Actual|University of Arizona||1|||f||||t||||||||||2017-10-10 22:59:37.133376|2017-10-10 22:59:37.133376
NCT02531906|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-04-24|||April 2015||2015-04-01|April 2017|2017-04-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation|Analysis of Analgesia Regimens During Concurrent Chemoradiation for Head and Neck Cancer: A Pilot Study|Recruiting||N/A|60|Anticipated|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-10 22:59:37.24193|2017-10-10 22:59:37.24193
NCT02531893|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2017-09-12|||August 13, 2015||2015-08-13|August 21, 2017|2017-08-21|December 30, 2022|Anticipated|2022-12-30|August 1, 2019|Anticipated|2019-08-01||Observational|||Psychological Treatments for Youth With Severe Irritability.|Psychological Treatments for Youth With Severe Irritability.|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 22:59:37.396087|2017-10-10 22:59:37.396087
NCT02531880|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-22|2017-10-05|||August 6, 2015||2015-08-06|June 21, 2017|2017-06-21|June 28, 2019|Anticipated|2019-06-28|June 30, 2018|Anticipated|2018-06-30||Interventional|||Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy|Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy|Suspended||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 22:59:37.50904|2017-10-10 22:59:37.50904
NCT02531867|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-03-28|2016-11-28||June 2015|Actual|2015-06-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||All patients who met all of the inclusion and none of the exclusion criteria were considered the Baseline Analysis Population.|Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan|A Multicenter, Post-Approval Clinical Study for Asfotase Alfa (Human Recombinant Tissue-nonspecific Alkaline Phosphatase Fusion Protein) Treatment for Patients With Hypophosphatasia (HPP) in Japan|Completed||Phase 4|13|Actual|Alexion Pharmaceuticals||1|||f||||f||||||||||2017-10-10 22:59:37.613566|2017-10-10 22:59:37.613566
NCT02531854|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-06-17|||December 2016||2016-12-01|June 2016|2016-06-01||||March 2019|Anticipated|2019-03-01||Interventional|||A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy|A Phase 2, Open-label, Randomized, Parallel Group, Controlled Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus-Positive, Non-Squamous, Non-Small Cell Lung Carcinoma Following First-Line Induction Chemotherapy|Not yet recruiting||Phase 2|124|Anticipated|Advaxis, Inc.||2|||f||||f||||||||||2017-10-10 22:59:37.873233|2017-10-10 22:59:37.873233
NCT02531841|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-24|||July 2014||2014-07-01|August 2015|2015-08-01|December 2019|Anticipated|2019-12-01|November 2017|Anticipated|2017-11-01||Interventional|MATRix||High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma|High-dose Chemotherapy and Autologous Stem Cell Transplant or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma - Randomized Phase III Trial|Recruiting||Phase 3|250|Anticipated|University Hospital Freiburg||2|||f||||t||||||||||2017-10-10 22:59:37.991318|2017-10-10 22:59:37.991318
NCT02531828|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-08-24|||August 2014||2014-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study Comparing the Polyurethane Films and Sugarcane Biopolymer Used as Dressings|Expansion of Prospective Randomized Study Comparing the Polyurethane Films and Sugarcane Biopolymer Used as Dressings|Completed||Phase 3|141|Actual|Polisa - Biopolímeros para Saúde||2|||f||||t||||||||||2017-10-10 22:59:38.124416|2017-10-10 22:59:38.124416
NCT02531815|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-08-10|||August 2015||2015-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Dose Escalation Study of PF-06741086 In Healthy Subjects|A Randomized, Double-blind, Sponsor-open, Placebo-controlled, Single Intravenous Or Subcutaneous Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Pf-06741086 In Healthy Subjects And An Open-label Evaluation In Healthy Japanese Subjects|Completed||Phase 1|41|Actual|Pfizer||8|||f||||f||||||||||2017-10-10 22:59:38.224878|2017-10-10 22:59:38.224878
NCT02531802|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-05-23|||October 2015||2015-10-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ETVAX/dmLT||Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh|A Randomized, Double-blind, Placebo-controlled, Dose-Escalation Study Evaluating the Safety, Tolerability, and Immunogenicity of an Oral Inactivated ETEC Vaccine (ETVAX) Alone and Together With dmLT Adjuvant in Descending Age Groups in Bangladesh|Recruiting||Phase 1/Phase 2|500|Anticipated|PATH||13|||f||||t||||||||||2017-10-10 22:59:38.35744|2017-10-10 22:59:38.35744
NCT02531789|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-20|||November 2010||2010-11-01|August 2015|2015-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|CPOP||Procedure Outcome Predictor (POP) Using the Complement Cascade|Procedure Outcome Predictor (POP) Using the Complement Cascade|Completed||N/A|45|Actual|University of Exeter|||1||f||||f||||||||||2017-10-10 22:59:38.548295|2017-10-10 22:59:38.548295
NCT02531776|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-08-20|||December 2014||2014-12-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|NEEDLE||Patient Experiences With Injection Needles|Patient Experiences With Injection Needles|Completed||N/A|30|Actual|University of Copenhagen||1|||f||||f||||||||||2017-10-10 22:59:38.642416|2017-10-10 22:59:38.642416
NCT02531763|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-08-29|||September 2015||2015-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|BEFIT||Behavioral Economics Framingham Incentive Trial (BE FIT)|Behavioral Economics Framingham Incentive Trial: A Randomized Controlled Trial|Completed||N/A|206|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-10-10 22:59:38.778114|2017-10-10 22:59:38.778114
NCT02531750|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Metabolic Complications Following Achilles Tendon Rupture - A Cohort Study|Metabolic Complications Following Achilles Tendon Rupture - A Cohort Study|Completed||N/A|14|Actual|Hvidovre University Hospital|||1||f||||t||||||Samples With DNA|"     Blod and urine samples   "|||2017-10-10 22:59:38.861372|2017-10-10 22:59:38.861372
NCT02531737|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-06-23|||September 2015||2015-09-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|REFRACT||Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer|Multicenter Phase II Trial of Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With no Squamous Non Small Cell Lung Cancer Refractory to First Line Chemotherapy|Recruiting||Phase 2|59|Anticipated|University Hospital, Limoges||1|||f||||t||||||||||2017-10-10 22:59:38.965056|2017-10-10 22:59:38.965056
NCT02531724|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-10-03|||September 2015||2015-09-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|LEVOAKI||Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery|Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery|Recruiting||Phase 4|30|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-10 22:59:39.307089|2017-10-10 22:59:39.307089
NCT02531711|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-04-19|||September 2015||2015-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|LRPD||Chronic Lumbosacral Radiculopathy: Impact of an Analgesic Dietary Intervention on Pain & Function|Chronic Lumbosacral Radiculopathy: Impact of an Analgesic Dietary Intervention on Pain & Function|Recruiting||N/A|52|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||Yes|Deidentified data will be shared with investigators at NIH.|2017-10-10 22:59:39.493719|2017-10-10 22:59:39.493719
NCT02531698|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-04-05|||August 27, 2015|Actual|2015-08-27|April 2017|2017-04-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years|A Phase 2, Randomized, Controlled, Observer-blinded Study To Describe The Immunogenicity, Safety, And Tolerability Of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent Rlp2086) In Healthy Subjects Aged >/= 24 Months To <10 Years|Completed||Phase 2|403|Actual|Pfizer||2|||f||||t||||||||||2017-10-10 22:59:39.655305|2017-10-10 22:59:39.655305
NCT02531672|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-09-26||||||September 2017|2017-09-01||||||||Expanded Access|||Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography|Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography: An Expanded Access Study|Available||N/A|||Memorial Sloan Kettering Cancer Center|||||||||||||||||||2017-10-10 22:59:40.048568|2017-10-10 22:59:40.048568
NCT02145676|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-03-14|2016-12-22||May 2014||2014-05-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity||Terminated||Phase 3|53|Actual|Allergan||3|||f||||t||||||||||2017-10-11 00:23:39.68945|2017-10-11 00:23:39.68945
NCT02531646|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-01-27|2016-09-14||November 2015||2015-11-01|August 2015|2015-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||37 live human DE cases, 18 live human DT cases, 11 phantom images.|Clinical Evaluation of CARESTREAM Dual Energy and Digital Tomosynthesis|Clinical Evaluation of CARESTREAM Dual Energy and Digital Tomosynthesis|Completed||N/A|66|Actual|Carestream Health, Inc.||3|||f||||f||||||||No||2017-10-10 22:59:40.162541|2017-10-10 22:59:40.162541
NCT02531633|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-07-17|||October 16, 2015||2015-10-16|July 2017|2017-07-01|November 27, 2020|Anticipated|2020-11-27|November 30, 2018|Anticipated|2018-11-30||Interventional|||Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Patients With Giant Cell Arteritis|Recruiting||Phase 3|204|Anticipated|GlaxoSmithKline||6|||f||||t||||||||||2017-10-10 22:59:40.657098|2017-10-10 22:59:40.657098
NCT02531620|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-11-22|||September 2015||2015-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Prehab||Prehabilitation in Elective Colorectal Resection: A Pilot Study (Prehab)|Prehabilitation Interventions in Elective Colorectal Resections: A Randomized Pilot Study (Prehab)|Recruiting||N/A|70|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-10 22:59:41.372414|2017-10-10 22:59:41.372414
NCT02531607|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-08-02|||June 2015||2015-06-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)|Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds Biomarkers in Bile and Serum in the Diagnosis of Malignant Biliary Strictures|Recruiting||N/A|500|Anticipated|Florida Hospital|||1||f||||f||||||Samples With DNA|"     bile and blood   "|||2017-10-10 22:59:41.471983|2017-10-10 22:59:41.471983
NCT02531594|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-04-12|||April 6, 2016|Actual|2016-04-06|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||An Intervention to Reduce Second Hand Smoke Exposure Among Pediatric Emergency Patients|An Intervention to Reduce Second Hand Smoke Exposure Among Pediatric Emergency Patients|Recruiting||N/A|750|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No||2017-10-10 22:59:41.546865|2017-10-10 22:59:41.546865
NCT02531581|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-08-10|||December 23, 2015|Actual|2015-12-23|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Interventional|||Diuretic Vascular Filling in the Initial Management of Acute PE With Right Ventricular Dysfunction Normotensive|Comparing a Diuretic Vascular Filling in the Initial Management of Acute Pulmonary Embolism With Right Ventricular Dysfunction Normotensive|Recruiting||Phase 4|60|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 22:59:41.65964|2017-10-10 22:59:41.65964
NCT02531568|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-10-07|||June 2015||2015-06-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Drug Interaction Study of Warfarin and MT-3995|A Phase I, Open-label, Single-Centre, Drug-Drug Interaction Study to Evaluate the Influence of MT-3995 on Pharmacokinetics(PK) and Pharmacodynamics of Warfarin in Healthy Subjects|Completed||Phase 1|20|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||||||||||||2017-10-10 22:59:41.761844|2017-10-10 22:59:41.761844
NCT02531555|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-21|||January 2013||2013-01-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Clinical Efficacy Of 810 Nanometer Diode Laser As An Adjunct To Mechanical Periodontal Treatment Of Residual Periodontal Pockets||Completed||N/A|11|Actual|Marmara University||3|||f||||f||||||||||2017-10-10 22:59:41.859166|2017-10-10 22:59:41.859166
NCT02531542|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-08-20|||September 2015||2015-09-01|August 2015|2015-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|READ||Evaluation of Rapid Emergency Echography for Acute Dyspnoea|Evaluation of Rapid Emergency Echography for Acute Dyspnoea for the Diagnosis of Acute Left-sided Heart Failure in Elderly Subjects Admitted to the Emergency Room (READ Protocol)|Unknown status|Not yet recruiting|N/A|500|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 22:59:41.952352|2017-10-10 22:59:41.952352
NCT02531529|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-21|||January 2014||2014-01-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Dexmedetomedine Infusion Versus Fentanyl Infusion for Donor Anlgesia During Living Donor Hepatectomy||Completed||N/A|70|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 22:59:42.050733|2017-10-10 22:59:42.050733
NCT02531516|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-09-21|||November 19, 2015|Actual|2015-11-19|September 2017|2017-09-01|October 6, 2026|Anticipated|2026-10-06|December 30, 2022|Anticipated|2022-12-30||Interventional|||An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS|ATLAS: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment With Primary Radiation Therapy|Recruiting||Phase 3|1500|Anticipated|Aragon Pharmaceuticals, Inc.||2|||f||||t||f||||||||2017-10-10 22:59:42.367005|2017-10-10 22:59:42.367005
NCT02531503|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-03-21|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|||Predicting Factors for Asthma Remission in Children|Predicting Factors for Asthma Remission in Children|Completed||N/A|200|Actual|Mahidol University|||1||f||||t|f|f||||||No||2017-10-10 22:59:43.641155|2017-10-10 22:59:43.641155
NCT02531490|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-02-04|||December 2015||2015-12-01|February 2016|2016-02-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|EVA||Early Vascular Adjustments During Hypertensive Pregnancy|Personalized Hemodynamically Guided Antihypertensive Treatment in Pregnant Women With Mild to Moderate Hypertension: a Randomized Controlled Trial|Recruiting||Phase 4|368|Anticipated|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-10 22:59:43.741559|2017-10-10 22:59:43.741559
NCT02531477|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-08-21|||January 2015||2015-01-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|ICAAD||Intra-carotid Anesthetic Agent Delivery||Unknown status|Recruiting|N/A|5|Anticipated|Mansoura University||1|||f||||f||||||||||2017-10-10 22:59:43.876143|2017-10-10 22:59:43.876143
NCT02531464|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-01-24|||July 2015||2015-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intervention to Improve Supportive Care for Family Caregivers of Patients With Lung Cancer|Effectiveness of a Multi-faceted Intervention to Improve Supportive Care for Family Caregivers of Patients With Lung Cancer|Recruiting||N/A|120|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 22:59:43.959866|2017-10-10 22:59:43.959866
NCT02531451|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-06-27|||September 2015||2015-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|NSAID2015||The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise in Healthy Adults|The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise|Completed||Phase 2|34|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 22:59:44.07178|2017-10-10 22:59:44.07178
NCT02531438|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-07-13|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|March 10, 2017|Actual|2017-03-10|February 5, 2017|Actual|2017-02-05||Interventional|||Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)|A Phase 3 Randomized, Double-Blind, Multi-Center Study to Compare the Safety and Efficacy of Omadacycline Intravenous (IV)/Oral (PO) to Moxifloxacin IV/PO for Treating Adults Subjects With Community-Acquired Bacterial Pneumonia|Completed||Phase 3|774|Actual|Paratek Pharmaceuticals Inc||2|||f||||t||||||||||2017-10-10 22:59:44.299381|2017-10-10 22:59:44.299381
NCT02531425|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-09-27|||September 2015||2015-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TNBC||Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC|Evaluation of Pharmacodynamic Effects of Intratumoral Delivery of Plasmid IL-12 Electroporation in Patients With Triple Negative Breast Cancer|Recruiting||Phase 1|10|Anticipated|OncoSec Medical Incorporated||1|||f||||f||||||||||2017-10-10 22:59:44.710783|2017-10-10 22:59:44.710783
NCT02531412|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-01-02|||October 2015||2015-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|SPIROCAN||Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients|Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients|Recruiting||Phase 2/Phase 3|24|Anticipated|Instituto Nacional de Cancerologia de Mexico||2|||f||||t||||||||No||2017-10-10 22:59:44.815338|2017-10-10 22:59:44.815338
NCT02531399|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-09-02|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Interventional|||Measurement of Total Retinal Blood Flow During Flicker Stimulation in Healthy Subjects|Measurement of Total Retinal Blood Flow During Flicker Stimulation in Healthy Subjects|Completed||N/A|20|Actual|Medical University of Vienna||1|||f||||||||||||||2017-10-10 22:59:44.936287|2017-10-10 22:59:44.936287
NCT02531386|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-11-06|||August 2015||2015-08-01|September 2015|2015-09-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||System Accuracy Evaluation of 6 CE-marked Blood Glucose Monitoring System Following ISO 15197:2013|System Accuracy Evaluation of Accu-Chek Aviva Nano (Roche Diagnostics), Accu-Chek Performa Nano (Roche Diagnostics), FreeStyle Lite (Abbott Diabetes Care), OneTouch Verio IQ (LifeScan), Contour Next Link 2.4 (Bayer Consumer Care), One Additional CE-marked Blood Glucose Monitoring System Following ISO 15197:2013|Completed||N/A|120|Anticipated|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm|||||f||||||||||||||2017-10-10 22:59:45.052589|2017-10-10 22:59:45.052589
NCT02531373|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-05-08|||September 15, 2015|Actual|2015-09-15|May 2017|2017-05-01|April 14, 2017|Actual|2017-04-14|April 14, 2017|Actual|2017-04-14||Interventional|||A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)|A Phase I-II, Randomized, Double-Blind, Study to Evaluate the Safety, Tolerability, and Immunogenicity of Different Formulations of V114 in Healthy Adults and Infants|Completed||Phase 1/Phase 2|338|Actual|Merck Sharp & Dohme Corp.||9|||f||||t||||||||||2017-10-10 22:59:45.127267|2017-10-10 22:59:45.127267
NCT02531360|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-12-15|||May 2015||2015-05-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies|Phase 0 Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Alzheimer's Disease and Other Tauopathies|Completed||Early Phase 1|7|Actual|Molecular NeuroImaging||1|||f||||f||||||||||2017-10-10 22:59:45.230048|2017-10-10 22:59:45.230048
NCT02531347|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-21|||March 2011||2011-03-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Telemedical and Conventional Treatment of Hypertension|Treatment of Hypertension Using Telemedical Home Blood Pressure Measurements|Completed||N/A|375|Actual|Regional Hospital Holstebro||2|||f||||f||||||||||2017-10-10 22:59:45.323926|2017-10-10 22:59:45.323926
NCT02531334|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-01-04|||August 2015||2015-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of TA-65, a Telomerase Activator on Metabolic Syndrome|Effects of TA-65, a Telomerase Activator on Metabolic Syndrome|Recruiting||N/A|40|Anticipated|University of Connecticut||2|||f||||f||||||||||2017-10-10 22:59:45.423325|2017-10-10 22:59:45.423325
NCT02531321|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-03-30|||August 2015||2015-08-01|March 2017|2017-03-01|November 1, 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics|Effects of Protease Inhibitor Use on Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics in HIV-positive Women|Terminated||Phase 4|17|Actual|University of Southern California||2||Difficulty recruiting|f||||f||||||||||2017-10-10 22:59:45.524672|2017-10-10 22:59:45.524672
NCT02531308|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-12-01|2016-12-01||July 2015||2015-07-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|DLBCL||Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)|A Phase ll Study Evaluating the Efficacy and Safety of Metformin in Combination With Standard Induction Therapy (RM-CHOP) for Previously Untreated Aggressive Diffuse Large B-cell Lymphoma|Terminated||Phase 2|5|Actual|Rush University Medical Center|Unable to report on endpoint of 2 year PFS as trial prematurely terminated|1||poor accrual|f||||t||||||||Undecided||2017-10-10 22:59:45.610488|2017-10-10 22:59:45.610488
NCT02531295|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-05-01|||June 1, 2018|Anticipated|2018-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study|Immunologic Response to Euphorbia Kansui Extract Powder Prepared as Tea in HIV-infected Antiretroviral Therapy (ART)-Suppressed Individuals: a Dose Escalation Study|Suspended||Phase 1|9|Anticipated|University of California, San Francisco||3||Investigate pre-clinical safety in a non-human primate dose escalation trial of kansui.|f||||t|t|f||||||||2017-10-10 22:59:45.819845|2017-10-10 22:59:45.819845
NCT02530931|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-05-02|||March 2016||2016-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|PROSPER||Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease|Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease|Recruiting||Phase 4|47|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 22:59:49.733595|2017-10-10 22:59:49.733595
NCT02531282|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2017-02-12|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of a Health Promotion Intervention for People With Chronic Pain at a Healthy Life Centre|Effect of and Experiences With a Health Promotion Intervention for People With Chronic Pain at a Healthy Life Centre - an Open, Pragmatic, Randomized Controlled Trial With a Nested Qualitative Study|Active, not recruiting||N/A|121|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 22:59:45.904072|2017-10-10 22:59:45.904072
NCT02531269|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-05-06|||March 2015||2015-03-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period|Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period|Completed||N/A|249|Actual|Bristol-Myers Squibb|||4||f||||f||||||||||2017-10-10 22:59:46.17248|2017-10-10 22:59:46.17248
NCT02531256|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-21|2016-02-28|||January 2014||2014-01-01|August 2015|2015-08-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|LMA||An Investigation of a New Laryngeal Mask Airway LMA Protector|An Investigation of a New Laryngeal Mask Airway LMA Protector|Completed||N/A|40|Actual|KK Women's and Children's Hospital||1|||f||||f||||||||No||2017-10-10 22:59:46.255635|2017-10-10 22:59:46.255635
NCT02531243|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-02-07|||September 2015||2015-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|CALMS||Computer-Aided Learning for Managing Stress|A Pilot Study of Computerized Biofeedback Games With Young People Experiencing Psychotic-Spectrum Symptoms|Recruiting||N/A|34|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||t||||||||No||2017-10-10 22:59:46.333768|2017-10-10 22:59:46.333768
NCT02531230|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-02-21|||August 2015||2015-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|LOCOMOTIVE||"All Comers Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes"|"All Comers Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes After Plain Old Balloon Angioplasty (POBA) and/or Drug Coated Balloon (DCB) Treatment in the Infra-inguinal Position With the objectiVE to Implant Multiple Stent Segments"|Active, not recruiting||N/A|75|Actual|B. Braun Melsungen AG|||1||f||||t||||||||Undecided||2017-10-10 22:59:46.42883|2017-10-10 22:59:46.42883
NCT02531217|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-05-15|||September 2015||2015-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety, Tolerability, PK, and Activity of ATYR1940 in Patients With Muscular Dystrophy - Study Extension|An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, Biological Activity, and Systemic Exposure of ATYR1940 in Adult Patients With Fascioscapulohumeral Muscular Dystrophy (FSHD)|Active, not recruiting||Phase 1/Phase 2|32|Anticipated|aTyr Pharma, Inc.||1|||f||||t||||||||||2017-10-10 22:59:46.517918|2017-10-10 22:59:46.517918
NCT02531204|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-08-20|||August 2014||2014-08-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules|Pharmacodynamic Study of ASP1585 - Verification of Bioequivalence Between ASP1585 Granules and ASP1585 Capsules|Completed||Phase 1|60|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 22:59:46.597467|2017-10-10 22:59:46.597467
NCT02531191|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-08-20|||June 2015||2015-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Bioequivalence Evaluation of a New and Current Tablet of ASP015K|ASP015K Pharmacokinetic Study - Bioequivalence Evaluation of a Small and Current Tablet of ASP015K|Completed||Phase 1|40|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 22:59:46.670432|2017-10-10 22:59:46.670432
NCT02531178|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-03-01|||July 2015||2015-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ABBV-257|Completed||Phase 1|8|Actual|AbbVie||3|||f||||f||||||||||2017-10-10 22:59:46.756896|2017-10-10 22:59:46.756896
NCT02531165|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-21|||September 2015||2015-09-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|PERSEUS||Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Comparison of Analgesia With Fentanyl and Morphine on Platelet Inhibition After Pre-hospital Ticagrelor Administration in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Unknown status|Not yet recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||||2017-10-10 22:59:46.873201|2017-10-10 22:59:46.873201
NCT02531152|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-04-26|||September 2015||2015-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension|A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension|Completed||Phase 1|54|Actual|Sanofi||6|||f||||f||||||||||2017-10-10 22:59:47.090363|2017-10-10 22:59:47.090363
NCT02531139|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-09-26|||March 1, 2017|Anticipated|2017-03-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery|The Effect of Blood Pressure on Cerebral Perfusion and Oxygenation During Vascular Surgery|Withdrawn||N/A|0|Actual|Rigshospitalet, Denmark||2||Study was not feasible.|f||||t|f|f||||||||2017-10-10 22:59:47.208904|2017-10-10 22:59:47.208904
NCT02531126|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-05-31|||December 2, 2015|Actual|2015-12-02|May 2017|2017-05-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis|A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis|Recruiting||Phase 3|1200|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 22:59:47.362236|2017-10-10 22:59:47.362236
NCT02096432|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-05-04|||October 2014||2014-10-01|May 2016|2016-05-01||||April 2017|Anticipated|2017-04-01||Interventional|||Suicide Prevention in Chinese Older Adults|Suicide Prevention in Chinese Older Adults|Recruiting||N/A|100|Anticipated|Rush University Medical Center||2|||f||||||||||||||2017-10-11 00:38:03.811271|2017-10-11 00:38:03.811271
NCT02531113|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-08-31|||October 9, 2015|Actual|2015-10-09|August 2017|2017-08-01|October 12, 2019|Anticipated|2019-10-12|January 9, 2018|Anticipated|2018-01-09||Interventional|||Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease|A Phase 2, Multi-Center, Open-Label Induction Trial With Extension Period to Access Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients With Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy|Active, not recruiting||Phase 2|69|Actual|Celgene||1|||f||||t||||||||||2017-10-10 22:59:47.966571|2017-10-10 22:59:47.966571
NCT02531100|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-12-06|||March 2016||2016-03-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||BonyPid-500TM Bone Graft Substitute Study|PolyPid, Ltd. Pilot Study of the BonyPid-500TM Bone Graft Substitute|Recruiting||N/A|77|Anticipated|PolyPid Ltd.||2|||f||||f||||||||No||2017-10-10 22:59:48.100111|2017-10-10 22:59:48.100111
NCT02531087|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-10-26|||September 2015||2015-09-01|October 2016|2016-10-01|September 2025|Anticipated|2025-09-01|September 2020|Anticipated|2020-09-01||Observational|||Urinary Biomarkers of OI Pathobiology|Cross-Linked Collagen Peptides as a Urinary Biomarker of OI Pathobiology|Recruiting||N/A|30|Anticipated|Baylor College of Medicine|||2||f||||f||||||Samples Without DNA|"     Urine samples will be collected   "|No||2017-10-10 22:59:48.189821|2017-10-10 22:59:48.189821
NCT02531074|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-05-11|||January 2015||2015-01-01|May 2016|2016-05-01||||June 2017|Anticipated|2017-06-01||Interventional|SOS||Swipe Out Stroke (SOS): Feasibility of Using a Consumer Based Electronic Application to Improve Compliance With Weight Loss in Obese Minority Stroke Patients|Swipe Out Stroke (SOS): Feasibility of Using a Consumer Based Electronic Application to Improve Compliance With Weight Loss in Obese Minority Stroke Patients|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 22:59:48.301813|2017-10-10 22:59:48.301813
NCT02531061|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2017-06-26|||May 5, 2013|Actual|2013-05-05|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy|Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 22:59:48.396956|2017-10-10 22:59:48.396956
NCT02531048|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-03-22|||February 2008||2008-02-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|April 2012|Actual|2012-04-01||Interventional|||Normative Values Laser Nociceptive Evoked Potentials Depending on the Age|Normative Values Laser Nociceptive Evoked Potentials Depending on the Age|Completed||N/A|120|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 22:59:48.500664|2017-10-10 22:59:48.500664
NCT02531035|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2016-11-03|||September 2015||2015-09-01|November 2016|2016-11-01||||March 2017|Anticipated|2017-03-01||Interventional|inTandem3||A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone|A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes|Active, not recruiting||Phase 3|1400|Anticipated|Lexicon Pharmaceuticals||2|||f||||t||||||||||2017-10-10 22:59:48.581782|2017-10-10 22:59:48.581782
NCT02531022|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-04-06|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|April 3, 2017|Actual|2017-04-03|February 2017|Actual|2017-02-01||Interventional|||Evaluating Increasing Physical Activity After Acute Coronary Syndrome|A Randomized, Controlled Trial Evaluating Methods to Use Physical Activity to Improve Outcomes After Acute Coronary Syndrome|Completed||N/A|105|Actual|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 22:59:48.99205|2017-10-10 22:59:48.99205
NCT02531009|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-10-30|||December 2015||2015-12-01|October 2015|2015-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Systemic Sclerosis Clinical and Biomarker Study|A Multicenter, Prospective, Longitudinal Study to Evaluate Gastrointestinal Function and Clinical and Molecular Biomarkers in Subjects With Early and Late Diffuse Cutaneous Systemic Sclerosis, Limited Cutaneous Systemic Sclerosis, and Healthy Volunteers|Withdrawn||N/A|0|Actual|Biogen|||2||f||||f||||||Samples With DNA|"     RNA (ribonucleic acid) will be extracted for gene expression from the skin biopsies, skin     tape, and blood.   "|||2017-10-10 22:59:49.089468|2017-10-10 22:59:49.089468
NCT02530996|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-08-10|||May 1, 2015|Actual|2015-05-01|August 2017|2017-08-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01|36 Months|Observational [Patient Registry]|Scleroderma||Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment|Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment|Recruiting||N/A|32|Anticipated|VA Office of Research and Development|||2||f||||f|f|f|||f|Samples With DNA|"     1. Plasma BH4 and BH2 levels        2. NO measurements.        3. Two 3 mm punch skin biopsies and skin resistance artery collection.        4. Spin trapping and electron paramagnetic resonance (EPR) spectroscopy in skin resistance          arteries.        5. Oxidant and antioxidant gene expression in skin arterioles and whole blood.        6. Oxidative stress and antioxidant activity in whole blood and plasma.        7. Spin trapping and EPR spectroscopy in whole blood.   "|||2017-10-10 22:59:49.172236|2017-10-10 22:59:49.172236
NCT02530983|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-12-20|||August 2015||2015-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CONDUIT||Mayo Clinic Conduit Report Card Questionnaires (CONDUIT)|Mayo Clinic Conduit Report Card Questionnaires|Recruiting||N/A|1000|Anticipated|Mayo Clinic|||1||f||||f||||||||No||2017-10-10 22:59:49.313978|2017-10-10 22:59:49.313978
NCT02530970|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-01-30|||October 2015||2015-10-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|SECURE||A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope|A Post Market Observational Study to Obtain Additional Information on the Use of Cormatrix® Cangaroo ECM® Envelope|Enrolling by invitation||N/A|1000|Anticipated|Aziyo Biologics, Inc.|||1||f||||f||||||||||2017-10-10 22:59:49.434011|2017-10-10 22:59:49.434011
NCT02530957|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-04-06|||June 23, 2015|Actual|2015-06-23|April 2017|2017-04-01|March 17, 2016|Actual|2016-03-17|February 28, 2016|Actual|2016-02-28||Interventional|OPTINIV||Non Invasive Ventilation Combined to High Flow Nasal Cannula Oxygen for Preoxygenation of Hypoxemic ICU Patients|Comparison of Two Methods of Preoxygenation Before Oro Tracheal Intubation in the Hypoxemic Patient in Intensive Care Unit : Non Invasive Ventilation (NIV) + High Flow Nasal Cannula Oxygen Versus NIV Alone : a Randomized Controlled Study|Completed||N/A|50|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 22:59:49.486636|2017-10-10 22:59:49.486636
NCT02530918|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of DS-7080a for the Treatment of Macular Degeneration|Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema|Active, not recruiting||Phase 1|63|Anticipated|Daiichi Sankyo, Inc.||6|||f||||f||||||||||2017-10-10 22:59:49.8544|2017-10-10 22:59:49.8544
NCT02530905|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-22|||October 2015||2015-10-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2016|Actual|2016-03-01||Interventional|||Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients|A Randomized, Double-Blind, Placebo-Controlled, Dose-Titration, Safety, Tolerability, and Pharmacokinetics Study Followed by an Open-Label Safety and Efficacy Evaluation of SRP-4045 in Advanced-Stage Patients With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping|Active, not recruiting||Phase 1|12|Anticipated|Sarepta Therapeutics||3|||f||||t||||||||||2017-10-10 22:59:50.0149|2017-10-10 22:59:50.0149
NCT02530892|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-12-29|||August 2015||2015-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|EMECH||Effect of Embryo Mechanical Properties on Clinical Pregnancy After In Vitro Fertilization|Measuring the Relationship Between Embryo Mechanical Properties and Embryo Development After In Vitro Fertilization|Active, not recruiting||N/A|50|Anticipated|Stanford University|||1||f||||f||||||||Undecided|Upon publication of study results, we may include de-identified participant data for people who wish to conduct their own analysis.|2017-10-10 22:59:50.152125|2017-10-10 22:59:50.152125
NCT02530879|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-07-07|||May 2016||2016-05-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Voice Therapy and Antireflex Therapy in LPR|Comparison of Voice Therapy and Antireflex Therapy in the Treatment of Laryngopharyngeal Reflux-related Hoarseness: A Prospective Randomized Control Trial|Recruiting||Phase 4|180|Anticipated|Temple University||3|||f||||f||||||||Yes|Data will be shared with participants at the completion of the 3 month study period|2017-10-10 22:59:50.287251|2017-10-10 22:59:50.287251
NCT02530866|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-23|||November 2015||2015-11-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|GDM-MOMS||Intensive Management for Gestational Diabetes|Randomized Controlled Clinical Pilot Trial of Intensive Management for Gestational Diabetes|Recruiting||N/A|60|Anticipated|University of Oklahoma||2|||f||||f||||||||||2017-10-10 22:59:50.451083|2017-10-10 22:59:50.451083
NCT02530853|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-21|||August 2014||2014-08-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|ACT-HAS||Acupuncture as a Complementary Treatment for Hypertension (ACT-HAS)|Acupuncture as Applied Technology to Nursing Care Adult Hypertensive: An Experimental Study.|Unknown status|Recruiting|N/A|110|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-10 22:59:50.560202|2017-10-10 22:59:50.560202
NCT02530840|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2017-02-12|||July 2014||2014-07-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Improving Adherence and Commitment to Treatment in Diabetic Patients|Impact:Improving Adherence and Commitment to Treatment|Recruiting||N/A|500|Anticipated|Clalit Health Services||4|||f||||t||||||||No||2017-10-10 22:59:50.688933|2017-10-10 22:59:50.688933
NCT02530827|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-20|||March 2013||2013-03-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Observational|||Energy Expenditure of People Living With HIV/AIDS|Influence of Lipid-lowering Drugs in Patients Seropositive for HIV With Lipodystrophy in Resting Energy Expenditure and Total Energy Expenditure|Completed||N/A|45|Actual|University of Sao Paulo General Hospital|||3||f||||t||||||Samples With DNA|"     urine.   "|||2017-10-10 22:59:50.805387|2017-10-10 22:59:50.805387
NCT02530814|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-03-16|||November 2015||2015-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Organochlorine Pesticide Exposure in Residents Near Lake Apopka|Organochlorine Pesticide Exposure in Residents Near Lake Apopka|Completed||N/A|20|Actual|University of Florida|||2||f||||t||||||Samples With DNA|"     Blood samples will be collected for analysis of organochlorine pesticides and     auto-antibodies.   "|Yes||2017-10-10 22:59:50.919371|2017-10-10 22:59:50.919371
NCT02530801|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-20|||September 2015||2015-09-01|August 2015|2015-08-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Interventional|REPEAT||Strategies for Management of Recurrent Pterygium|Management of Recurrent Pterygium to Prevent Visual Impairment|Not yet recruiting||Phase 4|25|Anticipated|University of Nottingham||1|||f||||f||||||||||2017-10-10 22:59:51.023328|2017-10-10 22:59:51.023328
NCT02530788|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-10-02|||August 2015|Actual|2015-08-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|July 2017|Actual|2017-07-01||Interventional|SOS-LVAD||High-dose Selenium Supplementation in Patients With Left Ventricular Assist|Perioperative High-dose Selenium Supplementation in Patients With Left Ventricular Assist Device - a Double Blinded Randomised Controlled Trial|Active, not recruiting||Phase 3|21|Actual|RWTH Aachen University||2|||f||||t||||||||||2017-10-10 22:59:51.161251|2017-10-10 22:59:51.161251
NCT02530775|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-12-15|||October 2015||2015-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||"Is Instrumentation Necessary for Static Degenerative Spondylolisthesis"|"Is Instrumentation Necessary for Static Degenerative Spondylolisthesis - A Prospective Randomized Clinical Study"|Withdrawn||N/A|0|Actual|University of Pittsburgh||2||The study did not receive IRB approval and was withdrawn|f||||f||||||||||2017-10-10 22:59:51.265079|2017-10-10 22:59:51.265079
NCT02530762|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-20|2015-08-20|||September 2014||2014-09-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary Fiber|A Randomized, Double-Blind, Crossover Study to Assess the Acute Gastrointestinal Tolerability Following a Single Serving of Cba-1, a Novel Dietary Fiber, in Healthy Men and Women|Completed||N/A|45|Actual|Cargill||5|||f||||t||||||||||2017-10-10 22:59:51.361713|2017-10-10 22:59:51.361713
NCT02530749|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-07-26|||April 2014||2014-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients|Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients|Recruiting||N/A|600|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 22:59:51.450561|2017-10-10 22:59:51.450561
NCT02530736|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-04-24|||February 2015||2015-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 17, 2016|Actual|2016-10-17||Observational|IPFRESP||Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis|Responsiveness of the 4 Metre Gait Speed in Patients With Idiopathic Pulmonary Fibrosis and Determination of the Minimum Important Difference|Active, not recruiting||N/A|120|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||||No||2017-10-10 22:59:51.545299|2017-10-10 22:59:51.545299
NCT02530723|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-21|||August 2015||2015-08-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|F-POW||Functional Changes and Power Training in Older Women.|The Effects of Low-intensity Power Training on Strength, Power, and Functional Outcomes in Older, Community-dwelling Women.|Unknown status|Recruiting|N/A|50|Anticipated|University of Toronto||4|||f||||f||||||||||2017-10-10 22:59:51.643601|2017-10-10 22:59:51.643601
NCT02530710|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-12-03|||August 2015||2015-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Doses of Q203 in Normal, Healthy, Male and Female Volunteers|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Doses of Q203 in Normal, Healthy, Male and Female Volunteers|Completed||Phase 1|56|Actual|Qurient Co., Ltd.||2|||f||||f||||||||||2017-10-10 22:59:51.746585|2017-10-10 22:59:51.746585
NCT02530697|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-05-22|||August 2015||2015-08-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil|The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: An Open-label, Randomized Clinical Trial in Brazil|Recruiting||Phase 2|40|Anticipated|University of Brasilia||2|||f||||f||||||||||2017-10-10 22:59:51.837394|2017-10-10 22:59:51.837394
NCT02530684|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-05-17|||October 2014||2014-10-01|May 2016|2016-05-01||||May 2017|Anticipated|2017-05-01||Observational|||Study of Various Insoles in Patients With Knee Osteoarthritis||Recruiting||N/A|30|Anticipated|University of Lausanne Hospitals|||2||f||||f||||||||||2017-10-10 22:59:51.928078|2017-10-10 22:59:51.928078
NCT02530671|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-03-24|2015-08-26||June 2011||2011-06-01|March 2016|2016-03-01||||June 2012|Actual|2012-06-01||Interventional|||Effect of a Multi-directional Power Toothbrush on Recession|Effect of a Multi-directional Power and a Manual Toothbrush in Subjects Susceptible to Gingival Recession: A 12-month Randomized Controlled Clinical Study|Completed||N/A|110|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-10 22:59:52.02296|2017-10-10 22:59:52.02296
NCT02530658|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-07-07|||August 28, 2015|Actual|2015-08-28|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|November 30, 2017|Anticipated|2017-11-30||Observational|||Next Generation Sequencing of Tumor and Normal Tissues Prospectively in Pediatric Oncology Patients at St. Jude Children's Research Hospital|Genomes for Kids (G4K)|Recruiting||N/A|400|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     Except for patients with retinoblastoma, craniopharyngioma, pontine glioma and optic pathway     tumors, tumor and normal tissue will be analyzed. For patients with retinoblastoma,     craniopharyngioma, pontine glioma and optic pathway tumors, only blood samples will be     collected and studied. Leukemia patients and patients with solid tumors and evidence of bone     marrow infiltration may undergo a skin biopsy procedure to obtain the germline specimen.   "|||2017-10-10 22:59:52.577297|2017-10-10 22:59:52.577297
NCT02530645|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-10-11|||November 2015||2015-11-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Development and Testing of a Smartphone Application to Reduce Substance Use and Sexual Risk Among Homeless Young Adults||Completed||N/A|60|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-10 22:59:52.734801|2017-10-10 22:59:52.734801
NCT02530632|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-04-12|||August 2015||2015-08-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||The Effects of General Anesthesia on Microcirculation of Central and Peripheral Soft Tissue: a Comparison of Inhalational and Intravenous Anesthetics|The Effects of General Anesthesia on Microcirculation of Central and Peripheral Soft Tissue: a Comparison of Inhalational and Intravenous Anesthetics|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 22:59:52.821763|2017-10-10 22:59:52.821763
NCT02530619|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-04-13|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|July 2017|Anticipated|2017-07-01||Interventional|||Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia|A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase A, in Adult Patients With Relapsed/Refractory Acute Megakaryoblastic Leukemia or Myelofibrosis (Including Primary and Post-Essential/Post-Polycythemic Myelofibrosis)|Recruiting||N/A|24|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 22:59:52.911093|2017-10-10 22:59:52.911093
NCT02530606|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer|Transvaginal Ultrasound and Photoacoustic Imaging of the Ovaries and the Fallopian Tubes: A Clinical Feasibility Study|Not yet recruiting||N/A|20|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 22:59:53.033927|2017-10-10 22:59:53.033927
NCT02530593|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-10-03|||June 2015||2015-06-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Observational|QoLiCOL||QoLiCOL - Quality of Life in Colon Cancer|QoLiCOL - Quality of Life in Colon Cancer|Recruiting||N/A|1500|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||Undecided||2017-10-10 22:59:53.147158|2017-10-10 22:59:53.147158
NCT02530580|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-07-26|||February 2016||2016-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effects of GABA Modulator AZD7325 on Cutaneous Sensation|A Phase I Single Site, Single Dose, Randomized, Double-blind, Placebo Controlled, 2-way Cross-over Biomarker Study Investigating the Effect of the GABA Modulator AZD7325 on Cutaneous Sensation in Healthy Volunteers|Completed||Phase 1|12|Actual|University College, London||2|||f||||t||||||||||2017-10-10 22:59:53.248228|2017-10-10 22:59:53.248228
NCT02530567|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-03-05|||October 2015||2015-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|ENIP||Non-invasive Evaluation of Portal Pressure by MRI|Using MRI for a Non-invasive Evaluation of Portal Pressure|Recruiting||N/A|100|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-10 22:59:53.329198|2017-10-10 22:59:53.329198
NCT02530515|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-07-12|||December 18, 2015|Actual|2015-12-18|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Trial of Immune Reconstitution With Activated T-Cells Following Lymphodepleting Chemotherapy in Patients With Chronic Lymphocytic Leukemia (CLL)|Trial of Immune Reconstitution With Activated T-Cells Following Lymphodepleting Chemotherapy in Patients With Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 2|8|Actual|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-10 22:59:53.70102|2017-10-10 22:59:53.70102
NCT02530502|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-10-31|||October 2015||2015-10-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma|Phase I/II Trial of Radiation Therapy Plus Temozolomide With MK-3475 in Patients With Newly Diagnosed Glioblastoma (GBM)|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 22:59:53.846883|2017-10-10 22:59:53.846883
NCT02530489|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-10-05|||February 4, 2016|Actual|2016-02-04|October 2017|2017-10-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Triple-Negative First-Line Study: Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A, a Pdl-1 Inhibitor in Patients With Triple Negative Breast Cancer|Triple-Negative First-Line Study: Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A, a Pdl-1 Inhibitor in Patients With Triple Negative Breast Cancer|Recruiting||Phase 2|37|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 22:59:53.973698|2017-10-10 22:59:53.973698
NCT02530476|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-05-30|||December 8, 2015|Actual|2015-12-08|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia|Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|52|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 22:59:54.076975|2017-10-10 22:59:54.076975
NCT02530463|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-05-30|||September 8, 2015|Actual|2015-09-08|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Nivolumab and Ipilimumab With 5-azacitidine in Patients With Myelodysplastic Syndromes (MDS)|Combination of Nivolumab and Ipilimumab With 5-azacitidine in Patients With Myelodysplastic Syndromes (MDS)|Recruiting||Phase 2|120|Anticipated|M.D. Anderson Cancer Center||6|||f||||f|t|f||||||||2017-10-10 22:59:54.21047|2017-10-10 22:59:54.21047
NCT02530450|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-09-07|2016-11-28||May 2011||2011-05-01|September 2017|2017-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Continuous Glucose Monitor in Children With Poorly Controlled Diabetes|iPro Continuous Glucose Monitor in Children With Poorly Controlled Diabetes: A 6-Month, Randomized, Interventional Pilot Study|Completed||N/A|30|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||f||||||||||2017-10-10 22:59:54.348418|2017-10-10 22:59:54.348418
NCT02530437|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-09-11|||March 7, 2017|Actual|2017-03-07|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|||Study of Taladegib in Combination With Weekly Paclitaxel, Carboplatin, and Radiation in Localized Adenocarcinoma of the Esophagus or Gastroesophageal Junction|A Phase 1B/2 Study of Taladegib in Combination With Weekly Paclitaxel, Carboplatin, and Radiation in Localized Adenocarcinoma of the Esophagus or Gastroesophageal Junction|Recruiting||Phase 1/Phase 2|66|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 22:59:56.516005|2017-10-10 22:59:56.516005
NCT02530424|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-04-07|||May 2015||2015-05-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|NA-PHER2||"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "|"Neo-Adjuvant Treatment With the CDK4,6 Inhibitor Palbociclib in HER2-positive and ER-positive Breast Cancer: Effect on Ki67 and Apoptosis Before, During and After Treatment "|Active, not recruiting||Phase 2|36|Actual|Fondazione Michelangelo||1|||f||||t||||||||||2017-10-10 22:59:56.654305|2017-10-10 22:59:56.654305
NCT02530411|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-08-19|||April 2015||2015-04-01|August 2015|2015-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|FURVA||Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer|A Randomised Double Blind Placebo Controlled Phase II Study of Fulvestrant With or Without the Addition of Vandetanib as Treatment for Patients With Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy|Recruiting||Phase 2|160|Anticipated|Velindre NHS Trust||2|||f||||t||||||||||2017-10-10 22:59:56.769778|2017-10-10 22:59:56.769778
NCT02530398|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-08-29|||July 2015||2015-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites|Single-arm, Non-randomized, Open, Drug Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion Treatment on Digestive System Cancer Patients With Ascites|Recruiting||Phase 1|48|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||1|||f||||t||||||||||2017-10-10 22:59:56.904329|2017-10-10 22:59:56.904329
NCT02530385|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-05-19|||June 2016||2016-06-01|May 2017|2017-05-01||||June 2018|Anticipated|2018-06-01||Interventional|||Fecal Microbiota Transplant for Obesity and Metabolism|Placebo Controlled Study of Fecal Microbiota Transplant (FMT) to Impact Body Weight and Glycemic Control in Adults Using a Frozen Encapsulated Inoculum|Recruiting||Phase 1/Phase 2|24|Anticipated|Massachusetts General Hospital||2|||f||||||||||||||2017-10-10 22:59:56.983091|2017-10-10 22:59:56.983091
NCT02530372|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2015-09-17|||September 2015||2015-09-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Feasibility of the UriCap-F for Urine Collection in Hospitalized Women|Feasibility of the UriCap-F for Urine Collection in Hospitalized Women|Unknown status|Enrolling by invitation|N/A|30|Anticipated|G.R. Dome Medical Ltd.||1|||f||||f||||||||||2017-10-10 22:59:57.057116|2017-10-10 22:59:57.057116
NCT02530359|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-08-19|||October 2015||2015-10-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|AKI||Pirfenidone Effect on the Recovery of Renal Function in Septic Acute Kidney Injury|Pirfenidone Effect on the Recovery of Renal Function in Patients With Septic Acute Kidney Injury|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Hospital Civil de Guadalajara||3|||f||||t||||||||||2017-10-10 22:59:57.140056|2017-10-10 22:59:57.140056
NCT02530346|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-12-20|||October 2015||2015-10-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Interventional|||Is Colostomy Closure Without Mechanical Bowel Preparation Safe in Pediatric Patients? Randomized Clinical Trial.|Is Colostomy Closure Without Mechanical Bowel Preparation Safe in Pediatric Patients? Randomized Clinical Trial.|Recruiting||N/A|130|Anticipated|Hospital Infantil de Mexico Federico Gomez||2|||f||||f||||||||No||2017-10-10 22:59:57.447641|2017-10-10 22:59:57.447641
NCT02530333|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-01-06|||May 2015||2015-05-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Differential Biomechanical Effects of an ACL Injury Prevention Program in Women's Basketball and Soccer Players|Differential Biomechanical Effects of an ACL Injury Prevention Program in Women's Basketball and Soccer Players|Completed||N/A|99|Actual|High Point University||4|||f||||f||||||||||2017-10-10 22:59:57.538924|2017-10-10 22:59:57.538924
NCT02530320|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-08-10|||July 2015||2015-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved|Phase II Pilot, Prospective, Open Label, Multicenter CT, to Evaluate the Safety and Efficacy of Palbociclib (PD0332991), a Cyclin-dependent Kinase 4 and 6 (CDK4 and CDK6) Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved|Recruiting||Phase 2|40|Anticipated|Grupo Español de Investigación en Neurooncología||1|||f||||f||||||||||2017-10-10 22:59:57.645409|2017-10-10 22:59:57.645409
NCT02530307|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-02-16|||February 2016||2016-02-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|RESTORE||HT-3951 vs. Placebo in Stroke Rehabilitation|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke|Recruiting||Phase 2|72|Anticipated|Dart NeuroScience, LLC||2|||f||||f||||||||||2017-10-10 22:59:57.790168|2017-10-10 22:59:57.790168
NCT02530294|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-03-30||2017-03-30|August 2015||2015-08-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of DRM04 in Subjects With Axillary Hyperhidrosis|A Phase 3, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhidrosis|Completed||Phase 3|353|Actual|Dermira, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:59:57.957716|2017-10-10 22:59:57.957716
NCT02530281|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-03-30||2017-03-30|July 2015||2015-07-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of DRM04 in Axillary Hyperhydrosis|A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhydrosis|Completed||Phase 3|344|Actual|Dermira, Inc.||2|||f||||f||||||||Undecided||2017-10-10 22:59:58.101807|2017-10-10 22:59:58.101807
NCT02530268|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-04-17|||March 2013||2013-03-01|April 2017|2017-04-01|December 2100|Anticipated|2100-12-01|December 2100|Anticipated|2100-12-01|15 Years|Observational [Patient Registry]|||The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry|Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry|Enrolling by invitation||N/A|5000|Anticipated|Corrona, LLC.|||2||f||||f||||||||No||2017-10-10 22:59:58.256571|2017-10-10 22:59:58.256571
NCT02530255|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-25|2016-01-11|||April 2016||2016-04-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Telomerase Activator and Retinal Amyloid|Evaluation of an Oral Telomerase Activator on Retinal Amyloid|Not yet recruiting||N/A|50|Anticipated|Chippewa Valley Eye Clinic||2|||f||||t||||||||||2017-10-10 22:59:58.323501|2017-10-10 22:59:58.323501
NCT02530242|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-12-07|||July 2015||2015-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|SCDCO||Carbon Monoxide Measurement to Screen for Sickle Cell Disease|Point-of-Care End-Tidal Carbon Monoxide Measurement to Screen for Sickle Cell Disease|Completed||N/A|20|Actual|Children's Hospital & Research Center Oakland||2|||f||||f||||||||||2017-10-10 22:59:58.409105|2017-10-10 22:59:58.409105
NCT02530229|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-20|||November 2014||2014-11-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01|3 Months|Observational [Patient Registry]|||Arthrocentesis Study|Early Diagnostics of Septic Arthritis and Periprosthetic Joint Infections With Calorimetry and Polymerase Chain Reaction (PCR) of Synovial Aspirate Fluid|Unknown status|Recruiting|N/A|400|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||Samples With DNA|"     joint aspirates of native joints and joints with suspected periprosthetic joint infection   "|||2017-10-10 22:59:58.481569|2017-10-10 22:59:58.481569
NCT02530216|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-10-07|||January 2017||2017-01-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|AEGIS||Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes|Automated Evaluation of Gastrointestinal Symptoms (AEGIS): A Pragmatic Clinical Trial Evaluating the Impact of AEGIS on Clinical Outcomes|Not yet recruiting||N/A|448|Anticipated|Cedars-Sinai Medical Center||2|||f||||||||||||||2017-10-10 22:59:58.576683|2017-10-10 22:59:58.576683
NCT02530203|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-04-05|||February 2015||2015-02-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|SCS-PAF||Spinal Cord Stimulation to Treat Post-operative Atrial Fibrillation|Spinal Cord Stimulation to Treat Post-operative Atrial Fibrillation|Terminated||N/A|4|Actual|Medtronic BRC||2||Due to a change in medication guidelines it became practically impossible to recruit patients|f||||f||||||||Undecided||2017-10-10 22:59:58.64585|2017-10-10 22:59:58.64585
NCT02530190|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-19|||May 2015||2015-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Investigation of Popular Recovery Techniques for Ultramarathon Recovery|Investigation of Popular Recovery Techniques for Ultramarathon Recovery|Completed||N/A|108|Actual|Western States Endurance Run Research Foundation||3|||f||||f||||||||||2017-10-10 22:59:58.738391|2017-10-10 22:59:58.738391
NCT02530177|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-09-29|||August 19, 2015||2015-08-19|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer|A Prospective, Longitudinal Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer|Recruiting||N/A|700|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||Samples With DNA|"     saliva (baseline only)   "|||2017-10-10 22:59:58.809134|2017-10-10 22:59:58.809134
NCT02530164|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-01-12|||September 2015||2015-09-01|January 2016|2016-01-01||||September 2018|Anticipated|2018-09-01||Interventional|DepressionDC||Transcranial Direct Current Stimulation (tDCS) As Treatment for Major Depression|Transcranial Direct Current Stimulation (tDCS) As Treatment for Major Depression - A Prospective Multicenter Double Blind Randomized Placebo Controlled Trial (DepressionDC)|Recruiting||N/A|152|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||||||||||||2017-10-10 22:59:58.907419|2017-10-10 22:59:58.907419
NCT02530151|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-09-12|||November 2015||2015-11-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy|Prospective Assessment of Intraoperative Intra-articular Morphine and Clonidine Injection in Hip Arthroscopy on Postoperative Pain Management|Completed||Phase 4|73|Actual|Northwestern University||2|||f||||f||||||||||2017-10-10 22:59:59.106321|2017-10-10 22:59:59.106321
NCT02530138|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-19|||August 2014||2014-08-01|August 2015|2015-08-01||||February 2016|Anticipated|2016-02-01||Interventional|||The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver||Unknown status|Recruiting|Phase 2/Phase 3|42|Anticipated|National Nutrition and Food Technology Institute||2|||f||||||||||||||2017-10-10 22:59:59.207395|2017-10-10 22:59:59.207395
NCT02530125|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-04-10|||September 2015||2015-09-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|June 2018|Anticipated|2018-06-01||Interventional|||Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission|Phase II Study of Pidilizumab (MDV9300) in Patients With Diffuse Large B-Cell Lymphoma Following First Remission|Active, not recruiting||Phase 2|30|Actual|Northwestern University||1|||f||||t||||||||||2017-10-10 22:59:59.30938|2017-10-10 22:59:59.30938
NCT02530112|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-12-06|||November 2013||2013-11-01|September 2016|2016-09-01||||November 2019|Anticipated|2019-11-01||Observational|||Functional Outcome Measures for Head and Neck Patients|Functional Outcome Measures for Head and Neck Patients|Recruiting||N/A|300|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||3||f||||t||||||||||2017-10-10 22:59:59.411882|2017-10-10 22:59:59.411882
NCT02530099|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-04-05|||September 2015||2015-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Simulation-based Training of Operating Assistants: Procedure- Versus Camera Navigation Training|Simulation-based Training of Operating Assistants: Procedure- Versus Camera Navigation Training - a Randomized Controlled Trial Examining Clinical Transfer|Completed||N/A|36|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-10 22:59:59.511499|2017-10-10 22:59:59.511499
NCT02530086|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-04-05|||August 2015||2015-08-01|April 2017|2017-04-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|NoNGT||Prospective Study of Non-operative Management of SBO Without Nasogastric Tube Placement|Prospective Study of Non-operative Management of SBO Without Nasogastric Tube Placement|Withdrawn||N/A|0|Actual|Yale University||2||Study was closed due to lack of personnel for recruitment/enrollment purposes.|f||||f||||||||||2017-10-10 22:59:59.590119|2017-10-10 22:59:59.590119
NCT02530073|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-09-01|||September 2015||2015-09-01|September 2017|2017-09-01|February 2023|Anticipated|2023-02-01|August 2022|Anticipated|2022-08-01||Interventional|FETO||Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO)|Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)|Recruiting||N/A|15|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-10 22:59:59.680189|2017-10-10 22:59:59.680189
NCT02530060|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-12-30|||August 2015||2015-08-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants|An Open-Label Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration of a Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine Fixed-Dose Combination Tablet in Healthy Japanese Adult Male Subjects|Completed||Phase 4|8|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-10 22:59:59.780848|2017-10-10 22:59:59.780848
NCT02530047|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-06-21|||May 16, 2016|Actual|2016-05-16|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Mesenchymal Stem Cells (MSC) for Ovarian Cancer|Phase 1 Study to Determine the Effects of Mesenchymal Stem Cells Secreting Interferon Beta in Patients With Advanced Ovarian Cancer|Active, not recruiting||Phase 1|5|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 22:59:59.886407|2017-10-10 22:59:59.886407
NCT02530034|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-08-25|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Phase I Study of Hu8F4 in Patients With Advanced Hematologic Malignancies|Phase I Study of Hu8F4 in Patients With Advanced Hematologic Malignancies|Not yet recruiting||Phase 1|60|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 23:00:00.026325|2017-10-10 23:00:00.026325
NCT02530021|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-03-14|||August 2015||2015-08-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|July 2016|Anticipated|2016-07-01||Observational|||Heart Rate Variability (HRV) Testing Compared With Exercise Stress Test in Hospitalized Patients With Chest Pain|Sixty Minutes Heart Rate Variability Testing Compared With Non-invasive Exercise Stress Test in Hospitalized Patients With Suspected Angina Pectoris|Recruiting||N/A|100|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-10 23:00:00.130292|2017-10-10 23:00:00.130292
NCT02530008|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-12-06|||October 2013||2013-10-01|September 2016|2016-09-01||||October 2017|Anticipated|2017-10-01||Observational|||Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer|Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer|Recruiting||N/A|200|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 23:00:00.247482|2017-10-10 23:00:00.247482
NCT02529995|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-03-30|2017-01-13||August 24, 2015|Actual|2015-08-24|March 2017|2017-03-01|December 29, 2017|Anticipated|2017-12-29|January 28, 2016|Actual|2016-01-28||Interventional|AURAChinaPK|All patients enrolled who received at least one dose of AZD9291.|Phase I, Study in Chinese NSCLC Patients|Phase I, Open-Label, Two Parts Study in Chinese Patients With Advanced NSCLC Who Have Progressed Following Prior Therapy With an EGFR Tyrosine Kinase Inhibitor Agent|Active, not recruiting||Phase 1|36|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:00:00.366363|2017-10-10 23:00:00.366363
NCT02529982|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-19|||July 2015||2015-07-01|July 2015|2015-07-01||||January 2016|Anticipated|2016-01-01||Interventional|||Effects of Curcumin Supplementation on Glycemic Control, Oxidative Stress, Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes|Effects of Curcumin Supplementation on Glycemic Control, Oxidative Stress, Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-10 23:00:01.168994|2017-10-10 23:00:01.168994
NCT02096250|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-09-22|||June 2014||2014-06-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|August 2014|Actual|2014-08-01||Interventional|||Iron Absorption in Haiti|Iron Absorption From Wheat Flour in Haiti|Completed||N/A|44|Actual|Swiss Federal Institute of Technology||3|||f||||f||||||||||2017-10-11 00:38:05.395123|2017-10-11 00:38:05.395123
NCT02529969|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-19|||July 2015||2015-07-01|July 2015|2015-07-01||||January 2016|Anticipated|2016-01-01||Interventional|||Effects of Curcumin Supplementation on Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes|Curcumin Supplementation and Type 2 Diabetes|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|National Nutrition and Food Technology Institute||2|||f||||||||||||||2017-10-10 23:00:01.24375|2017-10-10 23:00:01.24375
NCT02529956|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-19|||November 2012||2012-11-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis|A Randomized, Subject-blind, Investigator-blind, Placebo-controlled, Single-dose, Dose-escalating Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of UCB4940 in Patients With Mild to Moderate Psoriasis|Completed||Phase 1|39|Actual|UCB Pharma||6|||f||||f||||||||||2017-10-10 23:00:01.322579|2017-10-10 23:00:01.322579
NCT02529943|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-06-20|||May 2016||2016-05-01|June 2017|2017-06-01|February 1, 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Observational|||Changes in Motor Latency During Spinal Decompression: Relationship to Outcomes||Recruiting||N/A|50|Anticipated|University of Saskatchewan|||1||f||||f|f|f||||||||2017-10-10 23:00:01.432108|2017-10-10 23:00:01.432108
NCT02529930|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-10-31|||August 2015||2015-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)|An Exploratory Safety and Immunogenicity Study of Human Papillomavirus (HPV16+) Immunotherapy VB10.16 in Women With High Grade Cervical Intraepithelial Neoplasia (HSIL; CIN 2/3)|Active, not recruiting||Phase 1/Phase 2|36|Anticipated|Vaccibody AS||2|||f||||t||||||||||2017-10-10 23:00:01.532962|2017-10-10 23:00:01.532962
NCT02529917|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-05-02|||August 2015||2015-08-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Benefits of Hemp Protein Supplementation During Resistance Training|The Benefits of Hemp Protein Supplementation During Resistance Training|Completed||N/A|34|Actual|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 23:00:01.661932|2017-10-10 23:00:01.661932
NCT02529904|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-05-04|||August 2015||2015-08-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|April 2016|Actual|2016-04-01||Interventional|||ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults|A Phase II, Open Label Study to Describe Immune & Transcriptional Responses to MF59 Adjuvanted Trivalent Influenza Vaccine (ATIV) in Healthy 13-24 Month Children and Adults 18-65 Years|Active, not recruiting||Phase 2|120|Actual|University of Oxford||1|||f||||t||||||||||2017-10-10 23:00:01.763118|2017-10-10 23:00:01.763118
NCT02529891|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-03-30|||August 2014||2014-08-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|LAVOLEX||Identification of Volatile Organic Compounds in Exhaled Air During Exacerbation of Chronic Obstructive Pulmonary Disease|Identification of Volatile Organic Compounds in Exhaled Air During Exacerbation of Chronic Obstructive Pulmonary Disease|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||||||2017-10-10 23:00:01.926447|2017-10-10 23:00:01.926447
NCT02529878|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-07-23|||August 2015||2015-08-01|February 2016|2016-02-01|August 2019|Anticipated|2019-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer|A Prospective Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer|Recruiting||Phase 2|30|Anticipated|The First Affiliated Hospital of Zhejiang Chinese Medical University||1|||f||||t||||||||||2017-10-10 23:00:02.255948|2017-10-10 23:00:02.255948
NCT02529865|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-03-27|||July 2015||2015-07-01|March 2017|2017-03-01||||December 2018|Anticipated|2018-12-01||Interventional|ADRESU||Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence|Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the Treatment of Male Stress Urinary Incontinence|Recruiting||Phase 3|45|Anticipated|Nagoya University||1|||f||||||||||||||2017-10-10 23:00:02.374363|2017-10-10 23:00:02.374363
NCT02529852|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-05-11|||November 4, 2015|Actual|2015-11-04|May 2017|2017-05-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma|A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|59|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:00:02.581917|2017-10-10 23:00:02.581917
NCT02529839|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-08-19|||October 2015||2015-10-01|April 2015|2015-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)|Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation in Patients With Multiple Sclerosis|Unknown status|Not yet recruiting|N/A|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-10 23:00:02.755212|2017-10-10 23:00:02.755212
NCT02529826|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2015-08-19|||November 2015||2015-11-01|April 2015|2015-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Fertility Preservation in Prepubertal Boys: An Experimental Approach|Fertility Preservation in Prepubertal Boys: An Experimental Approach|Not yet recruiting||N/A|100|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-10-10 23:00:02.888391|2017-10-10 23:00:02.888391
NCT02529813|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-09-11|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||CD19+ CAR T Cells for Lymphoid Malignancies|CD19+ Chimeric Antigen Receptor T Cells for Patients With Advanced Lymphoid Malignancies|Recruiting||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:00:02.981975|2017-10-10 23:00:02.981975
NCT02529800|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetics Incorporating a Comparison of Fed/Fasted Pharmacokinetics of HIP1402 in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||No||2017-10-10 23:00:03.116393|2017-10-10 23:00:03.116393
NCT02529787|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-19|||February 2013||2013-02-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)|Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg DR Capsules (Takeda Pharmaceuticals America Inc., USA)|Completed||Phase 1|60|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||||2017-10-10 23:00:03.219247|2017-10-10 23:00:03.219247
NCT02529774|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-18|||September 2015||2015-09-01|August 2015|2015-08-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer|Efficacy and Safety of Alternating Systemic and Hepatic Artery Infusion Therapy Versus Systemic Chemotherapy Alone As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer: A Randomized, Parallel-Group, Open-Labelled, Active-Controlled Phase II/III Trial in China|Not yet recruiting||Phase 2/Phase 3|432|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 23:00:03.332948|2017-10-10 23:00:03.332948
NCT02529761|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-09-21|||August 2015||2015-08-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma|Transarterial Chemoembolization (TACE) With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma: a Multicenter Prospective Nonrandomized Study|Recruiting||N/A|330|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-10 23:00:03.450568|2017-10-10 23:00:03.450568
NCT02529748|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-19|||August 2015||2015-08-01|August 2015|2015-08-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||Pilot Study to Assess the Quantitative Dermal Transfer Efficiencies of Solids for Multiple Transfer Pathways|Pilot Study to Assess the Quantitative Dermal Transfer Efficiencies of Solids for Multiple Transfer Pathways|Unknown status|Not yet recruiting|N/A|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 23:00:03.573443|2017-10-10 23:00:03.573443
NCT02529735|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2015-08-20|||January 2016||2016-01-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|VALPARAISO||Study on Pressure Values Measured on Three Alternative Sites of the Lower Limbs Compared to the Arm|Etude Prospective Observationnelle Multicentrique Sur Volontaires Sains Des VALeurs de Pression Artérielle mesurées Sur Trois Sites alteRnAtIfS Des Membres inférieurs cOmparées au Site de référence|Not yet recruiting||N/A|2000|Anticipated|Centre Hospitalier Sud Francilien|||1||f||||f||||||||||2017-10-10 23:00:03.64946|2017-10-10 23:00:03.64946
NCT02529722|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-08-19|||January 2012||2012-01-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01|36 Months|Observational [Patient Registry]|||Biomarkers for the Progression of IgA Nephropathy|Histological and Clinical Biomarkers to Predict the Progression of IgA Nephropathy|Completed||N/A|120|Actual|Istanbul University|||1||f||||f||||||||||2017-10-10 23:00:03.700198|2017-10-10 23:00:03.700198
NCT02529709|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-04-19|||October 2015||2015-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Effect of Meal Composition on Blood Lipids|The Effect of Meal Composition on Blood Lipid Concentrations|Completed||N/A|24|Actual|Texas Christian University||2|||f||||f||||||||||2017-10-10 23:00:03.776457|2017-10-10 23:00:03.776457
NCT02529696|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-10-25|||September 2015||2015-09-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers|Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers|Recruiting||N/A|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||No||2017-10-10 23:00:03.868174|2017-10-10 23:00:03.868174
NCT02529683|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-19|||April 2014||2014-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya|Clinical Trial of Acceptability, Adherence and Immune/Microbiologic Effects of a Vaginal Contraceptive Ring Among HIV-negative Women in Western Kenya|Completed||N/A|200|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-10-10 23:00:03.965259|2017-10-10 23:00:03.965259
NCT02529670|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-03-14|||March 2014||2014-03-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|March 2016|Actual|2016-03-01||Interventional|||Low Level Laser Therapy in the Dorsal Root Ganglion in the Treatment of Chronic Low Back Pain|Study of the Effect of Low Level Laser Therapy in the Dorsal Root Ganglion in the Diagnosis and Treatment of Chronic Low Back Pain|Recruiting||N/A|31|Anticipated|University of Nove de Julho||3|||f||||t||||||||||2017-10-10 23:00:04.053309|2017-10-10 23:00:04.053309
NCT02529657|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2015-11-30|||February 2013||2013-02-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|November 2015|Actual|2015-11-01||Interventional|LASPINE||Low Level Laser Therapy to Reduce Comorbidity in Spinal Surgery|Analysis of Effect of Low Level Laser Therapy in Spinal Surgery|Active, not recruiting||N/A|48|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 23:00:04.170366|2017-10-10 23:00:04.170366
NCT02529644|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-10-14|||July 2015||2015-07-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|December 2017|Anticipated|2017-12-01||Interventional|TIPS||Church-based HIV Screening: Taking It to the Pews|Assessing HIV Screening in African American Churches|Recruiting||N/A|1540|Anticipated|University of Missouri, Kansas City||2|||f||||t||||||||Yes||2017-10-10 23:00:04.268301|2017-10-10 23:00:04.268301
NCT02529631|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-08-19|||November 2009||2009-11-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|June 2010|Actual|2010-06-01||Interventional|||RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity|Randomized, Double-blind, Clinical Investigation to Compare Orlistat 60 mg and a Customized Polyglucosamine, Two Treatment Methods for the Management of Overweight and Obesity|Completed||N/A|64|Actual|Certmedica International GmbH||2|||f||||f||||||||||2017-10-10 23:00:04.397667|2017-10-10 23:00:04.397667
NCT02529618|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-03-03|||August 2015||2015-08-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Field Implementation of iDETECT|Implementation of iDETECT for Field Triage of mTBI in Football Players|Completed||N/A|124|Actual|Emory University|||2||f||||f||||||||||2017-10-10 23:00:04.487393|2017-10-10 23:00:04.487393
NCT02529605|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-07-06|||September 2015||2015-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Relative Bioavailability of Two Different Milk Thistle Formulations|Relative Bioavailability of Two Different Milk Thistle Formulations: A Single Dose Randomized Crossover Pharmacokinetic Study|Completed||N/A|12|Actual|University of Florida||2|||f||||f|f|f||||||||2017-10-10 23:00:04.62253|2017-10-10 23:00:04.62253
NCT02529579|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-19|||June 2015||2015-06-01|January 2015|2015-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer||Recruiting||Phase 1/Phase 2|187|Anticipated|Changhai Hospital||2|||f||||||||||||||2017-10-10 23:00:04.854498|2017-10-10 23:00:04.854498
NCT02529566|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-02-13|||July 2013||2013-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|2 Years|Observational [Patient Registry]|||Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine|Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine|Enrolling by invitation||N/A|100|Anticipated|The Foundation for Spinal Research, Education and Humanitarian Care, Inc.|||1||f||||f||||||||||2017-10-10 23:00:04.990609|2017-10-10 23:00:04.990609
NCT02529553|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-05-25|||September 2015||2015-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of LY3076226 in Participants With Advanced or Metastatic Cancer|A Phase 1 Study of LY3076226, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody-Drug Conjugate, in Patients With Advanced or Metastatic Cancer|Recruiting||Phase 1|37|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 23:00:05.134309|2017-10-10 23:00:05.134309
NCT02529540|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2016-04-14|||September 2015||2015-09-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||The Children's WEAR 3|The Children's WEAR (Wearability and Evaluation of Adjustable Refraction) Trial (Phase 3)|Unknown status|Enrolling by invitation|Phase 3|4000|Anticipated|Sun Yat-sen University||3|||f||||f||||||||||2017-10-10 23:00:05.281453|2017-10-10 23:00:05.281453
NCT02529527|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-04-06|||September 2015||2015-09-01|April 2017|2017-04-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||Web-based Preconception Health Education Tool|MyFamilyPlan: A Patient-Centered Web-based Preconception Health Education Tool|Completed||N/A|292|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 23:00:05.396865|2017-10-10 23:00:05.396865
NCT02529514|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-05-11|||July 2015||2015-07-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Usage of Baclofen for Sleep Improvement After Cardiac Surgery|Usage of Baclofen for Sleep Improvement After Cardiac Surgery|Suspended||Phase 4|30|Anticipated|University Hospital of Liege||2|||f||||f||||||||||2017-10-10 23:00:05.486522|2017-10-10 23:00:05.486522
NCT02529501|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-11-17|||July 2015||2015-07-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|BAG||Spinal Versus General Anesthesia for Ambulatory Anesthesia|Factors Influencing the Choice of Anesthesia (Spinal Anesthesia or Short General Anesthesia) in Outpatient Surgery|Completed||N/A|595|Actual|Nordic Pharma SAS|||2||f||||f||||||||||2017-10-10 23:00:05.582896|2017-10-10 23:00:05.582896
NCT02529488|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2017-07-05|||September 7, 2015|Actual|2015-09-07|July 2017|2017-07-01|June 26, 2017|Actual|2017-06-26|November 30, 2016|Actual|2016-11-30||Interventional|||Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00|Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL Model TFNT00|Completed||N/A|167|Actual|Alcon Research||1|||f||||f|f|t|t||t|||||2017-10-10 23:00:05.651463|2017-10-10 23:00:05.651463
NCT02529475|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-03-09|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|HYDROPS||Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)|Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)|Recruiting||Phase 4|40|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-10 23:00:05.720454|2017-10-10 23:00:05.720454
NCT02529462|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-19|2016-12-02|||July 2014||2014-07-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients|Randomised, Controlled, Parallel Clinical Trial on the Efficacy of Pharmacogenetic Information Obtained With NEUROFARMAGEN in the Treatment of Patients With Mental Disorders|Completed||Phase 3|521|Actual|AB Biotics, SA||2|||f||||f||||||||No||2017-10-10 23:00:05.791668|2017-10-10 23:00:05.791668
NCT02529449|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-06-17|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus|Clinical Pharmacological Study of ASP1941 - A Clinical Pharmacological Study of ASP1941 in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 2|43|Actual|Astellas Pharma Inc||4|||f||||f||||||||Undecided||2017-10-10 23:00:06.082139|2017-10-10 23:00:06.082139
NCT02529436|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-09-07|||April 2015||2015-04-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Observational|OVADAD||Overuse of Antidepressant in Patients With Alzheimer Disease|Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study|Completed||N/A|54|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||Undecided||2017-10-10 23:00:06.229975|2017-10-10 23:00:06.229975
NCT02529423|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2017-06-15|||July 2015||2015-07-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|MoodFOOD||Multi-country Project on the Role of Diet, Food-related Behavior, and Obesity in the Prevention of Depression|Multi-country cOllaborative Project on the rOle of Diet, FOod-related Behaviour, and Obesity in the Prevention of Depression (MoodFOOD)|Active, not recruiting||N/A|1000|Anticipated|University of the Balearic Islands||4|||f||||f||||||||||2017-10-10 23:00:06.316855|2017-10-10 23:00:06.316855
NCT02529410|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-02-29|||August 2015||2015-08-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|STRIVE HF||Standard Care Versus Triventricular Pacing in Heart Failure|A Multicentre Randomised Control Trial Comparing Standard Cardiac Resynchronisation Pacing With Triventricular Pacing|Recruiting||Phase 3|100|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:00:06.465188|2017-10-10 23:00:06.465188
NCT02529397|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-10-24|||October 2015||2015-10-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|Focus||Obesity Treatment Enhanced With Working Memory Training|Obesity Treatment Enhanced With Working Memory Training|Completed||N/A|37|Actual|University of Vermont||2|||f||||f||||||||Undecided||2017-10-10 23:00:06.591902|2017-10-10 23:00:06.591902
NCT02529384|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-08-18|||January 2015||2015-01-01|August 2015|2015-08-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Observational|||Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast Lesions|Multiple B-value Diffusion-weighted Imaging in Evaluation of Breast Lesions：Compare Biexponential Model, Stretched Exponential Model, Conventional Monoexponential DWI and Pathological Specimens.|Recruiting||N/A|100|Anticipated|Tang-Du Hospital|||3||f||||t||||||Samples With DNA|"     After Surgical operation, specimen of lesion will be collected(Not every patient's specimen     will be collected. We should be approved by patient themselves). For analyze the relation     with biomarker from the MR imaging and pathological/molecular-biological biomarkers.   "|||2017-10-10 23:00:06.694723|2017-10-10 23:00:06.694723
NCT02529371|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2015-09-17|||September 2015||2015-09-01|September 2015|2015-09-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients|Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients|Unknown status|Enrolling by invitation|N/A|30|Anticipated|G.R. Dome Medical Ltd.||1|||f||||f||||||||||2017-10-10 23:00:06.812776|2017-10-10 23:00:06.812776
NCT02529358|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-08-19|||February 2012||2012-02-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Text Message Based Maintenance Intervention|Evaluation of a Transdiagnostic Text Message Based Maintenance Intervention After Inpatient Cognitive Behavioural Therapy|Completed||N/A|180|Actual|Friedrich-Alexander-Universität Erlange-Nürnberg||3|||f||||t||||||||||2017-10-10 23:00:06.927732|2017-10-10 23:00:06.927732
NCT02529345|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-07-31|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|April 2016|Actual|2016-04-01||Interventional|||Clear-Road Trial, Investigating the Efficacy of the RoadSaver Stent|CLEAR-ROAD; a Physician-initiated Carotid Trial Investigating the Efficacy of Endovascular Treatment of Carotid Arterial Disease With the Multi-layer RoadSaver Stent|Completed||Phase 2/Phase 3|100|Actual|Flanders Medical Research Program||1|||f||||t||||||||||2017-10-10 23:00:07.099884|2017-10-10 23:00:07.099884
NCT02529332|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-09-10|||September 2014||2014-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Omega-3 Supplementation for Smell Dysfunction|Effect of Omega-3 Supplementation in Patients With Smell Dysfunction Following Endoscopic Pituitary Tumor Resection|Recruiting||N/A|110|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 23:00:07.208209|2017-10-10 23:00:07.208209
NCT02529319|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-12-20|||July 2016||2016-07-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|DECAAFII||Efficacy of Delayed Enhancement MRI-Guided Ablation vs Conventional Catheter Ablation of Atrial Fibrillation|Efficacy of Delayed Enhancement MRI-Guided Ablation vs Conventional Catheter Ablation of Atrial Fibrillation: The DECAAF II Study|Recruiting||N/A|888|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-10 23:00:07.317545|2017-10-10 23:00:07.317545
NCT02529306|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-02-09|||September 1, 2015|Actual|2015-09-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|BZMC||The Correlation Between Testosterone and Cortisol Level and Inflammatory Markers Levels in Type 2 Diabetic Men.|The Correlation Between Testosterone and Cortisol Level and Inflammatory Markers Levels in Type 2 Diabetic Men.|Recruiting||N/A|40|Anticipated|Bnai Zion Medical Center|||1||f||||f||||||||||2017-10-10 23:00:07.419269|2017-10-10 23:00:07.419269
NCT02529293|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-12-17|||August 2015||2015-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers|A Pilot Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product (2 Single Doses of 0.2 U/kg) and U-200 Product (2 Single Doses of 0.2 U/kg) in Healthy Male and Female|Completed||Phase 1|26|Actual|Adocia||2|||f||||f||||||||||2017-10-10 23:00:07.512998|2017-10-10 23:00:07.512998
NCT02529280|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-07-20|||February 2012||2012-02-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Choices for Latinas and Clinical Trials|Choices: Increasing Access of Latinas Into Breast Cancer Clinical Trials|Completed||N/A|77|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 23:00:07.61033|2017-10-10 23:00:07.61033
NCT02529267|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-08-21|||August 2015||2015-08-01|August 2015|2015-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|PRAISE-2||Prospective Abuse and Intimate Partner Violence Surgical Evaluation|Prospective Abuse and Intimate Partner Violence Surgical Evaluation (PRAISE-2) : A Multicentre Pilot Prospective Cohort Study|Recruiting||N/A|250|Anticipated|McMaster University|||2||f||||f||||||||||2017-10-10 23:00:07.71716|2017-10-10 23:00:07.71716
NCT02529254|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-02-06|||May 2015||2015-05-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Video Coaching as an Efficient Teaching Method for Surgical Residents|Video Coaching as an Efficient Teaching Method for Surgical Residents A Randomized Control Trial|Completed||N/A|28|Actual|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-10 23:00:07.843806|2017-10-10 23:00:07.843806
NCT02529241|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-04-07|||July 2015||2015-07-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||An Open-label, Single Dose, Parallel Design, Phase 1 Clinical Study of LCB01-0371|An Open-label, Single Dose, Parallel Design, Phase I Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Oral Dosage Form of LCB01-0371 in Healthy Volunteers|Terminated||Phase 1|12|Actual|LegoChem Biosciences, Inc||2|||f||||f||||||||||2017-10-10 23:00:07.944911|2017-10-10 23:00:07.944911
NCT02529228|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-18|||December 2014||2014-12-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Combined Effects of Meal Frequency and Protein Load on Cardiometabolic Risk Factors||Completed||N/A|10|Actual|Clinical Nutrition Research Centre, Singapore||4|||f||||f||||||||||2017-10-10 23:00:08.037877|2017-10-10 23:00:08.037877
NCT02529215|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-05-10|||April 2015||2015-04-01|May 2016|2016-05-01||||April 2017|Anticipated|2017-04-01||Interventional|||Improving Team Training During Mock Code Blue Simulations|Improving the Quality of Team Training and Performance During Interprofessional in Situ Mock Code Blue Simulations: A Randomized Controlled Mixed-methods Study|Recruiting||N/A|264|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 23:00:08.127253|2017-10-10 23:00:08.127253
NCT02514720|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-06-16|||June 2015||2015-06-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|MET||Nicotine Metabolizers and [11C]-(+)-PHNO|Impact of Nicotine Metabolism on Brain Dopamine Transmission|Completed||N/A|16|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||Undecided||2017-10-10 23:04:27.79892|2017-10-10 23:04:27.79892
NCT02529202|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-01-10|||March 2016||2016-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia|Dexmedetomidine Use During Therapeutic Hypothermia Treatment for Neonates With Hypoxic-ischemic Encephalopathy: The Cool DEX Study|Completed||Early Phase 1|7|Actual|Seattle Children's Hospital||1|||f||||t||||||||No||2017-10-10 23:00:08.231331|2017-10-10 23:00:08.231331
NCT02529189|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-10-20|||November 2015||2015-11-01|October 2016|2016-10-01||||November 2018|Anticipated|2018-11-01||Interventional|NITRATE-OCT||Investigating the Effects of Dietary Nitrate on Vascular Function, Platelet Reactivity and Restenosis in Stable Angina|A Randomised, Double-blind, Placebo-controlled Study Investigating the Effects of Dietary Nitrate on Vascular Function, Platelet Reactivity and Restenosis in Stable Angina|Recruiting||Phase 2|246|Anticipated|Queen Mary University of London||2|||f||||t||||||||||2017-10-10 23:00:08.32158|2017-10-10 23:00:08.32158
NCT02529176|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-19|||November 2015||2015-11-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Trial of a Best-Practice Alert in the Electronic Medical Record to Reduce Unnecessary Telemetry Monitoring|Randomized Trial of a Best-Practice Alert in the Electronic Medical Record to Reduce Unnecessary Telemetry Monitoring|Unknown status|Not yet recruiting|N/A|384|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:00:08.443208|2017-10-10 23:00:08.443208
NCT02529163|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-04-06|||August 2015||2015-08-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|LLS-ICP||Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms|Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms|Active, not recruiting||N/A|24|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||Yes|We do plan to share individual data at the completion of the study. Data will be shared only if the participant has agreed to do so as indicated on their informed consent document. Data that is expected to be shared will include all assessments from each visit, time to relapse, and which arm of the study each participant is affiliated with. In addition, research data gathered as part of this study may be shared and provided to investigators affiliated with GMHS (or other secondary investigators ) for the purpose of conducting secondary analyses about late-life mental illness. If subjects are enrolled in multiple studies in GMHS, their research data will be shared across studies to reduce participant burden and avoid duplication of procedures.|2017-10-10 23:00:08.519085|2017-10-10 23:00:08.519085
NCT02529150|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-01-14|||May 2015||2015-05-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Interventional|||WISER After Ovarian Cancer - Exercise Pilot Study|WISER After Ovarian Cancer - Exercise Pilot Study|Active, not recruiting||Early Phase 1|10|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:00:08.633906|2017-10-10 23:00:08.633906
NCT02529124|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-06-24|||January 2012||2012-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|BCHA||Nutrient Support to Body Composition and Healthy Ageing|An Investigation of the the Effect of Nutrient Support, or Nutrient Plus Physical Activity on Musculoskeletal Health and Function in Men and Women Aged 55 to 70 Years|Completed||N/A|254|Actual|University of Limerick||3|||f||||t||||||||||2017-10-10 23:00:08.776002|2017-10-10 23:00:08.776002
NCT02529111|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-12-11|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CIA3DNAVIGATOR||Percutaneous Closure of Atrial Septal Defects in Children: Integration of 3D Echocardiography and Fluoroscopy Imaging.|Integration of Three-dimensional Echocardiography and Fluoroscopy Imaging During the Percutaneous Closure of intAtrial Septal Defects in Children: CIA-3D-navigator.|Recruiting||N/A|20|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-10 23:00:08.870725|2017-10-10 23:00:08.870725
NCT02529098|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-05-27|||June 2015||2015-06-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|PlainteIMF||Modification in Cortical Activation in Pseudophakic Patients With Visual Difficulties After a Multifocal Implantation|Modification in Cortical Activation by Functional Magnetic Resonance Imaging (fMRI) in Pseudophakic Patients With Visual Difficulties After a Multifocal Implantation|Withdrawn||N/A|0|Actual|University Hospital, Toulouse||2||default recruitment|f||||f||||||||||2017-10-10 23:00:08.97656|2017-10-10 23:00:08.97656
NCT02529085|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-05-06|||March 2013||2013-03-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||PWS European Blood Bank for Infants and Controls From 0 to 48 Months|Study of Early Endocrine Profile in Infants With Prader-Willi Syndrome (PWS) in Order to Unravel the Switch From Early Feeding Difficulties to Obesity and Hyperphagia.|Recruiting||N/A|500|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:00:09.063122|2017-10-10 23:00:09.063122
NCT02529072|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-09-28|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 15, 2017|Actual|2017-09-15||Interventional|AVERT||Nivolumab With DC Vaccines for Recurrent Brain Tumors|AVeRT: Anti-PD-1 Monoclonal Antibody (Nivolumab) in Combination With DC Vaccines for the Treatment of Recurrent Grade III and Grade IV Brain Tumors|Terminated||Phase 1|7|Actual|Duke University||2||Drug availability|f||||t||||||||||2017-10-10 23:00:09.197071|2017-10-10 23:00:09.197071
NCT02529059|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-15|||November 2015||2015-11-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms|A Phase IV, Open-label, Multi Centre Pilot Study to Assess Changes in Cerebral Function Parameters in Patients Without Perceived Central Nervous System (CNS) Symptoms When Switched From a Fixed Dose Combination of Tenofovir/Emtricitabine/Efavirenz (Atripla®) to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine (Eviplera®)|Completed||Phase 4|40|Anticipated|St Stephens Aids Trust||1|||f||||f||||||||||2017-10-10 23:00:09.300053|2017-10-10 23:00:09.300053
NCT02529046|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-18|||March 2007||2007-03-01|August 2015|2015-08-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|CLA||Conjugated Linoleic Acid in Obese Women|Effect of Conjugated Linoleic Acid Associated With Aerobic Exercise on Body Fat and Lipid Profile in Obese Women: A Randomized, Double-blinded and Placebo-controlled Trial|Completed||N/A|28|Actual|Universidade Estadual de Londrina||2|||f||||f||||||||||2017-10-10 23:00:09.400698|2017-10-10 23:00:09.400698
NCT02529020|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-18|||May 2014||2014-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Jaw Clenching on Anaerobic Ability and Ventilatory Flows|Acute Effects of Jaw Clenching Using a Customized Mouthguard on Anaerobic Ability and Ventilatory Flows|Completed||N/A|30|Actual|University Ramon Llull||2|||f||||t||||||||||2017-10-10 23:00:09.582539|2017-10-10 23:00:09.582539
NCT02529007|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-05-27|||September 2014||2014-09-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|E-CAP||Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening|Endo-cuff Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening Patients: A Randomised Controlled Trial. The E-CAP Study|Completed||N/A|534|Actual|Portsmouth Hospitals NHS Trust||2|||f||||t||||||||||2017-10-10 23:00:09.65213|2017-10-10 23:00:09.65213
NCT02528994|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-09-15|||September 2016||2016-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Short Term Dietary Serine Supplementation and Circulating Serine Levels|A Pilot Study to Test the Effect of Short Term Dietary Serine Supplementation on Circulating Serine Levels|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||4||The PI will be leaving the institution and not continuing the study|f||||f||||||||||2017-10-10 23:00:09.742653|2017-10-10 23:00:09.742653
NCT02528981|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-03-04|||August 2015||2015-08-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial|Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial|Completed||N/A|114|Actual|Ryerson University||2|||f||||f||||||||||2017-10-10 23:00:09.820135|2017-10-10 23:00:09.820135
NCT02528968|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-02-23|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|UK-PK||National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A|UK-PK Study: National Study of the Implementation of a Pharmacokinetic-Focused Educational Package for Patients Living With Severe Haemophilia A|Active, not recruiting||N/A|59|Actual|Hampshire Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:00:09.911001|2017-10-10 23:00:09.911001
NCT02528955|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-18|||October 2014||2014-10-01|August 2015|2015-08-01|October 2021|Anticipated|2021-10-01|October 2019|Anticipated|2019-10-01||Interventional|DIREKHT||De-Intensification Radiotherapy Postoperative Head Neck|De-intensification of Postoperative Radiotherapy in Selected Patients With Head and Neck Cancer|Recruiting||Phase 2|200|Anticipated|University of Erlangen-Nürnberg Medical School||3|||f||||f||||||||||2017-10-10 23:00:09.993566|2017-10-10 23:00:09.993566
NCT02528942|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-05-02|||April 22, 2016|Actual|2016-04-22|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients|Early Phase Clinical Trial Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients|Recruiting||N/A|70|Anticipated|University of Colorado, Denver||1|||f||||t||||||||No||2017-10-10 23:00:10.116982|2017-10-10 23:00:10.116982
NCT02528929|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-18|||September 2012||2012-09-01|August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Interventional|||Gluten-free Diet in Irritable Bowel Syndrome|Assessing the Clinical Response to a Gluten Free Diet in Patients With Diarrhoea Predominant Irritable Bowel Syndrome, in Whom Overt Coeliac Disease Has Been Excluded|Unknown status|Active, not recruiting|N/A|48|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||||||||||||2017-10-10 23:00:10.205915|2017-10-10 23:00:10.205915
NCT02528916|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2016-03-17|||April 2014||2014-04-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Nociceptin Concentration in Synovial Fluid and Plasma|Nociceptin Concentration in Synovial Fluid and Plasma in Patients Undergoing Primary Total Knee Arthroplasty: A Prospective Pilot Study|Completed||N/A|22|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-10-10 23:00:10.272798|2017-10-10 23:00:10.272798
NCT02528903|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-11-01|||August 2015||2015-08-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MHAB5553A in Healthy Volunteers|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MHAB5553A in Healthy Volunteers|Completed||Phase 1|26|Actual|Genentech, Inc.||5|||f||||||||||||||2017-10-10 23:00:10.336084|2017-10-10 23:00:10.336084
NCT02528890|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-04-04|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|GBS||Group B Streptococcal Carrier State Prevalence Among Arab Pregnant Women in Northern Israel District|Group B Streptococcal Carrier State Prevalence Among Arab Pregnant Women in Northern Israel District|Completed||N/A|196|Actual|The Nazareth Hospital, Israel|||1||f||||t||||||||||2017-10-10 23:00:10.565401|2017-10-10 23:00:10.565401
NCT02528877|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-09-12|||November 2015||2015-11-01|September 2016|2016-09-01||||September 2016|Actual|2016-09-01||Interventional|||Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis|A Phase I Trial of Ruxolitinib Combined With Tacrolimus and Sirolimus as Acute Graft-versus-Host Disease (aGVHD) Prophylaxis During Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis|Withdrawn||Phase 1|0|Actual|City of Hope Medical Center||1||The study design was revised so a new protocol will be opened.|f||||t||||||||||2017-10-10 23:00:10.655942|2017-10-10 23:00:10.655942
NCT02528864|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-08-12|||August 2015||2015-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|EMCAMRS||MRI and Metabolomics Biomarkers for Uterine Malignancy|Multiparametric Magnetic Resonance Imaging and Metabolomics Approaches to Study Biomarkers for Uterine Malignancy|Recruiting||N/A|150|Anticipated|Chang Gung Memorial Hospital|||2||f||||f||||||Samples Without DNA|"     1. Plasma sample preparation for global metabolites analysis and lipidomic analysis:        2. Urine samples will be diluted with distilled water. Samples are centrifuged at 14,000 g          for 5 min, and the supernatants will be collected for LC-MS analysis.        3. Cellular metabolites extraction: Extraction method will be carried out by the method          modified by Munger and Patterson. The medium will be aspirated from culture plates          containing cells and 80% methanol (at -80°C) will immediately be added.   "|No||2017-10-10 23:00:10.823391|2017-10-10 23:00:10.823391
NCT02509949|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-04-23|||May 2015||2015-05-01|April 2017|2017-04-01||||April 2018|Anticipated|2018-04-01||Interventional|||Effects of Dexmedetomidine on Delirium After Living Donor Renal Transplantation in Adult Patients||Recruiting||Phase 4|100|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 23:05:25.283036|2017-10-10 23:05:25.283036
NCT02528851|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-18|||October 2015||2015-10-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|CO-PAP||"Cardiorespiratory Effects of Higher Versus Equivalent CPAP Upon Extubation From High EAP in Preterm Infants"|"Cardiorespiratory Effects of Higher Versus Equivalent CPAP Upon Extubation From High Endotracheal Airway Pressures in Preterm Infants: A Randomized Cross-Over Trial"|Unknown status|Not yet recruiting|N/A|14|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 23:00:10.909593|2017-10-10 23:00:10.909593
NCT02528838|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-02-14|||May 2011||2011-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2016|Actual|2016-06-01||Observational|REVIEW||An Observational Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide.|A Non-interventional Observational Post Authorization Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide (REVIEW)|Active, not recruiting||N/A|238|Actual|Celgene|||1||f||||f||||||||||2017-10-10 23:00:11.012321|2017-10-10 23:00:11.012321
NCT02528825|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-18|||November 2014||2014-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect-site Concentration of Remifentanil for Smooth Removal of the Double-lumen Endotracheal Tube||Completed||Phase 4|25|Actual|Ajou University School of Medicine||1|||f||||||||||||||2017-10-10 23:00:11.104695|2017-10-10 23:00:11.104695
NCT02528812|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-19|||April 2014||2014-04-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Rolling Massage Decreases Pain Pressure Threshold|Pain Pressure Threshold of a Muscle Tender Spot Increases Following Local and Non-local Rolling Massage|Completed||N/A|150|Actual|Memorial University of Newfoundland||5|||f||||f||||||||||2017-10-10 23:00:11.199864|2017-10-10 23:00:11.199864
NCT02528799|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-04-20|||August 2015||2015-08-01|April 2017|2017-04-01|January 6, 2017|Actual|2017-01-06|January 6, 2017|Actual|2017-01-06||Interventional|||Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Nexvax2 Preceded by a Dose Titration Period in Subjects With Celiac Disease Currently on a Gluten-Free Diet|Completed||Phase 1|38|Actual|ImmusanT, Inc.||6|||f||||t||||||||||2017-10-10 23:00:11.319358|2017-10-10 23:00:11.319358
NCT02528773|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-11-18|||October 2014||2014-10-01|November 2016|2016-11-01||||October 2019|Anticipated|2019-10-01||Observational|ART-NET||Efficacy of ART to Interrupt HIV Transmission Networks|Efficacy of ART to Interrupt HIV Transmission Networks|Recruiting||N/A|425|Anticipated|University of California, San Diego|||1||f||||f||||||Samples With DNA|"     Blood Draws: Approximately 2 tablespoons (30 mL) of blood will be taken for blood tests and     storage at each visit. Participants' blood will be tested for:        -  CD4+/CD8+ T-cell Count. This is a measure of the immune system; T-cells help the immune          system fight infections.        -  HIV-1 RNA (Viral Load). This measures the amount of HIV in the blood.        -  HIV pol sequence. This measures the type of HIV in your blood.        -  Blood will be collected for storage for future HIV testing, studies to measure the          amount of residual HIV that remains in people who are doing well on HIV treatment,          genetic testing of the HIV virus and possible HLA genotype testing as determined by the          results of this and future studies.   "|||2017-10-10 23:00:11.586414|2017-10-10 23:00:11.586414
NCT02528760|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-06-08|||September 24, 2015|Actual|2015-09-24|September 2016|2016-09-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis|To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis- A Randomized Placebo Controlled Study|Recruiting||N/A|162|Anticipated|Institute of Liver and Biliary Sciences, India||3|||f||||f||||||||||2017-10-10 23:00:11.722674|2017-10-10 23:00:11.722674
NCT02528747|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-18|||January 2009||2009-01-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate|A Multi-Center Observational Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate (BONDORAL)|Completed||N/A|582|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:00:11.862399|2017-10-10 23:00:11.862399
NCT02528734|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-09-19|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Observational|||Prospective Evaluation of Needle Exsufflation for Pneumothorax|Impact of Pneumothorax Duration Before Treatment on the Success of Needle Exsufflation|Completed||N/A|71|Actual|Hôpital Louis Mourier|||1||f||||f||||||||||2017-10-10 23:00:11.997369|2017-10-10 23:00:11.997369
NCT02528721|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-01-12|2016-11-16||October 2015||2015-10-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection|Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the BreathID® Hp Lab System Compared to Biopsy Results|Completed||Phase 3|282|Actual|Exalenz Bioscience LTD.||2|||f||||f||||||||||2017-10-10 23:00:12.121393|2017-10-10 23:00:12.121393
NCT02528708|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-08-23|||September 2016||2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|PERFECT PPH||A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)|A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|Yale University||2|||f||||t||||||||||2017-10-10 23:00:12.529224|2017-10-10 23:00:12.529224
NCT02528695|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-05-29|||November 2014||2014-11-01|April 2016|2016-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ATI-DM2||Adipose Tissue Imaging in Type 2 Diabetes|Adipose Tissue Imaging in Patients With Type 2 Diabetes, Pilot Study|Completed||N/A|15|Actual|Radboud University||3|||f||||f||||||||||2017-10-10 23:00:12.641293|2017-10-10 23:00:12.641293
NCT02528136|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-11-04|||September 2015||2015-09-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|CMT||The Clinical Carbetocin Myocardium Trial|The Clinical Carbetocin Myocardium Trial|Recruiting||Phase 4|400|Anticipated|Oslo University Hospital||2|||f||||t||||||||No|Participant data will be analyzed in the Research Group only|2017-10-10 23:00:21.970942|2017-10-10 23:00:21.970942
NCT02528682|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-05-18|||January 2016||2016-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PSCT19||MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT|Vaccination With PD-L1/L2-silenced Minor Histocompatibility Antigen-loaded Donor DC Vaccines to Boost Graft-versus-tumor Immunity After Allogeneic Stem Cell Transplantation (a Phase I/II Study)|Recruiting||Phase 1/Phase 2|10|Anticipated|Radboud University||1|||f||||f||||||||||2017-10-10 23:00:12.762033|2017-10-10 23:00:12.762033
NCT02528669|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-08-18|||March 2014||2014-03-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|February 2016|Anticipated|2016-02-01||Interventional|||Patient Ambulation in Post-Op Recovery|Measuring Patient Ambulation in Post-Operative Recovery|Unknown status|Recruiting|N/A|3000|Anticipated|Intermountain Health Care, Inc.||2|||f||||f||||||||||2017-10-10 23:00:12.905542|2017-10-10 23:00:12.905542
NCT02528656|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-03-17|||January 12, 2015|Actual|2015-01-12|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|PECTUS||Physiological Assessments During Non Operative Treatment on the Chest Wall Deformities|Physiological Assessments During Non Operative Treatment on the Chest Wall Deformities. Pectus Excavatum Pectus-Carinatum. Single-center Study|Recruiting||N/A|52|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||No||2017-10-10 23:00:13.021524|2017-10-10 23:00:13.021524
NCT02528643|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-09-25|||November 9, 2015|Actual|2015-11-09|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 2|165|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-10 23:00:13.143658|2017-10-10 23:00:13.143658
NCT02528630|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-02-19|||October 2013||2013-10-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|January 2015|Actual|2015-01-01||Interventional|||Progressive Strength in Hand Osteoarthritis|Effectiveness of a Progressive Resistance Strength Program on Hand Osteoarthritis: a Randomized Controlled Trial|Completed||Phase 4|60|Actual|Federal University of São Paulo||2|||f||||||||||||||2017-10-10 23:00:13.31284|2017-10-10 23:00:13.31284
NCT02528617|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-05-30|||July 2015||2015-07-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease|The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease|Recruiting||Phase 4|23|Anticipated|Baylor Research Institute||1|||f||||f||||||||||2017-10-10 23:00:13.426827|2017-10-10 23:00:13.426827
NCT02528604|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-02-07|||July 2016||2016-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|CAPAPAF-65||Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation|Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation in Over 65s - The CAPAPAF-65 Study|Recruiting||Phase 4|75|Anticipated|Eastbourne General Hospital||3|||f||||f||||||||||2017-10-10 23:00:13.527606|2017-10-10 23:00:13.527606
NCT02528591|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-18|||March 2013||2013-03-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PACT||Prospective Single-center Study Evaluating the Central Blood Pressure in Renal Transplantation|Prospective Single-center Study Evaluating the Central Blood Pressure in Renal Transplantation|Completed||N/A|89|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:00:13.615441|2017-10-10 23:00:13.615441
NCT02528578|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-09-25|||June 2013|Actual|2013-06-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|MODOU||Modulation of Painful Perception|Modulation of Painful Perception|Completed||N/A|74|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||||2017-10-10 23:00:13.707638|2017-10-10 23:00:13.707638
NCT02528565|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-06-07|||August 2015||2015-08-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01|2 Years|Observational [Patient Registry]|||Gastric Banding After Failed Gastric Bypass|Laparoscopic Adjustable Gastric Banding With the Adhesix Bioring After Failed Gastric Bypass: a Prospective Evaluation in a High-volume Center|Recruiting||N/A|40|Anticipated|be Medical|||1||f||||f||||||||||2017-10-10 23:00:13.830757|2017-10-10 23:00:13.830757
NCT02528552|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-12-01|||August 2015||2015-08-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO|A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia|Active, not recruiting||Phase 2|80|Anticipated|Theradome, Inc.||2|||f||||f||||||||||2017-10-10 23:00:13.930311|2017-10-10 23:00:13.930311
NCT02528539|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-09-20|||August 2013||2013-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)|Prevention of Secondary Lymphedema by Utilizing Self-management Education in Conjunction With Acupuncture Among Breast Cancer Patients Who Are at High Risk of Developing Lymphedema|Recruiting||N/A|30|Anticipated|Huntington Memorial Hospital||1|||f||||f||||||||No||2017-10-10 23:00:14.013537|2017-10-10 23:00:14.013537
NCT02528526|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-08-18|||February 2014||2014-02-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|OXY1A||Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm|A Phase IB/IIA, Single-centered Study of the Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasia|Unknown status|Recruiting|Phase 1/Phase 2|69|Anticipated|University of Zurich||1|||f||||t||||||||||2017-10-10 23:00:14.149744|2017-10-10 23:00:14.149744
NCT02528513|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2016-04-26|||December 2015||2015-12-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Midazolam Used Alone or Sequential Use of Midazolam and Propofol/Dexmedetomidine in Mechanically Ventilated Patients|Midazolam Used Alone or Sequential Use of Midazolam and Propofol/Dexmedetomidine for Long-Term Sedation in Critically Ill, Mechanically Ventilated Patients: a Prospective, Randomized Study|Enrolling by invitation||Phase 4|240|Anticipated|West China Hospital||3|||f||||t||||||||||2017-10-10 23:00:14.257767|2017-10-10 23:00:14.257767
NCT02528123|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-07-07|||April 2016||2016-04-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia|VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia|Recruiting||N/A|187|Anticipated|London Vision Clinic||1|||f||||t||||||||||2017-10-10 23:00:22.144791|2017-10-10 23:00:22.144791
NCT02528500|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-09-28|||November 2015||2015-11-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|October 2017|Anticipated|2017-10-01||Interventional|TAMBE||GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms|Early Feasibility Assessment of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms Involving the Visceral Branch Vessels|Active, not recruiting||N/A|10|Actual|W.L.Gore & Associates||1|||f||||t||||||||||2017-10-10 23:00:14.354087|2017-10-10 23:00:14.354087
NCT02528487|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-08-15|||May 2015||2015-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?|Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?|Recruiting||N/A|270|Anticipated|Hopital du Sacre-Coeur de Montreal|||1||f||||f||||||||||2017-10-10 23:00:14.445124|2017-10-10 23:00:14.445124
NCT02528474|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-09-22|||August 2015||2015-08-01|September 2015|2015-09-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Comparison of Optical Coherence Tomographic Findings After Balloon Angioplasty With Two Different Paclitaxel-Coated Balloons for the Treatment of In-Stent Restenosis in Drug-Eluting Stents||Recruiting||N/A|120|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:00:14.541452|2017-10-10 23:00:14.541452
NCT02528461|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-05-11|||January 2015||2015-01-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C|Measuring Inflammation Cells (CD163 and CD206) With the Purpose of Examining Reduction of Fibrosis in the Liver of Chronic Hepatitis C Patients Following Treatment With the Medication Sofosbuvir|Recruiting||Phase 4|80|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-10-10 23:00:16.627703|2017-10-10 23:00:16.627703
NCT02528448|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-18|||March 2015||2015-03-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|KIPA||0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis|The Effect of 0,9% NaCl on the Kidney Function, Vasoactive Hormones, Biomarkers and Glycosaminglycanes in Plasma in Patients Operated on for Primary Hiparthrosis|Unknown status|Recruiting|Phase 4|40|Anticipated|Regional Hospital Holstebro||2|||f||||t||||||||||2017-10-10 23:00:16.754919|2017-10-10 23:00:16.754919
NCT02528422|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-18|||May 2015||2015-05-01|August 2015|2015-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|DOAG||The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers|The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers - A Randomized, Cross-over, Single-blind, Placebo-controlled Dose-response Study of the Acyl-ghrelin Induced Effects on GFR, Tubular Transport of Sodium and Water in Different Nephron Segments and Central and Peripheral Blood Pressure|Recruiting||Phase 1|15|Anticipated|Regional Hospital Holstebro||3|||f||||t||||||||||2017-10-10 23:00:16.960424|2017-10-10 23:00:16.960424
NCT02528409|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-01-09|||June 2016||2016-06-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Vortioxetine for Binge Eating Disorder|A Double-Blind, Placebo-Controlled Study of Vortioxetine in the Treatment of Binge Eating Disorder|Recruiting||Phase 2|80|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 23:00:17.030674|2017-10-10 23:00:17.030674
NCT02528396|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-03-14|||August 2015||2015-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus|A Randomized, Monocentric, Double-blind, Multiple Daily Dose, Two-period, 14 Day Cross-over Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus|Completed||Phase 1|36|Actual|Adocia||2|||f||||f||||||||||2017-10-10 23:00:17.128732|2017-10-10 23:00:17.128732
NCT02528383|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-09-15|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors|Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors: Systemic Impact Versus Local Objective Benefits and Quality of Life|Completed||N/A|3|Actual|UConn Health||1|||f||||f||||||||||2017-10-10 23:00:17.212401|2017-10-10 23:00:17.212401
NCT02528370|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-17|||May 2010||2010-05-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|telEPOC||Evaluation the Effectiveness of a Telemonitoring Program in a Cohort of COPD Patient With Frequent Readmissions|Evaluation the Effectiveness of a Telemonitoring Program in a Cohort of COPD Patient With Frequent Readmissions|Completed||N/A|197|Actual|Hospital Galdakao-Usansolo||2|||f||||f||||||||||2017-10-10 23:00:17.293079|2017-10-10 23:00:17.293079
NCT02528357|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-01-16|||September 2015||2015-09-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)|A Phase I, Open-Label Study of GSK3174998 Administered Alone and in Combination With Anticancer Agents Including Pembrolizumab in Subjects With Selected Advanced Solid Tumors|Recruiting||Phase 1|264|Anticipated|GlaxoSmithKline||4|||f||||f||||||||||2017-10-10 23:00:17.369474|2017-10-10 23:00:17.369474
NCT02528344|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-12-07|||September 2015||2015-09-01|June 2016|2016-06-01||||October 2016|Actual|2016-10-01||Interventional|||High Intensity Interval Training and Rheumatoid Arthritis|The Effects of High-Intensity Interval Training on Inflammation in Adults With Rheumatoid Arthritis|Completed||N/A|12|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 23:00:17.664449|2017-10-10 23:00:17.664449
NCT02528149|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-18|||September 2013||2013-09-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Renal Arteries Dysplastic Aneurysms: Anatomopathological and Genetic Study|Renal Arteries Dysplastic Aneurysms: Anatomopathological and Genetic Study|Completed||N/A|34|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"     blood samples and adjacent part and aneurysm of renal aneurysms   "|||2017-10-10 23:00:21.860097|2017-10-10 23:00:21.860097
NCT02528331|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-12-19|2016-11-29||March 2016||2016-03-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|CBT-TMS||Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study|Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study|Terminated||N/A|2|Actual|Duke University|This trial was terminated early leading to small numbers of subjects analyzed.|1||PI has left Duke|f||||t||||||||||2017-10-10 23:00:17.748503|2017-10-10 23:00:17.748503
NCT02528318|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-08-15|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|August 11, 2017|Actual|2017-08-11|May 31, 2017|Actual|2017-05-31||Interventional|||Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA|A Multicenter, Randomized, Open-label, Controlled Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA|Terminated||Phase 2|48|Actual|Windtree Therapeutics||5||Sponsor decision to terminate after 3 dosing groups|f||||t||||||||||2017-10-10 23:00:17.96749|2017-10-10 23:00:17.96749
NCT02528292|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2015-08-18|||October 2010||2010-10-01|August 2011|2011-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis|Phase 4 Study of Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Patients With Rheumatoid Arthritis Undergoing Treatment With Anti-TNF Therapy|Active, not recruiting||N/A|24|Anticipated|Barts & The London NHS Trust|||1||f||||f||||||Samples With DNA|"     Synovial tissue and blood   "|||2017-10-10 23:00:18.224277|2017-10-10 23:00:18.224277
NCT02528279|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-01-24|||October 2014||2014-10-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|REPLAMO||Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria|Prospective Assessment of Relapse Characteristics of Plasmodium Ovale and Antimalarial Treatment Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria in Gabon|Completed||N/A|50|Anticipated|Albert Schweitzer Hospital||1|||f||||f||||||||||2017-10-10 23:00:18.313333|2017-10-10 23:00:18.313333
NCT02528266|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-01-11|||January 2016||2016-01-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|STOP NEUROMA||Surgical Treatment of Symptomatic Neuroma|Open Non-randomized Clinical Investigation to Evaluate the Safety and Effectiveness of the Nerve Capping Device to Prevent Neuroma Formation After Traumatic Nerve Section|Recruiting||N/A|21|Anticipated|Polyganics Innovations BV||1|||f||||f||||||||||2017-10-10 23:00:18.414987|2017-10-10 23:00:18.414987
NCT02528253|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-10-02|||August 18, 2015|Actual|2015-08-18|October 2017|2017-10-01|January 8, 2019|Anticipated|2019-01-08|October 17, 2017|Anticipated|2017-10-17||Interventional|TANGO||A Phase 3 Study of Tanezumab for Chronic Low Back Pain|A Phase 3, Randomized, Double Blind, Placebo And Active‑Controlled, Multicenter, Parallel‑Group Study Of The Analgesic Efficacy And Safety Of Tanezumab In Adult Subjects With Chronic Low Back Pain|Recruiting||Phase 3|1800|Anticipated|Pfizer||5|||f||||t|t|f||||||||2017-10-10 23:00:18.601707|2017-10-10 23:00:18.601707
NCT02528240|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-05-03|||August 2015|Actual|2015-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|December 2016|Actual|2016-12-01||Interventional|||Endodontic Microsurgery With the Use of L-PRF and an Occlusive Membrane: a Randomized Controlled Clinical Trial|Endodontic Microsurgery With the Use of L-PRF and an Occlusive Membrane: a Randomized Controlled Clinical Trial|Active, not recruiting||Phase 3|56|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-10 23:00:19.422152|2017-10-10 23:00:19.422152
NCT02528227|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-12-19|||January 2013||2013-01-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|NICU PEP||NICU Parent Education Program|NICU Parent Education Program|Active, not recruiting||N/A|95|Actual|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||||2017-10-10 23:00:19.537859|2017-10-10 23:00:19.537859
NCT02528214|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-05-15|||October 15, 2015|Actual|2015-10-15|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 20, 2017|Anticipated|2017-09-20||Interventional|VENTURE||Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma|Active, not recruiting||Phase 3|180|Anticipated|Sanofi||2|||f||||t||||||||||2017-10-10 23:00:19.691494|2017-10-10 23:00:19.691494
NCT02528201|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-08-18|||September 2002||2002-09-01|August 2015|2015-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis|A Twelve Week, Randomized, Double Blind Parallel Group Study Of Two Doses Of Celecoxib Compared To Diclofenac In Patients With Ankylosing Spondylitis|Completed||Phase 4|330|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 23:00:19.977947|2017-10-10 23:00:19.977947
NCT02528188|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2017-10-02|||July 21, 2015|Actual|2015-07-21|October 2017|2017-10-01|February 26, 2019|Anticipated|2019-02-26|September 11, 2018|Anticipated|2018-09-11||Interventional|||Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee|A Phase 3 Randomized, Double-blind, Active-controlled, Multicenter Study Of The Long-term Safety And Efficacy Of Subcutaneous Administration Of Tanezumab In Subjects With Osteoarthritis Of The Hip Or Knee|Recruiting||Phase 3|3000|Anticipated|Pfizer||3|||f||||t|t|f||||||||2017-10-10 23:00:20.249584|2017-10-10 23:00:20.249584
NCT02528175|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-04-13|||April 2015||2015-04-01|April 2016|2016-04-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer|Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer - A Pilot Study|Recruiting||N/A|20|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-10 23:00:21.695218|2017-10-10 23:00:21.695218
NCT02528162|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-10-24|||October 2015||2015-10-01|August 2015|2015-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|||Evaluation of Education for Gestational Diabetes|Evaluation of Knowledge Regarding Gestational Diabetes and Evaluation of (Group) Education for Gestational Diabetes|Recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:00:21.788373|2017-10-10 23:00:21.788373
NCT02528110|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2016-07-11|||August 2015||2015-08-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer|A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Locally Advanced Gastric Cancer During Radical Gastrectomy|Not yet recruiting||Phase 2|100|Anticipated|Wuhan University||2|||f||||t||||||||||2017-10-10 23:00:22.277116|2017-10-10 23:00:22.277116
NCT02528097|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-05-26|2016-03-11||September 2010||2010-09-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis|A Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis|Terminated||N/A|2|Actual|New York University School of Medicine|Due to the extremely small sample size, and the fact that the PI left the institution, no data was analyzed for this study|2|||f||||t||||||||||2017-10-10 23:00:22.37797|2017-10-10 23:00:22.37797
NCT02528084|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-03-22|||October 20, 2015|Actual|2015-10-20|March 2017|2017-03-01|October 20, 2016|Actual|2016-10-20|October 20, 2016|Actual|2016-10-20||Interventional|||The Effects of Yoga on Patients With Rotator Cuff Injuries|The Effects of Yoga on Patients With Rotator Cuff Injuries|Completed||N/A|10|Actual|Lawson Health Research Institute||3|||f||||f||||||||Undecided||2017-10-10 23:00:22.633527|2017-10-10 23:00:22.633527
NCT02528071|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2016-08-10|||September 2014||2014-09-01|August 2016|2016-08-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|SLA||Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis|Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis : Impact and Prognosis. Single-center Prospective Pilot Study|Recruiting||N/A|165|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||||No||2017-10-10 23:00:22.72444|2017-10-10 23:00:22.72444
NCT02528058|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2015-08-17|||June 2010||2010-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Observational|||Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy|Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy|Completed||N/A|7|Actual|Kyorin University|||1||f||||f||||||Samples Without DNA|"     Excised internal limiting membrane during the surgical treatment for myopic traction     maculopathy   "|||2017-10-10 23:00:22.851047|2017-10-10 23:00:22.851047
NCT02528045|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2015-08-18|||June 2012||2012-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|July 2014|Actual|2014-07-01||Observational|||Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy|Efficacy of Surgical Treatment of Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy|Completed||N/A|16|Actual|Kyorin University|||1||f||||f||||||||||2017-10-10 23:00:22.933884|2017-10-10 23:00:22.933884
NCT02528032|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-09-09|||August 2015||2015-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RICART||Revisit the Value of Imaging in Best Using CArdiac Resynchronization Therapy|Revisit the Value of Imaging in Best Using CArdiac Resynchronization Therapy|Recruiting||N/A|80|Anticipated|Rennes University Hospital||1|||f||||f||||||||||2017-10-10 23:00:23.027405|2017-10-10 23:00:23.027405
NCT02528019|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-18|||August 2015||2015-08-01|August 2015|2015-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors|Effects of the DPP-4 or SGLT2 Inhibitors on the Metabolic Cardiovascular Systems in Patients With Type 2 Diabetes Mellitus.|Recruiting||Phase 4|100|Anticipated|Kurume University||3|||f||||||||||||||2017-10-10 23:00:23.139672|2017-10-10 23:00:23.139672
NCT02528006|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-16|||July 27, 2015|Actual|2015-07-27|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|March 29, 2017|Actual|2017-03-29||Interventional|||Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges|Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges|Active, not recruiting||Phase 2/Phase 3|20|Anticipated|Kumamoto University||1|||f||||t||||||||||2017-10-10 23:00:23.243456|2017-10-10 23:00:23.243456
NCT02527993|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-01-24|||October 2015||2015-10-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Hypoglycemia Following Gastric Bypass Surgery|Treatment of Hypoglycemia Following Gastric Bypass Surgery|Enrolling by invitation||Phase 4|16|Anticipated|Zealand University Hospital||5|||f||||t||||||||||2017-10-10 23:00:23.412062|2017-10-10 23:00:23.412062
NCT02527980|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-12-05|||September 2015||2015-09-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||E-Cigarettes: Dynamic Patterns of Use and Health Effects|E-Cigarettes: Dynamic Patterns of Use and Health Effects|Recruiting||N/A|450|Anticipated|University of Wisconsin, Madison|||2||f||||f||||||Samples Without DNA|"     urine samples retained for additional analyses   "|Yes||2017-10-10 23:00:23.534409|2017-10-10 23:00:23.534409
NCT02527967|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-17|||January 2013||2013-01-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Observational|||ERAS in Laparoscopic Surgery for Colorectal Cancer: Risk Factors for Delayed Recovery|Enhanced Recovery After Surgery Protocol in Laparoscopic Surgery for Colorectal Cancer: Risk Factors for Delayed Recovery|Completed||N/A|143|Actual|Jagiellonian University|||2||f||||f||||||||||2017-10-10 23:00:23.654179|2017-10-10 23:00:23.654179
NCT02527954|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-09-04|||September 2015||2015-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01|12 Months|Observational [Patient Registry]|||Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions|Impact of Y-chromosome Microdeletions From Infertile Men on the Chromosomal Constitution of Their Spermatozoa and Embryos. Combined IntraCytoplasmatic Sperm Injection (ICSI) and Preimplantation Genetic Screening (PGS) as Treatment Strategy.|Recruiting||N/A|300|Anticipated|Instituto Valenciano de Infertilidad, IVI Alicante|||2||f||||f||||||Samples With DNA|"     Whole blood, ejaculated semen or testicular biopsy, blastomere   "|||2017-10-10 23:00:23.754454|2017-10-10 23:00:23.754454
NCT02527941|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-02-09|||August 2015||2015-08-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology|Effect of Bacterial Vaginosis and Its Treatment on HIV Susceptibility and Female Genital Immunology|Completed||Phase 1|50|Actual|University of Toronto||1|||f||||f||||||||||2017-10-10 23:00:23.898946|2017-10-10 23:00:23.898946
NCT02059629|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-05-23|||February 2014||2014-02-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Observational|||Eluna Family / Sentus BP Master Study|Eluna Family / Sentus BP Master Study|Completed||N/A|167|Actual|Biotronik SE & Co. KG|||2||f||||f||||||||||2017-10-11 00:46:24.679164|2017-10-11 00:46:24.679164
NCT02527928|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-08-17|||September 2015||2015-09-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Observational|||Cost-Effectiveness of Amphotericin B|Cost-Effectiveness of Different Formulation of Amphotericin B in Private and Public Hospitals in Southern Brazil|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hospital Universitario Evangelico de Curitiba|||3||f||||f||||||||||2017-10-10 23:00:24.034075|2017-10-10 23:00:24.034075
NCT02527915|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-04-10|||August 2015||2015-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Mental Health eConsults|The Effects of Mental Health eConsults: A Clinic-level Randomized Trial|Completed||N/A|900000|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:00:24.128896|2017-10-10 23:00:24.128896
NCT02527902|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-18|||January 2011||2011-01-01|August 2015|2015-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy|Autonomic Nervous System (ANS) Analysis According to Different Renal Function Stage in Immunoglobin A (IgA) Nephropathy|Completed||N/A|12|Actual|Centre Hospitalier Universitaire de Saint Etienne||5|||f||||f||||||||||2017-10-10 23:00:24.414484|2017-10-10 23:00:24.414484
NCT02527889|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-08-19|||July 2015||2015-07-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of Resistive Exercise on Forearm Blood Flow and Tissue Oxygenation Among Breast Cancer Survivors With or at Risk for Breast Cancer-related Lymphoedema (BCRL)||Unknown status|Recruiting|N/A|160|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-10 23:00:24.549224|2017-10-10 23:00:24.549224
NCT02527876|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-11-03|||August 2015||2015-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|EASY-A||Exercise, Activity and Smoking in Young Adults|Exercise to Promote Quit Attempts in Young Adults|Completed||N/A|36|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-10 23:00:24.686684|2017-10-10 23:00:24.686684
NCT02527863|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-02-28|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|TOPO||Effect of the Aquaretic Tolvaptan on Nitric Oxide System|The Effects of Tolvaptan on Renal Handling of Water and Sodium, Vasoactive Hormones and Central Hemodynamics During Baseline Conditions and After Inhibition of the Nitric Oxide System in Patients With Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 2|18|Actual|Regional Hospital Holstebro||2|||f||||t||||||||||2017-10-10 23:00:24.808478|2017-10-10 23:00:24.808478
NCT02527850|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2015-08-20|||August 2015||2015-08-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Effect of Low Level Laser Irradiation on Muscle Performance and Recovery|Effect of Low Level Laser Irradiation on Muscle Performance and Recovery|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-10 23:00:24.94589|2017-10-10 23:00:24.94589
NCT02527837|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-08-17|||May 2015||2015-05-01|February 2015|2015-02-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|HYCA||The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects|The Effect of Sodium Nitrite Infusion on Renal Variables, Peripheral and Central Blood Pressure in Hypertensive Versus Normotensive Subjects in a Randomised, Placebo Controlled, Cross Over, Case-control Study|Unknown status|Recruiting|Phase 1|30|Anticipated|Regional Hospital Holstebro||2|||f||||f||||||||||2017-10-10 23:00:25.060747|2017-10-10 23:00:25.060747
NCT02527824|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-08-22|||March 2015||2015-03-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2016|Actual|2016-08-01||Interventional|||Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer|Phase II Study of S-1 in Combination With Oxaliplatin and Irinotecan in Patients With Advanced, Recurrent or Metastatic Biliary Tract Cancer|Active, not recruiting||Phase 2|31|Anticipated|Hallym University Medical Center||1|||f||||f||||||||||2017-10-10 23:00:25.166992|2017-10-10 23:00:25.166992
NCT02527811|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-06-13|||April 2015||2015-04-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery|A Randomized, Controlled Trial Evaluating Efficacy of Perioperative Organ Protection as Well as Safety of Ulinastatin Use in Pediatric Patients Undergoing Open Heart Surgery Through CPB to Treat Complex Congenital Heart Diseases|Enrolling by invitation||Phase 4|450|Anticipated|Techpool Bio-Pharma Co., Ltd.||2|||f||||t||||||||Undecided||2017-10-10 23:00:25.246493|2017-10-10 23:00:25.246493
NCT02527798|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-09-06|||August 2015||2015-08-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)|Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia|Recruiting||Phase 2|120|Anticipated|University of North Carolina, Chapel Hill||6|||f||||t||||||||||2017-10-10 23:00:25.358744|2017-10-10 23:00:25.358744
NCT02527785|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-08-22|||February 2015||2015-02-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|June 2016|Actual|2016-06-01||Interventional|||Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer|Phase II Study of S-1 in Combination With Oxaliplatin and Irinotecan in Patients With Advanced, Recurrent or Metastatic Gastric Cancer|Completed||Phase 2|44|Actual|Hallym University Medical Center||1|||f||||f||||||||||2017-10-10 23:00:25.737967|2017-10-10 23:00:25.737967
NCT02527772|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-03-17|||September 2015||2015-09-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|LD-FOX4/HCC||Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma|Liposomal Doxorubicin(LD) Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin(FOLFOX4) As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma(HCC)|Active, not recruiting||Phase 2/Phase 3|90|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-10 23:00:25.851993|2017-10-10 23:00:25.851993
NCT02527759|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-12-12|||January 2016||2016-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Patient Self Monitoring to Evaluate 30 Day Post Discharge Heart Failure Outcomes|Patient Self Monitoring to Evaluate 30 Day Post Discharge Heart Failure Outcomes|Recruiting||N/A|100|Anticipated|Georgetown University|||1||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-10 23:00:25.942457|2017-10-10 23:00:25.942457
NCT02527382|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2015-08-17|||January 2014||2014-01-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Peritoneal Bacterial Contamination Following Resection With Closed or Open Rectal Stump for Left-sided Cancer|Peritoneal Bacterial Contamination With Closed or Open Rectal Stump|Completed||N/A|26|Actual|Bucharest Emergency Hospital||2|||f||||t||||||||||2017-10-10 23:00:28.829268|2017-10-10 23:00:28.829268
NCT02527746|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-17|||December 2012||2012-12-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy|A Phase I, Single Center, Open-label, Dose Escalation Study of Recombinant Human Granulocyte Colony-stimulating Factor Fc Fusion Protein (F-627) in Breast Cancer Patient Receiving Adjuvant Chemotherapy|Completed||Phase 1/Phase 2|18|Actual|Generon (Shanghai) Corporation Ltd.||3|||f||||f||||||||||2017-10-10 23:00:26.015767|2017-10-10 23:00:26.015767
NCT02527733|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-08-17|||June 2015||2015-06-01|August 2015|2015-08-01||||September 2017|Anticipated|2017-09-01||Interventional|||Retinal Sensitivity in BRVO After Anti-VEGF Therapy|Retinal Sensitivity in Branch Retinal Vein Occlusion After Anti-VEGF Therapy|Unknown status|Recruiting|Phase 4|50|Anticipated|Fukushima Medical University||2|||f||||||||||||||2017-10-10 23:00:26.105631|2017-10-10 23:00:26.105631
NCT02527720|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-02-23|||June 2015||2015-06-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|BBMT||Changing Impulsivity With Mindful Breathing Therapy to Reduce Problem Drinking|Changing Impulsivity With Mindful Breathing Therapy to Reduce Problem Drinking|Recruiting||N/A|10|Anticipated|University of Maryland||1|||f||||f||||||||||2017-10-10 23:00:26.188394|2017-10-10 23:00:26.188394
NCT02527707|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-09-14|||September 2015||2015-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|LOWR 4||Titrating-Dose of Lonafarnib in Combination With Ritonavir|A Phase 2, Open-Label Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Activity of a Titrating-Dose Lonafarnib in Combination With Ritonavir in Patients Chronically Infected With Hepatitis Delta Virus|Completed||Phase 2|15|Actual|Eiger BioPharmaceuticals||1|||f||||t||||||||||2017-10-10 23:00:26.318294|2017-10-10 23:00:26.318294
NCT02527694|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-05-24|||August 2015||2015-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|ASIA-CPR||Comparison of Quality of Cardiopulmonary Resuscitation Between Flexible Stretcher and Standard Stretcher in Out-of-Hospital Cardiac Arrest|Comparison of Quality of Cardiopulmonary Resuscitation Between Flexible Stretcher and Standard Stretcher in Out-of-Hospital Cardiac Arrest: Ambulance Stretcher Innovation of Asian CPR (ASIA-CPR) Trial|Completed||N/A|31|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:00:26.413219|2017-10-10 23:00:26.413219
NCT02527681|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-05-12|||August 2014||2014-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics|An Open-label Study to Evaluate the Single-dose Pharmacokinetics and Safety of Ceftobiprole in Neonate and Infant Subjects Aged up to 3 Months Undergoing Treatment With Systemic Antibiotics|Recruiting||Phase 1|45|Anticipated|Basilea Pharmaceutica||1|||f||||f||||||||||2017-10-10 23:00:26.501553|2017-10-10 23:00:26.501553
NCT02527668|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-08-05|||September 2015||2015-09-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||To Test the Effect of Calcifediol Hy.D Supplementation on Muscle Function and Bone Quality in Younger Postmenopausal Women With Osteopenia|To Test the Effect of Calcifediol Hy.D Supplementation on Muscle Function and Bone Quality in Younger Postmenopausal Women With Osteopenia: a Double-blind Randomized Placebo-controlled Trial|Recruiting||Phase 2|150|Anticipated|DSM Nutritional Products, Inc.||3|||f||||f||||||||||2017-10-10 23:00:26.604649|2017-10-10 23:00:26.604649
NCT02527655|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-04-18|||August 2015||2015-08-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||The Men on the Move Study|Shape the Path: Targeting the Health and Mobility of Older Men Through Key Community Partnerships -- The Men on the Move Study|Active, not recruiting||N/A|58|Actual|Simon Fraser University||2|||f||||f||||||||||2017-10-10 23:00:26.734065|2017-10-10 23:00:26.734065
NCT02527642|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-04-27|||July 2015||2015-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|October 17, 2016|Actual|2016-10-17||Interventional|||Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media|Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media: A Randomized Controlled Trial by Time-Lapse System- Single Step vs Sequential Media|Terminated||N/A|13|Actual|Weill Medical College of Cornell University||4||Lack of recruitment|f||||f||||||||No||2017-10-10 23:00:26.819677|2017-10-10 23:00:26.819677
NCT02527629|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-08-03|||September 2015||2015-09-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Observational|ARISE||"Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the Surveillance)"|"Aortic Replacement Using Individualised Regenerative Allografts: Bridging the Therapeutic Gap - ARISE (the Surveillance)"|Recruiting||N/A|120|Anticipated|corlife|||1||f||||t||||||||||2017-10-10 23:00:26.918838|2017-10-10 23:00:26.918838
NCT02527616|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-12-13|||May 2016||2016-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||An Investigation to Evaluate an Over-The-Wire FFR Infusion Microcatheter (HYPEREM™IC) for Measuring Fractional Flow Reserve (FFR)|A Randomised, Crossover Investigation to Evaluate and Compare the Effectiveness, Safety and Feasibility of a Novel Dedicated Over-The-Wire FFR Infusion Microcatheter (HYPEREM™IC) for Measuring Fractional Flow Reserve (FFR) Using Intra-coronary Non-weight Adjusted Adenosine Infusion With the Standard Intra-venous Administration of Adenosine, in Subjects With Intermediate Coronary Artery Stenosis.|Completed||N/A|41|Actual|Diasolve Ltd||2|||f||||f||||||||No|individual data will not be shared|2017-10-10 23:00:27.053291|2017-10-10 23:00:27.053291
NCT02527603|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2017-03-20|||August 2015||2015-08-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Spaso Versus Self-assisted Maneuver for Anterior Shoulder Dislocation|Randomized Clinical Trial Comparing the Spaso Maneuver Versus the Self-assisted Boss-Holzach-Matter for Anterior Shoulder Dislocations|Completed||N/A|60|Actual|Corporacion Parc Tauli||2|||f||||t||||||||Undecided|Sharing for other RCT, reviews, Meta analysis. Available from August 2017 Contact: famarcano@tauli.cat|2017-10-10 23:00:27.132334|2017-10-10 23:00:27.132334
NCT02527590|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-01-19|||February 2011||2011-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|STIMEA||Development of Stimulator Pneumatic for Realization of Evoked Potential Allodynic/Somatosensory|Development of Stimulator Pneumatic for Realization of Evoked Potential Allodynic/Somatosensory|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 23:00:27.217401|2017-10-10 23:00:27.217401
NCT02527369|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-07-25|||July 2014||2014-07-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of the XP1100RF Therapy on Thighs Circumference Reduction|Effect of the XP1100RF Therapy on Thighs Circumference Reduction|Completed||N/A|40|Anticipated|BTL Industries Ltd.||1|||f||||f||||||||||2017-10-10 23:00:28.899317|2017-10-10 23:00:28.899317
NCT02527577|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-17|||April 2010||2010-04-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|BLOC-TAP||Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection.|Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection|Terminated||N/A|39|Actual|Centre Hospitalier Universitaire de Saint Etienne||2||difficulties to recruit patients|f||||f||||||||||2017-10-10 23:00:27.298721|2017-10-10 23:00:27.298721
NCT02527564|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-10-03|||September 2015||2015-09-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder|A Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Suvorexant for Treatment-resistant Insomnia in Patients With Bipolar Disorder|Recruiting||Phase 4|100|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 23:00:27.377729|2017-10-10 23:00:27.377729
NCT02527551|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-05-03|||November 2015||2015-11-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|April 2017|Anticipated|2017-04-01||Interventional|FEM||Efficacy of Deep Haptic Massage in Fibromyalgia : Preliminary Study|Efficacy of Deep Haptic Massage in Fibromyalgia : Preliminary Study|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||No||2017-10-10 23:00:27.457917|2017-10-10 23:00:27.457917
NCT02527538|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-01-26|||June 2015||2015-06-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Prediction of Hypotension During Beach Chair Position Using Pleth Variability Index|Pleth Variability Index Predicts Hypotension in Beach Chair Position in Mechanically Ventilated Adults During General Anesthesia|Unknown status|Recruiting|N/A|57|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine|||1||f||||f||||||||Undecided||2017-10-10 23:00:27.538971|2017-10-10 23:00:27.538971
NCT02527525|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2016-10-18|||April 2016||2016-04-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||First STEPS- Study of Type 1 in Early Childhood and Parenting Support|A Stepped Care Behavioral Intervention Trial for Young Children With T1D|Enrolling by invitation||N/A|200|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-10 23:00:27.634157|2017-10-10 23:00:27.634157
NCT02527512|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-07-21|||July 13, 2017|Actual|2017-07-13|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|||Bacterial Contamination: Iodine vs Saline Irrigation in Pediatric Spine Surgery|Bacterial Wound Contamination Prior to Closure: Povidone-Iodine Versus Saline Irrigation in Pediatric Spine Fusion Surgery|Recruiting||Phase 4|150|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f||||||||2017-10-10 23:00:27.704779|2017-10-10 23:00:27.704779
NCT02527499|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-08|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Combining Modified ride-on Cars With Bimanual Training on Enhancing Mobility, Socialization, Motor Function and Participation in Toddlers With Disabilities||Enrolling by invitation||N/A|75|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-10 23:00:27.806893|2017-10-10 23:00:27.806893
NCT02527486|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-08-17|||September 2011||2011-09-01|August 2015|2015-08-01|December 2031|Anticipated|2031-12-01|December 2021|Anticipated|2021-12-01|10 Years|Observational [Patient Registry]|||Seoul National University Airway Registry|Airway Registry for Chronic Airway Diseases|Recruiting||N/A|800|Anticipated|Seoul National University Hospital|||1||f||||t||||||Samples With DNA|"     Blood (whole blood, serum, plasma, buffy coat) Urine   "|||2017-10-10 23:00:27.898403|2017-10-10 23:00:27.898403
NCT02527473|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-17|||November 2014||2014-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Improving Bystander CPR Quality Through Dispatcher-assisted Basic Life Support Education Program|Improving Bystander CPR Quality Through Dispatcher-assisted Basic Life Support Education Program|Completed||N/A|24|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 23:00:27.979526|2017-10-10 23:00:27.979526
NCT02527460|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-07-26|||August 14, 2015||2015-08-14|July 19, 2017|2017-07-19|May 9, 2019|Anticipated|2019-05-09|May 9, 2019|Anticipated|2019-05-09||Interventional|||Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection|Anakinra, a Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection|Enrolling by invitation||Phase 1|50|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:00:28.044496|2017-10-10 23:00:28.044496
NCT02527447|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-18|2017-06-30|||August 11, 2015||2015-08-11|May 31, 2017|2017-05-31|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Observational|||Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)|A Pilot Study of Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in Patients With Relapsed Orrefractory Acute Myeloid Leukemia|Recruiting||N/A|36|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:00:28.13322|2017-10-10 23:00:28.13322
NCT02527434|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-08-03|||November 2, 2015|Actual|2015-11-02|August 2017|2017-08-01|October 5, 2018|Anticipated|2018-10-05|March 20, 2018|Anticipated|2018-03-20||Interventional|||Study of Tremelimumab in Patients With Advanced Solid Tumors|A Phase II, Multi-Center, Open-Label Study of Tremelimumab Monotherapy in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 2|64|Actual|AstraZeneca||1|||f||||f|t|f||||||||2017-10-10 23:00:28.409552|2017-10-10 23:00:28.409552
NCT02527421|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-08-02|||July 2015||2015-07-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||DFD01 Spray vs. Comp01 Lotion HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis||Recruiting||Phase 3|75|Anticipated|Promius Pharma, LLC||3|||f||||f||||||||||2017-10-10 23:00:28.544943|2017-10-10 23:00:28.544943
NCT02527408|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-04-04|||August 2015||2015-08-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|WEARIT-IN||Wearable Technology for Hospital Inpatients|Wearable Technology for Hospital Inpatients|Completed||N/A|50|Actual|Queen's University|||1||f||||f||||||||||2017-10-10 23:00:28.644003|2017-10-10 23:00:28.644003
NCT02527395|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-08-24|||October 2015||2015-10-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Association Between Heat Pain Detection Threshold and Area of Secondary Hyperalgesia|To Determine the Degree of Association Between Heat Pain Detection Threshold and Area of Secondary Hyperalgesia Following Brief Thermal Sensitization in Healthy Male Volunteers|Completed||N/A|121|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-10 23:00:28.713499|2017-10-10 23:00:28.713499
NCT02527356|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-02-05|||August 1, 2015|Actual|2015-08-01|January 2017|2017-01-01|July 31, 2018|Anticipated|2018-07-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Advancing Mobility and Socialization in Toddlers With Disabilities: a Trial to Assess the Effects of Modified Toy Cars Training With Different Postures||Recruiting||N/A|60|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-10 23:00:28.969868|2017-10-10 23:00:28.969868
NCT02527343|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-07-10|||October 31, 2015|Actual|2015-10-31|July 2017|2017-07-01||||September 30, 2017|Anticipated|2017-09-30||Interventional|||The BROADEN Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Familial Partial Lipodystrophy|A Randomized, Double-Blind, Placebo-Controlled, With an Open Label Extension, Phase 2/3 Study of ISIS 304801 Administered Subcutaneously to Patients With Familial Partial Lipodystrophy|Recruiting||Phase 2/Phase 3|60|Anticipated|Ionis Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-10 23:00:29.078602|2017-10-10 23:00:29.078602
NCT02527330|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-07-23|||January 2014||2014-01-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|CHFIRONMR||Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR Imaging|Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR Imaging|Completed||N/A|100|Actual|Chang Gung Memorial Hospital|||3||f||||f||||||||||2017-10-10 23:00:29.330691|2017-10-10 23:00:29.330691
NCT02527317|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-07-22|||January 2015||2015-01-01|August 2015|2015-08-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|||Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast Cancer|An Observational Study of Dose Dense Chemotherapy With Lipegfilgrastim Support|Unknown status|Active, not recruiting|N/A|40|Actual|Beaumont Hospital|||1||f||||f||||||||||2017-10-10 23:00:29.426834|2017-10-10 23:00:29.426834
NCT02527304|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-01-12|||June 2015||2015-06-01|January 2016|2016-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery|Adaptive Staged SBRT for Spinal Metastases|Recruiting||N/A|12|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-10 23:00:29.536735|2017-10-10 23:00:29.536735
NCT02527291|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-03-15|||November 2015||2015-11-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Observational|||Cytomegalovirus Reactivation in Non Immunocompromised Patients Undergoing Cardiac Surgery|Cytomegalovirus Reactivation in Non Immunocompromised Patients Undergoing Cardiac Surgery|Recruiting||N/A|200|Anticipated|Soroka University Medical Center|||3||f||||t||||||Samples Without DNA|"     Blood work: Cytomegalovirus Ab (CMV Ab), Cytomegalovirus Polymerase Chain Reaction (CMV PCR)     and Interleukin (IL28).   "|||2017-10-10 23:00:29.672565|2017-10-10 23:00:29.672565
NCT02527278|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-03-20|||July 30, 2015|Actual|2015-07-30|March 2017|2017-03-01|February 9, 2016|Actual|2016-02-09|February 9, 2016|Actual|2016-02-09||Observational|||Retrospective Claims Analysis of Hysterectomy After Sterilization|A Retrospective Claims Analysis to Calculate the Proportion of Women Undergoing Hysterectomy, Salpingectomy, Salpingostomy, Hysteroscopy or Who Had a Diagnosis of Pelvic Pain After Hysteroscopic Sterilization or Laparoscopic Tubal Ligation|Completed||N/A|19317|Actual|Bayer|||4||f||||f||||||||||2017-10-10 23:00:29.7866|2017-10-10 23:00:29.7866
NCT02527252|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-01-10|||July 2015||2015-07-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Craniosacral Therapy in Patients With Chronic Low Back Pain|Benefits of Craniosacral Therapy in Patients With Chronic Low Back Pain: A Randomized Controlled Trial|Completed||Early Phase 1|64|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-10 23:00:30.055123|2017-10-10 23:00:30.055123
NCT02527239|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-17|||September 2015||2015-09-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|PURF||Prevalence of Pompe's Disease in Respiratory Clinics|Prevalence of Pompe's Disease Amongst Patients With Unexplained Respiratory Muscle Weakness or Respiratory Failure|Unknown status|Not yet recruiting|N/A|400|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:00:30.156857|2017-10-10 23:00:30.156857
NCT02527226|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-09-14|||August 2015||2015-08-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors|Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors|Completed||N/A|76|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:00:30.229235|2017-10-10 23:00:30.229235
NCT02527213|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-01-19|||January 30, 2015||2015-01-30|January 2017|2017-01-01|August 29, 2016|Actual|2016-08-29|August 29, 2016|Actual|2016-08-29||Interventional|||Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopath|Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment|Terminated||Phase 3|40|Actual|Luitpold Pharmaceuticals||2||Company decision|f||||f||||||||No||2017-10-10 23:00:30.309006|2017-10-10 23:00:30.309006
NCT02527200|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-09-28|||November 9, 2015|Actual|2015-11-09|September 2017|2017-09-01|August 10, 2020|Anticipated|2020-08-10|August 10, 2020|Anticipated|2020-08-10||Interventional|||Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome|Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome.|Recruiting||Phase 3|60|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-10 23:00:30.404545|2017-10-10 23:00:30.404545
NCT02527187|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-02-24|||March 2014||2014-03-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|T502||Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa|Extract Allergen From Betula Verrucosa. Test Sensitivity and Specificity of Diagnostic in Prick Test Preparation|Recruiting||Phase 2/Phase 3|198|Anticipated|Inmunotek S.L.||1|||f||||f||||||||||2017-10-10 23:00:30.593961|2017-10-10 23:00:30.593961
NCT02526459|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-23|||October 2015||2015-10-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of Birth Plans on Obstetrical Outcomes|The Effect of Birth Plans on Obstetrical Outcomes: a Randomized Control Trial|Recruiting||N/A|200|Anticipated|Regina Qu'Appelle Health Region||2|||f||||t||||||||No||2017-10-10 23:00:39.859201|2017-10-10 23:00:39.859201
NCT02527174|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-04-03|||November 2016||2016-11-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|VIAC||A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia|A Phase I Study of Volasertib Combined With Standard Induction Chemotherapy for Previously Untreated Patients With Acute Myeloid Leukemia (VIAC)|Withdrawn||Phase 1|0|Actual|University of Alberta||1||Volasertib no longer available|f||||t||||||||Yes|Anonymized data will be made available to Boehringer-Ingelheim.|2017-10-10 23:00:30.692646|2017-10-10 23:00:30.692646
NCT02527161|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-04-25|2015-09-29||June 2011||2011-06-01|April 2017|2017-04-01||||November 2012|Actual|2012-11-01||Interventional||Baseline measurments are only available for participants who completed the study.|Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using ShapeMatch® Cutting Guides: Sub-Study B|A Prospective, Non-randomized, Longitudinal Study of the Clinical Outcomes of Participants That Receive the Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using ShapeMatch® Cutting Guides: Sub-Study B|Active, not recruiting||N/A|158|Actual|Stryker South Pacific||1|||f||||f||||||||||2017-10-10 23:00:30.800894|2017-10-10 23:00:30.800894
NCT02527148|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-12-07|2015-09-29||August 2011||2011-08-01|September 2015|2015-09-01||||September 2013|Actual|2013-09-01||Interventional|||A Trial of Mechanical Axis vs Kinematic Alignment in Total Knee Replacement|A Prospective, Randomized, Controlled Trial of Mechanical Axis vs Kinematic Alignment in TKR - With a Follow-up, Longitudinal Study of the Clinical and Radiographic Outcomes|Unknown status|Active, not recruiting|N/A|100|Actual|Stryker South Pacific||2|||f||||f||||||||||2017-10-10 23:00:31.450089|2017-10-10 23:00:31.450089
NCT02527135|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-14|||September 2013||2013-09-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|T2T||Text Messaging to Improve HIV Testing Among Young Women in Kenya|Evaluating Feasibility and Potential Impact of Text Messages on HIV Awareness Among Young Women in Rural Kenya: a Pilot Study|Completed||N/A|600|Actual|University of Washington||2|||f||||f||||||||||2017-10-10 23:00:31.897206|2017-10-10 23:00:31.897206
NCT02527122|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-03-10|||July 21, 2016|Actual|2016-07-21|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|MM09||Biological Stardadization of D. Pteronyssinus and D. Farinae Allergen Extracts|Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Allergen Extract. Determination of the Allergenic Potency in Vivo Histamine Equivalent Units (HEP)|Recruiting||N/A|30|Anticipated|Inmunotek S.L.||1|||f||||f|f|f||||||No||2017-10-10 23:00:31.983534|2017-10-10 23:00:31.983534
NCT02527109|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-28|||May 2016||2016-05-01|August 2017|2017-08-01||||October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure||Recruiting||Phase 2/Phase 3|330|Anticipated|RDD Pharma Ltd||3|||f||||f||||||||||2017-10-10 23:00:32.070296|2017-10-10 23:00:32.070296
NCT02527096|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-08-18|||September 17, 2015|Actual|2015-09-17|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)|A Pilot Trial Evaluating Maintenance Therapy With Lamivudine(Epivir®) and Dolutegravir(Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple HAART - ANRS 167 Lamidol|Completed||Phase 2|110|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-10 23:00:32.260462|2017-10-10 23:00:32.260462
NCT02527083|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-11-17|||January 2015||2015-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain|Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain|Enrolling by invitation||Phase 4|48|Anticipated|VA Pittsburgh Healthcare System||3|||f||||f||||||||||2017-10-10 23:00:32.385294|2017-10-10 23:00:32.385294
NCT02527070|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-10-13|||September 2015||2015-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|MRT01||Evaluating the State of Microvessels by Minimum Rise Time (MRT01)|Evaluating an Optical Index (Minimum Rise Time) as a Measure for the State of Microvessels|Completed||N/A|33|Actual|Afeka, The Tel-Aviv Academic College of Engineering||2|||f||||f||||||||Undecided||2017-10-10 23:00:32.457419|2017-10-10 23:00:32.457419
NCT02527057|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-08-15|||October 2014||2014-10-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Observational|||Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer|Diffusion-weighted Magnetic Resonance Imaging(DW-MRI) for Early Response Assessment of Neoadjuvant Chemoradiation Therapy(Neo-CRT) in Patients With Esophageal Squamous Cell Carcinoma(ESCC)|Recruiting||N/A|90|Anticipated|Hunan Province Tumor Hospital|||1||f||||f||||||||||2017-10-10 23:00:32.539645|2017-10-10 23:00:32.539645
NCT02527044|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-09-18|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|FFR||Impact of Preoperative FFR on Arterial Bypass Graft Functionality|Impact of Preoperative FFR on Arterial Bypass Graft Functionality: Towards a New CABG Paradigm|Recruiting||N/A|120|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||t|f|f||||||||2017-10-10 23:00:32.609058|2017-10-10 23:00:32.609058
NCT02527031|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-07-31|||March 2016||2016-03-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|ACPAR2||A Comparative Study Between a Pre-hospital and an In-hospital Circulatory Support Strategy (ECMO) in Refractory Cardiac Arrest (ACPAR2)|A Comparative Study Between a Pre-hospital and an In-hospital Circulatory Support Strategy (ECMO) in Refractory Cardiac Arrest|Recruiting||N/A|210|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:00:32.733472|2017-10-10 23:00:32.733472
NCT02527018|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-17|||November 2014||2014-11-01|June 2015|2015-06-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||A Comparison of B Type Natriuretic Peptide Levels and Hemodynamics Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women - A Pilot Study|A Comparison of B Type Natriuretic Peptide Levels and Hemodynamics Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women - A Pilot Study|Unknown status|Recruiting|Phase 1|66|Anticipated|University of California, Irvine||2|||f||||t||||||||||2017-10-10 23:00:32.855895|2017-10-10 23:00:32.855895
NCT02526069|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-05-10|||May 2015||2015-05-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ACT||An ACT Based Application for Young People With Type 1 Diabetes|An ACT Based Application for Young People With Type 1 Diabetes|Terminated||N/A|17|Actual|University of Edinburgh||1||No uptake from potential participants|f||||||||||||||2017-10-10 23:00:42.780182|2017-10-10 23:00:42.780182
NCT02527005|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-17|||September 2015||2015-09-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients|A Comparative Study of Azithromycin and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant HIV Positive Patients|Unknown status|Not yet recruiting|Phase 1|140|Anticipated|University of Ibadan||2|||f||||t||||||||||2017-10-10 23:00:33.005885|2017-10-10 23:00:33.005885
NCT02526992|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-08-17|||May 2009||2009-05-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation by HR-pQCT of Bone Microarchitecture Changes in Patients With Rheumatoid Arthritis Under Anti-TNF Therapy.|Evaluation by HR-pQCT of Bone Microarchitecture Changes in Patients With Rheumatoid Arthritis Under Anti-TNF Therapy.|Terminated||N/A|14|Actual|Centre Hospitalier Universitaire de Saint Etienne||1||recruitment difficulties|f||||f||||||||||2017-10-10 23:00:33.100097|2017-10-10 23:00:33.100097
NCT02526979|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-10-11|||November 2015||2015-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)|A Multicentre, Open-Label, Single Dose, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)|Completed||Phase 1|9|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-10 23:00:35.229165|2017-10-10 23:00:35.229165
NCT02526966|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-01-24|||March 2012|Actual|2012-03-01|March 2016|2016-03-01|June 30, 2014|Actual|2014-06-30|June 30, 2014|Actual|2014-06-30||Interventional|NIGA-RA||Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy|Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy|Completed||N/A|68|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f|f|f||||||No||2017-10-10 23:00:35.346052|2017-10-10 23:00:35.346052
NCT02526953|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-15|2017-06-08|||January 2016||2016-01-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients|Randomised Phase III Trial of Chemoradiotherapy With or Without Paclitaxel in Patients With Squamous-cell Anal Cancer|Enrolling by invitation||Phase 3|314|Anticipated|Blokhin's Russian Cancer Research Center||2|||f||||f||||||||||2017-10-10 23:00:35.445747|2017-10-10 23:00:35.445747
NCT02526940|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2015-10-30|||May 2015||2015-05-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|VIRECT||Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men|Impact of Pre- Antiretroviral Therapy (ART) Blood Cluster of Differentiation (CD)4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Saint Etienne|||3||f||||f||||||Samples Without DNA|"     blood specimen and rectal biopsies   "|||2017-10-10 23:00:35.559944|2017-10-10 23:00:35.559944
NCT02526927|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-01-20|||May 2015||2015-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AMOS||Bone Microarchitecture Evaluation by HR-pQCT in Youngs Who Developed AN in Peri or Prepubertal Period.|Monocentric Study Evaluating Bone Microarchitecture by High Resolution Quantitative Computerized Tomography (HR-pQCT) in Young Adults and Adolescents Who Developed Anorexia Nervosa (AN) in Peri or Prepubertal Period.|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 23:00:35.648423|2017-10-10 23:00:35.648423
NCT02526914|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-16|||October 2015||2015-10-01|August 2015|2015-08-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Intranasal Oxytocin and Vasopressin on Social Behavior and Decision Making|Effects of Intranasal Oxytocin and Vasopressin on Social Behavior and Decision Making|Unknown status|Not yet recruiting|N/A|432|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||||2017-10-10 23:00:35.760107|2017-10-10 23:00:35.760107
NCT02526901|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-16|||February 2012||2012-02-01|August 2015|2015-08-01||||December 2019|Anticipated|2019-12-01||Observational|BIGCS||The Born in Guangzhou Cohort Study (BIGCS)|The Born in Guangzhou Cohort Study (BIGCS)|Recruiting||N/A|30000|Anticipated|Guangzhou Women and Children's Medical Center|||1||f||||t||||||Samples With DNA|"     During pregnancy: maternal blood, urine and stool. At delivery: cord, cord blood and     placenta. During infancy: dry blood spot, stool and blood. Druing childhood: blood, buccal     swab and stool.   "|||2017-10-10 23:00:35.8691|2017-10-10 23:00:35.8691
NCT02526888|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-07-26|||September 1, 2015|Actual|2015-09-01|July 2017|2017-07-01|November 1, 2015|Actual|2015-11-01|November 1, 2015|Actual|2015-11-01||Interventional|||Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects|A Single-center, Open-label, Randomized, Two-way Crossover Study to Investigate the Effect of Multiple-dose Diltiazem on the Pharmacokinetics of a Single Dose of 25 mg ACT-541468 in Healthy Male Subjects|Completed||Phase 1|14|Actual|Actelion||2|||f||||f||||||||||2017-10-10 23:00:35.958023|2017-10-10 23:00:35.958023
NCT02526875|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-08-18|||April 2015||2015-04-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled|A Multicenter, Prospective, Randomized, Open-label, Phase 4 Trial Designed to Evaluate the Efficacy of a Telmisartan/S-Amlodipine(Telminuvo®Tab. 40/2.5mg) on 24-hour BP Control in Hypertensive Patients Inadequately Controlled|Recruiting||Phase 4|208|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:00:36.158636|2017-10-10 23:00:36.158636
NCT02526862|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-15|||February 2012||2012-02-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|PUPPVMNI||Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation|Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation. Randomized Clinical Trial|Completed||Phase 4|152|Actual|B. Braun Medical SA||4|||f||||f||||||||||2017-10-10 23:00:36.295115|2017-10-10 23:00:36.295115
NCT02526849|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-11-03|||November 2015||2015-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety of Fecal Microbiota Transplantation for Slow Transit Constipation|A Randomized Controlled Study of Efficacy, Safety and Durability of Fecal Microbiota Transplantation in Adult Patients With Slow Transit Constipation|Recruiting||Phase 2|100|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 23:00:36.424317|2017-10-10 23:00:36.424317
NCT02526836|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-06-08|||September 2014||2014-09-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer|Complete Mesocolic Excision (CME) With Central Supplying Vessel Ligation (CVL) Compared With Conventional Surgery for Colon Cancer: a Double-blinded Randomized Study|Recruiting||Phase 2/Phase 3|40|Anticipated|Mansoura University||2|||f||||f||||||||Yes|Yes|2017-10-10 23:00:36.532283|2017-10-10 23:00:36.532283
NCT02526823|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-04-17|||August 2015||2015-08-01|April 2016|2016-04-01|February 2019|Anticipated|2019-02-01|August 2017|Anticipated|2017-08-01||Interventional|||Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma|Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma|Recruiting||Phase 4|360|Anticipated|Shandong Provincial Hospital||2|||f||||||||||||||2017-10-10 23:00:36.647493|2017-10-10 23:00:36.647493
NCT02526810|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-19|||July 2015||2015-07-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|COGFOST||Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes|Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes|Unknown status|Recruiting|Phase 4|70|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-10 23:00:36.743171|2017-10-10 23:00:36.743171
NCT02526797|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2016-01-19|||January 2013||2013-01-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Observational|||Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance|Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance|Enrolling by invitation||N/A|150|Anticipated|Herlev Hospital|||1||f||||t||||||||||2017-10-10 23:00:36.877012|2017-10-10 23:00:36.877012
NCT02526784|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-07-03|||December 2015||2015-12-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer|A Multi-Centre, Open-Label, Randomised Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer|Completed||Phase 3|120|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-10-10 23:00:36.947941|2017-10-10 23:00:36.947941
NCT02526771|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-03-30|||August 2015||2015-08-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma|A Randomized Controlled Study of Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma|Recruiting||N/A|100|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 23:00:37.039453|2017-10-10 23:00:37.039453
NCT02526758|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-17|||April 2015||2015-04-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Small Airways Evaluation and Treatment|Evaluation and Treatment of Small Airways in COPD|Unknown status|Recruiting|Phase 4|90|Anticipated|Zhujiang Hospital||2|||f||||f||||||||||2017-10-10 23:00:37.128928|2017-10-10 23:00:37.128928
NCT02526745|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-08-12|||December 2015||2015-12-01|August 2015|2015-08-01||||July 2016|Actual|2016-07-01||Interventional|||Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older||Completed||Phase 1/Phase 2|440|Actual|Beijing Chaoyang District Centre for Disease Control and Prevention||6|||f||||||||||||||2017-10-10 23:00:37.230766|2017-10-10 23:00:37.230766
NCT02526732|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-17|2017-01-10|||September 2015||2015-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|HELP||Hepatic Inflammation and Physical Performance in Patients With NASH|Influence of Hepatic Inflammation and Hepatocellular Apoptosis on Physical Performance and Training Effect in Patients With Non - Alcoholic Steatohepatitis|Recruiting||N/A|45|Anticipated|Johannes Gutenberg University Mainz||1|||f||||f||||||||Yes|Publication in scientific journals and conferences|2017-10-10 23:00:37.310179|2017-10-10 23:00:37.310179
NCT02526719|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-10-30|||September 2015||2015-09-01|October 2015|2015-10-01|January 2016|Anticipated|2016-01-01|September 2015|Anticipated|2015-09-01||Interventional|||Nipple Delay Prior to Nipple Sparing Mastectomy: A Pilot RCT|Nipple Delay Prior to Nipple Sparing Mastectomy: A Pilot RCT|Withdrawn||N/A|0|Actual|University Health Network, Toronto||2||Study design changed, no longer a randomized trial design|f||||f||||||||||2017-10-10 23:00:37.412805|2017-10-10 23:00:37.412805
NCT02526706|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-19|||August 2015||2015-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery|VisionBlue for the Assessment of Filtering Bleb Functioning During Cataract Surgery|Completed||N/A|15|Actual|Wills Eye||1|||f||||f||||||||No||2017-10-10 23:00:37.478091|2017-10-10 23:00:37.478091
NCT02526693|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-14|||June 2014||2014-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Is the RAPDx Pupillograph Able to Distinguish Between Glaucoma Subjects and Healthy Subjects?|RAPDx Pupillography for Early Detection of Glaucoma|Completed||N/A|100|Actual|Wills Eye||2|||f||||f||||||||||2017-10-10 23:00:37.554363|2017-10-10 23:00:37.554363
NCT02526680|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-12-23|||May 2014||2014-05-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients?|The Impact of a Novel Artificial Vision Device (OrCam) on the Quality of Life of Patients With Advanced Glaucoma|Completed||N/A|13|Actual|Wills Eye||1|||f||||f||||||||Yes|A manuscript was submitted and pending publication.|2017-10-10 23:00:37.624635|2017-10-10 23:00:37.624635
NCT02526654|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-01-21|||July 2014||2014-07-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|HEP/OCT||Heidelberg Edge Perimetery Compared to Octopus Visual Field Testing and Investigation of New Ocular Imaging Parameters|Validation and Reproducibility of the Heidelberg Edge Perimeter in the Detection of Visual Field Defects in Glaucomatous Patients and Investigation of Novel Ocular Imaging Parameters|Completed||N/A|140|Actual|Wills Eye||2|||f||||f||||||||No||2017-10-10 23:00:37.776719|2017-10-10 23:00:37.776719
NCT02502292|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-04-20|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|IROHLA||Innovative Policies for Healthy Aging|Sustainable Health Systems Through Health Literacy for Healthy Aging|Completed||N/A|126|Actual|Jacobs University Bremen gGmbH||1|||f||||f||||||||||2017-10-10 23:06:55.9439|2017-10-10 23:06:55.9439
NCT02526641|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-03-28|||August 2015||2015-08-01|May 2016|2016-05-01|September 2022|Anticipated|2022-09-01|September 2017|Anticipated|2017-09-01||Observational|||Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C|New AbbVie Direct Acting Antiviral (DAA) Treatment of Chronic Hepatitis C Infection - Effects on the Macrophage Activation Marker Soluble CD163, Portal Hypertension, and Metabolic Liver Function|Recruiting||N/A|20|Anticipated|University of Aarhus|||1||f||||t||||||||||2017-10-10 23:00:37.852384|2017-10-10 23:00:37.852384
NCT02526628|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-05-12|||September 2015||2015-09-01|May 2016|2016-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Thrombosis and Neurocognition in Klinefelter Syndrome|The Haemostatic Balance and Neurocognitive Phenotype in Klinefelter Syndrome - The Effect of Testosterone Treatment|Recruiting||N/A|120|Anticipated|University of Aarhus|||4||f||||t||||||Samples With DNA|"     Bloodsamples   "|||2017-10-10 23:00:38.07651|2017-10-10 23:00:38.07651
NCT02526615|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-14|||October 2000||2000-10-01|August 2015|2015-08-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|ROSI||Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes|Comparison of Effects of Rosiglitazone and Metformin on Myocardial, Skeletal Muscle, Liver and Adipose Tissue Insulin Stimulated Glucose Uptake in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|48|Actual|Turku University Hospital||3|||f||||f||||||||||2017-10-10 23:00:38.225466|2017-10-10 23:00:38.225466
NCT02526602|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-17|||August 2015||2015-08-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.|Preservation of Endopelvic Fascia During Radical Prostatectomy: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.|Recruiting||N/A|180|Anticipated|Tampere University Hospital||2|||f||||f||||||||No||2017-10-10 23:00:38.342434|2017-10-10 23:00:38.342434
NCT02526589|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-03-20|||August 2015||2015-08-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|||Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy|Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy|Recruiting||N/A|201|Anticipated|Tampere University Hospital|||1||f||||f||||||||No||2017-10-10 23:00:38.43514|2017-10-10 23:00:38.43514
NCT02526576|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-10-16|||August 2015||2015-08-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|SVF||Adipose Derived Stem Cells in Facial Fat Grafting|A Phase II Double-blind, Randomized, Study to Assess the Efficacy of Facial Fat Grafts Supplemented With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)|Unknown status|Recruiting|Phase 2|34|Anticipated|Antria||2|||f||||f||||||||||2017-10-10 23:00:38.513075|2017-10-10 23:00:38.513075
NCT02526563|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-09-11|||August 2015||2015-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Observational|||Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia|Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia|Recruiting||N/A|10|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-10-10 23:00:38.626392|2017-10-10 23:00:38.626392
NCT02526550|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2016-10-13|2016-01-12||June 2014||2014-06-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX|Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine (IMOJEV) as a Booster Dose After a Primary Vaccination With CD.JEVAX in Thai Children|Completed||Phase 4|50|Actual|Siriraj Hospital||1|||f||||f||||||||No|The submission of study review and results to a peer-review journal is ongoing.|2017-10-10 23:00:38.735542|2017-10-10 23:00:38.735542
NCT02526537|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-11-02|||August 2015||2015-08-01|November 2016|2016-11-01|September 2022|Anticipated|2022-09-01|August 2022|Anticipated|2022-08-01||Observational|||Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients|The Postoperative Adjuvant Therapy of Gefitinib for High Risk Stage Ib NSCLC Patients With EGFR Sensitive Mutation, an Open, Paired, Non-interventional, Multi-center Clinical Study|Suspended||N/A|200|Anticipated|West China Hospital|||2||f||||t||||||||||2017-10-10 23:00:39.010906|2017-10-10 23:00:39.010906
NCT02526524|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-16|2017-01-04|||September 2015||2015-09-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM|Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|571|Actual|Elcelyx Therapeutics, Inc.||7|||f||||f||||||||||2017-10-10 23:00:39.127876|2017-10-10 23:00:39.127876
NCT02526511|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-21|||April 2015||2015-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors|Pilot Study of Renal Neoplasms With Perfusion Magnetic Resonance Imaging|Recruiting||N/A|50|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 23:00:39.484655|2017-10-10 23:00:39.484655
NCT02526498|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-09-21|||June 2015||2015-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRIUMPH-T||Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery|TRI-fraction Radiotherapy Utilized to Minimize Patient Hospital Trips : A Phase II Trial (TRIUMPH-T Trial)|Active, not recruiting||Phase 2|200|Actual|Rutgers, The State University of New Jersey||1|||f||||t|f|f||||||||2017-10-10 23:00:39.595316|2017-10-10 23:00:39.595316
NCT02526485|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-07|||March 2015||2015-03-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2||Recruiting||N/A|40|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||Samples With DNA|"     Whole blood will be stored in freezers at minus 80 degrees.   "|||2017-10-10 23:00:39.685522|2017-10-10 23:00:39.685522
NCT02526472|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-16|||January 2012||2012-01-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Transabdominal US-guided (UGET) vs. Modified Transvaginal US-guided (mTVET) Embryo Transfer in Human IVF|A Large Prospective Randomized Trial Comparing Trans-abdominal Ultrasound-guided Embryo Transfer (UGET) With a Novel, Modified Trans-vaginal Ultrasound-guided Embryo Transfer Technique (mTVET) Based on Previous Uterine Length Measurement|Completed||N/A|1648|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-10-10 23:00:39.768413|2017-10-10 23:00:39.768413
NCT02526446|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-10-25|||July 2016||2016-07-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Self-administered Acupressure for Symptom Management of Caregiver Stress|A Randomized, Wait-list Controlled Trial of Self-administered Acupressure for Symptom Management Among Chinese Family Caregivers With Caregiver Stress|Recruiting||N/A|200|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:00:39.940317|2017-10-10 23:00:39.940317
NCT02526433|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-04-12|||October 19, 2015|Actual|2015-10-19|April 2017|2017-04-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Observational|||The Impact of Creative Interventions on Symptoms of Postnatal Depression (Cohort Study)|The Impact of Creative Interventions on Symptoms of Postnatal Depression (Cohort Study)|Completed||N/A|2558|Actual|Royal College of Music|||1||f||||t||||||||||2017-10-10 23:00:40.037545|2017-10-10 23:00:40.037545
NCT02526420|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-11-07|||July 2015||2015-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|VITAL||Versartis International Trial in Adults With Long-Acting Growth Hormone|An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)|Completed||Phase 2|36|Actual|Versartis Inc.||3|||f||||f||||||||||2017-10-10 23:00:40.105416|2017-10-10 23:00:40.105416
NCT02526407|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-04-12|||October 19, 2015|Actual|2015-10-19|April 2017|2017-04-01|September 30, 2016|Actual|2016-09-30|July 31, 2016|Actual|2016-07-31||Interventional|||The Impact of Creative Interventions on Symptoms of Postnatal Depression|The Impact of Creative Interventions on Symptoms of Postnatal Depression|Completed||N/A|153|Actual|Royal College of Music||3|||f||||f||||||||||2017-10-10 23:00:40.21841|2017-10-10 23:00:40.21841
NCT02526394|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-05-30|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|Mutliboost||Pertussis and Meningitis C Concomitant Vaccination in Adolescents|A Phase III/IV Randomised Open-label Study and Comparison of the Immunogenicity and Safety of a Single Adolescent Booster Dose of a Meningococcal Group C Conjugate-containing Booster Vaccine (Meningitec™, OR NeisVac-C™ , OR Menitorix™), When Given Concurrently With an Acellular Pertussis-containing Booster Vaccine (Repevax™ or IPV-Boostrix™)|Completed||Phase 4|400|Actual|Public Health England||8|||f||||f||||||||||2017-10-10 23:00:40.435824|2017-10-10 23:00:40.435824
NCT02526381|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-11-19|||July 2015||2015-07-01|November 2015|2015-11-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Study On The Relation Among Prescription, Syndrome and Disease of Turbid Phlegm and Blood Stasis for Coronary Heart Disease|Study on the Relation Between Syndrome and Disease of Turbid Phlegm and Blood Stasis for Coronary Heart Disease and Its Biological Basis|Recruiting||N/A|120|Anticipated|Tianjin University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-10 23:00:40.55305|2017-10-10 23:00:40.55305
NCT02526368|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-06-09|||November 2015||2015-11-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|pyruvate||A Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer|A Pilot Study of Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (13C) to Detect High Grade Localized Prostate Cancer|Recruiting||Early Phase 1|50|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:00:40.647206|2017-10-10 23:00:40.647206
NCT02526355|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2017-01-13|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TechMother||Development and Assessment of a Mobile Phone Based Intervention to Reduce Postnatal Depression and Improve Child Health|Development and Assessment of a Mobile Phone Based Intervention to Reduce Postnatal Depression and Improve Child Health|Recruiting||N/A|36|Anticipated|Pakistan Institute of Learning and Living||2|||f||||f||||||||||2017-10-10 23:00:40.73067|2017-10-10 23:00:40.73067
NCT02526342|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-05-15|||August 2015||2015-08-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Impact of Negative Pressure Wound Therapy on Free Muscle Flaps|Impact of Negative Pressure Wound Therapy on Free Muscle Flaps|Recruiting||N/A|30|Anticipated|Klinik Bogenhausen||2|||f||||t||||||||||2017-10-10 23:00:40.824871|2017-10-10 23:00:40.824871
NCT02526329|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-02-14|||August 2015||2015-08-01|February 2017|2017-02-01||||October 2017|Anticipated|2017-10-01||Interventional|||Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant|A Phase 1 Single Center Safety and Feasibility Study of Primary T Regulatory Cell Therapy to Treat Visceral Acute Graft-versus-Host Disease Following Hematopoietic Cell Transplantation|Suspended||Phase 1|12|Anticipated|Stanford University||1||Logistics|f||||||||||||||2017-10-10 23:00:40.918688|2017-10-10 23:00:40.918688
NCT02526316|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-06-30|||June 2015||2015-06-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|VICORYX-2||Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers|Pilot Study on Concurrent Cisplatin-based Chemotherapy Combined With Vaccination Therapy With the P16_37-63 Peptide in Patients With HPV- and p16INK4a-positive Cancer|Completed||Phase 1|11|Actual|Oryx GmbH & Co. KG||1|||f||||t||||||||||2017-10-10 23:00:41.009474|2017-10-10 23:00:41.009474
NCT02526303|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-02-13||||||February 2017|2017-02-01||||February 2017|Actual|2017-02-01||Interventional|||Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis|Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis: a Single Center Prospective Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-10 23:00:41.106282|2017-10-10 23:00:41.106282
NCT02526277|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-22|||July 2015||2015-07-01|September 2017|2017-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome|A Randomized Prospective Study on the Efficacy of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome|Recruiting||Phase 3|40|Anticipated|Ohio State University||4|||f||||f||||||||||2017-10-10 23:00:41.303689|2017-10-10 23:00:41.303689
NCT02497092|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-04-17|||August 2015||2015-08-01|April 2016|2016-04-01||||August 2016|Anticipated|2016-08-01||Interventional|||Different Intravitreal Injection Techniques and Pain Level|Effect of Different Injection Techniques on Pain Level in Intravitreal Injections|Recruiting||N/A|300|Anticipated|Rabin Medical Center||4|||f||||t||||||||||2017-10-10 23:08:01.413695|2017-10-10 23:08:01.413695
NCT02526264|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-02|||November 2015||2015-11-01|August 2016|2016-08-01||||November 2017|Anticipated|2017-11-01||Interventional|STELLA||Evaluation of Quality of Life and Period of Hospitalization by Education|Clinical Trial to Evaluate Quality of Life, Period of Hospitalization and Complication Rates in Patients With Stoma Receiving Specific Preoperative Education vs. Standard Preoperative Education|Recruiting||N/A|138|Anticipated|Krankenhaus Nordwest||2|||f||||f||||||||||2017-10-10 23:00:41.443375|2017-10-10 23:00:41.443375
NCT02526251|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-09-27|||August 2015||2015-08-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|||Does the Microbiome in IBD Change Alongside Special Treatment Scenarios?|Does the Microbiome in IBD Change Alongside Special Treatment Scenarios?|Completed||N/A|80|Actual|Nordsjaellands Hospital|||1||f||||t||||||Samples With DNA|"     Fecal samples   "|||2017-10-10 23:00:41.554701|2017-10-10 23:00:41.554701
NCT02526238|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-08-29|||August 2015||2015-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness of Theta Burst Stimulation (TBS) and Voluntary Trunk Rotation for Neglect|The Treatment Effectiveness of Theta Burst Stimulation and Voluntary Trunk Rotation for Patients With Unilateral Neglect in Stroke|Recruiting||N/A|20|Anticipated|Kowloon Hospital, Hong Kong||2|||f||||f||||||||||2017-10-10 23:00:41.629745|2017-10-10 23:00:41.629745
NCT02526225|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-02-25|||June 2015||2015-06-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Interventional|||A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.|A Randomized,Double Blind,Placebo Parallel Controlled,Multicenter Clinical Sthdy of Ginkgo Diterpene Lactone Meglumine Injection for Acute Ischemic Stroke Efficacy Safety.|Enrolling by invitation||Phase 2|3452|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-10-10 23:00:41.730503|2017-10-10 23:00:41.730503
NCT02526212|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-04-06|||January 1, 2017|Actual|2017-01-01|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|October 1, 2017|Anticipated|2017-10-01||Interventional|G-BMT||Buprenorphine Group Medical Visits in Primary Care|Buprenorphine Group Medical Visits for Drug Users at Risk for HIV|Recruiting||N/A|80|Anticipated|Montefiore Medical Center||2|||f||||t|f|f||||||No||2017-10-10 23:00:41.823179|2017-10-10 23:00:41.823179
NCT02526199|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-09-22|||August 2015||2015-08-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Protracted Mixture of Local Anesthetics for Major Foot and Ankle Surgery|Protracted Mixture of Local Anesthetics for Major Foot and Ankle Surgery. A Randomized Double-blind, Controlled Study Comparing Bupivacaine-Epinephrine 0.5% Versus Bupivacaine-Epinephrine 0.5% With Dexamethasone|Completed||Phase 4|56|Actual|Kolding Sygehus||2|||f||||f||||||||||2017-10-10 23:00:41.91276|2017-10-10 23:00:41.91276
NCT02526186|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-08-09|||February 2016|Actual|2016-02-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Battlefield Auricular Acupuncture for Control of Post-partum Pain|Battlefield Auricular Acupuncture for Control of Post-partum Pain|Recruiting||N/A|90|Anticipated|Mike O'Callaghan Federal Hospital||2|||f||||f||||||||||2017-10-10 23:00:42.004175|2017-10-10 23:00:42.004175
NCT02526173|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-02-17|||October 2015||2015-10-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP)|A Prospective Randomized Clinical Trial Using Dehydrated Human Amnion/Chorion Membrane (dHACM) in Nerve Sparing Robotic Assisted Laparoscopic Radical Prostatectomy (RALP) - Effect on Potency Outcomes|Recruiting||N/A|230|Anticipated|MiMedx Group, Inc.||2|||f||||f||||||||||2017-10-10 23:00:42.085574|2017-10-10 23:00:42.085574
NCT02526160|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-05-02|||October 2015||2015-10-01|May 2017|2017-05-01|March 6, 2018|Anticipated|2018-03-06|December 22, 2017|Anticipated|2017-12-22||Interventional|||Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of KRN23 in Adults With X-linked Hypophosphatemia (XLH)|Active, not recruiting||Phase 3|134|Actual|Ultragenyx Pharmaceutical Inc||2|||f||||t||||||||||2017-10-10 23:00:42.179474|2017-10-10 23:00:42.179474
NCT02526147|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-08-24|||April 2011||2011-04-01|August 2015|2015-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||WFP Cash, Food, and Voucher Study in Ecuador||Completed||N/A|2580|Actual|International Food Policy Research Institute||4|||f||||f||||||||||2017-10-10 23:00:42.31457|2017-10-10 23:00:42.31457
NCT02526134|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-03-01|||April 2014||2014-04-01|February 2016|2016-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|FIDUCOR||Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and Rectum|Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and Rectum|Completed||Phase 2|29|Actual|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 23:00:42.38465|2017-10-10 23:00:42.38465
NCT02526121|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-08-29|||April 2013||2013-04-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia|Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia.|Completed||N/A|60|Actual|Instituto Aragones de Ciencias de la Salud||2|||f||||f||||||||Yes||2017-10-10 23:00:42.457719|2017-10-10 23:00:42.457719
NCT02526108|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-03-22|||August 2015||2015-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Energy Expenditure of High Intensity Functional Training|Energy Expenditure of High Intensity Functional Training|Completed||N/A|21|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-10 23:00:42.534969|2017-10-10 23:00:42.534969
NCT02526095|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-03-02|||June 2014||2014-06-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01|3 Years|Observational [Patient Registry]|FREGAT||The French EsoGastricTumours Data Base|National Oesophageal and Gastric Carcinomas Data Base Construction: the FREGAT (French EsoGastric Tumours) Data Base|Recruiting||N/A|15000|Anticipated|University Hospital, Lille|||1||f||||t|f|f||||||No||2017-10-10 23:00:42.610119|2017-10-10 23:00:42.610119
NCT02526082|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-08-14|||January 1964||1964-01-01|August 2015|2015-08-01|December 2040|Anticipated|2040-12-01|December 2040|Anticipated|2040-12-01||Observational|HBS||Long-term Follow-up of the Helsinki Businessmen Study|Long-term Follow-up of the Helsinki Businessmen Study Cohort of Men Born in 1919-1934|Active, not recruiting||N/A|3490|Actual|Helsinki University Central Hospital|||6||f||||f||||||Samples With DNA|"     APOE, telomeres, DNA collected for future use   "|||2017-10-10 23:00:42.70569|2017-10-10 23:00:42.70569
NCT02526056|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-07-07|||June 2015||2015-06-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Usability and Acceptance of Exergames Among Elderly People and Physiotherapists - a Mixed Method Approach|Usability and Acceptance of Exergames Among Elderly People and Physiotherapists - a Mixed Method Approach|Completed||N/A|27|Actual|Klinik Valens||2|||f||||f||||||||No||2017-10-10 23:00:42.848873|2017-10-10 23:00:42.848873
NCT02526043|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-10-09|||August 2015||2015-08-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma|A Prospective Randomized Control Trail of Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|Fudan University||2|||f||||f||||||||Undecided||2017-10-10 23:00:42.930855|2017-10-10 23:00:42.930855
NCT02526030|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-03-13|||October 2008|Actual|2008-10-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|February 2014|Actual|2014-02-01||Interventional|PAFIP2_3Y||Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up|Phase IV Study of Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in the Treatment of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program II (PAFIP II): a 3-year Follow-up|Completed||Phase 4|203|Actual|Fundación Marques de Valdecilla||3|||f||||f|f|f||||||No||2017-10-10 23:00:43.046026|2017-10-10 23:00:43.046026
NCT02526017|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-03-13|||September 2015||2015-09-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|FPA008-003||Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers|A Phase 1a/1b Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers|Recruiting||Phase 1|280|Anticipated|Five Prime Therapeutics, Inc.||3|||f||||t||||||||||2017-10-10 23:00:43.149472|2017-10-10 23:00:43.149472
NCT02526004|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-17|||January 2015||2015-01-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|September 2015|Anticipated|2015-09-01||Interventional|CFMATTERS||Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified|Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified|Unknown status|Recruiting|N/A|252|Anticipated|University College Cork||2|||f||||t||||||||||2017-10-10 23:00:43.504155|2017-10-10 23:00:43.504155
NCT02525991|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-03-28|||September 8, 2016|Actual|2016-09-08|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting|A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of Self-administered ADASUVE® (Staccato Loxapine for Inhalation) in Agitated Patients Outside the Hospital Setting|Recruiting||Phase 4|500|Anticipated|Ferrer Internacional S.A.||1|||f||||f||||||||||2017-10-10 23:00:43.621036|2017-10-10 23:00:43.621036
NCT02525978|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-08-10|||July 2015||2015-07-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Heart Rate Variability in Depression|Relationship Between Heart Rate Variability and Emotional Experience in Healthy and Depressed Adults|Recruiting||N/A|30|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 23:00:43.714356|2017-10-10 23:00:43.714356
NCT02525965|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-03-29|||August 2015||2015-08-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma|The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma After Hepatectomy: a Randomized Controlled Trial|Recruiting||N/A|194|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 23:00:43.839043|2017-10-10 23:00:43.839043
NCT02525952|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-03-30|||October 2015||2015-10-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System|A Randomized Controlled Trial to Compare the Outcomes Between Hepatectomy and Transarterial Chemoembolization for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System|Recruiting||N/A|320|Anticipated|Eastern Hepatobiliary Surgery Hospital||4|||f||||t||||||||||2017-10-10 23:00:43.948061|2017-10-10 23:00:43.948061
NCT02525939|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-05-06|||April 2016||2016-04-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|dal-GenE||Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS|A Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS): The Dal-GenE Trial|Recruiting||Phase 3|5000|Anticipated|DalCor Pharmaceuticals||2|||f||||t||||||||No||2017-10-10 23:00:44.157527|2017-10-10 23:00:44.157527
NCT02525926|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-08-22|||January 2016||2016-01-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|March 2017|Actual|2017-03-01||Interventional|DENERV'AP||Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension|Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 23:00:45.795926|2017-10-10 23:00:45.795926
NCT02525913|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-10-07|||September 2015||2015-09-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Feasibility Study of Cavity Radiofrequency Ablation in ex Vivo Mastectomy Breast Tissue|Feasibility Study of Cavity Radiofrequency Ablation in ex Vivo Mastectomy Breast Tissue|Withdrawn||N/A|0|Actual|University of Arkansas||1||Study was withdrawn from the IRB and never opened. No subjects were enrolled.|f||||f||||||||||2017-10-10 23:00:45.926144|2017-10-10 23:00:45.926144
NCT02525900|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-07-18|||September 2016||2016-09-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||ssTAP vs TAP Catheters in TAH|Comparing the Efficacy of Transversus Abdominis Plane Block, Both Single Injection and Continuous Block Technique, to Wound Infiltration for Total Abdominal Hysterectomy: A Prospective Randomized Study|Recruiting||Phase 3|60|Anticipated|University of Arkansas||3|||f||||f||||||||||2017-10-10 23:00:46.018132|2017-10-10 23:00:46.018132
NCT02525887|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-05-04|||July 2015||2015-07-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways|A Clinical Trial to Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways 2C19, 2C9, 2D6, 3A4, 3A5, Factor II, Factor V, MTHFR and VKORC1|Terminated||N/A|80|Actual|Bracane Company|||1|Study cancelled|f||||f||||||||||2017-10-10 23:00:46.130263|2017-10-10 23:00:46.130263
NCT02525874|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-08-24|||August 31, 2015|Actual|2015-08-31|August 2017|2017-08-01|May 21, 2018|Anticipated|2018-05-21|May 21, 2018|Anticipated|2018-05-21||Interventional|||Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).|An Open-Label Study to Assess the Effects of BG00012 on Lymphocyte Subsets in Subjects With Relapsing-Remitting Multiple Sclerosis|Active, not recruiting||Phase 3|218|Actual|Biogen||1|||f||||f||||||||||2017-10-10 23:00:46.215662|2017-10-10 23:00:46.215662
NCT02525861|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-09-08|||March 8, 2016|Actual|2016-03-08|September 2017|2017-09-01|February 26, 2018|Anticipated|2018-02-26|February 26, 2018|Anticipated|2018-02-26||Interventional|||Ph 3/4 GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study|A Phase 3/4 Study to Evaluate the Safety, Immunogenicity, and Effects on the Alpha1-Proteinase Inhibitor (A1PI) Levels in Epithelial Lining Fluid Following GLASSIA Therapy in A1PI-Deficient Subjects|Recruiting||Phase 3|36|Anticipated|Baxalta US Inc.||2|||f||||f||||||||||2017-10-10 23:00:46.369562|2017-10-10 23:00:46.369562
NCT02525848|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-03-22|||August 2015||2015-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PONV||Aprepitant Versus Gabapentin Prophylaxis for Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgeries|Aprepitant Versus Gabapentin Prophylaxis for Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgeries|Completed||Phase 2/Phase 3|150|Actual|Assiut University||3|||f||||t||||||||||2017-10-10 23:00:46.515651|2017-10-10 23:00:46.515651
NCT02525835|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-05-08|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Tissue Sodium in Autoimmune Disease|Tissue Sodium in Autoimmune Disease|Not yet recruiting||N/A|21|Anticipated|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-10 23:00:46.598082|2017-10-10 23:00:46.598082
NCT02525822|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-09-11|||September 2015||2015-09-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris|A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac® (Tazarotene) Cream, 0.1%, in the Treatment of Acne Vulgaris|Unknown status|Not yet recruiting|Phase 2|210|Anticipated|Valeant Pharmaceuticals||4|||f||||f||||||||||2017-10-10 23:00:46.66849|2017-10-10 23:00:46.66849
NCT02525809|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-14|||March 2010||2010-03-01|August 2015|2015-08-01||||June 2012|Actual|2012-06-01||Interventional|DOUMOB||Incidence of Dual Mobility Polyethylene Wear in Total Hip Prosthesis. Randomised Study Versus Fixed Insert by Radiostereometric Analysis.||Completed||N/A|82|Actual|University Hospital, Caen||3|||f||||f||||||||||2017-10-10 23:00:46.751589|2017-10-10 23:00:46.751589
NCT02525796|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-06-19|||January 2016||2016-01-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism|Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism|Recruiting||Phase 2/Phase 3|60|Anticipated|Brigham and Women's Hospital||3|||f||||f||||||||Yes|IPD will be shared with interested investigators upon request 1 year after the study is completed. Investigators may request IPD by contacting the PI and proposing a data analysis plan|2017-10-10 23:00:46.933806|2017-10-10 23:00:46.933806
NCT02525783|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-04-24|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:00:47.04746|2017-10-10 23:00:47.04746
NCT02525770|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-07-27|||June 2010||2010-06-01|July 2016|2016-07-01||||July 2016|Anticipated|2016-07-01||Interventional|COCYCOX||Comparative Study of the Wear of Uncemented Acetabular Conventional Polyethylene and X3 in Total Hip Replacement, for Stereo-radiographic Analysis||Active, not recruiting||N/A|112|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:00:47.086931|2017-10-10 23:00:47.086931
NCT02525757|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-09-25|||January 26, 2016|Actual|2016-01-26|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||MPDL3280A With Chemoradiation for Lung Cancer|DETERRED: PD-L1 blockadE To Evaluate the Safety of Lung CanceR Therapy Using Carboplatin, Paclitaxel, and Radiation CombinEd With MPDL3280A|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:00:47.161688|2017-10-10 23:00:47.161688
NCT02525744|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-10-14|||August 2015||2015-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of a New LY900014 Formulation in Healthy Participants|Pharmacokinetics, Glucodynamics, Safety, and Tolerability of a Novel LY900014 Formulation|Completed||Phase 1|20|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:00:47.290687|2017-10-10 23:00:47.290687
NCT02525731|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-07-19|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|TEACH||Targeting Effective Analgesia in Clinics for HIV - Patient Cohort|Collaborative Care Intervention to Improve Providers' Opioid Prescribing for HIV-infected Patients - Patient Cohort Component|Active, not recruiting||N/A|170|Actual|Boston Medical Center|||1||f||||f|f|f||||||||2017-10-10 23:00:47.373844|2017-10-10 23:00:47.373844
NCT02525718|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-02-22|||June 2015||2015-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction|Does Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction Reduce Postoperative Pain and Opioid Requirement?: A Prospective Double-Blinded Randomized Controlled Trial|Recruiting||Phase 2|46|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:00:47.459128|2017-10-10 23:00:47.459128
NCT02525705|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-05-17|||June 14, 2011|Actual|2011-06-14|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|DUMPING||Dumping Syndrome After Operation of Esophageal Atresia Type III|Frequency of Occurrence of Dumping Syndrome After Operation of Esophageal Atresia Type III|Recruiting||N/A|40|Anticipated|University Hospital, Lille||1|||f||||t|f|f||||||No||2017-10-10 23:00:47.550005|2017-10-10 23:00:47.550005
NCT02525692|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-03-19|||January 2016||2016-01-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Oral ONC201 in Adult Recurrent Glioblastoma|Oral ONC201 in Adult Recurrent Glioblastoma|Recruiting||Phase 2|53|Anticipated|Oncoceutics, Inc.||3|||f||||||||||||||2017-10-10 23:00:47.676927|2017-10-10 23:00:47.676927
NCT02525497|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-06-13|||July 2015||2015-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety, Effectiveness and Manipulability Evaluation of a Domestic PD Machine|A Randomized, Multicenter, Crossover Study Comparing the Domestic FM Peritoneal Dialysis Machine With Baxter HOMECHOICE|Recruiting||N/A|300|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||No||2017-10-10 23:00:51.030694|2017-10-10 23:00:51.030694
NCT02525679|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-06-08|||September 2015||2015-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers|Single-blind, Partially Randomised, Placebo-controlled Phase I Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses of BI 655130 in Healthy Male Volunteers|Completed||Phase 1|78|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:00:47.834587|2017-10-10 23:00:47.834587
NCT02525666|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-24|||August 2015||2015-08-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|September 2019|Anticipated|2019-09-01||Observational|BigWig||Bilateral Laparoscopic Repair of Groin Hernias With One Large Self-fixating Mesh (ProGripTM)|Evaluation of Bilateral Laparoscopic Repair of Groin Hernias With One Large Self-fixating Mesh (ProGripTM) in a Prospective Cohort Study|Active, not recruiting||N/A|100|Anticipated|Algemeen Ziekenhuis Maria Middelares|||1||f||||f||||||||||2017-10-10 23:00:47.923805|2017-10-10 23:00:47.923805
NCT02525653|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-08-07|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers|A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers|Recruiting||Phase 2|44|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:00:48.011962|2017-10-10 23:00:48.011962
NCT02525640|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-04-06|||August 1, 2015|Anticipated|2015-08-01|April 2017|2017-04-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Hearing Handicap in Patients With Single Sided Deafness|Hearing Handicap in Patients With Single Sided Deafness|Withdrawn||N/A|0|Actual|Cambridge University Hospitals NHS Foundation Trust||1||No participants recrui|f||||f||||||||||2017-10-10 23:00:48.17925|2017-10-10 23:00:48.17925
NCT02525627|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-12-05|||October 2010||2010-10-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|X3largeheads||A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads|A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads With Highly Cross Linked (X3) Acetabular Polyethylene Insert in the Hemispherical Trident Cup|Active, not recruiting||N/A|40|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-10-10 23:00:48.285854|2017-10-10 23:00:48.285854
NCT02525614|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-06-23|||February 2008||2008-02-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|TriathlonRSA||Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon Standard vs. Short Keel|Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon Standard vs. Short Keel|Active, not recruiting||N/A|59|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-10-10 23:00:48.401897|2017-10-10 23:00:48.401897
NCT02525601|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-06-23|||March 2009||2009-03-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|TriathlonRSA||Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon Cruciate Retaining - Cemented vs. Uncemented|Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon Cruciate Retaining (CR) - Cemented vs. Uncemented|Active, not recruiting||N/A|60|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-10-10 23:00:48.476744|2017-10-10 23:00:48.476744
NCT02525588|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-11-16|||September 2011||2011-09-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|X3vsN2Vac||Polyethylene Wear Study on the Triathlon Total Knee Prosthesis|Polyethylene Wear Study on the Triathlon Total Knee Prosthesis A Prospective Randomized Single Centre RSA Study|Active, not recruiting||N/A|100|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-10-10 23:00:48.570399|2017-10-10 23:00:48.570399
NCT02525575|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-06-21|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|PLF||"Suicide Safety Planning Group Treatment: Project Life Force"|"Suicide Safety Planning Group Treatment - Project Life Force"|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||1|||f||||t|f|f|||f|||No||2017-10-10 23:00:48.662952|2017-10-10 23:00:48.662952
NCT02525562|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-11-16|||June 2012||2012-06-01|November 2016|2016-11-01|March 2024|Anticipated|2024-03-01|March 2024|Anticipated|2024-03-01||Interventional|NTX||"Stryker NTX Registry Scorpio NRG (Re-Energize), Triathlon Total Knee, Triathlon Partial Knee Resurfacing (PKR) With X3 Polyethylene Insert"|Stryker NTX Registry Scorpio NRG Triathlon Total Knee, Triathlon PKR With X3 Insert International Multicentre Outcomes Register|Active, not recruiting||N/A|224|Actual|Stryker European Operations BV||3|||f||||f||||||||||2017-10-10 23:00:48.761882|2017-10-10 23:00:48.761882
NCT02525549|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2015-08-17||2015-08-17|December 2011||2011-12-01|August 2015|2015-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris||Completed||Phase 3|903|Actual|Perrigo Company||3|||f||||f||||||||||2017-10-10 23:00:48.852685|2017-10-10 23:00:48.852685
NCT02525536|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2015-08-19|2015-08-19||June 2009||2009-06-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Safety analysis set: all participants who received at least 1 dose of AMG 386.|A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors|A Phase 1, Open-Label, Dose Escalation Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386) in Adult Japanese Patients With Advanced Solid Tumors|Completed||Phase 1|18|Actual|Takeda||3|||f||||f||||||||||2017-10-10 23:00:48.963153|2017-10-10 23:00:48.963153
NCT02525523|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-03-08|||December 3, 2015|Actual|2015-12-03|March 2017|2017-03-01|January 18, 2018|Anticipated|2018-01-18|September 15, 2017|Anticipated|2017-09-15||Interventional|||Randomized Study of Topical Alicaforsen Enema in Antibiotic Refractory Pouchitis|A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis|Recruiting||Phase 3|138|Anticipated|Atlantic Pharmaceuticals Ltd||2|||f||||||||||||||2017-10-10 23:00:50.7161|2017-10-10 23:00:50.7161
NCT02525510|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-27|||July 26, 2017|Actual|2017-07-26|July 2017|2017-07-01|July 26, 2021|Anticipated|2021-07-26|July 26, 2020|Anticipated|2020-07-26||Interventional|||Deceased Organ Donor Interventions to Protect Kidney Graft Function|A Randomized Trial of Mild Hypothermia and Machine Perfusion in Deceased Organ Donors for Protection Against Delayed Graft Function in Kidney Transplant Recipients|Recruiting||N/A|2800|Anticipated|University of California, San Francisco||5|||f||||t|f|f||||||||2017-10-10 23:00:50.910096|2017-10-10 23:00:50.910096
NCT02525484|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2016-11-01|||August 2015||2015-08-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants|A Phase I, Open-Label, Randomized, Four-Treatment Period, Four-Sequence, Single-Dose, Crossover, Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers|Completed||Phase 1|44|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-10 23:00:51.311577|2017-10-10 23:00:51.311577
NCT02525471|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-04-06|||October 2015||2015-10-01|April 2017|2017-04-01||||March 2018|Anticipated|2018-03-01||Interventional|||A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)||Active, not recruiting||Phase 1|18|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:00:51.392244|2017-10-10 23:00:51.392244
NCT02525458|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2016-08-29|||July 2015||2015-07-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Quaternary Ammonium Methacryloxy Silicate-containing Acrylic Resin|Antimicrobial Activity of a Quaternary Ammonium Methacryloxy Silicate-containing Acrylic Resin: A Randomized Clinical Trial|Completed||Phase 2|32|Actual|Kimmerling Holdings Group, LLC||2|||f||||t||||||||||2017-10-10 23:00:51.465102|2017-10-10 23:00:51.465102
NCT02525445|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-17|||September 2013||2013-09-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ACU||Effects of Genuine vs Sham Acupuncture and Communication Type on Relaxation|Effects of Genuine vs Sham Acupuncture and Communication Type on Relaxation|Completed||Phase 4|243|Actual|Karolinska Institutet||4|||f||||f||||||||||2017-10-10 23:00:51.573532|2017-10-10 23:00:51.573532
NCT02525419|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-08-21|||August 2013||2013-08-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Intermittent Fasting, Caloric Restriction and Body Composition in Obese Men and Women|Effects of Intermittent Fasting and Caloric Restriction on Total and Regional Body Composition, Cardiometabolic, Oxidative Stress & Plasma Toxin Biomarkers, and Energy Metabolism in Overweight/Obese Men and Women|Completed||N/A|43|Actual|Skidmore College||2|||f||||t||||||||||2017-10-10 23:00:51.736692|2017-10-10 23:00:51.736692
NCT02525406|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-05-04|||July 2015||2015-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2015|Actual|2015-10-01||Observational|||Models for Improving Operating Room Productivity: Delays, Cancellations and Pre-admission Testing|Models for Improving Operating Room Productivity: Delays, Cancellations and Pre-admission Testing|Active, not recruiting||N/A|9240|Actual|University of Toledo Health Science Campus|||1||f||||f||||||||||2017-10-10 23:00:51.817821|2017-10-10 23:00:51.817821
NCT02525393|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-13|||March 2012||2012-03-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Transcranial Stimulation in Motor Stroke Rehabilitation|Safety and Efficacy of Non Invasive Transcranial Brain Stimulation in Motor Stroke Rehabilitation|Completed||N/A|34|Actual|University of Turin, Italy||3|||f||||f||||||||||2017-10-10 23:00:51.883176|2017-10-10 23:00:51.883176
NCT02525380|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-05-11|||September 2015||2015-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma|Phase4, to Assess Time to Progression (TTP) and Safety Profile of Doxorubicin-Eluting-Bead Embolization(DEBDOX) in Patients With Advanced HCC|Recruiting||Phase 4|30|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:00:51.969554|2017-10-10 23:00:51.969554
NCT02525367|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-08-25|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|July 7, 2017|Actual|2017-07-07|June 2017|Actual|2017-06-01||Interventional|||Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy|Clinical Pilot Study in the Feasibility and Effect of Online Cognitive Training on Cognitive Functions in Patients With Parkinson's Disease, Multiple Sclerosis and Depressive Patients Treated With Electroconvulsive Therapy|Terminated||N/A|28|Actual|VU University Medical Center||6||"All Parkinson's disease patients have finished training. The MS and ECT groups have not   finished as these groups had trouble including 20 patients."|f||||f||||||||||2017-10-10 23:00:52.05357|2017-10-10 23:00:52.05357
NCT02525354|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-08-13|||October 2001||2001-10-01|July 2015|2015-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Observational|||Dietary Arachidonic Acid, Obesity and Atopic Respiratory Disease|Obesity and Atopic-related Respiratory Disease: Possible Role of Dietary Omega 6 and 3 Fatty Acids|Completed||N/A|60|Actual|University of New Hampshire|||1||f||||f||||||Samples Without DNA|"     plasma samples   "|||2017-10-10 23:00:52.293957|2017-10-10 23:00:52.293957
NCT02525328|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-06-30|||May 2010|Actual|2010-05-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|GENOSCANN||Genome Study in Constitutional Thinness|Genome Study in Constitutional Thinness|Recruiting||N/A|350|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||Samples With DNA|"     blood or saliva specimen in families including at least one well phenotyped CT index case     (grade 2 or 3 of thinness according WHO classification). Family's members are : CT subjects     and subjects without CT.   "|||2017-10-10 23:00:52.563746|2017-10-10 23:00:52.563746
NCT02525315|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-14|||June 2007||2007-06-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|June 2012|Actual|2012-06-01||Interventional|TMS HALLU||Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations||Completed||Phase 2|15|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:00:52.67574|2017-10-10 23:00:52.67574
NCT02525302|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2017-07-05|||May 2015||2015-05-01|July 2017|2017-07-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|||HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02|HT-100 Long-term Safety and Pharmacodynamics in Patients With DMD Who Have Completed Protocols HALO-DMD-01 and HALO-DMD-02|Terminated||Phase 2|10|Actual|Akashi Therapeutics||5||Dosing stopped|f||||t||||||||||2017-10-10 23:00:52.766646|2017-10-10 23:00:52.766646
NCT02525289|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-08-13|||November 2012||2012-11-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01||Interventional|positioning||Impact of Three Body Positioning Strategies in the Drainage Fluids After Coronary Artery Bypass Surgery|Study of Impact of Three Body Positioning Strategies in the Drainage Fluids in the Immediate Postoperative Period in Patients After Coronary Artery Bypass Surgery|Completed||Phase 1|101|Actual|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-10 23:00:52.912734|2017-10-10 23:00:52.912734
NCT02525276|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-14|||August 2015||2015-08-01|August 2015|2015-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause|Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause|Not yet recruiting||N/A|48|Anticipated|Rigshospitalet, Denmark||4|||f||||f||||||||||2017-10-10 23:00:53.001926|2017-10-10 23:00:53.001926
NCT02525263|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-08-07|||July 2016||2016-07-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|RMCL-CL001||Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)|A Phase II, Open-label Safety and Efficacy Study of an Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease|Completed||Phase 2|1|Actual|inRegen||1|||f||||t||||||||||2017-10-10 23:00:53.082507|2017-10-10 23:00:53.082507
NCT02525250|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2015-08-13|||December 2012||2012-12-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide|Pilot Study Immunomonitoring NK Cells in Patients With Myeloid Malignancies|Completed||N/A|14|Actual|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 23:00:53.185603|2017-10-10 23:00:53.185603
NCT02525237|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-14|||August 2015||2015-08-01|August 2015|2015-08-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer|Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Qingdao Municipal Hospital||1|||f||||||||||||||2017-10-10 23:00:53.288496|2017-10-10 23:00:53.288496
NCT02525224|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults|Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults|Completed||N/A|40|Actual|Pharmanex||1|||f||||f||||||||||2017-10-10 23:00:53.376461|2017-10-10 23:00:53.376461
NCT02525211|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-06-20|||October 2012||2012-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|April 21, 2017|Actual|2017-04-21||Interventional|||Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment|Double-blind Randomized Prospective Phase III Study of a Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment of the Postoperative Pain From Hospital to Home|Terminated||Phase 3|59|Actual|Institut Paoli-Calmettes||2||Recruitment defect|f||||f||||||||||2017-10-10 23:00:53.456453|2017-10-10 23:00:53.456453
NCT02525198|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-11-17|||August 2015||2015-08-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|CANN||The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial|A Randomised Controlled Trial in 'At Risk' Humans Investigating the Cognitive Benefits of a Combined Flavonoid/Fatty Acid Intervention and Underlying Mechanisms of Action: The COGNITIVE AGING NUTRITION and NEUROGENESIS (CANN) Trial|Recruiting||N/A|240|Anticipated|University of East Anglia||2|||f||||f||||||||||2017-10-10 23:00:53.54773|2017-10-10 23:00:53.54773
NCT02525185|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Observational|CRID-CRT||Contractile Reserve in Dyssynchrony: A Novel Principle to Identify Candidates for Cardiac Resynchronization Therapy|Contractile Reserve in Dyssynchrony (CRID): A Novel Principle to Identify Candidates for Cardiac Resynchronization Therapy|Recruiting||N/A|240|Anticipated|Oslo University Hospital|||1||f||||f||||||||Undecided||2017-10-10 23:00:53.684215|2017-10-10 23:00:53.684215
NCT02525172|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-04-13|||August 2015||2015-08-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Immune Modulation Therapy for Pompe Disease|Immune Modulation Therapy for ERT-naïve or ERT-treated Pompe Disease Patients|Recruiting||Phase 4|8|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-10 23:00:53.7788|2017-10-10 23:00:53.7788
NCT02525159|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-13|||August 2006||2006-08-01|August 2015|2015-08-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|EDIMI216OHE1||Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio|Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio in Premenopausal Mexican Women With Risk of Breast Cancer|Completed||Phase 3|60|Actual|Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes||2|||f||||f||||||||||2017-10-10 23:00:53.915661|2017-10-10 23:00:53.915661
NCT02525146|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2016-08-07|||September 2013||2013-09-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|BA2C||Birmingham Access to Care Study||Completed||N/A|170|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:00:54.029329|2017-10-10 23:00:54.029329
NCT02525133|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-04-28|||August 2015||2015-08-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MATRIX-2||Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty|A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of the XaraColl® Bupivacaine Implant (300 mg Bupivacaine Hydrochloride) After Open Laparotomy Hernioplasty|Completed||Phase 3|319|Actual|Innocoll||2|||f||||f||||||||||2017-10-10 23:00:54.12101|2017-10-10 23:00:54.12101
NCT02525120|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-03-21|||July 2015||2015-07-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Post Market Non-Inferiority Study Comparing Triojection® to Discectomy for Lumbar Disc Herniation|Post Market Non-Inferiority Study Comparing Triojection® to Discectomy for Lumbar Disc Herniation|Recruiting||Phase 4|50|Anticipated|Minimus Spine, Inc||2|||f||||f||||||||||2017-10-10 23:00:54.265609|2017-10-10 23:00:54.265609
NCT02525107|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-08-14|||September 2015||2015-09-01|August 2015|2015-08-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|OM3FA||Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements|Omega 3 Fatty Acid Therapy for Prevention of Vaso-occlusive Crisis and Manifestations in Omani Patients With Sickle Cell Disease|Not yet recruiting||Phase 3|280|Anticipated|Sultan Qaboos University||2|||f||||t||||||||||2017-10-10 23:00:54.363113|2017-10-10 23:00:54.363113
NCT02525081|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-02-08|||July 2015||2015-07-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction|Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction and No Obstructive Coronary Artery Disease|Completed||Phase 4|63|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-10 23:00:54.596365|2017-10-10 23:00:54.596365
NCT02525068|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-08-13|||December 2014||2014-12-01|August 2015|2015-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|RE-AKT||A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC|A Randomised Phase II Study of Enzalutamide (MDV3100) in Combination With AZD5363 in Patients With Metastatic Castration‐Resistant Prostate Cancer (RE‐AKT)|Recruiting||Phase 2|136|Anticipated|Institute of Cancer Research, United Kingdom||3|||f||||t||||||||||2017-10-10 23:00:54.675887|2017-10-10 23:00:54.675887
NCT02525055|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-13|||January 2014||2014-01-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model|Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model|Completed||Phase 1/Phase 2|24|Actual|Hvivo||4|||f||||t||||||||||2017-10-10 23:00:54.767855|2017-10-10 23:00:54.767855
NCT02525042|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-13|||August 2011||2011-08-01|June 2015|2015-06-01||||January 2014|Actual|2014-01-01||Observational|GENOSPA||Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach|Study of the Genetic Susceptibility to Ankylosing Spondylitis by Functional Genomics Approach|Completed||N/A|97|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||Samples With DNA|"     RNA is extracted from cells obtained from blood samples (leukocytes).   "|||2017-10-10 23:00:54.991152|2017-10-10 23:00:54.991152
NCT02525029|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-11-02|||March 2016||2016-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD|Phase I/II Study of Human Chorionic Gonadotropin and Epidermal Growth Factor Supplementation (Pregnyl®) to Support Tolerance and Repair As Adjunct Therapy in High-Risk or Refractory Acute Graft-Versus-Host Disease|Recruiting||Phase 1/Phase 2|40|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-10-10 23:00:55.089733|2017-10-10 23:00:55.089733
NCT02525016|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-08-02|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|SPIRAL||Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery|Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery|Completed||Phase 3|50|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:00:55.213358|2017-10-10 23:00:55.213358
NCT02525003|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-13|||January 2014||2014-01-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|BreaD_ODIN||The BreaD Study - Bio-availability of D2 Vitamin Present in Bread|Work Package 5: The Potential Advantages and Limitations of Use of Novel Food-based Solutions for Prevention of Vitamin D Deficiency. Food-based Solutions for Optimal Vitamin D Nutrition and Health Through the Life Cycle (ODIN)|Completed||N/A|41|Actual|Helsinki University||4|||f||||f||||||||||2017-10-10 23:00:55.317264|2017-10-10 23:00:55.317264
NCT02524990|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-03-03|||April 2015||2015-04-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Simplified Medical Abortion Follow-Up|Simplified Medical Abortion Follow-Up Study|Terminated||N/A|53|Actual|Gynuity Health Projects||1||Integrated into another study|f||||f||||||||||2017-10-10 23:00:55.41234|2017-10-10 23:00:55.41234
NCT02524964|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-08-31|||December 2015||2015-12-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction|Effects of Sodium Tanshinone IIA Sulfonate on Left Ventricular Remodeling in Patients With ST-segment Elevation Myocardial Infarction Following Percutaneous Coronary Intervention|Recruiting||Phase 4|60|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||t||||||||No||2017-10-10 23:00:55.567768|2017-10-10 23:00:55.567768
NCT02524951|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-08-15|||April 2016||2016-04-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer|A Phase I Study of the Safety and Tolerability of Single Agent MSI-1436C in Metastatic Breast Cancer Patients|Suspended||Phase 1|21|Anticipated|Northwell Health||7||Pending revision of Treatment Schedule|f||||t||||||||||2017-10-10 23:00:55.685328|2017-10-10 23:00:55.685328
NCT02524938|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-08-16|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PoGlyDRI||Dietary Polyphenols and Glycation in Renal Insufficiency|PoGlyDRI - Impact of Dietary Polyphenols on Protein Glycation in Type 2 Diabetes Mellitus Subjects With Chronic Renal Insufficiency|Recruiting||N/A|118|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f|f|f||||||||2017-10-10 23:00:55.774059|2017-10-10 23:00:55.774059
NCT02524925|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-14|||April 2012||2012-04-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||Postoperative Stress Response in Patients Following Fast Track vs Conventional Protocol After Hepatectomy or Pancreatectomy|Postoperative Stress Response in Patients Following Fast Track Versus Conventional Protocol After Hepatectomy or Pancreatectomy|Completed||N/A|231|Actual|National and Kapodistrian University of Athens||2|||f||||t||||||||||2017-10-10 23:00:55.871697|2017-10-10 23:00:55.871697
NCT02524535|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-13|||April 2007||2007-04-01|August 2015|2015-08-01||||January 2013|Actual|2013-01-01||Interventional|IPSI2||Alliance With Therapeutic Entourage in Support of Young Suicidal||Completed||N/A|292|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:01:01.637035|2017-10-10 23:01:01.637035
NCT02524912|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-11-18|||April 2015||2015-04-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|1 Year|Observational [Patient Registry]|||Methadone Maintenance Outcome Study in Taiwan: 5-year Follow-up|Methadone Maintenance Outcome Study in Taiwan: 5-year Follow-up|Unknown status|Active, not recruiting|N/A|1200|Anticipated|National Health Research Institutes, Taiwan|||1||f||||||||||||||2017-10-10 23:00:55.948874|2017-10-10 23:00:55.948874
NCT02524899|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-02-24|||January 2014||2014-01-01|February 2017|2017-02-01|January 10, 2017|Actual|2017-01-10|January 10, 2017|Actual|2017-01-10||Interventional|||CRT-Guanfacine for SPD|Guanfacine Enhancement of Working Memory: Prospects for Augmenting Cognitive Remediation in the Schizophrenia Spectrum|Completed||Phase 2|45|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:00:56.006057|2017-10-10 23:00:56.006057
NCT02524886|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-05-22|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|June 25, 2017|Anticipated|2017-06-25|May 2, 2017|Actual|2017-05-02||Interventional|||Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia|Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia. Efficacy and Psychiatric and Cognitive Effects|Terminated||N/A|1|Actual|GGZ Centraal||2||"It was not possible to recruit and include a sufficient number of patients within the   timeframe."|f||||t||||||||||2017-10-10 23:00:56.1071|2017-10-10 23:00:56.1071
NCT02524873|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-03-18|||April 2015||2015-04-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Relationship Between Genes Important in Blood Pressure Regulation and Blood Pressure Therapy in Hypertension|Assessment of the Relationship Between Genes That Encode Proteins Important in Blood Pressure Regulation and Blood Pressure Therapy in Patients With Hypertension|Completed||N/A|99|Actual|Geneticure, LLC|||1||f||||f|f|f||||||No||2017-10-10 23:00:56.192491|2017-10-10 23:00:56.192491
NCT02524860|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-14|2017-03-14|||September 2015||2015-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device|Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device in Patients With an Elevated PSA and a Positive Multiparametric MRI|Enrolling by invitation||N/A|30|Anticipated|Focal Healthcare Inc.||1|||f||||f||||||||Undecided||2017-10-10 23:00:56.258921|2017-10-10 23:00:56.258921
NCT02524847|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-09-22|||January 20, 2016|Actual|2016-01-20|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||UVADEX® and ECP for the Treatment of Pediatric Patients With Steroid Refractory Acute Graft Versus Host Disease|Single-Arm Study to Assess the Efficacy of UVADEX® (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS® CELLEX® Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)|Recruiting||Phase 3|48|Anticipated|Mallinckrodt||1|||f||||t||||||||||2017-10-10 23:00:56.343784|2017-10-10 23:00:56.343784
NCT02524834|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-02-06|||July 2015||2015-07-01|September 2016|2016-09-01|July 2025|Anticipated|2025-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Endovascular Repair of Descending ThoracoAbdominal Aortic Pathologies Using Physician Modified Endovascular Prosthesis|Proposed Single Center Investigational Device Exemption: Endovascular Repair of Descending ThoracoAbdominal Aortic Pathologies Using Physician Modified Endovascular Prosthesis|Recruiting||N/A|15|Anticipated|Los Angeles Biomedical Research Institute||1|||f||||f||||||||Yes||2017-10-10 23:00:56.480324|2017-10-10 23:00:56.480324
NCT02524821|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-08-22|||September 2015||2015-09-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Gelesis100 on the Pharmacokinetics of Clopidogrel and Metformin|Randomized, Open-label, 4-Way Crossover Study Assessing the Effect of Gelesis100 on the Pharmacokinetics of Metformin, Administered Under Fasting and Fed Conditions|Completed||N/A|24|Actual|Gelesis, Inc.||4|||f||||f||||||||No||2017-10-10 23:00:56.589178|2017-10-10 23:00:56.589178
NCT02524808|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-13|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01|6 Months|Observational [Patient Registry]|FindBRCANess||"Prospective Identification and Validation of BRCANess Profile in Ovarian Epithelial Cancer"|"Multicentric Project for the Prospective Identification and Validation of Molecular Alterations That Define the BRCANess Profile in Ovarian Epithelial Cancer and Its Application as a Response Predictor to Platinum and Antitarget Therapies in the Clinical Practice. The Finding BRCANess Project"|Unknown status|Not yet recruiting|N/A|230|Anticipated|Fundación de investigación HM|||1||f||||f||||||||||2017-10-10 23:00:58.444207|2017-10-10 23:00:58.444207
NCT02524795|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-08-13|||March 2009||2009-03-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|August 2012|Actual|2012-08-01||Interventional|OM3LES||Omega 3 Fatty Acids and Systemic Lupus Erythematosus|Omega 3 Fatty Acids, Inflammatory Status and Biochemical Markers of Patients With Systemic Lupus Erythematosus: a Pilot Study|Completed||N/A|49|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-10 23:00:58.51144|2017-10-10 23:00:58.51144
NCT02524782|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-07-09|||October 7, 2015|Actual|2015-10-07|June 2017|2017-06-01|April 14, 2017|Actual|2017-04-14|April 14, 2017|Actual|2017-04-14||Interventional|||A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes|A Phase 1, Combined Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of MEDI4166 in Subjects With Type 2 Diabetes Mellitus (T2D)|Completed||Phase 1|103|Actual|MedImmune LLC||2|||f||||f|t|f||||||||2017-10-10 23:00:58.581091|2017-10-10 23:00:58.581091
NCT02524769|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-01-03|||December 2015||2015-12-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides|The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides|Active, not recruiting||N/A|27|Actual|Loyola University||1|||f||||t||||||||Undecided||2017-10-10 23:00:58.689267|2017-10-10 23:00:58.689267
NCT02524756|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-09-07|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy|Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy|Completed||N/A|46|Actual|Mansoura University||2|||f||||t||||||||||2017-10-10 23:00:58.78154|2017-10-10 23:00:58.78154
NCT02524743|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-13|||May 2014||2014-05-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||The Prevention of Pain Associated With Rocuronium Injection|The Prevention of Pain Associated With Rocuronium Injection: Effect of Pretreatment With Acetaminophen and Lidocaine|Completed||Phase 4|150|Actual|Suleyman Demirel University||5|||f||||f||||||||||2017-10-10 23:00:58.858341|2017-10-10 23:00:58.858341
NCT02524730|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-11-16|||May 2009||2009-05-01|November 2016|2016-11-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|ScorpioNRG||"Scorpio NRG (Re-Energize) Cruciate Retaining (CR) Post-market International Outcome Study"|Scorpio NRG Prospective, Open-label, Post-market International Multicentre Outcome Study|Active, not recruiting||N/A|216|Actual|Stryker European Operations BV||1|||f||||f||||||||||2017-10-10 23:00:58.948567|2017-10-10 23:00:58.948567
NCT02524717|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-04-21|||August 13, 2015|Actual|2015-08-13|April 2017|2017-04-01|February 9, 2017|Actual|2017-02-09|February 9, 2017|Actual|2017-02-09||Interventional|||A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function|A Single-Dose, Open-Label Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Subjects With Mild or Moderate Hepatic Impairment Compared With Subjects With Normal Hepatic Function|Completed||Phase 1|24|Actual|Aragon Pharmaceuticals, Inc.||1|||f||||f||f||||||||2017-10-10 23:00:59.035176|2017-10-10 23:00:59.035176
NCT02524704|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-01-30|||March 2015||2015-03-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|December 2016|Actual|2016-12-01||Observational|||Electrical Impedance Imaging of Patients With Cystic Fibrosis|Electrical Impedance Tomography (EIT): A Non-radiating Functional Imaging for Cystic Fibrosis|Enrolling by invitation||N/A|80|Anticipated|Colorado State University|||3||f||||t||||||||||2017-10-10 23:00:59.124759|2017-10-10 23:00:59.124759
NCT02524678|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-03-06|||August 5, 2015|Actual|2015-08-05|March 2017|2017-03-01|March 28, 2016|Actual|2016-03-28|October 7, 2015|Actual|2015-10-07||Interventional|||Phase 1 Study(Additional) of URC102 in Healthy Subjects|A Phase I, Placebo-controlled, Randomized, Double Blind, Dose-escalation Study to Assess the Safety and Pharmacokinetic and Pharmacodynamic Characteristics of Repeated-dose URC102 in Healthy Korean Adult Males|Completed||Phase 1|21|Actual|JW Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:00:59.401356|2017-10-10 23:00:59.401356
NCT02524665|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-03-16|2017-01-24||September 2009||2009-09-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne|U0289-404: An Evaluator Blinded, 8 Week, Split Face Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITYII and MURAD in Subjects With Acne|Completed||Phase 4|20|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 23:00:59.508938|2017-10-10 23:00:59.508938
NCT02524652|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-06-23|||September 2015||2015-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction|Postoperative Analgesic Efficacy of Local Infiltration Analgesia Versus Adductor Canal Block After Anterior Cruciate Ligament Reconstruction: A Randomised Controlled Double-blinded Trial|Recruiting||Phase 4|104|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 23:01:00.359224|2017-10-10 23:01:00.359224
NCT02524639|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-09-19|||August 2015||2015-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Sirolimus for the Treatment of Hyperinsulinism|Pilot Study of the Efficacy and Safety of Sirolimus in the Treatment of Congenital Hyperinsulinism.|Recruiting||Phase 1/Phase 2|6|Anticipated|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-10 23:01:00.465767|2017-10-10 23:01:00.465767
NCT02524626|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-07-10|||January 2015||2015-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Anti-inflammatory Effect of Peroperative Stimulation of the Vagus Nerve|Anti-inflammatory Effect of Peroperative Stimulation of the Vagus Nerve: A Potential New Therapeutical Intervention for Shortening Postoperative Ileus|Recruiting||Phase 3|130|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-10 23:01:00.551451|2017-10-10 23:01:00.551451
NCT02524613|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-13|||July 2015||2015-07-01|August 2015|2015-08-01||||May 2016|Anticipated|2016-05-01||Observational|||Prospective Bone Marrow Biopsy Safety and Efficacy Study||Unknown status|Active, not recruiting|N/A|50|Anticipated|Jacobi Medical Center|||1||f||||t||||||||||2017-10-10 23:01:00.651394|2017-10-10 23:01:00.651394
NCT02524600|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-13|||January 2012||2012-01-01|August 2015|2015-08-01||||June 2012|Actual|2012-06-01||Interventional|IQSCINTIMYOC||"Technical Performance of a New Cardiac Technology IQ-SPECT Applied to SCINTI-CT Myocardial Imaging With 99mTc-Sestamibi in Coronary Patients"||Completed||N/A|103|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:01:00.701013|2017-10-10 23:01:00.701013
NCT02524587|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-13|||January 2010||2010-01-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|POLYTITAN||Study of the Wear of a Highly Cross-linked Polyethylene Acetabular Doped With Vitamin E and Coated With Titanium in Total Hip Replacement||Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:01:00.764717|2017-10-10 23:01:00.764717
NCT02524574|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-03-07|||September 2010||2010-09-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|TEP-READ||Tomography Positron Emission Assessment of the Impact of Cardiac Rehabilitation on Coronary Endothelial Function in Cardiac Failure||Completed||N/A|54|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:01:00.9441|2017-10-10 23:01:00.9441
NCT02524561|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-01-18|2016-09-20||September 2005||2005-09-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|KEEPS MDBHAS|Population with mammographic density data from at least one time point during study.|KEEPS Mammographic Density And Breast Health Ancillary Study|KEEPS Mammographic Density And Breast Health Ancillary Study|Completed||N/A|517|Actual|Brigham and Women's Hospital||3|||f||||t||||||||Undecided|We are willing to share data with collaborators if analyses are approved by the investigative team and approved by our IRB.|2017-10-10 23:01:01.034068|2017-10-10 23:01:01.034068
NCT02524548|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-08-02|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||SMS Reminders to Improve Medication Adherence of Aromatase Inhibitors|Improving Medication Adherence With Adjuvant Aromatase Inhibitor in Women With Breast Cancer: A Randomised Controlled Trial to Evaluate the Effect of Short Message Service (SMS) Reminder|Recruiting||N/A|280|Anticipated|National University, Singapore||2|||f||||f|f|f||||||||2017-10-10 23:01:01.513444|2017-10-10 23:01:01.513444
NCT02524522|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-04-05|||August 2015||2015-08-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|WEAN-IPI||Perioperative Mechanical Ventilation and Postoperative Monitoring of IPI|Perioperative Pulmonary Recruitment and Postoperative Monitoring of Integrated Pulmonary Index in Off-pump Coronary Bypass Grafting|Completed||N/A|40|Actual|Northern State Medical University||2|||f||||f||||||||No||2017-10-10 23:01:01.715005|2017-10-10 23:01:01.715005
NCT02524509|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-28|||January 2012||2012-01-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|||the Safety and Efficacy Evaluation of Chondron Compared With Mircrofracture of Knee|An Inverstigational Clinical Trial for the Safety and Efficacy Evaluation of Chondron(Autologous Cultured Chondrocyte)Compared With Mircrofracture Surgery in Subjects With Cartilage Defects of the Knee Joint|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Sewon Cellontech Co., Ltd.|||2||f||||t||||||||||2017-10-10 23:01:01.8026|2017-10-10 23:01:01.8026
NCT02524496|ClinicalTrials.gov processed this data on October 10, 2017|2007-12-25|2015-08-13|||March 2001||2001-03-01|August 2015|2015-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Limited Access Protocol for the Use of Oral Cisapride|Limited Access, Open-label, Compassionate Use of Cisapride in the Treatment of Gastroparesis|Completed||Phase 4|3|Actual|Yale University|||1||f||||f||||||||||2017-10-10 23:01:01.886871|2017-10-10 23:01:01.886871
NCT02524483|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-12|||October 2014||2014-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Influence of High-Dosage Physical Therapy on the Balance and Mobility of Individuals With Multiple Sclerosis||Completed||N/A|32|Actual|University of Nebraska||2|||f||||||||||||||2017-10-10 23:01:01.97371|2017-10-10 23:01:01.97371
NCT02524470|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-05-30|||July 2014||2014-07-01|May 2017|2017-05-01|July 17, 2015|Actual|2015-07-17|July 17, 2015|Actual|2015-07-17||Interventional|VSP||Vital Signs Patch Early Feasibility and Usability Study v1.0|Feasibility Study for Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting v1.0|Completed||N/A|19|Actual|LifeWatch Services, Inc.||1|||f||||f|f|t|f|f|f|||||2017-10-10 23:01:02.079481|2017-10-10 23:01:02.079481
NCT02524457|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-13|||September 2015||2015-09-01|August 2015|2015-08-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Observational|||How Menopause Affects Lipid Metabolism in the Visceral Fat Depots|How Menopause Affects Lipid Metabolism in the Visceral Fat Depots|Not yet recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark|||3||f||||t||||||Samples With DNA|"     blood and fat biopsies   "|||2017-10-10 23:01:02.20007|2017-10-10 23:01:02.20007
NCT02524444|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-12|||September 2015||2015-09-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients|A Comparative Study of Mefloquine and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant Human Immunodeficiency Virus Positive Patients|Unknown status|Not yet recruiting|Phase 1|140|Anticipated|University of Ibadan||2|||f||||t||||||||||2017-10-10 23:01:02.283993|2017-10-10 23:01:02.283993
NCT02524431|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-18|||November 2014||2014-11-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Changes Within the Cells of the Drainage System of the Eye in Patients With Glaucoma|The Changes of Mitochondrial Dynamics and the Molecular Mechanisms in the Trabecular Meshwork of Patients With Glaucoma|Withdrawn||N/A|0|Actual|Wills Eye||2||Unable to obtain mitochondrial samples|f||||f||||||||Yes||2017-10-10 23:01:02.384752|2017-10-10 23:01:02.384752
NCT02524418|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-02-10|2016-04-26||August 2015||2015-08-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SPYDS|88 subjects signed consent but in 13 subjects a Spyglass examination was not done because of the lack of indication after performing standard cholangiography or pancreatography|Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS|Prospective Evaluation of the Clinical Utility of Endoscopic Retrograde Cholangiopancreatography (ERCP) Guided Cholangiopancreatoscopy With the SpyGlass DS.|Completed||N/A|88|Actual|University of Florida||1|||f||||f||||||||No||2017-10-10 23:01:02.470326|2017-10-10 23:01:02.470326
NCT02524405|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-04-18|||February 2016||2016-02-01|April 2016|2016-04-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Observational|BEAM||BEAM: Brain-Eye Amyloid Memory Study|The Brain Eye Amyloid Memory (BEAM) Study: Validation of Ocular Measures as Potential Biomarkers for Early Detection of Brain Amyloid and Neurodegeneration|Recruiting||N/A|320|Anticipated|Sunnybrook Health Sciences Centre|||5||f||||f||||||Samples With DNA|"     Blood samples for genetic testing including apoliprotein E4 status, as well as for proteomic,     lipidomic and other fluid biomarkers of neurodegeneration and vascular disease, will be     collected for each participant. All samples should be taken after a 10 hour fast; if not     possible, the participant should have a light meal only. Samples should be collected between     8am and 10am, in order to minimize circadian variations in biomarker levels.   "|||2017-10-10 23:01:02.757484|2017-10-10 23:01:02.757484
NCT02524392|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-12-02|||September 2015||2015-09-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|NIME||Effect Evaluation of Independent Medical Evaluation (IME) in Norway|Effect Evaluation of Independent Medical Evaluation (IME) After Six Months Sick Leave: A Randomized Controlled Trial of Independent Medical Evaluation (IME) Versus Treatment as Usual in Norway|Recruiting||N/A|3784|Anticipated|Uni Research||2|||f||||f||||||||||2017-10-10 23:01:02.867753|2017-10-10 23:01:02.867753
NCT02524379|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-03-23|||February 14, 2017|Actual|2017-02-14|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|SCING||Spinal Cord Injury Neuroprotection With Glyburide|Spinal Cord Injury Neuroprotection With Glyburide; Pilot Study: An Open-Label Prospective Evaluation of the Feasibility, Safety, Pharmacokinetics, and Preliminary Efficacy of Oral Glyburide (DiaBeta) in Patients With Acute Traumatic Spinal Cord Injury|Recruiting||Phase 1/Phase 2|10|Anticipated|Ohio State University||1|||f||||t|t|f|||f|||Undecided||2017-10-10 23:02:35.225796|2017-10-10 23:02:35.225796
NCT02524366|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-04-21|||September 2015||2015-09-01|April 2017|2017-04-01|August 2022|Anticipated|2022-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement|A Randomized Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement|Recruiting||N/A|394|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|t|f|f|f|||||2017-10-10 23:02:35.334839|2017-10-10 23:02:35.334839
NCT02523820|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-04-25|||January 2015||2015-01-01|April 2017|2017-04-01|August 30, 2016|Actual|2016-08-30|May 30, 2016|Actual|2016-05-30||Interventional|||Nebulized Corticosteroid for Post Extubation Stridor in Children|Nebulized Corticosteroid for Post Extubation Stridor in Children: A Randomized Double Blind Controlled Trial|Completed||Phase 3|144|Actual|Ramathibodi Hospital||2|||f||||t||||||||||2017-10-10 23:02:41.955128|2017-10-10 23:02:41.955128
NCT02524353|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-13|||August 2015||2015-08-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|Follow-up01||Follow-up Study of Patients Undergoing Cardiac Surgery|Follow-up Study of Functional Capacity and Respiratory Muscle Strength in Patients Undergoing Cardiac Surgery|Unknown status|Not yet recruiting|N/A|20|Anticipated|Centro Universitário de Votuporanga||1|||f||||f||||||||||2017-10-10 23:02:35.453698|2017-10-10 23:02:35.453698
NCT02524340|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-07-28|||September 2015||2015-09-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01|1 Year|Observational [Patient Registry]|||Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference|Patient Centered Adaptive Treatment Strategies for Juvenile Idiopathic Arthritis Using Bayesian Causal Inference|Recruiting||N/A|1144|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-10 23:02:35.557975|2017-10-10 23:02:35.557975
NCT02524327|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-09-19|||July 7, 2015|Actual|2015-07-07|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FRAGIL||Frail Status of Elderly Patients After Repair and Anesthesia Guided by the bispectraL Index|Influence of the Modality of General Anesthesia Guided by the Bispectral Index (Manual or Automated) on the Occurrence of a Loss of Capability in Elderly Patients (> 70 Yrs): a Randomized Multicenter Study|Recruiting||N/A|430|Anticipated|Hopital Foch||2|||f||||f||||||||||2017-10-10 23:02:35.639354|2017-10-10 23:02:35.639354
NCT02524314|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-06-06|||August 2015||2015-08-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|May 2017|Actual|2017-05-01||Interventional|||Safety and Efficacy Study of the Treatment of Humerus Fractures - Germany|CE Marking Study of the IlluminOss Photodynamic Bone Stabilization System for the Treatment of Humerus Fractures|Active, not recruiting||N/A|44|Actual|IlluminOss Medical, Inc.||1|||f||||||||||||||2017-10-10 23:02:35.771042|2017-10-10 23:02:35.771042
NCT02524301|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-05-29|||September 2009||2009-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study|Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study|Recruiting||N/A|45|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||||2017-10-10 23:02:36.073907|2017-10-10 23:02:36.073907
NCT02524288|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-25|2017-08-25||August 31, 2015|Actual|2015-08-31|August 2017|2017-08-01|September 16, 2016|Actual|2016-09-16|September 16, 2016|Actual|2016-09-16||Interventional|||Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)|A Phase 3, Single Arm, Clinical Trial to Study the Contraceptive Efficacy and Safety of the MK-8342B (Etonogestrel + 17β-Estradiol) Vaginal Ring in Healthy Women 18 Years of Age and Older, At Risk for Pregnancy|Terminated||Phase 3|1941|Actual|Merck Sharp & Dohme Corp.|Results for the Pearl Index should be interpreted with caution. Due to the discontinuation of product development and early trial termination, the number of “at risk” treatment cycles in the denominator is based on uncleaned diary data.|1||"This study was terminated by the Sponsor due to a business decision to discontinue product   development for reasons unrelated to safety or efficacy outcomes."|f||||f|t|f||||||||2017-10-10 23:02:36.236574|2017-10-10 23:02:36.236574
NCT02524275|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-08-17|||March 2015||2015-03-01|August 2016|2016-08-01||||April 2020|Anticipated|2020-04-01||Interventional|||Docetaxel and Capecitabine in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Phase II Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 2|43|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-10 23:02:37.264971|2017-10-10 23:02:37.264971
NCT02524262|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-01-21|||December 2012||2012-12-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde|Slow-release L-cysteine Capsule Prevents Carcinogenic Gastric Acetaldehyde Exposure in Helicobacter-associated Atrophic Gastritis|Completed||Phase 2|8|Actual|Uppsala University||2|||f||||f||||||||Yes|World J Gastroenterol|2017-10-10 23:02:37.445993|2017-10-10 23:02:37.445993
NCT02524249|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-11-19|||September 2015||2015-09-01|November 2015|2015-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Early Versus Late Caffeine for ELBW Newborns|A Randomized Double Blind Controlled Trial of Early Versus Late Caffeine for Extremely Low Birth Weight Newborns|Recruiting||N/A|220|Anticipated|Wayne State University||2|||f||||t||||||||||2017-10-10 23:02:37.582757|2017-10-10 23:02:37.582757
NCT02524236|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-02-17|||August 2015||2015-08-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.|Studying the Dose Response of 50 and 100 IU of Botox A Toxin Injection in the Prostates of BPH Patients.|Completed||Early Phase 1|40|Actual|Beni-Suef University||2|||f||||f||||||||Undecided||2017-10-10 23:02:37.696071|2017-10-10 23:02:37.696071
NCT02524223|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-07-17|||July 12, 2012|Actual|2012-07-12|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|April 2016|Actual|2016-04-01||Interventional|AMPAMAVIR||Prevalence of HPV Transmission During Medically Assisted Procreation Procedures|Prevalence of HPV Transmission During Medically Assisted Procreation Procedures|Active, not recruiting||N/A|915|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:02:37.796531|2017-10-10 23:02:37.796531
NCT02524210|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-01-22|||May 2014||2014-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|BIPP||Effect of Inhibitors of the Proton Pump on Intestinal Transporters|Effect of Inhibitors of the Proton Pump on Intestinal Transporters and Their Impact on the Pharmacokinetics of Dabigatran - Mechanistic and Clinical Approach -BIPP Study|Completed||Phase 1|12|Actual|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||||2017-10-10 23:02:37.900011|2017-10-10 23:02:37.900011
NCT02524197|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-01-30||2017-01-30|August 2015||2015-08-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee|A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee|Completed||Phase 2|81|Actual|Cara Therapeutics, Inc.||4|||f||||f||||||||||2017-10-10 23:02:38.035123|2017-10-10 23:02:38.035123
NCT02524184|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-08-31|||August 2015||2015-08-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity|Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity in Human Adults|Recruiting||Phase 4|11|Anticipated|Wuhan General Hospital of Guangzhou Military Command||2|||f||||t||||||||||2017-10-10 23:02:38.206681|2017-10-10 23:02:38.206681
NCT02524171|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-05-31|||April 4, 2016|Actual|2016-04-04|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|April 4, 2019|Anticipated|2019-04-04||Interventional|MRT||Justice-Involved Veterans and Moral Reconation Therapy|Improving Treatment Engagement and Outcomes Among Justice-involved Veterans|Recruiting||N/A|365|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Undecided||2017-10-10 23:02:38.345358|2017-10-10 23:02:38.345358
NCT02524145|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-05-10|||March 2013||2013-03-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Chronotropic Incompetence in Patients With HFpEF|Determinants of Chronotropic Incompetence in Patients With Heart Failure and a Preserved Ejection Fraction (HFpEF)|Recruiting||N/A|45|Anticipated|University of Texas Southwestern Medical Center||3|||f||||t||||||||||2017-10-10 23:02:39.232108|2017-10-10 23:02:39.232108
NCT02524132|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-08-13|||September 2011||2011-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|May 2012|Actual|2012-05-01||Interventional|||Physical Activity Intervention in Preschool Children|Physical Activity Intervention in Preschool Children|Completed||N/A|25|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:02:39.400369|2017-10-10 23:02:39.400369
NCT02524119|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-06-07|||April 2016||2016-04-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|LEE001||LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma|A Phase II Study of LEE011 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 2|40|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 23:02:39.490728|2017-10-10 23:02:39.490728
NCT02524106|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-01-18|||August 2016||2016-08-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|B-HIVE||Bococizumab HIV Evaluation (B-HIVE) Study|Bococizumab HIV Evaluation (B-HIVE) Study: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of Bococizumab, a PCSK9 Inhibitor, in HIV-Infected Subjects|Terminated||Phase 3|11|Actual|University of California, San Francisco||2||"Industry will not be moving forward with the production of bococizumab in the main trial of   PF-04950615"|f||||t||||||||||2017-10-10 23:02:39.590038|2017-10-10 23:02:39.590038
NCT02524093|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-12-02|||September 2015||2015-09-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|PosMTMS||The Impact of Positive Mental Training in Multiple Sclerosis|The Efficacy of Positive Mental Training in Patients With Multiple Sclerosis Experiencing Psychological Distress: A Pilot Randomised Controlled Trial|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-10-10 23:02:39.721596|2017-10-10 23:02:39.721596
NCT02524080|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-13|||September 2011||2011-09-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|June 2015|Actual|2015-06-01||Interventional|||Healthcare at Optimal Care Level for Patients Who Needs Primary Care|Healthcare at Optimal Care Level for Patients Who Needs Primary Care - Collaboration Between Care Providers From The Emergency Medical Services' Perspective|Unknown status|Active, not recruiting|N/A|200|Anticipated|University of Boras||2|||f||||t||||||||||2017-10-10 23:02:39.808026|2017-10-10 23:02:39.808026
NCT02524067|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-11-11|||September 2015||2015-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ABS||Modified Environment for Agitation in Patients With TBI|Modified Environment for Agitation in Patients With Traumatic Brain Injury: a Controlled Multicenter|Recruiting||N/A|42|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-10-10 23:02:39.883769|2017-10-10 23:02:39.883769
NCT02524041|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-05-24|||March 2014||2014-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism|Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism|Completed||N/A|22|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:02:40.097014|2017-10-10 23:02:40.097014
NCT02524028|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-08-13|||June 2012||2012-06-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|fMRI||Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation Using Functional MRI (fMRI)|Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation: A Prospective Functional MRI Study (fMRI)|Completed||N/A|21|Actual|University of Utah|||2||f||||f||||||||||2017-10-10 23:02:40.180579|2017-10-10 23:02:40.180579
NCT02524015|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-09-19|||September 2015||2015-09-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Novel Treatment For Pusher Syndrome Using Physical Therapy||Enrolling by invitation||N/A|50|Anticipated|Loma Linda University||2|||f||||f||||||||||2017-10-10 23:02:40.259971|2017-10-10 23:02:40.259971
NCT02524002|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2016-11-04|||August 2014||2014-08-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|August 2017|Anticipated|2017-08-01||Interventional|||Enhanced vs. Routine Clear Liquid Intake in Labor|Clear Liquids vs Enhanced Clear Liquids; Effect on Labor Performance|Recruiting||N/A|400|Anticipated|Temple University||2|||f||||f||||||||Yes||2017-10-10 23:02:40.342281|2017-10-10 23:02:40.342281
NCT02523807|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-09-01|||September 2015||2015-09-01|September 2015|2015-09-01||||August 2017|Anticipated|2017-08-01||Observational|||Tremor Monitoring Device|Tremor Monitoring Device|Unknown status|Not yet recruiting|N/A|50|Anticipated|Rambam Health Care Campus|||2||f||||f||||||||||2017-10-10 23:02:42.044194|2017-10-10 23:02:42.044194
NCT02523794|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-06-26|||August 2015||2015-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis|A Double Blind, Placebo-controlled Study Evaluating an Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis|Active, not recruiting||N/A|9|Actual|Revalesio Corporation||2|||f||||f||||||||||2017-10-10 23:02:42.275966|2017-10-10 23:02:42.275966
NCT02523989|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-08-13|||March 2010||2010-03-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01|3 Months|Observational [Patient Registry]|||The Relationship Between Arsenic Methylation Capability and Blood Metals in Children With Developmental Delays|The Relationship Between Genetic Polymorphism of Arsenic Methylation Enzymes, Arsenic Methylation Capability and Blood Metals, and Developmental Delays in Preschool Children|Completed||N/A|137|Actual|Taipei Medical University|||2||f||||f||||||Samples With DNA|"     Blood and urine samples of participants were collected and urine used for the analysis of the     arsenic species using high performance liquid chromatography linked hydride generator and     atomic absorption spectrometry. Buffy coat were separated from plasma and extract DNA to     analyze the genetic polymorphism of arsenic methylation related enzymes using polymerase     chain reaction and restriction fragment length polymorphism. 2 ml blood were digested for the     determination of mercury, lead and arsenic.   "|||2017-10-10 23:02:40.496934|2017-10-10 23:02:40.496934
NCT02523976|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-05-03|||August 2015||2015-08-01|May 2016|2016-05-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia|Dasatinib Plus Multi-agent Chemotherapy for New Diagnosed Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia|Enrolling by invitation||Phase 2|30|Anticipated|Institute of Hematology & Blood Diseases Hospital||1|||f||||f||||||||||2017-10-10 23:02:40.603224|2017-10-10 23:02:40.603224
NCT02523963|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-08-13|||August 2015||2015-08-01|August 2015|2015-08-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||Effects of Family Work Shop for Children With Developmental Delays|Effects of Family Work Shop for Children With Developmental Delays|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Taipei Medical University||2|||f||||f||||||||||2017-10-10 23:02:40.738409|2017-10-10 23:02:40.738409
NCT02523950|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-04-27|||March 2015||2015-03-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Staged and Combined Surgery for Cataract Patients With Corneal Endothelial Dysfunction|Evaluation of Staged and Combined Phacoemulsification With Intraocular Lens (IOL) Implantation and Descemet Membrane Endothelial Keratoplasty (DMEK) for Cataract Patients With Corneal Endothelial Dysfunction|Recruiting||N/A|100|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:02:40.844775|2017-10-10 23:02:40.844775
NCT02523937|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2017-04-21|||September 2015||2015-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FSET||Evaluation of Soluble Fibrin in Thrombosis Exclusion|Evaluation of Performances of Soluble Fibrin Assay in Exclusion of Pulmonary Embolism and Deep Venous Thrombosis|Recruiting||N/A|900|Anticipated|Diagnostica Stago R&D|||2||f||||f||||||Samples Without DNA|"     Frozen heparinized and citrated Poor Platelets Plasma   "|Undecided||2017-10-10 23:02:41.014096|2017-10-10 23:02:41.014096
NCT02523924|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-05-27|||May 2015||2015-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy|Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy|Active, not recruiting||N/A|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:02:41.112482|2017-10-10 23:02:41.112482
NCT02523911|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening|Sodium Sulfate/Potassium Sulfate/Magnesium Sulfate Bowel Preparation With and Without Simethicone for Routine Colonoscopy: A Double-blinded Randomized Controlled Trial|Recruiting||N/A|800|Anticipated|Mercy Medical Center, Des Moines, Iowa||2|||f||||t||||||||||2017-10-10 23:02:41.198386|2017-10-10 23:02:41.198386
NCT02523898|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2016-10-12|||November 2015||2015-11-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|April 2020|Anticipated|2020-04-01||Interventional|||Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant|Is the Co-administration of Metformine and CC as Compared to Placebo and CC Superior to Induce Ovulation in PCOS Patients With a Confirmed insulin-resistant-a Double Blind Randomized Clinical Trial|Enrolling by invitation||Phase 2|388|Anticipated|Semnan University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:02:41.337419|2017-10-10 23:02:41.337419
NCT02523885|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-02-25|||November 2013||2013-11-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ALPAJ||Use of Non Steroidal Antiinflammatory Drugs in Patients With Community Acquired Pneumonia|Descriptive Analysis of Non Steroidal Antiinflammatory Drugs Use in Patients Diagnosed With Community Acquired Pneumonia|Completed||N/A|181|Actual|Hôpital Louis Mourier|||1||f||||t||||||||||2017-10-10 23:02:41.466922|2017-10-10 23:02:41.466922
NCT02523872|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-13|||August 2015||2015-08-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Description of Fluid Balance in Patients With Acute Respiratory Failure|Description of Fluid Balance in Patients With Acute Respiratory Failure|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Smiths Medical, ASD, Inc.|||1||f||||f||||||||||2017-10-10 23:02:41.561763|2017-10-10 23:02:41.561763
NCT02523859|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-08-01|||July 2015||2015-07-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery|A Randomized, Single-blind, Propofol-controlled Phase III Study Evaluating the Efficacy and Safety of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the Post-anesthesia Care Unit/Intensive Care Unit|Terminated||Phase 3|25|Actual|Paion UK Ltd.||2||Poor recruitment|f||||f||||||||||2017-10-10 23:02:41.67628|2017-10-10 23:02:41.67628
NCT02523846|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-14|||August 2015||2015-08-01|August 2015|2015-08-01||||July 2016|Anticipated|2016-07-01||Interventional|||Patient Re-education vs. Background Morphine to IV-PCA in Patient With Unsatisfactory Analgesia Post Laparotomy|Comparing Effectiveness of Post-operative Analgesia Between Patient Re-education and the Additional of a Basal Morphine Infusion to IV-PCA Morphine in Patients With Unsatisfactory Analgesia After Laparotomy|Unknown status|Recruiting|Phase 4|160|Anticipated|Clinical Research Centre, Malaysia||2|||f||||t||||||||||2017-10-10 23:02:41.760816|2017-10-10 23:02:41.760816
NCT02523833|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2016-10-24|||September 2015||2015-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Small Airway Involvement in Patients With Chronic Hypersensitivity Pneumonitis|Evaluation of Small Airway Involvement in Patients With Chronic Hypersensitivity Pneumonitis and Its Impact on Exercise Limitation|Recruiting||N/A|28|Anticipated|University of Sao Paulo General Hospital||1|||f||||f||||||||||2017-10-10 23:02:41.849633|2017-10-10 23:02:41.849633
NCT02523781|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-12-06|||June 2015||2015-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation of an Information Pamphlet for Postpartum Women That Had a Hypertensive Pregnancy|Evaluation of an Information Pamphlet to Improve Knowledge Concerning the Impacts and the Importance of Healthy Lifestyle After a Pregnancy With Hypertension|Recruiting||N/A|90|Anticipated|Université de Sherbrooke||2|||f||||f||||||||No||2017-10-10 23:02:42.400975|2017-10-10 23:02:42.400975
NCT02523768|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-09-25|||January 2011||2011-01-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PIRAT||Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment|Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment|Active, not recruiting||Phase 4|115|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t|f|f||||||||2017-10-10 23:02:42.556544|2017-10-10 23:02:42.556544
NCT02523755|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-12-05|||September 2015||2015-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia|Evaluation of Regional Distribution of Ventilation in Spontaneous Breathing Patients During Labor With or Without Epidural Analgesia Using EIT (Electrical Impedance Tomography)|Completed||Phase 4|40|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||No||2017-10-10 23:02:42.703429|2017-10-10 23:02:42.703429
NCT02523742|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-13|||November 2005||2005-11-01|August 2015|2015-08-01||||November 2013|Actual|2013-11-01||Interventional|BIP||Study of the Hemispheric Specialization for Language in Subjects With Neuropsychiatric Disorders Compared to Control Subjects||Completed||N/A|152|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:02:42.830593|2017-10-10 23:02:42.830593
NCT02523729|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-08-13|||July 2013||2013-07-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Anke Malz on Women During Lactation|Effects of Anke Malz on Women During Lactation|Completed||N/A|38|Actual|China Medical University Hospital||3|||f||||t||||||||||2017-10-10 23:02:42.913558|2017-10-10 23:02:42.913558
NCT02523716|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-08-13|||May 2015||2015-05-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Effect of Short-term Simulated Altitude Exposure on Cardiopulmonary Functional Capacity|Effect of Short-term Simulated Altitude Exposure on Cardiopulmonary Functional Capacity|Unknown status|Active, not recruiting|N/A|8|Actual|University of Limerick||2|||f||||f||||||||||2017-10-10 23:02:43.010342|2017-10-10 23:02:43.010342
NCT02523703|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-13|||September 2007||2007-09-01|August 2015|2015-08-01||||February 2012|Actual|2012-02-01||Interventional|EXCEED||Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study||Completed||N/A|36|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:02:43.093244|2017-10-10 23:02:43.093244
NCT02523690|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-08-29|||September 2015||2015-09-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|EMILI||Evaluating Muscle Weakness Improvement With Lorcaserin in ICU|Evaluating Lorcaserin Drug Therapy For ICU-Acquired Weakness: A Pilot Randomized Trial|Enrolling by invitation||Phase 1/Phase 2|15|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:02:43.196876|2017-10-10 23:02:43.196876
NCT02523677|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-10-05|||July 2015||2015-07-01|October 2017|2017-10-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|ReFLECT||Relationships Among Cognitive Function, Lifestyle, and Exercise After Cancer Treatment|Relationships Among Cognitive Function, Lifestyle, and Exercise After Cancer Treatment|Completed||N/A|456|Actual|University of Illinois at Urbana-Champaign|||1||f||||f||||||||||2017-10-10 23:02:43.310178|2017-10-10 23:02:43.310178
NCT02523664|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-02-03|||January 2014||2014-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Cort-fMRI||Neural Correlates of Stress Hormones|Why Does Cortisol Enhance Memory Retrieval in Patients With Borderline Personality Disorder and Posttraumatic Stress Disorder? Investigating the Neuronal Correlates of Cortisol Administration and the Effects of Stress Exposure|Recruiting||N/A|75|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:02:43.42492|2017-10-10 23:02:43.42492
NCT02523651|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-08-13|||December 2014||2014-12-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Periodontal Regeneration of Chronic Periodontal Disease Patients Receiving Stem Cells Injection Therapy|Study of Local Periodontal Regeneration of Chronic Periodontal Disease Patients Receiving Allogeneic Human Dental Pulp Stem Cells Injection Therapy|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Capital Medical University||2|||f||||f||||||||||2017-10-10 23:02:43.527836|2017-10-10 23:02:43.527836
NCT02523638|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-02-16|||July 2015||2015-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PEN-PV||Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients|An Open-label, Single Arm, Phase III Study to Assess the Self-administration of AOP2014 Using a Pre-filled Pen, Developed for the Treatment of Polycythemia Vera Patients|Completed||Phase 3|30|Anticipated|AOP Orphan Pharmaceuticals AG||1|||f||||t||||||||||2017-10-10 23:02:43.639729|2017-10-10 23:02:43.639729
NCT02523625|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-12|||October 2015||2015-10-01|August 2015|2015-08-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Observational|GAULT||Giant Cell Arteritis: Improving Use of Ultrasound Evaluation|Can we Use Ultrasound in the Diagnosis and Monitoring of Patients With Giant Cell Arteritis?|Not yet recruiting||N/A|250|Anticipated|University of Oxford|||4||f||||f||||||Samples With DNA|"     Serum Plasma Whole blood   "|||2017-10-10 23:02:43.815257|2017-10-10 23:02:43.815257
NCT02523612|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-31|||June 2015||2015-06-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|NOMAT01||Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions|Prospective National Multicentre Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions|Recruiting||N/A|300|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 23:02:43.916798|2017-10-10 23:02:43.916798
NCT02523599|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-04-28|||August 2015||2015-08-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MATRIX-1||Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty|A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of the XaraColl® Bupivacaine Implant (300 mg Bupivacaine Hydrochloride) After Open Laparotomy Hernioplasty|Completed||Phase 3|305|Actual|Innocoll||2|||f||||f||||||||||2017-10-10 23:02:44.019184|2017-10-10 23:02:44.019184
NCT02523586|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-09-25|||May 2015||2015-05-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of Pharyngeal Oxygen Delivery by Different Oxygen Masks|Comparison of Pharyngeal Oxygen Delivery by Different Oxygen Masks|Completed||N/A|14|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-10-10 23:02:44.21207|2017-10-10 23:02:44.21207
NCT02523573|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-02-25|||November 2011||2011-11-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|Optibal||Study of High Flow Nasal Cannula Oxygen for Bronchoscopy With Bronchoalveolar Lavage in ICU Patients|High Flow Nasal Oxygen for Bronchoscopy With Bronchoalveolar Lavage in Acute Respiratory Failure Patients: the OptiBAL Study.|Completed||N/A|30|Actual|Hôpital Louis Mourier|||1||f||||f||||||||||2017-10-10 23:02:44.320479|2017-10-10 23:02:44.320479
NCT02523560|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-02-29|||June 2015||2015-06-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TELEREH-HF||Applying Telemedicine in a Model of Implementing Cardiac Rehabilitation in Heart Failure Patients|Applying Telemedicine Technologies in a Novel Model of Organizing and Implementing Comprehensive Cardiac Rehabilitation in Heart Failure Patients - TELEREH-HF|Recruiting||N/A|850|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||t||||||||||2017-10-10 23:02:44.437288|2017-10-10 23:02:44.437288
NCT02523547|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2015-08-13|||January 2015||2015-01-01|August 2015|2015-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude|PhaseIVstudy to Evaluate the Non-inferiority of Cavir®Tab. in Terms of Hepatitis B Virus(HBV)DNA Undetectability Comparing Baraclude® Tab. in Hepatitis B e Antigen(HBeAg)(+) Chronic Hepatitis B Patients Treated With Long-term Baraclude® Tab|Unknown status|Recruiting|Phase 4|134|Anticipated|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-10 23:02:44.578517|2017-10-10 23:02:44.578517
NCT02523534|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-09-20|||August 2015||2015-08-01|September 2016|2016-09-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Utilizing a Novel Method to Map Sources of Atrial Fibrillation|Pathophysiological Significance of Atrial Fibrillation Electrogram Patterns|Enrolling by invitation||N/A|50|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-10 23:02:44.706665|2017-10-10 23:02:44.706665
NCT02523521|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2015-08-13|||August 2015||2015-08-01|August 2015|2015-08-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Impact of an Exercise Program for Children Aged 4 to 6 Years With Bronchopulmonary Dysplasia|Impacte d'un Programa d'Exercici Per Nens d'Entre 4 a 6 Anys Amb Displàsia Broncopulmonar|Unknown status|Recruiting|N/A|52|Anticipated|Hospital de Nens de Barcelona||3|||f||||f||||||||||2017-10-10 23:02:44.797336|2017-10-10 23:02:44.797336
NCT02523508|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-13|2016-02-23|||June 2015||2015-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Does Passive Spinal Mobilization Improve Lower Limbs Strength and Function|Does Passive Spinal Mobilization Improve Lower Limbs Strength and Function|Completed||N/A|24|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||No||2017-10-10 23:02:44.88369|2017-10-10 23:02:44.88369
NCT02523495|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-02-17|||June 2012||2012-06-01|February 2016|2016-02-01||||July 2017|Anticipated|2017-07-01|5 Years|Observational [Patient Registry]|||The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer||Recruiting||N/A|120|Anticipated|Huazhong University of Science and Technology|||1||f||||||||||Samples With DNA|"     Whole blood   "|||2017-10-10 23:02:44.965273|2017-10-10 23:02:44.965273
NCT02523482|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-08-12|||June 2014||2014-06-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|PIP in LTC||Potentially Inappropriate Prescribing (PIP) in Long-Term Care (LTC) Patients|Potentially Inappropriate Prescribing (PIP) in Long-Term Care (LTC) Patients: Validation of the 2014 STOPP-START and 2012 Beers Criteria in a LTC Population|Unknown status|Recruiting|N/A|275|Anticipated|Bruyere Research Institute|||1||f||||t||||||||||2017-10-10 23:02:45.050188|2017-10-10 23:02:45.050188
NCT02523469|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-06-15|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase IB/II Study of Nivolumab In Combination With ALT-803 In Patients With Pretreated, Advanced, or Metastatic Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|91|Anticipated|Medical University of South Carolina||3|||f||||t||||||||||2017-10-10 23:02:45.174737|2017-10-10 23:02:45.174737
NCT02523456|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2017-06-05|||May 1, 2015|Actual|2015-05-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|EWS||Develop, Implement and Assess Effectiveness of Early Warning Score (EWS) for Moneragala District General Hospital|Develop, Implement and Assess Effectiveness of Early Warning Score (EWS) for Moneragala District General Hospital|Completed||N/A|18000|Actual|Ministry of Health, Sri Lanka||2|||f||||t||||||||Undecided||2017-10-10 23:02:45.316257|2017-10-10 23:02:45.316257
NCT02523443|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-01-30|||August 2015|Actual|2015-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection|A Prospective Randomized Controlled Clinical Trial of Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Open Liver Resection|Recruiting||Phase 3|240|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:02:45.428142|2017-10-10 23:02:45.428142
NCT02523430|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-07-17|||May 2015||2015-05-01|October 2015|2015-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma|HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma: Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:02:45.556826|2017-10-10 23:02:45.556826
NCT02523417|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-02-23|||May 2015||2015-05-01|October 2015|2015-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer|HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA for Breast Cancer: Clinical Trial|Completed||Phase 1/Phase 2|15|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:02:45.667359|2017-10-10 23:02:45.667359
NCT02523404|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-08-26|||May 2015||2015-05-01|October 2015|2015-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer|HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Cancer: Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:02:45.779242|2017-10-10 23:02:45.779242
NCT02523391|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-01-28|||July 2015||2015-07-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Bioequivalence Study of Capsule and Tablet Formulations of TA-8995|A Phase I, Randomised, Open-label Cross-over Bioequivalence Study of Capsule and Tablet Formulations of TA-8995 in Healthy Male Subjects|Completed||Phase 1|26|Actual|Xention Ltd||2|||f||||f||||||||||2017-10-10 23:02:45.888002|2017-10-10 23:02:45.888002
NCT02523378|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-03-28|||August 13, 2015|Actual|2015-08-13|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion|Edmonton Symptom Assessment Scale: Time Duration of Self-Completion Versus Assisted-Completion in Advanced Cancer Patient: a Randomized Controlled Trial|Active, not recruiting||N/A|138|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:02:46.086772|2017-10-10 23:02:46.086772
NCT02523365|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-08-26|||May 2015||2015-05-01|October 2015|2015-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma|HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma: Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:02:46.230073|2017-10-10 23:02:46.230073
NCT02523352|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-02-08|||June 2016||2016-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Magnetic Resonance Imaging Study in Obese Volunteers|Magnetic Resonance Imaging Study in Obese Volunteers to Evaluate the Effects of Recruitment Maneuver and Titrated Positive End-expiratory Pressure Ventilation on Lung's and Heart's Function and Heart-lung Interaction.|Enrolling by invitation||N/A|12|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:02:46.355655|2017-10-10 23:02:46.355655
NCT02523339|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-05-02|||October 2014||2014-10-01|May 2017|2017-05-01||||December 2017|Anticipated|2017-12-01||Observational|||Study of Retinal Oxygenation in Central Retinal Vein Occlusion|Multicenter Study of Retinal Oxygenation in Central Retinal Vein Occlusion|Recruiting||N/A|150|Anticipated|University of Iceland|||1||f||||||||||||||2017-10-10 23:02:46.491945|2017-10-10 23:02:46.491945
NCT02523326|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-12|||February 2015||2015-02-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|August 2015|Actual|2015-08-01||Observational|DPOGDNAS||Design of a Protocol for Obtaining Genomic DNA From Saliva|Design of a Protocol for Obtaining Genomic DNA From Saliva Using Mouthwash: Samples Taken From Patients With Periodontal Disease|Unknown status|Recruiting|N/A|60|Anticipated|Centro Interdisciplinario de Ciencias de la Salud Unidad Santo Tomás|||3||f||||t||||||Samples With DNA|"     the extraction of high quality genomic DNA from saliva samples obtained with mouthwash.   "|||2017-10-10 23:02:46.663278|2017-10-10 23:02:46.663278
NCT02523313|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-09-12|||July 2015||2015-07-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED|A Phase II Randomized, Double-Blind Trial of Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab Versus Double-Placebo Control as a Post-Surgical/Post-Radiation Treatment for Stage IV Melanoma With No Evidence of Disease|Recruiting||Phase 2|312|Anticipated|University Hospital, Essen||3|||f||||t||||||||No||2017-10-10 23:02:46.781838|2017-10-10 23:02:46.781838
NCT02523300|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-13|||October 2015||2015-10-01|August 2015|2015-08-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Glucocorticoid on the Prognosis of TEVAR|Prognostic Value of Single-dose Glucocorticoid After Endovascular Repair for Aortic Dissection|Not yet recruiting||N/A|240|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-10-10 23:02:46.969342|2017-10-10 23:02:46.969342
NCT02523287|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-06-06|||October 2014||2014-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses|Clinical Study to Generate a Set of Data Characterising Clinical Events, Physiological Responses, and Innate and Adaptive Immune Responses Following a Single IM Immunisation With Fluad Seasonal Influenza Vaccine or Placebo in Healthy Adults|Active, not recruiting||Phase 4|240|Actual|University Hospital, Ghent||4|||f||||f||||||||||2017-10-10 23:02:47.088648|2017-10-10 23:02:47.088648
NCT02523274|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-18|||June 2016||2016-06-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Resveratrol and Exercise to Treat Functional Limitations in Late Life|Resveratrol and Exercise to Treat Functional Limitations in Late Life|Recruiting||Phase 2|60|Anticipated|University of Florida||3|||f||||t|t|f||||||||2017-10-10 23:02:47.223988|2017-10-10 23:02:47.223988
NCT02523261|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-02-08|||October 10, 2015|Actual|2015-10-10|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ASTER||Interest of Direct Aspiration First Pass Technique (ADAPT) for Thrombectomy Revascularisation of Large Vessel Occlusion in Acute Ischaemic Stroke||Active, not recruiting||N/A|381|Actual|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||t||||||||||2017-10-10 23:02:47.341934|2017-10-10 23:02:47.341934
NCT02523248|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-27|||January 2016||2016-01-01|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparison Between UPPP and Tonsillectomy in Adult OSA|Randomized Control Study Between Uvulopalatopharyngoplasty and Tonsillectomy in Adult Sleep Apnea Patients|Recruiting||N/A|100|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-10 23:02:47.463814|2017-10-10 23:02:47.463814
NCT02523235|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2016-10-27|||August 2015||2015-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks|Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks|Recruiting||Phase 4|150|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:02:47.595343|2017-10-10 23:02:47.595343
NCT02523222|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-11-16|||July 2016||2016-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia|Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia|Completed||N/A|600|Anticipated|Baylor University||2|||f||||t||||||||||2017-10-10 23:02:47.705758|2017-10-10 23:02:47.705758
NCT02523209|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-05-29|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|TRANSBONE||Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation|Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation - A Monocentric Study|Completed||N/A|102|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-10 23:02:47.837272|2017-10-10 23:02:47.837272
NCT02523196|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-10-07|||March 2016||2016-03-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)|Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)|Recruiting||Phase 3|110|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:02:47.93252|2017-10-10 23:02:47.93252
NCT02523183|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-06-28|||July 2015||2015-07-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy|The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy|Recruiting||N/A|150|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     Whole blood samples will be collected   "|||2017-10-10 23:02:48.052748|2017-10-10 23:02:48.052748
NCT02523170|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-05-02|||July 2014||2014-07-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|CONCYST||A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas|A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas|Recruiting||N/A|80|Anticipated|University College, London||1|||f||||f||||||||||2017-10-10 23:02:48.155415|2017-10-10 23:02:48.155415
NCT02523157|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-03-03|||August 2015||2015-08-01|August 2015|2015-08-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|WiP||Wellbeing in Pregnancy: Evaluating an Intervention to Improve Women's Emotional Wellbeing in Pregnancy|Wellbeing in Pregnancy: Evaluating an Intervention to Improve Women's Emotional Wellbeing in Pregnancy|Completed||N/A|600|Actual|City, University of London||2|||f||||f||||||||||2017-10-10 23:02:48.304166|2017-10-10 23:02:48.304166
NCT02523144|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-07-28|||September 2014||2014-09-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Dexmedetomidine in Children Having Transthoracic Echocardiography|A Qualitative Comparison of Oral Chloral Hydrate vs 2.0 or 3.0 mcg/kg Nasal Dexmedetomidine in Children Undergoing Transthoracic Echocardiography|Completed||Phase 4|279|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||f||||||||||2017-10-10 23:02:48.437863|2017-10-10 23:02:48.437863
NCT02523131|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2017-03-08|||May 2016||2016-05-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|APCam11||Home Testing of Day and Night Closed Loop With Pump Suspend Feature|An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions|Recruiting||N/A|84|Anticipated|University of Cambridge||2|||||||t||||||||||2017-10-10 23:02:48.613171|2017-10-10 23:02:48.613171
NCT02523118|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-01-20|||July 2015||2015-07-01|January 2017|2017-01-01|January 2051|Anticipated|2051-01-01|December 2050|Anticipated|2050-12-01||Observational|OMEGA||OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages|A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EG) and Colitis (EC)|Recruiting||N/A|1050|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     Biopsies from the gastrointestinal (GI) tract may be collected and used to learn more about     eosinophilic gastrointestinal disorders. Genetic analysis may be performed on some of these     samples.   "|||2017-10-10 23:02:48.775049|2017-10-10 23:02:48.775049
NCT02523105|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-06-15|||September 2015|Actual|2015-09-01|July 2016|2016-07-01|January 5, 2017|Actual|2017-01-05|October 9, 2016|Actual|2016-10-09||Interventional|||Evaluation of Use of Brain Activity Monitoring for Evaluation of Depression Treatment|Evaluation of Use of Brain Activity Monitoring for Early Identification of Pharmaceutical Treatment Efficacy and Development of Depression Deterioration Events.|Completed||N/A|37|Actual|Brainmarc Ltd.||2|||f||||f||||||||||2017-10-10 23:02:48.900908|2017-10-10 23:02:48.900908
NCT02523092|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-10-03|||October 2016||2016-10-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|Acthar||Use of CXCL9 as a Biomarker of Acthar Efficacy|Use of CXCL9 as a Biomarker of Acthar Efficacy|Not yet recruiting||Phase 4|14|Anticipated|University of California, San Francisco||1|||f||||f||||||||No||2017-10-10 23:02:49.008275|2017-10-10 23:02:49.008275
NCT02523079|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-08-16|||January 2015||2015-01-01|July 2016|2016-07-01||||December 2018|Anticipated|2018-12-01||Interventional|CBT-INSOMNIA||Cognitive Behavioral Therapy for Insomnia Among Different Types of Shift Workers|Cognitive Behavioral Therapy for Insomnia Among Different Types of Shift Workers|Recruiting||N/A|120|Anticipated|Finnish Institute of Occupational Health||3|||f||||f||||||||||2017-10-10 23:02:49.117513|2017-10-10 23:02:49.117513
NCT02523066|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-13|||September 2014||2014-09-01|August 2015|2015-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients||Recruiting||N/A|200|Anticipated|Edwards (Shanghai) Lifesciences Medical Supplies Co.,Ltd.|||1||f||||t||||||||||2017-10-10 23:02:49.258112|2017-10-10 23:02:49.258112
NCT02523053|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-10-20|||April 2016||2016-04-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients|A Randomized Controlled Study on the Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Anti-tumor Recurrence in Hepatocellular Carcinoma Patients With High Risk of Microvascular Invasion Presence|Not yet recruiting||N/A|160|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-10 23:02:49.346866|2017-10-10 23:02:49.346866
NCT02523040|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-05-31|||August 2015||2015-08-01|May 2017|2017-05-01|August 2022|Anticipated|2022-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of Lenalidomide for Adult Histiocyte Disorders|A Phase II Study of Lenalidomide for Adult Histiocyte Disorders|Recruiting||Phase 2|12|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:02:49.446453|2017-10-10 23:02:49.446453
NCT02523027|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2016-05-23|||March 2016||2016-03-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Oral Nutritional Supplementation in Picky Eating Children|Oral Nutritional Supplementation in Picky Eating Children|Active, not recruiting||Phase 3|321|Anticipated|Abbott Nutrition||3|||f||||f||||||||No||2017-10-10 23:02:49.535478|2017-10-10 23:02:49.535478
NCT02523014|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-09-29|||August 2015||2015-08-01|September 2017|2017-09-01||||August 2019|Anticipated|2019-08-01||Interventional|||Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas|Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas With SMO/AKT/NF2 Mutations|Recruiting||Phase 2|69|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 23:02:49.762969|2017-10-10 23:02:49.762969
NCT02523001|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-11|||October 2013||2013-10-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|May 2014|Actual|2014-05-01||Observational|uAQP2/01||Effect of Statin Treatment on Urinary AQP2 (uAQP2/01)|Urinary AQP2 Excretion in Hypercholesterolemic Patients as a Measure of Effect of Statin Therapy|Completed||N/A|37|Actual|University of Bari|||4||f||||t||||||Samples Without DNA|"     Blood analyses (serum lipids, creatininemia, glucose, bilirubin) Urines (creatininuria,     urinary AQP2)   "|||2017-10-10 23:02:54.565832|2017-10-10 23:02:54.565832
NCT02522988|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-08-22|||June 2015||2015-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|OLPI||The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors|The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors|Active, not recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||4|||f||||f||||||||||2017-10-10 23:02:54.697155|2017-10-10 23:02:54.697155
NCT02522975|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-10-12|||August 2015||2015-08-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|BEAT_001||Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)|A Prospective, Randomized, Double Blind, Parallel Group Study to Establish the Therapeutic Equivalence of EPIAO® With the Standard Treatment EPREX® in Subjects With Chronic Kidney Disease (CKD) Related Anaemia Not Yet on Dialysis|Recruiting||Phase 4|96|Anticipated|Shenyang Sunshine Pharmaceutical Co., LTD.||2|||f||||t||||||||||2017-10-10 23:02:54.84113|2017-10-10 23:02:54.84113
NCT02522962|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-09-27|||September 2015||2015-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|September 2016|Actual|2016-09-01||Interventional|GroupCoreSIT||Innovative Physiotherapy and Coordination of Care for People With MS: a RCT and a Qualitative Study|Innovative Physiotherapy and Coordination of Care for People With Multiple Sclerosis: a Randomised Controlled Trial and a Qualitative Study|Active, not recruiting||N/A|80|Actual|Nordlandssykehuset HF||2|||f||||f||||||||||2017-10-10 23:02:55.024212|2017-10-10 23:02:55.024212
NCT02522949|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-08-12|||March 2013||2013-03-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|COLDPREV||Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold|Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Induced Rhinovirus Upper Respiratory Tract Infection in Healthy Volunteers. A Double-blind, Randomized, Placebo-controlled Study|Completed||N/A|46|Actual|Enzymatica AB||2|||f||||f||||||||||2017-10-10 23:02:55.189419|2017-10-10 23:02:55.189419
NCT02522936|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-05-03|||August 1, 2017|Anticipated|2017-08-01|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use|Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use|Not yet recruiting||Phase 4|120|Anticipated|University of Southern California||2|||f||||f|f|f||||||Undecided||2017-10-10 23:02:55.289178|2017-10-10 23:02:55.289178
NCT02522910|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-08-09|||August 2015||2015-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 1/Phase 2|0|Actual|Yonsei University||1|||f||||f||||||||||2017-10-10 23:02:55.531357|2017-10-10 23:02:55.531357
NCT02522897|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-11|||August 2015||2015-08-01|August 2015|2015-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PEARL||"Evaluation of the Treat-and-extend Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas"|"Evaluation of the Treat-and-extend Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas"|Not yet recruiting||Phase 4|60|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-10 23:02:55.61937|2017-10-10 23:02:55.61937
NCT02522884|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-05-09|||September 2015||2015-09-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|TOBA II||Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries|Tack Optimized Balloon Angioplasty Study for Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System™|Active, not recruiting||N/A|213|Actual|Intact Vascular||1|||f||||t||||||||||2017-10-10 23:02:55.738349|2017-10-10 23:02:55.738349
NCT02522871|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-02-10|||January 2016||2016-01-01|February 2016|2016-02-01||||October 2016|Anticipated|2016-10-01||Interventional|Liver PROTECT||TransMedics (OCS) Liver Trial: Preserving and Assessing Donor Livers for Transplantation|International Randomized Trial to Evaluate The Effectiveness of The Portable Organ Care System (OCS™) Liver For Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT Trial)|Recruiting||N/A|300|Anticipated|TransMedics||2|||f||||t||||||||||2017-10-10 23:02:55.912875|2017-10-10 23:02:55.912875
NCT02522858|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-01-14|||August 2015||2015-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Anticholinergic Premedication for Sedation With Dexmedetomidine During Spinal Anesthesia||Completed||Phase 4|120|Actual|Inje University||2|||f||||||||||||||2017-10-10 23:02:56.013221|2017-10-10 23:02:56.013221
NCT02522845|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-09-01|||May 2015||2015-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|COMETA||Compression Therapy Following Endothermal Ablation|Multicentre Randomised Controlled Trial of Compression Therapy Following Endothermal Ablation (COMETA)|Recruiting||N/A|180|Anticipated|Imperial College London||2|||f||||||||||||||2017-10-10 23:02:56.094866|2017-10-10 23:02:56.094866
NCT02522832|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-12|||January 2013||2013-01-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge|Discovering New Treatments for Asthma and COPD. The Use of the Human Viral Challenge Model With a Newly Manufactured and Characterised GMP Wild-Type Human Rhinovirus|Completed||N/A|17|Actual|Hvivo||3|||f||||t||||||||||2017-10-10 23:02:56.217132|2017-10-10 23:02:56.217132
NCT02522819|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2015-08-12|||October 2011||2011-10-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Feasibility Evaluation of CPAP in the Treatment of Obstructive Sleep Apnea Synchrone in the Acute Phase of Stroke|Feasibility Evaluation of Continuous Positive Airway Pressure (CPAP) in the Treatment of Obstructive Sleep Apnea Synchrone in the Acute Phase of Stroke|Completed||N/A|13|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:02:56.282209|2017-10-10 23:02:56.282209
NCT02522806|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-09-25|||September 2014||2014-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|BEONE||Endometrial Local Injury Before First IVF : Evaluation of Pregnancy Rate|Endometrial Local Injury Before First IVF : Evaluation of Pregnancy Rate|Recruiting||N/A|428|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 23:02:56.37895|2017-10-10 23:02:56.37895
NCT02522793|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-07-07|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|February 3, 2017|Actual|2017-02-03|February 3, 2017|Actual|2017-02-03||Observational|||Optical Spectroscopy for Cutaneous Cancer|Non-Invasive Optical Spectroscopy for Identification of Cutaneous Cancer|Completed||N/A|20|Actual|Duke University|||1||f||||f||||||||||2017-10-10 23:02:56.478745|2017-10-10 23:02:56.478745
NCT02522780|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-04-21|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 2 g Extended Release Granules (Sachet) for Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis|Recruiting||Phase 3|260|Anticipated|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:02:56.566388|2017-10-10 23:02:56.566388
NCT02522767|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-04-21|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|||Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 4 g Extended Release Granules (Sachet) for the Induction of Clinical and Endoscopic Remission in Active, Mild to Moderate Ulcerative Colitis|Recruiting||Phase 3|220|Anticipated|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:02:56.969293|2017-10-10 23:02:56.969293
NCT02522754|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-12|||January 2002||2002-01-01|August 2015|2015-08-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Development of an Intranasal Proteosome Influenza Vaccine|Study to Determine if Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine is Safe, Immunogenic and Efficacious in the Influenza Human Viral Challenge Model|Completed||Phase 1/Phase 2|174|Actual|Hvivo||4|||f||||t||||||||||2017-10-10 23:02:57.233154|2017-10-10 23:02:57.233154
NCT02522741|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-12-21|||November 2010||2010-11-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safe Mothers, Safe Children Initiative|Safe Mothers, Safe Children Initiative|Withdrawn||N/A|0|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 23:02:57.332491|2017-10-10 23:02:57.332491
NCT02522728|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-09-12|||January 23, 2007|Actual|2007-01-23|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|TriathlonRSA||Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon CR vs. PS|Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon CR vs. PS|Active, not recruiting||N/A|60|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-10-10 23:02:57.41933|2017-10-10 23:02:57.41933
NCT02522715|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-07-12|||June 28, 2015|Actual|2015-06-28|July 2017|2017-07-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer|A Phase I/II Trial of Concurrent Chemohormonal Therapy Using Enzalutamide (MDV-3100) and Cabazitaxel in Patients With Metastatic Castration Resistant Prostate Cancer|Recruiting||Phase 1/Phase 2|39|Anticipated|OHSU Knight Cancer Institute||1|||f||||t|t|f||||||||2017-10-10 23:02:57.510775|2017-10-10 23:02:57.510775
NCT02522702|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-08|2017-04-08|||August 2015||2015-08-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|January 2017|Actual|2017-01-01||Observational|||Computer Assisted Optical Assessment of Small Colorectal Polyps||Active, not recruiting||N/A|250|Anticipated|Technische Universität München|||1||f||||f||||||Samples Without DNA|"     Colonic Polyps   "|||2017-10-10 23:02:57.712047|2017-10-10 23:02:57.712047
NCT02522689|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2017-03-01|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Comparison of Ultra-mini PCNL and Micro PCNL|Comparison of Success Rates, Complication Rates and Injury to Kidneys of Ultra-mini PCNL and Micro PCNL in the Treatment of Kidney Stones|Not yet recruiting||N/A|60|Anticipated|Selcuk University||2|||f||||f|f|f||||||Undecided||2017-10-10 23:02:57.802731|2017-10-10 23:02:57.802731
NCT02522676|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2017-02-27|||September 2017|Anticipated|2017-09-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||Evaluation of Different Treatment Modalities for Lower Pole and Renal Pelvis Stones|Comparison of Success Rates, Complication Rates and Injury to Kidneys of Conventional PCNL, Mini PCNL, Ultra-mini PCNL, Micro PCNL, RIRS and ESWL in the Treatment of Lower Pole and Renal Pelvis Stone(s)|Not yet recruiting||N/A|300|Anticipated|Selcuk University||6|||f||||f|f|f||||||Undecided||2017-10-10 23:02:57.946301|2017-10-10 23:02:57.946301
NCT02522663|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-09-18|||August 20, 2015|Actual|2015-08-20|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|AVRre||The Impact of 24/7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial|The Impact of 24/7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial|Active, not recruiting||N/A|288|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:02:58.098909|2017-10-10 23:02:58.098909
NCT02522637|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-02-27|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Exercise Training in Severe COPD|What is the Best Frequency of Exercise Training in Severe COPD?|Recruiting||N/A|118|Anticipated|Fondazione Salvatore Maugeri||2|||f||||f||||||||Yes|Publication|2017-10-10 23:02:58.38595|2017-10-10 23:02:58.38595
NCT02522624|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-14|2016-08-25||September 2015||2015-09-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Supporting Decisions About Health Insurance to Improve Care for the Uninsured|Supporting Decisions About Health Insurance to Improve Care for the Uninsured|Completed||N/A|328|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 23:02:58.583817|2017-10-10 23:02:58.583817
NCT02522611|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-12|2017-06-30|||August 6, 2015||2015-08-06|June 2, 2017|2017-06-02|February 1, 2018|Anticipated|2018-02-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain|A Multicenter, Open-Label, Phase 1b Safety and Efficacy Trial of Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-Induced Bone Pain|Suspended||Phase 1/Phase 2|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:02:59.824069|2017-10-10 23:02:59.824069
NCT02522598|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-09-28|||August 2015||2015-08-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Laparoscopic-assisted Gastrectomy in Early Gastric Cancer Patients|Completed||Phase 2|38|Actual|Vivozon, Inc.||2|||f||||f||||||||||2017-10-10 23:02:59.929359|2017-10-10 23:02:59.929359
NCT02522585|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-04-19|||December 2011||2011-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|||p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management|Predictive Value of p16 and Ki-67 Immunohistochemical Staining and NK Cells in Expectant Management of Cervical Intraepithelial Neoplasia Grade 2|Completed||N/A|100|Actual|Parc de Salut Mar|||1||f||||t||||||Samples With DNA|"     Citologies and biopsies of the cervix. Blood cells.   "|||2017-10-10 23:03:00.03223|2017-10-10 23:03:00.03223
NCT02522572|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-24|||August 2015||2015-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Quantitating the Impact of Plerixafor|Quantitating the Impact of Plerixafor Alone or in Combination With Bortezomib on Plasma Cell Mobilization and the Subsequent Impact on HLA Antibody Levels|Recruiting||Phase 1/Phase 2|12|Anticipated|University of Cincinnati||3|||f||||t||||||||||2017-10-10 23:03:00.127673|2017-10-10 23:03:00.127673
NCT02522559|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-05-16|||April 2015||2015-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Using Herbs and Spices to Increase Children's Acceptance and Intake of Vegetables in School Lunches|Using Herbs and Spices to Increase Children's Acceptance and Intake of Vegetables in School Lunches|Recruiting||N/A|170|Anticipated|Penn State University||1|||f||||f||||||||||2017-10-10 23:03:00.324599|2017-10-10 23:03:00.324599
NCT02522546|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-08-23|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PIN||A Study to Assess the Carriage of Pneumococci in Children Aged 1-5 Years, and Their Household Contacts|A Study to Assess the Carriage of Pneumococci in Children Aged 1-5 Years, and Their Household Contacts|Completed||N/A|400|Actual|Public Health England|||1||f||||f||||||Samples Without DNA|"     Nasal swabs   "|||2017-10-10 23:03:01.262153|2017-10-10 23:03:01.262153
NCT02522533|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-05-10|||July 2015||2015-07-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Intervention for Pre-Frailty and Frailty in Thoracic Surgery Patients|Intervention for Pre-Frailty and Frailty in Thoracic Surgery Patients|Recruiting||N/A|105|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 23:03:01.402579|2017-10-10 23:03:01.402579
NCT02522520|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-04-26|||June 2015||2015-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pedometer Intervention and Health Effects for Sedentary Colorectal Cancer Patients During Adjuvant Chemotherapy|Pedometer Intervention, Health Counseling, Symptom Management for Sedentary Colorectal Cancer Patients During Adjuvant Chemotherapy.Two-armed Randomized Phase II Trial|Recruiting||N/A|48|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||No|Presently no plan to make IPD available to other researchers|2017-10-10 23:03:01.513488|2017-10-10 23:03:01.513488
NCT02522507|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-01-30|||January 2016||2016-01-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||A Peer E-mentoring Intervention to Improve Employment|A Peer E-mentoring Intervention to Improve Transition to Employment for Youth With Physical Disabilities|Recruiting||N/A|160|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:03:01.658575|2017-10-10 23:03:01.658575
NCT02522494|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-05-31|||July 1, 2016|Actual|2016-07-01|May 2017|2017-05-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|TELEHEALTH||Encouraging Patient-Centered Communication in Clinical Video Telehealth Visits|Encouraging Patient-Centered Communication in Clinical Video Telehealth Visits|Recruiting||N/A|470|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 23:03:01.831859|2017-10-10 23:03:01.831859
NCT02522481|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-07-11|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|May 31, 2017|Actual|2017-05-31||Interventional|||Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141|A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease|Active, not recruiting||Phase 3|175|Actual|Bracco Diagnostics, Inc||1|||f||||f||||||||||2017-10-10 23:03:01.982026|2017-10-10 23:03:01.982026
NCT02518763|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-06|||June 2011||2011-06-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|VITAD||Vitamin D Supplementation in Postmenopausal Women With Osteoporosis: Proposal of a Therapeutic Regimen in Practice||Unknown status|Active, not recruiting|Phase 3|120|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:41.963251|2017-10-10 23:03:41.963251
NCT02522468|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-06-26|||July 2015||2015-07-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|BCS-RSL-001||A Trial of RSL Versus WL for Malignant Breast Disease|A Randomized Single-Center Superiority Trial of Radioactive Seed Localization Versus Needle Localization for Malignant Breast Disease.|Recruiting||N/A|400|Anticipated|Carolinas Healthcare System||2|||f||||t||||||||||2017-10-10 23:03:02.107206|2017-10-10 23:03:02.107206
NCT02522455|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2017-02-11|||September 2015||2015-09-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|FLIPI||Flow-cycled Ventilation in Preterm Infants|Flow-cycled Ventilation in Preterm Infants (FLIPI): A Pilot Study Looking at the Tolerance of Flow-cycled Ventilation by Preterm Infants With Respiratory Distress Syndrome|Completed||N/A|6|Actual|Central Manchester University Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 23:03:02.231554|2017-10-10 23:03:02.231554
NCT02522442|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-08-12|||August 2007||2007-08-01|August 2015|2015-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|BiPAPRescue||Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)|Phase IV Study of Bi-Level Positive Positive Airway Pressure (BiPAP)Compared to Nasal Continuous Positive Airway Pressure (CPAP) Therapy|Completed||Phase 4|51|Actual|Philips Respironics||2|||f||||f||||||||||2017-10-10 23:03:02.393897|2017-10-10 23:03:02.393897
NCT02522429|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-04-21|||July 2015||2015-07-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|LIFUP||Thalamic Low Intensity Focused Ultrasound in Acute Brain Injury|Thalamic Low Intensity Focused Ultrasound Stimulation in Disorders of Consciousness Following Acute Severe Brain Injury|Recruiting||N/A|15|Anticipated|University of California, Los Angeles||1|||f||||t||||||||||2017-10-10 23:03:02.557632|2017-10-10 23:03:02.557632
NCT02522416|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-03-17|||November 30, 2015|Actual|2015-11-30|March 2017|2017-03-01|March 15, 2017|Actual|2017-03-15|January 30, 2017|Actual|2017-01-30||Observational|CECOT||A Comparison of Two Devices for Measuring the Central Thickness of the Cornea Before and After Surgery (CECOT)||Completed||N/A|50|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 23:03:02.678512|2017-10-10 23:03:02.678512
NCT02522390|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-04-24|||January 2015||2015-01-01|April 2017|2017-04-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|NRC250||The Nutrition Researcher Cohort 2014 Study|The Nutrition Researcher Cohort 2014 Study; New Standardized Self-quantification Methodologies Serving Both Research and Personal Health Maintenance|Active, not recruiting||N/A|192|Actual|TNO|||1||f||||f|f|f||||Samples With DNA|"     do-it-yourself, at-home measurements of blood glucose and blood cholesterol.      In addition, the plasma metabolome and selected biomarkers (from dried blood spot), urinary     metabolome (from collected urine), DNA damage (from dried blood spots, telomere length and     mitochondrial DNA deletions, DNA base damage/oxidation, gamma H2AX DNA strand break assay),     micronutrient analysis (from dried blood spot or capillary blood collection) and microbiome     (sequencing metagenomics/Fecal Swabs) will be offered to participants as additional     measurements, if funding or in-kind sponsoring is available.      Funding is already available for:        -  Dried blood spot collection for analysis of biomarkers (including fatty acids, vitamins,          amino acids) and metabolomics;        -  Faecal collection (swab) for metagenome analysis        -  Capillary blood collection for CRP, HbA1c and other parameters        -  OGTT sampling kit for analysis of insulin and c-peptide;   "|Yes|"An internal review board, consisting of Principal Investigators from all participating countries, will review all data requests.
A data request format is available that should be used for filing such a request. The format requires stating the research questions that should be answered with the requested data, type of data, populations requirements (exclusion criteria), data analysis and public disclosure.
All study participants have the ability to withdraw their data from use for answering specific research questions at any time."|2017-10-10 23:03:02.923274|2017-10-10 23:03:02.923274
NCT02522377|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-03-17|||August 2015||2015-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression|Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients With Treatment Resistant Depression: A Double Blind Placebo Controlled Trial|Recruiting||N/A|10|Anticipated|The Cleveland Clinic||2|||f||||f||||||||Undecided||2017-10-10 23:03:03.199854|2017-10-10 23:03:03.199854
NCT02522364|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-10|||August 2015||2015-08-01|August 2015|2015-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|POAF-ILR||Subclinical Postoperative Atrial Fibrillation|Subclinical Postoperative Atrial Fibrillation|Not yet recruiting||N/A|150|Anticipated|Sheba Medical Center||2|||f||||t||||||||||2017-10-10 23:03:03.38266|2017-10-10 23:03:03.38266
NCT02522351|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-10-04|||June 2015|Actual|2015-06-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|June 2017|Actual|2017-06-01||Interventional|||Reduction of Aspiration Through Cohesive Thin Liquids (CTL) in Patients With Mild Oropharyngeal Dysphagia|Reduction of Aspiration Through Cohesive Thin Liquids (CTL) in Patients With Mild Oropharyngeal Dysphagia Due to Ischemic/Hemorrhagic Cerebral Cause (Stroke)|Completed||N/A|35|Actual|Nestlé||6|||f||||f||||||||||2017-10-10 23:03:03.532671|2017-10-10 23:03:03.532671
NCT02522338|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-03-09|||February 2011||2011-02-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|HIVOL||Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance|Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance|Completed||Phase 4|300|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:03:03.699485|2017-10-10 23:03:03.699485
NCT02522325|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-09-26|||August 2015||2015-08-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|BED IN 31||Reinforcing Effects of Cocaine During Phendimetrazine Maintenance|Behavioral Effects of Drugs (Inpatient): 31 (Cocaine and Phendimetrazine)|Recruiting||Phase 1|36|Anticipated|University of Kentucky||2|||f||||f||||||||||2017-10-10 23:03:03.792208|2017-10-10 23:03:03.792208
NCT02522312|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-03-01|||September 2015||2015-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients|A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients|Completed||N/A|102|Actual|Hazleton Eye Specialists|||1||f||||f||||||||||2017-10-10 23:03:03.911148|2017-10-10 23:03:03.911148
NCT02522299|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-04-03|||November 1, 2015||2015-11-01|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 1, 2018|Anticipated|2018-04-01||Interventional|||A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation|A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 for 12 Weeks in Adult Subjects Diagnosed With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Recruiting||Phase 2|35|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:03:03.995602|2017-10-10 23:03:03.995602
NCT02522273|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-10|||October 2015||2015-10-01|August 2015|2015-08-01||||March 2016|Anticipated|2016-03-01||Observational|||Evaluation of the 'SensPoint' Lactate Meter in the Estimation of Foetal Scalp Blood and Umbilical Cord Blood Lactate|Evaluation of the 'SensPoint' Lactate Meter Validation of a Hand-Held Lactate Measuring System 'SensPoint' in the Estimation of Foetal Scalp Blood and Umbilical Cord Blood Lactate|Unknown status|Not yet recruiting|N/A|180|Anticipated|North Bristol NHS Trust|||1||f||||f||||||||||2017-10-10 23:03:04.229272|2017-10-10 23:03:04.229272
NCT02522260|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-08-16|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|November 2016|Actual|2016-11-01||Interventional|OptiTrain||OptiTrain - Optimal Training Women With Breast Cancer|OptiTrain - Optimal Training for Women With Breast Cancer During Chemotherapy Treatment|Active, not recruiting||N/A|240|Actual|Karolinska Institutet||3|||f||||t||||||||||2017-10-10 23:03:04.350328|2017-10-10 23:03:04.350328
NCT02522247|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-07-27||||||July 2017|2017-07-01||||February 2022|Anticipated|2022-02-01||Interventional|||RCT Between UPP and Controls in Adult OSA|Randomized Control Trial Between Uvulopalatoplasty and Delayed Surgery (Controls)|Withdrawn||N/A|0|Actual|Karolinska University Hospital||2||No patients have been enrolled, maybe in the future the study will start up again|f||||f||||||||||2017-10-10 23:03:04.483372|2017-10-10 23:03:04.483372
NCT02522234|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-10|||March 2014||2014-03-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy|A Phase Ib Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of F-627 as Prophylaxis Therapy to TAC Chemotherapy in Women With Breast Cancer|Unknown status|Recruiting|Phase 1/Phase 2|12|Anticipated|Generon (Shanghai) Corporation Ltd.||2|||f||||f||||||||||2017-10-10 23:03:04.591939|2017-10-10 23:03:04.591939
NCT02522221|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-06-23|||December 2016||2016-12-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TACT||Tecarfarin Anti-Coagulation Trial (TACT)|"A Real-World, Randomized, Open-Label, Study on the Efficacy, Safety, and Tolerability of Tecarfarin (ATI-5923) a Novel Vitamin K Antagonist, Versus Warfarin in Subjects Requiring Chronic Anticoagulation"|Not yet recruiting||Phase 3|3000|Anticipated|Armetheon Inc||2|||f||||t||||||||||2017-10-10 23:03:04.707666|2017-10-10 23:03:04.707666
NCT02522208|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-11-07|||September 2015||2015-09-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets|Randomized, Open-Label, Daily Dose, 2-sequence, 2-way Crossover Pharmacodynamic and Pharmacokinetic Study of BiDil XR Capsules and Commercial BiDil Tablets in Self-identified Black Patients, Who Are Slow Acetylators, With Heart Failure|Completed||Phase 1|12|Actual|Arbor Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 23:03:04.810985|2017-10-10 23:03:04.810985
NCT02522195|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-10|||November 2011||2011-11-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Observational|||Meal Distribution Across the Day in Female Nurses Working Shifts|Meal Distribution Across the Day in Female Nurses Working Shifts and Their Relationship With Nutritional Status|Completed||N/A|221|Actual|Federal University of Uberlandia|||1||f||||t||||||||||2017-10-10 23:03:04.913751|2017-10-10 23:03:04.913751
NCT02522182|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-02-05|||November 2013||2013-11-01|February 2016|2016-02-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|ALLEPRE||ALLiance for sEcondary PREvention After an Episode of Acute Coronary Syndrome (ALLEPRE)|ALLiance for sEcondary PREvention After an Episode of Acute Coronary Syndrome. The ALLEPRE Trial: a Fully Nurse-led Intensive Intervention Programme|Recruiting||N/A|2060|Anticipated|Azienda Ospedaliero-Universitaria di Parma||2|||f||||f||||||||||2017-10-10 23:03:04.988933|2017-10-10 23:03:04.988933
NCT02522169|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-08-12|||September 2015||2015-09-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TOPIT||TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease|Verbessertes Therapiemanagement für pädiatrische CED-Patienten Mit Chronisch-entzündlicher Darmerkrankung: Eine Randomisierte Multizentrische Studie, Welche Die Effektivität Einer Talspiegel-gesteuerten Infliximab-Erhaltungsphase Mit Dem herkömmlichen Dosierungsregime Vergleicht Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Randomized Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease|Unknown status|Not yet recruiting|N/A|120|Anticipated|Klinikum Westbrandenburg GmbH||2|||f||||f||||||||||2017-10-10 23:03:05.146048|2017-10-10 23:03:05.146048
NCT02522156|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-06-26|||February 2016||2016-02-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Looming Vulnerability and Smoking Cessation Attempts|Looming Vulnerability and Smoking Cessation Attempts|Recruiting||N/A|290|Anticipated|American University||2|||f||||f||||||||||2017-10-10 23:03:05.246991|2017-10-10 23:03:05.246991
NCT02522143|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-06-16|||February 2014||2014-02-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||College Students Who Self-Harm|College Students Who Self-Harm: An Intervention Study|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||No funding|f||||f||||||||||2017-10-10 23:03:05.327264|2017-10-10 23:03:05.327264
NCT02495363|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-01-08|||March 2015||2015-03-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Analgesic Effects of Ultrasound Guided PEC Blocks on Analgesic Opioid Consumption of Cancer Surgery Patients||Recruiting||Phase 4|100|Anticipated|Rabin Medical Center|||1||f||||f||||||||||2017-10-10 23:08:25.134309|2017-10-10 23:08:25.134309
NCT02522130|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-06-21|||July 2015||2015-07-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Different Analgesics Prior to Intrauterine Device (IUD) Insertion: Is There Any Evidence?|Different Analgesics Prior to IUD Insertion: Is There Any Evidence?|Recruiting||N/A|200|Anticipated|Al Hayat National Hospital||4|||f||||t||||||||||2017-10-10 23:03:05.425811|2017-10-10 23:03:05.425811
NCT02522117|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-08-12|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Interventional|ATORV15||Atorvastatin in the Recipient's Kidney Graft From a Living Donor|Effectiveness of Atorvastatin on IL2, IL6, TNFalpha and HLA Levels in the Recipient's Kidney Graft From a Living Donor|Unknown status|Active, not recruiting|Phase 3|48|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-10 23:03:05.558111|2017-10-10 23:03:05.558111
NCT02522104|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-01-23|||September 3, 2015|Actual|2015-09-03|January 2017|2017-01-01|November 28, 2016|Actual|2016-11-28|November 2016|Actual|2016-11-01||Interventional|||Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)|Evaluation of the Impact of Renal Function on the Pharmacokinetics of Hydroxyurea (SIKLOS ®) in Normal-renal Function, Hyperfiltrating and Renal Failure Sickle Cell Disease Patients (DARH)|Completed||Phase 4|40|Actual|ADDMEDICA SASA||3|||f||||f||||||||||2017-10-10 23:03:05.643467|2017-10-10 23:03:05.643467
NCT02522091|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-11|||November 2010||2010-11-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|IMPRO||Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRI||Unknown status|Recruiting|N/A|178|Anticipated|University Hospital, Caen||5|||f||||f||||||||||2017-10-10 23:03:05.814669|2017-10-10 23:03:05.814669
NCT02522078|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-03-24|||August 2015||2015-08-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|MisoWet||Dry vs Wet Misoprostol for Cervical Dilation in First Trimester Abortion|Dry vs Wet Misoprostol for Cervical Dilation in First Trimester Abortion - A Clinical Trial|Completed||Phase 4|46|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 23:03:06.024762|2017-10-10 23:03:06.024762
NCT02522065|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-02-13|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|neuroQWERTY||neuroQWERTY: a Transparent Patient-centered Outcome Method to Quantify Parkinsonian Motor Signs for Drug Trials|Motor Response to Dopaminergic Therapy in a Population of de Novo Parkinson's Disease Cases Quantified Via Typing Analyses - -neuroQWERTY|Completed||N/A|60|Actual|Fundación de investigación HM|||2||f||||f||||||||||2017-10-10 23:03:06.150934|2017-10-10 23:03:06.150934
NCT02522052|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-08-14|||August 2015||2015-08-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|MIRA||Mussels, Inflammation and Rheumatoid Arthritis (MIRA)|Mussels, Inflammation and Rheumatoid Arthritis (MIRA)|Completed||N/A|23|Actual|Göteborg University||2|||f||||f||||||||||2017-10-10 23:03:06.321778|2017-10-10 23:03:06.321778
NCT02522039|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-08-11|||May 2014||2014-05-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|pupil||Pupillary Response After Glaucoma Medication|Effect of Topical Anti-glaucoma Medications on Late Pupillary Light Reflex, as Evaluated by Pupillometry|Completed||N/A|21|Actual|Glostrup University Hospital, Copenhagen||4|||f||||f||||||||||2017-10-10 23:03:06.494119|2017-10-10 23:03:06.494119
NCT02522026|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-03-07|||August 2015||2015-08-01|March 2017|2017-03-01||||March 2017|Anticipated|2017-03-01||Observational|Ribo2||Follow-up-study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers|"Follow-up-study of Participants (COPD Patients and Healthy Control Subjects) From the Cross-sectional Study 11-03 Ribolution for the Evaluation of Predictive Biomarkers Based on Non-coding RNA"|Enrolling by invitation||N/A|100|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine|||5||f||||f||||||Samples With DNA|"     blood, sputum   "|||2017-10-10 23:03:06.645317|2017-10-10 23:03:06.645317
NCT02522013|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-08|2016-10-27|||October 2015||2015-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Aminophylline for Patients With Post-Dural Puncture Headache|Aminophylline for Patients With Post-Dural Puncture Headache: a Prospective, Multi-center, Randomized Controlled Trial|Completed||Phase 3|126|Actual|The First Affiliated Hospital of Zhengzhou University||2|||f||||t||||||||||2017-10-10 23:03:06.799699|2017-10-10 23:03:06.799699
NCT02522000|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-12|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Functional Dyspepsia and Symptom Perception|Symptom Perception in Patients With Functional Dyspepsia: Involvement of the TRPV-1 Neuropeptide Pathway|Unknown status|Recruiting|N/A|70|Anticipated|Maastricht University Medical Center|||2||f||||t||||||||||2017-10-10 23:03:06.95583|2017-10-10 23:03:06.95583
NCT02521987|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-07-27|||August 1, 2015|Actual|2015-08-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Port Size and Post-Operative Pain Perception by Patients|Port Size and Post-Operative Pain Perception by Patients|Recruiting||N/A|100|Anticipated|Loyola University||2|||f||||t||||||||||2017-10-10 23:03:07.097568|2017-10-10 23:03:07.097568
NCT02521974|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-07-10|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|September 29, 2016|Actual|2016-09-29|July 2016|Actual|2016-07-01||Interventional|M2-ABMG||A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children|A Phase 4 Study to Evaluate the Safety and Immunogenicity of Monovalent Oral Polio Vaccine Type 2 in Healthy Children Aged 1 to 5 Years and in bOPV-IPV Vaccinated Healthy Infants|Completed||Phase 4|164|Actual|Fidec Corporation||1|||f||||t||||||||||2017-10-10 23:03:07.210999|2017-10-10 23:03:07.210999
NCT02521961|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-02-07|||February 2016||2016-02-01|February 2017|2017-02-01||||October 2017|Anticipated|2017-10-01||Interventional|||Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors|Developing an Intervention to Reduce Stress and Improve Quality of Life in Underserved Urban Latina Breast Cancer Survivors|Recruiting||N/A|50|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-10 23:03:07.304962|2017-10-10 23:03:07.304962
NCT01949766|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2013-09-20||||||September 2013|2013-09-01||||||||Expanded Access|||Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease|Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease|No longer available||N/A|||University of Pittsburgh|||||||||||||||||||2017-10-11 01:16:08.770069|2017-10-11 01:16:08.770069
NCT02521935|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-04-25|||January 2017||2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Conventionally vs. Digitally Fabricated Complete Dentures: Clinical Treatment Outcome Differences|Conventionally vs. Digitally Fabricated Complete Dentures: Clinical Treatment Outcome Differences|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||2||The PI is deceased, decision was made to withdraw.|f||||f||||||||No||2017-10-10 23:03:07.569798|2017-10-10 23:03:07.569798
NCT02521922|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-03-31|||April 16, 2014||2014-04-16|March 2017|2017-03-01|April 1, 2017|Actual|2017-04-01|June 9, 2016|Actual|2016-06-09||Interventional|VSP||Vital Signs Patch Early Feasibility and Usability Study|Feasibility Study for Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting|Completed||N/A|72|Actual|LifeWatch Services, Inc.||1|||f||||f|f|t|f|f|f|||||2017-10-10 23:03:07.689311|2017-10-10 23:03:07.689311
NCT02521909|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-06-21|||September 2015||2015-09-01|June 2017|2017-06-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Observational|||Accuracy of Electronic Apex Locators ProMark, RootZX II and NRG Rider on Working Length of Multi-rooted Teeth|An in Vivo Evaluation of the ProMark, Root ZX II, and NRG Rider Electronic Apex Locators on the Accuracy of Working Length of Molars|Completed||N/A|20|Actual|University of Michigan|||1||f||||f||||||||No||2017-10-10 23:03:07.7853|2017-10-10 23:03:07.7853
NCT02521896|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-10|||August 2014||2014-08-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Performance Study to Evaluate Access to Pulmonary Veins for Treatment of Paroxysmal AF|Vado™ Steerable Sheath System; A Safety and Performance Study to Evaluate Access to the Pulmonary Veins in the Treatment of Paroxysmal and Persistent Atrial Fibrillation|Completed||N/A|8|Actual|Kalila Medical||1|||f||||f||||||||||2017-10-10 23:03:07.908769|2017-10-10 23:03:07.908769
NCT02521883|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-04-25|||March 2015||2015-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) as an add-on Therapy for Treatment of Major Depressive Disorder. (DEPTDCS2014)||Recruiting||Phase 2/Phase 3|120|Anticipated|Turku University Hospital||2|||f||||t||||||||||2017-10-10 23:03:07.990524|2017-10-10 23:03:07.990524
NCT02521870|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-04-07|||September 2015||2015-09-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma|A Phase 1b/2, Open-label, Multicenter, Dose-escalation and Expansion Trial of Intratumoral SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|156|Anticipated|Dynavax Technologies Corporation||5|||f||||t||||||||Yes|Data will be shared under guidance of the New Rule - FDAAA 801 eff. Jan 2017. 3/2017 - additional changes forthcoming.|2017-10-10 23:03:08.108672|2017-10-10 23:03:08.108672
NCT02521857|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-11-09|||July 2015||2015-07-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Water Consumption Study of ALKS 5461 in Healthy Volunteers|A Phase 1 Study to Evaluate the Impact of Water Consumption on the Pharmacokinetics of Sublingually Administered ALKS 5461|Completed||Phase 1|30|Actual|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 23:03:08.325774|2017-10-10 23:03:08.325774
NCT02521844|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-06-22|||October 2015||2015-10-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study to Evaluate the Safety and Tolerability of ETC-1922159 in Advanced Solid Tumours|A Phase 1A/B Study to Evaluate the Safety and Tolerability of ETC-1922159 in Advanced Solid Tumours|Recruiting||Phase 1|65|Anticipated|D3 (Drug Discovery and Development), Biomedical Sciences Institute||1|||f||||f||||||||||2017-10-10 23:03:08.403077|2017-10-10 23:03:08.403077
NCT02521831|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-10-10|||October 2015||2015-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neuroinflammatory and Neurocognitive Effects of Spinal vs. Inhalational Anesthesia for Elective Surgery in Infants|Neuroinflammatory and Neurocognitive Effects of Spinal vs. Inhalational Anesthesia for Elective Surgery in Infants: A Randomized, Controlled, Double-Blinded Study|Enrolling by invitation||Phase 3|100|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-10 23:03:08.525881|2017-10-10 23:03:08.525881
NCT02521818|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-08-29|||August 2015||2015-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Dietary Treatments for Cognitive Impairment in Older Adults|Feasibility and Efficacy of Dietary Interventions for Cognitive Impairment in Older Adults|Recruiting||N/A|50|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:03:08.596799|2017-10-10 23:03:08.596799
NCT02521805|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-04-29|||August 2015||2015-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SAPO||Enhanced Satiety With Pork Products Containing Dietary Fibre|Enhanced Satiety With Pork Products Containing Dietary Fibre|Completed||N/A|42|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-10 23:03:08.692302|2017-10-10 23:03:08.692302
NCT02521792|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-11-14|||January 2016||2016-01-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects|A Phase 2, In-Home, Safety and Efficacy Evaluation of Episodic Administration of Open-Label Palovarotene in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)|Suspended||Phase 2|40|Anticipated|Clementia Pharmaceuticals Inc.||1||Subjects were enrolled into a different Phase 2 study (PVO-1A-202, NCT02279095).|f||||f||||||||||2017-10-10 23:03:08.7918|2017-10-10 23:03:08.7918
NCT02521779|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-10|||April 2014||2014-04-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|||The Role of Dietary Fat on Postprandial Endotoxemia in Healthy Adults|Dietary Fat Affects Postprandial Serum Endotoxin Concentration in Healthy Adults|Completed||N/A|20|Actual|Iowa State University||4|||f||||f||||||||||2017-10-10 23:03:08.898639|2017-10-10 23:03:08.898639
NCT02521766|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-03-14|||September 1, 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:03:08.976982|2017-10-10 23:03:08.976982
NCT02521610|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-11-01|||August 2015||2015-08-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Multiple Ascending-Dose Study of RG7625 in Healthy Volunteers|A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Healthy Subjects|Completed||Phase 1|33|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:03:12.182462|2017-10-10 23:03:12.182462
NCT02521753|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-01-30|||August 2015||2015-08-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|OMgObPCOS||Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients|Effect Polyunsaturated Fatty Acids or Magnesium in Metabolic, Hormonal, and Inflammatory Profile in Obese Women With Polycystic Ovary Syndrome. A Randomized Clinical Trial|Recruiting||N/A|123|Anticipated|Coordinación de Investigación en Salud, Mexico||3|||f||||f||||||||No|There is not a plan to share data|2017-10-10 23:03:09.017754|2017-10-10 23:03:09.017754
NCT02521740|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-08-10|||March 2015||2015-03-01|August 2015|2015-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||CAREGIVER2, Caregiver's Health Assessment : Clinical and Biological Markers|Soutien Des Soins Informels Aux Personnes âgées Fragiles : Accompagnement Des Aidants Sur Base d'Une évaluation Clinique et Biologique de la Charge de Soins.|Unknown status|Recruiting|N/A|150|Anticipated|Centre Hospitalier Universitaire Dinant Godinne - UCL Namur|||2||f||||f||||||Samples With DNA|"     Blood samples taken between 8 and 11 am. Blood parameters including cell counts and assays of     acute phase proteins (C-reactive protein (CRP), albumin, pre-albumin) are determined     according to the routine of the hospital.      PBMC are isolated by centrifugation in a Lympho-Ficoll gradient by the biobank of CHU Dinant     Godinne.      Collected plasma is stored at −80 °C until analysis. The amounts of insulin-like growth     factor-1 (IGF-1), interleukin-6 (IL-6) are essayed by enzyme-linked immunosorbent assay     (ELISA).      PBMC are sent to Liege (GIGAI3) and Namur (URBC) for respectively ADN and ARN analyses.      ADN analyses concerned the immunity markers and ARN analyses concerned the transcriptomics     and epigenetic markers.      The biobank of the CHU Dinant-Godinne meets the requirements of the quality book developed by     the biobanks of Walonnie-Bruxelles (BWB).   "|||2017-10-10 23:03:09.143764|2017-10-10 23:03:09.143764
NCT02521727|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-04-23|||November 2015||2015-11-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|NonAA||To Investigate Risk of Colorectal Neoplasms in First-degree Relatives of Patients With Non-advanced Adenomas|A Prospective Colonoscopic Study to Investigate Risk of Colorectal Neoplasms in First-degree Relatives of Patients With Non-advanced Adenomas (NonAA Study)|Recruiting||N/A|828|Anticipated|Chinese University of Hong Kong|||2||f||||t||||||Samples With DNA|"     stool, colonic mucosa   "|No||2017-10-10 23:03:09.240814|2017-10-10 23:03:09.240814
NCT02521714|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2016-03-29|||August 2015||2015-08-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension|A Phase 1, Open-label, Randomized, Three-period, Two-way Crossover Study in Healthy Subjects to Evaluate the Bioavailability of a Test Lenalidomide Oral Suspension Relative to the Reference Capsule Formulation and to Assess the Effect of Food on the Bioavailability of Lenalidomide From the Oral Suspension|Completed||Phase 1|28|Anticipated|Celgene Corporation||3|||f||||f||||||||||2017-10-10 23:03:09.324929|2017-10-10 23:03:09.324929
NCT02521701|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-08-10|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|CESTO||Safety and Efficacity of NFL101 as Tobacco Therapy|Phase I Study Assessing Safety and Efficacity of NFL101 as Tobacco Therapy(CESTO)|Completed||Phase 1|24|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-10 23:03:09.440768|2017-10-10 23:03:09.440768
NCT02521688|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2015-08-11|||August 2013||2013-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|||Inflammatory Cytokines in GCF and Placental Tissues in Chronic Periodontitis Patients With Preterm Delivery|Inflammatory Cytokines in Gingival Crevicular Fluid and Placental Tissues in Chronic Periodontitis Patients With Preterm Delivery|Completed||N/A|40|Actual|Ain Shams University|||4||f||||t||||||Samples Without DNA|"     Placental tissue Gingival clevicular fluid from deepest pocket   "|||2017-10-10 23:03:09.530975|2017-10-10 23:03:09.530975
NCT02521675|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2016-07-25|||January 2016||2016-01-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|Diabrasport2||Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions|Multicentre Randomized Cross-over Study Assessing in Type 1 Diabetic Patients With Pump Insulin the Non-inferiority of Glycemic Control Obtained With the Algorithms Tested in DIABRASPORT Versus the Rest Period Without Physical Activity|Recruiting||N/A|100|Anticipated|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||||2017-10-10 23:03:09.625088|2017-10-10 23:03:09.625088
NCT02521662|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2017-02-16|||March 2016|Actual|2016-03-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|ASCEND-II||The Use of Nicotine Patches Together With E-cigarettes (With and Without Nicotine) for Smoking Cessation|A Randomised-controlled Clinical Trial to Evaluate the Effectiveness and Safety of Combining Nicotine Patches With E-cigarettes (With and Without Nicotine) Plus Behavioural Support, on Smoking Abstinence|Recruiting||Phase 3|1809|Anticipated|University of Auckland, New Zealand||3|||f||||f||||||||Undecided||2017-10-10 23:03:09.81543|2017-10-10 23:03:09.81543
NCT02521649|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-08-10|||September 1998||1998-09-01|August 2015|2015-08-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer|An Open, Dose-ranging, Multicenter Study to Determine the Antibody Response to G17DT and Its Safety and Tolerability in the Treatment of Patients With Gastric Cancer|Completed||Phase 2|52|Actual|Cancer Advances Inc.||5|||f||||||||||||||2017-10-10 23:03:09.954918|2017-10-10 23:03:09.954918
NCT02521636|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-10|||October 2010||2010-10-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|BPCTréa||Clinical Trial Assessing the Value of an Antibiotic Protocol Guided by Serum Procalcitonin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Intensive Care||Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:03:10.062942|2017-10-10 23:03:10.062942
NCT02521623|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-07-11|||August 2015||2015-08-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial|SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial|Recruiting||N/A|60|Anticipated|Aarhus University Hospital||2|||f||||t||||||||No||2017-10-10 23:03:12.076177|2017-10-10 23:03:12.076177
NCT02517190|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-05|||May 2012||2012-05-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|COSI@PFC||Effects of Repeated Short-term Microgravity During Parabolic Flight Conditions on Neuro-endocrine, Immune and Metabolic Changes||Completed||N/A|6|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:59.547898|2017-10-10 23:03:59.547898
NCT02521597|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-10-12|||August 2015||2015-08-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MOTO||Mobile Otoscopy - Efficacy of Residents to Diagnose Acute Otitis Media Using a Smartphone Otoscope Attachment|Mobile Otoscopy - Efficacy of Residents to Diagnose Acute Otitis Media Using a Smartphone Otoscope Attachment: A Randomized Controlled Trials|Completed||N/A|100|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-10 23:03:12.263271|2017-10-10 23:03:12.263271
NCT02521584|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2015-08-11|||January 2015||2015-01-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|||Ischemia Time and Graft Survival||Unknown status|Recruiting|N/A|150|Anticipated|Mansoura University|||1||f||||t||||||||||2017-10-10 23:03:12.357157|2017-10-10 23:03:12.357157
NCT02521571|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-06-21|||December 2011||2011-12-01|June 2016|2016-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Resilience Alliance|The Resilience Alliance|Completed||N/A|357|Actual|New York University School of Medicine||2|||f||||||||||||||2017-10-10 23:03:12.45383|2017-10-10 23:03:12.45383
NCT02521558|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-03-26|||September 2015||2015-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CTAD||Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease|Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease|Recruiting||N/A|100|Anticipated|Boston University||2|||f||||f|f|f||||||No||2017-10-10 23:03:12.556865|2017-10-10 23:03:12.556865
NCT02521545|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-09-03|||July 2015||2015-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Single-Dose Study of a New Formulation of BIIB061|A Single-Dose Study in Healthy Volunteers to Assess the Pharmacokinetic Profile of a New Formulation of BIIB061|Completed||Phase 1|8|Actual|Biogen||1|||f||||f||||||||||2017-10-10 23:03:12.674138|2017-10-10 23:03:12.674138
NCT02521532|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-10-22|||January 2015||2015-01-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A 2 Week, Crossover Trial of Dietary Nitrate in Chronic Obstructive Pulmonary Disease|Dietary Nitrate for COPD: a 14d, Randomized, Placebo-controlled, Crossover Trial|Completed||N/A|8|Actual|Royal College of Surgeons, Ireland||2|||f||||f||||||||||2017-10-10 23:03:12.756709|2017-10-10 23:03:12.756709
NCT02521519|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-09-12|||August 2014||2014-08-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Medial Branch Block vs Para-spinal Muscle Injection in Patients With Non-specific Chronic Low Back Pain|Medial Branch Block vs Para-spinal Injection in Patients With Non-specific Chronic Low Back Pain|Recruiting||Phase 3|84|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 23:03:12.871936|2017-10-10 23:03:12.871936
NCT02521506|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-03-06|||March 2015||2015-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ECOVIQ||Clinical Efficacy of OneTouch® Verio™IQ Meter|Clinical Efficacy of OneTouch® Verio™IQ Meter|Completed||N/A|90|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||f||||||||||2017-10-10 23:03:13.040064|2017-10-10 23:03:13.040064
NCT02521493|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-08-30|||November 2015||2015-11-01|August 2017|2017-08-01||||December 2019|Anticipated|2019-12-01||Interventional|||Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome|Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome|Recruiting||Phase 3|256|Anticipated|Children's Oncology Group||2|||f||||||||||||||2017-10-10 23:03:13.159529|2017-10-10 23:03:13.159529
NCT02521480|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-03-07|||July 2015||2015-07-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|TMS||Determination of Analgesic Effect From One Transcranial Magnetic Stimulation(TMS)Treatment Following Vaginal Reconstructive Surgery.|Determination of the Analgesic Effects of One Session of Postoperative Left Prefrontal Cortex Repetitive Transcranial Magnetic Stimulation (TMS) Following Vaginal Reconstructive Surgery.|Withdrawn||N/A|0|Actual|East Tennessee State University||2||Study not feasible or convenient for the subject|f||||t||||||||||2017-10-10 23:03:13.570664|2017-10-10 23:03:13.570664
NCT02521467|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-10|||January 2014||2014-01-01|August 2015|2015-08-01||||January 2015|Actual|2015-01-01||Interventional|||Adjunctive Role of PRF After Free Gingival Graft Harvesting - Case Series|Adjunctive Role of Platelets Rich Fibrin in Palatal Wound Healing After Free Gingival Graft Harvesting - Case Series|Completed||Phase 4|10|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:03:13.677289|2017-10-10 23:03:13.677289
NCT02521454|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-09-20|||August 2015||2015-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Pilot Trial of Mindfulness-Based Resilience Training Among Police Officers||Active, not recruiting||N/A|60|Anticipated|Pacific University||2|||f||||t||||||||||2017-10-10 23:03:13.7524|2017-10-10 23:03:13.7524
NCT02521441|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-11|||May 2014||2014-05-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.|A Multi-center, Randomized, Open-label, Active-controlled, Dose Finding Study to Evaluate the Efficacy and Safety of F-627 Compared to Filgrastim in Women With Breast Cancer Receiveing Myelotoxic Chemotherapy.|Unknown status|Recruiting|Phase 2|150|Anticipated|Generon (Shanghai) Corporation Ltd.||3|||f||||f||||||||||2017-10-10 23:03:13.82592|2017-10-10 23:03:13.82592
NCT02521428|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2015-08-11|||August 2008||2008-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|September 2011|Actual|2011-09-01||Observational|||End-of-Life Decisions in Surgical Intensive Care Medicine - The Relevance of Treatment Withholding|End-of-Life Decisions in Surgical Intensive Care Medicine - The Relevance of Treatment Withholding|Completed||N/A|226|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 23:03:13.933633|2017-10-10 23:03:13.933633
NCT02521415|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-09-30|||December 2015||2015-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||IN Sub-Dissociative Ketamine vs IN Fentanyl|Randomized Controlled Trial of Intranasal Ketamine Compared to Intranasal Fentanyl for Analgesia in Children With Suspected, Isolated Extremity Fractures in the Pediatric Emergency Department|Recruiting||Phase 2|80|Anticipated|Carolinas Healthcare System||2|||f||||t||||||||||2017-10-10 23:03:13.991942|2017-10-10 23:03:13.991942
NCT02521402|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-11|||August 2015||2015-08-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Pilot Study to Evaluate Clinical Outcomes With the Use of Biovance Following Keloid Scar Revision Surgery|Pilot Study to Evaluate Clinical Outcomes With the Use of Biovance, a Dehydrated Decellularized Human Amnion Membrane Allograft, Following Keloid Revision Surgery|Unknown status|Not yet recruiting|Phase 4|10|Anticipated|Golla Center for Plastic Surgery||1|||f||||f||||||||||2017-10-10 23:03:14.098174|2017-10-10 23:03:14.098174
NCT02521389|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-08-28|||June 29, 2015|Actual|2015-06-29|August 2017|2017-08-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Interventional|||Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143|Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of Various Formulations of PWT-143 in Healthy Subjects|Completed||Phase 1|35|Actual|MEI Pharma, Inc.||2|||f||||f||||||||||2017-10-10 23:03:14.203454|2017-10-10 23:03:14.203454
NCT02521376|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-09-15|||November 16, 2015|Actual|2015-11-16|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function|A Phase 1, Open-Label, Multiple Dose Study to Evaluate the Pharmacokinetics of Entospletinib in Subjects With Normal and Impaired Hepatic Function|Recruiting||Phase 1|80|Anticipated|Gilead Sciences||3|||f||||f|t|f||||||||2017-10-10 23:03:14.282305|2017-10-10 23:03:14.282305
NCT02521363|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-02-07|||July 2015||2015-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer|Pilot Trial of an Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer|Recruiting||N/A|12|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:03:14.366886|2017-10-10 23:03:14.366886
NCT02521350|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-08-10|||June 2015||2015-06-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Determination of Perioperative Acute Kidney Injury Incidence|Perioperative Acute Kidney Injury Incidence and Risk Factors in Non-cardiac Surgery|Unknown status|Active, not recruiting|N/A|5000|Anticipated|Acibadem University|||1||f||||f||||||||||2017-10-10 23:03:14.46098|2017-10-10 23:03:14.46098
NCT02521337|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2016-12-18|||January 2016||2016-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||PreTerm RNA in Maternal Serum||Recruiting||N/A|150|Anticipated|Hadassah Medical Organization|||3||f||||f||||||||||2017-10-10 23:03:14.538576|2017-10-10 23:03:14.538576
NCT02521324|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-02-28|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|2BRT01||Effect of Device Guided Breathing on Sleeplessness (2BRT01)|The Effect of Device-Guided Breathing on Healthy Subjects With Sleeplessness Using a Sensor and Mobile App|Not yet recruiting||N/A|40|Anticipated|Afeka, The Tel-Aviv Academic College of Engineering||2|||f||||f|f|f||||||Undecided||2017-10-10 23:03:14.634205|2017-10-10 23:03:14.634205
NCT02521311|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|ReCOVER||Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)|A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis|Recruiting||Phase 2|30|Anticipated|University of California, San Francisco||2|||f||||f|t|f||||||||2017-10-10 23:03:14.881797|2017-10-10 23:03:14.881797
NCT02521298|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-08-07|||October 2015||2015-10-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Treatment of Lateral Elbow Tendinopathy|Lateral Elbow Tendinopathy: A Randomized Controlled Trial Examining The Treatment Effect Of Strength Training Combined With Cortico-Steroid Injection, Dry-Needling Or Placebo|Recruiting||N/A|60|Anticipated|Bispebjerg Hospital||3|||f||||f||||||||||2017-10-10 23:03:15.0255|2017-10-10 23:03:15.0255
NCT02521285|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-11|2017-09-28|||January 15, 2016|Actual|2016-01-15|May 2017|2017-05-01||||April 30, 2019|Anticipated|2019-04-30||Interventional|||Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation|Effect of Aspirin on Biomarkers of Barrett's Esophagus After Successful Eradication of Barrett's Esophagus With Radiofrequency Ablation|Recruiting||Phase 2|118|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-10 23:03:15.146488|2017-10-10 23:03:15.146488
NCT02521272|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2015-08-11|||March 2012||2012-03-01|August 2015|2015-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|HyperAvaSM||Hypercapnia and Gas Exchange Under the Avalanche Snow Model (HyperAvaSM)|Hypercapnia and Gas Exchange Under the Simulated Avalanche Snow|Completed||N/A|12|Actual|Czech Technical University in Prague||1|||f||||f||||||||||2017-10-10 23:03:15.33271|2017-10-10 23:03:15.33271
NCT02521246|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-01-17|||November 2016||2016-11-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control|Efficacy and Safety Evaluation of the New Association on Fixed Dose of Candesartan Cilexetil + Chlorthalidone (16mg + 12.5mg and 16mg + 25mg) Compared With HYZAAR® in Hypertension Control|Withdrawn||Phase 3|0|Actual|EMS||3||Sponsor decision|f||||t||||||||||2017-10-10 23:03:15.52884|2017-10-10 23:03:15.52884
NCT02521233|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-01-17|||November 2016||2016-11-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control|Efficacy and Safety Evaluation of the New Association on Fixed Dose of Candesartan + Chlorthalidone, Produced by EMS S.A,in Arterial Hypertension Control|Withdrawn||Phase 3|0|Actual|EMS||3||Sponsor decision|f||||t||||||||||2017-10-10 23:03:15.613745|2017-10-10 23:03:15.613745
NCT02521220|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-03-13|||August 2016||2016-08-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CIPER||L-Citrulline in Peripheral Artery Disease|Beneficial Effects of the Amino-acid Food Supplement L-citrulline in Participants With Peripheral Artery Disease|Recruiting||N/A|36|Anticipated|Maastricht University||2|||f||||t||||||||Undecided||2017-10-10 23:03:15.6964|2017-10-10 23:03:15.6964
NCT02521025|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-07-26|||October 2015||2015-10-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Bedrest, Feeding Pattern, and Insulin Sensitivity|The Impact of Continuous Versus Intermittent Feeding on Changes in Insulin Sensitivity During Bed-rest|Completed||N/A|20|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:03:17.844558|2017-10-10 23:03:17.844558
NCT02521207|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-10-27|||July 2015||2015-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Pilot Study of OXP001(2) and Brufen in Healthy Subjects|A Two-Part, Randomised, Open-Label, Evaluator-Blinded, Multiple-Dose, Phase I Pilot Study With OXP001 Ibuprofen 400 mg Tablets and Brufen® 400 mg Tablets to Assess the Comparative Bioavailability (Part 1) and Effects on Gastroduodenal Irritation (Part 2) in Healthy Human Subjects|Completed||Phase 1|53|Actual|Oxford Pharmascience Ltd||4|||f||||f||||||||||2017-10-10 23:03:15.818736|2017-10-10 23:03:15.818736
NCT02521194|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-03-15|||November 13, 2015|Actual|2015-11-13|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Occupational Therapy in Palliative Care|Is Inpatient Occupational Therapy Perceived to be Beneficial by the Palliative Patient and Caregiver?|Active, not recruiting||N/A|86|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:03:15.90901|2017-10-10 23:03:15.90901
NCT02521181|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-02-25|||October 2015||2015-10-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|BASE||The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)|The BASE Study: Bicarbonate Administration to Stabilize eGFR|Recruiting||Phase 3|192|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-10-10 23:03:16.009361|2017-10-10 23:03:16.009361
NCT02521168|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-02-16|||July 2013||2013-07-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|OTICC||Oral Triiodothyronine for Children Undergoing Cardiopulmonary Bypass in Indonesia|Oral Triiodothyronine for Children Undergoing Cardiopulmonary Bypass in Indonesia|Completed||Phase 3|177|Actual|National Cardiovascular Center Harapan Kita Hospital Indonesia||2|||f||||t||||||||||2017-10-10 23:03:16.151325|2017-10-10 23:03:16.151325
NCT02521155|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-03-01|||July 2015||2015-07-01|September 2015|2015-09-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||"Safeguard Your Smile an Oral Health Literacy Intervention Promoting Positive Oral Hygiene Self-care Behavior"|"Safeguard Your Smile an Oral Health Literacy Intervention Promoting Positive Oral Hygiene Self-care Behavior Among Punjabi Immigrants: A Randomized Controlled Trial"|Completed||N/A|140|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-10 23:03:16.26545|2017-10-10 23:03:16.26545
NCT02521142|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-09-19|||October 2015||2015-10-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Observational|||Non-invasive Optical Angiography in Age-related Macular Degeneration||Recruiting||N/A|72|Anticipated|Medical University of Vienna|||2||f||||||||||||||2017-10-10 23:03:16.389875|2017-10-10 23:03:16.389875
NCT02521129|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-09|||September 2015||2015-09-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||A New Track Ablation Device for Liver Biopsy: A Feasibility Study|A New Track Ablation Device for Liver Biopsy: A Feasibility Study|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 23:03:16.509744|2017-10-10 23:03:16.509744
NCT02521116|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-09-19|||February 2016||2016-02-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|DVA-Oxymap||Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap|Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap|Recruiting||Phase 4|90|Anticipated|Medical University of Vienna||3|||f||||||||||||||2017-10-10 23:03:16.602213|2017-10-10 23:03:16.602213
NCT02521103|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-10|||August 2015||2015-08-01|May 2017|2017-05-01|June 2023|Anticipated|2023-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Triathlon Tritanium Cone Augments Outcomes Study|A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon TS Total Knee System With Triathlon Tritanium Cone Augments|Recruiting||N/A|125|Anticipated|Stryker Orthopaedics||1|||f||||f||||||||||2017-10-10 23:03:16.717051|2017-10-10 23:03:16.717051
NCT02521090|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2016-02-12|||August 2015||2015-08-01|February 2016|2016-02-01||||March 2016|Anticipated|2016-03-01||Interventional|||EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma|Targeting Recurrent Glioblastoma With Anti-CD3 x Anti-EGFR Bispecific Antibody Armed T Cells: A Phase I/II Study|Withdrawn||Phase 1/Phase 2|0|Actual|Barbara Ann Karmanos Cancer Institute||1||Due to lack of funding and a primary co-investigator of the trial leaving the institution.|f||||t||||||||||2017-10-10 23:03:16.843882|2017-10-10 23:03:16.843882
NCT02521077|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-06-23|||May 2017|Anticipated|2017-05-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer|Prospective Double Blind Study of the Effect of Intravenous High Dose Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer|Withdrawn||Phase 2|0|Actual|Midwestern Regional Medical Center||2||Manufacturer unwilling to provide information needed for IND application.|f||||f|f|f||||||||2017-10-10 23:03:17.409218|2017-10-10 23:03:17.409218
NCT02521064|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-04-30|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Effects of Exclusive Enteral Nutrition on the Microbiome in Pediatric Inflammatory Bowel Disease|The Role of Exclusive Enteral Nutrition in the Pediatric Inflammatory Bowel Disease Microbiome: a Pilot Study|Completed||N/A|31|Actual|McMaster Children's Hospital|||2||f||||f||||||Samples Without DNA|"     Bl   "|||2017-10-10 23:03:17.494921|2017-10-10 23:03:17.494921
NCT02521051|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-04-12|||October 2015||2015-10-01|April 2017|2017-04-01|June 2022|Anticipated|2022-06-01|October 2018|Anticipated|2018-10-01||Interventional|||Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer|A Phase I/II Trial to Evaluate the Safety and Tolerability of Alectinib and Bevacizumab in Patients With Advanced, ALK-Positive, Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|43|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:03:17.608837|2017-10-10 23:03:17.608837
NCT02521012|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-08-16|||November 2015||2015-11-01|August 2016|2016-08-01|October 2025|Anticipated|2025-10-01|October 2020|Anticipated|2020-10-01||Interventional|DepFuD||Follow-up Study With Clinical Vitamin D Supplementation Trial on Patients With Depression (DepFuD)|Follow-up Study With Randomized Clinical Vitamin D Supplementation Trial on Patients With Depression (DepFuD)|Recruiting||N/A|3028|Anticipated|Kuopio University Hospital||2|||f||||f||||||||||2017-10-10 23:03:17.939253|2017-10-10 23:03:17.939253
NCT02520999|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-11-25|||August 2015||2015-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|EPB||The Effect of Various External Pressure on Blood|Comparison of the Effect of Various External Pressure on Blood During Rapid Infusion|Completed||N/A|25|Actual|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-10 23:03:18.048132|2017-10-10 23:03:18.048132
NCT02520986|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-10-09|||October 2016||2016-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma|Carbon Dioxide Laser Ablation Versus Electrocoagulation - a Prospective, Randomized Multicenter Trial Comparing Two Surgical Treatments in Women Undergoing Therapy for Condyloma Acuminata|Recruiting||N/A|114|Anticipated|Zydolab - Institute of Cytology and Immune Cytochemistry||2|||f||||f||||||||No||2017-10-10 23:03:18.131135|2017-10-10 23:03:18.131135
NCT02520973|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-08-15|||May 2015||2015-05-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Screening for TB in Pregnancy. on HIV-Infected Pregnant Women|Screening for TB in Pregnancy A Supplement to: The Effect of Tuberculosis and Its Treatment on HIV-Infected Pregnant Women and Their Infants|Completed||N/A|1400|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:03:18.340383|2017-10-10 23:03:18.340383
NCT02520960|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-08-18|||November 2013||2013-11-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|Uniforce||Unipolar Atrial Electrogram Modification Combined to the Contact Force Sensing Technology for Pulmonary Vein Isolation|Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation by Combining the Analysis of the Unipolar Atrial Electrogram Modification With the Contact Force Sensing Technology: The Uniforce Study|Completed||Phase 4|215|Actual|Hôpital Privé Les Franciscaines|||1||f||||t||||||||||2017-10-10 23:03:18.426229|2017-10-10 23:03:18.426229
NCT02520947|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-12|||January 2014||2014-01-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||The Effect of BIS Monitorization to Intraoperative Anesthetic Consumption During Coronary Artery Surgery|The Effect of BIS Monitorization to Intraoperative Anesthetic and Analgesic Consumption During Coronary Artery Grafting Surgery and Postoperative Mortality and Morbidity|Completed||N/A|50|Actual|Baskent Univesity Ankara Hospital||2|||f||||t||||||||||2017-10-10 23:03:18.515838|2017-10-10 23:03:18.515838
NCT02520934|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-04-13|||July 2015||2015-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Miglustat on Gaucher Disease Type IIIB|Evaluation of Combination Therapy With Miglustat and Enzyme Replacement Therapy on Gaucher Disease Type IIIB|Recruiting||N/A|35|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:03:18.602598|2017-10-10 23:03:18.602598
NCT02520921|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-01-10|||June 2016||2016-06-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|ANDAMAN||Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome|Aspirin With a Novel Twice-a-day Administration in Diabetic Patients With Acute Coronary Syndrome to Minimize Recurrence of Acute Ischemic Events or New Urgent Revascularization|Recruiting||Phase 4|2574|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:03:18.717683|2017-10-10 23:03:18.717683
NCT02520908|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-11-18|||July 2016||2016-07-01|November 2016|2016-11-01|December 2024|Anticipated|2024-12-01|September 2021|Anticipated|2021-09-01||Observational|CUTALLO||Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis|Prospective, Controlled, Multicenter Cohort Study Evaluating the Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis|Recruiting||N/A|78|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     During the blood samples usually performed in routine patient management, 30 ml of peripheral     blood will be collected at inclusion and one year after inclusion and sent to the     investigator's central collection laboratory (INSERM UMRS 976, Saint-Louis Hospital, Paris,     France).   "|||2017-10-10 23:03:18.831433|2017-10-10 23:03:18.831433
NCT02520895|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-08-07|||September 2010||2010-09-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|RIPAL||Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia|Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia, Biomedical Research on Medical Devices Human ImmunTracker and Human Immun'IgH|Completed||N/A|98|Actual|Hospices Civils de Lyon|||8||f||||f||||||||||2017-10-10 23:03:18.933782|2017-10-10 23:03:18.933782
NCT02520882|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2017-04-05|||January 2015||2015-01-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas|Safety and Diagnostic Performance of 68Gallium-labeled NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas|Recruiting||Early Phase 1|30|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-10 23:03:19.045088|2017-10-10 23:03:19.045088
NCT02520869|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-09-16|||April 2014||2014-04-01|September 2016|2016-09-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Diagnostic Value of Sperm DNA Fragmentation and Sperm Morphology for Assisted Reproduction Treatment|Diagnostic Value of Sperm DNA Fragmentation and Sperm Morphology for Predicting Outcome of Assisted Reproduction Treatment|Withdrawn||Phase 2/Phase 3|0|Actual|Benha University||2|||f||||f||||||||||2017-10-10 23:03:19.143007|2017-10-10 23:03:19.143007
NCT02520856|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-07|||July 2015||2015-07-01|August 2015|2015-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|HYPERGEN||New Diagnostic Strategy in Hypertrophic Cardiomyopathy|New Diagnostic Strategy in Hypertrophic Cardiomyopathy Including a New Genetic Approach: A Multicentric Prospective Study|Recruiting||N/A|200|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-10 23:03:19.229957|2017-10-10 23:03:19.229957
NCT02520843|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-11-09|||October 2015||2015-10-01|November 2015|2015-11-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||An Innovative Treatment for Fistula-in-ano in Crohn Disease : Local Micro Reinjection of Autologous Fat and SVF|An Innovative Treatment for Fistula-in-ano in Crohn Disease : Local Micro Reinjection of Autologous Fat and Stromal Vascular Fraction|Recruiting||Phase 1/Phase 2|10|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||t||||||||||2017-10-10 23:03:19.319542|2017-10-10 23:03:19.319542
NCT02520830|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-11-02|||March 2014||2014-03-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Blueberry-polyphenols on Endothelial Function, Absorption and Metabolism|Sustained Effects of Blueberry Polyphenols on Vascular Function in Healthy Individuals|Completed||N/A|45|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-10 23:03:19.401827|2017-10-10 23:03:19.401827
NCT02520817|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-09|||January 2013||2013-01-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study|Professor of Tropical Medicine|Completed||N/A|58|Actual|Mansoura University|||2||f||||||||||||||2017-10-10 23:03:19.499038|2017-10-10 23:03:19.499038
NCT02520804|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-03-31|||November 2014||2014-11-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Normal Saline Versus Balance Salt Solution Resuscitation on Kidney Function|Effect of Normal Saline Versus Balance Salt Solution Resuscitation on Kidney Function; A Randomized Open Label Controlled Study|Recruiting||N/A|107|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-10 23:03:19.592803|2017-10-10 23:03:19.592803
NCT02520791|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-09-28|||April 22, 2016|Actual|2016-04-22|September 2017|2017-09-01||||May 31, 2018|Anticipated|2018-05-31||Interventional|||Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma|A Phase I Trial of MEDI-570 in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL)|Recruiting||Phase 1|46|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:03:19.72083|2017-10-10 23:03:19.72083
NCT02520778|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-10|2017-09-28|||March 31, 2016|Actual|2016-03-31|September 2017|2017-09-01||||December 30, 2017|Anticipated|2017-12-30||Interventional|||Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer|A Phase 1B Study of AZD9291 in Combination With Navitoclax in EGFR-Mutant Non-small Cell Lung Cancer Following Resistance to Initial EGFR Kinase Inhibitor|Recruiting||Phase 1|50|Anticipated|National Cancer Institute (NCI)||1|||||||f||||||||||2017-10-10 23:03:19.90892|2017-10-10 23:03:19.90892
NCT02520765|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2017-08-13|||October 2015||2015-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Obesity Index That Better Predict Ovarian Response|Obesity Index That Better Predict Ovarian Response: Body Mass Index, Waist Circumference, Waist Hip Ratio, or Waist Height Ratio in Women Undergoing ICSI|Recruiting||N/A|500|Anticipated|Ain Shams University|||1||f||||t||||||||||2017-10-10 23:03:20.090715|2017-10-10 23:03:20.090715
NCT02520752|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2017-08-24|||December 10, 2015|Actual|2015-12-10|August 2017|2017-08-01|September 12, 2017|Anticipated|2017-09-12|January 30, 2017|Actual|2017-01-30||Interventional|||A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors|A Phase I, Multicenter, Open-label, Single-sequence Drug-drug Interaction Study to Assess the Effect of INC280 on the Pharmacokinetics of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors|Active, not recruiting||Phase 1|37|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-10 23:03:20.168416|2017-10-10 23:03:20.168416
NCT02520739|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2016-03-02|||February 2014||2014-02-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|NUTRAOLEUM||New Industrial Procedures for Achieving a Nutritional Added Value of the Olive Oil. The NUTRAOLEUM Study|New Industrial Procedures for Achieving a Nutritional Added Value of the Olive Oil. The NUTRAOLEUM Study|Active, not recruiting||Phase 3|57|Actual|Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental||3|||f||||t||||||||||2017-10-10 23:03:20.285139|2017-10-10 23:03:20.285139
NCT02520726|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-10-24|||September 2013||2013-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims|A Randomized, Double-blind, Placebo-controlled Pilot Study of Sertraline for the Prevention of PTSD in Burn Victims|Terminated||Phase 4|5|Actual|University of Utah||2||Insufficient enrollment|f||||f||||||||||2017-10-10 23:03:20.390727|2017-10-10 23:03:20.390727
NCT02520713|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-05-31|||October 2015||2015-10-01|May 2017|2017-05-01|July 2022|Anticipated|2022-07-01|January 2020|Anticipated|2020-01-01||Interventional|||The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study|Multicenter Cohort Study To Evaluate Outcomes After Receipt of Targeted Therapy Matched to an Individualized Cancer Therapy (iCat) Recommendations in Children and Young Adults With Solid Tumors: The iCat2, GAIN Consortium Study|Recruiting||N/A|825|Anticipated|Dana-Farber Cancer Institute||1|||f||||f||||||||Undecided||2017-10-10 23:03:20.483876|2017-10-10 23:03:20.483876
NCT02520700|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-08-09|||September 2013||2013-09-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic Keratoses||Completed||N/A|22|Actual|St Vincent's University Hospital, Ireland||1|||f||||f||||||||||2017-10-10 23:03:20.616185|2017-10-10 23:03:20.616185
NCT02520687|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-18|||September 2015||2015-09-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effects of Dietary Nitrate in Hypertensive Pregnant Women|Feasibility Study on the Effects of Dietary Nitrate on Cardiovascular Function in Hypertensive Pregnant Women|Completed||Phase 1|40|Actual|University of Manchester||2|||f||||f||||||||||2017-10-10 23:03:20.712791|2017-10-10 23:03:20.712791
NCT02520674|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-11|||September 2014||2014-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Glaucoma Screening With Smartphone Ophthalmology||Completed||N/A|110|Actual|Università degli Studi di Brescia||1|||f||||f||||||||||2017-10-10 23:03:20.792048|2017-10-10 23:03:20.792048
NCT02520661|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Paramedic Coached ED Care Transitions to Help Older Adults Maintain Their Health|Paramedic Coached ED Care Transitions to Help Older Adults Maintain Their Health|Recruiting||N/A|2400|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||No||2017-10-10 23:03:20.909511|2017-10-10 23:03:20.909511
NCT02520648|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-04-29|||July 2015||2015-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|EffDorsMan||Immediate Changes After Manual Therapy in Patients With Non-specific Back Pain|Immediate Changes After Manual Therapy Techniques in Patients With Persistent Non-specific Back Pain|Completed||N/A|125|Actual|University of Valencia||3|||f||||f||||||||||2017-10-10 23:03:21.054901|2017-10-10 23:03:21.054901
NCT02520635|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-10-06|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients|A Clinical Study of Supra-early Post-Surgery Chemotherapy Plus Standard TEMODAL® Regimen Versus Standard TEMODAL® Regimen in the Treatment on Patients With Newly Diagnosed Glioblastoma Multiforme|Recruiting||Phase 4|100|Anticipated|Beijing Tiantan Hospital||2|||f||||f||||||||||2017-10-10 23:03:21.207735|2017-10-10 23:03:21.207735
NCT02520622|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-05-01|||February 16, 2015|Actual|2015-02-16|May 2017|2017-05-01|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Interventional|||Digital vs. Printed Photographs: Impact on Skin Self-Examinations|Evaluation of the Impact of Using Digital Photographs on a Mobile Device Versus Printed Photographs on Patient Conducted Skin Exams|Completed||N/A|69|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-10 23:03:21.322389|2017-10-10 23:03:21.322389
NCT02520609|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-08|2017-06-30|||August 6, 2015||2015-08-06|May 18, 2017|2017-05-18|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease|Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease|Recruiting||N/A|74|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:03:21.424631|2017-10-10 23:03:21.424631
NCT02520596|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-08-07|||November 2013||2013-11-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Absorption and Metabolism of Dietary Phenolics From Raspberries|Bioavailability of Anthocyanins in Humans Following the Ingestion of Berries and Grapes|Completed||N/A|10|Actual|University of Parma||1|||f||||f||||||||||2017-10-10 23:03:21.519354|2017-10-10 23:03:21.519354
NCT02520583|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-10-18|||February 2015||2015-02-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|PRO001||The Effects of Probiotic Supplementation on Markers of Muscle Damage and Performance Following Exercise Induced Muscle Damage|The Effects of Probiotic Supplementation on Markers of Muscle Damage and Performance Following Exercise Induced Muscle Damage|Completed||Phase 2|15|Actual|Texas Christian University||2|||f||||||||||||||2017-10-10 23:03:21.618594|2017-10-10 23:03:21.618594
NCT02520570|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-08|||August 2014||2014-08-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Post-market Safety Reassessment of Ulinastatin for Injection|Post-market Safety Reassessment of Ulinastatin for Injection|Recruiting||N/A|10000|Anticipated|Techpool Bio-Pharma Co., Ltd.|||2||f||||t||||||||||2017-10-10 23:03:21.700771|2017-10-10 23:03:21.700771
NCT02520557|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-11-16|||November 2015||2015-11-01|November 2016|2016-11-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Observational|||An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine Acetate|An Exploratory Case-Control Study of Genetic and Clinical Factors for Serious Cutaneous Reactions Among Users of Eslicarbazepine Acetate|Recruiting||N/A|500|Anticipated|Sunovion|||2||f||||f||||||Samples With DNA|"     Blood or Saliva   "|||2017-10-10 23:03:21.799647|2017-10-10 23:03:21.799647
NCT02520544|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-12-05|||January 2012||2012-01-01|December 2016|2016-12-01|February 2025|Anticipated|2025-02-01|February 2025|Anticipated|2025-02-01||Interventional|ATX||ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert|THE ATX REGISTRY ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert International Multicentre Surveillance Register|Active, not recruiting||N/A|497|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-10-10 23:03:21.877856|2017-10-10 23:03:21.877856
NCT02520531|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-12-05|||September 2010||2010-09-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|ScorpioNRGPS||"Scorpio Posterior Stabilised (PS) vs Scorpio NRG (Energize) PS - Total Knee Arthroplasty"|Scorpio PS vs Scorpio NRG PS - Total Knee Arthroplasty Comparative Investigation of Function|Active, not recruiting||N/A|88|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-10-10 23:03:22.149921|2017-10-10 23:03:22.149921
NCT02520518|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-07-20|||August 2015||2015-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss?|Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss?|Terminated||Phase 2|40|Actual|Colorado State University||4||Designed a new modified/simplified protocol see NCT 03180489|f||||f||||||||||2017-10-10 23:03:22.294196|2017-10-10 23:03:22.294196
NCT02520505|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2017-04-18|||April 2015||2015-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis|Determining the Fertility Benefit of Immediate SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis|Withdrawn||N/A|0|Actual|The Cleveland Clinic||2||no participants enrolled|f||||f||||||||||2017-10-10 23:03:22.462772|2017-10-10 23:03:22.462772
NCT02520492|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-07-18|||April 3, 2015|Actual|2015-04-03|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|GMaPIC||Non Invasive Measurements of Intracranial Pressure in Patients With Malignant Glioma|Non Invasive Measurements of Intracranial Pressure in Patients With Malignant Glioma|Recruiting||N/A|40|Anticipated|Centre Jean Perrin||1|||f||||f||||||||||2017-10-10 23:03:22.590571|2017-10-10 23:03:22.590571
NCT02520466|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-10-24|||July 2012||2012-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery Disease|Effect of Cocoa Flavanol-containing Drink on Coronary Vascular Function in Patients With Coronary Artery Disease|Recruiting||N/A|42|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 23:03:22.854294|2017-10-10 23:03:22.854294
NCT02520453|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-03-30|||February 2016||2016-02-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Adjuvant Durvalumab for Esophageal Cancer|Randomised, Double-blind, Phase II Trial of Adjuvant Durvalumab or Placebo for Completely Resected Esophageal Squamous Cell Carcinoma Previously Treated With Neoadjuvant Concurrent Chemoradiotherapy|Recruiting||Phase 2|84|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 23:03:22.955387|2017-10-10 23:03:22.955387
NCT02520440|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-07|||September 2014||2014-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|IN-PANCIA||INtestinal Failure, multiPle Organ Failure ANd CItrulline Assessment|Clinical Evaluation of Gastro Intestinal Failure, Multiple Organ Failure and Levels of Citrulline in Critical Ill Patients|Completed||N/A|42|Actual|Azienda Ospedaliera Spedali Civili di Brescia|||2||f||||f||||||||||2017-10-10 23:03:23.056429|2017-10-10 23:03:23.056429
NCT02520427|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-06-07|||August 31, 2015|Actual|2015-08-31|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Phase 1 Study of AMG 330 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia|A Phase 1 First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 330 Administered as Continuous Intravenous Infusion in Subjects With Relapsed/Refractory Acute Myeloid Leukemia|Recruiting||Phase 1|50|Anticipated|Amgen||1|||f||||f||||||||||2017-10-10 23:03:23.155179|2017-10-10 23:03:23.155179
NCT02520414|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-05-05|2017-03-23||November 2014||2014-11-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Symphion® System In-Office Study|A Pilot Study to Assess the Feasibility of the Symphion® Bipolar Hysteroscopic Tissue Resection System in an Office Environment|Completed||N/A|10|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-10 23:03:23.285231|2017-10-10 23:03:23.285231
NCT02520401|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-11-14|||October 2015||2015-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Use of a Probiotic Lozenge in the Treatment of Peri-implantitis|The Use of a Probiotic Lozenge in the Treatment of Peri-implantitis|Recruiting||N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-10 23:03:23.529943|2017-10-10 23:03:23.529943
NCT02520388|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-09-07||2017-09-07|August 2015||2015-08-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting|A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Evening-dosed HLD200, a Novel Delayed and Extended Release Formulation (DELEXIS) of Methylphenidate Hydrochloride, on Post-waking, Early Morning Function in Children Aged 6 to 12 With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|161|Actual|Ironshore Pharmaceuticals and Development, Inc||2|||f||||f||||||||||2017-10-10 23:03:23.62667|2017-10-10 23:03:23.62667
NCT02520375|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-03-10||||||March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effects of Prebiotic Oral Healthcare Products as an Adjunct to Non-surgical Periodontal Therapy|Effects of Prebiotic Oral Healthcare Products as an Adjunct to Non-surgical Periodontal Therapy|Withdrawn||N/A|0|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-10 23:03:23.790826|2017-10-10 23:03:23.790826
NCT02520362|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-06-09|||May 31, 2010|Actual|2010-05-31|June 2017|2017-06-01|May 23, 2023|Anticipated|2023-05-23|May 23, 2023|Anticipated|2023-05-23||Observational|||Safety Assessment Among Women With Postmenopausal Osteoporosis and Men With Osteoporosis in Multiple Observational Databases|Denosumab Global Safety Assessment Among Women With Postmenopausal Osteoporosis and Men With Osteoporosis in Multiple Observational Databases|Active, not recruiting||N/A|575462|Anticipated|Amgen|||4||f||||f||||||||||2017-10-10 23:03:23.874941|2017-10-10 23:03:23.874941
NCT02520349|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-01-10|||May 2016||2016-05-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Lab to Real World Assessment of E-cigarette Abuse Liability and Appeal|Lab to Real World Assessment of E-cigarette Abuse Liability and Appeal|Recruiting||N/A|30|Anticipated|Truth Initiative|||1||f||||t||||||Samples Without DNA|"     Plasma nicotine: Investigators will examine change in plasma nicotine concentration before     and after 5 minutes of directed product use (10 total puffs). At the start of the session, a     phlebotomist will draw 7mL of blood via venipuncture (no catheter). Participants will then be     directed to take a puff of their own brand/assigned e-cigarette device every 30 seconds for 5     minutes. At the end of the directed use session, the phlebotomist will draw another 7mL of     blood via venipuncture. Blood samples will be processed at the Center for Study of Tobacco     Products lab, frozen, and walked across the street to the Bioanalytical Mass Spectrometry     Core Laboratory at VCU for cotinine/3-OH analysis using previously developed assays. Blood     samples will not be retained for additional analyses.   "|Yes||2017-10-10 23:03:23.979072|2017-10-10 23:03:23.979072
NCT02520336|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-08-07|||July 2015||2015-07-01|August 2015|2015-08-01||||July 2016|Anticipated|2016-07-01||Interventional|||Postpartum Diabetes Screening in Women With Gestational Diabetes|Active Management of Postpartum Diabetes Screening After Gestational Diabetes: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|78|Anticipated|Thomas Jefferson University||2|||f||||||||||||||2017-10-10 23:03:24.0823|2017-10-10 23:03:24.0823
NCT02520323|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-06-02|||June 2015||2015-06-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||The Lung Microbiome in Sarcoidosis|The Lung Microbiome in Sarcoidosis|Completed||N/A|21|Actual|University of Michigan|||2||f||||f||||||||||2017-10-10 23:03:24.16584|2017-10-10 23:03:24.16584
NCT02520310|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-10-20|||August 2015||2015-08-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|July 2016|Actual|2016-07-01||Interventional|||AVJ-514 Japan Trial|A Prospective, Multi-Center, Single-Arm Clinical Evaluation of the AVJ-514 System for the Treatment of Symptomatic Chronic Severe Mitral Regurgitation|Active, not recruiting||N/A|30|Actual|Abbott Vascular||1|||f||||t||||||||||2017-10-10 23:03:24.268278|2017-10-10 23:03:24.268278
NCT02520297|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-07-07||2017-07-07|October 20, 2015|Actual|2015-10-20|July 2017|2017-07-01|October 23, 2015|Actual|2015-10-23|October 23, 2015|Actual|2015-10-23||Interventional|||A Pilot Study of TRV130 for the Treatment of Fracture Pain|A Phase 2, Open-label Pilot Study of TRV130 for the Treatment of Moderate to Severe Acute Pain Associated With Long Bone Fracture|Terminated||Phase 2|1|Actual|Trevena Inc.||1|||f||||f||||||||||2017-10-10 23:03:24.588489|2017-10-10 23:03:24.588489
NCT02520284|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-02-23||2017-02-23|September 2015||2015-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis|A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects With Moderately to Severely Active Ulcerative Colitis|Terminated||Phase 2/Phase 3|165|Actual|Gilead Sciences||7|||f||||t||||||||||2017-10-10 23:03:24.696211|2017-10-10 23:03:24.696211
NCT02517983|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-09-09|||August 2015||2015-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Phenotyping the Chronic Respiratory Diseases (CRD) in Ho Chi Minh City, Vietnam|Phenotyping the Chronic Respiratory Diseases (CRD) in Ho Chi Minh City, Vietnam|Completed||N/A|610|Actual|Brugmann University Hospital|||1||f||||f||||||||||2017-10-10 23:03:49.164109|2017-10-10 23:03:49.164109
NCT02520271|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2015-08-11|||October 2009||2009-10-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|October 2013|Actual|2013-10-01||Interventional|ODS||Ostrobothnia Depression Study (ODS). A Naturalistic Follow-up Study on Depression and Related Substance Use Disorders|ODS is a Naturalistic, Open Label, Non-randomized Follow-up Study on Depression and Related Substance Use Disorders (SUD). Study Targets: Efficacy of Psychosocial Treatment, Pharmacogenetics, Inflammation Related Biomarkers|Completed||N/A|242|Actual|Seinajoki Central Hospital||2|||f||||f||||||||||2017-10-10 23:03:25.028047|2017-10-10 23:03:25.028047
NCT02520258|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-02-21|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption|Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption|Recruiting||N/A|75|Anticipated|Rockefeller University||2|||f||||f||||||||No||2017-10-10 23:03:25.124132|2017-10-10 23:03:25.124132
NCT02520245|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-11-04|||August 2015||2015-08-01|May 2016|2016-05-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Interventional|||Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study||Withdrawn||Phase 1|0|Actual|Regeneron Pharmaceuticals||1|||f||||||||||||||2017-10-10 23:03:25.253364|2017-10-10 23:03:25.253364
NCT02520232|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-08-03|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|VIAGECO||Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition|Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition (VIAGECO)|Recruiting||N/A|360|Anticipated|University Hospital, Bordeaux||3|||f||||f||||||||||2017-10-10 23:03:25.337577|2017-10-10 23:03:25.337577
NCT02520219|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2015-08-06|||December 2014||2014-12-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study|The Efficacy and Safety Research of Endostar Combined With GDP to Treat Aggressive Peripheral T-cell Lymphoma (PTCL) in Phase II Clinical Study.|Unknown status|Recruiting|Phase 2|60|Anticipated|Nanjing NingQi Medicine Science and Technology Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:03:25.452843|2017-10-10 23:03:25.452843
NCT02520206|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-06|||January 2011||2011-01-01|August 2015|2015-08-01|August 2015|Anticipated|2015-08-01|July 2014|Actual|2014-07-01||Observational|||Adenosylmethionine Metabolism in Human Inflammation|Translational Study on the Regulation of Adenosylmethionine Synthesis During Chronic Inflammation|Unknown status|Enrolling by invitation|N/A|250|Anticipated|National Chung Hsing University|||2||f||||t||||||Samples With DNA|"     plasma, RBC, PBMC   "|||2017-10-10 23:03:25.539132|2017-10-10 23:03:25.539132
NCT02520193|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-05-04|||December 2015||2015-12-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|EarlyMob||Impact of Early Mobilization on Mechanical Ventilation Duration in Intubated Critically Ill Patients|Prospective, Randomized, Multi-center Trial to Assess the Impact of Early Mobilization on Mechanical Ventilation Duration in Intubated Critically Ill Patients|Recruiting||N/A|772|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 23:03:25.616591|2017-10-10 23:03:25.616591
NCT02520180|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-02-22|||December 2015||2015-12-01|February 2016|2016-02-01|June 2022|Anticipated|2022-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)|A Prospective Multicenter Post Market Trial to Assess the Safety and Effectiveness of the Firehawk™ Rapamycin Target Eluting Cobalt Chromium Coronary Stent System (Firehawk™ Stent System) for the Treatment of Atherosclerotic Lesion(s)|Recruiting||Phase 4|1656|Anticipated|Shanghai MicroPort Medical (Group) Co., Ltd.||2|||f||||t||||||||No||2017-10-10 23:03:25.76775|2017-10-10 23:03:25.76775
NCT02520167|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-10|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Partnership to Improve Nutrition and Adiposity in Prenatal Clinical Care: a Pilot and Feasibility Study|Partnership to Improve Nutrition and Adiposity in Prenatal Clinical Care: a Pilot and Feasibility Study|Completed||N/A|20|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:03:25.886149|2017-10-10 23:03:25.886149
NCT02520154|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-09-25|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer|Matched Paired Pharmacodynamics and Feasibility Study of Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer|Recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:03:25.974731|2017-10-10 23:03:25.974731
NCT02520141|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-06-21|||December 2015|Actual|2015-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Ramucirumab for Advanced Pre-Treated Biliary Cancers|A Phase II Study of Ramucirumab for Advanced, Pre-Treated Biliary Cancers|Recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:03:26.076302|2017-10-10 23:03:26.076302
NCT02520115|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-08-27|||August 2015||2015-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer|Study of Serum Measured Folate Receptor and Its Induction as a Biomarker in the Diagnosis and Surveillance of Ovarian Carcinoma|Recruiting||Phase 1|180|Anticipated|Barbara Ann Karmanos Cancer Institute||2|||f||||t||||||||||2017-10-10 23:03:26.644331|2017-10-10 23:03:26.644331
NCT02520102|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-04-19|||February 2017|Anticipated|2017-02-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia|A Phase II Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia|Withdrawn||Phase 2|0|Actual|Sanofi||1||Company has fulfilled post-marketing requirements|f||||f|t|f||||||||2017-10-10 23:03:26.89117|2017-10-10 23:03:26.89117
NCT02517970|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-21|||June 2015||2015-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MFS||Observing Infant Feeding Interactions||Recruiting||N/A|30|Anticipated|California Polytechnic State University-San Luis Obispo||1|||f||||t||||||||||2017-10-10 23:03:49.260259|2017-10-10 23:03:49.260259
NCT02520076|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-05-01|||August 2015||2015-08-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Aralast NP in Islet Transplant|Improving Single Donor Success Rate in Clinical Islet Transplantation Using Alpha-1 Antitrypsin (Aralast NP)|Active, not recruiting||Phase 1/Phase 2|12|Anticipated|University of Alberta||1|||f||||t||||||||||2017-10-10 23:03:27.202719|2017-10-10 23:03:27.202719
NCT02520063|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-12-22|||February 2016||2016-02-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||Preoperative Combination of Letrozole, Everolimus, and TRC105 in Postmenopausal Hormone-Receptor Positive and Her2 Negative Breast Cancer|A Phase I/II Study of Preoperative (Neoadjuvant) Combination of Letrozole (Femara), Everolimus (Afinitor), and TRC105 in Postmenopausal Women With Newly Diagnosed Local or Locally Advanced Potentially Resectable Hormone-Receptor Positive and Her2 Negative Breast Cancer|Recruiting||Phase 1/Phase 2|35|Anticipated|University of Alabama at Birmingham||4|||f||||t||||||||Undecided||2017-10-10 23:03:27.348063|2017-10-10 23:03:27.348063
NCT02520050|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-09-06|||April 2015||2015-04-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of 3 Different Models of MNT on DM Control in Overweight Patients With T2DM|The Effect of Three Different Models of Medical Nutrition Therapy (MNT) on Diabetes Control in Overweight and Obese Patients With Type 2 Diabetes: A Randomized Comparative Study. (Nutrition Path Study)|Active, not recruiting||N/A|108|Anticipated|Joslin Diabetes Center||3|||f||||f||||||||Undecided||2017-10-10 23:03:27.51761|2017-10-10 23:03:27.51761
NCT02520037|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-02-09|||June 15, 2015|Actual|2015-06-15|May 2016|2016-05-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Observational|||Fluid Responsiveness Prediction Using Extra Systoles|Fluid Responsiveness Prediction Using Extra Systoles in Critically Ill Patients|Completed||N/A|26|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-10 23:03:27.67646|2017-10-10 23:03:27.67646
NCT02520024|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2015-08-10|||January 2010||2010-01-01|August 2015|2015-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community Living||Completed||N/A|120|Actual|Temple University Collaborative on Community Inclusion||2|||f||||t||||||||||2017-10-10 23:03:27.76769|2017-10-10 23:03:27.76769
NCT02519998|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-08-06|||March 2015||2015-03-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Tissue Repository and Master Database for Concussion Biomarker and Risk Calculator Development|Tissue Repository and Master Database for Concussion Biomarker and Risk Calculator Development|Unknown status|Recruiting|N/A|1000|Anticipated|Thomas Jefferson University|||2||f||||t||||||Samples Without DNA|"     Urine Blood Saliva   "|||2017-10-10 23:03:28.120485|2017-10-10 23:03:28.120485
NCT02519985|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-03-10|||November 1, 2016|Actual|2016-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Repeatability and Reproducibility of the ArcScan Insight 100 VHF Digital Ultrasound|Repeatability and Reproducibility of Corneal and Anterior Segment Measurements by ArcScan Insight 100 Very High-frequency Digital Ultrasound|Recruiting||N/A|40|Anticipated|London Vision Clinic||1|||f||||t||||||||||2017-10-10 23:03:28.275563|2017-10-10 23:03:28.275563
NCT02519972|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-08-06|||August 2007||2007-08-01|August 2015|2015-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer|Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer|Completed||N/A|1102|Actual|Taichung Veterans General Hospital||1|||f||||t||||||||||2017-10-10 23:03:28.414537|2017-10-10 23:03:28.414537
NCT02519946|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-10-03|||August 2015||2015-08-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients||Recruiting||N/A|30|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-10 23:03:28.532464|2017-10-10 23:03:28.532464
NCT02519933|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-04-14|||January 2011||2011-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Comparison of mNT-BBAVF and BCAVF in Hemodialysis Patients|A Comparison of Modified Non-transposed Brachiobasilic Arteriovenous Fistula and Brachiocephalic Arteriovenous Fistula in Hemodialysis Patients|Recruiting||N/A|160|Anticipated|Shanghai 10th People's Hospital||2|||f||||t||||||||No||2017-10-10 23:03:28.636663|2017-10-10 23:03:28.636663
NCT02519920|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-10-19|||April 2015||2015-04-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the Skin|Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the Skin|Unknown status|Recruiting|Phase 2|63|Anticipated|Shandong University||4|||f||||t||||||||||2017-10-10 23:03:28.780088|2017-10-10 23:03:28.780088
NCT02519907|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-08-25|||September 2015||2015-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|EPIONE||Surface Electrical Stimulation for Treatment of Phantom Limb Pain|Natural Sensory Feedback for Phantom Limb Modulation and Therapy|Active, not recruiting||N/A|6|Actual|Indiana University||1|||f||||f||||||||||2017-10-10 23:03:28.882319|2017-10-10 23:03:28.882319
NCT02519894|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-09|2015-08-09|||August 2015||2015-08-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Effect of Intensive Low Sodium Restriction on Glomerular Infiltration Rate in Chronic Kidney Disease|Effect of Intensive Low Sodium Restriction on Glomerular Infiltration Rate in Chronic Kidney Disease|Unknown status|Enrolling by invitation|N/A|600|Anticipated|Ramathibodi Hospital||2|||f||||||||||||||2017-10-10 23:03:28.993946|2017-10-10 23:03:28.993946
NCT02519881|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-10|||February 2014||2014-02-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||the Efficacy and Safety of a Modified Microfracture Using Collagen Compared to Those of a Simple Microfracture in Ankle|This Clinical Trial Evaluated the Efficacy and Safety of a Modified Microfracture Using Collagen Compared to Those of a Simple Microfracture in Patients With Cartilage Defects in Their Ankles.|Recruiting||Phase 4|60|Anticipated|Sewon Cellontech Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:03:29.077141|2017-10-10 23:03:29.077141
NCT02519868|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-07-18|||August 2015||2015-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Chemical Block and Electrical Stimulation of the Carotid Body to Treat Refractory Hypertension|Chemical Block and Electrical Stimulation of the Carotid Body to Treat Refractory Hypertension|Recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||||2017-10-10 23:03:29.195114|2017-10-10 23:03:29.195114
NCT02519855|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-03-17|2016-12-22||September 2015||2015-09-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Participants are included as randomized|Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)|A Phase III, Double-Blind, Randomized, Multicenter Study to Evaluate the Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated)|Completed||Phase 3|882|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:03:29.333398|2017-10-10 23:03:29.333398
NCT02519842|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-03-08|||September 2015||2015-09-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondandsetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)|A Phase III, Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0517/Fosaprepitant and Ondansetron Versus Ondansetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Subjects Receiving Emetogenic Chemotherapy|Terminated||Phase 3|75|Actual|Merck Sharp & Dohme Corp.||2||"Further data are no longer required to support an application for use in pediatric patients.   The decision to terminate was not based on any new safety findings"|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:03:29.776394|2017-10-10 23:03:29.776394
NCT02519829|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-08-06|||January 2010||2010-01-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|July 2011|Actual|2011-07-01||Interventional|||A Clinical Trial Comparing Monocryl and Dermabond Closure Versus Staple Closure in Total Hip Arthroplasty|A Randomized Clinical Trial Comparing Monocryl and Dermabond Closure Versus Staple Closure in Total Hip Arthroplasty|Completed||N/A|139|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:03:29.881535|2017-10-10 23:03:29.881535
NCT02519816|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-08-15|||March 2016||2016-03-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Interventional|CARE||Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD|Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD|Recruiting||Phase 2|25|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||t||||||||||2017-10-10 23:03:29.95813|2017-10-10 23:03:29.95813
NCT02519803|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-06|||January 2016||2016-01-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PHIRST-SA||A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa|A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa|Not yet recruiting||N/A|4500|Anticipated|National Institute for Communicable Diseases, South Africa|||1||f||||f||||||||||2017-10-10 23:03:30.06147|2017-10-10 23:03:30.06147
NCT02519790|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2017-07-25|||August 2016||2016-08-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Observational|OPTI-MOM||Optimizing Medication Management for Mothers With Depression|Optimizing Medication Management for Mothers With Depression|Recruiting||N/A|200|Anticipated|Northwestern University|||1||f||||t||||||Samples With DNA|"     Whole blood, Cerebrospinal Fluid   "|||2017-10-10 23:03:30.168406|2017-10-10 23:03:30.168406
NCT02519777|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-09-13|||March 2016||2016-03-01|September 2017|2017-09-01||||October 2018|Anticipated|2018-10-01||Interventional|||Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)|A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV|Recruiting||Phase 4|186|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t|t|f||||||||2017-10-10 23:03:30.279337|2017-10-10 23:03:30.279337
NCT02519764|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2015-09-01|||August 2015||2015-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|NATRITRAIL||"Evaluation of the Impact of a Hydration Protocol at Thirst on Natremia of the Ultra Trail du Mont-Blanc, 2015 Runners"|"Evaluation of the Impact of a Hydration Protocol at Thirst on Natremia of the Ultra Trail du Mont-Blanc, 2015 Runners"|Completed||N/A|198|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 23:03:30.505734|2017-10-10 23:03:30.505734
NCT02519751|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-06|||October 2014||2014-10-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle Mass|Total Body Skeletal Muscle Mass Estimation by Creatine (Methyl-d3) Dilution in Athletes|Completed||N/A|20|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:03:30.633845|2017-10-10 23:03:30.633845
NCT02519738|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-03-26|||January 15, 2015|Actual|2015-01-15|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Granulation Tissue Treatment: Silver Nitrate vs Kenalog vs Washcloth Abrasion|Granulation Tissue at G Tube Site: Treatment With Kenalog vs Chemical Cauterization With Silver Nitrate vs Soap Washcloth Abrasion|Recruiting||Phase 3|120|Anticipated|University of Michigan||3|||f||||f||||||||||2017-10-10 23:03:30.696989|2017-10-10 23:03:30.696989
NCT02519725|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-07-27|||June 11, 2015|Actual|2015-06-11|June 2016|2016-06-01|July 15, 2017|Actual|2017-07-15|January 4, 2017|Actual|2017-01-04||Interventional|ICU-diary||Impact of an ICU Diary on the Well-being of Patients and Families. A Prospective Multicenter Mixed Study|ICU Diaries Impact of an ICU Diary on the Psychological Well-being of the Patients and Their Relatives. Mixed Multicenter Randomized Study With Blind Evaluation|Completed||N/A|700|Actual|Groupe Hospitalier Paris Saint Joseph||2|||f||||t||||||||||2017-10-10 23:03:30.788381|2017-10-10 23:03:30.788381
NCT02519712|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-09-26|||July 28, 2015|Actual|2015-07-28|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors|Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors|Terminated||N/A|4|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-10 23:03:32.588347|2017-10-10 23:03:32.588347
NCT02519699|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-04-02|||March 2013||2013-03-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension|Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension|Completed||Phase 4|40|Actual|Federal University of São Paulo||1|||f||||f||||||||Undecided|undecided|2017-10-10 23:03:32.687665|2017-10-10 23:03:32.687665
NCT02519686|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-11-01|||July 2015||2015-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Trendelenberg Versus Left Lateral Position for Colonoscopy|The Impact of Trendelenberg Positioning as Compared to Left Lateral Positioning on Ease of Colonoscope Insertion During Colonoscopy|Completed||N/A|150|Actual|Washington University School of Medicine|||2||f||||t||||||||||2017-10-10 23:03:32.782221|2017-10-10 23:03:32.782221
NCT02519673|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-03-17|||August 8, 2015|Actual|2015-08-08|March 2017|2017-03-01|March 15, 2017|Actual|2017-03-15|January 18, 2017|Actual|2017-01-18||Observational|LATAC||Comparison of Corneal Stromal Tissue Consumption (LATAC)|Comparison of Corneal Stromal Tissue Consumption Values Estimated When Programming the Intervention Versus the Values Measured by Pre and Postoperative Topography|Completed||N/A|50|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 23:03:32.8591|2017-10-10 23:03:32.8591
NCT02519660|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-07|2016-03-25|||April 2015||2015-04-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Needle Procedures Success Rate After Application of Ralydan vs EMLA in Children|Lidocaine/Tetracaine Patch (Ralydan) vs Lidocaine/Prilocaine Cream (EMLA) for Needle Related Procedures in Children: a Multicenter, Randomized Controlled Trial|Completed||Phase 3|339|Actual|IRCCS Burlo Garofolo||2|||f||||f||||||||||2017-10-10 23:03:32.934978|2017-10-10 23:03:32.934978
NCT02519647|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-08-10|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|S-Guide||Comparison of Intubation Conditions Between the Gliderite and the S-Guide|Comparison of Intubation Conditions Between the Gliderite and the S-Guide in Patients With Simulated Difficult Airways|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-10 23:03:33.054936|2017-10-10 23:03:33.054936
NCT02519634|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-06|||August 2015||2015-08-01|August 2015|2015-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||SMP vs RIRS for Symptomatic Lower Pole Renal Calculi of 10-20 mm Size: a Randomized Controlled Trial|Super-Mini Percutaneous Nephrolithotomy (SMP) Versus Retrograde Intrarenal Surgery (RIRS) for Symptomatic Lower Pole Renal Calculi of 10-20 mm Size: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|160|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||f||||||||||2017-10-10 23:03:33.140507|2017-10-10 23:03:33.140507
NCT02519621|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-05-05|||April 2016||2016-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|Cardinal PRO||To Compare the Efficacy of NPWT PRO Versus KCI Ulta® NPWT and to Compare NPWT PRO Versus NPWT PRO With Simultaneous Irrigation on Wound Healing|A Pilot Study to Compare the Efficacy of NPWT PRO Versus KCI Ulta® NPWT and to Compare NPWT PRO Versus NPWT PRO With Simultaneous Irrigation on Wound Healing|Recruiting||N/A|90|Anticipated|University of Texas Southwestern Medical Center||3|||f||||f||||||||||2017-10-10 23:03:33.241599|2017-10-10 23:03:33.241599
NCT02519608|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-14|||September 2015||2015-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Interventional|NATHAN-NEVER||ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts|Comparison Between Ticagrelor and Clopidogrel Effect on Endothelial, Platelet and Inflammation Parameters in Patients With Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease Undergoing PCI|Completed||Phase 2|44|Actual|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-10 23:03:33.348561|2017-10-10 23:03:33.348561
NCT02519595|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-08-18|2016-04-22||August 2010||2010-08-01|August 2016|2016-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Children aged3-18 years who received procedural sedation and analgesia in the Emergency Department|Optimal Dosing of Ketamine for Procedural Sedation and Analgesia in Children|Optimal Dosing of Ketamine for Procedural Sedation and Analgesia in Children|Completed||Phase 4|182|Actual|Children's Hospital of Michigan|Convenience sample of patients enrolled. One fourth of patients did not receive the dose that they were randomized to. We did not enroll children <3 years. We did not randomize by procedure type which could have confounded length of sedation.|3|||f||||f||||||||||2017-10-10 23:03:33.478559|2017-10-10 23:03:33.478559
NCT02519582|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-05-11|||August 2015||2015-08-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Nikolo||Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy|Phase II Trial to Investigate the Safety and Efficacy of Orally Applied Niclosamide in Patients With Metachronous or Synchronous Metastases of a Colorectal Cancer Progressing After Therapy|Recruiting||Phase 2|37|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-10 23:03:34.80351|2017-10-10 23:03:34.80351
NCT02519569|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-06|||August 2015||2015-08-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Internet-based Intervention for Complicated Grief: A Pilot Study|Internet-based Intervention for Complicated Grief: A Pilot Study|Unknown status|Not yet recruiting|N/A|10|Anticipated|University of Tromso||1|||f||||f||||||||||2017-10-10 23:03:34.916524|2017-10-10 23:03:34.916524
NCT02517177|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-05|||June 2011||2011-06-01|August 2015|2015-08-01||||December 2012|Actual|2012-12-01||Interventional|AUTOCARD||Alterations in Autonomic Cardiovascular Control Induced at Partial G Forces||Completed||N/A|12|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:59.663318|2017-10-10 23:03:59.663318
NCT02519556|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-04-28|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|August 2016|Actual|2016-08-01||Interventional|||Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children|Randomized, Double Blind, Controlled Trial on Effectiveness Combined Probiotics in the Treatment of Atopic Dermatitis in Children up to 6 Months|Completed||Phase 4|60|Actual|Casa Espirita Terra de Ismael||2|||f||||t||||||||||2017-10-10 23:03:34.991352|2017-10-10 23:03:34.991352
NCT02519543|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-03-10|||September 2015||2015-09-01|March 2016|2016-03-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Interventional|TRIO-BD||Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder|Treating Insulin Resistance to Improve Outcome in Refractory Bipolar Disorder: a Randomized, Double-blind, Placebo-control Study of the Efficacy of Metformin in Patients With Insulin Resistance and Non-remitting Bipolar Illness|Recruiting||Phase 3|110|Anticipated|Nova Scotia Health Authority||2|||f||||t||||||||No||2017-10-10 23:03:35.103028|2017-10-10 23:03:35.103028
NCT02519530|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-08-06|||August 2012||2012-08-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|||Multi-site Evaluation of an Evidence-based Positive Youth Development Program|Multi-site Evaluation of an Evidence-based Positive Youth Development Program: a School-level, Longitudinal, Randomized Controlled Trial|Completed||N/A|8161|Actual|University of South Florida||2|||f||||f||||||||||2017-10-10 23:03:35.243211|2017-10-10 23:03:35.243211
NCT02519517|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2015-08-06|||November 2011||2011-11-01|August 2015|2015-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Permissive Hypercapnia During One Lung Ventilation: Impact on Right Ventricular Systolic and Diastolic Functions During Lung Resection|Acute Permissive Hypercapnia During One Lung Ventilation: Impact on Right Ventricular Systolic and Diastolic Functions During Lung Resection|Completed||N/A|15|Actual|Cairo University||1|||f||||f||||||||||2017-10-10 23:03:35.32117|2017-10-10 23:03:35.32117
NCT02519504|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-07-25|||July 2015||2015-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Observational|||Intervention and Outcomes in Duarte Galactosemia|Intervention and Outcomes in Duarte Galactosemia|Recruiting||N/A|1200|Anticipated|Emory University|||3||f||||f||||||Samples With DNA|"     DNA isolated from saliva samples   "|||2017-10-10 23:03:35.392421|2017-10-10 23:03:35.392421
NCT02519491|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-06-29|||July 2015||2015-07-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study|Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study|Completed||N/A|438|Actual|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-10 23:03:35.508676|2017-10-10 23:03:35.508676
NCT02519478|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-01-19|||August 2015|Actual|2015-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|HuTT||Prevention of Head Impacts in Football: The HuTT Technique|Prevention of Head Impacts in Football: The HuTT Technique|Completed||N/A|111|Actual|University of New Hampshire||2|||f||||f||||||||No||2017-10-10 23:03:35.603086|2017-10-10 23:03:35.603086
NCT02519465|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-10|||July 2015||2015-07-01|August 2015|2015-08-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Evaluation of Lung Deposition of Aerosol Via HFNC in Healthy Adults|Evaluation of Lung Deposition of Aerosol Via HFNC in Healthy Adults|Unknown status|Recruiting|N/A|25|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 23:03:35.685671|2017-10-10 23:03:35.685671
NCT02519439|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-01-06|||February 2015||2015-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures|A follow-on, Two-year Open-label Extension Study of Ganaxolone as add-on Therapy in Adult Patients With Drug-resistant Partial-onset Seizures|Terminated||Phase 3|26|Actual|Marinus Pharmaceuticals||1||"Ganaxolone missed its primary endpoint in the double-blind portion of the 1042-0603 study. Due   to this outcome Marinus discontinued this extension study."|f||||f||||||||||2017-10-10 23:03:36.056235|2017-10-10 23:03:36.056235
NCT02519426|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-03-01|||February 2015||2015-02-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Clinical Validation of a Novel Classification for Predicting Surgical Complexity in Mandibular Wisdom Teeth Surgery|Clinical Validation of a Novel Classification for Predicting Surgical Complexity of Impacted Mandibular Third Molar Extraction: an Observational Clinical Trial|Active, not recruiting||N/A|110|Anticipated|Lithuanian University of Health Sciences|||6||f||||f||||||||||2017-10-10 23:03:36.170744|2017-10-10 23:03:36.170744
NCT02519413|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-08-25|||July 2015||2015-07-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|REALIZE||Tecfidera Lymphocyte Chart Review|A Retrospective, Multi-Center, Observational Study to Assess the Effect of Tecfidera® Delayed-Release Capsules on Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis (REALIZE)|Completed||N/A|483|Actual|Biogen|||1||f||||f||||||||||2017-10-10 23:03:36.290908|2017-10-10 23:03:36.290908
NCT02519400|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-09|||August 2015||2015-08-01|August 2015|2015-08-01||||October 2015|Anticipated|2015-10-01||Interventional|||A Genotype Stratification Study for Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Male Subjects|A Single Dose, Double-blind, Genotype-based Stratification Study to Explore the Pharmacokinetics and Pharmacodynamics of Amitriptyline According to CYP2D6 and CYP2C19 Polymorphisms in Healthy Korean Male Adult Subjects|Unknown status|Not yet recruiting|Phase 1|24|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-10 23:03:36.402585|2017-10-10 23:03:36.402585
NCT02519192|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-11-17|||January 2017||2017-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ECF||The Role of VAC Therapy Devices in Promoting Closure of Enterocutaneous Fistulae|The Role of VAC Therapy Devices in Promoting Closure of Enterocutaneous Fistulae: A Randomized Controlled Trial|Not yet recruiting||Early Phase 1|50|Anticipated|Denver Health and Hospital Authority||2|||f||||t||||||||No||2017-10-10 23:03:38.502813|2017-10-10 23:03:38.502813
NCT02519387|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-07-14|2016-05-15||July 2013||2013-07-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity|Multicentre Study for Evaluation of the Efficacy and Safety of Buprenorphine Transdermal Patch (SOVENOR®) 5mg and 10mg in Patients With Non-malignant Pain of Moderate Intensity Due to Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain and Joint/Muscle Pain, When an Opioid is Necessary for Obtaining Adequate Analgesia|Completed||Phase 4|78|Actual|Mundipharma Pharmaceuticals Sdn. Bhd.||1|||f||||f||||||||||2017-10-10 23:03:36.488033|2017-10-10 23:03:36.488033
NCT02519374|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-02-04|||June 2015||2015-06-01|July 2015|2015-07-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|FITIC||Fiber Tolerability in Children|Fiber Tolerability in Children|Completed||N/A|40|Actual|Nestlé||4|||f||||f||||||||||2017-10-10 23:03:36.81944|2017-10-10 23:03:36.81944
NCT02519361|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2015-08-05|||August 2015||2015-08-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Involvement of the Translation Initiation Factors in Resolution of Inflammation in the Elderly Population|The Involvement of the Translation Initiation Factors eIF4E and eIF4G in Resolution of Inflammation in the Elderly Population|Unknown status|Not yet recruiting|N/A|30|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-10 23:03:36.9221|2017-10-10 23:03:36.9221
NCT02519348|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-26|||October 19, 2015|Actual|2015-10-19|September 2017|2017-09-01|March 20, 2020|Anticipated|2020-03-20|March 20, 2020|Anticipated|2020-03-20||Interventional|||A Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Unresectable Hepatocellular Carcinoma|A Study of Safety, Tolerability, and Clinical Activity of MEDI4736 and Tremelimumab Administered as Monotherapy and in Combination to Subjects With Unresectable Hepatocellular Carcinoma|Recruiting||Phase 2|440|Anticipated|MedImmune LLC||4|||f||||f|t|f||||||||2017-10-10 23:03:36.988437|2017-10-10 23:03:36.988437
NCT02519335|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-03-21|||September 2014||2014-09-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation|Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation|Terminated||Phase 1|12|Actual|Medical City Children's Hospital||1||PI no longer at this facility|f||||t||||||||No||2017-10-10 23:03:37.19743|2017-10-10 23:03:37.19743
NCT02519322|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-09-14|||February 2, 2016|Actual|2016-02-02|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Neoadjuvant and Adjuvant Checkpoint Blockade in Patients With Clinical Stage III or Oligometastatic Stage IV Melanoma|Neoadjuvant and Adjuvant Checkpoint Blockade in Patients With Clinical Stage III or Oligometastatic Stage IV Melanoma|Active, not recruiting||Phase 2|30|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 23:03:37.33648|2017-10-10 23:03:37.33648
NCT02519309|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-02-22|||August 2015||2015-08-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Dietary Intervention in Type-2 Diabetes and Pre-Diabetes|Dietary Intervention in Type-2 Diabetics and Pre-Diabetics Emphasizing Personalized Carbohydrate Intake|Active, not recruiting||N/A|500|Anticipated|Virta Health||3|||f||||f||||||||||2017-10-10 23:03:37.446551|2017-10-10 23:03:37.446551
NCT02519296|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-08-09|||January 2016||2016-01-01|August 2016|2016-08-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A fMRI Study of the Treatment of Danish Veterans With PTSD With Prolonged Exposure Therapy|A fMRI Study of the Treatment of Danish Veterans With Post-Traumatic Stress Disorder With Prolonged Exposure Therapy: Study Protocol for a Case-control Trial|Active, not recruiting||N/A|60|Anticipated|Aalborg Universitetshospital||2|||f||||t||||||||||2017-10-10 23:03:37.552875|2017-10-10 23:03:37.552875
NCT02519283|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-10-31|||October 2015||2015-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|GUIDED-HF||Get With the Guidelines in ED Patients With Heart Failure|Get With the Guidelines in ED Patients With Heart Failure|Recruiting||N/A|700|Anticipated|Vanderbilt University||2|||f||||t||||||||Yes||2017-10-10 23:03:37.6316|2017-10-10 23:03:37.6316
NCT02519257|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2015-08-06|||August 2008||2008-08-01|August 2015|2015-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||The Relationship of Adiponectin in Adipose Tissue, Thy-1 in Plaques, and Inflammatory Mediators With Cardiac Diseases|The Relationship of Adiponectin in Adipose Tissue, Thy-1 in Plaques, and Inflammatory|Completed||N/A|96|Actual|Far Eastern Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:03:37.855462|2017-10-10 23:03:37.855462
NCT02519244|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-06-10|||May 2015||2015-05-01|June 2016|2016-06-01||||March 2018|Anticipated|2018-03-01||Interventional|||Wearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple Sclerosis|Wearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple Sclerosis|Recruiting||N/A|10|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||||||||||||2017-10-10 23:03:37.952628|2017-10-10 23:03:37.952628
NCT02519231|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-04-14|||February 2016||2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|CITROS||Copper IUD Treatment Observation Study|A Multi-Center, Double-Blinded, Randomized, Phase IV 6-Month Pilot Study to Compare Bleeding Patterns, Satisfaction and Quality of Life Among New Copper 380A IUD Users Treated With Naproxen Sodium (440mg Twice Daily) Versus Placebo|Recruiting||Phase 4|60|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 23:03:38.188049|2017-10-10 23:03:38.188049
NCT02519218|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-08-31|||August 2015||2015-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01|2 Years|Observational [Patient Registry]|||Ellipse Intramedullary High Tibial Osteotomy Nail Study|Outcomes Registry of Patients With Osteoarthritis and Varus Malalignment of the Knee Treated With Ellipse Intramedullary High Tibial Osteotomy (IM HTO) Nail System|Active, not recruiting||N/A|6|Actual|Ellipse Technologies, Inc.|||1||f||||f||||||||||2017-10-10 23:03:38.313982|2017-10-10 23:03:38.313982
NCT02519205|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-07-19|||October 2015||2015-10-01|February 2016|2016-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Measuring Fatigue in Triage: A Pilot Study|Measuring Fatigue in Triage: A Pilot Study|Completed||N/A|28|Actual|Duke University|||1||f||||f||||||||||2017-10-10 23:03:38.411078|2017-10-10 23:03:38.411078
NCT02519153|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-07-02|||July 2014||2014-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones|Role of Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) in Management of Distal Ureteral Stone|Active, not recruiting||Phase 4|100|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 23:03:38.773729|2017-10-10 23:03:38.773729
NCT02519140|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2016-02-21|||August 2014||2014-08-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections|Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections|Recruiting||Phase 3|32|Anticipated|Maimonides Medical Center||1|||f||||f||||||||||2017-10-10 23:03:38.845748|2017-10-10 23:03:38.845748
NCT02519127|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-09-12|||July 2015||2015-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Metflex: The Effectiveness of a Dietary Intervention|Employing Dynamic Kinetic Responses to Demonstrate the Effectiveness of Dietary Intervention: A Challenge-based Study Using a Low-glycaemic Load Diet|Recruiting||N/A|60|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:03:38.942129|2017-10-10 23:03:38.942129
NCT02519114|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-02-09|||August 2015||2015-08-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma|Natural Killer Cel Alloreactive Bone Marrow Transplantation for Multiple Myeloma|Recruiting||Phase 1/Phase 2|24|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||No||2017-10-10 23:03:39.039248|2017-10-10 23:03:39.039248
NCT02519101|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2017-08-29|||June 2015||2015-06-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ANIKOB||Effects of Continuous Noninvasive Arterial Pressure Measurement on Anaesthesia|Impact of Continuous Noninvasive Arterial Blood Pressure Monitoring on Blood Pressure Stability During General Anaesthesia in Orthopedic Patients|Completed||N/A|160|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-10 23:03:39.133681|2017-10-10 23:03:39.133681
NCT02519088|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-10-08|||August 2015||2015-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)|A New Approach to a Personalized Patient Blood Management Program in Total Hip Arthroplasty|Completed||N/A|477|Actual|Krankenhaus der Barmherzigen Brüder Trier|||1||f||||t||||||||||2017-10-10 23:03:39.213856|2017-10-10 23:03:39.213856
NCT02519075|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-11-18|||April 2015||2015-04-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Observational|||11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE|Diagnostic and Prognostic Role of 11C-Choline PET/CT and DWI MRI for Response Assessment in Patients Affected by Hepatocellular Carcinoma (HCC) and Candidate to TARE|Recruiting||N/A|20|Anticipated|Istituto Clinico Humanitas|||1||f||||t||||||None Retained|"     Biopsy specimen   "|||2017-10-10 23:03:39.288906|2017-10-10 23:03:39.288906
NCT02519062|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-11-18|||December 2014||2014-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Observational|||Role of FDG PET, Immune and Hypoxic Marker in NSCLC|FDG-PET, Marker Immunologici ed Ipossici in Pazienti Affetti da Carcinoma Polmonare Non a Piccole Cellule in Stadio I-III Sottoposti a Chirurgia Radicale|Recruiting||N/A|130|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples Without DNA|"     Tumor surgical specimen   "|||2017-10-10 23:03:39.404647|2017-10-10 23:03:39.404647
NCT02519049|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-11-18|||September 2014||2014-09-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Observational|||11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)|Diagnostic and Prognostic Role of 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM) and Candidate to Pleurodesis|Recruiting||N/A|20|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples Without DNA|"     Biopsy specimen   "|||2017-10-10 23:03:39.500826|2017-10-10 23:03:39.500826
NCT02519036|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2017-06-22|||August 31, 2015|Actual|2015-08-31|June 2017|2017-06-01|November 30, 2017|Anticipated|2017-11-30|July 31, 2017|Anticipated|2017-07-31||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 443139 in Patients With Early Manifest Huntington's Disease|Active, not recruiting||Phase 1/Phase 2|46|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 23:03:39.578594|2017-10-10 23:03:39.578594
NCT02519023|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-06-28|||July 2016||2016-07-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy|Transversus Abdominis Plane (TAP) Infiltration vs. Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Assisted Hysterectomy|Completed||Phase 4|75|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 23:03:39.698997|2017-10-10 23:03:39.698997
NCT02519010|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-08-05|||March 2011||2011-03-01|August 2015|2015-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)|Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)|Completed||Phase 1|36|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||||2017-10-10 23:03:39.816955|2017-10-10 23:03:39.816955
NCT02518997|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-01-03|||October 2014||2014-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Reading to Preterm Infants on Baby and Parents' Well Being|Effects of Reading to Preterm Infants on Baby and Parents' Well Being|Enrolling by invitation||N/A|80|Anticipated|Georgetown University||1|||f||||f||||||||||2017-10-10 23:03:39.919905|2017-10-10 23:03:39.919905
NCT02518984|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-08-10|||October 2013||2013-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2016|Anticipated|2016-08-01|3 Years|Observational [Patient Registry]|AFGenLT||Atrial Fibrillation General Registry|Atrial Fibrillation General Long Term Registry|Recruiting||N/A|10000|Anticipated|European Society of Cardiology|||1||f||||f||||||||No||2017-10-10 23:03:40.006856|2017-10-10 23:03:40.006856
NCT02518971|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-12-14|||August 2015||2015-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients|Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients|Recruiting||Phase 3|228|Anticipated|University of Michigan||2|||f||||f||||||||No||2017-10-10 23:03:40.098754|2017-10-10 23:03:40.098754
NCT02518958|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-07-02|||July 21, 2015|Actual|2015-07-21|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIMETIME||A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab|A Phase I, Open-Label, Multiple Ascending Dose Study to Assess the Safety and Tolerability of RRx-001 and Nivolumab in Subjects With Advanced Solid Tumors or Lymphomas For Which There Are No Currently Accepted Life-Prolonging Therapies (PRIMETIME)|Active, not recruiting||Phase 1|45|Anticipated|EpicentRx, Inc.||1|||f||||f||||||||||2017-10-10 23:03:40.189872|2017-10-10 23:03:40.189872
NCT02518945|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-08-07|||August 2015||2015-08-01|August 2015|2015-08-01||||April 2016|Anticipated|2016-04-01||Interventional|||Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes|Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes. A Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|30|Anticipated|University at Buffalo||2|||f||||t||||||||||2017-10-10 23:03:40.293235|2017-10-10 23:03:40.293235
NCT02518932|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-08-07|||March 2015||2015-03-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|LVKGR||The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man|The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man|Unknown status|Recruiting|Phase 1|20|Anticipated|Elahi, Dariush, PhD||2|||f||||f||||||||||2017-10-10 23:03:40.41651|2017-10-10 23:03:40.41651
NCT02518906|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-01-08|||September 2015||2015-09-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Evaluation of AIT Study|Process-Outcome Study on Psychotherapeutic Interventions in Adolescents With Personality Disorders|Recruiting||N/A|60|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||Undecided||2017-10-10 23:03:40.594054|2017-10-10 23:03:40.594054
NCT02518893|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-05-25|||April 2015||2015-04-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Health Research Participation: Experiences and Decisions of Military Members|Health Research Participation: Experiences and Decisions of Military Members|Recruiting||N/A|50|Anticipated|University of Washington|||1||f||||f||||||||||2017-10-10 23:03:40.708321|2017-10-10 23:03:40.708321
NCT02518880|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2015-08-06|||March 2010||2010-03-01|August 2015|2015-08-01||||February 2012|Actual|2012-02-01||Interventional|DYMCO||Dynamics of Stroke Volume and Cardiac Output During Parabolic Flight, and Its Relationship to Intravascular Volume||Completed||N/A|18|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:40.820451|2017-10-10 23:03:40.820451
NCT02518867|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-08-05|||March 2013||2013-03-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Motor Disability of Children With Cerebral Palsy Using Motor Transcranial Magnetic Stimulation|Modulating and Managing the Motor Disability of Children With Cerebral Palsy Using Motor Transcranial Magnetic Stimulation|Unknown status|Recruiting|N/A|90|Anticipated|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-10 23:03:40.882117|2017-10-10 23:03:40.882117
NCT02518854|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-07-19|||June 2015||2015-06-01|July 2017|2017-07-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||Identifying Biomarkers and Cardiovascular Risk Factors in Childhood Metabolic Syndrome|Identifying Biomarkers and Cardiovascular Risk Factors in Childhood Metabolic Syndrome|Completed||N/A|80|Actual|Chang Gung Memorial Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:03:40.973931|2017-10-10 23:03:40.973931
NCT02518841|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-06-13|||August 2015||2015-08-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparison of ThermaWedge™ Device and Achilles Tendon Stretching for the Treatment of Plantar Fasciopathy|A Comparison of ThermaWedge™ Device and Achilles Tendon Stretching for the Treatment of Plantar Fasciopathy|Recruiting||N/A|60|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:03:41.053104|2017-10-10 23:03:41.053104
NCT02518828|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-04-03|||January 2017|Actual|2017-01-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|HiLo||High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure|High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure|Recruiting||N/A|50|Anticipated|University of Alberta||2|||f||||f|f|||||||||2017-10-10 23:03:41.167356|2017-10-10 23:03:41.167356
NCT02518815|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-08-05|||May 2013||2013-05-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Preoperative Warming Prevents Postoperative Hypothermia in Laparoscopic Gynecologic Surgery. A Randomized Control Trial|Preoperative Active Warming Prevents Postoperative Hypothermia in Patients Undergoing Laparoscopic Gynecologic Surgery. A Randomized Control Trial|Completed||N/A|42|Actual|Toronto East General Hospital||2|||f||||f||||||||||2017-10-10 23:03:41.402295|2017-10-10 23:03:41.402295
NCT02518802|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-08-05|||January 2015||2015-01-01|April 2015|2015-04-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma|Pemetrexed Disodium and Cisplatin Chemotherapy Combined With Synchronous Gefitinib vs Chemotherapy Alone as Adjuvent Therapy in Patient With Stage II-IIIA, Epidermal Growth Factor Receptor Mutant Expressing Lung Adenocarcinoma|Recruiting||Phase 3|220|Anticipated|Tang-Du Hospital||2|||f||||t||||||||||2017-10-10 23:03:41.530339|2017-10-10 23:03:41.530339
NCT02518789|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-07|||September 2015||2015-09-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Effects and Mechanism of Pretreatment With Dexmedetomidine to Etomidate Induce Myoclonus|Effects and Mechanism of Pretreatment With Dexmedetomidine to Etomidate Induce Myoclonus During General Anesthesia Induction Period|Unknown status|Not yet recruiting|Phase 4|132|Anticipated|Tang-Du Hospital||3|||f||||f||||||||||2017-10-10 23:03:41.686476|2017-10-10 23:03:41.686476
NCT02518750|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-26|||November 23, 2016|Actual|2016-11-23|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma|A Phase II Study Incorporating Panobinostat, Bortezomib and Liposomal Vincristine Into Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma|Recruiting||Phase 2|40|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-10 23:03:42.074602|2017-10-10 23:03:42.074602
NCT02518737|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-07-27|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Examination of the Postprandial Bone Remodeling in Persons With Reduced GIP-Receptor Activity|Examination of the Postprandial Bone Remodeling in Persons With Reduced Activity of the Receptor for the Enteric Hormone Glucose-dependent Insulinotropic Polypeptide|Completed||N/A|36|Actual|University of Copenhagen|||2||f||||f||||||||||2017-10-10 23:03:42.267843|2017-10-10 23:03:42.267843
NCT02518724|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-12-23|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||The Effect of Remote Ischemic Preconditioning on Physical Performance and Exertional Rhabdomyolysis|The Effect of Remote Ischemic Preconditioning (RIPC) on Physical Performance and Exertional Rhabdomyolysis|Not yet recruiting||N/A|30|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:03:42.350133|2017-10-10 23:03:42.350133
NCT02518711|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-07|||September 2011||2011-09-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effectiveness Study of a Behavioral Teacher Program Targeting ADHD Symptoms|A Randomized Controlled Trial Into the Effectiveness of a Behavioral Teacher Program Targeting ADHD Symptoms|Completed||N/A|114|Actual|VU University of Amsterdam||2|||f||||f||||||||||2017-10-10 23:03:42.454012|2017-10-10 23:03:42.454012
NCT02518698|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-09-15|||August 31, 2015|Actual|2015-08-31|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population|Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases|Active, not recruiting||N/A|1163|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:03:42.574204|2017-10-10 23:03:42.574204
NCT02518685|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-04-11|||September 2015||2015-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss|Endoscopic Treatment for Weight Reduction in Patients With Obesity Using the TransPyloric Shuttle® System: A Multicenter, Prospective, Randomized, Double-Blind, Sham-Controlled, Parallel-Design Study|Active, not recruiting||N/A|270|Anticipated|BaroNova, Inc.||2|||f||||t||||||||||2017-10-10 23:03:42.673079|2017-10-10 23:03:42.673079
NCT02518672|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-10-03|||October 2015||2015-10-01|October 2017|2017-10-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|PREMDIC||Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)|Role of DHA Monoglyceride (MAG-DHA) in the Resolution of Pulmonary Inflammation of Patients With Cystic Fibrosis.|Terminated||Phase 2|11|Actual|SCF Pharma||2|||f||||t||||||||||2017-10-10 23:03:42.834259|2017-10-10 23:03:42.834259
NCT02518659|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-08-05|||February 2014||2014-02-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|Privet||Prevalence and Intervention of Hypomagnesemia in Users of Proton-pump Inhibitors|Inulin- a Potential Preventive Dietary Supplement Against PPI Induced Hypomagnesemia|Completed||N/A|21|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 23:03:42.957285|2017-10-10 23:03:42.957285
NCT02518646|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-05-17|||September 2015||2015-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|DECISION||DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models|DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models|Completed||N/A|2500|Actual|Radboud University|||1||f||||f||||||||No||2017-10-10 23:03:43.073357|2017-10-10 23:03:43.073357
NCT02518633|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-02-16|||March 2010||2010-03-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Observational|||Obstructive Sleep Apnoea and Adipose Tissue Dysfunction|Assessment of Hypoxia in Adipose Tissue of Subjects With Obstructive Sleep Apnoea|Completed||N/A|15|Actual|Royal Devon and Exeter NHS Foundation Trust|||2||f||||t||||||Samples Without DNA|"     adipose tissue and blood samples   "|||2017-10-10 23:03:43.173896|2017-10-10 23:03:43.173896
NCT02518620|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-09-07|||July 2015||2015-07-01|September 2017|2017-09-01||||September 2018|Anticipated|2018-09-01||Interventional|||An Extension Study Assessing the Long-Term Efficacy and Safety of Subcutaneous ALX-0061 in Subjects With Rheumatoid Arthritis|A Phase II Multicenter, Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of Subcutaneous ALX-0061 in Subjects With Moderate to Severe Rheumatoid Arthritis Who Have Completed One of the Preceding Phase IIb Studies With ALX 0061|Active, not recruiting||Phase 2|406|Actual|Ablynx||1|||f||||t||||||||||2017-10-10 23:03:43.270052|2017-10-10 23:03:43.270052
NCT02518607|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-03-16|||July 2015||2015-07-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety, Blood Levels and Effects of MGB-BP-3|A Single-centre, Double-blind, Placebo-controlled, Study in Healthy Men to Assess the Safety and Tolerability of Single and Repeated Ascending Doses of MGB-BP-3|Completed||Phase 1|40|Actual|MGB Biopharma Limited||18|||f||||f||||||||||2017-10-10 23:03:43.473288|2017-10-10 23:03:43.473288
NCT02518594|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-05-16|||November 13, 2015|Actual|2015-11-13|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|PROSPECT||A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix|A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix|Recruiting||Phase 3|630|Anticipated|The George Washington University Biostatistics Center||3|||f||||t||||||||Yes|The dataset will be shared per NIH policy after the completion and publication of the main analyses. Requests for datasets can be sent to mfmudatasets@bsc.gwu.edu.|2017-10-10 23:03:43.588573|2017-10-10 23:03:43.588573
NCT02518581|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-05-03|||August 12, 2015|Actual|2015-08-12|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DLW||Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus|Estimating Free-living Human Energy Expenditure - Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus|Recruiting||N/A|10|Anticipated|Profil Institut für Stoffwechselforschung GmbH||1|||f||||f||||||||||2017-10-10 23:03:43.76894|2017-10-10 23:03:43.76894
NCT02518568|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-09-27|||August 2015||2015-08-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia|Study of the Pharmacokinetics of Serum Iron After a Single Oral Administration of Ferrous Sulphate Supplement Synthetic Formula in Women With Iron Deficiency Anaemia.|Terminated||Phase 1|29|Actual|Pierre Fabre Medicament||1|||f||||||||||||||2017-10-10 23:03:43.855158|2017-10-10 23:03:43.855158
NCT02518555|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-09-18|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Early Intervention Trial of Ibrutinib for Patients With Asymptomatic, High-Risk Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Active, not recruiting||Phase 2|42|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:03:43.938115|2017-10-10 23:03:43.938115
NCT02518542|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-08-07|||June 2014||2014-06-01|August 2015|2015-08-01|June 2027|Anticipated|2027-06-01|June 2024|Anticipated|2024-06-01||Interventional|POETA||Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia|Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) as Additional Endoscopic Treatment Options for Achalasia and Other Esophageal Motility Disorders|Recruiting||N/A|400|Anticipated|Medical University of Vienna||4|||f||||f||||||||||2017-10-10 23:03:44.073415|2017-10-10 23:03:44.073415
NCT02518529|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-05|||February 2001||2001-02-01|August 2015|2015-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients|An Open, Multi-centre Study to Determine the Tolerability, Safety and Antibody Response Resulting From G17DT at 250mcg at Weeks 0, 2 and 6 With a Booster of 125mcg or 250mcg Given to Patients With Stage I - III Gastric Cancer|Completed||Phase 2|41|Actual|Cancer Advances Inc.||1|||f||||||||||||||2017-10-10 23:03:44.177364|2017-10-10 23:03:44.177364
NCT02518516|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-03-11|||January 2011||2011-01-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||High Potency Statins and Acute Kidney Injury|Use of High Potency Statins and Rates of Admission for Acute Kidney Injury: Multicenter, Retrospective Observational Analysis of Administrative Databases|Completed||N/A|2067639|Actual|Canadian Network for Observational Drug Effect Studies, CNODES|||2||f||||f||||||||||2017-10-10 23:03:44.255131|2017-10-10 23:03:44.255131
NCT02518503|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-03-11|||July 2012||2012-07-01|August 2015|2015-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|Statins-DM||High Potency Statins and the Risk of Diabetes|Higher Potency Statins and the Risk of New Diabetes: Multicentre, Observational Study of Administrative Databases|Completed||N/A|136966|Actual|Canadian Network for Observational Drug Effect Studies, CNODES|||2||f||||f||||||||||2017-10-10 23:03:44.350312|2017-10-10 23:03:44.350312
NCT02518490|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-10-12|||August 2015||2015-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:03:44.444642|2017-10-10 23:03:44.444642
NCT02518477|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-08-08|||September 2015||2015-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|LYCA||Preventive Intervention Against Lymphedema After Breast Cancer Surgery|LYCA: Preventive Intervention Against Lymphedema After Breast Cancer Surgery - a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|158|Anticipated|Danish Cancer Society||2|||f||||f||||||||||2017-10-10 23:03:44.484843|2017-10-10 23:03:44.484843
NCT02518464|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-06|2017-08-14|||October 2015||2015-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|TRACTOR||Ticagrelor Therapy for RefrACTORy Migraine Study|Ticagrelor Therapy for RefrACTORy Migraine Study Pilot (TRACTOR)|Active, not recruiting||Phase 4|40|Actual|Columbia University||1|||f||||t|t|f||||||||2017-10-10 23:03:44.592365|2017-10-10 23:03:44.592365
NCT02518451|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-06|||June 2013||2013-06-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|||Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg|Bioequivalence Study of 160 mg Valsartan Film-coated Caplets Produced by PT Dexa Medica in Comparison With the Innovator Film-coated Tablets (Diovan® 160, Novartis Pharma AG)|Completed||N/A|48|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-10 23:03:44.671466|2017-10-10 23:03:44.671466
NCT02518438|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-08-04|||May 2012||2012-05-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||The Analgesic Efficacy of Wound Infiltration With Tramadol|A Randomized Trial of the Analgesic Efficacy of Wound Infiltration With Tramadol After Cesarean Delivery Under General Anesthesia|Completed||Phase 4|60|Actual|Yeditepe University Hospital||2|||f||||f||||||||||2017-10-10 23:03:44.752476|2017-10-10 23:03:44.752476
NCT02518425|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-05-13|||April 2015||2015-04-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Improvement in Acoustic Voice Characteristics in Functional Dysphonia After Therapy|Which Instrumental Acoustic Voice Parameters Indicate Vocal Improvement After Voice Therapy in Patients With Functional Dysphonia|Completed||N/A|50|Actual|University of Zurich|||1||f||||t||||||||||2017-10-10 23:03:44.836933|2017-10-10 23:03:44.836933
NCT02518412|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-08-10|||May 2013||2013-05-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|tDCS||Transcranial Direct Current Stimulation (tDCS) as a Cognitive Enhancer for Patients With Alzheimers Disease|Transcranial Direct Current Stimulation (tDCS) as a Cognitive Enhancer for Patients With Alzheimers Disease|Unknown status|Recruiting|N/A|30|Anticipated|University of Tromso||2|||f||||f||||||||||2017-10-10 23:03:44.899108|2017-10-10 23:03:44.899108
NCT02518399|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-04|||April 2013||2013-04-01|August 2015|2015-08-01||||September 2015|Anticipated|2015-09-01||Interventional|CHT||Chronic Heat Therapy for Improving Vascular Health|Chronic Heat Therapy for Improving Biomarkers of Vascular Health in Young, Healthy, Humans|Unknown status|Active, not recruiting|N/A|20|Actual|University of Oregon||2|||f||||f||||||||||2017-10-10 23:03:44.975945|2017-10-10 23:03:44.975945
NCT02518386|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-08-04|||March 2015||2015-03-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|April 2015|Actual|2015-04-01|1 Month|Observational [Patient Registry]|EpiTox||Epidemiology of Acute Self-poisoning in Emergency Services in France|Evaluation of the Epidemiology and the Take Load of Voluntary Drug Intoxications by the Emergency Structures in France|Unknown status|Active, not recruiting|N/A|700|Actual|University Hospital, Grenoble|||1||f||||t||||||||||2017-10-10 23:03:45.053693|2017-10-10 23:03:45.053693
NCT02518373|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-05|||April 2000||2000-04-01|August 2015|2015-08-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|CC5||Effect of G17DT in Patients With Stage II/III Colorectal Cancer|An Open-label Volunteer Study of the Effect of G17DT on the Elevation of Plasma Gastrin Levels After Therapy With a Proton Pump Inhibitor (Omeperazole) in Patients With Treated Stage II/III Colorectal Cancer|Completed||Phase 2|22|Actual|Cancer Advances Inc.||1|||f||||f||||||||||2017-10-10 23:03:45.128268|2017-10-10 23:03:45.128268
NCT02518360|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-06-21|||September 2015||2015-09-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|Osteop-COP||Osteopathic Treatment in Patients With Low Back Pain: Stabilometry|Effect of Osteopathic Treatment in Patients With Nonspecific Low Back Pain: Stabilometry|Completed||N/A|50|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||||2017-10-10 23:03:45.207195|2017-10-10 23:03:45.207195
NCT02518347|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-06-09|||March 2015||2015-03-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|November 2016|Actual|2016-11-01||Interventional|||Strawberries and Knee Osteoarthritis (OA)|Effects of Freeze-dried Strawberries on Systemic Markers of Inflammation and Knee Function in Participants With Osteoarthritis (OA)|Completed||N/A|20|Actual|Oklahoma State University||2|||f||||f||||||||||2017-10-10 23:03:45.371907|2017-10-10 23:03:45.371907
NCT02518334|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2016-08-05|||March 2012||2012-03-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|WGC||Wine Consumption and Glycemic Control|Wine Consumption and Glycemic Control|Completed||N/A|14|Actual|University of Missouri-Columbia||1|||f||||f||||||||No||2017-10-10 23:03:45.47842|2017-10-10 23:03:45.47842
NCT02518321|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-08-05|||August 2015||2015-08-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Can Technology-Assisted Toilets Improve Hygiene and Independence in Geriatric Rehabilitation? A Cohort Study|Can Technology-Assisted Toilets Improve Hygiene and Independence in Geriatric Rehabilitation? A Cohort Study|Unknown status|Not yet recruiting|N/A|40|Anticipated|Bruyere Research Institute||2|||f||||f||||||||||2017-10-10 23:03:45.605058|2017-10-10 23:03:45.605058
NCT02518308|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-09-26|||October 2015||2015-10-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer|Mindfulness-Based Interventions in Patients Treated for Gynecologic Cancer - Impact on Patient Reported Outcomes and Immunologic Correlates|Recruiting||N/A|38|Anticipated|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-10 23:03:45.701676|2017-10-10 23:03:45.701676
NCT02518295|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion|β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion: Probiotic and Lactose Intolerance|Completed||N/A|41|Actual|Nestlé||4|||f||||t||||||||||2017-10-10 23:03:45.820433|2017-10-10 23:03:45.820433
NCT02518282|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-14|||January 2014||2014-01-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||High-sensitivity Troponin T in Acute Myocardial Infarction After Cardiac Valvular Surgery|High-sensitivity Troponin T in Acute Myocardial Infarction in Patients Undergoing Cardiac Valvular Surgery|Unknown status|Recruiting|N/A|800|Anticipated|University of Valladolid|||1||f||||t||||||||||2017-10-10 23:03:45.928684|2017-10-10 23:03:45.928684
NCT02518269|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-06-16|||May 2015||2015-05-01|June 2017|2017-06-01|December 2028|Anticipated|2028-12-01|December 2023|Anticipated|2023-12-01||Interventional|||A 3-Arm Study on G7 Acetabular Cup With Echo BiMetric Stem in Total Hip Arthroplasty|A Prospective 3-Arm Randomized Controlled Study on G7 Acetabular Cup With Echo BiMetric Stem in Total Hip Arthroplasty|Recruiting||N/A|360|Anticipated|Zimmer Biomet||3|||f||||f||||||||No|Plan is to publish articles for all the enrolled patients.|2017-10-10 23:03:46.060778|2017-10-10 23:03:46.060778
NCT02518256|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-08-04|||May 2014||2014-05-01|August 2015|2015-08-01||||May 2018|Anticipated|2018-05-01||Interventional|LUDOC II||Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity|Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity|Recruiting||N/A|540|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 23:03:46.233831|2017-10-10 23:03:46.233831
NCT02518243|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-08-05|||June 2015||2015-06-01|July 2015|2015-07-01||||September 2016|Anticipated|2016-09-01||Interventional|SaFEE2||Safe & Easy for Alzheimer's Disease and Related Pathologies||Unknown status|Active, not recruiting|N/A|14|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 23:03:46.37118|2017-10-10 23:03:46.37118
NCT02518230|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-05|||January 2014||2014-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants|Respiratory Severity and Caloric Consumption on NAVA: Randomized Crossover Trial of NAVA and SIMV|Completed||N/A|22|Actual|Children's Mercy Hospital Kansas City||2|||f||||t||||||||||2017-10-10 23:03:46.494829|2017-10-10 23:03:46.494829
NCT02518217|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-08-24|||December 2015||2015-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||ShapeUp Empower Study||Completed||N/A|130|Actual|The Miriam Hospital||3|||f||||f||||||||||2017-10-10 23:03:46.636924|2017-10-10 23:03:46.636924
NCT02518204|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-05-23|||July 2015||2015-07-01|May 2017|2017-05-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults|Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults|Completed||N/A|229|Actual|Lumos Labs, Inc.||2|||f||||f||||||||||2017-10-10 23:03:46.764459|2017-10-10 23:03:46.764459
NCT02518191|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-08-21|||August 2015||2015-08-01|August 2016|2016-08-01||||December 2020|Anticipated|2020-12-01||Interventional|||Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity|Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity in Women With Breast Cancer in China|Recruiting||Phase 3|500|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||2|||f||||t||||||||||2017-10-10 23:03:46.882177|2017-10-10 23:03:46.882177
NCT02518178|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2015-08-04|||August 2015||2015-08-01|August 2015|2015-08-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Khushi Baby (KB): Novel Mobile Health Solution for Vaccination Record Keeping in India|Khushi Baby (KB): Efficacy and Impact Assessment of Novel Mobile Health Solution for Vaccination Record Keeping in Rural Udaipur, Rajasthan, India|Unknown status|Enrolling by invitation|N/A|300|Anticipated|Khushi Baby Inc.||3|||f||||f||||||||||2017-10-10 23:03:47.035362|2017-10-10 23:03:47.035362
NCT02518165|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-02-24|||April 2015||2015-04-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effects of A Proprietary Spearmint Extract on Cognitive Performance|A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial to Assess the Effects of A Proprietary Spearmint Extract on Cognitive Performance, Mood, and Sleep in Men and Women|Active, not recruiting||N/A|134|Anticipated|Kemin Foods LC||2|||f||||f||||||||||2017-10-10 23:03:47.159973|2017-10-10 23:03:47.159973
NCT02518152|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-06|||October 2014||2014-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis|Efficacy Of Platelet Rich Fibrin With 1% Alendronate For Treatment Of Intrabony Defects In Chronic Periodontitis: A Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|90|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||f||||||||||2017-10-10 23:03:47.245248|2017-10-10 23:03:47.245248
NCT02518139|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-18|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)|A Phase 3, 52-week, Randomized, Active−Controlled Parallel Group Study to Evaluate the Safety and Tolerability of Nebulized TD−4208 in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|1080|Actual|Theravance Biopharma R & D, Inc.||3|||f||||f||||||||||2017-10-10 23:03:47.338299|2017-10-10 23:03:47.338299
NCT02518126|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-06|||August 2015||2015-08-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates|Comparison of LIF (Leukemia Inhibitory Factor) Level Between Neonates Who Are IUGR (Intra Uterine Growth Restriction) and Those Who Are AGA (Average for Gestational Age)|Unknown status|Not yet recruiting|N/A|40|Anticipated|Rambam Health Care Campus|||2||f||||||||||Samples Without DNA|"     Cord blood and a small peace of the placenta   "|||2017-10-10 23:03:47.425435|2017-10-10 23:03:47.425435
NCT02518113|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-10-02|||September 2015||2015-09-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL|A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination With Dexamethasone in T-ALL/T-LBL Patients|Recruiting||Phase 1/Phase 2|92|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 23:03:47.509805|2017-10-10 23:03:47.509805
NCT02518100|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-04-10|||September 22, 2015|Actual|2015-09-22|April 2017|2017-04-01|April 10, 2017|Actual|2017-04-10|August 16, 2016|Actual|2016-08-16||Interventional|VSP||Vital Signs Patch: Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting|Vital Signs Patch: Early Feasibility and Usability Study - Feasibility Study for Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting|Completed||N/A|32|Actual|LifeWatch Services, Inc.||2|||f||||f||t|f|f||||No||2017-10-10 23:03:47.781147|2017-10-10 23:03:47.781147
NCT02518087|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-03-20|||May 2016||2016-05-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Increased Adsorption Membranes During Cardiopulmonary Bypass|Increased Adsorption Membranes During Cardiopulmonary Bypass. A Randomized Controlled Trial to Evaluate Impact in Postsurgical Acute Kidney Injury|Recruiting||N/A|340|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-10 23:03:47.858651|2017-10-10 23:03:47.858651
NCT02518074|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-08-06|||October 2013||2013-10-01|August 2015|2015-08-01||||November 2017|Anticipated|2017-11-01||Interventional|AUDIOSELF||Hearing and Vestibular Interactions in the Collection of Own Body and Sense of Self||Recruiting||N/A|24|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:47.975493|2017-10-10 23:03:47.975493
NCT02518061|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-11-18|||July 2015||2015-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||11C-Methionine PET as Prognostic Marker of Gliomas|Role of 11C-Methionine PET for the Prognostic and Molecular Characterization of Gliomas Candidate to Surgery.|Recruiting||N/A|145|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples Without DNA|"     Tumor surgical specimen   "|No||2017-10-10 23:03:48.054204|2017-10-10 23:03:48.054204
NCT02518048|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-05-01|2016-11-28||August 2015||2015-08-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||35 subjects from 1 centre in France were enrolled into the trial. The first subject was enrolled on 22-Sep-2015 and the last subject completed the trial (last visit, including follow-up) on 07-Dec-2015.|A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris|A Phase 2a Trial Evaluating the Anti-psoriatic Effect of LEO 90100 Aerosol Foam Compared to Betesil® Medicated Plaster in the Treatment of Psoriasis Vulgaris|Completed||Phase 2|35|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 23:03:48.145453|2017-10-10 23:03:48.145453
NCT02518035|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-06|||July 2015||2015-07-01|July 2015|2015-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Silicone Gel to Improve Scar in Microtia Patients|Use of Silicone Gel to Improve Retroauricular Scar in Microtia Patients|Recruiting||Phase 4|32|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:03:48.630353|2017-10-10 23:03:48.630353
NCT02518022|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-08-03|||September 2015||2015-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BEER||How to be Safe With Alcoholic Drinks in Diabetes|A Monocentric, Controlled, Randomized, Open-label Cross-over Study to Explore the Possible Insulin Treatment of Beverages Containing Alcohol and Carbohydrates in Adolescents and Young Adults With Type 1 Diabetes|Withdrawn||N/A|0|Actual|Kinderkrankenhaus auf der Bult||2||unexpected low willingness of patient to participate on the study|f||||f||||||||No||2017-10-10 23:03:48.773832|2017-10-10 23:03:48.773832
NCT02518009|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-09-08|||April 2015||2015-04-01|August 2016|2016-08-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Observational|GETS||GEnder Dysphoria Treatment in Sweden|Phenotype Modulations Following Treatment With Contrary Sex Hormones|Recruiting||N/A|40|Anticipated|Karolinska Institutet|||2||f||||f||||||Samples With DNA|"     Tissue samples from blood, skin, muslce and fat   "|Undecided||2017-10-10 23:03:48.900512|2017-10-10 23:03:48.900512
NCT02517996|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-04-22|||February 2015||2015-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)|Use of Preemptive Pudendal Nerve Block Prior to Hydrodistension for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-blinded, Randomized Control Trial|Recruiting||N/A|60|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:03:49.007694|2017-10-10 23:03:49.007694
NCT02517944|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-08-04|||November 2014||2014-11-01|July 2015|2015-07-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01|4 Weeks|Observational [Patient Registry]|CHOLCOEUR||MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR)|MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA|Unknown status|Recruiting|N/A|110|Anticipated|Institute of Cardiometabolism and Nutrition, France|||2||f||||f||||||||||2017-10-10 23:03:49.407242|2017-10-10 23:03:49.407242
NCT02517918|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-09-28|||February 2015||2015-02-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|METZOLIMOS||Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma|Metronomic Cyclophosphamide and Methotrexate Combined With Zoledronic Acid and Sirolimus in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma. A Phase Ib Study From the French Sarcoma Group|Recruiting||Phase 1|26|Anticipated|Institut Bergonié||1|||f||||t||||||||||2017-10-10 23:03:49.559302|2017-10-10 23:03:49.559302
NCT02517905|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2016-02-09|||August 2015||2015-08-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Local Administration of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction|Completed||Phase 3|166|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-10-10 23:03:51.541443|2017-10-10 23:03:51.541443
NCT02517892|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-01-25|||December 2014||2014-12-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|MATCH-R||A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents|A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents|Recruiting||N/A|600|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 23:03:51.645461|2017-10-10 23:03:51.645461
NCT02517879|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-08-04|||November 2013||2013-11-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Community Point Distribution of Insecticide Treated Bed Nets|Measuring Attendance of Community Point Distribution of Insecticide-treated Bed Nets and the Impact of Community Health Worker Hang-up in Rural Zambia: A Randomized Controlled Trial and Cost Analysis|Completed||N/A|560|Actual|IDinsight||5|||f||||f||||||||||2017-10-10 23:03:51.747046|2017-10-10 23:03:51.747046
NCT02517853|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-02-09|||February 2016||2016-02-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficiency of Neurostimulation of Tibial Nerve in the Treatment of Low Anterior Resection Syndrome|Prospective and Randomized Study to Evaluate the Efficiency of Percutaneous Neurostimulation of Posterior Tibial Nerve in the Treatment of Low Anterior Resection Syndrome (LARS)|Recruiting||N/A|42|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-10 23:03:51.981919|2017-10-10 23:03:51.981919
NCT02517840|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2015-08-04|||January 2002||2002-01-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|NONA-CLI||Revascularization in Nonagenarian Patients With Critical Lower Limb Ischaemia|Revascularization Results in Nonagenarian Patients With Critical Lower Limb Ischaemia|Completed||N/A|53|Actual|Hospital Universitario Getafe|||1||f||||f||||||||||2017-10-10 23:03:52.066533|2017-10-10 23:03:52.066533
NCT02517827|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-07-05|||November 2016||2016-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|PESTO-AFC||Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions|Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions A Prospective, Multi-centre, Randomised Study|Recruiting||N/A|306|Anticipated|Herz-Zentrums Bad Krozingen||2|||f||||t||||||||||2017-10-10 23:03:52.134094|2017-10-10 23:03:52.134094
NCT02517814|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-06|||October 2015||2015-10-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Vitamin D Supplementation Can Improve Heart Function in Idiopathic Cardiomyopathy||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-10 23:03:52.255226|2017-10-10 23:03:52.255226
NCT02517801|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-11-02|||January 2015||2015-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Anthocyanins||Investigation on the Sustained Effect of Anthocyanins on Endothelial Function in Postmenopausal Women|Investigation on the Sustained Effect of Anthocyanins on Endothelial Function in Postmenopausal Women|Completed||N/A|20|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-10 23:03:52.367021|2017-10-10 23:03:52.367021
NCT02517788|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-07|||May 2006||2006-05-01|August 2015|2015-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Phase I BP Interferon (IFN) Beta-004|Comparative Pharmacokinetic Profile of Interferon Beta-1a (Bioferon®) Administered as Single i.v. Doses in HSA-free Formulation and HSA+ Solution and as Multiple s.c. Doses in Healthy Subjects|Completed||Phase 1|24|Actual|Centre Hospitalier Universitaire Vaudois||5|||f||||t||||||||||2017-10-10 23:03:52.590562|2017-10-10 23:03:52.590562
NCT02517775|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-11-02|||October 2014||2014-10-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Cranberry||Effects of Cranberry Consumption in Vascular Function in Healthy Individuals|Intake and Time-dependent Effects of Cranberry (Poly)Phenol Consumption in Vascular Function in Healthy Individuals|Completed||N/A|10|Actual|Heinrich-Heine University, Duesseldorf||6|||f||||f||||||||||2017-10-10 23:03:52.735146|2017-10-10 23:03:52.735146
NCT02517762|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2015-08-10|||March 2005||2005-03-01|August 2015|2015-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ALBP||Acute Low Back Pain: Causes, Mechanisms, Treatment and Followup|Labour Triggered Acute Low Back Pain: Origin, Mechanisms, Causes of Pain, Evaluation of Treatment and Followup|Completed||N/A|99|Actual|Göteborg University||2|||f||||t||||||||||2017-10-10 23:03:52.854983|2017-10-10 23:03:52.854983
NCT02517749|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-09-19|||August 2015||2015-08-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|OPTIMUM||Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management|Randomised Controlled Trial Comparing Outpatient Management of Malignant Pleural Effusion Via an Indwelling Pleural Catheter and Talc Pleurodesis Versus Standard Inpatient Management in Improving Health Related Quality of Life|Recruiting||N/A|142|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:03:52.933327|2017-10-10 23:03:52.933327
NCT02517736|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-01-31|||February 2012|Actual|2012-02-01|January 2017|2017-01-01|January 13, 2015|Actual|2015-01-13|January 13, 2015|Actual|2015-01-13||Interventional|O-Mel-Sora||Study Multicentre Evaluating the Effectiveness and Toxicity Sorafenib (Nexavar®) in Adult Patients With Uveal Melanoma and Metastatic Dissemination||Completed||Phase 2|32|Anticipated|University Hospital, Caen||1|||f||||t||||||||||2017-10-10 23:03:53.027773|2017-10-10 23:03:53.027773
NCT02517723|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-08-08|||April 2014||2014-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder|A Randomized Controlled Clinical Trial (RCCT) to Test the Effectiveness of Narrative Exposure Therapy (NET) Versus Dialectical-Behavioral Therapy in Reducing Trauma Related Symptoms in Women Suffering From Borderline Personality Disorder (BPD) and Posttraumatic Stress Disorder (PTSD)|Recruiting||N/A|60|Anticipated|Evangelisches Krankenhaus Bielefeld gGmbH||2|||f||||||||||||||2017-10-10 23:03:53.129363|2017-10-10 23:03:53.129363
NCT02517710|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-08-10|||April 2014||2014-04-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|Stratafix||Study to Compare Suture Material in Closure of Uterine Incision in Cesarian Section|Single-blinded Prospective Trial Comparing Quantitive Blood Loss, Operative Time, and Post Operative Pain Using Stratafix Barbed Suture in Cesarian Section to the Use of Traditional Suture Material|Unknown status|Recruiting|N/A|100|Anticipated|Evangelical Community Hospital, Lewisburg, PA||2|||f||||f||||||||||2017-10-10 23:03:53.285579|2017-10-10 23:03:53.285579
NCT02517697|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-24|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|ONPC||Oral Nitrite Trial for Hypertension and Metabolic Syndrome|Nitrite Modulation of Hypertension, Platelet Activation, and Endothelial and Mitochondrial Function|Not yet recruiting||Phase 2|40|Anticipated|University of Pittsburgh||2|||f||||f|t|f||||||||2017-10-10 23:03:53.418717|2017-10-10 23:03:53.418717
NCT02517684|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-02-08|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|TISKids||Top-down Infliximab Study in Kids With Crohn's Disease|Top-down Infliximab Study in Kids With Crohn's Disease|Enrolling by invitation||Phase 4|100|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 23:03:53.546291|2017-10-10 23:03:53.546291
NCT02517671|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-02-06|||January 2015||2015-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX|Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX|Recruiting||N/A|10|Anticipated|David Grant U.S. Air Force Medical Center||1|||f||||t||||||||||2017-10-10 23:03:53.749575|2017-10-10 23:03:53.749575
NCT02517645|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-07-19|||February 2015||2015-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:03:53.930757|2017-10-10 23:03:53.930757
NCT02517632|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-25|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|PEACH||Physical Exercise Program in Chronic Chagas Heart Disease|Impact of a Physical Exercise Program in Cardiopulmonary RehAbilitation In Patients With Chronic Chagas Heart Disease: a Randomized Controlled Trial (PEACH Trial)|Completed||Phase 3|30|Actual|Evandro Chagas National Institute of Infectious Disease||2|||f||||f||||||||||2017-10-10 23:03:53.975495|2017-10-10 23:03:53.975495
NCT02517619|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-25|||January 2016||2016-01-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|EGP-437-006||Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis|A Prospective, Multi-Center, Randomized, Double-Masked, Positive Controlled, Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients With Non-Infectious Anterior Segment Uveitis|Recruiting||Phase 3|250|Anticipated|Eyegate Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:03:54.07795|2017-10-10 23:03:54.07795
NCT02517606|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-01-09|||August 2016||2016-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Hip Posterolateral Complex Strengthening in Patients With Chronic Nonspecific Low Back Pain: a Randomized Clinical Trial|Hip Posterolateral Complex Strengthening in Patients With Chronic Nonspecific Low Back Pain: a Randomized Clinical Trial|Recruiting||Phase 2|70|Anticipated|Federal University of Bahia||2|||f||||t||||||||||2017-10-10 23:03:54.185093|2017-10-10 23:03:54.185093
NCT02517593|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-06-29|||March 2016||2016-03-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|November 2020|Anticipated|2020-11-01||Interventional|GENRE||Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake|Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake: A Pilot Study to Determine if a Polygenic Risk Score Influences the Decision to Accept Breast Cancer Preventive Medications (Tamoxifen, Raloxifene, or Exemestane) Amongst Non-BRCA Women at Risk|Recruiting||Phase 1/Phase 2|150|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:03:54.292747|2017-10-10 23:03:54.292747
NCT02516579|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-09-11|||January 2009||2009-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|ESCORT-HU||European Sickle Cell Disease Cohort - Hydroxyurea|ESCORT-HU : European Sickle Cell Disease Cohort - Hydroxyurea|Active, not recruiting||N/A|1928|Actual|ADDMEDICA SASA|||1||f||||t||||||||||2017-10-10 23:04:05.296002|2017-10-10 23:04:05.296002
NCT02517554|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-07-31|||August 2015||2015-08-01|July 2017|2017-07-01||||August 2018|Anticipated|2018-08-01||Observational|||A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services|A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services|Recruiting||N/A|210|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||3||f||||t||||||||||2017-10-10 23:03:54.732464|2017-10-10 23:03:54.732464
NCT02517541|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2016-03-30|||September 2015||2015-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products|A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products|Completed||N/A|74|Actual|Coloplast A/S||1|||f||||f||||||||||2017-10-10 23:03:54.846779|2017-10-10 23:03:54.846779
NCT02517528|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-05|2017-03-21|||July 2015||2015-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|September 2016|Actual|2016-09-01||Interventional|||ABT-450/Ritonavir/ ABT 267 (ABT-450/r/ABT-267) and ABT -333 Co-administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis|An Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Treatment-Naïve and Treatment-Experienced Asian Adults With GT1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis|Completed||Phase 3|104|Actual|AbbVie||1|||f||||t||||||||||2017-10-10 23:03:54.961084|2017-10-10 23:03:54.961084
NCT02517502|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-05-18|||July 2015||2015-07-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy|Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy|Enrolling by invitation||Early Phase 1|50|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||No|Global results will be published.|2017-10-10 23:03:55.423977|2017-10-10 23:03:55.423977
NCT02517489|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-09|||October 2015||2015-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|CAPE_COD||Community-Acquired Pneumonia : Evaluation of Corticosteroids|Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia|Recruiting||Phase 3|1200|Anticipated|University Hospital, Tours||2|||f||||t|f|f||||||No||2017-10-10 23:03:55.553847|2017-10-10 23:03:55.553847
NCT02517450|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-04|||April 2010||2010-04-01|August 2015|2015-08-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Effectiveness of an Adventure-based Training Programme|Effectiveness of an Adventure-based Training Programme in Promoting the Psychological Well-being of Primary School Children|Completed||N/A|120|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:03:56.051918|2017-10-10 23:03:56.051918
NCT02517437|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-06-28|||August 2015||2015-08-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|PASS||Suprascapular and Axillary Blocks Versus Interscalene Block for Shoulder Surgery|Novel Combination of Suprascapular & Axillary Nerve Blocks Versus Conventional Interscalene Brachial Plexus Block for Pain Relief Following Shoulder Surgery: A Multi-centre Randomized, Patient & Assessor Blinded, Non-inferiority Trial|Recruiting||Phase 4|130|Anticipated|University Health Network, Toronto||2|||f||||t||||||||Yes|publication|2017-10-10 23:03:56.138697|2017-10-10 23:03:56.138697
NCT02517424|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-04-09|||September 2016||2016-09-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder|Placebo-Controlled, Triple-Blind, Crossover Study of the Safety and Efficacy of Three Different Potencies of Vaporized Cannabis in 42 Participants With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)|Recruiting||Phase 2|42|Anticipated|Tilray||3|||f||||t||||||||||2017-10-10 23:03:56.280874|2017-10-10 23:03:56.280874
NCT02517411|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-10-30|||September 2015||2015-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease|Effects of a Physiotherapy Program in Patients With Stable Chronic Obstructive Pulmonary Disease|Completed||N/A|40|Actual|Universidad de Granada||2|||f||||t||||||||Undecided||2017-10-10 23:03:56.397512|2017-10-10 23:03:56.397512
NCT02517398|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-10-05|||August 31, 2015|Actual|2015-08-31|October 2017|2017-10-01|December 12, 2018|Anticipated|2018-12-12|May 21, 2018|Anticipated|2018-05-21||Interventional|||MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors|A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability,Pharmacokinetics, Biological and Clinical Activity of MSB0011359C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications|Recruiting||Phase 1|702|Anticipated|EMD Serono||1|||f||||t||||||||||2017-10-10 23:03:56.579506|2017-10-10 23:03:56.579506
NCT02517385|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-07-01|||August 2015||2015-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|EPLID||Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases|Multicenter Prospective Uncontrolled Non-comparative Open Interventional Clinical Study of Phase III for Assessment of the Safety and Effectiveness of Using the Drug Phosphatidylcholine Paste 600 mg in Patients With Acute and Chronic Liver Diseases and Clinical Symptoms of Dysfunction of the Gastrointestinal Tract During 12-week Therapy Course|Completed||Phase 3|147|Actual|Sanofi||1|||f||||f||||||||||2017-10-10 23:03:58.004304|2017-10-10 23:03:58.004304
NCT02517372|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-08-04|||October 2014||2014-10-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast|An Open-label, Single Center, Phase I, Dose Escalation Study Investigating the Safety, Tolerability and Pharmacokinetics of Pemirolast in Healthy Subjects|Completed||Phase 1|24|Actual|RSPR Pharma AB||3|||f||||f||||||||||2017-10-10 23:03:58.120458|2017-10-10 23:03:58.120458
NCT02517359|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-03-03|||July 2015||2015-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153|A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Treatment With Single and Repeat Doses of Inhaled RV6153 in Healthy Subjects and Subjects With Stable Asthma.|Terminated||Phase 1|55|Actual|Respivert Ltd||5||Preset pharmacokinetic stopping criteria met at lower doses than expected.|f||||f||||||||||2017-10-10 23:03:58.210422|2017-10-10 23:03:58.210422
NCT02517346|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-04-14|||January 2015||2015-01-01|August 2015|2015-08-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Efficacy of Telemonitoring on CPAP Treatment Compliance in Obstructive Sleep Apnea (OSA) Patients|Efficacy of Telemonitoring on CPAP Treatment Compliance in Obstructive Sleep Apnea (OSA) Patients|Completed||N/A|100|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||f||||||||||2017-10-10 23:03:58.347416|2017-10-10 23:03:58.347416
NCT02517333|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-09-27|||March 2014||2014-03-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|September 2016|Anticipated|2016-09-01||Interventional|EPIC||Exploring the Impact and Feasibility of a Pathway to Sport and Long-term Participation in Young People|Exploring the Impact and Feasibility of a Pathway to Sport and Long-term Participation in Young People|Enrolling by invitation||N/A|40|Actual|Oxford Brookes University||1|||f||||f||||||||||2017-10-10 23:03:58.459062|2017-10-10 23:03:58.459062
NCT02517320|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-03-01|||July 2015||2015-07-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy|A Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy|Completed||Phase 2|293|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||f||||||||||2017-10-10 23:03:58.58248|2017-10-10 23:03:58.58248
NCT02517307|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-09-26|||February 2016||2016-02-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Fatty Acid Oxidation Defects and Insulin Sensitivity|Role of Fatty Acid Oxidation Defects in Insulin Sensitivity|Recruiting||N/A|50|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 23:03:58.695512|2017-10-10 23:03:58.695512
NCT02517294|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-08-04|||June 2015||2015-06-01|August 2015|2015-08-01|June 2018|Anticipated|2018-06-01|July 2017|Anticipated|2017-07-01||Interventional|||", Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"|"Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"|Recruiting||N/A|80|Anticipated|Nemours Children's Clinic||2|||f||||f||||||||||2017-10-10 23:03:58.816423|2017-10-10 23:03:58.816423
NCT02517281|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-01-25|||July 2011||2011-07-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|SKINTARGET||Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies|Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies|Recruiting||N/A|700|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 23:03:58.917182|2017-10-10 23:03:58.917182
NCT02517268|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-12-20|||June 2015||2015-06-01|December 2016|2016-12-01||||August 2020|Anticipated|2020-08-01||Interventional|WARP||Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer|A Prospective Randomized Controlled Trial Evaluating an Accelerated 5 Day Pathway for Discharge Following Pancreaticoduodenectomy (PD): Whipple Accelerated Recovery Pathway (WARP Trial)|Recruiting||N/A|138|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-10 23:03:59.013778|2017-10-10 23:03:59.013778
NCT02517255|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-08-08|||July 2015||2015-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SAVEME||Salvage of Myocardial Infarction Documented by MRI in Patients Undergoing Rescue Percutaneous Coronary Intervention|Salvage of Myocardial Infarction Documented by Magnetic Resonance Imaging in Patients Undergoing Rescue Percutaneous Coronary Intervention|Recruiting||N/A|72|Anticipated|Federal University of São Paulo||1|||f||||f||||||||||2017-10-10 23:03:59.145931|2017-10-10 23:03:59.145931
NCT02517242|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-04|||May 2015||2015-05-01|August 2015|2015-08-01||||September 2016|Anticipated|2016-09-01||Interventional|||Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control|Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic controlCONTROL|Unknown status|Recruiting|Phase 4|112|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-10 23:03:59.247643|2017-10-10 23:03:59.247643
NCT02517229|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-05|||September 2012||2012-09-01|August 2015|2015-08-01||||October 2015|Anticipated|2015-10-01||Interventional|POSTURGRAV||The Effect of Altered Gravity Condition on Postural Control||Unknown status|Recruiting|N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:59.350767|2017-10-10 23:03:59.350767
NCT02517164|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-04|||July 2011||2011-07-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Observational|VITADCOG||Role of Vitamin D Levels (Serum 25-hydroxyvitamin D) and Cognitive Impairment in the Occurrence of Falls||Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Caen|||2||f||||f||||||Samples Without DNA|"     serum 25-hydroxyvitamin D   "|||2017-10-10 23:03:59.758023|2017-10-10 23:03:59.758023
NCT02517151|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-09-09|||October 2014||2014-10-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|MICI_2011-01||Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue|Effects of Iron Therapy in Patients With Chronic Fatigue and IBD|Unknown status|Recruiting|Phase 2|36|Anticipated|Istituto Clinico Humanitas||2|||f||||f||||||||||2017-10-10 23:03:59.86209|2017-10-10 23:03:59.86209
NCT02517138|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-05|||November 2011||2011-11-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|March 2013|Actual|2013-03-01||Interventional|DROITDEVANT||Right-front Direction in Parabolic Flight||Completed||N/A|10|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:03:59.983166|2017-10-10 23:03:59.983166
NCT02517125|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-06-08|||April 2015||2015-04-01|June 2016|2016-06-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01||Interventional|TORS||Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors|Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors|Recruiting||N/A|150|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||||||||||||2017-10-10 23:04:00.065793|2017-10-10 23:04:00.065793
NCT02517112|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-05|||December 2011||2011-12-01|August 2015|2015-08-01||||October 2015|Anticipated|2015-10-01||Interventional|B3D||3D Ballistocardiography in Microgravity||Unknown status|Recruiting|N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:04:00.156112|2017-10-10 23:04:00.156112
NCT02517099|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-08-31|||June 2015||2015-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PrIGMa||Preschool Wheeze: Inflammation/Infection Guided Management|Use of Pathological Phenotype to Determine Optimal Management for Moderate to Severe Preschool Wheeze|Recruiting||Phase 2|80|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-10 23:04:00.2486|2017-10-10 23:04:00.2486
NCT02517086|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-08-03|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|August 2015|Actual|2015-08-01||Interventional|||Vascular Changes Due to Different Treatments of Lymphedema Secondary to Postoperative Breast Cancer|Vascular Changes Due to Different Treatments of Lymphedema Secondary to Postoperative Breast Cancer|Unknown status|Not yet recruiting|N/A|3|Anticipated|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 23:04:00.351104|2017-10-10 23:04:00.351104
NCT02517073|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-01-26|||August 2015||2015-08-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Practice of Mechanical Ventilation in Patients With Severe Brain Injury in China|A Survey on the Practice of Mechanical Ventilation Among Patients With Severe Brain Injury in China: a Prospective Observational Study|Completed||N/A|104|Actual|Capital Medical University|||1||f||||t||||||||||2017-10-10 23:04:00.462493|2017-10-10 23:04:00.462493
NCT02517060|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-08-09|||August 2015||2015-08-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Neural Mechanisms of Tactile Priming on Social Perceptions - Pilot Study|Neural Mechanisms of Tactile Priming on Social Perceptions - Pilot Study|Completed||N/A|17|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 23:04:00.535225|2017-10-10 23:04:00.535225
NCT02517034|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-09-15|||August 2015||2015-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer|Advancing Screening and Treatment for Older Patients With Cancer|Recruiting||N/A|700|Anticipated|City of Hope Medical Center||2|||f||||t|f|f||||||||2017-10-10 23:04:00.887829|2017-10-10 23:04:00.887829
NCT02517021|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-09-07||2016-09-07|November 2015||2015-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting|A Phase 3, Multicenter, Randomized, Double-blind, Active Control Study to Evaluate the Safety and Efficacy of IV Pro-netupitant/Palonosetron (260 mg/0.25 mg) Combination for the Prevention of Chemotherapy-induced Nausea and Vomiting in Repeated Chemotherapy Cycles in Patients Receiving Highly Emetogenic Chemotherapy|Completed||Phase 3|405|Actual|Helsinn Healthcare SA||2|||f||||t||||||||||2017-10-10 23:04:01.027863|2017-10-10 23:04:01.027863
NCT02517008|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-08-04|||June 2013||2013-06-01|August 2015|2015-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The Impact of Non-monetary Incentives on Facility Delivery in Rural Zambia|Measuring the Impact of Non-monetary Incentives on Facility Delivery in Rural Zambia: A Clustered Randomized Controlled Trial|Completed||N/A|2159|Actual|IDinsight||2|||f||||f||||||||||2017-10-10 23:04:01.271937|2017-10-10 23:04:01.271937
NCT02516995|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-02-09|||August 2010||2010-08-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|June 2013|Actual|2013-06-01||Interventional|FIBROP||Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer|Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer|Completed||N/A|10|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 23:04:01.352538|2017-10-10 23:04:01.352538
NCT02516982|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-05-10|||October 2015||2015-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|AMHS||mHealth for Antenatal Mental Health|Tablet Computers for Implementing NICE Antenatal Mental Health Guidelines - Feasibility Study|Recruiting||N/A|500|Anticipated|Imperial College London|||4||f||||f||||||||Undecided||2017-10-10 23:04:01.437235|2017-10-10 23:04:01.437235
NCT02516969|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-04-24|||August 2015||2015-08-01|April 2017|2017-04-01|August 2021|Anticipated|2021-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Surgery With or Without Adjuvant Stereotactic Body Radiotherapy|A Prospective, Randomized Phase II Study of Surgery With or Without Adjuvant Stereotactic Body Radiotherapy (SBRT) in Patients With Previously-Irradiated Head and Neck Cancer|Recruiting||N/A|42|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:04:01.610852|2017-10-10 23:04:01.610852
NCT02516956|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-05-18|||June 2014||2014-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|||Impact of Different Breakfast Meals on Food Choices, Eating Behaviors and Brain Activation|Impact of Different Breakfast Meals on Food Choices, Eating Behaviors and Brain Activation|Completed||N/A|15|Actual|University of Parma||4|||f||||f||||||||Undecided||2017-10-10 23:04:01.746364|2017-10-10 23:04:01.746364
NCT02516943|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-12-10|||November 2014||2014-11-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effects of Using Pathological- Based Guidelines for Arterial Blood Gas Analysis in Patients Aftercardiac Surgery|The Effects of Using Pathological- Based Guidelines for Arterial Blood Gas Analysis in Patients Aftercardiac Surgery|Completed||Phase 4|140|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 23:04:01.893111|2017-10-10 23:04:01.893111
NCT02516930|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-25|2016-04-06|||September 2015||2015-09-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China|Crowdsourcing Versus Social Marketing Video Campaigns to Promote Condom Use: A Noninferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China|Completed||N/A|1173|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:04:02.001362|2017-10-10 23:04:02.001362
NCT02516917|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-10-24|||August 2015||2015-08-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Feasibility of a Brief Attention Training Technique in Improving Behaviour and Attention in Children With ADHD|The Feasibility of a Brief Attention Training Technique for Improving Behaviour and Attention in Children With ADHD|Completed||N/A|13|Actual|University of Manchester||1|||f||||||||||||No||2017-10-10 23:04:02.125785|2017-10-10 23:04:02.125785
NCT02516904|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-06-23|||July 2015||2015-07-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Single Ascending Dose Study of CD101 IV in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of CD101 Injection in Healthy Subjects|Completed||Phase 1|32|Actual|Cidara Therapeutics Inc.||2|||f||||f||||||||No||2017-10-10 23:04:02.219397|2017-10-10 23:04:02.219397
NCT02516891|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-04-05|||February 2012||2012-02-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|June 2015|Actual|2015-06-01||Interventional|||Jailed Wire Technique in the Treatment of Coronary Bifurcations Lesions With Stent: Stereoscopic Microscopy Study|Jailed Wire Technique in the Treatment of Coronary Bifurcations Lesions With Stent: Prospective Randomized Study With Stereoscopic Microscopy|Completed||Phase 4|235|Actual|Maimónides Biomedical Research Institute of Córdoba||2|||f||||f||||||||||2017-10-10 23:04:02.332871|2017-10-10 23:04:02.332871
NCT02516878|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-03-14|||August 2015||2015-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Acupuncture for Body Weight Control|Acupuncture for Body Weight Control: A Pilot Randomized Controlled Trial|Completed||N/A|72|Actual|Hong Kong Baptist University||2|||f||||f||||||||||2017-10-10 23:04:02.42106|2017-10-10 23:04:02.42106
NCT02516865|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-08-05|||April 2015||2015-04-01|August 2015|2015-08-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|PE Moms||Practical Approaches to Exercise in Moms|Practical Approaches to Exercise in Moms|Unknown status|Recruiting|Phase 1|30|Anticipated|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-10 23:04:02.512953|2017-10-10 23:04:02.512953
NCT02516852|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-05|||June 2014||2014-06-01|August 2015|2015-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Assessing the Effect of Sustainable Small-scale Egg Production on Maternal and Child Nutrition in Rural Zambia|Assessing the Effect of Sustainable Small-scale Egg Production on Maternal and Child Nutrition in Rural Zambia|Unknown status|Enrolling by invitation|N/A|6000|Anticipated|Cornell University||2|||f||||f||||||||||2017-10-10 23:04:02.613582|2017-10-10 23:04:02.613582
NCT02516839|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-08-16|||September 2015||2015-09-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|ROC||PACIFIC: Providing Adults Collaborative Interventions For Ideal Changes|Treatment of Obesity Targeting Appetite and Cue Reactivity|Recruiting||N/A|280|Anticipated|University of California, San Diego||4|||f||||t||||||||||2017-10-10 23:04:02.722005|2017-10-10 23:04:02.722005
NCT02516826|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-04|||August 2015||2015-08-01|August 2015|2015-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease|The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease by Smart Angioplasty Research Team: SMART-ROAD Trial|Not yet recruiting||Phase 2|504|Anticipated|Samsung Medical Center||3|||f||||f||||||||||2017-10-10 23:04:02.84223|2017-10-10 23:04:02.84223
NCT02516800|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-05-08|||May 2014||2014-05-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|||Prevalence and Significance of Mutations in Genes Encoding NaPi-co-transporters in the Development of CAVD|Prevalence and Significance of Mutations in Genes Encoding NaPi-co-transporters in the Development of CAVD|Recruiting||N/A|600|Anticipated|University of Aarhus|||2||f||||t||||||Samples With DNA|"     Full blood Aortic Valve   "|||2017-10-10 23:04:03.117609|2017-10-10 23:04:03.117609
NCT02516787|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-04|||November 2010||2010-11-01|August 2015|2015-08-01||||November 2013|Actual|2013-11-01||Interventional|CORTICOG||Coherence Between Brain Cortical Function and Neurocognitive Performance During Changed Gravity Conditions||Completed||N/A|24|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:04:03.208822|2017-10-10 23:04:03.208822
NCT02516774|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-01-25|||December 2014||2014-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TAM-RT||A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers|A Phase I Trial Assessing Adalimumab (Humira®), a Tumor Necrosis Factor α Inhibitor Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers|Withdrawn||Phase 1|0|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1||No patients enrolled|f||||f||||||||||2017-10-10 23:04:03.291544|2017-10-10 23:04:03.291544
NCT02516761|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-03-22|||July 2015||2015-07-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|EffMusFibro||Effect of Low-impact Aerobic Exercise and Music Therapy in Fibromyalgia|Effect of Low-impact Aerobic Exercise Combined With Music Therapy in Patients With Fibromyalgia|Completed||N/A|26|Actual|University of Valencia||3|||f||||f||||||||||2017-10-10 23:04:03.372536|2017-10-10 23:04:03.372536
NCT02516748|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-03-27|||August 2015||2015-08-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Real-time Diagnosis of Colorectal Polyps Using Narrow-Band Imaging|Prospective Study of Real-time Diagnosis of Colorectal Polyps Using Narrow-Band Imaging: Gangnam-ReaDi Study|Recruiting||N/A|5000|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-10 23:04:03.469738|2017-10-10 23:04:03.469738
NCT02516735|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-08-03|||May 2015||2015-05-01|August 2015|2015-08-01||||November 2015|Anticipated|2015-11-01||Interventional|||I-scan With Magnification for the Detection of Gastric Intestinal Metaplasia|I-scan With Magnification Targeted Biopsies Compared With a Standard Biopsy Protocol for the Detection of Gastric Intestinal Metaplasia in a High Risk Population: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|164|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 23:04:03.558297|2017-10-10 23:04:03.558297
NCT02516722|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-07-06|||February 2016||2016-02-01|April 2016|2016-04-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|TROPHY||TReatment Of Pulmonary HYpertension 1 Study|Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Pulmonary Artery Denervation (PDN) in Patients With Pulmonary Hypertension|Recruiting||N/A|15|Anticipated|SoniVie Ltd.||1|||f||||t||||||||||2017-10-10 23:04:03.651047|2017-10-10 23:04:03.651047
NCT02516709|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-08-17|||June 2015||2015-06-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|August 2020|Anticipated|2020-08-01|5 Years|Observational [Patient Registry]|CaRePC||Linear Source Registry for Prostate Cancer|CivaString Registry for Prostate Cancer|Recruiting||N/A|150|Anticipated|CivaTech Oncology|||1||f||||f||||||Samples With DNA|"     Blood, serum   "|||2017-10-10 23:04:03.731933|2017-10-10 23:04:03.731933
NCT02516696|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-02-06|||February 2016|Actual|2016-02-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|BiRd vs Rd||BiRd vs. Rd as Initial Therapy in Multiple Myeloma|Lenalidomide and Dexamethasone (Rd) Versus Clarithromycin [Biaxin®] / Lenalidomide [Revlimid®] / Dexamethasone (BiRd) as Initial Therapy in Multiple Myeloma|Recruiting||Phase 3|320|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-10 23:04:03.81697|2017-10-10 23:04:03.81697
NCT02516683|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2015-08-05|||December 2001||2001-12-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|December 2011|Actual|2011-12-01||Observational|||The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study|The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study|Completed||N/A|229|Actual|Yonsei University|||2||f||||t||||||||||2017-10-10 23:04:03.936332|2017-10-10 23:04:03.936332
NCT02516670|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|January 2030|Anticipated|2030-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer|A Randomized Phase 2 Trial of Ascorbic Acid in Combination With Docetaxel in Men With Metastatic Prostate Cancer|Recruiting||Phase 2|69|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:04:04.014709|2017-10-10 23:04:04.014709
NCT02516657|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-05-13|||May 2012||2012-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Observational|||Liraglutide in Adolescents With Type 1 Diabetes|Effect of Liraglutide on Glycemic Control, Glucagon Secretion and Inflammatory Markers in Adolescents With Type 1 Diabetes Mellitus|Recruiting||Phase 3|11|Anticipated|University at Buffalo|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:04:04.146377|2017-10-10 23:04:04.146377
NCT02516644|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-05-16|||February 2015||2015-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Feasibility and Effectiveness of Virtual Reality & Use of Body Weight Support Treadmill Training in Parkinson's Disease|Feasibility and Effectiveness of Virtual Reality and the Use of Body Weight Support Treadmill Training in Parkinson's Disease: an Explorative Study|Recruiting||N/A|20|Anticipated|University Hospital of Ferrara||2|||f||||t||||||||No||2017-10-10 23:04:04.347184|2017-10-10 23:04:04.347184
NCT02516631|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-12-05|||November 2014||2014-11-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Comparative Bioavailability Study of Two Misoprostol Formulations|A Comparative, Open-label, Parallel Design, Bioavailability Study of Two Misoprostol Formulations (Angusta™ 25 µg Dispersible Tablets vs. Cytotec® 200 µg Tablets) Following Single Oral or Sublingual Administration and Comparison of Safety of the Two Formulations Following Repeat Dosing Until Labour|Completed||Phase 1|72|Actual|Region Skane||3|||f||||f||||||||||2017-10-10 23:04:04.523722|2017-10-10 23:04:04.523722
NCT02516618|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-05-10|||July 2015||2015-07-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Fasinumab in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|72|Actual|Regeneron Pharmaceuticals||5|||f||||t||||||||||2017-10-10 23:04:04.661027|2017-10-10 23:04:04.661027
NCT02516592|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2016-09-20|||October 2015||2015-10-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|FLASH||Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort|A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel Group Study to Assess the Efficacy and Safety of Switching From Salmeterol/Fluticasone to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic COPD Patients|Recruiting||Phase 4|492|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 23:04:04.988642|2017-10-10 23:04:04.988642
NCT02516566|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-11-30|||September 2015||2015-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Effects of PEEP on Optic Nerve Sheath Diameter During Robot-Assisted Laparoscopic Prostatectomy|Effects of Positive End-Expiratory Pressure Ventilation on Optic Nerve Sheath Diameter in Patients Undergoing Robot-Assisted Laparoscopic Prostatectomy|Completed||N/A|38|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-10 23:04:05.557248|2017-10-10 23:04:05.557248
NCT02516553|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-10-02|||July 8, 2015|Actual|2015-07-08|October 2017|2017-10-01|February 7, 2019|Anticipated|2019-02-07|October 30, 2017|Anticipated|2017-10-30||Interventional|||BI 894999 First in Human Dose Finding Study in Advanced Malignancies|An Open Label, Phase Ia/Ib Dose Finding Study With BI 894999 Orally Administered Once a Day in Patients With Advanced Malignancies, With Repeated Administration in Patients With Clinical Benefit|Recruiting||Phase 1|143|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:04:05.640082|2017-10-10 23:04:05.640082
NCT02516540|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-04-27|||March 2015||2015-03-01|April 2017|2017-04-01|October 2021|Anticipated|2021-10-01|October 2017|Anticipated|2017-10-01||Interventional|LIBRE-2||Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers|Prospective Randomized Multicenter Trial to Assess the Efficacy of a Structured Physical Exercise Training and Mediterranean Diet in Women With BRCA1/2 Mutations|Recruiting||N/A|600|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-10 23:04:05.737382|2017-10-10 23:04:05.737382
NCT02516527|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-10-03|||October 16, 2015|Actual|2015-10-16|October 2017|2017-10-01|November 26, 2019|Anticipated|2019-11-26|February 25, 2018|Anticipated|2018-02-25||Interventional|||A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors|A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f|||t|||||2017-10-10 23:04:05.883083|2017-10-10 23:04:05.883083
NCT02516514|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-04|||December 2010||2010-12-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|HEMU||The Only Blood Culture for Diagnosis of Bacteremia - Comparative Study of Practice|The Only Blood Culture for Diagnosis of Bacteremia - Comparative Study of Practice|Completed||N/A|302|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:04:05.981841|2017-10-10 23:04:05.981841
NCT02516501|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-03-23|||June 2015||2015-06-01|March 2017|2017-03-01||||June 2018|Anticipated|2018-06-01||Interventional|KETOCOMP||Impact of a Ketogenic Diet Intervention During Radiotherapy on Body Composition|Investigating the Impact of a Ketogenic Diet Intervention During Radiotherapy on Body Composition: A Pilot Trial|Recruiting||Phase 1|85|Anticipated|MVZ Leopoldina GmbH||3|||f||||f||||||||||2017-10-10 23:04:06.062317|2017-10-10 23:04:06.062317
NCT02516488|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-18|||May 2015||2015-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|INDEX||Comparison of CLE in Vivo Diagnosis and ex Vivo Examination Against Surgical Histopathology of CPL|Comparison of Confocal Laser Endomicroscopic IN Vivo Diagnosis and EX Vivo Examination (INDEX Study) Against Surgical Histopathology of Cystic Pancreatic Lesions|Recruiting||N/A|50|Anticipated|Ohio State University|||1||f||||f||||||None Retained|"     Fluid from cyst in pancreas   "|||2017-10-10 23:04:06.164492|2017-10-10 23:04:06.164492
NCT02516475|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-08-03|||October 2014||2014-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Zinc Supplementation on Anthropometric Factors, Apelin and Inflammatory Markers in Obese Individuals|Effects of Zinc Supplementation on Weight, Body Mass Index (BMI), Waist Circumference, Fat Mass and Lean Mass, Apelin and Inflammatory Markers in Obese Individuals|Completed||Phase 2/Phase 3|50|Actual|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-10 23:04:06.257146|2017-10-10 23:04:06.257146
NCT02516462|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-03-25|||July 2015||2015-07-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Interventional|IVM||In Vitro Maturation of Human Eggs|In Vitro Maturation of Human Eggs|Recruiting||N/A|100|Anticipated|National Foundation for Fertility Research||1|||f||||f||||||||||2017-10-10 23:04:06.348173|2017-10-10 23:04:06.348173
NCT02516449|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-08-03|||March 2013||2013-03-01|August 2015|2015-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Assessment of Shared Decision Making Aids in Asthma|Utility of Two Patients Decision Aids About Asthma Inhaled Controller Medication Use in Adult Patients With Asthma|Completed||N/A|51|Actual|Laval University||2|||f||||f||||||||||2017-10-10 23:04:06.455481|2017-10-10 23:04:06.455481
NCT02516436|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-05-02||||||May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects|A Randomized, Double-blind, Active Control Evaluation of the Safety of BioErodible MucoAdhesive (BEMA®) Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects|Withdrawn||Phase 3|0|Actual|BioDelivery Sciences International||2||FDA did not require a clinical trial for indication.|f||||f||||||||||2017-10-10 23:04:06.540348|2017-10-10 23:04:06.540348
NCT02516423|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-04|2017-09-29|||December 2015||2015-12-01|September 2017|2017-09-01||||September 2024|Anticipated|2024-09-01||Interventional|||Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone|Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment With Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy|Recruiting||Phase 3|110|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 23:04:06.713906|2017-10-10 23:04:06.713906
NCT02516410|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-06-08||2017-06-08|August 2015||2015-08-01|June 2017|2017-06-01|June 7, 2016|Actual|2016-06-07|June 7, 2016|Actual|2016-06-07||Interventional|||A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation and With a Second CFTR Mutation That Is Not Likely to Respond to VX-661 and/or Ivacaftor Therapy (F508del/NR)|Completed||Phase 3|168|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||t||||||||||2017-10-10 23:04:10.491765|2017-10-10 23:04:10.491765
NCT02516397|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-04-27|||August 2015||2015-08-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|PEPOLUS||OMNIA Efficacy on Body Fat Mass Reduction|Randomised Controlled Trial, Double-blind, to Measure Efficiency and Tolerance of a New Food Supplement OMNIA on Body Fat Mass Reduction in Overweight Subjects|Active, not recruiting||Phase 3|70|Anticipated|Vivatech||2|||f||||f||||||||||2017-10-10 23:04:10.686709|2017-10-10 23:04:10.686709
NCT02516384|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-10-31|||July 2015||2015-07-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)|Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)|Active, not recruiting||Phase 1|20|Actual|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-10 23:04:10.783116|2017-10-10 23:04:10.783116
NCT02516371|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2015-08-25|||August 2015||2015-08-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|June 2016|Anticipated|2016-06-01||Interventional|CaLym||Lymphocytes Subpopulation in Cancer Patients|Lymphocytes Subpopulation and Its Relevance With Tumor Grade and Prognosis in Cancer Patients|Recruiting||N/A|100|Anticipated|The Catholic University of Korea||1|||f||||f||||||||||2017-10-10 23:04:10.876935|2017-10-10 23:04:10.876935
NCT02516358|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-08-31|||September 2015||2015-09-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|February 2016|Anticipated|2016-02-01||Observational|||Glycaemic Alterations in ICU|Glycaemic Alterations in ICU: an Observational, Prospective Cohort Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Catholic University of the Sacred Heart|||1||f||||t||||||||||2017-10-10 23:04:10.97122|2017-10-10 23:04:10.97122
NCT02516345|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-07-25|||November 25, 2015|Actual|2015-11-25|July 2017|2017-07-01|June 3, 2018|Anticipated|2018-06-03|May 2018|Anticipated|2018-05-01||Interventional|FIT-FAM||Randomized Controlled Trial of an Incentive-based Physical Activity Program Targeting Both Children and Adults (FIT-FAM)|Randomized Controlled Trial of an Incentive-based Physical Activity Program Targeting Both Children and Adults (FIT-FAM)|Active, not recruiting||N/A|644|Actual|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-10 23:04:11.14038|2017-10-10 23:04:11.14038
NCT02516332|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-06-21|||December 2015||2015-12-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Exercise and Pharmacotherapy for Anxiety in Cardiac Patients|Exercise and Pharmacotherapy for Anxiety in Cardiac Patients|Recruiting||N/A|150|Anticipated|Duke University||3|||f||||t||||||||||2017-10-10 23:04:11.269058|2017-10-10 23:04:11.269058
NCT02516319|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-01-14|||September 2012||2012-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Liver Function Assessment - Feasibility and Dosing Study|A Feasibility Study to Determine an Adequate Dose of ICG for the Liver Function Assessment System in Healthy Volunteers|Terminated||N/A|57|Actual|Cardiox Corporation||2||Business decision to discontinue product development.|f||||f||||||||||2017-10-10 23:04:11.382746|2017-10-10 23:04:11.382746
NCT02516306|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-03-10|2017-03-10||September 16, 2015|Actual|2015-09-16|March 2017|2017-03-01|April 2016|Actual|2016-04-01|March 10, 2016|Actual|2016-03-10||Interventional|||A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia|A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia|Completed||Phase 1/Phase 2|75|Actual|Encore Vision, Inc.||2|||f||||f|t|f||||||||2017-10-10 23:04:11.472761|2017-10-10 23:04:11.472761
NCT02516293|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-08-03|||May 2013||2013-05-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Interventional|||Cardiac Rehabilitation in Chagas Heart Failure|Cardiac Rehabilitation Program in Patients With Chagas Heart Failure: a Pilot Study|Completed||Phase 2/Phase 3|12|Actual|Evandro Chagas National Institute of Infectious Disease||1|||f||||f||||||||||2017-10-10 23:04:11.755906|2017-10-10 23:04:11.755906
NCT02516280|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-08-04|||January 2012||2012-01-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effects of Gaseous Cryotherapy on Knee ROM After TKA: A Feasibility Study|Effects of Hyperbaric Gaseous Cryotherapy on Knee Flexion Range of Motion in the First Two Days After Total Knee Arthroplasty: A Feasibility Randomized Controlled Trial|Completed||N/A|65|Actual|Centre Hospitalier de Verdun||2|||f||||f||||||||||2017-10-10 23:04:11.83402|2017-10-10 23:04:11.83402
NCT02516267|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-03|||July 2015||2015-07-01|August 2015|2015-08-01|July 2020|Anticipated|2020-07-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Platelet Aggregability in the Release of CABG in Patients With ACS With DAPT.|The Importance of Evaluation of Platelet Aggregability in the Release of Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome With Dual Antiplatelet Therapy.|Recruiting||N/A|246|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:04:11.959289|2017-10-10 23:04:11.959289
NCT02516254|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-05|||January 2015||2015-01-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Assessment of the Efficacy of Vitamin D-fortified Bread in Healthy Adults|Comparison of the Efficacy of Vitamin D-fortified Bread Versus Vitamin D Supplement in Healthy Adults: a Randomized Controlled Clinical Trial|Completed||Phase 2|60|Actual|National Nutrition and Food Technology Institute||3|||f||||t||||||||||2017-10-10 23:04:12.040291|2017-10-10 23:04:12.040291
NCT02516241|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-08-16|||November 2, 2015|Actual|2015-11-02|August 2017|2017-08-01|July 15, 2019|Anticipated|2019-07-15|April 2, 2018|Anticipated|2018-04-02||Interventional|||Study of MEDI4736 With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer|A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line MEDI4736 Monotherapy and MEDI4736 in Combination With Tremelimumab Versus Standard of Care Chemotherapy in Patients With Unresectable Stage IV Urothelial Cancer|Recruiting||Phase 3|1005|Anticipated|AstraZeneca||3|||f||||t||||||||||2017-10-10 23:04:12.173281|2017-10-10 23:04:12.173281
NCT02516228|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-08-01|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|GTEN||Transcranial Electrical Neuromodulation for Suppressing Epileptiform Discharges|Geodesic Transcranial Electrical Neuromodulation(GTEN100) Device|Recruiting||N/A|20|Anticipated|Electrical Geodesics, Inc.||2|||f||||f||||||||||2017-10-10 23:04:12.969938|2017-10-10 23:04:12.969938
NCT02516215|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-10-17|||September 2015||2015-09-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Sublingual Microcirculation Data of Patients With Systemic Diseases|Population Research of Sublingual Microcirculation Data of Patients With Systemic Diseases|Recruiting||N/A|360|Anticipated|National Taiwan University Hospital|||8||f||||f||||||||||2017-10-10 23:04:13.082421|2017-10-10 23:04:13.082421
NCT02516046|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-10-05|||September 2015||2015-09-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||18F-AV-1451 Autopsy Study|A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology|Recruiting||Phase 3|200|Anticipated|Avid Radiopharmaceuticals||1|||f||||t||||||||||2017-10-10 23:04:14.78126|2017-10-10 23:04:14.78126
NCT02516202|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-01-19|||April 2016||2016-04-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Vaginal Health Trial|The Vaginal Health Trial - Effects of Vaginal Estradiol Tablet and Moisturizing Gel on Postmenopausal Vaginal Symptoms|Active, not recruiting||Phase 4|300|Anticipated|Fred Hutchinson Cancer Research Center||3|||f||||t||||||||Yes|The DCC will perform the statistical analyses for the primary study results papers (and as many secondary papers as possible within our analytic resources). Once the primary study manuscripts are accepted for publication, a de-identified SAS dataset is made available to Network collaborators through the internal website for their use within the established Publications and Ancillary Study Committee policy. Within a 12-month period after publication of the main study results, the DCC will prepare datasets for public release that include all data elements in the main publication with certain deletions and recoding to protect study subject confidentiality. The public release datasets will include substantial documentation in electronic form, thus allowing external investigators to independently analyze the data. External investigators who wish to have access to network trial data prior to their readiness for public release can do so through collaboration with a network investigator.|2017-10-10 23:04:13.183901|2017-10-10 23:04:13.183901
NCT02516189|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-08-11|||August 2015||2015-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Strength Training for Elderlies and Their Effects on Muscle Fatigue and Microcirculation - Randomized Clinical Trial|Strength Training for Elderlies and Their Effects on Muscle Fatigue and Microcirculation - Randomized Clinical Trial|Completed||N/A|80|Actual|Professor Fernando Figueira Integral Medicine Institute||2|||f||||f||||||||||2017-10-10 23:04:13.295772|2017-10-10 23:04:13.295772
NCT02516176|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-08-18|||February 2015||2015-02-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Sideways Treadmill Training to Improve Paretic Leg Stepping in Persons Post-Stroke|The Feasibility and Efficacy of Induced Lateral Step Treadmill Training to Improve Paretic Limb Stepping Post-Stroke|Recruiting||N/A|25|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-10 23:04:13.374353|2017-10-10 23:04:13.374353
NCT02516163|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-12-07|2015-09-29||December 2010||2010-12-01|September 2015|2015-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||Baseline measurements are available only for the 24 participants who completed the study.|Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using Shapematch Cutting Guides:Sub-Study A|A Prospective, Non-randomized,Study of the Clinical Outcomes of Participants That Receive the Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using ShapeMatch® Cutting Guides: Sub-Study A|Completed||N/A|55|Actual|Stryker South Pacific||1|||f||||f||||||||||2017-10-10 23:04:13.454672|2017-10-10 23:04:13.454672
NCT02516150|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-07-31|2017-07-13||March 2016|Actual|2016-03-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon|Effect of Ethanol Intoxication on the Anti-hypoglycemic Action of Glucagon|Completed||Phase 4|26|Actual|Massachusetts General Hospital||2|||f||||t|t|f||||||||2017-10-10 23:04:13.640438|2017-10-10 23:04:13.640438
NCT02516137|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-06-01|||July 2015||2015-07-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Hamstring Tightness|Clinical Effects of Dry Needling Among Asymptomatic Individuals With Hamstring Tightness|Completed||N/A|28|Actual|Emory University||3|||f||||f||||||||||2017-10-10 23:04:13.929356|2017-10-10 23:04:13.929356
NCT02516124|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-07-25|||December 2012||2012-12-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|NISSC||EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients|Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis: a Prospective Non-Interventional Approach Across Europe (NISSC) for the Autoimmune Diseases Working Party of the EBMT|Active, not recruiting||N/A|82|Actual|European Group for Blood and Marrow Transplantation|||1||f||||f||||||||||2017-10-10 23:04:14.037763|2017-10-10 23:04:14.037763
NCT02516111|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-04|||September 2014||2014-09-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment|Comparative Evaluation of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Treatment of 2/3-walled Intrabony Defects in Chronic Periodontitis Subjects: a Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|120|Actual|Government Dental College and Research Institute, Bangalore||4|||f||||t||||||||||2017-10-10 23:04:14.114578|2017-10-10 23:04:14.114578
NCT02516098|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-03-07|2016-12-20||October 2015||2015-10-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||All subjects who received at least a single dose of the study medication were included in the safety population (safety population = 56 subjects).|Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide.|A Single Center, Single-dose, Double-blind, Randomized, Two Period Crossover, Two Stage Design to Determine Bioequivalence of Two Formulations Containing Hyoscine Butylbromide 10mg Sugar Coated Tablets, Under Fasting Conditions|Completed||Phase 1|56|Actual|Boehringer Ingelheim|There was a stage 2 planned after stage 1 which was not performed as bioequivalence was concluded after completion of Stage 1.|2|||f||||||||||||||2017-10-10 23:04:14.20281|2017-10-10 23:04:14.20281
NCT02516085|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-05|||January 2012||2012-01-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin||Completed||Phase 1|5|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-10 23:04:14.522631|2017-10-10 23:04:14.522631
NCT02516072|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-07-18|||January 2015||2015-01-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy|The Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Diagnostic or Therapeutic Peripheral Angiography: a Pilot Randomised Controlled Trial|Recruiting||N/A|40|Anticipated|Changi General Hospital||2|||f||||f||||||||||2017-10-10 23:04:14.584989|2017-10-10 23:04:14.584989
NCT02516059|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-03-06|||September 14, 2015|Actual|2015-09-14|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 20, 2017|Actual|2017-02-20||Interventional|||Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia|Does Postoperative Administration of Oral Oxycodone With/Without Naloxone, Reduce the Duration of Epidural Analgesia in Patients Undergoing Cystectomy Without Impairing Its Benefits? A Randomized, Double Blind Controlled Trial|Completed||Phase 4|90|Actual|University Hospital Inselspital, Berne||3|||f||||f||||||||||2017-10-10 23:04:14.667192|2017-10-10 23:04:14.667192
NCT02516033|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-07|||January 2015||2015-01-01|August 2015|2015-08-01|January 2025|Anticipated|2025-01-01|January 2021|Anticipated|2021-01-01|5 Years|Observational [Patient Registry]|||Hybrid Atrail Fibrillation Ablation Registry|Identification of a Risk Profile Associated With Failure of the Hybrid Ablation of Atrial Fibrillation.|Enrolling by invitation||N/A|250|Anticipated|University Medical Center Groningen|||1||f||||t||||||Samples With DNA|"     Full blood sample   "|||2017-10-10 23:04:15.099896|2017-10-10 23:04:15.099896
NCT02516020|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-04-17|||August 2015||2015-08-01|April 2017|2017-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Effectiveness of Single Step Culture Media and Sequential Culture Media on Blastulation Rate|Effectiveness of Single Step Culture Media and Sequential Culture Media on Blastulation Rate: a Randomized Controlled Trial.|Withdrawn||N/A|0|Actual|Vietnam National University||2|||f||||f||||||||||2017-10-10 23:04:15.177813|2017-10-10 23:04:15.177813
NCT02515994|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-06-14|2016-05-03||July 2015||2015-07-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||All subjects that were dispensed a study lens.|Evaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact Lens||Completed||N/A|224|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||t||||||||||2017-10-10 23:04:15.393811|2017-10-10 23:04:15.393811
NCT02515981|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-02-06|||May 2012||2012-05-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|April 2016|Actual|2016-04-01||Interventional|NHWIP||New Hampshire Medicaid Wellness Incentive Program|New Hampshire Medicaid Wellness Incentive Program|Active, not recruiting||N/A|2800|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 23:04:15.751978|2017-10-10 23:04:15.751978
NCT02515968|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-03|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Comparison of Desflurane and Propofol on Quality of Recovery in Patients Undergoing Robotic or Laparoscopic Gastrectomy||Unknown status|Not yet recruiting|N/A|84|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:04:15.877067|2017-10-10 23:04:15.877067
NCT02515955|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-06-03|||August 2015||2015-08-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants|A Randomized, Placebo- and Comparator-controlled, Double-blind, Multiple (Ascending) Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Subjects|Completed||Phase 1|76|Actual|Janssen-Cilag International NV||8|||f||||f||||||||||2017-10-10 23:04:15.976584|2017-10-10 23:04:15.976584
NCT02515942|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-09-26|||September 25, 2015|Actual|2015-09-25|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|August 14, 2017|Actual|2017-08-14||Interventional|||CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)|A Randomized, Multi-Center, Single Masked, Sham Controlled, Proof-of-Concept Study of Intravitreal CLG561 as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy|Active, not recruiting||Phase 2|114|Actual|Alcon Research||3|||f||||f||||||||||2017-10-10 23:04:16.119943|2017-10-10 23:04:16.119943
NCT02515929|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-08-04|||September 2013||2013-09-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs|Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With an Oligomeric Proanthocyanidins Nutritional Supplement|Completed||Phase 4|20|Actual|University of Seville||2|||f||||t||||||||||2017-10-10 23:04:16.241172|2017-10-10 23:04:16.241172
NCT02515916|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-05-15|||May 30, 2017|Anticipated|2017-05-30|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||Fertility Preservation- Oncology Treatment Effects and Psychological Impact|Fertility Preservation- Oncology Treatment Effects and Psychological Impact|Not yet recruiting||N/A|300|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No||2017-10-10 23:04:16.330427|2017-10-10 23:04:16.330427
NCT02515890|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-06-15|||August 2015||2015-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Memory Modulation by Pain During Anesthesia|Modulation of Long-term Memory by the Experience of Pain During Sedation With Anesthetics|Recruiting||N/A|50|Anticipated|University of Pittsburgh||3|||f||||f||||||||Yes|Data will be published. After all analysis and dissemination is complete, functional images will be shared via data repository.|2017-10-10 23:04:16.548055|2017-10-10 23:04:16.548055
NCT02515877|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-06-08|||January 2008||2008-01-01|June 2016|2016-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|HPV-RX||Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers|Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Phase I Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers|Completed||Phase 1|15|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 23:04:16.674196|2017-10-10 23:04:16.674196
NCT02515864|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-09-07|||August 2015||2015-08-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|||Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)|A Crossover Study to Assess the Effects of FYU-981 on the QT/QTc Interval in Healthy Male and Female Volunteers|Completed||Phase 2|48|Actual|Fuji Yakuhin Co., Ltd.||4|||f||||f||||||||||2017-10-10 23:04:16.769992|2017-10-10 23:04:16.769992
NCT02515838|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-04-07|||July 2015||2015-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD|A Multi-Centre, Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Investigate Efficacy and Safety of Sevuparin Infusion for the Management of Acute Vaso-Occlusive Crisis (VOC) in Subjects With Sickle-Cell Disease (SCD).|Recruiting||Phase 2|133|Anticipated|Modus Therapeutics AB||2|||f||||t||||||||Undecided||2017-10-10 23:04:17.732479|2017-10-10 23:04:17.732479
NCT02515825|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-07-11|||May 2016||2016-05-01|September 2015|2015-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|AMBIENCE||Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study)|Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study)|Completed||N/A|101|Actual|AUM Cardiovascular, Inc.|||1||f||||f||||||||||2017-10-10 23:04:17.937233|2017-10-10 23:04:17.937233
NCT02515812|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-02|||October 2012||2012-10-01|August 2015|2015-08-01||||March 2014|Actual|2014-03-01||Interventional|ADRECARD||Comparative Study of Cardiac Adrenergic Function Explored by I-123-MIBG and CZT Camera (D-SPECT) Versus Anger Camera in Patients With Heart Failure||Completed||N/A|45|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:04:18.017997|2017-10-10 23:04:18.017997
NCT02515799|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-08-02|||August 2014||2014-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Interventional|Tacho-COPD||Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis|A Double-blind, Placebo Controlled, Randomized Crossover Trial to Characterize the Mucolytic Effectiveness of Tacholiquine® in Chronic Bronchitis|Completed||Phase 4|27|Actual|bene-Arzneimittel GmbH||2|||f||||f||||||||||2017-10-10 23:04:18.128917|2017-10-10 23:04:18.128917
NCT02515786|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-11-23|||January 2013||2013-01-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Effects of Long-term Dry and Humidified Low-flow Oxygen Via Nasal Cannula|Effects of Long-term Dry and Humidified Low-flow Oxygen Via Nasal Cannula on Nasal Mucociliary Clearance, Mucus Properties, Inflammation and Airway Symptoms in Patients|Active, not recruiting||Phase 1/Phase 2|19|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:04:18.273905|2017-10-10 23:04:18.273905
NCT02515773|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-09-08|||December 2015||2015-12-01|August 2015|2015-08-01|October 2020|Anticipated|2020-10-01|December 2018|Anticipated|2018-12-01||Interventional|MOBILITY||Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs|MOBILITY- Metformin for Overweight & OBese ChILdren and Adolescents With BIpolar Spectrum Disorders Treated With Second-Generation AntipsYchotics|Recruiting||Phase 4|1800|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-10-10 23:04:18.391798|2017-10-10 23:04:18.391798
NCT02515760|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-05-03|||February 2014||2014-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Tumor-specific T Cells in Lung Cancer|Tumor-specific Effector T Cells in Non-small Cell Lung Cancer|Recruiting||N/A|80|Anticipated|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-10 23:04:18.59375|2017-10-10 23:04:18.59375
NCT02515747|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-08-01|||January 1993||1993-01-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|September 2006|Actual|2006-09-01||Interventional|PRELUDE||Prospective Russian Evaluation of Lp(a) Role in cardiovascUlar DiseasE|Role of Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype in Prediction of Coronary Events in General Population|Completed||N/A|1400|Actual|Russian Cardiology Research and Production Center||3|||f||||t||||||||||2017-10-10 23:04:18.68626|2017-10-10 23:04:18.68626
NCT02515734|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-08-04|||August 2015||2015-08-01|August 2015|2015-08-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Interventional|DEEPER||A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab|A Randomized Phase II Study to Investigate the Deepness of Response of FOLFOXIRI Plus Cetuximab (Erbitux) Versus FOLFOXIRI Plus Bevacizumab as the First-line Therapy in Metastatic Colorectal Cancer Patients With RAS Wild-type Tumors: DEEPER|Not yet recruiting||Phase 2|360|Anticipated|Japan Clinical Cancer Research Organization||2|||f||||t||||||||||2017-10-10 23:04:18.772164|2017-10-10 23:04:18.772164
NCT02515721|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-03|||July 2014||2014-07-01|August 2015|2015-08-01||||August 2015|Anticipated|2015-08-01||Interventional|PCLE||PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma|Probe-based Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia,Intraepithelial Neoplasia,and Carcinoma:A Multicenter,Randomized,Controlled Trial|Unknown status|Recruiting|N/A|242|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 23:04:18.8737|2017-10-10 23:04:18.8737
NCT02515708|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-20|||May 16, 2016|Actual|2016-05-16|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Pilot Study to Assess Safety and Feasibility of Normothermic Machine Preservation In Human Liver Transplantation|A Phase I Pilot Study to Assess Safety and Feasibility of Normothermic Machine Preservation In Human Liver Transplantation|Recruiting||N/A|25|Anticipated|The Cleveland Clinic||1|||f||||t|f|t|t|f||||||2017-10-10 23:04:18.971586|2017-10-10 23:04:18.971586
NCT02515695|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-08-04|||May 2005||2005-05-01|August 2015|2015-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Phase I BP Interferon (IFN) Beta-001|Bioavailability, Pharmacokinetic and Pharmacodynamic Profile of Interferon Beta-1a (Bioferon®) Administered i.v. and s.c. as Single Doses to Healthy Subjects|Completed||Phase 1|12|Actual|Centre Hospitalier Universitaire Vaudois||4|||f||||t||||||||||2017-10-10 23:04:19.072053|2017-10-10 23:04:19.072053
NCT02515682|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-08-03|||October 2015||2015-10-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Equol Supplementation on Blood Pressure and Vascular Function|Effect of Natural S-equol on Blood Pressure and Vascular funtion-a Six-month Randomized, Double-blind and Placebo-controlled Trial Among Equol Non-producers of Postmenopausal Women With Prehypertension or Untreated Stage 1 Hypertension|Not yet recruiting||N/A|207|Anticipated|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-10 23:04:19.150509|2017-10-10 23:04:19.150509
NCT02515669|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-08-02|||December 2, 2015|Actual|2015-12-02|August 2017|2017-08-01|August 4, 2020|Anticipated|2020-08-04|August 3, 2020|Anticipated|2020-08-03||Interventional|||Study of an Investigational Drug, BMS-986089, in Ambulatory Boys With DMD|A Multi-site, Randomized, Placebo-controlled, Double-blind, Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety Tolerability and Pharmacokinetics of BMS-986089 in Ambulatory Boys With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Hoffmann-La Roche||2|||f||||t|t|f||||||||2017-10-10 23:04:19.215564|2017-10-10 23:04:19.215564
NCT01933763|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-03-11|||August 2013||2013-08-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193||Completed||Phase 1|56|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:20:39.583691|2017-10-11 01:20:39.583691
NCT02515643|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-03-27|||July 2015||2015-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CONFUCIUS||Contribution of Renal Function to Endothelial Dysfunction in Living Kidney Donors and Transplant Recipients|Estimating the Contribution of Renal Function to Endothelial Dysfunction by a Two-cohort Study: Living Kidney Donors and Their Transplant Recipients|Recruiting||N/A|120|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||2||f||||f||||||||||2017-10-10 23:04:19.566304|2017-10-10 23:04:19.566304
NCT02515630|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2017-08-22|||January 29, 2016|Actual|2016-01-29|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|July 18, 2017|Actual|2017-07-18||Interventional|||Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)|A Phase 2, Open-label, Translational Biology Study of Momelotinib in Transfusion-Dependent Subjects With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)|Completed||Phase 2|41|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-10 23:04:19.841551|2017-10-10 23:04:19.841551
NCT02515617|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-07-18|||November 5, 2015|Actual|2015-11-05|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|DEMETER||Medico-economic Study of the Subglottic Secretions Drainage in Prevention of Ventilator-associated Pneumonia (DEMETER)|Drainage of Subglottic Secretions and Prevention of Ventilator-associated Pneumonia in Intensive carE Units: Medico-Economic Study With a Randomized clusTer and crossovER Design: DEMETER Study|Recruiting||N/A|2553|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-10 23:04:20.026476|2017-10-10 23:04:20.026476
NCT02515604|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-10-31|||August 2015||2015-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Comparison of Single and Repeated Dose of Vaginal Misoprostol for the Treatment of Early Pregnancy Failure|Comparison of Single and Repeated Dose of Vaginal Misoprostol for the Treatment of Early Pregnancy Failure - a Randomized Clinical Trial|Completed||Phase 4|180|Actual|Wolfson Medical Center||2|||f||||f||||||||||2017-10-10 23:04:20.314518|2017-10-10 23:04:20.314518
NCT02515591|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-10-05|||July 2015||2015-07-01|August 2015|2015-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|BALval||Validating the Use of Disposable Bronchoscopes for Research Bronchoalveolar Lavage|Validating the Use of Disposable Flexible Intubation Bronchoscopes for Research Bronchoalveolar Lavage|Completed||N/A|10|Actual|Royal Liverpool and Broadgreen University Hospitals NHS Trust|||1||f||||f||||||Samples With DNA|"     Bronchoalveolar lavage cells Bronchoalveolar lavage supernatent   "|||2017-10-10 23:04:20.40748|2017-10-10 23:04:20.40748
NCT02515578|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-08-29|||October 2015||2015-10-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Southwest Health Extension Partnership to Enhance Research Dissemination|Southwest Health Extension Partnership to Enhance Research Dissemination|Recruiting||N/A|10000|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:04:20.485112|2017-10-10 23:04:20.485112
NCT02515565|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-11-02|||May 2015||2015-05-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Physiotherapy in Patients Hospitalized Due to Pneumonia.|Effects of a Physiotherapy Program in Patients Hospitalized Due to Pneumonia|Recruiting||N/A|60|Anticipated|Universidad de Granada||2|||f||||t||||||||No||2017-10-10 23:04:20.602083|2017-10-10 23:04:20.602083
NCT02515552|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-03|||September 2008||2008-09-01|July 2015|2015-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Web-Based Program for Symptom Management in Fibromyalgia|Web-Based Program for Symptom Management in Fibromyalgia|Completed||Phase 2|883|Actual|Collinge and Associates, Inc.||1|||f||||f||||||||||2017-10-10 23:04:20.718605|2017-10-10 23:04:20.718605
NCT02515539|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2016-03-29|||August 2015||2015-08-01|August 2015|2015-08-01|July 2021|Anticipated|2021-07-01|August 2016|Anticipated|2016-08-01||Interventional|||Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)|Early Feasibility Study of the CardiAQ™ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems)|Withdrawn||N/A|0|Actual|Edwards Lifesciences||1||Edwards Lifesciences terminated the IDE associated with this study. No patients enrolled.|f||||t||||||||||2017-10-10 23:04:20.806136|2017-10-10 23:04:20.806136
NCT02515526|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2016-04-09|||June 2015||2015-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein|Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein|Active, not recruiting||N/A|16|Anticipated|University of Cologne||2|||f||||t||||||||||2017-10-10 23:04:20.906601|2017-10-10 23:04:20.906601
NCT02515513|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-14|||March 2016||2016-03-01|September 2017|2017-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||The Role of Muscle Cachexia in Pancreatic Cancer|The Role of Muscle Cachexia in Pancreatic Cancer|Recruiting||N/A|225|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 23:04:21.013998|2017-10-10 23:04:21.013998
NCT02515500|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-07-31|||September 2015||2015-09-01|July 2015|2015-07-01||||June 2016|Anticipated|2016-06-01||Interventional|||Cigarette Reduction Using the Quitbit Digital Lighter and Mobile Application for Smoking Cessation: a Randomized Controlled Trial|Cigarette Reduction Using the Quitbit Digital Lighter and Mobile Application for Smoking Cessation: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|200|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:04:21.142251|2017-10-10 23:04:21.142251
NCT02515487|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-07-05|||September 2013||2013-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|||An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer Survivors|An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer|Active, not recruiting||N/A|24|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 23:04:21.252115|2017-10-10 23:04:21.252115
NCT01842919|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-09-12|||April 2013|Actual|2013-04-01|September 2017|2017-09-01|July 8, 2016|Actual|2016-07-08|July 28, 2015|Actual|2015-07-28||Interventional|||Dance and Huntington Disease||Completed||N/A|53|Actual|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||f||||||||||2017-10-11 01:45:52.519754|2017-10-11 01:45:52.519754
NCT02515474|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-08-08|||September 2015||2015-09-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of LCBDE vs ERCP + LC for Choledocholithiasis|A Long Term Complications Comparison of Laparoscopic Common Bile Duct Exploration and Cholecystectomy Versus Sequential ERCP Followed by Laparoscopic Cholecystectomy for Choledocholithiasis: a Multicenter Randomized Controlled Study|Recruiting||N/A|1000|Anticipated|Hepatopancreatobiliary Surgery Institute of Gansu Province||2|||f||||t||||||||||2017-10-10 23:04:21.363588|2017-10-10 23:04:21.363588
NCT02515461|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-03-29|||July 2015||2015-07-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease|Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease|Recruiting||N/A|30|Anticipated|Odense University Hospital||1|||f||||t||||||||||2017-10-10 23:04:21.552653|2017-10-10 23:04:21.552653
NCT02515448|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-03-23|||October 2015|Actual|2015-10-01|May 2016|2016-05-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|GENTAERO||A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia||Completed||Phase 1|12|Actual|Poitiers University Hospital||1|||f||||||||||||||2017-10-10 23:04:21.665724|2017-10-10 23:04:21.665724
NCT02515435|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-08-15|||January 1, 2015||2015-01-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2016|Actual|2016-08-01||Interventional|||The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer|Single Arm Phase II Clinical Trial to Investigate the Efficacy and Safety of Apatinib as a Single Agent in Advanced NSCLC Who Failed to at Least Two Lines Systemic Treatment, or Were Not Amendable to Receive the Second-line Standard Therapy|Active, not recruiting||Phase 2|40|Anticipated|Tongji University||1|||f||||t||||||||||2017-10-10 23:04:21.756143|2017-10-10 23:04:21.756143
NCT02515422|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-03|||June 2014||2014-06-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Subcutaneous Wound Infiltration of Ketamine or Bupivacaine Pain Perception After Cesarean Section|Subcutaneous Wound Infiltration of Ketamine is Superior to Bupivacaine in Terms of Pain Perception and Opioid Consumption After Cesarean Section: a Double-blinded Randomized Placebo Controlled Clinical Trial.|Completed||Phase 1|120|Actual|Kayseri Education and Research Hospital||4|||f||||||||||||||2017-10-10 23:04:21.86188|2017-10-10 23:04:21.86188
NCT02515409|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2015-08-02|||August 2015||2015-08-01|June 2015|2015-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01|6 Months|Observational [Patient Registry]|||Heated Humidified High Flow Nasal Cannula for Children With Obstructive Sleep Apnea|Heated Humidified High Flow Nasal Cannula for Children With Obstructive Sleep Apnea|Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||t||||||||||2017-10-10 23:04:21.968173|2017-10-10 23:04:21.968173
NCT02515396|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-04-05|||July 2015||2015-07-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|March 2016|Actual|2016-03-01||Interventional|LPS||Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide|A Randomised, Double-Blind, Placebo-Controlled, Two-Way Crossover Study in Healthy Smokers to Investigate the Effect of Inhaled Dosing With MMI-0100 on Airway Inflammation as Assessed in Induced Sputum After Challenge With Inhaled Lipopolysaccharide (LPS)|Active, not recruiting||Phase 1|20|Anticipated|Moerae Matrix, Inc.||2|||f||||f||||||||||2017-10-10 23:04:22.066983|2017-10-10 23:04:22.066983
NCT02515383|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-10|||November 2016|Actual|2016-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)|Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)|Recruiting||N/A|105|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||||||2017-10-10 23:04:22.141402|2017-10-10 23:04:22.141402
NCT02515370|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-09-13|||May 2016||2016-05-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|FLCs||Friends for Life Circles for Option B Plus|Using Enhanced Peer Group Strategies to Support Prevention of Mother to Child HIV Transmission (PMTCT) Option B+ in Uganda|Recruiting||N/A|540|Anticipated|MU-JHU CARE||2|||f||||f||||||||||2017-10-10 23:04:22.231126|2017-10-10 23:04:22.231126
NCT02515357|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-08-02|||June 2015||2015-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Mediterranean Lifestyle Intervention in Patients With Obstructive Sleep Apnea|The Effect of a Mediterranean Lifestyle Intervention on Biochemical and Clinical Characteristics of Patients With Obstructive Sleep Apnea: a Randomized, Controlled, Single-Blind Clinical Trial|Recruiting||N/A|150|Anticipated|Harokopio University||3|||f||||f||||||||||2017-10-10 23:04:22.33864|2017-10-10 23:04:22.33864
NCT02515344|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-09-15|||August 2015||2015-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|IDLN||Impact of the Distribution to Attending Physicians of a Nominative List of Their Patients Not Participating in the Organised Screening of Colorectal Cancer|Impact of the Distribution to Attending Physicians of a Nominative List of Their Patients Not Participating in the Organised Screening of Colorectal Cancer: Randomised Study Measuring the Impact on Participation|Completed||N/A|48649|Actual|Nantes University Hospital||3|||f||||t||||||||||2017-10-10 23:04:22.446005|2017-10-10 23:04:22.446005
NCT02515331|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-09-12|||November 4, 2015|Actual|2015-11-04|September 2017|2017-09-01|August 17, 2017|Actual|2017-08-17|August 17, 2017|Actual|2017-08-17||Interventional|||Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients|A Randomized, Sponsor Open, Site and Subject Double Blind, Parallel Group, Placebo-controlled Study to Evaluate the Safety and Efficacy of LHW090 After 4 Weeks Treatment in Patients With Resistant Hypertension|Completed||Phase 2|57|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:04:22.520701|2017-10-10 23:04:22.520701
NCT02515318|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2015-12-03|||May 2015||2015-05-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|||Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Effects of a Physiotherapy Program in Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Active, not recruiting||N/A|60|Anticipated|Universidad de Granada||2|||f||||t||||||||||2017-10-10 23:04:22.642881|2017-10-10 23:04:22.642881
NCT02515305|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-06-28||2016-06-27|July 2015||2015-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris||Completed||Phase 3|890|Actual|Perrigo Company||3|||f||||f||||||||No||2017-10-10 23:04:22.733208|2017-10-10 23:04:22.733208
NCT02515292|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-04|||June 2014||2014-06-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|ModeInfIUGR||Evaluation of Infants With Intrauterine Growth Restriction|Multidimensional Modeling in Evaluation of Infants With Intrauterine Growth Restriction|Unknown status|Recruiting|N/A|60|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy|||2||f||||||||||||||2017-10-10 23:04:22.806734|2017-10-10 23:04:22.806734
NCT02515279|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-03-10|2016-01-12||November 2008||2008-11-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational||All participants who were enrolled in the study.|An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria|A Non-Interventional Trial of Pegasys/Copegus in HCV Patients for 12 Months|Completed||N/A|463|Actual|Hoffmann-La Roche|The sustained viral response that had to be filled out 6 months (or later) after the end of treatment was documented poorly due to reasons such as participants that were lost to follow-up or the study closure was before the visit date for the SVR.||1||f||||||||||||||2017-10-10 23:04:22.896018|2017-10-10 23:04:22.896018
NCT02515266|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-31|||May 2015||2015-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|PROTSUP||Additional Protein Fortification in Extremely Low Birth Weight Infants|Evaluation of Additional Protein Fortification in Extremely Low Birth Weight Infants Fed Human Milk: PROTSUP Study|Completed||N/A|152|Actual|Hôpital de la Croix-Rousse|||1||f||||f||||||||||2017-10-10 23:04:23.137599|2017-10-10 23:04:23.137599
NCT02515253|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-07-19|||October 2015||2015-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Breast Support Intervention for Women With Breast Pain|A Randomised Control Trial of an Individual Bra Prescription Versus Standard Care for Women With Larger Breasts and Breast Pain|Completed||N/A|18|Actual|University of Portsmouth||2|||f||||f||||||||||2017-10-10 23:04:23.189082|2017-10-10 23:04:23.189082
NCT02515240|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-08-05|||July 2010||2010-07-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Interventional|||Immune Response to Pneumococcal Vaccination in HIV Infected Individuals|Immune Response to Pneumococcal Vaccination in HIV Infected Individuals|Completed||Early Phase 1|124|Actual|University of Toledo Health Science Campus||6|||f||||f||||||||||2017-10-10 23:04:23.254382|2017-10-10 23:04:23.254382
NCT02515227|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-11-10|||November 2015||2015-11-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Interventional|Mel64;PATHVACS||Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab|A Trial to Evaluate the Safety, Immunogenicity, and Clinical Activity of a Helper Peptide Vaccine Plus PD-1 Blockade|Recruiting||Phase 1/Phase 2|47|Anticipated|University of Virginia||1|||f||||t||||||||||2017-10-10 23:04:23.35359|2017-10-10 23:04:23.35359
NCT02515214|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-10-28|||July 2012||2012-07-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|3 Years|Observational [Patient Registry]|AURORA||bAriatric sUrgery Registration in wOmen of Reproductive Age|Bariatric Surgery Registration in Women of Reproductive Age|Recruiting||N/A|500|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"     Breast milk samples   "|||2017-10-10 23:04:23.458232|2017-10-10 23:04:23.458232
NCT02515201|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-07-31|||September 2014||2014-09-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|March 2015|Actual|2015-03-01||Interventional|||Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children|Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children With Intestinal Failure|Unknown status|Active, not recruiting|Phase 4|20|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:04:23.652384|2017-10-10 23:04:23.652384
NCT02515188|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-02-15|||August 2015||2015-08-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Effect of Additional Propacetamol Infusion on Post Procedural Outcome and Opioid Consumption During Catheter Ablation of Atrial Fibrillation.||Recruiting||N/A|98|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:04:23.736741|2017-10-10 23:04:23.736741
NCT02515162|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-08-13|||July 2015||2015-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization|Fischer Cone Biopsy Excisor Versus Loop Excision Procedure. A Randomized Trial of Two Operation Techniques in Women Undergoing Conization for Cervical Dysplasia|Completed||N/A|178|Actual|Zydolab - Institute of Cytology and Immune Cytochemistry||2|||f||||f||||||||No||2017-10-10 23:04:24.050768|2017-10-10 23:04:24.050768
NCT02515149|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-03|2015-08-03|||July 2013||2013-07-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|CD4-POC||Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya|Randomized Controlled Trial to Assess Accuracy, Feasibility, Acceptability, Cost Effectiveness and Impact of Point of Care CD4 Testing on HIV Diagnosis, Linkage to Care and Time to Antiretroviral Therapy Initiation Among HIV Infected Patients in Rural Western Kenya|Completed||N/A|770|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 23:04:24.189502|2017-10-10 23:04:24.189502
NCT02515136|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-02-13|||July 2015||2015-07-01|February 2017|2017-02-01||||January 2018|Anticipated|2018-01-01||Interventional|SRlearning||Stimulus-response and Parkinson's Disease (SRlearning)|Stimulus-response Associations in Parkinson's Disease Patients|Recruiting||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f||||||||||2017-10-10 23:04:24.28838|2017-10-10 23:04:24.28838
NCT02515123|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-01-17|||February 2016||2016-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|PROPEL||Promotion of Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in ICU Patients.|Promotion of Regular Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in Long-stay ICU Patients. A Multicenter, Phase II, Sham-controlled, Randomized Trial. The PROPEL Study|Recruiting||Phase 2|140|Anticipated|E-Motion Medical Ltd.||2|||f||||t||||||||||2017-10-10 23:04:24.387995|2017-10-10 23:04:24.387995
NCT02514733|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-09-12|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Association of Donor Age With Recipient Outcomes in Kidney Transplant|Association of Donor Age With Recipient Outcomes in Kidney Transplant|Recruiting||N/A|80|Anticipated|Northwestern University|||2||f||||f||||||||||2017-10-10 23:04:27.726859|2017-10-10 23:04:27.726859
NCT02515110|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-09|||August 4, 2015||2015-08-04|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer|Hypofractionated Regional Nodal Irradiation Phase 2 Clinical Trial for Women With Breast Cancer - HeNRIetta|Recruiting||N/A|145|Anticipated|Virginia Commonwealth University||1|||f||||t|f|f|||t|||||2017-10-10 23:04:24.544792|2017-10-10 23:04:24.544792
NCT02515097|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-04-26|||November 10, 2015|Actual|2015-11-10|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|March 2017|Actual|2017-03-01||Interventional|||Safety and Efficacy of IDP-122 in the Treatment of Plaque Psoriasis|A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-122 in the Treatment of Plaque Psoriasis|Completed||Phase 3|213|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 23:04:24.695133|2017-10-10 23:04:24.695133
NCT02515084|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-08-23|||March 2011||2011-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|THYRIRMTEP||Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma|Preliminary Study of the Interest of Diffusion-weighted Magnetic Resonance Imaging in the Early Detection of Differentiated Thyroid Carcinoma Cervical Recurrence. Comparison with18F-FDG PET/CT|Completed||Phase 2|37|Actual|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 23:04:24.832006|2017-10-10 23:04:24.832006
NCT02515071|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-10-22|||January 2015||2015-01-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A 2 Week, Crossover Trial of Dietary Nitrate in Obstructive Sleep Apnoea Syndrome (OSAS).|Dietary Nitrate for OSAS: a Randomized, Placebo-controlled, Crossover Trial.|Completed||N/A|10|Actual|Royal College of Surgeons, Ireland||2|||f||||f||||||||||2017-10-10 23:04:24.942235|2017-10-10 23:04:24.942235
NCT02515045|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-07-24|2017-07-24||January 2015||2015-01-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Dropless vs. Standard Drops Contralateral Eye Study|Comparison of Dropless Prophylaxis After Routine Phacoemulsification to Standard Drops Regimen|Completed||Phase 4|59|Actual|Carolina Eyecare Physicians, LLC||3|||f||||f||||||||||2017-10-10 23:04:25.191457|2017-10-10 23:04:25.191457
NCT02515032|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-07-12|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia|A 12-week Double Blind, Placebo Controlled, Randomised Pilot Study Assessing Safety and Tolerability of Nutrifriend Cachexia in Patients Diagnosed With Non Small Cell Lung Cancer (NSCLC) With Involuntary Weight Loss|Completed||N/A|56|Actual|Smartfish AS||2|||f||||f||||||||||2017-10-10 23:04:25.617101|2017-10-10 23:04:25.617101
NCT02515019|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-30|||April 2011||2011-04-01|July 2015|2015-07-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||Bispectral Index Guided Sevoflurane Titration|Bispectral Index Guided Titration of Sevoflurane in On-pump Cardiac Surgery Reduces Plasma Sevoflurane Concentration and Vasopressor Requirements|Completed||N/A|60|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 23:04:25.769203|2017-10-10 23:04:25.769203
NCT02515006|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-08-02|||September 2014||2014-09-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Impact of Homeopathy for Persistent Insomnia in Patients With Cancer|Randomized Controlled Trial of Homeopathy Compared With Treatment As Usual for Persistent Insomnia in Patients With Cancer|Completed||N/A|160|Actual|Adwin Life Care||2|||f||||t||||||||||2017-10-10 23:04:25.880236|2017-10-10 23:04:25.880236
NCT02514993|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-08-03|||January 2003||2003-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||The Unstable Thoracic Cage Injury|The Unstable Thoracic Cage Injury: The Concomitant Sternal Fracture Indicates a Severe Thoracic Spine Fracture|Completed||N/A|130|Actual|BG Unfallklinik|||2||f||||t||||||||||2017-10-10 23:04:25.97895|2017-10-10 23:04:25.97895
NCT02514980|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-01|2017-01-28|||August 2015||2015-08-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|IFONB||Infra-orbital Nerve Block for Post Operative Analgesia in Children Undergoing Cleft Lip Surgery.|Infra-orbital Nerve Block for Post Operative Analgesia in Young Children Undergoing Pediatric Cleft Lip Surgery.|Completed||Phase 2/Phase 3|30|Actual|Assiut University||2|||f||||t||||||||No|This is a single center study with no plan to share data|2017-10-10 23:04:26.046241|2017-10-10 23:04:26.046241
NCT02514967|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-19|||June 2016|Actual|2016-06-01|May 2017|2017-05-01|February 28, 2017|Actual|2017-02-28|November 2016|Actual|2016-11-01||Interventional|||CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects With Systemic Lupus Erythematosus With or Without Nephritis|Terminated||Phase 3|3|Actual|Anthera Pharmaceuticals||2||Study halted prematurely and will not resume. Subjects were seen until February 2017|f||||t||||||||||2017-10-10 23:04:26.146872|2017-10-10 23:04:26.146872
NCT02514954|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-11-05|||July 2015||2015-07-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus|Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus|Completed||Phase 1|28|Actual|Adocia||2|||f||||f||||||||||2017-10-10 23:04:26.224627|2017-10-10 23:04:26.224627
NCT02514941|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-31|||June 2007||2007-06-01|July 2015|2015-07-01||||March 2010|Actual|2010-03-01||Interventional|||Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation|Bioavailability of Paracetamol, Amoxicillin and Talinolol and Expression of Intestinal Drug Metabolizing Enzymes and Transport Proteins Before, Immediately and One Year After Proximal Roux-en-Y Gastric Bypass Operation in Patients With Morbid Adipositas|Completed||Phase 1|12|Actual|University Medicine Greifswald||3|||f||||f||||||||||2017-10-10 23:04:26.299402|2017-10-10 23:04:26.299402
NCT02514928|ClinicalTrials.gov processed this data on October 10, 2017|2015-08-02|2016-08-10|||June 2015||2015-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas|Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas|Recruiting||Phase 3|430|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 23:04:26.386123|2017-10-10 23:04:26.386123
NCT02514915|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases|Phase II Study Determining the Efficacy of Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases|Recruiting||Phase 2|24|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:04:26.467337|2017-10-10 23:04:26.467337
NCT02514902|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-02-20|||March 25, 2015|Actual|2015-03-25|February 2017|2017-02-01|December 16, 2016|Actual|2016-12-16|December 16, 2016|Actual|2016-12-16||Interventional|STABILISER-I||Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)|Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)|Completed||N/A|48|Actual|University of Kentucky||1|||f||||f||||||||No||2017-10-10 23:04:26.545691|2017-10-10 23:04:26.545691
NCT02514876|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-04-21|||September 2015||2015-09-01|April 2017|2017-04-01|May 5, 2016|Actual|2016-05-05|April 8, 2016|Actual|2016-04-08||Interventional|||Foresight Intracardiac Echocardiography (ICE) System|Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System|Completed||Early Phase 1|10|Actual|Conavi||1|||f||||||||||||||2017-10-10 23:04:26.710011|2017-10-10 23:04:26.710011
NCT02514863|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-07-31|||December 2009||2009-12-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Electrode Placement in Electrical Velocimetry|Influence of Electrode Placement on Electrical Velocimetry Cardiac Output Measurements|Completed||N/A|92|Actual|Universitätsmedizin Mannheim|||1||f||||t||||||||||2017-10-10 23:04:26.771867|2017-10-10 23:04:26.771867
NCT02514850|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-11-30|||July 2015||2015-07-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes|A Randomised, Single Dose, Double-blind, Double-dummy, Three-period Cross-over Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes|Completed||Phase 1|24|Actual|Adocia||3|||f||||f||||||||||2017-10-10 23:04:26.827058|2017-10-10 23:04:26.827058
NCT02514837|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-31|||September 2015||2015-09-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|RTM||Microwave Radiometry for the Diagnosis and Monitoring of Breast Cancer|Microwave Radiometry for the Diagnosis and Monitoring of Breast Cancer|Unknown status|Not yet recruiting|Early Phase 1|300|Anticipated|University of Edinburgh||1|||f||||t||||||||||2017-10-10 23:04:26.920573|2017-10-10 23:04:26.920573
NCT02514824|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-05-19|||October 2015||2015-10-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|November 2018|Anticipated|2018-11-01||Interventional|||MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma|MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma|Recruiting||Phase 1/Phase 2|34|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No|Individual participant data (IPD) will not be shared. Cumulative data will be posted here and published.|2017-10-10 23:04:27.093771|2017-10-10 23:04:27.093771
NCT02514811|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-08-03|||September 2011||2011-09-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Replication of the Teen Outreach Program in the Pacific Northwest|Northwest Coalition for Adolescent Health (NWCAH) Teen Outreach Program Replication Study|Unknown status|Active, not recruiting|N/A|8686|Actual|Philliber Research & Evaluation||2|||f||||f||||||||||2017-10-10 23:04:27.192762|2017-10-10 23:04:27.192762
NCT02514798|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-01-19|||July 2015|Actual|2015-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study of Physiological Effect of High-Flow Nasal Cannula on Respiratory Pattern and Work of Breathing|Pilot Study of Physiological Effect of High-Flow Nasal Cannula on Respiratory Pattern and Work of Breathing in Severe COPD Patients|Recruiting||N/A|15|Anticipated|Tufts Medical Center||2|||f||||f||||||||No||2017-10-10 23:04:27.262642|2017-10-10 23:04:27.262642
NCT02514759|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-30|||September 2012||2012-09-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Replication of the Teen Outreach Program in Kansas City|The Women's Clinic of Kansas City Teen Outreach Program Replication Study|Unknown status|Active, not recruiting|N/A|1885|Actual|Philliber Research & Evaluation||2|||f||||f||||||||||2017-10-10 23:04:27.589894|2017-10-10 23:04:27.589894
NCT02514746|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-05|||July 2015|Actual|2015-07-01|March 2016|2016-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose|Assessment of Long Term Immunogenicity of Japanese Encephalitis Live Attenuated SA-14-14-2 Vaccine in Previously Vaccinated Bangladeshi Children and Antibody Response and Safety to a Booster Dose|Completed||Phase 4|561|Actual|PATH||1|||f||||t||||||||||2017-10-10 23:04:27.656096|2017-10-10 23:04:27.656096
NCT02514707|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-30|||January 2015||2015-01-01|July 2015|2015-07-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|ART Long Term||Outcomes of HIV Infected Individuals After Ten Years on Antiretroviral Treatment|Outcomes of HIV Infected Individuals After Ten Years on Antiretroviral Treatment|Recruiting||N/A|1000|Anticipated|Makerere University|||1||f||||f||||||Samples With DNA|"     plasma (4 aliquots), serum (4 aliquots), packed cells pellets (5 aliquots) for each patient   "|||2017-10-10 23:04:27.865112|2017-10-10 23:04:27.865112
NCT02514694|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-05-01|||July 2015||2015-07-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||LEO 32731 - A Phase I Study in Healthy Subjects|LEO 32731 - A Phase I, Single-Blind, Placebo-Controlled, Single and Multiple Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects|Completed||Phase 1|27|Actual|LEO Pharma||2|||f||||||||||||||2017-10-10 23:04:29.80206|2017-10-10 23:04:29.80206
NCT02514681|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-04-18|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|PRECIOUS||A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer|A Randomized, Open-label Phase III Trial to Evaluate the Efficacy and Safety of Pertuzumab Retreatment in Previously Pertuzumab, Trastuzuamb and Chemotherapy Treated Her2-Positive Metastatic Advanced Breast Cancer|Recruiting||Phase 3|370|Anticipated|Japan Breast Cancer Research Group||2|||f||||f||||||||No||2017-10-10 23:04:29.911645|2017-10-10 23:04:29.911645
NCT02514655|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-09-14|||August 2015||2015-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PAV-PROTECT||Simple Mechanical Device to Control Pressure in the Balloon of the Endotracheal Tube to Prevent Ventilator-acquired Pneumonia|Role of a Simple Mechanical Device of Pressure Control in the Balloon of the Endotracheal Tube to Prevent Ventilator-acquired Pneumonia|Recruiting||Phase 4|500|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:04:30.202123|2017-10-10 23:04:30.202123
NCT02514642|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-09-28|||July 2015||2015-07-01|July 2015|2015-07-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease|Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease: a Randomized, Single-blind, Crossover Clinical Trial|Unknown status|Recruiting|Phase 4|30|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||||2017-10-10 23:04:30.289084|2017-10-10 23:04:30.289084
NCT02514629|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-03-29|||July 4, 2013||2013-07-04|March 2017|2017-03-01|July 12, 2016|Actual|2016-07-12|July 12, 2016|Actual|2016-07-12||Interventional|||Testosterone, Metformin, or Both, for Hypogonadism in Obese Males|Randomized, Double-blind, Parallel, Placebo-controlled, Clinical Trial to Assess the Efficacy of Testosterone, Metformin, or Both, for the Treatment of Obesity-induced Male Hypogonadism|Completed||Phase 3|107|Actual|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||4|||f||||f||||||||||2017-10-10 23:04:30.385849|2017-10-10 23:04:30.385849
NCT02514616|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-11-19|||January 2015||2015-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|EST-SHAM-EUR||Electrical Stimulation Therapy (EST) of the Lower Esophageal Sphincter (GERD)|Electrical Stimulation Therapy (EST) of the Lower Esophageal Sphincter: a Multicenter, Randomized, Double-blind, Sham-controlled Parallel-group Trial Evaluating Short Term Efficacy of EndoStim Device on GERD|Terminated||N/A|1|Actual|Erasme University Hospital||2||Early termination due to a suspension of financial support|f||||f||||||||||2017-10-10 23:04:30.486862|2017-10-10 23:04:30.486862
NCT02514603|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-19|||October 2015||2015-10-01|May 2017|2017-05-01|April 10, 2017|Actual|2017-04-10|April 10, 2017|Actual|2017-04-10||Interventional|||A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers|A Phase 1 Study of LY2606368 in Japanese Patients With Advanced Solid Tumors|Completed||Phase 1|12|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-10-10 23:04:30.603176|2017-10-10 23:04:30.603176
NCT02514590|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-06-07|||July 2016|Actual|2016-07-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Wireless High Frequency Spinal Cord Stimulation for Chronic Pain|Multi-center, Prospective, Randomized, Controlled Clinical Trial of Wireless High Frequency Spinal Cord Stimulation to Demonstrate Non-Inferiority in the Treatment of Chronic Pain as Compared to Traditional Stimulation|Recruiting||N/A|80|Anticipated|Stimwave Technologies||2|||f||||t||||||||||2017-10-10 23:04:30.83438|2017-10-10 23:04:30.83438
NCT02514577|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-05-31|||November 20, 2015|Actual|2015-11-20|May 2017|2017-05-01|May 31, 2017|Actual|2017-05-31|May 2, 2017|Actual|2017-05-02||Interventional|||Safety and Efficacy of IDP-122 in the Treatment of Plaque Psoriasis|A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-122 in the Treatment of Plaque Psoriasis|Completed||Phase 3|217|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 23:04:30.998158|2017-10-10 23:04:30.998158
NCT02514564|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-03-01|||December 2014||2014-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases|The Effects of Aerobic Exercise Training in Patients With Cardiovascular Diseases Related to Microvascular Endothelium Function, Angiogenesis, Oxidative Stress and Aerobic Capacity|Completed||N/A|115|Actual|Instituto Nacional de Cardiologia de Laranjeiras|||3||f||||t||||||Samples Without DNA|"     Blood samples for nitrite/nitrate quantification.   "|||2017-10-10 23:04:31.14412|2017-10-10 23:04:31.14412
NCT02514551|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-10-03|||October 2015||2015-10-01|October 2017|2017-10-01|January 15, 2018|Anticipated|2018-01-15|October 15, 2017|Anticipated|2017-10-15||Interventional|||A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer|Randomized Phase 2 Trial Evaluating Alternative Ramucirumab Doses in Combination With Paclitaxel in Second-Line Metastatic or Locally Advanced, Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 2|240|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:04:31.261792|2017-10-10 23:04:31.261792
NCT02514538|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2015-07-31|||February 2012||2012-02-01|July 2015|2015-07-01||||July 2015|Actual|2015-07-01||Interventional|Paracetamol||EVALUATION OF THE RELATIONSHIP BETWEEN EFFERVESCENT PARACETAMOL AND BLOOD PRESSURE. CLINICAL TRIAL.|EVALUATION OF THE RELATIONSHIP BETWEEN EFFERVESCENT PARACETAMOL AND BLOOD PRESSURE. CLINICAL TRIAL.|Unknown status|Active, not recruiting|Phase 4|49|Actual|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-10-10 23:04:31.549928|2017-10-10 23:04:31.549928
NCT02514525|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-03-06|||October 2015||2015-10-01|July 2016|2016-07-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|ColdPlay3||Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System|Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients With Previously Untreated Dysplastic Barrett's Epithelium|Recruiting||N/A|60|Anticipated|C2 Therapeutics, Inc.||1|||f||||f||||||||No|Individual participant data will not be shared.|2017-10-10 23:04:31.641581|2017-10-10 23:04:31.641581
NCT02514512|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2016-10-05|||September 2015||2015-09-01|October 2016|2016-10-01|September 2022|Anticipated|2022-09-01|September 2017|Anticipated|2017-09-01||Interventional|LIGHTSABR||Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking|Phase I Feasibility Study of Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation and Radiofrequency Tracking|Recruiting||Phase 1|20|Anticipated|Royal North Shore Hospital||2|||f||||t||||||||Yes|Data is to be shared with USyd to fulfil the secondary endpoints of the trial|2017-10-10 23:04:31.791525|2017-10-10 23:04:31.791525
NCT02514499|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-01-10|||July 2014||2014-07-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Interventional|||Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study|Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study|Active, not recruiting||N/A|350||Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 23:04:31.888162|2017-10-10 23:04:31.888162
NCT02514486|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-12-06|||July 2014||2014-07-01|December 2016|2016-12-01||||July 2017|Anticipated|2017-07-01||Observational|||Assessment of Cancer Concerns at the End of Treatment (ACE)|Assessment of Cancer Concerns at the End of Treatment (ACE)|Recruiting||N/A|250|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 23:04:31.956565|2017-10-10 23:04:31.956565
NCT02514460|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-07-11|||January 2014||2014-01-01|December 2015|2015-12-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Clinical Study of Stent Versus Direct Atherectomy to Treat Lower Limb Ischemia||Completed||N/A|120|Actual|Xuanwu Hospital, Beijing||2|||f||||t||||||||Undecided||2017-10-10 23:04:32.255077|2017-10-10 23:04:32.255077
NCT02514447|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-08-07|||July 2015||2015-07-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy|Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Previously Treated Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Topotecan Chemotherapy|Recruiting||Phase 1/Phase 2|120|Anticipated|G1 Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:04:32.479307|2017-10-10 23:04:32.479307
NCT02514434|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-30|||March 2015||2015-03-01|July 2015|2015-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Usefulness of Ultrasonography Versus Non-contrast Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma (MIRACLE-HCC)|Usefulness of Ultrasonography Versus Non-contrast Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma (MIRACLE-HCC): a Prospective Randomized Trial|Recruiting||N/A|412|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:04:32.795603|2017-10-10 23:04:32.795603
NCT02514421|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-07-31|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma|Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma|Unknown status|Not yet recruiting|N/A|24|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 23:04:32.89887|2017-10-10 23:04:32.89887
NCT02514408|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-08-18|||December 4, 2017|Anticipated|2017-12-04|August 2017|2017-08-01|December 4, 2018|Anticipated|2018-12-04|December 4, 2018|Anticipated|2018-12-04||Observational|||Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer|The Impact Radical Cystectomy Has on the Expulsion of Circulating Tumor Cells|Not yet recruiting||N/A|10|Anticipated|University of Southern California|||1||f||||t|f|f||||Samples With DNA|"     Blood   "|||2017-10-10 23:04:33.004915|2017-10-10 23:04:33.004915
NCT02514395|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-31|||September 2012||2012-09-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Observational|||Translation & Linguistic Validation of Knee and Osteoarthritis Outcome Score (KOOS) Questionnaire in Marathi Language|Translation & Linguistic Validation of Knee and Osteoarthritis Outcome Score (KOOS) Questionnaire in Marathi Language: Cross Section Survey|Completed||N/A|32|Actual|TPCT's Terna College of Physiotherapy|||1||f||||f||||||||||2017-10-10 23:04:33.11683|2017-10-10 23:04:33.11683
NCT02514382|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-04-08|||August 21, 2015|Actual|2015-08-21|April 2017|2017-04-01|August 21, 2019|Anticipated|2019-08-21|August 21, 2018|Anticipated|2018-08-21||Interventional|||Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase 1b Study of REOLYSIN® (Reovirus Serotype 3 - Dearing Strain) Combined With Standard Doses of Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma|Recruiting||Phase 1|18|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 23:04:33.191923|2017-10-10 23:04:33.191923
NCT02514369|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-07-31|||November 2012||2012-11-01|July 2015|2015-07-01||||December 2015|Anticipated|2015-12-01||Observational|||Pharmacogenomics of New Antiretrovirals|Pharmacogenetics of New Antiretroviral Drugs|Unknown status|Recruiting|N/A|250|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-10-10 23:04:33.385106|2017-10-10 23:04:33.385106
NCT02514356|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-04-12|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|March 7, 2017|Actual|2017-03-07|March 7, 2017|Actual|2017-03-07||Interventional|SITA||SMS as an Incentive To Adhere (SITA) - An Intervention Communicating Social Norms by SMS to Improve ARV Adherence|A Small Randomized Controlled Trial Providing Weekly Information by SMS About Own and Group-level ARV Adherence to Patients in Two Clinics in Uganda|Completed||N/A|147|Actual|RAND||2|||f||||f||||||||||2017-10-10 23:04:33.479403|2017-10-10 23:04:33.479403
NCT02514343|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-24|||July 2015||2015-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Magnesium Sulfate and Bupivacaine for Rehabilitation After Distal Radius Fractures|Intra-articular Infiltration With Magnesium Sulphate and Bupivacaine in Distal Radius Fractures. Randomized, Double-blind Study|Recruiting||N/A|40|Anticipated|Universidad Autonoma de Nuevo Leon||2|||f||||t||||||||||2017-10-10 23:04:33.588368|2017-10-10 23:04:33.588368
NCT02514330|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-31|||March 2012||2012-03-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Running Slopes and Power Performance|Concurrent Effect of Running in Different Slopes on Power Performance|Completed||N/A|25|Actual|Universidade Federal do Rio de Janeiro||3|||f||||t||||||||||2017-10-10 23:04:33.722254|2017-10-10 23:04:33.722254
NCT02514317|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-31|||January 2012||2012-01-01|July 2015|2015-07-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|ECHOCARPE||Percutaneous Treatment of Carpal Tunnel Syndrome With Scan|Ultrasound-assisted Percutaneous Release of Carpal Tunnel Syndrome|Completed||Phase 2|40|Actual|University Hospital, Caen||1|||f||||t||||||||||2017-10-10 23:04:33.839001|2017-10-10 23:04:33.839001
NCT02514304|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-10-19|||September 2015||2015-09-01|October 2015|2015-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding|Study of Risk Factors for Gastrointestinal Bleeding and of the Determinants of Non-fatal and Fatal Cardiovascular Events After Gastrointestinal Bleeding in Patients Receiving Antithrombotic Therapy for Cardiovascular Prevention|Recruiting||N/A|600|Anticipated|Population Health Research Institute|||1||f||||f||||||||||2017-10-10 23:04:33.926204|2017-10-10 23:04:33.926204
NCT02514291|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-04-14|||July 2015||2015-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Sleep Intervention for Pediatric Epilepsy|Evaluation of a Clinic-based Sleep Intervention for Pediatric Epilepsy|Recruiting||N/A|400|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No||2017-10-10 23:04:34.010027|2017-10-10 23:04:34.010027
NCT02514278|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-07-25|||January 28, 2016|Actual|2016-01-28|July 2017|2017-07-01|March 2022|Anticipated|2022-03-01|January 2020|Anticipated|2020-01-01||Interventional|GRECCAR12||Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy|Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy|Recruiting||Phase 3|218|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 23:04:34.108585|2017-10-10 23:04:34.108585
NCT02514265|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-21|||July 1, 2015|Actual|2015-07-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|MAPP II SPS||Trans-MAPP Symptom Patterns Study (SPS)|MAPP Research Network: Trans-MAPP Study of Urologic Chronic Pelvic Pain: Symptom Patterns Study (SPS)|Recruiting||N/A|640|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     DNA Blood Urine Vaginal Swabs Rectal Swab   "|||2017-10-10 23:04:34.31612|2017-10-10 23:04:34.31612
NCT02514252|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-03-29|||February 2, 2016|Actual|2016-02-02|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Sublingual Fentanyl for the Management of Breakthrough Pain|A Preliminary Study of Sublingual Fentanyl for the Management of Breakthrough Pain Analgesia in Patients With Advanced Cancer|Active, not recruiting||Phase 2|6|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:04:34.444785|2017-10-10 23:04:34.444785
NCT02514239|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-10-02|||July 8, 2015|Actual|2015-07-08|October 2017|2017-10-01|December 14, 2018|Anticipated|2018-12-14|July 30, 2018|Anticipated|2018-07-30||Interventional|||Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients|An Open Label, Phase I, Dose Escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Doses of BI 836909 in Relapsed and/or Refractory Multiple Myeloma Patients|Recruiting||Phase 1|50|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:04:34.560826|2017-10-10 23:04:34.560826
NCT02514226|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-02-27|||August 2015||2015-08-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Periodontal Treatment in Patients With Bronchiectasis|Evaluation of Periodontal Treatment in Patients With Bronchiectasis: a Randomized, Single-center,One Year, Parallel Group, Non-inferiority Clinical Study|Recruiting||N/A|90|Anticipated|University of Nove de Julho||3|||f||||t||||||||Undecided||2017-10-10 23:04:34.653769|2017-10-10 23:04:34.653769
NCT02514213|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-07-12|||July 2015||2015-07-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|||Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer|Phase I, Open-label Trial to Evaluate the Safety and Immunogenicity of INO-5150 Alone or in Combination With INO-9012 in Men With Biochemically Relapsed (PSA) Prostate Cancer|Active, not recruiting||Phase 1|60|Anticipated|Inovio Pharmaceuticals||4|||f||||f||||||||No|combined results when available will be made available|2017-10-10 23:04:34.82009|2017-10-10 23:04:34.82009
NCT02514200|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-10-25|||March 2014||2014-03-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Treatment of Keratoconus With Advanced CXL-II|Treatment of Keratoconus With Advanced Corneal Crosslinking-II|Active, not recruiting||Phase 2|50|Actual|Umeå University||2|||f||||f||||||||||2017-10-10 23:04:35.02936|2017-10-10 23:04:35.02936
NCT02514187|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-07-18|||October 2015||2015-10-01|April 2016|2016-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients|A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients|Completed||N/A|60|Actual|British Columbia Cancer Agency||2|||f||||f||||||||||2017-10-10 23:04:35.125358|2017-10-10 23:04:35.125358
NCT02513966|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-10-31|||July 2015||2015-07-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|May 2017|Anticipated|2017-05-01||Observational|||Decreased Consumption of Blood Components During Cardiac Surgery Procedures: Causes and Effects.|Decreased Consumption of Blood Components During Cardiac Surgery Procedures: Causes and Effects.|Active, not recruiting||N/A|7835|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:04:36.925532|2017-10-10 23:04:36.925532
NCT02514174|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-10-03|||August 18, 2015|Actual|2015-08-18|October 2017|2017-10-01|December 18, 2018|Anticipated|2018-12-18|December 18, 2018|Anticipated|2018-12-18||Interventional|||Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older|A Single Arm Phase IV Study of Afatinib in Elderly Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Whose Tumors Have Epidermal Growth Factor Receptor (EGFR) Exon 19 Deletions or Exon 21(L858R) Substitution Mutations|Recruiting||Phase 4|50|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:04:35.283526|2017-10-10 23:04:35.283526
NCT02514161|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-11-30|||June 2015||2015-06-01|July 2015|2015-07-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Respiratory Exercises Versus Manual Therapy and Respiratory Exercises in Moderate Smokers|Effects of Manual Therapy and Respiratory Muscle Training on the Maximal Inspiratory Pressure in Moderate Smokers|Completed||N/A|53|Actual|Universidad Autonoma de Madrid||2|||f||||t||||||||||2017-10-10 23:04:35.406213|2017-10-10 23:04:35.406213
NCT02514148|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-17|||September 2015||2015-09-01|May 2016|2016-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients|Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients|Recruiting||N/A|86|Anticipated|Universidad Autonoma de Madrid||5|||f||||t||||||||||2017-10-10 23:04:35.507726|2017-10-10 23:04:35.507726
NCT02514135|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-03-01|||September 2015||2015-09-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|January 2016|Actual|2016-01-01||Observational|||Intra-abdominal Hypertension in Critically Ill Patients|Intra-abdominal Hypertension in Critically Ill Patients|Recruiting||N/A|300|Anticipated|Western University, Canada|||2||f||||t||||||||||2017-10-10 23:04:35.715099|2017-10-10 23:04:35.715099
NCT02514109|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-09-19|||May 2010||2010-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Clinical, Electrophysiological and Biological Diagnostic Criteria of Sensory Neuronopathies|Clinical, Electrophysiological and Biological Diagnostic Criteria of Sensory Neuronopathies|Terminated||N/A|80|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2|Start of a new study concerning the same patients|f||||f||||||Samples Without DNA|"     blood sample for antibodies measure   "|||2017-10-10 23:04:35.902886|2017-10-10 23:04:35.902886
NCT02514083|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-06-30|||July 28, 2015||2015-07-28|June 6, 2017|2017-06-06|July 1, 2020|Anticipated|2020-07-01|February 4, 2020|Anticipated|2020-02-04||Interventional|||A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|A Pilot Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|Recruiting||Phase 2|32|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:04:36.010136|2017-10-10 23:04:36.010136
NCT02514070|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2017-07-06|||July 28, 2015||2015-07-28|May 16, 2017|2017-05-16|February 9, 2018|Anticipated|2018-02-09|February 9, 2018|Anticipated|2018-02-09||Interventional|||Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults|Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults|Recruiting||Phase 2|200|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:04:36.107708|2017-10-10 23:04:36.107708
NCT02514057|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-10-25|||July 2017||2017-07-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Gastrointestinal Symptom Questionnaire Validation|Gastrointestinal Symptom Questionnaire Validation|Not yet recruiting||N/A|210|Anticipated|University of East Anglia|||3||f||||f||||||||Undecided||2017-10-10 23:04:36.201484|2017-10-10 23:04:36.201484
NCT02514044|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-07-30|||March 2015||2015-03-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Dextroamphetamine and tDCS to Improve the Fluency|Transcranial Direct Current Stimulation and Melodic Intonation Therapy Combined With Dextroamphetamine in Chronic Stroke Patients With Non-fluent Aphasia; Safety and Efficacy Phase|Unknown status|Recruiting|Phase 2|58|Anticipated|The University of Texas Health Science Center, Houston||6|||f||||t||||||||||2017-10-10 23:04:36.278782|2017-10-10 23:04:36.278782
NCT02514031|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-05-31|||October 2015||2015-10-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer|A Phase I/Ib, Single-Arm, Open-Label, Multi-Center Trial Using ARQ-761 (Beta-Lapachone) Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Metastatic, Unresectable, Or Recurrent Pancreatic Cancer|Recruiting||Phase 1|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-10 23:04:36.405896|2017-10-10 23:04:36.405896
NCT02514018|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-10-14|||September 2015||2015-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|KAVI-VZV-001||Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine|A Pilot Study to Characterize the Immune Response Induced by a Commercial Varicella Zoster Virus Vaccine in Healthy Adult Females in Nairobi, Kenya.|Active, not recruiting||Phase 4|45|Actual|University of Toronto||2|||f||||t||||||||||2017-10-10 23:04:36.520804|2017-10-10 23:04:36.520804
NCT02514005|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-10-25|||July 2015||2015-07-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|MTPSSFP||Manual Therapy and Dry Needling in Patellofemoral Syndrome|Effectiveness of Manual Therapy and Dry Needling in Nonspecific Patellofemoral Syndrome.|Completed||N/A|60|Actual|University of Valencia||2|||f||||f||||||||||2017-10-10 23:04:36.63364|2017-10-10 23:04:36.63364
NCT02513992|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2017-05-02|||May 2016||2016-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ictal SPECT With Intra-arterial Injection|Early Ictal SPECT With Intra-arterial Injection to Localize the Ictal Onset Zone in Refractory Focal Epilepsy.|Recruiting||N/A|1|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||Yes||2017-10-10 23:04:36.720904|2017-10-10 23:04:36.720904
NCT02513979|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-10-07|||August 2015||2015-08-01|July 2015|2015-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|PP&ARA||Postoperative Pain and Angiotensin II Receptor Antagonists|The Effect of Angiotensin II Receptor Antagonists on Acute and Chronic Postoperative Pain in Patients Treated for Hypertension.|Recruiting||Phase 4|90|Anticipated|University of Athens||2|||f||||f||||||||||2017-10-10 23:04:36.821022|2017-10-10 23:04:36.821022
NCT02513953|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-31|||June 2015||2015-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|mesosalpinx||Case Report of Endometrioma in Layers of Broad Ligament.|Endometrioma in Layers of Brot ad Ligament in Left Adnexa|Completed||N/A|1|Actual|Ruby Hall IVF and Endoscopy Centre||1|||f||||t||||||||||2017-10-10 23:04:36.972148|2017-10-10 23:04:36.972148
NCT02513940|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-02-28|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes|Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes|Recruiting||Phase 4|15|Anticipated|Indiana University||3|||f||||t||||||||Yes||2017-10-10 23:04:37.053029|2017-10-10 23:04:37.053029
NCT02513927|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-09-28|||August 2015||2015-08-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese|The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese: a Randomized Crossover Study|Recruiting||Phase 2/Phase 3|40|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||||2017-10-10 23:04:37.180169|2017-10-10 23:04:37.180169
NCT02513914|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-04-19|||August 2017|Anticipated|2017-08-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|July 2022|Anticipated|2022-07-01||Interventional|OPEN-UP||Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial|Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial (OPEN-UP)|Not yet recruiting||N/A|98|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||||||f|f|t|f|||||||2017-10-10 23:04:37.285226|2017-10-10 23:04:37.285226
NCT02513901|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-09-04|||August 2015||2015-08-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|CHARTER||Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir|Safety and Efficacy of the Histone Deacetylase Inhibitor Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir(CHARTER)|Completed||Phase 1/Phase 2|13|Actual|Tang-Du Hospital||1|||f||||t||||||||||2017-10-10 23:04:37.391258|2017-10-10 23:04:37.391258
NCT02513888|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-30|||February 2013||2013-02-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|PREVENT-WIN||Prevention of Type 2 Diabetes With Vitamin D Supplementation|Prevention of Type 2 Diabetes in Women With Prediabetes Using Vitamin D Supplementation and Lifestyle Intervention in North India (PREVENT-WIN Study)|Unknown status|Recruiting|N/A|150|Anticipated|Diabetes Foundation, India||2|||f||||t||||||||||2017-10-10 23:04:37.483734|2017-10-10 23:04:37.483734
NCT02513875|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-30|||February 2013||2013-02-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|PREVENT-WIN||Prevention of Type 2 Diabetes With Vitamin D|Prevention of Type 2 Diabetes in Women With Prediabetes Using Vitamin D Supplementation and Lifestyle Intervention in North India (PREVENT-WIN Study)|Unknown status|Recruiting|N/A|150|Anticipated|Diabetes Foundation, India||2|||f||||t||||||||||2017-10-10 23:04:37.57843|2017-10-10 23:04:37.57843
NCT02513862|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-11-15|||May 2015||2015-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery|Prospective Randomized Trial of Autologous Platelet Rich Plasma in Reducing Allogeneic Transfusions During Aortic Surgery Under Deep Hypothermic Circulatory Arrest|Completed||N/A|80|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-10 23:04:37.673595|2017-10-10 23:04:37.673595
NCT02513849|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-05-05|||December 2015||2015-12-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Tamoxifen in Patients With Oesophageal Cancer|A Pilot Study of Tamoxifen in Oesophageal Cancer|Recruiting||Phase 1|20|Anticipated|University of Nottingham||1|||f||||f||||||||||2017-10-10 23:04:37.769776|2017-10-10 23:04:37.769776
NCT02513836|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-05-03|||May 2015||2015-05-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Opioid Safety Program in Pain Clinics (Op-Safe):|Development of an Innovative Opioid Safety Program in Pain Clinics (Op-Safe): A Multi-Centre Project|Recruiting||N/A|304|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:04:37.874317|2017-10-10 23:04:37.874317
NCT02513823|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-05-08|||July 2015||2015-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Effectiveness of Vitamin D Supplementation|Effectiveness of Vitamin D Supplementation on Reducing Blood Pressure and Improving Endothelial Function of Pre-menopausal African American Women|Completed||N/A|27|Actual|Texas Woman's University||1|||f||||f||||||||No||2017-10-10 23:04:37.966602|2017-10-10 23:04:37.966602
NCT02513810|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-31|2016-09-05|||July 2015||2015-07-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation||Recruiting||N/A|3020|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:04:38.041715|2017-10-10 23:04:38.041715
NCT02513784|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-07-24|||August 2015||2015-08-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|Mouthwash||Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome|Pilot Randomized Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal and Gastric Microbiome|Active, not recruiting||N/A|21|Actual|Columbia University||2|||f||||f||||||||||2017-10-10 23:04:38.587073|2017-10-10 23:04:38.587073
NCT02513771|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-05-01|||September 2015||2015-09-01|May 2017|2017-05-01|January 10, 2017|Actual|2017-01-10|December 13, 2016|Actual|2016-12-13||Interventional|||Sitagliptin for Reducing Inflammation and Immune Activation|A Randomized, Double-Blinded, Placebo-Controlled Trial of a Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin, Januvia) for Reducing Inflammation and Immune Activation in HIV-Infected Men and Women: A Multicenter Trial of the AIDS Clinical Trials Group (ACTG)|Completed||Phase 2|90|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-10 23:04:38.710392|2017-10-10 23:04:38.710392
NCT02513758|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-03-22|||November 2002||2002-11-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Penetration and Compartimentation of HIV|Penetration and Compartimentation of HIV in Genital Mucosa|Completed||N/A|200|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     blood, saliva, sperm and cervicovaginal secretions   "|No||2017-10-10 23:04:38.862841|2017-10-10 23:04:38.862841
NCT02513745|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-03-06|||June 2015||2015-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Conventional Surgery vs. Verion/VerifEye|Refractive Outcomes Evaluation of the Verion Image Guided System + ORA System With VerifEye|Active, not recruiting||N/A|42|Actual|Carolina Eyecare Physicians, LLC||2|||f||||f||||||||||2017-10-10 23:04:38.977008|2017-10-10 23:04:38.977008
NCT02513732|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-06-20|||July 2014||2014-07-01|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)|XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance|Active, not recruiting||N/A|100|Actual|Abbott Vascular|||1||f||||t||||||||||2017-10-10 23:04:39.092109|2017-10-10 23:04:39.092109
NCT02513693|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-30|||July 2015||2015-07-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Deep Neuromuscular Blockade During Robotic Radical Prostatectomy|Effect of Deep Neuromuscular Blockade on Surgical Conditions and Recovery After Robotic Radical Prostatectomy: a Prospective Randomized Study|Unknown status|Recruiting|Phase 4|80|Anticipated|Palacky University||2|||f||||f||||||||||2017-10-10 23:04:39.463191|2017-10-10 23:04:39.463191
NCT02513680|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-31|||January 2015||2015-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Application LED Therapy and Laser Therapy in Facial Rejuvenation|Effects of Application LED Therapy and Laser Therapy in Facial Rejuvenation: Pilot Study|Completed||N/A|32|Actual|Federal University of Health Science of Porto Alegre||2|||f||||f||||||||||2017-10-10 23:04:39.587141|2017-10-10 23:04:39.587141
NCT02513667|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-05-31|||November 2015||2015-11-01|May 2016|2016-05-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma|Phase II Trial of Ceritinib in Combination With Stereotactic Ablative Radiation in ALK-rearranged Metastatic Lung Adenocarcinoma|Recruiting||Phase 2|33|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 23:04:39.679932|2017-10-10 23:04:39.679932
NCT02513654|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-05-03|||September 6, 2015|Actual|2015-09-06|May 2017|2017-05-01|November 11, 2015|Actual|2015-11-11|November 11, 2015|Actual|2015-11-11||Interventional|||Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects|An Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:04:39.806152|2017-10-10 23:04:39.806152
NCT02513641|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-04-03|||December 2015||2015-12-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SLEEPDM||Effect of 2-Week Nightly Moderate Hypoxia on Glucose Tolerance in Individuals With Type 2 Diabetes|Effect of 2-Week Nightly Moderate Hypoxia on Oral Glucose Tolerance in Individuals With Type 2 Diabetes|Recruiting||N/A|10|Anticipated|Pennington Biomedical Research Center||1|||f||||f||||||||||2017-10-10 23:04:39.906282|2017-10-10 23:04:39.906282
NCT02513628|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-07-30|||November 2011||2011-11-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01|3 Months|Observational [Patient Registry]|ONSD-CA||Optic Nerve Sheath Diameter for Prediction of Outcome After Cardiac Arrest|The Optic Nerve Sheath Diameter for Prediction of Outcome After Cardiac Arrest: a Pilot Prospective Study|Completed||N/A|36|Actual|Hopital of Melun|||1||f||||f||||||||||2017-10-10 23:04:40.027498|2017-10-10 23:04:40.027498
NCT02513615|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-03-21|||September 2015||2015-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Epigenetic Determinants of Peritoneal Fibrosis|Epigenetic Determinants of Peritoneal Fibrosis|Recruiting||N/A|50|Anticipated|McMaster University|||1||f||||f||||||Samples Without DNA|"     A 15ml sample of PD fluid   "|No||2017-10-10 23:04:40.08698|2017-10-10 23:04:40.08698
NCT02513602|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-11-01|||May 2014||2014-05-01|November 2016|2016-11-01|August 2022|Anticipated|2022-08-01|May 2020|Anticipated|2020-05-01||Observational|||Osseointegrated Dental Implants in Kidney Transplanted Patients|Peri-Implant Bone Assessment in Transplanted Patients: A Case Control Study|Recruiting||N/A|26|Anticipated|University of Trieste|||2||f||||t||||||Samples With DNA|"     bone specimen harvested during implant site preparation in order to obtain usefull samples     for hystomorphometrical analysis   "|||2017-10-10 23:04:40.177749|2017-10-10 23:04:40.177749
NCT02513589|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-08-08|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|PLAQINSTEP||Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke|Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke|Recruiting||Phase 2|10|Anticipated|University Hospital, Bordeaux||1|||f||||t|f|f||||||||2017-10-10 23:04:40.28208|2017-10-10 23:04:40.28208
NCT02513576|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-08-03|||October 2011||2011-10-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|January 2012|Actual|2012-01-01||Interventional|||Physiotherapy Exercises in Patients With Sternal Instability After Cardiovascular Surgery|A Randomized, Controlled Study of Physiotherapy Exercises in Patients With Sternal Instability Due to Mediastinitis After Cardiovascular Surgery|Completed||N/A|30|Actual|University of Sao Paulo General Hospital||1|||f||||f||||||||||2017-10-10 23:04:40.388406|2017-10-10 23:04:40.388406
NCT02513563|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-05-23|||September 8, 2015|Actual|2015-09-08|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer|A Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer|Recruiting||Phase 2|60|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 23:04:40.531947|2017-10-10 23:04:40.531947
NCT02513550|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-07|||August 2015||2015-08-01|September 2017|2017-09-01|August 3, 2017|Actual|2017-08-03|November 2016|Actual|2016-11-01||Interventional|IXORA-P||A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis|A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Dosing Regimens in Patients With Moderate-to-Severe Plaque Psoriasis|Completed||Phase 3|1227|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 23:04:40.673335|2017-10-10 23:04:40.673335
NCT02513537|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-10-27|||August 2015||2015-08-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Postoperative Delirium - European Society of Anaesthesiology Survey|Postoperative Delirium - European Society of Anaesthesiology Survey|Recruiting||N/A|400|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 23:04:41.04148|2017-10-10 23:04:41.04148
NCT02513524|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-09-20|||September 2015||2015-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Observational|DOT||Prevalence of Resistant Hypertension With DOT|The Prevalence of Pseudo-resistant Hypertension Using the Direct Observed Therapy Test: A Prospective Observational Study|Recruiting||N/A|60|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-10 23:04:41.145096|2017-10-10 23:04:41.145096
NCT02513511|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-08-06|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|Hypnotube||Hypnosis to Perform Awake Intubation|Hypnosis as a Sole Agent to Perform Awake Intubation|Unknown status|Not yet recruiting|N/A|30|Anticipated|University of Lausanne Hospitals||1|||f||||f||||||||||2017-10-10 23:04:41.263692|2017-10-10 23:04:41.263692
NCT02513498|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-09-12|||December 8, 2015|Actual|2015-12-08|September 2017|2017-09-01||||August 1, 2018|Anticipated|2018-08-01||Interventional|||Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease|Ixazomib for Treatment of Chronic Graft vs. Host Disease|Active, not recruiting||Phase 2|50|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f||||||||2017-10-10 23:04:41.354877|2017-10-10 23:04:41.354877
NCT02513485|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-11-01|||July 2015||2015-07-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa|"Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa; Inflammation Effects on Corticostriatal Connectivity and Reward: Role of Dopamine"|Recruiting||Phase 4|76|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 23:04:41.466204|2017-10-10 23:04:41.466204
NCT02513472|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-09-29|||August 28, 2015|Actual|2015-08-28|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Subjects With Metastatic Triple-Negative Breast Cancer (mTNBC)|An Open-Label, Single-Arm Multicenter Phase 1b/2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Subjects With Metastatic Triple-Negative Breast Cancer (mTNBC)|Active, not recruiting||Phase 1/Phase 2|107|Actual|Eisai Inc.||1|||f||||f|t|||||||||2017-10-10 23:04:41.56887|2017-10-10 23:04:41.56887
NCT02513446|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2016-03-16|||September 2015||2015-09-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1026706 in Healthy Male Subjects|Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1026706 in Healthy Male Subjects (an Open-label, Randomised, Two-period, Two-sequence Crossover Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:04:42.004447|2017-10-10 23:04:42.004447
NCT02513433|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2015-07-31|||December 2012||2012-12-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Comparison of Levobupivacaine, Ropivacaine and Bupivacaine in Epidural Anaesthesia|Comparative Evaluation of Newer Congeners i.e. Levobupivacaine and Ropivacaine With Bupivacaine, in Lumbar Epidural Anaesthesia for Hip Surgeries|Completed||N/A|90|Actual|Government Medical College, Haldwani||3|||f||||f||||||||||2017-10-10 23:04:42.112153|2017-10-10 23:04:42.112153
NCT02513420|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-05|||July 2015||2015-07-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Levator Ani Muscle Avulsion at First Birth of Mexican Women: Randomized Control Trial|Perineal Muscle Training Versus Usual Prenatal Care in the Incidence of Avulsion of the Levator Ani Muscle at First Birth of Mexican Women: Randomized Control Trial|Unknown status|Recruiting|N/A|228|Anticipated|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||||2017-10-10 23:04:42.236251|2017-10-10 23:04:42.236251
NCT02513407|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-07-18|||April 6, 2016|Actual|2016-04-06|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities|Reducing Cancer and Chronic Disease Risk in Medically Vulnerable Communities: A Feasibility Study Measuring Behavioral and Biological Outcomes of the Eat Move Live Intervention|Active, not recruiting||N/A|50|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-10 23:04:42.369813|2017-10-10 23:04:42.369813
NCT02513394|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-09-18|||August 2015||2015-08-01|September 2017|2017-09-01|September 2025|Anticipated|2025-09-01|September 2020|Anticipated|2020-09-01||Interventional|PALLAS||PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer|PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer|Recruiting||Phase 3|4600|Anticipated|Alliance Foundation Trials, LLC.||2|||f||||t||||||||||2017-10-10 23:04:42.592719|2017-10-10 23:04:42.592719
NCT02513381|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-12-28|||July 2015||2015-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effect of Vitamin D on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome|The Effect of Colecalciferol (Vitamin D) on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome (PCOS) - a Double Blind Randomised Placebo-controlled Study|Completed||N/A|40|Actual|University of Hull||2|||f||||t||||||||||2017-10-10 23:04:43.286036|2017-10-10 23:04:43.286036
NCT02513368|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-07-29|||January 2011||2011-01-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Peri Implant Soft Tissue Healing in Single Implant Restoration Using Two Different Techniques|Peri Implant Soft Tissue Healing in Single Implant Restoration Using the Guided Bone Regeneration Technique Ore a Connective Tissue Graft|Completed||Phase 2|32|Actual|University of Firenze and Siena, Napoli, Italy||2|||f||||f||||||||||2017-10-10 23:04:43.397067|2017-10-10 23:04:43.397067
NCT02513355|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-31|||February 2015||2015-02-01|February 2015|2015-02-01||||November 2017|Anticipated|2017-11-01||Interventional|||Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research||Recruiting||Phase 4|400|Anticipated|Nanjing NingQi Medicine Science and Technology Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:04:43.497113|2017-10-10 23:04:43.497113
NCT02513342|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-30|||March 2015||2015-03-01|March 2015|2015-03-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma|Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma Based on Chemotherapy for Advanced Non-small Cell Lung Squamous Carcinoma Patients：a Randomized Controlled,Open, Multicenter Clinical Study|Recruiting||Phase 4|400|Anticipated|Nanjing NingQi Medicine Science and Technology Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:04:43.648347|2017-10-10 23:04:43.648347
NCT02513329|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-09-16|||July 2015||2015-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Stellate Ganglion Block (SGB) For Women for Breast Cancer|Effects of Stellate Ganglion Block (SGB) on Vasomotor Symptoms in Women Receiving Anti-Estrogen Therapy for Breast Cancer|Recruiting||Phase 2|30|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:04:43.779679|2017-10-10 23:04:43.779679
NCT02513316|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-05-16|||October 2010||2010-10-01|July 2015|2015-07-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|CROMIS-2||Clinical Relevance of Microbleeds In Stroke|Microbleeds and Genetic Risk Factors to Predict the Risk of Intracranial Haemorrhage in Patients Treated With Anticoagulation Following Cardioembolic Stroke Due to Atrial Fibrillation|Unknown status|Active, not recruiting|N/A|2500|Anticipated|University College, London|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:04:43.918042|2017-10-10 23:04:43.918042
NCT02513303|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-08-08|||November 2015||2015-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|ACCESS||Safety and Efficacy of the Sirolimus-Eluting Collagen Implant to Assess AV Fistula Outcomes in Patients on Hemodialysis|A Phase 3, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus-Eluting Collagen Implant in Subjects on Hemodialysis|Recruiting||Phase 3|245|Anticipated|Vascular Therapies, Inc.||2|||f||||t||||||||||2017-10-10 23:04:44.016891|2017-10-10 23:04:44.016891
NCT02513290|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-05-01|||August 2013||2013-08-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|QolRhinitis||Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine|Quality of Life in Patients With Allergic Rhinitis: a Clinical Trial Comparing the Use of Bilastine Versus Loratadine|Completed||Phase 4|73|Actual|Universidade do Sul de Santa Catarina||2|||f||||t||||||||||2017-10-10 23:04:44.156539|2017-10-10 23:04:44.156539
NCT02513277|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-01-20|||February 2013||2013-02-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Diabetes Screening & Prevention for People With Learning (Intellectual) Disabilities:STOP Diabetes Study|Screening for Glucose Intolerance and Development of a Lifestyle Education Programme for Prevention of Type 2 Diabetes in a Population With Learning Disabilities|Completed||N/A|930|Actual|University of Leicester|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-10 23:04:44.267843|2017-10-10 23:04:44.267843
NCT02513264|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-09-14|||June 2015||2015-06-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01|7 Years|Observational [Patient Registry]|RACR2||Registry for Asthma Characterization and Recruitment 2|Registry for Asthma Characterization and Recruitment 2 (ICAC-25)|Recruiting||N/A|4100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:04:44.376334|2017-10-10 23:04:44.376334
NCT02513251|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-30|||July 2015||2015-07-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Chinese-Cantonese Version of Short Form McGill Pain Questionnaire Validation|Validation of the Traditional Chinese-Cantonese Version of Short Form McGill Pain Questionnaire (C-SF-MPQ-2)|Unknown status|Not yet recruiting|N/A|220|Anticipated|The University of Hong Kong|||1||f||||t||||||||||2017-10-10 23:04:44.529819|2017-10-10 23:04:44.529819
NCT02513238|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-08-16|||August 8, 2015|Actual|2015-08-08|August 2017|2017-08-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|MESRIX||Mesenchymal Stemcells for Radiation Induced Xerostomia|Mesenchymal Stem Cells for Radiation-induced Xerostomia (MESRIX) in Previous HPV-positive Oropharyngeal Head and Neck Cancer Patients - A Safety and Feasibility Study|Completed||Phase 2|30|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:04:44.604988|2017-10-10 23:04:44.604988
NCT02513225|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-07-28|||July 2015||2015-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Trial of an Adapted STD Screening and Risk Reduction Intervention|Randomized Controlled Trial of an Adapted STD Screening and Risk Reduction Intervention|Recruiting||N/A|350|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 23:04:44.761713|2017-10-10 23:04:44.761713
NCT02513212|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes||Completed||N/A|24|Actual|Procter and Gamble||2|||f||||||||||||||2017-10-10 23:04:44.883554|2017-10-10 23:04:44.883554
NCT02509572|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-06-06|||October 2014||2014-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SHS||Improvement of STI Detection in Adolescent Emergency Department Patients|Improvement of STI Detection in Adolescent Emergency Department Patients|Completed||N/A|720|Actual|Children's Research Institute||2|||f||||f||||||||||2017-10-10 23:05:28.502655|2017-10-10 23:05:28.502655
NCT02513199|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-30|2017-01-18|||November 2014||2014-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma|Assessment of Response of Unresectable Hepatocellular Carcinoma to Combination Chemoembolization and Stereotactic Body Radiation Therapy|Recruiting||Phase 2|30|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|f|f||||||||2017-10-10 23:04:44.970307|2017-10-10 23:04:44.970307
NCT02513186|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-27|||September 30, 2015|Actual|2015-09-30|September 2017|2017-09-01|November 18, 2024|Anticipated|2024-11-18|November 18, 2024|Anticipated|2024-11-18||Interventional|CyBorDSAR||Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant|A Dose Escalation, Safety, Pharmacokinetic, Pharmacodynamic and Preliminary Efficacy Study of SAR650984 (Isatuximab) Administered Intravenously in Combination With Bortezomib - Based Regimens in Adult Patients With Newly Diagnosed Multiple Myeloma Non Eligible for Transplantation|Recruiting||Phase 1|44|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-10 23:04:45.093397|2017-10-10 23:04:45.093397
NCT02513173|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-07-30|||January 2014||2014-01-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Effects of Different Verbal Instructions in Healthy Adults and Patients With Low Back Pain|Effects of Different Verbal Instructions on Lumbar Multifidus Muscle Activation in Healthy and Patients With Low Back Pain|Completed||N/A|42|Actual|Texas Woman's University|||2||f||||f||||||||||2017-10-10 23:04:45.217209|2017-10-10 23:04:45.217209
NCT02513160|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-08-09|2017-08-09||September 30, 2015|Actual|2015-09-30|August 2017|2017-08-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Interventional||Randomized; safety analysis set|Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 6-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) at 320 or 640 mcg/Day in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma|Completed||Phase 3|713|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-10-10 23:04:45.308666|2017-10-10 23:04:45.308666
NCT02513147|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-06-13|||June 2015||2015-06-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen|HIV Reservoir Dynamics After Switching to Dolutegravir in Patients With Two NRTI and a Protease Inhibitor Based Regimen. A Phase IV Open Randomized Trial|Completed||Phase 4|44|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-10 23:04:48.842707|2017-10-10 23:04:48.842707
NCT02513134|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-07-28|||June 2014||2014-06-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Intraocular Lens Power Calculation Using Pre- and Intra-operative Measurements|Intraocular Lens Power Calculation Using Pre- and Intra-operative|Completed||N/A|75|Actual|Vienna Institute for Research in Ocular Surgery|||1||f||||f||||||||||2017-10-10 23:04:48.962609|2017-10-10 23:04:48.962609
NCT02513121|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-05-10|||July 2015||2015-07-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|DTS||Dietary Treatment Study of Pediatric NAFLD|Randomized, Controlled Dietary Treatment Study of Pediatric NAFLD|Recruiting||N/A|40|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:04:49.233789|2017-10-10 23:04:49.233789
NCT02513108|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-30|||October 2015||2015-10-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|SPEEDY||Stavanger UncomPlicatEd Elective PCI Same DaY Discharge Study (SPEEDY Study)|Stavanger UncomPlicatEd Elective PCI Same DaY Discharge Study (SPEEDY Study)|Unknown status|Not yet recruiting|N/A|151|Anticipated|Helse Stavanger HF||2|||f||||f||||||||||2017-10-10 23:04:49.428321|2017-10-10 23:04:49.428321
NCT02513095|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-03-29|2017-03-29||September 2015||2015-09-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)|Phase 2, Single-Site, Open-Label, Randomized, 2-Arm Parallel Study to Assess the Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)|Completed||Phase 2|34|Actual|Eagle Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 23:04:49.580901|2017-10-10 23:04:49.580901
NCT02513082|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-11-03|||August 2015||2015-08-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Effectiveness of Pain Relief Between Adductor Canal Block and Femoral Nerve Block in Total Knee Arthroplasty|Effectiveness of Pain Relief Between Adductor Canal Block and Femoral Nerve Block in Total Knee Arthroplasty in General Anesthesia|Not yet recruiting||N/A|100|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 23:04:50.37651|2017-10-10 23:04:50.37651
NCT02513069|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-07-06|||November 2015||2015-11-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Mobile Contingency Management for Smoking Cessation in Returning US Veterans|Mobile Contingency Management for Smoking Cessation in Returning US Veterans|Enrolling by invitation||N/A|260|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 23:04:50.474482|2017-10-10 23:04:50.474482
NCT02513056|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-27|||August 17, 2015|Actual|2015-08-17|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01|6 Weeks|Observational [Patient Registry]|PM/ICD||Study Evaluating the Use of MRI on CMS Patients|Prospective Observational Study Evaluating the Use of MRI on CMS Beneficiaries With Non-Conditional Pacemakers and/or Implantable Cardioverter Defibrillators|Recruiting||N/A|600|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 23:04:50.597913|2017-10-10 23:04:50.597913
NCT02513043|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-05-10|||March 22, 2016||2016-03-22|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine|Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine|Recruiting||N/A|1000|Anticipated|Gynuity Health Projects|||1||f||||f||||||||||2017-10-10 23:04:50.704774|2017-10-10 23:04:50.704774
NCT02513030|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-07-28|||August 2015||2015-08-01|July 2015|2015-07-01||||March 2016|Anticipated|2016-03-01||Observational|SIMPLER||Cardioverter Defibrillator Replacement With Induction of Ventricular Fibrillation and Defibrillation Testing|Cardioverter Defibrillator Replacement With Induction of Ventricular Fibrillation and Defibrillation Testing|Unknown status|Not yet recruiting|N/A|50|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-10 23:04:50.8319|2017-10-10 23:04:50.8319
NCT02513017|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-30|||February 2009||2009-02-01|July 2015|2015-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Insomnia and Cardiovascular Diseases: Influence of Behavioral Treatments and Preferences|Insomnia and Cardiovascular Diseases: Influence of Behavioral Treatments and Preferences|Completed||N/A|204|Actual|Ryerson University||3|||f||||f||||||||||2017-10-10 23:04:50.949092|2017-10-10 23:04:50.949092
NCT02513004|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2017-02-08|||June 2015||2015-06-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel|"Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel in Patients Undergoing One-stop Hybrid Coronary Revascularization"|Recruiting||Phase 4|60|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-10 23:04:51.059934|2017-10-10 23:04:51.059934
NCT02512991|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-07-08|||January 2010||2010-01-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Follow-up of Patients Bound for PCI After Implementation of a Helicopter Emergency Medical System|Helicopter Versus Ground Emergency Medical Systems and the Effect on Mortality and Labour Market Affiliation of Patients Bound for Percutaneous Coronary Intervention|Completed||N/A|1604|Actual|Rigshospitalet, Denmark|||2||f||||t||||||||||2017-10-10 23:04:51.178326|2017-10-10 23:04:51.178326
NCT02512978|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-01-27|||August 2015||2015-08-01|August 2015|2015-08-01||||September 2017|Anticipated|2017-09-01||Interventional|RHYTHMIC||Reverse the HYpoTHyroid Status in Acute Myocardial InfarCtion (RHYTHMIC)|Reverse the HYpoTHyroid Status in Acute Myocardial InfarCtion (RHYTHMIC)|Unknown status|Recruiting|Phase 4|160|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-10 23:04:51.287715|2017-10-10 23:04:51.287715
NCT02512965|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-09-11|||July 2015||2015-07-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases|A Randomized Phase II/III Study Comparing Stereotactic Body Radiotherapy(SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Patients With Spinal Metastases|Recruiting||Phase 2/Phase 3|152|Anticipated|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-10 23:04:51.42488|2017-10-10 23:04:51.42488
NCT02512952|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-29|||June 2014||2014-06-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Treatment of Periodontal Intrabony Defects Using Autologous Platelet Rich Fibrin vs Titanium Platelet Rich Fibrin|Treatment of Periodontal Intrabony Defects Using Autologous Platelet Rich Fibrin and Titanium Platelet Rich Fibrin: A Randomized Clinical Comparative Study|Completed||Phase 2/Phase 3|38|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||f||||||||||2017-10-10 23:04:51.747775|2017-10-10 23:04:51.747775
NCT02512939|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-04-06|||July 2015||2015-07-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|Next Gen||Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection|Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection|Unknown status|Recruiting|N/A|2000|Anticipated|Public Health England||1|||f||||f||||||||||2017-10-10 23:04:51.85564|2017-10-10 23:04:51.85564
NCT02512926|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-10-03|||July 2015||2015-07-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|POE14-01||Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children|Phase I Study of Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children With Relapsed and Refractory Solid Tumors and Leukemias|Recruiting||Phase 1|50|Anticipated|Phoenix Children's Hospital||1|||f||||t||||||||||2017-10-10 23:04:52.009148|2017-10-10 23:04:52.009148
NCT02512913|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-08-29|||August 2015||2015-08-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|March 2019|Anticipated|2019-03-01||Interventional|QuitTogether||Family Smoking Cessation in Romania Using Pregnancy as a Window of Opportunity|Family Smoking Cessation in Romania Using Pregnancy as a Window of Opportunity|Recruiting||N/A|430|Anticipated|Michigan State University||2|||f||||f||||||||||2017-10-10 23:04:52.196016|2017-10-10 23:04:52.196016
NCT02512900|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-05-30|2017-01-03||September 10, 2015|Actual|2015-09-10|May 2017|2017-05-01|May 17, 2016|Actual|2016-05-17|May 17, 2016|Actual|2016-05-17||Interventional|||A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma|A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma|Completed||Phase 1|21|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-10 23:04:52.296473|2017-10-10 23:04:52.296473
NCT02512887|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-08-28|||July 2016||2016-07-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|CLASH||Caudal vs Local Anesthesia in Hypospadias|Caudal vs Local Anesthesia in Hypospadias: The CLASH Study|Recruiting||N/A|224|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 23:04:52.831311|2017-10-10 23:04:52.831311
NCT02512874|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-04-19|||July 2015||2015-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Does Pulmonary Rehabilitation Improve Frailty?|Does Pulmonary Rehabilitation Improve Frailty in Chronic Lung Disease?|Completed||N/A|65|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:04:52.983041|2017-10-10 23:04:52.983041
NCT02512861|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-07-28|||April 2014||2014-04-01|July 2017|2017-07-01|October 31, 2017|Anticipated|2017-10-31|October 2015|Actual|2015-10-01||Interventional|||Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery|Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery: A Prospective: Double-Blind, Randomized Controlled Trial|Active, not recruiting||Phase 4|93|Actual|Children's Hospitals and Clinics of Minnesota||2|||f||||t||||||||||2017-10-10 23:04:53.092842|2017-10-10 23:04:53.092842
NCT02512848|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-08-14|||April 2015||2015-04-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Observational|||The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period|The Feasibility Study of Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period|Active, not recruiting||N/A|100|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||1||f||||f||||||Samples Without DNA|"     endometrial sampling   "|Undecided||2017-10-10 23:04:53.19366|2017-10-10 23:04:53.19366
NCT02512835|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-06-09|||October 2015||2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 1, 2016|Actual|2016-11-01||Observational|||Understanding the Value of Community Vital Signs in Primary Care|Understanding the Value of Community Vital Signs in Primary Care|Active, not recruiting||N/A|120|Actual|Virginia Commonwealth University|||2||f||||f||||||||No||2017-10-10 23:04:53.285811|2017-10-10 23:04:53.285811
NCT02512809|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Isoflurane-induced Neuroinflammation in Children With Hydrocephalus|Isoflurane-induced Neuroinflammation in Children With Hydrocephalus: A Bench-to-bedside, Translational Study of Molecular Pathways and Therapeutic Approaches|Enrolling by invitation||Phase 3|120|Anticipated|Nationwide Children's Hospital||3|||f||||t||||||||||2017-10-10 23:04:53.463839|2017-10-10 23:04:53.463839
NCT02512796|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-30|||July 2015||2015-07-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||In Vitro Study of the Effect of Gadolinium Contrast on Fibrocytes|In Vitro Study of the Effect of Gadolinium Contrast on Fibrocytes|Recruiting||N/A|60|Anticipated|University of Virginia|||3||f||||f||||||Samples With DNA|"     Investigators plan to study the circulating fibrocytes numbers, changes in monocyte gene     transcripts, identify polymorphism in gadolinium transport genes (OATPB1/3 and MRP2) and     examine their osteogenic potential in cultures.   "|||2017-10-10 23:04:53.553011|2017-10-10 23:04:53.553011
NCT02512783|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2016-06-21|2016-02-22||May 2013||2013-05-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Decreasing Propofol Injection Pain by Pre-Treatment With Lidocaine in Pediatric Procedural Sedation|Decreasing Propofol Injection Pain by Pre-Treatment With Lidocaine in Pediatric Procedural Sedation|Terminated||N/A|171|Actual|Children's Hospitals and Clinics of Minnesota||2||Interim analysis indicated treatment was effective and statistically significant|f||||f||||||||No||2017-10-10 23:04:53.649527|2017-10-10 23:04:53.649527
NCT02512770|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2015-07-30|||January 2015||2015-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||Hemodynamic and Respiratory Effects of Esophageal Dilation in Children|Esaphageal Balloon Dilatation in Children: Hemodynamic , Ventilatory Changes and Complications|Completed||N/A|60|Actual|Istanbul University||2|||f||||t||||||||||2017-10-10 23:04:53.91091|2017-10-10 23:04:53.91091
NCT02512757|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-02-28|||July 2015||2015-07-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology|The AminoIndex™ Study - A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology|Recruiting||N/A|150|Anticipated|Innovis LLC|||3||f||||f||||||Samples With DNA|"     Subjects will consent to archiving and future analysis of their blood samples for up to     twenty (20) years.   "|No||2017-10-10 23:04:54.020897|2017-10-10 23:04:54.020897
NCT02512744|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-03-01|||May 1, 2016|Actual|2016-05-01|March 2017|2017-03-01|September 1, 2018|Anticipated|2018-09-01|May 1, 2018|Anticipated|2018-05-01||Interventional|REDECAP||Reducing Decannulation Time: Limitation of Decannulation Capping Trials (REDECAP)|Reducing Decannulation Time in Critically-ill Tracheostomized Patients: Decannulation Capping Trial Protocol vs Frequency Aspiration Protocol (REDECAP)|Recruiting||N/A|330|Anticipated|Hospital Virgen de la Salud||2|||f||||t||||||||||2017-10-10 23:04:54.121255|2017-10-10 23:04:54.121255
NCT02512731|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-12-02|||June 2012||2012-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2015|Actual|2015-09-01||Interventional|EDM||Intraoperative Fluid Therapy for Deceased Donor Renal Transplantation|Intraoperative Fluid Therapy for Deceased Donor Renal Transplantation|Completed||N/A|50|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:04:54.225955|2017-10-10 23:04:54.225955
NCT02512718|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-10-02|||July 2016||2016-07-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation|Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation|Recruiting||Phase 1|20|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-10 23:04:54.306731|2017-10-10 23:04:54.306731
NCT02512705|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-29|||September 2015||2015-09-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Medical Monitoring for Agitated Patients Pilot RCT - Medical Monitoring|A Pilot Randomized Control Trial: The Ability to Medically Monitor With Use of Physical and Chemical Restraints or Seclusion of Acutely Agitated or Violent Patients Who Present to the Psychiatric Emergency Services|Unknown status|Not yet recruiting|N/A|90|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||t||||||||||2017-10-10 23:04:54.419971|2017-10-10 23:04:54.419971
NCT02512692|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-05-04|||July 2015||2015-07-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|August 2018|Anticipated|2018-08-01||Interventional|||90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma|A Traditional Feasibility Study of Gemcitabine, Cisplatin, and 90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma|Recruiting||N/A|24|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-10-10 23:04:54.503757|2017-10-10 23:04:54.503757
NCT02512679|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-01-12|2016-01-29||February 2007||2007-02-01|January 2017|2017-01-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells|Protocol for Related Donor Hematopoietic Stem Cell Transplantation (HSCT) for Treatment of Symptomatic Genetic Lymphohematological Diseases|Terminated||Phase 2|20|Actual|Children's Hospital Los Angeles|De-escalation was not ensued. All enrolled subjects engrafted without toxicity for dose level one.|4||Optimal dose obtained for engraftment and minimizing toxicity|f||||t||||||||Yes|Tranplant data is reported to CIBMTR and is available to the other investigators|2017-10-10 23:04:54.739459|2017-10-10 23:04:54.739459
NCT02512666|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-09-28|||September 2015||2015-09-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Non Invasive Optical Imaging of WBC Count|Non Invasive Optical Imaging of Capillaries Through the Nailfold for White Blood Cell Enumeration in Patients With Hematologic Malignancies|Completed||N/A|45|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:04:55.1761|2017-10-10 23:04:55.1761
NCT02512653|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-06-17|||November 2015||2015-11-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)|Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)|Completed||Phase 2|33|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-10 23:04:55.310356|2017-10-10 23:04:55.310356
NCT02512276|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-10-05|||August 2015||2015-08-01|October 2017|2017-10-01|October 2017|Actual|2017-10-01|August 2017|Actual|2017-08-01||Interventional|STIC2IT||Tele-Pharmacy Intervention to Improve Treatment Adherence|The Study of a Tele-pharmacy Intervention for Chronic Diseases to Improve Treatment Adherence (STIC2IT)|Completed||N/A|4076|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:05:00.420157|2017-10-10 23:05:00.420157
NCT02512640|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-30|||May 2013||2013-05-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|August 2013|Actual|2013-08-01||Interventional|||Comparison of Oxidative Stress Changes in Different Ventilation Strategies During Gynecologic Laparoscopic Surgery|Comparison of Oxidative Stress Changes in Different Ventilation Strategies During Gynecologic Laparoscopic Surgery|Completed||N/A|52|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:04:55.444245|2017-10-10 23:04:55.444245
NCT02512627|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-07-06|||March 2015||2015-03-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evolving Methods to Combine Cognitive and Physical Training for Individuals With Mild Cognitive Impairment|Evolving Methods to Combine Cognitive and Physical Training for Individuals With Mild Cognitive Impairment: An Efficacy Study|Recruiting||N/A|80|Anticipated|Chang Gung Memorial Hospital||4|||f||||f||||||||||2017-10-10 23:04:55.580841|2017-10-10 23:04:55.580841
NCT02512614|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-29|||March 2012||2012-03-01|July 2015|2015-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Evaluation of Novel Antimicrobial Hand Towels|Evaluation of Novel Antimicrobial Hand Towels|Completed||Phase 2/Phase 3|449|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 23:04:55.848031|2017-10-10 23:04:55.848031
NCT02512601|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-08-30|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|SQUARES||Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide|Prospective Evaluation of the Quality of Life of Patients With Post-thrombotic Syndrome Who Receive Compression Therapy and Sulodexide — SQUARES Study|Terminated||Phase 4|13|Actual|Bama GeVe, S.L.U.||1||Poor inclusion|f||||f||||||||||2017-10-10 23:04:55.963519|2017-10-10 23:04:55.963519
NCT02512588|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2|A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2|Recruiting||Phase 2|120|Anticipated|Balance Therapeutics||2|||f||||t||||||||||2017-10-10 23:04:56.130453|2017-10-10 23:04:56.130453
NCT02512562|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-01-28|||July 2015||2015-07-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers|A Phase-1, Open-label, Two Group, Fixed-Sequence Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers|Completed||Phase 1|32|Actual|Alios Biopharma Inc.||2|||f||||f||||||||||2017-10-10 23:04:56.55856|2017-10-10 23:04:56.55856
NCT02512549|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-01-29|||November 2015|Actual|2015-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|RehabCOPD||A Trial to Study the Effects of Pulmonary Rehabilitation Program on Exercise Capacity and Quality of Life in Patients With Severe Form of Chronic Obstructive Pulmonary Disease (COPD)|'Effects of Structured Outpatient Pulmonary Rehabilitation Intervention on Exercise Capacity and Quality of Life in Patients With Severe Chronic Obstructive Pulmonary Disease: A Randomized Controlled Study'|Completed||N/A|80|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-10 23:04:56.685954|2017-10-10 23:04:56.685954
NCT02512536|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-05-11|||July 2016||2016-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Does Botulinum A Toxin Help With Pain From Rotator Cuff Arthropathy?|Do Ultrasound Guided Botulinum A Injections Relieve Pain in Rotator Cuff Arthropathy?|Recruiting||Phase 2|10|Anticipated|Royal Devon and Exeter NHS Foundation Trust||1|||f||||t||||||||No||2017-10-10 23:04:56.792857|2017-10-10 23:04:56.792857
NCT02512523|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-10-05|||August 2015||2015-08-01|October 2015|2015-10-01||||September 2016|Anticipated|2016-09-01||Interventional|||Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)|A Randomized, Double-blind, Active Control, Parallel Group, Exploratory Phase IV Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin in Patients With Inadequately Controlled Type2 Diabetes Mellitus in Metformin Only Treatment|Unknown status|Recruiting|Phase 4|40|Anticipated|Handok Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:04:56.916958|2017-10-10 23:04:56.916958
NCT02512510|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-07-18|||September 2015||2015-09-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|COPD||Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)|A Phase 3, 12-week, Randomized, Double-blind Placebo-controlled Parallel Group Study of Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|645|Actual|Theravance Biopharma R & D, Inc.||3|||f||||f||||||||||2017-10-10 23:04:57.079331|2017-10-10 23:04:57.079331
NCT02512497|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-09-19|||October 28, 2015|Actual|2015-10-28|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Romidepsin Maintenance After Allogeneic Stem Cell Transplantation|Romidepsin Therapy in Conditioning and Maintenance in Patients With T-Cell Malignancies Receiving Allogeneic Stem Cell Transplant|Active, not recruiting||Phase 1/Phase 2|6|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:04:57.205087|2017-10-10 23:04:57.205087
NCT02512484|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-03-15|||May 2016||2016-05-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|ACE||Improving the Detection of Active Tuberculosis in Accident and Emergency Departments|Improving the Detection of Active Tuberculosis in Accident and Emergency (A&E) Departments|Not yet recruiting||N/A|1000|Anticipated|Public Health England|||1||f||||f||||||Samples With DNA|"     Retention of residual blood samples after inital testing, with appropriate consent to do so     from individuals and ethics committee.   "|||2017-10-10 23:04:57.355212|2017-10-10 23:04:57.355212
NCT02512471|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-25|2016-02-18|||May 2015||2015-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||The Minimum Effective Volume of Ropivacaine in Ultrasound-guided Supraclavicular Block|The Minimum Effective Volume of Ropivacaine in Ultrasound-guided Supraclavicular Block|Completed||N/A|114|Actual|Huazhong University of Science and Technology||2|||f||||f||||||||||2017-10-10 23:04:57.469061|2017-10-10 23:04:57.469061
NCT02512445|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-07-08|||October 2015||2015-10-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|TrIGR||Trauma Informed Guilt Reduction Therapy|Trauma Informed Guilt Reduction Therapy|Recruiting||Phase 2|188|Anticipated|Veterans Medical Research Foundation||2|||f||||f||||||||No||2017-10-10 23:04:57.71777|2017-10-10 23:04:57.71777
NCT02512432|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-29|||July 2015||2015-07-01|July 2015|2015-07-01|June 2025|Anticipated|2025-06-01|June 2016|Anticipated|2016-06-01||Interventional|INTACS||INTACS (Intrastromal Corneal Ring Segments) For Corneal Ectasia|INTACS (Intrastromal Corneal Ring Segments) For Corneal Ectasia|Not yet recruiting||N/A|1000|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-10 23:04:57.826608|2017-10-10 23:04:57.826608
NCT02512419|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-10-05|||July 2015||2015-07-01|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Developing a Text-Message Enhanced Physical Activity Intervention for Latino Men|Developing a Text-Message Enhanced Physical Activity Intervention for Latino Men|Active, not recruiting||N/A|60|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:04:57.897402|2017-10-10 23:04:57.897402
NCT02512406|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-04-27|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|June 2, 2016|Actual|2016-06-02|January 2016|Actual|2016-01-01||Observational|||Sensory Processing in Tourette Syndrome|Sensory Processing in Tourette Syndrome|Completed||N/A|18|Actual|University of Florida|||1||f||||f||||||||||2017-10-10 23:04:57.989488|2017-10-10 23:04:57.989488
NCT02512393|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-06-07|2017-05-08||November 2015||2015-11-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Transcranial Direct Current Stimulation in Older Persons With Knee Pain (Knee Pain and tDCS): Randomized Pilot Study|Transcranial Direct Current Stimulation in Older Persons With Knee Pain: Randomized Pilot Study|Completed||N/A|40|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-10 23:04:58.111524|2017-10-10 23:04:58.111524
NCT02512380|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-08-06|||July 2015||2015-07-01|July 2015|2015-07-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer|Neoadjuvant S1, Oxaliplatin, and Docetaxel (SLOT) Versus S1, Oxaliplatin(SOX) in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer|Recruiting||Phase 3|380|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:04:59.301299|2017-10-10 23:04:59.301299
NCT02512367|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-29|||January 2016||2016-01-01|June 2015|2015-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|EBENE||Evaluate the Efficacy of a Global Dental Health Promotion Program on Dental Hygiene in Patients With Schizophrenia.|Efficacy of a Dental Health Promotion Program in Patients With Schizophrenia|Not yet recruiting||N/A|230|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 23:04:59.419128|2017-10-10 23:04:59.419128
NCT02512354|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-29|||March 2015||2015-03-01|February 2015|2015-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FOETEX||Contribution of High-throughput Exome Sequencing in the Diagnosis of the Cause Fetal Polymalformation Syndromes|Contribution of High-throughput Exome Sequencing in Fetopathology|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-10 23:04:59.574861|2017-10-10 23:04:59.574861
NCT02512341|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2015-07-29|||November 2013||2013-11-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01|1 Day|Observational [Patient Registry]|||Automatic Differentiation of Innocent and Pathologic Murmurs in Pediatrics|Automatic Differentiation of Innocent and Pathologic Murmurs in Pediatrics|Completed||N/A|106|Actual|CSD Labs GmbH|||1||f||||f||||||||||2017-10-10 23:04:59.710398|2017-10-10 23:04:59.710398
NCT02512328|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-07-27|||March 2015||2015-03-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|PERICLESAPPI||Improvement of Colonoscopy Preparation by New Media (APP)|First Experiences With an Offline App (SPA; Smartphone Application) for Colonoscopy Preparation- PERICLES-I APP; Prospective Evaluations of Improvement of Colonocopy Preparation by Optimized Visualization (PERICLES)|Unknown status|Recruiting|Phase 1|25|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-10 23:04:59.813155|2017-10-10 23:04:59.813155
NCT02512315|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-07-11|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|||A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma|4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation Versus Concurrent Chemoradiation Alone In Patients With Stage N2-3 Nasopharyngeal Carcinoma: A Phase 3 Multicenter Randomised Controlled Trial|Recruiting||Phase 3|144|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:04:59.957083|2017-10-10 23:04:59.957083
NCT02512302|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-05-06|||October 2015||2015-10-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|GOLDEN7||Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).|A Crossover Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of SUN-101 and Seebri® Breezhaler® Administered With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|30|Actual|Sunovion Respiratory Development Inc.||5|||f||||f||||||||||2017-10-10 23:05:00.160423|2017-10-10 23:05:00.160423
NCT02512289|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-07-27|||May 2014||2014-05-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Impact of Non-invasive Brain Stimulation, Associated With Upper Limb Robot-assisted Therapy, on Motor Recuperation|Impact of Non-invasive Brain Stimulation, Associated With Upper Limb Robot-assisted Therapy, on Motor Recuperation|Unknown status|Recruiting|N/A|40|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-10-10 23:05:00.293172|2017-10-10 23:05:00.293172
NCT01797276|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-08-07||||||August 2017|2017-08-01||||||||Expanded Access|CLA||Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Expanded Access|Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Expanded Access|No longer available||N/A|||University of Florida||||||t||t|||||||||||2017-10-11 01:58:02.074759|2017-10-11 01:58:02.074759
NCT02512263|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-28|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|October 2015|Anticipated|2015-10-01||Interventional|||Assessment of Adherence and Efficiency of a Home-based Training Program on Muscular Strength, Endurance and Qol for Colon Cancer Patients|Assessment of Adherence and Efficiency of a Home-based Training Program on the Muscular Strength, the Endurance and the Quality of Life for Colon Cancer Patients Treated by Chemotherapy|Unknown status|Recruiting|N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 23:05:00.510914|2017-10-10 23:05:00.510914
NCT02512250|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2017-04-26|||May 2015||2015-05-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01|10 Years|Observational [Patient Registry]|||Swiss Hemophilia Registry||Recruiting||N/A|900|Anticipated|Swiss Hemophilia Network|||1||f||||f||||||||||2017-10-10 23:05:00.593969|2017-10-10 23:05:00.593969
NCT02512237|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-06-26|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression|A Phase 1, Multicenter, Open-label, Multiple Dose-escalation Study of ARX788, Intravenously Administered as a Single Agent in Subjects With Advanced Cancers With HER2 Expression|Recruiting||Phase 1|80|Anticipated|Zhejiang Medicine Co., Ltd.||4|||f||||t||||||||No||2017-10-10 23:05:00.768771|2017-10-10 23:05:00.768771
NCT02512224|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-09-10|2015-08-05||April 2012||2012-04-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|March 2013|Actual|2013-03-01||Observational|||Comparison of Outcomes Between Parenteral and Enteral Nutrition|Comparison of Short-term Mortality and Morbidity Between Parenteral and Enteral Nutrition for Adults Without Cancer: a Propensity-matched Analysis Using a National Inpatient Database|Completed||N/A|5824|Actual|Tokyo University|||2||f||||f||||||||||2017-10-10 23:05:00.9158|2017-10-10 23:05:00.9158
NCT02512211|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-06-30|||October 2015||2015-10-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|May 2016|Actual|2016-05-01||Observational|VALIDATION||Validation of Questionnaires HAL and HEP|"Spanish Validation of Haemophilia Activities List (HAL) and Specific Sport Scale (HEP-Test-Q) Questionnaires"|Active, not recruiting||N/A|60|Anticipated|Universidad Católica San Antonio de Murcia|||3||f||||f||||||||||2017-10-10 23:05:01.302968|2017-10-10 23:05:01.302968
NCT02512198|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-09-15|||July 2015||2015-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|EPIPP||Electronic Prescription Data to Improve Primary Care Prescribing|Electronic Prescription Data to Improve Primary Care Prescribing|Active, not recruiting||N/A|236|Actual|University of Dundee||2|||f||||f||||||||||2017-10-10 23:05:01.387885|2017-10-10 23:05:01.387885
NCT02512185|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-05-03|||July 2015||2015-07-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Observational|TOPCOP||Towards Optimal Prescription of Chemotherapy in Prostate Cancer|TOward Personalizing Care for Older Men With mCRPC - Understanding and Predicting Treatment Toxicities (the TOPCOP Study)|Recruiting||N/A|332|Anticipated|University Health Network, Toronto|||3||f||||f||||||||No||2017-10-10 23:05:01.467306|2017-10-10 23:05:01.467306
NCT02512159|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-07-29|||March 2014||2014-03-01|February 2014|2014-02-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Skin Ulcers Treatment With an Handicraft Topical Device|Effectiveness of Topical Negative Handicraft Device for Versus Traditional Conservative Treatment in Skin Ulcers Management in Lower Limb|Completed||Phase 4|144|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||||2017-10-10 23:05:01.712265|2017-10-10 23:05:01.712265
NCT02512146|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-07-27|||June 2015||2015-06-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Observational|||The Expression of the Ionotropic Glutamate Receptors in Colon of IBS|The Expression of the Ionotropic Glutamate Receptors in Colon of IBS|Unknown status|Recruiting|N/A|80|Anticipated|Shandong University|||2||f||||t||||||Samples With DNA|"     Taken biopsies during Colonoscopy   "|||2017-10-10 23:05:01.823033|2017-10-10 23:05:01.823033
NCT02512133|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-07-29|||February 2012||2012-02-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|April 2014|Actual|2014-04-01||Interventional|||MIGS VS SLT Comparison in Glaucoma Patients|MIGS VS SLT in Glaucoma Patients: Prospective Study|Unknown status|Active, not recruiting|Phase 3|56|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-10-10 23:05:01.935263|2017-10-10 23:05:01.935263
NCT02512120|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2016-04-26|||August 2015||2015-08-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|VCVAFVCV||Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation|Comparison of Volume Controlled Ventilation(VCV) vs Autoflow-volume Controlled Ventilation(Autoflow-VCV) During Robot-assisted Laparoscopic Radical Prostatectomy|Withdrawn||N/A|0|Actual|Korea University Anam Hospital||2||The backgroud of this study was not well discussed.|f||||t||||||||||2017-10-10 23:05:02.028885|2017-10-10 23:05:02.028885
NCT02512107|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-29|||January 2015||2015-01-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Interventional|||Impact of JuicePlus+ on the Health Status of an Overweight Stressed Population|The Effect of Juice Plus+ on the Microbiome, Intestinal Permeability and Inflammatory Status of Psychologically Stressed Individuals With High Body Mass Indices|Unknown status|Recruiting|N/A|80|Anticipated|University of Memphis||2|||f||||f||||||||||2017-10-10 23:05:02.097979|2017-10-10 23:05:02.097979
NCT02512068|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-09-19|||July 8, 2015|Actual|2015-07-08|September 2017|2017-09-01|April 24, 2018|Anticipated|2018-04-24|April 24, 2018|Anticipated|2018-04-24||Interventional|||A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study to Evaluate the Safety and Efficacy of SYR-472 When Orally Administered at a Dose of 25 mg Once Weekly to Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure|Active, not recruiting||Phase 3|106|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:05:02.34379|2017-10-10 23:05:02.34379
NCT02512042|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-02-01|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes|A Multicentre, Double Blind, Active Controlled, Parallel Group, Two Arm, Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension (Manufactured by Indoco Remedies Ltd. for Watson Pharma Pvt Ltd.), to Brinzolamide (Azopt®) 1% Ophthalmic Suspension of Alcon Laboratories, Inc., In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes|Completed||Phase 3|1100|Actual|Actavis Inc.||2|||f||||f||||||||||2017-10-10 23:05:02.584888|2017-10-10 23:05:02.584888
NCT02512029|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-02-04|||October 2015||2015-10-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||18F-AV-1451 PET Imaging in TBI|18F-AV-1451 PET Imaging in Subjects With Subacute Traumatic Brain Injury|Withdrawn||Phase 1|0|Actual|Avid Radiopharmaceuticals||2|||f||||f||||||||||2017-10-10 23:05:02.691217|2017-10-10 23:05:02.691217
NCT02512016|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-05-18|||August 2015||2015-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Motherhood and Pelvic Health (MAP Study)|Bridging Physical and Cultural Determinants of Postpartum Pelvic Floor Support and Symptoms Following Vaginal Delivery|Recruiting||N/A|1530|Anticipated|University of Utah||1|||f||||t||||||||||2017-10-10 23:05:02.780393|2017-10-10 23:05:02.780393
NCT02512003|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-04-25|||December 2014||2014-12-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|July 2015|Actual|2015-07-01||Interventional|FANTOM I||Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I)|Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold|Active, not recruiting||N/A|7|Actual|REVA Medical, Inc.||1|||f||||t||||||||||2017-10-10 23:05:02.880544|2017-10-10 23:05:02.880544
NCT02511990|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-08-07|||July 2015||2015-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074|A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074 Monoclonal Antibody in HIV-infected and HIV-uninfected Individuals|Active, not recruiting||Phase 1|33|Actual|Rockefeller University||8|||f||||t||||||||||2017-10-10 23:05:02.972099|2017-10-10 23:05:02.972099
NCT02511977|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-07-27|||April 2013||2013-04-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|November 2013|Actual|2013-11-01||Observational|||Evaluation Clinical and Radiographic Images in Dental Implants Rehabilitated With Overdentures|Evaluation Clinical and Radiographic Images in Dental Implants Rehabilitated With Overdentures|Completed||N/A|64|Actual|Santos Metropolitan University|||2||f||||t||||||||||2017-10-10 23:05:03.244156|2017-10-10 23:05:03.244156
NCT02511964|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2015-07-27|||January 2013||2013-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|August 2013|Actual|2013-08-01||Interventional|Slope||High Intensity Interval Training in 1% or 10% Slope|Effect of Six Running Sessions of High Intensity Interval Training in Different Slopes on Aerobic Performance: a Randomized Controlled Trial|Completed||N/A|25|Actual|Universidade Federal do Rio de Janeiro||3|||f||||t||||||||||2017-10-10 23:05:03.425399|2017-10-10 23:05:03.425399
NCT02511951|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-16|||August 2015||2015-08-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy|A Prospective Randomized Clinical Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy: One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy|Recruiting||Phase 3|114|Anticipated|The Second Hospital of Anhui Medical University||2|||f||||t||||||||||2017-10-10 23:05:03.586986|2017-10-10 23:05:03.586986
NCT02511938|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-04-24|||December 2013||2013-12-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|KCRP||Kids' Choice Restaurant Program|Introducing Child Menus in Restaurants to Improve Access to Healthier Foods|Completed||N/A|106|Actual|San Diego State University||2|||f||||f||||||||Undecided||2017-10-10 23:05:03.762487|2017-10-10 23:05:03.762487
NCT02511925|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-07-27|||November 2013||2013-11-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|HANDS||Electronic Hand Hygiene Monitoring and ICU Infection Rates|A Pragmatic Crossover Cluster Randomised Study of Electronic Compliance Monitoring of Staff Hand Sanitisation in Critical Care (HANDS Study)|Completed||N/A|1065|Actual|Royal Brompton & Harefield NHS Foundation Trust|||3||f||||f||||||||||2017-10-10 23:05:03.88084|2017-10-10 23:05:03.88084
NCT02511912|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-09-05|||March 2017|Anticipated|2017-03-01|November 2016|2016-11-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|RELIEVE-HF||Reducing Lung Congestion Symptoms Using the V-wave Shunt in Advanced Heart Failure|Reducing Lung Congestion Symptoms Using the V-wave Shunt in Advanced Heart Failure|Withdrawn||N/A|0|Actual|V-Wave Ltd||1||Study was canceled|f||||t|f|f||||||||2017-10-10 23:05:04.021248|2017-10-10 23:05:04.021248
NCT02511899|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-08-06|||May 2015||2015-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Investigation of the Influence of Careless™, a Mangifera Indica Fruit Powder, on Microcirculation and Endothelial Function|Investigation of the Influence of Careless™, a Mangifera Indica Fruit Powder, on Microcirculation and Endothelial Function|Completed||N/A|10|Actual|Vital Solutions Swiss AG||2|||f||||f||||||||||2017-10-10 23:05:04.125477|2017-10-10 23:05:04.125477
NCT02511886|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-01-19||2017-01-19|September 2015|Actual|2015-09-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder|A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder|Completed||Phase 2|18|Actual|Indivior Inc.||2|||f||||t|t|f||||||No||2017-10-10 23:05:04.276577|2017-10-10 23:05:04.276577
NCT02511873|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-01-26|||January 2016||2016-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Fycompa in Subjects With Small Fiber Neuropathy (SFN)|Randomized Crossover Trial of Fycompa in the Treatment of Pain Associated With Small Fiber Neuropathy (SFN)|Active, not recruiting||Phase 2|30|Actual|PNA Center for Neurological Research||2|||f||||f||||||||||2017-10-10 23:05:04.435069|2017-10-10 23:05:04.435069
NCT02511860|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-29|||August 2015||2015-08-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||Burdock and Blood Pressure in African-American Women|Burdock and Blood Pressure in African-American Women: A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|60|Anticipated|Proactive Health Labs||2|||f||||t||||||||||2017-10-10 23:05:04.567211|2017-10-10 23:05:04.567211
NCT02511847|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-04-14|||August 2015||2015-08-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib|An Open Label, Phase II Trial of Afatinib With Paclitaxel for the Neoadjuvant Treatment of Triple-Negative Breast Cancer and Research of Biomarkers of Activity and Efficacy of Afatinib|Recruiting||Phase 2|40|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-10 23:05:04.689337|2017-10-10 23:05:04.689337
NCT02511834|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-25|2017-03-12|||October 19, 2015|Actual|2015-10-19|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|VEST III||VEST III PMS Clinical Protocol||Active, not recruiting||N/A|184|Actual|Vascular Graft Solutions Ltd.||2|||f||||f||||||||||2017-10-10 23:05:04.83036|2017-10-10 23:05:04.83036
NCT02511821|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-06-06|||July 22, 2015|Actual|2015-07-22|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery|Electronic Monitoring of Patient-Reported Outcomes and Function in GI Cancer Surgery: A Feasibility Study|Active, not recruiting||N/A|24|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:05:04.978674|2017-10-10 23:05:04.978674
NCT02511808|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-08-14|||March 2015||2015-03-01|August 2017|2017-08-01||||February 2020|Anticipated|2020-02-01||Interventional|||Adaptive Interventions for Problem Drinkers|Adaptive Interventions for Problem Drinkers|Recruiting||N/A|260|Anticipated|Northwell Health||4|||f||||t||||||||||2017-10-10 23:05:05.198187|2017-10-10 23:05:05.198187
NCT02511795|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-08-16|||August 6, 2015|Actual|2015-08-06|August 2017|2017-08-01|July 25, 2018|Anticipated|2018-07-25|September 27, 2017|Anticipated|2017-09-27||Interventional|||AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors|A Phase Ib Study of AZD1775 and Olaparib in Patients With Refractory Solid Tumours|Recruiting||Phase 1|102|Anticipated|AstraZeneca||2|||t||||f||||||||||2017-10-10 23:05:05.366303|2017-10-10 23:05:05.366303
NCT02511782|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-03-23|2016-04-07||February 2012||2012-02-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD|Use of a Transdermal Patch to Noninvasively Monitor Inflammatory Biomarkers of Acute and Chronic Skin GVHD|Completed||N/A|63|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||f||||||||||2017-10-10 23:05:05.543121|2017-10-10 23:05:05.543121
NCT02511769|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-01-30|||September 2013||2013-09-01|January 2017|2017-01-01|August 18, 2016|Actual|2016-08-18|August 18, 2016|Actual|2016-08-18||Interventional|Web-MAP||Web-MAP Intervention for Youth With Sickle Cell Disease|WEB MAP Intervention for Youth With Sickle Cell Disease|Completed||N/A|42|Actual|Connecticut Children's Medical Center||2|||f||||t||||||||No||2017-10-10 23:05:05.958645|2017-10-10 23:05:05.958645
NCT02511756|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-12-15|||July 2015||2015-07-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|December 2016|Actual|2016-12-01||Interventional|AVA-CTP||Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)|Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP) in mCRC Patients Treated With First-line Bevacizumab|Terminated||N/A|50|Anticipated|University of Zurich||1||Slow accrual|f||||f||||||||||2017-10-10 23:05:06.071914|2017-10-10 23:05:06.071914
NCT02511743|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-11-04|||April 2015||2015-04-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection|Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus|Completed||N/A|2871|Actual|Peking University First Hospital|||1||f||||f||||||||||2017-10-10 23:05:06.185812|2017-10-10 23:05:06.185812
NCT02511730|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-12-08|||June 2015||2015-06-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Pilot Mammography Reader Study to Assess Breast Cancer Detection in FFDM Plus DBT Versus FFDM Alone|A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of the Fujifilm Full Field Digital Mammography (FFDM) Plus Digital Breast Tomosynthesis (DBT) Versus FFDM Alone in the Detection of Breast Cancer|Completed||Phase 1|100|Actual|Fujifilm Medical Systems USA, Inc.||2|||f||||f||||||||||2017-10-10 23:05:06.277413|2017-10-10 23:05:06.277413
NCT02511717|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-08-23|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||A Trial of Transcutaneous Nerve Stimulation for OAB|A Randomized Trial of Transcutaneous Nerve Stimulation for Overactive Bladder Patients|Enrolling by invitation||N/A|60|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:05:06.406054|2017-10-10 23:05:06.406054
NCT02511704|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-28|||October 2014||2014-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette|Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine Administered by Electronic Cigarette and Cigarette|Completed||Phase 1|12|Actual|Parc de Salut Mar||2|||f||||t||||||||||2017-10-10 23:05:06.508506|2017-10-10 23:05:06.508506
NCT02511691|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-27|||July 2015||2015-07-01|July 2015|2015-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||PET/MRI Imaging of Glutamate Release in the Brain|PET/MRI Imaging of Glutamate Release in the Brain of Healthy Controls|Recruiting||Phase 2|60|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:05:06.637941|2017-10-10 23:05:06.637941
NCT02511665|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-29|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|METAL||Metformin And Longevity|METformin And Longevity (METAL): A Window of Opportunity Study Investigating Biological Effects of Metformin in Localised Prostate Cancer|Unknown status|Not yet recruiting|Phase 4|185|Anticipated|Guy's and St Thomas' NHS Foundation Trust||3|||f||||f||||||||||2017-10-10 23:05:06.904342|2017-10-10 23:05:06.904342
NCT02511652|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-02-19|||June 2015||2015-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Ambu AuraGain vs LMA Supreme in Laparoscopic Surgery|Comparison of the Ambu AuraGain vs. LMA Supreme in Paralysed Patients Undergoing Gynecologic Laparoscopic Surgery in the Trendelemburg Position|Completed||N/A|60|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-10 23:05:07.002133|2017-10-10 23:05:07.002133
NCT02511639|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-09-16|||July 2014||2014-07-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|MAIN-A||Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients|MAINtenance Afinitor: A Randomized Trial Comparing Maintenance Aromatase Inhibitors (AIs) + Everolimus (Afinitor) vs AIs in Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients With Disease Control After First Line Chemotherapy|Recruiting||Phase 3|253|Anticipated|Istituto Oncologico Veneto IRCCS||2|||f||||f||||||||||2017-10-10 23:05:07.159211|2017-10-10 23:05:07.159211
NCT02511626|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-03-10|||January 2010||2010-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Observational|||Quality of Life in Endometriosis - a Case Control Study|Quality of Life in Endometriosis - a Case Control Study Using Internationally Validated Questionnaires|Recruiting||N/A|1300|Anticipated|University of Zurich|||3||f||||t||||||||No||2017-10-10 23:05:07.343081|2017-10-10 23:05:07.343081
NCT02511613|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-04-25|||July 2015||2015-07-01|April 2017|2017-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration|A Study of Safety, Functional and Anatomical Effect of Squalamine Lactate Ophthalmic Solution, 0.2% Administered Twice Daily in Subjects With Neovascular Age-related Macular Degeneration|Withdrawn||Phase 2|0|Actual|Ohr Pharmaceutical Inc.||2||Company decision|f||||f||||||||||2017-10-10 23:05:07.447015|2017-10-10 23:05:07.447015
NCT02511600|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-12-14|||December 2015||2015-12-01|December 2015|2015-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication|A Randomized Phase III Trial to Compare the Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication for Mesothelioma or Other Pathologies|Withdrawn||Phase 3|0|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 23:05:07.544443|2017-10-10 23:05:07.544443
NCT02511587|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-29|||October 2012||2012-10-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®|Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®|Completed||Phase 4|116|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:05:07.631499|2017-10-10 23:05:07.631499
NCT02511574|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-01-26|||June 2014|Actual|2014-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison Between Natural Progesterone and Vaginal Pessary for the Prevention of Spontaneous Preterm Birth|Comparison Between Natural Progesterone and Vaginal Pessary for the Prevention of Spontaneous Preterm Birth in Pregnant Women With a Uterine Cervix Measuring 25 mm or Less in Length|Recruiting||Phase 4|200|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:05:07.702118|2017-10-10 23:05:07.702118
NCT02511561|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-01-21|||July 2015||2015-07-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||OTO-201 for the Treatment of Otitis Externa|A 1-Month, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration for Treatment of Otitis Externa|Completed||Phase 2|75|Actual|Otonomy, Inc.||3|||f||||f||||||||||2017-10-10 23:05:07.794785|2017-10-10 23:05:07.794785
NCT02511548|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-29|||August 2015||2015-08-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Increasing Medical Male Circumcision Uptake|Increasing Medical Male Circumcision Uptake in Orange Farm (South Africa): An Operational Study of Demand Creation|Unknown status|Not yet recruiting|Phase 3|140|Anticipated|Progressus||2|||f||||f||||||||||2017-10-10 23:05:07.880124|2017-10-10 23:05:07.880124
NCT02511535|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-28|||September 2013||2013-09-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||TBE Vaccination in Allergic Patients|TBE Vaccination in Allergic Patients|Unknown status|Recruiting|Phase 4|156|Anticipated|Medical University of Vienna||3|||f||||t||||||||||2017-10-10 23:05:07.964865|2017-10-10 23:05:07.964865
NCT02511522|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-03-13|||July 23, 2015||2015-07-23|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases|Phase III Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases|Recruiting||Phase 3|60|Anticipated|Canadian Cancer Trials Group||2|||f||||t||||||||No||2017-10-10 23:05:09.861494|2017-10-10 23:05:09.861494
NCT02511509|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-09-29|||September 2015||2015-09-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|ESBECT||Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With Schizophrenia|Comparison of the Efficacy and Safety of the Bifrontal Electroconvulsive Therapy (ECT) and the Standard Bitemporal ECT in the Treatment of Patients With Schizophrenia|Recruiting||N/A|100|Anticipated|Medical Universtity of Lodz||2|||f||||f||||||||||2017-10-10 23:05:10.025877|2017-10-10 23:05:10.025877
NCT02511496|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-07-30|||September 2015||2015-09-01|July 2015|2015-07-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01|5 Years|Observational [Patient Registry]|||Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia|Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia|Not yet recruiting||N/A|2800|Anticipated|Maimónides Biomedical Research Institute of Córdoba|||1||f||||f||||||||||2017-10-10 23:05:10.122703|2017-10-10 23:05:10.122703
NCT02511483|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-03-17|||December 2015||2015-12-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|PRO_GENE_POP||Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain|Contribution of COMT Haplotypes in Propranolol Analgesic Efficacy for Treating Post-surgical Pain After Laparoscopic Hemicolectomy|Recruiting||Phase 2|106|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 23:05:10.187781|2017-10-10 23:05:10.187781
NCT02511470|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-27|||October 2013||2013-10-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Use of a Metronome in Cardiopulmonary Resuscitation: A Simulation Study|The Use of an Audible Metronome Improves Chest Compression During Cardiopulmonary Resuscitation on a Pediatric Simulation Manikin|Completed||N/A|155|Actual|Nicklaus Children's Hospital f/k/a Miami Children's Hospital||2|||f||||f||||||||||2017-10-10 23:05:10.308888|2017-10-10 23:05:10.308888
NCT02511457|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-10-24|||October 2012||2012-10-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Comparison of Cardiac Output With LiDCO Rapid and TEE Against Thermodilution Technique in Cardiac Surgery|Validation of Measurement of Cardiac Output With LiDCO Rapid and TEE (Trans Esophageal Echocardiography) by Comparing With Intermittent Thermodilution Technique in Cardiac Surgical Patients|Completed||N/A|110|Actual|University of Iowa|||1||f||||t||||||||||2017-10-10 23:05:10.390767|2017-10-10 23:05:10.390767
NCT02511444|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-04-03|||July 2015||2015-07-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor|Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor|Completed||N/A|342|Actual|MemorialCare Health System||1|||f||||f||||||||||2017-10-10 23:05:10.47107|2017-10-10 23:05:10.47107
NCT02511431|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-06-30|||July 21, 2015||2015-07-21|February 23, 2017|2017-02-23|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir|Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir|Completed||Phase 2|22|Actual|National Institutes of Health Clinical Center (CC)||6|||f||||||||||||||2017-10-10 23:05:10.606596|2017-10-10 23:05:10.606596
NCT02511418|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-07-06||||||July 2017|2017-07-01||||January 2007|Actual|2007-01-01||Interventional|||Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure|Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure|Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-10-10 23:05:10.836238|2017-10-10 23:05:10.836238
NCT02511405|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-29|2017-04-18|||August 2015||2015-08-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|GLOBE||A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)|A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma|Active, not recruiting||Phase 3|252|Anticipated|Vascular Biogenics Ltd. operating as VBL Therapeutics||2|||f||||t||||||||||2017-10-10 23:05:10.91842|2017-10-10 23:05:10.91842
NCT02511392|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-29|||January 2014||2014-01-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|rTMS-OCD||Repetitive Transcranial Magnetic Stimulation in the Treatment of Obsessive Compulsive Disorders|Repetitive Transcranial Magnetic Stimulation in the Treatment of Obsessive-Compulsive Disorders: Double Blind Randomized Clinical Trial|Completed||N/A|45|Actual|Assiut University||3|||f||||f||||||||||2017-10-10 23:05:11.13578|2017-10-10 23:05:11.13578
NCT02511379|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-03-10|||November 2015||2015-11-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Clinical Evaluation of Systane® Balance in Dry Eye Subjects|Clinical Evaluation of Systane® Balance on Corneal Staining in Indian Subjects With Dry Eye|Suspended||N/A|14|Actual|Alcon Research||1||Management decision|f||||f||||||||||2017-10-10 23:05:11.207464|2017-10-10 23:05:11.207464
NCT02511366|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-11-02|||January 2015||2015-01-01|July 2015|2015-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Repetitive Brake Activation|The Effect of Repetitive Ileal Brake Activation on Food Intake, Satiety, Gastrointestinal Peptide Release, Gastric Emptying and Gallbladder Volume|Completed||N/A|30|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:05:11.283535|2017-10-10 23:05:11.283535
NCT02511353|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-09-06|||July 2015||2015-07-01|September 2016|2016-09-01||||July 2016|Actual|2016-07-01||Interventional|IVERMAL||Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study|Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study (IVERMAL)|Completed||Phase 2|141|Actual|Liverpool School of Tropical Medicine||3|||f||||t||||||||||2017-10-10 23:05:11.371367|2017-10-10 23:05:11.371367
NCT02511340|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2015-07-29|||January 2013||2013-01-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients|Multi-center, Single Stage Phase II Study to Evaluate the Efficacy and Safety of Flumatinib in Accelerated or Blastic Phase Chronic Myelogenous Leukemia Patients|Unknown status|Active, not recruiting|Phase 2|167|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:05:11.47|2017-10-10 23:05:11.47
NCT02511327|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-29|||January 2015||2015-01-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|MAMA||Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants|Pertussis Immunization During Pregnancy: Assessment of the Role of Maternal Antibodies on Immune Responses in Term and Preterm Infants: the MAMA Study|Recruiting||Phase 4|300|Anticipated|Universiteit Antwerpen|||4||f||||f||||||Samples Without DNA|"     Blood samples and breast milk samples   "|||2017-10-10 23:05:11.548012|2017-10-10 23:05:11.548012
NCT02511314|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-05-08|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|ARCTICC||A Trial of effectIveness of a Smart Sensor for Continence Care: the ARCTICC Study|A Randomised, Controlled Trial of effectIveness of a Smart Sensor for Continence Care: the ARCTICC Study|Not yet recruiting||N/A|86|Anticipated|University of Alberta||2|||f||||f|f|f||||||||2017-10-10 23:05:11.644726|2017-10-10 23:05:11.644726
NCT02511301|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-05-04|||June 2015||2015-06-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Circadian Thermal Sensing to Detect Breast Disease|Circadian Thermal Sensing for the Detection of Breast Disease as a Supplemental Cancer Screening System|Recruiting||Phase 1/Phase 2|173|Anticipated|Cyrcadia Health||1|||f||||t||||||||||2017-10-10 23:05:11.741558|2017-10-10 23:05:11.741558
NCT02511288|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-14|||July 2015||2015-07-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Observational|LIBIL||LIquid BIopsies in Lung Cancer (LIBIL)|Blood Collection for Patients With Advanced Non-small Cell Lung Cancer|Recruiting||N/A|900|Anticipated|Centre Leon Berard|||3||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:05:11.840903|2017-10-10 23:05:11.840903
NCT02511275|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-07-17|||February 3, 2015|Actual|2015-02-03|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|NECPAR||Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique|Assessment of Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique: NECPAR Study|Recruiting||N/A|10|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||t||||||||||2017-10-10 23:05:11.941135|2017-10-10 23:05:11.941135
NCT02511262|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-02-05|||August 2015||2015-08-01|February 2016|2016-02-01||||January 2016|Actual|2016-01-01||Observational|||Detection of Mycoplasma Pneumoniae|Clinical Trial Protocol for the Illumigene® Mycoplasma Direct Assay|Completed||N/A|471|Actual|Meridian Bioscience, Inc.|||1||f||||||||||Samples With DNA|"     Dual throat swabs.   "|||2017-10-10 23:05:12.033637|2017-10-10 23:05:12.033637
NCT02511249|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-07-29|||October 2010||2010-10-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke|Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke (AVCnn7 Years Study)|Completed||N/A|80|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-10 23:05:12.105686|2017-10-10 23:05:12.105686
NCT02511236|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-09-28|||August 2015||2015-08-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention|Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention|Recruiting||N/A|225|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 23:05:12.186176|2017-10-10 23:05:12.186176
NCT02511223|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-09-27|||July 2016|Actual|2016-07-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy and Safety of PARPi to Treat Pancreatic Cancer|PHASE II Study - EFFICACY AND SAFETY OF PARPi TO TREAT PANCREATIC CANCER|Recruiting||Phase 2|24|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:05:12.377987|2017-10-10 23:05:12.377987
NCT02511210|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-12-26|||June 2015||2015-06-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Regional Anesthesia / Peripheral Nerve Block and General Anesthesia on Preoperative Anxiety|Comparison of the Effects of Regional Anesthesia / Peripheral Nerve Block and General Anesthesia on Preoperative Anxiety|Unknown status|Recruiting|N/A|500|Anticipated|Cukurova University||2|||f||||f||||||||||2017-10-10 23:05:12.498911|2017-10-10 23:05:12.498911
NCT02511197|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-04-05|||May 2015||2015-05-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis|Safety and Diagnostic Performance of 68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis|Recruiting||Early Phase 1|30|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||||2017-10-10 23:05:12.636276|2017-10-10 23:05:12.636276
NCT02511184|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-28|||October 19, 2015|Actual|2015-10-19|September 2017|2017-09-01|October 7, 2019|Anticipated|2019-10-07|October 7, 2019|Anticipated|2019-10-07||Interventional|||Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients|A Phase 1b Study Of Crizotinib In Combination With Pembrolizumab (Mk-3475) In Patients With Untreated Advanced Alk-translocated Non Small Cell Lung Cancer|Recruiting||Phase 1|70|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 23:05:12.81027|2017-10-10 23:05:12.81027
NCT02511171|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-28|||June 2015||2015-06-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Parental Blinding in Clinical Trials of Osteopathy|A Study to Explore the Acceptability of Parental Blinding in Clinical Trials of Osteopathy With Excessively Crying Infants as Study Participants|Unknown status|Recruiting|N/A|30|Anticipated|European School of Osteopathy||2|||f||||||||||||||2017-10-10 23:05:13.006221|2017-10-10 23:05:13.006221
NCT02511158|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-08-02|||September 2012||2012-09-01|August 2016|2016-08-01|September 2052|Anticipated|2052-09-01|September 2032|Anticipated|2032-09-01|20 Years|Observational [Patient Registry]|FAST||French Prospective Anterior Cruciate Ligament Reconstruction Cohort Study (FAST)|Prospective Follow-up Study of Patients Undergoing Knee Ligament Surgery|Recruiting||N/A|7000|Anticipated|Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport|||1||f||||f||||||||||2017-10-10 23:05:13.143815|2017-10-10 23:05:13.143815
NCT02511145|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-30|||February 2014||2014-02-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration|Exploratory Study to Compare Mechanical Penetration Enhancers on Metvixia Skin Penetration|Completed||Phase 1|10|Actual|Galderma R&D||9|||f||||f||||||||||2017-10-10 23:05:13.260027|2017-10-10 23:05:13.260027
NCT02511132|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-09-26|||May 25, 2017|Actual|2017-05-25|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma|A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma|Active, not recruiting||Phase 2|22|Actual|Gradalis, Inc.||1|||f||||f|t|f||||||||2017-10-10 23:05:13.366908|2017-10-10 23:05:13.366908
NCT02511119|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2015-07-29|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2018|Anticipated|2018-07-01||Observational|||Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma||Not yet recruiting||N/A|300|Anticipated|Maimónides Biomedical Research Institute of Córdoba|||1||f||||f||||||||||2017-10-10 23:05:13.481058|2017-10-10 23:05:13.481058
NCT02511106|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-09-20|||October 21, 2015|Actual|2015-10-21|September 2017|2017-09-01|December 10, 2021|Anticipated|2021-12-10|December 10, 2021|Anticipated|2021-12-10||Interventional|ADAURA||AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.|A Phase III, Double-blind, Randomized, Placebo-controlled Multi-centre, Study to Assess the Efficacy and Safety of AZD9291 Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy (ADAURA).|Recruiting||Phase 3|700|Anticipated|AstraZeneca||2|||f||||t||||||||||2017-10-10 23:05:13.592812|2017-10-10 23:05:13.592812
NCT02511093|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-28|||September 2014||2014-09-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|TBC-HTA||A Team-Based Care for Hypertension Management (TBC-HTA)|A Team-Based Care for Hypertension Management (TBC-HTA): A Randomized Controlled Study|Recruiting||N/A|110|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 23:05:14.454485|2017-10-10 23:05:14.454485
NCT02511080|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-09-26|||July 2016||2016-07-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effectiveness of Spot-on ™ to Prevent Inadvertent Perioperative Hypothermia and Their Consecuences|Effectiveness of Spot-on ™ to Prevent Inadvertent Perioperative Hypothermia and Their Consecuences|Recruiting||N/A|70|Anticipated|Osakidetza||2|||f||||f||||||||Yes||2017-10-10 23:05:14.563934|2017-10-10 23:05:14.563934
NCT02511067|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-04-26|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Interventional|READ-4||Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study|Evaluation Of the Safety, Tolerability and Efficacy of Ranibizumab and Tocilizumab in Eyes With Diabetic Macular Edema.|Not yet recruiting||Phase 2|66|Anticipated|University of Nebraska||3|||f||||t|t|f||||||||2017-10-10 23:05:14.659435|2017-10-10 23:05:14.659435
NCT02511054|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-06-30|||July 21, 2015||2015-07-21|June 1, 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|October 21, 2016|Actual|2016-10-21||Interventional|||Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...|Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual Blood Stages of Plasmodium Falciparumc|Completed||Phase 1|57|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 23:05:14.772138|2017-10-10 23:05:14.772138
NCT02511041|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-06-30|||June 30, 2015||2015-06-30|January 24, 2017|2017-01-24|January 24, 2017|Actual|2017-01-24|January 24, 2017|Actual|2017-01-24||Interventional|||Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation|Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation|Terminated||Phase 1|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:05:14.879451|2017-10-10 23:05:14.879451
NCT02511028|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-10-05|||June 30, 2015||2015-06-30|March 6, 2017|2017-03-06|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging|In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging|Enrolling by invitation||Early Phase 1|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:05:14.965487|2017-10-10 23:05:14.965487
NCT02511015|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-09-12|||June 30, 2015||2015-06-30|August 25, 2017|2017-08-25|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Observational|||Hereditary Parkinson s Disease Natural History Protocol|Hereditary Parkinson's Disease Natural History Protocol|Completed||N/A|31|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:05:15.072303|2017-10-10 23:05:15.072303
NCT02511002|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-10-05|||June 24, 2015||2015-06-24|July 12, 2017|2017-07-12|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge|Long-Term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge|Enrolling by invitation||N/A|28|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:05:15.16715|2017-10-10 23:05:15.16715
NCT02510989|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-08-04|||July 2016||2016-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|OBEXOME||Phenotypic and Genotypic Characterization of Subjects With Syndromic Obesity: Identifying New Candidate Genes by Exome Sequencing (OBEXOME)|Phenotypic and Genotypic Characterization of Subjects With Syndromic Obesity: Identifying New Candidate Genes by Exome Sequencing|Recruiting||N/A|40|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Tubes of blood for genetic analysis (20 ml of blood/subject)   "|||2017-10-10 23:05:15.259979|2017-10-10 23:05:15.259979
NCT02510976|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-12-14|||November 2011||2011-11-01|July 2015|2015-07-01||||September 2015|Actual|2015-09-01||Interventional|||Prucalopride Versus Placebo in Gastroparesis|Prucalopride Versus Placebo in Functional Dyspepsia With Delayed Gastric Emptying|Unknown status|Recruiting|Phase 4|30|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 23:05:15.355033|2017-10-10 23:05:15.355033
NCT02510963|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-08-09|||November 2015||2015-11-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy|An Open-label, Randomized, Controlled Clinical Trial to Determine the Optimal Time for Tenofovir of Anti-HBV Treatment During the Pregnancy Among Chronic HBV-infected Pregnant Women With Normal Liver Function|Recruiting||N/A|300|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||3|||f||||||||||||||2017-10-10 23:05:15.459343|2017-10-10 23:05:15.459343
NCT02510950|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-07-18|||December 3, 2015|Actual|2015-12-03|July 2017|2017-07-01|October 31, 2019|Anticipated|2019-10-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma|A Pilot Study to Assess the Safety, Feasibility, and Preliminary Efficacy of a Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 1|10|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 23:05:15.579542|2017-10-10 23:05:15.579542
NCT02510937|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-03-30|||August 5, 2015|Actual|2015-08-05|March 2017|2017-03-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis|A Phase 1b, Multicenter, Open-label, Staggered-dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of CC-90001 for 3 Months in Patients With Pulmonary Fibrosis|Completed||Phase 1|16|Actual|Celgene||2|||f||||f||||||||||2017-10-10 23:05:15.707413|2017-10-10 23:05:15.707413
NCT02510729|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-08-14|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||SPG Neurostimulation in Cluster Patients|Sphenopalataine Ganglion (SPG) Stimulation in Cluster Headache Patients|Completed||N/A|21|Actual|Danish Headache Center||2|||f||||f||||||||||2017-10-10 23:05:18.603689|2017-10-10 23:05:18.603689
NCT02510924|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-03-07|||August 2015||2015-08-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|AirtraqMob||Role of Airtraq Mobile to Improve Intubation Conditions With Airtraq|Role of Airtraq Mobile to Improve Intubation Conditions With Airtraq in Adults With a Simulated Difficult Airway With a Cervical-spine Collar|Recruiting||N/A|100|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-10 23:05:15.812603|2017-10-10 23:05:15.812603
NCT02510911|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-07-20|||August 2015||2015-08-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|May 2020|Anticipated|2020-05-01||Interventional|CaCo||Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?|Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy? - A Randomized, Placebo-controlled Trial|Recruiting||N/A|180|Anticipated|Cantonal Hospital of St. Gallen||3|||f||||t||||||||||2017-10-10 23:05:15.913808|2017-10-10 23:05:15.913808
NCT02510898|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2016-05-23|||January 2016||2016-01-01|January 2016|2016-01-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Examining the Role of Expressive Writing (EW) to Improve Resilience|Examining the Role of Expressive Writing (EW) to Improve Resilience Among Those Experiencing an Emotional Upheaval or a Physical Health Challenge|Completed||N/A|39|Actual|Duke University||1|||f||||f||||||||||2017-10-10 23:05:16.057506|2017-10-10 23:05:16.057506
NCT02510885|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-28|2017-06-28|||July 2015||2015-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||SD-OCT Angiography|Spectral Domain-Optical Coherence Tomography Angiography of Retinal Diseases|Recruiting||N/A|100|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 23:05:16.143737|2017-10-10 23:05:16.143737
NCT02510872|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-27|||December 2011||2011-12-01|July 2015|2015-07-01||||April 2014|Actual|2014-04-01||Interventional|TEPVAD||Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection||Completed||N/A|19|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:05:16.230562|2017-10-10 23:05:16.230562
NCT02510859|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-27|||December 2010||2010-12-01|July 2015|2015-07-01||||January 2014|Actual|2014-01-01||Interventional|NUQUE2||Nutrition and Life QUality Patients With Head and Neck Cancers||Completed||N/A|117|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:05:16.303142|2017-10-10 23:05:16.303142
NCT02510846|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-10-07|||January 2016||2016-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|TDCHandi||Impact of an Intensive Multimodal Educative Program on Behavioral Disorders of Patients With Profound Multiple Disabilities and on the Quality of Life and Feelings of Caregivers|Impact of an Intensive Multimodal Educative Program on Behavioral Disorders of Patients With Profound Multiple Disabilities and on the Quality of Life and Feelings of Caregivers|Active, not recruiting||N/A|64|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:05:16.360571|2017-10-10 23:05:16.360571
NCT02510833|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-01-16|||January 2015||2015-01-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|HTE||Effects of Home Therapeutic Exercises Oriented for Patients With Parkinson's Disease|Home Therapeutic Exercises Oriented for People With Parkinson's Disease: Impact on the Disease and Quality of Life|Completed||N/A|28|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 23:05:16.448026|2017-10-10 23:05:16.448026
NCT02510820|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-01-30|2017-01-30||May 2015||2015-05-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||The Clinical Performance of the Biofinity Contact Lens (Comfilcon A) With Two Lens Care Systems|The Clinical Performance of the Biofinity Contact Lens (Comfilcon A) With Two Lens Care Systems|Completed||N/A|51|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 23:05:16.533435|2017-10-10 23:05:16.533435
NCT02510807|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2016-05-18|||July 2015||2015-07-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PAWS||The PaWS (Pedometer and Walking Study)|The PaWS (Pedometer and Walking Study): Comparing Education Alone and Education With Pedometer/Exercise Log Use in Self-monitored Walking in Peripheral Arterial Disease (PAD)|Recruiting||N/A|200|Anticipated|University Health Network, Toronto||2|||f||||f||||||||Undecided||2017-10-10 23:05:17.851418|2017-10-10 23:05:17.851418
NCT02510781|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-27|||January 2015||2015-01-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs|A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis Detecting Circulating Tumor Cells|Recruiting||Phase 2|200|Anticipated|Hospital Affiliated to Military Medical Science, Beijing||2|||f||||t||||||||||2017-10-10 23:05:18.221701|2017-10-10 23:05:18.221701
NCT02510768|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2017-07-30|||August 2015||2015-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba|A Randomized, Within-Subject, Placebo-Controlled, Single-Blind Study to Evaluate the Efficacy of ELAPR002f and ELAPR002g in Women With Striae Distensae (SD) Alba|Active, not recruiting||Phase 1|26|Actual|Elastagen Pty Ltd||3|||f||||f||||||||||2017-10-10 23:05:18.336507|2017-10-10 23:05:18.336507
NCT02510755|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-28|||May 2012||2012-05-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SEME||Stress and Emotional Memory|Stress and Emotional Memory : Functional Neuroanatomy of Post-traumatic Stress Disorder in Adolescents|Completed||N/A|19|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:05:18.438123|2017-10-10 23:05:18.438123
NCT02510742|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-28|||July 2015||2015-07-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Physiological Changes With SPG Stimulation in Migraine Patients|Physiological Changes Induced With SPG Stimulation in Migraine Patients - Amendment to the Pathway M-1 Trial|Unknown status|Recruiting|N/A|12|Anticipated|Danish Headache Center||2|||f||||||||||||||2017-10-10 23:05:18.512574|2017-10-10 23:05:18.512574
NCT02510716|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-10-19|||December 2015||2015-12-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Addressing Tobacco Use Disparities in Rural Older Adults Through an Innovative Mobile Phone Intervention|Addressing Tobacco Use Disparities in Rural Older Adults Through an Innovative Mobile Phone Intervention: Testing the Feasibility of the Textto4gotobacco Intervention|Completed||N/A|40|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:05:18.697939|2017-10-10 23:05:18.697939
NCT02510703|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-08-04|||March 2011||2011-03-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|D-TEP||Assessment of Coronary Endothelial Function in Diabetic Patients With Acute Coronary Syndrome Using 15O-water Positron Emission Tomography||Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:05:18.790383|2017-10-10 23:05:18.790383
NCT02510690|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2017-02-01|||October 2014||2014-10-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Observational|||Factors Associated With Poor Dengue Outcomes in Malaysia|Factors Associated With Poor Dengue Outcomes in Malaysia|Completed||N/A|20000|Actual|Clinical Research Centre, Malaysia|||1||f||||f||||||||||2017-10-10 23:05:18.873635|2017-10-10 23:05:18.873635
NCT02510677|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-01-31|||June 2013||2013-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|FAST DOGS||Three-dimensional Assessment of Intraventricular Dyssynchrony Using Fast Dobutamine Gated SPECT||Completed||N/A|21|Actual|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:05:18.957037|2017-10-10 23:05:18.957037
NCT02510664|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-03-20|||July 2014||2014-07-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|DSS||Diabetes Strengths Study - Pilot of Provider-delivered Strengths-based Intervention|Promoting Resilience in Youth With Type 1 Diabetes: Pilot of Strengths-Based Family Intervention to Improve Diabetes Outcomes (Diabetes Strengths Study)|Completed||N/A|84|Actual|Baylor College of Medicine||1|||f||||f||||||||Yes|Participants receive profile of results from two surveys completed during intervention, other participant data not returned to participant|2017-10-10 23:05:19.040986|2017-10-10 23:05:19.040986
NCT02510651|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-28|||January 2010||2010-01-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo|Effect of Procedural-Related Variables on Melanocyte-Keratinocyte Suspension Transplantation in Non-Segmental Stable Vitiligo: A Clinical and Immunohistochemical Study|Completed||Phase 1|40|Actual|Cairo University||1|||f||||t||||||||||2017-10-10 23:05:19.127266|2017-10-10 23:05:19.127266
NCT02510638|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2016-01-28|||September 2015||2015-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia|The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia|Completed||N/A|322|Actual|Clinical Research Centre, Malaysia|||1||f||||f||||||||||2017-10-10 23:05:19.208793|2017-10-10 23:05:19.208793
NCT02510625|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-02-08|||September 2015||2015-09-01|February 2017|2017-02-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|ATRASI||The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability|The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability: A Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Nova Scotia Health Authority||2|||f||||t|f|f||||||No||2017-10-10 23:05:19.276356|2017-10-10 23:05:19.276356
NCT02510612|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-28|||August 2015||2015-08-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|dadpgm||Dexmedetomidine Affect Diabetic Patient's Glucose Metabolism|Perioperative Dexmedetomidine Affect Diabetic Patient's Glucose Metabolism|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Shaanxi Provincial People's Hospital||2|||f||||f||||||||||2017-10-10 23:05:19.358987|2017-10-10 23:05:19.358987
NCT02510599|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-03-20||2017-03-17|December 2015|Actual|2015-12-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|January 27, 2017|Actual|2017-01-27||Interventional|||Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis|An Open Label, Proof of Principle Study to Evaluate the Efficacy and Safety of Solithromycin for the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis|Completed||Phase 2|10|Actual|Cempra Inc||1|||f||||t||||||||||2017-10-10 23:05:19.448065|2017-10-10 23:05:19.448065
NCT02510586|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-07-26|||August 2015||2015-08-01|July 2015|2015-07-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Sevoflurane and Hyperperfusion Syndrome|Effect of Sevoflurane-induced Postconditioning on the Incidence of Postoperative Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Adult Patients With Moyamoya Disease|Not yet recruiting||N/A|152|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:05:19.526542|2017-10-10 23:05:19.526542
NCT02510573|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2015-07-26|||April 2011||2011-04-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|July 2014|Actual|2014-07-01||Observational|||Low Serum Ficolin-3 Levels on Admission Are Associated With Poor Outcomes After Severe Traumatic Brain Injury|Prognostic Value of Serum Ficolin-3 Levels After Severe Traumatic Brain Injury：A Pilot Study|Completed||N/A|128|Actual|Sanmen People's Hospital|||1||f||||t||||||Samples Without DNA|"     All blood samples from the patients at admission were collected in the tubes and centrifuged     within 30 minutes at 1,000*g for 15 minutes. The serum was removed and frozen at -70°C until     measurement.   "|||2017-10-10 23:05:19.607203|2017-10-10 23:05:19.607203
NCT02510560|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-09-18|||October 2016||2016-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants|A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants|Recruiting||Phase 3|530|Anticipated|Nutrinia||3|||f||||t||||||||||2017-10-10 23:05:19.670202|2017-10-10 23:05:19.670202
NCT02510547|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-08-19|||September 2015||2015-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||"Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the CrossBoss First Trial"||Completed||Phase 4|246|Anticipated|North Texas Veterans Healthcare System||2|||f||||t||||||||||2017-10-10 23:05:19.786044|2017-10-10 23:05:19.786044
NCT02510339|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-04-07|||January 10, 2016|Actual|2016-01-10|October 2015|2015-10-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|||Tibial Shaft Nailing Treated With Suprapatellar Nailing|The Incidence of Associated Intra-articular Knee Pathology With Concomitant Tibial Shaft Fractures Treated With Suprapatellar Nailing|Completed||N/A|16|Actual|Orlando Health, Inc.|||1||f||||f||||||||||2017-10-10 23:05:21.604005|2017-10-10 23:05:21.604005
NCT02510534|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-09-22|||July 2015||2015-07-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin & IUI|A Prospective Randomized Trial to Study the Effect of Luteal Progesterone Support on Pregnancy Rates in Combined Clomiphene Citrate and Gonadotropin Ovulation Induction Protocol With Intrauterine Insemination.|Terminated||Phase 1|520|Actual|Northwest Center for Infertility and Reproductive Endocrinology||2||unable to enroll participants who meet the criteria|f||||t||||||||Undecided||2017-10-10 23:05:19.894279|2017-10-10 23:05:19.894279
NCT02510521|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-11-02|||February 2012||2012-02-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|ELECTRODIAB||Effects of Neuro-myo-electrical Stimulation on Insulin Sensitivity in Patients With Type 2 Diabetes||Completed||N/A|18|Actual|University Hospital, Caen||3|||f||||f||||||||||2017-10-10 23:05:19.973263|2017-10-10 23:05:19.973263
NCT02510508|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-08-16|||August 2015||2015-08-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||Group Version of CRAFT Compared to Self-Directed CRAFT Delivery and Non-intervention: a Three-armed RCT|A Group Version of Community Reinforcement and Family Training (CRAFT) Compared to Self-Directed CRAFT Delivery and Non-intervention: a Three-armed Randomized Clinical Trial|Terminated||N/A|29|Actual|IrisZorg||3||Not enough participants were included|f||||t||||||||||2017-10-10 23:05:20.062298|2017-10-10 23:05:20.062298
NCT02510495|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-09-30|||February 2016||2016-02-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Endoscopic Papillary Balloon Dilation on ERCP Complications|Effect of Different Endoscopic Papillary Balloon Dilation Duration Time on Complications of Common Bile Duct Stone Patient|Recruiting||N/A|3000|Anticipated|Hepatopancreatobiliary Surgery Institute of Gansu Province||5|||f||||t||||||||No||2017-10-10 23:05:20.27603|2017-10-10 23:05:20.27603
NCT02510482|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-03-21|||August 2015||2015-08-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis|Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis|Active, not recruiting||N/A|25|Anticipated|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-10 23:05:20.469416|2017-10-10 23:05:20.469416
NCT02510456|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-09-11|||January 2015||2015-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|DOSI||Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging|Monitoring Neoadjuvant Chemotherapy Response In Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging (DOSI)|Recruiting||N/A|37|Anticipated|Boston Medical Center||1|||f||||f|f|t|f|f|f|||||2017-10-10 23:05:20.651635|2017-10-10 23:05:20.651635
NCT02510443|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-09-12|||June 23, 2008|Actual|2008-06-23|September 2017|2017-09-01|November 25, 2016|Actual|2016-11-25|September 29, 2016|Actual|2016-09-29||Observational|SUCCES II||Observational Study on Contraception With Essure in France|Survey on Use and Characteristics of Definitive Contraception With ESsure®|Completed||N/A|2644|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:05:20.751461|2017-10-10 23:05:20.751461
NCT02510430|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-05-08|||September 2015||2015-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors|Randomized Controlled Trial of Sitting Time Interventions in Breast Cancer Survivors|Recruiting||N/A|60|Anticipated|University of Wisconsin, Madison||3|||f||||||||||||||2017-10-10 23:05:20.849325|2017-10-10 23:05:20.849325
NCT02510417|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-08-17|||October 2014||2014-10-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|||Allogeneic Virus-specific T Cell Lines (VSTs)|Administration of Most Closely HLA-matched Multivirus-specific Cytotoxic T-Lymphocytes for the Treatment of EBV, CMV, Adenovirus Infections Post Allogeneic Stem Cell Transplant|Recruiting||Phase 1|50|Anticipated|Children's Research Institute||1|||f||||t||||||||||2017-10-10 23:05:20.924876|2017-10-10 23:05:20.924876
NCT02510404|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-10-19|||April 2014||2014-04-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|September 2019|Anticipated|2019-09-01||Interventional|||Multivirus-specific Cytotoxic T Lymphocytes (mCTL)|Treatment of EBV, CMV, and Adenovirus Infections in Primary Immunodeficiency Disorders With Viral-specific Cytotoxic T-Lymphocytes|Recruiting||Phase 1|14|Anticipated|Children's Research Institute||1|||f||||t||||||||||2017-10-10 23:05:21.008784|2017-10-10 23:05:21.008784
NCT02510391|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-12-14|||October 2015||2015-10-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Modular Treatment for Preschool Anxiety|Modular Treatment for Preschool Anxiety|Recruiting||N/A|60|Anticipated|University of South Florida||1|||f||||f||||||||||2017-10-10 23:05:21.107108|2017-10-10 23:05:21.107108
NCT02510378|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-27|||January 2014||2014-01-01|July 2015|2015-07-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases|Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases|Recruiting||Phase 2|47|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-10 23:05:21.229907|2017-10-10 23:05:21.229907
NCT02510365|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2017-02-07|||April 2015||2015-04-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Functional Neural Regeneration Collagen Scaffold Transplantation in Acute Spinal Cord Injury Patients|Safety and Efficacy of Functional Neural Regeneration Collagen Scaffold Transplantation in Complete (AISA) Acute Spinal Cord Injury Patients|Recruiting||Phase 1|20|Anticipated|Chinese Academy of Sciences||1|||f||||f||||||||||2017-10-10 23:05:21.36469|2017-10-10 23:05:21.36469
NCT02510352|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-07-27|||April 2006||2006-04-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2009|Actual|2009-10-01||Observational|||Cohort of Patients With a Symptomatic Rotator Cuff Tear Treated Without Surgical Repair|Cohort of Patients With a Symptomatic Rotator Cuff Tear Treated Without Surgical Repair|Completed||N/A|150|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||t||||||||||2017-10-10 23:05:21.475895|2017-10-10 23:05:21.475895
NCT02510313|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2017-02-10|||May 30, 2017|Anticipated|2017-05-30|August 2016|2016-08-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||"Strong Families, Thriving Children Sugira Muryango_Activity C"|Effectiveness Trial of a Family Home Visiting Intervention to Promote Early Child Development Among Families Served by the Social Protection System in Rwanda|Not yet recruiting||N/A|1040|Anticipated|Harvard School of Public Health||4|||f|||||f|f||||||||2017-10-10 23:05:21.767755|2017-10-10 23:05:21.767755
NCT02510300|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-09-15|||October 2015||2015-10-01|September 2017|2017-09-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01|5 Years|Observational [Patient Registry]|||A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials|A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials|Enrolling by invitation||N/A|500|Anticipated|Gilead Sciences|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:05:21.883408|2017-10-10 23:05:21.883408
NCT02510287|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-05-19|||July 2015||2015-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Comparison of Epidural Analgesia: Continuous Infusion Versus Programmed Intermittent Boluses||Completed||N/A|128|Actual|Fundación Santa Fe de Bogota||2|||f||||||||||||||2017-10-10 23:05:22.082353|2017-10-10 23:05:22.082353
NCT02510274|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-27|||May 2014||2014-05-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan|A Phase 1, Single and Multiple Dosing Study to Evaluate Pharmacokinetics and Pharmacodynamics of ASP3325 in Patients With Chronic Kidney Disease and Hyperphosphatemia Undergoing Hemodialysis|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-10 23:05:22.203904|2017-10-10 23:05:22.203904
NCT02510261|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-04|||July 2015||2015-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|||The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)|A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients With Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Patisiran Clinical Study|Enrolling by invitation||Phase 3|228|Anticipated|Alnylam Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:05:22.357211|2017-10-10 23:05:22.357211
NCT02510248|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-01-28|||July 2015||2015-07-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C|A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-part Study of Orally Administered JNJ-54257099 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses (Part 1) and Food-effect (Part 2) in Healthy Subjects, and Multiple Doses in Subjects With Chronic Hepatitis C Infection (Part 3)|Terminated||Phase 1|40|Actual|Alios Biopharma Inc.||2|||f||||f||||||||||2017-10-10 23:05:22.536343|2017-10-10 23:05:22.536343
NCT02510235|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-28|||March 2015||2015-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Tolerability, Safety and Efficacy of Lubricin Eye Drops Versus Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye|A Multicenter, Randomized, Double-masked, Controlled, Non-inferiority Study to Evaluate Tolerability, Safety and Efficacy of Lubricin Eye Drops Versus Sodium Hyaluronate Eye Drops Administered Four Times a Day for 4 Weeks and 1 Week Follow-up in Subjects With Moderate Dry Eye|Completed||N/A|56|Actual|Dompé Farmaceutici S.p.A||2|||f||||f||||||||||2017-10-10 23:05:22.609958|2017-10-10 23:05:22.609958
NCT02510222|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2017-02-09|||May 2015||2015-05-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Magnesium Therapy in Children With Cerebral Palsy|Effect of Magnesium Therapy on Spasticity and Constipation in Children With Cerebral Palsy|Completed||N/A|64|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:05:22.687288|2017-10-10 23:05:22.687288
NCT02510209|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2015-07-27|||July 2011||2011-07-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluation of the Teen Outreach Program in Hennepin County, Minnesota|Evaluation of the Teen Outreach Program in Hennepin County, Minnesota: Findings From the Replication of an Evidence-Based Teen Pregnancy Prevention Program|Completed||N/A|1644|Actual|Abt Associates||2|||f||||f||||||||||2017-10-10 23:05:22.763293|2017-10-10 23:05:22.763293
NCT02510183|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2015-07-26|||February 2015||2015-02-01|June 2015|2015-06-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|||P6 Acupressure Before Laparoscopic Cholecystectomy|Evaluation of the Effects of P6 Acupressure Application on Postoperative Nausea and Vomiting Before Laparoscopic Cholecystectomy|Unknown status|Active, not recruiting|N/A|111|Anticipated|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||3|||f||||f||||||||||2017-10-10 23:05:22.902977|2017-10-10 23:05:22.902977
NCT02510170|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2017-02-12|||September 2015||2015-09-01|January 2016|2016-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|1 Day|Observational [Patient Registry]|||Fetal and Maternal Head Circumference During Pregnancy in Israeli Population|Fetal and Maternal Head Circumference During Pregnancy|Completed||N/A|188|Actual|Clalit Health Services|||1||f||||t||||||||||2017-10-10 23:05:22.997749|2017-10-10 23:05:22.997749
NCT02510157|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-16|2016-10-02|||May 2015||2015-05-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Dexamethasone on the Action of Sugammadex||Completed||N/A|44|Actual|Attikon Hospital||2|||f||||f||||||||||2017-10-10 23:05:23.062161|2017-10-10 23:05:23.062161
NCT02510144|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-05-11|||January 2016||2016-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Skin Prep to Reduce Postoperative Shoulder Infection|Adjusting Skin Prep to Decrease Risk of P. Acnes Related Shoulder Infection|Recruiting||N/A|120|Anticipated|University of Maryland||2|||f||||f||||||||||2017-10-10 23:05:23.157141|2017-10-10 23:05:23.157141
NCT02510131|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-05-09|||August 2015||2015-08-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Is Hyacinth Exercise Better Than Kegel's Exercise in Women With Urinary Incontinence?|Is Hyacinth Exercise Better Than Kegel's Exercise in Women With Urinary Incontinence?|Recruiting||N/A|180|Anticipated|University of Malaya||2|||f||||f||||||||Undecided||2017-10-10 23:05:23.259008|2017-10-10 23:05:23.259008
NCT02510118|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-30|||June 2015||2015-06-01|July 2015|2015-07-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients|Synergistic Anti-tumor Effect of ChangTai Keli Based on Chemotherapy for Colon Cancer Patients：a Randomized, Parallel-group, Double-blind, Multicenter Clinical Study|Recruiting||Phase 2/Phase 3|360|Anticipated|Nanjing NingQi Medicine Science and Technology Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:05:23.361181|2017-10-10 23:05:23.361181
NCT02510105|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-07-27|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PERVE-ARDS||Tomodensitometric Study of Pulmonary Effects of Intrapulmonary Percussive Ventilation in ARDS Patients|Tomodensitometric Study of Pulmonary Effects of Intrapulmonary Percussive Ventilation in ARDS Patients|Unknown status|Not yet recruiting|N/A|10|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 23:05:23.492632|2017-10-10 23:05:23.492632
NCT02510092|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-10-12|||July 2015||2015-07-01|October 2016|2016-10-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment|In Vivo Intravascular Diagnostics and Evaluation of New Therapeutic Modalities in Systemic Autoimmune and Coronary Artery Disease Patients|Recruiting||N/A|40|Anticipated|Semmelweis University Heart and Vascular Center||2|||f||||f||||||||||2017-10-10 23:05:23.58434|2017-10-10 23:05:23.58434
NCT02510079|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-09-25||||||September 2017|2017-09-01||||||||Expanded Access|||Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.|Emergent Expanded Access to Use Autologous Human Schwann Cell Augmentation of Nerve Autograft Repair in a Single Patient With Severe Peripheral Nerve Injury|Temporarily not available||N/A|||University of Miami|||||||||||||||||||2017-10-10 23:05:23.690552|2017-10-10 23:05:23.690552
NCT02510066|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-27|||July 2015||2015-07-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain|Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain: : a Randomized, Placebo Controlled Trial|Unknown status|Recruiting|Phase 3|62|Anticipated|Shanghai Cancer Hospital, China||2|||f||||t||||||||||2017-10-10 23:05:23.747779|2017-10-10 23:05:23.747779
NCT02510053|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-07-26|||July 2014||2014-07-01|July 2015|2015-07-01||||June 2016|Anticipated|2016-06-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit|PK-PD of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||1|||f||||f||||||||||2017-10-10 23:05:23.848466|2017-10-10 23:05:23.848466
NCT02510040|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-08-15|||August 17, 2015|Actual|2015-08-17|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|SAS1||A Prospective Observational Study of Adult Strabismus|A Prospective Observational Study of Adult Strabismus|Recruiting||N/A|650|Anticipated|Jaeb Center for Health Research|||3||f||||t||||||||||2017-10-10 23:05:23.927922|2017-10-10 23:05:23.927922
NCT02510027|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-07-27|||August 2013||2013-08-01|July 2015|2015-07-01||||December 2017|Anticipated|2017-12-01||Observational|FRIDA||Triage Strategies in Cervical Cancer Prevention|Molecular Triage in Cervical Cancer Prevention: The Tlaxcala Study|Recruiting||N/A|100000|Anticipated|Instituto Nacional de Salud Publica, Mexico|||1||f||||t||||||Samples With DNA|"     Two cervical samples will be collected using a Cervex-Brush® (Rovers®). The first collected     sample will be placed in a vial containing BD CytoRich™ preservative (BD Diagnostics,     Burlington, NC), and the second sample will be placed in a ThinPrep® vial (Hologic, Inc.,     Bedford, MA). Both samples will be temporarily stored at room temperature at the health     center until they are delivered to the lab facilities. Women who refuse a pelvic examination     will be offered the option to self-collect a vaginal sample at the health facility or at     their home that can be used for hrHPV testing. Only HR-HPV positive participants will move     onto the cytology/molecular triage testing phase. After triage procedures, all remaining     samples collected in either of the vials from HR-HPV positive women will be stored     independently for additional analysis as required by the study procedures.   "|||2017-10-10 23:05:24.05393|2017-10-10 23:05:24.05393
NCT02510014|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-07-27||2017-02-06|July 27, 2015|Actual|2015-07-27|July 2017|2017-07-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder|An Open-Label, Long-Term Safety and Tolerability Study of Depot Buprenorphine (RBP-6000) in Treatment-Seeking Subjects With Opioid Use Disorder|Completed||Phase 3|672|Actual|Indivior Inc.||2|||f||||f||||||||||2017-10-10 23:05:24.295304|2017-10-10 23:05:24.295304
NCT02510001|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-08-31|||November 2014||2014-11-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|MErCuRIC1||MErCuRIC1: MEK and MET Inhibition in Colorectal Cancer|A Sequential Phase I Study of MEK1/2 Inhibitors PD-0325901 or Binimetinib Combined With cMET Inhibitor PF-02341066 in Patients With RAS Mutant and RAS Wild Type (With Aberrant c-MET) Colorectal Cancer|Recruiting||Phase 1|78|Anticipated|University of Oxford||12|||f||||t||||||||No||2017-10-10 23:05:24.593762|2017-10-10 23:05:24.593762
NCT02509988|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-05-15|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|December 2018|Anticipated|2018-12-01||Interventional|NiPPeR||Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health|"Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health (NiPPeR)"|Active, not recruiting||N/A|1731|Actual|University of Southampton||2|||f||||t||||||||||2017-10-10 23:05:24.846335|2017-10-10 23:05:24.846335
NCT02509975|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-07-18|||September 2015||2015-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety and Efficacy of OCL 503 in Prostate Artery Embolization|An Open Label, Single Center, Pilot Study to Evaluate the Safety and Effectiveness of OCL 503 in Prostate Artery Embolization for the Treatment of Men With Benign Prostatic Hypertrophy|Active, not recruiting||N/A|15|Anticipated|IMBiotechnologies Ltd.||1|||f||||f||||||||||2017-10-10 23:05:25.03985|2017-10-10 23:05:25.03985
NCT02509962|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-07-18|||July 2015||2015-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2016|Actual|2016-06-01||Interventional|BSALT||Increased Salt Intake in Healthy Men|Effects of Increased Salt Intake on Metabolic, Cardiovascular and Immunoregulatory Functions in Healthy Men|Completed||N/A|14|Actual|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-10 23:05:25.160604|2017-10-10 23:05:25.160604
NCT02509936|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-12-03|||August 2015||2015-08-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children|Crowd Funding and Social Networks as a Novel Mechanism to Promote Sustainable Physical Growth and Positive Psychosocial and Neurodevelopmental Outcomes in Severely Stunted Guatemalan Children|Completed||N/A|324|Actual|Wuqu' Kawoq, Maya Health Alliance||2|||f||||f||||||||||2017-10-10 23:05:25.398511|2017-10-10 23:05:25.398511
NCT02509923|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-09-21|||July 2015||2015-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects|A Randomized, Open-label, Crossover, Pharmacokinetic and Pharmacodynamic Study of Z-215 Compared With Rabeprazole Sodium in Healthy Male Subjects|Completed||Phase 1|54|Actual|Zeria Pharmaceutical||3|||f||||f||||||||||2017-10-10 23:05:25.548741|2017-10-10 23:05:25.548741
NCT02509910|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-25|||July 2013||2013-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Implementation of a GDT Algorithm for Major Surgery Patients|Implementation and Effects of Pulse-contour-automated SVV/CI Guided Goal Directed Fluid Therapy Algorithm for the Routine Management of Major Abdominal Surgery Patients|Completed||N/A|300|Actual|Philipps University Marburg Medical Center|||2||f||||f||||||||||2017-10-10 23:05:25.680948|2017-10-10 23:05:25.680948
NCT02509897|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-09-13|||July 2015||2015-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|MS_EPOXI||Normobaric Hypoxic Training and Multiple Sclerosis|Cardiorespiratory, Metabolic and Immunoregulatory Response to Hypoxia in Multiple Sclerosis Patients: A Pilot Study|Active, not recruiting||N/A|39|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:05:25.810546|2017-10-10 23:05:25.810546
NCT02509884|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-27|||January 1992||1992-01-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|||Long-term Results of Comprehensive AE Management|Comprehensive Diagnosis and Treatment of Alveolar Echinococcosis : A Single-center, Longterm Observational Study of 312 Patients in Germany|Completed||N/A|312|Actual|University of Ulm|||1||f||||f||||||||||2017-10-10 23:05:25.926248|2017-10-10 23:05:25.926248
NCT02509871|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-12-13|||July 2015||2015-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|MetaCa2||Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)|Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer|Completed||N/A|33|Actual|Centre Jean Perrin||1|||f||||f||||||||||2017-10-10 23:05:26.024796|2017-10-10 23:05:26.024796
NCT02509858|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-26|2015-07-27|||February 2009||2009-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|February 2014|Actual|2014-02-01||Interventional|||The Effect of Administration of Small Doses of Thyroxine on Glucose and Lipid Metabolism, in Type 2 Diabetes Mellitus.|The Effect of Administration of Small Doses of Thyroxine on Glucose and Lipid Metabolism, at All Stages of Type 2 Diabetes Mellitus.|Completed||N/A|33|Actual|Attikon Hospital||3|||f||||f||||||||||2017-10-10 23:05:26.131344|2017-10-10 23:05:26.131344
NCT02509845|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-03-21||2017-03-21|July 2015||2015-07-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects|Completed||Phase 2|64|Actual|C3 Jian, LLC||3|||f||||f||||||||||2017-10-10 23:05:26.271715|2017-10-10 23:05:26.271715
NCT02509832|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-06-06|||July 2015||2015-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|March 2017|Actual|2017-03-01||Interventional|||COOL AMI EU Pilot Trial to Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction|COOL-AMI EU PILOT TRIAL: A Multicenter, Prospective, Randomized Controlled Trial To Assess Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With ACUTE MYOCARDIAL INFARCTION|Active, not recruiting||N/A|130|Anticipated|ZOLL Circulation, Inc., USA||2|||f||||t||||||||Undecided||2017-10-10 23:05:26.39332|2017-10-10 23:05:26.39332
NCT02509819|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-27|2017-02-16|||July 2015||2015-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Influence of Heel Wedge Properties on Roll-over of the Intrepid Dynamic Exoskeletal Orthosis (IDEO)|The Influence of Heel Wedge Properties on Roll-over of the Intrepid Dynamic Exoskeletal Orthosis (IDEO)|Recruiting||N/A|30|Anticipated|Brooke Army Medical Center||1|||f||||f||||||||||2017-10-10 23:05:26.536862|2017-10-10 23:05:26.536862
NCT02509793|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-08-09|||April 2014||2014-04-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)|A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)|Recruiting||Phase 4|20|Anticipated|The Methodist Hospital System||1|||f||||f|t|f|||f|||||2017-10-10 23:05:26.758672|2017-10-10 23:05:26.758672
NCT02509780|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Mineral Water of Vichy and the Urinary Alkalization: A Study of the Dose - Effect of Bicarbonate Salt Water on the Urinary pH in Healthy Volunteers|The Mineral Water of Vichy and the Urinary Alkalization: A Study of the Dose - Effect of Bicarbonate Salt Water on the Urinary pH in Healthy Volunteers|Completed||N/A|20|Actual|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 23:05:26.873369|2017-10-10 23:05:26.873369
NCT02509767|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-25|2017-05-01|||August 2015|Actual|2015-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|DSAS||Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood|Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood|Active, not recruiting||Phase 4|400|Actual|Planned Parenthood Federation of America||2|||f||||f||||||||||2017-10-10 23:05:26.981893|2017-10-10 23:05:26.981893
NCT02508272|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-22|||December 2009||2009-12-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|March 2012|Actual|2012-03-01||Observational|||Transcriptomic Profiling in Severely Injured Patients|Transcriptomic Profiling in Severely Injured Patients|Completed||N/A|115|Actual|University of Zurich|||1||f||||f||||||Samples Without DNA|"     total RNA. Serum, Plasma   "|||2017-10-10 23:05:41.834446|2017-10-10 23:05:41.834446
NCT02509754|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-12-02|||January 2016||2016-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|AFARC-LVF||Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function|Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Recently Diagnosed Impaired Left Ventricular Function: a Multicenter, Randomized Controlled Trial|Not yet recruiting||Phase 4|180|Anticipated|University of Turin, Italy||2|||f||||t||||||||||2017-10-10 23:05:27.085344|2017-10-10 23:05:27.085344
NCT02509741|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-27|||December 2013||2013-12-01|July 2015|2015-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Nutrition and Lifestyles on Obesity and Chronic Disease in China|Effect of Nutrition and Lifestyles on Obesity and Chronic Disease in China|Recruiting||N/A|1000|Anticipated|Chinese PLA General Hospital||4|||f||||t||||||||||2017-10-10 23:05:27.207593|2017-10-10 23:05:27.207593
NCT02509728|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-05-11|||July 2015||2015-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants|Nahrungsergänzung Mit Cholin- Und Docosahexaensäure Bei Sehr Unreifen Frühgeborenen|Recruiting||N/A|40|Anticipated|University Hospital Tuebingen||4|||f||||f||||||||||2017-10-10 23:05:27.320781|2017-10-10 23:05:27.320781
NCT02509715|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2015-08-04|||August 2015||2015-08-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|September 2015|Anticipated|2015-09-01||Interventional|||Effect of Intraoperative Nerve Monitoring on Voice Quality During Thyroid Surgery|Effect of Intraoperative Nerve Monitoring on Voice Quality During Thyroid Surgery|Unknown status|Not yet recruiting|N/A|100|Anticipated|Lütfiye Nuri Burat Government Hospital||2|||f||||f||||||||||2017-10-10 23:05:27.430681|2017-10-10 23:05:27.430681
NCT02509702|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-03-10|||August 2015||2015-08-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Connected to Care: Use of Mobile Short Message Services to Improve HPV Care|Connected to Care: Use of Mobile Short Message Services to Improve HPV Care - A Randomised Control Trial Among HPV-positive Tanzanian Women|Recruiting||N/A|950|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:05:27.531538|2017-10-10 23:05:27.531538
NCT02509689|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-06-19|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|GZNT||Neurofeedback Technology (GZNT) for Persistent Post-Concussive Symptoms in Soldiers|Feasibility Study of a Novel Neurofeedback Technology (GZNT) for Persistent Post-Concussive Symptoms in Soldiers|Active, not recruiting||N/A|172|Actual|The Defense and Veterans Brain Injury Center||1|||f||||f||||||||||2017-10-10 23:05:27.627505|2017-10-10 23:05:27.627505
NCT02509676|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-11-07|||June 2015||2015-06-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Dynamic Stretching Training and Muscle Tendon Unit|Effects of Dynamic Stretching Exercise Training on Muscle Tendon Unit|Completed||N/A|28|Actual|Tokat Gaziosmanpasa University||2|||f||||f||||||||||2017-10-10 23:05:27.753181|2017-10-10 23:05:27.753181
NCT02509663|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-11-25|||December 2015||2015-12-01|July 2015|2015-07-01||||September 2017|Anticipated|2017-09-01||Interventional|SIBA||Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons|Medico-economic Evaluation of the Balloon Sinuplasty as Mini-invasive Treatment of Frontal Sinusitis by a Randomized Multicenter Prospective Trial|Unknown status|Not yet recruiting|N/A|140|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:05:27.836988|2017-10-10 23:05:27.836988
NCT02509650|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-10-07|||September 2015||2015-09-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|DERMA-SEQ||Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing|Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing|Recruiting||N/A|25|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 23:05:27.920113|2017-10-10 23:05:27.920113
NCT02509637|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-02-21|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Acute Effects of a Flutter Device and Chest Wall Compression on Respiratory System Impedance in Bronchiectasis Patients|Acute Effects of a Flutter Device and Chest Wall Compression on Respiratory System Impedance in Bronchiectasis Patients|Completed||N/A|40|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 23:05:28.000061|2017-10-10 23:05:28.000061
NCT02509624|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-12-21|||August 2015||2015-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics of GS-4997 in Adults With Normal and Impaired Hepatic Function|A Phase 1, Open-Label, Parallel-Group, Single Dose Study to Evaluate the Pharmacokinetics of GS-4997 in Subjects With Normal and Impaired Hepatic Function|Completed||Phase 1|60|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-10 23:05:28.099564|2017-10-10 23:05:28.099564
NCT02509611|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-06-28|||August 2015||2015-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HYPD||Effects of Yoga on Parkinson's Disease|Effects of Yoga on Redox Status, Motor Function and Psychosocial Well-being in Individuals With Parkinson's Disease|Active, not recruiting||N/A|20|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 23:05:28.190555|2017-10-10 23:05:28.190555
NCT02509585|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-09-21|||January 2016||2016-01-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection|A Prospective, Open-Label Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection|Recruiting||Phase 2|40|Anticipated|Cardinal Health 414, LLC||1|||f||||f||||||||||2017-10-10 23:05:28.397568|2017-10-10 23:05:28.397568
NCT02509559|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-23|||October 2013||2013-10-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional|BBEmoMem_G||Effects of Propranolol (vs. Placebo) on Information Processing During Presentation of Emotionally Arousing Pictures|Effects of Propranolol (vs. Placebo) on Information Processing During Presentation of Emotionally Arousing Pictures After Single Dose (80 mg) Administration and Relationships Between ß1- and ß2-adrenoreceptors Genotype and Both the Information Processing and the Propranolol Effects in 64 Healthy Male Subjects|Completed||Phase 1|8|Actual|University Medicine Greifswald||2|||f||||t||||||||||2017-10-10 23:05:30.370577|2017-10-10 23:05:30.370577
NCT02509546|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-05-11|||September 2, 2015|Actual|2015-09-02|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||8-Chloro-Adenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase I/II Trial of 8-Chloro-Adenosine in Relapsed or Refractory Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|43|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:05:30.493478|2017-10-10 23:05:30.493478
NCT02509533|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-27|||September 2010||2010-09-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|||Comparison of the Use of VAC System in Transplants of Leg Ulcers Versus Usual Dressing Method|Comparison of the Use of VAC (Vacuum Assisted Closure) System in Transplants of Leg Ulcers Versus Usual Dressing Method. A Monocentric, Prospective, Randomized, Parallel Groups Study|Terminated||N/A|36|Actual|Centre Hospitalier Universitaire de Saint Etienne||2||difficulties to recruit patients.|f||||f||||||||||2017-10-10 23:05:30.596569|2017-10-10 23:05:30.596569
NCT02509520|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-08-25|||May 2015||2015-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|ExPrEs||Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes|Rehabilitation, NMES and High Protein to Reduce Post ICU Syndrome in the Elderly|Recruiting||N/A|60|Anticipated|University of Maryland||4|||f||||t||||||||||2017-10-10 23:05:30.681149|2017-10-10 23:05:30.681149
NCT02509507|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-06-27|||February 5, 2016|Actual|2016-02-05|June 2017|2017-06-01|February 14, 2023|Anticipated|2023-02-14|September 7, 2021|Anticipated|2021-09-07||Interventional|||Safety Study of Talimogene Laheraprepvec Injected Into Hepatocellular Carcinoma and Metastatic Liver Tumors|A Phase 1, Multicenter, Open-label Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Liver Tumors|Recruiting||Phase 1|100|Anticipated|Amgen||1|||f||||f||||||||||2017-10-10 23:05:30.780532|2017-10-10 23:05:30.780532
NCT02509481|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-08-22|||June 2015||2015-06-01|July 2015|2015-07-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|RIMDAMAL||Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study|Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study|Completed||Phase 2/Phase 3|2712|Actual|Colorado State University||2|||f||||f||||||||||2017-10-10 23:05:30.998875|2017-10-10 23:05:30.998875
NCT02509468|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-02-23|||September 30, 2015|Actual|2015-09-30|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PERFORMUS||suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS|Treatment of Superficial Voluminous Complicated Slow-flow Vascular Malformations With Sirolimus: a Phase 2 Trial in Children Observational-phase Designed|Recruiting||Phase 2|50|Anticipated|University Hospital, Tours||2|||f||||t||||||||||2017-10-10 23:05:31.104482|2017-10-10 23:05:31.104482
NCT02509455|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Balance Measures During Stance and Gait: Comparison of Gyroscopic Measurements of Trunk Sway|Quantified Balance Measures During Stance and Gait: Comparison of a New Micro-mechanical Gyro-system (Sensoro Von Hocoma AG) With SwayStar (Balance Int. Innov.) for Measurements of Balance Control of Healthy Controls.|Recruiting||N/A|300|Anticipated|University Hospital, Basel, Switzerland|||2||f||||t||||||||||2017-10-10 23:05:31.366761|2017-10-10 23:05:31.366761
NCT02509442|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-12-21|||July 2015||2015-07-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|PE&CE||Measure of the Potential Evoked by Electric Stimulation|Pilot Study: Measure of the Potential Evoked With Electroencephalography and Electrocorticography by Electric Stimulation of the Brain During the Neurosurgery Awakened of the Infiltrative Glioma of Low Grade (OMS Type II)|Recruiting||N/A|12|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:05:31.454649|2017-10-10 23:05:31.454649
NCT02509429|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-23|||June 2015||2015-06-01|July 2015|2015-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SHAN||Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic Children|Assessment of the Efficacy on the Reduction of Nocturnal Hypoglycemia in Children With Type 1 Diabetes of a Closed-loop Insulin Therapy (Artificial Pancreas) Compared to Insulin Pump Therapy Combined With Continuous Glucose Monitoring With Threshold Low Glucose Suspend of Infusion in Home-like Conditions|Unknown status|Recruiting|Phase 2|24|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:05:31.581072|2017-10-10 23:05:31.581072
NCT02509416|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-03-17|||July 2015||2015-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|RATES 2||Rapid Assessment of Trainee Endoscopy Skills (RATES) Study Two|Rapid Assessment of Trainee Endoscopy Skills (RATES) Study Two: A Prospective Multicenter Study Evaluating Competence in Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatogram Among Advanced Endoscopy Trainees|Enrolling by invitation||N/A|43|Anticipated|University of Colorado, Denver|||1||f||||f|f|f||||||||2017-10-10 23:05:31.71107|2017-10-10 23:05:31.71107
NCT02509403|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-05-08|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|WIPEAWAY||An Open-label Trial to Evaluate the Safety of an Essential Oil Infused Perineal Towel|An Open-label Trial to Evaluate the Safety of an Essential Oil Infused Perineal Towel - WIPEAWAY|Suspended||Phase 1|200|Anticipated|University of Alberta||1||The company responsible for funding has filed for bankruptcy|f||||f|f|f||||||||2017-10-10 23:05:31.805519|2017-10-10 23:05:31.805519
NCT02509390|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-07-27|||September 2014||2014-09-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Hyperfibrinogenemia After Major Trauma|Hyperfibrinogenemia Within the First Days After Major Trauma : Kinetic, Functionality, Impact of Fibrinogen Replacement Therapy and Trauma, Thrombosis Risk|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:05:31.913973|2017-10-10 23:05:31.913973
NCT02509377|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-06-12|||July 2015||2015-07-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|MOMSto40BMI||Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0|Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0|Terminated||N/A|1|Actual|St. Louis University||1|||f||||f||||||||||2017-10-10 23:05:32.034732|2017-10-10 23:05:32.034732
NCT02509364|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-24|||August 2015||2015-08-01|July 2015|2015-07-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Observational|||Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)||Unknown status|Enrolling by invitation|N/A|300|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China|||3||f||||||||||Samples With DNA|"     Sputum, throat swab, BALF and blood will be collected in this study.   "|||2017-10-10 23:05:32.147842|2017-10-10 23:05:32.147842
NCT02509351|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-11-09|||October 2015||2015-10-01|May 2016|2016-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?|Randomized, Placebo-controlled Double Blind Study of Preoperative Misorostol for Reduction of Intraoperative Bleeding in Women Delivered by Ceserean Section|Completed||Phase 2/Phase 3|280|Actual|Ain Shams University||2|||f||||t||||||||No||2017-10-10 23:05:32.259016|2017-10-10 23:05:32.259016
NCT02509338|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-27|||October 2013||2013-10-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|MONOCONTACT||Validation of the Implantation of a New Electrode for the Treatment of Dystonia|Validation of an Electrode Internal Globus Pallidum Deep Brain Stimulation Lead Implantation for Treatment of Dystonia|Unknown status|Recruiting|N/A|7|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:05:32.353575|2017-10-10 23:05:32.353575
NCT02509325|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-06-08|||July 2015||2015-07-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|KITE||Parkinson's KinetiGraph as Tool for DBS Eligibility Assessment|Evaluation of the Parkinson's KinetiGraph Data Logger (PKG) as a Tool to Measure Motor Fluctuations and Support the DBS Eligibility Assessment of Parkinson's Disease Patients.|Completed||N/A|38|Actual|Medtronic Bakken Research Center|||1||f||||f||||||||||2017-10-10 23:05:32.454056|2017-10-10 23:05:32.454056
NCT02509312|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-05-01|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Prospective Effect of Intravenous Ketorolac on Opioid Use and Complications Following Cesarean Delivery|A Prospective, Randomized, Control Trial of Ketorolac Versus Placebo on Opioid Analgesic Use and Complications Following Cesarean Delivery With Intra-Epidural Morphine|Recruiting||Phase 4|80|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t|t|f||||||No||2017-10-10 23:05:32.536559|2017-10-10 23:05:32.536559
NCT02509299|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2016-10-30|||September 2015||2015-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Physiotherapy on Perceived Health Status in Hospitalized COPD Patients|Effect of Different Physiotherapy Treatments on Perceived Health Status in Hospitalized COPD Patients|Completed||N/A|90|Actual|Universidad de Granada||3|||f||||t||||||||Undecided||2017-10-10 23:05:32.65533|2017-10-10 23:05:32.65533
NCT02509286|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-04-12|||January 2016||2016-01-01|April 2017|2017-04-01|June 2023|Anticipated|2023-06-01|January 2022|Anticipated|2022-01-01||Interventional|ESOPEC||Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus|Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus|Recruiting||Phase 3|438|Anticipated|University Hospital Freiburg||2|||f||||t||||||||||2017-10-10 23:05:32.748665|2017-10-10 23:05:32.748665
NCT02509273|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-07-29|||May 2016||2016-05-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|CloSed1||Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients|A Double Blind, Randomised, Multicentre, Active Controlled, Parallel-group, Phase III Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of Intravenous Clonidine (Hydrochloride) Compared to Midazolam for Sedation in Children From Birth to Less Than 18 Years of Age|Recruiting||Phase 3|300|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||Undecided||2017-10-10 23:05:32.935286|2017-10-10 23:05:32.935286
NCT02509260|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prevena™ Incisional Negative Pressure Wound Therapy in Re-operative Colorectal Surgery|A Randomized Controlled Trial of Prevena™ Incisional Negative Pressure Wound Therapy to Reduce Surgical Site Infection in Re-operative Colorectal Surgery|Recruiting||N/A|298|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 23:05:33.158113|2017-10-10 23:05:33.158113
NCT02509247|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-07-23|||August 2012||2012-08-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|TeleCPAP||Telemonitoring in CPAP Treatment|Telemonitoring in CPAP Treatment|Completed||N/A|111|Actual|Turku University Hospital||2|||f||||f||||||||||2017-10-10 23:05:33.270071|2017-10-10 23:05:33.270071
NCT02509234|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-24|||February 2014||2014-02-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|TrIPReSarc||Trabectedin and Irinotecan for Refractory Pediatric Sarcomas|Trabectedin and Irinotecan in Pediatric Refractory Sarcomas|Unknown status|Active, not recruiting|N/A|30|Anticipated|Technische Universität München|||1||f||||f||||||||||2017-10-10 23:05:33.367933|2017-10-10 23:05:33.367933
NCT02509221|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-23|||July 2015||2015-07-01|July 2015|2015-07-01||||May 2016|Anticipated|2016-05-01||Observational|||Effect of Duration of Exposure of Anesthesia With Sevoflurane on Emergence Delirium||Unknown status|Recruiting|N/A|114|Anticipated|State University of New York - Upstate Medical University|||3||f||||||||||||||2017-10-10 23:05:33.449055|2017-10-10 23:05:33.449055
NCT02509208|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-04-25|||July 2015||2015-07-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Assess the Safety and Performance of SurgiClot® in the Treatment of Cancellous Bone Bleeding|A Multicenter Study to Assess the Safety and Performance of SurgiClot® in the Treatment of Cancellous Bone Bleeding|Completed||N/A|30|Actual|St. Teresa Medical||1|||f||||f||||||||||2017-10-10 23:05:33.534238|2017-10-10 23:05:33.534238
NCT02509195|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-06-09|||July 2015||2015-07-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|February 13, 2017|Actual|2017-02-13||Interventional|||SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over|An Open Label Study to Investigate the Safety and Efficacy of Abacavir/Lamivudine/Dolutegravir and the Pharmacokinetic Profile of Dolutegravir in HIV-infected Patients of 60 Years of Age and Older|Active, not recruiting||Phase 4|40|Anticipated|St Stephens Aids Trust||1|||f||||||||||||||2017-10-10 23:05:33.653889|2017-10-10 23:05:33.653889
NCT02509182|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-08-23|||December 2016||2016-12-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Decreasing the Inspired Oxygen Concentration on Post-Operative Oxygenation After Primary Lobectomy|The Effect of Decreasing the Inspired Oxygen Concentration on Post-Operative Oxygenation After Primary Lobectomy: A Randomized Controlled Trial|Not yet recruiting||Phase 4|200|Anticipated|Yale University||2|||f||||t||||||||||2017-10-10 23:05:33.760162|2017-10-10 23:05:33.760162
NCT02509169|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-07-23|||October 2014||2014-10-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma|Trans-catheter Arterial p53-gene-embolization Using Gelatin Sponge Particles in Treatment of Patients With Advanced Hepatocellular Carcinoma: A Phase II Study|Unknown status|Recruiting|Phase 2|60|Anticipated|Shenzhen SiBiono GeneTech Co.,Ltd||2|||f||||f||||||||||2017-10-10 23:05:33.87866|2017-10-10 23:05:33.87866
NCT02509156|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-08-23|||August 2016||2016-08-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|SENECA||Stem Cell Injection in Cancer Survivors|A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy|Recruiting||Phase 1|36|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-10 23:05:33.992677|2017-10-10 23:05:33.992677
NCT02509143|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-03-07|||July 2015||2015-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|AcuPONV||Acupuncture for Postoperative Nausea and Vomiting in Patients Undergoing Colorectal Surgery|High-dose Acupuncture for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Colorectal Surgery: A Randomized Controlled Pilot Study|Completed||N/A|60|Actual|Pusan National University Yangsan Hospital||3|||f||||f||||||||||2017-10-10 23:05:34.200799|2017-10-10 23:05:34.200799
NCT02509130|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-09-26|||June 2015||2015-06-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|MISSION||MISSION Severe Asthma Modern Innovative Solutions to Improve Outcomes in Severe Asthma.|MISSION Severe Asthma: Modern Innovative Solutions to Improve Outcomes in Severe Asthma. A Mixed Methods Observational Comparison of Clinical Outcomes in MISSION Versus Current Care Delivery.|Completed||N/A|92|Actual|Portsmouth Hospitals NHS Trust|||4||f||||f||||||||||2017-10-10 23:05:34.377777|2017-10-10 23:05:34.377777
NCT02509104|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-05-12|||July 30, 2015|Actual|2015-07-30|May 2017|2017-05-01|October 10, 2015|Actual|2015-10-10|October 10, 2015|Actual|2015-10-10||Interventional|||Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects|An Open-label, Randomized, Single Dose, Two-way Crossover Study to Determine the Bioavailability of One Fixed Dose Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5 mg/0.2 mg) Relative to Coadministration of One Dutasteride 0.5 mg Capsule and One Tamsulosin Hydrochloride 0.2 mg Tablet in Healthy Male Subjects in the Fed and Fasted States|Completed||Phase 1|56|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:05:34.692307|2017-10-10 23:05:34.692307
NCT02509091|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-05-13|||December 2014||2014-12-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis|Clinical Efficacy and Safety of Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis:An Open-label Randomized Parallel Controlled Study|Recruiting||Phase 4|100|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||t||||||||Undecided||2017-10-10 23:05:34.832684|2017-10-10 23:05:34.832684
NCT02509078|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2017-05-23|||December 2015||2015-12-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|ROSE||Reevaluation Of Systemic Early Neuromuscular Blockade|Reevaluation Of Systemic Early Neuromuscular Blockade|Recruiting||Phase 3|1408|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||Yes|Data will be collected electronically and stored at the Clinical Coordinating Center at MGH. A de-identified database of all data will be available for use 3 years after the primary publication. Data can be accessed at that point via the NHLBI BioLINCC data repository.|2017-10-10 23:05:34.968683|2017-10-10 23:05:34.968683
NCT02509065|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-08-24|||August 2015||2015-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance|The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance|Recruiting||N/A|132|Anticipated|Massachusetts General Hospital||10|||f||||t||||||||||2017-10-10 23:05:35.223757|2017-10-10 23:05:35.223757
NCT02509052|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-05-31|||November 2, 2015|Actual|2015-11-02|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase I/II Dose-Escalation Trial of Leflunomide in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|39|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:05:35.354235|2017-10-10 23:05:35.354235
NCT02508857|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-07-24|||January 2010||2010-01-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Magnesium||Magnesium Sulfate Improves Postoperative Analgesia in Laparoscopic Gynecologic Surgeries|Magnesium Sulfate Improves Postoperative Analgesia in Laparoscopic Gynecologic Surgeries: a Double-blind Randomized Controlled Trial.|Completed||Phase 4|60|Actual|Instituto do Cancer do Estado de São Paulo||3|||f||||t||||||||||2017-10-10 23:05:37.127348|2017-10-10 23:05:37.127348
NCT02509039|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-11-01|||August 2015||2015-08-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL)|A Phase 1, Multi-center, Open-label Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of CC-122 Administered Orally to Adult Japanese Subjects With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|Recruiting||Phase 1|15|Anticipated|Celgene Corporation||1|||f||||||||||||||2017-10-10 23:05:35.451521|2017-10-10 23:05:35.451521
NCT02509026|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-09-27|||September 24, 2015|Actual|2015-09-24|September 2017|2017-09-01|November 4, 2019|Anticipated|2019-11-04|July 18, 2019|Anticipated|2019-07-18||Interventional|RE-EMBARK||Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA|A Multicenter Open-label Study Of Etanercept Withdrawal And Retreatment In Subjects With Non-radiographic Axial Spondyloarthritis Who Achieved Adequate 24 Week Response|Recruiting||Phase 4|200|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 23:05:35.55458|2017-10-10 23:05:35.55458
NCT02509013|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-06-20|||August 2015||2015-08-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|||Prevalence of Chronic Kidney Disease and Its Association With Clinical Outcome in Patients With Coronary Heart Disease|Prevalence of Chronic Kidney Disease and Its Association With Clinical Outcome in Patients With Coronary Heart Disease: a Prospective, Multi-center, Hospital-based Study|Recruiting||N/A|10000|Anticipated|Peking University First Hospital|||1||f||||f||||||||No||2017-10-10 23:05:35.925012|2017-10-10 23:05:35.925012
NCT02509000|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-10-20|||December 2013||2013-12-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01||Interventional|BIAPSY||Beijing Indoor Air Purifier Intervention Study|Beijing Indoor Air Purifier Intervention Study|Completed||N/A|35|Actual|Peking University||2|||f||||||||||||||2017-10-10 23:05:36.037305|2017-10-10 23:05:36.037305
NCT02508987|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-23|||September 2012||2012-09-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Obesity and Oxidative Stress in Patients With Different Periodontal Status|Obesity and Oxidative Stress in Patients With Different Periodontal Status: A Cross-sectional Study|Completed||N/A|93|Actual|Ondokuz Mayıs University|||6||f||||t||||||Samples Without DNA|"     gingival crevicular fluid   "|||2017-10-10 23:05:36.115077|2017-10-10 23:05:36.115077
NCT02508974|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-07-24|||January 2015||2015-01-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Prevalence of Hospital Malnutrition in Adult Patients|Prevalence and Impact of Hospital Malnutrition on Associated Outcomes|Unknown status|Recruiting|N/A|1100|Anticipated|University of Stellenbosch|||1||f||||f||||||||||2017-10-10 23:05:36.203563|2017-10-10 23:05:36.203563
NCT02508961|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-05-30|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|WEB-PaMS||WEB-Based Physiotherapy for People With Multiple Sclerosis|WEB-Based Physiotherapy for People With Multiple Sclerosis|Completed||N/A|90|Actual|University of Glasgow||2|||f||||f||||||||||2017-10-10 23:05:36.294182|2017-10-10 23:05:36.294182
NCT02508948|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-08-28|||August 2015||2015-08-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|28 Days|Observational [Patient Registry]|HEMAIR||Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study|Current State of Endotracheal Intubation Among the Critically Ill and Exploring Risk Factors for Immediate Complications of Endotracheal Intubation: a Prospective, Observational Multi-center Study (HEMAIR)|Active, not recruiting||N/A|1200|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-10 23:05:36.405265|2017-10-10 23:05:36.405265
NCT02508935|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-07-13|||June 2015||2015-06-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||PK and Safety Study of XARTEMIS® XR (7.5 mg Oxycodone HCl/325 mg APAP) in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain|A Phase 4, Open-Label Study of the Pharmacokinetics and Safety of XARTEMIS® XR (7.5 Oxycodone Hydrochloride/325 mg Acetaminophen) in Postsurgical Adolescent Subjects (Ages 12 to 17) With Moderate to Severe Acute Pain|Recruiting||Phase 4|60|Anticipated|Mallinckrodt||1|||f||||f||||||||||2017-10-10 23:05:36.513063|2017-10-10 23:05:36.513063
NCT02508922|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-10-24|||September 2015||2015-09-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Trial of Vitamin D3 Supplementation in Paediatric Autism|Vitamin D3 for Autism Spectrum Disorder: a Randomized, Double-blind, Placebo-controlled Trial.|Completed||N/A|42|Actual|University of Dublin, Trinity College||2|||f||||f||||||||||2017-10-10 23:05:36.606561|2017-10-10 23:05:36.606561
NCT02508909|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-23|||September 2011||2011-09-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Videoscopic Ilioinguinal Lymphadenectomy for Melanoma|Videoscopic Ilioinguinal Lymphadenectomy for Groin Lymph Node Metastases From Melanoma|Completed||N/A|23|Actual|Istituto Oncologico Veneto IRCCS||1|||f||||f||||||||||2017-10-10 23:05:36.718667|2017-10-10 23:05:36.718667
NCT02508896|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-24|2016-09-09|||July 2015||2015-07-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|May 2016|Actual|2016-05-01||Interventional|AFF012||Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects|A Single-blind Phase 1 Study Assessing the Safety, Immunogenicity and Low Density Lipoprotein Cholesterol (LDLc)-Lowering Activity of 2 Different Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Targeting AFFITOPE® Vaccines in Healthy Subjects|Active, not recruiting||Phase 1|72|Actual|Affiris AG||3|||f||||t||||||||||2017-10-10 23:05:36.808513|2017-10-10 23:05:36.808513
NCT02508883|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-10-05|||April 2015||2015-04-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Evaluation of Prognostic Scores in Patients With Upper Gastrointestinal Bleeding and Cancer|Comparison Among the Scores of Glasgow-Blacthford, Rockall and AIMS65 for the Prediction of Rebleeding and Mortality in Patients With Cancer and Upper Gastrointestinal Bleeding|Completed||N/A|243|Actual|Instituto do Cancer do Estado de São Paulo|||1||f||||t||||||||||2017-10-10 23:05:36.909629|2017-10-10 23:05:36.909629
NCT02508844|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-08-12|||April 2015||2015-04-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|POP||Effect of Probiotics (Vivomixx®) on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn|The POP-study: Effect of Probiotics on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn - a Randomized, Double-blind Placebo Controlled Trial With Vivomixx®|Recruiting||Phase 4|50|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-10 23:05:37.217854|2017-10-10 23:05:37.217854
NCT02508831|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-08-26|||July 2016||2016-07-01|August 2016|2016-08-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|DAMIE||Double Upper Limb Allograft: Intervention and Clinical Evaluation. A Pilot Study of 5 Cases|Double Upper Limb Allograft: Intervention and Clinical Evaluation. A Pilot Study of 5 Cases|Recruiting||N/A|5|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-10 23:05:37.309967|2017-10-10 23:05:37.309967
NCT02508818|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-23|||June 2011||2011-06-01|July 2015|2015-07-01||||November 2015|Anticipated|2015-11-01||Interventional|ORB||Cardiovascular Response to Orthostatic Fractional Gravity||Unknown status|Recruiting|N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:05:37.390728|2017-10-10 23:05:37.390728
NCT02508805|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-05-08|||May 2015|Actual|2015-05-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|NMRUS||Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy|Open Randomised Comparative Study of the Efficacy and Safety of Neuromultivit (Solution for Injections, 2 ml) in Patients With Vertebrogenic Radiculopathy|Completed||Phase 3|100|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-10 23:05:37.460535|2017-10-10 23:05:37.460535
NCT02508792|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-08-12|||August 2015||2015-08-01|August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Interventional|||Low Level Laser Therapy in Heart Failure Patients.|Acute Effects of Low Level Laser Therapy in Muscle Function of Patients With Heart Failure.|Unknown status|Recruiting|N/A|20|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||f||||||||||2017-10-10 23:05:37.550546|2017-10-10 23:05:37.550546
NCT02508779|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-10-25|||July 2015||2015-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|Bump2Be||BGAT (Blood Glucose Awareness Training) for Users Who Might Become Pregnant|Blood Glucose Training for Women With Type 1 Diabetes Contemplating Pregnancy|Completed||N/A|54|Actual|University of Virginia||2|||f||||f||||||||||2017-10-10 23:05:37.6361|2017-10-10 23:05:37.6361
NCT02508766|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-08-01|||July 2015||2015-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Effplant||Effect of Stimulating Plant on the Balance in Young Healthy|EFFECT OF MANUAL PLANTAR STIMULATION ON STATIC AND DYNAMIC POSTURAL CONTROL IN YOUNG HEALTHY SUBJECTS|Completed||N/A|184|Actual|University of Valencia||2|||f||||f||||||||||2017-10-10 23:05:37.72051|2017-10-10 23:05:37.72051
NCT02508753|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-17|2017-01-25|||June 2010||2010-06-01|January 2017|2017-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects|A Double-Blind, Double-Dummy, Randomized, Moxifloxacin and Placebo Controlled, Four-Way Crossover Study of the Effects of a Single Intravenous Supra-Therapeutic Dose and Single Intravenous Therapeutic Dose of CXA-101/Tazobactam on the QT/QTC Intervals in Healthy Subjects|Completed||Phase 1|52|Actual|Cubist Pharmaceuticals LLC||4|||f||||t||||||||||2017-10-10 23:05:37.798238|2017-10-10 23:05:37.798238
NCT02508740|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-23|||September 2013||2013-09-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment|Phase 1, Non-Randomized, Parallel-Group, Open-Label Study to Characterize the Pharmacokinetics of a Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment Compared to Healthy Subjects|Terminated||Phase 1|31|Actual|Cubist Pharmaceuticals LLC||5||Development of compound has been put on hold.|f||||f||||||||||2017-10-10 23:05:37.894885|2017-10-10 23:05:37.894885
NCT02508727|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-23|||March 2012||2012-03-01|July 2015|2015-07-01||||December 2015|Anticipated|2015-12-01||Interventional|DIRECT||Myocardial Deformation in Real-time 3D Ultrasound. Normal Values in Adults and Validation Against the Tagged MRI||Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Caen||3|||f||||f||||||||||2017-10-10 23:05:37.977876|2017-10-10 23:05:37.977876
NCT02508714|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-02-02|||October 7, 2016|Actual|2016-10-07|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|BIONYX||Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents|Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX): A Randomized Trial With Stent Evaluation in All-comers IV (TWENTE IV)|Active, not recruiting||N/A|2470|Actual|Thorax Centrum Twente||2|||f||||t|f|f||||||Undecided||2017-10-10 23:05:38.06417|2017-10-10 23:05:38.06417
NCT02508688|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-27|||January 2005||2005-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax|Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax: 10 Years' Experience From a Single Large-volume Center|Completed||N/A|63|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-10 23:05:38.248192|2017-10-10 23:05:38.248192
NCT02508675|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-08-25|||August 2015||2015-08-01|August 2015|2015-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|2 Years|Observational [Patient Registry]|βioς||Non-fatal Outcome After Trauma|Prevalence, Recovery Patterns and Risk Factors of Non-fatal Outcome and Costs After Trauma; a Prospective Follow up Study|Enrolling by invitation||N/A|6500|Anticipated|Network Emergency Care Brabant|||1||f||||f||||||||||2017-10-10 23:05:38.325592|2017-10-10 23:05:38.325592
NCT02508662|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-03-17|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Observational|||Registry Study for Personalized Cancer Therapy|Registry Study for Personalized Cancer Therapy|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     Blood (about 4 teaspoons) drawn to check for any genetic mutations.   "|||2017-10-10 23:05:38.39389|2017-10-10 23:05:38.39389
NCT02508636|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-11-01|||August 2015||2015-08-01|November 2016|2016-11-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate|Phase II Trial of Definitive Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer|Recruiting||Phase 2|53|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:05:38.579582|2017-10-10 23:05:38.579582
NCT02508623|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-27|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|ERASE||Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices|"Effect of Administration Add on of Rifaximin on Portal Hypertension of Patients With Liver Cirrhosis and Esophageal Varices in Standard Therapy With Propranolol"|Unknown status|Recruiting|Phase 3|60|Anticipated|University of Padua||2|||f||||f||||||||||2017-10-10 23:05:38.792812|2017-10-10 23:05:38.792812
NCT02508610|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2016-05-10|||November 2013||2013-11-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||DNA Sequencing of MDR TB in Eastern Siberia|DNA Sequencing of MDR TB in Eastern Siberia|Recruiting||N/A|630|Anticipated|University of Virginia|||1||f||||f||||||Samples With DNA|"     We will collect and use plasma and sputum specimens. For a minority of subjects,     leftover/discarded specimen may be used.      Specimens will be stored under appropriate refrigeration (-80) at the Irkutsk Oblast     Tuberculosis Dispensary and at UVa, MR6 Building Room 1701A, IBC# 327-05.      Further HPLC analysis of the plasma will be conducted by Charles Peloquin, Pharm.D., FCCP     (University of Florida).   "|||2017-10-10 23:05:38.91632|2017-10-10 23:05:38.91632
NCT02508597|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-07-25|||August 2014||2014-08-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Brief Tobacco Cessation Counselling: Mini Train-the-trainers Program|Brief Tobacco Cessation Counselling: Mini Train-the-trainers Program Among Physicians in Guangdong, China|Recruiting||N/A|120|Anticipated|The University of Hong Kong||1|||f||||t||||||||||2017-10-10 23:05:39.005357|2017-10-10 23:05:39.005357
NCT02508584|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-01-30|||April 12, 2016|Actual|2016-04-12|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Personalized Immunotherapeutic for Antibiotic-resistant Infection|Personalized Immunotherapeutic for Antibiotic-resistant Infection|Enrolling by invitation||Early Phase 1|1|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 23:05:39.104912|2017-10-10 23:05:39.104912
NCT02508558|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-23|||September 2014||2014-09-01|July 2015|2015-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|HopMot||Validation of Methods for Evaluating Operation Force, Motion and Visual Perception in Weightlessness||Recruiting||N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:05:39.319825|2017-10-10 23:05:39.319825
NCT02508545|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-24|||February 2014||2014-02-01|July 2015|2015-07-01||||October 2017|Anticipated|2017-10-01||Interventional|Blindpulling||Influence of Gravity on the Perception of Egocentric Distance (Blindpulling)||Unknown status|Recruiting|N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:05:39.397739|2017-10-10 23:05:39.397739
NCT02508532|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-08-02|||August 2015||2015-08-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|||Phase 1 Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors|A Phase 1 Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors|Recruiting||Phase 1|150|Anticipated|Blueprint Medicines Corporation||1|||f||||f||||||||||2017-10-10 23:05:39.491293|2017-10-10 23:05:39.491293
NCT02508519|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-08-14|||July 2015||2015-07-01|August 2015|2015-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Study of Zonal and Balance Acupuncture Pain Relief Effect|Study of Zonal and Balance Acupuncture Pain Relief Effect|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Bogomolets National Medical University||3|||f||||f||||||||||2017-10-10 23:05:39.619531|2017-10-10 23:05:39.619531
NCT02508506|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-02-03|||July 2015||2015-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function|A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of ALKS5461 in Subjects With Renal Impairment|Completed||Phase 1|22|Actual|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 23:05:39.696999|2017-10-10 23:05:39.696999
NCT02508493|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-09-13|||November 2015||2015-11-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Validation of the THINC-it Tool for Cognitive Dysfunction in Major Depressive Disorder|Validation of the THINC-it Tool for Cognitive Dysfunction in Major Depressive Disorder|Completed||N/A|200|Anticipated|Brain and Cognition Discovery Foundation|||2||f||||f||||||||||2017-10-10 23:05:39.795818|2017-10-10 23:05:39.795818
NCT02508480|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-09-22|||March 5, 2015|Actual|2015-03-05|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Photovoice||Testing Effectiveness of a Peer-Led Intervention to Enhance Community Integration|Testing Effectiveness of a Peer-Led Intervention to Enhance Community Integration|Recruiting||N/A|192|Anticipated|Boston University Charles River Campus||2|||f||||t||||||||||2017-10-10 23:05:39.905005|2017-10-10 23:05:39.905005
NCT02508467|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-02|||July 2015||2015-07-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Interventional|||A Phase 1 Study of BLU-554 in Patients With Hepatocellular Carcinoma|A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BLU-554 in Patients With Hepatocellular Carcinoma|Recruiting||Phase 1|130|Anticipated|Blueprint Medicines Corporation||1|||f||||f||||||||||2017-10-10 23:05:40.016962|2017-10-10 23:05:40.016962
NCT02508454|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-01-30|||August 2014||2014-08-01|January 2017|2017-01-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Observational|MiHEART||The Miami Heart Study at Baptist Health South Florida|The Miami Heart Study at Baptist Health South Florida: A Prospective Study of Sub-Clinical Cardiovascular Disease and Emerging Cardiovascular Risk Factors in Asymptomatic Young & Middle-Aged Adults|Recruiting||N/A|4000|Anticipated|Baptist Health South Florida|||2||f||||f||||||Samples With DNA|"     Approximately 115 mls of blood will be drawn by a Registered Nurse. Blood samples will be     tested for markers of the diseases and health conditions under investigation. These will     include standard markers (cholesterol, blood sugar, etc) and novel markers which are not     commonly evaluated by a physician. Additionally, any remaining blood samples will be stored     and kept for future risk factor evaluation, biomarker testing and genetic studies.      Whole blood and serum will be retained.   "|Undecided||2017-10-10 23:05:40.190601|2017-10-10 23:05:40.190601
NCT02508441|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-02-23|||December 2015||2015-12-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors|A Phase 1 Open-label First-in-human Dose-escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy is Available|Recruiting||Phase 1|91|Anticipated|Andes Biotechnologies||1|||f||||f||||||||No||2017-10-10 23:05:40.290117|2017-10-10 23:05:40.290117
NCT02508415|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-07-24|||February 2013||2013-02-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ROPD||Relationship Between Obesity and Periodontal Disease|Relationship Between Obesity and Periodontal Disease|Completed||N/A|62|Actual|University of Malaya||2|||f||||t||||||||||2017-10-10 23:05:40.493881|2017-10-10 23:05:40.493881
NCT02508402|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-01-29|||September 2015||2015-09-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect Of Intra-muscular Administration of Dexamethasone in Induction of Labour|Effect Of Intra-muscular Administration of Dexamethasone on the Duration of Induction of Labour in Primigravida Post-term Pregnancy.|Unknown status|Active, not recruiting|Phase 4|86|Anticipated|Kasr El Aini Hospital||2|||f||||t||||||||||2017-10-10 23:05:40.580841|2017-10-10 23:05:40.580841
NCT02508389|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-07-11|||October 2015||2015-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + IMRT for Locally Advanced Non-Metastatic SCC of the Oral Cavity/Oropharynx|Recruiting||Phase 2|200|Anticipated|Galera Therapeutics, Inc.||3|||f||||t||||||||||2017-10-10 23:05:40.683183|2017-10-10 23:05:40.683183
NCT02508376|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-09-14|||October 22, 2015|Actual|2015-10-22|April 5, 2017|2017-04-05|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects|A Phase 1, Randomized, Double Blind Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects|Completed||Phase 1|70|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f|||||t|f|||f|||||2017-10-10 23:05:41.076795|2017-10-10 23:05:41.076795
NCT02508363|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-08-01|||July 2015||2015-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Randomized Controlled Trial Examining Health Care Access Interventions for Taxi Drivers|Taxi HAILL: A Three-Arm Cluster Randomized Controlled Trial Examining Health Care Access Interventions for Taxi Drivers|Enrolling by invitation||N/A|900|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-10 23:05:41.181789|2017-10-10 23:05:41.181789
NCT02508350|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2015-07-22|||January 2015||2015-01-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock|The Pharmacokinetics and Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock|Unknown status|Recruiting|N/A|12|Anticipated|Zhongda Hospital||1|||f||||f||||||||||2017-10-10 23:05:41.281928|2017-10-10 23:05:41.281928
NCT02508337|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-01-23||2017-01-23|July 2015||2015-07-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain|A Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Phase III Study of the Efficacy and Safety of a Single Sub-conjunctival Injection of XG-102 for the Reduction of Post-cataract Surgery Intraocular Inflammation|Completed||Phase 3|309|Actual|Xigen SA||2|||f||||f||||||||||2017-10-10 23:05:41.401378|2017-10-10 23:05:41.401378
NCT02508324|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-03-01|||September 10, 2015|Actual|2015-09-10|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia|Parallel Phase II Trial of IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia|Recruiting||Phase 2|40|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 23:05:41.488995|2017-10-10 23:05:41.488995
NCT02508298|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-03-27|||April 2014||2014-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Surrogate Markers of Portal Pressure|Surrogate Markers of Portal Pressure and Changes in Portal Pressure in Patients With Compensated Cirrhosis Undergoing Anti-viral Therapy|Recruiting||N/A|33|Anticipated|VA Connecticut Healthcare System||3|||f||||f||||||||||2017-10-10 23:05:41.722449|2017-10-10 23:05:41.722449
NCT02508246|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-04-28|||July 22, 2015|Actual|2015-07-22|April 2017|2017-04-01||||October 2017|Anticipated|2017-10-01||Interventional|||WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck|A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Prior to Surgery in Squamous Cell Carcinoma of the Head and Neck (HNSCC)|Recruiting||Phase 1|18|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 23:05:42.019053|2017-10-10 23:05:42.019053
NCT02508233|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||September 2009||2009-09-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Cross-cultural Adaptation and Validation of the Ankle Osteoarthritis Scale (AOS) for Use in French-speaking Populations|Cross-cultural Adaptation and Validation of the Ankle Osteoarthritis Scale (AOS) for Use in French-speaking Populations|Completed||N/A|34|Actual|Université de Sherbrooke|||2||f||||f||||||||||2017-10-10 23:05:42.15675|2017-10-10 23:05:42.15675
NCT02508220|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-11-30|||July 2015||2015-07-01|July 2015|2015-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus|Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus|Completed||N/A|15|Actual|University of Regensburg||2|||f||||f||||||||||2017-10-10 23:05:42.219258|2017-10-10 23:05:42.219258
NCT02508207|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-08-08|||February 2016||2016-02-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Phase 2 Study to Evaluate Effects of VX-661/Ivacaftor on Lung and Extrapulmonary Systems in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|A Phase 2, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Exploratory Study to Evaluate Effects of VX-661 in Combination With Ivacaftor on Lung and Extrapulmonary Systems in Subjects Aged 18 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|Completed||Phase 2|34|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||||||||||||2017-10-10 23:05:42.295801|2017-10-10 23:05:42.295801
NCT02508168|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-10-04|||April 2016||2016-04-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Phase 1 Bioavailability Study of SYR-322MET|An Open-Label, Single-dose, Randomized, Crossover Study to Determine the Bioavailability and Bioequivalence of Alogliptin 12.5 mg and Metformin 1000 mg When Administered as Individual Tablets and as a Fixed-Dose Combination Tablet Vipdomet (Alogliptin FDC With Metformin) in Russian Healthy Subjects|Completed||Phase 1|24|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:05:42.899207|2017-10-10 23:05:42.899207
NCT02508155|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-09-29|||November 17, 2015|Actual|2015-11-17|September 2017|2017-09-01|April 22, 2018|Anticipated|2018-04-22|April 22, 2018|Anticipated|2018-04-22||Interventional|||A Study of MEDI7352 in Painful Osteoarthritis of the Knee|A Randomised, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEDI7352 in Subjects With Painful Osteoarthritis of the Knee.|Recruiting||Phase 1|160|Anticipated|AstraZeneca||4|||f||||f|f|f||||||||2017-10-10 23:05:43.039868|2017-10-10 23:05:43.039868
NCT02508142|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-29|||July 2015||2015-07-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|HNB||Analgesic Efficacy of Intravenous Hyoscine-N-Butylbromide (HNB) in Abdominal Colic Associated With Acute Gastroenteritis|Assessment of Analgesic Efficacy and Safety of Intravenous Hyoscine-N-Butylbromide in Patients With Abdominal Colic Associated With Acute Gastroenteritis; a Randomized, Double-blind, Placebo Controlled Study|Unknown status|Recruiting|Phase 4|126|Anticipated|Kocaeli University||2|||f||||t||||||||||2017-10-10 23:05:43.201247|2017-10-10 23:05:43.201247
NCT02508129|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-10-25|||August 2015||2015-08-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|HUSH||Hypertension With Unsatisfactory Sleep Health|Pragmatic Trial of Behavioral Interventions for Insomnia in Hypertensive Patients|Recruiting||N/A|625|Anticipated|University of Pittsburgh||3|||f||||t||||||||Undecided|Currently undecided as to whether data will be shared.|2017-10-10 23:05:43.332737|2017-10-10 23:05:43.332737
NCT02508116|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-09-13|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|ADAPT||Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention|Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention (ADAPT)|Completed||N/A|504|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:05:43.498194|2017-10-10 23:05:43.498194
NCT02508103|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-05-23|2017-04-10||July 2015||2015-07-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional||Within-person experimental design, each participant received oxytocin and placebo.|Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study|Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study|Completed||Phase 2/Phase 3|10|Actual|University of North Carolina, Chapel Hill|Results of this study should be interpreted with caution due to the small sample size.|2|||f||||f||||||||||2017-10-10 23:05:43.64784|2017-10-10 23:05:43.64784
NCT02493491|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-09-08|||June 2015||2015-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01|5 Years|Observational [Patient Registry]|StrongVoice||Neurogenic Dysphonia/Dysphagia Registry|Neurogenic Dysphonia/Dysphagia Registry|Terminated||N/A|146|Actual|Merz Pharmaceuticals, LLC|||1||f||||t||||||||||2017-10-10 23:08:44.77015|2017-10-10 23:08:44.77015
NCT02508090|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-09-01|||August 2013||2013-08-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin|Long-Term Extension to a Phase 2, Open-Label, Clinical Trial of Miravirsen Sodium in Null Responders to Pegylated-Interferon Alpha Plus Ribavirin in Subjects With Chronic Hepatitis C (CHC) Virus Genotype 1 Infection|Unknown status|Active, not recruiting|N/A|10|Actual|Hoffmann-La Roche|||1||f||||||||||Samples Without DNA|"     Blood and urine samples will be collected over a course of 7 study visits to obtain     hematology, chemistry, urinalysis, coagulation, HCV RNA, and viral resistance data.   "|||2017-10-10 23:05:44.194731|2017-10-10 23:05:44.194731
NCT02508077|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-15|||February 16, 2016|Actual|2016-02-16|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|September 13, 2017|Actual|2017-09-13||Interventional|||FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer|A Prospective Study of FOLFIRI Plus Panitumumab in Extended RAS Wild Type and BRAF Wild Type Metastatic Colorectal Cancer With Acquired Resistance to Prior Cetuximab (or Panitumumab) Plus Irinotecan-Based Therapy and Who Failed at Least One Subsequent Non-anti-EGFR Containing Regimen|Terminated||Phase 2|1|Actual|City of Hope Medical Center||1||Poor Accrual|f||||t||||||||||2017-10-10 23:05:44.28291|2017-10-10 23:05:44.28291
NCT02508064|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-07|||August 3, 2015|Actual|2015-08-03|September 2017|2017-09-01|November 5, 2015|Actual|2015-11-05|November 5, 2015|Actual|2015-11-05||Interventional|||Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet|A Two-Part Study to Evaluate the Bioavailability of BMS-626529 Administered as Prodrug BMS-663068 From Prototype Low-Dose Extended-Release Tablets (Part 1) and Prototype Multi-Particulate Formulations (Part 2) Relative to the 600 mg Extended Release Tablet in Healthy Subjects|Completed||Phase 1|27|Actual|ViiV Healthcare||11|||f||||f||||||||||2017-10-10 23:05:44.485451|2017-10-10 23:05:44.485451
NCT02508051|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-02-28|||October 2015||2015-10-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Make a Journal Feel as if it Was Mailed Back From the Future|Make a Journal Feel as if it Was Mailed Back From the Future Rather Than the Past so the Reader Will be More Likely to Read and Retain Journal Content|Withdrawn||N/A|0|Actual|Yale University||3||Never received funding|f||||f||||||||||2017-10-10 23:05:44.621693|2017-10-10 23:05:44.621693
NCT02508038|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-04-17|||January 2016||2016-01-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|May 2018|Anticipated|2018-05-01||Interventional|||TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate|TCR-αβ+ and CD19+ Depleted KIR/KIR Ligand-mismatched Haploidentical Hematopoietic Stem Cell Transplant and Zoledronate for Pediatric Relapsed/Refractory Hematologic Malignancies and High Risk Solid Tumors|Recruiting||Phase 1|21|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-10 23:05:44.740368|2017-10-10 23:05:44.740368
NCT02508025|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-22|||August 2015||2015-08-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|FCEinternat||Towards Better Understanding of FCE Performance in Different Societal Contexts|Towards Better Understanding of FCE Performance in Different Societal Contexts|Unknown status|Not yet recruiting|N/A|100|Anticipated|Klinik Valens|||1||f||||f||||||||||2017-10-10 23:05:44.869404|2017-10-10 23:05:44.869404
NCT02508012|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2015-07-23|||September 2015||2015-09-01|March 2015|2015-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|ATAIM||Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases|Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF Agents in the Management of Patients With Inflammatory Bowel Disease Treated With Anti-TNFalpha Biotherapy.|Not yet recruiting||N/A|280|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:05:44.951986|2017-10-10 23:05:44.951986
NCT02507999|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-09-06|||November 2015||2015-11-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Goal-directed Therapy in Endovascular Coiling of Cerebral Aneurysm Patients|Goal-directed Therapy in Endovascular Coiling of Cerebral Aneurysm Patients - A Prospective, Blinded Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 23:05:45.118145|2017-10-10 23:05:45.118145
NCT02507986|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-07-24|||July 2016||2016-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|MOBILE-AF||Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial Fibrillation|Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial Fibrillation|Recruiting||N/A|200|Anticipated|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 23:05:45.229004|2017-10-10 23:05:45.229004
NCT02507973|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-05-12|||July 2015||2015-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Observational|||Study of Airway Pressure Release Ventilation and Intracranial Pressure in Patients With Severe Traumatic Brain Injury|Study of APRV and ICP in Patients With Severe Traumatic Brain Injury|Recruiting||N/A|50|Anticipated|University of Maryland|||2||f||||f||||||||No||2017-10-10 23:05:45.397674|2017-10-10 23:05:45.397674
NCT02507960|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-08-16|||January 2016||2016-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Gamma Pod: A Clinical Feasibility Study Device GCC 1202: The Gamma Pod: A Clinical Feasibility Study|(GCC 1202): Tumor Bed Dose Delivery Using a Breast Specific Radiosurgery Device. The Gamma Pod : A Clinical Feasibility Study|Recruiting||N/A|17|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-10 23:05:45.549797|2017-10-10 23:05:45.549797
NCT02507947|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-08-07||||||February 2017|2017-02-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|5 Years|Observational [Patient Registry]|||SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access|SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access|Not yet recruiting||N/A|1500|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||Samples With DNA|"     FFPE block of tumor tissue, blood samples   "|||2017-10-10 23:05:45.673059|2017-10-10 23:05:45.673059
NCT02507206|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-03-23|||April 2013||2013-04-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A D1 Agonist For Working Memory|A D1 Agonist For Working Memory Enhancement In The Schizophrenia Spectrum|Recruiting||Phase 2|120|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||||2017-10-10 23:05:56.747547|2017-10-10 23:05:56.747547
NCT02507934|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-01-26|||June 2015||2015-06-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Tolerability, Safety and Efficacy of Lubricin (150 µg/ml) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops in Patients With Moderate Dry Eye (DE)|A 2 Week, Randomized, Double-masked, Controlled, Parallel Group and 1 Week Follow-up Study to Evaluate Tolerability, Safety and Efficacy of Lubricin (150 µg/ml) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops in Patients With Moderate Dry Eye (DE)|Completed||N/A|40|Actual|Dompé Farmaceutici S.p.A||2|||f||||f||||||||||2017-10-10 23:05:45.755803|2017-10-10 23:05:45.755803
NCT02507921|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-07-22|||May 2015||2015-05-01|July 2015|2015-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01|1 Day|Observational [Patient Registry]|RHINOS||Resistance in HIV+ in North and South|Comparing Type and Prevalence of HIV Drug Resistance in Treatment Experienced and naïve HIV-infected Adults in Uganda and Switzerland|Unknown status|Recruiting|N/A|2750|Anticipated|Makerere University|||1||f||||f||||||Samples Without DNA|"     Plasma for HIV viral load and serum for storage   "|||2017-10-10 23:05:45.88928|2017-10-10 23:05:45.88928
NCT02507908|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-05-04|||July 2015||2015-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|5-HIAA||5-HIAA in Urine Versus 5-HIAA in Plasma Patients With a Serotonin Producing Neuroendocrine Tumor'|'5-HIAA in Urine Versus 5-HIAA in Plasma in Patients With a Serotonin Producing Neuroendocrine Tumor'|Completed||N/A|59|Actual|University Medical Center Groningen|||1||f||||f||||||Samples Without DNA|"     blood and urine   "|||2017-10-10 23:05:45.998136|2017-10-10 23:05:45.998136
NCT02507895|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2015-07-23|||October 2013||2013-10-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of Brain-Computer Interfaced-Assisted Motor Imagery for Gait Retraining in Stroke Patients|Brain-Computer Interface-Assisted Motor Imagery for Gait Retraining in Neurorehabilitation|Unknown status|Recruiting|N/A|30|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-10 23:05:46.088302|2017-10-10 23:05:46.088302
NCT02507882|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||January 2016||2016-01-01|July 2015|2015-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma|Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma|Not yet recruiting||N/A|405|Anticipated|Egyptian Liver Hospital||3|||f||||||||||||||2017-10-10 23:05:46.231302|2017-10-10 23:05:46.231302
NCT02507869|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-23|||April 2013||2013-04-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Trial of an Affect-Guided Physical Activity Prescription|A Pilot Randomized Controlled Trial of an Affect-Guided Physical Activity|Completed||N/A|67|Actual|Southern Methodist University||2|||f||||f||||||||||2017-10-10 23:05:46.309368|2017-10-10 23:05:46.309368
NCT02507856|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01|3 Months|Observational [Patient Registry]|PRODAST||Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA|Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA|Recruiting||N/A|10000|Anticipated|University Hospital, Essen|||2||f||||t||||||||||2017-10-10 23:05:46.385519|2017-10-10 23:05:46.385519
NCT02507843|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-23|||January 2015||2015-01-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|VIDB||Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis|Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis: a Double-blind Randomised Controlled Trial|Unknown status|Recruiting|Phase 4|200|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||t||||||||||2017-10-10 23:05:46.699574|2017-10-10 23:05:46.699574
NCT02507830|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-03-02|||August 2015||2015-08-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Mesh Fixation With a Synthetic Glue in Primary Inguinal Hernia Repair|Mesh Fixation With a Synthetic Glue in Primary Inguinal Hernia Repair|Recruiting||N/A|150|Anticipated|Rambam Health Care Campus|||1||f||||t||||||||||2017-10-10 23:05:46.832468|2017-10-10 23:05:46.832468
NCT02507817|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-08-04|||August 2015||2015-08-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Correlation Between LIF (Leukemia Inhibitory Factor ) Levels in Cord and Maternal Blood in Women Treated With Mg|The Correlation Between LIF Levels in Cord Blood to Maternal Blood in Women Treated With Mg During Labor|Unknown status|Not yet recruiting|N/A|100|Anticipated|Rambam Health Care Campus|||4||f||||||||||Samples Without DNA|"     Samples without DNA   "|||2017-10-10 23:05:48.753342|2017-10-10 23:05:48.753342
NCT02507804|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-23|||July 2015||2015-07-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|July 2016|Anticipated|2016-07-01||Interventional|PROMs||A Study to Evaluate a Diary for Patient Reported Outcome Measures (PROMs)|A Single Centre Randomised Controlled Study to Evaluate a Diary for Patient Reported Outcome Measures (PROMs)|Recruiting||N/A|164|Anticipated|The Christie NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:05:48.859969|2017-10-10 23:05:48.859969
NCT02507791|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-23|||May 2015||2015-05-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Impact of Fitbit Plus Weight Management Program on Physical Activity and Metabolic Disease in Obese Adolescents|Impact of Fitbit Plus Weight Management Program on Physical Activity and Metabolic Disease in Obese Adolescents|Unknown status|Recruiting|N/A|60|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-10 23:05:48.947981|2017-10-10 23:05:48.947981
NCT02507778|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-09-22|||September 2015||2015-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Circulating Tumor Cells Spillage After Pulmonary Biopsy|Circulating Tumor Cells Spillage After Pulmonary Biopsy|Recruiting||N/A|40|Anticipated|Rabin Medical Center||1|||f||||f||||||||No||2017-10-10 23:05:49.066376|2017-10-10 23:05:49.066376
NCT02507765|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2017-06-09|||July 2015||2015-07-01|June 2017|2017-06-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|A Pilot Trial of Stereotactic Body Radiation Therapy (SBRT) to Induce Tumor Hyperemia in Combination With Transarterial Chemoembolization (TACE) for Unresectable Hepatocellular Carcinoma|Recruiting||N/A|15|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:05:49.171013|2017-10-10 23:05:49.171013
NCT02492204|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-07-03|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2015|Actual|2015-07-01|60 Days|Observational [Patient Registry]|||The Role of IL33/ST2 Axis in ARDS Patients||Unknown status|Recruiting|N/A|200|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||2||f||||||||||||||2017-10-10 23:08:58.531466|2017-10-10 23:08:58.531466
NCT02507752|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-23|2016-01-03|2015-10-26||July 2009||2009-07-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational||Baseline characteristics are summarized for the ITT population that included all screened participants who answered at least one short form 36 (SF-36) questionnaire.|An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab|An Observational, Prospective, Multicenter, Local, to Assess the Quality of Life Through the Use of Questionnaires in a Cohort of Patients With Rheumatoid Arthritis Treated With Anti-CD20 Therapy|Completed||N/A|94|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:05:49.340366|2017-10-10 23:05:49.340366
NCT02507739|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-23|||October 2012||2012-10-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PERIAMBU||Evaluation of the Impact of an Outpatient Obstetric Epidurals During Labor||Completed||N/A|320|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:05:50.2527|2017-10-10 23:05:50.2527
NCT02507726|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2016-09-22|||June 2015||2015-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Multicenter and Open Pilot Clinical Study on the Safety of a New One-piece Convex Appliance in Patients With Enterostomy|Multicenter and Open Pilot Clinical Study on the Safety of a New One-piece Convex Appliance in Patients With Enterostomy|Completed||N/A|40|Actual|BBraun Medical SAS||1|||f||||f||||||||||2017-10-10 23:05:50.349946|2017-10-10 23:05:50.349946
NCT02507713|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-23|||September 2013||2013-09-01|July 2015|2015-07-01||||April 2014|Actual|2014-04-01||Observational|ALS||Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS)|Ultrasound Markers for the Diagnosis, Disease Progression and Prognosis of Amyotrophic Lateral Sclerosis|Completed||N/A|60|Actual|Universidad Católica San Antonio de Murcia|||1||f||||||||||||||2017-10-10 23:05:50.457592|2017-10-10 23:05:50.457592
NCT02507700|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-06-10|||June 2015||2015-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Popliteal Block for Postoperative Pain in Knee-ankle Soft Tissue Surgery in Cerebral Palsy|Popliteal Block for Postoperative Pain in Knee-ankle Soft Tissue Surgery in Cerebral Palsy|Completed||N/A|60|Actual|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-10 23:05:50.557775|2017-10-10 23:05:50.557775
NCT02507687|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-06|||August 27, 2015|Actual|2015-08-27|September 2017|2017-09-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|||Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension|A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension|Recruiting||Phase 3|160|Anticipated|Allergan||2|||f||||f|t|f||||||||2017-10-10 23:05:50.710829|2017-10-10 23:05:50.710829
NCT02507674|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-03-21|||October 2015||2015-10-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Point of Care 3D Ultrasound for Pediatric Appendicitis: a Pilot Study|Point of Care 3D Ultrasound for Pediatric Appendicitis: a Pilot Study|Recruiting||N/A|50|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 23:05:50.968273|2017-10-10 23:05:50.968273
NCT02507661|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-10-25|||June 2015||2015-06-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|||Effect of Alveolar Ridge Preservation on Implant Esthetic Outcomes|Esthetic Outcomes of Implant-supported Crowns After Alveolar Ridge Preservation With Beta Tricalcium Phosphate and Collagen in the Maxillary Esthetic Zone|Recruiting||Phase 4|70|Anticipated|University of Belgrade||6|||f||||f||||||||||2017-10-10 23:05:51.06056|2017-10-10 23:05:51.06056
NCT02507648|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-23|||March 2013||2013-03-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)|Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||||2017-10-10 23:05:51.258969|2017-10-10 23:05:51.258969
NCT02507635|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-22|||February 2009||2009-02-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|November 2011|Actual|2011-11-01||Interventional|||Anti-inflammatory H1 Antihistamines Allergic Rhinitis|In Vivo Anti-inflammatory Effect of H1 Antihistamines in Allergic Rhinitis|Completed||Phase 4|115|Actual|Iuliu Hatieganu University of Medicine and Pharmacy||3|||f||||t||||||||||2017-10-10 23:05:51.372631|2017-10-10 23:05:51.372631
NCT02507622|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-23|||September 2014||2014-09-01|July 2015|2015-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|E-NOSE||E-NOSE for Breath Gas Analysis Under Microgravity Conditions||Recruiting||N/A|18|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:05:51.466815|2017-10-10 23:05:51.466815
NCT02507609|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-24|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium|The Effect of Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium of Elderly Patients Undergoing Total Hip Arthroplasty|Unknown status|Recruiting|Phase 4|82|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||||2017-10-10 23:05:51.544911|2017-10-10 23:05:51.544911
NCT02507596|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-07-16|||April 2015||2015-04-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of Nano-crystalline Hydroxyapatite Silica Gel in Management of Periodontal Intrabony Defects|Clinical and Radiographic Evaluation of Nano-crystalline Hydroxyapatite Silica Gel in the Treatment of Human Periodontal Intrabony Defects|Recruiting||N/A|30|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-10 23:05:51.648998|2017-10-10 23:05:51.648998
NCT02507193|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-21|||July 2015||2015-07-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Fibular Fixation in Ankle Fractures:Plate Verses Nail.|Fibular Fixation in Ankle Fractures: a Randomized-Controlled Trial Comparing Plating Versus Intramedullary Nailing|Enrolling by invitation||N/A|60|Anticipated|Orlando Health, Inc.||2|||f||||f||||||||||2017-10-10 23:05:56.858913|2017-10-10 23:05:56.858913
NCT02507570|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-04-27|||September 2015||2015-09-01|April 2017|2017-04-01||||February 2019|Anticipated|2019-02-01||Interventional|||Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis|Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis|Active, not recruiting||Phase 2|40|Actual|Carolina Research Professionals, LLC||1|||f||||f||||||||||2017-10-10 23:05:51.846527|2017-10-10 23:05:51.846527
NCT02507557|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-07-12|||May 2016||2016-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Effects of Intraoperative Goal-Directed Fluid Therapy on the Incidence of Postoperative Complications|Effects of Intraoperative Goal-Directed Fluid Therapy on the Incidence of Postoperative Complications Following Gastrointestinal Surgery|Recruiting||N/A|400|Anticipated|First Affiliated Hospital of Chongqing Medical University|||2||f||||f||||||||Undecided||2017-10-10 23:05:51.958287|2017-10-10 23:05:51.958287
NCT02507544|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer|A Phase I Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer|Recruiting||Phase 1|30|Anticipated|TaiRx, Inc.||1|||f||||f||||||||||2017-10-10 23:05:52.077256|2017-10-10 23:05:52.077256
NCT02507531|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-05-17|||May 2016||2016-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:05:52.219995|2017-10-10 23:05:52.219995
NCT02507518|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-07-19|||December 2013||2013-12-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|CALMETTE||Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer|Role of 18FDG PET in the Evaluation of Early Response to Maintenance Treatment With Bevacizumab or Pemetrexed in Advanced Non-small-cell Lung Cancer|Recruiting||Phase 2|80|Anticipated|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 23:05:52.279312|2017-10-10 23:05:52.279312
NCT02507505|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-30|||February 2016||2016-02-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|REGAIN||Regional Versus General Anesthesia for Promoting Independence After Hip Fracture|A Randomized Controlled Trial of Regional Versus General Anesthesia for Promoting Independence After Hip Fracture|Recruiting||N/A|2424|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:05:52.442722|2017-10-10 23:05:52.442722
NCT02507492|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-02-19|||January 2015||2015-01-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients|RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients|Recruiting||Phase 2|10|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-10 23:05:52.967024|2017-10-10 23:05:52.967024
NCT02507479|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2016-04-19|||September 2015||2015-09-01|April 2016|2016-04-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies|Phase II Trial of Fludarabine Combined With Intravenous Thiotepa and Allogeneic Hematopoietic Stem-cell Transplantation in Patients With Lymphatic Malignancies Including Multiple Myeloma, Non Hodgkin's, Hodgkin Lymphoma and CLL|Recruiting||Phase 2|24|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:05:53.086638|2017-10-10 23:05:53.086638
NCT02507466|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-04-24|||July 2015||2015-07-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|VIVRANT||Very Intensive Variable Repetitive AmbulatioN Training|Very Intensive Variable Repetitive AmbulatioN Training|Recruiting||N/A|90|Anticipated|Shirley Ryan AbilityLab||3|||f||||f||||||||||2017-10-10 23:05:53.227925|2017-10-10 23:05:53.227925
NCT02507453|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-23|||October 2013||2013-10-01|July 2015|2015-07-01||||October 2016|Anticipated|2016-10-01||Interventional|Massper||Influence of Gravity on the Size-mass Illusion||Unknown status|Recruiting|N/A|36|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:05:53.332881|2017-10-10 23:05:53.332881
NCT02507440|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-01-06|||September 2015||2015-09-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's|Impact of Topical Pharyngeal Anesthetics on Discharge of the Patients When Used in Conjunction With Propofol Sedation in Routine EGD's|Completed||Phase 4|100|Actual|Bassett Healthcare||2|||f||||f||||||||||2017-10-10 23:05:53.404281|2017-10-10 23:05:53.404281
NCT02507427|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-04-21|||July 2015||2015-07-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Interventional|||Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study)|Safety and Efficacy of Pelvic Autonomic Nerve Monitoring and Mapping During Robot Assisted Laparoscopic Radical Prostatectomy for Preservation of Erectile Function|Active, not recruiting||Phase 1/Phase 2|30|Actual|Seoul National University Hospital||1|||f||||t||||||||No|No part of IPD will be shared.|2017-10-10 23:05:53.502465|2017-10-10 23:05:53.502465
NCT02507414|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-10-04|||August 2014||2014-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Mesenteric Traction Syndrome During Upper Gastrointestinal Surgery|Characterization of the Mesenteric Traction Syndrome During Upper Gastrointestinal Surgery for Malignant Disease|Completed||N/A|75|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 23:05:53.603655|2017-10-10 23:05:53.603655
NCT02507401|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-05-01|||September 2015||2015-09-01|May 2017|2017-05-01|January 1, 2017|Actual|2017-01-01|December 31, 2016|Actual|2016-12-31|12 Months|Observational [Patient Registry]|||Mixed-species Biofilms and Silicone Device Longevity|Mixed-species Biofilm Composition as a Predictor of Device Longevity in Patients Using Silicone Medical Devices|Completed||N/A|14|Actual|University of Aberdeen|||1||f||||f||||||Samples Without DNA|"     Microbes isolated from in-dwelling medical device (voice prostheses) and oral rinse. No     patient biomaterial will be collected or retained.   "|No|No individual patient data are available to the study|2017-10-10 23:05:53.712429|2017-10-10 23:05:53.712429
NCT02506998|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-24|||August 2013||2013-08-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts|Evaluation of Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts as an Adjuvant|Completed||Phase 2|30|Actual|National Polytechnic Institute, Mexico||1|||f||||t||||||||||2017-10-10 23:05:58.241279|2017-10-10 23:05:58.241279
NCT02507388|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-05|2017-09-05||August 24, 2015|Actual|2015-08-24|September 2017|2017-09-01|September 6, 2016|Actual|2016-09-06|September 6, 2016|Actual|2016-09-06||Interventional||This analysis population includes all randomized subjects|Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration|A Randomized, Double Masked, Three Dose Safety and Pharmacokinetic Study of RTH258 Following Intravitreal (IVT) Injection in Subjects With Neovascular Age-Related Macular Degeneration|Completed||Phase 2|51|Actual|Alcon Research|Missing AUCinf and half life values attributable to concentration values below LLOQ may result in biased estimates. Causality assessment of the ADA status is limited due to the high number of subjects with positive ADA at baseline.|2|||f||||f|t|f||||||||2017-10-10 23:05:53.826933|2017-10-10 23:05:53.826933
NCT02507375|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-09-18|2015-07-31||September 2006||2006-09-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||All recruited participants who received at least 1 dose of both pertuzumab and erlotinib.|A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)|Phase Ib, Open-label, Multi-center Study of the Combination of Pertuzumab and Erlotinib in Patients With Locally Advanced or Metastatic (Stage IIIb/IV) NSCLC After Failure of at Least One Prior Chemotherapy Regimen.|Completed||Phase 1|17|Actual|Hoffmann-La Roche|Per Version A the protocol was halted for 2 DLTs (grade 3 manageable rash common for erlotinib) in the first 6 patients. Ethics committee approved redefining DLT and starting anew with Version B. No further DLTs were observed throughout the study.|2|||f||||||||||||||2017-10-10 23:05:54.901006|2017-10-10 23:05:54.901006
NCT02507362|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-07-22|||August 2014||2014-08-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus|Adapted Fluence Settings for Corneal Collagen Cross-linking in Progressive Mild to Moderate Keratoconus Aged 18 to 30|Unknown status|Active, not recruiting|Phase 1/Phase 2|40|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:05:55.62184|2017-10-10 23:05:55.62184
NCT02507349|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-05-16|||August 2014||2014-08-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|PCORI-SDM||Person-Centered Versus Measurement-Based Care in Mental Health|Amplifying the Patient's Voice: Person-Centered Versus Measurement-Based Approaches in Mental Health|Active, not recruiting||N/A|2405|Actual|UPMC||2|||f||||t||||||||||2017-10-10 23:05:55.731766|2017-10-10 23:05:55.731766
NCT02507336|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-08-16|||November 24, 2015|Actual|2015-11-24|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165|Long-term Follow-up and/or Continued Thalidomide (THALOMID®) Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165|Enrolling by invitation||N/A|22|Anticipated|University of Miami||3|||f||||t|||||f|||||2017-10-10 23:05:55.828318|2017-10-10 23:05:55.828318
NCT02507323|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-05-03|||February 2016||2016-02-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|TIPRIS||Ticagrelor vs. Prasugrel Effects on Infarct Size|TIPRIS: Ticagrelor vs. Prasugrel Effects on Infarct Size: A Head to Head Comparison With Prasugrel|Withdrawn||Phase 2|0|Actual|Baylor College of Medicine||2||collaborator withdrew the study|f||||t||||||||||2017-10-10 23:05:55.928283|2017-10-10 23:05:55.928283
NCT02507310|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-11-09|||May 2015||2015-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Influence of Ambient Temperature on Office Behaviors||Completed||N/A|25|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-10-10 23:05:56.027979|2017-10-10 23:05:56.027979
NCT02507297|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-28|||January 2016||2016-01-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|||Sleep-Disordered Breathing and PAP in Perinatal Depression|Sleep-Disordered Breathing and PAP in Perinatal Depression|Recruiting||Phase 2|50|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-10 23:05:56.101071|2017-10-10 23:05:56.101071
NCT02507284|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-06-30|||June 2016||2016-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease|An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects With Huntington's Disease (HD)|Recruiting||Phase 1/Phase 2|108|Anticipated|Azevan Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:05:56.191521|2017-10-10 23:05:56.191521
NCT02507271|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-07-05|||August 2010||2010-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Speed of Processing Training in Traumatic Brain Injury|Speed of Processing Training in Traumatic Brain Injury|Active, not recruiting||N/A|100|Actual|New York University School of Medicine||2|||f||||||||||||||2017-10-10 23:05:56.349071|2017-10-10 23:05:56.349071
NCT02507258|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-19|||December 2017|Anticipated|2017-12-01|June 2016|2016-06-01|December 2028|Anticipated|2028-12-01|December 2028|Anticipated|2028-12-01||Observational|||PMCF Study for PROFEMUR® Am Femoral Components and PROCOTYL® O HA Coated Acetabular Components|Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Am Femoral Components and PROCOTYL® O HA Coated Acetabular Components|Not yet recruiting||N/A|143|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||No||2017-10-10 23:05:56.431303|2017-10-10 23:05:56.431303
NCT02507245|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-07-22|||January 2014||2014-01-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|GHD||Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)|Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD): Lung Function Parameters Assessment; Quality of Life Assessment; Stress Parenting Assessment (Pneumo GHD)|Completed||N/A|48|Actual|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||1||f||||f||||||||||2017-10-10 23:05:56.511883|2017-10-10 23:05:56.511883
NCT02507232|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-08-13|||April 17, 2017|Actual|2017-04-17|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Interventional|||A Phase II Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas|A Single-Center, Open-Lable, Randomized Phase II Study of NovoTTF-200A Alone and Combined With Temozolomide in Patients With Low-Grade Gliomas|Recruiting||Phase 2|42|Anticipated|John Wayne Cancer Institute||2|||f||||f|f|t|f|f||||||2017-10-10 23:05:56.575538|2017-10-10 23:05:56.575538
NCT02507180|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-09-13|||September 2015||2015-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|LEaD||Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer|Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer: the LEaD Study. A Prospective Cohort Study.|Recruiting||N/A|366|Anticipated|Ottawa Hospital Research Institute|||1||f||||t||||||Samples Without DNA|"     At presentation, a blood sample will be collected for clinical D-dimer tested in real time     and a sample will be collected and the plasma will be frozen for analysis at the end of study     using Vidas D-dimer on all patient samples.   "|Undecided||2017-10-10 23:05:56.923585|2017-10-10 23:05:56.923585
NCT02507167|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||November 2012||2012-11-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|||Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8|Impact of Two Genetic Variants of OATP 1B3 or MRP 2 or Rifampin Mediated Transporter Inhibition on Systemic Disposition and Biological Efficacy of CCK-8 in 36 Healthy Male Individuals|Completed||Phase 1|19|Actual|University Medicine Greifswald||2|||f||||t||||||||||2017-10-10 23:05:56.993069|2017-10-10 23:05:56.993069
NCT02507154|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||July 2015||2015-07-01|July 2015|2015-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|NKEXPHNC||Reactivating NK Cells in Treating Refractory Head and Neck Cancer|Phase I/II Study of Expanded, Activated Autologous Natural Killer Cell Infusions With Cetuximab for Patients With EGFR-Positive Nasopharyngeal Carcinoma or Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|31|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-10 23:05:57.060707|2017-10-10 23:05:57.060707
NCT02507141|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-09-05|||July 21, 2015|Actual|2015-07-21|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology|Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology|Recruiting||N/A|80|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"     Samples of tissue from tumor and margin   "|||2017-10-10 23:05:57.135463|2017-10-10 23:05:57.135463
NCT02507128|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||July 2015||2015-07-01|July 2015|2015-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of Glucagon Like Peptide-1 on No-reflow|Effects of Glucagon Like Peptide-1 on No-reflow in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Unknown status|Recruiting|N/A|190|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:05:57.335279|2017-10-10 23:05:57.335279
NCT02507115|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||July 2012||2012-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|July 2014|Actual|2014-07-01||Interventional|TMAP||Text Messaging as a Novel Alcohol Intervention for Community College Students|Text Messaging as a Novel Alcohol Intervention for Community College Students|Completed||N/A|65|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-10-10 23:05:57.424715|2017-10-10 23:05:57.424715
NCT02507102|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-08-23|||July 2015||2015-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia|A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia|Active, not recruiting||N/A|11|Actual|Nativis, Inc.||1|||f||||f||||||||||2017-10-10 23:05:57.498934|2017-10-10 23:05:57.498934
NCT02507089|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-04-14|||July 2014||2014-07-01|April 2016|2016-04-01||||March 2019|Anticipated|2019-03-01||Interventional|TASHE||Tailored Approach to Sleep Health Education: A Community Engaged Approach||Recruiting||N/A|200|Anticipated|New York University Langone Medical Center||2|||f||||t||||||||||2017-10-10 23:05:57.569169|2017-10-10 23:05:57.569169
NCT02507076|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||April 2012||2012-04-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma|Isolated Limb Perfusion for Advanced Melanoma or Sarcoma Limited to Extremity With or Without Distant Metastases|Withdrawn||N/A|0|Actual|Albert Einstein College of Medicine, Inc.||1||no enrollment|f||||t||||||||||2017-10-10 23:05:57.654118|2017-10-10 23:05:57.654118
NCT02507063|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2017-05-22|||July 2016||2016-07-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Optic Nerve Sheath Diameter and Intracranial Pressure (ICP) in Children|Determining the Correlation of Optic Nerve Sheath Diameter With Intracranial Pressure in Children|Withdrawn||N/A|0|Actual|University of Louisville|||1||f||||t||||||||No||2017-10-10 23:05:57.76465|2017-10-10 23:05:57.76465
NCT02507050|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-08-24|||March 2016||2016-03-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MICRO-PCI||Ivabradine and Post-revascularisation Microcirculatory Dysfunction|Can Ivabradine Attenuate Post-revascularisation Microcirculatory Dysfunction in Flow Limiting Coronary Artery Disease?|Suspended||Phase 4|75|Anticipated|Liverpool Heart and Chest Hospital NHS Foundation Trust||2||Funding not yet achieved|f||||t||||||||||2017-10-10 23:05:57.840361|2017-10-10 23:05:57.840361
NCT02507037|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2016-03-17|||July 2014||2014-07-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Gum Chewing on Bowel Cleansing Before Colonoscopy|Effect of Gum Chewing on Bowel Cleansing Before Colonoscopy: A Prospective Randomized Study|Completed||Phase 4|300|Actual|Changhai Hospital||2|||f||||t||||||||||2017-10-10 23:05:57.948891|2017-10-10 23:05:57.948891
NCT02507024|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-05-01|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|3 Months|Observational [Patient Registry]|AAV-PRO||The ANCA Vasculitis Questionnaire (AAV-PRO©)|The ANCA Vasculitis Questionnaire (AAV-PRO©)|Completed||N/A|280|Actual|University of Pennsylvania|||1||f||||f|f|f||||||No||2017-10-10 23:05:58.025573|2017-10-10 23:05:58.025573
NCT02507011|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-11-15|||January 2016||2016-01-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Beta-blockers in Pulmonary Arterial Hypertension|Beta-blockers in Pulmonary Arterial Hypertension - A Phase 2 Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy, and Safety of Carvedilol for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension|Recruiting||Phase 2|26|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 23:05:58.133908|2017-10-10 23:05:58.133908
NCT02506985|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-01-24|||July 2015||2015-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|XENITH||XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis|XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis|Terminated||Phase 4|10|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 23:05:58.341252|2017-10-10 23:05:58.341252
NCT02506972|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-22|||November 2013||2013-11-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|Panther||Effect of Serving Size and Addition of Sugar on the Glycemic Response Elicited by Oatmeal|Effect of Varying Amounts of β-glucan and Sucrose in Oatmeal on Glycemic Response|Completed||N/A|38|Actual|Glycemic Index Laboratories, Inc||8|||f||||f||||||||||2017-10-10 23:05:58.470842|2017-10-10 23:05:58.470842
NCT02506959|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-06-16|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma|Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma|Recruiting||Phase 2|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:05:58.566563|2017-10-10 23:05:58.566563
NCT02506946|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-11-03|||July 2013||2013-07-01|November 2016|2016-11-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Observational|||NAFLD in Adolescents and Young Adults With PCOS|Nonalcoholic Fatty Liver Disease (NAFLD), Insulin Resistance and Dyslipidemia in Adolescents and Young Adults With Polycystic Ovary Syndrome (PCOS)|Recruiting||N/A|80|Anticipated|Columbia University|||2||f||||f||||||Samples Without DNA|"     Blood samples will be stored in a freezer for assays requiring batch testing   "|Undecided|We will consider this|2017-10-10 23:05:58.737071|2017-10-10 23:05:58.737071
NCT02506933|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-08-08|||November 5, 2015|Actual|2015-11-05|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant|A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate the Protective Function of a CMV-MVA Triplex Vaccine in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant|Recruiting||Phase 2|115|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-10 23:05:58.874967|2017-10-10 23:05:58.874967
NCT02506907|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-08-01|||August 2012||2012-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|VAMMPRIS||Characterizing Hemodynamic Compensation in Patients With Intracranial Stenosis|Vanderbilt Assessment of Multi-modal MRI in Patients At-Risk for Stroke With Intracranial Stenosis|Active, not recruiting||N/A|138|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||||2017-10-10 23:05:59.1464|2017-10-10 23:05:59.1464
NCT02506894|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-01-29|||July 2015||2015-07-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection|Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection|Completed||Early Phase 1|60|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:05:59.225809|2017-10-10 23:05:59.225809
NCT02506881|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-05-06|2016-03-30||March 2013||2013-03-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Population for safety analysis: all patients who received at least one study drug injection|Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers|International Multicenter Comparative Randomized Double-blind Crossover Study of Pharmacokinetics, Pharmacodynamics and Safety of BCD-066 and Aranesp® After Single Subcutaneous and Intravenous Injection in Healthy Volunteers.|Completed||Phase 1|74|Actual|Biocad||4|||f||||f||||||||||2017-10-10 23:05:59.335088|2017-10-10 23:05:59.335088
NCT02506868|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-09-01|||June 2016||2016-06-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients|Multicenter Double-blind Randomized Parallel Comparative Study of Efficacy and Safety of BCD-066 (CJSC BIOCAD, Russia) and Aranesp (Amgen Europe B.V., Netherlands) in Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis|Recruiting||Phase 3|172|Anticipated|Biocad||2|||f||||f||||||||Undecided||2017-10-10 23:06:00.284157|2017-10-10 23:06:00.284157
NCT02506855|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-05-12|||June 2015||2015-06-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|January 2016|Actual|2016-01-01||Interventional|GYNTAP||Intraoperative Transversus Abdominis Plane Block for Gynecologic Surgery (GYNTAP)|Intraoperative Transversus Abdominis Plane Block for Gynecologic Surgery (GYNTAP): Modifying an Existing Technique for Ease of Administration and Increased Accuracy|Withdrawn||Phase 3|0|Actual|University of Mississippi Medical Center||2||The investigator decided not to continue the study.|f||||f||||||||||2017-10-10 23:06:00.458141|2017-10-10 23:06:00.458141
NCT02506842|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2016-08-10|||June 2015||2015-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection|A Prospective, Multi-centric, Phase Ⅲ, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine (AG) Versus Oxaliplatin Plus Folinic Acid and Fluorouracil (OFF) for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection|Recruiting||Phase 3|300|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 23:06:00.54577|2017-10-10 23:06:00.54577
NCT02506829|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-04-19|||July 2015||2015-07-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|FIESTA||Financial Incentives for Smoking Treatment|A Randomized Comparative Effectiveness Trial Of Financial Incentives Versus Usual Care For Smokers Hospitalized In The Veterans Affairs Hospital System|Recruiting||N/A|182|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 23:06:00.687552|2017-10-10 23:06:00.687552
NCT02506816|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-11-07|||February 2016||2016-02-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|Polen||Preoperative Olaparib Endometrial Carcinoma Study (POLEN)|"A Preoperative Window-opportunity, Multicenter, Pharmacokinetic-pharmacodynamic Study to Evaluate the Inhibitory Effects of Single Agent AZD2281 (Olaparib), in Patients With Early-stage Endometrial Carcinoma"|Recruiting||Early Phase 1|36|Anticipated|MedSIR|||1||f||||f||||||Samples With DNA|"     Tumor cells Plasma   "|||2017-10-10 23:06:00.77832|2017-10-10 23:06:00.77832
NCT02506803|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2016-05-11|||July 2015||2015-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.|Phase I Study of Neoadjuvant Chemotherapy of Gemcitabine Plus Nab-paclitaxel for Patients With Borderline Resectable Pancreatic Cancer.|Recruiting||Phase 1|10|Anticipated|Wakayama Medical University||1|||f||||t||||||||||2017-10-10 23:06:00.862523|2017-10-10 23:06:00.862523
NCT02506790|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-04-03|||July 2015||2015-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer|Phase II Multicenter Randomized Study to Compare Neoadjuvant Toremifene With Melatonin or Metformin Versus Toremifene in the Therapy of Locally Advanced Breast|Recruiting||Phase 2|96|Anticipated|Petrov Research Institute of Oncology||3|||f||||t||||||||||2017-10-10 23:06:00.943992|2017-10-10 23:06:00.943992
NCT02506777|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-04-03|||July 2015||2015-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|MBC1||Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.|Phase II Multicenter Randomized Study to Compare Neoadjuvant FDC With Melatonin or Metformin Versus FDC Alone in The Therapy of Locally Advanced Breast Cancer.|Recruiting||Phase 2|96|Anticipated|Petrov Research Institute of Oncology||3|||f||||t||||||||||2017-10-10 23:06:01.049849|2017-10-10 23:06:01.049849
NCT02506751|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2017-06-12|||July 2015||2015-07-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Open-label Study of Liothyronine in MS|A Phase 1b, Open-label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals With MS|Active, not recruiting||Phase 1|20|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 23:06:01.162735|2017-10-10 23:06:01.162735
NCT02506738|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||August 2010||2010-08-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|mobileHF||mHealth to Early Detect Exacerbation for Older People With Heart Failure|(in Spanish) Utilidad de un Instrumento telediagnóstico en la detección de la reagudización de la Insuficiencia Cardiaca crónica en Ancianos|Completed||N/A|90|Actual|Hospital Universitario Getafe||2|||f||||t||||||||||2017-10-10 23:06:01.238169|2017-10-10 23:06:01.238169
NCT02506725|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-08-14|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|July 1, 2017|Actual|2017-07-01||Interventional|quarenta||Quarenta Semanas: Innovative Intervention in Prenatal Care for Reduction of Prematurity|Quarenta Semanas: Innovative Intervention in Prenatal Care for Reduction of Prematurity|Active, not recruiting||N/A|240|Actual|Oswaldo Cruz Foundation||2|||f||||t||||||||||2017-10-10 23:06:01.305629|2017-10-10 23:06:01.305629
NCT02506712|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-01-30|||September 20, 2011|Actual|2011-09-20|January 2017|2017-01-01|September 19, 2014|Actual|2014-09-19|February 27, 2014|Actual|2014-02-27||Interventional|SmartDrive||Evaluation of Physiological and Biomechanical Efficiency of the PAPAW|Evaluation of Physiological and Biomechanical Efficiency of the PAPAW|Completed||N/A|44|Actual|Centre d'Investigation Clinique et Technologique 805||2|||f||||f||||||||||2017-10-10 23:06:01.387058|2017-10-10 23:06:01.387058
NCT02506699|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||June 2013||2013-06-01|July 2015|2015-07-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|rTMSDOULNEURO||Observational Study of the Analgesic Effect of Treatment With rTMS in Patients With Chronic Neuropathic Pain|Observational Study of the Analgesic Effect of Treatment With rTMS in Patients Suffering From Chronic Neuropathic Pain Refractory to Conventional Treatment and Monitored and Evaluated in Consultation Multidisciplinary Chronic Pain in Lower Normandy|Unknown status|Recruiting|N/A|15|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 23:06:01.608209|2017-10-10 23:06:01.608209
NCT02506673|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-06-12|||November 2015||2015-11-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Audiovisual Aid Pilot Study|The Effect of Audiovisual Aids on Perioperative Stress Response, Pain and Overall Experience - a Randomized Controlled Pilot Study|Recruiting||N/A|30|Anticipated|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-10 23:06:01.787521|2017-10-10 23:06:01.787521
NCT02506660|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-11-11|||August 2015||2015-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|Dex ISB||Interscalene Block With Low-dose IV vs. Perineural Dexamethasone for Shoulder Arthroscopy|Interscalene Block With Low-dose IV vs. Perineural Dexamethasone for Shoulder Arthroscopy|Completed||Phase 4|128|Actual|Hospital for Special Surgery, New York||2|||f||||||||||||||2017-10-10 23:06:01.910926|2017-10-10 23:06:01.910926
NCT02506647|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-01-25|||December 2015|Actual|2015-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes|A Phase 1, Exploratory, Randomized, Double-Blind, Two-Way Cross Over Study to Assess Pharmacokinetic and Pharmacodynamic Effects of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|41|Actual|Gan and Lee Pharmaceuticals, USA||2|||f||||f||||||||||2017-10-10 23:06:02.023169|2017-10-10 23:06:02.023169
NCT02506634|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-01-13|||August 2015||2015-08-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department|The Primary Symptoms of GERD in Chinese Outpatients in Gastroenterology Department: A Cross-sectional Investigation|Recruiting||N/A|300|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||2||f||||t||||||||||2017-10-10 23:06:02.113313|2017-10-10 23:06:02.113313
NCT02506621|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-21|||September 2015||2015-09-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|REMAP-AF||ELR Monitoring Against Permanent Pacemaker in Atrial Fibrillation|Randomised ELR Monitoring Against Permanent Pacemaker in Atrial Fibrillation|Unknown status|Not yet recruiting|N/A|20|Anticipated|Eastbourne General Hospital||1|||f||||f||||||||||2017-10-10 23:06:02.213858|2017-10-10 23:06:02.213858
NCT02506608|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-22|||June 2015||2015-06-01|July 2015|2015-07-01||||October 2017|Anticipated|2017-10-01||Interventional|EPIONE||Use of Hand Prosthesis With Direct Nerve Stimulation for Treatment of Phantom Limb Pain|Natural Sensory Feedback for Phantom Limb Modulation and Therapy|Unknown status|Recruiting|N/A|2|Anticipated|Catholic University of the Sacred Heart||1|||f||||f||||||||||2017-10-10 23:06:02.298284|2017-10-10 23:06:02.298284
NCT02506595|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-06-15|||February 2016||2016-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Trial of Treatment for Trauma-Related Nightmares in Active Duty Military Personnel|A Pilot Randomized Controlled Trial of Treatment for Trauma-Related Nightmares Compared to Waitlist Control in Active Duty Military Personnel|Active, not recruiting||N/A|40|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||Undecided||2017-10-10 23:06:02.374671|2017-10-10 23:06:02.374671
NCT02506582|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-07-22|||June 2013||2013-06-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control|The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control|Completed||N/A|60|Actual|Yonsei University||2|||f||||t||||||||||2017-10-10 23:06:02.475264|2017-10-10 23:06:02.475264
NCT02506569|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-12-05|||January 2015||2015-01-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Observational|||ProMRI 3T ENHANCED Master Study|ProMRI 3T ENHANCED Master Study|Recruiting||N/A|129|Anticipated|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-10 23:06:02.574767|2017-10-10 23:06:02.574767
NCT02506556|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2015-07-22|||July 2015||2015-07-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PIKNIC||Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer|A Phase II Exploratory, Open-label, Single Arm Study of BYL719 Monotherapy, a Selective Phosphatidylinositol 3-kinase (PI3K) Alpha Inhibitor, in Adult Patients With Advanced Breast Cancer Progressing After First Line Therapy.|Recruiting||Phase 2|34|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||f||||||||||2017-10-10 23:06:02.693961|2017-10-10 23:06:02.693961
NCT02506543|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2016-10-31|||August 2015||2015-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|COMPASS||Creating Opportunities Through Mentoring, Parental Involvement and Safe Spaces - Ethiopia|Creating Opportunities Through Mentoring, Parental Involvement and Safe Spaces - Ethiopia|Completed||N/A|1014|Actual|Columbia University||2|||f||||f||||||||Undecided||2017-10-10 23:06:02.806599|2017-10-10 23:06:02.806599
NCT02506530|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-11-12|||September 2015||2015-09-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|ELOCS||Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema, During an Intensive Decongestive Treatment|Contribution of an Endermologie LPG Cellu M6 Treatment in the Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema, During an Intensive Decongestive Treatment.|Recruiting||N/A|93|Anticipated|University Hospital, Toulouse||3|||f||||t||||||||||2017-10-10 23:06:02.913415|2017-10-10 23:06:02.913415
NCT02506517|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-06-21|||August 2015||2015-08-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene|Molecular Basket Trial In Multiple Malignancies With Common Target Pathway Aberrancies|Recruiting||Phase 2|30|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:06:03.033006|2017-10-10 23:06:03.033006
NCT02506504|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-04-12|||June 2014||2014-06-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|QUADRIVEND||Prevention of Post-exercise Muscle Fatigue and Effect on Exercise Training in Severe Patients With COPD.|Prevention of Post-exercise Muscle Fatigue Using a Non Invasive Ventilation and Effect on Exercise Training in Severe Patients With COPD. QUADRIVEND Study|Recruiting||N/A|28|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 23:06:03.163248|2017-10-10 23:06:03.163248
NCT02506491|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-09-11|||September 2014||2014-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Pilates Exercise Program for Improving Core Strength, Balance and Functional Autonomy in Aged Women|A Pilates Exercise Program for Improving Core Strength, Balance and Functional Autonomy in Aged Women: Study Protocol for a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|80|Anticipated|Universidad Católica San Antonio de Murcia||3|||f||||t||||||||||2017-10-10 23:06:03.300917|2017-10-10 23:06:03.300917
NCT02506478|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-12-23|||May 2015||2015-05-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|JUICED||Juice Preference in the Emergency Department|Journey to Understand and Interpret Juice Preference in the Emergency Department|Completed||N/A|385|Actual|Minneapolis Medical Research Foundation|||1||f||||f||||||||||2017-10-10 23:06:03.422883|2017-10-10 23:06:03.422883
NCT02506465|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-09-25|||October 2015||2015-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pivotal Study to Assess the Safety and Effectiveness of the iTIND Device|Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTIND) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)|Active, not recruiting||Phase 2|150|Anticipated|Medi-Tate Ltd.||2|||f||||t||||||||||2017-10-10 23:06:03.52638|2017-10-10 23:06:03.52638
NCT02506452|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-05-15|||June 2015||2015-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Postmarket Study to Evaluate Biovance® in Diabetic Foot Ulcers|Evaluation of Biovance, a Dehydrated Decellularized Human Amniotic Membrane Allograft, in Diabetic Foot Ulcers|Active, not recruiting||N/A|51|Actual|Alliqua BioMedical, Inc||2|||f||||f||||||||No||2017-10-10 23:06:03.647085|2017-10-10 23:06:03.647085
NCT02506244|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-06-20|||November 2015||2015-11-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|March 2019|Anticipated|2019-03-01||Interventional|mSToPS||mHealth Screening to Prevent Strokes|mHealth Screening to Prevent Strokes (mSToPS)|Active, not recruiting||N/A|2274|Actual|Scripps Translational Science Institute||2|||f||||t|f|t|f|f|f|||Undecided||2017-10-10 23:06:05.937503|2017-10-10 23:06:05.937503
NCT02506439|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-05-02|||November 1, 2014|Actual|2014-11-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|DMAT||Nutritional Requirements for Vitamin D in Pregnant Women|Randomized Controlled Trial to Determine the Nutritional Requirement for Vitamin D for Prevention of Deficiency During Pregnancy and in the Early Neonatal Period (D-MAT)|Completed||N/A|144|Actual|University College Cork||3|||f||||f||||||||Undecided|IPD may be considered, for vitamin D intake and 25(OH)D data. Please contact m.kiely@ucc.ie.|2017-10-10 23:06:03.774211|2017-10-10 23:06:03.774211
NCT02506426|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-21|||July 2015||2015-07-01|July 2015|2015-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Endoscopic Sinus Surgery for Refractory Chronic Sinusitis|Endoscopic Sinus Surgery for Refractory Chronic Sinusitis: A Randomized, Double-blind Controlled Trial|Recruiting||N/A|44|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 23:06:03.90068|2017-10-10 23:06:03.90068
NCT02506413|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-09-18|||April 2016||2016-04-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Replicating MamaToto in Rural Tanzania|Replicating MamaToto in Rural Tanzania|Recruiting||N/A|5000|Anticipated|University of Calgary||1|||f||||f||||||||||2017-10-10 23:06:04.036542|2017-10-10 23:06:04.036542
NCT02506400|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-11-15|||July 2014||2014-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:06:04.141784|2017-10-10 23:06:04.141784
NCT02506387|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2016-08-07|||January 2015||2015-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Belgian Mitraclip Registry||Recruiting||N/A|200|Anticipated|Universiteit Antwerpen|||1||f||||f||||||Samples Without DNA|"     serum sample   "|||2017-10-10 23:06:04.193097|2017-10-10 23:06:04.193097
NCT02506374|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-01-11|||November 2014||2014-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|BEST-Sleep||Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads|Project BEST-Sleep: A Pilot Study to Develop a Biobehavioral Self-Management Therapeutic Intervention for Sleep in Alzheimer/Caregiver Dyads|Withdrawn||N/A|0|Actual|Yale University|||1|Never able to get any subjects enrolled|f||||f||||||||||2017-10-10 23:06:04.306125|2017-10-10 23:06:04.306125
NCT02506361|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-07-21|||May 2015||2015-05-01|May 2015|2015-05-01|October 2025|Anticipated|2025-10-01|May 2025|Anticipated|2025-05-01||Observational|||Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer|Evaluation of the Relationship of TOP2α Expression and Effect of Anthracyclines Followed Taxanes or Contains no Taxanes Non Dose-dense Chemotherapy for Breast Cancer: a Prospective, Non-interventional, Multicentre Trail|Recruiting||N/A|800|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||1||f||||t||||||||||2017-10-10 23:06:04.377976|2017-10-10 23:06:04.377976
NCT02506348|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-22|||July 2015||2015-07-01|July 2015|2015-07-01||||January 2016|Anticipated|2016-01-01||Interventional|||Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort||Unknown status|Recruiting|N/A|30|Anticipated|Wolfson Medical Center||1|||f||||f||||||||||2017-10-10 23:06:04.458644|2017-10-10 23:06:04.458644
NCT02506335|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-08-02|||June 2015||2015-06-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease|Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Passive Hepatic Congestion Secondary to Congenital Heart Disease (CHD) or Cardiomyopathy|Enrolling by invitation||Early Phase 1|10|Anticipated|Northwestern University||1|||f||||f||||||||No||2017-10-10 23:06:04.549886|2017-10-10 23:06:04.549886
NCT02506322|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-08-03|||August 2015||2015-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Interventional|A2BipoLife||Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolar Disorder|Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolar Disorder|Recruiting||N/A|300|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-10 23:06:04.660574|2017-10-10 23:06:04.660574
NCT02506309|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-04-30|2016-07-22||January 2012||2012-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2014|Actual|2014-12-01||Interventional|||Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence|Prospective Randomized Comparison of the Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence|Active, not recruiting||N/A|93|Actual|Brno University Hospital||2|||f||||f||||||||||2017-10-10 23:06:04.804597|2017-10-10 23:06:04.804597
NCT02506296|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-04-11|||October 2014||2014-10-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|GREAT||Glucose Response, Excursions And Treatment (GREAT) Study|The Influence of Residual Beta Cell Function on Hypoglycaemia Risk and Treatment Response in Type 2 Diabetes|Completed||N/A|53|Actual|Royal Devon and Exeter NHS Foundation Trust||1|||f||||f||||||||Undecided|access to data may be allowed via application to the study Chief Investigator|2017-10-10 23:06:05.13508|2017-10-10 23:06:05.13508
NCT02506283|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-10-04|||May 2015||2015-05-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|Cryotherapy||The Effect of Thermotherapy on Recovery and Performance|The Effect of Cryotherapy on Recovery and Performance: A Randomized Controlled Double Blind Trial|Active, not recruiting||N/A|40|Anticipated|University of Applied Sciences and Arts of Southern Switzerland||2|||f||||t||||||||||2017-10-10 23:06:05.255419|2017-10-10 23:06:05.255419
NCT02506270|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-21|||September 2014||2014-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Airseal System Valve-less Trocar on the Ventilatory Parameters During Robotic-assisted Radical Cystectomy||Completed||N/A|56|Actual|Regina Elena Cancer Institute||2|||f||||||||||||||2017-10-10 23:06:05.359193|2017-10-10 23:06:05.359193
NCT02506257|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-12-15|2016-08-05||November 2015||2015-11-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Adult healthy volunteers|Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects|Randomized, Double-Masked, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety and Tolerability of Different Doses of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects|Completed||Phase 1|90|Actual|SIFI SpA||4|||f||||t||||||||Undecided||2017-10-10 23:06:05.448662|2017-10-10 23:06:05.448662
NCT02506231|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-07-23|||October 2015||2015-10-01|June 2015|2015-06-01||||October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome|The Effect of Folinic Acid Rescue Following Methotrexate (MTX) Graft-versus-host Disease (GVHD) Prophylaxis on Regimen Related Toxicity and Transplantation Outcome: a Double Blind Randomized Controlled Study|Unknown status|Not yet recruiting|Phase 2/Phase 3|160|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:06:06.011966|2017-10-10 23:06:06.011966
NCT02506218|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-08-10|||April 2015||2015-04-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|S43||Optimizing Meal and Snack Timing to Promote Health|Optimizing Meal and Snack Timing to Promote Health|Unknown status|Active, not recruiting|N/A|18|Anticipated|Purdue University||3|||f||||f||||||||||2017-10-10 23:06:06.101902|2017-10-10 23:06:06.101902
NCT02506205|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-21|||October 2014||2014-10-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effect of LSVT LOUD for Mandarin-speaking Individuals With Hypokinetic Dysarthria Due to Parkinson's Disease||Unknown status|Recruiting|N/A|40|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-10-10 23:06:06.162381|2017-10-10 23:06:06.162381
NCT02506192|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-09-13|||July 2015||2015-07-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|GWIIRT||Gulf War Illness Inflammation Reduction Trial|Gulf War Illness Inflammation Reduction Trial|Recruiting||Phase 3|100|Anticipated|Minneapolis Veterans Affairs Medical Center||2|||f||||t||||||||||2017-10-10 23:06:06.246194|2017-10-10 23:06:06.246194
NCT02506166|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-22|||January 2016||2016-01-01|July 2015|2015-07-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|ESCAPE-SCD||European Sleep Apnea and Sudden CArdiac Death ProjEct|European Sleep Apnea and Sudden CArdiac Death ProjEct|Not yet recruiting||N/A|900|Anticipated|University Hospital Olomouc||4|||f||||t||||||||||2017-10-10 23:06:06.716699|2017-10-10 23:06:06.716699
NCT02506153|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-22|2017-10-02|||October 15, 2015|Actual|2015-10-15|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery|A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma|Active, not recruiting||Phase 3|1378|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 23:06:06.901662|2017-10-10 23:06:06.901662
NCT02506140|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2017-03-16|||August 2015||2015-08-01|March 2017|2017-03-01|March 14, 2018|Anticipated|2018-03-14|June 5, 2017|Anticipated|2017-06-05||Interventional|PRINCE||Platelet Reactivity in Acute Non-disabling Cerebrovascular Events|A Randomized, Open-label, Active-Controlled and Blinded-Endpoint Trial Comparing the Antiplatelet Effects of Ticagrelor Plus Aspirin Versus Clopidogrel Plus Aspirin in Chinese Patients With High-risk Transient Ischemic Attack or Minor Stroke.|Recruiting||Phase 2/Phase 3|952|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-10-10 23:06:08.467207|2017-10-10 23:06:08.467207
NCT02506127|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-05-01|||October 2016||2016-10-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|iTBS||Intermittent Theta Burst Stimulation for MDD|A Sham-controlled Study of Prefrontal Intermittent Theta Burst Stimulation in Major Depressive Disorder|Active, not recruiting||N/A|30|Anticipated|University of California, Los Angeles||3|||f||||f||f||||||||2017-10-10 23:06:08.64748|2017-10-10 23:06:08.64748
NCT02506114|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-06|||August 2016||2016-08-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer|An Open Label, Randomized Phase 2 Trial of Prostvac and Ipilimumab as Monotherapy or in Combination for Men With Localized Prostate Cancer Undergoing Radical Prostatectomy|Recruiting||Phase 2|75|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-10 23:06:08.717948|2017-10-10 23:06:08.717948
NCT02506088|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-08-28|||September 2015||2015-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Preventing Sexual Aggression Among High School Boys|Preventing Sexual Aggression Among High School Boys|Active, not recruiting||N/A|9000|Anticipated|Lifespan||2|||f||||t||||||||||2017-10-10 23:06:08.860146|2017-10-10 23:06:08.860146
NCT02506075|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-21|||April 2015||2015-04-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||A Study of tDCS for Unilateral Neglect in Stroke Patients|Effectiveness of Transcranial Direct Current Stimulation for Unilateral Neglect After Stroke|Unknown status|Recruiting|N/A|105|Anticipated|Pusan National University||3|||f||||f||||||||||2017-10-10 23:06:08.934953|2017-10-10 23:06:08.934953
NCT02506062|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-01|||July 2015||2015-07-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)|A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)|Enrolling by invitation||N/A|24|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:06:09.027237|2017-10-10 23:06:09.027237
NCT02506049|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-21|||April 2010||2010-04-01|June 2015|2015-06-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Interventional|TTTS||Laser Photocoagulation in Twin to Twin Transfusion Syndrome|Fetoscopic Directed Laser Photocoagulation of Communicating Placental Vessels in Twin to Twin Transfusion Syndrome|Enrolling by invitation||N/A|100|Anticipated|University of Tennessee||1|||f||||f||||||||||2017-10-10 23:06:09.151572|2017-10-10 23:06:09.151572
NCT02506036|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-04-07|||August 2015||2015-08-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia|Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia|Recruiting||N/A|50|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:06:09.216954|2017-10-10 23:06:09.216954
NCT02506023|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-08-16|||July 2015||2015-07-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers|Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers|Enrolling by invitation||Phase 1|25|Anticipated|Emory University||3|||f||||f||||||||||2017-10-10 23:06:09.290135|2017-10-10 23:06:09.290135
NCT02506010|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-10-14|||November 2016||2016-11-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Accuracy Validation of a Pulse Oximetry Monitor|SpO2 Accuracy Validation of a USB Pulse Oximetry Monitor Interface Cable Via Reference Co-Oximetry|Withdrawn||N/A|0|Actual|Medtronic - MITG|||1|Sponsor decided not to run this study.|f||||f||||||||Undecided|This study was cancelled.|2017-10-10 23:06:09.373318|2017-10-10 23:06:09.373318
NCT02505997|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-12-15|||June 2015||2015-06-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects|A Phase I Study to Evaluate the Effect of Repeated Oral Doses of Delafloxacin on the Pharmacokinetics of a Single Oral Dose of Midazolam in Healthy Subjects|Completed||Phase 1|22|Actual|Melinta Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 23:06:09.425902|2017-10-10 23:06:09.425902
NCT02505984|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2017-02-21|||October 2015||2015-10-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|IN-OXT||Preventing Postpartum Depression With Intranasal Oxytocin|Testing the Efficacy of Intranasal Oxytocin for the Prevention of Postpartum Depression and PTSD|Recruiting||Phase 2|20|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 23:06:09.51982|2017-10-10 23:06:09.51982
NCT02505971|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-01-04|||September 2015||2015-09-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nadolol Versus Propranolol in Children With Infantile Hemangiomas|Nadolol Versus Propranolol in Children With Infantile Hemangiomas: a Randomized, Controlled, Double-blinded Trial|Recruiting||Phase 3|80|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 23:06:09.630991|2017-10-10 23:06:09.630991
NCT02505958|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-01-07|||August 2014||2014-08-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||How Quickly Can the Effects of Excessive Caloric Intake on Insulin Resistance be Reversed?|How Quickly Can the Effects of Excessive Caloric Intake on Insulin Resistance be Reversed?|Active, not recruiting||N/A|1|Actual|Temple University||2|||f||||f||||||||||2017-10-10 23:06:09.746432|2017-10-10 23:06:09.746432
NCT02505945|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-07-20|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|CALIBER||The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease|The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease|Active, not recruiting||Phase 4|150|Actual|Torax Medical Incorporated||2|||f||||f||||||||||2017-10-10 23:06:09.848095|2017-10-10 23:06:09.848095
NCT02505932|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-20|||January 2012||2012-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Observational|Latarjet||Latarjet Procedure: Comparative Outcomes Study of Arthroscopic Versus Mini-open Approach With Minimum 2-year Follow-up|Latarjet Procedure: Comparative Outcomes Study of Arthroscopic Versus Mini-open Approach With Minimum 2-year Follow-up|Completed||N/A|58|Actual|Hospital Ambroise Paré Paris|||2||f||||f||||||||||2017-10-10 23:06:12.205052|2017-10-10 23:06:12.205052
NCT02505919|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-13|||November 2015|Actual|2015-11-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|June 2017|Anticipated|2017-06-01||Interventional|WATER||Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)|A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS|Active, not recruiting||N/A|203|Actual|PROCEPT BioRobotics||2|||f||||t||||||||||2017-10-10 23:06:12.287698|2017-10-10 23:06:12.287698
NCT02505906|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-10-25|||January 2008||2008-01-01|October 2016|2016-10-01||||January 2025|Anticipated|2025-01-01|5 Years|Observational [Patient Registry]|FUSIB||Late Toxicity in Breast Cancer Patients Treated With Breast-conserving Surgical Procedures and Radiotherapy Using the Simultaneous Integrated Boost Technique||Recruiting||N/A|10000|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:06:12.391439|2017-10-10 23:06:12.391439
NCT02505893|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-02-13|||April 2015||2015-04-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|MITO||Minimal Islet Transplant at Diabetes Onset|A Monocentric, Open-label Pilot Study to Assess the Safety and Efficacy of Minimal Islet Transplantation in Patients With New-onset Type 1 Diabetes|Recruiting||Phase 2|6|Anticipated|Ospedale San Raffaele||1|||f||||||||||||||2017-10-10 23:06:12.465918|2017-10-10 23:06:12.465918
NCT02505880|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-07-21|||June 2015||2015-06-01|July 2015|2015-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Hypnosis Versus General Anesthesia in Pediatric Surgery: Clinical and Medico-economic Interests|Evaluation of Perioperative Use of Hypnosis in Pediatric Surgery: Clinical and Medico-economic Interests|Unknown status|Active, not recruiting|N/A|60|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:06:12.583058|2017-10-10 23:06:12.583058
NCT02505867|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-01-13|||November 2014||2014-11-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|January 2017|Actual|2017-01-01||Interventional|||The Role of Sleep Disordered Breathing in Heart Failure Admissions|The Role of Sleep Disordered Breathing in Heart Failure Admissions|Terminated||Phase 2|12|Actual|Ohio State University||2||lack of funding|f||||t||||||||No||2017-10-10 23:06:12.672664|2017-10-10 23:06:12.672664
NCT02505854|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-05-01|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2016|Actual|2016-12-01||Interventional|||Influence of Probiotic and Symbiotic in Body Weight, Blood Sugar and Lipemia of Obese Women|Influence of Probiotic and Symbiotic in Body Weight, Blood Sugar and Lipemia of Obese Women|Active, not recruiting||N/A|32|Actual|Universidade Federal do Rio de Janeiro||3|||f||||f||||||||Undecided||2017-10-10 23:06:12.746854|2017-10-10 23:06:12.746854
NCT02505841|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-07-20|||May 2015||2015-05-01|May 2015|2015-05-01|June 2017|Anticipated|2017-06-01|May 2015|Actual|2015-05-01||Interventional|||Transversus Abdominis Plane Block for Laparoscopic Appendicectomy in Children|Transversus Abdominis Plane (TAP) Block for Laparoscopic Appendicectomy in Children: Opioid Saving and Alternative in the Curarization|Unknown status|Active, not recruiting|N/A|240|Anticipated|University Hospital, Montpellier||3|||f||||f||||||||||2017-10-10 23:06:12.847543|2017-10-10 23:06:12.847543
NCT02505828|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-07-20|||April 2015||2015-04-01|June 2015|2015-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|ARTEMIS||ARTEMIS Synovial Markers in Arthritis Childhood|ARTEMIS Synovial Markers in Arthritis Childhood|Unknown status|Active, not recruiting|N/A|30|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:06:12.949258|2017-10-10 23:06:12.949258
NCT02505815|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-07-20|||September 2014||2014-09-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|245_14_B||Neurocognitive Function After Regional and General Anesthesia (245_14 B)|Neurocognitive Function After Regional and General Anesthesia: a Randomized Control Trial|Unknown status|Recruiting|N/A|80|Anticipated|University of Erlangen-Nürnberg Medical School|||2||f||||f||||||||||2017-10-10 23:06:14.52561|2017-10-10 23:06:14.52561
NCT02505802|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-20|||January 2014||2014-01-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke Adults|Phase III Study of Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke Adults|Unknown status|Recruiting|Phase 4|30|Anticipated|Sir Run Run Shaw Hospital||2|||f||||t||||||||||2017-10-10 23:06:14.609899|2017-10-10 23:06:14.609899
NCT02505789|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-20|||May 2013||2013-05-01|July 2015|2015-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|TREASuRE||Transfusion-related EBV Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients|Transfusion-related Epstein-Barr Virus (EBV) Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients: a Multicenter Prospective Cohort Study (TREASuRE Study)|Recruiting||N/A|324|Anticipated|St. Justine's Hospital|||1||f||||f||||||||||2017-10-10 23:06:14.707932|2017-10-10 23:06:14.707932
NCT02505776|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-07-24|||December 8, 2014|Actual|2014-12-08|July 2017|2017-07-01|June 8, 2018|Anticipated|2018-06-08|June 8, 2018|Anticipated|2018-06-08||Observational|||Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan||Active, not recruiting||N/A|1704|Actual|Allergan|||1||f||||f|f|f||||||||2017-10-10 23:06:14.832774|2017-10-10 23:06:14.832774
NCT02505763|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-21|||July 2015||2015-07-01|July 2015|2015-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|ECHOPLEV||Thoracic Ultrasound in the Treatment of Pleural Effusion|Treatment of Pleural Effusion by Routine Thoracic Ultrasound|Recruiting||N/A|144|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-10 23:06:14.913894|2017-10-10 23:06:14.913894
NCT02505750|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-02-21|||March 2015||2015-03-01|February 2016|2016-02-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|OPERA||Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma|European Phase III Study Comparing a Radiation Dose Escalation Using 2 Different Approaches : External Beam Radiation Therapy Versus Endocavitary Radiation Therapy With Contact X-ray Brachytherapy 50 kiloVolts (kV) for Patients With Rectal Adenocarcinoma|Recruiting||Phase 3|236|Anticipated|Centre Antoine Lacassagne||2|||f||||t||||||||||2017-10-10 23:06:15.019104|2017-10-10 23:06:15.019104
NCT02505737|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-10-28|||July 2015||2015-07-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TH-CBT||Telephone-Based Counseling for Depression in Parkinson's Disease|Improving Access to Depression Care in Parkinson's Disease: A Telehealth Approach|Recruiting||Phase 2|144|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 23:06:15.223088|2017-10-10 23:06:15.223088
NCT02505724|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-21|||July 2014||2014-07-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Peer-coaching to Teach Faculty Surgeons an Advanced Laparoscopic Skill||Completed||N/A|18|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 23:06:15.395104|2017-10-10 23:06:15.395104
NCT02505711|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-11-04|||August 2015||2015-08-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|FAARM||Food and Agricultural Approaches to Reducing Malnutrition|Reducing Young Child Undernutrition Through an Integrated Agricultural Project With Women's Groups: A Cluster-randomized Trial in Rural Bangladesh|Enrolling by invitation||N/A|2700|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-10 23:06:15.484252|2017-10-10 23:06:15.484252
NCT02505698|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-03-07|||October 2015||2015-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment|A Data Collection Study for the Evaluation of Real Imaging's Real Imager 8 (RI-8) Developed for Risk Assessment of Breast Cancer|Suspended||N/A|300|Anticipated|Real Imaging Ltd.|||1|Suspended|f||||f||||||||||2017-10-10 23:06:15.601985|2017-10-10 23:06:15.601985
NCT02505685|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-11-17|||June 2015||2015-06-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Observational|||Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer|Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer|Active, not recruiting||N/A|200|Anticipated|Rabin Medical Center|||1||f||||f||||||||No|article will be released|2017-10-10 23:06:15.681076|2017-10-10 23:06:15.681076
NCT02505672|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2016-04-16|||August 2016||2016-08-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Observational|||Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma|Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma|Not yet recruiting||N/A|50|Anticipated|Rabin Medical Center|||1||f||||f||||||||||2017-10-10 23:06:15.801527|2017-10-10 23:06:15.801527
NCT02505659|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-07-28|||February 2015||2015-02-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|PRELIG||Efficacy of Preoperative Re-education on Patients With an Anterior Cruciate Ligament Rupture|Efficacy of Preoperative Re-education on Patients With an Anterior Cruciate Ligament Rupture: a Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:06:15.913077|2017-10-10 23:06:15.913077
NCT02505646|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-12-25|||July 2015||2015-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|FRANCK||Fluid Responsiveness Evaluation by AbdomiNal Compression in Kids Based on the STARLING Concept|Fluid Responsiveness Evaluation by AbdomiNal Compression in Kids Based on the STARLING Concept|Completed||N/A|40|Actual|Hopital Louis Pradel|||1||f||||f||||||||||2017-10-10 23:06:16.055232|2017-10-10 23:06:16.055232
NCT02505633|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-09-08|||July 2015||2015-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|US-SCBPB||Comparison 1 Plane-1 Injection and 2 Plane-2 Injection Ultrasound-guided Supraclavicular Brachial Plexus Block|A Randomized Comparison Between 1 Plane - 1 Injection (Cluster Approach) and 2 Plane - 2 Injection Ultrasound-guided Supraclavicular Brachial Plexus Block (US-SCBPB) in Upper Extremity Surgery|Completed||N/A|36|Actual|Gachon University Gil Medical Center||2|||f||||f||||||||||2017-10-10 23:06:16.144878|2017-10-10 23:06:16.144878
NCT02505620|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-07-20|||September 2014||2014-09-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|203_14_B||Neurocognitive Function After Therapy of OSAS|Neurocognitive Function After Surgical and Conservative Therapy in OSAS Patients: a Randomized Control Trial|Unknown status|Recruiting|Early Phase 1|80|Anticipated|University of Erlangen-Nürnberg Medical School|||2||f||||f||||||||||2017-10-10 23:06:16.242191|2017-10-10 23:06:16.242191
NCT02505607|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-12-29|||July 2015||2015-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Overactive Bladder Education|Overactive Bladder Education|Terminated||N/A|22|Actual|Hartford Hospital||2||feasibility issues|f||||f||||||||||2017-10-10 23:06:16.35416|2017-10-10 23:06:16.35416
NCT02505594|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2017-02-03|||July 2015||2015-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Potential Mechanism of Exercise Impairment in OSA|Pulmonary Vasoreactivity as a Potential Mechanism of Exercise Impairment in Obstructive Sleep Apnea|Recruiting||N/A|60|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-10-10 23:06:16.435548|2017-10-10 23:06:16.435548
NCT02505581|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-05-14|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|PROF-ATB||Parenteral Antibiotics Compared to Combination of Oral and Parenteral Antibiotics in Colorectal Surgery Prophylaxis|Parenteral Antibiotics Compared to Combination of Oral and Parenteral Antibiotics. A Prospective, Randomized, Controlled, Multicentric Study (PROF-ATB Trial)|Recruiting||Phase 4|536|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||No||2017-10-10 23:06:16.532477|2017-10-10 23:06:16.532477
NCT02505568|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-09-05|||July 22, 2015|Actual|2015-07-22|September 2017|2017-09-01|January 31, 2019|Anticipated|2019-01-31|December 31, 2017|Anticipated|2017-12-31||Interventional|BEGIN||A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease|An Interventional, Open-label, Single Arm, Multicenter Study to Evaluate Efficacy and Safety of Infliximab in Subject With Moderate-to-Severe Refractory Intestinal Behcet's Disease|Recruiting||Phase 3|37|Anticipated|Janssen Korea, Ltd., Korea||1|||f||||f|f|f||||||||2017-10-10 23:06:16.662738|2017-10-10 23:06:16.662738
NCT02505555|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-04|2015-07-21|||February 2013||2013-02-01|July 2015|2015-07-01||||February 2016|Anticipated|2016-02-01||Observational|||Feasibility of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency|Accuracy and Tolerability of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency|Unknown status|Recruiting|N/A|380|Anticipated|Peking University First Hospital|||1||f||||||||||||||2017-10-10 23:06:16.772248|2017-10-10 23:06:16.772248
NCT02505542|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-27|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|C-OPTIMISE||Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo|A Multicenter, Open-label (Part A) Followed by a Randomized, Double-blind, Parallel-group, Placebo Controlled Study (Part B) to Evaluate Maintenance of Remission in Subjects With Active Axial Spondyloarthritis (axSpA) Receiving Either Certolizumab Pegol 200 mg Q2W or 200 mg Q4W as Compared to Placebo|Active, not recruiting||Phase 3|736|Actual|UCB Pharma||7|||f||||f||||||||||2017-10-10 23:06:16.865479|2017-10-10 23:06:16.865479
NCT02505529|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-10-03|||July 2015||2015-07-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The UNCODE Study: Unravelling the Neural Contributors Of Dynapenia in Elders|Neural Mechanisms of Dynapenia|Recruiting||N/A|100|Anticipated|Ohio University||3|||f||||f||||||||Undecided||2017-10-10 23:06:17.355162|2017-10-10 23:06:17.355162
NCT02505516|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-21|||June 2013||2013-06-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS|BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION|Completed||Early Phase 1|150|Actual|University of Cape Coast||2|||f||||f||||||||||2017-10-10 23:06:17.975773|2017-10-10 23:06:17.975773
NCT02505503|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-09-13|||July 2015||2015-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|YORVIC||York Study of Unloading Shoes for Vascular Intermittent Claudication|Randomised Crossover Study With Nested Qualitative Component Investigating the Clinical Efficacy and Acceptability of Unloading Shoes in Patients With Intermittent Claudication Due to Peripheral Arterial Disease|Completed||N/A|38|Actual|York Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:06:18.057797|2017-10-10 23:06:18.057797
NCT02505490|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-07-14|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||The Effect of Television Watching on Liking of Food|The Effect of Television Watching on Liking of Food in Normal Weight Adults 18-35|Completed||N/A|20|Actual|University of Tennessee||2|||f||||f||||||||||2017-10-10 23:06:18.167402|2017-10-10 23:06:18.167402
NCT02505477|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-02-08|||February 6, 2017|Actual|2017-02-06|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|NAC2||Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine|Mechanisms of Improving Cognition and Negative Symptoms in Schizophrenia With N-Acetylcysteine: a Magnetic Resonance Spectroscopy Study of Glutamate and Glutathione|Recruiting||Phase 4|40|Anticipated|University of California, Los Angeles||2|||f||||f|t|f||||||No||2017-10-10 23:06:18.264992|2017-10-10 23:06:18.264992
NCT02505464|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-27|||May 2015||2015-05-01|June 2015|2015-06-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01|12 Months|Observational [Patient Registry]|FAR||Pregnancies Complicated by Fetal Anomalies|Characteristics of Pregnancies Complicated by Fetal Anomalies|Unknown status|Recruiting|N/A|500|Anticipated|University of Tennessee|||1||f||||f||||||||||2017-10-10 23:06:18.389504|2017-10-10 23:06:18.389504
NCT02505256|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2015-07-21|||April 2015||2015-04-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Study Into Treatment of Hyperplasia of Mammary Glands|Study Into Treatment of Hyperplasia of Mammary Glands|Recruiting||N/A|5000|Anticipated|Shandong University|||1||f||||f||||||None Retained|"     breast tissues   "|||2017-10-10 23:06:20.601719|2017-10-10 23:06:20.601719
NCT02505451|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2016-10-25|||July 2015||2015-07-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes|Comprehensive Analysis of Regional Myocardial Function in Response to Dobutamine Stress in Metabolic Syndrome and Type 2 Diabetic Patients. Effect of Cardiac Adiposity, Inflammation and Hyperglycaemia|Recruiting||N/A|115|Anticipated|University of Avignon||3|||f||||f||||||||||2017-10-10 23:06:18.490638|2017-10-10 23:06:18.490638
NCT02505438|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-12-08|||April 2013||2013-04-01|December 2015|2015-12-01||||December 2015|Anticipated|2015-12-01||Interventional|||Application of Deuterated Water (D2O) to Define the Etiology of Musculoskeletal Decline in Ageing and the Efficacy of Nutritional Supplementation||Recruiting||N/A|48|Anticipated|University of Nottingham||4|||f||||f||||||||||2017-10-10 23:06:18.593186|2017-10-10 23:06:18.593186
NCT02505425|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-04|||October 2015||2015-10-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|January 2020|Anticipated|2020-01-01||Interventional|ENABLE CHF PC||ENABLE CHF-PC (Comprehensive Heartcare For Patients and Caregivers)|Randomized Trial of ENABLE CHF-PC for Heart Failure Patients and Caregivers. (Comprehensive Heartcare For Patients and Caregivers)|Recruiting||N/A|462|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 23:06:18.721341|2017-10-10 23:06:18.721341
NCT02505412|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-21|||October 2015||2015-10-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Subtle Myocardial Deformation Abnormalities in Asymptomatic Nf-1 Patients|Prevalence of Subtle Myocardial Deformation Abnormalities in Asymptomatic Nf-1 Patients: is Cardiac Screening Needed?|Not yet recruiting||N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||||||2017-10-10 23:06:18.883022|2017-10-10 23:06:18.883022
NCT02505399|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-05-06|||November 2015||2015-11-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|TIRATROP||TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement: the TIRATROP Study|TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement: the TIRATROP Study, a Randomized Controlled Trial|Recruiting||Phase 4|180|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:06:18.966432|2017-10-10 23:06:18.966432
NCT02505386|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-09-22|||August 2014||2014-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|PHACINERTA||Pharmacokinetics of Ertapenem in Patients Aged Over 75|Pharmacokinetics of Ertapenem Following Subcutaneous or Intravenous Infusion in Patients Aged Over 75 (PHACINERTA)|Completed||Phase 4|27|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:06:19.145049|2017-10-10 23:06:19.145049
NCT02505373|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-01-13|||January 2009||2009-01-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|ASSIP||ASSIP, Attempted Suicide Short Intervention Program. Two Year Follow-Up Study|A Novel Brief Therapy for Attempted Suicide: Two Year Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP)|Completed||N/A|120|Actual|University of Bern||2|||f||||f||||||||||2017-10-10 23:06:19.281701|2017-10-10 23:06:19.281701
NCT02505360|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2015-07-21|||November 2014||2014-11-01|July 2015|2015-07-01||||November 2016|Anticipated|2016-11-01||Interventional|CARTOON||Biochemical and Histological Comparison of Nasal and Auricular Cartilage in the Fetus and Newborn With Cleft Lip Carrier|Comparaison Biochimique et Histologique Des Cartilages Nasal et Auriculaire Chez le fœtus et le Nouveau-né Porteur de Fente Labiale|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:06:19.412802|2017-10-10 23:06:19.412802
NCT02505347|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-10-13|||July 2015||2015-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Early Functional Return to Work Following Distal Biceps Repair|Early Functional Return to Work Following Distal Biceps Repair|Recruiting||Phase 4|100|Anticipated|Shoulder & Upper Extremity Research Group of Edmonton||2|||f||||f||||||||||2017-10-10 23:06:19.491126|2017-10-10 23:06:19.491126
NCT02505334|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-07-25|||July 28, 2015|Actual|2015-07-28|July 2017|2017-07-01|November 10, 2017|Anticipated|2017-11-10|November 10, 2017|Anticipated|2017-11-10||Interventional|||A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus|A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 3|470|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 23:06:19.607344|2017-10-10 23:06:19.607344
NCT02505321|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-08-17|||May 29, 2015|Actual|2015-05-29|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|fATDIVA||for Adipose Tissue DIabetes VAriants (fATDIVA)|Defining Adipose Tissue Lipid Deposition in Normal Weight Individuals With a Genetic Predisposition to Insulin Resistance|Recruiting||N/A|300|Anticipated|NIHR Exeter Clinical Research Facility||2|||f||||f||||||||||2017-10-10 23:06:19.787382|2017-10-10 23:06:19.787382
NCT02505308|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-08-17|||March 2015||2015-03-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|DIVA-Exeter||Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes|Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes (DIabetes VAriants)|Recruiting||N/A|260|Anticipated|NIHR Exeter Clinical Research Facility||2|||f||||f||||||||||2017-10-10 23:06:19.916366|2017-10-10 23:06:19.916366
NCT02505295|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2015-07-21|||July 2015||2015-07-01|July 2015|2015-07-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Selenium and Ischemic Stroke Outcome|Evaluation of Selenium Supplementation in Ischemic Stroke Outcome|Unknown status|Not yet recruiting|Early Phase 1|40|Anticipated|Mazandaran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:06:20.049366|2017-10-10 23:06:20.049366
NCT02505282|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-23|||April 2012||2012-04-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Observational|VITKOH||Vitamin K Status and Markers of Vascular Function in Patients With and Without Postural Hypotension|Vitamin K Status and Markers of Vascular Function in Patients With and Without Postural Hypotension|Completed||N/A|49|Actual|University of Dundee|||2||f||||f||||||||||2017-10-10 23:06:20.190396|2017-10-10 23:06:20.190396
NCT02505269|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-06-19|||August 7, 2015|Actual|2015-08-07|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|April 2019|Anticipated|2019-04-01||Interventional|||Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma|Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma|Recruiting||Phase 2|34|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:06:20.47039|2017-10-10 23:06:20.47039
NCT02505243|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-09-15|||June 2015||2015-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|RIBACOP||Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens|Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens|Completed||N/A|252|Actual|Radboud University|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-10 23:06:20.697708|2017-10-10 23:06:20.697708
NCT02505230|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-07-14|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Meal Presentation and Liking|Meal Presentation and Liking|Active, not recruiting||N/A|45|Anticipated|University of Tennessee||4|||f||||f||||||||||2017-10-10 23:06:20.793503|2017-10-10 23:06:20.793503
NCT02505217|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2016-06-15|||July 2015||2015-07-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Observational|||Novel Biomarkers of Thrombotic Risk||Recruiting||N/A|200|Anticipated|University of Vermont|||1||f||||f||||||Samples Without DNA|"     Blood for measuring clot generation, coagulation factors, and platelet measures   "|||2017-10-10 23:06:20.887742|2017-10-10 23:06:20.887742
NCT02505204|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-01-07|||August 2015||2015-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||PVB With vs. Without Clonidine for Ventral Hernia Repair|Paravertebral Block With Versus Without Clonidine for Patients Undergoing Ventral Hernia Repair: A Prospective Double-blinded Randomized Study|Recruiting||N/A|60|Anticipated|Makassed General Hospital||2|||f||||||||||||||2017-10-10 23:06:20.969022|2017-10-10 23:06:20.969022
NCT02505191|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-01-30|||November 2015||2015-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117|A Pilot Phase I, Randomised, Open Mono-center, Multiple Dose, Two Parallel Groups Clinical Trial Investigating the Pharmacokinetics of a Prolonged-release Formulation in Comparison to an Immediate-release Formulation of St. John's Wort Extract Ze 117 in Healthy Male Volunteers Under Fasting Condition|Completed||Phase 1|10|Actual|Max Zeller Soehne AG||2|||f||||f||||||||||2017-10-10 23:06:21.080505|2017-10-10 23:06:21.080505
NCT02505178|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2017-08-22|||August 2015||2015-08-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Examining the Feasibility and Effectiveness of Case Manager Delivered Problem Solving Therapy on Late Life Depression|Examining the Feasibility and Effectiveness of Case Manager Delivered Problem Solving Therapy on Late Life Depression; an Open-label Prospective Pilot Study.|Recruiting||N/A|90|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-10 23:06:21.176814|2017-10-10 23:06:21.176814
NCT02505165|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-09-28|||November 2015||2015-11-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|IMPACT||Illness Management and Parental Adjustment to Cancer Treatment|A Clinic-Based Interdisciplinary Intervention for Parents of Children With Cancer|Recruiting||N/A|296|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 23:06:21.296267|2017-10-10 23:06:21.296267
NCT02505152|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-11-10|||October 2010||2010-10-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy||Recruiting||N/A|50|Anticipated|Sun Yat-sen University||1|||f||||||||||||||2017-10-10 23:06:21.422205|2017-10-10 23:06:21.422205
NCT02505139|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-08-25|||December 2014||2014-12-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients|Using Circulating Tumor Cells to Diagnose and Predict Prognosis in Metastatic Nasopharyngeal Carcinoma Patients|Completed||N/A|166|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples Without DNA|"     The blood after separation and purification along with or without CTC.   "|||2017-10-10 23:06:21.52074|2017-10-10 23:06:21.52074
NCT02505126|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-07-29|||September 2015||2015-09-01|June 2015|2015-06-01||||March 2018|Anticipated|2018-03-01||Interventional|REDSTIM||A Clinical Trial on the Efficacy of tDCS) in Reducing Alcohol Consumption in Non-abstinent Patients (REDSTIM)|A Randomized Double-blind Clinical Trial on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Reducing Alcohol Consumption in Non-abstinent Patients With Alcohol Use Disorder|Recruiting||N/A|340|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 23:06:21.596142|2017-10-10 23:06:21.596142
NCT02505113|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-10-28|||October 2010||2010-10-01|October 2015|2015-10-01||||December 2020|Anticipated|2020-12-01||Observational|||Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis||Recruiting||N/A|150|Anticipated|Sun Yat-sen University|||2||f||||||||||||||2017-10-10 23:06:21.689497|2017-10-10 23:06:21.689497
NCT02505100|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-08-12|||October 2015||2015-10-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|Hypnorelax||Impact of Complementary Medicine Techniques (Therapeutic Touch and Hypno Analgesia) on the Term of Delivery of Patients Hospitalized for Preterm Labor (Hypnorelax)|Impact of Complementary Medicine Techniques (Therapeutic Touch and Hypno Analgesia) on the Term of Delivery of Patients Hospitalized for Preterm Labor (Hypnorelax)|Recruiting||N/A|150|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 23:06:21.781813|2017-10-10 23:06:21.781813
NCT02505087|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-11-18|||September 2015||2015-09-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SelNac||Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)|Pharmacological Treatment of a Rare Genetic Disease: Pilot Trial Phase II-III With N-acetylcysteine in Myopathy Associated SEPN1-RM (Selenoprotein N-related Myopathy)|Recruiting||Phase 2/Phase 3|48|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 23:06:21.874373|2017-10-10 23:06:21.874373
NCT02505074|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-01-30|||December 2014||2014-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Natural History of Melody Valve in the Mitral and Tricuspid Position|Natural History of Melody Valve in the Mitral and Tricuspid Position|Active, not recruiting||N/A|100|Anticipated|Boston Children’s Hospital|||2||f||||f||||||||||2017-10-10 23:06:21.980215|2017-10-10 23:06:21.980215
NCT02505061|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-07-20|||August 2013||2013-08-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Use of Modified ride-on Cars to Advance Mobility and Socialization in Young Children With Disabilities||Completed||N/A|60|Actual|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-10-10 23:06:22.074129|2017-10-10 23:06:22.074129
NCT02505048|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-02-09|||March 2016||2016-03-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|RUBY||A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature|A Single Arm, Open-label, Phase II Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature|Recruiting||Phase 2|41|Anticipated|UNICANCER||1|||f||||f||||||||Yes|In the medical clinical patient file|2017-10-10 23:06:22.150474|2017-10-10 23:06:22.150474
NCT02505035|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-08-14|||March 2016|Actual|2016-03-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|REDAPS||Randomized Evaluation of Default Access to Palliative Services|Default Palliative Care Consultation for Seriously Ill Hospitalized Patients|Recruiting||N/A|20000|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:06:22.259358|2017-10-10 23:06:22.259358
NCT02505022|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-03-29|||January 2016||2016-01-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||Role Functioning Changes NOS|Role Functioning Changes in New Onset Symptoms|Recruiting||N/A|40|Anticipated|Northwestern University|||1||f||||f||||||||||2017-10-10 23:06:22.385361|2017-10-10 23:06:22.385361
NCT02505009|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-08-01|||May 2015||2015-05-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy|Efficacy of HBV Therapeutic Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy: a Pilot Study|Enrolling by invitation||Phase 4|125|Anticipated|Chang Gung Memorial Hospital||4|||f||||t||||||||||2017-10-10 23:06:22.491665|2017-10-10 23:06:22.491665
NCT02504996|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-21|||January 2015||2015-01-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||IV Paracetamol vs IV Morphine vs Placebo in Sciatalgia|IV Paracetamol vs IV Morphine vs Placebo in Sciatalgia in Patients Presented With Sciatalgia to Emergency Department: A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|300|Anticipated|Akdeniz University||3|||f||||f||||||||||2017-10-10 23:06:22.627103|2017-10-10 23:06:22.627103
NCT02504983|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-08-01|||August 2015||2015-08-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma|Randomized, Open Label, Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE Therapy in Hepatocellular Carcinoma|Recruiting||Phase 4|200|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-10 23:06:22.764346|2017-10-10 23:06:22.764346
NCT02504970|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-21|||October 2009||2009-10-01|July 2015|2015-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|10 Years|Observational [Patient Registry]|AQINACOR||Anesthesia Quality Institute National Anesthesia Clinical Outcomes Registry|Anesthesia Quality Institute National Anesthesia Clinical Outcomes Registry Ongoing|Recruiting||N/A|500|Anticipated|Anesthesia Quality Institute|||1||f||||f||||||||||2017-10-10 23:06:22.889081|2017-10-10 23:06:22.889081
NCT02504957|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-10-23|||July 2015||2015-07-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Photodynamic Therapy With Polyhematoporphyrin for Malignant Biliary Obstruction|Photodynamic Therapy With Polyhematoporphyrin for Malignant Biliary Obstruction - a Retrospective Analysis.|Completed||N/A|88|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 23:06:22.953238|2017-10-10 23:06:22.953238
NCT02504944|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2016-07-12|||July 2015||2015-07-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)|Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Newborn With Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)|Recruiting||Phase 2|96|Anticipated|Azienda Ospedaliero, Universitaria Meyer||1|||f||||f||||||||||2017-10-10 23:06:23.022747|2017-10-10 23:06:23.022747
NCT02504931|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-04-24|||April 2011|Actual|2011-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|DDx||Serotonin Selective Reuptake Inhibitor Treatment of Dual Diagnosis Post-traumatic Stress Disorder and Alcohol Problems|SSRI Treatment of Dual Diagnosis PTSD and Alcohol Dependence: A Test of the Serotonergic Hypothesis|Completed||Phase 4|142|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 23:06:23.137763|2017-10-10 23:06:23.137763
NCT02504918|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-30|||July 6, 2015||2015-07-06|June 14, 2017|2017-06-14|June 14, 2017|Actual|2017-06-14|December 31, 2016|Actual|2016-12-31||Observational|||Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian Children|Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment|Completed||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:06:23.248544|2017-10-10 23:06:23.248544
NCT02504905|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-30|||July 14, 2015||2015-07-14|June 13, 2017|2017-06-13|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Propensity to Develop Plasticity in the Parieto- and Cerebello-Motor Networks in Dystonia From the Perspective of Abnormal High-Order Motor Processing|Propensity to Develop Plasticity in the Parieto- & Cerebello-Motor Networks in Dystonia From the Perspective of Abnormal High-Order Motor Processing|Recruiting||N/A|144|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:06:23.347497|2017-10-10 23:06:23.347497
NCT02504892|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-30|||July 10, 2015||2015-07-10|May 24, 2017|2017-05-24|June 1, 2020|Anticipated|2020-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer|Phase 2 Study of Everolimus Therapy in Patients With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer|Recruiting||Phase 2|18|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:06:23.448988|2017-10-10 23:06:23.448988
NCT02504879|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-30|||July 9, 2015||2015-07-09|May 31, 2017|2017-05-31|July 15, 2021|Anticipated|2021-07-15|July 15, 2021|Anticipated|2021-07-15||Observational|||Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease|Study of the Natural History, Pathogenesis and Outcome of Melorheostosis - a Rare Osteosclerotic Disease|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:06:23.55232|2017-10-10 23:06:23.55232
NCT02504138|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-07-03|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Hepatic Protection During Living-donor Liver Transplantation||Completed||Phase 4|136|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:06:36.30075|2017-10-10 23:06:36.30075
NCT02504866|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-10-05|||July 8, 2015||2015-07-08|October 2, 2017|2017-10-02|December 30, 2019|Anticipated|2019-12-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Exercise Training on Physical, Cognitive, and Behavioral Function in People With TBI|Effect of Exercise Training on Physical, Cognitive and Behavioral Function in Patients With Traumatic Brain Injury|Recruiting||Phase 1/Phase 2|80|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:06:23.617655|2017-10-10 23:06:23.617655
NCT02504840|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-21|2017-06-30|||June 30, 2015||2015-06-30|June 13, 2017|2017-06-13|August 26, 2041|Anticipated|2041-08-26|February 26, 2041|Anticipated|2041-02-26||Observational|||Natural History of Multiple Sclerosis and Its Mimickers|Thematic Studies of Multiple Sclerosis and Related Diseases|Recruiting||N/A|1300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:06:23.894302|2017-10-10 23:06:23.894302
NCT02504827|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-10-24|||September 2015||2015-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis|Steady-state Pharmacokinetics of Ceftazidime/Avibactam in CF|Completed||Phase 4|12|Actual|University of Southern California||1|||f||||f||||||||||2017-10-10 23:06:23.97639|2017-10-10 23:06:23.97639
NCT02504814|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-08-22|||June 2011||2011-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ATMOFLOW||Physiological and Clinical Changes in NHF Therapy|Physiological and Clinical Changes in NHF Therapy|Completed||N/A|64|Actual|University of Leipzig||1|||f||||f||||||||||2017-10-10 23:06:24.071046|2017-10-10 23:06:24.071046
NCT02504801|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-20|||July 2015||2015-07-01|July 2015|2015-07-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD|Efficacy of Nebulized Pulmicort Respules on Post Operation Pulmonary Complication During Pulmonary Single Lobectomy Surgery in Primary Lung Cancer Patients With COPD|Unknown status|Not yet recruiting|Phase 4|73|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t||||||||||2017-10-10 23:06:24.157969|2017-10-10 23:06:24.157969
NCT02504788|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-05|||January 18, 2013|Actual|2013-01-18|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline||Recruiting||Phase 2|100|Anticipated|Chang Gung Memorial Hospital||1|||f|||||f|f||||||||2017-10-10 23:06:24.229827|2017-10-10 23:06:24.229827
NCT02504775|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-07-05|2016-04-21||August 2015||2015-08-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Bioequivalence Study for Mejoral 500 Product|Single Blinded, Two-period, Two-treatment, Crossover, Randomized, Single Dose Bioequivalence Study of Two Oral Formulations With 500 mg of Paracetamol (Mejoral® 500 Tablets, Glaxosmithkline méxico s.a. De c.v. Vs. Tylenol® Caplets, Janssen Cilag de méxico, s. De r.l. De c.v.) in Healthy Subjects Under Fasting Conditions|Completed||N/A|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:06:24.32333|2017-10-10 23:06:24.32333
NCT02504762|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-01-09|||August 2015||2015-08-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|HYCARDS||HYbrid CoronAry Revascularization in DiabeticS|HYbrid CoronAry Revascularization in DiabeticS: A Randomized Controlled Trial (Pilot)|Recruiting||N/A|20|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||Yes|Findings from this study will be presented at conferences.|2017-10-10 23:06:24.592101|2017-10-10 23:06:24.592101
NCT02504749|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2016-01-29|||July 2015||2015-07-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||The Regain of Gastrointestinal Motility After General Anaesthesia Versus Spinal Anaesthesia in Caesarean Section|Randomised Study to Compare the Regain of Gastrointestinal Motility After General Anaesthesia Versus Spinal Anaesthesia in Caesarean Section.Kasr El Ainy,Egypt Experience|Unknown status|Recruiting|Phase 4|450|Anticipated|Kasr El Aini Hospital||2|||f||||t||||||||||2017-10-10 23:06:24.696023|2017-10-10 23:06:24.696023
NCT02504736|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-01-30|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|CLASS-ACT||Colesevelam, Lipids And Sugars, South Asian Canadian Trial|24 Week Open Label, Single Arm Study of Colesevelam in High Risk South Asians With Suboptimal LDL-c Levels Despite Maximally Tolerated Statin Therapy|Recruiting||N/A|250|Anticipated|Canadian Collaborative Research Network|||1||f||||f||||||||||2017-10-10 23:06:24.78675|2017-10-10 23:06:24.78675
NCT02504723|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-18|2017-07-27|2017-07-04||December 2011|Actual|2011-12-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding|Carvedilol Plus Endoscopic Cyanoacrylate Injection Versus Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding|Completed||Phase 4|121|Actual|Kaohsiung Veterans General Hospital.||2|||f||||t|f|f||||||||2017-10-10 23:06:24.890219|2017-10-10 23:06:24.890219
NCT02504710|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2016-05-11|||February 2015||2015-02-01|July 2015|2015-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Kinematic Real Time Feedback Used to Learn Manual Therapy on Peripherical Joints|Kinematic Real-Time Feedback, Obtained by Inertial Sensors, Used to Learn Manual Therapy on Peripherical Joints|Completed||N/A|60|Actual|University of Malaga||2|||f||||||||||||||2017-10-10 23:06:25.317591|2017-10-10 23:06:25.317591
NCT02504697|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-03-27|||September 2011|Actual|2011-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer|Detection of Early Lung Cancer Among Military Personnel Study 2 (DECAMP-2): Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer|Recruiting||N/A|800|Anticipated|Boston University|||1||f||||t|f|f||||Samples With DNA|"     Blood, Urine, Sputum, Nasal brushing, Buccal scraping, Bronchial Biopsy, Bronchial brushing,     lung tissue   "|Undecided||2017-10-10 23:06:25.439419|2017-10-10 23:06:25.439419
NCT02504684|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-20|||February 2013||2013-02-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Treatment of Saphenous Vein Reflux With 1920-nm Diode Laser|Endovenous Laser Ablation of the Great Saphenous Vein Comparing 1920-nm and 1470-nm Diode Laser|Completed||N/A|67|Actual|Instituto Vascular BH||2|||f||||t||||||||||2017-10-10 23:06:25.613949|2017-10-10 23:06:25.613949
NCT02504658|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-07-20|||December 2011||2011-12-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|BodiMojo||Mobile Motivation for Health Promotion Among Adolescents|Mobile Motivation for Health Promotion Among Adolescents|Completed||Phase 1|90|Actual|BodiMojo, Inc.||2|||f||||f||||||||||2017-10-10 23:06:25.970465|2017-10-10 23:06:25.970465
NCT02504645|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-01-24|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|LUPUZOR||A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus|A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus|Active, not recruiting||Phase 3|200|Anticipated|ImmuPharma||2|||f||||f||||||||No||2017-10-10 23:06:26.064359|2017-10-10 23:06:26.064359
NCT02504632|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-03-12|||May 2014||2014-05-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|TAVI||Study of Platelet Activation by Severe Aortic Stenosis and Its Correction by Transcatheter Aortic Valve Implantation|Study of Platelet Activation by Severe Aortic Stenosis and Its Correction by Transcatheter Aortic Valve Implantation (TAVI) Platelet Activation in TAVI|Completed||N/A|44|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:06:26.230229|2017-10-10 23:06:26.230229
NCT02504619|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-08-06|||May 2015||2015-05-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies|Allogeneic Stem Cell Transplantation of CordIn™, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies|Recruiting||Phase 1/Phase 2|15|Anticipated|Gamida Cell ltd||1|||f||||t||||||||||2017-10-10 23:06:26.311645|2017-10-10 23:06:26.311645
NCT02504606|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-20|||September 2014||2014-09-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject|A Randomized, Open-label, Single Dose, 2-Treatment, 2-Period, 2-Way Crossover Study to Assess Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject|Completed||Phase 1|60|Actual|Huons Co.,Ltd.||2|||f||||f||||||||||2017-10-10 23:06:26.403732|2017-10-10 23:06:26.403732
NCT02504593|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-05-24|||July 2015||2015-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Novel mHealth Platform to Ensure Quality of Community-based Malaria Diagnosis|Novel mHealth Platform to Ensure Quality of Community-based Malaria Diagnosis|Completed||N/A|100|Actual|Duke University||1|||f||||f||||||||||2017-10-10 23:06:26.467586|2017-10-10 23:06:26.467586
NCT02504580|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-26|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy|A Phase 2, Randomized, Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy|Completed||Phase 2|463|Actual|Heron Therapeutics||23|||f||||||||||||||2017-10-10 23:06:26.540747|2017-10-10 23:06:26.540747
NCT02504567|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-08-09|||July 2015||2015-07-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|November 2016|Actual|2016-11-01||Interventional|LASER||Laser Ablation Study for trEatment of atRial Fibrillation (LASER)|Laser Ablation Study for trEatment of atRial Fibrillation (LASER)|Recruiting||Phase 4|64|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-10 23:06:26.65874|2017-10-10 23:06:26.65874
NCT02504554|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-01-24|||July 2014||2014-07-01|January 2016|2016-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|BBT||Beneficial Bacteria Treatment|Treating Gastrointestinal Problems in Children With Autism Using Beneficial Bacteria Treatment (BBT)|Completed||Phase 1/Phase 2|20|Anticipated|Arizona State University||2|||f||||t||||||||||2017-10-10 23:06:26.740891|2017-10-10 23:06:26.740891
NCT02504541|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-08-01||2017-08-01|July 2015||2015-07-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|STEADY||Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (STEADY)|A 6-Month Safety Study of QuickShot™ Testosterone Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism|Completed||Phase 3|133|Actual|Antares Pharma Inc.||1|||f||||f||||||||||2017-10-10 23:06:26.824956|2017-10-10 23:06:26.824956
NCT02504528|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-20|||July 2015||2015-07-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Bronchial Allergen Provocation Tests in Asthmatics in Guangzhou|Bronchial Provocation Tests With House Dust Mite in Allergic Asthma in Guangzhou|Unknown status|Recruiting|N/A|60|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||t||||||||||2017-10-10 23:06:26.932958|2017-10-10 23:06:26.932958
NCT02504515|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-05-02|||April 2015||2015-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Homeopathy, Acupuncture or Anthroposophic Medicine in Women's Quality of Life|Evaluating Treatment With Homeopathy, Acupuncture, and Anthroposophic Medicine in Improving the Quality of Life for Women Treated at the Public Unified Healthcare System|Recruiting||N/A|906|Anticipated|Federal University of Minas Gerais||6|||f||||t||||||||||2017-10-10 23:06:27.014783|2017-10-10 23:06:27.014783
NCT02504502|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-03-30|2017-03-30||August 2015|Actual|2015-08-01|March 2017|2017-03-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Enhancing Genomic Laboratory Reports to Enhance Communication and Empower Patients|Enhancing Genomic Laboratory Reports to Enhance Communication and Empower Patients|Completed||N/A|52|Actual|Geisinger Clinic|Fewer parents than expected received a causal variant result for their child’s condition. Qualitative data indicate that parents without a causal variant did not feel need to open the enhanced report and did not find additional information helpful.|2|||f||||f||||||||||2017-10-10 23:06:27.111079|2017-10-10 23:06:27.111079
NCT02504489|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-03-17|||June 2016||2016-06-01|July 2016|2016-07-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|DUBLIN-3||Assessment of Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC With at Least One Measurable Lung Lesion|Randomized Blinded Phase III Assessment of Second or Third-Line Chemotherapy With Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced Non-Small Cell Lung Cancer and With at Least One Measurable Lung Lesion|Recruiting||Phase 3|550|Anticipated|BeyondSpring Pharmaceuticals Inc.||2|||f||||t||||||||No||2017-10-10 23:06:28.082489|2017-10-10 23:06:28.082489
NCT02504476|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-03-04|||August 2015||2015-08-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|MAD||Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective|A Phase I, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective Disorder on Antipsychotic Medication|Completed||Phase 1|52|Actual|Amgen||9|||f||||f||||||||||2017-10-10 23:06:28.304308|2017-10-10 23:06:28.304308
NCT02504463|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-09-17|||June 2015||2015-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers|A Single-Center, Open-Label Study to Evaluate the Absorption, Metabolism, and Excretion of Single Doses of [14c]-Samidorphan in Healthy Male Subjects|Completed||Phase 1|10|Actual|Alkermes, Inc.||3|||f||||f||||||||||2017-10-10 23:06:28.459883|2017-10-10 23:06:28.459883
NCT02504450|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-07-27|||April 2015||2015-04-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|OAMED||Outcomes of Antipsychotic Medication Used in the Emergency Department|Outcomes of Antipsychotic Medication Use in the Emergency Department: A Retrospective Comparison Study|Completed||N/A|93|Actual|Advocate Health Care|||1||f||||f||||||||No||2017-10-10 23:06:28.612478|2017-10-10 23:06:28.612478
NCT02504437|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-20|||November 2015||2015-11-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TPAABPIHD||Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease||Not yet recruiting||Phase 1/Phase 2|200|Anticipated|Academy Military Medical Science, China||3|||f||||t||||||||||2017-10-10 23:06:28.708199|2017-10-10 23:06:28.708199
NCT02504424|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-01-23|||October 2015||2015-10-01|January 2017|2017-01-01||||March 2017|Anticipated|2017-03-01||Interventional|XPAND II||AirXpanders AeroForm Tissue Expander System for Breast Reconstruction|AirXpanders AeroForm Tissue Expander System for Breast Reconstruction (XPAND II)|Active, not recruiting||N/A|60|Anticipated|AirXpanders, Inc.||1|||f||||t||||||||||2017-10-10 23:06:28.800226|2017-10-10 23:06:28.800226
NCT02504411|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-20|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||Outcomes of Disposable Distal Attachment Device (Endocuff and Transparent Plastic Cap) Assisted Colonoscopy|Outcomes of Disposable Distal Attachment Device (Endocuff and Transparent Plastic Cap) Assisted Colonoscopy Versus Standard Colonoscopy|Not yet recruiting||N/A|640|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 23:06:28.927945|2017-10-10 23:06:28.927945
NCT02504398|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-22|||July 2015||2015-07-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Speed of Injection and Pain During Routine Infant Vaccinations|A Randomized Controlled Trial of Injection Technique for Infant Vaccination|Unknown status|Recruiting|Phase 3|120|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-10 23:06:29.034987|2017-10-10 23:06:29.034987
NCT02504385|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2015-07-20|||August 2015||2015-08-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Virtual Reality on Motor Functioning and Participation Abilities Among Children With DCD|The Effect of Timocco's Virtual Reality Environment on the Motor Functioning and Participation Abilities Among Children With DCD|Unknown status|Not yet recruiting|N/A|30|Anticipated|Clalit Health Services||2|||f||||f||||||||||2017-10-10 23:06:29.173483|2017-10-10 23:06:29.173483
NCT02504372|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-09-28|||November 6, 2015|Actual|2015-11-06|September 2017|2017-09-01|August 19, 2021|Anticipated|2021-08-19|August 19, 2021|Anticipated|2021-08-19||Interventional|PEARLS||Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)|A Randomized, Phase 3 Trial With Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) Versus Placebo for Patients With Early Stage NSCLC After Resection and Completion of Standard Adjuvant Therapy (PEARLS)|Recruiting||Phase 3|1380|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 23:06:29.290724|2017-10-10 23:06:29.290724
NCT02504359|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-09-05|||July 20, 2015|Actual|2015-07-20|August 2017|2017-08-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma|A Feasibility Study of Myeloablative BEAM Allogeneic Transplantation Followed by Oral Ixazomib Maintenance Therapy in Patients With Relapsed High-Risk Multiple Myeloma|Recruiting||Phase 1|24|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 23:06:29.512393|2017-10-10 23:06:29.512393
NCT02504346|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-06-22|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|January 2018|Anticipated|2018-01-01||Interventional|TREM||AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies|AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies|Recruiting||Phase 2|200|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-10-10 23:06:29.678752|2017-10-10 23:06:29.678752
NCT02504333|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-11-15|||July 2015||2015-07-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|SEQUENCE||Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma|A Phase I/II Study of Nab-paclitaxel (Abraxane) and Gemcitabine Followed by Modified FOLFOX (AG-mFOLFOX) in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 1/Phase 2|180|Anticipated|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||2|||f||||f||||||||||2017-10-10 23:06:29.81476|2017-10-10 23:06:29.81476
NCT02502279|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2017-03-25|||July 2015||2015-07-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|LRvsCPAP||Lung Recruitment and Postoperative CPAP|Lung Recruitment and Postoperative CPAP in Pediatric Laparoscopic Surgery|Completed||Phase 2|60|Actual|Assiut University||3|||f||||f||||||||No||2017-10-10 23:06:56.024564|2017-10-10 23:06:56.024564
NCT02504320|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2016-11-25|2016-09-29||August 2015||2015-08-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional||Safety Set included all participants who were enrolled and received at least 1 dose of study drug.|Phase 1, Febuxostat XR Relative Bioavailability Study|A Phase 1, Randomized, Open-Label, Single-Dose, 4-Way Crossover Study to Assess the Relative Bioavailability of Four 80 mg Febuxostat XR Formulations|Completed||Phase 1|78|Actual|Takeda||4|||f||||f||||||||||2017-10-10 23:06:29.978742|2017-10-10 23:06:29.978742
NCT02504307|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-04-24|||July 2015||2015-07-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Laranjeiras||OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation|Randomized Evaluation of Vascular Healing After Implantation of Sirolimus Eluting Stent Inspiron™ Versus Its Own Bare Metal Version- An OCT Evaluation After 3 Months Follow-up|Recruiting||Phase 4|60|Anticipated|Scitech Produtos Medicos Ltda||2|||f||||f||||||||||2017-10-10 23:06:31.017984|2017-10-10 23:06:31.017984
NCT02504294|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-09-20||2017-09-07|July 2015||2015-07-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis|The Pieda Study: A Phase 3b Investigation Of Erythropoietin Drugs Using A Specified Dosing Algorithm: A Randomized Open Label Dosing Study In Adult Chronic Kidney Disease Subjects On Hemodialysis|Completed||Phase 3|432|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 23:06:31.105812|2017-10-10 23:06:31.105812
NCT02504281|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-19|2015-07-19|||January 2015||2015-01-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Study on the Association Between SXCI and RM and the Possible Genetic Mechanism|Study on the Association Between Skewed X Chromosome Inactivation(SXCI) and Recurrent Miscarriage(RM) and the Possible Genetic Mechanism|Unknown status|Recruiting|N/A|200|Anticipated|ShangHai Ji Ai Genetics & IVF Institute|||2||f||||t||||||Samples With DNA|"     Blood samples from the females   "|||2017-10-10 23:06:31.259291|2017-10-10 23:06:31.259291
NCT02504268|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-04-17|||August 2015||2015-08-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|January 2017|Actual|2017-01-01||Interventional|AVERT-2||Effects of Abatacept in Patients With Early Rheumatoid Arthritis|A Phase 3B, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC in Combination With Methotrexate Compared to Methotrexate Monotherapy in Achieving Clinical Remission in Adults With Early Rheumatoid Arthritis Who Are Methotrexate Naive|Active, not recruiting||Phase 3|1000|Anticipated|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-10 23:06:31.389656|2017-10-10 23:06:31.389656
NCT02504255|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-23|||April 2011||2011-04-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn's Disease|Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn's Disease : A Multicenter Cohort|Completed||Phase 3|144|Actual|Hospices Civils de Lyon|||1||f||||t||||||||||2017-10-10 23:06:33.620172|2017-10-10 23:06:33.620172
NCT02504242|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-08-30|||April 2015||2015-04-01|July 2015|2015-07-01||||April 2017|Anticipated|2017-04-01||Interventional|||A Multi-center, Comparative Clinical Trial to Evaluate the Efficacy and Safety of Inject BMP in Patients Undergoing Transforaminal Lumbar Interbody Fusion||Unknown status|Enrolling by invitation|Phase 3|128|Anticipated|BioAlpha Inc.||2|||f||||f||||||||||2017-10-10 23:06:33.7017|2017-10-10 23:06:33.7017
NCT02504229|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2015-07-20|||November 2014||2014-11-01|July 2015|2015-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment||Recruiting||Phase 2|80|Anticipated|Beijing Biohealthcare Biotechnology Co.,Ltd||2|||f||||||||||||||2017-10-10 23:06:33.773345|2017-10-10 23:06:33.773345
NCT02504216|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-09-27|||August 18, 2015|Actual|2015-08-18|September 2017|2017-09-01|January 15, 2019|Anticipated|2019-01-15|January 15, 2019|Anticipated|2019-01-15||Interventional|VOYAGER PAD||Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities|An International, Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Trial Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Thrombotic Vascular Events in Patients With Symptomatic Peripheral Artery Disease Undergoing Lower Extremity Revascularization Procedures|Recruiting||Phase 3|6500|Anticipated|Bayer||2|||f||||t|t|f||||||||2017-10-10 23:06:33.964981|2017-10-10 23:06:33.964981
NCT02504203|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-02-01|||November 2015||2015-11-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|BCGrural||Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial|Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial|Recruiting||Phase 4|5079|Anticipated|Bandim Health Project||2|||f||||t||||||||||2017-10-10 23:06:35.723835|2017-10-10 23:06:35.723835
NCT02504190|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-06-21|||July 16, 2015|Actual|2015-07-16|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|TEAM||Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)|Non-interventional Study Evaluating Efficacy and Tolerance on TEAM Conditioning (Thiotepa/Etoposide/Aracytin/Melphalan) Followed by Autologous Haematopoietic Stem Cells Transplantation in Patients With Lymphoma|Recruiting||N/A|30|Anticipated|Association for Training, Education, and Research in Hematology, Immunology, and Transplantation|||1||f||||f||||||||||2017-10-10 23:06:35.820319|2017-10-10 23:06:35.820319
NCT02504177|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-19|||June 2015||2015-06-01|July 2015|2015-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation||Recruiting||N/A|433|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:06:35.984557|2017-10-10 23:06:35.984557
NCT02504164|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-03-03|||September 2014||2014-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection||Completed||N/A|72|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:06:36.079011|2017-10-10 23:06:36.079011
NCT02504151|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-07-20|||August 2015||2015-08-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|CBD||Cannabidiol Treatment in Patients With Early Psychosis|Cannabidiol Treatment in Patients With Early Psychosis|Recruiting||Phase 2|72|Anticipated|Yale University||2|||f||||t||||||||||2017-10-10 23:06:36.180404|2017-10-10 23:06:36.180404
NCT02504125|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-03-03|||January 2013||2013-01-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|||The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty|The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty: a Randomized, Double-blind, Controlled Trial|Completed||Phase 4|120|Actual|Xijing Hospital||2|||f||||t||||||||||2017-10-10 23:06:36.390569|2017-10-10 23:06:36.390569
NCT02504112|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-03-31|||May 2016||2016-05-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Observational|||Zimmer CAS PSI X-Ray Knee in TKA (Total Knee Arthroplasty)|Evaluation of Zimmer® CAS PSI X-Ray Knee in Total Knee Arthroplasty (TKA): Technical Outcomes|Not yet recruiting||N/A|30|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-10 23:06:36.486826|2017-10-10 23:06:36.486826
NCT02504086|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-07-15|||August 2015||2015-08-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Online Support for Diabetes Self-Management|Online Support for Diabetes Self-Management|Terminated||N/A|11|Actual|University of British Columbia||1||Difficulty recruiting participants|f||||t||||||||No||2017-10-10 23:06:36.682528|2017-10-10 23:06:36.682528
NCT02504073|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-23|2016-03-13||March 2015||2015-03-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|||Clinical Reasoning Process of Physiotherapists When Observing Hemiplegic Gait|Clinical Reasoning Process of Physiotherapists When Observing Hemiplegic Gait|Completed||N/A|54|Actual|Technical University of Bern|||1||f||||f||||||||Yes||2017-10-10 23:06:36.778788|2017-10-10 23:06:36.778788
NCT02504060|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-17|||June 2015||2015-06-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment|Multicenter Randomized Double-blind Placebo-controlled Clinical Trials to Evaluate the Clinical Efficacy and Safety of N-acetyl Glucosamine Capsule for Irritable Bowel Syndrome With Diarrhea (IBS-D) Treatment|Unknown status|Recruiting|Phase 3|720|Anticipated|Third Military Medical University||2|||f||||t||||||||||2017-10-10 23:06:36.982127|2017-10-10 23:06:36.982127
NCT02504047|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-08-31|||February 2014||2014-02-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units|Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units|Recruiting||N/A|40|Anticipated|University of Calgary||1|||f||||t||||||||||2017-10-10 23:06:37.088806|2017-10-10 23:06:37.088806
NCT02504034|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-20|||October 2010||2010-10-01|July 2015|2015-07-01||||December 2020|Anticipated|2020-12-01||Interventional|||Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein|Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein|Recruiting||N/A|150|Anticipated|Sun Yat-sen University||1|||f||||||||||||||2017-10-10 23:06:37.205011|2017-10-10 23:06:37.205011
NCT02504021|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Family Meeting Study for End Stage Renal Disease|Family Consultation for High-Risk Inpatients With End Stage Renal Disease: A Randomized Trial|Completed||N/A|120|Actual|Wayne State University||2|||f||||f||||||||||2017-10-10 23:06:37.304255|2017-10-10 23:06:37.304255
NCT02503995|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-20|||March 2012||2012-03-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|EXPECT||Exercise in Pregnancy Evaluative Controlled Study|Influence of Regular Antenatal Physical Exercise on Cardiovascular, Haemodynamic and Autonomic Nervous System (CHANS) Function During and After Pregnancy|Completed||N/A|90|Actual|Swansea University||3|||f||||f||||||||||2017-10-10 23:06:37.550563|2017-10-10 23:06:37.550563
NCT02503982|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-03-05|2016-05-23||December 2014||2014-12-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients|Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients - a Prospective Study|Completed||Phase 4|13|Actual|Rabin Medical Center||1|||f||||f||||||||No||2017-10-10 23:06:37.638146|2017-10-10 23:06:37.638146
NCT02503969|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-12-01|||September 2015||2015-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Exploratory Analysis on the Impact of Morbidities on Colorectal Cancer Screening Uptake|Exploratory Analysis on the Impact of Morbidities on Colorectal Cancer Screening Uptake|Completed||N/A|8776|Actual|University of Sheffield|||2||f||||f||||||||||2017-10-10 23:06:37.815922|2017-10-10 23:06:37.815922
NCT02503956|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-09-28|||August 2015||2015-08-01|February 2017|2017-02-01|July 22, 2016|Actual|2016-07-22|July 22, 2016|Actual|2016-07-22||Interventional|||Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients|The Efficacy of Punctal Dilatation With Insertion of Perforated Punctal Plugs for the Management of Acquired Punctal Stenosis Due to Allergic Conjunctivitis|Completed||N/A|14|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:06:37.920789|2017-10-10 23:06:37.920789
NCT02503943|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-07-19|||May 2015||2015-05-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes|What is the Effects of Incretin on the Blood Pressure and Lipid in Overweight or Obese Diabetes Patients With Masked Hypertension: Liraglutide Plus Mitiglinide Comparing Metformin Plus Mitiglinide or Mitiglinide Alone（BLOOD STUDY）|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|Third Affiliated Hospital of Third Military Medical University||3|||f||||t||||||||||2017-10-10 23:06:38.005463|2017-10-10 23:06:38.005463
NCT02503930|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-19|||July 2015||2015-07-01|July 2015|2015-07-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effect of tDCS on a Motor-cognitive Dual-task Performance of Parkinson's Patients|The Effect of Transcranial Direct Cortical Stimulation (tDCS) on a Motor-cognitive Dual-task Performance of Parkinson's Patients|Not yet recruiting||N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:06:38.093788|2017-10-10 23:06:38.093788
NCT02503917|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-05-20|||September 2015||2015-09-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Observational|GENIUS||Gynaecologic Organ Segmentation and Motion Tracking Using Ultrasound||Recruiting||N/A|25|Anticipated|Royal Marsden NHS Foundation Trust|||2||f||||||||||||||2017-10-10 23:06:38.316155|2017-10-10 23:06:38.316155
NCT02503904|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2015-07-20|||October 2015||2015-10-01|July 2015|2015-07-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection|Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection: A Multicenter Open Label Randomized Clinical Trial|Not yet recruiting||Phase 2/Phase 3|400|Anticipated|Klein, Jeffrey A., M.D.||2|||f||||t||||||||||2017-10-10 23:06:38.414691|2017-10-10 23:06:38.414691
NCT02503891|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-18|||September 2015||2015-09-01|July 2015|2015-07-01|April 2019|Anticipated|2019-04-01|September 2016|Anticipated|2016-09-01||Interventional|||AL-2 MP-1 (Polyimide) Acetabular Liner|Total Hip Replacement - MP-1 Acetabular Liner|Not yet recruiting||N/A|50|Anticipated|M.M.A Tech Ltd.||1|||f||||f||||||||||2017-10-10 23:06:38.521822|2017-10-10 23:06:38.521822
NCT02503878|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-02-29|||December 2014||2014-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Sedline 4 Channel Electroencephalogram (EEG) Monitoring During Suppression of Unilateral Hemispheric Function (Wada Test|Sedline 4 Channel Electroencephalogram (EEG) Monitoring During Suppression of Unilateral Hemispheric Function (Wada Test)|Terminated||N/A|7|Actual|Medical University of South Carolina|||1|There was to much artifact on the readings and could not be interpreted|f||||f||||||||||2017-10-10 23:06:38.599546|2017-10-10 23:06:38.599546
NCT02503865|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-11-02|2015-07-21||January 2003||2003-01-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2008|Actual|2008-12-01||Interventional|DRWMNTMS||Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome|Phase 1-2 Study of Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome|Completed||Phase 1/Phase 2|351|Actual|Republican Scientific Center for Emergency Medicine|We acknowledge the randomized clinical trial have not a large sample size|3|||f||||t||||||||||2017-10-10 23:06:38.674488|2017-10-10 23:06:38.674488
NCT02503852|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-08-16|||November 2015||2015-11-01|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|STYLE||STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia|Subcutaneous Transplantation of Autologous Cell Enriched Adipose Tissue For Follicular Niche Stimulation in Early Stage Alopecia Androgenetica (STYLE): a Randomized, Blinded, Controlled Trial|Active, not recruiting||Phase 2|70|Actual|Kerastem Technologies, LLC||4|||f||||f||||||||||2017-10-10 23:06:39.086968|2017-10-10 23:06:39.086968
NCT02503839|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-12-06|||November 2015||2015-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|TBCOX2||Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic|Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the Multidrug-resistant Tuberculosis Pandemic; an Open Label Phase I Clinical Trial of the Therapeutic TB H56:IC31 Vaccine and Cyclooxygenase-inhibitors|Recruiting||Phase 1|40|Anticipated|Oslo University Hospital||4|||f||||t||||||||No||2017-10-10 23:06:39.204853|2017-10-10 23:06:39.204853
NCT02503813|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-17|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?|Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?|Unknown status|Recruiting|Early Phase 1|20|Anticipated|MemorialCare Health System||1|||f||||f||||||||||2017-10-10 23:06:39.408172|2017-10-10 23:06:39.408172
NCT02503800|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-20|||August 2015||2015-08-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy|The Significance of Blood-tryptase Levels and c-Kit Mutation in the Evaluation of Prognosis and Adverse Reactions in Subjects Undergoing Venom Immunotherapy for Insect Allergy|Unknown status|Not yet recruiting|N/A|200|Anticipated|Meir Medical Center|||1||f||||t||||||Samples With DNA|"     Biospecimen will include 5 ml of venous whole blood drawn for measurement of serum tryptase     and leukocyte c-Kit mutation.   "|||2017-10-10 23:06:39.493504|2017-10-10 23:06:39.493504
NCT02503787|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-08-17|2017-07-10||July 2015||2015-07-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional||Implanted and Device Activated subjects|OPTIONS Spinal Cord Stimulation Programming Parameters|A Prospective, Multi-center, Open-label Study of Programming Options in Spinal Cord Stimulation.|Completed||N/A|64|Actual|MedtronicNeuro||1|||f||||f||||||||||2017-10-10 23:06:39.574943|2017-10-10 23:06:39.574943
NCT02503774|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-25|||July 24, 2015|Actual|2015-07-24|September 2017|2017-09-01|February 15, 2021|Anticipated|2021-02-15|February 15, 2021|Anticipated|2021-02-15||Interventional|||MEDI9447 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors|A Phase 1 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI9447 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors|Recruiting||Phase 1|188|Anticipated|MedImmune LLC||2|||f||||t|t|f||||||||2017-10-10 23:06:39.847395|2017-10-10 23:06:39.847395
NCT02503748|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-04-21|||July 2015||2015-07-01|April 2017|2017-04-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|PROCET||Prostate Cancer E-Health-Tutorial|Prostate Cancer E-Health-Tutorial (PROCET): Multicenter, One-armed Intervention Study to Evaluate an Online Tutorial for Patients With Localized Prostate Cancer|Completed||N/A|53|Actual|Zurich University of Applied Sciences||1|||f||||f||||||||||2017-10-10 23:06:40.058755|2017-10-10 23:06:40.058755
NCT02503735|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-10-04|||July 15, 2015|Actual|2015-07-15|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effect of Harvoni on Proteinuria and Estimated Glomerular Filtration Rate (eGFR) in Hepatitis C (HCV) Associated Chronic Kidney Disease (CKD)|Effect of Ledipasvir and Sofosbuvir on Proteinuria and Estimated Glomerular Filtration Rate in Patients With Early Stage (1-3) Hepatitis C Associated Chronic Kidney Disease|Recruiting||N/A|24|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:06:40.150462|2017-10-10 23:06:40.150462
NCT02503722|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-09-12|||October 13, 2016|Actual|2016-10-13|September 2017|2017-09-01||||April 30, 2018|Anticipated|2018-04-30||Interventional|||TORC1/2 Inhibitor INK128 and EGFR Inhibitor AZD9291 in Treating Patients With Advanced EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor|A Phase 1 Trial of MLN0128 in Combination With AZD9291 in Advanced EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC) After Progression on a Previous EGFR Tyrosine Kinase Inhibitor|Recruiting||Phase 1|36|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-10 23:06:40.243068|2017-10-10 23:06:40.243068
NCT02503709|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-20|2017-09-11|||April 8, 2016|Actual|2016-04-08|September 2017|2017-09-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|A Phase 1 Trial of the Combination of the Heat Shock Protein-90 (HSP90) Inhibitor Onalespib (AT13387) and the Cyclin-Dependent Kinase (CDK) Inhibitor AT7519M in Patients With Advanced Solid Tumors|Recruiting||Phase 1|37|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:06:40.378981|2017-10-10 23:06:40.378981
NCT02503696|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-08-09|||September 2014||2014-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Observational|||Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)|Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)|Completed||N/A|697|Actual|Exact Sciences Corporation|||1||f||||f||||||Samples With DNA|"     Provide anonymous, clinically characterized specimens for bio-repository for future     colorectal cancer-related test development.   "|No||2017-10-10 23:06:40.498926|2017-10-10 23:06:40.498926
NCT02503683|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-06-02|||July 2015||2015-07-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|December 2015|Actual|2015-12-01||Interventional|||A Study of an Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease|A Phase 1/2, Randomized, Single-blind, Placebo-Controlled, Single Ascending Dose and Multiple Dose, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Subcutaneously Administered ALN-AAT in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease|Active, not recruiting||Phase 1/Phase 2|66|Anticipated|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:06:40.613764|2017-10-10 23:06:40.613764
NCT02503670|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-09-05|||December 2015||2015-12-01|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||An Intervention Study to Evaluate a Website Tailored to New Dads to Promote Mental Health|HealthyDads.Ca-Development and Pilot Evaluation of a Multimodal E-Health Intervention to Promote the Mental Health of Men at Risk for Depression|Active, not recruiting||N/A|72|Actual|McGill University||2|||f||||f||||||||||2017-10-10 23:06:40.686018|2017-10-10 23:06:40.686018
NCT02503657|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-08-10|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|A Randomized, Placebo-Controlled, Double-Blind Six Month Study Followed by an Open-Label Extension Phase to Evaluate the Efficacy, Safety and Tolerability of MN-001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Recruiting||Phase 2|15|Anticipated|MediciNova||2|||f||||f||||||||||2017-10-10 23:06:40.752447|2017-10-10 23:06:40.752447
NCT02503644|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-06-13|||October 2015||2015-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|FASST||Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis|A Randomized, Double-blind, Placebo-controlled, Multicentre Proof-of-concept Trial of IVA337 in the Treatment of Diffuse Cutaneous Systemic Sclerosis|Recruiting||Phase 2|132|Anticipated|Inventiva Pharma||3|||f||||f||||||||No||2017-10-10 23:06:40.836372|2017-10-10 23:06:40.836372
NCT02503631|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-07-12|||October 2014||2014-10-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Observational|||Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers|Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers|Active, not recruiting||N/A|300|Anticipated|Exact Sciences Corporation|||1||f||||f||||||Samples With DNA|"     Provide anonymous, clinically characterized specimens and blood samples for bio-repository     for future colorectal cancer-related test development.   "|||2017-10-10 23:06:41.186991|2017-10-10 23:06:41.186991
NCT02503618|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Understanding Substance Use and Incident HIV/STI Among Young Black MSM|Understanding Substance Use and Incident HIV/STI Among Young Black Men Having Sex With Men (MSM)|Recruiting||N/A|476|Anticipated|Emory University|||2||f||||f||||||Samples With DNA|"     Dried blood spot testing, whole blood   "|||2017-10-10 23:06:41.328566|2017-10-10 23:06:41.328566
NCT02503605|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-17|||October 2015||2015-10-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|BEMDON||Biosimilar Versus Urinary Gonadotropins|Prospective Randomized Clinical Trial to Test the Efficacy of a Biosimilar Recombinant Follicle Stimulating Hormone (FSH)vs. Urinary FSH in an Oocyte Donation Program|Unknown status|Not yet recruiting|Phase 4|130|Anticipated|IVI Madrid||2|||f||||f||||||||||2017-10-10 23:06:41.4158|2017-10-10 23:06:41.4158
NCT02503592|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-10-06|||April 2015||2015-04-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Vestibular Function After Cochlear Implantation Using Soft Surgery Techniques|Vestibular Function After Cochlear Implantation Using Soft Surgery Techniques|Recruiting||N/A|30|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 23:06:41.514383|2017-10-10 23:06:41.514383
NCT02503579|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-03-25|||August 2015||2015-08-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||The Role of Brain-derived Neurotropic Factor in the Relationship Between Executive Function and Physical Training|What's the Role of Brain-derived Neurotrophic Factor in the Relationship Between Executive Function and Physical Fitness/Training in Typically Developing Children? A Randomized Controlled Study|Completed||N/A|52|Actual|University Ghent||2|||f||||t||||||||||2017-10-10 23:06:41.594645|2017-10-10 23:06:41.594645
NCT02503566|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-17|||September 2014||2014-09-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|EARLY-OCT||Assessment of Cardiac Allograft Vasculopathy by Optical Coherence Tomography|Assessment of Cardiac Allograft Vasculopathy (CAV) by Optical Coherence Tomography (OCT)|Unknown status|Recruiting|N/A|100|Anticipated|Institute for Clinical and Experimental Medicine||1|||f||||f||||||||||2017-10-10 23:06:41.668059|2017-10-10 23:06:41.668059
NCT02503553|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-02-02||||||February 2016|2016-02-01||||August 2015|Actual|2015-08-01||Interventional|||Decision Aids in Cerebral Aneurysm Treatment|Decision Aids in Cerebral Aneurysm Treatment|Withdrawn||N/A|0|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-10 23:06:41.760531|2017-10-10 23:06:41.760531
NCT02503540|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-09-18|||August 18, 2015|Actual|2015-08-18|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PERMEATE||Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO|Peripheral and Macular Retinal Vascular Perfusion and Leakage Dynamics in Diabetic Macular Edema and Retinal Venous Occlusions During Intravitreal Aflibercept Injection (IAI) Treatment for Retinal Edema: PERMEATE Study|Active, not recruiting||Phase 4|31|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-10-10 23:06:41.842928|2017-10-10 23:06:41.842928
NCT02503527|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin Therapy|Effects of a Diabetes-specific Tube Feed on Glycemic Variability in Critically Ill Patients During Insulin Blood Glucose Management|Recruiting||N/A|40|Anticipated|Fresenius Kabi||2|||f||||f||||||||||2017-10-10 23:06:41.951092|2017-10-10 23:06:41.951092
NCT02503514|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-04-12|||August 2015||2015-08-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01|1 Year|Observational [Patient Registry]|APRIL||Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort|Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort - APRIL Cohort|Recruiting||N/A|400|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     Subjects will have blood drawn (10 mL EDTA tube, 10mL Serum Separator, and a 6 mL EDTA     tube)at their baseline visit. If a subject experiences a paradoxical reaction they will a     repeat of the blood draw done at their baseline visit.   "|||2017-10-10 23:06:42.071104|2017-10-10 23:06:42.071104
NCT02503501|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-05-15|||August 2015||2015-08-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease|A Phase II, Single Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and the Therapeutic Effectiveness of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease|Recruiting||Phase 2|90|Anticipated|HealthPartners Institute||2|||f||||t||||||||||2017-10-10 23:06:42.18454|2017-10-10 23:06:42.18454
NCT02503488|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-17|||June 2015||2015-06-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|||Decreasing Youth Involvement in Violence in Burundi|Decreasing Youth Involvement in Violence in Burundi|Unknown status|Enrolling by invitation|N/A|40|Anticipated|University of Konstanz||2|||f||||t||||||||||2017-10-10 23:06:42.292522|2017-10-10 23:06:42.292522
NCT02503475|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-04-15|||March 2015||2015-03-01|April 2016|2016-04-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Stanford Center for Back Pain|Stanford Center for Back Pain|Recruiting||N/A|324|Anticipated|Stanford University||3|||f||||t||||||||||2017-10-10 23:06:42.39417|2017-10-10 23:06:42.39417
NCT02503462|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-02-01|||July 2015||2015-07-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals|Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals|Terminated||Phase 4|7|Actual|University Hospital, Basel, Switzerland||1||No additional patients fulfilling the inclusion criteria|f||||f||||||||||2017-10-10 23:06:42.482675|2017-10-10 23:06:42.482675
NCT02503449|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2015-07-17|||December 2014||2014-12-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|1 Month|Observational [Patient Registry]|MCTOPCIC||Clinical Trial of Pulmonary Cryptococcosis in China|Multi-center Clinical Trial of Pulmonary Cryptococcosis in China|Enrolling by invitation||N/A|260|Actual|Chinese PLA General Hospital|||1||f||||t||||||Samples Without DNA|"     sputum,whole blood,pleural effusion,lung tissue,cerebrospinal fluid,fungus(smear     examination,culture and identification,antigen detection,drug sensitive test)   "|||2017-10-10 23:06:42.590374|2017-10-10 23:06:42.590374
NCT02503436|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-26|||October 28, 2015|Actual|2015-10-28|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30|66 Months|Observational [Patient Registry]|C-PATROL||C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population.|C-PATROL - a Single Arm, Prospective Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population|Recruiting||N/A|300|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:06:42.712689|2017-10-10 23:06:42.712689
NCT02503423|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-08-22|||July 2015||2015-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas|Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas|Recruiting||Phase 1/Phase 2|200|Anticipated|Astex Pharmaceuticals||9|||f||||t||||||||||2017-10-10 23:06:42.944127|2017-10-10 23:06:42.944127
NCT02503397|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-17|||July 2011||2011-07-01|July 2015|2015-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Latent Iron Deficiency at Birth Influences Auditory Neural Maturation in Late Preterm and Term Infants|Latent Iron Deficiency at Birth Influences Auditory Neural Maturation in Late Preterm and Term Infants|Completed||N/A|90|Actual|Sir Ganga Ram Hospital|||2||f||||f||||||||||2017-10-10 23:06:43.134989|2017-10-10 23:06:43.134989
NCT02503384|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-17|||July 2015||2015-07-01|July 2015|2015-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|CBSPLT||Clinical and Basic Study for Pediatric Liver Transplantation|Clinical and Basic Study for Pediatric Liver Transplantation|Recruiting||N/A|180|Anticipated|RenJi Hospital|||1||f||||f||||||||||2017-10-10 23:06:43.201684|2017-10-10 23:06:43.201684
NCT02503371|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-17|||December 2011||2011-12-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||The Effect of In Vitro Fertilization on Coagulation Parameters as Measured by Thromboelastogram||Completed||N/A|46|Actual|Rabin Medical Center|||1||f||||f||||||||||2017-10-10 23:06:43.275908|2017-10-10 23:06:43.275908
NCT02503358|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-04-25|||July 2016||2016-07-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer|A Randomized, Open-Label, Phase I Trial of Continuous, Intermittent, and Pulsatile Selumetinib (AZD6244) Plus Paclitaxel as Second-Line Treatment for Stage IIIB or IV Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|54|Anticipated|OHSU Knight Cancer Institute||3|||f||||t||||||||||2017-10-10 23:06:43.337402|2017-10-10 23:06:43.337402
NCT02503345|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-01-17|||July 2015||2015-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|August 2016|Actual|2016-08-01||Interventional|||Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones|A Phase 2b, Multi-center, Randomized, Double Blind, Placebo-controlled, Crossover Study to Evaluate Multiple Doses of ALLN-177 in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria|Completed||Phase 2|32|Actual|Allena Pharmaceuticals||4|||f||||f||||||||No||2017-10-10 23:06:43.450452|2017-10-10 23:06:43.450452
NCT02503332|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-10-20|||September 2015||2015-09-01|October 2016|2016-10-01||||August 2017|Anticipated|2017-08-01||Interventional|FILLY||Study of of APL-2 Therapy in Patients Geographic Atrophy|A Phase II, Multicenter, Randomized, Single-Masked, Sham-Controlled Study of Safety, Tolerability and Evidence of Activity of Intravitreal APL-2 Therapy in Patients Geographic Atrophy (GA)|Active, not recruiting||Phase 2|240|Anticipated|Apellis Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-10 23:06:43.565042|2017-10-10 23:06:43.565042
NCT02503319|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-01-20|||October 2015||2015-10-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|September 2016|Actual|2016-09-01||Interventional|TRANOXY2015||Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015)|Clinical Study,Longitudinal,Controlled, Randomized, Open-label, Phase III,to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the Post Partum Hemorrhage (PHH) in Patients at the End of Pregnancy (37-42 w) at Low Risk of PPH|Suspended||Phase 3|486|Anticipated|Azienda U.S.L. 1 di Massa e Carrara||3||Authorization denied|f||||t||||||||||2017-10-10 23:06:43.702359|2017-10-10 23:06:43.702359
NCT02503306|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2016-03-16|||July 2015||2015-07-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CEDAR||Efficacy and Tolerability Study of Avanafil in Russia|Clinical Trial on Efficacy and Tolerability of Two Different Single Doses of Avanafil in Russia|Completed||Phase 3|189|Actual|Sanofi||3|||f||||f||||||||||2017-10-10 23:06:43.788727|2017-10-10 23:06:43.788727
NCT02503293|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-07-31|||July 2015||2015-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push|A Randomised, Cross-over Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push|Recruiting||Phase 4|40|Anticipated|Octapharma||2|||f||||f||||||||||2017-10-10 23:06:43.874933|2017-10-10 23:06:43.874933
NCT02503280|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-04-25|||March 1, 2025|Anticipated|2025-03-01|April 2017|2017-04-01|March 2032|Anticipated|2032-03-01|March 2030|Anticipated|2030-03-01||Interventional|TAC-HFT-II||The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.|A Phase I/II, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Transendocardial Injection of Autologous Human Cells (Mesenchymal or the Combination of MSC and Cardiac Stem Cells) in Patients With Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction.|Not yet recruiting||Phase 1/Phase 2|55|Anticipated|University of Miami||3|||f||||f|t|f||||||Undecided||2017-10-10 23:06:44.167232|2017-10-10 23:06:44.167232
NCT02503267|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-03-24|||July 2015||2015-07-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|(CARDIoG)||"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"|"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects (CARDIoG)"|Recruiting||N/A|300|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||1||f||||f||||||Samples With DNA|"     Through the blood sample we will:        -  Identify Antitrombin III deficiency        -  Evaluate the glycosylation degree of different glycoproteins        -  Do a genetic analysis   "|||2017-10-10 23:06:44.329064|2017-10-10 23:06:44.329064
NCT02503254|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-01-19|2016-11-04||July 2015||2015-07-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional||"The study population consisted of all the randomized subjects who had at least 1 post randomization product use experience (CHTP 1.0 or CC), and at least 1 valid non-safety assessment.
80 randomized subjects: 41 in CHTP 1.0 and 39 in CC study arms. All the randomized subjects completed the study."|Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement.|A Randomized, Controlled, Open-label, 2-arm Parallel Group, Single Center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Healthy Smokers Switching to the Carbon Heated Tobacco Product 1.0 (CHTP 1.0) Compared to Continuing to Use Conventional Cigarettes During 5 Days in Confinement.|Completed||N/A|85|Actual|Philip Morris Products S.A.||2|||f||||f||||||||No||2017-10-10 23:06:44.456388|2017-10-10 23:06:44.456388
NCT02503241|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-09-22|||April 2016||2016-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Open Lung Strategy in Critically Ill Morbid Obese Patients|Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction|Active, not recruiting||N/A|21|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:06:44.949913|2017-10-10 23:06:44.949913
NCT02503228|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-08-16|||June 2015||2015-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|MTF-MOPS||Clinical Assessment of the Missouri Osteochondral Allograft Preservation System - MOPS|Clinical Assessment of the Missouri Osteochondral Allograft Preservation System - MOPS|Recruiting||N/A|60|Anticipated|University of Missouri-Columbia||1|||f||||f||||||||||2017-10-10 23:06:45.086679|2017-10-10 23:06:45.086679
NCT02503215|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2016-05-27|2016-03-21||August 2014||2014-08-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|EComStockOSA||Effects of Compression Stockings on Obstructive Sleep Apnea in Patients Under Hemodialysis|Effects of Compression Stockings on Obstructive Sleep Apnea and Autonomic Nervous System in Patients Under Hemodialysis|Completed||N/A|14|Actual|University of Sao Paulo|During heart rate variability analysis, two patients had techinical problems during electrocardiogram aquisition and could not habe their data analysed and were therefore excluded from final results.|1|||f||||f||||||||Yes||2017-10-10 23:06:45.197304|2017-10-10 23:06:45.197304
NCT02503202|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-10-04|||August 17, 2015|Actual|2015-08-17|October 2017|2017-10-01|September 29, 2017|Actual|2017-09-29|May 2, 2016|Actual|2016-05-02||Interventional|||Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)|A Phase III, Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Immunogenicity of Three Consistency Lots and a High Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults|Completed||Phase 3|1198|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-10 23:06:45.499601|2017-10-10 23:06:45.499601
NCT02503189|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-05-15||||||May 2017|2017-05-01||||January 2017|Actual|2017-01-01||Interventional|||A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome||Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 23:06:45.620892|2017-10-10 23:06:45.620892
NCT02503176|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-17||||||July 2015|2015-07-01||||April 2018|Anticipated|2018-04-01||Interventional|||An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome||Recruiting||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-10 23:06:45.713866|2017-10-10 23:06:45.713866
NCT02503163|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2015-07-17||||||July 2015|2015-07-01||||April 2018|Anticipated|2018-04-01||Interventional|||A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome||Recruiting||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-10 23:06:45.802004|2017-10-10 23:06:45.802004
NCT02503150|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-29|||July 2015||2015-07-01|July 2015|2015-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer|Phase III Trial of Antigen Pulsed Dendritic Cells (APDC) Combined With Chemotherapy in Metastatic Colorectal Cancer|Not yet recruiting||Phase 3|480|Anticipated|Second Military Medical University||2|||f||||t||||||||||2017-10-10 23:06:45.914402|2017-10-10 23:06:45.914402
NCT02503137|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-07-13|||August 2015||2015-08-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing|A Phase 2, Multicenter, Randomized, Double-Blind Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia (AGA) Analyzed by Biopsy of the Scalp Prior To and Post Dosing|Completed||Phase 2|49|Actual|Samumed LLC||3|||f||||f||||||||||2017-10-10 23:06:46.021594|2017-10-10 23:06:46.021594
NCT02503124|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-10-12|||July 2015||2015-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of a Single Nights' Wake Followed by Bright Light Therapy for Severe Depression|Wake and Bright Light Therapy for Depression Among Admitted Patients|Active, not recruiting||N/A|50|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||Undecided||2017-10-10 23:06:46.121193|2017-10-10 23:06:46.121193
NCT02503111|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-09-13|||November 2015||2015-11-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|HPV-SAVE||The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men|A Randomized Controlled, Open-label Trial Examining the Efficacy, Safety, and Tolerability of Ablative Therapies for High-grade Anal Dysplasia Versus Observation Alone in HIV-positive Men Who Have Sex With Men (MSM)|Enrolling by invitation||N/A|3000|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:06:46.220002|2017-10-10 23:06:46.220002
NCT02503098|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-02-16|||November 23, 2016|Actual|2016-11-23|February 2017|2017-02-01|May 23, 2018|Anticipated|2018-05-23|March 23, 2018|Anticipated|2018-03-23||Interventional|||Optimizing a Smartphone Application for Individuals With Eating Disorders|Optimizing a Smartphone Application for Individuals With Eating Disorders|Recruiting||N/A|5000|Anticipated|Recovery Record Research||2|||f||||t||||||||||2017-10-10 23:06:46.363279|2017-10-10 23:06:46.363279
NCT02503072|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-09-27|||March 2013||2013-03-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|RAP||Rewarding Adherence Program - an Intervention Using Small Prizes Allocated by a Prize Drawing to Increase ARV Adherence|Variable Rewards Incentives for ART Adherence in Uganda|Completed||N/A|157|Actual|RAND||2|||f||||f||||||||||2017-10-10 23:06:46.543254|2017-10-10 23:06:46.543254
NCT02503059|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-16|||November 2014||2014-11-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Observational|||Etanercept Survival in Elderly Population|Etanercept Survival in Elderly Population|Completed||N/A|70|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||||||2017-10-10 23:06:46.613451|2017-10-10 23:06:46.613451
NCT02503046|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-08-26|||February 2015||2015-02-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|EP3PGKG||Estimation of Pentraxin3 and PGingivalis Levels in Patients With Knee Joint and Gum Diseases|Estimation of Pentraxin 3 and Porphyromonas Gingivalis Levels in Patients With Rheumatoid Arthritis and Periodontitis- An Observational Study|Completed||N/A|90|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||3||f||||t||||||Samples With DNA|"     Pooled plaque sample will be collected and sent for DNA Extraction by PCR for asseessment of     levels of PGingivalis.      5ml of blood to be collected from each subject, centrifuged, to separate the plasma for     estimation of Pentraxin3 (Quantikine ELISA)   "|No||2017-10-10 23:06:46.684205|2017-10-10 23:06:46.684205
NCT02503033|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-08-15|||October 2015||2015-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies|A Phase I, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of HMPL-523 in Patients With Relapsed or Refractory Hematologic Malignancies|Recruiting||Phase 1|47|Anticipated|Hutchison Medipharma Limited||1|||f||||f||||||||||2017-10-10 23:06:46.76712|2017-10-10 23:06:46.76712
NCT02503020|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-17|||July 2011||2011-07-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Arachidonic Acid Supplementation in Very Preterm Infants|Effects of Different Arachidonic Acid Supplementation on Psychomotor Development in Very Preterm Infants, a Randomized Controlled Trial|Completed||Phase 2|45|Actual|Health Research Institute of Santiago||2|||f||||f||||||||||2017-10-10 23:06:46.889074|2017-10-10 23:06:46.889074
NCT02503007|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-11-24|||July 2015||2015-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Effects of 14-days of HMB-free Acid on Changes in Muscle During 4-days of Survival Training|The Effects of 14-days of HMB-Free Acid on Changes in Muscle Architecture, Blood Markers of Muscle Damage and Performance During 4-Days of Survival Training|Completed||N/A|27|Actual|Metabolic Technologies Inc.||2|||f||||f||||||||||2017-10-10 23:06:46.945887|2017-10-10 23:06:46.945887
NCT02502994|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-07-16|||May 2015||2015-05-01|July 2015|2015-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC|Phase 1 Dose-escalation, Safety / Tolerability and Preliminary Efficacy Study of Intratumoral and Subcutaneous Administration of GEN0101 in Patients With Recurrence of Castration Resistant Prostate Cancer|Unknown status|Recruiting|Phase 1|12|Anticipated|Osaka University||1|||f||||t||||||||||2017-10-10 23:06:47.025452|2017-10-10 23:06:47.025452
NCT02502981|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-06-30|||June 2014||2014-06-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|SPIRO-CKD||Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD|A Randomised Open Label, Blinded End Point Trial to Compare the Effects of Spironolactone With Chlortalidone on LV Mass in Stage 3 Chronic Kidney Disease (SPIRO-CKD)|Active, not recruiting||Phase 4|154|Actual|University Hospital Birmingham||1|||f||||t||||||||||2017-10-10 23:06:47.096987|2017-10-10 23:06:47.096987
NCT02502968|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-09-18|||September 2015||2015-09-01|September 2015|2015-09-01||||July 2018|Anticipated|2018-07-01||Interventional|BLAST||BL-8040 Addition to Consolidation Therapy in AML Patients|A Double- Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of BL-8040 Addition to Consolidation Therapy in AML Patients|Recruiting||Phase 2|194|Anticipated|Martin-Luther-Universität Halle-Wittenberg||2|||f||||t||||||||||2017-10-10 23:06:47.192788|2017-10-10 23:06:47.192788
NCT02502955|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-08-07|||May 2015||2015-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Observational|||Virtual Autopsy in Cardiology, Cardio- and Vascular-Surgery|Virtual Autopsy in Cardiology, Cardio- and Vascular-Surgery|Completed||N/A|50|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-10 23:06:47.26725|2017-10-10 23:06:47.26725
NCT02502942|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2017-09-15|||August 2015||2015-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Upper Airway Muscle Training on OSA|Effects of Upper Airway Muscle Training on Obstructive Sleep Apnea (OSA)|Recruiting||N/A|60|Anticipated|University of California, San Diego||4|||f||||t||||||||||2017-10-10 23:06:47.325778|2017-10-10 23:06:47.325778
NCT02502929|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-07-08|||November 2015||2015-11-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|DREAM||Diabetes Risk Reduction Through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians|Lifestyle and Medication Management to Lower Diabetes Risk in Severe Mental Illness|Recruiting||N/A|210|Anticipated|UConn Health||3|||f||||f||||||||||2017-10-10 23:06:47.424949|2017-10-10 23:06:47.424949
NCT02502916|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-16|||October 2009||2009-10-01|July 2015|2015-07-01|July 2012|Actual|2012-07-01|June 2010|Actual|2010-06-01||Observational|PRECOL||Enteral Feeding and Early Gut Colonization of Preterm Infants|Potential Role of the Enteral Feeding Systems on Early Bacterial Gut Colonization of Preterm Infants|Completed||N/A|32|Actual|Universidad Complutense de Madrid|||1||f||||f||||||Samples With DNA|"     meconium, fecal samples mother's milk donor's milk   "|||2017-10-10 23:06:47.512783|2017-10-10 23:06:47.512783
NCT02502903|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-04-24|||June 2015||2015-06-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|June 17, 2018|Anticipated|2018-06-17||Interventional|TNT009-01||Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders|Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement-mediated Disorders. A Single/Multiple Ascending Dose Phase 1 Study|Recruiting||Phase 1|98|Anticipated|True North Therapeutics||3|||f||||t||||||||||2017-10-10 23:06:47.574475|2017-10-10 23:06:47.574475
NCT02502890|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-02-17|||October 2015||2015-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|MUPPITS||Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy|Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)|Completed||N/A|208|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     Blood, Nasal Samples.   "|||2017-10-10 23:06:49.578439|2017-10-10 23:06:49.578439
NCT02502877|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-04-05|||July 2015||2015-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Core Temperature Variations During Midazolam vs Propofol Sedation for Neuraxial Anesthesia|Core Temperature Variations During Midazolam vs Propofol Sedation for Neuraxial Anesthesia|Completed||N/A|27|Actual|Hospital da Luz, Portugal||2|||f||||f||||||||||2017-10-10 23:06:49.658761|2017-10-10 23:06:49.658761
NCT02502864|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-06-30|||January 26, 2016|Actual|2016-01-26|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide|Multicenter Study Investigating Utilization of Pharmacokinetic(PK)-Guided Docetaxel in Senior Adult Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) Chemotherapy|Active, not recruiting||Phase 4|9|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 23:06:49.74287|2017-10-10 23:06:49.74287
NCT02502305|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-17|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|LIFE!||Liveonline Training Course to Improve Food Habits and Enhance Physical Activity in Older Adults|Liveonline Training Course to Improve Food Habits and Enhance Physical Activity in Older Adults|Completed||N/A|101|Actual|Jacobs University Bremen gGmbH||2|||f||||f||||||||||2017-10-10 23:06:55.848928|2017-10-10 23:06:55.848928
NCT02502851|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-06-18|||September 2014||2014-09-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|PREPARE-CALC||The Comparison of Strategies to PREPARE Severely CALCified Coronary Lesions Trial (PREPARE-CALC)|The Comparison of Strategies to PREPARE Severely CALCified Coronary Lesions Trial (PREPARE-CALC): A Prospective Randomized Controlled Trial of Rotational Atherectomy Versus Cutting/Scoring Balloon in Severely Calcified Coronary Lesions|Recruiting||N/A|200|Anticipated|Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH||2|||f||||t||||||||||2017-10-10 23:06:49.8436|2017-10-10 23:06:49.8436
NCT02502838|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-08-31|||May 2015||2015-05-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair|The Effect of an Additional TVT on OAB Symptoms in Surgical Repair of Pelvic Organ Prolapse|Completed||N/A|40|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||t||||||||||2017-10-10 23:06:49.946126|2017-10-10 23:06:49.946126
NCT02502825|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-17|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Comparison of Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers|Comparison of 2-min Tidal Breathing Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers|Unknown status|Recruiting|N/A|20|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||t||||||||||2017-10-10 23:06:50.026737|2017-10-10 23:06:50.026737
NCT02502812|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-05-03|||September 4, 2015|Actual|2015-09-04|May 2017|2017-05-01|September 24, 2015|Actual|2015-09-24|September 24, 2015|Actual|2015-09-24||Interventional|||Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects|An Open-label, Randomised, Single-dose, Three-way Cross Over, Six Sequence Study to Determine the Relative Bioavailability of Clopidogrel 75mg From Two Tablet Formulations of SB224326 Relative to One 75mg Reference Tablet of Clopidogrel in Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|18|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-10 23:06:50.118839|2017-10-10 23:06:50.118839
NCT02502799|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-08-07|||July 2015||2015-07-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Intervention for Teens With ADHD and Substance Use|Intervention for Teens With ADHD and Substance Use|Recruiting||Phase 3|300|Anticipated|Florida International University||3|||f||||f||||||||||2017-10-10 23:06:50.229538|2017-10-10 23:06:50.229538
NCT02502786|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-09-08|||July 2015||2015-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma|A Phase II Study of Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma|Recruiting||Phase 2|39|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:06:50.399267|2017-10-10 23:06:50.399267
NCT02502773|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-07-28|||February 2016||2016-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|FLASH||Fluid Loading in Abdominal Surgery: Saline Versus Hydroxyethyl Starch (FLASH Study)|Fluid Loading in Abdominal Surgery: Saline Versus Hydroxyethyl Starch: A Double-blinded Multicenter Prospective Randomized Trial (FLASH Study)|Recruiting||Phase 3|826|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:06:50.591906|2017-10-10 23:06:50.591906
NCT02502760|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-10-17|||August 2015||2015-08-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Using Multimodal Prehabilitation to Improve Outcomes for Frail Patients Undergoing Resection of Colorectal Cancer||Enrolling by invitation||N/A|120|Anticipated|McGill University Health Center||2|||f||||f||||||||Undecided||2017-10-10 23:06:50.798261|2017-10-10 23:06:50.798261
NCT02502747|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-02-09|||January 2016||2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|RIGENERA||RIGENERA 2.0 Trial|"RIGENERA 2.0 (Recupero Dall'Infarto Miocardico Con G-CSF E Nuovi Esempi di Rigenerazione Avanzata) Project: The Combined Effect of Subcutaneous Granulocyte - Colony Stimulating Factor and Myocardial Contrast Echocardiography With Intravenous Infusion of Sulphur Hexafluoride on Post-infarction Left Ventricular Function"|Active, not recruiting||Phase 2|120|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-10 23:06:50.940439|2017-10-10 23:06:50.940439
NCT02502734|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-08-16|2016-06-16||September 7, 2015||2015-09-07|June 2016|2016-06-01|December 21, 2015|Actual|2015-12-21|December 1, 2015|Actual|2015-12-01||Interventional|||Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma|A Randomised, Double-blind, Two-way Crossover Study to Investigate the Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma|Completed||Phase 3|60|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:06:51.082946|2017-10-10 23:06:51.082946
NCT02502721|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-08-24|||June 2015||2015-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152|A Randomized, Open-labeled, Oral Dose, Crossover Design Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152 in Healthy Male Subjects|Completed||Phase 1|58|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||||2017-10-10 23:06:51.377862|2017-10-10 23:06:51.377862
NCT02502708|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-01-09|||October 2015||2015-10-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors|A Phase I Trial of Indoximod and Temozolomide-Based Therapy for Children With Progressive Primary Brain Tumors|Recruiting||Phase 1|66|Anticipated|NewLink Genetics Corporation||3|||f||||f||||||||||2017-10-10 23:06:51.489178|2017-10-10 23:06:51.489178
NCT02502695|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-02-14|||June 2015||2015-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)|A Prospective, Observational, Quality Improvement Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)|Recruiting||N/A|400|Anticipated|Dana-Farber Cancer Institute|||2||f||||f||||||||||2017-10-10 23:06:51.614252|2017-10-10 23:06:51.614252
NCT02502682|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-07-06|||July 2015||2015-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Chlorhexidine Bathing Effect on Clostridium Difficile Rates|Effect of Daily Chlorhexidine Bathing on Clostridium Difficile Rates on the General Medical Floor in Patients Receiving Antibiotics|Completed||Phase 2|167|Actual|Northwestern Medicine Delnor Hospital||2|||f||||f||||||||||2017-10-10 23:06:51.725601|2017-10-10 23:06:51.725601
NCT02502669|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-07-19|||July 2015||2015-07-01|July 2017|2017-07-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Interventional|||Finasteride Treatment of Severe Nodulocystic Acne|A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne|Completed||Phase 2|106|Actual|Elorac, Inc.||3|||f||||f||||||||||2017-10-10 23:06:51.806976|2017-10-10 23:06:51.806976
NCT02502656|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-11-16|||July 2015||2015-07-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|RASANC||RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer|"RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer: Concordance With the Standard Testing Method From Tumor Tissue and Review of Associated Timelines and Costs"|Recruiting||N/A|425|Anticipated|Association des Gastroentérologues Oncologues|||1||f||||f||||||Samples With DNA|"     Blood collection will be performed on the day of the first oncological consultation   "|||2017-10-10 23:06:51.94094|2017-10-10 23:06:51.94094
NCT02502643|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-10-13|||July 2015||2015-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak|The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak|Recruiting||N/A|80|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:06:52.044025|2017-10-10 23:06:52.044025
NCT02502630|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-08-11|||June 2010||2010-06-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Microwave Ablation for Pulmonary Metastases From Colorectal Cancer|CT-guided Percutaneous Microwave Ablation for Pulmonary Metastases From Colorectal Cancer|Completed||N/A|32|Actual|The First People's Hospital of Changzhou||1|||f||||t||||||||Undecided||2017-10-10 23:06:52.127767|2017-10-10 23:06:52.127767
NCT02502617|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2016-10-18|||March 2016||2016-03-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|November 2018|Anticipated|2018-11-01||Observational|RESAN||Re-nutrition in Severe Anorexia Nervosa|Effect of Intensive Re-nutrition on Eating Disorder Psychopathology, Cognitive Functions, Anxiety, Depression, and Cortisol Level in Severe Anorexia Nervosa|Recruiting||N/A|60|Anticipated|Odense University Hospital|||2||f||||f||||||Samples Without DNA|"     Urine.   "|No|Data will be entered in Odense Patient data Explorative Network (OPEN).|2017-10-10 23:06:52.208988|2017-10-10 23:06:52.208988
NCT02502604|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-16|||September 2015||2015-09-01|July 2015|2015-07-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder|Investigating the Efficacy of a Top-Down Approach to Cognitive Remediation in Individuals With Affective Disorders|Not yet recruiting||N/A|128|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-10 23:06:52.443307|2017-10-10 23:06:52.443307
NCT02502591|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-05-08|||August 2015||2015-08-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|April 2017|Actual|2017-04-01||Interventional|PPPR||Pudendal Nerve Block for Postoperative Posterior Repair Pain Relief|Pudendal Nerve Block for Postoperative Pain Relief in Women Undergoing Posterior Vaginal Repairs: a Pilot Study|Active, not recruiting||Phase 2|40|Anticipated|Royal Devon and Exeter NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 23:06:52.574552|2017-10-10 23:06:52.574552
NCT02502578|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-09-27|||September 2015||2015-09-01|September 2016|2016-09-01||||June 2016|Actual|2016-06-01||Interventional|||Safety Study of CNT-01 in Patients With Idiopathic TGCV|Phase I/IIa Study of CNT-01 in Patients With Idiopathic Triglyceride Deposit|Completed||Phase 1/Phase 2|5|Actual|Osaka University||1|||f||||t||||||||||2017-10-10 23:06:52.702875|2017-10-10 23:06:52.702875
NCT02502565|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-03-28|||January 2012||2012-01-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|January 2018|Anticipated|2018-01-01||Observational|||Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia|Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia: Redefining Early Urate Disease|Recruiting||N/A|200|Anticipated|Washington D.C. Veterans Affairs Medical Center|||1||f||||f||||||||||2017-10-10 23:06:52.84873|2017-10-10 23:06:52.84873
NCT02502552|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-10-30|||November 2013||2013-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort|Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort - A Monocentric Study|Completed||N/A|80|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     blood specimen in IBD cohort of 195 patients followed in Saint-Etienne Hospital   "|||2017-10-10 23:06:52.946964|2017-10-10 23:06:52.946964
NCT02502539|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|AJI-APA||Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases|Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases|Recruiting||N/A|20|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 23:06:53.038061|2017-10-10 23:06:53.038061
NCT02502526|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-09-27|||July 27, 2015|Actual|2015-07-27|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|March 23, 2017|Actual|2017-03-23||Interventional|||Comparison of Centurion® Vision System With Balanced Tip and the Infiniti® Vision System With the Mini Flared Kelman (MFK) Tip During Cataract Extraction Surgery of Hard Lenses|Comparison of Cumulative Dissipated Energy (CDE) and Balanced Salt Solution (BSS) Fluid Used With the Centurion® With the 45° Degree Balanced Ultrasound (U/S) Tip vs the Centurion® With Mini Flared Kelman U/S Tip vs the Infiniti® With Mini Flared Kelman U/S Tip on Hard Lenses|Active, not recruiting||N/A|231|Actual|Alcon Research||3|||f||||f||||||||||2017-10-10 23:06:53.148985|2017-10-10 23:06:53.148985
NCT02502513|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-01-27|||June 2013||2013-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Prevention of Intrusive Memories and Posttraumatic Stress Symptoms After Emergency Cesarean Section|Can Playing Tetris Prevent the Development of Traumatic Intrusions in Mothers Following an Emergency Cesarean Section? A Pilot Study|Completed||N/A|56|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 23:06:53.245872|2017-10-10 23:06:53.245872
NCT02502500|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-10-20|||July 2015||2015-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Effect of AKB-6548 on the Pharmacokinetics of Celecoxib|An Open-label Study in Healthy Subjects to Assess the Effect of Once-daily Multiple Dosing of AKB-6548 on the Pharmacokinetics of the CYP2C9 Substrate Celecoxib|Completed||Phase 1|12|Actual|Akebia Therapeutics||2|||f||||f||||||||||2017-10-10 23:06:53.378527|2017-10-10 23:06:53.378527
NCT02502487|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-07-13|2016-04-14||June 2015||2015-06-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Dorsal Penile Nerve Block for Rigid Cystoscopy in Men|Dorsal Penile Nerve Block for Rigid Cystoscopy in Men: a Single-center, Randomized, Double-blind and Placebo-controlled Study|Completed||N/A|258|Actual|West China Hospital|The VAS scale was the only main observe index, and patients could have different cognition of pain and this may affect the evaluation of pain. The nerve block was not guided by ultrasound, which may improve the analgesic effect.|3|||f||||f||||||||No||2017-10-10 23:06:53.509546|2017-10-10 23:06:53.509546
NCT02502474|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-05-29|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|ColoStaph||Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne|Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne.|Recruiting||N/A|160|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:06:54.404383|2017-10-10 23:06:54.404383
NCT02502461|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-07-16|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Interventional|||Tracheal Palpation of Sliding Cuff to Assess Endotracheal Tube Location|Tracheal Palpation of Sliding Cuff to Assess Endotracheal Tube Location in Trachea - A Randomized Controlled Trial|Unknown status|Recruiting|N/A|90|Anticipated|University of Saskatchewan||2|||f||||t||||||||||2017-10-10 23:06:54.490216|2017-10-10 23:06:54.490216
NCT02502448|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-07-01|||December 2011||2011-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery|Impact of Acute Normovolemic Hemodilution on Whole Blood Coagulation Profile During Post-cardiopulmonary Bypass in Cardiac Surgery: Rotational Thromboelastometry Study|Completed||N/A|70|Actual|Konkuk University Medical Center||2|||f||||t||||||||||2017-10-10 23:06:54.58433|2017-10-10 23:06:54.58433
NCT02502435|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-07-27|||July 2015||2015-07-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Observational|||Human Plasma Fatty Acid Oscillations|Exploratory Phase I Study to Define Plasma Fatty Acid Oscillations in Patients With Night Eating Syndrome Compared to Healthy Volunteers.|Recruiting||N/A|12|Anticipated|University of Pennsylvania|||2||f||||f||||||||||2017-10-10 23:06:54.679336|2017-10-10 23:06:54.679336
NCT02502422|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-02-14|||August 2015||2015-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|RCVPE||Relationship Between Optimal Laryngeal Mask Airway Cuff Volume and Physical Examination of Head and Neck|Prediction of Optimal Laryngeal Mask Airway Cuff Volume From Parameters of Physical Examination of Head and Neck|Completed||N/A|170|Actual|Korea University Anam Hospital||1|||f||||t||||||||Undecided||2017-10-10 23:06:54.769994|2017-10-10 23:06:54.769994
NCT02502409|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-08-03|||July 2015||2015-07-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|B-Natural||Natural History Study of Factor IX Treatment and Complications|Natural History Study of Factor IX Treatment and Complications|Recruiting||N/A|550|Anticipated|Skane University Hospital|||1||f||||f||||||Samples With DNA|"     Serum, plasma, cells   "|||2017-10-10 23:06:54.842293|2017-10-10 23:06:54.842293
NCT02502396|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-12-05|||September 2015||2015-09-01|December 2016|2016-12-01||||September 2018|Anticipated|2018-09-01||Observational|||Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center|Retrospective Study: Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center|Recruiting||N/A|375|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-10 23:06:54.954036|2017-10-10 23:06:54.954036
NCT02502383|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-04-07|||January 2014||2014-01-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|ACTION PAC||ACTION PAC: Adolescents Committed to Improvement of Nutrition & Physical Activity|ACTION PAC: Adolescents Committed to Improvement of Nutrition & Physical Activity|Active, not recruiting||N/A|992|Actual|University of New Mexico||2|||f||||f||||||||||2017-10-10 23:06:55.05653|2017-10-10 23:06:55.05653
NCT02502370|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-16||||||July 2015|2015-07-01||||September 2023|Anticipated|2023-09-01||Interventional|BALLAD||Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma|PRODIGE 33 - BALLAD - Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma|Not yet recruiting||Phase 3|100|Anticipated|Centre Hospitalier Universitaire Dijon||4|||f||||||||||||||2017-10-10 23:06:55.12493|2017-10-10 23:06:55.12493
NCT02502357|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-03-14|||July 2015||2015-07-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|PHSPOPC||Healing Statements and Their Effect on Post Operative Pain|The Power of Healing Statements on Post Operative Pain Control: A Randomized Controlled Trial|Recruiting||N/A|32|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-10 23:06:55.372515|2017-10-10 23:06:55.372515
NCT02502344|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-07-19|||August 2015||2015-08-01|July 2016|2016-07-01||||August 2018|Anticipated|2018-08-01||Interventional|MIIIROPOAGT||Effect of Medical Interventions in Insulin Resistance on Prevalence of Abnormal Glucose Tolerance|The Research About the Influence of Medical Interventions in the Period of Insulin Resistance on Prevalence of Abnormal Glucose Tolerance|Recruiting||Phase 4|60|Anticipated|Beijing Tsinghua Chang Gung Hospital||2|||f||||t||||||||||2017-10-10 23:06:55.491556|2017-10-10 23:06:55.491556
NCT02502331|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-12-15|||March 2016||2016-03-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||Safety and Immunogenicity of a New Formulation of Euvichol®|A Randomized, Observer Blinded, Controlled Trial to Evaluate the Safety and Immunogenicity of a New Formulation of Euvichol® (Killed Bivalent Whole Cell Oral Cholera Vaccine Manufactured by EuBiologics Co. Ltd.) in Healthy Individuals|Not yet recruiting||Phase 3|442|Anticipated|International Vaccine Institute||2|||f||||f||||||||||2017-10-10 23:06:55.597995|2017-10-10 23:06:55.597995
NCT02502318|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-05|||July 2015||2015-07-01|April 2017|2017-04-01||||June 2019|Anticipated|2019-06-01||Interventional|LungSco01||Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung Cancer|Medicoeconomic Analysis of Lobectomy Using Thoracoscopy vs Thoracotomy for Lung Cancer: a Multicentric Randomized Controlled Trial.|Recruiting||N/A|600|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 23:06:55.702961|2017-10-10 23:06:55.702961
NCT02502266|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-17|2017-10-03|||February 5, 2016|Actual|2016-02-05|June 2017|2017-06-01||||June 30, 2023|Anticipated|2023-06-30||Interventional|||Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)|Suspended||Phase 2/Phase 3|680|Anticipated|National Cancer Institute (NCI)||7||Scheduled Interim Monitoring|f||||f||||||||||2017-10-10 23:06:56.152849|2017-10-10 23:06:56.152849
NCT02502253|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-03-03|||June 2015||2015-06-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|BDPP||BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)|BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)|Recruiting||Phase 1|48|Anticipated|Johns Hopkins University||3|||f||||||||||||||2017-10-10 23:06:57.007141|2017-10-10 23:06:57.007141
NCT02502240|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-03-01|||July 2015||2015-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01|1 Year|Observational [Patient Registry]|||ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)|Frequency of ALK Rearrangements in Non Small-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).|Recruiting||N/A|7000|Anticipated|Instituto Nacional de Cancerologia de Mexico|||1||f||||f||||||||No||2017-10-10 23:06:57.089278|2017-10-10 23:06:57.089278
NCT02502227|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-01-30|||July 2015||2015-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Mechanisms of Mindfulness Training and Stress Reduction|Mechanisms of Mindfulness Training and Stress Reduction|Completed||N/A|137|Actual|Carnegie Mellon University||3|||f||||t||||||||||2017-10-10 23:06:57.158999|2017-10-10 23:06:57.158999
NCT02502214|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-05-18|||November 12, 2015|Actual|2015-11-12|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Feasibility Study of Preimplantation Genetic Diagnosis for Single-gene Disorders|Feasibility Study of Preimplantation Genetic Diagnosis for Single-gene Disorders by Using Nextgeneration Sequencing|Recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f|f|f||||||No||2017-10-10 23:06:57.248989|2017-10-10 23:06:57.248989
NCT02502201|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-10-05|||October 2015||2015-10-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|6MWTAATD||Environment Effect on Six-Minute Walk Test Performance|Effect of the Environment on Six-minute Walk Test Performance in Individuals With Alpha-1 Antitrypsin Deficiency-Related Chronic Obstructive Pulmonary Disease|Recruiting||N/A|65|Anticipated|University of Florida||4|||f||||t|f|f||||||||2017-10-10 23:06:57.32686|2017-10-10 23:06:57.32686
NCT02502188|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-03-29|||July 2015||2015-07-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis|A Phase 1, Multicenter, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis|Terminated||Phase 1|24|Actual|Celgene Corporation||2||Business Decision|f||||f||||||||||2017-10-10 23:06:57.421829|2017-10-10 23:06:57.421829
NCT02502175|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-07-16|||September 2015||2015-09-01|July 2015|2015-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|OT-RCT||Comparing Opium Tincture (OT) With Methadone for Substitution Treatment of Opioid Dependence|Comparison of Opium Tincture (OT) and Methadone for Maintenance Treatment of Opioid Dependence: A Randomized Double-blind Controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 3|240|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 23:06:57.520741|2017-10-10 23:06:57.520741
NCT02502162|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-04-28|||June 2015||2015-06-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|LDN-CRPS||Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome|Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome|Recruiting||N/A|40|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 23:06:57.734981|2017-10-10 23:06:57.734981
NCT02502149|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-06-02|||August 2015||2015-08-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|April 2017|Actual|2017-04-01||Interventional|Elevate||Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale|A Randomized, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc; BIIB031) Manufactured at 15K Scale and at Different Vial Strengths in Previously Treated Subjects With Severe Hemophilia A|Active, not recruiting||Phase 3|24|Actual|Bioverativ Therapeutics Inc.||2|||f||||f||||||||||2017-10-10 23:06:57.839103|2017-10-10 23:06:57.839103
NCT02502136|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-16|||April 2011||2011-04-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy and Safety of Carbon Dioxide Insufflation During Endoscopy|The Assessment of Differences in Clinical Safety and Efficacy of Carbon Dioxide Insufflation During Sedated and Conventional Endoscopy|Completed||N/A|640|Actual|Chang Gung Memorial Hospital||8|||f||||t||||||||||2017-10-10 23:06:58.022903|2017-10-10 23:06:58.022903
NCT02502123|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-07-25|||July 2, 2015|Actual|2015-07-02|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Observational|PREDICT||Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®|Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Chronic Migraine and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (PREDICT)|Active, not recruiting||N/A|215|Actual|Allergan|||1||f||||f||||||||||2017-10-10 23:06:58.117051|2017-10-10 23:06:58.117051
NCT02502110|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-20|||August 2015||2015-08-01|July 2015|2015-07-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|||Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation|The Study of Rosuvastatin for Reduction of Postoperative Paroxysmal Atrial Fibrillation in Patient Undergoing Radiofrequency Catheter Ablation|Not yet recruiting||Phase 4|346|Anticipated|The Third Xiangya Hospital of Central South University||2|||f||||t||||||||||2017-10-10 23:06:58.217348|2017-10-10 23:06:58.217348
NCT02502097|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-05-30|||August 20, 2015|Actual|2015-08-20|May 2017|2017-05-01|July 14, 2016|Actual|2016-07-14|July 1, 2016|Actual|2016-07-01||Interventional|||A Study of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)|A Randomized Placebo-Controlled Study to Assess the Efficacy and Safety of AF-219, a P2X3 Receptor Antagonist, in Subjects With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough|Completed||Phase 2|51|Actual|Afferent Pharmaceuticals, Inc.||2|||f||||f|t|f||||||||2017-10-10 23:06:58.309342|2017-10-10 23:06:58.309342
NCT02502084|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-02-06|||August 2015||2015-08-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Safety and Effectiveness Evaluation of the Sinusway Device for Endoscopy of the Nasal Cavity and Paranasal Sinuses|Safety and Effectiveness Evaluation of the Sinusway Device for Endoscopy of the Nasal Cavity and Paranasal Sinuses|Active, not recruiting||Phase 1|17|Actual|3NT Medical Ltd.||1|||f||||f||||||||||2017-10-10 23:06:58.45352|2017-10-10 23:06:58.45352
NCT02502071|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-05-01|||January 2017||2017-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|Alk-UA||Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes|Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 DiabetesL a Open-label Trial|Recruiting||Phase 4|47|Anticipated|University of Colorado Denver School of Medicine Barbara Davis Center||1|||f||||t||||||||||2017-10-10 23:06:58.546554|2017-10-10 23:06:58.546554
NCT02502058|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-06-16|||July 2015||2015-07-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Dental Implant Stability When Using the Densah Bur™ Bone Compaction Process to Prepare Dental Implant Sites|Observational, Case-Series Study Evaluation of Bone Width and Dental Implant Stability When Using the Densah Bur™ Bone Compaction Process to Prepare Dental Implant Sites|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute|||1|Principal Investigator left her employment at the University.|f||||f||||||||No|No plan to share study data.|2017-10-10 23:06:58.64917|2017-10-10 23:06:58.64917
NCT02502045|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-02-17|||May 2012||2012-05-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's|A Study to Examine the Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's Disease|Completed||N/A|18|Actual|Yale University||2|||f||||f|f|f||||||||2017-10-10 23:06:58.729125|2017-10-10 23:06:58.729125
NCT02502032|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-10-08|||July 2015||2015-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effects of Cisatracurium on Sccinylcholine-induced Fasciculations|Effects of Pretreatment With Different Doses of Cisatracurium on Succinylcholine-induced Fasciculations|Completed||Phase 3|87|Actual|Yangzhou No.1 People's Hospital||3|||f||||t||||||||||2017-10-10 23:06:58.817421|2017-10-10 23:06:58.817421
NCT02502006|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-08-22|||November 2015||2015-11-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Variability in Response to Non-steroidal Anti-inflammatory Drugs|A Double-blind, Placebo-controlled Investigation of Inter-individual Variability in Pharmacologic Response to Non-steroidal Anti-inflammatory Drugs|Recruiting||Phase 1|288|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:06:58.982126|2017-10-10 23:06:58.982126
NCT02501993|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-04-25|||March 2012||2012-03-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Observational|||Nasopharyngeal Carcinoma Screening in Zhongshan City|Serology Screening Test for the Detection of Nasopharyngeal Carcinoma in Zhongshan City|Recruiting||N/A|25000|Anticipated|Zhongshan People's Hospital, Guangdong, China|||1||f||||f||||||Samples With DNA|"     Serum and tissue samples   "|||2017-10-10 23:06:59.105019|2017-10-10 23:06:59.105019
NCT02501980|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-04-25|||January 2012||2012-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01|10 Years|Observational [Patient Registry]|HCC||Hepatocellular Cancer (HCC) Screening in Zhongshan City|Searching for Early Detection Biomarkers and to Reduce Mortality Rate of Hepatocellular Cancer (HCC) in Zhongshan City|Active, not recruiting||N/A|20000|Actual|Zhongshan People's Hospital, Guangdong, China|||2||f||||||||||Samples Without DNA|"     Blood samples   "|||2017-10-10 23:06:59.187177|2017-10-10 23:06:59.187177
NCT02501967|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-08-23|||April 2014||2014-04-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|COMET||Care Planning for Older Persons With Multiple Conditions: Encouraging a Tailored Approach (COMET): Stage II|Care Planning for Older Persons With Multiple Conditions: Encouraging a Tailored Approach (COMET): Stage II|Completed||N/A|128|Actual|Yale University||2|||f||||f||||||||||2017-10-10 23:06:59.252407|2017-10-10 23:06:59.252407
NCT02501954|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-09-08|||March 2015||2015-03-01|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol|Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel Vs. Sandwich Therapy of Carboplatin and Paclitaxel Followed by Tumor Volume Directed Irradiation Then Further Carboplatin and Paclitaxel|Recruiting||Phase 3|450|Anticipated|Women's Cancer Care Associates, LLC||2|||f||||f||||||||||2017-10-10 23:06:59.31586|2017-10-10 23:06:59.31586
NCT02501941|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|SAKS||Spreading Depolarization and Ketamine Suppression|Spreading Depolarization and Ketamine Suppression|Recruiting||Phase 1|10|Anticipated|University of New Mexico||2|||f||||f||||||||||2017-10-10 23:06:59.410862|2017-10-10 23:06:59.410862
NCT02501928|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-10-03|||June 5, 2015|Actual|2015-06-05|October 2017|2017-10-01|June 30, 2020|Anticipated|2020-06-30|May 31, 2020|Anticipated|2020-05-31||Interventional|||Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.|Long-term Extension Study To Evaluate The Safety Of Fesoterodine In Japanese Pediatric Subjects With Symptoms Of Detrusor Overactivity Associated With A Neurological Condition (Neurogenic Detrusor Overactivity) Who Have Completed 24 Weeks Treatment In Study A0221047|Recruiting||Phase 3|9|Anticipated|Pfizer||4|||f||||t|f|f||||||||2017-10-10 23:06:59.506084|2017-10-10 23:06:59.506084
NCT02501915|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-07-17|||February 2014||2014-02-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Kinesio Taping Effects Applied With Different Directions and Tensions|Kinesio Taping Effects Applied With Different Directions and Tensions on Electromyography, Electroencephalography, Local Temperature and Muscle Strength|Completed||Phase 1|30|Actual|Universidade Estadual de Goiás||2|||f||||t||||||||||2017-10-10 23:06:59.616321|2017-10-10 23:06:59.616321
NCT02501902|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-09-28|||November 23, 2015|Actual|2015-11-23|September 2017|2017-09-01|September 18, 2018|Anticipated|2018-09-18|September 18, 2018|Anticipated|2018-09-18||Interventional|||Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC|An Open-label Phase Ib Study Of Palbociclib (Oral Cdk 4/6 Inhibitor) Plus Abraxane (Registered) (Nab-paclitaxel) In Patients With Metastatic Pancreatic Ductal Adenocarcinoma|Recruiting||Phase 1|100|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 23:06:59.706467|2017-10-10 23:06:59.706467
NCT02501889|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-09-21|||August 2015||2015-08-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Lean Living Study|Walnut Consumption in a Weight Loss Intervention: Effects on Weight Change, Satiety and Potential Mediating Factors|Active, not recruiting||Phase 2/Phase 3|100|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:06:59.978208|2017-10-10 23:06:59.978208
NCT02501876|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2017-04-11|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|September 2015|Actual|2015-09-01|2 Years|Observational [Patient Registry]|DIACEA||Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease|Type 2 Diabetes Mellitus as Accelerator for the Progression to Alzheimer's Disease in Patients With Mild Cognitive Impairment|Completed||N/A|202|Actual|Hospital Universitari Vall d'Hebron Research Institute|||2||f||||f||||||Samples With DNA|"     Whole blood will be preserved in order to perform a genetic study of 10 genes related both     with type 2 diabetes and Alzheimer´s disease.   "|No||2017-10-10 23:07:00.106862|2017-10-10 23:07:00.106862
NCT02501863|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-09-13|||October 2015||2015-10-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Analgesic Effect of Ropivacaine Plus Fentanyl vs Ropivacaine for Continuous 3-in-1 FNB After Total Knee Arthroplasty|Analgesic Effect of Ropivacaine Plus Fentanyl vs Ropivacaine for Continuous 3-in-1 FNB After Total Knee Arthroplasty|Completed||N/A|40|Actual|National Medical Center, Seoul||2|||f||||f||||||||No||2017-10-10 23:07:00.187498|2017-10-10 23:07:00.187498
NCT02501850|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2015-07-20|||October 2014||2014-10-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|EGLIPA||The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)|The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)|Unknown status|Recruiting|Phase 4|40|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-10 23:07:00.276891|2017-10-10 23:07:00.276891
NCT02501837|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-15|||July 2014||2014-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Influence of Oxytocin on Pair-bonding and Emotion Regulation|The Influence of Oxytocin on Pair-bonding and Emotion Regulation|Completed||Early Phase 1|40|Actual|University Hospital, Bonn||2|||f||||f||||||||||2017-10-10 23:07:00.374205|2017-10-10 23:07:00.374205
NCT02501824|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-15|||October 2010||2010-10-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Effectiveness of Anthroposophic Speech Therapy in Patients With Asthma|Effectiveness of Anthroposophic Therapeutic Speech in Patients With Asthma in a Real-life Outpatient Setting - a Randomised, Controlled, Multicentre Cross-over Trial|Completed||Phase 2|49|Actual|University of Bern||2|||f||||f||||||||||2017-10-10 23:07:00.440126|2017-10-10 23:07:00.440126
NCT02501811|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-07-05|||October 2015||2015-10-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|CONCERT-HF||Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure|A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, and Efficacy of Autologous Mesenchymal Stem Cells and C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic Heart Failure|Recruiting||Phase 2|144|Anticipated|The University of Texas Health Science Center, Houston||4|||f||||t||||||||||2017-10-10 23:07:00.537841|2017-10-10 23:07:00.537841
NCT02501798|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-05-12|||January 2013||2013-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|July 2015|Actual|2015-07-01||Interventional|||The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children With ADHD|The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children With ADHD: A Randomised Placebo Controlled Trial|Completed||Phase 4|61|Anticipated|VU University of Amsterdam||2|||f||||f||||||||||2017-10-10 23:07:00.793691|2017-10-10 23:07:00.793691
NCT02501785|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-07-05|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Caregiver Burden Within the Ambulatory Extended Recovery (AXR) Patient Population|Caregiver Burden Within the Ambulatory Extended Recovery (AXR) Patient Population|Active, not recruiting||N/A|94|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:07:00.980255|2017-10-10 23:07:00.980255
NCT02501772|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-27|||September 2014||2014-09-01|July 2015|2015-07-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Mackay Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:07:01.085238|2017-10-10 23:07:01.085238
NCT02501759|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-26|||May 2015||2015-05-01|April 2017|2017-04-01|February 10, 2017|Actual|2017-02-10|December 31, 2016|Actual|2016-12-31||Interventional|||Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer|Pilot Study of Transrectal Multiparametric MRI-Guided Biopsy: Role in Prostate Cancer Evaluation|Completed||N/A|2|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 23:07:01.212953|2017-10-10 23:07:01.212953
NCT02501746|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-03-29|||February 6, 2017|Actual|2017-02-06|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|July 2018|Anticipated|2018-07-01||Interventional|BIGPIC||Bridging Income Generation With Group Integrated Care|Bridging Income Generation With Group Integrated Care (BIGPIC)|Recruiting||N/A|3600|Anticipated|Icahn School of Medicine at Mount Sinai||4|||f||||t|f|f||||||||2017-10-10 23:07:01.334275|2017-10-10 23:07:01.334275
NCT02501733|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-09-20|||June 2015||2015-06-01|September 2016|2016-09-01|December 2023|Anticipated|2023-12-01|July 2022|Anticipated|2022-07-01||Interventional|||Medacta GMK Sphere® Multicenter Post-Market Outcomes Study|Medacta GMK Sphere® Medial Pivot, Cruciate Substituting Multicenter, Post-Market Outcomes Study|Recruiting||N/A|200|Anticipated|Medacta USA||1|||f||||f||||||||||2017-10-10 23:07:01.470525|2017-10-10 23:07:01.470525
NCT02501720|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-16|||September 2015||2015-09-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison of Outcome of Post Burn Flexion Contracture Release Under Tourniquet Verses Tumescent Technique in Children|Comparison of Outcome of Post Burn Flexion Contracture Release Under Tourniquet Verses Tumescent Technique in Children|Unknown status|Not yet recruiting|N/A|80|Anticipated|King Edward Medical University||2|||f||||t||||||||||2017-10-10 23:07:01.5991|2017-10-10 23:07:01.5991
NCT02501707|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-04-26|||April 25, 2017|Actual|2017-04-25|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Observational|||Echocardiography for RILI Prediction|The Value of Echocardiography for Prediction of Radiation-induced Lung Injury in Non-small Cell Lung Cancer Patients Treated With Chemoradiation: an Onco-cardiac Prospective Cohort Study.|Recruiting||N/A|120|Anticipated|Maastricht Radiation Oncology|||1||f||||f||||||Samples With DNA|"     Bloodsamples and saliva samples will be collected according to the biobank protocol at     Maastro clinic to explore the prognostic value of mitochondrial DNA for development of     radiation-induced lung injury.      Cardiac bloodmarkers: B-type Natriuretic Peptide (BNP), cardiac Troponin I and T will be     measured.      Haemoglobin and inflammatory parameters (CRP, IL-6 and TNFa)   "|||2017-10-10 23:07:01.715123|2017-10-10 23:07:01.715123
NCT02501694|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-12-15|||July 2015||2015-07-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|Stethosport||Evaluation of Patients With Suspected Endofibrosis|Enregistrement Des Bruits Vasculaires de l'artère Iliaque Externe Par STETHOscope électronique en Post - Effort Chez le SPORTif|Recruiting||N/A|100|Anticipated|University Hospital, Angers|||1||f||||f||||||||||2017-10-10 23:07:01.833379|2017-10-10 23:07:01.833379
NCT02501681|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-08-18|||February 2015||2015-02-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|Acibadem||Evaluation of Different Priming Solutions Effects on Microcirculation, Oxidative Stress and Morbidity in Cardiovascular Surgery Patients|Evaluation of Different Priming Solutions Effects on Microcirculation, Oxidative Stress and Morbidity in Cardiovascular Surgery Patients|Completed||Phase 4|40|Actual|Medical Centre Leeuwarden||2|||f||||f||||||||||2017-10-10 23:07:01.916816|2017-10-10 23:07:01.916816
NCT02501668|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2015-07-16|||July 2015||2015-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease|The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease|Completed||N/A|1375842|Actual|Keimyung University Dongsan Medical Center|||11||f||||f||||||||||2017-10-10 23:07:01.996815|2017-10-10 23:07:01.996815
NCT02501655|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-16|||July 2015||2015-07-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Analysis of Deposition With Nebulizers Membrane|ANALYSIS OF DEPOSITION RADIOAEROSOL NEBULIZERS MEMBRANE IN HEALTHY SUBJECTS|Unknown status|Recruiting|N/A|15|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 23:07:02.075324|2017-10-10 23:07:02.075324
NCT02501642|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-09-06|||December 2014||2014-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Smart Phone Application for Postconcussion Symptom Reduction|Smart Phone Application for Postconcussion Symptoms Reduction|Active, not recruiting||N/A|486|Anticipated|James A. Haley Veterans Administration Hospital||2|||f||||f||||||||Yes|To allow collaboration of information with other interested parties who may be researching the use of Apps for TBI Veterans.|2017-10-10 23:07:02.160596|2017-10-10 23:07:02.160596
NCT02501629|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-01-26|||September 2015||2015-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils|A Phase 3, 24-Week Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Reslizumab Subcutaneous Dosing (110 mg Every 4 Weeks) in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils|Active, not recruiting||Phase 3|177|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-10 23:07:02.247598|2017-10-10 23:07:02.247598
NCT02501616|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-15|||December 2014||2014-12-01|July 2015|2015-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Effect of Dapagliflozine on Systemic and Renal Endothelial Function|Effect of Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor on Systemic and Renal Endothelial Function in Patients With Type 2 Diabetes Mellitus Without History of Coronary Artery Disease (SOCCER Trial)|Unknown status|Recruiting|Phase 4|22|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 23:07:02.548507|2017-10-10 23:07:02.548507
NCT02501603|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-10-28|||July 2016||2016-07-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer|An Open-label, Multicenter Phase II Study of Afatinib Plus Weekly Taxol as Second Line Treatment for Advanced/Recurrent Gastric and Gastroesophageal Junction Cancer|Recruiting||Phase 2|72|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 23:07:02.637463|2017-10-10 23:07:02.637463
NCT02501590|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-04-27|2017-03-09||June 2015||2015-06-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Differences in Muscle Activity Patterns and Graphical Product Quality in Children With Graphomotor Impairment Copying and Tracing Activities on Horizontal or Vertical Surfaces|Differences in Muscle Activity Patterns and Graphical Product Quality in Children With Graphomotor Impairment Copying and Tracing Activities on Horizontal or Vertical Surfaces|Completed||N/A|48|Actual|Loewenstein Hospital|||2||f||||||||||||||2017-10-10 23:07:02.72677|2017-10-10 23:07:02.72677
NCT02501577|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-16|||March 2015||2015-03-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|supraview||Comparison of Various Supraglottic Airway Devices for Fiberoptical Guided Tracheal Intubation|Comparison of Various Supraglottic Airway Devices for Fiberoptical Guided Tracheal Intubation|Unknown status|Recruiting|N/A|30|Anticipated|University of Regensburg||2|||f||||f||||||||||2017-10-10 23:07:02.975942|2017-10-10 23:07:02.975942
NCT02501564|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-02-24|||May 2013||2013-05-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluation of NaproxenSodium and CodeinePhosphate Combination in Osteoarthritis|Randomized, Double-blind and Placebo-controlled Evaluation of Efficacy and Safety of Naproxen Sodium and Codeine Phosphate Combination in Osteoarthritis|Completed||Phase 4|135|Actual|Istanbul Medeniyet University||2|||f||||f||||||||||2017-10-10 23:07:03.058151|2017-10-10 23:07:03.058151
NCT02501551|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-01-09|||February 2015||2015-02-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy|A Phase II Study to Evaluate the Efficacy of Regorafenib in C-kit Mutated Metastatic Malignant Melanoma Failed First-Line Dacarbazine, Temozolomide or Immune Therapy|Recruiting||Phase 2|36|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 23:07:03.145283|2017-10-10 23:07:03.145283
NCT02501343|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-03-05|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ADIS||Alkaline Diet for Insulin Sensitivity|Alkaline Diet for Insulin Sensitivity|Completed||N/A|32|Actual|Garvan Institute of Medical Research||2|||f||||f|f|f|||f|||||2017-10-10 23:07:04.785194|2017-10-10 23:07:04.785194
NCT02501538|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-06-21|||June 2015||2015-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|March 2018|Anticipated|2018-03-01||Interventional|EO2||Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers|Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers|Recruiting||N/A|10|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||Undecided||2017-10-10 23:07:03.219494|2017-10-10 23:07:03.219494
NCT02501525|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2016-05-16|||August 2015||2015-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Ureteral Access Sheath Use on Postoperative Pain Level in Patients Undergoing RIRS|Effect of Ureteral Access Sheath Use on Postoperative Pain Level in Patients Undergoing Retrograde Intrarenal Surgery (RIRS)|Completed||N/A|80|Actual|Selcuk University||2|||f||||f||||||||Undecided||2017-10-10 23:07:03.32325|2017-10-10 23:07:03.32325
NCT02501512|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-05-12|||July 2015||2015-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Observational|||Maturational Changes in Newborn Infants|Maturational Changes in Coordination of Breathing, Heart Rate and Swallowing in Newborn Infants - a Single-centre Pilot Study|Completed||N/A|13|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||No||2017-10-10 23:07:03.410427|2017-10-10 23:07:03.410427
NCT02501499|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-15|||July 2015||2015-07-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Observational|||Breastfeeding Buddies: An Exploratory Evaluation Study|Breastfeeding Buddies: An Exploratory Evaluation Study of a Peer Support Program|Unknown status|Not yet recruiting|N/A|50|Anticipated|Manulife Centre for Community Health Research|||2||f||||f||||||||||2017-10-10 23:07:03.486722|2017-10-10 23:07:03.486722
NCT02501486|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-10-12|||July 2015||2015-07-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|Incorporate||Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-Patients|Inhalation or Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal Axis Suppression in HIV-infected Patients|Recruiting||N/A|30|Anticipated|Radboud University||1|||f||||t||||||||||2017-10-10 23:07:03.563854|2017-10-10 23:07:03.563854
NCT02501473|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-10|||June 2015||2015-06-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin's Lymphoma|Phase 1/2 Study of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|65|Anticipated|Immune Design||5|||f||||t||||||||||2017-10-10 23:07:03.658449|2017-10-10 23:07:03.658449
NCT02501460|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-06-14|||August 17, 2015|Actual|2015-08-17|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors|Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors|Recruiting||N/A|150|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|f|f||||||||2017-10-10 23:07:03.824639|2017-10-10 23:07:03.824639
NCT02501434|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-04-15|||March 2016||2016-03-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|February 2018|Anticipated|2018-02-01||Interventional|ASTROH||Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin|A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients With Significant Hemorrhage Burden|Recruiting||Phase 2|88|Anticipated|University of Louisville||2|||f||||t||||||||No|There is no plan to share data other than through publication or requests to Robert James by other investigators.|2017-10-10 23:07:04.184752|2017-10-10 23:07:04.184752
NCT02501421|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-16|||October 2013||2013-10-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|April 2014|Actual|2014-04-01||Interventional|||Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine||Completed||Phase 1|36|Actual|Research Institute for Biological Safety Problems||2|||f||||t||||||||||2017-10-10 23:07:04.304162|2017-10-10 23:07:04.304162
NCT02501408|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-12-15|||March 2015||2015-03-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|PROPRIO-FOOT||Comparing New Prothesis PROPRIO-FOOT® Versus Usual Prothesis Tasks Tibial Amputees|Comparaison du Pied Bionique Proprio-Foot® Versus le Pied Habituel Chez Les amputés Tibiaux|Recruiting||Phase 4|50|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 23:07:04.377531|2017-10-10 23:07:04.377531
NCT02501395|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-09-26|||September 2015||2015-09-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||MRI in Patients With Kennedy Disease|MRI in Patients With Kennedy Disease|Active, not recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark|||2||f||||||||||||||2017-10-10 23:07:04.452965|2017-10-10 23:07:04.452965
NCT02501382|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-07-15|||February 2013||2013-02-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|BIONEC-II||Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment|Biomarkers in Necrotizing Soft Tissue Infections - Effects of Hyperbaric Oxygen Treatment on the Immune Response|Unknown status|Recruiting|N/A|112|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||Samples Without DNA|"     Whole blood and plasma/serum   "|||2017-10-10 23:07:04.530366|2017-10-10 23:07:04.530366
NCT02501369|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Investigating the Use of a Positive Parenting Programme to Improve Treatment Adherence in Cystic Fibrosis|A Case Series Examining the Impact of a Positive Parenting Program (Self Directed Teen Triple P) on Treatment Adherence in Families With an Adolescent With Cystic Fibrosis|Completed||N/A|6|Actual|University of Manchester||1|||f||||f||||||||||2017-10-10 23:07:04.618923|2017-10-10 23:07:04.618923
NCT02501356|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-07-15|||April 2015||2015-04-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|ISOThrive||Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults|Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults|Unknown status|Recruiting|N/A|105|Anticipated|Griffin Hospital||3|||f||||f||||||||||2017-10-10 23:07:04.687582|2017-10-10 23:07:04.687582
NCT02501330|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-08-22|||July 1, 2015|Actual|2015-07-01|August 2017|2017-08-01|September 22, 2023|Anticipated|2023-09-22|September 22, 2023|Anticipated|2023-09-22||Observational|BLF||Safety And Efficacy Of Bosutinib|Drug Use Investigation Of Bosutinib For Cml (Post Marketing Commitment Plan)|Active, not recruiting||N/A|1|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 23:07:04.992605|2017-10-10 23:07:04.992605
NCT02501317|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-15|||January 2015||2015-01-01|July 2015|2015-07-01|September 2018|Anticipated|2018-09-01|December 2016|Anticipated|2016-12-01||Interventional|||"Scientific Validation of the Active Perineal Rehabilitation Protocol to Urinary Incontinence Treatment"|"Scientific Validation of the Active Perineal Rehabilitation Protocol to Urinary Incontinence Treatment"|Active, not recruiting||N/A|120|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 23:07:05.14105|2017-10-10 23:07:05.14105
NCT02501304|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-11-03||2016-10-03|May 2011||2011-05-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|August 2013|Actual|2013-08-01||Interventional|REV-001||Feasibility Study of the ReVENT Sleep Apnea System|Feasibility Study of the ReVENT Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)|Completed||N/A|40|Actual|Revent Medical International B.V.||1|||f||||f||||||||Yes||2017-10-10 23:07:05.275668|2017-10-10 23:07:05.275668
NCT02501291|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-02-29|||January 2013||2013-01-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Thalidomide in Treating Crohn's Disease|Thalidomide in Inducing and Maintaining Remission of Crohn's Disease|Completed||Phase 2|47|Actual|First Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||||2017-10-10 23:07:05.368444|2017-10-10 23:07:05.368444
NCT02501278|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer|A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer|Withdrawn||Phase 2|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC||3||company (Inovio) is no longer able to support the study|f||||t||||||||||2017-10-10 23:07:05.461476|2017-10-10 23:07:05.461476
NCT02501265|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-06-22|||June 6, 2017|Actual|2017-06-06|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Adaptive Pharmacotherapy for Tobacco Dependence|Randomized-Controlled Smoking Cessation Trial on Varenicline vs. Varenicline-based Adaptive Pharmacotherapy With Cross-Randomization to High vs. Low Intensity Behavioral Therapy|Enrolling by invitation||Phase 2|600|Anticipated|Duke University||4|||f||||f|t|f|||t|||No||2017-10-10 23:07:05.579258|2017-10-10 23:07:05.579258
NCT02501252|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-01-19|||November 2014||2014-11-01|July 2015|2015-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CORN||Effectiveness and Acceptability of Availing Skilled Birth Attendance (SBA) Services Through Community Reproductive Health Nurses (CORN) to a Household Level at Rural Communities of Ethiopia; A Cluster Community Trial in Gedeo Zone, SNNPR|Effectiveness and Acceptability of Availing Skilled Birth Attendance (SBA) Services Through Community Reproductive Health Nurses (CORN) to a Household Level at Rural Communities of Ethiopia A Cluster Randomized Controlled Community Trial in Gedeo Zone, SNNPR|Completed||Phase 2/Phase 3|2670|Actual|Dilla University||3|||f||||f||||||||||2017-10-10 23:07:05.756352|2017-10-10 23:07:05.756352
NCT02501239|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-08-09|||July 2015||2015-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women|Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women: A Randomized Controlled Trial|Recruiting||Phase 2|24|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-10 23:07:05.883802|2017-10-10 23:07:05.883802
NCT02501226|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-15|||September 2015||2015-09-01|July 2015|2015-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|PURE||Effectiveness of the First French Psychoeducational Program on Unipolar Depression|Effectiveness of the First French Psychoeducational Program on Unipolar Depression: Study Protocol for a Randomized Controlled Trial.|Not yet recruiting||N/A|332|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:07:06.006506|2017-10-10 23:07:06.006506
NCT02501213|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-08-09|||December 2015||2015-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)|A Randomized Cross-over Trial Evaluating the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Palliative Stage of Cancer|Recruiting||Phase 2|120|Anticipated|Centre Oscar Lambret||2|||f||||t||||||||No||2017-10-10 23:07:06.129639|2017-10-10 23:07:06.129639
NCT02501200|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-16|2016-12-22|||August 2015||2015-08-01|October 2015|2015-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||CKD-391 Pharmacokinetic Study Phase I|Clinical Trial to Assess the Pharmacokinetic Characteristics and Safety/Tolerability of CKD-391 in Healthy Male Subjects|Completed||Phase 1|46|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||No||2017-10-10 23:07:06.388114|2017-10-10 23:07:06.388114
NCT02501187|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-15|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2017|Anticipated|2017-07-01||Interventional|||Risk of Dry Eye Post Different Surgeries for Blepharoptosis Repair|Comparison Between Three Different Surgeries for Blepharoptosis Repair and Their Impact on Dry Eye Status|Unknown status|Not yet recruiting|N/A|75|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-10 23:07:06.474007|2017-10-10 23:07:06.474007
NCT02501174|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-15|||October 2014||2014-10-01|July 2015|2015-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).|Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).|Recruiting||N/A|2500|Anticipated|Centre Oscar Lambret|||1||f||||f||||||||||2017-10-10 23:07:06.557239|2017-10-10 23:07:06.557239
NCT02501161|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-09-26|||January 8, 2016|Actual|2016-01-08|September 2017|2017-09-01|October 3, 2018|Anticipated|2018-10-03|October 3, 2018|Anticipated|2018-10-03||Interventional|DUAL™ VIII||A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus|A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 3|1000|Anticipated|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 23:07:06.710649|2017-10-10 23:07:06.710649
NCT02501148|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-02|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01|30 Days|Observational [Patient Registry]|||A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection|A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection|Completed||N/A|106|Actual|Contego Medical, LLC|||1||f||||f|f|f||||||No||2017-10-10 23:07:07.058407|2017-10-10 23:07:07.058407
NCT02501135|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-09-08|||June 2015||2015-06-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||A Retrospective Investigation of Local Anesthetic Concentrations in Femoral Nerve Block|A Retrospective Investigation of Safety and Efficacy From Increasing Concentrations of Local Anesthetic in Pediatric Femoral Nerve Blocks|Completed||N/A|281|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 23:07:07.139288|2017-10-10 23:07:07.139288
NCT02501122|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-01-30|||December 2015||2015-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Retrospective Analysis in Quality of Care Measures in Pediatric Adenotonsillectomy Patients|Cost Savings From Non-pharmacological Interventions for Pediatric Patients Undergoing Diagnostic Imaging at Nationwide Children's Hospital|Completed||N/A|1000000|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 23:07:07.359507|2017-10-10 23:07:07.359507
NCT02501109|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-03-23|||October 2015||2015-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers|A Single-dose, Randomized, Three-period, Crossover Comparative Bioavailability Study of a Novel Formulation of Aripiprazole 10 mg Oral Soluble Film vs the Marketed Formulation Abilify® 10 mg Tablet in Healthy Volunteers|Completed||Phase 1|36|Actual|CMG Pharmaceutical Co. Ltd||3|||f||||f||||||||Yes||2017-10-10 23:07:07.425285|2017-10-10 23:07:07.425285
NCT02501096|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-09-29|||July 22, 2015|Actual|2015-07-22|September 2017|2017-09-01|January 19, 2019|Anticipated|2019-01-19|June 22, 2018|Anticipated|2018-06-22||Interventional|||Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors|A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors|Recruiting||Phase 1/Phase 2|250|Anticipated|Eisai Inc.||1|||f|||||t|f||||||||2017-10-10 23:07:07.504524|2017-10-10 23:07:07.504524
NCT02501083|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-01-30|||July 2016||2016-07-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Natural History of Cardiac and Respiration Function in Patients With Muscular Dystrophies on Home Mechanical Ventilation|Natural History of Cardiac and Respiratory Function in Patients With Muscular Dystrophies on Home Mechanical Ventilation|Active, not recruiting||N/A|170|Anticipated|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-10 23:07:07.691592|2017-10-10 23:07:07.691592
NCT02501070|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-07-18|||April 2015||2015-04-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|iPHENAMIC||Impact on Public HEalth of a Network in Acute Myocardial Infarction Care|Impact of Implantation of PROGALIAM Network (Galician Program of Care in Acute Myocardial Infarction) in Cardiovascular Health in the Northern Area of Galicia.|Completed||N/A|5937|Actual|Complexo Hospitalario Universitario de A Coruña|||2||f||||f||||||||||2017-10-10 23:07:07.769521|2017-10-10 23:07:07.769521
NCT02501057|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-10-05|||August 2016||2016-08-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Reducing Alcohol Dependence Among HIV-Positive Individuals|HealthCall: Enhancing Brief Intervention for HIV Primary Care Alcohol Dependence|Enrolling by invitation||N/A|300|Anticipated|Research Foundation for Mental Hygiene, Inc.||3|||f||||t||||||||||2017-10-10 23:07:07.856188|2017-10-10 23:07:07.856188
NCT02501044|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-15|||January 2012||2012-01-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Oxygen Desaturation During Hemodialysis|Oxygen Desaturation During Hemodialysis: Clinical Correlates and Association With Adverse Outcomes|Completed||N/A|5500|Actual|Renal Research Institute|||1||f||||||||||||||2017-10-10 23:07:07.930223|2017-10-10 23:07:07.930223
NCT02501031|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-07-13|||September 2015||2015-09-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|June 2016|Actual|2016-06-01||Interventional|||Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women|Effect of Dietary Flaxseed on Circulating Sex Hormone Levels Among Post-menopausal Women - an Intervention Trial to Explore Flaxseed Intake as a Possible Breast Cancer Prevention Strategy|Active, not recruiting||N/A|99|Actual|Cancer Care Ontario||2|||f||||f||||||||No||2017-10-10 23:07:07.994417|2017-10-10 23:07:07.994417
NCT02501018|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-23|||January 2016||2016-01-01|July 2015|2015-07-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01||Interventional|||Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)|A Prospective, Open Label, Controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI) Due to Arteriosclerosis Obliterans (ASO) With a Single-arm Substudy to Assess the Safety and Potential Efficacy of CLBS12 in Patients With CLI Due to Buerger's Disease (BD)|Not yet recruiting||Phase 2|35|Anticipated|Caladrius Biosciences, Inc.||3|||f||||t||||||||||2017-10-10 23:07:08.063131|2017-10-10 23:07:08.063131
NCT02501005|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-10-05|||June 2015||2015-06-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|BERLIN VT||Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction|Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction|Recruiting||N/A|208|Anticipated|Biotronik SE & Co. KG||2|||f||||t||||||||||2017-10-10 23:07:08.141231|2017-10-10 23:07:08.141231
NCT02500992|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-16|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Observational|||Bacterial Contamination in Transrectal Hybrid NOTES Sigmoidectomy|Bacterial Contamination in Transrectal Hybrid Natural Orifice Translumenal Endoscopic Surgery Sigmoidectomy for Diverticular Disease|Unknown status|Recruiting|N/A|40|Anticipated|Cantonal Hosptal, Baselland|||2||f||||f||||||Samples Without DNA|"     Microbacteriological swabs   "|||2017-10-10 23:07:08.249374|2017-10-10 23:07:08.249374
NCT02500966|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-04-24|||August 2015||2015-08-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|DUDA||How to Avoid Cervical Stenosis After LEEP in High Grade Cervical Dysplasia?|A Randomized Study to Evaluate the Safety, Efficacy and Quality of Life of a New Device to Prevent Cervical Stenosis After LEEP in High Grade Cervical Dysplasia|Recruiting||Phase 1/Phase 2|265|Anticipated|Barretos Cancer Hospital||2|||f||||t||||||||||2017-10-10 23:07:08.446256|2017-10-10 23:07:08.446256
NCT02500953|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-15|||July 2013||2013-07-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects|A Placebo-controlled, Double-blind, Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Japanese Male and Female Subjects and Caucasian Male Subjects|Completed||Phase 1|124|Actual|Astellas Pharma Inc||27|||f||||f||||||||||2017-10-10 23:07:08.536827|2017-10-10 23:07:08.536827
NCT02500940|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-07-14|||May 2015||2015-05-01|July 2015|2015-07-01|May 2021|Anticipated|2021-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma||Recruiting||Phase 3|54|Anticipated|Taichung Veterans General Hospital||2|||f||||||||||||||2017-10-10 23:07:08.685268|2017-10-10 23:07:08.685268
NCT02500927|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-07-09|||June 25, 2015|Actual|2015-06-25|July 2017|2017-07-01|June 9, 2017|Actual|2017-06-09|June 9, 2017|Actual|2017-06-09||Interventional|||A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations|Phase II Study of ASP8273 — An Open-Label, Study of the Oral Administration of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-NaïvePatients With Non-Small Cell Lung Cancer Harboring EGFR Mutations|Terminated||Phase 2|31|Actual|Astellas Pharma Inc||1||Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.|f||||f||||||||||2017-10-10 23:07:10.472866|2017-10-10 23:07:10.472866
NCT02500914|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-19|||June 2015||2015-06-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma|A Phase 1a/1b Dose Escalation and Expansion Study of Single-agent SC-002 in Subjects With Relapsed or Refractory Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma|Recruiting||Phase 1|102|Anticipated|Stemcentrx||1|||f||||f||||||||||2017-10-10 23:07:10.604391|2017-10-10 23:07:10.604391
NCT02500901|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-02-06|||March 2016||2016-03-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)|Combined Targeting of the Androgen Receptor in Metastatic Castrate-Resistant Prostate Cancer With Enzalutamide and the Poly (ADP- Ribose) Polymerase (PARP) Inhibitor Niraparib: Hoosier Cancer Research Network GU14-202|Active, not recruiting||Phase 1|2|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-10-10 23:07:10.699301|2017-10-10 23:07:10.699301
NCT02500888|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-08-18|||June 2015||2015-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder|Initial Evaluation of Efficacy and Adverse Events of Single Lesions in Bilateral Ventral-capsular and Ventral Capsulotomy-striatal by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder|Recruiting||Phase 1/Phase 2|10|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||f||||||||Undecided||2017-10-10 23:07:10.787519|2017-10-10 23:07:10.787519
NCT02500875|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2015-07-15|||January 2015||2015-01-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|PTN-INSTILL||Treatment of Infected Surgical Wounds With Negative Pressure Topical Therapy and Instillation (With or Without Antiseptic) Versus no Instillation|Treatment of Infected Surgical Wounds With Negative Pressure Topical Therapy and Instillation (With or Without Antiseptic) Versus no Instillation|Unknown status|Recruiting|Phase 3|120|Anticipated|Associazione Infermieristica per lo studio delle Lesioni Cutanee||3|||f||||t||||||||||2017-10-10 23:07:10.916155|2017-10-10 23:07:10.916155
NCT02500862|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-03-09|||September 2015||2015-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|EYE-MARKER||Characterization of Potential Biomarkers of Eye Disease and Vision|Characterization of Potential Biomarkers of Eye Disease and Vision Loss.|Active, not recruiting||N/A|100|Anticipated|Association for Innovation and Biomedical Research on Light and Image|||1||f||||f||||||||||2017-10-10 23:07:11.009253|2017-10-10 23:07:11.009253
NCT02500849|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-09-01|||July 2015||2015-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients|A Pilot Study to Evaluate the Feasibility, Safety and Engraftment of Zinc Finger Nuclease (ZFN) CCR5 Modified CD34+ Hematopoietic Stem/Progenitor Cells (SB-728mR-HSPC) in HIV-1 (R5) Infected Patients|Recruiting||Phase 1|12|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-10 23:07:11.074084|2017-10-10 23:07:11.074084
NCT02500836|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2017-04-11|2017-04-11||September 2015||2015-09-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional||The analysis of baseline characteristics includes all enrolled subjects.|Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) Anesthesia|Phase III Topical Application of Cocaine HCl 4% Solution on Safety/Efficacy & Cocaine HCl 4% & 10% Solution on Safety in Local Anesthesia for Diagnostic Procedures & Surgeries on or Through Accessible Mucous Membranes of the Nasal Cavities|Completed||Phase 3|646|Actual|Lannett Company, Inc.||3|||f||||f||||||||||2017-10-10 23:07:11.210495|2017-10-10 23:07:11.210495
NCT02500823|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-05-14|||April 2015||2015-04-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Observational|||Association Between Mitochondrial DNA Content and Risk of Coronary Heart Disease|Association Between Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Coronary Heart Disease|Completed||N/A|400|Actual|Fourth Military Medical University|||2||f||||f||||||Samples With DNA|"     Mitochondria are responsible for multiple cellular functions including regulation of energy     production, modulation of oxidation-reduction status, generation of reactive oxygen species     and apoptosis. Each mitochondrion possesses multiple copies of a mitochondrial genome     comprised of independently replicating double stranded DNA (mtDNA).   "|||2017-10-10 23:07:11.686292|2017-10-10 23:07:11.686292
NCT02500810|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2015-07-16|||July 2015||2015-07-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients|A Randomized, Controlled, Multicenter Phase II Clinical Trial of Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients|Recruiting||Phase 2|106|Anticipated|Beijing Cancer Hospital||2|||f||||f||||||||||2017-10-10 23:07:11.760079|2017-10-10 23:07:11.760079
NCT02500784|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-02-09|||January 2015||2015-01-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease|Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease|Recruiting||Phase 2|60|Anticipated|Palo Alto Veterans Institute for Research||2|||f||||f||||||||||2017-10-10 23:07:14.878485|2017-10-10 23:07:14.878485
NCT02500771|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-14|||June 2017||2017-06-01|July 2015|2015-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Feasibility Testing and Pilot Study of V-MOTIVE Protocol Software Version 1|Feasibility Testing and Pilot Study of V-MOTIVE Protocol Software Version 1|Not yet recruiting||N/A|12|Anticipated|Experiad LLC||1|||f||||t||||||||||2017-10-10 23:07:14.957799|2017-10-10 23:07:14.957799
NCT02500758|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2017-05-02|2016-01-04||June 2015||2015-06-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|ECP||Effectiveness of Preoperative Surgical Scrubbing Using Clorhexidine Digluconate and Parachlorometaxylenol (ECP)|Effectiveness of Preoperative Surgical Scrubbing in Reducing Bacterial Load, Using Chlorhexidine Digluconate (CHX) and Parachlorometaxylenol (PCMX)|Completed||N/A|30|Actual|Universidad Complutense de Madrid||2|||f||||f||||||||Undecided||2017-10-10 23:07:15.035308|2017-10-10 23:07:15.035308
NCT02500745|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-07-14|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Left Atrial Volume Index and Left Atrial Appendage Flow Velocities|Left Atrial Volume Index and Left Atrial Appendage Flow Velocities|Unknown status|Not yet recruiting|N/A|150|Anticipated|University of Cincinnati|||1||f||||t||||||||||2017-10-10 23:07:15.238769|2017-10-10 23:07:15.238769
NCT02500732|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-08-15|||July 2015||2015-07-01|August 2016|2016-08-01||||July 2018|Anticipated|2018-07-01||Interventional|POST6||Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope|A Proof of Principle Study of Atomoxetine for the Prevention of Vasovagal Syncope (VVS): POST 6|Recruiting||Phase 2|74|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-10 23:07:15.295428|2017-10-10 23:07:15.295428
NCT02500719|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-07-05|||August 2015||2015-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Real-time Functional MRI and Neurofeedback of Brain Networks Mediating Trauma Memory Recall in PTSD|Real-time Functional MRI and Neurofeedback of Brain Networks Mediating Trauma|Recruiting||N/A|27|Anticipated|University of Arkansas|||2||f||||f||||||||||2017-10-10 23:07:15.393167|2017-10-10 23:07:15.393167
NCT02500706|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-10-04|||May 4, 2016|Actual|2016-05-04|October 2017|2017-10-01|August 16, 2017|Actual|2017-08-16|August 16, 2017|Actual|2017-08-16||Interventional|onset®8||Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes.|Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes|Completed||Phase 3|1108|Actual|Novo Nordisk A/S||3|||f||||f|t|f||||||||2017-10-10 23:07:15.487787|2017-10-10 23:07:15.487787
NCT02500693|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-07-08|||November 2015||2015-11-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|AIR||Circulating Tumor Cells in Lung Cancer Screening|Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|600|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||t||||||||||2017-10-10 23:07:16.003061|2017-10-10 23:07:16.003061
NCT02500680|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-01-03|||July 2015||2015-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MER4101||The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)|A Phase IA/IB Trial to Evaluate the Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) With Hemagglutinin Dose Escalation Compared to Non-Adjuvanted Comparator Inactivated Influenza Vaccine (IIV) Standard Dose (SD) in Healthy Adults and High Dose (HD) IIV in Ambulatory Elderly Subjects|Active, not recruiting||Phase 1|102|Actual|Nova Immunotherapeutics Limited||7|||f||||t||||||||||2017-10-10 23:07:16.178566|2017-10-10 23:07:16.178566
NCT02500667|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-11-03|||June 2015||2015-06-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects|A Phase 1, Open-label, Drug-Drug Interaction Study to Assess the Steady State Pharmacokinetics of N91115 Alone and in the Presence of Multiple Dose Administration of Rifampin in Healthy Adult Subjects (SNO-5)|Completed||Phase 1|15|Actual|Nivalis Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:07:16.290761|2017-10-10 23:07:16.290761
NCT02500654|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2016-08-31|||December 2008||2008-12-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Regenerative Surgical Treatment of Peri-implantitis|Peri-implantitis - Regenerative Treatment With Enamel Matrix Derivative (EMD). Clinical Effects, Microbial Profiles and Molecular Mechanisms. A Randomised Controlled Pilot Study.|Completed||Phase 4|31|Actual|Region Gävleborg||2|||f||||f||||||||No||2017-10-10 23:07:16.380211|2017-10-10 23:07:16.380211
NCT02500641|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-01|||August 17, 2015|Actual|2015-08-17|September 2017|2017-09-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|FORWARD||Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout|The Effect of Intensive Urate Lowering Therapy (ULT) With Febuxostat in Comparison With Allopurinol on Cardiovascular Risk in Patients With Gout Using Surrogate Markers: a Randomized, Controlled Trial|Completed||Phase 4|197|Actual|Menarini International Operations Luxembourg SA||2|||f||||||||||||||2017-10-10 23:07:16.495599|2017-10-10 23:07:16.495599
NCT02500615|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-17|||July 2016||2016-07-01|May 2017|2017-05-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|||The Effect of Electronic Cigarette (ECIG) Liquid Vehicles on ECIG Acute Effects|The Effect of Electronic Cigarette (ECIG) Liquid Vehicles on ECIG Acute Effects|Completed||Phase 1|41|Actual|Virginia Commonwealth University||5|||f||||f||||||||||2017-10-10 23:07:16.735274|2017-10-10 23:07:16.735274
NCT02500602|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-05-04|||June 1, 2016|Actual|2016-06-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|February 2019|Anticipated|2019-02-01||Interventional|Doxazosin||CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders|CAP - Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders|Recruiting||Phase 2|144|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||Yes|Data Sharing Plan: The data collected from study participants, including PHI, will be entered into and securely stored in the STRONG STAR-CAP database on a secure UTHSCSA server by a member of the study research team under a signed Data Use Agreement between Ralph H. Johnson VA and UTHSCSA. Terms of the Data Use Agreement data have been reviewed and approved by VACO and found to meet VA security compliance standards. Electronic data will be stored, managed, and analyzed by the Data Management and Biostatistics Core staff of the STRONG STAR-CAP Consortium. The overall study PI and named collaborators will have access to identifiable data through the STRONG STAR-CAP website and UTHSCSA server.|2017-10-10 23:07:16.979792|2017-10-10 23:07:16.979792
NCT02500589|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-08-30|||May 31, 2016|Actual|2016-05-31|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|April 30, 2019|Anticipated|2019-04-30||Interventional|||Telephone-based Smoking Cessation|Adjunctive Mood Management for Telephone-based Smoking Cessation in Primary Care|Recruiting||N/A|350|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:07:17.098975|2017-10-10 23:07:17.098975
NCT02500563|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-07-27|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Exploratory/Proof of Principle Microbiota Study|Exploratory/Proof of Principle Microbiota Study|Completed||N/A|78|Actual|Mead Johnson Nutrition||3|||f||||f||||||||||2017-10-10 23:07:17.352383|2017-10-10 23:07:17.352383
NCT02500550|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-07-19|||October 9, 2015|Actual|2015-10-09|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor|An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of a Two-dose Regimen of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted ex Vivo of Host Alloreactive T-cells (Using Photodynamic Treatment), in Patients With a Hematologic Malignancy, Who Received a CD34-selected Hematopoietic Stem Cell Transplantation From a Haploidentical Donor|Recruiting||Phase 2|15|Anticipated|Kiadis Pharma||1|||f||||t||||||||||2017-10-10 23:07:17.45492|2017-10-10 23:07:17.45492
NCT02500537|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-02-16|2017-02-16||May 2015||2015-05-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||A Post-market Study of the Endo GIA™ Reinforced Reload With Tri-Staple™ Technology|A Post-market Study of the Endo GIA™ Reinforced Reload With Tri-Staple™ Technology|Completed||N/A|100|Actual|Medtronic - MITG||2|||f||||t||||||||No||2017-10-10 23:07:18.104322|2017-10-10 23:07:18.104322
NCT02500524|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-14|||July 1998||1998-07-01|July 2015|2015-07-01|January 1999|Actual|1999-01-01|January 1999|Actual|1999-01-01||Interventional|||Cocamide DEA vs Permethrin for Head Lice|A Randomised, Controlled, Assessor-blind, Parallel Group Clinical Trial to Assess the Efficacy, Safety and Acceptability of a Surfactant Based Lotion and a Permethrin Creme Rinse in the Treatment of Head Lice|Terminated||Phase 3|44|Actual|Medical Entomology Centre||2||Lack of efficacy|f||||f||||||||||2017-10-10 23:07:18.75367|2017-10-10 23:07:18.75367
NCT02500511|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-04-08|||June 2015||2015-06-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study|Duration of Protection Based on Persistent Antibody Titers 12-24 Months After Vaccination: Follow Up to Phase 2 Study of Meningococcal Serogroups A, C, Y & W-135 Polysaccharide Diphtheria Toxoid Conjugate Vaccine (NmVac4-A/C/Y/W-135-DT)|Completed||N/A|50|Actual|JN-International Medical Corporation|||1||f||||f||||||Samples Without DNA|"     Serum samples used for antibody assays.   "|||2017-10-10 23:07:18.853847|2017-10-10 23:07:18.853847
NCT02500498|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2015-07-15|||October 2014||2014-10-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Safety Profile of Nulojix in Home Infusion Settings|Safety Profile of Nulojix in Home Infusion Settings|Completed||N/A|37|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 23:07:18.93791|2017-10-10 23:07:18.93791
NCT02500485|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-11-23|||May 2015||2015-05-01|July 2015|2015-07-01||||July 2015|Actual|2015-07-01||Interventional|||The Drug-drug Interaction of SHR3824 and SP2086|Drug Interaction Study of Henagliflozin and Retagliptin in Healthy Subjects|Unknown status|Recruiting|Phase 1|12|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:07:19.017956|2017-10-10 23:07:19.017956
NCT02500472|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-10-04|||December 3, 2015|Actual|2015-12-03|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigation of Kava Effects on NNK Metabolism|Investigation of Kava Effects on the Metabolism of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Humans|Suspended||N/A|20|Anticipated|Masonic Cancer Center, University of Minnesota||1||Pending interim analysis.|f||||t||||||||||2017-10-10 23:07:19.127578|2017-10-10 23:07:19.127578
NCT02499211|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-09-26|||September 19, 2014|Actual|2014-09-19|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Healthy In-Store Marketing Study|The Impact of Healthy Food Marketing Strategies in Supermarkets|Recruiting||N/A|32|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:07:34.110192|2017-10-10 23:07:34.110192
NCT02500459|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-15|2017-03-29|||July 6, 2015|Actual|2015-07-06|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection|A Pilot Trial of Intraparenchymally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive WHO Grade III or IV (High Grade) Glioma Undergoing A Clinically-Indicated Surgical Resection (IND 117,240)|Recruiting||Early Phase 1|18|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|t|f|f||||||2017-10-10 23:07:19.216182|2017-10-10 23:07:19.216182
NCT02500446|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-05-03|||September 28, 2015|Actual|2015-09-28|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 16, 2016|Actual|2016-09-16||Interventional|DIORR||Dolutegravir Impact on Residual Replication|Dolutegravir Impact on Residual Replication: Dolutegravir Intensification Study|Active, not recruiting||Phase 4|40|Actual|University of Melbourne||2|||f||||f||f||||||No|No plan to share individual participant data|2017-10-10 23:07:19.338164|2017-10-10 23:07:19.338164
NCT02500433|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-07-15|||January 2013||2013-01-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||Virtual Reality in Children With Cerebral Palsy|Use of a Low Cost Videogame Console in Children With Cerebral Palsy in a School Environment|Completed||N/A|30|Actual|Universidad Rey Juan Carlos||2|||f||||f||||||||||2017-10-10 23:07:19.452745|2017-10-10 23:07:19.452745
NCT02500420|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-09-02|||December 2014||2014-12-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|August 2015|Actual|2015-08-01||Interventional|CMHStress||Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography||Unknown status|Active, not recruiting|N/A|25|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:07:19.53799|2017-10-10 23:07:19.53799
NCT02500407|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-09-14|||September 30, 2015|Actual|2015-09-30|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|October 31, 2020|Anticipated|2020-10-31||Interventional|||A Safety and Pharmacokinetic Study of BTCT4465A as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)|An Open-Label, Multicenter, Phase I/IB Trial Evaluating the Safety and Pharmacokinetics of Escalating Doses of BTCT4465A as a Single Agent and Combined With Atezolizumab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia|Recruiting||Phase 1|390|Anticipated|Genentech, Inc.||2|||f||||||||||||||2017-10-10 23:07:19.637564|2017-10-10 23:07:19.637564
NCT02500394|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-05-04|||June 2015||2015-06-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|BigpAK||Biomarker Guided Intervention for Prevention of Acute Kidney Injury|Biomarker Guided Intervention to Prevent Development of Acute Kidney Injury in High-risk Surgical Patients|Completed||N/A|135|Actual|University Hospital Regensburg||2|||f||||t||||||||||2017-10-10 23:07:19.771918|2017-10-10 23:07:19.771918
NCT02500368|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-12-27|2016-09-28||July 2015||2015-07-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||A Dispensing Clinical Trial of a Study Test Silicone Hydrogel Lens Against Control Lens Over 1 Week|A Dispensing Clinical Trial of a Study Test Silicone Hydrogel Lens Against Control Lens Over 1 Week|Completed||N/A|41|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 23:07:20.195858|2017-10-10 23:07:20.195858
NCT02500355|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-15|||January 2010||2010-01-01|July 2015|2015-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|CTR||Carpal Tunnel Release Via Two Small Incisions Comparing With Via Standard Incision And Under Endoscope|Carpal Tunnel Release With Partial Excision of the Flexor Retinaculum Through Two Small Incisions|Completed||N/A|220|Actual|The Second Hospital of Qinhuangdao||3|||f||||f||||||||||2017-10-10 23:07:21.134387|2017-10-10 23:07:21.134387
NCT02500342|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-09-12|||January 2014||2014-01-01|September 2017|2017-09-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|TRUST FATIGUE||Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism|Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism|Active, not recruiting||Phase 4|220|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:07:21.213813|2017-10-10 23:07:21.213813
NCT02500329|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-14|||September 2014||2014-09-01|July 2015|2015-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients|Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients (GetUp Trial)|Unknown status|Recruiting|Phase 4|54|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 23:07:21.294028|2017-10-10 23:07:21.294028
NCT02500316|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2016-08-17|||February 2013||2013-02-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children|Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children|Active, not recruiting||Phase 2|47|Actual|Opko Biologics||3|||f||||t||||||||||2017-10-10 23:07:21.367462|2017-10-10 23:07:21.367462
NCT02500303|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-07-20|||March 2014||2014-03-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|October 2015|Anticipated|2015-10-01|18 Months|Observational [Patient Registry]|||Influence of Diabetes on Lower Limb Amputation|Rehabilitation & Function Following Lower Limb Amputation: the Influence of Diabetes|Unknown status|Recruiting|N/A|170|Anticipated|University of Glasgow|||1||f||||t||||||||||2017-10-10 23:07:21.438326|2017-10-10 23:07:21.438326
NCT02500290|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-05-02|||November 2014||2014-11-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Antiplatelet Therapy in Acute Coronary Syndrome(ACS). Safety and Efficacy of Switching Antiplatelet|Antiplatelet Therapy in Acute Coronary Syndrome (ACS). Safety and Efficacy of Switching Antiplatelet|Recruiting||N/A|2000|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||||||2017-10-10 23:07:21.514223|2017-10-10 23:07:21.514223
NCT02482857|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-24|||December 2011||2011-12-01|June 2015|2015-06-01||||July 2015|Anticipated|2015-07-01||Interventional|||Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting||Unknown status|Active, not recruiting|Phase 2/Phase 3|45|Anticipated|Karolinska University Hospital||3|||f||||t||||||||||2017-10-10 23:11:02.221999|2017-10-10 23:11:02.221999
NCT02500277|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-10-04|||January 2015||2015-01-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|COFFEE||Yield of Cryoprobe vs Flexible Forceps Pleural Biopsy|A Study to Evaluate the Yield of Pleural Biopsy With a Flexible Cryoprobe Versus Flexible Forceps During Semirigid Thoracoscopy: a Comparative Study|Recruiting||N/A|50|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 23:07:21.708392|2017-10-10 23:07:21.708392
NCT02500264|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-09-19|||August 2015||2015-08-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||The Effect of Non Invasive Electrical Stimulation Therapy on Gastroesophageal Reflux Disease (GERD) Symptoms - Proof of Concept Study|The Effect of Non Invasive Electrical Stimulation Therapy on Gastroesophageal Reflux Disease (GERD) Symptoms - Proof of Concept Study|Recruiting||N/A|12|Anticipated|Rabin Medical Center||4|||f||||||||||||||2017-10-10 23:07:21.800097|2017-10-10 23:07:21.800097
NCT02500251|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-07-24|||June 2015||2015-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Belimumab Impacting Transplant Eligibility|Belimumab-Based Plasma Cell Targeted Therapy to Impact Transplant Eligibility|Recruiting||Phase 1/Phase 2|15|Anticipated|University of Cincinnati||3|||f||||f||||||||||2017-10-10 23:07:21.886593|2017-10-10 23:07:21.886593
NCT02500238|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-03-08|||November 2015||2015-11-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Comparison of Smoking and Vaping in Families|Comparison of Smoking and Vaping in Families|Completed||N/A|52|Actual|University of Florida|||3||f||||f|f|f||||Samples Without DNA|"     Saliva, urine, and toenail clippings   "|Undecided||2017-10-10 23:07:22.015442|2017-10-10 23:07:22.015442
NCT02500225|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-01-24|||January 2017||2017-01-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Comparison the Effects of Etomidate and Sevoflurane During Electroconvulsive Therapy|Ulku Ozgul, Associate Professor, Inonu University, Department of Anesthesiology and Reanimation|Active, not recruiting||Phase 4|25|Anticipated|Inonu University||2|||f||||f||||||||||2017-10-10 23:07:22.119732|2017-10-10 23:07:22.119732
NCT02500212|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-10-03|||July 2015||2015-07-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients|OPEN-LABEL, MULTICENTRE, RANDOMIZED CLINICAL TRIAL TO COMPARE THE PHARMACOKINETICS OF ENVARSUS® TABLETS AND ADVAGRAF® CAPSULES ADMINISTERED ONCE DAILY IN ADULT DE-NOVO KIDNEY TRANSPLANT PATIENTS|Completed||Phase 4|75|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-10 23:07:22.208987|2017-10-10 23:07:22.208987
NCT02500199|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors|A Two-part Phase I, Open Label, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Pyrotinib in Patients With HER2-positive Solid Tumors Whose Disease Progressed on Prior HER2 Targeted Therapy|Recruiting||Phase 1|50|Anticipated|Hengrui Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 23:07:22.297516|2017-10-10 23:07:22.297516
NCT02500186|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-08-30|||May 2015||2015-05-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor|The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor|Completed||N/A|24|Anticipated|Kansai Electric Power Hospital||3|||f||||f||||||||||2017-10-10 23:07:22.452139|2017-10-10 23:07:22.452139
NCT02500173|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-12-11|||June 2015||2015-06-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy|Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy - Quality Control Using Clinical Database|Recruiting||N/A|3000|Anticipated|Kantonsspital Graubuenden|||1||f||||f||||||||No||2017-10-10 23:07:22.588369|2017-10-10 23:07:22.588369
NCT02500147|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-11-03|||July 2013||2013-07-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)|Body Composition and Metabolic Manifestations of Insulin Resistance in Adolescents With Polycystic Ovary Syndrome: Ectopic Fat Deposition and Metabolic Markers: Intervention and Follow-up Portion|Recruiting||Phase 4|46|Anticipated|Columbia University||2|||f||||f||||||||Undecided|Will consider this option|2017-10-10 23:07:22.745308|2017-10-10 23:07:22.745308
NCT02500134|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-07-15|||March 2014||2014-03-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|August 2015|Anticipated|2015-08-01||Observational|||Using AS-OCT to Assess the Role of Age and Region in the Morphology and Epithelial Thickness of Limbus|Using AS-OCT to Assess the Role of Age and Region in the Morphology and Epithelial Thickness of Limbus|Unknown status|Active, not recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:07:22.880431|2017-10-10 23:07:22.880431
NCT02500121|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-13|||November 2015||2015-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer|A Randomized, Double-blinded, Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer: Hoosier Cancer Research Network GU14-182|Recruiting||Phase 2|200|Anticipated|Hoosier Cancer Research Network||2|||f||||t||||||||||2017-10-10 23:07:22.955197|2017-10-10 23:07:22.955197
NCT02500108|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-04-15|||May 2013||2013-05-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Domperidone and Risk of Sudden Cardiac Death|Domperidone Use in Parkinson's Disease and Risk of Sudden Cardiac Death|Completed||N/A|214962|Actual|Canadian Network for Observational Drug Effect Studies, CNODES|||2||f||||f||||||||||2017-10-10 23:07:23.170545|2017-10-10 23:07:23.170545
NCT02482090|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-08-14|||July 2015||2015-07-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||TIL Therapy for Metastatic Ovarian Cancer|T Cell Therapy for Patients With Metastatic Ovarian Cancer|Completed||Phase 1|6|Actual|Herlev Hospital||1|||f||||t||||||||||2017-10-10 23:11:11.265235|2017-10-10 23:11:11.265235
NCT02500095|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-11-22|||July 2015||2015-07-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During Fasting|Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During Fasting in Overweight and Obese Human Subjects and the Impact of Growth Hormone Receptor Blockade|Completed||N/A|10|Anticipated|University of Aarhus||3|||f||||t||||||||||2017-10-10 23:07:23.252664|2017-10-10 23:07:23.252664
NCT02500082|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-01-27||||||January 2016|2016-01-01||||||||Expanded Access|||Triheptanoin (UX007) to Treat Citrate Transporter Deficiency|Compassionate Use of Triheptanoin (UX007) to Treat Citrate Transporter Deficiency|No longer available||N/A|||Boston Children’s Hospital|||||||||||||||||||2017-10-10 23:07:23.330049|2017-10-10 23:07:23.330049
NCT02500069|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-07-14|||May 2014||2014-05-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Location Specific Differences in Intestinal Brake Activation|The Effect of Intestinal Brake Activation at Different Locations in the Gut on Food Intake and Hormone Release|Completed||N/A|16|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-10 23:07:23.394016|2017-10-10 23:07:23.394016
NCT02500056|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-06-08|2016-04-20||January 2011||2011-01-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|April 2012|Actual|2012-04-01||Interventional|||Study Evaluating the Impact of Mesh Pore Size on Chronic Pain After Lichtenstein Hernioplasty|Single-centre Single-blinded Randomised Study Evaluating the Impact of Mesh Pore Size on Chronic Pain After Lichtenstein Hernioplasty|Completed||N/A|143|Actual|Tartu University Hospital||2|||f||||f||||||||||2017-10-10 23:07:23.480195|2017-10-10 23:07:23.480195
NCT02500030|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-13|||June 2013||2013-06-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Air Stacking vs Glossopharyngeal Breathing in Neuromuscular Diseases|Effects of Air Stacking Versus Glossopharyngeal Breathing on Maximum Insufflation Capacity in Children and Adolescents With Neuromuscular Disease|Completed||N/A|15|Actual|University of Chile||2|||f||||t||||||||||2017-10-10 23:07:24.215643|2017-10-10 23:07:24.215643
NCT02500017|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-04-25|||September 24, 2015|Actual|2015-09-24|April 2017|2017-04-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|MLT||Melatonin Treatment for Night-Eating Syndrome|Melatonin Treatment for Night-Eating Syndrome|Terminated||N/A|2|Actual|Yale University||2||Difficulty recruiting appropriate participants|f||||f||||||||Yes|All de-identified data resulting from this award involving human subjects will be submitted to the NIMH Data Archive (NDA) - National Database for Clinical Trials Related to Mental Illness (NDCT) The Principal Investigator will work with NDA support staff to plan an appropriate data submission schedule and provide information on the steps for submission and sharing of data. Communication of this data sharing plan to appropriate research staff to ensure the timely submission of data. All human subject data provided will include an NDA Global Unique Identifier (GUID) and will not include personally identifiable information (PII). Analyzed data will be submitted no later than the time of publication. Even if a publication focuses on only part of an analyzed dataset, the entire analyzed dataset will be submitted when the first paper is published. All data made available for public use via NDA will be de-identified data.|2017-10-10 23:07:24.286333|2017-10-10 23:07:24.286333
NCT02500004|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-03-29|||June 2015||2015-06-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|BAT-Cachexia||Brown Adipose Tissue Activity and Energy Metabolism in Cachexia|Brown Adipose Tissue Activity and Energy Metabolism in Cachexia Induced by Cancer or Chronic Disease|Recruiting||N/A|50|Anticipated|Maastricht University Medical Center||5|||f||||f||||||||||2017-10-10 23:07:24.3687|2017-10-10 23:07:24.3687
NCT02499978|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-10-27|||May 2016||2016-05-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TMC114HIV2030||Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated Toxicity|Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated Toxicity (The 'deNUC' Study; TMC114HIV2030)|Withdrawn||Phase 2/Phase 3|0|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:07:24.567861|2017-10-10 23:07:24.567861
NCT02499965|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-15|||April 2015||2015-04-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Skin Refrigerant to Reduce the Pain Associated With IV Insertion|The Use of a Topical Anesthetic Skin Refrigerant to Reduce the Pain Associated With Intravenous Catheter Insertion, A Double Blinded, Patient/Placebo Controlled, Study|Completed||N/A|38|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-10-10 23:07:24.646773|2017-10-10 23:07:24.646773
NCT02499952|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-02-01|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|January 31, 2019|Anticipated|2019-01-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors|A Phase II Single-Arm Multi-Center Trial Evaluating the Efficacy of Pembrolizumab in the Treatment of Subjects With Incurable Platinum-Refractory Germ Cell Tumors: Hoosier Cancer Research Network GU14-206|Active, not recruiting||Phase 2|20|Anticipated|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-10-10 23:07:24.73863|2017-10-10 23:07:24.73863
NCT02499939|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-10-11|||December 2015||2015-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|ULTRA||Ultrasound Therapy and Therapeutic Exercise for Chemotherapy Induced Peripheral Neuropathy (CIPN)|Ultrasound Therapy and Therapeutic Exercise for Chemotherapy Induced Peripheral Neuropathy (CIPN) in Colon and Colorectal Cancer Patients: A Randomized Controlled Pilot Trial|Recruiting||Phase 1|30|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-10 23:07:24.830363|2017-10-10 23:07:24.830363
NCT02476656|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-03-08|||June 2015||2015-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Observational|PINC||Placental Inflammation in Prenatal Care|Placental Inflammation in Prenatal Care|Active, not recruiting||N/A|40|Actual|Greenville Health System|||2||f||||f||||||||||2017-10-10 23:12:14.652587|2017-10-10 23:12:14.652587
NCT02499926|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-07-13|||July 2015||2015-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lysine Oxidation in Response to Arginine Supplementation|Determination of Lysine Oxidation in Response to Arginine Supplementation in Adult Men Using in Vivo Stable Isotope Techniques|Active, not recruiting||N/A|2|Anticipated|University of British Columbia||1|||f||||t|f|f||||||||2017-10-10 23:07:25.033263|2017-10-10 23:07:25.033263
NCT02499913|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-06-22|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SK||Contingency Management to Reduce Alcohol Use in a Soup Kitchen Sample||Completed||N/A|27|Actual|UConn Health||2|||f||||t||||||||||2017-10-10 23:07:25.123568|2017-10-10 23:07:25.123568
NCT02499900|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-08-29|||August 31, 2015|Actual|2015-08-31|August 2017|2017-08-01|June 17, 2017|Actual|2017-06-17|June 17, 2017|Actual|2017-06-17||Interventional|||Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®|A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Treated With Subcutaneous Injections of Copaxone® (Glatiramer Acetate) 40 mg/mL Three Times a Week Compared to 20 mg/mL Daily|Completed||Phase 4|861|Actual|Teva Pharmaceutical Industries||2|||f||||f|t|f||||||||2017-10-10 23:07:25.233267|2017-10-10 23:07:25.233267
NCT02499887|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-01-07|||January 2016||2016-01-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Repeat Emergency Department Visits Among Patients With Asthma and COPD|Repeat Emergency Department Visits Among Patients With Asthma and COPD|Recruiting||N/A|250|Anticipated|State University of New York at Buffalo||2|||f||||f||||||||||2017-10-10 23:07:25.548724|2017-10-10 23:07:25.548724
NCT02499874|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-07-21|||August 2015||2015-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women|Pharmacokinetics of EFV 400mg Once Daily During Pregnancy in HIV+ Women|Active, not recruiting||Phase 1|25|Anticipated|St Stephens Aids Trust||1|||f||||t||||||||||2017-10-10 23:07:25.650921|2017-10-10 23:07:25.650921
NCT02499861|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-05-08|||July 2015||2015-07-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies|A Phase I/IIa Study of Decitabine in Combination With Genistein in Pediatric Patients With Relapsed or Refractory Solid Tumors and Leukemia|Recruiting||Phase 1/Phase 2|27|Anticipated|St. Justine's Hospital||1|||f||||t||||||||||2017-10-10 23:07:25.754977|2017-10-10 23:07:25.754977
NCT02499848|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer|Phase IIa Study, Evaluating the Safety and Tolerability of Targeted Intraprostatic Administration of PRX302 With Histologically Proven,Clinically Significant Localised, Low to Intermediate Risk Prostate Cancer Associated With MRI Lesion|Completed||Phase 2|18|Actual|Sophiris Bio Corp||1|||f||||f||||||||||2017-10-10 23:07:25.840036|2017-10-10 23:07:25.840036
NCT02499835|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-06-27|||July 1, 2015|Actual|2015-07-01|June 2017|2017-06-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer|Pilot Trial of pTVG-HP DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer|Recruiting||Phase 1/Phase 2|32|Anticipated|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-10 23:07:25.927504|2017-10-10 23:07:25.927504
NCT02499822|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-03-02|||October 2015||2015-10-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|REVERENT||REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial|Short - Medium and Long Term Blood Pressure Variability in Essential Hypertensive Patients Treated With Nifedipine GITS or Ramipril - a Randomized Trial|Recruiting||Phase 4|168|Anticipated|Istituto Auxologico Italiano||2|||f||||f||||||||||2017-10-10 23:07:26.079761|2017-10-10 23:07:26.079761
NCT02499809|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-06-12|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effects of Vibration Therapy as a Recovery Tool After Intense Exercise||Completed||N/A|13|Actual|Wingate Institute||2|||f||||f||||||||||2017-10-10 23:07:26.216069|2017-10-10 23:07:26.216069
NCT02499796|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-15|||April 2015||2015-04-01|July 2015|2015-07-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Short-term Effects of Humidification Devices on Respiratory Pattern and Work of Breathing During Invasive Ventilation|Short-term Effects of Humidification Devices on Respiratory Pattern and Work of Breathing During Invasive Ventilation|Unknown status|Recruiting|N/A|15|Anticipated|Fondazione Salvatore Maugeri||1|||f||||f||||||||||2017-10-10 23:07:26.297277|2017-10-10 23:07:26.297277
NCT02499783|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-08-22|||July 27, 2015||2015-07-27|August 2017|2017-08-01|December 15, 2017|Anticipated|2017-12-15|October 20, 2017|Anticipated|2017-10-20||Interventional|||Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease|A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Adalimumab for the Induction and Maintenance of Clinical Remission in Chinese Patients With Moderately to Severely Active Crohn's Disease and Elevated High-Sensitivity C-reactive Protein|Active, not recruiting||Phase 3|200|Anticipated|AbbVie||2|||f||||f||||||||||2017-10-10 23:07:26.387308|2017-10-10 23:07:26.387308
NCT02499770|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-15|||June 2015||2015-06-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)|Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin|Active, not recruiting||Phase 1/Phase 2|110|Anticipated|G1 Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 23:07:26.495169|2017-10-10 23:07:26.495169
NCT02499757|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-12-28|||May 2015||2015-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|FNC-nicotine||Does Sweet Taste Potentiate Nicotine Cue Reactivity?|Does Sweet Taste Potentiate Nicotine Cue Reactivity?|Completed||Phase 1|15|Actual|Yale University||4|||f||||t||||||||||2017-10-10 23:07:26.676418|2017-10-10 23:07:26.676418
NCT02496533|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-12-01|2016-01-08||February 2014||2014-02-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Patient Anxiety During Radiological Examination|The Prevalence of Anxiety in Patients Undergoing Radiologic Exam|Completed||Phase 2|217|Actual|Midwestern Regional Medical Center||2|||f||||f||||||||||2017-10-10 23:08:06.966993|2017-10-10 23:08:06.966993
NCT02499744|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2016-02-22|||February 2016||2016-02-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates|Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates as Primary Respiratory Support:a Randomized Controlled Trial|Active, not recruiting||Phase 1|200|Anticipated|Guangdong Women and Children Hospital||2|||f||||t||||||||Yes||2017-10-10 23:07:26.773183|2017-10-10 23:07:26.773183
NCT02499731|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-07-26|||March 2014||2014-03-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|June 2016|Actual|2016-06-01||Interventional|||Strong Hearts: Rural CVD Prevention|Strong Hearts, Healthy Communities: A Rural Community CVD Prevention Program|Active, not recruiting||N/A|194|Actual|Cornell University||2|||f||||f||||||||||2017-10-10 23:07:26.864834|2017-10-10 23:07:26.864834
NCT02499718|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-07-15|||January 2014||2014-01-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Non-invasive Positive Pressure (NPPV ) for Severe Stable Chronic Obstructive Pulmonary Disease|Non-invasive Positive Pressure Ventilation for the Treatment of Severe Stable Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|368|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||f||||||||||2017-10-10 23:07:27.162371|2017-10-10 23:07:27.162371
NCT02499705|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-07-18|||November 2014||2014-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adolescents|The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adolescents|Active, not recruiting||N/A|15|Actual|Yale University||3|||f||||t||||||||||2017-10-10 23:07:27.260506|2017-10-10 23:07:27.260506
NCT02499692|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-05-16|2015-12-11||May 2015|Actual|2015-05-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|October 2015|Actual|2015-10-01||Interventional|||SYNERGY China: Assess SYNERGY Stent in China|SYNERGY China: A Prospective, Multicenter Trial to Assess the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)|Active, not recruiting||N/A|103|Actual|Boston Scientific Corporation||1|||f||||f||||||||No||2017-10-10 23:07:27.345881|2017-10-10 23:07:27.345881
NCT02499679|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-02-22|||July 2015||2015-07-01|February 2017|2017-02-01|February 2021|Anticipated|2021-02-01|July 2020|Anticipated|2020-07-01|3 Years|Observational [Patient Registry]|ADVANCE||Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care|Assessing Diagnostic Value of Non-invasive FFRCT in Coronary CarE (ADVANCE)|Enrolling by invitation||N/A|5000|Anticipated|HeartFlow, Inc.|||1||f||||t||||||||||2017-10-10 23:07:27.567394|2017-10-10 23:07:27.567394
NCT02499666|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-07-15|||May 2015||2015-05-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|EXERTION||Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI|Evaluation of Exercise Capacity as Measured by Peak Oxygen Uptake, Before and After Percutaneous Revascularization of Chronic Total Occlusion|Unknown status|Recruiting|N/A|46|Anticipated|Henry Ford Health System|||2||f||||f||||||||||2017-10-10 23:07:27.6411|2017-10-10 23:07:27.6411
NCT02499653|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-04-18|||June 2015||2015-06-01|July 2016|2016-07-01||||August 2017|Anticipated|2017-08-01||Interventional|||A Psychological Intervention to Promote Acceptance and Adherence to NIV in People With COPD|A Psychological Intervention to Promote Acceptance and Adherence to Non-Invasive Ventilation (NIV) in People With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|150|Anticipated|Fondazione Don Carlo Gnocchi Onlus||2|||f||||||||||||||2017-10-10 23:07:27.755473|2017-10-10 23:07:27.755473
NCT02499640|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-15|||September 2014||2014-09-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effects of Cold Water Immersion With Different Dosages (Duration and Temperature Variations) on Heart Rate Variability Post-exercise Recovery|The Effects of Cold Water Immersion With Different Dosages (Duration and Temperature Variations) on Heart Rate Variability Post-exercise Recovery|Completed||N/A|100|Actual|Paulista University||5|||f||||f||||||||||2017-10-10 23:07:27.85313|2017-10-10 23:07:27.85313
NCT02499627|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-09-06|||October 2015||2015-10-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|FIL-BBV||Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting|A Phase II Study With Bendamustine Plus Brentuximab Vedotin in Hodgkin's Lymphoma and CD30+ Peripheral T-cell Lymphoma in First Salvage Setting: the BBV Regimen.|Recruiting||Phase 2|65|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-10 23:07:27.948321|2017-10-10 23:07:27.948321
NCT02499614|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-07-14|||December 2014||2014-12-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|METROS||Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS)|Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS)|Unknown status|Recruiting|Phase 2|40|Anticipated|Fondazione Ricerca Traslazionale||2|||f||||t||||||||||2017-10-10 23:07:28.098373|2017-10-10 23:07:28.098373
NCT02499601|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-09-01|||September 2015||2015-09-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD)|CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility|Recruiting||N/A|10|Anticipated|CorAssist Cadiovascular Ltd.||1|||f||||||||||||||2017-10-10 23:07:28.28499|2017-10-10 23:07:28.28499
NCT02499588|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-07-15|||June 2015||2015-06-01|July 2015|2015-07-01||||August 2016|Anticipated|2016-08-01||Observational|OSMOSE||User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™|Observational User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™|Unknown status|Recruiting|N/A|600|Anticipated|ConvaTec Inc.|||1||f||||f||||||||||2017-10-10 23:07:28.420377|2017-10-10 23:07:28.420377
NCT02499575|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-04-14|2016-11-30||July 2015||2015-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures|Exparel Pericapsular Injection: A Prospective Evaluation of Postoperative Pain in Bunion Surgery, First Metatarsophalangeal Joint Fusion, and Cheilectomy|Terminated||N/A|2|Actual|OhioHealth||2||Logistical issues prevent efficient enrollment|f||||f||||||||No||2017-10-10 23:07:28.532918|2017-10-10 23:07:28.532918
NCT02499198|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-07-13|||August 2015||2015-08-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Labeled Nornicotine in Smokeless Tobacco|Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure|Unknown status|Not yet recruiting|Phase 1|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute||7|||f||||t||||||||||2017-10-10 23:07:34.689347|2017-10-10 23:07:34.689347
NCT02499562|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-07-13|||July 2015||2015-07-01|May 2015|2015-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|HBV||A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis|Randomed and Double-blinded Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis|Unknown status|Recruiting|Phase 2|240|Anticipated|Shanghai Genomics, Inc.||4|||f||||t||||||||||2017-10-10 23:07:28.845108|2017-10-10 23:07:28.845108
NCT02499549|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-15|||October 1999||1999-10-01|July 2015|2015-07-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Two Treatment Regimens of Cocamide DEA Lotion for Head Lice|A Randomised, Parallel Group Clinical Trial to Assess the Efficacy, Safety and Acceptability of a Surfactant Based Lotion in the Treatment of Head Louse Infection.|Terminated||Phase 2/Phase 3|112|Actual|Medical Entomology Centre||2||Lack of efficacy|f||||f||||||||||2017-10-10 23:07:30.709466|2017-10-10 23:07:30.709466
NCT02499536|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-04-25|||July 2015||2015-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Relationship Between Atelectasis on Ultrasound and PaO2/FiO2|Relationship Between Intraoperative Atelectasis Findings on Transthoracic Lung Ultrasound and PaO2/FiO2|Completed||N/A|26|Actual|Severance Hospital||1|||f||||t||||||||||2017-10-10 23:07:30.819422|2017-10-10 23:07:30.819422
NCT02499523|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-03-24|||June 16, 2014|Actual|2014-06-16|March 2017|2017-03-01|October 21, 2016|Actual|2016-10-21|October 21, 2016|Actual|2016-10-21||Interventional|||Monocentric Study on Acetabulum Patient-specific Pin Drilling Guides|Prospective Randomised Controlled Monocentric Study on Acetabulum Patient-specific Pin Drilling Guides|Terminated||N/A|7|Actual|Materialise||2||Low recruitment rate|f||||f||||||||||2017-10-10 23:07:30.918407|2017-10-10 23:07:30.918407
NCT02499510|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-02-21|||October 2015||2015-10-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||First-in-man Study of Titanium-Nitride Coated Woven-nitinol Peripheral Arterial Stent|First-in-man Study to Assess Efficacy and Safety of a Novel Titanium-Nitride Coated Woven-nitinol Peripheral Arterial Stent|Recruiting||N/A|20|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-10 23:07:31.030922|2017-10-10 23:07:31.030922
NCT02499497|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-23|||July 2015||2015-07-01|May 2017|2017-05-01|November 2022|Anticipated|2022-11-01|March 2019|Anticipated|2019-03-01||Interventional|||A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer|A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer|Recruiting||Phase 2|350|Anticipated|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-10 23:07:31.158692|2017-10-10 23:07:31.158692
NCT02499484|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-10-05|||September 2016||2016-09-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|NEAT||Topical Glyceryl Trinitrate (GTN) and Eccentric Exercises in the Treatment of Midportion Achilles Tendinopathy|The Use of Topical Glyceryl Trinitrate (GTN) and Eccentric Exercises in the Treatment of Midportion Achilles Tendinopathy: a Randomized Placebo Controlled Trial|Recruiting||N/A|240|Anticipated|Royal College of Surgeons, Ireland||2|||f||||f||||||||Undecided||2017-10-10 23:07:31.298002|2017-10-10 23:07:31.298002
NCT02499471|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-20|||March 2012||2012-03-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|December 2012|Actual|2012-12-01||Interventional|||Brown Adipose Tissue Activity and Thyroid Hormone|Brown Adipose Tissue Activity and Thyroid Hormone|Completed||N/A|12|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:07:31.439488|2017-10-10 23:07:31.439488
NCT02499458|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-04-28|||November 2014||2014-11-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer|Prospective Validation of Circulating Tumor Cells (CTCs) and Circulating Endothelial Cells (CECs) as Prognostic Biomarkers in Clear Cell Renal Cancer|Recruiting||N/A|70|Anticipated|Lawson Health Research Institute|||1||f||||t||||||||||2017-10-10 23:07:31.569686|2017-10-10 23:07:31.569686
NCT02499445|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-07-15|||November 2007||2007-11-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Myocardial Injury in Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimens in OPCAB Surgery|Comparisons of Myocardial Injury After Using Different Anesthetics Regimens for Off-pump Coronary Artery Bypass Surgery: Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimen|Completed||N/A|120|Actual|Konkuk University Medical Center||3|||f||||t||||||||||2017-10-10 23:07:31.673627|2017-10-10 23:07:31.673627
NCT02499432|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-07-15|||January 2013||2013-01-01|July 2015|2015-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Improving Implementation of Evidence Based PTSD Psychotherapy for Veterans in the Community|Improving Implementation of Evidence Based PTSD Psychotherapy for Veterans in the Community|Completed||N/A|54|Actual|Veterans Medical Research Foundation||2|||f||||f||||||||||2017-10-10 23:07:31.928522|2017-10-10 23:07:31.928522
NCT02499419|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-07-13|||September 2015||2015-09-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Observational|||Exercise Capacity Evaluation in Patients With Non-rheumatic Mitral Valve Prolapse (MVP)|Exercise Capacity Evaluation in Patients With Non-rheumatic Mitral Valve Prolapse (MVP)|Unknown status|Not yet recruiting|N/A|80|Anticipated|Rambam Health Care Campus|||4||f||||||||||||||2017-10-10 23:07:32.019744|2017-10-10 23:07:32.019744
NCT02499406|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-03-31|||December 2014||2014-12-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Dialectical Behavior Therapy Skills Group Pilot Evaluation|Dialectical Behavior Therapy Skills Group Pilot Evaluation|Active, not recruiting||N/A|50|Anticipated|VA Connecticut Healthcare System||1|||f||||f||||||||||2017-10-10 23:07:32.122061|2017-10-10 23:07:32.122061
NCT02499393|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-15|||April 2010||2010-04-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|April 2013|Actual|2013-04-01||Interventional|Hemen||Hypothermia Enhanced by Magnesium Sulphate|Comparison of Two Method of Therapeutic Hypothermia Enhanced by Magnesium Sulphate in Neonatal Encephalopathy|Completed||Phase 2/Phase 3|75|Actual|Polish Mother Memorial Hospital Research Institute||2|||f||||f||||||||||2017-10-10 23:07:32.222546|2017-10-10 23:07:32.222546
NCT02499380|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-04-19|||June 2015||2015-06-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Changes in Lung Physiology and Cardiac Performance in Patients With Emphysema Post Bilateral RePneu Coil Treatment|Changes in Lung Physiology and Cardiac Performance in Patients With Emphysema Post Bilateral RePneu Coil Treatment|Recruiting||N/A|60|Anticipated|PneumRx, Inc.|||1||f||||f||||||||||2017-10-10 23:07:32.316806|2017-10-10 23:07:32.316806
NCT02499367|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-13|||August 2015||2015-08-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|August 2019|Anticipated|2019-08-01||Interventional|TONIC||Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients|Adaptive Phase II Randomized Non-comparative Trial of Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients: TONIC-trial|Recruiting||Phase 2|84|Anticipated|The Netherlands Cancer Institute||5|||f||||t||||||||||2017-10-10 23:07:32.443305|2017-10-10 23:07:32.443305
NCT02499354|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-01-23|||August 2014||2014-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)|Double-blind Comparator of Efficacy of Oral (Ferrous Sulfate) vs. Intravenous Iron (Ferumoxytol) for Treatment of the Restless Legs Syndrome (RLS) Occurring With Iron Deficient Anemia (IDA)|Recruiting||Phase 2|70|Anticipated|Auerbach Hematology Oncology Associates P C||2|||f||||f||||||||||2017-10-10 23:07:32.598233|2017-10-10 23:07:32.598233
NCT02499341|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-14|||July 2011||2011-07-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Comparison Study Between Ketamine Versus Tramadol for Pain Management After Major Upper Abdominal Surgery|Comparison Between Ketamine and Tramadol for Pain Management After Major Upper Abdominal Surgery|Completed||N/A|42|Actual|Attikon Hospital||2|||f||||||||||||||2017-10-10 23:07:32.730554|2017-10-10 23:07:32.730554
NCT02499328|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-08-28|||August 5, 2015|Actual|2015-08-05|August 2017|2017-08-01|August 29, 2018|Anticipated|2018-08-29|August 29, 2018|Anticipated|2018-08-29||Interventional|||Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck|A Phase 1b/2, Open-Label, Multicentre Study Assessing the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of MEDI4736 in Combination With AZD9150 or AZD5069 in Patients With Advanced Solid Malignancies and Subsequently Comparing AZD9150 and AZD5069 Both as Monotherapy and in Combination With MEDI4736 as Second Line Treatment in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1/Phase 2|147|Anticipated|AstraZeneca||14|||f||||f|t|f||||||||2017-10-10 23:07:32.834449|2017-10-10 23:07:32.834449
NCT02499315|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-05-05|||April 2015||2015-04-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis|A Randomized, Double-blind, Placebo-controlled, Ascending Multiple-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 357 in Female Subjects With Rheumatoid Arthritis|Terminated||Phase 1|32|Anticipated|Amgen||2||Study has stopped due to a decision by Amgen to terminate the program|f||||f||||||||||2017-10-10 23:07:33.113224|2017-10-10 23:07:33.113224
NCT02499302|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-06-27|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Mental Training for CFS Following EBV Infection in Adolescents|Mental Training for Chronic Fatigue Syndrome (CFS/ME) Following EBV Infection in Adolescents: A Randomised Controlled Trial|Active, not recruiting||N/A|50|Actual|University Hospital, Akershus||2|||f||||f||||||||||2017-10-10 23:07:33.189713|2017-10-10 23:07:33.189713
NCT02499289|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-09-14|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Effect of Ramadan Fasting on Ovulation and Insuline Resistance in Patients With PCOS|Does Prolonged Fasting Break the Vicious Circle of Polycystic Ovarian Syndrome of Insulin Resistance ?|Recruiting||N/A|80|Anticipated|Ain Shams University|||1||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-10 23:07:33.316859|2017-10-10 23:07:33.316859
NCT02499276|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-12-28|||May 2015||2015-05-01|July 2015|2015-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparative Effects of Variable Pressure Support, NAVA and PAV|Comparative Effects of Variable Pressure Support, Neurally Adjusted Ventilatory Assist (NAVA) and Proportional Assist Ventilation (PAV) on the Variability of the Breathing Pattern and on Patient Ventilator Interaction|Completed||N/A|12|Actual|Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil||1|||f||||t||||||||||2017-10-10 23:07:33.390703|2017-10-10 23:07:33.390703
NCT02499263|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-08-22|||June 11, 2015||2015-06-11|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30||Observational|EUREKA||A Prospective Non-interventional Multicentre Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice|A Prospective Non-interventional Multicentre Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice|Active, not recruiting||N/A|147|Anticipated|AbbVie|||1||f||||f||||||Samples Without DNA|"     Fecal samples : Fecal calprotectin and the composition of Fecal microbiota Blood samples :     Trough level of adalimumab & Antibodies against adalimumab   "|||2017-10-10 23:07:33.478214|2017-10-10 23:07:33.478214
NCT02499250|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2015-07-15|||January 2015||2015-01-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|June 2016|Anticipated|2016-06-01||Interventional|D-RIC-RAP||Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients|Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients and the Mechanism|Unknown status|Recruiting|N/A|30|Anticipated|Navy General Hospital, Beijing||2|||f||||f||||||||||2017-10-10 23:07:33.746895|2017-10-10 23:07:33.746895
NCT02499237|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2016-07-11|||July 2015||2015-07-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|AfterDmab||Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation|The Effect of Zoledronic Acid Infusion in the Bone Loss Observed Following Denosumab Discontinuation in Postmenopausal Women With Low Bone Mass|Recruiting||Phase 4|90|Anticipated|424 General Military Hospital||2|||f||||f||||||||||2017-10-10 23:07:33.860004|2017-10-10 23:07:33.860004
NCT02499224|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-03-21|||June 2015||2015-06-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|October 2016|Anticipated|2016-10-01||Interventional|||Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy|A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of YYB101, Hepatocyte Growth Factor (HGF)-Neutralizing Humanized Monoclonal Antibody (Mab), in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy|Recruiting||Phase 1|39|Anticipated|National OncoVenture||1|||f||||t||||||||Undecided||2017-10-10 23:07:33.998831|2017-10-10 23:07:33.998831
NCT02499185|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-10-13|||April 2015||2015-04-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients|A PILOT Study Evaluating Novel Biomarkers of AKI in Post-operative Patients Undergoing Major Intra-Abdominal Surgery|Recruiting||Phase 4|100|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||No||2017-10-10 23:07:34.848152|2017-10-10 23:07:34.848152
NCT02499172|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-02-28|||June 2015||2015-06-01|February 2017|2017-02-01|October 30, 2016|Actual|2016-10-30|October 30, 2016|Actual|2016-10-30||Interventional|||Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi|Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine|Completed||N/A|3553|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||||2017-10-10 23:07:34.976385|2017-10-10 23:07:34.976385
NCT02499159|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-03-07|||December 2014||2014-12-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|VATS Exparel||Pain Management in Response to Exparel vs. Standard Bupivicaine|A Randomized Controlled Trial of the Effectiveness of Liposomal Bupivacaine (Exparel) When Compared to Local Injection of Bupivacaine After Thoracoscopy|Recruiting||Phase 4|100|Anticipated|Inova Health Care Services||2|||f||||f||||||||||2017-10-10 23:07:35.098554|2017-10-10 23:07:35.098554
NCT02499146|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-09-28|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer|A Phase 1 Open-label Pharmacokinetics Study Of Palbociclib, A Cyclin-dependent Kinase 4 And 6 (cdk4/6) Inhibitor, In Postmenopausal Chinese Women With Er (+), Her2 (-) Advanced Breast Cancer|Active, not recruiting||Phase 1|26|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:07:35.290462|2017-10-10 23:07:35.290462
NCT02499133|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-12-21|||September 2015||2015-09-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|||Identification and Comprehension of Focused Stress in a Sentence Among Adults Who Suffered Traumatic Brain Injury|Identification and Comprehension of Focused Stress in a Sentence Among Adults Who Suffered Traumatic Brain Injury|Unknown status|Recruiting|N/A|30|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:07:35.470117|2017-10-10 23:07:35.470117
NCT02499120|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-09-28|||September 10, 2015|Actual|2015-09-10|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer|A Randomized, Multicenter, Double-blind Phase 2 Study Of Palbociclib Plus Cetuximab Versus Cetuximab For The Treatment Of Human Papillomavirus-negative, Cetuximab-naïve Patients With Recurrent/Metastatic Squamous Cell Carcinoma Of The Head And Neck After Failure Of One Prior Platinum-containing Chemotherapy Regimen|Recruiting||Phase 2|120|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 23:07:35.569206|2017-10-10 23:07:35.569206
NCT02499107|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-05-04|||April 2013||2013-04-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||The Effects of Carbohydrate Source on Food Intake, Blood Glucose and Gut Hormone Response in Healthy Children|The Effects of Potatoes and Other Carbohydrate Side Dishes Consumed With Meat on Food Intake, Glycaemia and Satiety Response in Children|Completed||N/A|32|Actual|University of Toronto||5|||f||||f||||||||||2017-10-10 23:07:35.90923|2017-10-10 23:07:35.90923
NCT02499094|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2015-07-14|||December 2014||2014-12-01|July 2015|2015-07-01||||July 2015|Actual|2015-07-01||Interventional|||Modeling and Predicting Real World Behavior Using Mobile Sensor Data on Patients With Major Depressive Disorder|Modeling and Predicting Real World Behavior Using Mobile Sensor Data on Patients With Major Depressive Disorder: Protocol for a Randomized Controlled Study|Completed||N/A|1004|Actual|Ginger.io||3|||f||||t||||||||||2017-10-10 23:07:36.013833|2017-10-10 23:07:36.013833
NCT02499081|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-10-02|||September 2015||2015-09-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment|Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment Relapsed/Refractory Multiple Myeloma Patients|Recruiting||Phase 2|20|Anticipated|University of Arkansas||1|||f||||t||||||||||2017-10-10 23:07:36.084746|2017-10-10 23:07:36.084746
NCT02499068|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-04-18|||December 2013||2013-12-01|April 2017|2017-04-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|PROMETE||Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home Telemonitoring|Proyecto Madrileño Sobre el Manejo de la Enfermedad Pulmonar Obstructiva Crónica Con Telemonitorización a Domicilio. (Multicentre Project on the Home Telemonitoring of Patients With Severe Chronic Obstructive Pulmonary Disease).|Completed||N/A|237|Actual|Universidad Autonoma de Madrid||2|||f||||t||||||||||2017-10-10 23:07:36.186057|2017-10-10 23:07:36.186057
NCT02499055|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-10-11|||August 2015||2015-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|IBT||A Randomised Feasibility Trial With Internet Based Self-help Therapy|Internet Based Self-help Therapy With FearFighter™ Versus no Intervention for Anxiety Disorders in Adult Persons: a Randomised Feasibility Trial|Active, not recruiting||N/A|64|Actual|Mental Health Services in the Capital Region, Denmark||2|||f||||t||||||||||2017-10-10 23:07:36.282775|2017-10-10 23:07:36.282775
NCT02499042|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-04|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|EXACT||rEduction of oXygen After Cardiac arresT: a Pilot Study|rEduction of oXygen After Cardiac arresT (EXACT): a Pilot Study|Completed||Phase 2|59|Actual|Monash University||2|||f||||f||||||||||2017-10-10 23:07:36.879445|2017-10-10 23:07:36.879445
NCT02499016|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-07-13|||June 2015||2015-06-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Appendectomy: a Randomized Controlled Trial|Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Multiport Appendectomy: a Randomized Controlled Trial|Recruiting||N/A|208|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-10 23:07:37.194352|2017-10-10 23:07:37.194352
NCT02499003|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-08|||August 2015||2015-08-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2018|Anticipated|2018-10-01||Interventional|||GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma|The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma|Recruiting||Phase 2|70|Anticipated|Johannes Gutenberg University Mainz||1|||f||||t||||||||||2017-10-10 23:07:37.348355|2017-10-10 23:07:37.348355
NCT02498990|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-08-24|||August 2015||2015-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|LCD||Low Calorie Diet and Diabetes|Long-term Metabol Control After Weight Reduction With Low Calorie Diet in Type 2 Diabetes|Enrolling by invitation||N/A|40|Anticipated|Karolinska University Hospital||1|||f||||f||||||||||2017-10-10 23:07:37.469849|2017-10-10 23:07:37.469849
NCT02498977|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-08-30|||October 2015||2015-10-01|August 2016|2016-08-01|March 2021|Anticipated|2021-03-01|October 2019|Anticipated|2019-10-01||Interventional|LIFT||Liver Immunosuppression Free Trial|Prospective Randomised Marker-based Trial to Assess the Clinical Utility and Safety of Biomarker-guided Immunosuppression Withdrawal in Liver Transplantation|Recruiting||Phase 4|148|Anticipated|King's College London||3|||f||||t||||||||||2017-10-10 23:07:37.584173|2017-10-10 23:07:37.584173
NCT02498964|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-04-04|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Observational|||Use of High Fidelity Simulation in Cardiac-specific Anesthesia Scenarios for Resident Education and Assessment|Use of High Fidelity Simulation in Cardiac-specific Anesthesia Scenarios for Resident Education and Assessment|Active, not recruiting||N/A|14|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-10 23:07:37.718577|2017-10-10 23:07:37.718577
NCT02498951|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-04-19|||July 2016||2016-07-01|April 2017|2017-04-01|April 2022|Anticipated|2022-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete Response|Maintenance Obinutuzumab for Primary Central Nervous System Lymphoma Complete Responders|Recruiting||Phase 2|120|Anticipated|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-10-10 23:07:37.828042|2017-10-10 23:07:37.828042
NCT02498938|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-08-26|||March 2015||2015-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|SA1PLG||The Association of SERPINA1 Gene Disturbance in Patients With Lung and Gum Disorders|Evaluation of SERPINA1 Gene Polymorphisms in COPD as a Risk Factor for Periodontitis|Completed||N/A|60|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||1||f||||t||||||Samples With DNA|"     2ml of blood sample from each subject will be collected in EDTA containing vials and kept at     -20 degrees until DNA extraction. the genomic DNA will be isolated and Z/S polumorphism in     SERPINA1 gene will be identified by PCR followed by restriction digestion pattern by Alu 1     restriction enzyme.   "|No||2017-10-10 23:07:37.95251|2017-10-10 23:07:37.95251
NCT02498925|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-09-12|||December 2015||2015-12-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||Examining Reward-Related Predictors and Mechanisms of Change in BA Treatment for Anhedonic Adolescents|Examining Reward-Related Predictors and Mechanisms of Change in BA Treatment for Anhedonic Adolescents|Recruiting||N/A|70|Anticipated|Mclean Hospital||1|||f||||t||||||||||2017-10-10 23:07:38.05454|2017-10-10 23:07:38.05454
NCT02498912|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-09-05|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors|A Phase I Clinical Trial of Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors|Recruiting||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:07:38.143924|2017-10-10 23:07:38.143924
NCT02498899|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-12-19|||July 2015||2015-07-01|December 2016|2016-12-01||||July 2018|Anticipated|2018-07-01||Interventional|||Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion|Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion|Active, not recruiting||N/A|148|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:07:38.254144|2017-10-10 23:07:38.254144
NCT02498886|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-02-03|||August 2015||2015-08-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||IHAT Absorption Kinetics|An Exploratory Study to Determine Bioavailability and Transferrin Saturation Following a Single Dose of a Novel Iron Supplement (IHAT) in Gambian Women.|Completed||Early Phase 1|34|Actual|Medical Research Council||3|||f||||f||||||||||2017-10-10 23:07:38.340047|2017-10-10 23:07:38.340047
NCT02498873|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2016-01-17|||August 2015||2015-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|Running||Linear Running Periodization x Nonlinear|Linear Running Periodization x Nonlinear: a Cross Effect of Five Months Controlled Running on VO2Max and Critical Power Performance|Completed||N/A|35|Actual|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-10 23:07:38.437532|2017-10-10 23:07:38.437532
NCT02498860|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-07-19|||July 2015||2015-07-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|APICAL||Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung|Efficacy and Safety of Pemetrexed Plus Cisplatin as Combination Chemotherapy for Post-operative Adenocarcinoma : Multi-center, Single Arm, Open-label, Phase Ⅱ Trial|Recruiting||Phase 2|106|Anticipated|Chonnam National University Hospital||1|||f||||f||||||||||2017-10-10 23:07:38.538737|2017-10-10 23:07:38.538737
NCT02498847|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-07-14|||March 2013||2013-03-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|ENGAGE||Occupational Therapy-Delivered Cognitive Behavioral Therapy for Symptomatic Knee Osteoarthritis|Occupational Therapy-Delivered Cognitive Behavioral Therapy for Symptomatic Knee Osteoarthritis: A Pilot Study|Completed||Phase 1/Phase 2|57|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:07:38.693193|2017-10-10 23:07:38.693193
NCT02498834|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-09-13|||July 2015||2015-07-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement|Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement|Active, not recruiting||N/A|359|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:07:38.783521|2017-10-10 23:07:38.783521
NCT02498821|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-03-02|2017-01-12||May 2015||2015-05-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation|Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation: A Comparison Between Standard of Care (Chest X-ray) and Sherlock 3CG® TCS|Completed||N/A|120|Actual|C. R. Bard||2|||f||||f||||||||No||2017-10-10 23:07:38.891309|2017-10-10 23:07:38.891309
NCT02498808|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-08-01|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|ILAND||Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?|Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?|Recruiting||N/A|85|Anticipated|University of Oxford|||4||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:07:39.380115|2017-10-10 23:07:39.380115
NCT02498795|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2017-07-23|||January 1, 2016|Actual|2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy|Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy|Recruiting||N/A|50|Anticipated|Universidad de Zaragoza||3|||f||||t|f|f||||||||2017-10-10 23:07:39.498499|2017-10-10 23:07:39.498499
NCT02498782|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2015-07-14|||July 2014||2014-07-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|September 2015|Anticipated|2015-09-01||Interventional|||Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease|Phase 2, Randomized, Multicenter, Placebo-controlled, Safety and Efficacy Study to Evaluate Six Oral Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chronic Indeterminate Chagas Disease.|Unknown status|Recruiting|Phase 2|140|Anticipated|Drugs for Neglected Diseases||7|||f||||t||||||||||2017-10-10 23:07:39.595839|2017-10-10 23:07:39.595839
NCT02498769|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-13|||September 2015||2015-09-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery|Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery|Recruiting||Phase 1/Phase 2|130|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:07:39.727802|2017-10-10 23:07:39.727802
NCT02498756|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-14|||August 2015||2015-08-01|July 2015|2015-07-01|August 2040|Anticipated|2040-08-01|August 2038|Anticipated|2038-08-01||Interventional|||Cytokine-induced Killer Study for Patients With Stage II Melanoma|A Study of Ipilimumab Plus Cytokine-induced Killer Immunotherapy for Stage II Melanoma Patients|Not yet recruiting||Phase 2|300|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:07:39.816079|2017-10-10 23:07:39.816079
NCT02498743|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-14|||February 2015||2015-02-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Television Cartoons in Patients Younger Than 3.5 Years During Echocardiography|Effect of Television Cartoons in Patients Younger Than 3.5 Years During Echocardiography.A Prospective Randomized Study|Completed||N/A|58|Actual|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||f||||||||||2017-10-10 23:07:39.884763|2017-10-10 23:07:39.884763
NCT02498730|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-11|2015-08-10|||August 2015||2015-08-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|HIIT||Interval Training in Bipolar Disorder|Can the High Intensity Interval Training (HIIT) Deliver Superior and Rapid Decrease of Symptoms of Bipolar Disorder? a Controlled and Randomized Study|Unknown status|Recruiting|N/A|36|Anticipated|Universidade Federal do Rio de Janeiro||3|||f||||t||||||||||2017-10-10 23:07:39.961936|2017-10-10 23:07:39.961936
NCT02498717|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-07-13|||June 2015||2015-06-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Preliminary Review of Cold and Active Compression Therapy for Traumatic Calcaneus or Ankle Fractures|Preliminary Efficacy and Cost-effectiveness Analysis of a Cold and Active Intermittent Compression Therapy Technique for Traumatic Calcaneus or Ankle Fractures|Unknown status|Recruiting|N/A|60|Anticipated|Florida Hospital||2|||f||||f||||||||||2017-10-10 23:07:40.069137|2017-10-10 23:07:40.069137
NCT02498704|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-02-22|||November 2014||2014-11-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Dry Needling and Stretching vs. Stretching Alone on Hamstring Flexibility in Patients With Knee Pain|The Effectiveness of Dry Needling and Stretching vs. Stretching Alone on Hamstring Flexibility in Patients With Knee Pain: A Randomized Controlled Trial|Completed||N/A|39|Actual|Keller Army Community Hospital||2|||f||||f||||||||||2017-10-10 23:07:40.167684|2017-10-10 23:07:40.167684
NCT02498691|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-12-23|||February 2016||2016-02-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|ENDOBST||Perinatal Consequences of Endometriosis|Perinatal Consequences of Endometriosis: Multicenter Prospective Comparative Study|Recruiting||N/A|1800|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 23:07:40.243999|2017-10-10 23:07:40.243999
NCT02498678|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-11-03|2015-07-17||January 2014||2014-01-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Tetanus on Neuromuscular Junction Monitor Performance in Pediatric Patients|Effect of Tetanus on Neuromuscular Junction Monitor Performance in Pediatric Patients Undergoing Abdominal and / or Perineal Surgical Procedures With Using of Rocuronium|Completed||N/A|50|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:07:40.327764|2017-10-10 23:07:40.327764
NCT02498665|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-12-21|||November 2015||2015-11-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Interventional|||A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies|A Phase I Clinical Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies|Recruiting||Phase 1|76|Anticipated|Boston Biomedical, Inc||1|||f||||||||||||||2017-10-10 23:07:40.767105|2017-10-10 23:07:40.767105
NCT02498444|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-10-14|||September 2015||2015-09-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation|Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation|Recruiting||N/A|42|Anticipated|Stanford University||2|||f||||t||||||||No||2017-10-10 23:07:43.522709|2017-10-10 23:07:43.522709
NCT02498639|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-13|||April 2015||2015-04-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|PNP||The Pacing vs No Pacing Study - PNP Study|Comparison of Safety and Efficacy of Percutaneous Balloon Aortic Valvuloplasty Performed With or Without Rapid Ventricular Pacing - The Pacing vs No Pacing Study (PNP Study)|Unknown status|Recruiting|Phase 4|100|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||f||||||||||2017-10-10 23:07:40.971937|2017-10-10 23:07:40.971937
NCT02498626|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-05-07|||July 2009||2009-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Mixed Venous Oxygen Saturation From Central Venous Line, Venous Side of Heart Lung Machine and the Pulmonary Artery|Are Venous Saturations From the Central Venous Line, Venous Side of the Heart Lung Machine Interchangeable or Not With Mixed Venous Saturation From the Pulmonary Artery in Children Undergoing Open Heart Surgery?|Completed||Phase 2|40|Actual|Assiut University|||1||f||||t||||||||||2017-10-10 23:07:41.075911|2017-10-10 23:07:41.075911
NCT02498600|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-14|2017-09-28|||June 29, 2015|Actual|2015-06-29|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Phase II Randomized Trial of Nivolumab With or Without Ipilimumab in Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Recruiting||Phase 2|96|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 23:07:41.379082|2017-10-10 23:07:41.379082
NCT02498587|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-01-30|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|October 2020|Anticipated|2020-10-01||Observational|SPRINT-SARI||Short Period Incidence Study of Severe Acute Respiratory Illness|Short Period Incidence Study of Severe Acute Respiratory Illness|Recruiting||N/A|1000|Anticipated|Australian and New Zealand Intensive Care Research Centre|||1||f||||t|f|f||||||Yes||2017-10-10 23:07:41.937076|2017-10-10 23:07:41.937076
NCT02498574|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-07-20|||August 2016||2016-08-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Interventional|||Performance Enhancement and Non-Invasive Brain Stimulation||Not yet recruiting||N/A|50|Anticipated|Bruyere Research Institute||2|||f||||||||||||||2017-10-10 23:07:42.062723|2017-10-10 23:07:42.062723
NCT02498561|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-14|||March 2013||2013-03-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Effects of Obesity on Glutathione Levels in Patients With Chronic Periodontitis Before and After Periodontal Therapy|Phase 1 Study of Periodontal Disease and Obese Individuals That Investigate of Local and Systemic Antioxidant Levels of Before and After Periodontal Treatment|Completed||Phase 1|60|Actual|Bulent Ecevit University||4|||f||||f||||||||||2017-10-10 23:07:42.173669|2017-10-10 23:07:42.173669
NCT02498548|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-06-29|||June 2015||2015-06-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Training of Eccentric Knee Function After SCI|Eccentric Motor Control Training to Improve Human Spinal Cord Injury: Knee Function During Walking|Recruiting||Phase 1/Phase 2|32|Anticipated|Ohio State University||3|||f||||f||||||||||2017-10-10 23:07:42.306546|2017-10-10 23:07:42.306546
NCT02498535|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2017-03-27|||February 22, 2017|Actual|2017-02-22|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients|Prospective, Randomized, Placebo Controlled Trial of the Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients|Recruiting||Phase 2|60|Anticipated|Novoteris, LLC||2|||f||||t|t|f||||||No||2017-10-10 23:07:42.434368|2017-10-10 23:07:42.434368
NCT02498522|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-04-13|2016-03-28||August 2015||2015-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|MIP||Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome|Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome|Completed||Early Phase 1|166|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-10 23:07:42.586899|2017-10-10 23:07:42.586899
NCT02498509|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2016-12-22|||May 2015||2015-05-01|July 2015|2015-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of CKD-342|A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Concomitant Mometasone Furoate and Levocabastine HCl in Perennial Allergic Rhinitis Patients|Completed||Phase 3|459|Anticipated|Chong Kun Dang Pharmaceutical||3|||f||||f||||||||||2017-10-10 23:07:42.943956|2017-10-10 23:07:42.943956
NCT02498496|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-02-22|||September 2016||2016-09-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Magnesium Sulfate to Prevent Hospitalisation of Acute Exacerbations of Chronic Obstructive Pulmonary Disease|MASTER-ED : Magnesium Sulfate to Prevent Hospitalisation of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Seen in the Emergency Department|Suspended||Phase 4|700|Anticipated|Hôpital de Verdun||2||financing delays|f||||t||||||||||2017-10-10 23:07:43.069188|2017-10-10 23:07:43.069188
NCT02498483|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-02-03|||September 2015||2015-09-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Acetaminophen and Post Circumcision Pain Control|Acetaminophen and Post Circumcision Pain Control|Recruiting||Phase 4|100|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-10 23:07:43.182921|2017-10-10 23:07:43.182921
NCT02498470|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2016-04-12|||January 2008||2008-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|PCI-registry||Prospective Registry to Assess the Cath Lab Percutaneous Coronary Intervention Long-term Outcomes: a Single Center|Prospective Registry to Assess the Cath Lab Percutaneous Coronary Intervention Long-term Outcomes: a Single Center|Recruiting||N/A|10000|Anticipated|Sun Yat-sen University|||1||f||||f||||||||No||2017-10-10 23:07:43.310043|2017-10-10 23:07:43.310043
NCT02498431|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-01-14|||June 2015||2015-06-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IRICARDIO||Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention|Serum Irisin Levels in Myocardial Infraction and Following Percutaneous Coronary Intevention|Completed||N/A|116|Actual|424 General Military Hospital||3|||f||||f||||||||||2017-10-10 23:07:43.61806|2017-10-10 23:07:43.61806
NCT02498418|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-06-26|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study Comparing Rifaximin With Xifaxan 200mg in Traveler's Diarrhea|A Randomized, Double-Blind, Parallel, Multicenter, Bioequivalence Study Comparing Rifaximin 200-mg Tablets With Xifaxan® 200-mg Tablets and With Placebo in the Treatment of Traveler's Diarrhea|Completed||Phase 3|778|Actual|Actavis Inc.||3|||f||||f||||||||No||2017-10-10 23:07:43.722065|2017-10-10 23:07:43.722065
NCT02498405|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-12-21|||December 2015||2015-12-01|December 2016|2016-12-01||||October 2016|Actual|2016-10-01||Observational|ST LEUIS||Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction|Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction (ST LEUIS Study)|Completed||N/A|53|Actual|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-10-10 23:07:43.801405|2017-10-10 23:07:43.801405
NCT02498392|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-09-04|||October 7, 2015|Actual|2015-10-07|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|August 15, 2018|Anticipated|2018-08-15||Interventional|||An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress|A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress|Suspended||Phase 2|140|Anticipated|Janssen Research & Development, LLC||4|||f||||f||f||||||||2017-10-10 23:07:43.860039|2017-10-10 23:07:43.860039
NCT02498379|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-04-26|||October 2014||2014-10-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)|PET-Magnetic Resonance (MR) Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With [64]Cu-25%CANF-Comb (Volunteer - BioDistribution and Safety Study)|Completed||Early Phase 1|8|Actual|Washington University School of Medicine||1|||f||||f||||||||Undecided||2017-10-10 23:07:43.99336|2017-10-10 23:07:43.99336
NCT02498366|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2015-07-14|||October 2015||2015-10-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty|Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty|Unknown status|Not yet recruiting|N/A|50|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:07:44.07257|2017-10-10 23:07:44.07257
NCT02498353|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2015-07-10|||July 2015||2015-07-01|July 2015|2015-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Comparing Preoperative Short-course Radiotherapy With or Without Local Boost for Rectal Cancer|Preoperative Short-course Radiotherapy With Local Boost Versus Conventional Preoperative Short-course Radiotherapy for Rectal Cancer|Not yet recruiting||N/A|100|Anticipated|Zhongnan Hospital||2|||f||||f||||||||||2017-10-10 23:07:44.321466|2017-10-10 23:07:44.321466
NCT02498340|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-14|||December 2015||2015-12-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Interventional|||Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation||Unknown status|Not yet recruiting|Phase 2/Phase 3|100|Anticipated|Ain Shams University||1|||f||||||||||||||2017-10-10 23:07:44.472947|2017-10-10 23:07:44.472947
NCT02498327|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-05-18|||January 2015||2015-01-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency|The Efficacy of Red Vine Leaf Extract, Butcher's Broom, Horse Chestnut and Vitamin B6 on the Quality of Life in Females With Chronic Venous Insufficiency|Completed||Phase 2|40|Actual|University of Johannesburg||2|||f||||t||||||||No||2017-10-10 23:07:44.582593|2017-10-10 23:07:44.582593
NCT02498314|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-06-29|||April 2015||2015-04-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Clinical Effects of Translatoric Grades of Movement in Hip Osteoarthritis Patients|Clinical Effects of Translatoric Grades of Movement in Hip Osteoarthritis Patients|Completed||N/A|60|Actual|Universidad de Zaragoza||3|||f||||||||||||||2017-10-10 23:07:44.681216|2017-10-10 23:07:44.681216
NCT02498301|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-06-06|||April 2016||2016-04-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|March 2017|Anticipated|2017-03-01||Interventional|||Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD|A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550 mg Daily or 550 mg Twice Daily) for Chemoprophylaxis Against Travelers' Diarrhea (TD) Among Active Duty Deployed U.S. and British Military Personnel|Recruiting||N/A|375|Anticipated|Uniformed Services University of the Health Sciences||3|||f||||f||||||||||2017-10-10 23:07:44.803824|2017-10-10 23:07:44.803824
NCT02498288|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-06-09|||May 31, 2013|Actual|2013-05-31|June 2017|2017-06-01|July 15, 2013|Actual|2013-07-15|July 15, 2013|Actual|2013-07-15||Interventional|||A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition|Bioequivalence Study for an Isotretinoin Pharmaceutical Preparation - Capsules. Open, Crossover, Randomized, Single Dose, Three Treatments, Three Periods and Six Sequences With Meal (Breakfast) Study|Completed||Phase 1|36|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:07:44.995159|2017-10-10 23:07:44.995159
NCT02498275|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-11-04|||July 2014||2014-07-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients||Terminated||N/A|14|Actual|Hoffmann-La Roche|||3||f||||||||||||||2017-10-10 23:07:45.128092|2017-10-10 23:07:45.128092
NCT02498262|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-03-09|||June 2015||2015-06-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|VR4VR||Using Virtual Reality and Robotics Technologies for Vocational Evaluation, Training and Placement|Using Virtual Reality and Robotics Technologies for Vocational Evaluation, Training and Placement|Recruiting||N/A|100|Anticipated|University of South Florida||1|||f||||||||||||||2017-10-10 23:07:45.225849|2017-10-10 23:07:45.225849
NCT02498067|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-09-12|||July 2015||2015-07-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Interventional|||rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities|rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities|Completed||N/A|104|Actual|University of Chicago||1|||f||||f||||||||||2017-10-10 23:07:47.068259|2017-10-10 23:07:47.068259
NCT02498249|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-10|||May 2015||2015-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Immediate Effect of Irradiation With Low-level Laser Therapy on the Electromyographic Activity of the Upper Trapezius Muscles and the Level of Pain Among Patients With Non-specific Neck Pain|Immediate Effect of Irradiation With Low-level Laser Therapy on the Electromyographic Activity of the Upper Trapezius Muscles and the Level of Pain Among Patients With Non-specific Neck Pain: a Randomized, Double-blinded, Sham-controlled, Crossover Study|Completed||Phase 1/Phase 2|20|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 23:07:45.336055|2017-10-10 23:07:45.336055
NCT02498236|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-08-07|||September 2015||2015-09-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|R21Dose||Target Engagement for Oxytocin: Dose Ranging Study|Target Engagement for Oxytocin: Response to 8 Doses|Completed||N/A|47|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 23:07:45.45633|2017-10-10 23:07:45.45633
NCT02498223|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-07-12|||September 2015||2015-09-01|July 2015|2015-07-01|November 2016|Anticipated|2016-11-01|June 2016|Anticipated|2016-06-01||Interventional|LCI||Adjusting the Load Carried by the Soldier According to Body Composition Measurements and Aerobic Capacity|Adjusting the Load Carried by the Soldier According to Body Composition Measurements and Aerobic Capacity|Unknown status|Not yet recruiting|N/A|50|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:07:45.585029|2017-10-10 23:07:45.585029
NCT02498210|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2015-07-14|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||IVM for Patients With Low Ovarian Response. Does it Improve IVFoutcomes and Does it Improve the Following IVF Cycle?|IVM Treatment in Patients With Low Ovarian Response. Does it Improve IVF Outcome or May it Cause Activation of Ovarian Follicles and Increase the Chances of Success in the Following IVF Cycle?|Unknown status|Not yet recruiting|N/A|25|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:07:45.71445|2017-10-10 23:07:45.71445
NCT02498197|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-09-22|||March 2016||2016-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|IRMA11||Participatory Intervention Among Construction Workers (IRMA11)|Deltagerinvolverende Intervention Mod Fysiske Risikofaktorer for Muskel- og skeletbesvær i Byggebranchen|Enrolling by invitation||N/A|80|Anticipated|National Research Centre for the Working Environment, Denmark||2|||f||||f||||||||||2017-10-10 23:07:45.863771|2017-10-10 23:07:45.863771
NCT02498184|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2016-11-01|||November 2016||2016-11-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Perioperative Acupuncture for Impacted Mandibular Third Molar Extractions|Perioperative Acupuncture for Impacted Mandibular Third Molar Extractions - a Double Blinded Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Ziv Hospital||2|||f||||f||||||||||2017-10-10 23:07:45.956195|2017-10-10 23:07:45.956195
NCT02498171|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-12|||January 2014||2014-01-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Labour Analgesia; Comparing a Combinations of Either Fentanyl or Bupivacaine With Intrathecal Morphine|Evaluation Of Efficacy And Safety Of Labour Analgesia By Intrathecal Morphine With Fentanyl Compared To Morphine With Bupivacaine In Mulago Hospital: A Double-blinded Randomized Control Trial|Completed||N/A|138|Actual|Makerere University||2|||f||||t||||||||||2017-10-10 23:07:46.081919|2017-10-10 23:07:46.081919
NCT02498158|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2015-07-19|||September 2015||2015-09-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|fMRI||Functional Neural Connectivity at Rest as a Diagnostic Tool for Intolerance to Heat|Functional Neural Connectivity at Rest, as a Diagnostic Tool for Intolerance to Heat and Return to Duty After Exertional Heat Stroke|Unknown status|Not yet recruiting|N/A|20|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-10 23:07:46.205279|2017-10-10 23:07:46.205279
NCT02498145|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-06-28|||October 2014||2014-10-01|April 2016|2016-04-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||Short Term Effects of Electronic Cigarettes in Tobacco Dependent Adults|Short Term Effects of Electronic Cigarettes in Tobacco Dependent Adults|Completed||N/A|40|Actual|Yale University||2|||f||||f||||||||||2017-10-10 23:07:46.327213|2017-10-10 23:07:46.327213
NCT02498132|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-02-24|||April 2016||2016-04-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Development and Testing of a Behavioral Activation Mobile Therapy for Elevated Depressive Systems|Development and Testing of a Behavioral Activation Mobile Therapy for Elevated Depressive Systems|Not yet recruiting||Phase 1|60|Anticipated|University of Maryland||3|||f||||||||||||||2017-10-10 23:07:46.433025|2017-10-10 23:07:46.433025
NCT02498119|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-06-20|||November 2014||2014-11-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|January 2016|Actual|2016-01-01|12 Months|Observational [Patient Registry]|||The Role of Arachidonic Acid Metabolites, From Patients With Metabolic Syndrome|The Role of Arachidonic Acid Metabolites, in the Lipid Droplets of Macrophages From Patients With Metabolic Syndrome|Recruiting||N/A|12|Anticipated|University of Malaya|||2||f||||f||||||Samples With DNA|"     Whole blood is collected and blood component separated for the future use. Whole blood, red     blood cells, plasma and buffy coat are was separated and kept in -80 degree Celsius.   "|||2017-10-10 23:07:46.582294|2017-10-10 23:07:46.582294
NCT02498106|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-07-25|||May 2015||2015-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Diet and Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Dietary Supplementation|Diet and Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Supplementation of Multivitamins, Minerals and n-3 Fatty Acids|Recruiting||N/A|200|Anticipated|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 23:07:46.724909|2017-10-10 23:07:46.724909
NCT02498093|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-01-25|||August 2015|Actual|2015-08-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Maximal Strength Training in Patients Undergoing Total Hip Arthroplasty|Maximal Strength Training in Patients Undergoing Total Hip Arthroplasty: Implementing Evidence Based Rehabilitation Into Clinical Practice, and the Influence of Supervised Training|Recruiting||N/A|50|Anticipated|Norwegian University of Science and Technology||2|||f||||t|f|f||||||Undecided||2017-10-10 23:07:46.842003|2017-10-10 23:07:46.842003
NCT02498080|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-13|||September 2015||2015-09-01|July 2015|2015-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Drug Eluting Balloons PTA in Infra-popliteal Arteries in Patients With Critical Limb Ischemia|Drug Eluting Balloons Versus Standard Percutaneous Transluminal Angioplasty in Infra-popliteal Arteries in Patients With Critical Limb Ischemia: a Randomized Clinical Trial|Not yet recruiting||N/A|60|Anticipated|Neuromed IRCCS||2|||f||||f||||||||||2017-10-10 23:07:46.971165|2017-10-10 23:07:46.971165
NCT02498054|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-09-12|||July 2015||2015-07-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Diabetic Mellitus Patients Glucose Range Awareness After Experiencing a New Blood Glucose Meter Feature|Diabetic Mellitus Patients Glucose Range Awareness After Experiencing a New Blood Glucose Meter Feature|Completed||N/A|80|Actual|LifeScan||1|||f||||f||||||||||2017-10-10 23:07:47.156987|2017-10-10 23:07:47.156987
NCT02498041|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-14|||April 2009||2009-04-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|NOSE||The Efficacy and Patient Tolerance of Ultrathin Nasal Endoscopy to Detect Barrett's Oesophagus|Study to Compare the Efficacy and Patient Tolerance of Ultrathin Nasal Endoscopy to Detect Barrett's Esophagus Compared With Conventional Endoscopy to Inform a Future Multicentre Screening Trial|Completed||N/A|115|Actual|University of Cambridge||2|||f||||t||||||||||2017-10-10 23:07:47.235872|2017-10-10 23:07:47.235872
NCT02498028|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2015-07-14|||January 2011||2011-01-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|June 2015|Actual|2015-06-01||Observational|||Clinical Outcome After Anterior Cervical Decompression and Fusion and Cervical Total Disc Replacement|Clinical Outcome After Anterior Cervical Decompression and Fusion and Cervical Total Disc Replacement|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Bonn|||2||f||||t||||||||||2017-10-10 23:07:47.349221|2017-10-10 23:07:47.349221
NCT02498015|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-03-08|||June 2016||2016-06-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|D3FEAT||A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection|A Phase IV Open-label, Multicentre, International Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir ±Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection and Recent Injection Drug Use or Receiving Opioid Substitution Therapy|Active, not recruiting||Phase 4|87|Actual|Kirby Institute||2|||f||||t||||||||No||2017-10-10 23:07:47.453988|2017-10-10 23:07:47.453988
NCT02498002|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-05-11|||May 2015||2015-05-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Impacts of Intermittent Fasting on Energy Balance and Associated Health Outcomes|Impacts of Intermittent Fasting in Adults on Energy Balance, Body Composition, Postprandial Hormone Profiles and Gene Expression in Adipose Tissue|Recruiting||N/A|72|Anticipated|University of Bath||3|||f||||f||||||||||2017-10-10 23:07:47.567921|2017-10-10 23:07:47.567921
NCT02497989|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-07-12|||February 2015||2015-02-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|TASCO||Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in Kenya|Male Circumcision for HIV Prevention in Kenya: Seeking Effective Strategies to Recruit Older Men|Unknown status|Recruiting|N/A|4932|Anticipated|Impact Research & Development Organization||4|||f||||f||||||||||2017-10-10 23:07:47.802992|2017-10-10 23:07:47.802992
NCT02497976|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-03-01|||December 15, 2015|Actual|2015-12-15|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis|Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis|Active, not recruiting||Phase 3|42|Actual|ICStudy, LLC||2|||f||||t||||||||No||2017-10-10 23:07:47.946586|2017-10-10 23:07:47.946586
NCT02497963|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-14|||August 2015||2015-08-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|FGTIP-TIP||Foreskin Graft Tubularized Incised Plate Urethroplasty vs Tubularized Incised Plate for Primary Hypospadias (FGTIP-TIP)|Foreskin Graft Tubularized Incised Plate Urethroplasty (TIP) vs Tubularized Incised Plate (TIP) for Primary Hypospadias. Randomized Clinical Trial (FGTIP-TIP)|Unknown status|Not yet recruiting|N/A|68|Anticipated|Hospital Infantil de Mexico Federico Gomez||2|||f||||t||||||||||2017-10-10 23:07:48.059176|2017-10-10 23:07:48.059176
NCT02497950|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2016-12-19|||February 2015||2015-02-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01|2 Years|Observational [Patient Registry]|ELEVATE™||HeartMate 3 ELEVATE™|Evaluating the HeartMate 3™ in a Post-Market Approval Setting: The HeartMate 3 Registry (ELEVATE™)|Recruiting||N/A|500|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-10 23:07:48.166353|2017-10-10 23:07:48.166353
NCT02497937|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-08-28|||April 13, 2016|Actual|2016-04-13|August 2017|2017-08-01|August 21, 2017|Actual|2017-08-21|August 21, 2017|Actual|2017-08-21||Interventional|||A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure|A Randomized, Double-blind, Placebo-controlled, Phase 2a Crossover Study to Evaluate the Effect of the TRPV4 Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure|Completed||Phase 2|11|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:07:48.399545|2017-10-10 23:07:48.399545
NCT02497924|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-13|2017-04-10|||June 2015|Actual|2015-06-01|September 2015|2015-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects|A Phase 1 Study to Investigate Absorption, Metabolism, and Excretion After Establishment of Steady State Via GBT440 Loading and Maintenance Dosing Followed by a Single Oral Dose Administration of [14C]-GBT440 in Healthy Male Subjects|Completed||Phase 1|7|Actual|Global Blood Therapeutics||1|||f||||f||||||||||2017-10-10 23:07:48.513765|2017-10-10 23:07:48.513765
NCT02497911|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-10-22|||January 2014||2014-01-01|October 2015|2015-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||A Trial Comparing Adductor Canal Catheter and Intraarticular Catheter Following Primary Total Knee Arthroplasty|A Randomized Controlled Trial Comparing the Adductor Canal Catheter (ACC) and Intra-articular Catheter (IAC) Following Primary Total Knee Arthroplasty|Unknown status|Enrolling by invitation|Phase 4|110|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-10 23:07:50.26756|2017-10-10 23:07:50.26756
NCT02497898|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-12|||July 2015||2015-07-01|June 2015|2015-06-01|July 2040|Anticipated|2040-07-01|July 2038|Anticipated|2038-07-01||Interventional|||Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma|A Randomized Controlled Clinical Trial of Cytokine-induced Killer (CIK) Cells Treatment in Patients With Refractory Non-Hodgkin Lymphoma|Not yet recruiting||Phase 2|1000|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:07:50.395996|2017-10-10 23:07:50.395996
NCT02497885|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-10-29|||August 2015||2015-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Seroprevalence of MERS-CoV IgG in Healthcare Workers|Seroprevalence of IgG Antibodies to Middle East Respiratory Syndrome Coronavirus in Asymptomatic Healthcare Workers After Treatment of Confirmed MERS Patient|Completed||N/A|737|Actual|Ewha Womans University Mokdong Hospital|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-10 23:07:50.475462|2017-10-10 23:07:50.475462
NCT02497872|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-07-12|||November 2011||2011-11-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Early Precut Versus Pancreatic Stent for Post-ERCP Pancreatitis|Early Precut Versus Pancreatic Duct Stent in Preventing Post-ERCP Pancreatitis in High-risk Subjects|Completed||N/A|100|Actual|Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno||2|||f||||f||||||||||2017-10-10 23:07:50.571486|2017-10-10 23:07:50.571486
NCT02497859|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-09-14|||September 2015||2015-09-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Breakfast Intake and Satiety Hormones|Does Higher Protein Quality Breakfast Reduce Energy Intake When Following a Weight Loss Diet Plan?|Completed||N/A|20|Actual|Texas Tech University||2|||f||||f||||||||No||2017-10-10 23:07:50.650301|2017-10-10 23:07:50.650301
NCT02497833|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-10|||November 2014||2014-11-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Retinoic Acid Supplementation and Subjects With Hypercholesterolemia|Effect of Retinoic Acid Supplementation on the HDL-Associated Paraoxonase 1 Activity in Subjects With Hypercholesterolemia: A Randomized, Double-Blinded, Placebo-Controlled Trial|Completed||Early Phase 1|130|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:07:50.85174|2017-10-10 23:07:50.85174
NCT02497820|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-08-24|||September 2016||2016-09-01|August 2016|2016-08-01|September 2027|Anticipated|2027-09-01|September 2027|Anticipated|2027-09-01||Interventional|CaPP3 Israel||Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers|A Randomised Double Blind Dose Non-inferiority Trial of a Daily Dose of 600mg Versus 300mg Versus 100mg of Enteric Coated Aspirin as a Cancer Preventive in Carriers of a Germline Pathological Mismatch Repair Gene Defect, Lynch Syndrome|Not yet recruiting||Phase 3|1800|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||t||||||||||2017-10-10 23:07:50.948831|2017-10-10 23:07:50.948831
NCT02497807|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-04-26|||December 2013||2013-12-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01|1 Day|Observational [Patient Registry]|PTS||The Pathophysiology of Tourette Syndrome: a Multimodal Study|fMRI Study on Iron Deficiency in the Pathological Mechanism of Tourette Syndrome|Recruiting||N/A|40|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University|||1||f||||t||||||None Retained|"     no biospecimens are to be retained   "|||2017-10-10 23:07:51.065951|2017-10-10 23:07:51.065951
NCT02497794|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2017-08-10|||January 2015||2015-01-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Gum Chewing on Bowel Function After Cesarean Section|Efficacy and Effectiveness of Gum Chewing on Bowel Function After Cesarean Section: a Randomized Controlled Trial|Completed||N/A|150|Actual|Sisli Etfal Training & Research Hospital||2|||f||||f||||||||||2017-10-10 23:07:51.158768|2017-10-10 23:07:51.158768
NCT02497768|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-03-08|||June 2015||2015-06-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|August 2015|Actual|2015-08-01||Interventional|||Particle Sizing of Masticated Tree Nuts - Pistachios and Brazils|Particle Sizing of Masticated Tree Nuts - Pistachios and Brazils|Active, not recruiting||N/A|10|Actual|King's College London||1|||f||||f||||||||||2017-10-10 23:07:51.782535|2017-10-10 23:07:51.782535
NCT02497742|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-25|||October 2015||2015-10-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Once Versus Twice Daily Electrolyte Monitoring in CHF|Once Versus Twice Daily Electrolyte Monitoring in CHF; a Study Monitoring Electrolytes in Congestive Heart Failure Patients Being Actively Diuresed in Hospital|Completed||N/A|96|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 23:07:52.011372|2017-10-10 23:07:52.011372
NCT02497729|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-09-16|||July 2015||2015-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|Check-UP||Checklists and Upright Positioning in Endotracheal Intubation of Critically Ill Patients (Check-UP) Trial|Checklists and Upright Positioning in Endotracheal Intubation of Critically Ill Patients (Check-UP) Trial|Completed||Phase 4|260|Actual|Vanderbilt University||4|||f||||f||||||||||2017-10-10 23:07:52.134083|2017-10-10 23:07:52.134083
NCT02497703|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-12|2017-09-15|||May 27, 2015|Actual|2015-05-27|September 2017|2017-09-01|December 31, 2016|Actual|2016-12-31|October 14, 2016|Actual|2016-10-14||Interventional|||Interactive Exoskeleton Robot for Walking - Knee Joint|Interactive Exoskeleton Robot for Walking - Knee Joint|Completed||N/A|25|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-10 23:07:52.502826|2017-10-10 23:07:52.502826
NCT02497690|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-07-26|||September 2013||2013-09-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|TACIT||Effectiveness of Therapy Via Telemedicine Following Cochlear Implants|Effectiveness of Therapy Via Telemedicine Following Cochlear Implants|Recruiting||Phase 2|100|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:07:52.588666|2017-10-10 23:07:52.588666
NCT02497677|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-11-22|||July 2015||2015-07-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|July 2017|Anticipated|2017-07-01||Interventional|CIMHP||Copenhagen Infant Mental Health Project: Enhancing Parental Sensitivity and Attachment (CIMHP)|Copenhagen Infant Mental Health Project: A Randomized Controlled Trial Comparing Circle of Security-Parenting and Care as Usual as Interventions Targeting Infant Mental Healths Risks|Recruiting||N/A|314|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:07:52.710199|2017-10-10 23:07:52.710199
NCT02497664|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-01-13|||January 2016||2016-01-01|November 2016|2016-11-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ABC||Optimizing (Breathing) Techniques for Radiotherapy of Esophageal and Lung Carcinomas|Optimizing (Breathing) Techniques for Radiotherapy of Esophageal and Lung Carcinomas|Completed||N/A|22|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-10 23:07:52.848515|2017-10-10 23:07:52.848515
NCT02497651|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-08-04|||May 2015||2015-05-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Interventional|SmokinGLP-1||Effect of Smoking on Postprandial Gastric Emptying, Glucose Tolerance and Secretion of Gut and Pancreatic Hormones||Completed||N/A|24|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-10 23:07:52.944366|2017-10-10 23:07:52.944366
NCT02497638|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-04-11|||March 2016||2016-03-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|LIGAND||LIpitor and biGuanide to Androgen Delay Trial|A Randomized, Double Blind, Trial of Metformin and Atorvastatin in Delaying Androgen Deprivation Therapy Among Men With Rising PSA Following Radical Prostatectomy or Radiotherapy: The LIGAND (LIpitor and biGuanide to Androgen Delay) Trial|Recruiting||Phase 2|110|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:07:53.054153|2017-10-10 23:07:53.054153
NCT02497625|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-05-08|||September 2015||2015-09-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|June 2017|Anticipated|2017-06-01||Interventional|TalkBack||Effectiveness of Therapeutic Alliance and Minimal Intervention for Chronic Low Back Pain|Effectiveness of the Addition of Therapeutic Alliance to Minimal Intervention Treatment for Chronic Low Back Pain With Low Risk of Psychosocial Factors: a Randomized Controlled Trial|Recruiting||N/A|222|Anticipated|Universidade Cidade de Sao Paulo||3|||f||||t||||||||No||2017-10-10 23:07:53.166467|2017-10-10 23:07:53.166467
NCT02497599|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-04-13|||June 2015||2015-06-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Intraoperative Dual-modality Imaging in Renal Cell Carcinoma|A Phase 1 Study to Evaluate the Safety and Feasibility of Intraoperative Detection of Clear Cell Renal Cell Carcinoma Using Indium-111-DOTA-girentuximab-IRDye800CW|Recruiting||Phase 1|22|Anticipated|Radboud University||1|||f||||t||||||||Undecided||2017-10-10 23:07:53.561373|2017-10-10 23:07:53.561373
NCT02497586|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-07-10|||August 2015||2015-08-01|July 2015|2015-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|MRS||Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer|Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer|Unknown status|Not yet recruiting|N/A|15|Anticipated|NHS Greater Glasgow and Clyde||1|||f||||f||||||||||2017-10-10 23:07:53.678557|2017-10-10 23:07:53.678557
NCT02497573|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-11-01|||May 2016||2016-05-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|MeRInO||Can DW MRI Predict Outcome During Radiotherapy for Head and Neck Cancer?|Study of Diffusion Weighted MRI as a Predictive Biomarker of Response During Radiotherapy for High and Intermediate Risk Squamous Cell Cancer of the Oropharynx (MeRInO Study)|Recruiting||N/A|80|Anticipated|NHS Greater Glasgow and Clyde|||1||f||||f||||||||No||2017-10-10 23:07:53.775168|2017-10-10 23:07:53.775168
NCT02497560|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-08-02|||March 2015||2015-03-01|August 2016|2016-08-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms|A Randomized Double Blind Placebo-Controlled Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms|Terminated||Phase 2/Phase 3|20|Actual|Physician Recommended Nutriceuticals||3||Role of calcium in menopause is not clear. Product maybe reformulated and the study relaunched.|f||||||||||||||2017-10-10 23:07:53.879981|2017-10-10 23:07:53.879981
NCT02497547|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-10-20|||October 2014||2014-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy|A Phase 2b, Double-blind, Randomized, Parallel, Placebo-Controlled, Multiple-Dose Study to Evaluate the 12-week Efficacy of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy|Completed||Phase 2|227|Actual|PepTonic Medical AB||3|||f||||f||||||||||2017-10-10 23:07:53.979202|2017-10-10 23:07:53.979202
NCT02497534|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-07|||September 2015||2015-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Biomarkers in Friedreich's Ataxia|Biomarkers in Friedreich's Ataxia|Recruiting||N/A|100|Anticipated|University of Florida|||2||f||||f|f|f||||||||2017-10-10 23:07:54.121335|2017-10-10 23:07:54.121335
NCT02497521|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-03-21|||November 2015||2015-11-01|March 2017|2017-03-01|December 2027|Anticipated|2027-12-01|November 2025|Anticipated|2025-11-01|10 Years|Observational [Patient Registry]|AD(H)PKD||The German ADPKD Tolvaptan Treatment Registry|The German ADPKD Tolvaptan Treatment Registry is a Prospective, Observational, Multicentric Study of Patients Suffering From ADPKD That Are Considered for Tolvaptan Treatment.|Recruiting||N/A|200|Anticipated|University of Cologne|||1||f||||f||||||||||2017-10-10 23:07:54.264035|2017-10-10 23:07:54.264035
NCT02497508|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-13|||July 2015||2015-07-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|NivoMes||Nivolumab in Patients With Recurrent Malignant Mesothelioma|A Single Arm Phase II Study of Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma: Interim Biopsy Analysis to Determine Efficacy. Acronym: NivoMes Study|Completed||Phase 2|33|Actual|The Netherlands Cancer Institute||1|||f||||t||||||||||2017-10-10 23:07:54.43758|2017-10-10 23:07:54.43758
NCT02497495|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-10|||September 2014||2014-09-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Behaviour After Exercise of Biological, Clinical and Metabolic Variables as From Different Temperatures and Times of Immersion Cold Water Application|Effects Post-exercise of Biological, Clinical and Metabolic Variables as From Different Temperatures and Times of Immersion Cold Water Application in Active Individuals|Completed||N/A|105|Actual|Paulista University||5|||f||||f||||||||||2017-10-10 23:07:54.546185|2017-10-10 23:07:54.546185
NCT02497469|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-10-03|||July 15, 2015|Actual|2015-07-15|October 2017|2017-10-01|January 19, 2019|Anticipated|2019-01-19|January 19, 2019|Anticipated|2019-01-19||Interventional|||An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis|A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis|Recruiting||Phase 3|658|Anticipated|Takeda||2|||f||||f||||||||||2017-10-10 23:07:54.810212|2017-10-10 23:07:54.810212
NCT02497456|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-03-22|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effectiveness of a Counselling Intervention on the Uptake of HIV Care Services Among HIV Infected Patients in Uganda|The Effectiveness of a Counselling Intervention on the Uptake of HIV Care Services Among HIV Infected Patients in Uganda|Completed||N/A|338|Actual|MRC/UVRI Uganda Research Unit on Aids||2|||f||||f||||||||No||2017-10-10 23:07:55.990128|2017-10-10 23:07:55.990128
NCT02497443|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-06-15|||April 2011||2011-04-01|April 2015|2015-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|AMSCDRSE||Safety of Autologous MSC Infusion to Treat Epilepsy|Phase 1 Study of Autologous Mesenchymal Stem Cell Application for Therapy of Drug-Resistant Symptomatic Epilepsy|Active, not recruiting||Phase 1/Phase 2|60|Actual|Ministry of Public Health, Republic of Belarus||2|||f||||f||||||||Undecided||2017-10-10 23:07:56.097475|2017-10-10 23:07:56.097475
NCT02497430|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-09-14|||March 2016||2016-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay|A Multi-Site Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay With Vaginal-Rectal Swab Specimens From Antepartum Pregnant Women|Completed||N/A|918|Actual|Luminex Molecular Diagnostics|||1||f||||f||||||Samples With DNA|"     vaginal-rectal swab   "|||2017-10-10 23:07:56.204696|2017-10-10 23:07:56.204696
NCT02497417|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-22|||October 2016||2016-10-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients|A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients|Completed||N/A|1021|Actual|Luminex Molecular Diagnostics|||1||f||||f||||||Samples With DNA|"     Stool   "|||2017-10-10 23:07:56.306889|2017-10-10 23:07:56.306889
NCT02497404|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-03-01|||February 13, 2015|Actual|2015-02-13|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR|Epigenetic Priming With 5-Azacytidine Prior to in Vivo T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With High Risk Myeloid Malignancies in Morphologic Remission|Recruiting||Phase 2|55|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 23:07:56.404454|2017-10-10 23:07:56.404454
NCT02497391|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-12-15|||July 2015||2015-07-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of Different Particle Sizes of Evacetrapib in Healthy Participants|A Bioequivalence Study in Healthy Subjects Administered Evacetrapib Tablets of Varying Particle Sizes|Completed||Phase 1|148|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 23:07:56.562923|2017-10-10 23:07:56.562923
NCT02497365|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-09-14|||September 2015||2015-09-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Besifloxacin in Bacterial Keratitis|Besifloxacin Ophthalmic Suspension in Patients With Bacterial Keratitis: A Prospective, Randomized Clinical Study|Recruiting||N/A|32|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 23:07:56.806504|2017-10-10 23:07:56.806504
NCT02497352|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-13|||February 2014||2014-02-01|December 2014|2014-12-01||||August 2014|Actual|2014-08-01||Interventional|||Effects of Flaxseed Supplementation in Metabolic Syndrome||Completed||Phase 2/Phase 3|44|Actual|National Nutrition and Food Technology Institute||2|||f||||||||||||||2017-10-10 23:07:56.932715|2017-10-10 23:07:56.932715
NCT02497339|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Mindfulness Training for Smoking Cessation in Women in Workplaces|Mindfulness Training for Smoking Cessation in Women in the Workplace - a Pilot Randomized Controlled Trial|Completed||N/A|215|Actual|The University of Hong Kong||2|||f||||||||||||||2017-10-10 23:07:57.015929|2017-10-10 23:07:57.015929
NCT02497326|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-10|||April 2015||2015-04-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Heparin for the Treatment of Burn Wound Pain|Comparative Study of Conventional and Topical Heparin Treatments in Second Degree Burn Patients for Burn Analgesia and Duration of Wound Healing|Unknown status|Recruiting|N/A|36|Anticipated|King Edward Medical University||2|||f||||||||||||||2017-10-10 23:07:57.101373|2017-10-10 23:07:57.101373
NCT02497313|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-05-02|||July 2015||2015-07-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes||Completed||N/A|15|Actual|University Hospital, Gentofte, Copenhagen||4|||f||||f||||||||||2017-10-10 23:07:57.227506|2017-10-10 23:07:57.227506
NCT02497300|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-15|||March 2015||2015-03-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|VEMAKD||Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease|Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease|Recruiting||Phase 2|62|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:07:57.352458|2017-10-10 23:07:57.352458
NCT02497287|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-09-22|||September 30, 2015|Actual|2015-09-30|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|SUSTAIN-2||A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression|An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression|Recruiting||Phase 3|750|Anticipated|Janssen Research & Development, LLC||1|||f||||t||f||||||||2017-10-10 23:07:57.522512|2017-10-10 23:07:57.522512
NCT02497274|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-15|||September 2015||2015-09-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|HumanFATaste||Obesity and Lipids: a Matter of Taste?|Obesity and Lipids: a Matter of Taste? Impact of Bariatric Surgery on Taste Receptors|Unknown status|Not yet recruiting|N/A|50|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-10 23:07:58.132703|2017-10-10 23:07:58.132703
NCT02497261|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-06-20|||July 2015||2015-07-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||Early Life Origins of the Food Allergy Epidemic|Early Life Origins of the Food Allergy Epidemic: Predictors of Persistent Peanut Allergy at Age 5 Years|Enrolling by invitation||N/A|200|Anticipated|University of Manitoba|||2||f||||f||||||Samples Without DNA|"     Blood for immunological markers of peanut allergy   "|Undecided||2017-10-10 23:07:58.210581|2017-10-10 23:07:58.210581
NCT02497248|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-10|||February 2015||2015-02-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Observational|PERSONALIZE||Non-invasive Characterization of the Mechanisms of Atrial Fibrillation Maintenance|PERSONALIZE-AF: Non-invasive Characterization of the Mechanisms of Atrial Fibrillation|Unknown status|Recruiting|N/A|50|Anticipated|Hospital General Universitario Gregorio Marañon|||3||f||||t||||||||||2017-10-10 23:07:58.315176|2017-10-10 23:07:58.315176
NCT02497235|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-02-28|2016-12-14||July 2015||2015-07-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional||Safety analysis set included all participants who were enrolled and received investigational drug ([18F]MNI-792 or TAK-935).|A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935|An Open-Label, Positron Emission Tomography, Phase 1 Study With [18F]MNI-792 to Determine Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935 After Single-Dose Oral Administration in Healthy Subjects.|Completed||Phase 1|11|Actual|Takeda||1|||f||||f||||||||||2017-10-10 23:07:58.464408|2017-10-10 23:07:58.464408
NCT02497222|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-10-03||||||October 2016|2016-10-01||||June 2016|Actual|2016-06-01||Interventional|||Pilot Study of RNS60 in Allergen-induced Bronchoconstriction|Pilot Study of RNS60 in Allergen-induced Bronchconstriction|Withdrawn||Phase 2|0|Actual|Revalesio Corporation||2|||f||||f||||||||||2017-10-10 23:07:59.625367|2017-10-10 23:07:59.625367
NCT02497209|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-04-06|||August 2015||2015-08-01|April 2016|2016-04-01|August 2025|Anticipated|2025-08-01|December 2016|Anticipated|2016-12-01||Observational|iAGD||International AGD Database; Determinants of AGD and Establishment of Normative Data|International AGD Database; Determinants of AGD and Establishment of Normative Data|Enrolling by invitation||N/A|6000|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-10 23:07:59.746803|2017-10-10 23:07:59.746803
NCT02497196|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-03-17|||July 2015||2015-07-01|March 2017|2017-03-01|December 1, 2016|Actual|2016-12-01|October 1, 2016|Actual|2016-10-01||Interventional|||Neurophysiological Effects on tPCS and tDCS on Healthy Subjects and on Patients With Chronic Visceral Pain|Neurophysiological Effects on tPCS and tDCS on Healthy Subjects and on Patients With Chronic Visceral Pain|Completed||N/A|54|Actual|Spaulding Rehabilitation Hospital||8|||f||||f||||||||||2017-10-10 23:07:59.842632|2017-10-10 23:07:59.842632
NCT02497183|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-13|||July 2015||2015-07-01|July 2015|2015-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Impact of Oral Contrast in the Large Intestine on the Recognition of Appendix|Impact of Presence of Oral Contrast Material in the Large Intestine on the Recognition of Appendix During an Ultrasound Exam|Unknown status|Recruiting|N/A|200|Anticipated|HaEmek Medical Center, Israel||1|||f||||t||||||||||2017-10-10 23:07:59.973209|2017-10-10 23:07:59.973209
NCT02497170|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2016-03-10|||September 2015||2015-09-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Implementation of A Patient Centered Self-Management Program for Patients With Type 2 Diabetes|Implementation of A Patient Centered Self-Management Program for Patients With Type 2 Diabetes|Completed||N/A|9|Actual|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-10-10 23:08:00.112712|2017-10-10 23:08:00.112712
NCT02497157|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-07-13|||April 2015||2015-04-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|BeTRI||Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer|Phase II Trial of FOLFOXIRI + Bevacizumab in Patients With Untreated Metastatic Colorectal Cancer|Recruiting||Phase 2|45|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||t||||||||||2017-10-10 23:08:00.206906|2017-10-10 23:08:00.206906
NCT02497144|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-07-03|||July 2015||2015-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Neuromuscular Electrical Stimulation in Patients With Interstitial Lung Disease|Effects of Neuromuscular Electrical Stimulation on Functional Exercise Capacity and Quality of Life in Patients With Interstitial Lung Disease|Recruiting||N/A|30|Anticipated|Gazi University||2|||f||||f||||||||||2017-10-10 23:08:00.889714|2017-10-10 23:08:00.889714
NCT02497131|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-08-24|||September 2015||2015-09-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|September 2016|Anticipated|2016-09-01||Interventional|||Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients|Phase II Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30 Positive Peripheral T Cell Lymphoma (PTCL) Patients|Recruiting||Phase 2|25|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-10 23:08:01.028525|2017-10-10 23:08:01.028525
NCT02497118|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2015-07-13|||August 2010||2010-08-01|May 2014|2014-05-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC|Clinical Study of Recombinant Human Endostatin Combined With NP Chemotherapy in the Treatment of Stage ⅢA Non Small Cell Lung Cancer|Completed||Phase 4|30|Actual|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-10 23:08:01.177502|2017-10-10 23:08:01.177502
NCT02497105|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-02-28|||January 2015||2015-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ketogenic Diet Program for Epilepsy|Ketogenic Diet Program for Epilepsy|Recruiting||N/A|30|Anticipated|Shriners Hospitals for Children||2|||f||||t||||||||Yes||2017-10-10 23:08:01.300589|2017-10-10 23:08:01.300589
NCT02497079|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-16|||July 2015||2015-07-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples|Comparison of the Diagnostic Accuracy of Nested and Real-time Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples in Patients With Isolated Intrathoracic Lymphadenopathy|Recruiting||N/A|100|Anticipated|Pusan National University Hospital||3|||f||||f||||||||||2017-10-10 23:08:01.495948|2017-10-10 23:08:01.495948
NCT02497066|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-10-31|||June 2015||2015-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy Study Comparing Compounded Topical Pain Creams vs. Placebo for Treating Pain Symptoms|Randomized, Controlled, Double-blind, Efficacy Study Comparing Compounded Topical Pain Creams vs. Placebo for Treating Pain Symptoms|Enrolling by invitation||Phase 3|399|Anticipated|Walter Reed National Military Medical Center||3|||f||||f||||||||||2017-10-10 23:08:01.621907|2017-10-10 23:08:01.621907
NCT02497053|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-13|||June 2015||2015-06-01|July 2015|2015-07-01||||June 2016|Anticipated|2016-06-01||Interventional|||Four Versus Six Cycles of Pemetrexed/Platinum for MPM|Four Versus Six Cycles of Pemetrexed/Platinum as a First Line Treatment of Malignant Pleural Mesothelioma; a Randomized Phase II Study|Unknown status|Recruiting|Phase 2|70|Anticipated|Ain Shams University||2|||f||||f||||||||||2017-10-10 23:08:01.843819|2017-10-10 23:08:01.843819
NCT02497027|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-05-02|||February 2015||2015-02-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|PGx-UPA||Pharmacogenetic Testing in an Outpatient Population of Patients With Depression|Pharmacogenetic Testing in an Outpatient Population of Patients With Major Depressive Disorder or Depressive Disorder Not Otherwise Specified|Completed||N/A|83|Actual|Avera McKennan Hospital & University Health Center||2|||f||||t||||||||||2017-10-10 23:08:02.103853|2017-10-10 23:08:02.103853
NCT02497014|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-03-07|||February 2016||2016-02-01|March 2016|2016-03-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|EBC MAIN||The European Bifurcation Club Left Main Study|The European Bifurcation Club Left Main Study: A Randomised Comparison of Single Versus Dual Stent Implantation for Distal Left Main True Coronary Bifurcation Lesions|Recruiting||N/A|450|Anticipated|European Cardiovascular Research Center||2|||f||||t||||||||No||2017-10-10 23:08:02.207056|2017-10-10 23:08:02.207056
NCT02497001|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-07-27|||August 10, 2015|Actual|2015-08-10|July 2017|2017-07-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|KRONOS||A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)|A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® as an Active Control in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease|Active, not recruiting||Phase 3|1800|Anticipated|Pearl Therapeutics, Inc.||4|||f||||t|t|f||||||||2017-10-10 23:08:02.464105|2017-10-10 23:08:02.464105
NCT02496988|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2015-07-13|||July 2015||2015-07-01|July 2015|2015-07-01|July 2030|Anticipated|2030-07-01|July 2028|Anticipated|2028-07-01||Interventional|||Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas|A Study of CIK in Combination With Temozolomide With and Without Radiation in Adults With Advanced Malignant Gliomas|Not yet recruiting||Phase 4|120|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:08:02.6782|2017-10-10 23:08:02.6782
NCT02496975|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-07-13|||July 2015||2015-07-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Traumatic Brain Injury and Effects of Acute Cyclosporine A|Oxidative Damage and Calcium-Activated Proteolytic Biomarkers After Traumatic Brain Injury and Effects of Acute Cyclosporine A|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-10 23:08:02.756274|2017-10-10 23:08:02.756274
NCT02496962|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2015-07-10|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Interventional|||Protective Effect of Statin on Sleep Deprivation|Protective Effect of Statin on Arrhythmia and Heart Rate Variability in Healthy People With 48 Hours of Sleep Deprivation|Unknown status|Recruiting|N/A|72|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:08:02.838093|2017-10-10 23:08:02.838093
NCT02496949|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2015-07-13|||November 2011||2011-11-01|July 2015|2015-07-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors|A Phase Ib ,Single Center, Open-labeling, Multiple Oral Dose Study to Assess the Safety, Tolerability，PK and Efficacy Profile for Advanced Solid Tumor Patients in China|Completed||Phase 1|28|Actual|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-10 23:08:02.947742|2017-10-10 23:08:02.947742
NCT02496936|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-20|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Acute Effects of Fats on Satiety and Energy Needs|Acute Effects of Fats on Satiety and Energy Needs|Recruiting||N/A|23|Anticipated|USDA Grand Forks Human Nutrition Research Center||5|||f||||f||||||||||2017-10-10 23:08:03.023927|2017-10-10 23:08:03.023927
NCT02496923|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-06-20|||August 2015||2015-08-01|June 2017|2017-06-01||||August 2017|Anticipated|2017-08-01||Interventional|||High Flow Nasal Oxygen Therapy (Optiflow™) in High-risk Cardiac Surgical Patients|A Randomised Controlled Trial of High-flow Nasal Oxygen (Optiflow™) and Standard Oxygen Therapy in High-risk Patients After Cardiac Surgery|Recruiting||N/A|74|Anticipated|Papworth Hospital NHS Foundation Trust||2|||f||||||||||||||2017-10-10 23:08:03.109741|2017-10-10 23:08:03.109741
NCT02496910|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-09-24|||June 2015||2015-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton|A Randomized,Open-label,Single Dose,Crossover Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Comparison to the Co-administration of Twynsta and Hygroton in Healthy Volunteers|Completed||Phase 1|180|Anticipated|Yuhan Corporation||4|||f||||f||||||||||2017-10-10 23:08:03.227321|2017-10-10 23:08:03.227321
NCT02496897|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-07-24|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B|A Phase I, Randomized, Double-blind, Placebo-controlled, Multi-centre, Ascending-dose Trial to Evaluate the Safety, Tolerability and Immunogenicity of Vaccine FP-02.2 in HBeAg-negative Hepatitis B Patients as an add-on Treatment to Entecavir or Tenofovir.|Recruiting||Phase 1|60|Anticipated|Altimmune, Inc.||6|||f||||t||||||||||2017-10-10 23:08:03.323892|2017-10-10 23:08:03.323892
NCT02496884|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-07-12|||June 2015||2015-06-01|July 2017|2017-07-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Interventional|||Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease|A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease|Completed||Phase 3|56|Actual|Daiichi Sankyo, Inc.||4|||f||||t|t|f||||||||2017-10-10 23:08:03.501222|2017-10-10 23:08:03.501222
NCT02496871|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-05-01|||July 2015||2015-07-01|May 2017|2017-05-01|January 30, 2018|Anticipated|2018-01-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Remote Delivery of Weight Management by Phone and Social Media|Remote Delivery of Weight Management by Phone and Social Media|Active, not recruiting||N/A|70|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 23:08:03.884214|2017-10-10 23:08:03.884214
NCT02496858|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-09|||August 2015||2015-08-01|July 2015|2015-07-01|August 2019|Anticipated|2019-08-01|August 2016|Anticipated|2016-08-01||Observational|GRAND||Clinical and Genetic Characteristics of Coronary Artery Disease in Chinese Young Adults|Clinical and Genetic Characteristics of Coronary Artery Disease in Chinese Young Adults|Not yet recruiting||N/A|300|Anticipated|Shanghai Zhongshan Hospital|||2||f||||t||||||Samples With DNA|"     2 samples of EDTA blood (2ml glass) and 1 sample of serum (2ml glass) will be retained in a     biobank.   "|||2017-10-10 23:08:03.997472|2017-10-10 23:08:03.997472
NCT02496845|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-07-13|||August 2015||2015-08-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|||Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction|An Open Label Randomized Study to Examine the Safety and Clinical Efficacy of Local Topical Dual Active Preparation for Erectile Dysfunction|Unknown status|Not yet recruiting|Phase 1/Phase 2|32|Anticipated|VasoLead (2012) Ltd.||2|||f||||t||||||||||2017-10-10 23:08:04.073822|2017-10-10 23:08:04.073822
NCT02496832|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-07-13|||November 2014||2014-11-01|July 2015|2015-07-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo|An Exploratory Study of Hypoxia Imaging Using 18F-FAZA-PET in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine + TH-302/Placebo (MAESTRO: EMR200592-001)|Suspended||N/A|30|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:08:04.199886|2017-10-10 23:08:04.199886
NCT02496819|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-05-10|||June 2015||2015-06-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Metacognitive Self-regulated Learning and Sensory Integrative Approaches for Children With Autism Spectrum Disorders|Metacognitive Self-regulated Learning and Sensory Integrative Approaches for Children With Autism Spectrum Disorders|Active, not recruiting||N/A|60|Actual|University of Western Sydney||3|||f||||f||||||||No||2017-10-10 23:08:04.33258|2017-10-10 23:08:04.33258
NCT02496806|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-09|||May 2011||2011-05-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SWAFAX||The Absorption and Metabolism of Seaweed Polyphenols in Humans|Seaweed Derived Anti-inflammatory Agents and Antioxidants|Completed||N/A|24|Actual|University of Reading||1|||f||||f||||||||||2017-10-10 23:08:04.455399|2017-10-10 23:08:04.455399
NCT02496793|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-13|||January 2012||2012-01-01|July 2015|2015-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Community-Based Peer Facilitator Intervention|A Community Randomized Study to Evaluate the Effect of a Community-Based Peer Facilitator Intervention on Prevention of Maternal to Child Transmission (PMTCT) of HIV Program Outcomes in Zimbabwe|Completed||N/A|1600|Actual|Elizabeth Glaser Pediatric AIDS Foundation||2|||f||||f||||||||||2017-10-10 23:08:04.535205|2017-10-10 23:08:04.535205
NCT02496780|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-11-29|||August 2015||2015-08-01|November 2016|2016-11-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients|The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients|Recruiting||Phase 2/Phase 3|80|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||No|No, individual data will remain with the PI.|2017-10-10 23:08:04.644632|2017-10-10 23:08:04.644632
NCT02496767|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-10|2017-08-04|||August 2015||2015-08-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|VITALITY-ALS||Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year|A Phase 3, Multi-National, Double-Blind, Randomized, Placebo-Controlled, Stratified, Parallel Group, Study to Evaluate the Safety, Tolerability and Efficacy of Tirasemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)|Active, not recruiting||Phase 3|743|Actual|Cytokinetics||4|||f||||t||||||||||2017-10-10 23:08:04.864465|2017-10-10 23:08:04.864465
NCT02496754|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-13|||June 2015||2015-06-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||The Application of a New Ovarian Stimulation Protocol in IVF|The Application of a New Ovarian Stimulation Protocol in IVF: a Randomized Controlled Study|Unknown status|Recruiting|N/A|50|Anticipated|The First Affiliated Hospital of Zhengzhou University||2|||f||||f||||||||||2017-10-10 23:08:05.153093|2017-10-10 23:08:05.153093
NCT02496741|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-11-14|||November 2015||2015-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|MACIST||Metformin And Chloroquine in IDH1/2-mutated Solid Tumors|Phase Ib Study of Metformin and Chloroquine in IDH1/2-mutated Patients With Glioma, Intrahepatic Cholangiocarcinoma or Chondrosarcoma|Recruiting||Phase 1/Phase 2|20|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 23:08:05.269296|2017-10-10 23:08:05.269296
NCT02496728|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-06-08|||May 2015||2015-05-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|November 2018|Anticipated|2018-11-01||Interventional|NUYou||NUYou:mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health|American Heart Association Strategically Focused Research Network: mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health|Enrolling by invitation||N/A|700|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 23:08:05.413791|2017-10-10 23:08:05.413791
NCT02496715|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-13|||September 2015||2015-09-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics|Randomized, Parallel, Placebo-controlled, Multiple Dose, Multicenter Study to Compare the Efficacy of Fluticasone/Salmeterol (Test) to Advair® Diskus (GSK) in Adult Asthma Patients|Unknown status|Not yet recruiting|Phase 3|1053|Anticipated|Actavis Inc.||3|||f||||f||||||||||2017-10-10 23:08:05.561862|2017-10-10 23:08:05.561862
NCT02496689|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-10-19||||||October 2016|2016-10-01||||||||Expanded Access|||Expanded Access Program for Asfotase Alfa Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP)|An Open-label, Multicenter, Expanded Access Program for Asfotase Alfa (Human Recombinant Tissue-nonspecific Alkaline Phosphatase Fusion Protein) Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP)|Approved for marketing||N/A|||Alexion Pharma GmbH|||||||||||||||||||2017-10-10 23:08:05.770971|2017-10-10 23:08:05.770971
NCT02496676|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-07-13|||June 30, 2015||2015-06-30|July 12, 2017|2017-07-12|December 1, 2020|Anticipated|2020-12-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Magnesium Supplementation in People With XMEN Syndrome|A Double-blind, Placebo-controlled, Crossover Study of Magnesium Supplementation in Patients With XMEN Syndrome|Recruiting||Phase 1/Phase 2|30|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 23:08:05.873705|2017-10-10 23:08:05.873705
NCT02496663|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-09-12|||March 24, 2016|Actual|2016-03-24|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Osimertinib and Necitumumab in Treating Patients With EGFR-Positive Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor|A Phase I Trial of AZD9291 and Necitumumab in EGFR-Mutant Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor|Recruiting||Phase 1|30|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:08:06.00438|2017-10-10 23:08:06.00438
NCT02496637|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-06-30|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||A Brief Appetite Awareness Intervention for Eating and Weight Regulation Among College Freshmen|A Brief Appetite Awareness Intervention for Eating and Weight Regulation Among College Freshmen: A Randomized Clinical Trial|Active, not recruiting||N/A|130|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-10 23:08:06.211883|2017-10-10 23:08:06.211883
NCT02496624|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-10-31|||June 2015||2015-06-01|October 2016|2016-10-01||||May 2019|Anticipated|2019-05-01||Interventional|||Cone-beam CT Guided Microcoil Localization of Pulmonary Nodules During Video Assisted Thoracic Surgery(VATS)|Cone-beam Computed Tomography (CT) Guided Microcoil Localization of Pulmonary Nodules During Video Assisted Thoracic Surgery(VATS)|Recruiting||N/A|40|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:08:06.305637|2017-10-10 23:08:06.305637
NCT02496611|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-09-26|||December 2015||2015-12-01|September 2016|2016-09-01||||July 2020|Anticipated|2020-07-01||Interventional|||Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity|Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity|Recruiting||Phase 2|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 23:08:06.388538|2017-10-10 23:08:06.388538
NCT02496598|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-05-16|||July 2015||2015-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|IVA||In Vitro Follicle Activation|In Vitro Activation of Primordial Follicles as a Method to Treat Infertility Caused by Primary Ovarian Insufficiency|Active, not recruiting||N/A|2|Actual|National Foundation for Fertility Research||1|||f||||f||||||||||2017-10-10 23:08:06.486406|2017-10-10 23:08:06.486406
NCT02496585|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-09-29|||July 2015||2015-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis|Phase II Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis|Recruiting||Phase 2|68|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:08:06.577091|2017-10-10 23:08:06.577091
NCT02496572|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-07-09|||September 2013||2013-09-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Observational|||Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan|Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistan|Unknown status|Active, not recruiting|Phase 3|110|Anticipated|Medecins Sans Frontieres, Netherlands|||1||f||||t||||||||||2017-10-10 23:08:06.693519|2017-10-10 23:08:06.693519
NCT02496559|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-12-02|||January 2013||2013-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Children With Fever and Respiratory Symptoms at Out-of-hours Services in Norway|Children With Fever and Respiratory Symptoms at Out-of-hours Services in Norway|Terminated||N/A|401|Actual|Uni Research||2||Lower prevalence than expected and the inclusion was difficult.|f||||f||||||||||2017-10-10 23:08:06.7922|2017-10-10 23:08:06.7922
NCT02496546|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-05-01|||July 2015||2015-07-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)|An Explorative Trial Evaluating the Effect of LEO 32731 Cream 20 mg/g in Adults With Mild to Moderate Atopic Dermatitis (AD)|Completed||Phase 1|30|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 23:08:06.867322|2017-10-10 23:08:06.867322
NCT02496520|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-07-16|||September 2014||2014-09-01|June 2015|2015-06-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|DEND/TIA||Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults|Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults|Recruiting||Phase 1/Phase 2|10|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||t||||||||||2017-10-10 23:08:07.519924|2017-10-10 23:08:07.519924
NCT02496507|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-13|||August 2013||2013-08-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Mixed-methods Evaluation of Sit-stand Workstations in an Office Setting|A Mixed-methods Evaluation of Sit-stand Workstations in an Office Setting: a Randomised Controlled Trial|Completed||N/A|47|Actual|Liverpool John Moores University||2|||f||||f||||||||||2017-10-10 23:08:07.640122|2017-10-10 23:08:07.640122
NCT02496494|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-07-13|||September 2012||2012-09-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients||Unknown status|Recruiting|Phase 4|50|Anticipated|Kyungpook National University||1|||f||||t||||||||||2017-10-10 23:08:07.762895|2017-10-10 23:08:07.762895
NCT02496481|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Brief MI Intervention in the ED to Increase Child Passenger Restraint Use|A Brief Motivational Interviewing Intervention in the Emergency Department to Increase Size-Appropriate Child Passenger Restraint Use|Completed||N/A|345|Actual|University of Michigan||4|||f||||f||||||||Undecided||2017-10-10 23:08:08.061812|2017-10-10 23:08:08.061812
NCT02496468|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2016-12-05|||January 2013||2013-01-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|ALLIANCE||Pediatric Arm of DZL All Age Asthma Cohort|The All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL), Pediatric Arm|Recruiting||N/A|500|Anticipated|Klinikum der Universitaet Muenchen|||3||f||||f||||||Samples With DNA|"     whole blood (EDTA), serum, stool samples, whole blood cell pellets, primary nasal epithelial     cells, induced sputum cells   "|||2017-10-10 23:08:08.188991|2017-10-10 23:08:08.188991
NCT02496455|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-01|||August 2015||2015-08-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|May 2017|Actual|2017-05-01||Observational|||The Impact of the SCN9A Gene Polymorphism on Postoperative Pain|The Impact of the Single Nucleotide Polymorphisms rs6746030,rs7604448, rs10930214, s7595255 in SCN9A Gene on Postoperative Pain and Analgesic Consumption After Cesarean Section|Active, not recruiting||N/A|200|Actual|Tokat Gaziosmanpasa University|||1||f||||t||||||Samples With DNA|"     Two ml blood will be collected from the peripheral venous before the operation and all blood     samples will be stored at -80℃. Genomic DNA will be extracted from the blood samples and     polymorphism in SCN9A gene will be identified by PCR   "|||2017-10-10 23:08:08.351903|2017-10-10 23:08:08.351903
NCT02496442|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-13|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan|Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan|Unknown status|Not yet recruiting|N/A|30|Anticipated|Flowmed||2|||f||||f||||||||||2017-10-10 23:08:08.443607|2017-10-10 23:08:08.443607
NCT02496429|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-09-23|||July 2015||2015-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|ESP||"Evaluation of the Reliability and Usability of the Reusable BrownieForSymphony Pump Set"|"ESP Evaluation of the Reliability and Usability of the Reusable BrownieForSymphony Pump Set"|Completed||N/A|25|Actual|Medela AG||1|||f||||f||||||||||2017-10-10 23:08:08.538978|2017-10-10 23:08:08.538978
NCT02496416|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Aquatic Exercise Intervention in Multiple Sclerosis|Aquatic Exercise Intervention in Multiple Sclerosis: A Randomized Clinical Trial|Active, not recruiting||N/A|15|Actual|Kessler Foundation||2|||f||||f||||||||||2017-10-10 23:08:08.621751|2017-10-10 23:08:08.621751
NCT02496403|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-11-09|||December 2015||2015-12-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence|Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence|Recruiting||N/A|300|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-10 23:08:08.705961|2017-10-10 23:08:08.705961
NCT02496390|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|FMT||Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD|Transplantation of Microbes of Fecal Origin for Prevention and Treatment of Metabolic Syndrome and Non Alcoholic Fatty Liver Disease|Recruiting||Phase 1/Phase 2|21|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||No||2017-10-10 23:08:08.834707|2017-10-10 23:08:08.834707
NCT02496377|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2015-07-09|||August 2014||2014-08-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Interventional|Cross Iron||Cross Iron (Comparative Randomized Oral Versus Systemic IRON)|Comparison of Preoperative Haemoglobin Level After Administration of Epoetin Alfa Associated With an Oral Versus Intravenous Iron Supplementation|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:08:08.936665|2017-10-10 23:08:08.936665
NCT02496364|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2016-05-09|||March 2015||2015-03-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Evaluation of Topical and Intravenous Tranexamic Acid in Surgical Treatment of Lumbar Degenerative Disease|Topical and Intravenous Use of Tranexamic Acid in Posterior Lumbar Interbody Fusion - A Prospective, Double-blind, Randomized Study|Enrolling by invitation||Phase 3|144|Anticipated|Instituto Nacional de Traumatologia e Ortopedia||4|||f||||t||||||||Undecided||2017-10-10 23:08:09.154347|2017-10-10 23:08:09.154347
NCT02496351|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-14|||May 2015||2015-05-01|June 2015|2015-06-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||TENS for Phantom Limb Pain Prevention Following Major Amputation|Transcutaneous Electrical Nerve Stimulation (TENS) for Phantom Limb Pain Prevention Following Arteriopathic Major Amputation: Clinical Trial|Unknown status|Recruiting|N/A|40|Anticipated|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||f||||||||||2017-10-10 23:08:09.378359|2017-10-10 23:08:09.378359
NCT02496338|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-13|||May 2014||2014-05-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Menopausal Health Training for Husbands on Women's Quality of Life and Marital Satisfaction|Effect of Menopausal Health Training for Husbands on Women's Quality of Life and Marital Satisfaction During Transitional Period|Completed||N/A|100|Actual|Gonabad University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:08:09.531946|2017-10-10 23:08:09.531946
NCT02496325|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-07-13|||September 2014||2014-09-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Ultrasound-guided Pudendal Nerve Block in Children: A Descriptive Study of Feasibility|Ultrasound-guided Pudendal Nerve Block in Children: A Descriptive Study of Feasibility|Completed||N/A|196|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:08:09.640872|2017-10-10 23:08:09.640872
NCT02496312|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-03-03|||July 2015||2015-07-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ECOCAPTURE||Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.|Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated in Healthy Subjects and Patients With Frontotemporal Dementia. Pilot Phase.|Completed||N/A|14|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-10 23:08:09.772845|2017-10-10 23:08:09.772845
NCT02496299|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2015-07-13|||September 2015||2015-09-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Effect of Dexamethasone Added To Bupivacaine During Caudal Block|Comparison Of The Effect Of Dexamethasone Added To Bupivacaine With Plain Bupivacaine For Caudal Block In Patients For Herniotomy.|Unknown status|Not yet recruiting|Phase 2|96|Anticipated|Lagos State University||2|||f||||f||||||||||2017-10-10 23:08:09.945104|2017-10-10 23:08:09.945104
NCT02496286|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-07-10|||June 2015||2015-06-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites|Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites|Terminated||Phase 1|10|Anticipated|Eastern Regional Medical Center||1||Lack of Enrollment|f||||f||||||||||2017-10-10 23:08:10.093098|2017-10-10 23:08:10.093098
NCT02496273|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-02-19|||January 2016||2016-01-01|February 2016|2016-02-01|December 2030|Anticipated|2030-12-01|December 2026|Anticipated|2026-12-01||Interventional|||Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer|Phase 1 Study of CEA Specific Cytotoxic T Lymphocytes Induced by Dendritic Cells Infected by Recombinant Adeno-associated Virus With CEA Gene in Stage IV Gastric Cancer|Active, not recruiting||Phase 1|60|Anticipated|The First People's Hospital of Changzhou||1|||f||||f||||||||||2017-10-10 23:08:10.199193|2017-10-10 23:08:10.199193
NCT02496260|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-08-22|||July 2015||2015-07-01|August 2016|2016-08-01||||March 2017|Anticipated|2017-03-01||Observational|||Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy|Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure|Recruiting||N/A|35|Anticipated|Henry Ford Health System|||1||f||||f||||||Samples With DNA|"     Collection of approximately 20 ml of blood will be performed by venipuncture at the specified     time points. When possible, blood collection will be coordinated with other routine blood     studies. These blood samples will be drawn at the clinical blood drawing station in the     Radiation Oncology department.      For fibrosis and left ventricular dysfunction, biomarkers include galectin-3 and NT-Pro brain     natriuretic peptide. For myocyte destruction, troponin; for inflammation and oxidative     stress, C-reactive protein, myeloperoxidase, and growth differentiation factor. Additional     blood will be collected and stored for future assessment of other candidate biomarkers.   "|||2017-10-10 23:08:10.302426|2017-10-10 23:08:10.302426
NCT02496247|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-02-10|||May 2015||2015-05-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Canned Herring for Prevention of Childhood Malnutrition During the Early Rainy Season in Rural Guinea-Bissau|Effectiveness of Canned Herring for Prevention of Childhood Malnutrition During the Early Rainy Season in Rural Guinea-Bissau|Completed||N/A|1200|Actual|Global Food & Nutrition Inc.||2|||f||||f||||||||||2017-10-10 23:08:10.411596|2017-10-10 23:08:10.411596
NCT02496234|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-11-22|||July 2015||2015-07-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery||Completed||N/A|186|Actual|HealthSpan Dx|||1||f||||f||||||Samples With DNA|"     White blood cells Plasma   "|||2017-10-10 23:08:10.511334|2017-10-10 23:08:10.511334
NCT02496221|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-06-09|2016-04-28||June 2015||2015-06-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects|A Randomized, Double-blind, Single-dose, Placebo Controlled, 2-way Cross-over Study Evaluating Effect of Albiglutide on Cholecystokinin-induced Gallbladder Emptying in Fasting Healthy Subjects|Completed||Phase 4|20|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:08:10.637507|2017-10-10 23:08:10.637507
NCT02496208|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-12|||July 9, 2015|Actual|2015-07-09|September 2017|2017-09-01||||December 29, 2017|Anticipated|2017-12-29||Interventional|||Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors|A Phase 1 Study of Cabozantinib Plus Nivolumab (CaboNivo) Alone or in Combination With Ipilimumab (CaboNivoIpi) in Patients With Advanced/Metastatic Urothelial Carcinoma and Other Genitourinary Tumors|Recruiting||Phase 1|135|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 23:08:11.421185|2017-10-10 23:08:11.421185
NCT02496182|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-13|||July 2015||2015-07-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|Picheon||Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment|Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Grupo Medifarma, S. A. de C. V.||3|||f||||t||||||||||2017-10-10 23:08:11.621481|2017-10-10 23:08:11.621481
NCT02496169|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-09|||July 2015||2015-07-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|ExPEND||Prospective multicEntric NonranDomized Registry|A Prospective, Multi-centric, Nonrandomised Interventional Study of a Sirolimus-eluting Stent With a Biodegradable Polymer for Percutaneous Coronary Revascularization|Not yet recruiting||N/A|400|Anticipated|Eucatech AG||1|||f||||t||||||||||2017-10-10 23:08:11.729148|2017-10-10 23:08:11.729148
NCT02496156|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-02-08|||February 2015||2015-02-01|February 2017|2017-02-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Interventional|||Shared Medical Decision Making in Pediatric Diabetes|Shared Medical Decision Making in Pediatric Diabetes|Completed||N/A|153|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-10-10 23:08:11.800883|2017-10-10 23:08:11.800883
NCT02496130|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-09-12|||April 2016||2016-04-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|||Perioperative Outcomes of Common Methods of Minimally Invasive Contained Tissue Extraction|A Partners Prospective Study Assessing the Perioperative Outcomes of Common Methods of Minimally Invasive Contained Tissue Extraction|Completed||N/A|70|Actual|Brigham and Women's Hospital|||2||f||||f||||||||||2017-10-10 23:08:11.96773|2017-10-10 23:08:11.96773
NCT02496117|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-20|||March 14, 2014|Actual|2014-03-14|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RNS||Renal Nerves Stimulation Study|Feasibility of Electrical Mapping and Stimulation of Renal Arteries in Patients Undergoing Renal Denervation|Recruiting||Phase 2|40|Anticipated|Diagram B.V.||2|||f||||f||||||||||2017-10-10 23:08:12.049117|2017-10-10 23:08:12.049117
NCT02496104|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-02|||July 9, 2015||2015-07-09|August 2017|2017-08-01|August 9, 2019|Anticipated|2019-08-09|August 9, 2018|Anticipated|2018-08-09||Observational|HABIPREMA||Habituation's Mechanisms in Preterm and Term Infants|Habituation's Mechanisms in Preterm and Term Infants. Behavioral Evaluation: APIB (Assessment of Preterm Infant's Behavior). Assessment of the Cortical and Vegetative Responses|Recruiting||N/A|60|Anticipated|University Hospital, Brest|||2||f||||t||||||||||2017-10-10 23:08:12.340268|2017-10-10 23:08:12.340268
NCT02496091|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-17|||August 31, 2015|Actual|2015-08-31|December 2016|2016-12-01||||September 30, 2017|Anticipated|2017-09-30||Observational|||Multicenter Retrospective Study Evaluating ATLANTIS™ Abutment Teeth Connected to Implants|A Retrospective Multicenter Study Evaluating ATLANTIS™ Abutments on Implants From Four Manufacturers|Recruiting||N/A|180|Anticipated|Dentsply Sirona Implants|||1||f||||||||||||||2017-10-10 23:08:12.430632|2017-10-10 23:08:12.430632
NCT02496078|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-04-17|||August 2015||2015-08-01|September 2016|2016-09-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Interventional|||A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection|A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection|Completed||Phase 3|207|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:08:12.550071|2017-10-10 23:08:12.550071
NCT02496065|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-07-11|||July 2015||2015-07-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery|A Phase 1 Exploratory Study of the Safety and ex Vivo Fluorescence of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Solid Tumors Undergoing Surgery|Completed||Phase 1|30|Actual|Blaze Bioscience Inc.||1|||f||||t||||||||||2017-10-10 23:08:12.700204|2017-10-10 23:08:12.700204
NCT02496052|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-15|||January 2013||2013-01-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions|The Efficacy and Safety of the Dried Biological Amnion Graft Following Hysteroscopic Lysis for the Prevention of Postoperative Adhesions in Patients With Intrauterine Adhesions|Unknown status|Recruiting|N/A|300|Anticipated|Beijing Obstetrics and Gynecology Hospital||2|||f||||f||||||||||2017-10-10 23:08:12.788081|2017-10-10 23:08:12.788081
NCT02496039|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-06-06|2017-04-18||September 2015||2015-09-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)|A Study to Assess Effectiveness, Safety, and Health-related Outcomes of NUEDEXTA® (Dextromethorphan Hydrobromide and Quinidine Sulfate) for the Treatment of Pseudobulbar Affect (PBA) in Nursing Home Patients|Terminated||Phase 4|5|Actual|Avanir Pharmaceuticals|The study was terminated prematurely because of difficulty with recruiting.|1||The study was terminated prematurely because of difficulty with recruiting.|f||||f||||||||||2017-10-10 23:08:12.914406|2017-10-10 23:08:12.914406
NCT02496026|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-07-01|||July 2014||2014-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Transcranial Direct Current Stimulation and Robotic Therapy in Upper Limb Motor Recovery After Stroke|Transcranial Direct Current Stimulation and Robotic Therapy in Upper Limb Motor Recovery After Stroke|Recruiting||N/A|20|Anticipated|Auxilium Vitae Volterra||2|||f||||f||||||||||2017-10-10 23:08:13.219323|2017-10-10 23:08:13.219323
NCT02496013|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-04-06|||January 2014||2014-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB|Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Diagnostic Performance of 68Ga-NEB in Healthy Volunteers and Patients With Hepatic Space-occupying Lesions and Suspicious Lymph Nodes Metastasis|Recruiting||Phase 1|70|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-10 23:08:13.312268|2017-10-10 23:08:13.312268
NCT02496000|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-02-19|2016-10-31||June 2015||2015-06-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus|Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Metformin|Completed||Phase 2|188|Actual|Oramed, Ltd.||3|||f||||f||||||||Undecided||2017-10-10 23:08:13.417421|2017-10-10 23:08:13.417421
NCT02495987|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-01-09|||March 2015||2015-03-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|WAT||White Adipose Tissue in Pregnancy Study|Adaptations in Subcutaneous and Visceral Adipose Tissue Metabolism During Normal and Pathological Pregnancies|Recruiting||N/A|40|Anticipated|Imperial College London|||1||f||||f||||||Samples Without DNA|"     Adipose tissue, serum   "|No|We will publish our results and findings in research publications.|2017-10-10 23:08:13.956223|2017-10-10 23:08:13.956223
NCT02495779|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-08-23|||July 2015||2015-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV|Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV|Active, not recruiting||N/A|54|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 23:08:21.164655|2017-10-10 23:08:21.164655
NCT02495974|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-10|||September 8, 2015|Actual|2015-09-08|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|PREMISE||European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)|A European Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Enzalutamide Treatment in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)|Active, not recruiting||N/A|1759|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 23:08:14.054935|2017-10-10 23:08:14.054935
NCT02495961|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-02-15|||June 2015||2015-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Study of Chronic Degenerative Diseases|Study of Chronic Degenerative Diseases, Translational Medicine Approach|Completed||N/A|57|Actual|Asociación Científica Latina A.C.|||2||f||||f||||||||||2017-10-10 23:08:16.558036|2017-10-10 23:08:16.558036
NCT02495948|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-11-07|2016-08-25||July 2015||2015-07-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||This analysis population includes all randomized participants (Intent-to-Treat (ITT) analysis set).|Comparison of Two Marketed Silicone Hydrogel Lenses|One Month Clinical Comparison of Lotrafilcon B and Samfilcon A|Completed||N/A|168|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:08:16.670922|2017-10-10 23:08:16.670922
NCT02495012|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-10|||August 2015||2015-08-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Interventional|||Anfibatide Treatment in STEMI Patients|A Multi-centered, Randomized, Double-blinded, Placebo-Parallel Controlled Phase IIb Clinical Study to Evaluate the Safety and Efficacy of Antiplatelet Thrombolysin Injection for the Treatment of Patients With ST Segment Elevation Myocardial Infarction (STEMI) Before Receiving PCI Therapy.|Unknown status|Not yet recruiting|Phase 2|240|Anticipated|Lee's Pharmaceutical Limited||2|||f||||t||||||||||2017-10-10 23:08:16.923092|2017-10-10 23:08:16.923092
NCT02494999|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-08-31|||June 2016||2016-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants|A Randomized, Double-blind, Parallel-Controlled Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants|Enrolling by invitation||Phase 3|900|Anticipated|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 23:08:17.048177|2017-10-10 23:08:17.048177
NCT02494986|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-05-23|||July 6, 2015|Actual|2015-07-06|May 2017|2017-05-01|November 4, 2031|Anticipated|2031-11-04|December 31, 2030|Anticipated|2030-12-31||Interventional|||A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in the Rilpivirine Pediatric Studies|An Open-label, Roll-over Study With Rilpivirine in Combination With a Background Regimen Containing 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N[t]RTIs) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Subjects Who Participated in the Rilpivirine Pediatric Studies|Recruiting||Phase 2|100|Anticipated|Janssen Sciences Ireland UC||1|||f||||f||f||||||||2017-10-10 23:08:17.149747|2017-10-10 23:08:17.149747
NCT02494973|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-07-11|||May 2015||2015-05-01|July 2016|2016-07-01|May 2026|Anticipated|2026-05-01|May 2026|Anticipated|2026-05-01||Interventional|PACHA-01||Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases|Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases - A Randomized Phase II/III Trial|Recruiting||Phase 2/Phase 3|220|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t||||||||||2017-10-10 23:08:17.292587|2017-10-10 23:08:17.292587
NCT02494960|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-03-26|||August 2014|Actual|2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Brief Tobacco Cessation Intervention|Brief Tobacco Cessation Intervention: a Randomized Controlled Trial in Guangdong, China|Active, not recruiting||N/A|16000|Anticipated|The University of Hong Kong||3|||f||||t||||||||||2017-10-10 23:08:17.40032|2017-10-10 23:08:17.40032
NCT02494947|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-01|||February 2016||2016-02-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|CENIT||Coronary Disease and the Effect of High-intensity Interval Training|Physical Activity and Lipid Content of Coronary Artery Atheromatous Plaques: a Randomised Trial Using Novel Intracoronary Imaging Techniques|Recruiting||N/A|60|Anticipated|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 23:08:17.513136|2017-10-10 23:08:17.513136
NCT02494934|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-08-30|||September 2009||2009-09-01|August 2015|2015-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effectiveness of Cognitive Behavioural Therapy and Physical Therapy for Provoked Vestibulodynia|A Randomized Comparison of Individual Cognitive-behavioural Therapy and Pelvic Floor Rehabilitation in the Treatment of Provoked Vestibulodynia|Completed||N/A|20|Actual|Queen's University||2|||f||||f||||||||||2017-10-10 23:08:18.208452|2017-10-10 23:08:18.208452
NCT02494921|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-06-06|||September 2015||2015-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC|A Phase 1b/2 Study of the Oral CDK4/6 Inhibitor LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in Metastatic Castration Resistant Prostate Cancer|Recruiting||Phase 1/Phase 2|47|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:08:18.29288|2017-10-10 23:08:18.29288
NCT02494908|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-09|||July 2015||2015-07-01|July 2015|2015-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Evidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease Patients|Can Diffusion Tensor MRI Brain Scan Demonstrate Microstructural Changes as Evidence of Neuroplasticity Following a Learning Process in Patients With Idiopathic Parkinson's Disease ?|Not yet recruiting||N/A|80|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:08:18.545745|2017-10-10 23:08:18.545745
NCT02494895|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-12-29|||August 2015||2015-08-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)||Recruiting||Phase 4|3056|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-10 23:08:18.680122|2017-10-10 23:08:18.680122
NCT02495766|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-12-14|||May 2015||2015-05-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|EMMES||Autologous Mesenchymal Stromal Cells for Multiple Sclerosis|Treatment of Autologous Mesenchymal Stem Cells Derived From Bone Marrow as a Potential Therapeutic Strategy for the Treatment of Multiple Sclerosis|Active, not recruiting||Phase 1/Phase 2|8|Anticipated|Banc de Sang i Teixits||2|||f||||f||||||||||2017-10-10 23:08:21.274922|2017-10-10 23:08:21.274922
NCT02494882|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-15|||June 29, 2015|Actual|2015-06-29|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older|Phase I Trial Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older.|Recruiting||Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:08:18.781095|2017-10-10 23:08:18.781095
NCT02494869|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-16|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Dose-Response of Aerobic Training in Post-Menopausal Women at High-Risk for Development of Breast Cancer|Dose-Response of Aerobic Training in Post-Menopausal Women at High-Risk for Development of Breast Cancer|Recruiting||N/A|100|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-10 23:08:18.910184|2017-10-10 23:08:18.910184
NCT02494856|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-11-03|||October 2014||2014-10-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar Removal|Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in the Control of Pain, Swelling and Trismus in Lower Third Molar Removal|Completed||Phase 4|50|Actual|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 23:08:19.043113|2017-10-10 23:08:19.043113
NCT02495935|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-08-20|||July 2015||2015-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:08:19.14688|2017-10-10 23:08:19.14688
NCT02495922|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-07-04|||June 2015||2015-06-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|June 2020|Anticipated|2020-06-01||Interventional|GMMG-HD6||A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma|A Randomized Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma|Recruiting||Phase 3|564|Anticipated|University of Heidelberg Medical Center||4|||f||||t||||||||||2017-10-10 23:08:19.217978|2017-10-10 23:08:19.217978
NCT02495909|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-07-10|||March 2016||2016-03-01|July 2015|2015-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment|Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment|Not yet recruiting||N/A|700|Anticipated|University of Edinburgh|||1||f||||f||||||||||2017-10-10 23:08:19.68002|2017-10-10 23:08:19.68002
NCT02495896|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-07-15|||September 2015||2015-09-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors|A Pilot Multi-arm Study of sEphB4-HSA in Combination With Different Chemotherapy Regimens in Patients With Specific Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|80|Anticipated|University of Southern California||3|||f||||t|t|f||||||||2017-10-10 23:08:19.762476|2017-10-10 23:08:19.762476
NCT02495883|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-10-26|||July 2011||2011-07-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response|Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response|Active, not recruiting||N/A|64|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:08:19.92257|2017-10-10 23:08:19.92257
NCT02495870|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-05-03|||November 2014||2014-11-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SAPO||The Acute Effects of Low Temperature for Long Time Heat Treatment of Pork Semitendinosus on Satiety||Completed||N/A|40|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-10 23:08:20.033193|2017-10-10 23:08:20.033193
NCT02495857|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-06-26|||August 15, 2015|Actual|2015-08-15|June 2017|2017-06-01|December 5, 2016|Actual|2016-12-05|December 5, 2016|Actual|2016-12-05||Interventional|||A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee|A Double-Blind, Randomized, Study of the Effectiveness and Safety of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee|Completed||N/A|600|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-10 23:08:20.10296|2017-10-10 23:08:20.10296
NCT02495844|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-08-16|||July 2015||2015-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|February 2017|Actual|2017-02-01||Interventional|||A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy|Double-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety/Tolerability, and Pharmacokinetic Profile of UCB0942 in Adults With Highly Drug-resistant Focal Epilepsy.|Completed||Phase 2|55|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-10 23:08:20.209212|2017-10-10 23:08:20.209212
NCT02495831|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2016-04-14|2016-01-22||May 2015||2015-05-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||males and females healthy volunteers, age 22-55 inclusive. This is a cross-over study, so 23 subjects were enrolled in total and participated in both groups|Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers|Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers|Completed||Phase 1|24|Actual|Zambon SpA|no limitations|2|||f||||f||||||||No|Bioequivalence data are to be considered as a whole in all subjects (90%CI).|2017-10-10 23:08:20.365414|2017-10-10 23:08:20.365414
NCT02495818|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-10-03|||June 2013||2013-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Suprascapular Nerve Block Guided by Ultrasound|Suprascapular Nerve Block Guided by Ultrasound in the Rehabilitation of the Supraspinatus Tendonitis - A Randomized Double Blind Controlled Trial|Recruiting||Phase 2|108|Anticipated|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 23:08:20.86609|2017-10-10 23:08:20.86609
NCT02495805|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-12-08|||September 2015||2015-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Ultrasound-guided Continuous Proximal Adductor Canal vs Continuous Femoral Nerve Block for Postoperative Pain Control and Rehabilitation Following Total Knee Arthroplasty|Ultrasound-guided Continuous Proximal Adductor Canal Versus Continuous Femoral Nerve Block for Postoperative Pain Control and Rehabilitation Following Total Knee Arthroplasty|Withdrawn||N/A|0|Actual|Yale University||2||Study never officially began- currently closed with IRB.|f||||t||||||||||2017-10-10 23:08:20.984357|2017-10-10 23:08:20.984357
NCT02495753|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2016-08-17|||August 2015||2015-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Vaginal Cleansing Before Cesarean Delivery to Reduce Infection|Vaginal Cleansing Before Cesarean Delivery to Reduce Infection: A Randomized Trial|Recruiting||N/A|608|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 23:08:21.387728|2017-10-10 23:08:21.387728
NCT02495740|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2015-07-10|||May 2012||2012-05-01|July 2015|2015-07-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|E-bike||E-Bike Versus Classic Bike Intervention Trial|E-Bike Study - Endurance Capacity Following 1 Month Training of Classic Bike Versus Electric-assisted Bike|Completed||N/A|33|Actual|University of Basel||2|||f||||f||||||||||2017-10-10 23:08:21.494345|2017-10-10 23:08:21.494345
NCT02495727|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-12-06|||July 2015||2015-07-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Two Weeks of Reduced Activity and Skeletal Muscle Health in Older Men|Effect of 14-days of Reduced Physical Activity on Muscle Function and Size, Inflammatory Profile, and Exercise-induced Activation of Stress Responses in Skeletal Muscle in Healthy Older Males|Recruiting||N/A|30|Anticipated|University of Bath||3|||f||||f||||||||Undecided||2017-10-10 23:08:21.587705|2017-10-10 23:08:21.587705
NCT02495714|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2017-09-06|||January 2015||2015-01-01|September 2017|2017-09-01|December 2023|Anticipated|2023-12-01|September 2017|Actual|2017-09-01||Interventional|HOPPLearning||HOPPLearning - Active Learning in Elementary Schools|HOPPLearning - Active Learning in Elementary Schools in Horten Municipality|Recruiting||N/A|2800|Anticipated|Kristiania University College||2|||f||||t||||||||||2017-10-10 23:08:21.733745|2017-10-10 23:08:21.733745
NCT02495701|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-06-14|||June 2015||2015-06-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Observational|||Complications Related to Arthroscopic Surgery of the Hip - a Prospective Cohort Study|Complications Related to Arthroscopic Surgery of the Hip - a Prospective Cohort Study|Recruiting||N/A|200|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-10 23:08:21.853522|2017-10-10 23:08:21.853522
NCT02495688|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-10|||March 2015||2015-03-01|July 2015|2015-07-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Regional or General Anesthesia for Distal Radius Fracture Surgery in a Day Surgery Setting|Regional or General Anesthesia for Distal Radius Fracture Surgery in a Day Surgery Setting - A Randomized Clinical Trial|Unknown status|Recruiting|N/A|90|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:08:21.961065|2017-10-10 23:08:21.961065
NCT02495675|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-07-10|||June 2015||2015-06-01|July 2015|2015-07-01||||October 2015|Anticipated|2015-10-01||Interventional|HDWOBSS||Effects of Treatment With High Flow Nasal Cannulas on Respiratory Pattern and Work of Breathing Among Healthy Subjects|Effects of Treatment With High Flow Nasal Cannulas on Respiratory Pattern and Work of Breathing Among Healthy Subjects|Unknown status|Recruiting|N/A|10|Anticipated|Laval University||5|||f||||f||||||||||2017-10-10 23:08:22.060993|2017-10-10 23:08:22.060993
NCT02495662|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-03-06|||November 2015||2015-11-01|June 2016|2016-06-01||||September 2018|Anticipated|2018-09-01||Interventional|LIPMAT||The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation|The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation|Recruiting||Phase 2|80|Anticipated|Leiden University Medical Center||2|||f||||t||||||||||2017-10-10 23:08:22.181048|2017-10-10 23:08:22.181048
NCT02495649|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-07-08|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Evaluation of Myocardial Sympathetic Denervation in Parkinson's Disease Using [18F]FDOPA|Evaluation of Myocardial Sympathetic Denervation in Parkinson's Disease Using [18F]FDOPA|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-10 23:08:22.312147|2017-10-10 23:08:22.312147
NCT02495636|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-06-21|||July 2015|Anticipated|2015-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer|Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Yale University||2||Study closed due to lack of enrollment|f||||t||||||||||2017-10-10 23:08:22.387826|2017-10-10 23:08:22.387826
NCT02495623|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-06-26|2017-01-18||June 2015||2015-06-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||A Study of the Effect of SYN-010 on Subjects With IBS-C|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Dose Study of the Effect of Two Dosage Strengths of SYN-010 Compared With Placebo on Breath Methane Production in Breath Methane-Positive Subjects With IBS-C|Completed||Phase 2|63|Actual|Synthetic Biologics Inc.||3|||f||||f||||||||||2017-10-10 23:08:22.473471|2017-10-10 23:08:22.473471
NCT02495610|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-07-21|||June 2015||2015-06-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|iNPH||Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With iNPH|A Prospective Single-centre Trial Investigating Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With Idiopathic Normal Pressure Hydrocephalus|Unknown status|Recruiting|N/A|70|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:08:22.755188|2017-10-10 23:08:22.755188
NCT02495597|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-22|||April 2013||2013-04-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Observational|FRABO-02||LCI and Bronchial Inflammation in Patients With BO|Lung Clearance Index (LCI) and Bronchial Inflammation in Patients With Bronchiolitis Obliterans (BO)|Completed||N/A|37|Actual|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples With DNA|"     blood, sputum cells, sputum supernatans   "|||2017-10-10 23:08:22.848474|2017-10-10 23:08:22.848474
NCT02495584|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-01-14|||September 2014||2014-09-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|D-Light||D-Light Intervention|D-Light Intervention: A Randomised Controlled Human Intervention Study to Assess the Impact of Vitamin D From Milk and Supplements on Functional Health Outcomes and Future Vitamin D Synthesis From UV Exposure|Completed||N/A|52|Actual|University of Ulster||4|||f||||f||||||||||2017-10-10 23:08:22.936489|2017-10-10 23:08:22.936489
NCT02495571|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-10-13|||October 2015||2015-10-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|October 2015|Actual|2015-10-01||Interventional|||Assessment of Voluntary and Reflex Cough in Patients With ALS|Pilot Observational Study, Assessing PCEF of the Voluntary and Reflex Cough in Patients With ALS|Unknown status|Recruiting|N/A|60|Anticipated|IRCCS San Camillo, Venezia, Italy||2|||f||||t||||||||||2017-10-10 23:08:23.048186|2017-10-10 23:08:23.048186
NCT02495558|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-10-13|||October 2015||2015-10-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|October 2015|Actual|2015-10-01||Interventional|||Cough Assessment in Patients With Severe Acquired Brain Injury|Pilot Study of the Cough Reflex Assessment in Patients With Tracheostomy Cannula Following Severe Acquired Brain Injury|Unknown status|Recruiting|N/A|30|Anticipated|IRCCS San Camillo, Venezia, Italy||1|||f||||t||||||||||2017-10-10 23:08:23.130128|2017-10-10 23:08:23.130128
NCT02495545|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-12-12|||October 2015||2015-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Cerebrospinal Fluid Drainage (CSFD) in Acute Spinal Cord Injury|A Multi-Center, Randomized, Controlled, Trial of Cerebrospinal Fluid Drainage (CSFD) in Acute Spinal Cord Injury|Recruiting||Phase 2|60|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||t||||||||||2017-10-10 23:08:23.210134|2017-10-10 23:08:23.210134
NCT02495532|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-07-08|||March 2015||2015-03-01|July 2015|2015-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer|Randomized Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer|Recruiting||N/A|126|Anticipated|Hospital Moinhos de Vento||2|||f||||f||||||||||2017-10-10 23:08:23.322683|2017-10-10 23:08:23.322683
NCT02495519|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-07-12|||April 2014||2014-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)|A Phase II Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)|Active, not recruiting||Phase 2|21|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 23:08:23.563884|2017-10-10 23:08:23.563884
NCT02495506|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-12-05|||March 2015||2015-03-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|4CPLT||Transfusion of Cold-stored Platelet Concentrates|Transfusion Therapy in Patients Undergoing Cardiac Surgery in Combination With Late Withdrawal of Drug Induced Platelet Inhibition or Prolonged Extra-corporal Circulation Time|Recruiting||N/A|60|Anticipated|Haukeland University Hospital||2|||f||||f||||||||No||2017-10-10 23:08:23.677386|2017-10-10 23:08:23.677386
NCT02495493|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-07-12|||July 2013||2013-07-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|May 2018|Anticipated|2018-05-01||Interventional|||S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma|S-1 Plus Cisplatin-based Chemoradiotherapy After Induction Chemotherapy for Locally Advanced Gastric Adenocarcinoma : Phase II Trial|Active, not recruiting||Phase 2|42|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-10 23:08:23.78564|2017-10-10 23:08:23.78564
NCT02495480|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-10|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Disposable Sheathed Gastroscopic System for Cecal Intubation|A Novel Disposable Sheathed Gastroscopic System for Cecal Intubation：Safety and Efficacy in Unsedated Colonoscopies|Unknown status|Not yet recruiting|N/A|120|Anticipated|General Hospital of Beijing PLA Military Region||2|||f||||||||||||||2017-10-10 23:08:23.87064|2017-10-10 23:08:23.87064
NCT02495467|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-01-25|||July 2015||2015-07-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)|A Randomised, Double-blind, Placebo-controlled, Home Use, Cross-over Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)|Recruiting||Phase 2|192|Anticipated|Futura Medical Developments Ltd.||2|||f||||f||||||||||2017-10-10 23:08:23.945947|2017-10-10 23:08:23.945947
NCT02495454|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-08-24|||May 2015||2015-05-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|FIL_GAEL||GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma|GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma A Phase II Study of the Fondazione Italiana Linfomi (FIL)|Recruiting||Phase 2|78|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-10 23:08:24.063694|2017-10-10 23:08:24.063694
NCT02495441|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-08-06|||August 2015||2015-08-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|December 2015|Anticipated|2015-12-01||Observational|||Rapid Immunoassay Tests for the Detection of Ruptured Membranes|A Comparison of Rapid Immunoassay Tests for the Detection of Ruptured Membranes|Unknown status|Recruiting|N/A|100|Anticipated|De Soysa Hospital for Women|||1||f||||f||||||||||2017-10-10 23:08:24.325514|2017-10-10 23:08:24.325514
NCT02495428|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-09-07|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Kinesio Taping in Muscle Fatigue|Effect of Kinesio Taping in Muscle Fatigue|Completed||N/A|40|Actual|CEU San Pablo University||2|||f||||f||||||||||2017-10-10 23:08:24.408157|2017-10-10 23:08:24.408157
NCT02495415|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-04-29|||January 2016||2016-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas|Phase II Trial of Intravenous Fenretinide (N-(4-hydroxyphenyl) Retinamide, 4-HPR) Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas (PTCL)|Recruiting||Phase 2|140|Anticipated|CerRx, Inc.||1|||f||||t||||||||Undecided||2017-10-10 23:08:24.485608|2017-10-10 23:08:24.485608
NCT02495402|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-04-14|||August 2015||2015-08-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment|Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention (MIBI) Experiment|Active, not recruiting||N/A|2592|Anticipated|RTI International||2|||f||||t|f|f||||||Yes|IPD Plan will be forthcoming|2017-10-10 23:08:24.633974|2017-10-10 23:08:24.633974
NCT02495389|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-08-22|||January 2015||2015-01-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Mirabegron and Urinary Urgency Incontinence|Mirabegron and Urinary Urgency Incontinence: The Clinical Response and the Female Urinary Microbiome|Recruiting||Phase 4|120|Anticipated|Loyola University||1|||f||||f||||||||||2017-10-10 23:08:24.823542|2017-10-10 23:08:24.823542
NCT02495376|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2016-09-20|||June 2014||2014-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|REDEFINEAYAO||Reducing Emotional Distress, Enhancing Function and Improving Network Engagement in Adolescent and Young Adult Oncology|REDEFINE AYAO: Reducing Emotional Distress, Enhancing Function and Improving Network Engagement in Adolescent and Young Adult Oncology|Active, not recruiting||N/A|150|Anticipated|Northwestern University||2|||f||||f||||||||Undecided||2017-10-10 23:08:24.938927|2017-10-10 23:08:24.938927
NCT02495350|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-11-21|||April 2015||2015-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|||The Correlation Between Prelabor Analgesic Plan and Actual Labor Analgesia With Satisfaction, Postpartum Depression, and Breast Feeding Success|The Correlation Between Prelabor Analgesic Plan and Actual Labor Analgesia With Satisfaction, Postpartum Depression, and Breast Feeding Success|Completed||N/A|1954|Actual|Rabin Medical Center|||4||f||||f||||||||||2017-10-10 23:08:25.246752|2017-10-10 23:08:25.246752
NCT02495337|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-10-31|||May 2015||2015-05-01|October 2016|2016-10-01||||May 2018|Anticipated|2018-05-01||Observational|||Tissue Collection Protocol|Tissue Collection for Gastro-esophageal Cancer Primary Cell Line Establishment|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     Biopsy Samples   "|||2017-10-10 23:08:25.335606|2017-10-10 23:08:25.335606
NCT02495324|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-07-03|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|FAST||Fimasartan Achieving SBP Target (FAST) Study|A Randomized, Double-blind, Active Control, 3-parallel Group, Forced Titration, Multicenter, Phase IV Study to Evaluate the Efficacy and Safety of Fimasartan Versus Valsartan Monotherapy in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 4|369|Actual|Boryung Pharmaceutical Co., Ltd||3|||f||||f||||||||||2017-10-10 23:08:25.431738|2017-10-10 23:08:25.431738
NCT02495311|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-04|2017-08-10|||November 2014||2014-11-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms|The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms and Gastrointestinal Symptoms|Recruiting||N/A|150|Anticipated|Far Eastern Memorial Hospital|||3||f||||t||||||||||2017-10-10 23:08:25.544037|2017-10-10 23:08:25.544037
NCT02495298|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-10-03|||August 2013||2013-08-01|October 2016|2016-10-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||Fascial Manipulation on the Treatment of Carpal Tunnel Syndrome|Evaluation of Fascial Manipulation for the Conservative Treatment of Carpal Tunnel Syndrome: Double Blind Randomized Clinical Trial, Phase II|Completed||Phase 2|14|Actual|University of Sao Paulo||2|||f||||t||||||||No||2017-10-10 23:08:25.655244|2017-10-10 23:08:25.655244
NCT02495285|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-10-10|||May 2015||2015-05-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|GPS||Gelatines in Pediatric PatientS|Infusion of Gelatine Solutions in Pediatric Patients Aged up to 12 Years|Recruiting||N/A|1000|Anticipated|B. Braun Melsungen AG|||2||f||||f||||||||||2017-10-10 23:08:25.748796|2017-10-10 23:08:25.748796
NCT02495272|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-07-08|||June 2014||2014-06-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Postpartum Uterotonic Administration|The Effect of the Timing of Uterotonic Administration in the Third Stage of Labour on Postpartum Hemorrhage|Unknown status|Recruiting|N/A|330|Anticipated|Bagcilar Training and Research Hospital||2|||f||||f||||||||||2017-10-10 23:08:25.889884|2017-10-10 23:08:25.889884
NCT02495259|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-09|2017-03-14|||July 2015||2015-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Double Lumen Tube Placement Techniques|Comparison of Placement of Double-lumen Endobronchial Tube Using GlideScope With 2 Different Stylet Configurations vs Standard Macintosh Laryngoscopy|Recruiting||Phase 4|130|Anticipated|Emory University||3|||f||||f||||||||||2017-10-10 23:08:26.012428|2017-10-10 23:08:26.012428
NCT02495246|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-06-19|||September 21, 2015|Actual|2015-09-21|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV|A Phase I, Safety and Immunogenicity Trial of the Heterologous Prime-boost Regimen Combining the Monovalent Zaire Ebola Viral Vector Candidates ChAd3-EBO-Z and Ad26.ZEBOV in Healthy UK Adults|Active, not recruiting||Phase 1|32|Actual|University of Oxford||4|||f||||||||||||||2017-10-10 23:08:26.118456|2017-10-10 23:08:26.118456
NCT02495233|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-14||2017-09-14|September 8, 2015|Actual|2015-09-08|August 2017|2017-08-01|September 28, 2016|Actual|2016-09-28|September 28, 2016|Actual|2016-09-28||Interventional|||A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI)|A Phase 1b/2 Study of ASP2215 in Combination With Erlotinib in Subjects With EGFR Activating Mutation-Positive (EGFRm+) Advanced NSCLC Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI)|Terminated||Phase 1/Phase 2|10|Actual|Astellas Pharma Inc||2||Study terminated due to adverse events related to the combination therapy|f||||f||||||||||2017-10-10 23:08:26.21999|2017-10-10 23:08:26.21999
NCT02495220|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-01-26|||July 2015||2015-07-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy of Dexmedetomidine for Postoperative Analgesia in Infantile Cataract Surgery|Subtenon Versus Intravenous Dexmedetomidine for Postoperative Analgesia and Vomiting Control in Infantile Cataract Surgery|Recruiting||Phase 2/Phase 3|80|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 23:08:26.321653|2017-10-10 23:08:26.321653
NCT02495207|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-07-26|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|April 14, 2017|Actual|2017-04-14|March 14, 2016|Actual|2016-03-14||Interventional|||A Comparison Between Conventional Surgery and Piezosurgery|A Histo-immunological Comparative Study of Bone Cutting by Conventional Surgery and Piezosurgery on the Secretion of Heat Shock Protein 70 (HSP70) and on the Bone Cells|Completed||N/A|15|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 23:08:26.412976|2017-10-10 23:08:26.412976
NCT02495194|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-05-06|||April 2015||2015-04-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2015|Actual|2015-10-01||Interventional|HTRCT||Effects of Horticultural Therapy on Asian Elderly' Mental Health|Effects of Horticultural Therapy on Asian Elderly' Mental Health: A Randomized Controlled Trial|Active, not recruiting||N/A|69|Actual|National University, Singapore||2|||f||||f||||||||||2017-10-10 23:08:26.500549|2017-10-10 23:08:26.500549
NCT02495181|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-06-07|||January 2016||2016-01-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ATLANTIC||Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy|A Randomized, Double-masked, Sham-controlled Phase 4 Study of the Efficacy, Safety, and Tolerability of IV Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With PCV.|Recruiting||Phase 4|50|Anticipated|Association for Innovation and Biomedical Research on Light and Image||2|||f||||f||||||||||2017-10-10 23:08:26.60314|2017-10-10 23:08:26.60314
NCT02495168|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-09-25|||December 2016|Actual|2016-12-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients|A Randomized, Parallel Group, Placebo-controlled, Multi-dose, Study Comparing the Generic Budesonide/Formoterol 4.5 mcg to Symbicort® 80/4.5 in Adult Asthmatic Patients|Recruiting||Phase 3|1200|Anticipated|Actavis Inc.||3|||f||||f|t|f||||||||2017-10-10 23:08:26.818361|2017-10-10 23:08:26.818361
NCT02495155|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-07-25|||June 2015||2015-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PROSPECT||Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer|Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer|Completed||N/A|45|Actual|University of Michigan||3|||f||||t||||||||||2017-10-10 23:08:26.944412|2017-10-10 23:08:26.944412
NCT02495142|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-09-21|||July 2010||2010-07-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Observational|LABS3||Psychosocial Issues and Bariatric Surgery|Psychosocial Issues and Bariatric Surgery|Active, not recruiting||N/A|202|Actual|Neuropsychiatric Research Institute, Fargo, North Dakota|||1||f||||t||||||||||2017-10-10 23:08:27.041376|2017-10-10 23:08:27.041376
NCT02495129|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-04-19|||December 2015||2015-12-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome|A Three-part, Partially Open Label and Double-blind, Randomized Study to Assess the Pharmacodynamic Effects, Safety, Tolerability and Preliminary Efficacy of VAY736 in Patients With Primary Sjögren's Syndrome Using [Zr-89]-Rituximab PET/CT|Withdrawn||Phase 1/Phase 2|0|Actual|Novartis||2|||f||||||||||||||2017-10-10 23:08:27.123733|2017-10-10 23:08:27.123733
NCT02495116|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-02-16|||May 15, 2015||2015-05-15||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:08:27.216463|2017-10-10 23:08:27.216463
NCT02495103|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-06-30|||June 30, 2015||2015-06-30|May 17, 2017|2017-05-17|May 1, 2022|Anticipated|2022-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|||Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma|Phase I/II Trial of Vandetanib in Combination With Metformin in Subjects With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma|Recruiting||Phase 1/Phase 2|73|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 23:08:27.26802|2017-10-10 23:08:27.26802
NCT02495090|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-07-10|||November 2014||2014-11-01|June 2015|2015-06-01|November 2016|Anticipated|2016-11-01|June 2016|Anticipated|2016-06-01||Interventional|||Hypospadias and Exome: Identification of New Genes for Familial Hypospadias|Hypospadias and Exome: Identification of New Genes for Familial Hypospadias|Unknown status|Enrolling by invitation|N/A|50|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-10 23:08:27.382802|2017-10-10 23:08:27.382802
NCT02495077|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-21|||September 2015||2015-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Effects of Inhibiting Early Inflammation in Kidney Transplant Patients|Randomized Controlled Trial of Infliximab (Remicade®) Induction Therapy for Deceased Donor Kidney Transplant Recipients (CTOT-19)|Recruiting||Phase 2|300|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:08:27.483086|2017-10-10 23:08:27.483086
NCT02495064|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2016-03-08|||January 2015||2015-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients|Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients Receiving Radiation Therapy|Recruiting||Phase 4|160|Anticipated|Mianyang Central Hospital||2|||f||||t||||||||||2017-10-10 23:08:27.684439|2017-10-10 23:08:27.684439
NCT02495051|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-07-10|||February 2010||2010-02-01|July 2015|2015-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|Oesophagix||Esophageal Atresia: Metaplasia, Barrett|Prevalence of Barrett's Esophagus in Adolescents and Young Adults With Esophageal Atresia|Completed||N/A|120|Actual|University Hospital, Lille|||1||f||||f||||||||||2017-10-10 23:08:27.787461|2017-10-10 23:08:27.787461
NCT02494843|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-07|||November 2014||2014-11-01|July 2015|2015-07-01||||March 2015|Actual|2015-03-01||Interventional|CAMRID||Dynamic Effects of Online HDF on Cardiac Function and Myocardial Perfusion Utilising Cardiac MRI (CAMRID)|Dynamic Effects of Online HDF on Cardiac Function and Myocardial Perfusion Utilising Cardiac MRI (CAMRID)|Completed||N/A|12|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-10 23:08:28.179705|2017-10-10 23:08:28.179705
NCT02494830|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-09|||August 2014||2014-08-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Single Dose Administration of Ketamine 10, 20, 40 and 80 mg and 5 mg Solution for Infusion in 15 Healthy Subjects|Comparative Bioavailability Study of Ketamine and Norketamine After Single Dose Administration of Ketamine 10, 20, 40 and 80 mg Prolonged Release Tablets in Fasting State and 5 mg Ketamine Solution for Infusion in 15 Healthy Subjects in Serum, Urine and Feces|Completed||Phase 1|15|Actual|University Medicine Greifswald||5|||f||||t||||||||||2017-10-10 23:08:28.26547|2017-10-10 23:08:28.26547
NCT02494817|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-05-10|||October 2015||2015-10-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|MCAP||HIV Prevention Toolkit for HIV-negative Male Couples|Development of a HIV Prevention Toolkit for At-risk HIV-negative Male Couples|Completed||N/A|512|Actual|University of Miami||2|||f||||f||||||||||2017-10-10 23:08:28.368103|2017-10-10 23:08:28.368103
NCT02494804|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-07-08|||July 2015||2015-07-01|July 2015|2015-07-01|July 2030|Anticipated|2030-07-01|July 2028|Anticipated|2028-07-01||Interventional|||Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas|A Study of CIK in Combination With Temozolomide With and Without Radiation in Adults With Stage I-II Malignant Gliomas|Not yet recruiting||Phase 1/Phase 2|80|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:08:28.442263|2017-10-10 23:08:28.442263
NCT02494791|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-04-15|||July 2015||2015-07-01|April 2016|2016-04-01|July 2025|Anticipated|2025-07-01|July 2019|Anticipated|2019-07-01||Interventional|LS2||Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer|Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer|Recruiting||N/A|915|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:08:28.554651|2017-10-10 23:08:28.554651
NCT02494778|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-08-22|||September 30, 2015|Actual|2015-09-30|August 2017|2017-08-01|October 20, 2022|Anticipated|2022-10-20|October 20, 2022|Anticipated|2022-10-20||Interventional|Open PRIDE-HD||A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease|A Multi-Center, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Pridopidine in Patients With Huntington's Disease|Enrolling by invitation||Phase 2|650|Anticipated|Teva Pharmaceutical Industries||1|||f||||t|t|f||||||||2017-10-10 23:08:28.661027|2017-10-10 23:08:28.661027
NCT02494765|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-09|||July 2015||2015-07-01|July 2015|2015-07-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Spatial Relationship of I-gelTM and Ambu® AuraOnceTM on Paediatric Airway: A Comparison on Three Dimensional MRI|Spatial Relationship of I-gelTM and Ambu® AuraOnceTM on Paediatric Airway: A Comparison on Three Dimensional MRI|Unknown status|Recruiting|N/A|60|Anticipated|King Saud University||2|||f||||t||||||||||2017-10-10 23:08:28.865708|2017-10-10 23:08:28.865708
NCT02494752|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-04|2015-07-09|||August 2015||2015-08-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Role of Mesenchymal Stem Cells in Fat Grafting|Potential of Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for Contour Deformities of Face|Unknown status|Not yet recruiting|N/A|30|Anticipated|King Edward Medical University||2|||f||||t||||||||||2017-10-10 23:08:28.96631|2017-10-10 23:08:28.96631
NCT02494739|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-01-31|||May 2015||2015-05-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Antioxidant and Anti-inflammatory Effects of Yogurt Enriched With Polyphenols|Investigation of the Antioxidant and Anti-inflammatory Effects of Yogurt Enriched With Polyphenols|Completed||N/A|18|Actual|University of Thessaly||2|||f||||f||||||||No||2017-10-10 23:08:29.070592|2017-10-10 23:08:29.070592
NCT02494726|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-04|2015-07-09|||November 2009||2009-11-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|TEG||Prospective Analysis of the Use of TEG in Stroke Patients|Prospective Analysis of the Use of Thromboelastography in Stroke Patients|Completed||N/A|178|Actual|The University of Texas Health Science Center, Houston|||3||f||||t||||||||||2017-10-10 23:08:29.171225|2017-10-10 23:08:29.171225
NCT02494713|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-03-01|||October 2015||2015-10-01|March 2017|2017-03-01|February 2029|Anticipated|2029-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer|Neoadjuvant Androgen Deprivation Therapy and Chemotherapy Followed by Radical Prostatectomy in Patients With Prostate Cancer|Recruiting||Phase 2|24|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||No||2017-10-10 23:08:29.275907|2017-10-10 23:08:29.275907
NCT02494700|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-01-20|||July 6, 2015|Actual|2015-07-06|January 2017|2017-01-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Ultra Low Dose 4 Gy Orbital Radiation for Definitive Therapy of Indolent B Cell Lymphoma|Ultra Low Dose 4 Gy Orbital Radiation for Definitive Therapy of Indolent B Cell Lymphoma|Recruiting||Phase 2|24|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:08:29.399389|2017-10-10 23:08:29.399389
NCT02494687|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-07-05||||||July 2017|2017-07-01||||||||Expanded Access|||Domperidone Expanded Access Program for Oncology Patients With Gastroparesis Who Have Failed Standard Therapy|Domperidone Expanded Access Program for Oncology Patients With Gastroparesis Who Have Failed Standard Therapy|Available||N/A|||Eastern Regional Medical Center|||||||||||||||||||2017-10-10 23:08:29.497551|2017-10-10 23:08:29.497551
NCT02494674|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-02-26|||July 2015||2015-07-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|Bites||Using Bite Counter for Weight Loss: A One-month Usability Trial to Test the Effectiveness of Using the Bite Counter|Using Bite Counter for Weight Loss: A One-month Usability Trial to Test the Effectiveness of Using a Wearable Bite Counter to Assist With Dietary Self-monitoring|Completed||Early Phase 1|12|Actual|University of South Carolina||1|||f||||f||||||||||2017-10-10 23:08:29.574829|2017-10-10 23:08:29.574829
NCT02494661|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-03-09|||October 2014||2014-10-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Nutritional Video Intervention Using Mindfulness-based Principles|"Healthy Plate Program in East and South Los Angeles: Testing Mindfulness-inspired Video in Community Settings"|Completed||N/A|218|Actual|University of Southern California||2|||f||||f||||||||||2017-10-10 23:08:29.6812|2017-10-10 23:08:29.6812
NCT02494648|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-09-13|||May 22, 2015|Actual|2015-05-22|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|RICAOS||Effects of Inspiratory Muscles Strengthening Among Coronary Patients on the Sleep Apnea Obstructive Syndrome|Effects of Inspiratory Muscles Strengthening Among Coronary Patients on the Sleep Apnea Obstructive Syndrome (SAOS)|Recruiting||N/A|48|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 23:08:29.79345|2017-10-10 23:08:29.79345
NCT02494635|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-06-23|||September 16, 2015|Actual|2015-09-16|June 2017|2017-06-01|September 16, 2019|Anticipated|2019-09-16|September 16, 2018|Anticipated|2018-09-16||Observational|||Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer|Ultrasound and Biomarker Tests of Bladder Cancer Invasiveness|Recruiting||N/A|40|Anticipated|University of Southern California|||1||f||||t||||||Samples With DNA|"     Tissue, bladder washings, and urine   "|||2017-10-10 23:08:29.931725|2017-10-10 23:08:29.931725
NCT02494622|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-07|||January 2008||2008-01-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Alternative Treatment of Giant Spinal Schwannomas|Alternatives to The Surgical Approach for Giant Spinal Schwannomas: A Clinic Trial|Completed||N/A|18|Actual|Umraniye Education and Research Hospital|||1||f||||f||||||||||2017-10-10 23:08:30.089464|2017-10-10 23:08:30.089464
NCT02494609|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-02-29|||July 2015||2015-07-01|February 2016|2016-02-01||||November 2015|Actual|2015-11-01||Interventional|||Oral Contraceptive DDI Study|A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women|Active, not recruiting||Phase 1|30|Anticipated|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-10-10 23:08:30.161837|2017-10-10 23:08:30.161837
NCT02494596|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2015-10-12|2015-07-30||January 2004||2004-01-01|October 2015|2015-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional||The Intent-To-Treat (ITT) Population included all participants who received any amount of the study medication. The baseline analysis population represents participants from all three cohorts.|A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors|A Phase Ib, Open-Label, Multicenter Study of the Safety and Pharmacokinetics of the Combination of RhuMab 2C4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors|Completed||Phase 1|19|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 23:08:30.279702|2017-10-10 23:08:30.279702
NCT02494583|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-08-30|||July 31, 2015|Actual|2015-07-31|August 2017|2017-08-01|June 6, 2020|Anticipated|2020-06-06|February 5, 2019|Anticipated|2019-02-05||Interventional|||Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)|A Randomized, Active-Controlled, Partially Blinded, Biomarker Select, Phase III Clinical Trial of Pembrolizumab as Monotherapy and in Combination With Cisplatin+5-Fluorouracil Versus Placebo+Cisplatin+5-Fluorouracil as First-Line Treatment in Subjects With Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma|Active, not recruiting||Phase 3|750|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-10 23:08:31.065368|2017-10-10 23:08:31.065368
NCT02494557|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-05-22|||September 2014||2014-09-01|May 2017|2017-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|CAD-risk||Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients|Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients|Completed||N/A|108|Actual|Acarix|||1||f||||f||||||Samples With DNA|"     Blood samples for biobank to be used in potential new studies.   "|Undecided||2017-10-10 23:08:31.469432|2017-10-10 23:08:31.469432
NCT02494544|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-07-13|||July 1, 2015|Actual|2015-07-01|July 2017|2017-07-01|August 2025|Anticipated|2025-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Multicenter Study to Evaluate Functional Outcome After Knee Replacement|A Prospective, Multicenter Study to Evaluate Functional Outcome After Knee Replacement|Recruiting||N/A|800|Anticipated|ConforMIS, Inc.||6|||f||||t|f|t|f|f||||||2017-10-10 23:08:31.603812|2017-10-10 23:08:31.603812
NCT02494531|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-12-02|||May 2015||2015-05-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|AVILL||Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging|Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging|Recruiting||N/A|80|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||||||||||||2017-10-10 23:08:31.827113|2017-10-10 23:08:31.827113
NCT02494518|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-10-02|||July 2015||2015-07-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Forced Aerobic Exercise for Stroke Rehabilitation|Forced Aerobic Exercise for Stroke Rehabilitation|Completed||N/A|30|Anticipated|The Cleveland Clinic||3|||f||||t||||||||||2017-10-10 23:08:31.99407|2017-10-10 23:08:31.99407
NCT02494505|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-10-07|||November 2013||2013-11-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|MYCOPID||Interest of Mycophenolate for CIDP Weaning|Does the Mycophenolate Improve the Ability of Weaning Patients Off the Treatment in Chronic Inflammatory Demyelinating Polyradiculopathy (CIDP)|Active, not recruiting||Phase 3|40|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:08:32.148587|2017-10-10 23:08:32.148587
NCT02494492|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-08-14|||March 2013||2013-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|UVEREG||Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose|Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose|Suspended||Phase 1/Phase 2|18|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:08:32.318904|2017-10-10 23:08:32.318904
NCT02494479|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-07-18|||August 2015||2015-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis|A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis|Completed||Phase 2|115|Actual|Cellceutix Corporation||4|||f||||f||||||||||2017-10-10 23:08:32.438338|2017-10-10 23:08:32.438338
NCT02494466|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-07-07|||May 2014||2014-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Preoperative Use of Montelukast Sodium|The Effects on Airway Reactivity of the Use of Preoperative Montelukast Sodium|Completed||Phase 4|30|Actual|Umraniye Education and Research Hospital||3|||f||||f||||||||||2017-10-10 23:08:32.594343|2017-10-10 23:08:32.594343
NCT02494453|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-10-13|||June 2015||2015-06-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy|Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy|Recruiting||N/A|25|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:08:32.732782|2017-10-10 23:08:32.732782
NCT02494440|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-07-11|2016-03-09||May 2015||2015-05-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational||Ninety pregnant women were recruited from the the Fetal Care Unit who fulfilled the inclusion criteria|Automated Fetal Femur Length Measurement by Five-Dimensional Ultrasound|Automated Fetal Femur Length Measurement by Five-Dimensional Ultrasound|Completed||N/A|90|Actual|Ain Shams University|||1||f||||t||||||||Yes|Automated Fetal Femur Length Measurement by Five-Dimensional Ultrasound|2017-10-10 23:08:32.861931|2017-10-10 23:08:32.861931
NCT02494427|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-05-20|||January 2014||2014-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|EVACFAOD||Comparison of Conventional and CAD/CAM Dental Restorations|Medico-economic Comparative Assessment of Conventional and CAD/CAM Dental Restorations; Impact on Hospital Dentistry Departments|Recruiting||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 23:08:33.11899|2017-10-10 23:08:33.11899
NCT02494414|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-06-23|||July 2015||2015-07-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|DESAC||Outcome of Cardiac Arrest Survivors|Outcome of Cardiac Arrest Survivors: Prospective Cohort of Ile-de-France|Recruiting||N/A|600|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:08:33.258743|2017-10-10 23:08:33.258743
NCT02494401|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-08-07|||March 6, 2016|Actual|2016-03-06|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|July 28, 2017|Actual|2017-07-28||Interventional|TOSS||Taking Charge of Systemic Sclerosis|Taking Charge of Systemic Sclerosis: Improving Patient Outcomes Through Self-management|Active, not recruiting||N/A|267|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:08:33.404701|2017-10-10 23:08:33.404701
NCT02494388|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-07-09|||June 2015||2015-06-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Observational|CINE-Cyst||Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions|Clinical Impact of Needle-based Confocal Laser Endomicroscopy of Cystic Pancreatic Lesions|Unknown status|Recruiting|Early Phase 1|200|Anticipated|University of Medicine and Pharmacy Craiova|||5||f||||t||||||Samples With DNA|"     Pancreatic cyst fluid   "|||2017-10-10 23:08:33.54423|2017-10-10 23:08:33.54423
NCT02494375|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-08-18|||June 28, 2015|Actual|2015-06-28|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SLEEPT1D||Sleep and Type 1 Diabetes|Sleep and Glycemic Control in Type 1 Diabetic Children|Active, not recruiting||N/A|70|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:08:33.7496|2017-10-10 23:08:33.7496
NCT02494362|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-05-11|||August 2015||2015-08-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Tele-rehabilitation in the Home With Gaming as a Method of Improving Upper Extremity Function After Stroke|Tele-rehabilitation in the Home With Gaming as a Method of Improving Upper Extremity Function After Stroke|Recruiting||N/A|15|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-10-10 23:08:33.834351|2017-10-10 23:08:33.834351
NCT02494349|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-06-23|||August 2015||2015-08-01|July 2015|2015-07-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.|Clinical Trial to Investigate and Compare the Pharmacokinetic Characteristics and Safety/Tolerability After Single Administration of JLP-1207 and Soifenacin/Tamsulosin in Healthy Male Volunteers.|Completed||Phase 1|54|Actual|Jeil Pharmaceutical Co., Ltd.||2|||f||||f||||||||No||2017-10-10 23:08:33.96392|2017-10-10 23:08:33.96392
NCT02494336|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-08-16|||June 2015||2015-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Trans-incisional vs Laparoscopic Guided Rectus Sheath Block for Pediatric Single Incision Laparoscopic Cholecystectomy|Trans-incisional Rectus Sheath Block Versus Laparoscopic Guided Rectus Sheath Block for Pediatric Single Incision Laparoscopic Cholecystectomy: A Prospective, Randomized Study|Recruiting||N/A|50|Anticipated|Johns Hopkins All Children's Hospital||2|||f||||t||||||||||2017-10-10 23:08:34.067239|2017-10-10 23:08:34.067239
NCT02494323|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-06-23|2016-01-13||March 2015||2015-03-01|February 2015|2015-02-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Interventional||Twenty subjects were evaluated to determine the most advantageous dual channel configuration. When this was determined, 50 additional subjects were evaluated to allow sufficient data do determine feasibility.|Evaluation of Dual Channel vs. Single Channel FES for Dropfoot|The Evaluation of Dual Channel vs Single Channel FES for Dropfoot|Completed||N/A|70|Actual|Bioness Neuromodulation|A spot test, no time adjusting to stimulation, no home use, indoor environment only, muscle fatigue is an influential factor that was not checked.|1|||f||||f||||||||No||2017-10-10 23:08:34.197835|2017-10-10 23:08:34.197835
NCT02494310|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-02-01|||September 1, 2015|Actual|2015-09-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|August 31, 2016|Actual|2016-08-31||Interventional|HRME-UH2||HRME: Screening for Cervical Cancer and Its Precursors in Low‐Resource Settings|Point‐of‐Care, Real‐Time Optical Imaging to Enable Screening for Cervical Cancer and Its Precursors in Low‐Resource Settings|Completed||N/A|200|Actual|Barretos Cancer Hospital||2|||f||||f||||||||||2017-10-10 23:08:34.436961|2017-10-10 23:08:34.436961
NCT02494297|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-11-02|||March 2015||2015-03-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Observational|||Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries|Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries|Recruiting||N/A|5000|Anticipated|Center for Epidemiology and Health Research, Germany|||1||f||||f||||||||||2017-10-10 23:08:34.525038|2017-10-10 23:08:34.525038
NCT02494284|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2017-02-20|||December 22, 2015|Actual|2015-12-22|February 2017|2017-02-01|February 13, 2017|Actual|2017-02-13|February 13, 2017|Actual|2017-02-13||Interventional|STAMP-DES||Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation|Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation : STAMP-DES Trial|Terminated||Phase 4|364|Actual|Asan Medical Center||2||Slow enrollment|f||||t||||||||||2017-10-10 23:08:34.611051|2017-10-10 23:08:34.611051
NCT02494271|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-07-09|||January 2015||2015-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||TIVA, Inhalation Anesthesia, and Surgical Site Infection||Completed||N/A|2046|Actual|Seoul National University Bundang Hospital|||2||f||||||||||||||2017-10-10 23:08:34.735778|2017-10-10 23:08:34.735778
NCT02494258|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2016-10-12|||October 2015||2015-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|||A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders.|A Phase 2, Open-Label, Single-Arm Rollover Study to Evaluate Long-Term Safety in Subjects Who Participated in Other Celgene Sponsored CC-486 (Oral Azacitidine) Clinical Trials in Solid Tumors and Hematological Disorders|Recruiting||Phase 2|125|Anticipated|Celgene Corporation||1|||f||||f||||||||||2017-10-10 23:08:34.806305|2017-10-10 23:08:34.806305
NCT02474823|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-01-16|||July 2015||2015-07-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Neck Grasp as a Predictor of Sleep Apnea|Neck Grasp as a Predictor of Sleep Apnea|Completed||N/A|45|Actual|Bassett Healthcare||1|||f||||f||||||||||2017-10-10 23:12:35.057695|2017-10-10 23:12:35.057695
NCT02494245|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-05-30|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Increasing Physical Activity in Stroke Survivors Using STARFISH, an Interactive Mobile Phone App|Increasing Physical Activity in Stroke Survivors Using STARFISH, an Interactive Mobile Phone Application: a Randomised Controlled Study|Recruiting||N/A|128|Anticipated|University of Glasgow||2|||f||||f||||||||||2017-10-10 23:08:34.897235|2017-10-10 23:08:34.897235
NCT02494232|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2015-07-08|||July 2013||2013-07-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Emergency Management of Minor Blunt Thoracic Trauma|To Review the Management and Follow-up of Patients With Minor Thoracic Injuries Treated by Emergency Physicians.|Completed||N/A|186|Actual|Antalya Training and Research Hospital|||1||f||||f||||||||||2017-10-10 23:08:35.089463|2017-10-10 23:08:35.089463
NCT02494219|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-07-07|||January 2008||2008-01-01|June 2015|2015-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Pharyngitis,Group A Streptococcal Infection,Rapid Streptococcal Test,Throat Swab Culture|Comparison of Immunochromatographic Test for Rapid Detection of Group A Streptococcal Antigen With Culture in Pediatric Patients|Completed||N/A|906|Actual|Hamad Medical Corporation||1|||f||||t||||||||||2017-10-10 23:08:35.168226|2017-10-10 23:08:35.168226
NCT02494206|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-05-24|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)|Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)|Active, not recruiting||N/A|9|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:08:35.246497|2017-10-10 23:08:35.246497
NCT02494193|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-05-02|||June 2015||2015-06-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Indirect Pulp Capping With Resin Modified Glass Ionomer|Indirect Pulp Capping With Resin Modified Glass Ionomer: a Randomized Controled Clinical Trial|Completed||N/A|112|Actual|Universidade Federal de Sergipe||2|||f||||f||||||||||2017-10-10 23:08:35.357467|2017-10-10 23:08:35.357467
NCT02494180|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-07-20|||July 2015||2015-07-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Non-inferiority Trial on Pain Relief During Oocyte Retrieval|A Prospective, Non-inferiority Randomized Double-blinded Trial Comparing Fentanyl and Midazolam vs Diazepam and Pethidine for Pain Relief During Oocyte Retrieval|Unknown status|Not yet recruiting|Phase 4|170|Anticipated|Kwong Wah Hospital||2|||f||||f||||||||||2017-10-10 23:08:35.497705|2017-10-10 23:08:35.497705
NCT02494167|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-08|2017-04-12|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|February 2024|Anticipated|2024-02-01|April 2019|Anticipated|2019-04-01||Interventional|||Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)|Administration of Donor Derived Multi-Tumor-Associated Antigen (TAA)- Specific T Cells to Patients With AML or MDS (ADSPAM)|Recruiting||Phase 1|28|Anticipated|Baylor College of Medicine||2|||f||||t|t|f||||||||2017-10-10 23:08:35.598565|2017-10-10 23:08:35.598565
NCT02494154|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-07-09|||May 2015||2015-05-01|July 2015|2015-07-01||||October 2015|Anticipated|2015-10-01||Interventional|HDWOBPT||Effects of Treatment With High Flow Nasal Cannulas on Respiratory Pattern and Work of Breathing Among Patients.|Effects of Treatment With High Flow Nasal Cannulas on Respiratory Pattern and Work of Breathing Among Patients.|Unknown status|Recruiting|N/A|16|Anticipated|Laval University||4|||f||||f||||||||||2017-10-10 23:08:35.695143|2017-10-10 23:08:35.695143
NCT02494141|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-07-26|||November 2015||2015-11-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD|Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD|Recruiting||Phase 4|68|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:08:35.795207|2017-10-10 23:08:35.795207
NCT02494128|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-03-09|||September 2014||2014-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Early Group Based Parental Support Within Child Health Service - Group Leadership|Early Group Based Parental Support Within Child Health Service - Group Leadership|Completed||N/A|56|Actual|Lund University||2|||f||||f||||||||Yes|Two articles will be published presenting the results.|2017-10-10 23:08:35.887798|2017-10-10 23:08:35.887798
NCT02494115|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-09-26|||January 2016||2016-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Comfort Subcutaneous Drainage: a Descriptive Study Among Palliative Phase Cancer Patients|Comfort Subcutaneous Drainage: a Descriptive Study Among Palliative Care Cancer Patients Presenting Severe Refractory Lower Limbs Lymphedema|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||t||||||||||2017-10-10 23:08:35.977429|2017-10-10 23:08:35.977429
NCT02494102|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-09-22|||February 2016||2016-02-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|ModOSA||Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea|A Randomized, Double Blind, Placebo Controlled Evaluation of Modafinil vs Placebo for the Treatment of General Anesthesia Related Delayed Emergence in Patients With the Diagnosis of Obstructive Sleep Apnea|Recruiting||Phase 4|124|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-10 23:08:36.068741|2017-10-10 23:08:36.068741
NCT02494089|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-07-19|||June 2015||2015-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Observational|SIMSTRESS||Analysis of the Stress Induced by in Situ Simulation|Analysis of the Stress Induced by in Situ Simulation|Completed||N/A|53|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-10 23:08:36.167692|2017-10-10 23:08:36.167692
NCT02494063|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-07-18|||June 2016||2016-06-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|SENTIX||Sentinel Lymph Node Biopsy in Patients With Early Stages Cervical Cancer|A Prospective Observational Trial on Sentinel Lymph Node Biopsy in Patients With Early Stage Cervical Cancer|Recruiting||N/A|350|Anticipated|Charles University, Czech Republic|||1||f||||f||||||||||2017-10-10 23:08:36.317995|2017-10-10 23:08:36.317995
NCT02494050|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-09-28|||June 2015||2015-06-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Telemedicine for Women With Anhedonia in Bipolar and Unipolar Disorder|Telemedicine for Women With Anhedonia in Bipolar and Unipolar Disorder: Patient Preferences and Outcomes|Completed||N/A|17|Actual|Northwestern University||3|||f||||t||||||||Undecided||2017-10-10 23:08:38.288602|2017-10-10 23:08:38.288602
NCT02494037|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-07-24|||January 2015||2015-01-01|July 2016|2016-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|CUSIOS||The Canadian/US Integrative Oncology Study|The Canadian/US Integrative Oncology Study (CUSIOS): Advanced Integrative Oncology Treatment for Patients With Advanced Stage Cancer: A Prospective Outcomes Study|Recruiting||N/A|400|Anticipated|The Canadian College of Naturopathic Medicine|||1||f||||f||||||||||2017-10-10 23:08:38.383734|2017-10-10 23:08:38.383734
NCT02494024|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-07-25|||July 2015||2015-07-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy|A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy|Completed||Phase 1|32|Anticipated|C2N Diagnostics||5|||f||||t||||||||||2017-10-10 23:08:38.539336|2017-10-10 23:08:38.539336
NCT02494011|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-04|2015-08-01|||January 2014||2014-01-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Closed Kinetic Chain Exercise Versus Russian Current Stimulation in Rehabilitation of Colles' Fracture.|Closed Kinetic Chain Exercise Versus Russian Current Stimulation in Rehabilitation of Colles' Fracture.|Completed||N/A|45|Actual|October 6 University||3|||f||||t||||||||||2017-10-10 23:08:38.662088|2017-10-10 23:08:38.662088
NCT02493998|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-10-25|||November 2015||2015-11-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Observational|||A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)|A Prospective, Observational Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)|Recruiting||N/A|30|Anticipated|BioMarin Pharmaceutical|||1||f||||f||||||||||2017-10-10 23:08:38.765972|2017-10-10 23:08:38.765972
NCT02493985|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2016-01-12|||June 2015||2015-06-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|SPACE-COT||Studying Physiological and Anatomical Cerebral Effects of Carbon Dioxide and Tilt|Studying Physiological and Anatomical Cerebral Effects of Carbon Dioxide and Tilt|Completed||Phase 1|6|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 23:08:38.879018|2017-10-10 23:08:38.879018
NCT02493972|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-06-01|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|CARPEMAN||Interest of the Manual Exploration as a Supplement to the Coelioscopy in the Evaluation of the Resectability of Peritoneal Carcinosis||Recruiting||N/A|74|Anticipated|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-10 23:08:38.975716|2017-10-10 23:08:38.975716
NCT02493959|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-09|||May 2014||2014-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Degradation of the Anorexic Hormone Peptide YY|Degradation of the Anorexic Hormone Peptide YY|Completed||Early Phase 1|8|Actual|Hvidovre University Hospital||1|||f||||t||||||||||2017-10-10 23:08:39.223784|2017-10-10 23:08:39.223784
NCT02493946|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-01-30|||April 2015||2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines|Phase III, Randomised, Double Blind, Placebo Controlled and Open Label Phase Multicentre Study to Investigate the Efficacy and Safety of BTX-A-HAC NG in the Treatment of Moderate to Severe Glabellar Lines, and Assess the Long Term Efficacy and Safety of BTX-A-HAC NG Following Repeated Treatments in This Indication|Completed||Phase 3|600|Actual|Ipsen||2|||f||||f||||||||||2017-10-10 23:08:39.323777|2017-10-10 23:08:39.323777
NCT02493933|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-07-10|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Phytoestrogen, NO Donors, N-acetyl Cysteine Add Therapy to Clomiphene Citrate to Improve Pregnancy Rate in PCO Patients|Phytoestrogen, NO Donors, N-acetyl Cysteine Add Therapy to Clomiphene|Unknown status|Not yet recruiting|Phase 1|240|Anticipated|Kasr El Aini Hospital||3|||f||||||||||||||2017-10-10 23:08:39.522376|2017-10-10 23:08:39.522376
NCT02493920|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-07-09|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Sustained Lung Inflation and Pulmonary Mechanics in Preterm Infant|Evaluation of Pulmonary Mechanics in Preterm Infant Treated With Sustained Lung Inflation at Birth|Unknown status|Not yet recruiting|N/A|48|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||||2017-10-10 23:08:39.601079|2017-10-10 23:08:39.601079
NCT02493907|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-04-27|||December 2014||2014-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Corrected Left Ventricular Electrical Delay Predicting Response to Cardiac Resynchronization Therapy|A Prospective Clinical Trial of Corrected Left Ventricular Electrical Delay Predicting Response to Cardiac Resynchronization Therapy in Chinese With Heart Failure|Recruiting||N/A|60|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|||1||f||||t||||||||||2017-10-10 23:08:39.712805|2017-10-10 23:08:39.712805
NCT02493894|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-07-07|||July 2014||2014-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of Bowel Preparation on Perioperative Bleeding|By Reza Abbasi and Isfahan University of Medical Sciences|Completed||Phase 1/Phase 2|105|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:08:39.801292|2017-10-10 23:08:39.801292
NCT02493868|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-09-22|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|SUSTAIN-1||A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression|A Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression|Recruiting||Phase 3|333|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 23:08:40.107258|2017-10-10 23:08:40.107258
NCT02493855|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-04-06|2017-04-06||June 2015|Actual|2015-06-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|||Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults|An Exploratory Study to Evaluate the Kinetics of Viral Load Decline With Ombitasvir/ABT 450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naïve Adults With Genotype 1a Chronic Hepatitis C Virus (HCV) Infection|Completed||Phase 2|46|Actual|AbbVie||3|||f||||f||||||||||2017-10-10 23:08:41.034442|2017-10-10 23:08:41.034442
NCT02493842|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-08-08|||June 2015||2015-06-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|EPIONE||Direct Nerve Stimulation for Treatment of Phantom Limb Pain|Natural Sensory Feedback for Phantom Limb Modulation and Therapy|Recruiting||N/A|4|Anticipated|Aalborg Universitetshospital||1|||f||||t||||||||||2017-10-10 23:08:41.790477|2017-10-10 23:08:41.790477
NCT02493829|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-04-12|||May 2017|Anticipated|2017-05-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX)|A Phase I Study of B7.1 (CD80)/IL-2 Immune Gene Therapy for High Risk MDS RAEB-2 and Acute Myeloid Leukaemia Patients Unsuitable for Allogeneic Haematological Stem Cell Transplant|Not yet recruiting||Phase 1|10|Anticipated|King's College London||1|||f||||t||||||||||2017-10-10 23:08:41.891568|2017-10-10 23:08:41.891568
NCT02493816|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-05-03|||September 2015||2015-09-01|May 2016|2016-05-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Interventional|||Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa|Phase I Study of Lentiviral-mediated COL7A1 Gene-modified Autologous Fibroblasts in Adults With Recessive Dystrophic Epidermolysis Bullosa.|Recruiting||Phase 1|10|Anticipated|King's College London||1|||f||||t||||||||No||2017-10-10 23:08:41.963539|2017-10-10 23:08:41.963539
NCT02493803|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-09-15|||December 2014||2014-12-01|February 2016|2016-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|DAI||Impact of Dietary Advice on the Progression of Tooth Wear|Impact of Dietary Advice on the Progression of Tooth Wear|Completed||N/A|60|Actual|King's College London||2|||f||||f||||||||||2017-10-10 23:08:42.074863|2017-10-10 23:08:42.074863
NCT02493790|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-12-19|||October 2014||2014-10-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|June 2015|Actual|2015-06-01||Observational|DysCo||Cognitive Dysfunction in COPD Patients : Role in the Performance of Cognitive-motor Dual Task Situation?|Impact of Cognitive Dysfunction in Chronic Obstructive Pulmonary Disease on Performance in Cognitive-motor Dual Task Situation|Completed||N/A|45|Actual|5 Santé|||2||f||||f||||||||||2017-10-10 23:08:42.171758|2017-10-10 23:08:42.171758
NCT02493777|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-20||2017-09-07|July 2015||2015-07-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting|A Phase 3, Multicenter, Open-label Treatment-optimized, Double-blind, Randomized, Placebo-controlled, Forced-withdrawal, Parallel Group Study to Evaluate the Safety and Efficacy of Evening Dosed HLD200, a Novel Delayed and Extended Release Formulation (DELEXIS) of Methylphenidate Hydrochloride, in Children Aged 6-12 With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting|Completed||Phase 3|165|Actual|Ironshore Pharmaceuticals and Development, Inc||2|||f||||f||||||||||2017-10-10 23:08:42.269944|2017-10-10 23:08:42.269944
NCT02493764|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-09-28|||November 24, 2015|Actual|2015-11-24|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|RESTORE-IMI 2||Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)|A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Subjects With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia|Recruiting||Phase 3|536|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 23:08:42.380549|2017-10-10 23:08:42.380549
NCT02493738|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-03-03|||July 2015||2015-07-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers|A Phase I Single-Center, Randomized, Open-label, Single Dose, Crossover Study in Korean Healthy Male Volunteers to Evaluate Pharmacokinetics of Lozanoc and Sporanox|Completed||Phase 1|24|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:08:42.826869|2017-10-10 23:08:42.826869
NCT02493712|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-02-22|||January 2016||2016-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M|A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M Delayed-release Capsules to Induce Remission in Patients With Active, Mild to Moderate Ulcerative Colitis|Recruiting||Phase 2|51|Anticipated|Holy Stone Healthcare Co., Ltd||3|||f||||f||||||||||2017-10-10 23:08:43.035454|2017-10-10 23:08:43.035454
NCT02493699|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-06|||May 2011||2011-05-01|July 2015|2015-07-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Martial Arts Therapy in Autism Spectrum Disorders|The Effect of Karate Techniques Training on Communication Deficit of Children With Autism Spectrum Disorders|Completed||N/A|30|Actual|University of Isfahan||2|||f||||f||||||||||2017-10-10 23:08:43.125515|2017-10-10 23:08:43.125515
NCT02493686|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-11-02|||September 2014||2014-09-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Age Dependence of Audiometric Bone Conduction Threshold in Normal Hearing Subjects|Age Dependence of Audiometric Bone Conduction Threshold in Normal Hearing Subjects|Completed||N/A|1093|Actual|University of Zurich|||1||f||||t||||||||||2017-10-10 23:08:43.209943|2017-10-10 23:08:43.209943
NCT02493673|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-08-09|||June 2015||2015-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of CPAP Withdrawal on Cerebral Vascular Reactivity and Brain Oxygenation in OSA|The Effects of Continuous Positive Airway Pressure Therapy Withdrawal on Cerebral Vascular Reactivity and Brain Oxygenation in Patients With Obstructive Sleep Apnoea: A Randomised Controlled Trial|Recruiting||N/A|42|Anticipated|University of Zurich||2|||f||||||||||||||2017-10-10 23:08:43.267653|2017-10-10 23:08:43.267653
NCT02493660|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-09-24|||July 2015||2015-07-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pivotal Study to Assess the InSpace™ Device for Treatment of Full Thickness Massive Rotator Cuff Tears|A Prospective, Single Blinded, Multi-center, Randomized, Controlled, Pivotal Study to Assess the Safety and Effectiveness of the InSpace™ Device for Treatment of Full Thickness Massive Rotator Cuff Tears|Recruiting||N/A|184|Anticipated|OrthoSpace Ltd.||2|||f||||t||||||||||2017-10-10 23:08:43.367042|2017-10-10 23:08:43.367042
NCT02493647|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-09-21|||September 2015||2015-09-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|December 2017|Anticipated|2017-12-01||Interventional|LSC||Love, Sex & Choices: A Web Series on Mobile Devices to Reduce Black Women's HIV Risk|Reducing Urban Women's HIV Risk: Soap Opera Videos on Mobile Devices|Recruiting||N/A|912|Anticipated|Northeastern University||2|||f||||t||||||||No||2017-10-10 23:08:43.558006|2017-10-10 23:08:43.558006
NCT02493634|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-09-21|||August 2015||2015-08-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|MRWIREPMCF||Post-market Clinical Follow-up Study With Magnetic Resonance Imaging Conditional Guide Wire|Post-market Clinical Follow-up Study With Magnetic Resonance Imaging Conditional Guide Wire|Recruiting||N/A|25|Anticipated|Nano4Imaging GmbH||1|||f||||f||||||||Undecided||2017-10-10 23:08:43.64899|2017-10-10 23:08:43.64899
NCT02493621|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-02-25|||December 2014||2014-12-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Compare Epidural vs. Lumbar Plexus Analgesia After Hip Arthroplasty|Compare Effectiveness of Epidural vs. Lumbar Plexus Blocks in Total Hip Arthroplasty (THA) Patients Using Multimodal Pain Control|Completed||N/A|48|Actual|Medical University of South Carolina|||2||f||||f||||||||||2017-10-10 23:08:43.75549|2017-10-10 23:08:43.75549
NCT02493608|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Scalpel vs Diathermy in Repeat Cesarean Delivery|Scalpel vs Diathermy in Making Abdominal Wall Incision During Repeat Cesarean Delivery|Recruiting||N/A|120|Anticipated|Texas Tech University Health Sciences Center||2|||f||||f||||||||||2017-10-10 23:08:43.826861|2017-10-10 23:08:43.826861
NCT02493595|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-07-08|||April 2015||2015-04-01|July 2015|2015-07-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Observational|MARIA||Synthetic Aperture Radar Detection of Breast Tumours|Post-CE Marking Continuing Evaluation of Multi-Static Microwave Imaging of the Female Breast in Controlled Trial to Identify Optimum Use of the MARIA Platform in the Clinical Workflow|Unknown status|Enrolling by invitation|N/A|300|Anticipated|Micrima, Ltd.|||1||f||||f||||||||||2017-10-10 23:08:43.913882|2017-10-10 23:08:43.913882
NCT02493582|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-02-04|||July 2015||2015-07-01|February 2016|2016-02-01|July 2033|Anticipated|2033-07-01|July 2030|Anticipated|2030-07-01||Interventional|||The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR|The Randomized, Controlled Clinical Trial of Apatinib Plus CIK as the Third Line Therapy for Lung Adenocarcinoma Patients With Wild-Type EGFR|Active, not recruiting||Phase 2|400|Anticipated|The First People's Hospital of Changzhou||2|||f||||f||||||||||2017-10-10 23:08:43.975879|2017-10-10 23:08:43.975879
NCT02493569|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2016-08-09|||October 2016||2016-10-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Observational|||A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China|A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China (Based on Hospital)|Not yet recruiting||N/A|3000|Anticipated|First Affiliated Hospital Xi'an Jiaotong University|||1||f||||||||||||||2017-10-10 23:08:44.046298|2017-10-10 23:08:44.046298
NCT02493556|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2015-10-13|||June 2015||2015-06-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Low-level Laser Therapy on Exercise-induced Muscle Damage|Effect of Low-level Laser Therapy on Exercise-induced Muscle Damage: a Randomized Clinical Trial|Completed||N/A|12|Actual|Federal University of Health Science of Porto Alegre||4|||f||||t||||||||||2017-10-10 23:08:44.117433|2017-10-10 23:08:44.117433
NCT02493543|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-08-16|||October 17, 2014|Actual|2014-10-17|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Autoantibodies on Spinal Cord Injury|Role of Autoantibodies in Spontaneous Functional Recovery After Spinal Cord Injury|Enrolling by invitation||N/A|110|Anticipated|Hospital Nacional de Parapléjicos de Toledo|||2||f||||f||||||Samples Without DNA|"     Blood serum   "|||2017-10-10 23:08:44.208147|2017-10-10 23:08:44.208147
NCT02493530|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-07-18|||July 2015||2015-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea|TGR-1202 + Ruxolitinib in Subjects With Myelofibrosis, MDS/MPN, or Polycythemia Vera Resistant to Hydroxyurea|Recruiting||Phase 1|80|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 23:08:44.331375|2017-10-10 23:08:44.331375
NCT02493517|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-02-27|||October 2014||2014-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|LANTERN||Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly|A Phase III, Prospective, Randomised, Open Label Study to Compare the Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg PR in Subjects With Active Acromegaly|Completed||Phase 3|128|Actual|Ipsen||2|||f||||f||||||||||2017-10-10 23:08:44.495697|2017-10-10 23:08:44.495697
NCT02493504|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-07|||January 2011||2011-01-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|April 2012|Actual|2012-04-01||Interventional|||Effects of Heparin on Arteriovenous Fistula Patency|Effects of Heparin on Early Patency of Arteriovenous Fistula in Angioaccess Surgery of Patients With End-Stage Renal Disease|Completed||Phase 4|150|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:08:44.645485|2017-10-10 23:08:44.645485
NCT02493478|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-01-11|||March 2010||2010-03-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|NEAR4KIDs||Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs|Observation of Multi-center Quality Improvement Project: Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs|Recruiting||N/A|150000|Anticipated|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-10-10 23:08:44.920362|2017-10-10 23:08:44.920362
NCT02493465|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-08|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study|Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study|Unknown status|Recruiting|Phase 4|50|Anticipated|Instituto de Urologia e Nefrologia||1|||f||||t||||||||||2017-10-10 23:08:45.341161|2017-10-10 23:08:45.341161
NCT02493452|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-10-03|||June 2015||2015-06-01|October 2017|2017-10-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|IBS-C||Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)|Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|Completed||Phase 3|1050|Anticipated|Synergy Pharmaceuticals Inc.||3|||f||||f||||||||||2017-10-10 23:08:45.480604|2017-10-10 23:08:45.480604
NCT02493439|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-14|||May 2015||2015-05-01|July 2015|2015-07-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||A Positive Activity Intervention to Promote Wellbeing in Romanian Immigrants|A Positive Activity Intervention to Promote Optimism and Psychological Wellbeing in Romanian Immigrants|Unknown status|Recruiting|N/A|80|Anticipated|Universitat Jaume I||2|||f||||t||||||||||2017-10-10 23:08:46.035279|2017-10-10 23:08:46.035279
NCT02493426|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-01-20|||May 2014||2014-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Single Dose Intranasal Oxytocin and Cognitive Effects in Autism|Single Dose Intranasal Oxytocin (IN-OT) Versus Placebo in Autism: Examining Cognitive Effects|Completed||Phase 2|30|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 23:08:46.138769|2017-10-10 23:08:46.138769
NCT02493413|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-08|||January 2012||2012-01-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|||The Stress-release Effects of Exercise in Obese Are Determined by DS14 Score and T-cell Activation Status|The Stress-release Effects of Exercise in Obese Are Determined by DS14 Score and T-cell Activation Status|Completed||N/A|30|Actual|Institute for Preventive Medicine, Trzaska|||2||f||||t||||||||||2017-10-10 23:08:46.222574|2017-10-10 23:08:46.222574
NCT02493400|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-08-04|||August 2014||2014-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Physiotherapist Led Group-exercise Compared Physical Activity on Prescription, a 3 Months Follow-up|Physiotherapist Led Group-exercise Compared Physical Activity on Prescription in Older Patients With Atrial Fibrillation, a 3 Months Follow-up|Recruiting||N/A|90|Anticipated|Göteborg University|||1||f||||f||||||||||2017-10-10 23:08:46.320054|2017-10-10 23:08:46.320054
NCT02493387|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-08-04|||January 2013||2013-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Supervised Exercise Compared to PAP in Patients With Permanent Atrial Fibrillation|Should Elderly Patients With Atrial Fibrillation be Offered Physiotherapist Group Exercise or Can Physical Activity on Prescription (PAP) be Used as an Alternative|Recruiting||N/A|90|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 23:08:46.399526|2017-10-10 23:08:46.399526
NCT02493374|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2016-12-06|||May 2016||2016-05-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Mitigation of Type 2 Diabetes by Partial Ileal Bypass|Mitigation of Type 2 Diabetes in Hypercholesterolemic Patients Undergoing a Partial Ileal Bypass|Recruiting||N/A|12|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     blood samples   "|Undecided||2017-10-10 23:08:46.491933|2017-10-10 23:08:46.491933
NCT02493361|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-10-02|||July 2015||2015-07-01|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Trial of pIL-12/MK-3475 in Metastatic Melanoma|An Open-label, Phase II, Multicenter Study of Enhancing Pembrolizumab Responses in Melanoma Through Intratumoral pIL-12 Electroporation|Active, not recruiting||Phase 2|24|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:08:46.560013|2017-10-10 23:08:46.560013
NCT02493348|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-09-02|||September 2015||2015-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||A Study of the Effect of Rhythmic Sensory Stimulation and Music on Fibromyalgia|A Study of the Effect of Rhythmic Sensory Stimulation and Music on Fibromyalgia|Unknown status|Recruiting|N/A|50|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-10 23:08:46.642724|2017-10-10 23:08:46.642724
NCT02493335|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-07|2017-02-03|||January 15, 2016|Actual|2016-01-15|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|EOS-2||Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis|Double-blind, Randomized, Placebo-controlled, Phase III Study on the Efficacy and Tolerability of a 48-week Treatment With Two Different Doses of Budesonide Effervescent Tablets vs. Placebo for Maintenance of Clinico-pathological Remission in Adult Patients With Eosinophilic Esophagitis|Recruiting||Phase 3|204|Anticipated|Dr. Falk Pharma GmbH||3|||f||||t||||||||No||2017-10-10 23:08:46.743989|2017-10-10 23:08:46.743989
NCT02493322|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-01-20|||June 2017|Anticipated|2017-06-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control|Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan + Chlorthalidone, Produced by EMS S.A,in Arterial Hypertension Control|Not yet recruiting||Phase 3|261|Anticipated|EMS||3|||f||||t|f|f||||||||2017-10-10 23:08:46.839316|2017-10-10 23:08:46.839316
NCT02493309|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-12-04|||October 2014||2014-10-01|October 2014|2014-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|FIT2SIT||FIT 2 SIT - Are Metabolic Responses to Sitting/Light Breaks Mediated by Fitness?|The Impact of Cardio-respiratory Fitness on an Individual's Metabolic Response to Sitting and Light Activity Breaks|Completed||N/A|34|Actual|University of Leicester||2|||f||||f||||||||||2017-10-10 23:08:46.920126|2017-10-10 23:08:46.920126
NCT02493296|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-23|||August 2012||2012-08-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|ESCAPE||The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study||Recruiting||N/A|146|Anticipated|University of Leicester|||1||f||||f||||||||||2017-10-10 23:08:47.009963|2017-10-10 23:08:47.009963
NCT02493283|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-06|||September 2011||2011-09-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|June 2012|Actual|2012-06-01||Interventional|||Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration|Pharmacokinetics and Distribution of Dapsone (DDS) in Leucocytes After Single-dose and Multiple-dose Administration in Healthy Subjects Genotyped for CYP2C9 and NAT2 and in Patients With Autoimmune Bullous Dermatoses|Completed||Phase 1|23|Actual|University Medicine Greifswald||2|||f||||t||||||||||2017-10-10 23:08:47.10165|2017-10-10 23:08:47.10165
NCT02493270|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-04-13|||May 2007||2007-05-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|EsCAPE||Effect of Smoking Cessation on Non-surgical Periodontal Therapy|Effect of Smoking Cessation on Non-surgical Periodontal Therapy|Completed||N/A|177|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-10 23:08:47.213106|2017-10-10 23:08:47.213106
NCT02493257|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-05-10|||October 2014||2014-10-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Intranasal Capsaicin Treatment for Non-Allergic Irritant Rhinitis|Double-Blinded Randomized Prospective Trial of Intranasal Capsaicin Treatment for Non-Allergic Irritant Rhinitis|Recruiting||Phase 2|22|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:08:47.299346|2017-10-10 23:08:47.299346
NCT02493244|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-01-07|||June 2015||2015-06-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|HONDA||Lipid Layer Thickness Pre and Post Lid Scrubs With Cliradex||Completed||N/A|20|Actual|University of Waterloo||2|||f||||f||||||||||2017-10-10 23:08:47.394876|2017-10-10 23:08:47.394876
NCT02493231|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-08-31|||March 2015||2015-03-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|||Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia||Unknown status|Recruiting|Phase 4|60|Anticipated|Hallym University Kangnam Sacred Heart Hospital||3|||f||||||||||||||2017-10-10 23:08:47.464147|2017-10-10 23:08:47.464147
NCT02493218|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-07-08|||October 2012||2012-10-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||D-Stress Baltimore: School-based Mindfulness Instruction|D-Stress Baltimore: School-based Mindfulness Instruction for Primary Prevention of Mental Health and Behavioral Problems in Middle School|Unknown status|Active, not recruiting|N/A|400|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:08:47.540189|2017-10-10 23:08:47.540189
NCT02493205|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-01-18|||June 2015||2015-06-01|January 2016|2016-01-01||||June 2016|Anticipated|2016-06-01||Observational|HALT||The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial|The Holding Area LINQ Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial Designed to Occur in the Holding Area of a Hospital Operating Room or Cardiac Catheterization/Electrophysiology Laboratory|Active, not recruiting||N/A|20|Actual|Holy Cross Hospital, Florida|||1||f||||f||||||||||2017-10-10 23:08:47.619296|2017-10-10 23:08:47.619296
NCT02493192|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-07-08|||July 2015||2015-07-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Birth Ball Versus Meperidine and Haloperidol Injection for Pain Relief During First Stage of Labour||Unknown status|Not yet recruiting|Phase 4|110|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-10 23:08:47.683179|2017-10-10 23:08:47.683179
NCT02493179|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-07-06|||June 2015||2015-06-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery|Efficacy Evaluation of the Dose Regimen of Serratiopeptidase (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery|Unknown status|Not yet recruiting|Phase 4|112|Anticipated|Hayat Pharmaceutical Co. PLC||2|||f||||t||||||||||2017-10-10 23:08:47.774522|2017-10-10 23:08:47.774522
NCT02493166|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-06-13|||March 2016||2016-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|DTC||Dual Task Cost in the Upper Limb in Persons With Multiple Sclerosis|Cognitive Motor Interference During Dual Tasking With Movements of the Upper Limb in Persons With Multiple Sclerosis|Completed||N/A|68|Actual|Hasselt University||2|||f||||f||||||||||2017-10-10 23:08:47.844304|2017-10-10 23:08:47.844304
NCT02493153|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-11-20|||October 2013||2013-10-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2015|Actual|2015-07-01||Observational|HSAC||Hepatic Steatosis After Cholecystectomy|A Prospective Study for the Effect of Cholecystectomy to the Liver in Consideration of Hepatic Steatosis 3months After Cholecystectomy With Ultrasound|Active, not recruiting||N/A|82|Anticipated|Soonchunhyang University Hospital|||1||f||||f||||||Samples Without DNA|"     Liver biopsy was performed during cholecystectomy using liver wedge resection in 10 patients     who had provided informed consent preoperatively. All specimens were reviewed by two     pathologists with single blinded method. Sections were stained with hematoxylin and eosin     (H&E) and examined at X40 magnification. Steatosis was divided into four stages using the     Brunt criteria.   "|||2017-10-10 23:08:48.020766|2017-10-10 23:08:48.020766
NCT02493140|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-08|||July 2015||2015-07-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of Efficacy of a Cashew Apple Extract on Weight Management and Associated Metabolic Risk Factors in Overweight/Obese Volunteers|Evaluation of Efficacy and Safety of a Cashew Apple Extract on Weight Management and Associated Metabolic Risk Factors in Overweight/Obese Volunteers: a Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Trial|Unknown status|Recruiting|N/A|66|Anticipated|Dialpha||2|||f||||f||||||||||2017-10-10 23:08:48.091016|2017-10-10 23:08:48.091016
NCT02493127|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-03-01|2016-12-20||June 2015||2015-06-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Priming of Questionnaire Content on Grip Strength in Patients With Hand and Upper Extremity Illness|The Effect of Priming of Questionnaire Content on Grip Strength in Patients With Hand and Upper Extremity Illness|Completed||N/A|122|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:08:48.203124|2017-10-10 23:08:48.203124
NCT02493114|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-03-10|||July 2015||2015-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|FSLC||Functional Status in Patients Undergoing Curative Treatment for Lung Cancer|Functional Status in Patients Undergoing Curative Treatment for Lung Cancer: a Prospective Follow-up Study|Recruiting||N/A|80|Anticipated|Hasselt University|||1||f||||f||||||Samples Without DNA|"     Blood plasma samples   "|||2017-10-10 23:08:48.681863|2017-10-10 23:08:48.681863
NCT02493101|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-08|||April 2013||2013-04-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients|Potential of Periostin as a Tissue and Urinary Biomarker in Lupus Nephritis and IgA Nephropathy Patients|Completed||N/A|100|Actual|Chulalongkorn University|||2||f||||t||||||Samples Without DNA|"     urine and kidney tissue   "|||2017-10-10 23:08:48.776314|2017-10-10 23:08:48.776314
NCT02493088|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-03-03|2016-07-29||March 2015||2015-03-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|CoDiRCE||Conduct Disorder in Prison: Search for Prospective and Retrospective Recurring and Contextual Elements|Passage à l'Acte en Maison d'arrêt : Recherche d'éléments Contextuels récurrents Prospectifs et rétrospectifs|Completed||N/A|11|Actual|Groupe Hospitalier de la Rochelle Ré Aunis|data collected by healthcare workers (no 24/7 recording of behaviors). Too small sample||1||f||||f||||||||||2017-10-10 23:08:48.847811|2017-10-10 23:08:48.847811
NCT02493075|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-08|||March 2015||2015-03-01|July 2015|2015-07-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population|Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population: A Prospective Randomized Single-center Trial|Recruiting||Phase 1/Phase 2|140|Anticipated|Sir Run Run Shaw Hospital||2|||f||||f||||||||||2017-10-10 23:08:49.056783|2017-10-10 23:08:49.056783
NCT02493062|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-08-22|||January 2015||2015-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|Hysterotomy||Evaluation of Hysterotomy Site After Open Fetal Surgery|Evaluation of Hysterotomy Site After Open Fetal Surgery|Recruiting||N/A|100|Anticipated|St. Louis University||1|||f||||f||||||||||2017-10-10 23:08:49.151205|2017-10-10 23:08:49.151205
NCT02493049|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-02-23|||August 2015||2015-08-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)|Randomized, Controlled Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis|Enrolling by invitation||Phase 2|24|Anticipated|University of Calgary||2|||f||||f||||||||No|consent to share IPD was not obtained so we cannot share|2017-10-10 23:08:49.265794|2017-10-10 23:08:49.265794
NCT02493036|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-06-26|2017-01-18||October 2015||2015-10-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C|A Single-Dose, Open-Label, Extension Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With Irritable Bowel Syndrome With Constipation|Completed||Phase 2|54|Actual|Synthetic Biologics Inc.||1|||f||||f||||||||||2017-10-10 23:08:49.383932|2017-10-10 23:08:49.383932
NCT02493023|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-03-29|||October 2011||2011-10-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Automatic CT-to-patient Registration During Navigated Bronchoscopy and EBUS|Assessment of a Novel, Fast and Automatic CT-to-patient Registration Method During Navigated Bronchoscopy and Endobronchial Ultrasound Bronchoscopy (EBUS)|Completed||N/A|26|Actual|St. Olavs Hospital||1|||f||||f||||||||||2017-10-10 23:08:49.686141|2017-10-10 23:08:49.686141
NCT02493010|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-07-31|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Arousal Training for Social Anxiety Disorder|Arousal Detection and Training for Social Anxiety Disorder (SAD)|Completed||N/A|50|Actual|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-10 23:08:49.777719|2017-10-10 23:08:49.777719
NCT02492997|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-02-22|||May 2015||2015-05-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference|Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference|Completed||N/A|44|Actual|Venus Concept||2|||f||||t||||||||||2017-10-10 23:08:49.86609|2017-10-10 23:08:49.86609
NCT02492984|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-02-16|2016-12-19||April 2015||2015-04-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional||As there were 2 participants who rolled over from the surgical prophylaxis group to the on-demand group should be counted once in total column, the total number of baseline participants was 85.|PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A|An Open-label, Single-arm, Post- Authorization Pragmatic Clinical Trial On The Safety And Efficacy Of Xyntha (Moroctocog-alfa (Af-cc), Recombinant Fviii) In Subjects With Hemophilia A In Usual Care Settings In China|Completed||Phase 4|85|Actual|Pfizer||1|||f||||t||||||||||2017-10-10 23:08:49.990964|2017-10-10 23:08:49.990964
NCT02492971|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-11-10|||September 2016||2016-09-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Function-oriented Assistive Technology Indexing System Development and Promotion|Development of a Function-oriented Assistive Technology Indexing System and Its Promotion in the Disabled Population|Recruiting||N/A|200|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-10 23:08:50.628328|2017-10-10 23:08:50.628328
NCT02492945|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-04-19|||June 2015||2015-06-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|BundangRISEe||Bundang Rehabilitative Impact Study of the Elbow Epicondylitis|Safety and Effects of PDRN(Polydeoxyribonucleotide) Injection in Patient With Elbow Epicondylitis in Randomized Double-blind Active-control Comparative Study|Completed||Phase 4|40|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||No||2017-10-10 23:08:50.799519|2017-10-10 23:08:50.799519
NCT02492932|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-07-06|||July 2015||2015-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Second Try During Landmark Approach of the Internal Jugular Vein: an Ultrasonographic Prelocation Study|The Second Try During Landmark Approach of the Internal Jugular Vein: an Ultrasonographic Prelocation Study|Recruiting||N/A|323|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 23:08:50.911797|2017-10-10 23:08:50.911797
NCT02492009|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-08-16|||June 2015|Actual|2015-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||Patient Decision Aid for Antidepressant Use in Pregnancy|Patient Decision Aid (PDA) for Antidepressant Use In Pregnancy: a Pilot RCT|Active, not recruiting||N/A|51|Actual|King's College London||2|||f||||f||||||||||2017-10-10 23:09:01.199418|2017-10-10 23:09:01.199418
NCT02492919|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-09-24|||January 2011||2011-01-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Medixair® System on Surgical Site Infection in Cardiac Patients|Impact of Medixair® System on Surgical Site Infection in Patients Admitted Into the Postoperative Cardiac Intensive Care Unit|Completed||N/A|1000|Actual|University of Valladolid||2|||f||||f||||||||||2017-10-10 23:08:51.002089|2017-10-10 23:08:51.002089
NCT02492906|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-06|||April 2011||2011-04-01|July 2015|2015-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Neuroimaging of Patients With Severe Knee Osteoarthrosis - Evaluation of Cerebral Volumetry|Neuroimaging of Patients With Severe Knee Osteoarthrosis - Evaluation of Cerebral Volumetry|Completed||N/A|56|Actual|University of Sao Paulo|||2||f||||t||||||||||2017-10-10 23:08:51.066609|2017-10-10 23:08:51.066609
NCT02492893|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-04-14|||December 2014||2014-12-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Yoga Intervention for Substance Use and ART Adherence in Community Reentry|Yoga Intervention for Substance Use and Antiretroviral Therapy Adherence in Community|Completed||N/A|72|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:08:51.129241|2017-10-10 23:08:51.129241
NCT02492880|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|||CoverEdge Algorithm Programming Study|Study to Characterize the Effects of Programming Features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator System Using the CoverEdge™ Surgical Leads|Active, not recruiting||N/A|15|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-10 23:08:51.191647|2017-10-10 23:08:51.191647
NCT02492854|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-07-07|||July 2015||2015-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|PICO-LEB||Standard Versus PICO Dressings in Lower-Extremity Bypass Patients|Standard Versus PICO Dressings in Lower-Extremity Bypass Patients|Recruiting||N/A|40|Anticipated|Boston Medical Center||2|||f||||f|f|t|f|f|t|||||2017-10-10 23:08:51.349938|2017-10-10 23:08:51.349938
NCT02492841|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-05-01|2017-05-01||April 2014||2014-04-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth|Controlled Clinical Trial of the Effect of Calcium Hydroxide, Mineral Trioxide Aggregate (MTA) and Biodentine (Trademark) as Direct Pulp Capping Materials of Permanent Teeth Affected by Caries, in Children From 7 to 16 Years|Completed||Phase 2/Phase 3|169|Actual|Universidad Los Andes, Chile|The small sample due to inclusion criteria. Lack of collaboration from the primary health providers. And the fact that the oral health seems not to be a priority and people only come when it hurts and it is too late for prevention.|3|||f||||t|f|f||||||No||2017-10-10 23:08:51.430246|2017-10-10 23:08:51.430246
NCT02492828|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-05-17|||June 2014||2014-06-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden|Adherence of Apixaban and Warfarin in Patients With Atrial Fibrillation in Real-world Setting in Sweden|Completed||N/A|41000|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 23:08:51.848211|2017-10-10 23:08:51.848211
NCT02492815|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-16|||October 31, 2013|Actual|2013-10-31|May 2017|2017-05-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Observational|||PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma|An Observational Study to Evaluate the Effectiveness and Safety of Ipilimumab, Administered During the European Expanded Access Programme in Pretreated Patients With Advanced (Unresectable or Metastatic) Melanoma|Completed||N/A|1773|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 23:08:51.938102|2017-10-10 23:08:51.938102
NCT02492802|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-08-24|||August 13, 2015|Actual|2015-08-13|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|June 1, 2017|Actual|2017-06-01||Observational|||Effect of Inflammation on Pharmacokinetics of Posaconazole|Effect of Inflammation on Pharmacokinetics of Posaconazole|Completed||N/A|65|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:08:52.048055|2017-10-10 23:08:52.048055
NCT02492789|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-09-14|||September 2015||2015-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients|An Open-label, Multicenter, Non-randomized, Dose Escalation Phase 1 Trial to Evaluate Safety and Tolerability of INCSHR01210 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|24|Anticipated|Incyte Corporation||1|||f||||f||||||||||2017-10-10 23:08:52.13294|2017-10-10 23:08:52.13294
NCT02492776|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-04-17|||July 7, 2015|Actual|2015-07-07|April 2017|2017-04-01|August 11, 2015|Actual|2015-08-11|August 4, 2015|Actual|2015-08-04||Interventional|||A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations|A Study in Healthy Subjects to Assess the Multiple-Dose Pharmacokinetics of Two AF-219 Formulations|Completed||Phase 1|14|Actual|Afferent Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:08:52.226756|2017-10-10 23:08:52.226756
NCT02492763|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-14|||July 27, 2015|Actual|2015-07-27|September 2017|2017-09-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|||A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)|A Phase IIa, Multicenter, Placebo- and Active-controlled, Randomized, Double-Blind, Clinical Trial to Evaluate the Safety and Efficacy of MK-8521 Compared to Placebo in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 2|178|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-10 23:08:52.304935|2017-10-10 23:08:52.304935
NCT02492750|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-06-28|||April 2016||2016-04-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma|Phase I/II Double Blind Randomized Trial of Lenalidomide/Dexamethasone/Anakinra vs. Lenalidomide/Dexamethasone/Placebo in Patients With Early Stage Multiple Myeloma and High Plasma Cell Growth Rate|Active, not recruiting||Phase 1/Phase 2|120|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:08:52.393687|2017-10-10 23:08:52.393687
NCT02492737|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-22|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation|A Phase I, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation|Active, not recruiting||Phase 1|46|Actual|Agios Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:08:52.563207|2017-10-10 23:08:52.563207
NCT02492724|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2015-07-08|||February 2007||2007-02-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2009|Actual|2009-12-01||Observational|||Activ C European Multicenter Study|Activ C Disc Prosthesis European Multi-Center Clinical Investigation|Completed||N/A|210|Actual|Aesculap AG|||1||f||||f||||||||||2017-10-10 23:08:52.673138|2017-10-10 23:08:52.673138
NCT02492711|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-09-13|||July 2015||2015-07-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|SOPHIA||Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer|A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment|Recruiting||Phase 3|530|Anticipated|MacroGenics||2|||t||||t||||||||||2017-10-10 23:08:52.802499|2017-10-10 23:08:52.802499
NCT02492698|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-05|||June 2014||2014-06-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Changes in Body Adiposity by Dual Probiotic Strains Positively Correlated With Changes in Lp-PLA2 Activity in Overweight Adults|Changes in Body Adiposity by Dual Probiotic Strains Positively Correlated With Changes in Lp-PLA2 Activity in Overweight Adults|Completed||Phase 3|120|Actual|Yonsei University||2|||f||||t||||||||||2017-10-10 23:08:53.85157|2017-10-10 23:08:53.85157
NCT02492685|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-08|||July 2015||2015-07-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||"Quantificational Enhancement Pattern Analysis Using a Novel Software Vuebox of Contrast-enhanced Harmonic Endoscopic Ultrasonography for Differential Diagnosis Between Adenomas and Cholesterol Polyps"||Unknown status|Not yet recruiting|N/A|79|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 23:08:53.921808|2017-10-10 23:08:53.921808
NCT02492672|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-05-10|||September 2014||2014-09-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|||Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease|A Multicenter Registry to Evaluate the Long-term Safety and Tolerability of Maintenance Treatment With Iron Sucrose (Venofer) in Pediatric Patients Ages ≥ 2 to ≤ 17 Years With Chronic Kidney Disease|Recruiting||N/A|50|Anticipated|Luitpold Pharmaceuticals|||1||f||||f||||||||Yes||2017-10-10 23:08:53.989727|2017-10-10 23:08:53.989727
NCT02492659|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2015-07-08|||October 2013||2013-10-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|FLACS||Clinical Research of Femtosecond Laser-Assisted Cataract Surgery|Clinical Research of Femtosecond Laser-Assisted Cataract Surgery: Randomized Clinical Trial|Completed||N/A|54|Actual|Wenzhou Medical University||2|||f||||t||||||||||2017-10-10 23:08:54.06148|2017-10-10 23:08:54.06148
NCT02492646|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-06-01|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|Lubrication||Effect of Saline Lubrication on Post-intubation Complications|Effect of Normal Saline Lubrication of Endotracheal Tube on Post-intubation Complications: A Prospective Non-inferiority Trial|Completed||N/A|300|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:08:54.137331|2017-10-10 23:08:54.137331
NCT02492633|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-06|2017-08-20|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Prospective Evaluation of a Comprehensive Smoke-Free Public Housing Policy in a Multi-State Setting|Prospective Evaluation of a Comprehensive Smoke-Free Public Housing Policy in a Multi-State Setting|Active, not recruiting||N/A|238|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-10 23:08:54.220278|2017-10-10 23:08:54.220278
NCT02492620|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-08-16|||March 2015||2015-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|05D||Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D|A Two-Arm, Open-Label, Standard of Care Control Evaluation of Ferric Citrate for the Transition From Chronic Kidney Disease Stage 4/5 to Chronic Kidney Stage 5D|Active, not recruiting||Phase 3|200|Actual|Denver Nephrologists, P.C.||2|||f||||f||||||||||2017-10-10 23:08:54.299757|2017-10-10 23:08:54.299757
NCT02492607|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-09-05|||February 13, 2017|Actual|2017-02-13|September 2017|2017-09-01|December 2029|Anticipated|2029-12-01|December 2029|Anticipated|2029-12-01||Interventional|LORD||Management of Low-risk DCIS|Management of Low Risk Ductal Carcinoma in Situ (Low-risk DCIS): a Randomized, Multicentre, Non-inferiority Trial, Between Standard Therapy Approach Versus Active Surveillance|Recruiting||Phase 3|1240|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t|f|f||||||||2017-10-10 23:08:54.450436|2017-10-10 23:08:54.450436
NCT02492594|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-07-03|||February 2015||2015-02-01|July 2015|2015-07-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|FUNGITECT||Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections|Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections|Recruiting||N/A|400|Anticipated|St. Anna Kinderkrebsforschung||2|||f||||f||||||||||2017-10-10 23:08:54.673148|2017-10-10 23:08:54.673148
NCT02492581|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-04-26|||February 2016||2016-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|USE-PACT||Use of Selincro and Impact on Usual Practice|Use of Selincro and Impact on Usual Practice|Active, not recruiting||N/A|698|Actual|University of Bordeaux|||1||f||||t||||||||||2017-10-10 23:08:54.779597|2017-10-10 23:08:54.779597
NCT02492568|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-09-13|||July 2015||2015-07-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PEMBRO-RT||Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC|Randomized Phase II, 2-arm Study of Pembrolizumab After High Dose Radiation (SBRT) Versus Pembrolizumab Alone in Patients With Advanced Non-small Cell Lung Cancer|Recruiting||Phase 2|74|Anticipated|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-10-10 23:08:54.870284|2017-10-10 23:08:54.870284
NCT02485457|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-05-18|||June 2015||2015-06-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|NICOM-VAL||Validation of Nicom Device to Measure Stoke Volume Variation|Validation of NICOM for the Detection of Modification of Stroke Volume|Recruiting||N/A|150|Anticipated|Hopital Foch||2|||f||||f||||||||||2017-10-10 23:10:28.564394|2017-10-10 23:10:28.564394
NCT02492555|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-04-11|||July 2015||2015-07-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|August 2016|Actual|2016-08-01||Interventional|||Is Relapse Rate Reduced by Home Monitoring of IBD Patients Tightly or on Demand by FC and Disease Activity?|Is Relapse Rate Reduced by Home Monitoring of IBD Patients Tightly or on Demand by FC and Disease Activity?|Active, not recruiting||N/A|120|Actual|Nordsjaellands Hospital||2|||f||||t||||||||||2017-10-10 23:08:54.968065|2017-10-10 23:08:54.968065
NCT02492542|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-07|||April 2015||2015-04-01|July 2015|2015-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Pelvic Floor Stimulation on the Pelvic Floor Function in Cervical Cancer Patients With Type III Hysterectomy|Effect of Pelvic Floor Stimulation on the Pelvic Floor Function in Cervical Cancer Patients With Type III Hysterectomy|Enrolling by invitation||Phase 1/Phase 2|208|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-10 23:08:55.044469|2017-10-10 23:08:55.044469
NCT02492529|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-05-17|||July 2015||2015-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EPMR-MA||Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease|Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease|Recruiting||N/A|100|Anticipated|Rennes University Hospital||3|||f||||f||||||||||2017-10-10 23:08:55.142426|2017-10-10 23:08:55.142426
NCT02492516|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-04-26|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS|Evaluation the Safety of Intravenous Injection of Adipose Derived Mesenchymal Stem Cell in Patients With ALS|Completed||Phase 1|19|Actual|Royan Institute||1|||f||||t||||||||||2017-10-10 23:08:55.231936|2017-10-10 23:08:55.231936
NCT02492503|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-07-07|||November 2013||2013-11-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix|An Open Label Randomized Phase 2, Pilot Study to Investigate the Effectiveness of Palliative Chemotherapy in Stage IVB, Recurrent or Persistent Carcinoma Cervix|Unknown status|Active, not recruiting|Phase 1/Phase 2|40|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-10-10 23:08:55.315162|2017-10-10 23:08:55.315162
NCT02492490|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-07-04|||December 2014||2014-12-01|November 2014|2014-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of SVF Derived MSC in DCD Renal Transplantation|Effect of Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cell in Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Randomized Controlled Trial|Unknown status|Recruiting|Phase 1/Phase 2|120|Anticipated|Fuzhou General Hospital||2|||f||||f||||||||||2017-10-10 23:08:55.411171|2017-10-10 23:08:55.411171
NCT02492477|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-08-07|||October 2015||2015-10-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|||TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients|TOP-TRIAL The Safety of Not Flushing the Non-used PORT-A-CATH® in Cancer Patients - a Prospective, Two-arm Phase I Trial, Pilot Trial|Recruiting||Phase 1|60|Anticipated|Krankenhaus Barmherzige Schwestern Linz||2|||f||||t||||||||||2017-10-10 23:08:55.528995|2017-10-10 23:08:55.528995
NCT02492464|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-12-05|||May 2015||2015-05-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|Monasc10_15||Effects of 10 mg Monacolins on Vascular Health: a Clinical Trial|Double-blind, Randomized Clinical Trial on the Middle-term Effect of the Red Yeast Rice Intake on Endothelial Function and Arterial Stiffness in Subjects With Suboptimal LDL-cholesterol Level in the Context of the Mediterranean Diet|Completed||N/A|40|Actual|University of Bologna||2|||f||||f||||||||No||2017-10-10 23:08:55.667248|2017-10-10 23:08:55.667248
NCT02492451|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-08-26|2016-07-15||June 2015||2015-06-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Endometrial Injury Versus Luteal Phase Support in Intrauterine Insemination Cycles|Endometrial Injury Versus Luteal Phase Support in Intrauterine Insemination Cycles|Terminated||N/A|118|Actual|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||3||Problems in recruitment|f||||f||||||||||2017-10-10 23:08:55.747019|2017-10-10 23:08:55.747019
NCT02492438|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2015-07-05|||February 2013||2013-02-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients|Immunogenicity and Safety of the 13-valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients That Are 23-valent Pneumococcal Polysaccharide Vaccine Naive and Pre-immunized.|Completed||Phase 4|154|Actual|AZ Sint-Jan AV||4|||f||||t||||||||||2017-10-10 23:08:55.980673|2017-10-10 23:08:55.980673
NCT02492425|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-10-14|||January 2016||2016-01-01|October 2015|2015-10-01|May 2018|Anticipated|2018-05-01|December 2016|Anticipated|2016-12-01||Observational|CAP-China||A Registry Study on Hospitalized Patients With Community-acquired Pneumonia in Real-life of China|Evaluating the Adherence to Guidelines' Empirical Antibiotic Recommendations and Outcome of Patients Admitted to a Hospital Ward With a Diagnosis of Community-acquired Pneumonia|Not yet recruiting||N/A|3000|Anticipated|Capital Medical University|||1||f||||f||||||||||2017-10-10 23:08:56.083379|2017-10-10 23:08:56.083379
NCT02492412|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-05|||May 2013||2013-05-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety of HE10 for Dry Eye Syndrome|Multi-center, Randomized, Double-blind, Active Comparator- Controlled, Parallel Study Evaluating the Efficacy and Safety of HE10 in Subjects With Dry Eye Syndrome|Completed||Phase 3|101|Actual|Huons Co.,Ltd.||2|||f||||f||||||||||2017-10-10 23:08:56.195653|2017-10-10 23:08:56.195653
NCT02492399|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-03-19|||January 2014||2014-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparisonof Extended Myoectomy and Myoectomy by Morrow in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM)|Compare the Results for the Extended Myoectomy and Standard Morrow's Myoectomy in Patients With Ventricular Obstruction of the Left Ventricular Output|Recruiting||N/A|60|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 23:08:56.276332|2017-10-10 23:08:56.276332
NCT02492386|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-05|||July 2015||2015-07-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|||Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction|Safety and Feasibility of Bioabsorbable Everolimus-Eluting Stents for Patients With Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction (PERFECT-ABSORB)|Unknown status|Not yet recruiting|Phase 2/Phase 3|15|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-10 23:08:56.36854|2017-10-10 23:08:56.36854
NCT02492373|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2016-05-31|||February 2015||2015-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser|Effect of Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation Following Q-switched Nd:YAG 532 nm Laser for Treatment of Facial Lentigines - A Pilot Study|Completed||N/A|21|Actual|Mahidol University||2|||f||||t||||||||||2017-10-10 23:08:56.444139|2017-10-10 23:08:56.444139
NCT02492360|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-08-29|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy|Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy|Not yet recruiting||N/A|40|Anticipated|Indiana University|||2||f||||t||||||Samples With DNA|"     Whole blood samples will be obtained from all patients so that peripheral blood mononuclear     cells (PBMCs) can be isolated and stored for the eventual creation of iPS cells. iPS cells     have the potential to make human neurons that the researchers would like to use for     functional studies of specific genes/genetic variants. All samples will also be tested for     infectious diseases (Hepatitis B, Hepatitis C, HIV 1 and HIV 2).   "|||2017-10-10 23:08:56.559361|2017-10-10 23:08:56.559361
NCT02492347|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-05-13|||February 2016||2016-02-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|SSRIs||Effect of Antenatal SSRI Exposure on the QT Interval of Neonates|Is Antenatal Exposure to Selective Serotonin Reuptake Inhibitors (SSRIs) Associated With Prolongation of the QT Interval in Term Neonates (Greater Than 37 Complete Weeks Gestation)?|Recruiting||N/A|242|Anticipated|University of Southampton||2|||f||||f||||||||Undecided|Not personal details but details in questionnaire will be included in articles as a group. Undecided whether it will draw on individual aspects|2017-10-10 23:08:56.657396|2017-10-10 23:08:56.657396
NCT02492334|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-05-11|||July 2016||2016-07-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|February 2019|Anticipated|2019-02-01||Interventional|||Doxazosin for PTSD and Alcohol Use Disorder|Doxazosin in the Treatment of Co-occuring PTSD and Alcohol Use Disorder|Not yet recruiting||Phase 1/Phase 2|126|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:08:56.753046|2017-10-10 23:08:56.753046
NCT02492321|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-02-10|||July 2015||2015-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|EBI-005-AC-2||A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis|A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled Evaluation of the Efficacy, Safety, and Tolerability of EBI-005 in Subjects With Moderate to Severe Ocular Allergic Conjunctivitis|Completed||Phase 3|250|Actual|Eleven Biotherapeutics||2|||f||||f||||||||||2017-10-10 23:08:56.867051|2017-10-10 23:08:56.867051
NCT02492308|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-04|2015-07-04|||December 2014||2014-12-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Induction With SVF Derived MSC in Living-related Kidney Transplantation|Effect of Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cell in Living-Related Kidney Transplants: A Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|120|Anticipated|Fuzhou General Hospital||2|||f||||f||||||||||2017-10-10 23:08:56.973565|2017-10-10 23:08:56.973565
NCT02492295|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-05-08|||August 2014|Actual|2014-08-01|May 2017|2017-05-01|January 1, 2016|Actual|2016-01-01|January 1, 2016|Actual|2016-01-01||Interventional|||Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department|Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department|Terminated||N/A|12|Actual|Albert Einstein Healthcare Network||1||Due to logistic reason|f||||t||||||||Undecided||2017-10-10 23:08:57.080273|2017-10-10 23:08:57.080273
NCT02492282|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-04|2016-06-17|||June 2015||2015-06-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of a Novel Closed-loop Propofol and Remifentanil System Guided by Bispectral Index Compared to a TCI Open-loop System|Evaluation of a Novel Closed-loop Propofol and Remifentanil System Guided by Bispectral Index Compared to a TCI Open-loop System: a Randomized Controlled Trial.|Completed||Phase 3|150|Actual|Universidad de Antioquia||2|||f||||t||||||||||2017-10-10 23:08:57.39141|2017-10-10 23:08:57.39141
NCT02492269|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-07-28|||May 2014||2014-05-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Stress Response and Neurodevelopmental Outcome After Cardiac Surgery Utilizing CPB in Children: A Prospective, Double Blinded and Randomized Study||Enrolling by invitation||Phase 2|50|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-10 23:08:58.060783|2017-10-10 23:08:58.060783
NCT02492256|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-02|||June 2015||2015-06-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Patients With Persistent AF|Atrial Ganglionated Plexi Ablation Guided by the SUMO Technology With and Without Conventional Pulmonary Vein Isolation in Persistent Atrial Fibrillation Patients: Prospective Randomized Study|Unknown status|Recruiting|Phase 2|60|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 23:08:58.150433|2017-10-10 23:08:58.150433
NCT02492243|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-02|||August 2011||2011-08-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Continuous Rhythm Monitoring in Patients After Acute Myocardial infaRction andpREServed Lef venTricle Ejection Fraction (ARREST)|Continuous Rhythm Monitoring in Patients After Acute Myocardial infaRction and pREServed Left venTricle Ejection Fraction|Completed||Phase 2|50|Actual|Meshalkin Research Institute of Pathology of Circulation||1|||f||||t||||||||||2017-10-10 23:08:58.247585|2017-10-10 23:08:58.247585
NCT02492230|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-09-06|||May 2015||2015-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Interventional|||Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI|Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent Percutaneous Coronary Intervention|Recruiting||Phase 2|50|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 23:08:58.334782|2017-10-10 23:08:58.334782
NCT02492217|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-09-18|||May 2015||2015-05-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients|Biomarkers Identification of Anti-TNF α Agent's Efficacy in Ankylosing Spondylitis Patients Using a Transcriptome Analysis and Mass Spectrometry|Recruiting||Phase 4|70|Anticipated|Universidade Nova de Lisboa||1|||f||||t||||||||||2017-10-10 23:08:58.442033|2017-10-10 23:08:58.442033
NCT02492191|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2016-09-26|||October 2015||2015-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|RAPP||RAPP- Systematic E-assessment of Postoperative Recovery in Patients Undergoing Day Surgery|RAPP- Systematic E-assessment of Postoperative Recovery in Patients Undergoing Day Surgery|Completed||N/A|1046|Actual|Örebro University, Sweden||2|||f||||f||||||||No||2017-10-10 23:08:58.641364|2017-10-10 23:08:58.641364
NCT02492178|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-12-02|||July 2015||2015-07-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|REACH||Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria||Completed||Phase 2|82|Actual|University of Oxford||2|||f||||t||||||||||2017-10-10 23:08:58.775025|2017-10-10 23:08:58.775025
NCT02492165|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-05|2016-10-04|2016-10-04||June 2015||2015-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects|Immunogenicity and Safety of a Single Primary Dose of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) Given to Healthy Subjects in Vietnam|Completed||Phase 3|250|Actual|Sanofi||4|||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 23:08:58.874254|2017-10-10 23:08:58.874254
NCT02492152|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-02|||August 2015||2015-08-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Does the Use of Dianatal Reduce the Rate of Episiotomy and Vaginal Tears in Birth?|Randomised ,Open Label in Meir Medical Center. Study the Potential of Dianatal Gel to Reduce the Rate of Episiotomy and Vaginal Tears in Birth|Unknown status|Not yet recruiting|N/A|400|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-10 23:09:00.015296|2017-10-10 23:09:00.015296
NCT02492139|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-01-25|||July 2015||2015-07-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|ESPII||"Evaluation of the Reliability and Usability of the Reusable BrownieForSymphony Pump Set in Home Use"|"ESP II Evaluation of the Reliability and Usability of the Reusable BrownieForSymphony Pump Set in Home Use"|Completed||N/A|22|Actual|Medela AG||1|||f||||f||||||||||2017-10-10 23:09:00.108657|2017-10-10 23:09:00.108657
NCT02492126|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-09-18|||January 2016||2016-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Esophageal Motility in Reflux Induced Cough|Chronic Cough and Reflux: Is Esophageal Motility the Key?|Recruiting||N/A|87|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 23:09:00.208023|2017-10-10 23:09:00.208023
NCT02492113|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-09-18|||November 2015||2015-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Different PEEP Levels on Work of Breathing in Morbidly Obese Patients Prior to and After Extubation|Effects of Different PEEP Levels on Work of Breathing in Morbidly Obese Patients Prior to and After Extubation|Recruiting||N/A|39|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:09:00.301255|2017-10-10 23:09:00.301255
NCT02492100|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-11-28|||June 2015||2015-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors|A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:09:00.424104|2017-10-10 23:09:00.424104
NCT02492087|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-03-15|||August 2015||2015-08-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TXACS||Topical Tranexamic Acid in Caesarean Section|Prophylactic Use of Topical Tranexamic Acid to Aid Surgical Haemostasis During Caesarean Sections in Parturients With Moderate to High Risk of Bleeding|Recruiting||Phase 3|84|Anticipated|Ministry of Health, Malaysia||2|||f||||t||||||||||2017-10-10 23:09:00.551455|2017-10-10 23:09:00.551455
NCT02492074|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-07-03|||April 2016||2016-04-01|July 2015|2015-07-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study|Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System and Brain Function|Unknown status|Not yet recruiting|Phase 1|60|Anticipated|Central Institute of Mental Health, Mannheim||4|||f||||f||||||||||2017-10-10 23:09:00.69944|2017-10-10 23:09:00.69944
NCT02492061|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2015-07-02|||August 2013||2013-08-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Demand Creation for Couples' HIV Counseling and Testing|Demand Creation for Couples' HIV Counseling and Testing, Linkage to and Retention in HIV Care Among Married Couples in Rakai, Uganda|Unknown status|Active, not recruiting|N/A|3076|Anticipated|Makerere University||2|||f||||f||||||||||2017-10-10 23:09:00.823014|2017-10-10 23:09:00.823014
NCT02492048|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-03-02|||February 2016||2016-02-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|||Effectiveness of CelluTome Epidermal Harvesting System in Autologous Skin Grafting of Chronic Wound Patients|Effectiveness of CelluTome Epidermal Harvesting System in Autologous Skin Grafting of Chronic Wound Patients|Recruiting||Phase 4|40|Anticipated|LifeBridge Health||2|||f||||f||||||||||2017-10-10 23:09:00.908715|2017-10-10 23:09:00.908715
NCT02492035|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-13|||February 2013||2013-02-01|September 2017|2017-09-01|December 23, 2016|Actual|2016-12-23|December 23, 2016|Actual|2016-12-23||Interventional|||Lifestyle Intervention for Treating Systemic Hypertension in Primary Care Setting|Lifestyle Intervention for Treating Systemic Hypertension in Primary Care Setting|Completed||N/A|60|Actual|Laval University||4|||f||||||||||||||2017-10-10 23:09:01.012816|2017-10-10 23:09:01.012816
NCT02492022|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-02-16|||May 2015||2015-05-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy of 2 Probiotics During Nicotine Replacement Therapy on Withdrawal Symptoms Associated With Smoking Cessation|A Double-blind Randomized Placebo-controlled Trial Assessing the Effectiveness of Two Probiotic Products During Nicotine Replacement Therapy for Managing Withdrawal Symptoms Associated With Smoking Cessation|Completed||Phase 2|75|Actual|Lallemand Health Solutions||3|||f||||f||||||||||2017-10-10 23:09:01.097532|2017-10-10 23:09:01.097532
NCT02483988|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-12-20|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:10:50.279336|2017-10-10 23:10:50.279336
NCT02491996|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-07-07|||June 2013||2013-06-01|July 2015|2015-07-01|March 2018|Anticipated|2018-03-01|March 2016|Anticipated|2016-03-01||Interventional|ETFDDG||The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers|The Efficacy of Cognitive-behavioral Therapy Focused on Desire-satisfaction for Treatment-seeking Disordered Gamblers|Recruiting||N/A|100|Anticipated|Kurihama Medical and Addiction Center||1|||f||||f||||||||||2017-10-10 23:09:01.313105|2017-10-10 23:09:01.313105
NCT02491983|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-09-13|||August 2015||2015-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|PARSIFAL||Study to Evaluate the Efficacy and Safety of Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Locally Advanced or Metastatic Breast Cancer|A Randomized, Multicenter, Open-label, Phase II Trial to Evaluate the Efficacy and Safety of Palbociclib in Combination With Fulvestrant or Letrozole in Patients With HER2 Negative, ER+ Metastatic Breast Cancer|Recruiting||Phase 2|486|Anticipated|MedSIR||2|||f||||f||||||||||2017-10-10 23:09:01.427058|2017-10-10 23:09:01.427058
NCT02491970|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-05-11|||August 31, 2015|Actual|2015-08-31|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 6, 2017|Actual|2017-04-06||Interventional|RECONFFIRM||Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol|A Single-blind, Randomized, Active-controlled, Multi-center and Phase IV Study to Evaluate the Small Airway Parameters of Fluticasone/Formoterol (Flutiform®) Compared to Fluticasone/Salmeterol in Asthma Patients|Completed||Phase 4|15|Actual|Mundipharma Korea Ltd||2|||f||||f||||||||No||2017-10-10 23:09:01.813933|2017-10-10 23:09:01.813933
NCT02491957|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-06-01|||July 28, 2015|Actual|2015-07-28|June 2017|2017-06-01|March 29, 2019|Anticipated|2019-03-29|March 29, 2018|Anticipated|2018-03-29||Interventional|||Impact of LOFT Therapy™ on Breast Cancer Survivors|Impact of LOFT Therapy™ on Breast Cancer Survivors: A Pilot Study|Recruiting||N/A|15|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 23:09:01.924547|2017-10-10 23:09:01.924547
NCT02491944|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2016-08-19|2016-08-19||July 2015||2015-07-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase I, Open-label Study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV Dose of [14C]AZD9291|A Phase I, Open-label, Single Dose, Single-Centre Study to Assess the Absolute Bioavailability of a Single Oral Dose of AZD9291 With Respect to an Intravenous Microdose of [14C]AZD9291 in Healthy Male Subjects|Completed||Phase 1|27|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:09:02.044802|2017-10-10 23:09:02.044802
NCT02491931|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-07-07|||January 2013||2013-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Oral Glutamine in Cardiopulmonary Bypass|Oral Glutamine Reduces Myocardial Damage After Coronary Revascularization Under Cardiopulmonary Bypass|Completed||Phase 4|28|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-10 23:09:02.510185|2017-10-10 23:09:02.510185
NCT02491918|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-02|||April 2013||2013-04-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Trial : Complications of in the Bag IOL Versus Optic Capture of IOL in Pediatric Cataract Surgery|Visual Axis Obscuration and Postoperative Complications Following Pediatric Cataract Surgery With Introacular Lens Implantation In-the-bag Versus Posterior Optic Capture : A Randomized, Clinical Trial|Completed||N/A|61|Actual|Iladevi Cataract and IOL Research Center||2|||f||||t||||||||||2017-10-10 23:09:02.596668|2017-10-10 23:09:02.596668
NCT02491905|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-02|||November 2013||2013-11-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients|Phase 2 Study to Assess Safety and Efficacy of HL Tablet on Reducing Hepatic Fat in Non-alcoholic Fatty Liver Disease Patients|Completed||Phase 2|69|Actual|Huons Co.,Ltd.||3|||f||||t||||||||||2017-10-10 23:09:02.669983|2017-10-10 23:09:02.669983
NCT02491892|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-08-24|2015-07-22||February 2003||2003-02-01|August 2015|2015-08-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional||Intent-to-Treat (ITT) Population: All randomized participants who received at least one dose of pertuzumab.|A Study of Pertuzumab in Participants With Metastatic Breast Cancer|Open-Label, Phase II, Multicenter, Randomized Study of Efficacy and Safety for Two Different Doses of a Recombinant Humanized Antibody to HER2 (rhuMAb 2C4) Administered Every 3 Weeks to Patients With Metastatic Breast Cancer With Low Expression of HER2|Completed||Phase 2|79|Actual|Hoffmann-La Roche|Recruitment was halted within the planned study design. The study was designed to stop recruitment following the interim analysis if the response rate (CR or PR) was <1 of 23 participants per arm after all participants completed at least 2 cycles.|2|||f||||||||||||||2017-10-10 23:09:02.757998|2017-10-10 23:09:02.757998
NCT02491879|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-12-02|||June 2015||2015-06-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Ketoprofen Gel vs Placebo in Low Back Pain|Ketoprofen Gel vs Placebo in Patients Presented With Low-back Pain to Emergency Department: A Ranodmized Controlled Trial|Recruiting||Phase 4|100|Anticipated|Akdeniz University||2|||f||||f||||||||||2017-10-10 23:09:05.021198|2017-10-10 23:09:05.021198
NCT02491866|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-08-08|||May 27, 2015|Actual|2015-05-27|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|August 2017|Actual|2017-08-01||Interventional|QDSPsyCAT||Computerized Adaptative Testing of Self-perceived Quality of Care in Psychiatry|Development and Implementation of a Computerized Adaptative Testing (CAT) of Self-perceived Quality of Care in Psychiatry|Recruiting||N/A|1400|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:09:05.124772|2017-10-10 23:09:05.124772
NCT02491853|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-08-11|||January 2014||2014-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01|1 Year|Observational [Patient Registry]|GulfICD||The Gulf Implantable Cardioverter-Defibrillator Registry|The Gulf Implantable Cardioverter-Defibrillator Registry (GulfICD)|Completed||N/A|1545|Actual|Gulf Heart Association|||1||f||||f||||||||No||2017-10-10 23:09:05.215325|2017-10-10 23:09:05.215325
NCT02491840|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-07|||May 2016|Actual|2016-05-01|September 2017|2017-09-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Interventional|||Biomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a Pilot Study|Biomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a Pilot Study|Recruiting||N/A|80|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 23:09:05.299118|2017-10-10 23:09:05.299118
NCT02491827|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-01-30|||December 2015||2015-12-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Observational|Cleopatra||Confocal Laser Endomicroscopy (CLE) During Medically Induced Neurosurgery in Craniobasal and Glioma Tumours|Adjoint Intra-operative Confocal Laser Endomicroscopy (CLE) to Present Tissue on the Cellular Level in Defined Lesions of the Central Nervous System (CNS) During Medically Induced Neurosurgery in Subcranial Tumors and Glioma|Suspended||N/A|60|Anticipated|Charalampaki, Cleopatra, M.D.|||1||f||||f||||||||No||2017-10-10 23:09:05.399532|2017-10-10 23:09:05.399532
NCT02491814|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Dairy and Non-dairy Alternatives on Satiety and Post-meal Glycemia in Healthy Young Adults|The Effect of Commercially-available Dairy and Non-dairy Alternatives When Consumed With a High Glycemic Cereal on Subjective Appetite Ratings and Post-meal Glycemia in Healthy Young Adults|Completed||Phase 1/Phase 2|28|Actual|University of Toronto||5|||f||||f||||||||||2017-10-10 23:09:05.526821|2017-10-10 23:09:05.526821
NCT02491801|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-09-20|||March 2015||2015-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Form of Dairy Products on Satiety, Food Intake and Post-meal Glycaemia in Young and Older Adults|The Effect of Solid, Semi-solid and Liquid Dairy Products on Satiety, Food Intake and Post-meal Glycaemia in Young and Older Adults|Recruiting||N/A|40|Anticipated|University of Toronto||5|||f||||f|f|f||||||||2017-10-10 23:09:05.655233|2017-10-10 23:09:05.655233
NCT02491788|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-11-01|||February 2016||2016-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers||Recruiting||Phase 4|38|Anticipated|VA Palo Alto Health Care System||2|||f||||t||||||||No|All relevant data will be provided in the publication|2017-10-10 23:09:05.793875|2017-10-10 23:09:05.793875
NCT02491775|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-02-22|||June 11, 2015|Actual|2015-06-11|February 2017|2017-02-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Observational|||Afatinib Genomic Landscape|Genomic Landscape of EGFR Mutant NSCLC Prior to Afatinib and at the Time of Disease Progression Following Afatinib|Recruiting||N/A|30|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||No||2017-10-10 23:09:06.002523|2017-10-10 23:09:06.002523
NCT02491762|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-07-13|||August 2015||2015-08-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||The Effect of Breast Reconstruction Surgery Using Tissue Expanders on Respiratory Functions|The Effect of Breast Reconstruction Surgery Using Tissue Expanders on Respiratory Functions|Unknown status|Not yet recruiting|N/A|45|Anticipated|Carmel Medical Center|||2||f||||t||||||||||2017-10-10 23:09:06.125863|2017-10-10 23:09:06.125863
NCT02491749|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2015-07-07|||February 2011||2011-02-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Impact of Immediate Versus Delayed Tracheal Extubation on Length of ICU Stay of Cardiac Surgical Patients|Impact of Immediate Versus Delayed Tracheal Extubation on Length of ICU Stay of Cardiac Surgical Patients|Completed||N/A|52|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:09:06.282929|2017-10-10 23:09:06.282929
NCT02491736|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-12-02|||June 2015||2015-06-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Ketoprofen Gel vs Placebo in Children With Ankle Sprain|Ketoprofen Gel vs Placebo in Children Presented With Ankle Sprain to the Emergency Department: A Randomised Controlled Trial|Recruiting||Phase 4|100|Anticipated|Akdeniz University||2|||f||||f||||||||||2017-10-10 23:09:06.356288|2017-10-10 23:09:06.356288
NCT02491723|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2016-10-12|||January 2014||2014-01-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa|Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa Via NLRC4 Inflammasome Signaling Pathway|Completed||N/A|71|Actual|Shanghai Pulmonary Hospital, Shanghai, China||1|||f||||t||||||||||2017-10-10 23:09:06.491421|2017-10-10 23:09:06.491421
NCT02491710|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2015-09-18|||August 2015||2015-08-01|September 2015|2015-09-01||||September 2015|Actual|2015-09-01||Interventional|||Comparison of an Inexpensive Tablet-based Laparoscopic Box Trainer With a Standard Box Trainer||Completed||N/A|32|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:09:06.588575|2017-10-10 23:09:06.588575
NCT02491697|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-02-21|||February 2016||2016-02-01|July 2015|2015-07-01|August 2033|Anticipated|2033-08-01|August 2030|Anticipated|2030-08-01||Interventional|||Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer|Randomized Controlled Trial Comparing Dendritic Cells Co-cultured With Cytokine-induced Killer Cells Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer|Active, not recruiting||Phase 2|400|Anticipated|The First People's Hospital of Changzhou||2|||f||||f||||||||||2017-10-10 23:09:06.672998|2017-10-10 23:09:06.672998
NCT02491684|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-12-14|||July 2015||2015-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|INEXAS||A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection|A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Phase IIa Study in Asthma Patients Comparing the Efficacy and Safety of Once Daily Inhaled Interferon Beta-1a to Placebo, Administered for 14 Days After the Onset of Symptoms of an Upper Respiratory Tract Infection for the Prevention of Severe Exacerbations|Completed||Phase 2|350|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:09:06.792718|2017-10-10 23:09:06.792718
NCT02491658|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-03|||April 2015||2015-04-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy of UC-MSCs in Patients With Psoriasis Vulgaris|A Study to Assess Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs) in Patients With Psoriasis Vulgaris|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-10 23:09:07.137936|2017-10-10 23:09:07.137936
NCT02491645|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-07-08|||February 2015||2015-02-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparison of Effectiveness of Home Based Sensory Interventions Along With Standard Therapy Versus Standard Therapy Alone in Autistic Children With Sensory Processing Abnormalities|Comparison of Effectiveness of Home Based Sensory Interventions Along With Standard Therapy Versus Standard Therapy Alone in Autistic Children With Sensory Processing Abnormalities :An Open Label Randomized Study|Unknown status|Recruiting|N/A|30|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 23:09:07.267797|2017-10-10 23:09:07.267797
NCT02491632|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2017-04-19|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Exercise + Dexamethasone for Cancer-Related Fatigue|Effects of Physical Activity Plus Short Course of Dexamethasone for Cancer-Related Fatigue in Advanced Cancer|Recruiting||Phase 2|70|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:09:07.347902|2017-10-10 23:09:07.347902
NCT02491619|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-06-02|||July 2015||2015-07-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Correlation Between Dental Inclination and Bone Thickness in Patients With Class III Dentofacial Deformities|Correlation Between Buccolingual Dental Inclination and Bone Thickness After Orthodontic Decompensation in Patients With Class III Dentofacial Deformities|Active, not recruiting||N/A|40|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-10 23:09:07.474936|2017-10-10 23:09:07.474936
NCT02491606|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-02|||May 1997||1997-05-01|July 2015|2015-07-01|September 1998|Actual|1998-09-01|September 1997|Actual|1997-09-01||Interventional|||Evaluation of Weekly Tafenoquine|Evaluation of Weekly Tafenoquine (SB 252263 / WR 238605) Compared to Placebo for Chemosuppression of Plasmodium Falciparum in Western Kenya|Completed||Phase 2|249|Actual|U.S. Army Medical Research and Materiel Command||4|||f||||f||||||||||2017-10-10 23:09:07.570245|2017-10-10 23:09:07.570245
NCT02491593|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-03-09|||April 2014||2014-04-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|FIKA||Quantitative Immunochemical Fecal Occult Blood Test in Symptomatic Patients|Quantitative Immunochemical Fecal Occult Blood Test in Symptomatic Patients|Enrolling by invitation||N/A|500|Anticipated|Uppsala University|||1||f||||f||||||||||2017-10-10 23:09:07.665071|2017-10-10 23:09:07.665071
NCT02491580|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-02|||October 2014||2014-10-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer|Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer|Completed||N/A|2370|Actual|Uppsala University|||2||f||||f||||||||||2017-10-10 23:09:07.737766|2017-10-10 23:09:07.737766
NCT02491567|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-12-29|||September 2014||2014-09-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Observational|THYRODNA||DNA Methylation and Autoimmune Thyroid Diseases|Study of DNA Methylation in Children and Adolescents With Autoimmune Thyroid Diseases|Active, not recruiting||N/A|100|Anticipated|Aristotle University Of Thessaloniki|||3||f||||f||||||Samples With DNA|"     Blood samples will be collected and centrifuged and then White Blood Cells (WBCs), plasma and     serum will be separated.   "|||2017-10-10 23:09:07.837998|2017-10-10 23:09:07.837998
NCT02491554|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-12-06|||August 2015||2015-08-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|DISTINCT||Deep braIn Stimulation for Tremor TractographIC Versus Traditional|Deep braIn Stimulation for Tremor TractographIC Versus Traditional|Recruiting||N/A|24|Anticipated|University Hospital Freiburg||2|||f||||f||||||||||2017-10-10 23:09:07.945392|2017-10-10 23:09:07.945392
NCT02491541|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-03|2015-07-08|||August 2012||2012-08-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects|A Single-centre, Randomized, Double-blind, Parallel Control, Phase 3 Study to Evaluate the Safety and Immunogenicity of a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects Aged 10-60 Years|Completed||Phase 3|1200|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 23:09:08.211784|2017-10-10 23:09:08.211784
NCT02491528|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-07-02|||June 2015||2015-06-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety|A Multi-center, Randomized, Open-label, Parallel-group, Phase Ⅲ Study to Evaluate the Efficacy and Safety of Insulin Aspart Injection in Patients With Diabetes Mellitus Compared to NovoRapid®|Unknown status|Recruiting|Phase 3|560|Anticipated|Tonghua Dongbao Pharmaceutical Co.,Ltd||2|||f||||f||||||||||2017-10-10 23:09:08.307725|2017-10-10 23:09:08.307725
NCT02491515|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2016-11-23|||July 2012||2012-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2017|Anticipated|2017-06-01||Observational|||Effects of Denosumab Therapy for Japanese|Effects of Denosumab Therapy for Japanese Osteoporotic Patients|Recruiting||N/A|500|Anticipated|Tomidahama Hospital|||1||f||||f||||||||||2017-10-10 23:09:08.424908|2017-10-10 23:09:08.424908
NCT02491502|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-04-26|||June 2015||2015-06-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Treatment of Benign Thyroid Nodules With FastScan HIFU|Treatment of Benign Thyroid Nodules With FastScan High Intensity Focused Ultrasound (HIFU)|Recruiting||N/A|15|Anticipated|Theraclion||1|||f||||f||||||||||2017-10-10 23:09:08.553907|2017-10-10 23:09:08.553907
NCT02491489|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-07|||March 2015||2015-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Activity of the Rotator Cuff During Glenohumeral Mobilization|A Comparison of the Effects of Glenohumeral Mobilization on Rotator Cuff Activity in Normal and Painful Shoulders|Completed||N/A|20|Actual|Texas Woman's University||2|||f||||f||||||||||2017-10-10 23:09:08.660757|2017-10-10 23:09:08.660757
NCT02491476|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-07-07|||March 2015||2015-03-01|July 2015|2015-07-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|Epi-FaR||"Recording Fast Ripples Using Microelectrodes During Stereo-encephalography in Patients With Drug-resistant Partial Epilepsy"|"Feasibility and Interest of Recording Fast Ripples Using Microelectrodes During Stereo-encephalography in Patients With Drug-resistant Partial Epilepsy"|Recruiting||N/A|18|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-10 23:09:08.748079|2017-10-10 23:09:08.748079
NCT02491268|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-09-26|||July 2015||2015-07-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|||A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)|A Trial of Cilostazol for Prevention of Conversion From Mild Cognitive Impairment to Dementia|Recruiting||Phase 2|200|Anticipated|National Cerebral and Cardiovascular Center||2|||f||||t||||||||||2017-10-10 23:09:11.034186|2017-10-10 23:09:11.034186
NCT02491450|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2015-07-02|||February 2015||2015-02-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)|Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||||2017-10-10 23:09:08.965053|2017-10-10 23:09:08.965053
NCT02491437|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-10-05|||July 2015||2015-07-01|October 2017|2017-10-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|LOTUS II||A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)|A Randomized, Open-label, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)|Completed||Phase 3|1066|Actual|Abbott||2|||f||||f||||||||||2017-10-10 23:09:09.065733|2017-10-10 23:09:09.065733
NCT02491424|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-04-12|||January 2007||2007-01-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|(ITAP)||Intraosseous Transcutaneous Amputation Prosthesis|Direct Skeletal Fixation of Prosthetic Limbs Following Trans- Femoral Amputation - Study of an Intraosseous Transcutaneous Amputation Prosthesis (ITAP)|Completed||N/A|20|Actual|Stanmore Implants Ltd.||1|||f||||t||||||||||2017-10-10 23:09:09.269498|2017-10-10 23:09:09.269498
NCT02491411|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-05-27|||September 2015||2015-09-01|May 2016|2016-05-01||||December 2018|Anticipated|2018-12-01||Interventional|DEXTER||Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel|A Pilot Study of Dexamethasone Therapy Prior to Rechallenge With Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer Dex EXTends Enza Response (The DEXTER Trial)|Recruiting||N/A|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:09:09.3749|2017-10-10 23:09:09.3749
NCT02491385|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-02|||April 2014||2014-04-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Thoracic Epidural for Postoperative Ileus|Effect of Thoracic Epidural Analgesia on Bowel Function Recovery in Major Upper Abdominal Surgeries|Completed||N/A|28|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 23:09:09.874507|2017-10-10 23:09:09.874507
NCT02491372|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-04-04|||September 2015||2015-09-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||A Pilot Study of the Effectiveness of Acceptance and Commitment Therapy With a Post-Upper GI Cancer Population|A Pilot Study of the Effectiveness of Acceptance and Commitment Therapy With a Post-Upper GI Cancer Population|Withdrawn||N/A|0|Actual|Queen's University, Belfast||2||Unable to recruit sufficient number of participants in the time available.|f||||f||||||||||2017-10-10 23:09:09.952017|2017-10-10 23:09:09.952017
NCT02491359|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-12-20|||November 2015||2015-11-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Interventional|||Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease|Carfilzomib for Treatment of Chronic Graft vs. Host Disease|Recruiting||Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-10 23:09:10.04694|2017-10-10 23:09:10.04694
NCT02491346|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-07-07|||October 2014||2014-10-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||A Trial Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Mechanical Ventilation in ICU|A Randomized Controlled Trial Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Mechanical Ventilation in ICU|Unknown status|Recruiting|Phase 4|46|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 23:09:10.18413|2017-10-10 23:09:10.18413
NCT02491333|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-02-14|||August 2015||2015-08-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The RCT of Acupuncture on PCOS Combined With IR|The Effect of Acupuncture on Insulin Sensitivity of Women With Polycystic Ovary Syndrome and Insulin Resistance: a Randomized Controlled Trial|Recruiting||Phase 3|342|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||3|||f||||t||||||||||2017-10-10 23:09:10.292398|2017-10-10 23:09:10.292398
NCT02491320|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-02-14|||August 2015||2015-08-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|PCOSAPct||The Clinical Trial of Acupuncture Pre-treatment on PCOS|Effect of Acupuncture Pre-treatment Combined With Letrozole on Live Birth in Infertile Women With Polycystic Ovary Syndrome|Recruiting||Phase 3|384|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-10 23:09:10.439975|2017-10-10 23:09:10.439975
NCT02491307|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-04-24|||July 2015||2015-07-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ginger.io Behavioral Health Study|Ginger.io Behavioral Health Study|Terminated||N/A|10|Actual|Community Health Center, Inc.||2|||f||||f||||||||||2017-10-10 23:09:10.569718|2017-10-10 23:09:10.569718
NCT02491294|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-07-28|||July 2012||2012-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|FFF||Fuel for Fun: Cooking With Kids Plus Parents and Play|Cooking With Kids 2.0: Plus Parents and Play|Active, not recruiting||N/A|2640|Anticipated|Colorado State University||5|||f||||f||||||||Yes|Once all data has been collected, analyzed and published we plan to explore how to share de-identified accelerometry data for children and adults.|2017-10-10 23:09:10.801151|2017-10-10 23:09:10.801151
NCT02491255|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-03-13|||June 22, 2015|Actual|2015-06-22|March 2017|2017-03-01|December 30, 2021|Anticipated|2021-12-30|January 30, 2017|Actual|2017-01-30||Interventional|||Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement (REPRISE Japan)|REPRISE Japan: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Clinical Evaluation in Japan|Active, not recruiting||N/A|70|Actual|Boston Scientific Corporation||1|||f||||t||||||||Undecided||2017-10-10 23:09:11.160029|2017-10-10 23:09:11.160029
NCT02491242|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2017-01-26|||November 2015||2015-11-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|12 Months|Observational [Patient Registry]|DOLBI||Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression|The Efficacy and Safety of Dolutegravir-based Dual Therapies in HIV-infected Patients With Intolerance or Toxicity to Nucleoside Analogues|Recruiting||N/A|100|Anticipated|Asociacion para el Estudio de las Enfermedades Infecciosas|||1||f||||f||||||||Undecided||2017-10-10 23:09:11.319852|2017-10-10 23:09:11.319852
NCT02491229|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-01-13|||January 2015||2015-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||"Hepafast in Non-alcoholic Fatty Liver Disease (NAFLD)"|"Clinical Trial for Investigating the Effects of Hepafast on Non-alcoholic Fatty Liver Disease (NAFLD)"|Completed||N/A|40|Actual|University of Hohenheim||2|||f||||f||||||||||2017-10-10 23:09:11.434807|2017-10-10 23:09:11.434807
NCT02491216|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-05-10|||August 2015||2015-08-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study on Effects of Acupressure Among the Frail Elderly in Residential Care Services for the Elderly|A Study on Effects of Acupressure Among the Frail Elderly in Homes for the Aged and Care and Attention Homes for the Elderly|Completed||N/A|65|Actual|The University of Hong Kong||2|||f||||t||||||||Undecided||2017-10-10 23:09:11.581309|2017-10-10 23:09:11.581309
NCT02491203|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-10-26|||September 2014||2014-09-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||Post-stroke Upper Limb Rehabilitation Using Telerehabilitation Interactive Virtual Reality System in the Patient's Home|Maximizing Post-stroke Upper Limb Rehabilitation Using a Novel Telerehabilitation Interactive Virtual Reality System in the Patient's Home|Active, not recruiting||N/A|52|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-10 23:09:11.711547|2017-10-10 23:09:11.711547
NCT02491190|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-05-12|||August 2015||2015-08-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Using Multimedia Digital Health to Enable and Engage Pediatric Inpatients and Their Parents|Using Multimedia Digital Health to Enable and Engage Pediatric Inpatients and Their Parents: A Pilot Study|Completed||N/A|58|Actual|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 23:09:11.828015|2017-10-10 23:09:11.828015
NCT02491177|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-12-22|||May 2014||2014-05-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|MOTIVATE!||Mother and Infant Visit Adherence and Treatment Engagement Study|Maximizing Adherence and Retention for Women and Infants in the Context of Option B+|Recruiting||N/A|1336|Anticipated|University of Colorado, Denver||4|||f||||f||||||||||2017-10-10 23:09:11.93519|2017-10-10 23:09:11.93519
NCT02491164|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-05-02|||April 2016||2016-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BAC TWO||Exploratory Study of Intrapulmonary Microdosing of Gram-negative Optical Imaging Detection Probe|Exploratory Clinical Study of Intrapulmonary Microdosing of Gram-negative Optical Molecular Imaging BACterial Detection Probe|Recruiting||Early Phase 1|12|Anticipated|University of Edinburgh||1|||f||||t||||||||No||2017-10-10 23:09:12.065481|2017-10-10 23:09:12.065481
NCT02491151|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-05-01|||October 2014||2014-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Variability of Fluconazole Concentration in Critically Ill Patients|Fluconazole Exposure in Critically Ill Patients and the Value of Therapeutic Drug Monitoring|Completed||N/A|50|Actual|University Medical Center Groningen|||1||f||||f||||||Samples Without DNA|"     Whole blood, serum   "|||2017-10-10 23:09:12.182957|2017-10-10 23:09:12.182957
NCT02491138|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-07-20|||July 2015||2015-07-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||An Evaluation of Appearance-based Interventions for the Promotion of Sleep||Completed||N/A|60|Actual|Yale-NUS College||2|||f||||||||||||||2017-10-10 23:09:12.265401|2017-10-10 23:09:12.265401
NCT02491125|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-07-01|||July 2015||2015-07-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prebiotics and Metabolism|Effect of Prebiotic Fibre AXOS on Intestinal Health and Functioning|Unknown status|Not yet recruiting|N/A|50|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:09:12.366044|2017-10-10 23:09:12.366044
NCT02491099|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-12-01|||June 2015||2015-06-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|Afatinib||A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma|A Phase II Evaluation of Afatanib, an Irreversible Human Epidermal Growth Factor Receptor 2 (Her2/Neu) Tyrosine Kinase Inhibitor, in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma|Recruiting||Phase 2|50|Anticipated|Yale University||1|||f||||t||||||||||2017-10-10 23:09:12.494668|2017-10-10 23:09:12.494668
NCT02491086|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|January 2016|Actual|2016-01-01||Interventional|||Motivating Smokers at Outdoor Public Smoking Hotspots to Have Quit Attempt With Nicotine Replacement Therapy Sampling|Motivating Smokers at Outdoor Public Smoking Hotspots to Have Quit Attempt With Nicotine Replacement Therapy Sampling: A Randomized Controlled Trial|Completed||N/A|100|Actual|The University of Hong Kong||2|||f||||f||||||||Yes||2017-10-10 23:09:12.643045|2017-10-10 23:09:12.643045
NCT02490514|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-08-17|||December 2009||2009-12-01|August 2015|2015-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis|Mircera In Patients With CKD Stages III-IV Not On Dialysis: Observational, Non-interventional Cohort Study|Completed||N/A|153|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:09:20.023127|2017-10-10 23:09:20.023127
NCT02491060|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-09-11|||September 2015||2015-09-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris|A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris|Unknown status|Not yet recruiting|Phase 3|800|Anticipated|Valeant Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:09:12.854248|2017-10-10 23:09:12.854248
NCT02491047|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-12-06|||October 2015||2015-10-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Performance of BonyPid-1000™ in the Treatment of Gustilo IIIA and IIIB Tibial Open Fractures|Safety and Performance of BonyPid-1000™ in the Treatment of Gustilo IIIA and IIIB Tibial Open Fractures|Recruiting||N/A|64|Anticipated|PolyPid Ltd.||2|||f||||f||||||||||2017-10-10 23:09:12.967735|2017-10-10 23:09:12.967735
NCT02491034|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-10-28|||January 2015||2015-01-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|DESEO||DESEO: DEpression Screening and Education: Options to Reduce Barriers to Treatment|DESEO: DEpression Screening and Education: Options to Reduce Barriers to Treatment|Enrolling by invitation||N/A|350|Anticipated|The University of Texas at Arlington||1|||f||||f||||||||||2017-10-10 23:09:13.090393|2017-10-10 23:09:13.090393
NCT02491021|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-07|||October 2007||2007-10-01|July 2015|2015-07-01||||December 2011|Actual|2011-12-01||Interventional|||Outpatient Based Physical Rehabilitation for Survivors of Prolonged Critical Illness|Outpatient Based Physical Rehabilitation for Survivors of Prolonged Critical Illness - a Randomised Controlled Trial|Completed||Phase 2|63|Actual|University Hospital Birmingham NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:09:13.173759|2017-10-10 23:09:13.173759
NCT02491008|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-01-31|||January 2014||2014-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TRUST BONE||Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction|Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction: a Prospective Evaluation and Impact of Treatment|Completed||Phase 4|145|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:09:13.262504|2017-10-10 23:09:13.262504
NCT02490995|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-06|||November 2014||2014-11-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Inform and Reduce Pre-surgical Anxiety of the Child and His Parents: Interest of an Explanatory Movie.|Inform and Reduce Pre-surgical Anxiety of the Child and His Parents: Interest of an Explanatory Movie About the Pathway of the Child in Pediatric Surgery.|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:09:13.371095|2017-10-10 23:09:13.371095
NCT02490982|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-05-23|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Teriflunomide Observational Effectiveness Study|Teriflunomide Observational Effectiveness Study|Enrolling by invitation||N/A|300|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||No||2017-10-10 23:09:13.51501|2017-10-10 23:09:13.51501
NCT02490969|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-05-23|||September 2015||2015-09-01|May 2017|2017-05-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23|28 Days|Observational [Patient Registry]|proCORE||Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19|Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19|Completed||N/A|2256|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||Undecided|Data will be shared on reasonable request|2017-10-10 23:09:13.617319|2017-10-10 23:09:13.617319
NCT02490956|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-07-02|||April 2015||2015-04-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Diagnostic Immunization With Rabies Vaccine in Patients With PID|Diagnostic Immunization With Rabies Vaccine in Patients With Primary Immunodeficiency Disorders|Unknown status|Recruiting|Phase 4|40|Anticipated|Chulalongkorn University||1|||f||||t||||||||||2017-10-10 23:09:13.705822|2017-10-10 23:09:13.705822
NCT02490943|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-01-31|||June 2015||2015-06-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|PEG-Thermal||A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS|A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in Multiple Sclerosis|Recruiting||N/A|28|Anticipated|Brown, Theodore R., M.D., MPH||3|||f||||f||||||||||2017-10-10 23:09:13.821503|2017-10-10 23:09:13.821503
NCT02490930|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-09-12|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma|A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma|Completed||Early Phase 1|5|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:09:13.935467|2017-10-10 23:09:13.935467
NCT02490917|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-11-02|||September 2015||2015-09-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|SU-ACT||ACT™ Balloons Versus Artificial Urinary Sphincter (AMS800™) for the Treatment of Female Stress Urinary Incontinence|Randomised Comparative Prospective Study of the Treatment of Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency : ACT™ Balloon Versus Artificial Urinary Sphincter ( AMS800™)|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:09:14.044993|2017-10-10 23:09:14.044993
NCT02490904|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-06-21|||October 2016||2016-10-01|June 2017|2017-06-01|July 2030|Anticipated|2030-07-01|July 2020|Anticipated|2020-07-01||Interventional|EPURE||Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)|Double-blind Placebo-Controlled Randomised Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenon After Renal Tranplantation : Effect on Graft Function at 3 Months.|Recruiting||Phase 3|132|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 23:09:14.143787|2017-10-10 23:09:14.143787
NCT02490891|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-07-19|||July 2015||2015-07-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|RGDLymphome||Study of the Angiogenesis by PET/CT in Patients With Lymphoma|Study of the Angiogenesis Measured by PET/CT With 18F-RGD-K5 in Patients With Lymphoma : a Preliminary Study|Recruiting||Phase 2|25|Anticipated|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 23:09:14.270419|2017-10-10 23:09:14.270419
NCT02490137|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-10-25|||June 2015||2015-06-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|BrainGame||Brain Changes With Game Training in Aging|Brain Changes With Game Training in Aging|Recruiting||N/A|40|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 23:09:26.989459|2017-10-10 23:09:26.989459
NCT02490878|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-09-29|||April 2016||2016-04-01|September 2017|2017-09-01||||April 2020|Anticipated|2020-04-01||Interventional|||Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases|Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases|Recruiting||Phase 2|130|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 23:09:14.385151|2017-10-10 23:09:14.385151
NCT02490865|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-09-18|||July 2015||2015-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Systemic Bioactivity of Inhaled Nebulized RNS60|Systemic Bioactivity of Inhaled Nebulized RNS60|Completed||Phase 1|56|Actual|Revalesio Corporation||2|||f||||||||||||||2017-10-10 23:09:15.841187|2017-10-10 23:09:15.841187
NCT02490852|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-09-18|||August 2015||2015-08-01|July 2017|2017-07-01||||January 2019|Anticipated|2019-01-01||Interventional|||Study of Nutritional Suitability of a New Infant Formula for Term Infants|Study of Nutritional Suitability of a New Infant Formula for Term Infants|Recruiting||N/A|258|Anticipated|Ausnutria Hyproca B.V.||3|||f||||||||||||||2017-10-10 23:09:15.917659|2017-10-10 23:09:15.917659
NCT02490839|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-09-19|||July 2015||2015-07-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection|Efficacy of High-dose Dual Therapy Versus Bismuth-containing Quadruple Therapy for Rescue Treatment of Helicobacter Pylori Infection - A Prospective, Randomized, Comparative Study|Recruiting||Phase 4|440|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-10 23:09:16.090986|2017-10-10 23:09:16.090986
NCT02490826|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-06-28|||October 2014||2014-10-01|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Table to Tablet (T2T): A Novel Intervention Framework for Children With Speech Sound Disorders|Intervention Software for Children With Speech Sound Disorders|Active, not recruiting||N/A|22|Actual|Aveiro University||2|||f||||f||||||||||2017-10-10 23:09:16.218384|2017-10-10 23:09:16.218384
NCT02490813|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-08-15|||August 2015||2015-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|TCMFA||Pilot Study on Traditional Chinese Medicine and Food Allergy|Pilot Study on Traditional Chinese Medicine and Food Allergy|Recruiting||N/A|24|Anticipated|Hong Kong Sanatorium & Hospital||2|||f||||t||||||||||2017-10-10 23:09:16.327372|2017-10-10 23:09:16.327372
NCT02490800|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-12-03|||June 2015||2015-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma|An Open-label Phase 1/2a Study of Oral BAL101553 in Adult Patients With Advanced Solid Tumors and in Adult Patients With Recurrent or Progressive Glioblastoma or High-grade Glioma|Recruiting||Phase 1/Phase 2|92|Anticipated|Basilea Pharmaceutica||1|||f||||f||||||||||2017-10-10 23:09:16.431933|2017-10-10 23:09:16.431933
NCT02490787|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-07-20|||September 10, 2015|Actual|2015-09-10|July 2017|2017-07-01|October 14, 2016|Actual|2016-10-14|October 14, 2016|Actual|2016-10-14||Interventional|||Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects|A Multi-centre, Randomised, Placebo Controlled, Double Blinded, Multiple Dose Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects (Explorer™3)|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 23:09:16.563263|2017-10-10 23:09:16.563263
NCT02490774|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-07-12|||June 22, 2015|Actual|2015-06-22|July 2017|2017-07-01|July 22, 2016|Actual|2016-07-22|May 26, 2016|Actual|2016-05-26||Interventional|||To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development|Multi-center, Randomized, Comparator-controlled, Single-blind, Parallel-group Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of an Intrauterine System Releasing BAY 1007626, as Compared With Mirena and Jaydess, in a Combined Proof-of-concept and Dose-finding Study in Healthy Pre Menopausal Women Treated for 90 Days|Completed||Phase 2|174|Actual|Bayer||6|||f||||f|f|f||||||||2017-10-10 23:09:16.742249|2017-10-10 23:09:16.742249
NCT02490761|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-08-16|||September 22, 2015|Actual|2015-09-22|August 2017|2017-08-01|August 3, 2016|Actual|2016-08-03|August 3, 2016|Actual|2016-08-03||Observational|||Food Intake in Older Patients|Food Intake and Preferences in Older Patients During Hospitalisation|Completed||N/A|48|Actual|NHS Greater Glasgow and Clyde|||1||f||||f||||||||||2017-10-10 23:09:16.869702|2017-10-10 23:09:16.869702
NCT02490748|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-02-21|||July 2015||2015-07-01|February 2016|2016-02-01|June 2040|Anticipated|2040-06-01|June 2038|Anticipated|2038-06-01||Interventional|||Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer|Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer|Active, not recruiting||Phase 2|10|Actual|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:09:16.949643|2017-10-10 23:09:16.949643
NCT02490735|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-02|||August 2015||2015-08-01|July 2015|2015-07-01|August 2042|Anticipated|2042-08-01|August 2040|Anticipated|2040-08-01||Interventional|||CIK in Treating Patients With Esophageal Cancer|A Randomized Controlled Study of Cytokine-induced Killer Cells (CIK) Treatment in Patients With Staging Ⅰ-Ⅲ of Esophageal Carcinoma|Not yet recruiting||Phase 2|2000|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:09:17.03887|2017-10-10 23:09:17.03887
NCT02490722|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-07-31|||January 2016||2016-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Patient Education on Functions in Patients With Non-specific and/or Degenerative Low Back Pain|The Effect of Interdisciplinary Group Based Patient Education on Functions in Patients With Non-specific and/or Degenerative Low Back Pain|Withdrawn||N/A|0|Actual|Nordsjaellands Hospital||2|||f||||f||||||||||2017-10-10 23:09:17.124837|2017-10-10 23:09:17.124837
NCT02490709|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2015-07-02|||April 2015||2015-04-01|July 2015|2015-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy|Local Excision of Clinical T3 Mid- or Low-Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy: Prospective Multicenter Single-arm Phase II Clinical Trial|Recruiting||Phase 2|86|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-10 23:09:17.216952|2017-10-10 23:09:17.216952
NCT02490696|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-07-19|||June 1, 2015|Actual|2015-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|RTEP6||Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer|Comparative Study of the Hypoxia Measured in FAZA and F-miso TEP/CT Scan in Patients With Non-small Cell Lung Cancer at the Time of Diagnosis : Correlation With Immunohistochemistry|Recruiting||Phase 2|20|Anticipated|Centre Henri Becquerel||2|||f||||f||||||||||2017-10-10 23:09:17.320673|2017-10-10 23:09:17.320673
NCT02490683|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Soy Based Dietary Supplements on Cardiometabolic Risk Factors.|The Effect of Soy-based Dietary Supplements on Cardiometabolic Risk Factors in Individuals at High Risk for Cardiovascular Disease|Completed||N/A|24|Actual|Loma Linda University||3|||f||||f||||||||||2017-10-10 23:09:17.431394|2017-10-10 23:09:17.431394
NCT02490670|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-09-05|2016-09-05||July 2015||2015-07-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||All randomized participants who received at least one dose of study drug.|A Study of Cephalexin Liquid in Healthy Participants|A Randomized, Open-label, Two-period, Two-treatment, Two-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of Two Oral Preparations in Suspension With 250 mg/5 ml of Cephalexin (Keflex® Liquido Made in Mexico by Eli Lilly y compañía De méxico, s.a. De cv. Vs. Keflex® Liquido Made by Antibioticos do Brasil Ltda for Eli Lilly y compañía de México, s.a. De c.v.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:09:17.520926|2017-10-10 23:09:17.520926
NCT02490657|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-06-19|||July 2015||2015-07-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation||Completed||N/A|44|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:09:18.364737|2017-10-10 23:09:18.364737
NCT02490644|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-01|||November 2014||2014-11-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Observational|||Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Valvular Heart Surgery||Unknown status|Recruiting|N/A|250|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-10 23:09:18.468704|2017-10-10 23:09:18.468704
NCT02490631|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-08-11|||August 2015||2015-08-01|June 2015|2015-06-01||||June 2017|Anticipated|2017-06-01||Interventional|DeSSI||2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients|A Randomized Controlled Trial of 2% Chlorhexidine Gluconate Skin Preparation Cloths for the Prevention of Post op Surgical Site Infections in Spine Patients (Decrease SSI or DeSSI)|Unknown status|Recruiting|Phase 3|150|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-10-10 23:09:18.719139|2017-10-10 23:09:18.719139
NCT02490618|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-03-02|||January 2016||2016-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Use of a Probiotic Lozenge in the Treatment of Residual Pockets After Classical Non-surgical Therapy|The Use of a Probiotic Lozenge in the Treatment of Residual Pockets After Classical Non-surgical Therapy|Recruiting||N/A|40|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 23:09:18.917806|2017-10-10 23:09:18.917806
NCT02490605|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-07-01|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|Simone||Effect of the Use of an Occlusal Plate on the Postural Alignment|Effect of the Use of an Occlusal Plate on the Postural Alignment and Balance of Individuals With Signs and Symptoms of Temporomandibular Joint Disorder|Unknown status|Not yet recruiting|N/A|46|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:09:19.08754|2017-10-10 23:09:19.08754
NCT02490592|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-07-06|||March 2014||2014-03-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Comparison of the Effect of Fluoride Remineralizer Gel and Foam|Comparison of the Effect of Fluoride Remineralizer Gel and Foam: a Randomized Clinical Trial|Completed||Phase 4|58|Actual|University Center of João Pessoa||2|||f||||t||||||||||2017-10-10 23:09:19.239321|2017-10-10 23:09:19.239321
NCT02490579|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-05-20|||May 2015||2015-05-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Observational|||Effectiveness of Video Messaging About Diet, Exercise and Weight Gain in Pregnancy in Regional and National Samples|Effectiveness of Video Messaging About Diet, Exercise and Weight Gain in Pregnancy in Regional and National Samples|Completed||N/A|1670|Actual|University of Michigan|||3||f||||f||||||||No||2017-10-10 23:09:19.373424|2017-10-10 23:09:19.373424
NCT02490566|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-07-23|||July 2015||2015-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Enhanced Primary Care and Technology for Children With Chronic Disease|Piloting Enhanced Pediatric Care for Children With Chronic Condition/Technology Trial|Completed||N/A|35|Actual|University of Miami||1|||f||||f||||||||||2017-10-10 23:09:19.541981|2017-10-10 23:09:19.541981
NCT02490553|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-01|||January 2011||2011-01-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Observational|ELISABET||Epidemiological Study on the Relationship Between Respiratory Health and Air Pollution From Industrial Sources|ELISABET : Enquête LIttoral Souffle Air Biologie Environnement|Completed||N/A|3276|Actual|University Hospital, Lille|||2||f||||f||||||Samples With DNA|"     -  A 2 ml aliquot of heparinized plasma stored at -20 ° C        -  Five 0.5 ml aliquots of EDTA plasma stored at -80 ° C        -  Two 1-ml aliquots of EDTA blood stored at -80 ° C        -  An aliquot of 10 ml and three aliquots of 5 ml of urine stored at -80 ° C        -  Two locks of hair preserved in an envelope at room temperature        -  Six 0.250 ml aliquots of condensate stored at -80 ° C        -  DNA extraction.   "|||2017-10-10 23:09:19.675212|2017-10-10 23:09:19.675212
NCT02490540|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-11-15|||June 2015||2015-06-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||ANI and SPI Guided Intraoperative Analgesia|ANI and SPI Guided Intraoperative Analgesia in Patients Undergoing Neurosurgical Procedures Under General Anaesthesia|Completed||N/A|72|Actual|University Hospital Hradec Kralove||3|||f||||f||||||||||2017-10-10 23:09:19.765403|2017-10-10 23:09:19.765403
NCT02490527|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-06-02|||June 2015||2015-06-01|June 2016|2016-06-01||||June 2019|Anticipated|2019-06-01||Interventional|||Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity|Effects of Epicatechin on Patients With Statin-induced Mitochondrial Dysfunction and Impaired Exercise Capacity|Recruiting||N/A|50|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:09:19.901302|2017-10-10 23:09:19.901302
NCT02490501|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-12-27|||June 2015||2015-06-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects|An Open, Randomized, Rehabilitation-controlled Study to Assess Safety, Tolerability, and Efficacy of Heparin Activated Recombinant Fibroblast Growth Factor 1 on a Biodegradable Device in Subjects With Traumatic Spinal Cord Injury|Recruiting||Phase 1/Phase 2|27|Anticipated|BioArctic Neuroscience AB||2|||f||||t||||||||||2017-10-10 23:09:20.15677|2017-10-10 23:09:20.15677
NCT02490488|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-07-02|||April 2014||2014-04-01|July 2015|2015-07-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Masitinib in Ovarian Cancer|A Prospective, Multicenter, Open-label, Centrally Allocated, Activecontrolled, Phase 2 Study to Evaluate the Efficacy and Safety of Masitinib in Ovarian Cancer|Active, not recruiting||Phase 2|68|Anticipated|AB Science||2|||f||||t||||||||||2017-10-10 23:09:20.289892|2017-10-10 23:09:20.289892
NCT02490475|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-04-12|2015-07-28||February 2004||2004-02-01|April 2017|2017-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional||The Intent-To-Treat (ITT) Population included all participants who received any amount of the study medication.|A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors|A Phase Ib, Open-Label, Multicenter Study of the Safety and Pharmacokinetics of the Combination of RhuMab 2C4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Docetaxel (Taxotere) in Patients With Advanced Solid Tumors|Completed||Phase 1|19|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 23:09:20.44423|2017-10-10 23:09:20.44423
NCT02490462|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-08-09|||May 2015||2015-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Impact of an Education Program for Parents of Children With Cerebral Palsy|Impact of Physical Therapy Associated With a Program of Education of Caregivers in Functioning and Quality of Life of Children With Cerebral Palsy|Active, not recruiting||N/A|30|Anticipated|Federal University of Bahia||2|||f||||f||||||||||2017-10-10 23:09:22.389357|2017-10-10 23:09:22.389357
NCT02490449|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2015-07-02|||December 2014||2014-12-01|July 2015|2015-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Dexlansoprazole MR in Nonerosive Reflux Disease||Unknown status|Enrolling by invitation|N/A|356|Anticipated|Soonchunhyang University Hospital||2|||f||||||||||||||2017-10-10 23:09:22.473002|2017-10-10 23:09:22.473002
NCT02490436|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-11-07|||October 2015||2015-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|NoTOPain||Novel Treatment Option for Neuropathic Pain|A Randomized, Cross-over, Placebo-controlled, Double-blind, Single-center, Phase II Study of Cetuximab in Patients With Treatment-refractory, Non-malignant Severe Chronic Neuropathic Pain|Completed||Phase 2|15|Actual|Sorlandet Hospital HF||2|||f||||t||||||||||2017-10-10 23:09:22.539763|2017-10-10 23:09:22.539763
NCT02490423|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-10-06|||March 2016||2016-03-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|ENCOURAGE||Improvement in Medication Compliance Through the Implementation of Personalized Nudges: the ENCOURAGE Trial|Improvement in Medication Compliance Through the Implementation of Personalized Nudges|Recruiting||N/A|200|Anticipated|Intermountain Health Care, Inc.||2|||f||||f||||||||||2017-10-10 23:09:22.625093|2017-10-10 23:09:22.625093
NCT02490410|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-02|||July 2015||2015-07-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Effects of Whey Protein Intervention on Body Composition and Muscle Function in the Elderly With Sacropenia|A Double-blind Randomized Controlled Study About the Effects of Whey Protein Intervention on Body Composition and Muscular Function in the Elderly With Sacropenia|Unknown status|Not yet recruiting|N/A|90|Anticipated|Sun Yat-sen University||3|||f||||||||||||||2017-10-10 23:09:22.736253|2017-10-10 23:09:22.736253
NCT02490397|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-09-21|||July 2015||2015-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Impact of Daylight on Patients With Acute Myocardial Infarction|Impact of Daylight on Period 2 Protein and Glycolytic Enzymes in Human Buccal Mucosa and Blood Samples|Recruiting||N/A|30|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:09:22.795951|2017-10-10 23:09:22.795951
NCT02490384|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-04-19|||June 2015||2015-06-01|April 2016|2016-04-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|TWIN-PEIC||Physical Exam Indicated Cerclage in Twin Gestations|Randomized Control Trial Physical Exam Indicated Cerclage in Twin Gestations|Recruiting||N/A|52|Anticipated|Thomas Jefferson University||2|||f||||t||||||||Undecided||2017-10-10 23:09:22.882463|2017-10-10 23:09:22.882463
NCT02490371|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2017-04-08|||December 2015||2015-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|PT||Low Frequency rTMS With Structured PT Training on Restoring Upper Extremity Function|The Effectiveness of Combination of Low Frequency Repetitive Transcranial Magnetic Stimulation With Structured Physiotherapy Training Program on Restoring Upper Extremity Function for Patients After Stroke|Recruiting||N/A|26|Anticipated|Queen Elizabeth Hospital, Hong Kong||2|||f||||t||||||||Yes||2017-10-10 23:09:23.025682|2017-10-10 23:09:23.025682
NCT02490358|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-02-02|||June 2015||2015-06-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers|A Sputum Sample Collection Protocol for Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-Smokers|Completed||N/A|25|Actual|Respivert Ltd|||3||f||||t||||||Samples With DNA|"     Sputum   "|||2017-10-10 23:09:23.105494|2017-10-10 23:09:23.105494
NCT02490345|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-08-21|||October 2015||2015-10-01|August 2017|2017-08-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Gabapentin as Adjunctive Treatment for Postoperative Pain Control|Effect of Gabapentin on Postoperative Pain Control After a Cesarean Section|Completed||Phase 1|13|Actual|Indiana University||2|||f||||t||||||||||2017-10-10 23:09:23.16132|2017-10-10 23:09:23.16132
NCT02490332|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-02-14|||February 2016||2016-02-01|February 2016|2016-02-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|SIUTIT||The Effects of Ventilation Tubes - The SIUTIT Trial|The Effects of Ventilation Tubes Versus no Ventilation Tubes for Recurrent Acute Otitis Media or Chronic Otitis Media With Effusion in 9 to 36 Month Old Greenlandic Children - a Randomised Clinical Trial|Recruiting||N/A|230|Anticipated|Zealand University Hospital||2|||f||||t||||||||Yes|The final dataset will be publically available in depersonalised format after the end of trial on the Danish Data Archive and ZENODO.|2017-10-10 23:09:23.236955|2017-10-10 23:09:23.236955
NCT02490319|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-08|||September 2008||2008-09-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Observational|||Study on the Biological Prediction Models of Radiation Pneumonitis|Study on the Biological Prediction Models of Radiation Pneumonitis|Unknown status|Recruiting|N/A|300|Anticipated|Huazhong University of Science and Technology|||1||f||||f||||||Samples With DNA|"     From peripheral blood   "|||2017-10-10 23:09:23.327307|2017-10-10 23:09:23.327307
NCT02490306|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-05-16|||July 2015||2015-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase|An Open Multicentre Trial on Suspected Stroke Patients Evaluating the Possibility to Use Microwave Technology to Differentiate Hemorrhage From Infarction in the Acute Phase|Recruiting||N/A|500|Anticipated|Sahlgrenska University Hospital, Sweden||3|||f||||f||||||||||2017-10-10 23:09:23.406083|2017-10-10 23:09:23.406083
NCT02490293|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-02-23|2016-10-20||June 2015||2015-06-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Is it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder?|Is it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder?; a Multicenter Randomized Controlled Trial|Completed||N/A|198|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:09:25.558071|2017-10-10 23:09:25.558071
NCT02490280|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-02|||April 2013||2013-04-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Examining Cortisol and Alpha Amylase in a Healthy Sample of Youth and Adults|Examining Biomarkers of Anxiety in a Healthy Sample of Youth and Adults|Completed||N/A|50|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 23:09:25.846391|2017-10-10 23:09:25.846391
NCT02490267|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-03-15|||June 2014||2014-06-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Quality of Life in Children Glaucoma and Cataract|Health- and Vision-Related Quality of Life in Children and Young People With Childhood Glaucoma, Childhood Cataract and Congenital Eye Defects|Completed||N/A|200|Actual|Moorfields Eye Hospital NHS Foundation Trust|||4||f||||f||||||||||2017-10-10 23:09:25.912934|2017-10-10 23:09:25.912934
NCT02490254|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-07|||October 2014||2014-10-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|1 Year|Observational [Patient Registry]|||Childhood Uveitis Initial Management and One-year Outcomes|Childhood Uveitis Not Associated With Juvenile Idiopathic Arthritis: Incidence, Initial Management and One-year Outcomes|Unknown status|Recruiting|N/A|500|Anticipated|Moorfields Eye Hospital NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:09:25.989745|2017-10-10 23:09:25.989745
NCT02490241|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-09-21|||April 2015||2015-04-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|LiThiUM||Lithium Therapy: Understanding Mothers, Metabolism and Mood|Lithium Therapy: Understanding Mothers, Metabolism and Mood|Recruiting||N/A|20|Anticipated|Northwestern University|||1||f||||t||||||Samples Without DNA|"     Blood serum specimen will be obtained to measure lithium levels. Urine will be collected to     measure lithium levels and creatinine clearance. Standard of care labs will be obtained on     every participant that is eligible and signs informed consent. Participants will also have     the option to have blood drawn for DNA banking.      Participants in the study that elect to receive analgesia for pain related to labor and have     a spinal-epidural at Northwestern University will have CSF stored and banked for future     analysis.   "|No||2017-10-10 23:09:26.063099|2017-10-10 23:09:26.063099
NCT02490228|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-01|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Interventional|||Effectivity and Safety Study of Trans-artificial-urethral Resection of Female Urethral Caruncle||Unknown status|Not yet recruiting|N/A|100|Anticipated|Peking University First Hospital||1|||f||||||||||||||2017-10-10 23:09:26.144548|2017-10-10 23:09:26.144548
NCT02490215|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-07-01|||January 2015||2015-01-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Observational|||Epidemiology of Acute Respiratory Distress Syndrome in Chinese ICUs|Epidemiology of Acute Respiratory Distress Syndrome in Chinese ICUs|Unknown status|Recruiting|N/A|1000|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||||||2017-10-10 23:09:26.211233|2017-10-10 23:09:26.211233
NCT02490202|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-10-26|||August 2015||2015-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant|A Randomized, Placebo-controlled, Prospective, Double-blind, Multicenter Phase 2/3 Study of the Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Recipients of a Donation After Brain Death Kidney Transplant|Completed||Phase 2/Phase 3|60|Actual|Prolong Pharmaceuticals||2|||f||||t||||||||No||2017-10-10 23:09:26.448105|2017-10-10 23:09:26.448105
NCT02490189|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-08-09|||July 2015||2015-07-01|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|November 2017|Anticipated|2017-11-01||Interventional|||Mindfulness-based Intervention Versus CBT for Social Anxiety Disorder|Comparative Trial of a Mindfulness-based Intervention Versus Cognitive Behavior Therapy for Social Anxiety Disorder|Active, not recruiting||N/A|97|Actual|Hopital Montfort||2|||f||||f|f|f||||||||2017-10-10 23:09:26.575551|2017-10-10 23:09:26.575551
NCT02490176|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-02-26|||July 2015||2015-07-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters|Effects of Liraglutide on Hemodynamic Parameters in Patients With Heart Failure|Recruiting||N/A|50|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:09:26.694857|2017-10-10 23:09:26.694857
NCT02490163|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-01-08|||August 2015||2015-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|CMNC_MNC||Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC)|Comparison of Two Automated Mononuclear Collection Systems (Spectra Optia CMNC and MNC) in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study.|Completed||Phase 3|51|Actual|IRCCS Policlinico S. Matteo||2|||f||||f||||||||||2017-10-10 23:09:26.795769|2017-10-10 23:09:26.795769
NCT02490150|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-05-15|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Corifollitropin Alfa on D5 Versus D7 After Contraceptive Pill|Administration of Corifollitropin Alfa on Day 5 Versus Day 7 After Last Oral Contraceptive Pill in a GnRH (Gonadotropin-releasing Hormone ) Antagonist Protocol in Donors|Completed||Phase 4|70|Actual|Institut Universitari Dexeus||2|||f||||f||||||||||2017-10-10 23:09:26.903008|2017-10-10 23:09:26.903008
NCT02490124|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-01-12|||December 2014||2014-12-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|EJB046||The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans|The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans|Completed||N/A|7|Actual|University of Virginia|||2||f||||f||||||||||2017-10-10 23:09:27.104365|2017-10-10 23:09:27.104365
NCT02490111|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-08-03|||April 2015||2015-04-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer|Efficacy and Safety of DWJ1319 in the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer: A Multicenter, Randomized, Double-blind, Placebo-controlled Study|Recruiting||Phase 3|519|Anticipated|Daewoong Pharmaceutical Co. LTD.||3|||f||||||||||||||2017-10-10 23:09:27.220201|2017-10-10 23:09:27.220201
NCT02490098|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-07-03|||January 2018|Anticipated|2018-01-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes|An Open-label, Randomized, Five-way, Cross-over Study to Compare the Efficacy of Single- and Dual-hormone Closed-loop Operations Combined With Either Conventional Carbohydrate Counting or a Simplified Qualitative Meal-size Estimation, and Sensor-augmented Pump Therapy in Regulating Glucose Levels in Children and Adults With Type 1 Diabetes|Not yet recruiting||Phase 2|30|Anticipated|Institut de Recherches Cliniques de Montreal||5|||f||||f|f|f||||||||2017-10-10 23:09:27.347682|2017-10-10 23:09:27.347682
NCT02490085|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-04-25|||October 2015||2015-10-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy|An Open-label, Randomized, Two-way, Cross-over Multicenter Study to Assess the Efficacy of Closed-loop Strategy as Compared to Multiple Daily Injections in Regulating Glucose Levels During 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy|Recruiting||Phase 2|16|Anticipated|Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||||2017-10-10 23:09:27.477404|2017-10-10 23:09:27.477404
NCT02490072|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-08-06|||July 2015||2015-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Echocardiographic Evaluation of the Effects of Dexmedetomidine in Diastolic Dysfunction||Completed||N/A|40|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:09:27.618446|2017-10-10 23:09:27.618446
NCT02490059|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-01|||November 2000||2000-11-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|November 2003|Actual|2003-11-01||Interventional|Babyscope||Ultrathin Bronchoscopy for Solitary Pulmonary Nodules|Ultrathin Bronchoscopy for Solitary Pulmonary Nodules: A Randomised Pilot Trial|Completed||Phase 4|40|Actual|University of Zurich||2|||f||||f||||||||||2017-10-10 23:09:27.699076|2017-10-10 23:09:27.699076
NCT02490046|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-07-01|||February 2015||2015-02-01|July 2015|2015-07-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||D-mannose for the Prevention of UTIs in Multiple Sclerosis|Single Centre Open-label Feasibility Study Evaluating the Use of D-mannose in Multiple Sclerosis|Unknown status|Recruiting|Phase 1|20|Anticipated|University College, London||2|||f||||t||||||||||2017-10-10 23:09:27.788073|2017-10-10 23:09:27.788073
NCT02490033|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-07-02|||April 2015||2015-04-01|July 2015|2015-07-01||||April 2017|Anticipated|2017-04-01||Interventional|VERISMART||The VERISMART Trial|Randomised Trial Comparing Conventional Versus Contact Force and Electrical Coupling Index in Atrial Flutter Ablation|Unknown status|Recruiting|N/A|120|Anticipated|The Leeds Teaching Hospitals NHS Trust||4|||f||||f||||||||||2017-10-10 23:09:27.893171|2017-10-10 23:09:27.893171
NCT02490020|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-02|||January 2016||2016-01-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death||Enrolling by invitation||Phase 1|260|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||8|||f||||t||||||||||2017-10-10 23:09:27.986601|2017-10-10 23:09:27.986601
NCT02490007|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-10-17|||October 2015||2015-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|PIFA||Pertussis Immunisation and Food Allergy|Case-control Study of the Association Between Pertussis Vaccination in Infancy and the Risk of IgE-mediated Food Allergy|Recruiting||N/A|11000|Anticipated|Telethon Kids Institute|||2||f||||f||||||||No||2017-10-10 23:09:28.069268|2017-10-10 23:09:28.069268
NCT02489994|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-03-17|||October 2014||2014-10-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Performance of the ePrime System for Cellulite|Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite|Active, not recruiting||N/A|51|Actual|Syneron Medical||1|||f||||f||||||||Undecided||2017-10-10 23:09:28.244655|2017-10-10 23:09:28.244655
NCT02489981|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-25|||June 1, 2015|Actual|2015-06-01|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Specific Use-result Surveillance of Spiriva Respimat in Asthmatics|Specific Use-result Surveillance of Spiriva Respimat in Asthmatics (Patients With Severe Persistent Asthma)|Active, not recruiting||N/A|359|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:09:28.381591|2017-10-10 23:09:28.381591
NCT02489968|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-07-21|||May 12, 2015|Actual|2015-05-12|July 2017|2017-07-01|June 16, 2017|Actual|2017-06-16|November 18, 2016|Actual|2016-11-18||Interventional|||Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus|A Phase III, Randomised, Double-blind, Parallel Group, 24-week Study to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg and Linagliptin 5 mg Fixed Dose Combination Compared With Empagliflozin 10 mg Plus Placebo and a 52-week Study to Evaluate Efficacy and Safety of Once Daily Empagliflozin 25 mg and Linagliptin 5 mg Fixed Dose Combination Compared With Empagliflozin 25 mg Plus Placebo in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control After 16-week Treatment With Empagliflozin (10 mg or 25 mg) Alone Once Daily.|Completed||Phase 3|889|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:09:28.495372|2017-10-10 23:09:28.495372
NCT02489955|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-07-02|||February 2015||2015-02-01|July 2015|2015-07-01||||February 2017|Anticipated|2017-02-01||Interventional|||Antibiotic Nephrotoxicity in Adult Patients With Cystic Fibrosis|Prospective Randomised Trial of 'Area Under the Curve' (AUC) Dosing Strategy for Intravenous Tobramycin Versus Standard Trough Dosing for Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis (CF)|Unknown status|Recruiting|N/A|||The Leeds Teaching Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 23:09:28.807251|2017-10-10 23:09:28.807251
NCT02489942|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-09-05|||June 12, 2015|Actual|2015-06-12|September 2017|2017-09-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Observational|||Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus|Post Marketing Surveillance in Japan on Long Term Drug Use of JARDIANCE® Tablets in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||N/A|5207|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:09:28.930688|2017-10-10 23:09:28.930688
NCT02489929|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-07-02|||August 2015||2015-08-01|July 2015|2015-07-01|March 2019|Anticipated|2019-03-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine|Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplasic Syndrom or an Acute Myeloid Leukemia and Treated by Azacytidine|Not yet recruiting||N/A|35|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:09:29.038866|2017-10-10 23:09:29.038866
NCT02489916|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2016-01-03|||March 2014||2014-03-01|October 2014|2014-10-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer|Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer: Multicentre, Open-label,Phase 1B Safety Study|Completed||Phase 1/Phase 2|47|Actual|Suzhou Zelgen Biopharmaceuticals Co.,Ltd||1|||f||||f||||||||||2017-10-10 23:09:29.138065|2017-10-10 23:09:29.138065
NCT02489903|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-09-06|||June 2015||2015-06-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|||RRx-001 in Small, Non-small Cell Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)|A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Lung Cancer, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)|Recruiting||Phase 2|90|Anticipated|EpicentRx, Inc.||4|||f||||f||||||||||2017-10-10 23:09:29.246405|2017-10-10 23:09:29.246405
NCT02489890|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-02-18|||February 2016||2016-02-01|February 2016|2016-02-01|July 2030|Anticipated|2030-07-01|July 2025|Anticipated|2025-07-01||Interventional|||CIK in Treating Patients With Bladder Cancer|A Randomized Controlled Study of Cytokine-induced Killer Cells (CIK) Treatment in Patients With Staging Ⅰ-Ⅲ of Urinary Bladder Carcinoma|Active, not recruiting||Phase 2|1500|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:09:29.473796|2017-10-10 23:09:29.473796
NCT02489877|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-01|||July 2015||2015-07-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|||Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and Herpesvirus|Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and Herpesvirus in Peripheral Blood of Patients|Unknown status|Not yet recruiting|N/A|84|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo|||3||f||||t||||||||||2017-10-10 23:09:29.585734|2017-10-10 23:09:29.585734
NCT02489864|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-02|||July 2015||2015-07-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure||Recruiting||Phase 4|30|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-10-10 23:09:29.701703|2017-10-10 23:09:29.701703
NCT02489851|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2016-05-22|||June 2015||2015-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Quadratus Lumborum Block vs Tranversus Abdominis Plane Block for Cesarean Section|Quadratus Lumborum Block vs Tranversus Abdominis Plane Block for Post Cesarean Section Analgesia. A Randomised Controlled Study|Completed||N/A|76|Actual|Corniche Hospital||2|||f||||f||||||||||2017-10-10 23:09:29.853889|2017-10-10 23:09:29.853889
NCT02489838|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2016-11-11|||September 2011||2011-09-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma|Analysis of Lung Dose Using Volumetric Analysis in Patients Treated With Yttrium-90 Microsphere Radioembolization for Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|University of Rochester|||1||f||||f||||||||||2017-10-10 23:09:29.982872|2017-10-10 23:09:29.982872
NCT02489825|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-09-04|||January 2015||2015-01-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Study About the Effect of Preventive Adjacent Level Cement Augmentation After Osteoporotic Vertebral Compression Fractures|Pilot Study: Does Preventive Adjacent Level Cement Augmentation Positively Affect Reoperation Rates After Osteoporotic Vertebral Compression Fractures?|Recruiting||Phase 4|100|Anticipated|University of Bern||2|||f||||f||||||||||2017-10-10 23:09:30.089673|2017-10-10 23:09:30.089673
NCT02489812|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-07-03|||March 2014||2014-03-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||Music Distraction Strategy in Children Dental Care||Completed||Phase 4|34|Actual|Federal University of Minas Gerais||1|||f||||t||||||||||2017-10-10 23:09:30.218535|2017-10-10 23:09:30.218535
NCT02489799|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-08-28|2017-03-29||July 2015|Actual|2015-07-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|ACPvideo||Utilizing Advance Care Planning Videos to Empower Perioperative Cancer Patients and Families|Utilizing Advance Care Planning Videos to Empower Perioperative Cancer Patients and Families|Completed||N/A|92|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:09:30.321193|2017-10-10 23:09:30.321193
NCT02489786|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-03|||October 2012||2012-10-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Prospective Study of Different Digoxin Treatment Regimens in Egyptian Hospital|A Prospective Randomized Study of Different Digoxin Treatment Regimens in Egyptian Hospital|Completed||Phase 4|71|Actual|Cairo University||4|||f||||f||||||||||2017-10-10 23:09:31.083725|2017-10-10 23:09:31.083725
NCT02489773|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-01-04|||June 2015||2015-06-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study|Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study|Completed||N/A|150|Actual|Asahi Kasei Pharma Corporation|||1||f||||f||||||Samples Without DNA|"     Blood   "|Undecided||2017-10-10 23:09:31.169737|2017-10-10 23:09:31.169737
NCT02489760|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2016-01-18|||July 2008||2008-07-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|December 2015|Actual|2015-12-01||Interventional|||Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study|Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study|Active, not recruiting||Phase 4|30|Actual|Chung Shan Medical University||2|||f||||f||||||||||2017-10-10 23:09:31.2519|2017-10-10 23:09:31.2519
NCT02489747|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-03-13|||November 2013||2013-11-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Wheat Bran Extract on Cognitive and Memory Function|Efficacy and Safety of Wheat Bran Extract on Improvement of Cognitive and Memory Function|Completed||N/A|70|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-10 23:09:31.477312|2017-10-10 23:09:31.477312
NCT02489734|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-10-14|||July 2015||2015-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Post Extubation Delirium and End-tidal Sevoflurane Concentration|Association Between Post Extubation Delirium and Pre-extubation End-tidal Sevoflurane Concentration in Children|Completed||N/A|92|Actual|Children's Hospital of Fudan University||2|||f||||f||||||||||2017-10-10 23:09:31.578154|2017-10-10 23:09:31.578154
NCT02489721|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-06-28|||June 2015||2015-06-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01|2 Years|Observational [Patient Registry]|PICC/MIDLINE||Major Complications Related to PICC and Midline Insertion|PICC and Midline Related Complications: A Multicenter Observational Study|Recruiting||N/A|547|Anticipated|Azienda Ospedaliera S. Maria della Misericordia|||1||f||||f||||||||||2017-10-10 23:09:31.67181|2017-10-10 23:09:31.67181
NCT02489695|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-09-11|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|AXIPAP||Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma|Multicenter Phase II Study of Axitinib in First Line Treatment for Patients With Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC)|Recruiting||Phase 2|50|Anticipated|Centre Leon Berard||1|||f||||f||||||||||2017-10-10 23:09:31.917394|2017-10-10 23:09:31.917394
NCT02489682|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-02|||December 2014||2014-12-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Informed Consent Format Evaluation|Clinical Informed Consent Format Evaluation|Completed||N/A|76|Actual|Carnegie Mellon University||3|||f||||f||||||||||2017-10-10 23:09:32.067722|2017-10-10 23:09:32.067722
NCT02489669|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-07-02|||July 2015||2015-07-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|REMEDIALIII||Renal Insufficiency Following Contrast Media Administration Trial III|Renal Insufficiency Following Contrast Media Administration Trial III (REMEDIAL III): Renalguard System Versus Left-ventricular End-diastolic Pressure-guided Hydration in High-risk Patients for Contrast-induced Acute Kidney Injury|Not yet recruiting||N/A|1272|Anticipated|Clinica Mediterranea||2|||f||||t||||||||||2017-10-10 23:09:32.175264|2017-10-10 23:09:32.175264
NCT02489656|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-07-01|||September 2013||2013-09-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Quality of Life in Patients With Double Loop Ureteral Stent (JJ Silicone Hydrogel Study)|Effect of a Silicone Hydrocoated Double Loop Ureteral Stent on Symptoms and Quality of Life in Patients Undergoing F-URS for Kidney Stone; a Comparative Randomized Multicenter Clinical Study.|Unknown status|Recruiting|Phase 4|140|Anticipated|Coloplast A/S||2|||f||||f||||||||||2017-10-10 23:09:32.289256|2017-10-10 23:09:32.289256
NCT02489643|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-02|||May 2014||2014-05-01|July 2015|2015-07-01||||May 2015|Actual|2015-05-01||Interventional|||Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis|Role of an Individualized Medical Training in Improving Efficacy and Adherence to a 4-week Treatment With Calcipotriol and Betamethasone Dipropionate Gel for Mild-to-moderate Plaque Psoriasis|Completed||N/A|60|Actual|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-10 23:09:32.430303|2017-10-10 23:09:32.430303
NCT02489630|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-06|||September 2013||2013-09-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department|Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department|Completed||Phase 4|116|Actual|Carilion Clinic||2|||f||||f||||||||||2017-10-10 23:09:32.530154|2017-10-10 23:09:32.530154
NCT02489617|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|October 2018|Anticipated|2018-10-01||Interventional|||The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy|The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy|Recruiting||N/A|221|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:09:32.651401|2017-10-10 23:09:32.651401
NCT02489604|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-07-19|||December 2013||2013-12-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|LUNET||Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors|Peptide Receptor Radionuclide Therapy (PRRT) With Radiolabelled Somatostatin Analogue 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors, 18F-2-fluoro-2-deoxy-D-glucose (FDG)-PET Negative Patients: a Prospective Phase II Randomized Study|Recruiting||Phase 2|98|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||||2017-10-10 23:09:32.87263|2017-10-10 23:09:32.87263
NCT02489591|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-04-12|||June 2015||2015-06-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Characterizing Upper Airway Collapse to Guide Patient Selection for Oral Appliance Therapy for Obstructive Sleep Apnea|Characterizing Site and Severity of Upper Airway Collapse to Guide Patient Selection for Oral Appliance Therapy for Obstructive Sleep Apnea|Recruiting||N/A|30|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:09:33.008308|2017-10-10 23:09:33.008308
NCT02489565|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-07-01|||May 2014||2014-05-01|July 2015|2015-07-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|Tele_DAC||Telemedicine Qualifying Transition Between Tertiary and Primary Health Care in Stable Coronary Artery Disease Patients|Telemedicine in Qualifying Care Transition Between Tertiary and Primary Health Care Among Stable Coronary Artery Disease Patients: a Randomized Non-inferiority Trial|Recruiting||N/A|264|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:09:33.274082|2017-10-10 23:09:33.274082
NCT02489539|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-04-26|||October 2017|Anticipated|2017-10-01|April 2017|2017-04-01|October 2024|Anticipated|2024-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms|Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms|Not yet recruiting||N/A|190|Anticipated|W.L.Gore & Associates||2|||f||||t|f|t|f|f||||No|Device and aneurysm status will be communicated to subject through standard of care evaluations. Core Lab data will not be available to subjects.|2017-10-10 23:09:33.411114|2017-10-10 23:09:33.411114
NCT02489526|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-12-09|||August 2015||2015-08-01|February 2016|2016-02-01||||August 2016|Actual|2016-08-01||Interventional|||Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectal Surgery|Completed||Phase 2|60|Actual|Vivozon, Inc.||2|||f||||f||||||||||2017-10-10 23:09:33.553152|2017-10-10 23:09:33.553152
NCT02489513|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-12-11|||June 2015||2015-06-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120|A Phase 1, Open-label Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120 Following Single Oral Dose Administration in Healthy Male Subjects|Completed||Phase 1|8|Actual|Agios Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:09:33.676259|2017-10-10 23:09:33.676259
NCT02489500|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-07-03|||June 2015||2015-06-01|July 2017|2017-07-01|May 2040|Anticipated|2040-05-01|May 2018|Anticipated|2018-05-01||Interventional|VelRand||Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib|Phase III Trial of High-dose Melphalan and Stem Cell Transplantation Versus High-dose Melphalan and Bortezomib and Stem Cell Transplantation in Patients With AL Amyloidosis|Terminated||Phase 3|3|Actual|Boston Medical Center||2||Enrollment held for toxicity evaluation|f||||t|t|f|||t|||||2017-10-10 23:09:33.800174|2017-10-10 23:09:33.800174
NCT02489487|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-06-30|||September 2014||2014-09-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500|Phase I, Drug-drug Interaction Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500 When Administered Orally, in Combination With Raltegravir or Darunavir|Completed||Phase 1|24|Actual|Viriom||3|||f||||f||||||||||2017-10-10 23:09:33.962503|2017-10-10 23:09:33.962503
NCT02489474|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-10-30|||June 2015||2015-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Association of Genetic Polymorphism and Acute Kidney Injury After Liver Transplantation||Recruiting||N/A|100|Anticipated|Yonsei University|||1||f||||f||||||Samples With DNA|"     blood obtained from enrolled patients before surgery   "|||2017-10-10 23:09:34.062858|2017-10-10 23:09:34.062858
NCT02489461|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-05-12|||August 2014||2014-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy, Safety and Optimal Dose Selection VM-1500 in Comparison to Efavirenz When Added to Standard-of-care Antiretroviral Therapy|International, Multicenter, Randomized, Partially Blind Clinical Study to Evaluate Efficacy, Safety and Selection of the Optimal Dose for VM-1500 in Comparison to Efavirenz in Combination With Two NRTIs in Treatment-naïve, HIV-1 Infected Patients|Active, not recruiting||Phase 2/Phase 3|150|Anticipated|Viriom||4|||f||||f||||||||||2017-10-10 23:09:34.146184|2017-10-10 23:09:34.146184
NCT02489448|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-07-12|||November 2015||2015-11-01|July 2016|2016-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer|Single Arm Neoadjuvant Phase I/II Study of MEDI4736 (Anti-PD-L1 Antibody) Concomitant With Weekly Nab-paclitaxel and Dose-dense Doxorubicin/Cyclophosphamide (ddAC) Chemotherapy for Clinical Stage I-III Triple Negative Breast Cancer|Recruiting||Phase 1/Phase 2|61|Anticipated|Yale University||1|||f||||t||||||||||2017-10-10 23:09:34.259077|2017-10-10 23:09:34.259077
NCT02489435|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-06-30|||July 2012||2012-07-01|June 2015|2015-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers|Randomized, Double-blind, Placebo-controlled, Phase Ib Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers|Completed||Phase 1|36|Actual|Viriom||3|||f||||f||||||||||2017-10-10 23:09:34.361104|2017-10-10 23:09:34.361104
NCT02489422|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-05-30|||August 2016||2016-08-01|March 2017|2017-03-01||||December 2020|Anticipated|2020-12-01||Interventional|PRO-YOU||Programs To Support You During Chemotherapy|GI 1549: PROGRAMS TO SUPPORT YOU DURING CHEMOTHERAPY (PRO-YOU) A Randomized Controlled Pilot Study of Yoga Compared to an Attention Control in Patients Receiving Chemotherapy|Recruiting||N/A|60|Anticipated|Wake Forest University Health Sciences||2|||f||||t|f|f||||||||2017-10-10 23:09:34.447143|2017-10-10 23:09:34.447143
NCT02489409|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-07-12|||October 2015||2015-10-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer|EndostarTM Injection Combined With Gemcitabine+Platinum (GP)/Navelbine+Platinum (NP)/Gemcitabine+Xeloda (GX)/Navelbine+Xeloda (NX) in Treatment of Recurrent Metastatic Breast Cancer: A Randomized, Opened and Controlled Clinical Study|Recruiting||Phase 2|120|Anticipated|Xinjiang Medical University||2|||f||||t||||||||||2017-10-10 23:09:34.598015|2017-10-10 23:09:34.598015
NCT02489396|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-10-24|||August 2015||2015-08-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment|Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment|Active, not recruiting||N/A|400|Actual|University of Vermont|||1||f||||f||||||||No|Because the data is coming from a private business, we do not plan to share the data publicly.|2017-10-10 23:09:34.729885|2017-10-10 23:09:34.729885
NCT02489383|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-10-16|||October 2015||2015-10-01|October 2015|2015-10-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison Between Continuous Versus Interval Exercise Training in Asthmatic Patients|Comparison to Short and Medium-term Effects of Continuous and Interval Aerobic Exercise Training in Improving Aerobic Capacity, Psychosocial Factors and Impact on the Level of Physical Activity in Patients With Asthma Moderate and Severe|Recruiting||N/A|60|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:09:34.817203|2017-10-10 23:09:34.817203
NCT02489370|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-02|||October 2014||2014-10-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||CHF Home Telemonitoring: A Home Telemonitoring Service for Chronic Heart Failure Patients on Trial|CHF Home Telemonitoring: A Home Telemonitoring Service for Chronic Heart Failure Patients on Trial|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-10-10 23:09:34.937034|2017-10-10 23:09:34.937034
NCT02489357|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-11-21|||November 2015||2015-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer|A Pilot Study of MK-3475 With Cryotherapy for Men With Newly Diagnosed Oligo-metastatic Prostate Cancer|Active, not recruiting||N/A|12|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-10 23:09:35.055085|2017-10-10 23:09:35.055085
NCT02489344|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-11-04|||July 2015||2015-07-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease|An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease|Active, not recruiting||Phase 2|8|Anticipated|Sanofi||1|||f||||t||||||||||2017-10-10 23:09:35.170017|2017-10-10 23:09:35.170017
NCT02489331|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-05-01|||July 2015||2015-07-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||"Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the New Drug Re-examination."|"Post Marketing Surveillance of Safety and Efficacy for Cholib® in Korean Patients Under the New Drug Re-examination."|Recruiting||N/A|600|Anticipated|Abbott|||1||f||||f||||||||||2017-10-10 23:09:35.259667|2017-10-10 23:09:35.259667
NCT02489318|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-08-21|||November 27, 2015|Actual|2015-11-27|August 2017|2017-08-01|July 13, 2022|Anticipated|2022-07-13|November 4, 2020|Anticipated|2020-11-04||Interventional|TITAN||A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC|A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)|Active, not recruiting||Phase 3|1054|Actual|Aragon Pharmaceuticals, Inc.||2|||f||||t||f||||||||2017-10-10 23:09:35.573507|2017-10-10 23:09:35.573507
NCT02489305|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-07-28|||December 15, 2014|Actual|2014-12-15|July 2017|2017-07-01|May 1, 2018|Anticipated|2018-05-01|April 30, 2018|Anticipated|2018-04-30||Observational|||Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)|A Prospective, Longitudinal, Observational Study to Evaluate Potential Predictors of Relapse in Subjects With Major Depressive Disorder Who Have Responded to Antidepressant Treatment|Recruiting||N/A|330|Anticipated|Janssen Research & Development, LLC|||1||f||||f||f||||||||2017-10-10 23:09:36.210138|2017-10-10 23:09:36.210138
NCT02489292|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-08-04|||October 2014||2014-10-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Study to Evaluate the Efficacy of HepaStem in Urea Cycle Disorders Paediatric Patients (HEP002)|Prospective, Open Label, Multicenter, Efficacy and Safety Study of Several Infusions of HepaStem in Urea Cycle Disorders Paediatric Patients|Recruiting||Phase 2|20|Anticipated|Promethera Biosciences||1|||f||||t||||||||||2017-10-10 23:09:36.38284|2017-10-10 23:09:36.38284
NCT02489279|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-09-11|||June 2015||2015-06-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|SAC-I||Training Attentional Awareness and Control in ADHD|Training Attentional Awareness and Control in Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|106|Actual|Think Now Incorporated||2|||f||||f||||||||||2017-10-10 23:09:36.523954|2017-10-10 23:09:36.523954
NCT02489266|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-02|2017-07-26|||June 24, 2015||2015-06-24|June 29, 2016|2016-06-29|June 29, 2016|Actual|2016-06-29|June 29, 2016|Actual|2016-06-29||Interventional|||In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma|A Phase I Trial for the Evaluation of the In Vivo Persistence of Adoptively-transferred Tumor-Infiltrating Lymphocytes Cultured With a Pharmacologic Inhibitor of AKT in Patients With Metastatic Melanoma|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:09:36.633643|2017-10-10 23:09:36.633643
NCT02489253|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2015-07-01|||April 2014||2014-04-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Observational|||Atherosclerosis in Familial Hypercholesterolemia|Incidence and Characteristics of Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia According to Monogenic Versus Polygenic Status|Unknown status|Recruiting|N/A|100|Anticipated|University College, London|||2||f||||t||||||||||2017-10-10 23:09:36.757149|2017-10-10 23:09:36.757149
NCT02489240|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy|Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy|Recruiting||N/A|306|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:09:36.878348|2017-10-10 23:09:36.878348
NCT02489227|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-06-09||2017-05-31|August 2015||2015-08-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|May 2016|Actual|2016-05-01||Interventional|PsOsim||Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis|A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis|Completed||Phase 3|545|Actual|Coherus Biosciences, Inc.||2|||f||||t||||||||||2017-10-10 23:09:37.018347|2017-10-10 23:09:37.018347
NCT02489188|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-07-25|||June 2015||2015-06-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|Asymmetry||Gait Asymmetry Assessed Using Portable Gait Analysis System|Gait Asymmetry in Orthopaedic Conditions of the Lower Extremity Assessed Using Portable and Laboratory Based Systems: Cross-sectional Observational Single-centre Pilot Study|Recruiting||N/A|120|Anticipated|University Hospital, Basel, Switzerland|||6||f||||f||||||||||2017-10-10 23:09:37.369789|2017-10-10 23:09:37.369789
NCT02489175|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-07-03|||July 2015||2015-07-01|July 2015|2015-07-01|July 2018|Anticipated|2018-07-01|July 2016|Anticipated|2016-07-01||Interventional|StoKo||Stomaplasty Ring (KoringTM) for Prevention of Parastomal Hernia|International Prospective Randomized Multicenter Trial to Analyze the Stomaplasty Ring (KoringTM) for Prevention of Parastomal Hernia|Not yet recruiting||Phase 3|102|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-10 23:09:37.528672|2017-10-10 23:09:37.528672
NCT02489162|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-08-16|||August 2015||2015-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|MyotonPRO||The Role of a Device to Evaluate the Neuromuscular Function in Assessing Muscle in Facial Paralysis Patients|The Role of MyotonPro in Assessing the Biomechanical Properties of Facial Muscles in Facial Paralysis Patients and Its Role in Monitoring Recovery Following Facial Reanimation Surgery|Recruiting||N/A|40|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||No||2017-10-10 23:09:37.686379|2017-10-10 23:09:37.686379
NCT02489149|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-01|||March 2015||2015-03-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Food and Nutrition Education in Quilombolas Communities With Food Insecurity: Multi-sector Intervention|Food and Nutrition Education in Quilombolas Communities With Food Insecurity: Intervention Based on Traditional Food Practices, Healthy Eating Promotion and Enforceability of Human Right to Adequate Food|Unknown status|Recruiting|N/A|4|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 23:09:37.800484|2017-10-10 23:09:37.800484
NCT02489136|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2017-09-14|||July 2014||2014-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|SSPNP||Study of Spirit Pass in Newborn and Patient|Effect of Spirit Pass on Serum Cortisol Levels, Pain, Physiological Parameters and Haematologic Response in Newborn and Patient|Completed||N/A|60|Actual|Universidade Federal do Triangulo Mineiro||3|||f||||t||||||||||2017-10-10 23:09:37.941568|2017-10-10 23:09:37.941568
NCT02489123|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-03-07|||August 11, 2015|Actual|2015-08-11|March 2017|2017-03-01||||July 2023|Anticipated|2023-07-01||Interventional|||Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma|Androgen Receptor Targeting in Mantle Cell Lymphoma: A Pilot Trial of Enzalutamide|Recruiting||N/A|20|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-10 23:09:38.062644|2017-10-10 23:09:38.062644
NCT02489110|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-09-28|||June 2015||2015-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Webnovela for Hispanic Dementia Family Caregivers|Webnovela for Hispanic Dementia Family Caregivers|Completed||N/A|150|Actual|Photozig, Inc.||2|||f||||||||||||||2017-10-10 23:09:38.186032|2017-10-10 23:09:38.186032
NCT02489097|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-05-19|||June 2013||2013-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|ISEP||International Substudy Enigma2 on Postoperative Cognitive Disorders|Evaluating the Incidence and Association Between Nitrous Oxide and Postoperative Cognitive Disorders in Anaesthesia|Recruiting||Phase 4|420|Anticipated|University Hospital, Geneva||2|||f||||t||||||||||2017-10-10 23:09:38.317591|2017-10-10 23:09:38.317591
NCT02489084|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-11-22|||September 2013||2013-09-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|HANS||Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP)|Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP)|Recruiting||N/A|2000|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:09:38.437868|2017-10-10 23:09:38.437868
NCT02489071|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-09-19|||August 2014||2014-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Cognitive Intervention After a Brain Tumor|Cognitive Intervention After a Brain Tumor|Active, not recruiting||N/A|26|Actual|University Health Network, Toronto||3|||f||||f||||||||||2017-10-10 23:09:38.517606|2017-10-10 23:09:38.517606
NCT02489058|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-06-21|||July 2015||2015-07-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|OLALA||A Study of Long-Term Responders on Olaparib|A Retrospective/Prospective Analysis of Characterization of the Long-Term Responders on Olaparib in Solid Tumours|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     -  Archival tumor tissue sample for biomarker research        -  Optional fresh tumor tissue sample for biomarker research (if participants are still on          olaparib and their disease progressed)        -  Blood sample for pharmacokinetics (if participants are still on olaparib)        -  Blood sample for pharmacogenomics (if participants are still on olaparib and their          disease progressed)        -  Blood samples for circulating tumor DNA (if participants are still on olaparib)        -  Blood sample for germline BRCA1/2 testing if not previously done (if participants are          still on olaparib and their disease progressed)   "|||2017-10-10 23:09:38.624026|2017-10-10 23:09:38.624026
NCT02489045|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-10-17|||April 2015||2015-04-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension|Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension|Recruiting||Phase 4|300|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 23:09:38.715467|2017-10-10 23:09:38.715467
NCT02489032|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-01-24|||June 22, 2016|Actual|2016-06-22|January 2017|2017-01-01|November 13, 2016|Actual|2016-11-13|November 13, 2016|Actual|2016-11-13||Interventional|BigAl2||Web-Based Training for EAP Alcohol Screening, Brief Intervention, and Refer|Web-Based Training for EAP Alcohol Screening, Brief Intervention, and Refer|Completed||N/A|330|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||No||2017-10-10 23:09:38.842865|2017-10-10 23:09:38.842865
NCT02489019|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-04-27|||July 2017|Anticipated|2017-07-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|July 2020|Anticipated|2020-07-01||Interventional|Fentanyl||Fentanyl Effect on Blood Pressure in Elderly Patients After Induction of General Anesthesia|Fentanyl Effect on Blood Pressure in Elderly Patients After Induction of General Anesthesia|Not yet recruiting||Phase 2/Phase 3|105|Anticipated|Loyola University||3|||f||||f|t|f|||f|||No||2017-10-10 23:09:38.933847|2017-10-10 23:09:38.933847
NCT02489006|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-07-18|||July 15, 2016|Actual|2016-07-15|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|NEO||A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|A Phase II, Open-Label, Randomized, Multi-Centre Study, of Neoadjuvant Olaparib in Patients With Platinum Sensitive Recurrent High Grade Serous Ovarian/Primary Peritoneal or Fallopian Tube Cancer|Recruiting||Phase 2|71|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:09:39.072765|2017-10-10 23:09:39.072765
NCT02488993|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-12-10|||June 2015||2015-06-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01|2 Years|Observational [Patient Registry]|PROSPER||Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)|PROSPER: Prospective Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin-α (TARGAXAN®/XIFAXAN®) 550 mg|Recruiting||N/A|550|Anticipated|Norgine|||3||f||||f||||||||||2017-10-10 23:09:39.208139|2017-10-10 23:09:39.208139
NCT02488980|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-04-26|2017-01-05||May 2000||2000-05-01|April 2017|2017-04-01|March 2003|Actual|2003-03-01|October 2000|Actual|2000-10-01||Interventional|||An Evaluation of Weekly Tafenoquine|A Randomized, Double Blind, Placebo Controlled Evaluation of Weekly Tafenoquine (WR 238605/SB252263) Compared to Mefloquine for Chemosuppression of Plasmodium Falciparum in Western Kenya|Completed||Phase 2|306|Actual|U.S. Army Medical Research and Materiel Command|Due to high failure rate a DMC was setup to assess if it was appropriate to continue study. DMC concluded that the study should continue in order to meet secondary objectives of evaluating the long-term safety and efficacy.|3|||f||||t||||||||Yes|SmithKline Beecham|2017-10-10 23:09:39.35137|2017-10-10 23:09:39.35137
NCT02488967|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-10-04|||July 2015||2015-07-01|October 2016|2016-10-01||||April 2021|Anticipated|2021-04-01||Interventional|||Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer|A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer|Recruiting||Phase 3|990|Anticipated|NRG Oncology||2|||f||||t||||||||||2017-10-10 23:09:41.165912|2017-10-10 23:09:41.165912
NCT02488954|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-07-03|||February 12, 2016|Actual|2016-02-12|February 2017|2017-02-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|EMMENTAL||Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis|Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis|Terminated||N/A|7|Actual|Rennes University Hospital||1||Recruitment difficulties|f||||f||||||||||2017-10-10 23:09:49.209941|2017-10-10 23:09:49.209941
NCT02488941|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-30|||June 2015||2015-06-01|June 2015|2015-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease|Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease|Recruiting||N/A|30|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Liver biopsy Blood : serum and plasma   "|||2017-10-10 23:09:49.309932|2017-10-10 23:09:49.309932
NCT02488928|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-04-13|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|E-PREDICT||E- Predict: EBUS ELASTOGRAPHY STRAIN in Lung Cancer|E-PREDICT Evaluating the Predictive Value of EBUS ELASTOGRAPHY STRAIN in Patients With (Suspected) Lung Cancer|Recruiting||N/A|300|Anticipated|Radboud University|||1||f||||f||||||||||2017-10-10 23:09:49.39657|2017-10-10 23:09:49.39657
NCT02488915|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-09-26|||November 2015||2015-11-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|ARISEII||Analysis of Revascularization in Ischemic Stroke With EmboTrap|ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) Study|Recruiting||N/A|228|Anticipated|Neuravi Inc.||1|||f||||t||||||||No||2017-10-10 23:09:49.500198|2017-10-10 23:09:49.500198
NCT02488902|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-12-28|||August 1998||1998-08-01|June 2015|2015-06-01|March 2003|Actual|2003-03-01|September 1998|Actual|1998-09-01||Interventional|||A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum|A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum in Semi-immune Adults Living in the Kassena-Nankana District of Northern Ghana|Completed||Phase 2|521|Actual|U.S. Army Medical Research and Materiel Command||6|||f||||f||||||||||2017-10-10 23:09:49.644776|2017-10-10 23:09:49.644776
NCT02488889|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-07-05|||August 2015||2015-08-01|July 2015|2015-07-01||||July 2017|Anticipated|2017-07-01||Interventional|VAR||Effects of Varenicline in Heavy Drinking Smokers||Unknown status|Not yet recruiting|Phase 4|22|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 23:09:49.898877|2017-10-10 23:09:49.898877
NCT02488876|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-10-02|||April 2009||2009-04-01|October 2017|2017-10-01|December 2099|Anticipated|2099-12-01|December 2099|Anticipated|2099-12-01|7 Days|Observational [Patient Registry]|||Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery|Non-individual Related Ongoing Collection of Blood Samples for the Compilation of a Unique Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery|Recruiting||N/A|1000|Anticipated|RWTH Aachen University|||1||f||||f||||||||||2017-10-10 23:09:50.036488|2017-10-10 23:09:50.036488
NCT02488863|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|NEPAL||NEPAL (Neuromodulatory Examination of Pain and Mobility Across the Lifespan)|Neuroimaging Age-related Versus Pain-related Changes in Pain Modulation|Recruiting||N/A|105|Anticipated|University of Florida|||2||f||||f|f|f||||Samples Without DNA|"     Blood plasma   "|||2017-10-10 23:09:50.131069|2017-10-10 23:09:50.131069
NCT02488850|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-07-06|||December 2012||2012-12-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Interventional|HAMLET||Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC|Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage Non-small Cell Lung Cancer HAMLET Study|Unknown status|Recruiting|N/A|40|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-10-10 23:09:50.277203|2017-10-10 23:09:50.277203
NCT02488837|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-04-10|||June 2014||2014-06-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|||Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing DBS for Movement Disorders|Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing Deep Brain Stimulation for Movement Disorders|Active, not recruiting||N/A|21|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-10-10 23:09:50.422059|2017-10-10 23:09:50.422059
NCT02488824|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-05-31|||April 1, 2015|Actual|2015-04-01|May 2017|2017-05-01|July 1, 2017|Anticipated|2017-07-01|April 30, 2017|Actual|2017-04-30||Interventional|||Effect of Heat Exposure on Cognition in Persons With Tetraplegia|Effect of Heat Exposure on Cognition in Persons With Higher Cord Lesions|Recruiting||Phase 4|40|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-10-10 23:09:50.500666|2017-10-10 23:09:50.500666
NCT02488798|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-06-30|||June 2013||2013-06-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Office Hysteroscopy and 3D Power Doppler Vaginal Ultrasound in Assessment of Postmenopausal Bleeding|The Role of Office Hysteroscopy and Endometrial Power Doppler Using the International Endometrial Tumor Analysis Group Classification in the Evaluation of Postmenopausal Bleeding|Completed||N/A|100|Actual|Cairo University|||1||f||||f||||||Samples Without DNA|"     Sample from the uterine endometrium for histopathological analysis   "|||2017-10-10 23:09:50.628427|2017-10-10 23:09:50.628427
NCT02488785|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-06-05|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|November 30, 2017|Anticipated|2017-11-30|March 31, 2017|Actual|2017-03-31||Interventional|||Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With Type 2 Diabetes Mellitus|The Impact of a Comprehensive Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With Type 2 Diabetes|Active, not recruiting||N/A|107|Actual|Joslin Diabetes Center||2|||f||||f||||||||||2017-10-10 23:09:50.704807|2017-10-10 23:09:50.704807
NCT02488772|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-01|||July 2015||2015-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|SOULMAN||Improving Sleep and the Patient Experience in the Emergency Department|SOULMAN Study - A Randomized Controlled Trial of Sound and Light Manipulation in the Emergency Department to Improve Sleep and the Patient Experience|Unknown status|Not yet recruiting|N/A|300|Anticipated|Kingston General Hospital||2|||f||||f||||||||||2017-10-10 23:09:50.801959|2017-10-10 23:09:50.801959
NCT02488759|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-09-27|||October 8, 2015|Actual|2015-10-08|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|May 13, 2019|Anticipated|2019-05-13||Interventional|CheckMate358||An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors|Non-Comparative, Open-Label, Multiple Cohort, Phase 1/2 Study of Nivolumab Monotherapy and Nivolumab Combination Therapy in Subjects With Virus-Positive and Virus-Negative Solid Tumors|Recruiting||Phase 1/Phase 2|500|Anticipated|Bristol-Myers Squibb||5|||f||||f|t|f||||||||2017-10-10 23:09:50.898215|2017-10-10 23:09:50.898215
NCT02488746|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-12-08|||March 2015||2015-03-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)|Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)|Terminated||N/A|5|Actual|Kliniken Ludwigsburg-Bietigheim gGmbH|||1|"According to study protocol the trial was terminated because the recruitment of trial   participants was insufficient."|f||||f||||||||||2017-10-10 23:09:51.336593|2017-10-10 23:09:51.336593
NCT02488733|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-07-05|||December 2015||2015-12-01|July 2017|2017-07-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01||Interventional|ESINODOP||Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients|Laparoscopic Sleeve Gastrectomy Versus Conventional Medical Therapy in Patients With Newly Diagnosed Type 2 Diabetes and Body Mass Index 30-42 Kg/m2: a Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|Azienda Ospedaliera Santa Maria, Terni, Italy||2|||f||||t||||||||||2017-10-10 23:09:51.41223|2017-10-10 23:09:51.41223
NCT02488707|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2015-07-01|||February 2014||2014-02-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|MISS-TRICR||Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).|Outcomes of Transanal Minimally Invasive TME Versus Laparoscopic Intersphincteric Resection Techniques for Rectal Cancer After Initial Neoadjuvant Chemo-radiotherapy: Double Blinded Study|Unknown status|Enrolling by invitation|Phase 2|250|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 23:09:51.737382|2017-10-10 23:09:51.737382
NCT02488694|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-08-16|||November 2015||2015-11-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|MARBLE||Maintaining ERBB Blockade in EGFR-mutated Lung Cancer|A Randomized, Open-label, Phase II Study of Maintaining Pan-ERBB Blockade Following Platinum-based Induction Chemotherapy in Patients With EGFR Mutated, Metastatic Non-small-cell Lung Cancer Progressing After Treatment With Afatinib as First EGFR-targeting Agent|Recruiting||Phase 2|210|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-10-10 23:09:51.828824|2017-10-10 23:09:51.828824
NCT02488681|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-08-29|||June 2015||2015-06-01|October 2015|2015-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Micra Transcatheter Pacing System Continued Access Study Protocol|Medtronic Micra Transcatheter Pacing System Continued Access Study|Completed||Phase 3|285|Actual|Medtronic||1|||f||||f||||||||||2017-10-10 23:09:52.015341|2017-10-10 23:09:52.015341
NCT02488668|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-08-09|||June 2015||2015-06-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|EPIONE||Surface Electrical Stimulation for Treatment of Phantom Limb Pain|Natural Sensory Feedback for Phantom Limb Modulation and Therapy|Recruiting||N/A|20|Anticipated|Aalborg University||1|||f||||f||||||||||2017-10-10 23:09:52.092101|2017-10-10 23:09:52.092101
NCT02488655|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-04-26|||June 2015||2015-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Treatment of Breast Fibroadenoma With FastScan HIFU|Treatment of Breast Fibroadenoma With FastScan High Intensity Focused Ultrasound (HIFU)|Recruiting||N/A|15|Anticipated|Theraclion||1|||f||||f||||||||||2017-10-10 23:09:52.197163|2017-10-10 23:09:52.197163
NCT02488642|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-07-22|||May 2008||2008-05-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Interventional|INPer||Medical Management of Late Intrauterine Death.|Medical Management of Late Intrauterine Death Using a Therapeutic Combination of Isosorbide Dinitrate and Oxytocin.|Completed||Phase 4|60|Actual|National Institute of Perinatology||2|||f||||f||||||||||2017-10-10 23:09:52.308695|2017-10-10 23:09:52.308695
NCT02488629|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-08-31|||September 2015||2015-09-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of SCB01A in Patient With Head and Neck Cancer|An Open-Label, Phase II Study to Evaluate SCB01A in Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer Who Have Received Platinum-Based Treatment|Recruiting||Phase 2|40|Anticipated|SynCore Biotechnology Co., Ltd.||1|||f||||t||||||||No||2017-10-10 23:09:52.4193|2017-10-10 23:09:52.4193
NCT02488616|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-08-29|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes|An Open-label, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 5 Days in Free-living Outpatient Conditions in Patients With Type 1 Diabetes|Not yet recruiting||Phase 2|45|Anticipated|Institut de Recherches Cliniques de Montreal||2|||f||||f|f|f||||||||2017-10-10 23:09:52.519447|2017-10-10 23:09:52.519447
NCT02488603|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-01|||August 2015||2015-08-01|June 2015|2015-06-01||||August 2018|Anticipated|2018-08-01||Interventional|||Decision Aids for Tamoxifen Treatment in Breast Cancer Patients|Utilization of Decision Aids for Tamoxifen Treatment in Breast Cancer Patients: A Randomized Controlled Trial.|Not yet recruiting||N/A|360|Anticipated|National Cancer Center, Korea||2|||f||||||||||||||2017-10-10 23:09:52.651053|2017-10-10 23:09:52.651053
NCT02488590|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-08-25|||July 2015||2015-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|ACOS||Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases|Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases|Active, not recruiting||N/A|180|Actual|Katholieke Universiteit Leuven|||5||f||||f||||||||||2017-10-10 23:09:52.735549|2017-10-10 23:09:52.735549
NCT02488577|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-07-01|||June 2015||2015-06-01|July 2015|2015-07-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|TAMIS||Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer|Outcomes Comparison of TAMIS-TME Versus Transanal Minimally Invasive Locoregional Resection for T2 Low Rectal Cancer: an Open Label Study|Enrolling by invitation||Phase 1/Phase 2|50|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 23:09:52.834054|2017-10-10 23:09:52.834054
NCT02488564|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-09-28|||October 2014||2014-10-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|met-HEReMYTA||A Study of Liposomal Doxorubicin + Docetaxel + Trastuzumab + Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer|Clinical and Translational Phase II Study of Liposomal Doxorubicin Plus Docetaxel and Trastuzumab With Metformin as Primary Systemic Therapy for Operable and Locally Advanced Recombinant Human ErbB-2 (HER2) Positive Breast Cancer|Recruiting||Phase 2|46|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-10 23:09:52.929818|2017-10-10 23:09:52.929818
NCT02488551|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-01-27|||July 2017||2017-07-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Computer-Assisted CBT Tool to Enhance Fidelity in CBOCs|A Computer-Assisted CBT Tool to Enhance Fidelity in CBOCs|Not yet recruiting||Phase 2|340|Anticipated|Central Arkansas Veterans Healthcare System||2|||f||||f||||||||||2017-10-10 23:09:53.065845|2017-10-10 23:09:53.065845
NCT02488538|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2017-01-20|||July 2015||2015-07-01|January 2017|2017-01-01||||July 2017|Anticipated|2017-07-01||Interventional|||Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome|The Synergistic Use of Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in the Management of Severe Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial|Recruiting||Phase 3|300|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 23:09:53.121419|2017-10-10 23:09:53.121419
NCT02488525|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-06-06|||January 2016||2016-01-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PHAM||Prevention of Hemorrhage After Implantation of Mechanical Circulatory Support|Prevention of Hemorrhage After Implantation of Mechanical Circulatory Support|Recruiting||Phase 3|156|Anticipated|University Hospital, Lille||2|||f||||t||||||||Undecided||2017-10-10 23:09:53.214698|2017-10-10 23:09:53.214698
NCT02488512|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-09-28|||February 2015||2015-02-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|itTRIOlym||Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas|Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell (DLBCL) and Mantle Cell Lymphomas (MCL)|Recruiting||Phase 2|35|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-10 23:09:53.300667|2017-10-10 23:09:53.300667
NCT02488499|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-02-06|||July 2010||2010-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ABATE||Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project)|Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project)|Completed||N/A|172|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-10 23:09:53.387202|2017-10-10 23:09:53.387202
NCT02488486|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-05-16|||May 2015||2015-05-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|SEDCAR||Postoperative Sedation After Cardiac Surgery|Postoperative Sedation After Cardiac Surgery: Pilot Study|Terminated||N/A|19|Actual|Hopital Foch||1||Intermediate analysis|f||||f||||||||||2017-10-10 23:09:53.462018|2017-10-10 23:09:53.462018
NCT02488473|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-01-04|||August 2015||2015-08-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Does Perineural Dexmedetomidine Prolong Duration of a Nerve Block?|Does Perineural Dexmedetomidine Prolong the Duration of an Adductor Canal Block When Controlling for a Systemic Effect? - A Randomised Paired Trial in Healthy Volunteers.|Completed||Phase 2|21|Actual|Zealand University Hospital||2|||f||||t||||||||||2017-10-10 23:09:53.539216|2017-10-10 23:09:53.539216
NCT02488460|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-07-01|||August 2012||2012-08-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Physical Activity on Math - an RCT|Effects of a School-based Physical Activity Intervention on Math Achievement - A Randomized Controlled Trial|Completed||N/A|545|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-10 23:09:53.61506|2017-10-10 23:09:53.61506
NCT02488447|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-04-28|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01|1 Year|Observational [Patient Registry]|ÍCARA||Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis|Prospective Study for Evaluating Life Quality and Its Determinant Factors as Treatment Adherence and Immunotherapy Satisfaction in Patients With Rhinoconjunctivitis With or Without Asthma, Sensitized at Least to One Aeroallergen|Active, not recruiting||N/A|202|Anticipated|Roxall Medicina España S.A|||1||f||||f||||||||||2017-10-10 23:09:53.680772|2017-10-10 23:09:53.680772
NCT02488434|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-08-11|||June 2015||2015-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility|The Effectiveness of Using Fertile Chip on Intracytoplasmic Sperm Injection Undergoing Ivf Programme in Unexplained Infertile Couples|Completed||Phase 3|122|Actual|Baskent University||2|||f||||t||||||||||2017-10-10 23:09:53.901553|2017-10-10 23:09:53.901553
NCT02488421|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-12-19|||June 2014||2014-06-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|REACT-AF2||Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2|Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF 2|Completed||N/A|38122|Actual|Bristol-Myers Squibb|||4||f||||f||||||||||2017-10-10 23:09:53.975668|2017-10-10 23:09:53.975668
NCT02488408|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-05-16|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Phase Ib/II Multicenter Open-label Study of BGB324 in Patients With AML or MDS|A Phase Ib/II Multicenter Open-label Study of BGB324 as a Single Agent and in Combination With Cytarabine or Decitabine in Patients With Acute Myeloid Leukemia or as a Single Agent in Patients With Myelodysplastic Syndrome|Recruiting||Phase 1/Phase 2|75|Anticipated|BerGenBio ASA||2|||f||||t|t|f||||||No||2017-10-10 23:09:54.059719|2017-10-10 23:09:54.059719
NCT02488395|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-10-14|||October 2015||2015-10-01|October 2015|2015-10-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Observational|AGIRPARK||Superior Colliculus Activity in Parkinson Disease: a Potential Marker?|Superior Colliculus Activity in Parkinson Disease: a Potential Marker? fMRI Brain Activation in Response to Visual Stimuli.|Recruiting||N/A|40|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||||||2017-10-10 23:09:54.189589|2017-10-10 23:09:54.189589
NCT02488382|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-04-19|||July 2016||2016-07-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Lonquek for Autologous Stem Cell Mobilization|Lonquek (Lipegfilgrastim) for Stem Cell Mobilization of Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma and Lymphoma|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:09:54.296114|2017-10-10 23:09:54.296114
NCT02488369|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-02-09|||March 2011||2011-03-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|TEP-LYMPHOME||Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents|Study on the Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents|Recruiting||N/A|200|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 23:09:54.368341|2017-10-10 23:09:54.368341
NCT02488356|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2015-08-25|||September 2012||2012-09-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Litramine for Weight Loss|Safety and Efficacy of Litramine IQP G-002AS for Weight Loss: A Randomised, Double-blind, Placebo-controlled, Parallel-group Study|Completed||N/A|99|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-10 23:09:54.443705|2017-10-10 23:09:54.443705
NCT02488343|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2017-06-13|||August 2015||2015-08-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Profile of Adherence to Therapy and Interventions to Promote Adherence in MS|Personal Profile of Adherence to Therapy and Tailored Interventions to Promote Adherence in Multiple Sclerosis Patients|Recruiting||N/A|400|Anticipated|Carmel Medical Center||2|||f||||t||||||||||2017-10-10 23:09:54.504592|2017-10-10 23:09:54.504592
NCT02488330|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-08-03|||August 27, 2015|Actual|2015-08-27|August 2017|2017-08-01|August 22, 2017|Anticipated|2017-08-22|August 22, 2017|Anticipated|2017-08-22||Interventional|||An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study|An Open-label, Multicenter Extension Study of Onartuzumab in Patients With Solid Tumors on Study Treatment Previously Enrolled in an F.Hoffmann-la Roche- and/or Genentech- Sponsored Study|Active, not recruiting||Phase 3|12|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 23:09:54.590546|2017-10-10 23:09:54.590546
NCT02488317|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-04-04|2016-06-24||May 2015||2015-05-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EPOCH-RRT|Baseline information was collected for 140, but only 133 participants completed the study.|Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT)|Empowering Patients On Choices for Renal Replacement Therapy (Aim 3)|Completed||N/A|234|Actual|Arbor Research Collaborative for Health||2|||f||||f||||||||||2017-10-10 23:09:54.78363|2017-10-10 23:09:54.78363
NCT02488304|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-10-02|||July 2015||2015-07-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)|Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)|Recruiting||Phase 2|10|Anticipated|FLUIDDA nv||1|||f||||f||||||||||2017-10-10 23:09:55.180785|2017-10-10 23:09:55.180785
NCT02488291|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2016-12-07|||April 2014||2014-04-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Sufentanil and Ropivacaine|Effect of 0.5µg/ml Sufentanil and Ropivacaine Towards Pregnant Women and Fetus in Analgesia Labor|Completed||N/A|120|Actual|Fudan University||2|||f||||t||||||||||2017-10-10 23:09:55.282525|2017-10-10 23:09:55.282525
NCT02488278|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-07-02|||July 2015||2015-07-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||GLUCOME USABILITY STUDY|GLUCOME USABILITY STUDY|Unknown status|Not yet recruiting|N/A|20|Anticipated|GlucoMe||1|||f||||t||||||||||2017-10-10 23:09:55.392277|2017-10-10 23:09:55.392277
NCT02487875|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-06-29|||January 2014||2014-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Sit-to-stand and Peripheral Muscle Strength in COPD|The One Repetition Maximum Test and the Sit-to-stand Test in the Assessment of a Specific Pulmonary Rehabilitation Program on Peripheral Muscle Strength in COPD Patients|Completed||N/A|60|Actual|Maugeri Foundation||2|||f||||f||||||||||2017-10-10 23:09:59.341157|2017-10-10 23:09:59.341157
NCT02488265|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-06-29|||July 2015||2015-07-01|June 2015|2015-06-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Protocol: Balance Training in Parkinson's Disease|Randomized Controlled Trial Protocol: Balance Training With Rhythmical Cues to Improve and Maintain Balance Control in Parkinson's Disease|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:09:55.479114|2017-10-10 23:09:55.479114
NCT02488252|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-10-25|||July 2015||2015-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy|Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy - A Pilot add-on, Randomised, Controlled, Multi-centre, Open-label Pragmatic Clinical Trial|Recruiting||Phase 2/Phase 3|148|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:09:55.576554|2017-10-10 23:09:55.576554
NCT02488239|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-04-25|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|Rally CRT-P||Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)|Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)|Completed||N/A|63|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-10 23:09:55.683387|2017-10-10 23:09:55.683387
NCT02488226|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-12-16|||June 2015||2015-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|ASD||Gaze Modification Strategies for Toddlers With Autism Spectrum Disorder|Gaze Modification Strategies for Toddlers With Autism Spectrum Disorder|Completed||N/A|81|Actual|Yale University||2|||f||||f||||||||||2017-10-10 23:09:55.771989|2017-10-10 23:09:55.771989
NCT02488213|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-08-24|||January 2015||2015-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Nutritional Counseling Based on Diet Quality on Metabolic Control in Patients With Type 2 Diabetes Mellitus|Effect of Nutritional Counseling Based on Diet Quality on Metabolic Control in Patients With Type 2 Diabetes Mellitus: Randomized Clinical Trial|Recruiting||N/A|196|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 23:09:55.844263|2017-10-10 23:09:55.844263
NCT02488200|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-08-16|||January 2015||2015-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01|1 Year|Observational [Patient Registry]|Peridialysis||Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis|Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis|Recruiting||N/A|1000|Anticipated|Herlev Hospital|||1||f||||f||||||||No||2017-10-10 23:09:55.933252|2017-10-10 23:09:55.933252
NCT02488187|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-01-18|||April 2013||2013-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|ABUS||Comparison of Preoperative ABUS and MRI in Newly Diagnosed Breast Cancer Patients|Comparison of Preoperative Automated Breast Ultrasound (ABUS) and Magnetic Resonance Imaging (MRI) in Newly Diagnosed Breast Cancer Patients|Active, not recruiting||N/A|115|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-10 23:09:56.023443|2017-10-10 23:09:56.023443
NCT02488174|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-01-19|||August 2015|Actual|2015-08-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|PROOFcheck||Prevention of Severe Acute Respiratory Failure in Patients With PROOFCheck|Prevention of Severe Acute Respiratory Failure in Patients With PROOFcheck - an Electronic Checklist to Prevent Organ Failure|Recruiting||N/A|3459|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||||||||||||2017-10-10 23:09:56.09321|2017-10-10 23:09:56.09321
NCT02488161|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-08-23|||June 2010||2010-06-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|December 2012|Actual|2012-12-01||Observational|CARESS-CCR||Factors Related to Adverse Events in Colorectal Cancer|Risk Factors of Adverse Outcomes at Short and Medium Term, and Development of Predictive Models, in Patients With Colorectal Cancer. IRYSS-coordinated Multicenter Study|Completed||N/A|2600|Actual|Hospital Galdakao-Usansolo|||1||f||||t||||||None Retained|"     Fragments of colon or rectum obtained in the surgical intervention   "|||2017-10-10 23:09:56.175074|2017-10-10 23:09:56.175074
NCT02488148|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-05-11|||September 2013||2013-09-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||The Effect of Bikram Yoga on Arterial Stiffness and Endothelial Function in Middle-Aged Adults|Bikram Yoga and Vascular Health|Recruiting||N/A|80|Anticipated|University of Texas at Austin||3|||f||||t||||||||||2017-10-10 23:09:56.24895|2017-10-10 23:09:56.24895
NCT02488122|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-02-09|||February 2016||2016-02-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of the High Impact Exercise on Bone Density in Prepuberal Girls|Effect of the High Impact Exercise on Bone Density in Prepuberal Girls in 12 Private Schools in Bogota - Colombia During 2016 - 2017. Open Label Randomized Controlled Trial|Suspended||N/A|276|Anticipated|Fundación Santa Fe de Bogota||2||Because the study has not yet sponsorship.|f||||f||||||||||2017-10-10 23:09:56.401701|2017-10-10 23:09:56.401701
NCT02488109|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-04-05|||February 2016||2016-02-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|StRONG||Study of Refeeding to Optimize iNpatient Gains|Multi-center Randomized Controlled Trial of Refeeding in Anorexia Nervosa|Enrolling by invitation||N/A|120|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:09:56.476963|2017-10-10 23:09:56.476963
NCT02488096|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-04-13|||December 2015||2015-12-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy|Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy|Recruiting||N/A|80|Anticipated|Regina Qu'Appelle Health Region||2|||f||||f||||||||No||2017-10-10 23:09:56.55041|2017-10-10 23:09:56.55041
NCT02488083|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-04-13|||June 2015||2015-06-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||UltraShape Device for Thigh Fat and Circumference Reduction vs. Control|Clinical Study to Evaluate the Performance of the UltraShape Device for Thighs Fat and Circumference Reduction vs. Control|Recruiting||N/A|60|Anticipated|Syneron Medical||1|||f||||f||||||||||2017-10-10 23:09:56.634001|2017-10-10 23:09:56.634001
NCT02488070|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-04-14|2017-01-23||June 2015|Actual|2015-06-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|||68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer|68Ga-PSMA PET/CT or PET/MRI in the Evaluation of Patients With Prostate Cancer: A Feasibility Study|Completed||Phase 1/Phase 2|10|Actual|Stanford University|lack of correlation with pathology results for all patients; limited patient enrollment (pilot study)|1|||f||||t|t|f|||f|||No||2017-10-10 23:09:56.725071|2017-10-10 23:09:56.725071
NCT02488057|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-10-05|||May 2016||2016-05-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Improving Beta Cell Function in Mexican American Women With Prediabetes|Improving Beta Cell Function in Mexican American Women With Prediabetes|Recruiting||Phase 4|360|Anticipated|Ohio State University||2|||f||||f||||||||Yes|Publication, presentation|2017-10-10 23:09:56.960107|2017-10-10 23:09:56.960107
NCT02488044|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-06-23|||June 2016||2016-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency|A Phase 1/2 Open-label Study in Patients With Arginase I Deficiency to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous AEB1102|Recruiting||Phase 1/Phase 2|10|Anticipated|Aeglea Biotherapeutics||1|||f||||t||||||||||2017-10-10 23:09:57.064105|2017-10-10 23:09:57.064105
NCT02488031|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-02-24|||March 2016||2016-03-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|SCA||Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia|Dysmetria in Motor Function in SCA: Mechanisms and Rehabilitation|Recruiting||N/A|60|Anticipated|University of Florida||2|||f||||f||||||||No||2017-10-10 23:09:57.151039|2017-10-10 23:09:57.151039
NCT02488018|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2016-11-02|2015-11-14||June 2015||2015-06-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Investigation of the Glycemic Index of Ethiopian Honey|Investigation of Ethiopian Honey: Botanical Origin, Physicochemical, Antioxidant, Microbial Quality, Glycemic Index and Sensory Properties|Completed||Early Phase 1|10|Actual|Addis Ababa University||1|||f||||t||||||||Undecided|Due to the Ethical issue, sharing data to 3rd party is not decided yet.|2017-10-10 23:09:57.280988|2017-10-10 23:09:57.280988
NCT02488005|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-09-01|||April 2016||2016-04-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction|The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction|Recruiting||N/A|30|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-10 23:09:57.622487|2017-10-10 23:09:57.622487
NCT02487992|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-02-23|||July 2015||2015-07-01|February 2016|2016-02-01|July 2045|Anticipated|2045-07-01|July 2043|Anticipated|2043-07-01||Interventional|||The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer|The Randomized, Controlled, Multicenter Clinical Trial of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer|Active, not recruiting||Phase 2|1200|Anticipated|The First People's Hospital of Changzhou||2|||f||||f||||||||||2017-10-10 23:09:57.722516|2017-10-10 23:09:57.722516
NCT02487979|ClinicalTrials.gov processed this data on October 10, 2017|2015-07-01|2017-10-02|||February 16, 2016|Actual|2016-02-16|September 2017|2017-09-01||||February 1, 2018|Anticipated|2018-02-01||Interventional|||Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma|A Phase 2 Study of GPNMB-Targeted Antibody-Drug Conjugate, CDX-011 (Glembatumumab Vedotin, CR011-vcMMAE; NSC# 763737), in Recurrent or Refractory Osteosarcoma|Active, not recruiting||Phase 2|38|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:09:57.819652|2017-10-10 23:09:57.819652
NCT02487966|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-03-17|||July 2015||2015-07-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)|Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)|Recruiting||N/A|132|Anticipated|Spaulding Rehabilitation Hospital||4|||f||||f||f||||||||2017-10-10 23:09:58.353682|2017-10-10 23:09:58.353682
NCT02487953|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-08-31|||July 2018|Anticipated|2018-07-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|ENDS-P50||Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment|Electronic Nicotine Delivery Systems (ENDS) as a Smoking Cessation Treatment|Not yet recruiting||Phase 2|300|Anticipated|Duke University||3|||f||||f|t|f|||t|||||2017-10-10 23:09:58.57767|2017-10-10 23:09:58.57767
NCT02487940|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-12-28|||October 2012||2012-10-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure|Assessment of the Efficacy of Intralipid 20% in Management of Women With Unexplained Recurrent Implantation Failure in IVF Cycles: A Double Blinded Randomised Controlled Trial|Completed||Phase 4|100|Actual|Dar El Teb Institute||2|||f||||t||||||||Yes||2017-10-10 23:09:58.709709|2017-10-10 23:09:58.709709
NCT02487927|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-06-29|||June 2012||2012-06-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||The Classification of Difficult Weaning and the Predictive Value of Relative Factors for Difficult Weaning|The Classification of Difficult Weaning and the Predictive Value of Relative Factors for Difficult Weaning|Unknown status|Recruiting|N/A|110|Anticipated|Southeast University, China|||2||f||||t||||||||||2017-10-10 23:09:58.817438|2017-10-10 23:09:58.817438
NCT02487914|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-07-01|||January 2013||2013-01-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of Pressure Sense Threshold and Tactile Sensation After Lidocaine Iontophoresis Using Interferential Current|Iontophoresis Effects on Senses|Completed||Phase 2/Phase 3|30|Actual|Shiraz University of Medical Sciences||3|||f||||f||||||||||2017-10-10 23:09:58.920964|2017-10-10 23:09:58.920964
NCT02487901|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-06-23|||June 2015||2015-06-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|SONO||Comparison of Ultrasonic Osteotome and Conventional Drill Osteotome|Randomized Controlled Trial: Comparison of Ultrasonic Osteotome and Conventional Drill Osteotome|Recruiting||N/A|190|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:09:59.057661|2017-10-10 23:09:59.057661
NCT02487888|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-03-28|||September 2014||2014-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|REVOLUTION||A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care|Randomized, Blinded, Controlled Trial to EValuate the EcOnomic and ClinicaL Outcomes of Utilizing Genetic Testing to Improve Therapeutic Decision-Making COmpared to Empiric Prescribing as the StaNdard of Care|Enrolling by invitation||N/A|100000|Anticipated|Proove Bioscience, Inc.||5|||f||||f||||||||||2017-10-10 23:09:59.166643|2017-10-10 23:09:59.166643
NCT02487849|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-08-07|||August 2017||2017-08-01|February 2016|2016-02-01||||December 2020|Anticipated|2020-12-01||Interventional|HIPEC||HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma|Feasability of an Unique Intraoperative Given Hyperthermal Intraperitoneal Chemotherapy With Carboplatin During a Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma|Suspended||Phase 2|10|Anticipated|Krankenhaus Barmherzige Schwestern Linz||1|||f||||t||||||||||2017-10-10 23:09:59.496509|2017-10-10 23:09:59.496509
NCT02487836|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-02-25|||October 2013||2013-10-01|October 2013|2013-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|PROPAC||Trial Evaluating the Efficacy of Laying a Biliary Stent for Producing a Heavy Chemotherapy in Unresectable Pancreatic Adenocarcinomas|Phase II Trial Evaluating the Efficacy of Laying a Biliary Stent for Producing a Heavy Chemotherapy in Unresectable Pancreatic Adenocarcinomas|Completed||Phase 2|6|Actual|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 23:09:59.588837|2017-10-10 23:09:59.588837
NCT02487823|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-03-01|||October 2014||2014-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|NCMPC-BKM||Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer|Phase Ib Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer|Terminated||Phase 1|6|Actual|Institut Paoli-Calmettes||3||Defect of recruitment|f||||f||||||||||2017-10-10 23:09:59.671024|2017-10-10 23:09:59.671024
NCT02487797|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-09-13|||September 2015||2015-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation|A Randomized Double Blind Clinical Trial Comparing Oxytocin Low-dose and High-dose Regimens for Labor Augmentation|Recruiting||Phase 4|1002|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 23:09:59.834843|2017-10-10 23:09:59.834843
NCT02487784|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-12-06|||August 2015||2015-08-01|June 2015|2015-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Ridge Augmentation: Particulate v/s Block Graft|Ridge Augmentation Comparing the Clinical and Histologic Healing of a Cancellous Block Allograft Versus Corticocancellous Particulate Allograft Mixed With Autogenous Bone Chips|Completed||Phase 4|15|Actual|University of Louisville||2|||f||||t||||||||||2017-10-10 23:09:59.932508|2017-10-10 23:09:59.932508
NCT02487771|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-08-25|2017-07-20||July 2008||2008-07-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional||Families who completed the parent trial were offered enrollment when their child was 2 yrs of age.|Kansas University DHA Outcome Study (KUDOS) Follow-Up|Kansas University DHA Outcome Study (KUDOS) Follow-Up|Completed||Phase 3|190|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 23:10:00.002037|2017-10-10 23:10:00.002037
NCT02487758|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-12-06|||August 2015||2015-08-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Ridge Preservation Comparing the Clinical and Histologic Healing of Flap vs. Flapless Approach to Grafting|Ridge Preservation Comparing the Clinical and Histologic Healing of Flap vs. Flapless Approach to Grafting|Completed||N/A|24|Actual|University of Louisville||2|||f||||f||||||||||2017-10-10 23:10:00.607934|2017-10-10 23:10:00.607934
NCT02487745|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-08-14|||November 2015||2015-11-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||The Long-Term Treatment of Drug Addiction and Unemployment|The Long-Term Treatment of Drug Addiction and Unemployment|Recruiting||N/A|120|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:10:00.693789|2017-10-10 23:10:00.693789
NCT02487732|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2016-12-23|||July 2015||2015-07-01|December 2016|2016-12-01||||August 2016|Actual|2016-08-01||Interventional|||Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting||Active, not recruiting||Phase 4|60|Actual|Korea University Anam Hospital||2|||f||||||||||||||2017-10-10 23:10:00.819716|2017-10-10 23:10:00.819716
NCT02487719|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-30|||June 2015||2015-06-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|EDISA||Different Iron Supplements for Prevention of Anemia in Pregnancy|Effektivität Der in Der Schwangerschaftsvorsorge routinemässig Angewandten Eisenprophylaxe|Unknown status|Recruiting|Phase 4|150|Anticipated|University of Zurich||3|||f||||f||||||||||2017-10-10 23:10:00.905862|2017-10-10 23:10:00.905862
NCT02487706|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-09-30|||June 2015||2015-06-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease|Removal of Dolutegravir by Hemodialysis in HIV-infected Patients With End-stage Renal Disease|Completed||Phase 4|5|Actual|Fundacio Lluita Contra la SIDA||1|||f||||f||||||||||2017-10-10 23:10:01.000531|2017-10-10 23:10:01.000531
NCT02487693|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-02-21|||July 2015||2015-07-01|February 2016|2016-02-01|June 2040|Anticipated|2040-06-01|June 2038|Anticipated|2038-06-01||Interventional|||Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma||Active, not recruiting||Phase 2|50|Anticipated|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:10:01.075699|2017-10-10 23:10:01.075699
NCT02487680|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-05-11|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism on Healthy Subjects|Effect of a Table Water Enriched With Amino Acids and Chromium on Blood Glucose and Insulin Levels After a Meal|Completed||N/A|20|Actual|DoubleGood AB||2|||f||||f||||||||||2017-10-10 23:10:01.151594|2017-10-10 23:10:01.151594
NCT02487667|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-29|||June 2014||2014-06-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Therapeutic Exercise Training in the Elderly|Effects of a Therapeutic Exercise Program by a Feedback a Motor Control System in the Elderly|Unknown status|Recruiting|N/A|120|Anticipated|Universidad de Zaragoza||2|||f||||t||||||||||2017-10-10 23:10:01.219255|2017-10-10 23:10:01.219255
NCT02487654|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-06-30|||December 2013||2013-12-01|June 2015|2015-06-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||The Role of Nerves in the Heart That Trigger Pulmonary Vein Extra Beats|The Role of Left Atrial Ganglionated Plexi Sites That Trigger Pulmonary Vein Ectopy in the Pathogenesis of Paroxysmal Atrial Fibrillation|Unknown status|Recruiting|N/A|180|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-10 23:10:01.294164|2017-10-10 23:10:01.294164
NCT02487641|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-11-09|||June 2015||2015-06-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|||Obese Pregnant Women: Optimizing Fetal Ultrasound|Obese Pregnant Women: Optimizing Mid-trimester Fetal Ultrasound for Risk Estimation During Pregnancy and Childhood|Recruiting||N/A|180|Anticipated|Holbaek Sygehus|||3||f||||t||||||||||2017-10-10 23:10:01.422599|2017-10-10 23:10:01.422599
NCT02487628|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-06-29|||November 2014||2014-11-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Evaluation of HQ® Matrix Soft Tissue Mesh for the Treatment of Inguinal Hernia|Multi-center, Randomized, Active-controlled, Single-blind, Parallel Two-group Trial of HQ® Matrix Soft Tissue Mesh and ULTRAPRO® Partially Absorbable Lightweight Mesh for the Treatment of Inguinal Hernia|Unknown status|Recruiting|N/A|144|Anticipated|Zhejiang Xingyue Biotechnology Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:10:01.542153|2017-10-10 23:10:01.542153
NCT02487615|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-02|||February 2010||2010-02-01|July 2015|2015-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Genetical, Anthropometrical and Biochemical Factors Influencing High Risk Subclinical Atherosclerosis|Subclinical Atherosclerosis: Biomarkers of Early Disease|Completed||N/A|340|Actual|Instituto Dante Pazzanese de Cardiologia|||1||f||||f||||||Samples With DNA|"     Plasma, Whole blood, DNA   "|||2017-10-10 23:10:01.678874|2017-10-10 23:10:01.678874
NCT02487602|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-08-22|||September 2015||2015-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects|A Randomized, Partially-blinded, Cross-over Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects|Completed||N/A|16|Actual|Gelesis, Inc.||5|||f||||f||||||||||2017-10-10 23:10:01.794066|2017-10-10 23:10:01.794066
NCT02487589|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-06-15|||May 2014||2014-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Falls in Elderly and Telehealth: a Randomized Controlled Study|Feasibility and Cost-effectiveness of a Multidisciplinary Home-telehealth Intervention Programme to Reduce Falls Among Elderly Discharged From Hospital: a Randomized Controlled Trial|Completed||N/A|280|Actual|Fondazione Salvatore Maugeri||2|||f||||f||||||||No||2017-10-10 23:10:01.904555|2017-10-10 23:10:01.904555
NCT02487576|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-08-10|||January 2014||2014-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|CLOCK||The CLOCK Study - A Human Dietary Intervention Study on Peripheral Circadian Clocks and Energy Metabolism|Interplay of Peripheral Circadian Clocks With Energy Balance and Body Weight Regulation|Completed||N/A|32|Anticipated|German Institute of Human Nutrition||2|||f||||f||||||||||2017-10-10 23:10:02.009186|2017-10-10 23:10:02.009186
NCT02487563|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2015-06-29|||August 2015||2015-08-01|June 2015|2015-06-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Prospective Study of Patients With Thrombocytopenia Following HSCT|A Prospective Study of Patients With Isolated Thrombocytopenia Following Hematopoietic Stem Cell Transplantation|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|The First Affiliated Hospital of Soochow University||2|||f||||f||||||||||2017-10-10 23:10:02.114457|2017-10-10 23:10:02.114457
NCT02487550|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-29|||August 2015||2015-08-01|June 2015|2015-06-01|July 2030|Anticipated|2030-07-01|July 2028|Anticipated|2028-07-01||Interventional|||DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating||Not yet recruiting||Phase 2|1200|Anticipated|The First People's Hospital of Changzhou||2|||f||||||||||||||2017-10-10 23:10:02.245811|2017-10-10 23:10:02.245811
NCT02487537|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-21|||March 2015||2015-03-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|ILIAS-2||Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 2|Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 2|Recruiting||N/A|16|Anticipated|German Institute of Human Nutrition||2|||f||||t||||||||||2017-10-10 23:10:02.340849|2017-10-10 23:10:02.340849
NCT02487524|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-08-26|||October 2014||2014-10-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer|Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer|Active, not recruiting||N/A|402|Actual|Helsinki University Central Hospital||3|||f||||f||||||||Undecided||2017-10-10 23:10:04.442596|2017-10-10 23:10:04.442596
NCT02487511|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-06-07|||August 1, 2015|Actual|2015-08-01|June 2017|2017-06-01|January 31, 2017|Actual|2017-01-31|August 31, 2016|Actual|2016-08-31||Interventional|||Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy|Comparison of the Eradication Rate Between 1- and 2-Week PPI Containing Therapies for Helicobacter Pylori Eradication|Completed||Phase 4|387|Actual|St.Paul's Hospital, Korea||2|||f||||f|f|f||||||No||2017-10-10 23:10:04.554014|2017-10-10 23:10:04.554014
NCT02487485|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-01-05|||March 2016||2016-03-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects|Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects|Recruiting||Phase 2|30|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-10 23:10:04.847152|2017-10-10 23:10:04.847152
NCT02487459|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-07-11|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|May 2019|Anticipated|2019-05-01||Interventional|||Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies|A Phase I/II Safety Study of Planned BPX-501 T Cell Infusion After Partially Mismatched, Related, HSCT in Adults With Advanced Hematologic Malignances at High Risk for Relapse|Not yet recruiting||Phase 1|40|Anticipated|Bellicum Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-10 23:10:05.108304|2017-10-10 23:10:05.108304
NCT02487433|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-08-17|||June 2015||2015-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study To Evaluate The Effect Of Food On The Behavior of Tofacitinib Modified Release 22 Milligram Tablets In Healthy Volunteers|A Phase 1, Randomized, Open Label, Single Dose, 2 Period Crossover Study To Evaluate The Effect Of Food On The Pharmacokinetics Of Tofacitinib Modified Release (mr) 22 Mg Tablets In Healthy Volunteers|Completed||Phase 1|18|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 23:10:05.65232|2017-10-10 23:10:05.65232
NCT02487420|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-06-09|||July 2015||2015-07-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|TETI||Gradual Egg-tolerance Induction in Hen's Egg Allergic Children|Trapsgewijze Ei-tolerantie-inductie Bij Kippenei-allergische Kinderen (TETI Studie)|Recruiting||N/A|60|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No|data will be analysed and grouped before release|2017-10-10 23:10:05.773635|2017-10-10 23:10:05.773635
NCT02487407|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-08-30|||July 2015||2015-07-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|ALS||Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis|Effects of ODM-109 on Respiratory Function in Patients With ALS. A Randomized, Double Blind, Placebo-controlled, Cross-over, 3-period, Multicenter Study With Open-label Follow-up Extension|Active, not recruiting||Phase 2|66|Actual|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-10-10 23:10:05.904686|2017-10-10 23:10:05.904686
NCT02487381|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-08-13|||April 2015||2015-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids|Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System, Cognition and Neuronal Oscillations|Completed||Phase 1|60|Anticipated|Central Institute of Mental Health, Mannheim||4|||f||||f||||||||||2017-10-10 23:10:06.17504|2017-10-10 23:10:06.17504
NCT02487368|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-01|||October 2009||2009-10-01|July 2015|2015-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|NRM_2009||Effects of a Mechanical Needle Stimulation Pad on Chronic Low Back Pain|Effects of a Mechanical Needle Stimulation Pad on Chronic Low Back Pain|Completed||N/A|166|Actual|Universität Duisburg-Essen||1|||f||||f||||||||||2017-10-10 23:10:06.309103|2017-10-10 23:10:06.309103
NCT02487355|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-09-25|||May 2015||2015-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|JASayed||Pediatric Caudal Dexmedetomidine Enhances Postoperative Analgesia of Magnesium Sulphate in Lower Abdominal Surgeries|Pediatric Caudal Epidural Dexmedetomidine Enhances Postoperative Analgesia of Magnesium Sulphate and Quality of Caudal Anesthesia in Lower Abdominal Surgeries|Recruiting||Phase 2/Phase 3|120|Anticipated|Assiut University||4|||f||||t||||||||||2017-10-10 23:10:06.406874|2017-10-10 23:10:06.406874
NCT02487342|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-09-27|||June 2014||2014-06-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Metabolic, Endocrine and Appetite-related Responses in Healthy, Adolescent Males After Acute and Daily Milk Consumption|Metabolic, Endocrine and Appetite-related Responses in Healthy, Adolescent Males After Acute and Daily Milk Consumption|Completed||N/A|30|Actual|Northumbria University||2|||f||||f||||||||||2017-10-10 23:10:06.547037|2017-10-10 23:10:06.547037
NCT02487329|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-26|||January 2015||2015-01-01|June 2015|2015-06-01||||June 2015|Actual|2015-06-01||Interventional|||The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping|Efficacy of Er,Cr:YSGG Laser Irradiation Combined With Resin Based Tricalcium Silicate and Calcium Hydroxide on Direct Pulp Capping: a Randomized Clinical Trial|Completed||N/A|60|Actual|Near East University, Turkey||4|||f||||f||||||||||2017-10-10 23:10:06.65006|2017-10-10 23:10:06.65006
NCT02487316|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2016-12-28|||July 2015||2015-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib|A Multicenter Prospective Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib|Withdrawn||Phase 4|0|Actual|Peking University||1|||f||||f||||||||||2017-10-10 23:10:06.772389|2017-10-10 23:10:06.772389
NCT02487303|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-03-24|||June 2015||2015-06-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Intravenous Versus Oral Acetaminophen for Postoperative Pain Control After Cesarean Delivery|Intravenous Versus Oral Acetaminophen for Postoperative Pain Control After Cesarean Delivery|Recruiting||N/A|141|Anticipated|Medical University of South Carolina||3|||f||||t||||||||||2017-10-10 23:10:06.897395|2017-10-10 23:10:06.897395
NCT02487290|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-06-29|||August 2015||2015-08-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Feasibility Study of ANEUFIX: a Novel Approach to Treat Type II Endoleaks Using ACP-T5|Feasibility Study of ANEUFIX: a Novel Approach to Treat Type II Endoleaks Using ACP-T5|Unknown status|Not yet recruiting|N/A|5|Anticipated|TripleMed B.V.||1|||f||||t||||||||||2017-10-10 23:10:07.033234|2017-10-10 23:10:07.033234
NCT02487277|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-06-09|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma|Perioperative Stromal Depletion Strategies in Pancreatic Ductal Adenocarcinoma|Recruiting||Phase 2|36|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:10:07.120961|2017-10-10 23:10:07.120961
NCT02487264|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2016-03-17|||June 2013||2013-06-01|March 2016|2016-03-01||||October 2016|Anticipated|2016-10-01||Observational|||Analysis of the Status, Treatment and Outcomes of Rib Fractures|Analysis of the Status, Treatment and Outcomes of Rib Fractures|Active, not recruiting||N/A|921|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-10-10 23:10:07.250721|2017-10-10 23:10:07.250721
NCT02487251|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2017-09-27|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|SimplyDinner||Effectiveness of Differing Levels of Support for Family Mealtimes on Obesity Prevention Among Head Start Preschools|Effectiveness of Differing Levels of Support for Family Mealtimes on Obesity Prevention Among Head Start Preschoolers|Recruiting||N/A|770|Anticipated|Michigan State University||2|||f||||f||||||||||2017-10-10 23:10:07.4967|2017-10-10 23:10:07.4967
NCT02487238|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-06-27|||November 2015||2015-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PediFETCh||Pediatric FEcal Microbial Transplant for Ulcerative Colitis|A Single-Blind, Randomized, Placebo-Controlled Trial of Human Fecal Microbial Transplantation for the Therapy of Pediatric Ulcerative Colitis and Inflammatory Bowel Disease Unclassified|Recruiting||Phase 1|50|Anticipated|McMaster Children's Hospital||2|||f||||f||||||||No||2017-10-10 23:10:07.684605|2017-10-10 23:10:07.684605
NCT02487225|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-09-14|||May 2015||2015-05-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|AP||Pentoxifylline Treatment in Acute Pancreatitis (AP)|Pentoxifylline Treatment in Acute Pancreatitis: A Double-Blind Placebo - Controlled Randomized Trial|Enrolling by invitation||Phase 3|150|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:10:07.89011|2017-10-10 23:10:07.89011
NCT02487212|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2015-06-30|||April 2014||2014-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery|Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery|Completed||Phase 4|24|Actual|Mahidol University||2|||f||||t||||||||||2017-10-10 23:10:08.024468|2017-10-10 23:10:08.024468
NCT02487199|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-04-26|||September 2015||2015-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease|An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-II)|Completed||Phase 3|18|Actual|AbbVie||2|||f||||f||||||||||2017-10-10 23:10:08.168569|2017-10-10 23:10:08.168569
NCT02487186|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-03-30|||March 2010||2010-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Locally Delivered Doxycycline Adjunct to Nonsurgical Periodontal Therapy.|Evaluation of PLGA Microspheres Loaded With Doxycycline Associated to Periodontal Debridement in the Treatment of Chronic Advanced Periodontitis.|Completed||Phase 4|30|Actual|University of Campinas, Brazil||2|||f||||t||||||||No||2017-10-10 23:10:08.317714|2017-10-10 23:10:08.317714
NCT02487173|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-07-14|||September 2015||2015-09-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B|A Prospective Multi-Centre Study of the Respirio Flu Test Performance Versus Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Sofia® Influenza A+B Fluorescent Immunoassay (FIA) for the Rapid Detection of Influenza A/B|Completed||N/A|83|Actual|Ellume Pty Ltd||1|||f||||f||||||||||2017-10-10 23:10:08.432166|2017-10-10 23:10:08.432166
NCT02487160|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-08-29|||August 2015||2015-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens|Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens|Recruiting||Phase 2/Phase 3|510|Anticipated|Lenstec Incorporated||2|||f||||f||||||||||2017-10-10 23:10:08.556938|2017-10-10 23:10:08.556938
NCT02487147|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-07-18|||November 14, 2016|Actual|2016-11-14|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Free Air Portable Air Powered Respirator|Evaluation of Free Air Portable Air Powered Respirator System for Prevention of Influenza Transmission|Recruiting||N/A|86|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-10 23:10:08.778255|2017-10-10 23:10:08.778255
NCT02487134|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2017-09-18|||June 2015||2015-06-01|September 2017|2017-09-01|June 2023|Anticipated|2023-06-01|June 2019|Anticipated|2019-06-01||Interventional|PrevMesh||Trial of Routine Abdominal Wall Closure Versus Reinforcement With TIGR Matrix Onlay|Trial of Routine Abdominal Wall Closure Versus Reinforcement With TIGR Matrix Onlay|Recruiting||N/A|200|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:10:08.942432|2017-10-10 23:10:08.942432
NCT02487121|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-06-29|||April 2010||2010-04-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ImWeL||Improving Weight Loss Maintenance Through Alternative Schedules of Treatment|Improving Weight Loss Maintenance Through Alternative Schedules of Treatment|Completed||N/A|108|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:10:09.074546|2017-10-10 23:10:09.074546
NCT02486926|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2015-07-02|||November 2012||2012-11-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||The Effects of Remifentanil and Remifentanil-Alfentanil Administration in Children|The Effects of Remifentanil and Remifentanil-Alfentanil Administration on Emergence Agitation After Brief Ophthalmic Surgery in Children|Completed||N/A|102|Actual|Hallym University Medical Center||5|||f||||t||||||||||2017-10-10 23:10:11.228777|2017-10-10 23:10:11.228777
NCT02487108|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-05-11|||August 2015||2015-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Patients With Moderate to Severe Pain Following Bunionectomy|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets (TV-46763) at Doses of 5.0 mg/325 mg, 7.5 mg/325 mg, and 10 mg/325 mg Every 4 to 6 Hours in Patients With Moderate to Severe Pain Following Bunionectomy|Completed||Phase 3|569|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-10-10 23:10:09.183752|2017-10-10 23:10:09.183752
NCT02487095|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2017-07-12|||June 18, 2015||2015-06-18|July 11, 2017|2017-07-11|October 30, 2020|Anticipated|2020-10-30|May 31, 2019|Anticipated|2019-05-31||Interventional|||Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Cancers|A Phase I/II Trial of Topotecan With VX970, an ATR Kinase Inhibitor in Small Cell Cancers|Recruiting||Phase 1/Phase 2|70|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:10:09.364794|2017-10-10 23:10:09.364794
NCT02487082|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-04-25|||June 2015||2015-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders|Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders|Recruiting||Phase 2|60|Anticipated|Stony Brook University||2|||f||||t||||||||No||2017-10-10 23:10:09.509391|2017-10-10 23:10:09.509391
NCT02487069|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2017-05-09|||June 2015||2015-06-01|June 2015|2015-06-01|August 2020|Anticipated|2020-08-01|May 2020|Anticipated|2020-05-01||Interventional|||Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy|Allogeneic Stem Cell Transplantation With Alternative Donor in Treatment of Hematologic Malignancy|Recruiting||N/A|600|Anticipated|Nanfang Hospital of Southern Medical University||3|||f||||t||||||||||2017-10-10 23:10:09.634137|2017-10-10 23:10:09.634137
NCT02487043|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-08-30|||August 2015||2015-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||A Telephone-based Case-management Intervention for Caries Prevention in Children With Severe Early Childhood Caries|A Telephone-based Case-management Intervention for Caries Prevention in Children With Severe Early Childhood Caries|Recruiting||N/A|130|Anticipated|Karolinska Institutet||2|||f||||f||||||||No|Data collected only for this study|2017-10-10 23:10:09.879852|2017-10-10 23:10:09.879852
NCT02487030|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2017-08-16|||September 7, 2015|Actual|2015-09-07|August 2017|2017-08-01|February 4, 2017|Actual|2017-02-04|November 11, 2016|Actual|2016-11-11||Interventional|||Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection|A Phase 3, Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection|Completed||Phase 3|255|Actual|Gilead Sciences||7|||f||||f|t|f|||t|||||2017-10-10 23:10:09.974249|2017-10-10 23:10:09.974249
NCT02487017|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-05-23|||May 2015||2015-05-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma|Phase 2 Study of DC-CIK Cells Combined With TACE in the Treatment of Hepatocellular Carcinoma|Recruiting||Phase 2|60|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||2|||f||||t||||||||Undecided||2017-10-10 23:10:10.136362|2017-10-10 23:10:10.136362
NCT02487004|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-06-27|||July 2015||2015-07-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||The Study of Association Between Intradialysis Sodium Balance and Clinical Outcomes in Chronic Hemodialysis Patients||Unknown status|Not yet recruiting|N/A|20|Anticipated|Chung-Ang University|||1||f||||t||||||||||2017-10-10 23:10:10.240287|2017-10-10 23:10:10.240287
NCT02486991|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-12-06|||August 2015||2015-08-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Tunnel With and Without Intramucosal Vertical Incisions|Impact of Intramucosal Vertical Incisions on the Coronally Positioned Tunnel Using Acellular Dermal Matrix|Completed||Phase 4|16|Actual|University of Louisville||2|||f||||t||||||||||2017-10-10 23:10:10.316093|2017-10-10 23:10:10.316093
NCT02486978|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-04-19|||June 2015||2015-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Polyphenols Found in Pomegranate and Olives Food Supplements on Postprandial Blood Glucose in Vivo.|Effects of Polyphenols Found in Pomegranate and Olives Food Supplements on Postprandial Blood Glucose in Vivo.|Completed||N/A|16|Actual|University of Leeds||3|||f||||t||||||||||2017-10-10 23:10:10.41072|2017-10-10 23:10:10.41072
NCT02486965|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-07-25|||October 2015||2015-10-01|July 2016|2016-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|DOUFISPORT||Impact of a Specific Training Program on the Neuromodulation of Pain in Fibromyalgia Subjects|Impact of a Specific Training Program on the Neuromodulation of Pain in Fibromyalgia Subjects|Recruiting||N/A|110|Anticipated|University Hospital, Brest||2|||f||||f||||||||||2017-10-10 23:10:10.497516|2017-10-10 23:10:10.497516
NCT02486952|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-01-22|2015-11-17||August 2005||2005-08-01|January 2016|2016-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational||Full analysis population included all participants enrolled in the study and who started induction therapy.|MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma|Open, Non-Interventional, Multicenter Trial of MabThera in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma|Completed||N/A|154|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:10:10.609389|2017-10-10 23:10:10.609389
NCT02486939|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-05-31|||July 2015||2015-07-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||A Long Term Safety Extension Study (CHS-0214-05)|An Open-Label Safety Extension Study (OLSES) Evaluating the Long Term Safety and Durability of Response of CHS-0214 (CHS-0214-05)|Active, not recruiting||Phase 3|359|Actual|Coherus Biosciences, Inc.||1|||f||||t||||||||||2017-10-10 23:10:11.133328|2017-10-10 23:10:11.133328
NCT02486913|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-02-27|||August 2015||2015-08-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Enhancing Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records|Enhancing the Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records|Recruiting||N/A|110|Anticipated|Queen Mary University of London||2|||f||||t||||||||Undecided||2017-10-10 23:10:11.391157|2017-10-10 23:10:11.391157
NCT02486900|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-10-03|||September 2015||2015-09-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Neurofeedback & Alcohol Dependence|Real-time fMRI Neurofeedback as a Treatment Tool for Alcohol Dependence|Active, not recruiting||N/A|52|Anticipated|Cardiff University||2|||f||||f||||||||||2017-10-10 23:10:11.519236|2017-10-10 23:10:11.519236
NCT02486887|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-29|||June 2015||2015-06-01|June 2015|2015-06-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|MEDIC||Home Electronic Monitoring of Chronic Heart Failure|Monitoring Electronique à Distance Des Patients Insuffisants Cardiaques|Not yet recruiting||N/A|210|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-10 23:10:11.653946|2017-10-10 23:10:11.653946
NCT02486874|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-29|||September 2009||2009-09-01|May 2015|2015-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Clinical Evaluation of PoreSkin|Clinical Evaluation of PoreSkin: A Human Acellular Dermal Matrix|Completed||Phase 1|11|Actual|Chulalongkorn University||1|||f||||f||||||||||2017-10-10 23:10:11.771988|2017-10-10 23:10:11.771988
NCT02486848|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-01-23|||June 2016||2016-06-01|January 2017|2017-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil|Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil|Withdrawn||N/A|0|Actual|Applied Biology, Inc.||2|||f||||f||||||||||2017-10-10 23:10:11.987065|2017-10-10 23:10:11.987065
NCT02486835|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-07-14|||December 23, 2015|Actual|2015-12-23|July 2017|2017-07-01|April 6, 2016|Actual|2016-04-06|April 3, 2016|Actual|2016-04-03||Interventional|||Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold|Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold|Completed||N/A|150|Actual|Clalit Health Services||2|||f||||f|f|f||||||||2017-10-10 23:10:12.125821|2017-10-10 23:10:12.125821
NCT02486822|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-05-09|||July 2015||2015-07-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|SLiP||Labor Scale Versus WHO Partograph in the Management of Labor|The Management of Spontaneous Labour in Primigravida (SLiP): Labor Scale Versus WHO Partograph|Active, not recruiting||N/A|120|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-10 23:10:12.265188|2017-10-10 23:10:12.265188
NCT02486809|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2016-11-01|||July 2015||2015-07-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Bioequivalence Study of Subcutaneous (SC) Lebrikizumab Administered by Needle and Syringe or by Prefilled Syringe With Needle Safety Device (PFS-NSD)|A Phase I, Randomized, Open-Label, Parallel-Group, Single-Dose, Multi-Center Study in Healthy Subjects to Investigate the Bioequivalence Between a High-Concentration Formulation of Lebrikizumab Administered Subcutaneously by a Needle and Syringe and a Low-Concentration Formulation of Lebrikizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device (PFS-NSD)|Completed||Phase 1|176|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-10 23:10:12.414333|2017-10-10 23:10:12.414333
NCT02486796|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-07-06|||February 19, 2016|Actual|2016-02-19|July 2017|2017-07-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer|A Comparison Study to Assess the Value of Naturopathic Medicine Given Immediately and Continuously or Delayed Until Cycle 3 in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer|Terminated||Phase 1/Phase 2|5|Actual|Midwestern Regional Medical Center||2||Operational barriers prevent critical specimen analyses from being performed.|f||||f|t|f||||||||2017-10-10 23:10:12.538169|2017-10-10 23:10:12.538169
NCT02486783|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-27|2016-10-20|||May 2015||2015-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|InSepSur||Infection, Sepsis and Meningitis in Surinamese Neonates|Infection, Sepsis and Meningitis in Surinamese Neonates|Completed||N/A|190|Actual|Academic Hospital Paramaribo|||5||f||||t||||||Samples Without DNA|"     Serum samples   "|||2017-10-10 23:10:12.674498|2017-10-10 23:10:12.674498
NCT02486770|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-12-28|||April 2015||2015-04-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study of Single Doses of IV Aerucin in Healthy Adults|A Phase 1 Single-center (U.S.), Open Label, Dose-escalation Study of the Safety and Pharmacokinetics of Single Doses of Intravenous AerucinTM in Healthy Adult Subjects|Completed||Phase 1|16|Actual|Aridis Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 23:10:12.782724|2017-10-10 23:10:12.782724
NCT02486757|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-30|||April 2015||2015-04-01|June 2015|2015-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Investigation of Female Reproductive Hormone Dynamics During Adolescence|Investigation of Female Reproductive Hormone Dynamics During Adolescence|Unknown status|Recruiting|N/A|45|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:10:12.897174|2017-10-10 23:10:12.897174
NCT02486744|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-02-08|||March 2015||2015-03-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population|Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population|Terminated||Phase 1|9|Actual|Youngstown State University||2||Recruitment challenges and unforseen costs to continue|f||||f||||||||No||2017-10-10 23:10:12.982691|2017-10-10 23:10:12.982691
NCT02486731|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-11-06|||November 2015||2015-11-01|November 2015|2015-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|NOLEO||Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes|Consequences of Noonan Syndrome/LEOPARD Syndrome Associated Shp2 Mutations on Different Signaling Pathways Activation: Relationship With Hormonal Sensitivity|Not yet recruiting||N/A|27|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||3||f||||t||||||Samples Without DNA|"     Fibroblasts, adipocytes, serum   "|||2017-10-10 23:10:13.117561|2017-10-10 23:10:13.117561
NCT02486718|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-09-22|||October 31, 2015|Actual|2015-10-31|September 2017|2017-09-01|September 25, 2026|Anticipated|2026-09-25|September 25, 2026|Anticipated|2026-09-25||Interventional|||Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]|A Phase III, Open-Label, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Best Supportive Care Following Adjuvant Cisplatin-Based Chemotherapy in Patients With Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer|Recruiting||Phase 3|1127|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:10:13.243873|2017-10-10 23:10:13.243873
NCT02486705|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-09-03|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evaluation of PTSD Family Coach, a Mobile Phone App for Family Members of Individuals With PTSD|Pilot Evaluation of PTSD Family Coach, a Mobile Phone App for Family Members of Individuals With PTSD|Completed||Phase 1|242|Actual|VA Palo Alto Health Care System||2|||f||||f||||||||||2017-10-10 23:10:14.120051|2017-10-10 23:10:14.120051
NCT02486679|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-04-28|||July 2015||2015-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Trial of Prostaglandin E2 Tablets Versus Foley Catheter for Labor Induction|Cervical Ripening at Term With Prostaglandin E2 Tablets Versus Foley Catheter: a Randomized Controlled Trial|Recruiting||Phase 4|300|Anticipated|Wolfson Medical Center||2|||f||||f||||||||||2017-10-10 23:10:14.326684|2017-10-10 23:10:14.326684
NCT02486666|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-03-24|||March 2016||2016-03-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FiXET||A Pilot Feasibility And Safety Multicenter Trial Of Administering Weight FiXET Study|A Pilot Feasibility And Safety Multicenter Trial Of Administering Weight Adjusted Fixed Dose Of Low Molecular Weight Heparin (Enoxaparin) To Neonates With Thrombosis (Fixet): Study Protocol|Recruiting||Phase 1|40|Anticipated|Hamilton Health Sciences Corporation||2|||f||||t||||||||No||2017-10-10 23:10:14.423451|2017-10-10 23:10:14.423451
NCT02486653|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-05-31|||July 2015||2015-07-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|POUR||Prevention of Post-operative Urinary Retention|Pre-operative Tamsulosin for the Prevention of Post-operative Urinary Retention: a Randomized, Double-blind, Placebo-controlled Trial|Recruiting||Phase 3|372|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||No||2017-10-10 23:10:14.544812|2017-10-10 23:10:14.544812
NCT02486640|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-09-27|||September 8, 2015|Actual|2015-09-08|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|June 30, 2019|Anticipated|2019-06-30||Observational|BETAPREDICT||Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon|BETAPREDICT - MS Patients Treated With BETAferon®: PREDICTors of Treatment Adherence|Recruiting||N/A|250|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 23:10:14.689653|2017-10-10 23:10:14.689653
NCT02486627|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-10-04|||January 2016||2016-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|EPIC||A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)|A Phase 3, Randomized, Multicenter, Double-Blind Study to Evaluate the Efficacy and Safety of Plazomicin Compared With Meropenem Followed by Optional Oral Therapy for the Treatment of Complicated Urinary Tract Infection (cUTI), Including Acute Pyelonephritis (AP), in Adults|Completed||Phase 3|609|Actual|Achaogen, Inc.||2|||f||||t||||||||||2017-10-10 23:10:14.790809|2017-10-10 23:10:14.790809
NCT02486614|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-10|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|Citroco||Effect of Citrate on the Coagulation System in Patients Receiving CRRT|The Effect of Regional Citrate Anti-coagulation on the Coagulation System in Critically Ill Patients Receiving Continuous Renal Replacement Therapy for Acute Kidney Injury - an Observational Cohort Study|Recruiting||N/A|22|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:10:14.903993|2017-10-10 23:10:14.903993
NCT02486601|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-07-29|||June 2015||2015-06-01|September 2016|2016-09-01|June 2022|Anticipated|2022-06-01|October 2017|Anticipated|2017-10-01||Interventional|FOXAGAST||NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma|Phase II Study of NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma|Recruiting||Phase 2|55|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||t||||||||||2017-10-10 23:10:14.994752|2017-10-10 23:10:14.994752
NCT02486588|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-29|2017-06-14|||October 2015||2015-10-01|June 2017|2017-06-01|April 30, 2017|Actual|2017-04-30|December 2016|Actual|2016-12-01||Interventional|||Increasing Engagement With a Healthy Food Benefit|Increasing Engagement With the Vitality HealthyFood Benefit: A Randomized Field Trial Proposal|Completed||N/A|7000|Anticipated|University of Pennsylvania||6|||f||||f||||||||No||2017-10-10 23:10:15.182964|2017-10-10 23:10:15.182964
NCT02486575|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-06-30|||January 2014||2014-01-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Trial on Laparoscopic Simulation Based on Mentoring|Comparison of Laparoscopic Simulation Training Between Mentoring and Self-learning Technique|Completed||N/A|60|Actual|Università degli Studi di Brescia||2|||f||||f||||||||||2017-10-10 23:10:15.290107|2017-10-10 23:10:15.290107
NCT02486562|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-07-13|||November 2014||2014-11-01|July 2016|2016-07-01||||October 2026|Anticipated|2026-10-01||Observational|iCMS||iConquerMS™ - A Patient-Powered Research Network for Multiple Sclerosis||Recruiting||N/A|20000|Anticipated|Accelerated Cure Project for Multiple Sclerosis|||1||f||||f||||||||||2017-10-10 23:10:15.372072|2017-10-10 23:10:15.372072
NCT02486549|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-02-20|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Supraclavicular Versus Interscalene Block for Shoulder Surgery|A Prospective Randomized Comparison of Ultrasound-guided Supraclavicular and Interscalene Block in Patients Undergoing Arthroscopic Shoulder Surgery|Completed||N/A|62|Actual|Tokat Gaziosmanpasa University||2|||f||||t||||||||||2017-10-10 23:10:15.463712|2017-10-10 23:10:15.463712
NCT02486536|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-06-20|||July 2015||2015-07-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||The Best Dosage and Timing of Polyethylene Glycol for Bowel Preparation Before Capsule Endoscopy|The Best Dosage and Timing of PEG for Bowel Preparation Before Capsule Endoscopy a Prospective, Single−Blind, Randomized, Multi-center Study|Completed||Phase 4|410|Actual|Shanghai Jiao Tong University School of Medicine||5|||f||||t||||||||||2017-10-10 23:10:15.562204|2017-10-10 23:10:15.562204
NCT02486523|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-09-06|||April 2015||2015-04-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|OUADINUT||Benefits of a Household WASH Package to Community-based Management of Acute Malnutrition (CMAM) Program, Chad|Benefits of a Household WASH Package to Community-based Management of Acute Malnutrition (CMAM) Program, Chad|Completed||N/A|1572|Actual|Action Contre la Faim||2|||f||||f||||||||||2017-10-10 23:10:15.657015|2017-10-10 23:10:15.657015
NCT02486497|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-21|||June 2015||2015-06-01|August 2016|2016-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining|Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining After Curative Surgery of Pancreatic Cancer|Completed||N/A|40|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:10:15.840314|2017-10-10 23:10:15.840314
NCT02486484|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2016-06-23|||March 2015||2015-03-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|Zaltrap||Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection|Phase 2 Ziv-aflibercept in Ocular Disease Short and Long-term Study|Recruiting||Phase 2|100|Anticipated|Rafic Hariri University Hospital||1|||f||||t||||||||Yes|"Three-month outcome of ziv-aflibercept for exudative age-related macular degeneration.
Mansour AM, Chhablani J, Antonios RS, Yogi R, Younis MH, Dakroub R, Chahine H. Br J Ophthalmol. 2016 Mar 30. pii: bjophthalmol-2015-308319. doi: 10.1136/bjophthalmol-2015-308319. [Epub ahead of print] PMID: 27030277"|2017-10-10 23:10:15.92426|2017-10-10 23:10:15.92426
NCT02486471|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2016-02-13|||July 2015||2015-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Hemostatic Procedure After Biopsy of the Cervix|Is a Hemostatic Procedure Required After Biopsy of the Cervix Uteri in Women Undergoing Colposcopy for Cervical Dysplasia? A Multicenter Randomized Non-inferiority Trial|Completed||N/A|166|Actual|Zydolab - Institute of Cytology and Immune Cytochemistry||2|||f||||f||||||||No||2017-10-10 23:10:16.031289|2017-10-10 23:10:16.031289
NCT02486458|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-05-07|||April 2015||2015-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Long-term Release of Fluoride Formed on Enamel by Fluoride Gel or Varnish to Biofilm Fluid|Retention of Fluoride Formed on Enamel by Fluoride Gel or Varnish Application and Its Release to Dental Biofilm Fluid - in Vivo Study|Completed||Early Phase 1|62|Actual|University of Campinas, Brazil||4|||f||||f||||||||||2017-10-10 23:10:16.131212|2017-10-10 23:10:16.131212
NCT02486445|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-09-29|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|Ri-Schedule||Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study|Rivaroxaban for Scheduled Work-up of Patients With Suspected Deep Venous Thrombosis|Recruiting||Phase 3|825|Anticipated|Ostfold Hospital Trust||1|||f||||t||||||||||2017-10-10 23:10:16.211449|2017-10-10 23:10:16.211449
NCT02486432|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-28|||April 2015||2015-04-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)|A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa) Doses Administered Using a Divided Dose Approach|Completed||Phase 1|6|Actual|NeuroDerm Ltd.||1|||f||||f||||||||||2017-10-10 23:10:16.294902|2017-10-10 23:10:16.294902
NCT02486419|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-08-02|||February 2015||2015-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Human Neck Brown Adipose Tissue mRNA Profile, a Seasonal Variation Study.|Human Neck Brown Adipose Tissue mRNA Profile, a Seasonal Variation Study.|Completed||N/A|95|Actual|Aarhus University Hospital|||2||f||||t||||||Samples With DNA|"     Adipose tissue biopsies   "|||2017-10-10 23:10:16.364604|2017-10-10 23:10:16.364604
NCT02486393|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-06-28|||November 2011||2011-11-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Observational|||Complications in Parotid Surgery|Complications in Parotid Surgery - a Prospective Cohort Study|Completed||N/A|178|Actual|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 23:10:16.596278|2017-10-10 23:10:16.596278
NCT02486380|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-06-27|||July 2015||2015-07-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Simplus and Eson Evaluation in Obesity Hypoventilation Syndrome (NZ)|Simplus and Eson Evaluation in Obesity Hypoventilation Syndrome (NZ)|Suspended||N/A|20|Anticipated|Fisher and Paykel Healthcare||1||Recruitment halted due to limited resource to recruit. Will start again in August 2016|f||||t||||||||||2017-10-10 23:10:16.65181|2017-10-10 23:10:16.65181
NCT02486367|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-09-30|||June 2015||2015-06-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)|Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)|Recruiting||Early Phase 1|60|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 23:10:16.720388|2017-10-10 23:10:16.720388
NCT02486354|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2015-06-28|||March 2010||2010-03-01|June 2015|2015-06-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|||Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy|Safety and Efficacy of Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy: a Single-arm, Phase 3 Study|Completed||Phase 3|128|Actual|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-10 23:10:16.794342|2017-10-10 23:10:16.794342
NCT02486341|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-02-11|||February 2016||2016-02-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|VARQUOGLY||Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin|Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin|Recruiting||N/A|30|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:10:16.883601|2017-10-10 23:10:16.883601
NCT02486315|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-30|||April 2012||2012-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01|9 Months|Observational [Patient Registry]|CARINAX||Treatment of Coronary ARtery bIfurcation Narrowing by AXxess Stent Implantation|Treatment of Coronary ARtery bIfurcation Narrowing by AXxess Stent Implantation|Completed||N/A|163|Actual|Clinica Mediterranea|||1||f||||t||||||||||2017-10-10 23:10:17.277894|2017-10-10 23:10:17.277894
NCT02486302|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2017-09-05|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|October 13, 2017|Anticipated|2017-10-13|October 13, 2017|Anticipated|2017-10-13||Observational|ADEQUATE||A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.|A Prospective, Multicenter Non-interventional Study To Evaluate The Efficacy Of Enbrel (Registered) (Etanercept) Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis With Particular Focus On The Clinical Status Improvements Still Observable After 12 Weeks Of Treatment|Recruiting||N/A|2100|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 23:10:17.410527|2017-10-10 23:10:17.410527
NCT02486289|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-04-06|||August 2015||2015-08-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|NBMI||Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication|A Randomized, Placebo-controlled Study to Explore Safety, Dose and Efficacy of NBMI in a Mercury Intoxicated Population|Completed||Phase 2|36|Actual|EmeraMed||3|||f||||f||||||||||2017-10-10 23:10:18.572072|2017-10-10 23:10:18.572072
NCT02486276|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-05-08|||June 2015||2015-06-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache|The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache. Development of a Pragmatic Migraine Model|Completed||N/A|30|Actual|Danish Headache Center||2|||f||||f||||||||||2017-10-10 23:10:18.688938|2017-10-10 23:10:18.688938
NCT02486263|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-07-24|||December 2012||2012-12-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|GMT||Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial|Pathophysiology of the Aerodigestive Reflex in Infants: GERD Management Trial|Recruiting||N/A|120|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-10 23:10:18.828956|2017-10-10 23:10:18.828956
NCT02486250|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-09-22|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|August 2017|Actual|2017-08-01|10 Years|Observational [Patient Registry]|NVP||Online Neuropsychological Test Validation Project With Imaging Pilot|Online Neuropsychological Test Validation Project With Imaging Pilot|Active, not recruiting||N/A|1000|Anticipated|University of California, San Francisco|||3||f||||||||||||||2017-10-10 23:10:18.964961|2017-10-10 23:10:18.964961
NCT02486237|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-07-25|||September 2015||2015-09-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Complications in Central American Diabetic Patients: Historic Cohort|Complications in Central American Diabetic Patients: Historic Cohort|Completed||N/A|225|Actual|Clínica Los Yoses|||1||f||||f||||||||Undecided||2017-10-10 23:10:19.100028|2017-10-10 23:10:19.100028
NCT02486224|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-06-09|||September 2015||2015-09-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||Post-exercise Hydration With Deep Sea Mineral Water on Exercise Performance|The Impact of Post-exercise Hydration With Deep Sea Mineral Water on Exercise Performance, Rehydration and Recovery|Recruiting||Phase 2|30|Anticipated|University of Arizona||3|||f||||t||||||||Yes|The University of Arizona (UA) will assure the timely release and sharing of data no later than the acceptance for publication of the main findings from the final dataset and will protect the rights and privacy of human subjects who participate in NIH sponsored research by redacting all identifiers and adoption of other strategies to minimize risks of unauthorized disclosure of personal identifiers in accordance with authorization and consent documents. UA will share data resulting from sponsored projects with research colleagues by depositing data on a secure web-accessible data warehouses or arranging distribution of data, reagents, protein targets, and protocols to other researchers using established mechanisms and repositories. Manuscripts will be submitted for publication in high-quality peer-reviewed journals, adhering to NIH Public Access Policy guidelines. Additionally, findings will be presented and discussed at relevant national conferences.|2017-10-10 23:10:19.266978|2017-10-10 23:10:19.266978
NCT02486211|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-08-08|||September 2015||2015-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|AWAKE||Amantadine to Speed Awakening After Cardiac Arrest|Amantadine to Speed Awakening After Cardiac Arrest|Recruiting||Phase 2|120|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:10:19.396145|2017-10-10 23:10:19.396145
NCT02486198|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2017-09-04|||May 2015||2015-05-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer|Monosialotetrahexosylganglioside Sodium Injection for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer|Recruiting||Phase 3|144|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-10 23:10:19.530651|2017-10-10 23:10:19.530651
NCT02486185|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-09-29|||August 2015||2015-08-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Interventional|SARCORSICA||SARCORSICA: SARC-F Questionnaire as a Screening Tool for Age-related Sarcopenia|Evaluation of the SARC-F Questionnaire, a New Screening Tool for Sarcopenia in People 65-year Old and Older in the Community|Unknown status|Recruiting|N/A|366|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 23:10:19.651697|2017-10-10 23:10:19.651697
NCT02486172|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-26|||July 2015||2015-07-01|June 2015|2015-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Multi-centre Peer Support Program in Type 2 Diabetes Patients in Hong Kong|Development and Evaluation of A Peer Support Program for Type 2 Diabetes Patients in Hong Kong as Quality Improvement in Diabetes Care Service|Unknown status|Not yet recruiting|N/A|434|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-10 23:10:19.758596|2017-10-10 23:10:19.758596
NCT02486159|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-05-11|||September 2009||2009-09-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and Acupuncture|The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and Acupuncture|Completed||N/A|50|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||No||2017-10-10 23:10:19.847816|2017-10-10 23:10:19.847816
NCT02486146|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-06-19|||October 2014||2014-10-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||GI Biorepository of Tissue and Bodily Fluids|GI Biorepository of Tissue and Bodily Fluids|Completed||N/A|789|Actual|University of California, Davis|||1||f||||t||||||||||2017-10-10 23:10:19.9365|2017-10-10 23:10:19.9365
NCT02486133|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-07-05|||July 2015||2015-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Dualis||Dual Therapy With Boosted Darunavir + Dolutegravir|A Prospective, Multicenter, Randomized, Open-label Trial to Assess the Safety, Tolerability and Efficacy of Dual Therapy With Boosted Darunavir + Dolutegravir When Switching From Standard of Care ART in HIV-patients With Sustained Virological Suppression: The DUALIS Study|Recruiting||Phase 3|320|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-10-10 23:10:20.012995|2017-10-10 23:10:20.012995
NCT02486120|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-30|2017-06-30|||June 22, 2015||2015-06-22|May 24, 2017|2017-05-24|May 24, 2017|Actual|2017-05-24|May 31, 2016|Actual|2016-05-31||Observational|||Are Genetic Counselors Screening for Adolescent Suicide Risk?|Are Genetic Counselors Screening Adolescents for Suicide Risk? A Mixed Methods Study|Completed||N/A|450|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:10:20.134198|2017-10-10 23:10:20.134198
NCT02486107|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-11-26|||May 2015||2015-05-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|PECD||Prospective Cohort Study of Outcome After Minimally Invasive Posterior Cervical Spine Surgery|Prospective Cohort Study of Outcome After Minimally Invasive Posterior Surgery (Posterior Percutaneous Endoscopic Foraminotomy or Tubular Retractor Assisted Micro-foraminotomy) for Single Level Cervical Foraminal Stenosis|Recruiting||N/A|156|Anticipated|Seoul National University Hospital|||3||f||||f||||||||||2017-10-10 23:10:20.199038|2017-10-10 23:10:20.199038
NCT02486094|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-06-09|||June 2015||2015-06-01|June 2015|2015-06-01|June 7, 2017|Actual|2017-06-07|September 1, 2016|Actual|2016-09-01||Observational|SOPRANO||Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging|Study Of PRoliferation and Apoptosis in Rectal caNcer as Predictive and Prognostic biOmarkers: a Histopathology and Imaging Analysis|Completed||N/A|148|Actual|Royal Marsden NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Pre-treatment biopsy and post surgical tissue   "|||2017-10-10 23:10:20.299979|2017-10-10 23:10:20.299979
NCT02486081|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-11-10|||April 2016||2016-04-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Development and Application-Smart Football for Movement Evaluation and Training in the Special Education Population|Assistive Device Design, Development and Application-Smart Football for Movement Evaluation and Training in the Special Education Population|Recruiting||N/A|20|Anticipated|Chang Gung Memorial Hospital|||2||f||||f||||||||||2017-10-10 23:10:20.369649|2017-10-10 23:10:20.369649
NCT02486068|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-06-17|||September 2015||2015-09-01|June 2016|2016-06-01|March 2022|Anticipated|2022-03-01|March 2018|Anticipated|2018-03-01||Interventional|Compare Absorb||ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis in Patients at High Risk of Restenosis|ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis|Recruiting||N/A|2100|Anticipated|European Cardiovascular Research Center||2|||f||||t||||||||||2017-10-10 23:10:20.47027|2017-10-10 23:10:20.47027
NCT02486055|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-12-20|||November 2015||2015-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Safety Study of Orally Administered BPM31510 in Healthy Subjects|A Phase I Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Orally Administered BPM 31510 in Healthy Subjects|Completed||Phase 1|20|Actual|Berg, LLC||2|||f||||f||||||||||2017-10-10 23:10:20.731695|2017-10-10 23:10:20.731695
NCT02486042|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-06-17|||March 2014||2014-03-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity|Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity: Proposal for a Prospective Randomized Controlled Masked Clinical Trial With Lipidomic and Transcriptomic Analyses|Recruiting||Phase 2|40|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:10:20.827788|2017-10-10 23:10:20.827788
NCT02486016|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-09-05|||June 2015||2015-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Transdermal Patch CVD 2000: The Effect of Heat on Fentanyl Release From Fentanyl Patches in Healthy Adults|Determination of Serum Fentanyl Levels After Using Reference and Generic Transdermal Fentanyl Patches With and Without Standardized Heat Application in Healthy Human Volunteers|Active, not recruiting||Phase 4|10|Actual|University of Maryland||3|||f||||f||||||||||2017-10-10 23:10:20.929167|2017-10-10 23:10:20.929167
NCT02486003|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-12-22|||May 2015||2015-05-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Testing mTBI in Athletes|The Use of a Portable 3D Head Mounted Display (HMD) With Integrated Eye Capture Technology for the Diagnosis of Dizziness Associated With Mild Traumatic Brain Injury (mTBI)|Recruiting||N/A|300|Anticipated|University of Miami|||3||f||||f||||||||||2017-10-10 23:10:21.013565|2017-10-10 23:10:21.013565
NCT02485990|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-04-20|||December 2015||2015-12-01|April 2016|2016-04-01||||September 2019|Anticipated|2019-09-01||Interventional|||Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)|An Open Label Dose Escalation/Expansion Study of Tremelimumab Alone or Combined With Olaparib for Recurrent or Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)|Recruiting||Phase 1/Phase 2|68|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-10 23:10:21.093036|2017-10-10 23:10:21.093036
NCT02485977|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-06-29|||July 2015||2015-07-01|June 2015|2015-06-01||||June 2016|Anticipated|2016-06-01||Observational|||Cardiac MRI in Pulmonary Hypertension||Unknown status|Not yet recruiting|N/A|24|Anticipated|University of California, San Francisco|||1||f||||f||||||||||2017-10-10 23:10:21.265095|2017-10-10 23:10:21.265095
NCT02485964|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-06-12|||August 2015||2015-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine|A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine|Active, not recruiting||N/A|10|Anticipated|University of Arkansas||1|||f||||f||||||||Undecided||2017-10-10 23:10:21.365713|2017-10-10 23:10:21.365713
NCT02485951|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-04-19|||January 2014||2014-01-01|June 2015|2015-06-01||||June 2015|Actual|2015-06-01||Interventional|||Central Versus Peripheral Air Injection for DALK (Deep Anterior Lamellar Keratoplasty)|Big-bubble Deep Anterior Lamellar Keratoplasty: Central Versus Peripheral Air Injection|Completed||N/A|49|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-10-10 23:10:21.457047|2017-10-10 23:10:21.457047
NCT02485938|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-11-07|||August 2015||2015-08-01|November 2016|2016-11-01|November 2021|Anticipated|2021-11-01|November 2017|Anticipated|2017-11-01||Interventional|HOPE||HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)|A Randomized, Open-label Study of the Safety and Efficacy of Multi- Vessel Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With Cardiomyopathy Secondary to Duchenne Muscular Dystrophy|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Capricor Inc.||2|||f||||t||||||||||2017-10-10 23:10:21.547665|2017-10-10 23:10:21.547665
NCT02485925|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-07-21|||July 1, 2015|Actual|2015-07-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||SMART China, A Multi-center Clinical Registry Study|The Effectiveness and Safety in the Treatment of Circumferential Pulmonary Vein Isolation (CPVI) for Symptomatic Paroxysmal Atrial Fibrillation With THERMOCOOL® SMARTTOUCH™ Catheter in China, A Multi-center Clinical Registry Study|Completed||Phase 4|200|Actual|Biosense Webster, Inc.||1|||f||||t|f|t|f||t|||||2017-10-10 23:10:21.674275|2017-10-10 23:10:21.674275
NCT02485912|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-02-12|||July 2015||2015-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination|A Phase Ib Safety and Immunogenicity Clinical Trial of Heterologous Prime-boost Immunisation With ChAd3-EBO Z and MVA-EBO Z in Healthy Senegalese Adult Volunteers Aged 18-50 Years.|Completed||Phase 1|40|Actual|University of Oxford||2|||f||||f||||||||||2017-10-10 23:10:21.80658|2017-10-10 23:10:21.80658
NCT02485899|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-10-28|||February 2015||2015-02-01|October 2016|2016-10-01||||December 2021|Anticipated|2021-12-01||Interventional|||A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease|A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease|Active, not recruiting||Phase 1/Phase 2|23|Actual|BioMarin Pharmaceutical||1|||f||||t||||||||||2017-10-10 23:10:21.948754|2017-10-10 23:10:21.948754
NCT02485886|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-04-05|||January 2015||2015-01-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis|Safety and Diagnostic Performance of 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis|Recruiting||Early Phase 1|20|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-10 23:10:22.077315|2017-10-10 23:10:22.077315
NCT02485873|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-11-10|||May 2015||2015-05-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|RELIEF||Real-Life Evidence on Stroke Prevention in SPAF|REal-LIfe Evidence on Stroke Prevention in Patients With Atrial Fibrillation|Completed||N/A|8607|Actual|Bayer|||2||f||||f||||||||||2017-10-10 23:10:22.202786|2017-10-10 23:10:22.202786
NCT02485860|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-08-11|||March 2016||2016-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|Pilomiel||Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst|Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst|Recruiting||Phase 4|100|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-10 23:10:22.322892|2017-10-10 23:10:22.322892
NCT02485847|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-07-11|||March 2014||2014-03-01|July 2016|2016-07-01|January 2100|Anticipated|2100-01-01|January 2100|Anticipated|2100-01-01|1 Year|Observational [Patient Registry]|IRISRegistry||IRIS Registry: Intelligent Research in Sight Registry|IRIS Registry: Intelligent Research in Sight Registry|Recruiting||N/A|20000000|Anticipated|American Academy of Ophthalmology|||1||f||||t||||||||No||2017-10-10 23:10:22.440851|2017-10-10 23:10:22.440851
NCT02485834|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-06-20|||August 2015||2015-08-01|June 2017|2017-06-01||||June 2019|Anticipated|2019-06-01||Interventional|||FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer|Impact of Early FDG-PET Directed Intervention on Preoperative Therapy for Locally Advanced Gastric Cancer: A Random Assignment Phase II Study|Active, not recruiting||Phase 2|5|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 23:10:22.615961|2017-10-10 23:10:22.615961
NCT02485821|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-02-14|||June 2015||2015-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Vaginal Estradiol Pretreatment in Labour Induction With Misoprostol|Vaginal Estradiol Pretreatment in Labour Induction With Misoprostol|Completed||Phase 2/Phase 3|200|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-10 23:10:22.893027|2017-10-10 23:10:22.893027
NCT02485808|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-08-17|||April 2015||2015-04-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Observational|||Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study|Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Phenotyping Study Protocol|Recruiting||N/A|1452|Anticipated|Arbor Research Collaborative for Health|||4||f||||t||||||Samples With DNA|"     Whole Blood - DNA Plasma Urine Vaginal Cultures (women) Perineal Cultures (men) Saliva   "|||2017-10-10 23:10:22.986492|2017-10-10 23:10:22.986492
NCT02485795|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-05-31|||September 2014||2014-09-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|MOSAIC||Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management|A Multicenter Longitudinal Observational Study Evaluating Genotypic Association wIth Clinical Outcomes in Interventional Pain Management Modalities|Enrolling by invitation||N/A|50000|Anticipated|Proove Bioscience, Inc.|||1||f||||f||||||||||2017-10-10 23:10:23.143289|2017-10-10 23:10:23.143289
NCT02485782|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-09-20|||June 2015||2015-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|CI/HD||Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis|Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis|Completed||N/A|48|Actual|Medical University of Warsaw|||1||f||||t||||||||||2017-10-10 23:10:23.28783|2017-10-10 23:10:23.28783
NCT02485769|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-05-15|||June 2015||2015-06-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects|A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Controlled, Sequential Group, Multiple Ascending Dose Escalation Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Orally Administered Pf 06650833 In Healthy Subjects|Completed||Phase 1|71|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 23:10:23.374779|2017-10-10 23:10:23.374779
NCT02485756|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-06-29|||June 2013||2013-06-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Counseling on the Interaction of Hormonal Contraceptives and Antiepileptics|An Educational Intervention to Increase Knowledge of Drug-drug Interactions Between Antiepileptics and Hormonal Contraception Among Reproductive-aged Women With Epilepsy.|Unknown status|Recruiting|N/A|80|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:10:23.461831|2017-10-10 23:10:23.461831
NCT02485743|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-09-14|||May 2016||2016-05-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|SATIN||A Trial Comparing a Diet Including Products Aimed at Targeting Satiety|A Randomized, Double-blind Multi-centre Trial Comparing a Diet Including Satiating Products Compared to Control Products - SATIN Satiety Diet - Proof of Concept|Completed||N/A|25|Actual|University of Liverpool||2|||f||||t||||||||||2017-10-10 23:10:23.538202|2017-10-10 23:10:23.538202
NCT02485730|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-03-01|||October 25, 2016|Actual|2016-10-25|March 2017|2017-03-01|October 2024|Anticipated|2024-10-01|October 2018|Anticipated|2018-10-01||Observational|ALFA Cohort||Early Identification of Markers in Alzheimer's Families / ALFA|Cohort Study for Early Identification of Markers in Cognitively Healthy Family Members of Patients With Alzheimer's Disease|Recruiting||N/A|400|Anticipated|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation|||1||f||||f||||||Samples With DNA|"     Whole blood, urine and CSF samples collection and analysis.   "|||2017-10-10 23:10:23.68595|2017-10-10 23:10:23.68595
NCT02485717|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-07-31|||May 2, 2017|Actual|2017-05-02|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies|A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety, Efficacy and Pharmacokinetics of Natroba™ (Spinosad) for the Treatment of Scabies|Recruiting||Phase 3|120|Anticipated|ParaPRO LLC||2|||f||||t|t|f||||||||2017-10-10 23:10:23.765013|2017-10-10 23:10:23.765013
NCT02485691|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-05-04|||November 2015||2015-11-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CARD||Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent|A Randomized, Open Label, Multicenter Study of Cabazitaxel Versus an Androgen Receptor (AR)-Targeted Agent (Abiraterone or Enzalutamide) in mCRPC Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent (CARD)|Recruiting||Phase 4|324|Anticipated|Sanofi||2|||f||||f||||||||||2017-10-10 23:10:24.000017|2017-10-10 23:10:24.000017
NCT02485678|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-28|||February 2016||2016-02-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|AToM||A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer|A Pragmatic Cluster-Randomized Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer (AToM)|Recruiting||N/A|1460|Anticipated|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-10-10 23:10:24.204032|2017-10-10 23:10:24.204032
NCT02485665|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-11-16|||July 2015||2015-07-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence|Efficacy of Personalized Extracorporeal Biofeedback Device for Pelvic Floor Muscle Training on Post-prostatectomy Incontinence|Recruiting||N/A|84|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:10:24.327463|2017-10-10 23:10:24.327463
NCT02485652|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-11-22|||July 2015||2015-07-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung|A Single Arm, Open-label, Phase 2 Study Evaluating the Efficacy, Safety and PK of HM61713 in Patients With T790M-positive NSCLC After Treatment With an Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor|Active, not recruiting||Phase 2|162|Actual|Hanmi Pharmaceutical Company Limited||1|||f||||t||||||||||2017-10-10 23:10:24.412422|2017-10-10 23:10:24.412422
NCT02485639|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-09-14|||December 23, 2015|Actual|2015-12-23|April 5, 2017|2017-04-05|June 4, 2020|Anticipated|2020-06-04|June 4, 2019|Anticipated|2019-06-04||Interventional|||Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination|Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination|Recruiting||Phase 4|55|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f|||||f|f|||f|||||2017-10-10 23:10:26.489848|2017-10-10 23:10:26.489848
NCT02485626|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-10-28|||April 2015||2015-04-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01|2 Years|Observational [Patient Registry]|HARBOR||Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors|HARBOR Study: Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors|Recruiting||N/A|628|Anticipated|The Netherlands Cancer Institute|||2||f||||f||||||Samples With DNA|"     Consent is obtained from participants to draw blood for DNA-analyses to evaluate whether     specific genes modify the risk of treatment-induced cardiovascular disease.   "|||2017-10-10 23:10:26.589104|2017-10-10 23:10:26.589104
NCT02485613|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-25|||January 2009||2009-01-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|||Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis|Bortezomib With Dexamethasone as the First-line Treatment for Immunoglobulin Light Chain(AL) Amyloidosis|Completed||N/A|72|Actual|Nanjing University School of Medicine|||1||f||||f||||||||||2017-10-10 23:10:26.695088|2017-10-10 23:10:26.695088
NCT02485600|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-08-24|||October 19, 2015||2015-10-19|August 2017|2017-08-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2021|Anticipated|2021-04-01||Observational|||Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients|Canadian Advanced Parkinson DUODOPA-Treated Patients Observational Study Evaluating Long-Term Health Outcomes in Centers of Excellence (CADENCE)|Recruiting||N/A|200|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-10 23:10:26.777376|2017-10-10 23:10:26.777376
NCT02485587|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-06-26|||September 2015||2015-09-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents|Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents (Part of EC FP7 Project Aggressotype: Aggression Subtyping for Improved Insight and Treatment Innovation in Psychiatric Disorders)|Recruiting||N/A|60|Anticipated|Central Institute of Mental Health, Mannheim||3|||f||||t||||||||||2017-10-10 23:10:26.901813|2017-10-10 23:10:26.901813
NCT02485574|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-06-30|||March 2015||2015-03-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Anterior Bridging Cage With Bone Substitute Versus Localized Autobone in Transforaminal Lumbar Interbody Arthrodesis|Prospective, Case Controlled Trial of Anterior Bridging Cage Augmented With Bone Substitute Versus Localized Autobone in Transforaminal Lumbar Interbody Arthrodesis|Recruiting||N/A|40|Anticipated|Zenoss Co, Ltd||1|||f||||f||||||||||2017-10-10 23:10:26.99888|2017-10-10 23:10:26.99888
NCT02485561|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-11-02|||June 2015||2015-06-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluating Strategies to Present Colon Cancer Screening Information|Comparing Screener vs. Survivor Role Models to Improve Colon Cancer Screening|Active, not recruiting||N/A|400|Anticipated|Washington University School of Medicine||3|||f||||f||||||||||2017-10-10 23:10:27.285858|2017-10-10 23:10:27.285858
NCT02485548|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2015-06-29|||June 2015||2015-06-01|June 2015|2015-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer|A Multicenter Phase Ⅲ Trial of Cisplatin Plus Raltitrexed or 5-fluorouracil in Concurrence With Intensity-modulated Radiotherapy (IMRT) for the Treatment of Locoregionally Advanced Head and Neck Squamous Cell Cancer|Recruiting||Phase 3|120|Anticipated|Jiangsu Cancer Institute & Hospital||2|||f||||f||||||||||2017-10-10 23:10:27.420607|2017-10-10 23:10:27.420607
NCT02485535|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-07-24|||September 4, 2015|Actual|2015-09-04|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant|Phase I Study to Assess the Tolerability and Efficacy of Selinexor (KPT-330) as Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Patients With AML and High Risk MDS After Allogeneic Stem Cell Transplantation|Recruiting||Phase 1|45|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-10 23:10:27.54189|2017-10-10 23:10:27.54189
NCT02485522|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-09-07|||July 2015||2015-07-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Diet and Stool Metabolites in Fecal Incontinence|Diet and Stool Metabolites in Women With Fecal Incontinence|Recruiting||N/A|30|Anticipated|University of Pennsylvania|||2||f||||||||||||||2017-10-10 23:10:27.653297|2017-10-10 23:10:27.653297
NCT02485509|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-06-25|||March 2013||2013-03-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection|Phase Ib/IIa, Single-Centre, Placebo-Controlled Randomized Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection|Completed||Phase 1/Phase 2|28|Actual|Viriom||4|||f||||t||||||||||2017-10-10 23:10:27.760746|2017-10-10 23:10:27.760746
NCT02485496|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-03-06|||June 2015||2015-06-01|February 2016|2016-02-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Observational|SECURE||E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms|SECURE - A poSt-market Registry in Patients With infrarEnal aortiC Aneurysm Undergoing endovasculaR Stenting With the New E-tegra Stent Graft System|Recruiting||N/A|100|Anticipated|JOTEC GmbH|||1||f||||f||||||||||2017-10-10 23:10:27.87151|2017-10-10 23:10:27.87151
NCT02485483|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-08-22|2016-08-22||November 2012||2012-11-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational||All VADERA I and VADERA II participants who had given informed consent and entered into the study database.|Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants|Validation of Standardized Questionnaires on Depression for Rheumatoid Arthritis (RA) (VADERA I) and Investigation of the Frequency of Depression in RA (VADERA II)|Completed||N/A|1292|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-10 23:10:28.012527|2017-10-10 23:10:28.012527
NCT02485470|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-09-14|||February 2016||2016-02-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy|Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy|Recruiting||Phase 2|180|Anticipated|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-10 23:10:28.467154|2017-10-10 23:10:28.467154
NCT02485444|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-28|2015-07-03|||June 2015||2015-06-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion|Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage Management After Second-trimester Abortion: A Randomized Clinical Trial|Unknown status|Recruiting|Phase 4|160|Anticipated|Ataturk University||2|||f||||f||||||||||2017-10-10 23:10:28.657989|2017-10-10 23:10:28.657989
NCT02485431|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-08-15|||June 2015||2015-06-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers|A Single-Dose, Single-Center, Randomized, Five Period Crossover Study Comparing Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers|Completed||Phase 1|45|Actual|PTC Therapeutics||5|||f||||f||||||||||2017-10-10 23:10:28.746099|2017-10-10 23:10:28.746099
NCT02485418|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-10-26|||June 2015||2015-06-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients|Low- Dose Propofol Infusion as an Abortive Treatment for Migraine Headaches in Pediatric Patients|Recruiting||N/A|40|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-10 23:10:28.837701|2017-10-10 23:10:28.837701
NCT02485405|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-06|||June 2015||2015-06-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|SP15||Gut Permeability and Stress|Gut Permeability in Volunteers Participating in a Stress Test|Completed||N/A|45|Actual|Lund University|||2||f||||f||||||Samples Without DNA|"     Saliva Plasma/Serum   "|||2017-10-10 23:10:28.917162|2017-10-10 23:10:28.917162
NCT02485392|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-09-08|||July 2015||2015-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|||A Comparison of Robot-assisted Single Site and Laparoscopic Single-incision Cholecystectomy for Benign Gallbladder|A Comparison of Robot-assisted Single Site and Laparoscopic Single-incision Cholecystectomy for Benign Gallbladder|Active, not recruiting||N/A|60|Actual|Kantonsspital Winterthur KSW||2|||f||||f||||||||||2017-10-10 23:10:29.11622|2017-10-10 23:10:29.11622
NCT02485379|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-07-20|||July 2015||2015-07-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|MRI-FIRST01||Assessment of Prostate MRI Before Prostate Biopsies|Improvement in the Detection of Aggressive Prostate Cancer by Targeted Biopsies Using Multiparametric MRI Findings|Completed||N/A|275|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:10:29.253061|2017-10-10 23:10:29.253061
NCT02485366|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-06-01|||June 2020|Anticipated|2020-06-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Rejuvenated, Washed Packed Red Blood Cells in Pediatric Cardiac Surgery|Rejuvenated, Washed Packed Red Blood Cells in Pediatric Cardiac Surgery|Not yet recruiting||Phase 4|15|Anticipated|Duke University||1|||f|||||t|f||||||||2017-10-10 23:10:29.395378|2017-10-10 23:10:29.395378
NCT02485353|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-08-24|2017-08-24||October 20, 2015|Actual|2015-10-20|August 2017|2017-08-01|February 16, 2017|Actual|2017-02-16|May 2, 2016|Actual|2016-05-02||Interventional|||Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML|Pilot Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML|Terminated||N/A|2|Actual|Indiana University|Due to the death of 2 patients which raised safety concerns, the study was closed with 2 patients enrolled.|1||Safety concerns|f||||t|t|f||||||||2017-10-10 23:10:29.512412|2017-10-10 23:10:29.512412
NCT02485340|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-01-21|||April 2015||2015-04-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache|The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache. Development of a Pragmatic Migraine Model|Completed||N/A|30|Actual|Danish Headache Center||2|||f||||f||||||||||2017-10-10 23:10:29.798546|2017-10-10 23:10:29.798546
NCT02485327|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-03-13|||July 2015||2015-07-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)|An Open-label, 2 Replicate Single Dose Euglycemic Glucose-Clamp Trial to Characterize PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)|Completed||Phase 1|22|Actual|Mannkind Corporation||1|||f||||f||||||||||2017-10-10 23:10:29.904708|2017-10-10 23:10:29.904708
NCT02485314|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-02-18|||December 2016||2016-12-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|||Reliability and Validity of Turkish Version of PEM-CY|Reliability and Validity of Turkish Version of the Participation and Environment Measure for Children and Youth|Unknown status|Not yet recruiting|N/A|650|Anticipated|Hacettepe University|||1||f||||f||||||||No||2017-10-10 23:10:29.998508|2017-10-10 23:10:29.998508
NCT02485288|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-07-20|||June 2015||2015-06-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|January 2018|Anticipated|2018-01-01|10 Years|Observational [Patient Registry]|||PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership Cohort|PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership Cohort|Active, not recruiting||N/A|1500|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:10:30.238145|2017-10-10 23:10:30.238145
NCT02485275|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-10-20|||July 2015||2015-07-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01|3 Months|Observational [Patient Registry]|SIPS||Stroke Imaging Package Study||Unknown status|Recruiting|N/A|1500|Anticipated|Peking Union Medical College Hospital|||1||f||||f||||||||||2017-10-10 23:10:30.322113|2017-10-10 23:10:30.322113
NCT02485262|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2015-06-29|||November 2013||2013-11-01|June 2015|2015-06-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01|12 Months|Observational [Patient Registry]|||Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience|Outcome of New Direct Acting Agents For Hepatitis C|Unknown status|Recruiting|N/A|340|Anticipated|Arrowhead Regional Medical Center|||1||f||||f||||||||||2017-10-10 23:10:30.519327|2017-10-10 23:10:30.519327
NCT02485249|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2016-08-01|||July 2015||2015-07-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema|Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema|Terminated||Phase 1/Phase 2|25|Actual|Eyegate Pharmaceuticals, Inc.||1||Slow enrollment|f||||f||||||||Undecided||2017-10-10 23:10:30.621102|2017-10-10 23:10:30.621102
NCT02485236|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-08-04|||June 2015||2015-06-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Postoperative Nasal High Flow Versus Oxygen for Positive Airway Pressure Non-Compliance Sleep Apnea Patients|Randomized Nasal High Flow Therapy Versus Oxygen Supplementation in Postoperative Care of Obstructive Sleep Apnea Patients With Continuous Positive Airway Pressure Non-Compliance|Recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-10 23:10:30.709565|2017-10-10 23:10:30.709565
NCT02485223|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-12-01|||May 2015||2015-05-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Observational|STAR-MS||Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis|Single Test to ARrive at MS Diagnosis. A Prospective, Longitudinal, Investigator Blinded, Pilot Study Assessing the Accuracy of a Single 3 Tesla MRI Scan in Predicting Multiple Sclerosis in Cases of Diagnostic Uncertainty|Enrolling by invitation||N/A|60|Anticipated|University of Nottingham|||1||f||||f||||||||||2017-10-10 23:10:30.807183|2017-10-10 23:10:30.807183
NCT02485210|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-05-03|||April 29, 2017|Actual|2017-04-29|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness of Photodynamic Therapy for Endodontic Treatment of Deciduous Teeth|Evaluation of the Effectiveness of Photodynamic Therapy as a Supporting for Endodontic Treatment of Deciduous Teeth|Recruiting||Phase 1|30|Anticipated|University of Nove de Julho||2|||f||||f|f|f||||||||2017-10-10 23:10:30.900739|2017-10-10 23:10:30.900739
NCT02485197|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-03-15|||March 2013||2013-03-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|October 2013|Actual|2013-10-01||Interventional|||Muscle Metabolic Function in Older Adults With Different Vitamin D Status Before and After Exercise|A Pilot Study Investigating Differences in Muscle Metabolic Function in Individuals Aged 65-75 Years With Different Vitamin D Status Before and After 7-days of Aerobic Training|Completed||N/A|7|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 23:10:30.981544|2017-10-10 23:10:30.981544
NCT02485184|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-07-18|||July 2015||2015-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis|TIPS Versus Endoscopic Therapy for the Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-10 23:10:31.071807|2017-10-10 23:10:31.071807
NCT02485171|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-08-21|||June 10, 2015|Actual|2015-06-10|August 2017|2017-08-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|SAFEER||SAFEWALKER Contribution to the Rehabilitation of Older People After a Post-fall Syndrome|Post-fall Syndrome of the Aged Person : Contribution of SAFEWALKER for Rehabilitation|Completed||N/A|20|Actual|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-10 23:10:31.218275|2017-10-10 23:10:31.218275
NCT02485158|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-10-06|2015-12-17||July 2013||2013-07-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|TDS||Individual Differences in the Response to Drugs|A Preliminary Investigation of Individual Differences in Subjective Responses to D-amphetamine, Alcohol, and Delta-9-tetrahydrocannabinol|Completed||N/A|28|Actual|University of Chicago||2|||f||||f||||||||||2017-10-10 23:10:31.332928|2017-10-10 23:10:31.332928
NCT02485145|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-25|||July 2015||2015-07-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||The Analgesic Activity of a Topical Formulation in Patients With Osteoarthritis of the Hands|The Analgesic Activity of a Topical Formulation in Patients With Osteoarthritis of the Hands|Unknown status|Not yet recruiting|Early Phase 1|40|Anticipated|Transdermal Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 23:10:33.152365|2017-10-10 23:10:33.152365
NCT02485132|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2017-06-26|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea|Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea, by Continuous Glucose monItoring System: A Multicenter Study. The HYPOTHESIS Trial|Terminated||N/A|2|Actual|Institut de Recherches Cliniques de Montreal|||1|Patients corresponding to the inclusion/exclusion criteria not found.|f||||f||||||||Undecided||2017-10-10 23:10:33.293361|2017-10-10 23:10:33.293361
NCT02485119|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-07-27|||August 14, 2015|Actual|2015-08-14|July 2017|2017-07-01|July 4, 2017|Actual|2017-07-04|April 28, 2017|Actual|2017-04-28||Interventional|||Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies|An Open Label, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks (Q3W) in Japanese Subjects With Advanced Malignancies|Completed||Phase 1|12|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 23:10:33.412591|2017-10-10 23:10:33.412591
NCT02485106|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-25|||July 2015||2015-07-01|June 2015|2015-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||Rifaximin Use in Severe Alcoholic Hepatitis|Effect of Gut Decontamination Using Rifaximin in the Patients With Severe Alcoholic Hepatitis|Unknown status|Not yet recruiting|Phase 3|170|Anticipated|Saint Vincent's Hospital, Korea||2|||f||||f||||||||||2017-10-10 23:10:33.538713|2017-10-10 23:10:33.538713
NCT02485093|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-06-29|||June 2009||2009-06-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|July 2013|Actual|2013-07-01||Interventional|OPTIMIST||To Pace or Not to Pace in Sinus Node Disease|Comparison of Ventricular Septal Pacing With Optimized Atrioventricular (AV) Delay to no Pacing in Sinus Node Disease (SND) Patients.|Completed||N/A|215|Actual|St. Jude Medical||2|||f||||f||||||||||2017-10-10 23:10:33.631684|2017-10-10 23:10:33.631684
NCT02485080|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1|Safety, Tolerability, and Efficacy of Simeprevir 150 mg Daily Plus Sofosbuvir 400 mg Daily for 24 Weeks in Patients With Chronic Hepatitis C Genotype 1 With CPT Score of 6 or Lower Who Are IFN-Intolerant or Unwilling to be Treated With IFN|Withdrawn||Phase 4|0|Actual|Stanford University||1||Withdrawn due to lack of resources|f||||f||||||||No||2017-10-10 23:10:33.722013|2017-10-10 23:10:33.722013
NCT02485067|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-01-11|||January 2015||2015-01-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB|Multicenter, Randomized, Double-blind, Parallel, Active Control, Phase III Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With Overactive Bladder Including an Open-label, Extension Study|Completed||Phase 3|384|Actual|SK Chemicals Co.,Ltd.||2|||f||||t||||||||||2017-10-10 23:10:33.835131|2017-10-10 23:10:33.835131
NCT02485054|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-02-03|||September 2015||2015-09-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Observational|VASCO||A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)|Development and Validation of a Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances|Recruiting||N/A|350|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||t||||||||||2017-10-10 23:10:33.992709|2017-10-10 23:10:33.992709
NCT02485041|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-25|||November 2014||2014-11-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg|An Open Label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetic Interaction of Dapoxetine 30 mg and Mirodenafil 100 mg in Healthy Male Volunteers|Completed||Phase 1|36|Actual|SK Chemicals Co.,Ltd.||6|||f||||f||||||||||2017-10-10 23:10:34.08523|2017-10-10 23:10:34.08523
NCT02485028|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-25|||October 2013||2013-10-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg|An Open Label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetic Interaction of Dapoxetine 30mg and Mirodenafil 50mg in Healthy Male Volunteers|Completed||Phase 1|36|Actual|SK Chemicals Co.,Ltd.||6|||f||||f||||||||||2017-10-10 23:10:34.197064|2017-10-10 23:10:34.197064
NCT02485015|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-02-18|||June 2015||2015-06-01|February 2016|2016-02-01|June 2033|Anticipated|2033-06-01|June 2030|Anticipated|2030-06-01||Interventional|||The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer|The Randomized, Controlled, Multicenter Clinical Trial of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer|Active, not recruiting||Phase 2|80|Actual|The First People's Hospital of Changzhou||2|||f||||f||||||||||2017-10-10 23:10:34.296822|2017-10-10 23:10:34.296822
NCT02485002|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-05-16|||June 2015||2015-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Differences in Urine NGAL Levels in Patients Undergoing RIRS With or Without Ureteral Access Sheath|Differences in Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels in Patients Undergoing Retrograde Intrarenal Surgery (RIRS) With or Without Ureteral Access Sheath (UAS)|Completed||N/A|60|Actual|Selcuk University||2|||f||||f||||||||Undecided||2017-10-10 23:10:34.380275|2017-10-10 23:10:34.380275
NCT02484989|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-03-15|||May 2013||2013-05-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01|1 Year|Observational [Patient Registry]|||UK Surveillance of Treated Retinopathy of Prematurity||Completed||N/A|270|Actual|Moorfields Eye Hospital NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:10:34.469689|2017-10-10 23:10:34.469689
NCT02484976|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-10-12|||September 2014||2014-09-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|BASIC-FMRI||Brain Activation and Satiety in Children: Functional Magnetic Resonance Imaging|Brain Systems and Behaviors Underlying Response to Obesity Treatment in Children|Recruiting||N/A|76|Anticipated|Seattle Children's Hospital||1|||f||||f||||||||No||2017-10-10 23:10:34.548689|2017-10-10 23:10:34.548689
NCT02484963|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-06-08|||May 15, 2015|Actual|2015-05-15|June 2016|2016-06-01|January 15, 2017|Actual|2017-01-15|January 15, 2017|Actual|2017-01-15||Interventional|||The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia|The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia|Completed||N/A|52|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:10:34.647167|2017-10-10 23:10:34.647167
NCT02484950|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-02-23|||November 2015||2015-11-01|February 2016|2016-02-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair|A Prospective Randomized Trial of Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Arthroscopic Rotator Cuff Repair|Recruiting||N/A|100|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-10 23:10:34.73035|2017-10-10 23:10:34.73035
NCT02484937|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-11-08|||January 2015||2015-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians for Pain Pts|Improving Functional Outcomes and Lowering Health Care Costs by Enhanced Integration of Primary Care Providers and Pain Medicine Physicians for Chronic Non-cancer Pain Patients|Recruiting||N/A|200|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-10 23:10:34.833535|2017-10-10 23:10:34.833535
NCT02484924|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-01-27|||June 2010||2010-06-01|January 2016|2016-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|ROBOT-ACS||The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome|The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome|Completed||N/A|5225|Actual|Aintree University Hospitals NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 23:10:34.939074|2017-10-10 23:10:34.939074
NCT02484911|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-02-13|2017-02-13||May 2015||2015-05-01|June 2016|2016-06-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|AOPDPCINV||Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting|Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting---A Randomized Single Center Phase III Trial|Completed||Phase 3|120|Actual|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||||2017-10-10 23:10:35.046763|2017-10-10 23:10:35.046763
NCT02484898|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-09-30|2016-09-30||June 2015||2015-06-01|December 2015|2015-12-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Observational|||SEEQ™ Performance Study|SEEQ™ Performance Study|Completed||N/A|200|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-10-10 23:10:35.85588|2017-10-10 23:10:35.85588
NCT02484885|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-05-25|||August 2011||2011-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Xenon-129 Magnetic Resonance Imaging of Healthy Subjects: Hardware and Software Development and Reproducibility|Xenon-129 Magnetic Resonance Imaging of Healthy Subjects: Hardware and Software Development and Reproducibility|Recruiting||N/A|50|Anticipated|Western University, Canada||1|||f||||f||||||||||2017-10-10 23:10:36.033326|2017-10-10 23:10:36.033326
NCT02484872|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-08-09|||May 2015||2015-05-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Has Inflammation a Significant Implication in Lung Cancer Evolution?|L'Inflammation A-t-elle Une Implication Significative Dans l'évolution du Cancer Bronchique?|Recruiting||N/A|400|Anticipated|European Lung Cancer Working Party|||1||f||||f||||||Samples Without DNA|"     Blood sampling (serum)   "|Undecided||2017-10-10 23:10:36.134088|2017-10-10 23:10:36.134088
NCT02484846|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-29|||February 2011||2011-02-01|June 2015|2015-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Impaired Vigilance, and Its Effects on Cognition and Behavior||Completed||N/A|50|Actual|VA Palo Alto Health Care System||7|||f||||f||||||||||2017-10-10 23:10:36.36412|2017-10-10 23:10:36.36412
NCT02484833|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-06-25|||February 2015||2015-02-01|June 2015|2015-06-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|ERMES||Erbitux MEtastatic Colorectal Cancer Strategy Study|Erbitux MEtastatic Colorectal Cancer Strategy Study: A Phase III Randomized Two Arm Study With FOLFIRI + Cetuximab Until Disease Progression Compared to FOLFIRI + Cetuximab for 8 Cycles Followed by Cetuximab Alone Until Disease Progression in First Line Treatment of Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer|Recruiting||Phase 3|600|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-10 23:10:36.440655|2017-10-10 23:10:36.440655
NCT02484820|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-05-29|||December 2015||2015-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PREMAPESSAIRE||Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor|PREMAPESSAIRE: Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor: a Prospective, Randomized Monocentric Clinical Trial|Recruiting||N/A|154|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 23:10:36.541019|2017-10-10 23:10:36.541019
NCT02484794|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-11-17|||September 2015||2015-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Augmenting Specialty Eating Disorder Clinical Treatment With a Smartphone Application|Efficacy and Acceptability of Augmenting Specialty Eating Disorder Clinical Treatment With a Smartphone Application: A Pilot RCT|Recruiting||N/A|100|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-10 23:10:36.83075|2017-10-10 23:10:36.83075
NCT02484781|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-07-14|||December 2015||2015-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Gait Analyses After Resurfacing Hip Arthroplasty Versus Metal on Metal Total Hip Arthroplasty, an Exploratory Study|Gait Analyses After Resurfacing Hip Arthroplasty Versus Metal on Metal Total Hip|Completed||N/A|34|Actual|Rijnstate Hospital||2|||f||||f||||||||||2017-10-10 23:10:36.962374|2017-10-10 23:10:36.962374
NCT02484768|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-06-25|||January 2015||2015-01-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||IV Iron Treatment of Restless Legs Syndrome|A Phase II, Six-week, Randomised, Comparative, Double-blind Study of Intravenous Iron Isomaltoside 1000 Versus Placebo in Subjects With Restless Leg Syndrome With a 3 Month Extension|Withdrawn||Phase 2|0|Actual|Pharmacosmos A/S||2||as per GCP sponsor/company decision|f||||f||||||||||2017-10-10 23:10:37.107364|2017-10-10 23:10:37.107364
NCT02484755|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2015-06-29|||June 2015||2015-06-01|June 2015|2015-06-01||||September 2015|Anticipated|2015-09-01||Interventional|||Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease|Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease|Unknown status|Recruiting|Phase 2|6|Anticipated|Huashan Hospital||1|||f||||t||||||||||2017-10-10 23:10:37.211679|2017-10-10 23:10:37.211679
NCT02484742|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-09-22|||July 2015||2015-07-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Pain Sensitization and Habituation in a Model of Experimentally-induced Insomnia Symptoms||Active, not recruiting||N/A|23|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-10 23:10:37.319307|2017-10-10 23:10:37.319307
NCT02484729|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-03-28|2016-11-25||July 2015||2015-07-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males|A Phase I, Randomized, Single-blind, Placebo-controlled Study to Access the Safety, Tolerability and Pharmacokinetics of AZD9977 Following Single Ascending Dose Administration to Healthy Male Subjects|Completed||Phase 1|196|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 23:10:37.445015|2017-10-10 23:10:37.445015
NCT02484716|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-06-27|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|TEMPO||Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)|Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo|Active, not recruiting||Phase 2|58|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:10:39.412261|2017-10-10 23:10:39.412261
NCT02473653|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-09||||||August 2017|2017-08-01||||||||Expanded Access|||Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer|Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive|No longer available||N/A|||University of Pennsylvania|||||||||||||||||||2017-10-10 23:12:48.505259|2017-10-10 23:12:48.505259
NCT02484703|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-07-04|||October 28, 2015|Actual|2015-10-28|July 2017|2017-07-01|August 3, 2016|Actual|2016-08-03|August 3, 2016|Actual|2016-08-03||Interventional|||A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group 26-Week Dose-Investigating Study to Explore the Pharmacokinetics, Pharmacodynamic Effects, Efficacy, Safety and Tolerability of RO5186582 in Children With Down Syndrome Aged 6-11 Years|Terminated||Phase 2|45|Actual|Hoffmann-La Roche||4||"Study was terminated due to data from another study showing no efficacy. There were no safety   issues of concern."|f||||||||||||||2017-10-10 23:10:39.502066|2017-10-10 23:10:39.502066
NCT02484690|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-08-25|||August 11, 2015|Actual|2015-08-11|August 2017|2017-08-01|September 21, 2017|Anticipated|2017-09-21|September 21, 2017|Anticipated|2017-09-21||Interventional|AVENUE||A Proof-of-Concept Study of RO6867461 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)|A Multiple-Center, Multiple-Dose and Regimen, Randomized, Active Comparator Controlled, Double-Masked, Parallel Group, 36 Week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|Active, not recruiting||Phase 2|273|Actual|Hoffmann-La Roche||5|||f|||||t|f||||||||2017-10-10 23:10:39.62827|2017-10-10 23:10:39.62827
NCT02484677|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-29|||June 2015||2015-06-01|June 2015|2015-06-01||||June 2017|Anticipated|2017-06-01||Interventional|5-FU||Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy|Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy|Unknown status|Recruiting|Phase 4|100|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:10:39.968915|2017-10-10 23:10:39.968915
NCT02484664|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-07-13|||January 2016||2016-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|COLA||COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC|COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC|Recruiting||Phase 2|12|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-10 23:10:40.099967|2017-10-10 23:10:40.099967
NCT02484651|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-07-13|||September 2016||2016-09-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|June 28, 2017|Actual|2017-06-28||Interventional|||Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?|Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade: a Randomized Controlled Study Assessing Propofol and Remifentanil Requirements and Quality of Recovery in Patients With a Standard Practice of Non-deep Rocuronium Neuromuscular Blockade Versus Deep Neuromuscular Blockade Reversed With Sugammadex|Completed||Phase 4|70|Actual|Centro Hospitalar do Porto||2|||f||||t||||||||||2017-10-10 23:10:40.214512|2017-10-10 23:10:40.214512
NCT02484625|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-06-26|||November 2011||2011-11-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Dairy and Non-dairy Snacks on Food Intake, Subjective Appetite in Children|The Effect of Solid, Semi-solid and Fluid Dairy Products on Short-term Food Intake and Satiety in Children|Completed||N/A|23|Actual|Mount Saint Vincent University||5|||f||||f||||||||||2017-10-10 23:10:40.512702|2017-10-10 23:10:40.512702
NCT02484612|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-05-10|||September 2016||2016-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Exercise Intensity and Appetite in Adolescents|Effect of Acute Exercise Intensity on Energy Intake in Adolescents: Effect of Weight Status|Not yet recruiting||N/A|30|Anticipated|Université Blaise Pascal, Clermont-Ferrand||2|||f||||f||||||||||2017-10-10 23:10:40.616452|2017-10-10 23:10:40.616452
NCT02484599|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-07-07|||June 2015||2015-06-01|July 2015|2015-07-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|CAT||Look at Food and Lose Your Fear - Evaluation of a Computerized Attention Training (CAT) for Anorexia Nervosa Patients|Evaluation of a Computerized Attention Training (CAT) to Modify Attention Bias for Food Cues in Anorexia Nervosa Patients|Unknown status|Recruiting|Phase 1|50|Anticipated|King's College London||2|||f||||f||||||||||2017-10-10 23:10:40.704486|2017-10-10 23:10:40.704486
NCT02484586|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-09-08|||October 2015||2015-10-01|September 2017|2017-09-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Interventional|||Dispensing Study to Assess the Visual Performance of Optimised Prototype Contact Lenses|Dispensing Study to Assess the Visual Performance of Optimised Prototype Contact Lenses|Completed||N/A|161|Actual|Brien Holden Vision||2|||f||||f||||||||||2017-10-10 23:10:40.831595|2017-10-10 23:10:40.831595
NCT02484573|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-11-07|||May 2015||2015-05-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Intestinal Permeability, Expression of Genes of Epithelial Integrity in the Duodenal Wall, Serum Inflammatory Cytokines, and Lipopolysaccharide in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)|Evaluation of Intestinal Permeability, Expression of Genes of Epithelial Integrity in the Duodenal Wall, Serum Inflammatory Cytokines, and Lipopolysaccharide in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)|Recruiting||N/A|39|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||1|||f||||f||||||||||2017-10-10 23:10:40.963659|2017-10-10 23:10:40.963659
NCT02484560|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-30|||June 2015||2015-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2|Efficacy of Allogenic Mesenchymal Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2|Unknown status|Active, not recruiting|Phase 1|10|Actual|University of Gaziantep||2|||f||||t||||||||||2017-10-10 23:10:41.090571|2017-10-10 23:10:41.090571
NCT02473458|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2015-06-11|||June 2012||2012-06-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy of Whole Extract of Licorice in Neurological Improvement of Patients After Acute Ischemic Stroke||Completed||Phase 1/Phase 2|75|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-10-10 23:12:50.074132|2017-10-10 23:12:50.074132
NCT02484547|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-10-01|||September 30, 2015|Actual|2015-09-30|October 2017|2017-10-01|April 30, 2022|Anticipated|2022-04-30|February 19, 2020|Anticipated|2020-02-19||Interventional|EMERGE||221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease|Recruiting||Phase 3|1350|Anticipated|Biogen||2|||f||||t||||||||||2017-10-10 23:10:41.200875|2017-10-10 23:10:41.200875
NCT02484534|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2017-08-09|||February 26, 2015|Actual|2015-02-26|August 2017|2017-08-01|January 18, 2017|Actual|2017-01-18|December 9, 2015|Actual|2015-12-09||Observational|||Thrombin Generation Test in Patient With Liver Cirrhosis|Thrombin Generation Test in Patient With Liver Cirrhosis|Completed||N/A|36|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-10 23:10:41.846773|2017-10-10 23:10:41.846773
NCT02484521|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-11-30|||June 2015||2015-06-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration|Characteristics of Prepulse Inhibition (PPI) of Startle Reflex in Patients With Schizophrenia in Relation to Type of Pharmacological Treatment and Duration of Illness|Recruiting||N/A|160|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||No||2017-10-10 23:10:41.941778|2017-10-10 23:10:41.941778
NCT02484508|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-24|||March 2015||2015-03-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis|A Randomized, Double Blind, Single Simulation, Parallel Controlled, Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis|Unknown status|Recruiting|Phase 4|220|Anticipated|Guizhou Bailing Group Pharmaceutical Co Ltd||2|||f||||f||||||||||2017-10-10 23:10:42.068235|2017-10-10 23:10:42.068235
NCT02484495|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-02-06|||March 2015||2015-03-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|May 2016|Actual|2016-05-01||Interventional|||Extended Pilot Project Community Based Production of Complementary Food in Ethiopia|Evaluate the Impact of Package of Interventions on Growth and Micronutrient Status of Infant and Young Children|Enrolling by invitation||N/A|1800|Actual|Ethiopian Public Health Institute||2|||f||||t||||||||||2017-10-10 23:10:42.189027|2017-10-10 23:10:42.189027
NCT02484482|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-12-04|||June 2015||2015-06-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)|A Randomized, Open-label, Single Dose, 3-treatment, 3-period, 6-sequence Crossover Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519 After Oral Administration in Healthy Adult Volunteers|Completed||Phase 1|45|Actual|Chong Kun Dang Pharmaceutical||6|||f||||||||||||||2017-10-10 23:10:42.314147|2017-10-10 23:10:42.314147
NCT02484469|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-06-26|||July 2014||2014-07-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial|Educational Virtual Objects (The Virtual Human Project) Assessment Inserted in Learning Based on Team (Team-based Learning) in Leprosy Education on Undergraduate Medical Setting|Completed||N/A|94|Actual|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.||2|||f||||f||||||||||2017-10-10 23:10:42.428969|2017-10-10 23:10:42.428969
NCT02484456|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-26|2017-10-05|||June 18, 2015||2015-06-18|July 18, 2017|2017-07-18|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder|An Investigation of the Antidepressant Effects of the Glycine Receptor Antagonist AV 101 (4-chlorokynurenine) in Major Depressive Disorder|Recruiting||Phase 2|25|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:10:42.50495|2017-10-10 23:10:42.50495
NCT02484417|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-10-05|||June 11, 2015||2015-06-11|July 12, 2017|2017-07-12|September 9, 2016|Actual|2016-09-09|September 9, 2016|Actual|2016-09-09||Interventional|||Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers|A Phase I Study of Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers|Completed||Phase 1|32|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:10:43.856327|2017-10-10 23:10:43.856327
NCT02484391|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-05-25|||September 2015||2015-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma|An Open Label Study to Evaluate the Feasibility of CPI-613 Given With High Dose Cytarabine and Mitoxantrone in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)|Recruiting||Phase 2|50|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-10 23:10:44.203339|2017-10-10 23:10:44.203339
NCT02484378|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-01-30|||August 2015|Actual|2015-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|CARAT||CER-001 Atherosclerosis Regression ACS Trial|CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome|Completed||Phase 2|301|Actual|Cerenis Therapeutics, SA||2|||f||||t||||||||Undecided|to be determined.|2017-10-10 23:10:44.4143|2017-10-10 23:10:44.4143
NCT02484365|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-03-08|||December 2014||2014-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Preoperative Noninvasive Hemoglobin Monitoring in Pediatric Patients|The Accuracy of the Noninvasive Hemoglobin Monitoring for Preoperative Evaluation for Pediatric Patients|Recruiting||N/A|177|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine|||1||f||||f||||||||Undecided||2017-10-10 23:10:44.63377|2017-10-10 23:10:44.63377
NCT02484352|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-07-18|||July 2015||2015-07-01|July 2017|2017-07-01|February 12, 2017|Actual|2017-02-12|October 2015|Actual|2015-10-01||Interventional|||Optimal Dose of Intravenous Oxycodone for Endotracheal Intubation|Optimal Dose of Intravenous Oxycodone for Attenuation of Hemodynamic|Completed||Phase 4|95|Actual|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||5|||f||||t||||||||||2017-10-10 23:10:44.760563|2017-10-10 23:10:44.760563
NCT02484339|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-04-26|||December 2014||2014-12-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|α-RT||Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)|Phase II Open-label Study to Evaluate the Efficacy and Safety of Radium in Combination With External Beam Radiotherapy (EBRT) vs. EBRT Alone in the Treatment of Castration Resistant Prostate Carcinoma With Limited Bone Metastases|Recruiting||Phase 2|274|Anticipated|University Hospital Freiburg||2|||f||||t||||||||No||2017-10-10 23:10:44.927123|2017-10-10 23:10:44.927123
NCT02484326|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-24|||January 2012||2012-01-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Clinical Risk Score Predicting the Cardiac Rupture in Patients With ST-elevation Myocardial Infarction|Development and Validation of a Clinical Risk Score Predicting the Cardiac Rupture in Patients With ST-elevation Myocardial Infarction|Completed||N/A|3779|Actual|Chinese PLA General Hospital|||1||f||||t||||||||||2017-10-10 23:10:45.129419|2017-10-10 23:10:45.129419
NCT02484313|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-06-25|||November 2011||2011-11-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Snacks on Glycaemic Regulation in Children|The Effect of Dairy and Non-Dairy Products on Blood Glucose Regulation in Children|Completed||N/A|18|Actual|Mount Saint Vincent University||2|||f||||f||||||||||2017-10-10 23:10:45.215799|2017-10-10 23:10:45.215799
NCT02484300|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-02-03|||July 2015|Actual|2015-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Melatonin on Sleep and Ventilatory Control in Obstructive Sleep Apnea|The Effect of Melatonin on Sleep and Ventilatory Control in Obstructive Sleep Apnea|Recruiting||N/A|60|Anticipated|University of California, San Diego||4|||f||||f||||||||||2017-10-10 23:10:45.293636|2017-10-10 23:10:45.293636
NCT02484287|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-25|||April 2016||2016-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Quality Control: A Prospective Analysis of EVD Effectiveness|Quality Control: A Prospective Analysis of External Ventricular Drain (EVD) Effectiveness|Recruiting||N/A|252|Anticipated|University of Oklahoma||3|||f||||t||||||||||2017-10-10 23:10:45.430342|2017-10-10 23:10:45.430342
NCT02484274|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-05-31|||January 6, 2016|Actual|2016-01-06|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|CARMA||Iron Deficiency (ID) in Infants|Iron Deficiency in Infants : Population-wide Study of the Protective Role of Toddler Milk Formula|Recruiting||N/A|1000|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-10 23:10:45.534239|2017-10-10 23:10:45.534239
NCT02484261|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-07-18|||May 2015||2015-05-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|July 2019|Anticipated|2019-07-01||Interventional|||Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children|Pilot Study to Evaluate the Tolerability of Velcade (Bortezomib) and Pravastatin for the Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children|Recruiting||Phase 1|50|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-10 23:10:45.664094|2017-10-10 23:10:45.664094
NCT02484248|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-06-24|||July 2015||2015-07-01|June 2015|2015-06-01||||March 2019|Anticipated|2019-03-01||Interventional|Ketotifen||Trial of Ketotifen in Children and Adolescents|Double-blind, Placebo-controlled, Cross-over Trial of Ketotifen in Children and Adolescents With Functional Dyspepsia in Association With Duodenal Eosinophilia|Not yet recruiting||Phase 3|100|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-10-10 23:10:45.796561|2017-10-10 23:10:45.796561
NCT02484235|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-06-25|||June 2015||2015-06-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|EHITSTR||Effects of High Intensity Interval Training and Strength Training in Obese|Effects of High Intensity Interval Training, Strength Training and the Combination in Overweight and Obese|Unknown status|Recruiting|N/A|30|Anticipated|University of Chile||3|||f||||f||||||||||2017-10-10 23:10:45.969238|2017-10-10 23:10:45.969238
NCT02484222|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-02-05|||September 2015||2015-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Fentanyl Test in Children's Adenotonsillectomy|Fentanyl Test Results and Its Association With Morphine Requirements in Children With Obstructive Sleep Apnea Syndrome After Adenotonsillectomy|Completed||N/A|77|Actual|Children's Hospital of Fudan University|||1||f||||f||||||||No||2017-10-10 23:10:46.181042|2017-10-10 23:10:46.181042
NCT02484209|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-07-25|||February 2016||2016-02-01|July 2017|2017-07-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|DiaFrail||DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study)|A 16 Week PILOT Study to Determine the Frequency of Sulphonylurea-Associated Hypoglycaemia in Older Moderately Frail Patients With Type 2 Diabetes Mellitus Poorly Controlled on Metformin: an Open Label Study ( DIAFRAIL Study)|Withdrawn||Phase 3|0|Actual|Diabetes Frail Ltd||2||Inclusion criteria too strict making it difficult to recruit in primary care|f||||f||||||||||2017-10-10 23:10:46.256049|2017-10-10 23:10:46.256049
NCT02484196|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-03-08|||June 2016||2016-06-01|March 2016|2016-03-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Observational|||Dyspareunia in Women With Endometriosis: Impact of Surgery on Sexual Health||Not yet recruiting||N/A|100|Anticipated|University of Cagliari|||2||f||||f||||||||||2017-10-10 23:10:46.359489|2017-10-10 23:10:46.359489
NCT02484183|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-09-15|||June 2015||2015-06-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|IMPACT||CPAP Improving Mortality for Pneumonia in African Children Trial|Effectiveness of Bubble Continuous Positive Airway Pressure (CPAP) in Reducing Childhood Pneumonia Mortality in Malawi|Recruiting||N/A|890|Anticipated|Johns Hopkins University||2|||f||||t||||||||Yes|Will be available upon request to principle investigator.|2017-10-10 23:10:46.41967|2017-10-10 23:10:46.41967
NCT02484170|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2015-11-09|||September 2015||2015-09-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|MannitolPHN||Mannitol Cream for Post Herpetic Neuralgia|Mannitol Cream in the Treatment of Post-herpeticNeuralgia;a Randomized Placebo-Controlled Crossover Pilot Study|Recruiting||Phase 1/Phase 2|20|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:10:46.521499|2017-10-10 23:10:46.521499
NCT02484157|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2015-06-26|||December 2012||2012-12-01|December 2012|2012-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of ACT Between Hemochron Jr and ACT Plus|Comparison of Activated Coagulation Time Between Hemochron Jr and ACT Plus During Cardiac Surgery for Patient Using Acute Normovolemic Hemodilution|Completed||N/A|26|Actual|Hallym University Medical Center||1|||f||||f||||||||||2017-10-10 23:10:46.654385|2017-10-10 23:10:46.654385
NCT02484144|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-10-13|||July 2015||2015-07-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|INFOCORO||Evaluation of the Information of the Patient Before a Scheduled Coronarography|Evaluation of the Information of the Patient Before a Scheduled Coronarography|Completed||N/A|821|Actual|French Cardiology Society|||2||f||||f||||||||||2017-10-10 23:10:46.762075|2017-10-10 23:10:46.762075
NCT02484131|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-03-23|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|March 20, 2017|Actual|2017-03-20|February 20, 2017|Actual|2017-02-20||Interventional|||Bone Health Management for Women Diagnosed With Breast Cancer|Bone Health Management for Women Diagnosed With Breast Cancer: A Pilot Study|Completed||N/A|54|Actual|University of British Columbia||3|||f||||f||||||||Undecided||2017-10-10 23:10:46.946959|2017-10-10 23:10:46.946959
NCT02484118|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-12-07|||May 2015||2015-05-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Hemodialysis Blood Flow and Urea Clearance|Examining the Effect of Blood Flow Rate on Hemodialysis Urea Clearance|Completed||N/A|24|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:10:47.055957|2017-10-10 23:10:47.055957
NCT02484105|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-09-28|||September 2015||2015-09-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|ComConEndo||Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction|Comforting Conversation During Colonoscopy: A Randomised Controlled Trial on Patient Satisfaction|Unknown status|Recruiting|Phase 4|62|Anticipated|Copenhagen University Hospital at Herlev||2|||f||||f||||||||||2017-10-10 23:10:47.153727|2017-10-10 23:10:47.153727
NCT02484092|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-09-28|||September 2015||2015-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||A Gene Therapy Study for Hemophilia B|Gene Therapy, Open-label, Dose-escalation Study of SPK-9001 [Adeno-associated Viral Vector With Human Factor IX Gene] in Subjects With Hemophilia B|Recruiting||Phase 1/Phase 2|15|Anticipated|Spark Therapeutics||1|||f||||t||||||||||2017-10-10 23:10:47.269154|2017-10-10 23:10:47.269154
NCT02484079|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-04-24|||August 2015||2015-08-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|HOT/COLD||Comparative Effectiveness of Hot Versus Cold Snare Polypectomy of Small Colorectal Polyps|Comparative Effectiveness of Hot Versus Cold Snare Polypectomy of Small Colorectal Polyps. A Randomized Controlled Trial|Enrolling by invitation||N/A|800|Anticipated|Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-10 23:10:47.436085|2017-10-10 23:10:47.436085
NCT02484066|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-26|||June 2015||2015-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||VBN-EBUS-GS-TBLB With or Without Fluoroscopy for the Diagnosis of PPLs|Diagnostic Value of Virtual Bronchoscopic Navigation (VBN) Combined With Endobronchial Ultrasound (EBUS) With a Guide Sheath (GS) for Peripheral Pulmonary Lesions (PPLs) Without Fluoroscopy: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|400|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||||2017-10-10 23:10:47.540028|2017-10-10 23:10:47.540028
NCT02484053|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-08-09|||June 2015||2015-06-01|August 2016|2016-08-01||||June 2020|Anticipated|2020-06-01||Interventional|||Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders|Implementation of Rapid Infusion Rituximab in a Pilot Group of Adolescents With Hematologic, Oncologic, and Rheumatologic Disorders|Recruiting||Early Phase 1|20|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:10:47.664501|2017-10-10 23:10:47.664501
NCT02484040|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-06-01|||December 2015||2015-12-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer|Two-Week COurse Versus Conventionally Fractionated Preoperative Chemoradiotherapy In Locally Advanced Rectal Cancer (TwoArc Trial): A Phase III Randomized Clinical Trial|Recruiting||Phase 3|370|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||Yes||2017-10-10 23:10:47.793965|2017-10-10 23:10:47.793965
NCT02484027|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-24|||September 2015||2015-09-01|June 2015|2015-06-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|REPAIRS||Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)|Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients|Not yet recruiting||Phase 4|456|Anticipated|Second Affiliated Hospital of Soochow University||2|||f||||t||||||||||2017-10-10 23:10:47.933131|2017-10-10 23:10:47.933131
NCT02484014|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-09-15|||June 2015||2015-06-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SEHER||Evaluation of School-based Health Promotion Programmes in Bihar, India|Strengthening the Evidence Base on Effective scHool Based intErventions for pRomoting Adolescent Health (SEHER)|Completed||N/A|14000|Actual|Sangath||3|||f||||t||||||||Yes||2017-10-10 23:10:48.10038|2017-10-10 23:10:48.10038
NCT02484001|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-03-17|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures|Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures: a Double-blind, Randomized, Active-controlled, Parallel-group, Multicenter Clinical Study - Open-label ESL Extension|Enrolling by invitation||Phase 3|300|Anticipated|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-10 23:10:50.176697|2017-10-10 23:10:50.176697
NCT02483975|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-05-19|2016-12-16||October 9, 2015|Actual|2015-10-09|May 2017|2017-05-01|June 20, 2016|Actual|2016-06-20|June 20, 2016|Actual|2016-06-20||Interventional|||Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma|Completed||Phase 3|111|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:10:50.339127|2017-10-10 23:10:50.339127
NCT02483962|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-05-18|||February 2015||2015-02-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Venavine Intensive® in the Treatment of Symptoms Associated With Chronic Venous Insufficiency|The Efficacy of Red Vine Leaf Extract, Butcher's Broom, Horse Chestnut and Vitamin B6 in the Treatment of Symptoms Associated With Chronic Venous Insufficiency|Completed||Phase 2|40|Actual|University of Johannesburg||2|||f||||t||||||||No||2017-10-10 23:10:50.933375|2017-10-10 23:10:50.933375
NCT02483949|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-07-21|||June 2015||2015-06-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|HEALD-GDM||Healthy Eating and Active Living for Diabetes - Gestational Diabetes Mellitus|Healthy Eating and Active Living for Diabetes - Gestational Diabetes Mellitus|Recruiting||N/A|100|Anticipated|Athabasca University||2|||f||||f||||||||||2017-10-10 23:10:51.05184|2017-10-10 23:10:51.05184
NCT02483936|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-01-20|||June 2017|Anticipated|2017-06-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control|Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan Medoxomil + Chlorthalidone (40mg + 12.5mg and 40mg + 25mg) Compared With BENICAR HCT® in Hypertension Control|Not yet recruiting||Phase 3|348|Anticipated|EMS||4|||f||||t|f|f||||||||2017-10-10 23:10:51.175095|2017-10-10 23:10:51.175095
NCT02483923|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-10-30|||June 2015||2015-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Analgesic Effect to Postoperative Pain After Mastectomy: Ultrasound-guided Serratus Anterior Plane Block||Recruiting||N/A|64|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:10:51.450678|2017-10-10 23:10:51.450678
NCT02483910|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-08-08|||October 2015||2015-10-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|DILL ASD||Direct Instruction Language for Learning in Autism Spectrum Disorder|Efficacy of the Direct Instruction Language for Learning Program to Promote Expressive and Receptive Language in Children With Autism Spectrum Disorder|Recruiting||N/A|100|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 23:10:51.57948|2017-10-10 23:10:51.57948
NCT02483897|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-03-28|||June 2015||2015-06-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion|Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion|Terminated||Phase 3|17|Actual|Queen's University||2||inabililty to recruit at required rate|f||||t||||||||||2017-10-10 23:10:51.717546|2017-10-10 23:10:51.717546
NCT02483884|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-03-20|||May 2015||2015-05-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer|An Open-label, Multi Center PET/CT Study for Investigation of Safety and Diagnostic Performance of the 68Ga Labeled PET Tracer [68Ga]RM2 in Patients With Primary Prostate Cancer|Terminated||Phase 1/Phase 2|30|Actual|Piramal Imaging SA||3||Business decision|f||||f||||||||||2017-10-10 23:10:51.799903|2017-10-10 23:10:51.799903
NCT02483871|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-06-02|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|||Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy||Withdrawn||Phase 1|0|Actual|Duke University||1||Enrollment did not meet anticipated goals. Eligibility was a challenge.|f||||f||||||||||2017-10-10 23:10:51.915667|2017-10-10 23:10:51.915667
NCT02483858|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-04-10|||January 2015||2015-01-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Oral PQR309 in Patients With Advanced Solid Tumors|Phase I Study of Oral PQR309 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|90|Anticipated|PIQUR Therapeutics AG||1|||f||||f||||||||Undecided||2017-10-10 23:10:52.029408|2017-10-10 23:10:52.029408
NCT02483845|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-02-08|||May 2013||2013-05-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|IBM-NAT||Natalizumab in Inclusion Body Myositis (IBM)|Pilot Study of Natalizumab in the Treatment of Patients With Inclusion Body Myositis|Active, not recruiting||Phase 1|6|Actual|Phoenix Neurological Associates, LTD||1|||f||||||||||||||2017-10-10 23:10:52.237843|2017-10-10 23:10:52.237843
NCT02483832|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-06-23|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|August 24, 2015|Actual|2015-08-24|August 24, 2015|Actual|2015-08-24||Interventional|CRC||Message Framing and Colorectal Cancer Screening|Effects of Message Framing and Risk Feedback on CRC Screening|Completed||N/A|640|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:10:52.367576|2017-10-10 23:10:52.367576
NCT02483819|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-01-24|||July 2, 2015|Actual|2015-07-02|January 2017|2017-01-01|February 27, 2016|Actual|2016-02-27|February 27, 2016|Actual|2016-02-27||Observational|||Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients||Completed||N/A|20|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 23:10:52.469361|2017-10-10 23:10:52.469361
NCT02483806|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2015-06-24|||June 2015||2015-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effects of Positive End-expiratory Pressure on Intrapulmonary Shunt, Oxygenation and Cardiac Function During One-lung Ventilation|The Effects of Positive End-expiratory Pressure on Intrapulmonary Shunt, Oxygenation and Cardiac Function During One-lung Ventilation : Prospective, Cross-over Study|Unknown status|Recruiting|N/A|36|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-10 23:10:52.548476|2017-10-10 23:10:52.548476
NCT02483793|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-26|||July 2015||2015-07-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population|Randomized Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Discomfort in the Pediatric Population|Unknown status|Not yet recruiting|N/A|60|Anticipated|Phoenix Children's Hospital||2|||f||||||||||||||2017-10-10 23:10:52.630761|2017-10-10 23:10:52.630761
NCT02483780|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-04-04|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||We Talk About Our Hypertension|"Culturally Adaptive Storytelling Method to Improve Hypertension Control in Vietnam -We Talk About Our Hypertension: a Pilot Cluster Randomized Controlled Trial"|Completed||N/A|160|Actual|Institute of Population, Health and Development, Vietnam||2|||f||||f||||||||||2017-10-10 23:10:52.73482|2017-10-10 23:10:52.73482
NCT02483767|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-24|||June 2015||2015-06-01|June 2015|2015-06-01|June 2022|Anticipated|2022-06-01|June 2017|Anticipated|2017-06-01||Interventional|POF||Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer|Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer|Not yet recruiting||Phase 3|260|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 23:10:52.819592|2017-10-10 23:10:52.819592
NCT02483754|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-01-24|||January 2011||2011-01-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|August 2011|Actual|2011-08-01||Observational|ARMOCA||Application and Revision of Montreal Cognitive Assessment in Chinese Retirees|Application and Revision of Montreal Cognitive Assessment in Military Retirees With Mild Cognitive Impairment|Completed||N/A|304|Actual|Xijing Hospital|||2||f||||t||||||||||2017-10-10 23:10:52.944847|2017-10-10 23:10:52.944847
NCT02483741|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-12-05|||June 2015||2015-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||The Use of Manuka Honey to Improve Healing After Third Molars Surgery|The Effect of Topical Application of Manuka Honey on Healing After Extraction of Impacted Lower Third Molars: A Split-Mouth Design Randomized Controlled Trial|Completed||N/A|50|Actual|Damascus University||2|||f||||t||||||||No||2017-10-10 23:10:53.033406|2017-10-10 23:10:53.033406
NCT02483728|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-10-31|||August 2014||2014-08-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Cutaneous and Systemic Reactions to Metal Implants|Cutaneous and Systemic Reactions to Metal Implants: Utility of Patch Testing Prior and Post Placement of Metal Orthopedic Implants|Recruiting||N/A|100|Anticipated|Winthrop University Hospital||2|||f||||f||||||||||2017-10-10 23:10:53.157474|2017-10-10 23:10:53.157474
NCT02483715|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-09-19|||July 2015||2015-07-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection|Efficacy of High-dose Dual Therapy Versus Bismuth-containing Quadruple Therapy for First-line Treatment of Helicobacter Pylori Infection - A Prospective, Randomized, Comparative Study|Recruiting||Phase 4|600|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-10 23:10:53.268304|2017-10-10 23:10:53.268304
NCT02483702|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-11-01|||August 2015||2015-08-01|November 2016|2016-11-01||||August 2017|Anticipated|2017-08-01||Interventional|||Irradiated Blood Versus Non Irradiated Blood Transfusions in Craniosynostosis Repair|The Affect of Radiated Versus Non-Irradiated Blood on Extracellular Potassium Levels in Infants Undergoing Craniosynostosis Repair|Recruiting||N/A|20|Anticipated|Valley Anesthesiology Consultants||2|||f||||||||||||||2017-10-10 23:10:53.394351|2017-10-10 23:10:53.394351
NCT02483689|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-11-01|||August 2015||2015-08-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Local Anesthetic at Incision Site|The Evaluation of Pre-incisional and Post-closure Local Anesthetic vs. Normal Saline on Postoperative Pain in Pediatric Appendectomies|Recruiting||N/A|100|Anticipated|Valley Anesthesiology Consultants||2|||f||||t||||||||||2017-10-10 23:10:53.684496|2017-10-10 23:10:53.684496
NCT02483676|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-09-26|||September 1, 2015|Actual|2015-09-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|April 1, 2019|Anticipated|2019-04-01||Interventional|||Ankle Robot to Reduce Foot-drop in Stroke|Adaptive Ankle Robot Control System to Reduce Foot-drop in Chronic Stroke|Recruiting||N/A|72|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|f|||||2017-10-10 23:10:53.844901|2017-10-10 23:10:53.844901
NCT02483663|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-11-30|||August 2010||2010-08-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|BRAT||Brain Regulation of Appetite in Twins|Brain Regulation of Appetite in Twins|Active, not recruiting||N/A|108|Anticipated|University of Washington|||2||f||||||||||||||2017-10-10 23:10:53.978217|2017-10-10 23:10:53.978217
NCT02483650|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-05-18|||January 2005||2005-01-01|May 2016|2016-05-01||||January 2020|Anticipated|2020-01-01|2 Months|Observational [Patient Registry]|HBOTR||Hyperbaric Oxygen Therapy Registry|The Registry of Hyperbaric Oxygen Therapy Treated Patients|Enrolling by invitation||N/A|5000|Anticipated|U.S. Wound Registry|||1||f||||t||||||||||2017-10-10 23:10:54.105504|2017-10-10 23:10:54.105504
NCT02483624|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-01-29|||January 2016||2016-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus|A Single-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of 3,3'-Diindolylmethane (BR-DIM) in Patients With Systemic Lupus Erythematosus (SLE)|Terminated||Phase 1|6|Actual|Northwell Health||3|||f||||t||||||||||2017-10-10 23:10:54.335321|2017-10-10 23:10:54.335321
NCT02483611|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-12-10|2015-09-15||July 2015||2015-07-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional||Forty-eight 18-60 yr. old ASA I/II patients, with a body mass index of 18 - 29 kg/m2 undergoing surgery at least 90 min. were randomly allocated to 3 treatment groups.Patients who were taking medications that could affect NMB and patients with neuromuscular, renal, hepatic, cardiac dysfunction, hypermetabolic or hypometabolic states were excluded.|Effects of Intravenous Lidocaine Associated With Magnesium Sulfate on the Cisatracurium-Induced Neuromuscular Block|Effect of Intravenous Infusion of Magnesium Sulfate Associated or Not to Lidocaine On the Neuromuscular Blockade Induced by Muscle Relaxant Cistracurium|Completed||Phase 4|48|Actual|University of Sao Paulo|-It was not possible to measure Magnesium sulfate and Lidocaine levels|3|||f||||t||||||||||2017-10-10 23:10:54.503713|2017-10-10 23:10:54.503713
NCT02483403|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-05-08|||September 2010||2010-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Longitudinal 3He Magnetic Resonance Imaging of Healthy Lung|Longitudinal 3He Magnetic Resonance Imaging of Healthy Lung|Recruiting||N/A|180|Anticipated|Western University, Canada||1|||f||||f||||||||||2017-10-10 23:10:57.982209|2017-10-10 23:10:57.982209
NCT02483598|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-24|||June 2015||2015-06-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Mechanistic Investigation Of Intestinal Cytochrome p450 3A4 Following Roux-en-Y Surgery And Its Effect on Plasma Concentrations of Buspirone||Unknown status|Enrolling by invitation|Phase 4|12|Anticipated|North Dakota State University||2|||f||||f||||||||||2017-10-10 23:10:56.034661|2017-10-10 23:10:56.034661
NCT02483585|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-05-30||2017-05-30|July 20, 2015|Actual|2015-07-20|May 2017|2017-05-01|March 20, 2017|Actual|2017-03-20|July 11, 2016|Actual|2016-07-11||Interventional|ARISE||Study to Evaluate the Efficacy and Safety of AMG 334 Compared to Placebo in Migraine Prevention|A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention|Completed||Phase 3|577|Actual|Amgen||2|||f||||t||||||||||2017-10-10 23:10:56.102072|2017-10-10 23:10:56.102072
NCT02483572|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-07-24|||September 2016||2016-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control|Treatment of Severe Destructive Behavior: Functional Communication Training Versus Wait-List Control|Recruiting||N/A|30|Anticipated|University of Nebraska||2|||f||||f||||||||||2017-10-10 23:10:56.448317|2017-10-10 23:10:56.448317
NCT02483559|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2017-02-06|||June 2015||2015-06-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|SWAG||Seeing the World Through Assorted Glasses|Seeing the World Through Assorted Glasses (SWAG)|Completed||N/A|15|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:10:56.55448|2017-10-10 23:10:56.55448
NCT02483546|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-06-17|||January 2014||2014-01-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|SIMCARE||High Fidelity Simulation vs Standard Teaching Training of Cardiac Resuscitation|High Fidelity Simulation In Medecine Education|Completed||N/A|181|Actual|University of Monastir||2|||f||||t||||||||Undecided||2017-10-10 23:10:56.650344|2017-10-10 23:10:56.650344
NCT02483533|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-26|||June 2015||2015-06-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202|A Double-Blind Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 in Subjects Who Completed Either the LIPO-202-CL-18 or LIPO-202-CL-19 Study|Unknown status|Enrolling by invitation|Phase 3|1600|Anticipated|Neothetics, Inc||2|||f||||f||||||||||2017-10-10 23:10:56.745226|2017-10-10 23:10:56.745226
NCT02483520|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-02-13|||March 2014||2014-03-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|FamTechCare||Supporting Family Caregivers With Technology for Dementia Home Care|Supporting Family Caregivers With Technology for Dementia Home Care|Recruiting||N/A|160|Anticipated|University of Kansas Medical Center||2|||f||||t|f|f||||||||2017-10-10 23:10:56.815104|2017-10-10 23:10:56.815104
NCT02483507|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-26|||May 2014||2014-05-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Ultrasound-guided Peripheral Vascular Access: What Approaches in Paediatrics?|Ultrasound-guided Peripheral Vascular Access: What Approaches in Paediatrics?|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Montpellier||3|||f||||t||||||||||2017-10-10 23:10:56.964536|2017-10-10 23:10:56.964536
NCT02483494|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-08-03|||July 8, 2015|Actual|2015-07-08|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|ALTRA||Effectiveness of Advanced Practice Nurse-Led Telehealth on Readmissions|Effectiveness of Advanced Practice Nurse-Led Telehealth on Readmissions and Health Related Outcomes Amongst Patients Post Acute Myocardial Infarction: ALTRA Study|Recruiting||N/A|300|Anticipated|National University Heart Centre, Singapore||2|||f||||f|f|f||||||||2017-10-10 23:10:57.055557|2017-10-10 23:10:57.055557
NCT02483481|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2017-08-02|||August 2015||2015-08-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Using Ultrasound Elastography to Predict Development of SOS|Using Ultrasound Elastography to Predict Development of Sinusoidal Obstruction Syndrome|Recruiting||N/A|45|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-10-10 23:10:57.156455|2017-10-10 23:10:57.156455
NCT02483468|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-03-25|||January 2015||2015-01-01|March 2016|2016-03-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||The Effects of Cognitive Behavioral Therapy and Transcranial Current Stimulation (tDCS) on Chronic Lower Back Pain|The Effects of Cognitive Behavioral Therapy and Transcranial Current Stimulation (tDCS) on Chronic Lower Back Pain|Recruiting||Phase 2/Phase 3|120|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:10:57.28113|2017-10-10 23:10:57.28113
NCT02483442|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-03-24|||December 2015||2015-12-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Observational|PEGeD||D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism|D-dimer Testing,Tailored to Clinical Pretest Probability to Reduce the Use of CT Pulmonary Angiography in Suspected Pulmonary Embolism: A Management Study (The Pulmonary Embolism Graduated D-dimer [PEGeD] Study)|Recruiting||N/A|2000|Anticipated|McMaster University|||2||f||||t||||||||||2017-10-10 23:10:57.518123|2017-10-10 23:10:57.518123
NCT02483429|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-06-06|||August 15, 2017|Anticipated|2017-08-15|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|AVERT||Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT)|Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT)|Not yet recruiting||N/A|226|Anticipated|Johns Hopkins University||2|||f||||t|f|t|f|||||||2017-10-10 23:10:57.678246|2017-10-10 23:10:57.678246
NCT02483416|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-10-03|||November 19, 2015|Actual|2015-11-19|October 2017|2017-10-01|March 18, 2018|Anticipated|2018-03-18|February 1, 2018|Anticipated|2018-02-01||Observational|||Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance|Evaluation of the Impact of a Nurse-led Telephone Follow-up on Treatment Compliance of Patients Treated From a Locally Advanced or Metastatic Non-small-cell Lung Cancer (NSCLC) With Activating Epidermal Growth Factor Receptor (EGFR) Mutation(s).The PARTAGE Study.|Recruiting||N/A|400|Anticipated|Boehringer Ingelheim|||2||f||||||||||||||2017-10-10 23:10:57.802945|2017-10-10 23:10:57.802945
NCT02483390|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-25|||June 2015||2015-06-01|June 2015|2015-06-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Use of Online Communications to Support Patients and Their Families in the Hospice Unit|Use of Online Communications to Support Patients and Their Families in the Hospice Unit|Unknown status|Not yet recruiting|N/A|20|Anticipated|Meir Medical Center||1|||f||||t||||||||||2017-10-10 23:10:58.069147|2017-10-10 23:10:58.069147
NCT02483377|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-04-18|||March 5, 2015|Actual|2015-03-05|April 2017|2017-04-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Observational|||Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer|Breast Cancer Patient Navigation and Tailored Treatment Planning: A Process Evaluation Study for LAC+USC Patient Navigation, Treatment Planning, and Ongoing Support for Latina Women|Terminated||N/A|13|Actual|University of Southern California|||1|Principal Investigator left|f||||t|f|f||||||||2017-10-10 23:10:58.140783|2017-10-10 23:10:58.140783
NCT02483364|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Clinical Trial to Assess the Effect of HC-SVT-1001 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones|A Phase II Clinical Trial to Assess the Effect of HC-SVT-1001 (Autologous Fat Stem Adult Mesenchymal Cells Expanded and Combined With a Tricalcium Phosphate Biomaterial) in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones|Recruiting||Phase 2|10|Anticipated|Salvat||1|||f||||t||||||||||2017-10-10 23:10:58.230696|2017-10-10 23:10:58.230696
NCT02483351|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-25|2016-12-08|||October 2015||2015-10-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2017|Anticipated|2017-03-01||Interventional|SAHaRA Pilot||Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome|Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial|Active, not recruiting||Phase 2/Phase 3|60|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 23:10:58.306708|2017-10-10 23:10:58.306708
NCT02483338|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-07-08|||July 2011||2011-07-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|FASS||FASS (Facial Action Summary Score) Scale to Differentiate the Pain of Postoperative Anxiety in Children Under 7 Years|Does the FASS (Facial Action Summary Score) Scale Allow to Differentiate the Pain of Postoperative Anxiety in Children Under 7 Years?|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:10:58.38744|2017-10-10 23:10:58.38744
NCT02483325|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-10-13|||September 2014||2014-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2016|Actual|2016-09-01||Interventional|BX-PK||Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases|Phase II Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases|Recruiting||Phase 2|33|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 23:10:58.473078|2017-10-10 23:10:58.473078
NCT02483312|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-10-31|||September 2015||2015-09-01|October 2016|2016-10-01|February 2021|Anticipated|2021-02-01|August 2020|Anticipated|2020-08-01||Interventional|||A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)|Phase I Study of Autologous Acute Myelogenous Leukemia (AML) Cells Containing Lentivirus Engineering Expression of IL-12|Recruiting||Phase 1|9|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:10:58.566935|2017-10-10 23:10:58.566935
NCT02483299|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-25|||January 2014||2014-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome||Completed||Phase 4|40|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-10 23:10:58.658185|2017-10-10 23:10:58.658185
NCT02483286|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-08-20|||May 29, 2015|Actual|2015-05-29|January 2016|2016-01-01|April 15, 2017|Actual|2017-04-15|October 5, 2016|Actual|2016-10-05||Interventional|||Osteoporosis and Fall Prevention With Multiple Interventions in the Metropolitan Area|Osteoporosis and Fall Prevention With Multiple Interventions in the Metropolitan Area|Completed||N/A|139|Actual|National Taiwan University Hospital||3|||f||||f||||||||||2017-10-10 23:10:58.754426|2017-10-10 23:10:58.754426
NCT02483273|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-03-02|||May 2011||2011-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Observational|||Alterations of Conjunctival Microcirculation in Brain Dead Patients|Alterations of Conjunctival Microcirculation in Brain Dead Patients|Completed||N/A|22|Actual|Lithuanian University of Health Sciences|||2||f||||t||||||||Undecided||2017-10-10 23:10:58.830084|2017-10-10 23:10:58.830084
NCT02483234|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-25|||May 2015||2015-05-01|June 2015|2015-06-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|PSARTROS||Psoriasis-Arthritis & Bone Program|Evaluation of Inflammatory and Structural Joint Damage in Patients With Psoriasis and Psoriatic Arthritis Treated With Secukinumab: A Phase 2, Single Arm, Single Centre Mode of Action Study (Psoriasis-Arthritis & Bone Program, PSARTROS)|Recruiting||Phase 2|40|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-10-10 23:10:59.093786|2017-10-10 23:10:59.093786
NCT02483221|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-07-26|||April 2015||2015-04-01|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Postoperative Pain Therapy With Hydromorphone TCI-PCA vs. Morphine PCA|Phase 4 Study of Postoperative Pain Therapy With Hydromorphone Using Patient-Controlled Target-Controlled Infusion (TCI-PCA) vs. Patient-Controlled Analgesia (PCA) With Morphine After Elective Cardiac Surgery|Completed||Phase 4|50|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-10 23:10:59.161355|2017-10-10 23:10:59.161355
NCT02483208|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-02-15|||June 2015||2015-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate|Single Dose, Open-label, Randomized, Crossover Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate|Completed||Phase 1|18|Actual|Bayer||2|||f||||f||||||||||2017-10-10 23:10:59.231963|2017-10-10 23:10:59.231963
NCT02483195|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-08-31|||August 2016||2016-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia|The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia|Withdrawn||Phase 4|0|Actual|University of Florida||2||PI indicating she was withdrawing her study submission due to lack of funding as of 6/20/2016|f||||f||||||||||2017-10-10 23:10:59.299726|2017-10-10 23:10:59.299726
NCT02483182|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-01-05|||September 2015||2015-09-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores|A Phase II, Randomized, Double-Blind, Parallel Group, Acyclovir-Controlled Study to Evaluate ZEP-3 Ointment for the Treatment of Cold Sores (Herpes Labialis).|Recruiting||Phase 2|210|Anticipated|Shulov Innovate for Science Ltd. 2012||2|||f||||f||||||||||2017-10-10 23:10:59.395342|2017-10-10 23:10:59.395342
NCT02483169|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-12-23|||June 2009||2009-06-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|PICASSO-IMT||PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study|Double Blind Placebo Controlled Multicenter Trial for Prevention of IMT Progression in the Ischemic Stroke Patients With High Risk of Cerebral Hemorrhage With Cilostazol and Probucol|Active, not recruiting||Phase 4|800|Anticipated|Asan Medical Center||4|||f||||t||||||||||2017-10-10 23:10:59.619599|2017-10-10 23:10:59.619599
NCT02483143|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-06-23|||February 2014||2014-02-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial|N-acetylcysteine, Sodium Bicarbonate and Normal Saline Alone Prophylaxis for Spiral Computed Tomography Pulmonary Angiography in the Emergency Department on Suspicion of Pulmonary Emboli: A Randomized Controlled Trial|Completed||Phase 4|231|Actual|Karadeniz Technical University||3|||f||||f||||||||||2017-10-10 23:10:59.86393|2017-10-10 23:10:59.86393
NCT02483130|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-08-30|||June 2015||2015-06-01|August 2016|2016-08-01||||February 2018|Anticipated|2018-02-01||Observational|NAC||Effect of N-acetylcysteine on Brain Glutamate|A Randomised Controlled Double Blind Crossover Study of the Effect of a Single Dose of N-acetylcysteine Versus Placebo on Brain Glutamate in Patients With Psychotic Disorders|Recruiting||N/A|20|Anticipated|King's College London|||1||f||||f||||||Samples With DNA|"     Samples are collected for two purposes.        1. Participants are invited to donate samples to the BRC Bioresource. These samples may be          used in the future for genetic, epigenetic, metabolomic or proteomic analysis.        2. Participants will also be asked for a blood sample after completion of each MRI scan.          These will be used to measure blood glutathione levels, which may be altered by          N-acetylcysteine and therefore provide indication of pharmacological effect.   "|||2017-10-10 23:10:59.993107|2017-10-10 23:10:59.993107
NCT02483117|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-23|||January 2010||2010-01-01|June 2015|2015-06-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|CIA||Adaptation and Validation of the Clinical Assessment Inventory for Eating Disorders (CIA)|Adaptation and Validation of the Clinical Assessment Inventory (CIA) for Eating Disorders. Assessment of Its Relation With Other Clinical Measures|Completed||N/A|244|Actual|Hospital Galdakao-Usansolo|||1||f||||f||||||||||2017-10-10 23:11:00.104152|2017-10-10 23:11:00.104152
NCT02483104|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2016-08-01|||July 2015||2015-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|||Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer|A Phase 1 Study of Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer|Completed||Phase 1|9|Actual|AbbVie||1|||f||||t||||||||||2017-10-10 23:11:00.177698|2017-10-10 23:11:00.177698
NCT02483091|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-09-12|||June 2015||2015-06-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Testing the Feasibility of Intervening to Optimize Chiropractic Care for Adults With Neck Pain Disorders|Chiropractors Can Do: Testing the Feasibility of Intervening to Optimize Chiropractic Care for Adults With Neck Pain Disorders: A Pilot Cluster Randomized Controlled Trial|Completed||Phase 1|32|Actual|McGill University||2|||f||||t||||||||Undecided||2017-10-10 23:11:00.281237|2017-10-10 23:11:00.281237
NCT02483078|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-09-05|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|PRO 140||A Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination w/ Optimized Background Therapy in Treatment-Experienced HIV Subjects|A Multi-center, Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination With Optimized Background Therapy in Treatment-Experienced HIV-1 Subjects|Recruiting||Phase 2/Phase 3|30|Anticipated|CytoDyn, Inc.||2|||f||||t||||||||||2017-10-10 23:11:00.386084|2017-10-10 23:11:00.386084
NCT02483065|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-06-23|||January 2012||2012-01-01|June 2015|2015-06-01||||January 2015|Actual|2015-01-01||Observational|||Impact of Hospital Admission on Patients With Dementia|Impact of Hospital Admission on Patients With Dementia|Unknown status|Active, not recruiting|N/A|413|Actual|Hospital Galdakao-Usansolo|||2||f||||f||||||||||2017-10-10 23:11:00.62164|2017-10-10 23:11:00.62164
NCT02483052|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-05-10|||August 2015||2015-08-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|LobectomyCAN||RejuvenAir Lobectomy for Safety and Histology|A Prospective Study of RejuvenAir System Radial Spray Cryotherapy to Determine Safety and Delayed Histological Effect in the Lung|Completed||Phase 1/Phase 2|6|Actual|CSA Medical, Inc.||1|||f||||t||||||||No||2017-10-10 23:11:00.717598|2017-10-10 23:11:00.717598
NCT02483039|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-10-04|||September 2015||2015-09-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|FUSION||Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization|Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization (FUSION): Vanguard Phase of a Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 23:11:00.824873|2017-10-10 23:11:00.824873
NCT02483026|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-06-18|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|LSG||Nutritional Deficiencies Preventive Treatment Prior to Laparoscopic Sleeve Gastrectomy|Nutritional Deficiencies Preventive Treatment Prior to Laparoscopic Sleeve Gastrectomy: Controlled Clinical Study|Not yet recruiting||N/A|250|Anticipated|Hadassah Medical Organization||2|||f||||f|f|f||||||No||2017-10-10 23:11:00.950418|2017-10-10 23:11:00.950418
NCT02483013|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-25|||August 2014||2014-08-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Clinical Study of the Whitening Dentifrices on Tooth Color and Sensitivity|Clinical, Controlled, Double-blind Study on the Effect of Whitening Dentifrices on Tooth Color and Tooth Sensitivity|Completed||Phase 4|60|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:11:01.035159|2017-10-10 23:11:01.035159
NCT02483000|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-27|||February 1, 2017|Actual|2017-02-01|September 2017|2017-09-01|March 1, 2025|Anticipated|2025-03-01|March 1, 2021|Anticipated|2021-03-01||Interventional|||Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies|Evaluation of Pretargeted Anti-CD20 Radioimmunotherapy Combined With BEAM Chemotherapy and Autologous Stem Cell Transplantation for High-Risk B-Cell Malignancies|Active, not recruiting||Phase 1|3|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f|t|f||||||||2017-10-10 23:11:01.133369|2017-10-10 23:11:01.133369
NCT02482987|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-02-06|||July 2015||2015-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Comparison of Two Different Alveolar Ridge Preservation Techniques|Comparison of Two Different Alveolar Ridge Preservation Techniques|Enrolling by invitation||N/A|150|Anticipated|Eisenhower Army Medical Center||2|||f||||f||||||||||2017-10-10 23:11:01.317159|2017-10-10 23:11:01.317159
NCT02482974|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-12-19|||July 2015||2015-07-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients|Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients: A 1-year Observational Study|Completed||N/A|66|Actual|Ege University|||1||f||||f||||||||||2017-10-10 23:11:01.427173|2017-10-10 23:11:01.427173
NCT02482961|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-23|||May 2015||2015-05-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|||Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection|Prospective Observational Study, Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection|Unknown status|Recruiting|N/A|50|Anticipated|DongGuk University|||1||f||||t||||||Samples Without DNA|"     blood   "|||2017-10-10 23:11:01.503138|2017-10-10 23:11:01.503138
NCT02482948|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-12-01|||June 2015||2015-06-01|June 2015|2015-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||MEDIHONEY® Gel Versus Collagenase for Wound Debridement|"Prospective, Randomized, Multi-Center, Efficacy Non-inferiority Study of MEDIHONEY® Gel Versus Collagenase for Wound Debridement"|Terminated||N/A|10|Actual|Derma Sciences, Inc.||2||Poor enrollment.|f||||t||||||||||2017-10-10 23:11:01.590071|2017-10-10 23:11:01.590071
NCT02482935|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-10-16|||June 2015||2015-06-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food.|The Effect of Food on the Pharmacokinetics of the Proposed Commercial Formulation of Abemaciclib in Healthy Subjects|Completed||Phase 1|36|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:11:01.702736|2017-10-10 23:11:01.702736
NCT02482922|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-04-13|||May 2015||2015-05-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Interventional|IETnutrition||Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors|Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk|Completed||N/A|15|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-10 23:11:01.803911|2017-10-10 23:11:01.803911
NCT02482909|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2015-06-25|||July 2005||2005-07-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma|A Prospective Randomized Study to Compare the Efficacy of Radiofrequency Ablation and Hepatic Resection as a Primary Treatment for Single Small Hepatocellular Carcinoma|Terminated||N/A|68|Actual|Seoul National University Hospital||2||The post-treatment recurrence rate was expected to be different between two treatment groups.|f||||t||||||||||2017-10-10 23:11:01.884631|2017-10-10 23:11:01.884631
NCT02482896|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-10-06|||February 2016||2016-02-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|LOFUS||The Lolland-Falster Health Study|The Lolland-Falster Health Study|Recruiting||N/A|25000|Anticipated|Region Sjælland|||1||f||||t||||||Samples With DNA|"     Blood, urine, faeces, saliva   "|||2017-10-10 23:11:01.959005|2017-10-10 23:11:01.959005
NCT02482883|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-10-10|||September 2015||2015-09-01|October 2016|2016-10-01||||March 2017|Anticipated|2017-03-01||Interventional|TRIVASOSTIM||Evaluation of Transcutaneous Trigeminal Nerve Stimulation for Prevention of Cerebral Vasospasm After Subarachnoid Haemorrhage|Evaluation of the Efficacy of Transcutaneous Trigeminal Nerve Stimulation for Prevention of Cerebral Vasospasm and Its Consequences After Subarachnoid Haemorrhage Due to Ruptured Aneurysm: a Multicentre, Randomized, Double-blind Study|Recruiting||N/A|60|Anticipated|Poitiers University Hospital||2|||f||||f||||||||||2017-10-10 23:11:02.040302|2017-10-10 23:11:02.040302
NCT02482844|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-07-25|||June 2015||2015-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LBBB-TAVI||Assessment of the Prognosis of Persistent Left Bundle Branch Block (LBBB)After Transcatheter Aortic Valve Implantation (TAVI ) by an Electrophysiological and Remote Monitoring Risk-adapted Algorithm|Assessment of the Prognosis of Persistent Left Bundle Branch Block (LBBB) After Transcatheter Aortic Valve Implantation (TAVI ) by an Electrophysiological and Remote Monitoring Risk-adapted Algorithm|Recruiting||Phase 4|200|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:11:02.31067|2017-10-10 23:11:02.31067
NCT02482831|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-23|||September 2014||2014-09-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|June 2015|Actual|2015-06-01||Observational|DSNBD||The Difference in Duration of Sciatic Nerve Block Between Diabetic and Non-diabetic Patients|The Difference in Duration of Sciatic Nerve Block Between Diabetic and Non-diabetic Patients|Unknown status|Recruiting|N/A|53|Anticipated|Peking Union Medical College Hospital|||2||f||||t||||||||||2017-10-10 23:11:02.407213|2017-10-10 23:11:02.407213
NCT02482818|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2017-04-26|||September 2015||2015-09-01|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Efficacy of Pregabalin on Chronic Cough|Efficacy of Pregabalin on Chronic Cough: A Double Blind, Randomized Control Trial Comparing Pregabalin With Placebo in Patients With Non-asthmatic Chronic Cough|Recruiting||Phase 1/Phase 2|40|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-10 23:11:02.509075|2017-10-10 23:11:02.509075
NCT02482792|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-05-12|||August 2013||2013-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NPMP||Norwegian Psychomotor Physiotherapy in Patients With Long-lasting Musculoskeletal Pain.|Norwegian Psychomotor Physiotherapy Versus Cognitive Patient Education and Active Physiotherapy|Recruiting||N/A|120|Anticipated|University of Bergen||2|||f||||t||||||||Undecided||2017-10-10 23:11:02.680693|2017-10-10 23:11:02.680693
NCT02482779|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-08-11|||January 2015||2015-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Smartphone Application-Based Vital Sign Monitors|Comparison of Smartphone Application-Based Vital Sign Monitors to Devices Used in Clinical Practice|Completed||N/A|120|Actual|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-10 23:11:02.764795|2017-10-10 23:11:02.764795
NCT02482766|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-04-07|||November 2015||2015-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||"Efficacy of a New Technique -IN-REC-SUR-E- in Preterm Neonates With RDS"|"Efficacy of a New Technique -IN-REC-SUR-E- in Preterm Neonates With Respiratory Distress Syndrome During Non Invasive Ventilation: a Randomized Controlled Trial"|Recruiting||N/A|206|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-10 23:11:02.820514|2017-10-10 23:11:02.820514
NCT02482753|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-02-04|||July 2015||2015-07-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer|A Phase III Trial of Chidamide in Combination With Exemestane in Patients With Hormone Receptor-Positive Advanced Breast Cancer (ACE)|Recruiting||Phase 3|348|Anticipated|Chipscreen Biosciences, Ltd.||3|||f||||t||||||||No||2017-10-10 23:11:03.02606|2017-10-10 23:11:03.02606
NCT02482740|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-06-23|||May 2015||2015-05-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|TGOG1005||A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix|An Open, Randomized, Multi-center, Phase 2 Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix: the Efficacy and New Biomarkers|Unknown status|Recruiting|Phase 2|44|Anticipated|Buddhist Tzu Chi General Hospital||2|||f||||t||||||||||2017-10-10 23:11:03.120939|2017-10-10 23:11:03.120939
NCT02482727|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-02-21|||June 2015||2015-06-01|July 2016|2016-07-01||||June 2018|Anticipated|2018-06-01||Interventional|BFR DISTRAD||BFR DISTRAD: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture Repair|BFR DISTRAD: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture Repair|Recruiting||N/A|52|Anticipated|Brooke Army Medical Center||2|||f||||f||||||||||2017-10-10 23:11:03.245392|2017-10-10 23:11:03.245392
NCT02482714|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-09-07|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|FIBROQUALLIFE||Life Quality Determinant Assessment of Fibromyalgia Patients|Life Quality Determinant Assessment of Fibromyalgia Patients Related to Health Devices|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:11:03.316909|2017-10-10 23:11:03.316909
NCT02482701|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-06-29|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|May 2017|Actual|2017-05-01|30 Days|Observational [Patient Registry]|||The Captivator EMR Registry|An International, Multicenter, Prospective, Post Market Registry Using a New Device for Endoscopic Resection of Early Neoplasia in Barrett's Esophagus|Active, not recruiting||N/A|297|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-10 23:11:03.402527|2017-10-10 23:11:03.402527
NCT02482688|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-06-25|||April 2015||2015-04-01|June 2015|2015-06-01||||September 2018|Anticipated|2018-09-01||Interventional|||A New Rehabilitation Treatment Following Stroke|A Randomised Controlled Study of Early vs. Late, and Unisensory vs. Multisensory Rehabilitation for Stroke Patients With Perceptual and Cognitive Impairments.|Recruiting||N/A|80|Anticipated|University of Oxford||4|||f||||||||||||||2017-10-10 23:11:03.649938|2017-10-10 23:11:03.649938
NCT02482675|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-04-03|||June 2015||2015-06-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Milk|Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Milk|Active, not recruiting||N/A|24|Anticipated|Ohio State University||4|||f||||f||||||||||2017-10-10 23:11:03.773265|2017-10-10 23:11:03.773265
NCT02482662|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-12-22|||November 2014||2014-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|December 2015|Actual|2015-12-01||Observational|||Diagnosis Test for Gestational Diabetes Mellitus|Assessment of the Diagnosis Test for Gestational Diabetes Mellitus|Active, not recruiting||N/A|104|Actual|Université de Sherbrooke|||1||f||||f||||||||||2017-10-10 23:11:03.917427|2017-10-10 23:11:03.917427
NCT02482649|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2015-06-24|||January 2013||2013-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||EAA/Therapy for Treating Children With ADHD|Equine-Assisted Activities and Therapy for Treating Children With Attention-Deficit/Hyperactivity Disorder|Unknown status|Recruiting|N/A|46|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 23:11:04.001131|2017-10-10 23:11:04.001131
NCT02482636|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-03-28|||August 2015||2015-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Baby Vaccine Study (Sched3)|Assessment of Post Booster Antibody Responses in UK Infants Given a Reduced Priming Schedule of Meningococcal Serogroup B and 13 Valent Pneumococcal Conjugate Vaccines|Active, not recruiting||Phase 2|189|Actual|University of Oxford||2|||f||||f||||||||||2017-10-10 23:11:04.140258|2017-10-10 23:11:04.140258
NCT02482623|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-12|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|March 1, 2018|Anticipated|2018-03-01||Interventional|DSM-H||The Dementia Symptom Management at Home Program|The Dementia Symptom Management at Home Program: A Bundled Interprofessional Intervention to Improve Dementia Patient-Caregiver Dyad Quality of Care and Quality of Life Through Home Healthcare.|Recruiting||N/A|150|Anticipated|New York University||2|||f||||f|f|f||||||||2017-10-10 23:11:04.282303|2017-10-10 23:11:04.282303
NCT02482610|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-09-06|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Fat|Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Fat|Active, not recruiting||N/A|22|Actual|Ohio State University||3|||f||||f||||||||||2017-10-10 23:11:04.408797|2017-10-10 23:11:04.408797
NCT02482597|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-07-25|||June 2015||2015-06-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Whole Body Periodic Acceleration on Blood Lactate and Recovery|The Effects of Whole Body Periodic Acceleration on Blood Lactate and Recovery in Trained Individuals|Recruiting||N/A|10|Anticipated|New York Institute of Technology||2|||f||||f||||||||||2017-10-10 23:11:04.509518|2017-10-10 23:11:04.509518
NCT02482584|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-03-27|||April 2015||2015-04-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Impact of CPAP Treatment on Arterial Stiffness in Patients With T2DM and Newly Diagnosed Obstructive Sleep Apnoea|DiaBOSA: Impact of CPAP Treatment on Arterial Stiffness in Patients With Type 2 Diabetes and Newly Diagnosed Obstructive Sleep Apnoea|Recruiting||N/A|70|Anticipated|Nordsjaellands Hospital||2|||f||||t||||||||||2017-10-10 23:11:04.620246|2017-10-10 23:11:04.620246
NCT02482571|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-01-20|||March 2016|Actual|2016-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Metabolic Changes in the Activated Human Visual Cortex During Mild Hypoxia|Metabolic Changes in the Activated Human Visual Cortex During Mild Hypoxia|Active, not recruiting||N/A|25|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||No||2017-10-10 23:11:04.726723|2017-10-10 23:11:04.726723
NCT02482558|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-06-23|||February 2013||2013-02-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|||Investigating the Effects of a High GI Versus a Low GI Diet on Hepatic Metabolism and Satiety Levels in Healthy Subjects|Investigating the Effects of a High GI Versus a Low GI Diet on Hepatic Metabolism and Satiety Levels in Healthy Subjects|Completed||N/A|8|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-10 23:11:04.820562|2017-10-10 23:11:04.820562
NCT02482545|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-03-07|||June 2015||2015-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|MRP||Breakfast Meal Replacement|Breakfast Meal Replacement Use on Body Composition and Health-related Quality of Life in Overweight Men and Women: a Randomized Controlled Trial|Completed||N/A|50|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:11:04.90975|2017-10-10 23:11:04.90975
NCT02482532|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-11-16|||January 2016||2016-01-01|November 2016|2016-11-01|December 2035|Anticipated|2035-12-01|June 2020|Anticipated|2020-06-01||Interventional|MARVSmALo||Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma|Phase I Study of Vaccine Enriched, Autologous, Activated T-Cells Redirected to the Tumor Marker GD2 in Patients With Relapsed/Refractory Melanoma|Recruiting||Phase 1|3|Anticipated|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-10 23:11:05.034723|2017-10-10 23:11:05.034723
NCT02482519|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-07-26|||November 2015||2015-11-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||The Effects of Acute Weight Gain and Acute Calorie Deprivation on Marrow Adipose Tissue|The Effects of Acute Weight Gain and Acute Calorie Deprivation on Marrow Adipose Tissue|Recruiting||N/A|34|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:11:05.135445|2017-10-10 23:11:05.135445
NCT02482506|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-06-23|||July 2011||2011-07-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|March 2016|Anticipated|2016-03-01||Interventional|||Moving Forward: A Weight Loss Intervention for African-American Breast Cancer Survivors|BRE-WL4AA Moving Forward: A Weight Loss Intervention for African-American Breast Cancer Survivors|Unknown status|Active, not recruiting|N/A|240|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-10 23:11:05.230862|2017-10-10 23:11:05.230862
NCT02482493|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-03-22|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|||All Polyethylene Versus Metal Backed Tibial Components in Knee Replacement|A Prospective Randomised Control Trial to Compare Clinical and Radiological Outcomes of the Press-Fit Condylar All-Polyethylene Tibial Component With Metal-Backed Tibial Component Implant, in Patients Aged 75 Years or Over|Recruiting||N/A|88|Anticipated|Maidstone & Tunbridge Wells NHS Trust||2|||f||||f||||||||||2017-10-10 23:11:05.318232|2017-10-10 23:11:05.318232
NCT02482480|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-03-17|||October 2014||2014-10-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Comprehensive Management for the Treatment of Obstructive Sleep Apnea|Effects of a Comprehensive Management Program for the Treatment of Obstructive Sleep Apnea Syndrome|Completed||N/A|27|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||Yes||2017-10-10 23:11:05.409121|2017-10-10 23:11:05.409121
NCT02482467|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-23|||November 2014||2014-11-01|February 2015|2015-02-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|KYSTOV||Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst|Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst|Recruiting||N/A|218|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:11:05.494754|2017-10-10 23:11:05.494754
NCT02482454|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-07-31|||July 2012||2012-07-01|February 2017|2017-02-01|July 2033|Anticipated|2033-07-01|July 2030|Anticipated|2030-07-01||Interventional|||Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma|Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma|Active, not recruiting||Phase 2/Phase 3|50|Actual|The First People's Hospital of Changzhou||2|||f||||f||||||||||2017-10-10 23:11:05.581871|2017-10-10 23:11:05.581871
NCT02482441|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-03-03|||June 2015||2015-06-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10|A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 in Advanced Solid Tumors and in Combination With FOLFIRI for Patients With Previously Treated Metastatic Colorectal Cancer|Recruiting||Phase 1|50|Anticipated|OncoMed Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:11:05.666556|2017-10-10 23:11:05.666556
NCT02482428|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-06-22|2017-05-31||May 12, 2015|Actual|2015-05-12|June 2017|2017-06-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Interventional|||Efficacy and Tolerability of Topical LFX453 for External Genital Warts|A Randomized, Vehicle Controlled, Active Comparator, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of Topical LFX453 Formulations in Patients With External Genital Warts (EGWs)|Completed||Phase 2|88|Actual|Novartis||5|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 23:11:05.794172|2017-10-10 23:11:05.794172
NCT02482415|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-08-03|||January 2013||2013-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of a Psycho-educational Intervention for Family Caregivers in Palliative Care||Active, not recruiting||N/A|270|Actual|Ersta Sköndal University College||2|||f||||||||||||||2017-10-10 23:11:06.38128|2017-10-10 23:11:06.38128
NCT02482402|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-10-21|||February 2015||2015-02-01|October 2015|2015-10-01||||September 2016|Anticipated|2016-09-01||Interventional|BRIDGE||Iloprost for Bridging to Heart Transplantation in PH|Iloprost for Bridging to Heart Transplantation in Patients With Pulmonary Hypertension and Left Heart Failure A Randomized, Controlled, Double-blind, Parallel Group, Proof-of-concept Trial|Withdrawn||Phase 2|0|Actual|Heidelberg University||2||Delay in recruitment|f||||t||||||||||2017-10-10 23:11:06.442811|2017-10-10 23:11:06.442811
NCT02482389|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-08-08|||October 2015||2015-10-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Study of Preoperative Boost Radiotherapy|A Phase II Study of Preoperative Boost Radiotherapy in Patients With Breast With Biomarker Analysis|Recruiting||Phase 2|40|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 23:11:06.564015|2017-10-10 23:11:06.564015
NCT02482376|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-08-08|||October 2015||2015-10-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer|A Phase II Preoperative Single-Fraction Partial Breast Radiotherapy in Early Stage Breast Cancer: Analysis of Pathologic Response|Recruiting||Phase 2|100|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 23:11:06.65353|2017-10-10 23:11:06.65353
NCT02482363|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-25|||November 2015||2015-11-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Vascular Responses to UV Exposure in Pregnancy|UVA Irradiation of Skin in Pregnant Women Increases Uterine Artery Blood Flow and Reduces Blood Flow Through a Nitric Oxide Pathway|Unknown status|Not yet recruiting|N/A|40|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-10-10 23:11:06.743869|2017-10-10 23:11:06.743869
NCT02482350|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-05-16|||July 2015||2015-07-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||App-delivered Therapy for Arabic Readers With Hemianopic Alexia|App-delivered Therapy for Arabic Readers With Hemianopic Alexia|Not yet recruiting||N/A|13|Anticipated|University College London Hospitals||1|||f||||t||||||||||2017-10-10 23:11:06.857941|2017-10-10 23:11:06.857941
NCT02482337|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-06-23|||June 2014||2014-06-01|June 2015|2015-06-01|December 2025|Anticipated|2025-12-01|January 2025|Anticipated|2025-01-01||Interventional|POEM||Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders|Prospective Evaluation of Per-Oral Endoscopic Myotomy (POEM) of the Lower Esophageal Sphincter for the Treatment of Esophageal Swallowing Disorders|Recruiting||N/A|20|Anticipated|Baylor Research Institute||1|||f||||t||||||||||2017-10-10 23:11:06.914342|2017-10-10 23:11:06.914342
NCT02482324|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-07-20|||June 2015||2015-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers|A Phase I, Randomized, Open-Labeled Pharmacokinetic Study of ALZT-OP1 in Normal Healthy Volunteers|Completed||Phase 1|26|Actual|AZTherapies, Inc.||2|||f||||f||||||||||2017-10-10 23:11:06.986319|2017-10-10 23:11:06.986319
NCT02482311|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-08-17|||July 1, 2015|Actual|2015-07-01|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours|A Phase Ib, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|97|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:11:07.071576|2017-10-10 23:11:07.071576
NCT02482285|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-09-14|||December 1, 2013||2013-12-01|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|FAC-C||Assessment of Frailty in Elderly Patients With Advanced Cancers|Assessment of Frailty in Elderly Patients With Advanced Cancers|Recruiting||N/A|30|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f||||||Samples With DNA|"     Blood samples and baseline, week 12 and weeks 24   "|||2017-10-10 23:11:07.275778|2017-10-10 23:11:07.275778
NCT02482272|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-12-29|||May 2015||2015-05-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B|Efficacy and Safety of Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With Chronic Hepatitis B Who Have Resistant Mutants to Lamivudine and Show Suboptimal Response to Combination of Lamivudine Plus Adefovir or Adefovir Monotherapy|Recruiting||Phase 4|90|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-10 23:11:07.334749|2017-10-10 23:11:07.334749
NCT02482259|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-09-14|||December 1, 2013|Actual|2013-12-01|September 2017|2017-09-01|July 19, 2016|Actual|2016-07-19|July 19, 2016|Actual|2016-07-19||Observational|FAC-L||Assessment of Frailty in Patients With Advanced Hepatocellular Cancers|Assessment of Frailty in Patients With Advanced Hepatocellular Cancers|Completed||N/A|28|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f|f|f||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:11:07.409559|2017-10-10 23:11:07.409559
NCT02482246|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-12-01|||January 2014||2014-01-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|||Coagulation Profile Surrounding Normal Cesarean Delivery|Coagulation Profile Surrounding Normal Cesarean Delivery|Completed||N/A|10|Actual|University of Chicago|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 23:11:09.337758|2017-10-10 23:11:09.337758
NCT02482233|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-09-11|||August 2015||2015-08-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||The END Perioperative Smoking Pilot Study|"A Pilot Randomized Controlled Clinical Trial - Electronic Nicotine Delivery Device (E-cigarette) for Perioperative Smoking Cessation in Veterans"|Unknown status|Recruiting|Phase 4|30|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:11:09.431687|2017-10-10 23:11:09.431687
NCT02482220|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-05-10|||June 2015||2015-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Physical Activity Program and Energy Intake Control in Obese Adolescents|Physical Activity and Energy Intake Control in Obese Adolescents: Effect of Exercise Programs of Various Intensities|Recruiting||N/A|70|Anticipated|Université Blaise Pascal, Clermont-Ferrand||2|||f||||f||||||||||2017-10-10 23:11:09.546598|2017-10-10 23:11:09.546598
NCT02482207|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-07-11|||November 2015||2015-11-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|RESERVE II||Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk|A Randomized, Double-blind, Active-controlled Study to Assess the Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk|Recruiting||Phase 4|128|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-10 23:11:09.625989|2017-10-10 23:11:09.625989
NCT02482194|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-06-28|||June 2013||2013-06-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study|Autologous Transplantation of Bone Marrow Mesenchymal Stem Cells in Patients of Spinal Cord Injury-Phase I Clinical Trial|Completed||Phase 1|9|Actual|Armed Forces Bone Marrow Transplant Center, Rawalpindi, Pakistan||1|||f||||t||||||||Undecided||2017-10-10 23:11:09.718293|2017-10-10 23:11:09.718293
NCT02482181|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2015-06-25|||January 2011||2011-01-01|June 2015|2015-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01|12 Months|Observational [Patient Registry]|DWIMRICSPL||Diffusion Weighted Magnetic Resonance Imaging for the Characterization of Solitary Pulmonary Lesions|Diffusion Weighted Magnetic Resonance Imaging for the Characterization of Solitary Pulmonary Lesions|Completed||N/A|46|Actual|Trakya University|||1||f||||f||||||||||2017-10-10 23:11:09.806138|2017-10-10 23:11:09.806138
NCT02482168|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-08-02|||May 2015||2015-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of the CD40 Agonistic Monoclonal Antibody APX005M|Phase 1 Study to Evaluate the Safety and Tolerability of the CD40 Agonistic Monoclonal Antibody APX005M in Subjects With Solid Tumors|Recruiting||Phase 1|50|Anticipated|Apexigen, Inc.||3|||f||||f||||||||||2017-10-10 23:11:09.875655|2017-10-10 23:11:09.875655
NCT02482155|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-23|||February 2015||2015-02-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Ibuprofen (MOMENT ACT ANALGESIC Granules) Pharmacokinetic Study|Pharmacokinetic Study of a Single Oral Administration of MOMENT ACT ANALGESIC Granules for Oral Solution to Healthy Volunteers Under Fasting Conditions Single Centre, Single Dose, Open-label, Bioavailability Study|Completed||Phase 1|24|Actual|Aziende Chimiche Riunite Angelini Francesco S.p.A||1|||f||||f||||||||||2017-10-10 23:11:09.970418|2017-10-10 23:11:09.970418
NCT02482142|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-07-12|||July 2015||2015-07-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|PinDIT||The Role of Phosphorus in Diet Induced Thermogenesis (DIT) of Both Lean and Obese Subjects|The Role of Phosphorus in Diet Induced Thermogenesis of Both Lean and Obese Subjects|Recruiting||N/A|64|Anticipated|American University of Beirut Medical Center||5|||f||||f||||||||||2017-10-10 23:11:10.067537|2017-10-10 23:11:10.067537
NCT02482129|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-07-28|2017-07-28|2017-01-13|July 17, 2015|Actual|2015-07-17|July 2017|2017-07-01|March 21, 2016|Actual|2016-03-21|March 21, 2016|Actual|2016-03-21||Interventional||This analysis population includes all randomized and treated subjects, as treated.|Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis|A Multicenter, Randomized, Double-Masked, Active-Controlled Study to Evaluate the Safety and Efficacy of LME636 in Patients With Acute Anterior Uveitis|Completed||Phase 2|45|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:11:10.181114|2017-10-10 23:11:10.181114
NCT02482116|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-08-30|||August 2015||2015-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||A Comparison of Diagnostic Approaches for Malaria and Pneumonia|Malaria and Pneumonia in Children Under the Age of Five Years Old Presenting to Primary Healthcare Centres in Benin City, Nigeria: a Comparison of Early Diagnostic Approaches|Active, not recruiting||N/A|1000|Actual|University of Nottingham|||1||f||||f||||||||||2017-10-10 23:11:11.084882|2017-10-10 23:11:11.084882
NCT02482103|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-25|||April 2013||2013-04-01|June 2015|2015-06-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01|5 Years|Observational [Patient Registry]|NL_RDN_REG||The Dutch National Renal Denervation Registry|Safety, Success Rate and Long Term Consequences of Renal Denervation in Patients With Therapy Resistant Hypertension. The Dutch National Renal Denervation Registry|Recruiting||N/A|1000|Anticipated|UMC Utrecht|||1||f||||f||||||||||2017-10-10 23:11:11.164196|2017-10-10 23:11:11.164196
NCT02482077|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-01-15|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients|Efficacy and Safety Study of Sofosbuvir Containing Regimens in Subjects With Chronic Hepatitis C Virus Genotype 2 Infection|Recruiting||Phase 4|120|Anticipated|Humanity and Health Research Centre||6|||f||||t||||||||||2017-10-10 23:11:11.356949|2017-10-10 23:11:11.356949
NCT02482064|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-06-08|||May 2015||2015-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Using Flexible Resin in Maxillary Obturators|A Clinical Comparative Study of Two Types of Maxillary Obturators Made of Heat Cure Acrylic Resin or Flexible Resin|Completed||N/A|10|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 23:11:11.469609|2017-10-10 23:11:11.469609
NCT02482051|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-07-12|||July 2015||2015-07-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood|Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood|Enrolling by invitation||N/A|2500|Anticipated|Denver Health and Hospital Authority|||1||f||||f||||||||||2017-10-10 23:11:11.550079|2017-10-10 23:11:11.550079
NCT02482038|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-04-12|||September 2016|Actual|2016-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Geko Venous Leg Ulcer Study|A Single Centre Open Label Pilot Study Measuring Lower Limb Blood Flow in Patients With Venous Leg Ulcers Using the Geko™ T-2 or gekoTM Plus [R-2] Neuromuscular Electro Stimulation Device|Recruiting||N/A|12|Anticipated|Firstkind Ltd||1|||f||||f||||||||||2017-10-10 23:11:11.633993|2017-10-10 23:11:11.633993
NCT02482025|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-05-05|||March 1, 2016|Actual|2016-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|SMMRT||The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial|The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial|Active, not recruiting||N/A|1400|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||No||2017-10-10 23:11:11.700132|2017-10-10 23:11:11.700132
NCT02482012|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-02-24|||June 2014||2014-06-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Observational|||Minor Increase Over Minimal Risk Research in NICU|Minor Increase Over Minimal Risk Without Direct Patient Benefit Research in the NICU: Parental and Staff Perspectives|Completed||N/A|96|Actual|Christiana Care Health Services|||2||f||||f||||||||||2017-10-10 23:11:11.782777|2017-10-10 23:11:11.782777
NCT02481999|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-08-10|||August 2015||2015-08-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|||Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years|Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years|Recruiting||N/A|550|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-10 23:11:11.85933|2017-10-10 23:11:11.85933
NCT02481986|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-08-07|||April 1, 2015|Actual|2015-04-01|August 2017|2017-08-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|||Asthma Action at Erie Trial|Asthma Action at Erie Trial|Active, not recruiting||Phase 3|223|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-10 23:11:12.152336|2017-10-10 23:11:12.152336
NCT02481973|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-05-18|||September 2014||2014-09-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome|The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome|Completed||Phase 2|10|Actual|University of Johannesburg||1|||f||||t||||||||No||2017-10-10 23:11:12.231821|2017-10-10 23:11:12.231821
NCT02481960|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-10-08|||July 2011||2011-07-01|May 2015|2015-05-01|June 2017|Anticipated|2017-06-01|August 2016|Anticipated|2016-08-01||Interventional|IDEB-glioma||Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma|A Phase I/II Multi Centre Single Arm, Open Label Study of Intraparenchymal Therapy With Irinotecan Hydrochloride Drug-eluting Beads (CM-BC2) as a Adjunct Therapy to Best Standard of Care in Patients With Recurrent, Surgically Resectable High Grade Glioma|Unknown status|Active, not recruiting|Phase 1/Phase 2|25|Anticipated|BTG International Inc.||1|||f||||t||||||||||2017-10-10 23:11:12.321843|2017-10-10 23:11:12.321843
NCT02481947|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-01-30||2017-01-30|May 2015||2015-05-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults|A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults|Completed||Phase 3|459|Actual|Braintree Laboratories||2|||f||||f||||||||||2017-10-10 23:11:12.425878|2017-10-10 23:11:12.425878
NCT02481934|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-03-18|2016-07-20||March 2013||2013-03-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|NK-VS-MM|The number of participants was directly related with the cost of expanded and activated NK cells production.|Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma|Phase 1 Clinical Trial to Evaluate Security and Dose of Expanded and Activated Autologous NK Cells Infusions in Consolidation of Multiple Myeloma Patients Treatment on Second or Later Relapse.|Completed||Phase 1|5|Actual|Hospital Universitario 12 de Octubre|Volume of the peripheral blood from patients was limiting in order to perform different cohorts with more NKAE cells infusions.|1|||f||||f||||||||Undecided||2017-10-10 23:11:12.596853|2017-10-10 23:11:12.596853
NCT02481921|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-08-02|||June 1, 2015|Actual|2015-06-01|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|April 30, 2019|Anticipated|2019-04-30||Interventional|MEDIC-HF||Group Medical Visits in Heart Failure|Group Medical Visits in Heart Failure for Post-Hospitalization Follow-Up|Recruiting||N/A|375|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:11:12.783007|2017-10-10 23:11:12.783007
NCT02481908|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-06-22|||September 2014||2014-09-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01|1 Year|Observational [Patient Registry]|STICOPD||STI Combined to Valsalva Maneuver for the Diagnosis of Left Ventricular Dysfunction in COPD Exacerbations|a New and Non Invasive Method to Calculate STI ( Systolic Time Intervals) Combined to Valsalva Maneuver in Patient With Acute Exacerbation of COPD|Unknown status|Recruiting|N/A|166|Anticipated|University of Monastir|||1||f||||t||||||||||2017-10-10 23:11:12.921871|2017-10-10 23:11:12.921871
NCT02481895|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-24|2017-02-21|||January 2014||2014-01-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of an Innovative E-neurocognitive Module for Bipolar Disorder|Efficacy of an Innovative E-neurocognitive Module as Adjunct to Functional Remediation for Bipolar Disorder|Recruiting||N/A|132|Anticipated|Centro de Investigación Biomédica en Red||2|||f||||f||||||||No||2017-10-10 23:11:13.002336|2017-10-10 23:11:13.002336
NCT02481882|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-05-10|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|CortHaem||Baseline Cortical Haemodynamics in MS|Investigating Baseline Cortical Haemodynamics in Multiple Sclerosis|Recruiting||N/A|80|Anticipated|University of Nottingham||2|||f||||f||||||||No||2017-10-10 23:11:13.093122|2017-10-10 23:11:13.093122
NCT02481869|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-07-04|||June 2015||2015-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Platelet Rich Plasma Injection in Pilon Fractures|Does Early Platelet Rich Plasma Injection Decrease the Risk of Post-traumatic Arthritis in Pilon Fractures Undergoing Two-staged Open Reduction With Internal Fixation?|Recruiting||N/A|50|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 23:11:13.180676|2017-10-10 23:11:13.180676
NCT02481856|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-01-18|||June 2015||2015-06-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber|A Dose-response Evaluation of the SQ Tree SLIT-tablet in Subjects With Moderate to Severe Allergic Rhinoconjunctivitis Induced by Pollens From the Birch Group During Controlled Exposure in an Environmental Exposure Chamber|Completed||Phase 2|219|Actual|ALK-Abelló A/S||4|||f||||f||||||||||2017-10-10 23:11:13.290647|2017-10-10 23:11:13.290647
NCT02481843|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-07-02|||April 2013||2013-04-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|||Hyperoxia, Erythropoiesis and Microcirculation in Critically Ill Patient|Hyperoxia, Erythropoiesis and Tissue Oxygenation in Critically Ill Patient|Completed||Phase 2|40|Actual|Università Politecnica delle Marche|||2||f||||f||||||Samples Without DNA|"     Blood samples for plasma and serum   "|||2017-10-10 23:11:13.393984|2017-10-10 23:11:13.393984
NCT02481830|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-04-18|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|March 2018|Anticipated|2018-03-01||Interventional|CheckMate331||Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer|An Open-label, Randomized, Phase 3 Study of Nivolumab or Chemotherapy in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First Line Chemotherapy (CheckMate 331: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 331)|Active, not recruiting||Phase 3|561|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-10-10 23:11:13.52308|2017-10-10 23:11:13.52308
NCT02481817|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-09-13|||August 28, 2015|Actual|2015-08-28|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|NoAAC PR-02||Treatment Alternatives in iSGS (NoAAC PR-02 Study)|Treatment Alternatives in Adult Rare Disease; Assessment of Options in Idiopathic Subglottic Stenosis North American Airway Collaborative PR-02 Study (NoAAC PR-02 Study)|Recruiting||N/A|1000|Anticipated|Vanderbilt University Medical Center|||1||f||||f|f|f||||Samples With DNA|"     Biospecimens collected during routine standard of care from each patient (such as tracheal     biopsies obtained during surgery, or surgical specimens generated thru open reconstructive     surgeries), will be annotated in the EDC with such data including specimen collection,     specimen type (e.g., frozen biopsy tissue; FFPE block), and storage location. We may examine     excess tissue obtained at standard of care surgical biopsy. Additionally if blood is     collected during standard of care (i.e., medically indicated labs, operative or office-based     procedures), we will ask participants to provide a one-time, 30 mL blood specimen for     research.   "|||2017-10-10 23:11:14.167086|2017-10-10 23:11:14.167086
NCT02481804|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-03-21|||May 2015||2015-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|DIVIT-pilot||Optimal Feeding for NET Patients|Towards Optimal Personalized Diet and Vitamin Supplementation in NET Patients; a Pilot Study|Completed||N/A|15|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-10 23:11:14.578322|2017-10-10 23:11:14.578322
NCT02481791|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-01-23|||July 2015||2015-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia|Study to Evaluate the Optimal Dose of Remifentanil Required to Ensure Apnoea During Magnetic Resonance Imaging of the Heart Under General Anaesthesia|Recruiting||Phase 3|35|Anticipated|Alder Hey Children's NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:11:14.679961|2017-10-10 23:11:14.679961
NCT02481778|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-09-21|||September 2015||2015-09-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|CARD||Monitoring Radiation Induced Cardiac Damage by Blood Markers|Monitoring Radiation Induced Cardiac Damage by Blood Markers|Recruiting||N/A|87|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:11:14.790991|2017-10-10 23:11:14.790991
NCT02481765|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-05-10|||June 2015||2015-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Feasibility and Dose Tolerability of HD-tDCS in Healthy Adults and Adults With Down Syndrome|Phase I Trial of the Feasibility and Dose Tolerability of High Definition Transcranial Direct Current Stimulation in Healthy Adults and Adults With Down Syndrome|Active, not recruiting||Phase 1|10|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-10 23:11:14.873722|2017-10-10 23:11:14.873722
NCT02481752|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-08-17|||July 2015||2015-07-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of AAT Training in Smokers|The Effect of AAT Training in Smokers|Completed||N/A|52|Actual|University of Texas at Austin||2|||f||||f||||||||||2017-10-10 23:11:14.949438|2017-10-10 23:11:14.949438
NCT02481739|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2017-01-05|||September 2015||2015-09-01|June 2015|2015-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Laparoscopic Surgical Management of Endometriosis on Fertility|Study of the Impact of Laparoscopic Surgical Management of Endometriosis on Fertility|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:11:15.035053|2017-10-10 23:11:15.035053
NCT02481726|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-06-24|||March 2014||2014-03-01|June 2015|2015-06-01||||October 2014|Actual|2014-10-01||Interventional|||68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT||Completed||Phase 1/Phase 2|31|Actual|Xijing Hospital||1|||f||||||||||||||2017-10-10 23:11:15.119084|2017-10-10 23:11:15.119084
NCT02481713|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-08-02|||December 1, 2015|Actual|2015-12-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Improving Adherence to Cognitive Rehabilitation|Enhancing Adherence to Cognitive Rehabilitation|Recruiting||N/A|120|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:11:15.186078|2017-10-10 23:11:15.186078
NCT02481700|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01|7 Days|Observational [Patient Registry]|||Epidemiological Study on the Surgical Removal of Third Molars|Epidemiological Study on the Surgical Removal of Third Molars|Enrolling by invitation||N/A|10000|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:11:15.275555|2017-10-10 23:11:15.275555
NCT02481687|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-06-24|||June 2015||2015-06-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Observational|I-Scan-CLE-IBD||The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease|The Value of Virtual Chromoendoscopy With i-SCAN and Confocal Laser Endomicroscopy in the Assessement of Dysplasia on Patients With Inflammatory Bowel Disease|Unknown status|Recruiting|N/A|15|Anticipated|University of Medicine and Pharmacy Craiova|||2||f||||t||||||Samples With DNA|"     One ml of whole blood and tissue biopsies from normal tissue and from modified areas of 2 to     3 mm each for molecular analysis.   "|||2017-10-10 23:11:15.337111|2017-10-10 23:11:15.337111
NCT02481661|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-24|||July 2015||2015-07-01|June 2015|2015-06-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|||Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC|A Phase III Randomized Trial of Anatomical Segmentectomy Versus Lobectomy by Minimal Incision for Stage IA Peripheral Non-Small Cell Lung Cancer (≤ 2cm)|Not yet recruiting||Phase 3|610|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-10 23:11:15.580716|2017-10-10 23:11:15.580716
NCT02481648|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-11|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|EMMPC||Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer|A Pilot Study to Evaluate Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Newly Diagnosed Prostate Cancer Patients Undergoing Radical Prostatectomy|Recruiting||N/A|20|Anticipated|Vancouver Prostate Centre||2|||f||||f||||||||||2017-10-10 23:11:15.666199|2017-10-10 23:11:15.666199
NCT02481635|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-01-04|||July 2016||2016-07-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|July 2020|Anticipated|2020-07-01||Interventional|||A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer|A Phase I/II Study Evaluating the Feasibility and Safety of Neoadjuvant Gemcitabine/Nab-paclitaxel (GA) and Concurrent Gemcitabine and Radiation Therapy Followed By Pancreatic Resection and Major Arterial Resection for Adenocarcinoma of the Pancreas (ARCAP) in Patients With Advanced Disease|Recruiting||Phase 1/Phase 2|30|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:11:15.756662|2017-10-10 23:11:15.756662
NCT02481622|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2017-04-21|||November 2015|Actual|2015-11-01|November 2015|2015-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||First Event of Infection by HIV-1 of Uterine Vaginal Tissue|Inhibition by the Antibody, First Event of Infection by HIV-1 of Uterine Vaginal Tissue|Recruiting||N/A|600|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:11:15.843421|2017-10-10 23:11:15.843421
NCT02481609|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-02-15|||July 2014||2014-07-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||NAC Trial for Anosmia|Pilot Study of Topical Intranasal N-acetyl Cysteine Administration for the Treatment of Anosmia|Recruiting||Early Phase 1|30|Anticipated|University of Miami||1|||f||||f||||||||||2017-10-10 23:11:15.903917|2017-10-10 23:11:15.903917
NCT02481596|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-06-01|||May 2016||2016-05-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||FAMS Mobile Health Intervention for Diabetes Self-care Support|Family-Focused Mobile Health Intervention: Targeting Family Behaviors to Improve Type 2 Diabetes Management Among Adults|Recruiting||N/A|500|Anticipated|Vanderbilt University Medical Center||3|||f||||t||||||||Undecided||2017-10-10 23:11:15.996797|2017-10-10 23:11:15.996797
NCT02481583|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2015-06-24|||March 2013||2013-03-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Pharmacokinetic Study of Levosulpiride|Tolerability and Pharmacokinetic Comparison of Oral, Intramuscular and Intravenous Administration of Levosulpiride After Single and Multiple Doses in Fasting Healthy Chinese Volunteers|Completed||Phase 1|42|Actual|Wuhan Union Hospital, China||2|||f||||t||||||||||2017-10-10 23:11:16.080399|2017-10-10 23:11:16.080399
NCT02481570|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-06|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|August 15, 2017|Actual|2017-08-15|November 21, 2016|Actual|2016-11-21||Interventional|AIS||Anesthetic Optimization in Scoliosis Surgery|Evaluation of an Anesthetic Optimization Technique in Adolescent Idiopathic Scoliosis Surgery|Completed||N/A|14|Actual|University of Florida||1|||f||||f||||||||||2017-10-10 23:11:16.151915|2017-10-10 23:11:16.151915
NCT02481557|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-06-29|||June 2015||2015-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects of an Oxalate Containing Product on Dentinal Hypersensitivity With Dental Prophylaxis||Completed||N/A|36|Actual|Procter and Gamble||2|||f||||||||||||||2017-10-10 23:11:16.218251|2017-10-10 23:11:16.218251
NCT02481544|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2016-11-06|||April 2015||2015-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|GRAT2015||The Effects of Journaling on Health-Related Mood and Clinical Outcomes in Post-MI Patients|The Effects of Journaling on Health-Related Mood and Clinical Outcomes in Post-MI Patients|Enrolling by invitation||N/A|108|Anticipated|University of California, San Diego||3|||f||||f||||||||||2017-10-10 23:11:16.277431|2017-10-10 23:11:16.277431
NCT02481531|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-03-24|||July 2015||2015-07-01|March 2017|2017-03-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||Growth and Tolerance of Cow's Milk-Based Infant Formulas|Growth and Tolerance of Cow's Milk-Based Infant Formulas|Completed||N/A|373|Actual|Mead Johnson Nutrition||2|||f||||f||||||||||2017-10-10 23:11:16.349921|2017-10-10 23:11:16.349921
NCT02481518|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-08-31|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|PRAGMATIC||Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity|Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity|Recruiting||Phase 4|100|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-10 23:11:16.554304|2017-10-10 23:11:16.554304
NCT02481505|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-01-13|||June 2015||2015-06-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Chloroprocaine 1 % - Spinal Block|Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration: a Prospective, Randomised, Observer-blind Study in Adult Patients|Completed||Phase 2|45|Actual|Sintetica SA||3|||f||||f||||||||||2017-10-10 23:11:16.652159|2017-10-10 23:11:16.652159
NCT02481492|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-01-20|||June 2015||2015-06-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Randomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip Technique|Randomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip Technique|Completed||N/A|100|Actual|Ningbo No. 1 Hospital||2|||f||||t|f|f||||||No||2017-10-10 23:11:16.766268|2017-10-10 23:11:16.766268
NCT02481479|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-10-14|||June 2015||2015-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|SCARF||Saxagliptin and Cardiac Structure and Function|SCARF: Saxagliptin on CArdiac StRucture and Function|Recruiting||Phase 4|40|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f||||||||Undecided||2017-10-10 23:11:16.882267|2017-10-10 23:11:16.882267
NCT02481466|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-29|||November 25, 2016|Actual|2016-11-25|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|PortfolioEx||The Combined Portfolio Diet and Exercise Study|The First Cross-Canada Trial of the Nutrition Trialists' Network--Enhanced Dietary Portfolio and Exercise on Arterial Damage (MRI-Enhanced Dietary Portfolio Plus Exercise on Cardiovascular Risk)|Recruiting||N/A|200|Anticipated|St. Michael's Hospital, Toronto||4|||f||||t||||||||||2017-10-10 23:11:16.99839|2017-10-10 23:11:16.99839
NCT02481453|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-01-17|||July 2015||2015-07-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|RAPAMI||Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis|"Étude de l'Effet de la Rapamycine Sur la Force Musculaire et la réponse Immunitaire au Cours de la Myosite à Inclusions: étude RAPAMI"|Active, not recruiting||Phase 2/Phase 3|44|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-10 23:11:17.192217|2017-10-10 23:11:17.192217
NCT02481440|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-05-07|||January 2014||2014-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Umbilical Cord Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury|Umbilical Cord Mesenchymal Stem Cells Transplantation for the Treatment of Spinal Cord Injury|Recruiting||Phase 1/Phase 2|44|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||Undecided||2017-10-10 23:11:17.292075|2017-10-10 23:11:17.292075
NCT02481427|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-10-18|||September 2015||2015-09-01|October 2016|2016-10-01|August 2027|Anticipated|2027-08-01|August 2017|Anticipated|2017-08-01||Interventional|FUNCTION||Finnish Unicompartmental and Total Knee Arthroplasty Investigation|Total Knee Arthroplasty Versus Unicondylar Knee Arthroplasty: a Randomized, Double-blind Multicenter Trial|Recruiting||N/A|140|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-10 23:11:17.416503|2017-10-10 23:11:17.416503
NCT02481414|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-07-18|||October 2015||2015-10-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions|A Phase II Clinical Trial of PepCan Randomized and Double-Blinded to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions|Recruiting||Phase 2|125|Anticipated|University of Arkansas||2|||f||||f|t|f||||||||2017-10-10 23:11:17.569407|2017-10-10 23:11:17.569407
NCT02481401|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-01-19|||November 2015||2015-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|FAMILIA||Family-based Approach to Promotion of Health Project 2|Family-based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health|Recruiting||N/A|600|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||f|f|f||||||||2017-10-10 23:11:17.667275|2017-10-10 23:11:17.667275
NCT02481388|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-24|||May 2014||2014-05-01|June 2015|2015-06-01||||January 2015|Actual|2015-01-01||Observational|||Optoelectronic Pletysmography and Diaphragmatic Thickness in Heart Failure Patients|Effect of Cardiomegaly Associated With Inspiratory Muscle Weakness on Diaphragm Thickness and Chest Wall Volume Distribution in Patients With Heart Failure|Unknown status|Recruiting|N/A|14|Anticipated|Universidade Federal de Pernambuco|||2||f||||f||||||||||2017-10-10 23:11:17.806847|2017-10-10 23:11:17.806847
NCT02481375|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-06-05|||July 2015||2015-07-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Is Iron Deficiency the Cause of Anemia Among Women in Cambodia?|Is Iron Deficiency the Cause of Anemia Among Women of Reproductive Age in Cambodia? A 2 x 2 Factorial Double Blind Randomized Controlled Trial of Oral Iron and Multiple Micronutrient Supplementation|Completed||N/A|809|Actual|University of British Columbia||4|||f||||f||||||||||2017-10-10 23:11:17.897249|2017-10-10 23:11:17.897249
NCT02481362|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-07-14|||June 2015||2015-06-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Food Choices in Healthy Weight Women|Food Choices in Healthy Weight Women|Completed||N/A|28|Actual|University of Tennessee||2|||f||||f||||||||||2017-10-10 23:11:18.01707|2017-10-10 23:11:18.01707
NCT02481349|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-08-02|||June 16, 2015|Actual|2015-06-16|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Couple-Based Yoga Program for Glioma Patients and Their Partners|Couple-Based Yoga Program for Glioma Patients and Their Partners|Active, not recruiting||N/A|64|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 23:11:18.118871|2017-10-10 23:11:18.118871
NCT02481336|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-08-15|||March 2015||2015-03-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|||To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity|Integrating Clinical and Genomic Profiles for Prediction and Prevention of Chemotherapy-induced Neuropathy Via Big Bio-Data Analytics|Recruiting||N/A|300|Anticipated|National Cheng-Kung University Hospital|||1||f||||t||||||Samples With DNA|"     Blood Sample Collection with DNA   "|||2017-10-10 23:11:18.663926|2017-10-10 23:11:18.663926
NCT02481323|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|Prevent-SVD||Lacunar Intervention Trial 1 (LACI-1)|Preventing Cognitive Decline and Dementia From Cerebral Small Vessel Disease|Recruiting||Phase 2|60|Anticipated|University of Edinburgh||4|||f||||t||||||||No||2017-10-10 23:11:18.772184|2017-10-10 23:11:18.772184
NCT02481310|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-08-11|||September 2015||2015-09-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma|A Phase I-II Trial of DA-EPOCH-R Plus Ixazomib as Frontline Therapy for Patients With MYC-aberrant Lymphoid Malignancies: The DACIPHOR Regimen|Recruiting||Phase 1/Phase 2|55|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 23:11:18.917052|2017-10-10 23:11:18.917052
NCT02481297|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-06-20|||June 23, 2015|Actual|2015-06-23|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients|Lirilumab (Anti-KIR mAb) Combined With Rituximab for Relapsed, Refractory or High-risk Untreated Patients With Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 2|8|Actual|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:11:19.212453|2017-10-10 23:11:19.212453
NCT02481284|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-06-22|||January 2008||2008-01-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|September 2009|Actual|2009-09-01||Observational|||Microcirculation of the Abdominal Skin After Deep Inferior Epigastric Artery Perforator Flap Procedure|Microcirculatory Evaluation of the Abdominal Skin in Breast Reconstruction With Deep Inferior Epigastric Artery Perforator Flap|Completed||N/A|20|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-10 23:11:19.323215|2017-10-10 23:11:19.323215
NCT02481271|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-05-23|||December 2015||2015-12-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MBM_Galle||Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Cholecystectomy|Effects of Preoperative Relaxation and Intensified Surgery Education on Preoperative Wellbeing and Postoperative Complaints in Patients Undergoing Cholcystectomy - a Randomized Controlled Trial|Recruiting||N/A|108|Anticipated|Universität Duisburg-Essen||4|||f||||f||||||||||2017-10-10 23:11:19.405328|2017-10-10 23:11:19.405328
NCT02481258|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-05-08|||June 2015||2015-06-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|September 30, 2017|Anticipated|2017-09-30||Interventional|CAVS||A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification|A Phase II Randomized, Placebo-Controlled, Double-Blinded Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification in Patients With Moderate Calcific Aortic Valve Stenosis|Active, not recruiting||Phase 2|35|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:11:19.550444|2017-10-10 23:11:19.550444
NCT02481245|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2017-09-07|||September 2015||2015-09-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study|A Pan-PPAR Agonist Treatment for Bipolar Depression: A Proof of Concept Study|Recruiting||Phase 2|30|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:11:19.63058|2017-10-10 23:11:19.63058
NCT02481232|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-23|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine|A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine|Unknown status|Recruiting|Phase 1|200|Anticipated|Lanzhou Institute of Biological Products Co., Ltd||2|||f||||t||||||||||2017-10-10 23:11:19.721329|2017-10-10 23:11:19.721329
NCT02481219|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-01-22|2016-03-06||May 2015||2015-05-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure|COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure|Completed||N/A|122|Actual|Medtronic - MITG||2|||f||||f||||||||No||2017-10-10 23:11:19.816675|2017-10-10 23:11:19.816675
NCT02481206|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-03-01|||June 2015||2015-06-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|August 2019|Anticipated|2019-08-01||Interventional|WED-HED||Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study|Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study|Active, not recruiting||N/A|65|Actual|Zoll Medical Corporation||2|||f||||t||||||||No||2017-10-10 23:11:20.346488|2017-10-10 23:11:20.346488
NCT02481193|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-22|||March 2013||2013-03-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia|Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia|Completed||Phase 3|90|Actual|Yangzhou No.1 People's Hospital||3|||f||||t||||||||||2017-10-10 23:11:20.62529|2017-10-10 23:11:20.62529
NCT02481180|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-06-01|||June 2015||2015-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)|An Open, Dose Escalation, Multiple Dose Study to Assess Tolerance、Pharmacokinetics、Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)|Recruiting||Phase 1|50|Anticipated|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||2|||f||||f||||||||||2017-10-10 23:11:20.713826|2017-10-10 23:11:20.713826
NCT02481167|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-24|||January 2015||2015-01-01|June 2015|2015-06-01|January 2018|Anticipated|2018-01-01|April 2016|Anticipated|2016-04-01||Observational|||Evaluation of Meibomian Gland Dysfunction in Chinese Old Patients||Recruiting||N/A|100|Anticipated|Wenzhou Medical University|||1||f||||||||||||||2017-10-10 23:11:20.831813|2017-10-10 23:11:20.831813
NCT02481154|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-03-23|||June 2015||2015-06-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation|A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation|Recruiting||Phase 1|150|Anticipated|Agios Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-10 23:11:20.921532|2017-10-10 23:11:20.921532
NCT02481128|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-01-31|||May 2014||2014-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer|Randomized Controlled Multicenter Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer; SenSzi (GBG80)|Completed||N/A|1198|Actual|Kliniken Essen-Mitte||2|||f||||f||||||||No||2017-10-10 23:11:21.106488|2017-10-10 23:11:21.106488
NCT02481115|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-05-08|||February 2013||2013-02-01|May 2017|2017-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Validation of the PreSchool Confusion Assessment Method for the Intensive Care Unit (psCAM-ICU)|Pediatric Delirium in Infants and Young Children: Validation of the PreSchool Confusion Assessment Method for the Intensive Care Unit (psCAM-ICU)|Completed||N/A|300|Actual|Vanderbilt University Medical Center|||1||f||||f||||||||No||2017-10-10 23:11:21.238766|2017-10-10 23:11:21.238766
NCT02481102|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-02-06|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01|4 Days|Observational [Patient Registry]|EASYER||EASYER (EpiAccess SYstem Registry) A Post Market Observational Registry|EASYER (EpiAccess SYstem Registry) - A Post Market Observational Registry|Recruiting||N/A|150|Anticipated|EpiEP, Inc.|||1||f||||f||||||||No||2017-10-10 23:11:21.311827|2017-10-10 23:11:21.311827
NCT02481089|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-02-17|||June 2015||2015-06-01|February 2016|2016-02-01||||December 2018|Anticipated|2018-12-01||Observational|||Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma||Recruiting||N/A|600|Anticipated|Hunan Province Tumor Hospital|||1||f||||||||||||||2017-10-10 23:11:21.3987|2017-10-10 23:11:21.3987
NCT02481076|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-08-15|||November 2013||2013-11-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|December 2015|Actual|2015-12-01||Interventional|CAT||Compression in Anklefracture Treatment, The CAT-study|Compression in Anklefracture Treatment, The CAT-study|Active, not recruiting||N/A|156|Actual|Hillerod Hospital, Denmark||2|||f||||f||||||||No||2017-10-10 23:11:21.485105|2017-10-10 23:11:21.485105
NCT02481063|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-08-20|||June 2015||2015-06-01|June 2015|2015-06-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Adaptation in Lower Extremity After 3 Running Days, With a Group Trained by Eccentric Overload|Differences in Muscle (Vastus Laterals and Gastrocnemius Medialis) and Tendon Adaptation (Patellar and Achilles) in Lower Extremity After 3 Running Days With a Group Trained by Eccentric Overload, Measured by Ultrasound and Thermography|Completed||N/A|19|Actual|Universidad San Jorge||2|||f||||t||||||||||2017-10-10 23:11:21.615591|2017-10-10 23:11:21.615591
NCT02481050|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-10-05|||June 16, 2015|Actual|2015-06-16|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|September 5, 2017|Actual|2017-09-05||Interventional|||Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer|To Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly for Subjects With HER2 Negative Metastatic Breast Cancer|Active, not recruiting||Phase 2|58|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-10 23:11:21.717065|2017-10-10 23:11:21.717065
NCT02481037|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-03-14|||June 2015||2015-06-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|||Primary Care Pathway for Childhood Asthma|Primary Care Pathway for Childhood Asthma|Active, not recruiting||N/A|22|Actual|University of Alberta||2|||f||||f||||||||No||2017-10-10 23:11:21.828435|2017-10-10 23:11:21.828435
NCT02481024|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-08-30|||June 2015||2015-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Impact of Care Transition on Medication Adherence in Cardiac Patients|'Moving From Hospital to Home' - Exploring the Impact of Care Transition on Medication Adherence in Cardiac Patients: a Qualitative Study Protocol|Completed||N/A|18|Actual|King's College London|||1||f||||f||||||||||2017-10-10 23:11:21.922345|2017-10-10 23:11:21.922345
NCT02481011|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-04-27|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|January 1, 2016|Actual|2016-01-01|January 1, 2016|Actual|2016-01-01||Observational|RICH||Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs|Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs: a Nationwide Study|Completed||N/A|22111|Actual|St. Olavs Hospital|||2||f||||f|f|f||||||||2017-10-10 23:11:22.023314|2017-10-10 23:11:22.023314
NCT02480998|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-05-19|||February 2015||2015-02-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults|A Randomized, Double-blind, Active Comparator, Phase I/Ⅱa Clinical Trial to Assess the Safety and Immunogenicity of the 'IL-YANG Flu Vaccine Quadrivalent Inj.' in Healthy Korean Adult Subjects|Completed||Phase 1/Phase 2|84|Actual|Il-Yang Pharm. Co., Ltd.||2|||f||||t||||||||Undecided||2017-10-10 23:11:22.124598|2017-10-10 23:11:22.124598
NCT02480985|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-03-24|||March 2015||2015-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The PIT-TBI Pilot Study|Clinical Outcomes and Predictors of PITuitary Disorders in Patients With Moderate and Severe Traumatic Brain Injury: the PIT-TBI Prospective Multicenter Pilot Cohort Study|Active, not recruiting||N/A|70|Anticipated|CHU de Quebec-Universite Laval||1|||f||||f||||||||||2017-10-10 23:11:22.200823|2017-10-10 23:11:22.200823
NCT02480972|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging|Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging (MRI)|Active, not recruiting||N/A|69|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:11:22.306705|2017-10-10 23:11:22.306705
NCT02480959|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-04-23|||August 2015||2015-08-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Medial Retinacular Plication Versus Medial Patellofemoral Ligament Reconstruction for Recurrent Patellar Instability|Functional Outcome of Surgical Treatment for Recurrent Patellar Instability: A Prospective Comparative Study Between Medial Retinacular Plication Versus Medial Patellofemoral Ligament Reconstruction|Recruiting||N/A|30|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-10 23:11:22.396969|2017-10-10 23:11:22.396969
NCT02480946|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-03-24|||July 2015||2015-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis|A Four-Part Phase-1 Study Investigating the Tolerability, Safety and Pharmacokinetics (PK) of MBS2320 in Healthy Subjects and in Subjects With Rheumatoid Arthritis (RA) Also Treated With Methotrexate|Completed||Phase 1|105|Actual|Modern Biosciences plc||4|||f||||t||||||||No||2017-10-10 23:11:22.49853|2017-10-10 23:11:22.49853
NCT02480933|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-06-28|||September 2016||2016-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|SISYPHUS||Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens|Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens|Active, not recruiting||N/A|768|Anticipated|Centro Hospitalar Lisboa Ocidental||2|||f||||f||||||||No||2017-10-10 23:11:22.619353|2017-10-10 23:11:22.619353
NCT02480920|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-07-25|||July 2015||2015-07-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Observational|NOAC-TR||Adherence to New Oral Anticoagulation Therapy in Turkey|Drug Adherence in Patients Taking New Oral Anticoagulation Therapy in Turkey|Completed||N/A|2734|Actual|Cardiovascular Academy Society, Turkey|||1||f||||f||||||||||2017-10-10 23:11:22.710965|2017-10-10 23:11:22.710965
NCT02480907|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-09-28|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SUCCEAT||Supporting Carers of Children and Adolescents With Eating Disorders in Austria (SUCCEAT)|Supporting Carers of Children and Adolescents With Eating Disorders in Austria (SUCCEAT) - A Randomized Controlled Trial to Compare Workshop, Internet-based and Conventional Parental Support Groups|Recruiting||N/A|144|Anticipated|Medical University of Vienna||3|||f||||f||||||||||2017-10-10 23:11:22.790872|2017-10-10 23:11:22.790872
NCT02480894|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-09-20|||July 7, 2015|Actual|2015-07-07|September 2017|2017-09-01|September 21, 2015|Actual|2015-09-21|September 21, 2015|Actual|2015-09-21||Interventional|||A Open-label, Drug-Drug Interaction With Maraviroc (DDI)|A Phase 1, Open-label, Drug-drug Interaction Study Between BMS-663068 and Maraviroc in Healthy Subjects|Completed||Phase 1|112|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-10-10 23:11:22.918998|2017-10-10 23:11:22.918998
NCT02480881|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-07-25|||July 7, 2015|Actual|2015-07-07|July 2017|2017-07-01|January 11, 2016|Actual|2016-01-11|January 11, 2016|Actual|2016-01-11||Interventional|||A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)|Effect of BMS-663068 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone Acetate in Healthy Female Subjects|Completed||Phase 1|26|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-10-10 23:11:23.012662|2017-10-10 23:11:23.012662
NCT02480868|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-07-17|||January 2014||2014-01-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||ARTEBONE Bone Void Filler in Arthrodesis Procedure of the Ankle|A Prospective Clinical Investigation to Assess Safety and Performance of ARTEBONE as Bone Void Filler in a Single Arthrodesis Procedure of the Ankle (Ankle Joint or Subtalar Joint)|Active, not recruiting||N/A|35|Anticipated|BBS-Bioactive Bone Substitutes Oy||1|||f||||f||||||||||2017-10-10 23:11:23.100295|2017-10-10 23:11:23.100295
NCT02480855|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-02-01|||June 2015||2015-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TIDAS||Early Identification of Persons at Risk for Sick-leave Due to Work-related Stress|Early Identification of People at Risk for Sick-leave Due to Work-related Stress - A Randomized Controlled Study of People With Mental Disorders and Physical Complaints Consulting Primary Health Care|Enrolling by invitation||N/A|420|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 23:11:23.182986|2017-10-10 23:11:23.182986
NCT02480842|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-25|||June 2015||2015-06-01|June 2015|2015-06-01||||June 2018|Anticipated|2018-06-01||Interventional|||Clinical Trial With Two Physical Therapy Protocols After Breast Cancer Surgery and Immediate Reconstruction|Randomized Clinical Trial With Two Physical Therapy Protocols After Breast Cancer Surgery and Immediate Reconstruction|Recruiting||N/A|120|Anticipated|Federal University of São Paulo||4|||f||||||||||||||2017-10-10 23:11:23.253754|2017-10-10 23:11:23.253754
NCT02480829|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-05-03|||June 2015||2015-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Cystoscopic Ablation Via RF Energy Clinical Trial (CARET 2)|Cystoscopic Ablation Via RF Energy Clinical Trial (CARET 2)|Recruiting||Phase 1/Phase 2|50|Anticipated|Amphora Medical, Inc.||1|||f||||t||||||||||2017-10-10 23:11:23.359383|2017-10-10 23:11:23.359383
NCT02480803|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-01-31|||December 2014||2014-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|INVEST||INfusion VErsus STimulation in Parkinson's Disease|Treatment in Advanced Parkinson's Disease: Continuous Intrajejunal Levodopa INfusion VErsus Deep Brain STimulation|Recruiting||Phase 4|66|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||Undecided||2017-10-10 23:11:23.549526|2017-10-10 23:11:23.549526
NCT02480790|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2015-06-22|||November 2014||2014-11-01|May 2015|2015-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Venous Thromboembolic Complications in Ovarian Cancer|Venous Thromboembolic Complications in Patients With Ovarian Cancer Compared to Patients With Benign Ovarian Tumours|Recruiting||N/A|150|Anticipated|Aalborg Universitetshospital|||2||f||||t||||||Samples With DNA|"     Tumor tissue and also healthy tissue for comparison are taken at surgery. Blood samples.   "|||2017-10-10 23:11:23.677701|2017-10-10 23:11:23.677701
NCT02480777|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2017-09-25||||||September 2017|2017-09-01||||||||Expanded Access|||Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair|Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair|No longer available||N/A|||University of Miami|||||||||||||||||||2017-10-10 23:11:23.759096|2017-10-10 23:11:23.759096
NCT02480764|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-09-12|||September 21, 2015|Actual|2015-09-21|September 2017|2017-09-01|October 9, 2017|Anticipated|2017-10-09|October 9, 2017|Anticipated|2017-10-09||Interventional|||TAK-491 (Azilsartan Medoxomil) Compared to Valsartan in Chinese Participants With Hypertension|A Phase 3, Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Valsartan in Chinese Subjects With Essential Hypertension|Recruiting||Phase 3|600|Anticipated|Takeda||3|||f||||f||||||||||2017-10-10 23:11:23.815313|2017-10-10 23:11:23.815313
NCT02480751|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2015-06-26|||October 2005||2005-10-01|June 2015|2015-06-01||||May 2008|Actual|2008-05-01||Interventional|||TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)||Completed||Phase 2|113|Actual|Toray Industries, Inc||3|||f||||t||||||||||2017-10-10 23:11:23.937335|2017-10-10 23:11:23.937335
NCT02480738|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-24|||June 2012||2012-06-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|CoCoTA||Effectiveness of Computerized Cognitive Training in the Elderly With Cognitive Impairment|Effectiveness of Computerized Cognitive Training Apparatus (CoCoTA) in the Elderly With Normal Cognition, Subjective Cognitive Impairment, Mild Cognitive Impairment|Unknown status|Active, not recruiting|N/A|30|Anticipated|Seoul National University Bundang Hospital||3|||f||||f||||||||||2017-10-10 23:11:24.012914|2017-10-10 23:11:24.012914
NCT02480725|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|July 2025|Anticipated|2025-07-01|July 2024|Anticipated|2024-07-01||Observational|||The Role of the Coagulation Pathway at the Synapse in Prion Diseases|The Role of the Coagulation Pathway at the Synapse in Prion Diseases|Not yet recruiting||N/A|50|Anticipated|Sheba Medical Center|||3||f||||f||||||Samples Without DNA|"     CSF samples   "|||2017-10-10 23:11:24.1012|2017-10-10 23:11:24.1012
NCT02480712|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-04-26|2017-04-26||July 1, 2015|Actual|2015-07-01|April 2017|2017-04-01|June 22, 2016|Actual|2016-06-22|April 29, 2016|Actual|2016-04-29||Interventional|ASTRAL-5|Safety Analysis Set: Participants who received at least one dose of study drug.|Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection|A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection|Completed||Phase 3|107|Actual|Gilead Sciences||1|||f||||f|t|f||||||||2017-10-10 23:11:24.205956|2017-10-10 23:11:24.205956
NCT02480699|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-24|||May 2015||2015-05-01|June 2015|2015-06-01||||August 2016|Anticipated|2016-08-01||Interventional|EVITUPH||Intra Individual Evaluation of Uremic Toxin Levels in Hemodialysed Patients|Intra Individual Evaluation of Uremic Toxin Levels in Hemodialysed Patients|Unknown status|Recruiting|N/A|75|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:11:25.103382|2017-10-10 23:11:25.103382
NCT02480686|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2016-08-18|||January 2015||2015-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Neutrino Regimen for Treatment-experienced HCV GT1 Patients|Efficacy and Safety of Neutrino Therapy for Chronic HCV Genotype 1b Treatment-experienced Patients|Completed||Phase 4|32|Actual|Humanity and Health Research Centre||1|||f||||f||||||||||2017-10-10 23:11:25.204122|2017-10-10 23:11:25.204122
NCT02480673|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-25|||June 2015||2015-06-01|June 2015|2015-06-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||EFFECT OF Salvia Hispanica l. (CHIA) IN THE BIOCHEMICAL METABOLIC SYNDROME COMPONENTS|EFFECT OF Salvia Hispanica L. ( CHIA ) IN THE BIOCHEMICAL METABOLIC SYNDROME COMPONENTS IN PATIENTS IN THE NATIONAL MEDICAL CENTER WEST OF THE MEXICAN SOCIAL SECURITY INSTITUTE|Unknown status|Recruiting|N/A|100|Anticipated|Instituto Mexicano del Seguro Social||4|||f||||t||||||||||2017-10-10 23:11:25.310159|2017-10-10 23:11:25.310159
NCT02480660|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-02-19|||November 2013||2013-11-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Adolescent to Adult-Oriented Health Care Transition Survey: Study of a Video-Based Educational Intervention|Adolescent to Adult-Oriented Health Care Transition Survey: Study of a Video-Based Educational Intervention|Completed||N/A|152|Actual|University of Rochester||2|||f||||f||||||||||2017-10-10 23:11:25.447647|2017-10-10 23:11:25.447647
NCT02480647|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-08-10|||May 2016|Actual|2016-05-01|June 2017|2017-06-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis|Randomized Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Pelvic Pain Control in Women With Endometriosis|Completed||Phase 4|100|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-10 23:11:25.536717|2017-10-10 23:11:25.536717
NCT02480634|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-06-09|||June 2016||2016-06-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer|Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer: A Non-inferiority, Randomized, Open, Parallel and Controlled Prospective Clinical Study|Not yet recruiting||Phase 4|280|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||f||||||||||2017-10-10 23:11:25.63423|2017-10-10 23:11:25.63423
NCT02480608|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-23|||April 2004||2004-04-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|August 2011|Actual|2011-08-01||Interventional|CML2004||Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)|Treatment of CML Patients With Imatinib and Hydroxyurea|Completed||Phase 1/Phase 2|113|Actual|University of Leipzig||2|||f||||t||||||||||2017-10-10 23:11:25.846225|2017-10-10 23:11:25.846225
NCT02480595|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-22|||April 2015||2015-04-01|June 2015|2015-06-01|April 2022|Anticipated|2022-04-01|April 2017|Anticipated|2017-04-01|5 Years|Observational [Patient Registry]|ARCHYTAS||AAA Registry: Clinical Outcomes of Highly Angulated anatomY Treated With the Aorfix™ Stent Graft|ARCHYTAS: AAA Registry: Clinical Outcomes of Highly Angulated anatomY Treated With the Aorfix™ Stent Graft|Recruiting||Phase 4|500|Anticipated|Lombard Medical|||1||f||||t||||||||||2017-10-10 23:11:25.927661|2017-10-10 23:11:25.927661
NCT02480582|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-01-25|2016-05-31||June 2015||2015-06-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional||Participants who completed all three study conditions were included in the analyses.|The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control|The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control|Completed||N/A|42|Actual|University of Leeds||6|||f||||f||||||||Yes|Results to be written up for submission to peer-review scientific journal.|2017-10-10 23:11:26.175608|2017-10-10 23:11:26.175608
NCT02480569|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-01-09|||June 2015||2015-06-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter|Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter|Completed||N/A|25|Actual|North Texas Veterans Healthcare System||2|||f||||f||||||||||2017-10-10 23:11:26.578776|2017-10-10 23:11:26.578776
NCT02480556|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-03-02|||July 2015||2015-07-01|August 2015|2015-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative Management|Comparing Blood Loss Between Manual Separation & Conservative Management for Removal of the Placenta During Caesarean Section; a Randomized Controlled Study|Completed||N/A|838|Actual|Kasr El Aini Hospital||2|||f||||f||||||||||2017-10-10 23:11:26.653369|2017-10-10 23:11:26.653369
NCT02480530|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-08-09|||January 2014||2014-01-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Using Feedback Reports to Improve Medication Adherence|Evaluating Individual and Patient-Selected Family/Friend/or Reciprocal Peer Notifications to Improve Statin Medication Adherence Among Patients With Coronary Artery Disease|Active, not recruiting||N/A|224|Anticipated|Corporal Michael J. Crescenz VA Medical Center||3|||f||||f||||||||||2017-10-10 23:11:26.798594|2017-10-10 23:11:26.798594
NCT02480517|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2016-01-06|||September 2016||2016-09-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension|Wave VI Feasibility Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension|Not yet recruiting||N/A|60|Anticipated|Kona Medical Inc.||2|||f||||t||||||||||2017-10-10 23:11:26.886609|2017-10-10 23:11:26.886609
NCT02480504|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-07-12|||September 2015||2015-09-01|September 2016|2016-09-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|||Effects of a 5:2 Diet on Weight Loss and Cardiovascular Risk Factors in Obesity|Effects of a 5:2 Diet on Weight Loss and Cardiovascular Risk Factors in Obesity|Completed||N/A|112|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:11:26.9807|2017-10-10 23:11:26.9807
NCT02480491|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-20|2015-06-23|||January 2014||2014-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Observational|||Study of Free DNA Content of Embryo Culture Medium as a Non-Invasive Tool for Embryo Assessment|Study of Cell Free DNA Content of Human Embryo Culture Medium as a Non-Invasive Tool for Embryo Assessment in ICSI Treatment Cycles|Completed||N/A|100|Actual|Sadat City University|||2||f||||f||||||Samples With DNA|"     cell free DNA content of the culture medium of the human embryo   "|||2017-10-10 23:11:27.053496|2017-10-10 23:11:27.053496
NCT02480478|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2016-04-19|||June 2015||2015-06-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|June 2016|Anticipated|2016-06-01||Observational|||Serum Autotaxin Levels in Cholestasis of Pregnancy|Diagnostic Accuracy of Serum Autotaxin Levels in Cholestasis of Pregnancy|Recruiting||N/A|50|Anticipated|Sisli Etfal Training & Research Hospital|||2||f||||f||||||Samples Without DNA|"     5ml whole blood sample   "|||2017-10-10 23:11:27.117842|2017-10-10 23:11:27.117842
NCT02480465|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-07-06|||January 2015||2015-01-01|May 2015|2015-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety of Lobeglitazone Versus Sitagliptin|Efficacy and Safety of Lobeglitazone Versus Sitagliptin in Inadequately Controlled by Metformin Alone Type 2 Diabetes Mellitus Patients With Metabolic Syndrome: 24-week, Multi-center, Randomized, Double-blind, Phase 4 Study|Unknown status|Recruiting|Phase 4|248|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:11:27.184704|2017-10-10 23:11:27.184704
NCT02480452|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2015-06-23|||May 2015||2015-05-01|June 2015|2015-06-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|||Brain Lesions in Relation to Motor Profiles of Children With Cerebral Visual Impairment.|Brain Lesions in Relation to Motor Profiles of Children With Cerebral Visual Impairment.|Active, not recruiting||N/A|600|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-10 23:11:27.276882|2017-10-10 23:11:27.276882
NCT02480439|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-07-19|2016-07-19||June 2015||2015-06-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional||Safety Set included of all participants who were enrolled and received at least 1 dose of study drug.|A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants|A Phase 1, Randomized, Open-Label, Single-Dose, 3-Way Crossover Study to Assess the Relative Bioavailability of a TAK-648 Tablet Compared With a TAK-648 Oral Solution, and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants|Completed||Phase 1|24|Actual|Takeda||3|||f||||f||||||||||2017-10-10 23:11:27.346331|2017-10-10 23:11:27.346331
NCT02480426|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||3D CT Guidance for Transjugular Intrahepatic Portosystemic Shunt Creation|Guidance for TIPS Creation: CT-image Versus CO2 Portography|Unknown status|Not yet recruiting|N/A|15|Anticipated|West China Hospital||2|||f||||f||||||||||2017-10-10 23:11:27.925054|2017-10-10 23:11:27.925054
NCT02480413|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2016-04-06|||July 2015||2015-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Evaluation of an Algorithm for Length Based Weight Estimation|Evaluation of an Algorithm for Length Based Weight Estimation in Comparison to Already Known Devices Like the Pediatric Emergency Tape (Pädiatrisches Notfalllineal - PNL)|Completed||N/A|492|Actual|University Children's Hospital, Zurich|||1||f||||t||||||||||2017-10-10 23:11:27.998028|2017-10-10 23:11:27.998028
NCT02480400|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-22|||June 2010||2010-06-01|June 2015|2015-06-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment Depression|The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment of Patients With Major Depressive Disorder.|Completed||N/A|52|Actual|Abarbanel Mental Health Center||2|||f||||f||||||||||2017-10-10 23:11:28.06057|2017-10-10 23:11:28.06057
NCT02480387|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-07-19|||May 2015||2015-05-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection|A Phase 2, Single-Center, Open-Label Pilot Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection|Completed||Phase 2|20|Actual|Peter J. Ruane, M.D., Inc.||1|||f||||f||||||||||2017-10-10 23:11:28.148729|2017-10-10 23:11:28.148729
NCT02480374|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2017-08-11|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2017|Actual|2017-06-01||Interventional|||Study of Safety & Biological Activity of IP GEN-1 With Neoadjuvant Chemo in Ovarian Cancer|A Phase I Study of the Safety and Biological Activity of Intraperitoneal GEN-1 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered In Combination With Standard Neoadjuvant Chemotherapy in Patients Newly Diagnosed With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Active, not recruiting||Phase 1|15|Anticipated|Celsion||1|||f||||t|t|f||||||||2017-10-10 23:11:28.214524|2017-10-10 23:11:28.214524
NCT02480361|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-22|||January 2013||2013-01-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EAPIG||Effect of Acupuncture on Postoperative Ileus After Gastric Surgery (EAPIG)|Effect of Acupuncture on Postoperative Ileus After Gastrectomy in Patients With Gastric Cancer: A Pilot Study|Completed||N/A|10|Actual|Daegu Catholic University Medical Center||2|||f||||f||||||||||2017-10-10 23:11:28.284574|2017-10-10 23:11:28.284574
NCT02480348|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-09-25|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|September 2016|Actual|2016-09-01||Interventional|RevElution||Medtronic RevElution Trial|Medtronic Polymer-Free Drug-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Active, not recruiting||N/A|100|Anticipated|Medtronic Vascular||1|||f||||||||||||||2017-10-10 23:11:30.103271|2017-10-10 23:11:30.103271
NCT02480335|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-19|||June 2015||2015-06-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CEASESTIFF||The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis|The Clinical Efficacy And Subclinical Effects on Arterial STIFFNESS of Bosentan Therapy Added to Usual Care in Patients With Systemic Sclerosis With Digital Ulcers|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-10 23:11:30.21198|2017-10-10 23:11:30.21198
NCT02480322|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-24|||May 2010||2010-05-01|June 2015|2015-06-01||||May 2012|Actual|2012-05-01||Observational|||Metabolomic Fingerprint After Bariatric Surgery|Metabolomic Fingerprint of Severe Obesity is Dynamically Affected by Bariatric Surgery in a Procedure-dependent Manner|Completed||N/A|106|Actual|eSwiss Medical & Surgical Center|||5||f||||||||||||||2017-10-10 23:11:30.351111|2017-10-10 23:11:30.351111
NCT02480296|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-03-21|||August 2015||2015-08-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers|A Phase 1, Double-blind, Randomized, Placebo-controlled, Ascending Multiple Oral Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MYK-461 in Healthy Volunteers|Completed||Phase 1|60|Actual|MyoKardia, Inc.||2|||f||||t||||||||||2017-10-10 23:11:30.418426|2017-10-10 23:11:30.418426
NCT02480283|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-01|||April 2016||2016-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response|Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response|Recruiting||N/A|100|Anticipated|University of Colorado, Denver|||2||f||||t||||||Samples With DNA|"     1. Urine        2. Exhaled Breath Condensate        3. Blood/Plasma        4. Bronchial brushings        5. Bronchoalveolar Lavage        6. Oral rinse   "|||2017-10-10 23:11:30.497581|2017-10-10 23:11:30.497581
NCT02480270|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-07-17|||August 2014||2014-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation|Prospective Clinical and Laboratory Evaluation of Outpatient Antibiotic Treatment for Pulmonary Exacerbations in Children With Cystic Fibrosis|Recruiting||N/A|40|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 23:11:30.590955|2017-10-10 23:11:30.590955
NCT02480257|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-06-11|||January 2014||2014-01-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||UCSF TARA Study: Training for Awareness, Resilience and Action|University of California San Francisco (UCSF) TARA Study: Training for Awareness, Resilience and Action|Completed||N/A|26|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:11:30.678152|2017-10-10 23:11:30.678152
NCT02480244|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-05-24|||July 2015||2015-07-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||PASOS: Improving the Health of Immigrant Workers|Translating Obesity and Diabetes Prevention Into the Worksite for Immigrant Populations|Recruiting||N/A|600|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-10-10 23:11:30.774338|2017-10-10 23:11:30.774338
NCT02480231|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-05-11|||September 2015||2015-09-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|MUST||Mid-Urethral Sling Tensioning Trial|Mid-Urethral Sling Tensioning Trial|Recruiting||N/A|318|Anticipated|University of Calgary||2|||f||||f||||||||No||2017-10-10 23:11:30.900226|2017-10-10 23:11:30.900226
NCT02480218|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-10-03|||July 2015|Actual|2015-07-01|October 2017|2017-10-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women|Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women|Completed||N/A|47|Actual|Sunnybrook Health Sciences Centre|||2||f||||f||||||||||2017-10-10 23:11:31.115258|2017-10-10 23:11:31.115258
NCT02480205|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-30|||August 2015||2015-08-01|January 2017|2017-01-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|NeuroPAP||"A Pilot Study of Synchronized and Non-invasive Ventilation (NeuroPAP) in Preterm Newborns"|"A Pilot Study of Synchronized and Non-invasive Ventilation (NeuroPAP) in Preterm Newborns"|Completed||N/A|20|Actual|St. Justine's Hospital||1|||f||||t||||||||||2017-10-10 23:11:31.231879|2017-10-10 23:11:31.231879
NCT02480192|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-04-14|||June 2015||2015-06-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CBTMENO||Cognitive Behavioural Therapy for Menopausal Symptoms|Cognitive Behavioural Therapy for Menopausal Symptoms: A Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-10 23:11:31.335267|2017-10-10 23:11:31.335267
NCT02480179|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|||CNS Modification of Food Craving by Neurofeedback|CNS Modification of Food Craving by Neurofeedback|Unknown status|Not yet recruiting|N/A|5|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:11:31.453944|2017-10-10 23:11:31.453944
NCT02480166|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-08-21|2017-07-17||June 2015||2015-06-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6|Comparative Efficacy of Fixed-dose Combination of Sofosbuvir and Ledipasvir for 8 or 12 Weeks for Chronic Hepatitis C Genotype 6|Completed||Phase 4|60|Actual|Stanford University|Our population was small and our study was not powered to be able to determine significant differences between groups.|2|||f||||f||||||||||2017-10-10 23:11:31.580869|2017-10-10 23:11:31.580869
NCT02480153|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-08-29|2017-08-29||June 25, 2015|Actual|2015-06-25|August 2017|2017-08-01|December 6, 2017|Anticipated|2017-12-06|August 31, 2016|Actual|2016-08-31||Interventional||The Intent-to-Treat (ITT) population was defined as all participants who were randomized to study treatment.|A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).|A Phase 3 Randomized, Double-blind Study Assessing The Efficacy And Safety Of Pf-06410293 And Adalimumab In Combination With Methotrexate In Subjects With Moderately To Severely Active Rheumatoid Arthritis Who Have Had An Inadequate Response To Methotrexate|Active, not recruiting||Phase 3|598|Actual|Pfizer|Only data from the first 26-week treatment period (from baseline to Week 26 pre-dose) are presented for this ongoing study. This report will be updated after completion of the study.|2|||f||||t||||||||||2017-10-10 23:11:32.364422|2017-10-10 23:11:32.364422
NCT02480140|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-06-26|||September 2008||2008-09-01|June 2015|2015-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Self-regulated Constraint-induced Movement Therapy in Subacute Stroke Patients|Self-regulated Constraint-induced Movement Therapy in Subacute Stroke Patients|Completed||N/A|76|Actual|University of Western Sydney||3|||f||||f||||||||||2017-10-10 23:11:33.188807|2017-10-10 23:11:33.188807
NCT02480127|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-06-19|||June 2014||2014-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Molecular Evaluation of Endometrium After Endometrial Injury|Molecular Evaluation of Endometrium Obtained From Women With Repeated Implantation Failure (RIF) After Endometrial Injury in Compare to Women Without Endometrial Injury; Phase 3 Clinical Trial|Unknown status|Recruiting|Phase 3|20|Anticipated|Royan Institute||2|||f||||t||||||||||2017-10-10 23:11:33.282535|2017-10-10 23:11:33.282535
NCT02480114|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-09-18|||January 2015||2015-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy|A Randomized Phase III Trial of Gabapentin Versus Standard of Care for Prevention and Treatment of Mucositis in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation|Recruiting||Phase 3|150|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-10-10 23:11:33.382414|2017-10-10 23:11:33.382414
NCT02480101|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-19|||October 2014||2014-10-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine|Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/Anhui/2013/61 (H7N9) Influenza Vaccine|Completed||Phase 1|40|Actual|Research Institute of Influenza, Russia||2|||f||||t||||||||||2017-10-10 23:11:33.522714|2017-10-10 23:11:33.522714
NCT02480088|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-21|||September 2014||2014-09-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism||Unknown status|Recruiting|Phase 4|300|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:11:33.607958|2017-10-10 23:11:33.607958
NCT02480075|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-03-28|||November 2015||2015-11-01|March 2016|2016-03-01|August 2020|Anticipated|2020-08-01|June 2020|Anticipated|2020-06-01||Observational|TROJAN||Observational Study Linking Genetic Variants With Clinical Outcomes in Pain Management|Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and Phenotypic Associations With Pain Management Outcomes|Enrolling by invitation||N/A|2000|Anticipated|Proove Bioscience, Inc.|||1||f||||f||||||||||2017-10-10 23:11:33.688946|2017-10-10 23:11:33.688946
NCT02480062|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-28|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|mWELLCARE||mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease|mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease|Completed||N/A|3702|Actual|Public Health Foundation of India||2|||f||||t||||||||||2017-10-10 23:11:33.794627|2017-10-10 23:11:33.794627
NCT02480049|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2015-06-21|||August 2014||2014-08-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair 10mg Tabs (Merck)|Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair® 10mg Tabs (Merck & Co, Egypt) to Healthy Adult Volunteers|Completed||Phase 1|26|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||||2017-10-10 23:11:34.013292|2017-10-10 23:11:34.013292
NCT02480036|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-09-29|||December 2014||2014-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|KYPHO-IORT||Combining Intraoperative Radiotherapy With Kyphoplasty for Treatment of Spinal Metastases|Combining Intraoperative Radiotherapy With Kyphoplasty for Treatment of Spinal Metastases|Recruiting||Phase 1|10|Anticipated|Loyola University||1|||f||||t||||||||||2017-10-10 23:11:34.098937|2017-10-10 23:11:34.098937
NCT02480023|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-01-09|||June 2015||2015-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Assessment of Bone Mineral Density During Pregnancy|Changes in Bone Mineral Density as Measured by Calcaneal Quantitative Ultrasound in Third Trimester of Pregnancy|Completed||Phase 1|173|Actual|Ain Shams University||1|||f||||t||||||||||2017-10-10 23:11:34.193141|2017-10-10 23:11:34.193141
NCT02480010|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-08-18|2015-07-22||September 2003||2003-09-01|August 2015|2015-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional||Intent-to-Treat (ITT) population consisted of all participants enrolled and who received at least one dose of study medication.|A Study of Pertuzumab in Participants With Prostate Cancer|An Open Label, Phase II, Multicenter Study to Evaluate the Efficacy and Safety of a Recombinant Humanized Antibody to HER2 (Pertuzumab) Administered Every 3 Weeks to Patients With Hormone-Refractory Prostate Cancer Who Have Not Been Treated With Chemotherapy|Terminated||Phase 2|68|Actual|Hoffmann-La Roche|The study was terminated at the time of interim analysis since none of the participants showed a PSA response.|2||"The study was terminated at the time of interim analysis since none of the participants showed   a PSA response."|f||||||||||||||2017-10-10 23:11:34.283854|2017-10-10 23:11:34.283854
NCT02479997|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-02-04|||April 2015||2015-04-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients|Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients Who Receive Neoadjuvant Therapy(Chemotherapy, Hormonal Therapy, Targeted Therapy); Clinical Study for 130 Patients|Recruiting||Phase 2|130|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-10 23:11:35.096643|2017-10-10 23:11:35.096643
NCT02479984|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-09-12|||August 2011||2011-08-01|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer|A Prospective Study Investigating the Role of Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer|Recruiting||N/A|193|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-10-10 23:11:35.181272|2017-10-10 23:11:35.181272
NCT02479971|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-22|||January 2014||2014-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Peritoneal Lavage With Clindamycin-gentamicin on Laparoscopic Sleeve Gastrectomy|Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Postoperative Pain and Analytic Acute Phase Reactants Following Laparoscopic Sleeve Gastrectomy|Completed||Phase 3|60|Actual|Hospital General Universitario Elche||2|||f||||t||||||||||2017-10-10 23:11:35.262748|2017-10-10 23:11:35.262748
NCT02479958|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-06-24|||May 2011||2011-05-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|July 2012|Actual|2012-07-01||Interventional|||An in Vitro Evaluation of Antimicrobial Photodynamic Therapy on Deciduous Carious Dentin|A Randomized in Vitro Evaluation of Antimicrobial Photodynamic Therapy on Deciduous Carious Dentin|Completed||Phase 1|58|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-10 23:11:35.347546|2017-10-10 23:11:35.347546
NCT02479945|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-09-18|||January 2012||2012-01-01|September 2016|2016-09-01||||December 2012|Actual|2012-12-01||Interventional|||Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer|Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer|Active, not recruiting||N/A|6|Actual|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 23:11:35.441133|2017-10-10 23:11:35.441133
NCT02479932|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-03-14|||June 2015||2015-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Comparison of Extraperitoneal Versus Transperitoneal Cesarean Section|A Comparison of Skin to Delivery Time at Exztraperitoneal vs. Transpirational Cesarean|Completed||N/A|210|Actual|Ataturk University||2|||f||||f||||||||||2017-10-10 23:11:35.502917|2017-10-10 23:11:35.502917
NCT02479919|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-07-19|||April 11, 2017|Actual|2017-04-11|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|TBS-COG||Treating Social Cognition With Theta Burst Stimulation: a Multicentric Study|Treating Social Cognition Impairments in Patients With Schizophrenia With Repetitive Transcranial Magnetic Stimulation (Theta-Burst; TBS); a Multicentric Study|Recruiting||N/A|61|Anticipated|University Hospital, Caen||3|||f||||t|f|f||||||||2017-10-10 23:11:35.595904|2017-10-10 23:11:35.595904
NCT02479906|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-07-25|||June 2015||2015-06-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)|A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-Traumatic Stress Disorder (PTSD)|Recruiting||N/A|176|Anticipated|Brainsway||2|||f||||t||||||||||2017-10-10 23:11:35.699519|2017-10-10 23:11:35.699519
NCT02479893|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-11-29|||January 2015||2015-01-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|July 2017|Anticipated|2017-07-01||Observational|||Cold Snare,Hot Snare and APC Polypectomy for the Complete Removal of Small Left Sided Colon Polyps|Cold Snare Polypectomy vs Hot Snare Polypectomy vs APC for the Complete Removal of Left Sided Colon Polyps. A Prospective,Randomized Trial|Recruiting||N/A|108|Anticipated|Evangelismos Hospital|||3||f||||t||||||Samples With DNA|"     colonic polyps tissue samples   "|Undecided||2017-10-10 23:11:35.850889|2017-10-10 23:11:35.850889
NCT02479880|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-06-30|||July 30, 2015|Actual|2015-07-30|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection|Pharmacoepidemiology Study to Define the Long-term Safety Profile of Tenofovir Disoproxil Fumarate (Tenofovir DF, Viread®) and Describe the Management of Tenofovir DF-associated Renal and Bone Toxicity in Chronic Hepatitis B (CHB)-Infected Adolescents Aged 12 to <18 Years in Europe|Active, not recruiting||Phase 4|30|Actual|Gilead Sciences||2|||f||||f|f|f||||||||2017-10-10 23:11:35.957157|2017-10-10 23:11:35.957157
NCT02479867|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-21|||March 2014||2014-03-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)|Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||||2017-10-10 23:11:36.072495|2017-10-10 23:11:36.072495
NCT02479854|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-21|||April 2014||2014-04-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck)|Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck) to Healthy Adult Volunteers Conditions.|Completed||Phase 1|24|Actual|Genuine Research Center, Egypt||2|||f||||f||||||||||2017-10-10 23:11:36.148012|2017-10-10 23:11:36.148012
NCT02479841|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-08-09|||February 2015||2015-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|REKV-13/1741||Health-promoting Competence, Coping and Quality of Life in Patients With COPD|Health-promoting Competence, Coping and Quality of Life in Patients With COPD|Active, not recruiting||N/A|225|Actual|Helse Fonna||2|||f||||t||||||||||2017-10-10 23:11:36.233717|2017-10-10 23:11:36.233717
NCT02479828|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-02|||May 2014||2014-05-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients|The Effect of Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients|Active, not recruiting||N/A|198|Actual|Asklepieion Voulas General Hospital||2|||f||||f||||||||||2017-10-10 23:11:36.303195|2017-10-10 23:11:36.303195
NCT02479815|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-02-06|||March 2015||2015-03-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Impact of Low Dose Iron-containing Micronutrient Powders on Iron Status and Morbidity of Young Children in Ethiopia|Assessing the Safety of Iron Supplementation in Micronutrient Powder (MNPs)|Completed||N/A|2356|Actual|Ethiopian Public Health Institute||1|||f||||t||||||||Undecided||2017-10-10 23:11:36.391563|2017-10-10 23:11:36.391563
NCT02479802|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-06-14|||November 2014||2014-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis|Pilot Study on the Effects of Plasma Exchange on Motor Dysfunction and Cognitive Function in Patients With Amyotrophic Lateral Sclerosis|Completed||Phase 2|13|Actual|Grifols Biologicals Inc.||1|||f||||f||||||||||2017-10-10 23:11:36.483912|2017-10-10 23:11:36.483912
NCT02479789|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2017-01-31|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Intravenous Lidocaine in the Operative Management of Thyroid Surgery With Intraoperative Nerve Monitoring|Efficacy of Intravenous Lidocaine in the Operative Management of Thyroid Surgery With Intraoperative Nerve Monitoring|Recruiting||Phase 4|60|Anticipated|Bronx-Lebanon Hospital Center Health Care System||2|||f||||f||||||||Undecided|Study still recruiting|2017-10-10 23:11:36.577719|2017-10-10 23:11:36.577719
NCT02479776|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-23|||May 2008||2008-05-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||A Trial of Autologous Bone Marrow Derived Stem Cells in Paediatric Heart Failure|A Randomized Study of Autologous Bone Marrow Derived Stem Cells in Pediatric Dilated Cardiomyopathy|Completed||N/A|10|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:11:36.69255|2017-10-10 23:11:36.69255
NCT02479763|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-01-23|2015-12-16||June 2015||2015-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Comparison Between Conventional and Waveform-Confirmed Loss-of-Resistance for Thoracic Epidural Blocks|A Randomized Comparison Between Conventional and Waveform-Confirmed Loss-of-Resistance for Thoracic Epidural Blocks|Completed||Phase 2/Phase 3|106|Actual|Montreal General Hospital||2|||f||||t||||||||||2017-10-10 23:11:36.76005|2017-10-10 23:11:36.76005
NCT02479750|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2016-09-12|||March 2016||2016-03-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|COLDPREVII||Evaluation of ColdZyme® on Experimentally Induced Common Cold.|Evaluation of ColdZyme® on Experimentally Induced Common Cold. -A Double-blind, Randomized, Placebo-controlled Study in Healthy Volunteers.|Active, not recruiting||N/A|88|Actual|Enzymatica AB||2|||f||||f||||||||No||2017-10-10 23:11:37.046087|2017-10-10 23:11:37.046087
NCT02479737|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-04-28|||April 2016||2016-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01|30 Days|Observational [Patient Registry]|||Active Clearance Technology (ACT) II German Multicenter Trial|The Active Clearance Technology (ACT) II German Multicenter Trial|Recruiting||N/A|1113|Anticipated|Paracelsus Medical University|||1||f||||f||||||||No||2017-10-10 23:11:37.117407|2017-10-10 23:11:37.117407
NCT02479724|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-22|2015-06-22|||January 2012||2012-01-01|June 2015|2015-06-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Observational|||A-line/CareTaker Comparison Study in ICU Patients|A-line/CareTaker Comparison Study in ICU Patients|Completed||N/A|60|Actual|Empirical Technologies Corporation|||1||f||||f||||||||||2017-10-10 23:11:37.213771|2017-10-10 23:11:37.213771
NCT02479711|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-08-24|||January 2014||2014-01-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||A Clinical Evaluation of a Glass Ionomer Cement (GIC) Based Restorative System Versus Bulk Filled Resin-based Composite|A Clinical Evaluation of a Glass Ionomer Cement (GIC) Based Restorative System|Unknown status|Active, not recruiting|N/A|35|Actual|Ege University||2|||f||||t||||||||||2017-10-10 23:11:37.271412|2017-10-10 23:11:37.271412
NCT02479698|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-09-29|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Study Assessing the Effect of BK Specific CTL Lines Generated by ex Vivo Expansion in Patients With BK Virus Infection and JC Virus Infection|Phase II Study Assessing the Effect of BK Specific CTL Lines Generated by ex Vivo Expansion in Patients With BK Virus Infection and JC Virus Infection|Recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:11:37.349271|2017-10-10 23:11:37.349271
NCT02479685|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-06-19|||June 2014||2014-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||SORD-BILL Vs Conventional Options During Sacral Colpopexy for POP|Prospective Randomized Trial on Laparoscopic Subtotal Hysterectomy During Sacral Colpopexy for the Treatment of Severe Pelvic Organ Prolapse (POP) With Bipolar Laparoscopic Loop/Bipolar Morcellator vs Conventional Monopolar Hook/Conventional Morcellator|Completed||N/A|100|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-10 23:11:37.427221|2017-10-10 23:11:37.427221
NCT02479672|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-10-10|||January 2016||2016-01-01|October 2016|2016-10-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Comparison of the VividTrac® Videolaryngoscope to Direct Laryngoscopy in Adults Under Manual Inline Stabilization|Comparison of the VividTrac® Videolaryngoscope to Direct Laryngoscopy in Adults Under Manual Inline Stabilization|Withdrawn||N/A|0|Actual|Loma Linda University||2||This study was never started.|f||||f||||||||||2017-10-10 23:11:37.501132|2017-10-10 23:11:37.501132
NCT02479659|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2015-06-30|||October 2013||2013-10-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services|A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis With the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Zambian Health Facilities|Completed||N/A|60|Actual|IDinsight||3|||f||||f||||||||||2017-10-10 23:11:37.568119|2017-10-10 23:11:37.568119
NCT02479646|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-07-28|||September 2014||2014-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta|Single Center, Randomized, Double-blind, 3-Period, 3-Treatments, 3-Way Crossover Pharmacokinetics (PK)/Pharmacodynamics (PD) Trial to Assess PK, PD,Safety and Tolerability of MYL-1401H After Single Subcutaneous Injection at One Dose Level (2 mg) Comparing to an EU and US Marketed Drug Product (Neulasta®) in Healthy Volunteers.|Completed||Phase 1|218|Actual|Mylan Inc.||3|||f||||f||||||||||2017-10-10 23:11:37.644596|2017-10-10 23:11:37.644596
NCT02479633|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-19|||January 2013||2013-01-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Predetermination for Gingival Recession|Predetermınatıon of Root Coverage for Recessıons Treated wıth Coronally Advanced Flap wıth Connectıve Tissue Graft: An Exploratıve Study|Completed||N/A|122|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:11:37.732175|2017-10-10 23:11:37.732175
NCT02479607|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-04-04|||June 30, 2015|Actual|2015-06-30|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PhONEME||Effects of an ICT-platform for Assessment and Management of Patient-reported Symptoms During Treatment for Breast Cancer|PhONEME - ParticipatOn Ehealth MobilE. Effects of an Interactive ICT-platform for Assessment and Management of Symptoms in Patients Treated for Breast Cancer.|Active, not recruiting||N/A|150|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:11:38.090301|2017-10-10 23:11:38.090301
NCT02479594|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-10-07|||August 2015||2015-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Competence-feedback and Therapy Outcome|The Importance of Competence-feedback for Therapy Outcome: a Randomized Controlled Trial|Recruiting||N/A|116|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f||||||||No||2017-10-10 23:11:38.178871|2017-10-10 23:11:38.178871
NCT02479568|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-06-03|||September 2015||2015-09-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|May 2017|Anticipated|2017-05-01||Interventional|CITRUS||Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular Diseases|Randomized, Parallel and Double Blind Placebo-controlled Study for the Evaluation of Both Acute and Chronic Role of Hesperidin Consumption in 100% Orange Juice|Recruiting||Phase 3|252|Anticipated|Technological Centre of Nutrition and Health, Spain||3|||f||||f||||||||||2017-10-10 23:11:38.481189|2017-10-10 23:11:38.481189
NCT02479555|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-03-21|||January 2016||2016-01-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|August 2018|Anticipated|2018-08-01||Interventional|LIMBO-PTA||Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization|LIMBO-PTA: Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization|Recruiting||Phase 2|120|Anticipated|Mercator MedSystems, Inc.||2|||f||||f||||||||No||2017-10-10 23:11:38.606311|2017-10-10 23:11:38.606311
NCT02479542|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-21|2017-04-24|||June 2015||2015-06-01|November 2015|2015-11-01|July 1, 2015|Actual|2015-07-01|June 1, 2015|Actual|2015-06-01||Interventional|||Addition of Negative Pressure Wound Therapy to Standard Gauze Dressings for Acute Wounds in a Limited-Resource Setting|Randomized Trial Comparing the Negative Pressure Wound Therapy to Standard Gauze Dressings for Acute Wounds in Mbingo Baptist Hospital, Cameroon|Withdrawn||N/A|0|Actual|Stanford University||2||Regulatory issues|f||||f||||||||||2017-10-10 23:11:38.735449|2017-10-10 23:11:38.735449
NCT02479529|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-10-20|||October 2014||2014-10-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SNEAD||Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.|Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.|Completed||Phase 3|130|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 23:11:38.838322|2017-10-10 23:11:38.838322
NCT02479516|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-19|||November 2015||2015-11-01|June 2015|2015-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CHAP-P||Community Health Assessment Program in the Philippines|Community Health Assessment Program in the Philippines|Unknown status|Not yet recruiting|Phase 1/Phase 2|45|Anticipated|McMaster University||2|||f||||||||||||||2017-10-10 23:11:38.946458|2017-10-10 23:11:38.946458
NCT02479503|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-19|||March 2015||2015-03-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|June 2015|Actual|2015-06-01||Observational|ATC||Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey|Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey|Unknown status|Recruiting|N/A|22|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 23:11:39.033923|2017-10-10 23:11:39.033923
NCT02479490|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-09-28|||September 2015||2015-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PREV||PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI|Phase II Study of Oral PRednisone 5 mg Bid Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of Vascular Endothelial Growth Factor Receptor-tyrosine Kinase Inhibitors|Recruiting||Phase 2|42|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-10 23:11:39.122239|2017-10-10 23:11:39.122239
NCT02479477|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-06-21|||July 2015||2015-07-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Impact of Labour Kinesiotherapy in the Quality Life of Auxiliary Nursing in the Surgery Center|Impact of Labour Kinesiotherapy in the Quality Life of Auxiliary Nursing in the Surgery Center|Unknown status|Not yet recruiting|N/A|46|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||1|||f||||t||||||||||2017-10-10 23:11:39.23061|2017-10-10 23:11:39.23061
NCT02479464|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-07-01|||October 2009||2009-10-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|September 2010|Actual|2010-09-01||Interventional|HAMM||Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical Setting|A Pilot Study for the Evaluation of the Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical Setting|Completed||N/A|60|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:11:39.302201|2017-10-10 23:11:39.302201
NCT02479451|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-09-12|||October 2015||2015-10-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|HONORR||Helping Olfaction and Nutrition On Renal Replacement|Helping Olfaction and Nutrition On Renal Replacement|Recruiting||Phase 2|20|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:11:39.394731|2017-10-10 23:11:39.394731
NCT02479438|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-06-23|||January 2014||2014-01-01|June 2015|2015-06-01|July 2030|Anticipated|2030-07-01|January 2030|Anticipated|2030-01-01|10 Years|Observational [Patient Registry]|GERD||Gastroesophageal Reflux Disease Prospective Registry|Gastroesophageal Reflux Disease Prospective Registry|Recruiting||N/A|5000|Anticipated|Baylor Research Institute|||1||f||||t||||||||||2017-10-10 23:11:39.507402|2017-10-10 23:11:39.507402
NCT02479425|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-07-05|||May 2011||2011-05-01|July 2015|2015-07-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||Two Points Versus Three Points Turning in Prevention of Bed Sores in Critically Ill Patients|Two Pints Versus Three Points Turning in Prevention of Bed Sores in Critically Ill Patients|Completed||N/A|150|Actual|Faculty of Medicine, University of Alexandria||2|||f||||f||||||||||2017-10-10 23:11:39.598867|2017-10-10 23:11:39.598867
NCT02479412|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-04-10|2017-01-27||June 25, 2015|Actual|2015-06-25|April 2017|2017-04-01|February 8, 2016|Actual|2016-02-08|February 8, 2016|Actual|2016-02-08||Interventional|||A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma|A RANDOMIZED, DOUBLE BLIND, MULTIPLE DOSING (14 DAYS), PLACEBO-CONTROLLED, INCOMPLETE BLOCK CROSSOVER, MULTI CENTER STUDY TO ASSESS EFFICACY AND SAFETY OF THREE DOSE LEVELS OF AZD7594, GIVEN ONCE DAILY BY INHALATION, IN PATIENTS WITH MILD TO MODERATE ASTHMA|Completed||Phase 2|110|Actual|AstraZeneca||9|||f||||f||||||||||2017-10-10 23:11:39.709766|2017-10-10 23:11:39.709766
NCT02479399|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-10-02|||July 17, 2014|Actual|2014-07-17|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|STELLALONGTERM||Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients|Specified Drug Use resulTs survEy of lpragLifLozin treAtment in type2 Diabetes Patients: LONG-TERM (STELLA-LONG TERM)|Active, not recruiting||N/A|11412|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 23:11:41.340865|2017-10-10 23:11:41.340865
NCT02479386|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-09-11|||June 24, 2015|Actual|2015-06-24|September 2017|2017-09-01|April 8, 2021|Anticipated|2021-04-08|April 8, 2021|Anticipated|2021-04-08||Interventional|Proxima A||A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration|A Multicenter, Prospective Epidemiologic Study of The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration|Active, not recruiting||N/A|296|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 23:11:41.427728|2017-10-10 23:11:41.427728
NCT02479373|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-06-19|||July 2012||2012-07-01|June 2015|2015-06-01||||October 2015|Anticipated|2015-10-01||Interventional|Joint Fitness||Exercise and Body Composition in Juvenile Idiopathic Arthritis|"Joint Fitness: A Double-Armed Controlled Intervention to Assess the Safety and Effectiveness of Resistance Exercise Training on Muscle, Bone, Strength, Symptoms, Quality of Life and Biological Parameters in Children and Young Adults With JIA"|Unknown status|Recruiting|N/A|||Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:11:41.811344|2017-10-10 23:11:41.811344
NCT02479360|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2015-10-05|||June 2015||2015-06-01|June 2015|2015-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Reliability of Functional Outcome Measures in Neurofibromatosis 1|A Study Investigating the Inter- and Intra- Rater Reliability of a Battery of Functional Standardised Outcome Measures in Neurofibromatosis 1|Completed||N/A|49|Actual|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:11:41.962784|2017-10-10 23:11:41.962784
NCT02479347|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-19|||March 2013||2013-03-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine|A Randomized, Blinded, Single Center Study to Assess the Incidence of Surgical Site Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine 2% in Alcohol 70% (CHLORAPREP ®) Versus 10% Povidone-iodine|Unknown status|Recruiting|Phase 4|2160|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-10 23:11:42.064157|2017-10-10 23:11:42.064157
NCT02479334|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-09-19|||June 2015||2015-06-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Acute Effects of Spices on Pathways Associated With Glucose Homeostasis and Inflammation on PBMCs of Healthy Subjects|Acute Effects of Spices on Pathways Associated With Glucose Homeostasis, Oxidative Stress and Inflammation in Healthy Subjects - Molecular Insights Through Transcriptomics of Peripheral Blood Mononuclear Cells (PBMC)|Completed||Phase 1/Phase 2|12|Actual|Lund University||4|||f||||f||||||||||2017-10-10 23:11:42.241197|2017-10-10 23:11:42.241197
NCT02479321|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-09-14|||June 2015||2015-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Perioperative Goal Directed Hemodynamic Therapy Based on Noninvasive Monitoring in Patients With Hip Fracture|Efficacy of Perioperative Goal Directed Hemodynamic Therapy Based on Noninvasive Monitoring to Reduce Perioperative Complications in Patients With Hip Fracture|Recruiting||N/A|568|Anticipated|Althaia Xarxa Assistencial Universitària de Manresa||2|||f||||f||||||||||2017-10-10 23:11:42.369994|2017-10-10 23:11:42.369994
NCT02479308|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-11-20|||June 2015||2015-06-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers|The Effect of ALKS 5461 on QT Intervals in Healthy Volunteers|Completed||Phase 1|129|Actual|Alkermes, Inc.||3|||f||||f||||||||||2017-10-10 23:11:42.48308|2017-10-10 23:11:42.48308
NCT02479295|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-08-09|||June 2015||2015-06-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|||Straight Versus Coiled Peritoneal Dialysis Catheter for Peritoneal Dialysis Patients|Randomized Controlled Trial of Straight Versus Coiled Peritoneal Dialysis|Recruiting||Phase 4|264|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:11:42.596917|2017-10-10 23:11:42.596917
NCT02479282|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2015-06-19|||June 2015||2015-06-01|June 2015|2015-06-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Effect of Natural Cesarean Section on Breastfeeding|Effect of Natural Cesarean Section in Comparison to Traditional Cesarean Section on Maternal and Fetal Recovery|Unknown status|Not yet recruiting|N/A|100|Anticipated|Ain Shams University||2|||f||||f||||||||||2017-10-10 23:11:42.724731|2017-10-10 23:11:42.724731
NCT02479269|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-05-08|||March 2015||2015-03-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|AEBNPCRP||The Influence of Aerobic Exercise on Serum Brain Natriuretic Peptide and C- Reactive Protein in Cardiovascular Disease|The Influence of Aerobic Exercise on Serum Brain Natriuretic Peptide and C- Reactive Protein in Cardiovascular Disease|Completed||N/A|60|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:11:42.823275|2017-10-10 23:11:42.823275
NCT02479256|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-05-15|||June 2015||2015-06-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOs|Clomiphene Citrate Versus Tamoxifen for Induction of Ovulation in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial|Completed||Phase 4|600|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:11:42.912945|2017-10-10 23:11:42.912945
NCT02479243|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-02-01|||January 2014||2014-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|3 Months|Observational [Patient Registry]|||Assessment and Quantification of Collateral by ASL MRI|Arterial Spin Labeling MRI Assessment and Quantification of Collateral Circulation in Unilateral Middle Cerebral Artery Atherosclerotic Stenosis|Recruiting||N/A|60|Anticipated|Chinese PLA General Hospital|||1||f||||t||||||||No||2017-10-10 23:11:43.034887|2017-10-10 23:11:43.034887
NCT02479230|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-04-17|||July 17, 2015|Actual|2015-07-17|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Pilot Trial of Type I-Polarized Autologous Dendritic Cell Vaccine Incorporating Tumor Blood Vessel Antigen-Derived Peptides in Patients With Metastatic Breast Cancer|Pilot Trial of Type I-Polarized Autologous Dendritic Cell Vaccine Incorporating Tumor Blood Vessel Antigen-Derived Peptides in Patients With Metastatic Breast Cancer|Recruiting||Phase 1|30|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 23:11:43.145628|2017-10-10 23:11:43.145628
NCT02479217|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-02-16|||July 2006||2006-07-01|February 2017|2017-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Safety of Xeloda in Solid Tumours|Safety of Xeloda in Solid Tumours|Completed||N/A|1268|Actual|Hoffmann-La Roche|||3||f||||||||||||||2017-10-10 23:11:43.297651|2017-10-10 23:11:43.297651
NCT02479204|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-07-25|||April 28, 2015|Actual|2015-04-28|July 2017|2017-07-01|May 1, 2016|Actual|2016-05-01|May 1, 2016|Actual|2016-05-01||Interventional|||Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441|Single-center, Open-label, Randomized, Multiple-dose, Parallel-group Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441 Combined With Calcium-channel Blocker (Diltiazem) or Beta-blocker (Atenolol) Treatment in Healthy Subjects|Terminated||Phase 1|32|Anticipated|Actelion||4||"Based on results from the pilot phase, the study is terminated. No safety events leading to   discontinuation were reported"|f||||f||||||||||2017-10-10 23:11:43.390721|2017-10-10 23:11:43.390721
NCT02479191|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-05-01|||August 2015||2015-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01|1 Year|Observational [Patient Registry]|LUCY||LUCY Study: TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair|The LUCY Study: TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair|Active, not recruiting||N/A|225|Actual|TriVascular, Inc.|||2||f||||f||||||||||2017-10-10 23:11:43.508927|2017-10-10 23:11:43.508927
NCT02479178|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-04-13|||June 2015||2015-06-01|April 2016|2016-04-01|January 2020|Anticipated|2020-01-01|October 2016|Anticipated|2016-10-01||Interventional|iNSITE2||A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck|A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 2|73|Actual|BIND Therapeutics||1|||f||||||||||||||2017-10-10 23:11:43.611975|2017-10-10 23:11:43.611975
NCT02479165|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-06-19|||May 2009||2009-05-01|June 2015|2015-06-01|September 2013|Actual|2013-09-01|September 2010|Actual|2010-09-01||Interventional|||Pain Management After Cardiac Surgery - Opioids or NSAID|Pain Management After Cardiac Surgery - Opioids or NSAID? A Randomized Prospective Study|Completed||Phase 4|182|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-10-10 23:11:43.726731|2017-10-10 23:11:43.726731
NCT02479152|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-08-02|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||The Haemodynamic Effects of Mechanical Standard and Active Chest Compression-decompression During Out-of-hospital CPR|The Haemodynamic Effects of Mechanical Standard and Active External Chest Compression-decompression During Out-of-hospital Cardiopulmonary Resuscitation|Completed||N/A|126|Actual|Physio-Control||2|||f||||t||||||||||2017-10-10 23:11:43.821629|2017-10-10 23:11:43.821629
NCT02479139|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-08-25|2017-08-25||June 3, 2015|Actual|2015-06-03|August 2017|2017-08-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29||Interventional|||Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis|Clinical Trial to Evaluate ANT-1207 in the Treatment of Primary Axillary Hyperhidrosis in Adults|Completed||Phase 2|145|Actual|Allergan||6|||f||||f|t|f||||||||2017-10-10 23:11:43.929301|2017-10-10 23:11:43.929301
NCT02479126|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-08-01|||July 2016||2016-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Observational|||Interstitial Lung Diseases in the Veterans Administration|Interstitial Lung Diseases in the Veterans Administration Health System - A Retrospective Description of Patient Characteristics, Management, and Outcomes|Active, not recruiting||N/A|3000|Anticipated|Durham VA Medical Center|||1||f||||f||||||||||2017-10-10 23:11:44.557754|2017-10-10 23:11:44.557754
NCT02479113|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-10-31|||March 2014||2014-03-01|October 2016|2016-10-01|December 2024|Anticipated|2024-12-01|December 2018|Anticipated|2018-12-01||Observational|||Maternal Hypertriglyceridaemia Study|Pregravid Body Mass Index (BMI), Maternal Hypertriglyceridemia During Pregnancy and Body Composition/Metabolic Health of Asian GDM Offspring|Recruiting||N/A|400|Anticipated|University of Malaya|||3||f||||t||||||Samples With DNA|"     Placental tissue for epigenetic studies of the leptin gene, and cord blood for leptin and     micro RNA29 (miR29) will be collected   "|No||2017-10-10 23:11:44.638941|2017-10-10 23:11:44.638941
NCT02479100|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-12-31|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|CONTEND||Contrast Enhanced Spectral Mammography (CESM) Study|An Assessment of the Impact of CONTrast ENhanceD Mammography (CESM) on Patient Management and Comparison With MRI (CONTEND Study)|Not yet recruiting||N/A|100|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:11:44.734902|2017-10-10 23:11:44.734902
NCT02479087|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-22|||January 2015||2015-01-01|June 2015|2015-06-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|ITI||Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients|IMMUNE TOLERANCE INDUCTION, BY FACTOR VIII CONCENTRATE CONTAINING VON WILLEBRAND FACTOR, IN SEVERE OR MODERATE HAEMOPHILIA A PATIENTS WITH INHIBITORS|Recruiting||Phase 4|20|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||1|||f||||f||||||||||2017-10-10 23:11:44.799948|2017-10-10 23:11:44.799948
NCT02479074|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-10-17|||February 2016||2016-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|TUF||The Utility of feNO in the Differential Diagnosis of Chronic Cough|The Utility of feNO in the Differential Diagnosis of Chronic Cough: The Response to Anti-inflammatory Therapy With Prednisolone and Montelukast|Recruiting||Phase 4|60|Anticipated|Hull and East Yorkshire Hospitals NHS Trust||3|||f||||t||||||||||2017-10-10 23:11:44.927285|2017-10-10 23:11:44.927285
NCT02479061|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-08-16|||June 2015||2015-06-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|March 2016|Actual|2016-03-01||Observational|PREPA-10||An Observational Study of the Prevalence of Patients Requiring Palliative Care in French Anti-cancer Centers.|An Observational Study of the Prevalence of Patients Requiring Palliative Care in the French Anti Cancer Centers.|Completed||N/A|846|Actual|Centre Leon Berard|||1||f||||f||||||||||2017-10-10 23:11:45.040358|2017-10-10 23:11:45.040358
NCT02479048|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-02-06|||June 2015||2015-06-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|AVOC1||Avocado Fruit on Postprandial Markers of the Glycemic Response, Satiety/Appetite and Cardiometabolic Risk|The Impact of Avocado Fruit on Postprandial Markers of the Glycemic Response, Satiety/Appetite and Cardiometabolic Risk: An Acute Dose Response Study|Active, not recruiting||N/A|24|Anticipated|Institute for Food Safety and Health, United States||3|||f||||f||||||||||2017-10-10 23:11:45.193021|2017-10-10 23:11:45.193021
NCT02479035|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-02-06|||June 2015||2015-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|RRB||Red Raspberries and Insulin Action|Red Raspberries and Insulin Action: Understanding the Role of Red Raspberry Consumption on Oxidative Stress- and Inflammatory- Mediated Insulin Action in Humans|Active, not recruiting||N/A|24|Anticipated|Institute for Food Safety and Health, United States||3|||f||||f||||||||No||2017-10-10 23:11:45.273942|2017-10-10 23:11:45.273942
NCT02479022|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-07-29|||June 2015||2015-06-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects|A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects|Completed||Phase 1|84|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-10 23:11:45.35786|2017-10-10 23:11:45.35786
NCT02479009|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-12-20|||June 2015||2015-06-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Fluoroscopy vs. Computed Tomography for Diagnosis of Displacement and Instability of Acute Scaphoid Waist Fractures|Fluoroscopy vs. Computed Tomography for Diagnosis of Displacement and Instability of Acute Scaphoid Waist Fractures|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||1||The investigator left the institution so the study was terminated.|f||||f||||||||||2017-10-10 23:11:45.447333|2017-10-10 23:11:45.447333
NCT02478996|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-05-11|||August 2015||2015-08-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|iPEP||Internet-based Perioperative Exercise Program in Patients With Barrett's Carcinoma Scheduled for Esophagectomy|Internet-based Perioperative Exercise Program in Patients With Barrett's Carcinoma Scheduled for Esophagectomy (iPEP Study) A Prospective Randomized-controlled Pilot Trial|Recruiting||N/A|80|Anticipated|University of Leipzig||2|||f||||||||||||||2017-10-10 23:11:45.506305|2017-10-10 23:11:45.506305
NCT02478983|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2017-05-03|||June 2014||2014-06-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Randomized Comparison of LMA (Laryngeal Mask Airway) Supreme and LMA Proseal in Infants Below 10kg|A Randomized Comparison of LMA Supreme and LMA Proseal in Infants Below 10kg|Completed||N/A|60|Actual|University of Malaya||2|||f||||t|f|f|||f|||Undecided||2017-10-10 23:11:45.616217|2017-10-10 23:11:45.616217
NCT02478970|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-04-26|||June 2014||2014-06-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Specular Microscopy Study|Comparison of Clinical Evaluation of Endothelial Cells With Paracentral and Central Specular Microscopy|Withdrawn||N/A|0|Actual|University of Michigan||2||Equipment/software did not work as anticipated|f||||f||||||||No||2017-10-10 23:11:45.690278|2017-10-10 23:11:45.690278
NCT02478957|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-09-27|||June 2015||2015-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Treatment of Indolent Systemic Mastocytosis With PA101|Randomized, Double-blind, Placebo-controlled, Crossover Design, Efficacy and Safety Study With PA101 in Patients With Indolent Systemic Mastocytosis|Completed||Phase 2|41|Actual|Patara Pharma||2|||f||||f||||||||||2017-10-10 23:11:45.754767|2017-10-10 23:11:45.754767
NCT02478944|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-06-29|||October 2014||2014-10-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|EMSIBD||Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD|Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD|Recruiting||N/A|40|Anticipated|University Hospital Erlangen||1|||f||||f||||||||||2017-10-10 23:11:45.844757|2017-10-10 23:11:45.844757
NCT02478931|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-06-20|||September 2013||2013-09-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|UCSD_PREDICT||Study of Personalized Cancer Therapy to Determine Response and Toxicity|UCSD Profile Related Evidence Determining Individualized Cancer Therapy (UCSD PREDICT)|Recruiting||N/A|2000|Anticipated|University of California, San Diego|||1||f||||f||||||Samples With DNA|"     Blood, urine, tissue, ascites   "|||2017-10-10 23:11:47.952651|2017-10-10 23:11:47.952651
NCT02478918|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-02-14|||June 2015||2015-06-01|February 2017|2017-02-01|May 15, 2016|Actual|2016-05-15|May 15, 2016|Actual|2016-05-15||Interventional|||Automated Telephone Reminder for Colonoscopy|Automated Telephone Reminder Prior to Outpatient Colonoscopy and the Effect on Bowel Preparation Quality|Completed||N/A|234|Actual|Queen's University||2|||f||||f||||||||No||2017-10-10 23:11:48.014453|2017-10-10 23:11:48.014453
NCT02478697|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-04-20|||October 2015||2015-10-01|April 2016|2016-04-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|TTEC||Tobacco Treatment for Employable Californians, Total IMPACT Study|Tobacco Treatment for Employable Californians (TTEC), Improving Employability Partnership: Alliance to Curb Tobacco (Total IMPACT)|Recruiting||N/A|360|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 23:11:49.772736|2017-10-10 23:11:49.772736
NCT02478905|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-05-12|||January 2016||2016-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01|1 Year|Observational [Patient Registry]|TransFLUas||Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting|TransFLUas: Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting: A Prospective Study Over Two Consecutive Influenza Seasons|Recruiting||N/A|1440|Anticipated|University of Zurich|||1||f||||f||||||Samples With DNA|"     Virological analyses        -  Influenza A and B PCR from nasal swabs        -  Whole genome sequencing of positive swabs   "|||2017-10-10 23:11:48.11093|2017-10-10 23:11:48.11093
NCT02478892|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2016-04-08|||May 2015||2015-05-01|March 2016|2016-03-01||||May 2020|Anticipated|2020-05-01||Observational|||Screening for PDAC in BRCA1/2 Patients|Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With BRCA1/2 Mutations|Recruiting||N/A|200|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 23:11:48.193799|2017-10-10 23:11:48.193799
NCT02478879|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-08-21|||June 2015||2015-06-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen|An Open-label Crossover Study to Determine the Patient Preference Between ZP-PTH Patches and Forteo Pens After Daily Treatment for 14 Days in Women 55-85 Years of Age|Completed||Phase 1|24|Anticipated|Zosano Pharma Corporation||2|||f||||f||||||||||2017-10-10 23:11:48.274001|2017-10-10 23:11:48.274001
NCT02478866|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-04-14|||August 2015||2015-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors|Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors: A Phase Ia Study, Open-label, Dose-escalation Study|Recruiting||Phase 1|30|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||No||2017-10-10 23:11:48.351689|2017-10-10 23:11:48.351689
NCT02478853|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-11-02|||March 2015||2015-03-01|June 2015|2015-06-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Impact of a Regional Program Agir Sur Sa SantE|Agir Sur Sa SantE- Impact of a Regional Integrated Prevention and Management of Cardio-metabolic Chronic Diseases Program in Primary Care|Active, not recruiting||N/A|1000|Anticipated|Université de Sherbrooke|||1||f||||f||||||||||2017-10-10 23:11:48.441818|2017-10-10 23:11:48.441818
NCT02478840|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-03-28|||February 2015||2015-02-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|rhLAMAN-10||Evaluation of Long-term Efficacy of Treatment With Lamazym|A Single Center, Open Label Clinical Trial Investigating the Long-term Efficacy of rhLAMAN (Recombinant Human Alpha-mannosidase or Lamazym) Treatment in Subjects With Alpha-Mannosidosis Who Previously Participated in Lamazym Trials|Completed||Phase 3|18|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-10 23:11:48.523656|2017-10-10 23:11:48.523656
NCT02478827|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Trial of Cognitive Training in Schizophrenia||Recruiting||N/A|81|Anticipated|University of Calgary||3|||f||||||||||||||2017-10-10 23:11:48.625508|2017-10-10 23:11:48.625508
NCT02478814|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Protein Requirements In Active Populations|Evaluation of Protein Requirements in Active, Young Adult Males|Active, not recruiting||Early Phase 1|7|Anticipated|University of Toronto||1|||f||||f||||||||||2017-10-10 23:11:48.845133|2017-10-10 23:11:48.845133
NCT02478801|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-06-15|||March 2015||2015-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|EP||Protein Requirements in Endurance-trained Athlete|Evaluation of Protein Requirements in Male Endurance Athletes|Completed||Early Phase 1|9|Actual|University of Toronto||1|||f||||f||||||||||2017-10-10 23:11:48.94017|2017-10-10 23:11:48.94017
NCT02478788|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-01-17|||November 2015||2015-11-01|June 2015|2015-06-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|NERF||Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder|Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder|Recruiting||Phase 4|240|Anticipated|University of Cincinnati||4|||f||||t||||||||||2017-10-10 23:11:49.020653|2017-10-10 23:11:49.020653
NCT02478775|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-08-29|||July 2015||2015-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Interventional|||Dysregulation of FSH in Obesity: Functional and Statistical Analysis|Dysregulation of Follicle Stimulating Hormone (FSH) in Obesity: Functional and Statistical Analysis|Recruiting||N/A|68|Anticipated|University of Colorado, Denver||1|||f||||f||||||||||2017-10-10 23:11:49.145121|2017-10-10 23:11:49.145121
NCT02478762|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-12-22|||March 2015||2015-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Glycemic Objectives of Women With Gestational Diabetes Mellitus|Reevaluation of the Glycemic Objectives of Women With Gestational Diabetes Mellitus|Terminated||Phase 3|5|Actual|Université de Sherbrooke||2||very difficult recruitment|f||||f||||||||||2017-10-10 23:11:49.271039|2017-10-10 23:11:49.271039
NCT02478749|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-02-22|||May 2015||2015-05-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Influence of Arm Retraction on the Supraclavicular Approach for Subclavian Vein Catheterization|Influence of Arm Retraction on the Relative Position of Clavicle and the Subclavian Vein,During Supraclavicular Approach for Central Venous Catheterization in Adults and Children|Completed||N/A|60|Actual|Seoul National University Hospital||3|||f||||t||||||||||2017-10-10 23:11:49.372341|2017-10-10 23:11:49.372341
NCT02478736|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-12-19|||June 2015||2015-06-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Observational|||Preoperative Transcranial Doppler as a Predictor for Delirium Following On-pump Cardiac Surgery||Recruiting||N/A|175|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-10 23:11:49.46455|2017-10-10 23:11:49.46455
NCT02478710|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-09-23|||June 2015||2015-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AAINTVAP||Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia|Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia: A Pilot Study|Recruiting||Phase 4|50|Anticipated|Wright State University||2|||f||||t||||||||No||2017-10-10 23:11:49.635909|2017-10-10 23:11:49.635909
NCT02478684|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-11-02|||July 2015||2015-07-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|DCC||Delayed Cord Clamping in Preterm Neonates|The Effects of Delayed Cord Clamping on Postnatal Circulatory Status in Preterm Neonates|Recruiting||N/A|150|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||Undecided||2017-10-10 23:11:49.907054|2017-10-10 23:11:49.907054
NCT02478671|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-02-24|2015-11-30||June 2015||2015-06-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Magnetic Resonance Imaging (MRI) to Assess Radial Artery Compression and Arterial Perfusion While TR Band is Applied|Magnetic Resonance Imaging (MRI) to Assess Radial Artery Compression and Arterial Perfusion While TR Band is Applied|Completed||N/A|4|Actual|Terumo Medical Corporation|Single center study with small sample size.|1|||f||||f||||||||No||2017-10-10 23:11:50.020493|2017-10-10 23:11:50.020493
NCT02478658|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-10-19|||February 2015||2015-02-01|June 2015|2015-06-01||||October 2015|Actual|2015-10-01||Interventional|||Circulatory Levels of Irisin in Response to Acute Resistance Training|Circulatory Levels of Irisin in Response to Acute Resistance Training|Completed||N/A|28|Actual|Texas Tech University||2|||f||||||||||||||2017-10-10 23:11:50.194392|2017-10-10 23:11:50.194392
NCT02478645|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-01-24|||June 19, 2015|Actual|2015-06-19|January 2017|2017-01-01|February 6, 2016|Actual|2016-02-06|February 6, 2016|Actual|2016-02-06||Interventional|||Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery||Completed||Phase 4|177|Actual|Yonsei University||3|||f||||f||||||||||2017-10-10 23:11:50.263259|2017-10-10 23:11:50.263259
NCT02478619|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-05-18|||January 2015||2015-01-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|January 2016|Actual|2016-01-01||Interventional|||Preoperative Inspiratory Muscle Training in Gastroplasty|Effects of Preoperative Inspiratory Muscle Training in Patients Undergoing Gastroplasty|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:11:50.495839|2017-10-10 23:11:50.495839
NCT02478606|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-05-10|||July 2015||2015-07-01|June 2015|2015-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Passive Static Stretching and Proprioceptive Neuromuscular Facilitation in Musculoskeletal Aspects|Comparison of Four Weeks of Passive Static Stretching and Proprioceptive Neuromuscular Facilitation (PNF) in Musculoskeletal Aspects of the Hamstrings: a Randomized Controlled Trial|Completed||N/A|18|Actual|Federal University of Rio Grande do Sul||3|||f||||||||||||||2017-10-10 23:11:50.680492|2017-10-10 23:11:50.680492
NCT02478593|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-05-10|||June 2015||2015-06-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Impact of Patient Education on Benzodiazepine Use in the Elderly|Impact of Patient Education on Benzodiazepine Use in the Elderly|Active, not recruiting||N/A|500|Anticipated|University of Vermont||2|||f||||f||||||||||2017-10-10 23:11:50.762674|2017-10-10 23:11:50.762674
NCT02478580|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-02-22|2016-02-22||August 2011||2011-08-01|February 2015|2015-02-01|January 2016|Actual|2016-01-01|September 2013|Actual|2013-09-01||Interventional||Patient with obstructive sleep apnea undergoing surgery|Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients|The Effects of Armodafinil (Nuvigil) on Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients|Completed||Phase 3|96|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 23:11:50.853476|2017-10-10 23:11:50.853476
NCT02478567|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-05-14|||August 2012||2012-08-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||Exercise Training Sequence for Subacromial Impingement Syndrome|The Effect of Axioscapular and Rotator Cuff Exercise Training Sequence in Patients With Subacromial Impingement Syndrome: A Randomized Crossover Trial|Completed||N/A|40|Actual|University of Texas Southwestern Medical Center||2|||f||||||||||||||2017-10-10 23:11:51.095021|2017-10-10 23:11:51.095021
NCT02478554|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-22|||August 2015||2015-08-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|ADEPT||Antenatal Development Evaluated Prospectively|Customized Versus Population Fetal Growth Curves: A Randomized Controlled Pilot Trial|Unknown status|Not yet recruiting|N/A|1200|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:11:51.171034|2017-10-10 23:11:51.171034
NCT02478541|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-01-19|||March 2015||2015-03-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Understanding Liver Fat Metabolism: Studies to Understand the Role of Dietary Sugars on Liver Fat Metabolism|Investigating Intra-hepatic Fatty Acid Partitioning and Its Regulation in Man. Studies to Understand the Role of Dietary Nutrients in Liver Fat Metabolism in Relation to Obesity in Man|Completed||N/A|16|Actual|University of Oxford||2|||f||||f||||||||||2017-10-10 23:11:51.240594|2017-10-10 23:11:51.240594
NCT02478528|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-06-02|||May 2015||2015-05-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LUMI||Study of Effects of Light on the Vigilance and Cognitive Performance Following a Night Without Sleep|Study of Effects of Light on the Vigilance and Cognitive Performance Following a Night Without Sleep|Completed||N/A|18|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 23:11:51.318873|2017-10-10 23:11:51.318873
NCT02478515|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-10-19|||January 2014||2014-01-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion|Evaluation of Visual Acuity Improvement of a PRN Regimen Using Ranibizumab for Macular Edema Due to Ischemic and Non- Ischemic Branch Retinal Vein Occlusion.|Recruiting||Phase 4|30|Anticipated|Nagoya City University||1|||f||||f||||||||No||2017-10-10 23:11:51.392086|2017-10-10 23:11:51.392086
NCT02478502|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-06-19|||June 2015||2015-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer|Phase 2 Study Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell|Recruiting||Phase 2|29|Anticipated|University Hospital, Akershus||1|||f||||t||||||||||2017-10-10 23:11:51.484062|2017-10-10 23:11:51.484062
NCT02478489|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-02-24|||June 2016||2016-06-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|ADOPT||Alcohol Disorder hOsPital Treatment Trial|Oral v. Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism|Enrolling by invitation||Phase 4|260|Anticipated|Boston University||2|||f||||f||||||||Undecided||2017-10-10 23:11:51.590162|2017-10-10 23:11:51.590162
NCT02478476|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-18|||July 2015||2015-07-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||DNA Single Nucleotide Polymorphisms as Predictors of Toxicity|DNA Single Nucleotide Polymorphisms as Predictors of Platinum and Taxane Related Adverse Events in Ovarian, Fallopian Tube, and Peritoneal Cancer Patients|Not yet recruiting||N/A|75|Anticipated|OvaGene Oncology, Inc.|||1||f||||t||||||||||2017-10-10 23:11:51.691311|2017-10-10 23:11:51.691311
NCT02478463|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-08-10|||February 27, 2017|Actual|2017-02-27|August 2017|2017-08-01|August 7, 2018|Anticipated|2018-08-07|August 7, 2018|Anticipated|2018-08-07||Interventional|||Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers|A Phase 1, Multicompartmental Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers|Recruiting||Phase 1|16|Anticipated|ViiV Healthcare||1|||f||||f|t|f||||||||2017-10-10 23:11:51.797961|2017-10-10 23:11:51.797961
NCT02478450|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-09-19|||November 2018|Anticipated|2018-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)|A Phase 1/2a Open-Label Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS): Assessment of Localized Therapeutic Activity by Blinded Observation and Lateral Transplantation (ALTA-BOLT)|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Q Therapeutics, Inc.||6|||f||||t|t|f||||||||2017-10-10 23:11:51.9018|2017-10-10 23:11:51.9018
NCT02478437|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-09-21|||June 2015||2015-06-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|STU00097239||A Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves for theTreatment of Lumbar Facet Syndrome|A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves for the Treatment of Lumbar Facet Syndrome|Recruiting||Phase 3|40|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 23:11:51.987832|2017-10-10 23:11:51.987832
NCT02478424|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-22|||July 2015||2015-07-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease|Extended Use of Cannabidiol for the Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation|Unknown status|Not yet recruiting|Phase 2|10|Anticipated|Rabin Medical Center||1|||f||||||||||||||2017-10-10 23:11:52.088834|2017-10-10 23:11:52.088834
NCT02478411|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2016-02-18|||June 2015||2015-06-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Early Cycloergometric Physiotherapy in Critically Ill Patients With Invasive Mechanical Ventilation|Functional and Motor Effects of an Early Cycloergometric Physiotherapy Program in Critically Ill Patients With Invasive Mechanical Ventilation. A Randomized Controlled Trial|Recruiting||Phase 4|68|Anticipated|Hospital Son Llatzer||2|||f||||f||||||||||2017-10-10 23:11:52.177458|2017-10-10 23:11:52.177458
NCT02478385|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-10-11|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Birth Environment of the Future|Birth Environment of the Future - a Randomised Controlled Study|Recruiting||Phase 4|656|Anticipated|Herning Hospital||2|||f||||t||||||||||2017-10-10 23:11:52.500857|2017-10-10 23:11:52.500857
NCT02478372|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-10-20|2015-08-11||April 2010||2010-04-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|August 2011|Actual|2011-08-01||Interventional||Total number of patients recruited to each arm|Patient Controlled Epidural Analgesia Versus Local Infiltration Analgesia Following Knee Arthroplasty|Patient Controlled Epidural Analgesia Versus Local Infiltration Analgesia Following Knee Arthroplasty Within an Enhanced Recovery Programme - a Randomised Controlled Trial|Completed||N/A|242|Actual|Golden Jubilee National Hospital||2|||f||||f||||||||||2017-10-10 23:11:52.5997|2017-10-10 23:11:52.5997
NCT02478359|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-08-26|||June 2015||2015-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Walk On! Physical Activity Coaching|Patient-Centered Physical Activity Coaching in COPD: A Pragmatic Trial|Enrolling by invitation||N/A|2700|Anticipated|Kaiser Permanente||2|||f||||t||||||||||2017-10-10 23:11:53.091238|2017-10-10 23:11:53.091238
NCT02478346|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-02-13|||May 2015||2015-05-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|Fluoescein||Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions|Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions|Recruiting||Phase 4|200|Anticipated|Florida Hospital||1|||f||||f||||||||||2017-10-10 23:11:53.19689|2017-10-10 23:11:53.19689
NCT02478333|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-07-07|||May 2015||2015-05-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants|A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Subjects|Completed||Phase 1|24|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-10-10 23:11:53.273548|2017-10-10 23:11:53.273548
NCT02478320|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2017-08-25|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors|A Proof-of-Concept Study for Ilorasertib (ABT-348) Activity in Patients With CDKN2A-Deficient Advanced Solid Cancers: a Phase II Basket Trial|Recruiting||Phase 2|65|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:11:53.372015|2017-10-10 23:11:53.372015
NCT02478307|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-06-02|||May 2015||2015-05-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|||Coping Skills Training for Living With Chronic Low Back Pain|Mechanisms of Mindfulness Meditation, Cognitive Therapy, and Mindfulness-Based Cognitive Therapy for Low Back Pain|Recruiting||Phase 1/Phase 2|63|Anticipated|The University of Queensland||3|||f||||t||||||||||2017-10-10 23:11:53.456289|2017-10-10 23:11:53.456289
NCT02478294|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-06-19|||January 2013||2013-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|5A||LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke|Evaluation of Thoracoscopic Left Atrial Appendage Excision Plus Atrial Fibrillation Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke and Non-central Nervous Systemic Embolism in Patients With AF: 5A Pilot Cohort|Recruiting||N/A|300|Anticipated|The First Affiliated Hospital with Nanjing Medical University|||2||f||||f||||||Samples Without DNA|"     Serum and plasma   "|||2017-10-10 23:11:53.5576|2017-10-10 23:11:53.5576
NCT02478281|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-06-18|||October 2012||2012-10-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults|A One-Period, Single-Dose, Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Injection USP Following a 1 mg/kg Intravenous Dose in Healthy Adult Volunteers|Completed||Phase 1|12|Actual|Luitpold Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:11:53.654365|2017-10-10 23:11:53.654365
NCT02478268|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-08-10|||May 2015||2015-05-01|August 2017|2017-08-01||||April 2019|Anticipated|2019-04-01||Interventional|||Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis|Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis|Recruiting||Phase 1|79|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:11:53.745168|2017-10-10 23:11:53.745168
NCT02478255|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-08-10|||February 2016||2016-02-01|August 2017|2017-08-01||||August 2019|Anticipated|2019-08-01||Interventional|||Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment|Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment|Recruiting||Phase 1|35|Anticipated|Duke University||2|||f||||||||||||||2017-10-10 23:11:53.873357|2017-10-10 23:11:53.873357
NCT02478242|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-22|||July 2010||2010-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy||Completed||Phase 4|60|Actual|Kyungpook National University||2|||f||||t||||||||||2017-10-10 23:11:54.008013|2017-10-10 23:11:54.008013
NCT02478229|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-08-04|||June 2015||2015-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)|Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)|Terminated||Phase 3|1|Actual|University Health Network, Toronto||1||difficulty recruiting patients|f||||t||||||||||2017-10-10 23:11:54.125976|2017-10-10 23:11:54.125976
NCT02478216|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-06-18|||March 2015||2015-03-01|June 2015|2015-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Remote Ischemic Preconditioning on Postoperative Cognitive Dysfunction in Total Knee Replacement|The Effect of Remote Ischemic Preconditioning on Postoperative Cognitive Dysfunction in Total Knee Replacement|Recruiting||N/A|108|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||||2017-10-10 23:11:54.234232|2017-10-10 23:11:54.234232
NCT02478203|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-02-02|||March 2015||2015-03-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Intubation on a Paediatric Manikin by Emergency Staff: a Comparison of Airtraq and Glidescope|Intubation on a Pediatric Manikin by Emergency Medical Staff: a Comparison of Direct Laryngoscopy, Airtraq and Glidescope in Normal, Tongue Edema and Face-to-face Intubation Models|Completed||N/A|13|Actual|Kocaeli University||3|||f||||f||||||||||2017-10-10 23:11:54.343303|2017-10-10 23:11:54.343303
NCT02478190|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-09-25|||June 2015||2015-06-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||ED Management of Severe Hyperglycemia: A Clinical Trial|ED Management of Severe Hyperglycemia: An Open-Label Randomized Clinical Trial|Recruiting||N/A|90|Anticipated|Minneapolis Medical Research Foundation||2|||f||||f||||||||||2017-10-10 23:11:54.452415|2017-10-10 23:11:54.452415
NCT02478177|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-11-28|||September 2015||2015-09-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01|6 Months|Observational [Patient Registry]|ARAMIS||Addressing Real-world Anticoagulant Management Issues in Stroke|Management of Acute Stroke Patients on Treatment With Novel Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry|Enrolling by invitation||N/A|10000|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 23:11:54.554306|2017-10-10 23:11:54.554306
NCT02478164|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-08-09|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Interventional|||Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma|Phase II Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma|Active, not recruiting||Phase 2|17|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:11:54.636465|2017-10-10 23:11:54.636465
NCT02478151|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-04-18|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Using Ex-vivo Normothermic Machine Perfusion With the Organox Metra™ Device to Store Human Livers for Transplantation|A Single Centre Study of the Feasibility and Safety of Using Ex-vivo Normothermic Machine Perfusion With the Organox Metra™ Device to Store Human Livers for Transplantation|Recruiting||Phase 1|40|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:11:54.731998|2017-10-10 23:11:54.731998
NCT02478138|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-10-31|||May 2015||2015-05-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|SLN Mapping||Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging|Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging|Recruiting||N/A|30|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:11:54.829769|2017-10-10 23:11:54.829769
NCT02478125|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-28|||July 2015||2015-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer|A Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer|Active, not recruiting||Phase 1|23|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-10 23:11:54.927579|2017-10-10 23:11:54.927579
NCT02478112|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-01-11|||November 2016||2016-11-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|November 2017|Anticipated|2017-11-01||Interventional|BioPro-RCMI||Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI)|Multicentre Study Evaluating the Use of a Biodegradable Balloon for the Treatment of Prostate Cancer (of Intermediate Risk) by Intensity Modulated Conformal Radiotherapy (BioPro-RCMI)|Recruiting||N/A|50|Anticipated|Centre Oscar Lambret||1|||f||||t||||||||No||2017-10-10 23:11:55.039027|2017-10-10 23:11:55.039027
NCT02478099|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-12-19|||February 2016||2016-02-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||MPDL3280A-treatment-IST-UMCG|MPDL3280A Treatment in Patients With Locally Advance or Metastatic Non-small Cell Lung, Bladder and Triple Negative Breast Cancer After Investigational Imaging|Active, not recruiting||Phase 2|22|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-10 23:11:55.162477|2017-10-10 23:11:55.162477
NCT02478073|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-17|||June 2015||2015-06-01|June 2015|2015-06-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||Piperacillin Pharmacokinetics in ICU Patients|Piperacillin Pharmacokinetics in Intensive Care Unit Patients Following Standard Treatment With Intermittent and Continuous Infusion|Unknown status|Recruiting|N/A|50|Anticipated|University of Aarhus|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-10 23:11:55.34508|2017-10-10 23:11:55.34508
NCT02478060|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-11-07|||July 2015||2015-07-01|November 2016|2016-11-01||||July 2016|Actual|2016-07-01||Interventional|||Birch-SPIRE Safety and Efficacy Study|A Double-Blind, Randomised, Placebo-Controlled, Escalating, Multiple Dose Study in to Assess the Safety, Tolerability and Pharmacodynamic Effects of Birch-SPIRE|Completed||Phase 2|64|Actual|Circassia Limited||5|||f||||f||||||||||2017-10-10 23:11:55.413015|2017-10-10 23:11:55.413015
NCT02478047|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-06-22|||June 2015||2015-06-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting||Unknown status|Not yet recruiting|N/A|240|Anticipated|Tianjin University of Traditional Chinese Medicine||4|||f||||t||||||||||2017-10-10 23:11:55.490241|2017-10-10 23:11:55.490241
NCT02478034|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-03-04|||May 2015||2015-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|MR-STIM||Effects of Mineralocorticoid Receptor Stimulation on Cognition|Effekte Von Fludrocortison Auf Soziale Kognition Und Gedächtnis Unter Berücksichtigung Von Geschlechtereffekten|Completed||N/A|80|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:11:55.584019|2017-10-10 23:11:55.584019
NCT02478021|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-18|||September 2014||2014-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CORT-COG||Effects of Hydrocortisone on Social Cognition and Memory|Effekte Von Hydrocortison Auf Soziale Kognition Und Gedächtnis Unter Berücksichtigung Von Geschlechtereffekten|Completed||N/A|80|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:11:55.665808|2017-10-10 23:11:55.665808
NCT02478008|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-03-29|||June 2015||2015-06-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)|A Clinical Study of the CardiAQ™ Transcatheter Mitral Valve Implantation (TMVI) System (Transapical Delivery System)|Terminated||N/A|2|Actual|Edwards Lifesciences||1||"Edwards acquired CardiAQ and opted to terminate this study. 2 patients were enrolled and   follow-up is complete. No further enrollment or follow-up will occur."|f||||t||||||||||2017-10-10 23:11:55.730634|2017-10-10 23:11:55.730634
NCT02477995|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-22|||December 2013||2013-12-01|July 2011|2011-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants|Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy Infants 3 to 5 Months of Age: A Randomized, Blinded, Single-center, Positive Controlled Clinical Trial|Completed||Phase 3|1200|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-10 23:11:55.8238|2017-10-10 23:11:55.8238
NCT02477982|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2015-06-18|||December 2012||2012-12-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Observational|||Influence of Obesity on Propofol Pharmacokinetics During Cardiopulmonary Bypass|Influence of Obesity on Propofol Pharmacokinetics During Cardiac Surgeries Using Cardiopulmonary Bypass: Derivation of a Pharmacokinetic Model|Completed||N/A|34|Actual|Cairo University|||2||f||||t||||||||||2017-10-10 23:11:55.903209|2017-10-10 23:11:55.903209
NCT02477969|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2017-01-21|||February 27, 2014|Actual|2014-02-27|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 22, 2016|Actual|2016-06-22||Interventional|||Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating PEGylated Loxenatide Injection（PEX168）Combined With Metformin in the Treatment of Type 2 Diabetes Mellitus|Active, not recruiting||Phase 3|587|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||3|||f||||t||||||||No||2017-10-10 23:11:55.959172|2017-10-10 23:11:55.959172
NCT02477956|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-06-22|||November 2012||2012-11-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Effect of a Monthly High Dose of Vitamin D3 on Bariatric Surgery Patients|Impact of Monthly High Dose Oral Cholecalciferol on Serum 25 Hydroxy Vitamin D Levels in Bariatric Surgery Subjects|Completed||Phase 1|31|Actual|Texas Tech University||2|||f||||t||||||||||2017-10-10 23:11:56.061256|2017-10-10 23:11:56.061256
NCT02477943|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-09-28|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|February 2017|Actual|2017-02-01||Observational|AheadCAS||Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization|Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization|Completed||N/A|520|Actual|BrainScope Company, Inc.|||2||f||||f||||||||||2017-10-10 23:11:56.27957|2017-10-10 23:11:56.27957
NCT02476669|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-02-18|||June 2010||2010-06-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Serial Plasma EBV DNA for Nasopharyngeal Carcinoma|Serial Plasma EBV DNA for Patients With Nasopharyngeal Carcinoma|Recruiting||N/A|300|Anticipated|The University of Hong Kong|||1||f||||f||||||||||2017-10-10 23:12:14.580679|2017-10-10 23:12:14.580679
NCT02477930|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-19|2015-06-23|||November 2014||2014-11-01|June 2015|2015-06-01|July 2025|Anticipated|2025-07-01|January 2025|Anticipated|2025-01-01|6 Months|Observational [Patient Registry]|||Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations|Prospective Registry The Treatment Of Upper And Lower Intestinal Anastomotic Leaks And Perforations|Recruiting||N/A|100|Anticipated|Baylor Research Institute|||1||f||||t||||||||||2017-10-10 23:11:56.380349|2017-10-10 23:11:56.380349
NCT02477917|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-04-28|||May 2015||2015-05-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica|A Multicenter, Open Clinical Trial With Subcutaneous Immunotherapy in Depot in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica|Completed||Phase 1|51|Actual|Roxall Medicina España S.A||1|||f||||f||||||||||2017-10-10 23:11:56.472234|2017-10-10 23:11:56.472234
NCT02477904|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-02-28|||March 2015||2015-03-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Ketogenic Diet Therapy for Autism Spectrum Disorder|Ketogenic Diet Therapy for Autism Spectrum Disorder|Recruiting||N/A|150|Anticipated|Shriners Hospitals for Children||3|||f||||t||||||||Yes||2017-10-10 23:11:56.58124|2017-10-10 23:11:56.58124
NCT02477891|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-09-21||||||September 2017|2017-09-01||||||||Expanded Access|||Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma|An Open-Label Treatment Use Protocol for Daratumumab in Subjects With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor and an Immunomodulatory Agent) or Are Double Refractory to a Proteasome Inhibitor and an Immunomodulatory Agent|Available||N/A|||Janssen Research & Development, LLC|||||||||||||||||||2017-10-10 23:11:56.754441|2017-10-10 23:11:56.754441
NCT02477878|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-06-28|||July 2016||2016-07-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant|A Phase I/II Study of Donor BPX-501 T Cell Infusion for Adults With Recurrent or Minimal Residual Disease Hematologic Malignancies Post-Allogeneic Transplant|Recruiting||Phase 1|24|Anticipated|Bellicum Pharmaceuticals||1|||f||||f||||||||Undecided||2017-10-10 23:11:57.078973|2017-10-10 23:11:57.078973
NCT02477865|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-01-21|||March 23, 2014|Actual|2014-03-23|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|May 15, 2016|Actual|2016-05-15||Interventional|||Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IIIa Clinical Study Evaluating PEGylated Loxenatide Injection（PEX168）in Monotherapy of Type 2 Diabetes Mellitus|Active, not recruiting||Phase 3|406|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||3|||f||||f||||||||No||2017-10-10 23:11:57.211702|2017-10-10 23:11:57.211702
NCT02477852|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-23|2015-06-22|||April 2015||2015-04-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis|The Study of Standardized Preoperative Anti-tuberculosis Treatment of Surgical Treatment of Spinal Tuberculosis Patients|Recruiting||Phase 4|400|Anticipated|Beijing Chest Hospital||2|||f||||f||||||||||2017-10-10 23:11:57.304549|2017-10-10 23:11:57.304549
NCT02477839|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-09-28|||June 2015||2015-06-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to < 4 Years With Partial-onset Seizures|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy >=1 Month to <4 Years of Age With Partial-onset Seizures|Recruiting||Phase 3|244|Anticipated|UCB Pharma||2|||f||||t||||||||||2017-10-10 23:11:57.430215|2017-10-10 23:11:57.430215
NCT02477826|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-08-22|||August 2015||2015-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|January 2018|Anticipated|2018-01-01||Interventional|CheckMate 227||An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)|An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Subjects With Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 3|2220|Anticipated|Bristol-Myers Squibb||4|||f||||t||||||||||2017-10-10 23:11:57.808895|2017-10-10 23:11:57.808895
NCT02477813|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-09-28|||January 2015||2015-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|TeRes||Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation|Phase II Trial of Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation (TeRes). GOPAV03|Recruiting||Phase 2|19|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-10 23:11:59.196848|2017-10-10 23:11:59.196848
NCT02477800|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-10-01|||August 31, 2015|Actual|2015-08-31|October 2017|2017-10-01|March 5, 2022|Anticipated|2022-03-05|November 18, 2019|Anticipated|2019-11-18||Interventional|ENGAGE||221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease|Recruiting||Phase 3|1350|Anticipated|Biogen||2|||f||||t||||||||||2017-10-10 23:11:59.364537|2017-10-10 23:11:59.364537
NCT02477787|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-03-23|||June 2015||2015-06-01|March 2016|2016-03-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|DNKI-4||Randomized Study of Haploidentical Hct and Subsequent Donor nk Cell Infusion in High-risk AML and MDS|Randomized Comparative Study for Efficacy and Safety Evaluation of HLA-haploidentical Hematopoietic Cell Transplantation With or Without Post-transplant Allogeneic Donor-derived Natural Killer Cell Infusion in High-risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome|Recruiting||Phase 2|96|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-10 23:12:00.053057|2017-10-10 23:12:00.053057
NCT02477774|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-05-12|||July 2016||2016-07-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Arista for ALT Donor Sites to Reduce Drain Output|Multi-Institutional Randomized Controlled Trial Evaluating Use of Arista Absorbable Surgical Hemostatic Powder in Anterolateral Thigh Donor Sites|Not yet recruiting||N/A|50|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:12:00.194676|2017-10-10 23:12:00.194676
NCT02477761|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-22|||June 2015||2015-06-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Sustained Effects of a Non-glucidic Nutrient Preload on Glucose Tolerance in Type 2 Diabetes|Sustained Effects of a Non-glucidic Nutrient Preload on Glucose Tolerance in Type 2 Diabetes|Unknown status|Not yet recruiting|N/A|7|Anticipated|Azienda Ospedaliero, Universitaria Pisana||2|||f||||f||||||||||2017-10-10 23:12:00.255721|2017-10-10 23:12:00.255721
NCT02477748|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-01-18|||June 2015||2015-06-01|April 2016|2016-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD|A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Terminated||Phase 3|283|Actual|Alcobra Ltd.||2||FDA Clinical hold|f||||t||||||||No||2017-10-10 23:12:00.332715|2017-10-10 23:12:00.332715
NCT02477735|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-06-17|||June 2015||2015-06-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||The Effect of Tympanostomy Tube Insertion on Sleep in Children With Chronic Otitis Media With Effusion|The Effect of Tympanostomy Tube Insertion on Sleep in Children With Chronic Otitis Media With Effusion|Not yet recruiting||N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||f||||||||||2017-10-10 23:12:00.47713|2017-10-10 23:12:00.47713
NCT02477722|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2017-03-20|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|NFPES||Neurofeedback Prevention For Early Stress Related Adversity|Neurofeedback Preventive Intervention for PTSD: a Method to Strengthen Mental and Emotional Resilience|Recruiting||N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:12:00.554863|2017-10-10 23:12:00.554863
NCT02477709|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-04-17|2016-12-07||July 17, 2015|Actual|2015-07-17|April 2017|2017-04-01|August 21, 2015|Actual|2015-08-21|August 7, 2015|Actual|2015-08-07||Interventional|||A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|A Study to Assess the Tolerability of a Single Dose of AF-219, a P2X3 Receptor Antagonist, in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 2|6|Actual|Afferent Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:12:00.649417|2017-10-10 23:12:00.649417
NCT02477696|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-05-29|||June 2015||2015-06-01|May 2017|2017-05-01||||June 2019|Anticipated|2019-06-01||Interventional|||Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia|A Randomized, Multicenter, Open-Label, Non-Inferiority, Phase III Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia|Recruiting||Phase 3|500|Anticipated|Acerta Pharma BV||2|||f||||t||||||||||2017-10-10 23:12:00.86536|2017-10-10 23:12:00.86536
NCT02477683|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-12-19|||October 2015||2015-10-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Pilot Evaluation of the FilmArray® Febrile Infant (FI) Panel|Pilot Evaluation of the FilmArray® Febrile Infant (FI) Panel|Completed||N/A|1514|Actual|BioFire Diagnostics, LLC|||1||f||||||||||Samples With DNA|"     Plasma and Whole Blood   "|||2017-10-10 23:12:02.822531|2017-10-10 23:12:02.822531
NCT02477670|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-10-04|||September 2015|Actual|2015-09-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) as an Adjunctive Treatment for Patients With Residual Schizophrenia.|Completed||Phase 2|145|Actual|Avanir Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:12:02.888634|2017-10-10 23:12:02.888634
NCT02477657|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-09-23|||April 2015||2015-04-01|September 2016|2016-09-01||||April 2017|Anticipated|2017-04-01||Observational|||Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology|Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology|Recruiting||N/A|55|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-10 23:12:02.9899|2017-10-10 23:12:02.9899
NCT02477644|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2016-09-13|||May 2015||2015-05-01|September 2016|2016-09-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|PAOLA-1||Platine, Avastin and OLAparib in 1st Line|Randomized, Double-Blind, Phase III Trial Olaparib vs. Placebo Patients With Advanced FIGO Stage IIIB-IV High Grade Serious or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer Treated Standard First-Line Treatment|Recruiting||Phase 3|612|Anticipated|ARCAGY/ GINECO GROUP||2|||f||||t||||||||||2017-10-10 23:12:03.102466|2017-10-10 23:12:03.102466
NCT02477631|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-04-24|||February 2016||2016-02-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients|The Effect of Treatment With the Oral Iron Chelator Deferiprone on the Oxidative Stress of Blood Cells and on Iron Overload Status in Transfusion Dependent, Iron-overloaded Patients With Low Risk Myelodysplastic Syndrome|Recruiting||Phase 2|20|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:12:04.005262|2017-10-10 23:12:04.005262
NCT02477618|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-09-08|||June 2015||2015-06-01|September 2017|2017-09-01|August 11, 2017|Actual|2017-08-11|July 18, 2017|Actual|2017-07-18||Interventional|||A Study With SAGE-547 for Super-Refractory Status Epilepticus|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status Epilepticus|Completed||Phase 3|132|Actual|Sage Therapeutics||2|||f||||t||||||||||2017-10-10 23:12:04.140397|2017-10-10 23:12:04.140397
NCT02477605|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-06-28|2017-05-30||July 16, 2015|Actual|2015-07-16|June 2017|2017-06-01|August 31, 2016|Actual|2016-08-31|June 1, 2016|Actual|2016-06-01||Interventional||This analysis population includes all randomized subjects (Intent-to-Treat Analysis Set).|Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes|Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes|Completed||N/A|137|Actual|Alcon Research||2|||f||||f|f|t|f|f|f|||||2017-10-10 23:12:04.667821|2017-10-10 23:12:04.667821
NCT02477592|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-17|||January 2015||2015-01-01|January 2015|2015-01-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||a Novel Individualized Substrate Modification Approach for the Treatment of Long-standing Persistent Atrial Fibrillation|A Prospective Randomized Study of a Novel Individualized Substrate Modification Approach Versus Stepwise Ablation for the Treatment of Long-standing Persistent Atrial Fibrillation|Unknown status|Recruiting|N/A|220|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-10 23:12:05.251966|2017-10-10 23:12:05.251966
NCT02477579|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-08-14|||May 17, 2015|Actual|2015-05-17|August 2017|2017-08-01|August 10, 2017|Actual|2017-08-10|August 10, 2017|Actual|2017-08-10||Interventional|||A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions|A Prospective, Multi-Center, Non-randomized, Single Arm, Open Label, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions|Completed||N/A|145|Actual|Nitiloop Ltd.||1|||f||||t||||||||||2017-10-10 23:12:05.370813|2017-10-10 23:12:05.370813
NCT02477566|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-22|||December 2014||2014-12-01|June 2015|2015-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI|Comparative Study of Long-acting and Short Acting Triptorelin on Pituitary Down-regulation in Long Protocol in PCOS Patients Who Underwent IVF/ICSI Treatment|Unknown status|Recruiting|N/A|200|Anticipated|Nanjing University||2|||f||||||||||||||2017-10-10 23:12:05.470276|2017-10-10 23:12:05.470276
NCT02477553|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-09-27|||June 2015||2015-06-01|September 2017|2017-09-01|August 25, 2017|Actual|2017-08-25|August 25, 2017|Actual|2017-08-25||Interventional|INFORM||Information With or Without Numbers For Optimizing Reasoning About Medical Decisions|Describing the Comparative Effectiveness of Colorectal Cancer Screening Tests: The Impact of Quantitative Information|Completed||N/A|728|Actual|Indiana University||2|||f||||f||||||||||2017-10-10 23:12:05.558817|2017-10-10 23:12:05.558817
NCT02477540|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-04-03|||July 2017|Anticipated|2017-07-01|June 2015|2015-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia|An Open Labeled, Single-center, Phase I Study Assessing the Safety and Efficacy of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia|Not yet recruiting||Phase 1|10|Anticipated|Pharmicell Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 23:12:05.651172|2017-10-10 23:12:05.651172
NCT02477527|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-06-30|2017-03-24||February 2015||2015-02-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Atripla to Stribild Switch Study to Evaluate Sleep Disturbances|Switching From Atripla to Stribild Leads to Improvements in Central Nervous System Side Effects and Sleep Disturbances|Completed||Phase 4|21|Actual|Midtown Medical Center, Tampa, FL||1|||f||||f||||||||||2017-10-10 23:12:05.734224|2017-10-10 23:12:05.734224
NCT02477514|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-08-21|||June 2015||2015-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004)|A Multiple-Dose Study to Evaluate the Effects of Steady-State Tedizolid Phosphate Administration on the Pharmacokinetics and Safety of a Single Dose of Midazolam and Rosuvastatin|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 23:12:05.975562|2017-10-10 23:12:05.975562
NCT02477501|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-08-28|||January 2016||2016-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Ephedrine vs. Nor Epinephrine Infusion in Preventing Hypotension After Spinal Anesthesia for Cesarean Section|Ephedrine vs. Nor-epinephrine Infusion in Preventing Hypotension After Spinal Anesthesia for Cesarean Section|Recruiting||Phase 4|120|Anticipated|University Tunis El Manar||2|||f||||f||||||||Undecided||2017-10-10 23:12:06.05157|2017-10-10 23:12:06.05157
NCT02477488|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-09-12|||June 2015||2015-06-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Optimal Administration of Allopurinol in Dialysis Patients|Optimal Administration of Allopurinol in Dialysis Patients : A Chronotherapy Trial|Completed||Phase 4|50|Actual|Maisonneuve-Rosemont Hospital||1|||f||||t||||||||||2017-10-10 23:12:06.147535|2017-10-10 23:12:06.147535
NCT02477475|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2017-06-20|||July 7, 2015|Actual|2015-07-07|June 2017|2017-06-01|February 20, 2017|Actual|2017-02-20|February 20, 2017|Actual|2017-02-20||Observational|||Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes|NEXIUM Capsule Specific Clinical Experience Investigation (S-CEI) to Investigate Treatment Response to NEXIUM in Patients With Reflux Esophagitis (RE) - Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes|Completed||N/A|1595|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:12:06.23866|2017-10-10 23:12:06.23866
NCT02477462|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-02-13|||May 2015||2015-05-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01|2 Years|Observational [Patient Registry]|||Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients|Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients|Recruiting||N/A|200|Anticipated|University of California, Davis|||2||f||||t||||||Samples With DNA|"     Biospecimens will include serum, plasma, DNA, and RNA. In 20 subjects liver biopsies will be     performed and retained.   "|||2017-10-10 23:12:06.508405|2017-10-10 23:12:06.508405
NCT02477449|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-19|||May 2015||2015-05-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers|A Phase I Dose Escalating Study Evaluating the Pharmacokinetics, Tolerability and Safety of Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers|Unknown status|Recruiting|Phase 1|32|Anticipated|Lee's Pharmaceutical Limited||3|||f||||||||||||||2017-10-10 23:12:06.615824|2017-10-10 23:12:06.615824
NCT02477436|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-23|||February 2008||2008-02-01|June 2015|2015-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction|A Randomized, Placebo Controlled, Double Blind, Multicenter Therapeutic Exploratory Clinical Study for the Evaluation of the Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction|Completed||Phase 2|159|Actual|Pusan National University Hospital||4|||f||||t||||||||||2017-10-10 23:12:06.701444|2017-10-10 23:12:06.701444
NCT02477423|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-07-11|||July 2015||2015-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Antibiotic Stewardship and Protection of the Developing Preterm Infant Microbiome|Antibiotic Stewardship and Protection of the Developing Preterm Infant Microbiome|Recruiting||N/A|80|Anticipated|University of Chicago||3|||f||||t||||||||||2017-10-10 23:12:06.817526|2017-10-10 23:12:06.817526
NCT02477410|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-01-10|||July 2015||2015-07-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SEPA||Effects of Hydrolysed Porcine Proteins on Muscle Protein Synthesis and Appetite|Effects of Hydrolysed Porcine Proteins on Muscle Protein Synthesis and Appetite|Completed||N/A|21|Actual|University of Copenhagen||3|||f||||f||||||||No||2017-10-10 23:12:06.930309|2017-10-10 23:12:06.930309
NCT02477397|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-19|||May 2015||2015-05-01|June 2015|2015-06-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD|Effectiveness of Single Inhaler Maintenance and Reliever Therapy With Spiromax® Budesonide/Formoterol (SMART) Versus Fixed Dose Treatment With Diskus® Fluticasone/Salmeterol in Patients With a Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 3|260|Anticipated|University Medical Center Groningen||2|||f||||t||||||||||2017-10-10 23:12:07.019639|2017-10-10 23:12:07.019639
NCT02477384|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-05-26|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding|Randomised Trial of 8mm Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Variceal Ligation Plus Propranolol for Prevention of Variceal Rebleeding|Recruiting||N/A|100|Anticipated|West China Hospital||2|||f||||f||||||||||2017-10-10 23:12:07.127726|2017-10-10 23:12:07.127726
NCT02477371|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-06-23|||June 2014||2014-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|FARGO||Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial|Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial|Unknown status|Recruiting|Phase 4|168|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:12:07.222698|2017-10-10 23:12:07.222698
NCT02477345|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-04-13|||August 2012||2012-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Compassionate Use of Omegaven IV Fat Emulsion|Compassionate Use of Omegaven IV Fat Emulsion|Recruiting||N/A|200|Anticipated|Northwell Health||1|||f||||f||||||||No||2017-10-10 23:12:07.408304|2017-10-10 23:12:07.408304
NCT02477332|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-08-02|||July 15, 2015|Actual|2015-07-15|August 2017|2017-08-01|June 12, 2017|Actual|2017-06-12|June 12, 2017|Actual|2017-06-12||Interventional|||Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU|A Multi-center, Randomized, Double-blind, Placebo, and Active-controlled Phase 2b Dose-finding Study of QGE031 as add-on Therapy to Investigate the Efficacy and Safety in Patients With Chronic Spontaneous Urticaria (CSU)|Completed||Phase 2|382|Actual|Novartis||6|||f||||f||||||||||2017-10-10 23:12:07.515527|2017-10-10 23:12:07.515527
NCT02477319|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-04-05|||June 2015||2015-06-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|PROSPECT||A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)|A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)|Active, not recruiting||N/A|100|Anticipated|University of Alabama at Birmingham|||2||f||||f||||||||||2017-10-10 23:12:07.808928|2017-10-10 23:12:07.808928
NCT02477306|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-17|||March 2014||2014-03-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)|Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)|Completed||Phase 1|60|Actual|Genuine Research Center, Egypt||1|||f||||f||||||||||2017-10-10 23:12:07.950891|2017-10-10 23:12:07.950891
NCT02477293|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-12-28|||August 2015||2015-08-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine|The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine|Completed||Phase 4|40|Actual|Kyung Hee University Hospital at Gangdong||1|||f||||t||||||||||2017-10-10 23:12:08.039082|2017-10-10 23:12:08.039082
NCT02477280|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-11-24|||November 2015||2015-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance|Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the Quantified Behavior Test in Patients With Untreated ADHD and Substance Use Disorder|Recruiting||Phase 4|40|Anticipated|Landstinget Västmanland||2|||f||||t||||||||||2017-10-10 23:12:08.131868|2017-10-10 23:12:08.131868
NCT02477267|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-18|2015-09-01|||June 2015||2015-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers|A Pivotal, Phase 1, Open-Label, Randomized, Crossover, Single-Dose, Comparative Bioavailability Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers|Completed||Phase 1|47|Actual|INSYS Therapeutics Inc||2|||f||||f||||||||||2017-10-10 23:12:08.256054|2017-10-10 23:12:08.256054
NCT02477254|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-10-17|||July 2015||2015-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Observational|||Long-term Immunogenicity of a HPV Vaccine in SLE|Long-term Immunogenicity of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With Systemic Lupus Erythematosus: a Case-control Study|Completed||N/A|84|Actual|Tuen Mun Hospital|||2||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-10 23:12:08.342297|2017-10-10 23:12:08.342297
NCT02477241|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-06-19|||September 2015||2015-09-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Brain Areas Involved in Bladder Filling and Contraction|Study of Brain Areas Involved in the Sensation of Bladder Filling in Healthy Females and Untreated Females With Overactive Bladder (OAB) Using fMRI and Water Pressure Urodynamics|Not yet recruiting||N/A|48|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-10 23:12:08.41267|2017-10-10 23:12:08.41267
NCT02477228|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2015-06-17|||January 2014||2014-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ERCP||Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography: Precut Versus Conventional Cannulation|Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography: Precut Versus Conventional Cannulation. A Prospective Randomized Study|Completed||N/A|100|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:12:08.488188|2017-10-10 23:12:08.488188
NCT02477215|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-06-07|||October 2015||2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma|Phase I/II Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|26|Anticipated|Medical College of Wisconsin||1|||f||||t|t|f||||||||2017-10-10 23:12:08.675962|2017-10-10 23:12:08.675962
NCT02477202|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-06-14|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation|Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation|Recruiting||N/A|28|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:12:08.790712|2017-10-10 23:12:08.790712
NCT02477189|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-06-19|||April 2015||2015-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Retrospective Analysis of the Safety and Effectiveness of Using the Silicone Block in Penile Surgery|Retrospective Analysis of the Safety and Effectiveness of Using the Silicone Block in Penile Surgery|Completed||N/A|400|Actual|International Medical Devices, Inc.|||1||f||||t||||||||||2017-10-10 23:12:08.924178|2017-10-10 23:12:08.924178
NCT02477176|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-08-15|||February 17, 2016|Actual|2016-02-17|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Lumbar Discectomy Control Study, Risk Factors for Reherniation|A Prospective, Multicenter Study Investigating Reherniation Risk Factors and Associated Costs in Primary Lumbar Disc Herniation Patients|Recruiting||N/A|100|Anticipated|Intrinsic Therapeutics|||2||f||||t|f|f||||||||2017-10-10 23:12:09.01729|2017-10-10 23:12:09.01729
NCT02477163|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-12-13|||January 2014||2014-01-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Ayurvedic Management of Chronic Kidney Disease|An Observational Clinical Study to Determine the Effect of Multi-modal Ayurvedic Treatment in the Patients of Chronic Kidney Disease|Recruiting||N/A|500|Anticipated|J.S. Ayurveda College|||1||f||||t||||||||||2017-10-10 23:12:09.139328|2017-10-10 23:12:09.139328
NCT02477137|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-07-31|||July 20, 2015|Actual|2015-07-20|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|PhONEME||Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer|PhONEME - PartipatOn Ehealth MobilE. Effects of an Interactive Information and Communications Technology (ICT) Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer|Active, not recruiting||N/A|150|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:12:09.296734|2017-10-10 23:12:09.296734
NCT02477124|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-04-26|||September 2015||2015-09-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A See and Treat Paradigm for Cervical Pre-cancer|A See and Treat Paradigm for Cervical Pre-cancer|Recruiting||N/A|200|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 23:12:09.381384|2017-10-10 23:12:09.381384
NCT02477111|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2016-11-16|||March 2015||2015-03-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|October 2016|Actual|2016-10-01||Observational|INSIGHT||European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms|A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT® Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects With Abdominal Aortic Aneurysms|Active, not recruiting||N/A|150|Anticipated|Cordis Corporation|||1||f||||f||||||||Undecided||2017-10-10 23:12:09.476081|2017-10-10 23:12:09.476081
NCT02477098|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-06-17|||October 2015||2015-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Preoperative Versus Postoperative Ultrasound-guided Rectus Sheath Block for Sleep Quality and Cytokines of Patients|Preoperative Versus Postoperative Ultrasound-guided Rectus Sheath Block for Improving Pain, Sleep Quality and Cytokine Levels of Patients With Open Midline Incisions Undergoing Transabdominal Gynaecological Operation|Completed||Phase 4|77|Actual|China Medical University, China||2|||f||||t||||||||||2017-10-10 23:12:09.551903|2017-10-10 23:12:09.551903
NCT02477085|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-01-10|||November 2015||2015-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Observational|MEDIP||Methods of Labor Induction and Perinatal Outcomes|Methods of Labor Induction and Perinatal Outcomes : a Prospective National Study in France|Completed||N/A|3049|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:12:09.63538|2017-10-10 23:12:09.63538
NCT02477072|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-01-11|||September 2015||2015-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Optimized Heparin Regimen in Vascular Surgery|A Pilot Study on the Influence of an Optimized Heparin Regimen on the Hemostatic Environment Downstream From the Surgical Clamp in Major Vascular Surgery.|Completed||N/A|32|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||3|||f||||f||||||||||2017-10-10 23:12:09.710127|2017-10-10 23:12:09.710127
NCT02477059|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-09-04|||November 20, 2015|Actual|2015-11-20|August 2017|2017-08-01|February 20, 2019|Anticipated|2019-02-20|January 5, 2019|Anticipated|2019-01-05||Interventional|TIDOA||Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis|Double-blind, Randomized, Placebo-controlled Trial Evaluating the Effect of Two Infusions Four Weeks Apart of Interleukin-6-Receptor Inhibitor (Tocilizumab) on Pain Relief in Patients With Severe Osteoarthritis of the Hand Refractory to Usual Treatment|Recruiting||Phase 3|110|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:12:09.826214|2017-10-10 23:12:09.826214
NCT02477033|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-17|||February 2014||2014-02-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional|||Impact of Butyricicoccus Pullicaecorum in Healthy Subjects|A Placebo-controlled Cross-over Randomized Study to Investigate the Impact of Butyricicoccus Pullicaecorum in Healthy Human Volunteers|Completed||Phase 1|30|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-10 23:12:10.071754|2017-10-10 23:12:10.071754
NCT02477020|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-09-03|2017-07-12|2016-11-29|July 1, 2015|Actual|2015-07-01|September 2017|2017-09-01|July 27, 2016|Actual|2016-07-27|July 13, 2016|Actual|2016-07-13||Interventional||All randomized participants who received at least 1 dose of study drug.|A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, 6-Week Study to Evaluate the Efficacy and Safety of TAK-063 in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 2|164|Actual|Takeda||2|||f||||f|t|f||||||||2017-10-10 23:12:10.195166|2017-10-10 23:12:10.195166
NCT02477007|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-07-31|||December 2015||2015-12-01|July 2016|2016-07-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|MORPHAPAIN||Analgesic Efficacy of Morphine Alone or Combined With Paracetamol and/or Ibuprofen for Long-bones Fractures in Children|Phase III Clinical Trial Studying Analgesic Efficacy of Morphine Alone or Combined With Paracetamol and/or Ibuprofen for Long-bones Fractures in Children|Recruiting||Phase 3|304|Anticipated|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||No||2017-10-10 23:12:11.859576|2017-10-10 23:12:11.859576
NCT02476994|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-03-02||2017-02-02|May 2015|Actual|2015-05-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion|A Randomized, Double-Blind, Controlled, Clinical Trial to Evaluate the Risk of Developing Essential Fatty Acid Deficiency in Pediatric Patients, Including Neonates, Receiving Either Clinolipid (Lipid Injectable Emulsion, USP) 20% or Standard-of-Care Soybean Oil-Based Lipid Emulsion|Terminated||Phase 4|1|Actual|Baxter Healthcare Corporation||2|||f||||t||||||||||2017-10-10 23:12:12.00603|2017-10-10 23:12:12.00603
NCT02476981|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-22|||August 2012||2012-08-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Comparison of Remifentanil and Dexmedetomidine for Monitored Anaesthesia Care During Vertebroplasty and Kyphoplasty|Comparison of Remifentanil and Dexmedetomidine for Monitored Anaesthesia Care|Completed||N/A|75|Actual|Hallym University Medical Center||5|||f||||f||||||||||2017-10-10 23:12:12.116871|2017-10-10 23:12:12.116871
NCT02476968|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-10-04|||September 28, 2015|Actual|2015-09-28|October 2017|2017-10-01|June 3, 2019|Anticipated|2019-06-03|June 3, 2019|Anticipated|2019-06-03||Interventional|ORZORA||To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer|An Open Label, Single Arm, Multicentre Study to Assess the Clinical Effectiveness and Safety of Lynparza (Olaparib) Capsules Maintenance Monotherapy in Platinum Sensitive Relapsed Somatic or Germline BRCA Mutated Ovarian Cancer Patients Who Are in Complete or Partial Response Following Platinum Based Chemotherapy (ORZORA).|Recruiting||Phase 4|275|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:12:12.223572|2017-10-10 23:12:12.223572
NCT02476942|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-26|||May 26, 2015|Actual|2015-05-26|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|||A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment|A Multicenter, Non-Interventional Study Evaluating Bleeding Incidence, Health-Related Quality of Life, and Safety in Patients With Hemophilia A Under Standard-of-Care Treatment|Completed||N/A|221|Actual|Hoffmann-La Roche|||3||f||||||||||||||2017-10-10 23:12:12.573823|2017-10-10 23:12:12.573823
NCT02476929|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-07-14|||January 2013||2013-01-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|EPONA||Detection and Use of Nasal Nitrous Oxide and the Electronic Nose|AssEssment and New Perspectives on Pathophysiogenesis, detectiOn and Use of NAsal Nitrous Oxide and the Electronic Nose (EPONA Project)|Active, not recruiting||N/A|139|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||Undecided||2017-10-10 23:12:12.728517|2017-10-10 23:12:12.728517
NCT02476916|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-06-27|||June 2015||2015-06-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 8, 2017|Actual|2017-05-08||Interventional|||A Study of AG-348 in Adult Patients With Pyruvate Kinase Deficiency|A Phase 2, Open Label, Randomized, Dose Ranging, Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of AG-348 in Adult Patients With Pyruvate Kinase Deficiency|Active, not recruiting||Phase 2|52|Actual|Agios Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 23:12:12.840973|2017-10-10 23:12:12.840973
NCT02476903|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-19|||June 2015||2015-06-01|June 2015|2015-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Viscosupplementation in the Hip Following Hip Arthroscopy|Viscosupplementation in the Hip Following Hip Arthroscopy|Unknown status|Not yet recruiting|N/A|||Rothman Institute Orthopaedics|||||f||||||||||||||2017-10-10 23:12:12.946232|2017-10-10 23:12:12.946232
NCT02476890|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-04-17|||October 28, 2015|Actual|2015-10-28|April 2017|2017-04-01|October 20, 2016|Actual|2016-10-20|October 20, 2016|Actual|2016-10-20||Interventional|||Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (Cough Challenge)|A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects|Completed||Phase 2|36|Actual|Afferent Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:12:13.016236|2017-10-10 23:12:13.016236
NCT02476877|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-01-23|||June 2014||2014-06-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse|A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse|Completed||N/A|75|Actual|Advanced Clinical Laboratory Solutions, Inc.|||2||f||||t||||||Samples With DNA|"     Each subject will be asked to provide a urine sample (minimum of 5 mL). If a subject cannot     provide a urine sample, a sample of oral fluids (1 mL) will be obtained.   "|||2017-10-10 23:12:13.09159|2017-10-10 23:12:13.09159
NCT02476864|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-04-21|||August 2015||2015-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy Adults|Single-center, Open-label, Randomized, Two-treatment, Single-dose, Crossover Study in Healthy Subjects to Investigate the Biocomparison of the Adult and Pediatric Formulation of Macitentan|Completed||Phase 1|12|Actual|Actelion||2|||f||||f||||||||||2017-10-10 23:12:13.160209|2017-10-10 23:12:13.160209
NCT02476851|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-02-18|||June 2015||2015-06-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder|Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder|Completed||N/A|62|Actual|Haemonetics Corporation||1|||f||||f||||||||||2017-10-10 23:12:13.23399|2017-10-10 23:12:13.23399
NCT02476825|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-09-29|||August 2015||2015-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2017|Actual|2017-09-01||Interventional|||A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy Volunteers|A Randomized, Open-labelled Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids (ICS) on Adult Healthy Volunteers|Active, not recruiting||Phase 4|30|Actual|University Hospitals, Leicester||2|||f||||f||||||||||2017-10-10 23:12:13.386528|2017-10-10 23:12:13.386528
NCT02476812|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-05-02|||June 2015||2015-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The Positive Piggy Bank - A Positive Activities Intervention for Improving Functional Status in Patients With Back Pain||Recruiting||N/A|200|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 23:12:13.467631|2017-10-10 23:12:13.467631
NCT02476799|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-18|||November 2014||2014-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Analgesic Effects of US Bilateral Rectus Sheath Block for Laparoscopic GY Surgery|Postoperative Analgesic Effects of Ultrasound-guided Bilateral Rectus Sheath Block for Laparoscopic Gynecologic Surgery|Completed||N/A|60|Actual|Ewha Womans University Mokdong Hospital||2|||f||||f||||||||||2017-10-10 23:12:13.555732|2017-10-10 23:12:13.555732
NCT02476786|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-06-22|||January 17, 2017|Actual|2017-01-17|June 2017|2017-06-01|July 31, 2023|Anticipated|2023-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score|Endocrine Treatment Alone as Primary Treatment for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score|Recruiting||Phase 2|50|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||No||2017-10-10 23:12:13.648215|2017-10-10 23:12:13.648215
NCT02476773|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-07-11|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|June 2017|Actual|2017-06-01||Interventional|||Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults|Phase 1 Study of the Safety and Immunogenicity of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel® in Brazilian Adults|Active, not recruiting||Phase 1|60|Actual|Baylor College of Medicine||6|||f||||f||||||||||2017-10-10 23:12:13.770471|2017-10-10 23:12:13.770471
NCT02476760|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2016-11-01|||March 2014||2014-03-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Incretin-based Drugs and Acute Pancreatitis|The Use of Incretin-based Drugs and the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes|Completed||N/A|1417914|Actual|Canadian Network for Observational Drug Effect Studies, CNODES|||5||f||||f||||||||||2017-10-10 23:12:13.877944|2017-10-10 23:12:13.877944
NCT02476747|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Cold Snare Polypectomy Versus. Endoscopic Mucosal Resection|Comparison of Efficacy Between Cold Snare Polypectomy and Endoscopic Mucosal Resection in Treatment of Small Polyp|Unknown status|Recruiting|N/A|103|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-10 23:12:14.027574|2017-10-10 23:12:14.027574
NCT02476734|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-09-21|||August 2014||2014-08-01|September 2016|2016-09-01||||February 2016|Actual|2016-02-01||Interventional|||FDG-PET/CT Imaging as Early Predictor of DP|A Pilot Study Using FDG-PET/CT Imaging as an Early Predictor of Disease Response in Lymphoma Subjects Receiving Redirected Autologous CART- 19 T-cell Immunotherapy|Active, not recruiting||Early Phase 1|9|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:12:14.122319|2017-10-10 23:12:14.122319
NCT02476721|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-18|||March 2014||2014-03-01|June 2015|2015-06-01||||March 2015|Actual|2015-03-01||Observational|||Characteristics of Patients With Missed Pulmonary Embolism in the ED: A Three Year Experience|Characteristics of Patients With Missed Pulmonary Embolism in the ED: A Three Year Experience|Completed||N/A|1251|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-10 23:12:14.188256|2017-10-10 23:12:14.188256
NCT02476708|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-06-26|||February 2016||2016-02-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CRC||A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia|A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia|Recruiting||N/A|40|Anticipated|Yale University||2|||f||||f||||||||Yes|All de-identified data resulting from this award involving human subjects will be submitted to the NIMH Data Archive (NDA) - National Database for Clinical Trials Related to Mental Illness (NDCT) The Principal Investigator will work with NDA support staff to plan an appropriate data submission schedule and provide information on the steps for submission and sharing of data. Communication of this data sharing plan to appropriate research staff to ensure the timely submission of data. All human subject data provided will include an NDA Global Unique Identifier (GUID) and will not include personally identifiable information (PII). Analyzed data will be submitted no later than the time of publication. Even if a publication focuses on only part of an analyzed dataset, the entire analyzed dataset will be submitted when the first paper is published. All data made available for public use via NDA will be de-identified data.|2017-10-10 23:12:14.244268|2017-10-10 23:12:14.244268
NCT02476695|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-06-16|||May 2014||2014-05-01|June 2015|2015-06-01||||September 2015|Anticipated|2015-09-01||Observational|||FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis|Research on FibroTouch Noninvasive Evaluation of Liver Fibrosis and Cirrhosis|Unknown status|Recruiting|N/A|600|Anticipated|Wuxi Hisky Medical Technology Co Ltd|||4||f||||||||||||||2017-10-10 23:12:14.352908|2017-10-10 23:12:14.352908
NCT02476682|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-12-15|||July 2016||2016-07-01|December 2015|2015-12-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Observational|FIT||Non-invasive Risk Stratification of CR AMN/SSP|Evaluation of Stool and Blood Based Tests for Colorectal Advanced Mucosal Neoplasia|Not yet recruiting||N/A|1725|Anticipated|Western Sydney Local Health District|||6||f||||f||||||Samples With DNA|"     2mg of stool per patient 18mL of blood per patient   "|||2017-10-10 23:12:14.500856|2017-10-10 23:12:14.500856
NCT02476643|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-05-22|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|InteGast||Integrative Gastroenterology - an Observational Trial|Integrative Therapy in Gastroenterology - a Prospective Observational Trial in a Department of Internal and Integrative Medicine|Active, not recruiting||N/A|200|Anticipated|Universität Duisburg-Essen|||1||f||||f||||||||||2017-10-10 23:12:14.708696|2017-10-10 23:12:14.708696
NCT02476630|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-12-13|||July 2015||2015-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Thenar Tissue Oxygen Concentration (StO2): A Non-invasive Surrogate for Central Venous Oxygen Saturation (ScvO2)|Thenar Tissue Oxygen Concentration (StO2): A Non-invasive Surrogate for Central Venous Oxygen Saturation (ScvO2)|Recruiting||N/A|100|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-10 23:12:14.781775|2017-10-10 23:12:14.781775
NCT02476617|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-09-05|2017-08-03||June 2015||2015-06-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional||Safety and demographic analyses were performed on safety population, which is the same as the ITT population.|Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults|An Exploratory Study to Evaluate Immune Restoration Following Removal of Viral Antigen in Treatment-Naïve and Treatment-Experienced Adults With Genotype (GT) 1a Chronic Hepatitis C Virus (HCV) Infection Administered Ombitasvir/ ABT-450/Ritonavir With Dasabuvir and Ribavirin (RBV) for 12 Weeks|Completed||Phase 3|25|Actual|AbbVie||1|||f||||f|t|f||||||||2017-10-10 23:12:14.983574|2017-10-10 23:12:14.983574
NCT02476604|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-05-17|||January 2012||2012-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SHU-PEP||Seton Hill University--Personal Empowerment Program|Seton Hill University--Personal Empowerment Program|Completed||N/A|70|Actual|Walter Reed National Military Medical Center||2|||f||||f||||||||||2017-10-10 23:12:15.547992|2017-10-10 23:12:15.547992
NCT02476591|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-05-08|||November 2, 2015|Actual|2015-11-02|May 2017|2017-05-01|October 3, 2016|Actual|2016-10-03|October 3, 2016|Actual|2016-10-03||Observational|PRICE||Charge Transparency in Critical Care Practice and Its Effects on Overall Cost of Care|Charge Transparency in Critical Care Practice and Its Effects on Overall Cost of Care: Physician Awareness of ICU Charge Environment: The PRICE Study|Completed||N/A|10720|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||||2017-10-10 23:12:15.65598|2017-10-10 23:12:15.65598
NCT02476578|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-12-03|||October 2015||2015-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|LIMIT||Low Indexes of Metabolism - Information to Teams (LIMIT)|Sending Advisory Electronic Mail to Primary Care Staff, Addressing Low Metabolic Measures: Assessing the Health Outcomes for Patients Above Age 75|Completed||N/A|8584|Actual|Clalit Health Services||2|||f||||f||||||||Yes||2017-10-10 23:12:15.733179|2017-10-10 23:12:15.733179
NCT02476565|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-11-17|||September 2014||2014-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme|Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme|Completed||N/A|11|Actual|Vanderbilt University||2|||f||||f||||||||No||2017-10-10 23:12:15.814895|2017-10-10 23:12:15.814895
NCT02476552|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-02-21|||February 2015||2015-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|December 2015|Actual|2015-12-01||Interventional|||Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer|Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer|Active, not recruiting||Phase 1|12|Actual|Tesaro, Inc.||2|||f||||f||||||||||2017-10-10 23:12:15.899022|2017-10-10 23:12:15.899022
NCT02476539|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-04-25|||October 14, 2015|Actual|2015-10-14|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer|An Ascending Single and Multiple Dose Study of the Pharmacokinetics, Safety and Tolerability of the Irreversible Epidermal Growth Factor Receptor Inhibitor Hemay022 in Patients With HER2-Positive Advanced Breast Cancer|Recruiting||Phase 1|57|Anticipated|Tianjin Hemay Pharmaceutical Co.,Ltd||1|||f||||f||||||||||2017-10-10 23:12:15.980204|2017-10-10 23:12:15.980204
NCT02476526|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-11-06|||September 2008||2008-09-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease|Safety of Low Dose Intravenous Contrast 64 Multi-Detector Computed Tomography Scanning in Patients With Chronic Kidney Disease|Recruiting||Phase 4|100|Anticipated|VA Greater Los Angeles Healthcare System||2|||f||||f||||||||No|Results will be published after completion of study.|2017-10-10 23:12:16.074438|2017-10-10 23:12:16.074438
NCT02476513|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-07-12|||February 2014||2014-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders|Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders|Completed||N/A|18|Actual|University of Alabama at Birmingham|||1||f||||t||||||Samples Without DNA|"     The H&E sections of all biopsy specimens will be reviewed by a GI diagnostic pathologist,     Leona Council, MD, for histopathologic parameters including histologic grade and type. The     histology will be characterized according to the scale depicted in figure 1, where 0     represents the earliest possible injury and 3 represents malignancy. All specimens will be     processed in the typical manner, but reviewed by Dr. Council in the pathology department.   "|||2017-10-10 23:12:16.191635|2017-10-10 23:12:16.191635
NCT02476500|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-11-28|||May 2015||2015-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|LLETZ-1||Construct Validity of a Large Loop Excision of the Transformation Zone (LLETZ) Training Model|Prospective Case-control Study to Assess the Construct Validity of a Large Loop Excision of the Transformation Zone (LLETZ) Training Model|Completed||N/A|150|Anticipated|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-10 23:12:16.259345|2017-10-10 23:12:16.259345
NCT02476487|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-04-12|||August 2015||2015-08-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia|The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia|Recruiting||N/A|60|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||Yes|Anonymized database will be made available in access/ Epi-Info format from the authors upon request|2017-10-10 23:12:16.347436|2017-10-10 23:12:16.347436
NCT02476474|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-01-19|||January 2016||2016-01-01|January 2016|2016-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||GERD Following Laparoscopic Sleeve Gastrectomy|Antral Length and GERD Following Sleeve Gastrectomy for Morbid|Active, not recruiting||N/A|20|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:12:16.42619|2017-10-10 23:12:16.42619
NCT02476461|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-06-16|||April 2015||2015-04-01|April 2015|2015-04-01|January 2021|Anticipated|2021-01-01|April 2016|Anticipated|2016-04-01||Interventional|PNFvsxiapex||Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture|Prospektiv Randomisert Sammenlikning Mellom Percutan nålefasciotomi og Xiapex for Dupuytrens Kontraktur|Recruiting||Phase 4|50|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 23:12:16.498816|2017-10-10 23:12:16.498816
NCT02476448|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-04-18|||February 2015||2015-02-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|JET||Evaluation of Ureteral Jets on Cystoscopy|Evaluation of Ureteral Jets on Cystoscopy: A Randomized Controlled Trial|Completed||N/A|177|Actual|The Cleveland Clinic||4|||f||||t||||||||No||2017-10-10 23:12:16.588357|2017-10-10 23:12:16.588357
NCT02476435|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-02-11|||June 2015||2015-06-01|February 2016|2016-02-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|PERSONA||Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation|Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation of Right Angular Gyrus.|Recruiting||N/A|102|Anticipated|Centre Hospitalier St Anne||2|||f||||f||||||||||2017-10-10 23:12:16.687277|2017-10-10 23:12:16.687277
NCT02476422|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-08-22|2016-06-29||April 2015||2015-04-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Randomized set included all subjects who were randomized into the study.|A Study to Assess the Efficacy and Tolerability of Diclofenac Potassium Soft Gelatin Capsules Compared With Ibuprofen Tablets in Patients With Moderate to Severe Postoperative Dental Pain|A Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Tolerability of 50 mg Diclofenac Potassium Soft Gelatin Capsules Compared With 400 mg Ibuprofen Tablets in Patients With Moderate to Severe Postoperative Dental Pain|Completed||Phase 3|328|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:12:16.810144|2017-10-10 23:12:16.810144
NCT02476409|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-03-27|||July 2015||2015-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|TROUPER||Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders|Tolvaptan Treatment to Reverse Worsening Outpatient Heart Failure: Possible Role of Copeptin In Identifying Responders (TROUPER)|Recruiting||Phase 4|40|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:12:17.371077|2017-10-10 23:12:17.371077
NCT02476396|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-11-02|||April 2015||2015-04-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Structural Stability of Carotid Plaque and Symptomatology|Structural Stability of Carotid Plaque and Symptomatology|Recruiting||N/A|194|Anticipated|University of Wisconsin, Madison|||2||f||||f||||||Samples With DNA|"     Subjects and controls will have 2 tubes of blood drawn. DNA will be removed and may be saved     for future testing. Some cells from the participant's blood may be kept alive and growing in     the laboratory as a cell line. Creating a cell line will allow the investigators to get     more DNA for future research.      Subjects will have their carotid plaques removed via standard carotid endarterectomy. This     surgical procedure is part of the standard clinical care.      Blood samples will be decoded and unidentifiable, kept in a secure freezer box (with a lock     and key) and stored in chamber of 1 -800C freezer used only to store human blood and RNA     samples.      Plaque specimens will be de-identified. Samples will be kept in a secure freezer box stored     in a chamber with authorized access only.   "|Undecided||2017-10-10 23:12:17.458275|2017-10-10 23:12:17.458275
NCT02476383|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-08-07|||September 2015||2015-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Spinal Manipulative Therapy Treatment Effect Modifiers in Individuals With Low Back Pain|Spinal Manipulative Therapy Treatment Effect Modifiers in Individuals With Low Back Pain|Recruiting||N/A|82|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-10 23:12:17.538938|2017-10-10 23:12:17.538938
NCT02476370|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-05-23|||June 2015||2015-06-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MBM_Hernio||Effects of Preoperative Relaxation and Intensified Surgery Education in Patients Undergoing Herniotomy|Effects of Preoperative Relaxation and Intensified Surgery Education on Preoperative Wellbeing and Postoperative Complaints in Patients Undergoing Herniotomy - a Randomized Controlled Trial|Recruiting||N/A|108|Anticipated|Universität Duisburg-Essen||4|||f||||f||||||||||2017-10-10 23:12:17.665426|2017-10-10 23:12:17.665426
NCT02476357|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-06-18|||January 2009||2009-01-01|June 2015|2015-06-01||||December 2013|Actual|2013-12-01||Interventional|||A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection|A Randomized Control Trial for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection|Completed||Phase 4|80|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-10 23:12:17.760841|2017-10-10 23:12:17.760841
NCT02476344|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2015-07-12|||July 2015||2015-07-01|July 2015|2015-07-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||Classification and Characterization of Physical Strains During Sorting Series: Physiological Aspects|Classification and Characterization of Physical Strains During Sorting Series: Physiological Aspects|Unknown status|Not yet recruiting|N/A|40|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:12:17.819844|2017-10-10 23:12:17.819844
NCT02476331|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-05-14|||August 2015||2015-08-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Trial of Cognitive Training in Euthymic Bipolar Disorder|A Randomized Control Trial of Cognitive Training in Euthymic Bipolar Disorder|Withdrawn||N/A|0|Actual|University of Calgary||2||Student no longer enrolled in program.|f||||f||||||||||2017-10-10 23:12:17.899293|2017-10-10 23:12:17.899293
NCT02476318|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-16|||June 2007||2007-06-01|June 2015|2015-06-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate the Safety and Performance of ArterX™ Vascular Sealant in Sealing Synthetic Arterial Grafts|A Study to Evaluate the Safety and Performance of ArterX™ Vascular Sealant in Sealing Synthetic Arterial Grafts|Completed||N/A|32|Actual|Tenaxis Medical, Inc.||1|||f||||f||||||||||2017-10-10 23:12:17.983481|2017-10-10 23:12:17.983481
NCT02476305|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-09-16|||May 2015||2015-05-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CRYODESMO01||Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment|Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical|Recruiting||N/A|50|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 23:12:18.057542|2017-10-10 23:12:18.057542
NCT02476292|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-01-26|||June 2015||2015-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Impact of Vasculitis on Employment and Income|Impact of Vasculitis on Employment and Income. An Online Survey of Participants in the VCRC Patient Contact Registry|Completed||N/A|426|Actual|University of South Florida|||1||f||||f||||||||||2017-10-10 23:12:18.142233|2017-10-10 23:12:18.142233
NCT02476279|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-09-12|||September 2015||2015-09-01|September 2016|2016-09-01||||March 2020|Anticipated|2020-03-01||Interventional|SVI||Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis|Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial|Recruiting||Phase 3|1430|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:12:18.22382|2017-10-10 23:12:18.22382
NCT02476266|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-04-18|||August 2015||2015-08-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Two Resistance Training Protocols to Reduce the Risk of Falls in Parkinson's Disease|Power Training to Reduce Falls in Parkinson's Disease|Active, not recruiting||N/A|53|Actual|Sun Life Financial Movement Disorders Research and Rehabilitation Centre||3|||f||||f||||||||||2017-10-10 23:12:18.801796|2017-10-10 23:12:18.801796
NCT02476253|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-04-20|||May 5, 2015|Actual|2015-05-05|March 2017|2017-03-01|October 13, 2017|Anticipated|2017-10-13|September 15, 2017|Anticipated|2017-09-15||Interventional|(BICAR-ICU)||Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill|Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill : A Multiple Center Randomized Clinical Trial (BICAR-ICU)|Recruiting||Phase 3|400|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:12:20.668238|2017-10-10 23:12:20.668238
NCT02476240|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-08-30|||August 2015||2015-08-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|DT-PDSAFEx||Evaluating the Influence of Externally vs. Internally Focused Exercise on Rehabilitation in Parkinson's Disease|Can Dual Task Walking Improve in Parkinson's Disease After External Focus of Attention Exercise? A Single Blind Randomized Controlled Trial|Completed||N/A|65|Actual|Sun Life Financial Movement Disorders Research and Rehabilitation Centre||3|||f||||t||||||||||2017-10-10 23:12:20.785495|2017-10-10 23:12:20.785495
NCT02476227|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-03-16|||April 2015||2015-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Operator-guided and Automatic Algorithm-guided Atrial Fibrillation Ablation|Comparison of Operator-guided and Automatic Algorithm-guided Atrial Fibrillation Ablation. Randomized Open-labeled Study|Recruiting||N/A|150|Anticipated|Military Institute of Medicine, Poland||2|||f||||f||||||||||2017-10-10 23:12:20.868486|2017-10-10 23:12:20.868486
NCT02476214|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|August 2017|Actual|2017-08-01||Interventional|||Comparison of Group Guidance to Routine Care for Pregnant Women at Low Risk|Comparison of Prenatal Care With Group Guidance to Routine Care for Pregnant Women at Low Risk in Maternal and Child Health Clinics|Active, not recruiting||N/A|291|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-10 23:12:20.968819|2017-10-10 23:12:20.968819
NCT02476201|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-04-27|||February 2016||2016-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|QUARTO III||Quartet Lead and Resynchronization Therapy Options III (QUARTO III)|Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6 Months in CRT Patients Implanted With a Quartet Left Ventricular(LV) Quadripolar Lead and the MultiPoint Pacing (MPP) Feature Activated|Recruiting||N/A|90|Anticipated|St. Jude Medical||1|||f||||f|f|f||||||No||2017-10-10 23:12:21.047661|2017-10-10 23:12:21.047661
NCT02476188|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-02-11|||July 2015||2015-07-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|NETs||Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke|Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke|Recruiting||N/A|100|Anticipated|Centre Hospitalier St Anne||3|||f||||f||||||||||2017-10-10 23:12:21.158216|2017-10-10 23:12:21.158216
NCT02476175|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2016-07-21|||April 2013||2013-04-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|Add-on-Mira||Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder|Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder|Completed||Phase 3|35|Actual|CHU de Quebec-Universite Laval||1|||f||||t||||||||Yes|Publication in preparation. To be submitted in second trimester of 2016|2017-10-10 23:12:21.247686|2017-10-10 23:12:21.247686
NCT02476162|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-09-13|||June 2015||2015-06-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Assessing Blood Pressure Remotely in Childhood Cancer Survivors|Feasibility of Assessing Blood Pressure Remotely in Childhood Cancer Survivors (Pilot Study-Survivor)|Completed||N/A|60|Actual|St. Jude Children's Research Hospital|||3||f||||f||||||||||2017-10-10 23:12:21.317837|2017-10-10 23:12:21.317837
NCT02476149|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2015-06-18|||June 2015||2015-06-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Biomechanical Properties of Keratoconic Eyes|Biomechanical Properties of Keratoconic Eyes|Unknown status|Not yet recruiting|N/A|35|Anticipated|University of Plymouth|||1||f||||f||||||||||2017-10-10 23:12:21.399657|2017-10-10 23:12:21.399657
NCT02476136|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-09-26|||May 2015||2015-05-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Observational|||Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis|Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis|Active, not recruiting||N/A|8800|Anticipated|University Medical Center Groningen|||2||f||||f||||||||No||2017-10-10 23:12:21.51409|2017-10-10 23:12:21.51409
NCT02476123|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-01-16|||June 2015||2015-06-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors|Phase 1 Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|108|Anticipated|Kyowa Hakko Kirin Co., Ltd||1|||f||||t||||||||||2017-10-10 23:12:21.671494|2017-10-10 23:12:21.671494
NCT02476110|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-01-20|||May 2015||2015-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|||The ONSHUG Survey : A Quality Care Programme|Oral Nutritive Supplements : Indications, Prescription and Follow-up for Hospitalized and Out-patients at Nutritional Risk or With Malnutrition. A Quality Care Programme at the Geneva University Hospital : The ONSHUG Survey|Completed||N/A|416|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 23:12:21.747296|2017-10-10 23:12:21.747296
NCT02476097|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-18|||June 2015||2015-06-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|PROGRESS||PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms|Study of the Effect of PROGRESSive Withdrawal Esomeprazole of on Acid-related Symptoms, PROGRESS Study A Randomized, Placebo-controlled, Double Blinded Study|Unknown status|Recruiting|Phase 4|156|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 23:12:21.82681|2017-10-10 23:12:21.82681
NCT02476084|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-05-10|||October 2014||2014-10-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Observational|BMUS||Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients|Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients: a Pilot Observational Study|Recruiting||N/A|100|Anticipated|University of Oxford|||5||f||||t||||||Samples With DNA|"     Blood and and Biologic samples collected will be processed in the CTU Translational Research     Lab and stored within the Botnar Research Centre adhering to local guidelines on sample     requirements, handling and storage. All biological samples will be available for future     studies for biomarker profiling.      The following blood samples will be drawn in order:        1. Two (10.0ml) K2EDTA tube        2. One (5.0ml) SST tube        3. One (3 ml) Tempus RNA tube        4. One (6 ml) DNA EDTA tube (only during Visit 1)   "|||2017-10-10 23:12:21.951476|2017-10-10 23:12:21.951476
NCT02476071|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-06-16|||October 2013||2013-10-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluating Demand Generation for Safe Voluntary Male Circumcision (VMC) for HIV Prevention (Stylish Man), Rakai, Uganda|Evaluating Demand Generation (Stylish Man) for Safe Voluntary Male Circumcision (VMC) for HIV Prevention, Rakai, Uganda|Unknown status|Active, not recruiting|N/A|1400|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 23:12:22.060196|2017-10-10 23:12:22.060196
NCT02476058|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-03-31|||June 11, 2015|Actual|2015-06-11|March 2017|2017-03-01|January 4, 2016|Actual|2016-01-04|January 4, 2016|Actual|2016-01-04||Interventional|||A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder|An Exploratory Multicenter, Double-Blind, Diphenhydramine- and Placebo-Controlled Safety, Efficacy and Biomarker Study With JNJ-42847922 in Subjects With Major Depressive Disorder|Completed||Phase 1|109|Actual|Janssen-Cilag International NV||3|||f||||t|f|||||||||2017-10-10 23:12:22.146488|2017-10-10 23:12:22.146488
NCT02476045|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-09-13|||June 2015||2015-06-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|Valentino||Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino)|First-line FOLFOX-4 Plus Panitumumab Followed by 5-FU/LV Plus Panitumumab or Single-agent Panitumumab as Maintenance Therapy in Patients With RAS Wild-type, Metastatic Colorectal Cancer: the VALENTINO Study|Recruiting||Phase 2|224|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-10 23:12:22.274136|2017-10-10 23:12:22.274136
NCT02476019|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-02-06|||June 2015||2015-06-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|FGFR4-CS2||A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients|A Double Blind, Randomized, Placebo-controlled, Single Center, Phase 2a Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 463588 (ISIS-FGFR4RX, an Antisense Inhibitor of Fibroblast Growth Factor Receptor 4) Administered Subcutaneously Once Weekly for 13 Weeks in Obese Patients|Completed||Phase 2|13|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:12:22.476381|2017-10-10 23:12:22.476381
NCT02476006|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-08-10|||June 23, 2015|Actual|2015-06-23|August 2017|2017-08-01|March 27, 2019|Anticipated|2019-03-27|March 27, 2019|Anticipated|2019-03-27||Interventional|||Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)|A Multi-country, Multicenter, Single-arm, Open-label Study to Document the Safety, Tolerability and Effect of Alirocumab on Atherogenic Lipoproteins in High Cardio-vascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies|Active, not recruiting||Phase 3|1300|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-10 23:12:22.565959|2017-10-10 23:12:22.565959
NCT02475993|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-04-20|||July 2015||2015-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge|SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||||||||||||2017-10-10 23:12:23.024368|2017-10-10 23:12:23.024368
NCT02475980|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-05-31|2016-05-31||February 2015||2015-02-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|PACER||Providing Adolescent Contraception in the Emergency Room|Providing Adolescent Contraception in the Emergency Room (PACER)|Completed||N/A|13|Actual|University of New Mexico|||1||f||||f||||||||||2017-10-10 23:12:23.129036|2017-10-10 23:12:23.129036
NCT02475967|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-08-09|||January 2016||2016-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|eEduHeart I||Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform|eEduHeart I: a Multi-center Randomized, Controlled Trial Investigating the Effectiveness of a Cardiac Web-based eLearning Platform|Recruiting||N/A|1000|Anticipated|Hasselt University||2|||f||||f||||||||||2017-10-10 23:12:23.373171|2017-10-10 23:12:23.373171
NCT02474446|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-06-12|||December 2014||2014-12-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Getting Vitamin D Dosing Right|Determining the Effects of Race, Skin Colour and Genotype on the Response to Vitamin D Therapy|Completed||N/A|60|Actual|Sheffield Children's NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:12:39.259787|2017-10-10 23:12:39.259787
NCT02475954|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-17|2017-05-23|||July 15, 2016|Actual|2016-07-15|May 2017|2017-05-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|TH-CBT||Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD)|Telehealth Cognitive-Behavioral Therapy for Depression in Parkinson's Disease|Recruiting||N/A|180|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Undecided||2017-10-10 23:12:23.477124|2017-10-10 23:12:23.477124
NCT02475941|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-17|||June 2015||2015-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Early Weight Bearing on Supracondylar Distal Femur Fractures in Elderly Patients|Early Weight Bearing on Supracondylar Distal Femur Fractures in Elderly Patients|Recruiting||N/A|200|Anticipated|St. Louis University||2|||f||||t||||||||||2017-10-10 23:12:23.588237|2017-10-10 23:12:23.588237
NCT02475928|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-06-16|||April 2015||2015-04-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|ZnDCP||Zinc Supplementation in Cirrhotic Patients|Zinc Supplementation as Treatment of Dysgeusias in Cirrhotic Patients|Unknown status|Recruiting|N/A|70|Anticipated|Fundación Clínica Médica Sur||2|||f||||t||||||||||2017-10-10 23:12:23.720938|2017-10-10 23:12:23.720938
NCT02475915|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-03-29|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection|A Randomized Study to Compare the Efficacy of Vorinostat/Hydroxychloroquine/Maraviroc (VHM) in Controlling HIV After Treatment Interruption in Subjects Who Initiated ART During Acute HIV Infection|Completed||Phase 1/Phase 2|15|Actual|South East Asia Research Collaboration with Hawaii||2|||f||||t||||||||Undecided||2017-10-10 23:12:23.825714|2017-10-10 23:12:23.825714
NCT02475902|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-26|||July 2015||2015-07-01|June 2015|2015-06-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|HiM-O||Health in Motion- Interactive Exercises for Safer Mobility|Health in Motion- Interactive Exercises for Safer Mobility|Unknown status|Not yet recruiting|N/A|36|Anticipated|Blue Marble Rehab Inc||2|||f||||t||||||||||2017-10-10 23:12:23.970606|2017-10-10 23:12:23.970606
NCT02475889|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2015-06-16|||November 2007||2007-11-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer|Hepatic Radiofrequency Ablation Increases T Cell Infiltraion and PD-L1 Expression in Primary Tumor in Patients With Synchronous Colorectal Cancer Liver Metastases|Completed||N/A|78|Actual|The First People's Hospital of Changzhou|||2||f||||f||||||Samples Without DNA|"     Paraffin-embedded tissues of endoscopic biopsy specimen and matched resected primary tumor     specimen   "|||2017-10-10 23:12:24.065576|2017-10-10 23:12:24.065576
NCT02475876|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-03-31|||November 2015||2015-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|PBPK||PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children|Pharmacokinetics of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children Using PBPK|Recruiting||Phase 1|54|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 23:12:24.136406|2017-10-10 23:12:24.136406
NCT02475863|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-19|||August 2015||2015-08-01|June 2015|2015-06-01|January 2018|Anticipated|2018-01-01|August 2016|Anticipated|2016-08-01||Interventional|WATCH||Model-based Versus Traditional Warfarin Dosing in Children|A Study to Compare Model-based Warfarin Dosing to the Traditional Approach in Children After Congenital Heart Surgery at Glenfield Hospital, Leicester|Not yet recruiting||N/A|45|Anticipated|De Montfort University||2|||f||||f||||||||||2017-10-10 23:12:24.23108|2017-10-10 23:12:24.23108
NCT02475850|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-05-04|||August 2015|Actual|2015-08-01|May 2017|2017-05-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|STRIDE||Strategies to Reduce Injuries and Develop Confidence in Elders|Randomized Trial of a Multifactorial Fall Injury Prevention Strategy|Active, not recruiting||Phase 3|5451|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 23:12:24.302161|2017-10-10 23:12:24.302161
NCT02475837|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-07-24|||August 26, 2015|Actual|2015-08-26|July 2017|2017-07-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access|A Double-blind, Randomized, Placebo Controlled Pilot Trial to Evaluate the Safety and Efficacy of Vorapaxar in Maturation of Arteriovenous Fistulae for Hemodialysis Access|Active, not recruiting||Phase 2|17|Actual|Stanford University||2|||f||||t|t|||||||||2017-10-10 23:12:24.409787|2017-10-10 23:12:24.409787
NCT02475824|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2016-11-20|||May 2015||2015-05-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Midazolam With Meperidine and Dexmedetomidine vs. Midazolam With Meperidine and Propofol for Sedation During ERCP|A Randomized Comparison of Midazolam With Meperidine and Dexmedetomidine Versus Midazolam With Meperidine and Propofol for Sedation During ERCP|Active, not recruiting||Phase 4|258|Anticipated|Dankook University||2|||f||||t||||||||||2017-10-10 23:12:24.502263|2017-10-10 23:12:24.502263
NCT02475811|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-03-22|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||3D Ultrasonography Fetal Lung Volume Measurement and Neonatal Respiratory Function|The Role of 3D Ultrasonography Fetal Lung Volume Measurement in the Prediction of Neonatal Respiratory Function Outcome|Completed||N/A|100|Actual|Cairo University|||1||f||||t||||||||||2017-10-10 23:12:24.595804|2017-10-10 23:12:24.595804
NCT02475798|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-03-03|||June 2015||2015-06-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|January 2017|Anticipated|2017-01-01||Expanded Access|||PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation|Clinical Study to Collect Confirmatory Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation|Available||N/A|||Cook Group Incorporated|||||||||||||||||||2017-10-10 23:12:24.657854|2017-10-10 23:12:24.657854
NCT02475785|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2017-07-19|||January 2015||2015-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of Mini Plates Anchorage With Forsus Fatigue Resistant Device|Evaluation of Mini Plates Anchorage in Conjunction With Forsus Fatigue Resistant Device for Correction of Skeletal Class II Malocclusion in Growing Subjects: A Randomized Controlled Trial|Completed||N/A|48|Actual|Cairo University||3|||f||||f||||||||||2017-10-10 23:12:24.769794|2017-10-10 23:12:24.769794
NCT02475772|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-11-13|||November 2016||2016-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis|A Phase I, Single-arm, Open-label, Three Step Dose Escalation Study With Intraperitoneal Pressurized Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis|Recruiting||Phase 1|15|Anticipated|Ruhr University of Bochum||1|||f||||f||||||||||2017-10-10 23:12:24.983077|2017-10-10 23:12:24.983077
NCT02475759|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-06-16|||February 2014||2014-02-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||Nutritional Prehabilitation Program and Cardiac Surgery Outcome in Pediatrics|Nutritional Prehabilitation Program and Cardiac Surgery Outcome in Pediatrics. A Randomized Controlled Trial|Completed||N/A|50|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:12:25.109464|2017-10-10 23:12:25.109464
NCT02475746|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-06-23|||July 2015||2015-07-01|June 2017|2017-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects|A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06372865 In Healthy Adult Subjects|Withdrawn||Phase 1|0|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:12:25.183757|2017-10-10 23:12:25.183757
NCT02475733|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2017-08-03|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Childern Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).|A Single Blind, Randomised, Multi-centre, Active Controlled, Trial To Evaluate Safety, Tolerability, Pharmacokinetics And Efficacy Of Ceftazidime And Avibactam When Given In Combination With Metronidazole, Compared With Meropenem, In Children From 3 Months To Less Than 18 Years Of Age With Complicated Intra-abdominal Infections (cIAIs)|Completed||Phase 2|83|Actual|Pfizer||2|||f|||||t|f||||||||2017-10-10 23:12:25.280859|2017-10-10 23:12:25.280859
NCT02475720|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-03-23|||June 19, 2015|Actual|2015-06-19|March 2017|2017-03-01|March 16, 2016|Actual|2016-03-16|March 16, 2016|Actual|2016-03-16||Observational|||Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)|Survey on the Treatment Reality of Patients With EGFR Mutation-positive Non-small Cell Lung Cancer|Completed||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:12:25.472571|2017-10-10 23:12:25.472571
NCT02475707|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-06-08|||February 2016||2016-02-01|June 2017|2017-06-01|March 2023|Anticipated|2023-03-01|April 2018|Anticipated|2018-04-01||Interventional|STELLA||Administration of Donor MultiTAA-Specific T Cells for ALL|Administration of Donor-Derived Multi-Tumor-Associated Antigen (TAA)-Specific T Cells to Patients With ALL|Recruiting||Phase 1|28|Anticipated|Baylor College of Medicine||2|||f||||t|t|f||||||||2017-10-10 23:12:25.547957|2017-10-10 23:12:25.547957
NCT02475694|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-06-16|||September 2008||2008-09-01|June 2015|2015-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|ALI||Acute Lung Injury After Cardiac Surgery: Pathogenesis|Acute Lung Injury After Cardiac Surgery: Pathogenesis|Completed||N/A|50|Actual|Aalborg Universitetshospital|||1||f||||t||||||Samples Without DNA|"     Plasma samples stored at -80 degrees of Celcius   "|||2017-10-10 23:12:25.668486|2017-10-10 23:12:25.668486
NCT02475681|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-05-29|||June 2015||2015-06-01|May 2017|2017-05-01||||December 2019|Anticipated|2019-12-01||Interventional|||Elevate CLL TN: Study of Obinutuzumab + Chlorambucil, Acalabrutinib (ACP-196) + Obinutuzumab, and Acalabrutinib in Subjects With Previously Untreated CLL|A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination With Chlorambucil, Acalabrutinib (ACP-196) in Combination With Obinutuzumab, and Acalabrutinib Monotherapy in Subjects With Previously Untreated CLL|Active, not recruiting||Phase 3|535|Actual|Acerta Pharma BV||3|||f||||t||||||||||2017-10-10 23:12:25.757708|2017-10-10 23:12:25.757708
NCT02475668|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-07-09|||June 2015||2015-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||SpO2 Accuracy Validation of Pulse Oximetry Systems During Motion and Non-Motion Conditions|SpO2 Accuracy Validation of Pulse Oximetry Systems During Motion and Non-Motion Conditions of Induced Hypoxia as Compared to Arterial Blood CO-Oximetry|Completed||N/A|13|Actual|Nonin Medical, Inc|||1||f||||f||||||||||2017-10-10 23:12:26.172265|2017-10-10 23:12:26.172265
NCT02475655|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-09-18|||February 2016||2016-02-01|September 2017|2017-09-01||||February 2018|Anticipated|2018-02-01||Interventional|||Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults|A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults|Recruiting||Phase 2|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:12:26.245057|2017-10-10 23:12:26.245057
NCT02475642|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-04-26|||March 2014||2014-03-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|POWDER-AF||Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation|Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation: A Prospective 2-Centre Randomized Controlled Clinical Study (POWDER-AF)|Active, not recruiting||Phase 4|152|Actual|VZW Cardiovascular Research Center Aalst||2|||f||||f||||||||||2017-10-10 23:12:26.432544|2017-10-10 23:12:26.432544
NCT02475629|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-02-06|||August 2015||2015-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV|A Phase 3, Single Arm, 24-Week, Multicenter Study of Ibalizumab Plus an Optimized Background Regimen (OBR) in Treatment-Experienced Patients Infected With Multi-Drug Resistant HIV-1|Completed||Phase 3|40|Actual|TaiMed Biologics Inc.||1|||f||||t||||||||||2017-10-10 23:12:26.533716|2017-10-10 23:12:26.533716
NCT02475616|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-11-17|||June 2015||2015-06-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Single Ascending Dose Study of PCO371 in Healthy Volunteers|A Randomized, Double-blind, Single Ascending Oral Dose Study To Evaluate Safety, Tolerability And Pharmacokinetics Of PCO371 In Healthy Volunteers|Terminated||Phase 1|64|Actual|Chugai Pharmaceutical||2|||f||||||||||||||2017-10-10 23:12:26.7043|2017-10-10 23:12:26.7043
NCT02475603|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-15|||September 2012||2012-09-01|September 2012|2012-09-01|January 2016|Anticipated|2016-01-01|June 2015|Actual|2015-06-01||Interventional|||Clinical, Biochemical and Neurophysiological Consequences of Intraoperative Tourniquet During Total Knee Arthroplasty|Clinical, Biochemical and Neurophysiological Consequences of Intraoperative|Unknown status|Recruiting|N/A|100|Anticipated|Universitätsmedizin Mannheim||2|||f||||f||||||||||2017-10-10 23:12:26.792608|2017-10-10 23:12:26.792608
NCT02475590|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-12-03|||March 2009||2009-03-01|December 2015|2015-12-01|July 2022|Anticipated|2022-07-01|July 2015|Actual|2015-07-01||Interventional|||Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass|Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass for Morbidly Obese Patients: a Prospective Randomized Clinical Trial|Active, not recruiting||N/A|100|Actual|IHU Strasbourg||2|||f||||f||||||||||2017-10-10 23:12:26.89272|2017-10-10 23:12:26.89272
NCT02475577|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-03-29|||June 2015||2015-06-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Determine Return on Investment in Heart Failure Remote Monitoring Program|A Prospective Randomized Controlled Trial to Determine Return on Investment in a Tablet/Smartphone-based Heart Failure Remote Monitoring Program|Recruiting||N/A|163|Anticipated|NCH Heatlhcare System Inc||3|||f||||f||||||||||2017-10-10 23:12:27.036058|2017-10-10 23:12:27.036058
NCT02475564|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-08-22|2016-03-24||June 2015||2015-06-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ResvEndo||Resveratrol for Pain Due to Endometriosis|The Use of Resveratrol for Pain in Endometriosis - A Clinical Trial|Completed||Phase 4|44|Actual|Hospital de Clinicas de Porto Alegre|There were only 42 days of treatment observed, a longer follow-up, for instance 6 months, may impact the results.|2|||f||||f||||||||Undecided||2017-10-10 23:12:27.248694|2017-10-10 23:12:27.248694
NCT02475551|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-07-11|||June 2015||2015-06-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation|A Phase II Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of Intravenous Ascending Doses of IdeS in Kidney Transplantation|Completed||Phase 2|10|Actual|Hansa Medical AB||1|||f||||t||||||||||2017-10-10 23:12:27.707095|2017-10-10 23:12:27.707095
NCT02475538|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-06-13|||July 2015||2015-07-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Electroacupuncture for Tapering Off Long-term Benzodiazepine Use|Electroacupuncture for Tapering Off Long-term Benzodiazepine Use: a Randomized Controlled Trial|Recruiting||N/A|144|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:12:27.80696|2017-10-10 23:12:27.80696
NCT02475525|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-05-11|||June 2015||2015-06-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Oral Nutritional Supplement in Reducing Surgical Site Infections|The Role of an Arginine Enriched Oral Nutritional Supplement in the Prevention of Wound Complication in Patients Undergoing Lower Limb Revascularization|Recruiting||N/A|60|Anticipated|University of Limerick||2|||f||||t||||||||Undecided||2017-10-10 23:12:27.90155|2017-10-10 23:12:27.90155
NCT02475512|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-02-08|||May 2015||2015-05-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly|A Total Body Wash Wipe Combined With a Genital Wipe Versus Standard Care (Water and pH Neutral Soap) for Washing of Incontinent Residents in a Long- Term Care Setting: a Multicenter Prospective Randomised Controlled Clinical Trial and Health Economical Analysis in Nursing Homes|Terminated||N/A|385|Actual|University Ghent||2|||f||||f||||||||||2017-10-10 23:12:28.003051|2017-10-10 23:12:28.003051
NCT02475499|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-03-11|||March 2014||2014-03-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Incretin-based Drugs and Pancreatic Cancer|The Use of Incretin-based Drugs and the Risk of Pancreatic Cancer in Patients With Type 2 Diabetes|Completed||N/A|886172|Actual|Canadian Network for Observational Drug Effect Studies, CNODES|||3||f||||f||||||||||2017-10-10 23:12:28.144058|2017-10-10 23:12:28.144058
NCT02475486|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-05-29|||February 25, 2016|Actual|2016-02-25|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|ANSRA||Role of the ANS Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated With Anti-TNF|Role of the Sympathetic Nervous System (ANS) Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated With Anti-TNF (Tumor Necrosis Factor) - a Monocentric Cross-sectional Study|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||No||2017-10-10 23:12:28.30443|2017-10-10 23:12:28.30443
NCT02475473|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-10-19|||February 2015||2015-02-01|September 2015|2015-09-01||||October 2015|Actual|2015-10-01||Interventional|||Circulatory Levels of Irisin in Response to Chronic Resistance Training|Circulatory Levels of Irisin in Response to Chronic Resistance Training|Completed||N/A|28|Actual|Texas Tech University||2|||f||||t||||||||||2017-10-10 23:12:28.414144|2017-10-10 23:12:28.414144
NCT02475460|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-07-20|||May 2015||2015-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|HM 3 LIS||HeartMate 3™ LIS Study|Thoratec Corporation HeartMate 3™ Less Invasive Surgery (LIS) Study|Completed||N/A|13|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-10 23:12:28.522908|2017-10-10 23:12:28.522908
NCT02475447|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-04-11|||July 2015||2015-07-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis|A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis|Recruiting||Phase 2|200|Anticipated|Tioga Pharmaceuticals||2|||f||||f||||||||No||2017-10-10 23:12:28.628327|2017-10-10 23:12:28.628327
NCT02475434|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-06-22|||June 10, 2015|Actual|2015-06-10|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants|A Randomized Trial of the Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants|Enrolling by invitation||N/A|210|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 23:12:28.836916|2017-10-10 23:12:28.836916
NCT02475421|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-17|||May 2015||2015-05-01|June 2015|2015-06-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Interventional|MCR Glucagon||Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance|Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance|Unknown status|Recruiting|N/A|32|Anticipated|University Hospital, Gentofte, Copenhagen||4|||f||||t||||||||||2017-10-10 23:12:28.952872|2017-10-10 23:12:28.952872
NCT02475408|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-05-10|||December 2014||2014-12-01|June 2015|2015-06-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|IMAO||Effect of Permanent Internal Mammary Artery Occlusion on Extracardiac Coronary Collateral Supply|Effect of Permanent Internal Mammary Artery Occlusion on Extracardiac Coronary Collateral Supply|Completed||Phase 1/Phase 2|50|Actual|University Hospital Inselspital, Berne||1|||f||||t||||||||||2017-10-10 23:12:29.046755|2017-10-10 23:12:29.046755
NCT02475395|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-06-21|2017-06-21||May 2015||2015-05-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study of the Consumer Use of a New Home Test to Measure Sperm Concentration|A Clinical Study Evaluating Consumer Use of a New Device (TRAK) to Measure Sperm Concentration From Human Semen Samples, and Comparing TRAK Test Results With Laboratory Reference Method Testing|Completed||N/A|239|Actual|Sandstone Diagnostics||2|||f||||||||||||||2017-10-10 23:12:29.15049|2017-10-10 23:12:29.15049
NCT02475382|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-07-25||||||July 2017|2017-07-01||||||||Expanded Access|CheckMate 169||Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen|Expanded Access Program With Nivolumab Monotherapy in Subjects With Advanced or Metastatic Squamous (Sq) or Non-Squamous (Non-Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimens for the Treatment of Stage IIIb/IV SqNSCLC|No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-10 23:12:29.564973|2017-10-10 23:12:29.564973
NCT02475369|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-08-01|||May 2015||2015-05-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Pancreatic Enzyme Supplementation for Celiac Disease|Pilot Study of the Efficacy of Pancreatic Enzyme Supplementation for Symptom Control in Celiac Disease Not Responding to the Gluten Free Diet|Recruiting||Phase 4|40|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-10 23:12:29.714221|2017-10-10 23:12:29.714221
NCT02475356|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-09-27|||August 4, 2015|Actual|2015-08-04|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Observational|J-MIRAI||Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea|Special Drug Use Investigation of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea|Recruiting||N/A|600|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 23:12:29.796832|2017-10-10 23:12:29.796832
NCT02475343|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-11-16|||February 2015||2015-02-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||A Novel Method to Assess the Cornea Biomechanical Properties With Schiotz Tonometer|A Novel Method to Assess the Cornea Biomechanical Properties With Schiotz|Recruiting||N/A|1000|Anticipated|Shandong Provincial Hospital||3|||f||||f||||||||||2017-10-10 23:12:29.880924|2017-10-10 23:12:29.880924
NCT02475330|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-09-23|||May 2015||2015-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Dietary Flaxseed in NSCLC|Phase II Trial of Flaxseed to Prevent Pneumonopathy After Chemoradiation for Lung Cancer|Recruiting||Phase 2|48|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:12:29.967534|2017-10-10 23:12:29.967534
NCT02475304|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2017-10-04|||May 2015||2015-05-01|October 2017|2017-10-01|June 2017|Anticipated|2017-06-01|October 2016|Actual|2016-10-01||Interventional|||Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis|A Randomized, Double Blind, Placebo-controlled Proof-of-concept Study of FP187 in Patients With Mild to Moderate Psoriatic Arthritis|Withdrawn||Phase 2|0|Actual|Skane University Hospital||2||Difficulties to enrol patients|f||||f||||||||||2017-10-10 23:12:30.127431|2017-10-10 23:12:30.127431
NCT02475291|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-07-25|||June 2015||2015-06-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|||Clinical Usefulness of Fractional Flow Reserve Measurement for Significant Stenosis in Proximal Coronary Artery||Completed||N/A|26|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 23:12:30.225262|2017-10-10 23:12:30.225262
NCT02475278|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-07-20|2016-09-07||February 26, 2015|Actual|2015-02-26|July 2017|2017-07-01|September 9, 2015|Actual|2015-09-09|April 7, 2015|Actual|2015-04-07||Interventional||Safety Analysis Set, all participants who received the trial vaccine (NoV Vaccine).|Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine|Phase II, Single Arm, Open Label Trial for Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of the Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine|Completed||Phase 2|50|Actual|Takeda||1|||f||||t||||||||||2017-10-10 23:12:30.285753|2017-10-10 23:12:30.285753
NCT02475265|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-26|||July 2015||2015-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|1180||Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa|Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa|Recruiting||Phase 2|10|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:12:30.821714|2017-10-10 23:12:30.821714
NCT02475252|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2016-01-19|||April 2015||2015-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|HSK-2||Construct Validity of a Diagnostic Hysteroscopy Training Model|Prospective Case-control Study to Assess the Construct Validity of a Diagnostic Hysteroscopy in a Pelvic Training Model Using an Objective Structured Assessment of Technical Skills (OSATS) Assessment|Terminated||N/A|15|Actual|Ruhr University of Bochum||2||Recruitment too slow; study completion not possible within frame|f||||f||||||||||2017-10-10 23:12:30.937216|2017-10-10 23:12:30.937216
NCT02475239|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-16|||December 2014||2014-12-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy of Postural Restriction in Treating Benign Paroxysmal Positional Vertigo|Efficacy of Postural Restriction in Treating Benign Paroxysmal Positional Vertigo|Unknown status|Recruiting|N/A|186|Anticipated|Prince of Songkla University||2|||f||||t||||||||||2017-10-10 23:12:31.041979|2017-10-10 23:12:31.041979
NCT02475226|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-17|||April 2015||2015-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Cases With Traumatic and Non Traumatic Brain Damage Treated in the Intensive Care|Distribution and Mortality Factors of Cases With Traumatic and Non Traumatic Brain Damage Treated in Intensive Care; Retrospective Clinical Trial|Completed||N/A|135|Actual|Umraniye Education and Research Hospital|||3||f||||f||||||||||2017-10-10 23:12:31.149788|2017-10-10 23:12:31.149788
NCT02475213|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-04-11|||July 2015||2015-07-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab in Refractory Cancer|A Phase 1, Open-Label, Dose Escalation Study of MGA271 in Combination With Pembrolizumab in Patients With B7-H3-Expressing Melanoma, Squamous Cell Cancer of the Head and Neck, Non-Small Cell Lung Cancer and Other B7H3 Expressing Cancers|Recruiting||Phase 1|75|Anticipated|MacroGenics||1|||f||||f||||||||Undecided||2017-10-10 23:12:31.271375|2017-10-10 23:12:31.271375
NCT02475200|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-05-31|||September 14, 2015|Actual|2015-09-14|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01|12 Months|Observational [Patient Registry]|||Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems|Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems|Enrolling by invitation||N/A|600|Anticipated|Volcano Corporation|||1||f||||f||||||||||2017-10-10 23:12:31.4667|2017-10-10 23:12:31.4667
NCT02475187|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2016-02-07|||September 2015||2015-09-01|February 2016|2016-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|thro-fract15||Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture|Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture|Recruiting||N/A|220|Anticipated|Vestre Viken Hospital Trust|||1||f||||f||||||Samples Without DNA|"     Blood tests for Measurments of thrombotic properies. No storage of specimens   "|||2017-10-10 23:12:31.567662|2017-10-10 23:12:31.567662
NCT02475174|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-15|||June 2015||2015-06-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|June 2015|Actual|2015-06-01||Interventional|||Manual Lymphatic Drainage in the Superior Member in Women in Post-surgery for Breast Cancer|Blood Circulation Assessment of the Superior Member in Women in Post-surgery for Breast Cancer Submitted to the Manual Lymphatic Drainage|Unknown status|Not yet recruiting|N/A|30|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:12:31.669718|2017-10-10 23:12:31.669718
NCT02475161|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-01-08|||June 2015||2015-06-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants|A Study to Investigate the Effect of Increased Gastric pH From the Administration of the Proton Pump Inhibitor (PPI) Rabeprazole on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Subjects|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 23:12:31.751557|2017-10-10 23:12:31.751557
NCT02475148|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2017-02-06|||June 2015||2015-06-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-54175446 in Healthy Participants|A Randomized, Placebo-controlled, Double-blind, Single Ascending Dose Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-54175446 in Healthy Subjects|Completed||Phase 1|76|Actual|Janssen-Cilag International NV||8|||f||||f||||||||||2017-10-10 23:12:31.856093|2017-10-10 23:12:31.856093
NCT02475135|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-10-21|||June 2015||2015-06-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination|A Single-dose, Open-label, Randomized, Crossover Study to Assess the Impact of Food on the Pharmacokinetics of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Administered as a Fixed-dose Combination Tablet, and the Relative Bioavailability|Completed||Phase 1|72|Actual|Janssen Sciences Ireland UC||6|||f||||f||||||||||2017-10-10 23:12:31.978056|2017-10-10 23:12:31.978056
NCT02475122|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-17|||October 2014||2014-10-01|November 2014|2014-11-01|April 2018|Anticipated|2018-04-01|April 2016|Anticipated|2016-04-01||Interventional|AzyMR||Prognostic Value of Measuring DsAz by MRI in Cirrhotic Patients on Prophylactic Treatment With β Blocker (AzyMR)|Prognostic Value of Measuring DsAz by MRI in Cirrhotic Patients on Prophylactic Treatment With β Blocker (AzyMR)|Recruiting||N/A|100|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 23:12:32.113075|2017-10-10 23:12:32.113075
NCT02475109|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-09-27|||August 2015||2015-08-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Study of Topical Ocular PAN-90806 in PDR|A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)|Completed||Phase 1|10|Actual|PanOptica, Inc.||1|||f||||t||||||||Undecided||2017-10-10 23:12:32.207284|2017-10-10 23:12:32.207284
NCT02475096|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-03-02|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Internet-delivered CBT for Children With Functional Gastrointestinal Disorders - an Open Pilot Study|Internet-delivered Cognitive Behavior Therapy for Children With Pain-predominant Functional Gastrointestinal Disorders - an Open Pilot Study|Completed||N/A|31|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 23:12:32.29237|2017-10-10 23:12:32.29237
NCT02475083|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-15|||January 2014||2014-01-01|August 2014|2014-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Use of Virtual Reality Games for the Treatment of Balance and Reducing the Occurrence of Falls in Patients After Stroke|Therapeutic Effect of Virtual Reality in Patients After Stroke|Completed||N/A|30|Actual|Pedreira, Érika, M.D.||2|||f||||f||||||||||2017-10-10 23:12:32.407899|2017-10-10 23:12:32.407899
NCT02475070|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-07-19|||January 2016||2016-01-01|September 2016|2016-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Vildagliptin Versus Dapagliflozin on Glucagon|Study of Ther Effect of Vildagliptin Versus Dapagliflozin on Glucagon Response to Mixed Meal in Metformin-treated Subjects With Type 2 Diabetes|Completed||Phase 4|28|Actual|Lund University||2|||f||||f||||||||||2017-10-10 23:12:32.489218|2017-10-10 23:12:32.489218
NCT02475057|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-07-13|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists|A Pilot Study on Endothelial Function and Cardiovascular Biomarkers in Prostate Cancer (PCa) Patients, With Pre-existing Cardiovascular Disease, Treated With Degarelix vs. Luteinizing Hormone-Releasing Hormone (LHRH) Agonists|Active, not recruiting||Phase 4|80|Actual|Rabin Medical Center||2|||f||||t||||||||||2017-10-10 23:12:32.574759|2017-10-10 23:12:32.574759
NCT02475044|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-10-09|||June 2015||2015-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Mild Traumatic Brain Injuries in Children: Predicting Behavioral and Emotional Deficits|Mild Traumatic Brain Injuries in Children: Predicting Behavioral and Emotional Deficits|Recruiting||N/A|200|Anticipated|Rabin Medical Center||2|||f||||f||||||||No||2017-10-10 23:12:32.679081|2017-10-10 23:12:32.679081
NCT02475031|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-04-10|2016-11-03||July 2012||2012-07-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TAP||Single-shot TAP Block vs Continuous TAP Block|Randomized, Prospective, Double Blind Study Comparing Single Shot Versus Continuous Transverses Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Live Donor Nephrectomy|Completed||Phase 4|70|Actual|Indiana University||2|||f||||t||||||||No||2017-10-10 23:12:32.777041|2017-10-10 23:12:32.777041
NCT02475018|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-16|||July 2014||2014-07-01|July 2014|2014-07-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Shuhua Milk Fortified With Plant Sterol Esters on Serum Cholesterol in Human|The Effect of Shuhua Milk Fortified With Plant Sterol Esters on Serum Cholesterol in Human|Completed||N/A|179|Actual|Inner Mongolia Yili Industrial Group Co., Ltd||3|||f||||f||||||||||2017-10-10 23:12:33.105693|2017-10-10 23:12:33.105693
NCT02475005|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-03-08|||May 2016||2016-05-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|TH||An Intervention to Improve Adolescent Headache Self-management|An Intervention to Improve Adolescent Headache Self-management|Not yet recruiting||N/A|144|Anticipated|Inflexxion, Inc.||2|||f||||||||||||||2017-10-10 23:12:33.181901|2017-10-10 23:12:33.181901
NCT02474992|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2016-05-18|||January 2016||2016-01-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Kanyakla Study: a Social Network Intervention for Promoting Engagement and Retention in HIV Care|The Kanyakla Study: a Social Network Intervention for Promoting Engagement and Retention in HIV Care|Recruiting||N/A|360|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:12:33.261527|2017-10-10 23:12:33.261527
NCT02474979|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-03-11|||March 2015||2015-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Reduced Pressure for Less Pressure Ulcers|Reduced Pressure for Less Pressure Ulcers. Effect of the CBPM-system in a Swedish University Hospital|Completed||N/A|190|Actual|Uppsala University||2|||f||||f||||||||||2017-10-10 23:12:33.354114|2017-10-10 23:12:33.354114
NCT02474966|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-17|||November 2014||2014-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study|Effects of Deep Transcranial Magnetic Stimulation on the Permeability of the Blood-brain Barrier in Patients With Glioblastoma Multiforme: a Pilot Study|Completed||Phase 2|15|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-10 23:12:33.429757|2017-10-10 23:12:33.429757
NCT02474953|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-09-22|||April 2015||2015-04-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|15PCHB||A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product|A Randomized, Double-blind, Crossover Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Formulation to a Comparator Curcumin Product|Completed||Phase 1|12|Actual|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-10 23:12:33.502929|2017-10-10 23:12:33.502929
NCT02474940|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-03-13|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ENHANCE||MS Symptom Management Study|Enhancing the Benefits of Pain and Fatigue Treatment in MS|Completed||N/A|37|Actual|University of Washington||3|||f||||f||||||||No||2017-10-10 23:12:33.586843|2017-10-10 23:12:33.586843
NCT02474927|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-03-03|||November 2015||2015-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation|Combination Therapy With the Proteasome Inhibitor Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation Trial (PICARD-Lung)|Recruiting||Phase 2|30|Anticipated|University of Pittsburgh||1|||f||||t||||||||Undecided||2017-10-10 23:12:33.670448|2017-10-10 23:12:33.670448
NCT02474914|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2017-08-18|||May 2014||2014-05-01|June 2014|2014-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|PD||Octreotide in the Prevention of Postoperative Complications After Pancreaticoduodenectomy|"Efficacy of Octreotide in the Prevention of Postoperative Complications After Pancreaticodudenectomy in Patients With Soft Pancreas and Non-dilated Pancreatic Duct: A Prospective Randomized Trial"|Completed||N/A|104|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:12:33.756382|2017-10-10 23:12:33.756382
NCT02474888|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-01-20|||October 2015||2015-10-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|MONITUX||Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis|Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis : a Predictive Factor of Clinical Outcome? (MONITUX)|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     blood specimen for serum rituximab level and serum anti-rituximab level   "|||2017-10-10 23:12:33.921071|2017-10-10 23:12:33.921071
NCT02474875|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-02-26|||June 2013||2013-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Explain Pain in Fibromyalgia Patients|Explain Pain in Fibromyalgia Patients|Completed||N/A|83|Actual|Cardenal Herrera University||4|||f||||f||||||||||2017-10-10 23:12:34.041736|2017-10-10 23:12:34.041736
NCT02474862|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-08-11|||March 2015||2015-03-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|HE||Healthy Expectations - A Program for Pregnant Women Experiencing Depressive Symptoms|RCT of a Tailored Walking Program to Reduce Stress Among Pregnant Women|Recruiting||N/A|152|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-10 23:12:34.628589|2017-10-10 23:12:34.628589
NCT02474849|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-09-14|||June 2015||2015-06-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Pharmacokinetic Study Comparing Nicotine Delivery From E-cigarettes and a Conventional Cigarette in Healthy Subjects|A Pharmacokinetic Study to Compare Nicotine Delivery From e Cigarettes and a Conventional Cigarette in Healthy Subjects During a Brief Period of ad Libitum Use|Completed||Early Phase 1|18|Actual|British American Tobacco (Investments) Limited||5|||f||||f||||||||||2017-10-10 23:12:34.724751|2017-10-10 23:12:34.724751
NCT02474836|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-04-28|||November 2012||2012-11-01|April 2017|2017-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Determination of Biological Activity of Three Allergen Extracts|Biological Standardization of Artemisia Vulgaris and/or Platanus Acerifolia Pollen Extract and Dermatophagoides Farinae Mite Extract in Patients Sensitized to Them|Completed||Phase 2|176|Actual|Roxall Medicina España S.A||3|||f||||f||||||||||2017-10-10 23:12:34.80052|2017-10-10 23:12:34.80052
NCT02474810|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-16|2015-06-17|||January 2013||2013-01-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol|Comparison of an Intensive Versus a Standard Hemodialysis Central Venous Catheter Dysfunction Protocol Using Alteplase|Unknown status|Active, not recruiting|N/A|35|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-10 23:12:35.217537|2017-10-10 23:12:35.217537
NCT02474797|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-07|||May 4, 2015|Actual|2015-05-04|September 2017|2017-09-01|September 3, 2017|Actual|2017-09-03|September 3, 2017|Actual|2017-09-03||Interventional|US-Diamonds||Ultrasound Diaphragmatic Thickening to Monitor Its Dysfunction in Patients With Sepsis|Assessment of Diaphragmatic Function by Ultrasonographic Measure of Diaphragmatic Thickening in Severe Sepsis or Septic Shock Patients Hospitalized in ICU: Diaphragmatic Dysfunction Frequency, Prognosis Values and Associated Factors|Completed||N/A|50|Actual|Groupe Hospitalier Paris Saint Joseph||1|||f||||f||||||||||2017-10-10 23:12:35.352867|2017-10-10 23:12:35.352867
NCT02474004|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-07-16|||February 2012||2012-02-01|July 2016|2016-07-01||||February 2017|Anticipated|2017-02-01||Interventional|||Gait Analysis Meniscal Repair|3D-gait Analysis in Patients With Medial Meniscus Repair vs. Partial Meniscectomy|Recruiting||N/A|30|Anticipated|Medical University Innsbruck||2|||f||||||||||||||2017-10-10 23:12:35.497412|2017-10-10 23:12:35.497412
NCT02474784|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-15|||October 2014||2014-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:12:35.598427|2017-10-10 23:12:35.598427
NCT02474771|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-15|||May 2010||2010-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:12:35.659279|2017-10-10 23:12:35.659279
NCT02474758|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-15|||February 2015||2015-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:12:35.718983|2017-10-10 23:12:35.718983
NCT02474745|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-07-28|||July 2015||2015-07-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|EOLE||Study of the Type of Pushing at Delivery|Effect of the Type of Maternal Pushing During the Second Stage of Labor on Obstetric and Neonatal Outcome: a Multicenter Randomized Trial|Recruiting||N/A|250|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:12:35.782385|2017-10-10 23:12:35.782385
NCT02474732|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-01-30|||February 2015||2015-02-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Usability Study for the Beactive Brace Instructions for Use|Assessment of User Comprehension of the BeActive™Brace User Guide|Completed||N/A|40|Actual|Benjamin L. England and Associates, LLC||1|||f||||f||||||||No|Redacted individual participant data is available through the Freedom of Information Act process through the FDA|2017-10-10 23:12:35.903865|2017-10-10 23:12:35.903865
NCT02474719|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-02-01|||January 2015||2015-01-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|TULIPE||Transfer and Ultrafiltration In Peritoneal Dialysis|Transfer and Ultrafiltration In Peritoneal Dialysis|Recruiting||N/A|24|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-10 23:12:35.990707|2017-10-10 23:12:35.990707
NCT02474706|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-10|||March 2016||2016-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|COLIFOX||Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli|Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli|Terminated||Phase 4|6|Actual|Central Hospital, Nancy, France||2||Lack of recruitment|f||||t||||||||||2017-10-10 23:12:36.097658|2017-10-10 23:12:36.097658
NCT02474693|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-01-27|||January 2014||2014-01-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Salt Sources Study|Assessment of the Proportion of Sodium Intake From a Variety of Sources - Salt Sources Study|Completed||N/A|450|Actual|Centers for Disease Control and Prevention|||1||f||||f||||||Samples Without DNA|"     24 hour urine samples   "|Yes|When data cleaning is completed, data can be obtained through submission of a proposal to the proposal and publication committee through contacting one of the investigators|2017-10-10 23:12:36.231325|2017-10-10 23:12:36.231325
NCT02474680|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-05-02|||November 1, 2015|Actual|2015-11-01|May 2017|2017-05-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Observational|PGx-TIME||Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes|Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes|Completed||N/A|84|Actual|Avera McKennan Hospital & University Health Center|||1||f||||t||||||Samples With DNA|"     serum   "|||2017-10-10 23:12:36.330097|2017-10-10 23:12:36.330097
NCT02474667|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-08-17|||January 2016||2016-01-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney|A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 to Reduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney|Recruiting||Phase 3|152|Anticipated|Angion Biomedica Corp||2|||f||||t||||||||||2017-10-10 23:12:36.999452|2017-10-10 23:12:36.999452
NCT02474654|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-06-15|||July 2015||2015-07-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Implementation of a Pain Management Protocol for Total Knee Arthroplasty|An Analysis of the Functional Benefit, Narcotic Use and Time to Discharge Readiness Following the Implementation of a Comprehensive Pain Management Protocol for Primary Total Knee Arthroplasty|Unknown status|Not yet recruiting|Phase 4|220|Anticipated|Health Sciences North Research Institute||5|||f||||f||||||||||2017-10-10 23:12:37.144734|2017-10-10 23:12:37.144734
NCT02474641|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-11-21|||June 2015||2015-06-01|November 2016|2016-11-01|June 2023|Anticipated|2023-06-01|June 2021|Anticipated|2021-06-01||Interventional|HYPOSIB||Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer|Adjuvant Radiotherapy After Breast-conserving Surgery in Early Breast Cancer: Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation|Recruiting||Phase 3|2324|Anticipated|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-10 23:12:37.288735|2017-10-10 23:12:37.288735
NCT02448472|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2016-02-14|||November 2015||2015-11-01|October 2015|2015-10-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Epidemiology of Sepsis in China|Chinese Epidemiological Study of Severe Sepsis.(CHESS Study)|Completed||N/A|2000|Anticipated|Southeast University, China|||1||f||||t||||||||||2017-10-10 23:17:29.373981|2017-10-10 23:17:29.373981
NCT02474628|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-17|||November 2013||2013-11-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Consistencies in Responses to Sodium Bicarbonate?|Consistencies in Responses to Sodium Bicarbonate Supplementation: a Randomised, Repeated Measures, Counterbalanced and Double-blind Study|Completed||N/A|15|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:12:37.584786|2017-10-10 23:12:37.584786
NCT02474615|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-06-17|||February 2013||2013-02-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||Applicability Clinic of Cement Portland Structural White in Endodontic Surgery|Applicability Clinic of Cement Portland Structural White in Endodontic Surgery|Completed||Phase 1/Phase 2|12|Actual|Universidade do Vale do Sapucai||2|||f||||f||||||||||2017-10-10 23:12:37.670637|2017-10-10 23:12:37.670637
NCT02474602|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-02-02|||June 2014||2014-06-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Phototherapy Applied in Association With Strength Training|Phototherapy Applied in Association of Muscle Training: Evaluation of Different Irradiation Protocols|Completed||N/A|48|Actual|University of Nove de Julho||4|||f||||t||||||||||2017-10-10 23:12:37.762898|2017-10-10 23:12:37.762898
NCT02474563|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-26|||May 2011||2011-05-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma|A Prospective, Open-label, Multicenter, Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone(VMP) for Initial Treatment in Patients With Multiple Myeloma Who do Not Undergo Autologous Stem Cell Transplantation|Completed||Phase 4|171|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-10 23:12:38.055352|2017-10-10 23:12:38.055352
NCT02474550|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-01-25|||April 2015||2015-04-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01|36 Months|Observational [Patient Registry]|||Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma|Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma|Recruiting||N/A|1000|Anticipated|Ajou University School of Medicine|||1||f||||t||||||||No||2017-10-10 23:12:38.176342|2017-10-10 23:12:38.176342
NCT02474537|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-05-16|||June 12, 2015|Actual|2015-06-12|May 2017|2017-05-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function|An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function|Recruiting||Phase 1|36|Anticipated|Novartis||4|||f||||f||||||||||2017-10-10 23:12:38.292096|2017-10-10 23:12:38.292096
NCT02474524|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2017-09-14|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|SMARTTherapy||Self-Management and Recovery Technology Psychosocial Intervention Trial|Psychosocial Intervention Using Online Resources to Promote Personal Recovery in Users of Specialist Mental Health Services|Completed||N/A|148|Actual|Swinburne University of Technology||2|||f||||f||||||||||2017-10-10 23:12:38.388783|2017-10-10 23:12:38.388783
NCT02474511|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2015-06-16|||June 2015||2015-06-01|June 2015|2015-06-01|April 2019|Anticipated|2019-04-01|June 2018|Anticipated|2018-06-01||Observational|||the Influence of General Anesthesia on Tumor Metastasis and Recurrence||Recruiting||N/A|300|Anticipated|RenJi Hospital|||2||f||||t||||||Samples Without DNA|"     blood   "|||2017-10-10 23:12:38.485461|2017-10-10 23:12:38.485461
NCT02474498|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-01-30|2016-03-21||March 2013||2013-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional||Potential patients were selected from those referred to the Graduate Clinic of the Piracicaba Dental School. All patients received a complete periodontal examination, including anamnesis, a full-mouth periodontal probing, and radiographic examination. One furcation defect per patient was chosen, using Nabers probe.|EMD and/or Bone Substitute for the Treatment of Class II Furcations|Enamel Matrix Protein Derivative and/or Synthetic Bone Substitute for the Treatment of Mandibular Class II Buccal Furcation Defects. A 12-month Randomized Clinical Trial|Completed||Phase 4|41|Actual|University of Campinas, Brazil|This clinical trial did not show limitations.|3|||f||||t||||||||No||2017-10-10 23:12:38.60381|2017-10-10 23:12:38.60381
NCT02474485|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-04-27|||March 2015||2015-03-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|May 2018|Anticipated|2018-05-01||Interventional|AbsorbISR||Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR|Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis|Terminated||N/A|53|Actual|SIS Medical AG||2||"Information of other studies with Abseb bioresorbable scaffolds showed a higher thrombotic risk   than before, the risk for the Patients is estimated too high"|f||||f||||||||||2017-10-10 23:12:39.00441|2017-10-10 23:12:39.00441
NCT02474472|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2016-10-24|||October 2013||2013-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PAIN||Postoperative Analgesia Investigation|A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control.|Enrolling by invitation||Phase 4|280|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Yes|University data-sharing agreement required.|2017-10-10 23:12:39.092854|2017-10-10 23:12:39.092854
NCT02474459|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2017-04-07|||July 2015||2015-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Mobile Decision Support System for Nurse Management of Neuromodulation Therapy||Recruiting||N/A|160|Anticipated|University of Utah||2|||f||||t|f|f||||||||2017-10-10 23:12:39.161823|2017-10-10 23:12:39.161823
NCT02447120|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-11-30|||May 2015||2015-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Topcon 3D OCT-1 Maestro Reference Database Study II|Topcon 3D OCT-1 Maestro Reference Database Study II|Completed||N/A|504|Actual|Topcon Medical Systems, Inc.||1|||f||||f||||||||||2017-10-10 23:17:45.723636|2017-10-10 23:17:45.723636
NCT02474433|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2016-04-28|||July 2015||2015-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Same-day Cervical Preparation With Misoprostol Before Hysteroscopy|Same-day Cervical Preparation With Misoprostol Before Hysteroscopy: a Randomized Trial of Different Routes of Administration|Recruiting||Phase 4|120|Anticipated|Wolfson Medical Center||3|||f||||||||||||||2017-10-10 23:12:39.321482|2017-10-10 23:12:39.321482
NCT02474420|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|CANALI||Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients|The Use of the Calcium Channel Blocker Amlodipine as an Adjuvant Treatment to Iron Chelation for the Prevention of Iron Overload Cardiomyopathy in Patients With Thalassemia|Recruiting||N/A|60|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:12:39.397014|2017-10-10 23:12:39.397014
NCT02474407|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-07-24|||June 2015||2015-06-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||A Study to Determine the Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)|An Open-Label, Randomized, Crossover Pharmacokinetic Study to Determine the Bioavailability, Safety and Tolerability of Single Doses of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®) in Patients With Refractory Epilepsy|Terminated||Phase 2|110|Actual|Acorda Therapeutics||1|||f||||t||||||||||2017-10-10 23:12:39.474706|2017-10-10 23:12:39.474706
NCT02474394|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2015-06-25|||February 2013||2013-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Videolaryngoscope on Intraocular Pressure|The Comparison of the Effects of McGrath Video Laryngoscope and the Macintosh Laryngoscope on Intraocular Pressure: A Randomized Trial|Completed||Phase 4|80|Actual|Tokat Gaziosmanpasa University||2|||f||||t||||||||||2017-10-10 23:12:41.280177|2017-10-10 23:12:41.280177
NCT02474381|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-12|||December 2012||2012-12-01|December 2012|2012-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Autologous Endothelial Progenitor Cells Treatment of Diabetic Foot|Efficacy Study of Autologous Endothelial Progenitor Cells Treatment of Diabetic Foot With Infrapopliteal Arterial Stenosis/Occlusion|Unknown status|Recruiting|N/A|60|Anticipated|Shanghai 10th People's Hospital||2|||f||||f||||||||||2017-10-10 23:12:41.343044|2017-10-10 23:12:41.343044
NCT02474368|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-08-05|||November 2015||2015-11-01|August 2016|2016-08-01|June 2021|Anticipated|2021-06-01|October 2018|Anticipated|2018-10-01||Interventional|||Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck|Phase I Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck|Recruiting||Phase 1|46|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||Undecided||2017-10-10 23:12:41.434522|2017-10-10 23:12:41.434522
NCT02474355|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-10-03|||September 18, 2015|Actual|2015-09-18|October 2017|2017-10-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|ASTRIS||Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC|Open Label, Multinational, Multicenter, Real World Treatment Study of Single Agent AZD9291 for Patients With Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR) T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Who Have Received Prior Therapy With an EGFR Tyrosine Kinase Inhibitor (EGFR-TKI)|Recruiting||Phase 3|3515|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:12:41.565166|2017-10-10 23:12:41.565166
NCT02474342|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-03-06|||July 7, 2015||2015-07-07|May 2016|2016-05-01|November 7, 2016|Actual|2016-11-07|November 2016|Actual|2016-11-01||Interventional|||Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease|Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Rotator Cuff Disease|Completed||N/A|18|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 23:12:42.26265|2017-10-10 23:12:42.26265
NCT02474316|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-12-02|||August 2014||2014-08-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients|A Prospective, Randomized, Multicenter, Open-label Study Evaluating HBeAg Seroconversion in HBeAg Positive CHB Patients on Treatment With NA Switched to Combined Therapy With Peginterferon Alfa-2a and NA for 48 Weeks|Recruiting||Phase 4|366|Anticipated|Ruijin Hospital||2|||f||||f||||||||||2017-10-10 23:12:42.470307|2017-10-10 23:12:42.470307
NCT02474303|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-10-26|||July 2015||2015-07-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Demonstration Project of PrEP Among Female Sex Workers in Dakar, Senegal|A Demonstration Project of HIV Pre-exposure Prophylaxis (PrEP) With Tenofovir DF/Emtricitabine (TDF/FTC Among Female Sex Workers in Dakar, Senegal|Unknown status|Recruiting|N/A|1500|Anticipated|Réseau Africain de Recherche sur le SIDA||1|||f||||f||||||||||2017-10-10 23:12:42.572324|2017-10-10 23:12:42.572324
NCT02474277|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-06-16|||November 2014||2014-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||How Well Does the 30-Second Chair Stand Test Predict Rehabilitation Needs in Acutely Admitted Elderly Patients|How Well Does the 30-second Chair Stand Test Predict Rehabilitation Needs in Acutely Admitted Elderly Patients?|Completed||N/A|156|Actual|University of Southern Denmark||1|||f||||f||||||||||2017-10-10 23:12:42.747075|2017-10-10 23:12:42.747075
NCT02474264|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-07-13|||February 2015||2015-02-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||The Link Between BRCA Mutation and Endothelial Function|The Link Between BRCA Mutation and Endothelial Function - A Pilot Study|Recruiting||N/A|82|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-10 23:12:42.809823|2017-10-10 23:12:42.809823
NCT02474251|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-10-05|||September 2015||2015-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Observational|Brain SCRAPs||Brain Sleep Clearance of Amyloid-Beta Peptides|Brain Sleep Clearance of Amyloid-Beta Peptides|Recruiting||N/A|55|Anticipated|New York University School of Medicine|||2||f||||f|f|t|f|f||Samples With DNA|"     Cerebrospinal Fluid Blood   "|||2017-10-10 23:12:42.89348|2017-10-10 23:12:42.89348
NCT02474238|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-08-08|||May 2015||2015-05-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy|Randomized Clinical Trial Comparing Neodynium:Ytrium-aluminium-garnet (Nd:YAG) Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy in Patients With Dark Iris|Recruiting||N/A|82|Anticipated|Prince of Songkla University||2|||f||||t||||||||||2017-10-10 23:12:43.086396|2017-10-10 23:12:43.086396
NCT02474225|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-16|||December 2013||2013-12-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Intraocular Pressure Change Following Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agent|Intraocular Pressure Change Following Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agent|Completed||N/A|70|Actual|Prince of Songkla University|||1||f||||f||||||||||2017-10-10 23:12:43.196126|2017-10-10 23:12:43.196126
NCT02474212|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2016-05-20|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery||Recruiting||Phase 4|80|Anticipated|Tampere University Hospital||4|||f||||f||||||||||2017-10-10 23:12:43.285914|2017-10-10 23:12:43.285914
NCT02474199|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-06-23|||September 2015||2015-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|ARTEMIS||Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction|Safety of Donor Alloantigen Reactive Tregs to Facilitate Minimization and/or Discontinuation of Immunosuppression in Adult Liver Transplant Recipients (CTOTC-12)|Recruiting||Phase 1/Phase 2|18|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-10 23:12:43.395263|2017-10-10 23:12:43.395263
NCT02474186|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-08-01|||April 2003||2003-04-01|August 2017|2017-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Phase II Study for Solid Metastatic Tumors|Phase II Study of Chemo-Radiation-Induced Abscopal Effect in Metastatic Breast Cancer and in Other Metastatic Sites of Solid Tumors|Completed||Phase 2|41|Actual|New York University School of Medicine||1|||f||||t|f|f|||f|||||2017-10-10 23:12:43.525459|2017-10-10 23:12:43.525459
NCT02474173|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-09-15|||January 15, 2016|Actual|2016-01-15|September 2017|2017-09-01||||January 1, 2018|Anticipated|2018-01-01||Interventional|||Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer|Phase 1b Study of HSP90 Inhibitor, AT13387 in Combination With Paclitaxel in Patients With Advanced, Triple Negative Breast Cancer|Recruiting||Phase 1|24|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:12:43.613705|2017-10-10 23:12:43.613705
NCT02474160|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-09-28|||May 15, 2015|Actual|2015-05-15|September 2017|2017-09-01||||May 4, 2020|Anticipated|2020-05-04||Observational|||Collection and Storage of Tissue and Blood Samples From Patients With Cancer|Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)|Recruiting||N/A|5000|Anticipated|National Cancer Institute (NCI)|||1||f||||f||||||||||2017-10-10 23:12:43.747719|2017-10-10 23:12:43.747719
NCT02474147|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-08-22|||August 2015||2015-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|RewCrav||Processed Meat and Brain Regions Related to Reward and Addiction|Effects of Processed Meat on Brain Regions Related to Reward and Craving in Patients With Type 2 Diabetes, Obese Subjects and Healthy Controls|Active, not recruiting||N/A|60|Anticipated|Institute for Clinical and Experimental Medicine||3|||f||||f||||||||||2017-10-10 23:12:44.370131|2017-10-10 23:12:44.370131
NCT02474134|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-11-13|||March 2015||2015-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Comparison Study of PF530 and Betaferon in Healthy Subjects|A Phase 1 Double-Blind, Randomised, Two-Treatment Cross-over Study Comparing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF530 and Betaferon Administered by Subcutaneous Injection in Healthy Adult Volunteers|Completed||Phase 1|12|Actual|Pfenex, Inc||2|||f||||f||||||||||2017-10-10 23:12:44.452155|2017-10-10 23:12:44.452155
NCT02474121|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-09-13||||||September 2017|2017-09-01||||||||Expanded Access|MOBILE-CA||Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access|MarrOwStim™ PAD Kit for the Treatment of Critical LimB IschemIa (CLI) in Subjects With Severe Peripheral ArteriaL DiseasE (PAD) (MOBILE) - Continued Access|Available||N/A|||Zimmer Biomet|||||||||||||||||||2017-10-10 23:12:44.525315|2017-10-10 23:12:44.525315
NCT02474108|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-09-08|||March 2, 2015|Actual|2015-03-02|September 2017|2017-09-01|October 20, 2016|Actual|2016-10-20|May 5, 2016|Actual|2016-05-05||Interventional|||Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement|Pilot, Randomized,Single Blind Trial of Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion|Completed||N/A|40|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 23:12:44.630115|2017-10-10 23:12:44.630115
NCT02474095|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-08-30|||November 4, 2014|Actual|2014-11-04|August 2017|2017-08-01|September 4, 2019|Anticipated|2019-09-04|September 4, 2018|Anticipated|2018-09-04||Interventional|||Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer|Two Versus Four Times-Weekly ALTENS for Treatment of Radiation-Induced Xerostomia: A Pilot Study|Active, not recruiting||N/A|30|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-10 23:12:44.791524|2017-10-10 23:12:44.791524
NCT02473874|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-02-08|||June 2015||2015-06-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Comparison Imaging System Between Spatially Modulated Quantitative Spectroscopy and Skin Spect Dermoscopy|Spectral Comparison Between Spatially Modulated Quantitative Spectroscopy and Polarization-Sensitive Hyperspectral Multimode Dermoscopy for the Purpose of Skin Compositional Analysis|Recruiting||N/A|30|Anticipated|University of California, Irvine|||2||f||||f||||||||||2017-10-10 23:12:47.022056|2017-10-10 23:12:47.022056
NCT02474056|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2016-09-28|||January 2010||2010-01-01|September 2016|2016-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||The Impact of the Fluid Resuscitation on the Venous Volume and Flow Characteristics in Hypovolemic Shock||Withdrawn||N/A|0|Actual|HaEmek Medical Center, Israel|||3|The researcher couldnt handle it|f||||||||||||||2017-10-10 23:12:45.369822|2017-10-10 23:12:45.369822
NCT02474043|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-15|2017-05-01|||August 2014||2014-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Hep-Net||A Community-based, Behavioral Intervention to Improve Screening for Hepatitis C Among High-risk Young Adults in Wisconsin|A Community-based, Behavioral Intervention to Improve Screening for Hepatitis C Among High-risk Young Adults in Wisconsin|Active, not recruiting||N/A|225|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 23:12:45.442677|2017-10-10 23:12:45.442677
NCT02474030|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-03-29|||February 2013||2013-02-01|March 2016|2016-03-01||||October 2015|Actual|2015-10-01||Observational|||Relationship Between Electrical Pain Tolerance Threshold of Alveolar Ridge and Individual Attributes||Recruiting||N/A|150|Anticipated|Nihon University|||1||f||||||||||||||2017-10-10 23:12:45.527552|2017-10-10 23:12:45.527552
NCT02474017|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-09-25|||May 2015||2015-05-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||An Open Study to Assess the Robustness of the CRC749 Inhaler|An Open Study to Assess the Robustness of the CRC749 Device by Pharmaceutical Performance Following Twice Daily Dosing of MGR001 Administered Via Oral Inhalation in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|111|Actual|Mylan Inc.||1|||f||||f||||||||||2017-10-10 23:12:45.592132|2017-10-10 23:12:45.592132
NCT02473991|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2017-04-21|2017-01-17||March 2015||2015-03-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight|Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight|Completed||N/A|395|Actual|Ain Shams Maternity Hospital|||1||f||||f||||||Samples Without DNA|"     placenta is weighed in grams as described by Azpurua et al.   "|No||2017-10-10 23:12:45.692483|2017-10-10 23:12:45.692483
NCT02473978|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-05-08|||April 2015||2015-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Cerebral Near-infrared Spectroscopy (NIRS) Monitoring Throughout Caesarean Deliveries|Cerebral Near-infrared Spectroscopy (NIRS) Monitoring Throughout Caesarean Deliveries|Completed||N/A|84|Actual|Rabin Medical Center|||2||f||||f||||||||||2017-10-10 23:12:45.904748|2017-10-10 23:12:45.904748
NCT02473965|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2017-06-16|||June 2015||2015-06-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis|Recruiting||Phase 2|60|Anticipated|Grifols Therapeutics Inc.||2|||f||||||||||||||2017-10-10 23:12:46.012506|2017-10-10 23:12:46.012506
NCT02473952|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2017-06-16|||July 2015||2015-07-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis|A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis|Recruiting||Phase 2|62|Anticipated|Grifols Therapeutics Inc.||2|||f||||||||||||||2017-10-10 23:12:46.294566|2017-10-10 23:12:46.294566
NCT02473939|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-12-19|||June 2015||2015-06-01|December 2016|2016-12-01||||April 2016|Actual|2016-04-01||Interventional|||An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma|A Randomised, Double-blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of VR942 in Healthy Subjects and Repeated Doses in Mild Asthmatics|Completed||Phase 1|85|Actual|Vectura Limited||5|||f||||f||||||||||2017-10-10 23:12:46.544068|2017-10-10 23:12:46.544068
NCT02473926|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-08-29|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes|Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes|Recruiting||N/A|130|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:12:46.611853|2017-10-10 23:12:46.611853
NCT02473913|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-01-09|||March 2015||2015-03-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Milk Thistle in Trichotillomania in Children and Adults|Silymarin Treatment of Trichotillomania in Children and Adults: A Double-Blind, Placebo-Controlled, Cross-Over Study|Recruiting||Phase 2|14|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-10 23:12:46.699522|2017-10-10 23:12:46.699522
NCT02473900|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-14|2016-10-12|||April 2015||2015-04-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluating the Bioequivalence of HIP1403, HGP0919|An Open-label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetics of HIP1403 in Healthy Male Subjects|Completed||Phase 1|32|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-10 23:12:46.782384|2017-10-10 23:12:46.782384
NCT02473887|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-06-14|||September 2014||2014-09-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting|Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting|Completed||Phase 1|40|Actual|Hamad Medical Corporation||1|||f||||t||||||||||2017-10-10 23:12:46.848221|2017-10-10 23:12:46.848221
NCT02473861|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-09-04|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|EXIT||EXercise Influence on Taxane Side Effects (EXIT) Study|EXercise Influence on Taxane Side Effects (EXIT) Study|Recruiting||N/A|43|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:12:47.123264|2017-10-10 23:12:47.123264
NCT02473848|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-05-10|||June 2015||2015-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|IMOT001||Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses|A Multi-center, Open-label, Uncontrolled, Investigator-initiated Trial to Evaluate the Safety and Efficacy of Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses on the Trunk and Extremities|Recruiting||Phase 3|165|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:12:47.235174|2017-10-10 23:12:47.235174
NCT02473835|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-12|||January 2013||2013-01-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of a Short Term Caloric Restriction on T Cell Activation in Fat|Effects of a Short Term Caloric Restriction on T Cell Activation in Fat|Completed||N/A|12|Actual|University of Bath||1|||f||||f||||||||||2017-10-10 23:12:47.313515|2017-10-10 23:12:47.313515
NCT02473822|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-06-12|||June 2015||2015-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||ACL Reconstruction With the TLS Technique|ACL Reconstruction With the TLS Technique (Tape Locking Screw) and Return to Sport: Serial 5-year Independent Designers|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:12:47.397733|2017-10-10 23:12:47.397733
NCT02473809|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-10-27|||August 2015||2015-08-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|LIRABONE||The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function|The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function|Recruiting||Phase 4|60|Anticipated|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-10 23:12:47.4591|2017-10-10 23:12:47.4591
NCT02473796|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-03-15|||January 2004||2004-01-01|March 2016|2016-03-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|HBCC||Home Based Child Care to Reduce Mortality and Malnutrition in Tribal Children of Melghat, India: CRCT|Effect of Home Based Child Care on Child Mortality and Malnutrition in a Tribal Population of Melghat, India: Cluster Randomised Control Field Trial|Completed||N/A|7594|Actual|MAHAN Trust||2|||f||||t||||||||||2017-10-10 23:12:47.574103|2017-10-10 23:12:47.574103
NCT02473770|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2017-06-30|||May 20, 2015||2015-05-20|April 26, 2017|2017-04-26|May 30, 2025|Anticipated|2025-05-30|May 30, 2025|Anticipated|2025-05-30||Observational|||Rapid Acquisition of Pre- and Post-Incident Disaster Data|Rapid Acquisition of Pre and Post-Incident Disaster Data Study|Not yet recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:12:47.72375|2017-10-10 23:12:47.72375
NCT02473757|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2017-06-30|||June 1, 2015||2015-06-01|May 4, 2017|2017-05-04|August 1, 2050|Anticipated|2050-08-01|July 1, 2034|Anticipated|2034-07-01||Observational|||Gene Therapy Follow-up Protocol for People Previously Enrolled in NCI Experimental Transplantation and Immunology Branch Studies|Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Experimental Transplantation and Immunology Branch Studies|Enrolling by invitation||N/A|17|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:12:47.785064|2017-10-10 23:12:47.785064
NCT02473744|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-09-02|||July 2015||2015-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|DSOPAL||Oedematous Lower Limb Subcutaneous Drainage in Palliative Care|Oedematous Lower Limb Subcutaneous Drainage in Palliative Care|Recruiting||N/A|31|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-10-10 23:12:47.85449|2017-10-10 23:12:47.85449
NCT02473731|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-05-11|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|October 10, 2016|Actual|2016-10-10|September 22, 2016|Actual|2016-09-22||Interventional|||A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients|A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients|Completed||Phase 1|12|Actual|Celldex Therapeutics||2|||f||||f||f||||||||2017-10-10 23:12:48.018548|2017-10-10 23:12:48.018548
NCT02473718|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-11|||January 2014||2014-01-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Fluid Balance in the ICU - Interventions to Minimize Fluids in Patients With Septic Shock||Completed||N/A|82|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 23:12:48.101925|2017-10-10 23:12:48.101925
NCT02473705|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-09-07|||January 2016||2016-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CKD&CAD||Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease|Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||4||Unable to find eligible participants to participate in the study.|f||||t||||||||||2017-10-10 23:12:48.189722|2017-10-10 23:12:48.189722
NCT02473692|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-08-02|||June 2017|Anticipated|2017-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Facilitating Migraine Medication Adherence and Optimizing Medication Use|Examining Feasibility and Effectiveness of an Internet-based Intervention for Facilitating Migraine Medication Adherence and Optimizing Medication Use|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences|||1|Delays in start date led to termination of the study prior to recruitment of participants.|f||||f|f|f||||||||2017-10-10 23:12:48.282665|2017-10-10 23:12:48.282665
NCT02473679|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-11-01|||January 2003||2003-01-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Influence of the Education in Layperson in Out of Hospital Resuscitation|Influence of the Education in Layperson Resuscitation and Preparation the Patrol Car of the City Police With Automatic External Defibrillators and Automated Ventilation Equipment on Out of Hospital Resuscitation Outcome|Completed||N/A|1662|Actual|University of Zurich|||1||f||||f||||||||||2017-10-10 23:12:48.352917|2017-10-10 23:12:48.352917
NCT02473666|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-05-11|||January 2012||2012-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PBM-USZ||Patient Blood Management - Use and Outcome|Patient Blood Management - Use and Outcome|Recruiting||N/A|300000|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 23:12:48.426645|2017-10-10 23:12:48.426645
NCT02473627|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-11-04|||May 2015||2015-05-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS|A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS|Completed||Phase 1|18|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-10 23:12:48.626344|2017-10-10 23:12:48.626344
NCT02473601|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2015-08-20|||October 2014||2014-10-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis|To Observe Mivacurium Chloramine Muscle Relaxation Effect in the Operation Anesthesia Patients With Liver Cirrhosis|Unknown status|Recruiting|Phase 2|80|Anticipated|Tang-Du Hospital||2|||f||||f||||||||||2017-10-10 23:12:48.786148|2017-10-10 23:12:48.786148
NCT02473588|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-12|||June 2015||2015-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Long Time Interval Analysis for Non Invasive Measurement of Cardiac Output|Comparison of Retia Medical (Long Time Interval Analysis) to Deltex Esophageal Doppler for Cardiac Output Measurement|Unknown status|Recruiting|N/A|60|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-10 23:12:48.875017|2017-10-10 23:12:48.875017
NCT02473575|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-04-18|||June 2015||2015-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Does a Caffeine Gum Improve 5 km Run Performance in a Competition/Field Setting?|Does a Commercial Caffeine Supplement Improve 5 km Run Performance in a Field Setting?|Completed||N/A|36|Actual|Sheffield Hallam University||3|||f||||f||||||||||2017-10-10 23:12:48.93628|2017-10-10 23:12:48.93628
NCT02473562|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-12-08|||May 2013||2013-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|VESPA||Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease|Varenicline, a Partial Nicotinic Receptor Agonist for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease: a Placebo-controlled Cross-over Pilot Study|Active, not recruiting||Phase 4|22|Actual|VU University Medical Center||2|||f||||f||||||||||2017-10-10 23:12:49.009464|2017-10-10 23:12:49.009464
NCT02473549|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2017-05-19|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|September 1, 2019|Anticipated|2019-09-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||Improving Motor Stroke Recovery Using Patient-tailored Non-invasive Brain Stimulation|Towards More Successful Clinical Trials: Using a Patient-tailored Approach in Brain Stimulation to Improve Recovery of Movements After Stroke|Not yet recruiting||N/A|26|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t|f|f||||||||2017-10-10 23:12:49.087383|2017-10-10 23:12:49.087383
NCT02473536|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-02-23|||June 2015||2015-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC|Safety Lead-in Phase II Trial of Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 23:12:49.15038|2017-10-10 23:12:49.15038
NCT02473523|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-01-17|2017-01-17||June 2015||2015-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia|Feasibility of Implementing Yoga Intervention for Adolescents at St. Jude Children's Research Hospital|Terminated||N/A|2|Actual|St. Jude Children's Research Hospital|The study was terminated because the principal investigator left the institution. One participant completed only 8 of 16 sessions and was not evaluable for study objectives.|1||The principal investigator left the institution.|f||||f||||||||||2017-10-10 23:12:49.239305|2017-10-10 23:12:49.239305
NCT02473510|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-10-05|2016-10-05||June 2015||2015-06-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|FluMist|The intent-to-treat (ITT) population included all participants that were randomized and treated with investigational product.|Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season|A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults|Completed||Phase 4|301|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-10 23:12:49.517821|2017-10-10 23:12:49.517821
NCT02473497|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-09-28||||||September 2017|2017-09-01||||||||Expanded Access|||Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients|Crizotinib (Xalkori(Registered)) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients With Solid Or Hematologic Malignancies That Harbor A Crizotinib-sensitive Molecular Alteration But Who Are Unable To Swallow Crizotinib Capsules|Available||N/A|||Pfizer||||||t|||||||||||||2017-10-10 23:12:49.863697|2017-10-10 23:12:49.863697
NCT02473484|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-05-17|||June 24, 2014|Actual|2014-06-24|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|GLIOMIC||Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas|Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas|Recruiting||N/A|50|Anticipated|University Hospital, Lille|||1||f||||t||||||Samples With DNA|"     tumoral DNA   "|No||2017-10-10 23:12:49.935533|2017-10-10 23:12:49.935533
NCT02473445|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-04-11|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|||A Long-Term Extension Study of RP103-MITO-001 (NCT02023866) to Assess RP103 in Children With Inherited Mitochondrial Disease|A Long-Term Open-Label Extension Study of RP103-MITO-001 to Assess the Safety, Tolerability and Efficacy of Cysteamine Bitartrate Delayed-release Capsules (RP103) for Treatment of Children With Inherited Mitochondrial Disease|Completed||Phase 2|22|Actual|Horizon Pharma USA, Inc.||1|||f||||f||||||||||2017-10-10 23:12:50.280225|2017-10-10 23:12:50.280225
NCT02473432|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-02-15|||December 2013||2013-12-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke|Neuromuscular Electroestimulation and Respiratory Muscle Training in the Management of Dysphagia of Subacute Stroke Patients|Completed||Phase 4|62|Actual|Parc de Salut Mar||3|||f||||f||||||||||2017-10-10 23:12:50.397274|2017-10-10 23:12:50.397274
NCT02473419|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-03-24|||May 2015||2015-05-01|March 2017|2017-03-01|March 2, 2017|Actual|2017-03-02|March 2, 2017|Actual|2017-03-02||Observational|VAYA-fMRI||Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment|Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment|Completed||N/A|107|Actual|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||||||2017-10-10 23:12:50.512079|2017-10-10 23:12:50.512079
NCT02473406|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-17|||August 2015||2015-08-01|June 2015|2015-06-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Severe Acute Pancreatitis|Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Severe Acute Pancreatitis|Unknown status|Not yet recruiting|Early Phase 1|510|Anticipated|Nanjing University School of Medicine||2|||f||||f||||||||||2017-10-10 23:12:50.600398|2017-10-10 23:12:50.600398
NCT02473393|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-08-16|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis||Active, not recruiting||Phase 2|60|Anticipated|Otsuka Pharmaceutical Co., Ltd.||4|||f||||t||||||||||2017-10-10 23:12:50.682506|2017-10-10 23:12:50.682506
NCT02473380|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-10-04|||August 2015||2015-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|GLIOSPECT||Fluorescence Spectroscopy Guided Surgery|Fluorescence Spectroscopy Guided Surgery for Brain Tumors Resection: a Feasibility Study in Human|Completed||Phase 1|11|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:12:50.757038|2017-10-10 23:12:50.757038
NCT02473367|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-02-20|2016-07-19||June 2015||2015-06-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)|A Study to Evaluate the Influence of Metal Cation-Containing Antacids on MK-0518 Pharmacokinetics in HIV-Infected Subjects on a Stable Raltegravir-Containing Regimen|Completed||Phase 1|20|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:12:50.842418|2017-10-10 23:12:50.842418
NCT02473354|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-27|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|(OIRD)||Predictors of Opioid-Induced Respiratory Depression (OIRD)|Predictors of Opioid-Induced Respiratory Depression (OIRD)|Recruiting||Phase 1|20|Anticipated|Duke University||1|||f||||f||||||||Undecided||2017-10-10 23:12:51.283529|2017-10-10 23:12:51.283529
NCT02473341|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-09-29|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|BASH||Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial|Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial|Not yet recruiting||Phase 3|250|Anticipated|Dayanand Medical College and Hospital||2|||f||||t|f|f||||||||2017-10-10 23:12:51.386641|2017-10-10 23:12:51.386641
NCT02473328|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-08-17|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ATALOW||Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients|Non-comparative Phase II Open Study Evaluating the Efficacy of a Reduced Dose Atazanavir / Ritonavir 200/100 mg + 2 NRTI in HIV-1-infected Patients With Virological Success With Atazanavir / Ritonavir 300/100 mg + 2 NRTI|Recruiting||Phase 2|90|Anticipated|Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida||1|||f||||t||||||||||2017-10-10 23:12:51.548407|2017-10-10 23:12:51.548407
NCT02473315|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-08-23|||July 2016||2016-07-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis|Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis|Recruiting||N/A|36|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:12:51.664265|2017-10-10 23:12:51.664265
NCT02473302|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-06-12|||April 2014||2014-04-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Preventive Strategies in Colorectal Carcinogenesis Production and Meat Processing|Preventive Strategies in Colorectal Carcinogenesis Production and Meat Processing|Completed||N/A|24|Actual|Institut National de la Recherche Agronomique||6|||f||||f||||||||||2017-10-10 23:12:51.743784|2017-10-10 23:12:51.743784
NCT02473289|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-09-22|||July 23, 2015|Actual|2015-07-23|September 2017|2017-09-01|May 31, 2018|Anticipated|2018-05-31|October 16, 2017|Anticipated|2017-10-16||Interventional|||An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder|A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a Monoaminergic Antidepressant in Adults With Major Depressive Disorder|Recruiting||Phase 2|192|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 23:12:51.855702|2017-10-10 23:12:51.855702
NCT02473276|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-07-23|||September 2015||2015-09-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||2 Dose Neuraxial Morphine for Prevention of PDPH|Two Dose Neuraxial Morphine for Prevention of Postdural Puncture Headache|Recruiting||Phase 4|400|Anticipated|Columbia University||4|||f||||t||||||||||2017-10-10 23:12:52.059334|2017-10-10 23:12:52.059334
NCT02473263|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-06-27|||May 2016||2016-05-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|SSS||Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock|Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock|Recruiting||Phase 3|550|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 23:12:52.153987|2017-10-10 23:12:52.153987
NCT02473250|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-03-28|||January 2015||2015-01-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging|Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging|Recruiting||Phase 4|25|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-10 23:12:52.253745|2017-10-10 23:12:52.253745
NCT02473237|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-10-14|||April 2013||2013-04-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|EMERAL||Efficacy in Walked Distance of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass (EMERALD)|Efficacy and Acute Effects on Walked Distance froM basEline and Post Dose of indacateRol vs Tiotropium in Women With modeRAte to Severe COPD Secondary to Biomass Exposure: Open Label Crossover Clinical Trial|Completed||Phase 4|40|Anticipated|National Institute of Respiratory Diseases, Mexico||2|||f||||t||||||||||2017-10-10 23:12:52.356769|2017-10-10 23:12:52.356769
NCT02473224|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-10-05|||October 28, 2015|Actual|2015-10-28|July 19, 2017|2017-07-19||||January 5, 2018|Anticipated|2018-01-05||Interventional|||Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies|Phase I Study to Determine the Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies|Recruiting||Phase 1|44|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f|||||t|f|||f|||||2017-10-10 23:12:52.452853|2017-10-10 23:12:52.452853
NCT02473211|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-01-15|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients|Efficacy and Safety of Sofosbuvir Plus Daclatasvir in Chinese Treatment-experienced Patients With Chronic Genotype 1b HCV Infection|Recruiting||Phase 2/Phase 3|100|Anticipated|Humanity and Health Research Centre||1|||f||||f||||||||||2017-10-10 23:12:52.542137|2017-10-10 23:12:52.542137
NCT02473198|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-03-16|||January 2014||2014-01-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Femoral Nerve Block Compared to Exparel in Total Knee Replacement|A Prospective Randomized Trial Comparing Femoral Nerve Black to Intraoperative Local Anesthetic Injection of Liposomal Bupivacaine (Exparel) in Total Knee Replacement|Active, not recruiting||Phase 3|312|Anticipated|The New England Baptist Hospital||2|||f||||t||||||||||2017-10-10 23:12:52.635956|2017-10-10 23:12:52.635956
NCT02473185|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-10-04|||September 2015||2015-09-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest|Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the Quantified Behavior Test in Patients With Untreated ADHD|Recruiting||Phase 4|40|Anticipated|Landstinget Västmanland||2|||f||||t||||||||||2017-10-10 23:12:52.727851|2017-10-10 23:12:52.727851
NCT02473172|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-11|||May 2013||2013-05-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|NAVA_PSV||Impact of the Assisted Ventilation Mode on Diaphragm Efficiency in Critically Ill Patients|Impact of Pressure Support Ventilation (PSV) Versus Neurally Adjusted Ventilatory Assist (NAVA) Diaphragm Efficiency|Completed||Phase 2|38|Actual|University of Bari||2|||f||||f||||||||||2017-10-10 23:12:52.819046|2017-10-10 23:12:52.819046
NCT02473159|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-06-17|||March 2015||2015-03-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Breast Cancer|Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Breast Cancer: Interventional Pilot Study for 5 Patients|Unknown status|Recruiting|Phase 2|5|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-10 23:12:52.897189|2017-10-10 23:12:52.897189
NCT02473146|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-03-17|||November 2015||2015-11-01|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|ALFA1401||Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4|Etude Exploratoire randomisée Comparant le Traitement Par Gemtuzumab Ozogamicin /Cytarabine au Traitement Standard Par Idarubicine/Cytarabinechez Les Sujets âgés de 60 à 80 Ans et présentant Une LAM et un Caryotype Non défavorable|Recruiting||Phase 2/Phase 3|225|Anticipated|Versailles Hospital||2|||f||||t||||||||||2017-10-10 23:12:52.981011|2017-10-10 23:12:52.981011
NCT02473133|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-07-27|||July 2015||2015-07-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|RTEP7||Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC|Randomized Phase II-III Study of Personalized Radiotherapy Dose Redistribution in Patients With Inoperable Stage III Non-small Cell Lung Cancer and a Persistent FDG Uptake at 42 Grays During Concomitant Radio-chemotherapy|Recruiting||Phase 2|150|Anticipated|Centre Henri Becquerel||2|||f||||t||||||||||2017-10-10 23:12:53.146683|2017-10-10 23:12:53.146683
NCT02473120|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-07-19|||June 2015||2015-06-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|FMER||Study of ESR1 Mutations in Metastatic Breast Cancer|Determination of ESR1 Mutations by Digital PCR During Aromatase Inhibitor Treatment in Metastatic Breast Cancer|Recruiting||N/A|125|Anticipated|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 23:12:53.233141|2017-10-10 23:12:53.233141
NCT02473107|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-05-27|||February 2015||2015-02-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Detecting Initial and Active Caries Lesions in Primary Teeth|CARies DEtection in Children - Cost-efficacy, Applicability and Impact on Quality of Life of Detecting Active Initial Caries Lesions in Primary Teeth|Recruiting||N/A|248|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:12:53.321666|2017-10-10 23:12:53.321666
NCT02473094|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-13|2016-05-16|||July 2015||2015-07-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|NEOMETRE||Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer|Metformin in Association to Chemoradiotherapy for the Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Randomized, Placebo-controlled Phase II Study|Recruiting||Phase 2|98|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||No||2017-10-10 23:12:53.431372|2017-10-10 23:12:53.431372
NCT02473081|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-11|||October 2012||2012-10-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Minimal Psychological Intervention in Diabetes Patients|The Long-term Effect of a Minimal Psychological Intervention on Type 2 Diabetes Patients' Depressive Symptom, Diabetes-related Distress and Glycemic Control|Completed||N/A|182|Actual|National Cheng-Kung University Hospital||2|||f||||||||||||||2017-10-10 23:12:53.531918|2017-10-10 23:12:53.531918
NCT02473068|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-08-08|||June 2015||2015-06-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||Non Invasive Ventilation Comfort Study|Non Invasive Ventilation Comfort Study|Recruiting||N/A|50|Anticipated|Fisher and Paykel Healthcare||2|||f||||||||||||||2017-10-10 23:12:53.597139|2017-10-10 23:12:53.597139
NCT02473055|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-16|||January 2003||2003-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|June 2008|Actual|2008-06-01||Interventional|||Kangaroo Care and Premature Infant Sleep|A Randomized Controlled Trial of Kangaroo Care (Skin-to-Skin) Effects on Sleep in Premature Infants|Completed||N/A|90|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-10-10 23:12:53.665242|2017-10-10 23:12:53.665242
NCT02473042|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-09-28|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)|Intraoperative Electrical Stimulation of the Acupoint P6 to Prevent Post-Operative Nausea and Vomiting in Women Undergoing Breast Cancer Surgery|Recruiting||N/A|176|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 23:12:53.761395|2017-10-10 23:12:53.761395
NCT02473029|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-02-03|||December 2014||2014-12-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|HORTIM||Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease||Recruiting||N/A|45|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 23:12:54.061275|2017-10-10 23:12:54.061275
NCT02473016|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-12-05|||September 2015||2015-09-01|December 2016|2016-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia|A Placebo-Controlled, Single-Blind Study Evaluating the Safety and Efficacy of Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia|Recruiting||Phase 2|50|Anticipated|Capnia, Inc.||1|||f||||f||||||||||2017-10-10 23:12:54.202873|2017-10-10 23:12:54.202873
NCT02473003|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-04-12|||March 2015||2015-03-01|April 2016|2016-04-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Interventional|Phys-Can||Physical Training and Cancer-a Multicenter Clinical Trial|Physical Training and Cancer- Effects and Understanding of Mechanisms for Prevent and Minimizing Cancer Related Fatigue, Improve Quality of Life and Disease Outcome|Enrolling by invitation||N/A|612|Anticipated|Uppsala University||4|||f||||f||||||||||2017-10-10 23:12:54.371149|2017-10-10 23:12:54.371149
NCT02472990|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-06-07|||July 2015||2015-07-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|MARCHE-DMD||Biomechanical and Morphological Changes in Dystrophic Muscle|Determining Biomechanical and Morphological Factors That Affect Children With Duchenne Muscular Dystrophy (DMD) Who Loss of the Ability to Walk|Recruiting||N/A|50|Anticipated|University Hospital, Brest||2|||f||||t||||||||||2017-10-10 23:12:54.506092|2017-10-10 23:12:54.506092
NCT02472977|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-03-09|||July 2015||2015-07-01|August 2016|2016-08-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|CXCessoR4||Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors|A Phase 1/2 Study of the Safety and Efficacy of Ulocuplumab Combined With Nivolumab in Subjects With Advanced or Metastatic Solid Tumors|Terminated||Phase 1/Phase 2|36|Actual|Bristol-Myers Squibb||2||Trial terminated because of lack of efficacy in the short term acute phase.|f||||t||||||||||2017-10-10 23:12:54.666331|2017-10-10 23:12:54.666331
NCT02472951|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-07-18|||August 2015||2015-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CutDM||Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study|Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study|Recruiting||N/A|36|Anticipated|Bispebjerg Hospital||3|||f||||t||||||||||2017-10-10 23:12:55.241141|2017-10-10 23:12:55.241141
NCT02472938|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-12-23|||July 2015||2015-07-01|December 2015|2015-12-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|PROMPT||Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis|Phase IV, Interventional, multicenteR, Double-blind, Randomized, Placebo-controlled Study tO Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With relapsingremitTing Multiple Sclerosis|Withdrawn||Phase 4|0|Actual|Biogen||2||Sponsor Decision|f||||f||||||||||2017-10-10 23:12:55.337427|2017-10-10 23:12:55.337427
NCT02472925|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-07-12|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|WTC||Way to Cure HCV Adherence|Way to Cure: Developing Effective Strategies to Promote Adherence to Hepatitis C Therapy Among Older Adults|Recruiting||N/A|60|Anticipated|University of Pennsylvania||3|||f||||f|f|f||||||||2017-10-10 23:12:55.434543|2017-10-10 23:12:55.434543
NCT02472912|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-15|||December 2014||2014-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Adalimumab PK Bioequivalence Study to EU and US Sourced Humira|Single Center, Randomized, Double-Blind, 3-Way Parallel Study to Compare the Pharmacokinetics, Safety and Tolerability of BMO-2 to EU and US Sourced Humira, Administered as a Single Dose (40 mg) Subcutaneous Injection in Healthy Adults|Completed||Phase 1|270|Actual|Mylan Inc.||3|||f||||f||||||||||2017-10-10 23:12:55.534804|2017-10-10 23:12:55.534804
NCT02472353|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-05-12|||July 2014||2014-07-01|May 2017|2017-05-01|July 2025|Anticipated|2025-07-01|July 2025|Anticipated|2025-07-01||Interventional|||Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer|A Phase II Pilot Study Using Metformin to Reduce Cardiac Toxicity in Breast Cancer Patients|Suspended||Phase 2|44|Anticipated|Avera McKennan Hospital & University Health Center||2|||f||||t||||||||||2017-10-10 23:13:04.986504|2017-10-10 23:13:04.986504
NCT02472899|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-05-04|||February 2007||2007-02-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|BiomarkerAD||Biomarker Study for Alzheimer's Disease|Peripheral Markers of Inflammation in Patients With Alzheimer's Disease Compared to Cognitively Normal Elderly|Recruiting||N/A|150|Anticipated|Beersheva Mental Health Center|||3||f||||f||||||Samples Without DNA|"     Frozen serum   "|||2017-10-10 23:12:55.639195|2017-10-10 23:12:55.639195
NCT02472886|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-03-30|2017-03-30||June 17, 2015|Actual|2015-06-17|March 2017|2017-03-01|June 30, 2016|Actual|2016-06-30|March 30, 2016|Actual|2016-03-30||Interventional||Safety Analysis Set included all participants who received at least 1 dose of study drug.|Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection|A Phase 3b, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection|Completed||Phase 3|153|Actual|Gilead Sciences||3|||f||||f|t|f|||t|||||2017-10-10 23:12:55.757594|2017-10-10 23:12:55.757594
NCT02472873|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-06-15|||June 2015||2015-06-01|June 2015|2015-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|EASLETE||Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas|Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas - a Prospective Case Control Study|Enrolling by invitation||N/A|120|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-10 23:12:56.505885|2017-10-10 23:12:56.505885
NCT02472860|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-08-29|||June 2015||2015-06-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|MGHTCT||Feasibility and Effectiveness of Computerized Cognitive Training in Adolescents With Autism Spectrum Disorder|Feasibility and Effectiveness of Computerized Cognitive Training in Adolescents With Autism Spectrum Disorder|Enrolling by invitation||N/A|30|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:12:56.617178|2017-10-10 23:12:56.617178
NCT02472847|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2015-07-28|2015-06-29||May 2012||2012-05-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Cannabinoid Control of Fear Extinction Neural Circuits in Humans|Cannabinoid Control of Fear Extinction Neural Circuits in Humans|Completed||Phase 4|85|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-10 23:12:56.69987|2017-10-10 23:12:56.69987
NCT02472834|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-11-09|||February 2016||2016-02-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CarRAAT-2||Trial of Carbamylation in Renal Disease-Modulation With Amino Acid Therapy|Amino Acid Therapy to Modify Protein Carbamylation in End Stage Renal Disease: A Randomized Trial|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:12:56.985011|2017-10-10 23:12:56.985011
NCT02472821|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-02-23|||February 17, 2015|Actual|2015-02-17|February 2017|2017-02-01|December 19, 2016|Actual|2016-12-19|December 19, 2016|Actual|2016-12-19||Interventional|FARMYOUTHEAR||Test of Hearing Health Education Programs for Farm and Rural Youth|Test of Hearing Health Education Programs for Farm and Rural Youth|Completed||N/A|2093|Actual|University of Michigan||3|||f||||f||||||||||2017-10-10 23:12:57.115975|2017-10-10 23:12:57.115975
NCT02472808|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-07-06|||June 2015||2015-06-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||A Trial to Compare Two Methods of Obtaining Tissue for Diagnosis of Sarcoidosis Namely the Conventional Method or the Ultrasound Guided Method|Diagnostic Utility of EBUS-TBNA Versus Conventional TBNA With Rapid on Site Evaluation in the Diagnosis of Sarcoidosis: a Randomised Study|Unknown status|Recruiting|N/A|80|Anticipated|All India Institute of Medical Sciences, New Delhi||4|||f||||f||||||||||2017-10-10 23:12:57.222468|2017-10-10 23:12:57.222468
NCT02472795|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-07-25|||June 1, 2015|Actual|2015-06-01|July 2017|2017-07-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus|A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-response Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus|Completed||Phase 2|64|Actual|Actelion||5|||f||||t||||||||||2017-10-10 23:12:57.355916|2017-10-10 23:12:57.355916
NCT02472782|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-07-12|||May 2015||2015-05-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01|2 Years|Observational [Patient Registry]|IASIS||Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication|Prospective,Non-interventional Study Investigating Possible Correlation Between Adherence to Postmenopausal and Steroid Induced Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication|Active, not recruiting||N/A|1000|Anticipated|251 Hellenic Air Force & VA General Hospital|||1||f||||f||||||||||2017-10-10 23:12:57.47385|2017-10-10 23:12:57.47385
NCT02472769|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-01-26|||May 2016||2016-05-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||IBP-9414 for the Prevention of Necrotizing Enterocolitis|A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.|Active, not recruiting||Phase 2|120|Actual|Infant Bacterial Therapeutics||2|||f||||||||||||||2017-10-10 23:12:57.550245|2017-10-10 23:12:57.550245
NCT02472756|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-06-26|2016-05-11||September 19, 2008|Actual|2008-09-19|June 2017|2017-06-01|May 30, 2014|Actual|2014-05-30|May 30, 2014|Actual|2014-05-30||Observational|REFLECT 2|Intent-to-treat (ITT) population included all treated participants.|A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma|Relapsed/Refractory Follicular Lymphoma - Rituximab Therapy in Combination With Chemotherapy|Completed||N/A|41|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:12:57.641077|2017-10-10 23:12:57.641077
NCT02472743|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-05-06|||December 2014||2014-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|DULight||Light Treatment for Scleroderma Finger Ulcers|Light-based Therapy as a Novel Treatment for Digital Ulcers in Patients With Systemic Sclerosis|Completed||N/A|10|Actual|University of Manchester||1|||f||||f||||||||||2017-10-10 23:12:57.865115|2017-10-10 23:12:57.865115
NCT02472730|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2016-06-16|||July 2015||2015-07-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Cap Assisted Colonoscopy Enhances Quality Based Competency in Colonoscopy Among Trainees|Cap Assisted Colonoscopy Enhances Quality Based Competency in Colonoscopy Among Trainees|Completed||N/A|219|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 23:12:57.941396|2017-10-10 23:12:57.941396
NCT02472717|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-07-14|||May 2015||2015-05-01|June 2015|2015-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|PLAQUE||Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study|Clinical Evaluation of Psoriatic Arthritis Treated With Liraglutide. The PLAQUE Study: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study|Withdrawn||Phase 2|0|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:12:59.864739|2017-10-10 23:12:59.864739
NCT02472704|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-15|||September 2011||2011-09-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo|Lymphocytic Enteritis and Suspected Coeliac Disease: Double-blind Gluten vs Placebo Rechallenge|Completed||N/A|18|Actual|Hospital Mutua de Terrassa||2|||f||||t||||||||||2017-10-10 23:13:00.003364|2017-10-10 23:13:00.003364
NCT02472691|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-08-30|||June 2015||2015-06-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|February 2020|Anticipated|2020-02-01||Interventional|AZALENA||Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT|Phase-II Trial to Assess the Efficacy and Safety of Lenalidomide in Addition to 5-Azacitidine and Donor Lymphocyte Infusions (DLI) for the Treatment of Patients With MDS, CMML or AML Who Relapse After Allogeneic Stem Cell Transplantation|Recruiting||Phase 2|50|Anticipated|Heinrich-Heine University, Duesseldorf||1|||f||||t||||||||||2017-10-10 23:13:00.120635|2017-10-10 23:13:00.120635
NCT02472678|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-05-04|||May 2015||2015-05-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|WIN||Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor|Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor|Completed||N/A|91|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-10 23:13:00.839896|2017-10-10 23:13:00.839896
NCT02472665|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-08-01|||December 2013||2013-12-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease|Evaluation of the Pharmacokinetic Profile, Clinical Efficacy and Safety of the Von Willebrand Factor Contained in FANHDI® (Double-inactivated Human Anti-hemophilic Factor) in Pediatric Patients With Von Willebrand Disease|Recruiting||Phase 4|8|Anticipated|Grifols Biologicals Inc.||1|||f||||f||||||||||2017-10-10 23:13:00.952711|2017-10-10 23:13:00.952711
NCT02472652|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-03-01|||June 2015||2015-06-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|December 31, 2016|Actual|2016-12-31||Interventional|KISS||Aripiprazole, Abilify Maintena Collaborative Clinical Protocol|An Open-label Study to Determine the Effect of Switching to Aripiprazole Once Monthly for Subjects With Schizophrenia Experiencing Worsening Sexual Dysfunction With Invega Sustenna or Risperdal Consta|Terminated||Phase 4|19|Actual|Gazda, Thomas D., M.D., PC||1||Lack of adequate enrollment|f||||f||||||||||2017-10-10 23:13:01.052084|2017-10-10 23:13:01.052084
NCT02472639|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-09-08|2017-09-08||June 10, 2015|Actual|2015-06-10|September 2017|2017-09-01|May 26, 2016|Actual|2016-05-26|May 26, 2016|Actual|2016-05-26||Interventional||Study was prematurely terminated. Data was not collected or analyzed due to issue with study compliance.|Impact of Ostom-i Alert Sensor on Quality of Life in Patients With Ileostomy|Impact of Ostom-i Alert Sensor on Quality of Life in Patients With Ileostomy|Terminated||N/A|40|Actual|Cedars-Sinai Medical Center|"Study only accrued 7 patients. Due to non-compliance and issues with the device it was decided to terminate the study.
No data analysis has been done and will not be done in the future. This study was been closed with the IRB."|2||Patient compliance issues|f||||f||||||||||2017-10-10 23:13:01.169499|2017-10-10 23:13:01.169499
NCT02472626|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-07-31|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||6,8-Bis(Benzylthio)Octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase I/II Study of CPI-613 in Combination With Induction/Consolidation in Older AML Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Wake Forest University Health Sciences||1||Drug Supply Issues|f||||f|t|f||||||||2017-10-10 23:13:01.434836|2017-10-10 23:13:01.434836
NCT02472613|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-01-02|||May 2016||2016-05-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|July 2017|Anticipated|2017-07-01||Interventional|||Acupuncture for Ischemic Post-stroke Depression|Comparison of Acupuncture and Fluoxetine for of Ischemic Post-stroke Depression：A Multicentre Randomized Controlled Trial|Recruiting||N/A|208|Anticipated|The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 23:13:01.60647|2017-10-10 23:13:01.60647
NCT02472600|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-06-26|||February 2016||2016-02-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|R-GNOSIS WP3||Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy|A Randomized Controlled Multicenter Trial of a Five Day Course of Oral Colistin and Neomycin Followed by Restoration of the Gut Microbiota Using Fecal Transplantation to Eradicate Intestinal Carriage of Extended Spectrum Beta-lactamase or Carbapenemase-producing Enterobacteriaceae in High-risk Patients|Active, not recruiting||Phase 2|39|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 23:13:01.902458|2017-10-10 23:13:01.902458
NCT02472587|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-11-22|||January 2013||2013-01-01|November 2015|2015-11-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Observational|||Assessing Chronic Pain Conditions in General Population||Active, not recruiting||N/A|2500|Anticipated|University of Cagliari|||1||f||||f||||||||||2017-10-10 23:13:02.094928|2017-10-10 23:13:02.094928
NCT02472574|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2015-06-11|||June 2015||2015-06-01|June 2015|2015-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Dose-effect Relationship of Rt-PA on ICH Evacuation|Phase 2 Study of Rt-PA Dose-effect Relationship on ICH Evacuation|Active, not recruiting||Phase 2|108|Anticipated|Tongji Hospital||3|||f||||t||||||||||2017-10-10 23:13:02.193749|2017-10-10 23:13:02.193749
NCT02472561|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-24|||July 2015||2015-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD)|Verizon mHealth Solution for Elderly Underserved Patients With Peripheral Artery Disease|Recruiting||N/A|45|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:13:02.330413|2017-10-10 23:13:02.330413
NCT02472366|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-08-14|2015-06-23||January 2014||2014-01-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy||Completed||Phase 4|16|Actual|Alimera Sciences||2|||f||||f||||||||||2017-10-10 23:13:04.620143|2017-10-10 23:13:04.620143
NCT02472548|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-04-08|||May 2015||2015-05-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|February 2017|Actual|2017-02-01||Interventional|||A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine|A Phase I Randomized, Observer-blind, Controlled, Dose Escalation Trial of the Safety and Tolerability of Two Intramuscular Doses of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine Containing Respiratory Syncytial Virus (RSV) SHe Antigen and a Novel Adjuvant DepoVaxTM, or SHe A Antigen Co-administered With Aluminum Hydroxide, or Placebo to Healthy Adults ≥50-64 Years of Age|Active, not recruiting||Phase 1|40|Actual|Dalhousie University||5|||f||||t||||||||||2017-10-10 23:13:02.470038|2017-10-10 23:13:02.470038
NCT02472535|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-03-08|||April 2015||2015-04-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study to Evaluate the Effects of MBX-8025 in Patients With HoFH|A 12-week, Open-label, Dose-escalating, Phase 2 Study to Evaluate the Effects of MBX-8025 in Patients With Homozygous Familial Hypercholesterolemia (HoFH)|Completed||Phase 2|13|Actual|CymaBay Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:13:02.597425|2017-10-10 23:13:02.597425
NCT02472522|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-05-25|2016-04-16||May 2015||2015-05-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Patients with term pregnancy who were posted for Lower segment caesarean section were recruited for the study|Comparative Study of Ropivacaine and Ropivacaine With Dexmeditomedine in TAP Blocks|Comparative Study of Ropivacaine and Ropivacaine With Dexmeditomedine in Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia in Patients Undergoing Cesarean Sections|Completed||N/A|100|Actual|Tata Main Hospital|"There was no mechanism in our study to ascertain the effectiveness or failure of the TAP block.
We did not ascertain if the effect of dexmedetomidine was by its systemic absorption or by a perineural effect."|2|||f||||t||||||||No||2017-10-10 23:13:02.738715|2017-10-10 23:13:02.738715
NCT02472496|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-02-14|||January 2015||2015-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Korean Coronary Overlapping Stenting Registy|Korean Coronary Overlapping Stenting Registy|Recruiting||N/A|2000|Anticipated|The Catholic University of Korea|||1||f||||f||||||||No||2017-10-10 23:13:03.533052|2017-10-10 23:13:03.533052
NCT02472483|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-02-11|||September 2012||2012-09-01|February 2016|2016-02-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|TCC-MBCT||Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response|Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response|Recruiting||N/A|672|Anticipated|Centre Hospitalier St Anne||3|||f||||f||||||||||2017-10-10 23:13:03.616518|2017-10-10 23:13:03.616518
NCT02472470|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-07-14|||June 2015||2015-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Biological Targets of Response to rTMS Therapy in Youth Depression|Efficacy and Biological Targets of Response to rTMS Therapy in Youth Depression|Recruiting||N/A|20|Anticipated|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-10-10 23:13:03.706046|2017-10-10 23:13:03.706046
NCT02472457|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-11-02|||June 2015||2015-06-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|CEASE||Crohn Disease Exclusion Diet After Single Medication De-escalation|Biologic and Immunomodulator Withdrawal in Pediatric Crohn Disease With Deep Clinical Remission Using the Crohn Disease Exclusion Diet|Recruiting||N/A|35|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 23:13:03.806076|2017-10-10 23:13:03.806076
NCT02472444|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-11|||January 2014||2014-01-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Gustatory Evoked-related Potentials in Humans|Etude du contrôle hédonique de la Prise Alimentaire Par l'Analyse Des Potentiels évoqués Gustatifs|Completed||N/A|15|Actual|Centre des Sciences du Goût et de l'Alimentation|||1||f||||f||||||||||2017-10-10 23:13:03.953295|2017-10-10 23:13:03.953295
NCT02472431|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-11-29|||April 2015||2015-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction|Effectiveness and Safety of Intracavernosal Administration of Autologous Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction|Completed||Phase 1/Phase 2|12|Actual|Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation||1|||f||||f||||||||||2017-10-10 23:13:04.101124|2017-10-10 23:13:04.101124
NCT02472405|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-12-16|||January 2015||2015-01-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Multiplex Laser vs. PDL (Pulsed Dye Laser ) in the Treatment of Surgical Scars|Comparing the 595/1064nm Multiplex Laser to the 595nm PDL in the Treatment of Surgical Scars in a Blinded, Randomized, Controlled Trial|Recruiting||N/A|50|Anticipated|University of Miami||3|||f||||t||||||||||2017-10-10 23:13:04.314032|2017-10-10 23:13:04.314032
NCT02472392|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-05-08|||April 2013||2013-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Ewing/Allo||Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma|A Phase I Study to Examine the Toxicity of Allogeneneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewings|Completed||Phase 1|10|Anticipated|University of Louisville||2|||f||||f||||||||||2017-10-10 23:13:04.407131|2017-10-10 23:13:04.407131
NCT02472379|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-05-01|||October 2015||2015-10-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Writing About Experiences and Health in Older Adults|Writing About Experiences and Health in Older Adults|Completed||N/A|78|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-10-10 23:13:04.518099|2017-10-10 23:13:04.518099
NCT02442414|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-08|||April 2015||2015-04-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors||Unknown status|Recruiting|Phase 1|30|Anticipated|Sihuan Pharmaceutical Holdings Group Ltd.||1|||f||||f||||||||||2017-10-10 23:19:03.365681|2017-10-10 23:19:03.365681
NCT02472340|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-07-29|||June 2015||2015-06-01|March 2016|2016-03-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Observational|||Mitophagy and Autophagy in Elderly Subjects|Assessment and Reproducibility of Mitochondrial Function and Mitophagy Measurements in Human Muscle Tissue of Active and Pre Frail Elderly Males|Completed||N/A|22|Actual|Amazentis SA|||2||f||||f||||||Samples With DNA|"     Muscle, Peripheral blood mononuclear cells (PBMC)   "|||2017-10-10 23:13:05.085641|2017-10-10 23:13:05.085641
NCT02472327|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-01-25|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Decreasing Patient Dissatisfaction With Unplanned Cesarean Sections|Decreasing Patient Dissatisfaction With Unplanned Cesarean Sections: A Prospective Trial|Recruiting||N/A|200|Anticipated|Albany Medical College||2|||f||||f||||||||||2017-10-10 23:13:05.169361|2017-10-10 23:13:05.169361
NCT02472314|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-08|||June 2015||2015-06-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Exparel for Postoperative Pain Management in Shoulder Surgery|A Novel Application of Exparel for Postoperative Pain Management in Shoulder Arthroplasty and Humerus Fracture Fixation|Completed||Phase 4|65|Actual|Wayne State University||4|||f||||f||||||||||2017-10-10 23:13:05.26706|2017-10-10 23:13:05.26706
NCT02472301|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-05-10|||August 2015|Actual|2015-08-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction in Rural Malawian Children 1-3 Year Olds|Randomized, Single-blinded, Prospective Clinical Trial Comparing the Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction and Stunting in Rural Malawian Children 1-3 Year Olds|Completed||N/A|337|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-10-10 23:13:05.378571|2017-10-10 23:13:05.378571
NCT02472288|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-08-29|||April 2015||2015-04-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Electroacupuncture on Post-stroke Urinary Retention|Multicenter, Randomised Controlled Trial of Electroacupuncture Versus Sham Electroacupuncture for Urinary Retention of Poststroke Patients: a Study Protocol|Terminated||N/A|25|Actual|Kyunghee University||2||Difficulty in enrolling participants|f||||f||||||||||2017-10-10 23:13:05.477205|2017-10-10 23:13:05.477205
NCT02472275|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-09-13|||June 2015||2015-06-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|June 1, 2018|Anticipated|2018-06-01||Interventional|||PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer|Targeting the Prostatic Tumor Microenvironment With PLX3397, a Tumor-Associated Macrophage Inhibitor in Men With Unfavorable Risk Prostate Cancer Undergoing Radiation Therapy and Androgen Deprivation Therapy|Recruiting||Phase 1|24|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-10 23:13:05.582926|2017-10-10 23:13:05.582926
NCT02472262|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-05-10|||August 2015|Actual|2015-08-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction in Rural Malawian Children 6-11 Months|Randomized, Single-blinded, Prospective Clinical Trials Comparing the Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction and Stunting in Rural Malawian Children 6-11 Months|Completed||N/A|312|Anticipated|Washington University School of Medicine||3|||f||||f||||||||||2017-10-10 23:13:05.734549|2017-10-10 23:13:05.734549
NCT02472249|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-05-16|||January 2016||2016-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC|Hepatic Arterial Blood Flow Modulation in Patients With Hepatocellular Carcinoma: Influence of Intra-arterial Norepinephrine Assessed With CT Perfusion|Recruiting||Phase 4|15|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:13:05.824984|2017-10-10 23:13:05.824984
NCT02472236|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-21|||June 8, 2015|Actual|2015-06-08|January 2016|2016-01-01|January 18, 2016|Actual|2016-01-18|September 24, 2015|Actual|2015-09-24||Interventional|||Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects|An Open-label,Sequential,Single-site Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Polyethylene Glycol Loxenatide (PEX168) in Healthy Adult Subjects|Completed||Phase 1|16|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:13:05.911831|2017-10-10 23:13:05.911831
NCT02472223|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-05-10|||March 2015||2015-03-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|RAPID||Reducing Adenoviral Patient Infected Days|Reducing Adenoviral Patient Infected Days|Recruiting||N/A|50|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:13:06.004466|2017-10-10 23:13:06.004466
NCT02472210|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-25|||July 2014||2014-07-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||The Use of Botox in Advanced Parkinson's Patients Experiencing Pain|A Study of the Utility of Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease Double Blind Placebo Control Crossover Pilot Study|Unknown status|Active, not recruiting|Phase 4|14|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:13:06.139208|2017-10-10 23:13:06.139208
NCT02472197|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-09-07|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|RESMO||Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy|Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy|Recruiting||N/A|90|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:13:06.212346|2017-10-10 23:13:06.212346
NCT02472184|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-12-19|||October 2015||2015-10-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy|Office Based Evaluation of Patients Presenting With Abnormal Uterine Bleeding and/or Uterine Fibroids With Concurrent Office Hysteroscopy and Endometrial Biopsy; Does the Order Matter?|Recruiting||N/A|78|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-10 23:13:06.294926|2017-10-10 23:13:06.294926
NCT02472171|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-01|||June 2015||2015-06-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Suppression of Postprandial Monocyte Activation by Blueberries or Docosahexaenoic Acid in Humans|Suppression of Postprandial Monocyte Activation by Fruit Rich in Anti-inflammatory Polyphenols or Docosahexaenoic Acid in Humans|Recruiting||N/A|60|Anticipated|USDA, Western Human Nutrition Research Center||6|||f||||f||||||||||2017-10-10 23:13:06.394334|2017-10-10 23:13:06.394334
NCT02472158|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-05-11|||April 2014||2014-04-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|October 2015|Actual|2015-10-01||Interventional|CISDCT||Chlorhexidine-Impregnated Sponge Dressing: A Clinical Trial|Use of Chlorhexidine-gel-Impregnated Dressing Compared to Transparent Polyurethane Film Dressing as Coverage of the Site of Insertion of Central Venous Catheter, in the Evaluation of Catheter Colonization in Critically Ill Adults Patients: A Randomized Controlled Trial|Active, not recruiting||N/A|120|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:13:06.502071|2017-10-10 23:13:06.502071
NCT02472145|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-09-13|||August 4, 2015|Actual|2015-08-04|September 2017|2017-09-01|January 25, 2018|Anticipated|2018-01-25|January 25, 2018|Anticipated|2018-01-25||Interventional|||An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy|A Randomized Phase 2/3 Study of DACOGEN® (Decitabine) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus DACOGEN (Decitabine) Alone in Patients With AML Who Are Not Candidates for Intensive Chemotherapy|Active, not recruiting||Phase 3|326|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 23:13:06.585726|2017-10-10 23:13:06.585726
NCT02472132|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-03-15|||July 2015||2015-07-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|October 2016|Anticipated|2016-10-01||Interventional|||The Use of Point of Care Ultra Sound for Correct Placement of Central Venous Catheter|The Use of Point of Care Ultra Sound for Correct Placement of Central Venous Catheter and for the Detection of Complications|Active, not recruiting||N/A|186|Actual|Soroka University Medical Center||2|||f||||t||||||||||2017-10-10 23:13:06.999403|2017-10-10 23:13:06.999403
NCT02472119|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-10|||June 2015||2015-06-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|WHETMIT||Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment.|Wheat Flour Subjected to Microbial Transglutaminase Enzymatic Treatment in the Presence of Lysine Ethyl Ester for Alimentary Use in the Treatment of Celiac Disease.|Unknown status|Recruiting|Phase 2|20|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-10 23:13:07.101739|2017-10-10 23:13:07.101739
NCT02472106|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-08-30|||June 2015||2015-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|PostCorE||Impact of Postdilatation With the InterValve V8 Aortic Valvuloplasty Balloon Following TAVI Procedure|Impact of Postdilatation With the InterValve V8 Aortic Valvuloplasty Balloon Following Medtronic CoreValve or Other Self-Expanding TAVI Procedure (PostCorE)|Completed||N/A|9|Actual|InterValve, Inc.|||1||f||||t||||||||||2017-10-10 23:13:07.232005|2017-10-10 23:13:07.232005
NCT02472093|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2015-06-10|||May 2012||2012-05-01|May 2012|2012-05-01|May 2013|Actual|2013-05-01|June 2012|Actual|2012-06-01||Interventional|||A New Rehabilitation Tool in Fibromyalgia|A New Rehabilitation Tool in Fibromyalgia: Efficacy of Perceptive Rehabilitation Versus Group Exercises on Pain and Function: a Clinical Randomized Controlled Trial (RCT)|Completed||N/A|88|Actual|University of Roma La Sapienza||3|||f||||t||||||||||2017-10-10 23:13:07.330356|2017-10-10 23:13:07.330356
NCT02472080|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-11-14|||April 2016||2016-04-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|THYGEMOX||Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study|Open Labeled Phase II Study Evaluating Efficacy and Safety of Chemotherapy With Gemcitabine - Oxaliplatin Combination for Advanced Refractory Thyroid Cancer Patients|Recruiting||Phase 2|30|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:13:07.407717|2017-10-10 23:13:07.407717
NCT02472054|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-12-02|||June 2015||2015-06-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|C-HLH||Treatment of Familiar Lymphohistiocytosis|First Line Treatment of Familiar Lymphohistiocytosis by Alemtuzumab (CAMPATH®)|Recruiting||Phase 1/Phase 2|30|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||No||2017-10-10 23:13:07.59067|2017-10-10 23:13:07.59067
NCT02472041|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-06-10|||January 2014||2014-01-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Effectiveness of Reanimator Muller in Patients With Chest Tube|Effectiveness of Reanimator Muller in Patients With Chest Tube|Unknown status|Recruiting|Phase 2/Phase 3|32|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-10 23:13:07.708323|2017-10-10 23:13:07.708323
NCT02472028|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-06-30|||September 2015||2015-09-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|LEOPOLD||Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals|LEukoaraiosis and blOod Pressure Reduction in OLD People|Recruiting||Phase 4|820|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:13:07.826237|2017-10-10 23:13:07.826237
NCT02472015|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-08-21|||June 2015||2015-06-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|DETECT||Dementia in Long Term Care Facilities: Telemedicine for the Management of Neuropsychiatric Symptoms|Dementia in Long Term Care Facilities: Telemedicine for the Management of Neuropsychiatric Symptoms.|Recruiting||N/A|200|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:13:07.948995|2017-10-10 23:13:07.948995
NCT02472002|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-02-20|||January 2014||2014-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MESHT||Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients|Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients|Suspended||Phase 1/Phase 2|14|Anticipated|Assistance Publique - Hôpitaux de Paris||1||Contamination of the Pitié-Salpêtrière biotherapy laboratory|f||||t||||||||||2017-10-10 23:13:08.063809|2017-10-10 23:13:08.063809
NCT02471989|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-12-17|||November 2015||2015-11-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EFFORR||FODMAPs and Refractory GERD|Randomized Controlled Study of Low-FODMAP Diet in Patients With GERD Refractory to Protons Pump Inhibitors|Recruiting||N/A|60|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:13:08.150467|2017-10-10 23:13:08.150467
NCT02471976|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-06-19|||October 2012|Actual|2012-10-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|LATAREA-IV||Impact of an Early Palliative Approach|Impact of a Computer-assisted Tool to Help Reflection on the Decision to Withhold or to Withdraw Treatments for Surgical Patients in Intensive Care Units|Completed||N/A|1172|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:13:08.262065|2017-10-10 23:13:08.262065
NCT02471963|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-10-28|||December 2014||2014-12-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function|Randomized, Double-blind, Placebo Controlled, Crossover Clinical Study to Analyse the Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function|Completed||Phase 3|74|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-10 23:13:08.352577|2017-10-10 23:13:08.352577
NCT02471950|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-10|||April 2015||2015-04-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Isoflurane During Cardiopulmonary Bypass|The Depth of Anaesthesia Associated With the Use of 2.5% Isoflurane During Cardiopulmonary Bypass|Unknown status|Recruiting|N/A|50|Anticipated|University of Edinburgh|||1||f||||f||||||Samples With DNA|"     Arterial and venous blood samples   "|||2017-10-10 23:13:08.44794|2017-10-10 23:13:08.44794
NCT02471937|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-06-27|||April 2015||2015-04-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|STREPB17||Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection|Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection|Active, not recruiting||N/A|151|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:13:08.536319|2017-10-10 23:13:08.536319
NCT02471924|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-03-30|||June 2015||2015-06-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Predicting Hypotension Related to Spinal Anesthesia for Caesarean Section With Ultrasonography|Predicting Hypotension Related to Spinal Anesthesia for Caesarean Section With Ultrasonography|Recruiting||N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:13:08.622915|2017-10-10 23:13:08.622915
NCT02471911|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-02-03|||November 2015||2015-11-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|August 2017|Anticipated|2017-08-01||Interventional|KPT-330+RICE||KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma|A Phase I Investigator-Initiated Study of Selinexor (KPT-330) Plus RICE in Patients With Relapsed or Refractory Aggressive B-cell Lymphomas|Recruiting||Phase 1|18|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 23:13:08.721033|2017-10-10 23:13:08.721033
NCT02471898|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-02-10||2017-02-10|June 2015||2015-06-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|HTX-011||A Phase 2, Two-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Four-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy|Completed||Phase 2|71|Actual|Heron Therapeutics||2|||f||||f||||||||||2017-10-10 23:13:08.832935|2017-10-10 23:13:08.832935
NCT02471885|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-10-13|||December 2015||2015-12-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ERIC-ONC||Effect of Remote Ischaemic Conditioning in Oncology Patients|A Single Centre Double-blinded Randomized Placebo Controlled Pilot Study Investigating the Effect of Remote Ischaemic preConditioning in ONCology Patients Undergoing Chemotherapy (ERIC-ONC)|Recruiting||N/A|128|Anticipated|University College, London||2|||f||||t||||||||Undecided||2017-10-10 23:13:08.909777|2017-10-10 23:13:08.909777
NCT02471872|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-06-10|||February 2015||2015-02-01|May 2015|2015-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|BREATHE||Behavioral Research of Environment and Air Pollution Through Education||Recruiting||N/A|600|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:13:09.033335|2017-10-10 23:13:09.033335
NCT02471859|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-03-15|||June 2015||2015-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending, Single- and Multiple-Oral-Dose, Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Subjects|Completed||Phase 1|8|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-10 23:13:09.111328|2017-10-10 23:13:09.111328
NCT02471846|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-03|||July 28, 2015|Actual|2015-07-28|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors|A Phase Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of GDC-0919 Administered With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors|Active, not recruiting||Phase 1|158|Actual|Genentech, Inc.||6|||f||||||||||||||2017-10-10 23:13:09.203983|2017-10-10 23:13:09.203983
NCT02471833|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-31|||April 2015||2015-04-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|HEART||Health Evaluation in African Americans Using RAS Therapy|Health Evaluation in African Americans Using RAS Therapy|Recruiting||Phase 1|66|Anticipated|Emory University||3|||f||||t||||||||||2017-10-10 23:13:09.346278|2017-10-10 23:13:09.346278
NCT02471820|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-10-14|||November 2014||2014-11-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|RAD||Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients|Phase II Open Label Study for the Assessment of the Efficacy and Safety of Lenalidomide & Adriamycin & Low Dose Dexamethasone (RAD) in Newly Diagnosed, Symptomatic Multiple Myeloma Patients|Completed||Phase 2|45|Actual|University of Athens||1|||f||||f||||||||Undecided||2017-10-10 23:13:09.448903|2017-10-10 23:13:09.448903
NCT02471807|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-03-09|||December 2015||2015-12-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|September 2017|Anticipated|2017-09-01||Interventional|||Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System|Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System|Recruiting||N/A|30|Anticipated|Edwards Lifesciences||1|||f||||t||||||||||2017-10-10 23:13:09.573833|2017-10-10 23:13:09.573833
NCT02471040|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-01-25|||November 2014||2014-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Brain Ketone Metabolism in Type 1 Diabetes|Impact of Recurrent Hypoglycemia on Brain Ketone Metabolism in Type 1 Diabetes|Recruiting||N/A|24|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 23:13:16.268427|2017-10-10 23:13:16.268427
NCT02471794|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-01-23|||December 2015||2015-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study|Personalized Health Planning in Shared Medical Appointments for Individuals With Type II|Completed||N/A|33|Actual|Duke University||3|||f||||f||||||||||2017-10-10 23:13:09.679035|2017-10-10 23:13:09.679035
NCT02471781|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-03-06|||April 2013||2013-04-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2016|Actual|2016-01-01||Expanded Access|||Zenith® TX2® Low Profile TAA Endovascular Graft|Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study|Approved for marketing||N/A|||Cook Group Incorporated|||||||||||||||||||2017-10-10 23:13:09.760989|2017-10-10 23:13:09.760989
NCT02471755|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-10-22|2015-07-04||April 2013||2013-04-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Electro-acupuncture for Menopausal Transition Symptoms|A Randomized Pilot Study of Electro-acupuncture for Menopausal Transition Symptoms|Completed||N/A|90|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||||2017-10-10 23:13:10.027252|2017-10-10 23:13:10.027252
NCT02471742|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-09-15|||January 2004||2004-01-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||NAC Sparing Mastectomy After Neo-adjuvant Chemotherapy|Nipple Areolar-complex Sparing Mastectomy After Neo-adjuvant Chemotherapy: Evaluation of Local Oncologic Safety in a Cohort Study Analysis|Completed||N/A|573|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||3||f||||f||||||||||2017-10-10 23:13:10.59678|2017-10-10 23:13:10.59678
NCT02471729|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-10-18|||January 2017||2017-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|DENRENIC||Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance Cardiaque|Evaluation à Six Mois du système de dénervation rénale Chez Les Patients Atteints d'Insuffisance Cardiaque|Not yet recruiting||Phase 1/Phase 2|12|Anticipated|Institute Arnault Tzanck, France||1|||f||||t||||||||No||2017-10-10 23:13:10.671197|2017-10-10 23:13:10.671197
NCT02471716|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-09-13|||June 2015||2015-06-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of FPA008 in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor|A Phase 1/2 Study of FPA008, an Anti-CSF1 Receptor Antibody, in Patients With Pigmented Villonodular Synovitis (PVNS)/ Diffuse Type Tenosynovial Giant Cell Tumor (Dt-TGCT)|Recruiting||Phase 1/Phase 2|45|Anticipated|Five Prime Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 23:13:10.76503|2017-10-10 23:13:10.76503
NCT02471703|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-02-21|||September 2010||2010-09-01|February 2017|2017-02-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|SMF-S&E||Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem|Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem|Active, not recruiting||N/A|126|Anticipated|Smith & Nephew, Inc.|||1||f||||f||||||||||2017-10-10 23:13:10.875279|2017-10-10 23:13:10.875279
NCT02471690|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-04-19|||July 2015||2015-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study to Evaluate the Safety,Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers|A Randomized, Double-Blind, Single Center Cohort Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of a Single 1200MG IV Dose of Oritavancin in Healthy Volunteers|Completed||Phase 1|56|Actual|The Medicines Company||2|||f||||f||||||||||2017-10-10 23:13:10.974905|2017-10-10 23:13:10.974905
NCT02471677|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-19|||September 2015||2015-09-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Corifollitropin Alfa Versus Follitropin Beta in High Responders|Corifollitropin Alfa (Elonva) Versus Follitropin Beta in High Responders: A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 4|62|Anticipated|Eugonia||2|||f||||f||||||||||2017-10-10 23:13:11.062912|2017-10-10 23:13:11.062912
NCT02471651|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-12-13|||June 2015||2015-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DIME||Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema|Dexamethasone Intravitreal Implant (0.7mg) for the Treatment of Persistent Diabetic Macular Edema Following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy|Recruiting||Phase 4|40|Anticipated|California Retina Consultants||2|||f||||f||||||||||2017-10-10 23:13:11.286502|2017-10-10 23:13:11.286502
NCT02471638|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-09-29|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||PQ Bypass Systems for Femoropopliteal Bypass II|PQ Bypass Systems for Femoropopliteal Bypass II (PQB 4 FP II)|Active, not recruiting||N/A|78|Actual|PQ Bypass, Inc.||1|||f||||t|f|t|t|f|t|||||2017-10-10 23:13:11.394947|2017-10-10 23:13:11.394947
NCT02471625|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-11-18|||April 2015||2015-04-01|November 2015|2015-11-01||||May 2016|Anticipated|2016-05-01||Observational|TBI||Traumatic Brain Injury Feasibility Study (EPIC-011)|Traumatic Brain Injury (TBI) Feasibility Study to Determine Possible Prognostic Indicators as Provided by the EPIC ClearView™|Active, not recruiting||N/A|200|Anticipated|Epic Research & Diagnostics, Inc.|||2||f||||f||||||||||2017-10-10 23:13:11.47777|2017-10-10 23:13:11.47777
NCT02471612|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-05-17|2015-12-20||December 2013||2013-12-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Comparative Analysis of APACHE II and P-POSSUM|Comparative Analysis of APACHE II and P-POSSUM Scoring Systems in Predicting Postoperative Mortality in Patients Undergoing Emergency Laparotomy|Completed||N/A|159|Actual|Tata Main Hospital|Observational study. So no specific adverse effect because of the study.||1||f||||t||||||||No||2017-10-10 23:13:11.565485|2017-10-10 23:13:11.565485
NCT02471599|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-06-10|||March 2011||2011-03-01|June 2015|2015-06-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|||Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy|Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy :a Prospective,Randomized,Controlled Study.|Suspended||N/A|100|Anticipated|Sun Yat-sen University||2||This study was suspended because that few participants was enrolled.|f||||t||||||||||2017-10-10 23:13:11.837459|2017-10-10 23:13:11.837459
NCT02471586|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-07-19|||May 2015||2015-05-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|July 2016|Actual|2016-07-01||Interventional|||ILUMIEN III: OPTIMIZE PCI|ILUMIEN III: OPTIMIZE PCI OPtical Coherence Tomography (OCT) Compared to Intravascular Ultrasound (IVUS) and Angiography to Guide Coronary Stent Implantation: a Multicenter RandomIZEd Trial in Percutaneous Coronary Intervention (PCI)|Active, not recruiting||N/A|450|Actual|St. Jude Medical||3|||f||||t||||||||||2017-10-10 23:13:11.927504|2017-10-10 23:13:11.927504
NCT02471573|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-09-06|||June 30, 2015|Actual|2015-06-30|September 2017|2017-09-01|February 1, 2017|Actual|2017-02-01|April 10, 2016|Actual|2016-04-10||Interventional|||Freeze All Protocol Versus Fresh Embryo Transfer in Women Undergoing In-vitro Fertilization (IVF)|The Effectiveness of a Freeze All Protocol Versus Fresh Embryo Transfer in Women Undergoing In-vitro Fertilization (IVF) - Intracytoplasmic Sperm Injection (ICSI)|Completed||N/A|782|Actual|Vietnam National University||2|||f||||t||||||||||2017-10-10 23:13:12.115443|2017-10-10 23:13:12.115443
NCT02471560|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-03-21|||November 2015||2015-11-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Tecfidera and the Gut Microbiota|The Effect of Tecfidera® (Dimethyl Fumarate, BG00012) on the Gut Microbiota as a Causal Factor for Gastro Intestinal Associated Adverse Events.|Recruiting||Phase 4|70|Anticipated|Biogen||2|||f||||f||||||||||2017-10-10 23:13:12.213972|2017-10-10 23:13:12.213972
NCT02471547|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-04-27|||January 2016||2016-01-01|April 2016|2016-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBT|Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBT- Prospective Controlled Study|Recruiting||N/A|300|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:13:12.31345|2017-10-10 23:13:12.31345
NCT02471534|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2016-04-28|||June 2015||2015-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study on Prediction of Fluid Responsiveness Using an Abdominal Compression-induced Change of Blood Pressure in Children|Study on Prediction of Fluid Responsiveness Using an Abdominal Compression-induced Change of Blood Pressure in Children|Completed||N/A|30|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:13:12.393707|2017-10-10 23:13:12.393707
NCT02471521|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2016-09-26|||February 2015||2015-02-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Optimal Inspiratory Pressure for Facemask Pressure-controlled Ventilation in Children|Optimal Inspiratory Pressure for Facemask Pressure-controlled Ventilation in Children: Study Using Detection of Gastric Insufflation Using Ultrasonography of the Antrum and Epigastric Auscultation|Completed||N/A|120|Actual|Seoul National University Hospital||3|||f||||t||||||||No||2017-10-10 23:13:12.458384|2017-10-10 23:13:12.458384
NCT02471508|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-02-28|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Safety and Efficacy of Body-mapping Tank Top Equipped With Biofeedback System for Adolescent With Early Scoliosis|An Innovative Body-Mapping Tank Top Equipped With Biofeedback System for Adolescents With Early Scoliosis|Completed||Phase 1|12|Actual|The Hong Kong Polytechnic University||1|||f||||t||||||||||2017-10-10 23:13:12.532596|2017-10-10 23:13:12.532596
NCT02471495|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-05-08|||September 2016||2016-09-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)|A Multicenter, Single-Arm Study Evaluating the Efficacy of Synergo® Radiofrequency-Induced Thermochemotherapy Effect With Mitomycin C in Non-Muscle Invasive Bladder Cancer Patients With BCG-refractory CIS|Not yet recruiting||Phase 3|116|Anticipated|Medical Enterprises Europe B.V.||1|||f||||t||||||||No||2017-10-10 23:13:12.594393|2017-10-10 23:13:12.594393
NCT02471482|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-02-22|||December 2013||2013-12-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Mozart Music on Cerebral Oxygenation and Behavioural Response of Premature Infants|Effect of Mozart Music on Cerebral Oxygenation and Behavioural Response of Premature Infants Between 28-32 Weeks of Corrected Gestation|Completed||N/A|30|Actual|Coombe Women and Infants University Hospital||2|||f||||t||||||||||2017-10-10 23:13:12.663845|2017-10-10 23:13:12.663845
NCT02471469|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-05-29|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|ILUMINATE||Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response|Personalizing Enzalutamide Therapy by Understanding the Relation Between the Decrease in the Expression Profile of a Panel of Preselected microRNAs, Tumor Related mRNAs and Treatment Response in Chemotherapy Naive Patients With mCRPC|Recruiting||N/A|40|Anticipated|Radboud University|||1||f||||f||||||||||2017-10-10 23:13:12.733771|2017-10-10 23:13:12.733771
NCT02471456|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-06-20|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|October 16, 2015|Actual|2015-10-16|October 16, 2015|Actual|2015-10-16||Observational|MAQEH||MACCE After Endoscopic Vein Harvest for CABG|Major Adverse Cardiac and Cerebrovascular Event (MACCE) & Patients' Quality of Life (QOL) After Endoscopic Vein Harvesting as Compared to Open Vein Harvest for Coronary Artery Bypass Grafting|Completed||N/A|100|Actual|The Royal Wolverhampton Hospitals NHS Trust|||2||f||||f||||||||||2017-10-10 23:13:12.807323|2017-10-10 23:13:12.807323
NCT02471443|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2016-04-04|||May 2004||2004-05-01|April 2016|2016-04-01|January 2040|Anticipated|2040-01-01|January 2025|Anticipated|2025-01-01||Observational|||Laparoscopic Surgery for Severe Recto-vaginal Endometriosis|Laparoscopic Surgery for Severe Recto-vaginal Endometriosis: A Prospective Cohort Study|Recruiting||N/A|1000|Anticipated|Royal Surrey County Hospital|||1||f||||t||||||||||2017-10-10 23:13:12.872327|2017-10-10 23:13:12.872327
NCT02471430|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-06-20|||May 2016||2016-05-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|September 2018|Anticipated|2018-09-01||Interventional|ACTIVATE||Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy|A Phase I-II Pilot Study to Assess the Safety and Efficacy of Combined Administration With Pegylated Interferon-alpha2a and the Histone Deacetylase Inhibitor (HDACi) Panobinostat for Reducing the Residual Reservoir of HIV-1 Infected Cells in cART-Treated HIV-1 Positive Individuals|Recruiting||Phase 1/Phase 2|8|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:13:12.952536|2017-10-10 23:13:12.952536
NCT02471417|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-06-10|||January 2015||2015-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Acute Dietary Nitrate in Dilated Cardiomyopathy|Dietary Nitrate Supplementation in Dilated Cardiomyopathy: An Acute, Double-blind, Randomized, Placebo-controlled, Crossover Trial.|Completed||N/A|12|Actual|Royal College of Surgeons, Ireland||2|||f||||f||||||||||2017-10-10 23:13:13.043665|2017-10-10 23:13:13.043665
NCT02471404|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-03-28|||September 21, 2015|Actual|2015-09-21|March 2017|2017-03-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|||Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea|A 52-Week, Multi-Centre, Randomised, Parallel-Group, Double-Blind, Active Controlled, Phase IV Study to Evaluate the Safety and Efficacy of Dapagliflozin or Dapagliflozin Plus Saxagliptin Compared With Sulphonylurea All Given as Add-on Therapy to Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Monotherapy|Completed||Phase 4|1359|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 23:13:13.116515|2017-10-10 23:13:13.116515
NCT02471391|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-08-27|||June 2015||2015-06-01|June 2015|2015-06-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|AIM||ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM)|A Phase 2 Study of ABT-199 in Combination With Ibrutinib in the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma (AIM Study)|Recruiting||Phase 2|24|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-10 23:13:13.612055|2017-10-10 23:13:13.612055
NCT02471378|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-06-30|||June 10, 2015||2015-06-10|May 15, 2017|2017-05-15|December 31, 2020|Anticipated|2020-12-31|June 30, 2020|Anticipated|2020-06-30||Observational|||Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates|In-Vitro Testing of Pregnancy Malaria Vaccine Candidates|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:13:13.711057|2017-10-10 23:13:13.711057
NCT02471365|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-08-22|||May 20, 2015||2015-05-20|August 8, 2017|2017-08-08|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Observational|||Study of Exposure to Chemicals in Consumer Products|NIEHS EPA Pilot Study of Exposure to Chemicals in Consumer Products|Not yet recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:13:13.80002|2017-10-10 23:13:13.80002
NCT02471352|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-07-21|||June 4, 2015||2015-06-04|April 20, 2017|2017-04-20|January 31, 2027|Anticipated|2027-01-31|January 1, 2026|Anticipated|2026-01-01||Observational|||Studies of Dermatologic Diseases Biospecimen Acquisition Protocol|Studies of Dermatologic Diseases-Biospecimen Acquisition Protocol|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:13:13.884793|2017-10-10 23:13:13.884793
NCT02471313|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-10-04|||May 20, 2015||2015-05-20|October 3, 2017|2017-10-03|November 21, 2019|Anticipated|2019-11-21|November 21, 2018|Anticipated|2018-11-21||Interventional|||Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization|A Pilot Study of an Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization|Suspended||Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:13:14.177973|2017-10-10 23:13:14.177973
NCT02471300|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-07-07|||May 21, 2015||2015-05-21|July 6, 2017|2017-07-06|March 5, 2018|Anticipated|2018-03-05|March 5, 2018|Anticipated|2018-03-05||Observational|||Effect of Fasting on the Asthma Inflammasome|Pilot Study to Evaluate the Effect of Fasting on the Asthma Inflammasome|Recruiting||N/A|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:13:14.292349|2017-10-10 23:13:14.292349
NCT02471287|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-12|2017-10-03|||May 1, 2015||2015-05-01|September 28, 2017|2017-09-28|March 2, 2019|Anticipated|2019-03-02|March 2, 2019|Anticipated|2019-03-02||Observational|||Genetics of Inherited Eye Disease|The Genetics of Inherited Eye Disease|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:13:14.394484|2017-10-10 23:13:14.394484
NCT02471274|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-11-15|||June 2015||2015-06-01|November 2016|2016-11-01||||December 2015|Actual|2015-12-01||Interventional|||PK Study of Sotagliflozin in Subjects With Hepatic Impairment|A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function|Completed||Phase 1|32|Actual|Lexicon Pharmaceuticals||4|||f||||f||||||||||2017-10-10 23:13:14.472417|2017-10-10 23:13:14.472417
NCT02471261|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2015-06-11|||May 2015||2015-05-01|June 2015|2015-06-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Observational|||Elastography as Gouty Arthropathy Outcome (EGO)|Elastography as Gouty Arthropathy Outcome (EGO), a Pilot Study.|Unknown status|Recruiting|N/A|10|Anticipated|Arthritis & Rheumatism Associates, P.C.|||1||f||||f||||||||||2017-10-10 23:13:14.575579|2017-10-10 23:13:14.575579
NCT02471248|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-15|||May 27, 2015|Actual|2015-05-27|September 2017|2017-09-01|December 31, 2016|Actual|2016-12-31|October 14, 2016|Actual|2016-10-14||Interventional|||Interactive Exoskeleton Robot for Walking - Ankle Joint|Interactive Exoskeleton Robot for Walking - Ankle Joint|Completed||N/A|25|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:13:14.651345|2017-10-10 23:13:14.651345
NCT02471235|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-09-05|||July 2015||2015-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Short-course Out-patient Pulmonary Rehabilitation and COPD Exacerbations|Effect of Short Course Out-patient Pulmonary Rehabilitation on the Activity and Frequency of Exacerbations of Patients With Chronic Obstructive Pulmonary Disease.|Recruiting||N/A|136|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:13:14.74753|2017-10-10 23:13:14.74753
NCT02471222|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-08-01||2017-08-01|May 2015||2015-05-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment|Safety and Efficacy of ADS-5102 (Amantadine HCl) Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment|Completed||Phase 2|60|Actual|Adamas Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:13:14.865936|2017-10-10 23:13:14.865936
NCT02471209|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-10|||January 2012||2012-01-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Observational|||Biliary Atresia, Hepatic Buffer Response and Sevoflurane||Completed||N/A|25|Actual|Children's Hospital of Fudan University|||1||f||||f||||||||||2017-10-10 23:13:14.9768|2017-10-10 23:13:14.9768
NCT02471196|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-07-28|||August 14, 2015|Actual|2015-08-14|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|October 30, 2017|Anticipated|2017-10-30||Interventional|Nebula||Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease|Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Patients With Alzheimer's Disease: A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre Study of 12 Weeks|Active, not recruiting||Phase 2|308|Actual|Orion Corporation, Orion Pharma||3|||f||||t||||||||||2017-10-10 23:13:15.06893|2017-10-10 23:13:15.06893
NCT02471183|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2017-06-01|||November 4, 2015|Actual|2015-11-04|June 2017|2017-06-01|December 5, 2016|Actual|2016-12-05|December 5, 2016|Actual|2016-12-05||Interventional|TRANSIT-1||Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension|Multicenter, Open-label, Single-group Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Adult Patients With Pulmonary Arterial Hypertension|Completed||Phase 3|30|Actual|Actelion||1|||f||||f||||||||||2017-10-10 23:13:15.159381|2017-10-10 23:13:15.159381
NCT02471170|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-11|2016-11-22|||June 2015||2015-06-01|November 2016|2016-11-01||||June 2018|Anticipated|2018-06-01||Observational|||Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases|Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases|Recruiting||N/A|100|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     The frequency of research blood collection will not exceed 60 mL in a 1 week period and will     not occur more frequently than 4 times in an 8 week period.   "|||2017-10-10 23:13:15.272418|2017-10-10 23:13:15.272418
NCT02471157|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-06-10|||January 2015||2015-01-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|HPOS||Hormonal Predictors of Oncologic Surgery|The Association of Hypogonadism and Post-operative Outcomes of Oncologic Surgery|Unknown status|Recruiting|N/A|200|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||Samples Without DNA|"     Serum samples   "|||2017-10-10 23:13:15.345002|2017-10-10 23:13:15.345002
NCT02471144|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-08-04|||September 2015||2015-09-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis|A Randomized, Double-blind, Placebo- and Active Controlled Multicenter Trial to Demonstrate Efficacy of Subcutaneous Secukinumab Compared to Placebo and Etanercept (in a Single-blinded Arm) After Twelve Weeks of Treatment, and to Assess the Safety, Tolerability, and Long-term Efficacy in Subjects From 6 to Less Than 18 Years of Age With Severe Chronic Plaque Psoriasis|Recruiting||Phase 3|160|Anticipated|Novartis||4|||f||||t||||||||||2017-10-10 23:13:15.429841|2017-10-10 23:13:15.429841
NCT02471131|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-01-10|||October 2015||2015-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|WINNING||WATCHMAN Implantation During Hybrid Ablation|WATCHMAN LAAC Device Implantation During Hybrid Atrial Fibrillation Ablation|Completed||N/A|10|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-10 23:13:15.599569|2017-10-10 23:13:15.599569
NCT02471118|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-04-10|||March 2015||2015-03-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|OKINADA||Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)|Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA): A Randomized Placebo-controlled Trial|Recruiting||Phase 2|130|Anticipated|Canadian Research & Education in Arthritis||3|||f||||f||||||||||2017-10-10 23:13:15.667534|2017-10-10 23:13:15.667534
NCT02471105|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-05-11|||September 2015||2015-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|SPORTII||Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml|IOP and Tolerability Study of Preserved Bimatoprost 0.1% or Tafluprost Unit Dose Preservative Free 15microgram/ml, in Patients With OHT or Glaucoma Suitable for Prostaglandin Therapy|Recruiting||Phase 4|67|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 23:13:15.787118|2017-10-10 23:13:15.787118
NCT02471092|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Milk Proteins on Satiety, Food Intake and Metabolic Control (Glycemia) in Early Adulthood|The Effect of Milk Proteins on Satiety, Food Intake and Metabolic Control (Glycemia) in Early Adulthood|Completed||N/A|32|Actual|University of Guelph||5|||f||||f||||||||||2017-10-10 23:13:15.904776|2017-10-10 23:13:15.904776
NCT02471079|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-12-08|||September 2014||2014-09-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|THORACES||TOxicity After Radiotherapy in breAst CancEr Survivors (ThORACeS) - A Retrospective Cohort Study|TOxicity After Radiotherapy in breAst CancEr Survivors (ThORACeS) - A Retrospective Cohort Study|Completed||N/A|706|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:13:16.031225|2017-10-10 23:13:16.031225
NCT02471066|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-12-22|||April 2015||2015-04-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|MOVHYSTIM||rTMS Effect in Functional Psychogenic Movement Disorders Applied Alone Then Combined With Hypnotherapy|Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Functional Psychogenic Movement Disorders Followed by a Feasibility Study of a Hypnotherapy Treatment as Adjuvant Therapy.|Recruiting||Phase 2/Phase 3|24|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:13:16.093707|2017-10-10 23:13:16.093707
NCT02471053|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-18|||February 2016||2016-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|EXACT||Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study|Exercise to Prevent AnthrCycline-based Cardio-Toxicity Study (EXACT)|Recruiting||N/A|20|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-10 23:13:16.167004|2017-10-10 23:13:16.167004
NCT02471027|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-11|||June 2015||2015-06-01|June 2015|2015-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|4 Years|Observational [Patient Registry]|||The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer|Optimization Research of Early Cervical Caner Treatment|Not yet recruiting||N/A|1000|Anticipated|Capital Medical University|||2||f||||t||||||Samples With DNA|"     frozen tissue and (or) whole blood   "|||2017-10-10 23:13:16.349556|2017-10-10 23:13:16.349556
NCT02471014|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-09-01|||December 2016||2016-12-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|ROVE||Effect of Obesity on Immune Response to Pneumovax 23|The Effect of Obesity on Immune Responses to Pneumococcal Polysaccharide Vaccine, ROVE Study|Recruiting||N/A|56|Anticipated|University of Florida|||2||f||||f||||||||||2017-10-10 23:13:16.429975|2017-10-10 23:13:16.429975
NCT02471001|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-11-23|||September 2015||2015-09-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|TLAHMHS||The Levels of Anaesthetics in Heart Muscle During Heart Surgery|Coronary Sinus Blood Isoflurane Concentration in Patients Undergoing Heart Surgery|Completed||N/A|23|Actual|University of Edinburgh|||1||f||||f||||||||No||2017-10-10 23:13:16.539452|2017-10-10 23:13:16.539452
NCT02470988|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-12-06|||June 2015||2015-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Does Disciplined Personal Involvement Precede Change in CBASP?|How is Psychological Change Experienced by Individuals Receiving Cognitive Behaviour Analysis System of Psychotherapy (CBASP) and How is This Affected by Disciplined Personal Involvement? A Multiple Baseline Single Case Design|Unknown status|Active, not recruiting|N/A|13|Actual|University of Edinburgh||2|||f||||f||||||||||2017-10-10 23:13:16.6244|2017-10-10 23:13:16.6244
NCT02470975|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-02-06|||June 2015||2015-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||How Family Coping With Child Cancer Affects Child's Quality of Life?|"How Families Cope With Child Cancer? A Longitudinal Study on the Role of We-appraisals on Child's Health-related Quality of Life"|Recruiting||N/A|300|Anticipated|University Children's Hospital, Zurich|||1||f||||t||||||||No||2017-10-10 23:13:16.687958|2017-10-10 23:13:16.687958
NCT02470962|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-10-12|||May 2015||2015-05-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy|Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy|Recruiting||N/A|40|Anticipated|University Children's Hospital, Zurich|||2||f||||f||||||||||2017-10-10 23:13:16.76211|2017-10-10 23:13:16.76211
NCT02470949|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-08-15|2016-05-17||September 2014||2014-09-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Influence of a Monopoly Game on Subtle Behaviors|Influence of a Monopoly Game on Subtle Behaviors|Completed||N/A|9|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:13:19.034682|2017-10-10 23:13:19.034682
NCT02470923|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-08-24|||August 2015||2015-08-01|May 2015|2015-05-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||In-patient Smoking Cessation Intervention Using Counseling, Spirometry and Nicotine Replacement Therapy|In-patient Smoking Cessation Intervention Using Counseling, Spirometry and Nicotine Replacement Therapy|Unknown status|Recruiting|N/A|90|Anticipated|Soroka University Medical Center||3|||f||||t||||||||||2017-10-10 23:13:19.384592|2017-10-10 23:13:19.384592
NCT02470910|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-25|||July 2015||2015-07-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|July 2018|Anticipated|2018-07-01||Interventional|||Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning|Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning: A Pilot Study to Quantitate the Potential to Limit Radiation Dose to Normal Tissues.|Active, not recruiting||N/A|15|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:13:19.482627|2017-10-10 23:13:19.482627
NCT02470897|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-05-19|||July 2015||2015-07-01|May 2017|2017-05-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer|A Phase I/II Study of Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer Using Simultaneous Integrated Boost and Urethral-Sparing IMRT Planning|Recruiting||N/A|160|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-10 23:13:19.571835|2017-10-10 23:13:19.571835
NCT02470884|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-03-02|||June 15, 2015|Actual|2015-06-15|March 2017|2017-03-01|March 31, 2022|Anticipated|2022-03-31|January 31, 2017|Actual|2017-01-31||Interventional|||FAST Feasibility Study|Fully Absorbable Scaffold Feasibility Study|Active, not recruiting||N/A|33|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-10 23:13:19.67419|2017-10-10 23:13:19.67419
NCT02470871|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-04-25|||July 2015||2015-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency|Multi-center, Randomized, Open-label, Parallel-Arm, Single-dose, Pharmacokinetic Study of rVIIa-FP (CSL689) in Subjects With Congenital Factor VII Deficiency|Completed||Phase 1|9|Actual|CSL Behring||2|||f||||||||||||||2017-10-10 23:13:19.762465|2017-10-10 23:13:19.762465
NCT02470858|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-02-26|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects|Effect of Triple Direct Acting Antiviral Agents (DAAs) for Non-cirrhotic Subjects With Chronic HCV G1b Infection|Completed||Phase 2|18|Actual|Humanity and Health Research Centre||3|||f||||f||||||||||2017-10-10 23:13:19.950343|2017-10-10 23:13:19.950343
NCT02470845|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-03-14|||July 2014||2014-07-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Trial of Tian Jiu Therapy for Allergic Rhinitis|A Randomized Controlled Trial of Tian Jiu Therapy for Allergic Rhinitis|Completed||N/A|136|Actual|Hong Kong Baptist University||3|||f||||t||||||||||2017-10-10 23:13:20.119584|2017-10-10 23:13:20.119584
NCT02470832|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-08-25|||May 2015||2015-05-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects||Completed||Phase 1|12|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 23:13:20.223635|2017-10-10 23:13:20.223635
NCT02470819|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-08-04|||March 2014||2014-03-01|March 2017|2017-03-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer|A Two Arm Pilot Study Utilizing Molecular Profiling to Find Potential Targets and Influence Treatments for Patients With Metastatic Breast Cancer or Advanced Gynecological Malignancies|Recruiting||N/A|500|Anticipated|Avera McKennan Hospital & University Health Center||1|||f||||t||||||||||2017-10-10 23:13:20.33116|2017-10-10 23:13:20.33116
NCT02470806|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-19|||July 2015||2015-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|NPWT||Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)|A Prospective, Randomized, Comparative Effectiveness Study of a Single-Use, Negative Pressure Wound Therapy System (PICO) Versus a Traditional Negative Pressure Wound Therapy System (tNPWT) in the Treatment of Lower Extremity Ulcers|Recruiting||Phase 4|160|Anticipated|Smith & Nephew, Inc.||2|||f||||f||||||||||2017-10-10 23:13:20.442891|2017-10-10 23:13:20.442891
NCT02470793|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2017-02-22|||September 2014||2014-09-01|February 2017|2017-02-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|TREK||Technique And Results In Endothelial Keratoplasty|Technique And Results Evaluation In Endothelial Keratoplasty|Recruiting||N/A|100|Anticipated|Hospital Mutua de Terrassa||2|||f||||t||||||||Undecided||2017-10-10 23:13:20.576889|2017-10-10 23:13:20.576889
NCT02470780|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-05-18|||December 2015||2015-12-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SIBO-PD||Treating Bacterial Overgrowth in Parkinson's Disease|Treating Bacterial Overgrowth in Parkinson's Disease|Recruiting||Phase 2/Phase 3|24|Anticipated|University of Cincinnati||2|||f||||f||||||||||2017-10-10 23:13:20.672549|2017-10-10 23:13:20.672549
NCT02470767|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-02-15|||May 2015||2015-05-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|SILVER-AP||An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres|An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres|Completed||N/A|792|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:13:20.762095|2017-10-10 23:13:20.762095
NCT02470754|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-08-30|||July 2015||2015-07-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Pharmacology of Electronic Cigarettes|Clinical Pharmacology of Electronic Cigarettes R01DA039264|Recruiting||N/A|36|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:13:20.853121|2017-10-10 23:13:20.853121
NCT02470741|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-07-14|||July 2015||2015-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PLUM||Pilot of Letrozole for Uterine Myomas|Pilot of Letrozole for Uterine Myomas|Active, not recruiting||Phase 4|20|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:13:20.965059|2017-10-10 23:13:20.965059
NCT02470728|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-05-22|||January 2016||2016-01-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Optimal Management of Pain in Hospitalized Patients - Opioid Tolerant Populations.|Pain Management Options for Opioid Tolerant Patients: a Randomized Controlled Trial|Recruiting||N/A|1560|Anticipated|Duke University||2|||f||||t|f|f||||||||2017-10-10 23:13:21.044477|2017-10-10 23:13:21.044477
NCT02470715|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-04-03|||April 2014||2014-04-01|April 2017|2017-04-01|April 2024|Anticipated|2024-04-01|April 2024|Anticipated|2024-04-01||Observational|||Identifying Molecular Drivers of Cancer|Identifying Molecular Drivers of Cancer|Suspended||N/A|1000|Anticipated|Avera McKennan Hospital & University Health Center|||1||f||||t||||||Samples With DNA|"     Participants will have up to 3 blood tubes (about 30 ml) drawn under the condition that     protocol criteria for blood sampling is met. Blood samples may be collected each time a     participant undergoes a provider-ordered blood draw. Urine samples may also be collected     approximately every 4-6 weeks.      Participants may be asked to provide approximately 60-120 ml of first-morning-void urine.     Tissue from a standard care surgical procedure or biopsy may be obtained. Additional core     biopsies (for research) or excess surgical waste will be collected during each biopsy     procedure when appropriate and will be processed and stored.   "|Undecided||2017-10-10 23:13:21.156984|2017-10-10 23:13:21.156984
NCT02470702|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-10-25|||June 2015||2015-06-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects|A Double-Blind Randomized Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple 1200 mg Dose Intravenous Oritavancin Infusions in Healthy Subjects|Completed||Phase 1|14|Actual|The Medicines Company||2|||f||||t||||||||||2017-10-10 23:13:21.23651|2017-10-10 23:13:21.23651
NCT02470689|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-06-09|||June 2015||2015-06-01|May 2015|2015-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Diacerin for the Treatment of Epidermolysis Bullosa Simplex|Diacerin for the Treatment of Epidermolysis Bullosa Simplex|Not yet recruiting||Phase 2|50|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-10 23:13:21.321981|2017-10-10 23:13:21.321981
NCT02470676|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-06-09|||July 2015||2015-07-01|June 2015|2015-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Cervical Pessary vs Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial|Cervical Pessary vs. Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial|Not yet recruiting||Phase 2/Phase 3|430|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-10 23:13:21.391212|2017-10-10 23:13:21.391212
NCT02470663|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-11|||July 2015||2015-07-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Bone Density in Children With IBD Treated With Amorphous Calcium or Commercial Crystalline Calcium|Bone Density in Children With IBD Treated With Amorphous Calcium or Commercial Crystalline Calcium: A Prospective Randomized Multicenter Trial|Not yet recruiting||N/A|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:13:21.478607|2017-10-10 23:13:21.478607
NCT02470325|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-08-17|||July 2015||2015-07-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients|A Randomized Double Blind Study of Cannabis on Dystonia and Spasticity in Pediatric Patients|Recruiting||Phase 2|40|Anticipated|Wolfson Medical Center||4|||f||||t||||||||||2017-10-10 23:13:26.682007|2017-10-10 23:13:26.682007
NCT02470650|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-06-29|||June 2015||2015-06-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive|Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive. Randomized Clinical, Not Masked, Trial Comparing DRVr3TC, ABC3TC (Kivexa) RPV, or EVG COBI FTC TDF (Stribild) for 48 Weeks|Recruiting||Phase 4|150|Anticipated|Hospital Clinic of Barcelona||3|||f||||f||||||||||2017-10-10 23:13:21.564483|2017-10-10 23:13:21.564483
NCT02470637|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-04-12|||June 2015||2015-06-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus|A Randomized, Controlled, 6-treatment, 6-sequence, 6-period Cross-over Dose Response Study of 3 Single Doses of Afrezza Inhaled Technosphere Insulin and of 3 Single Doses of SC Insulin Lispro in Patients With Diabetes Mellitus Type 1 Using the Euglycemic Clamp Technique|Completed||Phase 1|30|Actual|Mannkind Corporation||1|||f||||f||||||||||2017-10-10 23:13:21.673596|2017-10-10 23:13:21.673596
NCT02470624|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-10-22|||May 2015||2015-05-01|October 2015|2015-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|18 Months|Observational [Patient Registry]|CASTOR||Chinese Acute Ischemic Stroke Treatment Outcome Registry|Chinese Acute Ischemic Stroke Treatment Outcome Registry|Unknown status|Recruiting|N/A|10000|Anticipated|Peking University First Hospital|||1||f||||t||||||||||2017-10-10 23:13:21.868724|2017-10-10 23:13:21.868724
NCT02470611|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-09|||November 2012||2012-11-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|SANSPET||Sodium Alendronate in Non Surgical Periodontal Therapy|Effects of 1% Sodium Alendronate in Non Surgical Periodontal Therapy on Clinical and Tomographical Parameters: a Randomized Placebo Controlled 6-month Clinical Trial|Completed||Phase 4|32|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-10 23:13:21.950246|2017-10-10 23:13:21.950246
NCT02470598|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-04-29|||March 2015||2015-03-01|April 2016|2016-04-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|PD-IDEA||PD-Improved Dialysis Efficiency With Adapted APD|PD-Improved Dialysis Efficiency With Adapted APD - PD-IDEA|Recruiting||N/A|250|Anticipated|Fresenius Medical Care Deutschland GmbH|||1||f||||f||||||||||2017-10-10 23:13:22.048639|2017-10-10 23:13:22.048639
NCT02470572|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-03-24|||June 2015||2015-06-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|PrimeDx||Evaluation of the Omnyx™ Integrated Digital Pathology System in the Primary Diagnosis of Surgical Pathology Specimens|Evaluation of the Omnyx™ Integrated Digital Pathology System in the Primary Diagnosis of Surgical Pathology Specimens|Active, not recruiting||N/A|1000|Anticipated|Omnyx, LLC||2|||f||||f||||||||||2017-10-10 23:13:22.871632|2017-10-10 23:13:22.871632
NCT02470559|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-02-15|||June 2015||2015-06-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent|Treatment of High Risk or Recurrent Ovarian Cancer With Anti-CD3 x Anti-HER2 Bispecific Antibody Armed Activated T Cells (BATs), Low Dose IL-2, and GM-CSF (Phase I).|Withdrawn||Phase 1|0|Actual|Barbara Ann Karmanos Cancer Institute||1||Study did not accrue any participants, the PI has left the institution.|f||||t||||||||||2017-10-10 23:13:22.948174|2017-10-10 23:13:22.948174
NCT02470546|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2015-06-09|||March 2015||2015-03-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|EME||Metformin Experience on Minimal Hepatic Encephalopathy|Metformin Experience on Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis|Unknown status|Recruiting|Phase 4|30|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f||||||||||2017-10-10 23:13:23.059987|2017-10-10 23:13:23.059987
NCT02470533|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-06-02|||April 2015||2015-04-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|TRENDY||Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma|Transarterial Chemoembolization With Drug-Eluting Beads (Standard Arm) Versus Stereotactic Body Radiation Therapy (Experimental Arm) for Hepatocellular Carcinoma: A Multicenter Randomized Phase II Trial|Recruiting||Phase 2|100|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 23:13:23.158775|2017-10-10 23:13:23.158775
NCT02470520|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-05-16|||August 2013||2013-08-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2014|Actual|2014-11-01||Observational|||Essential Nutrients in Critically Ill Patients With Severe AKI Treated With and Without CRRT|Observational Study Measuring Essential Nutrients in Critically Ill Patients With Severe Acute Kidney Injury Treated With and Without Continuous Haemofiltration|Completed||N/A|40|Actual|Guy's and St Thomas' NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 23:13:23.323409|2017-10-10 23:13:23.323409
NCT02470507|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-07-10|||June 2013||2013-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Immune Function in Acute Kidney Injury|Evaluation of Immune Function in Patients With Acute Kidney Injury|Recruiting||N/A|120|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||4||f||||f||||||||||2017-10-10 23:13:23.382881|2017-10-10 23:13:23.382881
NCT02470494|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-05-25|2017-02-10||June 2015||2015-06-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|Spectrum||The EarLens Contact Hearing Device (CHD) Spectrum Study|The EarLens Contact Hearing Device (CHD) Spectrum Study|Completed||N/A|46|Actual|EarLens Corporation||1|||f||||f||||||||No||2017-10-10 23:13:23.468356|2017-10-10 23:13:23.468356
NCT02470312|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-03-02|||August 18, 2015|Actual|2015-08-18|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|February 10, 2017|Actual|2017-02-10|5 Days|Observational [Patient Registry]|||MediGuide Registry|MediGuide Registry|Terminated||N/A|558|Actual|St. Jude Medical|||2|"- Demonstrated through existing clinical trials that there is a positive reduction in   fluoroscopy with the use of MediGuide Technology."|f||||f||||||||||2017-10-10 23:13:26.863504|2017-10-10 23:13:26.863504
NCT02470481|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-09-01|||March 2015||2015-03-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|PARIS||A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics|Psoriatic Arthritis In Skin Clinics (PARIS) Study. A Multicentre, Observational, Descriptive Cross-Cultural Validation Study and Estimate of the Proportion of Patients With Psoriatic Arthritis Among Psoriasis Patients Attending Dermatology Clinics Selected for This Study|Completed||Phase 4|250|Actual|Janssen Research & Development, LLC|||1||f||||f||||||||||2017-10-10 23:13:23.845459|2017-10-10 23:13:23.845459
NCT02470468|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-19|||December 2014|Actual|2014-12-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer|A Phase I/II Study to Evaluate Safety and Efficacy of DCVAC/LuCa Added to Standard First Line ChT With Carboplatin and Paclitaxel +/- Immune Enhancers (Interferon-α and Hydroxychloroquine) vs ChT Alone in Patients With Stage IV NSCLC|Active, not recruiting||Phase 1/Phase 2|105|Anticipated|Sotio a.s.||3|||f||||f||||||||Undecided||2017-10-10 23:13:23.94176|2017-10-10 23:13:23.94176
NCT02470455|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-08-14|||July 2011||2011-07-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Effect of Atorvastatin on Glycemic Control in Prediabetic Patients|Effect of Atorvastatin on Glycemic Control in Prediabetic Patients|Completed||Phase 4|75|Actual|Shri Ramachandra Bhanj Medical College|||3||f||||f||||||||||2017-10-10 23:13:24.083124|2017-10-10 23:13:24.083124
NCT02470442|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-08-02|||June 2015||2015-06-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Desflurane in Children With Laryngeal Mask Airway|Sevoflurane Vs. Sevoflurane-desflurane Anesthesia in Children With Laryngeal Mask Airways; Difference in Respiratory Event, Recovery Time and Emergence Agitation|Completed||N/A|200|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:13:24.185713|2017-10-10 23:13:24.185713
NCT02470429|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-06-16|2017-04-04||July 17, 2015|Actual|2015-07-17|June 2017|2017-06-01|May 26, 2016|Actual|2016-05-26|May 26, 2016|Actual|2016-05-26||Interventional||This analysis population includes all subjects who were exposed to study drug (including the run-in therapy) (Safety Analysis Set).|Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION|Evaluation of Clinical Outcomes Following the Use of SYSTANE® HYDRATION in Subjects With Dry Eye|Completed||N/A|114|Actual|Alcon Research||2|||f||||f|f|f||||||||2017-10-10 23:13:24.283291|2017-10-10 23:13:24.283291
NCT02470416|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-12-15|||October 2015||2015-10-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|SPIDA||Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal Adenomas|A Prospective Case Control Study on the Prevalence of Small Bowel and Colonic Polyps in Patients With Duodenal Adenomas/Ampullomas Who do Not Have Familial Adenomatous Polyposis (FAP) or Peutz Jeghers Syndrom (PJS).|Recruiting||N/A|200|Anticipated|Western Sydney Local Health District||2|||f||||||||||||||2017-10-10 23:13:24.669592|2017-10-10 23:13:24.669592
NCT02470403|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-04-02|2017-04-02||June 5, 2015|Actual|2015-06-05|March 2017|2017-03-01|April 4, 2016|Actual|2016-04-04|April 4, 2016|Actual|2016-04-04||Interventional||The safety analysis set included all subjects that received any study drug|Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index|A Randomized, Double-blind, Placebo-controlled, Parallel Group, 2-part Study Investigating the Effect of LIK066 on Body Weight in Dysglycemic (Prediabetes or Type 2 Diabetes) and Normoglycemic Patients With Elevated Body Mass Index|Completed||Phase 2|181|Actual|Novartis||5|||f||||f||||||||||2017-10-10 23:13:24.812342|2017-10-10 23:13:24.812342
NCT02470377|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-03-06|||January 2012||2012-01-01|March 2017|2017-03-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome|Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome|Recruiting||N/A|300|Anticipated|Laureate Institute for Brain Research, Inc.||1|||f||||f|f|t|f|f|f|||No|Anonymized data may be shared with other researchers when there is sufficient recruitment to assure that no individual may be identified based on demographic or clinical characteristics.|2017-10-10 23:13:26.374166|2017-10-10 23:13:26.374166
NCT02470364|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2015-06-12|||June 2014||2014-06-01|October 2014|2014-10-01||||December 2014|Actual|2014-12-01||Observational|MGQOL-15-F||Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F|Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F|Completed||N/A|120|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:13:26.472974|2017-10-10 23:13:26.472974
NCT02470351|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-04-25|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Observational|||Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS|Study SEARCH 026Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS in Subjects Participating in Study SEARCH 019|Completed||N/A|9|Actual|South East Asia Research Collaboration with Hawaii|||1||f||||f||||||Samples With DNA|"     HIV RNA standard quantitation will be completed using the Roche COBAS/Amplicor HIV-1 Viral     Load v2.0 assay, with a lower limit of quantitation of 20cps/mL. Single Copy Assay (SCA) HIV     RNA quantitation in the setting of ART will be performed using 5-10 ml of CSF. In addition,     cell associated HIV-DNA (total, integrated and 2LTR circles in total CD4+ T cells will be     assessed at CRC-CHUM.   "|Undecided||2017-10-10 23:13:26.531655|2017-10-10 23:13:26.531655
NCT02470338|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-05-08|||June 2015||2015-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Modified Brostrӧm Procedure With and Without Possible Arthroscopy for Lateral Ankle Instability|A Single-Blinded Randomized Controlled Trial Comparing Modified Brostrӧm Procedure With and Without Diagnostic Arthroscopy for Treatment of Lateral Ankle Instability|Active, not recruiting||N/A|112|Anticipated|William Beaumont Army Medical Center||2|||f||||f||||||||Undecided||2017-10-10 23:13:26.597797|2017-10-10 23:13:26.597797
NCT02468804|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-01-04|||August 2013||2013-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|KL2||Cognitive Dysfunction In Parkinson's|Cognitive Dysfunction in Parkinson's Disease|Active, not recruiting||N/A|120|Anticipated|University of Colorado, Denver||2|||f||||f||||||||Undecided|In Progress|2017-10-10 23:13:44.822832|2017-10-10 23:13:44.822832
NCT02470299|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-09-15|||October 2015||2015-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients|A Randomized Placebo-controlled Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients|Recruiting||N/A|20|Anticipated|New Mexico Cancer Care Alliance||2|||f||||t||||||||||2017-10-10 23:13:26.992107|2017-10-10 23:13:26.992107
NCT02470286|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-06-02|||June 2015||2015-06-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers|A Block-randomized, Double-blind, Placebo-controlled, Single/Multiple-dose, Dose-escalation, Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers|Recruiting||Phase 1|96|Anticipated|Samjin Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 23:13:27.102474|2017-10-10 23:13:27.102474
NCT02470273|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-11|||August 2015||2015-08-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)|Multicenter Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)|Recruiting||N/A|1000|Anticipated|Rockefeller University|||1||f||||f||||||||||2017-10-10 23:13:27.183506|2017-10-10 23:13:27.183506
NCT02470260|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-09-14|||January 2012||2012-01-01|September 2015|2015-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|NOMEM||Northern Manhattan Study of Metabolism and Mind|Northern Manhattan Study of Metabolism and Mind|Recruiting||N/A|1000|Anticipated|Columbia University|||3||f||||f||||||Samples With DNA|"     whole blood for DNA extraction, plasma, sera   "|||2017-10-10 23:13:27.286712|2017-10-10 23:13:27.286712
NCT02470247|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-01-16|||July 2015||2015-07-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|IPC-Angio||Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy in High Risk Patients|IPC-Angio Trial : Interest of Remote Ischemic Preconditioning for Prevention of Contrast Medium-induced Nephropathy (Post-diagnostic Imaging) in Patients at High Risk of Contrast-induced Nephropathy|Recruiting||N/A|100|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-10 23:13:27.374234|2017-10-10 23:13:27.374234
NCT02470234|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-02-05|||February 2016||2016-02-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|PK003||Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD|A Pharmacokinetic Study of Aptensio XR® (Methylphenidate Hydrochloride Extended-release) Capsules in Male or Female Pre-School Children 4 to Under 6 Years of Age With ADHD in Fed Condition|Recruiting||Phase 4|60|Anticipated|Rhodes Pharmaceuticals, L.P.||1|||f||||t||||||||No||2017-10-10 23:13:27.475563|2017-10-10 23:13:27.475563
NCT02470221|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-09|||June 2015||2015-06-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Observational|||Goal-directed Intraoperative Fluid Therapy in High-risk Surgery|Effect of Goal-Directed Intraoperative Fluid Therapy on Outcomes Following Laparotomy of Gynecological Malignancies and Orthopedic Surgery|Unknown status|Not yet recruiting|N/A|300|Anticipated|Peking Union Medical College Hospital|||2||f||||f||||||||||2017-10-10 23:13:27.5803|2017-10-10 23:13:27.5803
NCT02470208|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-18|||June 2015||2015-06-01|June 2016|2016-06-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|REACT||Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation|A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study|Completed||N/A|250|Actual|Oxford Immunotec|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 23:13:27.661467|2017-10-10 23:13:27.661467
NCT02470195|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-07-05|||November 2014||2014-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PROSIDIAIR||Procedural Simulation for Difficult Airway Training in Anesthesiology Resident Education Program|Anesthesiology Education Implementation by Procedural Simulation Workshop for Difficult Airway Management: a Controlled Interregional French Study|Completed||N/A|60|Actual|Claude Bernard University||2|||f||||f||||||||No|data will be analysed by group, no plan to share data has been programmed|2017-10-10 23:13:27.750393|2017-10-10 23:13:27.750393
NCT02470182|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-05-07|||September 2014||2014-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Observational|||Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors|Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors|Active, not recruiting||N/A|52|Actual|Oregon Health and Science University|||3||f||||f||||||||||2017-10-10 23:13:27.820512|2017-10-10 23:13:27.820512
NCT02470169|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-01-20|||June 2015||2015-06-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis|Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis: A Randomized Controlled Trial|Recruiting||Phase 3|450|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 23:13:27.892806|2017-10-10 23:13:27.892806
NCT02470156|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-09-21|||May 2012||2012-05-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Interventional|UWAG-II||Coalition for a Healthier Community—Utah Women and Girls - Phase II (UWAG-II)|Coalition for a Healthier Community—Utah Women and Girls - Phase II|Active, not recruiting||N/A|400|Anticipated|University of Utah||2|||f||||f||||||||||2017-10-10 23:13:28.002087|2017-10-10 23:13:28.002087
NCT02470143|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-08-17|||August 2015||2015-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|BackonBike||a Bike Application to Support Cardiac Patient|Pilot Study, How a Bike Application Can Support Cardiac Patients in Their Rehabilitation Program?|Recruiting||N/A|75|Anticipated|Hasselt University|||1||f||||f||||||||||2017-10-10 23:13:28.085073|2017-10-10 23:13:28.085073
NCT02470130|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-07-05|||October 2014||2014-10-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|RELAXSIMHF||Relaxation Before Debriefing and Memorization in High Fidelity Simulation in Healthcare|Effect of a Debriefing Conversational Relaxation on Memorization of Critical Key Points in Resident High Fidelity Simulation Education Program|Completed||N/A|150|Actual|Claude Bernard University||4|||f||||f||||||||||2017-10-10 23:13:28.167461|2017-10-10 23:13:28.167461
NCT02469935|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-09|||October 2011||2011-10-01|June 2015|2015-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Accuracy of Surgeon-performed Ultrasound in Detecting Gallstones - a Validation Study|Accuracy of Surgeon-performed Ultrasound in Detecting Gallstones - a Validation Study|Completed||N/A|300|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 23:13:29.955197|2017-10-10 23:13:29.955197
NCT02470117|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-07-26|||June 2015||2015-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Alginate-based Reflux Suppressant and Magnesium-aluminium Antacid Gel for Treatment of Heartburn in Pregnancy|Comparison of the Efficacy of Alginate-based Reflux Suppressant and Magnesium-aluminium Antacid Gel for Treatment of Heartburn in Pregnancy : A Randomized Double-Blind Controlled Trial|Completed||Phase 4|100|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 23:13:28.250591|2017-10-10 23:13:28.250591
NCT02470104|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-09-18|||March 2015||2015-03-01|September 2017|2017-09-01|May 4, 2018|Anticipated|2018-05-04|May 25, 2017|Actual|2017-05-25||Interventional|||Donor Human Milk in Young Children Receiving Bone Marrow Transplantation|A Randomized Study of Enteral Donor Human Milk in Young Children Receiving Bone Marrow Transplantation|Active, not recruiting||Phase 1/Phase 2|42|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-10 23:13:28.339188|2017-10-10 23:13:28.339188
NCT02470091|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-07-19|||October 2015||2015-10-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma|Phase II Study of Denosumab (NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma|Recruiting||Phase 2|90|Anticipated|Children's Oncology Group||1|||f||||t||||||||||2017-10-10 23:13:28.422278|2017-10-10 23:13:28.422278
NCT02470078|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-05-18|||July 2015||2015-07-01|May 2016|2016-05-01||||July 2018|Anticipated|2018-07-01||Interventional|||Pharyngeal Electrical Stimulation for the Treatment of Post-extubation Dysphagia in Acute Stroke|Randomised Controlled Trial of Pharyngeal Electrical Stimulation for the Treatment of Post-extubation Dysphagia in Acute Stroke Patients|Recruiting||N/A|60|Anticipated|University Hospital Muenster||2|||f||||||||||||||2017-10-10 23:13:28.587|2017-10-10 23:13:28.587
NCT02470065|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2016-01-21|||January 2016||2016-01-01|January 2016|2016-01-01|January 2021|Anticipated|2021-01-01|September 2018|Anticipated|2018-09-01||Interventional|REMNANT||Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.|Resectable EGFR Mutant NSCLC With (or Without) Afatinib as Neoadjuvant Treatment; REMNANT an Exploratory Study of the EORTC Lung Cancer Group|Suspended||Phase 2|38|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2||Study never started|f||||t||||||||||2017-10-10 23:13:28.692444|2017-10-10 23:13:28.692444
NCT02470052|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-08-01|||August 2015||2015-08-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema|A Prospective, Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema|Recruiting||N/A|38|Anticipated|Olympus Corporation||1|||f||||f||||||||||2017-10-10 23:13:28.771516|2017-10-10 23:13:28.771516
NCT02470039|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-07-31||2016-11-09|June 1, 2015|Actual|2015-06-01|July 2017|2017-07-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy|An 8-week Randomised, Double-blind, Parallel, Multiple Dose Trial Comparing NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy|Completed||Phase 2|50|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 23:13:28.870139|2017-10-10 23:13:28.870139
NCT02470026|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2017-07-19|||June 2014||2014-06-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|YohCog||Noradrenergic Activity, Cognition and Major Depressive Disorder|Influences on Noradrenergic Activity for Cognition in Patients With Major Depressive Disorder|Recruiting||N/A|80|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:13:28.964993|2017-10-10 23:13:28.964993
NCT02470013|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-06-09|||November 2014||2014-11-01|June 2015|2015-06-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|ECONONS||Medical and Health Economic Benefit of Oral Nutritional Supplements (ONS) in Ambulant Patients|Medical and Health Economic Benefit of Oral Nutritional Supplements (ONS) in Ambulant Patients|Unknown status|Recruiting|N/A|156|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:13:29.052538|2017-10-10 23:13:29.052538
NCT02470000|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-08-01|||November 2014||2014-11-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Treatment of Chronic Myofascial Pain Syndrome Over Neck by Using Intravascular Laser Irradiation of Blood|Treatment of Chronic Myofascial Pain Syndrome Over Neck by Using Intravascular Laser Irradiation of Blood|Recruiting||N/A|36|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||No||2017-10-10 23:13:29.148793|2017-10-10 23:13:29.148793
NCT02469987|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-08-07|||April 2015||2015-04-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers|A Single Center, Randomized, Double-blind, 3-arm Parallel Phase1 Study to Assess PK, Safety, and Tolerability of a Single 90 Min iv Infusion of 1 mg/kg MYL-1402O, EU Avastin®, and US Avastin® in Healthy Male Volunteers|Unknown status|Active, not recruiting|Phase 1|111|Anticipated|Mylan Inc.||3|||f||||f||||||||||2017-10-10 23:13:29.268279|2017-10-10 23:13:29.268279
NCT02469974|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-08-11|||May 2015||2015-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Ruxolitinib in Combination With Autotransplant|Ruxolitinib in Combination With High Dose Therapy and Autologous Stem Cell Transplantation for Myelofibrosis|Withdrawn||N/A|0|Actual|Icahn School of Medicine at Mount Sinai||1||no enrollments|f||||t||||||||||2017-10-10 23:13:29.35938|2017-10-10 23:13:29.35938
NCT02469961|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-03-17|2015-09-15||October 2010||2010-10-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|August 2011|Actual|2011-08-01||Interventional|TIVA|45|Dexmedetomidine vs Propofol TIVA (Total Intravenous Anesthesia) and Interscalene Block|Dexmedetomidine vs Propofol TIVA and Interscalene Block for Shoulder Surgeries in a Beach Chair Sitting Position|Completed||Phase 4|50|Actual|Maimonides Medical Center|There was no limitations|2|||f||||f||||||||Yes||2017-10-10 23:13:29.452158|2017-10-10 23:13:29.452158
NCT02469948|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-10-12|||October 2015||2015-10-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Lower Extremities|Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Lower Extremities|Unknown status|Not yet recruiting|Phase 3|40|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:13:29.848832|2017-10-10 23:13:29.848832
NCT02469922|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-09-14|||June 2014||2014-06-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|TEmPoRAL||Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer|Prospective Study Assessing Predictive Value of 18 F-2-fluoro-2-deoxy-D-glucose Fluorodeoxyglucose (FDG) Positron Emission Tomography During Radio-chemotherapy for Locally Advanced Epidermoid Carcinoma of Head and Neck|Recruiting||N/A|123|Anticipated|Center Eugene Marquis||1|||f||||f||||||||||2017-10-10 23:13:30.044134|2017-10-10 23:13:30.044134
NCT02469909|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-02-28|||June 2015||2015-06-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison Between Immediate and Gradual Decannulation|Feasibility and Safety of Immediate Versus Gradual Decannulation: a Randomised Control Trial|Recruiting||N/A|100|Anticipated|Kaplan Medical Center||2|||f||||f||||||||||2017-10-10 23:13:30.138161|2017-10-10 23:13:30.138161
NCT02469896|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-08-23|||November 2015||2015-11-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|TCZALS-001||A Trial of Tocilizumab in ALS Subjects|A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects|Recruiting||Phase 2|24|Anticipated|Barrow Neurological Institute||2|||f||||t||||||||||2017-10-10 23:13:30.313155|2017-10-10 23:13:30.313155
NCT02469883|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-06-09|||March 2015||2015-03-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||A Study of Sinotecean on Tolerance and Pharmacokinetics|A Phase I Study of Sinotecean on Tolerance and Pharmacokinetics|Unknown status|Recruiting|Phase 1|20|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||f||||||||||2017-10-10 23:13:30.466716|2017-10-10 23:13:30.466716
NCT02469870|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-08-15|||August 2016||2016-08-01|August 2017|2017-08-01||||October 2017|Anticipated|2017-10-01||Interventional|APT||ASD Parent Trainer: Online Coaching for Parents of Children With Autism||Active, not recruiting||Phase 2|180|Anticipated|IRIS Media Inc||1|||f||||f||||||||||2017-10-10 23:13:30.550567|2017-10-10 23:13:30.550567
NCT02469844|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-10-05|||October 2014||2014-10-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Heart Rate Variability (HRV) Analysis in Patients With Nocturnal Epileptic Seizures|Heart Rate Variability (HRV) Analysis in Patients With Nocturnal Epileptic Seizures|Recruiting||N/A|40|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-10-10 23:13:30.950055|2017-10-10 23:13:30.950055
NCT02469831|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2017-03-25|||October 2014||2014-10-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Respiratory Mechanics and Metabolic Changes During Low Pressure Laparoscopic Cholecystectomy|The Impact of Deep Versus Moderate Neuromuscular Block on Respiratory System Mechanics and Metabolic Changes During Laparoscopic Cholecystectomy a Double‑Blind Randomized Clinical Trial.|Completed||Phase 2|40|Actual|Assiut University||2|||f||||||||||||||2017-10-10 23:13:31.032568|2017-10-10 23:13:31.032568
NCT02469818|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-12|||January 2015||2015-01-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Diagnostic Accuracy of Bedside Ultrasonography in the Management of the Shoulder Dislocations|Diagnostic Accuracy of Bedside Point of Care Ulrasound (POCUS) in the Management of the Shoulder Dislocations|Unknown status|Recruiting|N/A|100|Anticipated|Antalya Training and Research Hospital|||1||f||||f||||||||||2017-10-10 23:13:31.109813|2017-10-10 23:13:31.109813
NCT02469805|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-07-28|||June 2015||2015-06-01|July 2016|2016-07-01||||June 2017|Anticipated|2017-06-01||Interventional|||Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility|Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility: A Randomized Controlled Trial|Recruiting||Phase 3|450|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 23:13:31.199762|2017-10-10 23:13:31.199762
NCT02469792|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-07-19|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effectiveness and Safety of Autologous ADRC for Treatment of Anterior Cruciate Ligament Partial Rupture|Effectiveness and Safety of Intraarticular Administration of Autologous Adipose-Derived Regenerative Cells for Treatment of Anterior Cruciate Ligament Partial Rupture|Enrolling by invitation||Phase 1/Phase 2|12|Anticipated|Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation||1|||f||||f||||||||||2017-10-10 23:13:31.297704|2017-10-10 23:13:31.297704
NCT02469779|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-06-16|||December 2013|Actual|2013-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Middle and High School Students' Reactions to a Health Interactive Website: ASPIRE Reactions|Middle and High School Students' Reactions to a Health Interactive Website: ASPIRE Reactions|Active, not recruiting||N/A|700|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:13:31.383174|2017-10-10 23:13:31.383174
NCT02469766|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-08-28|||March 2015||2015-03-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Treatment of Upper Ureteric Stones|A Comparison Between Flexible Ureteroscopy, Semirigid Ureteroscopy and Extracorporeal Shockwaves Lithotripsy (SWL) in The Management of Proximal Ureteric Stones. A Randomized Controlled Trial|Recruiting||Phase 4|240|Anticipated|Mansoura University||3|||f||||t||||||||Undecided||2017-10-10 23:13:31.485451|2017-10-10 23:13:31.485451
NCT02469753|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-04-21|||October 2015|Actual|2015-10-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|STOP||Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes|Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes|Recruiting||Phase 3|225|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:13:31.582562|2017-10-10 23:13:31.582562
NCT02469740|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-03-10|||July 2015||2015-07-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI|Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone Percutaneous Coronary Intervention - a Randomised, Crossover Study.|Completed||Phase 4|61|Actual|University Hospital of Limerick||2|||f||||f||||||||||2017-10-10 23:13:31.742073|2017-10-10 23:13:31.742073
NCT02469727|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-10-12|||July 2015||2015-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||mHealth Intervention to Promote Cancer Survivors' Physical Activity|mHealth Intervention to Promote Cancer Survivors' Physical Activity|Completed||N/A|60|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-10 23:13:31.833608|2017-10-10 23:13:31.833608
NCT02469701|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-07-24|||February 2016||2016-02-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|October 2017|Anticipated|2017-10-01||Interventional|317||BrUOG 317:Nivolumab and Ablation For Patients With Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease|BrUOG L317: Nivolumab and Ablation For Patients With Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease: A Brown University Oncology Research Group Phase II Study|Active, not recruiting||Phase 2|10|Actual|Brown University||1|||f||||t|t|f|||f|||||2017-10-10 23:13:32.018988|2017-10-10 23:13:32.018988
NCT02469688|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-09-25|||June 2015||2015-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|November 2015|Actual|2015-11-01||Interventional|||A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy|A Phase 1 Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Cedar Pollinosis When Administered as Intramuscular (IM) Vaccination and Intradermal (ID) Vaccination|Completed||Phase 1|66|Actual|Astellas Pharma Inc||10|||f||||f||||||||||2017-10-10 23:13:32.100381|2017-10-10 23:13:32.100381
NCT02469675|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-02-23|||June 2015||2015-06-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS|Paired Stimulation to Increase Cortical Transmission to Hand Muscles: Pilot Study|Recruiting||N/A|30|Anticipated|Bronx VA Medical Center||8|||f||||f||||||||Yes|A Limited Dataset (LDS) will be shared in electronic format pursuant to a VA-approved Data Use Agreement. Individually Identifiable Data will be shared pursuant to valid HIPAA Authorization, Informed Consent, and an appropriate written agreement limiting use of the data to the conditions as described in the authorization and consent, and a written assurance from the recipient that the information will be maintained in accordance with the security requirements of 38 CFR Part 1.466.|2017-10-10 23:13:32.203043|2017-10-10 23:13:32.203043
NCT02469662|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-01-10|||June 2015||2015-06-01|January 2017|2017-01-01|December 2028|Anticipated|2028-12-01|December 2027|Anticipated|2027-12-01||Interventional|||Clinical Outcomes Study of the Nexel Total Elbow|Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow|Recruiting||N/A|120|Anticipated|Zimmer Biomet||2|||f||||f||||||||||2017-10-10 23:13:32.337131|2017-10-10 23:13:32.337131
NCT02469649|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-03-06|||January 27, 2016|Actual|2016-01-27|March 2017|2017-03-01|June 30, 2018|Anticipated|2018-06-30|January 10, 2018|Anticipated|2018-01-10||Interventional|DDRAMATIC-SVT||Dipole Density Mapping of Supraventricular Tachycardia|Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia|Active, not recruiting||N/A|10|Actual|Acutus Medical||1|||f||||f||f||||||Undecided||2017-10-10 23:13:32.440045|2017-10-10 23:13:32.440045
NCT02469636|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-03-06|||May 2015||2015-05-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|DDRAMATIC-SVT||Dipole Density Mapping in Supraventricular Tachycardia|Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia|Completed||N/A|3|Actual|Acutus Medical||1|||f||||f||f||||||||2017-10-10 23:13:32.506249|2017-10-10 23:13:32.506249
NCT02469623|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-06-27|||September 2014||2014-09-01|June 2017|2017-06-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Interventional|DDRAMATIC-SVT||Dipole Density Mapping in Supraventricular Tachycardia|Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia|Completed||N/A|29|Actual|Acutus Medical||1|||f||||f||f||||||Undecided||2017-10-10 23:13:32.566268|2017-10-10 23:13:32.566268
NCT02469610|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-02-05|||June 2015||2015-06-01|February 2017|2017-02-01|April 25, 2017|Anticipated|2017-04-25|January 30, 2017|Actual|2017-01-30||Interventional|||Assessment of Intercostal Block Scheduling in Preventing Acute Surgical and Post-surgical Pain in Thoracoscopic Surgery|Assessment of Intercostal Block Scheduling in Preventing Acute Surgical and Post-surgical Pain in Thoracoscopic Surgery|Recruiting||Phase 4|60|Anticipated|Carmel Medical Center||2|||f||||f||||||||Undecided|general discricptive data only|2017-10-10 23:13:32.636536|2017-10-10 23:13:32.636536
NCT02469597|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2016-06-30|2016-06-30||October 2013||2013-10-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis|Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis|Completed||Phase 2|46|Actual|Northwell Health|The trial was ended early due to recruitment difficulties.|2|||f||||t||||||||||2017-10-10 23:13:32.746866|2017-10-10 23:13:32.746866
NCT02469584|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-06-08|||October 2014||2014-10-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Small Stitch Study|Continuous Small Stitch Technique for Anterior Colporrhaphy: a Pilot Study|Unknown status|Recruiting|N/A|10|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 23:13:33.060281|2017-10-10 23:13:33.060281
NCT02469571|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|MGM-sepsis||Modulation of Gut Microbiota in Early Sepsis: A Pilot Study|Modulation of Gut Microbiota in Early Sepsis: A Pilot Study|Recruiting||N/A|40|Anticipated|Medical University of Graz||2|||f||||f||||||||||2017-10-10 23:13:33.15672|2017-10-10 23:13:33.15672
NCT02469558|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-11-29|||September 2015||2015-09-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|Diabesity||Probiotics in Diabesity: A Pilot Study|Probiotics in Diabesity: A Pilot Study|Recruiting||N/A|40|Anticipated|Medical University of Graz||2|||f||||f||||||||||2017-10-10 23:13:33.232005|2017-10-10 23:13:33.232005
NCT02469545|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-04-06|||June 2014||2014-06-01|August 2015|2015-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment|Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment|Completed||Phase 2|60|Actual|Medical University of Bialystok||2|||f||||t||||||||Undecided||2017-10-10 23:13:33.308053|2017-10-10 23:13:33.308053
NCT02469519|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-08-28|||March 2016||2016-03-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Interventional|ACSinPROM||Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes|A Randomized Double-blinded Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids on Neonatal Outcome in the Patient With Prelabor Premature Rupture of the Membranes|Recruiting||Phase 2/Phase 3|142|Anticipated|Mednax Center for Research, Education and Quality||2|||f||||t||||||||||2017-10-10 23:13:33.502645|2017-10-10 23:13:33.502645
NCT02469506|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-09-04|||February 2015||2015-02-01|September 2017|2017-09-01|August 30, 2016|Actual|2016-08-30|August 29, 2016|Actual|2016-08-29||Interventional|ANKL-ES||Neuromuscular Electrical Stimulation During Immobilization Due to Ankle Fractures|The Effects of Daily Neuromuscular Electrical Stimulation on Muscle Mass During Long-term Unilateral Ankle Immobilization in Adults With Ankle Fractures|Terminated||N/A|1|Actual|Maastricht University Medical Center||2||Minimal to no inclusion.|f||||t||||||||||2017-10-10 23:13:33.645956|2017-10-10 23:13:33.645956
NCT02469493|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-18|||January 2015||2015-01-01|June 2015|2015-06-01||||July 2017|Anticipated|2017-07-01||Interventional|||The Effect and Mechanism of Electroacupuncture on Acute Chemotherapy-induced Nausea and Vomiting||Unknown status|Recruiting|N/A|160|Anticipated|Xidian University||4|||f||||t||||||||||2017-10-10 23:13:33.833336|2017-10-10 23:13:33.833336
NCT02469480|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-11-02|||March 2015||2015-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.|Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.|Recruiting||Phase 2|64|Anticipated|Krankenhaus Nordwest||2|||f||||t||||||||||2017-10-10 23:13:33.913295|2017-10-10 23:13:33.913295
NCT02469467|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-02-04|||June 2015||2015-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis|A Dose Escalation Study of VS-505 to Evaluate the Tolerability, Safety and Efficacy in End Stage Renal Disease Patients Undergoing Hemodialysis|Recruiting||Phase 1/Phase 2|30|Anticipated|KDL Inc.||1|||f||||f||||||||||2017-10-10 23:13:34.050544|2017-10-10 23:13:34.050544
NCT02469454|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-11-02|||June 2015||2015-06-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development|Effect of the Immediately Postpartum Insertion of the Etonogestrel Releasing Implant on Infant Growth and Development|Completed||Phase 4|100|Actual|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 23:13:34.121752|2017-10-10 23:13:34.121752
NCT02469441|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-01-19|||August 1, 2014|Actual|2014-08-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|COFFEE||Does Coffee Intake Reduce Postoperative Ileus After Elective Colorectal Surgery|Does Coffee Intake Reduce Postoperative Ileus After Elective Colorectal Surgery - a Prospective, Randomized Controlled Study - the COFFEE STUDY|Completed||N/A|136|Actual|Kantonsspital Baden|||2||f||||t||||||||||2017-10-10 23:13:34.197442|2017-10-10 23:13:34.197442
NCT02469428|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-02-06|||December 2013||2013-12-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|Geminoz||Epigenetic Effect Modifications With Ozone Exposure on Healthy Volunteers|Epigenetic Effect Modifications With Ozone Exposure on Healthy Volunteers|Active, not recruiting||N/A|14|Actual|Environmental Protection Agency (EPA)||2|||f||||f||||||||||2017-10-10 23:13:34.34969|2017-10-10 23:13:34.34969
NCT02469415|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-10|2017-06-08|||September 30, 2015|Actual|2015-09-30|June 2017|2017-06-01|June 3, 2017|Actual|2017-06-03|June 3, 2017|Actual|2017-06-03||Interventional|||Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)|Phase II Study of Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes|Terminated||Phase 2|3|Actual|M.D. Anderson Cancer Center||1||FDA Clinical Hold|f||||f|t|f||||||||2017-10-10 23:13:34.501469|2017-10-10 23:13:34.501469
NCT02469402|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-10|||January 2014||2014-01-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|December 2015|Anticipated|2015-12-01||Interventional|||Nutritive Efficacy and Safety of a Modified Infant Formula With a Reduced Protein Content and Improved Protein Quality|Nutritive Efficacy and Safety of a Modified Infant Formula With a Reduced Protein: Content and Improved Protein Quality: LactPro-Minus|Unknown status|Recruiting|N/A|120|Anticipated|Waldkrankenhaus Protestant Hospital, Spandau||3|||f||||f||||||||||2017-10-10 23:13:34.629826|2017-10-10 23:13:34.629826
NCT02469389|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-04-19|||August 3, 2015|Actual|2015-08-03|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|||Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia|Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia|Recruiting||Phase 2/Phase 3|108|Anticipated|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-10 23:13:34.74782|2017-10-10 23:13:34.74782
NCT02469376|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-05-08|||September 2014||2014-09-01|May 2017|2017-05-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|PET-GP1_1||Evaluation of a New Imagingtechnologie for Thrombosis|Biodistribution, Imaging Properties, and Radiation Dosimetry of [18F]-GP1 Positron Emission Tomography (PET) Tracer in Vascular Disease Imaging|Terminated||Phase 1|4|Actual|University of Zurich||1||Slow recruitment|f||||f||||||||||2017-10-10 23:13:34.889054|2017-10-10 23:13:34.889054
NCT02469363|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-06-11|||August 2014||2014-08-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Hemodynamic Responses of Different Laryngoscopes|Comparison of Different Laryngoscopes in Terms of Hemodynamic Responses|Completed||Phase 4|170|Actual|Istanbul University||4|||f||||f||||||||||2017-10-10 23:13:34.995129|2017-10-10 23:13:34.995129
NCT02469350|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-02-24|||June 2015|Actual|2015-06-01|April 2016|2016-04-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|PARKGAME||Serious Game for Parkinson's Disease Patients|Feasibility and Acceptability Study of Serious Game Rehabilitation Program in Parkinson's Disease Patients With Resistant Gait and Balance Disorders|Completed||N/A|10|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-10 23:13:35.128254|2017-10-10 23:13:35.128254
NCT02469337|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-01-04|||May 2012||2012-05-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CARBEX||Role of Preoperative Carbohydrates Drinks, Dichloroacetate and Exercise on Postoperative Muscle Insulin Resistance|Randomized Control Trial of Dichloroacetate, Preoperative Carbohydrate Loading and Moderate Intensity Exercise on Muscle Insulin Resistance After Major Abdominal Surgery|Active, not recruiting||Phase 4|40|Anticipated|University of Nottingham||4|||f||||t||||||||No||2017-10-10 23:13:35.234584|2017-10-10 23:13:35.234584
NCT02469324|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-02-22|||April 2015||2015-04-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Comparative RCT of Brief Internet-based Compassionate Mind Training and Cognitive-behavioral Therapy for Mothers and Their Babies||Completed||N/A|86|Actual|i4Health||2|||f||||t||||||||||2017-10-10 23:13:35.340523|2017-10-10 23:13:35.340523
NCT02469311|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-12|||March 2012||2012-03-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|April 2014|Actual|2014-04-01||Interventional|SAGE||Prospective, Randomized Study Evaluating The Efficacy of Chlorhexidine Gluconate Impregnated No-Rinse Cloths.|Prospective, Randomized Study Evaluating The Efficacy of Chlorhexidine Gluconate Impregnated No-Rinse Cloths in Reducing Surgical Site Infections for Total Hip and Knee Arthroplasty.|Terminated||Phase 2|539|Actual|LifeBridge Health||8||Preliminary results showed that the use of the cloths helped prevent infections.|f||||f||||||||||2017-10-10 23:13:35.4816|2017-10-10 23:13:35.4816
NCT02469298|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-08-29|2017-07-23|2016-06-27|June 1, 2015||2015-06-01|July 2017|2017-07-01|April 25, 2016|Actual|2016-04-25|April 1, 2016|Actual|2016-04-01||Interventional|||Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza|A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Clinical Effect of Oral Danirixin (GSK1325756) in the Treatment of Healthy Adults With Acute, Uncomplicated Influenza (201682)|Completed||Phase 2|45|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-10 23:13:35.703536|2017-10-10 23:13:35.703536
NCT02469285|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2015-06-12|||September 2014||2014-09-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effect of Pork With Modified Fat Composition and Berries on Plasma Fatty Acids and Fecal Compounds in Healthy Adults|The Effect of Pork With Modified Fatty Acid Composition on Plasma Lipids and Fatty Acids and the Effect of Pork and Berries on Fecal Compounds in Healthy Adults|Completed||N/A|65|Actual|Helsinki University||3|||f||||f||||||||||2017-10-10 23:13:38.653603|2017-10-10 23:13:38.653603
NCT02469272|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-09|||May 2015||2015-05-01|June 2015|2015-06-01||||May 2016|Anticipated|2016-05-01||Interventional|||Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study|Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study|Unknown status|Recruiting|Phase 1|5|Anticipated|Lifespan||1|||f||||t||||||||||2017-10-10 23:13:38.737324|2017-10-10 23:13:38.737324
NCT02469259|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-05-10|||February 2016||2016-02-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|POP||The Effects of Oxytocin on Startle Hyperreactivity in Patients With AUD and PTSD|The Effects of Oxytocin on Social Ability, Alcohol Approach Bias, and Startle Hyperreactivity in Veterans With Alcohol Use Disorder and Post Traumatic Stress Disorder|Recruiting||Early Phase 1|100|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:13:38.815844|2017-10-10 23:13:38.815844
NCT02469246|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-04-12|||June 29, 2015|Actual|2015-06-29|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|April 7, 2017|Actual|2017-04-07||Interventional|||Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC|A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC|Active, not recruiting||Phase 3|500|Anticipated|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 23:13:38.899416|2017-10-10 23:13:38.899416
NCT02469233|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-08-16|||May 2015||2015-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes|A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes|Recruiting||N/A|120|Anticipated|University of California, Berkeley||2|||f||||t||||||||||2017-10-10 23:13:39.085841|2017-10-10 23:13:39.085841
NCT02469220|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-05-17|||June 2015||2015-06-01|May 2017|2017-05-01||||September 2017|Anticipated|2017-09-01||Interventional|||Effect of a Low FODMAP Diet in Patients With Ulcerative Colitis|Effect of a Low FODMAP Diet on Gut Microbiota, Inflammation and Gastrointestinal Symptoms in Patients With Ulcerative Colitis in Remission|Recruiting||N/A|30|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:13:41.44216|2017-10-10 23:13:41.44216
NCT02469207|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-07-13|||January 2016||2016-01-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|RCT||Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology|A Study Utilising Tissue From Deceased Organ Donors to Investigate Regenerative Cellular Therapies and Related Physiological and Developmental Processes|Recruiting||N/A|50|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     DNA data from tissue samples from donated organs may be retained anonymously for a period up     to 10 years   "|||2017-10-10 23:13:41.521517|2017-10-10 23:13:41.521517
NCT02469194|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-04-11|||June 2015||2015-06-01|April 2016|2016-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Mechanisms and Predictors of Unusual Radiation or Chemotherapy Toxicity|Mechanisms and Predictors of Unusual Radiation or Chemotherapy Toxicity|Recruiting||N/A|12|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     5-10 cc of whole blood will be obtained using standard, sterile venipuncture techniques   "|||2017-10-10 23:13:41.609006|2017-10-10 23:13:41.609006
NCT02469181|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-08|||October 2014||2014-10-01|June 2015|2015-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Impact of Enzyme Replacement Therapy on Cardiac Function in Patients With Fabry's Cardiomyopathy (RECAFTURE Trial)|Impact of Enzyme Replacement Therapy on Cardiac Function in Patients With Fabry's Cardiomyopathy : A Prospective Multi-modality Imaging Study Using Diastolic Stress Echocardiography, LV Vortex Flow and Cardiac MRI(RECAFTURE Trial)|Unknown status|Recruiting|N/A|28|Anticipated|Yonsei University|||1||f||||f||||||Samples Without DNA|"     Lyso GL-3   "|||2017-10-10 23:13:41.677576|2017-10-10 23:13:41.677576
NCT02469168|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-11-09|||December 2014||2014-12-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Epidermal Coverage of Traumatic Wound Injuries Via Use of Autologous Spray Skin Applied Over Bilayered Wound Matrix|Epidermal Coverage of Traumatic Wound Injuries Via Use of Autologous Skin Cell Harvesting Device in Combination With Widened Meshed Autograft Applied Over Bilayered Wound Matrix|Recruiting||N/A|20|Anticipated|Walter Reed National Military Medical Center||2|||f||||t||||||||||2017-10-10 23:13:41.756669|2017-10-10 23:13:41.756669
NCT02469155|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-03-09|||June 2015||2015-06-01|June 2016|2016-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment|A Randomized, Double-Blind, Placebo- and Active-Controlled, Multi-Center Study to Assess the Antipsychotic Efficacy of ITI-007 After 6 Weeks of Treatment in Patients With Schizophrenia|Completed||Phase 3|696|Actual|Intra-Cellular Therapies, Inc.||4|||f||||||||||||||2017-10-10 23:13:41.849399|2017-10-10 23:13:41.849399
NCT02469142|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-06-08|||January 2015||2015-01-01|June 2015|2015-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Use of Acellular Dermal in the Incarcerated Inguinal Hernia Tension-free Reconstructions|Use of Acellular Dermal in the Incarcerated Inguinal Hernia Tension-free Reconstructions|Active, not recruiting||Phase 2/Phase 3|100|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||t||||||||||2017-10-10 23:13:41.92392|2017-10-10 23:13:41.92392
NCT02469129|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-11-02|||March 2015||2015-03-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||PET Imaging of PARP Activity in Cancer|Positron Emission Tomography (PET) Imaging of Poly(ADP-Ribose) Polymerase (PARP) Activity in Cancer|Recruiting||Early Phase 1|50|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 23:13:41.998344|2017-10-10 23:13:41.998344
NCT02469116|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-07-11|2016-05-10||January 2006||2006-01-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma|Phase II Trial of Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in the Front-line Treatment of Patients With Advanced Stage Ovarian Carcinoma|Terminated||Phase 2|18|Actual|Washington University School of Medicine||1||Sponsor withdrew financial support|f||||f||||||||||2017-10-10 23:13:42.095365|2017-10-10 23:13:42.095365
NCT02469103|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-04-23|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis|The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis|Active, not recruiting||N/A|150|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||No||2017-10-10 23:13:42.487735|2017-10-10 23:13:42.487735
NCT02469090|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-08-03|||June 2015||2015-06-01|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease|"Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy, Safety and Tolerability of APL-130277 in Levodopa Responsive Patients With Parkinson's Disease Complicated by Motor Fluctuations (OFF Episodes)"|Active, not recruiting||Phase 3|126|Actual|Sunovion||2|||f||||t||||||||||2017-10-10 23:13:42.57246|2017-10-10 23:13:42.57246
NCT02469077|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-12-16|||August 2015||2015-08-01|December 2016|2016-12-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function|Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function|Recruiting||N/A|116|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 23:13:42.72696|2017-10-10 23:13:42.72696
NCT02469051|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-05-10|||May 2015||2015-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Breath-hold Cardiac Hybrid SPECT/CCTA|Usefulness of Breath-hold Triggered SPECT-MPI in Cardiac Hybrid SPECT/CCTA Imaging|Completed||N/A|50|Actual|University of Zurich||1|||f||||t||||||||||2017-10-10 23:13:42.940572|2017-10-10 23:13:42.940572
NCT02469038|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-12-06|||January 2017||2017-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|AccuCath||Ultrasound-Guided Peripheral Venous Access Using AccuCath|Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access Using AccuCath Versus Ultrasound-Guided Conventional Intravenous Catheter in the Emergency Department|Not yet recruiting||N/A|500|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-10 23:13:43.015554|2017-10-10 23:13:43.015554
NCT02469025|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-05-01|||January 2014||2014-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Grade III Traction-mobilization in End-range Joint Position in Patients With Hip Osteoarthritis||Completed||Phase 3|50|Actual|Universidad de Zaragoza||2|||f||||||||||||||2017-10-10 23:13:43.109009|2017-10-10 23:13:43.109009
NCT02469012|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-06-08|||October 2014||2014-10-01|June 2015|2015-06-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|IFNfreeCOG||Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy|Evaluation of Quality of Life, Neurocognitive Performance, Fatigue, and Emotional State in HCV Patients Before, During, and in the (Long-term) Follow-up of an IFN-free Antiviral Therapy|Unknown status|Recruiting|N/A|30|Anticipated|University of Wuerzburg||1|||f||||f||||||||||2017-10-10 23:13:43.185802|2017-10-10 23:13:43.185802
NCT02468999|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-01-07|||January 2015||2015-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans||Completed||N/A|21|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 23:13:43.304696|2017-10-10 23:13:43.304696
NCT02468986|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-06-08|||November 2011||2011-11-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|||Study of Venous Endothelial Cells in Rheumatoid Arthritis|Analysis of Endothelial Cells in Rheumatoid Arthritis|Unknown status|Recruiting|N/A|45|Anticipated|University of Texas Southwestern Medical Center|||3||f||||f||||||Samples Without DNA|"     Serum collected by serum separator tube. Will be processed and frozen at -80degrees.   "|||2017-10-10 23:13:43.391044|2017-10-10 23:13:43.391044
NCT02468973|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-07-21|||October 2015||2015-10-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Supporting Patients in Lifestyle Health Behavior Change by Medical Students at Primary Care Clinics in Zefat Israel|Accompanying and Supporting Patients in Lifestyle Health Behavior Change by Medical Students at Primary Care Clinics in Zefat Israel|Recruiting||N/A|30|Anticipated|Clalit Health Services||1|||f||||f||||||||||2017-10-10 23:13:43.492021|2017-10-10 23:13:43.492021
NCT02468960|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-04-27|||March 2015||2015-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)|Optimal Lesion Preparation With Non-compliant Balloons for the Implantation of Bioresorbable Vascular Scaffolds (BVS) -OPRENBIS Study|Terminated||N/A|44|Actual|SIS Medical AG||2||"Information of other studies with Absorb bioresorbable scaffold showed a higher thrombotic risk   than before, the risk for the Patients is estimated too high."|f||||f||||||||||2017-10-10 23:13:43.572468|2017-10-10 23:13:43.572468
NCT02468947|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-08-07|||April 2016||2016-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Finding Ideal Blood Culture Volume in NICU|Finding Ideal Blood Culture Volume in NICU|Recruiting||N/A|800|Anticipated|Shaare Zedek Medical Center|||1||f||||f||||||||||2017-10-10 23:13:43.685147|2017-10-10 23:13:43.685147
NCT02468934|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-09-26|||September 2015||2015-09-01|September 2017|2017-09-01|July 17, 2017|Actual|2017-07-17|April 28, 2017|Actual|2017-04-28||Interventional|||Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Using the SPRINT System|A Prospective Case Series Study of SPR Peripheral Nerve Stimulation (PNS) Therapy for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Utilizing Preoperative Lead Placement|Completed||N/A|24|Actual|SPR Therapeutics, LLC||1|||f||||f||||||||||2017-10-10 23:13:43.751097|2017-10-10 23:13:43.751097
NCT02468921|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-11-07|||November 2014||2014-11-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|SOLOIST||Goitres Influence on Voice Function - The Impact of Surgery|The Impact of Surgical Treatment of Benign Non-toxic Goiter on the Voice Function|Active, not recruiting||N/A|60|Anticipated|University of Southern Denmark|||1||f||||f||||||||||2017-10-10 23:13:43.862073|2017-10-10 23:13:43.862073
NCT02468908|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-02-20|||May 2015||2015-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single-Centre, Single Ascending Dose and Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Molgramostim When Administered by Inhalation to Healthy Adult Subjects|Completed||Phase 1|42|Actual|Savara Inc.||2|||f||||t||||||||||2017-10-10 23:13:43.92247|2017-10-10 23:13:43.92247
NCT02468895|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-01-31|||October 4, 2016|Actual|2016-10-04|January 2017|2017-01-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01|5 Years|Observational [Patient Registry]|MYOPROSP||MYOPROSP - a Prospective Cohort Study in Myositis|MYOPROSP: A Prospective Cohort Study to Identify a Stratified Approach in the Diagnosis, Treatment and Delivery of Care in Adult Idiopathic Inflammatory Myopathy|Recruiting||N/A|300|Anticipated|University of Manchester|||1||f||||t||||||Samples With DNA|"     DNA RNA Peripheral blood mononuclear cells Serum Plasma Urine Muscle biopsies Other     diagnostic tissue   "|Yes|Core/extended dataset, SOP definitions, data access/sharing policies, data available for sharing and metadata to describe these, will be made available though the planned UKMYONET study website, meetings and presentations. Links to the results and the UKMYONET website will be available via the Euromyositis registry front page and links from local CoI websites. All data generated during this project will be made available to the scientific community through full publication in a timely fashion using open access in highest possible impact scientific journals, presentation at scientific conferences and via SC application for data access. Genotype data will be deposited and made available through a publically available repository, such as the European Bioinformatics Institute, for secure data storage.|2017-10-10 23:13:44.068011|2017-10-10 23:13:44.068011
NCT02468882|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-06-08|||March 2014||2014-03-01|June 2015|2015-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Does Watercress Intake Have an Impact on Cancer Patients Outcomes: a Longitudinal Trial|Does Watercress Intake Have an Impact on Cancer Patients Outcomes: a Randomized Longitudinal Trial|Recruiting||Phase 3|200|Anticipated|University of Lisbon||2|||f||||f||||||||||2017-10-10 23:13:44.236001|2017-10-10 23:13:44.236001
NCT02468869|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-06-04|||January 2015||2015-01-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|BACOP2||Improving Discharge Communication|Improving Discharge Communication in the Emergency Department Through Information Structuring: A Cluster Randomized Controlled Trial|Recruiting||N/A|400|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-10 23:13:44.339467|2017-10-10 23:13:44.339467
NCT02468856|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-05-23|||May 21, 2017|Actual|2017-05-21|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Armodafinil on Simulated Driving|Effect of Armodafinil on Simulated Driving, Electroencephalogram and Cognitive Performance in Sleep Deprived Healthy Subjects|Recruiting||Phase 1|10|Anticipated|University of Florida||2|||f||||f|t|f|||t|||Undecided||2017-10-10 23:13:44.436482|2017-10-10 23:13:44.436482
NCT02468843|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-10-25|||July 2015||2015-07-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Observational|||Novel Stimulation Patterns for the Treatment of Dystonia|Novel Stimulation Patterns and Personalized Deep Brain Stimulation for the Treatment of Dystonia|Completed||N/A|10|Actual|University of Florida|||1||f||||f||||||||Yes||2017-10-10 23:13:44.553796|2017-10-10 23:13:44.553796
NCT02468830|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2016-11-27|||April 2013||2013-04-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|Mirabegron||Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder|Prospective Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder|Completed||Phase 3|58|Actual|CHU de Quebec-Universite Laval||1|||f||||t||||||||Yes|Publication submitted|2017-10-10 23:13:44.651574|2017-10-10 23:13:44.651574
NCT02468817|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-08-29|||August 2015||2015-08-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|June 2017|Actual|2017-06-01||Interventional|||PTH And Calcium Responses to Exercise (PACE) in Older Adults|PTH And Calcium Responses to Exercise (PACE) in Older Adults|Active, not recruiting||N/A|32|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:13:44.733696|2017-10-10 23:13:44.733696
NCT02468791|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-11-06|||May 2013||2013-05-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis|A Randomized, Double-blind, Parallel-group Comparative Bioequivalence Trial of MabionCD20® (Mabion SA) Compared to MabThera® (Rituximab, Roche) in Patients With Rheumatoid Arthritis|Recruiting||Phase 3|863|Anticipated|Mabion SA||2|||f||||||||||||||2017-10-10 23:13:44.919768|2017-10-10 23:13:44.919768
NCT02468778|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-02-03|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|SHIELD II||Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)|Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)|Suspended||N/A|425|Anticipated|St. Jude Medical||2|||f||||t||||||||||2017-10-10 23:13:45.269063|2017-10-10 23:13:45.269063
NCT02468765|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2016-09-19|||May 2015||2015-05-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|SepDep||Depression and Facial Identity Recognition Abilities in Patients With Multiple Sclerosis|Depression and Reconnaissance of Emotions in Multiple Sclerosis Patients|Recruiting||N/A|90|Anticipated|Lille Catholic University|||3||f||||f||||||||||2017-10-10 23:13:45.513511|2017-10-10 23:13:45.513511
NCT02468752|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-14|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|November 2018|Anticipated|2018-11-01||Interventional|||Reduction of Venous Emboli Load After Breathing Normobaric Oxygen Compared to Air|Mängden kvävgasbubblor i Blodet Efter Dykning Vid Syrgasandning jämfört Med Luftandning|Recruiting||Phase 2/Phase 3|16|Anticipated|Göteborg University||2|||f||||f|f|f||||||No||2017-10-10 23:13:45.59884|2017-10-10 23:13:45.59884
NCT02468739|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-09-08|||May 2015||2015-05-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer|The Effect of Monosialotetrahexosyl Ganglioside (GM1) in Prevention of Taxanes Induced Neurotoxicity in Breast Cancer Patients Who Received Taxanes-based Adjuvant Chemotherapy: A Multi-center, Randomized, Placebo-controlled Trial|Completed||Phase 3|206|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:13:45.695309|2017-10-10 23:13:45.695309
NCT02468726|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2015-06-10|||November 2011||2011-11-01|November 2011|2011-11-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Performance of NER1008 Enema Compared With Fleet® Enema in Bowel Cleansing|A Clinical Investigation to Demonstrate the Performance of NER1008 Enema in Bowel Cleansing Compared to Fleet® Enema|Completed||N/A|25|Actual|Norgine||2|||f||||f||||||||||2017-10-10 23:13:45.781973|2017-10-10 23:13:45.781973
NCT02468713|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-06-08|||January 2015||2015-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effect on Blood Chemistry and Inflammatory Marker of Omega-3 Enriched Total Parenteral Nutrition|An Open Label, Randomized, Single Dose, Crossover Study to Evaluate the Effect on Blood Lipid Profiles of Omega-3 Enriched Total Parenteral Nutrition in Healthy Korean Male Subjects|Completed||Phase 4|16|Actual|Chonbuk National University Hospital||2|||f||||f||||||||||2017-10-10 23:13:45.851338|2017-10-10 23:13:45.851338
NCT02468700|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-12-05|||January 2015||2015-01-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||Feasibility Study Evaluating Safety and Efficacy of OTX-DP (Sustained Release Dexamethasone, 0.4mg) for Treatment of Dry Eye|A Prospective, Multicenter, Randomized, Parallel-Arm, Bilateral, Double-Masked, Vehicle Controlled Feasibility Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye|Completed||Phase 2|43|Actual|Ocular Therapeutix, Inc.||2|||f||||f||||||||||2017-10-10 23:13:45.938551|2017-10-10 23:13:45.938551
NCT02468687|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-02-12|||August 2015||2015-08-01|February 2016|2016-02-01|February 2019|Anticipated|2019-02-01|January 2017|Anticipated|2017-01-01||Interventional|||NMP in Relapsed / Refractory Myeloma|A Phase I, Open Label Dose Escalation Trial of Orally Administered N-methyl-pyrrolidone (NMP) in Patients With Relapsed or Refractory Myeloma|Recruiting||Phase 1|20|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-10 23:13:46.02213|2017-10-10 23:13:46.02213
NCT02468674|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-09-06|||July 22, 2015|Actual|2015-07-22|September 2017|2017-09-01|August 19, 2019|Anticipated|2019-08-19|September 18, 2018|Anticipated|2018-09-18||Interventional|||A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study|A 24-week Off Drug Extension Parallel Group Study Assessing the Durability of Effect on Skeletal Muscle Strength and Function Following a 6-month Double-blind Placebo-controlled Study Evaluating Bimagrumab in Older Adults With Sarcopenia|Recruiting||Phase 2|200|Anticipated|Novartis||1|||f||||t|t|f||||||||2017-10-10 23:13:46.101363|2017-10-10 23:13:46.101363
NCT02468648|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-09|2017-09-07|||June 2, 2015||2015-06-02|August 30, 2017|2017-08-30|July 31, 2018|Anticipated|2018-07-31|July 21, 2018|Anticipated|2018-07-21||Interventional|||Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816|Investigation of Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816|Recruiting||Phase 2|140|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:13:46.551358|2017-10-10 23:13:46.551358
NCT02468635|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2017-05-24|||June 2015||2015-06-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Interventional|PR||Rehabilitation of Patients With Lung Chronic Obstructive Pulmonary Disease|Analysis of Pulmonary Rehabilitation on the Physical Capacity and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease Clinical Trial|Recruiting||N/A|2|Anticipated|Federal University of Bahia||2|||f||||f||||||||||2017-10-10 23:13:46.646972|2017-10-10 23:13:46.646972
NCT02468622|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-05-08|||August 2015||2015-08-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Transcriptomic and Biochemical Changes During a Migraine Attack|Transcriptomic and Biochemical Changes During Spontaneous Attacks of Migraine With Aura and Migraine Without Aura|Completed||N/A|30|Actual|Danish Headache Center|||2||f||||f||||||Samples With DNA|"     Bloodsamples   "|||2017-10-10 23:13:46.773523|2017-10-10 23:13:46.773523
NCT02468609|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-01-26|||January 2015||2015-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RADFL||Diagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CT||Recruiting||N/A|500|Anticipated|Cantonal Hospital of St. Gallen||1|||f||||f||||||||||2017-10-10 23:13:46.860663|2017-10-10 23:13:46.860663
NCT02468596|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-02-03|||December 2014||2014-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|EXCIMAG||Use of QTRAC Technique to Measure Axonal Excitability in Anti-MAG Neuropathy|Axonal Excitability Measured by QTRAC Technique in Patients With Anti-MAG Neuropathy|Recruiting||N/A|50|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||t||||||||||2017-10-10 23:13:46.947575|2017-10-10 23:13:46.947575
NCT02468583|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-08-08|||February 2015||2015-02-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee|A Double-Blind, Randomized, Parallel Group, Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee|Terminated||Phase 2|6|Actual|Flexion Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:13:47.057695|2017-10-10 23:13:47.057695
NCT02468570|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-01-30|||July 28, 2015|Actual|2015-07-28|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|February 8, 2017|Anticipated|2017-02-08||Observational|PRISM303||A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302|A Phase 3 Substudy to Evaluate Executive Function in Adults With Phenylketonuria Who Are Participating in the Phase 3 Study, 165-302|Active, not recruiting||N/A|100|Anticipated|BioMarin Pharmaceutical|||1||f||||f||||||||No||2017-10-10 23:13:47.169401|2017-10-10 23:13:47.169401
NCT02468557|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-05-03|||July 2015||2015-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma|A Phase 1b Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma|Terminated||Phase 1|16|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-10 23:13:47.300648|2017-10-10 23:13:47.300648
NCT02468544|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2017-02-01|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention|Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention|Suspended||N/A|10|Anticipated|Columbia University||1||Updating mobile phone platform in preparation for round two of testing.|f||||f|f|f||||||||2017-10-10 23:13:47.413532|2017-10-10 23:13:47.413532
NCT02468531|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-11-08|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Xenon Against Postoperative Oxygen Impairment|Protection of Xenon Against Postoperative Oxygen Impairment in Adults Undergoing Stanford Type-A Acute Aortic Dissection Surgery|Recruiting||N/A|160|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||No||2017-10-10 23:13:47.484804|2017-10-10 23:13:47.484804
NCT02468518|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-01-12|||March 2015||2015-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Vitamin E on Skin Aerobic Bacteria in Palmar Arsenical Keratosis|Randomized, Open Label Trial of Vitamin E on Change of Aerobic Bacterial Pattern|Completed||Phase 2|45|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||3|||f||||f||||||||||2017-10-10 23:13:47.580733|2017-10-10 23:13:47.580733
NCT02468505|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-06-09|||September 2014||2014-09-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|STEPS||STEPS: Stepped Transition in Education Program for Students With ASD|STEPS: Stepped Transition in Education Program for Students With ASD|Unknown status|Recruiting|N/A|50|Anticipated|Virginia Polytechnic Institute and State University||2|||f||||t||||||||||2017-10-10 23:13:47.674593|2017-10-10 23:13:47.674593
NCT02468492|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2017-08-13|||September 2014||2014-09-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pilot Synovial Fluid Molecular/Stem Cell Response to PRP in Knee Osteoarthritis: Clinical & Imaging Outcome Correlation|Synovial Fluid Biomarker and Mesenchymal Stem Cell Response to PRP in Knee Osteoarthritis With Clinical and Imaging Outcome Correlation: Proof of Concept Study|Completed||Early Phase 1|18|Actual|Hunter Holmes Mcguire Veteran Affairs Medical Center||2|||f||||f|f|t|f|||||||2017-10-10 23:13:47.750084|2017-10-10 23:13:47.750084
NCT02468479|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-04-18|||June 2015||2015-06-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis|Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients|Completed||N/A|200|Actual|General Hospital of Shenyang Military Region|||1||f||||f||||||||||2017-10-10 23:13:47.838312|2017-10-10 23:13:47.838312
NCT02468466|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-09|||January 2005||2005-01-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Community-based Depression Screening Intervention for Middle-aged Suicide|Impact of a Community-based Screening and Educational Intervention for Depression on Suicide Rates Among Japanese Middle-aged Adults|Completed||N/A|89700|Actual|Aomori University of Health and Welfare||2|||f||||t||||||||||2017-10-10 23:13:47.906844|2017-10-10 23:13:47.906844
NCT02468453|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2017-03-07|||July 2014||2014-07-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||VELOS for the Treatment of Vascular Lesions and Skin Rejuvenation|Multi-center, Multi-cohort, Prospective, Open-label Study of VELOS for Treatment of Vascular Skin Disorders|Recruiting||N/A|60|Anticipated|Syneron Medical||4|||f||||f||||||||||2017-10-10 23:13:48.027876|2017-10-10 23:13:48.027876
NCT02468440|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-12-14|||June 2015||2015-06-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ESPAIR||Evaluation of ESPAIR, an Educational Therapy's Program of Patients With Renal Insufficiency Before Kidney Transplant|Evaluation of ESPAIR, an Educational Therapy's Program of Patients With Renal Insufficiency Before Kidney Transplant|Recruiting||N/A|224|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:13:48.131424|2017-10-10 23:13:48.131424
NCT02468427|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-10-06|||March 2015||2015-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|VAC-OSATS||Objective Structured Assessment of Technical Skills (OSATS) Evaluation of Delivery by Vacuum Extraction|Objective Structured Assessment of Technical Skills (OSATS) Evaluation of Operative-Vaginal Delivery by Vacuum Extraction on a Pelvic Training Model|Completed||N/A|137|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-10 23:13:48.237768|2017-10-10 23:13:48.237768
NCT02468414|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-07-12|2017-06-08||June 2015||2015-06-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||TARGTEPO Treatment for Anemia in PD US Trial|Safety & Efficacy of Prolonged Physiologic EPO Level Treatment of Anemia in ESRD Patients Undergoing Peritoneal Dialysis Using MDGN201 TARGTEPO|Terminated||Phase 2|3|Actual|Aevi Genomic Medicine||1||"No statistical analysis was performed as only one subject was treated with MDGN201 TARGTEPO due   to the Sponsor's decision to discontinue study."|f||||t||||||||||2017-10-10 23:13:48.322319|2017-10-10 23:13:48.322319
NCT02468401|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-11-19|||September 2015||2015-09-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions|The Efficacy of a New Protocol for Preventing Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions|Completed||N/A|30|Actual|Meir Medical Center||1|||f||||||||||||||2017-10-10 23:13:48.658114|2017-10-10 23:13:48.658114
NCT02468388|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-07|||October 2011||2011-10-01|June 2015|2015-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Re-mineralization Effects of Sugar Free Chewing Gum Sweetened With Different Sugar-substitutes|Study on the Effect of Chewing Sugar-free Gum on Re-mineralization of Early Caries Via Quantitative Light-induced Fluorescence|Completed||N/A|482|Actual|Roquette Management (Shanghai) Co., Ltd.||4|||f||||f||||||||||2017-10-10 23:13:48.735408|2017-10-10 23:13:48.735408
NCT02468375|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-06-07|||June 2015||2015-06-01|June 2015|2015-06-01||||May 2017|Anticipated|2017-05-01||Interventional|||Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.|A Multicenter Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.|Unknown status|Not yet recruiting|Phase 4|434|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:13:48.825581|2017-10-10 23:13:48.825581
NCT02468362|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-06-09|||April 2014||2014-04-01|June 2015|2015-06-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|ISR-TME||Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer.|Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer: a Double Blind Randomized Clinical Trial|Enrolling by invitation||Phase 2|112|Anticipated|Mansoura University||2|||f||||||||||||||2017-10-10 23:13:48.910574|2017-10-10 23:13:48.910574
NCT02468349|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2017-04-12|||June 2015|Actual|2015-06-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|December 2017|Anticipated|2017-12-01||Interventional|IMMACULATE||IMproving reModeling in Acute myoCardial Infarction Using Live and Asynchronous TElemedicine.|IMproving reModeling in Acute myoCardial Infarction Using Live and Asynchronous TElemedicine.|Recruiting||N/A|300|Anticipated|National University Heart Centre, Singapore||2|||f||||f||||||||No||2017-10-10 23:13:48.989164|2017-10-10 23:13:48.989164
NCT02468336|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2017-02-06|||August 2015|Actual|2015-08-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||AngioDefender Versus Brachial Artery Ultrasound Imaging|Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging|Enrolling by invitation||N/A|162|Anticipated|Everist Genomics, Inc||2|||f||||f||||||||No||2017-10-10 23:13:49.086064|2017-10-10 23:13:49.086064
NCT02468323|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2017-03-08|||October 2015||2015-10-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|PONV||Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia|Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia: Study Single Center, Prospective, Double-blind, Randomized, Placebo Controlled|Completed||Phase 4|150|Actual|Hospital de Base||3|||f||||t||||||||||2017-10-10 23:13:49.162271|2017-10-10 23:13:49.162271
NCT02468310|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2017-08-16|||August 10, 2015|Actual|2015-08-10|August 2017|2017-08-01|April 9, 2017|Actual|2017-04-09|February 9, 2017|Actual|2017-02-09||Interventional|Accelerate||Evaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in Ghana|Evaluating the Effects of Clinical Decision Making Support Systems on Maternal and Neonatal Mortality and Morbidity in Ghana: a Cluster Randomized Controlled Trial|Completed||N/A|65831|Actual|Julius Global Health||2|||f||||f||||||||||2017-10-10 23:13:49.249928|2017-10-10 23:13:49.249928
NCT02468297|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2017-02-23|||April 15, 2009|Actual|2009-04-15|February 2017|2017-02-01|January 30, 2012|Actual|2012-01-30|January 30, 2012|Actual|2012-01-30||Interventional|EAS||Efficacy of the Electronic Acupuncture Shoes: A Clinical Trial for Chronic Low Back Pain|Efficacy of the Electronic Acupuncture Shoes: A Clinical Trial for Chronic Low Back Pain|Completed||N/A|60|Actual|Chang Gung Memorial Hospital||2|||f||||||||||||No||2017-10-10 23:13:49.337776|2017-10-10 23:13:49.337776
NCT02468284|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-05-29|||July 2015||2015-07-01|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|October 13, 2016|Actual|2016-10-13||Interventional|||Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer|An Open-label, Multi-Centre Trial Investigating Pharmacokinetics of Degarelix After a Starting Dose of 240 mg (40 mg/mL) Followed by Six Maintenance Doses of 80 mg (20 mg/mL) in Chinese Patients With Prostate Cancer Requiring Androgen Deprivation Therapy|Active, not recruiting||Phase 1|15|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:13:49.397928|2017-10-10 23:13:49.397928
NCT02468271|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-11-30|||October 2015||2015-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK|Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK|Recruiting||N/A|100|Anticipated|Queen's University, Belfast|||1||f||||f||||||Samples Without DNA|"     Blood plasma and sputum specimens   "|||2017-10-10 23:13:49.509476|2017-10-10 23:13:49.509476
NCT02467894|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-04-28|||August 2014||2014-08-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Group-based Chronic Kidney Disease Care|Group-based Chronic Kidney Disease Care|Recruiting||N/A|300|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-10 23:13:52.880079|2017-10-10 23:13:52.880079
NCT02468258|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-06|2016-09-16|||January 2013||2013-01-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Multi-factorial Analysis of the Follicular Fluid Milieu to Explore the Discrepant Effect of Follicular Fluid Endometrial Flushing on Outcome of Assisted Reproduction Trial|Multi-factorial Analysis of the Follicular Fluid Milieu to Explore the Discrepant Effect of Follicular Fluid Endometrial Flushing on Outcome of Assisted Reproduction Trial|Withdrawn||Phase 2/Phase 3|0|Actual|Benha University||2|||f||||t||||||||||2017-10-10 23:13:49.715645|2017-10-10 23:13:49.715645
NCT02468245|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-04-06|||January 2015||2015-01-01|April 2017|2017-04-01||||January 2018|Anticipated|2018-01-01||Interventional|||Does a Nursing Intervention Improve Adherence to Oral Chemotherapies in the Outpatient Cancer Treatment Setting?|Does a Nursing Intervention Improve Adherence to Oral Chemotherapies in the Outpatient Cancer Treatment Setting?|Recruiting||N/A|60|Anticipated|Bassett Healthcare||2|||f||||f||||||||||2017-10-10 23:13:49.800691|2017-10-10 23:13:49.800691
NCT02468232|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-10-03|||June 15, 2015|Actual|2015-06-15|October 2017|2017-10-01|November 26, 2018|Anticipated|2018-11-26|November 24, 2018|Anticipated|2018-11-24||Interventional|PARALLEL-HF||Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction|A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction|Active, not recruiting||Phase 3|225|Actual|Novartis||2|||f||||t||||||||||2017-10-10 23:13:49.893471|2017-10-10 23:13:49.893471
NCT02468219|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-06-05|||March 2015||2015-03-01|June 2015|2015-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Assessment and Cardiovascular Rehabilitation in Patients With Severe Aortic Stenosis|Multiparametric Assessment and Cardiovascular Rehabilitation in Patients With Severe Aortic Stenosis Undergoing Valve Surgery: Effects on Hemodynamics, Functional Capacity, Frailty, Prognosis and Quality of Life|Unknown status|Recruiting|N/A|60|Anticipated|Irmandade Santa Casa de Misericórdia de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:13:50.101903|2017-10-10 23:13:50.101903
NCT02468206|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-26|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Secondary Prophylaxis of Gastric Variceal Bleed|Endoscopic Cyanoacrylate Injection vs. Balloon-occluded Retrograde Transvenous Obliteration in the Prevention of Gastric Variceal Rebleeding|Recruiting||N/A|64|Anticipated|West China Hospital||2|||f||||||||||||||2017-10-10 23:13:50.205105|2017-10-10 23:13:50.205105
NCT02468180|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-26|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Primary Prophylaxis of Gastric Variceal Bleed|Primary Prophylaxis of Gastric Variceal Bleed: Endoscopic Cyanoacrylate Injection Versus Balloon-occluded Retrograde Transvenous Obliteration|Recruiting||N/A|70|Anticipated|West China Hospital||2|||f||||||||||||||2017-10-10 23:13:50.415235|2017-10-10 23:13:50.415235
NCT02468167|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-26|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO|Comparison of Endoscopic Cyanoacrylate Injection Versus Balloon-occluded Retrograde Transvenous Obliteration in the Management of Acute Gastric Variceal Bleeding|Recruiting||N/A|70|Anticipated|West China Hospital||2|||f||||f||||||||||2017-10-10 23:13:50.498936|2017-10-10 23:13:50.498936
NCT02468154|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-04-12|2016-02-08||November 2014||2014-11-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of Leg Casts With Heel Off-loaded in Children|Efficacy of Leg Casts With Heel Off-loaded in Children: Open Randomized Controlled Trial|Completed||N/A|57|Actual|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-10 23:13:50.591939|2017-10-10 23:13:50.591939
NCT02468141|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-07-19|||July 2015|Actual|2015-07-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients|Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients: A Randomized Double Blinded Placebo Controlled Pilot Study|Completed||N/A|32|Actual|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-10 23:13:50.911365|2017-10-10 23:13:50.911365
NCT02468128|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-07-01|||December 2012||2012-12-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management|A Randomized, Double Blind, Placebo-Controlled, Single Dose Study to Assess The Safety and Efficacy of Intramuscular Sebacoyl Dinalbuphine Ester (SDE) for Post-Hemorrhoidectomy Pain Management|Completed||Phase 2/Phase 3|221|Actual|Lumosa Therapeutics Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:13:51.001194|2017-10-10 23:13:51.001194
NCT02468115|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-04-04|||May 2015||2015-05-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Influenza Challenge Study of VIS410 in Healthy Volunteers|A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Antiviral Activity of a Single Intravenous Dose of VIS410 in Healthy Subjects After a Viral Inoculation With Influenza A (H1N1)|Completed||Phase 2|46|Actual|Visterra, Inc.||2|||f||||t||||||||||2017-10-10 23:13:51.150372|2017-10-10 23:13:51.150372
NCT02468089|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-01-01|||May 2015||2015-05-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis|A Randomized Study to Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis|Recruiting||N/A|150|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:13:51.376396|2017-10-10 23:13:51.376396
NCT02468076|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-05-10|||November 2014||2014-11-01|November 2014|2014-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|IGNITE-1||Radiofrequency Ablation for Biliopancreatic Malignancy|Investigation of the Effect of Intraductal Radiofrequency Ablation in Inoperable Biliopancreatic Tumors Complicated With Obstructive Jaundice|Completed||Phase 2|18|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-10 23:13:51.466603|2017-10-10 23:13:51.466603
NCT02468063|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-01-01|||May 2015||2015-05-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock|A Prospective Study to Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock|Recruiting||N/A|180|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:13:51.545971|2017-10-10 23:13:51.545971
NCT02468050|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2015-06-05|||February 2012||2012-02-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Study of Exercise to Manage Distress During Breast Screening|Effectiveness of Exercise Training and Self Management in the Attenuation of Anxiety and Depressive Symptoms Following Breast Biopsy|Completed||Phase 2|7|Actual|University of Western Ontario, Canada||3|||f||||f||||||||||2017-10-10 23:13:51.640044|2017-10-10 23:13:51.640044
NCT02468037|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-06-05|||April 2012||2012-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Iron Reduction by Phlebotomy for Type 2 Diabetes|Iron Reduction by Phlebotomy for the Prevention and Treatment of Type 2 Diabetes|Completed||N/A|12|Actual|University of Utah||2|||f||||t||||||||||2017-10-10 23:13:51.740332|2017-10-10 23:13:51.740332
NCT02468024|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-07-14|||July 2015||2015-07-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|STABLE-MATES||JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer|JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial|Recruiting||Phase 3|258|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-10 23:13:51.820965|2017-10-10 23:13:51.820965
NCT02468011|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-07-25|||June 2015||2015-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|WBVIMR-SL||Whole Body Vibration Induced Muscle Activity and Effect of the Changes in Length of Soleus Muscle and Angle of Ankle|Whole Body Vibration Induced Muscle Activity in Different Position of Lower Extremity: Effect of the Changes in Length of Soleus Muscle and Angle of Ankle|Completed||N/A|18|Actual|Bagcilar Training and Research Hospital||1|||f||||f||||||||||2017-10-10 23:13:51.959783|2017-10-10 23:13:51.959783
NCT02467998|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-05-18|||January 2005||2005-01-01|May 2016|2016-05-01||||January 2020|Anticipated|2020-01-01|3 Months|Observational [Patient Registry]|NPWTR||Negative Pressure Wound Therapy Registry|The Registry of Negative Pressure Wound Therapy for Chronic Wounds and Ulcers|Recruiting||N/A|50000|Anticipated|U.S. Wound Registry|||1||f||||t||||||||||2017-10-10 23:13:52.022174|2017-10-10 23:13:52.022174
NCT02467985|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-18|||April 2015||2015-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|FIGARO||A Trial to Reduce Referred Pain in the Shoulder Following a Laparoscopic Gynecological Surgery|FIGARO : A Double-blinded RCT to Reduce Referred Pain in the Shoulder Following a Laparoscopic Gynecological Surgery|Recruiting||N/A|175|Anticipated|Université de Sherbrooke||2|||f||||t||||||||||2017-10-10 23:13:52.118989|2017-10-10 23:13:52.118989
NCT02467972|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-15|||April 2012||2012-04-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Functional Ingredients: Effect in Gastrointestinal System|Functional Ingredients: Effect in Satiety and Intestinal Health|Completed||N/A|61|Actual|University of Sao Paulo||4|||f||||t||||||||||2017-10-10 23:13:52.207609|2017-10-10 23:13:52.207609
NCT02467959|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-06-09|||January 2015||2015-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Diagnostic Accuracy of Emergency Physician Performed Bedside Ultrasound in Suspected Acute Appendicitis|Diagnostic Accuracy and Clinic Utility of Bedside Ultrasonography Performed by Emergency Physicians in Suspected Acute Appendicitis|Unknown status|Recruiting|N/A|250|Anticipated|Antalya Training and Research Hospital|||1||f||||f||||||||||2017-10-10 23:13:52.293088|2017-10-10 23:13:52.293088
NCT02467946|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-02-21|||July 2015||2015-07-01|February 2016|2016-02-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|HALO||Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient|A Phase 1/2 Clinical Trial to Assess Safety and Efficacy of a New Treatment for Hodgkin Lymphoma's Disease Combining Adcetris® and Levact® in Old Patients|Recruiting||Phase 1/Phase 2|60|Anticipated|Centre Antoine Lacassagne||1|||f||||t||||||||||2017-10-10 23:13:52.374166|2017-10-10 23:13:52.374166
NCT02467933|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-03-07|||April 2015||2015-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Informative Letters on the Prescription and Receipt of Seroquel|The Effect of Informative Letters on the Prescription and Receipt of Seroquel|Active, not recruiting||N/A|5055|Actual|Abdul Latif Jameel Poverty Action Lab||2|||f||||f||||||||Undecided||2017-10-10 23:13:52.462727|2017-10-10 23:13:52.462727
NCT02467920|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-08-31|||August 2015||2015-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM|Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Switching Premix Human Insulin to Aspart30 in T2DM With Inadequate Glycaemic Control on Premixed Human Insulin and Metformin: a Randomized, Open, Parallel Trial|Active, not recruiting||Phase 4|349|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:13:52.544302|2017-10-10 23:13:52.544302
NCT02467907|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-10-02|||July 28, 2015|Actual|2015-07-28|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer|A Multicenter Open-Label Single-Arm Phase II Study Evaluating the Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel in Patients With Metastatic, Recurrent or Persistent Cervical Cancer|Active, not recruiting||Phase 2|150|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 23:13:52.621073|2017-10-10 23:13:52.621073
NCT02467881|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-11-10|||September 2015||2015-09-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Physical Activity and Sedentary Behavior Change; Impact on Lifestyle|Physical Activity and Sedentary Behavior Change; Impact on Lifestyle Intervention Effects for Diabetes Translation|Recruiting||N/A|321|Anticipated|University of Pittsburgh||3|||f||||t||||||||No||2017-10-10 23:13:52.978316|2017-10-10 23:13:52.978316
NCT02467868|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-03-15|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Efficacy and Safety Study With MYL-1401H and Neulasta|Multicenter, Double-Blind, Randomized, Comparative Efficacy and Safety Study of MYL-1401H and European Sourced Neulasta® in Stage II/III Breast Cancer Patients Receiving Neoadjuvant or Adjuvant Chemotherapy|Completed||Phase 3|193|Actual|Mylan Inc.||2|||f||||f||||||||||2017-10-10 23:13:53.093372|2017-10-10 23:13:53.093372
NCT02467855|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-11-12|||October 2014||2014-10-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Epidemiological Study in Thai Participants With Hypertension|A Multi-Centre, Non-Interventional, Hospital-Based, Cross-Sectional as Well as Longitudinal Epidemiological Study in Thai Subjects With Hypertension|Completed||N/A|2071|Actual|Takeda|||2||f||||f||||||||||2017-10-10 23:13:53.508292|2017-10-10 23:13:53.508292
NCT02467842|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-05|||September 2014||2014-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607) in Adults and Elderly Subjects|A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess the Immunogenicity and Safety of Quadrivalent Inactivated Cell Culture-derived Influenza Vaccine in Adults and Elderly Subjects|Completed||Phase 3|1503|Actual|SK Chemicals Co.,Ltd.||3|||f||||f||||||||||2017-10-10 23:13:53.652718|2017-10-10 23:13:53.652718
NCT02467829|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-01-07|||January 2016||2016-01-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Interventional|||Effects of Altering Handle Height of Posterior Walkers|What Are the Effects of Altering Handle Height of Posterior Walkers on Gait Parameters in Children With Spastic Cerebral Palsy?|Recruiting||N/A|15|Anticipated|University of Birmingham||3|||f||||f||||||||||2017-10-10 23:13:53.763149|2017-10-10 23:13:53.763149
NCT02467816|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-08|||March 2015||2015-03-01|June 2015|2015-06-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Technology and Design Innovation for School Lunch|Technology and Design Innovation to Support 21st Century School Nutrition|Active, not recruiting||N/A|14520|Anticipated|University of California, Berkeley||2|||f||||t||||||||||2017-10-10 23:13:53.899167|2017-10-10 23:13:53.899167
NCT02467803|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-05|||June 2015||2015-06-01|May 2015|2015-05-01||||January 2016|Anticipated|2016-01-01||Interventional|||Shoulder Functional Outcomes of Patients With Proximal Humerus Fractures: Comparison of Two Different Treatment Protocol||Unknown status|Not yet recruiting|Early Phase 1|50|Anticipated|Hacettepe University||2|||f||||||||||||||2017-10-10 23:13:54.069943|2017-10-10 23:13:54.069943
NCT02467790|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2016-01-23|||February 2015||2015-02-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Interventional|||Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function|Kinetic Study of Human Pharmacokinetics in Normal Renal Function, and Renal Insufficiency Subject of Polyethylene Glycol Loxenatide (PEX168)(Open, Non-randomized, Parallel-group)|Recruiting||Phase 1|24|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||3|||f||||t||||||||||2017-10-10 23:13:54.150495|2017-10-10 23:13:54.150495
NCT02467777|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-04-05|2016-08-17||June 2015||2015-06-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Forced Air and Conductive Patient Heating Systems During Ambulatory Surgeries||Completed||N/A|50|Actual|Fox Valley Orthopedic Institute||2|||f||||f||||||||||2017-10-10 23:13:54.262084|2017-10-10 23:13:54.262084
NCT02467764|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-06-07|||June 2015||2015-06-01|June 2015|2015-06-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||"Score Infectivity During Reoperation on Total Hip or Knee Prosthesis"|"Definition of a Score Infectivity During Reoperation on Total Hip or Knee Prosthesis"|Unknown status|Not yet recruiting|N/A|200|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:13:54.567415|2017-10-10 23:13:54.567415
NCT02467751|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-03-17|||January 2014||2014-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|PCOS||Women With Polycystic Ovary Syndrome (PCOS)|Metabolic Profile in Women of Different Body Composition With Polycystic Ovary Syndrome|Recruiting||N/A|90|Anticipated|Irmandade da Santa Casa de Misericordia de Sao Paulo|||1||f||||t||||||||No|When I have finished my recruitment and analysis of the results.|2017-10-10 23:13:54.645524|2017-10-10 23:13:54.645524
NCT02467738|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-10-18|||March 2015||2015-03-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer|A Pilot Study Using Surgical Resection and Intraoperative Cesium-131 Permanent Interstitial Brachytherapy Implant in Resectable Recurrent Head and Neck Cancer|Recruiting||N/A|47|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-10 23:13:54.741191|2017-10-10 23:13:54.741191
NCT02467725|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-27|||May 2015||2015-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|EnMotion||EnMotion, Embryo's Natural Motion|EnMotion, Embryo's Natural Motion: The Impact of Dynamic Culture on the Development of Useable Blastocysts|Active, not recruiting||N/A|200|Anticipated|Reproductive Medicine Associates of New Jersey||2|||f||||f||||||||||2017-10-10 23:13:54.857607|2017-10-10 23:13:54.857607
NCT02467712|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2015-06-07|||July 2015||2015-07-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Fungal Infection on a Joint Prosthesis|Change in Joint Prosthesis in One Step Due to Fungal Infection|Unknown status|Not yet recruiting|N/A|4|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:13:54.940495|2017-10-10 23:13:54.940495
NCT02467699|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-05-18|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Navigation System for in Vivo Measurement of the Kinematics of the Knee|Validation of a Noninvasive Navigation System for in Vivo Measurement of the Kinematics of the Knee|Recruiting||N/A|40|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:13:55.012175|2017-10-10 23:13:55.012175
NCT02467491|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-05-19|2016-02-17||September 2015||2015-09-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|Jintronix|Older adults living in the residential community Oak Hammock at University of Florida|A New Adaptive Physical Activity Technology in Older Adults|A New Adaptive Physical Activity Technology in Older Adults (Jintronix)|Completed||N/A|17|Actual|University of Florida||1|||f||||f||||||||||2017-10-10 23:13:58.778172|2017-10-10 23:13:58.778172
NCT02467686|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-03-17|||January 2014||2014-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|Cimicifuga||Breast Cancer, Sexuality and Black Cohosh|Effects of Cimicifuga Racemosa L. Nutt Sexuality of Women With Breast Cancer Using Tamoxifen or Aromatase Inhibitor|Recruiting||Phase 4|60|Anticipated|Irmandade da Santa Casa de Misericordia de Sao Paulo||2|||f||||f||||||||No|When I have finished my recruitment and analysis of the results.|2017-10-10 23:13:55.098418|2017-10-10 23:13:55.098418
NCT02467673|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-07|2016-05-21|||January 2012||2012-01-01|May 2016|2016-05-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|Nanoparticle||Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy|Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy: Effects on Blood Pressure, Insulin and C-reactive Protein and in Postmenopausal Women|Completed||Phase 2|185|Actual|University Potiguar||2|||f||||f||||||||||2017-10-10 23:13:55.215969|2017-10-10 23:13:55.215969
NCT02467660|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-04-11|||June 2015||2015-06-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Meditation or Health & Wellness Education Via Internet for Adults 50-80 Years Old|Meditation or Health & Wellness Education Via Internet for Adults 50-80 Years Old|Recruiting||N/A|200|Anticipated|Oregon Health and Science University||3|||f||||f||||||||||2017-10-10 23:13:55.321321|2017-10-10 23:13:55.321321
NCT02467647|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2015-06-09|||January 2015||2015-01-01|June 2015|2015-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|HLJDT-2016||The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy|Phase 1 Study of the Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy|Recruiting||Phase 1|500|Anticipated|Wuhan University||2|||f||||f||||||||||2017-10-10 23:13:55.42305|2017-10-10 23:13:55.42305
NCT02467634|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-05-31|||June 2015||2015-06-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|RADIANT||Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD|A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration|Terminated||Phase 2|3|Actual|StemCells, Inc.||1||Based on a business decision unrelated to any safety concerns.|f||||t||||||||||2017-10-10 23:13:55.521726|2017-10-10 23:13:55.521726
NCT02467621|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-04-27|||January 2016||2016-01-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|SUP-ICU||Stress Ulcer Prophylaxis in the Intensive Care Unit|Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU)|Recruiting||Phase 4|3350|Anticipated|Scandinavian Critical Care Trials Group||2|||f||||t||||||||Yes||2017-10-10 23:13:55.627919|2017-10-10 23:13:55.627919
NCT02467608|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2016-03-02|||December 2012||2012-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis|A Randomized, Double-Blind, Active Drug Controlled Study to Assess the Efficacy of HUEXC030 as Add-on Excipient to Eradicate Anti-Tuberculosis Drugs Induced Liver Injury in Subjects With Pulmonary Tuberculosis|Recruiting||Phase 2/Phase 3|352|Anticipated|Orient Pharma Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:13:55.838549|2017-10-10 23:13:55.838549
NCT02467595|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-01-26|||July 2015||2015-07-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||The Effect of no Muscle Relaxant Versus Reduced-dose Rocuronium on Anesthesia in Adenotonsillectomy|The Effect of no Muscle Relaxant Versus Reduced-dose Rocuronium on the Anesthetic Condition With Fentanyl in Children Undergoing Adenotonsillectomy|Enrolling by invitation||Phase 4|75|Anticipated|Korea University Anam Hospital||3|||f||||t||||||||No||2017-10-10 23:13:55.973869|2017-10-10 23:13:55.973869
NCT02467582|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-08-21|||April 26, 2016|Actual|2016-04-26|August 2017|2017-08-01|June 2029|Anticipated|2029-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Adjuvant Aspirin Treatment for Colon Cancer Patients|Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial|Recruiting||Phase 3|185|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||f|f|f||||||||2017-10-10 23:13:56.088548|2017-10-10 23:13:56.088548
NCT02467569|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-04-25|||July 3, 2015|Actual|2015-07-03|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer|Phase I Trial Evaluating Pharmacokinetics, Safety and Tolerability of the Irreversible Epidermal Growth Factor Receptor Inhibitor Hemay020 in Patients With Advanced Solid Cancer|Recruiting||Phase 1|55|Anticipated|Tianjin Hemay Pharmaceutical Co.,Ltd||1|||f||||f||||||||||2017-10-10 23:13:56.444517|2017-10-10 23:13:56.444517
NCT02467556|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2015-06-24|||March 2011||2011-03-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|MultiModCRPS||Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome|Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome|Completed||Phase 4|10|Actual|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-10 23:13:56.539772|2017-10-10 23:13:56.539772
NCT02467543|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-05-18|||February 2015||2015-02-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea|The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea|Completed||Phase 2|30|Actual|University of Johannesburg||2|||f||||t||||||||||2017-10-10 23:13:56.626589|2017-10-10 23:13:56.626589
NCT02467530|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-01-17|||January 2015||2015-01-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Food Preparation Effects on Gut Bacteria in Patients on Peritoneal Dialysis|Effect of a Low AGE Diet on Human Microbiome|Completed||N/A|103|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:13:56.70929|2017-10-10 23:13:56.70929
NCT02467517|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-07-28|||November 2015||2015-11-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|KETAPAIN||Ketamine and Neuropathic Pain|Ketamine and Neuropathic Pain|Recruiting||Phase 2|22|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 23:13:56.802976|2017-10-10 23:13:56.802976
NCT02467504|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-11-10|||July 2015||2015-07-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis|A Randomized, Double Blind, Placebo-controlled Pilot-study to Evaluate Efficacy and Safety of Low-dose hrIL-2 in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-Naive Patients With Rheumatoid Arthritis|Recruiting||Phase 2|60|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-10 23:13:56.927986|2017-10-10 23:13:56.927986
NCT02467478|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-08|2017-08-28|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Linagliptin's Effect on CD34+ Stem Cells|Role of Linagliptin in Improving Renal Failure by Improving CD34+ Stem Cell Number, Function and Gene Expression in Renal Function Impaired Type 2 Diabetes Patients.|Recruiting||Phase 4|40|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-10 23:13:59.055738|2017-10-10 23:13:59.055738
NCT02467465|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-06-09|||May 2014||2014-05-01|June 2015|2015-06-01|October 2017|Anticipated|2017-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Efficacy of Dry Needling in Plantar Fasciitis|Efficacy of Dry Needling in Plantar Fasciitis|Unknown status|Recruiting|N/A|30|Anticipated|Universidad Complutense de Madrid||2|||f||||t||||||||||2017-10-10 23:13:59.150349|2017-10-10 23:13:59.150349
NCT02467452|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-01-19|||May 2015||2015-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)|A Multinational, Multicentre, Randomised, Open-Label, Active-Controlled, 26-Week, 2-Arm, Parallel Group Study to Evaluate the Non-Inferiority of Fixed Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrronium Bromide (CHF 5993) Administered Via Pressurized Metered-dose Inhaler (pMDI) Versus Fixed Combination Of Fluticasone Furoate Plus Vilanterol Administered Via Dry Powder Inhaler (DPI) (Relvar®) Plus Tiotropium Bromide (Spiriva®) for the Treatment of Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|1479|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-10 23:13:59.238727|2017-10-10 23:13:59.238727
NCT02467439|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-11-04|||June 2015||2015-06-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Interventional|||Acute Partner and Social Contact Referral: iKnow|Acute Partner and Social Contact Referral: iKnow|Recruiting||N/A|5975|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:13:59.320098|2017-10-10 23:13:59.320098
NCT02467426|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-09|||September 2009||2009-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Observational|||Isolated Thoracic Perfusion (ITP-F) for MPM|Isolated Thoracic Perfusion With Hemofiltration (ITP-F) for Pretreated and Progressive Malignant Pleural Mesothelioma|Completed||Phase 2|23|Actual|Medias Klinikum for Surgical Oncology|||1||f||||f||||||||||2017-10-10 23:13:59.400011|2017-10-10 23:13:59.400011
NCT02467413|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-07-18|||December 1, 2017|Anticipated|2017-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||BAC in Patient With Alzheimer's Disease or Vascular Dementia|A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia|Not yet recruiting||Phase 2|125|Anticipated|Charsire Biotechnology Corp.||2|||f||||f|t|f||||||||2017-10-10 23:13:59.471208|2017-10-10 23:13:59.471208
NCT02467400|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism|Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism|Active, not recruiting||N/A|165|Actual|Mayo Clinic||5|||f||||f||||||||||2017-10-10 23:13:59.692751|2017-10-10 23:13:59.692751
NCT02467387|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-04-19|||June 2014||2014-06-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure|A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure|Active, not recruiting||Phase 2|23|Actual|CardioCell LLC||2|||f||||t||||||||||2017-10-10 23:13:59.804187|2017-10-10 23:13:59.804187
NCT02467374|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-05-24|||December 2014||2014-12-01|May 2017|2017-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder|Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:13:59.919376|2017-10-10 23:13:59.919376
NCT02467361|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-07-11|||August 2015||2015-08-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers|A Phase Ib/II Clinical Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors to Adult Patients With Advanced Cancers|Recruiting||Phase 1/Phase 2|120|Anticipated|Boston Biomedical, Inc||3|||f||||||||||||||2017-10-10 23:14:00.066973|2017-10-10 23:14:00.066973
NCT02467348|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-06-09|||March 2015||2015-03-01|January 2017|2017-01-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.|To Study the Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.|Recruiting||N/A|80|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:14:00.198609|2017-10-10 23:14:00.198609
NCT02467335|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-09-20|||January 29, 2015|Actual|2015-01-29|September 2017|2017-09-01|October 3, 2015|Actual|2015-10-03|October 3, 2015|Actual|2015-10-03||Interventional|||Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects|Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects|Completed||Phase 1|52|Actual|ViiV Healthcare||4|||f||||||||||||||2017-10-10 23:14:00.300339|2017-10-10 23:14:00.300339
NCT02467322|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-06-09|||February 23, 2015|Actual|2015-02-23|October 2016|2016-10-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.|To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion|Completed||N/A|80|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:14:00.388048|2017-10-10 23:14:00.388048
NCT02467309|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-06-05|||May 2015||2015-05-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Observational|||Vitamin d Levels in Children With Bacterial Meningitis|Association of Serum 25-hydroxyvitamin D Levels and Outcomes in Children With Bacterial Meningitis|Unknown status|Not yet recruiting|N/A|50|Anticipated|Beijing Children's Hospital|||1||f||||f||||||||||2017-10-10 23:14:00.510461|2017-10-10 23:14:00.510461
NCT02467296|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-04-24|||February 2015||2015-02-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|ProhibitSodium||Dietary Sodium Intake and Outcomes in Heart Failure|Rationale and Design of the PRevent Adverse Outcomes in Heart faIlure By limITing Sodium Study|Recruiting||N/A|50|Anticipated|Stony Brook University||2|||f||||t||||||||No||2017-10-10 23:14:00.620495|2017-10-10 23:14:00.620495
NCT02467283|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-08-30|||February 2013||2013-02-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|August 2015|Actual|2015-08-01||Observational|||Gene Expression Profiles in Chronic Periodontitis|Gene Expression Profiles in Chronic Periodontitis: A Gene Network-based Microarray Analysis|Active, not recruiting||N/A|46|Anticipated|Kocaeli University|||2||f||||f||||||||No||2017-10-10 23:14:00.724795|2017-10-10 23:14:00.724795
NCT02467270|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-09-05|||June 2015||2015-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|OPTIC||Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia (CML) to Characterize the Efficacy and Safety of a Range of Doses|A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses|Recruiting||Phase 2|450|Anticipated|Ariad Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:14:00.81793|2017-10-10 23:14:00.81793
NCT02467244|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-05-18|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism|Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism|Recruiting||Phase 4|100|Anticipated|All India Institute of Medical Sciences, Bhubaneswar||2|||f||||f|f|f||||||||2017-10-10 23:14:01.548037|2017-10-10 23:14:01.548037
NCT02467231|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-06-20|||February 2009||2009-02-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Observational|ORACLE||Ovarian Reserve After Cancer: Longitudinal Effects|Ovarian Reserve After Cancer: Longitudinal Effects A Multicenter Prospective Cohort Study by the Oncofertility Consortium|Recruiting||N/A|181|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-10 23:14:01.715553|2017-10-10 23:14:01.715553
NCT02467218|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-02-23|||November 2015||2015-11-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||HBOT in Fibromyalgia|Hyperbaric Oxygen Therapy in Fibromyalgia : Effect on Global Function|Active, not recruiting||N/A|16|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:14:01.8516|2017-10-10 23:14:01.8516
NCT02467205|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Walk for Rheumatoid Arthritis (WARA Study)|Effectiveness of Community Based Physical Activity on Step Count and Sedentary Behaviour in Patients With Rheumatoid Arthritis Within the First Five Years of Diagnosis|Completed||N/A|76|Actual|University of Glasgow||2|||f||||t||||||||||2017-10-10 23:14:01.977881|2017-10-10 23:14:01.977881
NCT02467192|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-06-05|||May 2015||2015-05-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|PneumOldCT||The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly|The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly: PneumOldCT|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-10-10 23:14:02.10331|2017-10-10 23:14:02.10331
NCT02467179|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-05|||June 2015||2015-06-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|June 6, 2017|Anticipated|2017-06-06||Interventional|Amigo-AFL||Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus|Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus|Recruiting||N/A|50|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 23:14:02.231329|2017-10-10 23:14:02.231329
NCT02467166|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-05|||June 2015||2015-06-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|CIRCA-EGD||Evaluation of the CIRCA Monitoring System in Prevention of Esophageal Lesions Following RFCA|A Prospective, Non-Randomized Study to Evaluate the CIRCA Esophageal Temperature Monitoring System in Prevention of Esophageal Lesions Following Atrial Fibrillation Radiofrequency Catheter Ablation|Recruiting||N/A|40|Anticipated|University of California, San Diego||1|||f||||f||||||||No||2017-10-10 23:14:02.401883|2017-10-10 23:14:02.401883
NCT02467153|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-04-27|||April 2016||2016-04-01|June 2015|2015-06-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|EXVITD||Vitamin D and Resistance Exercise Training; Effects on Musculoskeletal Health in Frail Older Men and Women|Influence of Combined Vitamin D Supplementation and Resistance Exercise Training on Musculoskeletal Health in Frail Older Men and Women (EXVITD)|Recruiting||N/A|114|Anticipated|University of Birmingham||2|||f||||f||||||||||2017-10-10 23:14:02.549312|2017-10-10 23:14:02.549312
NCT02467140|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-06-05|||May 2015||2015-05-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparing Pain After Laparoscopic Hernia Repair Using Two Different Types of Mesh Fixation|A Clinical Study of Postoperative Pain Following Laparoscopic Transabdominal Preperitoneal Inguinal Hernioplasty. Comparing Parietex ProGrib With Tacks for Mesh Fixation|Unknown status|Recruiting|N/A|500|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:14:02.710766|2017-10-10 23:14:02.710766
NCT02467127|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-30|||November 2015||2015-11-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|September 2016|Actual|2016-09-01||Interventional|VITDHEAD||Vitamin D Plasma Level and Its Role in Headache|The Role of Vitamin D Plasma Levels in the Development of Headache|Enrolling by invitation||N/A|600|Anticipated|University of Cantanzaro||4|||f||||t||||||||||2017-10-10 23:14:02.812038|2017-10-10 23:14:02.812038
NCT02467114|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-21|||June 2015||2015-06-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|AtNet||Interactions Between Attentional Networks and Their Influence on Perception|Interactions Between Attentional Networks and Their Influence on Perception: a Project in Healthy Subjects and Hemispatial Neglect Patients|Recruiting||N/A|214|Anticipated|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-10-10 23:14:02.923837|2017-10-10 23:14:02.923837
NCT02467101|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-06-04|||July 2015||2015-07-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|FFA||Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia|Prospective Double-blind, Placebo Controlled Study to Assess the Efficacy of Intralesional Corticoid on the Treatment of Frontal Fibrosing Alopecia|Unknown status|Not yet recruiting|N/A|10|Anticipated|Universitat Internacional de Catalunya||1|||f||||f||||||||||2017-10-10 23:14:03.070601|2017-10-10 23:14:03.070601
NCT02467088|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-05-18|||August 2014||2014-08-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome|An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome in Indian Females|Completed||Phase 2|10|Actual|University of Johannesburg||1|||f||||t||||||||No||2017-10-10 23:14:03.167249|2017-10-10 23:14:03.167249
NCT02467075|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-23|2017-04-03||July 2015|Actual|2015-07-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Double-Blind Placebo-Controlled CIN Trial|Phase IV Randomized Double-Blinded Placebo-Controlled Noninferiority Study of the Effect of Intravenous Low-Osmolality Iodinated Contrast Material On Renal Function in Postoperative Adults With Stage IIIb or Stage IV Chronic Kidney Disease|Terminated||Phase 4|1|Actual|University of Michigan|The decision to terminate the study due to low accrual potential was made in February 2016, but last data collection from the 1 subject was in September 2015.|2||Insufficient number of subjects could be enrolled.|f||||t|t|f|||t|||No||2017-10-10 23:14:03.251479|2017-10-10 23:14:03.251479
NCT02467062|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-12-05|||September 2015||2015-09-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Implementation of Non-size Markers Derived From 4D Flow MRI of Patients With Aortic Disease.|Implementation of Non-size Markers Derived From 4D Flow MRI of Patients With Aortic Disease.|Completed||N/A|36|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||No||2017-10-10 23:14:03.656126|2017-10-10 23:14:03.656126
NCT02467049|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-10-13|||June 2015||2015-06-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip|ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip|Recruiting||N/A|20|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||No||2017-10-10 23:14:03.732675|2017-10-10 23:14:03.732675
NCT02467036|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-08-16|||January 2014||2014-01-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FAB||Family Based Treatment for Weight Loss With Breakfast Prescription|A Pilot Study Examining the Impact of Eggs for Breakfast on Weight Loss and Hunger in Obese Children|Active, not recruiting||N/A|66|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:14:03.814237|2017-10-10 23:14:03.814237
NCT02467023|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-03-15|||September 2015||2015-09-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Project 4B: Lower Extremity Strength Training in ICU Patients|Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care: Project 4B: Lower Extremity Strength Training in ICU Patients|Recruiting||N/A|36|Anticipated|University of Florida||2|||f||||t||||||||||2017-10-10 23:14:03.910868|2017-10-10 23:14:03.910868
NCT02467010|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-06-08|||September 2008||2008-09-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|REMM||Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance|Bortezomib in Combination With Continuous Low-dose Oral Cyclophosphamide and Dexamethason Followed by Maintenance in Primary Refractory or Relapsed Bortezomib naïve Multiple Myeloma Patients. A Prospective Phase II Study.|Completed||Phase 2|73|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-10 23:14:04.19198|2017-10-10 23:14:04.19198
NCT02466997|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-03-09|||July 2015||2015-07-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|VITAC||Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC|Efficacy of Tacrolimus Ointment 0.1% Versus Placebo in Adults With Facial Non-segmental Vitiligo: a Randomized Double-blind Controlled Study|Recruiting||Phase 3|100|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 23:14:04.285483|2017-10-10 23:14:04.285483
NCT02466984|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-02-22|||July 2016||2016-07-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|SOPHA-Méto||Subcutaneous Route and Pharmacology of Metoclopramide|Subcutaneous Route and Pharmacology of Metoclopramide|Recruiting||Phase 3|24|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 23:14:04.407065|2017-10-10 23:14:04.407065
NCT02466958|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-02-01|||June 2016||2016-06-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|LMIL||Trial of Levomilnacipran in Geriatric Depression|Double-blind Placebo-controlled Trial of Levomilnacipran in Geriatric Depression|Recruiting||Phase 3|60|Anticipated|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-10 23:14:05.53082|2017-10-10 23:14:05.53082
NCT02466945|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-04|||September 2015||2015-09-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Oral and Dental Tolerance and Efficacy on Dentinal Hypersensitivity of a Dental Gel, on Adults|Oral and Dental Tolerance and Efficacy on Dentinal Hypersensitivity of a Dental Gel, on Adults|Unknown status|Not yet recruiting|N/A|55|Anticipated|Pierre Fabre Dermo Cosmetique||1|||f||||f||||||||||2017-10-10 23:14:05.618765|2017-10-10 23:14:05.618765
NCT02466932|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-04|||January 2011||2011-01-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|1 Day|Observational [Patient Registry]|||Effects of Birth Weight on Anterior Eye Segment Measurements in Full-Term Children by Galilei Dual-Scheimpflug Analyzer|Effects of Birth Weight on Anterior Eye Segment Measurements in Full-Term Children by Galilei Dual-Scheimpflug Analyzer|Completed||N/A|78|Actual|Neon Hospital|||1||f||||f||||||||||2017-10-10 23:14:05.694597|2017-10-10 23:14:05.694597
NCT02466919|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2016-09-01|||May 2014||2014-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients|Strategy on the Increment of H. Pylori Eradication Rate and Investigating the Gastric Pathology and Antimicrobial Resistance in Diabetic Patients|Completed||Phase 4|114|Actual|National Cheng-Kung University Hospital||2|||f||||t||||||||||2017-10-10 23:14:05.807517|2017-10-10 23:14:05.807517
NCT02466906|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-01-18|||June 2015||2015-06-01|December 2015|2015-12-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Interventional|||RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer|Recombinant Human Granulocyte-macrophage Colony-stimulating Factor as Adjuvant Immunotherapy in Treating Resectable Stage III Colon Cancer: A Randomized, Placebo-controlled Clinical Trial|Recruiting||Phase 2|60|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-10 23:14:05.916599|2017-10-10 23:14:05.916599
NCT02466893|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-09-29|||June 2015||2015-06-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Interventional|COMPASS||COMPASS Trial: a Direct Aspiration First Pass Technique|COMPASS Trial: a Direct Aspiration First Pass Technique|Active, not recruiting||N/A|250|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-10-10 23:14:06.032552|2017-10-10 23:14:06.032552
NCT02466880|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-03-21|||April 2015||2015-04-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|IDEAS||Intervention for Diabetes With Education, Advancement and Support|Intervention for Diabetes With Education, Advancement and Support (IDEAS) Study|Completed||N/A|240|Actual|Monash University||2|||f||||f||||||||Yes|Publication in peer review journal|2017-10-10 23:14:06.121147|2017-10-10 23:14:06.121147
NCT02466867|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-10-27||2016-10-27|January 2014||2014-01-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis|An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftin® (Naftifine Hydrochloride) Cream, 2% in Pediatric Subjects With Tinea Corporis|Completed||Phase 4|27|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 23:14:06.22384|2017-10-10 23:14:06.22384
NCT02466854|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-06-08|||January 2015||2015-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|BleeMACS||Bleeding Complications in a Multicenter Registry of Patients Discharged With Diagnosis of Acute Coronary Syndrome|Bleeding Complications in a Multicenter Registry of Patients Discharged With Diagnosis of Acute Coronary Syndrome and Underwent Percutaneous Coronary Intervention|Completed||N/A|15401|Actual|University of Santiago de Compostela|||1||f||||t||||||||||2017-10-10 23:14:06.310631|2017-10-10 23:14:06.310631
NCT02466841|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-10-25|||August 2015||2015-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Prospective Comparison of Techniques for Cubital Tunnel Release|Prospective Comparison of Techniques for Cubital Tunnel Release|Enrolling by invitation||N/A|200|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-10-10 23:14:06.373152|2017-10-10 23:14:06.373152
NCT02466828|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-10-04|||March 2015||2015-03-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.|Quantitative Blood Oxygenation Level Dependent (qBOLD) MR Imaging of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.|Active, not recruiting||Early Phase 1|27|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-10 23:14:06.46081|2017-10-10 23:14:06.46081
NCT02466815|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-10-28|||June 2015||2015-06-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Assess the Relative Bioavailability of JNJ-42756493 Tablets|Open-Label, Randomized, 3-Way Crossover Design to Assess the Relative Bioavailability of JNJ-42756493 Tablets|Completed||Phase 1|12|Actual|Janssen Research & Development, LLC||6|||f||||||||||||||2017-10-10 23:14:06.553137|2017-10-10 23:14:06.553137
NCT02466802|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-07-10|||July 1, 2015|Actual|2015-07-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|August 31, 2018|Anticipated|2018-08-31||Interventional|||Study of Regorafenib and Sildenafil for Advanced Solid Tumors|Phase I Study of Regorafenib and Sildenafil for Advanced Solid Tumors|Recruiting||Phase 1|29|Anticipated|Virginia Commonwealth University||1|||f||||t|t|f|||t|||||2017-10-10 23:14:06.667006|2017-10-10 23:14:06.667006
NCT02466789|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-08-30|||July 2015||2015-07-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|VWF-phV||Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)|Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)|Recruiting||N/A|100|Anticipated|Bleeding and Clotting Disorders Institute Peoria, Illinois|||1||f||||f||||||Samples Without DNA|"     Sodium Citrated Plasma samples   "|||2017-10-10 23:14:06.812636|2017-10-10 23:14:06.812636
NCT02466776|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-04|||May 2015||2015-05-01|June 2015|2015-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Staples Versus Subcuticular Suture in Class III Obese Women Undergoing Cesarean Delivery|Comparison of Staples Versus Subcuticular Suture in Class III Obese Women Undergoing Cesarean Delivery|Unknown status|Recruiting|N/A|242|Anticipated|MemorialCare Health System||2|||f||||f||||||||||2017-10-10 23:14:06.932904|2017-10-10 23:14:06.932904
NCT02466763|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-11-09|||May 2015||2015-05-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Prospective Study of Round Window Versus Cochleostomy Approach to CI Surgery|Prospective Randomized Controlled Double-blinded Study Comparing Cochlear Implantation Through a Round Window Versus Cochleostomy Approach|Recruiting||N/A|100|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:14:07.069849|2017-10-10 23:14:07.069849
NCT02466542|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-04-03|||June 2015||2015-06-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|Esmobreast||Analgesic Effect of Intraoperative Esmolol in Mastectomies|Analgesic Effect of Intraoperative Esmolol in Mastectomies: Single Center, Prospective, Double-blind, Randomized and Placebo Controlled Study|Completed||Phase 4|60|Anticipated|Hospital de Base||2|||f||||t||||||||||2017-10-10 23:14:09.427184|2017-10-10 23:14:09.427184
NCT02466724|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-06-14|||February 2015||2015-02-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Study on the Impact of Education Website on the Quality of Outpatient Bowel Preparation for Colonoscopy|Randomized Prospective Study on the Impact of the Patient Education Website on the Quality of Outpatient Bowel Preparation for Colonoscopy|Active, not recruiting||N/A|450|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:14:07.971931|2017-10-10 23:14:07.971931
NCT02466711|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2016-09-21|||June 2015||2015-06-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers|A Single-center, Placebo-controlled, Double-blind Study to Evaluate the Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers|Completed||Phase 1|16|Actual|Motus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:14:08.056715|2017-10-10 23:14:08.056715
NCT02466698|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-09-14|||August 2016||2016-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Intestinal Lavage for the Treatment of Severe C. Difficile Infections|A Feasibility Randomized Trial of Intestinal Lavage for the Treatment of Severe C. Difficile Infections|Recruiting||Phase 2/Phase 3|20|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||Yes|De-dentified data available upon reasonable request after publication of study results|2017-10-10 23:14:08.144043|2017-10-10 23:14:08.144043
NCT02466685|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-01-11|||September 2015||2015-09-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients|Testing the Ability of JNJ-18038683, a Selective Serotonin (5-HT)7 Antagonist, to Improve Cognition and Reduce Residual Depressive Symptoms in Stable Bipolar Patients (18038683BCD2001)|Recruiting||Phase 2|60|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:14:08.252933|2017-10-10 23:14:08.252933
NCT02466672|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-04|||February 2015||2015-02-01|June 2015|2015-06-01||||January 2016|Anticipated|2016-01-01||Observational|||The Role and Effect of Anemia in Children With Pneumonia|The Role and Effect of Anemia in Children With Pneumonia|Unknown status|Recruiting|N/A|150|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-10 23:14:08.338516|2017-10-10 23:14:08.338516
NCT02466646|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-06-04|||December 2012||2012-12-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of Efficacy of Full-mouth Disinfection in Generalized Aggressive Periodontitis Patients|Evaluation of Gingival Crevicular Fluid Interleukin-1β and Interleukin-17 Levels After Full-Mouth Disinfection Initial Periodontal Treatment in Generalized Aggressive Periodontitis Patients|Completed||Phase 4|42|Actual|Marmara University||3|||f||||f||||||||||2017-10-10 23:14:08.600641|2017-10-10 23:14:08.600641
NCT02466633|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-01-31|||September 2015||2015-09-01|January 2017|2017-01-01||||March 2020|Anticipated|2020-03-01||Interventional|||Effect of Monitoring System Design on Response Time to Cardiac Arrhythmias|Effect of Monitoring System Design on Response Time to Cardiac Arrhythmias|Enrolling by invitation||N/A|320|Anticipated|Duke University||1|||f||||t||||||||||2017-10-10 23:14:08.725197|2017-10-10 23:14:08.725197
NCT02466607|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-08|||March 2015||2015-03-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Study of Stimulus Parameters in Flicker Electroretinogram (ERG)|Study of Stimulus Parameters in Flicker Electroretinogram (ERG)|Unknown status|Recruiting|N/A|20|Anticipated|LKC Technologies, Inc.||2|||f||||f||||||||||2017-10-10 23:14:08.90806|2017-10-10 23:14:08.90806
NCT02466594|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-07-05|||November 2013||2013-11-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|||Impact of Active Thermoregulation on the Microcirculation of Free Flaps|Impact of Active Thermoregulation on the Microcirculation of Free Flaps|Completed||N/A|25|Actual|Klinik Bogenhausen||1|||f||||t||||||||||2017-10-10 23:14:09.007841|2017-10-10 23:14:09.007841
NCT02466581|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-06-07|||February 2015||2015-02-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity|A Multicenter, Randomized, Open-label, Blinded-assessor, Follow-up, Phase 4 Study in Patients With Rheumatoid Arthritis Who Have Completed the Initial Treatment Part in the NORD-STAR Study and Have Reached Stable Low Disease Activity|Recruiting||Phase 4|500|Anticipated|Karolinska Institutet||2|||f||||t||||||||No||2017-10-10 23:14:09.092445|2017-10-10 23:14:09.092445
NCT02466568|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-08-01|||November 2017|Anticipated|2017-11-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung|A Randomized Phase I/II Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|t|f||||||||2017-10-10 23:14:09.213572|2017-10-10 23:14:09.213572
NCT02466555|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Music Therapy in Sickle Cell Transition Study|The Effects of Music Therapy on Transition Outcomes in Young Adult Patients With Sickle Cell Disease|Completed||N/A|30|Actual|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-10-10 23:14:09.34266|2017-10-10 23:14:09.34266
NCT02466529|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-06-20|||June 2015||2015-06-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Natural History of Spinal Muscular Atrophy Type 1 in Taiwan|Natural History of Spinal Muscular Atrophy Type 1 in Taiwan|Completed||N/A|111|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||||No||2017-10-10 23:14:09.528736|2017-10-10 23:14:09.528736
NCT02466516|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-02-23||2017-02-23|June 2015||2015-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3|A Phase 2, Randomized, Open Label Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Subjects With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3|Completed||Phase 2|72|Actual|Gilead Sciences||5|||f||||t||||||||||2017-10-10 23:14:09.612589|2017-10-10 23:14:09.612589
NCT02466503|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-04|||August 2014||2014-08-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block|A Single-Dose, Randomized, Open-Label, Crossover, Pivotal, Comparative Bioavailability Study of Synflutide HFA 250/25 Inhaler and SeretideTM 250 EvohalerTM in Healthy Volunteers With Charcoal Block|Completed||Phase 1|45|Actual|Intech Biopharm Ltd.||2|||f||||t||||||||||2017-10-10 23:14:09.758416|2017-10-10 23:14:09.758416
NCT02466490|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-04|||April 2013||2013-04-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|FIRME-1||Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension|A 24-week Trial of the Effectiveness and Safety of Fimasartan 60 mg Alone as Initial Treatment and Its Randomized Escalation to Fimasartan 120 mg or Fimasartan 60 mg/HCTZ 12.5 mg in Mexican Patients With Grade 1 and 2 Essential Hypertension|Completed||Phase 3|272|Actual|Stendhal Americas, S.A.||4|||f||||f||||||||||2017-10-10 23:14:09.888542|2017-10-10 23:14:09.888542
NCT02466464|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2017-01-25|||January 1, 2015|Actual|2015-01-01|January 2017|2017-01-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Microporous Polysaccharide Hemospheres Epistaxis|Use of Microporous Polysaccharide Hemospheres (MPH) in Management of Acute Epistaxis|Withdrawn||N/A|0|Actual|Emory University||2||No patients were successfully recruited|f||||f||||||||||2017-10-10 23:14:10.169527|2017-10-10 23:14:10.169527
NCT02466451|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-03-11|||March 2014||2014-03-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|CDH-EA||Study in Children With the Diagnosis of Congenital Diaphragmatic Hernia (CDH) and Oesophageal Atresia (EA)|Observational Longitudinal Study in Children With the Diagnosis of Diaphragmatic Hernia and/or Oesophageal Atresia for Assessing Lung Function Parameters and Quality of Life|Completed||N/A|33|Actual|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||1||f||||f||||||||||2017-10-10 23:14:10.250608|2017-10-10 23:14:10.250608
NCT02466438|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-04-27|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PIP-TAZO||Safety and Pharmacokinetics of Piperacillin-tazobactam Extended Infusion in Infants and Children (PIP-TAZO)|Safety and Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Infants and Children|Recruiting||Phase 1|141|Anticipated|St. Justine's Hospital||1|||f||||t||||||||||2017-10-10 23:14:10.311171|2017-10-10 23:14:10.311171
NCT02466425|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-05-16|2017-01-30||June 2015||2015-06-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||Safety set consisted of all participants in the randomized set (participants who signed informed consent for whom a randomization number had been assigned) who had taken at least 1 dose of investigational product.|Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)|A Phase 3, Randomized, Double-blind, Multi-center, Placebo Controlled, Dose-Optimization, Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|264|Actual|Shire||2|||f||||f||||||||||2017-10-10 23:14:10.404271|2017-10-10 23:14:10.404271
NCT02466412|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-02-28|2017-02-17||May 2015||2015-05-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional||"The overall PK population consisted of 47 subjects.
1 subject was excluded from the PK population (sequence CHTP 1.1 M then mCC ) due to all plasma nicotine concentration measurements being below the quantification limit for both CHTP 1.1 M and mCC."|Nicotine Pharmacokinetic Profile of the CHTP 1.1 M|A Single-center, Open-label, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile of the Carbon Heated Tobacco Product 1.1 Menthol (CHTP 1.1 M) Following Single Use in Smoking, Healthy Subjects Compared to Menthol Conventional Cigarettes|Completed||N/A|56|Actual|Philip Morris Products S.A.||2|||f||||f|f|f||||||No||2017-10-10 23:14:10.702728|2017-10-10 23:14:10.702728
NCT02466399|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-04-20|||July 2015||2015-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma|An Open-label Comparison of the Safety and Efficacy of Subconjunctival Liposomal Latanoprost (POLAT-001) to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Primary Open Angle Glaucoma|Completed||Phase 2|81|Actual|Peregrine Ophthalmic||2|||f||||f||||||||||2017-10-10 23:14:10.969989|2017-10-10 23:14:10.969989
NCT02466386|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-01-26|||July 2015||2015-07-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder|A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years Diagnosed With Attention-deficit / Hyperactivity Disorder|Recruiting||Phase 3|100|Anticipated|Shire||2|||f||||t||||||||||2017-10-10 23:14:11.035834|2017-10-10 23:14:11.035834
NCT02466373|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-01-17|||December 2016||2016-12-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|Clokin1||Pharmacokinetics and Clinical Effects of Escalating Doses of Clonidine in ICU Patients|Pharmacokinetics and Clinical Effects of Escalating Doses of Clonidine in ICU Patients|Recruiting||Phase 3|32|Anticipated|Deventer Ziekenhuis||4|||f||||t||||||||No||2017-10-10 23:14:11.316004|2017-10-10 23:14:11.316004
NCT02466360|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-05|2015-06-08|||January 2012||2012-01-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||What Are the Brakes and Levers of Physical Activity Practice for Patients With Chronic Lower Back Pain?|What Are the Brakes and Levers of Physical Activity Practice for Patients With Chronic Lower Back Pain : a Qualitative Study|Completed||N/A|29|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:14:11.413298|2017-10-10 23:14:11.413298
NCT02466347|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-07-25|||June 2014||2014-06-01|July 2016|2016-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block|A Single-Dose, Randomized, Open-Label, Crossover, Pivotal, Comparative Bioavailability Study of Synflutide HFA 250/25 Inhaler and SeretideTM 250 EvohalerTM in Healthy Volunteers Without Charcoal Block|Completed||Phase 1|45|Actual|Intech Biopharm Ltd.||2|||f||||t||||||||||2017-10-10 23:14:11.506833|2017-10-10 23:14:11.506833
NCT02466334|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-01-12|||June 2015||2015-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients|CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients|Recruiting||N/A|45|Anticipated|Danish Headache Center||2|||f||||t||||||||Undecided||2017-10-10 23:14:11.594011|2017-10-10 23:14:11.594011
NCT02466321|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-08-28|||September 2005||2005-09-01|August 2017|2017-08-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Interventional|||Anatomical Shoulder™ Inverse/Reverse Study|Anatomical Shoulder™ Inverse/Reverse Post-Market Surveillance Study|Active, not recruiting||N/A|160|Actual|Zimmer Biomet||1|||f||||f||||||||||2017-10-10 23:14:11.681001|2017-10-10 23:14:11.681001
NCT02466308|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-01-29|||February 2014||2014-02-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Long Duration Therapeutic Ultrasound for Tendon Healing|Long Duration Therapeutic Ultrasound for Tendon Healing|Completed||N/A|28|Actual|ZetrOZ, Inc.||1|||f||||f||||||||||2017-10-10 23:14:11.769452|2017-10-10 23:14:11.769452
NCT02466295|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-03-11|||June 2015||2015-06-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||The Comparison of the Effect of Pressure-controlled Ventilation and Volume-controlled Ventilation on the Gastric Insufflations in I-gel||Completed||N/A|68|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:14:11.852341|2017-10-10 23:14:11.852341
NCT02466282|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-07-26|||June 2015||2015-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||A Comparison of Optical Coherence Tomography Guidance and Angiography-only Guidance for Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffold|A Randomized Controlled Comparison of Optical Coherence Tomography Guidance and Angiography-only Guidance for Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffold|Completed||N/A|13|Actual|Yonsei University||2|||f||||t||||||||||2017-10-10 23:14:11.916783|2017-10-10 23:14:11.916783
NCT02466269|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-08|||August 2014||2014-08-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Treatment of Diacapitular Condylar Fractures|A Modified Preauricular Approach to Treat Diacapitular Condylar Fractures: The Supratemporalis Approach|Completed||N/A|1|Actual|West China College of Stomatology|||1||f||||t||||||||||2017-10-10 23:14:11.991597|2017-10-10 23:14:11.991597
NCT02466256|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-08|||December 2013||2013-12-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Intra and Postoperative Outcomes With 3 Injectors|Comparison of Intraoperative Performance and Incision Morphology Using Three Injector Devices : Randomized, Clinical Trial|Completed||N/A|120|Actual|Iladevi Cataract and IOL Research Center||3|||f||||t||||||||||2017-10-10 23:14:12.171264|2017-10-10 23:14:12.171264
NCT02466243|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-09-06|||June 2015||2015-06-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis|A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis|Active, not recruiting||Phase 2|22|Anticipated|Corbus Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-10 23:14:12.269254|2017-10-10 23:14:12.269254
NCT02466230|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-02-24|||January 2011||2011-01-01|February 2017|2017-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Antidepressant Mechanisms of Transcranial Magnetic Stimulation|Predictive and Response Biomarkers of Effective Treatment With Transcranial Magnetic Stimulation for Major Depressive Disorder|Completed||N/A|28|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 23:14:12.369086|2017-10-10 23:14:12.369086
NCT02466217|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-12-12|||July 2015||2015-07-01|December 2016|2016-12-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Observational|TRANSIMMUNOM||Phenomics in Autoimmune and Inflammatory Diseases|Clinical and Multi-omics Cross-phenotyping of Patients With Autoimmune and Auto-inflammatory Diseases|Recruiting||N/A|1300|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 23:14:12.460177|2017-10-10 23:14:12.460177
NCT02466204|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-08-21|||June 1, 2015|Actual|2015-06-01|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|August 10, 2016|Actual|2016-08-10||Interventional|||Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients|An Efficacy and Safety Study of Corifollitropin Alfa Versus Daily Follitropin Beta for Controlled Ovarian Stimulation in Women 35-42 Years Old With a Body Weight ≥ 50 kg Undergoing IVF Treatment.|Completed||Phase 4|400|Actual|Vietnam National University||2|||f||||f||||||||||2017-10-10 23:14:12.619179|2017-10-10 23:14:12.619179
NCT02466191|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-05-03|||June 2015||2015-06-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Treatment of Pendular Nystagmus in OPT|Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Oculopalatal Tremor: a Controled Open-label Study|Completed||Phase 4|7|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:14:12.75174|2017-10-10 23:14:12.75174
NCT02466178|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-03-20|||February 2015||2015-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Observational|||Efficacy Trial for the Reduction of Glabellar Lines|Multicenter Efficacy Trial of the Serene RF System for the Reduction of Glabellar Lines|Completed||N/A|78|Actual|Serene Medical Inc|||1||f||||f||||||||||2017-10-10 23:14:12.866974|2017-10-10 23:14:12.866974
NCT02466165|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-06-19|||February 2015||2015-02-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Multiple Sclerosis: Associated Cardiometabolic Risks and Impact of Exercise Therapy|Multiple Sclerosis: Associated Cardiometabolic Risks and Impact of Exercise Therapy|Completed||N/A|80|Actual|Hasselt University||3|||f||||t||||||||||2017-10-10 23:14:12.957397|2017-10-10 23:14:12.957397
NCT02466152|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-05-05|||May 28, 2015|Actual|2015-05-28|May 2017|2017-05-01|October 27, 2015|Actual|2015-10-27|October 27, 2015|Actual|2015-10-27||Interventional|||Pharmacokinetic Study of Topical GSK2894512 Cream|A Pharmacokinetic Study for Systemic Exposure of Twice Daily Topically Applied GSK2894512 Cream in Subjects With Atopic Dermatitis|Completed||Phase 1|11|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:14:13.06137|2017-10-10 23:14:13.06137
NCT02466139|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-04|||April 2012||2012-04-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01|6 Months|Observational [Patient Registry]|CRP-IE||Early Clinical, Laboratory and Microbiological Predictors of Treatment Outcomes in Infective Endocaridtis|Early Clinical, Laboratory and Microbiological Predictors of Treatment Outcomes Among Infective Endocaridtis Patients in a Tertiary-care Centre in Kerala|Completed||N/A|102|Actual|Government Medical College, Kozhikode|||1||f||||t||||||||||2017-10-10 23:14:13.161254|2017-10-10 23:14:13.161254
NCT02466126|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-09-11|||December 1, 2015|Actual|2015-12-01|September 2017|2017-09-01|August 2, 2019|Anticipated|2019-08-02|December 1, 2018|Anticipated|2018-12-01||Interventional|My Brief CBT||Effectiveness and Implementation of Brief Cognitive Behavioral Therapy in CBOCs|Effectiveness and Implementation of Brief Cognitive Behavioral Therapy in CBOCs|Recruiting||N/A|232|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 23:14:13.220963|2017-10-10 23:14:13.220963
NCT02466113|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-06-08|||January 2016||2016-01-01|June 2015|2015-06-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01||Interventional|||A 6 microRNA Tool for Stratifying Stage II Colon Cancer of Receiving Adjuvant Chemotherapy|A Multi-site, Open, Perspective Study of Prognostic Value and Benefit From Chemotherapy of Stage II Colon Cancer Based on a 6 microRNA Stratified Tool|Not yet recruiting||N/A|430|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-10 23:14:13.334031|2017-10-10 23:14:13.334031
NCT02466100|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-10-24|||June 2013||2013-06-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|GoC||Goals of Care Communication|Goals of Care Communication in Advanced Heart Failure|Completed||Phase 1/Phase 2|80|Actual|University of Washington||2|||f||||t||||||||||2017-10-10 23:14:13.42597|2017-10-10 23:14:13.42597
NCT02466074|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-04-07|||May 2016||2016-05-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||The Role of Enhanced Cerebral Perfusion in Lesion Evolution|The Role of Enhanced Cerebral Perfusion in Lesion Evolution|Recruiting||Phase 1/Phase 2|20|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:14:13.563854|2017-10-10 23:14:13.563854
NCT02466061|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-06-01|||July 2014||2014-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors|Transdisciplinary Research on Energetics (TREC) and Cancer Cross Center Study / Obesity and Weight Loss in Endometrial Cancer Survivors: A Randomized, Multi-site Trial (Lifestyle Beyond Cancer Study)|Completed||N/A|207|Actual|Fred Hutchinson Cancer Research Center||3|||f||||f||||||||||2017-10-10 23:14:13.653635|2017-10-10 23:14:13.653635
NCT02466048|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-04|||August 2013||2013-08-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01||Interventional|||Efficacy and Safety of SurgiFill™ on Spinal Fusion|Clinical Trial to Evaluate the Efficacy and Safety of SurgiFill™ on Spinal Fusion -Comparison Between Autograft Mixed With SurgiFill™ and Autograft in Spinal Fusion-|Unknown status|Recruiting|Phase 4|20|Anticipated|Sewon Cellontech Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:14:13.750547|2017-10-10 23:14:13.750547
NCT02466035|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-07-25|||May 2014||2014-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Epigenetic Effects Involved in Children With Cow's Milk Allergy|Epigenetic Effects Involved in Children With Cow's Milk Allergy: A Possible Effect of Atopic March of Lactobacillus GG|Active, not recruiting||N/A|20|Actual|Federico II University||2|||f||||||||||||||2017-10-10 23:14:13.834048|2017-10-10 23:14:13.834048
NCT02466022|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-06-14|||June 2015||2015-06-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Dexmedetomidine for Sedation in Total Knee Replacements|Does Single Dose Dexmedetomidine for Procedural Sedation Reduce Post-operative Pain in Total Knee Arthroplasty? A Randomized Control Study|Completed||Phase 3|54|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-10 23:14:13.90319|2017-10-10 23:14:13.90319
NCT02466009|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-08-22|||March 2015||2015-03-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Regorafenib in Metastatic Colorectal Cancer|Regorafenib in Adults 70 Years or Older With Metastatic Colorectal Cancer: A Phase II Study|Recruiting||Phase 2|60|Anticipated|University of Rochester||1|||f||||t||||||||||2017-10-10 23:14:14.004171|2017-10-10 23:14:14.004171
NCT02465996|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-04|||July 2014||2014-07-01|June 2015|2015-06-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Gastric Barrier Dysfunction of Functional Dyspepsia and Therapeutic Response to Puyuanhewei Detected by Endomicroscopy|Gastric Barrier Dysfunction of Functional Dyspepsia and Therapeutic Response to Puyuanhewei Detected by Endomicroscopy|Unknown status|Recruiting|N/A|200|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 23:14:14.094089|2017-10-10 23:14:14.094089
NCT02465983|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-10-10|||May 2015||2015-05-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer|Pilot Study of Autologous T-cells Redirected to Mesothelin and CD19 With a Chimeric Antigen Receptor in Patients With Metastatic Pancreatic Cancer|Active, not recruiting||Phase 1|12|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:14:14.179681|2017-10-10 23:14:14.179681
NCT02465424|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-11-07|||December 2015||2015-12-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Observational|QaLM||Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients|Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients|Recruiting||N/A|200|Anticipated|Velindre NHS Trust|||1||f||||f||||||||||2017-10-10 23:14:26.281838|2017-10-10 23:14:26.281838
NCT02465970|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-09-09|||November 2015||2015-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|BRAINSTIM||Effects of Transcranial Direct Current Stimulation (TDCS) in Drug-resistant Partial Epilepsy|BRAINSTIM : Effects of Transcranial Direct Current Stimulation (TDCS) in Drug-resistant Partial Epilepsy|Recruiting||Phase 2|12|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-10 23:14:14.250302|2017-10-10 23:14:14.250302
NCT02465957|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-09|||August 2015||2015-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||QUILT-3.009: Study of aNK Infusions in Combination With ALT-803 in Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)|Phase 2 Study of aNK (Activated NK-92 Natural Killer Cells) Infusions in Combination With ALT-803 (IL-15) in Patients With Stage III (IIIB) or Stage IV Merkel Cell Carcinoma (MCC)|Recruiting||Phase 2|24|Anticipated|NantKwest, Inc.||1|||||||f|t|f||||||||2017-10-10 23:14:14.463714|2017-10-10 23:14:14.463714
NCT02465944|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-08-23|||January 2016||2016-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||A Pilot Study of FFP104 in Subjects With Crohn's Disease|A Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of FFP104 in the Treatment of Subjects With Moderate to Severely Active Crohn's Disease|Recruiting||Phase 1/Phase 2|24|Anticipated|Fast Forward Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:14:14.561213|2017-10-10 23:14:14.561213
NCT02465931|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-04-13|||March 14, 2016|Actual|2016-03-14|April 2017|2017-04-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|||Decisional Capacity and Informed Consent in Fragile X Syndrome|Decisional Capacity and Informed Consent in Fragile X Syndrome|Completed||N/A|156|Actual|RTI International||2|||f||||f||||||||No||2017-10-10 23:14:14.647738|2017-10-10 23:14:14.647738
NCT02465918|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-11-05|||July 2015||2015-07-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Cyclization of Motor Cortex Stimulation|The Relationship Between Cyclizing Stimulation and Effective Stimulation During Motor Cortex Stimulation|Completed||N/A|6|Actual|University of British Columbia||4|||f||||f||||||||||2017-10-10 23:14:14.743766|2017-10-10 23:14:14.743766
NCT02465905|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-04-13|||June 2012||2012-06-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|Petit Lait||"Oral Immunotherapy in Cow's Milk Allergy (CMA) in Children : Petit Lait Study"|"Oral Immunotherapy in Cow's Milk Allergy (CMA) in Children : Petit Lait Study"|Completed||N/A|50|Actual|Association Poumon et Enfance||2|||f||||f||||||||||2017-10-10 23:14:14.840584|2017-10-10 23:14:14.840584
NCT02465892|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-29|||May 2015||2015-05-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|Pillars4Life||Pillars4Life Trial|Pillars4Life Randomized Control Trial|Completed||N/A|284|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:14:14.939651|2017-10-10 23:14:14.939651
NCT02465879|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-06-29|||May 2015||2015-05-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|AHRT||Allied Health in Rheumatology Triage Project|Allied Health in Rheumatology Triage Project|Completed||N/A|295|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 23:14:15.043537|2017-10-10 23:14:15.043537
NCT02465866|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-03-30|2016-11-14||November 2014||2014-11-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions|A Single-Dose, Four-Period, Four-Treatment, Four-Way Crossover Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions|Completed||Phase 1|20|Actual|Charleston Laboratories, Inc||4|||f||||||||||||||2017-10-10 23:14:15.147607|2017-10-10 23:14:15.147607
NCT02465853|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-05-21|||January 2015||2015-01-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Hemiplegic Shoulder Pain and Rotator Cuff Injuries|Clinical Outcome in Subacute Stroke Patients With Hemiplegic Shoulder Pain and Rotator Cuff Injuries After Hyaluronic Acid Injection|Recruiting||N/A|50|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||No|no available now|2017-10-10 23:14:16.150787|2017-10-10 23:14:16.150787
NCT02465840|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hand Injury Patients Receiving Different Rehabilitation Programs|The Functional Outcome and Brain Functional MRI of Hand Injury Patients After Different Rehabilitation Programs|Not yet recruiting||N/A|50|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||No|no available now|2017-10-10 23:14:16.263483|2017-10-10 23:14:16.263483
NCT02465827|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-04|||January 2014||2014-01-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Ultrasound-guided Selective Blockade of the Saphenous and Obturator Nerves Following Total Knee Arthroplasty|Selective Blocks for Total Knee Arthroplasty|Completed||Phase 4|75|Actual|Bispebjerg Hospital||3|||f||||t||||||||||2017-10-10 23:14:16.369178|2017-10-10 23:14:16.369178
NCT02465814|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-11-21|||June 2015||2015-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ASTEROID 2||Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids|A Randomized, Parallel-group, Double-blind Placebo-controlled and Open Label Active Controlled, Multi-center Study to Assess the Efficacy and Safety of Vilaprisan in Patients With Uterine Fibroids|Completed||Phase 2|120|Actual|Bayer||7|||f||||f||||||||||2017-10-10 23:14:16.442092|2017-10-10 23:14:16.442092
NCT02465801|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-07-16|||December 16, 2014|Actual|2014-12-16|November 2014|2014-11-01|April 26, 2016|Actual|2016-04-26|December 23, 2015|Actual|2015-12-23||Interventional|||Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein|Efficacy and Safety Phase II Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein for Injection to Prevent Neutrophilic Granulocytopenia Among Chemotherapy Patients|Completed||Phase 2|216|Actual|Tianjin SinoBiotech Ltd.||3|||f||||f||||||||||2017-10-10 23:14:18.461714|2017-10-10 23:14:18.461714
NCT02465788|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-05-23|||May 2014||2014-05-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Combined 755nm Alexandrite Laser With Bipolar RF for Hair Reduction|LASER HAIR REDUCTION BY COMBINED BIPOLAR RF AND 755 nm LASER ENERGIES|Active, not recruiting||N/A|29|Actual|Syneron Medical||1|||f||||f||||||||||2017-10-10 23:14:19.119813|2017-10-10 23:14:19.119813
NCT02465775|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-04-13|||July 2015||2015-07-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Fat Reduction in the Flanks Area vs. Control|Clinical Study to Evaluate the Performance of the UltraShape Device for Fat Reduction Treatment in the Flanks Area vs. Control|Recruiting||N/A|60|Anticipated|Syneron Medical||1|||f||||f||||||||||2017-10-10 23:14:19.202731|2017-10-10 23:14:19.202731
NCT02465762|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-04-13|||August 2015||2015-08-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||UltraShape Device Using the U-Sculpt/VDF Transducer for Flanks Fat|Clinical Study to Evaluate the Safety and Efficacy of the UltraShape Device Using the U-Sculpt/VDF Transducer for Flanks Fat and Circumference Reduction|Suspended||N/A|60|Anticipated|Syneron Medical||1||Study design was amended to include a control - reregistered as NCT02465775|f||||f||||||||||2017-10-10 23:14:19.341366|2017-10-10 23:14:19.341366
NCT02465749|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-06-04|||May 2015||2015-05-01|June 2015|2015-06-01|June 2025|Anticipated|2025-06-01|June 2025|Anticipated|2025-06-01||Interventional|||Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa|Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa|Not yet recruiting||Early Phase 1|404|Anticipated|Sun Yat-sen University||4|||f||||t||||||||||2017-10-10 23:14:19.424493|2017-10-10 23:14:19.424493
NCT02465736|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2017-02-24|||July 2015||2015-07-01|February 2017|2017-02-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|||Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer|A Phase III Clinical Trial of Docetaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma|Recruiting||Phase 3|280|Anticipated|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 23:14:19.660146|2017-10-10 23:14:19.660146
NCT02465723|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-09-20|||June 2015||2015-06-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|||Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers|Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers|Withdrawn||N/A|0|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-10 23:14:19.823986|2017-10-10 23:14:19.823986
NCT02465710|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-12-15|||April 2015||2015-04-01|December 2015|2015-12-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Comparisons of Clinical Outcomes Between Novel Tailored Transvaginal Mesh Surgery and Vaginal Native Tissue Repair Surgery for Pelvic Organ Prolapse|Comparisons of Clinical Outcomes Between Novel Tailored Transvaginal Mesh Surgery and Vaginal Native Tissue Repair Surgery for Pelvic Organ Prolapse|Recruiting||N/A|350|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-10 23:14:19.958964|2017-10-10 23:14:19.958964
NCT02465697|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-17|||September 2011||2011-09-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions|An fMRI Study of the Enhancement of Emotion Regulation in Borderline Patients|Recruiting||N/A|288|Anticipated|Icahn School of Medicine at Mount Sinai||6|||f||||f||||||||||2017-10-10 23:14:20.083868|2017-10-10 23:14:20.083868
NCT02465684|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-07-16|||November 2016||2016-11-01|July 2016|2016-07-01||||January 2022|Anticipated|2022-01-01||Interventional|||Effect of Tourniquet on UKA|The Role of a Thigh Tourniquet in Unicondylar Knee Arthroplasty: a Randomized Controlled Trial|Not yet recruiting||N/A|30|Anticipated|Medical University Innsbruck||2|||f||||||||||||||2017-10-10 23:14:20.23608|2017-10-10 23:14:20.23608
NCT02465671|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-06-04|||August 2010||2010-08-01|June 2015|2015-06-01|February 2013|Actual|2013-02-01|August 2012|Actual|2012-08-01||Observational|||Prognostic Value of Plasma Thrombospondin-1 Levels After Acute Intracerebral Hemorrhage|Prognostic Value of Plasma Thrombospondin-1 Levels After Acute Intracerebral Hemorrhage：A Pilot Study|Completed||N/A|110|Actual|Jinhua People's Hospital|||1||f||||t||||||Samples Without DNA|"     All blood samples from the patients at admission were collected in the separator tubes and     centrifuged within 30 minutes at 1,000*g for 15 minutes. The plasma was removed and frozen at     -70°C until measurement.   "|||2017-10-10 23:14:20.303969|2017-10-10 23:14:20.303969
NCT02465658|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2015-12-15|||March 2015||2015-03-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Risk Factors for Co-existence of Cervical Elongation in Uterine Prolapse|Risk Factors for Co-existence of Cervical Elongation in Uterine Prolapse|Recruiting||N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-10 23:14:20.373607|2017-10-10 23:14:20.373607
NCT02465645|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-03-06|||June 2015||2015-06-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.|A Prospective Randomized Study to Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices|Recruiting||N/A|220|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:14:20.47992|2017-10-10 23:14:20.47992
NCT02465632|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-05-26|2017-04-18||April 2015||2015-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional||A total of 1100 subjects were randomized in the study; of these 27 subjects did not received the dose (Test=8, Reference=10, Placebo=9) and were excluded from the safety population randomized. Therefore the overall number of subjects in the Baseline Participants module is not consistent with any of the rows of the Participant Flow module.|To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) to the Marketed Product BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5% (Valeant Pharmaceuticals, US) in the Treatment of Acne Vulgaris.|Completed||Phase 3|1100|Actual|Glenmark Pharmaceuticals Ltd. India||3|||f||||f||||||||||2017-10-10 23:14:20.579439|2017-10-10 23:14:20.579439
NCT02465619|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-01-01|||June 2015||2015-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.|To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.|Recruiting||N/A|100|Anticipated|Institute of Liver and Biliary Sciences, India|||4||f||||f||||||||||2017-10-10 23:14:20.854976|2017-10-10 23:14:20.854976
NCT02465606|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-11-01|||July 2015||2015-07-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis|AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF LEBRIKIZUMAB COMPARED TO TOPICAL CORTICOSTEROIDS IN ADULT PATIENTS WITH PERSISTENT, MODERATE TO SEVERE ATOPIC DERMATITIS|Completed||Phase 2|55|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:14:20.946157|2017-10-10 23:14:20.946157
NCT02465593|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-10-16|||June 2015||2015-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer|A Phase Ib/II Study of PEP503 (Radioenhancer) With Radiotherapy, in Combination With Concurrent Chemotherapy for Patients With Locally Advanced or Unresectable Rectal Cancer|Recruiting||Phase 1/Phase 2|42|Anticipated|PharmaEngine||1|||f||||t||||||||||2017-10-10 23:14:21.06612|2017-10-10 23:14:21.06612
NCT02465580|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-04|||June 2015||2015-06-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus|A Phase II Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus|Recruiting||Phase 2|60|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-10 23:14:21.203904|2017-10-10 23:14:21.203904
NCT02465554|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-16|||September 2015||2015-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Imaging and Omics for Cardiovascular Risk During NASA Deep Space Missions||Enrolling by invitation||N/A|60|Anticipated|Oregon Health and Science University|||2||f||||t||||||||||2017-10-10 23:14:23.064775|2017-10-10 23:14:23.064775
NCT02465541|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-09-28|||July 2013||2013-07-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors|Lifestyle Interventions to Improve Physical Function and Quality of Life in Endometrial Cancer Survivors: The Role of a Gentle Yoga Based Exercise Program|Recruiting||N/A|40|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 23:14:23.153993|2017-10-10 23:14:23.153993
NCT02465528|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-05-03|||May 6, 2016|Actual|2016-05-06|May 2017|2017-05-01|March 11, 2019|Anticipated|2019-03-11|March 11, 2019|Anticipated|2019-03-11||Interventional|||Ceritinib Rare Indications Study in ALK+ Tumors|A Phase II, Open Label, Multi-center, Multi-arm Study of Ceritinib in Patients With Advanced Solid Tumors and Hematological Malignancies Characterized by Genetic Abnormalities of Anaplastic Lymphoma Kinase (ALK)|Recruiting||Phase 2|106|Anticipated|Novartis||1|||f||||f|f|f||||||No||2017-10-10 23:14:23.260741|2017-10-10 23:14:23.260741
NCT02465502|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-09-12|||July 21, 2015|Actual|2015-07-21|September 2017|2017-09-01|November 10, 2017|Anticipated|2017-11-10|May 2, 2017|Actual|2017-05-02||Interventional|||Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer|An Uncontrolled, Open-label Phase IIb Trial of Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer|Active, not recruiting||Phase 2|59|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 23:14:25.207126|2017-10-10 23:14:25.207126
NCT02465489|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-01-27|2015-12-18||June 2015||2015-06-01|June 2015|2015-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers|Single-dose Pharmacokinetic Study of Deferiprone Extended Release Tablets Versus Ferriprox Immediate Release Tablets Under Fasting and Fed Conditions in Healthy Volunteers|Completed||Phase 1|20|Actual|ApoPharma||5|||f||||f||||||||||2017-10-10 23:14:25.302478|2017-10-10 23:14:25.302478
NCT02465476|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-07-26|||January 2015||2015-01-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|Telemalrares||Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine|Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine|Recruiting||N/A|200|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:14:25.770076|2017-10-10 23:14:25.770076
NCT02465463|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-01-05|||June 2015||2015-06-01|August 2016|2016-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Early FMT for C.Difficile|A Pilot Study Examining the Safety and Efficacy of Early Fecal Transplant in Patients Infected With Clostridium Difficile at High Risk of Relapse|Completed||Phase 1/Phase 2|12|Actual|Emory University||2|||f||||t||||||||||2017-10-10 23:14:25.854325|2017-10-10 23:14:25.854325
NCT02465450|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-09-06|||September 29, 2015|Actual|2015-09-29|September 2017|2017-09-01|December 28, 2016|Actual|2016-12-28|December 28, 2016|Actual|2016-12-28||Interventional|||Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 in Cystic Fibrosis|A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 in Cystic Fibrosis|Completed||Phase 2|70|Actual|Corbus Pharmaceuticals Inc.||7|||f||||t||||||||||2017-10-10 23:14:25.926581|2017-10-10 23:14:25.926581
NCT02465437|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2016-10-17|||August 2015||2015-08-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis|A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Diffuse Cutaneous Systemic Sclerosis|Active, not recruiting||Phase 2|42|Actual|Corbus Pharmaceuticals Inc.||5|||f||||f||||||||||2017-10-10 23:14:26.176191|2017-10-10 23:14:26.176191
NCT02465411|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-11-14|||June 2015||2015-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections|Long-term Effects of Continuous Glucose Monitoring in Patients With Type 1 Diabetes Treated With Multiple Daily Insulin Injections - Extension of CGMMDI Trial|Active, not recruiting||N/A|130|Anticipated|Vastra Gotaland Region||1|||f||||f||||||||||2017-10-10 23:14:26.383134|2017-10-10 23:14:26.383134
NCT02465398|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-04|2017-08-28|||August 2006||2006-08-01|August 2017|2017-08-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Anatomical Shoulder™ Fracture PMCF Study|Anatomical Shoulder™ Fracture Post-Market Surveillance Study|Active, not recruiting||N/A|52|Actual|Zimmer Biomet||1|||f||||f||||||||||2017-10-10 23:14:26.50203|2017-10-10 23:14:26.50203
NCT02465385|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-07-13|||February 2015||2015-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Single-dose Linaclotide for Capsule Endoscopy Preparation|Single-dose Linaclotide for Capsule Endoscopy Preparation|Completed||Phase 4|30|Actual|University of Virginia||1|||f||||f||||||||||2017-10-10 23:14:26.578906|2017-10-10 23:14:26.578906
NCT02465372|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-02-01|||August 2014||2014-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|BAC!||Be a Champion! Comprehensive School Physical Activity Program|Utilizing Physical Activity Coordinators to Increase Physical Activity Among Youth|Enrolling by invitation||N/A|350|Anticipated|University of South Carolina||2|||f||||f||||||||||2017-10-10 23:14:26.650418|2017-10-10 23:14:26.650418
NCT02465359|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-03-23|||September 2014||2014-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SCIG||Subcutaneous Immunoglobulin for CIDP|A Study of Subcutaneous Immunoglobulin as Chronic Treatment for Patients With Chronic Inflammatory Demyelinating Polyneuropathy|Recruiting||N/A|15|Anticipated|University of South Florida||1|||f||||f||||||||||2017-10-10 23:14:26.722635|2017-10-10 23:14:26.722635
NCT02465346|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||"Mobile Stroke Unit-Concept for Delivery of Specialized Acute Stroke Care to Patients in Remote Areas"|"Mobile Stroke Unit-Concept for Delivery of Specialized Acute Stroke Care to Patients in Remote Areas"|Recruiting||N/A|250|Anticipated|University Hospital, Saarland||2|||f||||t||||||||||2017-10-10 23:14:26.802|2017-10-10 23:14:26.802
NCT02465333|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-04-25|||May 2015||2015-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Fat Grafting and Retention for Heel Fat Pad Atrophy|Fat Grafting and Retention for Heel Fat Pad Atrophy|Recruiting||N/A|20|Anticipated|University of Pittsburgh||2|||f||||f||||||||No||2017-10-10 23:14:27.006725|2017-10-10 23:14:27.006725
NCT02465320|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-07-12|||May 2015||2015-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy|A Muticenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single-Dose of COL-1077 in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy|Completed||Phase 2|187|Actual|Juniper Pharmaceuticals, Inc.||2|||f||||t||||||||Undecided||2017-10-10 23:14:27.131872|2017-10-10 23:14:27.131872
NCT02465307|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-06-01|||February 2016||2016-02-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|ICU_Delirium||Motion Analysis of Delirium in the ICU|Motion Analysis of Delirium in Intensive Care Units|Recruiting||N/A|60|Anticipated|University of Florida|||2||f||||f|f|f||||||No||2017-10-10 23:14:27.277902|2017-10-10 23:14:27.277902
NCT02465294|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-02-08|||February 2016||2016-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|WLP||The Influence of Probiotics on Body Weight and Composition|The Influence of Probiotics With a Behavioral Life Style Intervention on Body Weight and Composition in Overweight Participants: A Randomized, Double-blinded, Placebo-controlled Study.|Withdrawn||N/A|0|Actual|University of Florida||3||study withdrawn due to funding|f||||f||||||||No||2017-10-10 23:14:27.387604|2017-10-10 23:14:27.387604
NCT02465281|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-08-02|||October 2015||2015-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Correlation Analysis Between Brain Lesions and Sensorimotor Impairments in Individuals With Stroke (Preliminary Study)|Correlation Analysis Between Brain Lesions and Sensorimotor Impairments in Individuals With Stroke (Preliminary Study)|Recruiting||N/A|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-10 23:14:27.48008|2017-10-10 23:14:27.48008
NCT02465268|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-28|||August 2016||2016-08-01|September 2017|2017-09-01|June 2024|Anticipated|2024-06-01|June 2023|Anticipated|2023-06-01||Interventional|ATTAC-II||Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme|A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells With Tetanus-Diphtheria Toxoid Vaccine in Patients With Newly-Diagnosed Glioblastoma|Recruiting||Phase 2|150|Anticipated|University of Florida||3|||f||||t|t|f||||||||2017-10-10 23:14:27.545254|2017-10-10 23:14:27.545254
NCT02465255|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-08-17|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Sublingual Analgesia for Acute Abdominal Pain in Children|Sublingual Analgesia for Acute Abdominal Pain in Children. Ketorolac Versus Tramadol Versus Paracetamol, a Randomized, Control Trial|Completed||Phase 3|210|Actual|IRCCS Burlo Garofolo||3|||f||||f||||||||||2017-10-10 23:14:27.652121|2017-10-10 23:14:27.652121
NCT02465242|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-09-27|||September 2014||2014-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Pupillometry for the Prediction of Neurologic Outcomes in Severe Traumatic Brain Injury|Pupillometry for the Prediction of Neurologic Outcomes in Severe Traumatic Brain Injury|Recruiting||N/A|74|Anticipated|Our Lady of the Lake Regional Medical Center|||2||f||||f||||||||||2017-10-10 23:14:27.750339|2017-10-10 23:14:27.750339
NCT02465229|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2015-12-17|||December 2015||2015-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparison of Diagnostic Accuracy Before or After Stricture Dilation in Biliary Stricture|Comparison of Stricture Dilation Before or After Multimodal Tissue-sampling for the Diagnosis of Malignant Biliary Stricture: a Prospective Study|Not yet recruiting||N/A|60|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-10 23:14:27.829485|2017-10-10 23:14:27.829485
NCT02399163|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-04-07|2016-04-04||April 2015||2015-04-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Oral Hygiene Products in an In Situ Caries Model|Clinical Evaluation of Oral Hygiene Products in an In Situ Caries Model|Completed||N/A|80|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-10 23:27:15.658208|2017-10-10 23:27:15.658208
NCT02465216|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-02-28|||June 2015||2015-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion|A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety and Immunogenicity of the ID93 + GLA-SE Vaccine in HIV Uninfected Adult TB Patients After Treatment Completion|Completed||Phase 2|60|Actual|IDRI||4|||f||||t||||||||||2017-10-10 23:14:27.89185|2017-10-10 23:14:27.89185
NCT02465190|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-06-03|||June 2015||2015-06-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01|1 Day|Observational [Patient Registry]|||Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South Africa|Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South Africa|Not yet recruiting||N/A|175|Anticipated|National Institute for Communicable Diseases, South Africa|||1||f||||f||||||Samples With DNA|"     Nasopharyngeal swabs and aspirates   "|||2017-10-10 23:14:28.35825|2017-10-10 23:14:28.35825
NCT02465177|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-12-05|||July 2014||2014-07-01|August 2016|2016-08-01||||November 2017|Anticipated|2017-11-01||Observational|||Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors||Recruiting||N/A|28|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 23:14:28.441642|2017-10-10 23:14:28.441642
NCT02465164|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-02-17|||July 2015||2015-07-01|February 2016|2016-02-01||||July 2016|Anticipated|2016-07-01||Interventional|||Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin||Not yet recruiting||N/A|100|Anticipated|Henry Ford Health System||2|||f||||||||||||||2017-10-10 23:14:28.515269|2017-10-10 23:14:28.515269
NCT02465151|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-12-07|||April 2015||2015-04-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Assessment of the Optimal Amount of Proteins at Breakfast for Children|Assessment of the Optimal Amount of Proteins at Breakfast for Children|Completed||N/A|32|Actual|Nestlé||4|||f||||f||||||||No||2017-10-10 23:14:28.590732|2017-10-10 23:14:28.590732
NCT02465138|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-01-19|||April 2016||2016-04-01|January 2016|2016-01-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis|A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis|Not yet recruiting||Phase 4|450|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:14:28.676219|2017-10-10 23:14:28.676219
NCT02465125|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-07-22|||July 15, 2015|Actual|2015-07-15|July 2017|2017-07-01|January 9, 2017|Actual|2017-01-09|December 8, 2016|Actual|2016-12-08||Interventional|TV||The Transfusion Triggers in Vascular Surgery Trial|The Transfusion Triggers in Vascular Surgery Trial: Two Different Transfusion Triggers for Postoperative Haemoglobin Separation and Adherence to Transfusion Strategies in Vascular Surgery: a Randomised Clinical Feasibility Trial|Completed||Phase 2|58|Actual|Naestved Hospital||2|||f||||t||||||||||2017-10-10 23:14:28.802163|2017-10-10 23:14:28.802163
NCT02465112|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-09-13|||September 2015||2015-09-01|September 2016|2016-09-01|December 2023|Anticipated|2023-12-01|September 2018|Anticipated|2018-09-01||Interventional|TERAVECT||Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor|A Randomized Phase III of Adjuvant Targeted Radionuclide Therapy With In111-Pentetreotide in Patients With Digestive Neuroendocrine Tumors After Complete Surgical Resection of Liver Metastases.|Recruiting||Phase 3|126|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2|||f||||t||||||||||2017-10-10 23:14:28.896413|2017-10-10 23:14:28.896413
NCT02465086|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-04-04|||September 2015||2015-09-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Reasoning Skills in Theory of Mind and Linguistic Tests in the Autistic Population|Reasoning Skills in Theory of Mind and Linguistic Tests in the Autistic Population|Enrolling by invitation||N/A|60|Anticipated|Roskilde University||2|||f||||f||||||||No||2017-10-10 23:14:29.111055|2017-10-10 23:14:29.111055
NCT02465073|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-08-10|2015-12-11||July 2013||2013-07-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Clinical Efficacy of Next Science Wound Gel (NXTSC) in the Healing of Chronic Wounds|The Clinical Efficacy of Next Science Wound Gel (NXTSC) in the Healing of Chronic Wounds|Completed||N/A|49|Actual|Southwest Regional Wound Care Center||3|||f||||f||||||||||2017-10-10 23:14:29.197739|2017-10-10 23:14:29.197739
NCT02465047|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-05-13|||November 2014||2014-11-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Stress and Seizures - Can a Brief Self-help Book Help?|Stress and Seizures - Can a Brief Self-help Book Help?|Completed||N/A|82|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:14:36.044027|2017-10-10 23:14:36.044027
NCT02465034|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-01-17|||May 2015||2015-05-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke|Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke|Recruiting||N/A|75|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 23:14:36.108393|2017-10-10 23:14:36.108393
NCT02465021|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-25|||March 2015||2015-03-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Innovation of Breakfast Cereals and Snacks for Control of Appetite and Post-Prandial Glycemia|Innovation of Breakfast Cereals and Snacks for Control of Appetite and Post-Prandial Glycemia|Completed||N/A|30|Actual|University of Toronto||6|||f||||f||||||||||2017-10-10 23:14:36.209083|2017-10-10 23:14:36.209083
NCT02465008|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-07-19||||||July 2016|2016-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Analgesic Effect of Levobupivacaine in Breast Augmentation|Analgesic Efficacy of Levobupivacaine Administration in Periprosthetic Breast Augmentation With Implants|Suspended||Phase 4|66|Anticipated|Valencia University General Hospital||2||Not recruiting|f||||f||||||||||2017-10-10 23:14:36.284644|2017-10-10 23:14:36.284644
NCT02464995|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-08-07|||June 9, 2015|Actual|2015-06-09|August 2017|2017-08-01|November 9, 2020|Anticipated|2020-11-09|November 9, 2020|Anticipated|2020-11-09||Interventional|THERMASCORT||Bronchial Thermoplasty in Severe Asthma With Frequent Exacerbations|Bronchial Thermoplasty in Severe Asthma With Frequent Exacerbations|Recruiting||N/A|34|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:14:38.111415|2017-10-10 23:14:38.111415
NCT02464982|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-04-12|||February 2012||2012-02-01|April 2016|2016-04-01||||May 2015|Actual|2015-05-01||Observational|||Psycho-esthetic Impact of Tattoo Technology as Part of Mammary Reconstruction After Surgery Against Breast Cancer|Areola Tattoo: the End of a Long Therapeutic Process. A Patient's Quality of Life Dedicated Technology|Completed||N/A|107|Actual|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:14:38.207076|2017-10-10 23:14:38.207076
NCT02464969|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-10-01|||November 22, 2015|Actual|2015-11-22|October 2017|2017-10-01|December 6, 2018|Anticipated|2018-12-06|December 6, 2018|Anticipated|2018-12-06||Interventional|||Apixaban for the Acute Treatment of Venous Thromboembolism in Children|A Randomized, Open-label, Active Controlled, Safety And Extrapolated Efficacy Study In Pediatric Subjects Requiring Anticoagulation For The Treatment Of A Venous Thromboembolic Event|Recruiting||Phase 4|150|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 23:14:38.300581|2017-10-10 23:14:38.300581
NCT02464956|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-06-03|||July 2015||2015-07-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Production of iPSC Derived RPE Cells for Transplantation in AMD|Feasibility of Production of Induced Pluripotent Stem Cell Derived Retinal Pigment Epithelial Cells Fulfilling Regulatory Requirements for Human Transplantation in Dry Age-related Macular Degeneration|Unknown status|Not yet recruiting|N/A|10|Anticipated|Moorfields Eye Hospital NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Peripheral blood sample and a skin sample will be collected from the study participants   "|||2017-10-10 23:14:38.506291|2017-10-10 23:14:38.506291
NCT02464943|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-02-27|||April 2015||2015-04-01|February 2017|2017-02-01|August 2023|Anticipated|2023-08-01|July 2023|Anticipated|2023-07-01||Expanded Access|||Zenith® Dissection Endovascular System in the Treatment of Patients With Aortic Dissections|Zenith® Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissections|Available||N/A|||Cook Group Incorporated|||||||||||||||||||2017-10-10 23:14:38.559699|2017-10-10 23:14:38.559699
NCT02464930|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-04|||April 2015||2015-04-01|June 2015|2015-06-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Observational|||Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia|Evaluation of MicroRNA Expression in Blood and Cytology Specimens as a Novel Method for Detecting Barrett's Esophagus|Recruiting||N/A|220|Anticipated|Midwest Biomedical Research Foundation|||3||f||||f||||||Samples With DNA|"     blood, bile and tissue in a repository   "|||2017-10-10 23:14:38.635871|2017-10-10 23:14:38.635871
NCT02464917|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-04|||June 2015||2015-06-01|June 2015|2015-06-01||||November 2015|Anticipated|2015-11-01||Interventional|SOS||Supplemental Oxygen Study|Supplemental Oxygen Study|Unknown status|Recruiting|N/A|70|Anticipated|MemorialCare Health System||2|||f||||t||||||||||2017-10-10 23:14:38.843519|2017-10-10 23:14:38.843519
NCT02464904|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-12-20|||July 2015||2015-07-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Intrapleural Cryotherapy for Malignant Pleural Mesothelioma|Pilot Study Evaluating the Effects of Intrapleural Cryotherapy on Tumor Infiltrating Lymphocytes in Malignant Pleural Mesothelioma Using Cryospray Therapy|Recruiting||N/A|15|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-10 23:14:38.951296|2017-10-10 23:14:38.951296
NCT02464891|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-03-13|||June 4, 2015|Actual|2015-06-04|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|February 24, 2017|Actual|2017-02-24||Interventional|ACCESS||Complement Inhibition in aHUS Dialysis Patients|An Open-label Phase 2 Study to Assess the Effect of C5aR Antagonist Therapy by CCX168 Oral Administration on ex Vivo Thrombus Formation and Disease Activity in ESRD Patients With Atypical Hemolytic Uremic Syndrome|Terminated||Phase 2|6|Actual|Mario Negri Institute for Pharmacological Research||1||The study had accomplished its goal with the 6 patients who have been enrolled.|f||||f||||||||||2017-10-10 23:14:39.072699|2017-10-10 23:14:39.072699
NCT02464878|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-04-19|||January 2017||2017-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant||Recruiting||Phase 2|20|Anticipated|Massachusetts General Hospital||1|||f||||t|t|||||||||2017-10-10 23:14:39.176314|2017-10-10 23:14:39.176314
NCT02464865|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-03-26|||August 2015||2015-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Thiamin Deficiency in Obese Thai Children|Thiamin Deficiency in Obese Thai Children|Recruiting||Phase 4|124|Anticipated|Mahidol University||3|||f||||t||||||||||2017-10-10 23:14:39.29099|2017-10-10 23:14:39.29099
NCT02464852|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-10-13|||April 2015||2015-04-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Assessment of the Effects of Sheffield Support Snood in MND Patients|Assessment of the Effects of Sheffield Support Snood in MND Patients|Completed||N/A|15|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:14:39.388314|2017-10-10 23:14:39.388314
NCT02464839|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-09-08|||July 2015||2015-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Prevalence and Clinical Characteristics of the Fungal Nail and Feet Infection in Patients With Hallux Valgus|Prevalence and Clinical Characteristics of the Fungal Nail and Feet Infection in Patients With Hallux Valgus|Completed||N/A|81|Actual|Mahidol University|||1||f||||f||||||||||2017-10-10 23:14:39.458694|2017-10-10 23:14:39.458694
NCT02464826|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-06-16|||July 2015||2015-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment|A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment|Completed||Phase 4|19|Actual|Mahidol University||1|||f||||f||||||||||2017-10-10 23:14:39.51861|2017-10-10 23:14:39.51861
NCT02464813|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-02-16|||August 1, 2015|Actual|2015-08-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Pregabalin on Immediate Post-operative and Longterm Pain|Effect of Pregabalin on Immediate Post-operative and Longterm Pain and Spinal Cord Monitoring in Children Undergoing Instrumented Spinal Surgery.|Recruiting||Phase 4|60|Anticipated|Turku University Hospital||2|||f||||t||||||||||2017-10-10 23:14:39.585704|2017-10-10 23:14:39.585704
NCT02464800|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-03|||April 2007||2007-04-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Observational|||Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy|Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy|Completed||N/A|326|Actual|Kyorin University|||2||f||||f||||||||||2017-10-10 23:14:39.666694|2017-10-10 23:14:39.666694
NCT02464774|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-03|||July 2015||2015-07-01|June 2015|2015-06-01||||December 2022|Anticipated|2022-12-01||Interventional|||Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer|Impact of Breast-Conserving Therapy (BCT) on Recurrence in Patients With Triple-Negative Breast Cancer (TNBC) Compared With Mastectomy|Not yet recruiting||N/A|464|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:14:39.801302|2017-10-10 23:14:39.801302
NCT02464761|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-06-15|||June 2011||2011-06-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Photodynamic Therapy for the Treatment of Vertebral Metastases|Photodynamic Therapy (PDT) for the Treatment of Vertebral Metastases: A Prospective Phase I Clinical Trial|Recruiting||Phase 1|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||No||2017-10-10 23:14:39.868858|2017-10-10 23:14:39.868858
NCT02464748|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-04-26|||September 2014||2014-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|TiM||Telehealth in Motor Neurone Disease|Telehealth in Motor Neurone Disease: A Single Centre, Randomised Controlled Feasibility and Pilot Study of the Use of the TiM Telehealth System to Deliver Highly Specialised Care in Motor Neurone Disease at a Distance|Completed||N/A|77|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:14:39.948316|2017-10-10 23:14:39.948316
NCT02464735|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-03-02|||January 1, 2016|Actual|2016-01-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|SLEEWE||Effect of Sleep Disruption on the Outcome of Weaning From Mechanical Ventilation|Effect of Sleep Disruption on the Outcome of Weaning From Mechanical Ventilation|Recruiting||N/A|42|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-10 23:14:40.014484|2017-10-10 23:14:40.014484
NCT02464722|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-07-23|||August 2015||2015-08-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|November 2015|Anticipated|2015-11-01||Interventional|||Comparision Between Hemodynamic Response of Dexmedetomidine and Remifentanil on Anesthesia in Endoscopic Sinus Surgery|Comparision Between Hemodynamic Response of Dexmedetomidine and Remifentanil for Epinephrine Local Injection in Patient With Endoscopic Sinus Surgery Under General Anesthesia|Unknown status|Enrolling by invitation|Phase 4|50|Anticipated|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-10 23:14:40.148397|2017-10-10 23:14:40.148397
NCT02464709|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-04-02|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)|Daylight Mediated Photodynamic Therapy for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)|Active, not recruiting||Phase 4|72|Actual|Joint Authority for Päijät-Häme Social and Health Care||1|||f||||f||||||||||2017-10-10 23:14:40.426316|2017-10-10 23:14:40.426316
NCT02464696|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-12-27|||October 2015||2015-10-01|December 2016|2016-12-01||||October 2019|Anticipated|2019-10-01||Interventional|||Early Non Invasive Ventilation and Hematological Malignancies|Early Non-Invasive Ventilation in Patients With Hypoxemic Respiratory Failure and Hematological Malignancies: A Prospective Randomized Controlled Trial|Recruiting||N/A|366|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 23:14:40.604128|2017-10-10 23:14:40.604128
NCT02464683|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-06-03|||April 2014||2014-04-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|VitaminD||Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis|Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis in the National Institute of Respiratory Diseases|Unknown status|Recruiting|Phase 4|60|Anticipated|Instituto Nacional de Enfermedades Respiratorias||2|||f||||t||||||||||2017-10-10 23:14:40.751243|2017-10-10 23:14:40.751243
NCT02464670|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-08-29|||May 2015||2015-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers|Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Immunogenicity of INO-4212 and Its Components, INO-4201 and INO-4202, Given With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers|Active, not recruiting||Phase 1|240|Actual|Inovio Pharmaceuticals||13|||f||||f||||||||||2017-10-10 23:14:40.87149|2017-10-10 23:14:40.87149
NCT02464657|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-14|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)|Phase I/II Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)|Recruiting||Phase 1/Phase 2|75|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:14:40.9995|2017-10-10 23:14:40.9995
NCT02464644|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-06-03|||April 2012||2012-04-01|October 2012|2012-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Frequency of Common Medical Conditions in People With and Without HHT|A Questionnaire Study on Hereditary Hemorrhagic Telangiectasia (HHT) and Other Medical Conditions, Compared to the General Population|Completed||N/A|2174|Actual|Imperial College London||2|||f||||f||||||||||2017-10-10 23:14:41.139057|2017-10-10 23:14:41.139057
NCT02464631|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-01-18|||June 2015||2015-06-01|January 2016|2016-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis|"To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis - A Randomized Open- Label Study"|Terminated||N/A|62|Actual|Institute of Liver and Biliary Sciences, India||3||"In view of recent approval of NS5A inhibitors for treatment of hepatitis C such as Declatasvir   and Ledipasvir which have proven better efficacy in the HCV cure"|f||||f||||||||||2017-10-10 23:14:41.238776|2017-10-10 23:14:41.238776
NCT02464618|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-03|||May 2014||2014-05-01|June 2015|2015-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Using Patients' Social Contact to Improve Out-Patient Endoscopy Among Blacks|Improving Attendance to Outpatient Endoscopy Among Blacks|Recruiting||N/A|1000|Anticipated|Howard University||2|||f||||f||||||||||2017-10-10 23:14:41.345458|2017-10-10 23:14:41.345458
NCT02464605|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-10-19|||May 2015||2015-05-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels|An Open-Label, Sequential, Ascending Single-Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of an Intravenous Infusion of SEL-037 in Subjects With Elevated Blood Uric Acid Levels|Completed||Phase 1|22|Actual|Selecta Biosciences, Inc.||1|||f||||f||||||||||2017-10-10 23:14:41.445137|2017-10-10 23:14:41.445137
NCT02464592|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-09-27|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study|Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study|Completed||N/A|120|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-10 23:14:41.539206|2017-10-10 23:14:41.539206
NCT02464579|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-03|||May 2015||2015-05-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|BFRUHC||Breastfeeding Rates at the Department of Neonatology of University Hospital Cologne|Prospective Inquiry of Breastfeeding Success at the Department of Neonatology of University Hospital of Cologne and Analysis of Influencing Factors|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital of Cologne|||1||f||||f||||||||||2017-10-10 23:14:41.635598|2017-10-10 23:14:41.635598
NCT02464566|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-03|||January 2015||2015-01-01|June 2015|2015-06-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||12 Weeks Intensive Lifestyle Intervention Program in Primary Care Obesity Clinic for Obese Adults: Jeddah 2015|12 Weeks Intensive Lifestyle Intervention Program in Primary Care Obesity Clinic for Obese Adults: Randomized Control Trial, Jeddah 2015|Unknown status|Active, not recruiting|N/A|140|Actual|Saudi Commission for Health Specialties, Saudi Arabia||2|||f||||f||||||||||2017-10-10 23:14:41.705556|2017-10-10 23:14:41.705556
NCT02464553|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-08-17|||May 2015||2015-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|EPCSI||EuroPainClinics® Study I (Prospective Trial)|EuroPainClinics® Study I (Prospective Randomized Double Blinded Trial)|Recruiting||N/A|300|Anticipated|Europainclinics z.ú.||2|||f||||t||||||||||2017-10-10 23:14:41.782253|2017-10-10 23:14:41.782253
NCT02464540|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-02-17|||March 2015||2015-03-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Optical Properties of Light Cured Luting Agent on Laminate Veneer|Randomized Clinical Trial of Light Cured Luting Agents on Laminate Veneers|Recruiting||N/A|20|Anticipated|Federal University of Pelotas||2|||f||||t||||||||||2017-10-10 23:14:41.897665|2017-10-10 23:14:41.897665
NCT02464527|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-07-13|||June 2014||2014-06-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Stimulus-Stimulus Pairing Study|A Pilot Feasibility Study to Increase Vocal Language in Minimally Verbal Children Diagnosed With Autism Spectrum Disorders|Completed||N/A|16|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:14:41.978853|2017-10-10 23:14:41.978853
NCT02464514|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-08-06|||January 2004||2004-01-01|June 2015|2015-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Macronutrient Regulation of Ghrelin and Peptide YY|Investigation of the Developmental, Nutritional and Hormonal Regulation of Ghrelin in Children With Prader-Willi Syndrome (PWS) and Children With Hypothalamic-Derived Obesity: Macronutrient Regulation Sub-study|Completed||N/A|28|Actual|Duke University||2|||f||||t||||||||||2017-10-10 23:14:42.073931|2017-10-10 23:14:42.073931
NCT02464501|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-06-07|||May 20, 2015|Actual|2015-05-20|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|COPPER-A||The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee|The COPPER-A Trial: The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee|Recruiting||N/A|120|Anticipated|Horizons International Peripheral Group||1|||f||||t|f|t|f||t|||No||2017-10-10 23:14:42.174241|2017-10-10 23:14:42.174241
NCT02464488|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-03-06|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|ADAGE||New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study|Study of Interindividual Variability in the Response to New Oral Direct Anticoagulants (Dabigatran Etexilate, Rivaroxaban or Apixaban) in Patients 80 Years Old and Over, Using a Population Pharmacokinetics Approach.|Recruiting||N/A|225|Anticipated|Hôpital Charles Foix|||1||f||||f||||||Samples With DNA|"     Blood   "|No||2017-10-10 23:14:42.328092|2017-10-10 23:14:42.328092
NCT02464475|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-01-26|||June 2015||2015-06-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of OMT on Interoception|Effects of Osteopathic Manual Treatment on Interoception: 2- Armed RCT on cLBP Patients|Recruiting||N/A|40|Anticipated|Come Collaboration||2|||f||||t||||||||||2017-10-10 23:14:42.41695|2017-10-10 23:14:42.41695
NCT02397811|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-08-05|||June 2015||2015-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Astaxanthin Formulation Bioavailability|Bioavailability Testing of Astaxanthin Formulations|Completed||N/A|12|Actual|Cyanotech Corporation||6|||f||||f||||||||||2017-10-10 23:27:30.532158|2017-10-10 23:27:30.532158
NCT02464462|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-04|||May 2010||2010-05-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM Severity|The Role of Vitamin D and Calcium Supplementation in the Pathogenesis of Type 2 Diabetes Mellitus|Completed||Phase 1|11|Actual|York University||2|||f||||||||||||||2017-10-10 23:14:42.496035|2017-10-10 23:14:42.496035
NCT02464449|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-09-13|||July 24, 2017|Actual|2017-07-24|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|March 31, 2019|Anticipated|2019-03-31||Interventional|REACT (AI CBT)||Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools|Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools|Recruiting||N/A|276|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 23:14:42.571456|2017-10-10 23:14:42.571456
NCT02464436|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-04-23|||December 2015||2015-12-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|hRPCRP||Safety and Tolerability of hRPC in Retinitis Pigmentosa|First-in-human Phase I/IIa, Open-Label, Prospective Study of the Safety and Tolerability of Subretinally Transplanted Human Retinal Progenitor Cells (hRPC) in Patients With Retinitis Pigmentosa (RP)|Recruiting||Phase 1/Phase 2|15|Anticipated|ReNeuron Limited||1|||f||||t||||||||||2017-10-10 23:14:42.670291|2017-10-10 23:14:42.670291
NCT02464423|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-08-15|||January 2013||2013-01-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model|Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model|Recruiting||N/A|700|Anticipated|Hektoen Institute for Medical Research||2|||f||||t||||||||||2017-10-10 23:14:42.761312|2017-10-10 23:14:42.761312
NCT02464410|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-29|||August 4, 2016|Actual|2016-08-04|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|December 31, 2018|Anticipated|2018-12-31||Interventional|POST||Primary Care Intervention to Reduce Prescription Opioid Overdoses|Primary Care Intervention to Reduce Prescription Opioid Overdoses|Recruiting||N/A|450|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:14:42.845103|2017-10-10 23:14:42.845103
NCT02464397|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-03|||February 2015||2015-02-01|June 2015|2015-06-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|OPTIMAX-OCT||Comparison of Strut Coverage With OPTIMAX Versus SYNERGY Stents|A Randomized Prospective Multicenter Trial to Examine Vascular Healing at 1 and 6 Month(s) After Deployment of TItanium-nitride-oxide-coated OPTIMAX™ Bio-active-stent (BAS) Stent and SYNERGY™ Everolimus-Eluting Stent (EES) in Patients With Acute Coronary Syndromes by Means of Optical Coherence Tomography|Unknown status|Recruiting|Phase 4|110|Anticipated|The Hospital District of Satakunta||4|||f||||f||||||||||2017-10-10 23:14:43.082696|2017-10-10 23:14:43.082696
NCT02464384|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-12-02|||April 2016||2016-04-01|December 2015|2015-12-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Prediction of Erosive Disease in Early Rheumatoid Arthritis (RA) by Ultrasound and Cartilage Biodegradation Markers|Multicenter, Prospective, Open-label, Cohort Study With Collection of Blood Samples and Ultrasound / MRI and X-ray Examination|Not yet recruiting||N/A|24|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:14:43.229364|2017-10-10 23:14:43.229364
NCT02464371|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-05-15|||May 2015||2015-05-01|May 2017|2017-05-01|May 13, 2017|Actual|2017-05-13|May 3, 2017|Actual|2017-05-03||Observational|µARN||Interest of Plasma microRNAs|Interest of Plasma microRNAs Assay in ICU Acquired Muscle Weakness Diagnosis|Completed||N/A|58|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||Samples Without DNA|"     Blood samples will be drawn to compare the kinetics of microRNAs (miR-1, miR-21, miR-133,     miR-155, miR-206, miR-208a, miR-208b, miR-486, miR-499).   "|No||2017-10-10 23:14:43.344963|2017-10-10 23:14:43.344963
NCT02464358|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2015-06-04|||December 2011||2011-12-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|October 2012|Actual|2012-10-01||Interventional|||An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women|The Impact of an Information-Motivation-Behavioral Skills (IMB) Based Educational Intervention to Improve Gardasil Use in a Population of Undergraduate Women|Completed||N/A|70|Actual|University of Connecticut||2|||f||||f||||||||||2017-10-10 23:14:43.442632|2017-10-10 23:14:43.442632
NCT02464345|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-07-14|||July 2015||2015-07-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|HAPIFED||Healthy Approach to weIght Management and Food in Eating Disorders (HAPIFED)|A Randomised Controlled Trial of a New Integrated Approach to Management of Eating and Weight Disorders, Namely a Healthy APproach to weIght Management and Food in Eating Disorders (HAPIFED) Compared to Cognitive Behaviour Therapy Enhanced (CBT-E): A Pilot Study|Recruiting||Phase 2/Phase 3|100|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-10 23:14:43.527056|2017-10-10 23:14:43.527056
NCT02464332|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-05-24|||September 2015||2015-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery|A Phase 1 Study of BLZ-100 Administered by Intravenous Injection in Subjects With Soft Tissue Sarcoma Undergoing Surgery|Withdrawn||Phase 1|0|Actual|Blaze Bioscience Inc.||1||Study did not enroll any subjects|f||||t||||||||||2017-10-10 23:14:43.618962|2017-10-10 23:14:43.618962
NCT02464319|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2015-06-04|||June 2015||2015-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome|Safety and Efficiency Study of Low-dose IL-2 Treatment in Primary Sjögren's Syndrome|Unknown status|Recruiting|Phase 2|60|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-10 23:14:43.717893|2017-10-10 23:14:43.717893
NCT02464306|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-08-21|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection|Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection|Not yet recruiting||Phase 4|92|Anticipated|University of Colorado, Denver||2|||f||||f|f|f|||f|||||2017-10-10 23:14:43.811366|2017-10-10 23:14:43.811366
NCT02464293|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-06-01|||June 2015||2015-06-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington's Disease|A Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington's Disease|Active, not recruiting||N/A|16|Actual|Lancaster University||1|||f||||f||||||||||2017-10-10 23:14:43.893306|2017-10-10 23:14:43.893306
NCT02464280|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-05-03|||May 2016||2016-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||Tomosynthesis of Pathologies of the Chest and Skeletal Structures in Comparison to CT|Validation of Tomosynthesis for Indications for Clinical Questions Concerning Pathologies of the Chest and Skeletal Structures: When Can CT Been Omitted?|Recruiting||N/A|390|Anticipated|University of Zurich|||2||f||||f||||||||No||2017-10-10 23:14:44.064306|2017-10-10 23:14:44.064306
NCT02464267|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-05-09|||April 2015||2015-04-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation in CF|Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation of Patients Living With Cystic Fibrosis - Item Development|Recruiting||N/A|25|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 23:14:44.165584|2017-10-10 23:14:44.165584
NCT02464254|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-07-28|||April 2016||2016-04-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|INSPIRE||Intervention to Support Participation in Regular Exercise in the Elderly (INSPIRE)|Intervention to Support Participation in Regular Exercise in the Elderly (INSPIRE)|Recruiting||N/A|60|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||Yes||2017-10-10 23:14:44.2477|2017-10-10 23:14:44.2477
NCT02464241|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-05-24|||January 2015||2015-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Different Color Vision Tests in Children|Color Vision Tests in Children: Comparison of Standardized and Computer-assisted Examination|Recruiting||N/A|80|Anticipated|University of Zurich|||2||f||||f||||||||||2017-10-10 23:14:44.347314|2017-10-10 23:14:44.347314
NCT02464215|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-07-12|||January 2014||2014-01-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SWEET||Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric Cancer|Comparison of the Laparoscopy-Assisted Distal Gastrectomy(LADG) and Open Distal Gastrectomy(ODG) for Locally Advanced Gastric Cancer|Unknown status|Recruiting|N/A|440|Anticipated|Beijing Cancer Hospital||2|||f||||f||||||||||2017-10-10 23:14:44.532652|2017-10-10 23:14:44.532652
NCT02464202|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-10-25|||May 2013||2013-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of CBCT-based Tooth Replica in Tooth Autotransplantation to Improve the Outcome of Tooth Replacement in Children|Use of Stereolithographic Model in Tooth Autotransplantation and Periodontal Ligament Stem Cells for Pulp Revascularization and Reinnervation to Increase the Success Rate for Tooth Replacement in Children|Recruiting||N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||No|Patient is already informed and in follow-up after the surgery.|2017-10-10 23:14:44.625916|2017-10-10 23:14:44.625916
NCT02464189|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-01-03|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Q-KAP||Assessment of Asthma Knowledge Perception in Parents of Asthmatic Children. Pilot Study by Means of Q-KAP ( Questionnaire on Knowledge, Attitudes and Practices )|Assessment of Asthma Knowledge Perception in Parents of Asthmatic Children. Pilot Study by Means of Q-KAP ( Questionnaire on Knowledge, Attitudes and Practices )|Recruiting||N/A|390|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||1||f||||f||||||||Yes|"The IPD collected will be available on December 2016.
The following participant data will be shared:
Asthma severity level
Asthma control level
Pulmonary function tests
Demographic characteristics All IPD will be obtained from statistical analysis on the dedicated database in which all data are stored."|2017-10-10 23:14:44.714249|2017-10-10 23:14:44.714249
NCT02464176|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-01-21|||June 2015||2015-06-01|October 2016|2016-10-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Systemic Steroids for Peripheral Nerve Blocks|The Effects of Systemic Steroids on the Duration of a Psoas Compartment Block.|Completed||Phase 4|115|Actual|Wake Forest University Health Sciences||3|||f||||f||||||||||2017-10-10 23:14:44.793881|2017-10-10 23:14:44.793881
NCT02464150|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-05-26|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Gluten Challenge in Celiac Disease|Gluten Challenge in Celiac Disease|Recruiting||N/A|10|Anticipated|Oslo University Hospital||1|||f||||f|f|f||||||||2017-10-10 23:14:45.029984|2017-10-10 23:14:45.029984
NCT02464137|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-12-28|||April 2015||2015-04-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|HYDRA||HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer|A Phase I Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer|Active, not recruiting||Phase 1|7|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-10 23:14:45.107664|2017-10-10 23:14:45.107664
NCT02464124|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-08-16|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy|A Randomized, Double-blind, Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone Treatment of Overt Hepatic Encephalopathy|Recruiting||Phase 2/Phase 3|120|Anticipated|Tanta University||2|||f||||t||||||||||2017-10-10 23:14:45.188492|2017-10-10 23:14:45.188492
NCT02464111|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-09-04|||May 2015||2015-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women|Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women|Completed||N/A|30|Actual|USDA, Western Human Nutrition Research Center||6|||f||||f||||||||||2017-10-10 23:14:45.283735|2017-10-10 23:14:45.283735
NCT02464098|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-18|||November 19, 2015|Actual|2015-11-19|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients|Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients|Recruiting||N/A|200|Anticipated|St. Jude Children's Research Hospital|||2||f||||f|f|f||||Samples With DNA|"     All stool, blood and respiratory samples will be saved frozen for future testing.   "|||2017-10-10 23:14:45.401491|2017-10-10 23:14:45.401491
NCT02464085|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-01-09|||July 2015||2015-07-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|CARPSS||Characterising Arm Recovery in People With Severe Stroke|Characterising Arm Recovery in People With Severe Stroke|Recruiting||N/A|50|Anticipated|University of British Columbia|||1||f||||f||||||||Undecided||2017-10-10 23:14:45.503304|2017-10-10 23:14:45.503304
NCT02464072|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-06-04|||July 2012||2012-07-01|June 2015|2015-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis|Randomized Clinical Trial of Subtotal Parathyroidectomy or Total Parathyroidectomy With Immediate Heterotopic Autograft in Chronic Renal Disease Patients Stage V Under Dialysis|Recruiting||N/A|133|Anticipated|University of Sao Paulo General Hospital||3|||f||||f||||||||||2017-10-10 23:14:45.599331|2017-10-10 23:14:45.599331
NCT02464059|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-09-28|||June 2015||2015-06-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|||Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD|Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD|Enrolling by invitation||Phase 2|40|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||No|Individual participant data will not be made publicly available|2017-10-10 23:14:45.715713|2017-10-10 23:14:45.715713
NCT02464046|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2016-07-15||2016-07-15|July 2015||2015-07-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity|A Randomized, Placebo-controlled, 2-way Crossover, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of JNJ-42847922 in Subjects With Insomnia Disorder Without Psychiatric Comorbidity|Completed||Phase 2|92|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 23:14:45.798289|2017-10-10 23:14:45.798289
NCT02464033|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-01-09|||May 2015||2015-05-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes|Open Label Trial to Evaluate the Tolerability of a Combination Therapy Consisting of GAD-alum (Diamyd®), Etanercept and Vitamin D in Children and Adolescents Newly Diagnosed With Type 1 Diabetes|Active, not recruiting||Phase 2|20|Actual|Linkoeping University||1|||f||||t||||||||||2017-10-10 23:14:45.903409|2017-10-10 23:14:45.903409
NCT02464020|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-05-17|||July 2015||2015-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Interventional|||A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis|A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis|Active, not recruiting||Phase 4|8|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:14:46.003562|2017-10-10 23:14:46.003562
NCT02464007|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-04-29|||January 2016||2016-01-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of rSIFN-co for Patients With Advanced Solid Tumors|A Phase 1 Study of rSIFN-co for Subjects With Advanced Solid Tumors Where Interferons Are Known to Have Demonstrated Antitumor Activity|Recruiting||Phase 1|36|Anticipated|Sichuan Huiyang Life Science and Technology Corporation||1|||f||||t||||||||Undecided|This has not been determined.|2017-10-10 23:14:46.078101|2017-10-10 23:14:46.078101
NCT02463994|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-03-16|||October 2015||2015-10-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC|A Pilot Study of MPDL3280A (PD-L1) Antibody Therapy and Hypofractionated Image-guided Radiotherapy (HIGRT) in Patients With Metastatic Non-Small Cell Lung Cancer|Active, not recruiting||Early Phase 1|12|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:14:46.160492|2017-10-10 23:14:46.160492
NCT02463968|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-06-25|||August 27, 2016|Actual|2016-08-27|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Chikungunya Arthritis in the Americas|A Pilot Study of the Pathogenesis of Chikungunya Arthritis in the Americas|Completed||N/A|50|Actual|George Washington University|||3||f||||f||||||Samples With DNA|"     Cohort 1 CHRONIC CHIKUNGUNYA: Blood samples include one cell preparation tube with Sodium     Citrate will be collected for cytokine analysis by mesoscale and mass spectrophotometer     analyses, one blood RNA tube for PCR and one blood DNA tube for HLA typing. Synovial fluid     samples will be drawn for chronic patients with a knee effusion with one CPT and a blood RNA     tube.      Cohort 2 ACUTE CHIKUNGUNYA: Blood samples include one CPT for evaluation of biomarkers by     mass spectrophotometry, two blood RNA tubes drawn for mass spectrophotometry of viral     signaling and genomic analysis and one blood DNA tube for genomic analysis.      Cohort 3 HEALTHY CONTROLS: Participants will have one blood RNA tube, one blood DNA tube, and     one CPT tube drawn as controls for the other measurements.   "|||2017-10-10 23:14:46.519221|2017-10-10 23:14:46.519221
NCT02463955|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-16|||January 2016||2016-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|EXPLORE||Exploration of the Pleural Cavity Using a fleXible endoscoPe|Exploration of the Pleural Cavity Using a fleXible endoscoPe Under Two-Lung ventilatiOn With contRollEd Capnothorax|Withdrawn||N/A|0|Actual|University Hospital, Rouen||1||study never start|f||||t||||||||||2017-10-10 23:14:46.632056|2017-10-10 23:14:46.632056
NCT02463942|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2016-05-11|||September 2014||2014-09-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|TBE-LB2014||Tick-borne Encephalitis and Positive Borrelial Antibodies|Management of Patients With Tick-borne Encephalitis and Positive Anti-Lyme Borreliae Antibody Results|Recruiting||N/A|100|Anticipated|University Medical Centre Ljubljana||3|||f||||f||||||||||2017-10-10 23:14:46.728049|2017-10-10 23:14:46.728049
NCT02463929|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-06-02|||April 2014||2014-04-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Dyphenhidramine Effect on Prevention of Sevoflurane Induced Post Anesthesia Agitation in Pediatric|Dyphenhidramine Effect on Prevention of Sevoflurane Induced Post Anesthesia Agitation in Pediatric|Completed||Phase 4|50|Actual|Universitas Diponegoro||2|||f||||t||||||||||2017-10-10 23:14:46.834254|2017-10-10 23:14:46.834254
NCT02463916|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-06-03|||March 2015||2015-03-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|ExMET-IBD||A Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid Arthritis|The ExMET-IBD Study: A Randomized Control Trial to Determine the Effects of Exercise on Intestinal Microbiota and Immunological Markers in Patients With Inflammatory Bowel Disease and Rheumatoid Arthritis|Unknown status|Recruiting|Phase 2|60|Anticipated|University College Cork||2|||f||||f||||||||||2017-10-10 23:14:46.95418|2017-10-10 23:14:46.95418
NCT02463903|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-06-04|||March 2011||2011-03-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Coping Effectiveness Training in Patients With Chronic Heart Failure|Coping Effectiveness Training in Patients With Chronic Heart Failure - a Randomized Controlled Trial|Completed||N/A|103|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:14:47.068039|2017-10-10 23:14:47.068039
NCT02463890|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-09-15|||June 2015|Actual|2015-06-01|January 2017|2017-01-01|September 4, 2017|Actual|2017-09-04|November 30, 2016|Actual|2016-11-30||Interventional|EXESAS||Effect of Exercise Training on Obstructive Sleep Apnea Syndrome Severity|Effect of Exercise Training on Obstructive Sleep Apnea Syndrome Severity|Completed||N/A|96|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||||2017-10-10 23:14:47.161737|2017-10-10 23:14:47.161737
NCT02463877|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-03-07|||October 2014||2014-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy|A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy|Recruiting||Phase 1|25|Anticipated|University of California, San Diego||1|||f||||t||||||||Yes|Individual participant data will be shared with Genelux Corporation|2017-10-10 23:14:47.271901|2017-10-10 23:14:47.271901
NCT02463864|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-05-11|||March 2015||2015-03-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|APEP||A Twice-Daily Individual Targeted Exercise Program in Frail Hospitalised Older Medical In-patients (RCT)|A Randomised Controlled Trial to Measure the Effects of Twice-Daily Individual, Targeted, Strengthening, Balance and Endurance Exercise Sessions on Mobility, Quality of Life and Healthcare Utilisation for Frail Older Medical In-patients|Active, not recruiting||N/A|190|Actual|University College Cork||2|||f||||f||||||||||2017-10-10 23:14:47.354558|2017-10-10 23:14:47.354558
NCT02463851|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-04-10|||June 2015||2015-06-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|GOLD-FORCE||PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation|PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation|Recruiting||N/A|208|Anticipated|R&D Cardiologie||2|||f||||f||||||||||2017-10-10 23:14:47.448411|2017-10-10 23:14:47.448411
NCT02463838|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SFHP_CBCM||San Francisco Health Plan Care Support Trial|San Francisco Health Plan Care Support Intervention: A Randomized Trial|Active, not recruiting||N/A|292|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:14:47.56388|2017-10-10 23:14:47.56388
NCT02463825|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|August 2016|Actual|2016-08-01||Interventional|||A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALS|A Registry-Based Randomized-Controlled, Double-Blinded Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to Amyotrophic Lateral Sclerosis|Active, not recruiting||Phase 2|25|Anticipated|University of Calgary||3|||f||||f||||||||||2017-10-10 23:14:47.675107|2017-10-10 23:14:47.675107
NCT02463812|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Lipid Infusion Following Major Surgery|Energy Supplement With Lipid Emulsion Following Major Surgery|Active, not recruiting||N/A|90|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:14:47.778319|2017-10-10 23:14:47.778319
NCT02463799|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-05-25|||December 2015||2015-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC|A Phase 2 Study of Sipuleucel-T With or Without Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-Metastatic Castrate-Resistant Prostate Cancer|Recruiting||Phase 2|34|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:14:47.882496|2017-10-10 23:14:47.882496
NCT02463786|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-04-12|||July 2012||2012-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01|1 Day|Observational [Patient Registry]|INTERACTinHF||Improving Knowledge To Efficaciously RAise Level of Contemporary Treatment in Heart Failure (|Improving Knowledge To Efficaciously RAise Level of Contemporary Treatment in Heart Failure|Recruiting||N/A|200|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-10 23:14:48.020869|2017-10-10 23:14:48.020869
NCT02463773|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-08-15|||June 2015||2015-06-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Diaphragm Ultrasound Vs Transpulmonary Pressure To Set PEEP in ARDS|Diaphragm Excursion By Ultrasound As Compared To Transpulmonary Pressure To Optimize PEEP In ARDS: A Pilot Study|Completed||N/A|20|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-10 23:14:48.095976|2017-10-10 23:14:48.095976
NCT02463760|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-06-22|||August 2015||2015-08-01|June 2016|2016-06-01||||August 2017|Anticipated|2017-08-01||Observational|||Predicting Rupture of Abdominal Aortic Aneurysm (AAA) by Anatomic and Hemodynamic Markers From In-vivo and In-vitro Imaging.||Recruiting||N/A|14|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||Undecided||2017-10-10 23:14:48.178603|2017-10-10 23:14:48.178603
NCT02459847|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-03-07|||August 2014||2014-08-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Mind-Body Training for Hand Rehabilitation|Effects of Mind-body Interventions on Stress, Anxiety, and Pain in Hand Therapy Patients|Completed||N/A|21|Actual|University of Southern California||2|||f||||f||||||||No||2017-10-10 23:15:28.664771|2017-10-10 23:15:28.664771
NCT02463747|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-02|||June 2015||2015-06-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|RR||Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia|Prospective Unblinded Randomized Trial to Examine Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia|Unknown status|Not yet recruiting|Phase 4|110|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:14:48.255098|2017-10-10 23:14:48.255098
NCT02463734|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-12-01|||August 2015||2015-08-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|DQoL-OC||The Dementia Quality of Life Scale for Older Family Carers (DQoL-OC) Study|Development of the Dementia Quality of Life Scale for Older Family Carers of People With Dementia (DQoL-OC) and Evaluation of Its Psychometric Properties|Recruiting||N/A|300|Anticipated|University of Nottingham|||1||f||||t||||||||||2017-10-10 23:14:48.3784|2017-10-10 23:14:48.3784
NCT02463721|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Identification of Ascitic Fluid Bacterial Pathogens in Spontaneous Bacterial Peritonitis|Identification of Ascitic Fluid Bacterial Pathogens in Spontaneous Bacterial Peritonitis in Nile Delta and Its Impact on Clinical Outcome of These Patients|Recruiting||N/A|100|Anticipated|Tanta University||1|||f||||t||||||||||2017-10-10 23:14:48.516141|2017-10-10 23:14:48.516141
NCT02463708|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-06-24|||November 2013||2013-11-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|CREST||Evaluation of the PACE/PACENET BHL Caregiver Program|Evaluation of the PACE/PACENET BHL Caregiver Outreach and Telehealth Education Program|Enrolling by invitation||N/A|350|Anticipated|University of Pennsylvania|||1||f||||f||||||||No||2017-10-10 23:14:48.598171|2017-10-10 23:14:48.598171
NCT02463695|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-02|||October 2014||2014-10-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs)|Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs): A Comparative Study of Normal Ears Versus Those With Vestibular Deficits|Unknown status|Recruiting|N/A|51|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:14:48.674173|2017-10-10 23:14:48.674173
NCT02463682|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-04-07|||May 2015||2015-05-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting|Early Feasibility Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAS) in the Outpatient Setting|Completed||N/A|9|Actual|William Sansum Diabetes Center||2|||f||||f||||||||||2017-10-10 23:14:48.760843|2017-10-10 23:14:48.760843
NCT02463669|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2016-08-30|||April 2016||2016-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department|The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department|Recruiting||N/A|280|Anticipated|Jewish General Hospital|||1||f||||t||||||||Undecided||2017-10-10 23:14:48.867552|2017-10-10 23:14:48.867552
NCT02463656|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-07-17|||July 2015||2015-07-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|March 2016|Actual|2016-03-01||Observational|||Growth Arrest in Focal Dermal Hypoplasia||Active, not recruiting||N/A|16|Actual|University of Colorado, Denver|||1||f||||||||||||||2017-10-10 23:14:48.942495|2017-10-10 23:14:48.942495
NCT02463643|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-06-28|||May 2015||2015-05-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|October 2016|Actual|2016-10-01||Interventional|||To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis|A Randomized, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Z-215 Compared With Rabeprazole Sodium in the Treatment of Erosive Esophagitis|Completed||Phase 2|503|Actual|Zeria Pharmaceutical||4|||f||||f||||||||||2017-10-10 23:14:48.99016|2017-10-10 23:14:48.99016
NCT02463630|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-01|||July 2014||2014-07-01|January 2015|2015-01-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|CDR||Posterior Compression Distraction Reduction （CDR）Technique in the Treatment of BI-AAD|Posterior Compression - Distraction Reduction (CDR) Technique in the Treatment of Basilar Invagination Associated With Atlantoaxial Dislocation|Unknown status|Recruiting|Phase 3|22|Anticipated|Xuanwu Hospital, Beijing||1|||f||||t||||||||||2017-10-10 23:14:49.077728|2017-10-10 23:14:49.077728
NCT02463617|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-10-10|||December 2014||2014-12-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Impulsivity and Parkinson's Disease : a Neuropsychology With Magnetic Resonance Imaging Study|Impulsivity and Parkinson's Disease : a Neuropsychology With Magnetic Resonance Imaging Study|Recruiting||N/A|120|Anticipated|Poitiers University Hospital||1|||f||||t||||||||||2017-10-10 23:14:49.16322|2017-10-10 23:14:49.16322
NCT02463604|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-12-09|||June 2015||2015-06-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2016|Actual|2016-02-01||Interventional|PREPARE||Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography|Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography|Active, not recruiting||N/A|220|Actual|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 23:14:49.235026|2017-10-10 23:14:49.235026
NCT02463591|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Reversal of Dabigatran With Prothrombin Complex Concentrate|Reversal of Anticoagulant Effect of Dabigatran® by Prothrombin Complex Concentrate (Beriplex®), Assessed With a Novel Method of Blood Loss Measurement|Recruiting||Phase 2|12|Anticipated|University Medical Center Groningen||2|||f||||f||||||||No||2017-10-10 23:14:49.308036|2017-10-10 23:14:49.308036
NCT02463578|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-02-24|||June 2015||2015-06-01|December 2015|2015-12-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|||Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis|Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis: a Pilot Study Following New Vaccine Recommendations. PneumoVas Pilot 2|Recruiting||N/A|30|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:14:49.427975|2017-10-10 23:14:49.427975
NCT02463565|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-10|||September 1998||1998-09-01|January 2017|2017-01-01||||May 2016|Actual|2016-05-01||Observational|UN+||Assessment of Food Intake in Hospitalized Patients|Assessment of Food Intake in Hospitalized Patients: A Prospective Hospital Survey|Active, not recruiting||N/A|4152|Actual|University Hospital, Geneva|||1||f||||||||||||||2017-10-10 23:14:49.509995|2017-10-10 23:14:49.509995
NCT02463552|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Naproxen on Tooth Sensitivity Caused by In-office Bleaching|Rior Use of Naproxen on Tooth Sensitivity Reduction After In-office Bleaching: Randomized Clinical Trial|Completed||N/A|50|Actual|Universidade Federal de Sergipe||2|||f||||f||||||||||2017-10-10 23:14:49.587264|2017-10-10 23:14:49.587264
NCT02463539|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-08-18|||September 2015||2015-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Observational|||Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis|Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis. PneumoVas Pilot 1|Completed||N/A|19|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:14:49.66211|2017-10-10 23:14:49.66211
NCT02463526|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-12-20|||April 2015||2015-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Mulligan's Technique in Subjects With Shoulder Impingement Syndrome|The Effects of Mulligan's Technique on Range of Movement, Pressure Pain Threshold, Muscle Strength, and Functionality in Subjects With Shoulder Impingement Syndrome|Completed||N/A|27|Actual|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-10 23:14:49.739741|2017-10-10 23:14:49.739741
NCT02463513|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-05-12|||February 2013||2013-02-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIBOGENE||RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood Pressure|RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood Pressure|Active, not recruiting||N/A|243|Actual|University of Ulster||3|||f||||f||||||||||2017-10-10 23:14:49.815609|2017-10-10 23:14:49.815609
NCT02463500|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-05-04|||January 2015||2015-01-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01|2 Years|Observational [Patient Registry]|DFUDatabase||UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository|UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository|Recruiting||N/A|1000|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples Without DNA|"     Blood, bone and tissue samples will be banked in the UT Southwestern Department of Plastic     Surgery Laboratory and tested for bacteria, biomarkers, inflammatory cytokines and other     indicators of infection.   "|||2017-10-10 23:14:49.897597|2017-10-10 23:14:49.897597
NCT02463487|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-05-04|||June 2015||2015-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADA NPWT||Negative Pressure Wound Therapy as a Drug Delivery System|Negative Pressure Wound Therapy as a Drug Delivery System|Recruiting||N/A|150|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 23:14:49.983536|2017-10-10 23:14:49.983536
NCT02463474|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-01-13|||July 2015||2015-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mobile Health (mHealth) Black Women With Breast Cancer|Piloting the Acceptability of a Culturally Tailored Evidence-Based mHealth Intervention for Low-Income Black Women With Breast Cancer|Completed||N/A|6|Actual|University of Florida||1|||f||||f||||||||||2017-10-10 23:14:50.076855|2017-10-10 23:14:50.076855
NCT02463461|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-05-08|||August 2015||2015-08-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison Between Multiple Wrist-worn Actigraphy Devices and Polysomnography|Comparison Between Multiple Wrist-worn Actigraphy Devices and Polysomnography|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University||5||Not sure if we are going to do this study now.|f||||f||||||||Undecided||2017-10-10 23:14:50.16323|2017-10-10 23:14:50.16323
NCT02463448|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-06-02|||December 2015||2015-12-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Autologous Muscle Derived Cells for Underactive Bladder|Autologous Muscle Derived Cells for Underactive Bladder|Recruiting||Phase 1|20|Anticipated|William Beaumont Hospitals||1|||f||||t||||||||No||2017-10-10 23:14:50.23092|2017-10-10 23:14:50.23092
NCT02463435|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-04-06|||June 2015||2015-06-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Nutritional Intervention and Olive Oil in Severe Obesity|Effect of Nutritional Intervention and Olive Oil in Severe Obesity: Randomized Controlled Trial|Completed||N/A|229|Actual|Universidade Federal de Goias||3|||f||||f||||||||||2017-10-10 23:14:50.314775|2017-10-10 23:14:50.314775
NCT02463422|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-06-01|||August 2014||2014-08-01|June 2015|2015-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Detection of ASD at the 1st Birthday as Standard of Care: The Get SET Early Model|Detection of ASD at the 1st Birthday as Standard of Care: The Get SET Early Model|Recruiting||N/A|12000|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-10-10 23:14:50.55436|2017-10-10 23:14:50.55436
NCT02463409|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-30|2017-04-19||June 2015||2015-06-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional||All patients who enrolled in the study, not including screen fails|Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)|Effects of Theophylline on cAMP Signaling in Children With Pseudohypoparathyroidism Type 1a|Completed||Phase 2|6|Actual|Vanderbilt University Medical Center||1|||f||||t||||||||Yes|Investigators may contact Dr. Shoemaker for data after our primary analysis is completed and published (if applicable).|2017-10-10 23:14:50.667557|2017-10-10 23:14:50.667557
NCT02463383|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2015-06-03|||September 2013||2013-09-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|October 2014|Actual|2014-10-01||Interventional|EPPNASE||Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal Women|Alcohol-related Breast Cancer in Postmenopausal Women - Effect of PPARG2pro12ala Polymorphism on Female Sex-hormone Levels and Interaction With Alcohol Consumption and NSAID Usage|Unknown status|Active, not recruiting|Early Phase 1|25|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:14:51.091562|2017-10-10 23:14:51.091562
NCT02463370|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-01-07|||May 2015||2015-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Four vs. Ten Local Anesthetic Injections for SMR|Effectiveness of Four Versus Ten Local Anesthetic Injections for Post-submucosal Resection Pain Relief: a Randomized, Double Blinded Clinical Trial|Completed||N/A|120|Actual|Makassed General Hospital||2|||f||||f||||||||||2017-10-10 23:14:51.213342|2017-10-10 23:14:51.213342
NCT02463357|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-03-23|||August 2015||2015-08-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2016|Actual|2016-09-01||Interventional|||Three New Ideas to Protect Special Forces From the Stress of High Altitude|Three New Ideas to Protect Special Forces From the Stress of High Altitude|Active, not recruiting||Phase 4|148|Actual|University of Colorado, Denver||5|||f||||t||||||||||2017-10-10 23:14:51.309881|2017-10-10 23:14:51.309881
NCT02463344|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-09-07|||July 11, 2012|Actual|2012-07-11|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD|Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)|Active, not recruiting||N/A|11|Actual|Astellas Pharma Inc|||1||f||||t||||||||||2017-10-10 23:14:51.425981|2017-10-10 23:14:51.425981
NCT02463331|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-12-29|2016-11-02||May 2003||2003-05-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|June 2015|Actual|2015-06-01||Interventional|||Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial|Possible Role of Chloroquine in Conjunction to Prednisone to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial|Completed||Phase 4|57|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||No||2017-10-10 23:14:51.568838|2017-10-10 23:14:51.568838
NCT02463318|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-04-30|||September 2012||2012-09-01|June 2015|2015-06-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects||Completed||N/A|34|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:14:51.871518|2017-10-10 23:14:51.871518
NCT02463305|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-08-29|||April 2016||2016-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)|Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)|Recruiting||Early Phase 1|12|Anticipated|University of Colorado, Denver||3|||f||||t||||||||||2017-10-10 23:14:51.978303|2017-10-10 23:14:51.978303
NCT02463292|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-06-13|||May 2015||2015-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Quality of Life in Young Adults With Congenital Heart Disease|Quality of Life, Psychological Adjustment and Academic Achievement in Young Adults With Congenital Heart Disease|Completed||N/A|325|Actual|University Children's Hospital, Zurich|||2||f||||f||||||||||2017-10-10 23:14:52.09006|2017-10-10 23:14:52.09006
NCT02463279|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-12-11|||April 2015||2015-04-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|||SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study|SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study|Completed||N/A|30|Actual|SinuSys Corporation||1|||f||||f||||||||||2017-10-10 23:14:52.19537|2017-10-10 23:14:52.19537
NCT02463266|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-06-24|||March 2014||2014-03-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|SUSTAINIV||Evaluation of the PACE/PACENET BHL Clinical Program|Evaluation of the PACE/PACENET BHL Clinical Program|Enrolling by invitation||N/A|1000|Anticipated|University of Pennsylvania||2|||f||||f||||||||No||2017-10-10 23:14:52.285814|2017-10-10 23:14:52.285814
NCT02463253|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-05-23|||April 2015||2015-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01|12 Months|Observational [Patient Registry]|||Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients|Correlation of Molecular Biomarkers With Biopsy Findings and Outcomes in Renal Transplant Recipients|Completed||N/A|20|Actual|University of California, Davis|||1||f||||t||||||Samples Without DNA|"     Laboratory evaluations: The UC Davis laboratory will be used for clinical chemistry, and     hematology, as well as other outside laboratories that the participants may go to        1. Hematology: Routine hematological parameters will be analyzed as indicated by standard          clinical care        2. Clinical chemistry: Routine clinical chemistry parameters will be analyzed including          basic and comprehensive metabolic profiles as indicated by standard clinical care          Immunologic Profiles: As per standard routine monitoring with both indicated and          surveillance biopsies, donor specific antibodies will be monitored   "|||2017-10-10 23:14:52.388271|2017-10-10 23:14:52.388271
NCT02463227|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-03-09|2017-03-09||August 2015|Actual|2015-08-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional||All participants enrolled.|Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment Interruption|A Phase I, Open-Label Study of the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously to HIV-Infected Adults Undergoing a Brief Analytical Treatment Interruption|Completed||Phase 1|14|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-10 23:14:52.476915|2017-10-10 23:14:52.476915
NCT02463214|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-11-01|||September 2015||2015-09-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Prevention of Healthcare Associated Infections in Bone Marrow Transplant Patients|Prevention of Healthcare Associated Infections in Bone Marrow Transplant Patients|Active, not recruiting||N/A|50|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:14:52.817781|2017-10-10 23:14:52.817781
NCT02463201|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-06-28|||April 2015||2015-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|June 2017|Anticipated|2017-06-01||Observational|||Obstructive Sleep Apnea in Obese Children and Teenagers - Occurrence and Importance of Intervention|Obstructive Sleep Apnea in Obese Children and Teenagers - Occurrence and Importance of Intervention|Recruiting||N/A|150|Anticipated|Zealand University Hospital|||1||f||||f||||||||||2017-10-10 23:14:52.900903|2017-10-10 23:14:52.900903
NCT02463188|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-07-19|||February 2014||2014-02-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Promoting Sleep to Prevent Substance Use in Adolescence|Promoting Sleep to Prevent Substance Use in Adolescence|Completed||N/A|300|Actual|University of California, Berkeley||2|||f||||f||||||||||2017-10-10 23:14:52.994012|2017-10-10 23:14:52.994012
NCT02463175|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-03-24|||June 2015||2015-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CardioQ-RP||Effects of Goal-directed Fluid Therapy on Post-operative Outcomes in Children Undergoing Scoliosis Repair|A Randomized Controlled Pilot Study to Examine the Effects of Goal-directed Fluid Therapy on Post-operative Outcomes in Children Undergoing Scoliosis Repair|Terminated||N/A|14|Actual|University of British Columbia||2||Difficulties with protocol compliance in both arms. Will simplify protocol.|f||||f||||||||||2017-10-10 23:14:53.083017|2017-10-10 23:14:53.083017
NCT02463162|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-05-05|||June 2015||2015-06-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Trial of Advance Care Planning (ACP) & Goals of Care Designations (GCD) Discussions|Effectiveness and Economic Impact of Advance Care Planning and Goals of Care Designations Discussions: A Randomized Controlled Trial|Completed||N/A|240|Actual|University of Alberta||2|||f||||f||||||||||2017-10-10 23:14:53.181249|2017-10-10 23:14:53.181249
NCT02463149|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-03|||August 2011||2011-08-01|June 2015|2015-06-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|YCA||Pilot Evaluation of Youth Chef Academy|Pilot Evaluation of Youth Chef Academy: A Plant-based Cooking Program for Urban Middle School Students|Completed||N/A|248|Actual|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-10-10 23:14:53.291907|2017-10-10 23:14:53.291907
NCT02463136|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-11-09|||November 2015||2015-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|NF-AA||Fmri-based Neurofeedback With Anxious Adolescents Study|Using Real-time fMRI-based Neurofeedback With Anxious Adolescents|Recruiting||Phase 1|50|Anticipated|University of Oxford||1|||f||||t||||||||Yes|Data may be shared across the Braintrain consortium|2017-10-10 23:14:53.35539|2017-10-10 23:14:53.35539
NCT02463123|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-08-29|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|June 2017|Actual|2017-06-01|June 2016|Actual|2016-06-01||Observational|||Energy Expenditure Estimation in Cardiac Surgery|Resting Energy Expenditure in Cardiac Patients Operated Under Cardiopulmonary Bypass|Completed||N/A|240|Actual|Meshalkin Research Institute of Pathology of Circulation|||1||f||||f||||||||||2017-10-10 23:14:53.453631|2017-10-10 23:14:53.453631
NCT02463110|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-05-02|||July 2015||2015-07-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ANDROS||Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin|Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin: The ANDROS Study|Terminated||Phase 4|2|Actual|Assistance Publique - Hôpitaux de Paris||3||Investigator's decision|f||||f||||||||||2017-10-10 23:14:53.51351|2017-10-10 23:14:53.51351
NCT02463097|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-05-12|2017-03-07||June 2015||2015-06-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2016|Actual|2016-03-01||Interventional||All subjects wearing the MMT-670G insulin pump, using it with the closed loop algorithm.|Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes|Safety Evaluation of the Hybrid Closed Loop (HCL) System in Type 1 Diabetes|Active, not recruiting||N/A|124|Actual|Medtronic Diabetes||1|||f||||t||||||||||2017-10-10 23:14:53.653346|2017-10-10 23:14:53.653346
NCT02463084|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-04-17|||March 2013||2013-03-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MEAL-2||Macronutrient Effects on Alzheimer's Disease (MEAL-2)|Macronutrient Effects on Alzheimer's Disease: HTN and IR (Hypertension and Insulin Resistance) (MEAL-2)|Completed||N/A|60|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 23:14:53.960427|2017-10-10 23:14:53.960427
NCT02463071|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-03|2017-03-22|||June 10, 2015|Actual|2015-06-10|March 2017|2017-03-01|March 11, 2017|Actual|2017-03-11|March 11, 2017|Actual|2017-03-11||Interventional|||AZD0585 Phase III Long-term Study in Japan|A Randomised, Double-blind, Placebo Controlled, Parallel Group, Phase III Long-term Study to Evaluate Efficacy and Safety of 12 Weeks and 52 Weeks of AZD0585 Administration, Respectively, in Japanese Patients With Hyperlipidemia Accompanied by Hypertriglyceridemia.|Completed||Phase 3|886|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 23:14:54.052208|2017-10-10 23:14:54.052208
NCT02463058|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-12-23|||August 2015||2015-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Evaluating the Physiological Strain Induced by a BC Protective Undergarment Under Exercise-heat Stress|Evaluating the Physiological Strain Induced by a BC Protective Undergarment Under Exercise-heat Stress|Completed||N/A|10|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:14:54.178124|2017-10-10 23:14:54.178124
NCT02463045|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-05-22|||May 2015||2015-05-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects|A Phase I Study to Evaluate the Safety/Tolerability and Pharmacokinetics of TOP1288 Rectal Single and Multiple Ascending Doses in Healthy Subjects and Multiple Doses in Subjects With Ulcerative Colitis|Completed||Phase 1|67|Actual|Topivert Pharma Ltd||10|||f||||||||||||||2017-10-10 23:14:54.250573|2017-10-10 23:14:54.250573
NCT02463032|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-07-31|||August 2015|Actual|2015-08-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy and Safety of GTx-024 in Patients With ER+/AR+ Breast Cancer|A Phase 2 Open Label, Multi-Center, Multinational, Randomized, Parallel Design Study Investigating The Efficacy and Safety Of GTx-024 On Metastatic or Locally Advanced ER+/AR+ Breast Cancer (BC) in Postmenopausal Women|Active, not recruiting||Phase 2|88|Anticipated|GTx||2|||f||||t||||||||||2017-10-10 23:14:54.342422|2017-10-10 23:14:54.342422
NCT02463019|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-06-02|||January 2015||2015-01-01|June 2015|2015-06-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B|An Open-label Rollover Study in Chinese Patients After Finishing a 3-year Randomize Trial for Chronic Hepatitis B With High Serum Viral Load But Mild Elevated Aminotransferase|Enrolling by invitation||Phase 4|160|Anticipated|E-DA Hospital||1|||f||||f||||||||||2017-10-10 23:14:56.171001|2017-10-10 23:14:56.171001
NCT02463006|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-06-02|||January 2014||2014-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|September 2014|Actual|2014-09-01||Interventional|||Porous and Non-porous Bone Grafts in Intra-bony Periodontal Defects|Comparative Evaluation of Porous and Non Porous Variants of Bioactive Glass in the Treatment of Periodontal Intrabony Defects: A Cone Beam Computed Tomography Analysis|Completed||Phase 2/Phase 3|10|Actual|Dr. D. Y. Patil Dental College & Hospital||2|||f||||||||||||||2017-10-10 23:14:56.250043|2017-10-10 23:14:56.250043
NCT02462629|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-07-11|||June 2015||2015-06-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Study of BLZ-100 in Pediatric Subjects With CNS Tumors|A Phase 1 Dose-escalation and Expansion Study of BLZ-100 in Pediatric Subjects With Primary Central Nervous System Tumors|Active, not recruiting||Phase 1|27|Actual|Blaze Bioscience Inc.||1|||f||||t||||||||||2017-10-10 23:14:59.692183|2017-10-10 23:14:59.692183
NCT02462993|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-06-03|||February 2014||2014-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|August 2014|Actual|2014-08-01||Interventional|||Local Drug Delivery of Aloe Vera Gel in Chronic Periodontitis|EFFECT OF LOCALLY DELIVERED ALOE VERA GEL AS AN ADJUNCT TO SCALING AND ROOT PLANING IN THE TREATMENT OF CHRONIC PERIODONTITIS: A SPLIT-MOUTH CLINICAL AND MICROBIOLOGICAL STUDY|Completed||Phase 2/Phase 3|12|Actual|Dr. D. Y. Patil Dental College & Hospital||2|||f||||||||||||||2017-10-10 23:14:56.319601|2017-10-10 23:14:56.319601
NCT02462980|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-06-27|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|April 30, 2018|Anticipated|2018-04-30||Interventional|UNCOVER-AF||Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation|Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation|Active, not recruiting||N/A|4|Actual|Acutus Medical||1|||f||||t|f|t|t|f|t|||Undecided||2017-10-10 23:14:56.400377|2017-10-10 23:14:56.400377
NCT02462967|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-03-21|||June 2015||2015-06-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|NASH-CX||Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis|A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase 2 Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis|Active, not recruiting||Phase 2|156|Anticipated|Galectin Therapeutics Inc.||3|||f||||t||||||||||2017-10-10 23:14:56.488929|2017-10-10 23:14:56.488929
NCT02462954|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-05-26|||July 2015||2015-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Safety Study Of The Caya® Diaphragm Used With ContraGel®|A Phase I Safety Study Of The Caya® Diaphragm Used With ContraGel®|Completed||Phase 1|23|Actual|CONRAD||2|||f||||f||||||||No||2017-10-10 23:14:56.673335|2017-10-10 23:14:56.673335
NCT02462941|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-05-19|||July 2015||2015-07-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|April 2016|Actual|2016-04-01||Interventional|||Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart|Prospective Analysis of Low-Dose Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart|Active, not recruiting||Phase 1|80|Actual|Columbia University||1|||f||||f||||||||||2017-10-10 23:14:56.753776|2017-10-10 23:14:56.753776
NCT02462928|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-09-29|||June 25, 2015|Actual|2015-06-25|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|CDER||A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration|Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration|Active, not recruiting||Phase 3|900|Anticipated|Allergan||3|||f||||t|t|f||||||||2017-10-10 23:14:56.992505|2017-10-10 23:14:56.992505
NCT02462915|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-11-13|||June 2015||2015-06-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study Comparing the Supraglottic Airway Devices and Endotracheal Tube During Controlled Ventilation for Laparoscopic Surgery|A Study Comparing the Supraglottic Airway Devices and Endotracheal Tube During Controlled Ventilation for Laparoscopic Surgery|Recruiting||N/A|40|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:14:57.517275|2017-10-10 23:14:57.517275
NCT02462902|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-12-29|||February 2014||2014-02-01|May 2015|2015-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension|Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension|Completed||N/A|308|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:14:57.623907|2017-10-10 23:14:57.623907
NCT02462889|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-03-29|||June 2015||2015-06-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PRO-CON||IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD|A Prospective, Single-Blind, Randomized Study to Evaluate Intravitreal Aflibercept Injection (IAI) Versus Sham as PROphylaxis Against CONversion to Neovascular Age-Related Macular Degeneration (AMD) in High-Risk Eyes|Recruiting||Phase 2|128|Anticipated|Ophthalmic Consultants of Boston||2|||f||||f||||||||Yes||2017-10-10 23:14:57.703569|2017-10-10 23:14:57.703569
NCT02462876|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-09-26|||October 2015||2015-10-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|January 2019|Anticipated|2019-01-01||Observational|||Evaluation of the GORE® VIABAHN® Endoprosthesis for the Treatment of Popliteal Artery Aneurysm (PAA)|Post-market Study: Evaluation of the GORE® VIABAHN® Endoprosthesis for the Treatment of Popliteal Artery Aneurysm|Active, not recruiting||N/A|50|Actual|W.L.Gore & Associates|||1||f||||f||||||||||2017-10-10 23:14:57.81604|2017-10-10 23:14:57.81604
NCT02462863|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-07-27|||October 2015||2015-10-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Treatment of Type 2 Diabetes With Immunonutrients|Treatment of Type 2 Diabetes With Immunonutrients|Recruiting||Phase 1|6|Anticipated|The Christ Hospital||1|||f||||f||||||||||2017-10-10 23:14:57.881415|2017-10-10 23:14:57.881415
NCT02462850|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-11-02||2016-11-02|October 2014||2014-10-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip|A Phase 3 Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip|Completed||Phase 3|178|Actual|Charleston Laboratories, Inc||1|||f||||||||||||||2017-10-10 23:14:57.964177|2017-10-10 23:14:57.964177
NCT02462837|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-10-20|||May 2015||2015-05-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement|Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement|Recruiting||Phase 2|100|Anticipated|Southern Illinois University||2|||f||||f||||||||Undecided||2017-10-10 23:14:58.035689|2017-10-10 23:14:58.035689
NCT02462824|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-02-13|||April 2015||2015-04-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Patient Centered Home Exercise Program for Peripheral Artery Disease|HOme-based moNitORed Exercise for PAD: The HONOR Study|Recruiting||N/A|200|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 23:14:58.130628|2017-10-10 23:14:58.130628
NCT02462811|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-11-02||2016-11-02|September 2014||2014-09-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)|A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose, Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Pain and Opioid-Induced Nausea and Vomiting (OINV)|Completed||Phase 3|552|Actual|Charleston Laboratories, Inc||3|||f||||f||||||||||2017-10-10 23:14:58.349286|2017-10-10 23:14:58.349286
NCT02462798|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-03|||January 2010||2010-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|July 2013|Actual|2013-07-01||Interventional|||Does Sourdough Fermentation Improve Iron Uptake From Whole Grain Rye Bread?|Does Sourdough Fermentation Improve Iron Uptake From Whole Grain Rye Bread?|Unknown status|Active, not recruiting|N/A|102|Actual|Chalmers University of Technology||2|||f||||f||||||||||2017-10-10 23:14:58.451429|2017-10-10 23:14:58.451429
NCT02462785|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-11-08|||July 2014||2014-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||An Evaluation of Internet-based Carbohydrate Counting Education for Adolescents With Type 1 Diabetes|Carbohydrate Counting and Type 1 Diabetes: A Randomized Controlled Trial of Internet-based Teaching for Adolescents Learning to Count|Completed||N/A|48|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 23:14:58.523112|2017-10-10 23:14:58.523112
NCT02462772|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-11-04|||October 2015||2015-10-01|November 2015|2015-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CAPRISA014||Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa|Phase II Trial to Assess the Safety and Acceptability of the Long-acting Injectable HIV Integrase Inhibitor, Cabotegravir (GSK1265744), in HIV Uninfected Women in KwaZulu-Natal, South Africa|Withdrawn||Phase 2|0|Actual|Centre for the AIDS Programme of Research in South Africa||2|||f||||t||||||||||2017-10-10 23:14:58.622699|2017-10-10 23:14:58.622699
NCT02462759|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-09-19|||August 19, 2015|Actual|2015-08-19|September 2017|2017-09-01|April 9, 2019|Anticipated|2019-04-09|April 9, 2019|Anticipated|2019-04-09||Interventional|EMBRACE||A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).|A Phase 2, Randomized, Double-blind, Sham-procedure Controlled Study to Assess the Safety and Tolerability and Explore the Efficacy of ISIS 396443 (BIIB058) Administered Intrathecally in Subjects With Spinal Muscular Atrophy Who Are Not Eligible to Participate in the Clinical Studies ISIS 396443-CS3B or ISIS 396443-CS4|Active, not recruiting||Phase 2|21|Actual|Biogen||2|||t||||t|t|f||||||||2017-10-10 23:14:58.737444|2017-10-10 23:14:58.737444
NCT02462746|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-09-07|||March 2015||2015-03-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Effect of Cysteine, Tryptophan and Tyrosine Supplements on Breast Milk|The Effect of Cysteine, Tryptophan and Tyrosine Supplements on Breast Milk|Completed||Phase 1|24|Actual|Centre for Addiction and Mental Health||3|||f||||t||||||||No||2017-10-10 23:14:58.883079|2017-10-10 23:14:58.883079
NCT02462733|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-10-24|||April 2012||2012-04-01|October 2016|2016-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy of Tools of the Mind for Enhancing Self-Control in Preschoolers|Investigation of the Efficacy of Tools of the Mind for Enhancing Self-Control in Canadian Preschoolers|Completed||N/A|280|Actual|The Hospital for Sick Children||2|||f||||f||||||||No||2017-10-10 23:14:58.965659|2017-10-10 23:14:58.965659
NCT02462707|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-10-06|||July 2015||2015-07-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors|Phase 1 Study Of Pf-03084014 To Evaluate Safety And Pharmacokinetics In Japanese Patients With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:14:59.151915|2017-10-10 23:14:59.151915
NCT02462694|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-02-06|||April 2010||2010-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||High Risk Suicidal Behavior in Veterans|High Risk Suicidal Behavior in Veterans - Assessment of Predictors and Efficacy of Dialectical Behavior Therapy|Active, not recruiting||N/A|500|Anticipated|Bronx Veterans Medical Research Foundation, Inc||2|||f||||t||||||||||2017-10-10 23:14:59.227473|2017-10-10 23:14:59.227473
NCT02462681|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2017-06-29|||May 2015||2015-05-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery|Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery|Completed||Phase 1/Phase 2|90|Actual|Assiut University||3|||f||||f||||||||||2017-10-10 23:14:59.300533|2017-10-10 23:14:59.300533
NCT02462668|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2017-08-02|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|June 18, 2017|Actual|2017-06-18|June 11, 2017|Actual|2017-06-11||Interventional|FBAIDNIPPV||Fibreoptic Bronchoscopy Assisted Intubation During Noninvasive Positive Pressure Ventilation|The Efficiency and Safety of Fibreoptic Bronchoscopy Assisted Intubation During Noninvasive Positive Pressure Ventilation|Completed||N/A|106|Actual|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-10 23:14:59.399679|2017-10-10 23:14:59.399679
NCT02462655|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-03-07|||October 2015||2015-10-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|LA-PBMC||Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia|Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia|Completed||N/A|9|Actual|Laval University||2|||f||||f||||||||||2017-10-10 23:14:59.492096|2017-10-10 23:14:59.492096
NCT02462642|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-06-01|||March 2010||2010-03-01|June 2015|2015-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|Yaaddasht||Effect of Bacopa Monniera Extract on Cognition and Anxiety and Exploration of PK Properties|Chronic Effect of Brahmi on Cognition Performance and Anxiety in Healthy Indian Adults and Exploration of Pharmacokinetic Properties of Brahmi Components in Healthy Adult Males.|Completed||N/A|84|Actual|Unilever R&D||4|||f||||t||||||||||2017-10-10 23:14:59.572974|2017-10-10 23:14:59.572974
NCT02462616|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-05|||January 2011||2011-01-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Risk Analysis for Cardiovascular Autonomic Neuropathy|The Risk Analysis for Cardiovascular Autonomic Neuropathy in General Chinese Population|Completed||N/A|2100|Actual|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||||||||Samples With DNA|"     DNAs were extracted and genetyped.   "|||2017-10-10 23:14:59.78649|2017-10-10 23:14:59.78649
NCT02462603|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-06-29|||March 2016||2016-03-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety and Biomarker Study of EPI-589 in Parkinson's Disease|A Phase 2A Safety and Biomarker Study of EPI-589 in Mitochondrial Subtype and Idiopathic Parkinson's Disease Subjects|Recruiting||Phase 2|40|Anticipated|Edison Pharmaceuticals Inc||1|||f||||f||||||||||2017-10-10 23:14:59.876698|2017-10-10 23:14:59.876698
NCT02462590|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-06-02|||June 2015||2015-06-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PROSPECT||Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial|Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)|Recruiting||Phase 4|2650|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 23:15:00.043734|2017-10-10 23:15:00.043734
NCT02462577|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-12-29|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Locally Administered Morphine and Bupivicaine on Acute and Chronic Postmastectomy Pain|Effect of Locally Administered Morphine and Bupivicaine on Acute and Chronic Postmastectomy Pain|Completed||Phase 2|120|Actual|Assiut University||4|||f||||t||||||||||2017-10-10 23:15:00.268275|2017-10-10 23:15:00.268275
NCT02462564|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-08-16|||June 2014||2014-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Observational|||Risk Factors for Early POCD in the Patients With PSM Undergoing CRS-HIPEC|Risk Factors for Early POCD(Postoperative Cognitive Dysfunction) in the Patients With PSM(Peritoneal Surface Malignancies )Undergoing CRS(Cytoreductive Surgery) and HIPEC(Hyperthermic Intraperitoneal Chemo-therapy)|Completed||N/A|31|Actual|Wuhan University|||2||f||||t||||||Samples Without DNA|"     venous blood sample   "|||2017-10-10 23:15:00.350487|2017-10-10 23:15:00.350487
NCT02462551|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-04-05|||September 2013||2013-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|FEAST||Focal Electrically Administered Seizure Therapy for the Treatment of Depression|Investigating the Effects of Focal Electrically Administered Seizure Therapy (FEAST) for the Treatment of Depression|Recruiting||N/A|30|Anticipated|American University of Beirut Medical Center||1|||f||||f||||||||||2017-10-10 23:15:00.41461|2017-10-10 23:15:00.41461
NCT02462538|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-06-26|||May 2015||2015-05-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL|"A Window of Opportunity Trial With Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ Anaplastic Large Cell Lymphoma or Patients Ineligible for Chemotherapy"|Recruiting||Phase 1/Phase 2|10|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||||2017-10-10 23:15:00.609363|2017-10-10 23:15:00.609363
NCT02462525|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-06-01|||May 6, 2015||2015-05-06|June 2017|2017-06-01|May 21, 2019|Anticipated|2019-05-21|April 3, 2019|Anticipated|2019-04-03||Interventional|||Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma|A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma|Terminated||Phase 1|74|Actual|AbbVie||2||No Go decision for ABBV-838|f||||f||||||||||2017-10-10 23:15:00.742436|2017-10-10 23:15:00.742436
NCT02462512|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-10-30|||April 2015||2015-04-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|March 2016|Actual|2016-03-01||Observational|Elastography||Diagnostic Performance of Ultrasound Elastography for Detection of Thyroid Cancer|Validation of Diagnostic Performance of Ultrasound Elastography for Detection of Thyroid Cancer|Recruiting||N/A|590|Anticipated|Seoul St. Mary's Hospital|||1||f||||f||||||||||2017-10-10 23:15:00.873349|2017-10-10 23:15:00.873349
NCT02462499|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-10-15|||June 2014||2014-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population|Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population|Completed||Phase 4|28|Actual|Semmelweis University||1|||f||||f||||||||No||2017-10-10 23:15:00.987892|2017-10-10 23:15:00.987892
NCT02462486|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-09-29|||June 25, 2015|Actual|2015-06-25|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration|Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration|Active, not recruiting||Phase 3|900|Anticipated|Allergan||3|||f||||t|t|f||||||||2017-10-10 23:15:01.08887|2017-10-10 23:15:01.08887
NCT02462473|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-02-22|2016-11-29||May 2015||2015-05-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry|A Sequential and Parallel Cohort Design to Test the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry|Terminated||Phase 2|9|Actual|Janssen Research & Development, LLC|Due to poor enrollment, the study was terminated early by the sponsor after enrolling only 9 participants in Cohort 1 and no participants were enrolled in Cohorts 2 and 3.|3||"Due to poor enrollment sponsor terminated early after enrolling 9 in Cohort 1 and no enrollment   in Cohorts 2 and 3."|f||||f||||||||||2017-10-10 23:15:01.648446|2017-10-10 23:15:01.648446
NCT02462460|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-08-15|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI|Pilot Study Pancreatic and Ovarian Screening MR Imaging of Rapid With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI|Recruiting||N/A|60|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:15:02.327227|2017-10-10 23:15:02.327227
NCT02462278|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2017-04-05|||July 2015||2015-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Measuring Core Body Temperature Using TempuRing|A Study Measuring Core Body Temperature Using TempuRing in Women of Childbearing Age|Recruiting||N/A|25|Anticipated|Prima-Temp, Inc||1|||f||||f||||||||||2017-10-10 23:15:05.000381|2017-10-10 23:15:05.000381
NCT02462447|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-07-03|||June 2015||2015-06-01|July 2017|2017-07-01|February 8, 2017|Actual|2017-02-08|February 8, 2017|Actual|2017-02-08||Observational|||Carbon-11 Labeled Sarcosine in Prostate Cancer|Biodistribution and Mechanism of Action of the 11C-labeled PET Tracer Sarcosine in Patients With Prostate Cancer as Well as Radiation Dosimetry, Plasma Pharmacokinetics and Biodistribution in Healthy Volunteers|Completed||N/A|20|Actual|University of Michigan|||2||f||||t||||||Samples Without DNA|"     Group 1 (prostate cancer patients):      Tissue biopsies from prostate cancer lesions are performed as part of routine clinical care.     These tissues will however be used for research purposes.      Group 2 (healthy men):      No biopsies are performed in volunteers.   "|||2017-10-10 23:15:02.439825|2017-10-10 23:15:02.439825
NCT02462434|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-04-14|||April 2013||2013-04-01|April 2017|2017-04-01|November 15, 2016|Actual|2016-11-15|October 12, 2015|Actual|2015-10-12||Interventional|||Impact of Early Intervention on Maternal Stress in Mothers of Fetuses Diagnosed With Single Ventricle Physiology|Impact of Early Intervention on Maternal Stress in Mothers of Fetuses Diagnosed With Single Ventricle Physiology Requiring Neonatal Surgery|Completed||N/A|40|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:15:02.551292|2017-10-10 23:15:02.551292
NCT02462421|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-08-22|||June 2015||2015-06-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|SGLT2iPGx||Pharmacogenetics of SGLT2 Inhibitors|Pharmacogenetics of Sodium-dependent Glucose Transporter-2 (SGLT2) Inhibitors|Enrolling by invitation||Phase 4|125|Anticipated|University of Maryland||4|||f||||f||||||||||2017-10-10 23:15:02.672083|2017-10-10 23:15:02.672083
NCT02462408|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-06-01|||November 2012||2012-11-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Conventional Versus Posterior Approach in Ultrasound-Guided Parasagittal In-Plane Infraclavicular Brachial Plexus Block|A Prospective, Randomized Comparison Between Lateral and Posterior Approach In Ultrasound-Guided Parasagittal In-Plane Infraclavicular Brachial Plexus Block|Completed||N/A|46|Actual|University of Malaya||2|||f||||f||||||||||2017-10-10 23:15:02.775954|2017-10-10 23:15:02.775954
NCT02462395|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-12-06|||September 2014||2014-09-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ANODECCH||Anodal Transcranial Direct Stimulation (tDCS) for the Treatment of Chronic Cluster Headache|Anodal Transcranial Direct Stimulation (tDCS) of the Anterior Cingulate Gyrus for the Treatment of Chronic Cluster Headache: a Pilot Trial.|Completed||Phase 2/Phase 3|32|Actual|University Hospital of Liege||1|||f||||t||||||||||2017-10-10 23:15:02.861627|2017-10-10 23:15:02.861627
NCT02462382|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-09-21|||September 1, 2013|Actual|2013-09-01|September 2017|2017-09-01|May 20, 2016|Actual|2016-05-20|May 20, 2016|Actual|2016-05-20||Interventional|||Efficacy of Continuous Infusion Ropivacaine Interscalene Blocks|Efficacy of Continuous Infusion Ropivacaine Interscalene Blocks Versus Placebo for Pain Control After Arthroscopic Rotator Cuff Repair|Completed||Phase 4|18|Actual|Orlando Health, Inc.||3|||f||||f||||||||||2017-10-10 23:15:02.939404|2017-10-10 23:15:02.939404
NCT02462369|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-07-27|||June 2015||2015-06-01|April 2015|2015-04-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients|The Effects of Saxagliptin 5mg, Once Daily for 52 Weeks on 24 Hour Urine Albumin Creatinine Rate(ACR) , in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycaemic Control on Metformin or/and Acarbose|Unknown status|Enrolling by invitation|Phase 4|88|Anticipated|The Second Hospital of Nanjing Medical University||2|||f||||f||||||||||2017-10-10 23:15:03.013991|2017-10-10 23:15:03.013991
NCT02462343|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2015-06-03|||March 2007||2007-03-01|June 2015|2015-06-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD|Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD|Completed||N/A|26|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-10 23:15:03.359839|2017-10-10 23:15:03.359839
NCT02462330|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MESAMI2||Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)|Effect of Intramyocardial Mesenchymal Stem Cells Injection in Patients With Chronic Ischemic Cardiomyopathy and Left Ventricular Dysfunction Guide by NogaStar XP System Catheter.|Recruiting||Phase 2|90|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||No||2017-10-10 23:15:03.470558|2017-10-10 23:15:03.470558
NCT02462317|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-12-13|||April 2015||2015-04-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|BacloTox||Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment|Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment: Double Blinded Comparison Between Botulinum Toxin and Baclofen.|Recruiting||Phase 4|300|Anticipated|University Hospital, Toulouse||3|||f||||f||||||||Undecided||2017-10-10 23:15:03.648885|2017-10-10 23:15:03.648885
NCT02462304|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-04-17|||June 2015||2015-06-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|END-DME||To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema|To Compare the Efficacy of Monotherapy With Anti-Vascular Endothelial Growth Factor (Ranibizumab or Bevacizumab) Versus Combination Therapy With Anti-Vascular Endothelial Growth Factor and End-point-management Grid Laser Photocoagulation for Diabetic Macular Edema|Enrolling by invitation||Phase 4|60|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:15:03.876735|2017-10-10 23:15:03.876735
NCT02462291|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-01-30|2015-12-01||June 2015||2015-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|ABCD||New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders)|Effectiveness of Environmental Therapy in Patients With Alzheimer's Disease|Completed||N/A|163|Actual|Universita di Verona||2|||f||||t||||||||||2017-10-10 23:15:04.039023|2017-10-10 23:15:04.039023
NCT02462265|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-03-28|||January 2017||2017-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients|A Phase II, Open-Label, Single- Center Study to Assess the Activity of Oshadi D and Oshadi R in Combination With Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) Patients|Not yet recruiting||Phase 2|15|Anticipated|Oshadi Drug Administration||1|||f||||t||||||||||2017-10-10 23:15:05.093722|2017-10-10 23:15:05.093722
NCT02462252|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2017-08-16|||October 2015||2015-10-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome|A Phase IIA, Open-label Study Designed to Evaluate Efficacy and Safety of BL-8040 Followed by Anti-Thymocyte Globulin (hATG), Cyclosporine and Methylprednisolone in Adult Subjects With Aplastic Anemia (AA) or Hypoplastic Myelodysplastic Syndrome (MDS)|Recruiting||Phase 2|25|Anticipated|BioLineRx, Ltd.||1|||f||||t||||||||||2017-10-10 23:15:05.163124|2017-10-10 23:15:05.163124
NCT02462239|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-02-24|||January 2016||2016-01-01|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|April 2018|Anticipated|2018-04-01||Interventional|PET MUSE||Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging|Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging|Recruiting||N/A|291|Anticipated|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-10-10 23:15:05.266671|2017-10-10 23:15:05.266671
NCT02462226|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-04-19|||May 1, 2015|Actual|2015-05-01|April 2017|2017-04-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|Lymph-Flow||Enhancing Management of Chronic Pain and Symptoms Among Women Treated for Breast Cancer (Lymph-Flow)|The-Optimal-Lymph-Flow ™: An e-Health Approach to Enhancing Management of Chronic Pain and Symptoms Related to Lymphedema Among Women Treated for Breast Cancer|Completed||N/A|120|Actual|New York University School of Medicine||2|||f||||t|f|f||||||||2017-10-10 23:15:05.407452|2017-10-10 23:15:05.407452
NCT02462213|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-02|||October 2013||2013-10-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PICA-CMR||Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging|The Influence of Amyloid Protein on Myocardial Tissue Characteristics and Function: Prognostic and Diagnostic Significance of Cardiac Magnetic Resonance Findings|Active, not recruiting||N/A|40|Anticipated|University of Cincinnati|||2||f||||t||||||||||2017-10-10 23:15:05.489053|2017-10-10 23:15:05.489053
NCT02462200|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-06-08|||June 13, 2016|Actual|2016-06-13|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|SMART||Shave Margins in Breast Conservation Therapy|Shave Margins in Breast Conservation Therapy (SMART): A Randomized Controlled Trial|Recruiting||Phase 2|550|Anticipated|Washington University School of Medicine||2|||f||||t|f|t|f|f|f|||No||2017-10-10 23:15:05.6187|2017-10-10 23:15:05.6187
NCT02462187|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-01-03|||May 2015||2015-05-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|October 2016|Actual|2016-10-01||Interventional|||Topical NVN1000 for the Treatment of External Genital and Perianal Warts|A Phase 2, Multi-center, Double-blind, Randomized, Vehicle-controlled, Ascending Dose Study Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects With External Genital Warts and Perianal Warts|Active, not recruiting||Phase 2|108|Actual|Novan, Inc.||5|||f||||t||||||||No||2017-10-10 23:15:05.742701|2017-10-10 23:15:05.742701
NCT02462174|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-10-01|||May 2015||2015-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|TKversusCK||Topical Ketamine Versus Caudal Ketamine for Postoperative Analgesia in Children Undergoing Inguinal Herniotomy|Caudal Epidural Block Versus Topical Ketamine Application for Postoperative Pain Relief After Elective Inguinal Herniotomy|Completed||Phase 2/Phase 3|80|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 23:15:05.852968|2017-10-10 23:15:05.852968
NCT02462161|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-04-17|||May 2015||2015-05-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|SNIFF-Quick||Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart|Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart|Recruiting||Phase 1|30|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-10 23:15:05.942649|2017-10-10 23:15:05.942649
NCT02462148|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-09-06|||July 2015||2015-07-01|October 2016|2016-10-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Perineural Steroids for Peripheral Nerve Blocks|Perineural Steroids for Saphenous Peripheral Nerve Blocks: An Equivalency Dosing Study.|Completed||Phase 4|85|Actual|Wake Forest University Health Sciences||3|||f||||f||||||||||2017-10-10 23:15:06.033129|2017-10-10 23:15:06.033129
NCT02462135|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-03|||March 2014||2014-03-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|October 2016|Anticipated|2016-10-01||Interventional|||Protocol of Virtual Interactive Memory-Training Program|The Development and Evaluation of the Effectiveness of a Virtual Interactive Memory Training Program for Older Adults With Mild Cognitive Impairment: Protocol of a Randomized Controlled Study|Unknown status|Recruiting|N/A|150|Anticipated|Ministry of Science and Technology, Taiwan||2|||f||||t||||||||||2017-10-10 23:15:06.125882|2017-10-10 23:15:06.125882
NCT02462122|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-08-15|||July 2015||2015-07-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis|A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis|Active, not recruiting||Phase 3|210|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 23:15:06.215274|2017-10-10 23:15:06.215274
NCT02462109|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-02|||March 2013||2013-03-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CINS||Catatonia in Nodding Syndrome and Lorazepam Treatment|Catatonia in Ugandan Children With Nodding Syndrome and Effects of Treatment With Lorazepam: A Pilot Study|Completed||Phase 1|16|Actual|Makerere University||1|||f||||f||||||||||2017-10-10 23:15:06.306263|2017-10-10 23:15:06.306263
NCT02462096|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-04-18|||June 2015||2015-06-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|ReLeaf||A Feasibility Study of the ReLeaf Catheter System|A Feasibility Study of the InterVene ReLeaf Catheter System in the Creation of Tissue Leaflets in the Femoral and/or Popliteal Vein|Active, not recruiting||N/A|30|Anticipated|Intervene, Inc.||1|||f||||t||||||||||2017-10-10 23:15:06.37267|2017-10-10 23:15:06.37267
NCT02462083|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-04-26|||August 11, 2015|Actual|2015-08-11|April 2017|2017-04-01|April 24, 2017|Actual|2017-04-24|January 2017|Actual|2017-01-01||Interventional|||Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis|A Phase 3, Multicenter, Open Label Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis|Completed||Phase 3|555|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||Yes||2017-10-10 23:15:06.440554|2017-10-10 23:15:06.440554
NCT02462070|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-04-26|||August 11, 2015|Actual|2015-08-11|April 2017|2017-04-01|December 1, 2016|Actual|2016-12-01|November 8, 2016|Actual|2016-11-08||Interventional|||Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis|A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis|Completed||Phase 3|203|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-10 23:15:06.73624|2017-10-10 23:15:06.73624
NCT02462044|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-01-04|||August 2014||2014-08-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|EICAR||Contrast Enhancement on Coronary Computed Tomographic Angiography|Contrast Enhancement on Coronary Computed Tomographic Angiography : Effects on Intra-Coronary Attenuation Using Low Iodine Concentrations While Maintaining Identical IDR (EICAR-Trial)|Completed||Phase 4|200|Actual|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-10 23:15:06.925083|2017-10-10 23:15:06.925083
NCT02462031|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-06-02|||March 2015||2015-03-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects|A Randomized, Double-blind, Placebo-controlled, Single or Multiple Ascending Dose Phase I Clinical Trial to Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects|Unknown status|Recruiting|Phase 1|38|Anticipated|Kwang Dong Pharmaceutical co., ltd.||2|||f||||f||||||||||2017-10-10 23:15:07.025074|2017-10-10 23:15:07.025074
NCT02462018|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2015-05-31|||May 2015||2015-05-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of Functional Electrical Stimulation on Gait in Children With Cerebral Palsy|Effects of Functional Electrical Stimulation on Gait in Children With Hemiplegic and Diplegic Cerebral Palsy|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-10 23:15:07.13018|2017-10-10 23:15:07.13018
NCT02462005|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-08-22|||February 2015||2015-02-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01|24 Months|Observational [Patient Registry]|||Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter. All Comers Registry.|Ranger DEB All Comers Registry - Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter: An All Comers Registry.|Recruiting||N/A|250|Anticipated|Klinikum Arnsberg|||1||f||||f||||||||||2017-10-10 23:15:07.233388|2017-10-10 23:15:07.233388
NCT02461992|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-07-28|2016-05-09||July 2015||2015-07-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||The baseline analysis population included all participants who received at least 1 dose of study drug.|Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A|An Open-label, Single Dose Pharmacokinetic Study Of Xyntha (Moroctocog Alfa (Af-cc), Recombinant Factor Viii) In Male Chinese Subjects With Hemophilia A|Completed||Phase 1|13|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:15:07.343697|2017-10-10 23:15:07.343697
NCT02461979|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2016-10-17|||February 2015||2015-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis|The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis in Cirrhotic Patients Infected With Chronic Hepatitis C Virus|Recruiting||N/A|50|Anticipated|Tanta University||3|||f||||t||||||||No||2017-10-10 23:15:07.698826|2017-10-10 23:15:07.698826
NCT02461953|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2017-05-10|||June 2015||2015-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination of Hemodialysis With Hemoperfusion：A Clinical Study|HA130 Hemoperfusion Apparatus Combined Hemodialysis to Improve Quality of Life in Patients Undergoing Maintenance Hemodialysis：A Perspective, Randomized, Controlled Multicenter Clinical Study|Recruiting||N/A|400|Anticipated|Chinese PLA General Hospital||4|||f||||t||||||||||2017-10-10 23:15:07.886406|2017-10-10 23:15:07.886406
NCT02461940|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-05-06|||November 2009||2009-11-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||STI/HIV Prevention Intervention for Adolescents in Singapore|A Randomized Controlled Trial of an STI/HIV/AIDS Prevention Intervention for Adolescents Attending a Public STI Clinic in Singapore|Completed||N/A|688|Actual|National University, Singapore||2|||f||||t||||||||||2017-10-10 23:15:07.984489|2017-10-10 23:15:07.984489
NCT02461927|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-09-20|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder|Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder|Recruiting||Phase 1/Phase 2|65|Anticipated|VA Office of Research and Development||3|||f||||f|t|f|||t|||||2017-10-10 23:15:08.073251|2017-10-10 23:15:08.073251
NCT02461017|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-06-29|||December 7, 2015|Actual|2015-12-07|June 2017|2017-06-01|February 21, 2017|Actual|2017-02-21|January 9, 2017|Actual|2017-01-09||Observational|||Endotracheal Tube Audible Leak Test|Endotracheal Tube Audible Leak Test: What is the Accuracy?|Completed||N/A|86|Actual|University of Mississippi Medical Center|||1||f||||t||||||||||2017-10-10 23:15:18.237485|2017-10-10 23:15:18.237485
NCT02461914|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-23|||August 1, 2015|Actual|2015-08-01|January 2016|2016-01-01|July 13, 2016|Actual|2016-07-13|December 12, 2015|Actual|2015-12-12||Interventional|||Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects|An Open-label,Sequential,Single-site Study to Evaluate the Pharmacokinetics of Warfarin When Coadministered With Polyethylene Glycol Loxenatide (PEX168) in Healthy Adult Subjects|Completed||Phase 1|16|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||1|||f||||t||||||||No||2017-10-10 23:15:08.155393|2017-10-10 23:15:08.155393
NCT02461901|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-05-08|||January 2015||2015-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 31, 2016|Actual|2016-12-31||Observational|||Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?|Does Using Fidaxomicin to Treat Clostridium Difficile Infection (CDI) Reduce the Recovery of C. Difficile From Patients' Faeces, Skin and Their Immediate Environment, Compared to Treatment With Vancomycin or Metronidazole?|Active, not recruiting||N/A|203|Actual|University of Leeds|||2||f||||f||||||Samples Without DNA|"     Isolates of Clostridium difficile   "|Undecided||2017-10-10 23:15:08.240221|2017-10-10 23:15:08.240221
NCT02461888|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-11-16|||December 2015||2015-12-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|MUKEight||Phase II Randomised Trial of Cyclophosphamide and Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.|A Randomised Phase II Trial of Cyclophosphamide and Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma (RRMM) Patients Who Have Relapsed After Treatment With Thalidomide, Lenalidomide and Bortezomib.|Recruiting||Phase 2|250|Anticipated|University of Leeds||2|||f||||t||||||||Undecided||2017-10-10 23:15:08.357734|2017-10-10 23:15:08.357734
NCT02461875|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-11-15|||May 2013||2013-05-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome|Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome: a Randomized Controlled Trial|Recruiting||Phase 2|236|Anticipated|Aljazeera Hospital||2|||f||||t||||||||||2017-10-10 23:15:08.506283|2017-10-10 23:15:08.506283
NCT02461862|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-06-01|||January 2015||2015-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Vital Signs and Pain During Insertion of IUD|Assessment of Vital Signs and Pain During Insertion of Intra Uterine Device|Completed||N/A|285|Actual|Federal University of São Paulo|||1||f||||t||||||||||2017-10-10 23:15:08.612436|2017-10-10 23:15:08.612436
NCT02461849|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-02-15|||April 4, 2014|Actual|2014-04-04|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy|A Phase II, Open-label, Study in Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy|Recruiting||Phase 2|33|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:15:08.709263|2017-10-10 23:15:08.709263
NCT02461836|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-04-04|||August 2015||2015-08-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)|An Open-Labeled, Randomized Phase II Trial of Adjuvant Chemotherapy in Combination With Stereotactic Body Radiation Therapy (SBRT) Versus Adjuvant Chemotherapy Alone for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)|Recruiting||Phase 2|513|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||f||||||||No||2017-10-10 23:15:08.804341|2017-10-10 23:15:08.804341
NCT02461823|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-31|||June 2015||2015-06-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||The Influence of Porcelain Fused to Metal ( PFM) and Zirconia Crowns on Periodontal Health|The Influence of Porcelain Fused to Metal ( PFM) and Zirconia Crowns on Periodontal Health|Unknown status|Not yet recruiting|N/A|20|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-10 23:15:08.909743|2017-10-10 23:15:08.909743
NCT02461810|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-02-17|||April 2015||2015-04-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|SAKOS||Prospective Comparative Study to Compare Safety and Effectiveness of Two Vertebral Compression Fracture Reduction Techniques|A Prospective, Multicenter, Randomized, Comparative Clinical Study to Compare the Safety and Effectiveness of Two Vertebral Compression Fracture (VCF) Reduction Techniques: the SpineJack® and the KyphX Xpander® Inflatable Bone Tamp|Active, not recruiting||N/A|152|Actual|Vexim SA||2|||f||||t||||||||Undecided||2017-10-10 23:15:08.989204|2017-10-10 23:15:08.989204
NCT02461797|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-29|||August 2014||2014-08-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients|Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients|Completed||N/A|26|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||||2017-10-10 23:15:09.105732|2017-10-10 23:15:09.105732
NCT02461784|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-10-31|||June 2015||2015-06-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease|The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease|Recruiting||N/A|150|Anticipated|University of Wisconsin, Madison|||2||f||||f||||||||||2017-10-10 23:15:09.18833|2017-10-10 23:15:09.18833
NCT02461771|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-02|2016-06-08|||January 2015||2015-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ASAP II||Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal APL-2 for Patients With Wet AMD|Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal APL-2 Therapy for Neovascular Age-Related Macular Degeneration (AMD)|Completed||Phase 1|13|Actual|Apellis Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-10 23:15:09.274454|2017-10-10 23:15:09.274454
NCT02461758|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-11-29|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients|Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients|Recruiting||N/A|80|Anticipated|University of Wisconsin, Madison||3|||f||||f||||||||||2017-10-10 23:15:09.367603|2017-10-10 23:15:09.367603
NCT02460601|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-12-08|||December 2013||2013-12-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||The Efficacy and Safety of Qizhiweitong Granule on Patients With Functional Dyspepsia in a Multi-center Clinical Study||Completed||Phase 4|400|Actual|Wuhan Union Hospital, China||2|||f||||||||||||||2017-10-10 23:15:22.34801|2017-10-10 23:15:22.34801
NCT02461745|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-31|2016-10-18|||June 2015||2015-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|October 2016|Actual|2016-10-01||Interventional|||Real World Study: Genotype 1 Chronic HCV Treatment and Evaluation of Real World SVR and PROs|A Phase IV, Multisite Study of the Treatment of Chronic Hepatitis C Virus Infection Genotype 1 in a Real World Large Health Maintenance Organization: An Evaluation of Real World Sustained Virological Response and Patient Reported Outcomes|Active, not recruiting||Phase 4|200|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-10 23:15:09.44742|2017-10-10 23:15:09.44742
NCT02461732|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-05-09|||August 2014||2014-08-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence|Randomized Controlled Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence|Completed||N/A|60|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-10 23:15:09.536996|2017-10-10 23:15:09.536996
NCT02461706|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-03-01||||||March 2017|2017-03-01||||||||Expanded Access|Cannabidiol||Treatment of Drug Resistant Epilepsy|Physician Expanded Access to Investigational New Drug Cannabidiol for the Treatment of Drug Resistant Epilepsy|Available||N/A|||University of Florida|||||||||||||||||||2017-10-10 23:15:09.689211|2017-10-10 23:15:09.689211
NCT02461693|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-06-13|2017-03-07||June 2015||2015-06-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT|Evaluating the Role of Expectations in Response to Caffeine Consumption: A Randomized Control Trial|Completed||N/A|205|Actual|University of Alabama at Birmingham|Please refer to our publication in Psyhcological Methods|2|||f||||f||f|||f|||Yes|Raw de-identified data will be posted as a replication data set on ICPSR after publication of results in a journal. Data will be free to download and accessible to anyone with access to ICPSR replication data sets.|2017-10-10 23:15:09.769105|2017-10-10 23:15:09.769105
NCT02461680|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-07|||July 2015||2015-07-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|FLEXOR||Treatment for Partial Lesions of the Fingers Flexor Tendons : Tangential Resection or Direct Suture|Management Of The Partial Lesions Of The Fingers Flexor Tendons, Prospective Randomized Trial Of 2 Surgical Procedures: Tangential Resection Versus Direct Suture|Recruiting||N/A|50|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:15:10.12834|2017-10-10 23:15:10.12834
NCT02461667|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-31|||July 2014||2014-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Alendronate Compared to Metformin in Chronic Periodontitis|Comparative Evaluation of Subgingivally Delivered 1% Metformin and 1% Alendronate Gel in Treatment of Chronic Periodontitis: a Randomized Placebo Controlled Clinical Trial|Completed||Phase 2/Phase 3|108|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||t||||||||||2017-10-10 23:15:10.207196|2017-10-10 23:15:10.207196
NCT02461654|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-07-25|||May 2015||2015-05-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Observational|EPCSIII||EuroPainClinics® Study III (Prospective Observational Study)|EuroPainClinics® Study III (Prospective Observational Study)|Recruiting||N/A|150|Anticipated|Europainclinics z.ú.|||1||f||||t||||||||||2017-10-10 23:15:10.291105|2017-10-10 23:15:10.291105
NCT02461641|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-09-14|||March 2015||2015-03-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers|The NuTech NuShield and Affinity Membrane Product Evaluation for the Treatment Neuropathic Diabetic Ulcers (DFU)|Recruiting||N/A|100|Anticipated|NuTech Medical, Inc||3|||f||||f||||||||||2017-10-10 23:15:10.376766|2017-10-10 23:15:10.376766
NCT02461628|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-10-02|||July 2015||2015-07-01|March 2017|2017-03-01|July 12, 2017|Actual|2017-07-12|May 26, 2017|Actual|2017-05-26||Interventional|||Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (Aim 2)|Innovative Partnership to Target Antimalarial Subsidies in the Retail Sector|Completed||N/A|38005|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:15:10.512433|2017-10-10 23:15:10.512433
NCT02461615|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-08-26|||April 2015||2015-04-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01|5 Years|Observational [Patient Registry]|||A National Registry For Pulmonary Alveolar Proteinosis|A National Registry For Pulmonary Alveolar Proteinosis|Recruiting||N/A|500|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||Samples With DNA|"     Capillary blood samples on diagnostic blood spot cards may be retained.   "|||2017-10-10 23:15:10.753391|2017-10-10 23:15:10.753391
NCT02461602|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-11-25|||February 2016||2016-02-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01|6 Months|Observational [Patient Registry]|ELITE||Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients|Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients|Recruiting||N/A|500|Anticipated|Duke University|||1||f||||f||||||||No||2017-10-10 23:15:10.88787|2017-10-10 23:15:10.88787
NCT02461589|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-09-22||2017-09-22|September 21, 2015|Actual|2015-09-21|September 2017|2017-09-01|October 13, 2016|Actual|2016-10-13|October 13, 2016|Actual|2016-10-13||Interventional|||Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes|Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes|Completed||Phase 2|706|Actual|Novo Nordisk A/S||13|||f||||f||||||||||2017-10-10 23:15:11.14298|2017-10-10 23:15:11.14298
NCT02461576|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-02|||July 2015||2015-07-01|June 2015|2015-06-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Observational|||Clinical Evaluation of the Xpert® HIV-1 VL|Clinical Evaluation of the Xpert® HIV-1 VL: A Method Comparison Study|Unknown status|Not yet recruiting|N/A|400|Anticipated|Cepheid|||1||f||||f||||||Samples With DNA|"     Leftover plasma specimens will be retained in a biobank.   "|||2017-10-10 23:15:11.61985|2017-10-10 23:15:11.61985
NCT02461563|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-01-19|||June 2015||2015-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)|A Multiple-Dose Study to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of MK-1075 in GT3 and GT1 HCV Infected Patients|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-10 23:15:11.714265|2017-10-10 23:15:11.714265
NCT02461550|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-02-27|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Irreversible Electroporation Ablation for Colorectal Metastases to the Lung|Irreversible Electroporation Ablation for Colorectal Metastases to the Lung|Completed||N/A|2|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:15:11.813104|2017-10-10 23:15:11.813104
NCT02461537|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-09-04|||June 2015||2015-06-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|December 2018|Anticipated|2018-12-01||Interventional|ETAL3-ASAP||Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML|Evaluation of the Impact of Remission Induction Chemotherapy Prior to Allogeneic Stem Cell Transplantation in Relapsed and Poor-response Patients With AML|Recruiting||Phase 3|308|Anticipated|DKMS gemeinnützige GmbH||2|||f||||f||||||||||2017-10-10 23:15:11.92072|2017-10-10 23:15:11.92072
NCT02461524|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-01-11|||May 2015||2015-05-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Endurant Evo International Clinical Trial|Endurant Evo International Clinical Trial|Active, not recruiting||N/A|69|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-10-10 23:15:12.109191|2017-10-10 23:15:12.109191
NCT02461511|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-02|||June 2015||2015-06-01|May 2015|2015-05-01|November 2016|Anticipated|2016-11-01|July 2016|Anticipated|2016-07-01||Observational|ImETh||Impact of Therapeutic Education, Being Set up Under the Authorized Program for Diabetics Patients in Hospital|Impact Des Actions d'éducation thérapeutique Mises en Place Dans le Cadre d'un Programme autorisé auprès de Patients diabétiques hospitalisés|Unknown status|Not yet recruiting|N/A|150|Anticipated|Hôpital Léon Bérard|||3||f||||f||||||||||2017-10-10 23:15:12.205578|2017-10-10 23:15:12.205578
NCT02461498|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-05-29|||July 2011||2011-07-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||The AHEAD Study: Monitoring Anticoagulated Patients Who Suffer Head Injury|The AHEAD Study: Monitoring Anticoagulated Patients Who Suffer Head Injury|Completed||N/A|3556|Actual|University of Sheffield|||1||f||||f||||||||||2017-10-10 23:15:12.284597|2017-10-10 23:15:12.284597
NCT02461485|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-08-21|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|October 12, 2016|Actual|2016-10-12|July 2016|Actual|2016-07-01||Interventional|||Effect of a Fermented Milk Product With Probiotics Alone or in Combination With Fibers on Constipation Symptoms|Evaluation of Effects of Fermented Dairy Products Containing Probiotics Alone or in Association With Fibers on Bowel Functions, Constipation Symptoms and Health Related Quality of Life in Adult Subjects With Moderate Constipation: an Exploratory Randomized Double-blind, Controlled Adaptive Study|Completed||N/A|153|Actual|Danone Research||4|||f||||t||||||||||2017-10-10 23:15:12.371669|2017-10-10 23:15:12.371669
NCT02461472|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-09-05|||January 2013||2013-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Risk Analysis for Diabetic Cardiovascular Autonomic Neuropathy|The Risk Analysis for Diabetic Cardiovascular Autonomic Neuropathy in General Chinese Population|Recruiting||N/A|2000|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||t||||||||||2017-10-10 23:15:12.463235|2017-10-10 23:15:12.463235
NCT02461459|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-18|||May 2015||2015-05-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)|Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)|Recruiting||N/A|100|Anticipated|Boston Children’s Hospital|||1||f||||t||||||Samples With DNA|"     Blood draw for future correlative studies in the TSC Biorepository of the Developmental     Synaptopathies Consortium.   "|||2017-10-10 23:15:12.558679|2017-10-10 23:15:12.558679
NCT02461446|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-18|||May 2015||2015-05-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations|Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations|Recruiting||N/A|120|Anticipated|Boston Children’s Hospital|||4||f||||t||||||Samples With DNA|"     Blood draw for future correlative studies in the PTEN Biorepository of the Developmental     Synaptopathies Consortium.   "|||2017-10-10 23:15:12.686738|2017-10-10 23:15:12.686738
NCT02461420|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-18|||May 2015||2015-05-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome|Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome|Recruiting||N/A|105|Anticipated|Boston Children’s Hospital|||1||f||||t||||||Samples With DNA|"     Blood draw for future correlative studies in the PMS Biorepository of the Developmental     Synaptopathies Consortium   "|||2017-10-10 23:15:12.890777|2017-10-10 23:15:12.890777
NCT02461407|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-07-25|||June 2015||2015-06-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)|A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Compare the Efficacy and Safety of Anlotinib Versus Placebo in Patients With Gastric Cancer(ALTER0503)|Recruiting||Phase 2/Phase 3|378|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-10 23:15:13.012555|2017-10-10 23:15:13.012555
NCT02461394|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-01-25|||May 2015||2015-05-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Interventional|||User Performance Evaluation of Contour Plus, Accu-Chek Active, Accu-Chek Performa and OneTouch Select Simple Blood Glucose Monitoring Systems Following ISO 15197:2013|User Performance Evaluation of Contour Plus, Accu-Chek Active, Accu-Chek Performa and OneTouch Select Simple Blood Glucose Monitoring Systems Following ISO 15197:2013|Completed||N/A|150|Anticipated|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm|||||f||||||||||||||2017-10-10 23:15:13.18701|2017-10-10 23:15:13.18701
NCT02461381|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-09-05|||January 2013||2013-01-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Bayesian Estimation of Diagnostic Performance of Diabetic Cardiovascular Autonomic Neuropathy Without a Gold Standard|Bayesian Estimation of Diagnostic Performance of Short-term Heart Rate Variability for Diabetic Cardiovascular Autonomic Neuropathy in the Absence of a Gold Standard|Recruiting||N/A|200|Anticipated|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||t||||||||||2017-10-10 23:15:13.243324|2017-10-10 23:15:13.243324
NCT02461368|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-06-03|||December 2012||2012-12-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Ultrasound-Guided Glenohumeral Steroid Injection|Comparison Between Anterior and Posterior Approaches for Ultrasound-guided Glenohumeral Steroid Injection: A Randomized Controlled Trial|Completed||N/A|50|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||||2017-10-10 23:15:13.332882|2017-10-10 23:15:13.332882
NCT02461355|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-06-16|||June 2015||2015-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Transcranial Direct Current Stimulation for Post-Stroke Aphasia|Enhancing Aphasia Therapy With Anodal Transcranial Direct Current Stimulation in Chronic Stroke Patients|Terminated||N/A|2|Actual|Columbia University||2||Poor recruitment|f||||f||||||||||2017-10-10 23:15:13.472057|2017-10-10 23:15:13.472057
NCT02461342|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-09-20|||January 2011||2011-01-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|||Genetic, Environment and Its Interaction Analysis for Cardiovascular Autonomic Neuropathy|Genetic, Environment and Its Interaction Analysis for Cardiovascular Autonomic Neuropathy in Chinese Population|Completed||N/A|2100|Actual|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||t||||||Samples With DNA|"     DNAs were extracted and genetyped by using SNP.   "|||2017-10-10 23:15:13.549877|2017-10-10 23:15:13.549877
NCT02461329|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-06-02|||May 2015||2015-05-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|Gelaring||Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy|Comparison of the Effects of Gelatine (Gelofusine ® B. Braun) Versus Crystalloid Solution (Ringerfundin ® B. Braun) for Volume Therapy on Coagulation, Thrombocyte Function and Thrombelastometry (ROTEM ®), in Elective Hip Replacement Surgery|Unknown status|Not yet recruiting|N/A|50|Anticipated|Brno University Hospital||2|||f||||t||||||||||2017-10-10 23:15:13.632221|2017-10-10 23:15:13.632221
NCT02461316|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-11-01|||July 2009||2009-07-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia|Open, Non-Interventional, Multicentre Trial of Rituximab in Combination With FC for the First-Line Therapy of Patients With Chronic Lymphocytic Leukaemia|Completed||N/A|22|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:15:13.708541|2017-10-10 23:15:13.708541
NCT02461303|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-08-25|||November 2015||2015-11-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Fertility Assessment in Patients With Klinefelter Syndrome|Non-Invasive Methods to Maximize Fertility in Peri-Pubertal Patients With Klinefelter Syndrome|Recruiting||N/A|60|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Urine and semen samples   "|||2017-10-10 23:15:13.784802|2017-10-10 23:15:13.784802
NCT02461290|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-08-31|2015-08-31||April 2008||2008-04-01|August 2015|2015-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational||Intent-to-Treat (ITT) Population: All participants enrolled into the study.|Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1|Open, Noninterventional, Multicentre Trial of Rituximab in Combination With Chemotherapy (CVP, CHOP or FCM) Chemotherapy in Patients With Follicular Lymphoma|Completed||N/A|99|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:15:13.888034|2017-10-10 23:15:13.888034
NCT02461277|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-01|||April 2010||2010-04-01|May 2015|2015-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Postoperatory Recovery in Thoracic Surgical Procedure, Fast-track Protocol vs. Conventional Care|Postoperatory Recovery in Thoracic Surgical Procedure, Fast-track Protocol vs. Conventional Care|Completed||N/A|40|Actual|Instituto do Coracao||2|||f||||t||||||||||2017-10-10 23:15:14.131693|2017-10-10 23:15:14.131693
NCT02461264|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-08-30|||January 2016||2016-01-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|1VERSUS2CGR||Transfusion Strategy in Hematological Intensive Care Unit|Randomized Multicenter Trial of Two Transfusion Strategies for Patient Receiving Chemotherapy for Acute Leukemia or Hematopoietic Stem Cells With Medico-economic Evaluation of Cost Minimization.|Recruiting||Phase 3|230|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:15:16.181452|2017-10-10 23:15:16.181452
NCT02461251|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-10-20|||January 2016||2016-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ROTEM-PPH||Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients|Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients|Recruiting||N/A|60|Anticipated|Tampere University Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:15:16.283705|2017-10-10 23:15:16.283705
NCT02461238|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-29|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|FLAM||Impact of Vouchers and Nutrition Education on the Consumption of Fruits and Vegetables Among Vulnerable Families (FLAM)|Etude Fruits et Légumes à la Maison (FLAM)|Completed||N/A|92|Actual|University of Paris 13||2|||f||||f||||||||||2017-10-10 23:15:16.380605|2017-10-10 23:15:16.380605
NCT02461225|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-05-21|||August 23, 2015||2015-08-23||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:15:16.471204|2017-10-10 23:15:16.471204
NCT02461212|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-04-06|||July 1, 2015|Actual|2015-07-01|April 2017|2017-04-01|March 17, 2017|Actual|2017-03-17|March 17, 2017|Actual|2017-03-17||Interventional|||Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth|Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth|Completed||N/A|50|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:15:16.520761|2017-10-10 23:15:16.520761
NCT02461199|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-02|||February 2015||2015-02-01|June 2015|2015-06-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Observational|START||Stool Transplantation to Reduce Antibiotic Resistance Transmission|Prospective Observational Study of Fecal Microbiota Transplantation Used to Eradicate Gut-colonizing Multidrug-resistant Bacteria in Patients With Blood Disorders|Unknown status|Recruiting|N/A|50|Anticipated|Medical University of Warsaw|||1||f||||f||||||Samples With DNA|"     Stool samples collected before and after the procedure.   "|||2017-10-10 23:15:16.603866|2017-10-10 23:15:16.603866
NCT02461186|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-11-02|||June 2015||2015-06-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar|An Open-label Randomized Trial to Assess the Therapeutic Efficacy of Arterolane-piperaquine Versus Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Falciparum Malaria in Eastern Myanmar, an Area of Emerging Artemisinin-resistant Falciparum Malaria|Withdrawn||Phase 2/Phase 3|0|Actual|University of Oxford||2||Change of the study site due to the current political climate in Myanmar.|f||||t||||||||||2017-10-10 23:15:16.69688|2017-10-10 23:15:16.69688
NCT02461173|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-07-28|||June 2015||2015-06-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility|Comparison Between Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility|Recruiting||Phase 3|450|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 23:15:16.770467|2017-10-10 23:15:16.770467
NCT02461160|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-02-07|||June 2015||2015-06-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study|A Phase 1 Safety, Tolerability, Pharmacokinetic, Placebo-Controlled and Open-Label Study of Escalating Single and Multiple Oral Doses, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Subjects of TAK-915 in Healthy Subjects|Completed||Phase 1|112|Anticipated|Takeda||16|||f||||f||||||||||2017-10-10 23:15:16.887236|2017-10-10 23:15:16.887236
NCT02461147|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-06-03|||September 2013||2013-09-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Observational|||"Prospective Validation of Cholecystectomy First Strategy for Gallstone Migration"|Initial Cholecystectomy With Intraoperative Cholangiography for Patients at Intermediate Risk of Common Bile Duct Stone Migration : Prospective Validation and Analysis|Unknown status|Active, not recruiting|N/A|500|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 23:15:17.183397|2017-10-10 23:15:17.183397
NCT02461134|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-04-05|||February 1, 2016|Actual|2016-02-01|April 2017|2017-04-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD|A Phase 2, Open-label, Single-arm, Intra-subject Dose-escalation Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Moderate or Severe Chronic GVHD Inadequately Responding to First or Second Line Therapy|Terminated||Phase 2|30|Actual|Actelion||1||Low recruitment|f||||f|t|f||||||||2017-10-10 23:15:17.270913|2017-10-10 23:15:17.270913
NCT02461121|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-06-02|||May 2004||2004-05-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk|Compare the Safety and Effective of HLA-mismatched Microtransplantation With HLA-matched Nonmyeloablative Transplantation for Acute Myeloid Leukemia in Intermediate-risk|Completed||Phase 3|156|Actual|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||2|||f||||f||||||||||2017-10-10 23:15:17.376224|2017-10-10 23:15:17.376224
NCT02461108|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-01|||May 2010||2010-05-01|June 2015|2015-06-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Nudging Nutrition With Monetary Incentives Environmental Cues|Nudging Nutrition: Evaluating the Impact of Monetary Incentives and Environmental Cues on Food Choices|Completed||N/A|221|Actual|Cornell University||2|||f||||f||||||||||2017-10-10 23:15:17.493773|2017-10-10 23:15:17.493773
NCT02461095|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-01-30|||June 2015||2015-06-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of a Treatment Algorithm for Patients With Patellofemoral Pain Syndrome|Evaluation of a Treatment Algorithm for Patients With Patellofemoral Pain Syndrome: A Randomized Controlled Trial|Recruiting||N/A|58|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-10 23:15:17.601949|2017-10-10 23:15:17.601949
NCT02461082|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-05-11|||May 2015||2015-05-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|||EMST and TMS for Treatment of Dysphagia in Parkinson's Disease|Expiratory Muscle Strength Training (EMST) and Transcranial Magnetic Stimulation (TMS) for Treatment of Swallowing Disorders in Parkinson's Disease|Recruiting||N/A|40|Anticipated|University Hospital Muenster||4|||f||||f||||||||||2017-10-10 23:15:17.725041|2017-10-10 23:15:17.725041
NCT02461069|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-07-10|||May 2015||2015-05-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|DIMAT-MS||Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis|A 24-week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)|Active, not recruiting||Phase 4|75|Anticipated|University Hospital Muenster||2|||f||||f||||||||||2017-10-10 23:15:17.846895|2017-10-10 23:15:17.846895
NCT02461056|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-02|||June 2014||2014-06-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain|Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain|Completed||N/A|90|Actual|Samsung Medical Center||3|||f||||t||||||||||2017-10-10 23:15:17.953173|2017-10-10 23:15:17.953173
NCT02461043|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2015-08-29|||April 2015||2015-04-01|August 2015|2015-08-01|December 2023|Anticipated|2023-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma|Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma: A Randomized Phase 3 Trial|Recruiting||Phase 3|386|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:15:18.050008|2017-10-10 23:15:18.050008
NCT02461030|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-02|||August 2014||2014-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy of Two Oral Hygiene Regimens in the Reduction of Dentin Hypersensitivity After Periodontal Treatment|An 8-Week Clinical Study to Evaluate the Efficacy of Two Oral Hygiene Regimens in the Reduction of Dentin Hypersensitivity After Non-surgical Periodontal Treatment: Randomized Clinical Trial|Completed||Phase 4|60|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-10 23:15:18.147291|2017-10-10 23:15:18.147291
NCT02461004|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2016-10-13|||July 2015||2015-07-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||CKD-391 Pharmacokinetic Study|Clinical Trial to Assess the Pharmacokinetic Characteristics and Safety/Tolerability of CKD-391 in Healthy Male Subjects|Completed||Phase 1|52|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||No||2017-10-10 23:15:18.320574|2017-10-10 23:15:18.320574
NCT02460978|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2017-06-12|||July 8, 2015|Actual|2015-07-08|June 2017|2017-06-01|April 20, 2018|Anticipated|2018-04-20|September 18, 2017|Anticipated|2017-09-18||Interventional|DEPICT 2||Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus - Study Two|Active, not recruiting||Phase 3|727|Actual|AstraZeneca||3|||f||||t||||||||||2017-10-10 23:15:18.516851|2017-10-10 23:15:18.516851
NCT02460965|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-10-25|||November 2013||2013-11-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|UH-2||Understanding Hallucinations (Part II)|Understanding Hallucinations (Part II) - fMRI and EEG|Recruiting||N/A|240|Anticipated|UMC Utrecht|||8||f||||t||||||||||2017-10-10 23:15:19.288479|2017-10-10 23:15:19.288479
NCT02460952|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-02|||August 2014||2014-08-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|January 2016|Anticipated|2016-01-01||Observational|||The Clinic Study to Prevent Pulmonary Embolism in Patients With General Anesthesia Operation in Perioperative Period|The Clinic Study to Prevent Pulmonary Embolism in Patients With General Anesthesia Operation in Perioperative Period|Unknown status|Recruiting|N/A|500|Anticipated|Beijing Chao Yang Hospital|||1||f||||t||||||||||2017-10-10 23:15:19.397094|2017-10-10 23:15:19.397094
NCT02460939|ClinicalTrials.gov processed this data on October 10, 2017|2015-06-01|2015-06-02|||August 2014||2014-08-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|January 2016|Anticipated|2016-01-01||Observational|||The Study on the Pulmonary Vessel Disease and Its Changes in Metabolism of Small Molecules|The Study on the Pulmonary Vessel Disease and Its Its Changes in Metabolism of Small Molecules|Unknown status|Recruiting|N/A|18|Anticipated|Beijing Chao Yang Hospital|||1||f||||t||||||||||2017-10-10 23:15:19.486946|2017-10-10 23:15:19.486946
NCT02460926|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-05-30|||May 2012||2012-05-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|PERIOSYST-1||Acute Phase Response & Periodontal Treatment|Acute Phase Response Following Full Mouth Versus Quadrant Non-Surgical Periodontal Treatment. A Randomized Clinical Trial|Completed||N/A|38|Actual|University of Pisa||2|||f||||f||||||||||2017-10-10 23:15:19.594245|2017-10-10 23:15:19.594245
NCT02460913|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-06-06|||April 2012||2012-04-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|AcuMAP||Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in the Emergency Department|Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in the Emergency Department. An Efficacy and Safety Study|Completed||Phase 2|300|Actual|University of Monastir||2|||f||||f||||||||||2017-10-10 23:15:19.691265|2017-10-10 23:15:19.691265
NCT02460900|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-08-21|||July 2016|Actual|2016-07-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke||Recruiting||Phase 3|300|Anticipated|University of Maryland||4|||f||||t|t|f||||||||2017-10-10 23:15:19.785263|2017-10-10 23:15:19.785263
NCT02460887|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-10-05|||June 2015||2015-06-01|October 2017|2017-10-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT|A Randomized Trial Comparing Induction Gemcitabine and Cisplatin Plus Intensity-modulated Radiotherapy With Concurrent Cisplatin Plus Intensity-modulated Radiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 2|92|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:15:19.896756|2017-10-10 23:15:19.896756
NCT02460874|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-10-04|||August 16, 2017|Actual|2017-08-16|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)|A Pilot Study and Phase II Double Blind Placebo Controlled Randomized Trial Examining the Safety and Efficacy of Glyburide as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases|Recruiting||Phase 1/Phase 2|63|Anticipated|University of Alabama at Birmingham||2|||f||||t|t|f||||||||2017-10-10 23:15:20.032965|2017-10-10 23:15:20.032965
NCT02460861|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-05-29|||November 2011||2011-11-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|October 2013|Actual|2013-10-01||Interventional|iPROLOGX||Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy|Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy (RPVE) in Prostate Cancer (PCA) Patients for Molecular Tumor Marker Analysis|Unknown status|Active, not recruiting|N/A|279|Actual|University of Magdeburg||3|||f||||f||||||||||2017-10-10 23:15:20.143092|2017-10-10 23:15:20.143092
NCT02460848|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-01-04|||July 2015||2015-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Cash Transfers on Severe Acute Malnutrition|Effects of Unconditional Cash Transfers on the Management of Severe Acute Malnutrition (SAM) in the Democratic Republic of Congo: a Cluster Randomized Trial|Completed||N/A|1600|Actual|UNICEF||2|||f||||t||||||||||2017-10-10 23:15:20.246276|2017-10-10 23:15:20.246276
NCT02460835|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-07-03|||December 2015||2015-12-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma|A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma|Active, not recruiting||N/A|35|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:15:20.348242|2017-10-10 23:15:20.348242
NCT02460822|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-03-29|2017-03-29||October 2014||2014-10-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management|Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management|Completed||N/A|16|Actual|University of Michigan|This was a feasibility pilot study.|1|||f||||f||||||||||2017-10-10 23:15:20.449299|2017-10-10 23:15:20.449299
NCT02460809|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-12-06|||January 2017||2017-01-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Home-based Non-invasive Brain Stimulation and Hand Tracking Rehabilitation for People With Chronic Stroke|Home-based tDCS and Hand Tracking Rehabilitation for Chronic Stroke|Not yet recruiting||N/A|6|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 23:15:20.686375|2017-10-10 23:15:20.686375
NCT02460796|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-01|||June 2013||2013-06-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01|8 Weeks|Observational [Patient Registry]|||Hippotherapy and Parkinson's Disease|Hippotherapy on Functional Capacity and Quality of Life in Parkinson's Disease: a Prospective Study|Completed||N/A|18|Actual|University of Brasilia|||2||f||||t||||||||||2017-10-10 23:15:20.773723|2017-10-10 23:15:20.773723
NCT02460783|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-30|2017-09-12|||April 24, 2015||2015-04-24|August 30, 2017|2017-08-30|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function|Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function|Recruiting||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:15:20.851776|2017-10-10 23:15:20.851776
NCT02460770|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-07-02|||June 2015||2015-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MESAD||Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device|Pilot Study of Investigation of Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device|Recruiting||Phase 1|4|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||Undecided||2017-10-10 23:15:20.969438|2017-10-10 23:15:20.969438
NCT02460757|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-12-08|||February 2014||2014-02-01|December 2015|2015-12-01||||December 2015|Actual|2015-12-01||Observational|||Glottic Width and Respiratory Flow in Patients With Various Lung Diseases|Glottic Width and Respiratory Flow in Patients With Various Lung Diseases|Completed||N/A|56|Actual|University Hospital, Essen|||3||f||||f||||||||||2017-10-10 23:15:21.056883|2017-10-10 23:15:21.056883
NCT02460744|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-01|||June 2013||2013-06-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer|A Phase II Study of 2-weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiotherapy in Patients With Breast Cancer|Completed||Phase 2|50|Actual|Postgraduate Institute of Medical Education and Research||1|||f||||f||||||||||2017-10-10 23:15:21.130819|2017-10-10 23:15:21.130819
NCT02460731|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-12-02|||May 2015||2015-05-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Young Plasma Transfusions for Progressive Supranuclear Palsy|A 6 Month, Open-Label, Pilot Futility Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Progressive Supranuclear Palsy|Recruiting||Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:15:21.194072|2017-10-10 23:15:21.194072
NCT02460718|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-03-09|||February 2009||2009-02-01|March 2016|2016-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|ENCOURAGE||ENCOURAGE: Evaluating Community Peer Advisors and Diabetes Outcomes in Rural Alabama|ENCOURAGE: Evaluating Community Peer Advisors and Diabetes Outcomes in Rural Alabama|Completed||N/A|424|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||No|Data will stay at UAB|2017-10-10 23:15:21.294696|2017-10-10 23:15:21.294696
NCT02460705|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-11-01|||June 2015||2015-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Fecal Microbiota Transplant for Inflammatory Bowel Disease||Active, not recruiting||Early Phase 1|60|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:15:21.357925|2017-10-10 23:15:21.357925
NCT02460692|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-09-16|||September 2016||2016-09-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain|A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain|Recruiting||Phase 2|120|Anticipated|University of California, San Diego||3|||f||||t||||||||||2017-10-10 23:15:21.577902|2017-10-10 23:15:21.577902
NCT02460679|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-04-19|||December 2015||2015-12-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|EPI-589||Safety and Biomarker Study of EPI-589 in Subjects With ALS|A Phase 2A Safety and Biomarker Study of EPI-589 in Subjects With Amyotrophic Lateral Sclerosis|Recruiting||Phase 2|20|Anticipated|Edison Pharmaceuticals Inc||1|||f||||f||||||||||2017-10-10 23:15:21.715161|2017-10-10 23:15:21.715161
NCT02460666|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-06-02|||January 2016||2016-01-01|June 2016|2016-06-01|April 2020|Anticipated|2020-04-01|March 2020|Anticipated|2020-03-01||Interventional|||Brain Connectivity and Response to Tai Chi in Geriatric Depression|Brain Connectivity and Response to Tai Chi in Geriatric Depression|Recruiting||Phase 4|250|Anticipated|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-10 23:15:21.842662|2017-10-10 23:15:21.842662
NCT02460653|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-08-01|||May 2015||2015-05-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Interventional|HFNC||Effects of High Flow Nasal Cannula on Deadspace Reduction and Regional Distribution of Ventilation|Effects of High Flow Nasal Cannula on Deadspace Reduction and Regional Distribution of Ventilation|Recruiting||N/A|40|Anticipated|Boston Children’s Hospital||4|||f||||f||||||||||2017-10-10 23:15:21.952898|2017-10-10 23:15:21.952898
NCT02460640|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-04-25|||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Acute and Chronic Pain in the Minimally Invasive Partial Nephrectomy: Tap Block vs Intravenous Pca|Treatment of Acute and Chronic Pain in the Minimally Invasive Partial Nephrectomy: Transversus Abdominis Plane Block vs Intravenous Patient Controlled Analgesia. Prospective Randomized Trial|Recruiting||N/A|60|Anticipated|Regina Elena Cancer Institute||2|||f||||f||||||||||2017-10-10 23:15:22.058487|2017-10-10 23:15:22.058487
NCT02460627|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2015-06-01|||May 2015||2015-05-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Topical Lidocaine After Arthroscopy on Knee|Postoperative Pain Management With Topical Lidocaine After Arthroscopy on Knee. A Randomized Double-blind Study|Unknown status|Not yet recruiting|Phase 1|180|Anticipated|Northern Orthopaedic Division, Denmark||2|||f||||t||||||||||2017-10-10 23:15:22.160321|2017-10-10 23:15:22.160321
NCT02460614|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-06-02|||March 2013||2013-03-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis|Comparison Between Rhinopharyngeal Retrograde Clearance and Nasopharyngeal Aspiration in Children With Acute Viral Bronchiolitis|Completed||N/A|100|Actual|Pontificia Universidade Católica do Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 23:15:22.247433|2017-10-10 23:15:22.247433
NCT02460588|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-03-21|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EXAFIP||Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis|Cyclophosphamide Added to Corticosteroid in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Placebo-controlled Randomized Trial|Recruiting||Phase 3|120|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:15:22.432747|2017-10-10 23:15:22.432747
NCT02460575|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-09-13|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|PRIDEC Peru||Safety of Lactobacillus Reuteri in Healthy Children Aged 2-24 Months|L. Reuteri for Pediatric Diarrhea in Peru: Growth, Enteropathy, and Microbiota|Not yet recruiting||Phase 1|60|Anticipated|Tulane University||2|||f||||t|f|f||||||||2017-10-10 23:15:22.59517|2017-10-10 23:15:22.59517
NCT02460549|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-06-01|||April 2014||2014-04-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Nutriprophy||Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation|Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation|Completed||N/A|9|Actual|Institut de Cancérologie de la Loire||1|||f||||f||||||||||2017-10-10 23:15:22.819723|2017-10-10 23:15:22.819723
NCT02460536|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-10-25|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth|Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth|Recruiting||N/A|120|Anticipated|Tel Aviv University||4|||f||||f||||||||||2017-10-10 23:15:22.939847|2017-10-10 23:15:22.939847
NCT02460523|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-07-20|||April 2012||2012-04-01|April 2012|2012-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CBDS||Management of Borderline Common Bile Duct Stone|Management and Outcome of Borderline Common Bile Duct With Stone|Completed||N/A|35|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:15:23.057968|2017-10-10 23:15:23.057968
NCT02460510|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-02-15|||June 2014||2014-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Role of Hypertonic Saline Versus Mannitol in the Management of Raised Intracranial Pressure in Patients With ALF|Role of Hypertonic Saline Versus Mannitol in the Management of Raised Intracranial Pressure in Patients With ALF: A Randomized Open -Label Study|Completed||N/A|52|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:15:23.150929|2017-10-10 23:15:23.150929
NCT02460497|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-01-20|||May 2015||2015-05-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia|Multicenter, Open Label Clinical Trial to Evaluate the Effect and Tolerability of Minoxidil 2% Solution and Botanical Hair Solution Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia (Ludwig I and II)|Completed||N/A|61|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-10 23:15:23.240068|2017-10-10 23:15:23.240068
NCT02460484|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-08-23|||April 2015||2015-04-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke|Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal|Suspended||Phase 1/Phase 2|10|Anticipated|Florida Hospital||1||Restructuring Cell Lab|f||||t||||||||Undecided||2017-10-10 23:15:23.369081|2017-10-10 23:15:23.369081
NCT02460471|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-01|||June 2011||2011-06-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Palliative Radiotherapy Protocol in Head and Neck Cancer|Palliative Radiotherapy for Advanced Head and Neck Carcinomas, a Phase II Study|Completed||Phase 2|32|Actual|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||||2017-10-10 23:15:23.474769|2017-10-10 23:15:23.474769
NCT02460458|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-04-19|2016-02-03||December 2012||2012-12-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|3WINTERS-IPS|The study population should include a cohort of at least 250 patients with diagnosis of Type 3 Von Willebrand Disease enrolled using homogeneous and standardized criteria.|Type 3 Von Willebrand International Registries Inhibitor Prospective Study|Type 3 Von Willebrand International Registries Inhibitor Prospective Study|Active, not recruiting||N/A|266|Actual|Fondazione Angelo Bianchi Bonomi|||1||f||||t||||||Samples With DNA|"     Venous blood sample, that will be used to obtain both citrated Platelet Poor Plasma for VWF     assays and Cell Pellet for DNA extraction.   "|Undecided||2017-10-10 23:15:23.581787|2017-10-10 23:15:23.581787
NCT02460445|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-02-13|||January 2015||2015-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phlebotomy and Polycystic Ovary Syndrome|Effect of Decreasing Iron Tissue Depots on the Cardiovascular Risk of Women With Polycystic Ovary Syndrome|Recruiting||N/A|30|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||f||||||||Undecided||2017-10-10 23:15:23.977459|2017-10-10 23:15:23.977459
NCT02460419|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-23|2017-05-02|||April 2015||2015-04-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma|Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma: a Multicenter, Randomised, Phase 3 Study.|Recruiting||Phase 3|176|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:15:24.207133|2017-10-10 23:15:24.207133
NCT02460406|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-05-20|||September 2014||2014-09-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Progressive Functional Strength Training in Unilateral Spastic Cerebral Palsy|The Effects of Lower Limb Progressive Functional Strength Training Protocol on Body Functions and Activity in Children With Unilateral Spastic Cerebral Palsy: a Single-blind Randomized Controlled Trial|Completed||N/A|43|Actual|Hacettepe University||2|||f||||f||||||||No||2017-10-10 23:15:24.311687|2017-10-10 23:15:24.311687
NCT02460393|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-05-29|||May 2015||2015-05-01|February 2015|2015-02-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects|A Randomized, Double Blind, Placebo Controlled Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation to Explore the Tolerance, Safety and Pharmacokinetic Characteristics in Healthy Subjects|Unknown status|Recruiting|Phase 1|72|Anticipated|Shenyang Sunshine Pharmaceutical Co., LTD.||2|||f||||f||||||||||2017-10-10 23:15:24.397444|2017-10-10 23:15:24.397444
NCT02460367|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-02-02|||January 2016||2016-01-01|February 2016|2016-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer|A Phase 1b/2 Study of Tergenpumatucel-L (HyperAcute Lung) Immunotherapy in Combination With the IDO Pathway Inhibitor Indoximod and Docetaxel in Patients With Advanced Previously Treated Non-Small Cell Lung Cancer (NSCLS)|Recruiting||Phase 1/Phase 2|115|Anticipated|NewLink Genetics Corporation||2|||f||||t||||||||No||2017-10-10 23:15:24.566211|2017-10-10 23:15:24.566211
NCT02460354|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-07-10|||September 2015||2015-09-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Metformin and Congenital Nephrogenic Diabetes Insipidus|Use of Metformin to Treat Patients With Congenital Nephrogenic Diabetes Insipidus (NDI)|Active, not recruiting||Phase 1|20|Anticipated|Emory University||1|||f||||f||||||||||2017-10-10 23:15:24.682376|2017-10-10 23:15:24.682376
NCT02460341|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-04-09|||August 2015||2015-08-01|April 2017|2017-04-01|February 3, 2017|Actual|2017-02-03|February 3, 2017|Actual|2017-02-03||Interventional|||The Effects of Ondansetron on Brain Function|The Effects of Ondansetron on Brain Function|Completed||Phase 1|54|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||t|t|f||||||||2017-10-10 23:15:24.761832|2017-10-10 23:15:24.761832
NCT02460328|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-03-22|||February 2015||2015-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome|Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome|Completed||N/A|43|Actual|Mahidol University|||1||f||||f||||||||||2017-10-10 23:15:24.848338|2017-10-10 23:15:24.848338
NCT02460315|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-06-01|||May 2013||2013-05-01|May 2013|2013-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ERCP||Early Versus Late Cholecystectomy After Clearance of Common Bile Duct Stones|Early Versus Late Cholecystectomy After Clearance of Common Bile Duct Stones by Endoscopic Retrograde Cholangiopancreatography|Completed||N/A|50|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:15:24.915014|2017-10-10 23:15:24.915014
NCT02460302|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-12-05|||December 2016||2016-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy|Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy - a Double Blind Randomized Control Trial|Recruiting||Phase 2|80|Anticipated|Mount Sinai Hospital, Canada||2|||f||||t||||||||||2017-10-10 23:15:25.149318|2017-10-10 23:15:25.149318
NCT02460289|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-01-20|||May 2015||2015-05-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia|Multicenter, Open Label Clinical Trial to Evaluate the Effect and Tolerability of Minoxidil 5% Foam and Botanical Hair Solution Regimen in Men With Thinning Hair and Male Pattern of Hair Loss/Androgenic Alopecia (Norwood III & IV)|Completed||N/A|63|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-10 23:15:25.272431|2017-10-10 23:15:25.272431
NCT02460276|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-06-27|||April 2015||2015-04-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PHILEMON||A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma|A Phase II Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma|Recruiting||Phase 2|50|Anticipated|Lund University Hospital||1|||f||||f||||||||||2017-10-10 23:15:25.356856|2017-10-10 23:15:25.356856
NCT02460263|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-10-03|||May 2015||2015-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TABLO||The EvAluation of TaBlo In-CLinic and In-HOme|A Prospective Multicenter, Open Label, Non-Randomized, Cross-Over Study Evaluating the Use of the Tablo Hemodialysis System In-Center and In-Home by Subjects With End Stage Renal Disease (ESRD) Who Are on Stable Dialysis Regimens|Enrolling by invitation||N/A|50|Anticipated|Outset Medical||2|||f||||||||||||||2017-10-10 23:15:25.486676|2017-10-10 23:15:25.486676
NCT02460250|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-03-29|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|FIBROSCAME||Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death|Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death|Recruiting||N/A|740|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-10-10 23:15:25.581728|2017-10-10 23:15:25.581728
NCT02460237|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-05-11|||November 2015||2015-11-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|April 15, 2016|Actual|2016-04-15||Interventional|||HPV Self-Test Intervention in Ohio Appalachia|Pilot Testing an HPV Self-Test Intervention: A Novel Strategy for Reducing Cervical Cancer in Appalachia|Active, not recruiting||N/A|103|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:15:25.825771|2017-10-10 23:15:25.825771
NCT02460055|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-06-01|||March 2016||2016-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Trial- Dysphagia From ETT or GI Endoscopy|Randomized Controlled Trial Examining Effect Of Endotracheal Tube Intubation On Dysphagia In Children Presenting For Upper GI Endoscopy|Withdrawn||N/A|0|Actual|Baylor College of Medicine||2||no subject met enrollment criteria|f||||f||||||||Undecided||2017-10-10 23:15:27.283312|2017-10-10 23:15:27.283312
NCT02460224|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2017-09-22|||June 17, 2015|Actual|2015-06-17|September 2017|2017-09-01|April 28, 2019|Anticipated|2019-04-28|April 28, 2019|Anticipated|2019-04-28||Interventional|||Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.|A Phase I/II, Open Label, Multicenter Study of the Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 Administered to Patients With Advanced Malignancies|Recruiting||Phase 1/Phase 2|416|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 23:15:25.932841|2017-10-10 23:15:25.932841
NCT02460211|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-06-02|||June 2015||2015-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|ASSESS-D||Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D|Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D|Active, not recruiting||N/A|150|Actual|Intermountain Health Care, Inc.||2|||f||||t||||||||||2017-10-10 23:15:26.10839|2017-10-10 23:15:26.10839
NCT02460198|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-09-25|||August 25, 2015|Actual|2015-08-25|September 2017|2017-09-01|September 9, 2019|Anticipated|2019-09-09|September 9, 2019|Anticipated|2019-09-09||Interventional|||Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)|A Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects With Previously Treated Locally Advanced Unresectable or Metastatic (Stage IV) Mismatched Repair Deficient or Microsatellite Instability-High Colorectal Carcinoma (KEYNOTE-164)|Active, not recruiting||Phase 2|120|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 23:15:26.19818|2017-10-10 23:15:26.19818
NCT02460185|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-10-10|||May 2015||2015-05-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Role of Maternal Physical Exercise on Spontaneous Labor Onset|The Role of Maternal Physical Exercise on Spontaneous Labor Onset - A Randomized Clinical Trial|Completed||N/A|120|Actual|Centro Hospitalar Lisboa Norte||2|||f||||f||||||||||2017-10-10 23:15:26.300132|2017-10-10 23:15:26.300132
NCT02460172|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-06-26|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|May 2017|Actual|2017-05-01||Interventional|||Zip® Surgical Skin Closure Device vs. Staples for Skin Closure in Subjects Having Undergone Bilateral Knee Arthroplasty|A Prospective, Randomized Controlled Post-market Study to Compare the Use of the Zip® Surgical Skin Closure Device Versus Conventional Staples for Skin Closure in Subjects Having Undergone Bilateral Knee Arthroplasty|Active, not recruiting||N/A|25|Anticipated|ZipLine Medical Inc.||2|||f||||f||||||||No||2017-10-10 23:15:26.377694|2017-10-10 23:15:26.377694
NCT02460159|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-05-03|||June 23, 2015|Actual|2015-06-23|May 2017|2017-05-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Interventional|||A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)|A Phase III, Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Patients With Hypercholesterolemia Who Have Inadequate LDL-C Control on Ezetimibe or Atorvastatin Calcium Monotherapy|Completed||Phase 3|135|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 23:15:26.473147|2017-10-10 23:15:26.473147
NCT02460146|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2016-05-02|||April 2015||2015-04-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects|A Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects|Completed||Phase 1|43|Actual|Complexa, Inc.||2|||f||||t||||||||No||2017-10-10 23:15:26.562629|2017-10-10 23:15:26.562629
NCT02460133|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-05-04|||July 2015||2015-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment|Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment: A Pilot Project|Active, not recruiting||Phase 4|60|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-10 23:15:26.653682|2017-10-10 23:15:26.653682
NCT02460120|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-01-26|||July 2015||2015-07-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EAST||Evaluation of the Archimedes™ System for Transparenchymal Nodule Access|Evaluation of the Archimedes™ System for Transparenchymal Nodule Access|Terminated||N/A|9|Actual|Broncus Medical Inc||1||Updates to device|f||||f||||||||||2017-10-10 23:15:26.743536|2017-10-10 23:15:26.743536
NCT02460107|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-08-06|||May 2015||2015-05-01|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|November 30, 2016|Actual|2016-11-30||Interventional|BTXADMPPNP||Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy|Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy|Terminated||Early Phase 1|9|Actual|Catholic University of Korea Saint Paul's Hospital||3||Enrolling failure (lack of participants)|f||||t||||||||||2017-10-10 23:15:26.8532|2017-10-10 23:15:26.8532
NCT02460094|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-07-12|||September 9, 2015|Actual|2015-09-09|July 2017|2017-07-01|January 27, 2017|Actual|2017-01-27|November 18, 2016|Actual|2016-11-18||Interventional|CN002-003||Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy|Completed||Phase 1|48|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-10 23:15:26.952713|2017-10-10 23:15:26.952713
NCT02460081|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-04-20|||June 2015||2015-06-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease|A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose Range Finding Study to Evaluate the Safety, Hemodynamic Effects and Efficacy of Intramuscular Injection of Human Placenta-derived Cells (Pda-002) in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease|Withdrawn||Phase 2|0|Actual|Celgene Corporation||3||Discontinued due to significant delays in the expected availability of data.|f||||t||||||||||2017-10-10 23:15:27.057862|2017-10-10 23:15:27.057862
NCT02460068|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-06-01|||December 2012||2012-12-01|May 2015|2015-05-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|NIBIT-M2||A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis|A Randomized, Phase III Study of Fotemustine Versus the Combination of Fotemustine and Ipilimumab or the Combination of Ipilimumab and Nivolumab in Patients With Metastatic Melanoma With Brain Metastasis|Recruiting||Phase 3|168|Anticipated|Italian Network for Tumor Biotherapy Foundation||3|||f||||t||||||||||2017-10-10 23:15:27.145095|2017-10-10 23:15:27.145095
NCT02460042|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-07-26|||May 2015||2015-05-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Observational|CONSEQUENT||Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW)|CONSEQUENT ALL COMERS Clinical PMCF on Peripheral Arteries Treated With SeQuent® Please OTW Paclitaxel Coated Balloon Catheter in an All Comer Patient Population|Recruiting||N/A|500|Anticipated|B. Braun Melsungen AG|||1||f||||t||||||||||2017-10-10 23:15:27.369856|2017-10-10 23:15:27.369856
NCT02460029|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-07-24|||May 2015||2015-05-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|June 2020|Anticipated|2020-06-01||Observational|||MRI Imaging of Retromuscular Hernia Repair With CICAT Visible®|Prospective MRI Follow-up After Retromuscular Incisional Hernia Repair Using the Dynamesh CICAT Visible® Mesh|Recruiting||N/A|10|Anticipated|Algemeen Ziekenhuis Maria Middelares|||1||f||||f||||||||||2017-10-10 23:15:27.470181|2017-10-10 23:15:27.470181
NCT02460016|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-06-28|||September 2015||2015-09-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study of AK0529 in Infants Hospitalized With RSV|A Phase 1b, Open-label, Multicenter, Single Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of AK0529 in Infants Hospitalized With Respiratory Syncytial Virus Infection|Terminated||Phase 1|1|Actual|Ark Biosciences Inc.||1||We switched this study design to another study per IEC's recommendations.|f||||t||||||||No||2017-10-10 23:15:27.54486|2017-10-10 23:15:27.54486
NCT02460003|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-07-30|||April 2015||2015-04-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|PhyCH||Physiotherapy Program for Cluster Headache|Effectiveness of Physiotherapy Program in Patients With Cluster Headache|Unknown status|Enrolling by invitation|N/A|12|Actual|AG Clinic||2|||f||||t||||||||||2017-10-10 23:15:27.620785|2017-10-10 23:15:27.620785
NCT02459990|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-05-30|||June 2015||2015-06-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom|Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom|Completed||N/A|22000|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:15:27.698463|2017-10-10 23:15:27.698463
NCT02459977|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-29|||April 2012||2012-04-01|May 2015|2015-05-01||||June 2015|Anticipated|2015-06-01||Interventional|||The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea||Unknown status|Recruiting|N/A|40|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-10 23:15:27.761527|2017-10-10 23:15:27.761527
NCT02459964|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-09-19|||September 14, 2015|Actual|2015-09-14|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain|A Randomized Trial to Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain in Cancer Patients in the Emergency Department Setting|Active, not recruiting||Phase 4|84|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 23:15:27.838363|2017-10-10 23:15:27.838363
NCT02459938|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-08-14|||January 2015||2015-01-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia|A Randomized Open-label Crossover Study to Compare the Safety and Efficacy of ZP-Glucagon to Injectable Glucagon in the Treatment of Insulin-induced Hypoglycemia in Subjects With Type-1 Diabetes|Completed||Phase 1|16|Actual|Zosano Pharma Corporation||4|||f||||f||||||||||2017-10-10 23:15:27.985247|2017-10-10 23:15:27.985247
NCT02459925|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-01|||April 2015||2015-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MOMS-Hubs||MOMS Hubs- CT Dept of Social Services Block Grant|MOMS Partnership—Community-Based Hubs for Maternal Mental Health and Workforce Development, New Haven MOMS Partnership- CT Dept of Social Services Block Grant|Recruiting||N/A|120|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 23:15:28.077917|2017-10-10 23:15:28.077917
NCT02459912|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-11-02|||April 2015||2015-04-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|POTENT-C||Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer|Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer in Potent Men: A Prospective, Phase II Trial|Recruiting||Phase 2|86|Anticipated|Winthrop University Hospital||1|||f||||t||||||||Undecided||2017-10-10 23:15:28.194195|2017-10-10 23:15:28.194195
NCT02459899|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-08-23||2017-08-23|July 2015||2015-07-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|inTandem4||Dose-ranging Study in Patients With Type 1 Diabetes Mellitus|A Phase 2b, Dose-ranging, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study in Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy|Completed||Phase 2|141|Actual|Lexicon Pharmaceuticals||4|||f||||t||||||||||2017-10-10 23:15:28.316799|2017-10-10 23:15:28.316799
NCT02459886|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-09-29|||July 1, 2015|Actual|2015-07-01|September 2017|2017-09-01|November 20, 2017|Anticipated|2017-11-20|November 20, 2017|Anticipated|2017-11-20||Interventional|||Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease|A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects With Early Parkinson's Disease|Active, not recruiting||Phase 1|66|Actual|Biogen||7|||f||||f|t|f||||||||2017-10-10 23:15:28.41553|2017-10-10 23:15:28.41553
NCT02459873|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-04-14|||June 2015||2015-06-01|April 2017|2017-04-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|||Modeling and Testing Change in Mental Abilities in Childhood|Modeling and Testing Change in Mental Abilities in Childhood Through Computer-based Interventions|Completed||N/A|20|Actual|University of Southern California||2|||f||||f||||||||||2017-10-10 23:15:28.509048|2017-10-10 23:15:28.509048
NCT02459860|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-03-30|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Programa Esperanza (Project Hope): A Depression Program for Older Latinos With Chronic Medical Conditions|Programa Esperanza (Project Hope): A Depression Program for Older Latinos With Chronic Medical Conditions|Active, not recruiting||N/A|250|Anticipated|University of Southern California||2|||f||||t||||||||||2017-10-10 23:15:28.590274|2017-10-10 23:15:28.590274
NCT02459834|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-04|||November 2015||2015-11-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Fructose and Allulose Catalytic Effects (FACE) Trial|An Acute Randomized Dose-finding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Carbohydrate Metabolism: The Fructose and Allulose Catalytic Effects (FACE) Study|Completed||N/A|50|Actual|University of Toronto||3|||f||||||||||||||2017-10-10 23:15:28.748062|2017-10-10 23:15:28.748062
NCT02459821|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-09-09|||May 2015||2015-05-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of GE-O System on Gait Impairments in Multiple Sclerosis Subjects|The Effects of an Innovative Gait Robot for the Repetitive Practice of Floor Walking and Stair Climbing up and Down in Patients Suffered From Multiple Sclerosis: a Randomized Control Trial|Active, not recruiting||N/A|40|Actual|Universita di Verona||2|||f||||t||||||||||2017-10-10 23:15:28.844478|2017-10-10 23:15:28.844478
NCT02459808|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-05-11|||May 2015||2015-05-01|April 2015|2015-04-01||||May 2018|Anticipated|2018-05-01||Observational|||Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome|Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome|Suspended||N/A|30|Anticipated|University of Aarhus|||1||f||||t||||||||||2017-10-10 23:15:29.038605|2017-10-10 23:15:29.038605
NCT02459795|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-06-27||2016-06-27|May 2015||2015-05-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis||Completed||Phase 3|465|Actual|Perrigo Company||3|||f||||f||||||||||2017-10-10 23:15:29.133183|2017-10-10 23:15:29.133183
NCT02459782|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-05-28|||January 2012||2012-01-01|May 2015|2015-05-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||Ultrasound Guided Peribulbar Anaesthesia - A Novel Dual Quadrant Injection Technique|Ultrasound Guided Peribulbar Anaesthesia: a Real-time Ultrasound Guided Technique With a Novel Dual Quadrant Injection|Completed||N/A|22|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 23:15:29.234742|2017-10-10 23:15:29.234742
NCT02459769|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-23|||August 2015||2015-08-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Exercise Intervention for LGBT Cancer Survivors|Exercise Intervention for Lesbian, Gay, Bisexual, and Transgender (LGBT) Cancer Survivors and Caregivers|Recruiting||N/A|140|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 23:15:29.33155|2017-10-10 23:15:29.33155
NCT02459756|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-02-08|||June 2015||2015-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Anthocyanin-rich Blackcurrant and Vascular Function|Effects of an Anthocyanin-rich Blackcurrant Beverage on Cardiovascular Function|Completed||N/A|23|Actual|University of Reading||2|||f||||t||||||||||2017-10-10 23:15:29.435494|2017-10-10 23:15:29.435494
NCT02459743|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-06-04|||February 2015||2015-02-01|June 2015|2015-06-01|December 2018|Anticipated|2018-12-01|January 2017|Anticipated|2017-01-01|2 Years|Observational [Patient Registry]|RELab1||Molecular Disease Profile of Hematological Malignancies|Molecular Disease Profile of Haematological Malignancies. A Prospective Registry Study by the Rete Ematologica Lombarda (REL) Clinical Network|Recruiting||N/A|1000|Anticipated|University of Pavia|||1||f||||f||||||Samples With DNA|"     We developed a protocol to couple high-throughput sample handling with the power of massively     parallel sequencing to sequence all coding exons of a target list of candidate genes in the     cancer cells (i.e. peripheral blood granulocytes for myeloid malignancies and mononucleated     cells or CD19+ cells for limphoproliferative neoplasms), and normal control cells (i.e. T     lymphocytes for myeloid malignancies and buccal cells [swab] for lymphoproliferative     diseases), from a large, well-characterized prospective cohort of patients with hematological     malignancies   "|||2017-10-10 23:15:29.539893|2017-10-10 23:15:29.539893
NCT02459730|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-28|||February 2013||2013-02-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|||Glass-ionomer Cement Containing Chlorhexidine for ART|Glass-ionomer Cement Containing Chlorhexidine for ART|Completed||N/A|40|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-10 23:15:29.676993|2017-10-10 23:15:29.676993
NCT02459717|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-10-01|||June 2015||2015-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Pre-biotics and Probiotics for Constipation in Parkinson's Disease|Double Blind, Placebo-controlled Trial of a Fermented Milk Containing Multiple Probiotics Strains and Prebiotic Fiber for Constipation Associated With Parkinson's Disease|Completed||N/A|120|Actual|IRCCS Policlinico S. Matteo||2|||f||||f||||||||||2017-10-10 23:15:29.764867|2017-10-10 23:15:29.764867
NCT02459704|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-10-06|||June 2014||2014-06-01|May 2015|2015-05-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Semilunar Coronally Positioned Flap With or Without Enamel Matrix Derivative for the Treatment of Gingival Recessions|Semilunar Coronally Positioned Flap With or Without Enamel Matrix Derivative for the Treatment of Miller Class I Gingival Recessions: Randomized Clinical Trial|Completed||Phase 4|30|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-10 23:15:29.855139|2017-10-10 23:15:29.855139
NCT02459691|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-05-22|||September 2014||2014-09-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos)|Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos in Primary Care (E-LITE Latinos)|Active, not recruiting||N/A|191|Actual|Palo Alto Medical Foundation||2|||f||||t||||||||||2017-10-10 23:15:29.962557|2017-10-10 23:15:29.962557
NCT02459678|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-06-27|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||ART Readiness in HIV-infected Pregnant Women|ART Readiness in HIV-infected Pregnant Women: From Formative Qualitative Research to Individual Randomized Trial|Recruiting||N/A|526|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:15:30.089338|2017-10-10 23:15:30.089338
NCT02459665|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-05-02|||June 2015||2015-06-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2016|Actual|2016-12-01||Interventional|VMB||Rwanda VMB Restoration Study|Preparing for a Clinical Trial of Interventions to Maintain Normal Vaginal Microbiota for Preventing Adverse Reproductive Health Outcomes in Africa|Active, not recruiting||N/A|68|Actual|University of Liverpool||4|||f||||f||||||||||2017-10-10 23:15:30.245208|2017-10-10 23:15:30.245208
NCT02459275|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-03-16|||July 2015||2015-07-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||PEP uP Protocol in Surgical Patients|PEP uP Protocol (Enhanced Protein-Energy Provision Via the Enteral roUte Feeding Protocol) in Surgical Patients|Recruiting||N/A|100|Anticipated|Clinical Evaluation Research Unit at Kingston General Hospital||2|||f||||t||||||||||2017-10-10 23:15:35.012757|2017-10-10 23:15:35.012757
NCT02459652|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-06-28|||September 2012||2012-09-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|April 2016|Actual|2016-04-01||Interventional|||Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer|Phase II Study of Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer|Active, not recruiting||Phase 2|50|Anticipated|Japan Adjuvant Study Group of Pancreatic Cancer||1|||f||||||||||||||2017-10-10 23:15:30.335464|2017-10-10 23:15:30.335464
NCT02459639|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-06-02|||June 2015||2015-06-01|June 2015|2015-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|ExiGence||Existential Genomics: Effects of Multimodal Rehabilitation and Integrative Care on Patients With Chronic Pain|Existential Genomics (ExiGence): Effects of Multimodal Rehabilitation and Integrative Care on Pain, Quality of Life, and Genomic Stability in Patients With Chronic Pain|Unknown status|Not yet recruiting|N/A|100|Anticipated|The Integrative Care Science Center|||2||f||||t||||||Samples With DNA|"     Leucocyte cell extracts   "|||2017-10-10 23:15:30.469067|2017-10-10 23:15:30.469067
NCT02459626|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-04-11|||September 2014||2014-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Observational|STIFFMAP||Left Ventricular Stiffness vs. Fibrosis Quantification by T1 Mapping in Heart Failure With Preserved Ejection Fraction|Comparison of Non-invasive Assessment of Cardiac Fibrosis by MRI Derived T1-Mapping and Ventricular Intrinsic Diastolic Function by Pressure-volume-analysis in Patients With Heart Failure With Preserved Ejection Fraction|Recruiting||N/A|36|Anticipated|University of Leipzig|||3||f||||f||||||||||2017-10-10 23:15:30.574583|2017-10-10 23:15:30.574583
NCT02459613|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-07-13|||January 2016||2016-01-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|AnnIE||Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis|Evaluation de la rhAnnexine V-128 radiomarquée Dans le Diagnostic de l'Endocardite Infectieuse, du Thrombus Atrial et de Leurs Complications Emboliques associées|Recruiting||Phase 1/Phase 2|120|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-10 23:15:30.682914|2017-10-10 23:15:30.682914
NCT02459600|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-06-01|||May 2015||2015-05-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Refraction Measurments in Children Under General Anesthesia, With and Without Cycloplegic Drops|Methodes of Meausring Refraction in Children Under General Anesthesia|Unknown status|Recruiting|Early Phase 1|20|Anticipated|Soroka University Medical Center||1|||f||||f||||||||||2017-10-10 23:15:30.78337|2017-10-10 23:15:30.78337
NCT02459587|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2017-07-19|||March 24, 2016|Actual|2016-03-24|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|CLF||Crisis Line Facilitation|Facilitating Use of the Veterans Crisis Line in High-Risk Patients|Recruiting||N/A|500|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 23:15:30.871897|2017-10-10 23:15:30.871897
NCT02459574|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-09-19|||May 1, 2015|Actual|2015-05-01|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|August 31, 2018|Anticipated|2018-08-31||Interventional|AVATAR-AF||Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation|Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation|Active, not recruiting||N/A|300|Anticipated|Imperial College London||3|||f||||t||||||||||2017-10-10 23:15:30.991084|2017-10-10 23:15:30.991084
NCT02459561|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-02|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|EndoBarrier||EndoBarrier TM Gastrointestinal Liner Diabetes Trial|A Randomised Controlled Trial of a Duodenal Sleeve Bypass Device (EndoBarrier)Compared With Standard Medical Therapy for the Management of Obese Subjects With Type 2 Diabetes|Active, not recruiting||N/A|170|Actual|Imperial College London||2|||f||||t||||||||Yes||2017-10-10 23:15:31.129838|2017-10-10 23:15:31.129838
NCT02459548|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-11-25|||February 2014||2014-02-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|CPAP-SU-MAP||Continuous Positive Airway Pressure (CPAP) for Primary Care|Validation of a Programme of Treatment and Follow-Up for Obstructive Sleep Apnea (OSA) Patients to be Applied by General Practitioners (GPs). Collaborative Network System Between GPs, CPAP Provider Enterprise and Sleep Specialists|Recruiting||N/A|252|Anticipated|Hospital Universitario Araba||2|||f||||f||||||||||2017-10-10 23:15:31.293632|2017-10-10 23:15:31.293632
NCT02459535|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-21|||March 2015||2015-03-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|ILIAS-1||Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1|Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1|Recruiting||N/A|16|Anticipated|German Institute of Human Nutrition||7|||f||||t||||||||||2017-10-10 23:15:31.373607|2017-10-10 23:15:31.373607
NCT02459522|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-09-20|||January 2011||2011-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Bayesian Estimation of Diagnostic Performance for Cardiovascular Autonomic Neuropathy|Bayesian Estimation of Diagnostic Performance of Short-term Heart Rate Variability for Cardiovascular Autonomic Neuropathy Without a Gold Standard|Completed||N/A|88|Actual|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||t||||||||||2017-10-10 23:15:31.478116|2017-10-10 23:15:31.478116
NCT02459509|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-04-15|||June 2015||2015-06-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||A Comparison of Two Doses of Intranasal Dexmedetomidine for Premedication in Children|A Comparison of Two Doses of Intranasal Dexmedetomidine for Premedication in Children - a Double- Blind Randomised Controlled Trial|Recruiting||Phase 4|140|Anticipated|The University of Hong Kong||2|||f||||||||||||||2017-10-10 23:15:31.572095|2017-10-10 23:15:31.572095
NCT02459496|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-21|||September 2013||2013-09-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|DiNA-D||Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus|Dietary Strategies to Improve Metabolism and Body Weight in Type 2 Diabetes|Recruiting||N/A|200|Anticipated|German Institute of Human Nutrition||2|||f||||t||||||||||2017-10-10 23:15:31.672931|2017-10-10 23:15:31.672931
NCT02459483|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-29|2016-02-25|||December 2015||2015-12-01|February 2016|2016-02-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|ETICCO||Evaluation of a Telephone Care Nurse in the Management of Patients With Cancer and Treated by Oral Chemotherapy|Evaluation of a Telephone Care Nurse in the Management of Patients With Cancer and Treated by Oral Chemotherapy|Recruiting||N/A|184|Anticipated|Institut de Cancérologie de la Loire||2|||f||||t||||||||||2017-10-10 23:15:31.775281|2017-10-10 23:15:31.775281
NCT02459470|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-28|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney Transplantation|Utility of Stroke Volume Variation and Pulse Pressure Variation for Predicting Fluid Responsiveness in Chronic Renal Failure Patients Undergoing Kidney Transplantation|Completed||N/A|42|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:15:31.849459|2017-10-10 23:15:31.849459
NCT02459457|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-23|2017-08-20|||July 2015||2015-07-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|August 2019|Anticipated|2019-08-01||Interventional|||A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer|A Comparison of Paclitaxel in Combination With Cisplatin(TP), Carboplatin(TC) or Fluorouracil(TF) Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Squamous Cell Carcinoma: A Three-Arm Randomized Phase III Trial|Recruiting||Phase 3|321|Anticipated|Fudan University||3|||f||||t||||||||||2017-10-10 23:15:31.928569|2017-10-10 23:15:31.928569
NCT02459444|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-03-17|||May 2015||2015-05-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|IMT||Inspiratory Muscle Training and Hospital Complications|Safety and Efficacy of Inspiratory Muscle Training for Preventing Adverse Outcomes in Patients at Risk of Prolonged Hospitalization|Completed||N/A|54|Actual|Federal University of Bahia||2|||f||||f||||||||||2017-10-10 23:15:32.082013|2017-10-10 23:15:32.082013
NCT02459431|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-02|||December 2013||2013-12-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||RCT Comparing 21 and 22 G Needle in the Diagnosis of Sarcoidosis by EBUS TBNA|Impact of Needle Size on the Diagnosis of Sarcoidosis by Endobronchial Ultrasound Guided Transbronchial Needle Aspiration: Randomized Trial Comparing 21-Gauge and 22-Gauge Needles|Completed||N/A|151|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 23:15:32.186751|2017-10-10 23:15:32.186751
NCT02459405|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2017-05-01|||March 2013||2013-03-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Decreasing Leak Rate in Colorectal Surgery Using Near Infra-red (NIR) Imaging|Decreasing Leak Rate in Colorectal Surgery Using Near Infra-red (NIR) Imaging: a Multicentric Prospective Phase II Study|Completed||Phase 2|504|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-10-10 23:15:32.332961|2017-10-10 23:15:32.332961
NCT02459392|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-29|||May 2015||2015-05-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|EPCSII||EuroPainClinics® Study II (Prospective Trial)|EuroPainClinics® Study II (Prospective Randomized Double Blinded Trial)|Recruiting||N/A|300|Anticipated|Europainclinics z.ú.||2|||f||||t||||||||||2017-10-10 23:15:32.421239|2017-10-10 23:15:32.421239
NCT02459379|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-10|||June 2016||2016-06-01|August 2017|2017-08-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01|3 Months|Observational [Patient Registry]|CIED-MRI||Cardiac Implantable Electronic Device Magnetic Resonance Imaging Registry|Cardiac Implantable Electronic Device Magnetic Resonance Imaging Registry (CIED-MRI Registry)|Withdrawn||N/A|0|Actual|New York University Langone Medical Center|||1||f||||f||||||||||2017-10-10 23:15:32.53032|2017-10-10 23:15:32.53032
NCT02459366|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-12-29|||May 2015||2015-05-01|December 2015|2015-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Correlation of Thoracolumbar Fascia Mechanical Properties and Compensate Mechanisms of Asymmetric Skeletal Muscle|Study of School and Graduate Institute of Physical Therapy College of Medicine in Taiwan|Recruiting||N/A|270|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-10 23:15:32.577751|2017-10-10 23:15:32.577751
NCT02459353|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-07-12|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|DIVE||Effect of Dapagliflozin on Glycemic Variability|Effect of Dapagliflozin on Glycemic Variability as an add-on Therapy in Subjects With Type 2 Diabetes Mellitus With in Inadequate Glycemic Control in Insulin: a Multicenter, Placebo-controlled, Double-blind, Randomized Study|Completed||Phase 4|86|Actual|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 23:15:32.653268|2017-10-10 23:15:32.653268
NCT02459340|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-08-08|||June 2015||2015-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ECSR||Emotional and Cognitive Self-regulation, an EEG Study|Effectiveness of Therapeutic Treatment: Hot and Cold Self-regulation in Posttraumatic Stress Disorder, Dissociative Disorder, and Borderline Personality Disorder|Recruiting||N/A|175|Anticipated|Clienia Littenheid AG||2|||f||||f||||||||||2017-10-10 23:15:32.736103|2017-10-10 23:15:32.736103
NCT02459327|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-18|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Integrated Model for Promoting Parenting and Early School Readiness in Pediatrics||Enrolling by invitation||N/A|400|Anticipated|New York University||2|||f||||f||||||||||2017-10-10 23:15:34.555711|2017-10-10 23:15:34.555711
NCT02459314|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-05-28|||April 2013||2013-04-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|sterols||Comparison of the Efficacy of Plant Sterol-Enriched Soymilk Versus Plain Soymilk in Volunteers With High LDL-Cholesterol|Comparison of the Efficacy of Plant Sterol-Enriched Soymilk Versus Plain Soymilk in Volunteers With High LDL-Cholesterol|Completed||N/A|242|Actual|Chiang Mai University||2|||f||||t||||||||||2017-10-10 23:15:34.743907|2017-10-10 23:15:34.743907
NCT02459301|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-04-20|||August 24, 2015|Actual|2015-08-24|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies|A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies|Active, not recruiting||Phase 1|59|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-10 23:15:34.83448|2017-10-10 23:15:34.83448
NCT02459288|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-05-28|||January 2014||2014-01-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|APROVE-CKD||Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients|A comParison on Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Study Among SeVerE Chronic Kidney Disease/ End-Stage-Renal-Disease Patients With Recent Acute Coronary Syndrome.|Unknown status|Recruiting|Phase 4|80|Anticipated|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-10 23:15:34.919844|2017-10-10 23:15:34.919844
NCT02459262|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-09-15|||May 2015||2015-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|MVX13211||Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.|A Two-part, Phase I, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety, Tolerability and Immunogenicity of a Dose Range og Group B Streptococcus Vaccine in Healthy Female Volunteers Aged 18 to 40.|Completed||Phase 1|240|Actual|Minervax ApS||2|||f||||t||||||||||2017-10-10 23:15:35.147296|2017-10-10 23:15:35.147296
NCT02459249|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-02-23|||April 2015||2015-04-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|PrEVEnTYCM||Metabolic Syndrome Diagnosis and Treatment for Adults of Low Socioeconomic Status Communities|Treatment of Metabolic Alterations in Adults Living in Communities With Low Socioeconomic Status|Recruiting||N/A|120|Anticipated|Mexican National Institute of Public Health||2|||f||||t||||||||||2017-10-10 23:15:35.236942|2017-10-10 23:15:35.236942
NCT02459236|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-25||2017-09-18|June 2015||2015-06-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||A Study of Intermittent Doses of CERC-301 in MDD|A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment|Completed||Phase 2|115|Actual|Cerecor Inc||3|||f||||f||||||||||2017-10-10 23:15:35.332331|2017-10-10 23:15:35.332331
NCT02459210|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-03-10|||January 2015||2015-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CLUES||Adaptation of Cognitive Enhancement Therapy for Persons at Clinical High Risk for Psychosis|CLUES (Cognition for Learning and for Understanding Everyday Social Situations): An Adaptation of Cognitive Enhancement Therapy for Persons at Clinical High Risk for Psychosis|Recruiting||N/A|38|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-10 23:15:35.785063|2017-10-10 23:15:35.785063
NCT02459197|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-10-12|||June 2015||2015-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Proof of Concept Study to Investigate the Effect of a New Treatment in Patient With Chronic Pain|A Proof of Concept Study to Investigate the Effect of T4P1001 Treatment in Patients With Peripheral Neuropathic Pain or Osteoarthritic Pain of Knee or Hip|Completed||N/A|114|Actual|Tools4Patient||2|||f||||f||||||||||2017-10-10 23:15:35.927501|2017-10-10 23:15:35.927501
NCT02459184|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|IGNITE||addressInG iNcome securITy in Primary carE|IGNITE (addressInG iNcome securITy in Primary carE) Study: A Pragmatic Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f|f|f||||||||2017-10-10 23:15:36.075957|2017-10-10 23:15:36.075957
NCT02459158|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-07-03|||September 2015||2015-09-01|November 2016|2016-11-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|||A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia|A Randomized, Open-Label Phase 1b Study of ME1100 Inhalation Solution Plus Best Available Therapy in the Treatment of Mechanically Ventilated Subjects With Bacterial Pneumonia|Completed||Phase 1|25|Actual|Meiji Seika Pharma Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:15:36.292357|2017-10-10 23:15:36.292357
NCT02459145|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-01-25|||June 2015||2015-06-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Assessing the Effects of a Clinical Exercise Protocol on Children With Post-concussion Syndrome|Assessing the Effects of a Clinical Exercise Protocol on Children With Post-concussion Syndrome|Withdrawn||N/A|0|Actual|University of Arizona||2||PI Left Insitution - study no RCT|f||||f||||||||||2017-10-10 23:15:36.422762|2017-10-10 23:15:36.422762
NCT02459132|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-04-20|||July 2015||2015-07-01|September 2016|2016-09-01|April 2017|Actual|2017-04-01|September 2016|Actual|2016-09-01||Interventional|HIITTS||High-Intensity Aerobic Interval Training in Testicular Cancer Survivors|A Phase II Randomized Trial of High-Intensity Aerobic Interval Training and Surrogate Markers of Cardiovascular Disease in a Population-based Sample of Testicular Cancer Survivors|Completed||N/A|63|Actual|University of Alberta||2|||f||||f||||||||||2017-10-10 23:15:36.506485|2017-10-10 23:15:36.506485
NCT02459119|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-06-19|||May 2015||2015-05-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)|A Multicenter, Non-Randomized, Phase II Study of Regorafenib for Advanced Urothelial Cancer Following Prior Chemotherapy|Recruiting||Phase 2|35|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||No||2017-10-10 23:15:36.605632|2017-10-10 23:15:36.605632
NCT02459106|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-01-12|||May 2015||2015-05-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|miRNA||Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans|Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans|Recruiting||N/A|100|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida|||2||f||||f||||||Samples With DNA|"     Muscle and adipose tissue biopsies will be obtained.   "|||2017-10-10 23:15:36.707132|2017-10-10 23:15:36.707132
NCT02459093|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-12-15|||May 2015||2015-05-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Subcuticular Suture for Cesarean Skin Incision Closure|Comparison of Subcuticular Suture Type in Post-Cesarean Wound Complications|Completed||Phase 4|550|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 23:15:36.805269|2017-10-10 23:15:36.805269
NCT02459080|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-07-18|||September 2015||2015-09-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|COPD||Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)|A Phase 3, 12-week, Randomized, Double-blind Placebo-controlled Parallel Group Study of Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|619|Actual|Theravance Biopharma R & D, Inc.||3|||f||||f||||||||||2017-10-10 23:15:36.896202|2017-10-10 23:15:36.896202
NCT02459067|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-09-13|||December 2015||2015-12-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||ImmuniCell® in Patients With Advanced Cancers|Adaptive Study of the Safety, Tolerability & Efficacy of Autologous γδ T Lymphocyte Therapy (ImmuniCell®) in Patients With Advanced Cancers Refractory to Current Treatment or Have Indolent Disease for Which Immunotherapy May be Beneficial|Recruiting||Phase 2/Phase 3|60|Anticipated|TC Biopharm||1|||f||||f||||||||||2017-10-10 23:15:36.969583|2017-10-10 23:15:36.969583
NCT02459054|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-01-23|||October 2015|Actual|2015-10-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Syncardia 50cc TAH-t as a Bridge to Transplant|SynCardia 50cc Temporary Total Artificial Heart (TAH-t) as a Bridge to Transplant|Recruiting||N/A|72|Anticipated|SynCardia Systems. LLC||3|||f||||t||||||||||2017-10-10 23:15:37.066409|2017-10-10 23:15:37.066409
NCT02459041|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-05-28|||January 2015||2015-01-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Observational|ADVEUS||Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes|Real-time Semi-quantification of Endoscopic Ultrasound Elastography and Contrast-enhancement Using Strain Histograms (SH) and Contrast-enhancement (CE) for the Differentiation of Focal Pancreatic Masses and the Assessment of Lymph Node Involvement|Unknown status|Recruiting|N/A|150|Anticipated|University of Medicine and Pharmacy Craiova|||4||f||||t||||||Samples Without DNA|"     Pancreas and lymphnode samples (EUS-guided fine needle aspiration)   "|||2017-10-10 23:15:37.236153|2017-10-10 23:15:37.236153
NCT02459028|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-04-13|||May 2015||2015-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|T3P||Positive Psychology Interventions in Individuals With Chronic Pain and Spinal Cord Injury|A Phase II, Community-based, Single-blinded, Randomized Controlled, Parallel-group Trial to Assess the Effects of a Tailored Positive Psychology Intervention on Chronic Pain and Well-being in Individuals With Spinal Cord Injury|Completed||Phase 2|168|Actual|Swiss Paraplegic Research||2|||f||||f||||||||||2017-10-10 23:15:37.466114|2017-10-10 23:15:37.466114
NCT02459015|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-09-05|||June 2015||2015-06-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions|A Controlled, Randomized, Comparison, Blind Evaluation of Repair of Digital Nerve Lesions in Man Using an Implanted Reaxon® Nerve Guide|Recruiting||N/A|76|Anticipated|Medovent GmbH||2|||f||||||||||||||2017-10-10 23:15:37.551347|2017-10-10 23:15:37.551347
NCT02459002|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-12-08|||July 2012||2012-07-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Observational|||Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project|Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients|Recruiting||N/A|300|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||Samples With DNA|"     Blood specimens drawn (24 mL (8 mL x 3) at the following timepoints: baseline, every 4 weeks     (+ 5 days) until end of follow-up.   "|||2017-10-10 23:15:37.668498|2017-10-10 23:15:37.668498
NCT02458989|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-05-27|||March 2015||2015-03-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Thyroid Cosmesis Study at St. Paul's Hospital, Vancouver BC|A Randomized Controlled Trial Comparing The Cosmetic Outcome Of Electrocautery Versus Scalpel For Thyroidectomy Incisions|Unknown status|Recruiting|N/A|60|Anticipated|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-10 23:15:37.772576|2017-10-10 23:15:37.772576
NCT02458976|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-04-18|||June 2015||2015-06-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Pulsed-dye Laser Treatment Prior to Surgical Excision||Recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-10 23:15:37.872208|2017-10-10 23:15:37.872208
NCT02458963|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-05-08|||January 2016||2016-01-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS|In Vitro Fertilization Versus Gonadotropin Therapy in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome|Withdrawn||Phase 4|0|Actual|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 23:15:37.955969|2017-10-10 23:15:37.955969
NCT02458950|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-09-03|||December 2014||2014-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Characteristics and Clinical Outcomes of Anorexia Nervosa : Siriraj Hospital Experience|Characteristics and Clinical Outcomes of Anorexia Nervosa : Siriraj Hospital Experience|Recruiting||N/A|13|Anticipated|Mahidol University|||1||f||||t||||||||||2017-10-10 23:15:38.057603|2017-10-10 23:15:38.057603
NCT02458937|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-03-31|||June 5, 2015|Actual|2015-06-05|November 2016|2016-11-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis|Functional Outcomes for Children, Adolescents, and Young Adults With Osteonecrosis Following Hip Core Decompression|Recruiting||N/A|15|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-10 23:15:38.133552|2017-10-10 23:15:38.133552
NCT02458924|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-05-30|||January 2014||2014-01-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Niacin Skin Flush Response in Patients With Schizophrenia|Niacin Skin Flush Response in Patients With Schizophrenia, Their First Degree Relatives, Bipolar Disorder Patients, and Healthy Controls|Completed||Phase 2/Phase 3|100|Actual|Isfahan University of Medical Sciences||4|||f||||f||||||||||2017-10-10 23:15:38.2494|2017-10-10 23:15:38.2494
NCT02458911|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-08-30|||May 2014||2014-05-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01|1 Year|Observational [Patient Registry]|||Luminor Registry: Registry of the Results of Angioplasty With Drug-eluting Balloon (Paclitaxel) in the Treatment of Infrainguinal Occlusive Lesions and Restenosis From Prior Endovascular Procedures in This Sector.|Luminor Registry: Registry of the Results of Angioplasty With Drug-eluting Balloon (Paclitaxel) in the Treatment of Infrainguinal Occlusive Lesions (Superficial Femoral Artery (SFA), Popliteal Artery (PA) and Tibial Arteries (ATs)) and Restenosis From Prior Endovascular Procedures in This Sector.|Active, not recruiting||N/A|215|Actual|iVascular S.L.U.|||1||f||||t||||||||||2017-10-10 23:15:38.330783|2017-10-10 23:15:38.330783
NCT02458898|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-05-26|||February 2015||2015-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease|Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease|Completed||N/A|61|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:15:38.397646|2017-10-10 23:15:38.397646
NCT02458885|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-02|||April 2015||2015-04-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01|30 Days|Observational [Patient Registry]|ARGEN-IAM-ST||Pilot Study on ST Elevation Acute Myocardial Infarction|Relevamiento / Encuesta Nacional de Infarto Agudo de Miocardio Con elevación Del ST|Unknown status|Recruiting|N/A|1500|Anticipated|Sociedad Argentina de Cardiología|||1||f||||t||||||||||2017-10-10 23:15:38.47148|2017-10-10 23:15:38.47148
NCT02458872|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-06-01|||July 2015||2015-07-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Impact of a Data-driven Monitor Alarm Reduction Strategy Implemented in Safety Huddles|Impact of a Data-driven Monitor Alarm Reduction Strategy Implemented in Safety Huddles|Completed||N/A|77280|Actual|Children's Hospital of Philadelphia||2|||f||||f|f|f||||||||2017-10-10 23:15:38.54801|2017-10-10 23:15:38.54801
NCT02458859|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-07-07|||March 2012||2012-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Trial of PICO Versus Standard Care in Chronic and Sub-acute Wounds|A 100 Patient, Prospective, Randomised, Clinical Evaluation Comparing Clinical and Health Economic Outcomes Between Patients With Chronic or Sub-acute Wounds Treated With Either PICO or Standard Care Dressings and a Qualitative Study to Explore the Experiences of Patients Receiving PICO With Particular Emphasis on Concordance|Terminated||N/A|62|Actual|Smith & Nephew Medical Ltd||2||Poor recruitment|f||||f||||||||||2017-10-10 23:15:38.621433|2017-10-10 23:15:38.621433
NCT02458846|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-11-10|||September 2014||2014-09-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Vision Care for Children in Ontario|A Comparison of Tests for Preschool Vision Screening and Analysis of Their Cost-Effectiveness for Universal Use in Ontario|Recruiting||N/A|780|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 23:15:38.739408|2017-10-10 23:15:38.739408
NCT02458833|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-08-31|||June 2015||2015-06-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|July 2017|Actual|2017-07-01||Interventional|||Home Plate: A Trial to Improve Home Food Preparation Practices Among Parents of Toddlers|Home Plate: A Randomized Controlled Trial of a Community-Engaged Intervention to Improve Home Food Preparation Practices and Health During Early Childhood|Active, not recruiting||N/A|115|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 23:15:38.847363|2017-10-10 23:15:38.847363
NCT02458820|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-07-20|||June 2015||2015-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest|Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest|Recruiting||N/A|80|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 23:15:38.941975|2017-10-10 23:15:38.941975
NCT02458807|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-01-19|||August 2014||2014-08-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2015|Actual|2015-03-01||Observational|SENSOR||The SENSOR Study: A Mixed-methods Study of SElf-management Checks to Predict exacerbatioNs of Pseudomonas Aeruginosa in Patients With Long-term reSpiratORy Conditions|The SENSOR Study: A Mixed-methods Study of SElf-management Checks to Predict exacerbatioNs of Pseudomonas Aeruginosa in Patients With Long-term reSpiratORy Conditions|Active, not recruiting||N/A|30|Actual|Portsmouth Hospitals NHS Trust|||1||f||||f||||||Samples With DNA|"     Daily sputum and urine samples have been collected for study analysis. However we do not plan     to extract DNA.   "|||2017-10-10 23:15:39.028839|2017-10-10 23:15:39.028839
NCT02458794|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-07-27|||September 2015||2015-09-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Crossover Study of the LMA SupremeTM vs Ambu-Aura GainTM|A Randomized Crossover Study of the LMA SupremeTM Versus Ambu-Aura GainTM in Adult Patients|Unknown status|Not yet recruiting|N/A|200|Anticipated|Schulthess Klinik||2|||f||||f||||||||||2017-10-10 23:15:39.107629|2017-10-10 23:15:39.107629
NCT02458781|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-05-27|||January 2015||2015-01-01|May 2015|2015-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth|Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth: A Randomized, Double-Blind, Placebo-Controlled Trial Comparing Ciprofloxacin and Metronidazole|Enrolling by invitation||Phase 4|180|Anticipated|San Antonio Military Medical Center||3|||f||||t||||||||||2017-10-10 23:15:39.190607|2017-10-10 23:15:39.190607
NCT02458768|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-01-04|2015-11-23||July 2013||2013-07-01|May 2015|2015-05-01||||November 2014|Actual|2014-11-01||Interventional||Per-Protocol Set|Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.|A Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of s.c. Administration of IVF-M HP Inj. Versus Menopur® Inj. in Infertility Women Undergoing Controlled Ovarian Hyperstimulation for Assisted Reproductive Technologies (ART) Such as in Vitro Fertilization-embryo Transfer (IVF-ET)|Completed||Phase 4|112|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-10 23:15:39.269209|2017-10-10 23:15:39.269209
NCT02458755|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-04-25|||February 2012||2012-02-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|STAMINA-MRI||Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis|Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis - High-Resolution Magnetic Resonance Imaging Study (STAMINA-MRI Study)|Recruiting||Phase 4|80|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:15:39.475221|2017-10-10 23:15:39.475221
NCT02458352|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-10-28|||November 2015||2015-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Ultra Low Dose CT for CACS and AC of SPECT|Usefulness of Ultra Low Dose Cardiac CT for Coronary Calcium Scoring and for Attenuation Correction of SPECT|Completed||Phase 4|105|Actual|University of Zurich||2|||f||||t||||||||||2017-10-10 23:15:43.110333|2017-10-10 23:15:43.110333
NCT02458742|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-04-02|||June 2015||2015-06-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Spinal Morphine Provides an Effective Pain Control in Patients Undergoing Transurethral Resection of Prostate Gland|Spinal Morphine (0.05 mg) Provides an Effective Pain Control in Patients Undergoing Transurethral Resection of Prostate Gland- a Randomized Double-blinded Control Trial|Completed||N/A|80|Actual|Mahidol University||2|||f||||t||||||||||2017-10-10 23:15:39.553436|2017-10-10 23:15:39.553436
NCT02458729|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-05-28|||August 2012||2012-08-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Blood Saving Effect of Tranexamic Acid in Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis|The Blood Saving Effect and Wound-related Complications of Tranexamic Acid in Mininally Invasive Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis|Completed||Phase 4|294|Actual|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-10 23:15:39.626109|2017-10-10 23:15:39.626109
NCT02458716|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-05-16|||March 2015||2015-03-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer|Feasibility of Cytoreductive Prostatectomy in Men Newly Diagnosed With Metastatic Prostate Cancer|Active, not recruiting||Phase 1|26|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 23:15:39.734689|2017-10-10 23:15:39.734689
NCT02458703|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2015-05-29|||May 2015||2015-05-01|April 2015|2015-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ExercisePAVM2||Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction|Hypoxemia, Dyspnea, and Exercise Tolerance in Patients With Pulmonary Arteriovenous Malformations , With and Without Airflow Obstruction|Not yet recruiting||N/A|60|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-10 23:15:39.938585|2017-10-10 23:15:39.938585
NCT02458690|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-08-31|||July 2015||2015-07-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients|eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients|Enrolling by invitation||Phase 2|216|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 23:15:40.054392|2017-10-10 23:15:40.054392
NCT02458677|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-03-14|||May 2015||2015-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Single Ascending Dose Study of PRX003 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of PRX003 Administered by Intravenous Infusion in Healthy Subjects|Completed||Phase 1|40|Actual|Prothena Biosciences Limited||2|||f||||f||||||||||2017-10-10 23:15:40.1612|2017-10-10 23:15:40.1612
NCT02458664|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-11-30|||November 2013||2013-11-01|November 2015|2015-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|BASE HSP110||BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer|BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer|Active, not recruiting||N/A|597|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:15:40.235805|2017-10-10 23:15:40.235805
NCT02458651|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-08-18|||June 26, 2015|Actual|2015-06-26|August 2017|2017-08-01|October 29, 2018|Anticipated|2018-10-29|October 29, 2018|Anticipated|2018-10-29||Observational|||Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China|An Observational Study of Patients With Newly Diagnosed Unresectable Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) in China|Active, not recruiting||N/A|1378|Actual|Hoffmann-La Roche|||6||f||||||||||||||2017-10-10 23:15:40.309035|2017-10-10 23:15:40.309035
NCT02458638|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-07-19|||July 13, 2015|Actual|2015-07-13|July 2017|2017-07-01|February 12, 2021|Anticipated|2021-02-12|November 29, 2018|Anticipated|2018-11-29||Interventional|||A Study of Atezolizumab in Advanced Solid Tumors|An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors|Recruiting||Phase 2|725|Anticipated|Hoffmann-La Roche||1|||f||||f||||||||||2017-10-10 23:15:40.447395|2017-10-10 23:15:40.447395
NCT02458625|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-02-02|||April 2016||2016-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia|A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia|Recruiting||N/A|138|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-10 23:15:40.641079|2017-10-10 23:15:40.641079
NCT02458612|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-02-18|||June 2016||2016-06-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Effects of Mirror Therapy Combined With Progressive Strength Training in Unilateral Spastic Cerebral Palsy|Effectiveness of Mirror Therapy Combined With Progressive Strength Training on Upper Limb Function in Children With Unilateral Spastic Cerebral Palsy|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hacettepe University||2|||f||||f||||||||No||2017-10-10 23:15:40.731439|2017-10-10 23:15:40.731439
NCT02458599|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-08-12|||June 2015||2015-06-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy Study of Protein Supplementation in Attenuating the Decline in Performance After Strenuous Concurrent Exercise|A Study to Evaluate the Effects of Protein Supplementation in Attenuating the Decline in Performance Following Strenuous Concurrent Exercise|Completed||N/A|24|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:15:40.826673|2017-10-10 23:15:40.826673
NCT02458586|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-11-21|||May 2015||2015-05-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|UFOP-2||Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD)|Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD)|Recruiting||N/A|40|Anticipated|German Institute of Human Nutrition||2|||f||||f||||||||||2017-10-10 23:15:40.903224|2017-10-10 23:15:40.903224
NCT02458573|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-24|||June 4, 2015|Actual|2015-06-04|January 2017|2017-01-01|March 28, 2016|Actual|2016-03-28|March 28, 2016|Actual|2016-03-28||Interventional|||Comparison of the Effects of Continuous Epidural Analgesia and Continuous Intravenous Analgesia on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy||Completed||Phase 4|86|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:15:40.997849|2017-10-10 23:15:40.997849
NCT02357797|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-24|||February 2016||2016-02-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|AVIS||Adjunctive Vortioxetine in Schizophrenia|Adjunctive Vortioxetine in Schizophrenia|Recruiting||Phase 4|88|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-10 23:36:20.051764|2017-10-10 23:36:20.051764
NCT02458560|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2017-08-24|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|CENTERA-2||Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve|Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve|Active, not recruiting||N/A|200|Anticipated|Edwards Lifesciences||1|||f||||t||||||||||2017-10-10 23:15:41.082112|2017-10-10 23:15:41.082112
NCT02458547|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-05-29|||May 2015||2015-05-01|May 2015|2015-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect of Anesthesia Technique on Outcome After Hip Fracture Surgery in Elderly Adult Patients||Unknown status|Recruiting|N/A|186|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-10 23:15:41.218125|2017-10-10 23:15:41.218125
NCT02458534|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-08-18|||May 2015||2015-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Comparison of Mcgrath Mac, C-MAC, and Macintosh Laryngoscope in Novice Users: a Manikin Study||Completed||N/A|39|Actual|Yonsei University||3|||f||||f||||||||||2017-10-10 23:15:41.315385|2017-10-10 23:15:41.315385
NCT02458521|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-11-19|||August 2015||2015-08-01|November 2015|2015-11-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Transcranial Magnetic Stimulation (TMS) to Treat mTBI and PTSD|A Study of Bilateral Prefrontal Transcranial Magnetic Stimulation (TMS) to Treat the Symptoms of Mild TBI (mTBI) and PTSD|Recruiting||N/A|60|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||||2017-10-10 23:15:41.388868|2017-10-10 23:15:41.388868
NCT02458508|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-23|2016-05-10|||March 2015||2015-03-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|GLIOMELA||Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy|Retrospective Evaluation of Prognostic and/or Predictive Profile of Melanocortin Receptor-4 Gene Polymorphisms in Patient With a Diagnosis of Glioblastoma Treated With Upfront Concomitant Radio-chemotherapy or Chemotherapy|Recruiting||N/A|120|Anticipated|University of Pisa|||1||f||||t||||||Samples With DNA|"     Blood samples (3 ml) will be collected in EDTA tubes and stored at -80°C from glioblastoma     patients   "|||2017-10-10 23:15:41.491991|2017-10-10 23:15:41.491991
NCT02458495|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-10-31|||August 2015||2015-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|Diabetes MAP||The Diabetes Medication Adherence Promotion Intervention Trial|Leveraging Patient Portals to Improve Medication Adherence in Type 2 Diabetes|Completed||N/A|151|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-10 23:15:41.576153|2017-10-10 23:15:41.576153
NCT02458482|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-02-10|||July 2015||2015-07-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children|Randomized Control Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children|Recruiting||N/A|120|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||No||2017-10-10 23:15:41.663383|2017-10-10 23:15:41.663383
NCT02458469|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-21|||May 14, 2015|Actual|2015-05-14|July 2017|2017-07-01|April 1, 2018|Anticipated|2018-04-01|March 31, 2018|Anticipated|2018-03-31||Interventional|REST-SCI||Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI|Pathogenesis of Sleep Disordered Breathing in Spinal Cord Injury Patients|Recruiting||Phase 2|20|Anticipated|VA Office of Research and Development||3|||f||||t|t|f|||f|||||2017-10-10 23:15:41.795535|2017-10-10 23:15:41.795535
NCT02458456|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-08-01|||August 2014||2014-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Isometric Handgrip Exercise for Blood Pressure Management|Isometric Handgrip Exercise for Blood Pressure Management. A Randomized, Controlled Trial|Recruiting||N/A|120|Anticipated|University of New England||6|||f||||f||||||||||2017-10-10 23:15:41.888691|2017-10-10 23:15:41.888691
NCT02458443|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-08-01|||February 2016||2016-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Isometric Handgrip Exercise for Blood Pressure Management|Cardiovascular Response to Isometric Resistance Training in People With Hypertension for Blood Pressure Management|Recruiting||N/A|80|Anticipated|University of New England||4|||f||||f||||||||||2017-10-10 23:15:41.972223|2017-10-10 23:15:41.972223
NCT02458430|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|UDALL||Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease|Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease - Clin Core/Proj#2|Recruiting||N/A|120|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"     Saliva and Blood   "|||2017-10-10 23:15:42.062327|2017-10-10 23:15:42.062327
NCT02458417|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-03-31|||May 2015||2015-05-01|May 2015|2015-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients|Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients: a Randomized Controlled Study on the Recipient Site Preparation|Completed||Phase 4|10|Actual|Netherlands Institute for Pigment Disorders||4|||f||||f||||||||||2017-10-10 23:15:42.133009|2017-10-10 23:15:42.133009
NCT02458404|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-09-27|||March 2015||2015-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Varied Estrogen Doses on Endometrial Receptivity|Effects of Varied Estrogen Doses on Endometrial Receptivity|Active, not recruiting||N/A|19|Actual|Reproductive Medicine Associates of New Jersey||3|||f||||f||||||||||2017-10-10 23:15:42.24632|2017-10-10 23:15:42.24632
NCT02458391|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-08-05|||July 2015||2015-07-01|August 2015|2015-08-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Complete Decongestive Therapy in Breast Cancer-Related Lymphedema|Therapeutic Quantity of Complete Decongestive Therapy in Breast Cancer-Related Lymphedema: A Double Blinded Randomized Control Trial|Withdrawn||N/A|0|Actual|University of Indianapolis||2||No participants available|f||||t||||||||||2017-10-10 23:15:42.338324|2017-10-10 23:15:42.338324
NCT02458378|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-01-04|||May 2015||2015-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:15:42.415172|2017-10-10 23:15:42.415172
NCT02458365|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-03-23|2015-05-29||September 2009||2009-09-01|July 2015|2015-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Stage-Based Expert System for Teen Dating Violence Prevention|A Stage-Based Expert System for Teen Dating Violence Prevention|Completed||Phase 2|3901|Actual|Pro-Change Behavior Systems||2|||f||||t||||||||No||2017-10-10 23:15:42.457728|2017-10-10 23:15:42.457728
NCT02458339|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-08-17|||May 2015||2015-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors|Phase I Study of Methotrexate Infusion Into the Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors|Recruiting||Phase 1|18|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 23:15:43.187386|2017-10-10 23:15:43.187386
NCT02458326|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-05-27|||April 2015||2015-04-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Aerobic Training Effect on the Improvement of Pain Perception in Patients With Fibromyalgia and Migraine|Aerobic Training Effect on the Improvement of Pain Perception in Patients With Fibromyalgia and Migraine: a Randomized Clinical Trial|Unknown status|Recruiting|Phase 1|20|Anticipated|Universidade Federal de Pernambuco||2|||f||||f||||||||||2017-10-10 23:15:43.274018|2017-10-10 23:15:43.274018
NCT02458313|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-29|||November 2015||2015-11-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Nicotinic Agonist Effects on BMI and Neuronal Response|Nicotinic Agonist Effects on BMI and Neuronal Response in Overweight/Obese Adults|Recruiting||Phase 1|100|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:15:43.366553|2017-10-10 23:15:43.366553
NCT02458300|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-03-01|||January 2015||2015-01-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|FIBARRIX||Clinical Evaluation of the Response to Chest Physiotherapy in Children With Acute Bronchiolitis|"FIBARRIX Clinical Evaluation of the Response to Chest Physiotherapy in Infants With Acute Bronchiolitis"|Completed||N/A|77|Actual|Universidad Católica San Antonio de Murcia||2|||f||||f||||||||Undecided||2017-10-10 23:15:43.452677|2017-10-10 23:15:43.452677
NCT02458274|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-05-27|||July 2014||2014-07-01|May 2015|2015-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|MIBO||Microparticles and Bronchiolitis Obliterans Syndrome|Circulating and Pulmonary Microparticles for Early Diagnosis of Bronchiolitis Obliterans Syndrome After Lung Transplantation|Recruiting||N/A|60|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||Samples Without DNA|"     Plasma Broncho-alveolar lavage fluid   "|||2017-10-10 23:15:43.734929|2017-10-10 23:15:43.734929
NCT02458261|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-05-10|||March 2015||2015-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Continuous Renal Replacement Therapy|Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Continuous Renal Replacement Therapy|Enrolling by invitation||N/A|10|Anticipated|University of Cincinnati|||1||f||||f||||||Samples With DNA|"     Samples that are being collected are as follows: serum, continuous renal replacement therapy     effluent, and urine (if patient is making urine during sample collection). Drug assays will     be performed for each sample and samples will be disposed of after the final analysis is     complete. The assays are not interventional and patient care does not change as a result of     study enrollment.   "|Undecided||2017-10-10 23:15:43.817959|2017-10-10 23:15:43.817959
NCT02458248|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-12-15|||March 2016||2016-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|STICK||Sodium Intake in Chronic Kidney Disease (STICK)|Sodium Intake in Chronic Kidney Disease (STICK): A Randomised Controlled Trial|Recruiting||Phase 2|224|Anticipated|University College Hospital Galway||2|||f||||t||||||||||2017-10-10 23:15:43.874631|2017-10-10 23:15:43.874631
NCT02458235|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-05-23|||June 2015||2015-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation|A Phase II Study of Risk-adapted Donor Lymphocyte Infusion and Azacitidine for the Prevention of Hematologic Malignancy Relapse Following Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 2|67|Anticipated|University of California, San Francisco||1|||f||||t|t|f|||f|||||2017-10-10 23:15:43.973542|2017-10-10 23:15:43.973542
NCT02458222|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-05-27|||July 2015||2015-07-01|May 2015|2015-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|AphasiaGame||Efficacy of Language Games as Therapy for Post Stroke Aphasia|Efficacy of Language Games as Therapy for Post Stroke Aphasia|Not yet recruiting||N/A|40|Anticipated|University of Birmingham||2|||f||||f||||||||||2017-10-10 23:15:44.108861|2017-10-10 23:15:44.108861
NCT02458209|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-03-07|||May 2015||2015-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers|A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Comparability Study To Assess The Subcutaneous Pharmacokinetics And Pharmacodynamics Of Bococizumab In Healthy Adult Subjects For Comparisons Of Drug Substance Manufactured At Two Different Locations And Administration Via Prefilled Syringe Vs. Prefilled Pen|Completed||Phase 1|470|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 23:15:44.185718|2017-10-10 23:15:44.185718
NCT02458196|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-01-23|||April 2015||2015-04-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Treatment Response on IgG4 Related Disease (IgG4RD)|A Randomized Trial of Treatment in Patients With IgG4-Related Disease|Recruiting||Phase 2|60|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 23:15:44.30707|2017-10-10 23:15:44.30707
NCT02458183|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-02-03|||February 2015||2015-02-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|June 2017|Anticipated|2017-06-01||Interventional|Venus||Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS|A Multinational, Multicenter, Randomized, Comparative, Open-label, Phase 3 Study to Assess the Immunogenicity and Safety of DTaP-IPV (Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus) Vaccine Administered to Healthy Infants|Recruiting||Phase 3|464|Anticipated|Boryung Pharmaceutical Co., Ltd||2|||f||||t||||||||No||2017-10-10 23:15:44.407429|2017-10-10 23:15:44.407429
NCT02458170|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-05-29|||August 2013||2013-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Examination of Biopsies From Healthy Knee Joints|Examination of Biopsies From Healthy Knee Joints for the Use of Research Activities in Inflammatory Joint Diseases|Terminated||N/A|43|Actual|Northern Orthopaedic Division, Denmark|||1|Shutdown of The Department of Inflammatory Diseases at Novo Nordisk.|f||||f||||||Samples With DNA|"     Biopsies from synovial tissue.   "|||2017-10-10 23:15:44.570222|2017-10-10 23:15:44.570222
NCT02458157|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-03|||October 2015||2015-10-01|July 2017|2017-07-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|FFAKI||Forced Fluid Removal in High Risk Acute Kidney Injury|Forced Fluid Removal vs. Usual Intensive Care in High-risk Acute Kidney Injury With Severe Fluid Overload - A Randomized Controlled Trial|Terminated||Phase 4|21|Actual|Nordsjaellands Hospital||2||Very low recruitment rates|f||||t||||||||||2017-10-10 23:15:44.635054|2017-10-10 23:15:44.635054
NCT02458144|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-05-28|||January 2013||2013-01-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of MIS Anterior Versus MIS Anterolateral Approach|Comparison of Two Minimally Invasive Approaches to the Hip-anterior Versus Anterolateral - Which Technique is Less Invasive? A Prospective, Randomized, Controlled Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:15:44.735831|2017-10-10 23:15:44.735831
NCT02458131|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-04-04|||November 11, 2016|Actual|2016-11-11|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Community-based Adolescent Diabetes Prevention Program|TEEN HEED: An Adolescent Peer Led Diabetes Prevention Intervention|Recruiting||N/A|300|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 23:15:44.830397|2017-10-10 23:15:44.830397
NCT02458118|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-02-17|||June 2012||2012-06-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||Pancreatic Perfusion Using Secretin and MRI|Study to Assess Pancreatic Blood Flow at Rest and During Stimulation Using Magnetic Resonance Imaging (fMRI) in Patients With Chronic Pancreatitis|Recruiting||Phase 1/Phase 2|15|Anticipated|University of Nottingham||1|||f||||f||||||||No||2017-10-10 23:15:44.925333|2017-10-10 23:15:44.925333
NCT02458105|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-10-26|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acceptance & Commitment Therapy for Psychotic Inpatients|Acceptance & Commitment Therapy for Psychotic Inpatients|Suspended||N/A|54|Anticipated|Uppsala University||2||Required resources not available at the moment.|f||||f||||||||||2017-10-10 23:15:45.025807|2017-10-10 23:15:45.025807
NCT02458092|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-05-28|||April 2008||2008-04-01|May 2015|2015-05-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Controlled Double Blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly With GSK Biologicals' Adjuvant AS01B|Phase 1b Controlled Double Blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly With GSK Biologicals' Adjuvant AS01B|Completed||Phase 1|30|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-10-10 23:15:45.109319|2017-10-10 23:15:45.109319
NCT02458079|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-23|2017-09-24|||December 1, 2014|Actual|2014-12-01|July 2017|2017-07-01|July 27, 2016|Actual|2016-07-27|July 27, 2016|Actual|2016-07-27||Interventional|||Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis||Completed||N/A|32|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:15:45.189964|2017-10-10 23:15:45.189964
NCT02458066|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-28|||February 2014||2014-02-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Trial to Compare Effectiveness of 2 Insecticides in Preventing Malaria|Cluster Randomised Trial to Compare Effectiveness of Bendiocarb and Deltamethrin (Long‐Lasting) in Preventing Malaria Infection|Completed||N/A|2800|Actual|Medical Care Development, Inc.||2|||f||||f||||||||||2017-10-10 23:15:45.263299|2017-10-10 23:15:45.263299
NCT02458053|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-13|||February 2016||2016-02-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|December 2016|Actual|2016-12-01||Interventional|TEAM||Testing the Efficacy of a Spousal Support Enhanced Weight Loss Program on Weight Loss Among African American Men|Testing the Efficacy of a Spousal Support Enhanced Weight Loss Program on Weight Loss Among African American Men|Completed||N/A|104|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:15:45.33679|2017-10-10 23:15:45.33679
NCT02458040|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-28|||May 2015||2015-05-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs|Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs|Unknown status|Not yet recruiting|N/A|1|Anticipated|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||||||2017-10-10 23:15:45.424192|2017-10-10 23:15:45.424192
NCT02458027|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-26|||July 2015||2015-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|||A FINEH Protein Trial - Part 2|Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 2 - Are Acute Effects of Hemp Protein on Blood Glucose and Appetite Insulin-dependent?|Active, not recruiting||N/A|15|Anticipated|University of Manitoba||5|||f||||f||||||||||2017-10-10 23:15:45.484474|2017-10-10 23:15:45.484474
NCT02458014|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-04-07|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Study of Blinatumomab in Patients With B-cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual Disease|Phase II Study of Blinatumomab in Patients With B-cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual Disease|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:15:45.561172|2017-10-10 23:15:45.561172
NCT02458001|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-05-28|||July 2015||2015-07-01|May 2015|2015-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|SAFFRON||Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer|Developing a Stepped Approach to Improving Sexual Function After Gynaecological Cancer- a Feasibility Study and Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|University College, London||2|||f||||t||||||||||2017-10-10 23:15:45.644093|2017-10-10 23:15:45.644093
NCT02457988|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|Vivify||The Cirrhosis Outpatient Optimization, Readmission & Safety Study|COORS: The Cirrhosis Outpatient Optimization, Readmission & Safety Study|Terminated||Early Phase 1|120|Anticipated|University of California, Los Angeles||2||Increased recruitment difficulties|f||||f||||||||||2017-10-10 23:15:45.726197|2017-10-10 23:15:45.726197
NCT02456883|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-07-20|||March 4, 2016|Actual|2016-03-04|July 2017|2017-07-01|June 19, 2017|Actual|2017-06-19|May 20, 2017|Actual|2017-05-20||Interventional|||Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid Tumors|A Phase 1, Open-label Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid Tumors|Completed||Phase 1|6|Actual|Astellas Pharma Inc||1|||t||||f||||||||||2017-10-10 23:15:45.800565|2017-10-10 23:15:45.800565
NCT02456870|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-01-10|||June 2015||2015-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|EAT||Expandability of Aging Adipose Tissue|Aging Subcutaneous Adipose Tissue Response to Overfeeding|Active, not recruiting||N/A|30|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:15:45.896174|2017-10-10 23:15:45.896174
NCT02456857|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-05-23|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Women's Triple-Negative First-Line Study: Liposomal Doxorubicin, Bevacizumab and Everolimus (DAE) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy|Women's Triple-Negative First-Line Study: A Phase II Trial of Liposomal Doxorubicin, Bevacizumab and Everolimus (DAE) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy|Recruiting||Phase 2|37|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:15:45.979477|2017-10-10 23:15:45.979477
NCT02456844|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-01-29|||May 2015||2015-05-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients|Effects of BMS-986142 on the Single-dose Pharmacokinetics of Methotrexate and Probe Substrates Montelukast (CYP2C8), Flurbiprofen (CYP2C9), Midazolam (CYP3A4), Digoxin (P-gp), and Pravastatin (OATP1B1) in Healthy Subjects|Completed||Phase 1|24|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:15:46.080386|2017-10-10 23:15:46.080386
NCT02457975|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-07-26|||June 2015||2015-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:15:46.148013|2017-10-10 23:15:46.148013
NCT02457962|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-08-09|||April 2015||2015-04-01|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|April 2020|Anticipated|2020-04-01|100 Years|Observational [Patient Registry]|||Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study|Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study|Recruiting||N/A|5000|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 23:15:46.182125|2017-10-10 23:15:46.182125
NCT02457949|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-12-05|||October 2015||2015-10-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|TASA||The Impact of Alternative Social Assistance Disbursement on Drug-related Harm|The Impact of Alternative Social Assistance Disbursement on Drug-Related Harm: a Randomized Control Trial|Recruiting||N/A|273|Anticipated|University of British Columbia||3|||f||||t||||||||||2017-10-10 23:15:46.243691|2017-10-10 23:15:46.243691
NCT02457936|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-03-21|||April 2015||2015-04-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Examining Cognitive Mechanisms of Clinical Improvement Following Mindfulness Based Therapy for Depressed Individuals|Examining Cognitive Mechanisms of Clinical Improvement Following Mindfulness Based Cognitive Therapy for Depressed Individuals|Completed||N/A|52|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:15:46.331554|2017-10-10 23:15:46.331554
NCT02457923|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-27|||May 2015||2015-05-01|May 2015|2015-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|M-SAKHI||Mobile -Solutions Aiding Knowledge for Health Improvement|Mobile Health Solutions to Help Community Providers Promote Maternal & Infant Nutrition & Health - A Community-based Cluster RCT in Rural India to Evaluate M-SAKHI for Use by ASHAs to Reduce Malnutrition in Infants up to 24 Months|Not yet recruiting||N/A|2728|Anticipated|Lata Medical Research Foundation, Nagpur||2|||f||||t||||||||||2017-10-10 23:15:46.405677|2017-10-10 23:15:46.405677
NCT02457910|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-24|||June 2015||2015-06-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer|A Phase Ib/II Trial of Taselisib (GDC-0032), a PI3K Inhibitor, in Combination With Enzalutamide in Patients With Androgen Receptor Positive Triple Negative Metastatic Breast Cancer|Recruiting||Phase 1/Phase 2|73|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-10-10 23:15:46.687493|2017-10-10 23:15:46.687493
NCT02457897|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-10-03|||April 15, 2015||2015-04-15|September 26, 2017|2017-09-26|November 30, 2020|Anticipated|2020-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations|Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in Patients With Insulin Receptor Mutations|Recruiting||Phase 2|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:15:47.007078|2017-10-10 23:15:47.007078
NCT02457884|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-02-17|||May 2015||2015-05-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema|Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema (DMO)- Randomized Controlled Trial|Recruiting||N/A|152|Anticipated|The Hong Kong Polytechnic University||4|||f||||f||||||||||2017-10-10 23:15:47.149269|2017-10-10 23:15:47.149269
NCT02457871|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-05-11|||July 2014||2014-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ENCM||Promoting Self-Management in Low Income African Americans Living With Hypertension|Promoting Self-Management in Low Income African Americans Living With Hypertension|Completed||N/A|59|Actual|University of Wisconsin, Milwaukee||2|||f||||t||||||||No||2017-10-10 23:15:47.289336|2017-10-10 23:15:47.289336
NCT02457858|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-09-28|||August 2014||2014-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot Study|Manganese Porphyrin MnTE-2-PyP (BMX - 010) Preservation of Islet Cell Mass and Function for Clinical Islet Transplantation|Completed||Phase 1|5|Actual|University of Alberta||1|||f||||t||||||||||2017-10-10 23:15:47.382146|2017-10-10 23:15:47.382146
NCT02450721|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-05-03|||January 2011||2011-01-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2015|Actual|2015-01-01||Observational|CLAST||Clinical and Laboratory Biomarkers in Patients With Atherothrombotic Stroke||Recruiting||N/A|97|Anticipated|St. Petersburg State Pavlov Medical University|||3||f||||f||||||Samples With DNA|"     Blood serum   "|||2017-10-10 23:17:02.637254|2017-10-10 23:17:02.637254
NCT02457845|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-07-28|||May 2016||2016-05-01|July 2017|2017-07-01||||May 2019|Anticipated|2019-05-01||Interventional|||HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors|Phase I Clinical Trial of HSV G207 Alone or With a Single Radiation Dose in Children With Recurrent Supratentorial Brain Tumors|Recruiting||Phase 1|18|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-10 23:15:47.488993|2017-10-10 23:15:47.488993
NCT02457832|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-09-20|||November 3, 2014|Actual|2014-11-03|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Motor Training in PD|Optimizing Motor Training in Parkinson Disease Through Neural Mechanisms (NEURODEGEN)|Recruiting||N/A|99|Anticipated|VA Office of Research and Development||4|||f||||f|f|f|||f|||||2017-10-10 23:15:47.609085|2017-10-10 23:15:47.609085
NCT02457819|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-03-07|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Interventional|||Dasotraline Pediatric Extension Study|An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|330|Actual|Sunovion||1|||f||||t||||||||||2017-10-10 23:15:47.734159|2017-10-10 23:15:47.734159
NCT02457806|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-11-08|||August 2011||2011-08-01|November 2016|2016-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Comparison of Anesthetic Efficacy of Bilateral and Unillateral Application of Kovacaine Mist in Healthy Volunteers|Phase 1, Randomized, Double-Blind, Placebo-Controlled, 4-Period, Complete Cross-Over Comparison of the Anesthetic Efficacy of Bilateral and Unilateral Application of Kovacaine Mist in Healthy Volunteers|Completed||Phase 1|48|Actual|St. Renatus, LLC||4|||f||||f||||||||||2017-10-10 23:15:47.963113|2017-10-10 23:15:47.963113
NCT02457793|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-04-05|||June 17, 2015|Actual|2015-06-17|April 2017|2017-04-01|December 5, 2016|Actual|2016-12-05|December 5, 2016|Actual|2016-12-05||Interventional|||A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors|A Phase Ib, Open-Label, Dose-Escalation Study Of The Safety, Tolerability, and Pharmacokinetics of Cobimetinib and GDC-0994 In Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|27|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-10 23:15:48.080537|2017-10-10 23:15:48.080537
NCT02457780|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-12-21|||August 2013||2013-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Stress Management Program for World Trade Center (WTC) Responders|Mind-Body Treatment for WTC Responders With Comorbid PTSD and Respiratory Illness|Completed||N/A|157|Actual|Stony Brook University||2|||f||||f||||||||||2017-10-10 23:15:48.204488|2017-10-10 23:15:48.204488
NCT02457767|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-07-30|||June 2015||2015-06-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Observational|||Optimizing of Waiting - Time in the Anesthesia Admissions Ambulance of the Charité - University Medicine Berlin by Support of a Mobile Application - a Pilot Study|Optimization of Waiting - Time in the Anesthesia Admissions Ambulance Department of Anaesthesia and Intensive Care Medicine CVK/CCM, Charité - University Medicine Berlin by Support of a Mobile Application - a Pilot Study|Withdrawn||N/A|0|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 23:15:48.30623|2017-10-10 23:15:48.30623
NCT02457754|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-12-01|||January 2015||2015-01-01|December 2015|2015-12-01||||December 2015|Actual|2015-12-01||Observational|||Physical Fitness and Bone Structure Evaluation in Preschool Children|Physical Fitness and Bone Structure Evaluation in Preschool Children|Active, not recruiting||N/A|225|Anticipated|Universidad de Zaragoza|||1||f||||||||||||||2017-10-10 23:15:48.373453|2017-10-10 23:15:48.373453
NCT02457741|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-07-24|||June 2015||2015-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Validation of a Simple Approach to Estimate Alveolar Recruitability in ARDS Patients|A Simple Approach to Estimate Alveolar Recruitability in Patients With Acute Respiratory Distress Syndrome: a Validation Study|Recruiting||N/A|45|Anticipated|St. Michael's Hospital, Toronto|||1||f||||||||||||||2017-10-10 23:15:48.443644|2017-10-10 23:15:48.443644
NCT02457728|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2015-11-08|2015-08-16||January 2015||2015-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Mesh Fixation and Closure of Peritoneum Following Laparoscopic Hernia Repair Using N-butyl Cyanoacrylate|Mesh Fixation and Closure of Peritoneum Following Laparoscopic Hernia Repair Using N-butyl Cyanoacrylate|Completed||N/A|34|Actual|St John of God Hospital, Vienna||1|||f||||f||||||||||2017-10-10 23:15:48.547584|2017-10-10 23:15:48.547584
NCT02457715|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-02|||July 2015||2015-07-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis|Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis|Recruiting||N/A|50|Anticipated|Duke University|||4||f||||f||||||||||2017-10-10 23:15:48.712202|2017-10-10 23:15:48.712202
NCT02457702|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-12-28|||October 2015||2015-10-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|SLDglyc||Mitochondrial Function in Patients With Severe Liver Disease|Mitochondrial Function in Patients With Severe Liver Disease|Recruiting||N/A|15|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||No||2017-10-10 23:15:48.786269|2017-10-10 23:15:48.786269
NCT02457689|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-11-09|||July 2015||2015-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CUTHIVTHER001||The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo|A Randomized Phase I/II Study to Assess the Safety and Immunogenicity of the DNA-GTU Vaccine Administered by Two Novel Routes Compared to Placebo in HIV-infected Patients on Antiretroviral Therapy|Completed||Phase 1/Phase 2|30|Actual|Imperial College London||4|||f||||t||||||||||2017-10-10 23:15:48.873058|2017-10-10 23:15:48.873058
NCT02457676|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-05-26|||October 2009||2009-10-01|May 2015|2015-05-01||||June 2012|Actual|2012-06-01||Interventional|||Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention|Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention|Completed||N/A|65|Actual|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-10 23:15:48.971357|2017-10-10 23:15:48.971357
NCT02457663|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-31|||April 2015||2015-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|||Identification and Validation of Biomarkers for Infections in Burns|Identification and Validation of Established and Novel Biomarkers for Infections in Burns|Active, not recruiting||N/A|200|Actual|The University of Texas Medical Branch, Galveston|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:15:49.057011|2017-10-10 23:15:49.057011
NCT02457650|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-08-01|||April 2015||2015-04-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies|Phase I Study of Malignancies That Express NY-ESO-1 With T Cell Receptor-transduced T Cells Targeting NY-ESO-1|Recruiting||Phase 1|36|Anticipated|Shenzhen Second People's Hospital||1|||f||||f||||||||||2017-10-10 23:15:49.118833|2017-10-10 23:15:49.118833
NCT02457637|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2016-10-12|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Prospective Multicenter Study of Acute on Chronic Liver Failure in China||Recruiting||N/A|3000|Anticipated|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples With DNA|"     whole blood, serum, urine, stool, liver tissue   "|||2017-10-10 23:15:49.221575|2017-10-10 23:15:49.221575
NCT02457624|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-04-14|||March 2008||2008-03-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01|6 Years|Observational [Patient Registry]|||Gastric Cancer Screening Quality Improvement System Establishment|A Prospective Cohort Study for Development of Korean Gastric Cancer Prediction Model and Tailored Gastric Cancer Screening Program|Recruiting||N/A|17|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-10 23:15:49.348471|2017-10-10 23:15:49.348471
NCT02457611|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-01-06|2017-01-06||June 2015||2015-06-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Safety Analysis Set: participants who received at least 1 dose of study drug|Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection|Open-Label Study to Evaluate the Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Subjects With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection|Completed||Phase 2|26|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|1|||f||||f||||||||||2017-10-10 23:15:49.433339|2017-10-10 23:15:49.433339
NCT02457598|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-28|||June 16, 2015|Actual|2015-06-16|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|March 2019|Anticipated|2019-03-01||Interventional|||Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies|A Phase 1b Dose Escalation and Dose Expansion Study of ONO/GS-4059 in Combination With Other Targeted Anti-cancer Therapies in Subjects With B-cell Malignancies|Recruiting||Phase 1|368|Anticipated|Gilead Sciences||5|||f||||f|t|f||||||||2017-10-10 23:15:49.818843|2017-10-10 23:15:49.818843
NCT02457585|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-05-12|||March 2015||2015-03-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|August 2017|Anticipated|2017-08-01||Interventional|||Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis|Anti-tumor Necrosis Factor Therapy Effect on Takayasu Arteritis|Recruiting||Phase 2|11|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:15:49.957344|2017-10-10 23:15:49.957344
NCT02457572|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-09-11|||October 2014||2014-10-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Pulse Pressure Variation Measured During Valsalva Maneuver to Predict Fluid Responsiveness Under Open-chest Condition|Pulse Pressure Variation Measured During Valsalva Maneuver to Predict Fluid Responsiveness Under Open-chest Condition in the Patients Undergoing Off-pump Coronary Arterial Bypass Grafting|Completed||N/A|55|Actual|Samsung Medical Center|||1||f||||||||||||||2017-10-10 23:15:50.038855|2017-10-10 23:15:50.038855
NCT02457559|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-08-16|||November 5, 2015|Actual|2015-11-05|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies|An Open-label Study to Assess the Long-term Safety and Efficacy of ONO/GS-4059 in Subjects With Relapsed/Refractory B-cell Malignancies|Active, not recruiting||Phase 1|29|Actual|Gilead Sciences||1|||f||||f|t|f|||t|||||2017-10-10 23:15:50.097691|2017-10-10 23:15:50.097691
NCT02457546|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-19|||July 1, 2015|Actual|2015-07-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||The EVICEL® Neurosurgery Phase III Study|A Single-Blinded, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® Fibrin Sealant (Human) Compared to a Hydrogel Sealant as an Adjunct to Sutured Dural Repair|Recruiting||Phase 3|230|Anticipated|Ethicon, Inc.||2|||f||||f||||||||||2017-10-10 23:15:50.17252|2017-10-10 23:15:50.17252
NCT02457533|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-05-26|||April 2015||2015-04-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|||Case Management - Active Telephone Support to Patients With COLD|Active Support to Patient With COLD|Unknown status|Recruiting|N/A|400|Anticipated|Region Sjælland||2|||f||||f||||||||||2017-10-10 23:15:50.291822|2017-10-10 23:15:50.291822
NCT02457520|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-16|2017-08-29|||January 2015||2015-01-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||ABSORICA in Patients With Severe Recalcitrant Nodular Acne|An Open-label Study Evaluating the Long-term Efficacy, Quality of Life, and Safety of ABSORICA® (Isotretinoin) Capsules Administered Without Food in Patients With Severe Recalcitrant Nodular Acne|Active, not recruiting||Phase 4|200|Anticipated|Sun Pharmaceutical Industries Limited||1|||f||||f||||||||||2017-10-10 23:15:51.905694|2017-10-10 23:15:51.905694
NCT02457507|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-01-26|||August 2011||2011-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Vitamin B12 Supplement to Prevent Cognitive Decline||Completed||Phase 4|271|Actual|Chinese University of Hong Kong||2|||f||||||||||||||2017-10-10 23:15:52.006455|2017-10-10 23:15:52.006455
NCT02457494|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-07-12|||May 2015||2015-05-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Observational|CALVIH||Kidney Stone Risk Factors in Patients Infected With HIV|CALVIH: Determination of Kidney Stone Risk Factors in Patients Infected With HIV|Recruiting||N/A|100|Anticipated|Association pour le Developpement d'Investigations et de Thérapeutiques en Néphrologie|||1||f||||f||||||||||2017-10-10 23:15:52.077743|2017-10-10 23:15:52.077743
NCT02457481|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-09-30|||May 2015||2015-05-01|September 2015|2015-09-01||||August 2016|Anticipated|2016-08-01||Interventional|||An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro|An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro|Unknown status|Active, not recruiting|N/A|100|Anticipated|National Foundation for Fertility Research||1|||f||||f||||||||||2017-10-10 23:15:52.160578|2017-10-10 23:15:52.160578
NCT02448498|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-02-14|||February 2016||2016-02-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|STRONG-D||Strength Training Regimen for Normal Weight Diabetics||Recruiting||N/A|282|Anticipated|Stanford University||3|||f||||||||||||||2017-10-10 23:17:29.049943|2017-10-10 23:17:29.049943
NCT02457468|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2017-08-08|||June 2015||2015-06-01|April 2017|2017-04-01|June 2023|Anticipated|2023-06-01|June 2023|Anticipated|2023-06-01|5 Years|Observational [Patient Registry]|||The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology|The Coflex®COMMUNITY Study: An Observational Study of Coflex® Interlaminar Technology|Recruiting||N/A|500|Anticipated|Predicted, Reported and Observed Outcomes Foundation|||1||f||||f||||||||||2017-10-10 23:15:52.241|2017-10-10 23:15:52.241
NCT02457455|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-05-27|||October 2014||2014-10-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Observational|||Urgent Medical and Surgical Conditions During Flights|Inflight Emergencies During Eurasian Flights|Completed||N/A|1312|Actual|Antalya Training and Research Hospital|||1||f||||f||||||||||2017-10-10 23:15:52.43736|2017-10-10 23:15:52.43736
NCT02457442|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-21|||December 2015||2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SPRV||Interaction of Sevoflurane Propofol and Remifentanil in Anesthesia for Laparoscopic Surgery|Validation of the Interaction Model of the Anesthetic Potency of Sevoflurane, Propofol and Remifentanil|Recruiting||Phase 4|120|Anticipated|University Hospital Inselspital, Berne||6|||f||||f||||||||||2017-10-10 23:15:52.517656|2017-10-10 23:15:52.517656
NCT02457429|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-01-26|||January 2013||2013-01-01|January 2016|2016-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||A Validation Study of the Dx-pH Probe in Children for the Detection of Extra-oesophageal Reflux|A Validation Study of the Dx-pH Probe in Children for the Detection of Extra-oesophageal Reflux|Active, not recruiting||N/A|30|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:15:52.628513|2017-10-10 23:15:52.628513
NCT02457416|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-05-03|||March 2014||2014-03-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Take Away Food Allergy; Inducing Tolerance in Children Allergic to Peanut|Take Away Food Allergy; Inducing Tolerance in Children Allergic to Peanut|Active, not recruiting||N/A|77|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 23:15:52.850565|2017-10-10 23:15:52.850565
NCT02457403|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-03-28|||May 2015||2015-05-01|March 2017|2017-03-01||||May 2018|Anticipated|2018-05-01||Interventional|SCARLET||Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy: Rotational Thromboelastometry Versus Conventional Therapy||Enrolling by invitation||N/A|200|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-10 23:15:52.942479|2017-10-10 23:15:52.942479
NCT02457390|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-01-25|||January 2015||2015-01-01|January 2015|2015-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CE-LUS||The Value of CE-LUS During Robot-assisted Surgery for Primary Colorectal Cancer|The Value of Contrast Enhanced Laparoscopic Ultrasound Examination During Robot-assisted Surgery for Primary Colorectal Cancer|Completed||N/A|50|Actual|Odense University Hospital||1|||f||||t||||||||||2017-10-10 23:15:53.030899|2017-10-10 23:15:53.030899
NCT02457377|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2017-03-22|||January 2004||2004-01-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Laparoscopic Transabdominal Cerclage: New Approach|Laparoscopic Transabdominal Cerclage: A New Ideal Approach|Completed||N/A|15|Actual|Cairo University||1|||f||||t||||||||||2017-10-10 23:15:53.11585|2017-10-10 23:15:53.11585
NCT02457364|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-15|||July 2015||2015-07-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Non-Op Management of Ventral Hernia Patients|Prospective Observational Trial of Initial Non-operative Management of Ventral Hernia Repair|Active, not recruiting||N/A|143|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-10 23:15:53.196361|2017-10-10 23:15:53.196361
NCT02457351|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-28|2016-05-20|||July 2015||2015-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study|An Open-label, Non-randomized, Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Roniciclib in Patients With Advanced Solid Tumors|Completed||Phase 1|14|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:15:53.279152|2017-10-10 23:15:53.279152
NCT02457338|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-01|||November 2014||2014-11-01|September 2017|2017-09-01|June 2027|Anticipated|2027-06-01|June 2027|Anticipated|2027-06-01||Interventional|IMPRINT||Infant Microbiota and Probiotic Intake Study|Infant Supplementation With Probiotic Bifidobacterium Longum Subsp. Infantis Study|Active, not recruiting||Phase 1|120|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 23:15:53.383191|2017-10-10 23:15:53.383191
NCT02457312|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-12-08|||March 2013||2013-03-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||The Effect of 7 Days of Letrozole Pretreatment Combined With Misoprostol on the Placental and Decidual Tissues|The Effect of 7 Days of Letrozole Pretreatment Combined With Misoprostol on the Placental and Decidual Tissues|Completed||Phase 2|20|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:15:53.594096|2017-10-10 23:15:53.594096
NCT02457299|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-11-15|||May 2015||2015-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Esophagectomy With or Without Prior Ischemic Gastric Preconditioning|A Multicenter, Randomized Trial of Esophagectomy and Cervical Esophagogastrostomy With (Two-stage) or Without (One-stage) Prior Ischemic Gastric Preconditioning by Laparoscopic Ligation of Left Gastric and Short Gastric Arteries|Terminated||N/A|1|Actual|NorthShore University HealthSystem||2||Standard of care was modified at the primary institution|f||||f||||||||No||2017-10-10 23:15:53.671161|2017-10-10 23:15:53.671161
NCT02457286|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-07-26|||June 2015|Actual|2015-06-01|July 2016|2016-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study|Improving Insulin Resistance to Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study|Withdrawn||Phase 1|0|Actual|Northwell Health||2||patients do not want to participate|f||||f||||||||||2017-10-10 23:15:53.755344|2017-10-10 23:15:53.755344
NCT02445846|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-04-20|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Dual Rapid HIV & Syphilis Tests in Zambia|Field Performance Evaluation of Dual Rapid HIV & Syphilis Tests in Zambia|Completed||N/A|3010|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 23:18:15.957827|2017-10-10 23:18:15.957827
NCT02457273|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-05-26|||June 2015||2015-06-01|May 2015|2015-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients|An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of TLC388 as Second-line Treatment in Subjects With Poorly Differentiated Neuroendocrine Carcinomas|Not yet recruiting||Phase 2|44|Anticipated|National Health Research Institutes, Taiwan||1|||f||||t||||||||||2017-10-10 23:15:53.85287|2017-10-10 23:15:53.85287
NCT02457260|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-07-24|||January 8, 2016||2016-01-08|July 2017|2017-07-01|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|ONTx+HF||Oral Nitrite for Older Heart Failure Patients|Study of the Utility of Oral Nitrite Therapy to Improve Skeletal Muscle Bioenergetics and Physical Capacity in Older Heart Failure Patients|Completed||Phase 2|21|Actual|University of Pittsburgh||3|||f||||f||||||||||2017-10-10 23:15:53.952115|2017-10-10 23:15:53.952115
NCT02457247|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-08-29|2016-06-01||June 2015||2015-06-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Randomized Analysis Set included all randomized participants.|Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.|A Randomized, Open-Label, 2-Way Cross-Over, Phase 4 Study to Evaluate Subject Preference and Acceptability of a New Formulation of Calcichew D3 in Adult Patients Eligible for Calcium and Vitamin D Supplementation|Completed||Phase 4|276|Actual|Takeda||4|||f||||f||||||||||2017-10-10 23:15:54.062839|2017-10-10 23:15:54.062839
NCT02457234|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-05-27|||May 2014||2014-05-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|Traditions||Influence of Cultural Immersion on Willingness to Try Fruits and Vegetables Among Children in Guam: the Traditions Study|Examining the Influence of Cultural Immersion on Willingness to Try Fruits and Vegetables Among Children in Guam: the Traditions Study|Completed||N/A|104|Actual|University of Guam||3|||f||||f||||||||||2017-10-10 23:15:55.191015|2017-10-10 23:15:55.191015
NCT02457221|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-09-28|||March 10, 2015|Actual|2015-03-10|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis|A Phase III, Randomized, Open, Parallel-controlled, Multi-center Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis|Recruiting||Phase 3|294|Anticipated|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 23:15:55.29894|2017-10-10 23:15:55.29894
NCT02457195|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-09-14|||February 2016|Actual|2016-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|GTPPONV||Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting|Preoperative Use of Granisetron Transdermal Patch for Prevention of Postoperative Nausea and Vomiting (PONV) in Patients With History of Severe PONV - Open Label, Prospective, Pilot Study|Recruiting||Phase 2|60|Anticipated|Milton S. Hershey Medical Center||1|||f||||t||||||||||2017-10-10 23:15:55.584286|2017-10-10 23:15:55.584286
NCT02457169|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-10-26|||September 2014||2014-09-01|October 2016|2016-10-01||||September 2019|Anticipated|2019-09-01||Interventional|||Addressing Systemic Health Disparities in Early Identification and Treatment of Autism Spectrum Disorder (ASD): ABCD Project|Addressing Systemic Health Disparities in Early ASD Identification and Treatment|Enrolling by invitation||N/A|118|Anticipated|University of Massachusetts, Boston||2|||f||||f||||||||No||2017-10-10 23:15:55.767864|2017-10-10 23:15:55.767864
NCT02457156|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-05-19|||April 2015||2015-04-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|PANasta||Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy|PANasta Trial Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy - a Double Blinded Multi Centred Trial|Recruiting||Phase 3|506|Anticipated|University of Liverpool||2|||f||||f||||||||||2017-10-10 23:15:55.855003|2017-10-10 23:15:55.855003
NCT02457143|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-10-14|||July 2015||2015-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Comparing Methods of Recall for Cancer Screening in Primary Care: a Pragmatic Clinical Trial|Comparing Methods of Recall for Cancer Screening in Primary Care: a Pragmatic Randomized Clinical Trial|Completed||N/A|5270|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 23:15:55.965984|2017-10-10 23:15:55.965984
NCT02457130|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-04-13|||April 2015||2015-04-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|TICS-DM||Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)|Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM): a Randomized Pharmacodynamic Study|Recruiting||Phase 4|30|Anticipated|Spanish Society of Cardiology||2|||f||||f||||||||||2017-10-10 23:15:56.045553|2017-10-10 23:15:56.045553
NCT02457117|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-08-01|||May 2015||2015-05-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|5 Years|Observational [Patient Registry]|||A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI)|A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI)|Recruiting||N/A|200|Anticipated|Georgetown University|||1||f||||t||||||||||2017-10-10 23:15:56.151645|2017-10-10 23:15:56.151645
NCT02456922|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-05-25|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics|A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics|Not yet recruiting||N/A|100|Anticipated|Medtronic Diabetes||1|||f||||f|f|t|t|||||No||2017-10-10 23:15:57.688451|2017-10-10 23:15:57.688451
NCT02457104|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-05-23|||June 2015||2015-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||The Effect of PPI Therapy on Weight, Gut Microbiome, and Expression of GPR41 and GPR43|The Effect of PPI Therapy on Weight, Gut Microbiome, and Expression of GPR41 and GPR43|Recruiting||N/A|120|Anticipated|University of Colorado, Denver|||4||f||||f||||||Samples Without DNA|"     Stool aspirate will be frozen (temporarily banked) until a sufficient number of samples is     available to analyze the microbiome in a cost-effective manner. The samples will not be saved     after this microbiome analysis for any future analysis. The colonic and small intestinal     mucosal tissue will be frozen. The colonic and small instestinal samples will be used for RNA     isolation as a part of this study. The remainder of the sample will be banked for possible     future use.   "|||2017-10-10 23:15:56.251048|2017-10-10 23:15:56.251048
NCT02457091|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-12-01|||October 2013||2013-10-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|GetFit||Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS|Project GET FIT With MS: Guidelines for Exercise Training and Fitness Outcomes in MS|Completed||Phase 2|32|Actual|University of Illinois at Urbana-Champaign||2|||f||||t||||||||||2017-10-10 23:15:56.336857|2017-10-10 23:15:56.336857
NCT02457078|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-05-01|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Investigating the Effects of Nutrition on the Maturation of Brain Networks Associated With Memory in Infants|Investigating the Effects of Nutrition on the Maturation of Brain Networks Associated With Memory and Language in Infants|Recruiting||N/A|60|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||Undecided||2017-10-10 23:15:56.429309|2017-10-10 23:15:56.429309
NCT02457065|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-05-28|||March 2015||2015-03-01|April 2015|2015-04-01||||January 2016|Anticipated|2016-01-01||Interventional|||Skin Care Behaviors Among Melanoma Survivors and Their Families|Skin Care Behaviors Among Melanoma Survivors and Their Families|Unknown status|Recruiting|N/A|100|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||||||||||||2017-10-10 23:15:56.532683|2017-10-10 23:15:56.532683
NCT02457052|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-08-21|||October 2014||2014-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|DATP-DEG||Impact of a Transportable Customizable and Scalable Sitting Positioning Device on Swallowing Disorders|Impact of a Transportable Customizable and Scalable Sitting Positioning Device on Swallowing Disorders|Active, not recruiting||N/A|64|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:15:56.607303|2017-10-10 23:15:56.607303
NCT02457039|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-09-04|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Acupuncture Prevents Chemobrain in Breast Cancer Patients|An Assessor-Blinded, Randomised Controlled Trial of Acupuncture to Prevent Chemobrain in Breast Cancer Patients|Recruiting||N/A|168|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:15:56.6897|2017-10-10 23:15:56.6897
NCT02457026|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-25|||January 2016||2016-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD|Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in Patients With Neovascular Age-Related Macular Degeneration|Withdrawn||N/A|0|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:15:56.833301|2017-10-10 23:15:56.833301
NCT02457013|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-05-26|||October 2014||2014-10-01|May 2015|2015-05-01|November 2016|Anticipated|2016-11-01|April 2016|Anticipated|2016-04-01||Interventional|TRAMONTANE||Interest of High Flow Nasal Cannula (HFNC) Versus Non Invasive Ventilation During the Initial Management of Severe Bronchiolitis in Infants|Interest of High Flow Nasal Cannula (HFNC) Versus Non Invasive Ventilation During the Initial Management of Severe Bronchiolitis in Infants|Unknown status|Recruiting|N/A|142|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:15:56.950595|2017-10-10 23:15:56.950595
NCT02457000|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-12-03|||March 2015||2015-03-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Sleep, Circadian Rhythm & Skin Health|Sleep, Circadian Rhythm & Skin Health|Recruiting||N/A|50|Anticipated|University Hospitals Cleveland Medical Center|||2||f||||t||||||Samples Without DNA|"     Skin, blood, urine, saliva and hair follicle samples may be collected from volunteers to look     at various markers related to sleep, the circadian rhythm and skin disease.   "|||2017-10-10 23:15:57.029706|2017-10-10 23:15:57.029706
NCT02456987|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-09-27|||June 30, 2015|Actual|2015-06-30|September 2017|2017-09-01|November 21, 2016|Actual|2016-11-21|November 21, 2016|Actual|2016-11-21||Interventional|||Virtual Reality in Inpatients|The Feasibility, Usability, Acceptability, and Clinical Utility of a Virtual Reality Intervention in the Inpatient Setting|Completed||N/A|100|Actual|Cedars-Sinai Medical Center||2|||f||||f|f|f||||||||2017-10-10 23:15:57.102195|2017-10-10 23:15:57.102195
NCT02456974|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-09-08|||May 2012||2012-05-01|September 2017|2017-09-01|April 28, 2018|Anticipated|2018-04-28|December 2017|Anticipated|2017-12-01|3 Days|Observational [Patient Registry]|ADIC||Antibiotic Dosing in Pediatric Intensive Care|Antibiotic Dosing in Pediatric Intensive Care|Recruiting||N/A|640|Anticipated|University Hospital, Ghent|||7||f||||f||||||Samples Without DNA|"     blood samples and urine samples (only for ciprofloxacin)   "|||2017-10-10 23:15:57.171739|2017-10-10 23:15:57.171739
NCT02456948|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2017-07-18|||December 2015||2015-12-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|Mino-TRD||Adjunct Minocyline in Treatment-resistant Depression|A Double-blind, Placebo-controlled, Randomized, Multicenter Proof-of-principle Trial of Adjunctive Minocycline for Patients With Unipolar Major Depressive Disorder (MDD)|Recruiting||Phase 2|160|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 23:15:57.448507|2017-10-10 23:15:57.448507
NCT02456935|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2016-12-14|||May 2015||2015-05-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis|A Double-blind, Randomized, Active-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis|Completed||Phase 3|280|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-10 23:15:57.600679|2017-10-10 23:15:57.600679
NCT02456909|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-01-27|||April 2015||2015-04-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PCA Cues||Patient Controlled Analgesia Pump Cues on Patient Satisfaction|The Effect of Patient Controlled Analgesia Pump Cues on Patient Satisfaction|Recruiting||N/A|120|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-10 23:15:57.854523|2017-10-10 23:15:57.854523
NCT02456831|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-05-28|||December 1992||1992-12-01|May 2015|2015-05-01|June 1994|Actual|1994-06-01|June 1994|Actual|1994-06-01||Interventional|||Soy Formula Feedings in Healthy, Term Infants|Efficacy of Soy Formula Feedings in Healthy, Term Infants|Completed||N/A|115|Actual|Abbott Nutrition||4|||f||||f||||||||||2017-10-10 23:15:58.04332|2017-10-10 23:15:58.04332
NCT02456818|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-02-05|||January 2015||2015-01-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|CONTAIN||Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards|A Hospital-based Cohort Study in German Hematological / Oncological Wards to Assess the Effect of Contact Isolation on Nosocomial Colonization With ESBL-producing Escherichia Coli (CONTAIN Study)|Enrolling by invitation||N/A|2264|Anticipated|University of Cologne|||2||f||||f||||||Samples With DNA|"     Rectal swabs or stool samples   "|||2017-10-10 23:15:58.14645|2017-10-10 23:15:58.14645
NCT02456805|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-27|2015-05-27|||August 1996||1996-08-01|May 2015|2015-05-01|June 1997|Actual|1997-06-01|June 1997|Actual|1997-06-01||Interventional|||Alternate Formula Feedings in Formula Intolerant Infants|Efficacy of Alternate Formula Feedings in Formula Intolerant Infants|Completed||N/A|113|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-10 23:15:58.232192|2017-10-10 23:15:58.232192
NCT02456792|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-23|2017-05-08|||January 2016||2016-01-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||IVF Versus LOD in Women With CC Resistant PCOS|In Vitro Fertilization Versus Laparoscopic Ovarian Drilling in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome|Withdrawn||Phase 4|0|Actual|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 23:15:58.324242|2017-10-10 23:15:58.324242
NCT02456779|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-03-31|||May 2015||2015-05-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|PEPTESTCN||Validation of a Non-invasive In-vitro Diagnostic Test (Peptest) Against Other Diagnostic Methods for GERD|Assessment of Equivalence of a Non-invasive In-vitro Diagnostic Test (Peptest) in Comparison to Other Routine Clinical Diagnostic Methods for GERD by Testing a Large Number of Clinical Samples|Active, not recruiting||N/A|1020|Anticipated|MAAB (Shanghai) Medical Device Limited|||3||f||||f||||||Samples Without DNA|"     Saliva samples will be obtained from each subject. Specimens will be disposed of after     testing for presence of pepsin using Peptest.   "|||2017-10-10 23:15:58.421673|2017-10-10 23:15:58.421673
NCT02456766|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-05-27|||June 2014||2014-06-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis|A Multicenter Clinical Study on the Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for the Diagnosis of Hepatic Steatosis|Unknown status|Recruiting|N/A|240|Anticipated|Wuxi Hisky Medical Technology Co Ltd|||4||f||||||||||Samples Without DNA|"     Liver Biospy Specimens   "|||2017-10-10 23:15:58.535305|2017-10-10 23:15:58.535305
NCT02456753|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-09-19|||September 2012||2012-09-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ECHOTRANS||Assesment by Ultrasonography of the Perineal-cephalic Distance|Assesment by Ultrasonography of the Perineal-cephalic Distance in Consistence With the Notion of Clinical Fetal Head Engagement|Completed||N/A|411|Actual|Lille Catholic University|||1||f||||f||||||||||2017-10-10 23:15:58.654457|2017-10-10 23:15:58.654457
NCT02456740|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-06-20||2017-05-26|July 17, 2015|Actual|2015-07-17|June 2017|2017-06-01|June 19, 2017|Actual|2017-06-19|September 5, 2016|Actual|2016-09-05||Interventional|STRIVE||Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention|A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention|Completed||Phase 3|955|Actual|Amgen||3|||f||||t||||||||||2017-10-10 23:15:58.747344|2017-10-10 23:15:58.747344
NCT02456727|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-07-11|||May 2015||2015-05-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|AADDOPT-2||Acupuncture Approaches for Chronic Pain|Acupuncture Approaches to Decrease Disparities in Outcomes of Pain Treatment - A Two Arm Comparative Effectiveness Trial|Recruiting||N/A|720|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-10 23:15:59.079731|2017-10-10 23:15:59.079731
NCT02456714|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-06-23|||December 2015||2015-12-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|4CC||Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma|Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma|Recruiting||Phase 2|30|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 23:15:59.169694|2017-10-10 23:15:59.169694
NCT02456701|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-08-31|||June 2015||2015-06-01|August 2017|2017-08-01|October 13, 2016|Actual|2016-10-13|October 13, 2016|Actual|2016-10-13||Interventional|||Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379|Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI Refractory Thyroid Cancers With the Combination of BRAF Inhibitor Vemurafenib and Anti-ErbB3 Antibody KTN3379: A Pilot Study With a Phase 1 Run-in|Completed||Phase 1|7|Actual|Celldex Therapeutics||1|||f||||f||||||||||2017-10-10 23:15:59.275314|2017-10-10 23:15:59.275314
NCT02456688|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-05-26|||January 2015||2015-01-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency|An Open-label, Single-dose Study to Assess the Pharmacokinetics of Imrecoxib in Subjects With Impaired Hepatic Function|Unknown status|Recruiting|Phase 1|20|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:15:59.362963|2017-10-10 23:15:59.362963
NCT02455908|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-27|||February 2012||2012-02-01|May 2015|2015-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||IL-2 for Multi Drug Resistant Nephrotic Syndrome|Use of IL-2 for Pediatric, Multi Drug Resistant, Idiopathic Nephrotic Syndrome|Completed||Phase 1/Phase 2|5|Actual|Istituto Giannina Gaslini||1|||f||||f||||||||||2017-10-10 23:16:05.660036|2017-10-10 23:16:05.660036
NCT02456675|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-05-08|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|December 16, 2016|Actual|2016-12-16|December 16, 2016|Actual|2016-12-16||Interventional|||INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/Refractory Hodgkin Lymphoma|A Phase 2, Open-Label Study of the Safety and Efficacy of INCB40093 and INCB40093 Combined With Itacitinib (INCB039110) in Subjects With Relapsed or Refractory Hodgkin Lymphoma|Terminated||Phase 2|8|Actual|Incyte Corporation||2||"A decision was made to terminate the study due to the changing treatment landscape for the   development of new agents in combination in Hodgkin lymphoma."|f||||t||||||||||2017-10-10 23:15:59.434121|2017-10-10 23:15:59.434121
NCT02456662|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-22|||October 2015||2015-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|SPARED||Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) Trial|A Randomized Controlled Trial of Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline|Recruiting||N/A|300|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-10 23:15:59.515089|2017-10-10 23:15:59.515089
NCT02456649|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-09-30|||March 2015||2015-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MarginProbe||Study of the Outcomes of Intraoperative Margin Assessment With MarginProbe|A Phase II Study of the Outcomes of Intraoperative Margin Assessment With Adjunctive Use of MarginProbe in Addition to Standard|Completed||N/A|64|Actual|Huntington Memorial Hospital||1|||f||||f||||||||No||2017-10-10 23:15:59.604334|2017-10-10 23:15:59.604334
NCT02456636|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-08-11|||January 2016||2016-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|RE-POWER||Rural Engagement in Primary Care for Optimizing Weight Reduction|Rural Engagement in Primary Care for Optimizing Weight Reduction (RE-POWER)|Recruiting||N/A|1440|Anticipated|University of Kansas Medical Center||3|||f||||t||||||||||2017-10-10 23:15:59.678917|2017-10-10 23:15:59.678917
NCT02456623|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-02-06|||September 2013||2013-09-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Obesity Intervention for Low-Income African American Preschoolers|Parent Focused Obesity Intervention for Low-Income African American Preschoolers|Active, not recruiting||N/A|51|Actual|Eastern Michigan University||2|||f||||t||||||||No||2017-10-10 23:15:59.76743|2017-10-10 23:15:59.76743
NCT02456610|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-02-18|||May 2015||2015-05-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China|Adoptive Transfer of Peptide Stimulated CMV/EBV Specific Cytotoxic T Lymphocytes to Prevent and Treat EBV/CMV Infections in Patients Post Allogeneic Stem Cell Transplantation in China|Recruiting||Phase 1|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-10 23:15:59.850104|2017-10-10 23:15:59.850104
NCT02456597|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-10-13|||April 2015||2015-04-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Novel Concept for Continuous Peripheral Nerve Block - Sciatic Nerve|A Novel Concept for Continuous Peripheral Nerve Block - Popliteal Region|Completed||N/A|16|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-10-10 23:15:59.927497|2017-10-10 23:15:59.927497
NCT02456584|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-06-16|||September 2015||2015-09-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods|Pharmacodynamics (Suppression of Ovulation) and Pharmacokinetics Following a Single Subcutaneous Administration of Depo Provera® CI 150 mg/mL, Depo Provera® CI 300 mg/2 mL, or During Two Cycles of Depo-subQ Provera 104®|Active, not recruiting||Phase 1|42|Actual|FHI 360||3|||f||||f||||||||No||2017-10-10 23:15:59.996306|2017-10-10 23:15:59.996306
NCT02456571|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-07-11|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|||CTC Immune Checkpoint|Defining the Relevant Immune Checkpoints Expressed on Metastatic Prostate Cancer Circulating Tumor Cells|Recruiting||N/A|40|Anticipated|Duke University|||4||f||||f||||||||||2017-10-10 23:16:00.212865|2017-10-10 23:16:00.212865
NCT02456558|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-06-03|||June 2015||2015-06-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects|A Phase Ib Randomized, Double-blind, Placebo-controlled, Ascending Sequential Dose, Adaptive Design Study to Evaluate the Safety, Antiretroviral Activity, and Pharmacokinetics of Intravenous Deferiprone in Treatment-Naïve HIV-Positive Subjects|Completed||Phase 1|30|Actual|ApoPharma||3|||f||||t||||||||||2017-10-10 23:16:00.312199|2017-10-10 23:16:00.312199
NCT02456545|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-08-24|||June 2015||2015-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|BipoLife-A1||Improving Early Recognition and Intervention in At-risk Stages of Bipolar Disorders|Improving Early Recognition and Intervention in At-risk Stages of Bipolar Disorders|Recruiting||N/A|1650|Anticipated|Technische Universität Dresden|||4||f||||t||||||||||2017-10-10 23:16:00.409672|2017-10-10 23:16:00.409672
NCT02456532|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-02-22|||July 2015||2015-07-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|CIS2||Safety and Efficacy of Chronic Hypnotic Use 2|Risks for Transition From Therapeutic Hypnotic Use to Abuse|Recruiting||Phase 4|120|Anticipated|Henry Ford Health System||3|||f||||t||||||||||2017-10-10 23:16:00.548399|2017-10-10 23:16:00.548399
NCT02456519|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-02-09|||June 2015||2015-06-01|May 2015|2015-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Quality of Postoperative Recovery in Children and Young People|Quality of Postoperative Recovery in Children and Young People: The Modified QoR-15 Questionnaire|Completed||N/A|150|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:16:00.633872|2017-10-10 23:16:00.633872
NCT02456506|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-05-24|||June 2015||2015-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.|Multiple Centre, Randomised, Controlled Trial of Hyperfractionated IMRT and Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.|Recruiting||Phase 1/Phase 2|142|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:16:00.702773|2017-10-10 23:16:00.702773
NCT02456493|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||The Effect of Carotid IMT (Intima Media Thickness) on Postoperative Cognitive Dysfunction in Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery||Unknown status|Recruiting|N/A|274|Anticipated|Yonsei University|||3||f||||f||||||||||2017-10-10 23:16:00.803938|2017-10-10 23:16:00.803938
NCT02456480|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-07-25||2016-07-25|May 2015||2015-05-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis|A Randomized, Double-blind, Placebo Controlled Study to Assess the Pharmacodynamics, Safety/Tolerability and Efficacy of Omiganan in Patients With Mild to Moderate Atopic Dermatitis|Completed||Phase 2|37|Actual|Cutanea Life Sciences, Inc.||3|||f||||f||||||||||2017-10-10 23:16:00.869141|2017-10-10 23:16:00.869141
NCT02456467|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-10-26|||April 2015||2015-04-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||HemoSonics-UVA HemoSonics-UVA Cardiac Surgery Clinical Study Protocol|HemoSonics-UVA Cardiac Surgery Clinical Study Protocol|Completed||N/A|50|Actual|University of Virginia|||1||f||||f||||||||||2017-10-10 23:16:00.95241|2017-10-10 23:16:00.95241
NCT02456454|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-11-11|||January 2006||2006-01-01|November 2015|2015-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder|Placebo Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder|Completed||Phase 3|46|Actual|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-10 23:16:01.022601|2017-10-10 23:16:01.022601
NCT02456441|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-05-27|||March 2014||2014-03-01|May 2015|2015-05-01||||August 2014|Actual|2014-08-01||Interventional|||Effects of TENS in Autonomous System in Women With Overactive Bladder|The Effects of Transcutaneous Tibial Nerve Stimulation in Sympathetic and Parasympathetic System in Women With Overactive Bladder: Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|12|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||||2017-10-10 23:16:01.117686|2017-10-10 23:16:01.117686
NCT02456428|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-04-15|||March 2014||2014-03-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Incretin-based Drugs and the Risk of Heart Failure|Incretin-based Drugs and the Risk of Heart Failure: A Multi-center Network Observational Study|Completed||N/A|1499650|Actual|Canadian Network for Observational Drug Effect Studies, CNODES|||5||f||||f||||||||||2017-10-10 23:16:01.232221|2017-10-10 23:16:01.232221
NCT02456415|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-09-14|||July 2013||2013-07-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||The Efficacy and Safety of Magnesium Alloy Screw as a Novel Bioabsorbable Material in Patients Due to Hand Fractures|A Prospective, Single Center, Single Group, Open-label Study to Evaluate the Efficacy and Safety of Magnesium Alloy Screw as a Novel Bioabsorbable Material in Patients Requiring Internal Fixation Due to Hand Fractures|Completed||Phase 2|28|Actual|U&I Corporation||1|||f||||t||||||||||2017-10-10 23:16:01.405593|2017-10-10 23:16:01.405593
NCT02456402|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-06-01|||April 2015||2015-04-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions|Randomized Controlled Trial of Drug Coated Balloon Compared to Bare Metal Stent Using FFR-guidance for the Treatment of de Novo Coronary Artery Lesions|Unknown status|Recruiting|N/A|40|Anticipated|Ulsan University Hospital||2|||f||||t||||||||||2017-10-10 23:16:01.488986|2017-10-10 23:16:01.488986
NCT02456389|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-08-19|||July 2014||2014-07-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|PRS||Perioperative Risk Study|A Randomized Controlled Trial of Perioperative Risk Stratification and Risk-based, Protocol-driven Management in Patients Undergoing Elective Major Cancer Surgery|Recruiting||Phase 3|1456|Anticipated|Fox Chase Cancer Center||2|||f||||t||||||||||2017-10-10 23:16:01.591053|2017-10-10 23:16:01.591053
NCT02456376|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-05-26|||May 2014||2014-05-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Balance Control in Children With Cerebral Palsy|Sensor Fusion for Balance Control in Children With Cerebral Palsy|Unknown status|Recruiting|N/A|20|Anticipated|Temple University||2|||f||||f||||||||||2017-10-10 23:16:01.727774|2017-10-10 23:16:01.727774
NCT02456363|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2015-05-26|||November 2009||2009-11-01|May 2015|2015-05-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis|Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis—A Registry Project|Recruiting||Phase 2|300|Anticipated|Chung Shan Medical University||4|||f||||t||||||||||2017-10-10 23:16:01.847413|2017-10-10 23:16:01.847413
NCT02456350|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-08-01|||April 2015||2015-04-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies|Genetically Engineered T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor for Treatment of Patients With B Cell Malignancies|Recruiting||Phase 1|36|Anticipated|Shenzhen Second People's Hospital||1|||f||||f||||||||||2017-10-10 23:16:01.960024|2017-10-10 23:16:01.960024
NCT02456337|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-10-25|||July 2014||2014-07-01|December 2015|2015-12-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage|Xenogenous Collagen Matrix Graft Associated or Not With Enamel Matrix Derivative Proteins in the Treatment of Gingival Recession Class I and II of Miller: Randomized Controlled Clinical Study|Completed||Phase 4|49|Actual|University of Campinas, Brazil||4|||f||||t||||||||No||2017-10-10 23:16:02.070758|2017-10-10 23:16:02.070758
NCT02456324|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-05-26|||May 2015||2015-05-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||A Prospective European Post-Market Clinical Evaluation of the CuraSeal Percutaneous Intraluminal Closure System for Anorectal Fistulas|A Prospective European Post-Market Clinical Evaluation of the CuraSeal Percutaneous Intraluminal Closure System for Anorectal Fistulas|Unknown status|Recruiting|Phase 2|30|Anticipated|Curaseal Inc.||2|||f||||f||||||||||2017-10-10 23:16:02.16206|2017-10-10 23:16:02.16206
NCT02456311|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-11-24|||May 2015||2015-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Pulmonary Artery Harmonic Ace+7 Energy Sealing in Open Lobectomy|Pulmonary Artery Harmonic Ace+7 Energy Sealing in Open Lobectomy Human Pilot Study|Completed||Early Phase 1|10|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-10 23:16:02.253869|2017-10-10 23:16:02.253869
NCT02456298|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-04-12|||June 2015||2015-06-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Comparing Behavioral Assessments Using Telehealth for Children With Autism||Recruiting||N/A|102|Anticipated|University of Iowa||2|||f||||t||||||||||2017-10-10 23:16:02.328674|2017-10-10 23:16:02.328674
NCT02456285|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-07-25|||April 2015||2015-04-01|July 2016|2016-07-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Observational|CoSMIC||Colorectal Cancer With Liver-limited Synchronous Metastases: an Inception Cohort Study of Standardised Care Pathways|Colorectal Cancer With Liver-limited Synchronous Metastases: an Inception Cohort Study of Standardised Care Pathways|Recruiting||N/A|150|Anticipated|Central Manchester University Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-10-10 23:16:02.417666|2017-10-10 23:16:02.417666
NCT02456272|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-08-16|||September 2015||2015-09-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PARCO||Hearing Aid Versus Surgical Rehabilitation as Treatment of Otosclerosis: Pilot Study|Hearing Aid Versus Surgical Rehabilitation as Treatment of Otosclerosis: Pilot Study|Recruiting||Phase 3|30|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 23:16:02.497428|2017-10-10 23:16:02.497428
NCT02456259|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2016-09-28|||June 2015||2015-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Postoperative Patency of Internal Jugular Vein After Neck Cannula Insertion|Postoperative Patency of Internal Jugular Vein After Neck Cannula Insertion in Patients Undergoing Minimally Invasive Cardiac Surgery|Recruiting||N/A|40|Anticipated|University Hospital Hradec Kralove|||2||f||||f||||||||||2017-10-10 23:16:02.586116|2017-10-10 23:16:02.586116
NCT02456246|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-19|||May 2015||2015-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|SBRT FLT-PET||Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT|Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT|Recruiting||N/A|15|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:16:02.662866|2017-10-10 23:16:02.662866
NCT02456233|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2016-05-01|||April 2016||2016-04-01|May 2016|2016-05-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|RECONFIRM||Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF|Randomized Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human Atrial Fibrillation (RECONFIRM): A Randomized Clinical Trial|Recruiting||N/A|120|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 23:16:02.7379|2017-10-10 23:16:02.7379
NCT02456220|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-10-24|||March 2013||2013-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Dentoskeletal Changes Associated With Herbst Appliance Therapy|Three-dimensional Assessment of the Dentoskeletal Changes Associated With Herbst Appliance Therapy: A Controlled Clinical Trial|Completed||N/A|50|Actual|Pontifícia Universidade Católica de Minas Gerais||2|||f||||f||||||||||2017-10-10 23:16:02.837119|2017-10-10 23:16:02.837119
NCT02456207|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2015-05-27|||May 2015||2015-05-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma|A Phase II, Multi-center, Randomized and Open Study to Evaluate and Compare the PK, PD and Safety of SCT400 With Rituximab in Patients With CD20+ B-cell Non-Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 2|80|Anticipated|Sinocelltech Ltd.||2|||f||||f||||||||||2017-10-10 23:16:02.939536|2017-10-10 23:16:02.939536
NCT02456194|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-30|||September 2015||2015-09-01|January 2017|2017-01-01||||August 2018|Anticipated|2018-08-01||Interventional|||Management of Traumatic Bone Defects in Tibial Plateau Fractures With Antibiotic-Impregnated Biodegradable Calcium Sulfate Beads: A Prospective Clinical Trial||Recruiting||N/A|30|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-10 23:16:03.01843|2017-10-10 23:16:03.01843
NCT02456181|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-10-24|||March 2012||2012-03-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|August 2014|Actual|2014-08-01||Interventional|JUMP Math||Investigation of Instructional Approaches to Elementary Math|Investigation of the Efficacy of the JUMP Program of Mathematics Instruction|Active, not recruiting||N/A|1156|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-10 23:16:03.11471|2017-10-10 23:16:03.11471
NCT02456168|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-01-17|||January 2015||2015-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus|Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus|Recruiting||N/A|30|Anticipated|Northwell Health|||2||f||||||||||||||2017-10-10 23:16:03.172932|2017-10-10 23:16:03.172932
NCT02456155|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-27|||January 2014||2014-01-01|May 2015|2015-05-01||||January 2016|Anticipated|2016-01-01||Interventional|SAP||A Trial of Bedside Placement of Nasal Jejunal Tube Confirmed by Ultrasound Compared to Placement by Endoscope in Patients With SAP|Study to Compare the Placement Method of Nasal Jejunal Tube in Patients With Severe Acute Pancreatitis: Bedside Placement With Ultrasound Confirmation Versus Placement Endoscopically|Unknown status|Recruiting|Phase 1|60|Anticipated|Nanjing University||2|||f||||t||||||||||2017-10-10 23:16:03.242119|2017-10-10 23:16:03.242119
NCT02456142|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2016-04-08|||July 2015||2015-07-01|May 2015|2015-05-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|CaBuMorph||CAUDAL BUPIVACAINE VERSUS INTRAVENOUS MORPHINE ON TIME TO FIRST ANALGESIC REQUIREMENT|EFFECT OF CAUDAL BUPIVACAINE VERSUS INTRAVENOUS MORPHINE ON TIME TO FIRST ANALGESIC REQUIREMENT IN PEDIATRIC SURGICAL PATIENTS; A RANDOMISED CONTROLLED TRIAL.|Completed||Phase 4|70|Actual|Makerere University||2|||f||||t||||||||||2017-10-10 23:16:03.323046|2017-10-10 23:16:03.323046
NCT02456129|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-03-01|||July 2015||2015-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]Vilaprisan|An Open-label Study to Evaluate the Effect of Repeated Oral Administration of 200 mg Itraconazole(ITZ) Given Once Daily Over 14 Days on the Single Oral Dose Pharmacokinetics of Vilaprisan (BAY1002670) as Well as Assessment of Absolute Bioavailability Using a Single Intravenous Microtracer Dose of [14C]Vilaprisan in Healthy Postmenopausal Women|Completed||Phase 1|14|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:16:03.39359|2017-10-10 23:16:03.39359
NCT02456116|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-05-27|||September 2012||2012-09-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|APOPKA||Efficiency Study About the Effect of Acupuncture on Postoperative Pain After Total Knee Arthroplasty|Efficiency Study About the Effect of Acupunctur on Postoperative Pain After Total Knee Arthroplastry|Unknown status|Recruiting|N/A|90|Anticipated|Medical University of Vienna||3|||f||||f||||||||||2017-10-10 23:16:03.477429|2017-10-10 23:16:03.477429
NCT02456103|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-09-25|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Extension Study of Ataluren for Nonsense Mutation Cystic Fibrosis|A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Cystic Fibrosis|Terminated||Phase 3|246|Actual|PTC Therapeutics||1||CF Data from CF study 021 did not meet end points|f||||t||||||||||2017-10-10 23:16:03.581329|2017-10-10 23:16:03.581329
NCT02456090|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01|10 Years|Observational [Patient Registry]|||PaTH Clinical Data Research Network (CDRN) Study of Healthy Lifestyles and Health Care|PaTH Clinical Data Research Network (CDRN) Study of Healthy Lifestyles and Health Care|Recruiting||N/A|1500|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:16:03.953676|2017-10-10 23:16:03.953676
NCT02456077|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-08-29|||February 1, 2015|Actual|2015-02-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|January 31, 2016|Actual|2016-01-31||Interventional|||Strengthening Physician Communication About HPV Vaccines|Strengthening Physician Communication About HPV Vaccines|Completed||N/A|32673|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:16:04.072152|2017-10-10 23:16:04.072152
NCT02456064|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-24|2017-03-25|||May 2015||2015-05-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus|Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus With Poor Control of Their Disease|Completed||N/A|25|Actual|Equipo Multidisciplinar Sanitario CS Foietes||2|||f||||f|f|f||||||No||2017-10-10 23:16:04.17921|2017-10-10 23:16:04.17921
NCT02456051|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-05-27|||April 2015||2015-04-01|May 2015|2015-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|PaCANOD||Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients|Role of Adrenomedullin in Early Diagnosis of Pancreatic Cancer in New Onset Diabetes Patients|Recruiting||N/A|440|Anticipated|University of Roma La Sapienza|||2||f||||t||||||Samples Without DNA|"     Serum samples   "|||2017-10-10 23:16:04.277377|2017-10-10 23:16:04.277377
NCT02456038|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-03-29|||August 2014||2014-08-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)|A Multicenter Study of the Safety and Efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Patients With Hypophosphatasia (HPP)|Completed||Phase 2|13|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||f||||||||||2017-10-10 23:16:04.414584|2017-10-10 23:16:04.414584
NCT02456025|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2015-11-22|||April 2013||2013-04-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Topical Tacrolimus in Vernal Keratoconjunctivitis|Topical Tacrolimus in Vernal Keratoconjunctivitis|Recruiting||Phase 4|20|Anticipated|The Eye Center and The Eye Foundation for Research in Ophthalmology||2|||f||||f||||||||||2017-10-10 23:16:04.543798|2017-10-10 23:16:04.543798
NCT02456012|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-05-25|||May 2015||2015-05-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|Eso_1y_R6PUB||Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients|Secondary Prevention With Long-term Oral Esomeprazole for Peptic Ulcer Recurrence and Rebleeding in High-risk Rockall Scores ≥ 6 Patients|Unknown status|Recruiting|Phase 4|288|Anticipated|National Cheng-Kung University Hospital||3|||f||||t||||||||||2017-10-10 23:16:04.661663|2017-10-10 23:16:04.661663
NCT02455999|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-04-04|||June 2015||2015-06-01|April 2016|2016-04-01||||March 2016|Actual|2016-03-01||Interventional|||Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain||Completed||Phase 2|66|Actual|Sylentis, S.A.||3|||f||||||||||||||2017-10-10 23:16:04.857632|2017-10-10 23:16:04.857632
NCT02455986|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-14|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The StepSmart Project: A Pedometer Based Phased Intervention to Encourage Physical Activity in Schools|A Randomised Controlled Trial of a Pedometer Based Phased Intervention to Encourage Physical Activity in Schools: A Feasibility Study.|Completed||Phase 1|240|Actual|Queen's University, Belfast||2|||f||||f||||||||||2017-10-10 23:16:04.986602|2017-10-10 23:16:04.986602
NCT02455973|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2015-10-13|||March 2015||2015-03-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|MERC||Interdisciplinary Intervention With Motivational Approach in Adolescents With Overweight and Obesity.|Interdisciplinary Intervention Effectiveness on Motivational Approach in Lifestyle Modification in Adolescents With Overweight and Obesity|Recruiting||N/A|120|Anticipated|Pontificia Universidade Católica do Rio Grande do Sul||2|||f||||t||||||||||2017-10-10 23:16:05.076441|2017-10-10 23:16:05.076441
NCT02455960|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-05-27|||September 2014||2014-09-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Protective Effects of Oral L-Arginine CI-AKI|Protective Effects of Oral L-Arginine Supplement in Patients With CKD After Intravenous Contrast Media Injection|Unknown status|Recruiting|Phase 4|112|Anticipated|Phramongkutklao College of Medicine and Hospital||2|||f||||t||||||||||2017-10-10 23:16:05.226047|2017-10-10 23:16:05.226047
NCT02455947|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-05-27|||September 2013||2013-09-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|August 2014|Actual|2014-08-01||Interventional|||IBSR Meditation Technique for Teachers' Burnout|The Effect of Inquiry Based Stress Reduction (IBSR) Meditation Technique on Levels of Burnout and Wellbeing Among Teachers.|Completed||N/A|60|Actual|Tel Aviv Medical Center||2|||f||||t||||||||||2017-10-10 23:16:05.323949|2017-10-10 23:16:05.323949
NCT02455934|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-01-30|||April 2015||2015-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Effects of D-allulose (Psicose) With Sucrose Beverage on Glucose Tolerance and Insulin Level|The Dose-response Effects of D-allulose (Psicose) With Sucrose Beverage on Glucose Tolerance and Insulin Level in Healthy Volunteers and Volunteers With Impaired Fasting Glucose|Completed||N/A|30|Actual|Chiang Mai University||5|||f||||t||||||||No||2017-10-10 23:16:05.422224|2017-10-10 23:16:05.422224
NCT02455921|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-01-24|||May 2015|Actual|2015-05-01|May 2015|2015-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children|Comparative Effect of Neuromuscular Blockade Reversal Agent on Extubation Conditions, Postoperative Cognitive Function and Behaviour of School-aged Children Undergoing Ear Note Throat (ENT) Surgery|Recruiting||Phase 4|200|Anticipated|Attikon Hospital||2|||f||||f|f|f||||||No||2017-10-10 23:16:05.53709|2017-10-10 23:16:05.53709
NCT02455895|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-05-27|||May 2015||2015-05-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Interventional|||Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora|A Multicenter Randomized, Double-Masked Study Comparing the Efficacy of Novabay iLid Cleanser Versus Vehicle on Ocular Skin Flora|Unknown status|Recruiting|N/A|100|Anticipated|NovaBay Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:16:05.770863|2017-10-10 23:16:05.770863
NCT02455882|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-06-28|||January 2015||2015-01-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Observational|||Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer|Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer|Recruiting||N/A|100|Anticipated|University of Michigan|||3||f||||t||||||Samples With DNA|"     Tissue with invasive disease, blood, and urine samples will be obtained from patients with     breast cancer before, during, and after systemic treatment for primary breast cancer and at     the time of disease recurrence.   "|||2017-10-10 23:16:05.894897|2017-10-10 23:16:05.894897
NCT02455869|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-25|||July 2014||2014-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of Alendronate With Atorvastatin in Chronic Periodontitis|Comparative Evaluation of Subgingivally Delivered 1% Alendronate Versus 1.2% Atorvastatin Gel in Treatment of Chronic Periodontitis: a Randomized Placebo Controlled Clinical Trial|Completed||Phase 2/Phase 3|104|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||t||||||||||2017-10-10 23:16:05.994801|2017-10-10 23:16:05.994801
NCT02455856|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-07-06|||May 18, 2015|Actual|2015-05-18|July 2017|2017-07-01|June 19, 2015|Actual|2015-06-19|June 19, 2015|Actual|2015-06-19||Interventional|||Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male Participants|A Study to Investigate the Potential Effects of Repeated Administration of Itraconazole on the Pharmacokinetics of JNJ-42847922 in Healthy Male Subjects|Completed||Phase 1|16|Actual|Janssen Cilag N.V./S.A.||1|||f||||f||f||||||||2017-10-10 23:16:06.071789|2017-10-10 23:16:06.071789
NCT02455843|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-16|2017-09-18|||May 2015||2015-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC|A Multicenter, Randomized, Open-label Phase III Trial of Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC|Recruiting||Phase 3|275|Anticipated|Shandong Provincial Hospital||2|||f||||f||||||||||2017-10-10 23:16:06.168607|2017-10-10 23:16:06.168607
NCT02455830|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-05-26|||April 2015||2015-04-01|May 2015|2015-05-01|February 2018|Anticipated|2018-02-01|September 2016|Anticipated|2016-09-01||Observational|||Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy|A Study to Determine if Autologous Umbilical Cord Blood Cell Therapy Alters Serum Levels of Cytokines and Trophic Factors in Neonatal Encephalopathy|Recruiting||N/A|18|Anticipated|Neonatal Encephalopathy Consortium, Japan|||2||f||||t||||||||||2017-10-10 23:16:06.301352|2017-10-10 23:16:06.301352
NCT02455817|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-05-26|||June 2015||2015-06-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||REWARDS-Angina at Follow up Post Stenting||Unknown status|Not yet recruiting|N/A|1200|Anticipated|Medstar Health Research Institute|||6||f||||f||||||||||2017-10-10 23:16:06.406926|2017-10-10 23:16:06.406926
NCT02455804|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2016-01-17|||January 2016||2016-01-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|NIRTRAKS||NIRTRAKS Post-Market Study (NIRTRAKS)|NIRTRAKS Post-Market Study|Recruiting||N/A|131|Anticipated|Medinol Ltd.||1|||f||||t||||||||||2017-10-10 23:16:06.473013|2017-10-10 23:16:06.473013
NCT02455791|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2017-01-05|||June 2015||2015-06-01|January 2017|2017-01-01||||June 2018|Anticipated|2018-06-01||Interventional|||Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery|Pilot Study for Identification of Breast Cancer Patients for Potential Avoidance of Surgery: Accuracy of Image Guided Percutaneous Sampling Compared With Surgery to Evaluate Eradication of Breast Cancer After Preoperative Chemotherapy|Active, not recruiting||N/A|43|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:16:06.539421|2017-10-10 23:16:06.539421
NCT02455778|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2015-05-28|||August 2011||2011-08-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Oral Cinnamon Intervention in Metabolic Syndrome|Effect of Intervention With Oral Cinnamon on Metabolic Profile and Body Composition of Asian Indians With Metabolic Syndrome in North India: A 16 Week Double Blind Placebo Control Trial|Completed||N/A|103|Actual|Diabetes Foundation, India||2|||f||||t||||||||||2017-10-10 23:16:06.610411|2017-10-10 23:16:06.610411
NCT02455765|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-01-27|||June 2014||2014-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Glycemic Response of Co-ingesting Carbohydrate and Amino Acids|Glycemic Response of Co-ingesting Carbohydrate and Amino Acids|Completed||N/A|23|Actual|Clinical Nutrition Research Centre, Singapore||7|||f||||f||||||||||2017-10-10 23:16:06.683699|2017-10-10 23:16:06.683699
NCT02455752|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-26|2015-07-16|||March 2015||2015-03-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|LE-TME||Laparoscopic Extraperitoneal Total Mesorectal Excision (LE-TME): A New Feasible Technical Approach.|Laparoscopic Extraperitoneal Total Mesorectal Excision (LE-TME): A New Feasible Technical Approach.|Completed||N/A|5|Actual|Mansoura University||1|||f||||t||||||||||2017-10-10 23:16:06.76766|2017-10-10 23:16:06.76766
NCT02455739|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-05-27|||March 2015||2015-03-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Gum Chewing and Postoperative Intestinal Function After Gynecolgic Operations|Effect of Gum Chewing on Intestinal Functions After Gynecologic Operations|Unknown status|Recruiting|N/A|100|Anticipated|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t||||||||||2017-10-10 23:16:06.876094|2017-10-10 23:16:06.876094
NCT02455726|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-05-25|||September 2015||2015-09-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease|Magnesium Oral Supplementation to Reduce Pain in Patients With Severe Peripheral Arterial Occlusive Disease: The MAG-PAPER Randomized Clinical Trial|Not yet recruiting||N/A|150|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||f||||||||||2017-10-10 23:16:06.958688|2017-10-10 23:16:06.958688
NCT02455713|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2016-04-13|||February 2015||2015-02-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Positive Pressure Ventilation and Sternal Closure in HLHS|Effect of Positive Pressure Ventilation on Hemodynamics Around Delayed Sternal Closure Following Stage 1 Palliation of the Single Ventricle|Recruiting||Phase 2/Phase 3|20|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-10 23:16:07.078528|2017-10-10 23:16:07.078528
NCT02455700|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-04-26|||January 2016||2016-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|IER||Pain Associated With Interproximal Enamel Reduction in Orthodontics: a RCT|A Hospital Based Prospective Randomised Controlled Clinical Trial Comparing Pain Experience Using Manual and Rotary Interproximal Enamel Reduction Techniques in Orthodontic Patients|Recruiting||N/A|34|Anticipated|Royal Surrey County Hospital NHS Foundation Trust||2|||f||||t|f|f||||||No||2017-10-10 23:16:07.156015|2017-10-10 23:16:07.156015
NCT02455687|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-25|2017-01-22|||June 2014||2014-06-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.|Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose With/Without the Nebulized Budesonide for the Management of the Severe Asthma Exacerbation in the Emergency Room. A Randomized Controlled Trial.|Recruiting||Phase 3|240|Anticipated|Hamad Medical Corporation||4|||f||||t||||||||||2017-10-10 23:16:07.236257|2017-10-10 23:16:07.236257
NCT02455674|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-05-25|||December 2014||2014-12-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Using Mean Ages on Clothing Size Labels in Revised Advanced Pediatric Life Support Formulas for Weight Estimation|Weight Estimation of A Child With Unknown Age and Height: Using Mean Ages on Clothing Size Labels in Revised APLS Formulas for Weight Estimation. A Prospective Cross-Sectional Study|Completed||N/A|1094|Actual|Antalya Training and Research Hospital|||2||f||||t||||||||||2017-10-10 23:16:07.324462|2017-10-10 23:16:07.324462
NCT02455661|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-11-22|||February 2014||2014-02-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|May 2016|Actual|2016-05-01||Interventional|FERARI||Femoral Closure Versus Radial Compression Devices Related to Percutaneous Coronary Interventions Study||Recruiting||N/A|400|Anticipated|Universitätsmedizin Mannheim||2|||f||||f||||||||||2017-10-10 23:16:07.395337|2017-10-10 23:16:07.395337
NCT02455648|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-10-24|||January 2012||2012-01-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|CellSheet2||Autologous Cell Sheets Transplantation After ESD in the Esophagus|Transplantation of Autologous Cell Sheets After Endoscopic Submucosal Dissection (ESD) for Early Adenocarcinoma of the Esophagus|Recruiting||Phase 2|20|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-10 23:16:07.463148|2017-10-10 23:16:07.463148
NCT02455635|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-03-18|||January 2013||2013-01-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Lower Abdominal Pain During Office Hysteroscopy Can Assess Tubal Patency in Infertile Women|Lower Abdominal Pain During Office Hysteroscopy As A Guide In The Assessment Of Tubal Patency In Infertile Women|Completed||N/A|60|Actual|Cairo University||2|||f||||t||||||||Yes||2017-10-10 23:16:07.546812|2017-10-10 23:16:07.546812
NCT02455622|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-03-10|||June 2015||2015-06-01|March 2017|2017-03-01|August 2022|Anticipated|2022-08-01|February 2022|Anticipated|2022-02-01||Interventional|||Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age|A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients With MPS II Who Are Receiving Elaprase and Started Treatment With Elaprase at <6 Years of Age|Recruiting||Phase 4|15|Anticipated|Shire||1|||f||||t||||||||No||2017-10-10 23:16:07.619891|2017-10-10 23:16:07.619891
NCT02455609|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-27|||March 2015||2015-03-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain|Intrathecally Administered Ketamine, Dexmedetomidine, and Their Combination With Bupivacaine for Postoperative Analgesia in Major Abdominal Cancer Surgery|Unknown status|Active, not recruiting|Phase 2/Phase 3|90|Anticipated|Assiut University||3|||f||||f||||||||||2017-10-10 23:16:09.504635|2017-10-10 23:16:09.504635
NCT02455596|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-01-04|||May 2015||2015-05-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors|Phase II Study of Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors|Unknown status|Recruiting|Phase 2|20|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||1|||f||||f||||||||||2017-10-10 23:16:09.592028|2017-10-10 23:16:09.592028
NCT02455583|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-07-19|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|AIM||An Assessment of an HIV Prevention Intervention (Project AIM) Among Junior Secondary School Students in Eastern Botswana|An Assessment of an HIV Prevention Intervention (Project AIM) on Youth Sexual Intentions, Sexual Behaviors and HSV-2 Incidence and Prevalence in Junior Secondary Schools in Eastern Botswana.|Active, not recruiting||N/A|4732|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 23:16:09.709189|2017-10-10 23:16:09.709189
NCT02455570|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-10-27|||August 2014||2014-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Global Assessment of Endoscopic Ultrasound Performance Skills|Global Assessment of Endoscopic Ultrasound Performance Skills - a New Tool to Measure the Learning Curve and Technical Skills of Endosonografists|Recruiting||N/A|150|Anticipated|Sahlgrenska University Hospital, Sweden|||1||f||||||||||||||2017-10-10 23:16:09.819687|2017-10-10 23:16:09.819687
NCT02455557|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-04-06|||May 4, 2015|Actual|2015-05-04|April 2017|2017-04-01|April 2, 2019|Anticipated|2019-04-02|April 2, 2018|Anticipated|2018-04-02||Interventional|||SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma|A Phase II Study of the Safety and Efficacy of SVN53-67/M57-KLH (SurVaxM) in Survivin-Positive Newly Diagnosed Glioblastoma|Recruiting||Phase 2|50|Anticipated|Roswell Park Cancer Institute||1|||f||||||||||||||2017-10-10 23:16:09.896451|2017-10-10 23:16:09.896451
NCT02455544|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-01-12|||August 2014||2014-08-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|10 Months|Observational [Patient Registry]|||The Clinical Utility of the Congo-Red Dot Test for Diagnosis and Early Prediction of Preeclampsia During Pregnancy|The Clinical Utility of the Congo-Red Dot Test for Diagnosis and Early Prediction of Preeclampsia During Pregnancy|Recruiting||N/A|1000|Anticipated|Ohio State University|||1||f||||t||||||Samples With DNA|"     Urine specimens   "|||2017-10-10 23:16:10.044131|2017-10-10 23:16:10.044131
NCT02452255|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-06-02|||November 2015||2015-11-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Fenofibrate and Propranolol in Burn Patients|Mechanisms of Fenofibrate and Propranolol Alone or Combined in Burn Patients|Recruiting||Phase 2/Phase 3|330|Anticipated|The University of Texas Medical Branch, Galveston||4|||f||||t||||||||No||2017-10-10 23:16:44.975922|2017-10-10 23:16:44.975922
NCT02455531|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-09-27|||June 2015||2015-06-01|September 2016|2016-09-01|June 2025|Anticipated|2025-06-01|June 2020|Anticipated|2020-06-01||Observational|SVRIII||Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type|Long-term Outcomes of Children With HLHS (Hypoplastic Left Heart Syndrome) and the Impact of Norwood Shunt Type (A Study Conducted by the Pediatric Heart Network)|Enrolling by invitation||N/A|264|Anticipated|New England Research Institutes|||1||f||||t||||||Samples With DNA|"     Participants and their parents who have not yet contributed to the SVR Extension     biorepository will be offered the opportunity to provide saliva for extraction and storage of     DNA. If study participants have consented to participate in the biorepository through the SVR     Extension study but not yet contributed a sample, they will be asked to contribute at the     time of the SVR III participation. Families who were not previously approached, or who     declined participation in the biorepository earlier, may be offered the opportunity to     participate at the time of the SVR III participation.   "|||2017-10-10 23:16:10.13173|2017-10-10 23:16:10.13173
NCT02455518|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-09-15|||July 2015||2015-07-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Comparative Efficacy of 4 Oral Analgesics|Comparative Efficacy of 4 Oral Analgesics for the Initial Management of Acute Musculoskeletal Extremity Pain|Recruiting||Phase 4|400|Anticipated|Montefiore Medical Center||4|||f||||t||||||||||2017-10-10 23:16:10.194448|2017-10-10 23:16:10.194448
NCT02455505|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-09-20|||May 2015||2015-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Identifying Family Members in Need of Support During Cancer Care and Bereavement|Identifying Family Members in Need of Support During Cancer Care and Bereavement|Recruiting||N/A|22|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:16:10.383519|2017-10-10 23:16:10.383519
NCT02455492|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-05-27|||January 2004||2004-01-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Factors Associated With Perioperative Outcomes in Non-emergency Surgery|An Epidemiological Investigation Into the Association Between Recent Stroke, Acute Coronary Syndrome or Pneumonia and Adverse Perioperative Outcomes Following Elective Non-cardiac and Cardiac Surgery|Completed||N/A|266436|Actual|University of Nottingham|||1||f||||f||||||||||2017-10-10 23:16:10.493532|2017-10-10 23:16:10.493532
NCT02455479|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-05-23|||May 2015||2015-05-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals|Phase I Randomized, Double-blind, Placebo Control Study for an Anti-cocaine Vaccine|Recruiting||Phase 1|30|Anticipated|Weill Medical College of Cornell University||3|||f||||t||||||||Undecided||2017-10-10 23:16:10.575081|2017-10-10 23:16:10.575081
NCT02455466|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-05-29|||March 2015|Actual|2015-03-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Altered PSA Test Due to Possible Suspected Heterophilic Antibodies|Altered PSA Test Due to Possible Suspected Heterophilic Antibodies|Terminated||N/A|50|Actual|University of Zurich|||1|not enough recruitment|f||||f||||||Samples Without DNA|"     Blood serum of patients   "|||2017-10-10 23:16:10.679404|2017-10-10 23:16:10.679404
NCT02455453|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-04-13|||April 28, 2015|Actual|2015-04-28|April 2017|2017-04-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography|Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography|Recruiting||Phase 2|50|Anticipated|Washington University School of Medicine||1|||f||||t|t|t|f|f||||No||2017-10-10 23:16:10.737309|2017-10-10 23:16:10.737309
NCT02455440|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2015-07-07|||March 2014||2014-03-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Esmolol Infusion in Patients Undergoing Craniotomy|Esmolol Reduces Anesthetic Requirements Thereby Facilitating Early Extubation; a Prospective Controlled Study in Patients Undergoing Intracranial Surgery|Completed||Phase 3|50|Actual|George Papanicolaou Hospital||2|||f||||f||||||||||2017-10-10 23:16:10.85511|2017-10-10 23:16:10.85511
NCT02455427|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-04-28|||May 2015||2015-05-01|April 2017|2017-04-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|NEUROSTIM||Safety of Transcranial Direct Current Stimulation in the Subacute Phase After Stroke|Safety of Transcranial Direct Current Stimulation in the Subacute Phase After Stroke|Recruiting||N/A|40|Anticipated|Hospital Israelita Albert Einstein||2|||f||||t||||||||No|Deidentified imaging data will be shared with collaborators|2017-10-10 23:16:10.950451|2017-10-10 23:16:10.950451
NCT02455414|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-10-31|||April 2012||2012-04-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|TRACK||Tracking Neurodegeneration in Early Wolfram Syndrome|Tracking Neurodegeneration in Early Wolfram Syndrome|Recruiting||N/A|150|Anticipated|Washington University School of Medicine|||6||f||||f||||||Samples With DNA|"     A skin biopsy will be obtained from which the investigator will sequence all the exons and     exon-intron junctions of the WFS1 gene. In some cases, the investigator will also sequence     other genes related to Wolfram syndrome including WFS2, MANF, and Caspase-12. If the     investigator doesn't find mutations in these genes, a whole-exome sequencing may be     performed. The genetic test provided has the potential to create a uniquely-identifiable     fingerprint that could possibly identify a participant.   "|||2017-10-10 23:16:11.056205|2017-10-10 23:16:11.056205
NCT02455401|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-08-30|||May 2015||2015-05-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effect of Remifentanil on Postoperative Vomiting in Pediatric Strabismus Surgery|Effect of Remifentanil on Postoperative Vomiting in Children Undergoing Strabismus Surgery During Sevoflurane Anesthesia|Recruiting||N/A|105|Anticipated|Inje University||3|||f||||f||||||||No||2017-10-10 23:16:11.143726|2017-10-10 23:16:11.143726
NCT02455388|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-10-02|||April 2014|Actual|2014-04-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|||d13C Added Sugar Intake Biomarker: Determining Validity in Children|d13C Added Sugar Intake Biomarker: Determining Validity in Children|Active, not recruiting||N/A|32|Actual|Virginia Polytechnic Institute and State University||2|||f||||f||||||||||2017-10-10 23:16:11.252091|2017-10-10 23:16:11.252091
NCT02455375|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-02-01|||July 2015||2015-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|HANTADIAG||Diagnostic of Puumala Virus Infection in France|Puumala Hantavirus Infection in France: Evaluation of Commercial Assays for the Detection of Antibodies Against This Virus and the Use of Urine Samples for the Molecular Detection of This Infection|Recruiting||N/A|400|Anticipated|Centre Hospitalier de Charleville-Mézières|||2||f||||f||||||Samples Without DNA|"     Urine Plasma Serum   "|Undecided||2017-10-10 23:16:11.332663|2017-10-10 23:16:11.332663
NCT02455362|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-01-11|||May 2015||2015-05-01|January 2016|2016-01-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Opioids for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease|A Multi-site, Double-blind, Parallel Arm, Block Randomised, Placebo Controlled, Factorial Phase III Study of Opioids for Chronic Refractory Breathlessness in People With Chronic Obstructive Pulmonary Disease.|Withdrawn||Phase 3|0|Actual|Flinders University||12||'Recruitment not possible given changes to trial criteria|f||||t||||||||||2017-10-10 23:16:11.451315|2017-10-10 23:16:11.451315
NCT02455336|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-06-26|||May 18, 2015|Actual|2015-05-18|June 2017|2017-06-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Fenofibrate Treatment in SCI|An Open Label Safety and Efficacy Trial of Fenofibrate in Persons With SCI|Recruiting||Phase 2/Phase 3|30|Anticipated|VA Office of Research and Development||2|||f||||f|t|f|||t|||Undecided||2017-10-10 23:16:11.564609|2017-10-10 23:16:11.564609
NCT02455323|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-05-27|||March 2013||2013-03-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|MTheadacheQL||The Influence of Manual Therapy in the Quality of Life in Tension-Type Headache|Influence of Spinal Manipulation and Suboccipipital Inhibition as a Complementary Therapy for Tension Headache in Quality of Life: A Randomized Controlled Trial|Completed||N/A|76|Actual|University of Valencia||4|||f||||f||||||||||2017-10-10 23:16:11.663121|2017-10-10 23:16:11.663121
NCT02455310|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-02-17|||January 2011||2011-01-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|ExConEval||Extension Connection Evaluation|Extension Connection: Dissemination Effectiveness Evaluation|Active, not recruiting||N/A|60000|Anticipated|University of Iowa|||2||f||||f|f|f||||||No|Other than exposure data which is identifiable, the evaluation is based on CMS data which cannot be shared without a data reuse agreement.|2017-10-10 23:16:11.755904|2017-10-10 23:16:11.755904
NCT02455297|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-23|2017-09-29|||August 24, 2015|Actual|2015-08-24|September 2017|2017-09-01|August 31, 2016|Actual|2016-08-31|April 8, 2016|Actual|2016-04-08||Interventional|||Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)|A Single-arm, Open-label Phase IIa Study to Evaluate the Efficacy and Safety of Copanlisib Monotherapy in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL), Who Failed Ibrutinib Treatment or Were Unable to Tolerate Ibrutinib|Terminated||Phase 2|4|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:16:11.849023|2017-10-10 23:16:11.849023
NCT02455284|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-01-04|||October 2015||2015-10-01|January 2016|2016-01-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|FIBRATLAS||In Vivo and ex Vivo Validation of MR Tractography of Brain White Matter Tracts - FIBRATLAS II-III|In Vivo and ex Vivo Validation of MR Tractography of Brain White Matter Tracts - FIBRATLAS II-III|Recruiting||N/A|184|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 23:16:11.937895|2017-10-10 23:16:11.937895
NCT02455271|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-02-23|||October 1, 2012|Actual|2012-10-01|January 2017|2017-01-01|December 22, 2015|Actual|2015-12-22|March 30, 2015|Actual|2015-03-30||Observational|||Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients|Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients (Study LUN02T)|Completed||N/A|438|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-10 23:16:12.171471|2017-10-10 23:16:12.171471
NCT02455258|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-07-26|||March 2015||2015-03-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dancing for Better Aging: Evaluating the Impact of a Dance/Movement Therapy (D/MT) Program for Older Adults|Dancing for Better Aging: Evaluating the Impact of a Dance/Movement Therapy Program for Older Adults Through an Empirical Research Approach|Completed||N/A|75|Actual|Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal||3|||f||||f||||||||||2017-10-10 23:16:12.255685|2017-10-10 23:16:12.255685
NCT02455245|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-01-30|||March 2015||2015-03-01|January 2017|2017-01-01||||April 2020|Anticipated|2020-04-01||Interventional|||A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma|A Phase III Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma|Recruiting||Phase 3|160|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-10 23:16:12.354774|2017-10-10 23:16:12.354774
NCT02455232|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-01-30|||May 2015|Actual|2015-05-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|FLEXELBOW||Determine the Main Muscle Participant in the Deformation of the Elbow in Hemiplegic Patients|Determine the Main Muscle Participant in the Deformation of the Elbow in Hemiplegic Patients|Completed||N/A|20|Actual|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||||2017-10-10 23:16:12.510241|2017-10-10 23:16:12.510241
NCT02455219|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-12-03|||June 2015||2015-06-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Observational|||DatScan With Prototype Collimator|Investigating the Use of Siemens Prototype UHRSZ Collimator for Imaging DatScan SPECT/CT Imaging|Recruiting||N/A|25|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-10 23:16:12.590499|2017-10-10 23:16:12.590499
NCT02455206|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-01-04|||October 2015||2015-10-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Counseling During Pulmonary Rehabilitation|Effect of Counseling During Pulmonary Rehabilitation on Self-determined Motivation Towards Physical Activity in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|62|Anticipated|Zurich University of Applied Sciences||2|||f||||||||||||||2017-10-10 23:16:12.660794|2017-10-10 23:16:12.660794
NCT02455193|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-29|||August 2014||2014-08-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Neuronal Effects of Exercise in Schizophrenia|Neuronal Effects of Exercise in Schizophrenia|Recruiting||N/A|140|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:16:12.741449|2017-10-10 23:16:12.741449
NCT02455180|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-01|||March 2015||2015-03-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Pharmacokinetics of Two Different High-dose Regimens of Intravenous Vitamin C in Critically Ill Patients|Pharmacokinetics of Two Different High-dose Regimens of Intravenous Vitamin C in Critically Ill Patients|Completed||Phase 4|20|Actual|VU University Medical Center||4|||f||||f||||||||||2017-10-10 23:16:12.829311|2017-10-10 23:16:12.829311
NCT02454621|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-11-30|||May 2015||2015-05-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial of the Smoking Cessation Volitional Help Sheet in Primary Care|Randomized Controlled Trial of the Smoking Cessation Volitional Help Sheet in Primary Care|Withdrawn||Phase 1/Phase 2|0|Actual|University of Manchester||2||The researcher quit the study|f||||f||||||||||2017-10-10 23:16:18.396839|2017-10-10 23:16:18.396839
NCT02455167|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-07|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis|Reversal of Hepatic Impairment by Achieving Sustained Virologic Response (SVR) With 12 Weeks of Simeprevir(SMV)/Sofosbuvir(SOF)/Ribavirin(RBV) in Patients With Hepatitis C Virus (HCV) Genotype 1 Infection and Early Decompensation of Cirrhosis (MELD 10 or Less)|Active, not recruiting||Phase 3|9|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-10 23:16:12.92361|2017-10-10 23:16:12.92361
NCT02455154|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-09-20|||May 2015||2015-05-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|May 2018|Anticipated|2018-05-01||Interventional|COAT||Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy|Traditional Chinese Medicine as Preventive Method for Osteoporosis in Early Breast Cancer Patients Receiving Adjuvant Endocrine Therapy|Recruiting||Phase 2|300|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||t||||||||||2017-10-10 23:16:13.026268|2017-10-10 23:16:13.026268
NCT02455141|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2017-09-20|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|TCTN||Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer|Epirubicin-Cyclophosphamide Followed by Taxanes or Taxanes Plus Carboplatin in Triple-Negative Breast Cancer：A Prospective, Randomized, Phase III Trial|Recruiting||Phase 3|970|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 23:16:13.147933|2017-10-10 23:16:13.147933
NCT02455128|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-16|2017-08-11|||August 2014|Actual|2014-08-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|September 2015|Actual|2015-09-01||Interventional|||Therapeutic Listening in Patients With Colorectal Cancer|The Influence of Therapeutic Listening on Anxiety and Fear Related to Surgery in Patients Preoperatively of Colorectal Surgery: a Randomized Clinical Trial|Completed||N/A|50|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:16:13.321808|2017-10-10 23:16:13.321808
NCT02455115|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-09-26|||January 2015||2015-01-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Renal Perfusion, Filtration and Oxygenation After Liver Transplantation -Effects of av Postoperative Blood Pressure|Renal Perfusion, Filtration and Oxygenation After Liver Transplantation -Effects of av Postoperative Blood Pressure|Completed||N/A|12|Actual|Sahlgrenska University Hospital, Sweden||3|||f||||f||||||||||2017-10-10 23:16:13.408117|2017-10-10 23:16:13.408117
NCT02455102|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-12-21|||September 2014||2014-09-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Electronic Warning System for Atrial Fibrillation|Electronic Warning System to Improve Stroke Prevention in Atrial Fibrillation - A Quality Improvement Initiative at the University Hospital Bern|Completed||N/A|1707|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 23:16:13.516551|2017-10-10 23:16:13.516551
NCT02455089|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-11-02|||June 2015||2015-06-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|GADD34-LES||Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus|Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus|Recruiting||N/A|250|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||Yes|No data will be be shared with non associated investigator till publication. Possibility to share after publication, through formol requirement adressed to Grenoble hospital administration (AccueilRecherche@chu-grenoble.fr)|2017-10-10 23:16:13.59935|2017-10-10 23:16:13.59935
NCT02455063|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-01-04|||May 2015||2015-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:16:13.850261|2017-10-10 23:16:13.850261
NCT02455050|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-11-07|2016-07-29||December 2014||2014-12-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief||Completed||Phase 3|79|Actual|Allergan||4|||f||||f||||||||||2017-10-10 23:16:13.910113|2017-10-10 23:16:13.910113
NCT02455037|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-10-31|||May 2015||2015-05-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion|Evaluation of a Neck Strengthening Program as a Potential Intervention to Reduce the Risk of Sport-related Concussion|Completed||N/A|17|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:16:15.083903|2017-10-10 23:16:15.083903
NCT02455024|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-09-05|||May 2015||2015-05-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|OMNI||An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With Iclusig®|A Postmarketing Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With Iclusig® in Routine Clinical Practice in the United States (US).|Recruiting||N/A|300|Anticipated|Ariad Pharmaceuticals|||1||f||||f||||||||||2017-10-10 23:16:15.173843|2017-10-10 23:16:15.173843
NCT02455011|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-09-25|||September 2015||2015-09-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus|A Randomized, Placebo-controlled, Double-blind, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeated Subcutaneous (SC) Doses of REMD-477 in Subjects With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 1/Phase 2|75|Actual|REMD Biotherapeutics, Inc.||6|||f||||t||||||||||2017-10-10 23:16:15.271312|2017-10-10 23:16:15.271312
NCT02450773|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-05-08|||August 2015||2015-08-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Prevention of Severe Postpartum Hypertension|Furosemide for Prevention of Severe Postpartum Hypertension: a Randomized Controlled Trial|Recruiting||Phase 2|248|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:17:02.026583|2017-10-10 23:17:02.026583
NCT02454998|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-05-26|||February 2011||2011-02-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Alveolar Bone Grafting Outcome Between Patient With and Without Orthodontic Treatment|The Difference in the Surgical Outcome of Unilateral Cleft Lip and Palate Between Patients With and Without Pre-Alveolar Bone Graft Orthodontic Treatment|Unknown status|Active, not recruiting|N/A|24|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:16:15.373951|2017-10-10 23:16:15.373951
NCT02454972|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-08-22|||August 2015||2015-08-01|January 2017|2017-01-01||||July 2019|Anticipated|2019-07-01||Interventional|||Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors|A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors|Recruiting||Phase 2|325|Anticipated|PharmaMar||1|||f||||||||||||||2017-10-10 23:16:15.469421|2017-10-10 23:16:15.469421
NCT02454959|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-03-07|2017-03-07||May 1, 2015|Actual|2015-05-01|March 2017|2017-03-01|March 25, 2016|Actual|2016-03-25|March 25, 2016|Actual|2016-03-25||Interventional||The Modified-Intent-to-Treat (MITT) Population is a subset of the Intent-to-Treat (ITT) Population including subjects who received treatment and had post-treatment efficacy data for both treatment periods and is used for the baseline characteristics.|Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD|A Randomized, Phase III, Two-period, Open-label, Chronic-dosing (7 Days), Multicenter, Crossover Study to Assess the Efficacy, Safety and Pharmacokinetics of PT003 in Subjects With Moderate to Very Severe COPD With and Without a Valved Holding Chamber|Completed||Phase 3|80|Actual|Pearl Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:16:15.634087|2017-10-10 23:16:15.634087
NCT02454946|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-27|||January 2014||2014-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Blood Types and Erectile Dysfunction|The Relation Between ABO Blood Types and Erectile Dysfunction|Completed||N/A|102|Actual|T.C. ORDU ÜNİVERSİTESİ|||1||f||||f||||||||||2017-10-10 23:16:15.992132|2017-10-10 23:16:15.992132
NCT02454933|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-08-09|||July 15, 2015|Actual|2015-07-15|August 2017|2017-08-01|January 29, 2018|Anticipated|2018-01-29|August 21, 2017|Anticipated|2017-08-21||Interventional|CAURAL||Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours|A Phase III, Multi-Centre, Open Label, Randomized Study to Assess the Efficacy and Safety of AZD9291 in Combination With MEDI4736 Versus AZD9291 Monotherapy in Patients With Locally Advanced or Metastatic Epidermal Growth Factor Receptor T790M Mutation-positive Non-Small Cell Lung Cancer Who Have Received Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy (CAURAL)|Active, not recruiting||Phase 3|29|Actual|AstraZeneca||2|||f||||t|t|f||||||||2017-10-10 23:16:16.060333|2017-10-10 23:16:16.060333
NCT02454920|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-06-28|||May 2015||2015-05-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01|12 Months|Observational [Patient Registry]|||Measurement of Insertion of Extraocular Muscles Using Anterior Segment Optical Coherence Tomography|Measurement of the Distance Between the Limbus and Insertion of Extraocular Muscles Using Anterior Segment Optical Coherence Tomography|Completed||N/A|72|Actual|University of Miami|||1||f||||t||||||||No||2017-10-10 23:16:16.181635|2017-10-10 23:16:16.181635
NCT02454907|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-03-06|||June 1, 2017|Anticipated|2017-06-01|March 2017|2017-03-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||The Use of Technology to Improve MS Clinical Trials and Patient Care|The Use of Technology to Improve MS Clinical Trials and Patient Care|Not yet recruiting||N/A|150|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||||2017-10-10 23:16:16.247506|2017-10-10 23:16:16.247506
NCT02454894|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-10-28|||May 2015||2015-05-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|OLPIC||Optimization Lumbar Puncture In Children|Optimization Lumbar Puncture In Children|Withdrawn||N/A|0|Actual|Beijing Children's Hospital||4||"Due to the reason that not all participants agree to have anesthesia and postoperative   management at the same time"|f||||f||||||||||2017-10-10 23:16:16.319486|2017-10-10 23:16:16.319486
NCT02454881|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-11-03|||June 2015||2015-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DoserespDex||Dose Response Study of Dexmedetomidine in Orthopaedic Spine Surgery Patients|Dose Response Study of Patient Controlled Analgesia (PCA) of Dexmedetomidine in Orthopaedic Spine Surgery Patients|Recruiting||Phase 4|80|Anticipated|Turku University Hospital||4|||f||||f||||||||No||2017-10-10 23:16:16.409985|2017-10-10 23:16:16.409985
NCT02454868|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-07-18|||July 2016||2016-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade|Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade|Completed||Phase 4|30|Actual|Brasilia University Hospital||1|||f||||f||||||||||2017-10-10 23:16:16.528453|2017-10-10 23:16:16.528453
NCT02454855|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-06-19|||May 2015||2015-05-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|MEQAPAG||Impact of a Melatonin Supplementation on the Quality of Life in Elderly Metastatic Cancer Patients|Impact of a Melatonin Supplementation on the Quality of Life in Elderly Metastatic Cancer Patients (> = 70 Years) - PHRC-K13-170|Recruiting||Phase 3|500|Anticipated|Centre Jean Perrin||2|||f||||t||||||||||2017-10-10 23:16:16.62219|2017-10-10 23:16:16.62219
NCT02454842|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-02-23|||June 2015||2015-06-01|June 2016|2016-06-01|January 31, 2017|Actual|2017-01-31|January 2017|Actual|2017-01-01||Interventional|TH-4000||Study for Treatment of Patients With EGFR Mutant, T790M-negative NSCLC|A Phase 2 Study of TH-4000 (Tarloxotinib) in Patients With EGFR-Mutant, T790M-Negative, Advanced Non-Small Cell Lung Cancer Progressing on an EGFR Tyrosine Kinase Inhibitor|Terminated||Phase 2|37|Anticipated|Threshold Pharmaceuticals||1||Lack of efficacy|f||||t||||||||||2017-10-10 23:16:16.747983|2017-10-10 23:16:16.747983
NCT02454829|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-04-14|||March 2015||2015-03-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Follow-up of Ovarian Function in Young Women Who Underwent Ovarian Cortex Cryopreservation|Follow-up of Ovarian Function in Young Girls and Women Who Underwent Ovarian Cortex Cryopreservation for Fertility Preservation at the Cliniques Universitaires Saint-Luc|Completed||N/A|546|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||6||f||||f||||||||||2017-10-10 23:16:16.857025|2017-10-10 23:16:16.857025
NCT02454816|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-21|||May 2015||2015-05-01|May 2015|2015-05-01||||October 2015|Anticipated|2015-10-01||Interventional|||Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in Colombia|Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in COLOMBIA|Unknown status|Recruiting|Phase 2/Phase 3|12|Anticipated|Universidad Nacional de Colombia||2|||f||||t||||||||||2017-10-10 23:16:16.944504|2017-10-10 23:16:16.944504
NCT02454803|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-08-28|||January 2015||2015-01-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|ULIS III||Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice|An International, Multicentre, Observational, Prospective, Longitudinal Cohort Study to Assess the Impact of Integrated Upper Limb Spasticity Management Including the Use of BoNT-A- Injections on Patient-centred Goal Attainment in Real Life Practice|Active, not recruiting||N/A|1003|Anticipated|Ipsen|||1||f||||f||||||||||2017-10-10 23:16:17.031604|2017-10-10 23:16:17.031604
NCT02454790|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-09-07|||September 2014||2014-09-01|September 2017|2017-09-01|January 2028|Anticipated|2028-01-01|January 2025|Anticipated|2025-01-01|5 Years|Observational [Patient Registry]|SFP OES||Standard Follow-Up Program (SFP) for Patients With Esophageal Cancer|Standard Follow-up Program (SFP) for Esophageal Cancer Patients Treated With Radiotherapy or Chemoradiation|Recruiting||N/A|10000|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:16:17.187805|2017-10-10 23:16:17.187805
NCT02454777|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-12|||September 29, 2015|Actual|2015-09-29|July 2017|2017-07-01|September 29, 2020|Anticipated|2020-09-29|September 29, 2019|Anticipated|2019-09-29||Interventional|||High-Intensity Interval Training for Stage I-III Breast Cancer Patients|High-Intensity Interval Training (HIT) for Breast Cancer Patients During Trastuzumab Use|Recruiting||N/A|60|Anticipated|University of Southern California||2|||f||||t|f|f||||||||2017-10-10 23:16:17.282904|2017-10-10 23:16:17.282904
NCT02454764|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-12-23|||May 2017||2017-05-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALT|To Study the Efficacy of 'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALT - A Randomized Control Trial|Not yet recruiting||N/A|80|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:16:17.373373|2017-10-10 23:16:17.373373
NCT02454751|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-09-26|||October 2015||2015-10-01|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|June 30, 2017|Actual|2017-06-30||Interventional|||The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial|The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial|Completed||Phase 2|8|Actual|St. Boniface General Hospital Research Centre||1|||f||||f||||||||||2017-10-10 23:16:17.435825|2017-10-10 23:16:17.435825
NCT02454738|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-06-06|||June 2015||2015-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts|Ultralow Dose Computed Tomography in Close Contacts at High Risk for Developing Multidrug- or Extensively Drug-resistant Tuberculosis: A Pilot Study|Completed||N/A|6|Actual|Seoul National University Hospital||1|||f||||f||||||||Yes||2017-10-10 23:16:17.505513|2017-10-10 23:16:17.505513
NCT02454725|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-09-27|||June 2015||2015-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Regular HIV Testing Among At-Risk Latino Men|Regular HIV Testing Among At-Risk Latino Men|Enrolling by invitation||N/A|250|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-10 23:16:17.572536|2017-10-10 23:16:17.572536
NCT02454712|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-07-26|||November 16, 2016|Actual|2016-11-16|July 2017|2017-07-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|SAD||Study of PF614 Compared to OxyContin® in Healthy Volunteers|A Phase 1, Single-Center, Dose-Escalation Study to Determine the Safety and Pharmacokinetics of a Single Oral Dose of PF614 in Healthy Subjects Compared to OxyContin®|Completed||Phase 1|48|Actual|Ensysce Biosciences||2|||f||||t||||||||||2017-10-10 23:16:17.643096|2017-10-10 23:16:17.643096
NCT02454699|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-07-20|||November 10, 2015|Actual|2015-11-10|July 19, 2017|2017-07-19|December 1, 2017|Anticipated|2017-12-01|April 1, 2017|Actual|2017-04-01||Interventional|||Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers|A Phase 1 Trial to Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of MBX-400 in Healthy Volunteers|Terminated||Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4||Study is met halting criteria after cohort 3 enrollment.|f|||||t|f|||f|||||2017-10-10 23:16:17.863853|2017-10-10 23:16:17.863853
NCT02454686|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-26|||February 2012||2012-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Observational|Fibroscan||Fibroscan Predicts Complications After Hepatectomy|Role of Fibroscan in Predicting Complications After Hepatectomy|Completed||N/A|240|Actual|University of Milan|||1||f||||f||||||||||2017-10-10 23:16:17.958819|2017-10-10 23:16:17.958819
NCT02454673|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-05-26|||September 2013||2013-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal Cancer|Approximation to the Therapeutic Individualization in Patients With Locally Advanced Gastric and Gastroesophageal Cancer Through Modelling and Generation of Predictive Gene Signatures|Completed||N/A|121|Actual|Clinica Universidad de Navarra, Universidad de Navarra|||2||f||||f||||||Samples With DNA|"     Surgical specimen with potential for extraction of DNA.   "|||2017-10-10 23:16:18.010268|2017-10-10 23:16:18.010268
NCT02454660|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-04-07|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|November 4, 2016|Actual|2016-11-04|November 4, 2016|Actual|2016-11-04||Interventional|AIM@BP||Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages|Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages|Completed||N/A|49|Actual|University of Michigan||2|||f||||f||||||||No||2017-10-10 23:16:18.097493|2017-10-10 23:16:18.097493
NCT02454647|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-05-27|||September 2013||2013-09-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients|Induction Chemotherapy, Chemo-radiotherapy and Surgery in Locally Advanced Gastric Cancer Patients: Long Term Results From a Single Institution.|Completed||N/A|46|Actual|Clinica Universidad de Navarra, Universidad de Navarra|||1||f||||f||||||Samples With DNA|"     Surgical specimen with potential for extraction of DNA.   "|||2017-10-10 23:16:18.193395|2017-10-10 23:16:18.193395
NCT02454634|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-09-25|||June 2015||2015-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|NOA-16||Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas|Targeting IDH1R132H in WHO Grade III-IV IDH1R132H-mutated Gliomas by a Peptide Vaccine - a Phase I Safety, Tolerability and Immunogenicity Multicenter Trial (NOA-16)|Active, not recruiting||Phase 1|39|Actual|National Center for Tumor Diseases, Heidelberg||1|||f||||t||||||||||2017-10-10 23:16:18.292583|2017-10-10 23:16:18.292583
NCT02454608|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-03-24|2016-08-29||May 2015||2015-05-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||Intention-to-treat analysis|Trial of Verapamil in Chronic Rhinosinusitis|Randomized Double Blind Placebo Controlled Trial of Verapamil in Chronic Rhinosinusitis|Terminated||N/A|20|Actual|Massachusetts Eye and Ear Infirmary||2||Evidence that the dose is insufficient.|f||||f||||||||No||2017-10-10 23:16:18.486133|2017-10-10 23:16:18.486133
NCT02454595|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-08-31|||November 2014||2014-11-01|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03|3 Months|Observational [Patient Registry]|||Registry to Measure the Impact of Adding Genomic Testing|An Open Registry to Measure the Impact of Adding Genomic Testing (Prolaris®) on the Treatment Decision Following Biopsy in Newly Diagnosed Prostate Cancer Patients at Intermountain Hospitals|Terminated||N/A|116|Actual|Myriad Genetic Laboratories, Inc.|||1|lack of enrollment|f||||f||||||Samples With DNA|"     Formalin-fixed paraffin-embedded (FFPE) tissue from blocks or slides of prostatic     adenocarcinoma biopsies.   "|||2017-10-10 23:16:19.554417|2017-10-10 23:16:19.554417
NCT02454582|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-03-23|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Non-invasive Ventilation (NIV) on Cerebral Oxygenation|Effect of Non-invasive Ventilation (NIV) on Cerebral Oxygenation|Completed||Phase 4|40|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-10 23:16:19.6386|2017-10-10 23:16:19.6386
NCT02454569|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-12-30|||September 2009||2009-09-01|December 2016|2016-12-01|January 2040|Anticipated|2040-01-01|September 2039|Anticipated|2039-09-01|30 Years|Observational [Patient Registry]|VFHCS||Vicente Ferrer HIV Cohort Study|Vicente Ferrer HIV Cohort Study|Recruiting||N/A|30000|Anticipated|Rural Development Trust Hospital|||1||f||||f||||||||||2017-10-10 23:16:19.72839|2017-10-10 23:16:19.72839
NCT02454556|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-02-23|||April 2015||2015-04-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART||Completed||Phase 3|106|Actual|Gema Biotech S.A.||2|||f||||f||||||||||2017-10-10 23:16:19.83556|2017-10-10 23:16:19.83556
NCT02454543|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-07-19|||May 2015||2015-05-01|July 2017|2017-07-01|April 2025|Anticipated|2025-04-01|April 2020|Anticipated|2020-04-01||Interventional|g-RAMPP||Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases|Multicentric, Prospective, Randomized Controlled Trial Comparing Best Systemic Therapy (BST) With Radical Prostatectomy or BST Alone in the Management of Men With Pauci-metastatic Prostate Cancer|Recruiting||N/A|452|Anticipated|Martini-Klinik am UKE GmbH||2|||f||||f||||||||||2017-10-10 23:16:19.938833|2017-10-10 23:16:19.938833
NCT02454530|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-06-16|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|October 18, 2016|Actual|2016-10-18||Observational|VISTA||Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study|Prophylactic Treatment For Chemo-induced Neutropenia. Use Of G-csf Biosimilar (Nivestim(Registered)) According To The Chemotherapy Context: Adjuvant Versus Metastatic.|Completed||N/A|1154|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 23:16:20.119289|2017-10-10 23:16:20.119289
NCT02454517|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-02-15|||May 2016||2016-05-01|February 2017|2017-02-01||||May 2019|Anticipated|2019-05-01||Interventional|PALS||Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer|PALS: Prostate Cancer Active Lifestyle Study|Recruiting||Phase 3|200|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-10 23:16:20.446353|2017-10-10 23:16:20.446353
NCT02454504|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-04-25|||March 2015||2015-03-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Quality of Awakening and Impact on Cognitive Function After Administration of Sugammadex in Robotic Radical Cystectomy||Completed||N/A|120|Actual|Regina Elena Cancer Institute||2|||f||||||||||||||2017-10-10 23:16:20.581831|2017-10-10 23:16:20.581831
NCT02454491|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-10-01|||May 2015||2015-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|VERMUT||Verapamil vs Heparin in Transradial Procedures|Comparison of VERapamil vs. Heparin Therapy on Procedural sUccess During Transradial Coronary Procedures (VERMUT Study)|Completed||Phase 4|418|Actual|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-10 23:16:20.679568|2017-10-10 23:16:20.679568
NCT02454478|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-01-19|||July 2015||2015-07-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Study of Lenvatinib in Combination With Everolimus in Patients With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)|Phase 1 Study of Lenvatinib in Combination With Everolimus in Patients With Unresectable Advanced or Metastatic RCC|Active, not recruiting||Phase 1|7|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-10 23:16:20.786718|2017-10-10 23:16:20.786718
NCT02454465|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-21|||July 2015||2015-07-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Interventional|||Evaluation of an Acceptance and Commitment Therapy Group for Adjustment Difficulties in Neurological Conditions|"Time to ACT: Multi-site Evaluation of an Acceptance and Commitment Therapy Group Intervention for Adjustment Difficulties in Neurological Conditions"|Unknown status|Not yet recruiting|N/A|26|Anticipated|University of Hertfordshire||2|||f||||f||||||||||2017-10-10 23:16:20.902856|2017-10-10 23:16:20.902856
NCT02454452|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2017-08-17|||February 2013|Actual|2013-02-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Radiofrequency, Vein Stripping and CHIVA for Venous Insufficency|Comparative Randomized Clinical Study to Evaluate the Efficacy of Radiofrequency vs Surgical Technique of Internal Saphenous Vein Stripping and CHIVA Technique in the Treatment of Chronic Venous Insufficiency.|Completed||N/A|225|Actual|Corporacion Parc Tauli||3|||f||||f||||||||||2017-10-10 23:16:21.018682|2017-10-10 23:16:21.018682
NCT02454439|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-09-18|||May 2015||2015-05-01|September 2015|2015-09-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Assessment of Cardiac Resynchronization Therapy in Patients With Wide QRS and Non-specific Intraventricular Conduction Delay: a Randomized Trial|Assessment of Cardiac Resynchronization Therapy in Patients With Wide QRS and Non-specific Intraventricular Conduction Delay: a Randomized Trial|Recruiting||Phase 4|200|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:16:21.107169|2017-10-10 23:16:21.107169
NCT02454426|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-08-24|||April 2016||2016-04-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease|An 8-week, Open-Label Clinical Trial of the Efficacy and Safety of Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease|Withdrawn||Early Phase 1|0|Actual|Thomas Jefferson University||1||PI left institution|f||||f||||||||||2017-10-10 23:16:21.255686|2017-10-10 23:16:21.255686
NCT02454413|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-05-26|||April 2013||2013-04-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Microbial Evaluation of Denture Cleaning and Overnight Storage|ASSESSMENT OF THE IMPACT OF CLEANING METHODS AND OVERNIGHT DENTURE STORAGE ON BIOFILM FORMATION ON REMOVABLE ACRYLIC DENTURES.|Completed||N/A|13|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||||2017-10-10 23:16:21.407195|2017-10-10 23:16:21.407195
NCT02454400|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-03-24|||September 2012||2012-09-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PREPARE||Pre-surgery Physiotherapy for Patients With Specific Low Back Pain|Pre-surgery Physiotherapy for Patients With Specific Low Back Pain , RCT|Active, not recruiting||N/A|200|Anticipated|Linkoeping University||2|||f||||f||||||||||2017-10-10 23:16:21.568048|2017-10-10 23:16:21.568048
NCT02454387|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-06-29|||May 2015||2015-05-01|January 2016|2016-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers|A Double-blind, Single and Multiple Ascending Dose, Randomised, Placebo-controlled Study, in Healthy Adult and Elderly Subjects Exploring Safety, Tolerability, Pharmacokinetics of ONO-4474 and Pharmacology of ONO-4474 in NGF-hyperalgesia|Completed||Phase 1|141|Actual|Ono Pharmaceutical Co. Ltd||10|||f||||f||||||||||2017-10-10 23:16:21.694137|2017-10-10 23:16:21.694137
NCT02454374|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-06-02|||November 2014||2014-11-01|May 2015|2015-05-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Joint Loading vs Normal Physiotherapy Care in Degenerative Knees (V1)|Joint Loading vs Normal Physiotherapy Care in Degenerative Knees (V1)|Unknown status|Recruiting|N/A|144|Anticipated|Leeds Comunity Healthcare NHS Trust||2|||f||||f||||||||||2017-10-10 23:16:21.84347|2017-10-10 23:16:21.84347
NCT02454361|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-12-28|||May 2015||2015-05-01|August 2015|2015-08-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Safety, Tolerability and Pharmacokinetics of KBP-7072|A Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, Single Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-7072 Following Oral Administration|Completed||Phase 1|46|Actual|KBP Biosciences||6|||f||||f||||||||||2017-10-10 23:16:21.955783|2017-10-10 23:16:21.955783
NCT02454348|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-11-28|||November 2015||2015-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NOVEL||NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock|NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock (NOVEL Trial)|Active, not recruiting||Phase 4|82|Actual|University of Arkansas||2|||f||||f||||||||No||2017-10-10 23:16:22.0521|2017-10-10 23:16:22.0521
NCT02454335|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2017-05-22|||January 2015||2015-01-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|||POEM Anterior Versus Posterior Approach|Comparison of Outcome and Complications of Anterior Versus Posterior Myotomy in Per-oral Endoscopic Myotomy (POEM) Endoscopic Procedure for Treatment of Achalasia: Randomized Single Blinded Clinical Trial|Active, not recruiting||N/A|160|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:16:22.128186|2017-10-10 23:16:22.128186
NCT02454322|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-12-15|||May 2015||2015-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Observational|||The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience|The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience|Recruiting||N/A|300|Anticipated|Northwestern University|||2||f||||f||||||Samples Without DNA|"     Cerebrospinal fluid and peripheral serum   "|Undecided||2017-10-10 23:16:22.217997|2017-10-10 23:16:22.217997
NCT02454309|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-05-30|||July 2015||2015-07-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Cranberry for the Prevention of Urinary Tract Infections|A Randomised, Double-blind, Placebo Controlled Trial Evaluating the Effectiveness of a Cranberry Concentrate (CranrichTM) in Preventing Recurrent Urinary Tract Infections in Adult Women|Recruiting||Phase 4|150|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 23:16:22.344089|2017-10-10 23:16:22.344089
NCT02454296|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-03-02|2016-10-26||May 2015||2015-05-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Paracervical Block for Pain Associated With Laminaria Insertion|Paracervical Block for Pain Associated With Laminaria Insertion|Completed||N/A|41|Actual|University of Hawaii|"Overall pain scores lower than in other published studies - speaks to generalizability
Paracervical block formulation might not be what is commonly used elsewhere
76% of participants were able to correctly guess their group allocation"|2|||f||||f||||||||No||2017-10-10 23:16:22.465434|2017-10-10 23:16:22.465434
NCT02454283|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-08-23|2016-08-23||September 2015||2015-09-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|RESTORE SR||Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm|RESTORE SR: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of a Single Oral Dose of Vanoxerine for The Conversion Of Subjects With REcent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm|Terminated||Phase 3|41|Actual|Laguna Pharmaceuticals, Inc.||2||Cardiac safety finding|f||||t||||||||||2017-10-10 23:16:23.050265|2017-10-10 23:16:23.050265
NCT02454270|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-09-15|||June 15, 2015|Actual|2015-06-15|September 2017|2017-09-01|January 29, 2021|Anticipated|2021-01-29|January 21, 2020|Anticipated|2020-01-21||Interventional|||A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies|A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of Duvortuxizumab, A Humanized CD19 x CD3 Dual-Affinity Re-Targeting (DART®) Protein in Subjects With Relapsed or Refractory B-cell Malignancies|Active, not recruiting||Phase 1|220|Anticipated|Janssen Research & Development, LLC||6|||f||||f||f||||||||2017-10-10 23:16:24.044063|2017-10-10 23:16:24.044063
NCT02454257|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-03-31|||August 2015||2015-08-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Risk Modelling for Quality Improvement in the Critically Ill: Making Best Use of Routinely Available Data|Risk Modelling for Quality Improvement in the Critically Ill: Making Best Use of Routinely Available Data|Active, not recruiting||N/A|940000|Anticipated|Intensive Care National Audit & Research Centre|||2||f||||f||||||||Yes|An anonymised study dataset will be available on request from the Chief Investigator, subject to any necessary approvals|2017-10-10 23:16:24.265758|2017-10-10 23:16:24.265758
NCT02450760|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-10-27|||November 2015||2015-11-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|CHAMPS||Connected Health Blood Pressure Monitoring In Stroke and TIA Patients||Recruiting||N/A|90|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:17:02.150937|2017-10-10 23:17:02.150937
NCT02454244|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-08-09|||June 2015||2015-06-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Amygdala Retraining With Mindfulness (ART+MF) vs Compassion Therapy (CT) for the Treatment of Patients With Fibromyalgia|Efficacy of Amygdala Retraining With Mindfulness (ART+MF) vs Compassion Therapy (CT) for the Treatment of Patients With Fibromyalgia: A Three-arm Randomized, Controlled Trial.|Completed||N/A|60|Actual|Hospital Miguel Servet||3|||f||||f||||||||||2017-10-10 23:16:24.385289|2017-10-10 23:16:24.385289
NCT02454231|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-05-08|||September 2009||2009-09-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|SCELTA||Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)|Monocentric Randomized Study for the Therapy of Critic Limb Ischemia With Bone Marrow- or Peripheral Blood-derived Stem Cells|Completed||Phase 2/Phase 3|45|Actual|University of Florence||2|||f||||t||||||||||2017-10-10 23:16:24.534976|2017-10-10 23:16:24.534976
NCT02454218|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-05-21|||November 2014||2014-11-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|||Effect of Transcranial Direct-current Stimulation in Attentional Performance and Pain in Patients With Fibromyalgia|Effect of Transcranial Direct-current Stimulation in Attentional Performance and Pain in Patients With Fibromyalgia|Unknown status|Recruiting|Phase 1|40|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:16:24.729991|2017-10-10 23:16:24.729991
NCT02454205|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-10-25|||October 2015||2015-10-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|NEXT||An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis|Evaluating a New Treatment Regimen for Patients With Multidrug-resistant TB (MDR-TB) - a Prospective Open-label Randomised Controlled Trial|Recruiting||Phase 2/Phase 3|300|Anticipated|University of Cape Town||2|||f||||t||||||||No||2017-10-10 23:16:24.845988|2017-10-10 23:16:24.845988
NCT02454192|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-04-05|||October 2010||2010-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|January 2015|Actual|2015-01-01||Interventional|CHAMPS||Community Healthcare for Asthma Management and Prevention of Symptoms|A Study of the Feasibility and Effectiveness of Implementing and Diffusing an Evidence-based Childhood Asthma Management Intervention in Community Health Centers|Completed||N/A|599|Actual|George Washington University||2|||f||||f||||||||||2017-10-10 23:16:24.992494|2017-10-10 23:16:24.992494
NCT02454179|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2016-11-30|||May 2015||2015-05-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|KEYNOTE147||Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell Carcinoma|A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Advanced Head and Neck Squamous Cell Carcinoma|Active, not recruiting||Phase 2|74|Anticipated|Acerta Pharma BV||2|||f||||f||||||||||2017-10-10 23:16:25.121871|2017-10-10 23:16:25.121871
NCT02454166|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-22|2015-05-26|||May 2015||2015-05-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||The Analysis of Chinese Medical Syndromes Differentiation on Acute Ischemic Stroke|The Study of Chinese Medical Syndromes on Common Diseases: The Analysis of Chinese Medical Syndromes Differentiation on Acute Ischemic Stroke|Unknown status|Not yet recruiting|N/A|300|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-10 23:16:25.205921|2017-10-10 23:16:25.205921
NCT02454153|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-08-10|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|HYPNOS||Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy|Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy|Recruiting||N/A|204|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:16:25.277229|2017-10-10 23:16:25.277229
NCT02454140|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-05-21|||June 2014||2014-06-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|SBRT||Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer|Phase I Trial of Adaptive Stereotactic Body Radiotherapy (SBRT) Dose Escalation in Pancreatic Cancer|Recruiting||Phase 1|30|Anticipated|University of California, San Diego||5|||f||||t||||||||||2017-10-10 23:16:25.384705|2017-10-10 23:16:25.384705
NCT02454127|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-09-13|2015-05-28||July 2000||2000-07-01|September 2016|2016-09-01|January 2004|Actual|2004-01-01|January 2003|Actual|2003-01-01||Interventional|||Effectiveness of Four Popular Diet Strategies for Weight Loss and Cardiac Risk Reduction|Effectiveness of Four Dietary Treatment Strategies for Metabolic Syndrome: a Prospective Randomized Trial|Completed||N/A|160|Actual|Tufts Medical Center|The protocol provided dietary advice rather than food. The attrition rate was 35% to 50% in each group. Missing data were replaced with baseline data for intent-to-treat analysis. Long-term safety beyond 1-year was not assessed.|4|||f||||f||||||||Yes|Peer-reviewed publication|2017-10-10 23:16:25.5227|2017-10-10 23:16:25.5227
NCT02454114|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-26|||October 2013||2013-10-01|October 2012|2012-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|HOMEFIRST||HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections|HOME FIRST (HOME Followed - up With Infection Respiratory Support Team)|Completed||N/A|26|Actual|Royal Liverpool and Broadgreen University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 23:16:26.092273|2017-10-10 23:16:26.092273
NCT02454101|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2016-05-19|2016-03-08||August 2015||2015-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|MDCCT||Milking Versus Delayed Cord Clamping in Full Term Neonates|Milking Versus Delayed Cord Clamping in Full Term Neonates Delivered by Elective Cesarean Section A Randomized Controlled Trial|Completed||N/A|300|Actual|Ain Shams University||2|||f||||f||||||||Undecided|lecture and seminar|2017-10-10 23:16:26.200296|2017-10-10 23:16:26.200296
NCT02454088|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-02-27|||May 2015||2015-05-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||A Single-Center Investigator-Initiated Evaluator-Bilateral-Comparison Pilot Study of Injectable Calcium Hydroxylapatite With and Without Triamcinolone Acetate for the Treatment of Volume Loss to Dorsum Areas of the Hands||Completed||N/A|20|Actual|Goldman, Butterwick, Fitzpatrick and Groff||2|||f||||f||||||||||2017-10-10 23:16:26.59288|2017-10-10 23:16:26.59288
NCT02454075|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-21|||April 2011||2011-04-01|May 2015|2015-05-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Interventional|||YF476 and Type II Gastric Carcinoids|A Pilot Trial of YF476, a Gastrin Antagonist, in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome|Enrolling by invitation||Phase 2|30|Anticipated|Trio Medicines Ltd.||1|||f||||f||||||||||2017-10-10 23:16:26.667605|2017-10-10 23:16:26.667605
NCT02454062|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-12-21|||March 2013||2013-03-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Interventional|||A Trial of TAS-114 in Combination With S-1|A Phase I, Open-Label, Non-Randomized, Dose-Escalating Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|120|Anticipated|Taiho Oncology, Inc.||2|||f||||f||||||||||2017-10-10 23:16:26.753181|2017-10-10 23:16:26.753181
NCT02454049|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-09-04|||September 2016|Actual|2016-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|nitrate_TT||Influence of Dietary Nitrate on Time Trial Performance in Swiss Paracycling Athletes|Influence of Dietary Nitrate on Paralympics 2016 Time Trial Performance in Swiss Elite Paracycling Athletes|Active, not recruiting||N/A|16|Anticipated|Swiss Paraplegic Centre Nottwil||3|||f||||f||||||||||2017-10-10 23:16:26.963282|2017-10-10 23:16:26.963282
NCT02454036|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-11-22|||June 2015||2015-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Biobehavioral Intervention in Gynecologic Oncology Patients|Psychological Changes in Cancer Patients Receiving a Biobehavioral Intervention: A Program Evaluation|Recruiting||Phase 2|30|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-10-10 23:16:27.066993|2017-10-10 23:16:27.066993
NCT02454023|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-05-12|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|SLEAP SMART||SLEep APnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke|SLEep APnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke (SLEAP SMART): A Randomized Controlled Trial|Recruiting||N/A|238|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||Undecided||2017-10-10 23:16:27.190912|2017-10-10 23:16:27.190912
NCT02454010|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-07-07|||January 2016||2016-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer|A Phase 1 Dose-escalation Study of Radio- Labeled Antibody, FF-21101(90Y) for the Treatment of Advanced Cancer|Recruiting||Phase 1|54|Anticipated|Fujifilm Pharmaceuticals U.S.A., Inc.||5|||f||||t||||||||||2017-10-10 23:16:27.307339|2017-10-10 23:16:27.307339
NCT02453997|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-06-21|||October 2012||2012-10-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|October 2017|Anticipated|2017-10-01||Observational|||Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis|Mycophenolic Acid Pharmacokinetics and Pharmacogenomics - Impact on the Clinical Outcomes of Patients With Severe Lupus Nephritis|Recruiting||N/A|150|Anticipated|The University of Hong Kong|||1||f||||t||||||Samples With DNA|"     EDTA blood samples for pharmacogenomics analysis   "|||2017-10-10 23:16:27.392899|2017-10-10 23:16:27.392899
NCT02453984|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-06-01|||February 2016||2016-02-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||MPDL3280A-imaging-IST-UMCG|ImmunoPET Imaging With 89Zr-MPDL3280A in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Bladder Cancer or Triple-negative Breast Cancer Prior to MPDL3280A Treatment|Recruiting||Phase 1|30|Anticipated|University Medical Center Groningen||1|||f||||f||||||||||2017-10-10 23:16:27.460748|2017-10-10 23:16:27.460748
NCT02453971|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-12-11|||May 2015||2015-05-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PsSt||Trial to Evaluate the Effects of the German eCHECKUP TO GO in Students|German Title: Prävention Substanzbezogener Störungen Bei Studierenden|Completed||N/A|1465|Actual|Esslingen University of Applied Sciences||2|||f||||f||||||||||2017-10-10 23:16:27.548935|2017-10-10 23:16:27.548935
NCT02453958|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-05-21|||June 2011||2011-06-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|MTBID||Mild Traumatic Brain Injury Discrimination|Non-Invasive Assay to Discriminate Mild Traumatic Brain Injury|Completed||N/A|56|Actual|Empirical Technologies Corporation||2|||f||||f||||||||||2017-10-10 23:16:27.626421|2017-10-10 23:16:27.626421
NCT02453945|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-10-14|||November 2015||2015-11-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|||Use of a Support Bra to Reduce Pain and Improve Surgical Healing in Women Undergoing Sternotomy for Cardiac Surgery|Use of a Support Bra to Reduce Pain and Improve Surgical Healing in Women Undergoing Sternotomy for Cardiac Surgery|Recruiting||N/A|140|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 23:16:27.689652|2017-10-10 23:16:27.689652
NCT02453932|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-08-03|||January 2015||2015-01-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia|A Phase III, Multicenter, Randomized, Double-blind, Positive /Placebo Controlled, Parallel, Three Arms Study of Tianzhi Granule in Mild to Moderate Vascular Dementia|Recruiting||Phase 3|637|Anticipated|Dongzhimen Hospital, Beijing||3|||f||||t||||||||||2017-10-10 23:16:27.770768|2017-10-10 23:16:27.770768
NCT02453919|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-26|||February 2010||2010-02-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01|10 Years|Observational [Patient Registry]|RECOVIH||Register of Cardiovascular Complications Among People Living With HIV|Register of Cardiovascular Complications Among People Living With HIV|Unknown status|Recruiting|N/A|800|Anticipated|Saint Antoine University Hospital|||1||f||||f||||||||||2017-10-10 23:16:29.54311|2017-10-10 23:16:29.54311
NCT02453906|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-07-26|||May 2015||2015-05-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||XNKQ Acupuncture Compared to Control Interventions Measured With EEG and fMRI|Cerebral Response of Healthy Subjects to a Somatosensory Stimulation With XNKQ Acupuncture Compared to Control Interventions Measured With EEG and fMRI|Completed||N/A|29|Actual|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-10 23:16:29.638988|2017-10-10 23:16:29.638988
NCT02453893|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-26|||November 2013||2013-11-01|March 2015|2015-03-01||||June 2015|Anticipated|2015-06-01||Interventional|||Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia|Double-blind,Double-simulation,Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia|Unknown status|Recruiting|Phase 3|288|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:16:29.722377|2017-10-10 23:16:29.722377
NCT02453880|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-04-25|||January 2014||2014-01-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness|"Web-based Self-Help Cognitive Behavioral Therapy for Symptoms of Mild-to-Moderate Anxiety and Depression in Adolescents and Young Adults With Chronic Illness"|Completed||N/A|14|Actual|Stanford University||1|||f||||f||||||||||2017-10-10 23:16:29.808839|2017-10-10 23:16:29.808839
NCT02453867|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-08-08|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|REDUCE||Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients|Multicenter, Prospective, Randomized Study Investigating the Efficacy and Safety of a Reduced Immunosuppressive Therapy With Tacrolimus Once Daily in Comparison to Standard Triple Immunosuppression in Senior Renal Transplant Recipients|Not yet recruiting||Phase 4|400|Anticipated|Charite University, Berlin, Germany||2|||f||||t|f|f||||||||2017-10-10 23:16:29.888014|2017-10-10 23:16:29.888014
NCT02453854|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-21|||October 2011||2011-10-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Small Changes a One Year Protocol for Weight Management|Study Protocol: Small Changes, a One-year Weight Management Intervention for Adults Who Are Overweight or Obese|Completed||N/A|155|Actual|Small Changes||2|||f||||f||||||||||2017-10-10 23:16:29.973812|2017-10-10 23:16:29.973812
NCT02453841|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-12-20|||December 2015||2015-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption|Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption During Functional Endoscopic or Turbinate Reduction Surgery or Adenoidectomy|Enrolling by invitation||N/A|60|Anticipated|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-10 23:16:30.040278|2017-10-10 23:16:30.040278
NCT02453828|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-12-12|||June 2015||2015-06-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Intraoperative Anesthesia Care Transition Checklist|The Effects of Implementing an Anesthesia Information Management System Guided Intraoperative Anesthesia Care Transition Checklist on Postoperative Complications: A Randomized Trial|Active, not recruiting||N/A|13676|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 23:16:30.115827|2017-10-10 23:16:30.115827
NCT02453815|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-12-15|||June 2015||2015-06-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Do Arterial Catheters Reduce the Risk of Major Perioperative Complications|Do Arterial Catheters Reduce the Risk of Major Perioperative Complications|Recruiting||N/A|3784|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-10 23:16:30.187377|2017-10-10 23:16:30.187377
NCT02453802|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-05-26|||June 2015||2015-06-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty|Comparison of Topical and Infusion Tranexamic Acid on Blood Loss and Risk of Deep Vein Thrombosis After Total Knee Arthroplasty|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-10 23:16:30.273076|2017-10-10 23:16:30.273076
NCT02453789|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-01-26|||February 2015||2015-02-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|SMR-2591||A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection|A Randomized Double-blind, Placebo-controlled Cross-over Study of Inhaled Alginate Oligosaccharide (OligoG) for 28 Days in Subjects With Cystic Fibrosis Using Aztreonam Due to Chronic Colonization With Burkholderia Spp.|Active, not recruiting||Phase 2|15|Actual|AlgiPharma AS||2|||f||||t||||||||||2017-10-10 23:16:30.49233|2017-10-10 23:16:30.49233
NCT02453776|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-01-15|||May 2015||2015-05-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|PRECISION||Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab|Precision Dosing Versus Conventional Dosing of Infliximab Maintenance Therapy: a Randomized Controlled Multicenter Study in Patients With IBD in Clinical Remission|Recruiting||Phase 4|80|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 23:16:30.600094|2017-10-10 23:16:30.600094
NCT02453763|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-07|||June 2015||2015-06-01|July 2017|2017-07-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Observational|tDCS||In Vivo Imaging of Therapeutic Electric Current Flow|In Vivo Imaging of Therapeutic Electric Current Flow|Completed||N/A|17|Actual|University of Florida|||1||f||||t||||||||||2017-10-10 23:16:30.709442|2017-10-10 23:16:30.709442
NCT02453737|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-08-29|||June 16, 2015|Actual|2015-06-16|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca|A Phase II Study of Accelerated 3 Fraction Photon and Proton Partial Breast External Beam Radiotherapy and Partial Breast Brachytherapy for Early Invasive and Noninvasive Breast Cancer|Active, not recruiting||Phase 2|198|Actual|Mayo Clinic||3|||f||||t||||||||||2017-10-10 23:16:30.899869|2017-10-10 23:16:30.899869
NCT02453724|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-03-17|||August 2015||2015-08-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Lung Ultrasound Safety in Humans|Lung Ultrasound Safety in Humans|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-10 23:16:30.981981|2017-10-10 23:16:30.981981
NCT02453711|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-25|||October 1, 2015|Actual|2015-10-01|July 2017|2017-07-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|||Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus|Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus|Completed||Phase 2|957|Actual|Novo Nordisk A/S||9|||f||||f||||||||||2017-10-10 23:16:31.075206|2017-10-10 23:16:31.075206
NCT02453698|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-05-22|||January 2011||2011-01-01|May 2015|2015-05-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Stimulant Effects on Brain Activity|Stimulant Effects on Brain Activity During the Stop Signal Task|Completed||Phase 1|19|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 23:16:31.337887|2017-10-10 23:16:31.337887
NCT02453672|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-10|||April 2015||2015-04-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetic, Safety, Tolerability, and Immunogenicity Study of SB8 in Healthy Male Subjects|A Randomised, Double-blind, Three-arm, Parallel Group, Single-dose Study to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Three Formulations of Bevacizumab (SB8, EU Sourced Avastin®, and US Sourced Avastin®) in Healthy Male Subjects|Completed||Phase 1|119|Actual|Samsung Bioepis Co., Ltd.||3|||f||||f||||||||||2017-10-10 23:16:31.50865|2017-10-10 23:16:31.50865
NCT02453659|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-10-04|||January 2015||2015-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|WE QUIT||Women Engaging in Quitting Smoking Together|Distress Tolerance Treatment for Weight Concern in Smoking Cessation Among Women|Recruiting||N/A|60|Anticipated|Rhode Island Hospital||2|||f||||f||||||||||2017-10-10 23:16:31.592669|2017-10-10 23:16:31.592669
NCT02453633|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-05-22|||May 2015||2015-05-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Theory Based SMS Reminders - Text's Impact on Patient Attendance|Theory Based SMS Reminders - Text's Impact on Patient Attendance|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Lovisenberg Diakonale Hospital||2|||f||||f||||||||||2017-10-10 23:16:31.767917|2017-10-10 23:16:31.767917
NCT02453620|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-09-12|||November 6, 2015|Actual|2015-11-06|September 2017|2017-09-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer|A Phase 1 Study Evaluating Safety, Tolerability, and Preliminary Antitumor Activity of Entinostat and Nivolumab With or Without Ipilimumab in Advanced Solid Tumors|Recruiting||Phase 1|45|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:16:31.84566|2017-10-10 23:16:31.84566
NCT02453607|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-02-14|||November 17, 2014|Actual|2014-11-17|February 2017|2017-02-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease|The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease|Recruiting||N/A|225|Anticipated|McGill University Health Center|||2||f||||f||||||Samples With DNA|"     We will be storing, de-identified, blood samples on site in the lab of Dr Ernest Seidman   "|No||2017-10-10 23:16:32.136259|2017-10-10 23:16:32.136259
NCT02453594|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-03-16|||June 2015||2015-06-01|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)|A Phase II Clinical Trial of MK-3475 (Pembrolizumab) in Subjects With Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)|Active, not recruiting||Phase 2|210|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-10 23:16:32.248133|2017-10-10 23:16:32.248133
NCT02453581|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-08-04|2015-06-18||September 2012||2012-09-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||All subjects enrolled in the study received a single dose of OZ439.|Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers|An Experimental Study To Characterize the Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection In Healthy Volunteers|Completed||Phase 1|24|Actual|Medicines for Malaria Venture||3|||f||||f||||||||||2017-10-10 23:16:32.380669|2017-10-10 23:16:32.380669
NCT02453542|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-03-21|||March 2015||2015-03-01|March 2017|2017-03-01||||June 2018|Anticipated|2018-06-01|2 Years|Observational [Patient Registry]|||Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors|Global Haemostatic Methods to Measure the Treatment Effect Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors|Recruiting||N/A|20|Anticipated|Karolinska Institutet|||1||f||||f||||||Samples Without DNA|"     whole blood   "|||2017-10-10 23:16:32.968551|2017-10-10 23:16:32.968551
NCT02453529|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-07-31|||April 2015||2015-04-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects|A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects|Completed||Phase 1|36|Actual|Wockhardt||1|||f||||||||||||||2017-10-10 23:16:33.065523|2017-10-10 23:16:33.065523
NCT02453516|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-05-09|||October 2014||2014-10-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of the Serratus Block on Pain Control After Breast Surgery|The Effect of The Serratus Block on Analgesia After Breast Surgery A Randomized Controlled Double-Blinded Study|Recruiting||Phase 2/Phase 3|50|Anticipated|Women's College Hospital||2|||f||||f||||||||||2017-10-10 23:16:33.149013|2017-10-10 23:16:33.149013
NCT02453503|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-05-20|||January 2014||2014-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus|Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on the Duration and Symptoms of Lesions That Caused by Symptomatic Oral Lichen Planus|Completed||Phase 2|60|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:16:33.271241|2017-10-10 23:16:33.271241
NCT02450747|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-11-15|2016-09-21||April 2015||2015-04-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All subjects that were dispensed a study lens.|Performance of a Multifocal Contact Lens - Presbyopia Study||Completed||N/A|44|Actual|Johnson & Johnson Vision Care, Inc.||1|||f||||f||||||||||2017-10-10 23:17:02.245854|2017-10-10 23:17:02.245854
NCT02453490|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-04-04|||October 2015||2015-10-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis|The Second Affiliated Hospital of Zhejiang University|Recruiting||Phase 3|360|Anticipated|Zhejiang University||2|||f||||f||||||||||2017-10-10 23:16:33.361716|2017-10-10 23:16:33.361716
NCT02453477|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-06-05|||May 2015||2015-05-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|TIGET-BTHAL||Gene Therapy for Transfusion Dependent Beta-thalassemia|A Phase I/II Study Evaluating Safety and Efficacy of Autologous Hematopoietic Stem Cells Genetically Modified With GLOBE Lentiviral Vector Encoding for the Human Beta-globin Gene for the Treatment of Patients Affected by Transfusion Dependent Beta-thalassemia|Recruiting||Phase 1/Phase 2|10|Anticipated|IRCCS San Raffaele||3|||f||||t||||||||||2017-10-10 23:16:33.511881|2017-10-10 23:16:33.511881
NCT02453464|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-04-19|||August 2015||2015-08-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer|A Phase Ib, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Humanized Anti-VEGF Monoclonal Antibody(Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer|Recruiting||Phase 1|36|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:16:33.631128|2017-10-10 23:16:33.631128
NCT02453451|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-04-05|||July 2015||2015-07-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|MitraClipASD||The Effect of the Hole in the Cardiac Septum Developed by the MitraClip Procedure on the Blood Flow Mechanics|The Effect of the Iatrogenic Atrial Septal Defect After MitraClip Procedure on the Hemodynamic Outcome|Recruiting||N/A|40|Anticipated|RWTH Aachen University||1|||f||||t||||||||||2017-10-10 23:16:33.728131|2017-10-10 23:16:33.728131
NCT02453438|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-07-13|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|3 Years|Observational [Patient Registry]|||Mood Patient Powered Research Network (MoodNetwork)|Mood Patient Powered Research Network (MoodNetwork)|Recruiting||N/A|50000|Anticipated|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-10 23:16:33.820404|2017-10-10 23:16:33.820404
NCT02453425|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-04-24|||May 2011||2011-05-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||The Effects of Blood Pressure on Renal Function and Oxygenation in Septic Shock|Goal Directed Therapy in Septic Shock - the Effects of Mean Arterial Pressure Levels, Adjusted With Norepinephrine, on Renal Perfusion, Function and Oxygenation.|Completed||N/A|8|Actual|Sahlgrenska University Hospital, Sweden||3|||f||||f||||||||||2017-10-10 23:16:33.895807|2017-10-10 23:16:33.895807
NCT02453412|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-11-29|||May 2015||2015-05-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|3S||Preoperative Arteriovenous Fistula Simulation Study (ShuntSimulationStudy)|Randomized-controlled Clinical Trial for the Evaluation of the Efficacy of Computational Simulation for the Planning of Vascular Access Surgery in Hemodialysis Patients|Recruiting||Phase 2/Phase 3|372|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 23:16:33.985027|2017-10-10 23:16:33.985027
NCT02453399|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-05-24|||July 2015||2015-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Relief of Migraine Pain Through Electro Stimulation|Relief of Migraine Pain Through Transcutaneous Electro Stimulation|Completed||N/A|87|Actual|Siano Mobile Silicon||1|||f||||f||||||||||2017-10-10 23:16:34.091239|2017-10-10 23:16:34.091239
NCT02453386|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-12-16|||July 2015||2015-07-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|TOZ-PD||Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients Using Levodopa|"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose Wearing-Off (TOZ-PD)"|Recruiting||Phase 3|450|Anticipated|Biotie Therapies Inc.||3|||f||||t||||||||||2017-10-10 23:16:34.18091|2017-10-10 23:16:34.18091
NCT02453373|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-09-14|||January 25, 2017|Actual|2017-01-25|March 2017|2017-03-01|April 30, 2018|Anticipated|2018-04-30|January 25, 2018|Anticipated|2018-01-25||Interventional|SISCO||Helping Stroke Patients With ThermoSuit Cooling|Helping Stroke Patients With ThermoSuit Cooling|Recruiting||N/A|30|Anticipated|Life Recovery Systems||2|||f||||t|f|t|f|||||||2017-10-10 23:16:34.586852|2017-10-10 23:16:34.586852
NCT02453360|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-12-21|||May 2015||2015-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Adductor Canal Block for Total Knee Arthroplasty|Impact of Volume of Local Anesthetic Injected for Adductor Canal Block on Recovery Profile and Block Characteristics Following Total Knee Arthroplasty.|Recruiting||N/A|60|Anticipated|University of Wisconsin, Madison||3|||f||||f||||||||||2017-10-10 23:16:34.716605|2017-10-10 23:16:34.716605
NCT02453308|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-08-09|||August 2015||2015-08-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|TRACII||A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)|A Multi-centre, Open-label Randomised Trial to Assess the Efficacy, Safety and Tolerability of Triple Artemisinin-based Combination Therapies (TACTs) Com-pared to Artemisinin-based Combination Therapies (ACTs) in Uncomplicated Falciparum Malaria and to Map the Geographical Spread of Artemisinin and Partner Drug Resistance|Recruiting||Phase 2/Phase 3|2040|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 23:16:35.256563|2017-10-10 23:16:35.256563
NCT02453295|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-22|||June 2015||2015-06-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Testing an Intervention to Foster Hope for Cancer Survivors With Lymphedema|Testing an Intervention to Foster Hope for Cancer Survivors With Lymphedema|Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Ottawa||2|||f||||f||||||||||2017-10-10 23:16:35.4265|2017-10-10 23:16:35.4265
NCT02453282|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-01|||July 21, 2015|Actual|2015-07-21|April 2017|2017-04-01|June 14, 2018|Anticipated|2018-06-14|June 15, 2017|Anticipated|2017-06-15||Interventional|MYSTIC||Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC).|A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination With Tremelimumab Therapy or MEDI4736 Monotherapy Versus Standard of Care Platinum-Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic Non Small-Cell Lung Cancer (NSCLC) (MYSTIC)|Active, not recruiting||Phase 3|1118|Actual|AstraZeneca||3|||f||||t|t|f||||||||2017-10-10 23:16:35.522576|2017-10-10 23:16:35.522576
NCT02453269|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-05-20|||May 2013||2013-05-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|OTPACO||Transdisciplinary Program Against Childhood Obesity|Outcome of a 1-year Transdisciplinary Program Against Childhood Obesity|Completed||N/A|7|Actual|Fortaleza University||2|||f||||t||||||||||2017-10-10 23:16:35.954131|2017-10-10 23:16:35.954131
NCT02453256|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-25|||November 20, 2015|Actual|2015-11-20|July 2017|2017-07-01|February 12, 2019|Anticipated|2019-02-12|January 16, 2018|Anticipated|2018-01-16||Interventional|focuSSced||A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis|Active, not recruiting||Phase 3|212|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 23:16:36.052204|2017-10-10 23:16:36.052204
NCT02453243|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-02-08|||December 2015||2015-12-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ED-SAFE-2||Emergency Department Safety Assessment and Follow-up Evaluation 2|Emergency Department Safety Assessment and Follow-up Evaluation 2|Enrolling by invitation||N/A|15000|Anticipated|University of Massachusetts, Worcester||3|||f||||t||||||||Undecided||2017-10-10 23:16:36.308111|2017-10-10 23:16:36.308111
NCT02453230|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-09-05|||January 2015||2015-01-01|September 2017|2017-09-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||The Effect of Light on the Fetal Biophysical Profile|The Effect of Light on the Fetal Biophysical Profile|Completed||N/A|200|Actual|University of Nebraska||2|||f||||f||||||||||2017-10-10 23:16:36.556288|2017-10-10 23:16:36.556288
NCT02453217|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-07-02|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CHIP||The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial|The Potential Efficacy and Acceptability of the Chinese Health Improvement Profile (CHIP) in Improving the Physical Health of People With Severe Mental Illness - A Pilot Clustered Randomised Controlled Trial|Active, not recruiting||N/A|144|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||||2017-10-10 23:16:36.656664|2017-10-10 23:16:36.656664
NCT02453204|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-05-02|||April 2015||2015-04-01|June 2016|2016-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|STAND-UP||STAND UP - Sedentary Behaviour in Older Adults: Investigating a New Therapeutic Paradigm|STAND UP - Sedentary Behaviour in Older Adults: Investigating a New Therapeutic Paradigm Work Package 3: Investigating the Effect of Sedentary Time, Reduced Sedentary Time and Increased Light-intensity Physical Activity on Metabolic and Psychological Health in Older Adults|Completed||N/A|76|Actual|University of Leicester||3|||f||||t||||||||||2017-10-10 23:16:36.770489|2017-10-10 23:16:36.770489
NCT02453191|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-04-21|||July 2015||2015-07-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||TVEC and Preop Radiation for Sarcoma|Neoadjuvant Intralesional Injection of Talimogene Laherparepvec With Concurrent Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas|Recruiting||Phase 1/Phase 2|32|Anticipated|University of Iowa||1|||f||||t||||||||||2017-10-10 23:16:36.876265|2017-10-10 23:16:36.876265
NCT02453178|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|BIKE||Effects of a Bicycling Intervention on Cognitive Skills and Cardiovascular Health|Effects of a Bicycling Intervention on Cognitive Skills and Cardiovascular Health|Recruiting||N/A|48|Anticipated|University of Iowa||2|||f||||t||||||||Yes|In accord with NIH regulations, we will make the data and relevant documentation available to other investigators at their request upon acceptance of the main findings from the study for publication. Because the collected data are to remain anonymous, only a subject number will identify all data. To further protect the privacy and confidentiality of the data, data and documentation will be made available only under a data-sharing agreement that provides for restrictions for the transferring of data to others and a commitment that the data will be used for research purposes only and not for a profit-making enterprise.|2017-10-10 23:16:36.961853|2017-10-10 23:16:36.961853
NCT02453165|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-09-25|||January 2015||2015-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Vaginal Cuff Dehiscence Following Total Laparoscopic Hysterectomy: Laparoscopic vs. Transvaginal Cuff Closure|Randomized Clinical Trial About Vaginal Cuff Dehiscence Following Total Laparoscopic Hysterectomy: Laparoscopic vs. Transvaginal Cuff Suturing|Recruiting||Phase 3|2800|Anticipated|Università degli Studi dell'Insubria||2|||f||||t||||||||||2017-10-10 23:16:37.059168|2017-10-10 23:16:37.059168
NCT02453152|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-06-15|||October 2015||2015-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)|Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)|Active, not recruiting||N/A|12|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-10 23:16:37.183851|2017-10-10 23:16:37.183851
NCT02453139|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-12-02|||October 2014||2014-10-01|December 2015|2015-12-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|ExPeCT||Exercise, Prostate Cancer and Circulating Tumour Cells|Evasion of Immune Editing by Circulating Tumour Cells in an Exercise Modifiable Mechanism Underlying Aggressive Behaviour in Obese Men With Prostate Cancer|Recruiting||N/A|200|Anticipated|University of Dublin, Trinity College||2|||f||||f||||||||||2017-10-10 23:16:37.295401|2017-10-10 23:16:37.295401
NCT02453126|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-11-16|||December 2014||2014-12-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Fibrostenotic Eosinophilic Esophagitis: Assessment Tools|Fibrostenotic Eosinophilic Esophagitis: Endoscopic, Histologic and Molecular Characterization and Evaluation of Clinical Assessment Tools|Recruiting||N/A|150|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 23:16:37.396476|2017-10-10 23:16:37.396476
NCT02453113|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-02-08|||June 2015||2015-06-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment|Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment|Recruiting||Phase 1|10|Anticipated|University of California, Irvine||1|||f||||t||||||||||2017-10-10 23:16:37.475837|2017-10-10 23:16:37.475837
NCT02453100|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-09-14|||June 2015||2015-06-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Managing Urinary Incontinence in Elderly Village Women in Rural Bangladesh|Managing Urinary Incontinence in Elderly Village Women in Rural Bangladesh: a Cluster Randomized Trial of a Community Exercise-based Intervention|Recruiting||N/A|640|Anticipated|University of Alberta||2|||f||||t||||||||||2017-10-10 23:16:37.572277|2017-10-10 23:16:37.572277
NCT02453087|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-06-19|||May 31, 2015|Actual|2015-05-31|June 2017|2017-06-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma|An Open-label, Multicenter, Phase 1/1b Dose Escalation Study Evaluating the Pharmacokinetics, Safety, Tolerability, and Preliminary Efficacy of DCDS0780A, Alone or in Combination With Rituximab, or Obinutuzumab, in Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma|Recruiting||Phase 1|98|Anticipated|Hoffmann-La Roche||3|||f||||f|t|f||||||||2017-10-10 23:16:37.663198|2017-10-10 23:16:37.663198
NCT02453074|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-05-21|||January 2015||2015-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Observational|||Automated System for Gathering and Reporting Clinical Outcomes to Providers|Automated System for Gathering and Reporting Clinical Outcomes to Providers|Completed||N/A|326|Actual|Harvard Medical School|||1||f||||f||||||||||2017-10-10 23:16:37.807423|2017-10-10 23:16:37.807423
NCT02453061|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-03-08|||June 2015||2015-06-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|TRIHEP3||A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease|A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease|Recruiting||Phase 2|100|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-10 23:16:37.874894|2017-10-10 23:16:37.874894
NCT02453048|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-09-06|||September 2015||2015-09-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine|Phase Ib (High Dose), Single Centre, Dose-escalating, Placebo-controlled, Randomized Study of a Live Attenuated B. Pertussis Strain Given as a Single Intranasal Dose to Healthy Adult Volunteers|Active, not recruiting||Phase 1|54|Actual|Institut National de la Santé Et de la Recherche Médicale, France||4|||f||||t||||||||No||2017-10-10 23:16:37.987573|2017-10-10 23:16:37.987573
NCT02453035|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-08-26|||May 2015||2015-05-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01|3 Years|Observational [Patient Registry]|X-Pand||DESolve® X-Pand Global Post Market Registry|"X-Pand is Intended to Use the DESolve Scaffold System in Treatment of CAD Patients, by Including Real World Use of the DESolve Scaffold Over a Broad Spectrum of Geographies, A Wide Variety of Practicing Clinicians & A Minimum Degree Of Selection Criteria"|Recruiting||N/A|2000|Anticipated|Elixir Medical Corporation|||1||f||||f||||||||||2017-10-10 23:16:38.100105|2017-10-10 23:16:38.100105
NCT02453022|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-05-05|||May 18, 2015|Actual|2015-05-18|May 2017|2017-05-01|July 31, 2015|Actual|2015-07-31|July 31, 2015|Actual|2015-07-31||Interventional|||A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole|A Single Centre, Open-label, 5-Period, Cross Over, Randomized Study in Healthy Elderly Subjects to Evaluate the Relative Bioavailability of Hydrobromide Salt and Free Base Immediate Release Tablet Formulations of Danirixin in the Fed State, and to Evaluate the Effect of Food and Gastric Acid Secretion Suppression on Danirixin Pharmacokinetics Following Administration of Hydrobromide Salt Tablets|Completed||Phase 1|18|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:16:38.221548|2017-10-10 23:16:38.221548
NCT02453009|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-22|||October 2014||2014-10-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|CHEIRON||Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer|CHemotherapy Plus Enzalutamide In First Line Therapy for Castration Resistant prOstate caNcer|Unknown status|Recruiting|Phase 2|232|Anticipated|Santa Chiara Hospital||2|||f||||f||||||||||2017-10-10 23:16:38.324762|2017-10-10 23:16:38.324762
NCT02452996|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2015-08-19|||April 2015||2015-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers|A Randomised, Double-Blind, Placebo Controlled, Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers|Completed||Phase 1|21|Anticipated|GeNeuro Innovation SAS||3|||f||||f||||||||||2017-10-10 23:16:38.421542|2017-10-10 23:16:38.421542
NCT02452983|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-02-05|||May 2015||2015-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|SS1||Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome|SS1: Pilot Study of Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1|30|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 23:16:38.505342|2017-10-10 23:16:38.505342
NCT02450734|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-20|||April 2011||2011-04-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Ultrasound-guided Intermediate Cervical Plexus Block for Carotid Surgery|Safety and Efficiency of Ultrasound-guided Intermediate Cervical Plexus Block for Carotid Surgery|Completed||N/A|50|Actual|Institut Mutualiste Montsouris|||1||f||||f||||||||||2017-10-10 23:17:02.543742|2017-10-10 23:17:02.543742
NCT02452970|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-07-02|||July 16, 2015|Actual|2015-07-16|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|EPIC||RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy|A Phase 2, Single-Arm, Open-label, Study of RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy|Active, not recruiting||Phase 2|30|Anticipated|EpicentRx, Inc.||1|||f||||f||||||||||2017-10-10 23:16:38.625053|2017-10-10 23:16:38.625053
NCT02452944|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-01-12|2015-05-28||December 2014||2014-12-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve Block|Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve Block in Transurethral Resection of Bladder Tumors Under Spinal Anesthesia|Completed||N/A|62|Actual|Gachon University Gil Medical Center|We checked the success or fail with nerve stimulator only before beginning the surgery. Therefore, the possibility of incomplete anterior or posterior branch block due to the investigator’s miss still remained, which is a limitation of this study.|2|||f||||f||||||||||2017-10-10 23:16:38.78456|2017-10-10 23:16:38.78456
NCT02452931|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-09-27|||May 2015||2015-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty|An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty|Active, not recruiting||Phase 3|60|Anticipated|Tolmar Inc.||1|||f||||t||||||||||2017-10-10 23:16:39.072782|2017-10-10 23:16:39.072782
NCT02452918|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-10-03|||June 2015||2015-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||A Study to Evaluate the Safety of a Single IV Dose of Orbactiv (Oritavancin) in Subjects on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|An Open-Label Study to Evaluate the Safety of a Single 1200 mg IV Dose of Orbactiv (Oritavancin) in Subjects on Concomitant Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|Completed||Phase 4|17|Actual|The Medicines Company||1|||f||||f||||||||||2017-10-10 23:16:39.1774|2017-10-10 23:16:39.1774
NCT02452879|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2015-05-22|||October 2014||2014-10-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|||Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study|The Effectiveness, Superiority and Safety of EA on OAB:Multi-center Randomized Controlled Trial|Unknown status|Recruiting|N/A|180|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||3|||f||||t||||||||||2017-10-10 23:16:39.455032|2017-10-10 23:16:39.455032
NCT02452866|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-03-02||2016-03-02|June 2015||2015-06-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Open-Label Study to Evaluate the Safety of A Single Dose of SYM-1219, a Granule Formulation Containing 2 Grams of Secnidazole|A Phase 3, Multi-center, Prospective, Open-Label Study to Evaluate the Safety of A Single Dose of SYM-1219, a Granule Formulation Containing 2 Grams of Secnidazole, for the Treatment of Women and Postmenarchal Adolescent Girls With Bacterial Vaginosis|Completed||Phase 3|325|Actual|Symbiomix Therapeutics||1|||f||||f||||||||||2017-10-10 23:16:39.545586|2017-10-10 23:16:39.545586
NCT02452853|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-20|||May 2015||2015-05-01|May 2015|2015-05-01|May 2018|Anticipated|2018-05-01|May 2016|Anticipated|2016-05-01||Interventional|||HR Combined With FOLFOX4 for HCC With PVTT|Hepatic Resection Combined With or Without Oxaliplatin+5-Fluorouracil/ Leucovorin(5-FU/LV)(FOLFOX4) for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus|Active, not recruiting||Phase 2|51|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 23:16:39.675798|2017-10-10 23:16:39.675798
NCT02452840|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-07-25|||October 2014||2014-10-01|July 2017|2017-07-01|October 2022|Anticipated|2022-10-01|May 2018|Anticipated|2018-05-01||Observational|||Photodynamic Therapy for PDA in NV AMD|Adjunctive Photodynamic Therapy for Persistent Disease Activity in Patients With Neovascular Age-Related Macular Degeneration|Recruiting||N/A|100|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 23:16:39.902431|2017-10-10 23:16:39.902431
NCT02452827|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-20|||June 2015||2015-06-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||The Correlation of Myodural Bridges to Biomechanical Parameters in Patients Suffering From Primary Chronic Neck Pain||Unknown status|Not yet recruiting|N/A|20|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-10-10 23:16:40.004549|2017-10-10 23:16:40.004549
NCT02452632|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-01-25|||July 2015||2015-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin|A Phase 3, Multicenter, Double-Blind, Randomized, Parallel-group, Placebo-Controlled Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin|Completed||Phase 3|143|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 23:16:41.546376|2017-10-10 23:16:41.546376
NCT02452814|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-05|||May 7, 2014|Actual|2014-05-07|September 2017|2017-09-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Observational|||Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection|Long-term Extension to a Phase 2, Open-Label, Clinical Trial of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Null Responders to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Genotype 1 Infection|Completed||N/A|8|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:16:40.112674|2017-10-10 23:16:40.112674
NCT02452801|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2016-02-03|||May 2015||2015-05-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function|A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of ALKS 5461 in Subjects With Hepatic Impairment|Completed||Phase 1|40|Actual|Alkermes, Inc.||1|||f||||f||||||||||2017-10-10 23:16:40.199689|2017-10-10 23:16:40.199689
NCT02452788|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-20|||May 2015||2015-05-01|May 2015|2015-05-01||||July 2015|Anticipated|2015-07-01||Interventional|||Pharmaceutical Care in Ambulatory Hemodialysis Patients|Effectiveness of Pharmaceutical Care in Ambulatory Hemodialysis Patients: a Randomized Controlled Pilot Study|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hospital Moinhos de Vento||2|||f||||||||||||||2017-10-10 23:16:40.286078|2017-10-10 23:16:40.286078
NCT02452775|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-21|2017-01-12|||May 2015||2015-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Autologous OC-L Vaccine and Ovarian Cancer|A Randomized Pilot Trial to Test the Addition of Montanide and Polyiclc to Autologous Oxidized Tumor Cell Lysate Vaccine in Combination With Gmcsf in Primary Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Recruiting||N/A|12|Anticipated|Abramson Cancer Center of the University of Pennsylvania||4|||f||||t||||||||||2017-10-10 23:16:40.373946|2017-10-10 23:16:40.373946
NCT02452762|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-07-06|||January 2016||2016-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|VITdAL-PICU||Rapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial|Rapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial|Recruiting||Phase 2|60|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-10 23:16:40.485063|2017-10-10 23:16:40.485063
NCT02452749|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-02-23|||May 2015||2015-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Prospective Safety and Tolerability Assessment of a Cardiovascular Health Dietary Supplement|Prospective Safety and Tolerability Assessment of a Cardiovascular Health Dietary Supplement|Active, not recruiting||N/A|30|Anticipated|National University of Natural Medicine||1|||f||||f||||||||No||2017-10-10 23:16:40.626768|2017-10-10 23:16:40.626768
NCT02452736|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-04-06|||May 2015||2015-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)|CHINA RESOLUTE INTEGRITY STUDY Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use --A Prospective, Multi-center, Single Arm, Non-randomized Study|Completed||Phase 3|205|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-10-10 23:16:40.712733|2017-10-10 23:16:40.712733
NCT02452723|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-08-21|||March 2016||2016-03-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease|A Single Arm, Open-Label Phase 1 Study to Evaluate the Safety and Tolerability of ISC-hpNSC Injected Into the Striatum and Substantia Nigra of Patients With Parkinson's Disease|Recruiting||Phase 1|12|Anticipated|Cyto Therapeutics Pty Limited||1|||f||||t||||||||||2017-10-10 23:16:40.804562|2017-10-10 23:16:40.804562
NCT02452710|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-08-22|||August 2015||2015-08-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|September 2018|Anticipated|2018-09-01||Interventional|||Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors|Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors|Enrolling by invitation||N/A|120|Anticipated|Dana-Farber Cancer Institute||2|||f||||f||||||||||2017-10-10 23:16:40.896145|2017-10-10 23:16:40.896145
NCT02452697|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-06-21|||June 8, 2016|Actual|2016-06-08|June 2017|2017-06-01|July 2023|Anticipated|2023-07-01|July 2021|Anticipated|2021-07-01||Interventional|NK-DCI||Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT|A Randomized Phase II Trial to Evaluate Progression-Free Survival Rates in Patients Receiving NK Cell-Enriched Donor Cell Infusions When Administered Alone or Administered With the TLR9 Agonist, DUK-CPG-001, From a 4-6/8 HLA-Matched Related or 7-8/8 HLA-Matched Donor Following Reduced Intensity or Non-Ablative Allogeneic Stem Cell Transplantation|Recruiting||Phase 2|100|Anticipated|Duke University||4|||f||||t||||||||No||2017-10-10 23:16:40.994827|2017-10-10 23:16:40.994827
NCT02452684|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-02-23|||October 1, 2012|Actual|2012-10-01|January 2017|2017-01-01|December 22, 2015|Actual|2015-12-22|November 11, 2014|Actual|2014-11-11||Observational|||Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients|Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients (Study LUN01S)|Completed||N/A|4876|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-10 23:16:41.134084|2017-10-10 23:16:41.134084
NCT02452671|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-03-20|||June 2015||2015-06-01|July 2016|2016-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Observational Plan to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device|Observational Plan Designed to Obtain Clinical Experience and Follow up Data on the Use of the ProxiFuse Hammer Toe Device for the Fixation of Osteotomies and Reconstruction of the Lesser Toes Following Correction Procedures|Terminated||N/A|15|Actual|Cartiva, Inc.|||1|Enrollment temporarily stopped|f||||f||||||||||2017-10-10 23:16:41.242781|2017-10-10 23:16:41.242781
NCT02452658|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-01-26|||May 2015||2015-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Fast Food Photo Study 2|Detecting Changes on Fast Food Menu|Completed||N/A|311|Actual|Carnegie Mellon University||1|||f||||f||||||||||2017-10-10 23:16:41.352351|2017-10-10 23:16:41.352351
NCT02452645|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-07-17|||December 2015|Actual|2015-12-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Improving Nutrition and Physical Activity Environments in Home-based Child Care|Improving Nutrition and Physical Activity Environments in Home-based Child Care|Recruiting||N/A|132|Anticipated|Brown University||2|||f||||t||||||||||2017-10-10 23:16:41.437406|2017-10-10 23:16:41.437406
NCT02452619|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-10-23|||March 2015||2015-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||MRI Brain Changes Induced by Hyperbaric Oxygen Therapy in Brain Injury Patients|Brain Angiogenesis Induced by Hyperbaric Oxygen Therapy Can be Visualized by Perfusion MRI in Brain Injury Patients|Enrolling by invitation||N/A|30|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-10-10 23:16:41.690503|2017-10-10 23:16:41.690503
NCT02452606|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-07-11|||March 2015||2015-03-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease|Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease|Recruiting||N/A|100|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-10 23:16:41.81769|2017-10-10 23:16:41.81769
NCT02452580|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-05-21|||September 2013||2013-09-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||The Norwegian Family Centered Care Study|Impact of Family Centered Care on Preterm Infants and Their Parents|Unknown status|Recruiting|N/A|100|Anticipated|Vestre Viken Hospital Trust|||2||f||||t||||||||||2017-10-10 23:16:42.022916|2017-10-10 23:16:42.022916
NCT02452567|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-01-30|||May 2015||2015-05-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|MAL||Effect of Moderate Weight Loss in Metabolically Abnormal Lean Subjects|Effect of Moderate Weight Loss in Metabolically Abnormal Lean Subjects|Recruiting||N/A|15|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-10 23:16:42.138136|2017-10-10 23:16:42.138136
NCT02452554|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-01-20|||October 2015||2015-10-01|January 2017|2017-01-01||||March 2019|Anticipated|2019-03-01||Interventional|||Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma|A Phase 2 Study of IMGN901 (Lorvotuzumab Mertansine; NSC: 783609) in Children With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) and Synovial Sarcoma|Active, not recruiting||Phase 2|62|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-10 23:16:42.246786|2017-10-10 23:16:42.246786
NCT02452541|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-06-07|||April 2013||2013-04-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|||TBI-Prognosis Multicenter Prospective Study|Early Determination of Neurological Prognosis in ICU Patients With Severe Traumatic Brain Injury: The TBI-Prognosis Multicenter Prospective Study|Active, not recruiting||N/A|315|Actual|CHU de Quebec-Universite Laval||1|||f||||f||||||||||2017-10-10 23:16:42.484151|2017-10-10 23:16:42.484151
NCT02452515|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-04-07|||July 2015||2015-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|CHIARA MIA 1||A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction|A Single-blind, Multicenter Pilot Study to Investigate the Safety and Tolerability of a 14 Day Oral Treatment With Different Doses of the Chymase Inhibitor BAY1142524 in Comparison to Placebo in Clinically Stable Patients With Left-ventricular Dysfunction After Myocardial Infarction|Completed||Phase 2|49|Actual|Bayer||4|||f||||f||||||||||2017-10-10 23:16:42.694062|2017-10-10 23:16:42.694062
NCT02452502|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-04-18|||January 2015||2015-01-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|SEATIS||The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke|The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke|Recruiting||Phase 4|256|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||t||||||||||2017-10-10 23:16:42.792984|2017-10-10 23:16:42.792984
NCT02452489|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-05-21|||January 2015||2015-01-01|May 2015|2015-05-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Different Acupoints Compatibility Difference of the Effect of Treatment of the Diabetic Gastroparesis|Scheme Optimization of Acupoints Compatibility and Influence Factors of the Effect|Recruiting||Phase 1|99|Anticipated|Changchun University of Chinese Medicine||3|||f||||t||||||||||2017-10-10 23:16:42.886226|2017-10-10 23:16:42.886226
NCT02452476|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-01-12|||January 2016||2016-01-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|February 2018|Anticipated|2018-02-01||Interventional|||A Double Blind, Randomized, Controlled Study to Compare CHF 5633 (Synthetic Surfactant) and Poractant Alfa in RDS|A DOUBLE BLIND, RANDOMIZED, CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF SYNTHETIC SURFACTANT (CHF 5633) IN COMPARISON TO PORCINE SURFACTANT (PORACTANT ALFA, CUROSURF®) IN THE TREATMENT OF PRETERM NEONATES WITH RESPIRATORY DISTRESS SYNDROME|Recruiting||Phase 2|126|Anticipated|Chiesi Farmaceutici S.p.A.||2|||f||||t||||||||||2017-10-10 23:16:42.991258|2017-10-10 23:16:42.991258
NCT02452463|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-07-08|||June 29, 2015|Actual|2015-06-29|July 2017|2017-07-01|January 7, 2020|Anticipated|2020-01-07|January 7, 2019|Anticipated|2019-01-07||Interventional|||Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy|A Phase II Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis Against Radiation Pneumonitis in Patients With Unresectable NSCLC Undergoing Chemoradiation Therapy|Recruiting||Phase 2|99|Anticipated|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-10 23:16:43.085985|2017-10-10 23:16:43.085985
NCT02452437|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-05-21|||May 2015||2015-05-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|OCKD||Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis|Clinical Trial Simulation Using ODE/PDE Hemodialysis Model for Quantifying Oxycodone's Removal in End-Stage Kidney Disease|Unknown status|Recruiting|Phase 4|20|Anticipated|Emerio & Lourdes Linares Research and Education Center||2|||f||||f||||||||||2017-10-10 23:16:43.282862|2017-10-10 23:16:43.282862
NCT02452424|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-09-18|||June 2015||2015-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors|Phase 1/2a Study of Double-Immune Suppression Blockade By Combining a CSF1R Inhibitor (PLX3397) With An Anti-PD-1 Antibody (Pembrolizumab) To Treat Advanced Melanoma And Other Solid Tumors|Active, not recruiting||Phase 1/Phase 2|80|Actual|Plexxikon||1|||f||||f|t|f||||||||2017-10-10 23:16:43.404953|2017-10-10 23:16:43.404953
NCT02452411|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-23|||January 2013||2013-01-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy of Two Ways of Applying Homework Assignments in the Treatment of Adjustment Disorders|Differential Efficacy of Two Ways of Applying Homework Assignments in the Treatment of Adjustment Disorders: Application Supported by Information and Communication Technologies Versus Traditional Application|Completed||N/A|50|Actual|Universitat Jaume I||2|||f||||f||||||||||2017-10-10 23:16:43.539682|2017-10-10 23:16:43.539682
NCT02452398|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-04-19|||January 2015||2015-01-01|April 2017|2017-04-01|April 18, 2017|Actual|2017-04-18|March 27, 2017|Actual|2017-03-27||Interventional|||Clinical Evaluation of Hair Removal and Permanent Hair Reduction for Skin Types VI Using Intense Pulsed Light|Clinical Evaluation of Hair Removal and Permanent Hair Reduction for Skin Types V-VI Using Intense Pulsed Light|Completed||N/A|85|Actual|Venus Concept||1|||f||||t||||||||||2017-10-10 23:16:43.662093|2017-10-10 23:16:43.662093
NCT02452385|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-02-04|||March 2015||2015-03-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Phase 1 Study of CM082 in Patients With Wet-AMD|Phase 1 Study of CM082 in Patients With Wet-AMD: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy|Active, not recruiting||Phase 1|38|Actual|AnewPharma||1|||f||||f||||||||||2017-10-10 23:16:43.75602|2017-10-10 23:16:43.75602
NCT02452372|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-09-07|||May 2015||2015-05-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|||A Phase 1 Study of ALN-AS1 in Patients With Acute Intermittent Porphyria (AIP)|A Phase 1, Single-ascending Dose, Multiple-ascending Dose, and Multi-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Subcutaneously Administered ALN AS1 in Patients With Acute Intermittent Porphyria (AIP)|Completed||Phase 1|40|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:16:43.845132|2017-10-10 23:16:43.845132
NCT02452359|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-03-27|||March 2015||2015-03-01|September 2016|2016-09-01|March 1, 2017|Actual|2017-03-01|January 21, 2017|Actual|2017-01-21||Interventional|||Clinical Evaluation of Using Intense Pulsed Light for Improving the Appearance of Striae Distensae|Clinical Evaluation of Venus Versa SR Applicator Using Intense Pulsed Light on Skin Texture for Improving the Appearance of Striae Distensae|Completed||N/A|60|Anticipated|Venus Concept||1|||f||||t||||||||||2017-10-10 23:16:43.943641|2017-10-10 23:16:43.943641
NCT02452346|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-03-01|||March 20, 2015|Actual|2015-03-20|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Interventional|IST-CTI-MDS||Study of Clinical Efficacy and Safety of Tosedostat in MDS|Phase II Clinical Study of the Clinical Efficacy and Safety of Tosedostat in Atients With Myelodysplastic Syndromes (MDS) After Failure of Hypomethylating Agent‐Based Therapy|Recruiting||Phase 2|80|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-10-10 23:16:44.158273|2017-10-10 23:16:44.158273
NCT02452333|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-08-04|||May 2015||2015-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Oncoplastic Approach to Excisional Breast Biopsies|Oncoplastic Approach to Excisional Breast Biopsies: A Prospective Randomized Controlled Trial|Completed||N/A|80|Actual|Akdeniz University||2|||f||||t||||||||||2017-10-10 23:16:44.285197|2017-10-10 23:16:44.285197
NCT02452320|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-01-17|||February 2016||2016-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|Bariatricace||Prospective, Double Blind, Placebo Control, Bariatric IV Ace|Prospective, Double Blind, Placebo Control, Study of Acetaminophen iv on Hospital Length of Stay in Morbidly Obese Individuals Undergoing Elective Laparoscopic Sleeve Gastrectomy|Completed||Phase 4|136|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||No|We will not be making IPD available|2017-10-10 23:16:44.414107|2017-10-10 23:16:44.414107
NCT02452307|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-08-14|||April 2004||2004-04-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy|Prospective Randomized Trial of Peptide-specific Vaccination in HLA-A*02 Positive Prostate Carcinoma Patients With Biochemical Recurrence After Radical Prostatectomy|Active, not recruiting||Phase 1/Phase 2|36|Actual|University Hospital Tuebingen||5|||f||||f||||||||||2017-10-10 23:16:44.513303|2017-10-10 23:16:44.513303
NCT02452294|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-05-02|||July 2015||2015-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|BUMPER||Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)|An Open-label, Uncontrolled, Single Arm Phase II Trial of Buparlisib in Patients With Metastatic Melanoma With Brain Metastases Not Eligible for Surgery or Radiosurgery|Recruiting||Phase 2|22|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-10 23:16:44.623408|2017-10-10 23:16:44.623408
NCT02452281|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-01-22|||December 2015||2015-12-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma|Phase I-II Pilot Study to Evaluate the Immune-mediated Effects of an Autologous Tumor-derived Heat Shock Protein-peptide Complex 96 (HSPPC-96) Combined With Ipilimumab in Patients With Therapeutically Unresectable Stage III or Stage IV Malignant Melanoma|Withdrawn||Phase 1/Phase 2|0|Actual|The University of Texas Health Science Center, Houston||1||PI departure, operational issues|f||||f||||||||||2017-10-10 23:16:44.725029|2017-10-10 23:16:44.725029
NCT02452268|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-29|||July 13, 2015|Actual|2015-07-13|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers|A Phase 1 Study of Subcutaneous Recombinant Human NIZ985 ((hetIL-15) (IL15/sIL-15Ra)) Alone and in Combination With PDR001 in Adults With Metastatic Cancers|Recruiting||Phase 1|42|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 23:16:44.832687|2017-10-10 23:16:44.832687
NCT02452242|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-05-27|||January 2015||2015-01-01|May 2015|2015-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Safety, PK and PD Study of ABX464 in Untreated HIV Patients|A Phase 2, Dose Escalation, Schedule Comparison Study to Evaluate the Safety, Pharmacokinetics, and Viral Kinetics of ABX464 in Untreated Patients With HIV Infection in Mauritius|Completed||Phase 2|70|Actual|Abivax S.A.||2|||f||||t||||||||||2017-10-10 23:16:45.118532|2017-10-10 23:16:45.118532
NCT02452229|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-19|||March 2015||2015-03-01|May 2015|2015-05-01||||May 2015|Actual|2015-05-01||Observational|||Review of Human Herpes Viruses in Burns|Human Herpes Viruses in Burn Victims: A Systematic Review|Completed||N/A|10267|Actual|The University of Texas Medical Branch, Galveston|||1||f||||f||||||||||2017-10-10 23:16:45.235848|2017-10-10 23:16:45.235848
NCT02452216|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-08-30|||June 10, 2015|Actual|2015-06-10|August 2017|2017-08-01|January 12, 2017|Actual|2017-01-12|January 12, 2017|Actual|2017-01-12||Interventional|||Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS|MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI|Completed||Early Phase 1|10|Actual|Stanford University||1|||f||||t||||||||||2017-10-10 23:16:45.325995|2017-10-10 23:16:45.325995
NCT02452203|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-09-05|||May 2015||2015-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Examining the Effects of Reduced Environmental Stimulation on the Brain|Examining the Effects of Reduced Environmental Stimulation on the Brain|Recruiting||N/A|40|Anticipated|Laureate Institute for Brain Research, Inc.||2|||f||||f||||||||||2017-10-10 23:16:45.4475|2017-10-10 23:16:45.4475
NCT02452190|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-12-01|||September 2015||2015-09-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Reslizumab in Patients With Uncontrolled Asthma and Elevated Blood Eosinophils|A 52-Week Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Reslizumab 110 mg Fixed, Subcutaneous Dosing in Patients With Uncontrolled Asthma and Elevated Blood Eosinophils|Active, not recruiting||Phase 3|469|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-10 23:16:45.554903|2017-10-10 23:16:45.554903
NCT02452177|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-16|2015-05-21|||May 2015||2015-05-01|May 2015|2015-05-01|February 2016|Anticipated|2016-02-01|October 2015|Anticipated|2015-10-01||Interventional|||Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver Disease|Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver Disease: Clinical Observation and Experimental Study|Unknown status|Recruiting|N/A|30|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 23:16:46.03198|2017-10-10 23:16:46.03198
NCT02452164|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-11-15|||September 2015||2015-09-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|FamilymOTO||Family MobilePhone Otoscopy in Diagnostics of Otitis Media|Family MobilePhone Otoscopy in Diagnostics of Otitis Media. (Family mOTO-Study)|Completed||N/A|41|Actual|Turku University Hospital||2|||f||||f||||||||||2017-10-10 23:16:46.109933|2017-10-10 23:16:46.109933
NCT02452151|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-05-21|||August 2015||2015-08-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|SIMILAR||"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"|Santeon InflixMab biosimILAr Research A Randomized, Controlled, Double Blind, Phase 4 Noninferiority Trial to Assess Efficacy of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission.|Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Onze Lieve Vrouwe Gasthuis||2|||f||||f||||||||||2017-10-10 23:16:46.178078|2017-10-10 23:16:46.178078
NCT02452138|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2015-12-17|||January 2016||2016-01-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Endotoxin Activity Assay and Microcirculation in Severe Sepsis|Endotoxin Activity Assay and Microcirculation Examination in Patients With Severe Sepsis|Not yet recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-10 23:16:46.248282|2017-10-10 23:16:46.248282
NCT02452125|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-07-25|||May 2015||2015-05-01|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|PD||The Effects of Nicotine Chewing Gum in Parkinson's Disease|The Effects of Nicotine Chewing Gum on Acute Low Blood Pressure in Parkinson's Disease|Completed||N/A|10|Actual|New York Institute of Technology||1|||f||||f||||||||||2017-10-10 23:16:46.326076|2017-10-10 23:16:46.326076
NCT02452112|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-07-31|||November 2014||2014-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain||Completed||Phase 2/Phase 3|243|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-10 23:16:46.390785|2017-10-10 23:16:46.390785
NCT02452099|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-01-17|||January 2014||2014-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|DMSOconc3||Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.|Impact of Different DMSO Concentrations in Cryopreservation Mixture on Hematopoietic Recovery After Autologous Transplantation of Hematopoietic Stem Cells.|Completed||N/A|150|Actual|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||3|||f||||f||||||||||2017-10-10 23:16:46.485728|2017-10-10 23:16:46.485728
NCT02452086|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-05-29|||June 2013||2013-06-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Low Level Laser Therapy and Expression of VEGF, NO, VEGFR-2, HIF-1α in Diabetic Foot Ulcers|Effect of Low Level Laser With Ga-As (904 nm) on Expression of Angiogenic Factors (VEGF, VEGF Receptor-2,NO, HIF-1α), Oxygen Saturation of Peripheral Blood and Wound Surface Area in Ischemic Diabetic Foot Ulcers|Completed||N/A|27|Actual|Tarbiat Modarres University||2|||f||||f||||||||||2017-10-10 23:16:46.55961|2017-10-10 23:16:46.55961
NCT02452073|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-05-21|||January 2014||2014-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Observational|||An Analysis of the Relative Risk for Low Triiodothyronine Syndrome in Patients With Chronic Radiation Enteritis||Completed||N/A|48|Actual|Jinling Hospital, China|||3||f||||t||||||||||2017-10-10 23:16:46.626536|2017-10-10 23:16:46.626536
NCT02452060|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-04-19|||October 2014||2014-10-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy|Randomized, Double-blind, Placebo Controlled Study on the Effect of a Single Postoperative Administration of Low Dose Ketamine After Gastric Bypass and Gastrectomy Surgeries|Recruiting||Phase 2/Phase 3|100|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 23:16:46.683743|2017-10-10 23:16:46.683743
NCT02452047|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-09-27|||August 21, 2015|Actual|2015-08-21|September 2017|2017-09-01|September 18, 2017|Actual|2017-09-18|September 18, 2017|Actual|2017-09-18||Interventional|RESTORE-IMI 1||Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)|A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Estimate the Efficacy and Safety of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem/Cilastatin in Subjects With Imipenem-Resistant Bacterial Infection|Completed||Phase 3|50|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-10 23:16:46.807865|2017-10-10 23:16:46.807865
NCT02452021|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-09-19|||July 2015||2015-07-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Observational|||Pencil Beam Scanning Proton Radiotherapy for Esophageal Cancer|An Observational Study of Pencil Beam Scanning (PBS) Proton Radiotherapy (RT) as a Component of Trimodality Therapy for Esophageal Cancer|Active, not recruiting||N/A|30|Actual|Mayo Clinic|||1||f||||t||||||||||2017-10-10 23:16:47.017215|2017-10-10 23:16:47.017215
NCT02452008|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-07-28|||April 2016||2016-04-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer||Recruiting||Phase 2|60|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 23:16:47.079343|2017-10-10 23:16:47.079343
NCT02451995|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-09-07|||June 2015||2015-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|RIPPLE-AT||Effectiveness of Ripple Mapping in Atrial Tachycardia Ablation|A Prospective Multi-centre Study of Effectiveness of Ripple Mapping for Atrial Tachycardia Ablation|Recruiting||N/A|100|Anticipated|Imperial College London||2|||f||||f||||||||Undecided|Individual patient outcomes will be summarised and presented|2017-10-10 23:16:47.167204|2017-10-10 23:16:47.167204
NCT02451982|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-01-11|||February 2016||2016-02-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Neoadjuvant/Adjuvant GVAX Pancreas Vaccine (With CY) With or Without Nivolumab Trial for Surgically Resectable Pancreatic Cancer|A Randomized Study of a GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine With Our Without a PD-1 Blockade Antibody (Nivolumab) for the Neoadjuvant and Adjuvant Treatment of Patients With Surgically Resectable Adenocarcinoma of the Pancreas|Recruiting||Phase 1/Phase 2|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 23:16:47.2485|2017-10-10 23:16:47.2485
NCT02451969|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-05-01|||April 2015||2015-04-01|July 2015|2015-07-01|February 2017|Actual|2017-02-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly|Phase III Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine: A Double-blind, Randomized and Controlled Clinical Trial With 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults, and Elderly|Completed||Phase 3|1760|Actual|Sinovac Biotech Co., Ltd||2|||f||||f||||||||No||2017-10-10 23:16:47.335775|2017-10-10 23:16:47.335775
NCT02451956|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-15|||January 7, 2015|Actual|2015-01-07|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy||Recruiting||Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:16:47.416315|2017-10-10 23:16:47.416315
NCT02451943|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-08-25|||September 2015||2015-09-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|ANNOUNCE||A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin Plus Olaratumab Versus Doxorubicin Plus Placebo in Patients With Advanced or Metastatic Soft Tissue Sarcoma|Active, not recruiting||Phase 3|460|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 23:16:49.462273|2017-10-10 23:16:49.462273
NCT02451930|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-02-01|||September 2015||2015-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|January 26, 2017|Actual|2017-01-26||Interventional|||A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC|An Open-Label, Multicenter, Phase 1b Study With an Expansion Cohort to Evaluate Safety and Efficacy of the Combination of Necitumumab With Pembrolizumab in Patients With Stage IV Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1|75|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 23:16:49.8068|2017-10-10 23:16:49.8068
NCT02451904|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-05-19|||June 2015||2015-06-01|May 2015|2015-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Severe and Cerebral Malaria Investigated Through Host Metabolomics|Microvascular and Metabolic Dysregulation in the Pathogenesis of Severe and Cerebral Malaria Investigated Through Host Metabolomics|Not yet recruiting||N/A|840|Anticipated|University of Oxford|||6||f||||f||||||Samples With DNA|"     Blood, Urine, CSF, Stool   "|||2017-10-10 23:16:50.176113|2017-10-10 23:16:50.176113
NCT02451891|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-08-22|||April 2015||2015-04-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z|A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of MVA-EBO Z Alone and a Heterologous Prime-boost Immunisation With ChAd3-EBO Z and MVA-EBO Z in Healthy UK Volunteers|Active, not recruiting||Phase 1|38|Anticipated|University of Oxford||5|||f||||||||||||||2017-10-10 23:16:50.275139|2017-10-10 23:16:50.275139
NCT02451878|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-05-05|||May 2015||2015-05-01|May 2017|2017-05-01|May 3, 2018|Anticipated|2018-05-03|May 3, 2018|Anticipated|2018-05-03||Interventional|SocWell||Improving Wellbeing and Social Anxiety Symptoms (Shyness)|Effectiveness and Cost-effectiveness of a Fully Self-guided Internet-based Intervention for Shyness and Sub-clinical Social Anxiety Symptoms in the General Population: Pragmatic Randomised Controlled Trial|Active, not recruiting||N/A|2105|Actual|University of Oxford||2|||f||||f||||||||Undecided||2017-10-10 23:16:50.373289|2017-10-10 23:16:50.373289
NCT02451865|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-07-07|||June 2016||2016-06-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer|A Phase IB Dose Escalation and Expansion Trial of MEK 162 With Docetaxel in Previously Treated Stage IV, Non-small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 1|0|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:16:50.472181|2017-10-10 23:16:50.472181
NCT02451852|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-07-13||||||July 2016|2016-07-01||||||||Expanded Access|||AZD9291 US Expanded Access Program|A Multi-center, AZD9291 Expanded Access Program for the Treatment of Patients With Advanced/Metastatic EGFR T790M Mutation-positive Non-small Cell Lung Cancer (NSCLC) Who Have Received Prior EGFR TKI Therapy|No longer available||N/A|||AstraZeneca|||||||||||||||||||2017-10-10 23:16:50.584796|2017-10-10 23:16:50.584796
NCT02451839|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2017-07-06|||July 6, 2015||2015-07-06|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|VITALITY||An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)|An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)|Active, not recruiting||N/A|190|Anticipated|AbbVie|||3||f||||f||||||||||2017-10-10 23:16:50.702451|2017-10-10 23:16:50.702451
NCT02451826|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-08-11|||May 2015||2015-05-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|November 1, 2017|Anticipated|2017-11-01||Interventional|||A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women|A Randomized Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering a Daily Dose of 2500 μg of Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel 1.5mg Oral Dose on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women|Active, not recruiting||Phase 1/Phase 2|19|Actual|Population Council||2|||f||||f||||||||||2017-10-10 23:16:50.847497|2017-10-10 23:16:50.847497
NCT02451813|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-04-13|||October 2014||2014-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Relationship Between Needle Position and Injection Pressure During Femoral Nerve Block|The Relationship Between Needle Position and Injection Pressure During Femoral Nerve Block|Completed||N/A|20|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||t||||||||||2017-10-10 23:16:50.928743|2017-10-10 23:16:50.928743
NCT02451800|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-10-12|||February 2015||2015-02-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Exercise: Improving Compliance and Long-term Weight Loss|Exercise: Improving Compliance and Long-term Weight Loss With Sanford Profile Program|Completed||N/A|162|Actual|South Dakota State University||3|||f||||f||||||||No||2017-10-10 23:16:50.997996|2017-10-10 23:16:50.997996
NCT02451787|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-07-15|||December 2015||2015-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The 'Hidden' Biological Impact of Vitamin D Deficiency: a Biomarker Study; Part 2|The 'Hidden' Biological Impact of Vitamin D Deficiency: a Biomarker Study|Completed||Phase 2|27|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||No||2017-10-10 23:16:51.075276|2017-10-10 23:16:51.075276
NCT02451761|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-03-22|||April 2015||2015-04-01|August 2016|2016-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|ANI||Apparently Balanced Chromosomal Translocation/ Next-generation Sequencing/ Intellectual Disability|Molecular Characterization of Apparently Balanced Chromosomal Rearrangements by Next-generation Sequencing in 55 Patients With Intellectual Disability and/or Multiple Congenital Anomalies|Completed||N/A|55|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 23:16:51.407228|2017-10-10 23:16:51.407228
NCT02451748|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-01-09|||August 2015||2015-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IL-7 and IL-7R Expression in Peripheral Blood Mononuclear Cells, Peripheral Blood Monocytes or Differentiated Macrophages of Rheumatoid Arthritis Patients With Active vs. Inactive Disease Treated With DMARD and/or CIMZIA|IL-7 and IL-7R Expression in Peripheral Blood Mononuclear Cells, Peripheral Blood Monocytes or Differentiated Macrophages of Rheumatoid Arthritis Patients With Active vs. Inactive Disease Treated With DMARD and/or CIMZIA|Recruiting||Phase 4|200|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-10 23:16:51.497188|2017-10-10 23:16:51.497188
NCT02451735|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-05-18|||July 27, 2012|Actual|2012-07-27|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|July 11, 2016|Actual|2016-07-11||Interventional|||Genetic Counseling for Breast Cancer Survivors (GC for BC)|Genetic Counseling for Breast Cancer Survivors (GC for BC)|Active, not recruiting||N/A|157|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f|f|f||||||||2017-10-10 23:16:51.612051|2017-10-10 23:16:51.612051
NCT02451722|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-01-26|||May 2015||2015-05-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|Kyboot||Evaluation of Pressure Distribution of Kyboot Shoes in Comparison to Other Foot Wear|Evaluation of Pressure Distribution of Kyboot Shoes in Comparison to Other Foot Wear in Diabetic Patients and in Healthy Subjects|Completed||N/A|21|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:16:51.705356|2017-10-10 23:16:51.705356
NCT02451709|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-11-20|||October 2013||2013-10-01|May 2015|2015-05-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|STAAR||STudy of Asthma Adherence Reminders|Can Electronic Adherence Monitors With Feedback and Daily Reminders Improve Adherence and Health Outcomes in Children With Asthma?|Completed||N/A|90|Actual|Sheffield Children's NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:16:51.81431|2017-10-10 23:16:51.81431
NCT02451696|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-05-04|||January 2014||2014-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD|A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD|Recruiting||Phase 2|30|Anticipated|New York University School of Medicine||2|||f||||t|t|f||||||||2017-10-10 23:16:51.961237|2017-10-10 23:16:51.961237
NCT02451683|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-12-01|||April 2015||2015-04-01|December 2016|2016-12-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Corticospinal Function After Spinal Cord Injury|Corticospinal Function After Spinal Cord Injury|Recruiting||N/A|300|Anticipated|University of Miami||3|||f||||f||||||||Undecided||2017-10-10 23:16:52.108938|2017-10-10 23:16:52.108938
NCT02451670|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-11-14|||January 2016||2016-01-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|SMIWizard||Reducing Cardiovascular Risk in Adults With Serious Mental Illness|Reducing Cardiovascular Risk in Adults With Serious Mental Illness Using an Electronic Medical Record-based Clinical Decision Support|Enrolling by invitation||Early Phase 1|2250|Anticipated|HealthPartners Institute||2|||f||||t||||||||No||2017-10-10 23:16:52.242162|2017-10-10 23:16:52.242162
NCT02451657|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-20|2016-11-01|||June 2015||2015-06-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome|A Multicenter, Longitudinal, Non-drug Study to Assess the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome|Completed||N/A|40|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:16:52.394951|2017-10-10 23:16:52.394951
NCT02451644|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2016-04-12|||June 2015||2015-06-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Association Between Physical Activity and Pregnancy Rate Following Embryo Transfer|The Association Between Physical Activity and Pregnancy Rate Following Embryo Transfer|Recruiting||N/A|200|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:16:52.483311|2017-10-10 23:16:52.483311
NCT02451631|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-21|||April 2015||2015-04-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|November 2015|Anticipated|2015-11-01||Interventional|||The Mobile Diabetes Mgmt. Study With Type 2 Diabetes|A Multi-center, Randomized, Parallel, Open Clinical Trial to Evaluate the Glycemic Control Effect of the Mobile Healthcare Service in Patients With Type 2 Diabetes Mellitus|Unknown status|Recruiting|N/A|184|Anticipated|Healthconnect||2|||f||||f||||||||||2017-10-10 23:16:52.562218|2017-10-10 23:16:52.562218
NCT02451618|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-11-08|||May 2015||2015-05-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|NERDS||Novel Epidermal Recording and Detection of Seizures|A Pilot Study of Seizure Detection in Neonates Using Multimodal Temporary Epidermal Electronics|Recruiting||N/A|60|Anticipated|Sharp HealthCare|||2||f||||f||||||||||2017-10-10 23:16:52.695724|2017-10-10 23:16:52.695724
NCT02451605|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-21|||June 2015||2015-06-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Regional Anesthesia for Knee Prothesis Surgery|Regional Blockade for Knee Prothesis Surgery: Comparison Between Femoral, Sciatic and Adductor Canal Block|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Hospital of Liege||3|||f||||f||||||||||2017-10-10 23:16:52.796873|2017-10-10 23:16:52.796873
NCT02451592|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-10-19|||January 2011||2011-01-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Fungemia in Hematologic Malignancies|SEIFEM 2015: Fungemia in Hematologic Malignancies|Completed||N/A|300|Actual|Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne|||1||f||||f||||||||||2017-10-10 23:16:52.8967|2017-10-10 23:16:52.8967
NCT02451579|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-02-27|||February 2015||2015-02-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy|A Randomized, Double-blind, Placebo-controlled, Prospective Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy|Completed||N/A|20|Anticipated|Goldman, Butterwick, Fitzpatrick and Groff||2|||f||||f||||||||||2017-10-10 23:16:52.975086|2017-10-10 23:16:52.975086
NCT02451566|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-11-24|||November 2015||2015-11-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01|1 Month|Observational [Patient Registry]|||TriVascular Canadian LIFE Study: Least Invasive Fast-Track EVAR (Endovascular Aneurysm Repair)|TriVascular Canadian LIFE Study: Least Invasive Fast-Track EVAR With the Ovation Prime™ Abdominal Stent Graft System|Recruiting||N/A|20|Anticipated|TriVascular, Inc.|||3||f||||f||||||||||2017-10-10 23:16:53.05749|2017-10-10 23:16:53.05749
NCT02451553|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-08-04|||November 5, 2015|Actual|2015-11-05|August 2017|2017-08-01||||November 30, 2018|Anticipated|2018-11-30||Interventional|||Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer|Phase I/IB Multi-center Study of Irreversible EGFR/HER2 Tyrosine Kinase Inhibitor Afatinib (BIBW 2992) in Combination With Capecitabine for Advanced Solid Tumors and Pancretico-Biliary Cancers|Recruiting||Phase 1|48|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-10 23:16:53.158133|2017-10-10 23:16:53.158133
NCT02451540|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-10-02|||September 2015||2015-09-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging|Placebo Controlled Study to Assess the Effect of Roflumilast in Hyperinflated COPD Patients in Addition to LABA/LAMA Therapy Using Functional Respiratory Imaging.|Recruiting||Phase 2|40|Anticipated|FLUIDDA nv||2|||f||||f||||||||||2017-10-10 23:16:53.263447|2017-10-10 23:16:53.263447
NCT02451527|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-11-28|||May 2015||2015-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Interventional|||The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects|An Open-label，Single-arm，Sequential，Single-center Clinical Trial of the Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection (PEX168) in Healthy Adult Subjects|Completed||Phase 1|16|Actual|First Affiliated Hospital Xi'an Jiaotong University||1|||f||||t||||||||||2017-10-10 23:16:53.36003|2017-10-10 23:16:53.36003
NCT02451501|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-04-19|||July 2015||2015-07-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|NebuPostu||Influence of Body Posture on Pulmonary Aerosol Deposition||Completed||N/A|6|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 23:16:53.558064|2017-10-10 23:16:53.558064
NCT02451488|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-10-05|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma|Neoadjuvant GM-CSF Treatment and Modulation of Immune Cell Profile of the SLN in Melanoma|Recruiting||Phase 4|20|Anticipated|Mayo Clinic||2|||f||||t||||||||No|data will not be shared|2017-10-10 23:16:53.754536|2017-10-10 23:16:53.754536
NCT02451475|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-16|2015-05-21|||February 2013||2013-02-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Newer Antidepressants in Combination With Pregabalin for Fibromyalgia Syndrome|Comparative Effectiveness of Newer Antidepressants in Combination With Pregabalin for Fibromyalgia Syndrome: A Controlled Randomized Study|Completed||Phase 1/Phase 2|75|Actual|Mansoura University||3|||f||||t||||||||||2017-10-10 23:16:53.850939|2017-10-10 23:16:53.850939
NCT02451462|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients|Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients|Withdrawn||N/A|0|Actual|Stanford University||2||Logistics|f||||f||||||||||2017-10-10 23:16:53.954304|2017-10-10 23:16:53.954304
NCT02451449|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-09-09|||January 2015||2015-01-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Observational|CØF2015||Celiac Disease and Infertility Among Men and Women in Denmark|Celiac Disease and Infertility Among Men and Women in Denmark: Prevalence of Celiac Disease Among Men and Women Treated in Danish Public Fertility Clinics|Active, not recruiting||N/A|900|Actual|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Whole blood Biopsy of small-bowel   "|No||2017-10-10 23:16:54.037391|2017-10-10 23:16:54.037391
NCT02451436|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-01-03|||March 2015||2015-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Sleep and Media Use Intervention to Improve Adolescents' Weight and Risk of Type 2 Diabetes|Pilot Study of a Sleep and Media Intervention to Improve Adolescents' Metabolic Health and Weight Status|Recruiting||N/A|50|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:16:54.113009|2017-10-10 23:16:54.113009
NCT02451423|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-06-06|||April 2016||2016-04-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of MPDL3280A in Bladder Cancer|A Phase II Study of the Anti-PD-L1 Antibody MPDL3280A in Subjects With Non-metastatic Transitional Cell Carcinoma of the Bladder|Recruiting||Phase 2|42|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:16:54.219521|2017-10-10 23:16:54.219521
NCT02451410|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-09-18|||September 2015||2015-09-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||An Intervention to Improve Nutrition and Physical Activity in Preschoolers in Cuenca, Ecuador|Impact of an Intervention to Improve Nutrition and Physical Activity in Preschoolers in Cuenca, Ecuador|Unknown status|Recruiting|N/A|200|Anticipated|Universidad de Cuenca||1|||f||||f||||||||||2017-10-10 23:16:54.337033|2017-10-10 23:16:54.337033
NCT02451397|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-09-20|||January 2012||2012-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Associations Analysis Between Lifestyle and Osteoporosis|The Associations Analysis Between Lifestyle and Osteoporosis Among Chinese Population|Active, not recruiting||N/A|3100|Actual|Shanghai Tongji Hospital, Tongji University School of Medicine|||1||f||||t||||||||||2017-10-10 23:16:54.476987|2017-10-10 23:16:54.476987
NCT02451384|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-06-28|||June 2015||2015-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||According CTC to Compare the Influences of Different Methods to Remove the PDAC|To Compare the Influences of Different Methods to Remove the Pancreatic Ductal Adenocarcinoma With the Detection of Circulating Tumor Cells|Unknown status|Recruiting|N/A|45|Anticipated|Shanghai Zhongshan Hospital||3|||f||||t||||||||||2017-10-10 23:16:54.555858|2017-10-10 23:16:54.555858
NCT02451371|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-12-28|||August 2016||2016-08-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia|A Pilot Study for the Treatment of Refractory Auditory Verbal Hallucinations With Transcranial Direct Current Stimulation(tDCS) in Patients With Schizophrenia|Completed||Phase 1/Phase 2|10|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:16:54.648677|2017-10-10 23:16:54.648677
NCT02451358|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-06-22|||July 28, 2015|Actual|2015-07-28|June 2017|2017-06-01|January 28, 2017|Actual|2017-01-28|January 28, 2017|Actual|2017-01-28||Interventional|||Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India|Immunogenicity and Safety of a Single Dose or Two Doses Given 28 Days Apart of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Subjects Aged 6 Months or Older in India|Completed||Phase 3|400|Actual|Sanofi||4|||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-10 23:16:54.749165|2017-10-10 23:16:54.749165
NCT02450968|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-05-16|||May 2015||2015-05-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Altitude Related Illness In Patients With Respiratory Disease|Dexamethasone for Prophylaxis of Acute Mountain Sickness in Patients With Chronic Obstructive Pulmonary Disease Travelling to Altitude|Completed||Phase 4|124|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 23:17:00.182976|2017-10-10 23:17:00.182976
NCT02451345|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-12-03|||March 2015||2015-03-01|December 2015|2015-12-01|April 2025|Anticipated|2025-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model|Development, Validation, and Dissemination of an Integrated Risk Prediction Model and Decision Aid to Discern Aggressive vs Indolent Prostate Cancer (Aim 2A)|Recruiting||N/A|120|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:16:54.873882|2017-10-10 23:16:54.873882
NCT02451332|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-09-24|||October 2015||2015-10-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Prenatal Inflammation and Perinatal Outcomes|Prenatal Inflammation and Perinatal Outcomes|Recruiting||N/A|100|Anticipated|University of Calgary||1|||f||||||||||||||2017-10-10 23:16:54.974638|2017-10-10 23:16:54.974638
NCT02451319|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-20|||January 2015||2015-01-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Safety and Efficiency of 20w 30w Holmium Laser Device in Treatment of 1-2 cm Diameter Kidney Stones With RIRS|Comparison of Safety and Efficiency of 20w 30w Holmium Laser Device in Treatment of 1-2 cm Diameter Kidney Stones With RIRS|Unknown status|Recruiting|Phase 4|90|Anticipated|Diskapi Teaching and Research Hospital||3|||f||||f||||||||||2017-10-10 23:16:55.112963|2017-10-10 23:16:55.112963
NCT02451306|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-05-18|||June 2015||2015-06-01|May 2015|2015-05-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Quetiapine on Brain Activity Patterns in Patients With Heightened Risk of Bipolar Disorder|Cognitive Control and Functional Connectivity During Resting State in Patients With Heightened Risk of Bipolar Disorder - a Quetiapine Challenge|Not yet recruiting||N/A|54|Anticipated|RWTH Aachen University||3|||f||||f||||||||||2017-10-10 23:16:55.215867|2017-10-10 23:16:55.215867
NCT02451293|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-08-21|||January 18, 2016||2016-01-18|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|August 23, 2017|Anticipated|2017-08-23||Interventional|MEDACIS||The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome|The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome|Active, not recruiting||Phase 2/Phase 3|240|Anticipated|Zealand University Hospital||2|||f||||t||||||||||2017-10-10 23:16:55.319054|2017-10-10 23:16:55.319054
NCT02451280|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-07-06|||June 2015||2015-06-01|June 2016|2016-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Unilateral vs. Bilateral Approaches to Hybrid Stroke Rehabilitation|Unilateral vs. Bilateral Approaches to Hybrid Stroke Rehabilitation|Recruiting||N/A|72|Anticipated|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-10 23:16:55.467469|2017-10-10 23:16:55.467469
NCT02451267|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2017-06-27|||October 2015||2015-10-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Clinical Prediction Rules for Identifying Patients With Chronic Neck Pain Who Will Benefit From General Aerobic Exercise|Clinical Prediction Rule for Identifying Patients With Chronic Neck Pain Who Will Benefit From General Aerobic Exercise|Completed||N/A|122|Actual|Clalit Health Services||4|||f||||f||||||||||2017-10-10 23:16:55.604642|2017-10-10 23:16:55.604642
NCT02451254|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-07-06|||December 2015||2015-12-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Coagulation Activity and Thrombogenesis in Patients With Atrial Fibrillation|Coagulation Activity and Thrombogenesis in Patients With Atrial Fibrillation|Recruiting||N/A|120|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-10 23:16:55.714899|2017-10-10 23:16:55.714899
NCT02451241|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-05-01|||February 2015||2015-02-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|May 2015|Actual|2015-05-01||Interventional|||The Role of Acupuncture for the Treatment of Obstructive Sleep Apnea in Patients With Hypertension|The Role of Acupuncture for the Treatment of Obstructive Sleep Apnea in Patients With Hypertension|Completed||N/A|44|Actual|University of Pernambuco||2|||f||||||||||||||2017-10-10 23:16:55.823518|2017-10-10 23:16:55.823518
NCT02451228|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-07-07|||May 2015||2015-05-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Indomethacin PK and PD Therapy in Pregnancy|Pharmacokinetic and Pharmacogenomic Approach to Indomethacin Therapy in Pregnancy|Recruiting||N/A|300|Anticipated|The University of Texas Medical Branch, Galveston|||1||f||||t||||||Samples With DNA|"     Maternal Venous Blood for serum Maternal Blood for DNA (for CYP2C9) Maternal Urine Cord Blood     (Umbilical Vein and Artery) for serum   "|||2017-10-10 23:16:55.911659|2017-10-10 23:16:55.911659
NCT02451215|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-19|||April 2015||2015-04-01|May 2015|2015-05-01||||April 2025|Anticipated|2025-04-01||Interventional|||Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors|LITT for the Treatment of Newly Diagnosed Central Nervous System Tumors Located in Difficult to Surgically Access Regions of the Brain and Recurrent/Resistant Pediatric Central Nervous System Tumors Located Anywhere Within the Brain|Recruiting||N/A|18|Anticipated|Children's Hospitals and Clinics of Minnesota||1|||f||||t||||||||||2017-10-10 23:16:56.025077|2017-10-10 23:16:56.025077
NCT02451202|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-20|||July 2015||2015-07-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Deep vs Moderate Neuromuscular Blockade With Rocuronium in Patients Undergoing Endolaryngeal Procedures|A Comparison of Surgical Conditions Between Deep vs Moderate Neuromuscular Blockade With Rocuronium in Patients Undergoing Endolaryngeal Procedures.|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Chulalongkorn University||2|||f||||f||||||||||2017-10-10 23:16:56.106752|2017-10-10 23:16:56.106752
NCT02451189|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-04-27|||January 2015||2015-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PRO-ESTER||RCT to Describe the Effects of Colon Delivered Acetate, Propionate and Butyrate on Satiety and Glucose Homeostasis||Completed||N/A|23|Actual|Scottish Universities Environmental Research Centre||3|||f||||f||||||||||2017-10-10 23:16:56.19122|2017-10-10 23:16:56.19122
NCT02451176|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-03-13|||April 2015||2015-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|ventral hernia||Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias|A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias|Enrolling by invitation||N/A|250|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-10 23:16:56.311025|2017-10-10 23:16:56.311025
NCT02451163|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-04-11|||September 2014||2014-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|Fib-CC-2014||DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly|A Randomized, Controlled Clinical Study on the Effect of Polysaccharides From Wheat on Common Cold Infections in Elderly|Completed||Phase 2|247|Actual|Clinical Research Center Kiel GmbH||2|||f||||f||||||||||2017-10-10 23:16:56.410509|2017-10-10 23:16:56.410509
NCT02451150|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-03-08|2016-03-08||August 2015||2015-08-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension|An Open-label, Phase 3, Multicenter Study to Evaluate the Pharmacokinetics Following a Single Oral Dose of TAK-536 in Pediatric Patients 6 to Less Than 16 Years of Age With Hypertension|Completed||Phase 3|6|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:16:56.494554|2017-10-10 23:16:56.494554
NCT02451124|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-02-16|||July 2015||2015-07-01|February 2017|2017-02-01|January 29, 2017|Actual|2017-01-29|August 11, 2016|Actual|2016-08-11||Interventional|||Non-endoscopic Brushing of the Esophagus Using a Non-endoscopic Inflatable Balloon of the Esophagus in Screening for Barrett Esophagus|Office Based Screening Test for Barrett's Esophagus|Completed||N/A|150|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:16:58.800011|2017-10-10 23:16:58.800011
NCT02451111|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-08-21|||October 2015||2015-10-01|August 2017|2017-08-01|December 2029|Anticipated|2029-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma|Rituximab With or Without Ibrutinib for Untreated Patients With Advanced Follicular Lymphoma in Need of Therapy. A Randomized, Double-blinded, SAKK and NLG Collaborative Phase II Trial.|Recruiting||Phase 2|190|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-10 23:16:58.952457|2017-10-10 23:16:58.952457
NCT02451098|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-01-26|||March 2015||2015-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of CKD-391|A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group, Factorial Design, Phase III Clinical Trial To Evaluate the Efficacy and Safety of Atorvastatin+Ezetimibe Combination Therapy and Atorvastatin Monotherapy in Patients With Primary Hypercholesterolemia|Completed||Phase 3|385|Actual|Chong Kun Dang Pharmaceutical||6|||f||||f||||||||||2017-10-10 23:16:59.233166|2017-10-10 23:16:59.233166
NCT02451085|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-10-26|||July 2015||2015-07-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|May 2016|Anticipated|2016-05-01||Interventional|||The Effect of a Telerehabilitaion Program on Gait and Balance in Patients After Hip Surgery|The Effect of a Telerehabilitaion Program on Gait and Balance in Patients After Hip Surgery.|Unknown status|Recruiting|N/A|40|Anticipated|Reuth Medical Center||2|||f||||f||||||||||2017-10-10 23:16:59.366057|2017-10-10 23:16:59.366057
NCT02451072|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-01-29|||March 2015||2015-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers|The Role of 5-HT2A Receptor on Perception of the Self and Perception of Meaning in Healthy Volunteers|Completed||N/A|25|Actual|Psychiatric University Hospital, Zurich||1|||f||||t||||||||||2017-10-10 23:16:59.467893|2017-10-10 23:16:59.467893
NCT02451059|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-07-21|||September 2015||2015-09-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|WECARE01||Reducing Socioeconomic Disparities in Health at Pediatric Visits|Reducing Socioeconomic Disparities in Health at Pediatric Visits|Active, not recruiting||N/A|2050|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 23:16:59.559023|2017-10-10 23:16:59.559023
NCT02451046|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-20|||March 2014||2014-03-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01|7 Days|Observational [Patient Registry]|GST-LT||Usefulness of Alpha-GST in Liver Transplantation|Predictive Ability of Alpha-GST to Detect Graft Primary Dysfunction After Liver Transplantation|Unknown status|Recruiting|N/A|100|Anticipated|Beaujon Hospital|||1||f||||f||||||||||2017-10-10 23:16:59.652873|2017-10-10 23:16:59.652873
NCT02451033|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-08-26|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study|Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study|Completed||Phase 2/Phase 3|65|Actual|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||||2017-10-10 23:16:59.724457|2017-10-10 23:16:59.724457
NCT02451020|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-05-23|||May 2015||2015-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Acclimatization of Healthy Subjects During a Stay at 3200 m|Acclimatization of Healthy Subjects During a Stay at 3200 m|Active, not recruiting||N/A|10|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:16:59.802169|2017-10-10 23:16:59.802169
NCT02451007|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-09-21|||August 2015||2015-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors|Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization (QTc Duration) in Patients With Selected Solid Tumors|Completed||Phase 1|39|Actual|PharmaMar||1|||f||||||||||||||2017-10-10 23:16:59.877776|2017-10-10 23:16:59.877776
NCT02450994|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-12-18|||May 2015||2015-05-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Dexamethasone on Sleep Related Breathing Disturbances in Patients With COPD at Altitude|Dexamethasone for Prophylaxis of Sleep Related Breathing Disturbances in Patients With Chronic Obstructive Pulmonary Disease (COPD) Travelling to Altitude|Completed||Phase 4|124|Actual|University of Zurich||2|||f||||f||||||||||2017-10-10 23:16:59.948773|2017-10-10 23:16:59.948773
NCT02450981|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-03-30||||||March 2016|2016-03-01||||March 2016|Anticipated|2016-03-01||Interventional|||Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration|Multicentre Open Label Non-randomized Clinical Study Evaluating Pharmacokinetics, Safety, Tolerability of Multiple Intravitreal Injections of BCD-021 (CJSC BIOCAD, Russia) in Patients With Neovascular Wet Age-related Macular Degeneration|Withdrawn||Phase 1|0|Actual|Biocad||1|||f||||f||||||||||2017-10-10 23:17:00.106648|2017-10-10 23:17:00.106648
NCT02450786|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-03-11|||June 2015||2015-06-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Donepezil on Cognition in Parkinson's Disease With Mild Cognitive Impairment (PD-MCI)||Recruiting||Phase 2|80|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:17:01.928587|2017-10-10 23:17:01.928587
NCT02450955|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2015-05-20|||February 2014||2014-02-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|MANIHDI-II||Does the Addition of Manipulation Provide Added Benefit to Massage Therapy for Tension-type Headache Patients?|Does the Addition of Manipulation Provide Added Benefit to Massage Therapy for Tension-type Headache Patients? A Randomized Controlled Clinical Trial|Completed||N/A|105|Actual|University of Valencia||2|||f||||f||||||||||2017-10-10 23:17:00.386542|2017-10-10 23:17:00.386542
NCT02450942|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-04-05|||January 2015||2015-01-01|May 2015|2015-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection|Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Diagnostic Performance of 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection|Recruiting||Early Phase 1|30|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-10 23:17:00.471533|2017-10-10 23:17:00.471533
NCT02450929|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-08-06|||June 2011||2011-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Prospective Clinical Evaluation of the Taperguard Endotracheal Tube|Prospective Clinical Evaluation of the Taperguard Endotracheal Tube|Active, not recruiting||N/A|40000|Anticipated|Oregon Health and Science University|||2||f||||f||||||||||2017-10-10 23:17:00.559932|2017-10-10 23:17:00.559932
NCT02450916|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-18|||July 2014||2014-07-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||An Interview Study With Injured Workers Concerning Their Experiences With the Social Systems and Psychosocial Health Consequences|An Interview Study With Injured Workers Concerning Their Experiences With the Social|Completed||N/A|51|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:17:00.618943|2017-10-10 23:17:00.618943
NCT02450890|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-12-12|||June 2015||2015-06-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD|A Phase III, Multi-Center, Randomized, Double-blind, Placebo Controlled, Two-way Cross-over Clinical Study to Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD|Active, not recruiting||Phase 3|114|Actual|Orient Pharma Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:17:00.819941|2017-10-10 23:17:00.819941
NCT02450877|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-02-27|||August 12, 2015|Actual|2015-08-12|February 2017|2017-02-01|March 12, 2020|Anticipated|2020-03-12|July 13, 2018|Anticipated|2018-07-13||Interventional|||A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia.|A Randomized, Multicenter, Open-label, Phase 2 Study, With a Safety Run-in Part to Evaluate Safety, Pharmacodynamics and Efficacy of Azacitidine Compared to No Anticancer Treatment in Children and Young Adults With Acute Myeloid Leukemia in Molecular Relapse After First Complete Remission|Recruiting||Phase 2|80|Anticipated|Celgene||2|||f||||t||||||||||2017-10-10 23:17:00.913978|2017-10-10 23:17:00.913978
NCT02450864|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-02-05|||January 1, 2013||2013-01-01|February 2017|2017-02-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||The Biological Effect of ESWT and the Role of Proinflammatory Cytokines and Cannabinoid Receptor in Shoulder Stiffness|The Biological Effect of Extracorporeal Shockwave Technology (ESWT) and the Role of Proinflammatory Cytokines and Cannabinoid Receptor in Shoulder Stiffness|Recruiting||N/A|100|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:17:01.017076|2017-10-10 23:17:01.017076
NCT02450838|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-03-31|||April 2015||2015-04-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)|A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Tetravalent Recombinant Subunit Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-10 23:17:01.284258|2017-10-10 23:17:01.284258
NCT02450825|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-02-28|||July 2015|Actual|2015-07-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Comparison of Three Scores for Ultrasound Assessment and Monitoring of Pulmonary Aeration|Comparison of Three Scores for Ultrasound Assessment and Monitoring of Pulmonary Aeration|Completed||N/A|77|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||No||2017-10-10 23:17:01.380404|2017-10-10 23:17:01.380404
NCT02450799|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-10-17|2016-10-17||June 2015||2015-06-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional||This analysis population includes all subjects who used the study devices and underwent the long-term post-implantation visit examination (Safety Set).|Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation|Corrected VA With Long-Term Follow-Up After AcrySof® IOL Implantation|Completed||N/A|104|Actual|Alcon Research||3|||f||||f||||||||||2017-10-10 23:17:01.579427|2017-10-10 23:17:01.579427
NCT02450708|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-08-23|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes|Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes|Recruiting||N/A|300|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"     Blood   "|||2017-10-10 23:17:02.744922|2017-10-10 23:17:02.744922
NCT02450695|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-12-12|||July 2016||2016-07-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||rTMS in Treatment Refractory Obsessive-Compulsive Disorder|A Randomized Crossed-over Trial Examining Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment Refractory Obsessive-Compulsive Disorder.|Recruiting||N/A|25|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 23:17:02.878211|2017-10-10 23:17:02.878211
NCT02450682|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-01-14|||February 2016||2016-02-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|Apixaban||Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study|Evaluate the Safety of Apixaban in Patients Who Undergo Cardiovascular Implantable Electronic Device (CIED) Procedure: A Randomized Pilot Study|Withdrawn||Phase 2|0|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:17:02.97952|2017-10-10 23:17:02.97952
NCT02450669|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-04-20|||December 19, 2013|Actual|2013-12-19|March 2017|2017-03-01|July 30, 2015|Actual|2015-07-30|July 4, 2015|Actual|2015-07-04||Observational|Free-Rea||Predictors of Airway Extubation/Weaning Failure|Practices and Risk Factors for Weaning and Extubation Airway Failure in Adult Intensive Care Unit: a Multicenter Trial|Completed||N/A|417|Actual|University Hospital, Montpellier|||1||f||||f||||||||||2017-10-10 23:17:03.076879|2017-10-10 23:17:03.076879
NCT02450656|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-07-14|||June 2015||2015-06-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|M14AFS||Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer|Phase I/II Study With the Combination of Afatinib and Selumetinib in Advanced KRAS Mutant Positive and PIK3CA Wildtype Non-small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|320|Anticipated|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-10 23:17:03.166738|2017-10-10 23:17:03.166738
NCT02450643|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-07-31|||April 2015||2015-04-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula|Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula|Completed||N/A|83|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-10 23:17:03.286587|2017-10-10 23:17:03.286587
NCT02450630|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2015-05-18|||May 2015||2015-05-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Assessing the Effect of Strengthening Referral of Sick Children From the Private Health Sector and Its Impact on Referral Uptake in Uganda.|Strengthening Referral of Sick Children Form the Private Health Sector|Unknown status|Not yet recruiting|N/A|8910|Anticipated|Ministry of Health, Uganda||2|||f||||t||||||||||2017-10-10 23:17:03.376761|2017-10-10 23:17:03.376761
NCT02450617|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-05-03|||June 2014||2014-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|STAB||Stabilizing Group Treatment of Complex Trauma: A Randomized Controlled Trial|Stabilizing Group Treatment of Complex Trauma: A Randomized Controlled Trial|Enrolling by invitation||N/A|144|Anticipated|Modum Bad||4|||f||||f||||||||||2017-10-10 23:17:03.463187|2017-10-10 23:17:03.463187
NCT02450604|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-08-19|||March 2015||2015-03-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|DOUFABIS||Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain|Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain|Recruiting||N/A|1000|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||No||2017-10-10 23:17:03.557191|2017-10-10 23:17:03.557191
NCT02450591|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-06-13|||May 14, 2015|Actual|2015-05-14|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations|Pilot Study of Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations|Recruiting||N/A|5|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:17:03.694818|2017-10-10 23:17:03.694818
NCT02450578|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-07-10|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria|Evaluation of the Prophylactic Antimalarial Activity of a Single Dose of DSM265 in Non-immune Healthy Adult Volunteers by Controlled Human Malaria Infection With PfSPZ Challenge|Completed||Phase 1|22|Actual|Medicines for Malaria Venture||4|||f||||t||||||||||2017-10-10 23:17:03.802292|2017-10-10 23:17:03.802292
NCT02450565|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-20|||July 2015||2015-07-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Translation of the Self Completed-Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale|Translation and Validation of the Traditional Chinese-Cantonese Version of the Self Completed-Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale|Unknown status|Not yet recruiting|N/A|200|Anticipated|The University of Hong Kong|||2||f||||t||||||||||2017-10-10 23:17:03.897873|2017-10-10 23:17:03.897873
NCT02450552|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-06-20|||June 2015||2015-06-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Clinical Trial of Ezogabine (Retigabine) in ALS Subjects|A Phase 2 Pharmacodynamic Trial of Ezogabine (Retigabine) on Neuronal Excitability in Amyotrophic Lateral Sclerosis|Recruiting||Phase 2|192|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-10 23:17:04.128286|2017-10-10 23:17:04.128286
NCT02450539|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-05-18|||August 2015||2015-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer|A Randomized Phase 2 Study of Abemaciclib (LY2835219) Versus Docetaxel in Patients With Stage IV Squamous Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy|Active, not recruiting||Phase 2|150|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:17:04.312861|2017-10-10 23:17:04.312861
NCT02450526|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-05-29|||April 2015||2015-04-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|July 2016|Actual|2016-07-01||Interventional|||Dysport in the Treatment of Glabellar Lines in Chinese Subjects|A Phase III, Randomised, Double Blind and Open Label Phase, Multicentre, Active and Placebo Controlled Study to Investigate the Efficacy and Safety of Dysport Including a Comparison to Botox in the Treatment of Moderate to Severe Glabellar Lines, and to Assess the Long Term Efficacy and Safety of Dysport Following Repeated Treatments in This Indication|Active, not recruiting||Phase 3|520|Actual|Ipsen||4|||f||||f||||||||||2017-10-10 23:17:04.496916|2017-10-10 23:17:04.496916
NCT02450513|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-05-23|||March 2012||2012-03-01|May 2016|2016-05-01||||July 2016|Anticipated|2016-07-01||Observational|||Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study|Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study|Recruiting||N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:17:04.59209|2017-10-10 23:17:04.59209
NCT02450500|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-04-22|||March 2015||2015-03-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Prohealth@Home: A Feasibility Study Investigating the Use of a Lifestyle App in People at Risk of Type 2 Diabetes|Prohealth@Home: A Feasibility Study Investigating the Application of a Web Based Lifestyle App to Improve Glycaemic Control by Changing Dietary and Activity Behaviours in Individuals at High Risk of Type 2 Diabetes|Completed||N/A|10|Actual|University of Plymouth||1|||f||||f||||||||Yes|Participants will be provided with their biochemical results from their GPs and have access to dietary, weight and activity data through the lifestyle app.|2017-10-10 23:17:04.671251|2017-10-10 23:17:04.671251
NCT02450487|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-12-01|||October 2012||2012-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery|Influence of Genotype of Cytochrome P450 (CYP2C9) on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery|Completed||Phase 4|102|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-10 23:17:04.852881|2017-10-10 23:17:04.852881
NCT02450474|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-05-18|||February 2014||2014-02-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Mobilising Lower Limb Fluid for Hemodynamic Stability in Haemodialysis|Pilot Evaluation of Intermittent Pneumatic Compression and Neuromuscular Electrical Stimulation for Enhancing Vascular Refilling in Haemodialysis|Unknown status|Recruiting|N/A|12|Anticipated|The Leeds Teaching Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 23:17:04.949289|2017-10-10 23:17:04.949289
NCT02450461|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-08-09|||April 2015||2015-04-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2016|Actual|2016-06-01||Observational|||Breath Analysis in Asthma|Exhaled Breath Analysis by Secondary Electrospray Ionization (SESI-MS) in Patients With Asthma|Completed||N/A|60|Actual|University of Zurich|||2||f||||f||||||||||2017-10-10 23:17:05.053005|2017-10-10 23:17:05.053005
NCT02450448|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-12-28|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|Completed||N/A|60|Actual|Fuda Cancer Hospital, Guangzhou|||4||f||||t||||||||||2017-10-10 23:17:05.165857|2017-10-10 23:17:05.165857
NCT02450435|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-12-28|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|Completed||N/A|60|Actual|Fuda Cancer Hospital, Guangzhou|||4||f||||f||||||||||2017-10-10 23:17:05.275028|2017-10-10 23:17:05.275028
NCT02450422|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-12-28|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|Completed||N/A|60|Actual|Fuda Cancer Hospital, Guangzhou|||4||f||||t||||||||||2017-10-10 23:17:05.379434|2017-10-10 23:17:05.379434
NCT02450409|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-20|||January 2014||2014-01-01|May 2015|2015-05-01||||May 2015|Anticipated|2015-05-01||Interventional|||A New Technique to Produce Anatomical Alignment Results With Less Midflexion Instability in Total Knee Arthroplasty||Unknown status|Recruiting|N/A|56|Anticipated|University of Jena||2|||f||||||||||||||2017-10-10 23:17:05.473388|2017-10-10 23:17:05.473388
NCT02450396|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2016-06-23|||June 2014||2014-06-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|EGR2||Pregnancy and Medically Assisted Conception in Rare Diseases|Prospective Observational Study About Pregnancy and Medically Assisted Conception in Rare Diseases|Recruiting||N/A|1000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     serum, cord blood   "|||2017-10-10 23:17:05.565039|2017-10-10 23:17:05.565039
NCT02450383|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-08-19|2017-05-31||January 2015|Actual|2015-01-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Comparison of Two Different Surgical Approaches To Increase Peri-Implant Mucosa Thickness|Comparison of Two Different Surgical Approaches to Increase Peri-Implant Mucosa Thickness: A Randomized Controlled Clinical Trial|Completed||Phase 4|20|Actual|University of Iowa||2|||f||||f|t|f|||t|||||2017-10-10 23:17:05.672927|2017-10-10 23:17:05.672927
NCT02450370|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-06-13|||May 2015||2015-05-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Diets in Symptom Relief and the Influence of Quality of Life in People With Irritable Bowel Syndrome|Comparison of Symptom Response Following a Conventional Irritable Bowel Syndrome Dietary Advice Versus Low FODMAP Diet in Hong Kong Chinese Irritable Bowel Syndrome Patients|Recruiting||N/A|100|Anticipated|Hong Kong Sanatorium & Hospital||2|||f||||t||||||||||2017-10-10 23:17:06.024835|2017-10-10 23:17:06.024835
NCT02450357|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-12-28|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|Completed||N/A|60|Actual|Fuda Cancer Hospital, Guangzhou|||4||f||||t||||||||||2017-10-10 23:17:06.107766|2017-10-10 23:17:06.107766
NCT02450344|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-05-02|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Promoting Alcohol-related Attitudinal and Behavioural Change Amongst Adolescents Through Internet Intervention|Promoting Alcohol-related Attitudinal and Behavioural Change Amongst Adolescents Through Internet Intervention: A Cluster Randomised Controlled Trial|Completed||N/A|7933|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:17:06.19323|2017-10-10 23:17:06.19323
NCT02450331|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2017-08-01|||October 5, 2015|Actual|2015-10-05|August 2017|2017-08-01|April 30, 2022|Anticipated|2022-04-30|October 4, 2019|Anticipated|2019-10-04||Interventional|||A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma After Surgical Resection [IMvigor010]|A Phase III, Open-Label, Multicenter, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Versus Observation as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Urothelial Carcinoma After Surgical Resection|Recruiting||Phase 3|700|Anticipated|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 23:17:06.325198|2017-10-10 23:17:06.325198
NCT02450318|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-06-19|||June 2015||2015-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Acute Vascular Response to Exercise in Women With Nonobstructive Coronary Artery Disease|Acute Vascular Response to Exercise in Women With Nonobstructive Coronary Artery Disease|Recruiting||N/A|150|Anticipated|University of Florida||1|||f||||f|f|f||||||No||2017-10-10 23:17:06.947125|2017-10-10 23:17:06.947125
NCT02450305|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-11-07|||August 2013||2013-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects|Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects|Enrolling by invitation||N/A|40|Anticipated|State University of New York - Upstate Medical University|||2||f||||f||||||||||2017-10-10 23:17:07.020117|2017-10-10 23:17:07.020117
NCT02450292|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-18|||September 2015||2015-09-01|May 2015|2015-05-01||||March 2016|Anticipated|2016-03-01||Observational|||Retrospective CT Imaging of BioComposite Interference Screw With BTB|Retrospective CT Imaging of BioComposite Interference Screw in Patients Undergoing Anterior Cruciate Ligament Reconstruction With Bone-Patellar Tendon-Bone Graft|Unknown status|Not yet recruiting|N/A|5|Anticipated|State University of New York at Buffalo|||1||f||||f||||||||||2017-10-10 23:17:07.079364|2017-10-10 23:17:07.079364
NCT02450279|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-12-02|||March 2016||2016-03-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Scintigraphic Comparison of Lung Deposition With Two Nebulizers During Invasive Mechanical Ventilation||Recruiting||N/A|20|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 23:17:07.12929|2017-10-10 23:17:07.12929
NCT02450266|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-19|2015-05-20|||February 2015||2015-02-01|May 2015|2015-05-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|PROFUSE||Study Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided Biopsy|Prospective Multicenter, Randomized Study Comparing the Diagnostic Efficacy of a Targeted MRI/Ultrasound Fusion-guided Prostate Biopsy Versus a Systematic Transrectal Ultrasound-guided Biopsy in Men With at Least on Negative Prostate Biopsy|Recruiting||N/A|586|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-10-10 23:17:07.219948|2017-10-10 23:17:07.219948
NCT02450253|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-09-08|||September 2015||2015-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|PASTIS||Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial|Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial|Recruiting||Phase 2|54|Anticipated|St George's, University of London||2|||f||||f||||||||||2017-10-10 23:17:07.299895|2017-10-10 23:17:07.299895
NCT02450240|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-03-06|||January 2015||2015-01-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|||Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders|T-1000: Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders|Recruiting||N/A|1200|Anticipated|Laureate Institute for Brain Research, Inc.|||4||f||||f||||||Samples With DNA|"     Whole Blood, Serum, Plasma, Microbiome   "|||2017-10-10 23:17:07.395211|2017-10-10 23:17:07.395211
NCT02450227|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2016-03-21|||January 2015||2015-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Popeye||Carotenoid Absorption and Metabolism From Green-leafy Vegetable Matrices|"Carotenoid Absorption and Metabolism From Green-leafy Vegetable Matrices - a Explorative Study in Short-bowel Patients and Healthy Controls - The Popeye-study"|Terminated||N/A|22|Actual|University of Copenhagen||2||"It is considered non-achievable to recruit the target number of subjects in the short bowel   group (n = 12). 10 participants were recruited."|f||||f||||||||||2017-10-10 23:17:07.512194|2017-10-10 23:17:07.512194
NCT02450214|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-12-19|||June 2015||2015-06-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|KEMPLA||Intraoperative Ketamine and Magnesium Therapy for Control of Postoperative Pain After a Liposuction and Lipoabdominoplasty|Efficacy of Ketamine and Magnesium Association in the Postoperative Pain After Liposuction and Lipoabdominoplasty: Prospective, Randomized and Blinded Study|Unknown status|Enrolling by invitation|N/A|60|Anticipated|University of Chile||3|||f||||||||||||||2017-10-10 23:17:07.594927|2017-10-10 23:17:07.594927
NCT02450201|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-06-06|||June 2015||2015-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||MRI With C13 Pilot Study Prostate Cancer|A Pilot Study to Evaluate the Reproducibility of Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (13C) and Its Ability to Reflect Treatment Effects in Patients With Prostate Cancer|Recruiting||N/A|10|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:17:07.665311|2017-10-10 23:17:07.665311
NCT02450188|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-05-20|||March 2012||2012-03-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|STEDOV||Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)|An Integrated Approach With Vardenafil Orodispersible and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)|Completed||Phase 4|30|Actual|University of Florence||2|||f||||f||||||||||2017-10-10 23:17:07.741261|2017-10-10 23:17:07.741261
NCT02450175|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-20|||June 2014||2014-06-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls|Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls|Unknown status|Recruiting|N/A|50|Anticipated|Sinai Hospital of Baltimore||2|||f||||f||||||||||2017-10-10 23:17:07.813439|2017-10-10 23:17:07.813439
NCT02447133|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-12-05|2016-07-14||May 2015||2015-05-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Normal healthy eyes without any known eye conditions|TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro|TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro|Completed||N/A|12|Actual|Topcon Medical Systems, Inc.||1|||f||||f||||||||||2017-10-10 23:17:45.54383|2017-10-10 23:17:45.54383
NCT02450162|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-20|||May 2015||2015-05-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|AS-OCT||Lateral Rectus Muscle and Anterior Segment Optical Coherence Tomography (AS-OCT) in Two Recession Surgeries|Comparison of the Changes of Lateral Rectus Muscle Insertion Measured With AS-OCT in Two Recession Surgeries|Unknown status|Not yet recruiting|N/A|60|Anticipated|Samsung Medical Center|||2||f||||f||||||||||2017-10-10 23:17:07.888675|2017-10-10 23:17:07.888675
NCT02450149|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-03-10|||May 30, 2016|Actual|2016-05-30|March 2017|2017-03-01|August 9, 2016|Actual|2016-08-09|August 2016|Actual|2016-08-01||Interventional|||Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors||Completed||N/A|1|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:07.947521|2017-10-10 23:17:07.947521
NCT02450136|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-02-15|||October 8, 2015|Actual|2015-10-08|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors||Recruiting||N/A|5|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:09.908413|2017-10-10 23:17:09.908413
NCT02450123|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-02-15|||March 23, 2016|Actual|2016-03-23|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors||Recruiting||N/A|3|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:09.985913|2017-10-10 23:17:09.985913
NCT02450110|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-08-10|||February 2015||2015-02-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|RAPID-HELP||A Pilot Study of Spinal Cord Stimulation in Heart Failure Patients With Depressed Left Ventricular Function||Enrolling by invitation||N/A|40|Anticipated|Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health||2|||f||||||||||||||2017-10-10 23:17:10.07212|2017-10-10 23:17:10.07212
NCT02450097|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-03-11|||December 2013||2013-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Metabolic and Hormonal Effects of 5:2 Intermittent Fasting|Metabolic and Hormonal Effects of 5:2 Intermittent Fasting in Patients With Type 2 Diabetes and Subjects With Adiposity|Active, not recruiting||N/A|100|Actual|Karolinska University Hospital||1|||f||||t||||||||||2017-10-10 23:17:10.149596|2017-10-10 23:17:10.149596
NCT02450084|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-02-06|||May 2015||2015-05-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Ultrasound-guided Bilateral Rectus Sheath Block for Robotic Single-port Gynecologic Surgery|Postoperative Analgesic Effects of Ultrasound-guided Bilateral Rectus Sheath Block for Robotic Single-port Gynecologic Surgery|Completed||N/A|60|Actual|Ewha Womans University Mokdong Hospital||2|||f||||f||||||||||2017-10-10 23:17:10.219457|2017-10-10 23:17:10.219457
NCT02450071|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-08-21|||May 1, 2015|Actual|2015-05-01|August 2017|2017-08-01|March 1, 2017|Actual|2017-03-01|November 1, 2016|Actual|2016-11-01||Observational|PHAST||Pre-Hospital Advanced Airway Management in the Nordic Countries|Pre-Hospital Advanced Airway Management in the Nordic Countries - A Prospective Multicentre Observational Study|Completed||N/A|2028|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 23:17:10.297717|2017-10-10 23:17:10.297717
NCT02450058|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-18|||November 1996||1996-11-01|May 2015|2015-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|MIG5||Adjuvant FEC Versus EP in Breast Cancer (MIG5)|Fluorouracil, Epirubicin and Cyclophosphamide Versus Concurrent Epirubicin and Paclitaxel in Node Positive Early Breast Cancer Patients: a Randomized, Phase III Trial of Gruppo Oncologico Nord-Ovest - Mammella Intergruppo Group|Completed||Phase 3|1055|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||2|||f||||||||||||||2017-10-10 23:17:10.369435|2017-10-10 23:17:10.369435
NCT02450045|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Pre-op Femoral Nerve Block for Hip Fracture|Use of Pre-operative Nerve Blocks in Older Patients With Hip Fracture: A Pilot Study|Recruiting||N/A|75|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:17:10.457538|2017-10-10 23:17:10.457538
NCT02450032|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-05-20|||February 2000||2000-02-01|May 2015|2015-05-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|GC5||Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer|An Open, Multi-center Study to Determine the Antibody Response to 500µg G17DT Given at Weeks 0, 2, and 6 in the Treatment of Patients With Gastric Cancer|Completed||Phase 2|12|Actual|Cancer Advances Inc.||1|||f||||t||||||||||2017-10-10 23:17:10.545126|2017-10-10 23:17:10.545126
NCT02450019|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2016-11-11|||May 2015||2015-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|NeuroVentOR||Protective Ventilation in Neurosurgery, a Pilot Study|Protective Ventilation in Neurosurgery, a Pilot Study|Completed||N/A|40|Actual|IRCCS San Raffaele||2|||f||||t||||||||||2017-10-10 23:17:10.626311|2017-10-10 23:17:10.626311
NCT02450006|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-12-09|||April 2015||2015-04-01|October 2016|2016-10-01|April 2050|Anticipated|2050-04-01|April 2050|Anticipated|2050-04-01|50 Years|Observational [Patient Registry]|||Intermountain INSPIRE Registry|INtermountain Healthcare Biological Samples Collection Project and Investigational REgistry for the On-going Study of Disease Origin, Progression and Treatment (Intermountain INSPIRE Registry)|Recruiting||N/A|50000|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||Samples With DNA|"     Examples of the biological samples that may be collected are as follows (but not limited to):        -  Blood/Plasma        -  Bone Marrow        -  Buccal smear (cheek)        -  Cartilage        -  Cerebrospinal fluid        -  Mucus        -  Saliva        -  Sputum        -  Stool        -  Sweat        -  Synovial fluid        -  Tears        -  Tissue samples (e.g. muscle, skin, nails, tumor, etc)        -  Urine        -  Seminal fluid        -  Genetic material extracted from any biological sample        -  Other biological samples as identified by the Principal Investigator or Co-Investigators          and agreed by the patient.   "|||2017-10-10 23:17:10.807628|2017-10-10 23:17:10.807628
NCT02449993|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-01-17|||June 2014||2014-06-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy|Evaluation of the MammaTyper Kit, Ref 90020/90021 Performed on Clinical Material Obtained From Patients With Early Breast Cancer: Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy|Completed||N/A|101|Actual|Biontech Diagnostics GmbH|||1||f||||f||||||||||2017-10-10 23:17:10.871989|2017-10-10 23:17:10.871989
NCT02449980|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-11-15|||November 2016||2016-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|||Primary Versus Delayed Surgical Therapy for Pediatric Spontaneous Pneumothorax|Primary Versus Delayed Surgical Therapy for Pediatric Spontaneous Pneumothorax: A Randomized Controlled Trial|Active, not recruiting||N/A|56|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:17:10.948663|2017-10-10 23:17:10.948663
NCT02449967|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-08-03|||May 2015||2015-05-01|August 2015|2015-08-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer|HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer: Clinical Trial|Withdrawn||Phase 1/Phase 2|0|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:17:11.050585|2017-10-10 23:17:11.050585
NCT02449954|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-18|||June 2014||2014-06-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Morphine, Tramadol, and Ketorolac on Postoperative Stress and Immune Responses|Comparison Between the Effects of Intravenous Morphine, Tramadol and Ketorolac on Stress and Immune Responses in Patients Undergoing Modified Radical Mastectomy|Unknown status|Active, not recruiting|Phase 2/Phase 3|60|Actual|Assiut University||3|||f||||f||||||||||2017-10-10 23:17:11.144725|2017-10-10 23:17:11.144725
NCT02449941|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-12-04|||March 2014||2014-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Helicobacter Pylori and Proton Pump Inhibitor|Distribution of Helicobacter Pylori According to the Use of Proton Pump Inhibitor|Completed||N/A|30|Actual|Asan Medical Center|||1||f||||f||||||Samples Without DNA|"     endoscopic biopsy   "|No||2017-10-10 23:17:11.241275|2017-10-10 23:17:11.241275
NCT02449928|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-19|||September 2015||2015-09-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Using Sodium Lactate Ringer's Injection Resuscitate Septic Shock Patients|Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences,|Unknown status|Not yet recruiting|N/A|||Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-10 23:17:11.326691|2017-10-10 23:17:11.326691
NCT02449902|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-11-05|2015-07-23||July 2013||2013-07-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy|A Phase 1, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of TX-12-004-HR in Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy (VVA)|Completed||Phase 2|50|Actual|TherapeuticsMD||2|||f||||f||||||||||2017-10-10 23:17:11.540719|2017-10-10 23:17:11.540719
NCT02449889|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-09-25|||April 2016||2016-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|July 26, 2017|Actual|2017-07-26||Interventional|FASHION||A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation|A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Comparing the Efficacy and Safety of Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) for Triggering of Final Follicular Maturation in Women Undergoing Controlled Ovarian Stimulation|Active, not recruiting||Phase 3|176|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:17:12.086195|2017-10-10 23:17:12.086195
NCT02449876|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-04-11|||December 2015||2015-12-01|April 2017|2017-04-01|April 11, 2017|Actual|2017-04-11|September 2016|Actual|2016-09-01||Interventional|||The Feasibility of Using Neuroscience Education in Adults Over 65 Years Old With Chronic Low Back and/or Lower Extremity Pain|The Feasibility of Using Neuroscience Education in Adults Over 65 Years Old With Chronic Low Back and/or Lower Extremity Pain|Completed||N/A|25|Actual|State University of New York - Upstate Medical University||1|||f||||f||||||||||2017-10-10 23:17:12.19452|2017-10-10 23:17:12.19452
NCT02449863|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2015-05-19|||January 2014||2014-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|2 Days|Observational [Patient Registry]|||Lung Ultrasound as a Predictor of Mechanical Ventilation in Neonates Older Than 32 Weeks|Lung Ultrasound as a Predictor of Mechanical Ventilation in Neonates Older Than 32 Weeks|Completed||N/A|105|Actual|Hospital Sant Joan de Deu|||2||f||||t||||||||||2017-10-10 23:17:12.270325|2017-10-10 23:17:12.270325
NCT02449850|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-09-28|||December 14, 2014||2014-12-14|September 2017|2017-09-01|June 2044|Anticipated|2044-06-01|July 2020|Anticipated|2020-07-01||Interventional|PreventADALL||Preventing Atopic Dermatitis and ALLergies in Children|Preventing Atopic Dermatitis and ALLergies in Children|Active, not recruiting||N/A|2702|Actual|Oslo University Hospital||4|||f||||f||||||||||2017-10-10 23:17:12.35215|2017-10-10 23:17:12.35215
NCT02449837|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-01-30|||May 2014||2014-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy|Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy|Recruiting||N/A|210|Anticipated|UNC Lineberger Comprehensive Cancer Center|||6||f||||t||||||||||2017-10-10 23:17:12.472546|2017-10-10 23:17:12.472546
NCT02449824|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-05-17|||July 2015||2015-07-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|CHERNAC||MRI and Early Decision-making in Chemotherapy for Breast Cancer|Characterising Early Response to Neoadjuvant Chemotherapy With Quantitative Breast MRI|Recruiting||N/A|50|Anticipated|University of Leeds|||1||f||||f||||||Samples Without DNA|"     tumour biopsy samples and blood   "|No||2017-10-10 23:17:12.571238|2017-10-10 23:17:12.571238
NCT02449811|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-08-05|||April 2015||2015-04-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||RAS Peptide Profiles in Patients With Arterial Hypertension|Single-center, Randomized, Open-label, Parallel-group Study to Characterize Renin-angiotensin-system (RAS) Peptide Profiles Before and After Treatment Initiation With Different Antihypertensive Drug-classes in Patients With Treatment-naive Arterial Hypertension|Recruiting||N/A|80|Anticipated|University Hospital, Basel, Switzerland|||4||f||||f||||||Samples Without DNA|"     plasma samples   "|||2017-10-10 23:17:12.78395|2017-10-10 23:17:12.78395
NCT02449798|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-16|2017-03-03|2017-01-13||March 2015||2015-03-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||"Prospective Feasibility Trial of AccuCath 2.25 Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department"|"A Prospective Feasibility Trial of AccuCath 2.25 BC Intravascular Catheter System With Retractable Coiled Tip Guidewire Placed in Difficult Access Patients in the Emergency Department"|Completed||N/A|120|Actual|C. R. Bard||1|||f||||f||||||||No||2017-10-10 23:17:12.892799|2017-10-10 23:17:12.892799
NCT02449785|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-12-24|||September 2015||2015-09-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|MucoIRM||Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences|Assessment of Lung Involvement in Cystic Fibrosis Patients Using 1.5T MR Imaging With Ultrashort Echo Time (UTE) Pulse Sequences|Recruiting||N/A|33|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 23:17:13.166275|2017-10-10 23:17:13.166275
NCT02449772|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-12-24|||April 2015||2015-04-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Emergency Department (ED) Triage of Alcohol Abuse|Evaluation of ED Triage of Adult Patients With Alcohol Abuse|Completed||N/A|775|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 23:17:13.263573|2017-10-10 23:17:13.263573
NCT02449759|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-12-07|||April 2015||2015-04-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|ACT||An ACT Manual-based, Guided Self-help Intervention Pilot|Evaluating Acceptance and Commitment Therapy as a Low-intensity, Manual-based, Guided Self-help Intervention for Anxiety and Depression: A Pilot Study|Recruiting||N/A|52|Anticipated|University of Edinburgh||2|||f||||f||||||||No||2017-10-10 23:17:13.344953|2017-10-10 23:17:13.344953
NCT02449746|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-06-23|||August 2015||2015-08-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|SINAPPS-1||Study of Immunotherapy in Autoantibody Positive Psychosis|An Unblinded Study of the Feasibility of Plasmapheresis or Intravenous Immunoglobulin, Combined With Corticosteroids, in Patients With Acute Psychosis Associated With Anti-neuronal Membrane Auto-antibodies|Recruiting||N/A|10|Anticipated|University of Cambridge||2|||f||||f||||||||||2017-10-10 23:17:13.434911|2017-10-10 23:17:13.434911
NCT02449733|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-07-04|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|October 2016|Actual|2016-10-01||Interventional|||Comprehensive HIV Prevention Package for MSM in Port Elizabeth|Comprehensive HIV Prevention Package for MSM in Port Elizabeth|Completed||N/A|101|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:17:13.545341|2017-10-10 23:17:13.545341
NCT02449720|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-03-23|||May 2015||2015-05-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Intraperitoneal Local Anaesthetic in Bowel Surgery|The Effect of Intraperitoneal Local Anaesthetic on Functional Recovery Following Bowel Resection: A Prospective Randomised Blinded Trial|Completed||Phase 4|86|Actual|Royal Adelaide Hospital||4|||f||||f||||||||Undecided||2017-10-10 23:17:13.649547|2017-10-10 23:17:13.649547
NCT02449707|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-16|||April 2015||2015-04-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Evaluation of a Lateral Window Technique Augmentation for Maxillary Sinus Using Ultrasound Activated Pins|Evaluation of a Lateral Window Technique Augmentation for Maxillary Sinus Lift Using Ultrasound Activated Resorbable Poly-D-L-lactide Pins in Maxillary Sinus Lift - a Split Mouth Randomized Control Trial|Unknown status|Recruiting|Phase 4|20|Anticipated|Riyadh Colleges of Dentistry and Pharmacy||2|||f||||f||||||||||2017-10-10 23:17:13.756946|2017-10-10 23:17:13.756946
NCT02449694|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-15|||June 2015||2015-06-01|May 2015|2015-05-01|January 2018|Anticipated|2018-01-01|January 2016|Anticipated|2016-01-01||Interventional|REVIVE||Trial of the TransMedics Organ Care System™ Liver For Preserving and Assessing Donor Livers for Transplantation|Single-arm Prospective Trial to Evaluate The Safety and Performance of The Portable Organ Care System (OCS™) Liver For Preserving and Assessing Donor Livers for Transplantation|Not yet recruiting||N/A|25|Anticipated|TransMedics||1|||f||||t||||||||||2017-10-10 23:17:13.858143|2017-10-10 23:17:13.858143
NCT02449681|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-02-23|||August 2015||2015-08-01|November 2016|2016-11-01|January 31, 2017|Actual|2017-01-31|January 2017|Actual|2017-01-01||Interventional|||Study for Treatment of Patients With Recurrent or Metastatic SCCHN or SCCS|A Phase 2 Study of TH-4000 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin|Terminated||Phase 2|60|Anticipated|Threshold Pharmaceuticals||1||Lack of efficacy|f||||t||||||||||2017-10-10 23:17:13.937155|2017-10-10 23:17:13.937155
NCT02449668|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-05-19|||March 2012||2012-03-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|||Acupuncture Treatment of Shoulder Impingement Syndrome|Acupuncture Treatment of Shoulder Impingement Syndrome: a Randomized Controlled Trial|Completed||N/A|72|Actual|Rueda, Juan Carlos, M.D., Ph.D.||2|||f||||f||||||||||2017-10-10 23:17:14.044963|2017-10-10 23:17:14.044963
NCT02449655|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-10|||February 12, 2015|Actual|2015-02-12|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Trial of AZD5363 Plus Paclitaxel /AZD2014 Plus Paclitaxel in Biomarker Negative (PIK3CA/MEK/RAS/TP53/MET) Gastric Adenocarcinoma Patients as Second-line Chemotherapy||Recruiting||Phase 2|25|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 23:17:14.116085|2017-10-10 23:17:14.116085
NCT02449642|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-16|2015-08-16|||July 2015||2015-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation|LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation|Completed||N/A|10|Actual|Rambam Health Care Campus|||2||f||||t||||||Samples Without DNA|"     frequent blood tests for luteinizing hormone, estradil and progesterone levels   "|||2017-10-10 23:17:14.208555|2017-10-10 23:17:14.208555
NCT02449629|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-02-27|||June 2015||2015-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care|Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care|Completed||N/A|187|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||||||2017-10-10 23:17:14.278448|2017-10-10 23:17:14.278448
NCT02449616|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-10-26|||June 2015||2015-06-01|October 2016|2016-10-01||||September 2016|Actual|2016-09-01||Interventional|EPIC-E||Evaluation of Repeat Administration of Purified Poloxamer 188|Evaluation of Repeat Administration of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC-E): An Open-Label Safety Extension Trial Assessing Repeat Administration of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis|Completed||Phase 3|16|Actual|Mast Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:17:14.383808|2017-10-10 23:17:14.383808
NCT02449603|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-12-30|||November 2015||2015-11-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes|Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes : a Randomised Open Parallel-controlled Study|Recruiting||Phase 4|150|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-10 23:17:14.4724|2017-10-10 23:17:14.4724
NCT02449590|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-05-19|||August 2008||2008-08-01|May 2015|2015-05-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|M197||Onion, Cardiovascular Risk Markers and Gene Expression|The Effects of Onion on Plasma Lipoproteins, Blood Pressure and Gene Expression in Overweight Humans - a Double-blinded, Randomized Cross-over Study|Completed||N/A|10|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:17:14.563539|2017-10-10 23:17:14.563539
NCT02449577|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-05-19|||May 2013||2013-05-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|METABEER||Identification of Biomarkers for Acute Intake of Beer and Alcohol and Acute Effects on Plasma and Insulin Response|Metabolomics in Beer Research: Identification of Biomarkers for Acute Intake of Beer and Alcohol in Individuals With a High or Low Habitual Intake, and Acute Effects on Plasma Glucose and Insulin Response Compared to Regular Soda|Completed||Early Phase 1|19|Actual|University of Copenhagen||11|||f||||t||||||||||2017-10-10 23:17:14.659265|2017-10-10 23:17:14.659265
NCT02449564|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-16|||November 24, 2014|Actual|2014-11-24|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors||Recruiting||N/A|5|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:14.759468|2017-10-10 23:17:14.759468
NCT02449551|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-10|||February 10, 2016|Actual|2016-02-10|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment||Recruiting||Phase 2|20|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:14.831537|2017-10-10 23:17:14.831537
NCT02449538|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-16|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors||Completed||Phase 2|10|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:14.908158|2017-10-10 23:17:14.908158
NCT02449525|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-03-07|||June 2013||2013-06-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Extracorporeal Perfusion of Microvascular Free Flaps|Extracorporal Perfusion of Free Flaps in the Head and Neck|Recruiting||N/A|10|Anticipated|Technische Universität München||1|||f||||f||||||||||2017-10-10 23:17:14.971791|2017-10-10 23:17:14.971791
NCT02449512|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-09-11|||March 1, 2018|Anticipated|2018-03-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Observational|||Somatosensory Evoked Potentials From the Lower Urinary Tract|Somatosensory Evoked Potentials From the Lower Urinary Tract in Individuals With Neurogenic Lower Urinary Tract Dysfunction as a Result of Spinal Cord Injury|Not yet recruiting||N/A|26|Anticipated|Swiss Paraplegic Centre Nottwil|||2||f||||f||||||||||2017-10-10 23:17:15.159323|2017-10-10 23:17:15.159323
NCT02449499|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-10-14|||April 2015||2015-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Observational|||Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms|Interpersonally Focused Psychodynamic Group Psychotherapy as Adjunct Treatment for Residual Symptoms of Major Depressive Disorder|Terminated||N/A|25|Actual|Stanford University|||2||f||||t||||||||||2017-10-10 23:17:15.229805|2017-10-10 23:17:15.229805
NCT02449486|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-05-18|||January 2014||2014-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NAROSYD||Ropivacaine After Sternotomy||Recruiting||Phase 4|90|Anticipated|Kuopio University Hospital||2|||f||||f||||||||||2017-10-10 23:17:15.3095|2017-10-10 23:17:15.3095
NCT02449473|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-07-14|||September 29, 2015|Actual|2015-09-29|July 2017|2017-07-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|MESOS||Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids|A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, 12-Week, Ph 2 Study to Evaluate the Effect of Tralokinumab on Airway Inflammation in Adults With Asthma Inadequately Controlled on Inhaled Corticosteroid (MESOS)|Completed||Phase 2|79|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:17:15.395655|2017-10-10 23:17:15.395655
NCT02449460|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-08-01|||July 2012||2012-07-01|July 2016|2016-07-01|December 2022|Anticipated|2022-12-01|March 2021|Anticipated|2021-03-01||Observational|ESSE-RF||Cardiovascular Epidemiology in Russian Federation|Multicenter Observational Study of Epidemiology of Cardiovascular Diseases and Risk Factors in Different Regions of Russian Federation|Recruiting||N/A|18000|Anticipated|Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health|||1||f||||t||||||Samples With DNA|"     whole blood serum plasma urine   "|||2017-10-10 23:17:15.509428|2017-10-10 23:17:15.509428
NCT02449447|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-19|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2016|Actual|2016-06-01||Interventional|E-compared||Blended Depression Therapy: Cognitive Behaviour Therapy Face-to-face and Via Internet|European Comparative Effectiveness Research on Internet-based Depression in Sweden (E-compared) Treatment). A Randomized Controlled Trial Comparing Blended Internet and Face-to-face CBT Against Treatment as Usual|Completed||N/A|150|Anticipated|Linkoeping University||2|||f||||t||||||||||2017-10-10 23:17:15.606685|2017-10-10 23:17:15.606685
NCT02449434|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-08-01|||August 2014||2014-08-01|February 2016|2016-02-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Observational|||Timing of Dietary Acid Intake, Brushing Teeth and Acid Erosion.|Timing of Dietary Acid Intake, Brushing Teeth and Acid Erosion.|Completed||N/A|600|Actual|King's College London|||2||f||||t||||||||||2017-10-10 23:17:15.715234|2017-10-10 23:17:15.715234
NCT02449421|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-11-25|||December 2014||2014-12-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Sustaining and Improving Clinicians' Use of Evidence-Based Psychotherapy (EBP) for PTSD|A Comparison of the Effects of Internet-Based Strategies to Support Mental Health Clinicians' Use of an Effective Psychotherapy for Post Traumatic Stress Disorder (PTSD) in Mental Health Systems|Enrolling by invitation||N/A|90|Anticipated|Ryerson University||2|||f||||t||||||||No|No plan to share IPD.|2017-10-10 23:17:15.782365|2017-10-10 23:17:15.782365
NCT02449408|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2017-02-24|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Novel Screening Tools For the Evaluation and Management of Malnourished Children in the Developing World|Novel Screening Tools For the Evaluation and Management of Malnourished Children in the Developing World|Completed||N/A|11|Actual|Duke University|||2||f||||||||||||||2017-10-10 23:17:15.881181|2017-10-10 23:17:15.881181
NCT02449395|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2016-06-18|||April 2015||2015-04-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Observational|||Cross-sectional Study of Fibromyalgia|A Cross-sectional Study of Fibromyalgia in Beijing|Recruiting||N/A|500|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|||1||f||||t||||||||||2017-10-10 23:17:15.957047|2017-10-10 23:17:15.957047
NCT02449382|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-07-09|||June 2015||2015-06-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Continuous Venovenous Hemofiltration Versus Conventional Treatment for Acute Severe Hypernatremia|To Effect and Safety of Continuous Venovenous Hemofiltration (CVVH) Versus Conventional Treatment for Acute Severe Hypernatremia in Critical Ill Patients: A Randomized Clinical Trial|Unknown status|Recruiting|N/A|60|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-10 23:17:16.033934|2017-10-10 23:17:16.033934
NCT02449369|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-08-29|||April 2015||2015-04-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|IVAM||Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee|Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee Arthroplasty (TKA). Prospective, Randomized, Open-label Trial to Determine if Switching From Oral to Intravenous Acetaminophen and Orphenadrine for 48 Hours After TKA Improves Outcomes.|Completed||Phase 4|180|Actual|Florida Hospital||3|||f||||f||||||||||2017-10-10 23:17:16.140486|2017-10-10 23:17:16.140486
NCT02449356|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2017-03-30|2016-12-07||September 2015|Actual|2015-09-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional||all participants in both groups were analyzed|Clinical Study of the Endotracheal Tube Used in Prone Position Ventilation Condition|Clinical Study of the Endotracheal Tube Used in Prone Position Ventilation Condition|Completed||N/A|60|Actual|Central South University|No limitations and caveats.|2|||f||||f||||||||No||2017-10-10 23:17:16.260846|2017-10-10 23:17:16.260846
NCT02449343|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-04-23|||May 12, 2015|Actual|2015-05-12|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)|A Registered Randomized, Double-Blind, Placebo-Controlled (2:1), Multi-Centered Clinical Trial of Anlotinib as a Treatment for Soft Tissue Sarcoma|Active, not recruiting||Phase 2/Phase 3|233|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-10 23:17:16.62477|2017-10-10 23:17:16.62477
NCT02449330|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2015-05-17|||June 2015||2015-06-01|May 2015|2015-05-01||||June 2019|Anticipated|2019-06-01||Interventional|TOPLEVEL||Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study|Clinical Study for the Effect of Teneligliptin on the Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus|Not yet recruiting||Phase 4|936|Anticipated|National Cerebral and Cardiovascular Center||4|||f||||||||||||||2017-10-10 23:17:16.752406|2017-10-10 23:17:16.752406
NCT02449317|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2017-08-31|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|BELIEVE||Bioimpedance Analysis Guided Volume Expansion for the Prevention of Contrast Induced-acute Kidney Injury|Bioimpedance Analysis Guided Volume Expansion for the Prevention of Contrast|Completed||N/A|56|Actual|Mahidol University||2|||f||||t||||||||||2017-10-10 23:17:16.84349|2017-10-10 23:17:16.84349
NCT02449304|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-16|||March 2015||2015-03-01|May 2015|2015-05-01|April 2020|Anticipated|2020-04-01|October 2015|Anticipated|2015-10-01||Interventional|||Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device|Evaluation of Feasibility and Effectiveness of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device: a Cohort Study|Active, not recruiting||Phase 4|50|Actual|Birmingham Women's NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:17:16.916546|2017-10-10 23:17:16.916546
NCT02449291|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-18|2016-08-03|||September 2015||2015-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study of APD421 as PONV Treatment (no Prior Prophylaxis)|Randomised, Double-blind, Placebo-controlled Study of APD421 (Amisulpride for IV Injection) as Treatment of Established Post-operative Nausea and Vomiting, in Patients Who Have Had no Prior Prophylaxis|Completed||Phase 3|568|Actual|Acacia Pharma Ltd||3|||f||||t||||||||No||2017-10-10 23:17:16.986646|2017-10-10 23:17:16.986646
NCT02449278|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-12-11|||October 2015||2015-10-01|December 2015|2015-12-01|October 2025|Anticipated|2025-10-01|October 2019|Anticipated|2019-10-01||Interventional|||The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma|The Palliative Benefit of Involved-site Radiotherapy Following Effective Chemotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma: Wuhan University Cancer Center - NHL04 Trial|Recruiting||Phase 3|120|Anticipated|Wuhan University||2|||f||||t||||||||||2017-10-10 23:17:17.063449|2017-10-10 23:17:17.063449
NCT02449265|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-12-11|||October 2015||2015-10-01|December 2015|2015-12-01|October 2025|Anticipated|2025-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma|Efficacy of Consolidative Involved-site Radiotherapy Following Sufficient Chemotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma: Wuhan University Cancer Center -NHL03 Trial|Recruiting||Phase 3|160|Anticipated|Wuhan University||2|||f||||t||||||||||2017-10-10 23:17:17.158242|2017-10-10 23:17:17.158242
NCT02449252|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-12-11|||October 2015||2015-10-01|December 2015|2015-12-01|October 2025|Anticipated|2025-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma|Efficacy of Consolidative Involved-site Radiotherapy Following Effective Chemotherapy for Patients With Limited-stage Follicular Lymphoma: Wuhan University Cancer Center -NHL01 Trial|Recruiting||Phase 3|120|Anticipated|Wuhan University||2|||f||||t||||||||||2017-10-10 23:17:17.257486|2017-10-10 23:17:17.257486
NCT02449226|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2016-02-21|||May 2015||2015-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|June 2015|Actual|2015-06-01||Observational|(POCREA)||Accuracy of Point-of-Care Measurement With the RapidPoint 500 Blood Gas Analyser|Accuracy of Point-of-Care Measurement of Electrolytes, Glucose, Hemoglobin and Hematocrit With the RapidPoint 500 Blood Gas Analyser|Completed||N/A|51|Actual|Hôpital Européen Marseille|||1||f||||f||||||||||2017-10-10 23:17:17.645701|2017-10-10 23:17:17.645701
NCT02449213|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-17|2016-11-23|||January 2016||2016-01-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Observational|||A Biobehavioral Model of Diabetes Risk in Chinese Immigrants|A Biobehavioral Model of Diabetes Risk in Chinese Immigrants|Recruiting||N/A|600|Anticipated|Fox Chase Cancer Center|||1||f||||f||||||Samples With DNA|"     Serum, plasma, and hair samples will be obtained   "|||2017-10-10 23:17:17.697152|2017-10-10 23:17:17.697152
NCT02449200|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-06-28|||May 2015||2015-05-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PACeR||RCT of Multimodal Physiotherapy for Acute / Sub-acute Cervical Radiculopathy|A Randomised Controlled Trial of Multimodal Physiotherapy for Patients With Acute / Sub-acute Cervical Radiculopathy|Recruiting||N/A|64|Anticipated|Royal College of Surgeons, Ireland||2|||f||||f||||||||No||2017-10-10 23:17:17.757629|2017-10-10 23:17:17.757629
NCT02449187|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-07-27|||August 2017|Anticipated|2017-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers|Recruiting||Phase 1|16|Anticipated|Jeil Pharmaceutical Co., Ltd.||2|||f||||f|f|f||||||||2017-10-10 23:17:17.842723|2017-10-10 23:17:17.842723
NCT02449174|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-11-16|||September 2014||2014-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route|A Study of Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent C. Difficile Associated Diarrhea (RCDAD) Via Retention Enema or Oral Route|Recruiting||Phase 1/Phase 2|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:17:18.056888|2017-10-10 23:17:18.056888
NCT02449161|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-05-10|||June 2015||2015-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|MPA postAE||The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates|The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates: a RCT|Recruiting||Phase 3|100|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-10 23:17:18.169199|2017-10-10 23:17:18.169199
NCT02449148|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-07-10|||May 2015||2015-05-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|HELENA||Nutrition and Energy Restriction for Cancer Prevention|Healthy Nutrition and Energy Restriction as Cancer Prevention Strategies: a Randomized Controlled Intervention Trial|Completed||N/A|150|Actual|German Cancer Research Center||3|||f||||f||||||||||2017-10-10 23:17:18.274588|2017-10-10 23:17:18.274588
NCT02449135|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-02-23|||May 2015||2015-05-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma|Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma：Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:17:18.393727|2017-10-10 23:17:18.393727
NCT02449122|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-02-23|||May 2015||2015-05-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma|Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma：Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:17:18.483475|2017-10-10 23:17:18.483475
NCT02449109|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-02-23|||May 2015||2015-05-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma|Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma：Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:17:18.589661|2017-10-10 23:17:18.589661
NCT02449096|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-10-18|||July 2015||2015-07-01|October 2015|2015-10-01|June 2025|Anticipated|2025-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of the Results of Complex Ankle Fractures Treated With and Without Ankle Arthroscopy|Operative Treatment of Complex Ankle Fractures: Comparison of the Results With and Without Ankle Arthroscopy-a Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-10 23:17:18.695071|2017-10-10 23:17:18.695071
NCT02449083|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-11-19|||June 2014||2014-06-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Magnet Resonance Imaging to Evaluate of Dynamic T2 Preparation Puls by Patients With Shunt or Chronic Obstructive Pulmonary Disease|Cardiac Magnet Resonance Imaging to Evaluate of Dynamic T2 Preparation Puls by Patient With Shunt or Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|80|Actual|Heinrich-Heine University, Duesseldorf|||3||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 23:17:18.819563|2017-10-10 23:17:18.819563
NCT02449070|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-09-18|||May 2015||2015-05-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction|Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction : A Randomized Clinical Trial|Recruiting||Phase 3|86|Anticipated|Pusan National University Hospital||2|||f||||t||||||||||2017-10-10 23:17:18.936829|2017-10-10 23:17:18.936829
NCT02449057|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-05-15|||March 2014||2014-03-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|JUST||An Evaluation of JUST Court in Yuma County, AZ|An Evaluation of JUST (Juveniles Under Supervision and Treatment) Court in Yuma County, AZ|Unknown status|Recruiting|N/A|150|Anticipated|Pepperdine University||2|||f||||f||||||||||2017-10-10 23:17:19.054475|2017-10-10 23:17:19.054475
NCT02448485|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-09-29|||June 2015||2015-06-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|TASS-2||High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)|High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis|Recruiting||N/A|3000|Anticipated|Medical University Innsbruck|||2||f||||f||||||||||2017-10-10 23:17:29.214871|2017-10-10 23:17:29.214871
NCT02449044|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-12-15|2015-08-04||May 2004||2004-05-01|December 2015|2015-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia|International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia: Extension to Studies 156-02-235 and 156-03-238 to Assess One-year Safety|Completed||Phase 3|111|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-10 23:17:19.216528|2017-10-10 23:17:19.216528
NCT02449031|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-09-12|||May 5, 2015|Actual|2015-05-05|September 2017|2017-09-01|December 19, 2023|Anticipated|2023-12-19|December 19, 2023|Anticipated|2023-12-19|5 Years|Observational [Patient Registry]|||Observational Study in Cystic Fibrosis Patients Using TOBI® Podhaler™ or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs|A Prospective Observational Study in Cystic Fibrosis Patients With Chronic Respiratory Pseudomonas Aeruginosa Infection Treated With TOBI® Podhaler™ (Tobramycin Inhalation Powder) or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs|Recruiting||N/A|500|Anticipated|Novartis|||2||f||||f||||||||||2017-10-10 23:17:21.418765|2017-10-10 23:17:21.418765
NCT02449005|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-02-24|||January 2014||2014-01-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|July 2016|Actual|2016-07-01||Interventional|PerioRegen||Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects|A Phase I/II Double-Blind Randomised Controlled Clinical Trial To Study The Safety and Efficacy Of A Novel Regenerative Treatment Of Infrabony Periodontal Defects Using Autologous Alveolar Bone-Marrow Mesenchymal Stem Cells (aBM-MSCs).|Active, not recruiting||Phase 1/Phase 2|30|Actual|Aristotle University Of Thessaloniki||3|||f||||f||||||||Undecided||2017-10-10 23:17:21.674348|2017-10-10 23:17:21.674348
NCT02448992|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-07-26|||August 2015||2015-08-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer|Neuropsychological and Oncological Outcomes After Hippocampal-Sparing Prophylactic Cranial Irradiation in Postoperative Patients With Pathologically Nodal Positive Non-Small-Cell Lung Cancer - A Prospective Follow-up Study|Active, not recruiting||Phase 2/Phase 3|90|Anticipated|Chang Gung Memorial Hospital||2|||f||||||||||||||2017-10-10 23:17:21.770425|2017-10-10 23:17:21.770425
NCT02448979|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-17|||January 2015||2015-01-01|May 2015|2015-05-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach|Randomized Control Study on Surgical Treatment for Middle and Lower Thoracic Esophageal Cancer Patients Without Upper Mediastinal Lymph Node Metastasis Through Left Versus Right Transthoracic Approach|Recruiting||Phase 3|800|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:17:21.830306|2017-10-10 23:17:21.830306
NCT02448966|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-19|||January 2015||2015-01-01|May 2015|2015-05-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy|Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic/Laparoscopic Esophagectomy for cT1b-3N0-1M0 Thoracic Esophageal Cancer|Recruiting||N/A|1000|Anticipated|Chinese Academy of Medical Sciences|||2||f||||t||||||||||2017-10-10 23:17:21.912385|2017-10-10 23:17:21.912385
NCT02448953|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-17|||January 2015||2015-01-01|May 2015|2015-05-01|December 2019|Anticipated|2019-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement|Comparison of Lymph Node Dissection Results and Prognosis in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement: Two-field Versus Three-field Lymph Node Dissection|Recruiting||N/A|786|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:17:22.136739|2017-10-10 23:17:22.136739
NCT02448940|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-16|||February 2014||2014-02-01|June 2014|2014-06-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of Supplementation With Species of Lactobacillus on Anthropometric Measurements|The Effect of Supplementation With Species of Lactobacillus on Anthropometric Measurements, Body Composition, Appetite and Serum Lipid Profile in Overweight and Obese Adults|Completed||N/A|72|Actual|Urmia University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:17:22.291574|2017-10-10 23:17:22.291574
NCT02448927|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-05-19|||May 2015||2015-05-01|May 2015|2015-05-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|DIRECT||The preDIlatation in tRanscathEter aortiC Valve implanTation Trial|The preDIlatation in tRanscathEter aortiC Valve implanTation Trial|Recruiting||Phase 3|170|Anticipated|University of Athens||2|||f||||t||||||||||2017-10-10 23:17:22.394307|2017-10-10 23:17:22.394307
NCT02448914|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-04-19|2016-02-19||May 2015||2015-05-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients|A Single Centre, Two-period, Open Label, Randomised, Cross-over Study to Assess Plasma Levodopa, Carbidopa and Entacapone Concentrations After Continuous Infusion of TRIGEL or Duodopa in Patients With Advanced Parkinson´s Disease|Completed||Phase 1|11|Actual|LobSor Pharmaceuticals AB||2|||f||||f||||||||Undecided||2017-10-10 23:17:22.527377|2017-10-10 23:17:22.527377
NCT02448901|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-05-15|||April 2015||2015-04-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Observational|||Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography|Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography|Unknown status|Recruiting|N/A|40|Anticipated|LifeBridge Health|||1||f||||f||||||||||2017-10-10 23:17:22.911905|2017-10-10 23:17:22.911905
NCT02448888|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-11-08|||January 2015||2015-01-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Interventional|||Prevention and Treatment of Chronic Low Back Pain Through an Adapted Exercise Program|Prevention and Treatment of Chronic Low Back Pain Through an Adapted Exercise Program and General Exercise Recommendations Tailored to the Job on an Assembly Line Training Versus General Exercise Recommendations: Randomized Clinical Trial|Completed||N/A|18|Actual|Universidad San Jorge||2|||f||||t||||||||||2017-10-10 23:17:23.024855|2017-10-10 23:17:23.024855
NCT02448875|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-07-12|||June 2013|Actual|2013-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|ViscoPass||Clinical Evaluation of Visco-Assisted CyPass Micro-Stent Implantation in Patients With Open Angle Glaucoma|A Randomized, Prospective Clinical Evaluation of the Safety and Effectiveness of Visco-Assisted CyPass Micro-Stent Implantation in Patients With Open Angle Glaucoma|Completed||N/A|192|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:17:23.128559|2017-10-10 23:17:23.128559
NCT02448862|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-04-18|2015-10-03||May 2015||2015-05-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Differences in Incidence of Common Side Effects Between Young Adults and Elderly Patients While Using IV-PCA|Differences in Incidence of Common Side Effects Between Young Adults and Elderly Patients While Using Fentanyl-based IV-PCA|Completed||N/A|10575|Actual|Severance Hospital|||2||f||||f||||||||||2017-10-10 23:17:23.257091|2017-10-10 23:17:23.257091
NCT02448849|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-10-29|||June 2015||2015-06-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Autologous BM-MSC Transplantation in Combination With Platelet Lysate (PL) for Nonunion Treatment|Use of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Combination With Platelet Lysate Product for Human Long Bone Nonunion Treatment, A Phase 2-3 Clinical Trial|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Royan Institute||2|||f||||t||||||||||2017-10-10 23:17:23.617327|2017-10-10 23:17:23.617327
NCT02448836|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-14|||June 2015||2015-06-01|May 2015|2015-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD)|Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD)|Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-10 23:17:23.726973|2017-10-10 23:17:23.726973
NCT02448823|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-05-19|||August 2014||2014-08-01|May 2015|2015-05-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluating Demand Generation (Stylish Man , Stylshs Living) for HIV Prevention/Family Planning Services, Rakai, Uganda|Evaluating Demand Generation (Stylish Man, Stylish Living) for HIV Prevention/Family Planning Services, Rakai, Uganda|Active, not recruiting||N/A|15000|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 23:17:23.816116|2017-10-10 23:17:23.816116
NCT02448810|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-06-02|||May 20, 2015|Actual|2015-05-20|June 2017|2017-06-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer|A Phase 2a Randomized, Open-label Study to Assess the Safety, Tolerability, and Efficacy of BAX69 in Combination With 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer|Terminated||Phase 2|112|Actual|Baxalta US Inc.||6||Based on overall benefit-risk assessment.|f||||t||||||||||2017-10-10 23:17:23.901631|2017-10-10 23:17:23.901631
NCT02448797|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-10-10|||May 2015||2015-05-01|October 2016|2016-10-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|EVIDENCE||Icotinib Versus Vinorelbine/Platinum as Adjuvant Therapy in Stage II-IIIA Non-small Cell Lung Cancer With EGFR-mutation|Icotinib Versus Vinorelbine/Platinum as Adjuvant Therapy in Stage II-IIIA Non-small Cell Lung Cancer With EGFR-mutation: a Randomized, Positive-controlled, Phase 3 Study (EVIDENCE, CCTC-1501)|Recruiting||Phase 3|320|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-10 23:17:24.041921|2017-10-10 23:17:24.041921
NCT02448784|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-17|||April 20, 2015|Actual|2015-04-20|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).|Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies.|Active, not recruiting||N/A|591|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-10 23:17:24.16429|2017-10-10 23:17:24.16429
NCT02448771|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-01-22|||July 2015||2015-07-01|January 2017|2017-01-01|April 2022|Anticipated|2022-04-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer|A Phase Ib/II Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer|Recruiting||Phase 1/Phase 2|37|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:17:24.249396|2017-10-10 23:17:24.249396
NCT02448758|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-05-15|||September 2011||2011-09-01|May 2015|2015-05-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Observational|CB(NPC)²||Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)|Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais|Unknown status|Recruiting|N/A|785|Anticipated|Centre Oscar Lambret|||1||f||||f||||||||||2017-10-10 23:17:24.385018|2017-10-10 23:17:24.385018
NCT02448745|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-05-15|||January 2014||2014-01-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|October 2015|Anticipated|2015-10-01||Interventional|||Liberia Insecticide Treated Durable Wall Linings Study: Protocol for a Cluster Randomised Trial (DL)||Unknown status|Enrolling by invitation|N/A|1900|Anticipated|The Mentor Initiative||2|||f||||||||||||||2017-10-10 23:17:24.468717|2017-10-10 23:17:24.468717
NCT02448732|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-05-19|||December 2014||2014-12-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases|Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases|Unknown status|Recruiting|Early Phase 1|10|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 23:17:24.551088|2017-10-10 23:17:24.551088
NCT02448719|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-02-24|||May 2015||2015-05-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Single-Dose Phase 1 Study of TAK-792|A Single-Center, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Dose of TAK-792 in the Healthy Japanese and Adult|Completed||Phase 1|103|Actual|Takeda||12|||f||||||||||||||2017-10-10 23:17:24.636844|2017-10-10 23:17:24.636844
NCT02448706|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-09-16|||July 2015||2015-07-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Variability In Hearing Aid Outcomes In Older Adults|Characterizing Variability in Hearing Aid Outcomes Among Older Adults|Completed||N/A|50|Actual|Northwestern University||2|||f||||f||||||||||2017-10-10 23:17:24.73519|2017-10-10 23:17:24.73519
NCT02448693|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-05-03|||May 2015||2015-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CROMOPIE||Study of Narrow Band Imaging in the Characterization of Residual Neoplasia After Endoscopic Piecemeal Mucosal Resection|Randomised Tandem Colonoscopy of Narrow Band Imaging (NBI) and White Light Endoscopy in Patients With Endoscopic Piecemeal Mucosal Resection|Completed||N/A|120|Actual|Parc de Salut Mar||2|||f||||f||||||||No||2017-10-10 23:17:24.821861|2017-10-10 23:17:24.821861
NCT02448680|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-01-24|||December 2015||2015-12-01|January 2017|2017-01-01|August 30, 2017|Anticipated|2017-08-30|June 30, 2017|Anticipated|2017-06-30||Interventional|PERSEPT2||A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa|A Phase III Study on the Safety, Pharmacokinetics, and Efficacy of Coagulation Factor VIIa (Recombinant) in Congenital Hemophilia A or B Pediatric Patients From Birth to <12 Years Old With Inhibitors to Factor VIII or IX: PerSept 2|Recruiting||Phase 3|24|Anticipated|LFB USA, Inc.||2|||f||||t||||||||Undecided||2017-10-10 23:17:24.908718|2017-10-10 23:17:24.908718
NCT02448667|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-01-19|||January 2015||2015-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies|Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies|Recruiting||N/A|15|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||No||2017-10-10 23:17:25.0364|2017-10-10 23:17:25.0364
NCT02448641|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-09-13|||January 2016||2016-01-01|February 2017|2017-02-01|September 30, 2019|Anticipated|2019-09-30|May 30, 2019|Anticipated|2019-05-30||Interventional|ACTIsSIMA||Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke|A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke|Recruiting||Phase 2|156|Anticipated|SanBio, Inc.||3|||f||||t||||||||||2017-10-10 23:17:25.273786|2017-10-10 23:17:25.273786
NCT02448628|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-04-06|||May 2015||2015-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment|A Multi-center, Open Label, Dose Titration, Exploratory Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment.|Completed||Phase 2|33|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-10 23:17:25.494585|2017-10-10 23:17:25.494585
NCT02448615|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-07-13|||July 2015||2015-07-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Birth Cohort in Coast Province, Kenya|A Longitudinal Birth Cohort Study in Coast Province, Kenya|Completed||N/A|283|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-10 23:17:25.559365|2017-10-10 23:17:25.559365
NCT02448602|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-05-20|||January 2015||2015-01-01|May 2015|2015-05-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Different Acupoints Compatibility Difference of the Effect of Treatment of the Primary Insomnia|Scheme Optimization of Acupoints Compatibility and Influence Factors of the Effect|Recruiting||Phase 1|333|Anticipated|Changchun University of Chinese Medicine||3|||f||||t||||||||||2017-10-10 23:17:25.63529|2017-10-10 23:17:25.63529
NCT02448589|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-09-23|||September 2014||2014-09-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|||An Investigation of TAS-119 Monotherapy and in Combination With Docetaxel|A Phase I, Open-Label, Non-Randomized, Dose-Escalating Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of TAS-119 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|80|Anticipated|Taiho Oncology, Inc.||1|||f||||t||||||||||2017-10-10 23:17:27.475059|2017-10-10 23:17:27.475059
NCT02448576|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-05-30|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|August 2025|Anticipated|2025-08-01|August 2025|Anticipated|2025-08-01||Interventional|||PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy|A Phase III Randomized Controlled Trial of Prophylactic Cranial Irradiation in Patients With Advanced Triple Negative Breast Cancer Who Had a Response to First Line Chemotherapy|Not yet recruiting||N/A|326|Anticipated|Sun Yat-sen University||2|||f||||t|f|f||||||||2017-10-10 23:17:27.651817|2017-10-10 23:17:27.651817
NCT02448563|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-06-27|2016-07-25||August 2011||2011-08-01|June 2017|2017-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|RENEW||Reducing Obesity in Underserved Postpartum African American Women|Reducing Obesity in Underserved Postpartum African American Women|Completed||N/A|128|Actual|Boston Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-10 23:17:27.780015|2017-10-10 23:17:27.780015
NCT02448550|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-05-19|||May 2015||2015-05-01|May 2015|2015-05-01|November 2023|Anticipated|2023-11-01|November 2018|Anticipated|2018-11-01||Interventional|CALIFORNIA||Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial|Comparison of Unfractionated Heparin and Bivalirudin for Percutaneous Coronary Intervention for Stable Angina, Unstable Angina, and Non-ST Segment Elevation Myocardial Infarction|Terminated||Phase 3|250|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-10 23:17:28.416547|2017-10-10 23:17:28.416547
NCT02448537|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-04-26|||August 2015|Actual|2015-08-01|April 2017|2017-04-01|February 2021|Anticipated|2021-02-01|February 2017|Actual|2017-02-01||Interventional|||A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas|A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas|Active, not recruiting||Phase 2|43|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-10 23:17:28.497172|2017-10-10 23:17:28.497172
NCT02448524|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-12-15|||July 2015||2015-07-01|December 2016|2016-12-01|April 2022|Anticipated|2022-04-01|April 2018|Anticipated|2018-04-01||Interventional|DESSOLVE-C||Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)|A Prospective, Single-blinded, Multi-center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-eluting Stent (MiStent® System) in the Treatment of Patients With Coronary Heart Disease|Recruiting||Phase 3|428|Anticipated|Micell Technologies||2|||f||||t||||||||No||2017-10-10 23:17:28.613649|2017-10-10 23:17:28.613649
NCT02448511|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-14|||August 2013||2013-08-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Local Application of Ozone Gas for Infected Ulcers|Local Application of Ozone Gas for Infected Ulcers: A Double Blinded Randomized Control Trial|Completed||N/A|68|Actual|St. John's Research Institute||2|||f||||f||||||||||2017-10-10 23:17:28.886432|2017-10-10 23:17:28.886432
NCT02448459|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-05-19|||May 2015||2015-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|COOL-COS||COmbining Oral Letrozole and Clomiphene for Ovarian Stimulation (COOL-COS) Associated With Corifollitropin Alfa: a Pilot Study|COmbining Oral Letrozole and Clomiphene for Ovarian Stimulation (COOL-COS) Associated With Corifollitropin Alfa: a Pilot Study|Completed||Phase 1|40|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-10 23:17:29.481156|2017-10-10 23:17:29.481156
NCT02448446|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-04-13|||August 2015||2015-08-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates|The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Foveal Involving Edema and Lipid Exudates|Recruiting||Phase 1/Phase 2|30|Anticipated|South Coast Retina Center; Carson, McBeath, Boswell, Inc.||2|||f||||||||||||||2017-10-10 23:17:29.583566|2017-10-10 23:17:29.583566
NCT02448433|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-14|||April 2015||2015-04-01|May 2015|2015-05-01||||April 2017|Anticipated|2017-04-01||Interventional|||Phototherapy in Young People With Depression|Phototherapy in Young People With Depression; Investigating Associations Between Changes in Actigraphic Sleep-wake Profile and Depressive Symptoms|Unknown status|Recruiting|N/A|60|Anticipated|University of Ottawa||1|||f||||||||||||||2017-10-10 23:17:29.720207|2017-10-10 23:17:29.720207
NCT02448420|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-12-21|||July 2015||2015-07-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|PATRICIA||Study of Palbociclib and Trastuzumab With or Without Letrozole in HER2-positive Metastatic Breast Cancer|PATRICIA: A Phase II Clinical Trial of Combined Palbociclib and Trastuzumab, With or Without Letrozole, in Post-menopausal Patients With Previously-treated Locally Advanced or Metastatic HER2-positive Breast Cancer|Recruiting||Phase 2|138|Anticipated|SOLTI Breast Cancer Research Group||3|||f||||t||||||||||2017-10-10 23:17:29.829325|2017-10-10 23:17:29.829325
NCT02448407|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-15|||January 2014||2014-01-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Intraarticular Injections of Platelet-rich Plasma in Pain's Treatment of the Osteoarthritic Knee|Intraarticular Injections of Platelet-rich Plasma in Pain's Treatment of the Osteoarthritic Knee|Completed||Phase 3|52|Actual|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||2|||f||||f||||||||||2017-10-10 23:17:30.008537|2017-10-10 23:17:30.008537
NCT02448394|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-06-08|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|May 2020|Anticipated|2020-05-01||Interventional|SHAMA||Assessment of a Community Support Worker Intervention for Persons Living With HIV (PLWH) in Rural Ethiopia|Assessment of a Community Support Worker Intervention for PLWH in Rural Ethiopia|Active, not recruiting||N/A|1800|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t|f|f||||||No||2017-10-10 23:17:30.118377|2017-10-10 23:17:30.118377
NCT02448381|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-08-18|||December 2015||2015-12-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma|Recruiting||Phase 3|120|Anticipated|Soligenix||2|||f||||||||||||||2017-10-10 23:17:30.232818|2017-10-10 23:17:30.232818
NCT02448355|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-11-24|||March 2016||2016-03-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Ocular Effects of Carotid Endarterectomy|Ocular Effects of Carotid Endarterectomy A Cohort Longitudinal Study|Not yet recruiting||N/A|30|Anticipated|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-10-10 23:17:30.522255|2017-10-10 23:17:30.522255
NCT02448342|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2017-08-01|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|SMILE™||Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients|Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study|Recruiting||N/A|380|Anticipated|Sensible Medical Innovations Ltd.||2|||f||||t||||||||||2017-10-10 23:17:30.618166|2017-10-10 23:17:30.618166
NCT02448329|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-02-10|||January 14, 2015|Actual|2015-01-14|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of AZD1775 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring TP53 Mutation as a Second-line Chemotherapy||Recruiting||Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:31.126449|2017-10-10 23:17:31.126449
NCT02448316|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2017-03-01|||April 1, 2015|Actual|2015-04-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 1, 2016|Actual|2016-11-01||Interventional|||Plantar Fasciitis, Operation or Conservative Treatment|Randomized Clinical Trial Comparing Conventional Conservative Treatment for Plantar Fasciopathia With Endoscopic Surgery With Fascial Release.|Active, not recruiting||Phase 4|30|Anticipated|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-10 23:17:31.243673|2017-10-10 23:17:31.243673
NCT02448303|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-11-30|||May 2015||2015-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|KEYNOTE166||Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer|A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Advanced Non-small Cell Lung Carcinoma|Active, not recruiting||Phase 2|74|Actual|Acerta Pharma BV||2|||f||||f||||||||||2017-10-10 23:17:31.376326|2017-10-10 23:17:31.376326
NCT02448290|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-02-10|||November 12, 2014||2014-11-12|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy|Phase II, Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy|Recruiting||Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:31.471305|2017-10-10 23:17:31.471305
NCT02448277|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-03-20|||April 2012||2012-04-01|April 2011|2011-04-01|December 2015|Actual|2015-12-01|October 2012|Actual|2012-10-01||Interventional|||Comparison of Different Tools Inserted Nasal Endotracheal Tube|A Comparson Among the Use of Direct Laryngoscope.AirwayScope and GlideScope in General Anesthetized Patients Who Require Nasal Endotracheal Tube Intubation|Completed||N/A|120|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||t||||||||||2017-10-10 23:17:31.57444|2017-10-10 23:17:31.57444
NCT02448264|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-01-12|||May 2015||2015-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers|A Phase 1, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of BCX7353 in Healthy Subjects|Completed||Phase 1|122|Actual|BioCryst Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:17:31.664173|2017-10-10 23:17:31.664173
NCT02448251|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-07-26|||May 2015||2015-05-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer|A Phase I/II, Multicenter, Open-label Safety, Pharmacokinetic and Preliminary Efficacy Study of Wild-type Sparing EGFR Inhibitor, AC0010MA, in Adult Patients With Previously Treated EGFRmut and Acquired T790M Mutation Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|100|Anticipated|ACEA Biosciences, Inc.||2|||f||||f||||||||||2017-10-10 23:17:31.770853|2017-10-10 23:17:31.770853
NCT02448238|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-06-09|||May 2015||2015-05-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Pilot Study of Oral Probiotic Bacteria Supplementation to Reduce Chronic Immune Activation in HIV-infected Malian Women|A Pilot Study of Oral Probiotic Bacteria Supplementation to Reduce Microbial Translocation and Chronic Immune Activation in HIV-infected Malian Women|Completed||N/A|23|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-10-10 23:17:31.878873|2017-10-10 23:17:31.878873
NCT02448225|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-05-02|||June 2015||2015-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules|PET Imaging of Lung Cancer and Indeterminate Pulmonary Nodules With 18F-FSPG|Recruiting||Phase 2|30|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 23:17:31.973681|2017-10-10 23:17:31.973681
NCT02448212|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-02-10|||May 2015||2015-05-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male Subjects|A Phase 1 Receptor Occupancy Study Using Positron Emission Tomography to Investigate Novel Ligand [11C]TASP0410699 Alone and Following Single Oral Dose Administrations of TS-121 in Healthy Adult (Male) Subjects|Completed||Phase 1|15|Actual|Taisho Pharmaceutical R&D Inc.||2|||f||||f||||||||||2017-10-10 23:17:32.116245|2017-10-10 23:17:32.116245
NCT02448199|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-18|||July 2015||2015-07-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|ZDPC00213||Study of Association of Anti-inflammatory and Anti-rheumatic|Phase III Study Comparing Association of Anti-inflammatory and Anti-rheumatic|Unknown status|Not yet recruiting|Phase 3|375|Anticipated|Zodiac Produtos Farmaceuticos S.A.||3|||f||||f||||||||||2017-10-10 23:17:32.228758|2017-10-10 23:17:32.228758
NCT02448186|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-05-14|||July 2012||2012-07-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ESTEEM||Intervention Development for Social Stress, Mental Health, and HIV Risk MSM|Intervention Development for Social Stress, Mental Health, and HIV Risk Among MSM|Completed||N/A|63|Actual|Yale University||2|||f||||f||||||||||2017-10-10 23:17:32.366247|2017-10-10 23:17:32.366247
NCT02448173|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-07-24|||May 2015||2015-05-01|July 2015|2015-07-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|||A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer|A Randomized Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer|Recruiting||Phase 3|550|Anticipated|Vaccinogen Inc||2|||f||||t||||||||||2017-10-10 23:17:32.477932|2017-10-10 23:17:32.477932
NCT02448160|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-06-12|||January 2016||2016-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Alfapump-albumin Replacement Therapy|Study Into the Effects of Albumin Replacement Therapy on Renal and Circulatory Function in Patients Implanted With the Alfapump|Active, not recruiting||N/A|10|Anticipated|Sequana Medical AG||1|||f||||f||||||||Undecided||2017-10-10 23:17:32.592059|2017-10-10 23:17:32.592059
NCT02448147|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-14|||May 2011||2011-05-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Interval Versus Continuous Training in Heart Failure|Interval Training Versus Continuous Training on Peripheral Perfusion and Sympathetic Activity in Patients With Heart Failure|Completed||N/A|40|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 23:17:32.695137|2017-10-10 23:17:32.695137
NCT02448121|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-06-27|||August 2006||2006-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease|Treatment for Hip, Knee, Ankle and Shoulder Osteonecrosis With Autologous Mononuclear Cells Transplantation in People With Sickle Cell Disease|Active, not recruiting||Phase 1/Phase 2|100|Anticipated|Federal University of Bahia||1|||f||||f||||||||||2017-10-10 23:17:32.916075|2017-10-10 23:17:32.916075
NCT02448108|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-08-16|||November 2016||2016-11-01|August 2016|2016-08-01||||March 2018|Anticipated|2018-03-01||Interventional|||Internet Psychotherapy for Bipolar Disorder in Primary Care|Internet Psychotherapy for Treating Bipolar Disorder in Primary Care|Not yet recruiting||N/A|75|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-10 23:17:33.007207|2017-10-10 23:17:33.007207
NCT02448095|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-02-16|||December 2015||2015-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Retrospective Evaluation of CML Patients in the National Compassionate Program|Ponatinib Survey: Retrospective Evaluation of CML Patients in the National Compassionate Program According to the 648/96 Decree|Recruiting||N/A|80|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||No||2017-10-10 23:17:33.102686|2017-10-10 23:17:33.102686
NCT02448082|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-05-18|||October 2014||2014-10-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis|The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis|Completed||Phase 2|40|Actual|University of Johannesburg||2|||f||||t||||||||No||2017-10-10 23:17:33.256496|2017-10-10 23:17:33.256496
NCT02448069|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-06-20|||May 2015||2015-05-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ARTSS-IA||Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke|ARTSS-IA: A Pilot, Phase IIa, Safety and Feasibility Study of ARgatroban in Combination With Recombinant Tissue Plasminogen Activator Stroke Study - Intra-Arterial|Completed||Phase 2|10|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 23:17:33.370101|2017-10-10 23:17:33.370101
NCT02448056|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-05-14|||June 2015||2015-06-01|May 2015|2015-05-01|May 2025|Anticipated|2025-05-01|May 2017|Anticipated|2017-05-01|5 Years|Observational [Patient Registry]|||MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma|MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma|Not yet recruiting||N/A|150|Anticipated|National Taiwan University Hospital|||3||f||||f||||||Samples With DNA|"     serum; tissue: tumor/ non-tumor part.   "|||2017-10-10 23:17:33.449794|2017-10-10 23:17:33.449794
NCT02448043|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-10-27|||May 2015||2015-05-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|June 2016|Actual|2016-06-01||Interventional|||Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure|Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure|Active, not recruiting||N/A|45|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 23:17:33.68389|2017-10-10 23:17:33.68389
NCT02448030|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-18|||March 2015||2015-03-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of Functional Electrical Stimulation on Metaboreflex Activation in Healthy Individuals|Effects of Functional Electrical Stimulation Compared to Isometric Exercise on Metaboreflex Activation in Healthy Individuals: Randomized Crossover Clinical Trial|Unknown status|Recruiting|Early Phase 1|20|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:17:33.825517|2017-10-10 23:17:33.825517
NCT02448017|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-05-25|||July 2012||2012-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Herbst Appliance Therapy to Improve Airway Dimension|Effects of Herbst Appliance Therapy to Improve Airway Dimension|Active, not recruiting||N/A|50|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:17:33.947074|2017-10-10 23:17:33.947074
NCT02448004|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-06-30|||May 11, 2015|Actual|2015-05-11|June 2017|2017-06-01|June 24, 2015|Actual|2015-06-24|June 24, 2015|Actual|2015-06-24||Interventional|||Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Participants|A Phase 1, Open-label Study to Characterize the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Subjects|Completed||Phase 1|6|Actual|Janssen Cilag N.V./S.A.||1|||f||||f||f||||||||2017-10-10 23:17:34.032903|2017-10-10 23:17:34.032903
NCT02447991|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Rizatriptan for Episodic Dizziness in Vestibular Migraine|A Phase II/III Trial on Rizatriptan for Vestibular Migraine|Recruiting||Phase 2/Phase 3|200|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 23:17:34.132813|2017-10-10 23:17:34.132813
NCT02447978|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-10-29|||February 2015||2015-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Duration of Protection: GSK DTaP Vaccines|Duration of Protection Following Five Doses of GlaxoSmithKline's (GSK's) DTaP Vaccines in School Age Children|Completed||N/A|1|Actual|GlaxoSmithKline|||3||f||||||||||||||2017-10-10 23:17:34.267329|2017-10-10 23:17:34.267329
NCT02447965|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-19|||January 1, 2016||2016-01-01|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Pilot Study: Rectus Sheath Blocks for Improving Abdominal Surgery Conditions|Pilot Study: Rectus Sheath Blocks for Improving Abdominal Surgery Conditions: A Prospective Randomized Double-Blind Placebo Controlled Study|Terminated||N/A|6|Actual|University of Arkansas||2||difficult recruitment|f||||t|f|f||||||||2017-10-10 23:17:34.366058|2017-10-10 23:17:34.366058
NCT02447952|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-08-07|||June 30, 2015|Actual|2015-06-30|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis|An Exploratory Study to Investigate the Use of Biotelemetry to Identify Markers of Disease Progression in Subjects With Amyotrophic Lateral Sclerosis|Completed||N/A|25|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:17:34.975544|2017-10-10 23:17:34.975544
NCT02447939|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-01-25|||May 2017||2017-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With Melanoma|A Phase I Study to Evaluate the Pharmacokinetics and Safety of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib With Trametinib in Chinese Subjects With Melanoma|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||1||Change in strategy|f||||f||||||||||2017-10-10 23:17:35.134496|2017-10-10 23:17:35.134496
NCT02447926|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-09-23|||July 2014||2014-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies|Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies|Completed||N/A|1|Actual|Northwestern University||1|||f||||f||||||||||2017-10-10 23:17:35.264241|2017-10-10 23:17:35.264241
NCT02447913|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-14|||September 2011||2011-09-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Integrating Family Planning With Immunization to Improve Maternal and Child Health|To Observe the Effectiveness of a Demand-Side Financing Project in Increasing Demand and Utilization of Contraceptives for Birth Spacing Among Women From Poorest Two Quintiles in Faisalabad District of Pakistan|Unknown status|Recruiting|N/A|28000|Anticipated|Greenstar Social Maketing||2|||f||||f||||||||||2017-10-10 23:17:35.352786|2017-10-10 23:17:35.352786
NCT02447900|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-22|||July 2014||2014-07-01|May 2015|2015-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Marker Guided Breathhold Radiotherapy in NSCLC|Proof of Concept Study Evaluating Safety and Performance of a Gel Marker (BioXmark) Used for Image Guidance in Deep Inspiration Breathhold Radiotherapy (DIBH IGRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1|15|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 23:17:35.457298|2017-10-10 23:17:35.457298
NCT02447887|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-09-08|||August 14, 2015|Actual|2015-08-14|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2017|Actual|2017-08-01||Interventional|||Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)|Phase I/II Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)|Terminated||Phase 1/Phase 2|3|Actual|Fox Chase Cancer Center||1||IRB study closure facilitated by Investigator|f||||t||||||||||2017-10-10 23:17:35.543495|2017-10-10 23:17:35.543495
NCT02447874|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-04-21|||May 2015||2015-05-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|R34 pK/PD||Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease|Arginine Therapy for the Treatment of Vaso-Occlusive Events in Children With Severe Sickle Cell Disease|Enrolling by invitation||Phase 1/Phase 2|21|Anticipated|Emory University||3|||f||||f||||||||||2017-10-10 23:17:35.658151|2017-10-10 23:17:35.658151
NCT02447861|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-01-03|||July 2013||2013-07-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|5 Years|Observational [Patient Registry]|||Characterization of 3q29 Deletion Syndrome and 3q29 Duplication Syndrome|Behavioral, Molecular and Genetic Characterization of 3q29 Deletion Syndrome and 3q29 Duplication Syndrome|Recruiting||N/A|600|Anticipated|Emory University|||4||f||||f||||||||||2017-10-10 23:17:35.784015|2017-10-10 23:17:35.784015
NCT02447835|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-05-14|||August 2012||2012-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction|The Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction and Muscarinic Mediation of B-Cell Function: A Small Mechanistic, Single-Site Study|Completed||Phase 1|15|Actual|Monell Chemical Senses Center||2|||f||||f||||||||||2017-10-10 23:17:35.97463|2017-10-10 23:17:35.97463
NCT02447822|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2015-05-18|||June 2015||2015-06-01|May 2015|2015-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg)|A Prospective Randomized Controlled Study to Evaluate Feasibility and Safety of Early Steroid Withdrawal After 6mg/kg vs 4.5mg/kg Thymoglobulin Induction Therapy in Kidney Transplantation|Not yet recruiting||Phase 4|154|Anticipated|Asan Medical Center||2|||f||||||||||||||2017-10-10 23:17:36.094252|2017-10-10 23:17:36.094252
NCT02447809|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-02-11|||January 2015||2015-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PPRC||Plasma and Platelet microRNAs in Clopidogrel Low Response Patients|The Association Between Plasma or Platelet microRNAs and Clopidogrel Low Response and Its Mechanism|Recruiting||Phase 4|400|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||f||||||||||2017-10-10 23:17:36.19706|2017-10-10 23:17:36.19706
NCT02447796|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-18|||May 2015||2015-05-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery|A Comparative Study of Dexmedetomidine and Propofol As Sole Sedative Agent for Patients With End-Stage Renal Disease Undergoing Arteriovenous Fistula Surgery|Unknown status|Recruiting|Phase 4|48|Anticipated|Baskent University||2|||f||||t||||||||||2017-10-10 23:17:36.33036|2017-10-10 23:17:36.33036
NCT02447783|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-05-24|||June 2012||2012-06-01|May 2017|2017-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 2|Effect of Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 2|Completed||N/A|75|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 23:17:36.976552|2017-10-10 23:17:36.976552
NCT02447770|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2017-05-26|||May 2012||2012-05-01|May 2017|2017-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 1|Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 1|Completed||N/A|37|Actual|University of California, Davis||1|||f||||f||||||||||2017-10-10 23:17:37.075859|2017-10-10 23:17:37.075859
NCT02447757|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-15|2016-07-22|||January 2010||2010-01-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|January 2015|Actual|2015-01-01||Observational|||Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth|Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth: Retrospective Observational Study|Completed||N/A|66|Actual|Brno University Hospital|||1||f||||t||||||||||2017-10-10 23:17:37.157744|2017-10-10 23:17:37.157744
NCT02447744|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-08-01|||August 2014||2014-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Neural Changes Associated With a Mindfulness-based Intervention for Young Adults With Childhood Maltreatment|Neural Changes Associated With a Mindfulness-based Intervention for Young Adults With Childhood Maltreatment|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:17:37.23784|2017-10-10 23:17:37.23784
NCT02447731|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-05-01|||July 2016|Anticipated|2016-07-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Effects of Sound Energy on Pulmonary Gas Exchange|The Effects of Sound Energy on Pulmonary Gas Exchange|Withdrawn||N/A|0|Actual|Loma Linda University|||1|Principal Investigator passed away.|f||||t||||||||||2017-10-10 23:17:37.336274|2017-10-10 23:17:37.336274
NCT02447718|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-03-16|||November 2015||2015-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccinating Children After Chemotherapy|Vaccinating Children After Chemotherapy for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study|Recruiting||Phase 4|200|Anticipated|Dalhousie University||2|||f||||f||||||||||2017-10-10 23:17:37.424299|2017-10-10 23:17:37.424299
NCT02447705|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-02-05|||June 2013||2013-06-01|March 2013|2013-03-01|January 31, 2017|Actual|2017-01-31|December 31, 2016|Actual|2016-12-31||Interventional|||Replacement of Lamivudine by Telbivudine to Improve Renal Function|Replacement of Lamivudine by Telbivudine to Improve Renal Function for Post-transplant Hepatitis B Patients - a Randomized Clinical Trial|Completed||Phase 2/Phase 3|120|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:17:37.540809|2017-10-10 23:17:37.540809
NCT02447692|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-09-07|||September 2016||2016-09-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|PROMIZING||Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study|Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study|Recruiting||N/A|512|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-10 23:17:37.63892|2017-10-10 23:17:37.63892
NCT02447679|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-02-05|||August 2010||2010-08-01|December 2016|2016-12-01|February 2, 2017|Actual|2017-02-02|January 31, 2017|Actual|2017-01-31||Interventional|||Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence|Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrent After Hepatectomy in High Risk Patients -A Phase II Study|Completed||Phase 2|40|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-10 23:17:37.750776|2017-10-10 23:17:37.750776
NCT02447666|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-02-28|||September 15, 2015|Actual|2015-09-15|February 2017|2017-02-01|September 27, 2022|Anticipated|2022-09-27|October 15, 2018|Anticipated|2018-10-15||Interventional|||Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)|A Phase 2, Multicenter, Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Activity of Azacitidine and to Compare Azacitidine to Historical Controls in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome or Juvenile Myelomonocytic Leukemia Before Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|55|Anticipated|Celgene||2|||f||||t||||||||||2017-10-10 23:17:37.837336|2017-10-10 23:17:37.837336
NCT02447653|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-08-11|||July 2016||2016-07-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Hydroxyapatite (HA) Coating Versus Plasma Porous Spray (PPS) in Press-fit Acetabular Components Early Outcomes With DEXA|A Randomised Controlled Study Comparing Hydroxyapatite (HA) Coating Versus Plasma Porous Spray in Press-fit Acetabular Components Early Outcomes With Dual Energy X-ray Absorptiometry (DEXA)|Recruiting||N/A|50|Anticipated|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-10-10 23:17:38.023059|2017-10-10 23:17:38.023059
NCT02447640|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-03-03|||April 2015||2015-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration|An Open Label PET Imaging Study to Evaluate the mGlu5 Receptor Occupancy Following ADX48621 (Dipraglurant) Administration|Active, not recruiting||Phase 1|12|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:17:38.095451|2017-10-10 23:17:38.095451
NCT02447627|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-08-21|||June 2015||2015-06-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease|A Study of Methodologies to Measure Blood Flow and Oxygenation as Potential Biomarkers in Adults With Sickle Cell Disease|Completed||N/A|38|Actual|Bioverativ Therapeutics Inc.|||2||f||||f||||||Samples Without DNA|"     Blood samples will be collected for hematology, blood chemistry, and venous blood gas     analysis. Blood samples will also be used for exploratory biomarker development specific to     SCD.   "|||2017-10-10 23:17:38.176057|2017-10-10 23:17:38.176057
NCT02447614|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-02-04|||November 2014||2014-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Follow-up Studies of Primary Snoring(PS) and Obstructive Sleep Apnea Hypopnea Syndrome(OSAHS) in Chinese Children|Follow-up Studies of PS and OSAHS in Chinese Children|Recruiting||N/A|800|Anticipated|Beijing Children's Hospital||3|||f||||t||||||||No||2017-10-10 23:17:38.356354|2017-10-10 23:17:38.356354
NCT02447601|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-01-21|||March 30, 2015|Actual|2015-03-30|May 2015|2015-05-01|August 11, 2015|Actual|2015-08-11|May 14, 2015|Actual|2015-05-14||Interventional|||Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects|An Open-label,Sequential,Single-site Study to Evaluate the Pharmacokinetics of Simvastatin When Coadministered With Polyethylene Glycol Loxenatide (PEX168) in Healthy Adult Subjects|Completed||Phase 1|16|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||1|||f||||t||||||||No||2017-10-10 23:17:38.481476|2017-10-10 23:17:38.481476
NCT02447588|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-05-14|||July 2015||2015-07-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|IAD-P4||IUI Schedule in Cases of High Progesterone|Programming IUI With Sperm Donor in Patients With High Progesterone the Day of hCG Administration|Unknown status|Not yet recruiting|N/A|70|Anticipated|IVI Madrid||2|||f||||f||||||||||2017-10-10 23:17:38.569329|2017-10-10 23:17:38.569329
NCT02447575|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-10-10|||February 2015||2015-02-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And COPD Patients|Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And COPD Patients|Enrolling by invitation||N/A|120|Anticipated|Baylor College of Medicine||1|||f||||f||||||||No||2017-10-10 23:17:38.657502|2017-10-10 23:17:38.657502
NCT02447562|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-14|||June 2012||2012-06-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Model for the Integral Assessment of Chronic Disease Management Supported in Information Technology and Communication.|A Randomized Clinical Trial to Investigate the Management for the Integral Assessment Model of Chronic Disease Supported in Information Technology and Communication.|Completed||N/A|495|Actual|Instituto de Investigacion Sanitaria La Fe||3|||f||||f||||||||||2017-10-10 23:17:38.748878|2017-10-10 23:17:38.748878
NCT02447549|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-05-24|||September 2015||2015-09-01|May 2017|2017-05-01|March 2029|Anticipated|2029-03-01|June 2020|Anticipated|2020-06-01||Interventional|RAIDER||Study of Tumour Focused Radiotherapy for Bladder Cancer|A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder|Recruiting||Phase 2|240|Anticipated|Institute of Cancer Research, United Kingdom||3|||f||||t||||||||||2017-10-10 23:17:38.839416|2017-10-10 23:17:38.839416
NCT02447536|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-05-02|||May 2015||2015-05-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|BCGSTRAIN||Trial of Two Strains of BCG|Evaluating the Effect of Different BCG Strains on Early Life Hospital Admissions in Guinea-Bissau: A Randomised Trial|Recruiting||Phase 4|12000|Anticipated|Bandim Health Project||2|||f||||t||||||||Yes||2017-10-10 23:17:39.145554|2017-10-10 23:17:39.145554
NCT02447523|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-02-18|||September 2012||2012-09-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||The Impact of Metabolic Syndrome on Patients Undergoing Elective Laparotomy||Completed||N/A|105|Actual|University of Ioannina|||2||f||||f||||||||||2017-10-10 23:17:39.288921|2017-10-10 23:17:39.288921
NCT02447510|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-18|||September 2014||2014-09-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Growth Factors Release of PRF and PRGF|Crevicular Fluid Growth Factors Release Profile Following the Use of Platelets Rich Fibrin (PRF) and Plasma Rich Growth Factors (PRGF) in Treating Periodontal Intrabony Defects (Randomized Clinical Trial)|Completed||Phase 3|30|Actual|Al-Azhar University||3|||f||||f||||||||||2017-10-10 23:17:39.404635|2017-10-10 23:17:39.404635
NCT02447497|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-02-08||2017-02-08|March 2015||2015-03-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||In Vivo Patient Preoperative Skin Prep Persistence|Assessment of Antimicrobial Persistence of 3M CHG/IPA Preoperative Skin Preparation Against Resident Flora on the Abdominal and Inguinal Regions|Completed||Phase 2|27|Actual|3M||2|||f||||f||||||||No||2017-10-10 23:17:39.53113|2017-10-10 23:17:39.53113
NCT02447484|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-05-05|||July 1, 2015||2015-07-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|April 30, 2020|Anticipated|2020-04-30||Interventional|||Texting Intervention to Sustain HIV Prevention in Women in High-drug-use Contexts|Texting Intervention to Sustain HIV Prevention in Women in High-drug-use Contexts|Active, not recruiting||N/A|600|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:17:39.61669|2017-10-10 23:17:39.61669
NCT02447458|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-07-07|2015-07-07||September 2013||2013-09-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||MLN3126 Single Rising Dose Study|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study of Escalating Single Doses of MLN3126 in Healthy Subjects|Terminated||Phase 1|39|Actual|Takeda||7||Site non-compliance to GCP (No safety concerns. See detailed description)|f||||f||||||||||2017-10-10 23:17:39.808815|2017-10-10 23:17:39.808815
NCT02447445|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-10-12|||July 2015||2015-07-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Grip Strength Routine Implementation (GRImP)|Implementing Grip Strength Measurement Into Routine Clinical Practice; a Feasibility Study (GRImP)|Recruiting||N/A|100|Anticipated|University Hospital Southampton NHS Foundation Trust|||1||f||||t||||||||||2017-10-10 23:17:41.526991|2017-10-10 23:17:41.526991
NCT02447432|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-05-18|2017-01-23||June 11, 2015||2015-06-11|March 2017|2017-03-01|May 22, 2016|Actual|2016-05-22|January 23, 2016|Actual|2016-01-23||Interventional|||A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants|Study to Compare Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants|Completed||Phase 3|320|Actual|GlaxoSmithKline|None reported.|2|||f||||t||||||||||2017-10-10 23:17:41.652332|2017-10-10 23:17:41.652332
NCT02447419|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-04-25|||December 3, 2014|Actual|2014-12-03|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors||Recruiting||Phase 2|24|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:42.938937|2017-10-10 23:17:42.938937
NCT02447406|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-15|||April 30, 2015|Actual|2015-04-30|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment||Recruiting||Phase 1/Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:17:43.021806|2017-10-10 23:17:43.021806
NCT02447393|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-08-01|||March 18, 2008|Actual|2008-03-18|August 2017|2017-08-01|April 30, 2008|Actual|2008-04-30|April 30, 2008|Actual|2008-04-30||Interventional|||Phase 1 Study of Levocetirizine|A Single Blind, Randomized, Single Oral Dose Study to Compare the Oral Disposition of Levocetirizine When Given Alone (5mg) or as the Racemate (Cetirizine 10mg), and to Investigate the Safety and Tolerability and the Pharmacokinetics of Levocetirizine and Cetirizine, Following a Single Dose in Healthy Japanese Male Subjects|Completed||Phase 1|20|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-10 23:17:43.118358|2017-10-10 23:17:43.118358
NCT02447380|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-02-19|||March 2017|Anticipated|2017-03-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With MET Overexpression as a Second-line Treatment|SAMSUNG MEDICAL CENTER|Not yet recruiting||Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||f|f|f||||||||2017-10-10 23:17:43.217385|2017-10-10 23:17:43.217385
NCT02447367|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-06-23|||July 2015||2015-07-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers|Randomized, Open-label, Single Dose, Two-way Crossover, Clinical Trial to Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|54|Actual|Jeil Pharmaceutical Co., Ltd.||2|||f||||f||||||||No||2017-10-10 23:17:43.314669|2017-10-10 23:17:43.314669
NCT02447341|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-05-15|||March 2015||2015-03-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|October 2015|Actual|2015-10-01||Observational|||Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)|Multicenter Observational Study to Determine the Profile and Antithrombotic Management of Patients With Nonvalvular Atrial Fibrillation Attending Internal Medicine Departments in Spanish Hospitals (Perfilar Study)|Completed||N/A|987|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 23:17:43.3974|2017-10-10 23:17:43.3974
NCT02447315|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-08-10|||May 2015||2015-05-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects|A Phase 1 Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects|Completed||Phase 1|12|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-10 23:17:43.595377|2017-10-10 23:17:43.595377
NCT02447302|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-09-06|||July 2015|Actual|2015-07-01|September 2017|2017-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis||Recruiting||Phase 2|240|Anticipated|Arena Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:17:43.706314|2017-10-10 23:17:43.706314
NCT02447289|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-14|||June 2015||2015-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Interventional|NASO||Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment|Efficacy, Safety and Cost-effectiveness of Intranasal Sedation With Ketamine and Midazolam in Pediatric Dentistry: a Randomized Clinical Trial|Active, not recruiting||Phase 4|84|Actual|Universidade Federal de Goias||3|||f||||f||||||||||2017-10-10 23:17:44.026815|2017-10-10 23:17:44.026815
NCT02447276|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-03-24||2017-03-24|May 2015||2015-05-01|October 2016|2016-10-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|||Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip|A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip|Completed||Phase 2/Phase 3|421|Actual|Regeneron Pharmaceuticals||5|||f||||t||||||||||2017-10-10 23:17:44.121651|2017-10-10 23:17:44.121651
NCT02447263|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-02-23|||May 2015||2015-05-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer|HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer: Clinical Trial|Completed||Phase 1/Phase 2|87|Actual|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:17:44.473012|2017-10-10 23:17:44.473012
NCT02447250|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-15|||October 2013||2013-10-01|October 2013|2013-10-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Preterm Infant Inhaled Albuterol Dosing|Albuterol Dose-Response on Pulmonary Function Testing in Preterm Infants at Risk of Bronchopulmonary Dysplasia|Unknown status|Recruiting|Phase 4|20|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-10-10 23:17:44.556762|2017-10-10 23:17:44.556762
NCT02447237|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-08-25|||March 2015||2015-03-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients|Randomized Controlled Trial About the Effect of Liquid Compared to Solid Food on the Intake of Energy and Protein in Patients With Leukemia, Lymphoma or Other Malignant Hematologic Disease|Completed||N/A|20|Actual|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 23:17:44.652923|2017-10-10 23:17:44.652923
NCT02447224|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-09-20|||October 2014||2014-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2015|Actual|2015-10-01||Interventional|||Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis|A Pilot Study for a Randomized Trial of Antibiotics Versus Surgery for Treatment of Patients With Acute Uncomplicated Appendicitis|Active, not recruiting||Early Phase 1|30|Anticipated|Olive View-UCLA Education & Research Institute||2|||f||||f||||||||||2017-10-10 23:17:44.724859|2017-10-10 23:17:44.724859
NCT02447211|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-02-24|||May 2015||2015-05-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Topical Doxepin for Radiation-induced Dermatitis|Topical Doxepin for Prevention and Management of Radiation-induced Dermatitis|Recruiting||Phase 2|60|Anticipated|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:17:44.803007|2017-10-10 23:17:44.803007
NCT02447198|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-09-18|||November 2, 2015|Actual|2015-11-02|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Cannabidiol (CBD) and Pediatric Epilepsy|Cannabidiol (CBD) and Pediatric Epilepsy|Recruiting||N/A|300|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     Blood samples will be drawn up to 6 times. It will be centrifuged to collect the plasma. The     plasma will be used to obtain concentration of cannabinols and anticonvulsant medications in     order to perform pharmacokinetic calculations.      All urine output for the first 8 hours after initial CBD dose will be collected.   "|||2017-10-10 23:17:44.886094|2017-10-10 23:17:44.886094
NCT02447185|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-08-23|||June 2015||2015-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|aiRTo-PDR||25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial|25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China: a Randomized, Single Blind Trial|Recruiting||Phase 3|200|Anticipated|The First People's Hospital of Xuzhou||2|||f||||f||||||||Undecided||2017-10-10 23:17:44.943541|2017-10-10 23:17:44.943541
NCT02447172|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2016-06-07|||June 2015||2015-06-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|COACT-2||Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers|A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer|Active, not recruiting||Phase 3|524|Actual|Innocoll||3|||f||||f||||||||||2017-10-10 23:17:45.148489|2017-10-10 23:17:45.148489
NCT02447159|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-05-02|||August 2015|Actual|2015-08-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria|Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria|Completed||N/A|554|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:17:45.383466|2017-10-10 23:17:45.383466
NCT02447146|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-13|||January 2013||2013-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Resistance Training in Patients With Parkinson`s Disease.|Effects of Resistance Training on Bradykinesia and Physical Function in Patients With Parkinson`s Disease.|Completed||N/A|40|Actual|University of Brasilia||2|||f||||f||||||||||2017-10-10 23:17:45.46469|2017-10-10 23:17:45.46469
NCT02447107|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-02-28|||May 2015||2015-05-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Mobile Phone Technology for Chronic Pain Patients- A Feasibility Study|The Utilization of Mobile Phone Technology to Quantitatively Assess Functional Outcomes of Chronic Pain Patients- A Feasibility Study|Recruiting||N/A|35|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||No|There is no plan to share IPD|2017-10-10 23:17:45.814852|2017-10-10 23:17:45.814852
NCT02447094|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2016-02-08|||February 2015||2015-02-01|February 2016|2016-02-01||||February 2017|Anticipated|2017-02-01||Observational|STROKE TeleQOL||Quality of Life After Stroke Using a Telemedicine-based Stroke Network|Assessing the Impact of Care in A Telemedicine-based Stroke Network Using Patient-Centered Health Related Quality of Life Outcomes|Recruiting||N/A|300|Anticipated|Thomas Jefferson University|||2||f||||f||||||||||2017-10-10 23:17:45.924248|2017-10-10 23:17:45.924248
NCT02447081|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-12-14|||April 2015||2015-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|September 2016|Actual|2016-09-01|2 Years|Observational [Patient Registry]|Amulet™PMS||Amplatzer™Amulet™ Post-Market Study|Amplatzer™Amulet™ Observational Post-Market Study|Active, not recruiting||N/A|1088|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-10 23:17:46.030232|2017-10-10 23:17:46.030232
NCT02447068|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-05-18|||May 2015||2015-05-01|May 2015|2015-05-01||||September 2015|Anticipated|2015-09-01||Interventional|||Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis|A Proof of Concept, Investigator Blinded Study to Evaluate the Efficacy and Safety of a Novel Combination of a Home Narrow Band Ultraviolet B (NBUVB) Lamp With an Occlusive Dressing in Adult Subjects With Mild to Moderate Psoriasis Vulgaris|Unknown status|Recruiting|N/A|10|Anticipated|Illumicure Inc||4|||f||||t||||||||||2017-10-10 23:17:46.248229|2017-10-10 23:17:46.248229
NCT02447055|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-07-08|||December 2015||2015-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma|Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma: a Pilot Feasibility Study Using a Novel Protocol|Withdrawn||Early Phase 1|0|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 23:17:46.34397|2017-10-10 23:17:46.34397
NCT02447042|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-10-12|||November 2014||2014-11-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Minimal Volume for a Fluid Challenge in Septic Patients|Study of Changes on Mean Systemic Filling Pressure (Pmsf) and Microcirculation After a Fluid Challenge in Septic Patients: Looking for the Minimal Volume|Completed||N/A|80|Actual|St George's, University of London||4|||f||||f||||||||No||2017-10-10 23:17:46.466121|2017-10-10 23:17:46.466121
NCT02447029|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-07-20|2017-05-05||April 2015||2015-04-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|SALSA|Treated participants were analyzed for baseline characteristics.|Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial|Self-Administered Lidocaine Gel for Pain Management With First Trimester Surgical Abortion: A Randomized Controlled Trial|Completed||Phase 3|142|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:17:46.618674|2017-10-10 23:17:46.618674
NCT02447016|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2017-04-25|||May 2015||2015-05-01|April 2017|2017-04-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|DeepSwitch||Decrease of Neuropsychiatric Side Effects After Switching From Atripla to Eviplera|Decrease of Neuropsychiatric and Neurocognitive Side Effects Prevalence|Terminated||Phase 4|25|Actual|Sheba Medical Center||2||no more participants taking atripla|f||||f||||||||||2017-10-10 23:17:46.987825|2017-10-10 23:17:46.987825
NCT02447003|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-05-03|||June 11, 2015|Actual|2015-06-11|May 2017|2017-05-01|December 14, 2018|Anticipated|2018-12-14|December 14, 2018|Anticipated|2018-12-14||Interventional|||Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086)|A Phase II Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy for Metastatic Triple-Negative Breast Cancer (mTNBC) - (KEYNOTE-086)|Active, not recruiting||Phase 2|285|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 23:17:47.094034|2017-10-10 23:17:47.094034
NCT02446990|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-07-20|2015-05-20||September 2009||2009-09-01|July 2017|2017-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|SIGNIFY||Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure|Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure. A Randomised Double-blind Placebo-controlled International Multicenter Study. Study Assessing the Morbi-mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease|Completed||Phase 3|19102|Actual|Servier||2|||f||||t||||||||||2017-10-10 23:17:47.363819|2017-10-10 23:17:47.363819
NCT02446977|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-12|||March 2015||2015-03-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke|Randomized Clinical Trial to Investigate Whether Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke Causes a Reduction of Glutamate-mediated Excitotoxicity|Completed||Phase 2|50|Actual|Castillo, José, M.D.||2|||f||||f||||||||||2017-10-10 23:17:58.352368|2017-10-10 23:17:58.352368
NCT02446964|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-09-27|||June 5, 2015|Actual|2015-06-05|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia|Phase I Study of Escalating Doses of Total Marrow and Lymphoid Irradiation (TMLI) During Conditioning for HLA-Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide in Patients With Myelodysplasia or Acute Leukemia|Recruiting||Phase 1|24|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:17:58.4517|2017-10-10 23:17:58.4517
NCT02446951|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-01-30|||January 2015||2015-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department|Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department|Recruiting||N/A|1550|Anticipated|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||||2017-10-10 23:17:58.603856|2017-10-10 23:17:58.603856
NCT02446938|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2015-10-09|||May 2015||2015-05-01|June 2015|2015-06-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Position of Esophageal Balloon in Patients With Mechanical Ventilation|A Simple Method for Confirming the Optimal Position of Esophageal Balloon in Patients With Mechanical Ventilation|Completed||N/A|20|Actual|Capital Medical University|||1||f||||t||||||||||2017-10-10 23:17:58.684494|2017-10-10 23:17:58.684494
NCT02446925|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-11-14|||May 2015||2015-05-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot Study|Surefire Catheter Versus Standard End-hole Microcatheter in Yttrium-90 Distribution and Tissue Penetration: A Pilot Study|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Wright State University||2|||f||||f||||||||||2017-10-10 23:17:58.745459|2017-10-10 23:17:58.745459
NCT02446912|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-09-19|||June 9, 2015|Actual|2015-06-09|September 2017|2017-09-01|July 13, 2018|Anticipated|2018-07-13|July 13, 2018|Anticipated|2018-07-13||Interventional|||Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus|A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus|Active, not recruiting||Phase 3|460|Actual|AstraZeneca||3|||f||||t|t|f||||||||2017-10-10 23:17:58.835981|2017-10-10 23:17:58.835981
NCT02446899|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-09-05|||July 9, 2015|Actual|2015-07-09|September 2017|2017-09-01|September 13, 2018|Anticipated|2018-09-13|September 13, 2018|Anticipated|2018-09-13||Interventional|||Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus|A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus|Active, not recruiting||Phase 3|360|Anticipated|AstraZeneca||2|||f||||t|t|f||||||||2017-10-10 23:17:59.334497|2017-10-10 23:17:59.334497
NCT02446886|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-01-23|||June 2016|Actual|2016-06-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS|Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS|Recruiting||Phase 4|30|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-10 23:17:59.792132|2017-10-10 23:17:59.792132
NCT02446873|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-11-30|||February 2015||2015-02-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Cracking the Egg Potential: Improving Young Child Nutrition in Ecuador|Cracking the Egg Potential: Improving Young Child Nutrition in Ecuador|Active, not recruiting||N/A|180|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:17:59.895159|2017-10-10 23:17:59.895159
NCT02446860|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-05-13|||April 2015||2015-04-01|May 2015|2015-05-01|May 2018|Anticipated|2018-05-01|November 2016|Anticipated|2016-11-01||Interventional|ADAPTeR||A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)|A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)|Recruiting||Phase 2|19|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 23:17:59.983026|2017-10-10 23:17:59.983026
NCT02446847|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-03-08|||March 2015||2015-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|February 2017|Actual|2017-02-01||Interventional|||3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption|A Phase 2, Open Label Study of the Safety, Antiretroviral Activity and Pharmacokinetics of 3BNC117 During a Short Analytical Treatment Interruption in HIV-infected Subjects|Active, not recruiting||Phase 2|16|Actual|Rockefeller University||2|||f||||t||||||||No||2017-10-10 23:18:00.082868|2017-10-10 23:18:00.082868
NCT02446834|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-06-20|||April 2015||2015-04-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Research of Intensive Lifestyle Intervention for PCOS Patients With IGT|Research of Intensive Lifestyle Intervention for Overweight PCOS Patients With Impaired Glucose Tolerance in Their Metabolic and Reproductive Abnormalities Treatment|Recruiting||N/A|48|Anticipated|RenJi Hospital||4|||f||||f||||||||Undecided||2017-10-10 23:18:01.547355|2017-10-10 23:18:01.547355
NCT02446821|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-12-21|||June 2015||2015-06-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception|Evaluation of the Effectiveness, Safety and Tolerability of the ContraMed VeraCept Intrauterine Copper Contraceptive for Long-Acting Reversible Contraception|Active, not recruiting||Phase 2|286|Actual|ContraMed LLC||1|||f||||f||||||||||2017-10-10 23:18:01.719302|2017-10-10 23:18:01.719302
NCT02446808|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-03-02|||June 2015||2015-06-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Intraoperative Nerve Monitoring During Robot-assisted Laparoscopic Prostatectomy|Clinical Assessment of Intraoperative Nerve Monitoring During Robot-assisted Laparoscopic Prostatectomy|Recruiting||N/A|80|Anticipated|ProPep Surgical, LLC||1|||f||||t||||||||||2017-10-10 23:18:01.842449|2017-10-10 23:18:01.842449
NCT02446795|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-01-16|||November 2016||2016-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|QUASAR||Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial|Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial|Recruiting||Phase 1/Phase 2|104|Anticipated|Consorzio Oncotech||2|||f||||f||||||||No||2017-10-10 23:18:01.930012|2017-10-10 23:18:01.930012
NCT02446782|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2017-01-16|||January 2015||2015-01-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|APT||Efficacy and Safety of Prophylactic Use of an Antibiotic for Medical Thoracoscopy|A Study to Evaluate the Efficacy and Safety of a Single Dose of an Injectable Antibiotic for the Prophylaxis of Surgical Site and Pleural Space Infection After Medical Thoracoscopy|Completed||Phase 4|100|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 23:18:02.096814|2017-10-10 23:18:02.096814
NCT02446769|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-04-05|||February 2016||2016-02-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|STOP-BBACK||A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD|A Pilot, Multi-Center, Randomized, Open-Label, Parallel Group Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD|Recruiting||N/A|60|Anticipated|Philips Respironics||2|||f||||t||||||||||2017-10-10 23:18:02.225957|2017-10-10 23:18:02.225957
NCT02446756|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-13|||January 2010||2010-01-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Interventional|||Clinical Observation and MRI Influence of Acupuncture on Knee Osteoarthritis|Clinical Observation and MRI Influence of Acupuncture on Knee Osteoarthritis|Completed||N/A|50|Actual|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 23:18:02.323344|2017-10-10 23:18:02.323344
NCT02446730|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-15|||September 2014||2014-09-01|May 2015|2015-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|BEAUTY-II||Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome|A Prospective, Multicenter, Randomized, Open-label Trial to Evaluate Efficacy and Safety of 5mg Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention With BiomatrixTM Stent|Unknown status|Recruiting|Phase 4|1400|Anticipated|Chonnam National University Hospital||2|||f||||t||||||||||2017-10-10 23:18:02.5405|2017-10-10 23:18:02.5405
NCT02446717|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-08-17|2017-08-17|2017-01-31|April 2015|Actual|2015-04-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy|A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 (or ABT-493/ABT-530) With and Without Ribavirin in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Failed a Prior Direct-Acting Antiviral Agent (DAA)-Containing Therapy|Completed||Phase 2/Phase 3|141|Actual|AbbVie||5|||f||||f||||||||||2017-10-10 23:18:02.653168|2017-10-10 23:18:02.653168
NCT02446704|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-05-08|||September 2015||2015-09-01|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy|Phase I/II Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy|Active, not recruiting||Phase 1/Phase 2|29|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:18:03.256997|2017-10-10 23:18:03.256997
NCT02446691|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-06-15|||July 13, 2015|Actual|2015-07-13|June 2017|2017-06-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations|A Phase IV, Open-Label, Multi-Center Study to Evaluate the Safety and the 1-year Persistence of Antibody Response Among Children Who Received 4 Doses of the GSK MenACWY Conjugate Vaccine at 2, 4, 6 and 12 Months of Age in South Korea|Active, not recruiting||Phase 4|135|Anticipated|GlaxoSmithKline||1|||f|||||f|f||||||||2017-10-10 23:18:03.512401|2017-10-10 23:18:03.512401
NCT02446678|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-04-23|||November 2013||2013-11-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Interventional|||Use of PillCam ESO2 in Triaging Patients Present With Upper GIB|The Use Of PillCam Esophagus In Triaging Patients Presented With Upper Gastrointestinal Bleeding|Completed||N/A|68|Actual|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-10 23:18:03.594682|2017-10-10 23:18:03.594682
NCT02446665|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-10-27|||October 2014||2014-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Disease Status in Primary Sclerosing Cholangitis by Elastography|Comprehensive Evaluation of Disease Status in Primary Sclerosing Cholangitis by MRCP and MR Elastography Through Hepatic Fibrosis Estimation With Comparison to FibroScan|Suspended||N/A|120|Anticipated|University Health Network, Toronto||2||A key study collaborator is on a temporary leave of absence|f||||f||||||||||2017-10-10 23:18:03.670853|2017-10-10 23:18:03.670853
NCT02446652|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-05-13|||July 2015||2015-07-01|May 2015|2015-05-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer|"Phase III Clinical Trial: Evaluation of the Combination of TRANSKRIP ® Plus Carboplatin and Paclitaxel as First Line Chemotherapy on Survival of Patients With Recurrent - Persistent Cervical Cancer"|Not yet recruiting||Phase 3|230|Anticipated|National Institute of Cancerología||2|||f||||t||||||||||2017-10-10 23:18:03.751069|2017-10-10 23:18:03.751069
NCT02446639|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-05-22|||June 2014||2014-06-01|May 2017|2017-05-01|December 22, 2016|Actual|2016-12-22|May 2015|Actual|2015-05-01||Observational|ECHOTnT||Assessment the Dosage of Troponin T Hypersensitive Dosage in a Patient Population Hemodialysis and Peritoneal Dialysis|Assessment the Dosage of Troponin T Hypersensitive Dosage in a Patient Population Hemodialysis and Peritoneal Dialysis (ECHOTnT)|Completed||N/A|100|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 23:18:03.934676|2017-10-10 23:18:03.934676
NCT02446626|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-07-13|||May 1, 2015||2015-05-01|July 12, 2017|2017-07-12|December 1, 2030|Anticipated|2030-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||Xenodiagnosis After Antibiotic Treatment for Lyme Disease|Xenodiagnosis After Antibiotic Treatment for Lyme Disease - Phase II Study|Recruiting||Phase 1/Phase 2|240|Anticipated|National Institutes of Health Clinical Center (CC)||5|||f||||||||||||||2017-10-10 23:18:04.035678|2017-10-10 23:18:04.035678
NCT02446613|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-01-24|2017-01-24||June 2015||2015-06-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958|A Single-centre, Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Who Completed Treatment in Study TL7116958 in 2014|Completed||Phase 2|16|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:18:04.175356|2017-10-10 23:18:04.175356
NCT02446587|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-01-03|||January 2016||2016-01-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|SELECT||Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke|Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)|Recruiting||N/A|500|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||t||||||||||2017-10-10 23:18:06.757704|2017-10-10 23:18:06.757704
NCT02446574|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-07-30|||July 2007||2007-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma|Phase I /II Study of Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|33|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 23:18:06.975517|2017-10-10 23:18:06.975517
NCT02446561|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-08-30|||April 2015||2015-04-01|August 2017|2017-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication||Completed||Phase 1|32|Actual|Mundipharma Research Limited||4|||f||||f||||||||||2017-10-10 23:18:07.132814|2017-10-10 23:18:07.132814
NCT02446548|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-13|||March 2013||2013-03-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||Influence of Aliskiren on Albuminuria After Kidney Transplantation|Influence of Aliskiren on Albuminuria After Kidney Transplantation|Completed||N/A|18|Actual|Medical University of Gdansk||2|||f||||f||||||||||2017-10-10 23:18:07.243702|2017-10-10 23:18:07.243702
NCT02446535|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-05-13|||February 2015||2015-02-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|REST||Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW?|REST/Collaborative Study Initiative With the Aim of Providing More Objective Information on Volume Status and Guiding Physicians in the Quest for DW|Unknown status|Recruiting|N/A|60|Anticipated|Miulli General Hospital||1|||f||||t||||||||||2017-10-10 23:18:07.349442|2017-10-10 23:18:07.349442
NCT02446522|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-15|||January 2010||2010-01-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Compare Endoscopic and Open Methods of Vein Harvesting for Coronary Artery Bypass Grafting|Comparative Results of Endoscopic and Open Methods of Vein Harvesting for Coronary Artery Bypass Grafting: a Prospective Randomized Parallel-group Trial.|Completed||Phase 4|228|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||||||||||||2017-10-10 23:18:07.451789|2017-10-10 23:18:07.451789
NCT02446509|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-05-01|||September 2013||2013-09-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||A Psychoeducation Intervention for Caregivers of Patients With Bipolar Disorder|A Psychoeducation Intervention for Caregivers of Patients With Bipolar Disorder: A Feasibility Study|Recruiting||N/A|40|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:18:07.52845|2017-10-10 23:18:07.52845
NCT02446496|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-08-23|2017-03-15||March 31, 2014|Actual|2014-03-31|August 2017|2017-08-01|April 8, 2014|Actual|2014-04-08|April 8, 2014|Actual|2014-04-08||Interventional|||A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects|Comparative Randomized, Single Dose, Two-way Crossover, Open-label Study to Determine the Bioequivalence of Cefadroxil From Duricef 1 gm Film Coated Tablets (Smithkline Beecham Egypt, LLC Affiliated Co. to GalaxoSmithKline ) and Biodroxil 1 gm Film Coated Tablets (Kahira Pharm &Chem .Ind. Co. for Novartis Pharma ) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions|Completed||Phase 4|24|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:18:07.615459|2017-10-10 23:18:07.615459
NCT02446483|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-07-06|2017-03-28||March 1, 2014||2014-03-01|March 2017|2017-03-01|March 26, 2014|Actual|2014-03-26|March 1, 2014|Actual|2014-03-01||Interventional|||A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults|Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt)and PARIET 20 mg DR Tabs (JANSSEN, EGYPT) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions|Completed||Phase 4|60|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:18:07.860555|2017-10-10 23:18:07.860555
NCT02446470|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-13|||May 2015||2015-05-01|May 2015|2015-05-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Sinus Tarsi Versus Extensile Lateral Approach for Calcaneus Fractures|Sinus Tarsi Versus Extensile Lateral Approach for Open Reduction Internal Fixation of Intra-articular Calcaneus Fractures|Enrolling by invitation||N/A|110|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-10 23:18:08.286682|2017-10-10 23:18:08.286682
NCT02446457|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-09-25|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of Rituximab Plus Pembrolizumab (MK-3475) in Subjects With Relapsed Follicular Lymphoma|Phase II Study of Rituximab Plus Pembrolizumab (MK-3475) in Subjects With Relapsed Follicular Lymphoma|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:18:08.410899|2017-10-10 23:18:08.410899
NCT02446444|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-04-30|||March 2014||2014-03-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|ENZARAD||Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer|Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD|Recruiting||Phase 3|800|Anticipated|University of Sydney||2|||f||||t||||||||||2017-10-10 23:18:08.591785|2017-10-10 23:18:08.591785
NCT02446431|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-13|||July 2014||2014-07-01|May 2015|2015-05-01|July 2029|Anticipated|2029-07-01|July 2024|Anticipated|2024-07-01||Interventional|Metronomic||Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence|Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence: A Multi-Institutional Study|Recruiting||Early Phase 1|20|Anticipated|Miller Children's & Women's Hospital Long Beach||1|||f||||f||||||||||2017-10-10 23:18:09.264655|2017-10-10 23:18:09.264655
NCT02446236|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-08-09|||June 18, 2015|Actual|2015-06-18|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma|Phase Ib Dose Finding Study of Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765) Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma (MCL)|Recruiting||Phase 1|38|Anticipated|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-10 23:18:11.320063|2017-10-10 23:18:11.320063
NCT02446418|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-09-19|||July 9, 2015|Actual|2015-07-09|September 2017|2017-09-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma|A 6-month, Open Label, Randomised, Efficacy Study to Evaluate Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) Inhalation Powder Delivered Once Daily Via the Dry Powder Inhaler ELLIPTA™ Compared With Usual ICS/LABA Maintenance Therapy Delivered by Dry Powder Inhaler in Subjects With Persistent Asthma|Completed||Phase 3|423|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:18:09.383664|2017-10-10 23:18:09.383664
NCT02446405|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-03-26|||March 2014||2014-03-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|ENZAMET||Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer|Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET|Active, not recruiting||Phase 3|1125|Actual|University of Sydney||2|||f||||t||||||||||2017-10-10 23:18:09.672325|2017-10-10 23:18:09.672325
NCT02446392|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-03-01|||October 2014||2014-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Observational|TDM-ICU||The Distribution of Plasma Drug Concentrations of Beta-lactam Antibiotics in Intensive Care Unit Patients|The Distribution of Plasma Drug Concentrations of Beta-lactam Antibiotics in Intensive Care Unit Patients|Completed||N/A|120|Actual|Linkoeping University|||1||f||||f||||||Samples Without DNA|"     Plasma samples at three consecutive days for measurement of plasma drug concentrations   "|||2017-10-10 23:18:10.234928|2017-10-10 23:18:10.234928
NCT02446379|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-01-25||||||January 2017|2017-01-01||||January 1, 2016|Actual|2016-01-01||Observational|CLIO||Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery|Evaluation of the Use of Intra-operative Molecular Imaging With BetaScope and in Vitro Measurement With LightPath Specimen Analyser Devices in Gastrointestinal Tumour Surgery|Withdrawn||N/A|0|Actual|Lightpoint Medical Limited|||1|Technology licensed to third party. Sponsor did not proceed with study.|f||||f||||||||||2017-10-10 23:18:10.311362|2017-10-10 23:18:10.311362
NCT02446366|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-04-08|||May 12, 2015|Actual|2015-05-12|April 2017|2017-04-01|May 12, 2019|Anticipated|2019-05-12|May 12, 2018|Anticipated|2018-05-12||Interventional|||Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery|Phase I Dose-Escalation Study of Hypofractionated SBRT for Adjuvant/Salvage Radiotherapy in Prostate Cancer|Recruiting||N/A|36|Anticipated|University of Southern California||1|||f||||t|f|f||||||||2017-10-10 23:18:10.401328|2017-10-10 23:18:10.401328
NCT02446353|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-05-13|||April 2010||2010-04-01|May 2015|2015-05-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|Apetrol||Pharmacokinetics and Safety Study of Apetrol ES|A Randomized, Open Label, Single Dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and Megace® Under Fasting and Fed Conditions in Healthy Male Volunteers|Completed||Phase 1|79|Actual|LG Life Sciences||4|||f||||f||||||||||2017-10-10 23:18:10.482789|2017-10-10 23:18:10.482789
NCT02446327|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-05-13|||January 2012||2012-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|MEDIA-DHF||The Metabolic Road to Diastolic Heart Failure: Diastolic Heart Failure Study|The Metabolic Road to Diastolic Heart Failure : Diastolic Heart Failure Study (MEDIA-DHF)|Completed||N/A|47|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-10-10 23:18:10.654152|2017-10-10 23:18:10.654152
NCT02446314|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-08-14|||May 2015||2015-05-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|November 2016|Actual|2016-11-01||Interventional|||An Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults|A Randomized, Double-blind, Placebo-controlled Study Investigating the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults|Completed||N/A|121|Actual|University of Reading||4|||f||||||||||||||2017-10-10 23:18:10.718516|2017-10-10 23:18:10.718516
NCT02446301|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-18|||January 2015||2015-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers|A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection vs. Bain®. Nalbuphine HCl IM Injection, in Healthy Volunteers|Completed||Phase 1|12|Actual|Lumosa Therapeutics Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:18:10.894785|2017-10-10 23:18:10.894785
NCT02446288|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-13|||June 2015||2015-06-01|May 2015|2015-05-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||TMJ NextGen Pilot Study to Treat Subjects With Bruxism|A Pilot Study of the TMJ NextGeneration Compared to the DSG Relaxer for Reduction in Nocturnal Bruxism Episodes in Subjects Diagnosed With Sleep Bruxism|Unknown status|Not yet recruiting|N/A|20|Anticipated|Cardiox Corporation||2|||f||||f||||||||||2017-10-10 23:18:10.980757|2017-10-10 23:18:10.980757
NCT02446275|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-05-15|||January 2014||2014-01-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|MTHDIQMi||Efficacy of Manual Therapy in Migraine|DO SOFT TISSUE TECHNIQUES HAVE A POSITIVE EFFECT ON DISABILITY AND QUALITY OF LIFE IN MIGRAINE SUFFERERS?: A Randomized Controlled Trial|Completed||N/A|30|Actual|University of Valencia||2|||f||||f||||||||||2017-10-10 23:18:11.051025|2017-10-10 23:18:11.051025
NCT02446249|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-14|2017-06-30|||April 30, 2015||2015-04-30|May 15, 2017|2017-05-15|November 1, 2022|Anticipated|2022-11-01|November 1, 2022|Anticipated|2022-11-01||Interventional|||Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction|Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of an Adeno-Associated Virus Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals With Irradiation-Induced Parotid Salivary Hypofunction|Recruiting||Phase 1/Phase 2|50|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:18:11.213739|2017-10-10 23:18:11.213739
NCT02446223|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-02-27|||January 2015||2015-01-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%|A Pilot Prospective Clinical Trial to Evaluate the Efficacy and Safety of Large-Scale, Field-Directed Topical Therapy of Actinic Keratosis of the Chest With Ingenol Mebutate 0.015%|Completed||Phase 4|23|Actual|Goldman, Butterwick, Fitzpatrick and Groff||1|||f||||||||||||||2017-10-10 23:18:11.484404|2017-10-10 23:18:11.484404
NCT02446210|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-12-01|||March 2015||2015-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Neural Control of Bilateral Movements After SCI|Neural Control of Bilateral Hand, Arm, and Leg Movements After Spinal Cord Injury|Recruiting||N/A|514|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 23:18:11.579305|2017-10-10 23:18:11.579305
NCT02446197|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-01-15|||October 2014||2014-10-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Self Directed Stations for the Stroke Patient|Self Directed Stations for the Stroke Patient|Recruiting||Phase 1/Phase 2|77|Anticipated|Baylor Research Institute||2|||f||||f||||||||||2017-10-10 23:18:11.669255|2017-10-10 23:18:11.669255
NCT02446184|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-02-09|||December 4, 2014|Actual|2014-12-04|February 2017|2017-02-01|August 23, 2016|Actual|2016-08-23|August 2016|Actual|2016-08-01||Interventional|||Fetal Cystoscopy for Lower Urinary Tract Obstruction|Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction - a Prospective Trial|Terminated||N/A|8|Actual|Baylor College of Medicine||3||Original P.I. of this study transferred to a different institution.|f||||t|f|f||||||No||2017-10-10 23:18:11.777246|2017-10-10 23:18:11.777246
NCT02446171|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-01-30|2016-04-29||May 2015||2015-05-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution|An Open-Label, Randomized, 4-Period, 4-Treatment, Crossover, Single-Center, Single-Dose Bioavailability Study With Alternate Methods of Administration of Crushed Naloxegol Tablets, 25 mg and of a Naloxegol Solution Formulation, 25 mg, Compared to Whole Naloxegol Tablets, 25 mg, in Healthy Subjects|Completed||Phase 1|44|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-10 23:18:11.900002|2017-10-10 23:18:11.900002
NCT02446158|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-05-13|||May 2010||2010-05-01|May 2015|2015-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients|A Randomized Trial of Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients for Bacterial Decolonization and Prevention of Infection|Completed||Phase 4|89|Actual|E-DA Hospital||2|||f||||t||||||||||2017-10-10 23:18:12.784365|2017-10-10 23:18:12.784365
NCT02446145|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-01-05|||May 2015||2015-05-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|DELTA||A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients|A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients ≥65 Years of Age Not Eligible for Intensive Chemotherapy|Recruiting||Phase 2|238|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-10 23:18:12.846443|2017-10-10 23:18:12.846443
NCT02446132|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-22|||December 2015||2015-12-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type|A Phase 3, Multicenter, Long Term, Extension Study of the Safety and Efficacy of AVP-786 (Deuterated [d6] Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type|Recruiting||Phase 3|700|Anticipated|Avanir Pharmaceuticals||3|||f||||t|t|f||||||||2017-10-10 23:18:13.217489|2017-10-10 23:18:13.217489
NCT02446119|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2015-05-14|||May 2015||2015-05-01|May 2015|2015-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|PyloEndoFlip||Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlip|Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlip|Unknown status|Recruiting|N/A|70|Anticipated|Temple University|||2||f||||f||||||||||2017-10-10 23:18:13.68166|2017-10-10 23:18:13.68166
NCT02446106|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-15|||June 2012||2012-06-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Monosodium L-glutamate (MSG) on Satiety|The Effect of Monosodium L-glutamate (MSG) on Satiety and Energy Intake in Overweight and Obese Women|Completed||N/A|75|Actual|Ajinomoto Co., Inc.||2|||f||||t||||||||||2017-10-10 23:18:13.776449|2017-10-10 23:18:13.776449
NCT02446093|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-05-04|||October 2015||2015-10-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|PaTK02||Neoadjuvant GMCI Plus mFOLFIRINOX and Chemoradiation for Non-Metastatic Pancreatic Adenocarcinoma|Neoadjuvant GMCI Plus Modified FOLFIRINOX and Chemoradiation for Advanced Non-Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 1/Phase 2|44|Anticipated|Advantagene, Inc.||2|||f||||||||||||||2017-10-10 23:18:13.865812|2017-10-10 23:18:13.865812
NCT02446080|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-14|||December 2014||2014-12-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Drink Milk Consumption Benefits With Culture Probiotic in the Treatment of Constipation|The Drink Milk Consumption Benefits With Culture Probiotic in the Treatment of Constipation Women|Completed||N/A|60|Actual|Centro Universitário Univates||2|||f||||f||||||||||2017-10-10 23:18:13.991273|2017-10-10 23:18:13.991273
NCT02446067|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-14|||March 2010||2010-03-01|May 2015|2015-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Cerebral Hemodynamics With rTMS in Alcohol Dependence|Cerebral Hemodynamics With rTMS in Alcohol Dependence: A Randomized, Sham Controlled Study|Completed||N/A|75|Actual|Central Institute of Psychiatry, Ranchi, India||3|||f||||f||||||||||2017-10-10 23:18:14.078748|2017-10-10 23:18:14.078748
NCT02446054|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-01-27|||February 2014||2014-02-01|May 2015|2015-05-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease|A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease|Completed||N/A|30|Actual|Celio Technology Inc.||1|||f||||f||||||||||2017-10-10 23:18:14.183467|2017-10-10 23:18:14.183467
NCT02446041|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-10-10|||May 2015||2015-05-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||ICS/LABA Adherence and COPD Exacerbation|Adherence and COPD Exacerbation Rates in Patients Initiating ICS/LABA Therapy.|Completed||N/A|10000|Actual|AstraZeneca|||1||f||||||||||||||2017-10-10 23:18:14.272203|2017-10-10 23:18:14.272203
NCT02446028|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-03-09||2016-01-15|May 2015||2015-05-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes|A Randomized, Open-label Parallel Group Phase 2b Trial Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes|Suspended||Phase 2|13|Actual|Biodel||2||IND Withdrawn|f||||f||||||||||2017-10-10 23:18:14.357412|2017-10-10 23:18:14.357412
NCT02446015|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-04-04|2017-04-04||June 19, 2015|Actual|2015-06-19|April 2017|2017-04-01|June 21, 2016|Actual|2016-06-21|June 21, 2016|Actual|2016-06-21||Interventional||This analysis population includes all randomized subjects who received at least 1 dose of the randomized investigational product (Intent-to-Treat Analysis Set).|Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye|Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye|Completed||N/A|159|Actual|Alcon Research||2|||f||||f|f|f||||||||2017-10-10 23:18:14.472819|2017-10-10 23:18:14.472819
NCT02446002|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-05-01|||May 2015||2015-05-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects|Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects|Completed||Phase 1|25|Actual|US WorldMeds LLC||1|||f||||f||||||||||2017-10-10 23:18:14.77086|2017-10-10 23:18:14.77086
NCT02445989|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-05-16|||May 2016||2016-05-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity|Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity|Recruiting||Phase 4|120|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 23:18:14.856739|2017-10-10 23:18:14.856739
NCT02445976|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-09-20|||May 2015||2015-05-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.|A Phase 2 Open-label Study to Evaluate the Efficacy and Safety of Seviteronel in Subjects With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone|Recruiting||Phase 2|197|Anticipated|Innocrin Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:18:14.96457|2017-10-10 23:18:14.96457
NCT02445950|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-04-25|||November 2014||2014-11-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||With-Me - Technology-Aided Phone Coaching for Occupational Health Study|With-Me - Technology-Aided Phone Coaching for Occupational Health Study|Completed||N/A|50|Actual|VTT Technical Research Centre of Finland||2|||f||||f||||||||||2017-10-10 23:18:15.230851|2017-10-10 23:18:15.230851
NCT02445937|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-09-01|||June 2015||2015-06-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|||PARTNER II: Improving Patient and Family Centered Care in Advanced Critical Illness|Stepped Wedge Trial of an Intervention to Support Proxy Decision Makers in ICUs|Recruiting||N/A|1000|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 23:18:15.334571|2017-10-10 23:18:15.334571
NCT02445924|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-10-21|||May 2015||2015-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Observational|||Micro RNA Genetic Signature in NSCLC Egyptian Patients|Micro RNA Genetic Signature in Non-small Cell Lung Cancer Egyptian Patients|Completed||N/A|40|Actual|Tanta University|||3||f||||t||||||Samples With DNA|"     blood, bronchial lavage, bronchial biopsies   "|||2017-10-10 23:18:15.451971|2017-10-10 23:18:15.451971
NCT02445898|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-01-17|||September 2015||2015-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Methylprednisolone on Orthostatic Intolerance and Heart Rate Variability in Hip-arthroplasty Patients|Effect of Preoperative Intravenous High Dose Methylprednisolone on Orthostatic Intolerance and Heart Rate Variability in Patients Scheduled for Total Hip-arthroplasty|Completed||Phase 2/Phase 3|64|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:18:15.607944|2017-10-10 23:18:15.607944
NCT02445885|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-10-17|||May 2015||2015-05-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|April 2017|Anticipated|2017-04-01||Interventional|LATE-MI||Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction|Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction|Recruiting||Phase 2/Phase 3|150|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:18:15.694473|2017-10-10 23:18:15.694473
NCT02445872|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2015-12-08|||December 2015||2015-12-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy|Safety and Efficacy of Aprepitant for Chemotherapy-Induced Nausea and Vomiting in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy|Unknown status|Not yet recruiting|Phase 2|80|Anticipated|Zhejiang University||2|||f||||f||||||||||2017-10-10 23:18:15.790881|2017-10-10 23:18:15.790881
NCT02445859|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-10-24|||August 2015||2015-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|Colo-Pro||Continuous Antibiotic Prophylaxis in Colorectal Surgery|Colo-Pro Pilot: A Pilot Study to Compare Standard Single Dose Antibiotic Prophylaxis to Bolus-continuous Infusion Dosed Antibiotic Prophylaxis for the Prevention of Infections After Colorectal Surgery|Recruiting||Phase 2|60|Anticipated|University of Leeds||2|||f||||t||||||||No||2017-10-10 23:18:15.881164|2017-10-10 23:18:15.881164
NCT02445833|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-05-23|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|VIVIR-MEJOR||On-Line Intervention For Promoting Healthy Habits And Weight Loss In Hypertensive Patients|Design, Development And Validation Of A On-Line Intervention For Promoting Healthy Habits And Weight Loss In Hypertensive And Risk For Diabetes Mellitus People With Overweight And Type I Obesity|Completed||N/A|106|Actual|Universitat Jaume I||1|||f||||f||||||||||2017-10-10 23:18:16.165747|2017-10-10 23:18:16.165747
NCT02445820|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-10-29|||November 2014||2014-11-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||HES and Acute Kidney Injury in Adult Cardiac Surgery|The Association Between Hydroxyethyl Starch 130/0.4 and Acute Kidney Injury After Cardiopulmonary Bypass: a Single-center Retrospective Study|Completed||N/A|697|Actual|University Hospital of Liege|||2||f||||f||||||||||2017-10-10 23:18:16.242389|2017-10-10 23:18:16.242389
NCT02445807|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-08-01|||December 2015||2015-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis|A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days|Completed||Phase 3|265|Actual|Promius Pharma, LLC||2|||f||||f||||||||No||2017-10-10 23:18:16.316129|2017-10-10 23:18:16.316129
NCT02445794|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-10-03|||August 2015||2015-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||A First in Human Study of RT001 in Patients With Friedreich's Ataxia|A Randomized, Double-blind, Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of RT001 in Patients With Friedreich's Ataxia|Completed||Phase 1/Phase 2|19|Actual|Retrotope, Inc.||2|||f||||f||||||||||2017-10-10 23:18:16.450758|2017-10-10 23:18:16.450758
NCT02445781|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-02-09|||July 2015||2015-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Differing Levels of Hypoglycemia|Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Differing Levels of Hypoglycemia|Recruiting||Early Phase 1|32|Anticipated|University of Maryland||4|||f||||t||||||||||2017-10-10 23:18:16.542331|2017-10-10 23:18:16.542331
NCT02445768|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-09-08|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Functional Connectivity In Relation To Proprioception and Sensorimotor Recovery in Stroke Patients (Feasibility Study)|Functional Connectivity In Relation To Proprioception and Sensorimotor Recovery in Stroke Patients (Feasibility Study)|Recruiting||N/A|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:18:16.617318|2017-10-10 23:18:16.617318
NCT02445755|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-20|2015-05-20||June 2014||2014-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Transcutaneous Bilirubinometry in Neonates With the Bilicare System|Transcutaneous Bilirubinometry in Neonates With the Bilicare System|Completed||N/A|113|Actual|Stanford University|||1||f||||t||||||||||2017-10-10 23:18:16.687518|2017-10-10 23:18:16.687518
NCT02445742|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-01-11|||May 2015||2015-05-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|BOSTRO||CML Treated With Bosutinib After Relapse|Single Nucleotide Polymorphism Association With Response and Toxic Effects in Patients With Ph+ CP-CML Treated With Bosutinib After Relapse to Previous Treatment|Recruiting||Phase 2|50|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-10 23:18:17.02408|2017-10-10 23:18:17.02408
NCT02445729|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-01-12|||March 2015||2015-03-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Impact of Timing of Wound Dressing Removal After Cesarean Section|Impact of Timing of Wound Dressing Removal After Cesarean Section: Effect of Dressing Removal at 24 Hours Versus 48 Hours on Wound Healing and Incidence of Surgical Site Infections Following Cesarean Section|Enrolling by invitation||N/A|860|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-10 23:18:17.23852|2017-10-10 23:18:17.23852
NCT02445716|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-06-07|||October 2015||2015-10-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|Biolipid/B2||Transdermal Testosterone Nanoemulsion in Women Libido|Transdermal Testosterone Nanoemulsion Effects Emergent Loss of Libido in Women: A Randomized, Double-Blind, Placebo-Controlled Trial|Recruiting||Phase 2|70|Anticipated|University Potiguar||2|||f||||t||||||||||2017-10-10 23:18:17.403589|2017-10-10 23:18:17.403589
NCT02445703|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-13|||May 2014||2014-05-01|May 2015|2015-05-01||||January 2015|Actual|2015-01-01||Interventional|||Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine|Phase IV Immunogenicity and Safety Study of Different Immunization Schedules of Inactivated Hepatitis A Vaccine (HAV) and/ or Combined Hepatitis A and Hepatitis B Vaccine (HABV) in Healthy Chinese Infants|Completed||Phase 4|301|Actual|Sinovac Biotech Co., Ltd||3|||f||||f||||||||||2017-10-10 23:18:17.605747|2017-10-10 23:18:17.605747
NCT02445690|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-05-11|||May 2015||2015-05-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01|12 Months|Observational [Patient Registry]|||Thrombin Generation in Crohn's Disease|Correlation Between Thrombin Generation and Endoscopic Activity in Crohn's Disease|Unknown status|Recruiting|N/A|150|Anticipated|University of Sao Paulo General Hospital|||2||f||||t||||||Samples Without DNA|"     5ml of plasm   "|||2017-10-10 23:18:17.721166|2017-10-10 23:18:17.721166
NCT02445677|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-05-17|||September 2015||2015-09-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Using TENS to Relieve Pain and Potentiate the Rehabilitation of Pain Patients|Using Transcutaneous Electrical Nerve Stimulation (TENS) to Relieve Pain and Potentiate the Rehabilitation of Pain Patients: a Double Blind, Randomized Study Among Patients at the CSSS-IUGS Day Hospital|Withdrawn||N/A|0|Actual|Université de Sherbrooke||2||The study has now a correlational design: no participant recruitment is needed.|f||||f||||||||||2017-10-10 23:18:17.819153|2017-10-10 23:18:17.819153
NCT02445664|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-12|||August 2014||2014-08-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of a Tablet-administered Educational Video on Patients´ Knowledge on Osteoporosis and Treatment|Effect of a Tablet-administered Educational Video on Patients´ Knowledge on Osteoporosis and Treatment - a Randomized, Controlled Trial|Completed||N/A|67|Actual|University of Southern Denmark||2|||f||||||||||||||2017-10-10 23:18:17.910938|2017-10-10 23:18:17.910938
NCT02357342|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-06-20|2017-02-23||April 2015||2015-04-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD|Sirolimus Versus AntiVEGF for Wet AMD|Completed||Phase 2|40|Actual|Maturi, Raj K., M.D., P.C.||2|||f||||f||||||||No||2017-10-10 23:36:24.868296|2017-10-10 23:36:24.868296
NCT02445651|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-05-15|||March 2014||2014-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Physiological Effects of Nutritional Support in Patients With Parkinson's Disease|Physiological Effects of Nutritional Support in Patients With Parkinson's Disease|Enrolling by invitation||N/A|65|Anticipated|Thomas Jefferson University||2|||f||||f|f|f||||||Undecided|After each participant completes the study, study scan data will be shared with co-investigators; participants may receive a copy of each scan after study completion.|2017-10-10 23:18:17.992863|2017-10-10 23:18:17.992863
NCT02445638|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-13|||May 2015||2015-05-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||HDL Lipidomic, Proteomic and Functional Changes in Women After Eating Eggs|HDL Lipidomic, Proteomic and Functional Changes in Response to Whole Egg Consumption in Overweight and Obese Women|Recruiting||N/A|20|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 23:18:18.10178|2017-10-10 23:18:18.10178
NCT02445625|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-05-26|||May 2015||2015-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BCIAUT||BCI (Brain Computer Interface) Intervention in Autism|An Interventional Study to Improve Social Attention in Autistic Spectrum Disorder (ASD): A Brain Computer Interface (BCI) Approach|Enrolling by invitation||N/A|16|Anticipated|University of Coimbra||1|||f||||f||||||||||2017-10-10 23:18:18.218132|2017-10-10 23:18:18.218132
NCT02445612|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-09-07|||July 11, 2012|Actual|2012-07-11|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients|Long Term Follow Up to a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)|Active, not recruiting||N/A|13|Actual|Astellas Pharma Inc|||1||f||||t||||||||||2017-10-10 23:18:18.306965|2017-10-10 23:18:18.306965
NCT02445599|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-03-08|||April 2014||2014-04-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Diclofenac Premedication, as the Effect of Preemptive Analgesia After Post-thoracotomy Chest and Shoulder Pain|Diclofenac Premedication, as the Effect of Preemptive Analgesia After Post-thoracotomy Chest and Shoulder Pain, as Well as the Changes of the Postoperative Breathing Function Values, a Randomized, Controlled, Prospective Trial|Completed||Phase 4|3|Actual|University of Debrecen||2|||f||||t||||||||||2017-10-10 23:18:18.412362|2017-10-10 23:18:18.412362
NCT02445586|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-08-02|||August 17, 2015|Actual|2015-08-17|August 2017|2017-08-01|September 17, 2018|Anticipated|2018-09-17|September 17, 2018|Anticipated|2018-09-17||Interventional|||Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer|A Phase IV, Multicenter, Open-Label, Single-Arm Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in First Line Treatment of Indian Patients With HER2-Positive Advanced (Metastatic or Locally Recurrent) Breast Cancer|Active, not recruiting||Phase 4|52|Actual|Hoffmann-La Roche||1|||f|||||f|f||||||||2017-10-10 23:18:18.571674|2017-10-10 23:18:18.571674
NCT02445573|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-29|2015-05-15||December 2012||2012-12-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||All randomized population were included in baseline analysis.|Efficacy of Electroacupuncture (EA) for Women With Pure Stress Urinary Incontinence (SUI)|A Pilot Randomized Placebo Controlled Trial of Electroacupuncture for Women With Pure Stress Urinary Incontinence|Completed||N/A|80|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||||2017-10-10 23:18:18.692155|2017-10-10 23:18:18.692155
NCT02445560|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-04-14|||June 2015||2015-06-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Effects of a High Protein Diet on Microbiota, Gastrointestinal Function and Wellness in Older Women|The Effects of a High Protein Diet on Microbiota, Gastrointestinal Function, Wellness and the Potential Mitigating Effects of a Multi-strain Probiotic, Prebiotic, and Synbiotic: a Randomized, Double-blinded Crossover Study in Older Women.|Completed||N/A|29|Actual|University of Florida||4|||f||||f||||||||Undecided||2017-10-10 23:18:19.345984|2017-10-10 23:18:19.345984
NCT02445547|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-01-16|||June 2012||2012-06-01|January 2017|2017-01-01||||June 2015|Actual|2015-06-01||Interventional|||Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease|Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical Trial|Completed||Phase 1/Phase 2|82|Actual|Fuzhou General Hospital||2|||f||||t||||||||||2017-10-10 23:18:20.120648|2017-10-10 23:18:20.120648
NCT02445534|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-05-02|||January 2005||2005-01-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01|5 Years|Observational [Patient Registry]|RECORD||Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy|Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy|Recruiting||N/A|250|Anticipated|University Medical Centre Ljubljana|||1||f||||t||||||||||2017-10-10 23:18:20.202892|2017-10-10 23:18:20.202892
NCT02445521|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-12-09|||May 2015||2015-05-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Testing of Four Home Phenylalanine Monitoring Prototype Devices|Testing of Four Home Phenylalanine Monitoring Prototype Devices Using Whole Blood From Normal and PKU Subjects|Completed||N/A|9|Actual|Emory University|||5||f||||t||||||Samples Without DNA|"     Whole blood and plasma   "|||2017-10-10 23:18:20.277441|2017-10-10 23:18:20.277441
NCT02445508|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-05-02|||May 2015||2015-05-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion|Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion|Completed||N/A|15|Actual|University Hospital, Gentofte, Copenhagen||4|||f||||f||||||||||2017-10-10 23:18:20.364076|2017-10-10 23:18:20.364076
NCT02445495|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-12|||November 2013||2013-11-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Chart Review of the Efficacy of the GenesisPlus 1064 nm Nd:YAG Laser in the Treatment of Onychomycosis|A Single Centre Retrospective Chart Review Study to Assess the Efficacy of the GenesisPlus 1064 nm Nd:YAG Laser in the Treatment of Onychomycosis|Completed||N/A|100|Actual|Pacific Dermaesthetics|||1||f||||f||||||||||2017-10-10 23:18:20.453733|2017-10-10 23:18:20.453733
NCT02445300|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-05-12|||October 2013||2013-10-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy of Wound Care and Reduction of Wound Complications by Use of AQUACEL® Ag Surgical Dressing in MIS TKA|Efficacy of Wound Care and Reduction of Wound Complications by Use of AQUACEL® Ag Surgical Dressing in Minimally Invasive Total Knee Arthroplasty：A Prospective, Randomized Controlled Study|Completed||Phase 4|285|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:18:29.711328|2017-10-10 23:18:29.711328
NCT02445482|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-02-15|||October 2014||2014-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|AGATA||SOLTI Breast Cancer Molecular Screening Program (AGATA)|SOLTI Molecular Screening Program: a Pilot Study to Implement Personalized Therapy for Patients With Advanced or Metastatic Breast Cancer|Recruiting||N/A|260|Anticipated|SOLTI Breast Cancer Research Group|||1||f||||f||||||Samples With DNA|"     Collection of the archived initial or metastatic tumor sample (one 60 μm formalin-fixed,     paraffin-embedded tumor block). If archived material is not available, a biopsy of the     metastatic cancer should be performed to obtain such material   "|||2017-10-10 23:18:20.507057|2017-10-10 23:18:20.507057
NCT02445469|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-03-30|||December 2012||2012-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PARKIMAGE||Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes|Contribution of Magnetic Resonance Imaging (Diffusion Tensor Imaging and Magnetic Susceptibility Imaging and Resting Activation Imaging) in the Diagnosis of Parkinsonian Syndromes in Elderly Subjects.|Terminated||N/A|130|Actual|University Hospital, Montpellier||5||The results obtained are sufficient|f||||f||||||||||2017-10-10 23:18:20.840025|2017-10-10 23:18:20.840025
NCT02445456|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-01-30|||December 2016||2016-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|SentiRect||Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer|Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer|Recruiting||N/A|40|Anticipated|Oxford University Hospitals NHS Trust||2|||f||||f||||||||No||2017-10-10 23:18:20.931798|2017-10-10 23:18:20.931798
NCT02445443|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-04-24|||June 2015||2015-06-01|April 2017|2017-04-01|September 2023|Anticipated|2023-09-01|May 2018|Anticipated|2018-05-01||Observational|LINKS||LEGION Hinge Safety and Efficacy Study|A Prospective, Multi-center Clinical Study Evaluating the LEGION™ Hinge Knee System|Recruiting||N/A|45|Anticipated|Smith & Nephew, Inc.|||1||f||||f||||||||||2017-10-10 23:18:21.041033|2017-10-10 23:18:21.041033
NCT02445430|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-11-01|||May 2015||2015-05-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Observational|||Genetics of Arteriovenous Malformations|Genetics of Arteriovenous Malformations|Active, not recruiting||N/A|18|Actual|St. Joseph's Hospital and Medical Center, Phoenix|||1||f||||f||||||Samples With DNA|"     Saliva, blood, tissue (if undergoing AVM resection)   "|||2017-10-10 23:18:21.190034|2017-10-10 23:18:21.190034
NCT02445417|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-11-08|||May 2015||2015-05-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury|Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury|Recruiting||N/A|60|Anticipated|Sharp HealthCare|||2||f||||f||||||||||2017-10-10 23:18:21.276173|2017-10-10 23:18:21.276173
NCT02445404|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-04-08|||April 2015||2015-04-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL|Randomized Phase II Study to Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated Peripheral T-cell Lymphoma|Recruiting||Phase 2|134|Anticipated|Samsung Medical Center||2|||f||||f||||||||Yes||2017-10-10 23:18:21.374184|2017-10-10 23:18:21.374184
NCT02445391|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-10-03|||April 29, 2015|Actual|2015-04-29|October 2017|2017-10-01||||May 31, 2019|Anticipated|2019-05-31||Interventional|||Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy|A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy|Recruiting||Phase 3|562|Anticipated|Eastern Cooperative Oncology Group||3|||f||||f||||||||||2017-10-10 23:18:21.602516|2017-10-10 23:18:21.602516
NCT02445378|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-03-10|||December 2014||2014-12-01|March 2017|2017-03-01||||September 2016|Actual|2016-09-01||Interventional|||Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy|The Effect of Aromatherapy on Insomnia and Other Common Cancer Patient Symptoms|Completed||N/A|50|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:18:28.947904|2017-10-10 23:18:28.947904
NCT02445365|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-10-11|||May 2015||2015-05-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Remote Ischemic Conditioning in Patients With Ulcerative Colitis|Effect of Remote Ischemic Conditioning (RIC) on Inflammation and Remodelling of Extracellular Matrix Proteins in Patients With Inflammatory Bowel Diseases|Recruiting||N/A|38|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:18:29.051872|2017-10-10 23:18:29.051872
NCT02445352|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2015-05-14|||July 2014||2014-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|ROSE||Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia|A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R207 (Rosuvastatin /Ezetimibe Combination) and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia|Completed||Phase 3|379|Actual|Alvogen Korea||6|||f||||f||||||||||2017-10-10 23:18:29.142389|2017-10-10 23:18:29.142389
NCT02445339|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-07-20|||July 2015||2015-07-01|July 2017|2017-07-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|||Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users|Novel Interventions for Alcohol Dependent Frequent Emergency Department Users: Phase IV, Randomized, Open-label, Non-placebo-controlled Study of Extended-release Naltrexone and Care Management on Healthcare Use, Drinking, & Quality of Life|Recruiting||Phase 4|300|Anticipated|New York University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 23:18:29.260375|2017-10-10 23:18:29.260375
NCT02445326|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2016-12-05|||April 2015||2015-04-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis|A Multi-Center, Randomized, Double-Masked, Vehicle Controlled Phase 3 Study Evaluating the Efficacy and Safety of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model|Completed||Phase 3|72|Actual|Ocular Therapeutix, Inc.||2|||f||||f||||||||||2017-10-10 23:18:29.422898|2017-10-10 23:18:29.422898
NCT02445313|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-13|2017-02-14|||June 2015||2015-06-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device|Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device|Active, not recruiting||N/A|100|Anticipated|Doheny Image Reading Center|||2||f||||f||||||||||2017-10-10 23:18:29.487599|2017-10-10 23:18:29.487599
NCT02445287|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-12-02|2016-09-01||September 2015||2015-09-01|May 2015|2015-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||2D predicate and 3D reference devices were used on cadaveric specimens. Investigational CBCT 3D was used to image live humans.|Clinical Evaluation of CARESTREAM Cone Beam Computed Tomography (CBCT)|Clinical Evaluation of CARESTREAM Cone Beam Computed Tomography (CBCT)|Completed||N/A|48|Actual|Carestream Health, Inc.||2|||f||||f||||||||No||2017-10-10 23:18:29.807706|2017-10-10 23:18:29.807706
NCT02445274|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-04-29|||May 2015||2015-05-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Two Different Cataract Surgical Procedures to Prevent Posterior Capsule Opacification|Effectiveness of Two Different Surgical Procedures to Prevent Posterior Capsule Opacification in Age-related Cataract Patients|Recruiting||N/A|240|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:18:30.095873|2017-10-10 23:18:30.095873
NCT02445261|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-12|||June 2013||2013-06-01|May 2015|2015-05-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Mobile Phone Effects on Umbilical Artery Doppler and Heart Rate Tracing|The Effects of Mobile Phone on Umbilical Artery Doppler and Fetal Cardiotogogrphy in Normal and Gowth Restricted Fetuses|Unknown status|Recruiting|Phase 4|190|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-10 23:18:30.210603|2017-10-10 23:18:30.210603
NCT02445235|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-01-18|||April 2015||2015-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|SOPWS||Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar Therapy|Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar Therapy|Terminated||N/A|88|Actual|Bracane Company|||1|Sponsor discretion determined no clinical benefit|f||||f||||||||||2017-10-10 23:18:30.479022|2017-10-10 23:18:30.479022
NCT02445222|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-02-10|||November 2, 2015|Actual|2015-11-02|February 2017|2017-02-01|September 5, 2036|Anticipated|2036-09-05|September 5, 2036|Anticipated|2036-09-05||Interventional|||CD19 CART Long Term Follow Up (LTFU) Study|Long Term Follow-Up of Patients Exposed to Lentiviral-Based CD19 Directed CAR T-Cell Therapy|Recruiting||N/A|500|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 23:18:30.559411|2017-10-10 23:18:30.559411
NCT02445209|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-14|||September 2010||2010-09-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of Efficacy and Frequency of Adverse Events of 1st Line Palliative Chemotherapy EOX and mDCF Regimens in Advanced HER2-negative Gastric Carcinoma||Completed||Phase 3|56|Actual|Jagiellonian University||2|||f||||f||||||||||2017-10-10 23:18:30.934107|2017-10-10 23:18:30.934107
NCT02445196|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-02-15|2016-12-05||February 2014||2014-02-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||PTSD Coach App Evaluation|PTSD Coach App Evaluation|Completed||N/A|120|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:18:31.011942|2017-10-10 23:18:31.011942
NCT02445183|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-03-27|||December 2013||2013-12-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|5 Years|Observational [Patient Registry]|||COPDGene/Lung Cancer Center Database|COPDGene/Lung Cancer Center Database|Enrolling by invitation||N/A|250|Anticipated|National Jewish Health|||2||f||||f||||||||||2017-10-10 23:18:31.338303|2017-10-10 23:18:31.338303
NCT02445170|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-08-17|||July 2015||2015-07-01|August 2016|2016-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Heath-related Quality of Life of Diabetic Transmetatarsal Amputees and Below-knee Prosthetic Users|Heath-related Quality of Life of Diabetic Transmetatarsal Amputees and Below-knee Prosthetic Users|Withdrawn||N/A|0|Actual|Helsinki University Central Hospital|||2|The study is not eligible at present.|f||||f||||||||||2017-10-10 23:18:31.409734|2017-10-10 23:18:31.409734
NCT02445157|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-10-26|||February 2015||2015-02-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|IPFREL||Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis|Reliability of the 4 Metre Gait Speed in Patients With Idiopathic Pulmonary Fibrosis|Completed||N/A|46|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:18:31.494412|2017-10-10 23:18:31.494412
NCT02445144|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-07-18|||November 2014||2014-11-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease|Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease|Recruiting||N/A|30|Anticipated|Albert Einstein College of Medicine, Inc.|||2||f||||f||||||Samples With DNA|"     Blood samples for evaluation of inflammatory markers   "|Yes|Data will be made available after manuscript publication to those that request it|2017-10-10 23:18:31.57967|2017-10-10 23:18:31.57967
NCT02445131|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-09-23|||May 2015||2015-05-01|September 2016|2016-09-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG)|Prospective, Open-label, Multicenter Phase-II Trial to Evaluate Efficacy and Safety of a Sequential Regimen of Bendamustine Followed by GA101 (Obinutuzumab) and CAL-101 (Idelalisib) Followed by CAL-101 and GA101 Maintenance in CLL Patients|Recruiting||Phase 2|62|Anticipated|German CLL Study Group||1|||f||||f||||||||No||2017-10-10 23:18:31.667867|2017-10-10 23:18:31.667867
NCT02445118|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-08-09|||May 2015||2015-05-01|May 2015|2015-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Allograft Adipose Matrix (AAM) in Subcutaneous Dorsal Wrist|Local Skin and Volume Changes With the Use of Allograft Adipose Matrix (AAM) in the Subcutaneous Human Dorsal Wrist, a Pilot Study|Completed||N/A|15|Actual|Musculoskeletal Transplant Foundation|||1||f||||f||||||||No||2017-10-10 23:18:31.829536|2017-10-10 23:18:31.829536
NCT02445105|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Mobilizing Community Systems to Engage Families in Early Autism Spectrum Disorder (ASD) Detection & Services|Mobilizing Community Systems to Engage Families in Early Autism Spectrum Disorder (ASD) Detection & Services|Enrolling by invitation||N/A|72474|Anticipated|Florida State University||2|||f||||t||||||||||2017-10-10 23:18:31.911687|2017-10-10 23:18:31.911687
NCT02445092|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-09-25|||January 2014||2014-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||The Effect of Pre-washing the Insemination Catheter on Pregnancy Outcome|Double Blind Randomized Controlled Trial on the Effect of Pre-washing the Insemination Catheter on Pregnancy Outcome|Terminated||N/A|450|Actual|McGill University Health Center||2||"After reviewing the interim analysis results the study was terminated as a bigger sample size   was needed to find a significant difference between the groups."|f||||t||||||||||2017-10-10 23:18:32.036234|2017-10-10 23:18:32.036234
NCT02445079|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-08-30|||December 2013||2013-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|UGANDAC||Ugandan Non-Communicable Diseases and Aging Cohort|Epidemiology of Atherosclerosis Among Older-Age People in Southwestern Uganda|Recruiting||N/A|500|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples Without DNA|"     Annual collection of serum, plasma, and stool.   "|||2017-10-10 23:18:32.137581|2017-10-10 23:18:32.137581
NCT02445066|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-06-28|||October 2014||2014-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study to Examine the Effects of Vitamin D Supplementation on Mitochondrial Bioenergetics in Older Adults|A Pilot Study to Examine the Effects of Vitamin D Supplementation on Mitochondrial Bioenergetics in Older Adults - An EVIDENCE Sub-Study|Enrolling by invitation||N/A|15|Anticipated|Wake Forest University Health Sciences||1|||f||||t|f|f||||||||2017-10-10 23:18:32.232783|2017-10-10 23:18:32.232783
NCT02445053|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-08-09|||April 2015||2015-04-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|VOCAL||Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)|Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)|Active, not recruiting||N/A|90|Anticipated|Vertex Pharmaceuticals Incorporated|||1||f||||f||||||||||2017-10-10 23:18:32.303853|2017-10-10 23:18:32.303853
NCT02445040|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-05-12|||July 2015||2015-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates|A Clinical Study to Evaluate the Safety and Effectiveness of the Infinity Acute Care System Workstation Neonatal Care Babylog VN500 Device in High Frequency Oscillatory Ventilation (HFOV) Mode in Very Low Birth Weight (VLBW) Neonates|Recruiting||N/A|225|Anticipated|Draeger Medical Systems, Inc.||1|||f||||t||||||||No||2017-10-10 23:18:32.423852|2017-10-10 23:18:32.423852
NCT02445027|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-10-27|||August 2014||2014-08-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Pilot Study for Imaging of the Esophagus Using a Tethered Capsule OCT Endomicroscopy in the Primary Care Setting|Pilot Study for Imaging of the Esophagus Using a Tethered Capsule OCT Endomicroscopy in the Primary Care Setting|Active, not recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 23:18:32.589588|2017-10-10 23:18:32.589588
NCT02445014|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-07-11|||April 2015||2015-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SECM||Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic Capsule|Pilot Study for Imaging of Barrett's Esophagus Using an Spectrally Encoded Confocal Microscopy Tethered Endoscopic Capsule|Recruiting||N/A|36|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:18:32.662335|2017-10-10 23:18:32.662335
NCT02445001|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-01-20|||October 2013||2013-10-01|January 2016|2016-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|EGMRetinalDx||Erythrocyte Ghost Mediated Retinal Diagnosis|Erythrocyte Ghost Mediated Retinal Diagnosis|Withdrawn||N/A|0|Actual|Northwell Health||1||Withdrawn before recruitment started.|f||||f||||||||||2017-10-10 23:18:32.747997|2017-10-10 23:18:32.747997
NCT02444988|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-13|||June 1, 2015|Actual|2015-06-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|SMART-MED||Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit|Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit|Completed||Phase 3|5300|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 23:18:32.829727|2017-10-10 23:18:32.829727
NCT02444975|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-09-05|||December 2013||2013-12-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|S-HYDRACYST||The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST|The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST|Completed||N/A|140|Actual|Danone Research||2|||f||||f||||||||||2017-10-10 23:18:32.923456|2017-10-10 23:18:32.923456
NCT02444962|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-05-12|||June 2015||2015-06-01|May 2015|2015-05-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||BioComp Implants in Anaplastology - Pilot Study|Safe and Easy Application of BioComp Implants for Prosthetic Reconstruction of Craniofacial Defects|Not yet recruiting||N/A|10|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-10 23:18:32.996689|2017-10-10 23:18:32.996689
NCT02444949|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-05-14|||June 2014||2014-06-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma||Unknown status|Enrolling by invitation|Phase 3|72|Anticipated|China Three Gorges University, Yichang, China||2|||f||||||||||||||2017-10-10 23:18:33.061663|2017-10-10 23:18:33.061663
NCT02444923|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-09-07|||October 2015||2015-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Scleral Versus Corneal RGP Contact Lenses in Irregular Cornea Disorders|A Randomised Controlled Research to Asses the Clinical Performance and Effect on Vision Related Quality of Life of Rigid Gas Permeable Scleral Versus Corneal Contact Lenses for Keratoconus and Other Irregular Cornea Disorders|Enrolling by invitation||N/A|30|Anticipated|London South Bank University||2|||f||||t||||||||No||2017-10-10 23:18:33.19813|2017-10-10 23:18:33.19813
NCT02444910|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-11-15||2016-10-16|April 2015||2015-04-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects|Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects|Completed||Phase 2|9|Actual|KinDex Pharmaceuticals, Inc.||1|||f||||t||||||||No||2017-10-10 23:18:33.303716|2017-10-10 23:18:33.303716
NCT02444897|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2015-05-14|||September 2013||2013-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy|The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy|Completed||Phase 3|60|Actual|Keimyung University Dongsan Medical Center||2|||f||||f||||||||||2017-10-10 23:18:33.385007|2017-10-10 23:18:33.385007
NCT02444884|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-02-05|||September 2008||2008-09-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors|A Phase I/II Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children With Relapsed/Refractory Solid Tumors|Completed||Phase 1|54|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-10-10 23:18:33.511214|2017-10-10 23:18:33.511214
NCT02444871|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2015-05-27|||January 2013||2013-01-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||IgM-enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis|Immunoglobulin-M-enriched (IgM-enriched) Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis|Completed||N/A|30|Actual|Goethe University|||1||f||||f||||||||||2017-10-10 23:18:33.610849|2017-10-10 23:18:33.610849
NCT02444858|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-12|||May 2015||2015-05-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|UCMSC-PQLI||Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury|Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Paraquat Poisoning Induced Lung Injury|Recruiting||Phase 1/Phase 2|40|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-10 23:18:33.898658|2017-10-10 23:18:33.898658
NCT02444845|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-14|||May 2011||2011-05-01|May 2015|2015-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in Pakistan|Prevalence of Anaemia Secondary to Early Stage Chronic Kidney Disease in High Risk Diabetic and/or Hypertensive Population|Completed||N/A|246|Actual|Hoffmann-La Roche|||1||f||||||||||None Retained|"     Samples will be collected to determine glomerular filtration rate (eGFR) as well as anemia     profile.   "|||2017-10-10 23:18:34.046676|2017-10-10 23:18:34.046676
NCT02444832|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-14|||May 2015||2015-05-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|MACAARET||Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy|Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy|Recruiting||N/A|300|Anticipated|Hospital Clinic of Barcelona|||1||f||||f||||||||||2017-10-10 23:18:34.160109|2017-10-10 23:18:34.160109
NCT02444819|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-12-14|||March 2015||2015-03-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy|A Multicenter, Single-arm, Phase II Exploratory Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line Anticancer Agent in NSCLC Patients With EGFR Mutation|Active, not recruiting||Phase 2|33|Actual|Hanmi Pharmaceutical Company Limited||1|||f||||f||||||||||2017-10-10 23:18:34.2784|2017-10-10 23:18:34.2784
NCT02444806|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-07-11|||January 2015||2015-01-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||PSG Versus Oxim-capnography to Setup Home NIV|The Clinical Effectiveness of PSG Versus Limited Respiratory Polygraphy During NIV Set up in COPD-OSA Overlap Syndrome: A Randomised Controlled Trial|Completed||Phase 2|14|Actual|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f||||||||Undecided||2017-10-10 23:18:34.36273|2017-10-10 23:18:34.36273
NCT02444793|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-09-28|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors|A Phase 1b Study Of Pf-05082566 In Combination With Mogamulizumab (Kw-0761) In Patients With Advanced Solid Tumors|Recruiting||Phase 1|70|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 23:18:34.460592|2017-10-10 23:18:34.460592
NCT02444780|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-02-16|||June 2015||2015-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01|30 Days|Observational [Patient Registry]|||Observational Study on Plasma Glutamine Levels Before and After Cardiac Surgery|Observational Study on Plasma Glutamine Levels Before and After Cardiac Surgery|Completed||N/A|90|Actual|Medical Centre Leeuwarden|||1||f||||f||||||||||2017-10-10 23:18:34.61603|2017-10-10 23:18:34.61603
NCT02444767|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-13|||March 2015||2015-03-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Bimatoprost Ocular Insert Pharmacokinetic Study|A PK Study to Assess the Relative Systemic Exposure to Bimatoprost and Bimatoprost Acid After Administration of a Single 13 mg Bimatoprost Ocular Insert for 1 Week in Medically Stable Adult Subjects With or Without Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 1|11|Actual|ForSight Vision5, Inc.||1|||f||||f||||||||||2017-10-10 23:18:34.68175|2017-10-10 23:18:34.68175
NCT02444754|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-05-30|||January 2016||2016-01-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Attitudes and Knowledge Regarding Clinical Trials in Underserved Populations Receiving Care at the Comprehensive Cancer Center of Wake Forest University|Patient Experience Protocol (PEP): A Pilot Study of Underserved Populations at the Comprehensive Cancer Center of Wake Forest University (CCCWFU)|Recruiting||N/A|315|Anticipated|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-10 23:18:34.761487|2017-10-10 23:18:34.761487
NCT02444741|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-04-26|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||MK-3475 and Stereotactic Body Radiation Therapy (SBRT) in Patients With Non-Small Cell Lung Cancer (NSCLC)|Phase I/II Trial of MK-3475 and Hypofractionated Stereotactic Radiation Therapy in Patients With Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|104|Anticipated|M.D. Anderson Cancer Center||6|||f||||t|t|f||||||||2017-10-10 23:18:34.955091|2017-10-10 23:18:34.955091
NCT02444728|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-03-07|||July 2015||2015-07-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|CHORUS||Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE|Cyclophosphamide and Hydroxychloroquine for the Treatment of Severe Thrombocytopenia in Systemic Lupus Erythematosus|Recruiting||Phase 3|220|Anticipated|Chinese SLE Treatment And Research Group||2|||f||||f||||||||||2017-10-10 23:18:35.115387|2017-10-10 23:18:35.115387
NCT02444715|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-01-20|2015-06-08||January 2013||2013-01-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CAPSYS||Computer-Aided Prevention System|Study on Improved Prevention Methods for Cerebro-cardiovascular Diseases Based on a Computer-aided Prevention System|Completed||N/A|94|Actual|Luxembourg Institute of Science and Technology||2|||f||||t||||||||||2017-10-10 23:18:35.355893|2017-10-10 23:18:35.355893
NCT02444702|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-17|||June 2015||2015-06-01|April 2015|2015-04-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|||Clinical, Morphological and Functional Success Predictors Following Lumbar Spinal Surgery in Patients With Chronic Low Back Pain and Degenerative Disorders.|Clinical, Morphological and Functional Success Predictors Following Lumbar Spinal Surgery in Patients With Chronic Low Back Pain and Degenerative Disorders.|Not yet recruiting||N/A|150|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-10 23:18:35.949292|2017-10-10 23:18:35.949292
NCT02444689|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-03-09|||July 2015||2015-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||EMPower: Electronic Media Powering Positive Health Changes in Youth||Recruiting||N/A|90|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:18:36.048933|2017-10-10 23:18:36.048933
NCT02444676|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-08-30|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|HEFESTOS||Heart Failure STratification and OutcomeS|Heart Failure STratification and OutcomeS|Recruiting||N/A|360|Anticipated|Jordi Gol i Gurina Foundation|||1||f||||t||||||||||2017-10-10 23:18:36.143469|2017-10-10 23:18:36.143469
NCT02444663|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-11|||July 2015||2015-07-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Validation of a Stress Device for the Knee|Validation of a Device for Performing Valgus and Varus Stress X-rays of the Knee|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Oxford University Hospitals NHS Trust||4|||f||||f||||||||||2017-10-10 23:18:36.211226|2017-10-10 23:18:36.211226
NCT02444650|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-07-09|||April 2015||2015-04-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Measurement of Pulse Wave Velocity|Photoplethysmogram Measurement of Pulse Wave Velocity|Completed||N/A|32|Actual|Nonin Medical, Inc|||1||f||||f||||||||||2017-10-10 23:18:36.283923|2017-10-10 23:18:36.283923
NCT02444637|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-11|||April 2015||2015-04-01|May 2015|2015-05-01||||April 2017|Anticipated|2017-04-01||Interventional|||Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD|Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage Alzheimer's Disease Having Coexisting Small Vessel Cerebrovascular Disease|Unknown status|Recruiting|Phase 4|100|Anticipated|National Neuroscience Institute||1|||f||||t||||||||||2017-10-10 23:18:36.340853|2017-10-10 23:18:36.340853
NCT02444624|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-09-16|||May 2015||2015-05-01|September 2015|2015-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|CLOSNEC||Clostridium and Neonatal Necrotizing Enterocolitis Pathophysiology : Clinical and Molecular Approaches|Clostridium and Neonatal Necrotizing Enterocolitis Pathophysiology : Clinical and Molecular Approaches|Recruiting||N/A|120|Anticipated|Nantes University Hospital|||2||f||||f||||||Samples Without DNA|"     Fecal samples   "|||2017-10-10 23:18:36.42245|2017-10-10 23:18:36.42245
NCT02444611|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-08-29|||March 2015||2015-03-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|ELVIS||A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study|A Randomised, Controlled Trial Investigating the Influence of BCG (Bacillus Calmette-Guérin) and Hepatitis B Immunisation at Birth on Neonatal Immune Responses|Completed||N/A|185|Actual|Murdoch Childrens Research Institute||4|||f||||t||||||||||2017-10-10 23:18:36.493464|2017-10-10 23:18:36.493464
NCT02444598|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-05-09|||June 2015||2015-06-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|VACoCREW||Trial of Negative-pressure Wound Therapy Use in Conflict-related Extremity Wounds|A Prospective, Randomized, Controlled Trial of Negative-pressure Wound Therapy Use in Conflict-related Extremity Wounds (VACoCREW Trial)|Recruiting||N/A|116|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 23:18:36.586841|2017-10-10 23:18:36.586841
NCT02444585|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-04-24|||February 28, 2017|Actual|2017-02-28|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EDRPBLFHR||Longjohn Amgen Study - Effect of Denosumab...|Effect of Denosumab in Reversing Periprosthetic Bone Loss Following Hip Replacement|Recruiting||Phase 1|80|Anticipated|University of Southern California||2|||f||||t|t|f||||||||2017-10-10 23:18:36.702805|2017-10-10 23:18:36.702805
NCT02444572|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-11-02|||October 2015||2015-10-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|ENOXACARE||Comparison of Thromboembolic Events Between Enoxa® and Lovenox® in Patients Undergoing Digestive Cancer|Comparison of Thromboembolic Events Between EnoXA® and Lovenox® in Patients Undergoing Digestive CAncer and Subjected to Thromboprophylaxis|Recruiting||Phase 4|160|Anticipated|Les Laboratoires des Médicaments Stériles||2|||f||||t||||||||||2017-10-10 23:18:36.790608|2017-10-10 23:18:36.790608
NCT02444559|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-06-30|||May 2015||2015-05-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Does Perineural Clonidine Prolong Duration of a Nerve Block?|Does Perineural Clonidine Prolong the Duration of an Adductor Canal Block When Controlling for a Systemic Effect? - A Randomised Paired Trial in Healthy Volunteers.|Completed||Phase 2|21|Actual|Zealand University Hospital||2|||f||||t||||||||||2017-10-10 23:18:36.879684|2017-10-10 23:18:36.879684
NCT02444156|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-10-25|||June 2015||2015-06-01|May 2015|2015-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Rowing Away From Diabetes|Indoor Rowing in Adults With Impaired Glucose Regulation: a Pilot Study|Completed||N/A|12|Actual|University of Leicester||1|||f||||f||||||||||2017-10-10 23:18:40.711173|2017-10-10 23:18:40.711173
NCT02444533|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-06-16|2017-04-20||May 2015||2015-05-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional||Demographics include only subjects who were reported as having at least partial outcome data.|EXPAREL® for Pain After Tonsillectomy|A Phase IV Randomize, Single-Blind, Trial of Liposomal Bupivacaine (EXPAREL®) for Pain Control in Post-Tonsillectomy Patients|Completed||Phase 4|39|Actual|Mayo Clinic||2|||f||||f|t|f||||||No||2017-10-10 23:18:37.083867|2017-10-10 23:18:37.083867
NCT02444520|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-05-11|||May 2015||2015-05-01|May 2015|2015-05-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|PRINCE Primary||Persistent Physical Symptoms Reduction INtervention: a System Change & Evaluation in Primary Care|Persistent Physical Symptoms Reduction INtervention: a System Change & Evaluation in Primary Care|Unknown status|Not yet recruiting|N/A|240|Anticipated|King's College London||2|||f||||t||||||||||2017-10-10 23:18:37.482995|2017-10-10 23:18:37.482995
NCT02444507|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-11|||April 2015||2015-04-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product|A Randomized, Two-Way Crossover, Single-Dose Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product (Nexium Powder for Injection and Infusion 40 mg) in Healthy Adult Subjects|Unknown status|Recruiting|Phase 4|14|Anticipated|isRed Pharma & Biotech Research Corporation||2|||f||||||||||||||2017-10-10 23:18:37.584309|2017-10-10 23:18:37.584309
NCT02444494|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-11-30|||March 2015||2015-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01|9 Months|Observational [Patient Registry]|PSAS REGISTRY||Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After Stroke|Observational Prospective Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After Stroke, Under Conditions of Routine Clinical Practice|Completed||N/A|108|Actual|Ipsen|||1||f||||t||||||||||2017-10-10 23:18:37.811807|2017-10-10 23:18:37.811807
NCT02444481|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-05-11|||April 2009||2009-04-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Open Study of the Efficacy of the Local Treatment With Polygynax of Bacterial and/or Mycotic Vaginitis|Open Multicenter Clinical Study of the Efficacy of the Local Treatment With Polygynax of Mycotic and/or Bacterial Vaginitis|Completed||Phase 4|169|Actual|Laboratoire Innotech International||1|||f||||f||||||||||2017-10-10 23:18:37.894808|2017-10-10 23:18:37.894808
NCT02444468|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-08-17|||March 2015||2015-03-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Preoperative Treatment of Malleolar Fractures|A Randomized Study of In-cast Intermittent Pneumatic Foot-compression in the Preoperative Treatment of Malleolar Fractures|Recruiting||N/A|96|Anticipated|Hospital of Southern Jutland||2|||f||||t||||||||||2017-10-10 23:18:37.973736|2017-10-10 23:18:37.973736
NCT02444455|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-11|||May 2015||2015-05-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|UCMSC-ALI||Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Acute Lung Injury|Safety and Efficacy of Human Umbilical-Cord-Derived Mesenchymal Stem Cell Transplantation in Acute Lung Injury|Recruiting||Phase 1/Phase 2|20|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-10 23:18:38.071546|2017-10-10 23:18:38.071546
NCT02444442|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-13|||June 2015||2015-06-01|May 2015|2015-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension|The Australian SHAM Controlled Clinical Trial of Renal DeNervation in Patients With Resistant Hypertension (AUSHAM-RDN-01)|Not yet recruiting||N/A|105|Anticipated|Baker IDI Heart and Diabetes Institute||2|||f||||f||||||||||2017-10-10 23:18:38.167673|2017-10-10 23:18:38.167673
NCT02444429|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-08-05|||August 2015||2015-08-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|I4BiS||3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation|Evaluation of a Strategy Based on the 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation: the I4BiS Study|Recruiting||Phase 3|346|Anticipated|Hospices Civils de Lyon||4|||f||||t||||||||||2017-10-10 23:18:38.273437|2017-10-10 23:18:38.273437
NCT02444416|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-03-16|||December 2014||2014-12-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|||Prospective Registry of Acute Heart Failure|Prospective Registry of Acute Heart Failure|Recruiting||N/A|1200|Anticipated|University Hospital, Geneva|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-10 23:18:38.426214|2017-10-10 23:18:38.426214
NCT02444403|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-05-10|||June 2015||2015-06-01|May 2016|2016-05-01||||March 2020|Anticipated|2020-03-01||Interventional|ESCUDO||Police Training to Reduce Occupational Needlesticks and HIV Among Substance Users|Proyecto ESCUDO: Police Training to Reduce Occupational Needlesticks and HIV Among Substance Users|Recruiting||N/A|500|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-10 23:18:38.492218|2017-10-10 23:18:38.492218
NCT02444390|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-05-02|||May 19, 2015|Actual|2015-05-19|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|SAFIR-TOR||Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor|Identification of the Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor of HR+ Metastatic Breast Cancer in Post-menopausal Women|Recruiting||N/A|150|Anticipated|UNICANCER||1|||f||||f||||||||Undecided||2017-10-10 23:18:38.700027|2017-10-10 23:18:38.700027
NCT02444377|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-11-29|||August 2012||2012-08-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||High-intensity Interval Training in Overweight/Obese|Impact of Varying High-intensity Interval Protocols on Cardiometabolic Risk Factors in Overweight/Obese|Completed||N/A|76|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-10 23:18:38.880305|2017-10-10 23:18:38.880305
NCT02444364|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-05-30|||May 2015||2015-05-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus|Pilot Project Evaluation of the DPP-4 Inhibition With Sitagliptin on Calcium and Bone Metabolism in Patients With Type 2 Diabetes Mellitus|Withdrawn||Early Phase 1|0|Actual|University of Missouri-Columbia||1||Funding withdrawn; no participants enrolled.|f||||f||||||||No||2017-10-10 23:18:38.977169|2017-10-10 23:18:38.977169
NCT02357329|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-02-02|||October 2014||2014-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|FCandP||Food Composition and Palatability|Food Composition and Palatability|Completed||N/A|52|Actual|Purdue University|||1||f||||||||||||||2017-10-10 23:36:25.521199|2017-10-10 23:36:25.521199
NCT02444351|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-11|||April 2015||2015-04-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|June 2015|Anticipated|2015-06-01||Interventional|||Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Treatment of Nocturnal Calf Cramps in Patients With Lumbar Spinal Stenosis||Unknown status|Recruiting|N/A|50|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:18:39.096435|2017-10-10 23:18:39.096435
NCT02444338|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-06-06|||March 2015||2015-03-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|Reshape-HF2||A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation|A RandomizEd Study of tHe MitrACliP DEvice in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation|Recruiting||N/A|420|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||2|||f||||t||||||||||2017-10-10 23:18:39.205336|2017-10-10 23:18:39.205336
NCT02444325|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-05-11|||May 2015||2015-05-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Diabetes Group Prenatal Care|Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial|Recruiting||N/A|84|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:18:39.402867|2017-10-10 23:18:39.402867
NCT02444312|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-10-05|||June 2015||2015-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|BRiC||Trial of Benefit Finding in Caregivers: The Building Resources in Caregivers (BRiC) Study|A Randomised Controlled Trial of Benefit Finding in Caregivers: The Building Resources in Caregivers (BRiC) Study Protocol|Completed||N/A|88|Actual|University of Limerick||2|||f||||f||||||||||2017-10-10 23:18:39.525236|2017-10-10 23:18:39.525236
NCT02444299|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-03-02|||April 2011||2011-04-01|March 2017|2017-03-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|||Aequalis Resurfacing Head Study|An Observational Cohort Study Evaluating the Safety and Performance of Aequalis Resurfacing Head Implant in a Consecutive Series of Patients With Shoulder Arthroplasty|Active, not recruiting||N/A|100|Actual|Tornier, Inc.|||1||f||||f||||||||||2017-10-10 23:18:39.603535|2017-10-10 23:18:39.603535
NCT02444286|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-08-30|||January 2017||2017-01-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Observational|||The RESHAPE-HF1-FU Study|Observational Study of Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation - Follow Up of the Former Participants in the RESHAPE-HF Trial (Abbott Vascular).|Not yet recruiting||N/A|42|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH|||2||f||||t||||||||||2017-10-10 23:18:39.674473|2017-10-10 23:18:39.674473
NCT02444273|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-05-20|||October 2014||2014-10-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Feasibility of a Prehabilitation Program in the Liver Transplant Population at Barnes-Jewish Hospital|The Feasibility of a Prehabilitation Program in the Liver Transplant Population at Barnes-Jewish Hospital|Enrolling by invitation||N/A|200|Anticipated|Washington University School of Medicine||2|||f||||f||||||||Undecided||2017-10-10 23:18:39.766968|2017-10-10 23:18:39.766968
NCT02444260|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-13|||December 2013||2013-12-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Trial of Local Anaesthesia Versus Local Anaesthesia and Conscious Sedation for Hernioplasty|Improving Patient Outcomes With Inguinal Hernioplasty - a Randomized Controlled Trial of Local Anaesthesia Versus Local Anaesthesia and Conscious Sedation|Unknown status|Recruiting|Phase 3|180|Anticipated|The University of The West Indies||2|||f||||t||||||||||2017-10-10 23:18:39.844127|2017-10-10 23:18:39.844127
NCT02444247|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-09-21|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|Motiv2Ex||Motivation to Exercise|Motivation to Exercise|Completed||N/A|93|Actual|USDA Grand Forks Human Nutrition Research Center||3|||f||||f||||||||||2017-10-10 23:18:39.954388|2017-10-10 23:18:39.954388
NCT02444234|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-03-28|||July 2015||2015-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetics of Tedizolid Phosphate in Cystic Fibrosis|Steady-State Pharmacokinetics of Tedizolid in Plasma and Sputum of Patients With Cystic Fibrosis|Recruiting||Phase 4|12|Anticipated|University of Southern California||2|||f||||f||||||||||2017-10-10 23:18:40.045455|2017-10-10 23:18:40.045455
NCT02444221|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2015-05-13|||May 2015||2015-05-01|May 2015|2015-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|2 Years|Observational [Patient Registry]|RIVER||Rivaroxaban Evaluation in Real Life Settings|Rivaroxaban Evaluation in Real Life Settings|Recruiting||N/A|5000|Anticipated|Thrombosis Research Institute|||1||f||||t||||||||||2017-10-10 23:18:40.141297|2017-10-10 23:18:40.141297
NCT02444208|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-10-02|||May 2015||2015-05-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|RCT(01)||A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use|Randomized Clinical Trial (01): A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use|Recruiting||N/A|40|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-10 23:18:40.208879|2017-10-10 23:18:40.208879
NCT02444195|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-03-16|||April 2015||2015-04-01|March 2017|2017-03-01|May 1, 2016|Actual|2016-05-01|May 1, 2016|Actual|2016-05-01||Interventional|||Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients|Self-Administered Guided Imagery in the Perioperative Period to Reduce Postoperative Distress in Gynecologic Oncology Patients: A Randomized Control Trial|Completed||N/A|130|Actual|University of Michigan||2|||f||||f||||||||No||2017-10-10 23:18:40.28935|2017-10-10 23:18:40.28935
NCT02444182|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2016-02-16|2015-11-16||December 2014||2014-12-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional||Sample size determination was based on the data by Toiviainen et al. (2015). A sample size of 104 subjects (92 + 10% to provide cover in case of subject drop out) was predicted to provide 80% power with an α of 0.05.|Effects of Probiotics on Oral Health|Effect of Lactobacillus Rhamnosus LGG and Bifidobacterium Lactis BB-12 on Gingival Health and Dental Plaque in Healthy Adolescents: a Randomized Controlled Clinical Trial|Completed||Phase 1/Phase 2|108|Actual|Kuwait University|"limitations of this study include:
short period: only 4 weeks to reach maximum compliance
number of participants: just above the minimum sample size due to refusal of many parents to give consent for their children participation."|2|||f||||f||||||||||2017-10-10 23:18:40.373656|2017-10-10 23:18:40.373656
NCT02444169|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-08-07|||April 2015||2015-04-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Retrospective Evaluation of Combination Treatment With the Ulthera System|Retrospective Evaluation of Safety of Combination Treatment With the Ulthera® System and Xeomin, Belotero Balance, and Radiesse|Completed||N/A|101|Actual|Ulthera, Inc|||1||f||||f||||||||||2017-10-10 23:18:40.634642|2017-10-10 23:18:40.634642
NCT02444143|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-06-19|||May 2015||2015-05-01|June 2017|2017-06-01|June 9, 2017|Actual|2017-06-09|February 28, 2017|Actual|2017-02-28||Interventional|Tacrolimus ER||A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients|A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients|Completed||Phase 4|20|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-10 23:18:40.784688|2017-10-10 23:18:40.784688
NCT02444130|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-07-17|||February 2015||2015-02-01|May 2015|2015-05-01|February 2016|Anticipated|2016-02-01|May 2015|Actual|2015-05-01|8 Weeks|Observational [Patient Registry]|||Presbyopia Compensation: Looking for Electrophysiological Predictors|Presbyopia Compensation: Looking for Electrophysiological Predictors|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Tours|||1||f||||f||||||||||2017-10-10 23:18:40.850727|2017-10-10 23:18:40.850727
NCT02444117|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-05-11|||February 2015||2015-02-01|May 2015|2015-05-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01|2 Years|Observational [Patient Registry]|||Clinical and Neurophysiological Evolutions Through a Functional Rehabilitation of Social Communication in ASD|Autism Spectrum Disorders: Clinical and Neurophysiological Evolutions Through a Functional Rehabilitation of Social Communication|Recruiting||N/A|200|Anticipated|University Hospital, Tours|||1||f||||f||||||||||2017-10-10 23:18:40.917971|2017-10-10 23:18:40.917971
NCT02444104|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-10-09|||June 2015||2015-06-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Non-invasive Blood Pressure and Cardiac Output Measurement by Using Applanation Tonometry|Validation of Non-invasive Blood Pressure and Cardiac-output Measurement by Using Applanation Tonometry in Cardiological Patients|Unknown status|Recruiting|N/A|120|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||4||f||||f||||||||||2017-10-10 23:18:40.994945|2017-10-10 23:18:40.994945
NCT02444091|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-04-11|||March 2015||2015-03-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|CycloME||Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS)|Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS). Part A: an Open Label Phase-II Study With Six Intravenous Cyclophosphamide Infusions Four Weeks Apart, and Follow-up for 12 Months|Active, not recruiting||Phase 2|40|Anticipated|Haukeland University Hospital||1|||f||||t||||||||||2017-10-10 23:18:41.277278|2017-10-10 23:18:41.277278
NCT02444078|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-08-20|||August 2015||2015-08-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|LEDEN||Effects of Exercise on Functional Ability in People With Dementia in Nursing Homes:a Cluster Randomised Controlled Trial|Effects of a Long-term Exercise Program on Functional Ability in People With Dementia Living in Nursing Homes: a Cluster Randomised Controlled Trial. The LEDEN Study|Unknown status|Recruiting|Phase 3|140|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:18:41.367708|2017-10-10 23:18:41.367708
NCT02444065|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-05-13|||May 2014||2014-05-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CBT-RR||Rapid Response to Day Hospital Treatment in Bulimia Nervosa and Purging Disorder|Rapid Response to Day Hospital Treatment in Bulimia Nervosa and Purging Disorder: A Randomized Controlled Trial of an Intervention to Facilitate Early Symptom Change|Completed||N/A|44|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:18:41.496382|2017-10-10 23:18:41.496382
NCT02444052|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-07-03|||October 2015||2015-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation|Clinical and Histological Evaluation of Zimmer Puros® Allograft vs. Creos™ (Low-cost) Allograft for Alveolar Ridge Preservation Following Exodontia|Active, not recruiting||N/A|24|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-10 23:18:41.630197|2017-10-10 23:18:41.630197
NCT02444039|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-11-01|||November 2014||2014-11-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Slit Lamp and Digital Camera Attachment|Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment|Completed||N/A|20|Actual|Topcon Medical Systems, Inc.|||1||f||||f||||||||||2017-10-10 23:18:41.730722|2017-10-10 23:18:41.730722
NCT02444026|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-05-13|||December 2014||2014-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Feasibility and Efficacy of Internet-delivered CBT for Insomnia in a National Cohort of Danish Breast Cancer Survivors|Feasibility and Efficacy of an Internet-delivered Cognitive-behavioral Intervention for Insomnia in a National Cohort of Danish Breast Cancer Survivors|Unknown status|Recruiting|N/A|225|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:18:41.829059|2017-10-10 23:18:41.829059
NCT02444013|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-05-11|||May 2015||2015-05-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|FAPCIN||Folic Acid for Prevention of Contrast Induced Nephropathy|Periprocedural Administration of Folic Acid for Prevention of Contrast Induced Nephropathy in Patients Undergoing Coronary CTA/Angiography/Angioplasty|Unknown status|Recruiting|Phase 4|400|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 23:18:42.00378|2017-10-10 23:18:42.00378
NCT02444000|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-01-24|||June 2015||2015-06-01|August 2016|2016-08-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Interventional|POLCA||gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas|A Randomized Trial of Delayed Radiotherapy in Patients With Newly Diagnosed 1p/19q Codeleted Anaplastic Oligodendroglial Tumors: the POLCA Trial.|Recruiting||Phase 3|280|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 23:18:42.154134|2017-10-10 23:18:42.154134
NCT02443974|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-06-30|||April 2015||2015-04-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Bracing to Treat Knee Osteoarthritis in Elderly|Effectiveness of Knee Bracing in Elderly With Knee Osteoarthritis: a Randomized, Controlled Trial|Completed||Phase 4|120|Actual|Federal University of São Paulo||3|||f||||f||||||||No||2017-10-10 23:18:42.371045|2017-10-10 23:18:42.371045
NCT02443376|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-09-30|||May 2015||2015-05-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Observational|PWV/CP/HD||The Effects of Hemodialysis Session on Vascular Stiffness|The Effects of Hemodialysis Session on Pulse Wave Velocity and Central Arterial Pressure|Completed||N/A|90|Actual|Medical University of Warsaw|||2||f||||t||||||||||2017-10-10 23:18:49.103048|2017-10-10 23:18:49.103048
NCT02443961|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-02-16|||May 2017|Anticipated|2017-05-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies|Clinical Trial: Security and Feasibility of Mesenchymal Stem Cell Therapy in Treatment and Prevention of Bronchopulmonary Dysplasia in Preterm Babies|Not yet recruiting||Phase 1|10|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||1|||f||||f|f|f||||||||2017-10-10 23:18:42.467514|2017-10-10 23:18:42.467514
NCT02443948|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-02-13|||June 2014||2014-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)|Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST): Detection and Correlation With Disease Status Assessed by Conventional Technique. Prospective Observational Study|Recruiting||N/A|60|Anticipated|Fondazione del Piemonte per l'Oncologia|||3||f||||t||||||Samples With DNA|"     Cf-DNA blood samples will be collected in EDTA tubes during the routine blood test.   "|||2017-10-10 23:18:42.543982|2017-10-10 23:18:42.543982
NCT02443935|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-06-28|||April 2015||2015-04-01|April 2015|2015-04-01|June 25, 2017|Actual|2017-06-25|June 1, 2017|Actual|2017-06-01||Interventional|TEACH||Toll-like Receptor 9 Agonist Treatment in Chronic HIV-1 Infection|Toll-like Receptor 9 Enhancement of Antiviral Immunity in Chronic HIV-1 Infection: a Phase 1b/2a Trial|Completed||Phase 1/Phase 2|12|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-10 23:18:42.633793|2017-10-10 23:18:42.633793
NCT02443922|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-11|||June 2015||2015-06-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM|Dynamic Responsiveness of Insulin Secretory Parameters to Sitagliptin and Glimeperide Administration in Subjects With Type 2 Diabetes Mellitus: An Open Label Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Foundation for the National Institutes of Health||3|||f||||f||||||||||2017-10-10 23:18:42.717463|2017-10-10 23:18:42.717463
NCT02443909|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-13|||January 2015||2015-01-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Safety and Efficiency of 20w and 30w Holmium Laser Device in Management of 2-3 cm Diameter Kidney Stones With Retrograde Intrarenal Surgery||Unknown status|Recruiting|Phase 4|90|Anticipated|Diskapi Teaching and Research Hospital||3|||f||||f||||||||||2017-10-10 23:18:42.816904|2017-10-10 23:18:42.816904
NCT02443896|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-02-08|||April 2014||2014-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||The Use of Pit and Fissure Sealants in Children Requiring Caries Related Dental Extractions|A Pilot Study to Investigate the Use of Pit and Fissure Sealants in Children Requiring Caries Related Dental Extractions Under a Chair General Anaesthetic|Active, not recruiting||N/A|100|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-10 23:18:42.918906|2017-10-10 23:18:42.918906
NCT02443883|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-12|2017-06-13|||June 2015||2015-06-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|November 2016|Actual|2016-11-01||Interventional|||A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer|Randomized Phase 2 Trial Evaluating Pharmacokinetics and Safety of Four Ramucirumab Dosing Regimens in Second-Line Gastric or Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 2|160|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 23:18:42.998506|2017-10-10 23:18:42.998506
NCT02443870|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-11-21|||May 2015||2015-05-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Long-term Urodynamics in Individuals With Neurogenic Lower Urinary Tract Dysfunction|Retrospective Analysis of Long-term Urodynamics in Individuals With Neurogenic Lower Urinary Tract Dysfunction|Enrolling by invitation||N/A|500|Anticipated|Swiss Paraplegic Centre Nottwil|||1||f||||f||||||||||2017-10-10 23:18:44.962004|2017-10-10 23:18:44.962004
NCT02443857|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-02-22|||June 2015||2015-06-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Feasibility of a New Pediatric Arm Rehabilitation Robot ChARMin|Feasibility of a New Pediatric Arm Rehabilitation Robot ChARMin: A Monocentric Interventional Study|Recruiting||N/A|430|Anticipated|University Children's Hospital, Zurich||1|||f||||t||||||||||2017-10-10 23:18:45.057181|2017-10-10 23:18:45.057181
NCT02443844|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-11|||February 2015||2015-02-01|May 2015|2015-05-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression||Recruiting||Phase 4|40|Anticipated|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-10 23:18:45.184747|2017-10-10 23:18:45.184747
NCT02443831|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-09-01|||April 2016||2016-04-01|September 2016|2016-09-01|December 2028|Anticipated|2028-12-01|April 2018|Anticipated|2018-04-01||Interventional|||CARPALL: Immunotherapy With CD19 CAR T-cells for CD19+ Haematological Malignancies|Immunotherapy With CD19 CAR Redirected T-cells for High Risk, Relapsed Paediatric CD19+ Acute Lymphoblastic Leukaemia and Other Haematological Malignancies|Recruiting||Phase 1|18|Anticipated|University College, London||1|||f||||t||||||||||2017-10-10 23:18:45.291257|2017-10-10 23:18:45.291257
NCT02443818|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-01-18|||May 2015||2015-05-01|March 2015|2015-03-01||||September 2016|Anticipated|2016-09-01||Interventional|PROMISE||Sirolimus Effect on Hypertrophic Syndromes Related Gene PIK3CA|Non-randomised Open Label Pilot Study of Sirolimus Therapy for Segmental Overgrowth Due to PIK3CA- Related Overgrowth|Unknown status|Recruiting|Phase 2|15|Anticipated|Centre Hospitalier Universitaire Dijon|||||f||||||||||||||2017-10-10 23:18:45.419706|2017-10-10 23:18:45.419706
NCT02443805|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-07-25|||September 2015||2015-09-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis|A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis|Active, not recruiting||Phase 3|1740|Anticipated|Stallergenes Greer||2|||f||||t||||||||||2017-10-10 23:18:45.548113|2017-10-10 23:18:45.548113
NCT02443792|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-12-13|2015-10-29||April 2015||2015-04-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Unicirc004||Unicirc vs Open Surgical Circumcision|Adult Male Circumcision With Unicirc Under Topical Anesthetic vs Open Surgical Circumcision: a Randomized Controlled Trial|Completed||Phase 4|75|Actual|Simunye Primary Health Care||2|||f||||f||||||||||2017-10-10 23:18:45.749728|2017-10-10 23:18:45.749728
NCT02443766|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-01-19|||January 2012||2012-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|FETZER||Use of a Functional Neuroimaging Battery for the Evaluation of a Meditation Retreat|Use of a Functional Neuroimaging Battery for the Evaluation of a Meditation|Active, not recruiting||N/A|30|Anticipated|Thomas Jefferson University||1|||f||||f||||||||||2017-10-10 23:18:46.134112|2017-10-10 23:18:46.134112
NCT02443753|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-02-09|||May 2015||2015-05-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects|A Pilot Safety and Tolerability Study of the Use of the EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects|Terminated||N/A|7|Actual|GI Dynamics||1|||f||||f||||||||||2017-10-10 23:18:46.209721|2017-10-10 23:18:46.209721
NCT02443727|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-05-27|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||The Role of Oxytocin in the Perception of Faces|The Role of Oxytocin in the Perception of Infant Faces|Completed||Early Phase 1|71|Actual|Penn State University||2|||f||||t||||||||||2017-10-10 23:18:46.413629|2017-10-10 23:18:46.413629
NCT02443714|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-09-24|||April 2015||2015-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro Using Needle-Free Jet Injection Technology|Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro Using Needle-Free Jet Injection Technology|Completed||Phase 4|18|Actual|Chongqing Medical University||2|||f||||t||||||||||2017-10-10 23:18:46.503295|2017-10-10 23:18:46.503295
NCT02443701|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-08-10|||July 2015||2015-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Light Therapy and Electrical Stimulation on Functional Performance in Volleyball Athletes|Low Level Laser Therapy and Neuromuscular Electrical Stimulation on Knee Extension Strength and Jump in Volleyball Athletes: a Randomized Controlled Trial|Completed||N/A|36|Anticipated|Centro de Traumatologia do Esporte||3|||f||||t||||||||||2017-10-10 23:18:46.587952|2017-10-10 23:18:46.587952
NCT02443688|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-05-19|||October 2015||2015-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult CF Patients|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis|Active, not recruiting||Phase 2|200|Actual|Celtaxsys, Inc.||3|||f||||t||||||||||2017-10-10 23:18:46.676044|2017-10-10 23:18:46.676044
NCT02443675|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2015-05-13|||May 2015||2015-05-01|May 2015|2015-05-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Observational|||Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy|Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy|Active, not recruiting||N/A|300|Anticipated|Cure Cancer Worldwide, LLC|||1||f||||f||||||||||2017-10-10 23:18:46.87906|2017-10-10 23:18:46.87906
NCT02443649|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-12-14|||January 2015||2015-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Improving Sleep Quality in People With Insomnia|Improving Sleep Quality in People With Insomnia|Completed||N/A|40|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 23:18:47.00827|2017-10-10 23:18:47.00827
NCT02443636|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-04-25|||May 2015||2015-05-01|April 2017|2017-04-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01|10 Years|Observational [Patient Registry]|||The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry|The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry: Reliable Assessment to Enable Research and Improve Clinical Care|Recruiting||N/A|30000|Anticipated|Nova Scotia Health Authority|||1||f||||f||||||||||2017-10-10 23:18:47.235114|2017-10-10 23:18:47.235114
NCT02443623|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-08-19|||September 2015||2015-09-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV|Vaccinia Vaccination (ACAM2000®) of Plasma Donors for the Production of Vaccinia Immune Globulin Intravenous (VIGIV)|Recruiting||Phase 4|3000|Anticipated|Cangene Corporation||1|||f||||t||||||||Undecided||2017-10-10 23:18:47.358329|2017-10-10 23:18:47.358329
NCT02443610|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-04-28|||June 2015||2015-06-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|HEMOTHEPP||Haemorrhages and Thromboembolic Venous Disease of the Postpartum|Hémorragies et Maladie Veineuse Thromboembolique du Post-partum : Epidémiologie, Etudes Des déterminants Cliniques et Biologiques|Recruiting||N/A|20000|Anticipated|University Hospital, Brest|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:18:47.453228|2017-10-10 23:18:47.453228
NCT02443597|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2016-01-16|||June 2015||2015-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Can Increased Body Mass Index Prevent Adequate Ultrasound Examination for Trisomy 21 Risk Assessment?|Can Increased Body Mass Index Prevent Adequate Ultrasound Examination for Trisomy 21 Risk Assessment?|Completed||N/A|200|Actual|Benha University|||2||f||||f||||||||||2017-10-10 23:18:47.563437|2017-10-10 23:18:47.563437
NCT02443584|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-05-02|||February 1, 2015|Actual|2015-02-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|PGX-AMG||Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis|Pharmacogenetic Testing in an Outpatient Population of Patients With Major Depressive Disorder or Depressive Disorder Not Otherwise Specified With Avera Medical Group Clinics|Completed||N/A|84|Actual|Avera McKennan Hospital & University Health Center||2|||f||||t||||||||||2017-10-10 23:18:47.652352|2017-10-10 23:18:47.652352
NCT02443558|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-06-28|||December 15, 2016|Actual|2016-12-15|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 31, 2017|Anticipated|2017-07-31||Interventional|CSI:Brainwave||Brainwave Control of a Wearable Robotic Arm for Rehabilitation and Neurophysiological Study in Cervical Spine Injury|Brainwave Control of a Wearable Robotic Arm for Rehabilitation and Neurophysiological Study in Cervical Spine Injury|Enrolling by invitation||N/A|20|Anticipated|Aristotle University Of Thessaloniki||4|||f||||f|f|f||||||Undecided||2017-10-10 23:18:47.851446|2017-10-10 23:18:47.851446
NCT02443545|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-03-10|||May 2015||2015-05-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias|Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias|Enrolling by invitation||Phase 4|300|Anticipated|ApoPharma||2|||f||||t||||||||||2017-10-10 23:18:47.950544|2017-10-10 23:18:47.950544
NCT02443532|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-08-01|||March 2012||2012-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Structured Group Education on Quality of Life and Glycemic Control in Type 1 Diabetes|Quality of Life, Treatment Satisfaction, Fear of Hypoglycemia, Eating Habits, Ang Glucose Control in Patients With Type 1 Diabetes: Effects of Structured Group Education Versus Group Care.|Terminated||N/A|72|Actual|Azienda Ospedaliero-Universitaria Careggi||2||Insufficient recruitment|f||||f||||||||||2017-10-10 23:18:48.08445|2017-10-10 23:18:48.08445
NCT02443519|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-10-04|||May 2015||2015-05-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|BMBCT-M||Bronx MBCT-Migraine|Bronx Mindfulness Based Cognitive Therapy for Migraine: a Randomized Clinical Trial|Recruiting||N/A|80|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-10 23:18:48.172458|2017-10-10 23:18:48.172458
NCT02443506|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-13|||October 2004||2004-10-01|April 2015|2015-04-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus|A Randomized Double-blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 623 Following Single Dose Administration in Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|56|Actual|Amgen||2|||f||||f||||||||||2017-10-10 23:18:48.276811|2017-10-10 23:18:48.276811
NCT02443493|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-12|||April 2015||2015-04-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|TRANSDERMIS||Laser Therapy for the Prevention of Radiodermatitis in Breast Cancer Patients|Low-level Laser Therapy as a Tool for the Prevention of Radiodermatitis in Breast Cancer Patients|Unknown status|Recruiting|N/A|60|Anticipated|Hasselt University||2|||f||||f||||||||||2017-10-10 23:18:48.362745|2017-10-10 23:18:48.362745
NCT02443480|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-02-01|||September 2014||2014-09-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|August 2015|Actual|2015-08-01||Observational|||Development and Validation of the Saint Paul's Endoscopy Comfort Scale (SPECS) for Colonoscopy and Upper Endoscopy|Do You Have Your SPECS in Order? Development and Validation of the Saint Paul's Endoscopy Comfort Scale (SPECS) for Colonoscopy and Upper Endoscopy|Active, not recruiting||N/A|600|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-10 23:18:48.508485|2017-10-10 23:18:48.508485
NCT02443467|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-11-01|||July 2006||2006-07-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer||Completed||N/A|211|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:18:48.587402|2017-10-10 23:18:48.587402
NCT02443454|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-09-30|||May 2015||2015-05-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|PWV/CP/KTx||Short and Long-term Results of Arterial Stiffness and Central Aortic Pressure After Kidney Transplantation|Short and Long-term Results of Arterial Stiffness and Central Aortic Pressure After Kidney Transplantation|Completed||N/A|100|Actual|Medical University of Warsaw|||2||f||||t||||||||||2017-10-10 23:18:48.671817|2017-10-10 23:18:48.671817
NCT02443428|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-04-14|||August 2013||2013-08-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry|Eribulin (HALAVEN) Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry|Completed||N/A|77|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-10 23:18:48.747134|2017-10-10 23:18:48.747134
NCT02443415|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-10-13|||February 2015||2015-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Observational|DKA-Cog||Diabetic Ketoacidosis: Brain Morphology and Cognition|Acute and Long-term Neuroanatomical and Cognitive Evaluation of Adult Patients With First and Recurrent Episodes of Diabetic Ketoacidosis|Active, not recruiting||N/A|45|Actual|Emory University|||4||f||||t||||||||||2017-10-10 23:18:48.834309|2017-10-10 23:18:48.834309
NCT02443402|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-01-31|||January 2016||2016-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SITACABG NonDM||Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery|Sitagliptin for the Prevention and Treatment of Stress Hyperglycemia in Non-Diabetic Patients Undergoing Cardiac Surgery|Completed||Phase 4|68|Actual|Emory University||2|||f||||t||||||||||2017-10-10 23:18:48.906298|2017-10-10 23:18:48.906298
NCT02443389|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-03-30|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01|120 Days|Observational [Patient Registry]|AWAKEN||Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates|Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates|Completed||N/A|2186|Actual|University of Alabama at Birmingham|||1||f||||f||||||||No||2017-10-10 23:18:49.028574|2017-10-10 23:18:49.028574
NCT02443363|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-09-30|||April 2015||2015-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|eGFR||Estimated Glomerular Filtration Rate After Kidney Transplantation - the Formula MDRD, CKD-EPI or Cockroft-Gault?|Estimated Glomerular Filtration Rate After Kidney Transplantation - the Formula Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) or Cockroft-Gault?|Completed||N/A|170|Actual|Medical University of Warsaw|||1||f||||t||||||||||2017-10-10 23:18:49.18445|2017-10-10 23:18:49.18445
NCT02443350|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-05-10|||June 2014||2014-06-01|May 2015|2015-05-01||||May 2017|Anticipated|2017-05-01|24 Months|Observational [Patient Registry]|MuPRaNE||Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area||Unknown status|Recruiting|N/A|400|Anticipated|Beijing Tongren Hospital|||1||f||||||||||||||2017-10-10 23:18:49.242259|2017-10-10 23:18:49.242259
NCT02443337|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-25|||July 2015||2015-07-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A Study of LY3023414 and Necitumumab in Squamous Lung Cancer|A Phase II Study of the Combination of LY3023414 and Necitumumab After First-Line Chemotherapy for Metastatic Squamous Non-small Cell Carcinoma of the Lung|Active, not recruiting||Phase 2|48|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 23:18:49.296986|2017-10-10 23:18:49.296986
NCT02443324|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-21|||July 29, 2015|Actual|2015-07-29|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer|An Open-Label, Multicenter, Phase 1 Study of Ramucirumab Plus Pembrolizumab in Patients With Locally Advanced and Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Non-Small Cell Lung Cancer, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer|Active, not recruiting||Phase 1|155|Actual|Eli Lilly and Company||9|||f||||f||||||||||2017-10-10 23:18:49.531952|2017-10-10 23:18:49.531952
NCT02443298|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-06|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma|A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Assess the Safety and Efficacy of Subcutaneously Administered BI 655066/ABBV-066 (Risankizumab) as add-on Therapy Over 24 Weeks in Patients With Severe Persistent Asthma.|Active, not recruiting||Phase 2|214|Actual|AbbVie||2|||f||||t||||||||||2017-10-10 23:18:49.81141|2017-10-10 23:18:49.81141
NCT02443285|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-06-17|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?|Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?|Recruiting||Phase 3|100|Anticipated|Tanta University||2|||f||||t||||||||Undecided||2017-10-10 23:18:50.094428|2017-10-10 23:18:50.094428
NCT02443272|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-04-18|||September 2014||2014-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Comparison of Loop Drainage Versus Incision and Drainage for Abscesses in Children|A Randomized Comparison Study of Minimally Invasive Loop Drainage Versus Standard Incision and Drainage for Skin Abscesses in Children|Completed||N/A|81|Actual|Seton Healthcare Family||2|||f||||f||||||||||2017-10-10 23:18:50.225715|2017-10-10 23:18:50.225715
NCT02443259|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-03-06|||January 2014||2014-01-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|PRENB||Neurobehavioural Outcomes in Late Preterm Neonates|Short Term Neurobehavioural Outcomes in Late Preterm Neonates Born to Pre Eclamptic Mothers : a Prospective Observational Study|Completed||N/A|60|Actual|Lady Hardinge Medical College|||2||f||||f||||||||||2017-10-10 23:18:50.325841|2017-10-10 23:18:50.325841
NCT02443246|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-07-25|||November 2014||2014-11-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency|A Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency|Completed||Phase 3|84|Actual|Kwang Dong Pharmaceutical co., ltd.||2|||f||||f||||||||||2017-10-10 23:18:50.408007|2017-10-10 23:18:50.408007
NCT02443233|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-06-09|||January 2014||2014-01-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong||Completed||N/A|750|Actual|The University of Hong Kong|||2||f||||||||||||||2017-10-10 23:18:50.5046|2017-10-10 23:18:50.5046
NCT02443220|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-04-28|||August 2014||2014-08-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Electroacupuncture in Reducing the Dose of Analgesic in Patients Undergoing Off-pump Coronary Artery Bypass Grafting|Effects of Regional or Distant Combination of Acupoints Stimulated With Electroacupuncture on Patients Undergoing Off-pump Coronary Artery Bypass Grafting|Completed||Phase 1/Phase 2|186|Actual|Xijing Hospital||3|||f||||t||||||||||2017-10-10 23:18:50.573018|2017-10-10 23:18:50.573018
NCT02443207|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-12|||January 2013||2013-01-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01|1 Day|Observational [Patient Registry]|||Impact of Dental Pain on the Quality of Life|Perceived Impact of Dental Pain on the Quality of Life of Preschool Children and Their Families|Completed||N/A|843|Actual|Universidade Estadual da Paraiba|||1||f||||f||||||||||2017-10-10 23:18:50.675072|2017-10-10 23:18:50.675072
NCT02443194|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-12-02|||May 2015||2015-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients|The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients|Terminated||Phase 3|50|Actual|Tel-Aviv Sourasky Medical Center||2||principle investigator decision due to many adverse events in patients|f||||f||||||||||2017-10-10 23:18:50.745112|2017-10-10 23:18:50.745112
NCT02443181|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-05-24|||February 2015||2015-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Demand-driven Management of Essential Tremor|The Application of DBS Technologies for Demand-driven Management of Essential Tremor|Recruiting||N/A|10|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-10 23:18:50.827275|2017-10-10 23:18:50.827275
NCT02443168|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-10-09|||May 2015||2015-05-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Radiolabeled Study of AG-221 in Healthy Male Subjects.|A Phase 1, Open-Label, Two-Part Study to Evaluate the Metabolism, Excretion, and Absolute Bioavailability of AG-221 in Healthy Adult Male Subjects|Completed||Phase 1|8|Actual|Celgene||2|||f||||f||||||||||2017-10-10 23:18:50.926752|2017-10-10 23:18:50.926752
NCT02443155|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-22|||November 10, 2015|Actual|2015-11-10|September 2017|2017-09-01|March 1, 2019|Anticipated|2019-03-01|November 27, 2018|Anticipated|2018-11-27||Interventional|||A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Multi-centre Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function|Active, not recruiting||Phase 2|304|Anticipated|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-10 23:18:51.06119|2017-10-10 23:18:51.06119
NCT02443142|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-05-12|||May 2015||2015-05-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|IVAMTBI||Ibuprofen Versus Acetaminophen for Treatment of Mild Traumatic Brain Injury|Ibuprofen Versus Acetaminophen for Treatment of Mild Traumatic Brain Injury|Unknown status|Not yet recruiting|Phase 2|400|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:18:51.362638|2017-10-10 23:18:51.362638
NCT02443129|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-11-23|||May 2016||2016-05-01|November 2015|2015-11-01|August 2019|Anticipated|2019-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Swept Source Enhanced Depth Imaging Optical Coherence Tomography|Swept Source Enhanced Depth Imaging Optical Coherence Tomography (SS-EDI-OCT) and Study of the Retina, Choroid and Sclera in Health and Disease|Not yet recruiting||N/A|120|Anticipated|Shaare Zedek Medical Center||9|||f||||f||||||||||2017-10-10 23:18:51.490811|2017-10-10 23:18:51.490811
NCT02443116|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-03-08|||May 2015||2015-05-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)|A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group And An Open-Label Single-Blind Cohort Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of NGM282 Administrered for 12 Weeks in Patients With Histologically Confirmed Nonalcoholic Steatohepatits|Recruiting||Phase 2|140|Anticipated|NGM Biopharmaceuticals, Inc||5|||f||||f||||||||||2017-10-10 23:18:51.563864|2017-10-10 23:18:51.563864
NCT02443090|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2015-11-11|||May 2015||2015-05-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|October 2015|Actual|2015-10-01||Interventional|||Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men|An 8-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men|Active, not recruiting||Phase 2|160|Anticipated|NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)||2|||f||||f||||||||||2017-10-10 23:18:51.761187|2017-10-10 23:18:51.761187
NCT02443064|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2015-05-08|||January 2014||2014-01-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin|Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin in the Treatment of Methicillin-resistant Staphylococcus Aureus（MRSA） Blood Stream Infection (Septicemia) and Endocarditis in Chinese Patients|Unknown status|Recruiting|Phase 4|100|Anticipated|Zhejiang University||1|||f||||t||||||||||2017-10-10 23:18:53.609879|2017-10-10 23:18:53.609879
NCT02443051|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2017-05-12|||May 2013||2013-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Treatment of Social Anxiety in Youth|Attention Training for Adolescents With Social Anxiety Disorder|Completed||N/A|58|Actual|Virginia Polytechnic Institute and State University||2|||f||||f||||||||||2017-10-10 23:18:53.744018|2017-10-10 23:18:53.744018
NCT02443038|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-10-26|||April 2014||2014-04-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|Yoga/Falls||Yoga's Effect on Fall Risk Factors in the Rural, Older Adult Population; an Academic/Community Partnership|Yoga's Effect on Fall Risk Factors in the Rural, Older Adult Population; an Academic/Community Partnership|Completed||N/A|43|Actual|University of Wisconsin, Madison||2|||f||||f||||||||Yes|We plan to share our data after analysis and peer review of publication|2017-10-10 23:18:53.867453|2017-10-10 23:18:53.867453
NCT02443025|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-07-08|||November 2014||2014-11-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|TATU||Teens Against Tobacco Use: A Model for Universal Tobacco Prevention and Youth Advocacy|Teens Against Tobacco Use: A Model for Universal Tobacco Prevention and Youth Advocacy|Completed||N/A|2414|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:18:53.988158|2017-10-10 23:18:53.988158
NCT02443012|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2015-05-08|||March 2013||2013-03-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Topical Nepafenac as Supplement for Diabetic Macular Edema|Evaluation on Efficacy of Topical Nepafenac as Supplement Therapy in the Treatment of Diabetic Macular Edema|Completed||Phase 4|47|Actual|University of Science Malaysia||2|||f||||f||||||||||2017-10-10 23:18:54.08764|2017-10-10 23:18:54.08764
NCT02442999|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|SNORES||The SNORES Randomized Clinical Trial|Sleep Apnea in Non-ovulating REI Patients: The SNORES Randomized Clinical Trial|Terminated||N/A|4|Actual|University of South Florida||2||Poor enrollment|f||||f||||||||||2017-10-10 23:18:54.188508|2017-10-10 23:18:54.188508
NCT02442986|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-04-19|||November 2012|Actual|2012-11-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|NOSEPP||Neurological Outcome in Surgical and Non-surgical Septic Patients|Prospective Observational Study: Comparison of Neurological Outcome in Septic Surgical, Septic Non-surgical and Non-septic Patients on ICU|Completed||N/A|32|Actual|University of Rostock|||3||f||||f||||||||||2017-10-10 23:18:54.292945|2017-10-10 23:18:54.292945
NCT02442973|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-05-03|||February 2016||2016-02-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Handheld 3D Lumbar Spine Navigation: A Clinical Validation Study RM002|Handheld 3D Lumbar Spine Navigation: A Clinical Validation Study RM002|Recruiting||N/A|80|Anticipated|University of Virginia|||2||f||||f||||||||No||2017-10-10 23:18:54.389057|2017-10-10 23:18:54.389057
NCT02442960|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-05-10|||September 2014||2014-09-01|May 2016|2016-05-01||||September 2016|Anticipated|2016-09-01||Interventional|||Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis|An Open-Label, Dose-Escalation Phase Ib Study Evaluating the Safety and Preliminary Efficacy of Oral SA100 in the Treatment of Patients With Mild-to-Moderate Ulcerative Colitis|Recruiting||Phase 1|24|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-10 23:18:54.489247|2017-10-10 23:18:54.489247
NCT02442947|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-12-23|||June 2015||2015-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Examination of Textile Solutions for Reducing Physiological Stress|Physiological Examination of Textile Solutions for Stress Reduction When Dressed in Protective Garment and Work Clothes and Under Physical and Heat Stress Conditions|Completed||N/A|10|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:18:54.563478|2017-10-10 23:18:54.563478
NCT02442934|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-03-18|||October 2014||2014-10-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|IPREA3||Reducing Discomforts in Critically Ill Patients: the IPREA3 Study|A Multicomponent Intervention to Reduce Perceived Discomforts in Critically Ill Patients: a Randomized Controlled Trial|Completed||N/A|5411|Actual|Centre Hospitalier of Chartres||2|||f||||t||||||||Yes||2017-10-10 23:18:54.660637|2017-10-10 23:18:54.660637
NCT02442921|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-05-06|||February 22, 2016|Actual|2016-02-22|May 2017|2017-05-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Interventional|CDNT||Colchicine for Diabetic Nephropathy Trial|The Effect of Colchicine Treatment on the Progression of Proteinuria in Patients With Diabetic Nephropathy.|Recruiting||Phase 1/Phase 2|40|Anticipated|Sheba Medical Center||2|||f||||f||||||||Yes||2017-10-10 23:18:54.796154|2017-10-10 23:18:54.796154
NCT02442908|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-09-20|||May 2015||2015-05-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia|A 12-Week, Randomised, Placebo Controlled, Multi-Centre, Parallel Group Study Assessing the Safety and Tolerability of Nutrifriend Cachexia (Non-Complete Dietary Formula) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|45|Actual|Smartfish AS||2|||f||||f||||||||||2017-10-10 23:18:54.88089|2017-10-10 23:18:54.88089
NCT02442895|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-08|||February 2014||2014-02-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||Biomarkers of Ovarian Reserve and Correlation With IVF Treatments|Predictors of Ovarian Response in Women Undergoing Ovarian Stimulation for IVF|Completed||N/A|236|Actual|U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti|||3||f||||f||||||||||2017-10-10 23:18:54.965965|2017-10-10 23:18:54.965965
NCT02442882|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-07|||July 2016||2016-07-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|||The Acute Effect of Boxing on Balance, Neuropsychological, and Visual Functions|The Acute Effect of Boxing on Balance, Neuropsychological, and Visual Functions|Completed||N/A|61|Actual|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-10 23:18:55.081895|2017-10-10 23:18:55.081895
NCT02442869|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-09-25|||June 2015|Actual|2015-06-01|January 2017|2017-01-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|SMART||Developing Adaptive Interventions for Suicidal College Students Seeking Treatment - SMART|Developing Adaptive Interventions for Suicidal College Students Seeking Treatment - SMART|Completed||N/A|62|Actual|University of Nevada, Reno||4|||f||||t||||||||||2017-10-10 23:18:55.163438|2017-10-10 23:18:55.163438
NCT02442856|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-05-01|||June 2015||2015-06-01|May 2017|2017-05-01||||March 2018|Anticipated|2018-03-01||Interventional|TOMCAT||Non-invasive Measurement of Cerebral Dynamic Autoregulation||Recruiting||N/A|20|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 23:18:55.527863|2017-10-10 23:18:55.527863
NCT02442843|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-09-15|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2017|Actual|2017-08-01||Interventional|||Non Invasive Brain Stimulation for PTSD|Non-invasive Brain Stimulation for Post-Traumatic Stress Disorder|Active, not recruiting||Early Phase 1|18|Actual|University of Michigan||3|||f||||f||||||||||2017-10-10 23:18:55.663156|2017-10-10 23:18:55.663156
NCT02442830|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-07-06|||April 2015||2015-04-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|EDCAP||Comparing Early Capsule Deployment to Current Standard of Care for Management of Gastrointestinal Bleeding|A Comparison of Early Deployment of a Video Capsule (Endocapsule EC-10: Olympus Tokyo. Japan) in the Emergency Department Versus Standard of Care Workup of Non-hematemesis Gastrointestinal Bleeding|Enrolling by invitation||N/A|160|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-10 23:18:55.820641|2017-10-10 23:18:55.820641
NCT02442817|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-05-19|||April 2015||2015-04-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Linagliptin and Mesenchymal Stem Cells: A Pilot Study|Linagliptin and Mesenchymal Stem Cells: A Pilot Study|Recruiting||Phase 4|18|Anticipated|University of Nevada, Reno||2|||f||||f||||||||||2017-10-10 23:18:55.979781|2017-10-10 23:18:55.979781
NCT02442804|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-04-23|2017-01-07||June 2015||2015-06-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke|The Effects of Pomegranate Polyphenols on Neuropsychological Functioning Following Ischemic Stroke|Completed||Phase 2|16|Actual|Loma Linda University||2|||f||||f||||||||||2017-10-10 23:18:56.167463|2017-10-10 23:18:56.167463
NCT02442791|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2017-09-26|||June 2014||2014-06-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|GLIP1||GLP-1 Analogs for Neuroprotection After Cardiac Arrest|GLP-1 Analogs for Neuroprotection After Out-of-hospital Cardiac Arrest, a Randomized Clinical Trail|Completed||N/A|120|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:18:56.899826|2017-10-10 23:18:56.899826
NCT02442778|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-22|||September 2015||2015-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type.|Recruiting||Phase 3|470|Anticipated|Avanir Pharmaceuticals||3|||f||||t|t|f||||||||2017-10-10 23:18:57.555057|2017-10-10 23:18:57.555057
NCT02442765|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-22|||September 2015||2015-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type|Recruiting||Phase 3|380|Anticipated|Avanir Pharmaceuticals||3|||f||||t|t|f||||||||2017-10-10 23:18:57.874191|2017-10-10 23:18:57.874191
NCT02442752|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2017-09-14|||February 9, 2016|Actual|2016-02-09|September 2017|2017-09-01|December 23, 2020|Anticipated|2020-12-23|December 23, 2020|Anticipated|2020-12-23||Interventional|||Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months|A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases|Suspended||Phase 1|24|Anticipated|Takeda||4|||f||||f||||||||||2017-10-10 23:18:58.180633|2017-10-10 23:18:58.180633
NCT02442739|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-08-16|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers|A Randomized, Double Blind, Feasibility Study of Oral Ketamine Versus Placebo for Prevention of Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers|Recruiting||Early Phase 1|40|Anticipated|Cedars-Sinai Medical Center||2|||f||||t|t|f||||||||2017-10-10 23:18:58.291824|2017-10-10 23:18:58.291824
NCT02442726|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-12-02|||May 2015||2015-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|BI-Laser||Activation of A-delta-fibres and C-fibres in a First Degree Thermal Injury in Volunteers|Activation of A-delta-fibres and C-fibres in a First Degree Thermal Injury in Volunteers|Completed||N/A|18|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:18:58.399837|2017-10-10 23:18:58.399837
NCT02442700|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-08-16|2016-04-08||May 2014||2014-05-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir|Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-blind, Crossover Study|Completed||Phase 4|24|Actual|Ramathibodi Hospital|LImitation of this study is we did not adjust pitavastatin dosage according to lipid profiles,thus mean value of TC could not be lower than 200 mg/dL.|2|||f||||f||||||||||2017-10-10 23:18:58.584113|2017-10-10 23:18:58.584113
NCT02442687|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-08-04|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|September 1, 2017|Anticipated|2017-09-01||Interventional|||JKB-121 for the Treatment of Nonalcoholic Steatohepatitis|A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Phase II Trial of JKB-121 for the Treatment of Nonalcoholic Steatohepatitis (NASH)|Active, not recruiting||Phase 2|66|Actual|Duke University||3|||f||||t||||||||||2017-10-10 23:18:59.112512|2017-10-10 23:18:59.112512
NCT02442674|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-07-27|||November 2015||2015-11-01|July 2017|2017-07-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia|A Pilot Phase 3b,Multicenter,Randomized,Double-blind,Placebo-controlled Trial of the Safety,Efficacy,and Pharmacokinetics of Titrated Oral SAMSCA®(Tolvaptan) in Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia|Withdrawn||Phase 3|0|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2||Trial withdrawn due to inability to meet the trial objectives (Pilot).|f||||t||||||||||2017-10-10 23:18:59.269339|2017-10-10 23:18:59.269339
NCT02442661|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-06-08|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Observational|||Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer|Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer|Completed||N/A|103|Actual|University of Colorado, Denver|||1||f||||f|f|f||||||No|Participant data is only available to study personnel|2017-10-10 23:18:59.366557|2017-10-10 23:18:59.366557
NCT02442648|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-31|||December 2014||2014-12-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||B-Cell Targeted Carfilzomib Desensitization|B-Cell Targeted Desensitization With Carfilzomib for Preformed Anti-HLA Antibodies in Patients Awaiting Kidney Transplantation|Recruiting||Phase 1|32|Anticipated|University of Cincinnati||4|||f||||t||||||||||2017-10-10 23:18:59.438924|2017-10-10 23:18:59.438924
NCT02442635|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-09-07|||May 2015||2015-05-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Yoga During Chemotherapy Study|Developing a Yoga Intervention During Cancer Chemotherapy|Recruiting||N/A|100|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-10 23:18:59.552281|2017-10-10 23:18:59.552281
NCT02442622|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2016-11-29|||January 2015||2015-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Astym Treatment For de Quervain's Tenosynovitis|Effectiveness of Astym Treatment For de Quervain's Tenosynovitis|Recruiting||N/A|32|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 23:18:59.631241|2017-10-10 23:18:59.631241
NCT02442609|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-09|2016-05-31|||May 2015||2015-05-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|1 Day|Observational [Patient Registry]|e-anesth||Internet for Anesthesia Information : a Patient Questionaire|Does Patient Look to Internet for Anesthesia Information Before Surgery : a Prospective International Questionaire Study|Completed||N/A|4000|Actual|Pierre and Marie Curie University|||1||f||||t||||||||||2017-10-10 23:18:59.722085|2017-10-10 23:18:59.722085
NCT02442596|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-06-28|||January 2016||2016-01-01|June 2017|2017-06-01|April 2, 2017|Actual|2017-04-02|April 1, 2017|Actual|2017-04-01||Observational|AbSeS||Abdominal SepsiS Study: Epidemiology of Etiology and Outcome|Abdominal SepsiS Study: Epidemiology of Etiology and Outcome|Completed||N/A|2200|Actual|European Society of Intensive Care Medicine|||1||f||||f||||||||||2017-10-10 23:18:59.797482|2017-10-10 23:18:59.797482
NCT02442583|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-02-24|||May 2015||2015-05-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Reducing Sedentary Behaviors Among Colorectal Cancer Survivors|Reducing Sedentary Behaviors Among Colorectal Cancer Survivors: Cancer Survivorship Center Pilot Project|Completed||N/A|20|Actual|Duke University||3|||f||||f||||||||||2017-10-10 23:18:59.87095|2017-10-10 23:18:59.87095
NCT02442570|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-08-26|||September 2012||2012-09-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis|A Phase IIa, Randomized, Double-blind, Placebo-controlled, Exploratory, Dose-ranging Study to Evaluate the Safety, Effectiveness and Pharmacokinetics of Three Courses of DC-TAB Treatment in Patients With Multiple Sclerosis|Completed||Phase 2|32|Actual|Delta Crystallon BV||4|||f||||t||||||||||2017-10-10 23:19:02.034164|2017-10-10 23:19:02.034164
NCT02442557|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-05-12|||December 2009||2009-12-01|May 2015|2015-05-01|July 2011|Actual|2011-07-01|October 2010|Actual|2010-10-01||Interventional|||Safety and Dose-finding Study of DC-TAB in Healthy Subjects|A Phase I, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and T-cell Tolerizing Effect of DC-TAB in Healthy Volunteers|Completed||Phase 1|76|Actual|Delta Crystallon BV||9|||f||||f||||||||||2017-10-10 23:19:02.156431|2017-10-10 23:19:02.156431
NCT02442544|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-08-31|||September 2015||2015-09-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Prebiotic Fiber Supplement in T1DM Children|Effect of Prebiotic Fiber on Gut Microbiota, Intestinal Permeability and Glycemic Control in Children With Type 1 Diabetes: A Pilot Randomized, Double Blind, Placebo Controlled Study|Recruiting||Early Phase 1|30|Anticipated|University of Calgary||2|||f||||f||||||||Undecided||2017-10-10 23:19:02.241782|2017-10-10 23:19:02.241782
NCT02442531|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-09-14|||August 2015||2015-08-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|NAPOLY||A Study of CriPec® Docetaxel Given to Patients With Solid Tumours|A Phase I Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of CriPec® Docetaxel in Patients With Solid Tumours|Recruiting||Phase 1|36|Anticipated|Cristal Therapeutics||1|||f||||f||||||||||2017-10-10 23:19:02.326143|2017-10-10 23:19:02.326143
NCT02442518|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-12-14|||February 2015||2015-02-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|ADoPAD||Antenatal Diagnosis of Placental Attachment Disorders|Antenatal Diagnosis of Placental Attachment Disorders|Recruiting||N/A|2254|Anticipated|Università degli Studi di Brescia|||1||f||||t||||||Samples Without DNA|"     histopathological samples from women with placenta previa diagnosed with ultrasound in the     3rd trimester of pregnancy   "|||2017-10-10 23:19:02.418645|2017-10-10 23:19:02.418645
NCT02442505|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-05-08|||October 2013||2013-10-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Device-detected Paroxysmal Atrial Fibrillation|Validation of the Modified Microlife Blood Pressure Monitor in Patients With Paroxysmal Atrial Fibrillation|Unknown status|Recruiting|N/A|80|Anticipated|University of Birmingham|||1||f||||f||||||||||2017-10-10 23:19:02.516276|2017-10-10 23:19:02.516276
NCT02442492|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-01-11|||January 2017||2017-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|STRIDER Canada||Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction|STRIDER Canada: A Randomized Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction (Canada)|Recruiting||Phase 2/Phase 3|90|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 23:19:02.594765|2017-10-10 23:19:02.594765
NCT02442479|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-04-21|||April 2007||2007-04-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|||Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults|Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults|Completed||N/A|127|Actual|University of Alabama at Birmingham||4|||f||||f||||||||||2017-10-10 23:19:02.691232|2017-10-10 23:19:02.691232
NCT02442466|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-05-18|||May 2011||2011-05-01|May 2015|2015-05-01||||May 2012|Actual|2012-05-01||Interventional|||Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma||Terminated||Early Phase 1|5|Actual|MelCure SA||2||Difficulties to recruit on time the required patient population.|f||||||||||||||2017-10-10 23:19:02.768968|2017-10-10 23:19:02.768968
NCT02442453|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-08|||January 2014||2014-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Scaling and Root Planing Along With Topical Application of Commercially Available Curcuma Longa Gel on Superoxide Dismutase and Malondialdehyde Levels in Saliva of Chronic Periodontitis Patients||Completed||Phase 4|100|Actual|Tatyasaheb Kore Dental College||2|||f||||||||||||||2017-10-10 23:19:02.952364|2017-10-10 23:19:02.952364
NCT02442440|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-07-15|||April 2015||2015-04-01|July 2016|2016-07-01||||June 2018|Anticipated|2018-06-01||Interventional|ACIdoSIS||Anisodamine Critically Ill SeptIc Shock|Effectiveness of Anisodamine for the Treatment of Critically Ill Patients With Septic Shock: a Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|340|Anticipated|Jinhua Central Hospital||2|||f||||t||||||||||2017-10-10 23:19:03.037926|2017-10-10 23:19:03.037926
NCT02442427|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2016-08-28|||September 2014||2014-09-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||"Palivizumab Therapy for RSV-bronchiolitis"|Treatment of Respiratory Syncytial Virus Bronchiolitis in Young Infants With Humanized Monoclonal Antibody: A Randomized Clinical Trial (Palivizumab Study)|Recruiting||Phase 3|420|Anticipated|Hamad Medical Corporation||2|||f||||t||||||||No||2017-10-10 23:19:03.264303|2017-10-10 23:19:03.264303
NCT02442401|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-05-14|||January 2009||2009-01-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Role of Negative Pressure Wound Therapy in Latissimus Dorsi Flap Donor Site Seroma Prevention|Role of Negative Pressure Wound Therapy in Latissimus Dorsi Flap Donor Site Seroma Prevention|Completed||Phase 1|40|Actual|Chulalongkorn University||2|||f||||f||||||||||2017-10-10 23:19:03.482525|2017-10-10 23:19:03.482525
NCT02442388|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-05-08|||January 2014||2014-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Postoperative Pain of Root Canal Therapy With Three Techniques||Completed||N/A|96|Actual|Shahid Beheshti University of Medical Sciences||3|||f||||t||||||||||2017-10-10 23:19:03.550938|2017-10-10 23:19:03.550938
NCT02442375|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-09-18|||June 2016|Actual|2016-06-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2021|Anticipated|2021-06-01||Interventional|UPGRADE-RT||Uniform FDG‐PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity|Uniform FDG‐PET Guided GRAdient Dose prEscription to Reduce Late Radiation Toxicity (UPGRADE‐RT): a Randomised Controlled Trial With Dose Reduction to the Elective Neck in Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 3|300|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-10 23:19:03.625672|2017-10-10 23:19:03.625672
NCT02442362|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-10|2015-05-12|||January 2012||2012-01-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||TOF Versus SOX in Metastatic Gastric Cancer|Paclitaxel/Oxaliplatin/Fluorouracil (TOF) Regimen Versus S-1/Oxaliplatin (SOX) Regimen Metastatic Gastric Cancer Patients|Completed||Phase 2/Phase 3|60|Actual|The First People's Hospital of Changzhou||2|||f||||t||||||||||2017-10-10 23:19:03.738956|2017-10-10 23:19:03.738956
NCT02442349|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-08-04|2017-01-13||June 22, 2015|Actual|2015-06-22|July 2017|2017-07-01|April 17, 2018|Anticipated|2018-04-17|March 4, 2016|Actual|2016-03-04||Interventional|AURA17|All patients enrolled who received at least 1 dose of study treatment.|Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific|A Phase II, Open Label, Single-arm Study to Assess the Safety and Efficacy of AZD9291 in Asia Pacific Patients With Locally Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed With Previous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Whose Tumours Harbour a T790M Mutation Within the Epidermal Growth Factor Receptor Gene|Active, not recruiting||Phase 2|171|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:19:03.813958|2017-10-10 23:19:03.813958
NCT02442336|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-11-22|||June 2012||2012-06-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Web-Based Multimedia Intervention for Head and Neck Cancer Patients|A Web-based Multimedia Intervention for Head and Neck Cancer Patients|Active, not recruiting||N/A|80|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-10 23:19:04.11866|2017-10-10 23:19:04.11866
NCT02442323|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-07-31|||August 2013||2013-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients|A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients|Recruiting||N/A|50|Anticipated|Fox Chase Cancer Center||2|||f||||f||||||||||2017-10-10 23:19:04.183186|2017-10-10 23:19:04.183186
NCT02442310|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-04-08|2016-04-08||May 2015||2015-05-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers|Single Dose Crossover Comparative Bioavailability Study of Deferiprone 600 mg Delayed Release Tablets Versus Deferiprone Oral Solution in Healthy Male and Female Volunteers Following a 1200 mg Dose|Completed||Phase 1|20|Actual|ApoPharma||4|||f||||f||||||||||2017-10-10 23:19:04.261345|2017-10-10 23:19:04.261345
NCT02442297|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-09-08|||February 2016||2016-02-01|September 2017|2017-09-01|January 2031|Anticipated|2031-01-01|February 2018|Anticipated|2018-02-01||Interventional|iCAR||T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With Glioblastoma|Phase I Study of Intracranial Injection of T Cells Expressing HER2-specific Chimeric Antigen Receptors (CAR) in Subjects With Glioblastoma|Recruiting||Phase 1|14|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 23:19:04.734363|2017-10-10 23:19:04.734363
NCT02442271|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2017-07-05|2017-06-29||April 27, 2015|Actual|2015-04-27|July 2017|2017-07-01|September 26, 2016|Actual|2016-09-26|July 4, 2016|Actual|2016-07-04||Interventional|||A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil|An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Treatment-Naïve or Treatment-Experienced Adults in Brazil With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ III)|Completed||Phase 3|222|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 23:19:05.142687|2017-10-10 23:19:05.142687
NCT02442258|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-11|2016-02-18|||March 2015||2015-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function|Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function|Completed||Phase 1|46|Actual|AbbVie||6|||f||||f||||||||||2017-10-10 23:19:05.526221|2017-10-10 23:19:05.526221
NCT02442245|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-03-10|||February 2015||2015-02-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of XSurge Supplementation on Biomarkers and Performance From High Intensity Resistance Exercise|The Effect of XSurgeTM Supplementation on Biomarkers, Oxidative Stress, and Recovery From High Intensity Resistance Exercise|Active, not recruiting||N/A|41|Actual|Kemin Foods LC||3|||f||||||||||||||2017-10-10 23:19:05.630382|2017-10-10 23:19:05.630382
NCT02442232|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-08-25|||August 2015||2015-08-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Observational|||Hemodynamic Changes After Anesthesia With Propofol: Study of Biomarkers||Completed||N/A|65|Actual|Conselho Nacional de Desenvolvimento Científico e Tecnológico|||3||f||||||||||||||2017-10-10 23:19:05.703554|2017-10-10 23:19:05.703554
NCT02442219|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-04-04|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|||A Blood Based Diagnostic Test for Coeliac Disease|A Blood Based Diagnostic Test for Coeliac Disease|Completed||N/A|144|Actual|Oslo University Hospital|||3||f||||f||||||Samples With DNA|"     A tetramerbased bloodtest which will bind and identify gluten specific T-cells by the use of     a flow cytometer. 50 ml blood will be needed for this test, along with characterization of     other blood values (eg. Hb, leukocytes, transferrin binding, B12, biobanking etc).   "|||2017-10-10 23:19:05.767305|2017-10-10 23:19:05.767305
NCT02442206|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-08-07|||May 18, 2015|Actual|2015-05-18|August 2017|2017-08-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|CLAIM||Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients|A Randomized, Double-blinded, Single-center, Placebo Controlled, Cross-over Study to Assess the Effect of QVA149 (Indacaterol Maleate / Glycopyrronium Bromide) on Cardiac Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|62|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:19:05.833878|2017-10-10 23:19:05.833878
NCT02442193|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-09-21|||March 2016||2016-03-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|IPSOH||Individual Placement and Support for Patients With Offending Histories|Individual Placement and Support (IPS) for Patients With Offending Histories: Feasibility of an Evidence-based Approach in Forensic Mental Health Settings|Active, not recruiting||N/A|18|Actual|Nottinghamshire Healthcare NHS Trust||2|||f||||t||||||||||2017-10-10 23:19:05.932727|2017-10-10 23:19:05.932727
NCT02442180|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2016-05-04|||July 2015||2015-07-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|GraCiAH||Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid|Efficacy and Safety of Granulocyte-colony Stimulating Factor in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid: A Randomized, Double-blind, Placebo-controlled, Nationwide Multi-center Study|Recruiting||Phase 3|268|Anticipated|Chuncheon Sacred Heart Hospital||4|||f||||t||||||||No||2017-10-10 23:19:06.038345|2017-10-10 23:19:06.038345
NCT02442167|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-08|||March 2010||2010-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Performance of FISH for the Diagnosis of Malignant Biliary Strictures in Thai Patients|Fluorescence in Situ Hybridization (FISH) Improves Performance of Conventional Cytology for the Diagnosis of Malignant Biliary Tract Strictures in Thai Patients|Completed||N/A|101|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"     Brush samples obtained from endoscopic retrograde cholangiopancreatography   "|||2017-10-10 23:19:06.16084|2017-10-10 23:19:06.16084
NCT02442154|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-03-17|||June 2015||2015-06-01|August 2015|2015-08-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|E-Trac||Early Tracheostomy Versus Standard of Care in Patients With Severe Head Injury|EARLY TRACHEOSTOMY VERSUS STANDARD OF CARE, A RANDOMIZED CONTROLLED CLINICAL TRIAL IN PATIENTS WITH SEVERE HEAD INJURY IN MULAGO HOSPITAL|Completed||N/A|160|Actual|Makerere University||2|||f||||f||||||||||2017-10-10 23:19:06.214733|2017-10-10 23:19:06.214733
NCT02442141|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-01-20|||April 28, 2015|Actual|2015-04-28|January 2017|2017-01-01|December 30, 2018|Anticipated|2018-12-30|May 31, 2016|Actual|2016-05-31||Observational|||Peri-operative NIRS Monitoring In Infants|Cerebral Near-infrared Spectroscopy Monitoring in Infants During the Peri-operative Period: a Prospective Observational Cohort Study|Active, not recruiting||N/A|76|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-10-10 23:19:06.292|2017-10-10 23:19:06.292
NCT02442128|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2016-11-06|||June 2015||2015-06-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Fentanyl and Propofol for Tracheal Intubation During Sevoflurane Induction Without Muscle Relaxants in Children|Using Fentanyl and Propofol for Tracheal Intubation During Sevoflurane Induction Without Muscle Relaxants in Children: a Randomized Prospective Study|Completed||N/A|90|Actual|King Saud University||2|||f||||t||||||||Undecided||2017-10-10 23:19:06.348798|2017-10-10 23:19:06.348798
NCT02442115|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-09-14|||September 2009|Actual|2009-09-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress|The MET Signaling System, Autism and Gastrointestinal Dysfunction|Recruiting||N/A|600|Anticipated|Children's Hospital Los Angeles|||2||f||||f||||||Samples With DNA|"     Urine sample collection. Saliva sample collection for DNA extraction.   "|||2017-10-10 23:19:06.428412|2017-10-10 23:19:06.428412
NCT02442102|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-02-21|||July 2015||2015-07-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|PRESIDE||PReventing the EffectS of Intubation on DEglutition|Understanding and Improving Dysphagia After Mechanical Ventilation|Recruiting||Phase 2|40|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 23:19:06.517023|2017-10-10 23:19:06.517023
NCT02442089|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-06-10|||December 2013||2013-12-01|May 2015|2015-05-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|Health Call||Impact of Automated Calls on Pediatric Patient Attendance in Chile|Health Call: A Randomized Control Trial of Interactive Automated Reminder Calls to Reduce Failure to Attend Rates at an Urban Referral Hospital in Chile|Completed||N/A|263|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 23:19:06.612302|2017-10-10 23:19:06.612302
NCT02442063|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-11-29|||August 2015||2015-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions|An Open-label, Multi-center, Non-randomized Phase Ib Study to Investigate Safety and Tolerability of Radium Ra 223 Dichloride (BAY88-8223) Administered in Combination With Paclitaxel in Cancer Subjects With Bone Lesions|Completed||Phase 1|15|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:19:06.737072|2017-10-10 23:19:06.737072
NCT02442050|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-05-24|||January 2015||2015-01-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|April 2016|Actual|2016-04-01||Interventional|||Del Nido Cardioplegia Randomized Trial|The Use of Del Nido Cardioplegia in Adult Cardiac Surgery: A Prospective Randomized Trial|Active, not recruiting||N/A|500|Anticipated|Inova Health Care Services||2|||f||||f||||||||||2017-10-10 23:19:06.811086|2017-10-10 23:19:06.811086
NCT02442037|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-14|||May 2015||2015-05-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|UCMSC-UC||Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis|Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Active Ulcerative Colitis.|Recruiting||Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-10 23:19:06.894145|2017-10-10 23:19:06.894145
NCT02442024|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-05-08|||January 2014||2014-01-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Metabolic Effects of the Manipulation of Nutrient Sequence in the Main Meals in Type 2 Diabetic Patients|Metabolic Effects of the Manipulation of Nutrient Sequence in the Main Meals in Type 2 Diabetic Patients|Unknown status|Recruiting|N/A|20|Anticipated|Azienda Ospedaliero, Universitaria Pisana||2|||f||||f||||||||||2017-10-10 23:19:07.095875|2017-10-10 23:19:07.095875
NCT02442011|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-07-18|||January 2014||2014-01-01|July 2016|2016-07-01|December 2025|Anticipated|2025-12-01|December 2019|Anticipated|2019-12-01||Observational|||Hematology Biobank : Invitro Study of Blood Disorders|Hematology Biobank : Invitro Study of Blood Disorders|Recruiting||N/A|1000|Anticipated|Albert Einstein College of Medicine, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood samples will be processed fresh or frozen and stored in cryo vials at -80°C for     future isolation of DNA. DNA isolation will be done using commercially available kits such as     Applied Biosystems' DNA Isolation from Fresh and Frozen Blood, Tissue Culture     http://tools.lifetechnologies.com/content/sfs/manuals/cms_041387.pdf Plasma needed for     biomarkers analysis we be obtained from whole blood samples. Whole blood will be spun down,     plasma and sediment will be separated and stored in cryo vials at -80°C. Red cells and     platelets will be stored at 4C. Red cell hemolysate may be stored at 4C or stored in cryo     vials.   "|Yes|We will enter our deidentified data into REDCap which will make it available to others.|2017-10-10 23:19:07.196014|2017-10-10 23:19:07.196014
NCT02441998|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-12|||October 2013||2013-10-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Real-Time Characterizations of Diminutive Colorectal Polyps Using Narrow Band Imaging|Prospective Multi-Center Study Evaluating Real-Time Characterizations of Diminutive Colorectal Polyps Using Narrow Band Imaging: Implications for the Resect and Discard Strategy|Completed||N/A|26|Actual|University of Michigan|||1||f||||f||||||||||2017-10-10 23:19:07.28565|2017-10-10 23:19:07.28565
NCT02441985|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-05-26|||August 2015||2015-08-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||rTMS Therapy for Primary Orthostatic Tremor|rTMS Therapy for Primary Orthostatic Tremor: A Novel Treatment Approach|Recruiting||N/A|20|Anticipated|University of Florida||2|||f||||t||||||||||2017-10-10 23:19:07.379042|2017-10-10 23:19:07.379042
NCT02441972|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-03-09|||January 2012||2012-01-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics|Phase 1 Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics|Recruiting||Phase 1|200|Anticipated|Wuxi No. 4 People's Hospital||1|||f||||f||||||||||2017-10-10 23:19:07.500998|2017-10-10 23:19:07.500998
NCT02441959|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-11-20|||June 2015||2015-06-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Full-Endoscopic vs Open Discectomy for the Treatment of Symptomatic Lumbar Herniated Disc|Full-Endoscopic vs Open Discectomy for the Treatment of Symptomatic Lumbar Herniated Disc: A Prospective Multi-Center Randomized Study|Recruiting||N/A|200|Anticipated|Yale University||3|||f||||f||||||||Undecided||2017-10-10 23:19:07.59093|2017-10-10 23:19:07.59093
NCT02441946|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-05-16||2016-12-21|August 2015||2015-08-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|August 2016|Actual|2016-08-01||Interventional|neoMONARCH||A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer|neoMONARCH: A Phase 2 Neoadjuvant Trial Comparing the Biological Effects of 2 Weeks of Abemaciclib (LY2835219) in Combination With Anastrozole to Those of Abemaciclib Monotherapy and Anastrozole Monotherapy and Evaluating the Clinical Activity and Safety of a Subsequent 14 Weeks of Therapy With Abemaciclib in Combination With Anastrozole in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer|Completed||Phase 2|224|Actual|Eli Lilly and Company||3|||f||||f||||||||Yes|Lilly provides access to the individual participant data from studies on approved medicines and indications as defined by the sponsor specific information on linicalStudyDataRequest.com This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement.|2017-10-10 23:19:07.688563|2017-10-10 23:19:07.688563
NCT02441933|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-02-02|||December 2015||2015-12-01|February 2017|2017-02-01|June 2023|Anticipated|2023-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)|A Randomized, Multicenter, Open-label, Phase III Trial Comparing Anthracyclines Followed by Taxane Versus Anthracyclines Followed by Taxane Plus Carboplatin as (Neo) Adjuvant Therapy in Patients With Triple-negative Breast Cancer|Recruiting||Phase 3|840|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-10 23:19:07.917376|2017-10-10 23:19:07.917376
NCT02441920|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-02-08|||November 2010||2010-11-01|February 2017|2017-02-01|November 2030|Anticipated|2030-11-01|November 2012|Actual|2012-11-01||Observational|||Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis|Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis|Active, not recruiting||N/A|400|Anticipated|University of Birmingham|||1||f||||f||||||||||2017-10-10 23:19:08.065348|2017-10-10 23:19:08.065348
NCT02441894|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-01-23|||April 2015||2015-04-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|February 2016|Actual|2016-02-01||Interventional|PEGAZUS||Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer|Cabazitaxel in Combination With Prednisolone With Primary Prophylaxis With PEG-G-CSF for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer|Completed||Phase 4|21|Actual|Sanofi||1|||f||||f||||||||||2017-10-10 23:19:08.239996|2017-10-10 23:19:08.239996
NCT02441881|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-07|||September 2014||2014-09-01|May 2015|2015-05-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Trial of Radiofrequency Thermo-ablation Treatments of Great Saphenous Varicose Veins|A Double Blind Randomised Controlled Trial of Radiofrequency Thermo-ablation Treatments of Great Saphenous Varicose Veins: Venefit (Closurefast) vs. Radiofrequency Induced Thermal Therapy (RFITT) vs. Endovenous Radiofrequency (EVRF).|Unknown status|Recruiting|N/A|180|Anticipated|Worcestershire Acute Hospitals NHS Trust||3|||f||||f||||||||||2017-10-10 23:19:08.391849|2017-10-10 23:19:08.391849
NCT02441868|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-09-13|||October 15, 2015|Actual|2015-10-15|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care|Feasibility Testing of a Hospice Family Caregiver Intervention to Improve Patient Dyspnea Care|Recruiting||N/A|5|Anticipated|Wayne State University||1|||f||||f||||||||||2017-10-10 23:19:08.501779|2017-10-10 23:19:08.501779
NCT02441855|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-06-02|||March 2015||2015-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Potential Role for Echocardiography in Adult Patients With Community-Acquired Pneumonia|Is There a Potential Role for Echocardiography in Adult Patients With Community-Acquired Pneumonia Who Require Hospitalization ? A Pilot Study|Completed||N/A|210|Actual|Muğla Sıtkı Koçman University|||2||f||||f||||||||||2017-10-10 23:19:08.600349|2017-10-10 23:19:08.600349
NCT02441842|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-02-07|||March 2006||2006-03-01|February 2017|2017-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of Periop Biochemical Stress Factors in Craniotomy Neurosurgical Procedure With Respect to Preop Hypertension|Evaluation of Perioperative Biochemical Stress Factors in Craniotomy Neurosurgical Procedure With Respect to Preoperative Hypertension|Completed||Phase 4|85|Actual|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-10-10 23:19:08.684114|2017-10-10 23:19:08.684114
NCT02441829|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-12-18|||May 2015||2015-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function|A Phase 1 Open-Label, Parallel-Group, Adaptive, Single Dose Study to Evaluate the Pharmacokinetics of GS-6615 in Subjects With Normal and Impaired Renal Function|Completed||Phase 1|55|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-10 23:19:08.778989|2017-10-10 23:19:08.778989
NCT02441816|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-07-06|||November 2014||2014-11-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|VITAL||VITAL - Individualising Therapy for Neovascular AMD With Aflibercept|VITAL - Individualising Therapy for Neovascular AMD With Aflibercept|Active, not recruiting||Phase 4|50|Actual|Moorfields Eye Hospital NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 23:19:08.875464|2017-10-10 23:19:08.875464
NCT02441803|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-09-07|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)|Allogeneic Hematopoietic Stem Cell Transplantation as Initial Salvage Therapy for Patients With Primary Induction Failure Acute Myeloid Leukemia Refractory to High-Dose Cytarabine-Based Induction Chemotherapy|Recruiting||Phase 2|75|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 23:19:08.963105|2017-10-10 23:19:08.963105
NCT02441790|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-10-19|||May 2015||2015-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Early Range of Motion in 5th Metacarpal Fracture|Early Range of Motion in 5th Metacarpal Fracture: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 23:19:09.136823|2017-10-10 23:19:09.136823
NCT02441777|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-08-07|||August 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Polarization Sensitive Optical Coherence Tomography (PS-OCT) for Retinal Imaging|Polarization Sensitive Optical Coherence Tomography (PS-OCT) for Retinal Imaging|Not yet recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||||2017-10-10 23:19:09.235387|2017-10-10 23:19:09.235387
NCT02441764|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-06-01|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Halaven Post-Marketing Surveillance (PMS)|Post-Marketing Surveillance of Halaven Injection in Korean Patients|Recruiting||N/A|3000|Anticipated|Eisai Inc.|||1||f||||f||||||||||2017-10-10 23:19:09.322718|2017-10-10 23:19:09.322718
NCT02441751|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-11|||May 2015||2015-05-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||Intraoperative Volume Management and QT Interval|Intraoperative Repolisarisation - Etiology and Relevance for the Decision Making by Anesthesiologists in the Management of Volume Substitution and Transfusion|Recruiting||N/A|200|Anticipated|Technische Universität Dresden|||2||f||||t||||||||||2017-10-10 23:19:09.415338|2017-10-10 23:19:09.415338
NCT02441738|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-02-16|||June 2016||2016-06-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|HARTCAP-AF||Hybrid Versus Catheter Ablation in Persistent AF|Hybrid Thoracoscopic Surgical and Transvenous Catheter Ablation Versus Repeated Transvenous Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation|Recruiting||N/A|40|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:19:09.501705|2017-10-10 23:19:09.501705
NCT02441725|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|STAND-UP||Validation of the 1-minute Sit-to-stand Test in Patients With COPD|1-minute Sit-to-stand Test: A Multicentre Validation Study of a Simple Exercise Capacity Test in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|55|Actual|University of Zurich||2|||f||||f||||||||||2017-10-10 23:19:09.593384|2017-10-10 23:19:09.593384
NCT02441712|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-05-07|||March 2015||2015-03-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|PENS for PFP||Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain|Supervised Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain|Unknown status|Recruiting|Phase 2/Phase 3|32|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-10 23:19:09.684329|2017-10-10 23:19:09.684329
NCT02441166|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-04-24|||October 2015||2015-10-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|EvaTryMS||Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis|Evaluation of the Diagnostic Value of Level of Bone Marrow Tryptase in Adult Systemic Mastocytosis|Recruiting||N/A|200|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 23:19:19.488495|2017-10-10 23:19:19.488495
NCT02441699|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-08-23|||April 2015||2015-04-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Assessing the Health Impact of a Combined Water and Sanitation Intervention in Rural Odisha, India|Assessing the Health Impact of a Combined Water and Sanitation Intervention in Rural Odisha, India|Active, not recruiting||N/A|2940|Anticipated|London School of Hygiene and Tropical Medicine|||2||f||||f||||||Samples With DNA|"     Stool samples will be collected and divided into two aliquots. One aliquot will be fixed and     used for assessing the rate and intensity of soil-transmitted helminth (STH) infection and     the second aliquot will be frozen and used to assess biomarkers of environmental enteropathy     and enteric infection   "|||2017-10-10 23:19:09.768474|2017-10-10 23:19:09.768474
NCT02441686|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-09-01|||December 2015||2015-12-01|September 2017|2017-09-01|August 2022|Anticipated|2022-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma|A Phase II Study of the Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|45|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:19:09.833842|2017-10-10 23:19:09.833842
NCT02441673|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-08-31|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering|Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering Following Subarachnoid Block|Not yet recruiting||Phase 2|130|Anticipated|Lagos State Health Service Commission||2|||f||||f|f|f||||||||2017-10-10 23:19:09.921588|2017-10-10 23:19:09.921588
NCT02441660|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-08-21|||April 2016||2016-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|Capsaicin||Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain|Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain|Recruiting||N/A|20|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||||||||||||2017-10-10 23:19:10.25157|2017-10-10 23:19:10.25157
NCT02441634|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-05-03|||May 2015||2015-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:19:10.43688|2017-10-10 23:19:10.43688
NCT02441621|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-07|||June 2015||2015-06-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Prediction of Volume Responsiveness in Presence of Left Ventricular Diastolic Dysfunction|Prediction of Fluid Responsiveness in Presence of Diastolic Dysfunction|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Schleswig-Holstein||7|||f||||t||||||||||2017-10-10 23:19:10.47758|2017-10-10 23:19:10.47758
NCT02441595|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-03-07|||January 2015||2015-01-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|January 2017|Actual|2017-01-01||Interventional|MBCP||Mindfulness Based Childbirth and Parenting Education - RCT of Effects on Parent and Child Health|Mindfulness Based Childbirth and Parenting Education - RCT of Effects on Parent and Child Health|Active, not recruiting||N/A|193|Actual|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-10 23:19:10.683886|2017-10-10 23:19:10.683886
NCT02441582|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-03-07|||July 2015||2015-07-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effect of 12 Lead ECG Telemetry on Reperfusion Time in Resource-limited Settings||Recruiting||N/A|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:19:10.780321|2017-10-10 23:19:10.780321
NCT02441569|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-05-05|||September 2014||2014-09-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Common Engagement Strategies (Common Factors) for Childhood Anxiety|Common Engagement Strategies (Common Factors) for Childhood Anxiety|Completed||N/A|32|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||No||2017-10-10 23:19:10.867883|2017-10-10 23:19:10.867883
NCT02441556|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-12-13|||January 2015||2015-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|BEST||Acute Basilar Artery Occlusion: Endovascular Interventions vs Standard Medical Treatment|Acute Basilar Artery Occlusion: Endovascular Interventions vs Standard Medical Treatment|Recruiting||N/A|344|Anticipated|Jinling Hospital, China||2|||f||||t||||||||Undecided||2017-10-10 23:19:10.979473|2017-10-10 23:19:10.979473
NCT02441543|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-02-09|||April 2015||2015-04-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Observational|||Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus|Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus|Recruiting||N/A|45|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples Without DNA|"     Blood   "|Undecided||2017-10-10 23:19:11.294209|2017-10-10 23:19:11.294209
NCT02441530|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-11|||November 2012||2012-11-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|January 2013|Actual|2013-01-01||Interventional|||Effectiveness of Vitamin D in Primary Dysmenorrhoea|Vitamin D in the Treatment of Primary Dysmenorrhoea: A Prospective Randomised Controlled Trial|Completed||Phase 3|143|Actual|Bezmialem Vakif University||3|||f||||f||||||||||2017-10-10 23:19:11.382667|2017-10-10 23:19:11.382667
NCT02440958|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-05-07|||May 2015||2015-05-01|May 2015|2015-05-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial||Unknown status|Not yet recruiting|Phase 2|46|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 23:19:22.183183|2017-10-10 23:19:22.183183
NCT02441517|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2017-05-22|||October 28, 2015|Actual|2015-10-28|May 2017|2017-05-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment|A Multicenter, Open-label, Single-arm, Study of Enzalutamide Re-Treatment in Metastatic Castration-Resistant Prostate Cancer, As First Treatment Post-Chemotherapy in Patients Who Have Previously Received Enzalutamide in the Pre-Chemotherapy Setting|Terminated||Phase 4|4|Actual|Astellas Pharma Inc||1||The study is closed early for feasibility reasons|f||||f||||||||Undecided||2017-10-10 23:19:11.477324|2017-10-10 23:19:11.477324
NCT02441504|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-11|||January 2014||2014-01-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Low Intensity Aerobic Exercise on the Microvascular Endothelial Function of Patients With Type 1 Diabetes|Effects of Low Intensity Aerobic Exercise Training on the Microvascular Endothelial Function of Patients With Type 1 Diabetes: a Non-pharmacological Interventional Study|Completed||N/A|22|Actual|Instituto Nacional de Cardiologia de Laranjeiras||1|||f||||t||||||||||2017-10-10 23:19:11.579969|2017-10-10 23:19:11.579969
NCT02441491|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-05-17|||March 2015||2015-03-01|May 2016|2016-05-01|March 2023|Anticipated|2023-03-01|March 2022|Anticipated|2022-03-01||Interventional|||Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )|High-dose Cyclophosphamide for the Treatment of ROHHAD (Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation) Syndrome|Recruiting||N/A|12|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:19:11.65856|2017-10-10 23:19:11.65856
NCT02441478|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-09-21|||February 2015||2015-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Co-operative Behavior and Decision-making in Frontal Lobe Epilepsy|Co-operative Behavior and Decision-making in Frontal Lobe Epilepsy|Completed||N/A|30|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:19:11.747004|2017-10-10 23:19:11.747004
NCT02441465|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-06-15|||August 13, 2015|Actual|2015-08-13|June 2017|2017-06-01|January 9, 2017|Actual|2017-01-09|August 18, 2016|Actual|2016-08-18||Interventional|||Bioavailability Study of Vemurafenib in Participants With BRAF^V600 Mutation-Positive Malignancies|A Phase 1, Open-Label, Absolute Bioavailability Study of Vemurafenib in Patients With BRAF^V600 Mutation-Positive Malignancies|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||f||||||||||2017-10-10 23:19:11.838732|2017-10-10 23:19:11.838732
NCT02441452|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-05-07|||January 2013||2013-01-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Functional Capacity of Exercise and Lung Function in Patients Submitted Early Rehabilitation|Functional Capacity of Exercise and Lung Function in Patients Submitted to Early Rehabilitation Program After Nuss Procedure: a Randomized Controlled Trial|Completed||N/A|40|Actual|Instituto do Coracao||2|||f||||f||||||||||2017-10-10 23:19:11.941572|2017-10-10 23:19:11.941572
NCT02441439|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-08-14|||October 2017|Anticipated|2017-10-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy|To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy|Not yet recruiting||N/A|140|Anticipated|HaEmek Medical Center, Israel||2|||f||||f|f|f||||||||2017-10-10 23:19:12.01772|2017-10-10 23:19:12.01772
NCT02441426|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-05-07|||November 2008||2008-11-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Observational|MAL-ED||Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development|Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development|Unknown status|Active, not recruiting|N/A|1796|Anticipated|Foundation for the National Institutes of Health|||8||f||||f||||||Samples With DNA|"     plasma, stool, urine, saliva   "|||2017-10-10 23:19:12.096174|2017-10-10 23:19:12.096174
NCT02441413|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-03-28|||September 2015||2015-09-01|February 2016|2016-02-01|November 8, 2016|Actual|2016-11-08|November 8, 2016|Actual|2016-11-08||Interventional|TROFI_BE||Transplant Optimization Using Functional Imaging (TROFI)|Transplant Optimization Using Functional Imaging (TROFI)|Completed||N/A|3|Actual|FLUIDDA nv||1|||f||||f||||||||||2017-10-10 23:19:12.208741|2017-10-10 23:19:12.208741
NCT02441400|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-01-25|||May 2013||2013-05-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01|5 Years|Observational [Patient Registry]|RESTORE||EndoStim Patient Registry|EndoStim Patient Registry-LES Stimulation System for the Treatment of GERD|Recruiting||N/A|350|Anticipated|EndoStim Inc.|||1||f||||t||||||||||2017-10-10 23:19:12.298947|2017-10-10 23:19:12.298947
NCT02441387|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-05-15|||April 2015||2015-04-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01|18 Months|Observational [Patient Registry]|||Predictors of the Outcome of Late Life Depression|Clinical Characteristics and Structural Changes in Magnetic Resonance Imaging: Importance for the Outcome of Late Life Depression|Recruiting||N/A|120|Anticipated|University of Sao Paulo General Hospital|||2||f||||t||||||Samples With DNA|"     Peripheral venous blood (10mL) will be collected from participants, venocubital puncture into     tubes with anticoagulant ethylenediamine tetraacetic acid (EDTA). After collection, the tubes     will be properly stored at 4 ° C until the time of extraction. The genomic deoxyribonucleic     acid (DNA) will be extracted using a salting out technique (Miller et al. 1988). After DNA     extraction, the achieved concentration will be measured by reading the Gene Quant     spectrophotometer (Pharmacia Biotech).   "|Undecided||2017-10-10 23:19:12.445107|2017-10-10 23:19:12.445107
NCT02441374|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-05-15|||August 2016||2016-08-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|May 2017|Actual|2017-05-01||Interventional|||Checking a Security Protocol of Modified FUT and Efficacy Reducing the Constriction the Movement Time in 12 Hours|Checking a Security Protocol of Modified Forced Use Therapy and Efficacy Reducing the Constriction the Movement Time in 12 Hours|Recruiting||N/A|82|Anticipated|University of Sao Paulo||2|||f||||f||||||||No||2017-10-10 23:19:12.557044|2017-10-10 23:19:12.557044
NCT02441361|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-05-07|||March 2015||2015-03-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Exercise Training in Bariatric Patients|Effects of Exercise in Bariatric Patients: a Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:19:12.664262|2017-10-10 23:19:12.664262
NCT02441348|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-12-07|||August 2016||2016-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|||Efficacy of Conversation Training Therapy (CTT)|Efficacy of Conversation Training Therapy (CTT)|Recruiting||N/A|100|Anticipated|University of Pittsburgh|||1||f||||f||||||||Undecided||2017-10-10 23:19:12.739051|2017-10-10 23:19:12.739051
NCT02441335|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-12|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|January 2020|Anticipated|2020-01-01||Observational|CRIB||CellulaR Injury and Preterm Birth|CellulaR Injury and Preterm Birth|Recruiting||N/A|1120|Anticipated|University of Pennsylvania|||2||f||||f||||||Samples With DNA|"     1. Collect blood, urine and cervicovaginal cells from women with preterm labor and term labor     in order to investigate:        1. What is the role of bioenergetics in pregnancy and what are the pertubations in cell          metabolism that lead to spontaneous preterm birth        2. What are the interactions between the microbiome (oral, gut, cervicovaginal, and          placental) and host metabolic function in pregnancy        3. How do interactions between cell metabolism and the microbiome influence cervical          remodeling and placental function leading to spontaneous preterm delivery        4. What genetic and environmental factors influence the metabolic function of reproductive          tissues leading to spontaneous preterm delivery   "|||2017-10-10 23:19:12.813568|2017-10-10 23:19:12.813568
NCT02441322|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-05-01|||December 2014||2014-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating Therapeutic Response to Novo-TTF|High Resolution MRI and MRS to Evaluate Therapeutic Response to Novo-TTF in Newly and Recurrent Glioblastomas|Recruiting||N/A|30|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 23:19:12.884|2017-10-10 23:19:12.884
NCT02441296|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-07-08|||October 2013||2013-10-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Carbohydrate and Metabolism: a Pilot Study|Postprandial Serum Responses to Various Infant Formulas and Breast Milk in Infants- a Pilot Study|Completed||N/A|30|Actual|Umeå University||3|||f||||f||||||||No||2017-10-10 23:19:13.080492|2017-10-10 23:19:13.080492
NCT02441283|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-09-07|||June 22, 2015||2015-06-22|September 2017|2017-09-01|July 13, 2020|Anticipated|2020-07-13|April 26, 2019|Anticipated|2019-04-26||Interventional|||A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530|A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy (ABT-493 and/or ABT-530) in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatment of Chronic Hepatitis C Virus (HCV) Infection|Enrolling by invitation||Phase 2|400|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-10 23:19:13.140191|2017-10-10 23:19:13.140191
NCT02441270|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-05-07|||April 2015||2015-04-01|May 2015|2015-05-01||||October 2016|Anticipated|2016-10-01||Interventional|||Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients|Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients|Unknown status|Recruiting|Early Phase 1|5|Anticipated|University Hospital, Ghent||1|||f||||t||||||||||2017-10-10 23:19:13.279172|2017-10-10 23:19:13.279172
NCT02441257|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2015-05-11|||August 2015||2015-08-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|LMA||Gastroesophageal Reflux During LMA in Control Ventilation (LMA, Laryngeal Mask Airway)|Incidence of Gastroesophageal Reflux During LMA Application in Control and Spontaneous Ventilation|Unknown status|Not yet recruiting|N/A|200|Anticipated|Eastern Hepatobiliary Surgery Hospital||1|||f||||f||||||||||2017-10-10 23:19:13.359705|2017-10-10 23:19:13.359705
NCT02441244|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-03-10|||November 2015||2015-11-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PROOV IT I||Probiotic Visbiome for Inflammation and Translocation in HIV Ι|Probiotic Visbiome for Inflammation and Translocation in HIV I (PROOV IT I)|Recruiting||Phase 2|40|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:19:13.425737|2017-10-10 23:19:13.425737
NCT02441231|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-03-10|||November 2015||2015-11-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PROOV IT II||Probiotic Visbiome for Inflammation and Translocation in HIV II|Probiotic Visbiome for Inflammation and Translocation in HIV II (PROOV IT II)|Recruiting||Phase 2|36|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:19:13.519164|2017-10-10 23:19:13.519164
NCT02441218|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-05-23|2015-05-12||September 2006||2006-09-01|May 2016|2016-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|SHIFT||Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study||Completed||Phase 3|6505|Actual|Servier|The section Other Adverse Events (Not including serious) has been completed by the sponsor to include only the Non Serious Adverse Events emergent on treatment during the study.|2|||f||||t||||||||||2017-10-10 23:19:13.811757|2017-10-10 23:19:13.811757
NCT02441205|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-02-23|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Interval Training, Inflammation and Immune Function|The Impact of High Intensity Interval Training on Inflammatory State and Immune Function in Elderly Individuals|Active, not recruiting||N/A|30|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 23:19:17.235931|2017-10-10 23:19:17.235931
NCT02441192|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-06-10|||January 2013||2013-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|June 2013|Actual|2013-06-01||Interventional|TRAINING2014||Different Training (Aerobic, Resistance or Mixed) Physical Programs Affect to Physiological Responses (TRAINING2014)|Cardiovascular and Cardiorespiratory Coupling After Different Types of Training and Detraining|Completed||N/A|40|Actual|University of Barcelona||3|||f||||f||||||||||2017-10-10 23:19:17.302079|2017-10-10 23:19:17.302079
NCT02441179|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-04-21|2015-10-28||March 2015||2015-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Acute Intermittent Hypoxia and Body Weight Supported Treadmill Training for Incomplete Spinal Cord Injury Patients|Acute Intermittent Hypoxia and Body Weight Supported Treadmill Training: a Potential Therapy for Incomplete Spinal Cord Injury Patients|Completed||N/A|35|Actual|Instituto de Rehabilitación Infantil Teletón Chile|Our study included only 4 female subjects; thus, we could not investigate gender differences in response to IH.|2|||f||||f||||||||||2017-10-10 23:19:17.379725|2017-10-10 23:19:17.379725
NCT02440750|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-03-08|||June 2016||2016-06-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women||Not yet recruiting||Phase 4|50|Anticipated|University of Cagliari||2|||f||||f||||||||||2017-10-10 23:19:24.12206|2017-10-10 23:19:24.12206
NCT02441153|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-08|2015-05-08|||June 2015||2015-06-01|May 2015|2015-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|T4RC||Timing of Rectal Cancer Resection After Preoperative Chemoradiotherapy|T4RC North: Timing of Rectal Cancer Resection After Preoperative Chemoradiotherapy; Does a Longer Wait Improve Outcomes?|Not yet recruiting||N/A|80|Anticipated|Health Sciences North Research Institute|||2||f||||f||||||None Retained|"     To maximize the utility of this trial, immunohistochemical staining will be performed on     pre-CRT tumor samples to prospectively validate the scoring system proposed by Hur et al.     [28] The question being whether or not expression of these biomarkers can predict which     patients will experience pCR and disease-free survival.   "|||2017-10-10 23:19:19.640366|2017-10-10 23:19:19.640366
NCT02441140|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-12-09|||May 2015||2015-05-01|December 2016|2016-12-01|April 2020|Anticipated|2020-04-01|August 2018|Anticipated|2018-08-01||Interventional|||Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis|Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis|Recruiting||N/A|10|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:19:20.331961|2017-10-10 23:19:20.331961
NCT02441127|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-12|||October 2012||2012-10-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||Diode Laser for Harvesting Gingival Graft|Diode Laser For Harvesting Subepithelial Connective Tissue Graft in The Treatment of Gingival Recession Defects: A Novel Approach to Limit Morbidity|Completed||N/A|52|Actual|Cukurova University||2|||f||||t||||||||||2017-10-10 23:19:20.458006|2017-10-10 23:19:20.458006
NCT02441114|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-11-20|2016-04-24||July 2015||2015-07-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011)|A Pilot Study to Investigate Pharmacokinetic Characteristics After Co-administration of HCP0910 and HGP1011|Completed||Phase 1|10|Actual|Seoul National University Hospital||1|||f||||f||||||||No||2017-10-10 23:19:20.55691|2017-10-10 23:19:20.55691
NCT02441101|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-03-30|||August 2015||2015-08-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|SPARK||Right Ventricular Septal Pacing in Patients With Right Bundle Branch Block and Heart Failure (The SPARK Trial)|Right Ventricular Septal Pacing in Patients With Right Bundle Branch Block and Heart Failure, a Pilot Clinical Trial (The SPARK Trial)|Recruiting||N/A|40|Anticipated|University of Iowa||2|||f||||t||||||||||2017-10-10 23:19:20.786248|2017-10-10 23:19:20.786248
NCT02441088|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-04-27|||May 2015||2015-05-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|PRRT||Theranostics: 68GaDOTATOC and 90YDOTATOC|Dosimetry-Guided 90Y-DOTA-tyr3-Octreotide (90Y-DOTATOC) Peptide Receptor Radiotherapy (PRRT) in Children & Adults With Neuroendocrine and Other Somatostatin Receptor Expressing Tumors Determined by 68Ga-DOTA-tyr3-Octreotide (68Ga-DOTATOC) PET|Active, not recruiting||Phase 2|25|Actual|University of Iowa||1|||f||||t||||||||||2017-10-10 23:19:20.963232|2017-10-10 23:19:20.963232
NCT02441075|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-01-28|||May 2014||2014-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|70% EtOH||70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014|70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014|Completed||N/A|13|Actual|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-10 23:19:21.141178|2017-10-10 23:19:21.141178
NCT02441062|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-08-23|||September 2015||2015-09-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors|Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors|Recruiting||Phase 2|200|Anticipated|University of Iowa||1|||f||||t||||||||||2017-10-10 23:19:21.234224|2017-10-10 23:19:21.234224
NCT02441049|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-10-04|||July 2007||2007-07-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|February 2011|Actual|2011-02-01||Interventional|||Latino Mothers as Primary Agents of Change|Latino Mothers as Primary Agents of Change|Active, not recruiting||N/A|361|Actual|San Diego State University||2|||f||||t||||||||||2017-10-10 23:19:21.333959|2017-10-10 23:19:21.333959
NCT02441036|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-05-01|||May 1, 2015|Actual|2015-05-01|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Gene Expression Following Ultherapy® Treatment|Evaluation of Changes in Gene Expression Following Ultherapy® Treatment|Recruiting||N/A|15|Anticipated|Ulthera, Inc||5|||f||||f||||||||||2017-10-10 23:19:21.455508|2017-10-10 23:19:21.455508
NCT02441023|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-02-06|||March 2013||2013-03-01|May 2015|2015-05-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Nutritional Therapy and Education With Multimedia Application in Patients With Type 2 Diabetes|Nutritional Therapy and Education With a Multimedia Application in the Metabolic Control of Patients With Type 2 Diabetes. Randomized Clinical Trial|Completed||N/A|306|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||Yes|Provide nutritional and educational measures in long-term in diabetes care.|2017-10-10 23:19:21.589069|2017-10-10 23:19:21.589069
NCT02441010|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-03-17|||May 2014||2014-05-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Application of Monitoring and Intervention Technologies in Suboptimal Health Status|Application of Monitoring and Intervention Technologies in Suboptimal Health Status in a General Population in China|Completed||N/A|2014|Actual|Chinese PLA General Hospital||7|||f||||t||||||||||2017-10-10 23:19:21.69657|2017-10-10 23:19:21.69657
NCT02440997|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-04-07|||March 25, 2015|Actual|2015-03-25|April 2017|2017-04-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Interventional|||A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache|A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache|Completed||N/A|46|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-10-10 23:19:21.817534|2017-10-10 23:19:21.817534
NCT02440984|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-05-29|||June 15, 2015|Actual|2015-06-15|August 2016|2016-08-01|December 15, 2019|Anticipated|2019-12-15|June 15, 2019|Anticipated|2019-06-15||Interventional|ANOSPIN||Anorectal Dysfunction in Patients Suffering From Spina Bifida : From Clinic to Neuro-epithelial Function (ANOSPIN)|Anorectal Dysfunction in Patients Suffering From Spina Bifida : From Clinic to Neuro-epithelial Function|Recruiting||N/A|50|Anticipated|Rennes University Hospital||1|||f||||f||||||||||2017-10-10 23:19:21.961476|2017-10-10 23:19:21.961476
NCT02440971|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-05-07|||May 2013||2013-05-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Observational|||Adaptive Servo Ventilation (ASV) in Heart Failure|Adaptive Servo Ventilation (ASV) in the Management of Acute Decompensated Heart Failure (ADHF)|Unknown status|Recruiting|N/A|40|Anticipated|St Vincent's University Hospital, Ireland|||1||f||||f||||||||||2017-10-10 23:19:22.062124|2017-10-10 23:19:22.062124
NCT02440945|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-05-07|||October 2013||2013-10-01|April 2013|2013-04-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|DBSage||Use of the DBS for the Follow-up of Blood Clinical Parameters of Old People|Use of the DBS for the Follow-up of Blood Clinical Parameters of Old People|Unknown status|Recruiting|N/A|160|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:19:22.274134|2017-10-10 23:19:22.274134
NCT02440932|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-05-20|||November 2014||2014-11-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis|Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis|Completed||N/A|26|Actual|University of Glasgow||2|||f||||f||||||||||2017-10-10 23:19:22.365984|2017-10-10 23:19:22.365984
NCT02440919|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-05-10|||June 2013||2013-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|January 2015|Actual|2015-01-01||Interventional|OSVHES||Oxygen Supplementation and Ventilator Hyperinflation in the Endotracheal Suction (OSVHES)|Effects of Low Oxygen Supplementation and Ventilator Hyperinflation in the Endotracheal Suction of Mechanically Ventilated Patients|Active, not recruiting||N/A|78|Actual|Universidade Federal de Sao Carlos||4|||f||||t||||||||No||2017-10-10 23:19:22.466855|2017-10-10 23:19:22.466855
NCT02440906|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-10-02|||June 2012||2012-06-01|October 2017|2017-10-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|WIN||Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project|Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project|Completed||N/A|1663|Actual|University of Florida||3|||f||||f||||||||||2017-10-10 23:19:22.570779|2017-10-10 23:19:22.570779
NCT02440893|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-01-26|||September 2013||2013-09-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|MET||Metformin and Corus CAD|Understanding the Effect of Metformin on Corus® CAD (MET Study)|Completed||Phase 4|37|Actual|CardioDx||1|||f||||f||||||||||2017-10-10 23:19:22.668482|2017-10-10 23:19:22.668482
NCT02440880|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-08-02|||May 2015||2015-05-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Dexamethasone With TAP Block Increasing the Duration of the Peripheral Nerve Block in Caesarian Section|Dexamethasone With TAP Block Increasing the Duration of the Peripheral Nerve Block in Caesarian Section|Recruiting||N/A|150|Anticipated|Cairo University||5|||f||||t||||||||Undecided||2017-10-10 23:19:22.732441|2017-10-10 23:19:22.732441
NCT02440867|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-07-19|||May 2015||2015-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PilotTMS-COG||Treating Social Cognition With Theta Burst Stimulation; a Pilot Sudy|Treating Social Cognition Impairments in Patients With Schizophrenia With Repetitive Transcranial Magnetic Stimulation (Theta-Burst; TBS); a Pilot Study|Recruiting||N/A|40|Anticipated|University Hospital, Caen||4|||f||||t||||||||||2017-10-10 23:19:22.83374|2017-10-10 23:19:22.83374
NCT02440854|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-10-03|||February 16, 2016|Actual|2016-02-16|October 2017|2017-10-01|October 20, 2020|Anticipated|2020-10-20|June 30, 2020|Anticipated|2020-06-30||Observational|||Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings|A Multicentre, Cohort Study to Assess the Impact on SYMptom Burden and Patient Health-related Quality of Life of Afatinib Treatment in Advanced Non-small Cell Lung Cancer in a Real World Setting in Greece.|Recruiting||N/A|150|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:19:22.925035|2017-10-10 23:19:22.925035
NCT02440841|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-07-29|||May 2015||2015-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon|Single Center, Open-Label, Single-Sequence, Within-Subject Study In Two Cohorts Of Healthy Male Subjects Comparing Single-Dose Pharmacokinetics Of Fedovapagon Alone And In Combination With A CYP3A4 Inhibitor, Itraconazole, Or A CYP3A4 Inducer, Rifampicin|Completed||Phase 1|29|Actual|Vantia Ltd||2|||f||||f||||||||||2017-10-10 23:19:23.011057|2017-10-10 23:19:23.011057
NCT02440828|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-08-24|||March 2015||2015-03-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|VAPORISE||Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia|Ventilator Associated Pneumonia: Addition of Tobramycin Inhalation Antibiotic Treatment to Standard IV Antibiotic Treatment|Recruiting||Phase 4|80|Anticipated|Erasmus Medical Center||2|||f||||t||||||||||2017-10-10 23:19:23.1652|2017-10-10 23:19:23.1652
NCT02440815|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-10-23|||November 2015||2015-11-01|October 2015|2015-10-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression|Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression|Not yet recruiting||N/A|110|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:19:23.3912|2017-10-10 23:19:23.3912
NCT02440802|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-10-17|||April 2013||2013-04-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|Feel+||Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer|Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer|Recruiting||N/A|250|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||Samples With DNA|"     One saliva sample (2mL) will be collected once at baseline for single nucleotide polymorphism     analyses.   "|||2017-10-10 23:19:23.518035|2017-10-10 23:19:23.518035
NCT02440789|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-05-23|||August 2015||2015-08-01|May 2017|2017-05-01|January 22, 2018|Anticipated|2018-01-22|November 1, 2017|Anticipated|2017-11-01||Interventional|||Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART|Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy|Recruiting||Phase 1/Phase 2|30|Anticipated|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-10 23:19:23.696418|2017-10-10 23:19:23.696418
NCT02440776|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-01-05|||April 2015||2015-04-01|January 2017|2017-01-01|May 2023|Anticipated|2023-05-01|May 2022|Anticipated|2022-05-01|5 Years|Observational [Patient Registry]|SER||Pathway CH S&E Registry|Pathway CH S&E Registry: Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache - ATI Neurostimulation System is Branded Internationally as Pulsante™ Microstimulator System|Recruiting||N/A|30|Anticipated|Autonomic Technologies, Inc.|||1||f||||f||||||||||2017-10-10 23:19:23.888976|2017-10-10 23:19:23.888976
NCT02440763|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-06-28|||July 2005||2005-07-01|June 2017|2017-06-01|July 2050|Anticipated|2050-07-01|July 2050|Anticipated|2050-07-01||Observational|EUROSCA-NHS||The EUROSCA Natural History Study|The EUROSCA Natural History Study|Recruiting||N/A|400|Anticipated|Ataxia Study Group|||1||f||||f||||||Samples With DNA|"     DNA is obtained for genetic testing.   "|||2017-10-10 23:19:24.004227|2017-10-10 23:19:24.004227
NCT02440737|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-04-05|||May 2015||2015-05-01|April 2017|2017-04-01|February 2022|Anticipated|2022-02-01|December 2017|Anticipated|2017-12-01||Interventional|NEST||Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers|Navigated Early Survivorship Transition in Improving Survivorship Care Planning in Patients With Newly Diagnosed Cancer and Their Caregivers (NEST)|Active, not recruiting||N/A|67|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||No||2017-10-10 23:19:24.204792|2017-10-10 23:19:24.204792
NCT02440724|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-05-07|||August 2014||2014-08-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SEMS||The Usefulness of Self-expandable Metal Stents(SEMS) for Malignant Gastric Outlet Obstruction: a Prospective Study Using New Designed Stents|The Usefulness of Self-expandable Metal Stents(SEMS) for Malignant Gastric Outlet Obstruction: a Prospective Study Using New Designed Stents|Unknown status|Recruiting|N/A|33|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-10 23:19:24.327316|2017-10-10 23:19:24.327316
NCT02440711|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-04-06|||May 2015||2015-05-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluation of a Modified Running-specific Prosthetic Foot|Endurance, Energy Expenditure, Perceived Function, and Satisfaction of Persons With Transtibial Limb Loss Using a Running‐Specific Prosthesis Modified for Walking|Recruiting||N/A|30|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 23:19:24.432716|2017-10-10 23:19:24.432716
NCT02440698|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-05-11|||May 2015||2015-05-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Experiences With a Genetic Test for Personalized Nutrition Test for Personalized Nutrition|Experiences With a Healthcare Professional-mediated Genetic Test for Personalized Nutrition|Unknown status|Enrolling by invitation|N/A|80|Actual|University of Toronto|||1||f||||||||||||||2017-10-10 23:19:24.559525|2017-10-10 23:19:24.559525
NCT02440685|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-08-03|||May 2015||2015-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors|A Phase 1/2, Open-Label, Uncontrolled, Multiple Dose Escalation, Cohort Expansion Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of Asn002 In Relapsed/Refractory Lymphoma, Myelofibrosis, Chronic Lymphocytic Leukemia, And Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|148|Anticipated|Asana BioSciences||7|||f||||f|t|f||||||||2017-10-10 23:19:24.640531|2017-10-10 23:19:24.640531
NCT02440672|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-08-16|||September 2015||2015-09-01|August 2017|2017-08-01|February 2027|Anticipated|2027-02-01|December 2026|Anticipated|2026-12-01||Interventional|||JOURNEY™ II CR Total Knee System|A Prospective, Non-randomized, Single Cohort, Multicenter Study to Evaluate the Clinical Outcomes of Total Knee Arthroplasty (TKA) Using the JOURNEY™ II CR Total Knee System|Recruiting||N/A|170|Anticipated|Smith & Nephew, Inc.||1|||f||||f||||||||||2017-10-10 23:19:24.79046|2017-10-10 23:19:24.79046
NCT02440659|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-04-04|2016-06-24||February 2015||2015-02-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Observational|EPOCH-RRT|Some baseline characteristics were missing for some participants. 10 participants were missing gender information and 12 participants were missing age information.|Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)|Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)|Completed||N/A|2946|Actual|Arbor Research Collaborative for Health|||2||f||||f||||||||||2017-10-10 23:19:24.934101|2017-10-10 23:19:24.934101
NCT02440646|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-12-26|||May 2015||2015-05-01|December 2015|2015-12-01|August 2020|Anticipated|2020-08-01|July 2018|Anticipated|2018-07-01|5 Years|Observational [Patient Registry]|REALITY||Natural History of Atherosclerosis in Real-World Patients Underwent Computed Tomography Angiography|Natural History of Atherosclerosis Within the Concept of the Glagovian Artery Remodeling in REAL-world Chest Pain Population Underwent Computed Tomography Angiography and 3D Quantitative Coronary Angiography: Clinical potentIal and safeTY|Terminated||N/A|1080|Actual|Ural Medical University|||2|"The study was terminated under the political pressure of the Federal Security Service of the   Russian Federation (FSB) and the Russian Society of Cardiology"|f||||t||||||Samples Without DNA|"     Blood samples to examine level of thyroid hormones and kidney function   "|||2017-10-10 23:19:25.209132|2017-10-10 23:19:25.209132
NCT02440633|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-08-30|2016-07-10||May 2015||2015-05-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects||Completed||Phase 1|8|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:19:25.327437|2017-10-10 23:19:25.327437
NCT02440620|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-04-05|||October 2014||2014-10-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Observational|CaTOB||Cardiac Toxicity in Medical Treatment of Breast Cancer|Cardiac Toxicity in Medical Treatment of Breast Cancer|Recruiting||N/A|70|Anticipated|Odense University Hospital|||1||f||||t||||||Samples With DNA|"     Blood samples will be analyzed for N-terminal proBNP and ultra-sensitive TnT. Targeted     sequencing of a limited number of well-known genes related to heart failure will be conducted     and analysis of potential future biomarkers related to heart failure is possible from blood     samples stored in a biobank.   "|||2017-10-10 23:19:25.517887|2017-10-10 23:19:25.517887
NCT02440607|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-03-29|||March 2015||2015-03-01|October 2015|2015-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of an Electronic Cognitive Aid Versus Static Cognitive Aid on the Management of a Simulated Crisis|The Effect of an Electronic Dynamic Cognitive Aid Versus a Static Cognitive Aid on the Management of a Simulated Crisis|Completed||N/A|35|Actual|NorthShore University HealthSystem||2|||f||||f||||||||||2017-10-10 23:19:25.580027|2017-10-10 23:19:25.580027
NCT02440581|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-05-02|||July 2015||2015-07-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Renal Osteodystrophy: An Individual Management Approach|Renal Osteodystrophy: A Fresh Approach|Recruiting||N/A|120|Anticipated|University of Kentucky||4|||f||||t||||||||||2017-10-10 23:19:25.724805|2017-10-10 23:19:25.724805
NCT02440568|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-09-21|||May 2015||2015-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|AML-02||AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients|AML-02: Study of the Activity and Safety of the Addition of Omacetaxine to the Standard-of-Care Induction Therapy Regimen of Cytarabine and Idarubicin in Newly-Diagnosed AML Patients|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Illinois at Chicago||1|||f||||t||||||||No||2017-10-10 23:19:25.871173|2017-10-10 23:19:25.871173
NCT02440555|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-05-27|||November 2014||2014-11-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|Sainté Diabète||Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose|Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose Compared to Current Screening in the Priority Health Area of Saint-Etienne and the Sainté Diabète Network.|Completed||N/A|1305|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-10 23:19:26.065231|2017-10-10 23:19:26.065231
NCT02440542|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-05-06|||May 2015||2015-05-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Observational|||Popliteal Nerve Block for Postoperative Pain Control in Ankle and Hindfoot Reconstruction|Popliteal Nerve Block for Postoperative Pain Control in Patients Undergoing Ankle and Hindfoot Reconstruction About the Talus|Unknown status|Enrolling by invitation|N/A|20|Anticipated|University of Tennessee|||1||f||||f||||||||||2017-10-10 23:19:26.151742|2017-10-10 23:19:26.151742
NCT02440529|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Surgeon-Patient Communication: A Randomized Controlled Trial Evaluating the Impact of an Orthopaedic Related Smoking Cessation Discussion After Fracture Surgery||Terminated||N/A|1|Actual|University of Missouri, Kansas City||2|||f||||||||||||||2017-10-10 23:19:26.244485|2017-10-10 23:19:26.244485
NCT02440516|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-01-02|||February 2016||2016-02-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|"MS-Fit"||Standardized Ambulatory Neurorehabilitation Program for Patients With Multiple Sclerosis|Standardized Comprehensive Two-month Ambulatory Neurorehabilitation Program for Patients With Multiple Sclerosis: a Randomized-controlled Trial|Recruiting||N/A|62|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:19:26.335648|2017-10-10 23:19:26.335648
NCT02440503|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-06-28|||June 2014||2014-06-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Observational|FYI-FU||How Infant Diets Would Affect Growth in Early Childhood|Effect of Complementary Feeding With Different Macronutrient Quantities on Growth and Body Composition: a Follow-up Trial|Active, not recruiting||N/A|75|Actual|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     stool samples will be collected for microbiome analysis   "|||2017-10-10 23:19:26.443862|2017-10-10 23:19:26.443862
NCT02440490|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-03-21|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Optimising Cognitive Function in Patients With Chronic Pain|Optimising Cognitive Function in Patients With Chronic Pain|Completed||N/A|39|Actual|Monash University||2|||f||||f||||||||||2017-10-10 23:19:26.510206|2017-10-10 23:19:26.510206
NCT02440477|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-03-02|||July 1, 2015||2015-07-01|February 2017|2017-02-01|April 1, 2017|Anticipated|2017-04-01|April 1, 2017|Anticipated|2017-04-01||Observational|EOCPIS||The Effect of Changing Posture in Sitting on Selected Clinical Shoulder Tests|The Effect of Changing Posture in Sitting on Selected Clinical Shoulder Tests in Patients With Rotator Cuff Degenerative Tears|Active, not recruiting||N/A|100|Anticipated|Meir Medical Center|||2||f||||t||||||||Yes||2017-10-10 23:19:26.613819|2017-10-10 23:19:26.613819
NCT02440464|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-08-28|||August 2015||2015-08-01|August 2017|2017-08-01|March 2023|Anticipated|2023-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)|Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib After Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma (BMT CTN #1302)|Recruiting||Phase 2|138|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-10-10 23:19:26.724051|2017-10-10 23:19:26.724051
NCT02440451|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-05-26|||May 2015||2015-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NF-ASD||Rt-fMRI NF Intervention Study in ASD|Improving Facial Expression Identification in ASD: a Real-time fMRI Neurofeedback Approach|Enrolling by invitation||N/A|16|Anticipated|University of Coimbra||1|||f||||f||||||||||2017-10-10 23:19:27.024286|2017-10-10 23:19:27.024286
NCT02440438|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-10-05|||January 2014||2014-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ICD||Host Immune Response to Clostridium Difficile Infection (ICD)|Factors Associated With Relapses in Patients Suffering From Clostridium Difficile Infection: Immune Response|Completed||N/A|56|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:19:27.102327|2017-10-10 23:19:27.102327
NCT02440425|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-05-23|||August 12, 2015|Actual|2015-08-12|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer|Phase 2 Trial of Dose Dense (Weekly) Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Recurrent Ovarian Cancer|Recruiting||Phase 2|40|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 23:19:27.183|2017-10-10 23:19:27.183
NCT02440412|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-05-06|||July 2014||2014-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|MTCL||Effect of Massage Therapy in Cortisol Level|Effects of a Single Session of Massage Therapy in Salivary Cortisol Levels in Asymptomatic Persons With Administrative Tasks and / or Office Work.|Completed||N/A|15|Actual|University of Chile||3|||f||||f||||||||||2017-10-10 23:19:27.295696|2017-10-10 23:19:27.295696
NCT02440399|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-05-08|||July 2015||2015-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||To Compare the Efficacy and Patients' Satisfaction for the Treatment of Post Cesarean Pain of Two Protocols: Oral Medications in Fixed Time Interval Administration Versus Spinal Morphine|To Compare the Efficacy and Patients' Satisfaction for the Treatment of Post Cesarean Pain of Two Protocols: Oral Medications in Fixed Time Interval Administration Versus Spinal Morphine|Completed||N/A|200|Actual|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-10 23:19:27.393657|2017-10-10 23:19:27.393657
NCT02351856|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-09-18|||February 2015||2015-02-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|February 1, 2018|Anticipated|2018-02-01||Interventional|||A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy||Recruiting||Phase 2|12|Anticipated|Array BioPharma||1|||f||||f||||||||||2017-10-10 23:37:20.815781|2017-10-10 23:37:20.815781
NCT02440386|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-10-14|||April 2015||2015-04-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|July 2016|Actual|2016-07-01||Interventional|iLink||iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care|iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care|Active, not recruiting||N/A|87|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-10 23:19:27.483741|2017-10-10 23:19:27.483741
NCT02440373|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-02-08|||March 2014||2014-03-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|March 2016|Actual|2016-03-01||Observational|||Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome|Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome|Active, not recruiting||N/A|12|Anticipated|Advocate Health Care|||1||f||||f||||||Samples Without DNA|"     Blood drawn within 15 minutes of arrival to the Emergency Department and at 24, 48, and 74     hours. Each sample will be processed and stored for subsequent analysis of cytochrome c and     other markers of mitochondrial injury that may become available at a later time.   "|||2017-10-10 23:19:27.574176|2017-10-10 23:19:27.574176
NCT02440360|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|PFS:PSH-CH||Pay For Success: Permanent Supportive Housing for the Chronically Homeless|Evaluation of Provision of Permanent Supportive Housing for Chronically Homeless Individuals Through Pay for Success|Recruiting||N/A|300|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:19:27.709819|2017-10-10 23:19:27.709819
NCT02440347|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-07-23|||June 2014||2014-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block|Efficacy and Safety of Pulpal Anesthesia After Anterior and Middle Superior Alveolar (AMSA) Nerve Block Obtained by Articaine Computer-controlled and Conventional Delivery|Completed||Phase 4|30|Actual|University of Belgrade||2|||f||||f||||||||||2017-10-10 23:19:27.803454|2017-10-10 23:19:27.803454
NCT02440334|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-10-14|||May 2015||2015-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation||Recruiting||Phase 2|100|Anticipated|Thomas Jefferson University||1|||f||||f||||||||||2017-10-10 23:19:27.901115|2017-10-10 23:19:27.901115
NCT02440321|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-05-06|||April 2011||2011-04-01|May 2015|2015-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Parent-child Interactive Intervention in Preventing Children's Environmental Tobacco Smoke Exposure at Home|The Third Year Project of The Associated Factors of Smoking Around School-aged Children and The Intervention Development Using the Theory of Reasoned Action|Completed||N/A|150|Actual|Taipei Medical University||2|||f||||f||||||||||2017-10-10 23:19:27.984502|2017-10-10 23:19:27.984502
NCT02440308|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-02-28|2017-02-28||April 2015||2015-04-01|February 2017|2017-02-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Interventional|||68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer|68Ga-DOTA-Bombesin PET/MRI in the Evaluation of Patients With Prostate Cancer: A Feasibility Study|Completed||Phase 2|10|Actual|Stanford University||1|||f||||t|t||||f|||||2017-10-10 23:19:28.117577|2017-10-10 23:19:28.117577
NCT02440295|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-05-25|||May 2015||2015-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Pilot Study to Assess the Use of Spy Elite for Assessment of Amputation Healing||Recruiting||N/A|18|Anticipated|Spectrum Health Hospitals|||1||f||||f||||||||||2017-10-10 23:19:28.377081|2017-10-10 23:19:28.377081
NCT02440282|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-07-01|||January 2012||2012-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|||Comparison of Anesthetic Modalities on Hemodynamic Stability and Postoperative Pain in Diabetic Foot Patients Undergoing Minor Lower Extremity Amputation||Completed||N/A|86|Actual|Yonsei University|||3||f||||f||||||||||2017-10-10 23:19:28.488273|2017-10-10 23:19:28.488273
NCT02440269|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-08|||May 2015||2015-05-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|||The Effect of Circadian Rhythms on Norctrend Index in Anesthesia||Unknown status|Recruiting|N/A|60|Anticipated|Southwest Hospital, China|||2||f||||t||||||||||2017-10-10 23:19:28.554555|2017-10-10 23:19:28.554555
NCT02440256|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-04-24|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|EHOST||Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial|The Expanded HIV Care in Opioid Substitution Treatment (EHOST) Stepped-wedge, Cluster-randomized Trial|Completed||N/A|49|Actual|Simon Fraser University||3|||f||||f||||||||||2017-10-10 23:19:28.621605|2017-10-10 23:19:28.621605
NCT02440230|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2017-09-20|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|SEAT||Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients|Safety of Ovarian Function Suppression(OFS)Combined With Different Aromatase Inhibitors(AIs) Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients：A Randomized, Controlled, Prospective, Observational Study|Recruiting||Phase 2|110|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 23:19:28.755433|2017-10-10 23:19:28.755433
NCT02440217|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-07|||May 2015||2015-05-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Myocardial Metabolism in Patients With Dilated Cardiomyopathy|Abnormal Glucose Tolerance is Associated With a Reduced Myocardial Metabolic Flexibility in Patients With Dilated Cardiomyopathy|Unknown status|Enrolling by invitation|N/A|15|Anticipated|Azienda Ospedaliero, Universitaria Pisana|||3||f||||f||||||Samples Without DNA|"     Serum, whole blood   "|||2017-10-10 23:19:28.844942|2017-10-10 23:19:28.844942
NCT02440191|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-06-01|||May 2015||2015-05-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||3DCRT vs. IMRT in Early Breast Cancer|Postoperative Radiotherapy With Intensity-modulated Radiation Therapy (IMRT) Using Simultaneous Integrated Boost Versus 3-dimensional Conformal Radiotherapy (3D-CRT) in Early Breast Cancer: a Prospective Randomized Trial|Recruiting||Phase 3|690|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||Yes||2017-10-10 23:19:28.993676|2017-10-10 23:19:28.993676
NCT02440178|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-06|||May 2015||2015-05-01|April 2015|2015-04-01||||October 2016|Anticipated|2016-10-01||Interventional|||Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia|Phase II Trial of Micafungin Prophylaxis During Induction Chemotherapy for Patients With Acute Leukemia|Unknown status|Not yet recruiting|Phase 2|66|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 23:19:29.069328|2017-10-10 23:19:29.069328
NCT02440165|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-05-06|||January 2015||2015-01-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|BCR_N||Basic Care Revisited: Early Nutrition Intervention for Outpatients|Basic Care Revisited: an Early Nursing Nutrition Intervention for Outpatients in Need of Surgery|Unknown status|Recruiting|N/A|150|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-10 23:19:29.153387|2017-10-10 23:19:29.153387
NCT02440152|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2017-06-28|||February 1, 2017|Actual|2017-02-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention|The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention|Recruiting||Phase 2/Phase 3|6|Anticipated|Ruijin Hospital||1|||f||||f|f|f||||||No||2017-10-10 23:19:29.235506|2017-10-10 23:19:29.235506
NCT02440139|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-05-06|||April 2015||2015-04-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Evaluation of Computer-Aided Lung Nodule Detection Software in Thoracic CT for Riverain Technologies LLC|Computer-Aided System for the Improvement of Nodule Detection and Characterization in Thoracic CT Based on a Novel Vessel Suppressed CT Volume|Unknown status|Enrolling by invitation|N/A|12|Anticipated|Virginia Polytechnic Institute and State University||2|||f||||t||||||||||2017-10-10 23:19:29.396046|2017-10-10 23:19:29.396046
NCT02440126|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-07-05|||October 2014||2014-10-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Observational|SRA-001||Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk|Longitudinal Meta-Analysis and Further Sample Collection To Evaluate Potential Host Markers for PML Risk|Active, not recruiting||N/A|165|Actual|Rocky Mountain MS Research Group, LLC|||4||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:19:29.57687|2017-10-10 23:19:29.57687
NCT02440113|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-07-14|||December 2014||2014-12-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Post-operative CT Follow up After Nellix Endoprosthesis Implantation|Post-operative CT Follow up Measurement After Nellix Endoprosthesis Implantation in Patients With Abdominal Aortic Aneurysms.|Completed||N/A|50|Actual|Rijnstate Hospital|||1||f||||t||||||||Undecided||2017-10-10 23:19:29.671245|2017-10-10 23:19:29.671245
NCT02440100|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-11-08|||May 2015||2015-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Phase 1 Study To Characterize The Safety, Tolerability, PK And PK Of Repeat Doses Of PF-06648671 In Healthy Adults And Healthy Elderly Subjects|An Investigator-and-subject Blind, Phase 1 Study To Characterize The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Repeat Doses Of Pf-06648671 In Healthy Adult Subjects And Healthy Elderly Subjects|Completed||Phase 1|92|Anticipated|Pfizer||9|||f||||f||||||||||2017-10-10 23:19:29.77239|2017-10-10 23:19:29.77239
NCT02440087|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-04-01|||June 2015||2015-06-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|12 Months|Observational [Patient Registry]|Refill||Evaluation of the Dietary Supplement Refill Bypass to Reduce Nutritional Deficiencies of Patients Who Underwent Bariatric Surgery|Evaluation of the Dietary Supplement Refill Bypass Administered Sublingually to Reduce Nutritional Deficiencies of Patients Who Underwent Bariatric Surgery Type Gastric Bypass|Completed||N/A|35|Actual|Refill France|||1||f||||f||||||||||2017-10-10 23:19:29.967648|2017-10-10 23:19:29.967648
NCT02440074|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-05-06|||June 2011||2011-06-01|May 2015|2015-05-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|MSV-DISC||Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV)|Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV)|Withdrawn||Phase 1/Phase 2|0|Actual|Red de Terapia Celular||1||Not funded Administrative formalities not completed|f||||t||||||||||2017-10-10 23:19:30.075004|2017-10-10 23:19:30.075004
NCT02440061|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-10-02|||May 2018|Anticipated|2018-05-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Ghrelin and Beta Cell Function in Diabetes|Ghrelin Effect on Beta Cell Function in Health and Disease #2|Not yet recruiting||Phase 1|75|Anticipated|Duke University||2|||f|||||t|f||||||||2017-10-10 23:19:30.15674|2017-10-10 23:19:30.15674
NCT02440048|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2017-09-27|||June 16, 2015|Actual|2015-06-16|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Using Boned-Apatite Cement at the Time of Extraction for Ridge Preservation at These Sites|Using Boned-Apatite Cement at the Time of Extractions for Ridge Preservation at These Sites|Active, not recruiting||N/A|30|Actual|Rambam Health Care Campus||3|||f||||f||||||||||2017-10-10 23:19:30.308928|2017-10-10 23:19:30.308928
NCT02440035|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-08-18|||April 21, 2015|Actual|2015-04-21|August 2017|2017-08-01|June 9, 2016|Actual|2016-06-09|June 9, 2016|Actual|2016-06-09||Interventional|||A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants|Phase 1, First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Volunteers|Completed||Phase 1|48|Actual|Crucell Holland BV||4|||f||||t||f||||||||2017-10-10 23:19:30.410222|2017-10-10 23:19:30.410222
NCT02440022|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-08-11||2017-08-09|June 2015||2015-06-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|September 2016|Actual|2016-09-01||Interventional|||Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae|A Prospective, Global, Multicenter, Randomized, Controlled Study Comparing Lutonix® 035 AV Drug Coated Balloon PTA Catheter vs. Standard Balloon PTA Catheter for the Treatment of Dysfunctional AV Fistulae|Active, not recruiting||Phase 3|285|Actual|C. R. Bard||2|||f||||t||||||||||2017-10-10 23:19:30.525342|2017-10-10 23:19:30.525342
NCT02440009|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-04-25|||May 2015||2015-05-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|RIA||A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis|A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis|Recruiting||Phase 2/Phase 3|150|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 23:19:30.683749|2017-10-10 23:19:30.683749
NCT02439996|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-09-08|||January 2014||2014-01-01|January 2014|2014-01-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Different Doses of IVIG for Kawasaki Disease|Different Doses of IVIG for Kawasaki Disease: a Multicentre, Prospective, Randomised Trial|Completed||Phase 3|547|Actual|Children's Hospital of Fudan University||3|||f||||t||||||||||2017-10-10 23:19:30.797956|2017-10-10 23:19:30.797956
NCT02439983|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-02|||April 2015||2015-04-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Brain Imaging Study|A Randomized, Double-blind, Placebo-controlled Study Investigating the Effects of a Proprietary Nutritional Supplement on Brain Health|Completed||N/A|68|Actual|Pharmanex||2|||f||||f||||||||||2017-10-10 23:19:30.913231|2017-10-10 23:19:30.913231
NCT02439970|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-01-05|||September 2015||2015-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|BCV CMV vGCV||SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients|SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipient|Terminated||Phase 3|750|Anticipated|Chimerix||2||Study was terminated early due to results from another CMX study|f||||t||||||||||2017-10-10 23:19:31.001274|2017-10-10 23:19:31.001274
NCT02439957|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-03-07|||September 2015||2015-09-01|March 2017|2017-03-01|July 31, 2016|Actual|2016-07-31|May 15, 2016|Actual|2016-05-15||Interventional|BCV CMV vGCV||SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients (BCV CMV vGCV)||Terminated||Phase 3|520|Anticipated|Chimerix||2|||f||||t||||||||||2017-10-10 23:19:31.099262|2017-10-10 23:19:31.099262
NCT02439944|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-01-05|||July 2015||2015-07-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|iT-NRT||Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement|Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement: A Randomized, Controlled Pilot Study in Motivated Smokers Unable to Quit With Standard Dosing|Recruiting||Phase 2/Phase 3|50|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-10 23:19:31.183461|2017-10-10 23:19:31.183461
NCT02439931|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-05-12|||July 2015||2015-07-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Remote Psychosocial Intervention for Brain Tumour Survivors|Feasibility Study of a Remote Psychosocial Intervention for Brain Tumour Survivors|Unknown status|Not yet recruiting|N/A|10|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-10 23:19:31.299074|2017-10-10 23:19:31.299074
NCT02439918|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-06|||June 2012||2012-06-01|April 2015|2015-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa|Epidemic History and Iatrogenic Transmission of Blood-borne Viruses|Completed||N/A|839|Actual|Université de Sherbrooke|||1||f||||f||||||Samples With DNA|"     Laboratory assays Dry blood spots were made from capillary blood deposited on Whatman 3     filter paper (serology) and Whatman Protein Saver Card (molecular biology). To document our     two main outcomes (HCV and HTLV-1 infections), serological assays were performed as detailed     in Web extra material, Appendix. For HCV, PCR amplification of the NS5b (485-nt) and core/E1     (1026-nt) genome regions was attempted on reactive samples. For HTLV-1, the gp21 env gene was     amplified (885-nt).   "|||2017-10-10 23:19:31.372829|2017-10-10 23:19:31.372829
NCT02439905|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-12-13|||May 2015||2015-05-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Effects of Dexmedetomidine on Inflammatory Mediators After One Lung Ventilation During Video-assisted Thoracoscopic Surgery|The Effects of Dexmedetomidine on Inflammatory Mediators After One Lung Ventilation During Video-assisted Thoracoscopic Surgery|Completed||Phase 4|60|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:19:31.436875|2017-10-10 23:19:31.436875
NCT02439892|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-08-14|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Rehabilitation for Head and Neck Cancer|Rehabilitation During Versus After Radiotherapy in Head and Neck Cancer - a Pilot Randomised Controlled Trial|Completed||N/A|41|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:19:31.524416|2017-10-10 23:19:31.524416
NCT02439879|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-02-02|2015-12-01||December 2009||2009-12-01|February 2016|2016-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Alpha Lipoic Acid for Treatment of Diabetic Neuropathy|Treatment With Alpha-lipoic Acid Over 16 Weeks in Type 2 Diabetic Patients With Symptomatic Polyneuropathy Who Responded to Initial 4-week High-dose Loading|Completed||Phase 4|45|Actual|Universidad Popular Autónoma del Estado de Puebla||2|||f||||f||||||||No||2017-10-10 23:19:31.624778|2017-10-10 23:19:31.624778
NCT02439866|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-05-08|||February 2014||2014-02-01|January 2014|2014-01-01||||July 2015|Anticipated|2015-07-01||Interventional|NAION||Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy|The Effect of High Dose Steroid and Normobaric Oxygen Therapy on Recent Onset Non-arteritic Anterior Ischemic Optic Neuropathy(NAION); a Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|90|Anticipated|Shahid Beheshti University of Medical Sciences||3|||f||||||||||||||2017-10-10 23:19:31.868143|2017-10-10 23:19:31.868143
NCT02439853|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-08-05|||March 2013||2013-03-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Communication Bridge Speech Therapy Research Study|Communication Bridge Speech Therapy Research Study: Using Internet-Based Speech Therapy to Improve Quality of Life and Access to Care|Recruiting||N/A|40|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:19:31.952935|2017-10-10 23:19:31.952935
NCT02421471|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-08-08|||September 2014||2014-09-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||PMS to Evaluate the Safety and Efficacy of Picato® Gel|Post-Marketing Surveillance to Evaluate the Safety and Efficacy of Picato® Gel|Recruiting||N/A|3000|Anticipated|LEO Pharma|||1||f||||f||||||||||2017-10-10 23:23:01.651573|2017-10-10 23:23:01.651573
NCT02439840|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-08-04|||March 2015||2015-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|||Use of Bispectral Index Monitoring to Detect Deep Sedation in Mechanically Ventilated Patients: Validity Study|Use of Bispectral Index Monitoring to Detect Deep Sedation in Mechanically Ventilated Patients: Validity Study|Completed||N/A|45|Actual|Capital Medical University|||2||f||||t||||||||||2017-10-10 23:19:32.038671|2017-10-10 23:19:32.038671
NCT02439827|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2017-01-31|||July 2014||2014-07-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||"The Fortaleça Sua Saúde Program for Active and Healthy Lifestyle Among Brazilian Students"|"The Fortaleça Sua Saúde Program: A Cluster-randomized Controlled Trial to Promote Active and Healthy Lifestyle Among Brazilian Students"|Completed||N/A|1085|Actual|Universidade Federal de Santa Catarina||2|||f||||f||||||||||2017-10-10 23:19:32.100449|2017-10-10 23:19:32.100449
NCT02439814|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-09-12|||June 2015||2015-06-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pregnenolone and Marijuana Dependence|Effect of Pregnenolone on Cue-reactivity in Marijuana-dependent Individuals|Completed||Phase 2|21|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-10 23:19:32.185804|2017-10-10 23:19:32.185804
NCT02439801|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-06|||March 2015||2015-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|2 Days|Observational [Patient Registry]|||Comparison of Effects of PEEP Levels on Respiratory Mechanics in Patients Undergoing Laparoscopic Cholecystectomy|Comparison of Effects of 3 Different PEEP Levels on Hemodynamic, Respiratory Mechanics and Elimination of Volatile Anesthetic Agent in Patients Undergoing Laparoscopic Cholecystectomy|Completed||N/A|75|Actual|Umraniye Education and Research Hospital|||3||f||||f||||||||||2017-10-10 23:19:32.26443|2017-10-10 23:19:32.26443
NCT02439788|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-06-09|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|October 2030|Anticipated|2030-10-01|September 2019|Anticipated|2019-09-01||Interventional|GINAKIT||3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA|3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS TO TREAT CHILDREN WITH NEUROBLASTOMA (GINAKIT)|Withdrawn||Phase 1|0|Actual|Baylor College of Medicine||1||"Based on newly available preclinical data we changed the CAR construct to a more effective   version and will now study that product on a different protocol."|f||||t|t|f||||||||2017-10-10 23:19:32.353682|2017-10-10 23:19:32.353682
NCT02439762|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-06-13|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Intervening to Reduce Suicide Risk in Veterans With Substance Use Disorders||Recruiting||N/A|300|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-10 23:19:32.676228|2017-10-10 23:19:32.676228
NCT02439736|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-08-07|||June 2015||2015-06-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|ALERT-TBIx||EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY|A PROSPECTIVE CLINICAL EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY|Completed||N/A|119|Actual|Banyan Biomarkers, Inc|||1||f||||f||||||||||2017-10-10 23:19:32.953758|2017-10-10 23:19:32.953758
NCT02439723|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2015-12-31|||March 2016||2016-03-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients|A Phase I, Open Label Study of the Effects of Lean Body Mass (LBM) and Proton Pump Inhibitors (PPIs) on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients|Not yet recruiting||Phase 1|40|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-10 23:19:33.031348|2017-10-10 23:19:33.031348
NCT02439710|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-10-19|||June 2015||2015-06-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01|1 Year|Observational [Patient Registry]|PROBE||Patient Reported Outcomes Burdens and Experiences - Phase 2|Patient Reported Outcomes Burdens and Experiences - Phase 2 - Pilot Feasibility Study|Unknown status|Recruiting|N/A|600|Anticipated|McMaster University|||1||f||||f||||||||||2017-10-10 23:19:33.11921|2017-10-10 23:19:33.11921
NCT02439697|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients|A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients|Recruiting||N/A|50|Anticipated|The University of Hong Kong||3|||f||||t||||||||||2017-10-10 23:19:33.182875|2017-10-10 23:19:33.182875
NCT02439684|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-03-04|||May 2013||2013-05-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Can HbA1c Replace OGTT for the Diagnosis of Diabetes Mellitus Among Chinese Patients With IFG?|Can HbA1c Replace OGTT for the Diagnosis of Diabetes Mellitus Among Chinese Patients With IFG?|Completed||N/A|1357|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-10 23:19:33.277296|2017-10-10 23:19:33.277296
NCT02439671|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-05-08|||May 2012||2012-05-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||Transition Support Program for Young Adults With Autism Spectrum Disorders|A Service Delivery Model to Better Support Young Adults With Autism Spectrum Disorders in the Transition From School to the Community|Completed||N/A|34|Actual|McGill University||2|||f||||f||||||||||2017-10-10 23:19:33.344204|2017-10-10 23:19:33.344204
NCT02439658|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-03-27|||January 2014||2014-01-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|DOFEGEN||Genetics of QT Prolongation With Antiarrhythmics|Genetics of QT Prolongation With Antiarrhythmics|Recruiting||N/A|500|Anticipated|Massachusetts General Hospital|||2||f||||t||||||Samples With DNA|"     Blood samples for DNA extraction   "|||2017-10-10 23:19:33.442977|2017-10-10 23:19:33.442977
NCT02439645|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-03-27|||October 2013||2013-10-01|March 2016|2016-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|20 Years|Observational [Patient Registry]|BA-TdP||A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes|A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital|||1||f||||t||||||Samples With DNA|"     Blood samples from patients with a history of torsade de pointes.   "|||2017-10-10 23:19:33.532982|2017-10-10 23:19:33.532982
NCT02439632|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-07-15|||February 2014||2014-02-01|May 2015|2015-05-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control|A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control|Completed||Phase 3|216|Anticipated|Lee's Pharmaceutical Limited||2|||f||||f||||||||||2017-10-10 23:19:33.693647|2017-10-10 23:19:33.693647
NCT02439619|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-06|||October 2014||2014-10-01|May 2015|2015-05-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|TechCare||TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErvice|TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErvice|Unknown status|Recruiting|N/A|16|Anticipated|Lancashire Care NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 23:19:33.879923|2017-10-10 23:19:33.879923
NCT02439606|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-05-06|||May 2014||2014-05-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||GlideRite® Rigid Stylet Versus Parker Flex-It Stylet|GlideRite® Rigid Stylet Versus Parker Flex-It Stylet for Orotracheal Intubation by GlideScope|Completed||N/A|60|Actual|King Saud University||2|||f||||f||||||||||2017-10-10 23:19:34.023145|2017-10-10 23:19:34.023145
NCT02439593|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-07-31|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|June 30, 2021|Anticipated|2021-06-30||Interventional|HEATPAC||Concurrent Hyperthermia and Chemoradiotherapy in LAPC: Phase II Study|A Phase II Randomized Study of Concurrent Hyperthermia and Chemoradiotherapy vs. Chemoradiotherapy Alone Following Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer (HEATPAC)|Recruiting||Phase 2|78|Anticipated|Kantonsspital Aarau||2|||f||||t||||||||||2017-10-10 23:19:34.121181|2017-10-10 23:19:34.121181
NCT02439580|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-12|||October 2013||2013-10-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Annona Muricata Leaves on Colorectal Cancer Patients and Colorectal Cancer Cells|Effect of Annona Muricata Leaves on Nutritional Status, Quality of Life, Fecal Butyrate, Inflammation, and Colorectal Cancer Cells|Completed||Early Phase 1|30|Actual|Indonesia University||2|||f||||t||||||||||2017-10-10 23:19:34.235287|2017-10-10 23:19:34.235287
NCT02439567|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-05-10|||January 2015||2015-01-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|SPLEEN-C||Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)|Usefulness of Transient Elastography Assessing Liver Fibrosis and Portal Hypertension in Patients With HCV Cirrhosis Treated With New All Oral Antiviral Drugs|Completed||N/A|41|Actual|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||f||||||||||2017-10-10 23:19:34.317125|2017-10-10 23:19:34.317125
NCT02439554|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-09-05|||January 2013||2013-01-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|||Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients|Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients|Recruiting||N/A|1352|Anticipated|Hospital Galdakao-Usansolo|||1||f||||t||||||||||2017-10-10 23:19:34.416002|2017-10-10 23:19:34.416002
NCT02439541|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-03-14|||May 2015||2015-05-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|UCMSC-Heart||Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy|Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Ischemic Cardiomyopathy|Recruiting||Phase 1/Phase 2|40|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-10 23:19:34.494652|2017-10-10 23:19:34.494652
NCT02439528|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-08-21|||March 2015||2015-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GENES-SEF||Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome|Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome|Recruiting||N/A|500|Anticipated|Hospices Civils de Lyon||4|||f||||f||||||||||2017-10-10 23:19:34.605275|2017-10-10 23:19:34.605275
NCT02439515|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-03-06|||December 2014||2014-12-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Fall Prevention and Locomotion Recovery in Post-stroke Patients: A Multimodal Training|Fall Prevention and Locomotion Recovery in Post-stroke Patients: A Multimodal Training|Recruiting||N/A|72|Anticipated|Fondazione Salvatore Maugeri||2|||f||||f||||||||||2017-10-10 23:19:34.732842|2017-10-10 23:19:34.732842
NCT02439502|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-01-12|||April 2015||2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Fuse®||EndoChoice's Fuse® Endoscopic System Performance In Routine Practice|Single Center, Prospective, Open Label Post Marketing Study of EndoChoice's Fuse® Endoscopic System Performance In Routine Practice|Completed||Phase 4|29|Actual|EndoChoice Innovation Center, Ltd.||1|||f||||f||||||||||2017-10-10 23:19:34.867487|2017-10-10 23:19:34.867487
NCT02439489|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-04-07|||December 2012||2012-12-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors|Phase Ib Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|34|Actual|Fondazione Michelangelo||2|||f||||f||||||||||2017-10-10 23:19:34.941814|2017-10-10 23:19:34.941814
NCT02439476|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-06-21|||August 8, 2016|Actual|2016-08-08|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Observational|IFM-2015-03||Non-interventional Study on Salvage Auto in Relapsed Myeloma|Non-interventional Study Evaluating Plerixafor-based Mobilization for Salvage Autologous Hematopoietic Stem Cell Transplantation in Relapsed Myeloma|Recruiting||N/A|30|Anticipated|Association for Training, Education, and Research in Hematology, Immunology, and Transplantation|||1||f||||f||||||||||2017-10-10 23:19:35.051135|2017-10-10 23:19:35.051135
NCT02439463|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-08-14|||June 2015||2015-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01|2 Years|Observational [Patient Registry]|||Traumatic Below-knee Amputees With Prosthetics: Health-related Quality of Life and Locomotor Capabilities|Traumatic Below-knee Amputees With Prosthetics: Health-related Quality of Life and Locomotor Capabilities|Enrolling by invitation||N/A|20|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 23:19:35.136419|2017-10-10 23:19:35.136419
NCT02439450|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-07-18|||April 2015||2015-04-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer|"A Phase 1b/2 Study of Viagenpumatucel-L (HS-110) in Combination With Multiple Treatment Regimens in Patients With Non-Small Cell Lung Cancer (The DURGA Trial)"|Recruiting||Phase 1/Phase 2|100|Anticipated|Heat Biologics||3|||f||||t||||||||||2017-10-10 23:19:35.2097|2017-10-10 23:19:35.2097
NCT02439437|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-07-31|||September 2015||2015-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain|Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain|Recruiting||N/A|60|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:19:35.348672|2017-10-10 23:19:35.348672
NCT02439424|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-12-21|||December 2015||2015-12-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|REACT-ICD||The REACT-ICD Trial|The Effect of Reactive ATP™ on the Burden of Atrial Fibrillation in ICD Patients: The REACT-ICD Trial|Active, not recruiting||Phase 1/Phase 2|6|Actual|Hartford Hospital||1|||f||||f||||||||||2017-10-10 23:19:35.439677|2017-10-10 23:19:35.439677
NCT02439411|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-07-31|||January 2015||2015-01-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|DEIS||Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain|Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain|Completed||N/A|135|Actual|Grupo Español Multidisciplinar de Melanoma|||2||f||||t||||||||||2017-10-10 23:19:35.52169|2017-10-10 23:19:35.52169
NCT02439398|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-05-26|||June 2014||2014-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|CAREMI||Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI|First-in-human, Double Blind, Randomized With Placebo, Open for the 6 First Patients (Dose Ranging) to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human CSCs in Patients With AMI and Left Ventricular Dysfunction|Active, not recruiting||Phase 1/Phase 2|55|Anticipated|Coretherapix||2|||f||||t||||||||||2017-10-10 23:19:35.669152|2017-10-10 23:19:35.669152
NCT02439385|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2016-08-19|||August 2015||2015-08-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|May 2017|Anticipated|2017-05-01||Interventional|||Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis|First Line Avastin/FOLFIRI in Combination With Curcumin-containing Supplement in Colorectal Cancer Patients With Unresectable Metastasis|Enrolling by invitation||Phase 2|44|Anticipated|Gachon University Gil Medical Center||1|||f||||t||||||||||2017-10-10 23:19:35.769347|2017-10-10 23:19:35.769347
NCT02439372|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-07|||April 2015||2015-04-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|ACE-UC||Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis|Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis (ACE-UC)|Unknown status|Recruiting|N/A|80|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-10 23:19:35.84788|2017-10-10 23:19:35.84788
NCT02439359|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-12-12|||May 2015||2015-05-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects|A Phase 1, Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Male and Female Subjects|Completed||Phase 1|20|Actual|ContraFect||2|||f||||t||||||||Yes|Public Presentation at ECCMID April 2016|2017-10-10 23:19:35.917495|2017-10-10 23:19:35.917495
NCT02439346|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2017-07-12|||June 15, 2015|Actual|2015-06-15|June 2017|2017-06-01|April 24, 2017|Actual|2017-04-24|March 27, 2017|Actual|2017-03-27||Interventional|||Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel|An Open-label, Non-randomized, Multicenter Phase I Study to Characterize the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Maximum Tolerated Dose of Oral MKNK1 Inhibitor BAY 1143269 Given Alone or in Combination With Intravenous Docetaxel in Subjects With Advanced Solid Tumors|Terminated||Phase 1|15|Actual|Bayer||3||Study stopped due to project prioritization|f||||t|t|f||||||||2017-10-10 23:19:35.996672|2017-10-10 23:19:35.996672
NCT02439333|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-07|2016-11-15|||July 2015||2015-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Randomized Study of Nasal High Flow in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease||Recruiting||N/A|320|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-10 23:19:36.079007|2017-10-10 23:19:36.079007
NCT02439320|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-08-20|||April 2015||2015-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|SAMURAI||Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:|A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study|Completed||Phase 3|2232|Actual|CoLucid Pharmaceuticals||3|||f||||f||||||||||2017-10-10 23:19:36.169832|2017-10-10 23:19:36.169832
NCT02439307|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-04-11|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of Rifaximin on Minimal Hepatic Encephalopathy and Small Intestinal Bacterial Overgrowth|Effect of Rifaximin on Minimal Hepatic Encephalopathy and Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis|Recruiting||N/A|46|Anticipated|Coordinación de Investigación en Salud, Mexico||2|||f||||f|f|f||||||No||2017-10-10 23:19:36.384308|2017-10-10 23:19:36.384308
NCT02439294|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-11-30|||May 2015||2015-05-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|May 2018|Anticipated|2018-05-01||Interventional|SAS-IDM||Impact of the Obstructive Sleep Apnea Syndrome (OSAS) on the Ventricular Remodeling After Acute Myocardial Infarction||Recruiting||N/A|87|Anticipated|University Hospital, Montpellier||3|||f||||f||||||||||2017-10-10 23:19:36.52879|2017-10-10 23:19:36.52879
NCT02439281|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-08-11|||May 2015||2015-05-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Ropivacaine With Clonidine For Pediatric Rectus Sheath Blocks- The Magic Combination|ROPIVACAINE WITH CLONIDINE FOR PEDIATRIC RECTUS SHEATH BLOCKS- THE MAGIC COMBINATION? - A Double Blinded Prospective Study|Recruiting||N/A|100|Anticipated|Children's Hospital of Pittsburgh||2|||f||||t||||||||Undecided||2017-10-10 23:19:36.635129|2017-10-10 23:19:36.635129
NCT02439255|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-06-15|||June 2014||2014-06-01|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Effect of Black Raspberry Phytochemicals on Oral Microbiome in Current Smokers and Non-smokers|Interactive Omics: Black Raspberry Metabolites and the Oral Microbiome in Smokers|Recruiting||N/A|240|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:19:36.737114|2017-10-10 23:19:36.737114
NCT02439242|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-05-07|||June 2014||2014-06-01|May 2015|2015-05-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|ΔPP/HRvsΔSV||Correlation Between ΔPP/HR and ΔSV During Fluid Challenge.|Correlation Between the Pulse Pressure / Heart Rate Ratio Variations and Stroke Volume Variations During Fluid Challenge.|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 23:19:36.829449|2017-10-10 23:19:36.829449
NCT02439229|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-06|||January 2010||2010-01-01|May 2015|2015-05-01|December 2031|Anticipated|2031-12-01|December 2031|Anticipated|2031-12-01|18 Years|Observational [Patient Registry]|||The Vitamin D and Fetal Bone Length Study (VITFBL)|Decreased Femoral Bone Length by Fetal Ultrasound in Pregnant Women With Low Serum 25-hydroxyvitamin D: An Odense Child Cohort Study|Active, not recruiting||N/A|2874|Actual|Odense University Hospital|||1||f||||t||||||||||2017-10-10 23:19:36.898729|2017-10-10 23:19:36.898729
NCT02439216|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-04-28|||April 2016||2016-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2017|Actual|2017-01-01||Interventional|MoveDMD®||Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy|A Phase 1/2 Study of Edasalonexent (CAT-1004) in Pediatric Patients With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 1/Phase 2|31|Actual|Catabasis Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:19:36.956145|2017-10-10 23:19:36.956145
NCT02439203|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-01-11|||May 2015||2015-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|LID||Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia|A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Study in Subjects With Parkinson's Disease With Moderate to Severe Levodopa-induced Dyskinesia, to Assess the Efficacy, Safety/Tolerability and Pharmacokinetics of JM-010|Completed||Phase 2|30|Actual|Bukwang Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:19:37.041232|2017-10-10 23:19:37.041232
NCT02439190|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-09-07|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||CV004-007 Thrombosis Chamber Study|A Single Dose Study to Evaluate the Effect of BMS-986120 on Thrombus Formation in an Ex Vivo Thrombosis Chamber Model in Healthy Subjects|Completed||Phase 1|42|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:19:37.116303|2017-10-10 23:19:37.116303
NCT02439177|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-08-20|||May 2015||2015-05-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluating System Accuracy and User Performance of Omnitest® Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus|Evaluating System Accuracy and User Performance of Omnitest® Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus|Terminated||N/A|32|Actual|B. Braun Melsungen AG||2|||f||||f||||||||||2017-10-10 23:19:37.18374|2017-10-10 23:19:37.18374
NCT02439164|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-07-28|2017-06-30||May 26, 2015|Actual|2015-05-26|July 2017|2017-07-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional||One patient in non-neurosurgical group was dropped out because he reported his carotid disease history after the task testing. In glioma group, pathological diagnosis displayed two with metastasis and one with meningioma, which were excluded during follow-up. There are 15 in the glioma group and 17 in the control group for the analysis.|Sedatives' Effects on Neurological Function in Patients With Eloquent Area Glioma|Cohort Study of Sedatives' Effects on Neurological Function in Patients With Eloquent Area Glioma: Comparison With a Control Group Without Intracranial Pathology|Completed||N/A|36|Actual|Beijing Tiantan Hospital||2|||f||||||||||||||2017-10-10 23:19:37.249258|2017-10-10 23:19:37.249258
NCT02439151|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-05-06|||May 2015||2015-05-01|May 2015|2015-05-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Applied Research of New Lung Ventilation Strategies Guided by Transpulmonary Pressure in Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome||Not yet recruiting||N/A|30|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-10 23:19:39.524803|2017-10-10 23:19:39.524803
NCT02439138|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-11-14|2016-09-26||October 2015||2015-10-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia|Phase II Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia|Terminated||Phase 2|5|Actual|Dana-Farber Cancer Institute|This study was terminated early due to safety concerns from the previously untreated CLL experience. All participants who remained on study at that time were permanently removed from protocol therapy. The median time on protocol therapy was 1 cycle|1||Safety issues from trials in CLL|f||||t||||||||No||2017-10-10 23:19:39.612831|2017-10-10 23:19:39.612831
NCT02439125|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-04-20|||May 2015||2015-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients|Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, 4-way Crossover, Dose-finding Study, of Eltoprazine Safety, Tolerability and Efficacy in the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson's Disease|Active, not recruiting||Phase 2|60|Anticipated|Amarantus BioScience Holdings, Inc.||4|||f||||f||||||||||2017-10-10 23:19:39.925277|2017-10-10 23:19:39.925277
NCT02439112|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-01-25|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|EMMY||Exercise in Patients With Multiple Myeloma|Early Initiated Individualized Physical Training in Newly Diagnosed Multiple Myeloma Patients; Effects on Physical Function, Physical Activity, Quality of Life, Pain, and Bone Disease.|Recruiting||N/A|88|Anticipated|Zealand University Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:19:40.034996|2017-10-10 23:19:40.034996
NCT02439099|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-11-04|||March 2015||2015-03-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Observational|RAHND||Retinoic Acid Homeostasis in Neuropsychiatric Diseases|Retinoic Acid Homeostasis in Neuropsychiatric Diseases|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||5||f||||f||||||Samples With DNA|"     peripheral venous blood   "|No||2017-10-10 23:19:40.178064|2017-10-10 23:19:40.178064
NCT02439086|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-05-08|||September 2015||2015-09-01|May 2015|2015-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PRENT-LARC||Prediction of Response to Neoadjuvant Therapy in Rectal Cancer|Prediction of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.|Unknown status|Not yet recruiting|N/A|20|Anticipated|Colchester General Hospital||1|||f||||f||||||||||2017-10-10 23:19:40.383027|2017-10-10 23:19:40.383027
NCT02439073|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-06-23|||April 2014||2014-04-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PROLUCA||Postoperative Rehabilitation in Operation for LUng CAncer (PROLUCA)|Postoperative Rehabilitation in Operation for LUng CAncer (PROLUCA) - A Randomized Clinical Trial With Blinded Effect Evaluation|Active, not recruiting||N/A|235|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-10 23:19:40.499193|2017-10-10 23:19:40.499193
NCT02439060|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-04-14|||August 31, 2015|Actual|2015-08-31|April 2017|2017-04-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Biologic Mesh in Preventing Hernia in Patients With Bladder Cancer Undergoing Radical Cystectomy With Ileal Conduit Diversion|Prevention of Parastomal Hernia Following Radical Cystectomy and Ileal Conduit Using Biologic Mesh: Randomized Clinical Trial|Recruiting||N/A|110|Anticipated|University of Southern California||2|||f||||t|f|f||||||||2017-10-10 23:19:40.586994|2017-10-10 23:19:40.586994
NCT02439047|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-09-05|||June 2015||2015-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|November 2015|Actual|2015-11-01||Interventional|MESO-PATCH||Preliminary Study to the Manufacturing of a Non-stick Membrane for Surgery Using Patient's Own Cells (MESO-PATCH)|Non-stick Patch of Mesothelial Cells in a Hydrogel Matrix : Exploratory Analysis Assessing the Morphotype and Mesothelial Phenotype After Culture From 2 Cells Sources of Human Origin.|Terminated||N/A|6|Actual|Centre Oscar Lambret||1||difficulty of carrying out the analysis and low recruitment|f||||f||||||||||2017-10-10 23:19:40.710137|2017-10-10 23:19:40.710137
NCT02439034|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-07-27|||February 2015||2015-02-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|KETOCOL-1304||Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304)|Paracetamol With or Without Ketoprofen in the Management of Pain During Hospitalisation and at Home for Patients Receiving Brachytherapy: Phase-2 Randomized Study|Recruiting||Phase 2|120|Anticipated|Centre Oscar Lambret||2|||f||||f||||||||No||2017-10-10 23:19:40.809129|2017-10-10 23:19:40.809129
NCT02439021|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-05-05|||February 2012||2012-02-01|May 2015|2015-05-01||||January 2013|Actual|2013-01-01||Interventional|||Effectiveness of the New Perilaryngeal Airway in Comparison With the Laryngeal Mask Airway|Effectiveness of the New Perilaryngeal Airway (CobraPLA™) in Comparison With the Laryngeal Mask Airway (LMA™) to Improve Oropharyngeal Leak Pressure Among Obese and Overweight Patients|Completed||Phase 4|74|Actual|Qazvin University Of Medical Sciences||2|||f||||||||||||||2017-10-10 23:19:40.948108|2017-10-10 23:19:40.948108
NCT02439008|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-08-31|||September 2015||2015-09-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response|Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response|Recruiting||N/A|30|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||||2017-10-10 23:19:41.035319|2017-10-10 23:19:41.035319
NCT02438995|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-06-12|||May 2015||2015-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck|Phase I Trial of Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1|21|Anticipated|Northwell Health||2|||f||||||||||||||2017-10-10 23:19:41.156173|2017-10-10 23:19:41.156173
NCT02438982|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-07-30|||May 8, 2015|Actual|2015-05-08|July 2017|2017-07-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome|Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome|Completed||Phase 3|120|Actual|Nilratan Sircar Medical College||2|||f||||t||||||||||2017-10-10 23:19:41.271166|2017-10-10 23:19:41.271166
NCT02438969|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-08-04|||April 30, 2015||2015-04-30|July 25, 2017|2017-07-25|December 30, 2018|Anticipated|2018-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Epi-Genetic Modulators of Fear Extinction in Alcohol Dependence|(Epi)Genetic Modulators of Fear Extinction in Alcohol Dependence|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:19:41.36799|2017-10-10 23:19:41.36799
NCT02438956|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-01-10|||October 2015||2015-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2016|Actual|2016-06-01||Interventional|GSH||Oral Glutathione Supplementation in Older Healthy Adults and Its Effect on the Number of Healthy Days Experienced During Four Months of Supplementation Compared to Placebo|Oral Glutathione Supplementation in Older Healthy Adults and Its Effect on the Number of Healthy Days Experienced During Four Months of Supplementation Compared to Placebo|Active, not recruiting||N/A|124|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-10 23:19:41.461706|2017-10-10 23:19:41.461706
NCT02438943|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-05|||February 2014||2014-02-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||An Intervention to Improve Management of Dyslipidemia in Primary Care|A Cluster Randomized Controlled Trial of an Intervention to Improve the Management of Dyslipidemia in Primary Care|Unknown status|Recruiting|N/A|500|Anticipated|The University of The West Indies||2|||f||||f||||||||||2017-10-10 23:19:41.53981|2017-10-10 23:19:41.53981
NCT02438930|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-05-07|||May 2008||2008-05-01|May 2015|2015-05-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Client-Centered Counseling During Routine/Opt-Out HIV-Testing in Uganda|Client-Centered Counseling During Routine/Opt-Out HIV-Testing in Uganda|Completed||N/A|333|Actual|UConn Health||2|||f||||f||||||||||2017-10-10 23:19:41.638366|2017-10-10 23:19:41.638366
NCT02438917|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-04-10|||June 2015||2015-06-01|April 2017|2017-04-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Observational|||Biomarkers of Liver Fibrosis|Biomarkers of Liver Fibrosis|Terminated||N/A|10|Actual|Icahn School of Medicine at Mount Sinai|||1|collaborator Kinemend closed due to finances|f||||f||||||Samples With DNA|"     Whole blood, Urine, Saliva   "|||2017-10-10 23:19:41.716846|2017-10-10 23:19:41.716846
NCT02438904|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-02-17|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Compassionate Access of the Miltenyi Device for CD34+ Cell Selection|Compassionate Access of the Miltenyi Device for CD34+ Cell Selection|Recruiting||N/A|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:19:41.804026|2017-10-10 23:19:41.804026
NCT02438891|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-05-02|||May 2017|Anticipated|2017-05-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Internet-based CBT for Tinnitus|Evaluation of an Internet-based Sound and Cognitive Behavioral Therapy Course for Treatment for Tinnitus|Recruiting||N/A|200|Anticipated|University of California, Irvine||1|||f||||f|f|f||||||||2017-10-10 23:19:41.900258|2017-10-10 23:19:41.900258
NCT02438878|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-06-26|||March 2015||2015-03-01|June 2017|2017-06-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Supporting Baby Behavior Through Pediatric Offices|Supporting Baby Behavior Through Pediatric Offices|Active, not recruiting||N/A|480|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-10 23:19:42.003389|2017-10-10 23:19:42.003389
NCT02438865|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-03-23|||January 2015||2015-01-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.|Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.|Recruiting||Phase 2|80|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 23:19:42.086722|2017-10-10 23:19:42.086722
NCT02438852|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-09-12|||November 20, 2017|Anticipated|2017-11-20|September 2017|2017-09-01|November 20, 2020|Anticipated|2020-11-20|November 20, 2019|Anticipated|2019-11-20||Interventional|||Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer|Efficacy of Continuous Infusion of Local Anesthesia After Radical Cystectomy: A Randomized, Double Blind, Placebo Controlled Study|Not yet recruiting||Phase 3|90|Anticipated|University of Southern California||2|||f||||t|t|f|||t|||||2017-10-10 23:19:42.183044|2017-10-10 23:19:42.183044
NCT02438839|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-05-26|||April 2015||2015-04-01|May 2017|2017-05-01|December 2022||2022-12-01|December 2019|Anticipated|2019-12-01||Observational|WW2||Curative Chemoradiation of Low Rectal Cancer|Curative Chemoradiation of Low Rectal Cancer. A Prospective Multicenter Observational Study|Recruiting||N/A|105|Anticipated|Vejle Hospital|||1||f||||t||||||||||2017-10-10 23:19:42.311117|2017-10-10 23:19:42.311117
NCT02438826|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-09-25|||June 2015||2015-06-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of LY2951742 in Participants With Chronic Cluster Headache|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 With a Long-Term Open-Label Extension in Patients With Chronic Cluster Headache|Recruiting||Phase 3|162|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 23:19:42.524897|2017-10-10 23:19:42.524897
NCT02438813|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-01-19|||May 2015||2015-05-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01|12 Weeks|Observational [Patient Registry]|CONTOUR||Condition of Submental Fullness and Treatment Outcomes Registry|CONTOUR: Condition of Submental Fullness and Treatment Outcomes Registry (A Registry of Submental Fullness, Treatment Options Administered, and Associated Outcomes)|Completed||N/A|1031|Actual|Kythera Biopharmaceuticals|||1||f||||f||||||||||2017-10-10 23:19:42.842425|2017-10-10 23:19:42.842425
NCT02438800|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-05-16|||May 2015||2015-05-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Video Counseling for Effective Postpartum Contraception|Video Counseling for Effective Postpartum Contraception: a Randomized Clinical Trial|Completed||N/A|84|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||Undecided||2017-10-10 23:19:43.102831|2017-10-10 23:19:43.102831
NCT02438787|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-09-27|||July 31, 2015|Actual|2015-07-31|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Subjects With Active Radiographic Axial Spondyloarthritis|Terminated||Phase 3|315|Actual|Janssen Research & Development, LLC||3||"This study was stopped because ustekinumab did not achieve key endpoints in a related study.   The safety profile was consistent with past ustekinumab studies."|f||||t||f||||||||2017-10-10 23:19:43.189905|2017-10-10 23:19:43.189905
NCT02438774|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-09-14|||November 2013||2013-11-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|October 2015|Actual|2015-10-01||Interventional|||Intervention in Minimizing Aflatoxins and Fumonisins Exposure to Children Through Food and Breastfeeding in Tanzania|Effectiveness of Post-harvest Intervention Package in Minimizing Aflatoxins and Fumonisins Exposure to Infants and Young Children Through Maize Based Complementary Foods and Breastfeeding in Rural Tanzania|Completed||N/A|300|Actual|Tanzania Food and Drugs Authority||2|||f||||t||||||||||2017-10-10 23:19:43.589902|2017-10-10 23:19:43.589902
NCT02438761|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-08-25|||August 31, 2015|Actual|2015-08-31|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 10, 2017|Actual|2017-05-10||Interventional|LAM-PIK||PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML)|Phase II Evaluating the Efficacy of the Dual Inhibition of Phosphoinositide 3 Kinase (PI3K)/Akt /Mammalian Target Of Rapamycine (mTOR) Signaling Pathway by PF-05212384 (PKI-587) for Patients With Myeloid Neoplasm Secondary to Chemo-radiotherapy (t-AML/MDS) or de Novo Relapsed or Refractory AML.|Active, not recruiting||Phase 2|10|Actual|Institut Curie||1|||f||||f||||||||||2017-10-10 23:19:43.702859|2017-10-10 23:19:43.702859
NCT02438579|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-12-12|||August 2014||2014-08-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|ELVIS||Hypertonic Saline Nasal Irrigation and Gargling for the Common Cold.|Edinburgh and Lothians Viral Intervention Study (ELVIS). A Pilot Randomised Control Trial of Hypertonic Saline Nasal Irrigation and Gargling on Individuals With the Common Cold to Assess Recruitment, Retention, Side Effects & Effectiveness|Completed||N/A|66|Actual|NHS Lothian||2|||f||||f||||||||||2017-10-10 23:19:47.975152|2017-10-10 23:19:47.975152
NCT02438748|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-05-19|||May 2015||2015-05-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Observational|||Biological Markers of Treatment Response to Repetitive Transcranial Magnetic Stimulation for Depression|The Role of Biological Stress Markers in Predicting Treatment Response to Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder|Enrolling by invitation||N/A|60|Anticipated|University of Manitoba|||2||f||||f||||||Samples Without DNA|"     10ml of blood will be extracted at each collection. Patients will give two samples. Controls     will give one sample. Following collection, blood samples will be spun to separate and     extract plasma. The amount of oxidized phosphatidylcholines in the plasma will then be     quantified.   "|||2017-10-10 23:19:43.793454|2017-10-10 23:19:43.793454
NCT02438735|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-08-01|||April 2015||2015-04-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Observational|ERROR||Endometrioma Related Reduced Ovarian Reserve|The Effect Of The Presence Of Endometriomas On Ovarian Reserve|Completed||N/A|62|Actual|Uludag University|||1||f||||f||||||Samples Without DNA|"     Follicle stimulating hormone (FSH) Luteinizing hormone (LH) ESTRADİOL Anti-mullerian hormone     (AMH)   "|||2017-10-10 23:19:43.886525|2017-10-10 23:19:43.886525
NCT02438722|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-07-12|||March 2015||2015-03-01|July 2017|2017-07-01|February 2022|Anticipated|2022-02-01|February 2020|Anticipated|2020-02-01||Interventional|||S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer|A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2/Phase 3|605|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-10 23:19:44.14677|2017-10-10 23:19:44.14677
NCT02438709|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-05-05|||December 2012||2012-12-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|EOSCITPHO||Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy|Application of COX-2 Inhibitor for Treatment of Primary Hypertrophic Osteoarthropathy|Unknown status|Recruiting|Phase 3|30|Anticipated|Peking Union Medical College Hospital||1|||f||||f||||||||||2017-10-10 23:19:47.146159|2017-10-10 23:19:47.146159
NCT02438696|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-09-23|||May 2015||2015-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects|Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF) Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose) in Healthy Female Subjects (an Open-label, Randomised, Single-dose, Three-period, Three-sequence Crossover Study at Two Different Dose Strengths)|Completed||Phase 1|29|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 23:19:47.224763|2017-10-10 23:19:47.224763
NCT02438683|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-09-23|||May 2015||2015-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||BI 409306 Cardiac Safety Trial in Healthy Volunteers|A Randomized, Double-blind, Double Dummy, Placebo-controlled, Three-way Crossover Study to Assess Cardiac Effects After Single Oral Doses of BI409306 Under Resting and Exercise Conditions in Healthy Male Volunteers|Completed||Phase 1|12|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:19:47.318124|2017-10-10 23:19:47.318124
NCT02438670|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-07-20|||May 2015||2015-05-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||MPC Versus PID for Closed Loop Insulin Delivery|Use of a PID (Proportional-Integral-Derivative) Controller Versus an MPC (Model Predictive Control) Controller Algorithm and Health Monitoring System (HMS) for Closed-Loop Insulin Delivery|Completed||N/A|20|Actual|William Sansum Diabetes Center||3|||f||||f||||||||||2017-10-10 23:19:47.379781|2017-10-10 23:19:47.379781
NCT02438657|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-05-18|||May 2015||2015-05-01|May 2017|2017-05-01|November 3, 2017|Anticipated|2017-11-03|November 3, 2017|Anticipated|2017-11-03||Interventional|VMAL||Ultrasound-guided Nerve Block: Determination of the Minimal Effective Volume of Local Anesthetic|Ultrasound-guided Median Nerve Block With Dextrose 5% Hydrodissection: Determination of the Minimal Effective Volume of Local Anesthetic|Recruiting||Phase 4|60|Anticipated|Hopital Foch||1|||f||||f||||||||||2017-10-10 23:19:47.487261|2017-10-10 23:19:47.487261
NCT02438644|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-08-30|||July 2015||2015-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina|Observational Study of the Effectiveness and Safety of Vismodegib (Erivedge) in Patients Treated in Argentina|Enrolling by invitation||N/A|26|Anticipated|Hoffmann-La Roche|||1||f||||||||||||Undecided||2017-10-10 23:19:47.598082|2017-10-10 23:19:47.598082
NCT02438631|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-09-26|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|PIANO||Placental Passage and Disposition of Drugs: A Physiology-based Approach|Placental Passage and Disposition of Drugs: A Physiology-based Approach|Recruiting||N/A|100|Anticipated|Radboud University|||1||f||||f||||||Samples With DNA|"     Placental tissue is retained, limited sample. DNA will not be analysed.   "|||2017-10-10 23:19:47.64634|2017-10-10 23:19:47.64634
NCT02438618|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-08-31|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2017|Actual|2017-03-01||Interventional|C50||Minimally Invasive Surgery for Ponto Bone Anchored Hearing Implants|Minimally Invasive Surgery for Ponto Bone Anchored Hearing Implants|Active, not recruiting||N/A|62|Anticipated|Oticon Medical||2|||f||||f||||||||||2017-10-10 23:19:47.731342|2017-10-10 23:19:47.731342
NCT02438605|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-06-30|||April 2015||2015-04-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Dynamic CT Imaging After Nellix Endoprosthesis Implantation|Dynamic CT Imaging After Nellix Endoprosthesis Implantation|Completed||N/A|10|Actual|Rijnstate Hospital|||1||f||||f||||||||||2017-10-10 23:19:47.803063|2017-10-10 23:19:47.803063
NCT02438592|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-02-27|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders|PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders|Completed||N/A|924|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 23:19:47.877501|2017-10-10 23:19:47.877501
NCT02438566|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-03-21|||April 2015||2015-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery|Non-inferiority Trial of Oral Tranexamic Acid (OTA) vs. Intravenous Tranexamic Acid (IVTA) to Prevent Blood Loss in Joint Replacement Surgery|Active, not recruiting||Phase 3|118|Actual|The New England Baptist Hospital||2|||f||||t||||||||||2017-10-10 23:19:48.045482|2017-10-10 23:19:48.045482
NCT02438553|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2016-01-06|||May 2015||2015-05-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain|A Prospective, Randomized, Single Blind, Parallel-group, Placebo Controlled Clinical Study to Evaluate the Short-term Effectiveness of Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation (OS-TNS) in Reducing Migraine Related Pain|Completed||N/A|40|Actual|Neurolief Ltd.||2|||f||||f||||||||||2017-10-10 23:19:48.115403|2017-10-10 23:19:48.115403
NCT02438540|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-14|2016-03-24||May 2014||2014-05-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional||As a result, 39 participants were distributed by permuted-block randomization. 19 participants were assigned to the case group and 20 to the control group by an independent research assistant, and according to the above-mentioned method of randomization.|Comparative the Effect of Metformin and Acupuncture on Weight Loss and Insulin Sensitivity|Placebo-controlled, Randomized, Double Blind Trial, What is the Therapeutic Effect of Metformin and Acupuncture Combined Therapy in Comparison With Metformin Monotherapy on Weight Loss and Insulin Sensitivity in Diabetic Patients|Completed||N/A|43|Actual|Nanjing University of Traditional Chinese Medicine||2|||f||||f||||||||Undecided||2017-10-10 23:19:48.210376|2017-10-10 23:19:48.210376
NCT02438527|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-05|||June 2015||2015-06-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Flowchart-Assisted Resuscitation. Standard CPR vs. Chest Compressions Only: What Happened to the Quality?|Flowchart-Assisted Resuscitation. Standard CPR vs. Chest Compressions Only: What Happened to the Quality?|Unknown status|Not yet recruiting|N/A|84|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:19:50.565199|2017-10-10 23:19:50.565199
NCT02438514|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-08-23|||November 2014||2014-11-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Biological Biomarkers in MOMS Partnership|Biological Biomarkers in MOMS Partnership|Recruiting||N/A|30|Anticipated|Yale University|||1||f||||f||||||||||2017-10-10 23:19:50.646364|2017-10-10 23:19:50.646364
NCT02438501|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-12-11|||October 2015||2015-10-01|December 2015|2015-12-01|October 2025|Anticipated|2025-10-01|October 2019|Anticipated|2019-10-01||Interventional|WUCC-NHL02||Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma|A Prospective, Randomized, Open-label, Multi-center Study of Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma: Wuhan University Cancer Center -NHL02 Trial|Recruiting||Phase 3|166|Anticipated|Wuhan University||2|||f||||t||||||||||2017-10-10 23:19:50.714413|2017-10-10 23:19:50.714413
NCT02438488|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-11-24|||April 2015||2015-04-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Vitamin D and Mortality: an Individual Participant Data Meta-analysis of Standardized 25-hydroxyvitamin D|Vitamin D and Mortality: an Individual Participant Data Meta-analysis of Standardized 25-hydroxyvitamin D in 26916 Individuals of a European Consortium|Completed||N/A|26916|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-10 23:19:50.793628|2017-10-10 23:19:50.793628
NCT02438475|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-12-21|||June 2015||2015-06-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure||Recruiting||Phase 4|208|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-10 23:19:50.965321|2017-10-10 23:19:50.965321
NCT02438462|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-03-27|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|SOFIE||Soluble Fibrin for Diagnosing Pulmonary Embolism|Evaluation of Performances of Soluble Fibrin Assay for Diagnosing Pulmonary Embolism|Recruiting||N/A|500|Anticipated|Diagnostica Stago R&D|||2||f||||f||||||Samples Without DNA|"     Frozen citrated Poor Platelets Plasma   "|Undecided||2017-10-10 23:19:51.085541|2017-10-10 23:19:51.085541
NCT02438449|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-05-11|||July 2015||2015-07-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Cost-Effectiveness of Abdominal-based Autogenous Tissue vs Tissue Expander-Implant Reconstruction - A Feasibility Study|A Cost-Effectiveness Analysis Comparing Abdominal-based Autogenous Tissue (AAT) and Tissue Expander- Implant (TE/I) Reconstruction of the Breast After Mastectomy- A Feasibility Study|Recruiting||N/A|40|Anticipated|McMaster University|||2||f||||f||||||||||2017-10-10 23:19:51.198116|2017-10-10 23:19:51.198116
NCT02438436|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2015-08-31|||March 2015||2015-03-01|May 2015|2015-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SD/GC-HCC||Simo Decoction and Gum Chewing for Bowel Activity|Influence of Simo Decoction Plus Acupuncture and Gum Chewing on Postoperative Bowel Activity After Resection for Patients With HCC|Completed||Phase 3|180|Actual|Guangxi Medical University||3|||f||||f||||||||||2017-10-10 23:19:51.296011|2017-10-10 23:19:51.296011
NCT02438423|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-08-08|||June 2015||2015-06-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle|A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity of Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle|Active, not recruiting||Phase 1|100|Anticipated|Georgia Institute of Technology||4|||f||||t||||||||||2017-10-10 23:19:51.380748|2017-10-10 23:19:51.380748
NCT02438410|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-08-09|||May 2015||2015-05-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|||Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis|Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis|Recruiting||N/A|25|Anticipated|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"     Stool and blood laboratory data such as CBC with differential, creatinine, TNF levels,     albumin, fecal calprotectin, ESR, CRP, infliximab and antibodies to infliximab levels will be     obtained.   "|||2017-10-10 23:19:51.485686|2017-10-10 23:19:51.485686
NCT02438397|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-05|||December 2014||2014-12-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|CGMS||the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin|Explore the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin in Chinese Type 2 Diabetes by CGMS|Unknown status|Recruiting|Phase 4|80|Anticipated|Shanghai 6th People's Hospital||2|||f||||f||||||||||2017-10-10 23:19:51.587714|2017-10-10 23:19:51.587714
NCT02437461|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-05-10|||April 2015||2015-04-01|May 2016|2016-05-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic Polyarthritis|Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic Polyarthritis|Recruiting||Phase 4|160|Anticipated|Uppsala University||2|||f||||t||||||||||2017-10-10 23:20:00.435727|2017-10-10 23:20:00.435727
NCT02438384|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-04-18|||September 2015||2015-09-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|BETTER_Pilot||Patient Education to Improve Pain Management in Older Adults With Acute Musculoskeletal Pain: A Pilot Randomized Trial|Patient Education to Improve Pain Management in Older Adults With Acute Musculoskeletal Pain: A Pilot Randomized Trial|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-10 23:19:51.696743|2017-10-10 23:19:51.696743
NCT02438371|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-05-01|||May 2015||2015-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor|Nifedipine Alone or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor: An Open Label, Randomized Comparative Effectiveness Controlled Trial|Recruiting||Phase 4|144|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:19:51.801744|2017-10-10 23:19:51.801744
NCT02438345|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2017-03-01|||November 2012|Actual|2012-11-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||PRO 140 for Human Immunodeficiency Virus|A Phase 2b, Randomized, Double-blind, Placebo-controlled Clinical Trial of Observed Systemic, Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Recreational Drug Users With Viral Rebound and Poor Adherence to the Previous Antiretroviral Regimen|Withdrawn||Phase 2|0|Actual|Drexel University||2|||f||||t||||||||||2017-10-10 23:19:52.035419|2017-10-10 23:19:52.035419
NCT02438332|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-06|2016-07-22|||December 2014||2014-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|RANBI-I||Retrospective Study of Reoperation After Primary Augmentation With NATRELLE® INSPIRA® Breast Implants||Completed||N/A|330|Actual|Allergan|||4||f||||f||||||||||2017-10-10 23:19:52.136061|2017-10-10 23:19:52.136061
NCT02438319|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-06-19|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|Planimetry||Automatic vs. Manual Optic Disc Planimetry|Automatic vs. Manual Optic Cup and Optic Disc Segmentation in Glaucoma|Not yet recruiting||N/A|152|Anticipated|University of Zurich|||1||f||||f||||||||No||2017-10-10 23:19:52.294543|2017-10-10 23:19:52.294543
NCT02438306|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-02-08|||December 2016||2016-12-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||CardiAMP™ Heart Failure Trial|Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy in Patients With Post Myocardial Infarction Heart Failure (CardiAMP Heart Failure Trial)|Recruiting||Phase 3|250|Anticipated|BioCardia, Inc.||2|||f||||t||||||||No||2017-10-10 23:19:52.391344|2017-10-10 23:19:52.391344
NCT02438280|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-04-06|||May 2015|Actual|2015-05-01|April 2017|2017-04-01||||July 2016|Actual|2016-07-01||Interventional|||Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project||Completed||N/A|27|Actual|University of Washington||2|||f||||f||||||||||2017-10-10 23:19:52.611757|2017-10-10 23:19:52.611757
NCT02438267|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-03-09|||April 2015||2015-04-01|June 2016|2016-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|NC||Preterm Infants and Nephrocalcinosis|Preterm Infants and Nephrocalcinosis: Diagnosis and Pathogenesis|Completed||N/A|56|Actual|University of Utah|||2||f||||f||||||||||2017-10-10 23:19:52.705375|2017-10-10 23:19:52.705375
NCT02438254|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-02-24|||September 2014||2014-09-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Texas Family Health Patterns: A Study Across Generations|Oklahoma Family Health Patterns: A Study Across Generations|Completed||N/A|139|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||f||||||||||2017-10-10 23:19:52.842001|2017-10-10 23:19:52.842001
NCT02438241|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-07|||April 2015||2015-04-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|TENS||Transcutaneous Electrical Nerve Stimulation Post-thoracic Surgery in a Intensive Care Unit|Transcutaneous Electrical Nerve Stimulation Post-thoracic Surgery in a Intensive Care Unit: Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 1/Phase 2|45|Anticipated|Irmandade Santa Casa de Misericórdia de Porto Alegre||3|||f||||t||||||||||2017-10-10 23:19:53.060569|2017-10-10 23:19:53.060569
NCT02438228|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-02-10|||November 2014||2014-11-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Cardiac Output by Nine Different Pulse Contour Algorithms|Estimation of Cardiac Output by Nine Different Pulse Contour Algorithms Compared With Transpulmonary Thermodilution|Completed||N/A|30|Actual|University of Schleswig-Holstein||1|||f||||t||||||||||2017-10-10 23:19:53.193892|2017-10-10 23:19:53.193892
NCT02438215|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-05-07|||August 2014||2014-08-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of IRX4204 for Treatment of Early Parkinson's Disease|An Open-Label, Single Site Study Using [123I]β-CIT Single Photon Emission Tomography (SPECT) to Evaluate Dopamine Transporter Binding Following Treatment With IRX4204 in Early Parkinson's Disease Subjects|Completed||Phase 1|15|Actual|Io Therapeutics||1|||f||||t||||||||||2017-10-10 23:19:53.303003|2017-10-10 23:19:53.303003
NCT02438202|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-06-28|||January 2018|Anticipated|2018-01-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|ECTAD||Electroconvulsive Therapy for Treatment of Alzheimer´s Disease|Electroconvulsive Therapy for Treatment of Alzheimer´s Disease|Not yet recruiting||N/A|15|Anticipated|Central Institute of Mental Health, Mannheim||1|||f||||f|f|f||||||||2017-10-10 23:19:53.410806|2017-10-10 23:19:53.410806
NCT02435979|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-12-29|||May 2015||2015-05-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Proximal Strengthening for the Management of Wrist Pain|Proximal Strengthening for the Management of Wrist Pain: A Randomized Controlled Trial|Recruiting||N/A|38|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-10 23:20:18.984735|2017-10-10 23:20:18.984735
NCT02438189|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-08-26|||June 2015||2015-06-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PHM2||Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms|Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing|Completed||Phase 2|33|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-10 23:19:53.505547|2017-10-10 23:19:53.505547
NCT02438176|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-07|||April 2015||2015-04-01|May 2015|2015-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparison of Single Groin and Single Trans-septal Puncture and Conventional Bilateral Groin Puncture and Double Trans-septal Puncture in Catheter Ablation for Atrial Fibrillation||Recruiting||N/A|105|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:19:53.618954|2017-10-10 23:19:53.618954
NCT02438163|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-23|||March 21, 2014|Actual|2014-03-21|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|DEPLAS||Study of Neuroplasticity on Depressed Patients : Modulation of MEP Induced by Theta Burst Stimulation|Study of Neuroplasticity on Depressed Patients Versus Healthy Subjects : Modulation of the MEP Size Induced by Theta Burst Stimulation|Recruiting||N/A|40|Anticipated|Hôpital le Vinatier||2|||f||||t||||||||||2017-10-10 23:19:53.72931|2017-10-10 23:19:53.72931
NCT02438150|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-02-17|||February 2015||2015-02-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effectiveness of an On-line Training Program on Hospital Medical Staff to Improve Fire Knowledge|The Effectiveness of an On-line Training Program on Hospital Medical Staff to Improve Fire Knowledge|Completed||N/A|128|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||||2017-10-10 23:19:53.839747|2017-10-10 23:19:53.839747
NCT02438137|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-04-28|2017-04-28||May 2015||2015-05-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional||65 participants were randomized and included in baseline analyses. 14 participants withdrew from the study or were lost to followup. 51 participants completed study activities. 50 participants (35 DMF and 15 placebo) who both completed the study and had an interpretable Month 4 PSG were included in the final analyses.|Dimethyl Fumarate for Obstructive Sleep Apnea|A Randomized Clinical Trial of Dimethyl Fumarate as a Novel Therapeutic Agent for Obstructive Sleep Apnea|Completed||Phase 2|65|Actual|University of Michigan||2|||f||||f|t|f||||||No||2017-10-10 23:19:53.942191|2017-10-10 23:19:53.942191
NCT02438124|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-01-07|||September 2014||2014-09-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|BeatPark||Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's Disease - BeatPark Study|Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's|Recruiting||N/A|80|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:19:54.408297|2017-10-10 23:19:54.408297
NCT02438111|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-02-27|||December 2013||2013-12-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Observational|||The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)|The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)|Recruiting||N/A|200|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||Samples With DNA|"     blood serum/ stool   "|||2017-10-10 23:19:54.544904|2017-10-10 23:19:54.544904
NCT02438098|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-01-07|||June 2015||2015-06-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Rivaroxaban in Bariatric Surgery|Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban in Obesity Patients Before and After Bariatric Surgery|Completed||Phase 1|13|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-10-10 23:19:54.640512|2017-10-10 23:19:54.640512
NCT02438085|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-01-22|||June 2014|Actual|2014-06-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01|5 Years|Observational [Patient Registry]|ARYOSTO||Prospective Registry of Acute Coronary Syndromes in Ferrara|Acute coRonary sYndrOmes proSpective regisTry Of Ferrara|Recruiting||N/A|5000|Anticipated|University Hospital of Ferrara|||1||f||||t||||||Samples Without DNA|"     whole blood, plasma, serum   "|||2017-10-10 23:19:54.731649|2017-10-10 23:19:54.731649
NCT02438072|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-05|||December 2014||2014-12-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|METADEP||Drug Metabolism and Antidepressant|Cocktail Phenotypic Approach to Explore Antidepressant Pharmacokinetic Variability: a Pilot Study|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-10-10 23:19:54.835919|2017-10-10 23:19:54.835919
NCT02438059|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-05|||August 2012||2012-08-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||SoSu-liv. Mobile Media for Health Promotion|SoSu-liv. A Web- and App-based Intervention Study for Health Promotion Among Social and Health Care Workers in Denmark. A Randomized Controlled Trial|Completed||N/A|566|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-10 23:19:54.941866|2017-10-10 23:19:54.941866
NCT02438046|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-05|||May 2015||2015-05-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Platelet Rich Fibrin in the Treatment of Palatal Wounds|Platelet Rich Fibrin in the Treatment of Palatal Wounds After Epithelialized Free Gingival Grafts Harvesting. A Randomized Clinical Trial|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|G. d'Annunzio University||2|||f||||f||||||||||2017-10-10 23:19:55.020788|2017-10-10 23:19:55.020788
NCT02438033|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-02-24|||September 2015||2015-09-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Characterizing the Specificity and Stability of Local Field Potentials in the Globus Pallidus Internus of Patients Undergoing Deep Brain Stimulation for Parkinson's Disease|Characterizing the Specificity and Stability of Local Field Potentials in the Globus Pallidus Internus of Patients Undergoing Deep Brain Stimulation for Parkinson's Disease|Withdrawn||Phase 1|0|Actual|University of California, Los Angeles||1||Not approved by CMS|f||||t||||||||||2017-10-10 23:19:55.11329|2017-10-10 23:19:55.11329
NCT02438020|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-05|||June 2015||2015-06-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity|Double-blind Randomized Trial Using Oral Metformin Versus Placebo in the Treatment of Acanthosis Nigricans in Children With Obesity|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Universidad Autonoma de San Luis Potosí||2|||f||||f||||||||||2017-10-10 23:19:55.182032|2017-10-10 23:19:55.182032
NCT02438007|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-21||2017-09-21|June 2015||2015-06-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|ARMOR3-SV||A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC|ARMOR3-SV: A Phase 3, Randomized, Open Label, Multi-Center, Controlled Study of Galeterone Compared to Enzalutamide in Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic (M1) Castrate Resistant Prostate Cancer (CRPC)|Terminated||Phase 3|953|Actual|Novus Therapeutics, Inc||2|||f||||t||||||||||2017-10-10 23:19:55.291683|2017-10-10 23:19:55.291683
NCT02437994|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-05-05|||October 2013||2013-10-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|PROactive||Pulmonary Rehabilitation Program and PROactive Tool|Impact of a Pulmonary Rehabilitation Program on the PROactive Tool|Active, not recruiting||N/A|115|Actual|Thorax Research Foundation||2|||f||||f||||||||||2017-10-10 23:19:55.768653|2017-10-10 23:19:55.768653
NCT02437981|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-01-19|||December 2014||2014-12-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|PrEP-30||Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic|Thai Red Cross AIDS Research Centre (TRC-ARC)|Enrolling by invitation||N/A|20000|Anticipated|Thai Red Cross AIDS Research Centre|||1||f||||f||||||||||2017-10-10 23:19:55.851957|2017-10-10 23:19:55.851957
NCT02437968|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-11-08|||December 2010||2010-12-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|Cats&Dogs||Disseminating Evidence-based Practice to the Schools: CBT for Child Anxiety|Disseminating Evidence-based Practice to the Schools: CBT for Child Anxiety|Completed||N/A|76|Actual|Temple University||3|||f||||f||||||||||2017-10-10 23:19:55.912845|2017-10-10 23:19:55.912845
NCT02437955|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-11-27|||April 2015||2015-04-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|Fe_Senegal||Fe Absorption in Mother and Child Pairs From Wheat Fortified With Iron With and Without Phenolic Containing Beverages|Evaluating the National Fortification Policy in Senegal Assessment of Iron Bio-availability in Mother and Child Pairs From Wheat Flour Fortified With Iron With and Without Phenolic Containing Beverages|Completed||N/A|34|Actual|Swiss Federal Institute of Technology||4|||f||||f||||||||||2017-10-10 23:19:55.983392|2017-10-10 23:19:55.983392
NCT02437942|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-05|||April 2015||2015-04-01|May 2015|2015-05-01||||December 2018|Anticipated|2018-12-01||Interventional|||Anatomical, Radiological and Biomechanical Examination of Athletic Groin Pain Patients and Physical Therapy Intervention|An Examination of the Anatomical and Biomechanical Diagnoses That Exist in Athletic Groin Pain Patients and the Effects of a Biomechanics Led Rehabilitation Intervention in These Same Patients|Recruiting||N/A|600|Anticipated|Sports Surgery Clinic, Santry, Dublin||1|||f||||||||||||||2017-10-10 23:19:56.074166|2017-10-10 23:19:56.074166
NCT02437929|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-07-11|||June 2015||2015-06-01|December 2015|2015-12-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|||Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment|Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment. A Prospective, Cross-sectional, Multicenter, National Study|Completed||N/A|1079|Actual|Antea Associazione|||1||f||||f||||||||No||2017-10-10 23:19:56.180473|2017-10-10 23:19:56.180473
NCT02437916|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-02-02|||April 2015||2015-04-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety Study of AMG 228 to Treat Solid Tumors|A Phase 1 First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 228 in Subjects With Selected Advanced Solid Tumors|Terminated||Phase 1|30|Actual|Amgen||1||Business decision.|f||||f||||||||||2017-10-10 23:19:56.266911|2017-10-10 23:19:56.266911
NCT02437903|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-05-16|2017-04-13||August 7, 2015|Actual|2015-08-07|May 2017|2017-05-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|||Open Label Study Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions|Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions|Completed||N/A|30|Actual|Baumann Cosmetic and Research Institute||1|||f||||f||||||||||2017-10-10 23:19:56.399997|2017-10-10 23:19:56.399997
NCT02437890|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-06-06|||July 2015||2015-07-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus|A Phase II Multicenter, Randomized, Double-blind, Placebo Controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX 0061 Administered Subcutaneously in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus|Active, not recruiting||Phase 2|312|Actual|Ablynx||5|||f||||t||||||||||2017-10-10 23:19:57.044087|2017-10-10 23:19:57.044087
NCT02437877|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-20|2015-05-07|||August 2008||2008-08-01|May 2015|2015-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||The Influence of Breathing in Writing|The Influence of Mouth Breathing in the Discrimination of Sonority Perception in Writing|Completed||N/A|200|Actual|University of Campinas, Brazil|||2||f||||f||||||||||2017-10-10 23:19:57.363351|2017-10-10 23:19:57.363351
NCT02437864|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-05-10|||May 2015||2015-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Apneic Oxygenation During Airway Management in Pediatric Patients|Effect of Peri-intubation Apneic Oxygenation Via Nasal Cannula on Pediatric Patients' Oxygen Saturation During Airway Management|Recruiting||N/A|400|Anticipated|University of New Mexico||2|||f||||f||||||||||2017-10-10 23:19:57.435081|2017-10-10 23:19:57.435081
NCT02437851|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-07-20|||April 2015||2015-04-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection|A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons|Recruiting||Phase 2|56|Anticipated|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-10-10 23:19:57.500546|2017-10-10 23:19:57.500546
NCT02437838|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-06-19|||August 2015||2015-08-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Optimizing Drug Doses in Critically Ill|Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients|Completed||N/A|20|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 23:19:57.592918|2017-10-10 23:19:57.592918
NCT02437448|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Breath Analysis in Lung Fibrosis|Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS) in Patients With Pulmonary Fibrosis|Recruiting||N/A|50|Anticipated|University of Zurich|||2||f||||f||||||None Retained|"     Exhaled breath   "|||2017-10-10 23:20:00.525067|2017-10-10 23:20:00.525067
NCT02437825|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-09-12|||October 2015||2015-10-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery|Prospective Randomized, Double-blind, Placebo-controlled Parallel Group Study of the Efficacy of Octreotide in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery|Recruiting||Phase 2|40|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-10 23:19:57.65554|2017-10-10 23:19:57.65554
NCT02437812|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-02-24|||January 2014||2014-01-01|August 2016|2016-08-01|April 2021|Anticipated|2021-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma|A Phase II, Open-Label, Non-Randomized, Pilot Study of Paclitaxel, Carboplatin and Oral Metformin for Patients Newly Diagnosed With Stage II-IV Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Recruiting||Phase 2|30|Anticipated|Gynecologic Oncology Associates||1|||f||||f||||||||Yes|Data will be shared once all data is reviewed|2017-10-10 23:19:57.732303|2017-10-10 23:19:57.732303
NCT02437799|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|DINOCS||Dicrotic Notch and Hypotension at Caesarean Under Spinal Anaesthesia|Analysis of Changes in the Pulse Oximeter Waveform and Blood Pressure During Spinal Anaesthesia for Caesarean Section: an Observational Study|Completed||N/A|20|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:19:57.812167|2017-10-10 23:19:57.812167
NCT02437786|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-01-18|||September 2009||2009-09-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|GT-20||Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®|Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®|Completed||Phase 4|58|Actual|ALK-Abelló A/S||1|||f||||t||||||||No||2017-10-10 23:19:57.881538|2017-10-10 23:19:57.881538
NCT02437773|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2017-03-28|||September 2014||2014-09-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Neurocircuit Mechanisms of OCD Across the Lifespan|Neurocircuit Mechanisms of OCD Across the Lifespan|Recruiting||N/A|220|Anticipated|University of Michigan||8|||f||||f||||||||||2017-10-10 23:19:57.938942|2017-10-10 23:19:57.938942
NCT02437760|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2015-05-05|||February 2015||2015-02-01|May 2015|2015-05-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Observational|||The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring|Determination of the Prognostic and Predictive Value of the Cancer Antigen-125 (CA-125) Marker in Lung Cancer Monitoring|Recruiting||N/A|200|Anticipated|E-DA Hospital|||1||f||||t||||||||||2017-10-10 23:19:58.038266|2017-10-10 23:19:58.038266
NCT02437747|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-05|||June 2014||2014-06-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Locally Delivered Aloe Vera Gel in the Treatment of Chronic Periodontitis Patients With Diabetes Mellitus|Local Drug Delivery of Aloe Vera Gel in Chronic Periodontitis Patients With Controlled Diabetes Mellitus|Completed||Phase 4|15|Actual|Dr. D. Y. Patil Dental College & Hospital||2|||f||||t||||||||||2017-10-10 23:19:58.095202|2017-10-10 23:19:58.095202
NCT02437734|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-04-24|||August 13, 2013|Actual|2013-08-13|April 2017|2017-04-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Interventional|||Virtual Coronary Physiology: an Angiogram is All You Need|Virtual Coronary Physiology: an Angiogram is All You Need|Completed||N/A|119|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:19:58.278173|2017-10-10 23:19:58.278173
NCT02437721|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-08-23|||May 2015||2015-05-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|MEFOLIN||Suitability of an Infant Formula With L-5-Methyltetrahydrofolate for the Particular Nutritional Use in Infants|Suitability of an Infant Formula With L-5-Methyltetrahydrofolate for the Particular Nutritional Use in Infants|Recruiting||N/A|360|Anticipated|DSM Nutritional Products, Inc.||3|||f||||f||||||||||2017-10-10 23:19:58.355751|2017-10-10 23:19:58.355751
NCT02437708|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Regenerative Endodontic Procedure of Immature Permanent Teeth With L-PRF: a Pilot Controlled, Clinical Trial|Regenerative Endodontic Procedure of Immature Permanent Teeth With the Use of Autologous L-PRF: a Pilot Controlled, Clinical Trial|Active, not recruiting||Phase 3|29|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 23:19:58.472095|2017-10-10 23:19:58.472095
NCT02437695|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-12-07|||May 2015||2015-05-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Robot Assisted Radical Prostatecomy and Positional Injury|Robot Assisted Radical Prostatecomy and Positional Injury; 8 Years Survey|Completed||N/A|450|Actual|Umraniye Education and Research Hospital|||1||f||||f||||||||||2017-10-10 23:19:58.55689|2017-10-10 23:19:58.55689
NCT02437682|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-04-20|||January 2017||2017-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Translation and Validation of the PASS Test for GERD Patients With Partial Response to PPI in Chinese Population: PASS-C|Translation and Validation of the PASS Test for Gastro-esophageal Reflux Disease (GERD) Patients With Partial Response to PPI in Chinese Population: PASS-C|Recruiting||N/A|100|Anticipated|Chinese University of Hong Kong|||1||f||||f|f|f||||||No||2017-10-10 23:19:58.63337|2017-10-10 23:19:58.63337
NCT02437669|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-04-12|||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study.|Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study.|Recruiting||Phase 2|40|Anticipated|Columbia University||1|||f||||t||||||||||2017-10-10 23:19:58.722447|2017-10-10 23:19:58.722447
NCT02437656|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-01-12|||April 2015||2015-04-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP).|Phase II Study Evaluating the Efficacy of the Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer.|Active, not recruiting||Phase 2|60|Actual|Centre Oscar Lambret||1|||f||||f||||||||No||2017-10-10 23:19:58.822308|2017-10-10 23:19:58.822308
NCT02437643|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-07-27|||August 17, 2015|Actual|2015-08-17|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|DDYNAMO||An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition|An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition|Recruiting||N/A|70|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:19:58.931946|2017-10-10 23:19:58.931946
NCT02437630|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-06-06|||April 2016||2016-04-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Intrinsic PEEP and Laryngeal Aperture in COPD|An Investigation Into the Pressure and Airflow/Volume Changes Which Accompany Partial Closure of the Larynx During Expiration in Patients With COPD and the Effect of Applying a Positive End Expired Pressure by Facemask on These Parameters|Recruiting||N/A|30|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 23:19:59.036795|2017-10-10 23:19:59.036795
NCT02437617|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-08-21|||July 2012|Actual|2012-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Genomic Profiling Assay in Phase I|A Study Exploring the Use of the Foundation Medicine Genomic Profiling Assay in a Phase I Solid Tumor Patient Population|Active, not recruiting||N/A|300|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||Samples With DNA|"     Tumor specimens collected from patients for DNA extraction. All samples residual samples from     previously performed biopsies.   "|||2017-10-10 23:19:59.136152|2017-10-10 23:19:59.136152
NCT02437604|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-10-06|||May 2015||2015-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older|An Open-Label, Crossover Study to Determine the Pharmacokinetic Profile and Tolerability of Single Doses of High Strength Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older|Completed||Phase 1|43|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-10-10 23:19:59.216086|2017-10-10 23:19:59.216086
NCT02437591|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-09-19|||August 13, 2015|Actual|2015-08-13|September 2017|2017-09-01|October 24, 2016|Actual|2016-10-24|May 12, 2016|Actual|2016-05-12||Interventional|PROFILE||Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)|Open Label Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)|Completed||Phase 4|25|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-10-10 23:19:59.312896|2017-10-10 23:19:59.312896
NCT02437578|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-10-03|||May 2015||2015-05-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Observational|||Clinical Tests to Predict the Success of Assisted Reproductive Techniques|Development of Clinical Tests to Predict the Success of Assisted Reproductive Techniques in a Fertility Clinic|Recruiting||N/A|600|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||Samples With DNA|"     Serum Seminal plasma follicular fluid DNA granulosa cells   "|||2017-10-10 23:19:59.436631|2017-10-10 23:19:59.436631
NCT02437565|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-05-04|||August 2013||2013-08-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Checking Occlusion During Stainless Steel Crown Placement|Checking Occlusion During Stainless Steel Crown Placement in Children Under General Anesthesia - Evaluation of a Novel Technique|Completed||N/A|60|Actual|Riyadh Colleges of Dentistry and Pharmacy||2|||f||||t||||||||||2017-10-10 23:19:59.544709|2017-10-10 23:19:59.544709
NCT02437552|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-06|||March 2015||2015-03-01|May 2015|2015-05-01|March 2019|Anticipated|2019-03-01|June 2015|Anticipated|2015-06-01||Interventional|||Cycle Ergometer Exercise in Phase I of Cardiac Rehabilitation After Cardiac Surgery|Cycle Ergometer Exercise in Phase I of Cardiac Rehabilitation After Cardiac Surgery|Active, not recruiting||N/A|24|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:19:59.617435|2017-10-10 23:19:59.617435
NCT02437539|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-08-21|||May 2015||2015-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|uPAR-PET||Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography|68Ga-NOTA-AE105. Evaluation of a New Radiotracer Targeting uPAR (Urokinase Plasminogen Activator Receptor), for Positron Emission Tomography Imaging of the Invasive Cancer Phenotype. First in Human|Completed||Phase 1|10|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 23:19:59.690719|2017-10-10 23:19:59.690719
NCT02437526|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-03-21|||May 2015||2015-05-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Analytic Treatment Interruption (ATI) to Assess HIV Cure|Analytic Treatment Interruption of Antiretroviral Therapy to Assess for HIV Cure|Enrolling by invitation||N/A|10|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:19:59.768395|2017-10-10 23:19:59.768395
NCT02437513|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-08-23|2016-12-07||March 2016||2016-03-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Observational|||NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration|NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration|Terminated||N/A|2|Actual|ProTiP Medical|Very low recruitment achieved over all sites and early termination of the enrolled subjects gives insufficient data for any meaningful analysis of the product performance and safety in this study.||1|Recruitment rates too low to continue with the study|f||||f||||||||||2017-10-10 23:19:59.848851|2017-10-10 23:19:59.848851
NCT02437500|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-11-16|||May 2015||2015-05-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Expanded Access|ECOSPOR II||Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection|ECOSPOR II: An Expanded Access for Intermediate-size Patient Population and Open-Label Extension of Study SERES-004 to Evaluate SER-109 in Patients With Recurrent Clostridium Difficile Infection|No longer available||N/A|||Seres Therapeutics, Inc.|||||||||||||||||||2017-10-10 23:20:00.09958|2017-10-10 23:20:00.09958
NCT02437487|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-11-16|||May 2015||2015-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|ECOSPOR||SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)|ECOSPOR: A RandomizEd, Double Blind, Placebo COntrolled, Parallel Group Study of SER 109 to Prevent Recurrent ClOstRidium Difficile Infection|Completed||Phase 2|89|Actual|Seres Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 23:20:00.209597|2017-10-10 23:20:00.209597
NCT02437474|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-04-27|||April 2015||2015-04-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2016|Anticipated|2016-06-01||Observational|||Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study|Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study|Recruiting||N/A|10000|Anticipated|Verein Essen und Krebs|||3||f||||t||||||||No||2017-10-10 23:20:00.334395|2017-10-10 23:20:00.334395
NCT02437435|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-05-16|||April 2015||2015-04-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Physiotherapy Treatment for Uterine Blood Flow Improved Dimensional Ultrasound Evaluated With Angiography|Effectiveness of Physiotherapy Treatment to Improve the Flow on Vascular Area of the Endometrial / Subendometrial in Uterus of Infertile Women With Hypoestrogenemia Evaluated by Three-dimensional Ultrasound Angiography.|Active, not recruiting||N/A|54|Actual|University of Valencia||2|||f||||t||||||||||2017-10-10 23:20:00.607685|2017-10-10 23:20:00.607685
NCT02437422|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-04-15|||June 2015||2015-06-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease|A Phase Ib, Open-Label, Single Arm Study to Assess the Safety, Pharmacokinetics, and Impact on Humoral Sensitization of SANGUINATE Infusion in Patients With End-Stage Renal Disease (ESRD)|Recruiting||Phase 1|10|Anticipated|Prolong Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:20:00.698439|2017-10-10 23:20:00.698439
NCT02437409|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-07-19|2015-09-03||February 2013||2013-02-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Observational|ARTESp||Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)|Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)|Completed||N/A|115|Actual|Phenox GmbH|||1||f||||f||||||||||2017-10-10 23:20:00.793586|2017-10-10 23:20:00.793586
NCT02437396|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-05-10|||October 2015||2015-10-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Oxidative Stress-Related Biomarkers in Gaucher Disease: A Preliminary Study|Oxidative Stress-Related Biomarkers in Gaucher Disease: A Preliminary Study|Recruiting||N/A|15|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||3||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-10 23:20:01.017227|2017-10-10 23:20:01.017227
NCT02437383|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-12-01|||August 2015||2015-08-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SOPPRANO||Study of Orofacial Pain and PropRANOlol|Effect of COMT (Catecholamine-O-methyltransferase) Genetic Polymorphisms on Response to Propranolol Therapy in Temporomandibular Disorder|Recruiting||Phase 2|200|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 23:20:01.096785|2017-10-10 23:20:01.096785
NCT02437370|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-06-27|||August 2015||2015-08-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer|Feasibility Trial of MK3475 + Docetaxel or Gemcitabine in Platinum Pre-treated Urothelial Cancer|Recruiting||Phase 1|38|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-10-10 23:20:01.248392|2017-10-10 23:20:01.248392
NCT02437357|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-09-26|||March 2015||2015-03-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Trial on Metacognitive Training for Depression (D-MCT)|A Randomized-Controlled Trial on Metacognitive Training for Depression (D-MCT) - an New Group Intervention for Depressed Patients|Completed||N/A|60|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 23:20:01.344029|2017-10-10 23:20:01.344029
NCT02437344|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2017-08-07|2017-08-07||January 2015||2015-01-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence|Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence|Completed||Phase 2|16|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-10 23:20:01.432481|2017-10-10 23:20:01.432481
NCT02437305|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-11-30|2016-09-14||May 2015||2015-05-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Melanoma Perception and Health Literacy in People of Color|Melanoma Perception and Health Literacy in People of Color: A Targeted Educational Intervention|Completed||N/A|100|Actual|Northwestern University|Small sample size and high dropout rate; recruitment from dermatology clinic patients with a majority having college degrees or higher so the study results are less generalizable.|2|||f||||f||||||||||2017-10-10 23:20:02.992791|2017-10-10 23:20:02.992791
NCT02437292|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-06|||May 2015||2015-05-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Ischemic Compression With Stretching on Patients With Upper Back Pain|Effect of Ischemic Compression With Stretching on Pain Related Parameters in Patients With Upper Back Pain Associated With Myofascial Trigger Point|Unknown status|Not yet recruiting|N/A|30|Anticipated|Mae Fah Luang University Hospital||2|||f||||t||||||||||2017-10-10 23:20:03.5057|2017-10-10 23:20:03.5057
NCT02437279|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-07-17|||August 12, 2015|Actual|2015-08-12|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|OpACIN||Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients|Feasibility Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Stage III Melanoma Patients|Active, not recruiting||Phase 1|20|Actual|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-10 23:20:03.575696|2017-10-10 23:20:03.575696
NCT02437266|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-06|||May 2015||2015-05-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Scapular Mobilization on Patients With Scapular Pain|Effect of Scapular Mobilization on Patients With Scapular Pain Associated With Myofascial Trigger Point|Unknown status|Not yet recruiting|N/A|38|Anticipated|Mae Fah Luang University Hospital||2|||f||||t||||||||||2017-10-10 23:20:03.660743|2017-10-10 23:20:03.660743
NCT02437253|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-08-16|2017-05-03||May 2015||2015-05-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI|Pilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VI|Completed||Phase 1/Phase 2|2|Actual|Los Angeles Biomedical Research Institute|Small pilot study of 2 participants.|2|||f||||t||||||||||2017-10-10 23:20:03.747516|2017-10-10 23:20:03.747516
NCT02437240|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-05-04|||August 2014||2014-08-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|PBCPT||Pilates-based Cardiopulmonary Physical Therapy for In-Patients After Cardiac Surgery|Effects of Pilates-based Cardiopulmonary Physical Therapy for In-Patients After Cardiac Surgery|Unknown status|Active, not recruiting|N/A|140|Anticipated|National Yang Ming University||2|||f||||f||||||||||2017-10-10 23:20:04.155832|2017-10-10 23:20:04.155832
NCT02437227|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-04-06|||March 2015||2015-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2017|Anticipated|2017-12-01||Interventional|PanRAF||A Phase I, First in Man Study to Evaluate the Safety and Tolerability of a panRAF Inhibitor (CCT3833/BAL3833)in Patients With Solid Tumours|A Phase 1, First in Man, Dual Centre, Open-label Dose Escalation Study With Expansion to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CCT3833 (BAL3833), a panRAF Inhibitor, Given Orally in Patients With Advanced Solid Tumours, Including Metastatic Melanoma|Recruiting||Phase 1|69|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 23:20:04.246069|2017-10-10 23:20:04.246069
NCT02437214|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-02-03|||May 2008||2008-05-01|February 2016|2016-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Music to Decrease Pain and Anxiety During Head CTs Performed at the PEds ED|Randomized Single Blinded Clinical Trial on Effects of Nursery Songs in Infants and Young Children's Anxiety Prior and During Head CT|Completed||N/A|62|Actual|University of New Mexico||2|||f||||f||||||||No||2017-10-10 23:20:04.324419|2017-10-10 23:20:04.324419
NCT02437201|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-09-27|||July 2015||2015-07-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Liberty Program on Women's Health and Intimate Partner Violence|Study of Liberty Program on Women's Health and Intimate Partner Violence: Multinational, Open, Randomised, Controlled Clinical Study|Active, not recruiting||N/A|500|Anticipated|Macmillan Research Group UK||2|||f||||t||||||||||2017-10-10 23:20:04.424024|2017-10-10 23:20:04.424024
NCT02437188|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-04|||February 2015||2015-02-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|PreACT||Preventing Persistent Post-Surgical Pain and Opioid Use In At-Risk Veterans: Effect of ACT|Preventing Persistent Post-Surgical Pain and Opioid Use In At-Risk Veterans: Effect of ACT|Unknown status|Recruiting|N/A|72|Anticipated|University of Iowa||2|||f||||t||||||||||2017-10-10 23:20:04.510236|2017-10-10 23:20:04.510236
NCT02437175|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-04-03|||May 2015||2015-05-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of Trace Elements in the Treatment of Endometriosis: a Pilot Study|Efficacy of Food Supplements Containing Trace Elements in the Treatment of Endometriosis, Combined or Not to an Adenomyosis: a Pilot Study|Active, not recruiting||Phase 3|99|Actual|Laboratoires Pronutri||2|||f||||f||||||||||2017-10-10 23:20:04.594119|2017-10-10 23:20:04.594119
NCT02437162|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-09-27|||September 3, 2015|Actual|2015-09-03|September 2017|2017-09-01|September 6, 2017|Actual|2017-09-06|March 22, 2017|Actual|2017-03-22||Interventional|||A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF Alpha Naive Subjects With Active Radiographic Axial Spondyloarthritis|Terminated||Phase 3|347|Actual|Janssen Research & Development, LLC||3||"Neither dose achieved the study's primary or major secondary endpoints. The safety profile was   consistent with previous ustekinumab studies."|f||||t||f||||||||2017-10-10 23:20:04.669021|2017-10-10 23:20:04.669021
NCT02437136|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-09-20|||July 2015||2015-07-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer|A Phase 1b/2, Open-label, Dose Escalation Study of Entinostat in Combination With Pembrolizumab in Patients With Non-small Cell Lung Cancer, With Expansion Cohorts in Patients With Non-small Cell Lung Cancer, Melanoma, and Mismatch Repair-Proficient Colorectal Cancer|Recruiting||Phase 1/Phase 2|202|Anticipated|Syndax Pharmaceuticals||4|||f||||f||||||||||2017-10-10 23:20:04.893655|2017-10-10 23:20:04.893655
NCT02437123|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-07-14|||September 2014||2014-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Cedar Project: Impact of mHealth for HIV Prevention Among Young Indigenous People Who Use Illicit Drugs||Completed||N/A|180|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:20:06.715559|2017-10-10 23:20:06.715559
NCT02437110|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2017-10-05|||April 23, 2015||2015-04-23|February 1, 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)|HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)|Enrolling by invitation||Phase 1|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:20:06.787129|2017-10-10 23:20:06.787129
NCT02437097|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2016-07-09|||June 2015||2015-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Aerobic Exercise and Gaming on Cognitive Performance|The Effect of Aerobic Exercise and Gaming on Cognitive Performance|Completed||N/A|40|Actual|New York Institute of Technology||4|||f||||f||||||||||2017-10-10 23:20:06.868594|2017-10-10 23:20:06.868594
NCT02437084|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-10-21|||May 2015||2015-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling|Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling|Recruiting||Phase 4|20|Anticipated|Stanford University||2|||f||||f||||||||No||2017-10-10 23:20:06.941128|2017-10-10 23:20:06.941128
NCT02437071|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-06-21|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients|Single Arm Phase II Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients|Recruiting||Phase 2|48|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:20:07.015436|2017-10-10 23:20:07.015436
NCT02437058|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-05|2015-05-06|||January 2011||2011-01-01|April 2013|2013-04-01|May 2015|Actual|2015-05-01|April 2013|Actual|2013-04-01|3 Months|Observational [Patient Registry]|AHFRS||Validity of Scales to Assess Severity in Acute Heart Failure|Validition of Scales for the Assessment of Sverity in Acute Decompensated Heart Failure|Completed||N/A|1854|Actual|Hospital Galdakao-Usansolo|||1||f||||f||||||||||2017-10-10 23:20:07.100518|2017-10-10 23:20:07.100518
NCT02437045|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-11-13|||April 2015||2015-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|MERINO II||Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response|Pilot RCT of Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC Beta-lactamase Producing Enterobacter Spp., Citrobacter Freundii, Morganella Morganii, Providencia Spp. or Serratia Marcescens. in Low-risk Patients|Recruiting||Phase 4|100|Anticipated|The University of Queensland||2|||f||||t||||||||||2017-10-10 23:20:07.153115|2017-10-10 23:20:07.153115
NCT02437032|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2015-05-04|||April 2009||2009-04-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Gonadotropin Type in Ovarian Stimulation|Type of Gonadotropin During Controlled Ovarian Stimulation Affects the Endocrine Profile in Follicular Fluid and Apoptotic Rate in Granulose Cells|Completed||Phase 4|100|Actual|IVI Madrid||3|||f||||f||||||||||2017-10-10 23:20:07.271973|2017-10-10 23:20:07.271973
NCT02437019|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-03-17||||||March 2017|2017-03-01||||||||Expanded Access|||Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)|An Early Access Program (EAP) for Ibrutinib (PCI-32765) in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)|Approved for marketing||N/A|||Janssen-Cilag Farmaceutica Ltda.|||||f||||||||||||||2017-10-10 23:20:07.346257|2017-10-10 23:20:07.346257
NCT02437006|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-05-04|||March 2014||2014-03-01|March 2014|2014-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Early Intervention With a Low-intensity Leg Cycling Exercise Program for Individuals After Stroke|Early Intervention With a Low-intensity Leg Cycling Exercise Program for Individuals After Stroke|Unknown status|Recruiting|N/A|120|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||t||||||||||2017-10-10 23:20:07.516779|2017-10-10 23:20:07.516779
NCT02436993|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-11-28|||April 2015||2015-04-01|November 2016|2016-11-01|February 2037|Anticipated|2037-02-01|February 2022|Anticipated|2022-02-01||Interventional|||Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab|A Phase II Study of Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting|Recruiting||Phase 2|120|Anticipated|University of California, Irvine||2|||f||||t||||||||||2017-10-10 23:20:07.602859|2017-10-10 23:20:07.602859
NCT02436980|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-12|||January 2009||2009-01-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Premedication for ERCP With Midazolam or Tramadol|Effects of Midazolam or Tramadol Premedication on Early Cognitive Function in ERCP: a Randomized Controlled Double-Blind Study|Completed||Phase 4|40|Actual|Karadeniz Technical University||2|||f||||f||||||||||2017-10-10 23:20:07.710175|2017-10-10 23:20:07.710175
NCT02436967|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2016-09-01|||December 2014||2014-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Classification of Carotid Plaque With Computed Tomography With Fast kVp (Kilovolt Peak)-Switching Technique|Classification of Carotid Plaque With Computed Tomography With Fast kVp-switching Technique: A Comparison With Histology and 3-Tesla MRI|Recruiting||N/A|100|Anticipated|Karolinska Institutet|||1||f||||f||||||Samples Without DNA|"     The comparison CT vs histology requires a operated plaque for histology.   "|||2017-10-10 23:20:07.791838|2017-10-10 23:20:07.791838
NCT02436954|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-06-17|||June 2015||2015-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Regional Cerebral Oxygen Saturation in Laparoscopic Surgery|Impact of Neuromuscular Blockade on Cerebral Oxygen Saturation in Laparoscopic Surgery Employ Carbon Dioxide-pneumoperitoneum|Unknown status|Not yet recruiting|N/A|40|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||||2017-10-10 23:20:07.864473|2017-10-10 23:20:07.864473
NCT02436941|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-03-16|||October 2003||2003-10-01|March 2017|2017-03-01|October 2040|Anticipated|2040-10-01|March 2025|Anticipated|2025-03-01|99 Years|Observational [Patient Registry]|||Radiation Medicine Patient Registry, Loma Linda University Medical Center|Loma Linda University Medical Center Department of Radiation Medicine Patient Registry|Enrolling by invitation||N/A|75000|Anticipated|Loma Linda University|||1||f||||f||||||||||2017-10-10 23:20:07.931749|2017-10-10 23:20:07.931749
NCT02436928|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-08-18|||April 2015||2015-04-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects||Completed||Phase 1/Phase 2|200|Actual|Medigen Vaccine Biologics Corp.||4|||f||||t||||||||||2017-10-10 23:20:08.010997|2017-10-10 23:20:08.010997
NCT02436902|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-06-09|||February 2016||2016-02-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|A-TACE/S-HCC||Adjuvant Therapies for Patients With HCC and MVI|Adjuvant Transarterial Chemoembolization With or Without Sorafenib for Patients With Hepatocellular Carcinoma and Microvascular Invasion|Recruiting||Phase 3|240|Anticipated|Guangxi Medical University||4|||f||||||||||||||2017-10-10 23:20:08.207167|2017-10-10 23:20:08.207167
NCT02436889|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-09-15|||February 2016||2016-02-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|TRIUMPH||Treatment of Incontinence Without Memory Problems||Active, not recruiting||Phase 4|23|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:20:08.299668|2017-10-10 23:20:08.299668
NCT02436876|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-02-14|||January 2016||2016-01-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Osteosynthesis Sites|Phase 2a Randomized, Single-Blind, Placebo-Controlled, 24-week Escalating Dose Study to Assess the Safety, Tolerability and Clinical Activity of 3 Concentrations of Locally Applied MBN-101 to Infected Osteosynthesis Sites|Recruiting||Phase 2|24|Anticipated|Microbion Corporation||3|||f||||t|t|||||||||2017-10-10 23:20:08.37264|2017-10-10 23:20:08.37264
NCT02436863|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-04-18|||January 2015||2015-01-01|April 2016|2016-04-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|||Influence of Laminoplasty and Internal Fixation on Vertebral Stability After Laminectomy|Influence of Laminoplasty and Internal Fixation on Vertebral Stability After Cervical, Thoracic and Lumbar Laminectomy for Tumor Resection|Recruiting||N/A|120|Anticipated|Southern Medical University, China|||2||f||||f||||||||||2017-10-10 23:20:08.491351|2017-10-10 23:20:08.491351
NCT02436850|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-03-15|||August 2015||2015-08-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Bed Side Thoracentesis Among Non-Ventilated Patients With Respiratory Instability|Bed Side Thoracentesis Among Non-Ventilated Patients With Respiratory Instability|Recruiting||N/A|60|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-10-10 23:20:08.579185|2017-10-10 23:20:08.579185
NCT02436837|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-06|||January 2013||2013-01-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|AKS||Applicability of Kinect Sensor® in the Rehabilitation of Balance in the Elderly|Applicability of Kinect Sensor® in the Rehabilitation of Balance in the Elderly|Completed||N/A|20|Actual|Federal University of Juiz de Fora||2|||f||||t||||||||||2017-10-10 23:20:08.676868|2017-10-10 23:20:08.676868
NCT02436824|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-28||2016-08-25|April 2015||2015-04-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||A Study of a Topical Patch (AB001) in Patients With Chronic Low Back Pain|A Phase II, Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Determine the Safety and Efficacy of a Topical Patch (AB001) Following Daily Administration for 2 Weeks in Patients With Chronic Low Back Pain|Completed||Phase 2|146|Actual|Frontier Biotechnologies Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:20:08.751678|2017-10-10 23:20:08.751678
NCT02436811|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-04-02|2015-12-01||October 2014||2014-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Oral Health Literacy and Oral Education|Literacy and Information Retention in Pregnancy|Completed||N/A|180|Actual|Universidade Federal do Paraná||3|||f||||t||||||||||2017-10-10 23:20:08.856701|2017-10-10 23:20:08.856701
NCT02436798|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-05-30|||June 2014||2014-06-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||5-HT3 Antagonists (Antiemetics) and Cardiac Safety|5-HT3 Antagonists (Antiemetics) and Cardiac Safety Using an Active Surveillance Approach|Recruiting||N/A|250|Anticipated|University of British Columbia|||2||f||||f||||||Samples With DNA|"     DNA samples will be retained for genomic analyses.   "|||2017-10-10 23:20:09.316077|2017-10-10 23:20:09.316077
NCT02436785|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-05-02|||May 2015||2015-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?|Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening Over the 4 Weeks Using a Randomised Control Trial?|Active, not recruiting||N/A|20|Anticipated|University of British Columbia||2|||f||||f|f|f||||||No||2017-10-10 23:20:09.442922|2017-10-10 23:20:09.442922
NCT02436772|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-05-03|||May 13, 2015|Actual|2015-05-13|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC|Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC|Recruiting||N/A|100|Anticipated|SCRI Development Innovations, LLC|||1||f||||f||||||||||2017-10-10 23:20:09.57|2017-10-10 23:20:09.57
NCT02436759|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-12-06|||May 2015||2015-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis|A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis|Completed||Phase 3|139|Actual|RevitaLid Inc.||2|||f||||f||||||||||2017-10-10 23:20:09.643364|2017-10-10 23:20:09.643364
NCT02436746|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-04|||April 2015||2015-04-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|COVANTT||The Cognitive Variability in NF1 and TSC Monozygotic Twins|The Cognitive Variability in Neurofibromatosis Type I and Tuberous Sclerosis Complex Monozygotic Twins|Unknown status|Recruiting|N/A|116|Anticipated|Erasmus Medical Center|||2||f||||f||||||||||2017-10-10 23:20:09.759432|2017-10-10 23:20:09.759432
NCT02436733|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-09-19|||September 2016||2016-09-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|September 2019|Anticipated|2019-09-01||Interventional|||Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM|EORTC Randomized Phase II Study of Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage Malignant Pleural Mesothelioma|Not yet recruiting||Phase 2|64|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||No||2017-10-10 23:20:09.866883|2017-10-10 23:20:09.866883
NCT02436720|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-06|||January 2013||2013-01-01|May 2015|2015-05-01|May 2015|Anticipated|2015-05-01|March 2013|Actual|2013-03-01||Observational|PUL in DMD||Upper Limb Assessment in Duchenne Muscular Dystrophy|Performance of Upper Limb (PUL) in Duchenne Muscular Dystrophy|Unknown status|Active, not recruiting|N/A|300|Anticipated|Catholic University of the Sacred Heart|||1||f||||f||||||||||2017-10-10 23:20:09.962077|2017-10-10 23:20:09.962077
NCT02436707|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-05-08|||May 5, 2015||2015-05-05|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma|A Multi-Stage Randomized Phase II Study of Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma|Recruiting||Phase 2|320|Anticipated|Canadian Cancer Trials Group||3|||f||||t||||||||Undecided||2017-10-10 23:20:10.05403|2017-10-10 23:20:10.05403
NCT02436148|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2017-08-14|||March 2015||2015-03-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|1 Year|Observational [Patient Registry]|||Reliability and Validity of the Finnish Version of the Prothesis Evaluation Questionnaire|Reliability and Validity of the Finnish Version of the Prothesis Evaluation Questionnaire|Completed||N/A|140|Actual|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 23:20:16.74195|2017-10-10 23:20:16.74195
NCT02436694|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-11-25|||April 2015||2015-04-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Nerve Blocks With Dexamethasone and Local Anaesthetic to Improve Postoperative Analgesia|Can the Association of Dexamethasone and Local Anaesthetic in a Single-shot Femoral and Sciatic Nerve Block Improve Analgesia Postoperatively in Patients Submitted to Total Knee Arthroplasty|Recruiting||N/A|56|Anticipated|Centro Hospitalar do Porto||2|||f||||f||||||||||2017-10-10 23:20:10.219138|2017-10-10 23:20:10.219138
NCT02436681|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-07-14|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Miromatrix Biological Mesh for Hiatal Hernia Repair|A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Hiatal Hernia Repair|Active, not recruiting||N/A|50|Anticipated|Miromatrix Medical Inc.||1|||f||||f||||||||||2017-10-10 23:20:10.326041|2017-10-10 23:20:10.326041
NCT02436668|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-08-22|||May 2015||2015-05-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)|A Randomized, Multicenter, Double-blind, Placebo-controlled, Phase 2/3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2/Phase 3|429|Actual|Pharmacyclics LLC.||2|||f||||t||||||||||2017-10-10 23:20:10.420479|2017-10-10 23:20:10.420479
NCT02436655|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-05-02|||May 2015||2015-05-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|May 2018|Anticipated|2018-05-01||Interventional|AVATAR||Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis|Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: (AVATAR Trial): A Multicentre Randomized Controlled Trial|Recruiting||N/A|312|Anticipated|Clinical Centre of Serbia||2|||f||||t||||||||||2017-10-10 23:20:10.819783|2017-10-10 23:20:10.819783
NCT02436642|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-05-18|||May 2015||2015-05-01|May 2015|2015-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||AVERT Plus Post-Market Registry|AVERT Plus Post-Market Registry|Terminated||N/A|20|Actual|Osprey Medical, Inc|||1|business decision|f||||f||||||||No||2017-10-10 23:20:11.089763|2017-10-10 23:20:11.089763
NCT02436629|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-07-05|||May 2015||2015-05-01|March 2016|2016-03-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|NITR-ITE||Nitrate for High Intensity Intermittent Exercise|The Effect of Nitrate Supplementation on Sport Performance: High Intensity Intermittent Performance in Recreational Athletes|Completed||Phase 4|40|Actual|Maastricht University Medical Center||2|||f||||f||||||||No||2017-10-10 23:20:11.208191|2017-10-10 23:20:11.208191
NCT02436616|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-02-26|||January 2013||2013-01-01|November 2014|2014-11-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|||microEEG for Neonatal Apnea, Bradycardia and Desaturation|Wireless Novel microEEG for Neonatal Apnea and Community Neurological Network|Unknown status|Recruiting|N/A|50|Anticipated|Bio-Signal Group Corp.|||1||f||||t||||||||||2017-10-10 23:20:11.298807|2017-10-10 23:20:11.298807
NCT02436603|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-12-02|||April 2015||2015-04-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Integrative Approaches to Managing Irritable Bowel Syndrome (IBS)|Integrative Approaches to Managing Irritable Bowel Syndrome (IBS)|Recruiting||N/A|86|Anticipated|Beth Israel Medical Center||2|||f||||t||||||||||2017-10-10 23:20:11.388217|2017-10-10 23:20:11.388217
NCT02436590|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-09-12|||July 2016||2016-07-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee|A Prospective, Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee|Enrolling by invitation||N/A|150|Anticipated|Orthofix Inc.||2|||f||||f||||||||||2017-10-10 23:20:11.464375|2017-10-10 23:20:11.464375
NCT02436577|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-11-14|2016-08-16||June 2015||2015-06-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Per the Participant Screening Log a total of 51 subjects underwent screening visits and 7 subjects were considered screen failures. Of the 44 subjects who were determined eligible, 1 withdrew consent and 1 was not needed as the study was filled. Hence, only 42 subjects were randomized and received treatment.|Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects|An Open-label, Randomized, Three-period, Three-treatment, Crossover, Single-centre, Single-dose Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Healthy Japanese Subjects.|Completed||Phase 1|51|Actual|AstraZeneca||6|||f||||f||||||||||2017-10-10 23:20:11.555368|2017-10-10 23:20:11.555368
NCT02436564|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-07-13|||July 2015||2015-07-01|July 2016|2016-07-01||||September 2018|Anticipated|2018-09-01||Observational|||In Vitro Models of Liver and Pancreatic Cancer|A Study Designed to Develop in Vitro Models of Liver, Biliary and Pancreatic Cancer for the Investigation of Tumour Biology and Potential Therapies|Recruiting||N/A|75|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     fresh tissue, frozen tissue   "|||2017-10-10 23:20:12.523241|2017-10-10 23:20:12.523241
NCT02436551|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-08-28|||September 2015||2015-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|GESDICA||Gestational Diabetes in Central Asia: Prevalence and Management|Gestational Diabetes in Central Asia: Prevalence and Management|Active, not recruiting||N/A|3200|Actual|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||||2017-10-10 23:20:12.598355|2017-10-10 23:20:12.598355
NCT02436538|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-12-03|||April 2015||2015-04-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Correlation Between Serum Anti-Müllerian Hormone & Müllerian Ducts Anomalies in Infertility|Correlation Between Serum Anti-Müllerian Hormone (AMH) Levels & Müllerian Ducts Anomalies in Patients Undergoingintracytoplasmic Sperm Injection (ICSI)|Completed||N/A|226|Actual|Kasr El Aini Hospital|||1||f||||f||||||||||2017-10-10 23:20:12.672964|2017-10-10 23:20:12.672964
NCT02436525|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2015-05-05|||March 2015||2015-03-01|February 2015|2015-02-01||||April 2016|Anticipated|2016-04-01||Interventional|||Microbial and Periodontal Changes Associated With Conventional Versus Self Ligating Brackets|Faculty of Dental Medicine, Boys, Cairo Al-Azhar University|Unknown status|Recruiting|N/A|45|Anticipated|Al-Azhar University||3|||f||||f||||||||||2017-10-10 23:20:12.75938|2017-10-10 23:20:12.75938
NCT02436512|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-09-03|||June 2015||2015-06-01|June 2015|2015-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|EAGLE||Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide|A Phase 3 Open-label Multi-Center, Two-Part Single-arm Study to Evaluate the Acute Vasodilation Response of Inhaled Nitric Oxide as a Predictor of Successful Wean From Parental Prostacyclins in Subjects With Pulmonary Arterial Hypertension|Withdrawn||Phase 3|0|Actual|Geno LLC||1||Inability meet enrollment in study population.|f||||t||||||||||2017-10-10 23:20:12.844469|2017-10-10 23:20:12.844469
NCT02436499|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-09-14|||July 2015||2015-07-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes.|"Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes."|Completed||Phase 4|12|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-10 23:20:12.936159|2017-10-10 23:20:12.936159
NCT02436486|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-09-21|||May 2015||2015-05-01|September 2015|2015-09-01||||August 2015|Actual|2015-08-01||Interventional|||Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men|Interventional, Randomised, Double-blind, Placebo- and Positive Controlled, Single-dose, Cross-over Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men|Completed||Phase 1|76|Actual|H. Lundbeck A/S||4|||f||||t||||||||||2017-10-10 23:20:13.021659|2017-10-10 23:20:13.021659
NCT02436473|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2015-08-10|||December 2015||2015-12-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries Model|Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries Model|Withdrawn||N/A|0|Actual|GlaxoSmithKline||4||This study was cancelled. No subjects were enrolled and no data has been collected|f||||f||||||||||2017-10-10 23:20:13.117212|2017-10-10 23:20:13.117212
NCT02436460|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-03-28|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant|A Phase Ib Treatment Trial Using AbGn-168H to Treat Steroid Refractory Acute Graft-vs.-Host Disease (aGVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation|Terminated||Phase 1|4|Actual|AbGenomics B.V Taiwan Branch||1||Re-initiate a new trial per the discussion with FDA|f||||t||||||||No||2017-10-10 23:20:13.205655|2017-10-10 23:20:13.205655
NCT02436447|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-11-17|||May 2015||2015-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function|A Phase 1, 7 Day Repeat Dose, Parallel-Group, Open-Label Study to Evaluate the Safety and Pharmacokinetics of Intravenous Infusion of MTP-131 Administered in Subjects With Impaired Renal Function|Completed||Phase 1|23|Actual|Stealth BioTherapeutics Inc.||4|||f||||f||||||||||2017-10-10 23:20:13.288748|2017-10-10 23:20:13.288748
NCT02436434|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-11-30|||May 2015||2015-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||The Effect of Intra-articular Pulsed Radiofrequency in Osteoarthritis|The Effect of Intra-articular Pulsed Radiofrequency in Osteoarthritis|Withdrawn||N/A|0|Actual|Tri-Service General Hospital||2||The effect is poor|f||||t||||||||||2017-10-10 23:20:13.372351|2017-10-10 23:20:13.372351
NCT02436421|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2016-11-29|||June 2015||2015-06-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Impact of Best Practice Alerts in Cardiology Outpatient Clinics|Impact of Best Practice Alerts in Cardiology Outpatient Clinics|Completed||N/A|7000|Anticipated|Duke University||3|||f||||f||||||||||2017-10-10 23:20:13.457396|2017-10-10 23:20:13.457396
NCT02436408|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-09-14|||May 2015||2015-05-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|VISORB||VISmodegib for ORbital and Periocular Basal Cell Carcinoma|VISmodegib for ORbital and Periocular Basal Cell Carcinoma (VISORB)|Recruiting||Phase 4|50|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:20:13.526401|2017-10-10 23:20:13.526401
NCT02436395|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2015-05-03|||May 2015||2015-05-01|May 2015|2015-05-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Povidone-iodine and the Normal Saline Cleaning the Incision for the SSIs|Comparison the Influence of the Povidone-iodine or the Normal Saline Cleaning the Incision for the Incidence of the Surgical Site Infections for Gastric Cancer Patients With Gastrectomy- Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|340|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-10 23:20:13.607583|2017-10-10 23:20:13.607583
NCT02436382|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-05-10|||February 2015||2015-02-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|HEAT||Hypothermia and the Effect of Ambient Temperature|The Impact of Ambient Operative Room Temperature on Neonatal and Maternal Hypothermia|Completed||N/A|846|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-10 23:20:13.708726|2017-10-10 23:20:13.708726
NCT02436369|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2015-05-03|||September 2014||2014-09-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||The Effect of Yogurt Enriched With Flaxseed on Cardiovascular Risk Factors in Type 2 Diabetic Patients|The Effect of Yogurt Enriched With Flaxseed on Cardiovascular Risk Factors in Type 2 Diabetic|Completed||N/A|70|Actual|Urmia University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:20:13.788353|2017-10-10 23:20:13.788353
NCT02436356|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-08-14|||April 2015||2015-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||New Tools for Assessing Fracture Risk|New Tools for Assessing Fracture Risk|Enrolling by invitation||N/A|100|Anticipated|Vanderbilt University Medical Center||3|||f||||t|f|t|f|f||||||2017-10-10 23:20:13.880334|2017-10-10 23:20:13.880334
NCT02436343|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2017-01-30|||June 2015||2015-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Cardiac Performance in Pregnant Obese Women:Are They in Jeopardy?|Cardiac Performance in Pregnant Obese Women:Are They in Jeopardy?|Active, not recruiting||N/A|200|Anticipated|Benha University|||2||f||||f||||||||No||2017-10-10 23:20:13.979711|2017-10-10 23:20:13.979711
NCT02435992|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-07-13|||May 31, 2015|Actual|2015-05-31|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis|Recruiting||Phase 3|900|Anticipated|Celgene||2|||f||||t||||||||||2017-10-10 23:20:18.181977|2017-10-10 23:20:18.181977
NCT02436330|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-11-05|2015-05-28||March 2011||2011-03-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||The subjects were enrolled sequentially and randomized 2:1 into two arms: the intervention group receiving both didactic and exergaming physical activity curriculum and the control group, who received didactic curriculum only. The control group were offered participation in the exergaming activities 6 months after randomization.|Exergaming for Health: Impact of a Community-Based Active Video Gaming Curriculum in Pediatric Weight Management|Exergaming for Health: Impact of a Community-Based Active Video Gaming Curriculum in Pediatric Weight Management|Completed||N/A|84|Actual|University of Illinois at Chicago|Limitations: incomplete data collection (baseline & follow-up), those lost to follow-up may have been unwilling to continue because of weight gain, low enrollment numbers, and control subjects were offered intervention activities after 6 months.|2|||f||||f||||||||||2017-10-10 23:20:14.105409|2017-10-10 23:20:14.105409
NCT02436317|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-03-15|||July 2015||2015-07-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Point of Care Ultrasonography|Influence of Point of Care Ultrasonography on Outcome of Inpatients Admitted To the Internal Ward|Recruiting||N/A|60|Anticipated|Soroka University Medical Center||2|||f||||t||||||||||2017-10-10 23:20:14.858195|2017-10-10 23:20:14.858195
NCT02436304|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-04|2017-07-28|2017-07-28||June 19, 2015|Actual|2015-06-19|July 2017|2017-07-01|August 4, 2016|Actual|2016-08-04|August 4, 2016|Actual|2016-08-04||Interventional||This analysis population includes all randomized participants, including those who underwent concurrent adenoidectomy and/or tonsillectomy (Intent-to-treat (ITT) analysis set)|Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2|Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion|Completed||Phase 3|404|Actual|Alcon Research||3|||f||||f||||||||||2017-10-10 23:20:15.125061|2017-10-10 23:20:15.125061
NCT02436291|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-05-05|||October 2014||2014-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis|Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis|Unknown status|Recruiting|Phase 4|50|Anticipated|MB Mazor Ltd.||1|||f||||f||||||||||2017-10-10 23:20:15.477796|2017-10-10 23:20:15.477796
NCT02436278|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-04-24|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|IPFMORT||The Predictive Ability of 4MGS in IPF|Does 4 Metre Gait Speed (4MGS) Predict Mortality and Non-elective Hospitalisation in Patients With Idiopathic Pulmonary Fibrosis (IPF)?|Active, not recruiting||N/A|132|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:20:15.5994|2017-10-10 23:20:15.5994
NCT02436265|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-09-07|||February 2015||2015-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|June 23, 2017|Actual|2017-06-23||Interventional|||Low Dose IV Dexamethasone in Prolonging Caudal Anesthesia in Children Undergoing Genitourinary Surgery|Low Dose IV Dexamethasone in Prolonging Caudal Anesthesia in Children Undergoing Genitourinary Surgery|Terminated||Phase 4|2|Actual|Indiana University||2||Lack of enrollment/lack of potential subjects fitting criteria|f||||f||||||||||2017-10-10 23:20:15.684383|2017-10-10 23:20:15.684383
NCT02436252|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-03-01|||May 2015||2015-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MDS||Study of DSP-7888 in Patients With Myelodysplastic Syndrome|Phase 1/2 Study of DSP-7888 in Patients With Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1/Phase 2|54|Anticipated|Sumitomo Dainippon Pharma Co., Ltd.||1|||f||||||||||||||2017-10-10 23:20:15.798367|2017-10-10 23:20:15.798367
NCT02436239|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-02-07|||May 2015||2015-05-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|VLZ-MD-23||A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder|An Open-label Long-term Safety Study of Vilazodone in Pediatric Patients With Major Depressive Disorder|Recruiting||Phase 3|250|Anticipated|Forest Laboratories||1|||f||||f||||||||||2017-10-10 23:20:15.927331|2017-10-10 23:20:15.927331
NCT02436226|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-02|2017-05-08|||May 2015||2015-05-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS|Use of Low Dose of Human Chorionic Gonadotropin During Ovulation Induction With Clomiphene Citrate in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome|Recruiting||Phase 4|100|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 23:20:16.154557|2017-10-10 23:20:16.154557
NCT02436213|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-10-21|||April 2011||2011-04-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs|Hypoxemia, Dyspnea, and Exercise Tolerance in Patients With Pulmonary Arteriovenous Malformations|Unknown status|Recruiting|N/A|90|Anticipated|Imperial College London||3|||f||||f||||||||||2017-10-10 23:20:16.287554|2017-10-10 23:20:16.287554
NCT02436200|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-12-01|||December 2014||2014-12-01|August 2015|2015-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|IC||Neuromuscular Electrical Stimulation (NMES) in Patients With Intermittent Claudication|Neuromuscular Electrical Stimulation in Patients With Intermittent Claudication|Completed||N/A|21|Actual|Imperial College London||1|||f||||t||||||||||2017-10-10 23:20:16.400085|2017-10-10 23:20:16.400085
NCT02436187|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-05-01|||January 2003||2003-01-01|May 2015|2015-05-01||||June 2013|Actual|2013-06-01|10 Years|Observational [Patient Registry]|||Guideline Recommended Care and Excess Mortality for Non ST-elevation Myocardial Infarction : A National Cohort Study|Guideline Recommended Care and Excess Mortality for Non ST-elevation Myocardial Infarction : A National Cohort Study|Completed||N/A|389057|Actual|University of Leeds|||1||f||||f||||||||||2017-10-10 23:20:16.505376|2017-10-10 23:20:16.505376
NCT02436174|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-02-28|||October 2014||2014-10-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Observational|||Assessment Of Shivering With iSeismograph|Assessment Of Shivering With iSeismograph In Parturients Undergoing Surgical Procedures Under Epidural Anesthesia|Completed||N/A|20|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-10 23:20:16.574564|2017-10-10 23:20:16.574564
NCT02436161|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-05-03|||May 2011||2011-05-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|May 2013|Actual|2013-05-01||Interventional|PROMIC||Effectiveness of a Multidisciplinary Care Management Program for High-risk Patients With Heart Failure (PROMIC)|Effectiveness of a Multidisciplinary Care Management Program for High-risk Patients Who Are Admitted at Hospital Because of Heart Failure (PROMIC)|Completed||Phase 2|250|Actual|Basque Health Service||2|||f||||t||||||||||2017-10-10 23:20:16.645664|2017-10-10 23:20:16.645664
NCT02436122|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-17|||May 2015||2015-05-01|May 2015|2015-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer|Prospective Cohort Study for the Impact of Preoperative Glycemic Control Status Measured by HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer|Recruiting||N/A|264|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-10 23:20:16.910225|2017-10-10 23:20:16.910225
NCT02436109|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-11-15|||October 2014||2014-10-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Ultrasound Guidance for Epidural Analgesia and Anesthesia|Ultrasound Guidance for Epidural Analgesia and Anesthesia|Terminated||N/A|10|Actual|University of British Columbia|||1|study device broke|f||||f||||||||||2017-10-10 23:20:16.981186|2017-10-10 23:20:16.981186
NCT02436096|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-09-23|||April 2015||2015-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|AFFIRM||A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia|A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia|Completed||Phase 3|519|Actual|Tonix Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:20:17.059049|2017-10-10 23:20:17.059049
NCT02436083|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-05-05|||July 2007||2007-07-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|June 2012|Actual|2012-06-01||Interventional|||Antibiotics in Free Flaps Reconstructions|The Value of Perioperative Antibiotics on the Success of Oral Free Flap Reconstructions|Completed||Phase 4|350|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-10 23:20:17.255069|2017-10-10 23:20:17.255069
NCT02436070|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-05-05|||October 2014||2014-10-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Use of Text Messages to Improve Care For Children Following an ED Visit for Asthma|Use of Text Messages to Improve Care For Children Following an ED Visit for Asthma|Unknown status|Active, not recruiting|N/A|195|Anticipated|Children's Hospitals and Clinics of Minnesota||2|||f||||f||||||||||2017-10-10 23:20:17.332956|2017-10-10 23:20:17.332956
NCT02436057|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2016-01-13|||July 2014||2014-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform|Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform|Completed||N/A|255|Actual|Cedars-Sinai Medical Center||2|||f||||||||||||||2017-10-10 23:20:17.4053|2017-10-10 23:20:17.4053
NCT02436044|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2017-01-14|||April 2015||2015-04-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Expanded Access|||HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC|Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced Hepatocellular Carcinoma|Available||N/A|||Sun Yat-sen University|||||f||||||||||||||2017-10-10 23:20:17.474649|2017-10-10 23:20:17.474649
NCT02436031|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-02-11|2017-02-11||April 2015|Actual|2015-04-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|DESOSA||Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity in Patients With Obstructive Sleep Apnea - Study B|The Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity During Sleep in Patients With Obstructive Sleep Apnea - Study B|Completed||Phase 2|16|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:20:17.549202|2017-10-10 23:20:17.549202
NCT02436018|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-05-01|||March 2015||2015-03-01|May 2015|2015-05-01|November 2016|Anticipated|2016-11-01|March 2016|Anticipated|2016-03-01||Interventional|||WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy|Safety and Efficacy Evaluation of The Nasopharyngeal Airway Embedded With Jet Ventilation Catheter(WEI NASAL JET) Applied for The Sedation of Outpatient Upper Gastrointestinal Endoscopy|Unknown status|Recruiting|N/A|1800|Anticipated|RenJi Hospital||3|||f||||t||||||||||2017-10-10 23:20:17.766408|2017-10-10 23:20:17.766408
NCT02434913|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-03-07|||July 2013||2013-07-01|March 2016|2016-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Expanded Access|||HUD: PIP Joint Implant|HUD: Proximal Interphalangeal (PIP) Joint Implant Finger Prosthesis|No longer available||N/A|||The Hawkins Foundation|||||f||||||||||||||2017-10-10 23:20:17.858479|2017-10-10 23:20:17.858479
NCT02434900|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-05-05|||January 2010||2010-01-01|April 2015|2015-04-01|December 2031|Anticipated|2031-12-01|December 2031|Anticipated|2031-12-01|18 Years|Observational [Patient Registry]|VITAM||Vitamin D and Angiogenic Markers in Odense Child Cohort 1|Vitamin D and Angiogenic Markers in Odense Child Cohort 1: A Prospective Cohort Study on Their Role in Early Pregnancy Adverse Outcome|Active, not recruiting||N/A|2874|Actual|Odense University Hospital|||1||f||||t||||||||||2017-10-10 23:20:17.905917|2017-10-10 23:20:17.905917
NCT02434874|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-12-23|||January 2017||2017-01-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Sacral Nerve Stimulation to Treat Urgency Urinary Incontinence With Wireless Neuromodulation|Randomized, Multi-Center Pivotal Study for Sacral Nerve Stimulation to Treat Refractory Urgency Urinary Incontinence With Wireless Neuromodulation Technology|Not yet recruiting||Phase 3|60|Anticipated|StimGuard, LLC.||2|||f||||t||||||||||2017-10-10 23:20:18.018063|2017-10-10 23:20:18.018063
NCT02436005|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-08-10|||April 2015||2015-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:20:18.109452|2017-10-10 23:20:18.109452
NCT02435966|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-08-08|2015-08-08||May 2013||2013-05-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Interventional|||Dry Needling in Patients With Chronic Neck Pain|Effectiveness of Dry Needling on the Upper Trapezius and the Levator Scapulae in Patients With Chronic Neck Pain: Randomized Clinical Trial|Completed||N/A|131|Actual|European University of Madrid||3|||f||||t||||||||||2017-10-10 23:20:19.102573|2017-10-10 23:20:19.102573
NCT02435953|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2016-10-12|||April 2015||2015-04-01|October 2016|2016-10-01||||May 2023|Anticipated|2023-05-01||Interventional|||TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma|Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Intermediate-stage Hepatocellular Carcinoma|Recruiting||Phase 4|1|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:20:19.512302|2017-10-10 23:20:19.512302
NCT02435940|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-09-13|||June 2014||2014-06-01|September 2017|2017-09-01|June 2037|Anticipated|2037-06-01|June 2037|Anticipated|2037-06-01|20 Years|Observational [Patient Registry]|||Inherited Retinal Degenerative Disease Registry|Foundation Fighting Blindness Registry, My Retina Tracker|Recruiting||N/A|20000|Anticipated|Foundation Fighting Blindness Clinical Research Institute|||1||f||||f||||||||||2017-10-10 23:20:19.605175|2017-10-10 23:20:19.605175
NCT02435927|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-07-31|||August 2014||2014-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin|Phase I Study to Evaluate the Safety and Tolerability of ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin|Recruiting||Phase 1|18|Anticipated|National Cancer Centre, Singapore||2|||f||||f||||||||||2017-10-10 23:20:19.718964|2017-10-10 23:20:19.718964
NCT02435914|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-03-17||2017-03-17|June 2015||2015-06-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease||Completed||Phase 2|236|Actual|Allergan||4|||f||||f||||||||||2017-10-10 23:20:19.828146|2017-10-10 23:20:19.828146
NCT02435901|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-05-12|||December 2008||2008-12-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity|ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH HIGH RISK HEMOGLOBINOPATHIES LIKE SICKLE CELL DISEASE AND β-THALESSEMIA-MAJOR USING REDUCED INTENSITY CONDITIONING REGIMEN|Recruiting||Phase 1/Phase 2|29|Anticipated|Northwell Health||1|||f||||t||||||||Yes|Outcome data to include study findings.|2017-10-10 23:20:20.626066|2017-10-10 23:20:20.626066
NCT02435888|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-03|2015-05-05|||December 2012||2012-12-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Predictive Equations for Resting Energy Expenditure|Accuracy and Agreement of Predictive Equations for Resting Energy Expenditure Among Overweight Patients With Polycystic Ovary Syndrome|Completed||N/A|30|Actual|Federal University of Minas Gerais|||1||f||||f||||||||||2017-10-10 23:20:20.743371|2017-10-10 23:20:20.743371
NCT02435862|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-05-05|||April 2015||2015-04-01|April 2015|2015-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy|Protocol PVD-202: A Phase 2, Randomized, Double-Masked, Placebo-Controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD in Non-Proliferative Diabetic Retinopathy|Unknown status|Recruiting|Phase 2|100|Anticipated|Allegro Ophthalmics, LLC||4|||f||||t||||||||||2017-10-10 23:20:20.912297|2017-10-10 23:20:20.912297
NCT02435849|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-09-28|||April 8, 2015|Actual|2015-04-08|September 2017|2017-09-01|March 3, 2022|Anticipated|2022-03-03|December 15, 2017|Anticipated|2017-12-15||Interventional|ELIANA||Determine Efficacy and Safety of CTL019 in Pediatric Patients With Relapsed and Refractory B-cell ALL|A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Pediatric Patients With Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia|Recruiting||Phase 2|100|Anticipated|Novartis||1|||f||||t|t|f||||||||2017-10-10 23:20:21.036006|2017-10-10 23:20:21.036006
NCT02435836|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-08-18|2015-07-01||April 1998||1998-04-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia|An Open-Label Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia|Terminated||Phase 3|631|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|The study was terminated prematurely by the sponsor. The protocol specified that the study would run until Abilify (aripiprazole) was commercially available in all site countries.|1||Study terminated when aripiprazole available commercially per protocol|f||||f||||||||||2017-10-10 23:20:21.258204|2017-10-10 23:20:21.258204
NCT02435823|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-06-30|||March 2015||2015-03-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|AWARD||Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial Aneurysms|Adjunctive Wide-neck Aneurysm Reconstruction Device Post Market Clinical Study Europe|Unknown status|Recruiting|N/A|35|Anticipated|Pulsar Vascular||1|||f||||f||||||||||2017-10-10 23:20:24.860303|2017-10-10 23:20:24.860303
NCT02435810|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-08-22|||April 23, 2015||2015-04-23|August 17, 2017|2017-08-17|November 29, 2060|Anticipated|2060-11-29|November 29, 2025|Anticipated|2025-11-29||Observational|||Inflammatory and Infectious Diseases of the Nervous System|Natural History Study of Inflammatory and Infectious Diseases of the Nervous System|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:20:24.947531|2017-10-10 23:20:24.947531
NCT02435797|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-05-05|||April 2015||2015-04-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction|Effect of Early Administration of Intracoronary Nicorandil Via Thrombus Aspiration Catheter Device During Primary Percutaneous Coronary Intervention for the Patients of Acute ST Segment Elevation Myocardial Infarction|Unknown status|Recruiting|Phase 4|100|Anticipated|Xuzhou Central Hospital||2|||f||||t||||||||||2017-10-10 23:20:25.052418|2017-10-10 23:20:25.052418
NCT02435784|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-09-21|||May 2015||2015-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Two-Way Communication Checklist (2-COM) in First Episode Psychosis Patients in Hong Kong|The Two-Way Communication Checklist (2-COM) in First Episode Psychosis Patients in Hong Kong: an Open Label Randomized Controlled Trial|Completed||N/A|84|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:20:25.183248|2017-10-10 23:20:25.183248
NCT02435771|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-05-10|||July 2011||2011-07-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Efficacy Of Ergocalciferol In Adults According To BMI|Efficacy Of Ergocalciferol In Adults According To BMI|Terminated||Phase 4|44|Actual|Walter Reed National Military Medical Center||3||failed to meet enrollment goals|f||||t||||||||||2017-10-10 23:20:25.28759|2017-10-10 23:20:25.28759
NCT02435758|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-10-18|||April 2015||2015-04-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Multicenter Study on Preservation Versus Excision of Denonvilliers Fascia in L-PANP Surgery||Recruiting||N/A|264|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 23:20:25.374588|2017-10-10 23:20:25.374588
NCT02435745|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-12-10|||April 2015||2015-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|OSA in EDS||Obstructive Sleep Apnoea in Ehlers-Danlos Syndrome|Obstructive Sleep Apnoea in Ehlers-Danlos Syndrome|Completed||N/A|200|Actual|University of Zurich|||2||f||||f||||||||||2017-10-10 23:20:25.469907|2017-10-10 23:20:25.469907
NCT02435732|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-09-26|||May 2018|Anticipated|2018-05-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>85% Organs|A Phase I, Single Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Tolerability of C1 Inhibitor (CINRYZE) as a Donor Pre-treatment Strategy in Brain Dead Donors Who Meet a Kidney Donor Risk Index (KDRI) Above 85%|Not yet recruiting||Phase 1|72|Anticipated|University of Wisconsin, Madison||3|||f||||t|t|f||||||||2017-10-10 23:20:25.678757|2017-10-10 23:20:25.678757
NCT02435719|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-10-12|||October 2014||2014-10-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|WardGel||Alcohol Hand Gel Use in Mbale Regional Referral Hospital: a Cost Effectiveness Evaluation|Effectiveness Evaluation of Alcohol Hand Gel Use in Mbale Regional Referral Hospital, Rural Eastern Uganda|Completed||N/A|3626|Actual|Sanyu Africa Research Institute|||1||f||||f||||||||||2017-10-10 23:20:25.773225|2017-10-10 23:20:25.773225
NCT02435706|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-02-27|||December 2011||2011-12-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Esthetic Outcomes of Single Immediate Implant Placement|Esthetic Outcomes of Single Immediate Implant Placement With Immediate Restoration Performed With Two Surgical Techniques|Active, not recruiting||N/A|39|Actual|Columbia University||2|||f||||f||||||||No||2017-10-10 23:20:25.856129|2017-10-10 23:20:25.856129
NCT02435693|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2015-11-03|||July 2012||2012-07-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|pcp||Pharmaceutical Care Program for Type 2 Diabetes Mellitus|Evaluation of Pharmaceutical Care Program for Type 2 Diabetes Mellitus in Dhule|Completed||N/A|600|Anticipated|R. C. Patel Institute of Pharmaceutical Education & Research||2|||f||||f||||||||||2017-10-10 23:20:25.938146|2017-10-10 23:20:25.938146
NCT02435680|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-09-29|||August 10, 2015|Actual|2015-08-10|September 2017|2017-09-01|January 15, 2019|Anticipated|2019-01-15|March 30, 2018|Anticipated|2018-03-30||Interventional|TNBC||Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)|A Randomized Phase II Study of MCS110 Combined With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)|Active, not recruiting||Phase 2|50|Actual|Novartis||2|||f||||f|t|f||||||||2017-10-10 23:20:26.021646|2017-10-10 23:20:26.021646
NCT02435667|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-03-21|||June 2015||2015-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Resistance Training in HFpEF|Resistance Exercise Training in Heart Failure With Preserved Ejection Fraction (Resist - HFpEF)|Recruiting||N/A|24|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:20:26.164308|2017-10-10 23:20:26.164308
NCT02435654|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-11-30|||August 2015||2015-08-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia|Effects of 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Drug Plasma Concentration on Antipsychotic Response to Olanzapine in Treatment of Early-onset Schizophrenia|Recruiting||Phase 4|150|Anticipated|Kunming Medical University||1|||f||||f||||||||No||2017-10-10 23:20:26.256464|2017-10-10 23:20:26.256464
NCT02435641|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-04-02|||March 2015||2015-03-01|April 2017|2017-04-01|September 2022|Anticipated|2022-09-01|September 2020|Anticipated|2020-09-01||Observational|||Patient and Caregiver Psychological Functioning Following Neuro-ICU Admission: A Prospective Investigation|A Prospective Study to Investigate Relationships Between Patient and Family Caregiver Distress Following Neuroscience ICU Admission|Recruiting||N/A|100|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-10 23:20:26.370026|2017-10-10 23:20:26.370026
NCT02435628|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-04-02|||February 2015||2015-02-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF|Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis|Completed||N/A|86|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-10 23:20:26.467605|2017-10-10 23:20:26.467605
NCT02435615|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-10-26|||January 2016||2016-01-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue Diagnosis|Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue Diagnosis|Recruiting||N/A|100|Anticipated|University of Miami|||1||f||||t||||||||||2017-10-10 23:20:26.544598|2017-10-10 23:20:26.544598
NCT02435602|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2015-05-05|||December 2013||2013-12-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|||The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers|The Role of Narrow Band Imaging (NBI) Endoscopy Compared With Lugol Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers: a Prospective Randomized Study|Unknown status|Recruiting|N/A|300|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||f||||||||||2017-10-10 23:20:26.631992|2017-10-10 23:20:26.631992
NCT02435589|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-05-02|||March 2015||2015-03-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Interventional|||The Effects of a Systematic Pain Assessment Approach on Critically Ill Patients Outcomes in ICU|The Effects of a Systematic Pain Assessment Approach on Critically Ill Patients Outcomes: A Randomized Interventional Clinical Study|Unknown status|Recruiting|N/A|120|Anticipated|Cyprus University of Technology||2|||f||||f||||||||||2017-10-10 23:20:26.738702|2017-10-10 23:20:26.738702
NCT02435576|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-10-19|||March 2007||2007-03-01|October 2016|2016-10-01|January 2028|Anticipated|2028-01-01|January 2025|Anticipated|2025-01-01|5 Years|Observational [Patient Registry]|H&NTOX||Standard Follow-up Program (SFP) for Head and Neck Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation|Standard Follow-up Program (SFP) for Head and Neck Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SFP Head & Neck)|Recruiting||N/A|10000|Anticipated|University Medical Center Groningen|||1||f||||f||||||||No||2017-10-10 23:20:26.850498|2017-10-10 23:20:26.850498
NCT02435563|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-02-06|||August 2014||2014-08-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Dose Adaptation to Offset the Interaction Between Ticagrelor and Ritonavir by Population-based PK Modeling|Dose Adaptation to Offset the Pharmacokinetic Interaction Between Ticagrelor and Ritonavir in Healthy Volunteers by Population-based PK Modeling (Simcyp®)|Completed||Phase 2|22|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 23:20:26.95636|2017-10-10 23:20:26.95636
NCT02435550|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-08-03|||June 26, 2015|Actual|2015-06-26|August 2017|2017-08-01|June 26, 2021|Anticipated|2021-06-26|June 26, 2020|Anticipated|2020-06-26||Interventional|||iCare for Cancer Patients|iCare for Cancer Patients|Recruiting||N/A|435|Anticipated|University of Florida||5|||f||||t|f|f||||||||2017-10-10 23:20:27.041413|2017-10-10 23:20:27.041413
NCT02435537|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-05-05|||May 2013||2013-05-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ITMandDEX||Combined Intrathecal Morphine and Dexmedetomidine Analgesia|Safety and Efficacy of Dexmedetomidine Addition to Intrathecal Morphine for Postoperative Analgesia in Cancer Patients Undergoing Major Abdominal Surgery|Completed||Phase 2/Phase 3|90|Actual|Assiut University||3|||f||||t||||||||||2017-10-10 23:20:27.147591|2017-10-10 23:20:27.147591
NCT02435524|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-08-23|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Alive & Thrive Evaluation in Burkina Faso|Alive & Thrive Evaluation in Burkina Faso|Completed||N/A|2400|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-10 23:20:27.239434|2017-10-10 23:20:27.239434
NCT02435511|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-09-15|||December 2015||2015-12-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|December 2016|Anticipated|2016-12-01||Interventional|||Study the Impact of the CommunityRx Program on Health, Self-care and Cost|Evaluating CommunityRx, a Self-Care Innovation for Older Adults, Using Agent-Based Modeling: Collecting and Analyzing Data to Build the Agent Based Model|Active, not recruiting||N/A|413|Actual|University of Chicago||2|||f||||f||||||||||2017-10-10 23:20:27.324714|2017-10-10 23:20:27.324714
NCT02435498|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-04-19|||September 4, 2015|Actual|2015-09-04|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Web-based Education Module for Pain Management|A Web-based Education Module Versus Standard of Care for Pain Management Following a Fracture in Children: a Randomized Controlled Trial|Completed||N/A|311|Actual|Lawson Health Research Institute||3|||f||||f||||||||No||2017-10-10 23:20:27.398741|2017-10-10 23:20:27.398741
NCT02435485|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-04-12|||October 2014||2014-10-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||The Rehabilitation Outcome of Patients With Lumbar Spondylolisthesis. A Prospective Randomized Study|The Rehabilitation Outcome of Patients With Lumbar Spondylolisthesis. A Prospective Randomized Study|Recruiting||N/A|90|Anticipated|Chang Gung Memorial Hospital||3|||f||||t||||||||No||2017-10-10 23:20:27.478096|2017-10-10 23:20:27.478096
NCT02435472|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-04-03|||October 2016||2016-10-01|April 2017|2017-04-01|April 2025|Anticipated|2025-04-01|April 2020|Anticipated|2020-04-01||Interventional|ASX||Active Surveillance Exercise Clinical Trial|A Randomized Clinical Trial of Exercise vs. Usual Care Among Men Opting for Active Surveillance for Prostate Cancer|Recruiting||Phase 2|150|Anticipated|University of California, San Francisco||3|||f||||f||||||||||2017-10-10 23:20:27.71305|2017-10-10 23:20:27.71305
NCT02435459|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-05-05|||April 2012||2012-04-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effect of Different Lining Strategies on Amalgam Restorations|The Effect of Different Lining Strategies on Amalgam Restorations|Recruiting||N/A|640|Anticipated|University of Birmingham||4|||f||||f||||||||||2017-10-10 23:20:27.817124|2017-10-10 23:20:27.817124
NCT02435446|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-02-13|||October 2015||2015-10-01|February 2017|2017-02-01||||November 2017|Anticipated|2017-11-01||Interventional|TACOS||Cone Beam and CT Scan for the Diagnosis of Otosclerosis (TACOS)|Comparison of Cone Beam With CT Scan for the Diagnosis of Otosclerosis|Recruiting||N/A|133|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||f||||||||||2017-10-10 23:20:27.933815|2017-10-10 23:20:27.933815
NCT02435433|ClinicalTrials.gov processed this data on October 10, 2017|2015-05-01|2017-10-03|||July 2015||2015-07-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|January 2018|Anticipated|2018-01-01||Interventional|REACH-2||A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein|Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ramucirumab and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (AFP) Following First-Line Therapy With Sorafenib|Recruiting||Phase 3|279|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 23:20:28.050022|2017-10-10 23:20:28.050022
NCT02435420|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-08-30|||October 2015||2015-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|HISTORIC||A Retro-prospective Study of Total Hip Arthroplasty With EMPERION Modular Primary Stem in Australian Centres (HISTORIC)|A Retro-prospective Study of Total Hip Arthroplasty With EMPERION Modular Primary Stem in Australian Centres|Suspended||N/A|156|Anticipated|Smith & Nephew, Inc.|||1||f||||f||||||||||2017-10-10 23:20:28.596399|2017-10-10 23:20:28.596399
NCT02435407|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-09-28|||January 2015||2015-01-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|September 2015|Actual|2015-09-01||Interventional|SOS||The Sequential Oral Sensory Approach for Limited Food Repertoire in Children With Autism Spectrum Disorder|The Sequential Oral Sensory (SOS) Intervention in Treating Children With Autism Spectrum Disorder and Limited Food Repertoire|Unknown status|Active, not recruiting|N/A|20|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||f||||||||||2017-10-10 23:20:28.703447|2017-10-10 23:20:28.703447
NCT02435394|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-04-19|||July 2015||2015-07-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|Asthma||Web System for Engaging Families & Doctors in Continuous Asthma Quality Improvement|Web System for Engaging Families & Doctors in Continuous Asthma Quality Improvement|Withdrawn||N/A|0|Actual|Total Child Health, Inc.||3||After IRB review, this study is no longer considered a clinical trial|f||||t||||||||||2017-10-10 23:20:28.790547|2017-10-10 23:20:28.790547
NCT02435381|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2017-07-11|||February 2013||2013-02-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Carisbamate as a Potential Treatment for Alcohol Dependence|Carisbamate as a Potential Treatment for Alcohol Dependence|Active, not recruiting||Phase 1/Phase 2|26|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:20:28.903029|2017-10-10 23:20:28.903029
NCT02435368|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2015-04-30|||April 2015||2015-04-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|November 2015|Anticipated|2015-11-01||Observational|||The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear|The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and Lipopolysaccharide on Interleukin-1β Secretion by Mononuclear|Unknown status|Recruiting|N/A|10|Anticipated|The Third Affiliated Hospital of Southern Medical University|||1||f||||t||||||Samples Without DNA|"     Peripheral blood was obtained from healthy donors,mononuclear cells (PBMCs) were isolated     using Ficoll density gradient centrifugation, and LPS (1 μg/ml) and/or MPA were added. After     12 hours, the supernatants were harvested and stored at -80°C for ELISA.   "|||2017-10-10 23:20:28.991594|2017-10-10 23:20:28.991594
NCT02435355|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-05|||April 2010||2010-04-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Efficiency of a Phone Coaching for Sleep Apnea Hypopnea Syndrome Patients|Efficiency of a Phone Coaching Program on Adherence to Continuous Positive Airway Pressure in Sleep Apnea Hypopnea Syndrome|Completed||N/A|379|Actual|Sadir Association||2|||f||||f||||||||||2017-10-10 23:20:29.093766|2017-10-10 23:20:29.093766
NCT02435342|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-05-01|||October 2014||2014-10-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis|A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 in Active Plaque Psoriasis|Completed||Phase 1|24|Actual|Kineta Inc.||2|||f||||t||||||||||2017-10-10 23:20:29.169855|2017-10-10 23:20:29.169855
NCT02435329|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-03-14|||June 2015||2015-06-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Microcirculation and Bone Metabolism in Patients With Type 2 Diabetes Mellitus and Charcot Foot - A Pilot Study|Bone Metabolism and Endothelial Function in Patients With Type 2 Diabetes Mellitus and Charcot Foot - an Observational Comparative Study|Recruiting||N/A|50|Anticipated|Tameside General Hospital|||5||f||||f||||||Samples Without DNA|"     Analysis of serum samples for markers of endothelial function, inflammation and bone     metabolism   "|||2017-10-10 23:20:29.269549|2017-10-10 23:20:29.269549
NCT02435316|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-05|||April 2012||2012-04-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|PBS||Comparison of Educational Methods for Teaching Peripheral Blood Smears|A Randomized, Controlled Cross Over Trial of Two Educational Methods and Their Additive Effects in the Recognition of Abnormal Peripheral Blood Smears|Completed||N/A|30|Actual|The Reading Hospital and Medical Center||2|||f||||f||||||||||2017-10-10 23:20:29.368241|2017-10-10 23:20:29.368241
NCT02435303|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-07-11|||May 2016||2016-05-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SUPERIOR||Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)|Effect of Sildenafil for the Treatment of Sustained Pulmonary Artery Hypertension After Corrected Mitral Valve Disease|Active, not recruiting||Phase 2/Phase 3|46|Anticipated|Asan Medical Center||2|||f||||||||||||||2017-10-10 23:20:29.44051|2017-10-10 23:20:29.44051
NCT02435290|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-05-01|||March 2014||2014-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Enhancement of the Prediction of Chemotherapy Prescribing Errors for Oncology Patients|Cross-sectional Study to Enhance the Prediction of Prescribing Errors for Oncology Patients|Completed||N/A|500|Actual|Ain Shams University|||1||f||||t||||||||||2017-10-10 23:20:29.505702|2017-10-10 23:20:29.505702
NCT02435264|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-09-21|||October 2014||2014-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2015|Actual|2015-09-01||Interventional|Project CHEW||Choosing Healthier Eating Options at Work and School|Assessing the Barriers and Motivators to Providing and Consuming Healthier Foods in the Singaporean Hawker Center Setting and Evaluating the Healthier Hawker Programme (Now Called the Healthier Dining Program)|Active, not recruiting||N/A|476|Actual|National University, Singapore||2|||f||||f||||||||No||2017-10-10 23:20:29.66204|2017-10-10 23:20:29.66204
NCT02435251|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-01-04|||January 2014||2014-01-01|January 2016|2016-01-01||||April 2016|Anticipated|2016-04-01||Observational|CAS||Changes in Anthropometry Following Ambulatory Orthopaedic Surgery|Changes in Anthropometry Following Ambulatory Orthopaedic Surgery|Active, not recruiting||N/A|100|Anticipated|State University of New York at Buffalo|||1||f||||f||||||||||2017-10-10 23:20:29.71182|2017-10-10 23:20:29.71182
NCT02435238|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-09-27|||September 2014||2014-09-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|AWARE||AWARE - Chronic Urticaria|AWARE: A World-wide Antihistamine-Refractory Chronic Urticaria Patient Evaluation|Recruiting||N/A|250|Anticipated|Novartis|||1||f||||f||||||||||2017-10-10 23:20:29.767113|2017-10-10 23:20:29.767113
NCT02435225|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2015-04-30|||January 2014||2014-01-01|April 2015|2015-04-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Brain Connectivity and Mindfulness Training in Youth With Bipolar Disorder Not Otherwise Specified (NOS)|Brain Connectivity and Mindfulness Training in Youth With Bipolar Disorder NOS|Recruiting||N/A|50|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 23:20:29.850327|2017-10-10 23:20:29.850327
NCT02435212|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-07-27|||October 21, 2015|Actual|2015-10-21|July 2017|2017-07-01|March 29, 2024|Anticipated|2024-03-29|March 29, 2024|Anticipated|2024-03-29||Interventional|||Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload|A Randomized, Open-label, Multicenter, Two Arm, Phase II Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients With Iron Overload|Recruiting||Phase 2|240|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 23:20:30.034839|2017-10-10 23:20:30.034839
NCT02435199|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-08-25|||June 2015||2015-06-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Clinical Trial Designed to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy|A Double-blind, Placebo-controlled, Randomized Trial to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy|Withdrawn||Phase 2|0|Actual|Spinifex Pharmaceuticals Pty Ltd||2|||f||||f||||||||||2017-10-10 23:20:30.24749|2017-10-10 23:20:30.24749
NCT02435186|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-04-30|||June 2015||2015-06-01|April 2015|2015-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer|Recombinant Adenoviral p53 Human Gene Combined With Chemotherapy in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer|Not yet recruiting||Phase 2|100|Anticipated|Shenzhen SiBiono GeneTech Co.,Ltd||2|||f||||f||||||||||2017-10-10 23:20:30.343389|2017-10-10 23:20:30.343389
NCT02435173|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-06-19|||August 25, 2015|Actual|2015-08-25|June 2017|2017-06-01|February 22, 2019|Anticipated|2019-02-22|January 23, 2019|Anticipated|2019-01-23||Interventional|||Study of Efficacy of CDZ173 in Patients With APDS/PASLI|An Open-label, Non-randomized, Within-patient Dose-finding Study Followed by a Randomized, Double-blind Placebo Controlled Study With Extension to Assess the Safety and Efficacy of CDZ173 in Patients With APDS/PASLI (Activated Phosphoinositide 3-kinase Delta Syndrome/ p110δ-activating Mutation Causing Senescent T Cells, Lymphadenopathy and Immunodeficiency)|Recruiting||Phase 2/Phase 3|36|Anticipated|Novartis||1|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 23:20:30.461117|2017-10-10 23:20:30.461117
NCT02435160|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-05-05|||May 2015||2015-05-01|April 2015|2015-04-01||||May 2016|Anticipated|2016-05-01||Interventional|||The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis||Unknown status|Not yet recruiting|Phase 2/Phase 3|20|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||||||||||||2017-10-10 23:20:30.5741|2017-10-10 23:20:30.5741
NCT02435134|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-02-13|||October 7, 2015|Actual|2015-10-07|February 2017|2017-02-01|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Observational|HIRROM||Examination Chair for Hip Internal Rotation Range of Motion Measurement|Validation of a Test Protocol for Measuring the Hip Internal Rotation Range of Motion Using a Newly Developed Examination Chair|Completed||N/A|30|Actual|Schulthess Klinik|||1||f||||f||||||||||2017-10-10 23:20:30.744632|2017-10-10 23:20:30.744632
NCT02435121|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-02-23||2016-02-23|November 2015||2015-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification|Phase II, Open Label, Single Arm Study Assessing the Clinical Benefit of SAR125844, Administered as Single Agent by Weekly Intravenous (IV) Infusion, for the Treatment of Patients With Advanced Pretreated Non-Small Cell Lung Cancer (NSCLC) Harboring MET Gene Amplification|Completed||Phase 2|1|Actual|Sanofi||1|||f||||f||||||||||2017-10-10 23:20:30.818146|2017-10-10 23:20:30.818146
NCT02435108|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-02-16|||May 15, 2014|Actual|2014-05-15|February 2017|2017-02-01|July 15, 2016|Actual|2016-07-15|January 2016|Actual|2016-01-01||Interventional|||A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy|A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy|Completed||Phase 2|2|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:20:30.912481|2017-10-10 23:20:30.912481
NCT02435095|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-09-01|||May 2015||2015-05-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|September 2018|Anticipated|2018-09-01||Interventional|APIC||Antipsychotic Induced Structural and Functional Brain Changes|Are Antipsychotics Neurotoxic or Neuroprotective? A Long-term Comparison of Two Treatment Strategies|Active, not recruiting||Phase 4|544|Anticipated|RWTH Aachen University||2|||f||||t||||||||||2017-10-10 23:20:30.985787|2017-10-10 23:20:30.985787
NCT02435082|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-05-31|||April 2015||2015-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01|6 Months|Observational [Patient Registry]|VARIA||Vascular Assessment of Regulation Index Arrays Registry|Vascular Assessment of Regulation Index Arrays Registry|Completed||N/A|13|Actual|NeuroChaos Solutions, Inc.|||1||f||||f||||||||No||2017-10-10 23:20:31.093599|2017-10-10 23:20:31.093599
NCT02435069|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-04-27|||November 2015||2015-11-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children|A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children|Recruiting||Phase 4|12|Anticipated|Nemours Children's Clinic||2|||f||||t||||||||||2017-10-10 23:20:31.176151|2017-10-10 23:20:31.176151
NCT02435056|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-05|||July 2008||2008-07-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|July 2009|Actual|2009-07-01||Interventional|COMOESTAS||Medication Overuse Headache (MOH) and an Innovative Approach|Continuous Monitoring of Medication Overuse Headache in Europe and Latin America: Development and STAndardization of an Alert and Decision Support System|Completed||N/A|690|Actual|"IRCCS National Neurological Institute C. Mondino Foundation"||2|||f||||f||||||||||2017-10-10 23:20:31.326228|2017-10-10 23:20:31.326228
NCT02435043|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-09-28|||August 2012||2012-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|May 2015|Actual|2015-05-01||Interventional|NASTRU||A Trial of Nature-based Post-stroke Fatigue Rehabilitation (NASTRU)|A Randomized Controlled Trial of Nature-based Post-stroke Fatigue Rehabilitation (NASTRU)|Active, not recruiting||N/A|101|Actual|Region Skane||2|||f||||f||||||||||2017-10-10 23:20:31.419795|2017-10-10 23:20:31.419795
NCT02435030|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-05-17|||September 2015||2015-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C|A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C in Order to Characterise the Individual Patient Disease Profile and Historic Signo-symptomatology Progression Pattern|Completed||N/A|35|Actual|Orphazyme|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:20:31.51878|2017-10-10 23:20:31.51878
NCT02435017|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-03-15|||January 2003||2003-01-01|March 2016|2016-03-01|July 2009|Actual|2009-07-01|December 2006|Actual|2006-12-01||Observational|||Dietary Phosphate and Serum Phosphorus|Nutrition Risk Screening in Chronic Kidney Disease (CKD) From the National Health and Nutrition Examination Survey|Completed||N/A|7895|Actual|The Methodist Hospital System|||1||f||||f||||||||Undecided|Plan to share data to be determined.|2017-10-10 23:20:31.631398|2017-10-10 23:20:31.631398
NCT02435004|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-04-06|||April 2015||2015-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|NSI-TD-002||Dorsal Root Ganglion Stimulation for the Management of Painful Intractable Small Fibre Neuropathy:|Clinical Study Protocol Dorsal Root Ganglion Stimulation for the Management of Painful Intractable Small Fibre Neuropathy|Recruiting||N/A|31|Anticipated|Ospedale Regionale di Lugano||1|||f||||f||||||||||2017-10-10 23:20:31.713637|2017-10-10 23:20:31.713637
NCT02434991|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-09-12|||October 2016||2016-10-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Sensorimotor Dysfunction in Achalasia|Sensorimotor Dysfunction in Achalasia|Not yet recruiting||N/A|50|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:20:31.797155|2017-10-10 23:20:31.797155
NCT02434978|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-04-19|||January 2014||2014-01-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding||Recruiting||N/A|125|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:20:31.874598|2017-10-10 23:20:31.874598
NCT02434965|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-05-05|||August 2017|Anticipated|2017-08-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|HPDSC+HIE||Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy|A Safety and Feasibility Study of Autologous Cord Blood (CB) and Human Placental Derived Stem Cells (HPDSC) in Neonates With Severe Hypoxic-Ischemic Encephalopathy (HIE)|Not yet recruiting||Phase 2|20|Anticipated|New York Medical College||1|||f||||f|t|f||||||Undecided||2017-10-10 23:20:31.962867|2017-10-10 23:20:31.962867
NCT02434952|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-08-22|||October 2014||2014-10-01|August 2016|2016-08-01||||July 2016|Actual|2016-07-01||Interventional|||Safety and Tolerability of Low Dose Primaquine|The Tolerability and Safety of Low Dose Primaquine for Transmission Blocking in Symptomatic Falciparum Infected Cambodians|Completed||Phase 4|109|Actual|Malaria Consortium||4|||f||||t||||||||||2017-10-10 23:20:32.053819|2017-10-10 23:20:32.053819
NCT02434939|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-06-22|2016-04-27||June 2015||2015-06-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|KEM-VOC||Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers|Low-dose Ketamine Versus Morphine for Severe Painful Sickle Cell Crises in Children at Mulago Hospital: A Randomised Controlled Trial|Completed||Phase 4|240|Actual|Makerere University|single centre trial could limit generizability, ketamine specific side effects (nystagmus) led to potential unblinding and NRS and RSS not validated for use|2|||f||||t||||||||||2017-10-10 23:20:32.180962|2017-10-10 23:20:32.180962
NCT02434926|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-08-11|||May 2015||2015-05-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Anesthetic Management in Fetoscopic Surgery and Incidence of Complications|Anesthetic Management in Fetoscopic Surgery and Incidence of Complications - A Retrospective Review|Completed||N/A|152|Actual|Mahidol University|||1||f||||t||||||||Undecided||2017-10-10 23:20:32.676846|2017-10-10 23:20:32.676846
NCT02434861|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-08-21|||May 2015||2015-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects|An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (1.8 mg/mL Rolapitant IV Solution) on the Pharmacokinetics of Digoxin (P-gp); Sulfasalazine (BCRP); and the Cooperstown Cocktail (Midazolam [CYP3A4], Omeprazole [CYP2C19], Warfarin [CYP2C9], Caffeine [CYP1A2], and Dextromethorphan [CYP2D6]) in Healthy Subjects|Completed||Phase 1|102|Actual|Tesaro, Inc.||3|||f||||f||||||||||2017-10-10 23:20:32.747656|2017-10-10 23:20:32.747656
NCT02434848|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-05-04|||August 2015||2015-08-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses|A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses|Recruiting||Phase 2/Phase 3|30|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:20:32.826592|2017-10-10 23:20:32.826592
NCT02434835|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-04-15||||||April 2016|2016-04-01||||May 2015|Actual|2015-05-01||Interventional|||Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects||Completed||Phase 1|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-10 23:20:32.904542|2017-10-10 23:20:32.904542
NCT02434822|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-23|||April 2015||2015-04-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Interventional|||A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic|Safety and Immunogenicity of Two Doses of Oral Cholera Vaccine (ShancholTM) in Subjects Aged 1 Year and Older in Dominican Republic|Completed||Phase 3|336|Actual|Sanofi||3|||f||||f||||||||||2017-10-10 23:20:32.977161|2017-10-10 23:20:32.977161
NCT02434484|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-08-23|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Symbenda Post-Marketing Surveillance (PMS)|Post-Marketing Surveillance of Symbenda Injection (Bendamustine Hydrochloride) in Korean Patients|Not yet recruiting||N/A|600|Anticipated|Eisai Inc.|||1||f|||||f|f||||||||2017-10-10 23:20:35.973344|2017-10-10 23:20:35.973344
NCT02434809|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-06-09|||April 2015||2015-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies|Investigation of Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies|Recruiting||N/A|19|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:20:33.061534|2017-10-10 23:20:33.061534
NCT02434796|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-03-16|||May 2015||2015-05-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Interventional|TEVAW||Study of the Preliminary Effect of TEVAW: a Program to Address Intimate Partner Violence in Northern Tanzania|A Mixed Methods Study to Test the Preliminary Effect of Together to End Violence Against Women (TEVAW): a Program to Address Intimate Partner Violence in Northern Tanzania|Completed||N/A|900|Actual|Boston University||2|||f||||f||||||||||2017-10-10 23:20:33.138589|2017-10-10 23:20:33.138589
NCT02434783|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-04|||May 2015||2015-05-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||The Relationship Between Peripheral Arterial Disease and Mitochondrial Respiratory Capacity|The Relationship Between Peripheral Arterial Disease and Mitochondrial Respiratory Capacity|Completed||N/A|16|Actual|Norwegian University of Science and Technology|||4||f||||f||||||Samples With DNA|"     gastrocnemicus muscle biopsy   "|||2017-10-10 23:20:33.213122|2017-10-10 23:20:33.213122
NCT02434770|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-30|||August 2015||2015-08-01|March 2016|2016-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine|A Phase III Single-blind, Randomized, Controlled Study in Healthy Kenyan Infants to Assess the Immunogenicity and Safety of Beijing TiantanBio Liquid Bivalent Oral Poliomyelitis Vaccine in Comparison to a WHO Prequalified Comparator|Completed||Phase 3|750|Actual|PATH||3|||f||||f||||||||||2017-10-10 23:20:33.40409|2017-10-10 23:20:33.40409
NCT02434757|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-04-30|||February 2014||2014-02-01|September 2014|2014-09-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis|Addition of H. P Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis Inadequately Controlled With Biologic Disease-Modifying Antirheumatic Drugs|Unknown status|Recruiting|N/A|10|Anticipated|Phase III Clinical Research||1|||f||||t||||||||||2017-10-10 23:20:33.505956|2017-10-10 23:20:33.505956
NCT02434744|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-04-13||2016-03-15|April 2015||2015-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|121|Actual|Kadmon Corporation, LLC||8|||f||||f||||||||||2017-10-10 23:20:33.630925|2017-10-10 23:20:33.630925
NCT02434731|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-08-05|||April 2015||2015-04-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Vibration and Cold for Pain Relief During Peripheral Intravenous Cannulation in Children With Intellectual Disability|Randomized Controlled Trial to Evaluate the Effectiveness of Vibration and External Cold (Buzzy Device) for Pain Relief During Venipuncture or Intravenous Cannulation in Children With Intellectual Disability.|Completed||Phase 3|71|Actual|IRCCS Burlo Garofolo||2|||f||||f||||||||||2017-10-10 23:20:33.772365|2017-10-10 23:20:33.772365
NCT02434718|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-04-07|||June 30, 2015|Actual|2015-06-30|April 2017|2017-04-01|December 9, 2016|Actual|2016-12-09|December 9, 2016|Actual|2016-12-09||Interventional|PROPEL||Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Aducanumab (BIIB037) in Japanese Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|21|Actual|Biogen||4|||f||||t||||||||||2017-10-10 23:20:33.86282|2017-10-10 23:20:33.86282
NCT02434692|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-08-16|||May 2014||2014-05-01|August 2017|2017-08-01|April 11, 2017|Actual|2017-04-11|April 11, 2017|Actual|2017-04-11||Interventional|||Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)|A Prospective, Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of the ARGOS-IO System in Patients With Primary Open Angle Glaucoma (POAG)|Completed||N/A|22|Actual|Implandata Ophthalmic Products GmbH||1|||f||||t||||||||||2017-10-10 23:20:34.05851|2017-10-10 23:20:34.05851
NCT02434679|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-29|||October 2014||2014-10-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|DAIR3N||Dynamic of the Acquisition of Antibiotic Resistance in Integrons in Neonatology Newborns|Dynamic of the Acquisition of Antibiotic Resistance in Integrons in Neonatology Newborns|Completed||N/A|278|Actual|University Hospital, Limoges|||1||f||||f||||||Samples With DNA|"     The meconium or the first stool will be sampled at D0. The stool will then be sampled: at D7,     at D21 and every 15 days until the day of discharge.      If the NB has no stool on the given day, a period of 3 more days will be accepted from the     day the sampling was planned. After this period, no sample will be stated.      Meconiums and stool must be sampled in sterile jars, labelled and sent with the designation     DAIR3N protocol to the bacteriology laboratory of each center. If the local laboratory     cannot seed the samples 7 days a week, stool samples can be kept maximum 48h at +4°C before     management.      In the mother      Vaginal sample will be taken during the delivery according to care practices of each center     if:      it is a preterm vaginal delivery, early membrane rupture happens, there is a threat of very     preterm delivery. About 55% of inclusions should be subject to this type of sampling.     Sampling of mother's stool will be asked at the inclusion.   "|||2017-10-10 23:20:34.158463|2017-10-10 23:20:34.158463
NCT02434471|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-03-23|||January 12, 2016|Actual|2016-01-12|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Single Breath Hold Abdominal MRI|Single Breath Hold Abdominal MRI|Recruiting||N/A|100|Anticipated|Duke University||2|||f||||||||||||||2017-10-10 23:20:36.065846|2017-10-10 23:20:36.065846
NCT02434666|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-09-18|||January 8, 2015|Actual|2015-01-08|September 2017|2017-09-01|November 22, 2016|Actual|2016-11-22|October 18, 2016|Actual|2016-10-18||Interventional|||Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07|Safety and Tolerability of CPC-201 in Patients With Dementia of the Alzheimer's Type Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07|Completed||Phase 2|21|Actual|Chase Pharmaceuticals Corporation||1|||f||||t|t|f||||||||2017-10-10 23:20:34.234854|2017-10-10 23:20:34.234854
NCT02434653|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-07-12|||June 2015||2015-06-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries|A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries - Hemoglobin Screening in High Risk Population Versus by Symptoms|Completed||N/A|1679|Actual|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-10 23:20:34.320977|2017-10-10 23:20:34.320977
NCT02434640|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-05-18|||April 2015||2015-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women|Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women|Completed||Phase 1|51|Actual|Bayer||5|||f||||f||||||||||2017-10-10 23:20:34.441859|2017-10-10 23:20:34.441859
NCT02434627|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-10-14|||June 2015||2015-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Interventional|||Sodium Nitrate for Muscular Dystrophy|Sodium Nitrate for Muscular Dystrophy|Recruiting||Phase 1|12|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||No||2017-10-10 23:20:34.581981|2017-10-10 23:20:34.581981
NCT02434614|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-04-30|||March 2015||2015-03-01|April 2015|2015-04-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma|A Randomized Phase III Non-inferiority Study of Induction Chemotherapy Followed by IMRT Alone Versus Induction Chemotherapy Followed by IMRT Plus Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 3|360|Anticipated|Guilin Medical University, China||2|||f||||t||||||||||2017-10-10 23:20:34.706143|2017-10-10 23:20:34.706143
NCT02434601|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-04-30|||March 2011||2011-03-01|April 2015|2015-04-01|October 2016|Anticipated|2016-10-01|March 2013|Actual|2013-03-01||Interventional|||Dentin Treatments for Restorations of Cervical Lesions Non-Carious|Dentin Treatments for Restorations of Cervical Lesions Non-carious: a Randomized Clinical Trial of Three Years|Unknown status|Active, not recruiting|Phase 2/Phase 3|28|Anticipated|Federal University of Pelotas||3|||f||||t||||||||||2017-10-10 23:20:34.847162|2017-10-10 23:20:34.847162
NCT02434588|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-08-29|||April 14, 2015|Actual|2015-04-14|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|ADICC-ID||Evaluation of an Iris Dilatation Ring in Cataract Surgery (ADICC-ID)|Evaluation of an Iris Dilatation Ring in Cataract Surgery|Active, not recruiting||N/A|20|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||f||||||||||2017-10-10 23:20:34.944377|2017-10-10 23:20:34.944377
NCT02434575|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-07-24|||July 2014||2014-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01|12 Months|Observational [Patient Registry]|UK ROPE||UK ROPE Register Study|ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE)|Recruiting||N/A|300|Anticipated|Cardiff and Vale University Health Board|||3||f||||f||||||||||2017-10-10 23:20:35.017481|2017-10-10 23:20:35.017481
NCT02434562|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-01-23|||April 2012||2012-04-01|May 2016|2016-05-01|September 30, 2016|Actual|2016-09-30|September 2016|Actual|2016-09-01||Observational|||Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation|Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation by Human Serum|Completed||N/A|73|Actual|Universitaire Ziekenhuizen Leuven|||5||f||||f||||||Samples With DNA|"     Serum and urine   "|||2017-10-10 23:20:35.193877|2017-10-10 23:20:35.193877
NCT02434549|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-09-24|||August 2015||2015-08-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|BATCP||Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial|Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial|Recruiting||Phase 2|48|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 23:20:35.271947|2017-10-10 23:20:35.271947
NCT02434536|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-08-23|||October 2006||2006-10-01|August 2016|2016-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01|2 Months|Observational [Patient Registry]|IRYSS-COPD||Appropriate Admission in COPD Exacerbation From Emergency Department. Multicenter Study|Assessment of the Appropriateness Admission From Emergency Departments in the Exacerbation of COPD. Validity of Explicit Criteria and Study of the Variability Between Different Centers of NHS. Multicenter Study IRYSS-Appropriateness-COPD.|Completed||N/A|2487|Actual|Hospital Galdakao-Usansolo|||1||f||||f||||||||||2017-10-10 23:20:35.380693|2017-10-10 23:20:35.380693
NCT02434523|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-10-07|2016-03-29||September 2013||2013-09-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Trial of the Treatment of Chronic Laryngitis With Amitryptiline|Double-blind Placebo Controlled Trial of the Treatment of Chronic Laryngitis With Amitryptiline|Terminated||Phase 2/Phase 3|30|Actual|Boston Medical Center|Early termination leading to small numbers of subjects analyzed|2||concern regarding study design|f||||t||||||||Undecided|No plan to share individual data. Data in aggregate to be presented in national meeting and journal in otolaryngology|2017-10-10 23:20:35.465825|2017-10-10 23:20:35.465825
NCT02434510|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-02-26|||March 2015||2015-03-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Observational|||Bacterial Contamination of Operative Splash Basins|Bacterial Contamination of Operative Splash Basins: Can it be Prevented?|Completed||N/A|111|Actual|University of Utah|||2||f||||t||||||||||2017-10-10 23:20:35.80567|2017-10-10 23:20:35.80567
NCT02434458|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-09-12|||May 2015||2015-05-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Sudoscan in Patients With Autoimmune Disorders|Investigation of Sudoscan in the Evaluation of Small Fiber Dysfunction in Korean Patients With Autoimmune Disorders|Completed||N/A|85|Actual|The Catholic University of Korea|||3||f||||t||||||||||2017-10-10 23:20:36.140375|2017-10-10 23:20:36.140375
NCT02434445|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-06-21|||July 2012||2012-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients|Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients|Recruiting||N/A|100|Anticipated|The University of Hong Kong|||2||f||||t||||||Samples With DNA|"     patient's serum and urine samples   "|||2017-10-10 23:20:36.20654|2017-10-10 23:20:36.20654
NCT02434432|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-30|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|MTP||Music Therapy for Pain Management in the NICU Setting|Music Therapy as a Method of Non-Pharmacological Pain Management in the NICU Setting|Completed||N/A|40|Actual|American University of Beirut Medical Center||3|||f||||f||||||||||2017-10-10 23:20:36.276225|2017-10-10 23:20:36.276225
NCT02434419|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-04|||January 2014||2014-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Pectoral Electrostimulation on Reduction of Mammary Ptosis|Effect of Pectoral Electrostimulation on Reduction of Mammary Ptosis After Bariatric Surgery|Completed||Phase 3|45|Actual|Hospital General Universitario Elche||3|||f||||t||||||||||2017-10-10 23:20:36.372512|2017-10-10 23:20:36.372512
NCT02434406|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-06-12|||March 26, 2017|Actual|2017-03-26|February 2017|2017-02-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Website-Based Self-Help for Women With Anxiety After Childbirth|Feasibility of a Web-Based Intervention for Women With Postpartum Anxiety: A Randomized Controlled Trial|Active, not recruiting||N/A|89|Actual|City, University of London||2|||f||||f|f|f||||||||2017-10-10 23:20:36.435664|2017-10-10 23:20:36.435664
NCT02434393|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2016-11-07|||February 2015||2015-02-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|ADNI-D||Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project|Characterizing Cognitive Decline in Late Life Depression: The Alzheimer's Disease Neuroimaging Initiative - Depression Project|Recruiting||N/A|120|Anticipated|University of Southern California|||1||f||||f||||||Samples With DNA|"     blood, urine   "|||2017-10-10 23:20:36.539533|2017-10-10 23:20:36.539533
NCT02434380|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-03-23|||July 2015||2015-07-01|April 2016|2016-04-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes|Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes: a Randomized Controlled Trial in Pregnant Women With Hypovitaminosis D|Recruiting||Phase 3|280|Anticipated|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-10 23:20:36.638042|2017-10-10 23:20:36.638042
NCT02434367|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-11-04|||August 2014||2014-08-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and Older|Phase 2 Randomized Study of a Walking Intervention for Radiation-related Fatigue Among Breast Cancer Patients Receiving Adjuvant Radiation|Recruiting||Phase 2|50|Anticipated|The West Clinic, Memphis||2|||f||||f||||||||||2017-10-10 23:20:36.752307|2017-10-10 23:20:36.752307
NCT02434354|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-06-21|||April 2015||2015-04-01|June 2016|2016-06-01||||April 2022|Anticipated|2022-04-01||Interventional|||A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma|A Phase Ib Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma|Recruiting||Phase 1|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:20:36.854395|2017-10-10 23:20:36.854395
NCT02434341|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-04-27|||May 2015||2015-05-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Sleep in Critically Ill Patients on Mechanical Ventilation in ICU|Sleep Investigation in 3 Homogeneous Groups of Wake Mechanically Ventilated Patients in ICU: 1st Group - Septical Patients; 2nd Group - COPD Patients; 3rd Group - Surgical Patients, in Order to Define Common Sleep Features Within the Groups|Completed||N/A|33|Actual|University of Southern Denmark|||2||f||||t||||||||||2017-10-10 23:20:36.928107|2017-10-10 23:20:36.928107
NCT02434328|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-08-25|||July 28, 2015||2015-07-28|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|April 5, 2017|Actual|2017-04-05||Interventional|||Efficacy and Safety of RTH258 Versus Aflibercept - Study 2|A Two-Year, Randomized, Double-Masked, Multicenter, Two-Arm Study Comparing the Efficacy and Safety of RTH258 6 mg Versus Aflibercept in Subjects With Neovascular Age-Related Macular Degeneration|Active, not recruiting||Phase 3|1200|Anticipated|Alcon Research||2|||f||||t||||||||||2017-10-10 23:20:36.985556|2017-10-10 23:20:36.985556
NCT02434315|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-09-28|||April 2015||2015-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||FreeStyle Libre Pro Use in Primary & Secondary Care|Evaluation of the FreeStyle Libre Pro for Individuals With Insulin Managed Type 2 Diabetes in Primary & Secondary Care|Completed||N/A|175|Actual|Abbott Diabetes Care||3|||f||||f||||||||||2017-10-10 23:20:37.083932|2017-10-10 23:20:37.083932
NCT02434302|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-04|||August 2014||2014-08-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Characteristics and Outcomes of Childhood Moyamoya in the UK|Characteristics and Outcomes of Childhood Moyamoya in the UK|Unknown status|Recruiting|N/A|150|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:20:37.192719|2017-10-10 23:20:37.192719
NCT02434289|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-10-07|||April 2015||2015-04-01|October 2015|2015-10-01||||September 2015|Actual|2015-09-01||Interventional|||Feasibility of a Resistance Exercise and Dietary Protein Intervention in Elderly People in Practice (ProMuscle 65PK)|Pilot Study to Study the Feasibility and Potential Impact of a Combined Resistance Exercise and Increased Protein Intake Intervention in (Frail) Elderly People, in a Real-life Setting|Completed||N/A|23|Actual|Wageningen University||1|||f||||f||||||||||2017-10-10 23:20:37.47565|2017-10-10 23:20:37.47565
NCT02434276|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-06-25|||May 2015||2015-05-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|August 2015|Anticipated|2015-08-01||Interventional|||Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years|A Phase II, Multicenter, Randomized, Double-Blind, Active Comparator Controlled Study of the Immunogenicity and Safety of VAX2012Q, A Quadrivalent Influenza Vaccine in Healthy Adults 18-64 Years|Unknown status|Active, not recruiting|Phase 2|450|Anticipated|VaxInnate Corporation||3|||f||||t||||||||||2017-10-10 23:20:37.61654|2017-10-10 23:20:37.61654
NCT02434263|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-05-08|||June 1, 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve|A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve|Not yet recruiting||Phase 1|70|Anticipated|Vascular Innovations Co. Ltd.||1|||f||||t|f|f||||||||2017-10-10 23:20:37.742663|2017-10-10 23:20:37.742663
NCT02434250|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-06-19|||May 2015||2015-05-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|SLT||Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy|Effectiveness of Selective Laser Trabeculoplasty (SLT) After Failed Phacoemulsification Cataract Extraction Combined With Eximer Laser Trabeculectomy (Phaco-ELT) in Open Angle Glaucoma and Ocular Hypertension|Completed||N/A|203|Actual|University of Zurich||1|||f||||f|f|f||||||No||2017-10-10 23:20:37.857073|2017-10-10 23:20:37.857073
NCT02434237|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2015-05-04|||March 2005||2005-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Robot-Aided Neurorehabilitation of the Upper Extremities||Completed||N/A|45|Actual|University of Zurich|||2||f||||f||||||||||2017-10-10 23:20:37.969897|2017-10-10 23:20:37.969897
NCT02434224|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-06-19|||January 2015||2015-01-01|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Creative Music Therapy for Premature Infants|Creative Music Therapy for Premature Infants: Testing a Possible Influence on Brain Structure, Function and Neurobehavioral Outcome|Recruiting||N/A|60|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 23:20:38.044587|2017-10-10 23:20:38.044587
NCT02434211|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-04|||June 2015||2015-06-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|RISCOLAIRE2||Interventional Research in Schools - Second Part|Interventional Research in Schools - Second Part|Unknown status|Not yet recruiting|N/A|291|Anticipated|Institut de Cancérologie de la Loire||1|||f||||f||||||||||2017-10-10 23:20:38.166567|2017-10-10 23:20:38.166567
NCT02434198|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-04|||January 2015||2015-01-01|April 2015|2015-04-01||||December 2016|Anticipated|2016-12-01||Observational|||Falling in Patients With COPD Referred to Pulmonary Rehabilitation: Incidence, Risk Factors and Prediction Tools||Unknown status|Recruiting|N/A|100|Anticipated|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-10 23:20:38.249685|2017-10-10 23:20:38.249685
NCT02434185|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-05-21|||March 2015||2015-03-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||The Bilateral Deficit Phenomenon, Functional and Dynamometric Assessment in Postmenopausal Women|The Bilateral Deficit Phenomenon, Functional and Dynamometric Assessment in Postmenopausal Women|Completed||N/A|20|Actual|Universidad Católica San Antonio de Murcia|||1||f||||f||||||||||2017-10-10 23:20:38.347846|2017-10-10 23:20:38.347846
NCT02434172|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-10-25|||April 2015||2015-04-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|CryptoART||CryptoART Study: Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan Africa|The CryptoART Study: Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan Africa Through Early Detection and Prevention of Cryptococcal Disease|Active, not recruiting||N/A|1600|Anticipated|University of Zimbabwe|||1||f||||t||||||Samples Without DNA|"     Plasma, and peripheral blood mononuclear cells   "|||2017-10-10 23:20:38.454687|2017-10-10 23:20:38.454687
NCT02434159|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2015-04-30|||May 2012||2012-05-01|April 2015|2015-04-01||||September 2017|Anticipated|2017-09-01||Interventional|||Role of Cardiac Computed Tomography in Optimising Response to Cardiac Resynchronisation Therapy|Role of Cardiac Computed Tomography and Cardiac Magnetic Resonance in Optimising Response to Cardiac Resynchronisation Therapy|Unknown status|Recruiting|N/A|100|Anticipated|University College, London||2|||f||||||||||||||2017-10-10 23:20:38.569825|2017-10-10 23:20:38.569825
NCT02434146|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-04-27|2017-03-16||May 14, 2015||2015-05-14|April 2017|2017-04-01|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Interventional|||Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy|A Phase I/IIa Safety and Efficacy Study of Topical Phenylephrine Applied to Oral Mucosa in Bone Marrow Transplant Patients Receiving Cytoxan Plus Total Body Irradiation|Terminated||Phase 1/Phase 2|3|Actual|University of Wisconsin, Madison|This study was closed prematurely due to decreased numbers of eligible subjects. The full target accrual number was not achieved, and no study conclusions could be made.|1||A company in China has decided to license the product|f||||t||||||||||2017-10-10 23:20:38.675673|2017-10-10 23:20:38.675673
NCT02434133|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-01-20|||April 2015||2015-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients|Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients|Active, not recruiting||N/A|110|Anticipated|University of Wisconsin, Madison|||4||f||||f||||||Samples With DNA|"     Blood sample to measure antibody concentration   "|||2017-10-10 23:20:39.011171|2017-10-10 23:20:39.011171
NCT02434120|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2016-10-28|||November 2015||2015-11-01|November 2015|2015-11-01||||November 2018|Anticipated|2018-11-01||Observational|PERFORM||MRI Perfusion Curves Typology and Orbital Tumors (PERFORM)|Validation, for Orbital Tumors, of the MRI Perfusion Curves Typology Established for Salivary Tumors|Enrolling by invitation||N/A|200|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 23:20:39.112043|2017-10-10 23:20:39.112043
NCT02434107|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-05-02|||December 2005|Actual|2005-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01||Interventional|DeCOG-SLT||Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)|Controlled and Prospective Randomised Study to Compare Complete Lymph Node Dissection Versus Watchful Waiting in Patients With Malignant Melanoma With a Tumour Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node|Active, not recruiting||N/A|558|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 23:20:39.192151|2017-10-10 23:20:39.192151
NCT02434094|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|||Development of a Comprehensive AP Training Curriculum for Adults|Development of a Comprehensive AP Training Curriculum for Adults|Completed||N/A|24|Actual|University of Virginia|||3||f||||f||||||||||2017-10-10 23:20:39.364494|2017-10-10 23:20:39.364494
NCT02433496|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-03-30|||July 2014||2014-07-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Physician Coaching to Reduce Opioid-related Harms|Physician Coaching to Reduce Opioid-related Harms|Enrolling by invitation||N/A|28|Anticipated|University of Wisconsin, Madison|||2||f||||f||||||||||2017-10-10 23:20:45.923483|2017-10-10 23:20:45.923483
NCT02434081|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-08-18|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|NICOLAS||NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma|A Phase II Trial Evaluating the Safety and Efficacy of the Addition of Concurrent Anti-PD 1 Nivolumab to Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma|Active, not recruiting||Phase 2|78|Anticipated|European Thoracic Oncology Platform||1|||f||||t||||||||||2017-10-10 23:20:39.449709|2017-10-10 23:20:39.449709
NCT02434068|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-10-27|||March 2015||2015-03-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|||Assessment of Flexible Ureteroscopy Residual Fragments|Assessment of Flexible Ureteroscopy Residual Fragments|Enrolling by invitation||N/A|115|Anticipated|University of Sao Paulo General Hospital|||1||f||||f||||||||Undecided||2017-10-10 23:20:39.566872|2017-10-10 23:20:39.566872
NCT02434055|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-06-16|||April 2015||2015-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|AVERT-PLUS||Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS|Evaluation of a Novel Method of Contrast Volume Quantification - The AVERT PLUS|Terminated||N/A|10|Actual|The University of Texas Health Science Center at San Antonio|||1|Business purposes|f||||f||||||||||2017-10-10 23:20:39.646197|2017-10-10 23:20:39.646197
NCT02434042|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-06-19|||April 2015||2015-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effects of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses in Children|Study on Oral Administration of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses Compared to Placebo|Completed||Phase 2/Phase 3|520|Actual|University of Science Malaysia||2|||f||||f||||||||||2017-10-10 23:20:39.712422|2017-10-10 23:20:39.712422
NCT02434029|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-02-02|||November 11, 2015|Actual|2015-11-11|February 2017|2017-02-01|October 4, 2016|Actual|2016-10-04|August 4, 2016|Actual|2016-08-04||Interventional|EOS-1||Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis|Double-blind, Randomized, Placebo-controlled, Phase III Trial on the Efficacy and Tolerability of a 6-week Treatment With Budesonide Effervescent Tablets vs. Placebo for Induction of Clinico-pathological Remission in Adult Patients With Active Eosinophilic Esophagitis|Completed||Phase 3|88|Actual|Dr. Falk Pharma GmbH||2|||f||||t||||||||No||2017-10-10 23:20:39.795531|2017-10-10 23:20:39.795531
NCT02434016|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-04-18|||June 2015||2015-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|DIVIP||Assessing Diaphragm Muscle Inactivity in Mechanically Ventilated ICU Patients||Recruiting||N/A|75|Anticipated|St. Michael's Hospital, Toronto|||1||f||||||||||||||2017-10-10 23:20:39.864722|2017-10-10 23:20:39.864722
NCT02434003|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2016-03-30|||May 2014||2014-05-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis|Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis|Recruiting||N/A|1200|Anticipated|St. Justine's Hospital|||1||f||||t||||||||||2017-10-10 23:20:39.946409|2017-10-10 23:20:39.946409
NCT02433990|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-05-09|||April 2014||2014-04-01|April 2017|2017-04-01|June 1, 2017|Anticipated|2017-06-01|June 1, 2017|Anticipated|2017-06-01||Observational|||Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease|Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease|Enrolling by invitation||N/A|150|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-10 23:20:40.045816|2017-10-10 23:20:40.045816
NCT02433977|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-06-26|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|NICLA||The Effects of NOx and Conjugated Linoleic Acid on Asthmatics With the Metabolic Syndrome|A Proof of Concept Study to Determine the Effects of NOX and Conjugated Linoleic Acid on Asthmatics With the Metabolic Syndrome|Recruiting||Phase 2|20|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:20:40.104042|2017-10-10 23:20:40.104042
NCT02433964|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-05-04|||May 2012||2012-05-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of Therapeutic Effects of LED (627 +/- 10nm) The Initial Phase of the Ankle Sprains Treatment|EVALUATION OF THERAPEUTIC EFFECTS OF LED (627 +/- 10nm) THE INITIAL PHASE OF THE ANKLE SPRAINS TREATMENT - A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL|Completed||N/A|40|Actual|Universidade do Vale do Paraíba||2|||f||||f||||||||||2017-10-10 23:20:40.187186|2017-10-10 23:20:40.187186
NCT02433951|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-08-17|||February 2015||2015-02-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|ENDO-ACAB||Exercise Tolerance in Patients With CABG and Sternotomy vs. Patients With Minimally Invasive Coronary Surgery|Exercise Tolerance in Patients With Coronary Artery Bypass Surgery (CABG) and Sternotomy vs. Patients With Minimally Invasive Coronary Surgery|Completed||N/A|55|Actual|Hasselt University|||3||f||||f||||||||||2017-10-10 23:20:40.262872|2017-10-10 23:20:40.262872
NCT02433938|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-11-08|||July 2015||2015-07-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|TiRex||Role of Tibial Nerve Stimulation for Enhanced Postoperative Recovery After Colorectal Surgery|Role of Tibial Nerve Stimulation for Enhanced Postoperative Recovery After Colorectal Surgery|Completed||N/A|160|Actual|University of Florence||2|||f||||f||||||||||2017-10-10 23:20:40.324402|2017-10-10 23:20:40.324402
NCT02433925|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-04-29|||January 2013||2013-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Interventional|||Resveratrol's Effects on Inflammation and Oxidative Stress in Chronic Kidney Disease|Effects of Supplementation With Resveratrol on Inflammation and Oxidative Stress of Non-dialysis Chronic Kidney Disease Patients|Completed||Phase 3|20|Actual|Universidade Federal Fluminense||2|||f||||f||||||||||2017-10-10 23:20:40.38238|2017-10-10 23:20:40.38238
NCT02433912|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-05-04|||June 2002||2002-06-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Clinical Evaluation of Single-stage Advanced Versus Rotated Flaps in the Treatment of Gingival Recessions|Clinical Evaluation of Single-stage Advanced Versus Rotated Flaps in the Treatment of Gingival Recessions:Longitudinal, Controlled Clinical Trial.|Completed||Phase 4|36|Actual|Universidade Federal Fluminense||2|||f||||t||||||||||2017-10-10 23:20:40.451202|2017-10-10 23:20:40.451202
NCT02433899|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-05-04|||October 2010||2010-10-01|April 2015|2015-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Microsurgical Versus Conventional Semilunar Coronally Advanced Flap|A Clinical Comparison of Microsurgical Versus Conventional Surgical Approaches for the Semilunar Coronally Advanced Flap|Completed||Phase 4|14|Actual|Universidade Federal Fluminense||2|||f||||t||||||||||2017-10-10 23:20:40.549187|2017-10-10 23:20:40.549187
NCT02433886|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-04|||December 2014||2014-12-01|April 2015|2015-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Adverse Events of Bilateral Single-shot VC/VS Gamma Capsulotomy for OCD: a Pilot Study|Efficacy and Adverse Events of Bilateral Single-shot Ventral Capsular/Ventral Striatal Gamma Capsulotomy for Obsessive-compulsive Disorder: a Pilot Study|Recruiting||Phase 2|5|Anticipated|University of Sao Paulo General Hospital||1|||f||||f||||||||||2017-10-10 23:20:40.628443|2017-10-10 23:20:40.628443
NCT02433873|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2017-03-21|||April 2015||2015-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|||Prebiotic Effects of Isomalto-oligosaccharide|Prebiotic Effects of Isomalto-oligosaccharide|Completed||N/A|54|Actual|George Mason University||3|||f||||f||||||||||2017-10-10 23:20:40.693785|2017-10-10 23:20:40.693785
NCT02433860|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-09-20|||January 2015||2015-01-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation of the Effectiveness of Pharmacists in Implementing the SCRIPT Protocol|Evaluation of the Effectiveness of Pharmacists in Implementing the Smoking Cessation and Reduction in Pregnancy and Treatment (SCRIPT) Protocol|Completed||N/A|8|Actual|Providence Medical Research Center||1|||f||||f||||||||||2017-10-10 23:20:40.770505|2017-10-10 23:20:40.770505
NCT02433847|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-29|||May 2015||2015-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects||Unknown status|Not yet recruiting|Phase 4|20|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 23:20:40.83135|2017-10-10 23:20:40.83135
NCT02433834|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-05-31|2017-03-22||May 27, 2015|Actual|2015-05-27|May 2017|2017-05-01|March 26, 2016|Actual|2016-03-26|March 26, 2016|Actual|2016-03-26||Interventional||Intent to Treat (ITT) Population is all patients randomized to treatment and used for Participant Flow. Modified ITT (MITT) population, a subset of ITT Population is all subjects treated, with post-treatment efficacy data from at least 2 treatment periods, no major protocol violation precluding the use of data, used for Baseline Characteristics|Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma|A Randomized, Double-Blind, Chronic-Dosing (14 Days), 5-Period, 7-Treatment, Placebo-Controlled, Incomplete Block, Cross-Over, Multicenter, Dose-ranging Study to Assess the Efficacy and Safety of PT001 Relative to Placebo Metered Dose Inhaler and Open-Label Serevent® Diskus® in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma|Completed||Phase 2|248|Actual|Pearl Therapeutics, Inc.||7|||f||||f||||||||||2017-10-10 23:20:40.896825|2017-10-10 23:20:40.896825
NCT02433821|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-04-29|||February 2012||2012-02-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|August 2012|Actual|2012-08-01||Interventional|||Pilates to Treat Neck Pain|Effectiveness of Pilates to Treat Mechanical Neck Pain|Completed||Phase 3|64|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 23:20:43.389028|2017-10-10 23:20:43.389028
NCT02433795|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2017-06-08|||May 2015||2015-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)|A Phase II Study of Bendamustine Plus Rituximab (BR) in Patients With Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)|Recruiting||Phase 2|39|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:20:43.539311|2017-10-10 23:20:43.539311
NCT02433769|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-04-11|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||Acceleromyographic Assessment of Neuromuscular Blockade: TOF-Watch-SX Versus TOFscan|Acceleromyographic Assessment of Neuromuscular Blockade: TOF-Watch-SX Versus TOFscan|Active, not recruiting||Phase 4|30|Anticipated|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||||2017-10-10 23:20:43.726284|2017-10-10 23:20:43.726284
NCT02433756|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-03-29|||March 2013||2013-03-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|March 2016|Actual|2016-03-01|18 Months|Observational [Patient Registry]|ResQ CRT||RESponders and QUadripolar LV Lead in CRT|Responders and Quadripolar LV Lead in CRT|Recruiting||N/A|180|Anticipated|Ospedale Santa Croce-Carle Cuneo|||1||f||||||||||||||2017-10-10 23:20:43.803363|2017-10-10 23:20:43.803363
NCT02433743|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2015-04-29|||October 2011||2011-10-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|PLWHA||Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA|Daily Consumption of Ready-to-use Peanut-based Therapeutic Food Increased Fat Free Mass, Improved Anemia Status But Has no Impact on Zinc Status of People Living With HIV/AIDS (PLWHA)|Completed||N/A|65|Actual|Cheikh Anta Diop University, Senegal||2|||f||||f||||||||||2017-10-10 23:20:43.880452|2017-10-10 23:20:43.880452
NCT02433730|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-03-30|||May 2015||2015-05-01|March 2016|2016-03-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Testosterone Therapy in Hypogonadal Men Treated With Opioids|The Effect of Testosterone Replacement in Patients With Hypogonadotrophic Hypogonadism Due to Opioid Treatment for Non-malignant Disease|Recruiting||Phase 4|40|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-10 23:20:43.969924|2017-10-10 23:20:43.969924
NCT02433717|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-11-19|||April 2015||2015-04-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||A Pharmacokinetic Study of Paliperidone ER|A Study on the Efficacy, Pharmacokinetics and Adverse Effects of Paliperidone ER|Recruiting||Phase 4|40|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-10 23:20:44.17578|2017-10-10 23:20:44.17578
NCT02433704|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-07-27|||May 2015||2015-05-01|November 2015|2015-11-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Preoperative Antibiotic Dosing for Total Knee Arthroplasty|Preoperative Antibiotic Dosing for Total Knee Arthroplasty: Intraosseous Versus Systemic Infusion|Withdrawn||Phase 4|0|Actual|Duke University||2||Difficulty with enrollment|f||||f||||||||||2017-10-10 23:20:44.323989|2017-10-10 23:20:44.323989
NCT02433691|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-06-06|||January 2015||2015-01-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|MET||Memory and Exercise Training Study in Older Adults With Subjective Memory Complaints|Simultaneous Aerobic Exercise and Memory Training in Older Adults With Subjective Memory Complaints|Active, not recruiting||N/A|60|Actual|University of California, Los Angeles||3|||f||||t||||||||||2017-10-10 23:20:44.405415|2017-10-10 23:20:44.405415
NCT02433678|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-11-15|||November 2015||2015-11-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin|An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin|Recruiting||Phase 4|52|Anticipated|University at Buffalo||2|||f||||t||||||||||2017-10-10 23:20:44.491603|2017-10-10 23:20:44.491603
NCT02433665|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-12-09|||August 2015||2015-08-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Customized Contrast Media Dose Clinical Trial|Clinical Trial of a Novel Evidence-Based Formula for Customizing the Contrast Media Dose and Rate Administered During Multidetector-Row CT (MDCT) Scanning of the Abdomen and Pelvis|Enrolling by invitation||N/A|500|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 23:20:44.57674|2017-10-10 23:20:44.57674
NCT02433652|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-01-31|||September 2015||2015-09-01|January 2017|2017-01-01||||November 2016|Actual|2016-11-01||Interventional|||Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2|A Phase 1 Evaluation of the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2|Completed||Phase 1|24|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:20:44.653205|2017-10-10 23:20:44.653205
NCT02433639|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-04-29|||April 2015||2015-04-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer||Unknown status|Recruiting|Phase 2|36|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 23:20:44.746556|2017-10-10 23:20:44.746556
NCT02433626|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-02-07|||December 2015||2015-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|COTI2-101||A Study of Coti-2 for the Treatment of Advanced or Recurrent Gynecologic Malignancies|A Phase 1 Study of COTI-2 for the Treatment of Advanced or Recurrent Gynecologic Malignancies.|Recruiting||Phase 1|56|Anticipated|Critical Outcome Technologies Inc.||1|||f||||f||||||||No||2017-10-10 23:20:44.834923|2017-10-10 23:20:44.834923
NCT02433613|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-06-06|||April 2015||2015-04-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01|12 Months|Observational [Patient Registry]|||Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)|Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)|Active, not recruiting||N/A|1071|Actual|Medtronic Atrial Fibrillation Solutions|||1||f||||f||||||||||2017-10-10 23:20:44.932817|2017-10-10 23:20:44.932817
NCT02433600|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-03-14|||August 2015||2015-08-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Feeding Infant Formula With Enriched Protein Fractions in the US|The Effect of Feeding Infant Formula With Enriched Protein Fractions|Terminated||N/A|2|Actual|Mead Johnson Nutrition||2||Study was terminated due to lack of enrollment|f||||f||||||||||2017-10-10 23:20:45.107883|2017-10-10 23:20:45.107883
NCT02433587|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-06-15|||July 2016||2016-07-01|June 2016|2016-06-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Short Versus Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization|Evaluation of Short Versus Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization|Not yet recruiting||Phase 3|450|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 23:20:45.194704|2017-10-10 23:20:45.194704
NCT02433574|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-11-26|||November 2015||2015-11-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|LINNEARRE-I||Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection|Phase I Study: Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body Radiotherapy and REsection|Recruiting||Phase 1|20|Anticipated|Juravinski Cancer Center||1|||f||||t||||||||||2017-10-10 23:20:45.274819|2017-10-10 23:20:45.274819
NCT02433561|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-11-08|||November 2015||2015-11-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Intra- Versus Extraplexic Catheter Placement for Continuous Interscalene Brachial Plexus Block|Intra- Versus Extraplexic Catheter Placement for Continuous Interscalene Brachial Plexus Block: Respiratory-related and Pain-related Outcomes|Completed||Phase 4|70|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 23:20:45.347155|2017-10-10 23:20:45.347155
NCT02433548|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-09-26|||October 2014||2014-10-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Fascia Iliaca Block in the Emergency Department for Analgesia After Femoral Neck Fracture|Fascia Iliaca Block in the Emergency Department for Analgesia After Femoral Neck Fracture|Completed||Phase 4|30|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 23:20:45.430813|2017-10-10 23:20:45.430813
NCT02433535|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-09-22|||December 2013|Actual|2013-12-01|September 2017|2017-09-01|August 22, 2017|Actual|2017-08-22|August 22, 2017|Actual|2017-08-22||Interventional|||Trial of Simvastatin for the Treatment of Severe Asthma|Randomized Trial of Simvastatin for the Treatment of Severe Asthma|Withdrawn||Phase 2|0|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-10 23:20:45.505225|2017-10-10 23:20:45.505225
NCT02433522|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-09-14|||March 2015||2015-03-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|MAINRITSAN3||Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab|Extended Follow Up of the Mainritsan 2 Study. Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab: a Placebo- Controlled Randomized Trial|Active, not recruiting||Phase 3|97|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:20:45.599692|2017-10-10 23:20:45.599692
NCT02433509|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-04-17|||May 2015||2015-05-01|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke|Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke|Recruiting||Phase 1|6|Anticipated|China Medical University Hospital||1|||f||||t||||||||||2017-10-10 23:20:45.823991|2017-10-10 23:20:45.823991
NCT02433470|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2015-05-04|||April 2015||2015-04-01|May 2015|2015-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||Association of Functional Changes in the Brain and the Perception of Pain in Patients With Chronic Inflammatory Bowel Diseases (IBD)||Unknown status|Recruiting|Phase 2|20|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-10 23:20:46.133969|2017-10-10 23:20:46.133969
NCT02433457|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-29|||May 2014||2014-05-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Relative Bioavailability Study of CC-292|An Open-label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect and Dose Proportionality of CC-292 Spray Dried Dispersion Formulation in Healthy Volunteers|Completed||Phase 1|24|Actual|Celgene||7|||f||||f||||||||||2017-10-10 23:20:46.223891|2017-10-10 23:20:46.223891
NCT02433444|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-29|||May 2015||2015-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Computer Aided, Non-invasive, Acoustic Gastrointestinal Surveillance in Post-ERCP Pancreatitis|Computer Aided, Non-invasive, Acoustic Gastrointestinal Surveillance (AGIS) in Post-ERCP Pancreatitis (PEP)|Unknown status|Not yet recruiting|N/A|100|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 23:20:46.327285|2017-10-10 23:20:46.327285
NCT02433431|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-05-13|||February 2015||2015-02-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Mechanisms of Mindfulness and Stress Resilience: A Mobile App Mindfulness Training Study||Completed||N/A|153|Actual|Carnegie Mellon University||3|||f||||f||||||||||2017-10-10 23:20:46.403985|2017-10-10 23:20:46.403985
NCT02433418|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-01-20|||May 2015||2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tubal Flushing Using Water Soluble Media for Unexplained Infertility|Tubal Flushing Using Water Soluble Media for Unexplained Infertility: A Randomized Controlled Trial|Recruiting||Phase 3|300|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:20:46.510731|2017-10-10 23:20:46.510731
NCT02433405|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-04-29|||December 2013||2013-12-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Observational|||Serum Amyloid A Protein And Fetuin A Levels|Serum Amyloid A Protein And Fetuin A Protein Levels In Periodontal Health And Disease|Completed||Early Phase 1|60|Actual|Bulent Ecevit University|||3||f||||f||||||Samples Without DNA|"     Gingival crevicular fluid and Serum   "|||2017-10-10 23:20:46.608588|2017-10-10 23:20:46.608588
NCT02433392|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-07-29|||December 2011||2011-12-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.|A Phase 1 Study of Intraparenchymal Therapy With Irinotecan Hydrochloride Drug-eluting Beads (CM-BC2) as an Adjunct Therapy to Best Standard of Care in Patients With Recurrent, Surgically Resectable Glioblastoma Multiforme.|Terminated||Phase 1|10|Anticipated|BTG International Inc.||1||The decision to terminate the trial was based on the slow rate of recruitment.|f||||t||||||||||2017-10-10 23:20:46.699359|2017-10-10 23:20:46.699359
NCT02433379|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-09-27|||June 9, 2015|Actual|2015-06-09|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|UNTOUCHED||Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction|Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction|Recruiting||N/A|2015|Anticipated|Boston Scientific Corporation||1|||f||||f|f|t|f|f|t|||||2017-10-10 23:20:46.811976|2017-10-10 23:20:46.811976
NCT02433366|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-07-28|2016-07-28||January 2015||2015-01-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational||Physicians who were current prescribers of Pradaxa® for stroke prevention in patients with atrial fibrillation (AF) and AF patients who were currently receiving treatment with Pradaxa® entered this non-interventional survey|Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation|Post-authorisation Study to Evaluate the Effectiveness of the Risk Minimisation Activities in the Treatment of SPAF|Completed||N/A|1213|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-10 23:20:47.439578|2017-10-10 23:20:47.439578
NCT02433353|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-01-11|||January 2016||2016-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|EMDRVEN||Results From a 24 Week Trial of EMDR Combined With Venlafaxine XR|Results From a 24 Week, Double-blind, Placebo-controlled Trial of EMDR Combined With Venlafaxine XR in the Treatment of Posttraumatic Stress Disorder|Withdrawn||Phase 4|0|Actual|Bayne-Jones Army Community Hospital||2||PI was transferred to another base. No one else available to serve as PI.|f||||f||||||||||2017-10-10 23:20:48.102075|2017-10-10 23:20:48.102075
NCT02433340|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-06-23|2017-05-19||April 2015||2015-04-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study|Phase 2, Multicenter, Open-Label Extension (OLE) Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Phase 2 Randomized Controlled Trial (RCT)|Completed||Phase 2|158|Actual|AbbVie||1|||f||||t||||||||||2017-10-10 23:20:48.480481|2017-10-10 23:20:48.480481
NCT02433327|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-04-29|||April 2015||2015-04-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||Paediatric Early Warning System - A Danish Multi-center Study|Paediatric Early Warning System - A Danish Multi-center Study|Unknown status|Recruiting|N/A|8000|Anticipated|Aarhus University Hospital||2|||f||||f||||||||||2017-10-10 23:20:55.833695|2017-10-10 23:20:55.833695
NCT02433314|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-10-19||||||August 2015|2015-08-01||||||||Expanded Access|||An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus|An Open Label, Expanded Access Protocol to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status Epilepticus|Available||N/A|||Sage Therapeutics|||||||||||||||||||2017-10-10 23:20:55.930997|2017-10-10 23:20:55.930997
NCT02433301|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-10-04|||April 2015||2015-04-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy|PET/MR-imaging and Circulating Tumour Cells to Evaluate the Response of Chemotherapy in Patients With Gastroesophageal Junction Cancer|Completed||N/A|23|Actual|Rikshospitalet University Hospital|||1||f||||||||||None Retained|"     Four biopsies from each patient harvested from the Gastroesophageal junction cancer   "|||2017-10-10 23:20:56.001686|2017-10-10 23:20:56.001686
NCT02433275|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-03-15|||April 2015||2015-04-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Observational|||CHildhood ASthma and Environment Research Study - CHASER Study|CHildhood ASthma and Environment Research Study - CHASER Study|Recruiting||N/A|100|Anticipated|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||1||f||||f||||||||Yes|"The IPD collected will be available on December 2020.
The following participant data will be shared:
Asthma severity level
Asthma control level
Pulmonary function tests
Demographic characteristics All IPD will be obtained from statistical analysis on the dedicated database in which all data are stored."|2017-10-10 23:20:56.206607|2017-10-10 23:20:56.206607
NCT02433262|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||WHO Versus IADPSG Diagnostic Criteria of Gestational Diabetes Mellitus and Their Associated Maternal and Neonatal Outcomes|World Health Organisation (WHO) Versus International Association of Diabetes and Pregnancy Study Group (IADPSG) Diagnostic Criteria of Gestational Diabetes Mellitus and Their Associated Maternal and Neonatal Outcomes|Recruiting||N/A|506|Anticipated|Universiti Kebangsaan Malaysia Medical Centre||2|||f||||f||||||||||2017-10-10 23:20:56.275283|2017-10-10 23:20:56.275283
NCT02433249|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-09-14|||April 2014||2014-04-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ReadySteady||Developing a Intervention to Enhance Motivation for Physical Activities Known to Reduce Fall Risk|Enhancing Motivation for Physical Activity to Reduce the Risk of Falls Among Community-Dwelling Older Adults: A Wellness Intervention.|Completed||Phase 2|103|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||||2017-10-10 23:20:56.382317|2017-10-10 23:20:56.382317
NCT02433236|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-10-21|||September 2015||2015-09-01|October 2015|2015-10-01||||September 2015|Actual|2015-09-01||Interventional|||Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy|A Phase 2, Multi-Centre, Open Label Extension Study of Fostamatinib in the Treatment of IgA Nephropathy for Patients Who Participated in Study C-935788-050|Withdrawn||Phase 2|0|Actual|Rigel Pharmaceuticals||2||Study withdrawn prior to enrollment of first subject|f||||f||||||||||2017-10-10 23:20:56.494457|2017-10-10 23:20:56.494457
NCT02433223|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-04-06|||June 2016|Actual|2016-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Retrospective Evaluation of COPD Patient Care|Retrospective Evaluation of COPD Patient Care|Active, not recruiting||N/A|150|Anticipated|The Queen Elizabeth Hospital|||3||f||||f||||||||Yes|Available upon request|2017-10-10 23:20:56.590117|2017-10-10 23:20:56.590117
NCT02433210|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-07-05|||June 2015||2015-06-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients|A Clinical Study Comparing the Basic Performance and Blood Compatibility Characteristics of Nipro ELISIO-H, Gambro Polyflux Revaclear and Fresenius Optiflux Dialyzers|Recruiting||N/A|12|Anticipated|University of Missouri-Columbia||3|||f||||f||||||||||2017-10-10 23:20:56.672872|2017-10-10 23:20:56.672872
NCT02433197|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-03-30|||December 2015||2015-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|EFICATEST||Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer|Effectiveness of an Individualized Program of Muscular Strength and Endurance Program With Aerobic Training for Improving Germ Cell Cancer Related Fatigue in Men Undergoing Chemotherapy|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Malaga||2|||f||||t||||||||||2017-10-10 23:20:56.790441|2017-10-10 23:20:56.790441
NCT02433184|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-28|||July 2011||2011-07-01|April 2015|2015-04-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|VEDERA||Very Early Versus Delayed Etanercept in Patients With RA|A Prospective, Single-centre, Randomised Study Evaluating the Clinical, Imaging and Immunological Depth of Remission Achieved by Very Early Versus Delayed Etanercept in Patients With Rheumatoid Arthritis|Unknown status|Recruiting|Phase 4|120|Anticipated|University of Leeds||2|||f||||f||||||||||2017-10-10 23:20:56.8869|2017-10-10 23:20:56.8869
NCT02433171|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-12-15|||January 2015||2015-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following Radiosurgery|Studies of Methionine-PET and PBR28-PET in Brain Metastases to Differentiate Tumor Recurrence and Radiation Necrosis Following Stereotactic Radiosurgery|Recruiting||N/A|40|Anticipated|Yale University|||2||f||||f||||||||||2017-10-10 23:20:57.018037|2017-10-10 23:20:57.018037
NCT02433158|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-09-05|||December 16, 2015|Actual|2015-12-16|September 2017|2017-09-01|July 13, 2020|Anticipated|2020-07-13|July 13, 2020|Anticipated|2020-07-13||Interventional|||Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease|An Open-label Extension Study To Evaluate The Safety Of Rivipansel (Gmi-1070) In The Treatment Of One Or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease|Recruiting||Phase 3|250|Anticipated|Pfizer||2|||f||||t|t|f||||||||2017-10-10 23:20:57.150143|2017-10-10 23:20:57.150143
NCT02433145|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-04-29|||October 2014||2014-10-01|April 2015|2015-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Explore the Association Between Neuropsychological Functions and ADHD Diagnosis and Comorbid Using Longitudinal Study in Preschool Children|Explore the Association Between Neuropsychological Functions and ADHD Diagnosis and Comorbid Using Longitudinal Study in Preschool Children|Unknown status|Recruiting|N/A|220|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-10 23:20:57.479289|2017-10-10 23:20:57.479289
NCT02433132|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-09-27|||March 2015||2015-03-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|MUCO-BROCC||Cystic Fibrosis Diagnosis by Analyzing Nasal Brushing|Study of Ion Transport From Nasal Epithelial Cells Collected by Brushing (CCBN) in the Diagnosis of Atypical Forms of Cystic Fibrosis|Recruiting||N/A|128|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:20:57.561026|2017-10-10 23:20:57.561026
NCT02433119|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-04-11|||March 16, 2015|Actual|2015-03-16|April 2017|2017-04-01|September 8, 2016|Actual|2016-09-08|September 8, 2016|Actual|2016-09-08||Interventional|||The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy|A Multi-center, Randomized, Double-blind, Phase IV Clinical Trial to Compare the Efficacy and Safety of OROSARTAN® Tablet 5/160mg Versus CODIOVAN® Tablet 160/12.5mg in Patients With Essential Hypertension Uncontrolled With Valsartan 160mg Monotherapy|Completed||Phase 4|238|Actual|Dong-A ST Co., Ltd.||2|||f||||||||||||||2017-10-10 23:20:57.818885|2017-10-10 23:20:57.818885
NCT02433106|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-28|||September 2012||2012-09-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effects of an Exercise Programme on Neuromuscular Outcomes in Gaelic Sport|The Effects of an Exercise Based Injury Prevention Programme on Neuromuscular Outcomes in Gaelic Football and Hurling Players, a Randomised Controlled Trial|Completed||N/A|78|Actual|University College Dublin||2|||f||||f||||||||||2017-10-10 23:20:57.899021|2017-10-10 23:20:57.899021
NCT02433093|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-11-01|||April 2015||2015-04-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)|A Single-Center, Randomized, Investigator/Participant-Blind, Placebo-Controlled, Multiple-Ascending Dose, Semi-Sequential Adaptive Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Basimglurant Following Oral Administration in Healthy Subjects and in Patients With Major Depressive Disorder|Completed||Phase 1|56|Actual|Hoffmann-La Roche||7|||f||||||||||||||2017-10-10 23:20:57.984451|2017-10-10 23:20:57.984451
NCT02433080|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-10-25|||April 2015||2015-04-01|August 2015|2015-08-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|DEUS||Diet and Physical Activity in Uterine Cancer Survivors|Randomised, Controlled, Pilot Clinical Trial to Assess the Feasibility of a Healthy Eating and Physical Activity Program in Endometrial Cancer Survivors|Completed||Phase 2|60|Actual|University College, London||2|||f||||f||||||||||2017-10-10 23:20:58.082381|2017-10-10 23:20:58.082381
NCT02433067|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-04-28|||April 2015||2015-04-01|April 2015|2015-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|CARDAPAC||Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast Cancer|Impact of Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast Cancer, During Treatment With Trastuzumab in Adjuvant|Recruiting||N/A|117|Anticipated|University of Franche-Comté||2|||f||||f||||||||||2017-10-10 23:20:58.161944|2017-10-10 23:20:58.161944
NCT02433054|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-05-02|||January 2015||2015-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Bern Venous Stent Registry|Bern Venous Stent Registry|Recruiting||N/A|500|Anticipated|University Hospital Inselspital, Berne|||1||f||||||||||||||2017-10-10 23:20:58.257629|2017-10-10 23:20:58.257629
NCT02433041|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-01-11|||July 2013||2013-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIDe||Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial|Baden PRIDe Trial - Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial|Recruiting||Phase 4|200|Anticipated|University Hospital, Basel, Switzerland||4|||f||||t||||||||||2017-10-10 23:20:58.346751|2017-10-10 23:20:58.346751
NCT02433028|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-11-02|||June 2012||2012-06-01|November 2016|2016-11-01||||January 2042|Anticipated|2042-01-01||Observational|SMSC||Swiss Multiple Sclerosis Cohort-Study|Swiss Multiple Sclerosis Cohort-Study: A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options|Recruiting||N/A|1200|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-10 23:20:58.450641|2017-10-10 23:20:58.450641
NCT02433015|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-06-27|||January 2015||2015-01-01|June 2017|2017-06-01|September 24, 2016|Actual|2016-09-24|September 24, 2016|Actual|2016-09-24||Interventional|ECIG||Neurophysiological and Immunological Effects of the Transition From Combustible to Electronic Cigarettes|Neurophysiological and Immunological Effects of the Transition From Combustible to Electronic Cigarettes|Completed||N/A|27|Actual|Laureate Institute for Brain Research, Inc.||2|||f||||f||||||||||2017-10-10 23:20:58.5441|2017-10-10 23:20:58.5441
NCT02433002|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-05-01|||April 2014||2014-04-01|May 2017|2017-05-01|December 2029|Anticipated|2029-12-01|December 2019|Anticipated|2019-12-01||Observational|eGFR-C||Accuracy of Glomerular Filtration Rate (GFR) Estimation Using Creatinine and Cystatin C and Albuminuria|Accuracy of Glomerular Filtration Rate Estimation Using Creatinine & Cystatin C & Albuminuria for Monitoring Disease Progression in Patients With Stage 3 Chronic Kidney Disease: Prospective Longitudinal Study in a Multi-ethnic Population|Active, not recruiting||N/A|1249|Actual|University of Birmingham|||3||f||||f||||||Samples Without DNA|"     Serum/plasma and urine will be stored for potential analysis of future markers.   "|||2017-10-10 23:20:58.763418|2017-10-10 23:20:58.763418
NCT02432989|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-28|||April 2015||2015-04-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Establishing Early Exercise Interventions in Concussion Recovery|Rest vs. Early Return to Exercise Following Concussion (H15-00307)|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:20:58.872099|2017-10-10 23:20:58.872099
NCT02432976|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2015-05-07|||May 2015||2015-05-01|May 2015|2015-05-01||||December 2017|Anticipated|2017-12-01||Interventional|ExeQOL||Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients|Impact of Intravenous Exenatide Versus Insulin on Quality of Life in Cardiac Surgery Patients: an Ancillary Study of the ExSTRESS Phase II/III Clinical Trial|Recruiting||Phase 2/Phase 3|544|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-10 23:20:58.977477|2017-10-10 23:20:58.977477
NCT02432963|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-10-04|||November 17, 2015||2015-11-17|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy|A Phase I Study of a p53MVA Vaccine in Combination With Pembrolizumab|Recruiting||Phase 1|19|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:20:59.105728|2017-10-10 23:20:59.105728
NCT02432950|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-09-25|||January 7, 2016|Actual|2016-01-07|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer|PANCREATIC NUTRITIONAL PROGRAM (PNP): A Novel Weight Reduction Program in Overweight/Obese Breast Cancer Survivors|Active, not recruiting||N/A|20|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:20:59.212936|2017-10-10 23:20:59.212936
NCT02432937|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-11-02|||January 2015||2015-01-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Corever in the Treatment of Hypertension|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Phase III Study of Corever for the Treatment of Hypertension|Completed||Phase 3|134|Actual|TSH Biopharm Corporation Limited||3|||f||||f||||||||||2017-10-10 23:20:59.329323|2017-10-10 23:20:59.329323
NCT02432924|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-11-18|||October 2014||2014-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Using Combined Instantaneous and Multidimensional Feedback to Support a Change in Physical Activity Behaviour|The Effect of Using Combined Personalised Instantaneous and Multidimensional Physical Activity Feedback on Motivation and Behaviour|Completed||N/A|57|Actual|University of Bath||2|||f||||f||||||||||2017-10-10 23:20:59.437413|2017-10-10 23:20:59.437413
NCT02432911|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-10-06|||April 2015||2015-04-01|May 2016|2016-05-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old|A Multicenter，Open-label，Randomized Study on the Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old|Recruiting||N/A|300|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 23:20:59.538552|2017-10-10 23:20:59.538552
NCT02432898|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-11-01|||July 2014||2014-07-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|||Non-Invasive Imaging of the Human Eye|Non-Invasive Imaging of the Human Eye|Withdrawn||N/A|0|Actual|Topcon Medical Systems, Inc.|||1|No subjects were enrolled in this protocol|f||||f||||||||Undecided||2017-10-10 23:20:59.640012|2017-10-10 23:20:59.640012
NCT02432885|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-05-01|||June 2009||2009-06-01|April 2015|2015-04-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Interventional|||Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial|Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - Angiotensin-Converting-Enzyme (ACE) Inhibitor Therapy|Completed||Phase 3|76|Actual|InCor Heart Institute||2|||f||||f||||||||||2017-10-10 23:20:59.746507|2017-10-10 23:20:59.746507
NCT02432872|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-10-06|||April 2015||2015-04-01|May 2016|2016-05-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years|A Multicenter，Open-label，Radonmized Study on the Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years Old|Recruiting||N/A|300|Anticipated|Chinese Academy of Medical Sciences||4|||f||||t||||||||Undecided||2017-10-10 23:20:59.84144|2017-10-10 23:20:59.84144
NCT02432859|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-07-29|||November 2013||2013-11-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Electrical Stimulation and Expression of VEGF, VEGFR-2, HIF and NO in the Diabetic Foot Ulcer|The Effect of Electrical Stimulation on the Expression of VEGF, VEGFR-2, HIF and NO in the Diabetic Foot Ulcer|Completed||N/A|30|Actual|Tarbiat Modarres University||2|||f||||f||||||||||2017-10-10 23:20:59.967358|2017-10-10 23:20:59.967358
NCT02432846|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-09-27|||April 2015||2015-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MERECA||Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)|An Open-label, Randomized, Controlled, Multicenter, Phase II Study Evaluating Safety and Efficacy of Intratumorally Administered Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy, Compared to Sunitinib Post-nephrectomy in Metastatic Renal Cell Carcinoma Patients|Recruiting||Phase 2|90|Anticipated|Immunicum AB||2|||f||||f|t|f||||||||2017-10-10 23:21:00.076281|2017-10-10 23:21:00.076281
NCT02432833|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-03-08|||May 2015||2015-05-01|March 2017|2017-03-01|January 24, 2017|Actual|2017-01-24|January 24, 2017|Actual|2017-01-24||Interventional|STEADY||Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients|Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients|Completed||Phase 4|428|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||Undecided||2017-10-10 23:21:00.26656|2017-10-10 23:21:00.26656
NCT02432820|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-04-06|||April 2015||2015-04-01|April 2017|2017-04-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Observational|||Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy|Assessment of 3D Transperineal Ultrasound Imaging With Matrix Array Transducers as a Potential Imaging Modality for Adaptive Prostate and Post-Prostatectomy Radiotherapy|Terminated||N/A|7|Actual|Stanford University|||1|Business decision|f||||f||||||||||2017-10-10 23:21:00.368215|2017-10-10 23:21:00.368215
NCT02432807|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-07-25|||May 2015||2015-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis|A Randomized, Multicenter, Double-Masked, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Vancomycin Hydrochloride Ophthalmic Ointment 1.1% in Patients With Moderate to Severe Bacterial Conjunctivitis|Recruiting||Phase 3|150|Anticipated|Kurobe LLC||2|||f||||f||||||||||2017-10-10 23:21:00.462685|2017-10-10 23:21:00.462685
NCT02432794|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-08-26|||May 2015||2015-05-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|APIL_2013||Trial on Delay Phenomenon Utility in Preventing Anastomotic Leakage After an Esophagectomy|A Prospective Randomized Clinical Trial on Delay Phenomenon Utility in Preventing Oesophagogastric Anastomotic Dehiscence After an Ivor-Lewis Esophagectomy|Recruiting||N/A|60|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-10 23:21:00.586653|2017-10-10 23:21:00.586653
NCT02432781|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-10-13|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Oral Carbohydrate in DM Patients Undergoing Total Knee Arthroplasty|Effect of Preoperative Oral Carbohydrates on Postoperative Nausea and Vomiting and Quality of Recovery in DM Patients Undergoing Total Knee Arthroplasty|Recruiting||N/A|82|Anticipated|Severance Hospital||2|||f||||f||||||||||2017-10-10 23:21:00.708156|2017-10-10 23:21:00.708156
NCT02432768|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-31|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)|The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)|Recruiting||Phase 2|28|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:21:00.801593|2017-10-10 23:21:00.801593
NCT02432755|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-02-05|||March 2016||2016-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effects of Home-based Mirror Therapy Combined With Task-oriented Training for Patients With Stroke|Effects of Home-based Mirror Therapy Combined With Task-oriented Training for Patients With Stroke: a Randomized Controlled Trial|Completed||N/A|3|Actual|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-10 23:21:00.924378|2017-10-10 23:21:00.924378
NCT02432742|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-10-13|||May 2015||2015-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate and Severe Nasolabial Folds|A Randomised, Multi-center, Evaluator-blinded Study in China to Evaluate the Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds|Completed||N/A|100|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-10 23:21:01.035369|2017-10-10 23:21:01.035369
NCT02432729|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-09-21|||May 5, 2015|Actual|2015-05-05|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|RIBESC||A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation|A Multi-center, Multi-region Smoking Cessation Study to Understand the Biological and Functional Changes Related to Smoking Cessation in Healthy Smokers Who Are Continuously Abstinent From Smoking for One Year|Completed||N/A|1185|Actual|Philip Morris Products S.A.|||1||f||||f||||||Samples Without DNA|"     Blood and urine bio-banking samples   "|||2017-10-10 23:21:01.114671|2017-10-10 23:21:01.114671
NCT02432716|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-04-24|||April 2015||2015-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigation of the Safety of Intranasal Glulisine in Down Syndrome|A Double-Blind, Placebo-Controlled Pilot Investigation of the Safety of Intranasal Glulisine in Down Syndrome|Recruiting||Phase 1|12|Anticipated|HealthPartners Institute||2|||f||||t||||||||||2017-10-10 23:21:01.227152|2017-10-10 23:21:01.227152
NCT02432703|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-09-22|||June 15, 2015|Actual|2015-06-15|September 2017|2017-09-01|July 10, 2018|Anticipated|2018-07-10|July 10, 2018|Anticipated|2018-07-10||Interventional|||A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder|A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Social Anxiety Disorder.|Recruiting||Phase 2|122|Anticipated|Janssen Research & Development, LLC||2|||f||||f||f||||||||2017-10-10 23:21:01.335242|2017-10-10 23:21:01.335242
NCT02432690|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2017-03-25|||June 2015||2015-06-01|March 2017|2017-03-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation|A Phase II Clinical Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation|Active, not recruiting||Phase 2|30|Anticipated|Boston Biomedical, Inc||1|||f||||||||||||||2017-10-10 23:21:01.46395|2017-10-10 23:21:01.46395
NCT02432677|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-28|||July 2014||2014-07-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of the Potentiating Effect of tDCS on Opioid Analgesia of Pain Threshold in Humans|Evaluation of the Potentiating Effect of Transcranial Direct Current Stimulation (tDCS) on Opioid Analgesia of Pain Threshold in Humans|Unknown status|Recruiting|Phase 2|48|Anticipated|Hospital de Clinicas de Porto Alegre||4|||f||||f||||||||||2017-10-10 23:21:01.538053|2017-10-10 23:21:01.538053
NCT02432664|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-06-30|||April 14, 2015|Actual|2015-04-14|June 2017|2017-06-01|April 22, 2016|Actual|2016-04-22|April 22, 2016|Actual|2016-04-22||Interventional|FIMTRIP||Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ODM-108: in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Single and Multiple Escalating Doses of ODM-108: A Single Centre Study in Healthy Male Volunteers|Terminated||Phase 1|85|Actual|Orion Corporation, Orion Pharma||6||"The study was terminated after the second cohort had completed Part II due complex PK results.   There were no safety concerns."|f||||t||||||||||2017-10-10 23:21:01.635092|2017-10-10 23:21:01.635092
NCT02432651|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-03|||March 2015||2015-03-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|June 2016|Actual|2016-06-01||Interventional|||Xanthohumol and Prevention of DNA Damage|Prevention of Oxidative DNA Damage by Xanthohumol|Active, not recruiting||Phase 1|64|Actual|Oregon State University||3|||f||||t||||||||No||2017-10-10 23:21:01.739115|2017-10-10 23:21:01.739115
NCT02432638|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-11-30|||April 2015||2015-04-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01|19 Years|Observational [Patient Registry]|PROMIS||Pierre Robin Sequence Outcome Assessment Multi Institutional Study|Pierre Robin Sequence Outcome Assessment Multi Institutional Study (PROMIS)|Recruiting||N/A|200|Anticipated|New York University School of Medicine|||1||f||||f||||||||||2017-10-10 23:21:01.943804|2017-10-10 23:21:01.943804
NCT02432625|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-10-26|||June 2015||2015-06-01|October 2016|2016-10-01|June 2025|Anticipated|2025-06-01|June 2020|Anticipated|2020-06-01||Observational|||BBD Longitudinal Study of Osteogenesis Imperfecta|Rare Diseases Clinical Research Network Brittle Bone Disease Consortium Longitudinal Study of Osteogenesis Imperfecta|Recruiting||N/A|1000|Anticipated|Baylor College of Medicine|||1||f||||t||||||Samples With DNA|"     1. Blood        2. Skin cells        3. Urine   "|||2017-10-10 23:21:02.068752|2017-10-10 23:21:02.068752
NCT02432612|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-03-01|||October 2015||2015-10-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer|An Open-label, Multi-centre, Single-dose Clinical Trial to Assess the Pharmacokinetic (PK) Properties and Tolerability of a Single Oromucosal Dose of 6 Sprays of Sativex® in Patients With Advanced Cancer Currently on Background Step III Opioid Therapy|Withdrawn||Phase 1|0|Actual|GW Pharmaceuticals Ltd.||1|||f||||f||||||||||2017-10-10 23:21:02.202553|2017-10-10 23:21:02.202553
NCT02432599|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-29|2016-08-02|||March 2015||2015-03-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|APACH1||Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas|Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas|Recruiting||Phase 2|24|Anticipated|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-10 23:21:02.324049|2017-10-10 23:21:02.324049
NCT02432586|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-06-21|||July 2014||2014-07-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|August 2016|Actual|2016-08-01||Interventional|TotCamp||Pilot Study: Intensive Education in a Residential Camp Setting for Families of Young Children With Type 1 Diabetes|Pilot Study: Intensive Education in a Residential Camp Setting for Families of Young Children With Type 1 Diabetes|Completed||N/A|18|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||No||2017-10-10 23:21:02.422533|2017-10-10 23:21:02.422533
NCT02432573|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-02-11|||May 2015||2015-05-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PP rounds||Timing of Morning Rounds for Postpartum Hospitalized Women|Timing of Morning Rounds for Postpartum Hospitalized Women: A Randomized Controlled Quality Improvement Trial|Completed||N/A|150|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:21:02.499967|2017-10-10 23:21:02.499967
NCT02432560|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-05-01|||March 2015||2015-03-01|April 2015|2015-04-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Observational|MIDAS||Safety and Durability of Sirolimus for Treatment of LAM|Multicenter International Durability and Safety of Sirolimus in LAM Trial (MIDAS)|Recruiting||N/A|300|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||t||||||||||2017-10-10 23:21:02.584061|2017-10-10 23:21:02.584061
NCT02432547|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-06-02|||June 2015||2015-06-01|June 2015|2015-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|LADAMO||Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)|A Phase IV Randomised Clinical Trial of Laser Therapy for Peripheral Retinal Ischaemia Combined With Intravitreal Aflibercept (Eylea®) Versus Intravitreal Aflibercept Monotherapy for Diabetic Macular Oedema|Recruiting||Phase 4|80|Anticipated|University of Sydney||2|||f||||t||||||||||2017-10-10 23:21:02.701767|2017-10-10 23:21:02.701767
NCT02432534|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-03-30|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|February 2017|Actual|2017-02-01||Interventional|||Atorvastatin in Active Vitiligo|Atorvastatin in Active Vitiligo: a Bicentric Prospective Randomized Trial|Active, not recruiting||Phase 2|28|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 23:21:02.935947|2017-10-10 23:21:02.935947
NCT02432521|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-07-03|||March 2015||2015-03-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|June 2017|Actual|2017-06-01||Observational|||Predictors of Treatment Response of Motor Sequels After a Stroke|Predictors of Treatment Response of Motor Sequels After a Cerebrovascular Accident|Active, not recruiting||N/A|49|Actual|University of Sao Paulo General Hospital|||1||f||||t||||||||||2017-10-10 23:21:03.030414|2017-10-10 23:21:03.030414
NCT02432508|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-05-01|||October 2014||2014-10-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis|Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis: A Multiple Centers, Randomized, Assessor- and Participant-blind, Controlled, Cross-over Clinical Trial|Unknown status|Recruiting|N/A|200|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-10 23:21:03.120823|2017-10-10 23:21:03.120823
NCT02432495|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-28|||April 2008||2008-04-01|April 2015|2015-04-01||||January 2014|Actual|2014-01-01||Observational|||Anterior Screw Fixation Versus Halo Immobilization of Type II Odontoid Fractures in Geriatric Patients With Increased Anesthesia Risk||Completed||N/A|80|Actual|Medical University of Vienna|||2||f||||||||||||||2017-10-10 23:21:03.212325|2017-10-10 23:21:03.212325
NCT02432482|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-04-28|||August 2015||2015-08-01|April 2015|2015-04-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|||A Mobile Intervention to Promote Cessation in HIV-infected Smokers|A Mobile Intervention to Promote Cessation in HIV-infected Smokers|Unknown status|Not yet recruiting|N/A|100|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 23:21:03.301899|2017-10-10 23:21:03.301899
NCT02432469|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2015-06-21|||June 2015||2015-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|MISSION-2||Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence|Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence|Unknown status|Recruiting|N/A|1000|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t||||||||||2017-10-10 23:21:03.415542|2017-10-10 23:21:03.415542
NCT02432456|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-02-12|||September 2015||2015-09-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients|Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients|Recruiting||Phase 4|132|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||Undecided||2017-10-10 23:21:03.529401|2017-10-10 23:21:03.529401
NCT02432443|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-03-21|||June 2015||2015-06-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|PLAY||Play and Pre-Literacy Among Young Children|Play and Pre-Literacy Among Young Children|Completed||N/A|53|Actual|McMaster University||2|||f||||f||||||||||2017-10-10 23:21:03.68666|2017-10-10 23:21:03.68666
NCT02432430|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-05-01|||June 2013||2013-06-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|CIzQIDS||Comparison of Immunization Quality Improvement Dissemination Study||Completed||N/A|2186|Actual|Children's Research Institute||2|||f||||f||||||||||2017-10-10 23:21:03.805666|2017-10-10 23:21:03.805666
NCT02432417|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-05-16|||January 2018|Anticipated|2018-01-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The Addition of Chloroquine to Chemoradiation for Glioblastoma,|A Phase II Randomized Controlled Trial for the Addition of Chloroquine, an Autophagy Inhibitor, to Concurrent Chemoradiation for Newly Diagnosed Glioblastoma|Not yet recruiting||Phase 2|156|Anticipated|Maastricht Radiation Oncology||2|||f||||t|f|f||||||||2017-10-10 23:21:03.889391|2017-10-10 23:21:03.889391
NCT02432404|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-10-27|||March 2016||2016-03-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity|Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity|Recruiting||Phase 4|120|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 23:21:03.990767|2017-10-10 23:21:03.990767
NCT02432391|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-04-28|||May 2013||2013-05-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Lifestyle Modification for Type 2 Diabetes Involving Reduction of After-meal Blood Glucose Elevations|Self-Monitoring of Blood Glucose (SMBG) as an Educational Tool and a Negative Feedback Loop to Reinforce Blood Glucose Lowering and Discourage Blood Glucose Elevating Self-Management Behaviors in Adults With T2DM|Completed||N/A|47|Actual|University of Virginia||2|||f||||f||||||||||2017-10-10 23:21:04.102463|2017-10-10 23:21:04.102463
NCT02432378|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-09-25|||July 2015||2015-07-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|July 31, 2018|Anticipated|2018-07-31||Interventional|||Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines|A Phase 1-2 Neoadjuvant Dose Finding, Safety, and Immunologic Efficacy Trial of Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer and Tumor-Specific Intranodal Autologous Alpha-DC1 Vaccines|Recruiting||Phase 1/Phase 2|40|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 23:21:04.188775|2017-10-10 23:21:04.188775
NCT02432365|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-05-01|||February 2015||2015-02-01|April 2015|2015-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy|Phase II Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy|Recruiting||Phase 2|64|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-10 23:21:04.321949|2017-10-10 23:21:04.321949
NCT02432352|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2017-07-31|||May 2015||2015-05-01|July 2017|2017-07-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Our Family Our Future: Acceptability and Feasibility Study of a Family Prevention Program for HIV Risk and Depression|Our Family Our Future: Family Prevention of HIV Risk and Depression in HIV-endemic South Africa|Completed||Phase 1|152|Anticipated|Brown University||2|||f||||f||||||||||2017-10-10 23:21:04.42325|2017-10-10 23:21:04.42325
NCT02432339|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-12-07|||April 2014||2014-04-01|December 2016|2016-12-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|MMF||Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress|Comparing the Effects of an Immunosuppressant (Mycophenolate Mofetil or MMF) on the Urinary Sodium Excretion Response to Mental Stress in a Crossover Design (MMF)|Recruiting||Phase 1/Phase 2|50|Anticipated|Augusta University||2|||f||||t||||||||Yes|"The following avenues of dissemination will be used to share the research results:
Publications: Study results that are published will be made available in PubMed-cited journals and submitted to PubMed Central in a timely fashion. All data that involves human subjects will be de-identified and presented in a format that protects the identity and privacy of study participants. Publication of results in professional peer reviewed journals will be a priority. All publications will acknowledge the support of the NIH/NHLBI per notice of award guidelines. Every effort will be made to publish scientific results from this project in a timely manner.
Presentation at Scientific meetings: Abstracts will be submitted to the local, regional, and national association meetings such as annual meetings of the American Heart Association Council for High Blood Pressure Research, American Society of Hypertension, and American Society of Nephrology as well as Experimental Biology."|2017-10-10 23:21:04.516798|2017-10-10 23:21:04.516798
NCT02432313|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-10-30|||January 2015||2015-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Modified and Immediate Release Anatabine Citrate Formulations|3-Part Study With 2 6-Period Single Dose Parts (Pt 1, Pt 2 Optional) Followed by a 1-Period Multiple Dose Part (Pt 3) to Evaluate Prototype Modified Release Matrix and Multi Particulate Formulations of Anatabine Citrate to Determine PK|Completed||Phase 1|37|Actual|Rock Creek Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:21:04.720317|2017-10-10 23:21:04.720317
NCT02432287|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-06-26|||October 2014|Actual|2014-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MILES||Metformin in Longevity Study|Metformin in Longevity Study|Active, not recruiting||Phase 4|15|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-10 23:21:04.883757|2017-10-10 23:21:04.883757
NCT02432274|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-09-29|||December 29, 2014|Actual|2014-12-29|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma|Phase 1/2 Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma|Recruiting||Phase 1/Phase 2|108|Anticipated|Eisai Inc.||5|||f||||f|t|f||||||||2017-10-10 23:21:04.955235|2017-10-10 23:21:04.955235
NCT02432261|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-04-18|||April 2015||2015-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men|A Randomized, Two Center, Double-Blind Trial to Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Healthy Men|Completed||Phase 1|44|Actual|Health Decisions||2|||f||||t||||||||||2017-10-10 23:21:05.110561|2017-10-10 23:21:05.110561
NCT02432248|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-04-28|||February 2015||2015-02-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of DHEA on Patients With Poor Ovarian Responds|Effect of Dehydroepiandrosterone on Live Birth Rate in Subfertile Patients With Poor Ovarian Responds|Recruiting||N/A|350|Anticipated|The Affiliated Hospital of Inner Mongolia Medical University||2|||f||||f||||||||||2017-10-10 23:21:05.300244|2017-10-10 23:21:05.300244
NCT02432222|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-07-11|||April 2015||2015-04-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Visual Arts Training on Dementia|Effects of Visual Arts Training on Dementia|Completed||N/A|23|Actual|York University||3|||f||||f||||||||Undecided||2017-10-10 23:21:05.533903|2017-10-10 23:21:05.533903
NCT02432209|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-05-05|||August 2015||2015-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|FIT-PLESE||Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility|Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility|Recruiting||Phase 3|390|Anticipated|Yale University||2|||f||||t||||||||Yes|IPD will be shared with other researchers through the NICHD DASH system. It will be available 6 months after publication of the primary results.|2017-10-10 23:21:05.623739|2017-10-10 23:21:05.623739
NCT02432196|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-08-08|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2016|Actual|2016-02-01||Interventional|EFS||Safety and Early Feasibility Study of the Harpoon Medical Device|First In Man - Clinical Validation of the TSD-5|Active, not recruiting||N/A|13|Actual|Harpoon Medical||1|||f||||f||||||||||2017-10-10 23:21:05.76447|2017-10-10 23:21:05.76447
NCT02432183|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-06-09|||September 2012||2012-09-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|||Longitudinal Follow-up of High School Athletes|Longitudinal Follow-up of Exercise-induced Bronchoconstriction and Airway Inflammation in High School Athletes|Completed||N/A|125|Actual|Universitaire Ziekenhuizen Leuven|||4||f||||f||||||Samples With DNA|"     induced sputum sample and venous blood (serum)   "|||2017-10-10 23:21:05.833534|2017-10-10 23:21:05.833534
NCT02432170|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-05-10|||April 2015||2015-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe|Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe|Recruiting||N/A|50|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 23:21:05.897768|2017-10-10 23:21:05.897768
NCT02432157|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-02-10|||January 2015||2015-01-01|February 2016|2016-02-01||||January 2017|Anticipated|2017-01-01||Interventional|HS3||Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:|Hypertonic Saline Solution in Aneurysmal Subarachnoid Hemorrhage: A Randomized - Phase II Single Blinded Clinical Trial|Recruiting||Phase 1/Phase 2|50|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-10 23:21:05.969667|2017-10-10 23:21:05.969667
NCT02432144|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-04-18|||October 2015||2015-10-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects With MPS 7|A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects With MPS 7|Active, not recruiting||Phase 3|20|Anticipated|Ultragenyx Pharmaceutical Inc||1|||f||||f||||||||No|There is no plan to share data at this time.|2017-10-10 23:21:06.060464|2017-10-10 23:21:06.060464
NCT02432131|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-11-22|||May 2015||2015-05-01|November 2016|2016-11-01|February 2022|Anticipated|2022-02-01|December 2021|Anticipated|2021-12-01|3 Years|Observational [Patient Registry]|DIVER-PFO||Decompression Sickness in Divers With or Without Patent Foramen Ovale|Incidences of Decompression Sickness in SCUBA DIVERs With or Without Patent Foramen Ovale (DIVER-PFO); A Double-blinded, Prospective Cohort Study|Recruiting||N/A|220|Anticipated|Sejong General Hospital|||2||f||||f||||||||||2017-10-10 23:21:06.145509|2017-10-10 23:21:06.145509
NCT02432118|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-01-31|||May 2015||2015-05-01|January 2017|2017-01-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing Lumpectomy|A Feasibility Study of Radiofrequency Identification (RFID) Localization of Breast Lesions|Withdrawn||N/A|0|Actual|Stanford University||1||Insufficient resources|f||||t||||||||||2017-10-10 23:21:06.220237|2017-10-10 23:21:06.220237
NCT02432105|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-06-15|2017-06-15||June 25, 2015|Actual|2015-06-25|June 2017|2017-06-01|June 15, 2016|Actual|2016-06-15|June 15, 2016|Actual|2016-06-15||Interventional||This analysis population includes all randomized subjects, including those who underwent concurrent adenoidectomy and/or tonsillectomy (Intent-to-treat (ITT) analysis set).|Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)|Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion|Completed||Phase 3|470|Actual|Alcon Research||3|||f||||f||||||||||2017-10-10 23:21:06.294844|2017-10-10 23:21:06.294844
NCT02432092|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-08-22|||April 2014||2014-04-01|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Observational|||Pediatric Cardiomyopathy Mutation Analysis|Pediatric Cardiomyopathy Mutation Analysis|Recruiting||N/A|300|Anticipated|Indiana University|||2||f||||f||||||Samples With DNA|"     Whole Blood, Saliva, Tissue   "|||2017-10-10 23:21:06.620046|2017-10-10 23:21:06.620046
NCT02432079|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-08-22|||July 2009||2009-07-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Molecular Genetics of Heterotaxy and Related Congenital Heart Defects|Molecular Genetics of Heterotaxy and Related Congenital Heart Defects|Recruiting||N/A|2000|Anticipated|Indiana University|||1||f||||f||||||Samples With DNA|"     Whole Blood, Tissue Sample, Cheek Swabs, Saliva   "|||2017-10-10 23:21:06.690395|2017-10-10 23:21:06.690395
NCT02432053|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-04-28|||March 2012||2012-03-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India|An Open Label, Multi-centre, Prospective Study to Demonstrate Safety and Efficacy of Once Daily Advagraf in Patients Undergoing Kidney or Liver Transplantation in India|Completed||Phase 4|92|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-10 23:21:08.809757|2017-10-10 23:21:08.809757
NCT02432040|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2015-10-21|2015-05-02||February 2013||2013-02-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis|Atorvastatin as Adjunctive Therapy for Chronic Plaque Type Psoriasis Versus Betamethasone Valerate Alone:A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|28|Actual|Philippine Dermatological Society||2|||f||||t||||||||||2017-10-10 23:21:08.954371|2017-10-10 23:21:08.954371
NCT02431832|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-08-28|||February 2015||2015-02-01|August 2016|2016-08-01||||October 2015|Actual|2015-10-01||Interventional|||Exploration of microRNA and Metabolomics Biomarkers Predicting Drug Induced Liver Injury in Elderly People||Completed||Phase 1|17|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-10 23:21:11.125335|2017-10-10 23:21:11.125335
NCT02432027|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-08-16|||June 2015||2015-06-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test|A Single-Center, Randomized, Observer Blind, Vehicle- and Comparator-controlled Trial to Evaluate the Antipsoriatic Efficacy and Safety of Topical Formulations of C-82 in a Psoriasis Plaque Test|Completed||Phase 1/Phase 2|14|Actual|Prism Pharma Co., Ltd.||4|||f||||f||||||||||2017-10-10 23:21:09.44976|2017-10-10 23:21:09.44976
NCT02432014|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-05-10|||January 2012||2012-01-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Parent Preferences and Family Engagement in a Conduct Problems Prevention Program|DCISR for Adaptive Intervention Models in Children's Mental Health|Completed||N/A|134|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||||2017-10-10 23:21:09.541458|2017-10-10 23:21:09.541458
NCT02432001|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-07-20|||January 2013||2013-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Radiologically Guided Biopsies of mCRPC|Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer (mCRPC) to Identify Adaptive Mechanisms of Resistance|Recruiting||N/A|300|Anticipated|University of California, San Francisco|||1||f||||t||||||||||2017-10-10 23:21:09.637438|2017-10-10 23:21:09.637438
NCT02431988|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-09-01|||June 2016||2016-06-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|COBALT||Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation|COBALT: Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation|Recruiting||Phase 1|12|Anticipated|University College, London||1|||f||||t||||||||||2017-10-10 23:21:09.729003|2017-10-10 23:21:09.729003
NCT02431975|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-07-18|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|LEOPARD||Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial|Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial|Recruiting||Phase 4|60|Anticipated|Columbia University||1|||f||||t|f|f|||f|||||2017-10-10 23:21:09.969982|2017-10-10 23:21:09.969982
NCT02431962|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-10-05|||April 2015||2015-04-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Alberta Lung Cancer Screening Program|Alberta Lung Cancer Screening Program|Active, not recruiting||N/A|800|Anticipated|University of Calgary||3|||f||||f||||||||||2017-10-10 23:21:10.116771|2017-10-10 23:21:10.116771
NCT02431949|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-05-24|||June 2015||2015-06-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01|2 Weeks|Observational [Patient Registry]|MARS||The Music Study in Refractory Psychosis|A Cross-sectional Analysis of Musical Ability in Patients With Refractory Schizophrenia|Recruiting||N/A|100|Anticipated|University of British Columbia|||2||f||||f||||||||||2017-10-10 23:21:10.212913|2017-10-10 23:21:10.212913
NCT02431936|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-10-19|||April 2015||2015-04-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress|Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress in a Randomized Double Blind Placebo Controlled Design|Recruiting||Phase 2|50|Anticipated|Augusta University||2|||f||||t||||||||Yes|Dissemination will be carried out in a variety of ways that will be accessible to other scientists studying psychosocial stress, hypertension, and the control of fluid-electrolyte balance and blood pressure. These include publications made available through PubMed-cited journals and presentations at scientific meetings and various organizations.|2017-10-10 23:21:10.30232|2017-10-10 23:21:10.30232
NCT02431923|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-30|2017-07-13|||April 24, 2015||2015-04-24|July 12, 2017|2017-07-12|January 1, 2030|Anticipated|2030-01-01|May 31, 2025|Anticipated|2025-05-31||Observational|||Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up|Partnership for Research on Ebola Virus (PREVAIL) III: Ebola Natural History Study|Recruiting||N/A|7500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:21:10.4135|2017-10-10 23:21:10.4135
NCT02431910|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-04-24|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IDEKTNP||Immediate and Delayed Effects of Kinesio Taping on the Neuromuscular Performance|Immediate and Delayed Effects of Kinesio Taping on the Neuromuscular Performance, Balance and Lower Limb Function of Healthy Subjects: Randomized Clinical Trial|Completed||N/A|60|Actual|Universidade Federal do Rio Grande do Norte||3|||f||||f||||||||||2017-10-10 23:21:10.501829|2017-10-10 23:21:10.501829
NCT02431897|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-12-08|||December 2016||2016-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Interventional|IMPROVE||Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen|Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen|Recruiting||Phase 4|222|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 23:21:10.598602|2017-10-10 23:21:10.598602
NCT02431884|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-09-17|||January 2012||2012-01-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01|1 Day|Observational [Patient Registry]|||Tissue Samples and Bodily Fluid Specimens Banking|Tissue and Bodily Fluid Specimens From Women Presenting to the Reproductive Endocrinology Clinic|Unknown status|Recruiting|N/A|200|Anticipated|University of Tennessee|||1||f||||f||||||Samples Without DNA|"     A portion of blood/tissue specimens that will be generated during the participants office     visit or surgery.   "|||2017-10-10 23:21:10.736669|2017-10-10 23:21:10.736669
NCT02431871|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-05-03|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|December 2026|Anticipated|2026-12-01|December 2019|Anticipated|2019-12-01||Observational|||Sequelae of Developmental Dysplasia of the Hip|Structural and Functional Sequelae of Developmental Dysplasia of the Hip|Recruiting||N/A|340|Anticipated|University of Oulu|||2||f||||f||||||||||2017-10-10 23:21:10.835541|2017-10-10 23:21:10.835541
NCT02431858|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-04-18|||May 2015||2015-05-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Catheter Over Needle vs Catheter Through Needle|Catheter Over Needle Technique Causes Less Leakage and Secondary Failure Than Catheter Through Needle Technique for Continuous Femoral Nerve Block|Completed||Phase 4|110|Actual|Sir Charles Gairdner Hospital||2|||f||||f||||||||||2017-10-10 23:21:10.941739|2017-10-10 23:21:10.941739
NCT02431845|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-04-24|||January 2013||2013-01-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Pharmacogenetic Study of Obsessive-Compulsive Disorder|Pharmacogenetic Study of Obsessive-Compulsive Disorder|Recruiting||N/A|200|Anticipated|Severance Hospital||1|||f||||t|f|f||||||No||2017-10-10 23:21:11.034158|2017-10-10 23:21:11.034158
NCT02431819|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-03-09|||February 2015||2015-02-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Evaluation of the Safety of Compressive Socks to Treat Venous Insufficiency in Patients With Peripheral Arterial Disease|Single Center Prospective Study Evaluating the Safety of Progressive Compressive Stockings for the Treatment of Venous Insufficiency in Patients With Peripheral Arterial Disease|Completed||N/A|18|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||t||||||||||2017-10-10 23:21:11.195055|2017-10-10 23:21:11.195055
NCT02431793|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-01-20|||May 2015||2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|EMC2||EHR‐Based Medication Complete Communication Strategy to Promote Safe Opioid Use|EHR‐Based Medication Complete Communication Strategy to Promote Safe Opioid Use|Recruiting||N/A|816|Anticipated|Northwestern University||3|||f||||t||||||||||2017-10-10 23:21:11.721992|2017-10-10 23:21:11.721992
NCT02431780|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-03-29|||March 2015||2015-03-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2017|Actual|2017-02-01||Interventional|ANSeR||A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection|A Multi-centre, Randomised, Controlled, Clinical Investigation of a Standalone Decision Support Algorithm for Neonatal Seizure Recognition|Active, not recruiting||N/A|264|Actual|University College Cork||2|||f||||f||||||||||2017-10-10 23:21:11.82027|2017-10-10 23:21:11.82027
NCT02431767|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-10-17|||August 2015||2015-08-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Interventional|||Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of PENNVAX®-GP (Gag, Pol, Env) DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adult Participants|Active, not recruiting||Phase 1|94|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||t||||||||||2017-10-10 23:21:11.929596|2017-10-10 23:21:11.929596
NCT02431754|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-06-02|2017-01-10||April 2015||2015-04-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||All randomized participants.|A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).|A Post-Marketing Clinical Study of LY450190 (Combined With Alpha1 Blocker Treatment)|Completed||Phase 4|171|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:21:12.063371|2017-10-10 23:21:12.063371
NCT02431741|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-04-18|2016-03-04||October 2014||2014-10-01|April 2015|2015-04-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Performance and Safety of an Antimicrobial Foam Transferring Dressing in Patients With Malignant Wounds|Title: A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Performance and Safety of an Antimicrobial Foam Transferring Dressing in Patients With Malignant Wounds|Completed||N/A|14|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-10 23:21:12.839229|2017-10-10 23:21:12.839229
NCT02431728|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2016-08-04|||May 2015||2015-05-01|August 2015|2015-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|M-PAWS||The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program|The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program: A Randomized, Double Blind, Placebo, Controlled Trial|Completed||Phase 1/Phase 2|70|Actual|Duquesne University||2|||f||||f||||||||No|All data were in aggregrate with no personal identification.|2017-10-10 23:21:13.061011|2017-10-10 23:21:13.061011
NCT02431715|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-12-28|||October 2012||2012-10-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Expanded Access|||18F-FDOPA PET in Neuroendocrine Tumours|[18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA) Positron Emission Tomography (PET) in Neuroendocrine Tumours|Available||N/A|||British Columbia Cancer Agency|||||f||||||||||||||2017-10-10 23:21:13.155423|2017-10-10 23:21:13.155423
NCT02431702|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-09-22|||July 8, 2015|Actual|2015-07-08|September 2017|2017-09-01|November 19, 2019|Anticipated|2019-11-19|July 20, 2018|Anticipated|2018-07-20||Interventional|DREaM||A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform|A Prospective, Matched-Control, Randomized, Open-Label, Flexible-Dose, Study in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics|Recruiting||Phase 3|275|Anticipated|Janssen Scientific Affairs, LLC||6|||f||||f||f||||||||2017-10-10 23:21:13.244798|2017-10-10 23:21:13.244798
NCT02431689|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-02-07|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Delayed Embryo Transfer in Poor Responders|Antagonist and Short Protocols in Invitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) Cycles With Delayed Embryo Transfer in Poor Ovarian Response|Active, not recruiting||N/A|400|Actual|Cairo University||2|||f||||t|f|f||||||No||2017-10-10 23:21:13.43823|2017-10-10 23:21:13.43823
NCT02431676|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-04-26|||May 2015||2015-05-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|SPIRIT||Survivorship Promotion In Reducing IGF-1 Trial|Trial of Behavioral Weight Loss and Metformin Treatment to Lower Insulin Growth Factor in Cancer Survivors|Active, not recruiting||Phase 2|121|Actual|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-10 23:21:13.514288|2017-10-10 23:21:13.514288
NCT02431663|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-05-04|||April 2015||2015-04-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|KETASER01||Ketamine in Refractory Convulsive Status Epilepticus|Efficacy of Ketamine in Refractory Convulsive Status Epilepticus in Children: a Multicenter, Randomized, Controlled, Open-label, No-profit, With Sequential Design Study.|Unknown status|Recruiting|Phase 3|57|Anticipated|Meyer Children's Hospital||2|||f||||f||||||||||2017-10-10 23:21:13.597148|2017-10-10 23:21:13.597148
NCT02431650|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-06-15|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|OZGAM||Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent|A Proof-Of-Concept Study to Assess the Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent in Experimental P. Falciparum Infection|Completed||Phase 1/Phase 2|12|Actual|Medicines for Malaria Venture||2|||f||||f||||||||No||2017-10-10 23:21:13.788536|2017-10-10 23:21:13.788536
NCT02431637|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-06-15|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|EFITA||Experimental Falciparum Transmission to Anopheles|Blood Stage Challenge Study to Asses Mosquito Transmissibility in Participants Inoculated With Plasmodium Falciparum|Completed||Phase 1|6|Actual|Medicines for Malaria Venture||1|||f||||f||||||||No||2017-10-10 23:21:13.904427|2017-10-10 23:21:13.904427
NCT02431624|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-02-08|||March 2015||2015-03-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|||An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion|A Two Period, Randomised, Open-label, Crossover Study to Assess the Adhesion of Buprenorphine Transdermal Delivery System 40 µg/h Patch and 20 µg/h Patch, in Healthy Volunteers|Completed||Phase 1|40|Actual|Mundipharma Research Limited||2|||f||||f||||||||||2017-10-10 23:21:14.001178|2017-10-10 23:21:14.001178
NCT02431611|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-09-05|||March 2015||2015-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MAW Phase 3||Biomarker Feedback to Motivate Cessation in Pregnancy|Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women (MAW) - Phase 3 Pilot Clinical Trial|Active, not recruiting||Phase 2|60|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:21:14.080531|2017-10-10 23:21:14.080531
NCT02431598|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-03-03|2016-09-15||June 2015||2015-06-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Eovist vs. Dotarem Healthy Volunteer MRI|Randomized, Blinded, Placebo-controlled Crossover Study Assessing Association Between Gadolinium-based Contrast Agent Administration and Transient Dyspnea/Arterial Phase Motion Artifact|Completed||Phase 4|44|Actual|Duke University||3|||f||||f||||||||||2017-10-10 23:21:14.165674|2017-10-10 23:21:14.165674
NCT02431585|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-04-30|||April 2015||2015-04-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|GS-IBS||Prevalence of Gluten Sensitivity in Irritable Bowel Syndrome: The First Study in Paediatrics.|Prevalence of Gluten Sensitivity in Irritable Bowel Syndrome: The First Study in Paediatrics. (GS-IBS)|Unknown status|Recruiting|N/A|100|Anticipated|University of Bari||1|||f||||t||||||||||2017-10-10 23:21:14.497291|2017-10-10 23:21:14.497291
NCT02431572|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-03-01|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|July 2018|Anticipated|2018-07-01||Interventional|||A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy|A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-10 23:21:14.611934|2017-10-10 23:21:14.611934
NCT02431559|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-07-06|||November 2015||2015-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 1/2 Study of Motolimod (VTX-2337) and MEDI4736 in Subjects With Recurrent, Platinum-Resistant Ovarian Cancer for Whom Pegylated Liposomal Doxorubicin (PLD) is Indicated|A Phase 1/2 Study of Chemo-immunotherapy With Toll-like Receptor 8 Agonist Motolimod (VTX-2337) and Anti-PD-L1 Antibody MEDI4736 in Subjects With Recurrent, Platinum-Resistant Ovarian Cancer for Whom Pegylated Liposomal Doxorubicin (PLD) is Indicated|Recruiting||Phase 1/Phase 2|53|Anticipated|Ludwig Institute for Cancer Research||2|||f||||f||||||||||2017-10-10 23:21:14.727691|2017-10-10 23:21:14.727691
NCT02431546|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-04-03|||July 2015||2015-07-01|April 2017|2017-04-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Interventional|||VIDA Mobile Health Cardiovascular Prevention Program|A Lifestyle-Based Mobile Health Strategy for Cardiovascular Disease Prevention in Graduates From Cardiac Rehabilitation: VIDA Pilot Study|Completed||N/A|34|Actual|Duke University||2|||f||||t||||||||||2017-10-10 23:21:14.840984|2017-10-10 23:21:14.840984
NCT02431533|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-09-26|||January 2016||2016-01-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome|The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome: A Randomized, Double-Blind Placebo Controlled Clinical Trial|Recruiting||Phase 2|94|Anticipated|Pharmabiotix Inc||2|||f||||f||||||||||2017-10-10 23:21:14.933341|2017-10-10 23:21:14.933341
NCT02431520|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-05-05|||May 2007||2007-05-01|May 2015|2015-05-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Patient Compliance to Self-collection for Detection of HPV-DNA|Patient Compliance to Self-collection for Detection of HPV-DNA in Cervical Cancer Prevention: A Clinical Trial|Completed||N/A|100|Actual|Oswaldo Cruz Foundation||2|||f||||f||||||||||2017-10-10 23:21:15.04103|2017-10-10 23:21:15.04103
NCT02431507|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-05-05|||September 2015||2015-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|MAGNAP||Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety|Magnetic Apnea Prevention (MAGNAP) Device to Treat Obstructive Sleep Apnea: First-In-Human Study of Feasibility and Safety|Recruiting||N/A|10|Anticipated|University of California, San Francisco||1|||f||||t||||||||Undecided||2017-10-10 23:21:15.127904|2017-10-10 23:21:15.127904
NCT02431494|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-05-02|||February 2015||2015-02-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris|Safety and Preliminary Efficacy of Combination Blue Light Phototherapy and Microcurrent Therapy for the Treatment of Acne Vulgaris|Recruiting||N/A|60|Anticipated|Nova Southeastern University||3|||f||||f||||||||||2017-10-10 23:21:15.228982|2017-10-10 23:21:15.228982
NCT02431468|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-10-11|||November 2015||2015-11-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease|A Randomized, Double-Blind,Placebo-Controlled, Phase 2 Study Assessing the Safety, Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease|Active, not recruiting||Phase 2|150|Anticipated|Neurotrope Bioscience, Inc.||3|||f||||t||||||||||2017-10-10 23:21:15.451629|2017-10-10 23:21:15.451629
NCT02431455|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-07-15|2016-04-04||June 2015||2015-06-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Effect of Postoperative Incentive Spirometry on Pulmonary Function and Pulmonary Complications in Bariatric Surgery|The Effect of Postoperative Incentive Spirometry on Pulmonary Function and Pulmonary Complications in Bariatric Surgery|Completed||N/A|224|Actual|Lahey Clinic||2|||f||||f||||||||||2017-10-10 23:21:15.595058|2017-10-10 23:21:15.595058
NCT02431442|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-04-30|||January 2012||2012-01-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers|A Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM 493 Administered to Healthy Obese Non-diabetic Volunteers|Completed||Phase 1|57|Actual|Rhythm Pharmaceuticals, Inc.||12|||f||||f||||||||||2017-10-10 23:21:15.864955|2017-10-10 23:21:15.864955
NCT02431429|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-02-28|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01||Observational|||Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis|Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis|Recruiting||N/A|55|Anticipated|Knight Therapeutics (USA) Inc|||1||f||||f||||||||||2017-10-10 23:21:15.963581|2017-10-10 23:21:15.963581
NCT02431416|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-04-19|||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty|Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Precocious Puberty|Recruiting||N/A|20|Anticipated|Region Örebro County||2|||f||||f||||||||No||2017-10-10 23:21:16.061527|2017-10-10 23:21:16.061527
NCT02431403|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-05-03|||February 2015||2015-02-01|May 2015|2015-05-01||||February 2020|Anticipated|2020-02-01||Interventional|||ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma|Open-labeled, Multicenter, Phase I/II Study of Imatinib Combined With ESHAP as Salvage Therapy in Relapsed/Refractory Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|94|Anticipated|Pusan National University Hospital||4|||f||||f||||||||||2017-10-10 23:21:16.150548|2017-10-10 23:21:16.150548
NCT02431390|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2015-04-27|||May 2015||2015-05-01|April 2015|2015-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Upper Limb Biofeedback Rehabilitation System (RAPAELⓇ Smart Glove Digital Treatment System) Training for Stroke Recovery|Effect of RAPAELⓇ Smart Glove Digital Treatment System on Upper Limb Functional Recovery and Brain Plasticity in Stroke Patients|Unknown status|Not yet recruiting|N/A|80|Anticipated|Pusan National University||2|||f||||t||||||||||2017-10-10 23:21:16.255114|2017-10-10 23:21:16.255114
NCT02431377|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-11-02|||April 2015||2015-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula|Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study|Completed||N/A|40|Actual|Nestlé||1|||f||||f||||||||||2017-10-10 23:21:16.36296|2017-10-10 23:21:16.36296
NCT02431364|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-12-02|||May 2015||2015-05-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential, Dose-Escalating Trial to Evaluate the Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adult Subjects|Completed||Phase 1|32|Actual|Karyopharm Therapeutics Inc||7|||f||||f||||||||||2017-10-10 23:21:16.429473|2017-10-10 23:21:16.429473
NCT02431351|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-03-28|||November 2015||2015-11-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01||Interventional|SIER||Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients|A Phase 2, Open-Label, Single Arm Study Evaluating the Efficacy and Safety of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Erythropoietin (EPO)-Refractory Lower-Risk Myelodysplastic Syndrome (MDS)|Withdrawn||Phase 2|0|Actual|Karyopharm Therapeutics Inc||1||Trial never opened.|f||||f||||||||||2017-10-10 23:21:16.508378|2017-10-10 23:21:16.508378
NCT02431338|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-04-30|||February 2007||2007-02-01|April 2015|2015-04-01|September 2015|Anticipated|2015-09-01|January 2012|Actual|2012-01-01||Interventional|||Cost-effectiveness of Remote Ischemic Conditioning as an Adjunct to Primary Percutaneous Coronary Intervention|Cost-effectiveness of Remote Ischemic Conditioning as an Adjunct to Primary Percutaneous Coronary Intervention in Patients With ST-elevation Myocardial Infarction|Unknown status|Active, not recruiting|N/A|333|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:21:16.594072|2017-10-10 23:21:16.594072
NCT02431325|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-10-19|||December 2015||2015-12-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV|A Study to Investigate Gastrointestinal Epithelial Integrity and Arterial Inflammation in Individuals With and Without HIV|Recruiting||Phase 2|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:21:16.710152|2017-10-10 23:21:16.710152
NCT02431312|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-09-07|||January 2015||2015-01-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects|Phase I, Randomized, Open-Label, Active-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability & Immunogenicity of INO-1800 Alone or in Combination With INO-9112 Delivered IM Followed by EP in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients|Active, not recruiting||Phase 1|90|Anticipated|Inovio Pharmaceuticals||6|||f||||f||||||||||2017-10-10 23:21:16.905519|2017-10-10 23:21:16.905519
NCT02430987|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-05-12|||September 2014||2014-09-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Prevalence of Metabolic Syndrome in Postmenopause Woman With Hypoactive Sexual Desire Disorder|Prevalence of Metabolic Syndrome in Postmenopause Woman With Hypoactive Sexual Desire Disorder|Recruiting||N/A|200|Anticipated|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t||||||||Yes|June 1, 2017|2017-10-10 23:21:19.807568|2017-10-10 23:21:19.807568
NCT02431299|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-11-19|2015-08-31||September 2012||2012-09-01|November 2015|2015-11-01||||July 2014|Actual|2014-07-01||Observational|IT IS VALID|One clinician did not complete the baseline measures, thus leaving us the baseline characteristics for 62 IMR Clinicians. The only baseline measure collected for the IMR Clinicians were demographic variables (i.e. Age, Gender, Region of Employment). The remaining outcome measures aren't collected because they are specific to the patient population.|Illness Management and Recovery Treatment Integrity Scale Validation and Leadership Intervention Development|Illness Management and Recovery Treatment Integrity Scale Validation and Leadership Intervention Development|Completed||N/A|299|Actual|Indiana University|Unable to randomly assign a level of competency in providing IMR. Geographically limited to three states within the United States. Relatively brief observation period (3-months).||1||f||||f||||||||||2017-10-10 23:21:17.06924|2017-10-10 23:21:17.06924
NCT02431286|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2015-04-30|||October 2014||2014-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PONV||Palonosetron Associated to Aprepitant in Prophylaxis of PONV|Evaluation of Palonosetron and Palonosetron/Aprepitant in Post Operative Nausea and Vomiting Incidence in Oncological Patients|Unknown status|Recruiting|Phase 4|90|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||t||||||||||2017-10-10 23:21:17.517134|2017-10-10 23:21:17.517134
NCT02431273|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-01-31|||June 2015|Actual|2015-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women|Open-Label Safety and Pharmacokinetic Study of Single (TDF), Dual (TDF-FTC), and Triple ARV IVR (TDF-FTC-MVC) in Healthy Women|Completed||Early Phase 1|6|Actual|Auritec Pharmaceuticals||3|||f||||f||||||||||2017-10-10 23:21:17.642008|2017-10-10 23:21:17.642008
NCT02431260|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-10-03|||May 2015||2015-05-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies|A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054329 in Subjects With Advanced Malignancies|Active, not recruiting||Phase 1/Phase 2|69|Actual|Incyte Corporation||1|||f||||f||||||||||2017-10-10 23:21:17.747146|2017-10-10 23:21:17.747146
NCT02431234|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-09-25|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2016|Actual|2016-02-01||Observational|DIACART||Arterial Calcification in the Diabetes|Study of the Mechanisms of the Arterial Calcification of the Members Subordinates in the Diabetes (Implication of the System RANK / RANKL / OSTEOPROTEGERINE)|Active, not recruiting||N/A|169|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-10 23:21:18.134341|2017-10-10 23:21:18.134341
NCT02431221|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-07-12||||||July 2017|2017-07-01||||July 2017|Actual|2017-07-01||Interventional|||Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure|A Study on the Efficacy, Safety, and Tolerability of Perhexiline Maleate in Subjects With Hypertrophic Cardiomyopathy and Moderate-To-Severe Heart Failure|Withdrawn||Phase 3|0|Actual|Heart Metabolics Limited||2||Lack of efficacy in a preceding study.|f||||t||||||||||2017-10-10 23:21:18.208316|2017-10-10 23:21:18.208316
NCT02431208|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-09-28|||July 22, 2015|Actual|2015-07-22|September 2017|2017-09-01|September 26, 2020|Anticipated|2020-09-26|September 26, 2020|Anticipated|2020-09-26||Interventional|||A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)|A Phase Ib Study of the Safety and Pharmacokinetics of Atezolizumab (Anti-PD-L1 Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Patients With Multiple Myeloma (Relapsed/Refractory and Post-Autologous Stem Cell Transplantation)|Suspended||Phase 1|288|Anticipated|Hoffmann-La Roche||10|||f||||||||||||||2017-10-10 23:21:18.308684|2017-10-10 23:21:18.308684
NCT02431195|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-07-24|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|SOCIOB||Analysis of Changes in Eating Habits on Post Bariatric Surgery Patients and Their Family Members|Analysis of Changes in Eating Behaviors and Physical Activity on Post Bariatric Surgery Patients and Their Family Members : Comparison Between Men and Women|Active, not recruiting||N/A|96|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:21:18.504025|2017-10-10 23:21:18.504025
NCT02431182|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-04-27|||January 2012||2012-01-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Trial to Evaluate the Effectiveness of Memory Training Workshops in People From 65 to 80 Years|Randomized Control Trial to Evaluate the Effectiveness of Memory Training Workshops in People From 65 to 80 Years|Completed||N/A|300|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 23:21:18.573575|2017-10-10 23:21:18.573575
NCT02431169|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-02-23|||April 30, 2015|Actual|2015-04-30|February 2017|2017-02-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|||Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression|Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression Following Erlotinib|Recruiting||N/A|40|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||Samples With DNA|"     -  Specimen (tissue and blood) acquisition will take place under Washington University's          study HRPO# 201305031 and will be analyzed under this study.        -  Fresh tissue will be taken at the time of diagnosis of metastatic disease and again at          progression.   "|No||2017-10-10 23:21:18.643705|2017-10-10 23:21:18.643705
NCT02431156|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-29|||March 2015||2015-03-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Functional Assessment of Activities of Daily Living (ADL) in Patients Who Underwent Mini-monovision Correction|Retrospective Functional Assessment of Activities of Daily Living (ADL) in Patients Who Underwent Mini-monovision Correction With Bilateral Implantation of Aspheric Monofocal Intraocular Lenses|Unknown status|Recruiting|N/A|40|Anticipated|Democritus University of Thrace|||1||f||||t||||||||||2017-10-10 23:21:18.738098|2017-10-10 23:21:18.738098
NCT02431143|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-10-10|||May 2015||2015-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa|An Open-label Clinical Trial to Assess the Pharmacokinetics and Safety of Miltefosine Allometric Dose for the Treatment of Children With Primary Visceral Leishmaniasis in Eastern Africa|Completed||Phase 2|30|Actual|Drugs for Neglected Diseases||1|||f||||f||||||||||2017-10-10 23:21:18.822572|2017-10-10 23:21:18.822572
NCT02431130|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-27|||February 2012||2012-02-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|January 2013|Actual|2013-01-01||Interventional|||Low-fidelity Simulation to Teach Anesthetists' Non-technical Skills in Rwanda||Completed||N/A|20|Actual|Dalhousie University||2|||f||||||||||||||2017-10-10 23:21:18.895332|2017-10-10 23:21:18.895332
NCT02431117|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-07-07|||June 2015||2015-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30|A Multicenter, Longitudinal, Non-drug Study to Assess the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Japanese Individuals With Down Syndrome Aged 6-30|Completed||N/A|43|Actual|Chugai Pharmaceutical|||1||f||||||||||||||2017-10-10 23:21:18.960188|2017-10-10 23:21:18.960188
NCT02431104|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-07-25|||April 2015||2015-04-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Clinical Evaluation of Tattoo Removal Using a Novel Dual-Wavelength, Dual-Pulse Duration Laser|"Clinical Evaluation of Tattoo Removal Using a Novel Dual-Wavelength, Dual-Pulse Duration Laser"|Terminated||N/A|10|Actual|Cutera Inc.||1||Sponsor terminated study.|f||||f||||||||Undecided||2017-10-10 23:21:19.042933|2017-10-10 23:21:19.042933
NCT02431091|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-07-18|||April 2015||2015-04-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|OCT-HIV||Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder|Evaluation of the Role of Optical Coherence Tomography (OCT) in the Detection of HIV-associated Neurocognitive Disorder|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire Saint Pierre||3|||f||||f||||||||||2017-10-10 23:21:19.114409|2017-10-10 23:21:19.114409
NCT02431078|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-07-28|||June 2015||2015-06-01|April 2015|2015-04-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||The Expression of ZEB1 in CTCs Associated With Metastasis and Recurrence for Gastric Cancer|The Expression of Zinc Finger E-Box Binding Homeobox 1 (ZEB1) in Circulating Tumor Cells(CTCs) Associated With Metastasis and Recurrence for Gastric Cancer|Active, not recruiting||N/A|100|Anticipated|Chinese PLA General Hospital|||2||f||||f||||||Samples With DNA|"     Circulating Tumor Cells   "|||2017-10-10 23:21:19.188582|2017-10-10 23:21:19.188582
NCT02431065|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-04-30|||May 2015||2015-05-01|April 2015|2015-04-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Ultrasonography-guided and Surgical Rectus Sheath Block in Single-port Access Laparoscopy|Comparing the Analgesic Effects of Ultrasonography-guided and Direct-surgical Rectus Sheath Block in Single-port Access Laparoscopy Patients|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Chungnam National University Hospital||3|||f||||t||||||||||2017-10-10 23:21:19.263702|2017-10-10 23:21:19.263702
NCT02431052|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-05-16|||April 2015||2015-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris|A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris|Completed||Phase 2|420|Actual|Dermira, Inc.||5|||f||||f||||||||||2017-10-10 23:21:19.348444|2017-10-10 23:21:19.348444
NCT02431039|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-08-12|||May 2015||2015-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison Between NEOSORB Plus and NEOSORB|Comparison of Intraoperative Handling and Wound Healing Between NEOSORB Plus Antibacterial Suture With NEOSORB Suture: Prospective, Single-blind, Randomized Controlled Trial|Completed||Phase 2|100|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:21:19.475919|2017-10-10 23:21:19.475919
NCT02431026|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-09-04|||April 2015||2015-04-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|TEM-C||Temperature Evaluation by MRI Thermometry During Cervical Cooling|Temperature Evaluation by MRI Thermometry During Cervical Cooling|Completed||N/A|6|Actual|University of Vermont||2|||f||||||||||||||2017-10-10 23:21:19.569757|2017-10-10 23:21:19.569757
NCT02431013|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-29|||April 2015||2015-04-01|April 2015|2015-04-01||||August 2015|Anticipated|2015-08-01||Interventional|||Cilostazol-Simvastatin Drug Interaction Study|A Randomized, Open-label, Multiple-dose, Parallel Study to Investigate The Effect of Cilostazol on the Disposition of Simvastatin in Healthy Male Volunteers|Unknown status|Recruiting|Phase 1|20|Anticipated|Ajou University School of Medicine||2|||f||||f||||||||||2017-10-10 23:21:19.635148|2017-10-10 23:21:19.635148
NCT02431000|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-09-17|||May 2015||2015-05-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Observational|||Male Fertility and Sperm Cryopreservation|Male Fertility Pre- and Post- Radiation and Chemotherapy, and Sperm Preservation|Unknown status|Recruiting|N/A|100|Anticipated|University of Tennessee|||1||f||||f||||||Samples With DNA|"     Subject who express the desire to have pre-treatment sperm cryopreservation. These subjects     will undergo an informed consent process. If the five years of storage are up before subjects     are ready to claim it, it will be their responsibility to keep the account open by paying a     fee of about $300.00 per any additional year in storage. If they withdraw from the study     before the five years are up, they will be free to claim the sperm from storage or to leave     it there until the five years are up. Afterwards, they will be responsible for the annual     fees.      Long term Semen Freezing :      After freezing, sperm samples will be sent to FairFax Cryobank in Austin, Texas for long-term     storage. A storage agreement plan has been pre-arranged with FairFax and UTMG.   "|||2017-10-10 23:21:19.720513|2017-10-10 23:21:19.720513
NCT02430974|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-04-26|||January 2011||2011-01-01|April 2015|2015-04-01|January 2018|Anticipated|2018-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Chemotherapy of NSCLC With or Without Icotinib|Icotinib as Maintenance Treatment After Chemotherapy for Patients Undergoing Resection of EGRF Mutation-positive Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|50|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||||||||||||2017-10-10 23:21:19.89008|2017-10-10 23:21:19.89008
NCT02430961|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-04-29|||June 2015||2015-06-01|April 2015|2015-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Predictors of Apnea and Prediction of Time to Death in Donation After Cardiac Death||Unknown status|Not yet recruiting|N/A|158|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:21:19.942496|2017-10-10 23:21:19.942496
NCT02430948|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-04-19|||January 2014||2014-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Improving Compliance With Medical Testing Guidelines|Improving Compliance With Medical Testing Guidelines|Recruiting||N/A|218|Anticipated|Beth Israel Medical Center||4|||f||||f||||||||||2017-10-10 23:21:20.202463|2017-10-10 23:21:20.202463
NCT02430935|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-14|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of the Effectiveness of Cognitive Adaptation Training in Early Intervention for Psychosis|A Study of the Effectiveness of Cognitive Adaptation Training in Early Intervention for Psychosis|Active, not recruiting||N/A|80|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-10 23:21:20.746772|2017-10-10 23:21:20.746772
NCT02430922|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-07-31|||April 2015||2015-04-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||a Physician-inititated Trial Investigating the iVolution Nitinol Stent|EVOLUTION STUDY, a Physician-inititated Trial Investigating the Efficacy of the Self-Expanding iVolution Nitinol Stent for Treatment of Femoropopliteal Lesions|Recruiting||Phase 2/Phase 3|120|Anticipated|Flanders Medical Research Program||1|||f||||t||||||||||2017-10-10 23:21:20.8872|2017-10-10 23:21:20.8872
NCT02430909|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-05-29|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis|A Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Multiple Doses of UCB4940 Administered as Add-on to Certolizumab Pegol Therapy in Subjects With Moderate-to-Severe Rheumatoid Arthritis|Completed||Phase 2|159|Actual|UCB Pharma||3|||f||||t||||||||||2017-10-10 23:21:21.045635|2017-10-10 23:21:21.045635
NCT02430896|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-07-17|||February 2015||2015-02-01|July 2016|2016-07-01|February 2020|Anticipated|2020-02-01|December 2017|Anticipated|2017-12-01||Observational|||Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD|Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of Attention-Deficit/Hyperactivity Disorder (ADHD)|Recruiting||N/A|600|Anticipated|Asan Medical Center|||2||f||||f||||||Samples With DNA|"     whole blood sample for GWAS (Genome-Wide Association Study)   "|No||2017-10-10 23:21:21.261727|2017-10-10 23:21:21.261727
NCT02430883|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-04-27|||January 2015||2015-01-01|April 2015|2015-04-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Is There Any Relation Between Pain and Stone Location in Retrograde Intrarenal Surgery?||Unknown status|Recruiting|Phase 4|300|Anticipated|Diskapi Teaching and Research Hospital||5|||f||||f||||||||||2017-10-10 23:21:21.415933|2017-10-10 23:21:21.415933
NCT02430870|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-07-19|2016-07-19||April 2015||2015-04-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional||Randomized Set included all randomized participants.|TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Multiple Oral TAK-648 Doses in Healthy Japanese Subjects and Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|48|Actual|Takeda||8|||f||||f||||||||||2017-10-10 23:21:21.586943|2017-10-10 23:21:21.586943
NCT02430857|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-05-17|||October 2015||2015-10-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01||Interventional|||Osteopathy and Latent Hypothyroidism|Osteopathy and Latent Hypothyroidism: Effectiveness of Osteopathic Treatment on TSH in Patients With Latent Hypothyroidism|Unknown status|Not yet recruiting|N/A|40|Anticipated|Diekmann, Emanuel Amier||2|||f||||t||||||||||2017-10-10 23:21:23.497454|2017-10-10 23:21:23.497454
NCT02430844|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-05-23|||May 6, 2015|Actual|2015-05-06|May 2017|2017-05-01|May 8, 2017|Actual|2017-05-08|May 8, 2017|Actual|2017-05-08||Observational|||Role of Biomarkers in Predicting Contrast-induced Acute Kidney Injury in Critically Ill Patients|"Role of Biomarkers in Predicting Contrast-induced Acute Kidney Injury in Critically Ill Patients: a Prospective Observational Study"|Completed||N/A|85|Actual|Sanjay Gandhi Postgraduate Institute of Medical Sciences|||1||f||||f||||||||||2017-10-10 23:21:23.554549|2017-10-10 23:21:23.554549
NCT02430831|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-28|||May 2015||2015-05-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Effect of Milk Formula Supplemented With L. Reuteri on Crying Time in Colicky Infants Less Than 3 Months Old|Randomized Controlled Trial Testing the Effect of Milk Formula Supplemented With L. Reuteri on Crying Time in Colicky Infants Less Than 3 Months Old|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|University of Bari||2|||f||||f||||||||||2017-10-10 23:21:23.612344|2017-10-10 23:21:23.612344
NCT02430818|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2016-05-23|||April 2015||2015-04-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparing Ketamine and Morphine in the Treatment of Acute Fracture Pain|Comparing the Effectiveness of Low-dose Ketamine With Morphine to Treat Pain in Patients With Long Bone Fractures|Recruiting||N/A|40|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 23:21:23.687684|2017-10-10 23:21:23.687684
NCT02430805|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-05|2015-04-27|||November 2008||2008-11-01|February 2010|2010-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Hypercare||Predisposition and Transition Mechanisms From Arterial Hypertension to Heart Failure|Genetics and Genomics of Hypertension Associated With Microinflammation, Oxydative Stress, Chronic Renal Disease and Heart Failure (A2-B2-B3)|Completed||N/A|60|Actual|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-10 23:21:23.809486|2017-10-10 23:21:23.809486
NCT02428868|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-04-28|||April 2015||2015-04-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||IV Iron in Association With Tranexamic Acid for Hip Fracture|Use of Combined Tranexamic Acid and Intravenous Iron for Hip Fracture Surgery in Elderly|Unknown status|Not yet recruiting|N/A|150|Anticipated|Institut Kassab d'Orthopédie||3|||f||||t||||||||||2017-10-10 23:21:41.632207|2017-10-10 23:21:41.632207
NCT02430792|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-07-19|||May 2015||2015-05-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|FC-PC||Effectiveness of Community-based Football in Prostate Cancer|Effectiveness of Community-based Football Compared With Usual Care on Quality of Life in Men With Prostate Cancer: the FC Prostate Community Randomized Controlled Trial|Active, not recruiting||N/A|200|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:21:23.890564|2017-10-10 23:21:23.890564
NCT02430779|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms|Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:23.987359|2017-10-10 23:21:23.987359
NCT02430766|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve)|Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:24.071032|2017-10-10 23:21:24.071032
NCT02430753|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency|Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:24.149326|2017-10-10 23:21:24.149326
NCT02430740|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-10-12|||January 2016||2016-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Tailored Ovarian Stimulation Based on BMI, AMH, AFC|Multicentric Randomized Controlled Study to Determine a Tailored Strategy for Controlled Ovarian Stimulation in IVF Based on AMH, BMI and AFC|Recruiting||Phase 4|300|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||No||2017-10-10 23:21:24.232496|2017-10-10 23:21:24.232496
NCT02430714|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-02-20|||May 20, 2015|Actual|2015-05-20|January 2017|2017-01-01|March 2026|Anticipated|2026-03-01|March 2025|Anticipated|2025-03-01||Observational|||Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)|Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)|Recruiting||N/A|400|Anticipated|Eisai Inc.|||1||f||||f||||||||||2017-10-10 23:21:24.317914|2017-10-10 23:21:24.317914
NCT02430701|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms|Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:24.39128|2017-10-10 23:21:24.39128
NCT02430688|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms|Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:24.474293|2017-10-10 23:21:24.474293
NCT02430675|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms|Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:26.264022|2017-10-10 23:21:26.264022
NCT02430662|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms|Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:26.358169|2017-10-10 23:21:26.358169
NCT02430649|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms|Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:26.444994|2017-10-10 23:21:26.444994
NCT02430636|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms|Irreversible Electroporation(IRE) For Unresectable Stmoach Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:26.526829|2017-10-10 23:21:26.526829
NCT02430623|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms|Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:26.617603|2017-10-10 23:21:26.617603
NCT02430610|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms|Irreversible Electroporation(IRE) For Unresectable Uterine Cervical Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:26.709847|2017-10-10 23:21:26.709847
NCT02430597|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms|Irreversible Electroporation(IRE) For Unresectable Hilus Plumonis Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:21:26.801329|2017-10-10 23:21:26.801329
NCT02430584|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-05-04|||March 2015||2015-03-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||Whole Blood Specimen Collection From Pregnant Subjects|Whole Blood Specimen Collection From Pregnant Subjects|Recruiting||N/A|5000|Anticipated|Progenity, Inc.|||1||f||||f||||||Samples With DNA|"     Study will collect up to 50 mL of whole blood at one or more monthly clinic visits (≥25 days     apart) from pregnant women carrying a single fetus of 10 to 26 weeks of gestational age   "|||2017-10-10 23:21:26.881984|2017-10-10 23:21:26.881984
NCT02430571|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-11-29|||April 2015||2015-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Case Series to Evaluate the Identification of Anatomical Markers Using the KANGAROO™ Feeding Tube|A Prospective, Single-Center, Open Label, Within-Subject Case Series to Evaluate the Identification of Anatomical Markers in the Gastrointestinal Tract Using the KANGAROO™ Feeding Tube With IRIS Technology|Completed||N/A|49|Actual|Medtronic - MITG|||1||f||||f||||||||Yes||2017-10-10 23:21:26.954102|2017-10-10 23:21:26.954102
NCT02430558|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2016-04-01|||July 2015||2015-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|ODPHOENIX2||Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft|Second Line Treatment of Knee Osteochondral Lesion With Decellularized Treated Osteochondral Allograft. Phase IIa Trial|Not yet recruiting||Phase 1/Phase 2|40|Anticipated|TBF Genie Tissulaire||1|||f||||t||||||||||2017-10-10 23:21:27.008242|2017-10-10 23:21:27.008242
NCT02430545|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2015-06-24|||May 2015||2015-05-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics|A Phase 1, Open-label, Fixed-sequence, 2-period Study In Healthy Volunteers To Investigate The Effect Of Multiple Doses Of Rifampin On Single Dose Glasdegib (Pf-04449913) Plasma Pharmacokinetics|Completed||Phase 1|12|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:21:27.076745|2017-10-10 23:21:27.076745
NCT02430532|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-03-27|2016-12-12||May 2015||2015-05-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|INSPIRE||BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis|Terminated||Phase 3|58|Actual|Biogen|The study was terminated early by the sponsor for business reasons. Efficacy, patient-reported outcomes, and pharmacodynamic data were not analyzed.|2||Sponsor Decision|f||||t||||||||||2017-10-10 23:21:27.276828|2017-10-10 23:21:27.276828
NCT02430519|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-04-05|||September 2012||2012-09-01|April 2017|2017-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PRFMMFD||Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects|Effect of Autologous Platelet Rich Fibrin In Human Mandibular Molar Grade II Furcation Defects- A Clinical and Radiological Study|Completed||N/A|22|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||f||||||||No||2017-10-10 23:21:27.747396|2017-10-10 23:21:27.747396
NCT02430506|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2016-04-25|||September 2008||2008-09-01|April 2016|2016-04-01|July 2010|Actual|2010-07-01|June 2009|Actual|2009-06-01||Interventional|C-012-402||A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB|A Phase I Randomized Placebo-controlled Double-blind Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QuantiFERON®-TB Gold (+) and QuantiFERON®-TB Gold (-) Adults Without Evidence of Tuberculosis.|Completed||Phase 1|20|Actual|Aeras||2|||f||||t||||||||||2017-10-10 23:21:27.853129|2017-10-10 23:21:27.853129
NCT02430493|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-27|2017-04-28|||May 28, 2015|Actual|2015-05-28|April 2017|2017-04-01|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29|1 Year|Observational [Patient Registry]|YingLong||Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients|A Multi-Centre, Prospective Cohort, Non-Interventional Study About Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients|Completed||N/A|1066|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:21:27.936305|2017-10-10 23:21:27.936305
NCT02430480|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-28|2017-07-26|||April 23, 2015||2015-04-23|July 20, 2017|2017-07-20|January 1, 2020|Anticipated|2020-01-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer|Neoadjuvant Androgen Deprivation and Enzalutamide: Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer|Recruiting||Phase 2|55|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:21:28.053445|2017-10-10 23:21:28.053445
NCT02430467|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-07-26|||July 2015||2015-07-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Caregiver-Guided Pain Management Training in Palliative Care|Caregiver-Guided Pain Management Training in Palliative Care|Recruiting||N/A|472|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:21:28.159135|2017-10-10 23:21:28.159135
NCT02430454|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-01-07|||April 2015||2015-04-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|November 2015|Actual|2015-11-01||Interventional|||Impact of Bed Availability and Cognitive Load on Intensive Care Unit Bed Allocation: a Vignette-based Clinical Trial|Vignette-based Randomized Controlled Trial of the Decision Making Process of Bed Allocation in the Intensive Care Unit: Impact of Bed Availability and Cognitive Load.|Active, not recruiting||N/A|178|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:21:28.268513|2017-10-10 23:21:28.268513
NCT02430441|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-26|2015-04-29|||April 2015||2015-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:21:28.3263|2017-10-10 23:21:28.3263
NCT02430428|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-07-18|||March 2015||2015-03-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Correction of Myopia Wtih or Without Astigmatism Using the VisuMax™ Femtosecond Laser|Use of the VisuMax™ Femtosecond Laser Lenticule Removal Procedure for the Correction of Myopia Wtih or Without Astigmatism|Active, not recruiting||N/A|360|Anticipated|Carl Zeiss Meditec, Inc.||1|||f||||f||||||||||2017-10-10 23:21:28.371498|2017-10-10 23:21:28.371498
NCT02430415|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-04-26|||May 2015||2015-05-01|April 2015|2015-04-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Laryngoscope-assisted Lightwand Intubation and Cervical Spine Motion|A Randomized Trial on Comparison of Effects of Two Lightwand Intubation Techniques on Cervical Spine Motion: Laryngoscope-assisted vs. Conventional Lightwand Intubation|Unknown status|Not yet recruiting|N/A|22|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:21:28.450106|2017-10-10 23:21:28.450106
NCT02430402|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-08-14|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Rehabilitation of Young Patients With Rheumatic Diseases in a Warm Climate|Effect of Rehabilitation of Young Patients With Rheumatic Diseases in a Warm Climate. A Pilot Randomised Controlled Trial|Completed||N/A|64|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 23:21:28.524534|2017-10-10 23:21:28.524534
NCT02430389|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2015-06-25|2015-05-21||July 2012||2012-07-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Remifentanil on Hemodynamic Stability During Placement of a Mayfield Head Fixation Device for Craniotomy|Effect of Remifentanil Administration on Hemodynamic Stability During Placement of a Mayfield Head Fixation Device for Craniotomy|Terminated||N/A|20|Actual|Northwestern University|Study terminated early due to interim analysis with patients in placebo group having substantially higher systemic HTN requiring rescue meds compared to study drug group. Another limitation is difficulty defining baseline BP preoperatively.|2||A priori hypothesis confirmed with interim analysis.|f||||f||||||||||2017-10-10 23:21:28.611342|2017-10-10 23:21:28.611342
NCT02430376|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2017-06-30|||April 6, 2015||2015-04-06|March 14, 2017|2017-03-14|March 23, 2016|Actual|2016-03-23|March 23, 2016|Actual|2016-03-23||Observational|||dbGaP Protocol: Genetic Variants Associated With Pentalogy of Cantrell|dbGaP Protocol: Genetic Variants Associated With Pentalogy of Cantrell|Completed||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:21:28.843607|2017-10-10 23:21:28.843607
NCT02430363|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-02-23|||March 2013||2013-03-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475|Phase IIb Trial Evaluations Of The Effectiveness Of Treatment Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 (Pembrolizumab)|Enrolling by invitation||Phase 1/Phase 2|58|Anticipated|Medical Research Council||2|||f||||f||||||||||2017-10-10 23:21:28.907868|2017-10-10 23:21:28.907868
NCT02430350|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-01-12|||May 2015||2015-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke|Compound Edaravone Injection for Acute Ischemic Stroke, a Multi-center, Randomized, Double-blind, Parallel, and Active-controlled PhaseⅢTrial|Completed||Phase 3|1200|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||t||||||||Undecided||2017-10-10 23:21:29.185141|2017-10-10 23:21:29.185141
NCT02430337|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-07-31|||April 2013|Actual|2013-04-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|June 2014|Actual|2014-06-01||Interventional|||A Technology-Enhanced Approach for Implementing Evidence-Based Practices in Child Welfare|A Technology-Enhanced Approach for Implementing Evidence-Based Practices in Child Welfare|Completed||N/A|62|Actual|Georgia State University||2|||f||||f||||||||||2017-10-10 23:21:29.380032|2017-10-10 23:21:29.380032
NCT02430324|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-27|||December 2009||2009-12-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||The Multicenter Italian INCEPT (INfarto CErebrale Post-Traumatico) Study|Post Traumatic Cerebral Infarction Increases Mortality and Morbidity in Patients With Moderate or Severe Head Trauma. The Multicenter Italian INCEPT (INfarto CErebrale Post-Traumatico) Study|Completed||N/A|143|Actual|Azienda Ospedaliera Spedali Civili di Brescia|||2||f||||f||||||||||2017-10-10 23:21:29.472323|2017-10-10 23:21:29.472323
NCT02430298|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-02-22|||July 2013||2013-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients|Topical and Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis and Xerostomia in Head and Neck Cancer Patients|Completed||Phase 2|39|Actual|Khon Kaen University||2|||f||||t||||||||||2017-10-10 23:21:29.702382|2017-10-10 23:21:29.702382
NCT02430285|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-29|||January 2010||2010-01-01|April 2015|2015-04-01|June 2013|Actual|2013-06-01|July 2012|Actual|2012-07-01||Interventional|||Early EUS in Acute Biliary Pancreatitis|Early Endoscopic Ultrasound (EUS) in Acute Biliary Pancreatitis: a Prospective Pilot Study|Completed||N/A|181|Actual|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-10 23:21:29.82445|2017-10-10 23:21:29.82445
NCT02430272|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-04-29|||May 2014||2014-05-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Anticholinergic Premedication Induced Fever in Pediatric Ambulatory Anesthesia With Ketamine|Anticholinergic Premedication Induced Fever in Pediatric Ambulatory Anesthesia With Ketamine|Completed||N/A|84|Actual|Inje University||2|||f||||||||||||||2017-10-10 23:21:29.927951|2017-10-10 23:21:29.927951
NCT02430259|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-25|||March 2015||2015-03-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention|Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months for Tuberculosis Preventive Treatment: A Randomized Controlled Study in China|Recruiting||Phase 3|566|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-10 23:21:30.026377|2017-10-10 23:21:30.026377
NCT02430246|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-08-12|||January 2016||2016-01-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||The Association Between the Transfer of Lactobacilli From the Gastrointestinal Tract to the Vagina and the Prevention / Eradication of Abnormal Vaginal Flora in High Risk Pregnancies|The Association Between the Transfer of Lactobacilli From the Gastrointestinal Tract to the Vagina and the Prevention / Eradication of Abnormal Vaginal Flora in High Risk Pregnancies|Recruiting||N/A|414|Anticipated|HaEmek Medical Center, Israel||8|||f||||f||||||||||2017-10-10 23:21:30.14115|2017-10-10 23:21:30.14115
NCT02430233|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-08-16|||October 2016||2016-10-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor|Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor - Randomized Double Blind Placebo Controlled Trial|Not yet recruiting||N/A|120|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-10 23:21:30.264101|2017-10-10 23:21:30.264101
NCT02430207|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-02-18|||May 2015||2015-05-01|April 2015|2015-04-01||||May 2016|Anticipated|2016-05-01||Interventional|||Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein|Study of Incidence of Pulmonary Embolism During Peroperative Period of Temporary Pacing Via Femoral Vein Versus Subclavian Vein in China|Unknown status|Not yet recruiting|N/A|360|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-10 23:21:30.362565|2017-10-10 23:21:30.362565
NCT02430194|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-07-27|||December 2014|Actual|2014-12-01|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|April 18, 2017|Actual|2017-04-18||Interventional|LOWR-2||Lonafarnib With Ritonavir in HDV (LOWR-2)|An Open-label, Dose-ranging, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Lonafarnib With Ritonavir-Boosting in Patients Chronically Infected With Delta Hepatitis (HDV) (LOWR-2)|Completed||Phase 2|58|Actual|Eiger BioPharmaceuticals||10|||f||||t||||||||||2017-10-10 23:21:30.476364|2017-10-10 23:21:30.476364
NCT02430181|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-01-18|||November 2014||2014-11-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|LOWR-1||Lonafarnib With and Without Ritonavir in HDV (LOWR-1)|An Open-label, Dose-ranging, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Lonafarnib With and Without Ritonavir Boosting in Patients Chronically Infected With Delta Hepatitis (HDV) (LOWR-1)|Completed||Phase 2|21|Actual|Eiger BioPharmaceuticals||7|||f||||t||||||||||2017-10-10 23:21:30.593559|2017-10-10 23:21:30.593559
NCT02430168|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-04-29|||December 2014||2014-12-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of RIRS Versus PCNL Methods, According to Postoperative Pain and Analgesic Demand in 2 to 4 cm Renal Stones||Unknown status|Recruiting|Phase 4|100|Anticipated|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-10 23:21:30.713282|2017-10-10 23:21:30.713282
NCT02430155|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-04-25|||July 2014||2014-07-01|March 2015|2015-03-01||||July 2015|Anticipated|2015-07-01||Interventional|UBT||Balloon Tamponade for Atonic Primary Postpartum Hemorrhage|Comparison of Condom-Loaded Foley's Catheter Versus Bakri Balloon for Treatment of Primary Postpartum Hemorrhage: A Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 2|66|Actual|Assiut University||2|||f||||||||||||||2017-10-10 23:21:30.811049|2017-10-10 23:21:30.811049
NCT02430142|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Observational|||Microcirculatory Oxygen Uptake in Sepsis|Microcirculatory Oxygen Uptake in Sepsis, Severe Sepsis and Septic Shock|Active, not recruiting||N/A|102|Actual|Universitätsmedizin Mannheim|||3||f||||f||||||||||2017-10-10 23:21:30.892345|2017-10-10 23:21:30.892345
NCT02430129|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-01-05|||February 2016||2016-02-01|January 2016|2016-01-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||Unicondylar Knee Arthroplasty Versus Total Knee Arthroplasty in Patients With Anteromedial Osteoarthritis of the Knee|Unicondylar Knee Arthroplasty Versus Total Knee Arthroplasty in Patients With Anteromedial Osteoarthritis of the Knee|Not yet recruiting||N/A|38|Anticipated|Alberta Hip and Knee Clinic||2|||f||||||||||||||2017-10-10 23:21:30.972669|2017-10-10 23:21:30.972669
NCT02430116|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-29|||June 2014||2014-06-01|April 2015|2015-04-01||||May 2015|Anticipated|2015-05-01||Interventional|||Mitochondrial Apoptotic Pathway Induced by Myocardial Ischemia-Reperfusion Injury in Human|Mitochondrial Apoptotic Pathway Induced by Myocardial Ischemia-Reperfusion Injury in Human|Unknown status|Recruiting|N/A|40|Anticipated|Shenzhen Sun Yat-sen Cardiovascular Hospital||3|||f||||||||||||||2017-10-10 23:21:31.047543|2017-10-10 23:21:31.047543
NCT02430103|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-25|||June 2015||2015-06-01|April 2015|2015-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|PORF||Study of Preservation of Ovarian Reserve Function During Chemotherapy for Breast Cancer Patients at Reproductive Age|A PhaseⅡ, Prospective, Non-randomized, Open-label ,Single-center Study of Effect of Gonadotropin-releasing Hormone Agonist (Goserelin) on the Preservation of Ovarian Reserve Function During (Neo)Adjuvant Chemotherapy for Breast Cancer Patients at Reproductive Age|Not yet recruiting||N/A|240|Anticipated|Peking University People's Hospital|||2||f||||f||||||||||2017-10-10 23:21:31.120702|2017-10-10 23:21:31.120702
NCT02430090|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-05-26|2015-05-04||November 2006||2006-11-01|May 2015|2015-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional||45 female pregnant|Comparison of Intratechal Levobupivacaine and Adding With Sufetanil and Fentanyl in Ceserean Section|Comparison of Intratechal Low-Dose Levobupivacaine With Levobupivacaine-Fentanyl and Levobupivacaine-Sufentanil Combinations for Cesarean Section|Completed||Phase 2|45|Actual|Ankara Numune Training and Research Hospital|A limitation of this study is that the baricity of the local anaesthetic could have been affected as the fentanyl and sufentanil were diluted within a mixture. Using these opiods in undiluted form in future studies would remove this limitation.|3|||f||||f||||||||||2017-10-10 23:21:31.215727|2017-10-10 23:21:31.215727
NCT02430077|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-09-21|||June 2016||2016-06-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients|Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients|Recruiting||Phase 2|20|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||Undecided||2017-10-10 23:21:31.607034|2017-10-10 23:21:31.607034
NCT02430064|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-04-28|||November 2014||2014-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Chronic Intake of Processed Foods on Circulating Inflammatory Markers in Healthy Men|Effects of Chronic Intake of Processed Foods on Circulating Inflammatory Markers in Healthy Men|Completed||N/A|16|Actual|University of Leicester||1|||f||||f||||||||||2017-10-10 23:21:31.715244|2017-10-10 23:21:31.715244
NCT02430051|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-03-29|||May 2015||2015-05-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|June 2019|Anticipated|2019-06-01||Interventional|SADE-2||Sensory Adapted Dental Environments to Enhance Oral Care for Children|Sensory Adapted Dental Environments to Enhance Oral Care for Children (SADE-2)|Recruiting||N/A|184|Anticipated|University of Southern California||2|||f||||t||||||||||2017-10-10 23:21:31.949315|2017-10-10 23:21:31.949315
NCT02430038|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-09-01|||April 2015||2015-04-01|February 2016|2016-02-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Observational|||Transperineal Ultrasound to Assess the Progress of Labour|The Sono-VE Study: Assessing the Acceptability and Feasibility of Transperineal Ultrasound and Developing an Ultrasound Based Predictive Model for Labour Outcome.|Recruiting||N/A|700|Anticipated|Imperial College London|||2||f||||f||||||||||2017-10-10 23:21:32.061328|2017-10-10 23:21:32.061328
NCT02428127|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-07-02|||May 2015||2015-05-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children|Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children|Completed||N/A|30|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:21:50.163249|2017-10-10 23:21:50.163249
NCT02430025|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-28|||June 2015||2015-06-01|April 2015|2015-04-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|FJCVD||Fujian Province Cardiovascular Diseases Study|Fujian Province Cardiovascular Diseases Study|Not yet recruiting||N/A|8000|Anticipated|Fujian Provincial Hospital|||4||f||||t||||||Samples Without DNA|"     Approximately 30 mls of blood will be dispensed as follows :      3 x 10 mls EDTA Tube (Blood was collected from overnight-fasted subjects into ice-cold tubes     containing EDTA) (6 mmol/L final concentration).   "|||2017-10-10 23:21:32.160583|2017-10-10 23:21:32.160583
NCT02430012|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2015-07-23|||June 2015||2015-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|MISSION-1||Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention|Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention|Unknown status|Recruiting|N/A|5720|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t||||||||||2017-10-10 23:21:32.229214|2017-10-10 23:21:32.229214
NCT02429999|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-25|2016-07-13|||April 2015||2015-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Letrozole in Assisted Reproductive Technology|The Role of Aromatase Inhibitor (Letrozole) in Minimal Ovarian Stimulation Protocols in Assisted Reproductive Technology. A Randomized Controlled Trial|Recruiting||Phase 2|80|Anticipated|Assiut University||2|||f||||||||||||||2017-10-10 23:21:32.315526|2017-10-10 23:21:32.315526
NCT02429986|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-03-27|||March 13, 2015|Actual|2015-03-13|March 2017|2017-03-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|OTRLASV||"Adaptive Servo-Ventilation in Real Life Conditions : the OTRLASV Study"|"Observational and Transversal Study of Patients Treated in Real LifeConditions With Adaptive Servo-Ventilation"|Completed||N/A|214|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:21:32.403597|2017-10-10 23:21:32.403597
NCT02429973|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-04-28|||July 2012||2012-07-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|GEIS-29||Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma|Multicenter and Prospective Phase II Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma|Completed||Phase 2|33|Actual|Broto, Javier Martín, M.D.||1|||f||||f||||||||||2017-10-10 23:21:32.516|2017-10-10 23:21:32.516
NCT02429960|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-12-02|||April 2015||2015-04-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|AMUPS||Comparison of Different Analgesia-Monitors in Tracing Unconscious Pain Sensations|Investigation of the Clinical Use of Different Analgesia-Monitors for Tracing Unconscious Pain Sensations During General Anesthesia|Completed||N/A|30|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-10-10 23:21:32.603441|2017-10-10 23:21:32.603441
NCT02429947|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-06-09|||July 2012||2012-07-01|June 2017|2017-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients|An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients|Completed||N/A|411|Actual|University of South Florida|||1||f||||f||||||||No||2017-10-10 23:21:32.699756|2017-10-10 23:21:32.699756
NCT02429934|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-05-12|||October 2015||2015-10-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Abatacept for SLE Arthritis (IM101-330)|Efficacy of Abatacept in Inflammatory Polyarthritis of Systemic Lupus Erythematosus (SLE)|Recruiting||Phase 1/Phase 2|64|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 23:21:32.783224|2017-10-10 23:21:32.783224
NCT02429921|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-03-29|||October 2015||2015-10-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||High-selenium Lentils Versus Arsenic Toxicity|Mitigating Arsenic Toxicity in Bangladeshi People by Supplementing Their Diets With High Selenium Lentils|Completed||N/A|400|Actual|University of Calgary||2|||f||||t||||||||||2017-10-10 23:21:32.923595|2017-10-10 23:21:32.923595
NCT02429908|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-03-15|||March 2014||2014-03-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Post-Market Surveillance Study of the TM Ardis Interbody Fusion System|A Prospective, Multi-Center, Post-Market Surveillance Study to Assess the Clinical Efficacy and Fusion Rates of the Zimmer TM Ardis Interbody Fusion System|Active, not recruiting||Phase 4|80|Actual|Zimmer Biomet||1|||f||||f||||||||Undecided||2017-10-10 23:21:33.035684|2017-10-10 23:21:33.035684
NCT02429895|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-06-16|||October 2015||2015-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197|A Phase 2, Multicenter, Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 Phase 2 Randomized Controlled Trial (RCT)|Terminated||Phase 2|168|Actual|AbbVie||1||Internal business decision|f||||t||||||||||2017-10-10 23:21:33.15209|2017-10-10 23:21:33.15209
NCT02429882|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-06-17|||May 2015||2015-05-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis|A Randomized, Double-blind, Placebo-controlled Study With an Open Label Extension to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Axial Spondyloarthritis|Withdrawn||Phase 2|0|Actual|Amgen||2||"Per Amgen's decision to discontinue co-development and co-commercialization of brodalumab,   study is being cancelled/closed."|f||||f||||||||||2017-10-10 23:21:33.316993|2017-10-10 23:21:33.316993
NCT02429869|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-02-25|||February 2016||2016-02-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|HIVTR-EVE||Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant|Impact of Everolimus on HIV Persistence Post Kidney (and Kidney/Pancreas) or Liver Transplant|Recruiting||Phase 4|10|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:21:33.416522|2017-10-10 23:21:33.416522
NCT02427594|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-08-29|||April 2015||2015-04-01|April 2017|2017-04-01|August 25, 2017|Actual|2017-08-25|August 25, 2017|Actual|2017-08-25||Interventional|ABC||Acid-Base Compensation in Chronic Kidney Disease|Acid-Base Compensation in Chronic Kidney Disease: Measurement and Physiologic Impact|Completed||Phase 1|14|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:21:55.468917|2017-10-10 23:21:55.468917
NCT02429843|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-12-28|||January 2016||2016-01-01|December 2016|2016-12-01||||January 2019|Anticipated|2019-01-01||Interventional|||A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer|A Phase 1B Dose-Escalation Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Patients With Stage 4 Non-Squamous Cell Lung Cancer|Recruiting||Phase 1|18|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||Undecided||2017-10-10 23:21:33.587327|2017-10-10 23:21:33.587327
NCT02429830|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-07-20|||April 5, 2017|Actual|2017-04-05|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|RELIEF||A Study of Reflux Management With the LINX® System for Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy|RELIEF Study: A Prospective, Multicenter Study of REflux Management With the LINX® System for Gastroesophageal REFlux Disease After Laparoscopic Sleeve Gastrectomy|Recruiting||N/A|30|Anticipated|Torax Medical Incorporated||1|||f||||f|f|t|f|f||||||2017-10-10 23:21:33.697497|2017-10-10 23:21:33.697497
NCT02429817|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-12-02|||April 2015||2015-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Tomographic Comparison of Aerosol Lung Distribution With Two Nebulizers Through a High Flow Nasal Cannula||Completed||N/A|6|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 23:21:33.797812|2017-10-10 23:21:33.797812
NCT02429804|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-05-24|||April 2015||2015-04-01|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer|"Combined One Stop Shop NaF/FDG PET/MRI Evaluation of Response to Xofigo® in mCRPC Patients: A Pilot Study"|Terminated||Phase 1|4|Actual|Stanford University||1||Accrual factor|f||||t||||||||||2017-10-10 23:21:33.894637|2017-10-10 23:21:33.894637
NCT02429778|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-07-21|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|BREATHE||Relaxation Treatment for Anxiety in Adults Aged 60 or Older|Reducing Late-Life Anxiety and Improving Functioning With Self-Directed Relaxation|Completed||N/A|40|Actual|Palo Alto Veterans Institute for Research||2|||f||||f||||||||||2017-10-10 23:21:34.244311|2017-10-10 23:21:34.244311
NCT02429765|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-12-13|||October 2015||2015-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Aclidinium/Formoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease|Effect of Aclidinium Bromide/Formoterol on Nighttime Lung Function, Respiratory Mechanics and Early Morning Symptoms in Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 4|20|Anticipated|Queen's University||2|||f||||t||||||||||2017-10-10 23:21:34.322196|2017-10-10 23:21:34.322196
NCT02429752|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-08-30|||October 2015||2015-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|LBP&BPD||Low Back Pain and Breathing Pattern Dysfunction|The Association of Breathing Pattern Dysfunction and Low Back Pain Presentation and Outcomes Following Physical Therapy|Completed||N/A|31|Actual|University of Miami||1|||f||||f||||||||||2017-10-10 23:21:34.419318|2017-10-10 23:21:34.419318
NCT02429739|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-04-25|||October 2014||2014-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Working Memory Training for Children With Dyslexia|Computerized Working Memory Training for Children With Dyslexia|Completed||N/A|32|Actual|Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-10 23:21:34.497408|2017-10-10 23:21:34.497408
NCT02429726|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2015-04-24|||June 2015||2015-06-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion|Recombinant Adenoviral Human p53 Gene With or Without Cisplatin in Treatment of Malignant Pleural - a Phase 2, Double Blinded, Randomized, Active Controlled Study|Unknown status|Not yet recruiting|Phase 2|90|Anticipated|Shenzhen SiBiono GeneTech Co.,Ltd||3|||f||||f||||||||||2017-10-10 23:21:34.575255|2017-10-10 23:21:34.575255
NCT02429713|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-04-24|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||The Effects of Tourniquet Use in Total Knee Arthroplasty|The Effects of Tourniquet Use in Total Knee Arthroplasty: A Randomized Controlled Trial|Completed||N/A|50|Actual|Peking University People's Hospital||2|||f||||f||||||||||2017-10-10 23:21:34.65647|2017-10-10 23:21:34.65647
NCT02429700|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-02-14|||April 2015||2015-04-01|February 2016|2016-02-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|SCST-01||TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors|A Multicenter, Prospective, Randomized Trial Comparing Paclitaxel and Carboplatin or Bleomycin, Etoposide and Cisplatin in the Treatment of Ovarian Malignant Sex Cord-Stromal Tumors|Enrolling by invitation||Phase 3|132|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 23:21:34.732411|2017-10-10 23:21:34.732411
NCT02429687|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-02-14|||April 2015||2015-04-01|February 2016|2016-02-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|MOGCT-01||TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors|A Multicenter, Prospective, Randomized Trial Comparing Paclitaxel and Carboplatin or Bleomycin, Etoposide and Cisplatin in the Treatment of Malignant Ovarian Germ Cell Tumors|Enrolling by invitation||Phase 3|129|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-10 23:21:34.945889|2017-10-10 23:21:34.945889
NCT02429674|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-07-13|||February 2015||2015-02-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||The Efficacy of a Depression Intervention for Adolescents With Depression and Sleep Disturbances|The Efficacy of a Depression Intervention for Adolescents With Depression and Sleep Disturbances|Recruiting||N/A|20|Anticipated|New York State Psychiatric Institute||1|||f||||f|f|f||||||||2017-10-10 23:21:35.06452|2017-10-10 23:21:35.06452
NCT02429661|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-04-24|||May 2013||2013-05-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Girls First - India (2013-2015)|Girls First - India Evaluation (2013-2015)|Completed||N/A|4592|Actual|CorStone||4|||f||||f||||||||||2017-10-10 23:21:35.174947|2017-10-10 23:21:35.174947
NCT02429648|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-01|2017-02-09|||June 2009|Actual|2009-06-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|July 2013|Actual|2013-07-01||Interventional|||Timing of Direct Current Cardioversion (DCC) in Patients Undergoing Ablation of Persistent/Permanent Atrial Fibrillation|Timing of DCC in Patients Undergoing Pulmonary Vein Isolation Ablation (PVI) of Persistent/Permanent Atrial Fibrillation|Completed||N/A|90|Actual|The Cleveland Clinic||2|||f||||t|f|f||||||No||2017-10-10 23:21:35.251705|2017-10-10 23:21:35.251705
NCT02429635|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-09-18|||January 2015||2015-01-01|September 2017|2017-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Myexercise||My Exercise. A Team-based Workplace Intervention for Increased Exercise|Workplace Health and Wellness Promotion: Investigating the Effects of a Team-based Intervention on Individual Motivation and Enhanced Physical Activity, Health and Work-functioning|Completed||N/A|202|Actual|Norwegian School of Sport Sciences||2|||f||||t||||||||||2017-10-10 23:21:35.335399|2017-10-10 23:21:35.335399
NCT02429622|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-01-16|||January 2015||2015-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma|A Phase Ⅰ/Ⅱ Study of Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy in Patients With Locally Advanced Esophageal Carcinoma|Completed||Phase 1/Phase 2|80|Actual|Chinese Academy of Medical Sciences||4|||f||||t||||||||||2017-10-10 23:21:35.437689|2017-10-10 23:21:35.437689
NCT02429609|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-24|||May 2015||2015-05-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|MACK||Exploring the Psychophysics of Keratoconus Using the Moorfields Acuity Chart|Exploring the Psychophysics of Keratoconus Using the Moorfields Acuity Chart|Unknown status|Not yet recruiting|N/A|80|Anticipated|Moorfields Eye Hospital NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:21:35.574016|2017-10-10 23:21:35.574016
NCT02429596|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-04-28|||May 2012||2012-05-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||A Trial of Generic Substitution of Antiepileptic Drugs|A Randomized Controlled Trial of Generic Substitution of Antiepileptic Drugs|Unknown status|Recruiting|Phase 4|200|Anticipated|"IRCCS National Neurological Institute C. Mondino Foundation"||2|||f||||f||||||||||2017-10-10 23:21:35.659266|2017-10-10 23:21:35.659266
NCT02429583|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-01-03|||April 2015||2015-04-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects of Persistent Innate Immune Activation on Vaccine Efficacy|Effects of Persistent Innate Immune Activation on Vaccine Efficacy|Recruiting||Phase 4|130|Anticipated|Rockefeller University||2|||f||||f||||||||Undecided||2017-10-10 23:21:35.846142|2017-10-10 23:21:35.846142
NCT02429570|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-07-12|||April 22, 2015|Actual|2015-04-22|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary|Pilot Study of Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary|Recruiting||N/A|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:21:35.942776|2017-10-10 23:21:35.942776
NCT02429557|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-01-16|||April 2015||2015-04-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01||Interventional|||Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure|Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure|Recruiting||Phase 1|20|Anticipated|Vanderbilt University Medical Center||4|||f||||f||||||||||2017-10-10 23:21:36.054854|2017-10-10 23:21:36.054854
NCT02429544|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-07-29|||August 2016||2016-08-01|July 2016|2016-07-01||||August 2018|Anticipated|2018-08-01||Interventional|||Effects of a Group Residential Retreat on Cancer Outcomes|Effects of a Group Residential Retreat on Cancer Outcomes|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||3||Study is unfunded and lack of resources|f||||f||||||||||2017-10-10 23:21:36.173331|2017-10-10 23:21:36.173331
NCT02429531|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-10-06|||October 2015||2015-10-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|PARS||Polysaccharide Antibody Response Study|The Polysaccharide Antibody Response Study: Typhim Vi Response and Allohemagglutinins Versus Pneumovax 23 Vaccine Response in the Diagnosis of Specific Polysaccharide Antibody Deficiency|Unknown status|Recruiting|Phase 4|200|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-10 23:21:36.274955|2017-10-10 23:21:36.274955
NCT02429518|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-02-28|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis|Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis|Recruiting||N/A|40|Anticipated|Knight Therapeutics (USA) Inc|||1||f||||f||||||||||2017-10-10 23:21:36.384376|2017-10-10 23:21:36.384376
NCT02429505|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-02-28|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01|6 Months|Observational [Patient Registry]|||Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry|Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry|Recruiting||N/A|25|Anticipated|Knight Therapeutics (USA) Inc|||1||f||||f||||||||||2017-10-10 23:21:36.476109|2017-10-10 23:21:36.476109
NCT02429492|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-07-09|||September 2015||2015-09-01|July 2015|2015-07-01|September 2021|Anticipated|2021-09-01|March 2020|Anticipated|2020-03-01||Interventional|SpineBioMark||Spinal Interneuron Excitability in ALS|Electrophysiological Biomarkers of Spinal Neural Activity: Study in Healthy Subjects Matched to ALS Patient Group|Not yet recruiting||N/A|120|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-10 23:21:36.556988|2017-10-10 23:21:36.556988
NCT02429479|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-03-30|||June 1, 2013|Actual|2013-06-01|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|August 31, 2016|Actual|2016-08-31||Interventional|||Preparing Family Caregivers to Make Medical Decisions for Their Loved Ones|Preparing Family Caregivers of Very Ill Patients for End-of-Life Decision Making|Recruiting||N/A|600|Anticipated|Milton S. Hershey Medical Center||4|||f||||t||||||||Yes|We will present our findings at conferences and in peer-reviewed publications.|2017-10-10 23:21:36.644304|2017-10-10 23:21:36.644304
NCT02429466|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-08-29|||April 27, 2015|Actual|2015-04-27|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Study of the Hypomethylating Drug SGI-110 Plus Cisplatin in Relapsed Refractory Germ Cell Tumors|Phase I Study of the Hypomethylating Drug SGI-110 Plus Cisplatin in Relapsed Refractory Germ Cell Tumors|Recruiting||Phase 1|15|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 23:21:36.768157|2017-10-10 23:21:36.768157
NCT02429453|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-11-15|||April 2015||2015-04-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||FFP Versus PCC in Intracranial Hemorrhage|Fresh Frozen Plasma Versus Four Factor Prothrombin Complex Concentrate for Reversal of Vitamin K Antagonists in Intracranial Hemorrhage|Withdrawn||N/A|0|Actual|University of Utah||2||Lack of enrolment|f||||t||||||||||2017-10-10 23:21:36.86902|2017-10-10 23:21:36.86902
NCT02429440|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-08-14|||May 2005||2005-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|UroRCC||Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides|Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides|Active, not recruiting||Phase 1/Phase 2|40|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 23:21:36.957353|2017-10-10 23:21:36.957353
NCT02429427|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-08-15|||December 2005||2005-12-01|August 2016|2016-08-01|November 2022|Anticipated|2022-11-01|November 2017|Anticipated|2017-11-01||Interventional|REACT||European Celecoxib Trial in Primary Breast Cancer|A Phase III Multicentre Double Blind Randomised Trial of Celecoxib Versus Placebo in Primary Breast Cancer Patients|Active, not recruiting||Phase 3|2639|Actual|Imperial College London||2|||f||||t||||||||||2017-10-10 23:21:37.030214|2017-10-10 23:21:37.030214
NCT02429414|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-08-09|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Video Double-Lumen Tube Prospective Randomized Study|Prospective Randomized Study on Video Double-Lumen Tube Versus Double-Lumen Tube|Active, not recruiting||Phase 3|83|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:21:37.111093|2017-10-10 23:21:37.111093
NCT02429401|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-10-25|||August 2015||2015-08-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|Project Valor||Culturally Adapted Brief Intervention for Heavy Drinking Hispanic Men|Culturally Adapted Brief Intervention for Heavy Drinking Hispanic Men: a Randomized Clinical Trial Among Injured Patients|Terminated||N/A|87|Actual|University of Texas, El Paso||2||Study terminated due to low recruitment (funding agency halted study).|f||||f||||||||||2017-10-10 23:21:37.199353|2017-10-10 23:21:37.199353
NCT02429388|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2016-04-19|||May 2014||2014-05-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure|High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure|Withdrawn||Phase 4|0|Actual|The University of Texas Health Science Center at San Antonio||2||Principal Investigator left institution prior to subjects being enrolled|f||||f||||||||||2017-10-10 23:21:37.29324|2017-10-10 23:21:37.29324
NCT02429375|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-04-25|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma|Phase IB/II Study of Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma|Active, not recruiting||Phase 1/Phase 2|7|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:21:37.38807|2017-10-10 23:21:37.38807
NCT02429362|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-01-25|||May 2015||2015-05-01|December 2015|2015-12-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01|1 Day|Observational [Patient Registry]|||Obstetrical Repository of Biological Materials|Obstetrical Repository of Biological Materials|Recruiting||N/A|10000|Anticipated|University of Tennessee|||1||f||||f||||||Samples With DNA|"     Sample collections for purposes of: understanding of normal events in pregnancy; disease     conditions of the woman/baby during pregnancy; and future use in studies to develop cell     lines for research, create tests to diagnose disease, or develop treatments.   "|||2017-10-10 23:21:37.471784|2017-10-10 23:21:37.471784
NCT02429349|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-07-28|||May 2015||2015-05-01|April 2015|2015-04-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Preservation of Ovarian Tissue and Chemo-Radiotherapy|Surgical Ovarian Preservation in Females Undergoing Chemo-Radiotherapy|Recruiting||N/A|100|Anticipated|University of Tennessee||1|||f||||f||||||||||2017-10-10 23:21:37.538696|2017-10-10 23:21:37.538696
NCT02429336|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-04-28|||January 2012||2012-01-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Characteristics of Women With Reproductive Concerns|Clinical Characteristics of Women Presenting to the Reproductive Endocrinology Clinic|Unknown status|Recruiting|N/A|200|Anticipated|University of Tennessee|||1||f||||f||||||||||2017-10-10 23:21:37.682473|2017-10-10 23:21:37.682473
NCT02429323|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2015-04-28|||June 2011||2011-06-01|April 2015|2015-04-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Endotracheal Intubation With Sevoflurane in Surgical Pediatric Patients|Endotracheal Intubation With Sevoflurane in Surgical Pediatric Patients: Incremental Versus High Concentration Inhalation Induction|Completed||N/A|100|Actual|University of Sulaimani||2|||f||||f||||||||||2017-10-10 23:21:37.751404|2017-10-10 23:21:37.751404
NCT02429310|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-02-15|||December 2014||2014-12-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|AdjIC||Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC|Adjuvant Benefit of Neuromuscular Electrical Stimulation to Supervised Exercise in Patients With Intermittent Claudication|Recruiting||N/A|42|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-10 23:21:37.82356|2017-10-10 23:21:37.82356
NCT02429297|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-05-04|||June 2014||2014-06-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Developing Accessible Telehealth Programs for Diabetes and Hypertension Management in Bolivia|Developing Accessible Telehealth Programs for Diabetes and Hypertension Management in Bolivia|Completed||N/A|110|Actual|University of Michigan||3|||f||||f||||||||No||2017-10-10 23:21:37.908006|2017-10-10 23:21:37.908006
NCT02429284|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-03-01|||April 2015||2015-04-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01|4 Years|Observational [Patient Registry]|||U.S. CTEPH Registry|United States CTEPH Registry|Recruiting||N/A|750|Anticipated|University of California, San Diego|||1||f||||t||||||||||2017-10-10 23:21:37.982497|2017-10-10 23:21:37.982497
NCT02429271|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-07-27|||August 2015||2015-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|MIRTOS||A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study|A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study|Recruiting||Phase 3|358|Anticipated|Hellenic Cardiovascular Research Society||2|||f||||f||||||||||2017-10-10 23:21:38.065533|2017-10-10 23:21:38.065533
NCT02429258|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-05-18|2016-10-07||May 2015||2015-05-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||100 subjects were included in the safety and ITT population. 99 subjects were included in the evaluable population. 1 subject did not meet the I/E criteria.|Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin|Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin|Completed||Phase 4|226|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:21:38.162498|2017-10-10 23:21:38.162498
NCT02429245|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-04-28|||May 2015||2015-05-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Single Cutting Guides System for the Installation of a Total Knee Replacement|Evaluation of the Accuracy of a Single Cutting Guides System for the Installation of a Total Knee Replacement|Unknown status|Not yet recruiting|N/A|20|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:21:38.945996|2017-10-10 23:21:38.945996
NCT02429232|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-10-25|||October 2015||2015-10-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers|A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers|Not yet recruiting||Phase 4|160|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:21:39.024383|2017-10-10 23:21:39.024383
NCT02429219|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-04-28|||November 2013||2013-11-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|SATURN-P||Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate|Prospective Study of Monitoring the Alcohol Concentration in Breathing Air During Transurethral Prostate Resection of Benign Prostate Hyperplasia (BPH) Assessing the Uptake of Irrigation Fluids|Completed||N/A|60|Actual|University of Magdeburg||2|||f||||f||||||||||2017-10-10 23:21:39.140159|2017-10-10 23:21:39.140159
NCT02429206|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-08-19|||April 2015||2015-04-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Efficacy of SQIN™ on Xerosis in Adults With Mobility Problems and Paralysis|Prospective, Double Blind, Randomized Phase II/III Study to Assess the Safety and Efficacy of SQIN™ on Xerosis in Adults Suffering of Mobility Impairment and/or Complete Paralysis Associated With Chronic Spinal Cord Injury.|Completed||Phase 2/Phase 3|10|Actual|Nordic Life Science Pipeline Inc.||2|||f||||f||||||||||2017-10-10 23:21:39.259418|2017-10-10 23:21:39.259418
NCT02429193|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-04-11|||March 2016||2016-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|BARRIER-P||Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA|An Open-label Phase 2 Multi-center Study of Enzalutamide and Abiraterone and Biomarkers of Androgen Response and Resistance During Rising PSA: BARRIER-P Trial|Recruiting||Phase 2|16|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:21:39.371014|2017-10-10 23:21:39.371014
NCT02429180|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-09-22|||July 31, 2015|Actual|2015-07-31|September 2017|2017-09-01|January 27, 2016|Actual|2016-01-27|January 27, 2016|Actual|2016-01-27||Interventional|ReTrain||Rehabilitation Training After Stroke|Community-based Rehabilitation Training After Stroke: a Pilot Randomised Controlled Trial|Completed||Phase 1|48|Anticipated|NIHR Exeter Clinical Research Facility||2|||f||||t||||||||||2017-10-10 23:21:39.486655|2017-10-10 23:21:39.486655
NCT02429167|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-08-02|||August 2015||2015-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:21:39.601609|2017-10-10 23:21:39.601609
NCT02429154|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-10-30|||September 2015||2015-09-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|VARO||Assessment of Cerebral Vasoreactivity Using Near-infrared Spectroscopy (NIRS) in Infants (VARO)|Assessment of Cerebral Vasoreactivity Using Near-infrared Spectroscopy (NIRS) in Infants|Recruiting||N/A|16|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 23:21:39.645946|2017-10-10 23:21:39.645946
NCT02429141|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2016-08-26|||January 2015||2015-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Periarterial Injection Versus Multiple Periveural Injection|The Ultrasound Guided Periarterial Injection Technique To Axilary Brachial Plexus Block Versus Perineural Multiple InjectionTechnique|Completed||N/A|50|Actual|North American Institute for Continuing Medical Education (NAICE)||2|||f||||f||||||||||2017-10-10 23:21:39.746458|2017-10-10 23:21:39.746458
NCT02429128|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-08-02|||July 2014||2014-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||14 Weeks Exercise Training on Lean Women With and Without PCOS|14 Weeks Exercise Training on Lean Women With and Without PCOS|Completed||N/A|22|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:21:39.845671|2017-10-10 23:21:39.845671
NCT02429115|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-09-12|||February 2015||2015-02-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Peer-mentoring, Quality of Life and Caregiver Burden in Patients With Chronic Kidney Disease and Their Caregivers|Improving Patient Quality of Life and Caregiver Burden by a Peer-Led Mentoring Program for Patients With Chronic Kidney Disease and Their Caregivers|Recruiting||N/A|216|Anticipated|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-10-10 23:21:39.937731|2017-10-10 23:21:39.937731
NCT02429102|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-01-04|||April 2015||2015-04-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects||Completed||Phase 1|135|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-10 23:21:40.044166|2017-10-10 23:21:40.044166
NCT02429089|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-10-13|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|CETLEE011||Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck|Phase I Study of LEE011plus Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1|26|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-10-10 23:21:40.143535|2017-10-10 23:21:40.143535
NCT02429076|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-01|||June 2017|Anticipated|2017-06-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||EEG Studies of IV Methylphenidate-Induced Emergence From Anesthesia|Electroencephalogram Studies of Intravenous Methylphenidate-Induced Emergence From General Anesthesia|Withdrawn||Phase 1/Phase 2|0|Actual|Massachusetts General Hospital||2||We are not going to complete this study with healthy volunteers at this time.|f||||f|t|f||||||||2017-10-10 23:21:40.267804|2017-10-10 23:21:40.267804
NCT02429063|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-04-10|||July 17, 2015|Actual|2015-07-17|December 2016|2016-12-01|March 31, 2019|Anticipated|2019-03-31|September 30, 2018|Anticipated|2018-09-30||Interventional|||Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study|Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study|Recruiting||N/A|55|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|f|t|f|||||||2017-10-10 23:21:40.369439|2017-10-10 23:21:40.369439
NCT02429050|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-05-30|||November 1, 2016||2016-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MORDYC||Morphine for Treatment of Dyspnea in Patients With COPD|Morphine for Palliative Treatment of Refractory Dyspnea in Patients With Advanced COPD: Benefits and Respiratory Adverse Effects|Recruiting||Phase 4|124|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:21:40.484394|2017-10-10 23:21:40.484394
NCT02429037|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-23|||May 2015||2015-05-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer|Recombinant Adenoviral Human p53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable, Locally Advanced Head and Neck Cancer - a Open-labeled Randomized Phase 2 Study|Not yet recruiting||Phase 2|60|Anticipated|Shenzhen SiBiono GeneTech Co.,Ltd||2|||f||||f||||||||||2017-10-10 23:21:40.591109|2017-10-10 23:21:40.591109
NCT02429024|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-09-12|||May 2015||2015-05-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences|Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences|Completed||Phase 4|138|Actual|LifeScan||2|||f||||f||||||||||2017-10-10 23:21:40.693499|2017-10-10 23:21:40.693499
NCT02429011|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-04-05|||July 15, 2011|Actual|2011-07-15|April 2017|2017-04-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Observational|||MRI Studies of Emotion in Depression|Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response|Completed||N/A|135|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||f|f|f||||||||2017-10-10 23:21:40.784699|2017-10-10 23:21:40.784699
NCT02428998|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-08-09|||September 2014||2014-09-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|August 2016|Actual|2016-08-01||Interventional|||Safety for 24 Weeks Intake of Korean Red Ginseng in Adults|Safety Evaluation for 24 Weeks Intake of Korean Red Ginseng in Adults: A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center, Exploratory Trial|Completed||N/A|1000|Actual|Korea Ginseng Corporation||2|||f||||f||||||||||2017-10-10 23:21:40.861954|2017-10-10 23:21:40.861954
NCT02428985|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-09-26|||June 29, 2015|Actual|2015-06-29|September 2017|2017-09-01|January 16, 2024|Anticipated|2024-01-16|March 31, 2023|Anticipated|2023-03-31||Observational|JPMS-PAH||Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)|Drug Use Investigation of Riociguat for Pulmonary Arterial Hypertension (PAH)|Recruiting||N/A|600|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 23:21:40.944208|2017-10-10 23:21:40.944208
NCT02428972|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-01-23|||August 2017|Anticipated|2017-08-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Assessment of Cognitive Functions and Quality of Life in Patients Undergoing Surgery for Supratentorial Brain Tumor|Assessment of Cognitive Functions and Quality of Life in Patients Undergoing Surgery for Supratentorial Brain Tumor - a Comparison of Two Anaesthetic Techniques|Not yet recruiting||N/A|30|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t|f|f||||||No||2017-10-10 23:21:41.027172|2017-10-10 23:21:41.027172
NCT02428959|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-23|||June 2014||2014-06-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|Amyl Nitrite||Prospective Study to Assess the Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)|Prospective Study to Assess the Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)|Unknown status|Recruiting|N/A|1000|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 23:21:41.101656|2017-10-10 23:21:41.101656
NCT02428946|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-05-23|||October 2014||2014-10-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|BIS||Bromocriptine and Insulin Sensitivity|Bromocriptine and Insulin Sensitivity in Lean and Obese Subjects|Completed||N/A|15|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 23:21:41.194742|2017-10-10 23:21:41.194742
NCT02428933|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-04-24|||October 2013||2013-10-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|DEBAT||Dopaminergic Effects on Brown Adipose Tissue|Dopaminergic Effects on Brown Adipose Tissue: the DEBAT Trial|Completed||N/A|8|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 23:21:41.272285|2017-10-10 23:21:41.272285
NCT02428920|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2016-09-07|||July 2014||2014-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|GHP CHANGE||Grenada Heart Project - Community Health Action to Encourage Healthy Behaviors|Grenada Heart Project - Community Health Action to Encourage Healthy Behaviors|Completed||Phase 3|400|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 23:21:41.346533|2017-10-10 23:21:41.346533
NCT02428907|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-04-24|||October 2012||2012-10-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Observational|||Simulation Training of Endoscopy Staff to Improve Patient Experience in Colonoscopy|Simulation Based Team Training of Endoscopy Staff May Improve Patients' Perception of Colonoscopy|Completed||N/A|539|Actual|Aalborg Universitetshospital|||1||f||||f||||||||||2017-10-10 23:21:41.421355|2017-10-10 23:21:41.421355
NCT02428894|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-07-14|||October 2014||2014-10-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation|Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation|Completed||N/A|20|Actual|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     Change in plasma proteins. [Time Frame, Days 7, 14, 30, 60, 90, and 180 post-LVAD     implantation][Designated as safety issue: No]   "|||2017-10-10 23:21:41.486527|2017-10-10 23:21:41.486527
NCT02428881|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-23|||November 2009||2009-11-01|April 2015|2015-04-01||||July 2012|Actual|2012-07-01||Interventional|||Botulinum Toxin A Injections in Patients With Fowler's Syndrome|Open Label Pilot Study to Treat Women With Chronic Urinary Retention or Voiding Dysfunction Due to a Primary Disorder of Sphincter Relaxation (Fowler's Syndrome) With Outpatient Urethral Injections of Botulinum Toxin A (BoNT-A)|Completed||Phase 2/Phase 3|10|Actual|University College, London||2|||f||||t||||||||||2017-10-10 23:21:41.552869|2017-10-10 23:21:41.552869
NCT02428855|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-02-16|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|September 2022|Anticipated|2022-09-01|January 2019|Anticipated|2019-01-01||Interventional|||Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma|Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma|Active, not recruiting||Phase 2|8|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:21:41.772755|2017-10-10 23:21:41.772755
NCT02428842|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-11-10|||July 2013||2013-07-01|July 2016|2016-07-01||||July 2019|Anticipated|2019-07-01||Interventional|BIO-RAIDs||Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)|Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)|Active, not recruiting||N/A|419|Actual|Institut Curie||1|||f||||f||||||||||2017-10-10 23:21:41.864073|2017-10-10 23:21:41.864073
NCT02428829|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-04-11|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|RAPID||Does Rapid Mobilisation Improve Length of Stay and Outcomes Post THR|Does Rapid Mobilisation as Part of an Enhanced Recovery Pathway Improve Length of Stay, Return to Function and Patient Satisfaction Post Primary Total Hip Arthroplasty?|Recruiting||N/A|212|Anticipated|The Royal Bournemouth Hospital||2|||f||||f||||||||||2017-10-10 23:21:42.015839|2017-10-10 23:21:42.015839
NCT02428816|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-04-23|||January 2013||2013-01-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|MultiPAMS||Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes|Evaluation and Validation of a Multimodal MRI Neuroimaging Method: Application to Differential Diagnosis and Disease Progression in Parkinsonian Syndromes|Unknown status|Active, not recruiting|N/A|60|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-10 23:21:42.091044|2017-10-10 23:21:42.091044
NCT02428803|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-04-17|||April 2015||2015-04-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|Telemedicine||Interactive Videoconferencing in the Provision of Remote Peritoneal Dialysis|Interactive Videoconferencing in the Provision of Remote Peritoneal Dialysis|Recruiting||N/A|40|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||||||2017-10-10 23:21:42.160204|2017-10-10 23:21:42.160204
NCT02428790|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-12-01|||May 2015||2015-05-01|January 2015|2015-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Gastrointestinal Transit Time in Patients With Severe Acquired Brain Injury|Gastrointestinal Transit Time in Patients With Severe Acquired Brain Injury|Completed||N/A|25|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-10 23:21:42.230439|2017-10-10 23:21:42.230439
NCT02428777|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-24|2017-01-20|||April 2015||2015-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tramadol Versus Diclofenac for Prevention of Pain in Operative Outpatient Hysteroscopy|Tramadol Versus Diclofenac for Prevention of Pain in Operative Outpatient Hysteroscopy: A Randomized Double Blind Placebo Controlled Trial|Recruiting||Phase 3|210|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 23:21:42.28259|2017-10-10 23:21:42.28259
NCT02428751|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-11-17|||September 2015||2015-09-01|November 2015|2015-11-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Interventional|||R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma|Rituximab, Cyclophosphamide, Vincristine, and Prednisone in Combination With Doxorubicin (R-CHOP) Versus in Combination With Pegylated-liposomal Doxorubicin (R-CDOP) as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma: a Randomised, Multicentre, Non-inferiority Study|Recruiting||Phase 3|216|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:21:44.36631|2017-10-10 23:21:44.36631
NCT02428738|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-23|||November 2013||2013-11-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Observational|||Text Message Reminders for Influenza Vaccine in Pregnancy|Text Message Reminders for Influenza Vaccine in Pregnancy|Completed||N/A|317|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-10 23:21:44.548691|2017-10-10 23:21:44.548691
NCT02428725|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-08-23|||April 2015||2015-04-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome|Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome|Recruiting||N/A|640|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:21:44.611892|2017-10-10 23:21:44.611892
NCT02428712|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-09-19|||April 2015||2015-04-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors|A Phase 1/2a Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients With Advanced Unresectable Solid Tumors|Recruiting||Phase 1/Phase 2|107|Anticipated|Plexxikon||1|||f||||f||||||||||2017-10-10 23:21:44.69199|2017-10-10 23:21:44.69199
NCT02428686|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2015-04-28|||June 2010||2010-06-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|EPO-QoL||Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)|Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome With Analysis of the Impact on Quality of Life and Functional Capacity of Patients|Completed||Phase 2|50|Actual|Groupe Francophone des Myelodysplasies||1|||f||||f||||||||||2017-10-10 23:21:44.877789|2017-10-10 23:21:44.877789
NCT02428673|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-09-06|||December 2015||2015-12-01|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions|Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions|Active, not recruiting||N/A|5|Anticipated|Gillette Children's Specialty Healthcare||1|||f||||t||||||||||2017-10-10 23:21:45.014925|2017-10-10 23:21:45.014925
NCT02428660|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-02-22|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM|Medication Therapy Management Combined With Drug and Gene Interaction Software and Cytochrome DNA Testing Among a Population of Polypharmacy Medicare Patients|Completed||N/A|341|Actual|Genelex Corporation||3|||f||||f||||||||Undecided||2017-10-10 23:21:45.198441|2017-10-10 23:21:45.198441
NCT02428647|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-06-19|||September 2015||2015-09-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation|Lao Zinc Study: The Effects of Two Forms of Daily Preventive Zinc Supplementation Versus Therapeutic Zinc Supplementation for Diarrhea on Young Children's Physical Growth and Risk of New Episodes of Diarrhea|Active, not recruiting||N/A|3400|Anticipated|University of California, Davis||4|||f||||t|f|f||||||Undecided||2017-10-10 23:21:45.313682|2017-10-10 23:21:45.313682
NCT02428634|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-08-09|||September 2014||2014-09-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|PSIE||The Program SI! for Cardiovascular Health Promotion at Elementary School|The Program SI! for Cardiovascular Health Promotion for Elementary Students Aged 6 to 11: a Cluster Randomized Trial|Active, not recruiting||N/A|2238|Actual|Foundation for Science, Health and Education, Spain||4|||f||||f||||||||||2017-10-10 23:21:45.440931|2017-10-10 23:21:45.440931
NCT02428621|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-09-12|||July 2015||2015-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|EffTwicare||Early Treatment for Class II Division 1 Malocclusion With Twicare® and Herbst Removable Appliances|Prospective Multicentric, Open-label, Randomized Study Assessing the Efficacy of the Removable and Adjustable Preformed Twicare® Appliance Versus Removable Herbst Appliance Treatment in Class II Malocclusion|Active, not recruiting||N/A|148|Anticipated|FCI System||3|||f||||f||||||||||2017-10-10 23:21:45.537891|2017-10-10 23:21:45.537891
NCT02428608|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-03-20||2017-02-01|May 2015||2015-05-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|EV-006||Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006|A Multi-center, Open Label, Single Dose, Phase II Trial to Demonstrate the Safety of DWP-450 in Adult Subjects for Treatment of Moderate-to-severe Glabellar Lines|Completed||Phase 2|570|Actual|Evolus, Inc.||1|||f||||f||||||||Undecided|Developing a plan|2017-10-10 23:21:45.64149|2017-10-10 23:21:45.64149
NCT02428595|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-02-16|||May 2015||2015-05-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|LIBERATE||A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women|A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women|Active, not recruiting||N/A|75|Anticipated|Pelvalon, Inc.||1|||f||||f||||||||||2017-10-10 23:21:45.729855|2017-10-10 23:21:45.729855
NCT02428582|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-05-18|||May 2016||2016-05-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Covered Stents Versus Bare-Metal Stents|Covered Stents Versus Bare-Metal Stents in Chronic Atherosclerotic Gastrointestinal Ischemia|Recruiting||N/A|84|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 23:21:45.856686|2017-10-10 23:21:45.856686
NCT02428569|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-11-30|||May 2015||2015-05-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PREPARE NOW||Providing Resources to Enhance Patients' Readiness to Make Decisions About Kidney Disease: The PREPARE NOW Study|Providing Resources to Enhance Patients' Readiness to Make Decisions About Kidney Disease: Partnering to Break the News, Review All Options, Weigh Pros and Cons (PREPARE NOW)|Completed||N/A|24|Actual|Duke University||2|||f||||t||||||||||2017-10-10 23:21:45.957502|2017-10-10 23:21:45.957502
NCT02428556|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-04-28|||June 2014||2014-06-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||"FDA Breakthrough Drugs: A Trial Testing the Effect of Alternative Language on Public Perceptions"|"FDA Breakthrough Drugs: A Randomized Trial Testing the Effect of Alternative Language on Public Perceptions"|Completed||N/A|458|Actual|Dartmouth-Hitchcock Medical Center||5|||f||||f||||||||||2017-10-10 23:21:46.036251|2017-10-10 23:21:46.036251
NCT02428543|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-08-19|||July 2013||2013-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01||Interventional|PONATINIB-AML||Ponatinib for FLT3-ITD Acute Myelogenous Leukemia|A Phase I - II Study to Assess Safety and Efficacy of the Combination of Ponatinib With High or Intermediate-Dose Cytarabine as Consolidation Therapy for Patients With Intermediate-Risk Cytogenetic FLT3-ITD AML iIn First Complete Remission|Recruiting||Phase 1/Phase 2|40|Anticipated|Versailles Hospital||1|||f||||t||||||||||2017-10-10 23:21:46.126887|2017-10-10 23:21:46.126887
NCT02428530|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-27|||June 2013||2013-06-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Partner Involvement During Pregnancy and Its Association With Maternal Health Behaviors|Partner Involvement During Pregnancy and Its Association With Maternal Health Behaviors|Completed||N/A|159|Actual|Ohio State University|||1||f||||f||||||||||2017-10-10 23:21:46.293638|2017-10-10 23:21:46.293638
NCT02428517|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-07-13|||April 2015||2015-04-01|July 2016|2016-07-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Observational|ATLAS2015||Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015)|A Prospective Study Evaluating the Efficacy of the Allogeneic Hematopoietic Cell Transplantation With Antithymocyte Globulin (ATG)-Based Conditioning of Adult Acute Lymphoblastic Leukemia in First / Second Complete Hematologic Remission|Terminated||Phase 2|20|Actual|Asan Medical Center|||4|"The PI resigned the institute, and the rest investigators at the institute decided to terminate   the study."|f||||f||||||||||2017-10-10 23:21:46.350564|2017-10-10 23:21:46.350564
NCT02428504|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2016-03-08|||June 2012||2012-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Decision Making in End of Life as Individual Preferences|Decision Making in End of Life: Individual Preferences|Completed||N/A|148|Actual|St. Luke's-Roosevelt Hospital Center|||1||f||||t||||||||||2017-10-10 23:21:46.48894|2017-10-10 23:21:46.48894
NCT02428491|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-06-28|||April 2015||2015-04-01|June 2017|2017-06-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Interventional|||Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine|Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T Combined Vaccine Given as a Three-Dose Primary Series at 2, 3, and 4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth|Completed||Phase 3|354|Actual|Sanofi||2|||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available the company continue to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 23:21:46.553371|2017-10-10 23:21:46.553371
NCT02428478|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-02-11|2017-02-11||March 2015|Actual|2015-03-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|DESOSA||Effect of Desipramine on Genioglossus Muscle Activity in Healthy Adults Study A|The Effect of Desipramine on Genioglossus Muscle Activity During Sleep in Healthy Control Subjects|Completed||Phase 2|17|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:21:46.654143|2017-10-10 23:21:46.654143
NCT02428465|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-24|||November 2015||2015-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Purposeful Parenting: Enhanced Anticipatory Guidance for the First Year of Life|Purposeful Parenting: Enhanced Anticipatory Guidance for the First Year of Life|Active, not recruiting||N/A|260|Anticipated|Boston Medical Center||2|||f||||f||||||||||2017-10-10 23:21:47.011555|2017-10-10 23:21:47.011555
NCT02428452|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-07-11|||May 2011||2011-05-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Social ABCs for Toddlers With Signs of Autism Spectrum Disorder: Trial of a Parent-Mediated Intervention|Social ABCs for Toddlers With Signs of Autism Spectrum Disorder: RCT of a Parent-Mediated Intervention|Completed||N/A|63|Actual|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||f||||||||||2017-10-10 23:21:47.118237|2017-10-10 23:21:47.118237
NCT02428439|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-07-17|||April 2015||2015-04-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression|Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression|Recruiting||N/A|80|Anticipated|Asan Medical Center|||2||f||||f||||||Samples With DNA|"     whole blood sample for GWAS(Genome-Wide Association Study)   "|No||2017-10-10 23:21:47.212682|2017-10-10 23:21:47.212682
NCT02428426|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-23|||September 2014||2014-09-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.|Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.|Unknown status|Recruiting|N/A|20|Anticipated|Shandong University|||2||f||||t||||||Samples With DNA|"     The metagenome was obtained from biopsy specimen.   "|||2017-10-10 23:21:47.323178|2017-10-10 23:21:47.323178
NCT02428413|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-10-12|2016-04-15||April 2015||2015-04-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Evaluation and Control of WAG in PACU Within Patient and Caregiver Breathing Zone|Evaluation and Control of Waste Anesthetic Gas (WAG) in the Post Anesthesia Care Unit (PACU) Within Patient and Caregiver Breathing Zone|Completed||N/A|125|Actual|Teleflex|Precise dosing of anesthetic gas was not recorded. Dosing is practitioner dependent. Duration of surgery, PACU nurse interactions with patients, including proximity, attention to patient, and number of patients.|2|||f||||f||||||||Yes|The aggregate study results will be reported collectively, not individually by participant.|2017-10-10 23:21:47.419282|2017-10-10 23:21:47.419282
NCT02428400|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-08-17|||October 2015||2015-10-01|August 2017|2017-08-01||||June 2019|Anticipated|2019-06-01||Interventional|||Safety and Tolerability of TG1050: A Dose-finding Study|A Phase I/IB Randomized, Double-blind, Placebo Controlled, Dose-finding Study to Evaluate Safety, Tolerability of TG1050 Single/Multiple Doses, and Evaluation of TG1050 Immunologic/Antiviral Activity in Patients With Chronic Hep B Infection|Recruiting||Phase 1|96|Anticipated|Transgene||2|||f||||t||||||||||2017-10-10 23:21:47.706567|2017-10-10 23:21:47.706567
NCT02428387|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-05-28|||April 2015||2015-04-01|May 2017|2017-05-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|||"Evaluation of My Tools 4 Care for Family Caregivers of Persons With Dementia"|Evaluation of a Transition Intervention for Family Caregivers of Persons With Alzheimer Disease and Multiple Chronic Conditions|Completed||N/A|199|Actual|University of Alberta||2|||f||||f||||||||No||2017-10-10 23:21:47.809101|2017-10-10 23:21:47.809101
NCT02428374|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-06-10|||May 2015||2015-05-01|June 2015|2015-06-01|July 2019|Anticipated|2019-07-01|April 2018|Anticipated|2018-04-01||Interventional|BATTLE-AMI||Role of Immune Responses After Acute Myocardial Infarction|Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)|Recruiting||Phase 4|300|Anticipated|Federal University of São Paulo||4|||f||||t||||||||||2017-10-10 23:21:47.899607|2017-10-10 23:21:47.899607
NCT02428361|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-03-20|||May 2015||2015-05-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Fecal Microbiota Transplant (FMT) for Pouchitis||Active, not recruiting||Early Phase 1|30|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:21:48.111342|2017-10-10 23:21:48.111342
NCT02428348|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||EEG@HOME (Phase 3b of the Project, Interviews)||Withdrawn||N/A|0|Actual|University Hospital, Ghent||1|||f||||t||||||||||2017-10-10 23:21:48.189677|2017-10-10 23:21:48.189677
NCT02428335|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-04-28|||June 2015||2015-06-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib|Evaluation of Technetium-99m Sestamibi to Determine Muscle Energy Metabolism in RCC (Renal Cell Cancer) Patients Treated With Sunitinib|Unknown status|Not yet recruiting|N/A|30|Anticipated|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-10 23:21:48.259109|2017-10-10 23:21:48.259109
NCT02428322|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2015-12-01|||October 2013||2013-10-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|NCHVitDAst||Trial of Vitamin D3 Supplementation in Paediatric Asthma|Randomized, Double-blind, Placebo Controlled Trial of Vitamin D3 Supplementation on Clinical, and Subjective Symptoms of Paediatric Asthma|Completed||N/A|53|Actual|University of Dublin, Trinity College||2|||f||||f||||||||||2017-10-10 23:21:48.331026|2017-10-10 23:21:48.331026
NCT02428309|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Autologous Polyclonal Tregs for Lupus|A Phase I, Open-Label, Dose Escalation Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults With Active Cutaneous Lupus (ALE08)|Active, not recruiting||Phase 1|1|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||Yes|The plan is to share participant level data and additional relevant materials in the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts. Currently: study in progress-no data sharing.|2017-10-10 23:21:48.400836|2017-10-10 23:21:48.400836
NCT02428296|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-06-30|||April 20, 2015||2015-04-20|March 9, 2017|2017-03-09|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation|Nonrandomized Open Label Pilot Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation|Recruiting||Phase 2|15|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:21:48.493984|2017-10-10 23:21:48.493984
NCT02428283|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-01-23|||May 2015||2015-05-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Scalp Nerve Block on Emergence Agitation|The Effect of Scalp Nerve Block on the Emergence Agitation in Children Undergoing Nevus Surgery During Sevoflurane Anesthesia|Completed||Phase 4|44|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-10 23:21:48.573086|2017-10-10 23:21:48.573086
NCT02428270|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-10-05|||April 2016||2016-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer|Molecular Basket Trial In Multiple Malignancies With Common Target Pathway Aberrancies: A Phase II Trial of GSK2256098 and Trametinib in Patients With Advanced Pancreatic Cancer|Recruiting||Phase 2|24|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:21:48.65679|2017-10-10 23:21:48.65679
NCT02428257|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-27|||June 2015||2015-06-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Continuous Spinal Anesthesia With Hypobaric Bupivacaine to Preserve Hemodynamics in Elderly|Hypobaric Rather Than Isobaric Bupivacaine to Prevent Anesthesia-induced Hypotension in Patients Undergoing Surgical Repair of Hip Fracture Under Continuous Spinal Anesthesia: a Prospective Randomized Controlled Study.|Unknown status|Not yet recruiting|N/A|120|Anticipated|Institut Kassab d'Orthopédie||2|||f||||||||||||||2017-10-10 23:21:48.754224|2017-10-10 23:21:48.754224
NCT02428244|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-08-15|||November 2014||2014-11-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|STOP||Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients|Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients. A Prospective Randomized Trial|Recruiting||N/A|600|Anticipated|University of Maryland||3|||f||||t||||||||||2017-10-10 23:21:48.855714|2017-10-10 23:21:48.855714
NCT02428231|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-03-27|2016-12-12||April 2015||2015-04-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|TITRATION||Tecfidera Slow-Titration Study|A Multicenter, Treatment-Blind Phase 3b Study to Evaluate Whether 6-Week Up-Titration in Tecfidera® Dose is Effective in Reducing the Incidence of Gastrointestinal Adverse Events in Patients With Multiple Sclerosis|Terminated||Phase 3|62|Actual|Biogen|The Sponsor decided to terminate the study as a result of an evaluation of ongoing development programs.|2||Sponsor decision|f||||f||||||||||2017-10-10 23:21:48.971701|2017-10-10 23:21:48.971701
NCT02428218|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-04-11|||May 2016||2016-05-01|April 2016|2016-04-01|January 2027|Anticipated|2027-01-01|January 2027|Anticipated|2027-01-01||Interventional|||Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)|A Randomized, Placebo-Controlled, Parallel-Group Study in Pediatric Subjects Ages 10 Through 17 Years to Evaluate the Efficacy and Safety of BG00012 for the Treatment of Relapsing-Remitting Forms of Multiple Sclerosis|Withdrawn||Phase 3|0|Actual|Biogen||2||Feasibility|f||||t||||||||||2017-10-10 23:21:49.447409|2017-10-10 23:21:49.447409
NCT02428205|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-10-04|||April 2015||2015-04-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Combined Effects of Early Behavioral Intervention and Propranolol on ASD|Combined Effects of Early Behavioral Intervention and Propranolol on ASD|Recruiting||N/A|30|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 23:21:49.53857|2017-10-10 23:21:49.53857
NCT02428192|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-09-12|||April 22, 2015|Actual|2015-04-22|September 2017|2017-09-01||||January 7, 2018|Anticipated|2018-01-07||Interventional|||Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma|A Phase 2 Study of Nivolumab and Ipilimumab in Advanced Leiomyosarcoma of the Uterus|Recruiting||Phase 2|37|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 23:21:49.664952|2017-10-10 23:21:49.664952
NCT02428179|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-03-14|||April 2015||2015-04-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|StOP||Impact of Structured Communication in the OR on Surgical Site Infections: Prospective Observational Clinical Trial|StOP?-Trial: Impact of Structured Communication in the OR on Surgical Site Infections: Prospective Observational Clinical Trial|Completed||N/A|3003|Actual|University Hospital Inselspital, Berne|||2||f||||t||||||||||2017-10-10 23:21:49.794678|2017-10-10 23:21:49.794678
NCT02428166|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-06-01|||February 2015||2015-02-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Corneal Changes After Crosslinking in Keratoconus Patients Compared to the Untreated Fellow Eye|Corneal Changes After Crosslinking in Keratoconus Patients Compared to the Untreated Fellow Eye|Active, not recruiting||N/A|50|Anticipated|Heidelberg University|||1||f||||f||||||||||2017-10-10 23:21:49.886764|2017-10-10 23:21:49.886764
NCT02428153|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-07-23|||April 2015||2015-04-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Effect Of Static And Dynamic Stretching On Muscle Tendon Unit|Investigation Of Muscle-Tendon Unit By Ultrasound After Static And Dynamic Stretching|Completed||N/A|28|Actual|Tokat Gaziosmanpasa University||1|||f||||f||||||||||2017-10-10 23:21:49.958201|2017-10-10 23:21:49.958201
NCT02428140|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-05-10|||July 2015||2015-07-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|PERDIEM||Post-Embolic Rhythm Detection With Implantable Versus External Monitoring|Post-Embolic Rhythm Detection With Implantable Versus External Monitoring: Pilot and Feasibility Study|Recruiting||N/A|200|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:21:50.056079|2017-10-10 23:21:50.056079
NCT02428114|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-09-27|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|React-G||A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)|A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)|Completed||N/A|142|Actual|Ottawa Hospital Research Institute|||3||f||||f||||||||||2017-10-10 23:21:50.246536|2017-10-10 23:21:50.246536
NCT02428101|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-07-21|||December 2014||2014-12-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer|Relation of Genetic Polymorphism of ABCG2 Gene And Occurrence of Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer|Enrolling by invitation||N/A|100|Anticipated|Ain Shams University|||1||f||||t||||||||||2017-10-10 23:21:50.32588|2017-10-10 23:21:50.32588
NCT02428088|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-06-26||2017-06-26|April 2015||2015-04-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Dasotraline Pediatric ADHD Study|A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2/Phase 3|330|Actual|Sunovion||3|||f||||t||||||||||2017-10-10 23:21:50.399661|2017-10-10 23:21:50.399661
NCT02428075|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-02-23|||November 2015||2015-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|COBIN||Community-based Management of Hypertension in Nepal|Protocol for Community-based Intervention for Blood Pressure Reduction in Nepal: a Community-based Cluster Randomized Controlled Trial|Completed||N/A|1638|Actual|University of Aarhus||6|||f||||f||||||||||2017-10-10 23:21:50.596061|2017-10-10 23:21:50.596061
NCT02428062|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-28|||October 2014||2014-10-01|April 2015|2015-04-01||||December 2018|Anticipated|2018-12-01||Interventional|THE BRIDGE||Target Hemodynamics and Brain Injury During General Anesthesia in the Elderly|Effect of Target Intraoperative Blood Pressure on the Incidence of Post-operative Cognitive Dysfunction in Patients Aged 75 and Older Undergoing General Anesthesia for Non-cardiac Surgery: an International Multicenter Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|1812|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||3|||f||||f||||||||||2017-10-10 23:21:50.691744|2017-10-10 23:21:50.691744
NCT02428049|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-12-06|||October 2013||2013-10-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Observational|||Lung Function Changes After Curative Targeted Radiotherapy of Non-small-cell Lung Carcinoma|Lung Function Changes After Curative Targeted Radiotherapy of Non-small-cell Lung Carcinoma|Recruiting||N/A|130|Anticipated|Sykehuset i Vestfold HF|||2||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:21:50.900665|2017-10-10 23:21:50.900665
NCT02428036|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-06-29|||June 2015||2015-06-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|October 2016|Actual|2016-10-01||Interventional|||A Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions|A Phase I Study of Repeated Intratumoral Administration of TBI-1401(HF10), a Replication Competent HSV-1 Oncolytic Virus, in Patients With Solid Tumors With Superficial Lesions|Completed||Phase 1|6|Actual|Takara Bio Inc.||2|||f||||f||||||||Undecided||2017-10-10 23:21:51.006932|2017-10-10 23:21:51.006932
NCT02428023|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-01-08|||March 2015||2015-03-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01|5 Years|Observational [Patient Registry]|||B-Thalasaemia Trait and Its Possible Cardioprotective Role|B-Thalasaemia Trait and Its Possible Cardioprotective Role|Recruiting||N/A|2500|Anticipated|404 General Military Hospital, Larissa|||2||f||||f||||||||||2017-10-10 23:21:51.089925|2017-10-10 23:21:51.089925
NCT02427997|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2015-04-27|||June 2015||2015-06-01|April 2015|2015-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||VR-treadmill Combined Intervention for Enhancing Mobility and Cognitive Function in Patients With Multiple Sclerosis|Virtual Reality-treadmill Combined Intervention for Enhancing Mobility and Cognitive Function in Patients With Multiple Sclerosis|Not yet recruiting||N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:21:51.272006|2017-10-10 23:21:51.272006
NCT02427984|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-04-18|2016-02-08||August 2012||2012-08-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|PF||Pending Failure in Hard-hard Total Hip Arthroplasty|Early Diagnosis of Pending Failures of Total Hip Arthroplasty With Hard to Hard Bearings|Completed||N/A|148|Actual|Istituto Ortopedico Rizzoli|||3||f||||t||||||Samples With DNA|"     Whole blood, serum, synovial fluid, urines, periprosthetic tissues, at -80°C   "|||2017-10-10 23:21:51.356939|2017-10-10 23:21:51.356939
NCT02427971|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-04-27|||January 2015||2015-01-01|April 2015|2015-04-01|April 2015|Anticipated|2015-04-01|April 2015|Actual|2015-04-01||Observational|ConsoHalo||A Comparison Between the Aysis® Cs2 (General Electrics) Ventilator in EtControl® Mode and the Perseus® A 500 (Dräger) in VaporView® Mode on Maniability and Consumption of Desflurane|A Comparison Between the Aysis® Cs2 (General Electrics) Ventilator in EtControl® Mode and the Perseus® A 500 (Dräger) in VaporView® Mode on Maniability and Consumption of Desflurane|Unknown status|Recruiting|N/A|60|Anticipated|Saint Antoine University Hospital|||2||f||||f||||||||||2017-10-10 23:21:51.671668|2017-10-10 23:21:51.671668
NCT02427958|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2017-04-13|||August 11, 2015|Actual|2015-08-11|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Patients|An Open Label, Multicenter Study to Assess the Safety and Efficacy of Leuprorelin in the Treatment of Central Precocious Puberty|Active, not recruiting||Phase 4|300|Anticipated|Takeda||1|||f||||f||||||||||2017-10-10 23:21:51.735256|2017-10-10 23:21:51.735256
NCT02423785|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-09-12|||May 2014||2014-05-01|September 2016|2016-09-01||||May 2018|Anticipated|2018-05-01||Observational|||Ocular Blood Flow in Colorectal Cancer Patients|Exploratory Study Investigating Ocular Blood Flow in Colorectal Cancer Patients Before and After Treatment With Anti-angiogenic Therapy|Recruiting||N/A|30|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 23:22:38.899952|2017-10-10 23:22:38.899952
NCT02427945|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-02-23|||May 2015||2015-05-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Leveraging an Existing Large-scale Safe Water Program to Deliver Nutrition Messages at a Low Marginal Cost|Leveraging an Existing Large-scale Safe Water Program to Deliver Nutrition Messages at a Low Marginal Cost|Active, not recruiting||N/A|1671|Actual|Institute for Fiscal Studies||3|||f||||f||||||||||2017-10-10 23:21:51.825405|2017-10-10 23:21:51.825405
NCT02427932|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-05-08|||May 2015|Actual|2015-05-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients|PK and PD Modeling of Ampicillin and Gentamicin in Peripartum Patients|Completed||N/A|45|Actual|Stanford University|||4||f||||f||||||||||2017-10-10 23:21:51.92247|2017-10-10 23:21:51.92247
NCT02427919|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-04-22|||March 2015||2015-03-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DeGREE||Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML|The DEtection of G-CSF REceptor With Flow Cytometry and Identification of the Effect of G-CSF After Salvage Chemotherapy in Relapsed or Refractory AML|Recruiting||Phase 2/Phase 3|56|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-10 23:21:52.007367|2017-10-10 23:21:52.007367
NCT02427906|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-10-26|||August 2014||2014-08-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01|6 Months|Observational [Patient Registry]|||Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients|Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota and Associated Inflammatory Factors in Cirrhotic Patients|Unknown status|Recruiting|N/A|50|Anticipated|West China Hospital|||2||f||||t||||||Samples With DNA|"     whole blood, serum，stool   "|||2017-10-10 23:21:52.103329|2017-10-10 23:21:52.103329
NCT02427893|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-11-14|||August 2015||2015-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma|An Exploratory Study of the Immunological Effects of Vemurafenib and Cobimetinib, Administered Alone and in Combination, in Subjects With Advanced BRAF V600E/K Mutant Melanoma|Withdrawn||Phase 3|0|Actual|Sidney Kimmel Comprehensive Cancer Center||2||no patients were enrolled|f||||t||||||||||2017-10-10 23:21:52.185923|2017-10-10 23:21:52.185923
NCT02427880|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-02-21|||April 2015||2015-04-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema|Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Hydrochlorothiazide and Furosemide Followed by Furosemide for the Treatment of Adults With Refractory Nephrotic Edema: A Randomized, Double-Blind Trial|Completed||Phase 4|20|Actual|Shiraz University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:21:52.260373|2017-10-10 23:21:52.260373
NCT02427867|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-03-08|||April 2015||2015-04-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|PRINCE||Ischaemic PReconditioning In Non Cardiac surgEry|Ischaemic PReconditioning In Non Cardiac surgEry|Recruiting||N/A|1100|Anticipated|Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-10-10 23:21:52.344568|2017-10-10 23:21:52.344568
NCT02427854|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-02-28|||February 2015||2015-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PPS||Palestinian Perineum and Birth Complication Study|Can Perineal Tears and Obstetric Anal Sphincter Injuries in Palestine be Prevented? A Study of Two Different Interventions|Recruiting||N/A|70000|Anticipated|Oslo University Hospital||3|||f||||f||||||||||2017-10-10 23:21:52.59336|2017-10-10 23:21:52.59336
NCT02427841|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-05-05|||January 2016||2016-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery|Phase 2 Study of Preoperative Chemotherapy With Abraxane and Gemcitabine Followed by Chemoradiation for Borderline Resectable or Node-Positive Pancreatic Cancer|Recruiting||Phase 2|46|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 23:21:52.727843|2017-10-10 23:21:52.727843
NCT02427828|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-04-27|||March 2013||2013-03-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|VRES||VRES Study in Two Phases to Monitor Cardiac Surgical Patients Following Discharge From ICU|Continuous, Ambulatory, Non Invasive, Vital Sign Monitoring Using VRES of Cardiac Surgical Patients Following Discharge From Intensive Care. Impact on Detection of Physiological Deterioration|Completed||N/A|208|Actual|OBS Medical Ltd||2|||f||||f||||||||||2017-10-10 23:21:52.896191|2017-10-10 23:21:52.896191
NCT02427815|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-03-27|||May 2014||2014-05-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|PEERS-ED||Peer-Enhanced Education to Reduce Sleep Ethnic Disparities|Tailored Peer-Based Sleep Health Education and Social Support Among Blacks With Obstructive Sleep Apnea|Recruiting||N/A|398|Anticipated|New York University Langone Medical Center||2|||f||||t||||||||||2017-10-10 23:21:52.973037|2017-10-10 23:21:52.973037
NCT02427802|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-06-07|||May 2015||2015-05-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|COACT-1||Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers|A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer|Active, not recruiting||Phase 3|613|Actual|Innocoll||3|||f||||f||||||||||2017-10-10 23:21:53.095797|2017-10-10 23:21:53.095797
NCT02427789|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-04-28|||March 2012||2012-03-01|January 2013|2013-01-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Therapeutic Effectiveness of Exercise Associated to the Pharmacotherapy in Major Depression|Therapeutic Effectiveness of Exercise Associated to the Pharmacotherapy in Major Depression|Completed||N/A|40|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:21:53.387797|2017-10-10 23:21:53.387797
NCT02427581|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-04-12|||September 29, 2015|Actual|2015-09-29|April 2017|2017-04-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy|Recruiting||Phase 1|15|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||No||2017-10-10 23:21:55.586083|2017-10-10 23:21:55.586083
NCT02427776|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-08-18|||January 2015||2015-01-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|SCLEROLYM||A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis|A Clinical Trial to Document Safety and Radiological Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis Treated With Autologous CD4+ T Cells, Stimulated and Expanded ex Vivo by a Myelin Oligodendrocyte Glycoprotein Peptide Modified by the Introduction of a Thioreductase Motif Into the Flanking Residues of the Cell Epitope - A First-in-human Trial (SCLEROLYM TRIAL)|Terminated||Phase 1/Phase 2|2|Actual|Imcyse SA||1||"study ended prior enrollment of the first patient because of unexpected issues in the   manufacturing process prevented production of adequate clinical batches"|f||||f||||||||||2017-10-10 23:21:53.474331|2017-10-10 23:21:53.474331
NCT02427763|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-04-22|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Microbiological and Epithelial Evaluation Related to the Use of Orthodontic Thermoplastic Device|Epithelial Changes and Streptococci Mutans and Lactobacilli Quantify Related With the Use of Thermoplastic Aligner|Completed||Early Phase 1|105|Actual|Universidade Positivo||2|||f||||t||||||||||2017-10-10 23:21:53.57573|2017-10-10 23:21:53.57573
NCT02427750|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-09-22|2015-08-18||April 2015||2015-04-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects.|A Phase II, Open-Label, Single-Arm, Multicenter Study to Evaluate the Safety and Immunogenicity of a Surface Antigen, Inactivated, Egg-Derived, Trivalent Influenza (Agrippal®) Virus Vaccine, Southern Hemisphere Formulation 2015, in Healthy Adults.|Completed||Phase 2|126|Actual|Novartis||1|||f||||f||||||||||2017-10-10 23:21:53.717218|2017-10-10 23:21:53.717218
NCT02427737|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-09-08|||April 2015||2015-04-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|ComfortTalk®||Comfort Talk and Economic Outcomes in MRI|Amelioration of Claustrophobia and Disruptive Patient Motion in MRI Imaging (Phase 2 Randomized Training of Sites)|Completed||N/A|12|Actual|Hypnalgesics, LLC||2|||f||||t||||||||||2017-10-10 23:21:54.329929|2017-10-10 23:21:54.329929
NCT02427724|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-12-05|||April 2015||2015-04-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser|The Effect of Topical Anesthetic Using Lidocaine 2.5%/Prilocaine 2.5% Versus Lidocaine 7%/Tetracaine 7% Cream on Patients' Pain and Operative Experience During Treatment With QSwitched 532nm Laser|Active, not recruiting||N/A|48|Anticipated|Northwestern University||3|||f||||t||||||||||2017-10-10 23:21:54.44836|2017-10-10 23:21:54.44836
NCT02427711|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-08-13|||October 2013||2013-10-01|April 2015|2015-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Reduced Total Blood Loss and Blood Transfusion in Non-Septic Revision Knee Arthroplasty Using a Bipolar Sealer|Reduced Total Blood Loss and Blood Transfusion in Non-Septic Revision Knee Arthroplasty Using a Bipolar Sealer - A Prospective Cohort Study With Retrospective Controls|Completed||N/A|60|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-10 23:21:54.54356|2017-10-10 23:21:54.54356
NCT02427698|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-02-07|||August 2015||2015-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cyrolipolysis vs Cyrolipolysis and Subcision for Cellulite|Comparison of the Efficacy Between Cryolipolysis Versus Cryolipolysis Plus Subcision For Treatment of Cellulite: A Prospective Randomized Control Trial|Active, not recruiting||N/A|15|Actual|Northwestern University||2|||f||||t||||||||||2017-10-10 23:21:54.63799|2017-10-10 23:21:54.63799
NCT02427685|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-06-16|||April 2015||2015-04-01|April 2015|2015-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Dysfunctional Hemoglobin CO-ox|Dysfunctional Hemoglobin|Completed||N/A|27|Actual|Nonin Medical, Inc|||1||f||||f||||||||||2017-10-10 23:21:54.712053|2017-10-10 23:21:54.712053
NCT02427672|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-04-25|||March 2015||2015-03-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior|The Effect of Transcranial Direct Current Stimulation of the Prefrontal Cortex on Antisocial and Aggressive Behavior|Recruiting||N/A|86|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:21:54.778886|2017-10-10 23:21:54.778886
NCT02427659|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-08-30|||November 2011||2011-11-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|November 2016|Actual|2016-11-01||Interventional|VRH2O||VR High Tech Pain Control Burn Wound Care|High Technology Pain Control During Burn Wound Care|Completed||N/A|100|Anticipated|National Institute of General Medical Sciences (NIGMS)||3|||f||||f||||||||||2017-10-10 23:21:54.885596|2017-10-10 23:21:54.885596
NCT02427646|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-10-31|||October 2011||2011-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Use of Kinematic Assessment of Hand Tremor Pre- and Post- Treatment With Botulinum Toxin Type A in Essential Tremor and Parkinson Disease|Use of Kinematic Assessment of Hand Tremor Pre- and Post- Treatment With Botulinum Toxin Type A in Essential Tremor and Parkinson Disease|Enrolling by invitation||Phase 2|54|Actual|Western University, Canada||2|||f||||f||||||||||2017-10-10 23:21:54.974462|2017-10-10 23:21:54.974462
NCT02427633|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-05-11|||September 2014||2014-09-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|September 2015|Anticipated|2015-09-01||Interventional|||Study of Body Positions in Unconsciousness|A Randomised Controlled Study of the Use of Recovery Positions for Comatose Patients in a Resource Limited Setting|Unknown status|Recruiting|N/A|1377|Anticipated|University of Oxford||3|||f||||t||||||||||2017-10-10 23:21:55.065529|2017-10-10 23:21:55.065529
NCT02427620|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-05-30|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||A Study of Ibrutinib Plus Rituximab With Hyper-CVAD Consolidation in Newly Diagnosed Young Patients With Mantle Cell Lymphoma|A Phase II Study of Ibrutinib Plus Rituximab With Hyper-CVAD Consolidation in Newly Diagnosed Young Patients With Mantle Cell Lymphoma: A Window Period for Bioimmunotherapy Before Chemotherapy|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:21:55.195711|2017-10-10 23:21:55.195711
NCT02427568|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-09-07|||April 2015||2015-04-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||MDMA-assisted Psychotherapy for Anxiety Associated With a Life-threatening Illness|Randomized, Double-Blind, Placebo-Controlled Phase 2 Pilot Study of MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness|Active, not recruiting||Phase 2|18|Anticipated|Multidisciplinary Association for Psychedelic Studies||2|||f||||f||||||||||2017-10-10 23:21:55.74764|2017-10-10 23:21:55.74764
NCT02427555|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-05-16|||April 2015||2015-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Barley Based Food Products on Metabolism and Gut Microflora|Effects of Barley Based Food Products on Metabolism and Gut Microflora|Completed||N/A|100|Actual|Lund University||2|||f||||||||||||||2017-10-10 23:21:55.902327|2017-10-10 23:21:55.902327
NCT02427542|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-08-04|||March 2015||2015-03-01|February 2016|2016-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Feasibility Trial of CBT for Depersonalisation in Psychosis|A Brief Cognitive Behavioural Therapy (CBT) Intervention for Depersonalisation/Derealisation in Psychosis: a Feasibility Study|Completed||Phase 1|20|Actual|King's College London||2|||f||||f||||||||||2017-10-10 23:21:55.995502|2017-10-10 23:21:55.995502
NCT02427529|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2015-04-27|||May 2011||2011-05-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)|Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)|Completed||Phase 1/Phase 2|59|Actual|Dr. Emma's Corporation||2|||f||||f||||||||||2017-10-10 23:21:56.086835|2017-10-10 23:21:56.086835
NCT02427516|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-23|2016-09-19|||January 2009||2009-01-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Observational|||Cost of Monitoring Patients Treated With Vitamin K Antagonists in Spain|Cost of Monitoring Patients Treated With Vitamin K Antagonists in Spain|Completed||N/A|1144|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 23:21:56.171986|2017-10-10 23:21:56.171986
NCT02427503|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-30|||May 2015||2015-05-01|March 2015|2015-03-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01|6 Months|Observational [Patient Registry]|ATP||ATP Project (Asthma afTer Polypectomy)|Sinonasal Functional Impact of Endoscopic Surgery for Bilateral Polyposis on Bronchial Inflammation, Control and Lung Function in Asthma|Unknown status|Not yet recruiting|N/A|240|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||f||||||||||2017-10-10 23:21:56.228136|2017-10-10 23:21:56.228136
NCT02427490|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-07-24|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|May 24, 2017|Actual|2017-05-24|April 29, 2017|Actual|2017-04-29||Interventional|||A Problem-Solving Intervention for Family Caregivers in Palliative Oncology|A Problem-Solving Intervention for Family Caregivers in Palliative Oncology|Completed||N/A|83|Actual|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 23:21:56.317788|2017-10-10 23:21:56.317788
NCT02427477|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-07-27|2016-05-05||March 2015||2015-03-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All subjects that randomized to one of two sequences of lens wear.|A Comparison of Two Daily Disposable Soft Contact Lenses||Completed||N/A|120|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-10 23:21:56.406153|2017-10-10 23:21:56.406153
NCT02427464|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-07-26|||April 2016||2016-04-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase 3 Gene Therapy for Painful Diabetic Neuropathy|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy|Recruiting||Phase 3|477|Anticipated|ViroMed Co., Ltd. dba VM BioPharma||2|||f||||t||||||||||2017-10-10 23:21:56.951526|2017-10-10 23:21:56.951526
NCT02427451|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-06-14|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia|Obinutuzumab, Ibrutinib, and Venetoclax for Relapsed and Previously Untreated Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 1/Phase 2|63|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:21:57.254554|2017-10-10 23:21:57.254554
NCT02427438|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-09-30|||February 2015||2015-02-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Home Program Education for Patients With Low Back Pain|Home Program Education for Patients With Low Back Pain: Does it Matter? A Prospective Study|Suspended||N/A|10|Anticipated|University of Wisconsin, Madison||2||Not recruiting subjects currently|f||||f||||||||||2017-10-10 23:21:57.415513|2017-10-10 23:21:57.415513
NCT02427425|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-04-22|||June 2010||2010-06-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effectiveness of Transcutaneous Electrical Nerve Stimulation in Patients With Acute Low Back Pain||Completed||Phase 4|71|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-10 23:21:57.582002|2017-10-10 23:21:57.582002
NCT02427412|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-08-13|||January 2014||2014-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty|Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty - A Randomized, Prospective, Placebo-Controlled Study|Completed||Phase 4|60|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 23:21:57.667951|2017-10-10 23:21:57.667951
NCT02427399|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-06-19|2017-02-18||January 2013||2013-01-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|December 2014|Actual|2014-12-01||Interventional|||Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients|Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients at an Urban Community Health Center|Completed||N/A|1100|Actual|Fenway Community Health||5|||f||||f||||||||||2017-10-10 23:21:57.784599|2017-10-10 23:21:57.784599
NCT02427386|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-02-22|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional|||Homeopathic Treatment of Chronic Pelvic Pain in Women With Endometriosis|Phase 4 Randomized Controlled Trial of Dynamized Estrogen in Individualized Homeopathic Treatment of Chronic Pelvic Pain of Endometriosis|Completed||Phase 4|50|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:21:58.449017|2017-10-10 23:21:58.449017
NCT02423772|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-06-09|||August 2014||2014-08-01|June 2016|2016-06-01||||July 2017|Anticipated|2017-07-01||Interventional|||Pilot Study of Combined Treatment for Veterans With Chronic Pain & Opiate Misuse|Pilot Study of Combined Treatment for Veterans With Chronic Pain & Opiate Misuse|Recruiting||N/A|120|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-10-10 23:22:38.964892|2017-10-10 23:22:38.964892
NCT02427373|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-27|||June 2014||2014-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|KOMPARE||A Parallel Bioavailability Study of Fish Oil-Ethyl Ester Versus Fish Oil-Triglyceride Versus Krill Oil|A Parallel Bioavailability Study of Fish Oil-Ethyl Ester Versus Fish Oil-Triglyceride Versus Krill Oil|Completed||N/A|66|Actual|DSM Nutritional Products, Inc.||3|||f||||f||||||||||2017-10-10 23:21:58.565462|2017-10-10 23:21:58.565462
NCT02427360|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-12-14|||May 2015||2015-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|MMA||Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers|Evaluating the Efficacy of Artesunate-mefloquine on the Thai-Myanmar Border and the Relative Roles of Resistance Genetic Markers: A Retrospective Cohort Study|Completed||N/A|1022|Actual|University of Oxford|||1||f||||f||||||||||2017-10-10 23:21:58.647347|2017-10-10 23:21:58.647347
NCT02427347|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-07-06|||June 2014||2014-06-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|April 2015|Actual|2015-04-01||Interventional|||Acupuncture in the Regulation of Dai Meridian for the Metabolism of Visceral Adipose Tissue in Abdominal Obese Patients||Active, not recruiting||N/A|120|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||2|||f||||t||||||||||2017-10-10 23:21:58.724106|2017-10-10 23:21:58.724106
NCT02427334|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-01-20|||April 2015||2015-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome|Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial|Recruiting||Phase 3|210|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 23:21:58.834062|2017-10-10 23:21:58.834062
NCT02427321|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-01-13|||May 2015||2015-05-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|CICERO||Cystoscopic Imaging Collection and Enhancement pROject|Cystoscopic Imaging Collection and Enhancement pROject: A Prospective, Non-randomised, Observational Proof-of-concept Study of Flexible Cystoscopic Examination Recordings From a Symptomatic Adult Population|Completed||N/A|123|Actual|Biosignatures Limited|||1||f||||f||||||||||2017-10-10 23:21:58.930601|2017-10-10 23:21:58.930601
NCT02427308|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-02-28|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|March 2026|Anticipated|2026-03-01|March 2025|Anticipated|2025-03-01|9 Months|Observational [Patient Registry]|||Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry|Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry|Recruiting||N/A|2|Anticipated|Knight Therapeutics (USA) Inc|||1||f||||f||||||||||2017-10-10 23:21:59.03146|2017-10-10 23:21:59.03146
NCT02427295|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-04-22|||March 2014||2014-03-01|April 2015|2015-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|acromegaly||Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues|Long-term (up to 3 Years) Clinical and Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues: Open-labeled, Prospective, Parallel Group Study|Recruiting||Phase 4|1|Anticipated|Asan Medical Center||3|||f||||f||||||||||2017-10-10 23:21:59.121989|2017-10-10 23:21:59.121989
NCT02427282|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2015-04-30|||July 2012||2012-07-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|AU||Distalization by Miniscrew|Miniscrew-supported Versus Standard Frog Molar Distalizing Appliances (Clinical Study)|Completed||Phase 1|20|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:21:59.222151|2017-10-10 23:21:59.222151
NCT02427269|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-05-15|||May 2015||2015-05-01|May 2017|2017-05-01|May 2025|Anticipated|2025-05-01|May 2025|Anticipated|2025-05-01||Observational|BEECAB||UNC Barrett's Esophagus and Esophageal Cancer Biorepository|UNC Barrett's Esophagus and Esophageal Cancer Biorepository|Enrolling by invitation||N/A|1000|Anticipated|University of North Carolina, Chapel Hill|||5||f||||f||||||Samples With DNA|"     -  1 10mL red tube and 1 8.5mL yellow tube for serum, plasma, and buffy collection        -  Up to 10 research-specific biopsies (tissue samples) obtained from the esophagus during          the routine care EGD.        -  Pathology slides from routine care biopsies taken during the procedure        -  Up to 4 cytology brushes during the procedure   "|||2017-10-10 23:21:59.286838|2017-10-10 23:21:59.286838
NCT02427256|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-12-01|||February 2015||2015-02-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements|Comparative Study of the Topcon Specular Microscope SP-1P and the Konan Specular Microscope CELLCHEK XL (Predicate Device) for the Measurements of Endothelial Cell Density Measurements, Coefficient of Variation of Endothelial Cell Area, ％ Hexagonality, Central Corneal Thickness|Completed||N/A|76|Actual|Topcon Medical Systems, Inc.|||3||f||||f||||||||||2017-10-10 23:21:59.397111|2017-10-10 23:21:59.397111
NCT02427243|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-11-01|||April 2015||2015-04-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous Dose|A Phase 1, Single-Dose, Randomized, Open-Label, Parallel Group Study to Assess the Relative Bioavailability and Tolerability of Two Formulations of Crenezumab in Healthy Subjects Following Subcutaneous Administration|Completed||Phase 1|60|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-10 23:21:59.463805|2017-10-10 23:21:59.463805
NCT02427230|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-08-21|||May 2015||2015-05-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Treatment of Urinary Incontinence in Women With Spinal Cord Injury|The Effect of Pelvic Floor Muscle Training and Neuromuscular Electrical Stimulation on Urinary Incontinence and Quality of Life in Women With Spinal Cord Injury|Completed||N/A|27|Actual|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-10-10 23:21:59.548069|2017-10-10 23:21:59.548069
NCT02427217|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-08-24|||May 7, 2015||2015-05-07|August 2017|2017-08-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency|A Multicenter Study on the Retrospective Safety and Efficacy of Fibrinogen Concentrate (Human) (FCH) for Routine Prophylaxis, Treatment of Bleeding or Surgery in Subjects With Congenital Fibrinogen Deficiency With a Prospective Followup Component|Active, not recruiting||N/A|23|Anticipated|CSL Behring|||1||f||||||||||||||2017-10-10 23:21:59.657279|2017-10-10 23:21:59.657279
NCT02420730|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-07-13|||June 2015||2015-06-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye||Completed||Phase 1|77|Actual|Allergan||8|||f||||t||||||||||2017-10-10 23:23:09.383121|2017-10-10 23:23:09.383121
NCT02427204|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-08-22|||June 2015||2015-06-01|August 2017|2017-08-01|November 18, 2017|Anticipated|2017-11-18|November 18, 2017|Anticipated|2017-11-18||Observational|||Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality|Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality of Life, Fatigue, Work Productivity, Liver Status and Cost-per-SVR/Health Care Utilization|Active, not recruiting||N/A|150|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||||||2017-10-10 23:21:59.742049|2017-10-10 23:21:59.742049
NCT02427191|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-02-17|||March 2015||2015-03-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|dHACM||Micronized dHACM Injectable for the Treatment of Plantar Fasciitis|A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis|Recruiting||Phase 2/Phase 3|146|Anticipated|MiMedx Group, Inc.||2|||f||||t||||||||||2017-10-10 23:21:59.812707|2017-10-10 23:21:59.812707
NCT02427178|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-01-25|||March 2015||2015-03-01|January 2017|2017-01-01|June 2023|Anticipated|2023-06-01|June 2022|Anticipated|2022-06-01||Interventional|MASS||MNGIE Allogeneic Hematopoietic Stem Cell Transplant Safety Study|MNGIE (Mitochondrial Neurogastrointestinal Encephalomyopathy) AHSCT (Allogeneic Hematopoietic Stem Cell Transplant) Safety Study|Recruiting||Phase 1|12|Anticipated|Columbia University||1|||f||||t||||||||Yes|When applicable, we will submit a manuscript describing the results|2017-10-10 23:22:00.00344|2017-10-10 23:22:00.00344
NCT02427165|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-09-08|||April 2015||2015-04-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients|A Phase II, Randomised, Double Blind, Placebo Controlled, Seven Way Crossover Study to Assess the Effect of Single Doses of RPL554 Compared to Salbutamol and Placebo Administered by Nebuliser on Lung Function of Patients With Chronic Asthma|Completed||Phase 2|29|Actual|Verona Pharma plc||7|||f||||f||||||||||2017-10-10 23:22:00.098219|2017-10-10 23:22:00.098219
NCT02427152|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-05-29|||March 2015||2015-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Pre-meal Planning and Expected Satiety||Recruiting||N/A|60|Anticipated|University Hospital Tuebingen|||2||f||||||||||||||2017-10-10 23:22:00.194665|2017-10-10 23:22:00.194665
NCT02427139|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-05-21|||March 2015||2015-03-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|ANSS-ALP||ANSiStim Study for Active Labor Pain|Study of ANSiStim for Pain Relief During Active Labor Phase Through Continues Checking of VAS SCORE|Recruiting||N/A|50|Anticipated|DyAnsys, Inc.||1|||f||||f||||||||||2017-10-10 23:22:00.263974|2017-10-10 23:22:00.263974
NCT02427126|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-03-24|||December 2015||2015-12-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ATTICUS||Apixaban for Treatment of Embolic Stroke of Undetermined Source|Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS Randomized Trial)|Recruiting||Phase 3|500|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 23:22:00.348415|2017-10-10 23:22:00.348415
NCT02427113|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-05-10|||May 2015||2015-05-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|TMD||What Are the Effects of Music on Temporomandibular Disorder Symptoms?|What Are the Effects of Music on TMD Symptoms?|Recruiting||N/A|24|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-10 23:22:00.525712|2017-10-10 23:22:00.525712
NCT02427087|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-04-24|||January 2013||2013-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity|Anthropometric Evaluation and Body Composition in Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity|Completed||N/A|40|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:22:00.702585|2017-10-10 23:22:00.702585
NCT02427074|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2016-01-07|||February 2014||2014-02-01|January 2016|2016-01-01||||June 2016|Anticipated|2016-06-01||Interventional|||Comparison Between Radiofrequency and Balloon Compression in the Treatment of Idiopathic Trigeminal Neuralgia|Comparative Study Between Radiofrequency and Balloon Compression of the Gasserian Ganglion in the Treatment of Idiopathic Trigeminal Neuralgia|Recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:22:02.611017|2017-10-10 23:22:02.611017
NCT02427061|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-09-22|||April 2015||2015-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Engendering Healthy Masculinities to Prevent Sexual Violence|Engendering Healthy Masculinities to Prevent Sexual Violence|Active, not recruiting||N/A|868|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:22:02.727005|2017-10-10 23:22:02.727005
NCT02427048|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-02-01|||July 2015||2015-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|||Clinical Practice Guidelines and Impact of Audit and Feedback in the Emergency Department|Adherence to Clinical Practice Guidelines and the Impact of Audit and Feedback in the Emergency Department|Completed||N/A|24|Actual|Denver Health and Hospital Authority||2|||f||||f||||||||No||2017-10-10 23:22:02.812402|2017-10-10 23:22:02.812402
NCT02427035|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-09-18|||May 2015||2015-05-01|September 2017|2017-09-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||A Study of CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment|A Double-blind, Randomized, Placebo-controlled, Pharmacokinetic, Safety and Tolerability Study of CSL112 in Adult Subjects With Moderate Renal Impairment and in Healthy Adult Subjects With Normal Renal Function|Completed||Phase 1|32|Actual|CSL Behring||2|||f||||t||||||||||2017-10-10 23:22:02.887515|2017-10-10 23:22:02.887515
NCT02427022|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-04-24|||September 2010||2010-09-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|||Implementation, Fidelity, and Outcomes Following Novel and Usual Critical Time Intervention Training|Phase II Evidence-Based Practice in Community-Based Social Work: A Multi-Media Strategy|Completed||Phase 2|179|Actual|Center for Social Innovation, Massachusetts||2|||f||||f||||||||||2017-10-10 23:22:03.002954|2017-10-10 23:22:03.002954
NCT02427009|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-01-30|||December 2015||2015-12-01|January 2017|2017-01-01|April 23, 2016|Actual|2016-04-23|April 21, 2016|Actual|2016-04-21||Interventional|UpSideDown||Maintaining a Prone Position After Use of an Epidural Blood Patch for the Treatment of Post-dural Puncture Headache|Effectiveness of Maintaining a Prone Position After Use of an Epidural Blood Patch for the Treatment of Post-dural Puncture Headache|Terminated||N/A|3|Actual|Centre Hospitalier Universitaire de Nīmes||1||no inclusion|f||||f||||||||||2017-10-10 23:22:03.10494|2017-10-10 23:22:03.10494
NCT02426996|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-05-23|||May 2016||2016-05-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|IACE Scan||The Latarjet-type Procedure Using the SEM Positioner: Using a Scan to Assess Consolidation|Treatment of Chronic Anterior Shoulder Instability by a Latarjet-type Bone Block Procedure Using the SEM (Science Et Medecine) Positioning Tool: Using a Scan to Assess Consolidation and Return to Normal Activity at 3 Months|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 23:22:03.212423|2017-10-10 23:22:03.212423
NCT02426983|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-21|||April 2015||2015-04-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|September 2015|Anticipated|2015-09-01||Interventional|||Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination|A Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Auditory Sensory Memory Processing|Unknown status|Not yet recruiting|Phase 1/Phase 2|12|Anticipated|University of Ottawa||4|||f||||||||||||||2017-10-10 23:22:03.323679|2017-10-10 23:22:03.323679
NCT02426970|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-06-16|||April 3, 2017|Actual|2017-04-03|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|COP-PAIN||Are Acceptance and Commitment Related to Treatment Response in Chronic Low Back Pain|Are Acceptance and Commitment Related to Treatment Response in Chronic Low Back Pain|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 23:22:03.417544|2017-10-10 23:22:03.417544
NCT02426957|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-12-29|||October 2014||2014-10-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Brief Alcohol Intervention for Adolescents Who Have Attempted Suicide|Brief Alcohol Intervention for Adolescents Who Have Attempted Suicide|Recruiting||Phase 1|50|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:22:03.67784|2017-10-10 23:22:03.67784
NCT02426944|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-07-31|||April 2015||2015-04-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|PRAGUE-17||Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation|Interventional Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in High-risk Patients With Atrial Fibrillation (PRAGUE-17 Study)|Recruiting||Phase 4|400|Anticipated|Charles University, Czech Republic||2|||f||||t||||||||||2017-10-10 23:22:03.815211|2017-10-10 23:22:03.815211
NCT02426931|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-04-22|||April 2015||2015-04-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Tip-flexible Semi-rigid Ureterorenoscope Versus Flexible Ureteroscopy in Renal Calculi|Tip-flexible Semi-rigid Ureterorenoscope Versus Flexible Ureteroscopy for the Treatment of Renal Calculi < 3 cm - Efficacity Prospective Randomized Multicentre Trial|Unknown status|Not yet recruiting|N/A|280|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-10-10 23:22:03.953372|2017-10-10 23:22:03.953372
NCT02426918|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-09-29||2017-08-21|May 2015||2015-05-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Study of Debio 1450 for Bacterial Skin Infections|A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin|Completed||Phase 2|330|Actual|Debiopharm International SA||3|||f||||f||||||||||2017-10-10 23:22:04.086378|2017-10-10 23:22:04.086378
NCT02426905|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-08-22|||January 2016||2016-01-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine|Multicentre, Retrospective and Prospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine|Active, not recruiting||Phase 4|90|Anticipated|Univar BV||2|||f||||f||||||||||2017-10-10 23:22:04.251365|2017-10-10 23:22:04.251365
NCT02426892|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-03-24|||December 23, 2015|Actual|2015-12-23|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors|Phase II Trial of Nivolumab and HPV-16 Vaccination in Patients With HPV-16-Positive Incurable Solid Tumors|Active, not recruiting||Phase 2|34|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:22:04.346641|2017-10-10 23:22:04.346641
NCT02426879|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-04-21|||February 2015||2015-02-01|April 2015|2015-04-01|February 2025|Anticipated|2025-02-01|February 2020|Anticipated|2020-02-01||Interventional|Node||Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node Metastases|Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node Metastases Node Study|Recruiting||N/A|20|Anticipated|UMC Utrecht||1|||f||||t||||||||||2017-10-10 23:22:04.443704|2017-10-10 23:22:04.443704
NCT02426866|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-04-22|||December 2014||2014-12-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Risk of CV Events With EFV vs. EFV-free Regimens|The Risk of Cardiovascular Events Among HIV Patients Initiating Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens|Completed||N/A|29612|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 23:22:04.549512|2017-10-10 23:22:04.549512
NCT02426853|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-09-21|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Ultraviolet (UV) Photography in Adolescents|Sun Protection, Tanning Behaviors and Attitudes in Adolescents|Active, not recruiting||Early Phase 1|293|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:22:04.614493|2017-10-10 23:22:04.614493
NCT02426840|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-07-18|||April 2015||2015-04-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|CAL-D||Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and Adolescents|Effect of Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among Perinatally HIV-infected Children and Adolescents|Recruiting||Phase 2|200|Anticipated|Chiang Mai University||2|||f||||f||||||||||2017-10-10 23:22:04.713354|2017-10-10 23:22:04.713354
NCT02426827|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-05-20|||July 2016||2016-07-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|SCSinCV||Cervical Spinal Cord Stimulation in Cerebral Vasospasm|A Safety and Feasibility Study of the Use of Cervical Spinal Cord Stimulation for Treatment of Cerebral Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage|Not yet recruiting||Phase 1|5|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:22:04.831811|2017-10-10 23:22:04.831811
NCT02426814|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-03-28|||August 2015||2015-08-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Assessment of a Mobile Intervention to Increase Adherence to Asthma Medication Among Adolescents|Assessment of a Mobile Intervention to Increase Adherence to Asthma Medication Among Adolescents|Active, not recruiting||N/A|50|Anticipated|CoheroHealth||2|||f||||f|f|||||||No||2017-10-10 23:22:04.91123|2017-10-10 23:22:04.91123
NCT02426788|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-02-09|||July 2015||2015-07-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||PRINCE Secondary Trial|The PRINCE Secondary Study: Persistent Physical Symptoms Reduction Intervention: a System Change and Evaluation in Secondary Care|Recruiting||N/A|450|Anticipated|King's College London||2|||f||||t||||||||||2017-10-10 23:22:05.110302|2017-10-10 23:22:05.110302
NCT02426775|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-03-14|||November 2015||2015-11-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|December 2017|Anticipated|2017-12-01||Interventional|CAMP||Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia|Randomized Multicentre Comparative Trial to Evaluate the Long Term Effectiveness of the Use of Carbaglu® in Patients With Propionic Acidemia (PA) or Methylmalonic Acidemia (MMA)|Active, not recruiting||Phase 3|33|Actual|King Abdullah International Medical Research Center||4|||f||||t||||||||||2017-10-10 23:22:05.211461|2017-10-10 23:22:05.211461
NCT02426762|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-08-11|||February 2015||2015-02-01|August 2015|2015-08-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery|Use of a Quick Skin Sealant in Prevention of Surgical Site Infection After Laparoscopic Tumor Resection|Unknown status|Recruiting|Phase 2|100|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||||2017-10-10 23:22:05.401415|2017-10-10 23:22:05.401415
NCT02426749|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-05-01|||September 2015||2015-09-01|October 2016|2016-10-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Treatment and Recovery Monitoring of Post TBI Symptoms|Treatment and Recovery Monitoring of Post Traumatic Brain Injury (TBI) Symptoms|Completed||N/A|20|Actual|University of Manitoba||2|||f||||f||||||||No||2017-10-10 23:22:05.505652|2017-10-10 23:22:05.505652
NCT02426736|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-06-13|||June 2015||2015-06-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Dexamethasone Dose and Route on Duration of Interscalene Block After Outpatient Shoulder Surgery|Effect of Dexamethasone Dose and Route on Duration of Interscalene Brachial Plexus Block for Outpatient Arthroscopic Shoulder Surgery - A Randomized Controlled Trial|Active, not recruiting||Phase 4|280|Anticipated|University of Manitoba||4|||f||||f||||||||||2017-10-10 23:22:05.594404|2017-10-10 23:22:05.594404
NCT02426723|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-03-29|||October 2015||2015-10-01|March 2016|2016-03-01||||July 2017|Anticipated|2017-07-01||Interventional|||Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients|A Phase 1a/1b Multicenter, Open Label, Dose-Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CWP232291 Administered Intravenously Either Alone or in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Myeloma (MM)|Recruiting||Phase 1|60|Anticipated|JW Pharmaceutical||1|||f||||||||||||||2017-10-10 23:22:05.757271|2017-10-10 23:22:05.757271
NCT02426710|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-07-31|||June 2014||2014-06-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|FLS-ICE-R||Intracardiac Echocardiography in Atrial Flutter Ablation|The Usefulness of Intracardiac Echocardiography in Atrial Flutter Ablation - a Randomized Study|Recruiting||Phase 3|100|Anticipated|Charles University, Czech Republic||2|||f||||f||||||||||2017-10-10 23:22:05.86566|2017-10-10 23:22:05.86566
NCT02426697|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-07-19|||May 2015||2015-05-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|PARABONE||Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy|Phase 3 Study Evaluating Fentanyl Transmucosal in the Prevention of Pain Induced by Mobilization During Radiotherapy in Patients With Bone Metastasis|Recruiting||Phase 3|120|Anticipated|Centre Henri Becquerel||2|||f||||f||||||||||2017-10-10 23:22:05.954194|2017-10-10 23:22:05.954194
NCT02426684|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-09-25|||April 2015||2015-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Ides in Highly Sensitized Patients Awaiting Kidney Transplantation|A Phase I/II Trial to Evaluate the Safety and Tolerability of Ides® (IgG Endopeptidase) to Eliminate Donor Specific HLA Antibodies (DSAs) and Prevent Antibody-Mediated Rejection Post-Transplant in Highly-HLA Sensitized Patients.|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-10-10 23:22:06.065106|2017-10-10 23:22:06.065106
NCT02426671|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-23|||June 2012||2012-06-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Tinnitus Alleviation Via Sensory Stimulation|Tinnitus Alleviation Via Sensory Stimulation (Modulation of Tinnitus Through Simultaneous Auditory and Transcutaneous Tactile Stimulation of the Tongue)|Completed||N/A|60|Actual|National University of Ireland, Maynooth||1|||f||||f||||||||||2017-10-10 23:22:06.154454|2017-10-10 23:22:06.154454
NCT02426658|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2017-08-14|||May 2015||2015-05-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3|A Pilot Study Evaluating Pemetrexed in ECOG Performance Status 3 Patients With Stage IV Non-squamous Non-small Cell Lung Cancer|Recruiting||Phase 2|30|Anticipated|Wake Forest University Health Sciences||1|||f||||t|t|f||||||||2017-10-10 23:22:06.231988|2017-10-10 23:22:06.231988
NCT02425904|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-04-25|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|September 2022|Anticipated|2022-09-01|January 2019|Anticipated|2019-01-01||Interventional|||Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis|Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis|Recruiting||Phase 2|85|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 23:22:12.36093|2017-10-10 23:22:12.36093
NCT02426645|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-05-05|||April 2015||2015-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||Microcirculatory Alteration and Biomarkers: New Approach for Early Assessment of Septic Multi-organ Dysfunction|Microcirculatory Alteration and Biomarkers: New Approach for Early Assessment of Septic Multi-organ Dysfunction|Recruiting||N/A|25|Anticipated|University Hospital Regensburg|||1||f||||f||||||Samples With DNA|"     Blood Urine   "|||2017-10-10 23:22:06.339941|2017-10-10 23:22:06.339941
NCT02426632|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-05-20|||March 2015||2015-03-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants|A Phase 1, Double-blind, Randomized, Trial to Evaluate the Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Subjects|Completed||Phase 1|12|Actual|Janssen Sciences Ireland UC||12|||f||||f||||||||||2017-10-10 23:22:06.440161|2017-10-10 23:22:06.440161
NCT02426619|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-03-04|||September 2012||2012-09-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Arresting Active Dental Caries in Preschool Children by Topical Fluorides|A Randomized Clinical Trial on the Use of Sodium Fluoride Varnish and Silver Diamine Fluoride Solution for Arresting Active Dental Caries in Preschool Children|Completed||Phase 2/Phase 3|371|Actual|The University of Hong Kong||3|||f||||t||||||||||2017-10-10 23:22:06.667824|2017-10-10 23:22:06.667824
NCT02426606|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Lentil Consumption on Post-prandial Blood Glucose and Insulin|The Love of Lentils (LoL) Study: The Effects of Acute Consumption of Common Lentil Varieties on Post-prandial Blood Glucose and Insulin Levels in Healthy Adult|Completed||N/A|48|Actual|University of Guelph||9|||f||||f||||||||No||2017-10-10 23:22:06.747586|2017-10-10 23:22:06.747586
NCT02426593|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2015-10-13|||April 2015||2015-04-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology|Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology|Completed||N/A|100|Anticipated|Intersection Medical, Inc.|||1||f||||f||||||||||2017-10-10 23:22:06.842076|2017-10-10 23:22:06.842076
NCT02426580|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-22|2016-10-14|||October 2015||2015-10-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|DIPIPD||Dietary Education Intervention Impact on Dietary Protein Intake in PD|Dietary Education Intervention With Wechat Model Will Impact on Dietary Protein Intake in Patient Treated With Peritoneal Dialysis: a Prospective Randomized Controlled Pilot Trial|Enrolling by invitation||Phase 4|120|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||Yes||2017-10-10 23:22:06.913063|2017-10-10 23:22:06.913063
NCT02426567|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-06-12|||November 2014||2014-11-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||"The Impact of Crohn's Disease-TReatment-with-EATing Diet and Exclusive Enteral Nutrition on Healthy Gut Bacteria"|An Exploratory Study on the Impact of a Food-based Restrictive Diet (Crohn's Disease-TReatment-with EATing/CD-TREAT Diet) and Liquid Exclusive Enteral Nutrition (EEN) on Healthy Gut Microbiota Composition and Metabolic Activity|Completed||N/A|28|Actual|University of Glasgow||2|||f||||f||||||||No||2017-10-10 23:22:06.991797|2017-10-10 23:22:06.991797
NCT02426554|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-08-02|||January 2011||2011-01-01|August 2016|2016-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Dietary Supplementation of of DHA, Vitamin D3 and Uridine in Children||Completed||N/A|16|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:22:07.07833|2017-10-10 23:22:07.07833
NCT02426528|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-06-07|||September 2016||2016-09-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|URCULTHEA||R.CULT.HEA - URban Environment, CULTural Social Use of Space and HEAlth / Well-being Effect on Population|UR.CULT.HEA - URban Environment, CULTural Social Use of Space and HEAlth / Well-being Effect on Population: Study Protocol for a Cluster Randomized Trial|Not yet recruiting||N/A|625|Anticipated|University of Bologna||2|||f||||f||||||||||2017-10-10 23:22:07.247896|2017-10-10 23:22:07.247896
NCT02426515|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-02-08|||August 2015||2015-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|COOL||Cryotherapy to Improve Outcomes in Lower Third Molar Surgery|Cryotherapy to Improve Outcomes in Lower Third Molar Surgery|Active, not recruiting||N/A|60|Anticipated|University of Birmingham||2|||f||||f||||||||||2017-10-10 23:22:07.310182|2017-10-10 23:22:07.310182
NCT02426502|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-06-05|||April 2016||2016-04-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|OnceDaily||Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients|Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients: A Pilot Study|Recruiting||N/A|75|Anticipated|University of British Columbia||1|||f||||t||||||||||2017-10-10 23:22:07.381193|2017-10-10 23:22:07.381193
NCT02426489|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-05-08|||July 2016||2016-07-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MRI-PEM||Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) System|Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) System|Not yet recruiting||N/A|70|Anticipated|Weinberg Medical Physics LLC||2|||f||||f||||||||||2017-10-10 23:22:07.481313|2017-10-10 23:22:07.481313
NCT02426476|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-08-24|||June 10, 2015|Actual|2015-06-10|August 2017|2017-08-01|December 30, 2019|Anticipated|2019-12-30|July 1, 2019|Anticipated|2019-07-01||Interventional|HRVB-PP||HRV Biofeedback in Pain Patients|HRV Biofeedback in Pain Patients: Pilot Intervention for Pain, Fatigue & Sleep|Recruiting||N/A|80|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:22:07.541829|2017-10-10 23:22:07.541829
NCT02424929|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-04-06|||April 2015||2015-04-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|September 2020|Anticipated|2020-09-01||Interventional|||Asleep Versus Awake Deep Brain Stimulation Surgery|Asleep Versus Awake Deep Brain Stimulation Surgery|Recruiting||N/A|100|Anticipated|Providence Medical Research Center||2|||f||||f||||||||Yes||2017-10-10 23:22:24.508787|2017-10-10 23:22:24.508787
NCT02426463|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-09-11|||April 20, 2015|Actual|2015-04-20|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 28, 2017|Actual|2017-02-28||Interventional|NeoPopGen||Clinical Trial on Individual Characteristics Affecting Pain Drug Therapy in Neonates|Individualising Drug Therapy in Neonates Using Pharmacogenomic Profiling, Population Based Modeling and Simulations|Active, not recruiting||Phase 4|80|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-10 23:22:07.625424|2017-10-10 23:22:07.625424
NCT02426450|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-21|||April 2015||2015-04-01|April 2015|2015-04-01|April 2017|Anticipated|2017-04-01|October 2015|Anticipated|2015-10-01||Interventional|||RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC|RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC:an Open Lable, Single-arm, Prospective Study|Unknown status|Active, not recruiting|Phase 2|28|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 23:22:07.703765|2017-10-10 23:22:07.703765
NCT02426437|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-09-05|||February 2015||2015-02-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Examining Pulmonary Rehabilitation on Discharged COPD Patients|How Does Early Rehabilitation Affect Patient-centred Health Outcomes and Cardiovascular Risk in COPD Patients|Recruiting||N/A|150|Anticipated|University of Alberta||3|||f||||f||||||||||2017-10-10 23:22:07.779057|2017-10-10 23:22:07.779057
NCT02426424|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-03-19|||January 2018|Anticipated|2018-01-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Effect Of Early C-PAP Treatment For Sleep Apnea On Rehabilitation Of Stroke Patients|Effect Of Early C-PAP Treatment For Sleep Apnea On Rehabilitation Of Stroke Patients|Not yet recruiting||Phase 4|140|Anticipated|Soroka University Medical Center||2|||f||||f|f|f||||||||2017-10-10 23:22:07.89856|2017-10-10 23:22:07.89856
NCT02426411|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-08-25|||June 2015||2015-06-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN|A Double-blind, Placebo-controlled, Randomized Dose Ranging Trial to Determine the Safety and Efficacy of Two Dose Levels of EMA401 in Patients With Postherpetic Neuralgia|Withdrawn||Phase 2|0|Actual|Spinifex Pharmaceuticals Pty Ltd||3|||f||||f||||||||||2017-10-10 23:22:08.120318|2017-10-10 23:22:08.120318
NCT02426398|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-04-26|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Developing a New EEG Method for the Early Diagnosis of Dementia|Developing a New EEG Method for the Early Diagnosis of Dementia. Using Novel EEG Analyses to Create a Diagnostic Test and Biomarker for Use With People With Dementia|Recruiting||N/A|25|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 23:22:08.226226|2017-10-10 23:22:08.226226
NCT02426385|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-09-26|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Comparison of Viusal Outcomes After Implantation of the POD 26% FineVision Toric (PhysIOL) and POD 26% Toric (PhysIOL)|Comparison of Viusal Outcomes After Implantation of the POD 26% FineVision|Withdrawn||N/A|0|Actual|Physiol|||2|lack of suitable patients|f||||f||||||||||2017-10-10 23:22:08.310808|2017-10-10 23:22:08.310808
NCT02426372|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-08-23|||July 2015||2015-07-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis|An Open Label, Dose Ranging, Exploratory Study to Evaluate the Safety, Tolerability, Compliance, Mechanism of Action and Efficacy of QBECO Site Specific Immunomodulation for the Induction of Clinical Response and Remission in Subjects With Moderate to Severe Ulcerative Colitis|Completed||Phase 2|11|Actual|Qu Biologics Inc.||3|||f||||t||||||||||2017-10-10 23:22:08.383839|2017-10-10 23:22:08.383839
NCT02426359|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-12-03|||April 2015||2015-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients||Completed||Phase 2|57|Actual|Qurient Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:22:08.473816|2017-10-10 23:22:08.473816
NCT02426346|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-04-20|||September 2014||2014-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|TEEN JOIN||A Scalable Weight Control Intervention for Adolescents|TEEN JOIN: A Scalable Weight Control Intervention for Adolescents|Recruiting||Phase 2|120|Anticipated|The Miriam Hospital||2|||f||||t||||||||||2017-10-10 23:22:08.561751|2017-10-10 23:22:08.561751
NCT02426333|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-05-29|||January 2016|Actual|2016-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|OPTIMUM||Optimizing Abiraterone Therapy|Optimizing Abiraterone (Zytiga®) Therapy by Exploring the Relation Between an Early Biomarker ‐ Drug Exposure ‐ as a Predictor for Drug Response in Patients With mCRPC|Recruiting||N/A|50|Anticipated|Radboud University|||1||f||||f||||||Samples With DNA|"     Blood samples for abiraterone concentrations and also blood samples to assess biomarkers     (some contain DNA)   "|No||2017-10-10 23:22:08.65861|2017-10-10 23:22:08.65861
NCT02426320|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-04-23|||April 2015||2015-04-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Pilot Study for Sedation Interruption in Children|Daily Interruption of Sedative Infusions in Mechanically Ventilated Children: A Randomized Pilot Study|Unknown status|Recruiting|N/A|30|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-10 23:22:08.753022|2017-10-10 23:22:08.753022
NCT02426307|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|March 2017|Anticipated|2017-03-01||Observational|SAVORY||Subclinical Aortic Valve Bioprosthesis Thrombosis Assessed With 4D CT|Subclinical Aortic Valve biOprosthesis thRombosis Assessed With 4D Computed tomographY Imaging|Enrolling by invitation||N/A|75|Anticipated|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-10 23:22:08.847207|2017-10-10 23:22:08.847207
NCT02426294|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-04-21|||February 2015||2015-02-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin|A Phase IV, Multicenter, Randomized, Active Comparator Controlled Study of the Addition of Pioglitazone Compared With Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Alogliptin|Unknown status|Recruiting|Phase 4|154|Anticipated|Pusan National University Hospital||2|||f||||t||||||||||2017-10-10 23:22:08.951879|2017-10-10 23:22:08.951879
NCT02423980|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-06-07|2017-02-12||April 2015||2015-04-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional||All enrolled subjects|G-Pen™ for Hypoglycemia Rescue in T1D Patients|G-Pen™ (Glucagon Injection) for Induced Hypoglycemia Rescue in Adult Patients With T1D|Completed||Phase 2|7|Actual|Xeris Pharmaceuticals||1|||f||||f||||||||No||2017-10-10 23:22:34.634147|2017-10-10 23:22:34.634147
NCT02426281|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-02-15|||June 4, 2015|Actual|2015-06-04|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma|A Phase 2 Study to Evaluate the Safety and Efficacy of Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma|Recruiting||Phase 2|65|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:22:09.046883|2017-10-10 23:22:09.046883
NCT02426268|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-05-01|||May 2014||2014-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FORE-SIGHT||FORE-SIGHT Tissue Oximeter During Cardiac Surgery|CAS Medical Systems FORE-SIGHT Elite Tissue Oximeter During Cardiac Surgery|Recruiting||N/A|75|Anticipated|University of California, Los Angeles|||1||f||||f||||||||||2017-10-10 23:22:09.157334|2017-10-10 23:22:09.157334
NCT02426255|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-09-20|||February 2013||2013-02-01|September 2016|2016-09-01|January 2050|Anticipated|2050-01-01|January 2050|Anticipated|2050-01-01||Observational|||Post Traumatic Critical Complications: a Prospective Cohort Study (ATLANREA)|Prospective Cohort of Severe Trauma Patients Hospitalized in West French Intensive Care Units|Recruiting||N/A|5000|Anticipated|Nantes University Hospital|||1||f||||f||||||Samples Without DNA|"     Plasma, sera, peripheral blood mononuclear cells, RNA   "|||2017-10-10 23:22:09.238298|2017-10-10 23:22:09.238298
NCT02426242|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-09-12|||April 2013||2013-04-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Evaluation of Risk Factors Regarding Extubation Failure in Severe Brain Injured Patients.|Observational Evaluation of Risk Factors Regarding Extubation Failure in Severe Brain-injured Patients|Completed||N/A|450|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 23:22:09.351575|2017-10-10 23:22:09.351575
NCT02426229|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-03-22|||February 2016||2016-02-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma|Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma|Recruiting||Phase 1|15|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-10-10 23:22:09.44332|2017-10-10 23:22:09.44332
NCT02426216|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-10-25|||March 2015||2015-03-01|October 2015|2015-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention|Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention|Recruiting||N/A|300|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples Without DNA|"     Blood, urine, prostate tissue   "|||2017-10-10 23:22:09.537586|2017-10-10 23:22:09.537586
NCT02426203|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-04-27|||May 2015||2015-05-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|||3D Echocardiographic Assessment of RV Function in Patients Undergoing Pulmonary Endarterectomy|Three-dimensional Echocardiographic Assessment of Right Ventricular Function in Patients Undergoing Pulmonary Endarterectomy|Unknown status|Not yet recruiting|N/A|51|Anticipated|Papworth Hospital NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:22:09.61743|2017-10-10 23:22:09.61743
NCT02426190|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-21|||October 2014||2014-10-01|April 2015|2015-04-01||||September 2016|Anticipated|2016-09-01||Interventional|KAROS||Knee Arthroplasty Rehabilitation Outcomes Study|Knee Arthroplasty Rehabilitation Outcomes Study|Unknown status|Recruiting|N/A|360|Anticipated|MedStar National Rehabilitation Network||4|||f||||f||||||||||2017-10-10 23:22:09.698894|2017-10-10 23:22:09.698894
NCT02426177|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-04-23|||May 2015||2015-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension|Comparison of Oral Labetalol and Oral Nifedipine for Postpartum Hypertension Management|Unknown status|Not yet recruiting|Phase 3|98|Anticipated|Dow University of Health Sciences||2|||f||||t||||||||||2017-10-10 23:22:09.77811|2017-10-10 23:22:09.77811
NCT02426164|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-03-18|||June 2015||2015-06-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Liposomal Bupivacaine in Total Knee Arthroplasty|Analgesic Efficacy of Liposomal Bupivacaine in Total Knee Arthroplasty|Withdrawn||Phase 4|0|Actual|Miller Orthopedic Specialists||2||Could not receive facility approval|f||||||||||||||2017-10-10 23:22:09.856577|2017-10-10 23:22:09.856577
NCT02426151|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-03-17|||April 2015||2015-04-01|April 2015|2015-04-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects|A Randomized, Open Label, Single-dose 2x2 Crossover Study to Compare Pharmacokinetic, Pharmacodynamic Profiles, and Tolerability of EPO (BEPO-A (4000 IU)) and EPO (REPO-A (4000 IU)) in Healthy Male Subjects|Completed||Phase 1|46|Actual|LG Life Sciences||2|||f||||f||||||||No||2017-10-10 23:22:09.946001|2017-10-10 23:22:09.946001
NCT02426138|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2017-08-28|||April 1, 2015|Actual|2015-04-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|July 31, 2017|Actual|2017-07-31||Interventional|||Community Servings: Food as Medicine for Diabetes|Community Servings: Food as Medicine for Diabetes|Active, not recruiting||N/A|50|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:22:10.032271|2017-10-10 23:22:10.032271
NCT02426112|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-08-23|||June 2016||2016-06-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|BREATHE||Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children|Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children|Recruiting||Phase 3|400|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-10 23:22:10.530576|2017-10-10 23:22:10.530576
NCT02426099|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-04-23|||October 2011||2011-10-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|SPIRY||Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension|Prevalence and Treatment of Resistant Hypertension in Diabetic Patients in Yaounde|Completed||Phase 4|17|Actual|Yaounde Central Hospital||2|||f||||t||||||||||2017-10-10 23:22:10.634274|2017-10-10 23:22:10.634274
NCT02426086|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-31|||June 2015||2015-06-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor|A Randomized, Single-Blind, Multicenter Phase 2 Study to Evaluate the Activity of 2 Dose Levels of Imetelstat in Subjects With Intermediate-2 or High-Risk Myelofibrosis (MF) Relapsed/Refractory to Janus Kinase (JAK) Inhibitor|Suspended||Phase 2|160|Anticipated|Janssen Research & Development, LLC||2||"Current participants remain active and on study treatment; new enrollment may resume pending   collection/review of more mature data"|f||||f||||||||||2017-10-10 23:22:10.715827|2017-10-10 23:22:10.715827
NCT02426073|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-01-26|||March 2016||2016-03-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Observational|||Glucose Metabolism, Muscle Mass/Function and Inflammation in the Elderly|Pilot Observational Study to Characterize Glucose Metabolism, Muscle Mass/Function and Inflammatory Profile in Elderly Individuals|Not yet recruiting||N/A|76|Anticipated|Catholic University of the Sacred Heart|||4||f||||||||||||||2017-10-10 23:22:11.060343|2017-10-10 23:22:11.060343
NCT02426060|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-04-23|||January 2015||2015-01-01|April 2015|2015-04-01|April 2015|Anticipated|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers|Effect of Imrecoxib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects|Unknown status|Active, not recruiting|Phase 1|12|Actual|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:22:11.146799|2017-10-10 23:22:11.146799
NCT02426047|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-08-18|||March 2015||2015-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy|The Feasibility and Tolerability of Medium Chain Triglycerides as an Adjunct to the Dietary Management of Epilepsy in Women With a Catamenial Seizure Pattern on the Modified Atkins Diet|Recruiting||N/A|20|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 23:22:11.23548|2017-10-10 23:22:11.23548
NCT02426034|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-04-18|||February 2015||2015-02-01|April 2016|2016-04-01||||December 2018|Anticipated|2018-12-01||Interventional|||Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer|An Open Label, Single Group Assigned, Multicenter Study of Apatinib in Patients With Chemo-refractory Advanced or Metastatic Adenocarcinoma of Stomach or Gastroesophageal Junction|Recruiting||Phase 4|2000|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||||||||||||2017-10-10 23:22:11.344152|2017-10-10 23:22:11.344152
NCT02426021|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-26|||April 2015||2015-04-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Phase 1 Single Subcutaneous Dose Study of MLN1202|A Phase 1, Single-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Subcutaneous Injection of MLN1202 in the Japanese and Caucasian Healthy Male Participants|Withdrawn||Phase 1|0|Actual|Takeda||10||Business decision; No Safety or Efficacy Concerns|f||||f||||||||||2017-10-10 23:22:11.438411|2017-10-10 23:22:11.438411
NCT02426008|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-07-11|||February 2015||2015-02-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Improving Embryogenesis by Adding Growth Factors to In Vitro Human Culture Media||Completed||N/A|400|Actual|Ibn Sina Hospital||3|||f||||f||||||||||2017-10-10 23:22:11.53151|2017-10-10 23:22:11.53151
NCT02425995|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-10-03|||April 2015||2015-04-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Interest of Additional Arthroscopic Portals in Diagnosis of Hidden Lesions of the Medial Meniscus in Pediatrics Knees With ACL Deficiency|Prevalence and Diagnosis of Hidden Lesions of the Posterior Horn of the Medial Meniscus in Pediatric Anterior Cruciate Ligament (ACL) Lesions : Interest of Arthroscopic Intercondylar and Posteromedial Portals|Completed||N/A|43|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:22:11.612879|2017-10-10 23:22:11.612879
NCT02425982|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-01-03|||August 2015||2015-08-01|January 2017|2017-01-01|May 2025|Anticipated|2025-05-01|December 2017|Anticipated|2017-12-01||Observational|FINITE||Finnish Tennis Elbow Trial Pilot Study|Finnish Tennis Elbow Trial Pilot Study|Recruiting||N/A|300|Anticipated|Helsinki University|||2||f||||f||||||||||2017-10-10 23:22:11.695431|2017-10-10 23:22:11.695431
NCT02425969|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-03-02|||April 2015||2015-04-01|March 2015|2015-03-01|October 1, 2016|Actual|2016-10-01|October 1, 2016|Actual|2016-10-01||Interventional|GzFFR||A Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values|A Randomised Controlled Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values With Evaluation of the Diagnostic Utility of Invasive Coronary Physiological Indices and Quantitative Perfusion MRI. The GzFFR Study|Completed||N/A|108|Actual|Golden Jubilee National Hospital||2|||f||||t||||||||||2017-10-10 23:22:11.852443|2017-10-10 23:22:11.852443
NCT02425956|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-22|2017-04-28||April 2015||2015-04-01|June 2017|2017-06-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Non-invasive Quantification of Liver Iron With MRI|Non-invasive Quantification of Liver Iron With MRI|Completed||N/A|21|Actual|GE Healthcare||1|||f||||f||||||||No||2017-10-10 23:22:11.949134|2017-10-10 23:22:11.949134
NCT02425943|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-06-14|||May 2015||2015-05-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|May 2020|Anticipated|2020-05-01||Interventional|||Sculptra Aesthetic Post-Approval Study|A Prospective, Open-Label, Multicenter Study to Evaluate the Long-Term Safety of Sculptra®Aesthetic in Immuno-Competent Subjects Stratified by Fitzpatrick Skin Type I-VI)|Active, not recruiting||Phase 4|863|Anticipated|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-10 23:22:12.112804|2017-10-10 23:22:12.112804
NCT02425930|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-04-21|||August 2013||2013-08-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Observational|||The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer|The Relationship Between Complement C3 Depletion and Metastatic Gastric Cancer: A Prospective Pilot Study|Completed||N/A|85|Actual|First Affiliated Hospital, Sun Yat-Sen University|||2||f||||f||||||||||2017-10-10 23:22:12.198795|2017-10-10 23:22:12.198795
NCT02425917|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-07-18|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||IPC-CALF Versus GEKO in Post-op Total Hip Patients|Comparison of Intermittent Pneumatic Compression (IPC) of the Calf and gekoTM Neuromuscular Electrostimulation (NMES) Device on Lower Limb Circulation Following Elective Total Hip Replacement (THR)|Withdrawn||N/A|0|Actual|Firstkind Ltd||2||not relevant to the sponsor|f||||f|f|f||||||||2017-10-10 23:22:12.292032|2017-10-10 23:22:12.292032
NCT02425891|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-08-01|||June 23, 2015|Actual|2015-06-23|August 2017|2017-08-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)|A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Patients With Previously Untreated Metastatic Triple-Negative Breast Cancer|Active, not recruiting||Phase 3|900|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:22:12.538036|2017-10-10 23:22:12.538036
NCT02425878|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-08-29|||May 2015||2015-05-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Ulipristal Acetate 10 mg and Asisted Reproduction|Uterine Fibroids: Impact of Ulipristal Acetate 10 mg on ART Results|Completed||Phase 3|2|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||t||||||||||2017-10-10 23:22:13.267389|2017-10-10 23:22:13.267389
NCT02425865|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-11-20|||January 2016||2016-01-01|November 2015|2015-11-01|November 2019|Anticipated|2019-11-01|April 2019|Anticipated|2019-04-01||Interventional|TARGET||Intermittent Treatment After Reaching the taRget With Golimumab for ulcErative coliTis - (TARGET)|Intermittent Treatment After Reaching the taRget With Golimumab for ulcErative coliTis - TARGET|Not yet recruiting||Phase 4|200|Anticipated|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||1|||f||||f||||||||||2017-10-10 23:22:13.33731|2017-10-10 23:22:13.33731
NCT02425852|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-04-23|||September 2015||2015-09-01|April 2015|2015-04-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|ACTIVE||A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis|A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus Infliximab to Corticosteroids Plus Azathioprine for Acute Severe Colitis|Not yet recruiting||Phase 4|150|Anticipated|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||2|||f||||f||||||||||2017-10-10 23:22:13.406459|2017-10-10 23:22:13.406459
NCT02425839|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-11-05|||May 2015||2015-05-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|EVEREST||Assessment of Correlation Between Changes of Shear Wave Elastography and Surface Electromyogram of the Masseter|Assessment of Correlation Between Changes of Shear Wave Elastography and Surface Electromyogram of the Masseter, in Rest and Maximal Voluntary Contraction|Completed||N/A|20|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:22:13.479458|2017-10-10 23:22:13.479458
NCT02425826|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-05-09|2017-02-11||April 20, 2015|Actual|2015-04-20|May 2017|2017-05-01|November 22, 2016|Actual|2016-11-22|February 12, 2016|Actual|2016-02-12||Interventional|UNVEIL|The intent to treat (ITT) population consisted all participants who were randomized. Participants were included in the treatment arm which they were randomized into the ITT population.|A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.|A Phase 4, Multicenter, Randomized, Placebo-controlled, Double-blind, Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate Plaque Psoriasis|Completed||Phase 4|221|Actual|Celgene||2|||f||||f||||||||||2017-10-10 23:22:13.559462|2017-10-10 23:22:13.559462
NCT02425813|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-07-31|||October 2015||2015-10-01|October 2015|2015-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract|Intra-Arterial Steroid Administration of De Novo Acute Graft-vs-Host Disease of the Gastrointestinal Tract: A Phase II Study|Withdrawn||Phase 2|0|Actual|Wake Forest University Health Sciences||1||Slow Accrual|f||||f|t|f||||||||2017-10-10 23:22:14.563759|2017-10-10 23:22:14.563759
NCT02425800|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-08-14|||March 2015||2015-03-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells|Optimizing Human Prostate Extracellular Matrix as a Structure for Maintenance and Studying of Prostate Cancer Stem Cells|Recruiting||N/A|60|Anticipated|Wake Forest University Health Sciences|||1||f||||f|f|f||||Samples Without DNA|"     prostate tissue   "|||2017-10-10 23:22:14.689151|2017-10-10 23:22:14.689151
NCT02425787|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-02-17|||March 1, 2016|Actual|2016-03-01|February 2017|2017-02-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|||Bereaved Parent Study|The Bereaved Parent Study|Recruiting||N/A|120|Anticipated|St. Jude Children's Research Hospital|||4||f||||f|f|f||||||||2017-10-10 23:22:14.809494|2017-10-10 23:22:14.809494
NCT02425774|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-07-10|||July 2014||2014-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway|Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway: A Potential New Therapeutical Intervention for Postoperative Ileus|Recruiting||Phase 4|30|Anticipated|Katholieke Universiteit Leuven||3|||f||||f||||||||||2017-10-10 23:22:14.922015|2017-10-10 23:22:14.922015
NCT02425761|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-04-15|||April 2015||2015-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||The CSF Shunt Entry Site Trial|A Randomized Controlled Trial of Anterior Versus Posterior Entry Site for Cerebrospinal Fluid Shunt Insertion|Recruiting||Phase 3|448|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:22:15.060157|2017-10-10 23:22:15.060157
NCT02425748|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-07-17|||April 2015||2015-04-01|April 2015|2015-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)|γδ T Cell Immunotherapy for Treatment of|Completed||Phase 1/Phase 2|40|Actual|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:22:15.282762|2017-10-10 23:22:15.282762
NCT02425735|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-07-17|||April 2015||2015-04-01|April 2015|2015-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer|γδ T Cell Immunotherapy for Treatment of Hepatocellular Liver Cancer|Completed||Phase 1/Phase 2|40|Actual|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:22:15.370837|2017-10-10 23:22:15.370837
NCT02425722|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-12-16|||April 2015||2015-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Evaluate Dose-responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation|Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Chronic Constipation (Not Including Constipation Due to Organic Diseases)|Completed||Phase 2|383|Actual|Astellas Pharma Inc||5|||f||||f||||||||Undecided||2017-10-10 23:22:15.464343|2017-10-10 23:22:15.464343
NCT02425709|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-01-20|||April 2015||2015-04-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Tramadol Versus Diclofenac for Reducing Pain Before Outpatient Hysteroscopy in Post Menopausal Women|Tramadol Versus Diclofenac for Reducing Pain Before Outpatient Hysteroscopy in Post Menopausal Women: A Randomized Double Blind Placebo Controlled Trial|Recruiting||Phase 3|210|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 23:22:15.699502|2017-10-10 23:22:15.699502
NCT02425696|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-10-12|||June 2015||2015-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01|1 Year|Observational [Patient Registry]|||Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population|Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population|Recruiting||N/A|1500|Anticipated|First Hospital of Jilin University|||2||f||||f||||||||Undecided||2017-10-10 23:22:15.789254|2017-10-10 23:22:15.789254
NCT02425683|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-05-17|||March 2015|Actual|2015-03-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX|A Randomized, Phase II Study of High-Risk Colorectal Cancer Patients (Stage IIIC) Treated With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX|Active, not recruiting||Phase 2|24|Actual|US Oncology Research||2|||f||||t||||||||||2017-10-10 23:22:15.873517|2017-10-10 23:22:15.873517
NCT02425670|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-21|||January 2009||2009-01-01|April 2015|2015-04-01|June 2011|Actual|2011-06-01|October 2010|Actual|2010-10-01||Interventional|InVeST||Stem Cell Therapy For Acute Ischemic Stroke Patients|Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke: A Multi-Institutional Project|Completed||Phase 2|120|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-10 23:22:15.959853|2017-10-10 23:22:15.959853
NCT02425657|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-04-21|||August 2015||2015-08-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|||Fast Track Module Based Colonoscopy Training Programme for Surgical Trainees at North Jutland Surgical Departments|Fast Track Module Based Colonoscopy Training Programme for Surgical Trainees at North Jutland Surgical Departments|Unknown status|Not yet recruiting|N/A|10|Anticipated|Aalborg Universitetshospital|||1||f||||f||||||||||2017-10-10 23:22:16.053356|2017-10-10 23:22:16.053356
NCT02425644|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-10-02|||April 1, 2015||2015-04-01|October 2017|2017-10-01|May 15, 2019|Anticipated|2019-05-15|April 17, 2019|Anticipated|2019-04-17||Interventional|OPTIMUM||Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis|Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis|Active, not recruiting||Phase 3|1100|Actual|Actelion||2|||f||||t|t|f||||||||2017-10-10 23:22:16.143385|2017-10-10 23:22:16.143385
NCT02425631|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-09-12|||October 2014||2014-10-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||CT Follow-Up of the SImmetry Sacroiliac Joint Fusion System|CT Follow-Up of the SImmetry Sacroiliac Joint Fusion System|Completed||N/A|19|Actual|Zyga Technology, Inc.|||1||f||||f||||||||||2017-10-10 23:22:16.516367|2017-10-10 23:22:16.516367
NCT02425618|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-06-03|||April 2015||2015-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Comparison of the Effect of Pressure-controlled Ventilation and Volume-controlled Ventilation on the Gastric Insufflations in I-gel||Completed||N/A|10|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:22:16.568532|2017-10-10 23:22:16.568532
NCT02425605|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-04-20|||January 2015||2015-01-01|April 2015|2015-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma|Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: a Prospective Phase 2 Trial|Recruiting||Phase 2|47|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 23:22:16.621013|2017-10-10 23:22:16.621013
NCT02425592|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-12-02|||April 2015||2015-04-01|December 2016|2016-12-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|ASPIRE||Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)|Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)|Recruiting||N/A|150|Anticipated|Yale University|||1||f||||f||||||||No||2017-10-10 23:22:16.694137|2017-10-10 23:22:16.694137
NCT02425579|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-08-29|||April 2015||2015-04-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)|A Phase I Trial of Inhaled Carbon Monoxide for the Treatment of Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)|Recruiting||Phase 1|38|Anticipated|Brigham and Women's Hospital||6|||f||||t||||||||||2017-10-10 23:22:18.576788|2017-10-10 23:22:18.576788
NCT02425566|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-08-17|||April 2015||2015-04-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|July 2020|Anticipated|2020-07-01||Interventional|||Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension|Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension|Recruiting||Phase 1|12|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 23:22:18.694579|2017-10-10 23:22:18.694579
NCT02425553|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-06-26|||April 2015||2015-04-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Effects of Diet on Reflux and Dyspepsia|Effects of Diet and Alcohol on Fullness, Reflux and Dyspeptic Symptoms After Meals|Completed||N/A|84|Actual|University of Zurich|||1||f||||f||||||||||2017-10-10 23:22:18.790471|2017-10-10 23:22:18.790471
NCT02425540|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-04-20|||March 2015||2015-03-01|August 2013|2013-08-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Observational|IOTAMRI||Characterization of Ovarian Masses Unable to Classify With Gynecological Ultrasonography: Value of Pelvic MRI With Perfusion- and Diffusion-weighted Imaging|Characterization of Ovarian Masses Unable to Classify With Gynecological Ultrasonography: Value of Pelvic MRI With Perfusion- and Diffusion-weighted Imaging|Recruiting||N/A|74|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:22:18.880156|2017-10-10 23:22:18.880156
NCT02425527|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-02-12|||June 2015||2015-06-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|PLAY||Digital Gaming for Persons With Traumatic Brain Injury|Digital Gaming Used to Improve the Cognitive Functioning and Well-being of People With Traumatic Brain Injury: a Feasibility Study|Active, not recruiting||N/A|90|Actual|University of Turku||3|||f||||t||||||||||2017-10-10 23:22:18.950737|2017-10-10 23:22:18.950737
NCT02425514|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2015-04-23|||May 2015||2015-05-01|April 2015|2015-04-01||||May 2016|Anticipated|2016-05-01||Interventional|||Evaluation of Bone Union Following Anterior Cervical Fusion Using a NovoMax™|Evaluation of Bone Union Following Anterior Cervical Fusion Using a Bioactive Glass-Ceramic Spacer (NovoMax™): Comparison With a PEEK Cage Filled With β-Tricalcium Phosphate (Cervios ChronOs™)|Unknown status|Not yet recruiting|Phase 4|66|Anticipated|BioAlpha Inc.||2|||f||||f||||||||||2017-10-10 23:22:19.037091|2017-10-10 23:22:19.037091
NCT02425501|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-07-20|||January 20, 2015|Actual|2015-01-20|July 2017|2017-07-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2019|Anticipated|2019-05-31||Observational|||Special Drug Use Investigation of EYLEA for Diabetic Macular Edema|Special Drug Use Investigation of EYLEA for Diabetic Macular Edema|Active, not recruiting||N/A|664|Actual|Bayer|||1||f||||f|f|f||||||||2017-10-10 23:22:19.111582|2017-10-10 23:22:19.111582
NCT02425488|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-09-26|||April 2015||2015-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|NEHF||Nursing Therapeutics Education and Heart Failure (HF): a Study Protocol|Nursing Therapeutics Education and Heart Failure (HF): an Experimental Study|Recruiting||N/A|100|Anticipated|University of Turin, Italy||2|||f||||t||||||||Undecided||2017-10-10 23:22:19.19501|2017-10-10 23:22:19.19501
NCT02425475|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-05-02|||August 2014|Actual|2014-08-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Observational|FLIMMA||FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA)|A Prospective, Non-controlled, Multicenter Clinical Study to Evaluate the Diagnostic Accuracy of the Stepwise Two Photon Excited Melanin Fluorescence of Potentially Malignant Pigmented Lesions as Compared to Histopathological Diagnosis|Completed||N/A|500|Actual|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-10 23:22:19.307843|2017-10-10 23:22:19.307843
NCT02425462|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-07-17|||April 28, 2015|Actual|2015-04-28|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Observational|ENVISIOeN||To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis|EffectiveNess of VISanne® in Improving Quality of Life in asIan wOmen With eNdometriosis|Active, not recruiting||N/A|902|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:22:19.485974|2017-10-10 23:22:19.485974
NCT02425449|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-09-21|||April 2015||2015-04-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Fade Upon TOF Stimulation Induced by Succinylcholine|Characterizing Fade Upon Train-of Four Stimulation During Onset and Offset of Neuromuscular Block Produced by Succinlycholine|Recruiting||Phase 4|50|Anticipated|University of Toledo Health Science Campus||5|||f||||f||||||||No|In all the subjects we studied we found that succinylcholine contrary to established teaching produced fade upon TOF stimulation. However, the fade produced by succinylcholine was distinctly different from that produced by non depolarizing muscle relaxants.|2017-10-10 23:22:19.584297|2017-10-10 23:22:19.584297
NCT02425436|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2016-03-20|||May 2014||2014-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Role of Ginkgo Biloba Extract in IUGR|Effects of Oral Ginkgo Biloba Extract on Pregnancy Complicated by Asymmetrically Intrauterine Growth Restriction: a Double-blinded Randomized Placebo-controlled Trial|Completed||Phase 2|226|Actual|Assiut University||2|||f||||f||||||||Yes||2017-10-10 23:22:19.682507|2017-10-10 23:22:19.682507
NCT02425423|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-23|||June 2013||2013-06-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|SONAR||Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula||Completed||Phase 3|100|Actual|United Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:22:19.753844|2017-10-10 23:22:19.753844
NCT02425410|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-06-27|||March 2010||2010-03-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|ISIS-VIRUS||Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early Onset|Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early Onset|Recruiting||N/A|2000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     whole blood (already collected for the Isis-Diab project)   "|||2017-10-10 23:22:19.831568|2017-10-10 23:22:19.831568
NCT02425397|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-04-23|||February 2011||2011-02-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|October 2015|Anticipated|2015-10-01||Observational|OTOPLAT||Cancer and Hearing Loss Related in Children|Cancer and Deafness Associated With the Use of Platinum Derivatives in Children|Unknown status|Active, not recruiting|N/A|103|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     Saliva   "|||2017-10-10 23:22:19.925412|2017-10-10 23:22:19.925412
NCT02425384|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-23|||October 2008||2008-10-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Accelerometer-linked Online Intervention to Promote Physical Activity in Adolescents|Accelerometer-linked Online Intervention to Promote Physical Activity in Adolescents|Completed||N/A|182|Actual|HopeLab Foundation||3|||f||||f||||||||||2017-10-10 23:22:20.029581|2017-10-10 23:22:20.029581
NCT02425371|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-05-29|||September 2014||2014-09-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|OPTIMIZE-HFPEF||Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years)|Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years) (OPTIMIZE-HFPEF)|Recruiting||Phase 3|410|Anticipated|Göteborg University||2|||f||||t||||||||||2017-10-10 23:22:20.141454|2017-10-10 23:22:20.141454
NCT02425358|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-04-23|||February 2005||2005-02-01|April 2015|2015-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Timing for Bone Marrow Mononuclear Cells After Acute Myocardial Infarction|Timing for Intracoronary Administration of Bone Marrow Mononuclear Cells After Acute ST-elevated Myocardial Infarction: a Pilot Study|Completed||Phase 2/Phase 3|104|Actual|The First Affiliated Hospital of Dalian Medical University||4|||f||||f||||||||||2017-10-10 23:22:20.258545|2017-10-10 23:22:20.258545
NCT02425345|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-10-02|||April 2015||2015-04-01|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|WHISH||Women's Health Initiative Strong and Healthy Study|Women's Health Initiative Strong and Healthy Study|Active, not recruiting||Phase 3|49376|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-10 23:22:21.066421|2017-10-10 23:22:21.066421
NCT02425332|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-10-28|||May 2015||2015-05-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||Validation of a Novel Robot-aided Assessment of Gait Ability|Validation of Lokomat-aided Assessment of Gait Ability|Suspended||N/A|50|Anticipated|University of Zurich||1|||f||||t||||||||||2017-10-10 23:22:21.172047|2017-10-10 23:22:21.172047
NCT02425319|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-04-19|||September 2016||2016-09-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||CapFlex-PIP© Motion|Motion Analysis of the Proximal Interphalangeal Joint in Healthy Hands, as Well as in Osteoarthritis Hands Following Implantation With the New CapFlex-PIP© Implant Compared With Silicone Implants|Not yet recruiting||N/A|30|Anticipated|Schulthess Klinik|||3||f||||||||||||||2017-10-10 23:22:21.249506|2017-10-10 23:22:21.249506
NCT02425306|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-09-01|||May 2015||2015-05-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|Mel63; CHAMP||Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma|A Trial to Evaluate the Immunogenicity and Safety of a Melanoma Helper Peptide Vaccine Plus Novel Adjuvant Combinations (MEL63)|Recruiting||Phase 1/Phase 2|74|Anticipated|University of Virginia||4|||f||||t||||||||||2017-10-10 23:22:21.30717|2017-10-10 23:22:21.30717
NCT02425293|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-04-20|||June 2012||2012-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|INCAS||INCAS - Integrated Care of Asthma in Switzerland||Completed||N/A|223|Actual|Cantonal Hosptal, Baselland||2|||f||||f||||||||||2017-10-10 23:22:21.416166|2017-10-10 23:22:21.416166
NCT02425280|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-05-11|||November 2014||2014-11-01|May 2016|2016-05-01||||August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness of Narrative Exposure Therapy Among Refugee Children and Adolescents|How to Help War-affected Children and Adolescents: the Role of Memory Functions in Therapeutic Intervention|Recruiting||N/A|80|Anticipated|University of Tampere||2|||f||||||||||||||2017-10-10 23:22:21.499789|2017-10-10 23:22:21.499789
NCT02425267|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-05-17|||June 2015||2015-06-01|May 2016|2016-05-01||||May 2017|Anticipated|2017-05-01||Interventional|TeleFracture||Effectiveness of a Home Telerehabilitation Program for People With Proximal Humerus Fracture|Effectiveness of a Home Telerehabilitation Program for People With Proximal Humerus Fracture Treated Conservatively: a Randomized Clinical Trial.|Recruiting||N/A|52|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-10 23:22:21.597054|2017-10-10 23:22:21.597054
NCT02425254|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-12-02|||January 2016||2016-01-01|December 2015|2015-12-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|PPPP||Preemptive Paracetamol for Postoperative Pain|Preemptive Paracetamol for Postoperative Pain: a Randomised, Double-blind, Two Way Crossover Trial|Not yet recruiting||Phase 4|50|Anticipated|University of Nottingham||2|||f||||f||||||||||2017-10-10 23:22:21.705978|2017-10-10 23:22:21.705978
NCT02425241|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-04-22|||October 2013||2013-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|HIV-CORE003||Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination|A Randomised Double-blind, Placebo-controlled Phase I/IIa Trial to Investigate the Effect of Depletion of Serum Amyloid P Component (SAP) on the Immune Response to DNA Vaccination in Healthy Male Volunteers|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|University College, London||2|||f||||t||||||||||2017-10-10 23:22:21.809744|2017-10-10 23:22:21.809744
NCT02425228|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-08-24|||December 4, 2014||2014-12-04|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|December 4, 2018|Anticipated|2018-12-04|1 Month|Observational [Patient Registry]|Paired Cap||Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer|Paired CAP: Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer|Recruiting||N/A|300|Anticipated|Jonsson Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-10 23:22:21.923471|2017-10-10 23:22:21.923471
NCT02425215|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-12-02|||June 2014||2014-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||HBOT Late Radiation Tissue Injury|Does Hyperbaric Oxygen Therapy (HBOT) Reduce Pain, Improve Depression and Impact on Patients' Quality of Life for Those Suffering From Late Radiation Tissue Injury?|Recruiting||N/A|300|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:22:22.129758|2017-10-10 23:22:22.129758
NCT02425202|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-10-27|||December 2014||2014-12-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|KOSATA||Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy|Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome After Tonsillectomy: A Randomized Controlled Trial|Recruiting||Phase 4|72|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-10 23:22:22.238872|2017-10-10 23:22:22.238872
NCT02425189|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-05-16|||November 2014||2014-11-01|May 2016|2016-05-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01|3 Years|Observational [Patient Registry]|LQTSREG||The Canadian National Long QT Syndrome Registry|"National Long QT Syndrome Registry: Canadian Genetic Heart Rhythm Network |Research Data Registry and Bio Bank"|Recruiting||N/A|600|Anticipated|University of British Columbia|||2||f||||f||||||Samples With DNA|"     Blood Samples drawn:      1 X 9 ml EDTA      Samples for bio banking will be stored long-term   "|||2017-10-10 23:22:22.355667|2017-10-10 23:22:22.355667
NCT02425176|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-20|||September 2009||2009-09-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological Diseases|A Double-blind Randomised Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological Diseases|Completed||Phase 2/Phase 3|30|Actual|University of Malaya||3|||f||||t||||||||||2017-10-10 23:22:22.451898|2017-10-10 23:22:22.451898
NCT02425163|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-04-20|||March 2012||2012-03-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|March 2013|Actual|2013-03-01||Interventional|ElaProC||Shear Wave Elastography of Prostate Cancer|Shear Wave Elastography of Prostate Cancer|Completed||Phase 2|73|Actual|University of Magdeburg||1|||f||||f||||||||||2017-10-10 23:22:22.600396|2017-10-10 23:22:22.600396
NCT02425150|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-10-24|||October 2009||2009-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Treatment of Keratoconus With Advanced Corneal Crosslinking|Treatment of Keratoconus With Advanced Corneal Crosslinking|Active, not recruiting||Phase 2|120|Actual|Umeå University||4|||f||||f||||||||||2017-10-10 23:22:22.702554|2017-10-10 23:22:22.702554
NCT02425137|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-07-05|||April 2015||2015-04-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|May 2017|Actual|2017-05-01||Interventional|||A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer|A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer|Active, not recruiting||Phase 2|51|Actual|TTY Biopharm||1|||f||||f||||||||||2017-10-10 23:22:22.800695|2017-10-10 23:22:22.800695
NCT02425124|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-06-06|||April 2015||2015-04-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|October 2016|Actual|2016-10-01||Interventional|||Strengthening Mental Health Care in Chronic Care Patients With Hypertension. A Cluster Randomised Control Trial|Strengthening Mental Health Care in Chronic Care Patients With Hypertension. A Cluster Randomised Control Trial|Active, not recruiting||N/A|1052|Actual|University of KwaZulu||2|||f||||t||||||||||2017-10-10 23:22:22.898252|2017-10-10 23:22:22.898252
NCT02425111|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-07-28|||April 13, 2015|Actual|2015-04-13|July 2017|2017-07-01|March 7, 2018|Anticipated|2018-03-07|May 31, 2017|Actual|2017-05-31||Interventional|||Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease|An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV|Active, not recruiting||Phase 3|101|Actual|Takeda||1|||f||||f||||||||||2017-10-10 23:22:23.002125|2017-10-10 23:22:23.002125
NCT02425085|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-20|||April 2015||2015-04-01|April 2015|2015-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Comparative Study of Multi-endodiathermy Retinectomy Versus Relaxing Retinectomy for Retinal Re-detachment|Comparative Study of Multi-endodiathermy Retinectomy Versus Relaxing Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye|Recruiting||N/A|328|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:22:23.398044|2017-10-10 23:22:23.398044
NCT02425072|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-08-08|||April 2016||2016-04-01|August 2017|2017-08-01|July 2022|Anticipated|2022-07-01|July 2021|Anticipated|2021-07-01||Interventional|||NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer|NovoTTFTM-100A System Therapy for Refractory CNS Involved Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|University of Kentucky||1||slow accrual|f||||t||||||||||2017-10-10 23:22:23.510281|2017-10-10 23:22:23.510281
NCT02425059|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms|Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:22:23.593009|2017-10-10 23:22:23.593009
NCT02425046|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-05-09|||March 2015||2015-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Family Obesity Intervention: Motivational Interviewing and Community Support|Family Obesity Intervention: Motivational Interviewing and Community Support|Recruiting||N/A|3780|Anticipated|University of Iowa||2|||f||||t||||||||||2017-10-10 23:22:23.69115|2017-10-10 23:22:23.69115
NCT02425033|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-10-27|||April 2015||2015-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||POEM for Spastic Esophageal Disorders|Endoscopic Submucosal Tunnel Dissection for Endoluminal Partial Myotomy of the Lower Esophageal Sphincter in Patients With Spastic Esophageal Disorders Such as Achalasia|Recruiting||N/A|50|Anticipated|University Health Network, Toronto||1|||f||||f||||||||Undecided|Undecided|2017-10-10 23:22:23.795853|2017-10-10 23:22:23.795853
NCT02425020|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-22|||February 2015||2015-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Meat and Whey Protein Supplementation in Athletes|Effects of Meat Protein Administration on Body Composition, Strength, Muscle Structure and Markers of Muscle Damage and Health in Athletes|Completed||N/A|30|Actual|University of Greenwich||3|||f||||t||||||||||2017-10-10 23:22:23.918504|2017-10-10 23:22:23.918504
NCT02425007|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-11-25|||April 2015||2015-04-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacity of Incentive Spirometry in Elderly People||Completed||N/A|32|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-10 23:22:24.003372|2017-10-10 23:22:24.003372
NCT02424994|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-20|||April 2015||2015-04-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|HCM||Morbidity and Mortality in Patients With Hypertrophic Cardiomyopathy: a CALIBER Study|Morbidity and Mortality in Patients Diagnosed With Hypertrophic Cardiomyopathy: a CALIBER Study|Unknown status|Active, not recruiting|N/A|12464|Actual|University College, London|||1||f||||t||||||||||2017-10-10 23:22:24.086347|2017-10-10 23:22:24.086347
NCT02424981|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-09-14|||April 2015||2015-04-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Efficiency of Inspiratory Muscle Training in Elderly People||Unknown status|Recruiting|N/A|32|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 23:22:24.16156|2017-10-10 23:22:24.16156
NCT02424955|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-06-29|||November 2014||2014-11-01|June 2017|2017-06-01|December 14, 2019|Anticipated|2019-12-14|December 14, 2019|Anticipated|2019-12-14||Observational|||Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation|Feasibility of 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation|Recruiting||N/A|12|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-10 23:22:24.360779|2017-10-10 23:22:24.360779
NCT02424942|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-08-16|||April 2015||2015-04-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||First-in-human Study With Ascending Single Intra-articular Doses of GZ389988 in Patients With Painful Osteoarthritis of the Knee|A Two Part Protocol Using Double Blind Placebo Control to Assess the Safety, Tolerability, and Pharmacokinetics of Single Escalating Intra-articular Doses Followed by Assessment of Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Intra-articular Dose of the TrkA Inhibitor, GZ389988, in Patients With Painful Osteoarthritis of the Knee|Completed||Phase 1|28|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 23:22:24.432978|2017-10-10 23:22:24.432978
NCT02424916|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-06-28|||May 26, 2015|Actual|2015-05-26|June 2017|2017-06-01|May 26, 2020|Anticipated|2020-05-26|May 26, 2020|Anticipated|2020-05-26||Interventional|MelSort||Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study|Adoptive Transfer of CD8+ T Cells, Sorted With HLA-peptide Multimers and Specific for Melan-A and MELOE-1 Melanoma Antigens, to Metastatic Melanoma Patients. A Phase I/II, Non-randomized, Open Monocentric Study|Recruiting||Phase 1/Phase 2|17|Anticipated|Nantes University Hospital||1|||f||||t|f|f||||||||2017-10-10 23:22:24.725571|2017-10-10 23:22:24.725571
NCT02424903|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-04-20|||May 2015||2015-05-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|April 2017|Anticipated|2017-04-01||Observational|EPJIC||European Prosthetic Joint Infection Cohort Study- Hip, Knee and Shoulder Prosthetic Joint Infection|European Prosthetic Joint Infection Cohort Study (EPJIC): Evaluation of the Treatment Approach for Hip, Knee and Shoulder Prosthetic Joint Revision Surgery|Not yet recruiting||N/A|5000|Anticipated|Pro-Implant Foundation|||2||f||||f||||||||||2017-10-10 23:22:24.820757|2017-10-10 23:22:24.820757
NCT02424890|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-10-12|||August 2013||2013-08-01|October 2016|2016-10-01||||September 2014|Actual|2014-09-01||Interventional|||Trial of Multidisciplinary Team Stress and Performance in Immersive Simulation for Management of Infant in Shock||Completed||N/A|48|Actual|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 23:22:24.927913|2017-10-10 23:22:24.927913
NCT02424877|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-10-04|||August 1, 2013|Actual|2013-08-01|October 2017|2017-10-01|January 2, 2017|Actual|2017-01-02|January 30, 2016|Actual|2016-01-30||Interventional|SandRA||Cell Phone Based Automated Monitoring of Patients With Early Rheumatoid Arthritis|Cell Phone Based Automated Monitoring of Patients With Early Rheumatoid Arthritis|Completed||N/A|165|Actual|Medcare Oy||2|||f||||f||||||||||2017-10-10 23:22:25.008019|2017-10-10 23:22:25.008019
NCT02424864|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-26|||August 2014||2014-08-01|January 2017|2017-01-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||4D FDG PET in Esophageal Cancer|4D PET-CT Imaging in Esophageal Cancer|Completed||N/A|54|Actual|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-10 23:22:25.105455|2017-10-10 23:22:25.105455
NCT02424851|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-02-22|||November 2014||2014-11-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|OPTIMAL||Optimising Renal Outcome in Myeloma Renal Failure|A Study of Thalidomide, Bendamustine and Dexamethasone (BTD) Versus Bortezomib, Bendamustine and Dexamethasone (BBD) in Patients With Renal Failure Defined as a GFR Below 30 Mls/Min|Recruiting||Phase 2|120|Anticipated|Oxford University Hospitals NHS Trust||2|||f||||t||||||||||2017-10-10 23:22:25.188447|2017-10-10 23:22:25.188447
NCT02424825|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-04-22|||February 2015||2015-02-01|April 2015|2015-04-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Rouxbe Pilot for MS|A Low-fat, Plant-based Cooking Course for Patients With Multiple Sclerosis|Unknown status|Recruiting|N/A|15|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-10-10 23:22:25.467937|2017-10-10 23:22:25.467937
NCT02424812|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-03-07|||February 2016|Actual|2016-02-01|March 2017|2017-03-01|February 27, 2017|Actual|2017-02-27|November 10, 2016|Actual|2016-11-10||Interventional|||Evaluation Of The Unilever Lifebuoy School-Based Handwashing Campaign (School Of 5) In Rural Bihar, India|Evaluation Of The Unilever Lifebuoy School-Based Handwashing Campaign (School Of 5) In Rural Bihar, India|Completed||N/A|2628|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||No||2017-10-10 23:22:25.559258|2017-10-10 23:22:25.559258
NCT02424799|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-08-17|||November 17, 2014|Actual|2014-11-17|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264|A Randomised Double Blind (Sponsor Unblinded), Single and Repeat Ascending Dose First Time in Human Study in Healthy Subjects, Cold Urticaria and Chronic Spontaneous Urticaria Subjects to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264|Recruiting||Phase 1|80|Anticipated|GlaxoSmithKline||4|||f||||||||||||||2017-10-10 23:22:25.645498|2017-10-10 23:22:25.645498
NCT02424786|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-09-19|||May 2015||2015-05-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Non-adherence and Polypharmacy in Elderly Patients|Non-adherence and Polypharmacy in Elderly Patients With Chronic Renal Failure: Predictors and an Intervention|Completed||N/A|180|Actual|University Hospital, Akershus||2|||f||||f||||||||||2017-10-10 23:22:25.782552|2017-10-10 23:22:25.782552
NCT02424773|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-04-15|||November 2012||2012-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|RESPIR-OH||Oxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients|Oxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients|Completed||Phase 3|100|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:22:25.871735|2017-10-10 23:22:25.871735
NCT02424760|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-03-02|||March 2011||2011-03-01|March 2017|2017-03-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||Clinical Outcomes in Shoulder Hemi-arthroplasty Using a PyC Spherical Interpositional Implant|A Prospective Cohort Study to Document the Clinical Outcomes in Shoulder Hemi-arthroplasty Using a PyC Spherical Interpositional Implant|Active, not recruiting||N/A|67|Actual|Tornier, Inc.|||1||f||||f||||||||||2017-10-10 23:22:25.952306|2017-10-10 23:22:25.952306
NCT02424747|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-04-23|||January 2005||2005-01-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01|5 Years|Observational [Patient Registry]|||Long-term Survival and Renal Outcomes in Critically Ill Patients After Acute Kidney Injury: Swedish Multi-centre Cohort Study|Long Term Survival and Renal Outcomes in Critically Ill Patients After Acute Kidney Injury: Swedish Multi-centre Cohort Study|Completed||N/A|103000|Actual|Karolinska Institutet|||2||f||||f||||||||||2017-10-10 23:22:26.021891|2017-10-10 23:22:26.021891
NCT02424721|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-06-26|||May 2015||2015-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|SABER||Sepsis Assessment in Belgian Emergency Rooms|Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein Assay to Assist in Evaluation of Patients With Suspected Infection Following Emergency Department Admission|Suspended||N/A|400|Anticipated|Axis Shield Diagnostics Ltd|||1|Resource constraints at participating sites|f||||||||||Samples Without DNA|"     Plasma - NaCitrate and LiHep   "|||2017-10-10 23:22:26.250237|2017-10-10 23:22:26.250237
NCT02424695|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-04-22|||June 2015||2015-06-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome|Effects of Gabapentin Enacarbil on Intensity of Cortical Arousal, Heart Rate, Blood Pressure and Anterior Tibialis EMG Responses Associated With PLMs During Sleep in Patients With RLS Using a Novel Computer Assisted Scoring System|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|Cleveland Sleep Research Center||1|||f||||f||||||||||2017-10-10 23:22:26.437972|2017-10-10 23:22:26.437972
NCT02424682|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-11-01|||August 2007||2007-08-01|November 2016|2016-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Safety of Herceptin/Trastuzumab in Metastatic Breast Cancer|Safety of Herceptin in Metastatic Breast Cancer|Completed||N/A|69|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:22:26.558673|2017-10-10 23:22:26.558673
NCT02424669|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2015-11-16|||May 2015||2015-05-01|November 2015|2015-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients|Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients|Recruiting||N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||||||||||||2017-10-10 23:22:26.636506|2017-10-10 23:22:26.636506
NCT02424656|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-06-01|||September 2014||2014-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|ABCinTBI||Alterations in the Brain's Connectome After Severe Traumatic Brain Injury|Alterations in the Brain's Connectome in Severe Traumatic Brain Injury|Recruiting||N/A|50|Anticipated|Danish Research Centre for Magnetic Resonance|||2||f||||||||||||||2017-10-10 23:22:26.728501|2017-10-10 23:22:26.728501
NCT02424643|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-05-05|||April 2015||2015-04-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Improving Survey Procedures for Young Men Who Have Sex With Men in Web-based HIV Prevention: Retention Study|Improving Survey Procedures for Young Men Who Have Sex With Men in Web-based HIV Prevention: Retention Study|Completed||N/A|1131|Actual|Emory University||4|||f||||f||||||||||2017-10-10 23:22:26.821847|2017-10-10 23:22:26.821847
NCT02424617|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-07-03|||March 2015||2015-03-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of BGB324 in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer|A Multi-Center Open-Label Phase I/2 Study of BGB324 in Combination With Erlotinib in Patients With Stage IIIb or Stage IV Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|66|Anticipated|BerGenBio ASA||4|||f||||t||||||||||2017-10-10 23:22:26.987118|2017-10-10 23:22:26.987118
NCT02424604|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-03-10|||April 2015||2015-04-01|March 2016|2016-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Recurrency After Inguinal Herniorraphy With Bi-layer Mesh (BLM)|Recurrency After Inguinal Herniorraphy With Bi-layer Mesh|Completed||N/A|2000|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 23:22:27.120139|2017-10-10 23:22:27.120139
NCT02424591|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-05-19|2016-12-05||August 2014||2014-08-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|January 2016|Actual|2016-01-01||Interventional|||A Comparison of Intra-op Ketamine vs Placebo in Patients Having Spinal Fusion|A Prospective, Randomized, Single Blinded Comparison of Intraoperative Ketamine Infusion Versus Placebo in Patients Having Spinal Fusion|Completed||Phase 4|46|Actual|New York University School of Medicine||2|||f||||t||||||||Yes||2017-10-10 23:22:27.192144|2017-10-10 23:22:27.192144
NCT02424578|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-06-14|2017-06-14||May 2015||2015-05-01|June 2017|2017-06-01|April 19, 2016|Actual|2016-04-19|April 2016|Actual|2016-04-01||Interventional||Safety Population (all subjects receiving at least one dose of study medication)|Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age|A Phase IIA, Open-Label, Safety and Pharmacokinetic Study of Diclofenac Capsules in Pediatric Subjects 6 to <17 Years of Age With Mild to Moderate Acute Postoperative Pain Following Elective Surgery|Completed||Phase 2|30|Actual|Iroko Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 23:22:27.563311|2017-10-10 23:22:27.563311
NCT02424565|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-07-18|2016-02-04||May 2015||2015-05-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional||Baseline measures is presenting the data of Intent to treat (ITT) population.|Effect of Topical Application of Iodex® Balm on Local Surface Temperature|An Exploratory Study to Assess the Effect of Topical Application of Iodex® Balm on Local Surface Temperature Using Infra Red Thermal Imaging Technique|Completed||Phase 4|15|Actual|GlaxoSmithKline|Primary outcome measure was to detect significant increase in surface temperature. Since this was not observed for either treatment, there was no statistical analysis comparing the two arms.|2|||f||||f||||||||||2017-10-10 23:22:27.98337|2017-10-10 23:22:27.98337
NCT02424552|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-04-28|||June 26, 2015|Actual|2015-06-26|April 2017|2017-04-01|March 9, 2017|Actual|2017-03-09|February 9, 2017|Actual|2017-02-09||Interventional|EVITA||Effect of Vitamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma|EVITA Trial: Effect of VItamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma: a Randomized, Double-blind, Placebo-controlled Trial|Terminated||Phase 4|54|Actual|Johannes Gutenberg University Mainz||2||recruitment problems|f||||t||||||||Undecided||2017-10-10 23:22:28.347479|2017-10-10 23:22:28.347479
NCT02424539|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-03-20|||September 2015||2015-09-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)|A Randomized, Doubled-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of Fluticasone Furoate Nasal Spray 55 mcg and 110 mcg for 4 Weeks in Chinese Pediatric Subjects Ages 2 to 12 Years With Allergic Rhinitis|Recruiting||Phase 4|360|Anticipated|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:22:28.484557|2017-10-10 23:22:28.484557
NCT02424526|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy|Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy|Recruiting||N/A|24|Anticipated|California State University, Sacramento||2|||f||||f||||||||||2017-10-10 23:22:28.704863|2017-10-10 23:22:28.704863
NCT02424513|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-05-29|||March 2015||2015-03-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer|A Phase 2 Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer|Withdrawn||Phase 2|0|Actual|ImaginAb, Inc.||1||Clinical trial was postponed as a result of restructured business priorities.|f||||t||||||||||2017-10-10 23:22:28.830096|2017-10-10 23:22:28.830096
NCT02424500|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-03-10|||January 2015||2015-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:22:28.918362|2017-10-10 23:22:28.918362
NCT02424487|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-01-30|||May 2015||2015-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Intracuff Pressure During One-lung Ventilation in Infants and Children|Intracuff Pressure During One-lung Ventilation in Infants and Children|Enrolling by invitation||N/A|50|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 23:22:28.965726|2017-10-10 23:22:28.965726
NCT02424474|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-11|||June 2015|Actual|2015-06-01|September 2016|2016-09-01|February 14, 2017|Actual|2017-02-14|September 2016|Actual|2016-09-01||Interventional|DEPOSA||T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients|Fetal Aneuploidies Screening (21,18 and 13) by Cell Free Fetal DNA Analysis. Pilot Study in Low Risk Population and Pregnant Women After in Vitro Fertilisation (IFV)|Completed||N/A|933|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:22:29.064095|2017-10-10 23:22:29.064095
NCT02424461|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-06-23|||February 2015||2015-02-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PROSTASHORT||Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection|Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection Due to Fluoroquinolones Susceptible Bacteria: a Multicentre, Non-inferiority, Double Blind, Randomized Placebo-controlled Trial|Recruiting||Phase 3|400|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:22:29.182731|2017-10-10 23:22:29.182731
NCT02424448|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-07-25|||December 2014||2014-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|BIOMETHS||Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer|BIOMETHS Study. A Methodology Study to Determine the Feasibility, Evaluability and Temporal Variability in Candidate Pharmacodynamic Markers of Drug Action in Castration Resistant Prostate Cancer|Completed||N/A|6|Actual|The Christie NHS Foundation Trust|||1||f||||t||||||Samples With DNA|"     Original diagnostic tumour blocks will be returned at the end of the study. Biopsy samples     taken will either be retained or disposed of when the study is completed.   "|||2017-10-10 23:22:29.281695|2017-10-10 23:22:29.281695
NCT02424435|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-06-19|||June 2015||2015-06-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Methylprednisolone Treatment of Friedreich Ataxia|Open-label Pilot Study of Methylprednisolone for the Treatment of Patients With Friedreich Ataxia (FRDA)|Active, not recruiting||Early Phase 1|10|Anticipated|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-10-10 23:22:29.366577|2017-10-10 23:22:29.366577
NCT02424422|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-06-08|||February 2015||2015-02-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|||The Effect of Expansion on Craniofacial Sutures in Children Using 3D Imaging|The Effect of Rapid Maxillary Expansion on Craniofacial Sutures in Children Using Cone Beam Computed Tomography|Completed||N/A|15|Actual|Damascus University|||1||f||||t||||||||No||2017-10-10 23:22:29.456039|2017-10-10 23:22:29.456039
NCT02424409|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-06-30|||August 2015||2015-08-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|ASUR-R||Evaluation of the Relapse Rate One Month After Discharge From Emergency Department for Asthmatic Patients Given a Strict Formalized Follow up Protocol|Evaluation of the Relapse Rate One Month After Discharge From Emergency Department for Asthmatic Patients Given a Strict Formalized Follow up Protocol. Multicenter, Prospective, Cluster-randomized|Recruiting||N/A|1500|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:22:29.532392|2017-10-10 23:22:29.532392
NCT02424396|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-06-27|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|MS-IL2||Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis|Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis. Multicentric Randomized Study|Recruiting||Phase 2|30|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:22:29.649115|2017-10-10 23:22:29.649115
NCT02424383|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-01-04|||April 2015||2015-04-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01|3 Years|Observational [Patient Registry]|SAFE-DCB||Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter|A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter in Arteries of the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) (SAFE-DCB U.S. Registry)|Active, not recruiting||N/A|1006|Actual|C. R. Bard|||1||f||||f||||||||Undecided||2017-10-10 23:22:29.812005|2017-10-10 23:22:29.812005
NCT02351843|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-03-21|||February 2015||2015-02-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy and Safety of Low Amplitude Electroconvulsive Therapy|Efficacy and Safety of Low Amplitude Electroconvulsive Therapy|Terminated||N/A|1|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:37:20.916092|2017-10-10 23:37:20.916092
NCT02424370|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-01-03|||December 2015||2015-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|EVA-G-TAVI||Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation|Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation. Multicenter Observational Study|Recruiting||N/A|500|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:22:30.083534|2017-10-10 23:22:30.083534
NCT02424331|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-04-22|||March 2014||2014-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Pursed Lips Breathing on Chest Wall, Mobility Diaphragmatic and Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease||Completed||N/A|14|Actual|Universidade Federal de Pernambuco||1|||f||||t||||||||||2017-10-10 23:22:30.407685|2017-10-10 23:22:30.407685
NCT02424305|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-05-01|||May 2015||2015-05-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions|Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions|Completed||Phase 1|60|Actual|LEO Pharma||3|||f||||f||||||||||2017-10-10 23:22:30.552119|2017-10-10 23:22:30.552119
NCT02424292|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-04-20|||April 2015||2015-04-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|I-Move||Evaluation of a Physical Activity Program in Overweight Breast Cancer Patients|"Evaluating the Outcome of a Personalised Oncological Rehabilitation Program in Overweight and Obese Breast Cancer Patients on Adjuvant Anti-hormonal Treatment I-Move"|Recruiting||N/A|141|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:22:30.636317|2017-10-10 23:22:30.636317
NCT02424279|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-04-18|||September 2014||2014-09-01|April 2015|2015-04-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder|Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder|Unknown status|Recruiting|N/A|90|Anticipated|Medical University of Gdansk||2|||f||||f||||||||||2017-10-10 23:22:30.729071|2017-10-10 23:22:30.729071
NCT02424266|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-22|||April 2015||2015-04-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01|4 Weeks|Observational [Patient Registry]|3D-WLT||Three Dimension Tomography of Eye Structures by White Light Imaging Device|Three Dimension Tomography of Eye Structures by White Light Imaging Device|Unknown status|Not yet recruiting|N/A|60|Anticipated|Meir Medical Center|||2||f||||f||||||||||2017-10-10 23:22:30.797172|2017-10-10 23:22:30.797172
NCT02424253|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-07-14|||May 2015||2015-05-01|April 2015|2015-04-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis|A Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Determine the Effects of 8 Weeks Treatment With Oral ZPL-3893787 (30 mg od x 56 Days) on Pruritus in Adult Subjects With Moderate to Severe Atopic Dermatitis|Completed||Phase 2|98|Actual|Ziarco Pharma Ltd||2|||f||||f||||||||||2017-10-10 23:22:30.861717|2017-10-10 23:22:30.861717
NCT02424240|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2015-04-21|||May 2011||2011-05-01|April 2015|2015-04-01||||August 2014|Actual|2014-08-01||Observational|||Growth Hormone (GH) Deficiency & Insulin Like Growth Factor 1 (IGF-I)/ Insulin Like Growth Factor Binding Protein 3 (IGFBP-3) Ratio|The Emerging Role of Serum IGF-I/IGFBP-3 Ratio in the Diagnosis of Children With Growth Hormone Deficiency|Completed||N/A|134|Actual|University of Jordan|||2||f||||f||||||||||2017-10-10 23:22:30.95697|2017-10-10 23:22:30.95697
NCT02424227|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2016-06-13|||April 2015||2015-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|DART||Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation|Circulating Donor-Derived Cell-free DNA in Blood for Diagnosing Acute Rejection in Kidney Transplant Recipients|Active, not recruiting||N/A|401|Actual|CareDx|||1||f||||f||||||Samples With DNA|"     cfDNA samples collected in Cell-Free DNA BCT and mRNA collected in PAX gene tubes will be     retained   "|||2017-10-10 23:22:31.017073|2017-10-10 23:22:31.017073
NCT02424214|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2016-06-27|||January 2015||2015-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Artificial Oocyte Activation Comparing Tow Different Agents||Completed||N/A|450|Actual|Ibn Sina Hospital||3|||f||||f||||||||||2017-10-10 23:22:31.107089|2017-10-10 23:22:31.107089
NCT02424201|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2015-04-29|||June 2015||2015-06-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja.|Comparative Study on Effects of Sublingual Misoprostol in Addition to Standard Active Management of Third Stage of Labour in Low Risk Parturients in Lagos State University Teaching Hospital, Ikeja.|Unknown status|Not yet recruiting|Early Phase 1|660|Anticipated|Lagos State University||2|||f||||t||||||||||2017-10-10 23:22:31.176914|2017-10-10 23:22:31.176914
NCT02424188|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2015-04-21|||July 2015||2015-07-01|April 2015|2015-04-01||||June 2019|Anticipated|2019-06-01||Interventional|TRIUMPH||Trial of Integrated Smoking Cessation, Exercise and Weight Management in Serious Mental Illness: TRIUMPH|Trial of Integrated Smoking Cessation, Exercise and Weight Management in Serious Mental Illness: TRIUMPH|Not yet recruiting||N/A|220|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:22:31.238973|2017-10-10 23:22:31.238973
NCT02424162|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-04-21|||November 2014||2014-11-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Comparative Study of Two Multifocal Intraocular Lens With Different Add Power||Unknown status|Recruiting|N/A|60|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:22:31.374074|2017-10-10 23:22:31.374074
NCT02424149|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-10-11|2016-08-15||April 2015||2015-04-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|Phenazo||Phenazopyridine for Confirmation of Ureteral Patency|Use of Phenazopyridine for Confirmation of Ureteral Patency During Intraoperative Cystoscopy|Completed||N/A|107|Actual|Hartford Hospital||2|||f||||t||||||||||2017-10-10 23:22:31.451456|2017-10-10 23:22:31.451456
NCT02424136|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2016-09-05|||July 2015||2015-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PEAAP||PEAnut Anaphylaxis Predictors|PEAnut Anaphylaxis Predictors|Recruiting||N/A|400|Anticipated|John Hunter Children's Hospital||1|||f||||f||||||||No||2017-10-10 23:22:31.848467|2017-10-10 23:22:31.848467
NCT02424123|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-20|2017-06-16|||October 11, 2016|Actual|2016-10-11|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|SeizS100B||Is Protein S100B a Predictor of First-to-chronic Seizure Conversion in Adults?|Is Protein S100B a Predictor of First-to-chronic Seizure Conversion in Adults? A Prognostic Cohort Study|Recruiting||N/A|75|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||Samples Without DNA|"     Processing of blood samples: 4-5ml of the blood sample will be centrifuged to isolate serum;     S100B, IL-1b, IL-6, NSE levels will be investigated at D0 (T0+6h, T0+12h where T0 is seizure     time) D14-D28. The remaining blood and cells will be stored at -80°C for future analyses.   "|||2017-10-10 23:22:32.117277|2017-10-10 23:22:32.117277
NCT02424110|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-01-25|||July 2015||2015-07-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation|Bipolar Radiofrequency Ablation Plus Endocardial Ablation Using Argon Beam Coagulator for Atrial Fibrillation Treatment in Patients With Rheumatic Heart Disease|Recruiting||N/A|200|Anticipated|Xinqiao Hospital of Chongqing||2|||f||||f||||||||Undecided||2017-10-10 23:22:32.253556|2017-10-10 23:22:32.253556
NCT02424097|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-11-21|||May 2013||2013-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|GC-WS||MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study|MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study|Completed||Phase 4|40|Actual|University of California, San Francisco||2|||f||||f||||||||No||2017-10-10 23:22:32.38085|2017-10-10 23:22:32.38085
NCT02424084|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-01-28|||March 2015||2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bone Microcirculation After Extracorporeal Shock Wave Therapy|Effects of Extracorporeal Shock Wave Therapy in Bone Microcirculation|Recruiting||N/A|80|Anticipated|University of Schleswig-Holstein||5|||f||||f||||||||||2017-10-10 23:22:32.52089|2017-10-10 23:22:32.52089
NCT02424071|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2017-04-25|||July 2015||2015-07-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Effect of Premedication With Melatonin on Postoperative Recovery From Bariatric Surgery|The Effect of Premedication With Melatonin on Postoperative Recovery From Bariatric Surgery: a Prospective Randomised Controlled Cohort Study|Completed||Phase 4|60|Actual|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 23:22:32.643655|2017-10-10 23:22:32.643655
NCT02424058|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2015-04-18|||July 2014||2014-07-01|April 2015|2015-04-01||||July 2015|Anticipated|2015-07-01||Observational|||The Investigation of Thoracic Spinal Curvature and Mobility in Subjects With and Without Neck Pain: Cut-off Points|The Investigation of the Sagittal Thoracic Spinal Curvature and Mobility in Subjects With and Without Chronic Neck Pain: Cut-off Points and Pain Relationship|Unknown status|Recruiting|N/A|100|Anticipated|Ataturk Training and Research Hospital|||2||f||||||||||||||2017-10-10 23:22:32.736165|2017-10-10 23:22:32.736165
NCT02424045|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-05-18|||May 2015||2015-05-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma|A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma: BENCART Trial|Active, not recruiting||Phase 2|30|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:22:32.828659|2017-10-10 23:22:32.828659
NCT02424032|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-18|||February 2013||2013-02-01|April 2015|2015-04-01||||May 2015|Anticipated|2015-05-01||Interventional|||Stabilization Exercises With and Without Connective Tissue Massage for Chronic Mechanical Neck Pain||Unknown status|Recruiting|Phase 2|53|Anticipated|Ataturk Training and Research Hospital||2|||f||||||||||||||2017-10-10 23:22:32.921777|2017-10-10 23:22:32.921777
NCT02424019|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-01-05|||April 2015||2015-04-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PALADIN||Phase 4 IOP Signals Associated With ILUVIEN®|A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg|Active, not recruiting||Phase 4|153|Actual|Alimera Sciences||1|||f||||f||||||||||2017-10-10 23:22:33.04995|2017-10-10 23:22:33.04995
NCT02424006|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-04-21|||May 2015||2015-05-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar Keratoplasty|A Prospective, Randomized, Open Label Clinical Trial to Evaluate the Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea Compared to Human Cornea in Patients Requiring Anterior Lamellar Keratoplasty|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|L.V. Prasad Eye Institute||2|||f||||t||||||||||2017-10-10 23:22:33.209116|2017-10-10 23:22:33.209116
NCT02423993|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2015-12-07|2015-08-04||October 2009||2009-10-01|December 2015|2015-12-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|EASEDIAP||Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump Therapy|Efficiency Assessment of the Structured Education Program for Type 1 Diabetes Patients on Insulin Pump Therapy|Completed||N/A|77|Actual|Endocrinology Research Centre, Moscow||4|||f||||f||||||||||2017-10-10 23:22:33.328398|2017-10-10 23:22:33.328398
NCT02423967|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-03-31|||April 2015||2015-04-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Fresh Versus Frozen Stool for Fecal Transplant in Children|A Comparison of Efficacy of Fresh Versus Frozen Donor Stool for Fecal Microbial Transplant in Children With Recurrent Clostridium Difficile Infections|Recruiting||Phase 1|40|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:22:34.88418|2017-10-10 23:22:34.88418
NCT02423954|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-06-23|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|NivoPlus||Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)|A Phase Ib/II Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)|Active, not recruiting||Phase 1/Phase 2|49|Anticipated|Western Regional Medical Center||3|||f||||f||||||||Undecided||2017-10-10 23:22:34.965806|2017-10-10 23:22:34.965806
NCT02423941|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2016-12-31|||April 2015||2015-04-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|REDLIT||A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation|A Randomized Clinical Study of Retrograde Caval or Antegrade Portal Reperfusion for Early Graft Dysfunction Prevention in Deceased Brain Dead Donor Liver Transplantation|Recruiting||N/A|90|Anticipated|Republican Scientific and Practical Center for Organ and Tissue Transplantation||2|||f||||t||||||||||2017-10-10 23:22:35.085693|2017-10-10 23:22:35.085693
NCT02423928|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-07-19|||May 2015||2015-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|CryoIT||Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer|A Phase I Clinical Trial of Combined Cryotherapy and Intra-tumoral Immunotherapy With Autologous Immature Dendritic Cells in Men With Castration Resistant Prostatic Cancer and Metastases to Lymph Nodes and/or Bone Pre or Post Chemotherapy|Recruiting||Phase 1|20|Anticipated|Alden Cancer Therapy II||1|||f||||t||||||||Yes|Abstract will be submitted to ASCO 2017 meeting|2017-10-10 23:22:35.214259|2017-10-10 23:22:35.214259
NCT02423915|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-08-08|||July 30, 2015|Actual|2015-07-30|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention|Pilot Study of Infusion of Fucosylated Regulatory T Cells to Prevent Graft Versus Host Disease|Recruiting||Phase 1/Phase 2|47|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 23:22:35.312595|2017-10-10 23:22:35.312595
NCT02423902|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-02-13|||April 2015||2015-04-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer|A Single-arm, Open-label Study of Ad-RTS-hIL-12 + Veledimex Following First-, Second-, or Third-Line Standard Treatment in Subjects With Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Ziopharm||1|||f||||f||||||||||2017-10-10 23:22:35.478447|2017-10-10 23:22:35.478447
NCT02423889|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-05-10|||April 2013||2013-04-01|May 2016|2016-05-01||||September 2015|Actual|2015-09-01||Interventional|||Stereotactic Volumetric Radiotherapy in Prostate Cancer|Stereotactic Radiotherapy in Low Risk Prostate Cancer: a Phase II Study|Completed||Phase 2|28|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||1|||f||||||||||||||2017-10-10 23:22:35.59338|2017-10-10 23:22:35.59338
NCT02423876|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-01-20|||March 2015||2015-03-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery|UW14030: Epidural Anesthesia as Part of an Enhanced Recovery Pathway in Gynecologic Surgery|Recruiting||Phase 3|110|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-10 23:22:35.694169|2017-10-10 23:22:35.694169
NCT02423863|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-09-19|||March 2015||2015-03-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|Poly-ICLC||In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®|In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® (Poly-ICLC): An Adaptive, Multicenter, Phase II Clinical Study|Recruiting||Phase 2|100|Anticipated|Oncovir, Inc.||1|||f||||t||||||||||2017-10-10 23:22:35.814056|2017-10-10 23:22:35.814056
NCT02423850|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-02-23|||August 2015||2015-08-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Volumetric Measurements of Diabetic Foot Ulcers|Volumetric Measurements for Monitoring Ulcer Healing of Diabetic Foot Ulcers and Venous Leg Ulcers|Recruiting||N/A|150|Anticipated|Odense University Hospital|||1||f||||t||||||||Undecided||2017-10-10 23:22:35.963436|2017-10-10 23:22:35.963436
NCT02423837|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-04-19|||December 2013||2013-12-01|April 2015|2015-04-01|April 2021|Anticipated|2021-04-01|February 2016|Anticipated|2016-02-01||Interventional|BRiF||Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma|Prospective Multicenter Study: Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma|Recruiting||Phase 3|200|Anticipated|National Research Center for Hematology, Russia||1|||f||||f||||||||||2017-10-10 23:22:36.045179|2017-10-10 23:22:36.045179
NCT02423811|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2015-04-21|||April 2015||2015-04-01|April 2015|2015-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||To Study the Effect of Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy|To Study the Effect of Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy|Recruiting||Phase 2|120|Anticipated|National Cheng-Kung University Hospital||1|||f||||||||||||||2017-10-10 23:22:36.217021|2017-10-10 23:22:36.217021
NCT02423798|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-08-28|2017-08-28||April 2015||2015-04-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||New Generation Enlite Accuracy Study|Accuracy and Performance Evaluation of the Medtronic New Generation Enlite Glucose Sensor in Conjunction With the Medtronic 640G System Components - in Clinic and at Home|Completed||N/A|24|Actual|Medtronic||1|||f||||f||||||||||2017-10-10 23:22:36.2936|2017-10-10 23:22:36.2936
NCT02423759|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-04-02|||April 2015||2015-04-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|January 16, 2017|Actual|2017-01-16||Interventional|||A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy|A Randomized Controlled Trial Comparing Rectal Swab Culture Based Chemoprophylaxis Versus Combined Single-Shot Gentamycin and Ciprofloxacin Versus Ciprofloxacin Alone for Peri-procedure Chemoprophylaxis During Transrectal Prostate Biopsy.|Completed||Phase 4|510|Actual|Mansoura University||3|||f||||t||||||||||2017-10-10 23:22:39.047716|2017-10-10 23:22:39.047716
NCT02423746|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-01-20|||April 2015||2015-04-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Assessing and Addressing Behaviors in Children With Hearing Loss|Assessing and Addressing Behaviors in Children With Hearing Loss|Enrolling by invitation||N/A|24|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 23:22:39.129655|2017-10-10 23:22:39.129655
NCT02423733|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-02-21|||April 2015||2015-04-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|July 2016|Actual|2016-07-01||Interventional|||Can E-therapies Reduce Waiting Lists in Secondary Mental Health Care? A Randomized Controlled Trial|Can E-therapies Reduce Waiting Lists in Secondary Mental Health Care? A Randomized Controlled Trial|Active, not recruiting||N/A|110|Anticipated|University of Ottawa||2|||f||||f||||||||||2017-10-10 23:22:39.207928|2017-10-10 23:22:39.207928
NCT02423707|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-02-12|||August 2010||2010-08-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy|Intralymphatic Allergen-specific Immunity as a New Administration Route for Treatment of Pollen-induced Allergic Diseases|Active, not recruiting||Phase 2/Phase 3|110|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:22:39.376133|2017-10-10 23:22:39.376133
NCT02423681|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-02-13|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Comparison of CPAP With and Without Humidification: A Pilot Study|Evaluation of Overall Therapy Cost Comparing First Intention and Second Intention Heated Humidification for CPAP: A Pilot Study.|Completed||N/A|20|Actual|Fisher and Paykel Healthcare||2|||f||||t||||||||||2017-10-10 23:22:39.549927|2017-10-10 23:22:39.549927
NCT02423668|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2015-04-21|||January 2015||2015-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Pseudophakic Anterior Chamber Depth Measurement in Second Eye Refinement Cataract Surgery|Pseudophakic Anterior Chamber Depth Measurement in Second Eye Refinement Cataract Surgery|Completed||N/A|88|Actual|Centro Hospitalar do Baixo Vouga|||3||f||||f||||||||||2017-10-10 23:22:39.733909|2017-10-10 23:22:39.733909
NCT02423655|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-05-21|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|RADDI||Routine and Deferred Dialysis Initiation|A Randomized, Controlled Trial to Evaluate Routine and Deferred Dialysis Initiation in Chinese Population|Recruiting||N/A|1700|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-10 23:22:39.816309|2017-10-10 23:22:39.816309
NCT02423642|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-19|||July 2013||2013-07-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy||Completed||N/A|30|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 23:22:39.935016|2017-10-10 23:22:39.935016
NCT02423629|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-08-14|||May 2014||2014-05-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Agili-C™ Implant Performance Evaluation in the Repair of Cartilage and Osteochondral Defects|Agili-C™ Implant Performance Evaluation in the Repair of Cartilage and Osteochondral Defects (OCD)|Recruiting||Phase 4|150|Anticipated|Cartiheal (2009) Ltd||1|||f||||f||||||||||2017-10-10 23:22:40.017556|2017-10-10 23:22:40.017556
NCT02423616|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2015-04-27|||March 2012||2012-03-01|April 2015|2015-04-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Interventional|CBMIPHGFHI||Correlation Between Maximal Inspiratory Pressure and Hand Grip Force|Correlation Between Maximal Inspiratory Pressure and Hand Grip Force in Healthy Individuals|Completed||N/A|50|Actual|Attikon Hospital||1|||f||||f||||||||||2017-10-10 23:22:40.101607|2017-10-10 23:22:40.101607
NCT02423603|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-08-29|||May 2014||2014-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PAKT||PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer|A Phase II, Double-blind, Randomised, Placebo-controlled Study of the AKT Inhibitor AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer (PAKT).|Active, not recruiting||Phase 2|140|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-10-10 23:22:40.179919|2017-10-10 23:22:40.179919
NCT02423590|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-08-21|||June 2014||2014-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers|A Phase II Randomised, Open-label Study of Gemcitabine/Carboplatin First-line Chemotherapy in Combination With or Without the Antisense Oligonucleotide Apatorsen (OGX-427) in Advanced Squamous Cell Lung Cancers|Active, not recruiting||Phase 2|140|Anticipated|Queen Mary University of London||2|||f||||t||||||||||2017-10-10 23:22:40.354669|2017-10-10 23:22:40.354669
NCT02423577|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-19|2017-08-11|2017-07-03||September 2015||2015-09-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain|A Phase 2a, Randomized, Double-blind, Placebo-controlled Assessment of the Safety and Protective Efficacy of FF-3 Dry Powder Administered by Nasal Inhalation for 5 Days to Healthy Adult Subjects Who Are Experimentally Infected With a Challenge Strain of Influenza A Virus|Completed||Phase 2|79|Actual|Autoimmune Technologies, LLC||2|||f||||t||||||||||2017-10-10 23:22:40.499234|2017-10-10 23:22:40.499234
NCT02423564|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-06-08|||May 2015||2015-05-01|June 2016|2016-06-01||||April 2016|Actual|2016-04-01||Interventional|||A Study Investigating the Effect of Digesta-Lac in Healthy Adults With Occasional Constipation|A Double-blind, Placebo-controlled, Parallel Study Investigating the Effect of Digesta-Lac in Healthy Adults With Occasional Constipation|Completed||Phase 2|54|Actual|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-10 23:22:40.878428|2017-10-10 23:22:40.878428
NCT02423551|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-04-16|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||MRE Consumption and Gut Health|Effects of Meal, Ready-to-Eat (MRE) Consumption on Gut Health|Completed||N/A|71|Actual|United States Army Research Institute of Environmental Medicine||2|||f||||f||||||||||2017-10-10 23:22:40.964412|2017-10-10 23:22:40.964412
NCT02423538|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-01-24|||April 2015||2015-04-01|January 2016|2016-01-01||||July 2016|Anticipated|2016-07-01||Interventional|||First-in-Human Single Ascending Dose of SHR0302|A Phase I, Randomized, Placebo-Controlled, Single Dose Escalation Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics of SHR0302 in Healthy Volunteers|Active, not recruiting||Phase 1|64|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:22:41.031162|2017-10-10 23:22:41.031162
NCT02423525|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-03-03|||December 2016|Actual|2016-12-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Safety Study of Afatinib for Brain Cancer|A Phase I Dose Escalation and Central Nervous System (CNS) Pharmacokinetic Study of the ErbB Family Inhibitor Afatinib in Patients With Recurrent or Progressive Brain Cancer|Recruiting||Phase 1|24|Anticipated|John Wayne Cancer Institute||1|||f||||f|t|f|||t|||Undecided||2017-10-10 23:22:41.099742|2017-10-10 23:22:41.099742
NCT02423512|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-09-11|||June 2015||2015-06-01|September 2017|2017-09-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Observational|||The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness|The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness: A Biomarker Study.|Completed||N/A|50|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||t||||||Samples With DNA|"     Whole blood, serum, mucosal tissue   "|||2017-10-10 23:22:41.187273|2017-10-10 23:22:41.187273
NCT02423499|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-05-19|||May 2015||2015-05-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|REMBAU||Features Emotional Responses in Adults With Autism: Comparison With Bipolar Disorder (REMBAU)|Features Emotional Responses in Adults With Autism: Comparison With Bipolar Disorder|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Tours|||3||f||||t||||||||||2017-10-10 23:22:41.385192|2017-10-10 23:22:41.385192
NCT02423486|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-04-17|||November 2013||2013-11-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||The Comparison of Efficacy Between Electromagnetic Stimulation Therapy and Electromagnetic Stimulation Therapy With Extracorporeal Biofeedback|The Comparison of Efficacy Between Electromagnetic Stimulation Therapy and Electromagnetic Stimulation Therapy With Extracorporeal Biofeedback|Unknown status|Recruiting|N/A|60|Anticipated|Samsung Medical Center||2|||f||||||||||||||2017-10-10 23:22:41.482076|2017-10-10 23:22:41.482076
NCT02423473|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-04-22|||August 2011||2011-08-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||Composite Resin Plus Connective Tissue Graft.|Composite Resin Plus Connective Tissue Graft to Treat Gingival Recession Associated With Non-carious Cervical Lesion. Randomized Clinical Trial|Completed||N/A|36|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||2|||f||||f||||||||||2017-10-10 23:22:41.582183|2017-10-10 23:22:41.582183
NCT02423460|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2016-09-08|||May 2015||2015-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Threonine Requirement in IBD Adults and Healthy Adult Controls|Threonine Requirement in Healthy Adult Subjects and in Patients With Crohn's Disease and With Ulcerative Colitis Using the Indicator Amino Acid Oxidation (IAAO) Methodology|Recruiting||N/A|105|Anticipated|Nestlé||1|||f||||f||||||||||2017-10-10 23:22:41.660573|2017-10-10 23:22:41.660573
NCT02423447|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-12-07|2015-08-13||November 2013||2013-11-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||All participants had the diagnosis of cystic fibrosis. All enrolled had baseline sputum production and were deemed at their baseline health status.|Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and the G5 Flimm-Fighter in Patients With CF|Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and the G5 Flimm-Fighter in Patients With Cystic Fibrosis (CF)|Completed||N/A|25|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:22:41.750574|2017-10-10 23:22:41.750574
NCT02423434|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-04-29|||September 2014||2014-09-01|April 2016|2016-04-01||||August 2017|Anticipated|2017-08-01||Observational|||Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes|Multinational Collaborative Evaluation of Corneal Confocal Microscopy as a Surrogate Endpoint for the Identification and Prediction of Diabetic Neuropathy in Type 1 Diabetes|Enrolling by invitation||N/A|729|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||1||f||||t||||||||||2017-10-10 23:22:41.98669|2017-10-10 23:22:41.98669
NCT02423421|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-04-17|||March 2015||2015-03-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Faecal Microbiota Transplantation in Irritable Bowel Syndrome|Randomised Placebo Controlled Trial of Faecal Microbiota Transplantation in Irritable Bowel Syndrome|Unknown status|Recruiting|Phase 2|50|Anticipated|University College Cork||2|||f||||f||||||||||2017-10-10 23:22:42.099357|2017-10-10 23:22:42.099357
NCT02423408|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-03-13|2016-12-27||June 2015||2015-06-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache|A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache|Completed||Phase 2|165|Actual|Tonix Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:22:42.207111|2017-10-10 23:22:42.207111
NCT02423395|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-05-24|||January 2015||2015-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pilot Study of Orphenadrine` in the Treatment of Muscle Cramps in Patients With Cirrhosis|Pilot Study of Orphenadrine` in the Treatment of Muscle Cramps in Patients With Cirrhosis|Recruiting||Phase 3|30|Anticipated|Tanta University||2|||f||||t||||||||Undecided||2017-10-10 23:22:42.584286|2017-10-10 23:22:42.584286
NCT02423382|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-04-21|||February 2014||2014-02-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Measurement of the Retinal Oxygen Saturaiton After Long-term Silicon Oil Tamponade|Measurement of the Retinal Oxygen Saturaiton After Long-term Silicon Oil Tamponade With Oxymap|Completed||N/A|49|Actual|Sun Yat-sen University||3|||f||||f||||||||||2017-10-10 23:22:42.676043|2017-10-10 23:22:42.676043
NCT02423369|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-12-12|||March 2013||2013-03-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|NEMARKO||Cerebral Oxymetry and Neuronal Markers in Newborns and Infants Undergoing Surgery|Cerebral Oxymetry and Neuronal Biomarkers in Newborns and Infants During Perioperative Period|Completed||N/A|49|Actual|Lithuanian University of Health Sciences||1|||f||||f||||||||||2017-10-10 23:22:42.761604|2017-10-10 23:22:42.761604
NCT02423356|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-09-29|||April 23, 2015|Actual|2015-04-23|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin|The Ability of Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Standard Chemotherapy Regimens Containing Doxorubicin|Recruiting||N/A|150|Anticipated|Indiana University|||1||f||||t||||||||||2017-10-10 23:22:42.847758|2017-10-10 23:22:42.847758
NCT02423343|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-09-01|||October 2015||2015-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma|A Phase 1b/2 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of a Novel Transforming Growth Factor-beta Receptor I Kinase Inhibitor (Galunisertib) Administered in Combination With Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors (Phase 1b) and in Recurrent or Refractory Non-small Cell Lung Cancer or Hepatocellular Carcinoma (Phase 2)|Recruiting||Phase 1/Phase 2|75|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 23:22:42.954452|2017-10-10 23:22:42.954452
NCT02423330|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-04-08|||March 2015||2015-03-01|April 2016|2016-04-01||||January 2017|Anticipated|2017-01-01||Interventional|||A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula|A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula|Recruiting||Phase 4|15|Anticipated|Rush University Medical Center||1|||f||||t||||||||||2017-10-10 23:22:43.103087|2017-10-10 23:22:43.103087
NCT02423317|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2016-02-11|2015-09-23||May 2013||2013-05-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Miller's Blade and Airtraq Laryngoscope in Children|A Comparative Evaluation of Airtraq Optical LaryngoscopeTM and Miller Blade in Pediatric Patients Undergoing Elective Surgery Requiring Tracheal Intubation.|Completed||N/A|60|Actual|Government Medical College, Haldwani||2|||f||||t||||||||||2017-10-10 23:22:43.179026|2017-10-10 23:22:43.179026
NCT02423304|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2015-04-21|||May 2015||2015-05-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Observational|SEGPPAH||Serological Evaluation of 77A/G and 11A/12A Gene of MMP-13 in Periodontitis Affected and Healthy Individuals|A Serological Evaluation of 77A/G and 11A/12A Associated Gene Polymorphisms of MMP-13 in Periodontitis Affected and Healthy Individuals|Unknown status|Not yet recruiting|N/A|100|Anticipated|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||2||f||||t||||||Samples With DNA|"     blood serum   "|||2017-10-10 23:22:43.434544|2017-10-10 23:22:43.434544
NCT02423291|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-04-10|2017-02-24||October 2013||2013-10-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|FIL_SGN01||A Study of SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL|A Phase II Study of SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (PMLBCL)|Completed||Phase 2|15|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||t||||||||||2017-10-10 23:22:43.496345|2017-10-10 23:22:43.496345
NCT02423278|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-21|||January 2010||2010-01-01|April 2015|2015-04-01|December 2020|Anticipated|2020-12-01|June 2016|Anticipated|2016-06-01||Interventional|||The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer|The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer: a Multicenter, Open-label, Randomized Trial|Recruiting||Phase 2/Phase 3|200|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 23:22:43.806531|2017-10-10 23:22:43.806531
NCT02423265|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2017-06-03|||June 2015||2015-06-01|June 2017|2017-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries|The Effectiveness of Ranolazine in Reducing Cardiac Ischaemia Induced by Chronic Total Occlusions of Coronary Arteries|Withdrawn||Phase 4|0|Actual|East Carolina University||2|||f||||f||||||||Undecided||2017-10-10 23:22:43.940193|2017-10-10 23:22:43.940193
NCT02423252|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-28|2015-04-17|||March 2015||2015-03-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Interventional|||Effects of a Psycho-cognitive Nursing Intervention on Patients' Outcomes in Critical Illness|The Effects of a Psycho-cognitive Nursing Intervention on Clinical and Psychological Outcomes of Critically Ill Patients: A Randomized Controlled Trial|Unknown status|Recruiting|Early Phase 1|60|Anticipated|Cyprus University of Technology||2|||f||||f||||||||||2017-10-10 23:22:44.080224|2017-10-10 23:22:44.080224
NCT02423239|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-04-05|||April 2015||2015-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours|A Phase 1b Study to Assess the Safety and Anti-tumour Activity of Dexanabinol Monotherapy and Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours|Active, not recruiting||Phase 1|112|Anticipated|e-Therapeutics PLC||3|||f||||f||||||||||2017-10-10 23:22:44.222485|2017-10-10 23:22:44.222485
NCT02423226|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-21|||October 2008||2008-10-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer|Phase II Study of Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer|Completed||Phase 2|56|Actual|The First People's Hospital of Changzhou||2|||f||||f||||||||||2017-10-10 23:22:44.351597|2017-10-10 23:22:44.351597
NCT02423213|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-10-05|||January 2014||2014-01-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Observational|DISCOVER||DISCOVER Study: Microscope-integrated Intraoperative OCT Study|Determination of Feasibility of Intraoperative Spectral Domain Microscope Combined/Integrated OCT Visualization During En Face Retinal and Ophthalmic Surgery: DISCOVER Study|Recruiting||N/A|1500|Anticipated|The Cleveland Clinic|||1||f||||f||||||||No||2017-10-10 23:22:44.433091|2017-10-10 23:22:44.433091
NCT02423200|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-04-13|||April 2015||2015-04-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD|A Randomized, Open-Label, Multiple Dose Clinical Pharmacology Study of Two Doses of a Selective p38 MAP Kinase Inhibitor, VX-745 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) or With Mild AD|Completed||Phase 2|16|Actual|EIP Pharma, LLC||2|||f||||f||||||||||2017-10-10 23:22:44.516954|2017-10-10 23:22:44.516954
NCT02423187|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-04-11|||March 17, 2015|Actual|2015-03-17|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Observational|||Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin|Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin|Active, not recruiting||N/A|1568|Actual|Eisai Inc.|||1||f||||||||||||||2017-10-10 23:22:44.595528|2017-10-10 23:22:44.595528
NCT02423174|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-02-09|||January 2016|Actual|2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Eval. of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Total Mesorectal Excision Surgery|Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Total Mesorectal Excision Surgery|Withdrawn||N/A|0|Actual|Domain Surgical, Inc.|||1|Funding|f||||f||||||||||2017-10-10 23:22:44.673466|2017-10-10 23:22:44.673466
NCT02423161|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-08-01|||August 2011||2011-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2014|Actual|2014-08-01||Observational|PIONEER||PIONEER: Intraoperative and Perioperative OCT Study|Prospective Intraoperative and Perioperative Ophthalmic Imaging With Optical Coherence Tomography: PIONEER Study|Active, not recruiting||N/A|750|Actual|The Cleveland Clinic|||1||f||||f||||||||||2017-10-10 23:22:44.74844|2017-10-10 23:22:44.74844
NCT02423148|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2016-08-24|||May 2015||2015-05-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|April 2017|Anticipated|2017-04-01||Interventional|||Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer|A Pilot Study of a Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer in Combination With Indo-Cyanine Green|Recruiting||N/A|5|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:22:44.822254|2017-10-10 23:22:44.822254
NCT02423122|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-04-13|||April 2015||2015-04-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)|A Clinical Study of Two Doses of a Selective p38 MAP Kinase Inhibitor, VX-745, to Evaluate the Effects of 12-Week Oral Twice-Daily Dosing on Amyloid Plaque Load as Assessed by Quantitative Dynamic 11C-PiB Positive Emission Tomography (PET) Amyloid Scanning|Completed||Phase 2|16|Actual|EIP Pharma, LLC||2|||f||||f||||||||||2017-10-10 23:22:44.980878|2017-10-10 23:22:44.980878
NCT02423096|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-11-09|||December 2013||2013-12-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|12 Weeks|Observational [Patient Registry]|||Neuroendocrine and Metabolite Substrates in Schizophrenia|Neuroendocrine, Metabolite Substrates, Clinical Symptoms and Cognitive Function in Schizophrenia|Recruiting||N/A|200|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||Samples Without DNA|"     Blood samples of patients and control subjects will be obtained to measure the levels of     neuroendocrine substrates (didehydroepiandrosterone, dehydroepiandrosterone sulfate,     pregnenolone, and cortisol) and metabolite markers (lipid profiles, glycerate, eicosenoic     acid, pyruvate, b-hydroxybutyrate, Cysteine)   "|||2017-10-10 23:22:45.105801|2017-10-10 23:22:45.105801
NCT02423083|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-21|2017-06-30|||April 15, 2015||2015-04-15|February 14, 2017|2017-02-14|January 20, 2018|Anticipated|2018-01-20|January 20, 2018|Anticipated|2018-01-20||Interventional|||Oral Guanabenz for Multiple Sclerosis|Phase I Study of Oral Guanabenz for Multiple Sclerosis|Recruiting||Phase 1|12|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:22:45.204359|2017-10-10 23:22:45.204359
NCT02423070|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-09-12|||March 30, 2015||2015-03-30|August 25, 2017|2017-08-25|November 30, 2024|Anticipated|2024-11-30|November 30, 2024|Anticipated|2024-11-30||Observational|||Genome Transplant Dynamics|Genome Transplant Dynamics|Recruiting||N/A|495|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:22:45.300217|2017-10-10 23:22:45.300217
NCT02423057|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-10-05|||April 13, 2015||2015-04-13|March 1, 2017|2017-03-01|April 18, 2018|Anticipated|2018-04-18|March 21, 2018|Anticipated|2018-03-21||Interventional|||Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors|Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors|Recruiting||Phase 1|46|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:22:45.383101|2017-10-10 23:22:45.383101
NCT02423044|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-06-30|||April 13, 2015||2015-04-13|December 21, 2016|2016-12-21|January 4, 2018|Anticipated|2018-01-04|January 4, 2018|Anticipated|2018-01-04||Observational|||Spatial Context and Fear Learning|fMRI Spatial Context and Fear Conditioning|Recruiting||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:22:45.47473|2017-10-10 23:22:45.47473
NCT02423031|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-18|2017-09-27|||March 31, 2015||2015-03-31|March 20, 2017|2017-03-20|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial Distress|Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial Distress|Recruiting||N/A|290|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:22:45.557817|2017-10-10 23:22:45.557817
NCT02423018|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-03-21|||April 2015||2015-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal Symptoms|Evaluation of Pregabalin's Abuse Liability and Its Effects on Benzodiazepine Withdrawal Symptoms in Inpatients Undergoing Medically Assisted Benzodiazepine Withdrawal|Terminated||Phase 4|1|Actual|Centre for Addiction and Mental Health||2||Low enrollment.|f||||f||||||||Undecided||2017-10-10 23:22:45.644091|2017-10-10 23:22:45.644091
NCT02422641|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-07-24|||April 2015||2015-04-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis|Traditional Incision and Drainage of Cutaneous Abscess Vs. Minimally Invasive Incision and Drainage With Vessel Loop: A Randomized Controlled Trail|Recruiting||Phase 2|16|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-10 23:22:48.898705|2017-10-10 23:22:48.898705
NCT02423005|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-06-08|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US|A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients|Completed||N/A|180|Actual|Bio-Medical Research, Ltd.||2|||f||||f||||||||||2017-10-10 23:22:45.768488|2017-10-10 23:22:45.768488
NCT02422992|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-11-28|||February 2013||2013-02-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|HPPD||Haptoglobin and Iron in Parkinson's Disease|Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease|Completed||N/A|342|Actual|Bastyr University|||2||f||||t||||||Samples Without DNA|"     We collect serum and plasma samples during the study, that were tested for total serum iron     and iron-binding proteins.   "|||2017-10-10 23:22:45.895881|2017-10-10 23:22:45.895881
NCT02422979|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-06-21|||June 2015||2015-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer|A Phase 1/2a Multicenter, Open-Label, Dose-Escalation, Combination Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer, Who in the Opinion of Their Physician, Cannot Be Satisfactorily Treated With Surgery, Radiation or Platinum Chemotherapy|Recruiting||Phase 1/Phase 2|24|Anticipated|Aspyrian Therapeutics, Inc.||1|||f||||f||||||||Undecided||2017-10-10 23:22:45.973984|2017-10-10 23:22:45.973984
NCT02422966|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-09-07|||December 2015||2015-12-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Paracetamol in Patent Ductus Arteriosus|Efficacy and Safety of Paracetamol in Comparison to Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants: A Randomized, Open Label, Comparator-controlled, Prospective Study|Recruiting||Phase 2|110|Anticipated|Aziende Chimiche Riunite Angelini Francesco S.p.A||2|||f||||f||||||||||2017-10-10 23:22:46.099899|2017-10-10 23:22:46.099899
NCT02422953|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-02-02|||January 2014||2014-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Stunting Prevention Project in Thatta and Sajawal Districts, Sindh Province, Pakistan|Effectiveness of Food/Nutrient Based Interventions to Prevent Stunting Among Children Under Five in Thatta and Sajawal Districts, Sindh Province, Pakistan|Active, not recruiting||N/A|6990|Actual|Aga Khan University||2|||f||||t||||||||Yes|Data are sharing with funding agency on 6-monthly basis|2017-10-10 23:22:46.212483|2017-10-10 23:22:46.212483
NCT02422940|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-02-14|||April 2015||2015-04-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|MILESTONE℠||An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits in Subjects Who Participated in the DALF-PS-1016 Study||Terminated||Phase 3|294|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-10-10 23:22:46.31629|2017-10-10 23:22:46.31629
NCT02422927|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-16|||July 2014||2014-07-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Nutraceutical Combination in Patients With Low-grade Systemic Inflammation|Effect of a Nutraceutical Combination on Endothelial Injury and C-reactive Protein in Patients With Low-grade Systemic Inflammation|Completed||Phase 4|100|Actual|University Of Perugia||2|||f||||f||||||||||2017-10-10 23:22:46.509673|2017-10-10 23:22:46.509673
NCT02422914|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-04-21|||September 2014||2014-09-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|BETOFREE||Benefits of Tobacco Free Cigarette|Benefits of Tobacco Free Cigarette Among Heavy Smokers Undergoing a Lung Cancer Screening Program: a Randomized Controlled Study|Unknown status|Recruiting|N/A|210|Anticipated|University of Milan||3|||f||||f||||||||||2017-10-10 23:22:46.593307|2017-10-10 23:22:46.593307
NCT02422901|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-04-05|||November 2012||2012-11-01|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|November 2022|Anticipated|2022-11-01||Observational|||A Long-term Study to Describe the Use of PASCORBIN® 7.5 g in Patients With Vitamin C Deficiency|A Long-term Observational Study to Describe the Use of PASCORBIN® 7.5 g in Patients With Vitamin C Deficiency|Recruiting||N/A|5000|Anticipated|Pascoe Pharmazeutische Praeparate GmbH|||2||f||||f||||||||No|All data are anonymous. Patient data list only will be sent to regulatory authorities.|2017-10-10 23:22:46.681887|2017-10-10 23:22:46.681887
NCT02422888|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-10-31|||May 2015||2015-05-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|REDUCE-MVI||Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor|Reducing Micro Vascular Dysfunction In Revascularized ST-elevation Myocardial Infarction Patients by Off-target Properties of Ticagrelor|Recruiting||Phase 4|110|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-10 23:22:46.919941|2017-10-10 23:22:46.919941
NCT02422875|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-07-31|||August 2012||2012-08-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|3 Days|Observational [Patient Registry]|||Comparative Autoantibody and Immunologic Cell Marker Study|Comparative Autoantibody and Immunologic Cell Marker Study|Enrolling by invitation||N/A|100|Anticipated|Emory University|||5||f||||f|f|f||||Samples With DNA|"     Acquisition and storage of blood and bone marrow samples   "|||2017-10-10 23:22:47.041814|2017-10-10 23:22:47.041814
NCT02422862|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-02-25|||January 2014||2014-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||Clinical Effects of Upper Cervical Translatoric Mobilization in Patients With Headache||Completed||N/A|162|Actual|Universidad de Zaragoza||2|||f||||f||||||||||2017-10-10 23:22:47.135927|2017-10-10 23:22:47.135927
NCT02422849|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-02-13|||November 2013||2013-11-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|ACCESS||Acute Combined Care for Seniors in Southern Denmark|Acute Combined Care for Seniors in Southern Denmark|Completed||N/A|131|Actual|University of Southern Denmark||2|||f||||f||||||||No||2017-10-10 23:22:47.228412|2017-10-10 23:22:47.228412
NCT02422836|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-16|||February 2013||2013-02-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Tolerability and Efficacy of Anti-Aging Treatment Regimen in Subjects With Photodamage|The Tolerability and Efficacy of a Three Product Anti-Aging Treatment Regimen in Subjects With Moderate to Severe Photodamage|Completed||N/A|25|Actual|US CosmeceuTechs, LLC||1|||f||||f||||||||||2017-10-10 23:22:47.30749|2017-10-10 23:22:47.30749
NCT02422810|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-06-15|||May 2015||2015-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||High-Shear Microfluidic Thrombosis Assay|Characterization of a Novel High-Shear Thrombosis Assay in Normal and Aspirin-treated Patients|Enrolling by invitation||N/A|45|Anticipated|Emory University|||3||f||||f||||||||||2017-10-10 23:22:47.505544|2017-10-10 23:22:47.505544
NCT02422784|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-02-22|||July 2016||2016-07-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|VITD-2013||Effects of Vitamin D Fortification on Vitamin D Metabolite Profiles and Status in Vitamin D Insufficient Individuals|A Double-Blind, Randomized, Control Study to Examine the Effects of Vitamin D Fortification on Vitamin D Metabolite Profiles and Status in Vitamin D Insufficient Individuals.|Withdrawn||Phase 1|0|Actual|University of Manitoba||3|||f||||f||||||||||2017-10-10 23:22:47.834293|2017-10-10 23:22:47.834293
NCT02422771|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-10-24|||October 2015||2015-10-01|December 2015|2015-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of the FIFA 11+ Injury Prevention Program on Performance & Movement Control in Young Female Athletes|Effect of the Fédération Internationale de Football Association (FIFA) 11+ Injury Prevention Program on Performance & Movement Control in Young Female Athletes|Completed||N/A|47|Actual|University of Manitoba||2|||f||||f||||||||No||2017-10-10 23:22:47.933242|2017-10-10 23:22:47.933242
NCT02422758|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-02-04|||May 2015||2015-05-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||Prewarming Effect in Preventing Perioperative Hypothermia|Prewarming Effect in Preventing Perioperative Hypothermia|Active, not recruiting||Phase 3|86|Anticipated|Universidade Estadual de Londrina||2|||f||||t||||||||||2017-10-10 23:22:48.017829|2017-10-10 23:22:48.017829
NCT02422745|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-17|2017-07-12|||June 2015||2015-06-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|March 2020|Anticipated|2020-03-01||Interventional|COSMOS||COcoa Supplement and Multivitamin Outcomes Study|COcoa Supplement and Multivitamin Outcomes Study|Recruiting||Phase 4|18000|Anticipated|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-10 23:22:48.110511|2017-10-10 23:22:48.110511
NCT02422732|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-08-18|||March 2009||2009-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Functional Imaging and Reading Deficit in Children With NF1|Functional Magnetic Resonance Imaging and Reading Deficit in Children With NF1 Children|Completed||N/A|25|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:22:48.209529|2017-10-10 23:22:48.209529
NCT02422719|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2016-05-10|||April 2015||2015-04-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|REVITAL||Radotinib as 3rd or Later Line Therapy in CP-CML|Radotinib Efficacy and Safety Validation in Chronic Phase Chronic Myeloid Leukemia Patients Who Are Intolerant or Resistant to at Least Two Tyrosine Kinase Inhibitors As a Third or Subsequent Line Therapy|Recruiting||Phase 2|73|Anticipated|Ulsan University Hospital||1|||f||||f||||||||||2017-10-10 23:22:48.302918|2017-10-10 23:22:48.302918
NCT02422706|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-04-23|||January 2015||2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori|Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori|Recruiting||Phase 3|120|Anticipated|Tanta University||3|||f||||t||||||||Undecided||2017-10-10 23:22:48.399238|2017-10-10 23:22:48.399238
NCT02422693|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-07-05|||June 29, 2015|Actual|2015-06-29|July 2017|2017-07-01|May 10, 2017|Actual|2017-05-10|January 29, 2017|Actual|2017-01-29||Interventional|||Aquatic Exercises for Patients With Chronic Low Back Pain|Aquatic Exercises Versus Aquatic Exercises Associated to Deep Water-running for Patients With Chronic Low Back Pain: Randomized Controlled Trial|Completed||N/A|120|Actual|Universidade Estadual de Londrina||2|||f||||t|f|f||||||||2017-10-10 23:22:48.513775|2017-10-10 23:22:48.513775
NCT02422680|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-04-16|||April 2015||2015-04-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|June 2015|Anticipated|2015-06-01|1 Day|Observational [Patient Registry]|||Colonoscopy Quality Assurance With Focus on Key Quality Indicators and Patient Satisfaction at Aalborg University Hospital|Colonoscopy Quality Assurance With Focus on Key Quality Indicators and Patient Satisfaction at Aalborg University Hospital|Unknown status|Recruiting|N/A|500|Anticipated|Aalborg Universitetshospital|||1||f||||t||||||||||2017-10-10 23:22:48.608818|2017-10-10 23:22:48.608818
NCT02422667|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-05-02|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|April 2025|Anticipated|2025-04-01|April 2020|Anticipated|2020-04-01|10 Years|Observational [Patient Registry]|iCORE||iCORE: Collaborative Orthopedics Outcomes Registry|iCORE: Collaborative Orthopedics Outcomes Registry|Recruiting||N/A|10000|Anticipated|SCRI Development Innovations, LLC|||1||f||||f||||||||||2017-10-10 23:22:48.706146|2017-10-10 23:22:48.706146
NCT02422654|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-05-26|||April 2015||2015-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Taste Evaluation of Different Liquid Formulations With Eliglustat|A Single-blind, Randomized, Unbalanced Crossover Design With 5 Vehicles, 5 Periods, and 5 Sequences, Repeated-doses (With no Ingestion) Study to Assess the Palatability of Eliglustat Prototype Liquid Formulations in Healthy Subjects|Completed||Phase 1|8|Actual|Sanofi||15|||f||||f||||||||||2017-10-10 23:22:48.79231|2017-10-10 23:22:48.79231
NCT02422459|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-09-13|||September 2013||2013-09-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|COMMENCE||Chronic Pain Self-management Support With Pain Education and Exercise|Chronic Pain Self-Management Support With Pain Education and Exercise (COMMENCE): A Randomized Controlled Trial|Completed||N/A|102|Actual|McMaster University||2|||f||||f||||||||||2017-10-10 23:22:50.827497|2017-10-10 23:22:50.827497
NCT02422628|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2016-12-12|||April 2015||2015-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC|Correlation Between Epithelial Growth Factor Receptor(EGFR) Mutation Using cfDNA and CTCs in Patients With Non-Small Cell Lung Cancer|Enrolling by invitation||N/A|400|Anticipated|National Taiwan University Hospital|||3||f||||f||||||Samples With DNA|"     Blood samples every 3 months till disease progression or intolerable due to side effect.   "|||2017-10-10 23:22:49.004397|2017-10-10 23:22:49.004397
NCT02422602|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-08-31|||November 2013||2013-11-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|May 2015|Actual|2015-05-01||Interventional|MONACO||Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program||Unknown status|Active, not recruiting|N/A|196|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:22:49.525526|2017-10-10 23:22:49.525526
NCT02422589|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-05-25|||October 23, 2015|Actual|2015-10-23|May 2017|2017-05-01|September 22, 2017|Anticipated|2017-09-22|September 22, 2017|Anticipated|2017-09-22||Interventional|||A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors|A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam Administered as a Two-drug Cocktail in Patients With ALK-positive Advanced Tumors Including Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|35|Anticipated|Novartis||1|||f||||f|t|f||||||No||2017-10-10 23:22:49.602355|2017-10-10 23:22:49.602355
NCT02422576|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-12-05|||March 2015||2015-03-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy of Natural Ingredient to Improve the Swallowing Response of Patients With Oropharyngeal Dysphagia|Efficacy of Natural Ingredient to Improve the Swallowing Response of Patients With Oropharyngeal Dysphagia|Recruiting||N/A|84|Anticipated|Nestlé||3|||f||||f||||||||||2017-10-10 23:22:49.710314|2017-10-10 23:22:49.710314
NCT02422563|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-04-20|||October 2015||2015-10-01|April 2015|2015-04-01|October 2025|Anticipated|2025-10-01|October 2020|Anticipated|2020-10-01||Interventional|NACOPRAD||NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB|Multicenter Prospective Randomized Study on NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Patients With Cervical Cancer FIGO Stage IB2 and IIB|Not yet recruiting||Phase 3|534|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 23:22:49.791719|2017-10-10 23:22:49.791719
NCT02422550|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-03-02|||April 9, 2015|Actual|2015-04-09|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment|Development and Evaluation of Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment|Recruiting||N/A|116|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:22:49.876687|2017-10-10 23:22:49.876687
NCT02422537|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-01-30|||February 2015||2015-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Different Bran-based Dietary Platforms on the Colon Metabolism in Healthy Volunteers|The Effect of One Single Dose of Different Bran-based Dietary Platforms on the Colon Metabolism - A Study With (Stable) Isotopes in Healthy Volunteers|Completed||N/A|10|Actual|Katholieke Universiteit Leuven||4|||f||||f||||||||||2017-10-10 23:22:49.949895|2017-10-10 23:22:49.949895
NCT02422524|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-10-22|||September 2015||2015-09-01|October 2015|2015-10-01||||October 2016|Anticipated|2016-10-01||Interventional|||Pharmacokinetics and Safety of PA-824 in Subjects With Mild, Moderate, and Severe Hepatic Impairment to Matched, Non-Hepatically Impaired Subjects|A Phase I, Single Dose, Open-Label, Sequential Group Study Comparing the Pharmacokinetics and Safety of PA-824 in Subjects With Mild, Moderate, and Severe Hepatic Impairment to Matched, Non-Hepatically Impaired Subjects|Suspended||Phase 1|36|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-10 23:22:50.148788|2017-10-10 23:22:50.148788
NCT02422511|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-01-31|||May 2015||2015-05-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Genomic Sequencing for Childhood Risk and Newborn Illness|Genomic Sequencing for Childhood Risk and Newborn Illness (The BabySeq Project)|Recruiting||N/A|1440|Anticipated|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-10 23:22:50.250942|2017-10-10 23:22:50.250942
NCT02422485|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-07-27|||April 2015||2015-04-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy|A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy|Recruiting||Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||f|t|f||||||||2017-10-10 23:22:50.576866|2017-10-10 23:22:50.576866
NCT02422472|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-02-01|||June 2015||2015-06-01|February 2017|2017-02-01||||June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Ultrasound Guided Peripheral IV Placement With and Without Use of a Guidewire|Comparison of Ultrasound Guided Peripheral IV Placement With and Without Use of a Guidewire|Recruiting||N/A|70|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 23:22:50.743196|2017-10-10 23:22:50.743196
NCT02422446|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-04-12|||April 2015||2015-04-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects|Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects: A Pilot Trial|Terminated||Phase 3|9|Actual|Brigham and Women's Hospital||2||Difficulty enrolling patients with elevated triglycerides under statin treatment|f||||f||||||||||2017-10-10 23:22:50.929453|2017-10-10 23:22:50.929453
NCT02422433|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-10-27|||June 2014||2014-06-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Capsule Marking Using an OFDI Capsule|OFDI Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule|Recruiting||N/A|130|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 23:22:51.023164|2017-10-10 23:22:51.023164
NCT02422420|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-10-14|||March 2013||2013-03-01|March 2016|2016-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MMIPCD||Minnesota Medicaid Incentives to Prevent Chronic Disease|Minnesota Medicaid Incentives to Prevent Chronic Disease|Completed||N/A|1500|Anticipated|Minnesota Department of Human Services||3|||f||||f||||||||||2017-10-10 23:22:51.111706|2017-10-10 23:22:51.111706
NCT02422407|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-08-03|||March 26, 2015|Actual|2015-03-26|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Observational|||Sjögren's Biomarker Study|A Biomarker Study to Determine the Gene Expression Signatures of Salivary Gland and Blood in Subjects With Incident Primary Sjögren's Syndrome, Subjects With Sicca, and Healthy Volunteers|Active, not recruiting||N/A|100|Actual|Biogen|||4||f||||f||||||Samples With DNA|"     A lip biopsy is taken to determine Sjogrens diagnosis.   "|||2017-10-10 23:22:51.211782|2017-10-10 23:22:51.211782
NCT02422394|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-08-16|||April 2015||2015-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Eltrombopag for Inherited Thrombocytopenias|Eltrombopag for Inherited Thrombocytopenias|Active, not recruiting||Phase 2|24|Actual|IRCCS Policlinico S. Matteo||1|||f||||f||||||||||2017-10-10 23:22:51.326358|2017-10-10 23:22:51.326358
NCT02422381|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-09-18|||April 16, 2015||2015-04-16|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)|A Phase I/II Study of MK-3475 With Gemcitabine in Patients With Previously-Treated Advanced Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|46|Anticipated|Providence Health & Services||1|||f||||f||||||||||2017-10-10 23:22:51.426589|2017-10-10 23:22:51.426589
NCT02422368|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2017-03-11|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease|The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease, a Double Blind Placebo Controlled Randomized Clinical Trial|Not yet recruiting||Phase 2/Phase 3|110|Anticipated|Iran University of Medical Sciences||2|||f||||f|f|f||||||||2017-10-10 23:22:51.574217|2017-10-10 23:22:51.574217
NCT02422355|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-09-29|||September 30, 2017|Actual|2017-09-30|October 2016|2016-10-01|March 31, 2021|Anticipated|2021-03-31|December 31, 2018|Anticipated|2018-12-31|12 Months|Observational [Patient Registry]|FR_FNS||A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures|A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures|Recruiting||N/A|112|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f|f|f||||||||2017-10-10 23:22:51.716222|2017-10-10 23:22:51.716222
NCT02422342|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-08-18|||April 2015||2015-04-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Comparison Study of Non-invasive Measurement of Blood Pressure and Cardiac Output During Stress Echocardiography|Comparison Study of Non-invasive Measurement of Blood Pressure and Cardiac Output During Stress Echocardiography|Unknown status|Recruiting|N/A|50|Anticipated|HeartBeat Technologies LTD|||1||f||||f||||||||||2017-10-10 23:22:51.84908|2017-10-10 23:22:51.84908
NCT02422329|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-09-12|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention|Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention|Active, not recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:22:51.925907|2017-10-10 23:22:51.925907
NCT02422316|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-02-16|||September 2014||2014-09-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Non-contrast Cardiac CT as a Risk Stratification Tool in Patients With Non-cardiac Chest Pain||Completed||N/A|248|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-10 23:22:52.036019|2017-10-10 23:22:52.036019
NCT02422303|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-09-20|||December 2015||2015-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms|Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms|Terminated||N/A|12|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||No||2017-10-10 23:22:52.105091|2017-10-10 23:22:52.105091
NCT02422290|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-09-25|||March 2015||2015-03-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)|Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)|Recruiting||Phase 1/Phase 2|10|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-10 23:22:52.206536|2017-10-10 23:22:52.206536
NCT02422277|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-05-04|||March 2015||2015-03-01|May 2015|2015-05-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy|Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy|Unknown status|Recruiting|Phase 2|60|Anticipated|Mansoura University||3|||f||||t||||||||||2017-10-10 23:22:52.342697|2017-10-10 23:22:52.342697
NCT02422251|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-08-02|||August 2015||2015-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Biomechanical Assessment of a High Congruency Knee Bearing|Clinical Investigation of the Functional Outcomes of High Congruency Versus Low Congruency Knee Bearings|Recruiting||N/A|120|Anticipated|Golden Jubilee National Hospital||4|||f||||f||||||||||2017-10-10 23:22:52.632544|2017-10-10 23:22:52.632544
NCT02422238|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-09-12|||June 2015||2015-06-01|September 2016|2016-09-01|December 2027|Anticipated|2027-12-01|December 2017|Anticipated|2017-12-01||Observational|NAFLD-cohort||Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease|Disease Mechanisms and Markers for Non-alcoholic Steatohepatitis in a Population With Non-alcoholic Fatty Liver Disease: a Prospective Cohort Study With Biobank|Recruiting||N/A|500|Anticipated|Maastricht University Medical Center|||1||f||||f||||||Samples With DNA|"     Blood, urine, faeces and exhaled air will be collected. The buffy coat of blood collected in     an EDTA-tube to obtain plasma, will be stored for isolation of DNA.   "|||2017-10-10 23:22:52.729927|2017-10-10 23:22:52.729927
NCT02422225|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-07-20|||April 2015||2015-04-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study of tDCS for Swallowing Difficulties in Stroke Patients|Improvement of Swallowing Function of Stroke Patients by Dual Transcranial Direct Current Stimulation(tDCS)|Unknown status|Recruiting|N/A|120|Anticipated|Pusan National University||2|||f||||f||||||||||2017-10-10 23:22:52.798182|2017-10-10 23:22:52.798182
NCT02422212|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-22|||January 2014||2014-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|RYGBP||Diet-induced Thermogenesis in Patients With Postoperative Roux-in-Y Gastric Bypass (RYGBP) Weight Regain|Diet-induced Thermogenesis in Patients With Postoperative RYGBP Weight Regain|Completed||N/A|45|Actual|Gastrocirurgia, Brazil||3|||f||||f||||||||||2017-10-10 23:22:52.878406|2017-10-10 23:22:52.878406
NCT02422199|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-07-07|||May 2015||2015-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|||A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab|A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab|Active, not recruiting||Phase 1/Phase 2|128|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:22:52.956471|2017-10-10 23:22:52.956471
NCT02422186|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-09-26|||August 25, 2015|Actual|2015-08-25|September 2017|2017-09-01|August 10, 2017|Actual|2017-08-10|August 10, 2017|Actual|2017-08-10||Interventional|TRANSFORM-3||A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression|A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Subjects With Treatment-resistant Depression|Completed||Phase 3|139|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 23:22:53.094193|2017-10-10 23:22:53.094193
NCT02422173|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-04-16|||January 2015||2015-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Transcranial Direct Current Stimulation on the Risk of Falls and Lower Limb Function for Acute Stroke|Effects of Different Montages of Transcranial Direct Current Stimulation on the Risk of Falls and Lower Limb Function for Acute Stroke Patients: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|60|Actual|Federal University of Paraíba||4|||f||||f||||||||||2017-10-10 23:22:53.279705|2017-10-10 23:22:53.279705
NCT02422160|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-10-12|||April 2015||2015-04-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Observational|||Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration|Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-10 23:22:53.357073|2017-10-10 23:22:53.357073
NCT02422147|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-08-02|||May 2016||2016-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01|12 Months|Observational [Patient Registry]|||EUS-guided Ablation of Pancreatic Cyst Neoplasms|Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cyst Neoplasms|Recruiting||N/A|1000|Anticipated|Florida Hospital|||1||f||||f||||||||||2017-10-10 23:22:53.419841|2017-10-10 23:22:53.419841
NCT02422134|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-06-28|||June 2014||2014-06-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Novel Approach for Embryo Transfer Medium by Adding Cytokine to Hyaluronan Enriched Embryo Transfer Medium (Embryo Glue)||Completed||N/A|400|Actual|Ibn Sina Hospital||2|||f||||f||||||||||2017-10-10 23:22:53.489955|2017-10-10 23:22:53.489955
NCT02422121|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-12-07|||April 2015||2015-04-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge|A Phase IIa Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Multiple Doses of Inhaled RNS60 and Budesonide on the Late Phase Asthmatic Response to Allergen Challenge in Patients With Mild Asthma. (This Study Has Been Amended to no Longer be a Cross Over Study; it Will be a Parallel (RNS60/Placebo) 1 Period Study and no Longer Involves the Administration of Budesonide)|Completed||Phase 2|30|Actual|Revalesio Corporation||2|||f||||f||||||||||2017-10-10 23:22:53.557923|2017-10-10 23:22:53.557923
NCT02422108|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-01-20|||May 2015||2015-05-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|February 2016|Actual|2016-02-01||Interventional|||TNFSF11 Inhibition and Fertility: a Prospective Study|Denosumab and Male Infertility: a Prospective Intervention Study|Active, not recruiting||Phase 2|15|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-10 23:22:55.473915|2017-10-10 23:22:55.473915
NCT02422095|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-08-02|||February 2015||2015-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01|36 Months|Observational [Patient Registry]|||Registry for Endoscopic Ultrasound (EUS) Evaluation of Pancreatic Cysts|Registry for Endoscopic Ultrasound (EUS) Evaluation of Pancreatic Cysts|Recruiting||N/A|1000|Anticipated|Florida Hospital|||1||f||||f||||||||||2017-10-10 23:22:55.598216|2017-10-10 23:22:55.598216
NCT02422082|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-08-18|||April 2015||2015-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of Lactobacillus Reuteri ATCC PTA 6475 on Volumetric Bone Mineral Density in Patients With Osteopenia|The Effect of Lactobacillus Reuteri ATCC PTA 6475 on Volumetric Bone Mineral Density in Patients With Osteopenia|Active, not recruiting||N/A|90|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||t|f|f||||||||2017-10-10 23:22:55.681299|2017-10-10 23:22:55.681299
NCT02422069|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-11-01|||April 2010||2010-04-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan|Registry on Post Menopausal Osteoporosis in Gynecology Setting in Pakistan (REPOSE)|Completed||N/A|624|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:22:55.800349|2017-10-10 23:22:55.800349
NCT02422056|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-20|||December 2013||2013-12-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Acid Tranexamic Effectiveness in Reducing the Intraoperative Bleeding in Palatoplasty|Acid Tranexamic Effectiveness in Reducing the Intraoperative Bleeding in Palatoplasty : Randomized Study|Completed||Phase 4|66|Actual|Professor Fernando Figueira Integral Medicine Institute||2|||f||||f||||||||||2017-10-10 23:22:55.874402|2017-10-10 23:22:55.874402
NCT02422043|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-10-22|||January 2015||2015-01-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Description of Socio-cognitive and Clinic Changes for Type 1 Diabetes Adolescents Cohort With Therapeutic Patient Education Program|Description of Socio-cognitive and Clinic Changes for Type 1 Diabetes Adolescents Cohort With Therapeutic Patient Education Program|Recruiting||N/A|80|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:22:55.958071|2017-10-10 23:22:55.958071
NCT02422030|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-08-07|||March 17, 2015|Actual|2015-03-17|March 2015|2015-03-01|April 30, 2015|Actual|2015-04-30|March 22, 2015|Actual|2015-03-22||Interventional|||CKD-337(2) Drug-drug Interaction Study|A Randomized, Open-label, Multiple Dosing, 3-way Crossover Study to Evaluate the Drug-drug Interaction Between Atorvastatin and Fenofibric Acid in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Chong Kun Dang Pharmaceutical||6|||f||||f||||||||||2017-10-10 23:22:56.04815|2017-10-10 23:22:56.04815
NCT02422017|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-11-29|||April 2015||2015-04-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|May 2016|Actual|2016-05-01||Interventional|EETUV||Topical Timolol Benefit in Venous Ulcers|Topical Timolol Benefit in Venous Ulcers|Recruiting||Phase 2|48|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 23:22:56.142535|2017-10-10 23:22:56.142535
NCT02422004|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-20|||August 2012||2012-08-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Healing of Human Achilles Tendon Rupture|Healing of Human Achilles Tendon Rupture: Loading Pattern After Surgical Repair to Achieve Optimal Mechanical Properties and Clinical Outcome|Unknown status|Recruiting|N/A|75|Anticipated|Bispebjerg Hospital||3|||f||||t||||||||||2017-10-10 23:22:56.24|2017-10-10 23:22:56.24
NCT02421991|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-12-05|||November 2015||2015-11-01|December 2016|2016-12-01|November 2019|Anticipated|2019-11-01|January 2019|Anticipated|2019-01-01||Interventional|TALK||Telephone-Delivered Interventions for Smoking Cessation|Telephone-Delivered Interventions for Smoking Cessation|Enrolling by invitation||N/A|1168|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-10 23:22:56.457352|2017-10-10 23:22:56.457352
NCT02421978|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-10-10|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Inflammation-Induced CNS Glutamate During Breast Cancer Treatment|Inflammation-Induced CNS Glutamate During Breast Cancer Treatment|Recruiting||N/A|90|Anticipated|Emory University|||3||f||||f||||||Samples With DNA|"     Cytokine Multiplex, CRP, TRP, KYN, mRNA analysis, methylation analysis, and gene analysis   "|||2017-10-10 23:22:56.527853|2017-10-10 23:22:56.527853
NCT02421965|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-05-23|||June 2015||2015-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness|Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness: Patient Engagement, Satisfaction, and Outcomes|Active, not recruiting||N/A|174|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 23:22:56.64206|2017-10-10 23:22:56.64206
NCT02421952|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-07-29|||April 2013||2013-04-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|BARF||Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children|Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children|Recruiting||N/A|336|Anticipated|Baylor College of Medicine|||2||f||||f||||||||No||2017-10-10 23:22:56.735446|2017-10-10 23:22:56.735446
NCT02421939|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2017-08-23|||October 20, 2015|Actual|2015-10-20|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation|A Phase 3 Open-Label, Multicenter, Randomized Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FLT3 Mutation|Recruiting||Phase 3|369|Anticipated|Astellas Pharma Inc||2|||t||||t||||||||||2017-10-10 23:22:56.845176|2017-10-10 23:22:56.845176
NCT02421926|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2016-07-12|||October 2014||2014-10-01|July 2016|2016-07-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Observational|IDEAL-E||Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)|Extension Study of a Study to Evaluate Efficacy and Safety of Imatinib (Glinib®) 600mg/Day Depending on Early Molecular Response in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase|Withdrawn||N/A|0|Actual|Asan Medical Center|||1||f||||f||||||||||2017-10-10 23:22:57.281075|2017-10-10 23:22:57.281075
NCT02421913|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-16|2015-04-21|||June 2012||2012-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Interventional|||Efficacy of S(+)-Ketamine Administered as a Continuous Infusion for the Control of Postoperative Pain|Efficacy of S(+)-Ketamine Administered as a Continuous Infusion for the Control of Postoperative Pain: a Randomized Controlled Trial|Completed||Phase 4|42|Actual|Centro Medico Campinas||2|||f||||t||||||||||2017-10-10 23:22:57.400857|2017-10-10 23:22:57.400857
NCT02421900|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-10-30|||April 2015||2015-04-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Analysis of the Role of T-cell Response in Patients With Atrial Fibrillation for Clinical Application||Recruiting||N/A|100|Anticipated|Yonsei University|||1||f||||f||||||Samples Without DNA|"     40cc blood sampling   "|||2017-10-10 23:22:57.474521|2017-10-10 23:22:57.474521
NCT02421887|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-28|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MOXI||Males, Antioxidants, and Infertility Trial|Males, Antioxidants, and Infertility (MOXI) Trial|Active, not recruiting||Phase 2|190|Anticipated|Yale University||2|||f||||t||||||||||2017-10-10 23:22:57.545225|2017-10-10 23:22:57.545225
NCT02421874|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Development and Testing of an Electronic Behavioral Health Record Specific to the Wraparound Care Coordination Process|Development, Usability Testing, and Effectiveness Evaluation of Wraparound Team Monitoring System|Active, not recruiting||Phase 1/Phase 2|160|Actual|University of Washington||2|||f||||t||||||||Undecided||2017-10-10 23:22:57.769113|2017-10-10 23:22:57.769113
NCT02421861|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-10-28|||April 2015||2015-04-01|October 2016|2016-10-01||||February 2016|Actual|2016-02-01||Interventional|CALM||Critical Care Anxiety and Long-Term Outcomes Management||Terminated||Phase 2|10|Actual|University of Washington||2|||f||||||||||||||2017-10-10 23:22:57.852818|2017-10-10 23:22:57.852818
NCT02421835|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-05-27|||April 2013||2013-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Interventional|||Olive Leaf Extract as Part of a Healthy Lifestyle in the Reduction of Blood Pressure|Olive Leaf Extract as Part of a Healthy Lifestyle in the Reduction of Blood Pressure|Completed||N/A|120|Actual|University of Reading||4|||f||||t||||||||||2017-10-10 23:22:57.997897|2017-10-10 23:22:57.997897
NCT02421822|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-20|||April 2015||2015-04-01|April 2015|2015-04-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||BMI Study for Children Ages 6-9 Years and Parents|BMI Study for Children Ages 6-9 Years and Parents|Not yet recruiting||N/A|925|Anticipated|UPMC St. Margaret Family Health Centers||1|||f||||t||||||||||2017-10-10 23:22:58.088668|2017-10-10 23:22:58.088668
NCT02421809|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|October 2016|Actual|2016-10-01||Observational|||Oral Lesions In Non-Celiac Wheat Sensitivity Patients|Oral Lesions In Non-Celiac Wheat Sensitivity Patients|Recruiting||N/A|270|Anticipated|University of Palermo|||3||f||||f||||||Samples Without DNA|"     Biopsy specimens will be obtained from the bulb and the second duodenal portion.   "|||2017-10-10 23:22:58.175043|2017-10-10 23:22:58.175043
NCT02421796|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|October 2016|Actual|2016-10-01||Observational|||Malnutrition In Non-Celiac Wheat Sensitivity Patients|Malnutrition In Non-Celiac Wheat Sensitivity Patients|Recruiting||N/A|270|Anticipated|University of Palermo|||3||f||||f||||||Samples Without DNA|"     Biopsy specimens will be obtained from the bulb and the second duodenal portion   "|||2017-10-10 23:22:58.274473|2017-10-10 23:22:58.274473
NCT02421783|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|October 2016|Actual|2016-10-01||Observational|||Osteoporosis In Non-Celiac Wheat Sensitivity Patients|Osteoporosis In Non-Celiac Wheat Sensitivity Patients|Recruiting||N/A|270|Anticipated|University of Palermo|||3||f||||f||||||Samples Without DNA|"     Biopsy specimens will be obtained from the bulb and the second duodenal portion   "|||2017-10-10 23:22:58.372721|2017-10-10 23:22:58.372721
NCT02421770|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-11-30|||January 2014||2014-01-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Interventional|lichenPlanus||Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus|Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treatment Oral LichenPlanus|Completed||Phase 3|30|Anticipated|Universidad de Murcia||2|||f||||t||||||||||2017-10-10 23:22:58.485728|2017-10-10 23:22:58.485728
NCT02421757|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-09-26|||August 22, 2016|Actual|2016-08-22|September 2017|2017-09-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)|Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)|Completed||N/A|20|Actual|University of Maryland||2|||f||||f||||||||||2017-10-10 23:22:58.581262|2017-10-10 23:22:58.581262
NCT02421744|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-06-27|||March 2015||2015-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||A Task-oriented Circuit Training in Multiple Sclerosis|A Task-oriented Circuit Training in Multiple Sclerosis: a Multicentric Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-10 23:22:58.667109|2017-10-10 23:22:58.667109
NCT02421731|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-02-02|||February 2014||2014-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Robot-assisted Gait Training on Mobility in Severely Disabled Multiple Sclerosis Patients|Effectiveness of Robot-assisted Gait Training Versus Conventional Therapy on Mobility in Severely Disabled Multiple Sclerosis Patients|Recruiting||N/A|98|Anticipated|University Hospital of Ferrara||2|||f||||f||||||||||2017-10-10 23:22:58.778746|2017-10-10 23:22:58.778746
NCT02421718|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-10-03|||March 2013||2013-03-01|October 2016|2016-10-01|January 2028|Anticipated|2028-01-01|January 2025|Anticipated|2025-01-01|5 Years|Observational [Patient Registry]|||Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation|Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation|Recruiting||N/A|10000|Anticipated|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:22:58.90842|2017-10-10 23:22:58.90842
NCT02421705|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-02-07|||February 2010||2010-02-01|February 2017|2017-02-01|January 2099|Anticipated|2099-01-01|January 2099|Anticipated|2099-01-01||Interventional|||Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)|Visceral Sensitivity in IBD and IBS: Role of Inflammation, Immune Activity and Genetic Factors|Recruiting||N/A|99999999|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-10 23:22:59.019731|2017-10-10 23:22:59.019731
NCT02421692|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-11-11|||April 2015||2015-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SNF||Improving Physical Function in Skilled Nursing Facility Residents|Improving Physical Function in Skilled Nursing Facility Residents|Terminated||N/A|153|Actual|University of Colorado, Denver||2|||f||||||||||||||2017-10-10 23:22:59.113537|2017-10-10 23:22:59.113537
NCT02421679|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-03-24|||April 2015||2015-04-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|P202||Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions|A 12-Week, Open-Label, Multicenter, Extension Study To TNX-CY-P201 To Evaluate The Safety And Efficacy Of TNX-102 SL Taken Daily At Bedtime In Patients With Military-Related PTSD And Related Conditions|Active, not recruiting||Phase 2|200|Anticipated|Tonix Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:22:59.188441|2017-10-10 23:22:59.188441
NCT02421666|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-01-10|||September 2014||2014-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV|A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV|Active, not recruiting||N/A|500|Actual|Temple University||2|||f||||t||||||||Undecided||2017-10-10 23:22:59.29017|2017-10-10 23:22:59.29017
NCT02421653|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-01-27|||December 2015||2015-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||RCT of Iodine-containing MNPs vs Oral Iodized Oil to Prevent Iodine Deficiency in Weaning Infants|A Randomised Controlled Trial of Iodine-containing Micronutrient Powders Versus Oral Iodised Oil to Prevent Iodine Deficiency in Weaning Infants|Withdrawn||N/A|0|Actual|Swiss Federal Institute of Technology||4|||f||||t||||||||||2017-10-10 23:22:59.34879|2017-10-10 23:22:59.34879
NCT02421640|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2016-10-17|||March 2015||2015-03-01|September 2016|2016-09-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Interventional|TIL||Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC|A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes and Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma|Recruiting||Phase 2|116|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided|decided by the results|2017-10-10 23:22:59.434358|2017-10-10 23:22:59.434358
NCT02421627|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-09-11|||April 2015||2015-04-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Moxibustion for Diarrhea-predominant Irritable Bowel Syndrome|Study on the Mechanism of Moxibustion Effect on Treating Diarrhea-predominant Irritable Bowel Syndrome|Recruiting||Early Phase 1|104|Anticipated|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-10 23:22:59.524579|2017-10-10 23:22:59.524579
NCT02421614|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-03-21|||August 2013||2013-08-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Enteral Feeding Composition and Acute Respiratory Failure|Effect of Enteral Feeding's Macronutrient Composition on Inflammatory Mediators, Oxidative Stress and Outcomes in Intensive Care Unit Patients With Acute Respiratory Failure|Completed||Phase 2/Phase 3|48|Actual|Shahid Beheshti University||3|||f||||f||||||||||2017-10-10 23:22:59.614601|2017-10-10 23:22:59.614601
NCT02421601|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-09-11|||March 2015||2015-03-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Study of SI-6603 in Patients With Lumbar Disc Herniation|A Multicenter, Open-label Study of SI 6603 in Patients With Lumbar Disc Herniation (Phase III)|Active, not recruiting||Phase 3|1000|Anticipated|Seikagaku Corporation||1|||f||||||||||||||2017-10-10 23:22:59.687721|2017-10-10 23:22:59.687721
NCT02421588|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-01-03|||May 2015||2015-05-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|CORAIL||Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients|Phase III Randomized Clinical Trial of Lurbinectedin (PM01183) Versus Pegylated Liposomal Doxorubicin or Topotecan in Patients With Platinum-resistant Ovarian Cancer (CORAIL Trial)|Active, not recruiting||Phase 3|443|Anticipated|PharmaMar||2|||f||||||||||||||2017-10-10 23:22:59.965026|2017-10-10 23:22:59.965026
NCT02421575|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-02-01|||July 2012||2012-07-01|February 2017|2017-02-01|February 26, 2016|Actual|2016-02-26|February 26, 2016|Actual|2016-02-26||Interventional|||Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance|Assessment of the Biological Effect of Autophagic Inhibition With Hydroxychloroquine in Prostate Cancer|Terminated||Early Phase 1|4|Actual|Rutgers, The State University of New Jersey||3||slow accrual|f||||f||||||||||2017-10-10 23:23:00.131963|2017-10-10 23:23:00.131963
NCT02421562|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2015-04-15|||February 2015||2015-02-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|HYPNO-DIS||Training Nurses in Basic Hypnoanalgesia Techniques|Training Nurses in Basic Hypnoanalgesia Techniques to Reduce Procedural Distress and Pain in Children: a Pilot Study|Unknown status|Recruiting|N/A|36|Anticipated|St. Justine's Hospital||1|||f||||f||||||||||2017-10-10 23:23:00.24791|2017-10-10 23:23:00.24791
NCT02421549|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-02-20|||December 2014||2014-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|REM RED||Remote Interrogation in Rural Emergency Departments|Remote Interrogation of Implantable Cardiac Devices in Rural Emergency Departments|Withdrawn||Phase 4|0|Actual|St. Jude Medical||2|||f||||f||||||||||2017-10-10 23:23:00.34261|2017-10-10 23:23:00.34261
NCT02421536|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-10-05|||March 2016||2016-03-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Vibrent Smartphone Mobile Application|A Feasibility Study of the VibrentTM Smartphone App for Head & Neck Cancer Patients: Supporting Pain Management of Radiation-Induced Mucositis|Recruiting||N/A|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 23:23:01.047025|2017-10-10 23:23:01.047025
NCT02421523|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-08-07|||May 30, 2015|Actual|2015-05-30|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Strength Training in Duchenne Muscular Dystrophy|Development of a Strength Training Protocol in Duchenne Muscular Dystrophy|Recruiting||N/A|32|Anticipated|University of Florida||3|||f||||t|f|f||||||||2017-10-10 23:23:01.129897|2017-10-10 23:23:01.129897
NCT02421510|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-02-07|||May 2015||2015-05-01|February 2017|2017-02-01||||November 2016|Actual|2016-11-01||Interventional|inTandem2||Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy|A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of LX4211 as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy|Active, not recruiting||Phase 3|782|Actual|Lexicon Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:23:01.241253|2017-10-10 23:23:01.241253
NCT02421497|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-06-20|||April 2015||2015-04-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Observational|||MRI Technical Development and Applications in Kidney Disease|MRI Technical Development and Applications in Kidney Disease|Active, not recruiting||N/A|180|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||5||f||||f||||||||Undecided||2017-10-10 23:23:01.481551|2017-10-10 23:23:01.481551
NCT02421484|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2017-07-17|||May 2015||2015-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|CISS||Cellular Immunotherapy for Septic Shock: A Phase I Trial|Cellular Immunotherapy for Septic Shock: A Phase I Trial|Active, not recruiting||Phase 1|9|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-10 23:23:01.572002|2017-10-10 23:23:01.572002
NCT02421458|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-09-26|||November 2015||2015-11-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2019|Anticipated|2019-11-01||Interventional|COOPERATION||Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer|Dutch Randomized Multicenter Trial COmparing twO PalliativE RAdiaTION Schemes for Incurable Head and Neck Cancer (COOPERATION)|Recruiting||N/A|300|Anticipated|The Netherlands Cancer Institute||2|||f||||f|f|f||||||||2017-10-10 23:23:01.760379|2017-10-10 23:23:01.760379
NCT02421445|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-11-28|||April 2015||2015-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Analyses of Human Milk From Mother Delivering Small for Gestational Age (SGA) and Appropriate for Gestational Age (AGA) Infants|An Observational Study to Characterize Human Milk From Mothers Delivering Term SGA and AGA Infants.|Recruiting||N/A|300|Anticipated|Nestlé|||1||f||||f||||||||||2017-10-10 23:23:01.91597|2017-10-10 23:23:01.91597
NCT02421432|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2015-11-25|||April 2015||2015-04-01|November 2015|2015-11-01|April 2020|Anticipated|2020-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Evaluation of the Safety and the Efficacy of Transanal TME in Difficult Cases|A Pilot Study for the Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision in Difficult Cases of Laparoscopic Surgery for Rectal Cancer|Recruiting||Phase 1|12|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-10 23:23:01.987534|2017-10-10 23:23:01.987534
NCT02421406|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-04-06|||May 2015||2015-05-01|January 2017|2017-01-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||An Internet-based Behavioral Weight Loss Program for HIV+ Patients|An Internet-based Behavioral Weight Loss Program for HIV+ Patients|Completed||N/A|50|Anticipated|The Miriam Hospital||2|||f||||f||||||||||2017-10-10 23:23:02.221142|2017-10-10 23:23:02.221142
NCT02421393|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-03-22|||March 1, 2017|Actual|2017-03-01|March 2017|2017-03-01|November 1, 2023|Anticipated|2023-11-01|May 1, 2018|Anticipated|2018-05-01||Interventional|SWEET-BONE||Study to Weigh the Effect of Exercise Training on BONE (SWEET-BONE) Quality and Strength in Type 2 Diabetes|Study to Weigh the Effect of Exercise Training on BONE Quality and Strength (SWEET-BONE) in Type 2 Diabetes: an Exercise Intervention Program for Reducing the Risk of Fractures|Recruiting||N/A|200|Anticipated|Metabolic Fitness Association, Italy||2|||f||||f|f|f||||||No||2017-10-10 23:23:02.313296|2017-10-10 23:23:02.313296
NCT02421380|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-07-11|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Characterization of Hyperpolarized Pyruvate MRI Reproducibility|Characterization of Hyperpolarized Pyruvate MRI Reproducibility|Recruiting||N/A|100|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:23:02.466027|2017-10-10 23:23:02.466027
NCT02421354|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-01-05|||May 2015||2015-05-01|January 2017|2017-01-01||||May 2020|Anticipated|2020-05-01||Interventional|||Study of Nivolumab in Patients With Myelofibrosis|Phase 2 Study of Nivolumab in Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:23:02.668017|2017-10-10 23:23:02.668017
NCT02421341|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-03-21|||July 2012||2012-07-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Mechanisms of Altered Ventilatory Control in Heart Failure|Mechanisms of Altered Ventilatory Control in Heart Failure|Recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:23:02.759429|2017-10-10 23:23:02.759429
NCT02421328|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-03-09|||May 2015|Actual|2015-05-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study of the Effects of CPAP and HHHFNC on Diaphragmatic Dimensions in Preterm Infants|Comparative Study of the Effects of Continuous Positive Airway Pressure and Heated, Humidified High Flow Nasal Cannula on Diaphragmatic Dimensions in Preterm Infants|Completed||N/A|24|Actual|Mansoura University Children Hospital||2|||f||||t||||||||||2017-10-10 23:23:02.854353|2017-10-10 23:23:02.854353
NCT02421315|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-06-12|||October 2014||2014-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Overlapping Neural Circuits in Pediatric OCD|Overlapping Neural Circuits Implicated in Pediatric OCD|Recruiting||N/A|80|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||Yes||2017-10-10 23:23:02.929981|2017-10-10 23:23:02.929981
NCT02421302|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-04-15|||February 2015||2015-02-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|NOURISH||The Pediatric HIV Nutrition Study in Uganda|The Role of Nutrition as a Determinant of Immune Function and Pharmacological Outcome Amongst HIV Infected Malnourished Children in Uganda|Unknown status|Recruiting|N/A|150|Anticipated|Makerere University||3|||f||||f||||||||||2017-10-10 23:23:03.004649|2017-10-10 23:23:03.004649
NCT02421276|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-05-15|||October 19, 2015|Actual|2015-10-19|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome|Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome|Recruiting||N/A|50|Anticipated|University of Colorado, Denver||2|||f||||t|f|f||||||||2017-10-10 23:23:03.174214|2017-10-10 23:23:03.174214
NCT02421263|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-04-29|||April 2015||2015-04-01|April 2015|2015-04-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals|A Randomized Controlled Trial of the Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion|Recruiting||Phase 1|12|Anticipated|New York University||2|||f||||t||||||||||2017-10-10 23:23:03.378694|2017-10-10 23:23:03.378694
NCT02421250|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|SpHb||Noninvasive Hemoglobin Monitor in the ER|Comparison of Accuracy and Clinical Outcomes of a Continuous Noninvasive Hemoglobin Monitor in the Emergency Room Setting|Unknown status|Not yet recruiting|N/A|300|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 23:23:03.480482|2017-10-10 23:23:03.480482
NCT02421237|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-03-03|||March 2013||2013-03-01|March 2017|2017-03-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Trial of Treatment for Internalized Stigma in Schizophrenia|Randomized Controlled Trial of Treatment for Internalized Stigma in Schizophrenia|Enrolling by invitation||N/A|175|Anticipated|John Jay College of Criminal Justice, City University of New York||2|||f||||t|f|f||||||No||2017-10-10 23:23:03.574429|2017-10-10 23:23:03.574429
NCT02421224|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-10-26|||April 2015||2015-04-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SMILE||Social and Monetary Incentives for Smoking Cessation at Large Employers|Social and Monetary Incentives for Smoking Cessation at Large Employers|Unknown status|Recruiting|N/A|7500|Anticipated|University of California, Berkeley||9|||f||||f||||||||||2017-10-10 23:23:03.656337|2017-10-10 23:23:03.656337
NCT02421211|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-05-05|2016-11-07||May 19, 2015|Actual|2015-05-19|May 2017|2017-05-01|January 27, 2016|Actual|2016-01-27|November 10, 2015|Actual|2015-11-10||Interventional|||A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection|A Phase 2, 2-panel, Open-label Randomized Study in Hepatitis C Virus Infected Subjects to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir and Ledipasvir in Treatment-naive Participants.|Completed||Phase 2|41|Actual|Janssen Sciences Ireland UC||2|||f||||f||||||||||2017-10-10 23:23:03.802747|2017-10-10 23:23:03.802747
NCT02421185|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-09-14|||May 25, 2015|Actual|2015-05-25|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma|A Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects With Advanced Hepatocellular Carcinoma|Recruiting||Phase 1|55|Anticipated|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-10 23:23:04.833172|2017-10-10 23:23:04.833172
NCT02421172|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-03-14|||April 13, 2015|Actual|2015-04-13|March 2017|2017-03-01|November 23, 2016|Actual|2016-11-23|November 23, 2016|Actual|2016-11-23||Interventional|||Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients|A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Clinical Efficacy, Safety, Tolerability, Dose Relation, Pharmacokinetics and Pharmacodynamics of CJM112 in Moderate to Severe Chronic Hidradenitis Suppurativa Patients|Completed||Phase 2|66|Actual|Novartis||3|||f||||f||||||||||2017-10-10 23:23:04.961791|2017-10-10 23:23:04.961791
NCT02421159|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-03-29|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|January 2016|Actual|2016-01-01||Interventional|BCU||Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care Linkage|Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care Linkage|Completed||N/A|500|Actual|New York University||1|||f||||t||||||||||2017-10-10 23:23:05.106901|2017-10-10 23:23:05.106901
NCT02421146|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-05-04|||April 2015||2015-04-01|May 2017|2017-05-01|September 12, 2016|Actual|2016-09-12|September 12, 2016|Actual|2016-09-12||Interventional|||The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study|The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study|Completed||N/A|12|Actual|Northwell Health||4|||f||||f||||||||No|via email request|2017-10-10 23:23:05.176796|2017-10-10 23:23:05.176796
NCT02421133|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-09-30|||July 2015||2015-07-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PROUST||Impact of a Transitional Care Program on 30-Day Hospital Readmissions for Elderly Patients Discharged From a Short Stay Geriatric Ward|Impact of a Transitional Care Program Involving an Advanced Practice Nurse on 30-Day Hospital Readmissions for Elderly Patients Discharged From a Short Stay Geriatric Ward (PROUST Study)|Recruiting||N/A|630|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:23:05.259145|2017-10-10 23:23:05.259145
NCT02421120|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-05-02|2017-02-28||September 2015||2015-09-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|||Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients|A Prospective, Multicenter, Open-Label Study to Assess Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients Admitted With Acute Pulmonary Exacerbation|Completed||Phase 4|21|Actual|Hartford Hospital||1|||f||||f||||||||||2017-10-10 23:23:05.39231|2017-10-10 23:23:05.39231
NCT02421107|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-04-17|||April 2015||2015-04-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||GlySure Acute Care Settings Study|A Clinical Study to Evaluate the Safety of the GlySure Continuous Intravascular Glucose Monitoring System, and Its Performance in Comparison to Intermittent Blood Glucose Monitoring in Adult Intensive Care Unit Patients|Unknown status|Not yet recruiting|N/A|40|Anticipated|GlySure||1|||f||||f||||||||||2017-10-10 23:23:05.666589|2017-10-10 23:23:05.666589
NCT02420522|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-09-13|||September 2015||2015-09-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|||Magnetic Brain Stimulation in the Treatment of Mild Cognitive Impairment|The Use of Repetitive Transcranial Magnetic Stimulation in the Treatment of Mild Cognitive Impairment Due to Brain Injury|Enrolling by invitation||Phase 2|32|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-10 23:23:11.079179|2017-10-10 23:23:11.079179
NCT02421094|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-07-06||2017-07-06|September 2015|Actual|2015-09-01|July 2017|2017-07-01|September 27, 2016|Actual|2016-09-27|September 27, 2016|Actual|2016-09-27||Interventional|NASH-FX||Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis|Phase 2 Study to Evaluate Non-Invasive Imaging Methods in Efficacy Assessment of GR-MD-02 for the Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis|Completed||Phase 2|30|Anticipated|Galectin Therapeutics Inc.||2|||f||||f||||||||||2017-10-10 23:23:05.733053|2017-10-10 23:23:05.733053
NCT02421081|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-14|2016-10-10|||August 2014||2014-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|ECLAR||Effect of Cell Surface Markers and Lymphoid Cell Distribution on the Arterial Tissue Repair (ECLAR)|Effect of Cell Surface Markers Like CD 34 - CD 133 - CD 309 and Lymphoid Cell Distribution on the Wrist Laceration With Radial or Ulnar Arterial Tissue Repair|Recruiting||N/A|30|Anticipated|TC Erciyes University||3|||f||||f||||||||||2017-10-10 23:23:05.812449|2017-10-10 23:23:05.812449
NCT02421068|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-07-10|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30|1 Month|Observational [Patient Registry]|DINO||Population PK/PD of Off Label Drugs in Premature Neonates|Pharmacokinetic and Pharmacodynamic Modelling of Routinely Used Off Label Drugs in Premature Neonates|Completed||N/A|600|Anticipated|Erasmus Medical Center|||1||f||||t||||||Samples With DNA|"     blood   "|||2017-10-10 23:23:05.926872|2017-10-10 23:23:05.926872
NCT02421055|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-08-16|||June 2015||2015-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|2 Years|Observational [Patient Registry]|||Longitudinal Phenotyping of Bariatric Surgery Patients|Longitudinal Phenotyping of Bariatric Surgery Patients|Active, not recruiting||N/A|130|Anticipated|Imperial College London|||2||f||||f||||||Samples With DNA|"     Serum, urine and stool preoperatively and at 3 months and 1 year postoperatively.      Resected stomach tissue from patients undergoing Sleeve Gastrectomy.   "|||2017-10-10 23:23:06.01518|2017-10-10 23:23:06.01518
NCT02421042|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-05-04|||June 2011||2011-06-01|May 2015|2015-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Pharmacokinetic and Safety Study of E7080 in Subjects With Mild (10 mg), Moderate (10 mg), and Severe Hepatic Impairment (5 mg) and Normal Hepatic Function (10 mg)||Completed||Phase 1|14|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-10 23:23:06.095716|2017-10-10 23:23:06.095716
NCT02421029|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-08-28|||July 2017|Anticipated|2017-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prolonged Gadolinium Retention After MRI Imaging|Prolonged Gadolinium Retention After MRI Imaging in Patients With Normal Renal Function|Withdrawn||Phase 4|0|Actual|Mt. Sinai Medical Center, Miami||1||it was logistically difficult to obtain the drug needed to conduct the study|f||||f|t|f||||||||2017-10-10 23:23:06.175803|2017-10-10 23:23:06.175803
NCT02421016|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-06-01|||May 2015||2015-05-01|April 2015|2015-04-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Test Efficacy With Bioresorbable Polymer Coating Versus Bioresorbable Polymer Backbone (ISAR-RESORB)|A Prospective, Randomized Trial of SYNERGY Bioresorbable Polymer Coated Stents Versus ABSORB Bioresorbable Backbone Stents in Patients Undergoing Coronary Stenting (ISAR-RESORB)|Unknown status|Recruiting|N/A|230|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||||2017-10-10 23:23:06.254442|2017-10-10 23:23:06.254442
NCT02421003|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-08-02|||January 2015||2015-01-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Blood-in-drape||Exploratory Study, Prospective, of Volume, Composition and Bacteriology of the Recovered Blood of Multi-perforated Catheter Inserted in the Drapes Thickness of Incisional Sternal Area During Heart Surgery|Exploratory Study, Prospective, of Volume, Composition and Bacteriology of the Recovered Blood of Multi-perforated Catheter Inserted in the Drapes Thickness of Incisional Sternal Area During Heart Surgery|Completed||N/A|60|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-10 23:23:06.346273|2017-10-10 23:23:06.346273
NCT02420990|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-02-26|||April 2015||2015-04-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|CASALEAP IT2A||Integrated Treatment for Adolescents With ADHD|Randomized Comparison of Evidence-Based Protocols for Adolescents With ADHD in Specialty Care: Behavioral Only Versus Integrated Behavioral and Medication Interventions|Recruiting||N/A|140|Anticipated|The National Center on Addiction and Substance Abuse at Columbia University||2|||f||||f||||||||||2017-10-10 23:23:06.419593|2017-10-10 23:23:06.419593
NCT02420977|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-04-17|||July 2015||2015-07-01|April 2015|2015-04-01||||July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer|Evaluation of PSMA-based PET as an Imaging Biomarker of Androgen Receptor Signaling in High-Risk Localized and Locally Advanced Prostate Cancer|Not yet recruiting||N/A|24|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:23:06.511724|2017-10-10 23:23:06.511724
NCT02420964|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-17|||June 2012||2012-06-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|||Effectiveness of Web-based Teaching to Traditional Patient Education in the Use of Injectable Fertility Medications|Effectiveness of Web-based Teaching to Traditional Patient Education in the Use of Injectable Fertility Medications|Completed||N/A|80|Actual|Carolinas Healthcare System||2|||f||||f||||||||||2017-10-10 23:23:06.583109|2017-10-10 23:23:06.583109
NCT02420951|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-03-17|2017-01-30||October 5, 2015|Actual|2015-10-05|March 2017|2017-03-01|December 9, 2016|Actual|2016-12-09|March 22, 2016|Actual|2016-03-22||Interventional|||Local Injection of Local Anesthetic 24 Hours After Knee Replacement Surgery May Decrease Pain for Several More Hours|Local Injection of Local Anesthetic 24 Hours After Knee Replacement Surgery|Completed||N/A|50|Actual|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 23:23:06.850721|2017-10-10 23:23:06.850721
NCT02420938|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-12-05|||July 2015||2015-07-01|December 2016|2016-12-01||||July 2020|Anticipated|2020-07-01||Interventional|||Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients|Urelumab (CD137 mAb) Combined With Rituximab for Relapsed, Refractory or High-risk Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:23:07.207462|2017-10-10 23:23:07.207462
NCT02420925|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-10-13|||October 2014||2014-10-01|October 2016|2016-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis|Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis|Withdrawn||N/A|0|Actual|Stanford University||1||"enrollment 0"|f||||f||||||||||2017-10-10 23:23:07.299506|2017-10-10 23:23:07.299506
NCT02420912|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-03-31|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Nivolumab With Ibrutinib for Relapsed, Refractory or High-Risk Untreated Patients With Chronic Lymphocytic Leukemia (CLL)|Nivolumab Combined With Ibrutinib for Relapsed, Refractory or High-Risk Untreated Patients With Chronic Lymphocytic Leukemia (CLL)|Recruiting||Phase 2|72|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 23:23:07.386798|2017-10-10 23:23:07.386798
NCT02420899|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-06-06|||April 2015||2015-04-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients|Effect of Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in Chinese ACS Patients|Unknown status|Recruiting|N/A|100|Anticipated|Beijing Friendship Hospital||1|||f||||f||||||||||2017-10-10 23:23:07.491901|2017-10-10 23:23:07.491901
NCT02420886|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-06-27|||March 2015||2015-03-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Adding Cytokine to In Vitro Human Culture Media to Improve Embryogenesis and Implantation||Completed||N/A|400|Actual|Ibn Sina Hospital||2|||f||||f||||||||||2017-10-10 23:23:07.585727|2017-10-10 23:23:07.585727
NCT02420873|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-06-13|||May 12, 2015|Actual|2015-05-12|June 2017|2017-06-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Interventional|||An Open-label Phase II Study of Lorvotuzumab Mertansine|An Open-label Phase II Study of Lorvotuzumab Mertansine (IMGN901) in CD56 Expressing Hematological Malignancies|Completed||Phase 2|9|Actual|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 23:23:07.669824|2017-10-10 23:23:07.669824
NCT02420860|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-09-19|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Elotuzumab With Lenalidomide as Maintenance After Autologous Stem Cell Transplant (ASCT)|Phase II Study of the Combination of Elotuzumab With Lenalidomide as Maintenance Therapy Post Autologous Stem Cell Transplant in Patients With Multiple Myeloma|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:23:07.783748|2017-10-10 23:23:07.783748
NCT02420847|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-09-12|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||A Two-Dimensional Dose-Finding Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension to Assess the Efficacy of This Combination in Metastatic, Surgically Unresectable Urothelial Cancer|A Phase I Two-Dimensional Dose-Finding Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension to Assess the Efficacy of This Combination in Metastatic, Surgically Unresectable Urothelial Cancer|Recruiting||Phase 1/Phase 2|57|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:23:07.90595|2017-10-10 23:23:07.90595
NCT02420834|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-01-30|||April 2015||2015-04-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Dry Eye Treatment With Artificial Tears|Dry Eye Treatment With Artificial Tears|Active, not recruiting||N/A|50|Anticipated|Aston University||4|||f||||f||||||||||2017-10-10 23:23:08.009852|2017-10-10 23:23:08.009852
NCT02420821|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-08-01|||May 31, 2015|Actual|2015-05-31|August 2017|2017-08-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma [IMmotion151]|A Phase III, Open-Label, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Bevacizumab Versus Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 3|915|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:23:08.117076|2017-10-10 23:23:08.117076
NCT02420808|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-03-01|||March 2012||2012-03-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Observational|PHAETHON||An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study|An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study|Completed||N/A|800|Actual|Hellenic Cardiovascular Research Society|||1||f||||t||||||||||2017-10-10 23:23:08.753604|2017-10-10 23:23:08.753604
NCT02420795|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-05-26|||November 3, 2015|Actual|2015-11-03|May 2017|2017-05-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Study of Oral ONC201 in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma|Phase I/II Study of Oral ONC201 in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:23:08.827742|2017-10-10 23:23:08.827742
NCT02420782|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2016-06-30|||May 2015||2015-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology|A Phase 1 Combined Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6282 in Healthy Nonelderly and Elderly Male and Female Subjects, Including a Food Effect Cohort and Drug-drug Interaction Cohort With Itraconazole|Completed||Phase 1|116|Actual|Astellas Pharma Inc||10|||f||||f||||||||Undecided||2017-10-10 23:23:08.928864|2017-10-10 23:23:08.928864
NCT02420769|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2017-06-06|||September 2014||2014-09-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|CLCA125||Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion|Color Doppler of CL and Uterine Artery With Serum Progesterone and CA125 in Threatened Abortion|Completed||N/A|100|Actual|Beni-Suef University|||1||f||||t||||||||Undecided||2017-10-10 23:23:09.076014|2017-10-10 23:23:09.076014
NCT02420743|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SFMCA||Serum Ferritin Concentration and Fetal MCA Doppler as Predictors for Preterm Delivery|Third Trimester Serum Ferritin Concentration and Fetal MCA Peak Systolic Velocity as Predictors for Preterm Delivery|Recruiting||N/A|100|Anticipated|Beni-Suef University|||1||f||||t||||||||||2017-10-10 23:23:09.292163|2017-10-10 23:23:09.292163
NCT02420717|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-08-16|||July 2015|Actual|2015-07-01|August 2017|2017-08-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|||Ruxolitinib or Dasatinib With Chemotherapy in Patients With Philadelphia Chromosome (Ph)-Like Acute Lymphoblastic Leukemia (ALL)|A Phase II Study of the Combination of Ruxolitinib or Dasatinib With Chemotherapy in Patients With Philadelphia Chromosome (Ph)-Like Acute Lymphoblastic Leukemia (ALL)|Recruiting||Phase 2|92|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:23:09.471697|2017-10-10 23:23:09.471697
NCT02420704|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-04-18|||November 2014||2014-11-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Observational|||Effect of Endometrial Thickness on IVF Outcome|Effect of Endometrial Thickness on IVF Outcome: a Prospective Observational Study of Both Cleavage Stage and Blastocyst Stage Embryo Transfer Cycles|Unknown status|Recruiting|N/A|500|Anticipated|The First Affiliated Hospital of Zhengzhou University|||6||f||||t||||||||||2017-10-10 23:23:09.635487|2017-10-10 23:23:09.635487
NCT02420691|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-09-20|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||LEE011 in Neuroendocrine Tumors of Foregut Origin|A Phase II Study of LEE011 (Ribociclib) in Patients With Advanced Neuroendocrine Tumors of Foregut Origin (CLEE011 XUS02T)|Active, not recruiting||Phase 2|21|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:23:09.730118|2017-10-10 23:23:09.730118
NCT02420678|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-04-25|||April 2015||2015-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Quality of Life in Patients With Hepatocellular Carcinoma|Validation of Questionnaire Module for Quality of Life and Analysis of Its Association With Clinical Outcomes; a Cohort Study in Patients With Hepatocellular Carcinoma|Recruiting||N/A|300|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-10 23:23:09.809245|2017-10-10 23:23:09.809245
NCT02420665|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-09-07|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Interventional|||Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia|Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia|Recruiting||N/A|800|Anticipated|M.D. Anderson Cancer Center||1|||f||||t|t|t|f|||||||2017-10-10 23:23:09.872796|2017-10-10 23:23:09.872796
NCT02420652|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-09-21|||June 23, 2015|Actual|2015-06-23|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|PRIMA||Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy|A Phase 2 Randomized Discontinuation Trial in Patients With Hormone-Dependent Rising Prostate-Specific Antigen Progression After Local Therapy for Prostate Cancer Evaluating the Synergy of Metformin Plus Aspirin (PRIMA Trial)|Recruiting||Phase 2|66|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 23:23:09.969242|2017-10-10 23:23:09.969242
NCT02420639|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-01-23|||August 2015||2015-08-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Prospective, Interventional Study Evaluating the Feasibility and Safety of the Esophageal Cooling Device|Prospective, Interventional Study Evaluating the Feasibility and Safety of the Esophageal Cooling Device in 15 Patients Suffering From Traumatic Brain Injury and Treated With Targeted Temperature Management|Recruiting||N/A|15|Anticipated|Advanced Cooling Therapy, LLC||1|||f||||f||||||||||2017-10-10 23:23:10.080013|2017-10-10 23:23:10.080013
NCT02420626|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-04-21|||January 2016||2016-01-01|December 2015|2015-12-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Observational|||Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System|Volcano Crux Vena Cava Filter Registry|Withdrawn||N/A|0|Actual|Volcano Corporation|||1|An industry-wide, alternative, post-market study has been initiated|f||||f||||||||||2017-10-10 23:23:10.160317|2017-10-10 23:23:10.160317
NCT02420613|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-02-20|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of Suberoylanilide Hydroxamic Acid (SAHA) With Temsirolimus in Children With Diffuse Intrinsic Pontine Glioma (DIPG)|A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA, Vorinostat) With Temsirolimus in Children With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma (DIPG)|Recruiting||Phase 1|18|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:23:10.22049|2017-10-10 23:23:10.22049
NCT02420600|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-08-13|||January 2015||2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|||The Clinical Relevance of Immune Cells and CTC in HNSCC Patients|The Clinical Relevance of Immune Cells and Circulating Tumor Cells in Patients With Head and Neck Cancer|Recruiting||N/A|300|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||||||2017-10-10 23:23:10.327074|2017-10-10 23:23:10.327074
NCT02420587|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2015-04-17|||October 2014||2014-10-01|April 2015|2015-04-01||||October 2019|Anticipated|2019-10-01||Interventional|||AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)|Phase 2 Study of AMG 208 Evaluating the Tumor Microenvironment in Metastatic Castration-Resistant Prostate Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:23:10.400072|2017-10-10 23:23:10.400072
NCT02420574|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-17|||February 2014||2014-02-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|April 2014|Actual|2014-04-01||Interventional|||Assessment of Drug Efficacy of Local Albendazole|Assessment of Drug Efficacy of Albendazole Bought on Local Market Against Soil-transmitted Helminth Infections in School Children in Jimma, Ethiopia|Completed||N/A|679|Actual|University Ghent||2|||f||||f||||||||||2017-10-10 23:23:10.480483|2017-10-10 23:23:10.480483
NCT02420561|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-06-08|||October 2010||2010-10-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Motivational Interviewing to Reduce Substance Use Among Depression Patients|Motivational Interviewing to Reduce Substance Use Among Depression Patients|Completed||N/A|307|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:23:10.558273|2017-10-10 23:23:10.558273
NCT02420548|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-09-12|||July 1, 2014||2014-07-01|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|SHARP-Teen||Safe, Healthy, Adolescent Relationships and Peers|Preventing Drug Use and Risk Behaviors in Adolescent Girls|Active, not recruiting||N/A|123|Actual|University of Oregon||2|||f||||f||||||||||2017-10-10 23:23:10.902775|2017-10-10 23:23:10.902775
NCT02420535|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-12-15|||May 2015||2015-05-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||An Innovative Caregiver Tool to Assess and Manage Behavioral Symptoms of Dementia|An Innovative Caregiver Tool to Assess and Manage Behavioral Symptoms of Dementia|Completed||N/A|114|Actual|University of Michigan||2|||f||||t||||||||||2017-10-10 23:23:10.993741|2017-10-10 23:23:10.993741
NCT02420509|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-08-27|||April 2015||2015-04-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|February 9, 2017|Actual|2017-02-09||Observational|||Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis|Phase II Study to Evaluate Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis|Terminated||N/A|50|Anticipated|University of California, San Diego|||1|unable to accrue|f||||t||||||||||2017-10-10 23:23:11.169402|2017-10-10 23:23:11.169402
NCT02420496|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-06-20|||June 2016||2016-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants|Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo (?) for the Treatment of Cholestasis in Infants|Withdrawn||Phase 2|0|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-10-10 23:23:11.259645|2017-10-10 23:23:11.259645
NCT02420483|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-05-02|||December 2015||2015-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lung Ventilation During Cardiopulmonary Resuscitation||Recruiting||N/A|25|Anticipated|University of Thessaly||1|||f||||t||||||||||2017-10-10 23:23:11.374909|2017-10-10 23:23:11.374909
NCT02420470|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-03-30|||April 2015||2015-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Observational|||The Early Warning System for the Diabetic Encephalopathy|The Early Warning System for the Central Nervous System Micro-structure Alterations During Early Diabetes Based on the Multi-mode MRIs|Recruiting||N/A|300|Anticipated|Tang-Du Hospital|||3||f||||t||||||||||2017-10-10 23:23:11.464493|2017-10-10 23:23:11.464493
NCT02420457|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-04-12|||March 2015||2015-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Tracking Outcomes in Pain Patients Using Fitness Devices|Tracking Outcomes in Pain Patients Using Fitness Devices|Recruiting||N/A|40|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 23:23:11.574635|2017-10-10 23:23:11.574635
NCT02420444|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-01-23|||January 2011||2011-01-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|May 2012|Actual|2012-05-01||Interventional|C-013-404||A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults|A Phase I Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of BCG and AERAS-404 Administered as a Prime-Boost Regimen to HIV-Negative, TB-Negative, BCG-Naive Adults|Completed||Phase 1|70|Actual|Aeras||3|||f||||f||||||||Undecided||2017-10-10 23:23:11.691326|2017-10-10 23:23:11.691326
NCT02420431|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-05-03|||July 2015||2015-07-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Interventional|PATHWAY||Treating Depression and Anxiety in the Cardiac Rehabilitation Pathway|Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in the Cardiac Rehabilitation Pathway: A Single-blind Randomised Controlled Trial|Recruiting||N/A|432|Anticipated|University of Manchester||2|||f||||t||||||||||2017-10-10 23:23:11.802446|2017-10-10 23:23:11.802446
NCT02420418|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-06-22|||July 2015||2015-07-01|June 2015|2015-06-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|nac||The Effect of N- Acetylcysteine on Inflammatory and Oxidative Stress Biomarkers|The Effect of N- Acetylcysteine on Inflammatory and Oxidative Stress Biomarkers in Patients With Tobacco Use Disorders and Bipolar Disorders ..|Unknown status|Not yet recruiting|N/A|72|Anticipated|Universidade Estadual de Londrina||2|||f||||t||||||||||2017-10-10 23:23:11.924312|2017-10-10 23:23:11.924312
NCT02420405|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-02-15|||March 2015||2015-03-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||Mutation Detection of EBUS-TBNA Specimens Using NGS|Mutation Detection of Small Specimens Obtained by Endobronchial Ultrasound Transbronchial Needle Aspiration in Advanced Nonsquamous Non-small Cell Lung Cancer Using Next-generation Sequencing|Completed||N/A|78|Actual|Shanghai Chest Hospital||2|||f||||t||||||||No||2017-10-10 23:23:12.024349|2017-10-10 23:23:12.024349
NCT02420392|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2016-04-20|||February 2015||2015-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell|Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell|Completed||N/A|30|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:23:12.118371|2017-10-10 23:23:12.118371
NCT02420379|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-10-02|||May 2015||2015-05-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy|An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy|Active, not recruiting||Phase 2|40|Anticipated|Sarepta Therapeutics||2|||f||||f||||||||||2017-10-10 23:23:12.219409|2017-10-10 23:23:12.219409
NCT02420366|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-16|||May 2014||2014-05-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae|Multi-center, Retrospective Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae|Completed||N/A|257|Actual|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)|||1||f||||f||||||||||2017-10-10 23:23:12.332769|2017-10-10 23:23:12.332769
NCT02420353|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-04-24|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears|Evaluation of Recombinant Growth Hormone Therapy to Prevent Muscle Atrophy in Patients With Anterior Cruciate Ligament Tears|Enrolling by invitation||Phase 2|48|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-10 23:23:12.462277|2017-10-10 23:23:12.462277
NCT02420340|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-08-01|||September 2014||2014-09-01|August 2016|2016-08-01||||December 2015|Actual|2015-12-01||Interventional|||Using The HOPES Program in Transition Care||Completed||N/A|12|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-10 23:23:12.564793|2017-10-10 23:23:12.564793
NCT02420327|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-05-01|||September 2014||2014-09-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|GalaNic||Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine|The Use of Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine|Completed||N/A|27|Actual|University of Maryland||4|||f||||f||||||||||2017-10-10 23:23:12.661333|2017-10-10 23:23:12.661333
NCT02420314|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-07-19|||April 2015||2015-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacological Ascorbate for Lung Cancer|A Phase II Trial of High-Dose Ascorbate in Stage IV Non-Small Cell Lung Cancer|Recruiting||Phase 2|42|Anticipated|University of Iowa||1|||f||||t|t|f||||||||2017-10-10 23:23:12.762497|2017-10-10 23:23:12.762497
NCT02420301|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-16|||July 2012||2012-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Self-administered Exercises on PRMD|Effects of Self-administered Exercises Based on Tuina Techniques on Musculoskeletal Disorders of Professional Orchestra Musicians|Completed||N/A|69|Actual|Universidade do Porto||2|||f||||t||||||||||2017-10-10 23:23:12.902755|2017-10-10 23:23:12.902755
NCT02420288|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-02-13|||November 2014||2014-11-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Physical Exercise Program on Fetoplacental Growth|Effect of Physical Exercise Program on Fetoplacental Growth: a Randomized Controlled Trial|Active, not recruiting||N/A|124|Actual|Universidad Politecnica de Madrid||2|||f||||t||||||||||2017-10-10 23:23:12.964257|2017-10-10 23:23:12.964257
NCT02420275|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-01-30|||May 2015||2015-05-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|phototrauma||Trial Estimating the Efficiency of the Light Therapy in Brain Trauma Sequel Fatigue|Controlled Randomized Trial Estimating the Efficiency of Blue Enriched White Light on Sequel Fatigue, in Victims of Severe Cranial Traumas|Recruiting||N/A|20|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||f||||||||||2017-10-10 23:23:13.050392|2017-10-10 23:23:13.050392
NCT02420249|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-12-13|||March 2015||2015-03-01|December 2015|2015-12-01||||May 2017|Anticipated|2017-05-01||Interventional|||Qigong for Breast Cancer Survivors|Randomised Controlled Trial of Qigong Training Programme to Alleviate Arm Oedema, ¬Reduce Shoulder Impairment, Improve Body Balance and Quality of Life in Community-dwelling Breast Cancer Survivors|Recruiting||N/A|60|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:23:13.44041|2017-10-10 23:23:13.44041
NCT02420236|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-03-22|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|March 15, 2017|Actual|2017-03-15|January 4, 2017|Actual|2017-01-04||Interventional|||Effects of Resistance Training on Pain, Function and Work Ability in Patients With Moderate to Severe Low Back Pain|Effects of Resistance Training on Pain, Function and Work Ability in Patients With Moderate to Severe Low Back Pain|Completed||N/A|99|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 23:23:13.507769|2017-10-10 23:23:13.507769
NCT02420223|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-03-24|||August 2015||2015-08-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Pilot Study Using Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in Hematopoietic Stem Cell Transplant Recipients|Randomized Controlled Pilot Study Using Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in Hematopoietic Stem Cell Transplant Recipients|Recruiting||Phase 2|40|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-10 23:23:13.582658|2017-10-10 23:23:13.582658
NCT02420210|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-09-15|||November 2015||2015-11-01|September 2016|2016-09-01||||August 2016|Actual|2016-08-01||Interventional|||Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma|Multicenter Phase II Study of the Bendamustine, Obinutuzumab, and Dexamethasone (BOD) Regimen in Un-fit Elderly ≥ 70 Years of Age Diffuse Large B-Cell Non-Hodgkin Lymphoma (DLBCL) Patients|Completed||Phase 2|30|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-10 23:23:13.661602|2017-10-10 23:23:13.661602
NCT02420197|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-04-20|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|||Effects of Resistance Training on Pain, Function and Work Ability in Patients With Moderate to Severe Neck Pain|Effects of Resistance Training on Pain, Function and Work Ability in Patients With Moderate to Severe Neck Pain|Completed||N/A|74|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-10 23:23:13.75698|2017-10-10 23:23:13.75698
NCT02420184|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-04-26|||June 2015||2015-06-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Treatment of Obstructive Sleep Apnea in Chronic Kidney Disease|Treatment of Obstructive Sleep Apnea in Chronic Kidney Disease|Enrolling by invitation||N/A|40|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-10 23:23:13.837362|2017-10-10 23:23:13.837362
NCT02420171|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-07-11|||January 2015||2015-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Adding Insulin to IVF Culture Media Significantly Improve Outcome||Completed||N/A|360|Actual|Ibn Sina Hospital||2|||f||||f||||||||||2017-10-10 23:23:13.905884|2017-10-10 23:23:13.905884
NCT02420158|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-05-31|||May 2015|Actual|2015-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|StVSII||Trans-cutaneous Vagal Nerve Electrical Stimulation and Irritable Bowel Syndrome|Sympatho-vagal Balance in Patients With Irritable Bowel Syndrome, and Evaluation of a Transcutaneous Vagal Nerve Electrical Stimulation on Symptoms and Quality of Life|Recruiting||N/A|20|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:23:13.973793|2017-10-10 23:23:13.973793
NCT02420145|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-09-22|||April 2015||2015-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Yoga for Abdominal Obesity|Randomized-controlled Trial of Yoga for Women With Abdominal Obesity|Completed||N/A|60|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-10 23:23:14.059862|2017-10-10 23:23:14.059862
NCT02420132|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-07-13|||April 20, 2015|Actual|2015-04-20|July 2017|2017-07-01|August 25, 2016|Actual|2016-08-25|August 25, 2016|Actual|2016-08-25||Observational|||Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)|Decentralized Pilot Study to Evaluate MyVisionTrack^TM Home Vision Testing in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration Currently Receiving Intravitreal Lucentis® Therapy.|Completed||N/A|47|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-10 23:23:15.778424|2017-10-10 23:23:15.778424
NCT02420119|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-10-27|||January 2015||2015-01-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Does Intravenous Iron Therapy Decrease Serum Phosphorous Levels?|Does Intravenous Iron Therapy Decrease Serum Phosphorous and Vitamin D Levels in Patients With and Without Chronic Renal Failure?|Completed||N/A|41|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||No||2017-10-10 23:23:15.880733|2017-10-10 23:23:15.880733
NCT02420093|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-04-09|2016-11-18||January 2015||2015-01-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Investigating the Clinical Effects of Supporting Neutral Pelvic Position in Sitting|Investigating the Clinical Effects of Supporting Neutral Pelvic Position in Sitting|Completed||N/A|17|Actual|Oakland University||2|||f||||t||||||||No|There is no plan to make individual participant data (IPD) available|2017-10-10 23:23:16.034308|2017-10-10 23:23:16.034308
NCT02420080|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-01-05|||February 2015||2015-02-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|||A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304|A Multicenter Non-Interventional Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304|Terminated||N/A|100|Actual|Chimerix|||2|Study was terminated early due to results from previous CMX study|f||||f||||||||||2017-10-10 23:23:16.322875|2017-10-10 23:23:16.322875
NCT02420067|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-05-06|||February 2011||2011-02-01|May 2017|2017-05-01|December 2026|Anticipated|2026-12-01|December 2017|Anticipated|2017-12-01||Observational|||Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients|An International Collaborative Study: Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients|Recruiting||N/A|380|Anticipated|University of Copenhagen|||1||f||||f||||||||||2017-10-10 23:23:16.440597|2017-10-10 23:23:16.440597
NCT02420054|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-05-16|||April 2015||2015-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Interventional|IFAST||Short Term Intermittent Fasting and Insulin Resistance|Effects of Short Term Intermittent Fasting on Insulin Resistance in Type 2 Diabetes|Active, not recruiting||N/A|20|Anticipated|University of Copenhagen||2|||f||||f||||||||Undecided||2017-10-10 23:23:16.642681|2017-10-10 23:23:16.642681
NCT02420041|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-10-07|2015-06-26||October 2012||2012-10-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Comparing the Effects of Ultrasound Versus Fluoroscopy for Sacroiliac Joint Injections|Comparison of the Efficacy of Two Techniques for Sacroiliac Joint Injection: Ultrasound Guidance Versus Fluoroscopic Guidance|Completed||N/A|28|Actual|United States Naval Medical Center, San Diego||2|||f||||t||||||||||2017-10-10 23:23:16.743889|2017-10-10 23:23:16.743889
NCT02420028|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-02-28|||April 2015||2015-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic Population|A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic Population|Suspended||N/A|334|Anticipated|Optomeditech Oy||2||Inability to recruit patients sufficiently|f||||f||||||||||2017-10-10 23:23:17.142134|2017-10-10 23:23:17.142134
NCT02420015|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-08-25|||March 27, 2017|Actual|2017-03-27|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia|Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia|Recruiting||Phase 4|36|Anticipated|Duke University||2|||f||||f|t|f||||||||2017-10-10 23:23:17.230494|2017-10-10 23:23:17.230494
NCT02420002|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-10-26|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|Hypno-Mo||Pediatric Emergency Suture Care: a Trial Comparing the Analgesic Efficacy of Hypnosis Versus MEOPA|Suture Care in the Pediatric Emergency Department: a Randomized Trial Comparing the Analgesic Efficacy of Hypnosis Versus MEOPA|Recruiting||Phase 4|60|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 23:23:17.351166|2017-10-10 23:23:17.351166
NCT02419989|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-12-20|||May 2014||2014-05-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|PATIENCE||PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis|Cystic Fibrosis Nontuberculous Mycobacteria Treatment Protocol|Recruiting||N/A|60|Anticipated|National Jewish Health|||1||f||||f||||||Samples With DNA|"     serum sputum NTM isolates   "|||2017-10-10 23:23:17.463204|2017-10-10 23:23:17.463204
NCT02419976|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-01-24|||February 2015||2015-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|Fast Breath||Electronic Nose Identification of Fasting and Non-fasting Breath Profiles|Electronic Nose Identification of Fasting and Non-fasting Breath Profiles|Enrolling by invitation||N/A|350|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 23:23:17.545196|2017-10-10 23:23:17.545196
NCT02419963|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-07-05|||May 2015||2015-05-01|July 2017|2017-07-01|December 12, 2016|Actual|2016-12-12|December 12, 2016|Actual|2016-12-12||Interventional|||Analyzing IBS to Identify Biomarkers and Microbiome Signatures|A New Dimension in Modeling Irritable Bowel Syndrome (IBS) to Elucidate Novel Diagnostic Biomarkers and Microbiome Signatures|Completed||N/A|26|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:23:17.613414|2017-10-10 23:23:17.613414
NCT02419950|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-04-14|||November 2008||2008-11-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|May 2010|Actual|2010-05-01|5 Years|Observational [Patient Registry]|register||Mesh Fixation inTEP Inguinal Hernia Repair|Impact of Mesh Fixation on Chronic Pain in Total Extraperitoneal (TEP) Inguinal Hernia Repair - a National Register Based Study|Completed||N/A|1110|Actual|Skane University Hospital|||2||f||||f||||||||||2017-10-10 23:23:17.694406|2017-10-10 23:23:17.694406
NCT02419924|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-06-17|||April 2015||2015-04-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||"Proof of Concept: Bottom's Up Seat to Treat Constipation"|Proof of Concept: A Commode Assist Device for Excessive Perineal Descent|Enrolling by invitation||N/A|10|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:23:17.870883|2017-10-10 23:23:17.870883
NCT02419911|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-09-25|||January 2015||2015-01-01|May 2015|2015-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparison FloShield Air System Versus Clearify Visualization System (D-HELP)|Prospective, Randomized Comparison of the Use of FloShield Air System Versus Clearify Visualization System (D-HELP) During Laparoscopic Surgery to Evaluate the Operative Interruption for Lens Cleaning|Completed||Phase 4|62|Actual|Minimally Invasive Devices, Inc.||2|||f||||f||||||||||2017-10-10 23:23:17.939936|2017-10-10 23:23:17.939936
NCT02419898|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-09-30|||April 2013||2013-04-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|OxWATCH||Oxfordshire Women and Their Children's Health|Oxfordshire Women and Their Children's Health- A Feasibility Study|Recruiting||N/A|300|Anticipated|Oxford University Hospitals NHS Trust|||1||f||||t||||||Samples With DNA|"     SST Serum, Citrate Platelet Free Plasma, EDTA Plasma, whole blood for DNA extraction, urine     and saliva will be stored at -80°C for future studies.   "|Undecided||2017-10-10 23:23:18.027642|2017-10-10 23:23:18.027642
NCT02419885|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-14|||January 2012||2012-01-01|December 1990|1990-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of Result and Influence Factors on Composite Graft in Fingertip Amputation|Evaluation of Result and Influence Factors on Composite Graft in Fingertip Amputation|Unknown status|Recruiting|N/A|40|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||||||2017-10-10 23:23:18.116045|2017-10-10 23:23:18.116045
NCT02419872|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-04-24|||May 31, 2015|Actual|2015-05-31|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Observational|SPRINT||Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease|A Phase IV Real-World Multi-Country Observational Study on Patients' Disease Control and Self-Reported Outcomes During Fixed Dose Combination Inhaler Treatment for Persistent Asthma and COPD|Active, not recruiting||N/A|1714|Anticipated|Teva Pharmaceutical Industries|||1||f||||f|f|f||||||||2017-10-10 23:23:18.21129|2017-10-10 23:23:18.21129
NCT02419859|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-07-25|||February 2015||2015-02-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus|A Prospective, Single Center Study to Assess the Performance, Safety, and Patient Reported Outcomes of Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus|Completed||N/A|20|Actual|CeQur Corporation||1|||f||||f||||||||Yes|No plan to share individual data sets, but will publish the results.|2017-10-10 23:23:18.674542|2017-10-10 23:23:18.674542
NCT02419846|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-10-04|||October 2015||2015-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program|The Effectiveness of a Proposed Prostate Cancer Outreach Program in a Predominantly African American Community That Promotes Informed Decision-making for Prostate Cancer Screening and Utilizes Community Navigation|Recruiting||N/A|400|Anticipated|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:23:18.773908|2017-10-10 23:23:18.773908
NCT02419833|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-04-14|||September 2009||2009-09-01|April 2015|2015-04-01|February 2018|Anticipated|2018-02-01|March 2013|Actual|2013-03-01||Interventional|RIDDLE-NSTEMI||Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients|Randomized Study of ImmeDiate Versus DeLayEd Invasive Intervention in Patients With Non ST-segment Elevation Myocardial Infarction|Active, not recruiting||N/A|323|Actual|Clinical Centre of Serbia||2|||f||||t||||||||||2017-10-10 23:23:18.896128|2017-10-10 23:23:18.896128
NCT02419820|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-04-16|||March 2015||2015-03-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Dose-escalation, Repeated and Single Oral Dosing Study|Randomized, Double-blind, Placebo-controlled, Dose-escalation, Repeated and Single Oral Dosing Phase I Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Temanogrel Co-administered With Aspirin and Clopidogrel|Unknown status|Enrolling by invitation|Phase 1|144|Anticipated|IlDong Pharmaceutical Co Ltd||16|||f||||f||||||||||2017-10-10 23:23:18.991457|2017-10-10 23:23:18.991457
NCT02419807|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-03-16|||February 17, 2015|Actual|2015-02-17|March 2017|2017-03-01|September 16, 2018|Anticipated|2018-09-16|September 16, 2017|Anticipated|2017-09-16||Interventional|||Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer|Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer|Recruiting||N/A|130|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|f|||f|||||2017-10-10 23:23:19.131818|2017-10-10 23:23:19.131818
NCT02419794|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01|90 Days|Observational [Patient Registry]|||Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2|Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2|Completed||N/A|2420|Actual|Hyogo College of Medicine|||2||f||||t||||||||||2017-10-10 23:23:19.244354|2017-10-10 23:23:19.244354
NCT02419781|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-08-20|||October 2014||2014-10-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan RCT|Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Randomized Controlled Trial|Terminated||N/A|19|Actual|Hyogo College of Medicine||2||Evidence of thrombectomy for acute stroke was established|f||||t||||||||||2017-10-10 23:23:19.330504|2017-10-10 23:23:19.330504
NCT02419768|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-01-27|||June 2014||2014-06-01|January 2016|2016-01-01||||May 2016|Anticipated|2016-05-01||Interventional|||Effects of Exercise on Long-Range Autocorrelations in Parkinson's Disease|Locomotion of Parkinsonian Patient: Are There Relations Between the Long Range Autocorrelations and the Neurological Impairments, Walking Abilities and the Practice of Physical Exercise?|Recruiting||N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-10-10 23:23:19.422573|2017-10-10 23:23:19.422573
NCT02419755|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-01-05|||April 2015||2015-04-01|January 2016|2016-01-01|October 2026|Anticipated|2026-10-01|December 2016|Actual|2016-12-01||Interventional|||Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies|A Phase II Study of Bortezomib and Vorinostat in Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies|Terminated||Phase 2|12|Actual|St. Jude Children's Research Hospital||2||Accrual goals were no longer feasible based on restrictions imposed by the DSMB.|f||||t||||||||||2017-10-10 23:23:19.537108|2017-10-10 23:23:19.537108
NCT02419729|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-06-24|||March 2015||2015-03-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy|Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy|Completed||Phase 3|45|Actual|Faculdade de Medicina do ABC||3|||f||||f||||||||||2017-10-10 23:23:19.785849|2017-10-10 23:23:19.785849
NCT02419716|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-07-28|||April 2015||2015-04-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Observational|||A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval|A Longitudinal Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval|Active, not recruiting||N/A|2173|Anticipated|Exact Sciences Corporation|||1||f||||f||||||Samples With DNA|"     A portion of the stool sample may be retained, if any remains after the study-related tests     for use in a sample bank for use in the future. The samples may be stored for up to twenty     (20) years. These stool samples will de-identified.   "|||2017-10-10 23:23:19.883596|2017-10-10 23:23:19.883596
NCT02419703|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-04-10|||October 2015||2015-10-01|April 2017|2017-04-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20|12 Months|Observational [Patient Registry]|||The STAR™ Tumor Ablation Registry|The STAR™ Tumor Ablation Registry|Terminated||N/A|65|Actual|Merit Medical Systems, Inc.|||1|Difficulty Enrolling|f||||f||||||||||2017-10-10 23:23:20.030481|2017-10-10 23:23:20.030481
NCT02419690|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-12|||April 2015||2015-04-01|August 2016|2016-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Dual Protection Project|Effectiveness of a Patient Centered Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Disease Among Adolescents|Completed||N/A|250|Actual|Denver Health and Hospital Authority||2|||f||||f||||||||No||2017-10-10 23:23:20.117188|2017-10-10 23:23:20.117188
NCT02419677|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-14|||January 2010||2010-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases|Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases|Completed||Phase 2/Phase 3|60|Actual|The First People's Hospital of Changzhou||2|||f||||f||||||||||2017-10-10 23:23:20.184148|2017-10-10 23:23:20.184148
NCT02419664|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-02-01|||January 2015||2015-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ga-68-DOTATOC -PET in the Management of Pituitary Tumours|Ga-68-DOTATOC -PET in the Management of Pituitary Tumours|Recruiting||Phase 3|45|Anticipated|Göteborg University||1|||f||||f||||||||||2017-10-10 23:23:20.373707|2017-10-10 23:23:20.373707
NCT02419651|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-01-20|||April 2015||2015-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tramadol Versus Diclofenac for Reducing Pain Before Outpatient Hysteroscopy|Tramadol Versus Diclofenac for Reducing Pain Associated With Outpatient Hysteroscopy: A Randomized Double Blind Placebo-Controlled Trial|Recruiting||Phase 3|210|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-10 23:23:20.516741|2017-10-10 23:23:20.516741
NCT02419638|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-02-26|||May 2015||2015-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS||Withdrawn||N/A|0|Actual|Brigham and Women's Hospital|||2|Collaborative decision between study PI and sponsor.|f||||t||||||||||2017-10-10 23:23:20.633446|2017-10-10 23:23:20.633446
NCT02419625|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2016-07-20|||June 2015||2015-06-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk Factors|The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk Factors, a Multicenter, Comparative, Cross-sectional Study|Enrolling by invitation||N/A|200|Anticipated|Carmel Medical Center||1|||f||||f||||||||||2017-10-10 23:23:21.192218|2017-10-10 23:23:21.192218
NCT02419599|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-10-24|||August 2015||2015-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||High vs Standard Energy Children's Drink Study|The Effect of Standard Versus High Energy Density, Low Volume Oral Nutritional Supplements in Children Requiring Nutritional Support - a Pilot Trial|Completed||N/A|51|Actual|Nutricia UK Ltd||2|||f||||f||||||||Undecided||2017-10-10 23:23:21.555982|2017-10-10 23:23:21.555982
NCT02419586|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-04-14|||January 2015||2015-01-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Effectiveness of Gum Chewing on Ileus in Chinese Colorectal Patients Underwent Laparoscopic Colorectal Surgery|Effectiveness of Gum Chewing on Reduction of Postoperative Paralytic Ileus for Chinese Colorectal Cancer Patients Underwent Laparoscopic Colorectal Surgery and Enhanced Recovery Program|Unknown status|Recruiting|N/A|92|Anticipated|Hospital Authority, Hong Kong||2|||f||||t||||||||||2017-10-10 23:23:21.639227|2017-10-10 23:23:21.639227
NCT02419573|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-03-30|||December 2015||2015-12-01|March 2017|2017-03-01|November 2020|Anticipated|2020-11-01|September 2020|Anticipated|2020-09-01||Interventional|PART||Pragmatic Airway Resuscitation Trial|Pragmatic Trial of Airway Management in Out-of-Hospital Cardiac Arrest|Recruiting||N/A|3000|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||No||2017-10-10 23:23:21.741416|2017-10-10 23:23:21.741416
NCT02419560|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-03-16|||April 2015||2015-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL|Multi-institution Phase I/Ib Study of Ibrutinib With ABT-199 in Relapsed/Refractory Mantle Cell Lymphoma|Suspended||Phase 1|28|Anticipated|University of Virginia||1||Protocol Amendment is under further consideration.|f||||t||||||||||2017-10-10 23:23:21.878901|2017-10-10 23:23:21.878901
NCT02419547|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-04-14|||July 2014||2014-07-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia|Inducibility and Stability of Ventricular Tachycardia in Patients With Structural Heart Disease Undergoing VT Ablation Under General Anesthesia (Pilot Study)|Unknown status|Recruiting|N/A|20|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 23:23:21.994828|2017-10-10 23:23:21.994828
NCT02419534|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-02-27|||November 2014||2014-11-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Pediatrics Anal Fissures Treatment With Polyethylene Glycol|Randomized Controlled Trial Comparing the Efficacy of Polyethylene Glycol Alone and Polyethylene Glycol Combined With Topical Diltiazem in Treating Anal ﬁssure in Children|Recruiting||Phase 4|46|Anticipated|King Saud University||2|||f||||f||||||||||2017-10-10 23:23:22.103872|2017-10-10 23:23:22.103872
NCT02419521|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-06-30|2017-06-30||July 7, 2015|Actual|2015-07-07|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 5, 2016|Actual|2016-07-05||Interventional|||Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study|A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study|Active, not recruiting||N/A|75|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-10-10 23:23:22.251961|2017-10-10 23:23:22.251961
NCT02419508|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-06-12|||August 7, 2015|Actual|2015-08-07|June 2017|2017-06-01|February 22, 2018|Anticipated|2018-02-22|February 22, 2018|Anticipated|2018-02-22||Interventional|||SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)|Additive Effect of Twice Daily Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue|Recruiting||Phase 4|280|Anticipated|Alcon Research||2|||f||||f||||||||||2017-10-10 23:23:22.724878|2017-10-10 23:23:22.724878
NCT02419495|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-06-20|||June 26, 2015|Actual|2015-06-26|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Phase IB of Selinexor in Combination With Standard Chemotherapy in Patients With Advanced Malignancies|Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy Agents in Patients With Advanced Malignancies|Recruiting||Phase 1|588|Anticipated|M.D. Anderson Cancer Center||13|||f||||f|t|f||||||||2017-10-10 23:23:22.83591|2017-10-10 23:23:22.83591
NCT02419482|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-07-27|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|IMPROV-IT||Improving Reproductive Function in Women With Polycystic Ovary Syndrome by High Intensity Interval Training|Improving Reproductive Function in Women With Polycystic Ovary Syndrome by High Intensity Interval Training: A Randomized Controlled Trial.|Recruiting||N/A|66|Anticipated|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-10 23:23:23.021896|2017-10-10 23:23:23.021896
NCT02419469|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-06-26|||November 13, 2015|Actual|2015-11-13|June 2017|2017-06-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f|t|f||||||||2017-10-10 23:23:23.136767|2017-10-10 23:23:23.136767
NCT02419456|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-05-03|||June 2015||2015-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Pharmacokinetics of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048|Phase 1 Pharmacokinetic Trial of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048|Completed||Phase 1|19|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:23:23.270949|2017-10-10 23:23:23.270949
NCT02419443|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-04-08|||August 2011||2011-08-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair|The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair|Active, not recruiting||Phase 4|100|Anticipated|United States Naval Medical Center, San Diego||2|||f||||f||||||||Undecided|Aggregated results will be made available.|2017-10-10 23:23:23.335199|2017-10-10 23:23:23.335199
NCT02419430|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-05-14|||April 2015||2015-04-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|MBRT||Mindfulness Based Resilience Training|Mindfulness Based Resilience Training for Employees at Mayo Clinic|Completed||N/A|60|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-10 23:23:23.412851|2017-10-10 23:23:23.412851
NCT02419417|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-09-15|||June 5, 2015|Actual|2015-06-05|September 2017|2017-09-01|December 17, 2018|Anticipated|2018-12-17|December 16, 2018|Anticipated|2018-12-16||Interventional|BET||Study of BMS-986158 in Subjects With Select Advanced Solid Tumors|A Phase I/IIa Trial With BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects With Selected Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|150|Anticipated|Bristol-Myers Squibb||6|||f||||f|t|f||||||||2017-10-10 23:23:23.49263|2017-10-10 23:23:23.49263
NCT02419404|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-11-11|||May 2013||2013-05-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Response of Pulse Pressure Variation in PA Catheter Tracing to IV Fluid Bolus in the ICU|Response of Pulse Pressure Variation in PA Catheter Tracing to IV Fluid Bolus in the ICU|Completed||N/A|70|Actual|University of Virginia|||1||f||||f||||||||No||2017-10-10 23:23:23.837294|2017-10-10 23:23:23.837294
NCT02419196|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-02-29|||January 2015||2015-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Perioperative Change of Regional Ventilation During Spontaneous Breathing|Perioperative Change of Regional Ventilation During Spontaneous Breathing|Completed||N/A|72|Actual|Wuerzburg University Hospital|||3||f||||f||||||||||2017-10-10 23:23:25.845949|2017-10-10 23:23:25.845949
NCT02419391|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-08-09|||August 2015||2015-08-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine|A Randomized, Single-blind, Placebo-controlled Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine in Healthy Adult Subjects|Completed||Phase 1|63|Actual|Bavarian Nordic||3|||f||||f||||||||Undecided||2017-10-10 23:23:23.937499|2017-10-10 23:23:23.937499
NCT02419378|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-06-17|||May 2015||2015-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|ALAIN01||Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential|Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential|Recruiting||Phase 4|15|Anticipated|University Hospital Muenster||1|||f||||f||||||||||2017-10-10 23:23:24.064549|2017-10-10 23:23:24.064549
NCT02419365|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-04-13|||January 2014||2014-01-01|April 2015|2015-04-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|20 Years|Observational [Patient Registry]|||International Prospective Patient Registry for Primary Ciliary Dyskinesia (PCD)|Prospective Primary Ciliary Dyskinesia (PCD) Registry for Systematic Data Collection on Incidence, Clinical Presentation, Treatment and Course of the Disease|Recruiting||N/A|800|Anticipated|University Hospital Muenster|||1||f||||f||||||||||2017-10-10 23:23:24.274896|2017-10-10 23:23:24.274896
NCT02419352|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-12-28|||September 2010||2010-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Sugammadex and Cognitive Function|Effect of Sugammadex Versus Neostigmine/Atropine Combination on Cognitive Function After Elective Adult Surgery|Completed||N/A|160|Actual|Attikon Hospital||2|||f||||f||||||||||2017-10-10 23:23:24.390437|2017-10-10 23:23:24.390437
NCT02419339|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-05-04|||May 2015||2015-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction|Prospective Multicenter Observational Study of Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction|Recruiting||N/A|31|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-10-10 23:23:24.500869|2017-10-10 23:23:24.500869
NCT02419326|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-10-25|||September 2014||2014-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|UNITE||Uniting Couples In the Treatment of Eating Disorders (UNITE)|Uniting Couples In the Treatment of Eating Disorders (UNITE): Pilot Study for a Couple-based Intervention for Binge-eating Disorder|Completed||N/A|11|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-10 23:23:24.607692|2017-10-10 23:23:24.607692
NCT02419313|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-02-15|2015-09-23||August 2012||2012-08-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||double blind cross over study aimed at 30 patients 33 enrolled- 30 completed|Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Tremor: A Customized Approach|Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Disease Tremor: A Customized Approach|Completed||Phase 2|33|Actual|Yale University||2|||f||||t||||||||No||2017-10-10 23:23:24.783463|2017-10-10 23:23:24.783463
NCT02419287|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-10-27|||April 2015||2015-04-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas|Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas|Recruiting||Phase 2|12|Anticipated|University of Milano Bicocca||1|||f||||f||||||||||2017-10-10 23:23:25.180799|2017-10-10 23:23:25.180799
NCT02419274|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-02-23|||March 2014||2014-03-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|ALLIANCE||Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)|The All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL), Adult Arm|Recruiting||N/A|250|Anticipated|LungenClinic Grosshansdorf|||1||f||||f||||||Samples With DNA|"     Collection of blood, nasal secretions, sputum and exhaled breath, such as pharyngeal and     nasopharyngeal swabs   "|||2017-10-10 23:23:25.295946|2017-10-10 23:23:25.295946
NCT02419261|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-05-10|||October 2014||2014-10-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|May 2017|Anticipated|2017-05-01||Interventional|ACB||Assessment of Adductor Canal Blockade in Anterior Cruciate Ligament Surgery|Assessment of Sensory and Motor Blockade of the Adductor Canal Blockade Performed for Surgery of Arthroscopic Anterior Cruciate Ligament Repair|Recruiting||N/A|40|Anticipated|University Hospital of Liege||2|||f||||f||||||||||2017-10-10 23:23:25.391841|2017-10-10 23:23:25.391841
NCT02419248|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2015-11-09|||June 2015||2015-06-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|DERM EV TOPIC||Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation|Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation|Completed||N/A|55|Actual|Kley Hertz S/A|||1||f||||||||||||||2017-10-10 23:23:25.494181|2017-10-10 23:23:25.494181
NCT02419235|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2016-05-16|||October 2014||2014-10-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of a Homoeopathic Complex on Blood Pressure in Refractory Hypertension|The Effect of a Homoeopathic Complex (Amylenum Nitrosum 6CH, Crataegus Oxyacantha 6CH, Natrum Muriaticum 6CH and Scutellaria Lateriflora 6CH) on Blood Pressure in Refractory Hypertension|Completed||Phase 2|30|Actual|University of Johannesburg||2|||f||||t||||||||No||2017-10-10 23:23:25.559654|2017-10-10 23:23:25.559654
NCT02419222|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2017-08-16|||January 2015||2015-01-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke|Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke Survivors With Multiple Lesions|Completed||N/A|30|Actual|Kessler Foundation||1|||f||||f||||||||||2017-10-10 23:23:25.651014|2017-10-10 23:23:25.651014
NCT02419209|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-05-16|||January 2015||2015-01-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Individualised Homeopathic Treatment on Low Sexual Desire in Perimenopause|The Effect of Individualised Homeopathic Treatment on Low Sexual Desire in Perimenopause|Completed||Phase 2|10|Actual|University of Johannesburg||1|||f||||t||||||||||2017-10-10 23:23:25.749746|2017-10-10 23:23:25.749746
NCT02419183|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-14|2016-06-30|||May 2015||2015-05-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||A Study of a Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR) in Participants With Mild Cognitive Impairment|A Randomized Cross-over, Controlled Feasibility, and Validation Study of a Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR) in Subjects With Mild Cognitive Impairment|Completed||Early Phase 1|153|Actual|Janssen Research & Development, LLC|||2||f||||f||||||||||2017-10-10 23:23:25.983794|2017-10-10 23:23:25.983794
NCT02419170|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-07-14|||July 2016||2016-07-01|July 2016|2016-07-01|October 2023|Anticipated|2023-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)|Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)|Withdrawn||Early Phase 1|0|Actual|Washington University School of Medicine||1||Investigator who manufactured the vaccine left the university.|f||||f||||||||||2017-10-10 23:23:26.096884|2017-10-10 23:23:26.096884
NCT02419157|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2015-04-16|||October 2012||2012-10-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Selective Enamel Etching in Self-etching Adhesives: a 2-year Clinical Trial|Effectiveness of One- and Two-step Self-etching Adhesives Applied With or Without Selective Enamel Etching: a 2-year Randomized Controlled Clinical Trial|Completed||N/A|25|Actual|University of Guarulhos||4|||f||||t||||||||||2017-10-10 23:23:26.190413|2017-10-10 23:23:26.190413
NCT02419144|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-11-03|||May 2015||2015-05-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Good Oral Health - A Bi-level Intervention to Improve Older Adult Oral Health||Recruiting||Phase 2/Phase 3|450|Anticipated|UConn Health||2|||f||||f||||||||Yes||2017-10-10 23:23:26.331994|2017-10-10 23:23:26.331994
NCT02419131|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-11-01|||May 2015||2015-05-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cognitive-Behavior Therapy for Posttraumatic Headache|Coalition to Alleviate PTSD: Randomized Clinical Trial of Cognitive-Behavior Therapy for Posttraumatic Headache|Recruiting||N/A|285|Anticipated|Wake Forest University Health Sciences||3|||f||||t||||||||Yes|Data sharing as per CAP (Consortium to Alleviate PTSD) established protocol.|2017-10-10 23:23:26.454598|2017-10-10 23:23:26.454598
NCT02419118|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-10-13|||January 2015||2015-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|DARA||"Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab "|"Monoclonal Antibodies for Treatment of Multiple Myeloma. Present Status and Aspects of Effector Mechanisms With Emphasis on the CD38 Antibody Daratumumab "|Recruiting||Phase 2/Phase 3|50|Anticipated|Vejle Hospital||2|||f||||f||||||||||2017-10-10 23:23:26.546023|2017-10-10 23:23:26.546023
NCT02419105|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-08-16|||September 2015||2015-09-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|T&D||Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors|Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors. Double Blind, 2x2 Factorial, Randomized Placebo-‐Controlled Clinical Trial|Recruiting||Phase 3|168|Anticipated|University of Zurich||4|||f||||f||||||||||2017-10-10 23:23:26.651451|2017-10-10 23:23:26.651451
NCT02419092|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-06-10|||April 2015||2015-04-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Observational|||Obstructive Sleep Apnea-induced Changes in Adipose and Liver Tissue and Effects of Massive Weight Loss on Inflammation|Investigation of Inflammation Induced by Obstructive Sleep Apnea: Effects of Continuous Positive Airway Pressure (CPAP), Massive Weight Loss and the Bioactive Compound Resveratrol|Recruiting||N/A|24|Anticipated|University of Aarhus|||2||f||||t||||||Samples With DNA|"     Blood samples, urine, subcutaneous adipose tissue, visceral adipose tissue and liver tissue.   "|Undecided||2017-10-10 23:23:26.777963|2017-10-10 23:23:26.777963
NCT02419066|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-19|||February 2015||2015-02-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|META||Examining HIV Treatment Adherence During Early Disease|Examining HIV Treatment Adherence During Early Disease|Active, not recruiting||N/A|904|Actual|Massachusetts General Hospital|||3||f||||f||||||Samples Without DNA|"     plasma, dried blood spots   "|||2017-10-10 23:23:26.858305|2017-10-10 23:23:26.858305
NCT02419053|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-10-12|||October 2008||2008-10-01|October 2016|2016-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Evaluating the Effect of Surgical Safety Checklists on Perioperative Complications in Children|Evaluating the Effect of Surgical Safety Checklists on Perioperative Complications in Children|Completed||N/A|28772|Actual|The Hospital for Sick Children|||2||f||||f||||||||||2017-10-10 23:23:26.932082|2017-10-10 23:23:26.932082
NCT02419040|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-09-14|||April 2015||2015-04-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of Calcific Tendinitis of the Rotator Cuff|Treatment of Calcific Tendinitis of the Rotator Cuff - a Multi-centre, Randomized and Sham Controlled Trial (KALK Study)|Recruiting||N/A|210|Anticipated|Martina Hansen's Hospital||3|||f||||f||||||||||2017-10-10 23:23:27.012792|2017-10-10 23:23:27.012792
NCT02419027|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-16|||May 2015||2015-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||A Multi-center Human Study to Evaluate the Efficacy and Safety of ®GI Flora in Subjects With Irritable Bowel Syndrome||Unknown status|Not yet recruiting|N/A|116|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 23:23:27.124599|2017-10-10 23:23:27.124599
NCT02419014|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-07-01|||February 2014||2014-02-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|CES in RLS||Cranial Electrotherapy for Military Beneficiaries With Restless Legs Syndrome|Cranial Electrotherapy for Military Beneficiaries With Restless Legs Syndrome|Active, not recruiting||N/A|48|Actual|Tripler Army Medical Center||3|||f||||t||||||||||2017-10-10 23:23:27.185949|2017-10-10 23:23:27.185949
NCT02419001|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-06-26|2016-11-15||March 2015||2015-03-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy|A Phase 1b/2a, Randomized, Multi-center, Open-label, Fixed-sequence Study to Evaluate the Effect of Oral SYN-004 on the Pharmacokinetics of Intravenous Ceftriaxone in Healthy Adult Subjects With a Functioning Ileostomy|Completed||Phase 1/Phase 2|11|Actual|Synthetic Biologics Inc.||4|||f||||f||||||||||2017-10-10 23:23:27.279473|2017-10-10 23:23:27.279473
NCT02418988|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-13|||July 2014||2014-07-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma|Multicenter, Open-labeled, Controlled Phase II Study: Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma|Recruiting||Phase 2|120|Anticipated|Shenzhen SiBiono GeneTech Co.,Ltd||2|||f||||f||||||||||2017-10-10 23:23:27.563183|2017-10-10 23:23:27.563183
NCT02418975|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-03-17|||April 2015||2015-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pre-operative Very Low-calorie Protein-based Versus Hypocaloric Enteral Nutrition|Pre-operative Very Low-calorie Protein-based Versus Hypocaloric Enteral Nutrition to Improve Intra- and Post-operative Outcomes of Severely Obese Patients Undergoing Bariatric Surgery|Recruiting||N/A|140|Anticipated|San Giuseppe Moscati Hospital||2|||f||||f||||||||||2017-10-10 23:23:27.642569|2017-10-10 23:23:27.642569
NCT02418962|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-03-01|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults|Phase 1, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Equatoguinean Adults|Completed||Phase 1|33|Actual|Sanaria Inc.||3|||f||||t||||||||||2017-10-10 23:23:27.743024|2017-10-10 23:23:27.743024
NCT02418949|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-06-12|||November 2015||2015-11-01|June 2017|2017-06-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Altering Activation Patterns Post-stroke|Altering Activation Patterns in the Distal Upper Extremity After Stroke|Recruiting||N/A|100|Anticipated|Shirley Ryan AbilityLab||4|||f||||f||||||||No||2017-10-10 23:23:27.958561|2017-10-10 23:23:27.958561
NCT02418936|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-15|||January 2015||2015-01-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Development and Clinical Application of Two New Genetic Deafness Gene Diagnostic Kit|Development and Clinical Application of Two New Genetic Deafness Gene|Recruiting||N/A|100|Anticipated|Xiangya Hospital of Central South University|||2||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-10 23:23:28.108487|2017-10-10 23:23:28.108487
NCT02418923|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-05-10|||April 2015||2015-04-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||HemoSonics-UVA Spinal Surgery|HemoSonics-UVA Spinal Surgery Clinical Study Protocol|Completed||N/A|51|Actual|University of Virginia|||1||f||||f||||||||No||2017-10-10 23:23:28.211586|2017-10-10 23:23:28.211586
NCT02418910|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-05-02|||October 2015||2015-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods|Comparative Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods: A Randomized, Open 52 Week Study for Persons With Bipolar Disorder|Completed||N/A|50|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-10-10 23:23:28.276651|2017-10-10 23:23:28.276651
NCT02418897|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-11-15|||April 2015||2015-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Role of Neuromuscular Junction Function in Motor Fatigue in Multiple Sclerosis|Does Abnormal Neuromuscular Junction Function Play a Role in the Pathogenesis of Motor Fatigue in Women With Multiple Sclerosis?|Completed||N/A|40|Actual|Texas Tech University Health Sciences Center|||1||f||||t||||||||||2017-10-10 23:23:28.347255|2017-10-10 23:23:28.347255
NCT02418884|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-13|||April 2015||2015-04-01|April 2015|2015-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus|The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus|Not yet recruiting||Phase 4|122|Anticipated|Sir Run Run Shaw Hospital||1|||f||||t||||||||||2017-10-10 23:23:28.422654|2017-10-10 23:23:28.422654
NCT02418871|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-04-25|||January 2015||2015-01-01|April 2016|2016-04-01|October 2018|Anticipated|2018-10-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of the FluidVisionTM AIOL With an Improved Injector|Clinical Evaluation of the FluidVisionTM Accommodating Intraocular Lens With an Improved Injector System|Active, not recruiting||Phase 3|60|Anticipated|PowerVision||1|||f||||f||||||||||2017-10-10 23:23:28.519817|2017-10-10 23:23:28.519817
NCT02418858|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-10-08|||February 2015||2015-02-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Essential Tremor|Randomized Controlled Clinical Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Essential Tremor|Withdrawn||N/A|0|Actual|St. Joseph's Hospital and Medical Center, Phoenix||2||Lack of subject enrollment|f||||f||||||||||2017-10-10 23:23:28.62233|2017-10-10 23:23:28.62233
NCT02418845|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-03-02||2016-03-02|May 2015||2015-05-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis|A Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 2 Grams for the Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis|Completed||Phase 3|189|Actual|Symbiomix Therapeutics||2|||f||||f||||||||||2017-10-10 23:23:28.721833|2017-10-10 23:23:28.721833
NCT02418832|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-05-23|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Testis Needle Aspiration of Sperm in Men With Azoospermia|Rete Testis Needle Aspiration for Retrieval of Sperm in Men With Azoospermia Using Ultrasound Guidance|Not yet recruiting||N/A|150|Anticipated|Hadassah Medical Organization||1|||f||||f|f|f||||||||2017-10-10 23:23:28.845634|2017-10-10 23:23:28.845634
NCT02351817|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-12-07|2015-10-27||February 2015||2015-02-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Ileostomy opereated subjects|An Explorative Randomized Controlled Investigation Evaluating Newly Developed Ostomy Products||Completed||N/A|10|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-10 23:37:21.072859|2017-10-10 23:37:21.072859
NCT02418806|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-01-19|||January 2014||2014-01-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|July 2014|Actual|2014-07-01||Interventional|cuiDem||Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres|Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres|Completed||N/A|231|Actual|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation||3|||f||||f||||||||||2017-10-10 23:23:29.074225|2017-10-10 23:23:29.074225
NCT02418793|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-09-13|||May 2015||2015-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B|A Phase 1/2a, Open-Label, Multicenter, Dose Escalation Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) Profile of a Long Acting Recombinant FVIIa (MOD-5014) in Adult Men With Hemophilia A or B|Recruiting||Phase 1/Phase 2|24|Anticipated|Opko Biologics||6|||f||||t||||||||||2017-10-10 23:23:29.206664|2017-10-10 23:23:29.206664
NCT02418780|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-08-18|||May 2014||2014-05-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease|Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease|Completed||N/A|32|Actual|Harvard University Faculty of Medicine||2|||f||||t||||||||||2017-10-10 23:23:29.371161|2017-10-10 23:23:29.371161
NCT02418767|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-10-28|||January 2015||2015-01-01|April 2015|2015-04-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers|A Randomized, Double-blind, Vehicle-controlled, Parallel Group, Single Dose Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Three Doses of Long Acting HGH Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers|Completed||Phase 1|42|Actual|Opko Biologics||3|||f||||f||||||||||2017-10-10 23:23:29.46963|2017-10-10 23:23:29.46963
NCT02418754|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-02-16|||April 2015||2015-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|August 2016|Actual|2016-08-01||Interventional|CAPELLA||"Study of Intravitreal REGN2176-3 in Patients With Neovascular (Wet) Age-Related Macular Degeneration (AMD)"|A Phase 2, Double-Masked, Randomized, Controlled, Multiple-Dose, Regimen-Ranging Study of the Efficacy and Safety of Intravitreal REGN2176-3 in Patients With Neovascular Age-Related Macular Degeneration|Terminated||Phase 2|505|Actual|Regeneron Pharmaceuticals||3||No additional efficacy seen with REGN2176-3 over aflibercept alone|f||||f||||||||||2017-10-10 23:23:29.571527|2017-10-10 23:23:29.571527
NCT02418741|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2015-04-18|||August 2013||2013-08-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|THHEIEIA||Head Position for Endotracheal Intubation|The Degree of Neck Flexion Does Not Influence on the Laryngeal View and Discomfort During Endotracheal Intubation in Adult Patients|Completed||N/A|50|Actual|National Medical Center, Seoul||1|||f||||t||||||||||2017-10-10 23:23:29.839465|2017-10-10 23:23:29.839465
NCT02418728|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-11-17|||August 2014||2014-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Observational|BALO||The Role of Atrial Natriuretic Peptide in the Lipolytic Process: Effect of Obesity and Exercise|The Contribution of Atrial Natriuretic Peptide in Lipid Mobilization of Subjects With Obesity, Both During Rest and Exercise|Completed||N/A|30|Actual|Hasselt University|||2||f||||f||||||||Undecided||2017-10-10 23:23:29.906246|2017-10-10 23:23:29.906246
NCT02418715|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-15|||February 2011||2011-02-01|April 2015|2015-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women|Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women: A Randomized Controlled Trial|Completed||N/A|30|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||||||||||||2017-10-10 23:23:29.989129|2017-10-10 23:23:29.989129
NCT02418702|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-08-18|||December 2016||2016-12-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study to Decrease Suicidal Thinking Using Ketamine|A Randomized Controlled Trial to Decrease Suicidal Thinking Using Ketamine|Not yet recruiting||Phase 3|40|Anticipated|United States Naval Medical Center, San Diego||2|||f||||t||||||||||2017-10-10 23:23:30.05936|2017-10-10 23:23:30.05936
NCT02418689|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-02-26|||March 2015||2015-03-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens|A Prospective, Open-label, Single-arm, Multi-Center, Phase II Trial of NOV120101 in Patients With HER2-overexpressed Recurrent Stage IV Breast Cancer Who Have Received at Least 2 Prior HER2-directed Regimens|Active, not recruiting||Phase 2|104|Anticipated|National OncoVenture||1|||f||||t||||||||||2017-10-10 23:23:30.153508|2017-10-10 23:23:30.153508
NCT02418676|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-12-09|2015-06-10||March 2013||2013-03-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Insulin Complexation With Hydroxypropyl-beta-cyclodextrin: Use of the Complex in Gel for Healing of Pressure Ulcers|Insulin Complexation With Hydroxypropyl-beta-cyclodextrin: Spectroscopic Evaluation of Molecular Inclusion and Use of the Complex in Gel for Healing of Pressure Ulcers|Completed||Phase 1/Phase 2|15|Actual|State University of Maringá|Small numbers of subjects analyzed because of the type of pressure ulcer selected.|3|||f||||f||||||||||2017-10-10 23:23:30.244345|2017-10-10 23:23:30.244345
NCT02418663|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-05-14|||June 2015||2015-06-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Fluid Responsiveness in the Postoperative Patient: a Prospective Study|Fluid Responsiveness in the Postoperative Patient: a Prospective Study|Unknown status|Not yet recruiting|N/A|245|Anticipated|McGill University Health Center||1|||f||||f||||||||||2017-10-10 23:23:30.490379|2017-10-10 23:23:30.490379
NCT02418650|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-06-22|||March 2015||2015-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|ARIADME||Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male Subjects|A Two-Part Open-Label, Single-Centre Mass Balance, Pharmacokinetics, Biotransformation and Absolute Bioavailability Study of ODM-201 in Healthy Male Subjects|Completed||Phase 1|12|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-10 23:23:30.589303|2017-10-10 23:23:30.589303
NCT02418637|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-11-07|||April 2015||2015-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Pilot Study Testing Feasibility of Health Screening at Farm Site|Worksite Screening for Cardiovascular Risk Factors Among Migrant Agricultural Workers|Completed||N/A|40|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:23:30.728263|2017-10-10 23:23:30.728263
NCT02418624|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-01-20|||May 2015||2015-05-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|REVIVAL||Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer|A Phase I Followed by a Randomized Phase II Trial of Two Cycles Carboplatin-Olaparib Followed by Olaparib Monotherapy Versus Capecitabine in BRCA-1 or -2 Mutated Her2 Negative Advanced Breast Cancer as First Line Treatment|Recruiting||Phase 1|15|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-10 23:23:30.793881|2017-10-10 23:23:30.793881
NCT02418598|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2016-08-29|||April 2015||2015-04-01|August 2016|2016-08-01|January 2022|Anticipated|2022-01-01|October 2017|Anticipated|2017-10-01||Interventional|||AADC Gene Therapy for Parkinson's Disease|A Phase I /II Study of Intra-putaminal Infusion of Adeno-Associated Virus Encoding Human Aromatic L-Amino Acid Decarboxylase in Subjects With Parkinson's Disease|Recruiting||Phase 1/Phase 2|6|Anticipated|Jichi Medical University||2|||f||||t||||||||||2017-10-10 23:23:30.878885|2017-10-10 23:23:30.878885
NCT02418585|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-08-21|||August 7, 2015|Actual|2015-08-07|August 2017|2017-08-01|January 15, 2018|Anticipated|2018-01-15|June 1, 2017|Actual|2017-06-01||Interventional|TRANSFORM-2||A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression|A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects With Treatment-resistant Depression|Active, not recruiting||Phase 3|236|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 23:23:30.976584|2017-10-10 23:23:30.976584
NCT02418572|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-12-19|||April 2015||2015-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|T-TRANSPORT||Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial|Transdermal Testosterone Gel for Poor Ovarian Responders. A Multicenter Double-blind Placebo Controlled Randomized Trial|Recruiting||Phase 3|400|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||t||||||||||2017-10-10 23:23:31.155079|2017-10-10 23:23:31.155079
NCT02418559|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-09-21|||May 2015||2015-05-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult Participants|A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult Subjects|Completed||Phase 1|24|Actual|Janssen Infectious Diseases BVBA||3|||f||||f||||||||||2017-10-10 23:23:31.264094|2017-10-10 23:23:31.264094
NCT02418546|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-14|||April 2015||2015-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|EAT MORE||Electronic-health Application To Measure Outcomes REmotely Clinical Trial|Electronic-health Application To Measure Outcomes REmotely Clinical Trial|Active, not recruiting||N/A|150|Anticipated|Massachusetts General Hospital||3|||f||||f||||||||||2017-10-10 23:23:33.283079|2017-10-10 23:23:33.283079
NCT02418533|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-06-03|||March 2015||2015-03-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Mono-menotropins Versus rFSH Protocol on Embryo Quality|A Prospective, Randomized Trial to Compare Mono-menotropins Protocol for Controlled Ovarian Stimulation (COS) Versus Recombinant Follicle Stimulating Hormone (rFSH) Protocol on Embryo Quality Parameters in IVF Patients|Recruiting||N/A|100|Anticipated|Main Line Fertility Center||2|||f||||f||||||||||2017-10-10 23:23:33.411776|2017-10-10 23:23:33.411776
NCT02418520|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-13|||September 2015||2015-09-01|April 2015|2015-04-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|Miswak||The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection|The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection|Unknown status|Not yet recruiting|N/A|100|Anticipated|King Saud Bin Abdulaziz University for Health Sciences||2|||f||||t||||||||||2017-10-10 23:23:33.527985|2017-10-10 23:23:33.527985
NCT02418507|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-04-13|||April 2015||2015-04-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||An Evaluation of the Effectiveness of a Proprietary Probiotic Blend on Functional Constipation|A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Effectiveness of a Proprietary Probiotic Blend on Functional Constipation|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-10 23:23:33.589146|2017-10-10 23:23:33.589146
NCT02418494|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-06-08|||April 2015||2015-04-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions|Development of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)|Completed||N/A|85|Actual|AIDS Malignancy Consortium|||1||f||||f||||||||||2017-10-10 23:23:33.669047|2017-10-10 23:23:33.669047
NCT02418481|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-07-17|||April 2015||2015-04-01|April 2015|2015-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)|γδ T Cell Immunotherapy for Treatment of Breast Cancer|Completed||Phase 1/Phase 2|40|Actual|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:23:33.761632|2017-10-10 23:23:33.761632
NCT02418468|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-04-19|2017-04-19||April 28, 2015|Actual|2015-04-28|April 2017|2017-04-01|April 19, 2016|Actual|2016-04-19|April 19, 2016|Actual|2016-04-19||Interventional|||Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations|Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations|Completed||Phase 4|24|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:23:33.854758|2017-10-10 23:23:33.854758
NCT02418455|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2017-03-06|||July 2015||2015-07-01|March 2017|2017-03-01||||March 2018|Anticipated|2018-03-01||Interventional|||An Open-Label Study of UX003-rhGUS Enzyme Replacement Treatment in MPS 7 Patients Less Than 5 Years of Age||Active, not recruiting||Phase 2|15|Anticipated|Ultragenyx Pharmaceutical Inc||1|||f||||f||||||||||2017-10-10 23:23:34.118718|2017-10-10 23:23:34.118718
NCT02418442|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-06-06|||July 2015||2015-07-01|May 2017|2017-05-01|December 2028|Anticipated|2028-12-01|June 2028|Anticipated|2028-06-01|10 Years|Observational [Patient Registry]|||Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry|Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry|Recruiting||N/A|10000|Anticipated|Duke University|||1||f||||f||||||Samples With DNA|"     The biosample collection will be in the future. This effort is currently not funded.   "|||2017-10-10 23:23:34.290254|2017-10-10 23:23:34.290254
NCT02418429|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-04-24|||August 2013||2013-08-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2014|Actual|2014-12-01||Interventional|||Resistant Starch and Whey Protein on Energy Metabolism|Combined Effects of Dietary Supplementation With Dietary Resistant Starch (RS) and Whey Protein on Resting Energy Expenditure and Blood Sugar and Insulin Responses in Lean and Obese Men and Women|Active, not recruiting||N/A|32|Actual|Skidmore College||4|||f||||f||||||||Undecided||2017-10-10 23:23:35.013377|2017-10-10 23:23:35.013377
NCT02418416|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-09-04|||May 2015||2015-05-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Novel Approach With Double Agent Artificial Oocyte Activation for Repeated Fertilization Failure Due to Combined Sperm and Oocyte Factor||Completed||N/A|400|Actual|Ibn Sina Hospital||2|||f||||f||||||||||2017-10-10 23:23:35.113591|2017-10-10 23:23:35.113591
NCT02418403|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-06-13|||March 2015||2015-03-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Consumer Engagement to Increase Advance Care Planning: Patient Randomization|Consumer-directed Financial Incentives to Increase Advance Care Planning Among Medi-Cal Patients|Completed||Phase 2/Phase 3|376|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:23:35.205568|2017-10-10 23:23:35.205568
NCT02418390|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-10-23|||April 2015||2015-04-01|October 2016|2016-10-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma|The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma|Recruiting||N/A|5750|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-10 23:23:35.281804|2017-10-10 23:23:35.281804
NCT02418377|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2017-09-16|||August 2015||2015-08-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01|3 Weeks|Observational [Patient Registry]|||Whole-exome Sequencing in Childhood Obesity|Whole-exome Sequencing to Identify Genetic Variants Associated With Severe Childhood Obesity, and Tracking the Changing Prevalence of Obesity Related Complications|Recruiting||N/A|1200|Anticipated|National University, Singapore|||2||f||||f||||||Samples With DNA|"     15-19mls of blood will be extracted from each subject. Blood will be processed to obtain     plasma/serum and DNA will be extracted from blood cells.      Plasma/serum and DNA samples will be stored at -80degree Celsius.   "|||2017-10-10 23:23:35.37316|2017-10-10 23:23:35.37316
NCT02418364|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-04-12|||May 2015||2015-05-01|February 2015|2015-02-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of Reflexology Treatments on IVF Outcome|Randomised ,Blind, Placebo Controlled in Meir Center. Study the Potential of Reflexology Treatments to Help Implant Pregnancy in Ivf Patients|Not yet recruiting||N/A|240|Anticipated|Meir Medical Center||3|||f||||f||||||||||2017-10-10 23:23:35.479867|2017-10-10 23:23:35.479867
NCT02418351|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-11-03|||February 2015||2015-02-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS|An Open-label, Non-randomized, Phase I/II Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS|Terminated||Phase 1/Phase 2|69|Anticipated|Genesis Limited||1||Lack of funding|f||||t||||||||||2017-10-10 23:23:35.570082|2017-10-10 23:23:35.570082
NCT02418338|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-01-25|||January 2014||2014-01-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children|Evaluation of Myocardial Function by Two Dimensional Speckle Tracking Echocardiography in Children With Duchenne Muscular Dystrophy Versus Healthy Children: a Comparative Transversal Multicenter Study|Recruiting||N/A|99|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:23:35.678778|2017-10-10 23:23:35.678778
NCT02418325|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-11-03|||February 2015||2015-02-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS|An Open-label, Non-randomized, Phase I/II Study of Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and Liberation Therapy (When Associated With Chronic Cerebrovascular Venous Insufficiency) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)|Terminated||Phase 1/Phase 2|69|Anticipated|Genesis Limited||1||Lack of funding|f||||t||||||||||2017-10-10 23:23:35.767586|2017-10-10 23:23:35.767586
NCT02418312|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2016-02-05|||January 2012||2012-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer|Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer|Recruiting||N/A|236|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||No||2017-10-10 23:23:35.887232|2017-10-10 23:23:35.887232
NCT02418299|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-16|||March 2012||2012-03-01|April 2015|2015-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Er:YAG Laser Treatment for Female Stress and Mixed Urinary Incontinence (IncontiLase)|Prospective, Single Centre Study of Er:YAG Laser Treatment for Female Stress and Mixed Urinary Incontinence (IncontiLase)|Completed||N/A|175|Actual|Juna d.o.o.||1|||f||||f||||||||||2017-10-10 23:23:36.209778|2017-10-10 23:23:36.209778
NCT02418286|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-03-14|||March 2015||2015-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|3 Months|Observational [Patient Registry]|KLOS||Korean Medicine Registry for Low Back Pain-prospective Observational Multicenter Study (KLOS)|Korean Medicine Registry for Low Back Pain-prospective Observational Multicenter Study (KLOS)|Recruiting||N/A|150|Anticipated|Gachon University Gil Oriental Medical Hospital|||1||f||||f||||||||||2017-10-10 23:23:36.323903|2017-10-10 23:23:36.323903
NCT02418273|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-08-16|||August 1, 2019|Anticipated|2019-08-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders|Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders: a Pilot Study|Not yet recruiting||Phase 1/Phase 2|24|Anticipated|Indiana University||2|||f||||t|t|f||||||||2017-10-10 23:23:36.456975|2017-10-10 23:23:36.456975
NCT02418260|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-10-04|||June 2014||2014-06-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Surgical Interventions for the Treatment of Humeral Shaft Fractures|Surgical Interventions for the Treatment of Humeral Shaft Fractures: Randomized Controlled Clinical Trial|Recruiting||Phase 3|120|Anticipated|Federal University of São Paulo||3|||f||||f||||||||||2017-10-10 23:23:36.622535|2017-10-10 23:23:36.622535
NCT02418247|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-01-18|||May 2013|Actual|2013-05-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer|Phase Ⅱ Non-randomized Multicenter Controlled Trial About Effect of Remnant Ablation Therapy on the Recurrence in Low-risk Differentiated Thyroid Cancer Patients|Active, not recruiting||Phase 2/Phase 3|556|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-10 23:23:36.820383|2017-10-10 23:23:36.820383
NCT02418234|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-08-08|2016-05-19||March 2015||2015-03-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Observational|||T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure|Frequency and Abundance of T790M Mutation on Circulating Tumor DNA in Patients With Non-small Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment Failure: a Perspective Observational Study|Active, not recruiting||N/A|314|Actual|First People's Hospital of Hangzhou|||1||f||||t||||||||||2017-10-10 23:23:36.922154|2017-10-10 23:23:36.922154
NCT02418221|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-04-15|||February 2014||2014-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|||A Provocation Study Using Biogenic Amines to Show the Efficacy of Oral Diamine Oxidase Supplementation|A Doubleblind, Placebo-controlled, Cross-over Provocation Study Using Biogenic Amines to Show the Efficacy of Oral Diamine Oxidase (DAOSiN®) Supplementation in Case of DAO Enzyme Deficiency|Completed||N/A|72|Actual|IPSC AG||1|||f||||t||||||||||2017-10-10 23:23:37.223189|2017-10-10 23:23:37.223189
NCT02418208|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-07-26|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|Normative||Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials|Clinical Trial Protocol for the Establishment of Normative Data of Brain Network Activation (BNA) Using Evoked Response Potentials in Adolescents, Young Adults and Adults|Recruiting||N/A|1500|Anticipated|ElMindA Ltd|||2||f||||f||||||||||2017-10-10 23:23:37.344632|2017-10-10 23:23:37.344632
NCT02418195|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2016-10-25|||April 2015||2015-04-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome|Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome|Recruiting||Phase 2|240|Anticipated|University of Alabama at Birmingham||4|||f||||t||||||||||2017-10-10 23:23:37.451908|2017-10-10 23:23:37.451908
NCT02418169|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-15|||May 2015||2015-05-01|April 2015|2015-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|||Association Between Craniofacial Fractures and Brain Injuries: Diagnostic and Therapeutic Considerations|Association Between Craniofacial Fractures and Brain Injuries: Diagnostic and Therapeutic Considerations|Not yet recruiting||N/A|1000|Anticipated|Turku University Hospital|||4||f||||f||||||||||2017-10-10 23:23:37.699934|2017-10-10 23:23:37.699934
NCT02418156|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-06-28|||May 2015||2015-05-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|PERFORM||A Study on the Use of CorMatrix ®ECM® for Femoral Arterial Reconstruction|A Post Market Observational Study on the Use of CorMatrix ®ECM® for Femoral Arterial Reconstruction|Active, not recruiting||N/A|100|Anticipated|Aziyo Biologics, Inc.|||1||f||||f||||||||||2017-10-10 23:23:37.768356|2017-10-10 23:23:37.768356
NCT02418143|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-06-28|||September 2015||2015-09-01|June 2017|2017-06-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Observational|JUMP||A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope|A Post Market Observational Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope|Withdrawn||N/A|0|Actual|Aziyo Biologics, Inc.|||1||f||||f||||||||||2017-10-10 23:23:37.84972|2017-10-10 23:23:37.84972
NCT02418130|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-04-15|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Ursa Complex Soft Cap. (UDCA-004)' in Patients With Physical Fatigue.||Completed||Phase 4|166|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-10 23:23:37.919603|2017-10-10 23:23:37.919603
NCT02418117|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-01-26|||July 2015||2015-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|STIMPLANTSRG||Accuracy of Computer Guided Implant Surgery|Accuracy of Computer Guided Implant Surgery With the Use of R2Gate Stereolitographic Template|Completed||N/A|25|Actual|Concordia Dent Srl||1|||f||||f||||||||||2017-10-10 23:23:37.999853|2017-10-10 23:23:37.999853
NCT02418104|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-01-05|||May 2015||2015-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Assessing the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta®|A Randomized, Double-Blind, 2-Period Parallel-Arm Study to Assess the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta® in Healthy Subjects|Completed||Phase 1|303|Actual|Coherus Biosciences, Inc.||2|||f||||f||||||||||2017-10-10 23:23:38.100686|2017-10-10 23:23:38.100686
NCT02418091|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-11-18|||March 2015||2015-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|STOP-DKD APP||Integrated Population Program for Diabetic Kidney Disease|STOP-DKD Automated Population Program (APP)|Completed||N/A|131|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:23:38.189467|2017-10-10 23:23:38.189467
NCT02418078|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2015-04-12|||February 2015||2015-02-01|February 2015|2015-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Retrospective Analysis of the Geriatric Patients Underwent Unilateral Inguinal Herniorrhaphy|Retrospective Analysis of the Geriatric Patients Underwent Unilateral Inguinal Herniorrhaphy at Our Institution|Completed||N/A|370|Actual|Diskapi Teaching and Research Hospital|||2||f||||f||||||||||2017-10-10 23:23:38.290509|2017-10-10 23:23:38.290509
NCT02417883|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-13|||April 2015||2015-04-01|April 2015|2015-04-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|FST-IFTA||Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease|Furosemide Stress Test as a Predictor of Tubular Atrophy and Interstitial Fibrosis in Patients With Chronic Kidney Disease|Unknown status|Recruiting|Phase 3|100|Anticipated|Instituto Nacional de Cardiologia Ignacio Chavez||1|||f||||t||||||||||2017-10-10 23:23:40.558922|2017-10-10 23:23:40.558922
NCT02418065|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-07-28|||December 2013||2013-12-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|AMERICANO||Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO)|Multimodal Therapeutic Approach by Exercise, Oral Nutritional Supplementation, Omega 3 and Androgen in Undernourished Maintenance Hemodialysis Patients (AMERICANO)|Recruiting||Phase 3|120|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:23:38.378826|2017-10-10 23:23:38.378826
NCT02418052|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-12|2015-04-15|||January 2014||2014-01-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE|Effect of Neck Flexion on Post-operative Esophagogastric Anastomotic Leakage After Minimally Invasive Esophagectomy: a Single-center Randomized Controlled Trial|Unknown status|Recruiting|N/A|60|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-10 23:23:38.496506|2017-10-10 23:23:38.496506
NCT02418039|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-04-11|||March 10, 2017|Actual|2017-03-10|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy|Effect of a High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy. Double-blind Clinical Trial|Recruiting||N/A|80|Anticipated|Coordinación de Investigación en Salud, Mexico||2|||f||||f|f|f||||||||2017-10-10 23:23:38.579268|2017-10-10 23:23:38.579268
NCT02418026|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-01-11|2016-11-15||February 2013||2013-02-01|January 2017|2017-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Improving Cesarean Section Experience Through Hypnotherapy|Improving Cesarean Section Experience Through Hypnotherapy: a Prospective Single Center Case-control Study|Completed||N/A|79|Actual|Groupe Hospitalier de la Rochelle Ré Aunis||2|||f||||f||||||||||2017-10-10 23:23:38.672254|2017-10-10 23:23:38.672254
NCT02418013|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-01-11|||March 2015||2015-03-01|January 2016|2016-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Clinical Trial to Evaluate the Potential Efficacy and Safety of Human Umbilical Cord Blood and Plasma|A Randomized, Double-blinded and Placebo-controlled Pilot Clinical Trial to Evaluate the Potential Efficacy and Safety of Human Umbilical Cord Blood and Plasma by Clinical Markers of Frailty in Adult Who Defined Pre-Frailty|Active, not recruiting||Phase 1|64|Anticipated|Bundang CHA Hospital||4|||f||||f||||||||||2017-10-10 23:23:39.232505|2017-10-10 23:23:39.232505
NCT02418000|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-08-30|||April 2015||2015-04-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|AML||A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 Mutation|A Phase 1/2a Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 Mutation, Including Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (CMML)|Terminated||Phase 1/Phase 2|28|Anticipated|Strategia Therapeutics||5||Insufficient efficacy in Phase 1 dose-escalation portion of study|f||||t||||||||||2017-10-10 23:23:39.349363|2017-10-10 23:23:39.349363
NCT02417987|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-04-20|||May 2012||2012-05-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||High Volume Injection or Autologous Conditioned Plasma (ACP) in Chronic Achilles Tendinopathy|High Volume Injection (HVI) or Autologous Conditioned Plasma (ACP) in Chronic Achilles Tendinopathy: A Randomized Controlled Double Blinded Trial|Completed||N/A|60|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-10-10 23:23:39.448346|2017-10-10 23:23:39.448346
NCT02417974|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-03-02|||September 2015||2015-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)|Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)|Recruiting||Phase 2|44|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-10 23:23:39.533587|2017-10-10 23:23:39.533587
NCT02417961|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-05-12|2017-03-13||April 27, 2015|Actual|2015-04-27|May 2017|2017-05-01|March 14, 2016|Actual|2016-03-14|March 14, 2016|Actual|2016-03-14||Interventional|||Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home|A Multicenter, Open-Label, Functionality, Reliability, and Performance Study of an Accessorized Pre-filled Syringe With Home-administered Subcutaneous Benralizumab in Adult Patients With Severe Asthma (GREGALE)|Completed||Phase 3|162|Actual|AstraZeneca||1|||f||||t||||||||||2017-10-10 23:23:39.638086|2017-10-10 23:23:39.638086
NCT02417948|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-12-02|||April 2015||2015-04-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans|Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans|Completed||N/A|143|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:23:40.099079|2017-10-10 23:23:40.099079
NCT02417935|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-06-20|||April 2015||2015-04-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)|A Japan Post-Marketing, Randomized, Double-Blind, Parallel-Group, Flexible Dose Comparative Study to Assess the Non-Inferiority of Duloxetine Compared With Pregabalin in Patients With Diabetic Peripheral Neuropathic Pain|Completed||Phase 4|100|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:23:40.186291|2017-10-10 23:23:40.186291
NCT02417922|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-04-15|||February 2011||2011-02-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Autologous Conditioned Plasma Treatment for Conservative Treated Total Achilles Tendon Tears|The Effect of Autologous Conditioned Plasma Treatment for Conservative Treated Total Achilles Tendon Tears: Randomized Double Blinded Placebo Control Trial|Completed||N/A|40|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-10 23:23:40.287544|2017-10-10 23:23:40.287544
NCT02417909|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-08-04|||July 2011||2011-07-01|May 2015|2015-05-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Observational|QOL-ADOB||Overweight, Quality of Life and Psychological Difficulties in Teenagers|Quality of Life and Psychological Difficulties in Relation With the Weight of Teenagers|Completed||N/A|173|Actual|Lille Catholic University|||2||f||||f||||||||||2017-10-10 23:23:40.36531|2017-10-10 23:23:40.36531
NCT02417896|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-15|||April 2013||2013-04-01|March 2013|2013-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery|Pilot Non Randomised Controlled Trial of Short Term Spironolactone Use for Prevention of Acute Kidney Injury After Cardiac Surgery|Unknown status|Recruiting|N/A|150|Anticipated|Instituto Nacional de Cardiologia Ignacio Chavez||2|||f||||f||||||||||2017-10-10 23:23:40.445384|2017-10-10 23:23:40.445384
NCT02417870|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-07-17|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|||Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation|Safety and Efficacy of Treatment With Ultra-low Dose Subcutaneous IL-2 to Promote Regulatory T Cells Post Renal Transplantation|Active, not recruiting||Phase 1/Phase 2|5|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-10 23:23:40.651431|2017-10-10 23:23:40.651431
NCT02417857|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-15|||January 2011||2011-01-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of Single İncision Laparoscopic Cholecystectomy Versus Laparoscopic Cholecystectomy|Quality-of-life, Body Image and Cosmesis After Single Incision Laparoscopic Cholecystectomy (SILC) Versus Conventional Laparoscopic Cholecystectomy (CLC)|Completed||N/A|58|Actual|Ankara Mevki Military Hospital||2|||f||||t||||||||||2017-10-10 23:23:40.723508|2017-10-10 23:23:40.723508
NCT02417844|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-07-21|||April 2015||2015-04-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.|Single Center, Single Dose, Open-label, Randomized, Two-way Crossover Study to Determine Bioequivalence of Two Formulations Containing Tamsulosin HCl 04.mg MR Capsules in at Least 30 Healthy Male Subjects Under Fed Conditions|Completed||Phase 1|||Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:23:40.799942|2017-10-10 23:23:40.799942
NCT02417831|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-07-21|||April 2015||2015-04-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.|Single Center, Single Dose, Open-label, Randomized, Two-way Crossover Study to Determine Bioequivalence of Two Formulations Containing Tamsulosin HCl 04.mg MR Capsules in at Least 30 Healthy Male Subjects Under Fasted Conditions|Completed||Phase 1|||Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:23:40.884635|2017-10-10 23:23:40.884635
NCT02417818|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-01-28|||March 2015||2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cutaneous Microcirculation After Plasma Therapy|Effects of Plasma Therapy in Cutaneous Microcirculation of Different Wounds|Recruiting||N/A|240|Anticipated|University of Schleswig-Holstein||12|||f||||f||||||||||2017-10-10 23:23:40.967894|2017-10-10 23:23:40.967894
NCT02417805|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-01-28|||March 2015||2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cutaneous Microcirculation After Remote Ischemic Preconditioning|Effects of Remote Ischemic Preconditioning in Cutaneous Microcirculation of Different Wounds|Recruiting||N/A|80|Anticipated|University of Schleswig-Holstein||4|||f||||f||||||||||2017-10-10 23:23:41.065934|2017-10-10 23:23:41.065934
NCT02417792|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2015-04-16|||May 2015||2015-05-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|January 2016|Anticipated|2016-01-01||Observational|PIB||The Association Between Psoriasis and Intestinal Bacterial Population|The Association Between Psoriasis and Intestinal Bacterial Population|Unknown status|Not yet recruiting|N/A|40|Anticipated|Assuta Hospital Systems|||3||f||||f||||||Samples Without DNA|"     stool   "|||2017-10-10 23:23:41.145809|2017-10-10 23:23:41.145809
NCT02417779|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-01-28|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy|Effects of Extracorporeal Shock Wave Therapy in Cutaneous Microcirculation of Different Wounds|Recruiting||N/A|240|Anticipated|University of Schleswig-Holstein||12|||f||||f||||||||||2017-10-10 23:23:41.212732|2017-10-10 23:23:41.212732
NCT02417766|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-10-05|||April 7, 2015||2015-04-07|July 12, 2017|2017-07-12|December 31, 2018|Anticipated|2018-12-31|July 31, 2018|Anticipated|2018-07-31||Observational|||NIAID Clinical Center Genomics Opportunity Protocol|NIAID Clinical Center Genomics Opportunity Protocol|Active, not recruiting||N/A|138|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:23:41.305947|2017-10-10 23:23:41.305947
NCT02417753|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-05-05|2017-03-23||April 3, 2015|Actual|2015-04-03|May 2017|2017-05-01|April 7, 2016|Actual|2016-04-07|April 7, 2016|Actual|2016-04-07||Interventional|||AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites|A Pilot Study of AZD9150, a STAT3 Antisense Oligonucleotide in Malignant Ascites|Terminated||Phase 2|1|Actual|National Institutes of Health Clinical Center (CC)||1||Study was closed because we could not find these types of patients.|f||||f|t|f||||||No||2017-10-10 23:23:41.373059|2017-10-10 23:23:41.373059
NCT02417740|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-06-30|||March 30, 2015||2015-03-30|January 4, 2017|2017-01-04|December 31, 2050|Anticipated|2050-12-31|December 31, 2050|Anticipated|2050-12-31||Observational|||Natural History of Noncirrhotic Portal Hypertension|Natural History of Noncirrhotic Portal Hypertension|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:23:41.650996|2017-10-10 23:23:41.650996
NCT02417727|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-06-30|||March 23, 2015||2015-03-23|October 23, 2015|2015-10-23|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Feasibility Study of Deep Brain Recordings for Learning and Memory|A Feasibility Study of Deep Brain Recordings for Learning and Memory|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:23:41.722976|2017-10-10 23:23:41.722976
NCT02417714|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-15|2017-10-05|||September 3, 2014||2014-09-03|August 25, 2017|2017-08-25|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)|Prospective Evaluation of Next Generation CT Reconstruction|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:23:41.776551|2017-10-10 23:23:41.776551
NCT02417688|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2016-12-11|||April 2015||2015-04-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis|PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With [64]Cu-25%CANF-Comb|Recruiting||Phase 1|22|Anticipated|Washington University School of Medicine||1|||f||||f||||||||Undecided||2017-10-10 23:23:41.936203|2017-10-10 23:23:41.936203
NCT02338063|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-04-05|||May 2010||2010-05-01|April 2016|2016-04-01||||January 2016|Actual|2016-01-01||Interventional|||Eliciting Affect in Teens in a Virtual World (Project AVATAR)|Eliciting Affect in Teens in a Virtual World (Project AVATAR)|Completed||Phase 1/Phase 2|196|Actual|Rhode Island Hospital||2|||f||||f||||||||||2017-10-10 23:39:55.914523|2017-10-10 23:39:55.914523
NCT02417675|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-12-04|||February 2015||2015-02-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|PACER||Postpartum Adherence Clubs to Enhance Support: the PACER Study|Postpartum Adherence Clubs to Enhance Support: the PACER Study|Active, not recruiting||N/A|258|Actual|Columbia University||2|||f||||t||||||||||2017-10-10 23:23:42.020875|2017-10-10 23:23:42.020875
NCT02417662|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-05-16|||August 2016||2016-08-01|August 2016|2016-08-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|SARON||Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer|Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer. A Randomised Phase III Trial|Recruiting||Phase 3|340|Anticipated|University College, London||2|||f||||t||||||||||2017-10-10 23:23:42.104868|2017-10-10 23:23:42.104868
NCT02417649|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-04-10|||September 2009||2009-09-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|AIACE||Advanced Immunological Approach in COPD Exacerbation|Sublingual Administration of a Polyvalent Mechanical Bacterial Lysate in Patients With Moderate, Severe or Very Severe COPD According to GOLD Classification: a Multicenter, Double Blind, Randomized, Controlled, Phase IV Study|Completed||Phase 4|288|Actual|Lallemand Pharma International||2|||f||||t||||||||||2017-10-10 23:23:42.344231|2017-10-10 23:23:42.344231
NCT02417636|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-04-14|||February 2015||2015-02-01|April 2015|2015-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SHARE||Sharing HIV/AIDS Responsibilities and Efforts|Impact of Task Shifting Type II for ART Delivery on Patient and Process Outcomes in Uganda|Unknown status|Recruiting|N/A|1600|Anticipated|Makerere University||2|||f||||t||||||||||2017-10-10 23:23:42.462498|2017-10-10 23:23:42.462498
NCT02417623|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-14|||January 2015||2015-01-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|OBSBIT||Smartphone Application for Weight Loss|Efficacy of a Mobile Application for Weight Loss in Overweight and Obese Adults: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|76|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-10-10 23:23:42.551595|2017-10-10 23:23:42.551595
NCT02417610|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-04-14|||September 2014||2014-09-01|April 2015|2015-04-01|September 2017|Anticipated|2017-09-01|September 2015|Anticipated|2015-09-01||Interventional|PNHA1401||Comparative Assessment of Viscosupplementation With Polynucleotides and Hyaluronic Acid|Comparative Assessment of Viscosupplementation With Polynucleotides and Hyaluronic Acid to Viscosupplementation With Hyaluronic Acid in the Treatment of Osteoarthritis of the Knee. Randomized, Double-blind, Controlled Study|Unknown status|Recruiting|N/A|100|Anticipated|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-10 23:23:42.660899|2017-10-10 23:23:42.660899
NCT02417597|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2016-05-17|||April 2015||2015-04-01|October 2015|2015-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)|Safety and Immunogenicity Study of the Recombinant Hepatitis E Vaccine(Escherichia Coli) in Healthy Volunteers Aged Over 65 Years|Completed||Phase 4|600|Actual|Xiamen Innovax Biotech Co., Ltd||3|||f||||f||||||||||2017-10-10 23:23:42.764213|2017-10-10 23:23:42.764213
NCT02417584|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2015-04-14|||June 2009||2009-06-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy of PAP Therapy on Blood Pressure|The Role of Compliance With Positive Airway Pressure Use on Blood Pressure in Patients With Obstructive Sleep Apnea|Completed||N/A|1168|Actual|University of Crete||1|||f||||f||||||||||2017-10-10 23:23:42.857034|2017-10-10 23:23:42.857034
NCT02417571|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2015-04-22|||April 2015||2015-04-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|ACCURATE||Effect of Ambulatory BP Monitoring on the CliniCal coUrse and RenAl ouTcomE of CKD|Effect of Ambulatory BP Monitoring on the CliniCal coUrse and RenAl ouTcomE of Chronic Kidney Disease|Recruiting||Phase 4|188|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:23:42.943041|2017-10-10 23:23:42.943041
NCT02417558|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-14|||February 2015||2015-02-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|AlterniityAR||Cognitive/Physical Computer-Game Blended Training With Personalized Brain Network Activation Technology for the Elderly|Study to Evaluate the Effectiveness of Personalized Brain Network Activation Technology in a Cognitive/Physical Computer-Game Blended Training of Elderly (Alterniity AR)|Enrolling by invitation||N/A|800|Anticipated|XtremeVRI AG||5|||f||||f||||||||||2017-10-10 23:23:43.055404|2017-10-10 23:23:43.055404
NCT02417545|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-10-24|||February 2015||2015-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|November 2015|Actual|2015-11-01||Observational|Gaze||Gaze and Stair Walking in Patients With Vestibular Dysfunction|Gaze and Movement Behavior of Patients With Vestibular Dysfunction During Level Floor, Ramp, and Stair Walking|Completed||N/A|48|Actual|University of Zurich|||1||f||||f||||||||Yes|Publication|2017-10-10 23:23:43.150114|2017-10-10 23:23:43.150114
NCT02417532|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2016-12-26|2016-12-26||May 2015||2015-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SAFE RAPPER||Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX|Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX|Terminated||N/A|57|Actual|Rex Bionics Plc|Trial was terminated early. PI determined that after 57 subjects with successful results and no AE's, remaining subjects would add not statistical relevance to trial success.|1||PI determined additional subjects would not change outcome|f||||f||||||||No||2017-10-10 23:23:43.218872|2017-10-10 23:23:43.218872
NCT02417519|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-11|2015-04-11|||April 2014||2014-04-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|September 2014|Actual|2014-09-01||Interventional|||Coffee Roasting and Glucose Tolerance|Acute Effects of Light and Dark Roasted Coffee on Glucose Tolerance: A Randomized, Controlled Crossover Trial in Healthy Volunteers|Unknown status|Active, not recruiting|N/A|11|Actual|University of Copenhagen||6|||f||||f||||||||||2017-10-10 23:23:43.526945|2017-10-10 23:23:43.526945
NCT02417506|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-05-06|||August 2014||2014-08-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Osteolanc||Study to Assess the Effect of E-OA-07 on Acute Pain Response in Subjects Suffering From Knee OA|A Double Blind Randomized Comparator Controlled Study to Assess the Effect of E-OA-07 (Lanconone) on Acute Pain Response in Subjects Suffering From Osteoarthritis of the Knee|Completed||N/A|72|Actual|Vedic Lifesciences Pvt. Ltd.||2|||f||||f||||||||||2017-10-10 23:23:43.638758|2017-10-10 23:23:43.638758
NCT02417493|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-06-30|||March 2015||2015-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Self-injection and Self-management|Epinephrine Self-injection and Self-management of Food Allergies|Completed||N/A|60|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:23:43.723925|2017-10-10 23:23:43.723925
NCT02417480|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-05-10|||April 2015||2015-04-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|VeganBytes||Differences in Eating Frequency Between Vegan and Omnivorous Diets|Differences in Eating Frequency Between Vegan and Omnivorous Diets|Completed||Phase 1|34|Actual|University of South Carolina||2|||f||||f||||||||Undecided||2017-10-10 23:23:43.807602|2017-10-10 23:23:43.807602
NCT02417467|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-12-07|||November 2016||2016-11-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial|Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial|Recruiting||Phase 3|486|Anticipated|McGill University||3|||f||||t||||||||||2017-10-10 23:23:43.889276|2017-10-10 23:23:43.889276
NCT02417454|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-01-15|||September 2015||2015-09-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Study on the Effects of a Probiotic on Autonomic and Psychological Stress|A Double Blind Placebo Controlled Study on the Effects of a Probiotic on Autonomic and Psychological Stress Responses in Volunteers|Active, not recruiting||Phase 3|128|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 23:23:43.990997|2017-10-10 23:23:43.990997
NCT02417441|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-02-27|||June 2015||2015-06-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|TiLE||TiLE (Time Lapse Eeva) Clinical Trial|A Phase IV, Prospective, Randomized, Exploratory, Multicenter, Eeva™ Trial (Time Lapse Eeva - TiLE)|Completed||Phase 4|1002|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-10 23:23:44.092552|2017-10-10 23:23:44.092552
NCT02417428|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-12-15|||June 2015||2015-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CITEX||Citrulline Supplementation Combined With Exercise: Effect on Muscle Function in Elderly People (CITEX Study)|Effects of Citrulline Supplementation Combined With Exercise on Muscle Function and Functional Capacity in Older Obese Men and Women|Recruiting||Phase 1/Phase 2|160|Anticipated|Universite du Quebec a Montreal||4|||f||||f||||||||||2017-10-10 23:23:44.167952|2017-10-10 23:23:44.167952
NCT02417415|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-06-01|||April 2015||2015-04-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Local Heat Stress in Autonomic Failure Patients With Supine Hypertension|Local Heat Stress in Autonomic Failure Patients With Supine Hypertension|Recruiting||N/A|21|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 23:23:44.314515|2017-10-10 23:23:44.314515
NCT02417402|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-10|||May 2015||2015-05-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Efficacy of Educating Physical Therapists in the Treatment of Patients With Nonspecific Chronic Low Back Pain|Efficacy of Educating Physical Therapists on Clinical Practice Guidelines and Pain Management in the Treatment of Patients With Nonspecific Chronic Low Back Pain: a Cluster Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|150|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||f||||||||||2017-10-10 23:23:44.417796|2017-10-10 23:23:44.417796
NCT02417389|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-11|||May 2008||2008-05-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|October 2011|Actual|2011-10-01||Interventional|CA-PHP||Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism|Efficacy of a Calcimimetic (Cinacalcet) in the Long Term Control of Patients With Primary Hyperparathyroidism|Completed||Phase 4|22|Actual|Istituto Auxologico Italiano||1|||f||||f||||||||||2017-10-10 23:23:44.511914|2017-10-10 23:23:44.511914
NCT02417376|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2017-01-05|2016-02-25||May 2013||2013-05-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||All are CHD patients - never smoker, without any other systemic disease|Changes in the Risk Factors of Coronary Heart Disease Observed After Scaling and Root Planing|Effect of Nonsurgical Periodontal Treatment on Systemic Risk Markers of Cardiovascular Disease Clinically and Biochemically: A Randomized Trial|Completed||N/A|70|Actual|Government College of Dentistry, Indore|populations were taken only from a single center, the dropout, strict inclusion criteria, total number of patients to be included in the study was limited, influence of medical drug management of CHD not taken into consideration.|2|||f||||f||||||||No||2017-10-10 23:23:44.617894|2017-10-10 23:23:44.617894
NCT02417363|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-04-16|||October 2013||2013-10-01|April 2015|2015-04-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Observational|||Study on the Relationship Between Periodontitis and Renal Disease|Affiliated Hospital of Stomatology, School of Medicine, Zhejiang University|Unknown status|Recruiting|N/A|200|Anticipated|Zhejiang University|||4||f||||t||||||Samples Without DNA|"     Samples are placed into 1.5 ml Eppendorf tubes and maintained at -70℃ for further analysis   "|||2017-10-10 23:23:45.1061|2017-10-10 23:23:45.1061
NCT02417350|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-11-04|||April 2015||2015-04-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ketogenic Diet - a Randomized, Controlled, Cross-over Study|A Randomized Controlled Diet Intervention Comparing Effects of a Ketogenic Diet Versus a National Food Administration Recommended Diet Among Healthy Female Adults|Completed||N/A|24|Actual|Umeå University||2|||f||||f||||||||||2017-10-10 23:23:45.173757|2017-10-10 23:23:45.173757
NCT02417324|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-09-08|||January 2015||2015-01-01|September 2016|2016-09-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||International HIT-MED Registry (I-HIT-MED)|International HIT-MED Registry (I-HIT-MED) for Children, Adolescents, and Adults With Medulloblastoma, Ependymoma, Pineoblastoma, CNS-primitive Neuroectodermal Tumours|Recruiting||N/A|500|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||Samples With DNA|"     Tumour samples   "|||2017-10-10 23:23:45.346235|2017-10-10 23:23:45.346235
NCT02417311|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-09-19|||June 2014||2014-06-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|IndivuHeart||Individualized Early Risk Assessment for Heart Diseases|Individualized Early Risk Assessment for Heart Diseases|Recruiting||N/A|80|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||3||f||||f||||||Samples With DNA|"     Skin biopsy and blood   "|||2017-10-10 23:23:45.487664|2017-10-10 23:23:45.487664
NCT02417298|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-01-30|||November 2015||2015-11-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|KISS||Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department|Ketamine Infusion for Acute Sickle Cell crisiS in the Emergency Department|Recruiting||N/A|60|Anticipated|The Brooklyn Hospital Center||2|||f||||f||||||||||2017-10-10 23:23:45.595168|2017-10-10 23:23:45.595168
NCT02417285|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-05-09|||May 22, 2015|Actual|2015-05-22|May 2017|2017-05-01|July 16, 2018|Anticipated|2018-07-16|June 16, 2018|Anticipated|2018-06-16||Interventional|||A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapsed/Refractory DLBCL and iNHL.|A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 in Combination With Obinutuzumab (GA101) in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Indolent Non-Hodgkin's Lymphoma|Recruiting||Phase 1|79|Anticipated|Celgene||1|||f||||f||||||||||2017-10-10 23:23:45.701236|2017-10-10 23:23:45.701236
NCT02417272|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-06-02|||November 2015||2015-11-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|CERVIDISC||Total Disc Replacement Versus Anterior Cervical Decompression and Fusion|Comparison of 2 Surgical Approaches in the Treatment of Cervical Degenerative Disc Disease: Total Disc Replacement Versus Anterior Cervical Decompression and Fusion|Recruiting||N/A|110|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:23:45.793162|2017-10-10 23:23:45.793162
NCT02417259|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-08-15|||July 2015||2015-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Observational|||Near Infrared Spectroscopy in Cyanotic Congenital Heart Disease|Changes in Cerebral and Somatic Near Infrared Spectroscopy Monitoring Before and After Surgery for in Children With Cyanotic Heart Disease|Active, not recruiting||N/A|40|Actual|KK Women's and Children's Hospital|||1||f||||f||||||||||2017-10-10 23:23:46.003515|2017-10-10 23:23:46.003515
NCT02417246|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-06-02|||August 2015||2015-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Open-Labeled PK-PD Studies of Metoprolol ER|Open-Labeled Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Metoprolol ER|Recruiting||Phase 4|50|Anticipated|University of Florida||2|||f||||t|t|f||||||||2017-10-10 23:23:46.077034|2017-10-10 23:23:46.077034
NCT02417220|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-03-28|||April 2015||2015-04-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|WWO 2015||Weight Watchers Online 2015||Completed||N/A|92|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-10-10 23:23:46.301772|2017-10-10 23:23:46.301772
NCT02417207|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-10|||April 2015||2015-04-01|April 2015|2015-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation|Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation|Not yet recruiting||Phase 4|60|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 23:23:46.37953|2017-10-10 23:23:46.37953
NCT02417194|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-05-05|||April 2015||2015-04-01|May 2015|2015-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|36 Months|Observational [Patient Registry]|||Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell Carcinoma|Prospective Cohort Study for the Impact of Preoperative Glycemic Control Status Measured by HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Renal Cell Carcinoma|Recruiting||N/A|238|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-10 23:23:46.487203|2017-10-10 23:23:46.487203
NCT02417181|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-04-06|||April 2014||2014-04-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The (Cost-)Effectiveness of Physician Assistants Working at the Primary Out of Hours Emergency Service|The (Cost-)Effectiveness of Physician Assistants Working at the Primary Out of Hours Emergency Service|Completed||N/A|10161|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 23:23:46.568147|2017-10-10 23:23:46.568147
NCT02417168|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-04-24|||April 2015||2015-04-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study|Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients - Pilot Study|Unknown status|Recruiting|N/A|50|Anticipated|CAMC Health System|||1||f||||f||||||||||2017-10-10 23:23:46.654485|2017-10-10 23:23:46.654485
NCT02417155|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-11-09|||November 2014||2014-11-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|INADRI||Increasing Plasma Adrenaline Levels Through Breathing Techniques - an Explorative Study|Increasing Plasma Adrenaline Levels Through Breathing Techniques - an Explorative Study|Completed||N/A|40|Actual|Radboud University||4|||f||||f||||||||||2017-10-10 23:23:46.735636|2017-10-10 23:23:46.735636
NCT02417142|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-10-28|||September 2014||2014-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia|Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia|Recruiting||Phase 4|70|Anticipated|University of Massachusetts, Worcester||2|||f||||||||||||||2017-10-10 23:23:46.839605|2017-10-10 23:23:46.839605
NCT02417129|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-12-05|2016-12-05||April 2015||2015-04-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||"The randomized set (RS) includes all subjects who were randomized to a treatment.
No patient was randomized to rituximab."|BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma|A Phase III, Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate Efficacy and Safety of BI 695500 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma|Terminated||Phase 3|2|Actual|Boehringer Ingelheim|As the program was prematurely discontinued and only two patients were randomized at the time of discontinuation, the planned statistical analysis was not performed and safety data are therefore presented in this abbreviated Clinical Trial Report.|2|||f||||||||||||||2017-10-10 23:23:46.935793|2017-10-10 23:23:46.935793
NCT02417116|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-01-30|||June 2015||2015-06-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Tear Osmolarity Clinical Utility in Dry Eye Disease|Tear Osmolarity Clinical Utility in Dry Eye Disease|Active, not recruiting||N/A|120|Anticipated|Aston University||3|||f||||f||||||||||2017-10-10 23:23:47.249697|2017-10-10 23:23:47.249697
NCT02417103|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-08-02|||December 2011||2011-12-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid|Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon|Terminated||Phase 3|2|Actual|Universitätsklinikum Hamburg-Eppendorf||2||Recruiting failure|f||||f||||||||||2017-10-10 23:23:47.379193|2017-10-10 23:23:47.379193
NCT02417090|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-04-14|||May 2015||2015-05-01|April 2015|2015-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|DIARA2||Late Metabolic Effects of Metformin Therapy in Gestational Diabetes|Metformin Therapy for Gestational Diabetes - Metabolic Late Effects on Child at 9 Years of Age|Enrolling by invitation||N/A|317|Anticipated|Turku University Hospital|||2||f||||f||||||Samples With DNA|"     Whole blood for DNA extraction   "|||2017-10-10 23:23:47.468483|2017-10-10 23:23:47.468483
NCT02417077|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-03-10|||December 2015||2015-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Perception of Facial Expression in Subjects With and Without Crow's Feet Lines||Completed||N/A|393|Actual|Allergan|||1||f||||f||||||||||2017-10-10 23:23:47.559947|2017-10-10 23:23:47.559947
NCT02417064|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-09-22|||August 10, 2015|Actual|2015-08-10|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|April 18, 2018|Anticipated|2018-04-18||Interventional|TRANSFORM-1||A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression|A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects With Treatment-resistant Depression|Recruiting||Phase 3|348|Anticipated|Janssen Research & Development, LLC||3|||f||||t||f||||||||2017-10-10 23:23:47.653811|2017-10-10 23:23:47.653811
NCT02417051|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2016-12-15|||April 2015||2015-04-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||The Efficacy of a Brief Resilience Training Program for Hurricane Sandy Disaster Responders|The Efficacy of a Brief Resilience Training Program for Hurricane Sandy Disaster Responders|Completed||N/A|202|Actual|Stony Brook University||2|||f||||f||||||||||2017-10-10 23:23:48.06485|2017-10-10 23:23:48.06485
NCT02417038|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-05-03|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|April 15, 2016|Actual|2016-04-15|April 15, 2016|Actual|2016-04-15||Observational|||Postoperative Respiratory Monitoring After Neuraxial Opioid Administration for Cesarean Delivery|Postoperative Respiratory Monitoring After Neuraxial Opioid Administration for Cesarean Delivery|Completed||N/A|80|Actual|Stanford University|||1||f||||f||||||||||2017-10-10 23:23:48.142407|2017-10-10 23:23:48.142407
NCT02417025|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-09-29|||August 2014||2014-08-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Innovative Delivery of Evidence Based Psychotherapy to Women With Military Sexual Trauma|Do You Really Expect Me to Get MST Care in a VA Where Everyone is Male? Innovative Delivery of Evidence Based Psychotherapy to Women With Military Sexual Trauma (MST)|Recruiting||N/A|100|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:23:48.226522|2017-10-10 23:23:48.226522
NCT02417012|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-04-27|||April 2015||2015-04-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Lifestyle and Glucose Lowering Medication in T2DM|Does Intensive Life Style Intervention Reduce the Need for Glucose Lowering Medications in Patients With Type 2 Diabetes? The U-TURN Project|Active, not recruiting||N/A|97|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:23:48.334227|2017-10-10 23:23:48.334227
NCT02416999|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-02-17|||May 2015||2015-05-01|February 2016|2016-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas|Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas|Not yet recruiting||N/A|30|Anticipated|Hebei Yanda Hospital||1|||f||||t||||||||||2017-10-10 23:23:48.429879|2017-10-10 23:23:48.429879
NCT02416986|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-01-30|||October 2014||2014-10-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|CC2pilot||Effects of Smoking Environment on Craving and Smoking|Effects of Smoking Environment on Craving and Smoking: A Pilot Study|Completed||N/A|41|Actual|Duke University||1|||f||||f||||||||||2017-10-10 23:23:48.572155|2017-10-10 23:23:48.572155
NCT02416973|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-12-19|2016-10-26||March 2015||2015-03-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study of PEMF (Pulsed Electromagnetic Field) Therapy in the Treatment of Persistent Post-Operative Pain Following Lumbar Surgery||Completed||N/A|41|Actual|Regenesis Biomedical, Inc.||3|||f||||||||||||||2017-10-10 23:23:48.634799|2017-10-10 23:23:48.634799
NCT02416960|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-14|||January 2012||2012-01-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of the Glycemic Index of Diet on Metabolic and Reproductive Parameters in Overweight and Obese Infertile Women|Effect of a Hypocaloric Diet With Different Glycemic Indexes on Ghrelin and Leptin Levels, Metabolic Parameters, and Reproductive Outcomes in Overweight and Obese Infertile Women: A Randomized Clinical Trial|Completed||N/A|45|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||||2017-10-10 23:23:48.945142|2017-10-10 23:23:48.945142
NCT02416947|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-14|||March 2012||2012-03-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal Women|The Effect of Soluble Corn Fiber (SCF) on Bone Resorption in Post-Menopausal Women Using 41Calcium Technology|Completed||N/A|14|Actual|Purdue University||3|||f||||f||||||||||2017-10-10 23:23:49.0547|2017-10-10 23:23:49.0547
NCT02416934|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-11-15|||July 2012||2012-07-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Interventional|DysDexVSSal||Dysphagia Following Anterior Cervical Spine Surgery; Steroid vs Saline|The Effects of Perioperative Steroids on Dysphagia Following Anterior Cervical Spine Surgery: A Randomized, Prospective, Double-Blind Study.|Active, not recruiting||N/A|74|Actual|West Virginia University||2|||f||||t||||||||Yes|Group data will be available via publication. Participants are told their randomization assignment at one year, or up to two year, follow up post surgery, dependent on their return to clinic.|2017-10-10 23:23:49.130755|2017-10-10 23:23:49.130755
NCT02416921|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-05-20|||April 2015||2015-04-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|FB--Pilot||Preventing Weight Gain in African American Reproductive-Aged Women|Preventing Weight Gain in African American Reproductive-Aged Women: Pilot Program|Completed||N/A|18|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:23:49.219944|2017-10-10 23:23:49.219944
NCT02416908|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-20|||June 16, 2015|Actual|2015-06-16|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia|An Investigator Sponsored Phase I/II Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|52|Anticipated|Washington University School of Medicine||3|||f||||t|t|f||||||||2017-10-10 23:23:49.294964|2017-10-10 23:23:49.294964
NCT02416895|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-04-04|||April 2014||2014-04-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Vitamin D Status and Immune Function|Vitamin D Status and in Vivo Immune Function|Completed||N/A|264|Actual|Bangor University|||1||f||||t||||||Samples Without DNA|"     Blood serum collected at Week 1 (start of training) and Week 13 (end of training).   "|||2017-10-10 23:23:51.40474|2017-10-10 23:23:51.40474
NCT02416882|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-09-21|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|ExGenes||Exercise Genes: Genomic Association With Exercise Reinforcement|Exercise Genes: Genomic Association With Exercise Reinforcement|Completed||N/A|88|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 23:23:51.479121|2017-10-10 23:23:51.479121
NCT02416869|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-05-03|||January 2014||2014-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dexamethasone in Lower Third Molar Surgery|Effectiveness of Different Application Modalities of Dexamethasone on Clinical Parameters and Quality of Life After Lower Third Molar Surgery|Recruiting||Phase 4|60|Anticipated|University of Belgrade||6|||f||||f||||||||||2017-10-10 23:23:51.556509|2017-10-10 23:23:51.556509
NCT02416856|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-14|||June 2014||2014-06-01|April 2015|2015-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Brain Connectivity Supporting Language Recovery in Aphasia|Brain Connectivity Supporting Language Recovery in Aphasia|Recruiting||Phase 2|74|Anticipated|Medical University of South Carolina|||1||f||||f||||||||||2017-10-10 23:23:51.659591|2017-10-10 23:23:51.659591
NCT02416843|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-15|||September 2011||2011-09-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Metabolic and Immune System Responses to a Mixed Meal|Metabolic and Immune System Responses to a Mixed Meal in Human Adipose Tissue and the Circulation|Completed||N/A|30|Actual|University of Bath||3|||f||||f||||||||||2017-10-10 23:23:51.740391|2017-10-10 23:23:51.740391
NCT02416830|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-14|||April 2014||2014-04-01|April 2015|2015-04-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01|12 Months|Observational [Patient Registry]|EmboReg||Worldwide Therapeutic Embolization Cohort Post Market Registry|Worldwide Therapeutic Embolization Cohort Post Market Registry|Recruiting||N/A|250|Anticipated|EmboCoH|||1||f||||f||||||||||2017-10-10 23:23:51.824688|2017-10-10 23:23:51.824688
NCT02416817|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-11-01|||July 2014||2014-07-01|November 2015|2015-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|STATA||Strategy of Transfusion in Trauma Patients - STATA Trial|Clinical Trial: Evaluation of 2 Different Protocols of Blood Derivates Transfusion in Acute Trauma Patients in a Brazilian Tertiary Hospital|Completed||Phase 4|156|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||Yes|Individual patient data collected can be shared if needed.|2017-10-10 23:23:51.895532|2017-10-10 23:23:51.895532
NCT02416804|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-05-02|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|July 2016|Actual|2016-07-01||Interventional|||Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery|Postoperative Analgesia With Buprenorphine Transdermal System (BTDS) Versus Tramadol for Postoperative Pain Control and Quality of Life After Spinal Surgery|Completed||Phase 4|69|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:23:51.96756|2017-10-10 23:23:51.96756
NCT02416791|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-05-15|||June 2015||2015-06-01|December 2015|2015-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ROTS||Robotic Therapy and Transcranial Direct Current Stimulation in Patients With Stroke|Robotic Therapy and Transcranial Direct Current Stimulation in Patients With Stroke|Terminated||N/A|9|Actual|University of Sao Paulo General Hospital||3||Because of low recruitment rates|f||||t||||||||||2017-10-10 23:23:52.043812|2017-10-10 23:23:52.043812
NCT02416778|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-09-27|||February 2015||2015-02-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Intravenous Iron (Ferinject®) on Exercise Capacity and Quality of Life of Stable COPD Patients|Effect of Intravenous Iron (Ferinject®) on Exercise Capacity and Quality of Life of Stable COPD Patients|Recruiting||Phase 4|20|Anticipated|Otto Wagner Hospital||1|||f||||f||||||||||2017-10-10 23:23:52.140253|2017-10-10 23:23:52.140253
NCT02416765|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-11-13|||May 2015||2015-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes|An Open-label, Randomized, Five-way, Cross-over Study to Compare the Efficacy of Single- and Dual-hormone Closed-loop Operations Combined With Either Conventional Carbohydrate Counting or a Simplified Qualitative Meal-size Estimation, and Sensor-augmented Pump Therapy in Regulating Glucose Levels in Adults With Type 1 Diabetes|Completed||Phase 2|15|Actual|Institut de Recherches Cliniques de Montreal||5|||f||||f||||||||||2017-10-10 23:23:52.331356|2017-10-10 23:23:52.331356
NCT02416752|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-14|||August 2011||2011-08-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Effect of Remifentanil on the Recovery Profile After Prolonged Head and Neck Surgery|Effect of Remifentanil on the Recovery Profile After Prolonged Head and Neck Surgery|Completed||N/A|222|Actual|Singapore General Hospital|||2||f||||f||||||||||2017-10-10 23:23:52.465721|2017-10-10 23:23:52.465721
NCT02416739|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-04-03|||March 2015||2015-03-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Anticancer Activity of Nicotinamide on Lung Cancer|Randomized Double-blinded Comparative Trial to Study the Add-on Activity of Combination Treatment of Nicotinamide on Progression Free Survival for EGFR Mutated Lung Cancer Terminal Stage Patients Being Treated With Gefitinib or Erlotinib|Recruiting||Phase 2/Phase 3|110|Anticipated|Chungbuk National University||2|||f||||t||||||||Undecided||2017-10-10 23:23:52.569892|2017-10-10 23:23:52.569892
NCT02416713|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-01-09|||April 2015||2015-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Way to Safety Cellphone Blocking|Way to Safety: Cellphone Blocking Technology to Reduce Cellphone Use While Driving Among Teens|Recruiting||N/A|250|Anticipated|Children's Hospital of Philadelphia||4|||f||||f||||||||||2017-10-10 23:23:52.801532|2017-10-10 23:23:52.801532
NCT02416700|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-05-24|||May 2016||2016-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|Mpigozzo||Evaluation of Peri Implant Bone Loss of Immediately Versus Conventionally Loaded Implants With a Single Prosthesis|Evaluation of Peri Implant Bone Loss of Immediately Loaded Versus Conventionally Loaded Implants With a Single Prosthesis: A Randomized and Clinical Study Split-mouth Experimental Design|Recruiting||N/A|12|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:23:52.909461|2017-10-10 23:23:52.909461
NCT02416687|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-22|||March 2014||2014-03-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Etonogestrel Implant and Postpartum Insertion|Immediate Post-partum Initiation of Etonogestrel-releasing Implant: a Randomized Controlled Trial on Breastfeeding Impact|Completed||Phase 4|24|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:23:53.009776|2017-10-10 23:23:53.009776
NCT02416674|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-07-18|||March 2015||2015-03-01|July 2016|2016-07-01|February 2025|Anticipated|2025-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects|Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects|Recruiting||Early Phase 1|10|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||No||2017-10-10 23:23:53.125232|2017-10-10 23:23:53.125232
NCT02416661|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-05-04|||March 2015||2015-03-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Observational|LYSO-PROVE||LYSO-PROVE - Determine the Prognostic Value of Lyso-Gb1 for Monitoring the Progress of Gaucher Disease|Lyso-Gb1 as Long-term Prognostic Biomarker in Gaucher Disease - an International Multicenter Epidemiological Study (LYSO-PROVE) to Determine the Prognostic Value of Lyso-Gb1 for Monitoring the Progress of Gaucher Disease|Recruiting||N/A|250|Anticipated|University of Rostock|||1||f||||f||||||Samples With DNA|"     lyso-Gb1 as biomarker for Gaucher Disease For the purpose of measuring lyso-Gb1 one filter     card is sent to the following laboratory, Centogene AG, Schillingallee 68, 18057 Rostock,     Germany   "|Undecided||2017-10-10 23:23:53.224445|2017-10-10 23:23:53.224445
NCT02416648|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-04-14|||January 2014||2014-01-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effectiveness of Clinician Client Centered Counseling on Sexual Behaviors of Antiretroviral Therapy Patients in Nigeria|Effectiveness of Clinician Client Centered Counseling on Knowledge, Attitudes and Sexual Behaviors of Antiretroviral Therapy Patients in Yola, Nigeria|Completed||N/A|386|Actual|Universiti Putra Malaysia||3|||f||||t||||||||||2017-10-10 23:23:53.39217|2017-10-10 23:23:53.39217
NCT02416635|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2015-12-28|||June 2013||2013-06-01|April 2015|2015-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|Completed||N/A|60|Actual|Fuda Cancer Hospital, Guangzhou|||4||f||||f||||||||||2017-10-10 23:23:53.455607|2017-10-10 23:23:53.455607
NCT02416596|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-10|||January 2016||2016-01-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility|Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility: A Randomized Control Trial|Not yet recruiting||N/A|680|Anticipated|Ain Shams Maternity Hospital||2|||f||||f||||||||||2017-10-10 23:23:53.743921|2017-10-10 23:23:53.743921
NCT02416583|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-02-14|||April 2015||2015-04-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term|Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term|Recruiting||N/A|140|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:23:53.825652|2017-10-10 23:23:53.825652
NCT02416570|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-09-15|||April 2015||2015-04-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?|Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?|Terminated||Phase 2|1|Actual|University of Nottingham||2||At 6 months 1 participant recruited. Study deemed not feasible and discontinued.|f||||f||||||||||2017-10-10 23:23:53.908023|2017-10-10 23:23:53.908023
NCT02416557|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-09|||May 2015||2015-05-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of PEEP on Intraoperative Hypothermia|Effect of Positive End Expiratory Pressure on Intraoperative Body Temperature in Patients Undergoing Spine Surgery; a Prospective Randomized Study|Unknown status|Not yet recruiting|N/A|42|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:23:53.992284|2017-10-10 23:23:53.992284
NCT02416544|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2015-04-14|||April 2014||2014-04-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|HPH||The Effectiveness of Low Calorie Low Salt Lunch for Weight Reduction of Workers of a Health Promoting Hospital||Completed||N/A|109|Actual|Seoul National University Hospital||3|||f||||f||||||||||2017-10-10 23:23:54.189953|2017-10-10 23:23:54.189953
NCT02416531|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|August 2016|Actual|2016-08-01||Interventional|VLSCBCPPTLIL||Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser|Vulvar Lichen Sclerosus: Therapeutic Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser|Active, not recruiting||N/A|60|Anticipated|University of Nove de Julho||3|||f||||f||||||||||2017-10-10 23:23:54.294292|2017-10-10 23:23:54.294292
NCT02416518|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-05-23|||May 2014||2014-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Observational|GEMMA||Genetic Exploration of the Molecular Basis of Malignancy in Adults|Genetic Exploration of the Molecular Basis of Malignancy in Adults|Active, not recruiting||N/A|120|Actual|Sanford Health|||1||f||||t||||||Samples With DNA|"     Tissue and blood samples   "|No||2017-10-10 23:23:54.441134|2017-10-10 23:23:54.441134
NCT02416505|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-10-02|||September 2014||2014-09-01|October 2016|2016-10-01||||March 2015|Actual|2015-03-01||Interventional|||The Age of OrthoInfo: A Randomized Controlled Trial Evaluating Patient Comprehension of Informed Consent||Completed||N/A|67|Actual|University of Missouri, Kansas City||3|||f||||||||||||||2017-10-10 23:23:54.518301|2017-10-10 23:23:54.518301
NCT02416492|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-13|||January 2016||2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|STEMTRA||A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)|A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)|Recruiting||Phase 2|52|Anticipated|SanBio, Inc.||2|||f||||t||||||||||2017-10-10 23:23:54.597258|2017-10-10 23:23:54.597258
NCT02416479|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2016-10-24|||June 2014||2014-06-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MAGIC||SystemCHANGE: An Intervention for Medication Change in Adult Kidney Transplant Patients|SystemCHANGE: An Intervention for Medication Adherence in Transplant Recipients|Recruiting||Phase 3|92|Anticipated|University of Missouri, Kansas City||2|||f||||t||||||||||2017-10-10 23:23:54.756065|2017-10-10 23:23:54.756065
NCT02416466|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-03-02|||April 2015||2015-04-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|HITM-SIR||CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases|Phase Ib Trial of CAR-T Hepatic Artery Infusions Followed by Selective Internal Radiation Therapy (SIRT) With Yttrium-90 Sir-Spheres® for CEA-Expressing Liver Metastases|Active, not recruiting||Phase 1|8|Actual|Roger Williams Medical Center||1|||f||||t||||||||No||2017-10-10 23:23:54.854275|2017-10-10 23:23:54.854275
NCT02416453|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-10|2017-10-02|||June 15, 2015|Actual|2015-06-15|October 2017|2017-10-01|November 17, 2017|Anticipated|2017-11-17|November 17, 2017|Anticipated|2017-11-17||Interventional|||A Study to Assess Safety Tolerability and Immunogenicity of Three Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults|A Randomized, Observer-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Prime-Boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo in Healthy Adults in Europe|Active, not recruiting||Phase 2|408|Actual|Janssen Vaccines & Prevention B.V.||3|||f||||t||f||||||||2017-10-10 23:23:54.944652|2017-10-10 23:23:54.944652
NCT02416440|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-04-09|||January 2014||2014-01-01|April 2014|2014-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|DDS||Durban Diabetes Study:A Study of the Epidemiology of Diabetes Mellitus in Urban South Africans of African Descent (DDS)|Durban Diabetes Study: A Population Based Cross-sectional Study of the Epidemiology of Diabetes Mellitus in Urban South Africans of African Descent|Completed||Early Phase 1|1200|Actual|University of KwaZulu|||1||f||||f||||||Samples With DNA|"     1. whole blood for DNA extraction and genetic analysis.        2. EDTA whole blood for Full Blood Count and Glycosylated Haemoglobin        3. EDTA whole blood for Hepatitis C Viral load test and RNA extraction for whole virus          genome sequencing.        4. Plain serum for liver function test, serum lipids, insulin and c-peptide, and for viral          markers- HIV, Hepatitis .        5. Sodium Fluoride tubes for plasma glucose   "|||2017-10-10 23:23:55.074327|2017-10-10 23:23:55.074327
NCT02416427|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-04-09|||May 2015||2015-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TRINACRIA||Targeting the Hippo Transducer TAZ in Breast Cancer With Statins|A Phase II, Randomized, Non-comparative, Pre-surgical Study of Atorvastatin or Observation in Ki-67 Positive, TAZ-expressing Early Breast Cancer Patients (TRINACRIA Trial)|Unknown status|Not yet recruiting|Phase 2|78|Anticipated|Regina Elena Cancer Institute||2|||f||||f||||||||||2017-10-10 23:23:55.167276|2017-10-10 23:23:55.167276
NCT02416414|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-03-28|||July 2015||2015-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients||Terminated||N/A|166|Actual|QIAGEN Gaithersburg, Inc|||2|Sponsor decided not to go forward with study for FDA submission.|f||||f||||||||||2017-10-10 23:23:55.244245|2017-10-10 23:23:55.244245
NCT02416401|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-09-29|||November 2015||2015-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALERT||Attention Training for Learning Enhancement and Resilience Trial|Attention Training for Learning Enhancement and Resilience Trial|Recruiting||N/A|120|Anticipated|Posit Science Corporation||2|||f||||t||||||||||2017-10-10 23:23:55.346133|2017-10-10 23:23:55.346133
NCT02416388|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-04-12|||January 2015||2015-01-01|April 2017|2017-04-01||||June 2024|Anticipated|2024-06-01||Interventional|BIG-1||Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR|Phase II/III Randomized Study to Improve Overall Survival in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus Mycophenolate Mofetil Prophylaxis of Graft Versus Host Disease in Allografted Patients in First CR : a Backbone InterGroup-1 Trial|Recruiting||Phase 2/Phase 3|3100|Anticipated|University Hospital, Angers||10|||f||||t||||||||||2017-10-10 23:23:55.486431|2017-10-10 23:23:55.486431
NCT02416375|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-02-16|||May 2015||2015-05-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Observational|SmartCare||Home Monitoring to Predict Exacerbation in Cystic Fibrosis|A Standardized Multi-centre Analysis of Remote Monitoring in Cystic Fibrosis Adult Patients to Reduce Pulmonary Exacerbations|Recruiting||N/A|200|Anticipated|Papworth Hospital NHS Foundation Trust|||1||f||||t||||||Samples Without DNA|"     Daily sputum samples   "|||2017-10-10 23:23:55.852144|2017-10-10 23:23:55.852144
NCT02416362|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-04-09|||August 2014||2014-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Immediate Effects of Whole Body Vibration on Neuromuscular Performance of Quadriceps Femoris and Balance|Immediate Effects of Whole Body Vibration on Neuromuscular Performance of Quadriceps Femoris and Balance of Healthy Women: a Randomized Controlled Trial|Completed||N/A|60|Actual|Universidade Federal do Rio Grande do Norte||3|||f||||f||||||||||2017-10-10 23:23:55.944733|2017-10-10 23:23:55.944733
NCT02416349|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-04-09|||November 2013||2013-11-01|March 2014|2014-03-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Acute Effects After Stretching Respiratory Muscles on Ventilatory Pattern and Volume Distribution of Chest Wall|Acute Effects After Stretching Respiratory Muscles on Ventilatory Pattern and Volume Distribution of Chest Wall in Patients With Stroke: a Randomized Crossover Clinical Trial|Completed||N/A|10|Actual|Universidade Federal de Pernambuco||2|||f||||f||||||||||2017-10-10 23:23:56.012518|2017-10-10 23:23:56.012518
NCT02416336|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-04-03|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes|Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes|Completed||N/A|100|Actual|Oncovision Inc||1|||f||||||||||||||2017-10-10 23:23:56.118878|2017-10-10 23:23:56.118878
NCT02416323|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-09|||April 2012||2012-04-01|April 2015|2015-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|AIM HI||Effectiveness and Implementation of a Mental Health Intervention for ASD|Effectiveness and Implementation of a Mental Health Intervention for ASD|Unknown status|Enrolling by invitation|N/A|607|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:23:56.197312|2017-10-10 23:23:56.197312
NCT02416297|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-09-05|||April 2015||2015-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|January 2016|Actual|2016-01-01||Interventional|||Three- Dimensional Evaluation of Accelerated Tooth Movement|Three- Dimensional Evaluation of Accelerated Tooth Movement|Active, not recruiting||N/A|22|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:23:56.36216|2017-10-10 23:23:56.36216
NCT02416284|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-04-14|||September 2012||2012-09-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Compliance to the Norwegian Food-Based Dietary Guidelines in Young Females||Completed||N/A|14|Actual|University of Oslo||1|||f||||||||||||||2017-10-10 23:23:56.450295|2017-10-10 23:23:56.450295
NCT02416271|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-09|||April 2001||2001-04-01|April 2015|2015-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|FACT||The Forteo Alendronate Comparator Trial|Teriparatide Compared With Alendronate on Spine Bone Mineral Density in Postmenopausal Women With Osteoporosis|Completed||Phase 4|203|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 23:23:56.541027|2017-10-10 23:23:56.541027
NCT02416258|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LP0113-1123||A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)|A Phase 2a Trial Evaluating the Anti-psoriatic Effect of LP0113 Aerosol Spray Compared With Its Vehicle and With Daivobet® Gel, LEO 90100 Aerosol Foam, Betamethasone Dipropionate Aerosol Spray and Calcipotriol Aerosol Spray in the Treatment of Psoriasis Vulgaris|Completed||Phase 2|50|Actual|LEO Pharma||6|||f||||f||||||||||2017-10-10 23:23:56.86842|2017-10-10 23:23:56.86842
NCT02416245|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-07-02|||July 2014||2014-07-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children|Impact of a Beverage Powder Fortified With Multiple Micronutrients (MMN) and Bacopa Monnieri Extract (EBM) on Cognitive Variables in Indian School Children (7-12yrs; Inclusive) After 4 Months of Intervention: a Double Blind, Randomized Controlled Trial|Completed||N/A|310|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-10 23:23:57.473211|2017-10-10 23:23:57.473211
NCT02416232|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-08-09||||||August 2017|2017-08-01||||||||Expanded Access|||Access Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma|An Open Label Non Randomized Access Study of Trametinib for Patients With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma|No longer available||N/A|||GlaxoSmithKline|||||f||||||||||||||2017-10-10 23:23:57.60557|2017-10-10 23:23:57.60557
NCT02416219|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-03-02|||May 2015||2015-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|||Efficacy of Surface Landmark Palpation for Identification of the Cricoid Cartilage in Obstetric Patients|Efficacy of Surface Landmark Palpation for Identification of the Cricoid Cartilage in Obstetric Patients|Completed||N/A|90|Actual|Lawson Health Research Institute|||1||f||||t||||||||||2017-10-10 23:23:57.791107|2017-10-10 23:23:57.791107
NCT02416206|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-06-08|||April 2015||2015-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma|A Phase II Trial of High-dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) in the Up-front Treatment of Multiple Myeloma|Recruiting||Phase 2|65|Anticipated|Northside Hospital, Inc.||1|||f||||f||||||||||2017-10-10 23:23:57.917805|2017-10-10 23:23:57.917805
NCT02416193|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-08-11|||April 2015||2015-04-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|THINK-D||Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)|Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)|Recruiting||Phase 2|80|Anticipated|Loyola University||2|||f||||f||||||||||2017-10-10 23:23:58.068979|2017-10-10 23:23:58.068979
NCT02415998|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-26|||July 2012||2012-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 23, 2017|Actual|2017-09-23||Observational|||Transesophageal Echocardiography (TEE) to Guide and Confirm Epidural Catheters in Pediatric Patients|Transesophageal Echocardiography (TEE) to Guide and Confirm Epidural Catheters in Pediatric Patients|Recruiting||N/A|20|Anticipated|University of Iowa|||1||f||||f||||||||||2017-10-10 23:23:59.840646|2017-10-10 23:23:59.840646
NCT02416180|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-04-26|2016-04-07||June 18, 2015|Actual|2015-06-18|April 2017|2017-04-01|August 20, 2015|Actual|2015-08-20|August 20, 2015|Actual|2015-08-20||Interventional|||Study to Evaluate Handling Errors in Usage of SERETIDE® Metered Dose Inhaler (MDI) (EVOHALER®) by Adult Subjects Currently Using the SERETIDE DISKUS® Inhaler|An Open-label Study Investigating Critical and Overall Errors Following 14 Days of Treatment With SERETIDE Metered Dose Inhaler (EVOHALER) in Adult Subjects With Controlled Asthma Currently Using the SERETIDE DISKUS Inhaler|Completed||Phase 4|111|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 23:23:58.244491|2017-10-10 23:23:58.244491
NCT02416167|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-02-13|||May 2015||2015-05-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Study of FYU-981 in Hyperuricemia With or Without Gout|Confirmatory Study of FYU-981 for Hyperuricemia With or Without Gout (Phase II (IIb) Study)|Completed||Phase 2|200|Anticipated|Fuji Yakuhin Co., Ltd.||5|||f||||f||||||||||2017-10-10 23:23:58.600342|2017-10-10 23:23:58.600342
NCT02416154|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-05-03|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Observational|Epsilon||Expression of IFN-epsilon in the Female Reproductive Tract|IFN-epsilon and Hormonal Contraceptive Modulation of the Risk of HIV Acquisition, Part 1: Expression in the Female Reproductive Tract|Active, not recruiting||N/A|32|Anticipated|University of Pittsburgh|||2||f||||f||||||Samples Without DNA|"     whole blood plasma vaginal swabs cervical swabs Vaginal fluid collected by sponge     cervicovaginal lavage fluid cervical cells collected by cytobrush vaginal biopsies cervical     biopsies endometrial biopsies   "|||2017-10-10 23:23:58.692223|2017-10-10 23:23:58.692223
NCT02416141|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-08|||April 2015||2015-04-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Fast-release Orodispersible Tramadol as Analgesia in Termination of Pregnancy by Vacuum Aspiration.|Fast-release Orodispersible Tramadol as Analgesia in Termination of Pregnancy by Vacuum Aspiration.|Unknown status|Not yet recruiting|Phase 4|128|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-10 23:23:58.78576|2017-10-10 23:23:58.78576
NCT02416128|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-09|||April 2015||2015-04-01|April 2015|2015-04-01||||March 2016|Anticipated|2016-03-01||Interventional|||Use of Topical Euphrasia, a Homeopathic Remedy in Ophthalmology|Use of Topical Euphrasia, a Homeopathic Remedy in Ophthalmology|Unknown status|Enrolling by invitation|Phase 2|100|Anticipated|Larkin Community Hospital||2|||f||||t||||||||||2017-10-10 23:23:58.87845|2017-10-10 23:23:58.87845
NCT02416115|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-02-19|||July 2014||2014-07-01|April 2014|2014-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia|Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia After Gynecologic Surgery|Completed||N/A|90|Actual|Kyungpook National University||3|||f||||f||||||||||2017-10-10 23:23:58.979705|2017-10-10 23:23:58.979705
NCT02416102|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-06-16|||October 2015|Actual|2015-10-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis|Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis|Recruiting||N/A|60|Anticipated|University of Miami||2|||f||||f||||||||No|individual participant data will be use for analysis only. This is a proof of concept protocol. Results are for research purpose only.|2017-10-10 23:23:59.065754|2017-10-10 23:23:59.065754
NCT02416089|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-11-28|||April 2015||2015-04-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Tampostat for Management of Postpartum Hemorrhage|Tampostat: A Low-cost, Self-regulating Tamponade for Management of Postpartum Hemorrhage in Bangladesh|Recruiting||Phase 1/Phase 2|344|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 23:23:59.180909|2017-10-10 23:23:59.180909
NCT02416076|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-02-16|||December 2014||2014-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers|Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck Using Standard Transducers Versus Simulines Transducers|Completed||N/A|42|Actual|Ulthera, Inc||6|||f||||f||||||||||2017-10-10 23:23:59.298881|2017-10-10 23:23:59.298881
NCT02416063|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-04-08|||January 2014||2014-01-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children|Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children: A Randomised Controlled Double Blind Study|Completed||Phase 2|75|Actual|University of Jordan||3|||f||||t||||||||||2017-10-10 23:23:59.393912|2017-10-10 23:23:59.393912
NCT02416050|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-09-28|||February 2015||2015-02-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|QUIT-COC||Predicting Relapse After Cocaine Inpatient Cessation|Prospective Prediction of Cocaine Relapse After Inpatient Cessation by Combining Functional Imaging and Neuropsychological Biomarkers With Craving and Impulsivity Measures|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-10-10 23:23:59.489291|2017-10-10 23:23:59.489291
NCT02416037|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-01-05|||January 2016||2016-01-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|T3P||Trans-pulmonary Pressure in ARDS|Trans-Pulmonary Pressure and Prone Position in Ards Patients|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:23:59.575356|2017-10-10 23:23:59.575356
NCT02416024|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-26|||August 2013||2013-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|||Arterial Stiffness and General Anesthesia Induced Hypotension in Patients on Angiotensin-converting Enzyme Inhibitors|Arterial Stiffness as a Predictor of Refractory Hypotension After Induction of General Anesthesia in Patients Chronically Treated With Angiotensin-converting Enzyme Inhibitors|Active, not recruiting||N/A|80|Anticipated|University of Iowa|||2||f||||f||||||||||2017-10-10 23:23:59.678326|2017-10-10 23:23:59.678326
NCT02416011|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-08-04|||March 31, 2015|Actual|2015-03-31|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes|Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes|Active, not recruiting||N/A|2896|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f|f|f||||||||2017-10-10 23:23:59.75119|2017-10-10 23:23:59.75119
NCT02415985|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-08-09|||June 2015||2015-06-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly|A Pilot Study of the Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly With Lopinavir/Ritonavir Based HAART in HIV/TB Co-infected Patients|Recruiting||Phase 2|40|Anticipated|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||f||||||||||2017-10-10 23:23:59.928868|2017-10-10 23:23:59.928868
NCT02415972|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-07-08|||October 2012||2012-10-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|March 2014|Actual|2014-03-01||Observational|||Dynamic Contrast-enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Acute Ischemic Stroke|Dynamic Contrast-enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Acute Ischemic Stroke|Completed||N/A|33|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 23:24:00.079977|2017-10-10 23:24:00.079977
NCT02415959|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-03-07|2016-01-20||March 2015||2015-03-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|A Phase II, Multicenter, Parallel-Group, Active-Controlled, Randomized, Double-blind, Dose-Ranging Study to Evaluate the Efficacy and Safety of Different Doses of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|Completed||Phase 2|70|Actual|Abbott||5|||f||||f||||||||||2017-10-10 23:24:00.182558|2017-10-10 23:24:00.182558
NCT02415946|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-05-10|||February 2015||2015-02-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|SmartLiftRER||Sinus Lift: Saving Time and Reducing Morbidity|Efficacy of a Novel Simplified, Minimally-invasive Procedure for Sinus Floor Elevation in the Atrophic Posterior Maxilla: a Multicenter, Randomized Study|Recruiting||N/A|64|Anticipated|University Hospital of Ferrara||2|||f||||f||||||||||2017-10-10 23:24:00.805776|2017-10-10 23:24:00.805776
NCT02415933|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-02-16|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Child Protective Outcomes Among Ultra-poor Families in Burkina Faso|Evaluating Child Protective Effects of Economic Strengthening and Child Rights Interventions Among Ultra-poor Families in Burkina Faso|Completed||N/A|720|Actual|University of Chicago||3|||f||||f|f|f||||||||2017-10-10 23:24:01.047919|2017-10-10 23:24:01.047919
NCT02415920|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-11-14|||February 2017||2017-02-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||The Influence of Intranasal Oxytocin on Communication|The Influence of Intranasal Oxytocin on Communication|Not yet recruiting||N/A|600|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:24:01.168718|2017-10-10 23:24:01.168718
NCT02415907|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-07-17|||April 2015||2015-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Investigating the Absorption, Metabolism and Excretion (AME) of Idalopirdine|Interventional, Open-label, Two Single Dose, Fixed-sequence Study Investigating the Absorption, Metabolism and Excretion (AME) of Idalopirdine Following a Single Oral Dose of Lu AF67708 ([Ethyl-1-14C]-Idalopirdine) and Lu AF67709 ([Benzyl-7-14C]-Idalopirdine) in Healthy Men|Completed||Phase 1|6|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-10 23:24:01.256855|2017-10-10 23:24:01.256855
NCT02415894|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-07-21|||April 2015||2015-04-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine|Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Ukraine|Completed||N/A|172|Actual|Gynuity Health Projects|||1||f||||f||||||||||2017-10-10 23:24:01.341336|2017-10-10 23:24:01.341336
NCT02415881|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-08-22|||November 2015||2015-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I Panitumumab IRDye800 Optical Imaging Study|Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures|Recruiting||Phase 1|23|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 23:24:01.437759|2017-10-10 23:24:01.437759
NCT02415868|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-02-22|||December 2015||2015-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|FLORA||Ex Vivo High-Throughput Assay for Vaginal Community Post-menopausal Women|Development of an Ex-vivo High-throughput Screening Assay for the Vaginal Microbiota of Post-menopausal Women|Completed||N/A|10|Actual|Kimberly-Clark Corporation|||2||f||||f||||||Samples Without DNA|"     Microbiota from Vaginal Swab   "|No||2017-10-10 23:24:01.563633|2017-10-10 23:24:01.563633
NCT02415855|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-09-19|||March 2015||2015-03-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01|30 Days|Observational [Patient Registry]|CPASS||Canadian Pradaxa Acute Stroke Safety Study|Canadian Pradaxa Acute Stroke Safety Study|Recruiting||N/A|500|Anticipated|University of Alberta|||1||f||||t||||||||||2017-10-10 23:24:01.650178|2017-10-10 23:24:01.650178
NCT02415842|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-05-02|||October 26, 2015|Actual|2015-10-26|May 2017|2017-05-01|June 14, 2019|Anticipated|2019-06-14|June 14, 2019|Anticipated|2019-06-14||Observational|||A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines|An Exploratory, Retrospective Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 HA Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GSK Biologicals' Pandemic Influenza Vaccines|Recruiting||N/A|1|Anticipated|GlaxoSmithKline|||9||f||||||||||Samples With DNA|"     Serum samples   "|||2017-10-10 23:24:01.768439|2017-10-10 23:24:01.768439
NCT02415829|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-09|||November 2014||2014-11-01|April 2015|2015-04-01||||January 2016|Anticipated|2016-01-01||Interventional|||Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients||Unknown status|Recruiting|Phase 2|55|Anticipated|Fudan University||1|||f||||||||||||||2017-10-10 23:24:01.928895|2017-10-10 23:24:01.928895
NCT02415816|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-03-30|||April 9, 2015|Actual|2015-04-09|January 2017|2017-01-01|April 30, 2027|Anticipated|2027-04-30|March 31, 2022|Anticipated|2022-03-31||Interventional|||Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas|Diffusion Weighted Magnetic Resonance Imaging in Pediatric Sarcomas|Recruiting||N/A|50|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|f|t|f|f||||||2017-10-10 23:24:02.024303|2017-10-10 23:24:02.024303
NCT02415803|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-09|||December 2014||2014-12-01|December 2014|2014-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS|Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With Non-ST-Elevation Acute Coronary Syndrome: A Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|75|Anticipated|First Affiliated Hospital of Harbin Medical University||3|||f||||t||||||||||2017-10-10 23:24:02.187488|2017-10-10 23:24:02.187488
NCT02415790|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-03-07|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects|A 4-Part, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult, Elderly and Japanese Subjects, and the Pharmacodynamics in Healthy Adult Subjects|Completed||Phase 1|112|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-10 23:24:02.323007|2017-10-10 23:24:02.323007
NCT02415777|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-01-21|||October 2014||2014-10-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction||Completed||Phase 4|168|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-10 23:24:02.446172|2017-10-10 23:24:02.446172
NCT02415764|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-07-26|||June 2015||2015-06-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant|OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant|Completed||Phase 1|19|Actual|Center for Social Innovation, Massachusetts||1|||f||||f||||||||No||2017-10-10 23:24:02.542173|2017-10-10 23:24:02.542173
NCT02415751|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-12-06|||June 2015||2015-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||The Impact of a Heart Failure Review on Self-Care Knowledge, Adherence and Clinical Outcomes|The Impact of a Heart Failure Review on Self-Care Knowledge, Adherence and Clinical Outcomes|Recruiting||N/A|100|Anticipated|Creighton University|||1||f||||f||||||||||2017-10-10 23:24:02.646952|2017-10-10 23:24:02.646952
NCT02415738|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-03-09|||April 2015||2015-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|OXYDV||Changes in Cerebral Oxygenation During the Prone Position in Patients With Acute Respiratory Distress Syndrome|Changes in Cerebral Oxygenation During the Prone Position in Patients With Acute Respiratory Distress Syndrome|Completed||N/A|10|Actual|Centre Hospitalier Bretagne Atlantique|||1||f||||f||||||||||2017-10-10 23:24:02.744442|2017-10-10 23:24:02.744442
NCT02415725|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-04-09|||September 2014||2014-09-01|March 2015|2015-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Detection of Lymphedema After Cancer Treatments|Early Detection of Secondary Lymphedema After Cancer Treatments|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire Saint Pierre||1|||f||||f||||||||||2017-10-10 23:24:02.828148|2017-10-10 23:24:02.828148
NCT02415712|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-06-05|||February 2, 2015|Actual|2015-02-02|June 2017|2017-06-01|July 1, 2022|Anticipated|2022-07-01|June 1, 2022|Anticipated|2022-06-01||Observational|||Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)|"Specified Drug-use Survey of Fomepizole Intravenous Infusion Takeda (All-case Surveillance)"|Recruiting||N/A|168|Anticipated|Takeda|||1||f||||f||||||||||2017-10-10 23:24:02.913545|2017-10-10 23:24:02.913545
NCT02415699|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-13|||August 2015||2015-08-01|April 2015|2015-04-01|July 2020|Anticipated|2020-07-01|July 2017|Anticipated|2017-07-01||Interventional|||DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer|Randomized Controlled Trial Comparing DC-CIK Immunotherapy Combined With Adjuvant Chemotherapy and Adjuvant Chemotherapy Alone in Stage III Colorectal Cancer.|Not yet recruiting||Phase 2/Phase 3|100|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||||||||||||2017-10-10 23:24:02.996177|2017-10-10 23:24:02.996177
NCT02415686|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-01-24|||June 2015||2015-06-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Cardiac Arrhythmias in Dravet Syndrome|Cardiac Arrhythmias in Dravet Syndrome: an Observational, International, Multicentre Study|Recruiting||N/A|60|Anticipated|Stichting Epilepsie Instellingen Nederland|||1||f||||f||||||||||2017-10-10 23:24:03.091725|2017-10-10 23:24:03.091725
NCT02415660|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-07-18|||June 2016||2016-06-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Short-Term Response of Thoracic Spine Manipulation With or Without Trigger Point Dry Needling for Mechanical Neck Pain|Short-Term Response of Thoracic Spine Manipulation With or Without Trigger Point Dry Needling for Mechanical Neck Pain: A Randomized Clinical Trial|Recruiting||N/A|58|Anticipated|Brooke Army Medical Center||2|||f||||f||||||||No||2017-10-10 23:24:03.243345|2017-10-10 23:24:03.243345
NCT02415647|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-10-03|||October 2014||2014-10-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria|Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria|Recruiting||N/A|2800|Anticipated|State University of New York - Upstate Medical University|||2||f||||f||||||Samples With DNA|"     Whole blood samples.   "|||2017-10-10 23:24:03.357697|2017-10-10 23:24:03.357697
NCT02415634|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-11-16|||November 2014||2014-11-01|April 2015|2015-04-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|RECAP||REhabilitation After Critical Illness Assisted Discharge Pack (RECAP)|Investigation of Physiotherapy Led ICU Discharge Facilitation Using the REhabilitation After Critical Illness Assisted Discharge Pack (RECAP) Model; a Pilot Randomized Controlled Trial.|Completed||N/A|20|Actual|St Vincent's University Hospital, Ireland||2|||f||||f||||||||||2017-10-10 23:24:03.450131|2017-10-10 23:24:03.450131
NCT02415621|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-07-28|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer|A Pilot Study of Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer|Recruiting||N/A|25|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-10 23:24:03.533627|2017-10-10 23:24:03.533627
NCT02415608|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-06-27|||March 2015||2015-03-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis|A Phase II Study of Ibrutinib in Advanced Systemic Mastocytosis|Recruiting||Phase 2|11|Anticipated|Stanford University||1|||f||||t||||||||No||2017-10-10 23:24:03.623391|2017-10-10 23:24:03.623391
NCT02415582|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-13|||March 2014||2014-03-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|HPE||Post-Exercise Hypotension in Elderly Hypertensive Men|Effects of Different Exercises on Post-Exercise Blood Pressure in Elderly Hypertensive: A Cross-Over Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|18|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||||2017-10-10 23:24:03.96031|2017-10-10 23:24:03.96031
NCT02415569|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-04-28|||January 2015||2015-01-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Tailored Bowel Preparation According to Bristol Stool Form Scale|Tailored Bowel Preparation According to Bristol Stool Form Scale: a Prospective, Randomized, Controlled, Investigator-blinded, Multicenter Study|Completed||Phase 4|700|Actual|Shandong University||3|||f||||t||||||||||2017-10-10 23:24:04.056603|2017-10-10 23:24:04.056603
NCT02415556|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-02-13|||July 2015||2015-07-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|MemAID||Memory Aid by Intranasal Insulin in Diabetes (MemAID)|Memory Advancement by Intranasal Insulin in Type 2 Diabetes|Recruiting||Phase 2/Phase 3|400|Anticipated|Beth Israel Deaconess Medical Center||4|||f||||t||||||||Yes|BWH's site data will be shared with BIDMC site upon BWH's site recruitment initiation|2017-10-10 23:24:04.1382|2017-10-10 23:24:04.1382
NCT02415543|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-08-25|||March 2016||2016-03-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SIL-TEP vs TEP for Inguinal Hernia Repair in Day Surgery|A Prospective, Randomized, Controlled Trial of Comparing Single Incisional Laparoscopic Total Extraperitoneal(SIL-TEP) Inguinal Hernia Repair With Traditional Laparoscopic Total Extraperitoneal(TEP) Inguinal Hernia Repair in Day Surgery|Recruiting||N/A|100|Anticipated|RenJi Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:24:04.24037|2017-10-10 23:24:04.24037
NCT02415504|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-09-20|||July 2014||2014-07-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Comprehensive Care Transition: A Trial of an Enhanced Care Transition Process in Dementia|Comprehensive Care Transition: A Randomized Control Trial of an Enhanced Care Transition Process in Dementia|Terminated||N/A|29|Actual|Baycrest||2||Funding problems, slow recruitment, PI location change|f||||f||||||||No||2017-10-10 23:24:04.518292|2017-10-10 23:24:04.518292
NCT02415491|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-02-17|||May 2015||2015-05-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|ASO||Cardiovascular MRI and Cardiopulmonary Exercise Capacity After Neonatal ASO) in Young Adults|Cardiovascular Magnetic Resonance at Rest and Stress in Relation to Cardiopulmonary Exercise Capacity in Young Adults After Arterial Switch Operation (ASO) for Transposition of the Great Arteries (TGA)|Recruiting||N/A|100|Anticipated|RWTH Aachen University||1|||f||||f||||||||||2017-10-10 23:24:04.605016|2017-10-10 23:24:04.605016
NCT02415478|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-11-18|||September 2015||2015-09-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|BLVR||Bronchioscopic Lung Volume Reduction (BLVR)|The Effect of Endoscopic Lung Volume Reduction Via Endobronchial Valves on Breath Muscle Power by Patients With COPD|Recruiting||N/A|20|Anticipated|RWTH Aachen University|||1||f||||f||||||||||2017-10-10 23:24:04.69147|2017-10-10 23:24:04.69147
NCT02415465|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-04-14|||January 2015||2015-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Continuous Adductor Canal Block (CACB) vs. Combined Spinal Epidural (CSE) in Total Knee Arthroplasty|Continuous Adductor Canal Block (CACB) vs. Combined Spinal Epidural (CSE) in Total Knee Arthroplasty|Completed||N/A|157|Actual|Rush University Medical Center||3|||f||||f||||||||||2017-10-10 23:24:04.761316|2017-10-10 23:24:04.761316
NCT02415452|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2016-01-16|||July 2006||2006-07-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|May 2013|Actual|2013-05-01||Observational|REACS||Researches of Retinal Artery Lesions and Acute Coronary Syndrome|Retinal Artery Lesions to Predict Long-term Outcomes in Patients With Acute Coronary Syndrome After Drug-Eluting Stent Implantation|Active, not recruiting||N/A|660|Actual|Capital Medical University|||1||f||||f||||||||||2017-10-10 23:24:04.838909|2017-10-10 23:24:04.838909
NCT02415439|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-01-30|2016-06-09||January 2015||2015-01-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Interventional|||A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects|A Phase 1 Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects|Completed||Phase 1|86|Actual|ReveraGen BioPharma, Inc.||13|||f||||f||||||||Undecided||2017-10-10 23:24:05.0725|2017-10-10 23:24:05.0725
NCT02415426|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-09-27|||June 2015||2015-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|DMKT||Metacognitive Training Program With Depression||Recruiting||N/A|45|Anticipated|Psychiatric University Hospital, Zurich|||1||f||||||||||||||2017-10-10 23:24:06.389344|2017-10-10 23:24:06.389344
NCT02415413|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2016-11-10|||May 2015||2015-05-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma|A Study of Carfilzomib, Lenalidomide and Dexamethasone (KRd) Plus High-dose Therapy With Melphalan and Autologous Stem Cell Transplantation, Followed by Consolidation With KRd, and Maintenance With Lenalidomide and Dexamethasone in Patients Under 65 Years With High Risk Smoldering Multiple Myeloma|Recruiting||Phase 2|90|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-10 23:24:06.483639|2017-10-10 23:24:06.483639
NCT02415400|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-10-03|||June 4, 2015|Actual|2015-06-04|October 2017|2017-10-01|December 28, 2018|Anticipated|2018-12-28|December 27, 2018|Anticipated|2018-12-27||Interventional|||A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart|An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention|Recruiting||Phase 4|4600|Anticipated|Bristol-Myers Squibb||4|||f||||t|t|f||||||||2017-10-10 23:24:06.900152|2017-10-10 23:24:06.900152
NCT02415387|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-09-18|||January 2014|Actual|2014-01-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|IMPACT||Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer Who Received Chemotherapy|The IMPACT Study: Inflammatory Responses, Mood and Physical Fitness After Cancer Treatment|Recruiting||N/A|180|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:24:11.781467|2017-10-10 23:24:11.781467
NCT02415374|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-08|||February 2015||2015-02-01|April 2015|2015-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||Bioavailability and Metabolism of Avenanthramide: a Novel Oat Phytochemical|Bioavailability and Metabolism of Avenanthramide: a Novel Oat Phytochemical|Unknown status|Active, not recruiting|N/A|16|Anticipated|PepsiCo Global R&D||2|||f||||f||||||||||2017-10-10 23:24:11.868287|2017-10-10 23:24:11.868287
NCT02415361|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-09-27|||April 2015||2015-04-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Follow Ups of Parents With Infants With Cleft Lip and Palate|Follow Ups of Parents With Infants With Cleft Lip and Palate|Recruiting||N/A|52|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:24:11.930907|2017-10-10 23:24:11.930907
NCT02415348|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-05-13|||April 2015||2015-04-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers|The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac Pacemakers and/or Implantable Cardioverter-Defibrillators|Active, not recruiting||N/A|200|Anticipated|University of Saskatchewan||1|||f||||f||||||||||2017-10-10 23:24:12.013275|2017-10-10 23:24:12.013275
NCT02415335|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-02-22|||April 2015||2015-04-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis|Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis|Completed||Phase 2|119|Actual|Nordsjaellands Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:24:12.079845|2017-10-10 23:24:12.079845
NCT02415322|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-09-23|||May 2015||2015-05-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Observational|||Cohort Study on Internet Game and Smart Phone Addiction|A Prospective Cohort Study to Identify Pathogenesis and Risk Factors on Internet Game and Smart Phone Addiction|Enrolling by invitation||N/A|3000|Anticipated|National Clinical Research Coordination Center, Seoul, Korea|||1||f||||t||||||||||2017-10-10 23:24:12.211144|2017-10-10 23:24:12.211144
NCT02415309|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-08-18|||July 2016||2016-07-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Premedication With Melatonin in Lumbar Medial Branch Block Procedure|Premedication With Melatonin vs. Placebo in Patients Undergoing Interventional Pain Procedure|Recruiting||Phase 3|120|Anticipated|United States Naval Medical Center, San Diego||3|||f||||t||||||||No||2017-10-10 23:24:12.268838|2017-10-10 23:24:12.268838
NCT02415296|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-08|||May 2015||2015-05-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|EDEIN||Screening for Excessive Gambling Behaviors on the Internet|Screening for Excessive Gambling Behaviors on the Internet (EDEIN Study). Study of the Database of French Online Gambling Sites.|Not yet recruiting||N/A|20240|Anticipated|Nantes University Hospital|||3||f||||f||||||||||2017-10-10 23:24:12.510313|2017-10-10 23:24:12.510313
NCT02415283|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2015-04-09|||May 2015||2015-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Observational|||OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI|Evaluation of the Capability of the ¹³C-Octanoate Breath Test (OBT) Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI in Patients With Chronic Liver Disease|Unknown status|Not yet recruiting|Phase 2|2|Anticipated|Beijing 302 Hospital|||2||f||||t||||||||||2017-10-10 23:24:12.631862|2017-10-10 23:24:12.631862
NCT02415257|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-09-06|||April 2015||2015-04-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function|Gentamicin Treatment Prior to Vestibular Schwannoma Surgery in Patients With no Measurable Remaining Vestibular Function|Recruiting||Phase 4|40|Anticipated|Lund University||2|||f||||f||||||||||2017-10-10 23:24:12.861481|2017-10-10 23:24:12.861481
NCT02415244|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-09-26|||July 2012||2012-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 23, 2017|Actual|2017-09-23||Observational|||Transesophageal Echocardiography (TEE): A Novel Technique for Spinal Cord Imaging|Transesophageal Echocardiography (TEE): A Novel Technique for Spinal Cord Imaging|Recruiting||N/A|75|Anticipated|University of Iowa|||3||f||||f||||||||||2017-10-10 23:24:12.998057|2017-10-10 23:24:12.998057
NCT02415231|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-03-15|||April 2015||2015-04-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||"The Effect of Humor and Laughter on C Reactive Protein: A Pilot Study"|"The Effect of Humor and Laughter on C Reactive Protein: A Pilot Study"|Completed||N/A|48|Actual|Loma Linda University||2|||f||||t|f|f||||||No||2017-10-10 23:24:13.109851|2017-10-10 23:24:13.109851
NCT02415218|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-13|||April 2013||2013-04-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Transplantation of Autologous Oral Mucosal Epithelial Sheets for Limbal Stem-cell Deficiency|Clinical Study of Transplantation of Autologous Cultivated Oral Mucosal Epithelial Sheets for Limbal Stem-cell Deficiency|Unknown status|Recruiting|Phase 1/Phase 2|12|Anticipated|Siriraj Hospital||1|||f||||t||||||||||2017-10-10 23:24:13.210529|2017-10-10 23:24:13.210529
NCT02415205|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-09|2017-08-21|||April 2015||2015-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Pain and Stress Assessment and ROP Screening|Pain and Stress Assessment and ROP Screening Examination in Premature Infants|Recruiting||N/A|80|Anticipated|Loma Linda University|||1||f||||t||||||||||2017-10-10 23:24:13.312547|2017-10-10 23:24:13.312547
NCT02415192|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-04-18|||July 2014||2014-07-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Observational|||Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients|A Multicenter, Prospective Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Patient With Essential Hypertension|Recruiting||N/A|2001|Anticipated|LG Life Sciences|||2||f||||f||||||||||2017-10-10 23:24:13.391041|2017-10-10 23:24:13.391041
NCT02415153|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-13|2017-09-12|||July 14, 2015|Actual|2015-07-14|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors|A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors|Active, not recruiting||Phase 1|42|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:24:13.696853|2017-10-10 23:24:13.696853
NCT02415140|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-13|||October 2013||2013-10-01|April 2015|2015-04-01||||February 2015|Actual|2015-02-01||Observational|||Prevalence and Predictors of Depression in COPD|Prevalence and Independent Predictors of Depression in COPD|Completed||N/A|161|Actual|Kwong Wah Hospital|||2||f||||||||||||||2017-10-10 23:24:13.823482|2017-10-10 23:24:13.823482
NCT02415127|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-12-19|||June 2015||2015-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|STEADFAST||Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia|Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy, Safety, and Pharmacokinetic Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia|Completed||Phase 3|92|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||2|||f||||t||||||||||2017-10-10 23:24:13.887863|2017-10-10 23:24:13.887863
NCT02415114|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-09-22|||March 2015||2015-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||An Open Label Study Evaluating the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10|An Open Label Pilot Study to Evaluate the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10 in Healthy Subjects and Subjects on Statins|Completed||Phase 1|50|Anticipated|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-10 23:24:13.986754|2017-10-10 23:24:13.986754
NCT02415101|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-09-09|||February 2015||2015-02-01|September 2016|2016-09-01|August 2022|Anticipated|2022-08-01|February 2018|Anticipated|2018-02-01||Interventional|NeoResII||Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer|Randomized Clinical Trial Comparing the Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Cancer of the Esophagus or Gastric Cardia|Recruiting||N/A|180|Anticipated|Karolinska University Hospital||2|||f||||t||||||||||2017-10-10 23:24:14.221942|2017-10-10 23:24:14.221942
NCT02415088|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2016-04-02|||April 2015||2015-04-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Ultrasound-guided Selective Shoulder Block Versus Ultrasound-guided Interscalene Brachial Plexus Block, an RCT|Treatment of Postoperative Pain After Shoulder Surgery. Ultrasound-guided Block of the Axillary and Suprascapular Nerves (Selective Shoulder Block) Versus Ultrasound-guided Interscalene Brachial Plexus Block: An Observer-blinded RCT|Completed||N/A|100|Actual|Jessa Hospital||2|||f||||f||||||||||2017-10-10 23:24:14.334082|2017-10-10 23:24:14.334082
NCT02415075|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-06-21|||October 2014||2014-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|EXPERTIS||Prevention of Reduced Employability With an Expert System With Telephone, Motivational Interviews Supporting Self-management|Experten-Prävention Bei gefährdeter Erwerbsfähigkeit Durch Telefonische, Motivierende Interviews Zur Unterstützung Des Selbstmanagements|Recruiting||N/A|1045|Anticipated|Jacobs University Bremen gGmbH|||1||f||||f||||||||||2017-10-10 23:24:14.408342|2017-10-10 23:24:14.408342
NCT02415062|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-14|2015-08-05|||July 2015||2015-07-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Interventional|CUPID||The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia|The Efficacy of 23mg Versus 10mg of Donepezil in ParkInson's Disease With Dementia|Recruiting||Phase 2|150|Anticipated|Inje University||2|||f||||t||||||||||2017-10-10 23:24:14.4922|2017-10-10 23:24:14.4922
NCT02415049|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2016-05-12|||January 2014||2014-01-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Trial to Assess Optimal Postoperative Feeding Regiments Following Pyloromyotomy|A Prospective Randomized Trial to Assess Optimal Postoperative Feeding Regiments Following Pyloromyotomy|Completed||N/A|163|Actual|Indiana University||2|||f||||t||||||||||2017-10-10 23:24:14.588821|2017-10-10 23:24:14.588821
NCT02414867|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-06-28|||February 2015||2015-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Total Energy Expenditure and Fat Oxidation in 2 Year Old Children|Total Energy Expenditure and Fat Oxidation in 2 Year Old Children|Active, not recruiting||N/A|16|Actual|Arkansas Children's Hospital Research Institute|||2||f||||t||||||Samples Without DNA|"     Urine collected   "|||2017-10-10 23:24:16.362395|2017-10-10 23:24:16.362395
NCT02415036|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-07-25|||June 2014||2014-06-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma|An International Multi-center Phase 2 Study to Evaluate the Efficacy and Safety of Melphalan Hydrochloride for Injection for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma|Recruiting||Phase 2|42|Anticipated|Delcath Systems Inc.||2|||f||||f||||||||||2017-10-10 23:24:14.67991|2017-10-10 23:24:14.67991
NCT02415023|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-02-23|||September 2014||2014-09-01|February 2017|2017-02-01|March 31, 2017|Anticipated|2017-03-31|March 31, 2017|Anticipated|2017-03-31||Interventional|||A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer|A Phase Ib/2 Clinical Study to Evaluate the Safety, Pharmacokinetic Characteristics and Preliminary Efficacy of Fruquintinib Combined With Paclitaxel in Patients With Advanced Gastric Cancer|Active, not recruiting||Phase 1/Phase 2|34|Actual|Hutchison Medipharma Limited||1|||f||||t||||||||Undecided||2017-10-10 23:24:14.779698|2017-10-10 23:24:14.779698
NCT02415010|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-14|||July 1, 2015|Actual|2015-07-01|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|September 1, 2017|Anticipated|2017-09-01||Observational|SUNRISE-2||Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms|A Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms|Recruiting||N/A|50|Anticipated|Codman & Shurtleff|||1||f||||f|f|t|f|f|f|||||2017-10-10 23:24:14.858469|2017-10-10 23:24:14.858469
NCT02414997|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-04-08|||February 2015||2015-02-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Remote Ischemic Preconditioning (RIPC) on Blood Pressure and Its Vascular Protection Effect|The Effect of Remote Ischemic Preconditioning (RIPC) on Blood Pressure and Its Vascular Protection Effect Among Chinese Young Healthy Adults and Primary Hypertensive Patients Stage I|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-10 23:24:15.099666|2017-10-10 23:24:15.099666
NCT02414984|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-02-10|||March 2015||2015-03-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01|24 Months|Observational [Patient Registry]|Go-Compl-Ar||Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab|Registry of Patients With Rheumatoid Arthritis Exposed to Golimumab (Go-Compl-Ar): Review and Analysis of Compliance in Colombia|Terminated||N/A|37|Actual|Janssen-Cilag, S.A.|||1|Insufficient enrollment (Terminated due to lack of patient recruitment)|f||||f||||||||No||2017-10-10 23:24:15.202206|2017-10-10 23:24:15.202206
NCT02414971|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-10-04|||April 2015|Actual|2015-04-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Relationship of Mitochondrial Enzymes With Cancer Related Fatigue|Relationship of Mitochondrial Enzymes With Cancer Related Fatigue|Recruiting||N/A|25|Anticipated|University of Florida|||1||f||||t|f|f||||Samples Without DNA|"     Buccal swabs Whole blood   "|||2017-10-10 23:24:15.31651|2017-10-10 23:24:15.31651
NCT02414958|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-15|||June 30, 2015|Actual|2015-06-30|August 2017|2017-08-01|October 17, 2017|Anticipated|2017-10-17|April 20, 2017|Actual|2017-04-20||Interventional|||Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)|A Phase III, Randomised, Double Blind, Placebo-controlled, Parallel Group, Efficacy, Safety and Tolerability Trial of Once Daily, Oral Doses of Empagliflozin as Adjunctive to inSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)|Active, not recruiting||Phase 3|730|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:24:15.416231|2017-10-10 23:24:15.416231
NCT02414945|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-05-31|||June 2015||2015-06-01|May 2016|2016-05-01|November 2025|Anticipated|2025-11-01|June 2025|Anticipated|2025-06-01||Interventional|||Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2 Therapy Following Cyclophosphamide and Fludarabine in Patients With Pleural Mesothelioma|Phase I/II Study Evaluating the Infusion of Tumor-Infiltrating Lymphocytes (TILs) and Low-Dose Interleukin-2 (IL-2) Therapy Following a Preparative Regimen of Non-myeloablative Lymphodepletion Using Cyclophosphamide and Fludarabine in Patients With Malignant Pleural Mesothelioma|Recruiting||Phase 1/Phase 2|10|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:24:15.800602|2017-10-10 23:24:15.800602
NCT02414932|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-06-12|||April 2015||2015-04-01|June 2017|2017-06-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|KEEP-WELL||Ketamine for Depression Relapse Prevention Following ECT|Ketamine for Depression Relapse Prevention Following ECT: a Randomised Pilot Trial With Blood Biomarker Evaluation|Completed||Early Phase 1|6|Actual|St Patrick's Hospital, Ireland||2|||f||||t||||||||No||2017-10-10 23:24:15.908501|2017-10-10 23:24:15.908501
NCT02414919|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-03-14|||April 1, 2015|Actual|2015-04-01|March 2017|2017-03-01|March 28, 2016|Actual|2016-03-28|March 28, 2016|Actual|2016-03-28||Observational|||Duration of Use of Highly Effective Reversible Contraception|Real-world Duration of Use for Highly Effective Reversible Contraception (HERC): A Retrospective Review|Completed||N/A|13880|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:24:16.018811|2017-10-10 23:24:16.018811
NCT02414906|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-08|||June 2010||2010-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|GDT-AKIN||Goal Directed Therapy for Acute Kidney Injury in Critical Ill Patients|Goal Directed Therapy in the Early Phase of Acute Kidney Injury in Critical Ill Patients|Completed||Phase 2|99|Actual|Barretos Cancer Hospital||2|||f||||f||||||||||2017-10-10 23:24:16.109337|2017-10-10 23:24:16.109337
NCT02414893|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-10|||September 2009||2009-09-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01|1 Day|Observational [Patient Registry]|||Hunger/Satiety's Physiopathologic Study in Morbidly Obese Patients|Hunger/Satiety's Physiopathologic Study in Morbidly Obese Patients: Relation Between Hunger/Satiety, Gastric Emptying, Gallbladder Motility and Peripheral Neurohormonal Signs|Completed||N/A|40|Actual|Consorci Sanitari del Maresme|||3||f||||f||||||||||2017-10-10 23:24:16.17709|2017-10-10 23:24:16.17709
NCT02414880|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2016-01-30|||December 2014||2014-12-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection|Sugammadex Versus Neostigmine for Antagonism of Rocuronium-induced Neuromuscular Blockade in Patients With Liver Cirrhosis Undergoing Liver Resection: A Controlled Randomized Study|Completed||Phase 4|60|Actual|Cairo University||4|||f||||t||||||||||2017-10-10 23:24:16.258877|2017-10-10 23:24:16.258877
NCT02414854|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-09-11|||April 2015||2015-04-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|July 29, 2017|Actual|2017-07-29||Interventional|||Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)|A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Persistent Asthma|Active, not recruiting||Phase 3|1902|Actual|Sanofi||4|||f||||t||||||||||2017-10-10 23:24:16.44144|2017-10-10 23:24:16.44144
NCT02414841|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-08-15|||August 2015|Actual|2015-08-01|August 2017|2017-08-01||||November 2018|Anticipated|2018-11-01||Interventional|||A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)|Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease|Recruiting||Phase 3|500|Anticipated|Proteon Therapeutics||2|||f||||t||||||||||2017-10-10 23:24:17.619674|2017-10-10 23:24:17.619674
NCT02414828|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-04-01|2016-03-04||October 2008||2008-10-01|April 2016|2016-04-01|November 2010|Actual|2010-11-01|July 2010|Actual|2010-07-01||Interventional|C-010-402||A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB|A Phase II Double-Blind, Randomized, Placebo-controlled, Dose Escalation Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary Tuberculosis|Completed||Phase 2|72|Actual|Aeras||4|||f||||t||||||||Undecided||2017-10-10 23:24:17.837885|2017-10-10 23:24:17.837885
NCT02414815|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-04-07|||October 2014||2014-10-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Reverse Prediction of Ion Channel Remodeling in Patients With Atrial Fibrillation Utilizing Monophasic Action Potential and Mathematical Modeling|Reverse Prediction of Ion Channel Remodeling in Patients With Atrial Fibrillation Utilizing Monophasic Action Potential and Mathematical Modeling|Unknown status|Recruiting|N/A|45|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-10 23:24:19.247567|2017-10-10 23:24:19.247567
NCT02414802|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-01-15|||December 2014||2014-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis|Study on the Application of a Novel Aspiration Thrombectomy Device Combined With Catheter-directed Thrombolysis for the Treatment of Acute Iliofemoral Deep Venous Thrombosis|Enrolling by invitation||N/A|40|Anticipated|Xuzhou Medical University||2|||f||||f||||||||No||2017-10-10 23:24:19.312102|2017-10-10 23:24:19.312102
NCT02414789|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-09-07|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|DIABOLYC||Lyme Borreliosis and Early Cutaneous Diagnostic|Lyme Borreliosis and Early Cutaneous Diagnostic|Recruiting||N/A|40|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 23:24:19.392107|2017-10-10 23:24:19.392107
NCT02414776|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-09-25|||July 2014||2014-07-01|September 2017|2017-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ABC01||Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy|Phase Ib/II Study of Hydroxychloroquine in Metastatic ER-Positive Breast Cancer Progressing on Hormonal Therapy|Terminated||Phase 1|3|Actual|Western Regional Medical Center||1||PI Leaving Site|f||||f||||||||||2017-10-10 23:24:19.478755|2017-10-10 23:24:19.478755
NCT02414763|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-10-31|||July 2014||2014-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors|Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors|Active, not recruiting||Phase 1|69|Actual|Western Kentucky University||2|||f||||t||||||||||2017-10-10 23:24:19.665391|2017-10-10 23:24:19.665391
NCT02414750|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-05-23|||December 2014||2014-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|REPOSIT||Vemurafenib Plus Cobimetinib in Metastatic Melanoma|A Phase II, Open-Label, Multicenter Study of Vemurafenib Plus Cobimetinib (GDC-0973) in Unresectable Stage IIIc or Stage IV Melanoma; Response Monitoring and Resistance Prediction With Positron Emission Tomography and Tumor Characteristics|Recruiting||Phase 2|90|Anticipated|Netherlands Working Group on Immunotherapy of Oncology||1|||f||||f|f|f||||||Undecided||2017-10-10 23:24:19.741242|2017-10-10 23:24:19.741242
NCT02414737|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2017-06-19|||February 2016||2016-02-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|OSSIE||Ovarian Stimulation Single Injection Elonva|Ovarian Stimulation Single Injection Elonva- The OSSIE Study|Completed||Phase 3|20|Actual|Flinders Fertility||1|||f||||f||||||||No||2017-10-10 23:24:19.875547|2017-10-10 23:24:19.875547
NCT02414724|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-09-09|||May 2015||2015-05-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study of CDK4/6 Inhibitor LEE011 Combined With Gemcitabine in Patients With Advanced Solid Tumors or Lymphoma|Terminated||Phase 1|10|Actual|Roswell Park Cancer Institute||1||PI left institute|f||||f||||||||||2017-10-10 23:24:19.942232|2017-10-10 23:24:19.942232
NCT02414711|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-01-11|||June 2015||2015-06-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|February 2016|Actual|2016-02-01||Interventional|HSCL25||Validation of the French Translation of the Scale HSCL25 in the Diagnosis of Depression in Primary Care|Validation of the French Translation of the Scale HSCL25 in the Diagnosis of Depression in Primary Care|Completed||N/A|1128|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-10-10 23:24:20.051731|2017-10-10 23:24:20.051731
NCT02414698|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-11|||March 2015||2015-03-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy|Single Center, Randomized PROspective Study Comparing Percutaneous HydroDiscectomy to Transforaminal Epidural Steroid Injections in the Treatment Of Radiculopathy Secondary to Lumbar Disc Herniation (PROPHESOR)|Recruiting||Phase 4|90|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-10-10 23:24:20.131636|2017-10-10 23:24:20.131636
NCT02414685|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2016-07-14|||April 2015||2015-04-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|TIP||First Line TIP in Poor Prognosis TGCTs.|A Treatment Strategy of the Use of 1st Line Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors Based on Tumor Marker Decline: A Phase II Trial of Paclitaxel, Ifosfamid and Cisplatin Regimen.|Recruiting||Phase 2|37|Anticipated|National Cancer Institute, Slovakia||1|||f||||t||||||||Undecided||2017-10-10 23:24:20.235232|2017-10-10 23:24:20.235232
NCT02414672|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-08-21|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients|CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients|Recruiting||N/A|400|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:24:20.33208|2017-10-10 23:24:20.33208
NCT02414659|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2015-06-22|||March 2015||2015-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Effects of In-utero Cord Blood Collection on Post-operative Hemoglobin Levels|Effects of In-utero Cord Blood Collection on Post-operative Hemoglobin Levels|Completed||N/A|399|Actual|Ankara University|||2||f||||f||||||||||2017-10-10 23:24:20.556517|2017-10-10 23:24:20.556517
NCT02414646|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-05-05|||April 2015||2015-04-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer|ATOP Trial: Adjuvant Ado-Trastuzumab Emtansine (T-DM1) for Older Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer|Recruiting||Phase 2|200|Anticipated|Academic and Community Cancer Research United||1|||f||||t||||||||||2017-10-10 23:24:20.663138|2017-10-10 23:24:20.663138
NCT02414633|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-05-15|||April 1, 2015||2015-04-01|May 2017|2017-05-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Observational|||Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment (WPAI))|Special Investigation (Working Productivity and Activity Impairment / WPAI in Japanese Patients With Psoriatic Arthritis / PsA)|Completed||N/A|150|Actual|AbbVie|||1||f||||||||||||||2017-10-10 23:24:21.494957|2017-10-10 23:24:21.494957
NCT02414620|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-08|2015-04-10|||August 2012||2012-08-01|July 2012|2012-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy of the Dental Vibe Unit for Use of Reduction or Elimination of Pain During Dental Anesthetic Injection|Efficacy of the Dental Vibe Unit for Use of Reduction or Elimination of Pain During Dental Anesthetic Injection|Completed||Phase 4|80|Actual|University of the Pacific||1|||f||||f||||||||||2017-10-10 23:24:21.845014|2017-10-10 23:24:21.845014
NCT02414607|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-02-06|||September 2016||2016-09-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment|Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment|Recruiting||Phase 1/Phase 2|40|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-10 23:24:21.912775|2017-10-10 23:24:21.912775
NCT02414594|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-02-22|||April 2015||2015-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS APO(a)-LRx in Healthy Volunteers With Elevated Lipoprotein(a)|A Blinded, Placebo-Controlled, Dose-Escalation, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 681257 Administered Subcutaneously to Healthy Volunteers With Elevated Lipoprotein(a)|Completed||Phase 1|60|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:24:22.032782|2017-10-10 23:24:22.032782
NCT02414581|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-09-27|||April 2015||2015-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%|Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% to Reduce the Rate Oral Colonization by Gram-negative Bacteria in Patients With Chemotherapy|Completed||Phase 3|60|Actual|Hospital Regional de Alta Especialidad del Bajio||3|||f||||t||||||||||2017-10-10 23:24:22.122286|2017-10-10 23:24:22.122286
NCT02414568|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-04-11|||July 2015||2015-07-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|PVAB||Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin|A Prospective Phase II Study of Bendamustine in Patients Aged Over 60 Years With Classical Hodgkin Lymphoma Treated by Prednisone, Vinblastine and Doxorubicin|Recruiting||Phase 2|90|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t|f|f||||||No||2017-10-10 23:24:22.238497|2017-10-10 23:24:22.238497
NCT02414555|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-04-28|||March 2015||2015-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|KATECHOL||Perioperative Fluid Management in Patients Receiving Major Abdominal Surgery - Effects of Normal Saline Versus an Acetate Buffered Balanced Infusion Solution on the Necessity of Catecholamines for Cardiocirculatory Support|Perioperative Fluid Management in Patients Receiving Major Abdominal Surgery - Effects of Normal Saline Versus an Acetate Buffered Balanced Infusion Solution on the Necessity of Catecholamines for Cardiocirculatory Support, a Randomized Controlled Double-blind Trial|Terminated||Phase 4|60|Actual|Medical University of Vienna||2||Patient Safety|f||||t||||||||||2017-10-10 23:24:22.557101|2017-10-10 23:24:22.557101
NCT02414542|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-03-06|||September 2013||2013-09-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Minima Clinical Study|A Multicentre, Prospective, Observational Clinical Study Evaluating the Outcomes of a Cementless Metaphyseal Short Stem After Hip Arthroplasty|Active, not recruiting||N/A|130|Actual|Limacorporate S.p.a|||1||f||||f||||||||||2017-10-10 23:24:22.692063|2017-10-10 23:24:22.692063
NCT02414529|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-03-15|||November 2013||2013-11-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese Adolescents|Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese Adolescents|Completed||N/A|20|Actual|New York University School of Medicine||2|||f||||t|f|f|||f|||||2017-10-10 23:24:22.781022|2017-10-10 23:24:22.781022
NCT02414516|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-04-09|||March 2015||2015-03-01|April 2015|2015-04-01||||February 2017|Anticipated|2017-02-01||Interventional|||A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors|A Phase 1a Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors|Unknown status|Recruiting|Phase 1|36|Anticipated|Oncolys BioPharma Inc||1|||f||||f||||||||||2017-10-10 23:24:22.863893|2017-10-10 23:24:22.863893
NCT02414503|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-09-26|||April 2015||2015-04-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder|A Randomized, Placebo Controlled, Double-blind, 3-period Cross-over Study in Adult Patients With Autism Spectrum Disorders Evaluating Cognitive Response After Single- Dose Oxytocin 8 or 24 IU Intranasal Administration Using the OptiNose Bi-directional Nose-to-brain Device|Completed||Phase 1/Phase 2|17|Actual|OptiNose AS||3|||f||||f||||||||||2017-10-10 23:24:22.927074|2017-10-10 23:24:22.927074
NCT02414490|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-06-16|||March 2015||2015-03-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|GRIPPER||IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements|Intravenous Immunoglobulin (IVIg) Treatment-Related Fluctuations in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients Using Daily Grip Strength Measurements (GRIPPER)|Recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||||||||Samples With DNA|"     Blood taken for future use will be obtained with each serum IgG sample.   "|||2017-10-10 23:24:23.011645|2017-10-10 23:24:23.011645
NCT02414477|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-10-04|||October 2017|Anticipated|2017-10-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Metabolism of Deuterated NNN in Smokeless Tobacco Users|Metabolism of Deuterated NNN in Smokeless Tobacco Users|Not yet recruiting||Phase 1|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t|f|f||||||||2017-10-10 23:24:23.136899|2017-10-10 23:24:23.136899
NCT02414464|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-04-09|||February 2013||2013-02-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|September 2014|Actual|2014-09-01||Interventional|||Tooth Bleaching for Young Patients Using a Hydrogen Peroxide-based Gel|In-Office Tooth Bleaching for Young Patients Using a Hydrogen Peroxide-based Gel: a Randomized, Controlled, Clinical Trial|Unknown status|Active, not recruiting|N/A|53|Actual|University of Nove de Julho||3|||f||||f||||||||||2017-10-10 23:24:23.253075|2017-10-10 23:24:23.253075
NCT02414451|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-10-03|||September 2016||2016-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response|Trial of Propranolol in Adults and Adolescents With Autism Spectrum Disorder (ASD) and Predictors of Response|Withdrawn||N/A|0|Actual|University of Missouri-Columbia||2||No need for a pilot study. New study will be opened.|f||||f||||||||||2017-10-10 23:24:23.324842|2017-10-10 23:24:23.324842
NCT02414438|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-07|||August 2014||2014-08-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study|Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study|Completed||N/A|217|Actual|Qure Healthcare, LLC||3|||f||||f||||||||||2017-10-10 23:24:23.409953|2017-10-10 23:24:23.409953
NCT02414425|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-12-06|||December 2015||2015-12-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|FI_TOXIN||Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence|Effect And Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence|Recruiting||Phase 3|200|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 23:24:23.515079|2017-10-10 23:24:23.515079
NCT02414412|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-10-30|||February 2015||2015-02-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Immunity Improvement Effect of Ulmus Macrocarpa Water Extract in Adults|Immunity Improvement Effect of Ulmus Macrocarpa Water Extract in Adults|Completed||Phase 3|58|Actual|Pusan National University Hospital||2|||f||||t||||||||||2017-10-10 23:24:23.812792|2017-10-10 23:24:23.812792
NCT02414399|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-07-14|||June 2016||2016-06-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|Toto Bora||Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children|Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children|Recruiting||Phase 4|1400|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-10 23:24:23.891184|2017-10-10 23:24:23.891184
NCT02414386|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-07-09|||August 2015||2015-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|VitDcrrt||Serum Vitamin D Levels in Critically Ill Patients Undergoing Regional Citrate Anticoagulation CRRT|Serum Vitamin D Levels in Multi-organ Failure Critically Ill Patients Undergoing Regional Citrate Anticoagulation Continuous Renal Replacement Therapies - Prospective Observational Case-control Study|Recruiting||N/A|40|Anticipated|Publiczny Samodzielny Zaklad Opieki Zdrowotnej Wojewodzkie Centrum Medyczne|||2||f||||f||||||Samples With DNA|"     blood samples taken from the arterial catheter every 12 hours to obtain vitamin D,     parathormon, calcium, magnesium, phosphate, globulin, albumin plasma levels   "|||2017-10-10 23:24:24.020636|2017-10-10 23:24:24.020636
NCT02414373|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-05-17|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||Effects of Thoracic Epidural Administered Ropivacaine Versus Bupivacaine on Bladder Function|Effects of Thoracic Epidural Administered Ropivacaine Versus Bupivacaine on Lower Urinary Tract Function: A Randomized, Controlled Study|Completed||Phase 4|42|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 23:24:24.115027|2017-10-10 23:24:24.115027
NCT02414360|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-04-07|||July 2014||2014-07-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Using a Systematic Review in Clinical Decision Making: a Pilot Parallel, Randomized Controlled Trial|Using a Systematic Review in Clinical Decision Making: a Pilot Parallel, Randomized Controlled Trial|Completed||N/A|56|Actual|University of Toronto||2|||f||||f||||||||||2017-10-10 23:24:24.21267|2017-10-10 23:24:24.21267
NCT02414347|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-05-09|||October 2014||2014-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|T807IND||F 18 T807 Tau PET Imaging of Alzheimer's Disease|F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A|Recruiting||Phase 2|100|Anticipated|Washington University School of Medicine||1|||f||||f||||||||Yes|"We will share the data with other researchers. They may be doing research in areas similar to this research or in other unrelated areas. These researchers may be at Washington University, at other research centers and institutions, or industry sponsors of research. We may also share the research data with large data repositories (a repository is a database of information) for broad sharing with the research community. The participants individual research data is placed in one of these repositories only qualified researchers, who have received prior approval from individuals that monitor the use of the data, will be able to look at this information."|2017-10-10 23:24:24.278455|2017-10-10 23:24:24.278455
NCT02414334|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-01-13|||June 2015||2015-06-01|January 2017|2017-01-01||||June 2019|Anticipated|2019-06-01||Interventional|SABR-SCAN||SABR-SCAN Trial for Pulmonary Oligometastases|Immediate Versus Delayed Stereotactic Ablative Radiotherapy (SABR) for Patients With Pulmonary Oligometastases From Colorectal Cancer: SABR SCAN Trial A Randomised Clinical Trial|Recruiting||Phase 2|40|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-10 23:24:24.366437|2017-10-10 23:24:24.366437
NCT02414321|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-05-20|||June 2015||2015-06-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||The Role of the Pulmonary Vasculature in the Fontan Circulation|The Role of the Pulmonary Vasculature in the Fontan Circulation|Recruiting||N/A|20|Anticipated|University Medical Center Groningen|||2||f||||f||||||||||2017-10-10 23:24:24.453294|2017-10-10 23:24:24.453294
NCT02414308|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-04-09|||June 2013||2013-06-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Management of Peyronie's Disease With Adipose Tissue Stem Cell|The Role of Adipose Tissue Stem Cell Injection Through Corpora Cavernosa and Intra Dorsal Penile Artery in Management of Erectile Dysfunction Associated With Peyronie's Disease|Unknown status|Recruiting|N/A|20|Anticipated|Man Clinic for Andrology, Male Infertility and Sexual Dysfunction||1|||f||||t||||||||||2017-10-10 23:24:24.555793|2017-10-10 23:24:24.555793
NCT02414295|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-04-09|||August 2013||2013-08-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection|Management of Azoospermic Patients With Kleinfelter Syndrome Patients With Mesenchymal Stem Cell Injection|Completed||N/A|1|Actual|Man Clinic for Andrology, Male Infertility and Sexual Dysfunction||1|||f||||f||||||||||2017-10-10 23:24:24.645282|2017-10-10 23:24:24.645282
NCT02414282|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-05-09|||March 2015||2015-03-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|Protocol E||F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)|F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction Due to Alzheimer Disease|Recruiting||Phase 2|25|Anticipated|Washington University School of Medicine||1|||f||||f||||||||Yes|We will share this data with other researchers. They may be doing research in areas similar to this research or in other unrelated areas. These researchers may be at Washington University, at other research centers and institutions, or industry sponsors of research. We may also share your research data with large data repositories (a repository is a database of information) for broad sharing with the research community. If the individual research data is placed in one of these repositories only qualified researchers, who have received prior approval from individuals that monitor the use of the data, will be able to look at the information.|2017-10-10 23:24:24.748784|2017-10-10 23:24:24.748784
NCT02414269|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-08-15|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin|A Phase I Clinical Trial of Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin|Recruiting||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:24:24.852028|2017-10-10 23:24:24.852028
NCT02414256|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-01-27|||January 2015||2015-01-01|April 2015|2015-04-01|June 2016|Actual|2016-06-01|April 2015|Actual|2015-04-01||Observational|||PECS Block in Breast Surgery: an Observational Multicenter Study|PECS Block in Breast Surgery: an Observational Multicenter Study|Completed||N/A|250|Actual|Ospedale di Circolo - Fondazione Macchi|||1||f||||f||||||||||2017-10-10 23:24:24.969022|2017-10-10 23:24:24.969022
NCT02414243|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-07-19|||April 2015||2015-04-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|RAF||Study to Assess Hypoallergenicity of a New Amino-acid Based Infant Formula in Children With Cow's Milk Allergy|A Multicenter, Randomized, Controlled, Cross-over Study to Assess Hypoallergenicity of a New Amino-acid Based Infant Formula in Children With Cow's Milk Allergy|Recruiting||Phase 2|29|Anticipated|Laboratorios Ordesa||2|||f||||t||||||||||2017-10-10 23:24:25.053362|2017-10-10 23:24:25.053362
NCT02414230|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-05-09|||February 2015||2015-02-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|March 2020|Anticipated|2020-03-01||Interventional|T807ALS||F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis|F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis (IND 123119 Protocol B)|Recruiting||Phase 2|20|Anticipated|Washington University School of Medicine||1|||f||||f||||||||Yes|We will share the data with other researchers. They may be doing research in areas similar to this research or in other unrelated areas. These researchers may be at Washington University, at other research centers and institutions, or industry sponsors of research. We may also share this research data with large data repositories (a repository is a database of information) for broad sharing with the research community. If the individual research data is placed in one of these repositories only qualified researchers, who have received prior approval from individuals that monitor the use of the data, will be able to look at the information.|2017-10-10 23:24:25.159066|2017-10-10 23:24:25.159066
NCT02414217|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-09-21|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|October 31, 2016|Actual|2016-10-31|February 2016|Actual|2016-02-01||Interventional|IntEND||Intervention to Enhance Numeracy in Diabetes (IntEND)|Intervention to Enhance Numeracy in Diabetes|Completed||N/A|65|Actual|University of Colorado, Denver||3|||f||||f|f|f||||||||2017-10-10 23:24:25.250241|2017-10-10 23:24:25.250241
NCT02414204|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-07-06|||April 2015||2015-04-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|June 30, 2017|Actual|2017-06-30||Interventional|||Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula|Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula|Active, not recruiting||N/A|21|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:24:25.380452|2017-10-10 23:24:25.380452
NCT02414191|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-04-05|||February 2015||2015-02-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Feedback on Perioperative Temperature Management and Patient Outcomes: Three-arm Trial to Compare Feedback|Effect of Audit and Feedback on Physicians' Perioperative Temperature Management and Patient Outcomes: A Three-arm Cluster Randomized Controlled Trial to Compare Benchmarked and Ranked Feedback|Recruiting||N/A|45|Anticipated|Ottawa Hospital Research Institute||3|||f||||f||||||||||2017-10-10 23:24:25.459767|2017-10-10 23:24:25.459767
NCT02414178|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-09-19|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|February 2020|Anticipated|2020-02-01||Interventional|||F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)|F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network|Recruiting||Phase 2|130|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 23:24:25.536655|2017-10-10 23:24:25.536655
NCT02414165|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-02-08|||November 2015||2015-11-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|November 2017|Anticipated|2017-11-01||Interventional|Toca5||P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA|A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma|Active, not recruiting||Phase 2/Phase 3|187|Actual|Tocagen Inc.||2|||f||||t||||||||||2017-10-10 23:24:27.723944|2017-10-10 23:24:27.723944
NCT02414152|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-01-31|2016-08-09||October 2013||2013-10-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|SSNHL||Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss|A Phase I & II Open-label Study of the Effects of Anakinra (Kineret) in Corticosteroid-resistant Subjects With Sudden Sensorineural Heaing Loss (SSNHL)|Terminated||Phase 1/Phase 2|2|Actual|Northwell Health|Early termination of the study secondary to inability to secure funding.|1||Early study termination occurred due to inability to secure funding|f||||t||||||||||2017-10-10 23:24:28.002219|2017-10-10 23:24:28.002219
NCT02414139|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-07-28|||June 1, 2007|Actual|2007-06-01|July 2017|2017-07-01|January 28, 2020|Anticipated|2020-01-28|September 4, 2018|Anticipated|2018-09-04||Interventional|||Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer|A Phase II, Multicenter Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|318|Anticipated|Novartis||5|||f||||f|t|f||||||||2017-10-10 23:24:28.244348|2017-10-10 23:24:28.244348
NCT02414126|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-08-25|||July 2015||2015-07-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|IC-E-PPC||Evaluation of Breathing, Sleep and the Effects of Continuous Positive Airway Pressure During Wakefulness in Children With Heart Failure|Evaluation of Breathing, Sleep and the Effects of Continuous Positive Airway Pressure During Wakefulness in Children With Heart Failure|Recruiting||N/A|45|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 23:24:30.299328|2017-10-10 23:24:30.299328
NCT02414113|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-06-26|||March 25, 2015|Actual|2015-03-25|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant|A Blinded, Prospective Non-Interventional Observational Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant|Recruiting||N/A|300|Anticipated|Washington University School of Medicine|||2||f||||f|f|f||||Samples With DNA|"     -At the time of HLA confirmatory typing, 24 mL of whole blood will be collected from all     potential donors who agree to participate.   "|No||2017-10-10 23:24:30.505378|2017-10-10 23:24:30.505378
NCT02414100|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-05|||December 12, 2013|Actual|2013-12-12|September 2017|2017-09-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Observational|||Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy|Generation of Patient Derived Pancreatic Cancer Cell Lines to Determine Mechanisms of Chemoresistance|Withdrawn||N/A|0|Actual|Thomas Jefferson University|||1|No subjects were enrolled. Study team was not able to grow cell lines for the tumors.|f||||t||||||Samples With DNA|"     Blood, tissue   "|||2017-10-10 23:24:30.650724|2017-10-10 23:24:30.650724
NCT02414087|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-04-09|||April 2015||2015-04-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Therapeutic Effects of Customized Insoles on Children With Flat Foot|Therapeutic Effects of Customized Insoles on Children With Flat Foot|Unknown status|Not yet recruiting|Phase 4|52|Anticipated|Taipei Medical University||2|||f||||f||||||||||2017-10-10 23:24:30.754003|2017-10-10 23:24:30.754003
NCT02414074|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-04-21|||June 2013||2013-06-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Adaptive Intervention Strategies in Conduct Problems Prevention|Adaptive Intervention Strategies in Conduct Problems Prevention|Completed||N/A|200|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-10 23:24:30.842456|2017-10-10 23:24:30.842456
NCT02414061|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-10|||April 2014||2014-04-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Metabolic and Appetite Parameters Following Addition of Whey Protein to a Carbohydrate-based Breakfast|The Influence of Whey Protein Addition to a Carbohydrate-based Breakfast on Metabolic and Appetite Parameters Following a Second Meal|Completed||N/A|10|Actual|Northumbria University||3|||f||||f||||||||||2017-10-10 23:24:30.925946|2017-10-10 23:24:30.925946
NCT02414048|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-06-16|||April 2015||2015-04-01|June 2016|2016-06-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Hypoxia Analysis in Head and/or Neck Cancer|Predictive Methods Determining Tumour Hypoxia in Head and Neck Cancer Patients - a Prospective Project|Recruiting||Phase 2|10|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:24:31.00281|2017-10-10 23:24:31.00281
NCT02414035|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-07|||March 2015||2015-03-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|MISSION-AF||Monitor System for the Safety of Dabigatran Treatment|A Monitor System for the Safety of Dabigatran Anticoagulation Treatment in Nonvalvular Atrial Fibrillation|Unknown status|Recruiting|N/A|2000|Anticipated|Second Affiliated Hospital of Nanchang University|||1||f||||f||||||Samples With DNA|"     Samples with DNA for genetic variants test which could contribute to interindividual     variability in blood concentrations of the active metabolite of dabigatran etexilate and     influence the safety and efficacy of dabigatran.   "|||2017-10-10 23:24:31.083431|2017-10-10 23:24:31.083431
NCT02414022|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-03-23|||April 2015||2015-04-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Observational|||Economic Analysis of Alliance A041202 CLL Study|A Prospective Economic Analysis NCIC CTG CLC.2/ALLIANCE A041202: A Randomized Phase III CLL Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (≥65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||N/A|51|Actual|Canadian Cancer Trials Group|||1||f||||t||||||||No||2017-10-10 23:24:31.154861|2017-10-10 23:24:31.154861
NCT02413658|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-09|||March 2015||2015-03-01|April 2015|2015-04-01||||April 2016|Anticipated|2016-04-01||Interventional|||Phenytoin in the Healing of Clean Surgical Wounds|Phenytoin in the Healing of Clean Surgical Wounds|Unknown status|Recruiting|Phase 2|100|Anticipated|Children's Surgical Center, Cambodia||3|||f||||||||||||||2017-10-10 23:24:34.24655|2017-10-10 23:24:34.24655
NCT02414009|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-03-15|||September 2014||2014-09-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CAPTEM||Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients|Open-label, Randomized, Multicenter, Phase II Trial to Compare Efficacy of CAPTEM Versus FOLFIRI as Second Line in Patients Progressed on or After First-line Oxaliplatin Chemo for Advanced, MGMT Methylated, RAS Mutated Colorectal Cancer|Recruiting||Phase 2|82|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-10 23:24:31.215939|2017-10-10 23:24:31.215939
NCT02413996|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-09-06|||September 2014||2014-09-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effects of Virtual Reality Rehabilitation in Patients With Total Knee Arthroplasty|Effects of Virtual Reality Rehabilitation in Patients With Total Knee Arthroplasty: A Randomised Controlled Trial|Recruiting||Phase 3|142|Anticipated|Istituto Ortopedico Galeazzi||2|||f||||t||||||||||2017-10-10 23:24:31.30519|2017-10-10 23:24:31.30519
NCT02413983|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-04-07|||April 2015||2015-04-01|April 2015|2015-04-01||||April 2016|Anticipated|2016-04-01||Observational|||Comparison of Postoperative Outcome of Hepatectomy for Living Donors According to Three Different Incision|Comparison of Postoperative Outcome of Hepatectomy for Living Donors According to Three Different Incision: Conventional Incision vs Minimal Incision vs Transverse Incision Assisted by Laparoscopy|Unknown status|Not yet recruiting|N/A|60|Anticipated|Samsung Medical Center|||3||f||||f||||||||||2017-10-10 23:24:31.395721|2017-10-10 23:24:31.395721
NCT02413970|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-08|||May 2015||2015-05-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|||Inspire® Post-Approval Study / Protocol Number 2014-001|Inspire® Upper Airway Stimulation System (UAS): Post-Approval Study Protocol Number 2014-001|Recruiting||Phase 4|127|Anticipated|Inspire Medical Systems, Inc.||1|||f||||f||||||||||2017-10-10 23:24:31.481484|2017-10-10 23:24:31.481484
NCT02413957|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-01-10|||January 2015||2015-01-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Medication Reconciliation in Comparison to an Extensive Medication Safety Check|Pilot Project to Investigate the Influence of Medication Reconciliation and an Extensive Medication Safety Check on the Number of Adverse Drug Events in the Elderly|Completed||N/A|220|Actual|RWTH Aachen University||3|||f||||f||||||||||2017-10-10 23:24:31.747991|2017-10-10 23:24:31.747991
NCT02413944|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-10-26|||April 2015||2015-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Standardized 1µg Adrenocorticotropic Hormone Stimulation Test, and Salivary Cortisol Concentration During the Test|Standardized Protocol for 1µg Adrenocorticotropic Hormone (ACTH) Stimulation Test, Minimizing Technical Issues That Could Influence Test Accuracy; and Determining Salivary Free Cortisol Concentration in Healthy Controls During the Test|Completed||Phase 4|20|Actual|Bnai Zion Medical Center||1|||f||||f||||||||No||2017-10-10 23:24:31.855193|2017-10-10 23:24:31.855193
NCT02413931|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-10-05|||May 2015||2015-05-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Nosocomial Transmission of MDR-TB in Bucharest, Romania|Nosocomial Transmission of Multidrug-resistant Tuberculosis at the Marius Nasta Institute in Bucharest, Romania|Recruiting||N/A|100|Anticipated|Research Center Borstel|||1||f||||f||||||Samples Without DNA|"     Sputum, blood and urine samples   "|Undecided|this will be decided at a later time point|2017-10-10 23:24:31.944967|2017-10-10 23:24:31.944967
NCT02413905|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-07|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Characterizing the Gut Microbiota Alteration Associated With Severe Acute Malnutrition|Characterizing the Gut Microbiota Alteration Associated With Severe Acute Malnutrition|Completed||N/A|100|Actual|Institut Hospitalo-Universitaire Méditerranée Infection|||2||f||||f||||||Samples With DNA|"     Stool samples   "|||2017-10-10 23:24:32.151921|2017-10-10 23:24:32.151921
NCT02413892|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-03|||May 2015|Actual|2015-05-01|April 2016|2016-04-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Observational|CASPOLOAD||Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients|Impact of a Loading Dose of Caspofungin on Pharmacokinetic and Pharmacodynamic Parameters Target Achievements for Severe Candida Infections in ICU Patients|Completed||N/A|15|Actual|Outcome Rea|||1||f||||f||||||Samples Without DNA|"     The samples were collected as part of patient care in medical monitoring and resuscitation     infectious Bichat Hospital. They will be used to search within the site.      In these severe patients, arterial catheter is systematically implemented. The investigators     plan to collect thru this catheter five blood 4ml tubes on 24hours to measure the     pharmacodynamic parameters of caspofungin.   "|Undecided||2017-10-10 23:24:32.233801|2017-10-10 23:24:32.233801
NCT02413879|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-07-26|2017-06-16||March 2015||2015-03-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CIRCE||Cleancision IntRaoperative Contamination prEvention Study|An Evaluation of the Safety and Efficacy of the CleanCision Wound Retraction and Protection System in Protecting Surgical Incisions From Intraoperative Contamination When Used During Colorectal Surgery|Completed||N/A|108|Actual|Prescient Surgical||1|||f||||f||||||||||2017-10-10 23:24:32.31937|2017-10-10 23:24:32.31937
NCT02413866|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-12-16|||January 2015||2015-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|WORDS||Weight Outlooks by Restriction of Diet and Sleep|Weight Outlooks by Restriction of Diet and Sleep|Completed||N/A|36|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-10 23:24:32.64113|2017-10-10 23:24:32.64113
NCT02413853|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-04-13|||November 2015|Anticipated|2015-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|PRIMIER||Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer|PRIMIER*: Randomized Phase II Trial of mFOLFOX6/Bevacizumab With or Without PRI‐724 as First Line Treatment for Metastatic Colorectal Cancer|Withdrawn||Phase 2|0|Actual|University of Southern California||2||Study drug supply issues|f||||t|t|f||||||||2017-10-10 23:24:32.730199|2017-10-10 23:24:32.730199
NCT02413840|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-04-07|||December 2014||2014-12-01|April 2015|2015-04-01||||May 2015|Anticipated|2015-05-01||Interventional|||Evaluation, Psychological Intervention and Follow-up Study of Anxiety and Depression in Stable COPD Patients|Evaluation, Psychological Intervention and Follow-up Study of Anxiety and Depression in Stable Chronic Obstructive Pulmonary Disease Patients|Unknown status|Recruiting|N/A|60|Anticipated|Capital Medical University||2|||f||||t||||||||||2017-10-10 23:24:32.844298|2017-10-10 23:24:32.844298
NCT02413827|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-04-06||2017-04-06|April 2015|Actual|2015-04-01|April 2017|2017-04-01|November 9, 2016|Actual|2016-11-09|November 2, 2016|Actual|2016-11-02||Interventional|||A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma|A Phase 1 Safety Pilot/Phase II, Open-label Study of Varlilumab (CDX-1127) in Combination With Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or Stage IV Melanoma|Terminated||Phase 1/Phase 2|9|Actual|Celldex Therapeutics||2||Feasibility concerns due to changes in standard of care|f||||t||||||||||2017-10-10 23:24:32.937078|2017-10-10 23:24:32.937078
NCT02413814|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-09-08|||April 2015||2015-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Computerized Anger-Reduction Treatment for Smoking Cessation|Computerized Anger-Reduction Treatment for Smoking Cessation|Recruiting||N/A|114|Anticipated|Florida State University||2|||f||||t||||||||||2017-10-10 23:24:33.050077|2017-10-10 23:24:33.050077
NCT02413801|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-08-15|||March 19, 2015|Actual|2015-03-19|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|RRF||Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients|Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients|Active, not recruiting||N/A|103|Actual|University of Rochester|||2||f||||f|f|f||||Samples With DNA|"     Peripheral blood and bone marrow samples that remain after study assays are completed may be     stored for future non-genetic research.   "|||2017-10-10 23:24:33.143173|2017-10-10 23:24:33.143173
NCT02413788|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-08-31|||September 2015||2015-09-01|August 2015|2015-08-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Impact of Aerobic Training and Combined in Inflammatory Markers in Patients With Adolescent Idiopathic Scoliosis|Impact of Aerobic Training and Combined in Inflammatory Markers in Patients With Adolescent Idiopathic Scoliosis|Completed||N/A|40|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t||||||||||2017-10-10 23:24:33.211252|2017-10-10 23:24:33.211252
NCT02413775|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-08-02|||April 2015||2015-04-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|April 2015|Actual|2015-04-01||Observational|||Patient Survey as a Tool to Quality Assurance and Quality Improvement|Patient Survey as a Tool to Quality Assurance and Quality Improvement - Department of Anesthesiology and Intensive Care, CVK/CCM, Charité - University Medicine Berlin|Recruiting||N/A|2000|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 23:24:33.296821|2017-10-10 23:24:33.296821
NCT02413762|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-04-07|||March 2015||2015-03-01|March 2015|2015-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||The Role of Gut Hormones and Hepcidin in Type 2 Diabetes Mellitus|The Role of Gut Hormones and Hepcidin in Type 2 Diabetes Mellitus|Unknown status|Recruiting|N/A|2000|Anticipated|Imperial College London Diabetes Centre|||5||f||||f||||||Samples Without DNA|"     Blood plasma   "|||2017-10-10 23:24:33.391822|2017-10-10 23:24:33.391822
NCT02413749|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-08-15|||April 13, 2015|Actual|2015-04-13|August 2017|2017-08-01|December 28, 2016|Actual|2016-12-28|December 28, 2016|Actual|2016-12-28||Observational|Incubator||DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsA|DC-STAMP and TRAF3: Regulators of Osteoclastogenesis and Biomarkers in Psoriatic Arthritis|Completed||N/A|68|Actual|University of Rochester|||2||f||||f|f|f|||f|Samples With DNA|"     Peripheral blood samples that remain after study assays are completed may be stored for     future non-genetic research.   "|||2017-10-10 23:24:33.496062|2017-10-10 23:24:33.496062
NCT02413736|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-08-09|||May 2015||2015-05-01|August 2017|2017-08-01|May 2028|Anticipated|2028-05-01|May 2028|Anticipated|2028-05-01||Interventional|||Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST|Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST With a High Risk for Recurrence: A Randomised Phase III Study|Recruiting||Phase 3|300|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-10 23:24:33.564346|2017-10-10 23:24:33.564346
NCT02413723|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-28|2016-07-14|||May 2015||2015-05-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|MACMAN||McGrath Mac Videolaryngoscope Versus Macintosh Laryngoscope for Orotracheal Intubation in Critical Care Unit|McGrath Mac Videolaryngoscope Versus Macintosh Laryngoscope for Orotracheal Intubation in Critical Care Unit|Completed||N/A|371|Actual|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-10 23:24:33.646651|2017-10-10 23:24:33.646651
NCT02413710|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-04-07|||February 2015||2015-02-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of Soy Protein on Body Composition and General Health in Healthy Children|A Randomized, Controlled, Parallel Study to Assess the Effects of Soy Protein on Body Composition and General Health Parameters in Healthy Children|Unknown status|Recruiting|N/A|46|Anticipated|DuPont Nutrition and Health||2|||f||||f||||||||||2017-10-10 23:24:33.743289|2017-10-10 23:24:33.743289
NCT02413697|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2017-08-03|||April 2015||2015-04-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|April 2016|Actual|2016-04-01||Interventional|||Three-dimensional Versus Two-dimensional Ultrasound Guided Embryo Transfer in Women Undergoing ART Treatment|A Randomised Control Trial of Three-dimensional Versus Two-dimensional Ultrasound Guided Embryo Transfer in Women Undergoing Artificial Reproductive Technology Treatment|Active, not recruiting||N/A|481|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:24:33.814027|2017-10-10 23:24:33.814027
NCT02413671|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-10-12|||June 2013||2013-06-01|October 2016|2016-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|NPS||The Role of Whey and Lupin in Glycemic Control (Nutritional Pre-Study)|Short-term Effects of Lupin Versus Whey Protein on Glucose and Insulin Responses to a Standardized Meal in a Randomized Controlled Trial|Completed||N/A|12|Actual|DLR German Aerospace Center||3|||f||||f||||||||||2017-10-10 23:24:34.154359|2017-10-10 23:24:34.154359
NCT02413645|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-08-02|||June 2015||2015-06-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||A Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy|A Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy|Active, not recruiting||Phase 1|21|Anticipated|Fundacion Clinic per a la Recerca Biomédica||5|||f||||t||||||||||2017-10-10 23:24:34.359912|2017-10-10 23:24:34.359912
NCT02413632|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2017-08-08|||April 2015||2015-04-01|August 2017|2017-08-01|April 14, 2017|Actual|2017-04-14|April 14, 2017|Actual|2017-04-14||Interventional|DRIVER||Screening Strategy for Asymptomatic Sexually Transmitted Infections (STI) in a Cohort of HIV Outpatients Men Who Have Sex With Men (DRIVER)|Asymptomatic Sexually Transmitted Infections (STI) : Comparison of Two Screening Strategies Routine Screening Versus Screening as Reported by the Risks Taken by the Patient, in a Cohort of HIV Outpatients Men Who Have Sex With Men|Completed||N/A|495|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-10 23:24:34.484654|2017-10-10 23:24:34.484654
NCT02413619|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-11-09|||May 2014||2014-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|EPIREF||Refractive Consequences of Epiretinal Membrane Surgery|Refractive Consequences of Epiretinal Membrane Surgery|Completed||N/A|62|Actual|Glostrup University Hospital, Copenhagen||3|||f||||f||||||||||2017-10-10 23:24:34.639033|2017-10-10 23:24:34.639033
NCT02413606|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-01-30|||September 2015|Actual|2015-09-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|ENSURE||ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?|ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More? Randomized Controlled Trial to Evaluate Patient Satisfaction and Cost-effectiveness of a Reduced Follow-up Schedule|Recruiting||N/A|282|Anticipated|Comprehensive Cancer Centre The Netherlands||2|||f||||f||||||||Yes|After ending the study and analysis of the data, data becomes available for use by other researchers via PROFILES registry, according to the their terms|2017-10-10 23:24:34.744681|2017-10-10 23:24:34.744681
NCT02413593|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-12-22|2016-12-22||April 2015||2015-04-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional||Safety Analysis Set: all enrolled participants who received at least 1 dose of study drug.|Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection|A Phase 2 Open- Label Study to Evaluate The Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naïve Patients With Chronic HCV Genotype 3 Infection|Completed||Phase 2|111|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-10 23:24:35.000733|2017-10-10 23:24:35.000733
NCT02413580|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-08-02|||March 2015||2015-03-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations|A Multicenter, Prospective, Open-label, Non-controlled Clinical Trial to Assess the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Patients With Myasthenia Gravis Exacerbations|Recruiting||Phase 3|50|Anticipated|Grifols Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 23:24:35.504021|2017-10-10 23:24:35.504021
NCT02413567|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-07-12|||January 2015||2015-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 Diabetes|Evaluation of Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes|Active, not recruiting||N/A|50|Anticipated|Fractyl Laboratories, Inc.||1|||f||||t||||||||||2017-10-10 23:24:35.759838|2017-10-10 23:24:35.759838
NCT02413541|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-01-26|||January 2015||2015-01-01|December 2015|2015-12-01||||December 2015|Actual|2015-12-01||Interventional|||The Pilot Study of the Efficacy of Polymyxin-B Hemoperfusion in Critically Ill Patients With Severe Sepsis||Recruiting||N/A|90|Anticipated|Chulalongkorn University||3|||f||||||||||||||2017-10-10 23:24:35.950255|2017-10-10 23:24:35.950255
NCT02413528|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-08-03|||October 2014||2014-10-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Pilot Study of a Mobile Asthma Adherence Intervention|Pilot Study of a Mobile Intervention to Increase Adherence to Asthma Medication Among Adolescents|Terminated||N/A|12|Actual|CoheroHealth||2||Wireless connectivity challenges with device and mobile app|f||||f||||||||No||2017-10-10 23:24:36.045465|2017-10-10 23:24:36.045465
NCT02413515|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-08-03|||March 26, 2015|Actual|2015-03-26|August 2017|2017-08-01|August 8, 2016|Actual|2016-08-08|August 8, 2016|Actual|2016-08-08||Interventional|ADEPT||Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.|Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapy: A Prospective, Open-label, Multicenter, Single-arm, 8-week Study.|Completed||Phase 4|278|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-10 23:24:36.129346|2017-10-10 23:24:36.129346
NCT02413502|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-10-07|||May 2015||2015-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US|Collection and Storage of Biological Samples Obtained by Leukapheresis for the Future Study of Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US (A-046)|Completed||Early Phase 1|10|Actual|Aeras||1|||f||||f||||||||||2017-10-10 23:24:36.234986|2017-10-10 23:24:36.234986
NCT02413489|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-06-29|||September 2, 2015|Actual|2015-09-02|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma|An Open Label, Phase 2 Study to Evaluate Efficacy and Safety of Daratumumab in Relapsed or Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma|Terminated||Phase 2|42|Actual|Janssen Research & Development, LLC||1||"DLBCL and FL cohorts met the pre-specified futility criteria and will not proceed. The MCL   cohort was terminated due to slow recruitment and aggressive disease."|f||||f||f||||||||2017-10-10 23:24:36.298802|2017-10-10 23:24:36.298802
NCT02413476|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-05-17|||May 2015||2015-05-01|April 2015|2015-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy|Compared With Robotic-assisted and Laparoscopic-assisted Gastrectomy for Gastric Cancer on Surgical,Clinical and Oncological Outcomes|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-10 23:24:36.432055|2017-10-10 23:24:36.432055
NCT02413463|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-02-13|||January 2016||2016-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison Between Augmented Recession and Posterior Scleral Fixation in Partially Accommodative Esotropia|Comparison Between Augmented Recession and Posterior Scleral Fixation in Partially Accommodative Esotropia|Recruiting||N/A|50|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-10 23:24:36.52359|2017-10-10 23:24:36.52359
NCT02413450|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-08-10|||August 2013||2013-08-01|August 2017|2017-08-01|August 2023|Anticipated|2023-08-01|August 2023|Anticipated|2023-08-01|1 Day|Observational [Patient Registry]|||Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias|Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias (Long QT Syndrome, Brugada Syndrome, CPVT and Early Repolarization Syndrome)|Enrolling by invitation||N/A|100|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"     induced pluripotent stem cells (iPSC)   "|||2017-10-10 23:24:36.608075|2017-10-10 23:24:36.608075
NCT02413437|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-05-04|||April 2015||2015-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms|The Multi-center Study of Percutaneous Focal Liver Lesions Biopsy Guided by Contrast-Enhanced Ultrasound|Recruiting||N/A|2088|Anticipated|Beijing Cancer Hospital||2|||f||||t||||||||||2017-10-10 23:24:36.672182|2017-10-10 23:24:36.672182
NCT02413424|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-19|||April 2015||2015-04-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|December 2016|Actual|2016-12-01||Interventional|NNS||Metabolic Effects of Non-nutritive Sweeteners|Metabolic Effects of Non-nutritive Sweeteners|Completed||N/A|38|Actual|University of Illinois at Urbana-Champaign||3|||f||||t||||||||||2017-10-10 23:24:36.956359|2017-10-10 23:24:36.956359
NCT02413411|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-08|||May 2010||2010-05-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|REPAIR||Race and Preference for Knee Replacement: A Patient-Centered Intervention|Race and Preference for Knee Replacement: A Patient-Centered Intervention|Completed||N/A|493|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:24:37.061058|2017-10-10 23:24:37.061058
NCT02413398|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-07-13|||June 15, 2015|Actual|2015-06-15|July 2017|2017-07-01|November 8, 2017|Anticipated|2017-11-08|November 8, 2017|Anticipated|2017-11-08||Interventional|DERIVE||A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes|A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase III Study to Evaluate the Glycemic Efficacy and Renal Safety of Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment (CKD 3A) Who Have Inadequate Glycemic Control.|Active, not recruiting||Phase 3|321|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:24:37.161204|2017-10-10 23:24:37.161204
NCT02413385|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-27|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Interventional|HeSP||Evidence-Based Lifestyle Prescription Program: Pilot Study|Canadian Diabetes Strategy Research Project - HealtheSteps™: Exercise and Healthy Eating Prescriptions to Reduce the Risk of Diabetes in Rural and Remote Communities: A Pilot Pragmatic Randomized Controlled Trial (Project 3).|Completed||N/A|118|Actual|Western University, Canada||2|||f||||f||||||||||2017-10-10 23:24:37.441242|2017-10-10 23:24:37.441242
NCT02413359|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-09-20|||May 2015||2015-05-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||High Risk Populations Among COPD Patients in Japan|Research Study in Patients With COPD in High Risk Population in Japan: Proportion of Overlap Between COPD and Asthma, and the Relationship With COPD Exacerbation|Completed||N/A|1016|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:24:37.690777|2017-10-10 23:24:37.690777
NCT02413346|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-02-23|||March 2015||2015-03-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris|A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris|Completed||Phase 3|490|Actual|Warner Chilcott||1|||f||||f||||||||||2017-10-10 23:24:37.76673|2017-10-10 23:24:37.76673
NCT02413333|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2016-07-29|2016-07-29||April 2015||2015-04-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Safety analysis set, defined as all participants randomized and treated. Two participants inadvertently used the incorrect product during the second period, and they are defined according to the treatment received.|Clear Care® Plus vs. PeroxiClear™|Comparison of Two One-Step Hydrogen Peroxide Lens Care Solutions in Symptomatic Contact Lens Wearers|Completed||N/A|133|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:24:37.940042|2017-10-10 23:24:37.940042
NCT02413320|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-01-04|||July 2015||2015-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|NeoSTOP||Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer|Randomized Open Label Phase II Trial of Neoadjuvant Carboplatin Plus Docetaxel or Carboplatin Plus Paclitaxel Followed by Doxorubicin Plus Cyclophosphamide in Stage I-III Triple-negative Breast Cancer|Recruiting||Phase 2|100|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-10 23:24:38.302824|2017-10-10 23:24:38.302824
NCT02413307|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-12-01|||February 2014||2014-02-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Development and Evaluation of a Brief CFT Intervention for Trauma|The Development and Evaluation of a Brief Self-practice Compassion Focused Therapy (CFT) Intervention as an Adjunct to TAU for Trauma Patients|Recruiting||Phase 1/Phase 2|40|Anticipated|University of Lincoln||2|||f||||f||||||||No|Currently no plans to share IPD. If researchers wish to view data analysis following the study they can contact the researcher.|2017-10-10 23:24:38.457136|2017-10-10 23:24:38.457136
NCT02413294|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-04-04|2017-02-16||April 2015||2015-04-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|STAMP|Baseline measures are given for the study sample that completed study procedures.|Sleep to Activate Mood Promotion|Sleep to Activate Mood Promotion- Intervention|Completed||N/A|12|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 23:24:38.567853|2017-10-10 23:24:38.567853
NCT02413281|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2015-11-09|||March 2015||2015-03-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users|A Phase 1, Single-Dose, Double-Blind, Placebo-and Active-Controlled, Randomized, 6-way Crossover Human Abuse Liability Evaluation of ALKS 5461|Completed||Phase 1|56|Actual|Alkermes, Inc.||6|||f||||f||||||||||2017-10-10 23:24:39.031302|2017-10-10 23:24:39.031302
NCT02413268|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-03-11|||March 2016||2016-03-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|NTP-RAO||Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial|Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial|Recruiting||Phase 3|2400|Anticipated|Total Cardiovascular Solutions||2|||f||||f||||||||||2017-10-10 23:24:39.105309|2017-10-10 23:24:39.105309
NCT02413255|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-05-23|||April 6, 2015|Actual|2015-04-06|May 2017|2017-05-01|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential-Panel, Ascending Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-020 in Healthy Volunteers|Completed||Phase 1|120|Actual|Takeda||16|||f||||f|t|f||||||||2017-10-10 23:24:39.188816|2017-10-10 23:24:39.188816
NCT02413242|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-05-17|||April 2015||2015-04-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|ASPIRE-ICU||Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU|Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU|Recruiting||N/A|2000|Anticipated|UMC Utrecht|||2||f||||f||||||Samples Without DNA|"     -  Microbiological samples:             -  Nose swabs - at day of informed consent form (ICF), day 4, day 7.             -  Peri-anal swabs - at day of ICF, day 4, day 7, then twice weekly until day 30.             -  Lower respiratory tract (LRT) sample - at day of ICF, day 4, day 7, then twice               weekly until day 30, day of ICU pneumonia, day 7 after ICU pneumonia. The LRT               sample can be defined as the collection of an endotracheal aspirate (ETA). If an               ETA cannot be collected, a sputum sample may be taken.             -  Broncho alveolar lavage - If available through clinical procedures, BAL specimens               will be collected for study purposes.        -  Blood samples * Blood samples will be taken at day of ICF, day 7 and day 30 or day of          ICU discharge (whichever occurs first), day of ICU pneumonia, day 7 after ICU pneumonia          and day 30 after ICU pneumonia.   "|Undecided||2017-10-10 23:24:39.330651|2017-10-10 23:24:39.330651
NCT02413229|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-05-03|||April 2015||2015-04-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study|A Randomized Double Blind Vehicle Controlled Dose Ranging Multiple Site Phase 2 Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Moderate to Severe Scalp Psoriasis|Completed||Phase 2|151|Actual|Taro Pharmaceuticals USA||2|||f||||f||||||||No||2017-10-10 23:24:39.428768|2017-10-10 23:24:39.428768
NCT02413216|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-11-17|||August 2015||2015-08-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)|Creating a Computerized Self-administered Version of Comprehensive Behavioral Intervention for Tics|Recruiting||N/A|64|Anticipated|University of Utah||2|||f||||f||||||||||2017-10-10 23:24:39.499276|2017-10-10 23:24:39.499276
NCT02413203|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-04-17|2017-03-06||March 2015||2015-03-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B|A Randomized, Double-blinded, Placebo-controlled Study Investigating the Pharmacological Response to Celecoxib Using ex Vivo Human Whole-blood Assay (hWBA) and Broad-spectrum Lipidomics Analysis|Completed||N/A|20|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:24:39.59713|2017-10-10 23:24:39.59713
NCT02413177|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|ATTEND||Augmenting Mindfulness Training Through Experience-driven Neurofeedback|Augmenting Mindfulness Training Through Experience-driven Neurofeedback|Enrolling by invitation||N/A|120|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-10 23:24:39.940036|2017-10-10 23:24:39.940036
NCT02413164|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-12-02|||December 2015||2015-12-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|October 2016|Actual|2016-10-01||Interventional|||Effectiveness of a Physical Therapy Program on Self-assessment Health and Quality of Life in Patients With Schizophrenia|Effectiveness of a Physical Therapy Program on Self-assessment Health and Quality of Life in Patients With Schizophrenia|Recruiting||N/A|50|Anticipated|University of Malaga||2|||f||||t||||||||||2017-10-10 23:24:40.015254|2017-10-10 23:24:40.015254
NCT02413138|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-04|||March 2015||2015-03-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)|A Randomized, Phase 2/3, Open-Label, Multi-center Study of the Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of A Long-acting Human Growth Hormone (Somavaratan, VRS-317) in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD)|Recruiting||Phase 2/Phase 3|48|Anticipated|Versartis Inc.||2|||f||||t||||||||No||2017-10-10 23:24:40.420147|2017-10-10 23:24:40.420147
NCT02413125|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-04-12|||February 2015||2015-02-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Comparison of Nasal Saline Irrigation Bottle Contamination Between Two Solutions|Comparison of Nasal Saline Irrigation Bottle Contamination Between Two Solutions|Unknown status|Recruiting|N/A|20|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-10 23:24:40.795277|2017-10-10 23:24:40.795277
NCT02413112|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|PoKu||Get in Shape in the Team Research: Porukalla Kuntoon Tutkimus|Minimum Resistance Training Frequency: Effect on Motivation and Adherence to Train, Overall Health Status and Neuromuscular Performance|Completed||N/A|105|Actual|University of Jyvaskyla||4|||f||||f||||||||||2017-10-10 23:24:40.913213|2017-10-10 23:24:40.913213
NCT02413099|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-08|||February 2012||2012-02-01|April 2015|2015-04-01||||November 2012|Actual|2012-11-01||Interventional|||The Efficacy and Safety of New Herbal Formula (KBMSI-2) in the Treatment of Erectile Dysfunction|The Efficacy and Safety of New Herbal Formula (KBMSI-2) in the Treatment of Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 4|44|Actual|Pusan National University Hospital||2|||f||||f||||||||||2017-10-10 23:24:41.010589|2017-10-10 23:24:41.010589
NCT02413086|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-04-08|||April 2015||2015-04-01|April 2015|2015-04-01||||April 2018|Anticipated|2018-04-01||Interventional|||Effectiveness and Safety of Early-Stage Amputation and External Herbs Chitosan for Diabetic Foot Ulcer||Not yet recruiting||N/A|320|Anticipated|Heilongjiang University of Chinese Medicine||4|||f||||t||||||||||2017-10-10 23:24:41.088972|2017-10-10 23:24:41.088972
NCT02413073|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-29|2016-11-13|||April 2015||2015-04-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Whole Body Vibration in Kidney Disease|Effectiveness of Whole Body Vibration for Patients With Chronic Kidney Disease in the Interdialytic Period on Muscle Strength, Balance, Quality of Life and Functional Capacity: Randomized Clinical Trial|Completed||Phase 4|16|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 23:24:41.21018|2017-10-10 23:24:41.21018
NCT02413060|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-10-13|||March 2015||2015-03-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||The Impact of Resistance Training on Type 2 Diabetes Patients.||Unknown status|Enrolling by invitation|N/A|400|Anticipated|Huashan Hospital||2|||f||||||||||||||2017-10-10 23:24:41.312464|2017-10-10 23:24:41.312464
NCT02413047|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-09-01|||May 2015||2015-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator|A Pilot Study to Evaluate if Response to Infliximab or Adalimumab May be Regained With the Addition of an Immunomodulator|Recruiting||N/A|20|Anticipated|Indiana University||1|||f||||f||||||||||2017-10-10 23:24:41.407512|2017-10-10 23:24:41.407512
NCT02413034|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-06-22|2016-03-28||November 2013||2013-11-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||The Influence of Antibiotic Prophylaxis on Intraoperative Prosthetic Joint Infection Cultures|The Influence of Antibiotic Prophylaxis on Intraoperative Prosthetic Joint Infection Cultures|Completed||N/A|28|Actual|Parc de Salut Mar||2|||f||||t||||||||No||2017-10-10 23:24:41.549976|2017-10-10 23:24:41.549976
NCT02413021|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2016-02-24|||May 2016||2016-05-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens|Phase 1 Study of Deferasirox in Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens|Not yet recruiting||Phase 1|40|Anticipated|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:24:41.843065|2017-10-10 23:24:41.843065
NCT02413008|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-04-12|||April 2015||2015-04-01|April 2017|2017-04-01|February 10, 2017|Actual|2017-02-10|February 10, 2017|Actual|2017-02-10||Interventional|BLISSAFE||A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting|A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multi-Centre Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting|Completed||Phase 2|70|Anticipated|ITF Research Pharma, S.L.U.||2|||f||||||||||||||2017-10-10 23:24:41.962994|2017-10-10 23:24:41.962994
NCT02412995|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-04-08|||October 2012||2012-10-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|November 2012|Actual|2012-11-01||Interventional|OPUS-WP3C||The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite|The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite - A Randomised, Controlled, Crossover Study of Danish Berries in Overweight and Obese Male Subjects|Completed||Early Phase 1|18|Actual|University of Copenhagen||6|||f||||f||||||||||2017-10-10 23:24:42.086158|2017-10-10 23:24:42.086158
NCT02412982|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-05-01|||March 2016||2016-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients|Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients: A Prospective Randomized Trial of Standard Enoxaparin Versus Two Anti-Xa Adjusted Dosing Strategies|Recruiting||Phase 4|200|Anticipated|University of Cincinnati||3|||f||||f||||||||No||2017-10-10 23:24:42.191904|2017-10-10 23:24:42.191904
NCT02412969|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-08-16|||August 2014||2014-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Impact of Dural Puncture Epidural Versus Traditional Lumbar Epidural on Onset of Labor Analgesia|Impact of Dural Puncture Epidural Versus Traditional Lumbar Epidural on Onset of Labor Analgesia|Completed||N/A|101|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:24:42.290762|2017-10-10 23:24:42.290762
NCT02412956|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-02-10|||January 2013||2013-01-01|February 2016|2016-02-01||||March 2016|Anticipated|2016-03-01||Interventional|SmokefreeMOM||SmokefreeMOM: Reaching Pregnant Smokers With Health Information Via Text Messaging|Quit4Baby: Reaching Pregnant Smokers With Health Information Via Text|Recruiting||N/A|300|Anticipated|George Washington University||3|||f||||||||||||||2017-10-10 23:24:42.36025|2017-10-10 23:24:42.36025
NCT02412943|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-05-27|||April 2015||2015-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pappalysin 2 (PAPP-A2) Enzyme Replacement|PAPP-A2 Enzyme Replacement Therapy Using Plasma Transfusion|Completed||Phase 1|1|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 23:24:42.432948|2017-10-10 23:24:42.432948
NCT02412930|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-03-21|||March 2012|Actual|2012-03-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Comparative Study of Ultrasound-guided Paravertebral Block Versus Intravenous Tramadol in Percutaneous Nephrolithotomy|Comparative Study of Ultrasound-guided Paravertebral Block Versus Intravenous Tramadol for Postoperative Pain Control in Percutaneous Nephrolithotomy|Completed||Phase 4|53|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:24:42.500799|2017-10-10 23:24:42.500799
NCT02412917|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-06-03|||June 2015||2015-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia|A Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia and Treatment of Acute Herpes Zoster Associated Pain|Recruiting||Phase 3|825|Anticipated|ContraVir Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-10 23:24:42.583096|2017-10-10 23:24:42.583096
NCT02412904|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-08-19|||January 2014||2014-01-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist|Phase 4 Study Comparing Recombinant Follicle Stimulating Hormone (rFSH) or Ultra-pure to HMG in Patients Submitted to IVF Using Gnrh Antagonist|Completed||Phase 4|188|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:24:42.679169|2017-10-10 23:24:42.679169
NCT02412891|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-09-28|||August 2015||2015-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||"Evaluation of UroShield Device Impact Upon Side Effects and Complications of Urinary Catheter Usage"|"Evaluation of UroShield Device Impact Upon Side Effects and Complications of Urinary Catheter Usage"|Withdrawn||N/A|0|Actual|HaEmek Medical Center, Israel||2||Cancelled due to financial reasons|f||||t||||||||||2017-10-10 23:24:42.765343|2017-10-10 23:24:42.765343
NCT02412878|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-04-18|||September 2015||2015-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing (ARROW)|A Randomized, Open-label, Phase 3 Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing|Active, not recruiting||Phase 3|478|Actual|Amgen||2|||f||||t||||||||||2017-10-10 23:24:42.842509|2017-10-10 23:24:42.842509
NCT02412865|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-02-25|||April 2015||2015-04-01|February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Interventional|Quit4Baby||Quit4Baby Evaluation|Developing and Scaling a Text Messaging Tool to Help Pregnant Smokers|Completed||N/A|505|Actual|George Washington University||2|||f||||||||||||||2017-10-10 23:24:42.974011|2017-10-10 23:24:42.974011
NCT02412839|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-12-20|||April 2015||2015-04-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Observational|||Sublingual Microcirculation of Healthy Volunteers by Using the Third Generation Microcirculation Video Microscope|Population Research of Sublingual Microcirculation Data of Healthy Volunteers by Using the Third Generation Microcirculation Video Microscope|Recruiting||N/A|150|Anticipated|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-10 23:24:43.133081|2017-10-10 23:24:43.133081
NCT02412826|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-03-01|||April 2015||2015-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Abstats: Computer-aided, Non-invasive, Acoustic Gastrointestinal Surveillance (AGIS) in Acute Pancreatitis|Abstats: Computer-aided, Non-invasive, Acoustic Gastrointestinal Surveillance (AGIS) in Acute Pancreatitis|Active, not recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 23:24:43.195769|2017-10-10 23:24:43.195769
NCT02412813|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-03-08|||January 2016||2016-01-01|March 2016|2016-03-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01||Interventional|||LEGION™ Revision Metal Hypersensitivity Study|A Prospective, Randomized, Multi-Center, Metal Hypersensitivity Study Comparing OXINIUM and Cobalt Chrome Femoral Components in Failed Total Knee Arthroplasty|Withdrawn||N/A|0|Actual|Smith & Nephew, Inc.||2||Overhaul of Study Design|f||||f||||||||||2017-10-10 23:24:43.312732|2017-10-10 23:24:43.312732
NCT02412800|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-10-28|||April 2015||2015-04-01|October 2015|2015-10-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Risk Factors of Postoperative Acute Lung Injury Following Liver Transplantation|Risk Factors of Postoperative Acute Lung Injury Following Liver Transplantation|Unknown status|Recruiting|N/A|250|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:24:43.393222|2017-10-10 23:24:43.393222
NCT02412787|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-03-28|||April 2015||2015-04-01|March 2017|2017-03-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Long-Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Patients With Hunter Syndrome That Have Completed Study HGT-HIT-094|An Open Label Extension of Study HGT-HIT-094 Evaluating Long Term Safety and Clinical Outcomes of Intrathecal Idursulfase Administered in Conjunction With Elaprase® in Patients With Hunter Syndrome and Cognitive Impairment|Enrolling by invitation||Phase 2/Phase 3|49|Anticipated|Shire||1|||f||||t||||||||||2017-10-10 23:24:43.459396|2017-10-10 23:24:43.459396
NCT02412774|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-09-12|||April 2015||2015-04-01|September 2017|2017-09-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Effects of Replacing Diet Beverages With Water on Weight Loss and Plasma Glucose Control in Type 2 Diabetes|Effects of Replacing Diet Beverages With Water on Type 2 Diabetic Obese Females Attending a Weight Loss Program - a Randomized, 24 Week Clinical Trial|Completed||N/A|81|Actual|Novindiet Clinic||2|||f||||f||||||||||2017-10-10 23:24:43.552208|2017-10-10 23:24:43.552208
NCT02412761|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-05-04|||June 2013||2013-06-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension|Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension|Completed||N/A|42|Actual|The University of Texas Health Science Center, Houston||3|||f||||f||f||||||No||2017-10-10 23:24:43.627081|2017-10-10 23:24:43.627081
NCT02412748|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-04-30|||February 2015||2015-02-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|DAAD||The Dedicated African American Dad Study|African American Non-Resident Fatherhood Program: Effects on Child/Family Outcomes|Recruiting||N/A|180|Anticipated|Rush University Medical Center||2|||f||||t||||||||||2017-10-10 23:24:43.716217|2017-10-10 23:24:43.716217
NCT02412735|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-10-04|||March 2015||2015-03-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|MSB-DR003||A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined With Hyaluronic Acid (HA) in Subjects With Chronic Low Back Pain|A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined With Hyaluronic Acid (HA) in Subjects With Chronic Low Back Pain|Recruiting||Phase 3|360|Anticipated|Mesoblast, Ltd.||3|||f||||t||||||||||2017-10-10 23:24:43.824012|2017-10-10 23:24:43.824012
NCT02412722|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-04-18|||March 12, 2015|Actual|2015-03-12|April 2017|2017-04-01|October 31, 2017|Anticipated|2017-10-31|February 26, 2016|Actual|2016-02-26||Interventional|||Safety, Tolerability, and Pharmacokinetics of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies|A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLN0128 (an Oral mTORC 1/2 Inhibitor) as a Single Agent and in Combination With Paclitaxel in Adult Patients With Advanced Nonhematologic Malignancies|Active, not recruiting||Phase 1|61|Actual|Takeda||3|||f||||f||||||||||2017-10-10 23:24:45.760258|2017-10-10 23:24:45.760258
NCT02412709|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-09-26|||June 2015||2015-06-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Long QT Syndrome Screening in Newborns|ECG Device for Long QT Syndrome Screening in Newborns|Recruiting||Phase 2|4000|Anticipated|QT Medical, Inc.||2|||f||||t||||||||||2017-10-10 23:24:45.861331|2017-10-10 23:24:45.861331
NCT02412696|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-03-22|||June 2015||2015-06-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|PAP-SAP||Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)|Placental Role in Mediating Adverse Outcomes in Obstructive Sleep Apnea|Recruiting||N/A|262|Anticipated|The Miriam Hospital||2|||f||||t||||||||Yes|Presentations at national and international scientific meetings, and publications in scientific journals.|2017-10-10 23:24:45.999024|2017-10-10 23:24:45.999024
NCT02412683|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-09-06|||January 2014||2014-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer|Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer|Completed||N/A|50|Actual|Linkoeping University|||1||f||||f||||||||||2017-10-10 23:24:46.085607|2017-10-10 23:24:46.085607
NCT02412670|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-08-19|||April 2015||2015-04-01|August 2015|2015-08-01||||February 2020|Anticipated|2020-02-01||Interventional|||Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer|A Prospective Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients With High Grade Upper Tract Urothelial Carcinoma|Recruiting||Phase 2|60|Anticipated|Eastern Cooperative Oncology Group||2|||f||||||||||||||2017-10-10 23:24:46.192021|2017-10-10 23:24:46.192021
NCT02412657|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-10-30|2016-03-14||September 2014||2014-09-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block|Impact of Two Doses of Intravenous Dexamethasone on the Analgesic Duration of a Single-shot Interscalene Block With Ropivacaine for Shoulder Arthroscopy; a Prospective, Randomized, Placebo-controlled Study|Completed||N/A|75|Actual|Maisonneuve-Rosemont Hospital||3|||f||||t||||||||Yes||2017-10-10 23:24:47.103602|2017-10-10 23:24:47.103602
NCT02412631|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-08-09|||June 2016||2016-06-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|||Addressing Post Cessation Weight Gain|Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention|Recruiting||Phase 2/Phase 3|100|Anticipated|Mayo Clinic||2|||f||||t||||||||Undecided||2017-10-10 23:24:47.451655|2017-10-10 23:24:47.451655
NCT02412605|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-07-03|||April 2015||2015-04-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Observational|||Effect of Trophectoderm Biopsy for Sex Selection on the Pregnancy and Miscarriage Rates of Women Undergoing IVF/ICSI|Effect of Trophectoderm Biopsy for Sex Selection on the Pregnancy and Miscarriage Rates of Women Undergoing IVF/ICSI|Recruiting||N/A|5000|Anticipated|Cairo University|||3||f||||f||||||||||2017-10-10 23:24:47.624628|2017-10-10 23:24:47.624628
NCT02412592|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2016-08-17|||January 2013||2013-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy|Sustained Viral Response and Clincal Relapse in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion by Interferon Therapy|Recruiting||N/A|260|Anticipated|Beijing Ditan Hospital|||1||f||||f||||||||||2017-10-10 23:24:47.702533|2017-10-10 23:24:47.702533
NCT02412579|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-07-17|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation|Circulating MicroRNA Isoforms as Biomarkers in Hepatocellular Carcinoma and Associated Liver Transplantation|Active, not recruiting||N/A|40|Actual|Baylor Research Institute|||2||f||||f||||||Samples With DNA|"     Hepatocellular carcinoma tumor tissue Background liver tissue   "|||2017-10-10 23:24:47.883457|2017-10-10 23:24:47.883457
NCT02412566|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-07-12||||||July 2017|2017-07-01||||||||Expanded Access|SMOF||SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury|Compassionate Use of an Intravenous Fat Emulsion Comprised of Soy Oil, Medium Chain Triglycerides, Olive Oil, and Fish Oil for Children With Parenteral Nutrition Induced Liver Injury|Available||N/A|||Baylor College of Medicine|||||||||||||||||||2017-10-10 23:24:47.994467|2017-10-10 23:24:47.994467
NCT02412553|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-03-21|||October 2014||2014-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis||Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:24:48.096073|2017-10-10 23:24:48.096073
NCT02412540|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-07-11|||April 2015||2015-04-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH|A Parallel Cohort Controlled Trial of Outcome of Nonalcoholic Steatohepatitis in Adolescents After Bariatric Surgery vs. Comprehensive Lifestyle Intervention (NASH ABC)|Recruiting||N/A|70|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 23:24:48.17954|2017-10-10 23:24:48.17954
NCT02412527|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-06|||April 2015||2015-04-01|April 2015|2015-04-01||||April 2016|Anticipated|2016-04-01||Observational|||Verification of Computerized Sleep-wake Analysis in Sleep Disorders||Unknown status|Not yet recruiting|N/A|330|Anticipated|Chang Gung Memorial Hospital|||4||f||||||||||||||2017-10-10 23:24:48.292628|2017-10-10 23:24:48.292628
NCT02412514|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-07-19|||April 2015||2015-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules|Assessing the Intestinal and Humoral Immunity of Sequential Schedules of Inactivated Poliovirus Vaccine and Bivalent Oral Poliovirus Vaccine for Routine Childhood Immunization in Bangladesh|Completed||Phase 4|456|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-10 23:24:48.390265|2017-10-10 23:24:48.390265
NCT02412501|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-05-16|||April 6, 2015|Actual|2015-04-06|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|February 13, 2017|Actual|2017-02-13||Interventional|||Medtronic Resolute Onyx 2.0 mm Clinical Study|A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study|Active, not recruiting||N/A|101|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-10-10 23:24:48.495841|2017-10-10 23:24:48.495841
NCT02412475|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2017-08-15|||February 2015||2015-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Epigenetic Reprogramming in Relapse AML|Epigenetic Reprogramming in Relapse AML: A Phase 1 Study of Decitiabine and Vorinostat Followed by Fludarabine, Cytarabine and G-CSF (FLAG) in Children and Young Adults With Relapsed/Refractory AML|Active, not recruiting||Phase 1|24|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-10 23:24:48.675042|2017-10-10 23:24:48.675042
NCT02412462|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-06-27|||April 2015||2015-04-01|July 2016|2016-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy|A Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AB-16B5 in Subjects With an Advanced Solid Malignancy|Completed||Phase 1|15|Actual|Alethia Biotherapeutics||1|||f||||||||||||||2017-10-10 23:24:48.785215|2017-10-10 23:24:48.785215
NCT02412449|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-05-06|||April 2015||2015-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects|A Randomized, Open-Label, Single-Dose, Three-Period Crossover Study in Healthy Adults to Assess the Relative Bioavailability of Test and Reference Formulations of AKB-6548 Tablets and to Evaluate the Effect of Food on the Bioavailability of AKB-6548|Completed||Phase 1|18|Actual|Akebia Therapeutics||3|||f||||f||||||||||2017-10-10 23:24:48.865313|2017-10-10 23:24:48.865313
NCT02412436|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-09-11|||September 2015||2015-09-01|September 2017|2017-09-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|PRIDE-HT||PK Study of Rifampicin Interactions With DMPA and Efaviranz in TB|An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Among Depot Medroxyprogesterone Acetate (DMPA), Rifampicin (RIF), and Efavirenz (EFV) in Women Co-infected With Human Immunodeficiency Virus (HIV) and Tuberculosis (TB)|Completed||Phase 2|62|Actual|AIDS Clinical Trials Group||1|||f||||t||||||||||2017-10-10 23:24:48.976851|2017-10-10 23:24:48.976851
NCT02412423|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2016-09-26|||March 2015||2015-03-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|August 2016|Actual|2016-08-01||Interventional|||Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors||Recruiting||Phase 4|30|Anticipated|Peking University People's Hospital||1|||f||||||||||||||2017-10-10 23:24:49.079943|2017-10-10 23:24:49.079943
NCT02412397|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-08||||||April 2015|2015-04-01||||December 2020|Anticipated|2020-12-01||Observational|||DePuy Global Unite Shoulder System||Enrolling by invitation||N/A|80|Anticipated|Rothman Institute Orthopaedics|||1||f||||||||||||||2017-10-10 23:24:49.252949|2017-10-10 23:24:49.252949
NCT02412384|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-05|2016-02-23|||June 2013||2013-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment|Completed||N/A|120|Actual|Fuda Cancer Hospital, Guangzhou|||4||f||||t||||||||||2017-10-10 23:24:49.325363|2017-10-10 23:24:49.325363
NCT02412371|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-07-06|||April 30, 2015||2015-04-30|July 2017|2017-07-01|November 22, 2020|Anticipated|2020-11-22|September 3, 2018|Anticipated|2018-09-03||Interventional|||A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Subjects With Stage III Non-Small Cell Lung Cancer|A Phase 1 Dose Escalation and Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Subjects With Stage III Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|186|Anticipated|AbbVie||3|||f||||t||||||||||2017-10-10 23:24:49.421387|2017-10-10 23:24:49.421387
NCT02412358|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-08|||May 2008||2008-05-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Clinical Comparision of Three Types of Toothbrushes Pulsar, Crossaction and Butler on Gingivitis and Plaque Removal|Clinical Comparison of Three Types of Toothbrushes Pulsar, Crossaction and Butler on Gingivitis and Plaque Removal|Completed||Phase 1/Phase 2|30|Actual|Mashhad University of Medical Sciences||3|||f||||f||||||||||2017-10-10 23:24:49.598974|2017-10-10 23:24:49.598974
NCT02412345|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2017-05-01|||January 2015||2015-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Extracorporeal Shockwave Therapy in the Treatment for Erectile Dysfunction in Male Renal Transplant Recipients|Extracorporeal Shockwave Therapy in the Treatment for Erectile Dysfunction in Male Renal Transplant Recipients|Active, not recruiting||N/A|20|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:24:49.674841|2017-10-10 23:24:49.674841
NCT02412332|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-05-21|||April 2015||2015-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|||Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients|Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients|Enrolling by invitation||Phase 1/Phase 2|20|Anticipated|UPECLIN HC FM Botucatu Unesp||4|||f||||f||||||||||2017-10-10 23:24:49.758112|2017-10-10 23:24:49.758112
NCT02412319|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-04-05|||October 2014||2014-10-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection|The Efficacy and Safety of the Anti Hepatitis B Placenta Transfer Factor Injection in the Treatment of HBeAg Positive Chronic Hepatitis B, Randomized, Double Blind, Placebo Controlled, Multi Center Clinical Trial|Active, not recruiting||Phase 4|288|Anticipated|Shineway Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-10 23:24:49.84229|2017-10-10 23:24:49.84229
NCT02412306|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-09-18|||June 4, 2015|Actual|2015-06-04|September 2017|2017-09-01|April 22, 2019|Anticipated|2019-04-22|August 7, 2017|Actual|2017-08-07||Interventional|||Study of Blinatumomab in Japanese Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia|A Phase 1b/2 Study of Blinatumomab in Japanese Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (Horai Study)|Active, not recruiting||Phase 1/Phase 2|35|Actual|Amgen||1|||f||||t||||||||||2017-10-10 23:24:49.93408|2017-10-10 23:24:49.93408
NCT02412293|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-05|||July 2001||2001-07-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|February 2006|Actual|2006-02-01||Interventional|||Community-based Perinatal and Newborn Care in Gilgit District, Northern Areas, Pakistan: an AKU-AKHSP Collaboration|Community-based Perinatal and Newborn Care in Gilgit District, Northern Areas, Pakistan: an AKU-AKHSP Collaboration|Completed||N/A|3200|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-10 23:24:50.206126|2017-10-10 23:24:50.206126
NCT02412280|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-06|2015-04-06|||April 2015||2015-04-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|ProgModels||Validity of Different Prognostic Models Assessing 1 Year Survival After Liver Transplantation||Completed||N/A|200|Actual|Mansoura University|||1||f||||t||||||||||2017-10-10 23:24:50.309544|2017-10-10 23:24:50.309544
NCT02412267|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-03-21|||April 2011||2011-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|DLBL||Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)|An Open-label, Non-randomized Phase 2 Study of Ofatumomab (O) in Combination With ICE (Ifosfamide, Carboplatin, Etoposide)-Chemotherapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)|Completed||Phase 2|17|Actual|National Cancer Centre, Singapore||1|||f||||f||||||||||2017-10-10 23:24:50.377144|2017-10-10 23:24:50.377144
NCT02412254|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-02-28|||May 2015||2015-05-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ACHIEVE-P||Aging, Cognition, and Hearing Evaluation in Elders Study|Aging, Cognition, and Hearing Evaluation in Elders Pilot Study|Active, not recruiting||N/A|40|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:24:50.465382|2017-10-10 23:24:50.465382
NCT02412241|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-01-19|||June 2015||2015-06-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients|Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients|Recruiting||N/A|90|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t|f|f||||||Undecided||2017-10-10 23:24:50.54406|2017-10-10 23:24:50.54406
NCT02412228|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-06-08|||August 2015||2015-08-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||BrUOG 299 :Ixazomib, Oral Metronomic Cyclophosphamide and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study.|BrUOG 299: Ixazomib, Oral Metronomic Cyclophosphamide and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study.|Recruiting||Phase 2|20|Anticipated|Brown University||1|||f||||t||||||||||2017-10-10 23:24:50.647662|2017-10-10 23:24:50.647662
NCT02412215|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2015-04-08|||March 2015||2015-03-01|April 2015|2015-04-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|T-IOL||Rotational Stability After Nanoflex Collamer Toric Intraocular Lens Implantation in Astigmatic Patients|Rotational Stability After Nanoflex Collamer Toric Intraocular Lens Implantation in Astigmatic Patients Undergoing Cataract Surgery|Unknown status|Recruiting|N/A|60|Anticipated|University of Turin, Italy||1|||f||||f||||||||||2017-10-10 23:24:50.757257|2017-10-10 23:24:50.757257
NCT02412202|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-12-01|||March 2015||2015-03-01|December 2015|2015-12-01||||December 2015|Actual|2015-12-01||Interventional|ECHOBAG||Echocardiographic Detection of Extravascular Lung Water Increase During Weaning From Mechanical Ventilation||Completed||N/A|30|Actual|University of Thessaly||1|||f||||||||||||||2017-10-10 23:24:50.882943|2017-10-10 23:24:50.882943
NCT02412176|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-08-06|||January 2014||2014-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MS-R||Right Ventricular Apical Versus True Mid-septal Pacing|A Comparison Between Right Ventricular Apical Pacing and True Mid-septal Pacing, Verified With Computed Tomography: a Randomized Study|Recruiting||Phase 4|200|Anticipated|Charles University, Czech Republic||2|||f||||f||||||||||2017-10-10 23:24:51.072563|2017-10-10 23:24:51.072563
NCT02412163|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-08-31|||July 2015||2015-07-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|July 2015|Actual|2015-07-01||Observational|IM HTO||Ellipse Intramedullary Nail High Tibial Osteotomy Study|A Multicenter Study of Patients Treated With the Ellipse Technologies Intramedullary High Tibial Osteotomy (IM HTO) Nail System for Osteoarthritis and Varus Malalignment of the Knee|Completed||N/A|41|Actual|Ellipse Technologies, Inc.|||1||f||||f|f|t|t||t|||||2017-10-10 23:24:51.200059|2017-10-10 23:24:51.200059
NCT02412150|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-01-30|||April 2014||2014-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effect of Dexmedetomidine After Thyroidectomy|Effect of Dexmedetomidine Infusion for Postoperative Outcome and Smooth Emergence After Thyroidectomy|Recruiting||N/A|120|Anticipated|Chosun University Hospital||2|||f||||f||||||||||2017-10-10 23:24:51.319941|2017-10-10 23:24:51.319941
NCT02412137|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-04-14|||December 2007||2007-12-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Compliance Counseling on Brace Success in Patients With Idiopathic Scoliosis|Effect of Compliance Counseling on Brace Success in Patients With Idiopathic Scoliosis|Completed||Early Phase 1|245|Actual|Texas Scottish Rite Hospital for Children||2|||f||||t||||||||||2017-10-10 23:24:51.480766|2017-10-10 23:24:51.480766
NCT02412124|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-08-18|||July 2015||2015-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers|Quality of Life Outcomes From a Peer-to-Peer Support Program for Women With Gynecologic Cancer|Recruiting||N/A|30|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:24:51.550995|2017-10-10 23:24:51.550995
NCT02412111|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 3 Study of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor|A Phase 3, Randomized, Double-Blind, Ivacaftor-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation and a Second CFTR Allele With a Gating Defect That Is Clinically Demonstrated to be Ivacaftor Responsive|Active, not recruiting||Phase 3|200|Anticipated|Vertex Pharmaceuticals Incorporated||2|||f||||t||||||||||2017-10-10 23:24:51.664254|2017-10-10 23:24:51.664254
NCT02412098|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-04-27|||March 2015||2015-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function|A Phase 1, Open-Label, Parallel-Group, Adaptive, Single Dose Study to Evaluate the Pharmacokinetics of GS-6615 in Subjects With Normal and Impaired Hepatic Function|Completed||Phase 1|49|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-10 23:24:51.882757|2017-10-10 23:24:51.882757
NCT02412085|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-07|||March 2015||2015-03-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|UC-GOL||Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission|Pilot Study to Evaluate the Efficacy of Golimumab for Induction and Maintenance of Clinical and Endoscopic Remission in Patients With Steroid-dependent Ulcerative Colitis|Unknown status|Recruiting|Phase 4|100|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-10-10 23:24:51.987326|2017-10-10 23:24:51.987326
NCT02412072|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2015-04-07|||April 2015||2015-04-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||Comparison of Dilatation & Curettage and Endometrial Aspiration Biopsy Accuracy in Patients Treated With Progestin for Endometrial Hyperplasia: A Korean Gynecologic Oncology Group Study||Recruiting||N/A|75|Anticipated|Korean Gynecologic Oncology Group|||1||f||||f||||||||||2017-10-10 23:24:52.075933|2017-10-10 23:24:52.075933
NCT02412059|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-01-28|||August 2015||2015-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear|Topical Use of Corticosteroid to Prevent Epiretinal Membrane Formation in Eyes With Retinal Tear Undergoing Laser Retinopexy: a Pilot Prospective Clinical Study|Completed||N/A|200|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 23:24:52.159079|2017-10-10 23:24:52.159079
NCT02412046|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-08-03|||October 2015||2015-10-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics|Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics|Recruiting||N/A|48|Anticipated|University Hospital, Montpellier||4|||f||||f||||||||||2017-10-10 23:24:52.249306|2017-10-10 23:24:52.249306
NCT02412033|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2016-05-30|||March 2016||2016-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Misoprostol Prior to Intrauterine Contraceptive Device Insertion|Vaginal Misoprostol Prior to Intrauterine Contraceptive Device Insertion in Women With Previous Caesarean Section|Completed||Phase 1|140|Actual|Assiut University||2|||f||||t||||||||Undecided||2017-10-10 23:24:52.3388|2017-10-10 23:24:52.3388
NCT02412020|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-02-18|||February 2015||2015-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Treatment of Refractory Chronic Cough With PA101|Treatment of Chronic Idiopathic Cough and Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis With PA101|Completed||Phase 2|52|Actual|Patara Pharma||2|||f||||f||||||||||2017-10-10 23:24:52.400497|2017-10-10 23:24:52.400497
NCT02412007|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-04-07|||October 2014||2014-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Individualized Comprehensive Home-Centred Activity Based Therapy for Children With Diplegic Cerebral Palsy|A Prospective Study (RCT) to Evaluate the Efficacy of an Individualized Comprehensive Home-Centred Activity Based Therapy for Children With Diplegic Cerebral Palsy|Unknown status|Recruiting|N/A|30|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 23:24:52.479247|2017-10-10 23:24:52.479247
NCT02411994|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-04-13|||October 2015||2015-10-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PAAL||Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria|Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Uncomplicated Falciparum Malaria in Western Kenya|Recruiting||Phase 3|450|Anticipated|Royal Tropical Institute||2|||f||||t||||||||||2017-10-10 23:24:52.562666|2017-10-10 23:24:52.562666
NCT02411981|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-03-19|||April 2015||2015-04-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Effects of Chest Physiotherapy (CPT) on Lung Clearance Index (LCI) in Non Cystic Fibrosis (CF) Bronchiectasis|Short-term Effects of Chest Physiotherapy on Ventilation Inhomogeneity in Non-CF Bronchiectasis|Completed||N/A|24|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-10 23:24:52.660775|2017-10-10 23:24:52.660775
NCT02411968|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-10-12|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Follow up After Cryoablation of Small Renal Masses.|Follow up After Percutaneous MR-guided Cryoablation of Small Renal Masses.|Recruiting||N/A|12|Anticipated|Radboud University|||1||f||||t||||||Samples Without DNA|"     Needle biopsy kidney tumor.   "|||2017-10-10 23:24:52.726018|2017-10-10 23:24:52.726018
NCT02411955|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2017-05-03|||June 2014||2014-06-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris|A Multiple-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to Tazorac® (Tazarotene Cream 0.1%) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris|Completed||Phase 1|1077|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||No||2017-10-10 23:24:52.802107|2017-10-10 23:24:52.802107
NCT02411942|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-04|2017-05-03|||August 2014||2014-08-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris|A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study Comparing Adapalene Gel 0.3% to Differin® (Adapalene Gel 0.3%) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris|Completed||Phase 1|753|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-10 23:24:52.881321|2017-10-10 23:24:52.881321
NCT02411929|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-02-22|2016-01-19||October 2014||2014-10-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020)|A Phase 1, Open-Label, Non-Randomized, 2-Period, Fixed Sequence, Study to Assess the Absolute Bioavailability and Fraction Absorbed of Ertugliflozin in Health Male Subjects Using a 14^C-Microdose Approach|Completed||Phase 1|8|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 23:24:53.134426|2017-10-10 23:24:53.134426
NCT02411916|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-04-06|||April 2012||2012-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Adjunctive Misoprostol Treatment on Blood Loss at Vaginal Delivery|Effect of Adjunctive Misoprostol on Blood Loss at Vaginal Delivery|Recruiting||N/A|800|Anticipated|New York City Health and Hospitals Corporation||2|||f||||f||||||||||2017-10-10 23:24:53.541529|2017-10-10 23:24:53.541529
NCT02411903|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-06-14|||March 2015||2015-03-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction||Unknown status|Enrolling by invitation|Phase 4|160|Anticipated|The Third Affiliated Hospital of Guangzhou Medical University||2|||f||||||||||||||2017-10-10 23:24:53.642727|2017-10-10 23:24:53.642727
NCT02411890|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2016-01-17|||February 2015||2015-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Postoperative Pain Between ACB and FNB After ACLR|The Comparison of Postoperative Analgesia Between Adductor Canal Block and Femoral Nerve Block After Arthroscopic ACL Reconstruction With Hamstring Graft: A Randomized Controlled Trial|Completed||Phase 4|60|Actual|Thammasat University||2|||f||||f||||||||||2017-10-10 23:24:53.724235|2017-10-10 23:24:53.724235
NCT02411877|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-02-16|||February 2016||2016-02-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|RECCLAIM-II||REperfusion With Cooling in CerebraL Acute IscheMia II|REperfusion With Cooling in CerebraL Acute IscheMia II|Withdrawn||Phase 2|0|Actual|WellStar Health System||2||It was decided that it was not feasible to continue this study.|f||||f||||||||||2017-10-10 23:24:53.83761|2017-10-10 23:24:53.83761
NCT02411864|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-07-02|||November 2014||2014-11-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Optimal Low B-value in Intravoxel Incoherent Motion Diffusion-weighted MR Imaging of the Brain|Can the Distribution of Low B-value and the NEX Influence the Pseudodiffusion Parameter Derived From IVIM in Brain?|Completed||N/A|20|Actual|Tang-Du Hospital|||5||f||||f||||||||||2017-10-10 23:24:53.94466|2017-10-10 23:24:53.94466
NCT02411851|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-01-30|||March 2015||2015-03-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Treatment of Actinic Keratoses (AK) on the Face|An Investigator-Initiated Study to Assess the Efficacy and Degree of Irritation of Ingenol Mebutate 0.015% Gel and Dermasil Lotion Versus Ingenol Mebuate 0.015% Alone in the Treatment of Actinic Keratoses (AK) on the Face.|Completed||Phase 1|20|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:24:54.022864|2017-10-10 23:24:54.022864
NCT02411838|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-04-27|||February 2014||2014-02-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Calorie Restriction in Multiple Sclerosis Patients|A Pilot Study of Adipokines and Calorie Restriction in Multiple Sclerosis Patients|Recruiting||N/A|16|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:24:54.10477|2017-10-10 23:24:54.10477
NCT02411825|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-01-21|||March 2015||2015-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of Repeated Subcutaneous Doses of SAR425899 in Healthy Male Subjects and Overweight to Obese Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|40|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 23:24:54.213386|2017-10-10 23:24:54.213386
NCT02411812|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-04-04|||August 2015||2015-08-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|September 2016|Anticipated|2016-09-01||Interventional|HASA||Effects of the Herbst Appliance With Skeletal and Dental Anchorage in Lower Incisors in Class II Malocclusion|Effects of the Herbst Appliance With Skeletal Anchorage and Dental Anchorage in Lower Incisors in Class II Malocclusion: A Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|Rio de Janeiro State University||2|||f||||f||||||||||2017-10-10 23:24:54.331771|2017-10-10 23:24:54.331771
NCT02411799|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-03-09|||April 2015||2015-04-01|March 2017|2017-03-01|April 2023|Anticipated|2023-04-01|April 2018|Anticipated|2018-04-01|60 Months|Observational [Patient Registry]|||Instrumented Thoracic and Lumbar Arthrodesis Supplemented by the Implanet Jazz SystemTMd|Prospective Multi-Center Follow-up of Patients Undergoing Instrumented Thoracic and Lumbar Arthrodesis Supplemented by the Implanet Jazz SystemTM|Recruiting||N/A|100|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-10 23:24:54.462299|2017-10-10 23:24:54.462299
NCT02411786|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-05-23|||July 2015||2015-07-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF|A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD), With or Without Granulocyte Macrophage Colony-Stimulating Factor Adjuvant, in Patients With Metastatic Prostate Cancer|Recruiting||Phase 1|40|Anticipated|University of Wisconsin, Madison||4|||f||||t||||||||||2017-10-10 23:24:54.551176|2017-10-10 23:24:54.551176
NCT02411773|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-05-06|||May 2015||2015-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Sym-CKD||Sympatholysis in Chronic Kidney Disease|Functional Sympatholysis and Exercise Intolerance in Chronic Kidney Disease|Recruiting||Phase 2|110|Anticipated|Emory University||5|||f||||f||||||||||2017-10-10 23:24:54.678605|2017-10-10 23:24:54.678605
NCT02411760|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-09-27|||May 2014||2014-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|BCD||Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection|Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection|Recruiting||N/A|60|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||Undecided||2017-10-10 23:24:54.781771|2017-10-10 23:24:54.781771
NCT02411747|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-06-15|2016-04-05||February 2015||2015-02-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Simulation-based Training for Flexible Cystoscopy - a Patient Transfer Randomized Trial|Simulation-based Training for Flexible Cystoscopy - a Patient Transfer Randomized Trial|Completed||N/A|32|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:24:54.87324|2017-10-10 23:24:54.87324
NCT02411734|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-05-10|||April 2015||2015-04-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01|30 Days|Observational [Patient Registry]|Executive||Effect of Executive Dysfunction on Rehabilitation Potential|Effect of Executive Dysfunction on Rehabilitation Potential|Terminated||N/A|21|Actual|University of South Florida|||1|Administrative problems with study director|f||||f||||||||||2017-10-10 23:24:55.14277|2017-10-10 23:24:55.14277
NCT02411721|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-02|||May 2015||2015-05-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|yes||The Effects of Dog Intervention on Anxiety Levels in Children Undergoing an MRI Examination|The Effects of Dog Intervention on Anxiety Levels in Children Undergoing an MRI Examination ; Open Label, Randomized Controlled Trail|Unknown status|Not yet recruiting|N/A|52|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-10 23:24:55.19519|2017-10-10 23:24:55.19519
NCT02411695|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-02-14|||March 2015||2015-03-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia|A Phase 1, Multicenter, Open-label, Dose-Escalation Trial to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia|Completed||Phase 1|40|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||5|||f||||f||||||||No||2017-10-10 23:24:55.40089|2017-10-10 23:24:55.40089
NCT02411682|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-04-07|||May 2014||2014-05-01|April 2015|2015-04-01|April 2015|Anticipated|2015-04-01|July 2014|Actual|2014-07-01||Interventional|B-PPHG||Breakfast on Postprandial Hyperglycemia|Effect of Breakfast on Overall Postprandial Hyperglycemia in T2D|Unknown status|Active, not recruiting|N/A|28|Anticipated|Hospital de Clinicas Caracas||2|||f||||t||||||||||2017-10-10 23:24:55.514542|2017-10-10 23:24:55.514542
NCT02411669|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-08-22|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|MoSTRA||Impact of Tools for the Development of Patient Centered Care at Hospital|Effectiveness and Determinants of Effectiveness of Implementation of Tools for the Development of Patient Centred Care at Hospital|Completed||N/A|950|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 23:24:55.585525|2017-10-10 23:24:55.585525
NCT02411656|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-09-08|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)|A Phase II Study of Anti-PD-1 (MK-3475) Therapy in Patients With Metastatic Inflammatory Breast Cancer (IBC) or Non-IBC Triple Negative Breast Cancer (TNBC) Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy|Recruiting||Phase 2|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:24:55.703258|2017-10-10 23:24:55.703258
NCT02408991|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-04-07|||September 2014||2014-09-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Use Art-assist and Neupogen to Treat Chronic Limb Ischemia|Proteomics and Stem Cell Therapy as a New Vascularization Strategy|Withdrawn||Phase 4|0|Actual|University of Chicago||1||PI left University|f||||t||||||||No||2017-10-10 23:25:27.057933|2017-10-10 23:25:27.057933
NCT02411630|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-02-27|||June 2013||2013-06-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Factors Affecting PrEP Adherence|Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men|Completed||N/A|167|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 23:24:55.856374|2017-10-10 23:24:55.856374
NCT02411617|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-04-02|||January 2013||2013-01-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Single vs. Double Drain in Modified Radical Mastectomy|Single vs. Double Drain in Modified Radical Mastectomy: A Randomized Control Trial|Completed||N/A|176|Actual|Memon Medical Institute||2|||f||||t||||||||||2017-10-10 23:24:55.946237|2017-10-10 23:24:55.946237
NCT02411604|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-01-19||||||December 2015|2015-12-01||||||||Expanded Access|||Expanded Access Study for Renal Transplant Patients With Envarsus XR ™|Expanded Access Study for Renal Transplant Patients With Envarsus XR™: Envarsus 3007|Approved for marketing||N/A|||Veloxis Pharmaceuticals|||||||||||||||||||2017-10-10 23:24:56.014248|2017-10-10 23:24:56.014248
NCT02411591|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-07-12|||June 2015||2015-06-01|July 2017|2017-07-01|November 12, 2018|Anticipated|2018-11-12|June 23, 2017|Actual|2017-06-23||Interventional|||A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)|A Single-Arm, Multicenter, Phase 1b Study With an Expansion Cohort to Evaluate Safety and Efficacy of Necitumumab in Combination With Abemaciclib in Treatment of Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1|70|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 23:24:56.06892|2017-10-10 23:24:56.06892
NCT02411565|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-08-15|||March 1, 2016|Actual|2016-03-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 3, 2017|Actual|2017-08-03||Interventional|||Fermented Wheat Germ Extract in Women With Ovarian Cancer|A Pilot Randomized, Placebo-Controlled, Trial of Fermented Wheat Germ Extract in Women With Ovarian Cancer|Active, not recruiting||N/A|3|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-10 23:24:56.270257|2017-10-10 23:24:56.270257
NCT02411552|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-02|||September 2011||2011-09-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Systematic Initiative to Increase Activity in Schools|Systematic Initiative to Increase Activity in Schools|Completed||N/A|4894|Actual|University of Wisconsin, Madison|||2||f||||f||||||||||2017-10-10 23:24:56.546964|2017-10-10 23:24:56.546964
NCT02411539|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-05-03|2017-03-17||August 25, 2015|Actual|2015-08-25|May 2017|2017-05-01|September 29, 2016|Actual|2016-09-29|April 15, 2016|Actual|2016-04-15||Interventional||All participants enrolled|Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)|A Phase I Study to Evaluate the Safety, Tolerability, and Effect of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), on Markers of HIV Persistence in ART-treated, HIV-infected Adults|Completed||Phase 1|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:24:56.677827|2017-10-10 23:24:56.677827
NCT02411526|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-09-16|||February 2015||2015-02-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia|An Open-Label, Multiple Dose, Safety and Pharmacokinetic Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|60|Actual|Zogenix, Inc.||4|||f||||f||||||||||2017-10-10 23:24:58.302502|2017-10-10 23:24:58.302502
NCT02411513|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-12-03|||April 2015||2015-04-01|December 2015|2015-12-01||||October 2015|Actual|2015-10-01||Interventional|||Acute Treatment of Migraine Using the CEFALY Device|Open-trial on the Acute Treatment of Migraine Using the CEFALY Device|Completed||Phase 1|30|Actual|Cefaly Technology||1|||f||||f||||||||||2017-10-10 23:24:58.387869|2017-10-10 23:24:58.387869
NCT02411500|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-11-17|||February 2015||2015-02-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males|A Randomized, Open Label, Four Period, Cross-Over Study to Evaluate the Pharmacokinetics of Single Doses of Various TRV734 Formulations in Healthy Male Subjects|Completed||Phase 1|18|Actual|Trevena Inc.||6|||f||||f||||||||||2017-10-10 23:24:58.461576|2017-10-10 23:24:58.461576
NCT02411487|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-01-23|||March 16, 2015|Actual|2015-03-16|January 2017|2017-01-01|August 3, 2015|Actual|2015-08-03|August 3, 2015|Actual|2015-08-03||Observational|||Meibomian Gland Dysfunction (MGD) and Tear Cytokines After Cataract Surgery According to Preoperative Meibomian Gland Status||Completed||N/A|50|Actual|Yonsei University|||1||f||||f||||||Samples With DNA|"     TEAR   "|||2017-10-10 23:24:58.541602|2017-10-10 23:24:58.541602
NCT02411474|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-04-02|||March 2014||2014-03-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Tear Cytokine Analysis as a Prediction or Diagnostic Marker in Ocular GvHD||Completed||N/A|21|Actual|Yonsei University|||1||f||||f||||||Samples Without DNA|"     TEAR   "|||2017-10-10 23:24:58.609962|2017-10-10 23:24:58.609962
NCT02411461|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-01-17|||December 2014||2014-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism|Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism|Completed||N/A|42|Actual|Vanderbilt University Medical Center|||3||f||||f||||||||No||2017-10-10 23:24:58.678593|2017-10-10 23:24:58.678593
NCT02411448|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-10-03|||May 2015||2015-05-01|October 2017|2017-10-01|August 2021|Anticipated|2021-08-01|October 2018|Anticipated|2018-10-01||Interventional|RELAY||A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Participants With EGFR Mutation-Positive Metastatic NSCLC|A Multicenter, Randomized, Double-Blind Study of Erlotinib in Combination With Ramucirumab or Placebo in Previously Untreated Patients With EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer|Recruiting||Phase 3|462|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 23:24:58.775412|2017-10-10 23:24:58.775412
NCT02408978|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-06-17|||May 2015||2015-05-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Pilot Study of OXP005 to Assess Gastroduodenal Irritation||Completed||Phase 1|||Oxford Pharmascience Ltd||2|||f||||||||||||||2017-10-10 23:25:27.14298|2017-10-10 23:25:27.14298
NCT02411435|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-01-04|||July 2015||2015-07-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects|Phase I, Single-center, Open Label, Fixed-sequence Cross-over Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects|Completed||Phase 1|15|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-10-10 23:24:59.271053|2017-10-10 23:24:59.271053
NCT02411422|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-04-13|||April 2015||2015-04-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|i-gel_br||Comparison of Efficiency Between I-gel Blind Intubation and I-gel Bronchoscopic Intubation During Resuscitation|Comparison of Efficiency Between I-gel-Assisted Blind Intubation and I-gel-assisted Bronchoscopic Intubation During Cardiopulmonary Resuscitation: Randomized Simulation Study|Completed||N/A|23|Actual|Hallym University Kangnam Sacred Heart Hospital||3|||f||||f||||||||||2017-10-10 23:24:59.342874|2017-10-10 23:24:59.342874
NCT02411409|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-09-15|||March 2013||2013-03-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Impact of the CommunityRx Program on Health, Service Utilization and Costs|Impact of the CommunityRx Program on Health, Service Utilization and Costs|Recruiting||N/A|200000|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 23:24:59.405083|2017-10-10 23:24:59.405083
NCT02411396|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-03-21|||April 2016|Actual|2016-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|ESCAPED||Comparison of Patient Centered Outcomes for People With SCD in the Acute Care Setting|Patient Centered Outcomes Research Institute (PCORI) ESCAPED Study: Comparison of Patient Centered Outcomes for People With SCD in the Acute Care Setting|Active, not recruiting||N/A|483|Actual|Johns Hopkins University|||1||f||||f||||||||Undecided||2017-10-10 23:25:01.228107|2017-10-10 23:25:01.228107
NCT02411383|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-04-12|||February 2015||2015-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Clinical Study to Investigate Safety and Performance of NeuRx DPS in Patients Undergoing Bilateral Lung Transplantation|Prospective, Single-centre, Open-label Clinical Study to Investigate the Safety and Performance of the NeuRx Diaphragm Pacing System (DPS) in Patients Undergoing Bilateral Lung Transplantation|Completed||N/A|4|Actual|Synapse Biomedical||1|||f||||f||||||||||2017-10-10 23:25:01.356687|2017-10-10 23:25:01.356687
NCT02411370|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-10-14|||February 2015||2015-02-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Observational|PHONORESPI||Correlation Between Respiratory Impairment and Phonemes Alteration in Dystrophinopathy Patients With Respiratory Failure||Completed||N/A|30|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||||||||||||2017-10-10 23:25:01.461694|2017-10-10 23:25:01.461694
NCT02411357|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-04-17|||March 2015||2015-03-01|April 2017|2017-04-01||||May 2019|Anticipated|2019-05-01||Interventional|||Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II||Recruiting||N/A|195|Anticipated|University of Vermont||3|||f||||t||||||||||2017-10-10 23:25:01.548732|2017-10-10 23:25:01.548732
NCT02411344|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-09-16|||February 2014||2014-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PER-ELISA||Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Patients With Breast Cancer Sensitive to Hormonal Therapy|PERtuzumab-trastuzumab Plus lEetrozoLe In Endocrine Sensitive Breast Cancer: a Phase II neoAdjuvant Study|Recruiting||Phase 2|68|Anticipated|Istituto Oncologico Veneto IRCCS||1|||f||||f||||||||||2017-10-10 23:25:01.657997|2017-10-10 23:25:01.657997
NCT02411331|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-07-25|||March 2015||2015-03-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|Etha-LOCK||Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci|Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci|Recruiting||N/A|180|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:25:01.793436|2017-10-10 23:25:01.793436
NCT02411318|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-05-10|||September 2014||2014-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Influence of Lifestyle Factors on Neutrophil Migration Pilot Study|Influence of Lifestyle Factors on Neutrophil Migration Pilot Study|Recruiting||N/A|60|Anticipated|University of Wisconsin, Madison||3|||f||||f||||||||||2017-10-10 23:25:01.946437|2017-10-10 23:25:01.946437
NCT02411305|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-02-02|||February 2015||2015-02-01|December 2015|2015-12-01||||September 2015|Actual|2015-09-01||Observational|QFT||Feasibility Testing of the Quality-monitoring Tool, Qdact, for the Palliative Care Research Cooperative|Testing the Feasibility of a Point-of-care Quality Monitoring Infrastructure for the PCRC|Completed||N/A|40|Actual|Duke University|||1||f||||||||||||||2017-10-10 23:25:02.03749|2017-10-10 23:25:02.03749
NCT02411292|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-08-15|2017-06-29||March 2015|Actual|2015-03-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional||The sixteen participants that were discharged before the third enoxaparin dose were excluded from the analysis.|Enoxaparin Metabolism in Reconstructive Surgery Patients|Enoxaparin Metabolism in Reconstructive Surgery Patients|Completed||Phase 2|110|Actual|University of Utah||1|||f||||t||||||||||2017-10-10 23:25:02.191312|2017-10-10 23:25:02.191312
NCT02411279|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-05-18|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|e-INCA||Anticipation and Detection of Heart Failure Decompensation With Automatic Treatment of Informations|Anticipation and Detection of Heart Failure Decompensation With Automatic Treatment of Informations Derived From Non Intrusive Sensors and Devices|Recruiting||N/A|20|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||||||2017-10-10 23:25:02.577596|2017-10-10 23:25:02.577596
NCT02411266|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-05-05|||January 2008||2008-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PreLIMBS||Preconditioning With Limb Ischemia for Subarachnoid Hemorrhage|Remote Ischemic Preconditioning to Ameliorate Delayed Ischemic Neurological Deficit After Aneurysmal Subarachnoid Hemorrhage: a Safety and Feasibility Study|Recruiting||N/A|60|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 23:25:02.676319|2017-10-10 23:25:02.676319
NCT02410720|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-12-28|||June 2013||2013-06-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||The Effectiveness of a Customized Mobile Application in Colonoscopy Preparation|The Effectiveness of a Customized Mobile Application in Colonoscopy Preparation: A Randomized Controlled Trial|Completed||N/A|160|Actual|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-10 23:25:08.408426|2017-10-10 23:25:08.408426
NCT02411253|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-08|||June 2015||2015-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|DIABIL-2||Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes|European Phase-IIb Clinical Trial Evaluating Efficacy of Low Dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes DIABIL-2|Recruiting||Phase 2|138|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:25:02.788305|2017-10-10 23:25:02.788305
NCT02411240|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-04-02|||July 2014||2014-07-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|ELIFA||Air Pollution Reduction in the Elderly and Cardiovascular and Cognitive Outcomes|Air Pollution Reduction in the Elderly and Cardiovascular and Cognitive Outcomes, an Intervention Study|Recruiting||N/A|60|Anticipated|Hasselt University||1|||f||||f||||||||||2017-10-10 23:25:03.0669|2017-10-10 23:25:03.0669
NCT02411227|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-07|2017-10-05|||March 23, 2015||2015-03-23|July 20, 2017|2017-07-20|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Interventional|||Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury|Evaluation of Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury|Completed||Phase 2|37|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:25:03.165436|2017-10-10 23:25:03.165436
NCT02411214|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-04-07|||January 2013||2013-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Decisional Process in Male Fertility Preservation|Fertility Preservation in the Male Pediatric Population: a Patient and Parent Perspective of Factors Influencing the Decisional Process|Completed||N/A|348|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||3||f||||t||||||||||2017-10-10 23:25:03.254594|2017-10-10 23:25:03.254594
NCT02411201|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-01-20|2016-11-21||March 2015||2015-03-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||51 pediatric subjects were included in the study. 4 subjects could not be randomized due to consent withdrawal (n=1), adverse event (n=1) or other reason (n=2). 2 subjects did not receive DOTAREM due to consent withdrawal for 1 subject and adverse event for the second subject.|DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years|DOTAREM® Pharmacokinetics, Safety and Efficacy Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)|Completed||Phase 4|51|Actual|Guerbet||1|||f||||f||||||||||2017-10-10 23:25:03.329413|2017-10-10 23:25:03.329413
NCT02411188|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-10-31|||February 2016||2016-02-01|November 2015|2015-11-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|FHHS: STEP||For Her Heart's Sake STEP Project: A Clinical Trial|For Her Heart's Sake: A Clinical Trial to Assess Strategies to Enhance Participation in Cardiac Rehabilitation - STEP Project|Withdrawn||N/A|0|Actual|University of Manitoba||2||recruitment issues; changed protocol to prospective cohort study|f||||f||||||||||2017-10-10 23:25:03.643048|2017-10-10 23:25:03.643048
NCT02411175|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-05-18|||October 2014||2014-10-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Efficacy of Individualised Homeopathic Treatment on Constipation|The Efficacy of Individualised Homeopathic Treatment on Constipation|Completed||Phase 2|10|Actual|University of Johannesburg||1|||f||||t||||||||No||2017-10-10 23:25:03.72668|2017-10-10 23:25:03.72668
NCT02411162|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-05-05|||July 7, 2015|Actual|2015-07-07|May 2017|2017-05-01|September 24, 2015|Actual|2015-09-24|September 24, 2015|Actual|2015-09-24||Interventional|||A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream|Skin Residency Study of Topically Applied GSK2894512 Cream in Healthy Volunteers|Completed||Phase 1|15|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:25:03.813781|2017-10-10 23:25:03.813781
NCT02411149|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-08-16|||April 2014||2014-04-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|ACB in TKA||Adductor Canal Block and Recovery After Total Knee Replacement Surgery|Adductor Canal Block and Functional Recovery After Total Knee Arthroplasty. A Double-Blind, Randomized Controlled Trial|Recruiting||Phase 4|200|Anticipated|University Health Network, Toronto||3|||f||||f||||||||||2017-10-10 23:25:03.945424|2017-10-10 23:25:03.945424
NCT02411136|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-04-07|||May 2005||2005-05-01|April 2015|2015-04-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 623 Following Multi-dose Administration in Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|64|Actual|Amgen||2|||f||||f||||||||||2017-10-10 23:25:04.15826|2017-10-10 23:25:04.15826
NCT02411123|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-12-28|||March 2015||2015-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders|Prospective Randomized Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders|Completed||N/A|220|Anticipated|AltheaDx||2|||f||||f||||||||||2017-10-10 23:25:04.237708|2017-10-10 23:25:04.237708
NCT02411110|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-09-06|||May 21, 2015|Actual|2015-05-21|September 2017|2017-09-01|February 14, 2017|Actual|2017-02-14|October 12, 2016|Actual|2016-10-12||Interventional|||A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome|A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome|Completed||Phase 2|131|Actual|Allergan||2|||f||||f||||||||||2017-10-10 23:25:04.33567|2017-10-10 23:25:04.33567
NCT02411097|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-04-02|||September 2014||2014-09-01|March 2015|2015-03-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism|Prevention of Deep Venous Thromboembolism: Effect of Preemptive Analgesic of Femoral Nerve Block in Patients Undergoing Total Knee Arthroplasty|Unknown status|Recruiting|N/A|120|Anticipated|General Hospital of Ningxia Medical University||1|||f||||t||||||||||2017-10-10 23:25:04.487526|2017-10-10 23:25:04.487526
NCT02411084|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-09-20|||February 2016||2016-02-01|June 2017|2017-06-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||"Study of BEGEDINA® vs Conventional Treatment for Treating Steroid-Resistant Acute GvHD"|"Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA® Versus Conventional Treatment for Treating Steroid Resistant Acute Graft-versus Host Disease"|Terminated||Phase 3|36|Actual|Adienne SA||2||Insufficient rate of accrual|f||||f||||||||||2017-10-10 23:25:04.586244|2017-10-10 23:25:04.586244
NCT02411071|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-12-02|||December 2014||2014-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens|Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens|Active, not recruiting||N/A|1000|Anticipated|University Hospital, Essen|||2||f||||f||||||None Retained|"     Cells and DNA/RNA extracted from whole blood samples   "|||2017-10-10 23:25:04.747863|2017-10-10 23:25:04.747863
NCT02411058|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-10-07|||March 2015||2015-03-01|July 2015|2015-07-01||||May 2015|Actual|2015-05-01||Interventional|||Attention to Incentives|Attention to Incentives|Completed||N/A|2055|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:25:04.840474|2017-10-10 23:25:04.840474
NCT02411045|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2015-09-02|||April 2015||2015-04-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Dress for Success: Can Just Dressing for the Gym Help Going to the Gym?|Dress for Success: Can Just Dressing for the Gym Help Going to the Gym?|Completed||N/A|1310|Actual|University of Pennsylvania||3|||f||||||||||||||2017-10-10 23:25:04.921599|2017-10-10 23:25:04.921599
NCT02411032|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-05-02|||April 2015||2015-04-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Fresh Start Experiment|Fresh Start Experiment|Completed||N/A|13323|Actual|University of Pennsylvania||5|||f||||f||||||||||2017-10-10 23:25:05.010127|2017-10-10 23:25:05.010127
NCT02411019|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-07-11|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|GX-188E||Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation|A Prospective, Observational, Open-label, Multi-center, Follow-up Clinical Study to Determine Recurrence of Cervical Intraepithelial Neoplasia and Evaluate the Long-term Safety of GX-188E, a DNA-based Therapeutic Vaccine, Administered Intramuscularly by Electroporation (EP) in Subjects Who Were Diagnosed With HPV(Human Papillomavirus) 16 or 18 Positive Cervical Intraepithelial Neoplasia 3 (CIN 3) and Participated in Phase 2 Trial (GX-188E_CIN3_P2)|Active, not recruiting||N/A|67|Actual|Genexine, Inc.|||1||f||||f||||||Samples Without DNA|"     plasma and PBMC (peripheral blood mononeuclear cell)   "|||2017-10-10 23:25:05.111315|2017-10-10 23:25:05.111315
NCT02411006|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-09-26|||November 2014||2014-11-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Reminders on Adherence|Prediction and Pre-commitment Mailings for Medication Adherence|Completed||N/A|47088|Actual|University of Pennsylvania||6|||f||||||||||||||2017-10-10 23:25:05.202104|2017-10-10 23:25:05.202104
NCT02410993|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2016-07-25|||April 2015||2015-04-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||Current Treatment Strategy of Patients With Multivessel Disease or Left Main Coronary Artery Disease Indicated for Coronary Artery Bypass Graft Surgery||Recruiting||N/A|2500|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-10 23:25:05.303211|2017-10-10 23:25:05.303211
NCT02410980|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-03-03|||August 2015||2015-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies|In-vivo Non-invasive Skin Imaging Pilot Study to Assess the Effects of Tretinoin Cream Using Multi-photon Microscopy and Multi-spectral Imaging|Completed||Early Phase 1|15|Actual|University of California, Irvine||1|||f||||t||||||||No||2017-10-10 23:25:05.390352|2017-10-10 23:25:05.390352
NCT02410967|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-08-01|||July 2014||2014-07-01|August 2017|2017-08-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Attention Bias Modification Training in Youth With Subthreshold Impairing Anxiety|Attention Bias Modification Training in Youth With Subthreshold Impairing Anxiety|Recruiting||N/A|66|Anticipated|Florida International University||2|||f||||t||||||||||2017-10-10 23:25:05.473268|2017-10-10 23:25:05.473268
NCT02410954|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-04-28|||December 2015||2015-12-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|tDCS||Transcranial Direct Current Stimulation (tDCS) as a Treatment for Acute Fear|Transcranial Direct Current Stimulation (tDCS) as a Treatment for Acute Fear|Active, not recruiting||N/A|10|Actual|University of California, San Francisco||2|||f||||t|f|||||||No||2017-10-10 23:25:05.565977|2017-10-10 23:25:05.565977
NCT02410941|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-08-29|||January 2016||2016-01-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Improving the Stewardship of Diagnostic Imaging Resources in Alberta Emergency Departments|Improving the Stewardship of Diagnostic Imaging Resources in Alberta Emergency Departments|Recruiting||N/A|52058|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-10 23:25:05.655457|2017-10-10 23:25:05.655457
NCT02410928|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2017-09-10|||April 2015|Actual|2015-04-01|February 2015|2015-02-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Comparison of the Vocal Cord Imaging Techniques After Thyroidectomy|Comparison of the Vocal Cord Imaging Techniques After Thyroidectomy|Completed||N/A|75|Actual|Diskapi Teaching and Research Hospital||3|||f||||f|f|f||||||||2017-10-10 23:25:05.822701|2017-10-10 23:25:05.822701
NCT02410915|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-05-17|||February 2014||2014-02-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|HAL-RCT||A Comparison Between the Exoskeleton Hybrid Assistive Limb and Conventional Gait Training Early After Stroke|Gait Training Early After Stroke - a Comparison Between Training With the Exoskeleton Hybrid Assistive Limb and Conventional Gait Training|Completed||N/A|32|Actual|Danderyd Hospital||2|||f||||f||||||||||2017-10-10 23:25:05.905049|2017-10-10 23:25:05.905049
NCT02410902|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-06|||May 2015||2015-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)|A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT)|Active, not recruiting||Phase 3|300|Anticipated|Curemark||2|||f||||f||||||||||2017-10-10 23:25:05.998657|2017-10-10 23:25:05.998657
NCT02410889|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-10-11|||January 2007||2007-01-01|April 2015|2015-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||EEG-fMRI: Towards a Useful Clinical Tool in Epilepsy|EEG-fMRI: Towards a Useful Clinical Tool in Epilepsy|Completed||N/A|29|Actual|University of Birmingham|||1||f||||||||||||||2017-10-10 23:25:06.142368|2017-10-10 23:25:06.142368
NCT02410707|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-03-28|||February 2015||2015-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults|Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults, a Pilot Study|Recruiting||N/A|80|Anticipated|Albert Einstein Healthcare Network||1|||f||||t||||||||No||2017-10-10 23:25:08.505007|2017-10-10 23:25:08.505007
NCT02410876|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-10-25|||June 2015||2015-06-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|MoVe||Changes of microRNA Expression in Obstructive and Neurogenic Bladder Dysfunction|Changes of microRNA Expression in Obstructive and Neurogenic Bladder Dysfunction Reveal Common Signalling Pathways Relevant for Disease Progression and Recovery|Recruiting||N/A|100|Anticipated|University Hospital Inselspital, Berne|||5||f||||f||||||Samples Without DNA|"     cold cup biopsies of the bladder wall   "|||2017-10-10 23:25:06.366412|2017-10-10 23:25:06.366412
NCT02410863|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-09-12|||June 2015||2015-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|BOTTOM||Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma|Biopsy- and Biology-driven Optimization of Targeted Therapy of Metastatic Melanoma in BRAF Inhibitor Non-pretreated and Pretreated Subjects With Advanced, Non-resectable (STAGE IIIC) or Metastatic (StAGE IV) BRAF Mutation-positive Melanoma|Recruiting||Phase 2|70|Anticipated|University Hospital, Essen||3|||f||||f||||||||||2017-10-10 23:25:06.466009|2017-10-10 23:25:06.466009
NCT02410850|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-06-12|||August 1, 2017|Anticipated|2017-08-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|||Long Term Oral Appliance Therapy Effectiveness for Obstructive Sleep Apnea Syndrome|Long Term Oral Appliance Therapy Effectiveness for Obstructive Sleep Apnea: A Multicenter Cohort Study|Not yet recruiting||N/A|1000|Anticipated|University of British Columbia|||13||f||||f||||||||||2017-10-10 23:25:06.604898|2017-10-10 23:25:06.604898
NCT02410837|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-10-02|||April 2015||2015-04-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|2 Years|Observational [Patient Registry]|||NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™|NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™|Active, not recruiting||N/A|1391|Actual|Medtronic - MITG|||1||f||||||||||||||2017-10-10 23:25:06.744696|2017-10-10 23:25:06.744696
NCT02410824|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-07-20|2017-01-18||April 2015||2015-04-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism|Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism|Completed||N/A|52|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 23:25:06.939025|2017-10-10 23:25:06.939025
NCT02410811|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2016-09-09|||October 2013||2013-10-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|September 2017|Anticipated|2017-09-01||Observational|||Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease|Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease|Active, not recruiting||N/A|26|Actual|Children's Hospital Medical Center, Cincinnati|||3||f||||f||||||Samples With DNA|"     Participants will have to give blood and urine.      Visit 1:      Sample of blood (about 2 tablespoons) for:        -  routine lab tests to check the health of the heart and the extent of participants sickle          cell disease        -  research lab tests to check for biomarkers (substances found in blood that are signs of          a disease, condition or normal/abnormal process) of heart problems, blood clotting          activity and to extract DNA for genetic testing        -  1 tablespoon of urine for routine tests to check health      Visit 2 (1 year after 1st visit):        -  Sample of blood (about 2 tablespoons) for routine and research lab tests        -  1 tablespoon of urine for routine tests to check health           24-Hour Urine Sample (after Visits 1, 2, and 3):        -  Participants will be asked to collect and return a 24 hour urine sample after visits 1,          2, and 3.   "|||2017-10-10 23:25:07.504016|2017-10-10 23:25:07.504016
NCT02410798|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-09-01|||May 2015||2015-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Clinical Study to Investigate Safety and Performance of TransLoc Electrodes in Patients Undergoing Surgical Procedures|Early Feasibility Clinical Study to Investigate the Safety and Performance of TransLoc® Electrodes for Temporary Diaphragm Pacing in Patients Undergoing Surgical Procedures|Completed||N/A|12|Actual|Synapse Biomedical||1|||f||||f||||||||||2017-10-10 23:25:07.595844|2017-10-10 23:25:07.595844
NCT02410785|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-01-26|||August 2009||2009-08-01|March 2015|2015-03-01|October 2010|Actual|2010-10-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy of Polyglucosamine for Weight Loss|Efficacy of Polyglucosamine for Weight Loss - in a Randomized, Double-blind, Placebo-controlled Clinical Investigation|Completed||N/A|115|Actual|Certmedica International GmbH||2|||f||||f||||||||No||2017-10-10 23:25:07.668419|2017-10-10 23:25:07.668419
NCT02410772|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-07-07|||January 2016||2016-01-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|S31/A5349||TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens|Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349|Recruiting||Phase 3|2500|Anticipated|Centers for Disease Control and Prevention||3|||f||||t||||||||Yes|Data being collected in CDISC format.|2017-10-10 23:25:07.759218|2017-10-10 23:25:07.759218
NCT02410759|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-07-03|||April 2015||2015-04-01|July 2016|2016-07-01||||March 2017|Anticipated|2017-03-01||Interventional|||Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally|Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial|Recruiting||Phase 3|200|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:25:08.066586|2017-10-10 23:25:08.066586
NCT02410746|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-07-23|||January 2016||2016-01-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Nerve Block Versus Non-targeted Local Anaesthesia in Breast Surgery|A Prospective, Randomised Double Blinded Study Comparing a Pectoral Nerve Block With Non-targeted Local Anaesthetic in Bilateral Breast Surgery|Recruiting||N/A|50|Anticipated|BMI Healthcare||2|||f||||t||||||||Yes|yes on individual request of the patient when study is completed|2017-10-10 23:25:08.16894|2017-10-10 23:25:08.16894
NCT02410733|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-06-07|||March 2015||2015-03-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|Lipo-MERIT||Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma|Clinical First-in-human Dose Escalation Study Evaluating the Safety and Tolerability of Intravenous Administration of a Tetravalent RNA-lipoplex Cancer Vaccine Targeting Four Tumour-associated Antigens in Patients With Advanced Melanoma|Recruiting||Phase 1|39|Anticipated|Biontech RNA Pharmaceuticals GmbH||1|||f||||t||||||||||2017-10-10 23:25:08.295114|2017-10-10 23:25:08.295114
NCT02410694|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-06-01|||April 2015||2015-04-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma|Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 2|77|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||t||||||||||2017-10-10 23:25:08.614211|2017-10-10 23:25:08.614211
NCT02410681|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-07-29|||March 2015||2015-03-01|July 2016|2016-07-01||||March 2018|Anticipated|2018-03-01||Observational|||Sleep Bruxism and (Peri-)Implant Complications|Associations Between Sleep Bruxism and (Peri-)Implant Complications: a Follow-up Study|Recruiting||N/A|98|Anticipated|Academic Centre for Dentistry in Amsterdam|||1||f||||t||||||Samples With DNA|"     Peri-implant intrasulcular biofilm.   "|||2017-10-10 23:25:08.759546|2017-10-10 23:25:08.759546
NCT02410668|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-04-06|||March 2014||2014-03-01|March 2014|2014-03-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese Subject|The Effects of Flaxseed Supplement on Weight, Lipid Profile and Inflammatory Factors in Overweight and Obese Subjects|Completed||Phase 2/Phase 3|50|Actual|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-10 23:25:08.838387|2017-10-10 23:25:08.838387
NCT02410655|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-07-27|||November 2015||2015-11-01|July 2017|2017-07-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Interventional|||An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery|An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery|Withdrawn||Phase 4|0|Actual|New York University School of Medicine||2||Submission discarded. Study never enrolled subjects.|f||||t||||||||||2017-10-10 23:25:08.90094|2017-10-10 23:25:08.90094
NCT02410642|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-03-07|||November 2011||2011-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|CPBNAG||NAG-excretion During Cardiopulmonary Bypass|Effects of Cardiopulmonary Bypass on Urinary Secretion of NAG|Completed||N/A|65|Actual|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||||2017-10-10 23:25:08.968018|2017-10-10 23:25:08.968018
NCT02410629|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-04-06|||March 2015||2015-03-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||To Determine the Therapeutic Effect of the Music Glove and Conventional Hand Exercises to Subacute Stroke Patients|Influence of Timing on Motor Learning|Unknown status|Recruiting|N/A|40|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-10-10 23:25:09.027278|2017-10-10 23:25:09.027278
NCT02410616|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-09-20|||March 2015||2015-03-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|E-COMPARED_CH||E-Compared-CH: Comparative Effectiveness Research on Internet-based Depression Treatment - Swiss Trial|European Comparative Effectiveness Research on Internet-based Depression Treatment - Swiss Trial|Completed||N/A|50|Actual|University of Bern||2|||f||||f||||||||||2017-10-10 23:25:09.099224|2017-10-10 23:25:09.099224
NCT02410603|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer|Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer|Recruiting||N/A|20|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Blood samples   "|No||2017-10-10 23:25:09.280735|2017-10-10 23:25:09.280735
NCT02410590|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-07-10|||July 2015||2015-07-01|July 2015|2015-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|BENN||Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)|"Randomized, Parallel Group, Controlled Trial to Compare Two Different NMB + Reversal Strategies in Adult Obese Patients Undergoing Laparoscopic Abdominal Surgery"|Withdrawn||Phase 4|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 23:25:09.368892|2017-10-10 23:25:09.368892
NCT02410577|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-02-07|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme|A Pilot Study of 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme|Active, not recruiting||N/A|2|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:25:09.464761|2017-10-10 23:25:09.464761
NCT02410564|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-02-09|||December 2014||2014-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|||CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients|Testing an Accessible Cognitive Behavioral Therapy for Insomnia (CBT-I) Intervention in Newly Diagnosed Cancer Patients|Terminated||N/A|29|Actual|Virginia Commonwealth University||2||insufficient staff|f||||t||||||||||2017-10-10 23:25:09.56019|2017-10-10 23:25:09.56019
NCT02410551|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-01-23|||June 15, 2015|Actual|2015-06-15|January 2017|2017-01-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)|Pacritinib Prior to Transplant for Patients With Myeloproliferative Neoplasms (MPN)|Terminated||Phase 2|4|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:25:09.648826|2017-10-10 23:25:09.648826
NCT02410538|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-10-27|||April 2014||2014-04-01|April 2016|2016-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|FamiréaXVII||Frequently Asked Questions for ICU Patients' Families|Frequently Asked Questions as an Help to Improve the Information of ICU Patients' Families.|Completed||N/A|300|Actual|Assistance Publique Hopitaux De Marseille|||2||f||||f||||||||||2017-10-10 23:25:09.762743|2017-10-10 23:25:09.762743
NCT02410525|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-10-27|||May 2015||2015-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning|A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects|Completed||Phase 1|8|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 23:25:09.836627|2017-10-10 23:25:09.836627
NCT02410343|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-04-26|||April 2015||2015-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Study of TV-1106 in Growth Hormone-Deficient Adults|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy, Safety, and Tolerability Study of TV-1106 in Growth Hormone-Deficient Adults Who Are Not Current Users of rhGH Treatment|Terminated||Phase 3|14|Actual|Teva Pharmaceutical Industries||2||Business decision|f||||t||||||||||2017-10-10 23:25:11.476068|2017-10-10 23:25:11.476068
NCT02410512|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-09-21|||April 24, 2015|Actual|2015-04-24|September 2017|2017-09-01|August 12, 2018|Anticipated|2018-08-12|August 12, 2018|Anticipated|2018-08-12||Interventional|||A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors|A Phase Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|610|Anticipated|Genentech, Inc.||2|||f||||||||||||||2017-10-10 23:25:09.952357|2017-10-10 23:25:09.952357
NCT02410499|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-09-22|||May 20, 2015|Actual|2015-05-20|September 2017|2017-09-01|November 17, 2015|Actual|2015-11-17|November 17, 2015|Actual|2015-11-17||Interventional|||Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria|A Multicenter, Randomized, Double Blind, Placebo Controlled, Proof of Concept, Phase 2 Study to Evaluate the Efficacy and Safety of Weekly Subcutaneous MLN1202, in Improving Diabetic Nephropathy in Subjects With Macroalbuminuria|Withdrawn||Phase 2|0|Actual|Takeda||4|||f||||t||||||||||2017-10-10 23:25:10.136597|2017-10-10 23:25:10.136597
NCT02410486|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-10-02|||April 2015|Actual|2015-04-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|EOSII||Early-Onset Sepsis an NICHD/CDC Surveillance Study|Early-Onset Sepsis an NICHD/CDC Surveillance Study|Recruiting||N/A|480|Anticipated|NICHD Neonatal Research Network|||5||f||||t||||||||||2017-10-10 23:25:10.238432|2017-10-10 23:25:10.238432
NCT02410473|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-06-05|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Evaluation of Coagulation Testing in Patients Undergoing Cardiac Surgery|Evaluation of Coagulation Testing in Patients Undergoing Cardiac Surgery|Recruiting||N/A|100|Anticipated|Boston Children’s Hospital|||1||f||||f||||||Samples Without DNA|"     Collect discarded blood from 4 routine blood samples. These will be obtained at 4 different     time-points: 1. After induction of anesthesia and placement of arterial line, 2. After     cardiopulmonary Bipass (CPB), 3 minutes after protamine administration, 3. At the end of the     surgery, before transfer to CICU, 4. 24- 48 hrs post-surgery in the ICU.      Collect two 5 mL of urine samples. One sample prior to CPB, as well as following CPB, from an     routinely placed Foley catheter.   "|||2017-10-10 23:25:10.442405|2017-10-10 23:25:10.442405
NCT02410447|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-04-06|||May 2012||2012-05-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Defocused Shock Wave Therapy for Chronic Wounds|Defocused Shock Wave Therapy for Chronic Soft Tissue Wounds of the Lower Limbs. A Pilot Study|Completed||Phase 3|10|Actual|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-10 23:25:10.649759|2017-10-10 23:25:10.649759
NCT02410434|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-04-11|||February 2015||2015-02-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Reducing Lesbian, Gay , Bisexual and Transgender (LGBT) Stigma in Swaziland and Lesotho|Examining Performance Ethnography as a Lesbian, Gay , Bisexual and Transgender (LGBT) Stigma Reducing Strategy in Swaziland and Lesotho|Completed||N/A|106|Actual|University of Toronto||1|||f||||f||||||||||2017-10-10 23:25:10.738181|2017-10-10 23:25:10.738181
NCT02410421|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-01-04||||||January 2016|2016-01-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||e-PAT Neuromod Evaluation of Personalized rTMS for Resistant Depression|Validation of Individualized rTMS Protocol Using Non Invasive Functional Brain Imaging and Robotic Coil Placement in Resistant Depression: Comparison With Classical rTMS and tDCS|Withdrawn||Phase 2|0|Actual|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-10-10 23:25:10.81708|2017-10-10 23:25:10.81708
NCT02410408|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2016-01-02|||January 2016||2016-01-01|December 2015|2015-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|ASV||Apps to Reduce the Impact That Adverse Events Among Health Professionals|Designing Guides and Tools to Reduce the Impact That Adverse Events Also Have Among Professionals and Health Institutions|Completed||N/A|84|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||||2017-10-10 23:25:10.909479|2017-10-10 23:25:10.909479
NCT02410395|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-06|||March 2015||2015-03-01|March 2015|2015-03-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|NICUM||NIche Development With Closure of Cesarean Uterotomy by Modified or Conventional Two-layer Technique|NIche Development With Closure of Cesarean Uterotomy by Modified or Conventional Two-layer Technique (NICUM Study)|Recruiting||N/A|230|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:25:11.003393|2017-10-10 23:25:11.003393
NCT02410382|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-12-05|||August 2014||2014-08-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer|A Phase II Randomized Study of Short-Term Dexamethasone Versus Placebo for Fatigue in Patients Receiving Radiation Alone or Radiation and Chemotherapy for the Treatment of Head and Neck and Non-Small Cell Lung Cancers|Recruiting||Phase 2|80|Anticipated|University of Arizona||2|||f||||t||||||||||2017-10-10 23:25:11.085437|2017-10-10 23:25:11.085437
NCT02410369|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-03-14|||March 2015||2015-03-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|March 2020|Anticipated|2020-03-01||Interventional|||Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer|Phase II Study of S-588410 as Maintenance Monotherapy After Adjuvant Chemotherapy in Patients With Completely Resected Non-small- Cell Lung Cancer|Recruiting||Phase 2|60|Anticipated|Tokyo University||2|||f||||t||||||||No||2017-10-10 23:25:11.184702|2017-10-10 23:25:11.184702
NCT02410356|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-04-26|||April 2015||2015-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)|A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency|Terminated||Phase 3|34|Actual|Teva Pharmaceutical Industries||2||Business decision|f||||f||||||||||2017-10-10 23:25:11.293489|2017-10-10 23:25:11.293489
NCT02408965|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-04-28|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|UPT||Uterotonic Prophylaxis Trial|Uterotonic Prophylaxis Trial|Completed||Phase 4|320|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:25:27.211281|2017-10-10 23:25:27.211281
NCT02410330|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-07|||May 2014||2014-05-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01|6 Months|Observational [Patient Registry]|||Therapeutic Use of Ultrasound in Acute Coronary Artery Disease|Therapeutic Use of Ultrasound in Acute Coronary Artery Disease|Recruiting||Phase 1|100|Anticipated|University of Sao Paulo General Hospital|||3||f||||t||||||Samples With DNA|"     Blood sample   "|||2017-10-10 23:25:11.634469|2017-10-10 23:25:11.634469
NCT02410317|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-11-02|||February 2015||2015-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ROMANCE||Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section|Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section|Recruiting||Phase 3|110|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 23:25:11.735951|2017-10-10 23:25:11.735951
NCT02410291|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-12-28|2016-10-12||July 2015||2015-07-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Impact on Instructional Video on Patients' Compliance With Preparation During CT Planning for Prostate Cancer|Empowering Patients Through Education- Online, Written, and Personal Education Resource for Prostate Cancer Patients Who Need Radiation Therapy to Ensure Patient Preparedness (Compliance and Understanding) for Their Simulation and Treatment|Completed||N/A|58|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||No||2017-10-10 23:25:11.941163|2017-10-10 23:25:11.941163
NCT02410278|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-05-01|||June 29, 2015|Actual|2015-06-29|April 2017|2017-04-01|May 15, 2017|Anticipated|2017-05-15|March 6, 2017|Actual|2017-03-06||Interventional|MITIGATE||Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera|A Multicenter, Double- Blind, Placebo- Controlled Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera® (Dimethyl Fumarate) Delayed Release Capsules|Active, not recruiting||Phase 4|63|Actual|Biogen||2|||f||||f||||||||||2017-10-10 23:25:12.142027|2017-10-10 23:25:12.142027
NCT02410265|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-06-25|||January 2015||2015-01-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Online, Guided Interventions to Reduce Generalized Anxiety Disorder Among Indian University Students|Using Technology to Address Anxiety and Stress in Indian University Students|Completed||N/A|193|Actual|Stanford University||3|||f||||f||||||||||2017-10-10 23:25:12.398891|2017-10-10 23:25:12.398891
NCT02410252|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-07-24|||May 2015||2015-05-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies|Use Feasibility of the iThermonitor in Pediatric Patients on Myelosuppresive Therapies for Acute Leukemia and Other Childhood Cancers|Active, not recruiting||N/A|25|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:25:12.509569|2017-10-10 23:25:12.509569
NCT02410239|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-02-17|||June 2015|Anticipated|2015-06-01|February 2017|2017-02-01|July 2022|Anticipated|2022-07-01|July 2017|Anticipated|2017-07-01||Interventional|||MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)|MT2014-14 Intrathecal Administration of Mesenchymal Stem Cells (IT-MSC) for the Treatment of Advanced Cerebral Adrenoleukodystrophy (cALD)|Withdrawn||Phase 1|0|Actual|Masonic Cancer Center, University of Minnesota||1||Research cancelled|f||||t||||||||||2017-10-10 23:25:12.595086|2017-10-10 23:25:12.595086
NCT02410226|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-09-21|||April 2015||2015-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Ultrasound Versus Palpation for Epidural Catheterization|Comparison Between Ultrasound-assisted and Conventional Palpation Techniques for Epidural Catheterization Before Cesarean Section|Completed||N/A|110|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:25:12.677894|2017-10-10 23:25:12.677894
NCT02410200|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-03-20|2017-03-20||September 2015||2015-09-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|FOCUS||Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS|Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years|Completed||Phase 2|22|Actual|Biogen||1|||f||||f||||||||||2017-10-10 23:25:12.922448|2017-10-10 23:25:12.922448
NCT02410187|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-03-02|||March 2016||2016-03-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||SBRT for Extra-cranial Oligorecurrent Tumor|Stereotactic Body Radiotherapy for Extra-cranial Oligorecurrent Tumor: Randomized Phase II Clinical Trial|Not yet recruiting||Phase 2|1|Anticipated|Korea Cancer Center Hospital||2|||f||||f||||||||||2017-10-10 23:25:13.346768|2017-10-10 23:25:13.346768
NCT02410174|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-01-06|||May 2012||2012-05-01|April 2016|2016-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors|Phase I Trial of Stereotactic Body Radiotherapy (SBRT) of the Primary Tumor in Renal Cell Carcinoma (RCC)|Terminated||Phase 1|3|Actual|Beth Israel Medical Center||1||Poor Accural|f||||f||||||||||2017-10-10 23:25:13.446538|2017-10-10 23:25:13.446538
NCT02410148|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-04-07|||April 2015||2015-04-01|April 2015|2015-04-01|March 2017|Anticipated|2017-03-01|July 2016|Anticipated|2016-07-01||Interventional|aICP Ophtha||aICP in Glaucoma and Papilledema|Non-invasive Absolute Intracranial Pressure (ICP) Measurement in Patients With Open-angle Glaucoma and Papilledema|Unknown status|Recruiting|N/A|60|Anticipated|Kantonsspital Aarau||2|||f||||f||||||||||2017-10-10 23:25:13.654285|2017-10-10 23:25:13.654285
NCT02410135|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-08-25|||April 2015||2015-04-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)|Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)|Recruiting||N/A|100|Anticipated|Southern Illinois University|||1||f||||f||||||||||2017-10-10 23:25:13.78069|2017-10-10 23:25:13.78069
NCT02410122|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-09-21|||December 2014||2014-12-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|ProgStar-4||The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy|The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4 (STGD4): A Prospective Longitudinal Observational Study of Stargardt Disease Type 4, a PROM1- Related Macular Dystrophy|Active, not recruiting||N/A|15|Actual|Johns Hopkins University|||1||f||||f||||||||No||2017-10-10 23:25:13.90276|2017-10-10 23:25:13.90276
NCT02410109|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-04-05|||May 2013||2013-05-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Developing an Integrated Model for Home Visitation||Active, not recruiting||Phase 1/Phase 2|178|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:25:14.006002|2017-10-10 23:25:14.006002
NCT02410096|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-09-02|||April 2015||2015-04-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|||Bronchial Inflammation and Hyperresponsiveness After Oil Supplementation|Examination of Bronchial Inflammation and Hyperresponsiveness After Oil Supplementation With Middle-chain and Polyunsaturated Fatty Acids in an Exercise-induced Asthma Provocation Model|Completed||N/A|73|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-10 23:25:14.085502|2017-10-10 23:25:14.085502
NCT02410083|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-03-12|||November 2012||2012-11-01|March 2015|2015-03-01|December 2015|Actual|2015-12-01|April 2013|Actual|2013-04-01||Interventional|||Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent|Multicenter, Randomized, Open Study, Investigator-initiated Trial for Comparison of Eight Weeks Efficacy and Tolerability of Clopirin and Clopidogrel With Aspirin in Korean Patients With Post-Percutaneous Coronary Artery Intervention|Completed||Phase 4|448|Actual|Jeil Pharmaceutical Co., Ltd.||4|||f||||f||||||||No||2017-10-10 23:25:14.200351|2017-10-10 23:25:14.200351
NCT02410070|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-04-01|||January 2011||2011-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||A Comparison of Minimal Approach With Conventional Approach for Distal Radial Fractures|A Comparison of Minimal Approach With Conventional Approach for Distal Radial Fractures|Completed||N/A|157|Actual|The Second Hospital of Qinhuangdao||2|||f||||t||||||||||2017-10-10 23:25:14.288478|2017-10-10 23:25:14.288478
NCT02410057|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-04-01|||November 2014||2014-11-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula|ALFoNS - Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula Compared to Breastfed Infants|Recruiting||Phase 1/Phase 2|320|Anticipated|Skane University Hospital||4|||f||||f||||||||||2017-10-10 23:25:14.38515|2017-10-10 23:25:14.38515
NCT02410044|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-10-21|||December 2014||2014-12-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|PROBone||Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer|Open-labeled, Multicenter, Non-interventional Prospective PRO/QoL Registry for Patients With Osteoprotective Treatment for Bone Metastases of Breast or Prostate Cancer|Recruiting||N/A|500|Anticipated|iOMEDICO AG|||1||f||||f||||||||No||2017-10-10 23:25:14.492233|2017-10-10 23:25:14.492233
NCT02410031|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2017-04-04|||June 26, 2015|Actual|2015-06-26|April 2017|2017-04-01|March 4, 2016|Actual|2016-03-04|March 4, 2016|Actual|2016-03-04||Observational|||Risk Minimisation Study for Diane-35 and Its Generics|Study to Evaluate Physician Knowledge of Safety and Safe Use Information for Diane-35 and Its Generics in Europe: An Observational Post-Authorisation Safety Study|Completed||N/A|759|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:25:14.568184|2017-10-10 23:25:14.568184
NCT02410005|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-06-13|||October 2014||2014-10-01|June 2017|2017-06-01|September 7, 2015|Actual|2015-09-07|September 7, 2015|Actual|2015-09-07||Interventional|IDEAL||Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)|Kidney Disease in Type 2 Diabetes Mellitus: Biomarker Discovery and Novel Therapeutics|Terminated||Phase 2/Phase 3|56|Actual|Weill Cornell Medical College in Qatar||2||Logistic challenges|f||||t|f|f||||||||2017-10-10 23:25:14.725292|2017-10-10 23:25:14.725292
NCT02409992|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-05-24|||June 2015||2015-06-01|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|HNC-EC||Parent Training and Emotion Coaching for Children With Limited Prosocial Emotions|Parent Training and Emotion Coaching for Children With Limited Prosocial Emotions|Recruiting||N/A|140|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-10 23:25:14.81326|2017-10-10 23:25:14.81326
NCT02409979|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-11-04|||April 2015||2015-04-01|October 2015|2015-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Impact of Carbon Dioxide Insufflation and Water Exchange on Post-Colonoscopy Outcomes|Impact of Carbon Dioxide Insufflation and Water Exchange on Post-Colonoscopy Outcomes: A Randomized Controlled Trial|Completed||N/A|246|Actual|Presidio Ospedaliero Santa Barbara||3|||f||||t||||||||||2017-10-10 23:25:14.912387|2017-10-10 23:25:14.912387
NCT02409966|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-06|||February 2011||2011-02-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Periodontitis Treatment on Quality of Life and Experiences of Fear, Anxiety and Pain|Impact of Different Protocols for Treatment of Chronic Periodontitis on the Following Patient-centered Variables: Oral Health Related Quality of Life and Experiences of Fear, Anxiety and Pain: a 6 Month Randomized Clinical Trial|Completed||N/A|90|Actual|University of Taubate||2|||f||||f||||||||||2017-10-10 23:25:15.033516|2017-10-10 23:25:15.033516
NCT02409940|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-11-07|||September 2013||2013-09-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|September 2016|Actual|2016-09-01||Interventional|||To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients|A Randomized Trial to Elucidate Effect of Mesenchymal Stem Cells on Immune Modulation in Living Related Kidney Transplant Patients|Active, not recruiting||Phase 1|17|Actual|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||||2017-10-10 23:25:15.184314|2017-10-10 23:25:15.184314
NCT02409901|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-03-01|||October 2014||2014-10-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|PACK||Physical Activity and Diet on Kidney Transplant Recipients|Randomized Case-Control Trial About the Impact of Targeted Physical Activity and Diet Modification on Kidney Transplant Recipients' Outcome|Recruiting||N/A|150|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-10 23:25:15.484509|2017-10-10 23:25:15.484509
NCT02409888|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-08-03|||November 2015||2015-11-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|February 2019|Anticipated|2019-02-01||Interventional|||Evaluating Interventions for Alcohol Use Disorder||Recruiting||N/A|600|Anticipated|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-10 23:25:15.581062|2017-10-10 23:25:15.581062
NCT02409875|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-02-22|||February 2011|Actual|2011-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2012|Actual|2012-10-01||Observational|ES-China||The Early Stockholm Obesity Prevention Project in China|Baby-STOPP: Targeted Obesity Prevention Directed to Overweight Parents With Young Children|Active, not recruiting||N/A|300|Anticipated|Huazhong University of Science and Technology|||1||f||||f||||||||||2017-10-10 23:25:15.66316|2017-10-10 23:25:15.66316
NCT02409862|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-08-01|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30||Interventional|||Faces: Choices Study|Faces: Choices Study|Not yet recruiting||Phase 2/Phase 3|24|Anticipated|University of Florida||2|||f||||f|t|f||||||||2017-10-10 23:25:15.742486|2017-10-10 23:25:15.742486
NCT02409849|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-06|||April 2015||2015-04-01|April 2015|2015-04-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|||Octreotide LAR as Maintenance Treatment for Patients With NEC|Randomized Phase II Study of Octreotide LAR as Maintenance Treatment After First-line Chemotherapy for Patients With Unresectable or Metastatic Gastro-entero-pancreatic or Esophageal Neuroendocrine Carcinomas|Not yet recruiting||Phase 2|92|Anticipated|Peking University||2|||f||||f||||||||||2017-10-10 23:25:15.829367|2017-10-10 23:25:15.829367
NCT02409836|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-04-01|||May 1993||1993-05-01|April 2015|2015-04-01|July 1993|Actual|1993-07-01|July 1993|Actual|1993-07-01||Interventional|||A Study to Assess the Ingestion of Dentifrice by Children|A Study to Assess the Ingestion of Dentifrice by Children|Completed||N/A|90|Actual|Procter and Gamble||3|||f||||f||||||||||2017-10-10 23:25:15.917516|2017-10-10 23:25:15.917516
NCT02409823|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-10-19|||February 2015||2015-02-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Clinical Registry of Patients Under Treatment With Atypical Antipsychotics|Clinical Registry of Patients Under Treatment With Atypical Antipsychotics|Completed||N/A|665|Actual|Pontifical Catholic University of Argentina|||1||f||||f||||||||||2017-10-10 23:25:15.995802|2017-10-10 23:25:15.995802
NCT02409810|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-06|||March 2015||2015-03-01|March 2015|2015-03-01|April 2020|Anticipated|2020-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes|Safety, Feasibility, and Acceptability of Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes|Recruiting||Phase 1/Phase 2|20|Anticipated|Ohio State University||1|||f||||f||||||||||2017-10-10 23:25:16.061149|2017-10-10 23:25:16.061149
NCT02409797|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-03-28|||March 2015||2015-03-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|INSIGHT||measurINg forceS durInG cHiropractic Treatment|measurINg forceS durInG cHiropractic Treatment (INSIGHT): A Single-Arm Clinical Case Series|Completed||N/A|12|Actual|Palmer College of Chiropractic||1|||f||||t||||||||No|Feasibility/pilot study|2017-10-10 23:25:16.135242|2017-10-10 23:25:16.135242
NCT02409771|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-04-03|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|||Clinical Trial With PRECIZON Presbyopic|Prospective Multicenter Clinical Trial With the PRECIZON Presbyopic Multifocal Intraocular Lens|Completed||N/A|70|Actual|Ophtec BV||1|||f||||f||||||||Undecided||2017-10-10 23:25:18.239812|2017-10-10 23:25:18.239812
NCT02409758|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-04-06|||January 2011||2011-01-01|April 2015|2015-04-01|August 2012|Actual|2012-08-01|December 2011|Actual|2011-12-01||Interventional|Voicetherapy||Comprehensive Voice Rehabilitation Program Compared With Vocal Function Exercises|The Effectiveness of the Comprehensive Voice Rehabilitation Program Compared With Vocal Function Exercises Method in Behavioral Dysphonia: A Randomized Controlled Clinical Trial.|Completed||Early Phase 1|106|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 23:25:18.34929|2017-10-10 23:25:18.34929
NCT02409745|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-04-18|||February 2015||2015-02-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effectiveness of Endometrial Injury in IVF|The Effectiveness of Endometrial Injury in Different Phase of Menstrual Cycle:a Prospective Controlled Clinical Study|Unknown status|Recruiting|N/A|400|Anticipated|The First Affiliated Hospital of Zhengzhou University||4|||f||||t||||||||||2017-10-10 23:25:18.431506|2017-10-10 23:25:18.431506
NCT02409732|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-05-12|||April 2015||2015-04-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis|Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis|Active, not recruiting||Phase 4|20|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-10-10 23:25:18.53849|2017-10-10 23:25:18.53849
NCT02409719|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-01|||July 2014||2014-07-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Home Rehabilitation in Patients After Primary Total Knee Arthroplasty|Home Rehabilitation in Patients After Primary Total Knee Arthroplasty|Unknown status|Recruiting|N/A|70|Anticipated|Universidad Autonoma de Nuevo Leon||2|||f||||t||||||||||2017-10-10 23:25:18.64339|2017-10-10 23:25:18.64339
NCT02409706|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-06-15|||August 2014||2014-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|MC5||Micronutrients in Children in Critical Care With Cardiac Conditions|Micronutrient Deficiencies in Children and Infants With Congenital Heart Diseases (CHD) Admitted for Cardiac Surgery: A Proof-of-concept Study|Completed||N/A|50|Actual|NHS Greater Glasgow and Clyde|||1||f||||f||||||Samples Without DNA|"     Whole blood Plasma Red blood cells   "|No||2017-10-10 23:25:18.762277|2017-10-10 23:25:18.762277
NCT02409693|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-10-26|||April 2015||2015-04-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Retrospective Analysis of Perioperative Anesthetic Care and Analgesia Management of Patient Undergoing Bilateral Myringotomy With Tube Insertion||Withdrawn||N/A|0|Actual|Nationwide Children's Hospital|||1|Unable to obtain funding|f||||f||||||||||2017-10-10 23:25:18.876344|2017-10-10 23:25:18.876344
NCT02409680|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-12-15|||March 2016||2016-03-01|December 2016|2016-12-01||||July 2018|Anticipated|2018-07-01||Interventional|ASPIRIN||Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)|Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)|Recruiting||N/A|11000|Anticipated|NICHD Global Network for Women's and Children's Health||2|||f||||t||||||||||2017-10-10 23:25:18.968736|2017-10-10 23:25:18.968736
NCT02409667|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-08-19|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|May 8, 2017|Actual|2017-05-08|May 8, 2017|Actual|2017-05-08||Interventional|OPTIMISE||Plaque Psoriasis Efficacy and Safety With Secukinumab|Long Term Clear Skin Maintenance Treatment Optimization in Patients With Moderate to Severe Chronic Plaque Psoriasis: A Randomized, Multicenter, Open-label With Blinded-assessment, Comparative, 52 Week Study to Evaluate the Efficacy, Safety and Tolerability of Secukinumab 300 mg s.c.|Completed||Phase 3|1580|Actual|Novartis||4|||f||||f||||||||||2017-10-10 23:25:19.377984|2017-10-10 23:25:19.377984
NCT02409654|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-02-21|||January 2015||2015-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Hong Kong Outpatient AF Screening Using Single-lead ECG Device|Randomized Controlled Trial of Tailored Stroke Prevention Strategy for Newly Diagnosed Atrial Fibrillation From a Targeted Screening Program Using Handheld Single-lead ECG Device|Recruiting||N/A|500|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:25:20.002411|2017-10-10 23:25:20.002411
NCT02409641|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-04-07|||February 2015||2015-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Pilot Study Investigating the Impact of Different IOL Designs on Subjective 2D and 3D Image Quality|A Pilot Study Investigating the Impact of Different IOL Designs on Subjective 2D and 3D Image Quality|Completed||N/A|30|Actual|Medical University of Vienna||1|||f||||||||||||||2017-10-10 23:25:20.113911|2017-10-10 23:25:20.113911
NCT02409628|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-09-14|||April 23, 2015|Actual|2015-04-23|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds|EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds|Completed||N/A|12|Actual|Neotherix Limited||1|||f||||f||||||||||2017-10-10 23:25:20.20476|2017-10-10 23:25:20.20476
NCT02409615|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-09-12|||August 2014||2014-08-01|March 2016|2016-03-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|||Complementary Therapies in Spinal Fusion Patients|A Pilot Study of the Effectiveness of Complementary Therapies to Reduce Pain in Spinal Fusion Patients|Completed||N/A|30|Actual|Nemours Children's Clinic||3|||f||||t||||||||||2017-10-10 23:25:20.306175|2017-10-10 23:25:20.306175
NCT02409602|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-03-20|||October 2014||2014-10-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Influence of BIIAL Following PPH on Dorsal Clitoral Artery Blood Flow and FSFI|Comparison of the Dorsal Clitoral Artery Doppler Examination Results and the Female Sexual Function Index in Women With Postpartum Hemorrhage Who Underwent Bilateral Internal Iliac Artery Ligation and Age-matched Healthy Postpartum Women|Completed||N/A|20|Actual|Near East University, Turkey|||2||f||||t||||||||||2017-10-10 23:25:20.551859|2017-10-10 23:25:20.551859
NCT02409589|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-06|||March 2015||2015-03-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|PROJECT_EGG||An Intracavitary Electrocardiographic System for Real-time Positioning Peripherally Inserted Central Catheter Tip|A Randomized Open-labeled Multicenter Study to Assess a New Intracavitary Electrocardiographic Guiding Method for Real-time Positioning the Tip of Three-way Valve Type Peripherally Inserted Central Catheters (PROJECT_EGG)|Unknown status|Recruiting|Phase 4|1000|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||||2017-10-10 23:25:20.668421|2017-10-10 23:25:20.668421
NCT02409576|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-06-21|||February 2015||2015-02-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|NKEXPSARC||Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas|Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas|Recruiting||Phase 1/Phase 2|20|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-10 23:25:20.822469|2017-10-10 23:25:20.822469
NCT02409017|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2015-04-02|||April 2015||2015-04-01|April 2015|2015-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial|A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial|Unknown status|Recruiting|N/A|30|Anticipated|WellSpan Health||2|||f||||f||||||||||2017-10-10 23:25:26.918106|2017-10-10 23:25:26.918106
NCT02409563|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-04-08|||January 2014||2014-01-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis|Effectiveness of Nasal Budesonide on Control of Airway Inflammation by Determining FeNO in Children With Allergic Rhinitis.|Completed||Phase 4|39|Actual|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy||2|||f||||||||||||||2017-10-10 23:25:20.982172|2017-10-10 23:25:20.982172
NCT02409550|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-07-14|||April 2015||2015-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in Children|CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in Children|Completed||N/A|113|Actual|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||1||f||||f||||||||Yes|"The IPD collected will be available on May 2016.
The following participant data will be shared:
Asthma severity level
Asthma control level
Pulmonary function tests
Demographic characteristics All IPD will be obtained from statistical analysis on the dedicated database in which all data are stored."|2017-10-10 23:25:21.60468|2017-10-10 23:25:21.60468
NCT02409537|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2015-04-01|||March 2013||2013-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|RWTAC||Effects of Dietary Antioxidants to Prevent Cardiovascular Disease|Cardiovascular Risk and Benefits From Antioxidant Dietary Intervention With Red Wine in Asymptomatic Hypercholesterolemics|Completed||Phase 2|37|Actual|Aeromedical Center, Thessaloniki||2|||f||||t||||||||||2017-10-10 23:25:21.70673|2017-10-10 23:25:21.70673
NCT02409524|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-07-10|||July 2016||2016-07-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|July 2017|Anticipated|2017-07-01||Interventional|||An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects|Phase II Clinical Study Of An Individualized Anti-Cancer Vaccine (CRCL-ALLOVAX) in Subjects With Advanced Hepatocellular Carcinoma|Recruiting||Phase 2|30|Anticipated|Immunovative Therapies, Ltd.||1|||f||||f||||||||No||2017-10-10 23:25:21.835941|2017-10-10 23:25:21.835941
NCT02409511|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-07-24|||January 2016||2016-01-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Observational|||Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)|Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)|Recruiting||N/A|75|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||5||f||||f||||||||||2017-10-10 23:25:21.99251|2017-10-10 23:25:21.99251
NCT02409498|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-04-23|||October 2015||2015-10-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Use of Pre-Emptive Pudendal Nerve Block for Pelvic Reconstructive Surgery|A Randomized Controlled Trial of Use of Pre-emptive Pudendal Nerve Block for Pelvic Reconstructive Surgery|Withdrawn||N/A|0|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:25:22.129267|2017-10-10 23:25:22.129267
NCT02409485|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-08-24|||November 2014||2014-11-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Improving Self-Management in Head and Neck Cancer|Improving Self-Management in Head and Neck Cancer|Recruiting||N/A|60|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:25:22.244898|2017-10-10 23:25:22.244898
NCT02409472|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-08|||April 1998||1998-04-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|GILDA||Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma|A Randomized Trial Of Intensive Versus Minimal Surveillance Of Patients With Resected Dukes B2-C Colorectal Carcinoma|Completed||N/A|1242|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-10 23:25:22.364584|2017-10-10 23:25:22.364584
NCT02409446|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-05-04|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins|Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins in Older Adults at Risk for Adverse Outcomes - a Pilot Study|Recruiting||N/A|54|Anticipated|Helse Stavanger HF||2|||f||||f||||||||No||2017-10-10 23:25:22.556964|2017-10-10 23:25:22.556964
NCT02409433|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-01-05|||August 2014||2014-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Comparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management|Prospective, Randomized, Single-blinded Comparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management|Terminated||Phase 4|3|Actual|Lawson Health Research Institute||2||due to slow recruitment and budgetary restraints study was prematurely terminated|f||||f||||||||||2017-10-10 23:25:22.668836|2017-10-10 23:25:22.668836
NCT02409420|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-03-01|||November 2014||2014-11-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|PACT||A Trial of Brief Physiotherapy Informed by Acceptance and Commitment Therapy for Chronic Low Back Pain: the PACT Study|A Randomised Controlled Trial of Brief Physiotherapy Informed by Acceptance and Commitment Therapy for Chronic Low Back Pain: the PACT Study|Active, not recruiting||N/A|248|Actual|King's College London||2|||f||||t||||||||||2017-10-10 23:25:22.758435|2017-10-10 23:25:22.758435
NCT02409407|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-03|||April 2015||2015-04-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Misoprostol Before Hysteroscopy in Infertile Cases|Effectiveness of Oral Versus Vaginal Misoprostol Before Office Hyteroscopy in Infertile Patients|Unknown status|Recruiting|Phase 2|120|Anticipated|Kasr El Aini Hospital||3|||f||||||||||||||2017-10-10 23:25:22.83331|2017-10-10 23:25:22.83331
NCT02409394|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2015-04-03|||March 2014||2014-03-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy Subjects|Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy Subjects|Completed||Phase 1|12|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:25:22.915772|2017-10-10 23:25:22.915772
NCT02409004|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-31|||March 2015||2015-03-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Effects of Rifampin on the Pharmacokinetics of Ataluren|A Phase I Study Assessing the Effects of Rifampin on the Pharmacokinetics of Ataluren in Healthy Subjects|Unknown status|Not yet recruiting|Phase 1|15|Anticipated|PTC Therapeutics||1|||f||||f||||||||||2017-10-10 23:25:26.990904|2017-10-10 23:25:26.990904
NCT02409381|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2016-08-24|||June 2015||2015-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis|Clinical Trial, Multicenter, Phase IV, Open, Randomized, Parallel, Controlled, Non-inferiority, to Evaluate the Efficacy and Safety of Motore® Compared to Alivium® in the Treatment of Adults With Knee Osteoarthritis|Completed||Phase 4|288|Actual|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f||||||||||2017-10-10 23:25:22.981101|2017-10-10 23:25:22.981101
NCT02409368|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-09-14|||April 23, 2015|Actual|2015-04-23|September 2017|2017-09-01|July 30, 2021|Anticipated|2021-07-30|May 31, 2021|Anticipated|2021-05-31||Interventional|Checkmate 171||An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC|An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC|Active, not recruiting||Phase 2|800|Anticipated|Bristol-Myers Squibb||1|||f||||t||||||||||2017-10-10 23:25:23.066574|2017-10-10 23:25:23.066574
NCT02409355|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-07-03|||May 31, 2015|Actual|2015-05-31|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)|A Phase III, Open-Label, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Compared With Gemcitabine+Cisplatin or Carboplatin for PD-L1-Selected, Chemotherapy Naive Patients With Stage IV Squamous Non-Small Cell Lung Cancer|Active, not recruiting||Phase 3|8|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:25:23.458699|2017-10-10 23:25:23.458699
NCT02409342|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-01|2017-08-01|||July 20, 2015|Actual|2015-07-20|August 2017|2017-08-01|April 23, 2020|Anticipated|2020-04-23|January 17, 2019|Anticipated|2019-01-17||Interventional|||A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]|A Phase III, Open Label, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Compared With a Platinum Agent (Cisplatin or Carboplatin) in Combination With Either Pemetrexed or Gemcitabine for PD-L1-Selected, Chemotherapy-Naive Patients With Stage IV Non-Squamous Or Squamous Non-Small Cell Lung Cancer|Recruiting||Phase 3|555|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:25:23.755993|2017-10-10 23:25:23.755993
NCT02409329|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-05-15|||May 2016|Actual|2016-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes|Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes|Recruiting||N/A|500|Anticipated|Vanderbilt University Medical Center||3|||f||||t|f|f||||||Undecided||2017-10-10 23:25:24.264435|2017-10-10 23:25:24.264435
NCT02409316|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-10-03|||May 2015||2015-05-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||[18F]FES PET/CT in Endocrine Refractory Breast Cancer|[18F]Fluoroestradiol (FES) PET/CT Imaging to Evaluate in Vivo ER in Endocrine Refractory Metastatic Breast Cancer|Recruiting||Phase 2|75|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:25:24.363929|2017-10-10 23:25:24.363929
NCT02409303|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01||||June 2019|Anticipated|2019-06-01||Interventional|||An SRT Model for Early Access to ASD Intervention|A Screen-Refer-Treat (SRT) Model to Promote Earlier Access to ASD Intervention|Recruiting||N/A|||University of Washington|||||f||||f||||||||||2017-10-10 23:25:24.452206|2017-10-10 23:25:24.452206
NCT02409290|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-07-03|||April 2016||2016-04-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|April 2021|Anticipated|2021-04-01||Interventional|STREAM||The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB|STREAM: The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB|Recruiting||Phase 3|1155|Anticipated|IUATLD, Inc||4|||f||||t||||||||||2017-10-10 23:25:24.535807|2017-10-10 23:25:24.535807
NCT02409264|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-05-16|||January 2015||2015-01-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Individualised Homeopathic Treatment of Insomnia Disorder in Females|The Effect of Individualised Homeopathic Treatment of Insomnia Disorder in Females|Completed||Phase 2|10|Actual|University of Johannesburg||1|||f||||t||||||||||2017-10-10 23:25:24.848363|2017-10-10 23:25:24.848363
NCT02409251|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-31|||February 2012||2012-02-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Rheumatologists and the Requesting of Antinuclear Antibodies (ANA) Tests in Patients With Rheumatologic Complaints|Requesting Behaviour of Rheumatologists Regarding Antinuclear Antibodies (ANA) in Patients With Rheumatologic Complaints|Completed||N/A|29|Actual|Sint Maartenskliniek||1|||f||||f||||||||||2017-10-10 23:25:24.912159|2017-10-10 23:25:24.912159
NCT02409238|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-03-30|||April 2015||2015-04-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Interventional|IRMCI||Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study|Insulin Resistance and Mild Cognitive Impairment (MCI) in Older Chinese Adults With Pre-Diabetes and Diabetes: Cognitive Effects of Lifestyle Intervention and Metformin Treatment in a Randomized Controlled Trial|Recruiting||Phase 4|360|Anticipated|SingHealth Polyclinics||2|||f||||f||||||||||2017-10-10 23:25:25.096888|2017-10-10 23:25:25.096888
NCT02409225|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-07-22|||September 2014||2014-09-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|RESULT||Remote Supervision to Decrease Hospitalization Rate|Remote Supervision to Decrease Hospitalization Rate (RESULT)|Completed||N/A|600|Actual|Silesian Centre for Heart Diseases||2|||f||||f||||||||||2017-10-10 23:25:25.240811|2017-10-10 23:25:25.240811
NCT02409212|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-11-16|||May 2015||2015-05-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|PANTERA||Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer|Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer: the PANTERA Trial (Prostate cAncer Novel ThERApy)|Active, not recruiting||Phase 2|50|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:25:25.342038|2017-10-10 23:25:25.342038
NCT02409199|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-11-17|||June 2015||2015-06-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer|A Randomized, Multicenter Study To Evaluate The Efficacy And Safety Of Apatinib Versus Docetaxel In Patients With Previously Treated Locally Advanced Or Metastatic Gastric Cancer, Including Adenocarcinoma Of The Gastroesophageal Junction|Recruiting||Phase 2/Phase 3|66|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-10 23:25:25.430146|2017-10-10 23:25:25.430146
NCT02409186|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-04-19|||March 2015||2015-03-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma|A Randomized, Controlled, Double-blind Study to Evaluate Efficacy and Survival of Combining Nimotuzumab Plus Concurrent Chemo-radiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma|Recruiting||Phase 3|200|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||t||||||||||2017-10-10 23:25:25.538198|2017-10-10 23:25:25.538198
NCT02409173|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-11-27|||January 2015||2015-01-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||NPPV on Inflammatory Markers and Sleep in Severe Obese Patients With Metabolic Syndrome Undergone to Bariatric Surgery|Effects of Noninvasive Positive Pressure Ventilation on Inflammatory Markers, Sleep, Pulmonary Function and HRQoL in Severe Obese Patients With Metabolic Syndrome Undergone to Bariatric Surgery. A Randomized Controlled Clinical Trial|Enrolling by invitation||N/A|17|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 23:25:25.751589|2017-10-10 23:25:25.751589
NCT02409160|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-06-07|||March 2015||2015-03-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Sleep and Immune Response in Severe Obese Patients Undergoing Bariatric Surgery.|Sleep, Pulmonary Function, Systemic and Adipose Immune Response and Quality of Life in Severe Obese Patients Undergoing Bariatric Surgery. A Protocol of Randomized Controlled Clinical Trial|Recruiting||N/A|17|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 23:25:25.861351|2017-10-10 23:25:25.861351
NCT02409147|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01||||September 2018|Anticipated|2018-09-01||Interventional|||Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center|Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center|Not yet recruiting||N/A|5|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-10 23:25:25.985581|2017-10-10 23:25:25.985581
NCT02409134|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-10-25|||April 2015||2015-04-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat|Cognitive Function and Patient-Reported Psychological and Functional/Quality of Life Outcomes Investigation in Patients Taking Vorinostat for Graft-versus-Host Disease Prophylaxis|Recruiting||N/A|20|Anticipated|University of Michigan Cancer Center|||1||f||||t||||||||||2017-10-10 23:25:26.095078|2017-10-10 23:25:26.095078
NCT02409121|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-10-25|||September 2015||2015-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers|A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers|Recruiting||N/A|20|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:25:26.184816|2017-10-10 23:25:26.184816
NCT02409108|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-03-03|||July 2015||2015-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Perfusion-Induced Hyperthermia in Lung Cancer|An Early Feasibility Study Of Perfusion-Induced Hyperthermia For Metastatic Non-Small Cell Lung Carcinoma|Recruiting||Phase 1|10|Anticipated|University of Kentucky||1|||f||||t||||||||Undecided||2017-10-10 23:25:26.277422|2017-10-10 23:25:26.277422
NCT02409095|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-04-13|||January 2015||2015-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants|A Phase IV, Non-Inferiority, Observer Blind, Randomized Clinical Study Comparing Safety And Immunogenicity Of DTP-HB-Hib Vaccination by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Healthy Infants In India|Terminated||Phase 4|211|Actual|Serum Institute of India Pvt. Ltd.||2|||f||||f||||||||||2017-10-10 23:25:26.378366|2017-10-10 23:25:26.378366
NCT02409082|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-04-25|||September 11, 2013|Actual|2013-09-11|April 2017|2017-04-01|December 20, 2016|Actual|2016-12-20|June 22, 2015|Actual|2015-06-22||Observational|ADhipfract||Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures|The Presence of Pre-Alzheimers/Alzheimers Disease (AD) and Neuromarkers Related to Morbidity/Mortality in Patients With Acute Hip Fractures|Completed||N/A|400|Actual|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||Samples Without DNA|"     AD correlated factors like betamayloid and tau as well as interleukins   "|||2017-10-10 23:25:26.455697|2017-10-10 23:25:26.455697
NCT02409069|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-10-25|||March 2015||2015-03-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Influence of Non-invasive Neurostimulation (Transcutaneous Vagus Nerve Stimulation) on 1. the Noradrenergic Release in the Brain and 2. a Neuropsychological Memory Task||Recruiting||N/A|20|Anticipated|University Hospital, Ghent||3|||f||||t||||||||||2017-10-10 23:25:26.513105|2017-10-10 23:25:26.513105
NCT02409056|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-09-13|||November 2015||2015-11-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|WorkCDSMP||Putting CDSMP to Work|Putting CDSMP to Work: Implementation of the Live Healthy, Work Healthy Program|Recruiting||N/A|800|Anticipated|University of Georgia||3|||f||||t||||||||||2017-10-10 23:25:26.599021|2017-10-10 23:25:26.599021
NCT02409043|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-09-07|||July 2014||2014-07-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Neuronal and Glial Biomarkers in Stroke|Neuronal and Glial Biomarkers in Stroke|Completed||N/A|99|Actual|University of Florida|||4||f||||f|f|f||||Samples Without DNA|"     Serum and packed red blood cells   "|||2017-10-10 23:25:26.754034|2017-10-10 23:25:26.754034
NCT02409030|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-09-26|||January 2014||2014-01-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Observational|RH-VAL||Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease|Validation Trial for a Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease|Active, not recruiting||N/A|700|Anticipated|Raman Health Technologies, S.L.|||3||f||||f||||||Samples With DNA|"     3 tubes of blood ( 30 mL of blood in total) for further analysis of their products (plasma,     cells and DNA) in Alzheimer's research unit project CIEN Foundation would be extracted .   "|||2017-10-10 23:25:26.84523|2017-10-10 23:25:26.84523
NCT02408952|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-05-01|||October 2011||2011-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|October 2013|Actual|2013-10-01||Interventional|||Screening for Youth Alcohol and Drug Use: A Study of Primary Care Providers|Screening for Youth Alcohol and Drug Use: A Study of Primary Care Providers|Active, not recruiting||N/A|9084|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-10-10 23:25:27.290845|2017-10-10 23:25:27.290845
NCT02408939|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-03-13|||March 2015||2015-03-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Steroids and Post-resuscitation Infectious (Septic) Complications|Effect of Stress-dose Steroids on Post-resuscitation Infectious (Septic) Complications After In-hospital Cardiac Arrest. Individual Patient Data-based Re-analysis of Synthesized Prior Randomized Clinical Trial Data|Completed||N/A|191|Actual|University of Athens|||2||f||||f||||||||No||2017-10-10 23:25:27.464084|2017-10-10 23:25:27.464084
NCT02408926|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-05-26|||April 2015||2015-04-01|May 2015|2015-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand|Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand|Recruiting||Phase 4|300|Anticipated|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-10 23:25:27.568601|2017-10-10 23:25:27.568601
NCT02408913|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-07-06|||March 26, 2015||2015-03-26|April 6, 2017|2017-04-06|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|||VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults|VRC 208: Phase 1/1b Open-Label Clinical Trial to Evaluate Dose, Safety and Immunogenicity of Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine,VRC-EBOMVA079-00-VP, Administered Alone or as Boost to cAd3-Ebola Vaccines in Healthy Adults|Completed||Phase 1|64|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 23:25:27.66068|2017-10-10 23:25:27.66068
NCT02408900|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-09-15|||March 25, 2015||2015-03-25|August 3, 2015|2015-08-03|August 3, 2015|Actual|2015-08-03|August 3, 2015|Actual|2015-08-03||Observational|||Muscle Ultrasound Measures as Biomarkers of Upper Motor Neuron Function|A Pilot Study of Muscle Ultrasound Measures as Biomarkers of Upper Motor Neuron Function|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:25:27.743775|2017-10-10 23:25:27.743775
NCT02408887|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-06-30|||March 25, 2015||2015-03-25|June 20, 2017|2017-06-20|April 7, 2025|Anticipated|2025-04-07|April 7, 2025|Anticipated|2025-04-07||Interventional|||Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer|Randomized Controlled Trial of Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in Patients With Low-risk Papillary Thyroid Cancer|Recruiting||Phase 2|225|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:25:27.910384|2017-10-10 23:25:27.910384
NCT02408874|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-06-30|||March 25, 2015||2015-03-25|March 16, 2017|2017-03-16|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Inhaled Nanosilver Study|Study to Assess the Impact of Inhaled Silver Nanoparticles on Lung Cell Immune Response|Not yet recruiting||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:25:28.020137|2017-10-10 23:25:28.020137
NCT02408861|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-03|2017-09-04|||August 27, 2015|Actual|2015-08-27|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV-Associated Solid Tumors With Expansion Cohorts in HIV-Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin Lymphoma|Recruiting||Phase 1|84|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:25:28.108986|2017-10-10 23:25:28.108986
NCT02408848|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-04-26|||March 2015||2015-03-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||The Value of Three Dimensional Echocardiography in Congenital Cardiac Surgery|Three Dimensional Echocardiography in Congenital Cardiac Surgery|Recruiting||N/A|300|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||||||||||||2017-10-10 23:25:28.329015|2017-10-10 23:25:28.329015
NCT02408835|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-04-03|||July 2015||2015-07-01|April 2015|2015-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Negative Pressure Wound Therapy in Groin Dissection|A Randomised Controlled Trial Comparing PICO™ Single Use Negative Pressure Wound Therapy System (Smith & Nephew Healthcare Limited, UK) to Conventional Wound Care Following Inguinal Lymphadenectomy for Metastatic Cutaneous Malignancy|Not yet recruiting||N/A|22|Anticipated|South Eastern Health and Social Care Trust||2|||f||||f||||||||||2017-10-10 23:25:28.405542|2017-10-10 23:25:28.405542
NCT02408822|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-03-31|||July 2015||2015-07-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|B3AV||Drug-Eluting Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis (DEBAVAS)|Superiority of Drug-eluting Balloon Angioplasty Versus Plain Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis : a Multicentre, Randomized, Controlled Trial|Not yet recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 23:25:28.501447|2017-10-10 23:25:28.501447
NCT02408809|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-06-11|||March 2015||2015-03-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Impact of Orthopaedic Smoking Cessation Education on Cigarette Abstinence Self-Efficacy: A Randomized Controlled Trial||Completed||N/A|60|Actual|University of Missouri, Kansas City||2|||f||||t||||||||||2017-10-10 23:25:28.631402|2017-10-10 23:25:28.631402
NCT02408796|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-06-17|||March 2015||2015-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Open-Label Study of OTO-201 for Treatment of AOMT|A 1-Month, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Supra-Tympanostomy Tube Administration for Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Subjects|Completed||Phase 2|39|Actual|Otonomy, Inc.||1|||f||||f||||||||||2017-10-10 23:25:28.70253|2017-10-10 23:25:28.70253
NCT02408783|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-11-28|||July 2015||2015-07-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|SGAS||Simplified Gestational Age Score|Validation of a New Simplified Score for Assessing Gestational Age of Newborns in Community|Completed||N/A|15920|Actual|NICHD Global Network for Women's and Children's Health|||1||f||||t||||||||||2017-10-10 23:25:28.786026|2017-10-10 23:25:28.786026
NCT02408770|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-10-26|||September 2015||2015-09-01|October 2015|2015-10-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|BC-APPS1||Breast Cancer - Anti-Progestin Prevention Study 1|A Pilot Prevention Study of the Effects of the Anti-progestin Ulipristal Acetate (UA) on Surrogate Markers of Breast Cancer Risk|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|University Hospital of South Manchester NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:25:28.854177|2017-10-10 23:25:28.854177
NCT02408757|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-06-07|||September 2015||2015-09-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Observational|||Sonographic Monitoring of Weaning of Cerebrospinal Fluid Drainages|Multimodal Sonographic Monitoring of Cerebral Perfusion, Ventricle Seize and Optic Nerve Diameter During Weaning of Cerebrospinal Fluid Drainage Catheters: a Single Centre Observational Trial|Recruiting||N/A|90|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 23:25:28.928806|2017-10-10 23:25:28.928806
NCT02408744|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-02|||September 2009||2009-09-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2010|Actual|2010-09-01||Interventional|||Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease|Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease|Completed||Phase 1/Phase 2|30|Actual|University of Guadalajara||1|||f||||t||||||||||2017-10-10 23:25:29.043639|2017-10-10 23:25:29.043639
NCT02408731|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-04-26|||October 2014||2014-10-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled Phase I Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of PMZ-2010 (Centhaquin) in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Pharmazz, Inc.||6|||f||||t||||||||||2017-10-10 23:25:29.119313|2017-10-10 23:25:29.119313
NCT02408718|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-09-20|||July 2015||2015-07-01|April 2016|2016-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ADT||Assistive Device Training in Multiple Sclerosis|Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis|Completed||N/A|40|Actual|Portland VA Medical Center||2|||f||||f||||||||||2017-10-10 23:25:29.206936|2017-10-10 23:25:29.206936
NCT02408705|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-09-09|||January 2015||2015-01-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects|A Randomized, Double Blind, Two-period Cross-over Trial Investigating the Effect of Liraglutide as Add on to Intensive Insulin Treatment on the Endogenous Glucose Production in Subjects With C-peptide Positive Type 1 Diabetes Mellitus|Completed||Phase 2|14|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-10 23:25:29.29344|2017-10-10 23:25:29.29344
NCT02408692|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-04-29|2017-04-29||February 2015||2015-02-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Emergency Contraception and Body Weight: Pilot Study|Emergency Contraception and Body Weight: Pilot Study|Completed||Phase 4|10|Actual|Oregon Health and Science University||3|||f||||t||||||||Yes|PI acknowledges willingness to share data and materials with other investigators through established means. Data will be presented via presentation and publication. Transfer of resources is subject to the acceptance of a Materials Transfer Agreement as required by policy at OHSU. OHSU complies with NIH policy on Sharing Research Data.|2017-10-10 23:25:29.447838|2017-10-10 23:25:29.447838
NCT02408679|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-03-31|||January 2015||2015-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Predictive Questionnaire for Vitamin D Insufficiency in Healthy Adults|A Study to Validate a Predictive Questionnaire for Vitamin D Insufficiency in Healthy Adults|Completed||N/A|300|Actual|Lesieur|||1||f||||f||||||||||2017-10-10 23:25:29.757347|2017-10-10 23:25:29.757347
NCT02408666|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-12-07|||April 2014||2014-04-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||EEG@HOME (Phase 1 of the Project)||Completed||N/A|20|Actual|University Hospital, Ghent||1|||f||||t||||||||||2017-10-10 23:25:29.848966|2017-10-10 23:25:29.848966
NCT02408653|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-02|||April 2014||2014-04-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||EEG@HOME (Phase 2 of the Project)||Completed||N/A|4|Actual|University Hospital, Ghent||3|||f||||t||||||||||2017-10-10 23:25:29.929139|2017-10-10 23:25:29.929139
NCT02408640|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-08-30|||April 2015||2015-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Internet-Based Treatment for Individuals With Regular Cannabis Use: A Randomized Controlled Trial|Internet-Based Treatment for Individuals With Regular Cannabis Use: A Randomized Controlled Trial|Recruiting||N/A|352|Anticipated|Karolinska Institutet||2|||f||||||||||||||2017-10-10 23:25:30.00766|2017-10-10 23:25:30.00766
NCT02408627|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-12-07|||January 2015||2015-01-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||EEG@HOME (Phase 3a of the Project, Comparison of EEG-recordings)||Enrolling by invitation||N/A|5|Anticipated|University Hospital, Ghent||3|||f||||t||||||||||2017-10-10 23:25:30.120945|2017-10-10 23:25:30.120945
NCT02408614|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-12-13|||June 2015||2015-06-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Acute Effect of Exercise on Vascular Function|Acute Effect of Exercise on Vascular Function|Recruiting||N/A|200|Anticipated|University of Florida|||3||f||||f||||||||||2017-10-10 23:25:30.211127|2017-10-10 23:25:30.211127
NCT02408601|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-03-07|||March 2015||2015-03-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||A Clinical Trial to Assess the Retention and Caries Preventive Effect of Resin Based Sealants Versus ART Sealants||Active, not recruiting||Phase 2|180|Actual|Kamineni Institute of Dental Sciences||2|||f||||f||||||||||2017-10-10 23:25:30.295459|2017-10-10 23:25:30.295459
NCT02408588|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-12-01|||February 2015||2015-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Evaluation of Compensatory Reserve in Obstetrical Patients|Evaluation of Compensatory Reserve in Obstetrical Patients|Enrolling by invitation||N/A|200|Anticipated|University of Colorado, Denver|||4||f||||f||||||||||2017-10-10 23:25:30.387124|2017-10-10 23:25:30.387124
NCT02408575|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-10-25|||February 2015||2015-02-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|NoA-Tin||"Hearing Aids With Notched Amplification for the Treatment of Chronic Tinnitus"|"Hearing Aids With Notched Amplification for the Treatment of Chronic Tinnitus - A Controlled Randomized Pilot Study on Safety, Tolerability and Clinical Performance"|Completed||N/A|44|Actual|University of Regensburg||2|||f||||t||||||||||2017-10-10 23:25:30.483423|2017-10-10 23:25:30.483423
NCT02408562|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-01-26|||January 2015||2015-01-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD|A Phase 1, Multicentre, Randomised, Double-blind Study to Assess Safety and Tolerability of Repeated Intracerebroventricular Administration of sNN0031 Infusion Solution to Patients With Parkinson's Disease|Terminated||Phase 1/Phase 2|1|Actual|Newron Sweden AB||2||"Issues with development and supply of infusion system for delivery of IMP. Prolonged approval   process for the clinical study sNN0031-004."|f||||t||||||||||2017-10-10 23:25:30.597139|2017-10-10 23:25:30.597139
NCT02408549|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-09-28|||May 2015||2015-05-01|September 2017|2017-09-01|August 2023|Anticipated|2023-08-01|July 2023|Anticipated|2023-07-01||Interventional|VALUE||Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic Clonic Seizures|An Open-label, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy|Enrolling by invitation||Phase 3|200|Anticipated|UCB Pharma||1|||f||||f||||||||||2017-10-10 23:25:30.704418|2017-10-10 23:25:30.704418
NCT02408536|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-07-14|||October 2014||2014-10-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|MITO 22||Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer|Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer|Recruiting||N/A|150|Anticipated|National Cancer Institute, Naples|||1||f||||f||||||Samples With DNA|"     Archival tissue tumor samples in paraffin blocks for evaluation of diagnosis and biomarkers   "|||2017-10-10 23:25:31.246636|2017-10-10 23:25:31.246636
NCT02408523|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-09-28|||April 2015||2015-04-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|VALOR||A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications|A Double-blind, Randomized, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy|Recruiting||Phase 3|200|Anticipated|UCB Pharma||2|||f||||t||||||||||2017-10-10 23:25:31.374251|2017-10-10 23:25:31.374251
NCT02408510|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-18|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Pilot Project to Examine the Effects of Exercise on Nocturnal Lipolysis in Men and Women||Recruiting||N/A|10|Anticipated|University of Colorado, Denver|||1||f||||t||||||||||2017-10-10 23:25:31.964691|2017-10-10 23:25:31.964691
NCT02408497|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-08-01|||April 2015||2015-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy|Evaluation of the Use of Non-invasive 4D Ultrasound Clarity System in Real-time Tracking of the Target Volume in Prostate IMRT/RapidArc Therapy|Active, not recruiting||N/A|60|Anticipated|National Cancer Centre, Singapore|||1||f||||f||||||||||2017-10-10 23:25:32.053124|2017-10-10 23:25:32.053124
NCT02408484|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-05-04|||December 2015||2015-12-01|May 2016|2016-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency|Prospective, Open-label, Uncontrolled, Phase III Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery in Paediatric Subjects With Congenital Fibrinogen Deficiency|Recruiting||Phase 3|6|Anticipated|Octapharma||1|||f||||t||||||||No||2017-10-10 23:25:32.143096|2017-10-10 23:25:32.143096
NCT02408471|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-07|||February 2002|Actual|2002-02-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2015|Actual|2015-01-01||Interventional|MCP||Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis|Post-Approval Study Protocol; Ascension® MCP Finger Implant; PyroCarbon Metacarpophalangeal Total Joint Prosthesis|Terminated||N/A|96|Actual|Integra LifeSciences Corporation||1||Business Priorities|f||||t||||||||||2017-10-10 23:25:32.277433|2017-10-10 23:25:32.277433
NCT02408458|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-10-02|||June 2015||2015-06-01|October 2017|2017-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MIROMESH PM-1||Miromatrix Biological Mesh for Ventral Hernia Repair|A Prospective Post-Market Clinical Evaluation of Miromatrix Biological Mesh for Ventral Hernia Repair|Withdrawn||N/A|0|Actual|Miromatrix Medical Inc.||1||enrollment rate|f||||f||||||||||2017-10-10 23:25:32.414826|2017-10-10 23:25:32.414826
NCT02408432|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-09-25|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|||Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy|Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy|Recruiting||Phase 1|45|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 23:25:32.654708|2017-10-10 23:25:32.654708
NCT02408419|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-09-11|||March 2015||2015-03-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|OPAD||Obturator Nerve Block in Patients With Hip Fracture|Proximal Obturator Nerve Block After Insufficient Analgesic Effect of Femoral Nerve Block in Patients With Hip Fracture|Withdrawn||Phase 4|0|Actual|University of Aarhus||2||The study was completely redesigned|f||||t||||||||||2017-10-10 23:25:32.759982|2017-10-10 23:25:32.759982
NCT02408406|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-09-15|||July 2015||2015-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers|PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum|Recruiting||N/A|516|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-10 23:25:32.858915|2017-10-10 23:25:32.858915
NCT02408393|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-03-22|||March 2015||2015-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|MIRs03||MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery|MIRs03: A Double-blind Randomized Trial of Paravertebral Block With Ropivacaine Before Breast Cancer Surgery: Effects on Chronic Postoperative Pain|Recruiting||Phase 3|380|Anticipated|Institut Curie||2|||f||||f||||||||Undecided||2017-10-10 23:25:32.974527|2017-10-10 23:25:32.974527
NCT02408380|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-04-02|||September 2014||2014-09-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|MS||Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)|Analysis of a Biomarker Signature, Consisting of Toll-like Receptor 2 (TLR2), TLR4 and CCR1, by Flow Cytometry in Patients With MS Treated With Gilenya (FTY720)|Unknown status|Recruiting|N/A|216|Anticipated|McGill University|||1||f||||f||||||Samples Without DNA|"     Cryopreserved peripheral blood mononuclear cells.   "|||2017-10-10 23:25:33.114538|2017-10-10 23:25:33.114538
NCT02408354|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-03-06|||March 2015||2015-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|HEMIHEP||Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood|"Etude Pilote, Comparative, Monocentrique, randomisée, en Cross Over, en Double Aveugle, Contre Placebo, Testant l'efficacité de l'Huile triheptanoïne Dans Les Hémiplégies Alternantes de l'Enfant HEMIHEP"|Active, not recruiting||Phase 2|10|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-10 23:25:33.302851|2017-10-10 23:25:33.302851
NCT02408341|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-03-31|||March 2012||2012-03-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Propofol Induction's Effect on Cardiac Function|Effect of Intravenous Propofol Anesthesia Induction on Cardiac Function|Completed||N/A|19|Actual|Konkuk University Medical Center|||1||f||||f||||||||||2017-10-10 23:25:33.422144|2017-10-10 23:25:33.422144
NCT02408328|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-07-25|||January 2017||2017-01-01|July 2016|2016-07-01|April 2019|Anticipated|2019-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Management of Apnea in Late Preterm and Term Infants|Management of Apnea in Late Preterm and Term Infants|Not yet recruiting||Phase 2|150|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-10 23:25:33.484633|2017-10-10 23:25:33.484633
NCT02408315|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-08-21|||September 2015||2015-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|IMPROVE||Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)|Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium|Recruiting||Phase 3|300|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 23:25:33.557827|2017-10-10 23:25:33.557827
NCT02408302|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-04-08|||April 2015||2015-04-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||Buccal Midazolam Versus Nasal or Oral Midazolam Sedation for Minor Invasive Procedures in Children|Buccal Midazolam Versus Nasal or Oral Midazolam Sedation for Minor Invasive Procedures in Children: A Prospective Randomized Control Study|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Carmel Medical Center||3|||f||||f||||||||||2017-10-10 23:25:33.667726|2017-10-10 23:25:33.667726
NCT02408289|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-01-12|||March 2015||2015-03-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Randomized Controlled Cocoa-Appetite Trial|A Pilot Randomized Human Trial on The Effects of Cocoa on Appetite.|Completed||N/A|28|Actual|Brooklyn College of the City University of New York||4|||f||||f||||||||||2017-10-10 23:25:33.76197|2017-10-10 23:25:33.76197
NCT02408276|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-03-15|||December 2014||2014-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Longitudinal Evaluation of Hip Cartilage Degeneration: FAI|Longitudinal Evaluation of Hip Cartilage Degeneration: the Effect of Femoroacetabular Impingement|Recruiting||N/A|130|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-10 23:25:33.829502|2017-10-10 23:25:33.829502
NCT02408250|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-04-02|||April 2015||2015-04-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Tolerance of Early Exercise in Intensive Care Unit|Tolerance of Early Exercise in Intensive Care Unit|Unknown status|Not yet recruiting|N/A|30|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:25:33.991177|2017-10-10 23:25:33.991177
NCT02408237|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-03-27|||March 28, 2017|Actual|2017-03-28|March 2017|2017-03-01|October 17, 2017|Anticipated|2017-10-17|August 31, 2017|Anticipated|2017-08-31||Interventional|||Transcranial Direct Current Stimulation Apparatus for Domiciliary Use|Development of Apparatus of Transcranial Direct Current Stimulation (tDCS) for Domiciliary Use|Recruiting||N/A|15|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f|f|f||||||No||2017-10-10 23:25:34.07778|2017-10-10 23:25:34.07778
NCT02408224|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-07-10|||April 27, 2015|Actual|2015-04-27|July 2017|2017-07-01|June 24, 2017|Actual|2017-06-24|June 24, 2017|Actual|2017-06-24||Observational|TREASURE||An Observational Prospective Study to Understand the Usage Pattern of Ticagrelor With ACS (Acute Coronary Syndrome)|A Non-interventional Prospective Observational Study to Understand the Usage Pattern of Ticagrelor in Indian Patients With Acute Coronary Syndrome.|Completed||N/A|3000|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:25:34.174703|2017-10-10 23:25:34.174703
NCT02408198|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-03-16|||February 2015||2015-02-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||The Street Smart Group: A Feasibility Trial of a Group Intervention Targeting Anxiety Processes in Paranoia|The Street Smart Group: A Feasibility Trial of a Group Intervention Targeting Anxiety Processes in Paranoia|Completed||Phase 2|18|Actual|King's College London||2|||f||||f||||||||||2017-10-10 23:25:34.280174|2017-10-10 23:25:34.280174
NCT02408185|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-02-02|||October 2011||2011-10-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|COLPHAR||Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients|Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients With Severe Infections for Dose Optimization Study|Completed||Phase 1|20|Actual|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f||||||||No||2017-10-10 23:25:34.346073|2017-10-10 23:25:34.346073
NCT02408172|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-02-13|||October 2013||2013-10-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome|The Study Was Approved by the Ethics Committee of Our Institution, Which is Accredited by the Office of Human Research Protection as an Institutional Review Board|Recruiting||Phase 2/Phase 3|20|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||||2017-10-10 23:25:34.431263|2017-10-10 23:25:34.431263
NCT02408159|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-06-29|||June 2016||2016-06-01|August 2016|2016-08-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy|A Double Blind Placebo-controlled Randomized Study of Varicella Zoster Vaccine in Patients With Moderate-to-severe Plaque Psoriasis Who Are Candidates for Biologic Therapy|Terminated||Phase 4|3|Actual|Innovaderm Research Inc.||2||Recruitment difficulties|f||||f||||||||||2017-10-10 23:25:34.509796|2017-10-10 23:25:34.509796
NCT02408146|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-04-02|||January 2014||2014-01-01|March 2014|2014-03-01||||July 2015|Anticipated|2015-07-01||Interventional|||The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection||Unknown status|Recruiting|N/A|80|Anticipated|First Affiliated Hospital of Harbin Medical University||3|||f||||||||||||||2017-10-10 23:25:36.263071|2017-10-10 23:25:36.263071
NCT02408133|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-09-28|||February 2016||2016-02-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effectiveness of Home-based Exercise in Quality of Life and Physical Fitness in Older Woman in Breast Cancer Treatment|Effectiveness of Home-based Exercise in Quality of Life and Physical Fitness in Older Woman in Breast Cancer Treatment: Randomized Clinical Trial|Completed||N/A|75|Actual|Professor Fernando Figueira Integral Medicine Institute||2|||f||||f||||||||||2017-10-10 23:25:36.358132|2017-10-10 23:25:36.358132
NCT02408120|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-10-20|||October 2015||2015-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes|Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes Treated With Basal Bolus Insulin Regimen|Recruiting||Phase 4|250|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 23:25:36.44401|2017-10-10 23:25:36.44401
NCT02408107|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-12|||January 2010||2010-01-01|April 2015|2015-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|PHAB||A Home-based Physical Activity Intervention in Breast Cancer Survivors|Randomised Controlled Trial of a Home-based Physical Activity Intervention in Breast Cancer Survivors|Completed||Phase 3|80|Actual|Dudley Group NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:25:36.55591|2017-10-10 23:25:36.55591
NCT02408094|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-04-22|||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Observational|||Screening Protein Markers in Patients With Rheumatoid Arthritis and Hot-dampness and Blood Stasis Syndrome|Screening Sensitive Protein Markers and Exploring Application in Syndrome Diagnosis of Hot-dampness and Blood Stasis Syndrome in Patients With Rheumatoid Arthritis|Recruiting||N/A|90|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|||1||f||||t||||||||Undecided||2017-10-10 23:25:36.647037|2017-10-10 23:25:36.647037
NCT02408081|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-11-30|||April 2015||2015-04-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|||Family Focused Nursing for Elderly Medical Patients|Family-Focused Nursing for Elderly Medical Patients and Their Family: A Randomized Controlled Trial|Suspended||N/A|212|Anticipated|University of Southern Denmark||2||not able to be completed|f||||f||||||||||2017-10-10 23:25:36.721213|2017-10-10 23:25:36.721213
NCT02408055|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-09-30|||June 2015||2015-06-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||ADME Study in Healthy Male Subjects With TA-8995|A Phase I Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolism and Excretion of 14C-TA-8995 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Xention Ltd||1|||f||||f||||||||||2017-10-10 23:25:36.905244|2017-10-10 23:25:36.905244
NCT02408042|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-06-23|||April 2015||2015-04-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)|A Phase Ib/II Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)|Withdrawn||Phase 1/Phase 2|0|Actual|Western Regional Medical Center||3|||f||||f||||||||||2017-10-10 23:25:36.974736|2017-10-10 23:25:36.974736
NCT02408029|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-01-26|||March 2015||2015-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Trauma Equivalency Study of the CORA® and TEG® 5000 Systems|Trauma Equivalency Study of the CORA® and TEG® 5000 Systems|Completed||N/A|325|Actual|Coramed Technologies LLC|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:25:37.225443|2017-10-10 23:25:37.225443
NCT02408016|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-08-22|||May 20, 2015|Actual|2015-05-20|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma|Phase I/II Study in WT1-Expressing Non-small Cell Lung Cancer and Mesothelioma, Comparing Cellular Adoptive Immunotherapy With Polyclonal Autologous Central Memory to Naïve CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T-Cell Receptor|Active, not recruiting||Phase 1/Phase 2|9|Actual|Fred Hutchinson Cancer Research Center||3|||f||||t||||||||||2017-10-10 23:25:37.332641|2017-10-10 23:25:37.332641
NCT02408003|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-05-08|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||Changes in Cardiac Deformation Following Physiologic Alterations and Inotropic Support.|What Are the Changes in Cardiac Deformation Variables and Hemodynamic Parameters Following Changes in Cardiac Loading Conditions and After Administration of Two Different Inotropic Drugs.|Completed||N/A|30|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||No||2017-10-10 23:25:37.477263|2017-10-10 23:25:37.477263
NCT02407990|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-02-21|||June 2015||2015-06-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Subjects With Advanced Tumors|A Phase 1A/1B, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics and Antitumor Activities of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Subjects With Advanced Tumors|Recruiting||Phase 1|450|Anticipated|BeiGene||1|||f||||f||||||||||2017-10-10 23:25:37.583692|2017-10-10 23:25:37.583692
NCT02407977|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-07-07|||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation Therapy|Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation Therapy|Recruiting||N/A|30|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 23:25:37.747999|2017-10-10 23:25:37.747999
NCT02407964|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Observational|DILI-R||A Retrospective Study on Drug Induced Liver Injury in China|A Retrospective Epidemiologic Study on Incidence and Treatment Status of Hospitalized Drug Induced Liver Injury Patients in Mainland China|Completed||N/A|15000|Actual|Drug Induced Liver Disease Study Group|||1||f||||f||||||||No||2017-10-10 23:25:37.863738|2017-10-10 23:25:37.863738
NCT02407951|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-03-31|||April 2015||2015-04-01|March 2015|2015-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Group Intervention for Children With Chronic Tics Syndrome or Tourette Syndrome: CBIT vs Psycho-Educational Intervention|Tel Aviv Sourasky Medical Center|Not yet recruiting||N/A|96|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:25:38.755152|2017-10-10 23:25:38.755152
NCT02407938|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-12-10|||January 2014||2014-01-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Rice||Normal Values for Esophageal High Resolution Manometry in an Advanced Protocol Including Liquid Swallows and a Solid Test Meal|Normal Values for Esophageal High Resolution Manometry in an Advanced Protocol Using a Test Meal|Completed||N/A|73|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 23:25:38.834082|2017-10-10 23:25:38.834082
NCT02407925|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-01-24|||January 1, 2015||2015-01-01|January 2017|2017-01-01|July 31, 2017|Anticipated|2017-07-31|January 31, 2017|Anticipated|2017-01-31||Observational|DISCOUNT2||Implementation of Optical Diagnosis for Diminutive Polyps Amongst Endoscopists: Training and Long-term Quality Assurance|Implementation of Optical Diagnosis for Diminutive Polyps Amongst Accredited Endoscopists for the Dutch Bowel Cancer Screening Program: Training and Long-term Quality Assurance|Active, not recruiting||N/A|1500|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||3||f||||t||||||||||2017-10-10 23:25:38.916246|2017-10-10 23:25:38.916246
NCT02407912|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2015-11-18|||March 2015||2015-03-01|November 2015|2015-11-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer|Intrapleural Hypertonic Cisplatin Treatment for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer.|Recruiting||N/A|50|Anticipated|Shantou University Medical College||2|||f||||t||||||||||2017-10-10 23:25:39.034602|2017-10-10 23:25:39.034602
NCT02407899|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-05-04|||March 2015||2015-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes|A Randomized Controlled, Open-label, Multi-center Study With 104-week Fixed Dose of Saxagliptin or (and) Vitamin D3 Assessing Protective Effects on Beta Cell Function in Latent Autoimmune Diabetes in Adults (LADA) Treated With Insulin|Recruiting||Phase 4|300|Anticipated|Second Xiangya Hospital of Central South University||3|||f||||f||||||||||2017-10-10 23:25:39.116824|2017-10-10 23:25:39.116824
NCT02407886|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-05-24|||March 2015||2015-03-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Observational|||Retinal Ganglion Cell Layer in Patients With Intracerebral Processes||Completed||N/A|20|Actual|University of Zurich|||1||f||||f||||||||||2017-10-10 23:25:39.221096|2017-10-10 23:25:39.221096
NCT02407873|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-10-29|||February 2014||2014-02-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01|30 Days|Observational [Patient Registry]|||Prognostic Impact of Frailty Assessed by Edmondon in Elderly Patient Undergoing Cardiac Surgery|Prognostic Impact of Frailty Assessed by Edmondon in Elderly Patient Undergoing Cardiac Surgery|Unknown status|Recruiting|N/A|250|Anticipated|University Hospital of Liege|||1||f||||f||||||||||2017-10-10 23:25:39.276556|2017-10-10 23:25:39.276556
NCT02407860|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-12-21|||December 2014||2014-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of an Osteopathic Treatment for Mechanical Sucking Dysfunctions in Newborn|Efficacy of an Osteopathic Treatment for Mechanical Sucking Dysfunctions in Newborn|Completed||N/A|98|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-10 23:25:39.351031|2017-10-10 23:25:39.351031
NCT02407847|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-04-06|||May 2014||2014-05-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Effect of Substitution of Out-of-hours Care From General Practitioners to Nurse Practitioners|The (Cost-)Effectiveness of Substitution in Out-of-hours Primary Care; Towards an Optimal Balance Between General Practitioners and Nurse Practitioners.|Completed||N/A|9647|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 23:25:39.433595|2017-10-10 23:25:39.433595
NCT02407834|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-04-02|||August 2012||2012-08-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Effectiveness of Hygiene Solutions on Denture Biofilm|Clinical Evaluation of an Experimental Solution Based on Ricinus Communis Compared to Sodium Hypochlorite for Denture Cleansing|Completed||Phase 4|64|Actual|University of Sao Paulo||4|||f||||t||||||||||2017-10-10 23:25:39.514802|2017-10-10 23:25:39.514802
NCT02407626|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-11-14|||September 2015||2015-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|OPT||Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery|Optimierung Der Kardioprotektion Durch Inhalative Anästhetika Eine Untersuchung Bei Patienten Mit Diabetes Mellitus während Off-pump Herzchirurgie|Recruiting||N/A|24|Anticipated|Triemli Hospital||2|||f||||f||||||||No||2017-10-10 23:25:41.406232|2017-10-10 23:25:41.406232
NCT02407821|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-08-24|||March 2015||2015-03-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|RoSIE||The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)|A Pilot Study to Evaluate the Feasibility and Safety of Performing a Double Blind, Placebo-controlled, Randomized Controlled Trial of the Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:25:39.607842|2017-10-10 23:25:39.607842
NCT02407808|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-02-22|||February 2015||2015-02-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|THC-Memory||Cannabinoids, Learning, and Memory|Cannabinoids, Learning, and Memory|Recruiting||Phase 1|80|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 23:25:39.704404|2017-10-10 23:25:39.704404
NCT02407795|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-03-30|||May 2015||2015-05-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|RACOST||Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases|A RAndomized Trial Comparing COnventional With STereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases (RACOST-trial)|Recruiting||Phase 3|386|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-10 23:25:39.910507|2017-10-10 23:25:39.910507
NCT02407782|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-06-03|||January 2016||2016-01-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SCRATCH||Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children|Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children: a Cluster Multicenter Randomized Trial|Recruiting||Phase 3|502|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 23:25:40.054832|2017-10-10 23:25:40.054832
NCT02407769|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-04-02|||February 2014||2014-02-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Late Evening Supplementation With Branched Chain Amino Acids in Liver Transplantation|Effect of a Late Evening Supplementation With Branched Chain Amino Acids on the Nutritional Status in Patients on the Waiting List for Liver Transplantation|Recruiting||N/A|38|Anticipated|Universidad de Guanajuato||2|||f||||t||||||||||2017-10-10 23:25:40.274829|2017-10-10 23:25:40.274829
NCT02407756|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2016-08-19|||March 2015||2015-03-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)|A Phase 2a Study Investigating the Safety, Pharmacokinetics, Immunogenicity, and Exploratory Efficacy of Dupilumab in Patients Aged ≥6 to <18 Years With Atopic Dermatitis|Completed||Phase 2|78|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:25:40.384849|2017-10-10 23:25:40.384849
NCT02407743|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-12-12|||August 2015||2015-08-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|TEMPOS||TEMporal PostOperative Pain Signatures|Finding Good TEMporal PostOperative Pain Signatures (TEMPOS)|Recruiting||N/A|500|Anticipated|University of Florida|||1||f||||f||||||||No||2017-10-10 23:25:40.520406|2017-10-10 23:25:40.520406
NCT02407730|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-12-02|||January 2015||2015-01-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Observational|||EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies|EFFects of Thrombophilia on the Outcomes of Assisted Reproduction|Recruiting||N/A|715|Anticipated|G. d'Annunzio University|||1||f||||f||||||||||2017-10-10 23:25:40.619383|2017-10-10 23:25:40.619383
NCT02407717|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-12-02|||January 2015||2015-01-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer|Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer|Recruiting||N/A|715|Anticipated|G. d'Annunzio University|||1||f||||f||||||||||2017-10-10 23:25:40.693402|2017-10-10 23:25:40.693402
NCT02407704|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-12-08|||March 2015||2015-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|MEDEX||A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise|A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise|Completed||N/A|31|Actual|University of Pittsburgh||2|||f||||f||||||||No||2017-10-10 23:25:40.782415|2017-10-10 23:25:40.782415
NCT02407691|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-02-08|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|COBALT||Collaborative Care for the Detection and Management of Depression Among Adults Receiving Antiretroviral Therapy in South Africa|Collaborative Care for the Detection and Management of Depression Among Adults Receiving Antiretroviral Therapy in South Africa: a Pragmatic Cluster Randomized Controlled Trial|Recruiting||N/A|2000|Anticipated|University of Cape Town||2|||f||||t||||||||||2017-10-10 23:25:40.918301|2017-10-10 23:25:40.918301
NCT02407678|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-05-02|||August 2016||2016-08-01|May 2017|2017-05-01||||August 2018|Anticipated|2018-08-01||Interventional|REGENERATE||REP1 Gene Replacement Therapy for Choroideremia|An Open Label Phase 2 Clinical Trial of Retinal Gene Therapy for Choroideremia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1)|Recruiting||Phase 2|30|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 23:25:41.045258|2017-10-10 23:25:41.045258
NCT02407665|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-02-09|||March 2015||2015-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|fMRI/FMEX||Tai Chi Intervention and Brain Imaging Study Among Fibromyalgia Patients and Healthy Controls|A Pilot fMRI Study of Fibromyalgia: Tai Chi Intervention|Completed||N/A|55|Actual|Tufts Medical Center||2|||f||||f||||||||No||2017-10-10 23:25:41.139208|2017-10-10 23:25:41.139208
NCT02407652|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-12-16|||December 2014||2014-12-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Cognitive Control Training for Remitted Depressed Patients|Cognitive Control Training as a Preventive Intervention for Depression: A Double-blind Randomized Controlled Trial Study|Completed||N/A|68|Actual|University Ghent||2|||f||||f||||||||||2017-10-10 23:25:41.241748|2017-10-10 23:25:41.241748
NCT02407639|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-12-12|||March 2015||2015-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Insufflation in Children Undergoing Colonoscopy|Randomized, Double-blind Trial of CO2 vs. Air Insufflation in Children Undergoing Colonoscopy|Completed||Phase 4|78|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-10 23:25:41.32144|2017-10-10 23:25:41.32144
NCT02407613|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-05-11|||March 2015||2015-03-01|May 2016|2016-05-01||||February 2016|Anticipated|2016-02-01||Interventional|||Efficacy of MR-HIFU Ablation of Breast Cancer|Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|UMC Utrecht||1||Patient recruitment was not feasible.|f||||f||||||||||2017-10-10 23:25:41.532797|2017-10-10 23:25:41.532797
NCT02407600|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-04-02|||April 2015||2015-04-01|March 2015|2015-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy|Phase II, Double-blind, Placebo-controlled, Crossover Study Evaluating a 5HT3 Antagonist Plus Dexamethasone With or Without Fosaprepitant in Patients With Advanced NSCLC Receiving Carboplatin Based Chemotherapy|Not yet recruiting||Phase 2|150|Anticipated|State University of New York - Upstate Medical University||2|||f||||f||||||||||2017-10-10 23:25:41.648225|2017-10-10 23:25:41.648225
NCT02407587|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-04-02|||May 2013||2013-05-01|March 2015|2015-03-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Neuroplastic Changes Seen in Cochlear Implants With Preserved Hearing|Cortical Activity in Subjects With Unilateral Cochlear Implants and Preserved Ipsilateral Residual Hearing and the Evolution of Temporal Cortex Changes in New Recipients of Cochlear Implants.|Unknown status|Recruiting|N/A|20|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:25:41.774991|2017-10-10 23:25:41.774991
NCT02407574|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-30|||May 2015||2015-05-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Assessment of the Force Frequency Relationship of the Myocardium After On-pump CABG Surgery||Unknown status|Not yet recruiting|N/A|20|Anticipated|University Hospital of Liege||2|||f||||t||||||||||2017-10-10 23:25:41.873881|2017-10-10 23:25:41.873881
NCT02407561|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-07-29|||February 2015||2015-02-01|July 2016|2016-07-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01||Observational|||Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays|Prospective Validation Study Under CLIA-compliant SOPs for the Proprietary Rectal and Anal Cancer Protein Expression Assays|Terminated||N/A|3|Actual|Castle Biosciences Incorporated|||1|Futility - unable to secure sites and samples for participation|f||||f||||||Samples With DNA|"     Formalin Fixed Paraffin Embedded (FFPE) H&E stained tumor samples(biopsy and resection) cDNA-     tumor sample IHC Stained FFPE- tumor samples   "|||2017-10-10 23:25:41.940536|2017-10-10 23:25:41.940536
NCT02407548|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-06-21|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|TEDSCD||The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia|The Effects of Dietary Supplement of Coenzyme Q10 on Dyslipidemia|Completed||Phase 3|150|Actual|Sun Yat-sen University||3|||f||||f||||||||||2017-10-10 23:25:42.008006|2017-10-10 23:25:42.008006
NCT02407535|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-02-14|||March 2015||2015-03-01|February 2017|2017-02-01|October 13, 2018|Anticipated|2018-10-13|April 13, 2018|Anticipated|2018-04-13||Interventional|||Assessing Uterine Ultrasound Done as a Diagnostic Tool for the Depth of Carcinoma Invasion|Assessing the Ultrasound Done on a the Uterus After Hysterectomy as a Diagnostic Tool for the Depth of Endometrial Carcinoma Invasion Into the Myometrium|Recruiting||N/A|100|Anticipated|Carmel Medical Center||1|||f||||||||||||No||2017-10-10 23:25:42.094799|2017-10-10 23:25:42.094799
NCT02407522|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-02|||June 2014||2014-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|IDSBRMS||The Improvements of Dietary Supplement of Black Rice on Metabolic Syndrome|The Improvements of Dietary Supplement of Black Rice on Metabolic Syndrome and Its Correlation With Metabolism of Gut Microbiota|Completed||Phase 2/Phase 3|101|Actual|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:25:42.167965|2017-10-10 23:25:42.167965
NCT02407509|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-04-02|||May 2013||2013-05-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|DDU RAF/MEK||Phase I Trial of RO5126766|A Phase I Trial of RO5126766 (a Dual RAF/MEK Inhibitor) Exploring Intermittent, Oral Dosing Regimens in Patients With Solid Tumours or Multiple Myeloma|Unknown status|Recruiting|Phase 1|42|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:25:42.241577|2017-10-10 23:25:42.241577
NCT02407496|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-09-18|||June 2014||2014-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Observational|NAT-I||Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)|Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|80|Actual|Think Now Incorporated|||2||f||||f||||||||||2017-10-10 23:25:42.315714|2017-10-10 23:25:42.315714
NCT02407483|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-04-02|||March 2015||2015-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|LVG||Laparoscopic Training With Laser Guidance Trial|Laparoscopic Simulator Training With or Without Laser Visual Guidance -A Randomized Trial|Unknown status|Enrolling by invitation|N/A|32|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:25:42.380305|2017-10-10 23:25:42.380305
NCT02407470|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-02|||January 2015||2015-01-01|March 2015|2015-03-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia|A Multicenter, Randomized, Controlled Study of the Efficacy and Safety of the Combination of Adipose Tissue-derived Hematopoietic Stem Cells (AD-HSCs) and ATG in the Treatment of Severe Aplastic Anemia|Unknown status|Recruiting|Phase 1/Phase 2|90|Anticipated|Navy General Hospital, Beijing||3|||f||||t||||||||||2017-10-10 23:25:42.602208|2017-10-10 23:25:42.602208
NCT02407457|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-02-01|||March 2015||2015-03-01|January 2016|2016-01-01|September 2022|Anticipated|2022-09-01|September 2017|Anticipated|2017-09-01||Interventional|LEOPARD||Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices|Multicenter, Post-Market Study to Assess Outcomes of Patients Treated With the AFX System Compared to Other EVAR Devices for Endovascular Abdominal Aortic Aneurysm Repair: LEOPARD|Enrolling by invitation||Phase 4|800|Anticipated|Endologix||2|||f||||f||||||||||2017-10-10 23:25:42.730816|2017-10-10 23:25:42.730816
NCT02407444|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-03-19|||July 2015||2015-07-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Treatment Efficacy of Leg Cycling as Part of Physiotherapy Treatment in Elderly Patients With Hip Fracture|A Comparison of Two Physiotherapy Treatment Protocols, With and Without Cycling Training , in Elderly Patients With Hip Fractures at Their Subacute Stage Following Surgery|Recruiting||N/A|60|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:25:42.8294|2017-10-10 23:25:42.8294
NCT02407431|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|10 Years|Observational [Patient Registry]|||PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort|PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort|Recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:25:42.957579|2017-10-10 23:25:42.957579
NCT02407418|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-31|||April 2012||2012-04-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effects of Spinal Manipulation on Thigh Muscle Strength|The Effects of Lumbosacral Manipulation on Isokinetic Strength of the Knee Extensors and Flexors|Completed||N/A|21|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-10 23:25:43.058072|2017-10-10 23:25:43.058072
NCT02407405|ClinicalTrials.gov processed this data on October 10, 2017|2015-04-02|2016-12-30|||December 2015||2015-12-01|December 2016|2016-12-01||||June 2019|Anticipated|2019-06-01||Interventional|||Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery|Phase II Trial of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas|Recruiting||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-10 23:25:43.174126|2017-10-10 23:25:43.174126
NCT02407392|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-03-31|||July 2015||2015-07-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|ABBA||"Using Dilute Vinegar to Find Changes in Cells During Endoscopy for Patients With Barrett's Oesophagus (The ABBA Study)"|Acetic Acid Guided Biopsies in Barrett's Surveillance for Neoplasia Detection Versus Non-targeted Biopsies (Seattle Protocol): A Feasibility Study for a Randomised Tandem Endoscopy Trial. The ABBA Study.|Recruiting||N/A|200|Anticipated|Portsmouth Hospitals NHS Trust||2|||f||||t||||||||||2017-10-10 23:25:43.293467|2017-10-10 23:25:43.293467
NCT02407379|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-09-22|||October 2015||2015-10-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|October 2016|Actual|2016-10-01||Interventional|PAPD||Diode Laser and SRP in Chronic Periodontitis|Photoablative-photodynamic (PAPD) Diode Laser Therapy Adjunctive to Scaling and Root Planing in Periodontitis|Active, not recruiting||N/A|27|Anticipated|Odontostomatologic Laser Therapy Center, Florence, Italy||2|||f||||f||||||||||2017-10-10 23:25:43.394837|2017-10-10 23:25:43.394837
NCT02407366|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-03-30|||December 2014||2014-12-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer|A Phase 2 Study of Icotinib With Concurrent Radiotherapy vs. Pemetrexed+ Carboplatin With Concurrent Radiotherapy in Unresectable Stage III Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor ( EGFR) Mutation|Recruiting||Phase 2|80|Anticipated|People's Hospital of Guangxi||2|||f||||f||||||||||2017-10-10 23:25:43.483319|2017-10-10 23:25:43.483319
NCT02407353|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-03-21|||October 2015||2015-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)|A Phase 1 Investigator-and-subject Blind, Randomized, Placebo Controlled, Parallel Study In Healthy Subjects To Evaluate The Pharmacodynamic Effects Of Single Oral Doses Of Pf-06648671 On Aβ Concentrations In Cerebrospinal Fluid Using Serial Sampling Methodology|Completed||Phase 1|22|Actual|Pfizer||4|||f||||f||||||||||2017-10-10 23:25:43.620536|2017-10-10 23:25:43.620536
NCT02407340|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-13|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|June 28, 2017|Actual|2017-06-28||Interventional|||Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder|Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder|Active, not recruiting||Phase 1|27|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:25:43.725074|2017-10-10 23:25:43.725074
NCT02407327|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-04-05|||December 2013||2013-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|2012/52||Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling|Trattamento Personalizzato Del Tumore NSCLC Avanzato: Potenziali Applicazioni Della Caratterizzazione Fenotipica e Molecolare Delle Cellule Tumorali Circolanti (CTC)|Active, not recruiting||N/A|215|Actual|Istituto Oncologico Veneto IRCCS|||1||f||||t||||||Samples Without DNA|"     Whole blood.   "|||2017-10-10 23:25:43.814679|2017-10-10 23:25:43.814679
NCT02407314|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-03-02|||June 2015||2015-06-01|March 2017|2017-03-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|||Ticagrelor and Peripheral Arterial Disease|Impact of Ticagrelor and Aspirin Versus Clopidogrel and Aspirin in Patients With Claudication and Peripheral Arterial Disease (PAD): Thrombus Burden Assessed by Optical Coherence Tomography|Terminated||Phase 4|26|Actual|Arkansas Heart Hospital||2||AZ discontinued study|f||||t||||||||||2017-10-10 23:25:43.906418|2017-10-10 23:25:43.906418
NCT02407301|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-05-11|||April 2015||2015-04-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Cough in Reduced True Vocal Fold Mobility|Voluntary Cough Airflow Dynamics and True Vocal Fold Kinematics in Persons With Reduced True Vocal Fold Mobility|Completed||N/A|15|Actual|University of Florida|||1||f||||f||||||||Undecided||2017-10-10 23:25:44.01072|2017-10-10 23:25:44.01072
NCT02407288|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-05-04|||March 12, 2015|Actual|2015-03-12|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TDCSTOC||tDCS as an add-on Treatment in SSRI-resistant OCD|Transcranial Direct Current Stimulation as an add-on Treatment in SSRI-resistant Obsessive Compulsive Disorder : a Randomized Clinical Trial|Recruiting||N/A|46|Anticipated|Hôpital le Vinatier||2|||f||||f||||||||No||2017-10-10 23:25:44.126002|2017-10-10 23:25:44.126002
NCT02407275|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-03-30|||February 2015||2015-02-01|March 2015|2015-03-01||||September 2015|Anticipated|2015-09-01||Interventional|||Rhinosinusites Chroniques|ETUDE DU MICROBIOTE DES RHINOSINUSITES CHRONIQUES DIFFICILES A TRAITER PAR METAGENOMIQUE ET CULTUROMIQUE|Unknown status|Recruiting|N/A|20|Anticipated|Institut Hospitalo-Universitaire Méditerranée Infection||1|||f||||t||||||||||2017-10-10 23:25:44.214819|2017-10-10 23:25:44.214819
NCT02407262|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-05-10|||May 2015||2015-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes|Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes|Completed||Phase 2|80|Actual|University College, London||2|||f||||t||||||||||2017-10-10 23:25:44.296294|2017-10-10 23:25:44.296294
NCT02407249|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-08-17|||April 2015||2015-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Topera C-FIRM Registry|Control for EU (European Union) Focal Impulse and Rotor Modulation Registry - Topera C-FIRM Registry-|Active, not recruiting||N/A|120|Anticipated|I-Med-Pro GmbH|||1||f||||f||||||||||2017-10-10 23:25:44.388258|2017-10-10 23:25:44.388258
NCT02407236|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-06|||July 10, 2015|Actual|2015-07-10|September 2017|2017-09-01|October 13, 2021|Anticipated|2021-10-13|April 12, 2018|Anticipated|2018-04-12||Interventional|UNIFI||A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis|A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis|Active, not recruiting||Phase 3|966|Actual|Janssen Research & Development, LLC||10|||f||||t||f||||||||2017-10-10 23:25:44.47622|2017-10-10 23:25:44.47622
NCT02407223|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-08-11|||July 13, 2015|Actual|2015-07-13|August 2017|2017-08-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Subjects With Active Nonradiographic Axial Spondyloarthritis|Active, not recruiting||Phase 3|356|Actual|Janssen Research & Development, LLC||3|||f||||||f||||||||2017-10-10 23:25:45.126484|2017-10-10 23:25:45.126484
NCT02407210|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-03-30|||January 2015||2015-01-01|January 2015|2015-01-01||||October 2015|Anticipated|2015-10-01||Interventional|||Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension|A Phase 3, Double-Blind, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension|Unknown status|Recruiting|Phase 3|304|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||||||||||||2017-10-10 23:25:45.428341|2017-10-10 23:25:45.428341
NCT02407197|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-03-30|||January 2011||2011-01-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|T1-CMR||International T1 Multicentre CMR Outcome Study in Patients With Nonischaemic Cardiomyopathies|International T1 Multicentre CMR Study|Recruiting||N/A|1500|Anticipated|King's College London|||1||f||||f||||||||||2017-10-10 23:25:45.522148|2017-10-10 23:25:45.522148
NCT02407184|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-03-15|||April 2015||2015-04-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|December 2017|Anticipated|2017-12-01||Interventional|PRIME||Potential Restoration of the Infant Microbiome|Potential Restoration of the Infant Microbiome|Recruiting||N/A|78|Anticipated|New York University School of Medicine||3|||f||||t||||||||||2017-10-10 23:25:45.607311|2017-10-10 23:25:45.607311
NCT02407171|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-07-24|||April 1, 2015|Actual|2015-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC|A Phase I/II Trial of Evaluating the Combination of MK-3475 and Stereotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC|Recruiting||Phase 1/Phase 2|60|Anticipated|Yale University||4|||f||||t||||||||||2017-10-10 23:25:45.689461|2017-10-10 23:25:45.689461
NCT02407158|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-08-18|||May 2015||2015-05-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Pilot Study for Verifying Endotracheal Tube Repositioning Using Ultrasound|A Pilot Study to Explore Alternative Methods for Verifying Endotracheal Tube Repositioning in the Surgical Intensive Care Unit|Recruiting||N/A|25|Anticipated|Yale University|||1||f||||f||||||||||2017-10-10 23:25:45.783536|2017-10-10 23:25:45.783536
NCT02407145|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-30|||August 2015||2015-08-01|March 2015|2015-03-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Observational|||Safety and Efficacy of PVDF (DynaMesh®-SIS Soft) Retropubic Midurethral Slings in Stress Urinary Incontinence in Women|Safety and Efficacy of Low-elasticity Polyvinylidene Fluoride (DynaMesh®-SIS Soft) Retropubic Tension Free Midurethral Sling in the Treatment of Stress Urinary Incontinence in Women|Not yet recruiting||N/A|268|Anticipated|Norfolk and Norwich University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:25:45.853787|2017-10-10 23:25:45.853787
NCT02407132|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-12-16|||June 2015||2015-06-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Family Model of Diabetes Self-Management Education in the Marshallese Community|Family Model of Diabetes Self-Management Education in the Marshallese Community|Recruiting||Phase 1|2300|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-10-10 23:25:45.981786|2017-10-10 23:25:45.981786
NCT02407119|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-09-14|||June 2003||2003-06-01|September 2017|2017-09-01|June 2022|Anticipated|2022-06-01|June 2016|Actual|2016-06-01||Interventional|||Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD|Effect of Helicobacter Pylori Eradication on Glandular Atrophy and Metachronous Cancer in Patients Undergoing Endoscopic Mucosal Resection for Gastric Cancer|Active, not recruiting||Phase 3|470|Actual|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-10 23:25:46.068815|2017-10-10 23:25:46.068815
NCT02407106|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-02|||September 2015||2015-09-01|April 2015|2015-04-01||||March 2016|Anticipated|2016-03-01||Interventional|||Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children|Efficacy of Streptococcus Salivarius BLIS (Bacteriocin-like Inhibitory Substance) K12 as Preventive Measure for Rheumatic Children.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Kaplan Medical Center||1|||f||||f||||||||||2017-10-10 23:25:46.170471|2017-10-10 23:25:46.170471
NCT02407093|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-06-05|||September 2015||2015-09-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|ATHIS||Army Training at High Intensity Study|HIFT for Obesity Prevention, Fitness and Health Promotion in Military Personnel|Enrolling by invitation||N/A|200|Anticipated|Kansas State University||2|||f||||f||||||||No||2017-10-10 23:25:46.270595|2017-10-10 23:25:46.270595
NCT02407080|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-01-16|||April 2015||2015-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia|Open Label Phase I Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia (With Pilot Feasibility Study in Combination With Pegylated Interferon Alfa 2a for Patients Who do Not Respond to the Single Agent at Each Dose Level)|Recruiting||Phase 1|30|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-10 23:25:46.390792|2017-10-10 23:25:46.390792
NCT02407067|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-03-06|||April 2015||2015-04-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Comparison of Voice Amplifiers and Personal Communication Systems in Individuals With Parkinson's Disease|A Comparison of Voice Amplifiers and Personal Communication Systems in Individuals With Parkinson's Disease|Enrolling by invitation||N/A|20|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||No||2017-10-10 23:25:46.582468|2017-10-10 23:25:46.582468
NCT02407054|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-25|||April 2015||2015-04-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer|A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer|Recruiting||Phase 2|144|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:25:46.700054|2017-10-10 23:25:46.700054
NCT02407041|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-07-31|||September 2015||2015-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis|A Single-Center, Open-Label Phase 2a Clinical Trial to Evaluate the Safety and Efficacy of GR-MD-02 for the Treatment of Patients With Moderate to Severe Plaque Psoriasis|Enrolling by invitation||Phase 2|10|Anticipated|Galectin Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 23:25:47.02924|2017-10-10 23:25:47.02924
NCT02407028|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-09-13|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|March 2022|Anticipated|2022-03-01||Interventional|HOBIT||Hyperbaric Oxygen Brain Injury Treatment Trial|Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial|Not yet recruiting||Phase 2|200|Anticipated|Minneapolis Medical Research Foundation||3|||f||||t|t|f||||||||2017-10-10 23:25:47.10937|2017-10-10 23:25:47.10937
NCT02407015|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-10-12|||December 2014||2014-12-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of 3D Autostereoscopic Video-game Play on the Visual Fatigue in Children|A Randomised Control Trial to Evaluate the Effect of 3D Autostereoscopic Video-game Play on the Total Horizontal Fusional Vergence Amplitudes of 7 to 11 Year Old Children|Completed||N/A|41|Actual|University of Sheffield||2|||f||||f||||||||||2017-10-10 23:25:47.224161|2017-10-10 23:25:47.224161
NCT02407002|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-08-23|||June 2015||2015-06-01|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|December 31, 2016|Actual|2016-12-31||Observational|||Safety of Nitroglycerin for Field Treatment of STEMI|The Use of Nitroglycerin by Paramedics for Treatment of Acute ST-elevation Myocardial Infarction (STEMI) in the Field|Completed||N/A|940|Actual|Los Angeles Biomedical Research Institute|||1||f||||f||||||||||2017-10-10 23:25:47.298195|2017-10-10 23:25:47.298195
NCT02406989|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-03-14|||April 2015||2015-04-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||A Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Phase 1, Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers|Completed||Phase 1|32|Actual|MingSight Pharmaceuticals Pty Limited||2|||f||||t||||||||||2017-10-10 23:25:47.372732|2017-10-10 23:25:47.372732
NCT02406976|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-03-10|||August 2010||2010-08-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect Physical Exercise in Morbid Obesity|Effect of Physical Exercise on Different Approaches to Treatment of Morbid Obesity|Active, not recruiting||N/A|60|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||Undecided||2017-10-10 23:25:47.447256|2017-10-10 23:25:47.447256
NCT02406963|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-03-21|||June 2015||2015-06-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Photographic Email Correspondence for Pediatric Urology Post-Operative Patients|Photographic Email Correspondence for Pediatric Urology Post-Operative Patients|Completed||N/A|40|Actual|McMaster Children's Hospital||2|||f||||f||||||||||2017-10-10 23:25:47.528789|2017-10-10 23:25:47.528789
NCT02406950|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-14|2015-04-01|||February 2015||2015-02-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Sitagliptin and Endothelial Dysfunction|Preventive Effects of Sitagliptin on Endothelial Dysfunction Induced by Forearm Ischemia-Reperfusion Injury Model|Unknown status|Recruiting|Phase 3|10|Anticipated|Kyunghee University Medical Center||3|||f||||t||||||||||2017-10-10 23:25:47.60009|2017-10-10 23:25:47.60009
NCT02406937|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-08-16|2016-02-18||January 2015||2015-01-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||New Stage 1 Formula on Gut Comfort and Gut Health|Efficacy of New Stage 1 Formula on the Improvement of Gut Comfort and Gut Health|Completed||Phase 4|180|Actual|Heilongjiang Feihe Dairy Co. Ltd.||3|||f||||f||||||||||2017-10-10 23:25:47.693286|2017-10-10 23:25:47.693286
NCT02406924|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-01|||April 2015||2015-04-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|PaMP||Bone Augmentation Using Particulated Biomaterial and Autogenous Bone, Stabilized by Collagen Membrane and Pins (PaMP)|Maxillary Horizontal and Vertical Bone Augmentation Using Particulated Biomaterial Associated With Autogenous Bone, Covered and Stabilized by a Collagen Membrane and Pins|Unknown status|Not yet recruiting|N/A|24|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:25:48.47823|2017-10-10 23:25:48.47823
NCT02406911|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-14|2015-03-30|||February 2015||2015-02-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Ticagrelor and Anti-inflammatory Effects|Relationship of Dose of Ticagrelor and Anti-inflammatory Effect in Patients With End Stage Renal Disease on Hemodialysis: PIANO-6 Randomized Crossover Study|Unknown status|Recruiting|Phase 3|25|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-10 23:25:48.804882|2017-10-10 23:25:48.804882
NCT02406898|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-09-28|||April 2015||2015-04-01|May 2015|2015-05-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation of a Hysteroscopic Morcellator in Hysteroscopic Treatment of Submucosal Fibroids|Operative Hysteroscopy for Fibroma by Classic Resection Versus Morcellation: a Ramdomised Study|Recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-10-10 23:25:48.965858|2017-10-10 23:25:48.965858
NCT02406885|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-08-29|||December 2016||2016-12-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|APB||Apixaban Pharmacokinetics in Bariatric Patients (APB)|APB Study: Apixaban Pharmacokinetics in Bariatric Patients|Not yet recruiting||Phase 4|30|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:25:49.073815|2017-10-10 23:25:49.073815
NCT02406872|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-12-29|||December 2014||2014-12-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study Comparing Remimazolam Tosilate and Propofol for Intravenous General Anaesthesia in Operations||Completed||Phase 2|144|Actual|Jiangsu HengRui Medicine Co., Ltd.||4|||f||||t||||||||||2017-10-10 23:25:49.18765|2017-10-10 23:25:49.18765
NCT02406846|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-12-28|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|2 Years|Observational [Patient Registry]|||The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.|The Detection of Circulating Tumor Cells (CTCs) in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.|Completed||N/A|80|Actual|Fuda Cancer Hospital, Guangzhou|||4||f||||t||||||||||2017-10-10 23:25:49.420392|2017-10-10 23:25:49.420392
NCT02406833|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-09-05|||April 2015||2015-04-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy|A Phase I, Open-Label, Dose-Escalation Study to Investigate the Safety of ISTH0036, a 'Next Generation' TGF-β2-Selective Antisense Oligonucleotide, in Subjects With Primary Open-Angle Glaucoma Undergoing Trabeculectomy|Active, not recruiting||Phase 1|13|Actual|Isarna Therapeutics GmbH||1|||f||||f||||||||||2017-10-10 23:25:49.541527|2017-10-10 23:25:49.541527
NCT02406820|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-08-28|||April 2015||2015-04-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Correlating Noninvasive Cardiovascular Measures to Left Ventricular End Diastolic Pressure in Heart Failure|Characterizing Noninvasive Cardiovascular Measures Collected Passively and In Response to an Isometric Handgrip Stress Test From CVInsight®, Connex ProBP, and Zio® XT Patch in Patients With Acute Decompensated Heart Failure|Terminated||N/A|1|Actual|Intelomed, Inc.|||3|Strategic closure by sponsor to pursue other indications.|f||||f||||||||||2017-10-10 23:25:49.67668|2017-10-10 23:25:49.67668
NCT02406807|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-03-30|||May 2012||2012-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||H-reflex Responses to High-Velocity Low-Amplitude Manipulation|H-reflex Responses to High-Velocity Low-Amplitude Manipulation in Adults With Chronic Non-specific Low Back Pain|Completed||N/A|28|Actual|Instituto Brasileiro de Osteopatia||2|||f||||t||||||||||2017-10-10 23:25:49.787885|2017-10-10 23:25:49.787885
NCT02406794|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-03-30|||May 2016||2016-05-01|October 2016|2016-10-01|March 2017|Actual|2017-03-01|September 2016|Actual|2016-09-01||Interventional|KITMYCAN||Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors|Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women: Randomised Controlled Trial|Completed||Phase 1/Phase 2|156|Actual|University of Malaga||2|||f||||t||||||||||2017-10-10 23:25:49.884388|2017-10-10 23:25:49.884388
NCT02406781|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-09-28|||March 2015||2015-03-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PEMBROSARC||Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial|Combination of MK3475 and Metronomic Cyclophosphamide in Patients With|Recruiting||Phase 2|163|Anticipated|Institut Bergonié||1|||f||||t||||||||||2017-10-10 23:25:50.005333|2017-10-10 23:25:50.005333
NCT02406768|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-03-30|||October 2010||2010-10-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||A Sub-study of PREDICT Neurodevelopment Protocol|The Neurodevelopment in Normal Children in Cambodia and Thailand|Completed||N/A|300|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||2||f||||f||||||||||2017-10-10 23:25:50.272386|2017-10-10 23:25:50.272386
NCT02406755|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-09-01|||July 2014||2014-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||H-Senses Project - Self Care Mediated by the Senses|H-SENSES PROJECT Self Care Mediated by the Senses: Assessing the Impact on Self-esteem, Stress and Well-being of Female Health Professionals|Completed||N/A|123|Actual|Hospital Israelita Albert Einstein||4|||f||||t||||||||||2017-10-10 23:25:50.388116|2017-10-10 23:25:50.388116
NCT02406742|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-05-31|||July 27, 2015|Actual|2015-07-27|May 2017|2017-05-01|July 18, 2024|Anticipated|2024-07-18|July 18, 2024|Anticipated|2024-07-18||Interventional|ENHANCE||A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Phase 1/2 Study to Determine the Safety, Pharmacokinetics, and Efficacy of Single Agent CC-122 and the Combinations CC-122 AND Ibrutinib and CC-122 and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Recruiting||Phase 1/Phase 2|152|Anticipated|Celgene||3|||f||||t||||||||||2017-10-10 23:25:50.505898|2017-10-10 23:25:50.505898
NCT02406729|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-12-19|||February 2016||2016-02-01|December 2016|2016-12-01|November 2022|Anticipated|2022-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine|Phase III Trial to Evaluate Efficacy and Safety of a Dengue 1,2,3,4 (Attenuated) Vaccine|Recruiting||Phase 3|16944|Anticipated|Butantan Institute||2|||f||||t||||||||||2017-10-10 23:25:50.7093|2017-10-10 23:25:50.7093
NCT02406716|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2015-03-30|||April 2015||2015-04-01|March 2015|2015-03-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01|6 Months|Observational [Patient Registry]|||Semaphorins 3A and 4D Levels in Heart Failure Patients|Semaphorins 3A and 4D Levels in Heart Failure Patients: Pathogenesis and Clinical Correlation|Unknown status|Not yet recruiting|N/A|120|Anticipated|Bnai Zion Medical Center|||2||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:25:50.881547|2017-10-10 23:25:50.881547
NCT02406703|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-07-13|||January 2014|Actual|2014-01-01|July 2017|2017-07-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||The Impact of Chloroprocaine 3% for Ambulatory Foot Surgery on Perioperative Process Costs||Completed||N/A|100|Actual|Ospedale Regionale Bellinzona e Valli|||2||f||||f||||||||||2017-10-10 23:25:50.962998|2017-10-10 23:25:50.962998
NCT02406690|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-10-03|||November 2014||2014-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects|Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects|Enrolling by invitation||N/A|20|Anticipated|Reproductive Medicine Associates of New Jersey|||2||f||||f||||||Samples With DNA|"     One tube of serum (approximately 3.5 mL) will be collected from participant at each visit via     venipuncture. An uterine aspiration and endometrial biopsy sample will be taken at Day 6 of     Progestrone Adminstration.   "|No||2017-10-10 23:25:51.031465|2017-10-10 23:25:51.031465
NCT02406677|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-08-11|||June 5, 2015|Actual|2015-06-05|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|ARTEMIS||Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study|Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study|Active, not recruiting||Phase 4|11001|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:25:51.14564|2017-10-10 23:25:51.14564
NCT02406664|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-02-18|||January 2015||2015-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of Bariatric/Metabolic Surgery on GFR|Prospective Cohort Study of the Effect of Bariatric/Metabolic Surgery on Morbid Obesity Patients With Metabolic Syndrome|Recruiting||N/A|30|Anticipated|Hanyang University||2|||f||||f||||||||||2017-10-10 23:25:51.804685|2017-10-10 23:25:51.804685
NCT02406651|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-05-01|||May 12, 2016|Actual|2016-05-12|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD|A Phase IIa Study of Recombinant Human Interleukin-22 IgG2-Fc (F 652) in Combination With Systemic Corticosteroids for the Treatment of Newly Diagnosed Grade II-IV Lower Gastrointestinal Acute Graft-versus-Host Disease (aGVHD) in Hematopoietic Stem Cell Transplantation Recipients (HSCT)|Recruiting||Phase 1/Phase 2|27|Anticipated|Generon (Shanghai) Corporation Ltd.||1|||f||||f|t|f||||||||2017-10-10 23:25:53.635897|2017-10-10 23:25:53.635897
NCT02406638|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-01|||April 2013||2013-04-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Observational|||Pelvic Floor 3D USG Three Years After Mid-urethral Slings ( TVT-R, TVT-O, TVT-S)|Pelvic Floor 3D Ultrasound of Women Who Underwent TVT-R, TVT-O, TVT-S Surgery at Three Years Follow-up|Completed||N/A|158|Actual|Federal University of São Paulo|||3||f||||f||||||||||2017-10-10 23:25:53.747277|2017-10-10 23:25:53.747277
NCT02406625|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-02-16|||November 2014||2014-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|DBT||Dialectical Behavioral Therapy in Adolescents With Suicidal Behaviors|Clinical and Neural Changes Associated With Dialectical Behavioral Therapy in Adolescents With Suicidal Behaviors|Completed||N/A|52|Anticipated|Fundacion Clinic per a la Recerca Biomédica||3|||f||||||||||||||2017-10-10 23:25:53.842072|2017-10-10 23:25:53.842072
NCT02406599|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-08-20|||June 2015||2015-06-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||MarginProbe® System U.S. Post-Approval Study|MarginProbe® System U.S. Post-Approval Study Protocol CP-07-001|Recruiting||N/A|440|Anticipated|Dune Medical Devices||2|||f||||f||||||||||2017-10-10 23:25:53.988945|2017-10-10 23:25:53.988945
NCT02406586|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-05-11|2015-05-11||July 2009||2009-07-01|May 2015|2015-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|FFAADA|All but one of the subjects that completed the study were included in the baseline analysis. No data was recorded for one subject who withdrew from the study.|Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)|Free Fatty Acids-Induced Hypertension, Endothelial Dysfunction, Inflammation, Insulin Resistance, and Autonomic Dysfunction in Lean and Obese Subjects (Aim #2)|Completed||N/A|36|Actual|Emory University||3|||f||||t||||||||||2017-10-10 23:25:54.091308|2017-10-10 23:25:54.091308
NCT02406573|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-06-18|||March 2015||2015-03-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Pilot Study to Assess Nominal Versus Controlled Stimuli on Dentinal Hypersensitivity||Completed||N/A|30|Actual|Procter and Gamble||1|||f||||||||||||||2017-10-10 23:25:54.814501|2017-10-10 23:25:54.814501
NCT02406560|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-08-06|||April 2015||2015-04-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food|A Phase 1, Open-label, Randomized, Crossover, Oral, Single Dose Study To Estimate The Relative Bioavailability Of Pf-06291826 (Tafamidis) Following Administration Of A Tafamidis Free Acid Tablet Formulation In Healthy Subjects Under Fasted And Fed Conditions|Completed||Phase 1|12|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 23:25:54.891938|2017-10-10 23:25:54.891938
NCT02406547|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-05-03|||March 2015||2015-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|CROMOSER||Study of Narrow Band Imaging in the Characterization of Serrated Lesions|Randomised Tandem Colonoscopy of Narrow Band Imaging (NBI) and White Light Endoscopy in Patients With Serrated Lesions|Completed||N/A|41|Actual|Parc de Salut Mar||2|||f||||f||||||||No||2017-10-10 23:25:54.985553|2017-10-10 23:25:54.985553
NCT02406534|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-05-04||||||May 2015|2015-05-01||||April 2016|Anticipated|2016-04-01||Observational|||A Prospective, Observational Study of COPD Patients in U.S. Hospitals||Withdrawn||N/A|0|Actual|EPI-Q|||2|Study entered in error|f||||f||||||||||2017-10-10 23:25:55.088465|2017-10-10 23:25:55.088465
NCT02406521|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-08-01|||April 2015||2015-04-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets|Phase I Study of Radium-223 and Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Metastases|Active, not recruiting||Phase 1|30|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 23:25:55.160575|2017-10-10 23:25:55.160575
NCT02406508|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-07-25|||October 2014||2014-10-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC|An International Multi-center Phase 2 Study to Evaluate the Safety and Efficacy of Sequential Melphalan Hydrochloride for Injection for Use With the Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable Hepatocellular Carcinoma|Recruiting||Phase 2|31|Anticipated|Delcath Systems Inc.||1|||f||||t||||||||||2017-10-10 23:25:55.269049|2017-10-10 23:25:55.269049
NCT02406495|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2016-03-30|2016-02-24||April 2015||2015-04-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Performance of Habitual Wearers of Bioclear 1-day Lenses When Refitted With Biomedics 1-day Extra for 1 Week|Clinical Performance of Habitual Wearers of Bioclear 1-day Lenses When Refitted With Biomedics 1-day Extra for 1 Week|Completed||N/A|40|Actual|Coopervision, Inc.||1|||f||||f||||||||||2017-10-10 23:25:55.414485|2017-10-10 23:25:55.414485
NCT02406482|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-09-04|||April 2015||2015-04-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MFKZ||Evaluating a Microfinance Intervention for Vulnerable Women in Kazakhstan|Evaluating a Microfinance Intervention for Vulnerable Women in Kazakhstan|Active, not recruiting||N/A|350|Actual|Columbia University||2|||f||||f||||||||||2017-10-10 23:25:56.036012|2017-10-10 23:25:56.036012
NCT02406469|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-01|||October 2014||2014-10-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior|Comparative Effects of Milk With A2 Type Beta Casein Versus Milk With A1 and A2 Beta Casein Proteins on Gastrointestinal Physiology, Symptoms and Cognitive Behavior for the Health People Who Are Intolerant to Traditional Cow Milk|Completed||Phase 4|45|Actual|a2 Milk Company Ltd.||2|||f||||f||||||||||2017-10-10 23:25:56.121026|2017-10-10 23:25:56.121026
NCT02406456|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-11-10|||March 2015||2015-03-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Optimisation of Functional MRI-based Neurofeedback for Alcohol Use Disorders|Real-time fMRI Neurofeedback as a Treatment Tool for Alcohol Dependence - Protocol Optimisation Phase|Completed||N/A|15|Actual|Cardiff University||1|||f||||f||||||||||2017-10-10 23:25:56.189138|2017-10-10 23:25:56.189138
NCT02406430|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-03-30|||April 2009||2009-04-01|March 2015|2015-03-01||||October 2013|Actual|2013-10-01||Observational|||Prognostic Factors in Epiretinal Membrane Surgery|Preoperative Prognostic Factors and Predictive Score in Patients Operated on for Combined Cataract and Idiopathic Epiretinal Membrane.|Completed||N/A|142|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 23:25:56.355651|2017-10-10 23:25:56.355651
NCT02406417|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-30|||August 2015||2015-08-01|March 2015|2015-03-01|April 2017|Anticipated|2017-04-01|August 2016|Anticipated|2016-08-01||Interventional|||Reflective Testing for Early Diagnosis of Pituitary Dysfunction|The Use of Reflex Strategies and Reflective Testing in the Clinical Chemistry Laboratory for Early Detection of Pituitary Dysfunction in Patients From Primary Care.|Unknown status|Not yet recruiting|N/A|120|Anticipated|Nova Scotia Health Authority||1|||f||||t||||||||||2017-10-10 23:25:56.41171|2017-10-10 23:25:56.41171
NCT02406404|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2015-03-29|||August 2013||2013-08-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Change of Pulmonary Function After Incentive Spirometer Training in Children With Cerebral Palsy||Unknown status|Recruiting|N/A|45|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:25:56.470567|2017-10-10 23:25:56.470567
NCT02406391|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-04-09|||April 2015||2015-04-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|Adh-NYC-EP||Adherence to Preventive Care for Cervical Cancer|Adherence to Screening and Follow-up Diagnostic and Treatment Services for Cervical Cancer Prevention|Not yet recruiting||N/A|400|Anticipated|Brookdale University Hospital Medical Center|||1||f||||||||||||||2017-10-10 23:25:56.653965|2017-10-10 23:25:56.653965
NCT02406365|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-04-09|||April 2015||2015-04-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|FFC||Diagnostic Imaging Aid for Management of Cervical Lesions|Development and Application of a Diagnostic Imaging Aid for One-visit Management of Cervical Lesions in Low-resource Settings|Not yet recruiting||Phase 2|618|Anticipated|Brookdale University Hospital Medical Center||1|||f||||||||||||||2017-10-10 23:25:56.754094|2017-10-10 23:25:56.754094
NCT02406352|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-04-09|||March 2015||2015-03-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|MDCwProbe||Multispectral Digital Colposcope With Probe for Detection of Cervical Intraepithelial Neoplasia|Development and Application of a Multispectral Digital Colposcope and Probe Algorithm for Detection of Cervical Intraepithelial Neoplasia|Recruiting||N/A|618|Anticipated|Brookdale University Hospital Medical Center||1|||f||||||||||||||2017-10-10 23:25:56.849734|2017-10-10 23:25:56.849734
NCT02406339|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-14|2017-07-19|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Effectiveness of NMES Associated to Vascular Occlusion in Functional Performance and Muscle Hypertrophy in Athlete's|Analysis of the Effectiveness of Neuromuscular Electrical Stimulation Associated to Vascular Occlusion in Functional Performance and Muscle Hypertrophy in Athlete's Basketball of High Performance. Blind Randomized Clinical Trial|Completed||N/A|45|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-10 23:25:56.95993|2017-10-10 23:25:56.95993
NCT02406326|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-01|||January 2009||2009-01-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2012|Actual|2012-12-01|12 Months|Observational [Patient Registry]|MeriT-II||An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study The BioMime™1 Trial|A Prospective Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study The BioMime™1 Trial|Active, not recruiting||N/A|250|Anticipated|Meril Life Sciences Pvt. Ltd.|||1||f||||f||||||||||2017-10-10 23:25:57.054597|2017-10-10 23:25:57.054597
NCT02406313|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-02-28|||March 2015||2015-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|FiETT||Fibromyalgia Therapeutic Education in Thermal Cure|Evaluation of the Efficiency of a Therapeutic Education Program in Standardized Thermal Cure for Fibromyalgia Patients|Active, not recruiting||N/A|152|Actual|Association Francaise pour la Recherche Thermale||2|||f||||f||||||||No||2017-10-10 23:25:57.119704|2017-10-10 23:25:57.119704
NCT02406300|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2015-04-01|||April 2015||2015-04-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Anesthesia And Post-operative Mortality After Proximal Femur Fractures|Contribution Of Anesthesia Technique For Post-operative Mortality Reduction After Proximal Femur Fractures Surgical Treatment - A Randomized Clinical Trial|Unknown status|Enrolling by invitation|N/A|260|Anticipated|Centro Hospitalar do Porto||2|||f||||f||||||||||2017-10-10 23:25:57.300458|2017-10-10 23:25:57.300458
NCT02406287|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-09-12|||April 2015||2015-04-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers||Completed||Phase 1|10|Actual|Aerie Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:25:57.407401|2017-10-10 23:25:57.407401
NCT02406274|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-30|2017-04-19|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities|Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities|Recruiting||N/A|250|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:25:57.485892|2017-10-10 23:25:57.485892
NCT02406261|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-05-25|||April 2015||2015-04-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants|A Study to Characterize LY3314814 Pharmacokinetics as a Function of Dosing Duration and to Determine the Effect of LY3314814 on the Pharmacokinetics of CYP3A Substrates in Healthy Subjects|Completed||Phase 1|82|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:25:57.570863|2017-10-10 23:25:57.570863
NCT02406248|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-03-10|||April 23, 2015|Actual|2015-04-23|March 2017|2017-03-01|February 9, 2017|Actual|2017-02-09|February 9, 2017|Actual|2017-02-09||Interventional|||Brilinta Taiwan Post Approval Safety Study|A Multicenter, Single Arm, Open Label, Phase IV Study to Evaluate Safety and to Describe the Cumulative Incidence of Major Cardiovascular Events of Ticagrelor in Taiwanese Patients With Non ST-segment Elevation Myocardial Infarction|Completed||Phase 4|113|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:25:57.697264|2017-10-10 23:25:57.697264
NCT02406235|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-09-18|||April 21, 2015|Actual|2015-04-21|September 2017|2017-09-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Observational|ENGAGE||Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer|Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer - ENGAGE Study|Completed||N/A|710|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:25:57.808383|2017-10-10 23:25:57.808383
NCT02406222|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-06-14|||March 2016||2016-03-01|June 2017|2017-06-01|March 2023|Anticipated|2023-03-01|March 2019|Anticipated|2019-03-01||Interventional|MUKseven||Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)|Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)|Recruiting||Phase 2|250|Anticipated|University of Leeds||2|||f||||t||||||||Undecided||2017-10-10 23:25:57.916718|2017-10-10 23:25:57.916718
NCT02406209|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-05-25|||March 2015||2015-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis|A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis|Completed||Phase 2|45|Actual|Aldeyra Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 23:25:58.074901|2017-10-10 23:25:58.074901
NCT02406183|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-01-09|||March 2015||2015-03-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma|Phase I Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Immune Checkpoint Inhibitors in Metastatic Melanoma: Dose Limiting Toxicity and Abscopal Effect|Completed||Phase 1|13|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-10 23:25:58.220474|2017-10-10 23:25:58.220474
NCT02406170|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-07-26|||April 2015||2015-04-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|REPEAT||Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma|The REPEAT Trial: Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma, a Phase 1b Study|Recruiting||Phase 1/Phase 2|48|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-10 23:25:58.30377|2017-10-10 23:25:58.30377
NCT02406144|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-12-08|||November 2014||2014-11-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|September 2020|Anticipated|2020-09-01||Interventional|||Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma||Recruiting||Phase 3|316|Anticipated|PETHEMA Foundation||2|||f||||t||||||||||2017-10-10 23:25:58.523753|2017-10-10 23:25:58.523753
NCT02406131|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-22|||April 2018|Anticipated|2018-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effects of Remote Ischemic Preconditioning on Restenosis Post Lower Limb Revascularization Angioplasty|Effects of Remote Ischemic Preconditioning on Restenosis Post Lower Limb Revascularization Angioplasty: A Pilot Randomized Control Trial|Suspended||N/A|40|Anticipated|National University of Ireland, Galway, Ireland||2||"logistic issues - no available scans for participants at the moment need to postponed starting   dates"|f||||t|f|f||||||||2017-10-10 23:25:58.946117|2017-10-10 23:25:58.946117
NCT02406118|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-11-25|||March 2015||2015-03-01|November 2015|2015-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TME|Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal Total Mesorectal Excision|Recruiting||Phase 2|49|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-10 23:25:59.082837|2017-10-10 23:25:59.082837
NCT02406105|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-04-01|||January 2015||2015-01-01|March 2015|2015-03-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|||An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease|An Evaluation of Effectiveness and Toxicity of CyberKnife Based Functional Radiosurgery for Parkinson Disease Patients Suffering From Tremor and Its Implementation in Poland|Recruiting||Phase 2|27|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||1|||f||||t||||||||||2017-10-10 23:25:59.164991|2017-10-10 23:25:59.164991
NCT02406092|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-10-02|||October 13, 2015|Actual|2015-10-13|October 2017|2017-10-01|May 30, 2021|Anticipated|2021-05-30|May 30, 2021|Anticipated|2021-05-30||Interventional|||Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A|An Open-Label, Multinational, Multicenter, Phase IIIB Study to Assess Safety of Rituximab Following Subcutaneous Administration in Patients With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A|Active, not recruiting||Phase 3|122|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 23:25:59.284204|2017-10-10 23:25:59.284204
NCT02406079|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-01|||January 2013||2013-01-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Impact of Tracheotomy on Procalcitonin|Impact of Tracheotomy on Levels of Serum Procalcitonin in Patients Without Sepsis: a Prospective Study|Completed||N/A|1|Actual|First People's Hospital of Chenzhou||1|||f||||f||||||||||2017-10-10 23:25:59.403049|2017-10-10 23:25:59.403049
NCT02406066|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-07-21|||March 2015||2015-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001)|Phase 1 Combined Single and Multiple Rising Dose Study of the Safety and Pharmacokinetics of Metyrapone/Oxazepam Combination (EMB-001)|Completed||Phase 1|24|Actual|Embera NeuroTherapeutics, Inc.||4|||f||||f||||||||||2017-10-10 23:25:59.466985|2017-10-10 23:25:59.466985
NCT02406053|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-27|||April 2014||2014-04-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Oxidative Damage and Antioxidant Mechanisms in COPD|Evaluation of Oxidative Damage and Antioxidant Mechanisms in COPD, Lung Cancer, and Obstructive Sleep Apnea Syndrome|Completed||N/A|111|Actual|Yuzuncu Yıl University|||4||f||||t||||||||||2017-10-10 23:25:59.561743|2017-10-10 23:25:59.561743
NCT02406040|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-28|2016-03-14|||June 2015||2015-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of Short-term Energy Deficit on Muscle Protein Turnover|Effects of Short-term Energy Deficit on Muscle Protein Turnover|Completed||N/A|24|Actual|McMaster University||2|||f||||f||||||||||2017-10-10 23:25:59.638057|2017-10-10 23:25:59.638057
NCT02406027|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-08-11|||July 2, 2015|Actual|2015-07-02|August 2017|2017-08-01|October 14, 2022|Anticipated|2022-10-14|October 14, 2022|Anticipated|2022-10-14||Interventional|||An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum|A Randomized, Two-Period, Double-Blind Placebo-Controlled and Open-Label, Multicenter Extension Study to Determine the Long-Term Safety and Tolerability of JNJ-54861911 in Subjects in the Early Alzheimer's Disease Spectrum|Active, not recruiting||Phase 2|90|Actual|Janssen Research & Development, LLC||5|||f||||t||f||||||||2017-10-10 23:25:59.719507|2017-10-10 23:25:59.719507
NCT02406014|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-05-08|||April 2015||2015-04-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp|Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp|Completed||Phase 4|502|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 23:25:59.845857|2017-10-10 23:25:59.845857
NCT02406001|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-03-31|||June 2010||2010-06-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Reconstruction of Peri-implant Osseous Defects: A Randomized Trial|Reconstructive Surgical Treatment of Peri-implant Intra-osseous Defects - A MULTICENTER RANDOMIZED PROSPECTIVE CLINICAL STUDY|Completed||N/A|70|Actual|Tigran Technologies AB||2|||f||||t||||||||||2017-10-10 23:25:59.930557|2017-10-10 23:25:59.930557
NCT02405988|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-28|2017-02-02|||April 2015||2015-04-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|OPI-15-001||Pharmacodynamics and Arteriovenous Differences of Naloxone in Healthy Participants Exposed to an Opioid|Pharmacodynamics and Arteriovenous Differences of Naloxone in Healthy Participants Exposed to an Opioid|Completed||N/A|12|Actual|Norwegian University of Science and Technology||1|||f||||t||||||||||2017-10-10 23:26:00.043536|2017-10-10 23:26:00.043536
NCT02405975|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-28|2015-04-07|||August 2014||2014-08-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||RCT Assessing the Impact of Online Training on Doctors' Prescribing for Older Patients|A Randomized Controlled Trial Assessing the Impact of an Online Educational Tool on Doctors' Knowledge and Confidence With Regards to Prescribing for Older Patients|Unknown status|Recruiting|N/A|100|Anticipated|University College Cork||2|||f||||f||||||||||2017-10-10 23:26:00.138287|2017-10-10 23:26:00.138287
NCT02405949|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-28|2015-03-31|||July 2013||2013-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|October 2013|Actual|2013-10-01||Observational|OBEGEN||GENETIC SUSCEPTIBILITY FACTOR AS A PREDICTOR OF TYPE 2 DIABETES REMISSION AND WEIGHT LOSS AFTER BARIATRIC SURGERY|GENETIC SUSCEPTIBILITY FACTOR AS A PREDICTOR OF TYPE 2 DIABETES REMISSION AND WEIGHT LOSS AFTER BARIATRIC SURGERY: HOW TO IDENTIFY THE PATIENTS IN WHICH BARIATRIC SURGERY WILL FAIL?|Completed||N/A|100|Actual|Hospital Universitari Vall d'Hebron Research Institute|||4||f||||f||||||Samples With DNA|"     Blood sample   "|||2017-10-10 23:26:00.358223|2017-10-10 23:26:00.358223
NCT02405936|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-28|2015-04-02|||March 2015||2015-03-01|April 2015|2015-04-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Observational|||Prospective Data Collection of Patients Undergoing Gynecologic Surgery|Prospective Data Collection of Patients Undergoing Gynecologic Surgery|Recruiting||N/A|3000|Anticipated|Kangbuk Samsung Hospital|||1||f||||f||||||||||2017-10-10 23:26:00.462088|2017-10-10 23:26:00.462088
NCT02405923|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-07-19|||July 2014||2014-07-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|GRITO-14||Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy|Clinical Trial Evaluating the Effects on Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula Compared to a Cow's Milk Extensively Hydrolysed Protein Formula in Infants With Cow's Milk Protein Allergy|Recruiting||Phase 4|150|Anticipated|Laboratorios Ordesa||2|||f||||t||||||||||2017-10-10 23:26:00.56063|2017-10-10 23:26:00.56063
NCT02405910|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-09-14||||||September 2015|2015-09-01|April 2023|Anticipated|2023-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.|A Phase II Randomized Study of Nab-paclitaxel With Gemcitabine at Two Different Dose Combinations to Determine Efficacy in Patients With Advanced Non- Squamous Non-small Cell Lung Cancer (NSCLC).|Withdrawn||Phase 2|0|Actual|West Virginia University||2||PI Left Institution|f||||t||||||||||2017-10-10 23:26:00.70371|2017-10-10 23:26:00.70371
NCT02405312|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-07-03|||September 2014||2014-09-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|SDMRSC||Shared Decision Making and Renal Supportive Care|Shared Decision Making and Renal Supportive Care|Completed||N/A|172|Actual|Baystate Medical Center||1|||f||||f||||||||||2017-10-10 23:26:05.93898|2017-10-10 23:26:05.93898
NCT02405897|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-01-02|||April 2015||2015-04-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Fenestrated Cup Forceps Versus Fenestrated Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With Sarcoidosis|A Study to Evaluate the Efficacy and Safety of Fenestrated Cup Forceps Versus Fenestrated Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With Sarcoidosis|Completed||N/A|150|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 23:26:00.812994|2017-10-10 23:26:00.812994
NCT02405884|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-31|||January 2014||2014-01-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|EHPIOBRAZIL||Intraocular Pressure and Hemodialysis Midwestern Brazil|Effects of Hemodialysis on Intraocular Pressure in a University Hospital Located in Midwestern Brazil|Completed||N/A|39|Actual|VER Excelência em Oftalmologia||1|||f||||f||||||||||2017-10-10 23:26:00.895493|2017-10-10 23:26:00.895493
NCT02405871|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-08-29|||March 2015||2015-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:26:00.976184|2017-10-10 23:26:00.976184
NCT02405858|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-09-19|||April 10, 2015|Actual|2015-04-10|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy|A Phase 4 Study of Zytiga in Poor-risk mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients Who Was Failed the First-line CAB (Combined Androgen Blockade) Therapy|Active, not recruiting||Phase 4|50|Actual|Janssen Pharmaceutical K.K.||1|||f||||t|f|f||||||||2017-10-10 23:26:01.015363|2017-10-10 23:26:01.015363
NCT02405845|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-03-14|||March 2015||2015-03-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Prospective Evaluation of Carotid Free-floating Thrombus|Prospective Evaluation of Intraluminal Internal Carotid Artery Free-Floating Thrombus|Recruiting||N/A|60|Anticipated|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-10-10 23:26:01.135493|2017-10-10 23:26:01.135493
NCT02405832|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-04-01|||March 2015||2015-03-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|June 2015|Anticipated|2015-06-01||Interventional|||Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome|Zinc Lozenges and Their Effect on Postoperative Sore Throat Syndrome: A Randomized, Double-blinded, Placebo-controlled Prospective Study|Unknown status|Recruiting|N/A|80|Anticipated|University of Vermont||2|||f||||f||||||||||2017-10-10 23:26:01.219501|2017-10-10 23:26:01.219501
NCT02405819|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-04-20|||February 2015||2015-02-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Patient and Provider Initiated Survivorship Care Planning|Patient and Provider Initiated Survivorship Care Planning: a Randomized Pilot Study|Completed||N/A|41|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 23:26:01.31591|2017-10-10 23:26:01.31591
NCT02405806|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-04-16|||November 2014||2014-11-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|October 15, 2015|Actual|2015-10-15||Interventional|||Clinical Effects of Nutrition on Metabolic Risk Factors and Mechanisms|Clinical Effects of Nutrition on Metabolic Risk Factors and Mechanisms|Active, not recruiting||N/A|50|Actual|Region Skane||2|||f||||f||||||||||2017-10-10 23:26:01.400359|2017-10-10 23:26:01.400359
NCT02405793|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-07-08|||May 2015||2015-05-01|July 2015|2015-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain|A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip|Withdrawn||Phase 2|0|Actual|Iroko Pharmaceuticals, LLC||3||Internal business decision not to move forward with study|f||||f||||||||||2017-10-10 23:26:01.465465|2017-10-10 23:26:01.465465
NCT02405780|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-08-03|||June 2015||2015-06-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|ARABESC-OLE||A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients|An Open-label Extension Study to Compare the Long-term Efficacy, Safety, Immunogenicity and Pharmacokinetics of FKB327 and Humira® in Patients With Rheumatoid Arthritis on Concomitant Methotrexate|Active, not recruiting||Phase 3|645|Actual|Fujifilm Kyowa Kirin Biologics Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:26:01.570465|2017-10-10 23:26:01.570465
NCT02405767|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-05-09|||April 2015||2015-04-01|May 2017|2017-05-01|September 2, 2016|Actual|2016-09-02|September 2, 2016|Actual|2016-09-02||Interventional|BIPPED||BioimPEDance of Diabetic Foot Ulcers|Characterisation by Electric Impedance Measurements of the Different Wound Healing Phases of Diabetic Foot Ulcers|Completed||N/A|20|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 23:26:01.957945|2017-10-10 23:26:01.957945
NCT02405741|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-31|||March 2015||2015-03-01|March 2015|2015-03-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|||Hyperbaric Chamber for Central Retinal Vein Occlusion (CRVO) Patients|Does Hyperbaric Chamber Improve the Functionality and Symptoms Related to Central Retinal Vein Occlusion (CRVO)?|Unknown status|Recruiting|Phase 2|20|Anticipated|Assaf-Harofeh Medical Center||1|||f||||f||||||||||2017-10-10 23:26:02.115198|2017-10-10 23:26:02.115198
NCT02405728|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-07-29|||February 2015||2015-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Vascular Access in Hematological Patients - PICC Versus CVC|Vascular Access in Hematological Patients - PICC Versus CVC in a Phase IV Randomized Controlled Trial|Enrolling by invitation||N/A|152|Actual|Federico II University|||2||f||||f||||||||||2017-10-10 23:26:02.185036|2017-10-10 23:26:02.185036
NCT02405715|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-07-28|||February 2015||2015-02-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|TOAD2015||Therapy With an Oxytocin Adjunct for Major Depression|Combined Use of Intranasal Oxytocin and Interpersonal Psychotherapy for the Treatment of Major Depressive Disorder (MDD): A Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|32|Anticipated|Concordia University||2|||f||||t||||||||||2017-10-10 23:26:02.262328|2017-10-10 23:26:02.262328
NCT02405702|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2015-04-02|||March 2015||2015-03-01|April 2015|2015-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Importance of Patient Selection for Treatment of Infected Total Knee Prosthesis|Does the Selection of Patients Helps Healing the Infection After Change in One Step of a Knee Replacement?|Unknown status|Not yet recruiting|N/A|60|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:26:02.369876|2017-10-10 23:26:02.369876
NCT02405689|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-12-09|||December 2014||2014-12-01|March 2015|2015-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Myocardial Protection and Anesthetic Agents|The Effect of Sevoflurane-dexmedetomidine and Sevoflurane-remifentanil on Biochemical Markers During Open Heart Surgery|Completed||Phase 4|60|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:26:02.431003|2017-10-10 23:26:02.431003
NCT02405676|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-07-27|||January 2015||2015-01-01|July 2016|2016-07-01|December 2024|Anticipated|2024-12-01|June 2021|Anticipated|2021-06-01||Interventional|BNHL-2015||BNHL-2015 for Children or Adolescents in China|Treatment Regimen or Children or Adolescent With Mature B-cell NHL or B-AL in China|Recruiting||Phase 2/Phase 3|200|Anticipated|Children's Cancer Group, China||4|||f||||f||||||||||2017-10-10 23:26:02.535111|2017-10-10 23:26:02.535111
NCT02405663|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-05-24|||April 2015||2015-04-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Methods of Placental Delivery and the Amount of Blood Loss During Cesarean Section|How Can Methods of Placental Delivery Affect the Amount of Blood Loss During Cesarean Section?|Completed||N/A|288|Actual|Benha University||2|||f||||t||||||||||2017-10-10 23:26:02.676593|2017-10-10 23:26:02.676593
NCT02405650|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-07-11|||April 2015||2015-04-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Observational|CRIC-VAP||CRIC-Visceral Adiposity and Physical Fitness in Chronic Kidney Disease|Visceral Adiposity and Physical Fitness in CKD|Recruiting||N/A|526|Anticipated|Baylor College of Medicine|||1||f||||f||||||None Retained|"     serum, blood   "|||2017-10-10 23:26:02.772181|2017-10-10 23:26:02.772181
NCT02405637|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-03-28|||March 2014||2014-03-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Simulated Amniotic Fluid In Preventing Feeding Intolerance and Necrotizing Enterocolitis VLBW Neonates|Enteral Administration of a Simulated Amniotic Fluid In Preventing Feeding Intolerance And Necrotizing Enterocolitis In Very Low Birth Weight Neonates|Unknown status|Recruiting|Phase 1|40|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:26:02.917898|2017-10-10 23:26:02.917898
NCT02405624|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-21|2015-03-31|||June 2014||2014-06-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||CPAP for Infantile Pompe Disease|Efficacy of Continuous Positive Airway Pressure of Treatment of Hypernasality of Children With Infantile Pompe Disease|Unknown status|Recruiting|Phase 4|3|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-10 23:26:03.015191|2017-10-10 23:26:03.015191
NCT02405611|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-07-22|||March 2015||2015-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||A Multi-component Intervention on Improving Fruit and Vegetable Consumption in Teenagers and Their Mothers|A Multi-component Intervention on Improving Fruit and Vegetable Consumption in Teenagers and Their Mothers|Completed||N/A|1500|Actual|Qazvin University Of Medical Sciences||3|||f||||f||||||||||2017-10-10 23:26:03.100302|2017-10-10 23:26:03.100302
NCT02405598|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2016-09-18|||October 2013||2013-10-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease|Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease|Completed||Phase 4|14|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-10 23:26:03.186356|2017-10-10 23:26:03.186356
NCT02405585|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-06-30|||April 2015||2015-04-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer|An Exploratory Phase 2 Study of Neoadjuvant Chemotherapy Followed by Stereotactic Body Radiation Therapy (SBRT) With Algenpantucel-L (HyperAcute®-Pancreas) Immunotherapy in Subjects With Borderline Resectable Pancreatic Cancer|Terminated||Phase 2|10|Actual|NewLink Genetics Corporation||1|||f||||f||||||||||2017-10-10 23:26:03.264135|2017-10-10 23:26:03.264135
NCT02405572|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-05-11|||February 2015||2015-02-01|May 2016|2016-05-01||||March 2016|Actual|2016-03-01||Interventional|||Feeding Tolerance Evaluation|Feeding Tolerance Evaluation|Completed||N/A|43|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 23:26:03.390705|2017-10-10 23:26:03.390705
NCT02405559|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-31|||May 2015||2015-05-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Lymphatic Occlusion Pressure in Lower Limb|The Occlusion Pressure of Superficial Lymphatics in the Lower Extremity of Healthy Volunteers: A Near Infrared Lymphofluoroscopy Approach|Unknown status|Not yet recruiting|Early Phase 1|32|Anticipated|Centre Hospitalier Universitaire Saint Pierre||1|||f||||f||||||||||2017-10-10 23:26:03.477869|2017-10-10 23:26:03.477869
NCT02405546|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-03-22|||August 2013||2013-08-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||ETT Rotation During Nasal Fiberoptic Intubation|Effect of 90° Degree Counterclockwise Rotation of the Endotracheal Tube on Its Advancement Through the Larynx During Nasal Fiberoptic Intubation in Children: A Randomized and Blinded Study|Completed||N/A|40|Actual|Nemours Children's Clinic||2|||f||||t||||||||||2017-10-10 23:26:03.587856|2017-10-10 23:26:03.587856
NCT02405533|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-11-09|||March 2015||2015-03-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|AHCC4HPV||Phase II Evaluation of AHCC for the Eradication of HPV Infections|Phase II Randomized, Double-blind, Placebo-controlled Evaluation of AHCC (Active Hexose Correlated Compound) for the Eradication of HPV Infections in Women With HPV Positive Pap Smears|Recruiting||Phase 2|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:26:03.695753|2017-10-10 23:26:03.695753
NCT02405520|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-07-13|||March 2015||2015-03-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine|A Phase I Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Safety and Immunogenicity of the Recombinant (E.Coli) Human Papillomavirus Type 6/11 Bivalent Vaccine in Healthy Volunteers Aged 18-55 Years|Active, not recruiting||Phase 1|144|Anticipated|Xiamen University||4|||f||||f||||||||||2017-10-10 23:26:03.79831|2017-10-10 23:26:03.79831
NCT02404194|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-26|||March 2015||2015-03-01|March 2015|2015-03-01||||September 2019|Anticipated|2019-09-01||Interventional|||Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis|Optimizing Cognitive Training to Improve Functional Outcome in Clinical High Risk (CHR)|Recruiting||N/A|76|Anticipated|Harvard University||2|||f||||t||||||||||2017-10-10 23:26:22.885455|2017-10-10 23:26:22.885455
NCT02405507|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-05-04|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of Wheat Germ on Gastrointestinal Discomfort, Blood Cholesterol and Postprandial Glycaemic Response|The Effect of Wheat Germ on Gastrointestinal Discomfort, Blood Cholesterol and Postprandial Glycaemic Response in Healthy Volunteers|Completed||Phase 2|55|Actual|Universidade do Porto||2|||f||||f||||||||||2017-10-10 23:26:03.913786|2017-10-10 23:26:03.913786
NCT02405494|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-04-09|||February 2011||2011-02-01|April 2015|2015-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effect of Liquid Volume and the Amount of Incorporated Gas Into a Carbohydrate/Protein Beverage on Satiety|Effect of Liquid Volume and the Amount of Incorporated Gas Into a Carbohydrate/Protein Beverage on Satiety: a Response-surface-model Study|Completed||N/A|96|Actual|Unilever R&D||9|||f||||f||||||||||2017-10-10 23:26:04.022586|2017-10-10 23:26:04.022586
NCT02405481|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-04-19|||June 2013||2013-06-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SEPA III||SEPA III: The Effectiveness Trial|SEPA III: The Effectiveness Trial|Completed||Phase 3|320|Actual|University of Miami||2|||f||||f||||||||||2017-10-10 23:26:04.113497|2017-10-10 23:26:04.113497
NCT02405468|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-02-14|||July 2013||2013-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|FLORINF||Identification of the Blood Microbiota in Patient Suffering From Myocardial Infraction|Identification of the Blood Microbiota in Patient Suffering From Myocardial Infraction|Completed||N/A|202|Actual|University Hospital, Toulouse|||2||f||||f||||||Samples With DNA|"     blood sample   "|No||2017-10-10 23:26:04.177488|2017-10-10 23:26:04.177488
NCT02405455|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-09-18|||June 2014||2014-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CEPEIC||Cerclage vs Cervical Pessary in Women With Cervical Incompetence|Cerclage vs Cervical Pessary in Women With Cervical Incompetence|Recruiting||Phase 4|60|Anticipated|Maternal-Infantil Vall d´Hebron Hospital||2|||f||||f||||||||||2017-10-10 23:26:04.247299|2017-10-10 23:26:04.247299
NCT02405442|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-02-23||2017-02-23|April 2015||2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease|A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of GS-5745 in Subjects With Moderately to Severely Active Crohn's Disease|Terminated||Phase 2|187|Actual|Gilead Sciences||6|||f||||t||||||||||2017-10-10 23:26:04.348738|2017-10-10 23:26:04.348738
NCT02405429|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-05-15|2017-03-07||May 2014||2014-05-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Temporal Artery Temperature Measurement in Neonates|Comparing Temporal Artery and Axillary Temperatures With Rectal Temperature in Neonates|Completed||N/A|49|Actual|University of Iowa|||1||f||||f||||||||||2017-10-10 23:26:04.558422|2017-10-10 23:26:04.558422
NCT02405416|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-03-31|||March 2015||2015-03-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Infrahepatic Inferior Vena Cava Clamping Versus Selective Hepatic Vascular Exclusion Involving the Portal Triad Clamping|A Prospective Randomized Controlled Trial to Compare Infrahepatic Inferior Vena Cava Clamping With Selective Hepatic Vascular Exclusion Involving the Portal Triad Clamping in Hepatectomy|Unknown status|Recruiting|N/A|120|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:26:04.770422|2017-10-10 23:26:04.770422
NCT02405403|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-05-29|||March 2015|Anticipated|2015-03-01|May 2017|2017-05-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|MARIA||Microglial Activation Role In ALS (MARIA)|Microglial Activation Role In ALS (MARIA)|Withdrawn||Early Phase 1|0|Actual|University Hospital, Tours||1||"It was more difficult than planned to find patients filling inclusion criteria and those which   corresponded didn't agree to participate"|f||||t||||||||||2017-10-10 23:26:04.857329|2017-10-10 23:26:04.857329
NCT02405390|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-05-11|2017-03-03||February 2015||2015-02-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Head Motion in Pediatric Patients Endotracheally Intubated With Video Laryngoscopy Versus Direct Laryngoscopy|Comparison of Head Motion in Pediatric Patients Endotracheally Intubated With Video Laryngoscopy (Storz C-Mac®) Versus Direct Laryngoscopy|Completed||N/A|92|Actual|Nicklaus Children's Hospital f/k/a Miami Children's Hospital||2|||f||||f||||||||No||2017-10-10 23:26:04.935461|2017-10-10 23:26:04.935461
NCT02405377|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-31|||February 2014||2014-02-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy|Chinese People's Liberation Army General Hospital|Completed||N/A|264|Actual|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:26:05.21834|2017-10-10 23:26:05.21834
NCT02405364|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-07-11|||February 2014|Actual|2014-02-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2017|Actual|2017-06-01||Interventional|IFM-CRd||Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction|Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Induction Followed by Autologous Stem Cell Transplantation, CRd Consolidation and Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma Patients ≤65 Years Old|Active, not recruiting||Phase 2|46|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 23:26:05.304457|2017-10-10 23:26:05.304457
NCT02405351|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-06-30|||April 2015||2015-04-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TEAMS||Telerehabilitation for Attention and Memory in Stroke|Telerehabilitation for Attention and Memory in Stroke (TEAMS): Development and Initial Evaluation of an Internet-Based Training Program|Recruiting||N/A|20|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-10 23:26:05.380968|2017-10-10 23:26:05.380968
NCT02405338|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-11-14|||March 2015||2015-03-01|November 2016|2016-11-01||||June 2019|Anticipated|2019-06-01||Interventional|||DC Vaccination for Post-remission Therapy in AML|Dendritic Cell-based Active Immunotherapy of Patients With Acute Myeloid Leukemia Using Autologous Cells Transfected With RNA Encoding Two Different Leukemia-associated Antigens|Recruiting||Phase 1/Phase 2|20|Anticipated|Medigene AG||1|||f||||t||||||||||2017-10-10 23:26:05.709102|2017-10-10 23:26:05.709102
NCT02405299|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-03-31|||October 2013||2013-10-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ERNTITDAH||Assessment of Neurocognitive Rehabilitations of Inhibition of Disorders in ADHD in Children (ERNTITDAH)|Evaluation Des rééducations Neuropsychologiques Des Troubles de l'Inhibition Chez l'Enfant Avec un TDAH|Unknown status|Enrolling by invitation|N/A|60|Anticipated|L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône||2|||f||||f||||||||||2017-10-10 23:26:06.045652|2017-10-10 23:26:06.045652
NCT02405286|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-31|||May 2014||2014-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage|Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage|Completed||N/A|50|Actual|Ain Shams University|||1||f||||f||||||||||2017-10-10 23:26:06.140128|2017-10-10 23:26:06.140128
NCT02405273|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-07-11|||April 2015||2015-04-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|PUREAIR||Pulmonary Resection And Intensive Rehabilitation|Effects of Early Pulmonary Rehabilitation and Long-term Exercise on Functioning, Quality of Life and Postoperative Outcome in Lung Cancer Patients|Recruiting||N/A|140|Anticipated|Arcispedale Santa Maria Nuova-IRCCS||2|||f||||f||||||||No||2017-10-10 23:26:06.236512|2017-10-10 23:26:06.236512
NCT02405260|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-02-09||2017-02-09|March 2015||2015-03-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|AGATA||Add Glucokinase Activator to Target A1c|A Multi-Center, Adaptive Phase 2, Randomized, Double-Blind, Placebo- and Active-Controlled (Sitagliptin), Parallel Group Study to Evaluate the Safety and Efficacy of TTP399 Following 6 Months Administration in Subjects With Type 2 Diabetes Mellitus on A Stable Dose of Metformin|Completed||Phase 2|190|Actual|vTv Therapeutics||4|||f||||f||||||||||2017-10-10 23:26:06.387099|2017-10-10 23:26:06.387099
NCT02405247|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-07-30|||June 2015||2015-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|TAURAS||TAURAS - T790 AURA ScreenFailure SOC Registry Study|TAURAS - T790 AURA ScreenFailure SOC Registry Study|Terminated||N/A|400|Anticipated|AstraZeneca|||1|Team's request.|f||||f||||||||||2017-10-10 23:26:06.564263|2017-10-10 23:26:06.564263
NCT02405234|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-07|||January 2009||2009-01-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|March 2015|Actual|2015-03-01||Interventional|CMRH||Ascension PyroCarbon Radial Head Study|Safety and Effectiveness Study of Ascension PyroCarbon Radial Head Compared to Ascension Metal Radial Head|Terminated||N/A|78|Actual|Integra LifeSciences Corporation||2||Business Decision|f||||t||||||||||2017-10-10 23:26:06.718711|2017-10-10 23:26:06.718711
NCT02405221|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-10-02|||November 2017|Anticipated|2017-11-01|October 2017|2017-10-01|November 2022|Anticipated|2022-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer|A Pilot Clinical Trial Assessing the Safety and Feasibility of Intramuscular Administration of the TA-CIN Vaccine as Adjuvant Therapy for Patients With History of HPV16 Associated Cervical Cancer|Not yet recruiting||Phase 1|14|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-10 23:26:06.822503|2017-10-10 23:26:06.822503
NCT02405208|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-05-24|||May 2010||2010-05-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|CHRA||A Multi-center Outcomes Clinical Study of the PyroTITAN™ HRA Shoulder Implant in Humeral Head Resurfacing|A Multi-center Outcomes Clinical Study of the PyroTITAN™ HRA Shoulder Implant in Humeral Head Resurfacing|Active, not recruiting||N/A|142|Actual|Integra LifeSciences Corporation|||1||f||||f||||||||||2017-10-10 23:26:06.940409|2017-10-10 23:26:06.940409
NCT02405195|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-01-05|||October 2011||2011-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|ECCSTUD||Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)|Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)|Completed||N/A|18|Actual|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||||2017-10-10 23:26:07.043594|2017-10-10 23:26:07.043594
NCT02405182|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-07-06|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|March 2018|Anticipated|2018-03-01||Observational|||MRI Biomarkers in ALS|Magnetic Resonance Imaging Biomarkers in Amyotrophic Lateral Sclerosis|Recruiting||N/A|195|Anticipated|University of Alberta|||2||f||||f||||||||||2017-10-10 23:26:07.124114|2017-10-10 23:26:07.124114
NCT02405169|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-03-02|||December 2013||2013-12-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|March 2017|Actual|2017-03-01||Interventional|||4 vs 6 Implants in Totally Edentulous Patient in Maxilla With Ti. Cad-cam Framework|Four Versus Six Endosseous Implants to be Used in the Rehabilitation of Totally Edentulous Patient in the Maxilla With Titanium Milled Framework|Active, not recruiting||Phase 2|50|Actual|Institute Franci||2|||f||||f||||||||||2017-10-10 23:26:07.280042|2017-10-10 23:26:07.280042
NCT02405156|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-01-25|||March 2015||2015-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Letrozole Pretreatment With Misoprostol for Second-Trimester Medical Abortion|A Prospective Double-Blind, Randomized, Placebo-Controlled Trial on the Use of Letrozole Pretreatment With Misoprostol for Second-Trimester Medical Abortion|Completed||Phase 2/Phase 3|400|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-10 23:26:07.385188|2017-10-10 23:26:07.385188
NCT02405143|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-03-27|||April 2015||2015-04-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|REVIS||Restoration of Vision After Stroke|Electrical Stimulation for Restoration of Vision After Stroke in the Damaged Visual Field of Patients With Unilateral Stroke (REVIS Helsinki)|Unknown status|Not yet recruiting|N/A|50|Anticipated|Helsinki University Central Hospital||2|||f||||t||||||||||2017-10-10 23:26:07.48797|2017-10-10 23:26:07.48797
NCT02405130|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-02-10|||April 2015||2015-04-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|RESTORE-SIRIO||The RESTORE-SIRIO Randomized Controlled Trial|Impact of intRacoronary adrEnaline on Myocardial reperfuSion in STEMI paTients With Persistent Impaired cORonary Flow After pErcutaneous Coronary Intervention: the RESTORE-SIRIO Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-10 23:26:07.572025|2017-10-10 23:26:07.572025
NCT02405117|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-04-18|||January 10, 2014|Actual|2014-01-10|April 2017|2017-04-01|April 10, 2017|Actual|2017-04-10|April 10, 2017|Actual|2017-04-10||Interventional|||A Mobile Behavioral Monitoring Intervention for Bipolar Disorder|A Mobile Behavioral Monitoring Intervention for Bipolar Disorder|Completed||N/A|14|Actual|Northwestern University||2|||f||||t||||||||Undecided||2017-10-10 23:26:07.662102|2017-10-10 23:26:07.662102
NCT02405104|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-04-11|||September 2015||2015-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|chlorzoxazon||Chlorzoxazone in Hip and Knee Arthroplasty|Analgetic Effects of Chlorzoxazone in Total Hip and Knee Arthroplasty|Active, not recruiting||Phase 4|400|Actual|Northern Orthopaedic Division, Denmark||4|||f||||t||||||||||2017-10-10 23:26:07.743791|2017-10-10 23:26:07.743791
NCT02405091|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-03-15|||March 2015||2015-03-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|Kinect 4||Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia|A Phase 3, Open-Label, Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia|Completed||Phase 3|168|Actual|Neurocrine Biosciences||2|||f||||f||||||||||2017-10-10 23:26:07.871895|2017-10-10 23:26:07.871895
NCT02405078|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-08-21|||October 2015|Actual|2015-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Pilot Project for Creation of the Diffuse Large B-cell Lymphoma (DLBCL) Response Prediction Model|Pilot Project for Creation of the DLBCL Response Prediction Model: Combining Early Interim Functional Imaging, Detection Of A Tumor-Specific Clonotype and Metabolic Profiling of Blood In Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma To Predict Response To Standard Immunochemotherapy|Recruiting||N/A|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:26:08.019757|2017-10-10 23:26:08.019757
NCT02405065|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-02-05|||January 2015||2015-01-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573|Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573 in Solid Tumors|Active, not recruiting||Phase 1|180|Anticipated|Hanmi Pharmaceutical Company Limited||1|||f||||f||||||||Undecided||2017-10-10 23:26:08.101916|2017-10-10 23:26:08.101916
NCT02405052|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-29|2015-03-31|||July 2013||2013-07-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Observational|||Validation of the Panic Screening Score in Patient With Unexplained Chest Pain|A Prospective Cohort Study to Refine and Validate the Panic Screening Score for Identifying Panic Attacks Associated With Unexplained Chest Pain in the Emergency Department|Unknown status|Recruiting|N/A|3000|Anticipated|Hôtel-Dieu de Lévis|||1||f||||||||||||||2017-10-10 23:26:08.167738|2017-10-10 23:26:08.167738
NCT02405039|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-06-02|||April 2015||2015-04-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|EBI-005||Study of EBI-005 in Dry Eye Disease (DED)|A Multi-Center, Double-Masked, Randomized, One-Year Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle-Control in Subjects With Dry Eye Disease (DED)|Unknown status|Active, not recruiting|Phase 3|188|Anticipated|Eleven Biotherapeutics||2|||f||||t||||||||||2017-10-10 23:26:08.254387|2017-10-10 23:26:08.254387
NCT02405026|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-10-02|||December 2014||2014-12-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients|HIV and Asthma in the Post-ART (Antiretroviral Therapy) Era|Completed||N/A|83|Actual|Duke University|||3||f||||f||||||Samples With DNA|"     serum, plasma, sputum supernatant, sputum cell pellet   "|||2017-10-10 23:26:08.350248|2017-10-10 23:26:08.350248
NCT02405013|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-07-10|||October 2015|Actual|2015-10-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|TAC||Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa|TAC (Treatment Africa Hepatitis C) : Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa|Active, not recruiting||Phase 2|120|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-10 23:26:08.423685|2017-10-10 23:26:08.423685
NCT02405000|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2017-07-25|||April 2015||2015-04-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Improving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance|Improving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance|Recruiting||N/A|10|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-10 23:26:08.564857|2017-10-10 23:26:08.564857
NCT02404987|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2015-03-27|||June 2014||2014-06-01|March 2015|2015-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||An Oral Nutritional Supplement Study in Older Malnourished Spanish Population|A Prospective, Observational Study, of a High Calorie and Protein Oral Nutritional Supplement, in an Older Malnourished Spanish Population|Unknown status|Recruiting|N/A|224|Anticipated|Abbott Nutrition|||1||f||||f||||||||||2017-10-10 23:26:08.637295|2017-10-10 23:26:08.637295
NCT02404974|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-01-21|||November 2014||2014-11-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|exercise/OA||Using Web-based Tools to Facilitate Tailored Exercise for People With Osteoarthritis|Using Web-based Tools to Facilitate Tailored Exercise for People With Osteoarthritis|Completed||N/A|10|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||No||2017-10-10 23:26:08.71267|2017-10-10 23:26:08.71267
NCT02404961|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-03-26|||September 2009||2009-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Women's Health Study: Immunological Factors and Risk of Vulvodynia|Immunological Factors and Risk of Vulvodynia|Completed||N/A|30675|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||Samples With DNA|"     Venous Blood and Vulvar punch biopsy   "|||2017-10-10 23:26:08.785151|2017-10-10 23:26:08.785151
NCT02404948|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-15|||April 2015||2015-04-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|July 2016|Actual|2016-07-01||Observational|PRV-KORO||PRV-based Detection of CAD in Comparison to Standard Methods|Comparison of a Pulse Wave Based Approach for Detection of Coronary Artery Disease Compared to Standard Methods|Recruiting||N/A|200|Anticipated|University Medicine Greifswald|||1||f||||f||||||||||2017-10-10 23:26:08.852244|2017-10-10 23:26:08.852244
NCT02404935|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-01-24|||February 2014||2014-02-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|February 2018|Anticipated|2018-02-01||Interventional|TIME||Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)|Randomized Phase II Study of First-line FOLFIRI Plus Cetuximab for 8 Cycles Followed by Either Single-agent Cetuximab as Maintenance Therapy or Observation in Patients With Wild-type KRAS and NRAS Metastatic Colorectal Cancer|Recruiting||Phase 2|168|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-10 23:26:08.937897|2017-10-10 23:26:08.937897
NCT02404922|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-27|2016-02-03|||March 2015||2015-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Multiple Ascending Dose Study in Healthy Volunteers|A Phase I Single Center, Double-Blind, Placebo-Controlled, Multiple Dose-Ascending Study to Evaluate the Pharmacokinetics and Tolerability of CTP-730 Immediate Release at Steady State in Healthy Adults|Completed||Phase 1|30|Actual|Concert Pharmaceuticals||3|||f||||f||||||||||2017-10-10 23:26:09.154355|2017-10-10 23:26:09.154355
NCT02404909|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-21|2015-03-26|||January 2005||2005-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|IVC||Inferior Vena Cava Index in Patients Undergoing Liver Resection|Does Inferior Vena Cava Collapsibility Correlate With Fluid Regimen and Outcome in Patients Undergoing Liver Resection?|Completed||N/A|91|Actual|University of Milan|||1||f||||f||||||||||2017-10-10 23:26:11.09682|2017-10-10 23:26:11.09682
NCT02404896|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-02-03|||January 2015||2015-01-01|February 2017|2017-02-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Interventional|||Expanded Access Metreleptin Study|Expanded-Access for the Use of Metreleptin in Patients With Partial Lipodystrophy Associated With Diabetes Mellitus or Hypertriglyceridemia|Active, not recruiting||Phase 2|11|Actual|University of Michigan||1|||f||||f||||||||||2017-10-10 23:26:11.1539|2017-10-10 23:26:11.1539
NCT02404883|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-08-02|||October 2014||2014-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|Fertionco||Decisional Conflict of Young Cancer Patients With Regard to Fertility Preservation|Decisional Conflict of Young Cancer Patients With Regard to Fertility Preservation - Effects of an Online Decision-aid Tool|Recruiting||N/A|120|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 23:26:11.22459|2017-10-10 23:26:11.22459
NCT02404870|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-31|2017-06-30|||September 10, 2014||2014-09-10|January 31, 2017|2017-01-31|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers|Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers|Recruiting||Phase 1|175|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:26:11.303486|2017-10-10 23:26:11.303486
NCT02404857|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-11-23|||January 2015||2015-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|BCI-stroke||BCI Post-stroke Neurorehabilitation|A Novel BCI-controlled Pneumatic Glove System for Neurorehabilitation Post-stroke|Completed||N/A|20|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:26:11.409649|2017-10-10 23:26:11.409649
NCT02404844|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-03-21|||December 2014||2014-12-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|PIKTAM||Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer|Molecularly Stratified Parallel Cohort, Single Arm Phase II Trial of the Phosphoinositide 3-kinase (PI3K) Inhibitor Buparlisib (BKM120) in Combination With Tamoxifen in Patients With Hormone Receptor-positive, HER2-negative Inoperable (Locally Advanced or Metastatic) Breast Cancer With Prior Exposure to Antihormonal Therapy|Active, not recruiting||Phase 2|48|Actual|University Hospital, Essen||1|||f||||f||||||||||2017-10-10 23:26:11.494229|2017-10-10 23:26:11.494229
NCT02404831|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-07-23|||April 2014||2014-04-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|webbasedPR||An Evaluation of Web Based Pulmonary Rehabilitation|An Evaluation of Web Based Pulmonary Rehabilitation- Pilot Study|Completed||Phase 1/Phase 2|20|Actual|University of Glasgow||2|||f||||f||||||||||2017-10-10 23:26:11.582715|2017-10-10 23:26:11.582715
NCT02404818|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-08-10|||April 2015||2015-04-01|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Observational|||Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy|UFPTI 1431 - HL02: Investigating Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Survivors Treated With Either Photon or Proton Radiation|Active, not recruiting||N/A|5|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-10 23:26:11.66545|2017-10-10 23:26:11.66545
NCT02404805|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-11-21|||February 2016||2016-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers|Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/Hepatitis C Virus (HCV) Seronegative Volunteers|Completed||N/A|25|Actual|University of Colorado, Denver||6|||f||||f||||||||||2017-10-10 23:26:11.754518|2017-10-10 23:26:11.754518
NCT02404792|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-06-21|||April 2015||2015-04-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Exercise for Healthy Aging: The Impact of HIV and Aging on Physical Function and the Somatopause|Exercise for Healthy Aging: The Impact of HIV and Aging on Physical Function and the Somatopause|Active, not recruiting||N/A|72|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:26:11.85248|2017-10-10 23:26:11.85248
NCT02404779|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-09-18|||March 2015||2015-03-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|THIC Cu||Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents|Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents. A Controlled Randomized Study Versus Placebo|Unknown status|Recruiting|Phase 4|34|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:26:12.065252|2017-10-10 23:26:12.065252
NCT02404766|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-03-30|||December 2012||2012-12-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of C0-C1 Mobilization in the Neutral Position in Subjects With Upper Cervical Rotational Hypomobility||Completed||Phase 3|48|Actual|Universidad de Zaragoza||3|||f||||||||||||||2017-10-10 23:26:12.185589|2017-10-10 23:26:12.185589
NCT02404753|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-02-27|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|REALIZATION||A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant Chemotherapy|A Randomized, Single Center, Controlled Phase II Study to Compare Laparoscopic Versus Open Distal Gastrectomy in Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy|Enrolling by invitation||Phase 2|96|Anticipated|Peking University||2|||f||||f||||||||||2017-10-10 23:26:12.275662|2017-10-10 23:26:12.275662
NCT02404181|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-05-02|||March 2014||2014-03-01|May 2017|2017-05-01|December 1, 2016|Actual|2016-12-01|July 1, 2016|Actual|2016-07-01|4 Days|Observational [Patient Registry]|||Validation of a Delirium Monitor|Validation of a Delirium Monitor in Postoperative Elderly Patients|Completed||N/A|159|Actual|UMC Utrecht|||1||f||||t||||||||||2017-10-10 23:26:23.016608|2017-10-10 23:26:23.016608
NCT02404740|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-12-01|||February 2015||2015-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Noninvasive Intracranial Pressure and Hydrocephalus Patients|Continuous Noninvasive Estimation of Intracranial Pressure to Assess Ventriculoperitoneal Shunt Malfunction in Patients With Hydrocephalus|Enrolling by invitation||N/A|150|Anticipated|University of Colorado, Denver|||3||f||||f||||||||||2017-10-10 23:26:12.3733|2017-10-10 23:26:12.3733
NCT02404727|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-03-30|||October 2014||2014-10-01|December 2014|2014-12-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis|Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis|Recruiting||Phase 3|60|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:26:12.455607|2017-10-10 23:26:12.455607
NCT02404714|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-02-20|||February 8, 2017|Actual|2017-02-08|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||A Multi-Center Study of the CF Quantum® Sweat Test System|A Multi-Center Study of A New Method of Sweat Testing: The CF Quantum® Sweat Test|Recruiting||N/A|300|Anticipated|Polychrome Medical, Inc.|||2||f||||f|f|t|t|f||Samples Without DNA|"     Sweat samples will be collected per standard sweat testing procedure.   "|No||2017-10-10 23:26:12.562698|2017-10-10 23:26:12.562698
NCT02404701|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-10-26|||February 2015||2015-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk|Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk|Completed||N/A|45|Actual|University of Wisconsin, Madison||8|||f||||f||||||||||2017-10-10 23:26:12.682802|2017-10-10 23:26:12.682802
NCT02404688|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-06-21|||February 2015||2015-02-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|THC-ETOH||Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition|Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition|Recruiting||Phase 1|40|Anticipated|Yale University||4|||f||||f||||||||||2017-10-10 23:26:12.790297|2017-10-10 23:26:12.790297
NCT02404675|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-07-27|||April 2015||2015-04-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|INCREASE||High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation|High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation (INCREASE): a Randomized, Open-label Study|Recruiting||Phase 4|240|Anticipated|Betta Pharmaceuticals Co.,Ltd.||3|||f||||f||||||||||2017-10-10 23:26:12.901075|2017-10-10 23:26:12.901075
NCT02404662|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-10-04|||March 2015||2015-03-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Trial of Supportive Text Messages for Patients With Alcohol Use Disorder and a Co-morbid Depression|Single Blind Randomised Trial of Supportive Text Messages for Patients With Alcohol Use Disorder and a Co-morbid Depression|Active, not recruiting||N/A|107|Actual|St Patrick's Hospital, Ireland||2|||f||||t||||||||||2017-10-10 23:26:12.987026|2017-10-10 23:26:12.987026
NCT02404649|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-03-14|2016-03-28||July 2012||2012-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2014|Actual|2014-10-01||Interventional||Units: participants|Comparing Conventional Dental Implants and Trabecular Metal™ Dental Implants After Sinus Floor Elevation|A Prospective Clinical Trial Comparing Conventional Dental Implants and Trabecular Metal™ Dental Implants After Staged Sinus Floor Elevation Procedures|Active, not recruiting||N/A|33|Actual|Harvard Medical School||2|||f||||t||||||||No||2017-10-10 23:26:13.07834|2017-10-10 23:26:13.07834
NCT02404636|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-04-06|||January 2012||2012-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|ADDUP||Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis|Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis|Active, not recruiting||N/A|50|Anticipated|University Hospital Birmingham|||2||f||||f||||||||||2017-10-10 23:26:13.321906|2017-10-10 23:26:13.321906
NCT02404623|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-03-29|||April 2015||2015-04-01|March 2017|2017-03-01|May 16, 2018|Anticipated|2018-05-16|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Vitamin D Administration to Premature Infants on Vitamin D Status and Respiratory Morbidity|The Effect of Vitamin D Administration to Premature Infants on Vitamin D Status and Respiratory Morbidity During the First Year of Life|Recruiting||N/A|60|Anticipated|Soroka University Medical Center||2|||f||||f||||||||Yes||2017-10-10 23:26:13.396334|2017-10-10 23:26:13.396334
NCT02404610|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-09-20|||July 2014||2014-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Moderate Versus Deep Procedural Sedation With Propofol in the Emergency Department|Moderate Versus Deep Procedural Sedation With Propofol in the Emergency Department|Recruiting||Phase 4|150|Anticipated|Minneapolis Medical Research Foundation||2|||f||||f||||||||||2017-10-10 23:26:13.481298|2017-10-10 23:26:13.481298
NCT02404597|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-09-11|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Cardiac Output Monitoring in Burn Patients|Non-invasive Cardiac Output Monitoring in Patients With Burn Injuries|Suspended||N/A|20|Anticipated|Emory University||2||Potential participants have not yet been identified.|f||||f|f|t|f|f||||||2017-10-10 23:26:13.565131|2017-10-10 23:26:13.565131
NCT02404584|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-07-05|||December 2015||2015-12-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|April 2017|Anticipated|2017-04-01||Observational|GenCInibs-Suni||The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer|The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer: Searching for Pharmacogenetic Determinants|Recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 23:26:13.654387|2017-10-10 23:26:13.654387
NCT02404571|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-07-25|||January 2011||2011-01-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||GDP in Frontline Chemotherapy for Patients With PTCL-NOS|The Efficacy and Toxicity of GDP Chemotherapy in Patients With Peripheral T-cell Lymphoma: An Open-label, Single-arm, Phase II Clinical Trial|Recruiting||Phase 2|28|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 23:26:13.765763|2017-10-10 23:26:13.765763
NCT02404558|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-03-25|||May 2015||2015-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis|An Open-label, Randomized, Parallel Group, Single-dose Study to Describe the Safety of IL-6 Receptor Blockade With Sarilumab or Tocilizumab Monotherapy in Japanese Patients With Rheumatoid Arthritis|Completed||Phase 1|30|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 23:26:13.953098|2017-10-10 23:26:13.953098
NCT02404545|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-08-24|2017-07-25||August 14, 2015|Actual|2015-08-14|August 2017|2017-08-01|March 2017|Actual|2017-03-01|August 2016|Actual|2016-08-01||Interventional|||Prevention of Parastomal Hernia by Mesh Placement|A Randomized Study of the Utility of Composite Mesh Placement to Prevent Parastomal Hernia in Patients Undergoing Urinary Diversion With Ileal Conduit|Terminated||N/A|12|Actual|University of Miami|This study required a minimum of 13 participants enrolled per arm. Due to the manufacturer's (Ethicon) termination of the Physiomesh device, the study was prematurely closed with fewer than minimum number of participants required per arm.|2||Sponsor stopped producing device|f||||t||||||||||2017-10-10 23:26:14.06076|2017-10-10 23:26:14.06076
NCT02404532|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-02-01||2016-02-01|February 2015||2015-02-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|OSMITTER||Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)|OSMITTER 316-13-206B Substudy: A Substudy to Measure the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1) System and Determine the Latency Period|Completed||Phase 4|30|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-10-10 23:26:14.431804|2017-10-10 23:26:14.431804
NCT02404519|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-09-12|||June 2015||2015-06-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Vitamin K2 Effect on Vascular Stiffening in Subjects With a Poor Vitamin K-status|Intervention Study on the Effect of Vitamin K2 (Menaquinone-7) Supplementation on the Vascular Stiffness in Subjects With Poor Vitamin K-status|Active, not recruiting||N/A|240|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:26:14.507366|2017-10-10 23:26:14.507366
NCT02404506|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-08-02|||August 2015||2015-08-01|August 2017|2017-08-01|October 2023|Anticipated|2023-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer|Eribulin as 1st Line Treatment in Elderly Patients (≥ 70 Years) With Advanced Breast Cancer: a Multicenter Phase II Trial|Recruiting||Phase 2|77|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-10 23:26:14.596825|2017-10-10 23:26:14.596825
NCT02404493|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-02-06|2016-11-28||March 2015||2015-03-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin|A Clinical Trial to Evaluate the Efficacy of an Investigational Nighttime Moisturizing Balm in the Management of Mild to Moderate Atopic Dermatitis in Infants and Toddlers|Terminated||N/A|23|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|A decision was made by the sponsor to terminate the study prior to enrolling 50 subjects as enrollment was not completed prior to the summer months, and the incidence of atopic dermatitis is low in the summer months.|2||Lack of subject enrollment and the eczema season has completed|f||||f||||||||||2017-10-10 23:26:14.951694|2017-10-10 23:26:14.951694
NCT02404480|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-07-24|||March 2015||2015-03-01|July 2015|2015-07-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||PTC596 in Patients With Advanced Solid Tumors|A Phase 1 Study of PTC596 in Patients With Advanced Solid Tumors|Unknown status|Recruiting|Phase 1|60|Anticipated|PTC Therapeutics||1|||f||||f||||||||||2017-10-10 23:26:19.030728|2017-10-10 23:26:19.030728
NCT02404454|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-03-08|||June 2016||2016-06-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel||Not yet recruiting||N/A|50|Anticipated|University of Cagliari||1|||f||||f||||||||||2017-10-10 23:26:19.264707|2017-10-10 23:26:19.264707
NCT02404441|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-05-15|||April 27, 2015|Actual|2015-04-27|May 2017|2017-05-01|July 12, 2018|Anticipated|2018-07-12|February 13, 2018|Anticipated|2018-02-13||Interventional|||Phase I/II Study of PDR001 in Patients With Advanced Malignancies|Open Label Multicenter Phase I/II Study of the Safety and Efficacy of PDR001 Administered to Patients With Advanced Malignancies|Recruiting||Phase 1/Phase 2|288|Anticipated|Novartis||2|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 23:26:19.443357|2017-10-10 23:26:19.443357
NCT02404428|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-23|||February 2015||2015-02-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ESCAPE-ING||Utilizing MRI to Study the Effect of Sulforaphane on Prostate Cancer|Effect of Sulforaphane on Prostate CAncer PrEvention-imagING Evaluation|Terminated||N/A|5|Actual|Quadram Institute||2||Problems with recruitment|f||||f||||||||||2017-10-10 23:26:19.674474|2017-10-10 23:26:19.674474
NCT02404415|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-10-27|||October 2011||2011-10-01|October 2016|2016-10-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01|10 Years|Observational [Patient Registry]|VAFAR||The Vanderbilt Atrial Fibrillation Ablation Registry|The Vanderbilt Atrial Fibrillation Ablation Registry|Recruiting||N/A|3000|Anticipated|Vanderbilt University|||1||f||||t||||||||||2017-10-10 23:26:19.778885|2017-10-10 23:26:19.778885
NCT02404402|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-06-30|||May 1, 2015|Actual|2015-05-01|June 2017|2017-06-01|November 30, 2018|Anticipated|2018-11-30|March 31, 2018|Anticipated|2018-03-31||Interventional|LED-TBI||LED Treatment to Improve Cognition and Promote Recovery in TBI|Noninvasive LED Treatment to Improve Cognition and Promote Recovery in Blast TBI|Recruiting||Phase 2|32|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:26:19.892711|2017-10-10 23:26:19.892711
NCT02404376|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-09-22|||March 2016|Actual|2016-03-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|COMBAT-MI||COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial|COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial|Recruiting||Phase 3|400|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||4|||f||||f||||||||||2017-10-10 23:26:20.118067|2017-10-10 23:26:20.118067
NCT02404363|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-08-28|||January 11, 2016|Actual|2016-01-11|August 2017|2017-08-01|June 26, 2018|Anticipated|2018-06-26|December 26, 2017|Anticipated|2017-12-26||Interventional|PANCREADOGREL||Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy|A Phase III Multi-centre Double-blind Placebo Controlled Study Analysing the Efficacy and Safety of Daily Administration of a P2Y12 Inhibitor (Clopidogrel) for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer|Active, not recruiting||Phase 3|39|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:26:20.263405|2017-10-10 23:26:20.263405
NCT02404350|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-08-03|||August 2015||2015-08-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|FUTURE5||Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis|A Phase III, Randomized, Double-blind, Placebo Controlled Multi-center Study of Subcutaneous Secukinumab (150 mg and 300 mg) in Prefilled Syringe to Demonstrate Efficacy (Including Inhibition of Structural Damage), Safety, and Tolerability up to 2 Years in Subjects With Active Psoriatic Arthritis (FUTURE 5)|Recruiting||Phase 3|990|Anticipated|Novartis||5|||f||||f||||||||||2017-10-10 23:26:20.401264|2017-10-10 23:26:20.401264
NCT02404337|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-08-12|||July 2015||2015-07-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|HCTBETAINE||Betaine METABOLISM OF PATIENTS With Homocystinuria|Betaine METABOLISM OF PATIENTS With Homocystinuria|Recruiting||Phase 2|18|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:26:20.815354|2017-10-10 23:26:20.815354
NCT02404324|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-04-09|||January 2012||2012-01-01|March 2015|2015-03-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Conservative Treatment of Esotropia in Children up to 3 Years Old|Prescription of Full Optical Correction in Refractive Errors to Treat Esotropia in Children up to 3 Years Old|Active, not recruiting||N/A|150|Anticipated|National Centre of Ophthalmology named after academician Zarifa Aliyeva||1|||f||||t||||||||No||2017-10-10 23:26:20.935533|2017-10-10 23:26:20.935533
NCT02404311|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-12-09|||January 2015||2015-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Safety and Immune Response Study of 2 Experimental HIV Vaccines|A Phase 1-2 Randomized, Double-blind, Placebo-controlled Clinical Trial of Clade C ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120/MF59® in HIV-uninfected Adults at Low Risk of HIV Infection|Active, not recruiting||Phase 1/Phase 2|252|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:26:21.014542|2017-10-10 23:26:21.014542
NCT02404298|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-09-19|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|PHARMACOPID||Transcriptome Analysis of the Peripheral Blood in CIDP|Identification of the Mechanisms of Action of Intravenous Immunoglobulins in CIDP by Analysis of the Genetic Expression Profile in Blood Mononuclear Cells|Recruiting||N/A|50|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:26:21.705093|2017-10-10 23:26:21.705093
NCT02404272|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-03-08|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|TOP||Effectiveness of an Oral Feeding Educational Nurse Program on Feeding Performance in Preterm Neonates|Evaluation de la Formation Des infirmières à la Stimulation de l'oralité Des Nouveau-nés Dans Une unité de Réanimation néonatale et Néonatologie : Impact Sur Les Connaissances, Les Pratiques et Sur la qualité Des Soins|Completed||N/A|729|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-10 23:26:21.995881|2017-10-10 23:26:21.995881
NCT02404259|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-03-30|||June 2010||2010-06-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||PK TDF in Thai HIV-infected Children|Pharmacokinetics Study of Tenofovir in HIV-infected Thai Children Using Tenofovir-based Regimen|Completed||N/A|32|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||f||||||||||2017-10-10 23:26:22.116953|2017-10-10 23:26:22.116953
NCT02404233|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-03-30|||March 2015||2015-03-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|PREZENT||Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects|A Phase IV 48 Week, Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects (PREZENT)|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Therapeutic Concepts||1|||f||||f||||||||||2017-10-10 23:26:22.554987|2017-10-10 23:26:22.554987
NCT02404220|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-09|||May 28, 2015|Actual|2015-05-28|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoid Leukemia (ALL)|A Phase 1b, Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) With Vincristine and Dexamethasone in Adult Subjects With Relapsed or Refractory Acute Lymphoid Leukemia (ALL)|Recruiting||Phase 1|35|Anticipated|Gilead Sciences||1|||f||||f|t|f||||||||2017-10-10 23:26:22.665739|2017-10-10 23:26:22.665739
NCT02404207|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-05-10|||March 2015||2015-03-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|STAR||Soybean Oil Trial of cArdiovascular Risk|The Effect of High-Oleic Soybean Oil on Biomarkers of Risk for Metabolic Syndrome|Completed||N/A|60|Actual|USDA Beltsville Human Nutrition Research Center||4|||f||||f||||||||||2017-10-10 23:26:22.797281|2017-10-10 23:26:22.797281
NCT02404168|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-25|||April 2015||2015-04-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients|Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients|Unknown status|Not yet recruiting|Phase 4|6|Anticipated|University of Maryland||4|||f||||f||||||||||2017-10-10 23:26:23.098535|2017-10-10 23:26:23.098535
NCT02404155|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-08-08|||July 2015||2015-07-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|BEN||Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)|Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)|Recruiting||N/A|250|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-10 23:26:23.186115|2017-10-10 23:26:23.186115
NCT02404142|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-06-08|||February 2015||2015-02-01|June 2016|2016-06-01||||February 2018|Anticipated|2018-02-01||Interventional|GICAC||Curarisation and Intubation Conditions During Videolaryngoscopy With Glidescope Titanium||Recruiting||Phase 4|180|Anticipated|CHU de Reims||2|||f||||f||||||||||2017-10-10 23:26:23.2729|2017-10-10 23:26:23.2729
NCT02404129|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-26|||April 2015||2015-04-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Interventional|||Validity of TURN 180 Test to Distinguish Between the Fallers and Non-Fallers|Validity of TURN 180 Test to Distinguish Between the Fallers and Non-fallers|Unknown status|Not yet recruiting|N/A|75|Anticipated|Clalit Health Services||3|||f||||f||||||||||2017-10-10 23:26:23.456658|2017-10-10 23:26:23.456658
NCT02404116|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-02-06|||March 2015||2015-03-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Metacognitive Therapy for Health Anxiety|Metacognitive Therapy for Health Anxiety: A Randomised Control Trial|Completed||N/A|21|Actual|University of Manchester||2|||f||||t||||||||||2017-10-10 23:26:23.609685|2017-10-10 23:26:23.609685
NCT02404090|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-03-26|||August 2015||2015-08-01|March 2015|2015-03-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Observational|CT-OAM||Impact of the Excess Weight Loss on Mineralization Patterns of the Knee After Bariatric Operations|Impact of the Excess Weight Loss on Mineralization Patterns of the Knee After Bariatric Operations - a Prospective CT-osteoabsorptiometry-based Study|Not yet recruiting||N/A|50|Anticipated|Spital Limmattal Schlieren|||1||f||||t||||||||||2017-10-10 23:26:23.842796|2017-10-10 23:26:23.842796
NCT02404077|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-04-19|||April 2015||2015-04-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Use of Clonidine to Prevent Withdrawal Following Prolonged Dexmedetomidine Infusions||Completed||N/A|712|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 23:26:23.92557|2017-10-10 23:26:23.92557
NCT02404064|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2015-03-26|||March 2015||2015-03-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Laparoscopic Appendectomy for Uncomplicated Appendicitis: Does Antimicrobial Prophylaxis Really Matter?|Laparoscopic Appendectomy for Uncomplicated Appendicitis: Does Antimicrobial Prophylaxis Really Matter? Randomized Control Trial|Unknown status|Not yet recruiting|N/A|288|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-10 23:26:24.013779|2017-10-10 23:26:24.013779
NCT02404051|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-06-14|||December 2015||2015-12-01|June 2016|2016-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|FEVEX||Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer|Fulvestrant Followed by Everolimus Plus Exemestane vs Examestane and Everolimus Followed by Fulvestrant in Postmenopausal Women With HR+ and HER2- Locally Advanced (LABC) or Metastatic Breast Cancer (MBC) Previously Treated With NSAI|Recruiting||Phase 3|745|Anticipated|Consorzio Oncotech||2|||f||||t||||||||No||2017-10-10 23:26:24.128739|2017-10-10 23:26:24.128739
NCT02404038|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-07-21|||July 2015||2015-07-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|UChoose||A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods|An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prevention Methods|Active, not recruiting||N/A|131|Actual|Desmond Tutu HIV Centre||3|||f||||f||||||||||2017-10-10 23:26:24.404971|2017-10-10 23:26:24.404971
NCT02404025|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-10-05|||May 2015|Actual|2015-05-01|October 2017|2017-10-01|September 6, 2017|Actual|2017-09-06|September 6, 2017|Actual|2017-09-06||Interventional|||Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects|A Non-randomized, Phase II Study of Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A (ATG/CsA) in Subjects With Moderate or More Severe Aplastic Anemia Who Have Not Received Prior ATG/Anti-lymphocyte Globulin (ALG)-Based Immunosuppressive Therapy|Completed||Phase 2|11|Actual|Novartis||1|||f||||f||||||||||2017-10-10 23:26:24.510839|2017-10-10 23:26:24.510839
NCT02404012|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-04-18|||November 2014||2014-11-01|April 2017|2017-04-01|December 31, 2022|Anticipated|2022-12-31|December 2019|Anticipated|2019-12-01||Interventional|||Iron Supplement to Improve Iron Status Following Bariatric Surgery|Comparison of Iron Supplement Formulations to Improve Iron Status Following Roux-en-Y and Sleeve Gastrectomy Bariatric Surgery|Recruiting||N/A|64|Anticipated|Purdue University||2|||f||||f||||||||||2017-10-10 23:26:24.649599|2017-10-10 23:26:24.649599
NCT02403986|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-05-08|||April 2015||2015-04-01|May 2017|2017-05-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|||An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face|A Randomised, Multi-centre, Parallel-group, Efficacy and Safety Study Evaluating Two and Three Initial Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face|Completed||Phase 4|50|Anticipated|Q-Med AB||2|||f||||f||||||||||2017-10-10 23:26:24.829818|2017-10-10 23:26:24.829818
NCT02401321|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-03-06|||April 1, 2015|Actual|2015-04-01|March 2017|2017-03-01||||June 23, 2016|Actual|2016-06-23||Interventional|||Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers|A Pilot Feasibility Study: Taking Care of Her|Completed||N/A|14|Actual|University of Washington||1|||f||||f||||||||||2017-10-10 23:26:55.490316|2017-10-10 23:26:55.490316
NCT02403973|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-30|||April 2010||2010-04-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2012|Actual|2012-11-01||Interventional|||Trial Comparing Perioperative Care for Breast Cancer Patients at a Patient Hotel vs a General Surgical Ward|Randomized Clinical Trial Comparing Perioperative Care for Breast Cancer Patients at a Patient Hotel Versus a General Surgical Ward|Completed||N/A|151|Actual|Danderyd Hospital||2|||f||||f||||||||||2017-10-10 23:26:24.901874|2017-10-10 23:26:24.901874
NCT02403960|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-10-30|||June 2010||2010-06-01|October 2015|2015-10-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|||Probiotic Use in Chronic Periodontitis Patients|The Effect of a Streptococcus Probiotic in Periodontal Therapy: a Randomized Controlled Trial|Completed||N/A|48|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:26:24.984677|2017-10-10 23:26:24.984677
NCT02403947|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-07-24|||February 2015||2015-02-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MESEMS||MEsenchymal StEm Cells for Multiple Sclerosis|Treatment of Multiple Sclerosis With Mesenchymal Stem Cells: Phase I/II Study|Recruiting||Phase 1/Phase 2|12|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-10 23:26:25.084348|2017-10-10 23:26:25.084348
NCT02403934|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-08-18|||October 2014||2014-10-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Jaw Elevation Device in Deep Sedation Study|The Use of Jaw Elevation Device in Deep Sedation|Completed||N/A|50|Actual|United States Naval Medical Center, San Diego|||1||f||||f||||||||No||2017-10-10 23:26:25.201712|2017-10-10 23:26:25.201712
NCT02403921|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-03-30|||March 2015||2015-03-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Association Between Cortisol, Cortisone, Cotinine, Nicotine, Caffeine, Melatonin Levels in Hair, Serum, Urine, Saliva and Chronic Stress||Unknown status|Not yet recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:26:25.270826|2017-10-10 23:26:25.270826
NCT02403908|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-25|||February 2015||2015-02-01|March 2015|2015-03-01|January 2019|Anticipated|2019-01-01|January 2016|Anticipated|2016-01-01||Interventional|CADOPA||Catheter Denervation of Pulmonary Arteries in Treatment of IPAH & SPAH|Catheter Denervation of Pulmonary Arteries in The Treatment of Idiopathic (PAH) & Secondary Pulmonary Hypertension (PH)|Recruiting||Phase 1|60|Anticipated|Clinical Hospital Centre Zagreb||2|||f||||t||||||||||2017-10-10 23:26:25.398302|2017-10-10 23:26:25.398302
NCT02403895|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2017-01-27|||April 2015||2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||AZD2014 and Weekly Paclitaxel in Squamous NSCLC|A Phase 2a, Multi-centre, Single-arm Trial of the Combination of AZD2014 and Weekly Paclitaxel in Patients With Relapsed or Refractory Squamous Non-Small Cell Lung Cancer After At Least One Line of Prior Therapy|Completed||Phase 2|11|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:26:25.494426|2017-10-10 23:26:25.494426
NCT02403882|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-04-23|||October 2014||2014-10-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Behavioral Economic Interventions at Food Pantries|An Analysis of Behavioral Economic Interventions at Client-Choice Food Pantries|Enrolling by invitation||N/A|443|Anticipated|Auburn University||5|||f||||f||||||||||2017-10-10 23:26:25.614765|2017-10-10 23:26:25.614765
NCT02403869|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-07-24|||March 12, 2014|Actual|2014-03-12|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|June 30, 2016|Actual|2016-06-30||Observational|DD-CMM||Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy|Study of Quality of Life in Patients With Metastatic Breast Cancer Treated With Second-line Monochemotherapy|Active, not recruiting||N/A|148|Actual|Celgene|||1||f||||f||||||||||2017-10-10 23:26:25.697506|2017-10-10 23:26:25.697506
NCT02403856|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-12-23|||April 2015||2015-04-01|December 2015|2015-12-01|April 2018|Anticipated|2018-04-01|May 2017|Anticipated|2017-05-01||Interventional|CALCECHO||Efficacy and Tolerance of Ultrasound-guided Needling and Lavage of Calcific Tendinitis of the Rotator Cuff Performed With or Without Subacromial Corticosteroid Injection|Efficacy and Tolerance of Ultrasound-guided Needling and Lavage of Calcific Tendinitis of the Rotator Cuff Performed With or Without Subacromial Corticosteroid Injection: A Double Blind Controlled Study|Recruiting||Phase 4|136|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-10 23:26:25.928054|2017-10-10 23:26:25.928054
NCT02403830|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-04-27|2017-03-14||August 2015||2015-08-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine|Effect of the Peripheral Opioid Receptor Antagonist Methylnaltrexone on the Pharmacokinetic and Pharmacodynamic Profiles of Ticagrelor in Patients Receiving Morphine: a Prospective, Randomized Placebo-controlled Trial|Completed||Phase 4|30|Actual|University of Florida||2|||f||||t||||||||No||2017-10-10 23:26:26.157037|2017-10-10 23:26:26.157037
NCT02403817|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-05-02|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Training Attention and Eye Movement in ASD|Wireless EEG System for Training Attention and Eye Movement in ASD|Recruiting||N/A|40|Anticipated|University of California, San Diego||2|||f||||f|f|f||||||Yes|De-identified IPD is being shared through NIH NDAR.|2017-10-10 23:26:26.409576|2017-10-10 23:26:26.409576
NCT02403804|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-07-17|||April 2015||2015-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Dietary Supplementation to Increase Serum Choline Levels|Dietary Supplementation to Increase Serum Choline Levels|Active, not recruiting||N/A|10|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-10 23:26:26.497904|2017-10-10 23:26:26.497904
NCT02403791|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-03-25|||March 2014||2014-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PoCBLUEPlus||Point-of-Care Bedside Lung Ultrasound Examination Advanced Trial Protocol|A Prospective, Multi-center, Open-label and Double-blind, Standard-controlled, Non-inferiority, Diagnostic Study of Lung Ultrasound for Management of Mechanical Ventilation in Neonatal Acute Respiratory Distress Syndrome|Completed||N/A|1000|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-10-10 23:26:26.579561|2017-10-10 23:26:26.579561
NCT02403778|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-07-17|||December 17, 2015|Actual|2015-12-17|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Stage IV Melanoma|Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Stage IV Melanoma|Active, not recruiting||Phase 2|10|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:26:26.670417|2017-10-10 23:26:26.670417
NCT02403765|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-04-01|||April 2015||2015-04-01|April 2015|2015-04-01|April 2018|Anticipated|2018-04-01|October 2016|Anticipated|2016-10-01||Observational|||Diagnostic Tools for Parkinson's Disease|Realization of Diagnostic Tools for the Early Analysis of Parkinson's Disease Through the Identification of Genetic Risk Profiles|Not yet recruiting||N/A|500|Anticipated|Neuromed IRCCS|||2||f||||f||||||Samples With DNA|"     Blood samples for DNA extraction   "|||2017-10-10 23:26:26.743523|2017-10-10 23:26:26.743523
NCT02403752|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-06-01|||March 2015||2015-03-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|PairedPLIE||Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE)|Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers|Active, not recruiting||N/A|20|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:26:26.813981|2017-10-10 23:26:26.813981
NCT02403739|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-06-19|||March 2015||2015-03-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Observational|||Visual Interpretation of Neonatal Growth Charts|Visual Interpretation of Neonatal Growth Charts: A Comparison of Z-score Charts and Traditional Charts|Completed||N/A|50|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-10 23:26:26.89723|2017-10-10 23:26:26.89723
NCT02403726|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-03-25|||January 2011||2011-01-01|March 2015|2015-03-01||||March 2015|Actual|2015-03-01||Observational|||Osteoporosis Associated Vertebral Fractures - Medical and Socio-economic Aspects in Austria||Completed||N/A|694|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-10 23:26:26.969594|2017-10-10 23:26:26.969594
NCT02403713|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-09-25|||August 2014||2014-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|October 2014|Actual|2014-10-01||Interventional|||A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers|A Randomised, Open-label, 2-group PK (3-period) and PD (5-period) Crossover Study to Compare Systemic Exposure and Pharmacodynamic Effects of Fluticasone/Formoterol BAI and pMDI in Healthy Volunteers|Completed||Phase 1|125|Anticipated|Mundipharma Research Limited||5|||f||||f||||||||||2017-10-10 23:26:27.047166|2017-10-10 23:26:27.047166
NCT02403700|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-03-25|||October 2009||2009-10-01|March 2015|2015-03-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Observational|Alterations||Dimensional Soft and Hard Tissue Alterations Following Single Tooth Extraction in the Anterior Maxilla - A Prospective Clinical Study|Ridge Alterations Following Single Tooth Extraction in the Anterior Maxilla - A Prospective Clinical Study|Completed||N/A|39|Actual|University of Bern|||1||f||||f||||||||||2017-10-10 23:26:27.134272|2017-10-10 23:26:27.134272
NCT02403687|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-01-19|||June 2015||2015-06-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01|52 Weeks|Observational [Patient Registry]|PACE||Prospective Analgesic Compound Efficacy (PACE) Study|Prospective Analgesic Compound Efficacy (PACE) Study|Enrolling by invitation||N/A|500|Anticipated|Express Specialty Pharmacy|||1||f||||f||||||||No||2017-10-10 23:26:27.219513|2017-10-10 23:26:27.219513
NCT02403674|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-08-03|||June 5, 2015|Actual|2015-06-05|August 2017|2017-08-01|February 25, 2020|Anticipated|2020-02-25|March 20, 2017|Actual|2017-03-20||Interventional|||Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)|A Phase III Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-1439A Once-Daily Versus ATRIPLA™ Once-Daily in Treatment-Naïve HIV-1 Infected Subjects|Active, not recruiting||Phase 3|734|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 23:26:27.312473|2017-10-10 23:26:27.312473
NCT02403661|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-03-31|||March 2013||2013-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|June 2016|Anticipated|2016-06-01||Interventional|||Electrical Stimulation to Enhance Peripheral Nerve Regeneration|The Effectiveness of a New Treatment for Patients With Peripheral Nerve Injuries in the Upper Limb|Recruiting||Phase 2|80|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:26:29.306418|2017-10-10 23:26:29.306418
NCT02403648|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-01-14|||November 2014||2014-11-01|January 2016|2016-01-01||||March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons|Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Glucagon for Injection (Eli Lilly) and GlucaGen® (Novo Nordisk) Administered by Subcutaneous and Intramuscular Injection in Normal, Healthy Volunteers|Completed||Phase 1|15|Actual|Biodel||6|||f||||f||||||||||2017-10-10 23:26:29.39002|2017-10-10 23:26:29.39002
NCT02403635|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-08-17|||April 2015||2015-04-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Drug-Drug Interaction Study: ASP2151 and Midazolam|A Single-centre, Open-label Study in Healthy Men to Investigate the Effect of Repeated Oral Doses of ASP2151 on the Pharmacokinetics of Midazolam in Healthy Men|Completed||Phase 1|27|Actual|Maruho Europe Limited||1|||f||||f||||||||||2017-10-10 23:26:29.470414|2017-10-10 23:26:29.470414
NCT02403622|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-07-01|||March 2015||2015-03-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Observational|STOOL||Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection|Safety of Fecal Microbiota Transplantation: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection|Recruiting||N/A|200|Anticipated|Microbiome Health Research Institute|||1||f||||t||||||||No||2017-10-10 23:26:29.56851|2017-10-10 23:26:29.56851
NCT02403609|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-03-02|||March 2015||2015-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||An Online Study of the Reliability of the Brain Performance Test (BPT)|An Online Study of the Reliability of the Brain Performance Test (BPT)|Completed||N/A|1357|Actual|Lumos Labs, Inc.||1|||f||||f||||||||||2017-10-10 23:26:29.673586|2017-10-10 23:26:29.673586
NCT02403596|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-03-03|||October 20, 2015|Actual|2015-10-20|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|ESPER||Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban|Study ESPER: Blood-sparing During the Placement of a Total Hip Prosthesis With the Exacyl® in Patients Treated With Rivaroxaban, Phase IV|Active, not recruiting||Phase 3|231|Anticipated|University Hospital, Brest||3|||f||||t||||||||||2017-10-10 23:26:29.754492|2017-10-10 23:26:29.754492
NCT02403583|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-04-04|||August 1, 2014|Actual|2014-08-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Jamii Bora: A Home-Based Couples Intervention|Jamii Bora: A Home-based Couples Intervention|Completed||N/A|233|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:26:29.85622|2017-10-10 23:26:29.85622
NCT02400918|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-11-23|||March 2015||2015-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Self-help for Treating Social Anxiety Disorder: An Evaluation of a Mindfulness and Acceptance-based Approach||Completed||N/A|170|Actual|Wilfrid Laurier University||2|||f||||||||||||||2017-10-10 23:26:58.925729|2017-10-10 23:26:58.925729
NCT02403570|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-10-18|||February 2015||2015-02-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|ROMUS||Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis|Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis|Recruiting||N/A|80|Anticipated|Turku University Hospital|||1||f||||f||||||||||2017-10-10 23:26:29.945265|2017-10-10 23:26:29.945265
NCT02403557|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-03-01|||February 2012||2012-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Internet-delivered Cognitive Behaviour Therapy for Older Adults With Anxiety|Individually-tailored Internet-delivered Cognitive Behaviour Therapy Treatment for Older Adults With Anxiety and Depression: a Randomized Controlled Trial|Completed||N/A|66|Actual|Linkoeping University||2|||f||||||||||||||2017-10-10 23:26:30.141286|2017-10-10 23:26:30.141286
NCT02403544|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-01-04|||September 2013||2013-09-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma|Image-Guided Radiation Therapy (IGRT) Associated With Concurrent Capecitabine and Oxaliplatin in the Treatment of Locally Advanced or Inoperable Hepatocellular Carcinoma (HCC): A Phase I Study|Recruiting||Phase 1|30|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 23:26:30.222593|2017-10-10 23:26:30.222593
NCT02403531|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-10-03|||May 2015|Actual|2015-05-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|September 2017|Actual|2017-09-01||Interventional|||Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer|A Phase II Randomized Trial of Induction Chemotherapy Versus no Induction Chemotherapy Followed by Definitive Chemoradiotherapy in Patients With Inoperable Thoracic Esophageal Cancer|Active, not recruiting||Phase 2|114|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:26:30.340052|2017-10-10 23:26:30.340052
NCT02403518|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-03-24|||October 2016||2016-10-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Outcomes of the Freedom Spinal Cord Stimulation (SCS) System for the Management of Chronic Back and Leg Pain|A Prospective, Multi-National, Post-Marketing Study of the Clinical Outcomes of Wireless Neuromodulation Via the Freedom Spinal Cord Stimulation (SCS) System for the Management of Chronic Back and Leg Pain|Recruiting||N/A|45|Anticipated|Stimwave Technologies||3|||f||||||||||||||2017-10-10 23:26:30.455456|2017-10-10 23:26:30.455456
NCT02403505|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2017-05-28|||March 2, 2017|Actual|2017-03-02|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|Drugs-SNPs||Discovery Stage Clinical Study About Oncology Drugs and Single Nucleotide Polymorphisms|Discover the Relationship Between the Oncology Drug Therapeutic Efficacy and the Relative Drug Target SNP Genotyping, and the Relationship Between the Oncology Drug Therapeutic Safety and the Relative Drug Target SNP Genotyping.|Active, not recruiting||Phase 3|600|Anticipated|Medicine Invention Design, Inc||2|||f||||t|t|f||||||No||2017-10-10 23:26:30.577537|2017-10-10 23:26:30.577537
NCT02403492|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-05-04|||August 2013||2013-08-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|TREAT||Treatment of Obstructive Sleep Apnea in Children: An Opportunity for Cardiovascular Risk Modification|Treatment of Obstructive Sleep Apnea in Children: An Opportunity for Cardiovascular Risk Modification|Completed||N/A|59|Actual|The Hospital for Sick Children||3|||f||||t||||||||||2017-10-10 23:26:30.721934|2017-10-10 23:26:30.721934
NCT02403466|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-03-30|||September 2010||2010-09-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|I-PASS||IIPE-PRIS Accelerating Safe Signouts|Bundling Effective Resident Handoff Tools to Improve Patient Safety: A Multi-Center Pediatric Residency Quality Improvement Initiative|Completed||N/A|875|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-10 23:26:30.941282|2017-10-10 23:26:30.941282
NCT02403453|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-08-22|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Observational|||RHINE™ Cervical Disc Clinical Study: A Prospective Observational Study for Patients Requiring 1-2 Level C-spine Surgery|RHINE™ Cervical Disc Clinical Study|Enrolling by invitation||N/A|166|Anticipated|K2M, Inc.|||1||f||||t||||||||||2017-10-10 23:26:31.063425|2017-10-10 23:26:31.063425
NCT02403440|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-03-30|||April 2014||2014-04-01|March 2015|2015-03-01||||April 2015|Anticipated|2015-04-01||Interventional|||A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients|A Safety, Pharmacokinetics and Pharmacodynamics Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura|Unknown status|Recruiting|Phase 1|24|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:26:31.141386|2017-10-10 23:26:31.141386
NCT02403427|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-05-06|||March 2015||2015-03-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|VoiceDiab||The Expert System VoiceDiab in Children With Diabetes|The Voice Decision Support Expert System in Basal-bolus Insulin Therapy of Diabetes Patients.|Unknown status|Recruiting|N/A|42|Anticipated|Instytut Diabetologii Sp. z o.o.||2|||f||||t||||||||||2017-10-10 23:26:31.208348|2017-10-10 23:26:31.208348
NCT02403414|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-01-23|||March 2015||2015-03-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation|Assessment of Airway in Patients With Acromegaly Undergoing Surgery: Predicting Successful Tracheal Intubation|Recruiting||N/A|50|Anticipated|All India Institute of Medical Sciences, New Delhi|||1||f||||t||||||||No||2017-10-10 23:26:31.318748|2017-10-10 23:26:31.318748
NCT02403401|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-07-04|||May 15, 2015|Actual|2015-05-15|June 2017|2017-06-01|July 7, 2016|Actual|2016-07-07|July 7, 2016|Actual|2016-07-07||Interventional|||Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women|Multi-center, Open-label, Single-arm Study to Assess the Safety and Contraceptive Efficacy of a Levonorgestrel-containing Intravaginal Ring During a Treatment Period of One Year in Healthy Women 18 to 35 Years of Age|Completed||Phase 3|1471|Actual|Bayer||1|||f||||f|t|f||||||||2017-10-10 23:26:31.408233|2017-10-10 23:26:31.408233
NCT02403388|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-08-10|||June 2015||2015-06-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|PRisM||Assessment of a Multifaceted Risk Management Program in French Multiprofessional Offices in Primary Care|Implementation and Assessment of a Multifaceted Risk Management Program in French Multiprofessional Offices in Primary Care : the PRisM Study|Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 23:26:31.851347|2017-10-10 23:26:31.851347
NCT02403375|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-10-02|||May 17, 2015|Actual|2015-05-17|October 2017|2017-10-01|November 7, 2017|Anticipated|2017-11-07|November 7, 2017|Anticipated|2017-11-07||Interventional|Insight Kids||Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes|Insight Kids Study: Reaching HbA1c Targets in Children and Adolescents With Type 1 Diabetes|Active, not recruiting||Phase 4|43|Actual|Hoffmann-La Roche||1|||f|||||f|f||||||||2017-10-10 23:26:31.958384|2017-10-10 23:26:31.958384
NCT02403362|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-03-25|||June 2014||2014-06-01|March 2015|2015-03-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis|A Phase 2, Open-Label, Multi-Center , Dose-Ranging Study of the Safety and Efficacy of Pegol-Sihematide (EPO-018B) for the Treatment of Anemia in Patients With Chronic Kidney Disease Not Requiring Dialysis.|Unknown status|Recruiting|Phase 2|60|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||3|||f||||t||||||||||2017-10-10 23:26:32.061931|2017-10-10 23:26:32.061931
NCT02403349|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-26|||May 2012||2012-05-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Interventional|FAVOR||Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol|Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol|Unknown status|Active, not recruiting|Phase 4|105|Actual|Ajou University School of Medicine||3|||f||||f||||||||||2017-10-10 23:26:32.160684|2017-10-10 23:26:32.160684
NCT02403336|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-08-03|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Health Education in Perimenopausal Women to Promote Self-care and Quality of Life|Health Education in Perimenopausal Women to Promote Self-care and Quality of Life: Randomized Clinical Trial|Completed||N/A|356|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||f||||||||||2017-10-10 23:26:32.268553|2017-10-10 23:26:32.268553
NCT02403323|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-03-15|||June 30, 2015|Actual|2015-06-30|March 2017|2017-03-01|May 31, 2024|Anticipated|2024-05-31|May 31, 2024|Anticipated|2024-05-31||Interventional|||Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144|AN OPEN-LABEL EXTENSION AND SAFETY MONITORING STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE PREVIOUSLY ENROLLED IN THE ETROLIZUMAB PHASE III PROTOCOL GA29144|Recruiting||Phase 3|900|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:26:32.388971|2017-10-10 23:26:32.388971
NCT02403310|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-05-23|||June 9, 2015|Actual|2015-06-09|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 13, 2016|Actual|2016-09-13||Interventional|||A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML|A Phase 1 Investigator Sponsored Study of Selinexor in Combination With Daunorubicin and Cytarabine in Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia|Active, not recruiting||Phase 1|21|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 23:26:33.629331|2017-10-10 23:26:33.629331
NCT02403297|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-08-16|||March 2015||2015-03-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Observational|||Rapid Point-of-Care Salivary Diagnostic for Periodontal Health|Rapid Point-of-Care Salivary Diagnostic for Periodontal Health|Terminated||N/A|93|Actual|Innovative Diagnostics Inc|||3||f||||t||||||Samples Without DNA|"     5ml of saliva will be collected. A small sample of the saliva will be used chair side to     analyze on the device. The remaining saliva will be aliquoted into five samples and kept     frozen until analyzed on a Luminex machine.   "|||2017-10-10 23:26:33.74975|2017-10-10 23:26:33.74975
NCT02403284|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-06-28|||March 2013||2013-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|||The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans|The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans|Active, not recruiting||Phase 4|35|Anticipated|Phoenix VA Health Care System||2|||f||||f||||||||No|Subject to VA regulation.|2017-10-10 23:26:33.844517|2017-10-10 23:26:33.844517
NCT02403271|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-09-05|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors|A Multi-Center Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With Durvalumab (MEDI4736), in Subjects With Relapsed or Refractory Solid Tumors|Completed||Phase 1/Phase 2|124|Actual|Pharmacyclics LLC.||1|||f||||t||||||||||2017-10-10 23:26:33.965628|2017-10-10 23:26:33.965628
NCT02403258|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-05-07|||January 2015||2015-01-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effect and Safety of Plum-blossom Needle for Tourette Syndrome|The Effect and Safety of Plum-blossom Needle for Tourette Syndrome: a Randomized Controlled Trial|Recruiting||Phase 1|60|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||||2017-10-10 23:26:34.119539|2017-10-10 23:26:34.119539
NCT02403245|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-25|||March 2012||2012-03-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Social Interactions Between People With Dementia in Nursing Home|The Impact of a Social Stimulation on Social Interactions in Institutionalized People With Dementia|Completed||N/A|60|Actual|Paris West University Nanterre La Défense||2|||f||||f||||||||||2017-10-10 23:26:34.232456|2017-10-10 23:26:34.232456
NCT02403232|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-03-31|||December 2014||2014-12-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ASPEFIC1||Autologous Adipose-derived Stem Cells (ASCs) for the Treatment of Perianal Fistula in Crohn Disease: A Pilot Study|Autologous Adipose-derived Stem Cells (ASCs) for the Treatment of Perianal Fistula in Crohn Disease: A Pilot Study|Recruiting||Phase 2|10|Anticipated|Papa Giovanni XXIII Hospital||1|||f||||||||||||||2017-10-10 23:26:34.320768|2017-10-10 23:26:34.320768
NCT02403219|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-03-30|||May 2013||2013-05-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional|||Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry Eye|Paralysis of the Orbicularis Muscle of the Eye by Using Botulinum Toxin Type A in the Treatment for Dry Eye|Completed||Phase 1|20|Actual|Instituto de Oftalmología Fundación Conde de Valenciana||2|||f||||t||||||||||2017-10-10 23:26:34.434376|2017-10-10 23:26:34.434376
NCT02403206|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-06-26|2017-05-30||March 26, 2015|Actual|2015-03-26|June 2017|2017-06-01|August 24, 2016|Actual|2016-08-24|July 12, 2016|Actual|2016-07-12||Interventional||This analysis population includes subjects who signed an informed consent form, were randomized, and underwent the removal of an intumescent cataract with subsequent IOL implantation (Intent-to-Treat (ITT)).|Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts|Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts|Completed||N/A|406|Actual|Alcon Research||2|||f||||f|f|t|f|f|t|||||2017-10-10 23:26:34.539217|2017-10-10 23:26:34.539217
NCT02403193|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-09-15|||October 2015||2015-10-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|AdenONCO||Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Phase I/Ib Trial of Single Agent PBF-509 and in Combination With PDR001 for Patients With Advanced NSCLC|Recruiting||Phase 1/Phase 2|92|Anticipated|Palobiofarma SL||9|||f||||f||||||||||2017-10-10 23:26:34.893756|2017-10-10 23:26:34.893756
NCT02403180|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2016-07-10|2016-07-10||May 2015||2015-05-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Intention to treat, defined as the set of all randomized participants.|DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance|Comparative Assessment of Visual Performance Between DAILIES® AquaComfort Plus® (DACP) Multifocal (MF) and PROCLEAR 1 Day Multifocal (PROCLEAR 1D MF)|Completed||N/A|70|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:26:35.0386|2017-10-10 23:26:35.0386
NCT02402049|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-24|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Homeopathic Treatment of Premenstrual Syndrome|Is Homeopathic Treatment a Placebo Treatment? - Homeopathic Treatment of Premenstrual Syndrome- A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 3|180|Anticipated|Shaare Zedek Medical Center||12|||f||||f||||||||||2017-10-10 23:26:35.285363|2017-10-10 23:26:35.285363
NCT02402036|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-08-30|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer|Regorafenib in Metastatic Colorectal Cancer: An Exploratory Biomarker Study|Active, not recruiting||Phase 2|10|Actual|Georgetown University||1|||f||||t||||||||||2017-10-10 23:26:35.386813|2017-10-10 23:26:35.386813
NCT02402023|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-12-15|||October 2014||2014-10-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery|Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery|Recruiting||N/A|40|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 23:26:35.45243|2017-10-10 23:26:35.45243
NCT02402010|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-01-11|||January 2014||2014-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Pilot Study of Adjunctive Yoga for Bipolar Depression|Pilot Study of Adjunctive Yoga for Bipolar Depression|Completed||N/A|37|Actual|Brown University||2|||f||||f||||||||||2017-10-10 23:26:35.716278|2017-10-10 23:26:35.716278
NCT02401997|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-08-05|||January 2014||2014-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of the Sexual Abstinence Period on the Production of Reactive Oxygen Species in Patients Who Planned to Take Part in Intrauterine Insemination||Completed||N/A|90|Actual|Gazi University||3|||f||||||||||||||2017-10-10 23:26:35.802326|2017-10-10 23:26:35.802326
NCT02403167|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2015-07-21|||April 2015||2015-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:26:35.878328|2017-10-10 23:26:35.878328
NCT02403141|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-03-01|||March 2015||2015-03-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|ADSA||Abu Dhabi Sleep Apnea (ADSA) Study|Abu Dhabi Sleep Apnea (ADSA) Study|Active, not recruiting||N/A|1400|Anticipated|Imperial College London Diabetes Centre|||4||f||||||||||||||2017-10-10 23:26:36.044568|2017-10-10 23:26:36.044568
NCT02403128|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-08-17|||May 14, 2015|Actual|2015-05-14|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms|Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms|Recruiting||Phase 1|5|Anticipated|Illinois Retina and Eye Associates||1|||f||||f||||||||||2017-10-10 23:26:36.110933|2017-10-10 23:26:36.110933
NCT02403115|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-05-03|||October 2014||2014-10-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Observational|||Prediction of Outcome of Lupus Nephritis|Validation of the Assay of Circulating Antibodies Against Glomerular Neo-autoantigens as a Surrogate Biomarker of the Development of Lupus Nephritis|Recruiting||N/A|800|Anticipated|Istituto Giannina Gaslini|||5||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:26:36.186249|2017-10-10 23:26:36.186249
NCT02403102|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-14|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|iTIMM||Imageguided Theranostics in Multiple Myeloma|Imageguided Theranostics in Multiple Myeloma|Recruiting||N/A|60|Anticipated|Institute of Cancer Research, United Kingdom|||1||f||||f||||||Samples With DNA|"     Patients who undergo autograft have regular blood tests and marrow sampling and we will use     these samples, to look at other factors which influence patient outcomes such as genetics,     without compromising routine care. Some of the genetic tests performed on the bone marrow are     not routine so we will obtain additional consent to do this.   "|||2017-10-10 23:26:36.27968|2017-10-10 23:26:36.27968
NCT02402920|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-06-01|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|||Phase I Trial of MK-3475 and Concurrent Chemo/Radiation for the Elimination of Small Cell Lung Cancer|Phase I Trial of MK-3475 and Concurrent Chemo/Radiation for the Elimination of Small Cell Lung Cancer|Recruiting||Phase 1|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:26:37.872904|2017-10-10 23:26:37.872904
NCT02403089|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-08-12|||March 2015||2015-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|NEOMAIT||Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients|Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     funds tubes samples taken as part of routine care for newborns and in allograft recipients     children will be recovered. Mononuclear cells from cord blood will be isolated and stored in     liquid nitrogen in the laboratory of Immunology before achieving functional tests.      • Rectal swabs and gastric aspirates aliquots made as part of routine care for newborns, and     rectal swabs made as part of routine care in HSCT allograft recipients, will be stored at -80     ° C in the laboratory of Immunology.   "|||2017-10-10 23:26:36.358448|2017-10-10 23:26:36.358448
NCT02403076|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-07-06|||January 2015||2015-01-01|July 2015|2015-07-01||||January 2018|Anticipated|2018-01-01|7 Days|Observational [Patient Registry]|||Gastrointestinal Bleeding Management|Management of Patients With Gastrointestinal Bleeding - a Prospective Single Center Registry Study|Active, not recruiting||N/A|500|Anticipated|Dr. Horst Schmidt Klinik GmbH|||1||f||||f||||||||||2017-10-10 23:26:36.45412|2017-10-10 23:26:36.45412
NCT02403063|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-11-19|||September 2015||2015-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|REDNESII||Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade|Electromyographic Activity of the Diaphragm and of the Rectus Abdominis and Intercostal Muscles During Neostigmine, Sugammadex, or Neostigmine-sugammadex Enhanced Recovery After Neuromuscular Blockade With Rocuronium. A Randomised Controlled Study in Healthy Volunteers|Completed||Phase 4|18|Actual|Onze Lieve Vrouw Hospital||3|||f||||t||||||||||2017-10-10 23:26:36.514443|2017-10-10 23:26:36.514443
NCT02403050|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-25|||March 2015||2015-03-01|March 2015|2015-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Feasibility Study of Fiducial Markers in Oesophageal Cancer|Feasibility Study to Assess the Benefit of Using Fiducial Markers for Patients Receiving Radiotherapy for Cancer of the Oesophagus|Recruiting||N/A|40|Anticipated|NHS Greater Glasgow and Clyde|||2||f||||f||||||||||2017-10-10 23:26:36.609725|2017-10-10 23:26:36.609725
NCT02403037|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-05-27|||July 2015||2015-07-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients|The Effects of Auricular Acupressure on Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients: A Pilot Randomized Controlled Trial|Completed||N/A|114|Actual|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-10 23:26:36.700857|2017-10-10 23:26:36.700857
NCT02403024|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-09-22|||August 2015||2015-08-01|September 2017|2017-09-01|September 22, 2017|Actual|2017-09-22|September 22, 2017|Actual|2017-09-22||Interventional|||Feasibility and Efficacy of Interval Walking in Patients With Colorectal Cancer|I-Walk-CRC - Feasibility and Efficacy of Interval Walking in Patients With Colorectal Cancer|Completed||N/A|39|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:26:36.820212|2017-10-10 23:26:36.820212
NCT02403011|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2015-11-06|||January 2014||2014-01-01|November 2015|2015-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Investigating the Effectiveness of Mobilization on Congenital Muscular Torticollis and Deformational Plagiocephaly|A Randomized Controlled Study in the Efficiency of Soft Tissue Mobilization in Babies With Congenital Muscular Torticollis and Deformational Plagiocephaly|Recruiting||N/A|30|Anticipated|Hacettepe University||2|||f||||t||||||||||2017-10-10 23:26:36.920899|2017-10-10 23:26:36.920899
NCT02402998|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2017-02-17|||June 2015||2015-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia|Eltrombopag as Second Line Therapy in Adult Patients With Primary Immune Thrombocytopenia (ESTIT Study) in an Attempt to Achieve Long-term Remission: a Single Arm Multicenter Phase II Clinical and Biological Study|Recruiting||Phase 2|52|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-10 23:26:37.0174|2017-10-10 23:26:37.0174
NCT02402985|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-04-29|||September 2013||2013-09-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|LeguAN||Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics|"Comparison of a High-protein, Carbohydrate-restricted Diet With a High Proportion of Leguminous Protein Compared to Animal Protein on Metabolic Control in Patients With Type 2 Diabetes, LeguAN Study"|Completed||N/A|44|Actual|German Institute of Human Nutrition||2|||f||||f||||||||||2017-10-10 23:26:37.168779|2017-10-10 23:26:37.168779
NCT02402972|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-03-25|||February 2015||2015-02-01|January 2015|2015-01-01|February 2022|Anticipated|2022-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer|A Multi-center Randomized Controlled Trial: Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer|Recruiting||Phase 3|700|Anticipated|Fudan University||2|||f||||||||||||||2017-10-10 23:26:37.264993|2017-10-10 23:26:37.264993
NCT02402959|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-03-30|||March 2015||2015-03-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Observational|||Individualized Treatment With Traditional Chinese Medicine for the Patients With Insomnia Disorder: a Cohort Study|Individualized Treatment With Traditional Chinese Medicine Pattern Differentiation for the Patients With Insomnia Disorder: a Cohort Study|Unknown status|Recruiting|N/A|600|Anticipated|China Academy of Chinese Medical Sciences|||10||f||||f||||||||||2017-10-10 23:26:37.373277|2017-10-10 23:26:37.373277
NCT02402946|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-11-17|||February 2015||2015-02-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Placebo-controlled, Randomized Trial of a Simplified Biofeedback Technique for the Treatment of Rumination|Valoración Objetiva y Tratamiento de la rumiación|Completed||N/A|24|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-10 23:26:37.494739|2017-10-10 23:26:37.494739
NCT02402933|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-06-02|2016-11-02|2016-04-26|March 2015||2015-03-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional||All enrolled participants.|Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents|A Multiple Center, Open Label, Prospective Study to Evaluate the Effectiveness and Ease-Of-Use of AMG504-1 Administered in the Home or School Environments for Treating Hypoglycemia in Children and Adolescents With T1D|Completed||Phase 3|26|Actual|Eli Lilly and Company|Participants from non-GCP compliant site were excluded from the analysis.|1|||f||||f||||||||No||2017-10-10 23:26:37.582163|2017-10-10 23:26:37.582163
NCT02402907|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-01-17|||April 2015||2015-04-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||STRIPES Study: Study To Reduce Infection Post cEsarean Section|A Randomized Trial to Determine if a Pre-operative Wash With a Chlorhexidine Cloth Reduces Infectious Morbidity in Patients Undergoing Cesarean Section|Recruiting||N/A|930|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 23:26:37.986084|2017-10-10 23:26:37.986084
NCT02402894|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-10-19|||February 2015||2015-02-01|October 2015|2015-10-01|December 2065|Anticipated|2065-12-01|December 2016|Anticipated|2016-12-01||Observational|||Follow-up of Person-centered Care of Young Adults With Rheumatic Disease|Follow-up of Person-centered Care of Young Adults With Rheumatic Disease Uppföljning av Personcentrerat omhändertagande av Unga Vuxna Med Reumatisk Sjukdom (Unga-vuxna Studien) (Swedish)|Recruiting||N/A|100|Anticipated|Vastra Gotaland Region|||1||f||||f||||||||||2017-10-10 23:26:38.094529|2017-10-10 23:26:38.094529
NCT02402881|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-04-07|||April 2015||2015-04-01|April 2015|2015-04-01|April 2020|Anticipated|2020-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Education Bundle to Decrease Patient Refusal of VTE Prophylaxis|Patient-centered Education Bundle to Decrease Patient Refusal of Venous Thromboembolism Prophylaxis|Enrolling by invitation||N/A|1000|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 23:26:38.165715|2017-10-10 23:26:38.165715
NCT02402868|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-06-09|||January 2016||2016-01-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children|Intranasal Ketamine Versus Intravenous Ketamine for Procedural Conscious Sedation in Children: a Multi-centre Randomized Controlled Non-inferiority Trial|Recruiting||Phase 3|200|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 23:26:38.243358|2017-10-10 23:26:38.243358
NCT02402855|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-09-05||||||September 2017|2017-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||NAITRE (PreNAtal Care in deprIvaTed enviRonnEment)|Impact of Conditional Financial Support on Pregnancy Outcomes in Pregnant Women With Low Incomes: Pragmatic Randomized Cluster Trial, With Parallel Arms|Recruiting||N/A|4000|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-10 23:26:38.327372|2017-10-10 23:26:38.327372
NCT02402842|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-10-05|||September 2014||2014-09-01|October 2017|2017-10-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|Epitopes-HPV02||Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma|Assessment of the Clinical Value of a Docetaxel, Cisplatin and 5-fluorouracil (DCF) Strategy Adapted to Patients for the Management of Metastatic or Locally Advanced Anal Resistant Radiochemotherapy Squamous Cell Anal Carcinoma.|Active, not recruiting||Phase 2|70|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 23:26:38.556843|2017-10-10 23:26:38.556843
NCT02402829|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-03-27|||November 2014||2014-11-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|CVL#2||A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture|A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture|Unknown status|Recruiting|N/A|70|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-10-10 23:26:38.669293|2017-10-10 23:26:38.669293
NCT02402816|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-02-18|||May 2016||2016-05-01|February 2016|2016-02-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||MPP Narrow QRS:Pilot Study on Multipoint Pacing in Patients With QRS Beetwen 100 and 130 Msec|MPP Narrow QRS:Pilot Study on Multipoint Pacing in Patients With Narrow QRS|Not yet recruiting||N/A|50|Anticipated|Humanitas Hospital, Italy||2|||f||||f||||||||||2017-10-10 23:26:38.753039|2017-10-10 23:26:38.753039
NCT02402803|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-03-23|||October 2015||2015-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|DBS||Dried Blood Spot- Statin Pilot Study|Dried Blood Spot- Statin Pilot Study|Recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||Samples Without DNA|"     cholesterol panel (total cholesterol, LDL-C, triglycerides, HDL-C), Apo A-I, Apo B, Apo E,     IgM, plasminogen, TIMP-1, Von Willebrand factor, antithrombin III, cystatin C, mesothelin,     C-reactive protein, SAA, LPS-binding protein, mannose-binding lectin, myeloperoxidase,     fibrinogen, alpha-1-acid glycoprotein, soluble transferrin receptor, haptoglobin.   "|Yes||2017-10-10 23:26:38.854457|2017-10-10 23:26:38.854457
NCT02402764|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-07-28|2017-02-10||July 2015||2015-07-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 10, 2016|Actual|2016-03-10||Interventional||All participants|Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC)|Investigator-Initiated Phase 2 Clinical Trial of Selinexor (KPT-330) for the Treatment of Metastatic Triple Negative Breast Cancer|Active, not recruiting||Phase 2|10|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-10 23:26:38.939488|2017-10-10 23:26:38.939488
NCT02402751|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-08-23|||March 2015||2015-03-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|||Development, Implementation and Initiation of Normative Database Quantitative Ultra High Field MRI Paramaters|Development, Implementation and Initiation of Normative Database Quantitative Ultra High Field MRI Paramaters|Recruiting||N/A|400|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:26:39.219347|2017-10-10 23:26:39.219347
NCT02402738|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-01-11|||April 2014||2014-04-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Adjunctive Psychotherapy for Perinatal Bipolar Disorder|Adjunctive Psychotherapy for Perinatal Bipolar Disorder|Recruiting||N/A|52|Anticipated|Brown University||2|||f||||f||||||||||2017-10-10 23:26:39.302354|2017-10-10 23:26:39.302354
NCT02402725|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-02-14|||May 2015||2015-05-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|UltraDex||A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma|A Phase II, Open-label, Single Center Study of Ultra-High Dose Dexamethasone (UHDD) Administered Intravenously and Orally as Monotherapy for the Treatment of Relapsed Multiple Myeloma|Withdrawn||Phase 2|0|Actual|Boston Medical Center||1||poor accrual|f||||t||||||||No||2017-10-10 23:26:39.390863|2017-10-10 23:26:39.390863
NCT02402712|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-09-26|||May 6, 2015|Actual|2015-05-06|September 2017|2017-09-01|March 19, 2019|Anticipated|2019-03-19|March 19, 2019|Anticipated|2019-03-19||Interventional|||Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer||Active, not recruiting||Phase 3|418|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-10 23:26:39.488934|2017-10-10 23:26:39.488934
NCT02402699|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-09-26|||May 23, 2015|Actual|2015-05-23|September 2017|2017-09-01|December 30, 2019|Anticipated|2019-12-30|December 30, 2019|Anticipated|2019-12-30|6 Months|Observational [Patient Registry]|Yervoy RMP||Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan|Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan|Recruiting||N/A|2|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 23:26:39.790786|2017-10-10 23:26:39.790786
NCT02402686|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-09-26|||May 31, 2015|Actual|2015-05-31|September 2017|2017-09-01|February 26, 2019|Anticipated|2019-02-26|February 26, 2019|Anticipated|2019-02-26||Observational|SIMPACT||Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)|Open-Label, Multi-Center, Non-Interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab SC Monotherapy in Daily Clinical Practice (SIMPACT)|Recruiting||N/A|350|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:26:39.868255|2017-10-10 23:26:39.868255
NCT02402673|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-01-26|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Multidimensional Diagnostics and Effect of Activity Modification in Young Adolescents With Patellofemoral Pain|Multidimensional Diagnostics and Effect of Activity Modification in Young Adolescents With Patellofemoral Pain|Active, not recruiting||N/A|152|Actual|Aalborg University||1|||f||||f||||||||||2017-10-10 23:26:39.986648|2017-10-10 23:26:39.986648
NCT02402660|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-10-05|||August 2015||2015-08-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|TEASE||Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease|A Phase 2 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Long Term Safety, Tolerability, Pharmacokinetics and Effects of ALK-001 on the Progression of Stargardt Disease|Recruiting||Phase 2|50|Anticipated|Alkeus Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 23:26:40.100509|2017-10-10 23:26:40.100509
NCT02402647|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-08-07|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|January 1, 2019|Anticipated|2019-01-01||Interventional|CREST||Cognitive Rehab and Exposure Treatment for Hoarding|Cognitive Rehabilitation and Exposure Therapy for Veterans With Hoarding Disorder|Recruiting||N/A|136|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:26:40.229736|2017-10-10 23:26:40.229736
NCT02402634|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-07-06|||January 2015||2015-01-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Inflammatory Gene Polymorphism and Prolonged Mechanical Ventilation After Liver Transplantation||Unknown status|Recruiting|N/A|100|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-10 23:26:40.325806|2017-10-10 23:26:40.325806
NCT02402621|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-11-30|||April 2015||2015-04-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparison Between Conventional and Model-based Infusion Strategy of IV PCA in Patients Undergoing RALP|Comparison Between Conventional and Model-based Infusion Strategy of Intravenous Patient-controlled Analgesia in Patients Undergoing Robot Assisted Laparoscopic Radical Prostatectomy|Completed||N/A|111|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-10 23:26:40.405037|2017-10-10 23:26:40.405037
NCT02402608|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-03-25|||January 2012||2012-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy of Dietary Supplementation and Physical Activity in Sarcopenic Elderly|Whey Protein, Amino Acids and Vitamin D Supplementation With Physical Activity Increases Muscle Mass and Strength, Functionality and Quality of Life and Decreases Inflammation in Sarcopenic Elderly|Completed||N/A|130|Actual|Azienda di Servizi alla Persona di Pavia||2|||f||||t||||||||||2017-10-10 23:26:40.476234|2017-10-10 23:26:40.476234
NCT02402595|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-03-16|||March 2015||2015-03-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|DDI||Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts|A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, Drug Interaction Study Between AVP-923 and Itraconazole, and Between AVP-786 and Itraconazole in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Avanir Pharmaceuticals||4|||f||||f||||||||||2017-10-10 23:26:40.569|2017-10-10 23:26:40.569
NCT02402582|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-03-27|||June 2012||2012-06-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Family-Centered Empowerment Model|Family-Centered Empowerment Model With Four-stage Including Perceived Threat With Group Discussion Method, Self-efficacy With Problem Solving Method, Self-esteem With Educational Partnership, and Outcome and Process Evaluations|Completed||N/A|70|Actual|Baqiyatallah Medical Sciences University||1|||f||||t||||||||||2017-10-10 23:26:40.669093|2017-10-10 23:26:40.669093
NCT02402569|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|SIV2||Multi-electrodes Set for Deep Brain Stimulation in Parkinson Disease|Implantation Feasibility Study of a Multi-electrodes Set for Deep Brain Stimulation in Parkinson Disease (Smart in Vivo 2)|Recruiting||Early Phase 1|5|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 23:26:40.747346|2017-10-10 23:26:40.747346
NCT02402556|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-12-01|||May 2014||2014-05-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Mother and Child Education Program in Palestinian Refugee Camps|Implementation and Impact Evaluation of the Mother and Child Education Program (MOCEP) Among Children and Families in Palestinian Refugee Camps in Beirut, Lebanon|Completed||N/A|106|Actual|Yale University||2|||f||||t||||||||||2017-10-10 23:26:40.830536|2017-10-10 23:26:40.830536
NCT02402543|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-05-16|||June 2014||2014-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PEAARS||Pre-Emptive Analgesia in Ano-Rectal Surgery|Pre-Emptive Analgesia in Ano-Rectal Surgery|Recruiting||N/A|90|Anticipated|University of Vermont||2|||f||||t||||||||||2017-10-10 23:26:40.915448|2017-10-10 23:26:40.915448
NCT02402530|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-11-11|||April 2015||2015-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I|A Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)|Completed||Phase 2/Phase 3|464|Actual|Grünenthal GmbH||3|||f||||t||||||||||2017-10-10 23:26:41.053925|2017-10-10 23:26:41.053925
NCT02400177|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-23|||March 2015||2015-03-01|March 2015|2015-03-01|November 2017|Anticipated|2017-11-01|February 2017|Anticipated|2017-02-01||Interventional|||Parents Workgroup About Emotion Regulation|Parenting Workshop on Emotion Regulation|Not yet recruiting||Phase 1|60|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 23:27:08.200864|2017-10-10 23:27:08.200864
NCT02402517|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-09-26|||August 2015||2015-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|||PERFECT Project - Part 2 - Study 1|Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 1|Active, not recruiting||N/A|30|Anticipated|University of Manitoba||6|||f||||f||||||||||2017-10-10 23:26:41.244996|2017-10-10 23:26:41.244996
NCT02402504|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2017-09-26|||March 2015||2015-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|||PERFECT Project - Part 1 - Study 1|Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 1 - Acute Effects of Pulse Ingredients in Snack Products on Appetite, Blood Glucose, and Food Intake in Adults - Study 1|Active, not recruiting||N/A|30|Anticipated|University of Manitoba||6|||f||||||||||||||2017-10-10 23:26:41.340042|2017-10-10 23:26:41.340042
NCT02402491|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-27|||January 2013||2013-01-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis|Twelve Versus 24 Months of Dual Antiplatelet Therapy in Patients With Percutaneous Coronary Intervention for In-stent Restenosis|Unknown status|Active, not recruiting|Phase 4|1000|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||||2017-10-10 23:26:41.59856|2017-10-10 23:26:41.59856
NCT02402478|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-03-24|||July 2009||2009-07-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|4C||Clinical Cohorts in Coronary Disease Collaboration|Clinical Cohorts in Coronary Disease Collaboration|Completed||N/A|3345|Actual|University College, London|||1||f||||t||||||Samples With DNA|"     DNA, plasma and serum   "|||2017-10-10 23:26:41.727019|2017-10-10 23:26:41.727019
NCT02402465|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-07-19|||February 2015||2015-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis|Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis|Recruiting||Phase 4|20|Anticipated|University of Chicago||3|||f||||f||||||||||2017-10-10 23:26:41.818482|2017-10-10 23:26:41.818482
NCT02402452|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-10-12|||May 2015||2015-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetics of GS-9857 in Adults With Normal Renal Function and Severe Renal Impairment|A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-9857 in Subjects With Normal Renal Function and Severe Renal Impairment|Completed||Phase 1|20|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-10 23:26:41.944124|2017-10-10 23:26:41.944124
NCT02402439|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-07-25|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol|Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol|Active, not recruiting||Phase 1|6|Anticipated|University of California, San Francisco||1|||f||||t|t|f||||||||2017-10-10 23:26:42.043199|2017-10-10 23:26:42.043199
NCT02402426|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-03-01|||September 2013||2013-09-01|March 2017|2017-03-01|September 2028|Anticipated|2028-09-01|September 2023|Anticipated|2023-09-01|10 Years|Observational [Patient Registry]|BHR||Brain Health Registry|Brain Health Registry|Recruiting||N/A|50000|Anticipated|University of California, San Francisco|||1||f||||t||||||||||2017-10-10 23:26:42.162301|2017-10-10 23:26:42.162301
NCT02402413|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-03-08|||June 2016||2016-06-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Ultrasound Three-dimensional Characterization of Ovarian Morphology in Women With Polycystic Ovary Syndrome (PCOS)||Not yet recruiting||N/A|100|Anticipated|University of Cagliari||1|||f||||f||||||||||2017-10-10 23:26:42.274537|2017-10-10 23:26:42.274537
NCT02402400|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-03-19|||July 2015||2015-07-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study|Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome|Completed||Phase 4|50|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:26:42.376655|2017-10-10 23:26:42.376655
NCT02402387|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-01-23|||May 12, 2015|Actual|2015-05-12|January 2017|2017-01-01|August 27, 2015|Actual|2015-08-27|August 27, 2015|Actual|2015-08-27||Interventional|||The Influence of Head and Neck Position on the Oropharyngeal Leak Pressure Using Air-Q SP Airway||Completed||N/A|51|Actual|Yonsei University||4|||f||||f||||||||||2017-10-10 23:26:42.460048|2017-10-10 23:26:42.460048
NCT02402374|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-09-26|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Evaluate the Safety and Efficacy of RegenKit Autologous PRP Gel for the Treatment of Diabetic Foot Ulcer|Randomized, Placebo-controlled, Blind-assessor Study to Evaluate the Safety and Efficacy of Autologous Platelet Rich Plasma Gel Prepared With the RegenKit-BCT Plus Family of Kits for the Treatment of Diabetic Foot Ulcer|Not yet recruiting||N/A|192|Anticipated|Regen Lab SA||2|||f||||f|f|t|f||f|||||2017-10-10 23:26:42.565586|2017-10-10 23:26:42.565586
NCT02402361|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-10-01|||April 2016|Actual|2016-04-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|Neuropathic||Understanding Risk Factors and Determinants for Neuropathic Pain|Understanding Risk Factors and Determinants for Neuropathic Pain|Recruiting||N/A|200|Anticipated|Rambam Health Care Campus|||1||f||||||||||||||2017-10-10 23:26:42.654273|2017-10-10 23:26:42.654273
NCT02402348|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-02-06|||December 2014||2014-12-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis|Pilot Study of Metformin (MF) IN HNSCC (Head and Neck Squamous Cell Carcinoma) as Window Trial Design in Operable HNSCC, to Investigate the Effects of MF, Tumor Genotype and MF Genotype Interactions, on Tumor Metabolism and Anoikis|Terminated||Early Phase 1|3|Actual|West Virginia University||1||Funding not available, PI left institution|f||||t||||||||No||2017-10-10 23:26:42.74011|2017-10-10 23:26:42.74011
NCT02402153|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-08-29|||November 2014||2014-11-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - the Pilot 2 Study - Healthy Subjects|Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - the Pilot 2 Study - Healthy Subjects|Completed||Early Phase 1|18|Actual|Hypo-Safe A/S||1|||f||||t||||||||||2017-10-10 23:26:44.838296|2017-10-10 23:26:44.838296
NCT02402335|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-03-24|||February 2015||2015-02-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Observational|||Study of Different Types of Backache in Groups of Patients With Different Diagnoses of Degenerative Diseases|Study of Different Types of Pains in Groups of Patients With Different Diagnoses of Degenerative Diseases and Their Related Surgeries|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Bonn|||2||f||||t||||||||||2017-10-10 23:26:42.845021|2017-10-10 23:26:42.845021
NCT02402322|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-10-27|2015-08-07||August 2013||2013-08-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Internet-based Self-help Treatment for Panic Disorder: Two Ways of Complementary Psychological Support|Internet-based Self-help Treatment for Panic Disorder: A Randomised Controlled Trial of Two Ways of Administrating the Complementary Psychological Support (Scheduled vs. Non-scheduled)|Completed||N/A|77|Actual|Universitat Autonoma de Barcelona||3|||f||||f||||||||||2017-10-10 23:26:42.935434|2017-10-10 23:26:42.935434
NCT02402309|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-08-01|||March 2015||2015-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)|Phase II Study of the Safety, Pharmacokinetics, and Exploratory Activity of Once Daily (QD) Topical Application of NS2 Cream to Treat Ichthyosis in Subjects With Sjögren-Larsson Syndrome (SLS)|Completed||Phase 2|12|Actual|Aldeyra Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:26:43.557475|2017-10-10 23:26:43.557475
NCT02402296|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-05-21|2015-04-24||January 2013||2013-01-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis|Efficacy of β-glucan in Treatment of Localized Aggressive Periodontitis: A Short Term Double-blinded, Placebo-controlled, Randomized Clinical Trial|Completed||Phase 4|30|Actual|Al-Azhar University|No limitations or caveats were reported throughout the study period.|2|||f||||f||||||||||2017-10-10 23:26:43.650319|2017-10-10 23:26:43.650319
NCT02402283|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-06-22|||May 2015||2015-05-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate|Comparative Randomized, Single Dose, Two-Way Crossover Open Label Bioequivalence Study of Terix Labs Ltd Metronidazole Benzoate (400 mg Metronidazole Per Sachet Oral Granules) Versus Zentiva Flagyl™ 400 mg Tablets (400 mg Metronidazole Per Film Coated Tablet), After An Oral Administration Of 400 mg to Healthy Adults Under Fasting Conditions|Completed||Phase 1|20|Actual|Verisfield UK Ltd. Greek Branch||2|||f||||f||||||||||2017-10-10 23:26:43.959959|2017-10-10 23:26:43.959959
NCT02402270|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-05-18|||May 2015||2015-05-01|May 2015|2015-05-01||||May 2016|Anticipated|2016-05-01||Interventional|||Safety and Tolerability Study of an Edible Colon Preparation|An Adaptive, Single-Blind, Parallel, Randomized, Phase 2, Formulation Screening/Proof of Concept, Safety, Tolerability and Efficacy Study of Three Formulations/Dosing Regimens of ECP (PEG 3350) Colon Prep Kit Compared to Comparators.|Unknown status|Recruiting|Phase 2|110|Anticipated|ColonaryConcepts LLC||5|||f||||t||||||||||2017-10-10 23:26:44.057035|2017-10-10 23:26:44.057035
NCT02402257|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-03-07|||January 2014||2014-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Central Venous Catheter Insertion Train the Trainer|Dissemination of a Simulation-based Mastery Learning Curriculum for Central Venous Catheter Insertion at Veterans Affairs Hospitals: A Quantitative Study|Active, not recruiting||N/A|226|Actual|Northwestern University|||2||f||||f||||||||||2017-10-10 23:26:44.159715|2017-10-10 23:26:44.159715
NCT02402244|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-11-18|||October 2015||2015-10-01|November 2016|2016-11-01||||January 2100|Anticipated|2100-01-01||Observational|||Project: Every Child for Younger Patients With Cancer|The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study|Recruiting||N/A|33000|Anticipated|Children's Oncology Group|||1||f||||t||||||Samples With DNA|"     tissue, blood, bone marrow, plasma, serum, buccal cells, saliva, cerebrospinal fluid, or     urine   "|||2017-10-10 23:26:44.245057|2017-10-10 23:26:44.245057
NCT02402231|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2016-02-24|||October 2013||2013-10-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|FASTX||Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy|Explorative Open Phase II-study, Food Allergy Suppression Therapy During Protection With Xolair|Active, not recruiting||Phase 2|23|Actual|Karolinska Institutet||1|||f||||t||||||||||2017-10-10 23:26:44.322871|2017-10-10 23:26:44.322871
NCT02402218|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-06-21|||March 2015|Actual|2015-03-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CHAMPS||CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS|CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS|Active, not recruiting||Phase 4|150|Actual|Johns Hopkins University||3|||f||||t||||||||Undecided||2017-10-10 23:26:44.394334|2017-10-10 23:26:44.394334
NCT02402205|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2015-03-27|||July 2011||2011-07-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||TF-CBT for Adjudicated Youth in Residential Treatment|TF-CBT for Adjudicated Youth in Residential Treatment|Completed||N/A|210|Actual|Allegheny Singer Research Institute||2|||f||||t||||||||||2017-10-10 23:26:44.548696|2017-10-10 23:26:44.548696
NCT02402192|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-03-24|||April 2015||2015-04-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|PEM-ESD||Type of Gonadotropin and Embryo Kinetics of Development|A Prospective Randomized Trial to Analyze the Effect of the Gonadotropin Administered During Control Ovarian Stimulation on Embryo Kinetics of Development|Unknown status|Not yet recruiting|Phase 4|201|Anticipated|IVI Madrid||3|||f||||f||||||||||2017-10-10 23:26:44.621376|2017-10-10 23:26:44.621376
NCT02402179|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-11-11|||March 2015||2015-03-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Metabolic Availability of Tryptophan From White Maize|Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Tryptophan From White Maize Protein, in Young Adult Men|Completed||N/A|7|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-10 23:26:44.699876|2017-10-10 23:26:44.699876
NCT02402140|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-10-30|||February 2014||2014-02-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|PharmCare||Influence of Pharmaceutical Care on the Intraindividual Variability of Tacrolimus Concentrations|A Prospective Randomized Trial Investigating the Influence of Pharmaceutical Care on the Intraindividual Variability of Tacrolimus Concentrations Early After Kidney Transplant.|Completed||N/A|128|Actual|Hospital do Rim e Hipertensão||2|||f||||f||||||||||2017-10-10 23:26:44.902222|2017-10-10 23:26:44.902222
NCT02402127|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2016-07-25|2016-07-25||May 2015||2015-05-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Intention to treat, defined as the set of all randomized participants|Lubricity Post-Wear - Competitive Lenses Pilot|Evaluation of the Lubricity of Daily Disposable Silicone Hydrogel Contact Lenses After Wear|Completed||N/A|24|Actual|Alcon Research||6|||f||||f||||||||||2017-10-10 23:26:44.972274|2017-10-10 23:26:44.972274
NCT02402114|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-05-08|||February 2, 2015|Anticipated|2015-02-02|May 2017|2017-05-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|HP-PTSD||Hydrocortisone for Prevention of Post-Traumatic Stress Disorder|Hydrocortisone for Prevention of Post-Traumatic Stress Disorder|Withdrawn||N/A|0|Actual|Albert Einstein Healthcare Network||2||Never started or submitted to IRB|f||||t||||||||No||2017-10-10 23:26:45.381321|2017-10-10 23:26:45.381321
NCT02402101|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-08-22|||February 2015||2015-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|DOPA-STIM||Effect of the Transcranial Direct Current Stimulation on the Dopaminergic Transmission in Healthy Subjects|Effect of the Transcranial Direct Current Stimulation on the Dopaminergic|Completed||Phase 3|36|Actual|Hôpital le Vinatier||2|||f||||t||||||||||2017-10-10 23:26:47.44676|2017-10-10 23:26:47.44676
NCT02402088|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-11-29|||August 2013||2013-08-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Role of Emotional Arousal in Food Preference and Taste|The Purpose of This Study is to Investigate the Role of Stress in Food Craving and Food Consumption by Examining Stress Response Using Subjective, Physiological and Neurobiological Measurements|Recruiting||N/A|150|Anticipated|Yale University||3|||f||||t||||||||||2017-10-10 23:26:47.530102|2017-10-10 23:26:47.530102
NCT02402075|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-27|||January 2014||2014-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Spinal Motor Evoked Potentials in Brain Surgery|Spinal Motor Evoked Potentials During Neurosurgical Procedures Within the Central Region|Unknown status|Recruiting|N/A|40|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-10 23:26:47.623518|2017-10-10 23:26:47.623518
NCT02402062|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-03-10|||February 2015||2015-02-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours|A Phase II Study to Assess the Activity and Safety of TH-302 in Combination With Sunitinib in Treatment-naïve Patients With Well- and Moderately-differentiated Metastatic Pancreatic Neuroendocrine Tumours (pNET)|Recruiting||Phase 2|43|Anticipated|Grupo Espanol de Tumores Neuroendocrinos||1|||f||||t||||||||||2017-10-10 23:26:47.738541|2017-10-10 23:26:47.738541
NCT02401984|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-02-06|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|ZASMD||Zurcher Adolescent Screening for Mental Disorder|Zürcher Adoleszenz-Screening-Instrument Psychischer Störungen|Completed||N/A|83|Actual|Zurich University of Applied Sciences|||1||f||||f||||||||||2017-10-10 23:26:47.874732|2017-10-10 23:26:47.874732
NCT02401971|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-27|||August 2014||2014-08-01|September 2014|2014-09-01|August 2018|Anticipated|2018-08-01|August 2016|Anticipated|2016-08-01||Interventional|ITAGC||Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer|Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer : A Multicenter, Randomized, Controlled and Prospective Trial|Recruiting||Phase 4|900|Anticipated|Zhengzhou University||2|||f||||t||||||||||2017-10-10 23:26:47.956899|2017-10-10 23:26:47.956899
NCT02401958|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-05-16|||March 2014||2014-03-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Acute Effect of Resistance Training in Inflammatory Markers in Women With Rheumatoid Arthritis||Completed||Phase 4|34|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-10 23:26:48.079305|2017-10-10 23:26:48.079305
NCT02401945|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-05-12|||April 2015||2015-04-01|May 2017|2017-05-01|October 31, 2016|Actual|2016-10-31|June 22, 2016|Actual|2016-06-22||Interventional|VAPOR1||A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration|A Multicenter, Randomized, Open Label, Phase IIa Study Assessing the Efficacy, Safety and Duration of Effect of Intravitreal Injections of DE-120 as Monotherapy and With a Single Eylea® Injection in Subjects With Treatment-Naive Exudative Age-Related Macular Degeneration|Completed||Phase 2|16|Actual|Santen Inc.||2|||f||||t||||||||||2017-10-10 23:26:48.173383|2017-10-10 23:26:48.173383
NCT02401932|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-11-08|||January 2014||2014-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Retrospective Analysis for Patients With Hemophagocytosis in Bone Marrow|Comparison of Malignant and Non-malignant Disorders Associated Bone Marrow Hemophagocytosis: A Single Center Experience|Completed||N/A|300|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 23:26:48.367206|2017-10-10 23:26:48.367206
NCT02401919|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-24|||May 2014||2014-05-01|March 2015|2015-03-01|May 2019|Anticipated|2019-05-01|December 2015|Anticipated|2015-12-01||Interventional|BCR_C||Basic Care Revisited_Communication for Patient Participation|BASIC CARE REVISITED - Building the Evidence Base in Core Nursing Practice|Recruiting||N/A|175|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-10 23:26:48.44223|2017-10-10 23:26:48.44223
NCT02401906|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-10-28|||May 2015||2015-05-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|MEDORT||MRI and Orbital Tumours (MEDORT)|MRI for the Etiological Diagnosis of Orbital Tumours|Recruiting||N/A|200|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 23:26:48.57726|2017-10-10 23:26:48.57726
NCT02401893|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-27|||September 2009||2009-09-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|July 2010|Actual|2010-07-01||Observational|||Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults|Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults|Completed||N/A|510|Actual|Vanderbilt University|||1||f||||f||||||Samples With DNA|"     serum samples were collected   "|||2017-10-10 23:26:48.659387|2017-10-10 23:26:48.659387
NCT02401880|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-02-23|||May 2015||2015-05-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology|Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology and Metabolic Control in Patients With Type 2 Diabetes Mellitus on Stable Metformin Treatment|Completed||Phase 4|89|Actual|Profil Institut für Stoffwechselforschung GmbH||3|||f||||f||||||||||2017-10-10 23:26:48.726784|2017-10-10 23:26:48.726784
NCT02401867|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-04-11|2017-01-24||January 2015||2015-01-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational||Enrolled =150, analytic sample =131: 10 participants did not receive the vaginal HPV DNA self-swab and provider cervical swab; 7 received the self-swab, but not the provider; 1 received the provider-swab, but not the self; and 2 did not receive either test. Additionally, 9 of the provider samples could not be assayed due to low cellular content.|Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients|Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients|Completed||N/A|150|Actual|Fenway Community Health|||1||f||||f||||||||No||2017-10-10 23:26:48.833056|2017-10-10 23:26:48.833056
NCT02401854|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-04-27|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01|60 Days|Observational [Patient Registry]|ASSERT-III||Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder|Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder Using Automatic Algorithms for AF Detection: A Pilot Study (ASSERT-III)|Completed||N/A|129|Actual|Population Health Research Institute|||1||f||||f||||||||||2017-10-10 23:26:49.221542|2017-10-10 23:26:49.221542
NCT02401841|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-10-19|||January 2015||2015-01-01|October 2015|2015-10-01||||March 2015|Actual|2015-03-01||Observational|||Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex|Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex|Unknown status|Recruiting|N/A|40|Anticipated|Policlinico Hospital|||2||f||||||||||||||2017-10-10 23:26:49.291495|2017-10-10 23:26:49.291495
NCT02401828|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-02-06|||March 2015||2015-03-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|DOMONO||The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial|The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial|Active, not recruiting||Phase 4|134|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 23:26:49.368552|2017-10-10 23:26:49.368552
NCT02401815|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-18|||March 2015||2015-03-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|August 2019|Anticipated|2019-08-01||Interventional|||PLX9486 as a Single Agent and in Combination With PLX3397 or PLX9486 With Sunitinib in Patients With Advanced Solid Tumors|A Phase 1b and 2a Study to Assess Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLX9486 as a Single Agent and in Combination With PLX3397 or Sunitinib (Sutent®) in Patients With Advanced Solid Tumors and Patients With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumor (GIST) Who Have Been Previously Treated With Imatinib Mesylate/KIT-Directed Tyrosine Kinase Inhibitor (TKI) Therapy|Recruiting||Phase 1/Phase 2|200|Anticipated|Plexxikon||7|||f||||f||||||||||2017-10-10 23:26:49.459306|2017-10-10 23:26:49.459306
NCT02401802|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-02-14|||January 2015||2015-01-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|DIETCOL||Low-fiber Diet for Colorectal Cancer Screening Colonoscopy|Low-fiber Diet for Colorectal Cancer Screening Colonoscopy. Randomized Clinical Trial. Dietcol Study|Completed||N/A|276|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-10 23:26:49.559002|2017-10-10 23:26:49.559002
NCT02401789|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-08-30|||January 2015||2015-01-01|August 2016|2016-08-01|December 2022|Anticipated|2022-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Dimensional Alterations of the Edentulous Ridge Following Removal of Multiple Adjacent Teeth|Dimensional Alterations of the Edentulous Ridge Following Removal of Multiple Adjacent Teeth|Recruiting||Phase 2|40|Anticipated|Institute Franci||2|||f||||f||||||||||2017-10-10 23:26:49.644128|2017-10-10 23:26:49.644128
NCT02401776|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-10-17|||March 2014||2014-03-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Caffeine on Heart Function|An Evaluation of the Heart Rate, Blood Pressure and Repolarization Effects of an Energy Drink as Compared to Coffee|Completed||N/A|30|Actual|University of Texas at Austin||3|||f||||f||||||||||2017-10-10 23:26:49.739014|2017-10-10 23:26:49.739014
NCT02401763|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-03-31|||April 2015||2015-04-01|March 2015|2015-03-01||||April 2016|Anticipated|2016-04-01||Observational|||Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis|Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis|Unknown status|Not yet recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-10 23:26:49.823064|2017-10-10 23:26:49.823064
NCT02401750|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-08-04||2016-08-04|June 2015||2015-06-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery|A Multi-center, Randomized, Multiple-dose, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Abuse-deterrent Capsules Oxycodone Hydrochloride Plus Naltrexone Hydrochloride (a) or Oxycodone Hydrochloride Plus Naltrexone Hydrochloride (b) for the Treatment of Adults With Moderate to Severe Pain Following Bunionectomy Surgery|Completed||Phase 3|163|Actual|Elite Laboratories, Inc||3|||f||||f||||||||||2017-10-10 23:26:49.88242|2017-10-10 23:26:49.88242
NCT02401737|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-03-15|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients|A Phase 1b Dose-Ranging Study to Assess the Safety, Pharmacokinetics and Initial Antiviral Efficacy of NVR 3-778 in Patients With HBeAg-Positive Chronic Hepatitis B Virus Infection|Active, not recruiting||Phase 1|84|Anticipated|Novira Therapeutics, Inc.||4|||f||||t||||||||||2017-10-10 23:26:49.972647|2017-10-10 23:26:49.972647
NCT02401724|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-27|||March 2015||2015-03-01|March 2015|2015-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|RTNIBS||NonInvasive Brain Stimulation in Stroke Patients|A Randomised Trial of Non-Invasive Brain Stimulation (NIBS) in Stroke Survivors|Not yet recruiting||N/A|60|Anticipated|NHS Greater Glasgow and Clyde||4|||f||||f||||||||||2017-10-10 23:26:50.263756|2017-10-10 23:26:50.263756
NCT02401711|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-05-14|||February 2014||2014-02-01|May 2016|2016-05-01||||August 2015|Actual|2015-08-01||Interventional|||How Should Surgical Residents Be Educated About Patient Safety|How Should Surgical Residents Be Educated About Patient Safety in the Operating Room: a Pilot Randomized Trial|Active, not recruiting||N/A|58|Actual|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-10 23:26:50.369035|2017-10-10 23:26:50.369035
NCT02401698|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-01-08|||December 2014||2014-12-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Observational|||Exploring Cerebellar Inhibition of the Motor Cortex in Stroke Patients|Exploring Cerebellar Inhibition of the Motor Cortex in Stroke Patients|Suspended||N/A|8|Anticipated|University of Sao Paulo General Hospital|||1|To perform a interim analyzes|f||||t||||||||||2017-10-10 23:26:50.450608|2017-10-10 23:26:50.450608
NCT02401685|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-08-20|||January 2014||2014-01-01|August 2016|2016-08-01|December 2023|Anticipated|2023-12-01|March 2023|Anticipated|2023-03-01||Interventional|POSNOC||POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer|POSNOC - POsitive Sentinel NOde: Adjuvant Therapy Alone Versus Adjuvant Therapy Plus Clearance or Axillary Radiotherapy. A Randomised Controlled Trial of Axillary Treatment in Women With Early Stage Breast Cancer Who Have Metastases in One or Two Sentinel Nodes|Recruiting||N/A|1900|Anticipated|Derby Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:26:50.533991|2017-10-10 23:26:50.533991
NCT02401672|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-24|||May 2014||2014-05-01|March 2015|2015-03-01||||April 2016|Anticipated|2016-04-01||Interventional|||rTMS for Smoking Cessation|Developing rTMS as a Potential Treatment for Nicotine Addiction|Unknown status|Recruiting|Phase 2|42|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-10 23:26:50.820949|2017-10-10 23:26:50.820949
NCT02401659|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-04-18|||May 2014||2014-05-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Observational|VALIOSA||Importance of Patient´s Satisfaction With Telemedicine Based on Monitoring Systems||Active, not recruiting||N/A|180|Anticipated|Medtronic Bakken Research Center|||2||f||||f||||||||||2017-10-10 23:26:50.92994|2017-10-10 23:26:50.92994
NCT02401646|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-24|||March 2015||2015-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Clinical Trials for the Effects of Polygoni Multiflori Radix Complex Extract on Memory Improvement|Clinical Trials for the Effects of Polygoni Multiflori Radix Complex Extract on Memory Improvement|Unknown status|Not yet recruiting|Phase 4|54|Anticipated|Korean Medicine Hospital of Pusan National University||2|||f||||t||||||||||2017-10-10 23:26:51.013935|2017-10-10 23:26:51.013935
NCT02401633|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2017-04-20|||February 2015||2015-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|TANGO2||Compression Only-CPR Versus Standard-CPR - the Pilot Phase|A Randomized Trial Comparing the Effect of a Simplified Form of Cardiopulmonary Resuscitation (CPR) Consisting of Only Chest Compressions Compared to CPR With Compressions and Rescue Breaths - the Run-in Phase|Recruiting||N/A|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||No|Data will be published on group level only|2017-10-10 23:26:51.104741|2017-10-10 23:26:51.104741
NCT02401620|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-03-24|||January 2014||2014-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Observational|||Validation of a Tolerability Questionnaire in Rheumatoid Arthritis|Validation of a Specific Questionnaire to Assess the Tolerability of the Different Therapeutic Strategies in Rheumatoid Arthritis|Unknown status|Recruiting|N/A|66|Anticipated|Corporacion Parc Tauli|||1||f||||f||||||||||2017-10-10 23:26:51.206555|2017-10-10 23:26:51.206555
NCT02401607|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-07-28|||March 2015||2015-03-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|SEEK||SEEK Study - Study on Emergency Health Care Workers' Job Strain Evaluated by Karasek Questionnaire|SEEK Study - Study on Emergency Health Care Workers' Job Strain Evaluated by Karasek Questionnaire|Recruiting||N/A|100|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:26:51.326077|2017-10-10 23:26:51.326077
NCT02401594|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-07-17|||December 8, 2015|Actual|2015-12-08|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PRONOMOS||PROphylaxis in NOn Major Orthopaedic Surgery|A Multicentre, Randomised, Double-blind, Controlled, Phase IIIb Study to Assess the Efficacy and Safety of Rivaroxaban 10mg od Versus Enoxaparin 4000 UI for VTE PROphylaxis in NOn Major Orthopaedic Surgery|Recruiting||Phase 3|4400|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t|f|f||||||||2017-10-10 23:26:51.439759|2017-10-10 23:26:51.439759
NCT02401581|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-03-24|||February 2015||2015-02-01|March 2015|2015-03-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Interventional|PRECOCE||Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours|Study ¨PRECOCE Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours|Unknown status|Recruiting|N/A|300|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 23:26:51.709754|2017-10-10 23:26:51.709754
NCT02401568|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-03-07|||February 2015||2015-02-01|March 2016|2016-03-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|EDLIS||Morphologic and Biomechanical Analysis of the Carpal Ligaments|Morphologic and Biomechanical Analysis of the Carpal Ligaments: a Kinematic Study on Dynamic Area Detector CT|Recruiting||N/A|300|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-10-10 23:26:51.841095|2017-10-10 23:26:51.841095
NCT02401555|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-02-08|2015-11-24||April 2013||2013-04-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay|Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay|Completed||N/A|419|Actual|Bio-Rad Laboratories|||3||f||||f||||||Samples Without DNA|"     Serum and plasma samples   "|||2017-10-10 23:26:51.935354|2017-10-10 23:26:51.935354
NCT02401542|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-09-13|||June 2015||2015-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FIERCE 21||A Phase 1b/2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma|A Phase 1b/2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of B-701 Plus Docetaxel Versus Placebo Plus Docetaxel in the Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma in Subjects Who Have Relapsed After, or Are Refractory to Standard Therapy|Recruiting||Phase 1/Phase 2|261|Anticipated|BioClin Therapeutics, Inc.||3|||f||||t|t|f||||||||2017-10-10 23:26:52.341896|2017-10-10 23:26:52.341896
NCT02401529|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-21|2015-06-20|2015-05-06||January 2013||2013-01-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Steroids on Post-tonsillectomy Morbidities|Effect of Steroids on Post-tonsillectomy Morbidities|Completed||Phase 2|100|Actual|King Fahd General Hospital||2|||f||||f||||||||||2017-10-10 23:26:52.762974|2017-10-10 23:26:52.762974
NCT02401516|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-12|||May 2014||2014-05-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIBP||Reprogramming Insoles In Regulating Blood Pressure In Hypertensive Subjects|Effect Of Postural Reprogramming Insoles In Regulating Blood Pressure, Posture And Quality Of Life In Hypertensive Subjects|Recruiting||N/A|60|Anticipated|Escola Bahiana de Medicina e Saude Publica||2|||f||||t|f|f||||||No||2017-10-10 23:26:53.415224|2017-10-10 23:26:53.415224
NCT02401503|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-09-23|||May 2015||2015-05-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG)|A Prospective, Open-label, Multicenter Phase-II Trial to Evaluate the Efficacy and Safety of a Sequential Regimen of Bendamustine Followed by GA101 and ABT-199 Followed by ABT-199 and GA101 Maintenance in CLL Patients|Active, not recruiting||Phase 2|66|Actual|German CLL Study Group||1|||f||||f||||||||No||2017-10-10 23:26:53.560637|2017-10-10 23:26:53.560637
NCT02401490|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-12-20|||April 2015||2015-04-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|BETA||Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy|Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy|Recruiting||Phase 4|128|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||||||||||||2017-10-10 23:26:53.652448|2017-10-10 23:26:53.652448
NCT02401477|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-11-02|||December 2014||2014-12-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection|Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection; Studies From Korea|Completed||Phase 4|90|Actual|Il-Yang Pharm. Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:26:53.76948|2017-10-10 23:26:53.76948
NCT02401464|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-05-25|2016-05-25||March 2015||2015-03-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||The pharmacokinetic analysis set included all participants who received the study drug, completed the minimum protocol-specified procedures without any major protocol deviations, and were evaluable for pharmacokinetics.|A Bioequivalence Study of TAK-536 Pediatric Formulation|A Randomized, Open-label, 2×2 Crossover, Phase I Study to Evaluate the Bioequivalence of Single Oral Dose of TAK-536 Pediatric Formulations and TAK-536 Commercial Tablet in Healthy Adult Male Subjects|Completed||Phase 1|52|Actual|Takeda||4|||f||||f||||||||||2017-10-10 23:26:53.870224|2017-10-10 23:26:53.870224
NCT02401451|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-08-09|||October 2014||2014-10-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|SL-AF||SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])|SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])|Completed||N/A|750|Actual|Cardiocity Limited||1|||f||||f||||||||Undecided||2017-10-10 23:26:54.558563|2017-10-10 23:26:54.558563
NCT02401438|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-07-30|||March 2015||2015-03-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Accuracy of 5D LB Ultrasound in Predicting Birth Weight of Preterm Fetuses : A Pilot Study||Recruiting||N/A|100|Anticipated|Ain Shams University|||1||f||||||||||||||2017-10-10 23:26:54.654032|2017-10-10 23:26:54.654032
NCT02401425|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-09-27|||March 2015||2015-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Use of Letrozole Pretreatment With Misoprostol for First-Trimester Medical Abortion|Use of Letrozole Pretreatment With Misoprostol for First-Trimester Medical Abortion: Randomised Controlled Trial|Completed||Phase 2/Phase 3|423|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-10 23:26:54.747646|2017-10-10 23:26:54.747646
NCT02401412|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-05-25|||March 16, 2015|Actual|2015-03-16|May 2017|2017-05-01|February 3, 2017|Actual|2017-02-03|January 20, 2017|Actual|2017-01-20||Interventional|||The Advocate Study|A Study Determining Variances in Ostomy Skin Conditions And The Economic Impact.|Completed||N/A|153|Actual|Hollister Incorporated||2|||f||||f||||||||Yes||2017-10-10 23:26:54.850977|2017-10-10 23:26:54.850977
NCT02401399|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-24|||January 2014||2014-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Preoperative Diet Before Sleeve Gastrectomy|Preoperative Regular Diet of 900 Kcal/Day vs Balanced Energy High Protein Formula vs Immunonutrition Formula: Effect on Postoperative Pain After Laparoscopic Sleeve Gastrectomy|Completed||Phase 3|60|Actual|Hospital General Universitario Elche||3|||f||||f||||||||||2017-10-10 23:26:54.949923|2017-10-10 23:26:54.949923
NCT02401386|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-08-27|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|February 2017|Actual|2017-02-01||Interventional|||Lu Eight Brocades for Treating Patients With Fibromyalgia|A Randomized Controlled Trial of Lu Eight Brocades to Improve Quality of Life in Patients With Fibromyalgia|Completed||N/A|62|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||||2017-10-10 23:26:55.038875|2017-10-10 23:26:55.038875
NCT02401373|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-07-15|||March 2015||2015-03-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.|A Phase 1, Dose-escalation, Open Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of the Recombinant Human Type 5 Adenovirus Vector Based Ebola Vaccine (Ad5-EBOV) in Healthy Adult Africans Aged Between 18-60 Years in China|Completed||Phase 1|61|Actual|First Affiliated Hospital of Zhejiang University||2|||f||||t||||||||||2017-10-10 23:26:55.12805|2017-10-10 23:26:55.12805
NCT02401360|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-10-04|||April 2013||2013-04-01|October 2017|2017-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study to Assess Clinical Gingivitis and Microbiome Following the Use of Multiple Oral Hygiene Products|A Controlled Study to Assess Clinical Gingivitis and Microbiome Following the Use of Multiple Oral Hygiene Products|Completed||N/A|106|Actual|Procter and Gamble||2|||f|||||f|f||||||||2017-10-10 23:26:55.221368|2017-10-10 23:26:55.221368
NCT02401347|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-08-09|||August 2015||2015-08-01|August 2015|2015-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Talazoparib Beyond BRCA (TBB) Trial|A Phase II Clinical Trial of BMN 673 in BRCA1 and BRCA2 Wild-Type Patients With (i) Advanced Triple-Negative Breast Cancer and Homologous Recombination Deficiency as Assessed by the HRD Assay, and (ii) Advanced HER2-Negative Breast Cancer With Either a Germline or Somatic Mutation in Homologous Recombination Pathway Genes|Recruiting||Phase 2|58|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 23:26:55.299163|2017-10-10 23:26:55.299163
NCT02401334|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-02-09|||June 2015||2015-06-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|AMEX||Antimicrobial Hernia Repair Device Clinical Study|Feasibility Study of the Antimicrobial Hernia Repair Device for Repair of Ventral or Incisional Hernia|Active, not recruiting||N/A|24|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-10 23:26:55.414927|2017-10-10 23:26:55.414927
NCT02401308|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-07-31|||January 15, 2015|Actual|2015-01-15|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|December 15, 2016|Actual|2016-12-15||Interventional|||Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease|Randomized Controlled Clinical Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease|Terminated||N/A|1|Actual|St. Joseph's Hospital and Medical Center, Phoenix||2||Lack of subject enrollment.|f||||f||||||||||2017-10-10 23:26:55.579441|2017-10-10 23:26:55.579441
NCT02401295|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-02-20|||May 2015||2015-05-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|August 2015|Actual|2015-08-01||Interventional|||ATRA, Celecoxib, and Itraconazole as Maintenance|An Open-Label Phase I Trial to Evaluate the Safety and Tolerability of ATRA, Celecoxib, and Itraconazole Administered As Maintenance Treatment Post-Autologous Transplantation in Relapsed Multiple Myeloma|Completed||Phase 1|1|Actual|University of Iowa||1|||f||||t||||||||||2017-10-10 23:26:55.670956|2017-10-10 23:26:55.670956
NCT02401282|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-04-17|||December 2011||2011-12-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|BRAINS||Attention and Social Behavior in Children||Active, not recruiting||N/A|240|Anticipated|Penn State University||2|||f||||f||||||||||2017-10-10 23:26:55.783539|2017-10-10 23:26:55.783539
NCT02401269|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-01-13|||April 2015||2015-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|MHEART||Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study|Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study|Completed||Phase 1/Phase 2|91|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:26:56.107294|2017-10-10 23:26:56.107294
NCT02401243|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-03-25|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|TITRATION||Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients|A Pilot Descriptive Canadian, Multicenter, Open-label, Randomized Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients|Completed||Phase 3|253|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 23:26:56.356713|2017-10-10 23:26:56.356713
NCT02401230|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-04-21|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Interventional|||PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV|Defining the Rectal Mucosa in Men Who Have Sex With Men at Risk of HIV Infection|Completed||Phase 4|85|Actual|Emory University||3|||f||||f|t|t|f|||||Undecided||2017-10-10 23:26:56.506488|2017-10-10 23:26:56.506488
NCT02401217|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-01-11|||April 2015||2015-04-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Tolerance of Healthy Infants Fed Infant Formulas|Tolerance of Healthy Infants Fed Infant Formulas|Completed||N/A|126|Actual|Abbott Nutrition||3|||f||||t||||||||||2017-10-10 23:26:56.609956|2017-10-10 23:26:56.609956
NCT02401204|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-10-05|||March 2015||2015-03-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|BTS||Bacterial Transmission Dynamics Study|Bacterial Transmission Surveillance in Neonatal Intensive Care Unit: Transmission Dynamics and Drug Resistance Patterns|Unknown status|Recruiting|N/A|300|Anticipated|University of Oxford|||1||f||||f||||||Samples Without DNA|"     Stool Tracheal suction swab Rectal swab   "|||2017-10-10 23:26:56.70726|2017-10-10 23:26:56.70726
NCT02401191|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-11-26|||March 2015||2015-03-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis|A Non-controlled, Open Study for Assessing the Safety and Effectiveness of a Twice-daily FEX 60 mg - PE 10 mg (FEX60/PE10) Fixed Combination Tablet in Patients With Allergic Rhinitis|Completed||Phase 3|105|Actual|Sanofi||1|||f||||f||||||||||2017-10-10 23:26:56.792371|2017-10-10 23:26:56.792371
NCT02401178|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-08-30|||May 2014||2014-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Observational|FLG-FADSgen||The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants|The Role of Fillagrin Gene Mutations and FADS Genes Variation Through Its Effect on the Concentration of Polyunsaturated Fatty Acids Towards the Occurance of Atopic Dermatitis in Indonesian Infants|Completed||N/A|400|Actual|Indonesia University|||1||f||||f||||||Samples With DNA|"     Buffy coat-plasma-cheeck cell   "|||2017-10-10 23:26:56.883778|2017-10-10 23:26:56.883778
NCT02401165|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-24|||March 2013||2013-03-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|GADD34-RA||Quantification of GADD34 Expression in RA|Quantification of GADD34 Expression in Rheumatoid Arthritis|Completed||N/A|100|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 23:26:56.976047|2017-10-10 23:26:56.976047
NCT02401152|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-12-14|||February 2015||2015-02-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Low-osmolaric Glucose Polymer Drink for Gastric Distress and Running Performance|The Effect of a Potato Based Low-osmolaric Glucose Polymer Drink on Gastric Distress and Running Performance|Completed||N/A|43|Actual|InnoSportNL||3|||f||||f||||||||||2017-10-10 23:26:57.070743|2017-10-10 23:26:57.070743
NCT02401139|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-26|||March 2015||2015-03-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Ketamine Trial for the Treatment of Depression|Ketamine Therapy Among Patients With Treatment-resistant Depression: a Randomised, Double-blind, Placebo-controlled Trial: Pilot Phase|Unknown status|Recruiting|Phase 1|10|Anticipated|The University of New South Wales||2|||f||||f||||||||||2017-10-10 23:26:57.186123|2017-10-10 23:26:57.186123
NCT02401126|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-04-29|||March 2015||2015-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Dietary Nitrate Supplementation on Cardiorespiratory Control in Chronic Heart Failure|Dietary Nitrate Supplementation and Cardiorespiratory Control in Chronic Heart Failure: a Randomized, Placebo-controlled Trial|Completed||Phase 4|13|Actual|Queen's University||2|||f||||f||||||||||2017-10-10 23:26:57.283598|2017-10-10 23:26:57.283598
NCT02292576|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-14|||June 2012||2012-06-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|April 2013|Actual|2013-04-01||Interventional|||Genetic and Epigenetic Mechanisms Underlying Cocoa Health Benefits|Genetic and Epigenetic Mechanisms Underlying Cocoa Health Benefits|Completed||N/A|50|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 23:49:04.40526|2017-10-10 23:49:04.40526
NCT02401113|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-10-30|||November 2014||2014-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|||Effect of Ursolic Acid of Loquat Extract on Function of Muscle|Effect of Ursolic Acid of Loquat Extract on Function of Muscle in Human|Completed||Phase 2/Phase 3|54|Actual|Pusan National University Hospital||2|||f||||t||||||||||2017-10-10 23:26:57.375157|2017-10-10 23:26:57.375157
NCT02401100|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-06-28|||May 2015||2015-05-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|||Anastomotic Leakage After Anterior Resection for Rectal Cancer - Predictive Biomarkers and Rectal Blood Flow|Anastomotic Leakage After Anterior Resection for Rectal Cancer - Predictive Biomarkers and Rectal Blood Flow|Recruiting||N/A|90|Anticipated|Umeå University|||1||f||||f||||||Samples Without DNA|"     Preoperative and postoperative blood samples. Postoperative drain fluid samples. Tissue     samples from the perianastomotic region taken perioperatively.   "|No||2017-10-10 23:26:57.451949|2017-10-10 23:26:57.451949
NCT02401087|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-26|||May 2014||2014-05-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Observational|||The Anaesthesiological Approach to Varicocele Correction in Outpatients Setting: an Observational Analisy|The Anaesthesiological Approach to Varicocele Correction in Outpatients Setting: an Observational Analisy|Unknown status|Recruiting|N/A|40|Anticipated|Ospedale di Circolo - Fondazione Macchi|||1||f||||t||||||||||2017-10-10 23:26:57.536388|2017-10-10 23:26:57.536388
NCT02401074|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-09-28|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|RATE||Airway Temperature|Role of Airway Tissue Temperature in Asthma Exacerbation|Not yet recruiting||Phase 1|8|Anticipated|University of Kentucky||1|||f||||t|t|f||||||||2017-10-10 23:26:57.631521|2017-10-10 23:26:57.631521
NCT02401061|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-08-26|||September 2015||2015-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP|A Phase 1/2, Open-Label, Dose Escalation Study of PRTX-100 in Adult Patients With Persistent/Chronic Immune Thrombocytopenia|Recruiting||Phase 1/Phase 2|36|Anticipated|Protalex, Inc.||1|||f||||t||||||||||2017-10-10 23:26:57.72679|2017-10-10 23:26:57.72679
NCT02401048|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-05|||May 2015||2015-05-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas|A Multi-Center Open-Label Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With MEDI4736, in Subjects With Relapsed or Refractory Lymphomas|Active, not recruiting||Phase 1/Phase 2|109|Anticipated|Pharmacyclics LLC.||3|||f||||f||||||||||2017-10-10 23:26:57.852804|2017-10-10 23:26:57.852804
NCT02401022|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-04-21|||July 2015||2015-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||The Study of AZD8529 for Smoking Cessation in Female Smokers|The Study of AZD8529 for Smoking Cessation in Female Smokers|Completed||Phase 2|214|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||No||2017-10-10 23:26:58.140992|2017-10-10 23:26:58.140992
NCT02401009|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-03-21|||January 1972||1972-01-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01|100 Years|Observational [Patient Registry]|||Protocol for a Research Database for HCT, Other Cellular Therapies and Marrow Toxic Injuries|Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries|Active, not recruiting||N/A|390000|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-10-10 23:26:58.237783|2017-10-10 23:26:58.237783
NCT02400996|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-04-10|2015-03-26||March 2011||2011-03-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|June 2011|Actual|2011-06-01||Observational|||An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms|A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.|Completed||N/A|40|Actual|Medical College and Hospital Kolkata|The analysis was done from a prospectively maintained database and target followup done for a period of 5 years after surgery||1||f||||f||||||||||2017-10-10 23:26:58.313819|2017-10-10 23:26:58.313819
NCT02400983|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-30|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|||Real Life Automatic Atrial Capture Device Control|Registry on Automatic Algorhitm on Atrial Capture: REAL ACap Registry|Completed||N/A|318|Actual|Maria Vittoria Hospital|||1||f||||f||||||||||2017-10-10 23:26:58.519339|2017-10-10 23:26:58.519339
NCT02400970|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-26|||November 2014||2014-11-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|November 2015|Anticipated|2015-11-01||Observational|TESTIMAR||Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors|Study About Contamination of Testicle Tissue by RT-PCR in Children With Solid Tumors|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:26:58.590087|2017-10-10 23:26:58.590087
NCT02400957|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-26|||September 2014||2014-09-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Addition of Silver Nanoparticles to a Orthodontic Primer in Preventing Enamel Demineralization Adjacent Brackets|Effectiveness of the Addition of Silver Nanoparticles to a Orthodontic Primer in Preventing Enamel Demineralization Adjacent Brackets. ECCA|Unknown status|Active, not recruiting|Phase 3|40|Anticipated|Universidad Autonoma de San Luis Potosí||2|||f||||t||||||||||2017-10-10 23:26:58.66596|2017-10-10 23:26:58.66596
NCT02400944|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-08-21|||March 2015||2015-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Determinants of Bladder Cancer Recurrence Study (The DETER Study)|Determinants of Bladder Cancer Recurrence Study (The DETER Study)|Recruiting||N/A|600|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     Saliva and/or urine sample   "|||2017-10-10 23:26:58.75539|2017-10-10 23:26:58.75539
NCT02400931|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-01-23|||April 28, 2015|Actual|2015-04-28|January 2017|2017-01-01|November 23, 2015|Actual|2015-11-23|November 23, 2015|Actual|2015-11-23||Interventional|||The Necessity of Routine Mask Ventilation in Adults||Completed||N/A|288|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:26:58.855925|2017-10-10 23:26:58.855925
NCT02400905|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-04-17|||June 2015||2015-06-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|MIMICS-2||Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System|MIMICS-2: Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease|Active, not recruiting||N/A|271|Actual|Veryan Medical Ltd.||1|||f||||t||||||||||2017-10-10 23:26:58.997859|2017-10-10 23:26:58.997859
NCT02400892|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2016-09-06|||March 2015||2015-03-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Patent Foramen Ovale and the Risk of Postoperative Delirium Following Elective Hip and Knee Arthroplasty Surgeries|Patent Foramen Ovale and the Risk of Postoperative Delirium Following Elective Hip and Knee Arthroplasty Surgeries|Completed||N/A|226|Actual|Lawson Health Research Institute|||2||f||||f||||||||||2017-10-10 23:26:59.15738|2017-10-10 23:26:59.15738
NCT02400879|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2015-08-13|||October 2015||2015-10-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Remifentanil Anesthesia and Postoperative BIS in Cardiac Surgery|Comparisons of Postoperative BIS Profile and Extubation Time After Valvular Heart Surgery: Remifentanil-based Propofol-supplemented Versus Sevoflurane-sufentanil Balanced Anesthesia Regimen|Unknown status|Not yet recruiting|N/A|40|Anticipated|Konkuk University Medical Center||2|||f||||t||||||||||2017-10-10 23:26:59.231069|2017-10-10 23:26:59.231069
NCT02400866|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-26|||May 2015||2015-05-01|March 2015|2015-03-01|April 2017|Anticipated|2017-04-01|November 2015|Anticipated|2015-11-01||Interventional|||A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy||Unknown status|Not yet recruiting|Phase 2|58|Anticipated|Korean South West Oncology Group||2|||f||||f||||||||||2017-10-10 23:26:59.329077|2017-10-10 23:26:59.329077
NCT02400853|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-12-06|||July 2015||2015-07-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|HEMO PREMA||Research a New Predictive Marker of Intraventricular Hemorrhage in Very Preterm Infants|Research a New Predictive Marker of Intraventricular Hemorrhage in Very Preterm Infants: HEMO PREMA Study|Recruiting||N/A|120|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 23:26:59.396436|2017-10-10 23:26:59.396436
NCT02400840|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-05-25|||January 2015||2015-01-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|DRAGON||Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging|Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging|Withdrawn||N/A|0|Actual|University Hospital, Rouen||2||Study is not feasable yet, due to evolution in the patients' care|f||||f||||||||||2017-10-10 23:26:59.480633|2017-10-10 23:26:59.480633
NCT02400827|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2015-03-26|||November 2014||2014-11-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|November 2015|Anticipated|2015-11-01||Observational|OVAMAR||Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors|Study About Contamination of Ovarian Tissue by RT-PCR in Children With Solid Tumors.|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:26:59.658588|2017-10-10 23:26:59.658588
NCT02400814|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-02-14|||December 2015||2015-12-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Interventional|||MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer|Pilot Study of MPDL3280A Plus Stereotactic Ablative Radiotherapy (SAR) in Stage IV Non-small Cell Lung Cancer|Recruiting||Phase 1|45|Anticipated|University of California, Davis||3|||f||||t||||||||||2017-10-10 23:26:59.776016|2017-10-10 23:26:59.776016
NCT02400801|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-06-08|||June 2013||2013-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients||Active, not recruiting||N/A|166|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 23:26:59.918425|2017-10-10 23:26:59.918425
NCT02400788|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-07-03|||April 2013||2013-04-01|July 2016|2016-07-01||||October 2016|Anticipated|2016-10-01||Interventional|||Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)|A Phase I/II Study in Combination of Resminostat and Sorafenib in Patients With Advanced Hepatocellular Carcinoma Previously Untreated With Systemic Chemotherapy|Active, not recruiting||Phase 1/Phase 2|150|Anticipated|Yakult Honsha Co., LTD||2|||f||||||||||||||2017-10-10 23:27:00.044425|2017-10-10 23:27:00.044425
NCT02400775|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-05-23|||March 2015||2015-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ALIVE||A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.|A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.|Withdrawn||Phase 4|0|Actual|Takeda||1|||f||||||||||||||2017-10-10 23:27:00.160278|2017-10-10 23:27:00.160278
NCT02400762|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-08-29|||October 2013||2013-10-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|Intebody||Prospective Study of Safety and Efficacy of InQu® Bone Graft Extender in Lumbar Interbody Fusion Surgery|A Prospective Study of the Safety and Efficacy of InQu® Bone Graft Extender in Transforaminal and Posterior Lumbar Interbody Fusion Surgery|Recruiting||N/A|130|Anticipated|ISTO Technologies, Inc.|||1||f||||f||||||||||2017-10-10 23:27:00.257152|2017-10-10 23:27:00.257152
NCT02400749|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-02-06|||May 2015||2015-05-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Apremilast in Palmo-Plantar Psoriasis|A Double-blind, Placebo-controlled, Randomized Study on the Safety and Efficacy of Apremilast in Patients With Moderate to Severe Plaque Psoriasis Involving Palms and/or Soles|Completed||Phase 4|100|Actual|Innovaderm Research Inc.||2|||f||||f||||||||No||2017-10-10 23:27:00.363279|2017-10-10 23:27:00.363279
NCT02400736|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-06-20|||August 3, 2015|Actual|2015-08-03|June 2017|2017-06-01|March 29, 2019|Anticipated|2019-03-29|February 15, 2019|Anticipated|2019-02-15||Interventional|||Supported Employment in OIF/OEF PACT|Efficacy of Supported Employment Within the OIF/OEF Patient Aligned Care Team|Recruiting||N/A|150|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-10 23:27:00.508021|2017-10-10 23:27:00.508021
NCT02400723|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-05-16|||January 1, 2018|Anticipated|2018-01-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|BREATHE||Anxiety in Older Veterans|Reducing Anxiety and Improving Functioning in Older Veterans|Not yet recruiting||N/A|60|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 23:27:00.630103|2017-10-10 23:27:00.630103
NCT02400710|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-01-04|2015-11-19||April 2013||2013-04-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Participants completed self-report measures at baseline.|Clinician-Supported PTSD Coach vs. Self-Managed PTSD Coach|Clinician-Supported PTSD Coach vs. Self-Managed PTSD Coach: A Pilot Feasibility Trial|Completed||N/A|20|Actual|Syracuse VA Medical Center||2|||f||||f||||||||||2017-10-10 23:27:00.759084|2017-10-10 23:27:00.759084
NCT02400697|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-24|2017-03-15|||September 2014||2014-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Placental Transfusion Project for Preterm Infants|"Placental Transfusion in Preterm Infants Born at Less Than 34 Weeks of Gestation … Role of Delayed Cord Clamping and Umbilical Cord Milking"|Completed||N/A|2856|Actual|Indiana University|||2||f||||f||||||||||2017-10-10 23:27:01.151704|2017-10-10 23:27:01.151704
NCT02400684|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-09-14|||June 2015||2015-06-01|September 2015|2015-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|1 Year|Observational [Patient Registry]|ENDRO||ENDmetriosis and Reserve Ovarienne|ENDmetriosis and Reserve Ovarienne|Recruiting||N/A|130|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||Samples Without DNA|"     3 times blood sample retrieval and use serum to measure AMH the primary end point but also     FSH, LH, estradiol which are study usually.   "|||2017-10-10 23:27:01.235445|2017-10-10 23:27:01.235445
NCT02400671|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-05-25|||November 2015|Actual|2015-11-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|Mobile WAChx||Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ART|Evaluation of Mhealth Strategies to Optimize Adherence and Efficacy of PMTCT/ART|Active, not recruiting||N/A|825|Actual|University of Washington||3|||f||||t||||||||||2017-10-10 23:27:01.32457|2017-10-10 23:27:01.32457
NCT02400658|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-11-21|||March 2015||2015-03-01|November 2016|2016-11-01|September 2023|Anticipated|2023-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer|A Prospective Single-Arm Phase II Study To Investigate The Efficacy Of Single-Fraction Intraoperative Radiation Treatment Using A Multi-Lumen Balloon Applicator And In-Room CT Imaging For The Treatment Of Early-Stage Breast Cancer|Recruiting||Phase 2|260|Anticipated|University of Virginia||1|||f||||t||||||||||2017-10-10 23:27:01.419156|2017-10-10 23:27:01.419156
NCT02400645|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-05-16|||March 2015||2015-03-01|March 2015|2015-03-01|May 2016|Actual|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|LATAP||TAP Block With Liposomal Bupivacaine Versus Pre-incisional Wound Infiltration With Bupivacaine for Postoperative Pain|Comparison of Laparoscopically Assisted Transversus Abdominis Plane Block Using Liposomal Bupivacaine With Pre-incisional Bupivacaine for Post-operative Pain Control in Patients Undergoing Laparoscopic or Robotic Hysterectomy|Terminated||Phase 1|69|Actual|University of Tennessee||2||It was determined that one member of the team had falsified data.|f||||f||||||||||2017-10-10 23:27:01.533171|2017-10-10 23:27:01.533171
NCT02400632|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-04-24|||June 2015||2015-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MAGIC-TOUCH||MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions|Assessment of the Novel MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions|Recruiting||Phase 3|60|Anticipated|Scitech Produtos Medicos Ltda||1|||f||||f||||||||||2017-10-10 23:27:01.626902|2017-10-10 23:27:01.626902
NCT02400619|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-03-09|||September 2014||2014-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT|Efficacy of Radial Extracorporeal Shock Waves Compared to Botulinum Toxin Type A in the Treatment of Spasticity of the Lower Extremities in Patients With Cerebral Palsy: a Crossover Randomized Clinical Trial.|Completed||Phase 1|70|Actual|University Ramon Llull||2|||f||||f||||||||Yes||2017-10-10 23:27:01.730319|2017-10-10 23:27:01.730319
NCT02400606|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-26|||January 2013||2013-01-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||The Effect of Constructing Virtual Patient Cases|The Effect of Constructing Versus Solving Virtual Patient Cases on Transfer of Learning: A Randomized Trial|Completed||N/A|39|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:27:01.882438|2017-10-10 23:27:01.882438
NCT02400593|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-07-14|||August 2015||2015-08-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|HEELD||Health Experiences & Early Life Disadvantages|An Affective Intervention to Reverse the Biological Residue of Low Childhood SES|Completed||N/A|113|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:27:01.962168|2017-10-10 23:27:01.962168
NCT02400567|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-05-03|||January 2015||2015-01-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|January 2018|Anticipated|2018-01-01||Interventional|NeoPAL||Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women|Open-label, Randomized, Multicenter, International, Parallel Exploratory Phase II Study, Comparing 3 FEC-3 Docetaxel Chemotherapy to Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women|Active, not recruiting||Phase 2|125|Actual|UNICANCER||2|||f||||t||||||||||2017-10-10 23:27:02.153156|2017-10-10 23:27:02.153156
NCT02400554|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Yappalli - The Road to Choctaw Health|Yappalli - The Road to Choctaw Health|Recruiting||N/A|150|Anticipated|University of Washington||2|||f||||t||||||||No||2017-10-10 23:27:02.241262|2017-10-10 23:27:02.241262
NCT02400541|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-08-12|||March 2015||2015-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RECOGAMEA||Efficacity of Cognitive Remediation Treatment Compared to a Controlled Group in Young Patient With Anorexia Nervosa|Prospective Evaluation of Neuropsychological and Clinical Impact of Cognitive Remediation Program Among Children and Adolescents Treated for Anorexia Nervosa|Recruiting||Phase 1|60|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:27:02.328654|2017-10-10 23:27:02.328654
NCT02400528|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-03-23|||February 2015||2015-02-01|February 2015|2015-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|Eval-PLH||Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their Families|Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their Families|Recruiting||N/A|1200|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:27:02.41967|2017-10-10 23:27:02.41967
NCT02400515|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-23|||August 2007||2007-08-01|March 2015|2015-03-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Influence of Regular Exercise and Detraining on Metabolic and Emotional Parameters in Diabetic Individuals|Influence of Regular Exercise and Detraining on Metabolic and Emotional Parameters in Diabetic and Hypertensive Individuals|Completed||N/A|12|Actual|University of Campinas, Brazil||1|||f||||t||||||||||2017-10-10 23:27:02.529101|2017-10-10 23:27:02.529101
NCT02400502|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-04-07|||March 2015||2015-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|I-CAT||Integrated Coping and Awareness Training|Targeting Stress Reactivity in Schizophrenia: Integrating Coping Awareness Therapy (I-CAT) Pilot Trial|Completed||N/A|6|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-10 23:27:02.595062|2017-10-10 23:27:02.595062
NCT02400489|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-08-06|||September 2014||2014-09-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Observational|||Clinical Study to Evaluate the Performance of Perimount Heart Valve in Chinese Patients||Unknown status|Recruiting|N/A|240|Anticipated|Edwards (Shanghai) Lifesciences Medical Supplies Co.,Ltd.|||1||f||||f||||||||||2017-10-10 23:27:02.673372|2017-10-10 23:27:02.673372
NCT02400476|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-08-08|||February 2015|Actual|2015-02-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide|An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Intensive Loperamide Prophylaxis|Recruiting||Phase 2|240|Anticipated|Puma Biotechnology, Inc.||4|||f||||||||||||||2017-10-10 23:27:02.74205|2017-10-10 23:27:02.74205
NCT02400463|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-03-02|||September 2015||2015-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|||A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome|Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome|Recruiting||Early Phase 1|10|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:27:02.902438|2017-10-10 23:27:02.902438
NCT02400450|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-02-21|||September 2016||2016-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PREFFER-2014||Designer Functional Foods on Parameters of Metabolic and Vascular in Prediabetes|Assessment of Designer Functional Foods on Parameters of Metabolic and Vascular Status in Individuals With Prediabetes.|Withdrawn||N/A|0|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-10 23:27:02.980572|2017-10-10 23:27:02.980572
NCT02400437|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-07-20|||April 2015||2015-04-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|January 2019|Anticipated|2019-01-01||Interventional|||Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia|Phase II Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia|Active, not recruiting||Phase 2|33|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:27:03.092431|2017-10-10 23:27:03.092431
NCT02400424|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-03-30|||February 2015||2015-02-01|March 2016|2016-03-01|January 2021|Anticipated|2021-01-01|August 2020|Anticipated|2020-08-01||Interventional|GFPC_01-14||Study of the Efficacy of SBRT on Unresectable Peripheral Primary Tumor|Multicenter Prospective Study of the Efficacy of Stereotactic Lung Radiation Therapy After Concomitant Radio-chemotherapy for Unresectable Stage III Non-small Cell Lung Carcinoma (NSCLC) With Peripheral Primary Tumor.|Recruiting||N/A|70|Anticipated|Centre Leon Berard||1|||f||||t||||||||||2017-10-10 23:27:04.884415|2017-10-10 23:27:04.884415
NCT02400411|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-09-03|||March 2015||2015-03-01|September 2015|2015-09-01||||October 2015|Anticipated|2015-10-01||Interventional|||The Glycemic and Insulinemic Responses Elicited by Meals Containing Whole Grain Rye Bread or White Wheat Bread|The Effects of Margarine and Ham or Vegetable Soup on the on the Glycemic and Insulinemic Responses Elicited by Whole Grain Rye Bread or White Wheat Bread|Unknown status|Active, not recruiting|N/A|15|Anticipated|Helsinki University||6|||f||||f||||||||||2017-10-10 23:27:04.978264|2017-10-10 23:27:04.978264
NCT02400398|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-11-04|||April 2015||2015-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|PanCax||Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients|A Longitudinal, Single Institution Study Evaluating Weight Stability in Advanced Pancreatic Cancer Patients With Cachexia Who Are Receiving Enteral Feeding|Recruiting||Phase 2|37|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||No||2017-10-10 23:27:05.069535|2017-10-10 23:27:05.069535
NCT02400385|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-01-30|||October 2014||2014-10-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma|A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma|Withdrawn||Phase 2|0|Actual|California Pacific Medical Center Research Institute||1||With recent advances in immunotherapy scientific question not significant|f||||f||||||||No||2017-10-10 23:27:05.153897|2017-10-10 23:27:05.153897
NCT02400372|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-10-25|||May 2015||2015-05-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site|The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site|Recruiting||Phase 4|135|Anticipated|HaEmek Medical Center, Israel||3|||f||||f||||||||||2017-10-10 23:27:05.239353|2017-10-10 23:27:05.239353
NCT02400359|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-01-25|||October 2014||2014-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Lorcaserin in Obesity: Identification of CNS Targets Using fMRI|Lorcaserin in Obesity: Identification of CNS Targets Using fMRI|Active, not recruiting||Phase 4|40|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-10-10 23:27:05.317828|2017-10-10 23:27:05.317828
NCT02399982|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-05-02|||February 2013||2013-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Smartphone Technology and CBT-GSH in Binge Eaters|Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters|Completed||Phase 1|66|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 23:27:09.492437|2017-10-10 23:27:09.492437
NCT02400346|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-07-11|2017-06-02||March 2015||2015-03-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment|Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment|Completed||Phase 3|132|Actual|H. Lundbeck A/S||1|||f||||||||||||||2017-10-10 23:27:05.431897|2017-10-10 23:27:05.431897
NCT02400333|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-08-16|2016-05-18||June 2015||2015-06-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet|An Open-label, Randomised, Four-period, Four-treatment, Crossover, Single-centre, Single-dose Study to Assess the Bioavailability of Ticagrelor Orodispersible Tablets, Compared to Ticagrelor Immediate-release Tablets in Healthy Subjects|Completed||Phase 1|100|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-10 23:27:05.919371|2017-10-10 23:27:05.919371
NCT02400320|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-09-11|||March 1, 2016|Anticipated|2016-03-01|September 2017|2017-09-01|June 30, 2016|Anticipated|2016-06-30|June 1, 2016|Anticipated|2016-06-01||Interventional|||Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol|Cumulative Skin Irritation Study Evaluating the Skin Irritancy Potential of Topical Analgesic Vovilup Spray Containing a Combination of Diclofenac, Menthol, Methyl Salicylate and Linseed Oil and Comparing it With a Marketed Formulation - Iodex Ultragel|Withdrawn||Phase 4|0|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:27:06.876364|2017-10-10 23:27:06.876364
NCT02400307|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-09-18|||April 2015||2015-04-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pharmacokinetics of GS-9883 in Adults With Normal and Impaired Renal Function|A Phase 1, Open-Label, Parallel-Group, Adaptive Single-dose Study to Evaluate the Pharmacokinetics of GS-9883 in Subjects With Normal and Impaired Renal Function|Completed||Phase 1|18|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-10 23:27:06.944601|2017-10-10 23:27:06.944601
NCT02400294|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-05-02|||July 2014||2014-07-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Prevention of Ventilator Associated Pneumonia With Toothbrushing in Oral Care of Critically Ill Mechanically Ventilated Patients|Prevention of Ventilator Associated Pneumonia With Toothbrushing in Oral Care of Critically Ill Mechanically Ventilated Patients|Completed||N/A|2030|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:27:07.027941|2017-10-10 23:27:07.027941
NCT02400281|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-08-09|||September 2015||2015-09-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients|Phase I-II Study of Crenolanib Combined With Standard Salvage Chemotherapy, and Crenolanib Combined With 5-Azacitidine in Acute Myeloid Leukemia Patients With FLT3 Activating Mutations|Recruiting||Phase 1/Phase 2|88|Anticipated|Arog Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:27:07.11066|2017-10-10 23:27:07.11066
NCT02400268|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-03-09|||September 2014||2014-09-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|December 2, 2016|Actual|2016-12-02||Interventional|SHORTEN||Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae|Phase 4, Randomized, Controlled Multicentric, Open-label Clinical Trial to Prove That the 7 Day Course of Treatment for Enterobacteriaceae Bacteremia is More Efficient and Equally Safe Than 14 Day Scheme|Completed||Phase 3|238|Actual|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f|f|f||||||Yes|Anonimized data for primary and secondary variables is planned to be shared with all the participants within 6 months of data completion.|2017-10-10 23:27:07.219387|2017-10-10 23:27:07.219387
NCT02400255|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-08-09|||September 2015||2015-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients|A Phase II Study of Crenolanib Besylate Maintenance Following Allogeneic Stem Cell Transplantation in Patients With FLT3-positive Acute Myeloid Leukemia|Recruiting||Phase 2|48|Anticipated|Arog Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:27:07.31057|2017-10-10 23:27:07.31057
NCT02400242|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-10-02|||May 7, 2015|Actual|2015-05-07|October 2017|2017-10-01|June 29, 2018|Anticipated|2018-06-29|February 20, 2018|Anticipated|2018-02-20||Interventional|||Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma|A Phase 1a/1b Multicenter, Single-Arm, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Preliminary Activity of Oral ACY-241 Alone and in Combination With Pomalidomide and Low-Dose Dexamethasone in Patients With Relapsed or Relapsed-and-Refractory Multiple Myeloma|Active, not recruiting||Phase 1|80|Actual|Celgene||1|||f||||f||||||||||2017-10-10 23:27:07.391127|2017-10-10 23:27:07.391127
NCT02400229|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-05-24|||October 2015||2015-10-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|DISCHARGE||Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease|Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies) - A Pragmatic Randomised Controlled Trial of CT Versus ICA|Recruiting||N/A|3546|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||Undecided||2017-10-10 23:27:07.633875|2017-10-10 23:27:07.633875
NCT02400216|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-26|2017-09-20|||March 20, 2015||2015-03-20|April 25, 2017|2017-04-25|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Observational|||Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis|A Multidisciplinary Approach to Deciphering the Mechanisms Involved In Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:27:07.91574|2017-10-10 23:27:07.91574
NCT02400203|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-09-25|||August 2015||2015-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|February 2016|Actual|2016-02-01||Interventional|FREEHEMP||FREE Living Hulled HEMP Seed and Oil Trial|FREE Living Hulled HEMP Seed and Oil Trial|Active, not recruiting||N/A|30|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-10 23:27:07.98241|2017-10-10 23:27:07.98241
NCT02400190|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-12-15|||March 2015||2015-03-01|December 2015|2015-12-01|March 2026|Anticipated|2026-03-01|March 2026|Anticipated|2026-03-01||Interventional|||The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)|The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)|Recruiting||N/A|200|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:27:08.069183|2017-10-10 23:27:08.069183
NCT02400164|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-06-12|||March 2015||2015-03-01|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|January 19, 2017|Actual|2017-01-19||Interventional|MOSAIC||A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites|A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites|Active, not recruiting||N/A|30|Actual|Sequana Medical AG||1|||f||||||||||||||2017-10-10 23:27:08.269169|2017-10-10 23:27:08.269169
NCT02400151|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-06-16|||March 30, 2015|Actual|2015-03-30|June 2017|2017-06-01|June 24, 2016|Actual|2016-06-24|June 24, 2016|Actual|2016-06-24||Interventional|VIDADO||Vascular and Metabolic Effects of Vitamin D Supplementation Associated With Lifestyle Management in Obese Adolescents|Vascular and Metabolic Effects of Vitamin D Supplementation Associated With Lifestyle Management in Obese Adolescents: Prospective, Randomized, Controlled Trial|Completed||Phase 4|49|Actual|Centre Hospitalier Universitaire de Nīmes||3|||f||||f||||||||||2017-10-10 23:27:08.352962|2017-10-10 23:27:08.352962
NCT02400138|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-07-29|||February 2016|Actual|2016-02-01|July 2017|2017-07-01|July 15, 2017|Actual|2017-07-15|June 30, 2017|Actual|2017-06-30||Interventional|||Home-based Respiratory Training After Stroke|Effects of Home-based Respiratory Training After Stroke: A Randomized Controlled Trial|Completed||N/A|36|Actual|Federal University of Minas Gerais||2|||f||||f|f|f||||||||2017-10-10 23:27:08.454519|2017-10-10 23:27:08.454519
NCT02400125|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-12-15|||March 2013||2013-03-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01|1 Year|Observational [Patient Registry]|CCSR||China Cardiovascular Surgery Registry|China Cardiovascular Surgery Registry|Recruiting||N/A|90000|Anticipated|China National Center for Cardiovascular Diseases|||2||f||||t||||||||||2017-10-10 23:27:08.533409|2017-10-10 23:27:08.533409
NCT02400112|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-23|||March 2015||2015-03-01|November 2014|2014-11-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures|Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures|Enrolling by invitation||Phase 4|200|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-10 23:27:08.626103|2017-10-10 23:27:08.626103
NCT02400099|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-23|||June 2015||2015-06-01|March 2015|2015-03-01||||June 2016|Anticipated|2016-06-01||Interventional|||Protein-rich Diet and NAFLD in Bariatric Surgery|Protein-rich Diet and Non-Alcoholic Fatty Liver Disease in Bariatric Surgery|Unknown status|Not yet recruiting|N/A|60|Anticipated|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-10 23:27:08.69754|2017-10-10 23:27:08.69754
NCT02400086|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-01-30|||February 2015||2015-02-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|January 2017|Actual|2017-01-01||Observational|ECOTRACH||Bacterial Colonization in Tracheostomized Patients With Neurological or Neuromuscular Disease|Study of Bacterial Colonization of the Respiratory Tract in Long-term Tracheostomized Patients With Neurological or Neuromuscular Disease|Recruiting||N/A|100|Anticipated|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-10 23:27:08.784454|2017-10-10 23:27:08.784454
NCT02400073|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-02-09|||April 2015||2015-04-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|FEM-PAP||AutoSet for Her Quality of Life Clinical Trial|Assessment of a New AutoSet Device Designed for Female Obstructive Sleep Apnea Patients on the Quality of Life of Users|Active, not recruiting||N/A|121|Actual|ResMed||1|||f||||f||||||||||2017-10-10 23:27:08.861855|2017-10-10 23:27:08.861855
NCT02400060|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-10-28|||March 2014||2014-03-01|October 2016|2016-10-01||||May 2016|Actual|2016-05-01||Interventional|||Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer|Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility|Active, not recruiting||N/A|39|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 23:27:08.93268|2017-10-10 23:27:08.93268
NCT02400047|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-01-16|||June 2015||2015-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|DEXA OP||Dexamethasone, Can it Replace Ketoprofen in the Strategy of Intraoperative Multimodal Analgesia in Paediatric Surgery ? A Prospective Randomized Double-blinded Study. DEXA OP|Dexamethasone, Can it Replace Ketoprofen in the Strategy of Intraoperative Multimodal Analgesia in Paediatric Surgery ? A Prospective Randomized Double-blinded Study. DEXA OP|Recruiting||Phase 3|567|Anticipated|Rennes University Hospital||3|||f||||f||||||||||2017-10-10 23:27:09.033889|2017-10-10 23:27:09.033889
NCT02400034|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-10-19|||March 2015||2015-03-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Comparing Voiding Trials After Midurethral Sling for Stress Incontinence|A Randomized Controlled Trial Comparing Force of Stream to Traditional Retrograde Fill Voiding Trial After Midurethral Sling With or Without Vaginal Prolapse Surgery|Completed||N/A|112|Actual|Northwell Health||2|||f||||t||||||||||2017-10-10 23:27:09.131015|2017-10-10 23:27:09.131015
NCT02400021|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-07-28|||August 2015||2015-08-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ProSPAR||Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals|Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Mount Sinai Hospital, Canada||2|||f||||t||||||||||2017-10-10 23:27:09.235371|2017-10-10 23:27:09.235371
NCT02400008|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-06-13|||November 2014||2014-11-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|SEQLAR||Selective Bilateral Laryngeal Reinnervation as a Secondary Treatment in Case of Bilateral Vocal Fold Paralysis|Selective Bilateral Laryngeal Reinnervation as a Secondary Treatment in Case of Bilateral Vocal Fold Paralysis: Analysis of Phonatory and Ventilatory Results|Recruiting||N/A|5|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 23:27:09.33933|2017-10-10 23:27:09.33933
NCT02399995|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-05-19|||March 2015|Actual|2015-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time|Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time|Recruiting||N/A|150|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:27:09.413551|2017-10-10 23:27:09.413551
NCT02399969|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-05-04|||March 2015||2015-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department|Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department|Completed||Phase 1/Phase 2|30|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:27:09.689711|2017-10-10 23:27:09.689711
NCT02399956|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-12-08|||March 2015||2015-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Lactation Outcomes Among Survivors of Pediatric Cancer|Lactation Outcomes Among Survivors of Pediatric Cancer|Completed||N/A|471|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-10 23:27:09.786599|2017-10-10 23:27:09.786599
NCT02399943|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-06-21|||June 2015||2015-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer|Molecular Basket Trial In Multiple Malignancies With Common Target Pathway Aberrancies|Recruiting||Phase 2|26|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:27:09.879688|2017-10-10 23:27:09.879688
NCT02399930|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-05-19|||April 2015||2015-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Automated Respiration Rate to Improve Accuracy of the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm|Automated Respiration Rate Evaluation to Improve Accuracy of the Early Warning Score Procedure Determined by the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm|Completed||N/A|133|Actual|University of Chicago|||1||f||||f||||||||||2017-10-10 23:27:09.973753|2017-10-10 23:27:09.973753
NCT02399917|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-09-28|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia|An Open-label Phase II Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/Relapsed Acute Myeloid Leukemia|Recruiting||Phase 2|64|Anticipated|M.D. Anderson Cancer Center||1|||f||||t|t|f||||||||2017-10-10 23:27:10.061777|2017-10-10 23:27:10.061777
NCT02399904|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-03-25|||November 2012||2012-11-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|CTPT||Effect of California Tri-pull Taping Method on Shoulder Subluxation, Pain, Active Range of Motion and Upper Limb Functional Recovery After Stroke - A Pre Test Post Test Design|Effect of California Tri-pull Taping Method on Shoulder Subluxation, Pain, Active Range of Motion and Upper Limb Functional Recovery After Stroke - A Pre Test Post Test Design|Completed||Phase 1|10|Actual|Maharishi Markendeswar University||1|||f||||t||||||||||2017-10-10 23:27:10.16243|2017-10-10 23:27:10.16243
NCT02399891|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-06-07|||December 2011||2011-12-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|AMIQA||Acute Myocardial Infarction Quality Assurance Project|Acute Myocardial Infarction Quality Assurance Project|Recruiting||N/A|6000|Anticipated|University of Calgary|||2||f||||f||||||||||2017-10-10 23:27:10.247902|2017-10-10 23:27:10.247902
NCT02399878|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-03-29|||January 2007||2007-01-01|March 2016|2016-03-01||||August 2014|Actual|2014-08-01||Observational|||Intra-operative Inspiratory Oxygen Fraction and Postoperative Respiratory Complications|Intra-operative Inspiratory Oxygen Fraction and Postoperative Respiratory Complications|Active, not recruiting||N/A|70000|Anticipated|Massachusetts General Hospital|||1||f||||||||||||||2017-10-10 23:27:10.355124|2017-10-10 23:27:10.355124
NCT02399865|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-26|||May 2014||2014-05-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|YSBNT||Family and Social Intervention for Young People|A Randomised Controlled Trial of Family and Social Network Intervention for Young People Who Misuse Alcohol and Drugs: a Feasibility Study [Y-SBNT]|Unknown status|Active, not recruiting|N/A|53|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-10 23:27:10.442509|2017-10-10 23:27:10.442509
NCT02399852|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-25|||April 2015||2015-04-01|March 2015|2015-03-01||||April 2021|Anticipated|2021-04-01|2 Years|Observational [Patient Registry]|||Effects of Lomitapide on Carotid and Aortic Atherosclerosis|Effects of Lomitapide on Carotid and Aortic Atherosclerosis in Patients Treated With Lomitapide in Usual Care (CAPTURE)|Not yet recruiting||N/A|57|Anticipated|Aegerion Pharmaceuticals, Inc.|||1||f||||t||||||||||2017-10-10 23:27:10.536462|2017-10-10 23:27:10.536462
NCT02399839|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-01-13|||October 2014||2014-10-01|October 2014|2014-10-01|March 2028|Anticipated|2028-03-01|March 2028|Anticipated|2028-03-01|2 Years|Observational [Patient Registry]|||Global Lomitapide Pregnancy Exposure Registry|Global Lomitapide Pregnancy Exposure Registry|Enrolling by invitation||N/A|30|Anticipated|Aegerion Pharmaceuticals, Inc.|||1||f||||t||||||||||2017-10-10 23:27:10.618349|2017-10-10 23:27:10.618349
NCT02399826|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-08-14|||March 2015||2015-03-01|August 2016|2016-08-01||||January 2017|Anticipated|2017-01-01||Interventional|||Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers|A Prospective, Randomized, Comparative Parallel Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers|Recruiting||N/A|40|Anticipated|Lower Extremity Institute for Research and Therapy||2|||f||||f||||||||||2017-10-10 23:27:10.680039|2017-10-10 23:27:10.680039
NCT02399813|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-04-27|||September 2015||2015-09-01|April 2017|2017-04-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Phase 2 Study of ADXS11-001 in Subjects With Carcinoma of the Anorectal Canal|PHASE 2 STUDY OF ADXS11-001 IN SUBJECTS WITH PERSISTENT/RECURRENT, LOCO-REGIONAL OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE ANORECTAL CANAL|Active, not recruiting||Phase 2|55|Anticipated|Advaxis, Inc.||1|||f||||f||||||||||2017-10-10 23:27:10.782189|2017-10-10 23:27:10.782189
NCT02399800|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2017-04-18|||December 2014||2014-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Celiac Plexus Block for Chronic Pancreatitis RCT|Prospective Randomized Trial of EUS Guided Celiac Plexus Block for Chronic Pancreatitis|Recruiting||N/A|95|Anticipated|University of Southern California||2|||f||||t||||||||Undecided||2017-10-10 23:27:10.864326|2017-10-10 23:27:10.864326
NCT02399787|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-05-13|||April 2015||2015-04-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Geneexpression as a Marker of Embryo Viability|Geneexpression as a Marker of Embryo Viability|Active, not recruiting||N/A|20|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-10 23:27:10.977154|2017-10-10 23:27:10.977154
NCT02399774|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-05-17|||May 2015||2015-05-01|March 2015|2015-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Dental Support Device During Breastfeeding as a Mean for Pain Control|Dental Support Device During Breastfeeding as a Mean for Pain Control|Unknown status|Not yet recruiting|Phase 3|1500|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-10 23:27:11.042508|2017-10-10 23:27:11.042508
NCT02399761|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-21|2017-04-26|||August 2012||2012-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency|Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency|Completed||N/A|154795|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:27:11.115601|2017-10-10 23:27:11.115601
NCT02399748|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-21|2017-07-13|||April 2007||2007-04-01|July 2017|2017-07-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|||A Long-term Study for the Outcome of Pompe Disease|A Long-term Study for the Outcome of Pompe Disease|Recruiting||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:27:11.181387|2017-10-10 23:27:11.181387
NCT02399735|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-07-19|||October 2014||2014-10-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation|Safety Study of Nature Killer Cells From Sibship to Treat the Recurrence of Hepatocellular Carcinoma After Liver Transplantation|Recruiting||Phase 1|18|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||3|||f||||t||||||||||2017-10-10 23:27:11.252147|2017-10-10 23:27:11.252147
NCT02399722|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-03-25|||October 2011||2011-10-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Combination of a Polymeric Membrane Dressing Plus Negative Pressure Wound Therapy Against Negative Pressure Wound Therapy Alone|Prospective Randomized Trial Comparing the Combination of a Polymeric Membrane Dressing Plus Negative Pressure Wound Therapy Against Negative Pressure Wound Therapy Alone: The WICVAC Study|Completed||N/A|60|Actual|Wilhelminenspital Vienna||2|||f||||f||||||||||2017-10-10 23:27:11.343916|2017-10-10 23:27:11.343916
NCT02399709|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-10-10|||March 2015||2015-03-01|October 2016|2016-10-01||||December 2015|Actual|2015-12-01||Interventional|ADDICSTATINE||Trial to Evaluate the Efficacy of Simvastatin for Smoking Cessation|Pilot Randomized Double Blind, Placebo Controlled Trial of the Efficacy of Simvastatin for Smoking Cessation|Recruiting||Phase 2|100|Anticipated|Poitiers University Hospital||2|||f||||f||||||||||2017-10-10 23:27:11.419721|2017-10-10 23:27:11.419721
NCT02399696|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-26|||March 2013||2013-03-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Primary Care-Based Mindfulness Intervention for Veterans With PTSD|Primary Care-Based Mindfulness Intervention for Veterans With PTSD|Completed||N/A|62|Actual|Syracuse VA Medical Center||2|||f||||f||||||||||2017-10-10 23:27:11.507257|2017-10-10 23:27:11.507257
NCT02399683|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-11-18|||February 2012||2012-02-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Immune Modulation From Trichuris Trichiura|Mucosal and Systemic Immune Modulation From Trichuris Trichiura in a Self-infected Individual|Completed||N/A|1|Actual|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Blood cell and intestinal biopsies   "|||2017-10-10 23:27:11.5795|2017-10-10 23:27:11.5795
NCT02399670|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-10-28|||September 2010||2010-09-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||The Influence of Global Femoral-offset Changes After Total Hip Arthroplasty|The Influence of Global Femoral-offset Changes After Total Hip Arthroplasty on Function, Quality of Life and Abductor Muscle Strength: a Prospective Cohort Study|Completed||N/A|222|Actual|Sundsvall Hospital|||3||f||||f||||||||||2017-10-10 23:27:11.666315|2017-10-10 23:27:11.666315
NCT02399657|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-04-02|||February 2015||2015-02-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema|A Single Arm, Single Dose Study to Evaluate the Effect of Intravitreal Dexamethasone Implant (Ozurdex®) on Hard Exudates of Diabetic Macular Edema|Unknown status|Recruiting|Phase 4|48|Anticipated|Inje University||1|||f||||t||||||||||2017-10-10 23:27:11.746926|2017-10-10 23:27:11.746926
NCT02399644|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-03-25|||January 2011||2011-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|FACTA||Physical Activity and Acceptance and Commitment Therapy as Treatment for Long Term Pain|Physical Activity and Acceptance and Commitment Therapy as Treatment for Long Term Pain. A Randomized Controlled Trial|Unknown status|Recruiting|N/A|180|Anticipated|Linkoeping University||3|||f||||f||||||||||2017-10-10 23:27:11.868748|2017-10-10 23:27:11.868748
NCT02399631|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-21|||January 2012||2012-01-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Enhanced Recovery Program After Laparoscopic Colon Cancer Surgery|Implementation of an Enhanced Recovery Program After Laparoscopic Colon Cancer Surgery|Recruiting||N/A|248|Anticipated|Kyungpook National University||2|||f||||t||||||||||2017-10-10 23:27:11.948688|2017-10-10 23:27:11.948688
NCT02399618|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-21|2016-05-24|||March 2015||2015-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Freeze-dried, Capsulized FMT for RCDI|Freeze-dried, Capsulized Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection|Recruiting||Phase 1|20|Anticipated|Jinling Hospital, China||1|||f||||t||||||||||2017-10-10 23:27:12.01783|2017-10-10 23:27:12.01783
NCT02399605|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-21|||March 2015||2015-03-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|March 2015|Actual|2015-03-01||Interventional|SESPI||Subcutaneous Electrical Stimulation in the Prevention of Postoperative Ileus|Subcutaneous Electrical Stimulation in the Prevention of Postoperative Ileus in Colorectal Surgery|Unknown status|Active, not recruiting|N/A|500|Anticipated|Hospital General Universitario Elche||2|||f||||f||||||||||2017-10-10 23:27:12.091849|2017-10-10 23:27:12.091849
NCT02399592|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-05-26|||March 2015||2015-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|Toco-Ovar||Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer|Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer|Recruiting||Phase 2|23|Anticipated|Vejle Hospital||1|||f||||t||||||||||2017-10-10 23:27:12.153811|2017-10-10 23:27:12.153811
NCT02399579|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-07-01|||March 2015||2015-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients|Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients|Completed||N/A|10|Actual|University of Zurich||1|||f||||||||||||||2017-10-10 23:27:12.221945|2017-10-10 23:27:12.221945
NCT02399566|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-03-25|||May 2015||2015-05-01|March 2015|2015-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma|Comparative Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma|Not yet recruiting||Phase 4|300|Anticipated|Hunan Province Tumor Hospital||2|||f||||f||||||||||2017-10-10 23:27:12.288748|2017-10-10 23:27:12.288748
NCT02399553|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-05-11|||September 2013||2013-09-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|FUTBOMAS||Effect of the Interaction Between the Type of Artificial Turf and Boots Model of Bone Health in Children Soccer Players|Effect of the Interaction Between the Type of Artificial Turf and Boots Model of Bone Health in Children Soccer Players|Completed||N/A|129|Actual|Universidad de Zaragoza||5|||f||||||||||||||2017-10-10 23:27:12.353662|2017-10-10 23:27:12.353662
NCT02399540|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2016-08-01|||March 2015||2015-03-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Late LTP-like Plasticity Effects of tDCS in Chronic Stroke Patients||Completed||N/A|84|Actual|Erasmus Medical Center||4|||f||||f||||||||||2017-10-10 23:27:12.411088|2017-10-10 23:27:12.411088
NCT02399527|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-07-26|||June 2013||2013-06-01|July 2016|2016-07-01||||June 2025|Anticipated|2025-06-01|15 Years|Observational [Patient Registry]|||Lymphatic Anomalies Registry|Lymphatic Anomalies Registry|Recruiting||N/A|1000|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-10 23:27:12.479749|2017-10-10 23:27:12.479749
NCT02399514|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-02-24|||November 2014||2014-11-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Improvement of Sleep Quality by RePneu® Coils in Advanced Pulmonary Emphysema|Verbesserung Der Schlafqualität Durch RePneu® Coils Zur Behandlung Des Fortgeschrittenen Lungenemphysems|Recruiting||N/A|25|Anticipated|Institut für Pneumologie Hagen Ambrock eV||1|||f||||f||||||||||2017-10-10 23:27:12.704321|2017-10-10 23:27:12.704321
NCT02399501|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-03-18|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Sonohysterography , 3D Ultrasonography and Hysteroscopy in Assessment of Uterine Factor in Cases of Female Infertility|Sonohysterography and 3D Ultrasonography Versus Diagnostic Hysteroscopy in Assessment of Uterine Factor in Cases of Female Infertility|Completed||N/A|100|Actual|Cairo University||1|||f||||t||||||||||2017-10-10 23:27:12.795326|2017-10-10 23:27:12.795326
NCT02399488|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-08-16|||February 2012||2012-02-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|June 2015|Actual|2015-06-01||Observational|||Validation of Continuous Noninvasive Haemoglobin Monitoring by the Radical 7 Pulse CO-Oximetry Monitor After in Vivo Adjustment.|Validation of a Continuous Noninvasive Haemoglobin Determination Monitor (Radical 7 Pulse CO-Oximeter, SpHb) Compared to the Central Laboratory Coulter (LabHb) and a Point of Care (POC) Invasive Cooximeter (COoxHb) After in Vivo Adjustment.|Unknown status|Recruiting|N/A|60|Anticipated|Hospital Universitario Doctor Peset|||1||f||||f||||||||||2017-10-10 23:27:12.900279|2017-10-10 23:27:12.900279
NCT02399475|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-06-20|||January 2015||2015-01-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Mechanistic Study of Subclinical Hypothyroidism In the Elderly|The Thyroid Axis in Older Individuals With Persistent Subclinical Hypothyroidism: a Mechanistic, Randomized, Double-Blind, Cross-Over Study of Levothyroxine and Liothyronine Administration|Recruiting||N/A|30|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:27:12.980555|2017-10-10 23:27:12.980555
NCT02399462|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-05-17|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Acthar for Treatment of Post-transplant FSGS|Acthar for Treatment of Post-transplant FSGS|Not yet recruiting||Phase 4|20|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f|t|f||||||No||2017-10-10 23:27:13.083057|2017-10-10 23:27:13.083057
NCT02399449|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-26|||September 15, 2017|Actual|2017-09-15|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|||IV Iron Safety: Evaluation of Iron Species in Healthy Subjects|Evaluation of Iron Species in Healthy Subjects Treated With Generic and Reference Sodium Ferric Gluconate|Recruiting||Phase 4|44|Anticipated|University of Maryland||2|||f||||f|t|f|||f|||||2017-10-10 23:27:13.171884|2017-10-10 23:27:13.171884
NCT02399436|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-04-17|||January 2015||2015-01-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Appal-TREE||Appalachians Together Restoring the Eating Environment||Completed||N/A|720|Actual|University of Kentucky||3|||f||||t||||||||||2017-10-10 23:27:13.273928|2017-10-10 23:27:13.273928
NCT02399423|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-20|||March 2015||2015-03-01|March 2015|2015-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|GlasVEGAS||The GlasVEGAS Study (Glasgow Visceral & Ectopic Fat With Weight Gain in South AsianS)|The GlasVEGAS Study (Glasgow Visceral & Ectopic Fat With Weight Gain in South AsianS) - Does Adipose Tissue Expandibility Differ Between South Asians and Europeans and Does This Contribute to Differences in Cardio-metabolic Disease Risk?|Unknown status|Recruiting|N/A|60|Anticipated|University of Glasgow||2|||f||||f||||||||||2017-10-10 23:27:13.367469|2017-10-10 23:27:13.367469
NCT02399410|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-20|||May 2015||2015-05-01|March 2015|2015-03-01|April 2020|Anticipated|2020-04-01|August 2018|Anticipated|2018-08-01||Interventional|||Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis|BEV-IP: Perioperative Chemotherapy With Bevacizumab in Patients Undergoing Cytoreduction and Intraperitoneal Chemoperfusion for Colorectal Carcinomatosis|Not yet recruiting||Phase 2|45|Anticipated|University Hospital, Ghent||1|||f||||t||||||||||2017-10-10 23:27:13.49581|2017-10-10 23:27:13.49581
NCT02399397|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-01-24|||February 2014||2014-02-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ROCSEPSIS||Influence of Age, Sepsis and SLCO1A2 Polymorphisms on Rocuronium Pharmacokinetics|Influence of Sepsis, Age and SLCO1A2 Genetic Polymorphisms on Rocuronium Pharmacokinetics-pharmacodynamics in ASA I-III Surgical Patients|Completed||Phase 4|36|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||t||||||||||2017-10-10 23:27:13.618154|2017-10-10 23:27:13.618154
NCT02399384|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-01-12|||January 2015||2015-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Pericardial Fat and Inflammation in HIV Patients and Controls|Myocardial Adipose Inflammation and Pericardial Adipose Volume as Markers for Coronary Artery Disease In HIV Positive Patients|Recruiting||N/A|12|Anticipated|University of Cincinnati|||4||f||||f||||||Samples Without DNA|"     Blood   "|No|Only researchers approved on the IRB protocol will have access to the data.|2017-10-10 23:27:13.746366|2017-10-10 23:27:13.746366
NCT02399371|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-11-14|||March 2015||2015-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Pembrolizumab in Treating Patients With Malignant Mesothelioma|A Phase II Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Malignant Mesothelioma|Recruiting||Phase 2|65|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 23:27:13.876633|2017-10-10 23:27:13.876633
NCT02399176|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2016-01-10|||January 2005||2005-01-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Yoga in the Treatment of Osteoporosis|Yoga in the Treatment of Osteoporosis|Completed||N/A|741|Actual|Manhattan Physical Medicine and Rehabilitation, LLP||1|||f||||f||||||||||2017-10-10 23:27:15.564177|2017-10-10 23:27:15.564177
NCT02399358|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Observational|||Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide|Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide: Prospective Cohort Study|Not yet recruiting||N/A|200|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-10 23:27:13.998014|2017-10-10 23:27:13.998014
NCT02399345|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-10-19|2016-10-19||March 2015||2015-03-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults|An Open-Label, Treatment Duration-Ranging Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/ Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Naive Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection|Completed||Phase 3|10|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 23:27:14.099264|2017-10-10 23:27:14.099264
NCT02399332|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-22|||April 2015||2015-04-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Involvement of Community Pharmacists in Complex Care Plans for Diabetic Patients, a Pilot Study|A Collaborative Care Model for Chronic Disease Management in Diabetes - Involvement of Community Pharmacists in Complex Care Plans, a Pilot Study|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 23:27:14.419187|2017-10-10 23:27:14.419187
NCT02399319|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-07-21|||October 2014||2014-10-01|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Comparison of INFIX and Plating for Pelvic Ring Injuries With Symphysis Disruptions|"Prospective Randomized Comparison of Subcutaneous Internal Fixation (INFIX) and Plating for Pelvic Ring Injuries With Symphysis Disruptions"|Terminated||N/A|4|Actual|Indiana University||4||Principle Investigator left the institution|f||||t||||||||||2017-10-10 23:27:14.517269|2017-10-10 23:27:14.517269
NCT02399306|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-11-11|||March 2015||2015-03-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Chemoradiotherapy With or Without Enteral Nutrition Intervention for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma|A Prospective, Multicenter, Randomized Controlled Study to Compare Chemoradiotherapy With or Without Enteral Nutrition Intervention for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma|Recruiting||Phase 3|210|Anticipated|Sichuan Cancer Hospital and Research Institute||2|||f||||f||||||||||2017-10-10 23:27:14.631858|2017-10-10 23:27:14.631858
NCT02399293|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-20|||April 2013||2013-04-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Interventional|||Computer-based Attention Training in Patients With Acquired Brain Injury|Computer-based Attention Training in Patients With Acquired Brain Injury|Completed||N/A|78|Actual|University of Aarhus||4|||f||||f||||||||||2017-10-10 23:27:14.734811|2017-10-10 23:27:14.734811
NCT02399280|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2017-04-03|||February 2015||2015-02-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Effect of High Caloric Intake at Lunch Against Dinner on Weight Loss|Effect of High Caloric Intake at Lunch Against Dinner on Weight Loss of Overweight and Obese Women Attending a Weight Loss Program, a Randomized Clinical Trial|Completed||N/A|70|Actual|Novindiet Clinic||2|||f||||f||||||||Undecided||2017-10-10 23:27:14.824594|2017-10-10 23:27:14.824594
NCT02399267|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2017-06-01|||July 2016||2016-07-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|FAST||Frequency of Screening and SBT Technique Trial|The Frequency of Screening and SBT Technique Trial|Active, not recruiting||Phase 2|100|Anticipated|St. Michael's Hospital, Toronto||4|||f||||f||||||||||2017-10-10 23:27:14.915951|2017-10-10 23:27:14.915951
NCT02399254|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-01-03|||April 2015||2015-04-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||The Trajectory of Physical Activity Following Pulmonary Rehabilitation|The Trajectory of Physical Activity Following Pulmonary Rehabilitation|Recruiting||N/A|50|Anticipated|Saint Francis Care|||1||f||||f||||||||||2017-10-10 23:27:15.040122|2017-10-10 23:27:15.040122
NCT02399241|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-06-21|||May 2015||2015-05-01|June 2017|2017-06-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|RIGHT-CF||Using Remote Telemonitoring to Detect Early Decline in Lung Function & Streamline Clinics in Adults With Cystic Fibrosis|Using Remote Telemonitoring to Detect Early Decline in Lung Function & Streamline Clinics in Adults With Cystic Fibrosis|Completed||N/A|50|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:27:15.122071|2017-10-10 23:27:15.122071
NCT02399228|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-06-19|||October 2015||2015-10-01|June 2017|2017-06-01|May 20, 2017|Actual|2017-05-20|May 20, 2017|Actual|2017-05-20||Interventional|||A Mouth Rinse Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis|An Open-Label, Proof of Concept Trial to Evaluate the Efficacy, Safety and Tolerability Trial of a Mouth Rinse Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis Induced by Radiation Therapy|Completed||Phase 2|7|Actual|Santalis Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:27:15.184361|2017-10-10 23:27:15.184361
NCT02399215|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-07-08|||May 15, 2015|Actual|2015-05-15|July 2017|2017-07-01|January 7, 2018|Anticipated|2018-01-07|January 7, 2018|Anticipated|2018-01-07||Interventional|||Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors|Multicenter Phase 2 Study of Nintedanib for Patients With Advanced Carcinoid Tumors|Recruiting||Phase 2|30|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-10 23:27:15.27022|2017-10-10 23:27:15.27022
NCT02399202|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-07-28|||November 6, 2015|Actual|2015-11-06|July 2017|2017-07-01|March 21, 2016|Actual|2016-03-21|March 21, 2016|Actual|2016-03-21||Interventional|||A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function|A Phase I, Open-label, Multi-center, Single Dose, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of LCI699 in Subjects With Varying Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function|Completed||Phase 1|15|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-10 23:27:15.386458|2017-10-10 23:27:15.386458
NCT02399189|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-04-10|||May 2014||2014-05-01|April 2015|2015-04-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|||MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma|MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma|Recruiting||Phase 2|39|Anticipated|Peking University||1|||f||||t||||||||||2017-10-10 23:27:15.466293|2017-10-10 23:27:15.466293
NCT02399150|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-05-08|||May 2015||2015-05-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|BIOMAB||Biomarkers in Acute Abdomen|Biomarkers in Acute Abdomen (BIOMAB)|Completed||N/A|300|Actual|Pitié-Salpêtrière Hospital|||1||f||||f||||||Samples Without DNA|"     EDTA and serum blood, saliva   "|||2017-10-10 23:27:16.243806|2017-10-10 23:27:16.243806
NCT02399137|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-06-23|||May 2015||2015-05-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|CARRIE||A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer|A Randomized, Double-blind, Placebo-controlled Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine Versus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer|Active, not recruiting||Phase 2|88|Actual|Merrimack Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:27:16.318852|2017-10-10 23:27:16.318852
NCT02399124|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-02-17|||July 2014||2014-07-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|June 2017|Anticipated|2017-06-01||Interventional|ICE-SECRET||Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma|ICE-SECRET PROSENSE™ Cryotherapy For Renal Cell Carcinoma Trial|Recruiting||Phase 4|50|Anticipated|IceCure Medical Ltd.||1|||f||||f||||||||||2017-10-10 23:27:16.517027|2017-10-10 23:27:16.517027
NCT02399111|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-11-18|2016-11-16||October 2013||2013-10-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Trial to Evaluate Negative Pressure Incision Management System for Groin Wounds in Vascular Surgery Patients|A Prospective Randomized Control Trial to Evaluate Negative Pressure Incision Management System for Groin Wounds in Vascular Surgery Patients|Terminated||N/A|9|Actual|Northwell Health||4||PI Decision|f||||f||||||||||2017-10-10 23:27:16.744038|2017-10-10 23:27:16.744038
NCT02399098|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2015-03-22|||April 2015||2015-04-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effectiveness of Attentional Strategies on Throwing Performance and Gaze Behavior of Self-paced Tasks Under Fatigue and Non-fatigue Conditions|The Effectiveness of Attentional Strategies on Throwing Performance and Gaze Behavior of Self-paced Tasks Under Fatigue and Non-fatigue Conditions|Not yet recruiting||N/A|100|Anticipated|Hillel Yaffe Medical Center||3|||f||||f||||||||||2017-10-10 23:27:17.11842|2017-10-10 23:27:17.11842
NCT02399085|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-08-09|||December 2015||2015-12-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|L-MIND||A Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL|A Phase II, Single-Arm, Open-Label, Multicentre Study to Evaluate the Safety and Efficacy of Lenalidomide Combined With MOR00208 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL)|Recruiting||Phase 2|80|Anticipated|MorphoSys AG||1|||f||||f||||||||||2017-10-10 23:27:17.213117|2017-10-10 23:27:17.213117
NCT02399072|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-09-28|||March 30, 2015|Actual|2015-03-30|September 2017|2017-09-01|May 21, 2022|Anticipated|2022-05-21|May 21, 2022|Anticipated|2022-05-21||Interventional|||A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration|A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration|Active, not recruiting||N/A|200|Anticipated|Hoffmann-La Roche||1|||f||||f|f|f||||||||2017-10-10 23:27:17.470262|2017-10-10 23:27:17.470262
NCT02399059|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-25|||January 2011||2011-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution & Oncologic Outcome|Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution During Elective Colorectal Cancer Surgery on the Oncologic Outcome|Completed||Phase 3|106|Actual|Hospital General Universitario Elche||2|||f||||t||||||||||2017-10-10 23:27:17.711763|2017-10-10 23:27:17.711763
NCT02399046|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-08-29|||May 2016||2016-05-01|February 2016|2016-02-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||A Clinical Trial Study of Knee System in Primary Total Knee Arthroplasty in China|A Prospective, Randomized, Multicenter, Controlled Study Comparing the Outcomes of Primary Total Knee Arthroplasty Devices Manufactured in China Versus Devices Manufactured Outside of China|Not yet recruiting||Phase 3|160|Anticipated|Johnson & Johnson Medical (Suzhou) Ltd.||2|||f||||f||||||||||2017-10-10 23:27:17.805557|2017-10-10 23:27:17.805557
NCT02399033|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-03-22|||June 2014||2014-06-01|February 2015|2015-02-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy|Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy: A Multicenter Randomized Controlled Trial|Recruiting||Phase 4|1000|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||f||||||||||2017-10-10 23:27:17.940014|2017-10-10 23:27:17.940014
NCT02399020|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2015-03-23|||January 2011||2011-01-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Social Cognition and Interaction Training for Adults With Psychotic Disorders: An Open Pilot Study in Finland|Social Cognition and Interaction Training (SCIT) for Adults With Psychotic Disorder: An Open Pilot Study in Finland|Completed||N/A|33|Actual|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-10 23:27:18.03858|2017-10-10 23:27:18.03858
NCT02399007|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-05-17|||June 2015||2015-06-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China|A Prospective, Randomized, Multicenter, Controlled Study Comparing the Outcomes of Primary Total Hip Arthroplasty Devices Manufactured in China Versus Devices Manufactured Outside of China|Active, not recruiting||Phase 3|160|Anticipated|Johnson & Johnson Medical (Suzhou) Ltd.||2|||f||||f||||||||Undecided|In data celaction status now|2017-10-10 23:27:18.126287|2017-10-10 23:27:18.126287
NCT02398994|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2016-07-18|||March 2015||2015-03-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|STRIVE||A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis|A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin (IVIg) Versus Standard Therapy for the Treatment of Transverse Myelitis in Adults and Children|Terminated||Phase 3|2|Actual|Guy's and St Thomas' NHS Foundation Trust||2||Continued effort did not successfully increase recruitment into the study.|f||||t||||||||||2017-10-10 23:27:18.2422|2017-10-10 23:27:18.2422
NCT02398981|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-04-25|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CERTAINp||Implementation of a Web Based Real Time Clinical Decision Support Tool.|Design and Pilot Implementation of a Web Based Real Time Clinical Decision Support Tool. (Checklist for Early Recognition and Treatment of Acute Illness in Pediatrics. CERTAINp|Active, not recruiting||Phase 1|720|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:27:18.401886|2017-10-10 23:27:18.401886
NCT02398968|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-04-29|||August 2013||2013-08-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Iron Supplementation Outcome on Recurrent Upper Respiratory Tract Infections in 6-15 Years Old Egyptian School Children|Effect of Iron Supplementation on Recurrent Upper Respiratory Tract Infections in Egyptian School Children: A One Year Prospective Study|Unknown status|Recruiting|N/A|1000|Anticipated|Ain Shams University||3|||f||||t||||||||||2017-10-10 23:27:18.493232|2017-10-10 23:27:18.493232
NCT02398955|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-22|2015-03-25|||June 2014||2014-06-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01|1 Year|Observational [Patient Registry]|BELLINI||Biomime Stent in All-comers PCI Patients Registry|Biomime Biosorbable Polymer Sirolimus-ELuting Stent in alL-comers patIeNts Treated With Percutaneous Coronary Interventions: the BELLINI Registry|Unknown status|Recruiting|N/A|250|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita|||1||f||||f||||||||||2017-10-10 23:27:18.590179|2017-10-10 23:27:18.590179
NCT02398942|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-12-20|||March 2015||2015-03-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Proximal Pole Fractures of the Scaphoid|A Prospective Study of Proximal Pole Fractures of the Scaphoid|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||1|The investigator left the institution so the study was terminated.|f||||f||||||||||2017-10-10 23:27:18.68451|2017-10-10 23:27:18.68451
NCT02398929|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-20|||January 2013||2013-01-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|BRAVE||BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study)|An Open Label, Pharmacogenetic Study of Bisoprolol Treatment in Patients With Uncontrolled Essential Hypertension (BRAVE)|Unknown status|Recruiting|Phase 4|50|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-10 23:27:18.743691|2017-10-10 23:27:18.743691
NCT02398916|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-08-29|||February 2015||2015-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Music Listening to Reduce Pain and Anxiety During LEEP|Effects of Music Listening During Loop Electrosurgical Excision Procedure on Anxiety, Pain, and Satisfaction: a Randomized Controlled Trial|Completed||N/A|150|Actual|Chiang Mai University||2|||f||||f||||||||||2017-10-10 23:27:18.831088|2017-10-10 23:27:18.831088
NCT02398903|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-05-14|||March 16, 2015|Actual|2015-03-16|May 2016|2016-05-01|September 16, 2018|Anticipated|2018-09-16|July 2017|Anticipated|2017-07-01||Observational|OBECO||Evaluation of Hormonal Contraceptive Treatments in Obese Women|Pharmacological Evaluation of Hormonal Contraceptive Treatments in Obese Women Before and After Bariatric Surgery|Recruiting||N/A|174|Anticipated|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||Samples Without DNA|"     Blood samples for measurement of drug Css   "|No||2017-10-10 23:27:18.901068|2017-10-10 23:27:18.901068
NCT02398890|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-05-02|||January 2015||2015-01-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|SALTO||Follow-up of Oncology Patients After Hospitalization in ICU|Follow-up of Oncology Patients After Hospitalization in ICU|Active, not recruiting||N/A|309|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-10-10 23:27:18.986887|2017-10-10 23:27:18.986887
NCT02398877|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-03-04|||February 2013||2013-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|Cort-Metab||HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms|Altered Hypothalamic-Pituitary-Adrenal Axis (HPA-Axis) Activity Due To Early Traumatic Stress and Its Relevance for Metabolic Symptoms|Completed||N/A|140|Actual|Charite University, Berlin, Germany||4|||f||||f||||||||||2017-10-10 23:27:19.043142|2017-10-10 23:27:19.043142
NCT02398864|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-03-20|||March 2015||2015-03-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|EBUS-nonM||Accuracy and Safety of Endobronchial Ultrasound (EBUS) in Suspected Non-malignant Mediastinal Lymphadenopathy|Accuracy and Safety of Endobronchial Ultrasound (EBUS) in Suspected Non-malignant Mediastinal Lymphadenopathy|Unknown status|Not yet recruiting|N/A|120|Anticipated|Hannover Medical School||1|||f||||f||||||||||2017-10-10 23:27:19.116784|2017-10-10 23:27:19.116784
NCT02398851|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-08-15|||March 2015||2015-03-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|TacTIC||TacTIC- Trans-disciplinary Chronic Disease Continuity of Care Model|TacTIC- Trans-disciplinary Chronic Disease Continuity of Care Model|Recruiting||N/A|2957|Anticipated|Hackensack University Medical Center||2|||f||||f||||||||||2017-10-10 23:27:19.175506|2017-10-10 23:27:19.175506
NCT02398838|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-04-02|||December 2009||2009-12-01|April 2015|2015-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Georgia|Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Georgia: A Study of 400 mcg Buccal Misoprostol Following 200 mg Mifepristone for Abortion up to 63 Days Gestation|Completed||N/A|622|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-10 23:27:19.247941|2017-10-10 23:27:19.247941
NCT02398812|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-06-10|||February 2015||2015-02-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2016|Actual|2016-06-01||Interventional|||The Interprofessional Medication Assessment for Older Patients|The Interprofessional Medication Assessment for Older Patients - a Multicenter Randomized Trial in Primary Care Setting|Active, not recruiting||N/A|514|Actual|East Savo Hospital District||2|||f||||f||||||||||2017-10-10 23:27:19.458234|2017-10-10 23:27:19.458234
NCT02398799|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-03-24|||January 2005||2005-01-01|March 2015|2015-03-01|December 2010|Actual|2010-12-01|March 2009|Actual|2009-03-01||Interventional|||Supporting Dyads Affected by Heart Failure|Supporting Dyads Affected by Heart Failure - A Randomised Controlled Study Evaluating a Psychoeducational Intervention|Completed||N/A|155|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-10 23:27:19.53179|2017-10-10 23:27:19.53179
NCT02398786|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-03-28|||February 2013||2013-02-01|March 2016|2016-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01|5 Years|Observational [Patient Registry]|MDFR||Myotonic Dystrophy Family Registry|Myotonic Dystrophy Family Registry|Recruiting||N/A|3000|Anticipated|Myotonic Dystrophy Foundation|||1||f||||t||||||||||2017-10-10 23:27:19.594689|2017-10-10 23:27:19.594689
NCT02398773|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-25|2017-09-14|||February 2, 2016|Actual|2016-02-02|September 2017|2017-09-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy|[18F] Fluoroestradiol (FES) PET as a Predictive Measure for Endocrine Therapy in Patients With Newly Diagnosed Metastatic Breast Cancer|Recruiting||Phase 2|99|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-10 23:27:19.678468|2017-10-10 23:27:19.678468
NCT02398760|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-06-12|||July 2014||2014-07-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Relationship Between Clinical Tests and Clinical Outcomes After Motor Control Exercises Intervention|Relationship Between Clinical Tests and Clinical Outcomes After Motor Control Exercises Intervention for Non-specific Chronic Low Back Patients|Completed||N/A|68|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||1|||f||||t||||||||||2017-10-10 23:27:19.824963|2017-10-10 23:27:19.824963
NCT02398747|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-07-10|||March 17, 2015|Actual|2015-03-17|July 2017|2017-07-01|December 28, 2017|Anticipated|2017-12-28|December 28, 2017|Anticipated|2017-12-28||Interventional|||Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies|A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AZD2014 Administered to Japanese Patients With Advanced Solid Malignancies|Active, not recruiting||Phase 1|27|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:27:19.908232|2017-10-10 23:27:19.908232
NCT02398734|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-04-11|||October 2015||2015-10-01|April 2017|2017-04-01|January 2023|Anticipated|2023-01-01|October 2021|Anticipated|2021-10-01||Interventional|SONOBIRDIE||SONOlysis in Prevention of Brain InfaRctions During Internal Carotid Endarterectomy|Risk Reduction of Symptomatic and Silent Brain Infarctions During Carotid Endarterectomy by the Ultrasound Activation of Endogenous Fibrinolytic System Using Sonolysis (Transcranial Doppler Monitoring)|Recruiting||N/A|1408|Anticipated|University Hospital Ostrava||2|||f||||t||||||||Undecided||2017-10-10 23:27:19.974538|2017-10-10 23:27:19.974538
NCT02398721|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-04-28|||March 31, 2015|Actual|2015-03-31|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|July 2017|Anticipated|2017-07-01||Interventional|||Study on HRQOL and Cost-effectiveness Analysis in Management of Patients With <2cm Thyroid Nodules|A Prospective Randomized Study on Health-related Quality of Life of Patients With Incidental Small (<2cm) Asymptomatic Thyroid Nodules and Cost-effectiveness Analysis in Managing Small Incidental Thyroid Nodules|Active, not recruiting||N/A|314|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:27:20.075912|2017-10-10 23:27:20.075912
NCT02398708|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-01-04|||May 2015||2015-05-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT|Comparison of the Fecal Microbiome, Peripheral Inflammatory Markers, and Symptoms in Individuals Discordant for GVHD After Allogeneic Hematopoietic Stem Cell Transplant|Completed||N/A|38|Actual|University of Florida|||2||f||||f||||||Samples With DNA|"     Whole blood and stool specimens   "|||2017-10-10 23:27:22.137978|2017-10-10 23:27:22.137978
NCT02398695|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-08-16|||October 2012||2012-10-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Oral Alkali Production and Caries Prevention in Children (Longitudinal)|Oral Alkali Production and Caries Prevention in Children (Longitudinal Component)|Active, not recruiting||N/A|310|Anticipated|University of Florida|||2||f||||f||||||Samples With DNA|"     Saliva and Plaque   "|||2017-10-10 23:27:22.264648|2017-10-10 23:27:22.264648
NCT02398682|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-02-27|||October 2014||2014-10-01|February 2017|2017-02-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Interventional|AKORDD||Acute Kidney Outreach to Reduce Deterioration and Death (AKORDD)|Acute Kidney Outreach to Reduce Deterioration and Death (AKORDD) - A Pilot Study to Look at Enhancing Patient Care, Improving Patient Outcomes and Reducing NHS Costs|Active, not recruiting||N/A|1800|Anticipated|Heart of England NHS Trust||4|||f||||f||||||||Yes|Contact the Chief Investigator mark.thomas@heartofengland.nhs.uk|2017-10-10 23:27:22.376495|2017-10-10 23:27:22.376495
NCT02398669|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-11-02|||March 2015||2015-03-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age|An Open-Label, Single Dose Study to Assess Pharmacokinetics, Safety and Tolerability of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age|Completed||Phase 1|10|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-10 23:27:22.47859|2017-10-10 23:27:22.47859
NCT02398656|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-07-10|||April 2015||2015-04-01|July 2015|2015-07-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|TEMPO-2||A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion|Long Title: Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in the Prevention of Disability at 3 Months in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion|Recruiting||Phase 3|1274|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-10 23:27:22.572926|2017-10-10 23:27:22.572926
NCT02398643|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-09-05|||March 2015||2015-03-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Examine the Impact of Early Education on COPD Management|Examine the Impact of Early Chronic Disease Management Education Following Hospital Discharge in Acute Exacerbation of COPD|Recruiting||N/A|150|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:27:22.693601|2017-10-10 23:27:22.693601
NCT02398630|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-05-31|||September 2014||2014-09-01|May 2016|2016-05-01||||August 2016|Anticipated|2016-08-01||Interventional|HSG-RM||"Magnetic Resonance Imaging Hysterosalpingography for the Integral Evaluation of the Infertile Patient."|"Estudio de Histerosalpingografía Por Resonancia Magnética Para la evaluación Integral de la Paciente infértil."|Recruiting||N/A|50|Anticipated|Diagnostico Maipu||1|||f||||t||||||||||2017-10-10 23:27:22.810261|2017-10-10 23:27:22.810261
NCT02398617|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-06-20|||December 2014||2014-12-01|June 2017|2017-06-01|December 2015|Anticipated|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||End-Of-Life Decision Making and Preparedness Planning Among Heart Failure Patients Hospitalized for Advanced Disease|Facilitating End-Of-Life Decision Making and Preparedness Planning Among Heart Failure Patients Hospitalized for Advanced Disease|Withdrawn||N/A|0|Actual|Saint Luke's Health System||1||Low enrollment and need to refine protocol|f||||f||||||||||2017-10-10 23:27:22.935044|2017-10-10 23:27:22.935044
NCT02398227|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-09-26|||January 2013||2013-01-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|HOPE||Treatment of PTSD in Residents of Battered Women's Shelters|Treatment of PTSD in Residents of Battered Women's Shelters|Completed||Phase 2/Phase 3|172|Actual|The University of Akron||2|||f||||t||||||||||2017-10-10 23:27:26.122412|2017-10-10 23:27:26.122412
NCT02398604|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-03-09|||April 2015||2015-04-01|March 2017|2017-03-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Interventional|ELPIS||Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome|Allogeneic Human MEsenchymal Stem Cell (hMSC) Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.|Recruiting||Phase 1|30|Anticipated|University of Miami||2|||f||||t|t|f||||||Undecided||2017-10-10 23:27:23.044067|2017-10-10 23:27:23.044067
NCT02398591|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-07-06|||April 1, 2015|Actual|2015-04-01|July 2017|2017-07-01|July 15, 2015|Actual|2015-07-15|July 15, 2015|Actual|2015-07-15||Interventional|||A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult Participants|A Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult Subjects|Completed||Phase 1|24|Actual|Janssen Sciences Ireland UC||3|||f||||f||f||||||||2017-10-10 23:27:23.320354|2017-10-10 23:27:23.320354
NCT02398578|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-05-03|||November 2014||2014-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CARETI||Cystoscopic Ablation Via RF Energy Clinical Trial|Cystoscopic Ablation Via RF Energy Clinical Trial|Active, not recruiting||Phase 1/Phase 2|63|Actual|Amphora Medical, Inc.||1|||f||||f||||||||||2017-10-10 23:27:23.42758|2017-10-10 23:27:23.42758
NCT02398565|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-01-11|||March 2015||2015-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Observational|||Pregnancy Subsequent to Ventral Hernia Repair|Pregnancy Subsequent to Ventral Hernia Repair: a Nationwide Cohort Study|Completed||N/A|7612|Actual|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-10 23:27:23.515303|2017-10-10 23:27:23.515303
NCT02398552|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-02-27|||March 2015||2015-03-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.|A Randomized Phase II Trila of Sunitinib Four-weeks on/Two-weeks Off Versus Two-weeks on/One-week Off as First Line Therapy in Metastatic Renal Cell Carcinoma.|Recruiting||Phase 2|80|Anticipated|Beijing Cancer Hospital||2|||f||||t||||||||||2017-10-10 23:27:23.588923|2017-10-10 23:27:23.588923
NCT02398539|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-05-28|||April 2015||2015-04-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Silver Nitrate Application and Topical Corticosteroids for Hypergranulation Tissue|Randomized Clinical Trial Comparing Silver Nitrate Application With Topical Corticosteroids for Hypergranulation Tissue at Gastrostomy Sites|Unknown status|Recruiting|Phase 4|50|Anticipated|Akron Children's Hospital||2|||f||||f||||||||||2017-10-10 23:27:23.735308|2017-10-10 23:27:23.735308
NCT02398526|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-09-29|||March 19, 2015|Actual|2015-03-19|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|June 30, 2018|Anticipated|2018-06-30||Observational|PARABO||Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases|PARABO - Pain Evaluation in Radium-223 (Xofigo®) Treated mCRPC Patients With Bone Metastases - a Non-interventional Study in Nuclear Medicine Centers|Recruiting||N/A|350|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-10 23:27:23.819374|2017-10-10 23:27:23.819374
NCT02398513|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-07-29|||April 2015||2015-04-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|||Regorafenib Phase I Study in Mainland Chinese Patients|Uncontrolled, Open-label, Non-randomized, Phase I Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of Regorafenib in Chinese Patients (China Mainland) With Advanced, Refractory Solid Tumors)|Completed||Phase 1|18|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:27:23.924007|2017-10-10 23:27:23.924007
NCT02398500|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-07-13||2017-01-13|July 2015||2015-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|February 2016|Actual|2016-02-01||Interventional|||Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration|An Open-label Single Ascending Dose and Randomized Double-Masked, Ranibizumab Controlled, Safety, Tolerability, and Efficacy Study of Intravitreal LMG324 in Subjects With Neovascular Age-Related Macular Degeneration|Suspended||Phase 1/Phase 2|25|Actual|Alcon Research||3||Management decision|f||||f||||||||||2017-10-10 23:27:24.01118|2017-10-10 23:27:24.01118
NCT02398487|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-12-01|||October 2014||2014-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|VAPECIG 2||Personal Vaporizer vs Cigalike|Head-To-Head Comparision of Personal Vaporizers Versus Cigalike: Prospective 6-Month Randomized Control Design Study|Completed||N/A|200|Actual|Universita degli Studi di Catania||3|||f||||f||||||||||2017-10-10 23:27:24.123852|2017-10-10 23:27:24.123852
NCT02398474|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-07-19|||April 2015||2015-04-01|March 2015|2015-03-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|TFP||Ultrasound TFP (Transversalis Fascia Plane) for Analgesia After Iliac Crest Bone Graft Harvest|Intérêt du TFP (Transversalis Fascia Plane) Bloc échoguidé Pour l'analgésie du prélèvement Osseux de crête Iliaque|Recruiting||Phase 4|40|Anticipated|Rennes University Hospital||2|||f||||||||||||||2017-10-10 23:27:24.199156|2017-10-10 23:27:24.199156
NCT02398461|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-07-27|||April 2015||2015-04-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse|A Double-Blind, Placebo-Controlled, Single Ascending Dose Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse|Active, not recruiting||Phase 1|30|Anticipated|Acorda Therapeutics||2|||f||||t||||||||||2017-10-10 23:27:24.271504|2017-10-10 23:27:24.271504
NCT02398435|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-12-05|||February 2015||2015-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease|Open-label, Multicenter, Dose-escalating Phase II Study to Investigate the Safety, Tolerability, and Early Signs of Efficacy of Subcutaneous Administrations of Tadekinig Alfa (IL-18BP) in Patients With Adult -Onset Still's Disease (AoSD) During 12 Weeks|Completed||Phase 2|23|Actual|AB2 Bio Ltd.||2|||f||||t||||||||Undecided||2017-10-10 23:27:24.445129|2017-10-10 23:27:24.445129
NCT02398422|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-08-16|||October 2015||2015-10-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Listening Project at Reiss-Davis/Vista Del Mar Child and Family Services|The Listening Project at Reiss-Davis/Vista Del Mar Child and Family Services|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-10 23:27:24.556432|2017-10-10 23:27:24.556432
NCT02398409|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-06-12|||November 3, 2014|Actual|2014-11-03|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|December 1, 2017|Anticipated|2017-12-01||Interventional|||Informal Caregivers ANSWERS-VA|Telephone Assessment and Skill-Building Intervention for Informal Caregivers|Recruiting||N/A|330|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-10 23:27:24.640134|2017-10-10 23:27:24.640134
NCT02398396|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-09-29|||April 2015||2015-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|November 2015|Actual|2015-11-01||Interventional|||Investigating Meningococcal Vaccines in Adults|Investigating Meningococcal Vaccines in Adults - An Exploratory, Open-label, Immunogenicity Study of a Licensed Meningococcal Capsular Group B Vaccine (4CMenB, Bexsero®) in Adults|Active, not recruiting||N/A|15|Actual|University of Oxford||1|||f||||f||||||||||2017-10-10 23:27:24.730839|2017-10-10 23:27:24.730839
NCT02398383|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-07-28|||March 2015||2015-03-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes|Role of Glucagon in Glucose Control in Cystic Fibrosis Related Diabetes|Recruiting||Early Phase 1|30|Anticipated|Yale University||3|||f||||f||||||||||2017-10-10 23:27:24.803544|2017-10-10 23:27:24.803544
NCT02398370|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-04-24|||July 2013||2013-07-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|PMD-MSC-ED-01||Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED|Evaluate the Safety and Feasibility of Injecting Placental Matrix-Derived Mesenchymal Stem Cells Into the Penis to Treat the Symptoms of Mild to Moderate Erectile Dysfunction|Completed||Phase 1|8|Actual|Z Urology||1|||f||||t||||||||||2017-10-10 23:27:25.014466|2017-10-10 23:27:25.014466
NCT02398357|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-12-08|||March 2015||2015-03-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis|A Zelen-design Randomized Controlled Trial of the Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis|Recruiting||Phase 4|96|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 23:27:25.135714|2017-10-10 23:27:25.135714
NCT02398344|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2016-05-12|||February 2014||2014-02-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||tDCS Immediate Effect on Cardiorespiratory Parameters in Hemiparetics Adults Patients Due to Stroke.|THE IMMEDIATE EFFECT OF ELECTRICAL STIMULATION TRANSCRANIAL DIRECT CURRENT (tDCS) ON CARDIORESPIRATORY PARAMETERS IN HEMIPARETICS ADULTS PATIENTS DUE TO STROKE|Completed||Phase 1/Phase 2|20|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 23:27:25.237372|2017-10-10 23:27:25.237372
NCT02398331|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-02-08|||July 2015|Actual|2015-07-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|SexSIFem||Sexual Health of Spinal Cord Injured Females|Impact of an Information and Education Program on Sexuality and Social Integration in Women With a Spinal Cord Injury|Recruiting||N/A|94|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:27:25.328564|2017-10-10 23:27:25.328564
NCT02398318|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-12-04|||April 2015||2015-04-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|October 2016|Anticipated|2016-10-01||Interventional|CRODS||China Refractory Obsessive-Compulsive Disorder Deep Brain Stimulation Study|China Refractory-Obsessive Compulsive Disorder Deep Brain Stimulation Study|Withdrawn||Phase 2/Phase 3|0|Actual|Ruijin Hospital||2||A pilot study is recruiting|f||||t||||||||||2017-10-10 23:27:25.434967|2017-10-10 23:27:25.434967
NCT02398305|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-03-24|||October 2012||2012-10-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Shortening Compression Time After Radial Access for Cardiac Catheterisation|Shortening Compression Time of the Access Site After Cardiac Catheterisation Through the Radial Artery|Completed||N/A|173|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-10 23:27:25.550135|2017-10-10 23:27:25.550135
NCT02398292|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-09-19|||February 2015||2015-02-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|July 2016|Actual|2016-07-01||Interventional|M3||A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis|Meals, Mindfulness & Moving Forward: A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youth Suffering From Psychosis|Active, not recruiting||N/A|33|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-10 23:27:25.636847|2017-10-10 23:27:25.636847
NCT02398279|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-03-19|||June 2011||2011-06-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||L-arginine add-on Therapy in Patients With Schizophrenia|L-Arginine add-on Treatment for Schizophrenia: A Randomized, Double Blind, Placebo Controlled, Cross Over Study|Completed||N/A|12|Actual|Hacettepe University||2|||f||||f||||||||||2017-10-10 23:27:25.727018|2017-10-10 23:27:25.727018
NCT02398266|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-06-16|||August 1, 2016|Actual|2016-08-01|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid|Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid|Recruiting||Phase 2|55|Anticipated|Oregon Health and Science University||3|||f||||f||||||||||2017-10-10 23:27:25.837999|2017-10-10 23:27:25.837999
NCT02398253|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-04-03|||February 2015||2015-02-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Cognitive Behavioral Therapy (CBT) on Weight Maintenance After Successful Weight Loss|Effects of Cognitive Behavioral Therapy After a Successful Weight Loss by a Comprehensive Weight Loss Plan (NovinDiet Plan) on Weight Maintenance in Healthy Obese Female Adults: a Randomized Clinical Trial|Completed||N/A|100|Actual|Novindiet Clinic||2|||f||||f||||||||||2017-10-10 23:27:25.917995|2017-10-10 23:27:25.917995
NCT02398240|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2016-10-04|||May 2015||2015-05-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Brentuximab for Newly Diagnosed Hodgkin Disease|A Pilot Study of Risk Adapted Therapy Utilizing Upfront Brentuximab With Combination Chemotherapy in the Treatment of Children, Adolescents and Young Adults With Newly Diagnosed Hodgkin Lymphoma|Recruiting||Phase 2|40|Anticipated|New York Medical College||3|||f||||f||||||||No||2017-10-10 23:27:26.012441|2017-10-10 23:27:26.012441
NCT02398214|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2017-04-14|||November 2012||2012-11-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Sleep Hygiene-based Intervention Program for Infants and Toddlers|A Sleep Hygiene-based Intervention Program for Infants and Toddlers|Completed||N/A|247|Actual|National Taiwan University Hospital||2|||f||||t||||||||No||2017-10-10 23:27:26.222691|2017-10-10 23:27:26.222691
NCT02398201|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-09-20|||September 2015||2015-09-01|September 2017|2017-09-01|March 23, 2017|Actual|2017-03-23|January 2017|Actual|2017-01-01||Interventional|||A Study of Bezafibrate in Mitochondrial Myopathy|A Feasibility Study of Bezafibrate in Mitochondrial Myopathy|Completed||Phase 2|6|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||1|||f||||t||||||||||2017-10-10 23:27:26.331255|2017-10-10 23:27:26.331255
NCT02398188|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-01-06|||April 2015||2015-04-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Interventional|||Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)|A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Non-Obese Subjects|Active, not recruiting||Phase 3|800|Anticipated|Neothetics, Inc||2|||f||||f||||||||||2017-10-10 23:27:26.444916|2017-10-10 23:27:26.444916
NCT02398175|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-19|||January 2008||2008-01-01|March 2015|2015-03-01||||January 2015|Actual|2015-01-01||Observational|||Thoracic Injuries in Pediatric Polytraumatized Patients: Epidemiology, Treatment and Outcome||Completed||N/A|71|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-10 23:27:26.610735|2017-10-10 23:27:26.610735
NCT02398162|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-08-31|||July 2015||2015-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|STP||Scrub Typhus Pediatric Immunology Study|The Natural Immune Response In Pediatric Scrub Typhus In Chiangrai|Recruiting||N/A|170|Anticipated|University of Oxford|||3||f||||||||||||||2017-10-10 23:27:26.675182|2017-10-10 23:27:26.675182
NCT02398149|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-28|||October 2013||2013-10-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis|Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis|Completed||N/A|267|Actual|Mount Sinai Rehabilitation Hospital|||1||f||||f||||||||||2017-10-10 23:27:26.760492|2017-10-10 23:27:26.760492
NCT02398136|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-03-19|||December 2014||2014-12-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD|Randomized Controlled Trial of Repeated Dose Ketamine in Post Traumatic Stress Disorder (PTSD)|Withdrawn||Phase 2/Phase 3|0|Actual|Icahn School of Medicine at Mount Sinai||2||FDA and IRB recommended different mode of medication administration|f||||t||||||||||2017-10-10 23:27:26.816483|2017-10-10 23:27:26.816483
NCT02398123|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-09-14|||March 2015||2015-03-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Transversus Abdominis Plane Versus Caudal Block for Pediatrics|Transversus Abdominis Plane (TAP) Blocks Versus Caudal Block for Postoperative Pain Control After Unilateral Lower Abdominal Surgeries in Pediatrics: A Prospective, Randomized Study.|Completed||Phase 1|28|Actual|Mansoura University||2|||f||||t||||||||||2017-10-10 23:27:26.891398|2017-10-10 23:27:26.891398
NCT02398110|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-08-10|||March 2015||2015-03-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Transvaginal NOTES Nephrectomy Versus Conventional Laparoscopic Nephrectomy|Transvaginal NOTES Nephrectomy Versus Conventional Laparoscopic Nephrectomy: a Randomized Clinical Trial|Unknown status|Recruiting|N/A|60|Anticipated|First Affiliated Hospital of Gannan Medical University||2|||f||||t||||||||||2017-10-10 23:27:26.97142|2017-10-10 23:27:26.97142
NCT02398097|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-03-24|||November 2011||2011-11-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects|Safety and Immunogenicity of Influenza Vaccine Among HIV-infected Young Subjects: Conventional Vaccine Versus Intradermal Vaccine|Completed||Phase 4|88|Actual|Korea University Guro Hospital||3|||f||||t||||||||||2017-10-10 23:27:27.045102|2017-10-10 23:27:27.045102
NCT02398084|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-03-08|||February 2015||2015-02-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|April 2015|Actual|2015-04-01||Interventional|||Particle Sizing of Masticated Tree Nuts - Cashews and Walnuts|Particle Sizing of Masticated Tree Nuts - Cashews and Walnuts|Active, not recruiting||N/A|10|Anticipated|King's College London||1|||f||||f||||||||||2017-10-10 23:27:27.112739|2017-10-10 23:27:27.112739
NCT02398071|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-19|||August 2014||2014-08-01|March 2015|2015-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||The Effects of Positive Expiratory Pressure Breathing on The Rate of Post-exercise Recovery in Patients With COPD|The Effects of Breathing With a Positive Expiratory Pressure Device on The Rate of Post-exercise Recovery in Patients With COPD|Unknown status|Recruiting|N/A|20|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-10-10 23:27:27.188505|2017-10-10 23:27:27.188505
NCT02398058|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-03-07|||October 2014|Actual|2014-10-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|February 2017|Actual|2017-02-01||Interventional|TOMAS||Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)|A Phase Ib Study on the Combination of Trabectedin and Olaparib in Unresectable Advanced/Metastatic Sarcomas After Failure of Standard Therapies|Active, not recruiting||Phase 1|50|Actual|Italian Sarcoma Group||1|||f||||t||||||||||2017-10-10 23:27:27.280685|2017-10-10 23:27:27.280685
NCT02398045|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-08-29|||October 2015||2015-10-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|CCBT||Developing Computerised CBT for Adults With OCD|Developing Computerised Cognitive Behavioural Therapy for Adults With Obsessive-compulsive Disorder|Recruiting||Early Phase 1|12|Anticipated|Institute of Psychiatry, London||1|||f||||t||||||||||2017-10-10 23:27:27.494324|2017-10-10 23:27:27.494324
NCT02398032|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-05-02|||May 2013||2013-05-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SAHS2-3||CPAP in SAHS Patients With Hypertension|CPAP Effect on Nocturnal Evolution of Chemosensitivity Determinants in Sleep Apnea-hypopnea Patients With Isolated Nocturnal Hypertension or Day-nigh Sustained Hypertension|Completed||Phase 4|32|Actual|Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-10 23:27:27.597201|2017-10-10 23:27:27.597201
NCT02398019|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-01-27|||March 2015||2015-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Clinical Trial to Evaluate the Use of an Adsorption Membrane (OXIRIS®) During Cardiopulmonary Bypass Surgery|Clinical Trial to Evaluate Facticity and Security for the Use of an Increased Adsorption Capacity Membrane (OXIRIS®) During Cardiopulmonary Bypass Surgery|Completed||Phase 4|20|Actual|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-10 23:27:27.689195|2017-10-10 23:27:27.689195
NCT02398006|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-19|||April 2015||2015-04-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Conservative Interventions for Treating Clavicle Fractures in Adults|Figure-of-eight Bandage Versus Arm Sling for Treating Middle Third Clavicle Fractures in Adults: Study Protocol for a Randomised Controlled Trial|Not yet recruiting||N/A|110|Anticipated|Hospital Israelita Albert Einstein||2|||f||||t||||||||||2017-10-10 23:27:27.771036|2017-10-10 23:27:27.771036
NCT02397993|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2017-02-28|||March 2015||2015-03-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Serum Parameter Prior and After EUS-guided Fine Needle Aspiration of the Pancreas|Serum Lipase, Amylase and CA 19-9 Prior and After EUS-guided Fine Needle Aspiration of the Pancreas|Recruiting||N/A|208|Anticipated|Helios Albert-Schweitzer-Klinik Northeim|||1||f||||f||||||Samples Without DNA|"     Pancreatic cells obtained by fine needle aspiration during endosonography Blood samples prior     and after EUS with a assessment of CA19-9, Lipase and Amylase   "|||2017-10-10 23:27:27.863437|2017-10-10 23:27:27.863437
NCT02397980|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-03-24|||March 2015||2015-03-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|I-care||Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia|A Multicenter, Randomized Trial to Assess Efficacy of Therapeutic Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia|Unknown status|Not yet recruiting|N/A|80|Anticipated|Ewha Womans University Mokdong Hospital||2|||f||||t||||||||||2017-10-10 23:27:27.968227|2017-10-10 23:27:27.968227
NCT02397967|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-03-25|||June 2009||2009-06-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Reading Disability in Children With NF1|Neuropsychological Characterisation of Cognitive Deficits Involved in Reading Disability in Children With NF1|Completed||N/A|181|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:27:28.058826|2017-10-10 23:27:28.058826
NCT02397954|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-04-04||2017-04-04|March 2015||2015-03-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)|A Phase 2a Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)|Completed||Phase 2|4|Actual|Ophthotech Corporation||1|||f||||t||||||||||2017-10-10 23:27:28.170601|2017-10-10 23:27:28.170601
NCT02397941|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-05-08|||December 2015||2015-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Diastasis Recti Abdominis and Abdominal Muscles|Diastasis Recti Abdominis and Abdominal Muscles in Pregnant and Non-pregnant Women|Recruiting||N/A|80|Anticipated|University of Zurich|||3||f||||f||||||||||2017-10-10 23:27:28.262269|2017-10-10 23:27:28.262269
NCT02397928|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-05-07|||February 2015||2015-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)|A Phase II Trial of Pemetrexed and Cisplatin or Carboplatin in Combination With TTFields (150 kHz) as First-line Treatment in Malignant Pleural Mesothelioma|Active, not recruiting||Phase 2|82|Actual|NovoCure Ltd.||1|||f||||f||||||||||2017-10-10 23:27:28.353506|2017-10-10 23:27:28.353506
NCT02397915|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-04-25|2016-01-28||March 26, 2015|Actual|2015-03-26|April 2017|2017-04-01|June 8, 2015|Actual|2015-06-08|June 8, 2015|Actual|2015-06-08||Interventional|||Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays|A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects With Allergic Rhinitis|Completed||Phase 4|300|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 23:27:28.533863|2017-10-10 23:27:28.533863
NCT02397902|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-08|||March 2015||2015-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products|Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products|Active, not recruiting||N/A|60|Actual|University of Texas at Austin||2|||f||||t||||||||||2017-10-10 23:27:29.940166|2017-10-10 23:27:29.940166
NCT02397889|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-08-23|||May 2015||2015-05-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Repeated-Dose Intravenous Ketamine for PTSD|Randomized Controlled Trial of Repeated-Dose Intravenous Ketamine for PTSD|Recruiting||Phase 2/Phase 3|40|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:27:30.021281|2017-10-10 23:27:30.021281
NCT02397876|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-12-06|||March 2015||2015-03-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients|Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients|Completed||N/A|10|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 23:27:30.136851|2017-10-10 23:27:30.136851
NCT02397863|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-04-23|||December 2014||2014-12-01|April 2015|2015-04-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Expanded Access|CBD||Epidiolex and Drug Resistant Epilepsy in Children|An Open Label, Multi-Center Study to Investigate the Safety of Cannabinoid (GWP42003-P) in Children With Medication Resistant Epilepsy|Available||N/A|||Augusta University|||||||||t||||||||||2017-10-10 23:27:30.20596|2017-10-10 23:27:30.20596
NCT02397850|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-10-24|||February 2015||2015-02-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Development of a Telephone-based Continuation Treatment for Patients With Chronic Depression.|Optimizing Psychotherapeutic Aftercare for Patients Suffering From Chronic/Recurrent Depression: Development and First Evaluation of a Telephone-based Continuation Treatment (Pilot Study).|Active, not recruiting||N/A|7|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 23:27:30.276534|2017-10-10 23:27:30.276534
NCT02397837|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-04-26|||October 2014||2014-10-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PRAM-BD||Targeting Cognition in Bipolar Disorder With Pramipexole|Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)|Recruiting||Phase 4|100|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 23:27:30.351767|2017-10-10 23:27:30.351767
NCT02397824|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-12-17|||January 2015||2015-01-01|December 2015|2015-12-01||||December 2020|Anticipated|2020-12-01||Observational|||Orodental Manifestations of Rare Diseases||Recruiting||N/A|200|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:27:30.471997|2017-10-10 23:27:30.471997
NCT02397798|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-10-19|||February 2015||2015-02-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Improved Ability to Cope With Everyday Life Through a Person-centered Training Program in Elderly Patients With Rheumatoid Arthritis - PEP-walk Study|Improved Ability to Cope With Everyday Life Through a Person-centered Training Program in Elderly Patients With Rheumatoid Arthritis - PEP-walk Study|Recruiting||N/A|100|Anticipated|Vastra Gotaland Region||2|||f||||||||||||||2017-10-10 23:27:30.77634|2017-10-10 23:27:30.77634
NCT02397785|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-09-28|||April 2015||2015-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intra-vaginal Electrical Stimulation Device Compared to Sham Device for Chronic Pelvic Pain|Treatment of Pain Using a Non-implanted Intra-vaginal Electrical Stimulation Device Compared to Sham Device in Chronic Pelvic Pain|Active, not recruiting||N/A|52|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-10 23:27:30.890895|2017-10-10 23:27:30.890895
NCT02397772|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-05-28|||March 2015||2015-03-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|TUMIKIA||Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya|The Impact of Different Treatment Strategies on the Transmission Dynamics of Soil-transmitted Helminths: a Cluster Randomised Trial in Kenya|Recruiting||Phase 4|30000|Anticipated|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-10-10 23:27:31.018394|2017-10-10 23:27:31.018394
NCT02397759|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-03-20|||November 2013||2013-11-01|March 2015|2015-03-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Metabolomic Profile and Proteasic Activity as Biomarkers for Early Detection of Arterial Vasospas in Arterial Vasospasm After Aneurysmal Subarachnoid Hemorrhage|Analysis of Cerebral Spinal Fluid and Plasma After Aneurysmal Subarachnoid Hemorrhage by Evaluating a Metabolomic Profile and the Proteasic Activity as Biomarkers for Early Detection of Arterial Vasospasm|Recruiting||N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-10 23:27:31.169656|2017-10-10 23:27:31.169656
NCT02397746|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-06-19|||July 2015||2015-07-01|June 2017|2017-06-01|April 2029|Anticipated|2029-04-01|April 2028|Anticipated|2028-04-01||Observational|||Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator Cemented Femoral Stems|Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator Cemented Femoral Stems|Enrolling by invitation||N/A|75|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||||2017-10-10 23:27:31.273229|2017-10-10 23:27:31.273229
NCT02397733|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2015-03-20|||March 2015||2015-03-01|March 2015|2015-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Memory Preservation of Prophylactic Cranial Irradiation With Hippocampal Avoidance (PREMER-TRIAL)|Phase III Trial Evaluating Memory Preservation of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance in Small Cell LUNG Cancer (PREMER-TRIAL)|Recruiting||Phase 3|150|Anticipated|Grupo de Investigación Clínica en Oncología Radioterapia||2|||f||||f||||||||||2017-10-10 23:27:31.365387|2017-10-10 23:27:31.365387
NCT02397720|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-06-22|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of Nivolumab (BMS-936558) in Combination With 5-azacytidine (Vidaza) or Nivolumab With Ipilimumab in Combination With 5-azacytidine for Patients With Refractory/ Relapsed Acute Myeloid Leukemia (AML)|An Open-Label Phase II Study of Nivolumab (BMS-936558) in Combination With 5-azacytidine (Vidaza) or Nivolumab With Ipilimumab in Combination With 5-azacytidine for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia and Newly Diagnosed Older AML (>65 Years) Patients|Recruiting||Phase 2|182|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 23:27:31.462788|2017-10-10 23:27:31.462788
NCT02397707|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2016-03-15|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Pharmacokinetics of GS-9857 in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment|A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-9857 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment|Completed||Phase 1|33|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-10 23:27:31.598644|2017-10-10 23:27:31.598644
NCT02397694|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-20|2017-06-30||2016-08-22|March 2015||2015-03-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|October 2015|Actual|2015-10-01||Interventional|||Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults|A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9883 + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults|Active, not recruiting||Phase 2|98|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-10 23:27:31.703412|2017-10-10 23:27:31.703412
NCT02397681|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-01-20|||January 2015||2015-01-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Autonomic Responses During the Valsalva Maneuver and Deep Breathing Test Depend on the Experimental Setup|Autonomic Responses During the Valsalva Maneuver and Deep Breathing Test Depend on the Experimental Setup|Completed||N/A|40|Actual|Danish Pain Research Center||1|||f||||t||||||||||2017-10-10 23:27:31.892342|2017-10-10 23:27:31.892342
NCT02397668|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-07-18|||May 2015||2015-05-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|January 2018|Anticipated|2018-01-01||Interventional|||CorMatrix ECM Tricuspid Valve Replacement|CorMatrix ECM Tricuspid Valve Replacement Safety and Early Feasibility|Active, not recruiting||N/A|9|Actual|CorMatrix Cardiovascular, Inc.||1|||f||||t||||||||||2017-10-10 23:27:31.969908|2017-10-10 23:27:31.969908
NCT02397655|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-09-18|2016-09-18||June 2015||2015-06-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Vascular Ultrasound Screening in Patients With Ischemic Cerebrovascular Disease: a Multi-center Registry Study|Screening Carotid Artery and Intracranial Arteries by Ultrasound in Chinese Population With Transient Ischemic Attack and Ischemic Stroke: a Multi-center Registry Study|Completed||N/A|12012|Actual|Xuanwu Hospital, Beijing|||1||f||||f||||||||No||2017-10-10 23:27:32.049108|2017-10-10 23:27:32.049108
NCT02397642|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-02-07|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Dual Trigger Versus Booster Dose of HCG|Dual Trigger Versus Booster Dose of HCG on Ovum Pickup Day in Antagonist IVF/ICSI Cycles Triggered With GnRH Agonist in High Responder Females to Salvage the Luteal Phase|Active, not recruiting||N/A|200|Actual|Cairo University||2|||f||||f||||||||||2017-10-10 23:27:32.224592|2017-10-10 23:27:32.224592
NCT02397629|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-05-25|||May 2013||2013-05-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis|Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis|Completed||N/A|62|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||Samples Without DNA|"     Serum samples for measurement of PTHrP   "|||2017-10-10 23:27:32.315163|2017-10-10 23:27:32.315163
NCT02397616|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-12-10|||January 2015||2015-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Effects of Position and a Test Meal on Esophago-gastric Junction Morphology and Function Assessed by High-resolution Impedance Manometry (HRM)|Effects of Position and a Test Meal on Esophago-gastric Junction Morphology and Function Assessed by High-resolution Impedance Manometry (HRM)|Recruiting||N/A|700|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 23:27:32.386596|2017-10-10 23:27:32.386596
NCT02397603|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2016-01-30|||February 2015||2015-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine Induced Paravertebral Block in Patients Undergonig Thoracotomy|Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine-induced Paravertebral Block in Patients Undergoing Thoracotomy|Completed||Phase 2|40|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:27:32.479387|2017-10-10 23:27:32.479387
NCT02397590|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-07-21|||March 2015||2015-03-01|March 2015|2015-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers|A Randomized, Open-label, Six-sequence, Three-period, Multiple Dosing Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Boryung Pharmaceutical Co., Ltd||6|||f||||t||||||||||2017-10-10 23:27:32.576802|2017-10-10 23:27:32.576802
NCT02397577|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-12-10|||February 2015||2015-02-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|13C||Reference Values for Gastric Emptying|Normal Values for Gastric Emptying in a 13C-octanoate Breath Test Using a Solid Test Meal|Recruiting||N/A|75|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:27:32.671657|2017-10-10 23:27:32.671657
NCT02397564|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-05|2016-07-20||March 2015||2015-03-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Er:YAG||Treatment of Post-Surgical Scars With Traditional Ablative Er:YAG Versus Fractional Ablative Er:YAG|Treatment of Post-Surgical Scars With Traditional Ablative Er:YAG Versus Fractional Ablative Er:YAG|Completed||N/A|20|Actual|University of Louisville||1|||f||||t||||||||||2017-10-10 23:27:32.773418|2017-10-10 23:27:32.773418
NCT02397551|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-02-07|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day|Supplementing the Luteal Phase With Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day in Antagonist IVF/ICSI Cycles Triggered With GnRH Agonist in High Responder Females to Salvage the Luteal Phase|Active, not recruiting||Phase 4|200|Actual|Cairo University||2|||f||||f||||||||||2017-10-10 23:27:32.956336|2017-10-10 23:27:32.956336
NCT02397538|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-07-21|||February 2015||2015-02-01|March 2015|2015-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects|An Open-label, Fixed-sequence, Crossover Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects|Completed||Phase 1|50|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||||||||||||2017-10-10 23:27:33.036607|2017-10-10 23:27:33.036607
NCT02397525|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-08-11|||March 2015||2015-03-01|August 2015|2015-08-01||||June 2016|Anticipated|2016-06-01||Interventional|||An Open-Label Study to Evaluate Retreatment With LIPO-202|An Open-Label Study to Evaluate Retreatment With LIPO-202|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|Neothetics, Inc||1|||f||||||||||||||2017-10-10 23:27:33.124597|2017-10-10 23:27:33.124597
NCT02397512|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-07-10|||February 2015||2015-02-01|July 2017|2017-07-01|October 1, 2015|Actual|2015-10-01|October 1, 2015|Actual|2015-10-01||Interventional|Lactulose||Elucidating the Influence of Lactulose Intake on the Gut Microbiota Composition|Elucidating the Influence of Lactulose Intake on the Gut Microbiota Composition|Completed||N/A|32|Actual|University of Zurich||2|||f||||f||||||||||2017-10-10 23:27:33.208503|2017-10-10 23:27:33.208503
NCT02397499|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-01-06|||April 2015||2015-04-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Interventional|AbCONTOUR1||Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat|A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Non-Obese Subjects|Completed||Phase 3|800|Anticipated|Neothetics, Inc||2|||f||||f||||||||||2017-10-10 23:27:33.29076|2017-10-10 23:27:33.29076
NCT02397486|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-07-15|||May 2015||2015-05-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients|The Impact of Pentoxifylline and Vitamin E on The Incidence and Severity of Radiotherapy- Induced Oral Mucositis and Dysphagia in Patients With Head and Neck Cancer|Recruiting||Phase 2|60|Anticipated|Ain Shams University||2|||f||||f||||||||Undecided||2017-10-10 23:27:33.421025|2017-10-10 23:27:33.421025
NCT02397473|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-25|||May 2015||2015-05-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of LY2951742 in Participants With Episodic Cluster Headache|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Cluster Headache|Recruiting||Phase 3|162|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 23:27:33.518389|2017-10-10 23:27:33.518389
NCT02397460|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-17|||April 29, 2015|Actual|2015-04-29|April 2017|2017-04-01|May 16, 2016|Actual|2016-05-16|April 22, 2016|Actual|2016-04-22||Interventional|||Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity|A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects|Completed||Phase 2|50|Actual|Afferent Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:27:33.787349|2017-10-10 23:27:33.787349
NCT02396355|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-02-07|||February 2015||2015-02-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Accuracy Evaluation of the BD FACS Presto System|Accuracy Evaluation of the BD FACS Presto System: Instrument, Software and BD CD4/%CD4/Hb Cartridge Assay|Completed||N/A|583|Actual|Becton, Dickinson and Company|||1||f||||f||||||||No||2017-10-10 23:27:46.042119|2017-10-10 23:27:46.042119
NCT02397447|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-01-08|||March 2013||2013-03-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion|Effect of Momordica Charantia Administration on Insulin Sensitivity and Insulin Secretion in Patients With Type 2 Diabetes Mellitus, Without Pharmacological Treatment|Completed||Phase 2|24|Actual|University of Guadalajara||2|||f||||f||||||||||2017-10-10 23:27:33.866467|2017-10-10 23:27:33.866467
NCT02397434|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-04-15|||October 2014||2014-10-01|April 2016|2016-04-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer|Adjuvant Radiotherapy After Cystectomy for Patients With Muscle Invasive Bladder Cancer: a Phase II Trial.|Recruiting||N/A|76|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-10 23:27:33.959642|2017-10-10 23:27:33.959642
NCT02397421|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-09-07|||March 2015||2015-03-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|REFORM||Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes|Research Into the Effect of SGLT2 Inhibition on Left Ventricular Remodeling in Patients With Heart Failure and Diabetes Mellitus|Active, not recruiting||Phase 4|56|Actual|University of Dundee||2|||f||||f||||||||||2017-10-10 23:27:34.073202|2017-10-10 23:27:34.073202
NCT02397408|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-08-28|||April 2, 2015|Actual|2015-04-02|August 2017|2017-08-01|November 22, 2016|Actual|2016-11-22|November 22, 2016|Actual|2016-11-22||Interventional|||11C- and 18F-Choline PET/MR Imaging for Prostate Cancer|Phase 2 Study of 11C- and 18F-Choline PET/MR Imaging in Patients With Unfavorable Intermediate to High-Risk Prostate Cancer|Completed||Phase 2|18|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:27:34.174399|2017-10-10 23:27:34.174399
NCT02397395|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-07-15|||May 2015||2015-05-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.|A Phase 2, Open-label, Single-arm Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of 12 Weeks Treatment With Simeprevir and Daclatasvir in Subjects With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.|Withdrawn||Phase 2|0|Actual|Janssen R&D Ireland||1||Trial has been cancelled due to availability of new therapeutic options for patient population|f||||f||||||||||2017-10-10 23:27:34.890022|2017-10-10 23:27:34.890022
NCT02397382|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-19|||June 18, 2015|Actual|2015-06-18|September 2017|2017-09-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|||Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis|A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Guselkumab (CNTO 1959) on Cytochrome P450 Enzyme Activities Following a Single Subcutaneous Administration in Subjects With Moderate to Severe Plaque-type Psoriasis|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-10 23:27:34.988845|2017-10-10 23:27:34.988845
NCT02397369|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-23|||March 2015||2015-03-01|March 2015|2015-03-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Evaluation of Efficacy of Different Methods of Tobacco Cessation Interventions Among BEST Employees in Mumbai|Comparative Evaluation of Efficacy of Different Methods of Tobacco Cessation Interventions Among BEST Employees in Mumbai : A Randomized Controlled Trial|Not yet recruiting||N/A|4000|Anticipated|Tata Memorial Hospital||4|||f||||t||||||||||2017-10-10 23:27:35.337485|2017-10-10 23:27:35.337485
NCT02397356|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-12-23|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia|Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia|Recruiting||Phase 4|20|Anticipated|Tampere University Hospital||2|||f||||f||||||||No||2017-10-10 23:27:35.475212|2017-10-10 23:27:35.475212
NCT02397343|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-07-03|||February 2015||2015-02-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|HBO-SHA||The Effect of Hyperbaric Oxygen Therapy on Inflammatory Parameters Induced by a Heat Injury Model|The Effect of Hyperbaric Oxygen Therapy on Inflammatory Parameters Induced by a Heat Injury Model|Unknown status|Recruiting|Phase 2|26|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:27:35.620562|2017-10-10 23:27:35.620562
NCT02397330|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-23|||April 2015||2015-04-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||is There an Alternative to Ultrasound Guided Interscalene Block?|the Association of Ultrasound Guided Suprascapular and Supraclavicular Nerve Block Provides Adequate Analgesia in Comparison With Ultrasound Guided Interscalene Block|Unknown status|Not yet recruiting|N/A|60|Anticipated|Tunisian Military Hospital||2|||f||||f||||||||||2017-10-10 23:27:35.721024|2017-10-10 23:27:35.721024
NCT02397317|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-06-20|||February 2016||2016-02-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|SPARK||Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring|Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction|Recruiting||Phase 2|48|Anticipated|University of Sydney||1|||f||||t||||||||No||2017-10-10 23:27:35.832712|2017-10-10 23:27:35.832712
NCT02397304|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-18|||April 2015||2015-04-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Nutrition, Exercise and Muscle Metabolism in Obesity|Influence of Pre- or Post-exercise Food Intake on Muscle Metabolism in Obesity|Unknown status|Not yet recruiting|N/A|8|Anticipated|University of Birmingham||2|||f||||||||||||||2017-10-10 23:27:35.973841|2017-10-10 23:27:35.973841
NCT02397291|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-10-04|||January 2001||2001-01-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|December 2016|Actual|2016-12-01||Interventional|||Transplacental Gradients and Transport in Intrauterine Growth Restricted (IUGR) Pregnancies Compared to Normal Pregnancies.|Project 1A) To Determine Whether the Transplacental Gradients for 6 Polyols and Mannose Are Altered in IUGR Pregnancies Compared to Normal Pregnancies. Project 1B) To Determine the Relative Contributions of Transplacental Transport vs. Production by the Conceptus of Both Myoinositol (Major Polyol) and Mannose in IUGR and Normal Pregnancies Using Stable Isotopic Methodology.|Suspended||N/A|80|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:27:36.075393|2017-10-10 23:27:36.075393
NCT02397278|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-03-23|||March 2015||2015-03-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee:|Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee: Does it Help? A Clinical and Magnetic Resonance Imaging (MRI) Study.|Recruiting||N/A|24|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:27:36.176433|2017-10-10 23:27:36.176433
NCT02397265|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-03-21|||December 2014||2014-12-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals|Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals|Suspended||N/A|50|Anticipated|Imperial College London||2||Awaiting further funding|f||||t||||||||||2017-10-10 23:27:36.305115|2017-10-10 23:27:36.305115
NCT02397252|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-08-16|||June 2015||2015-06-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CASSIS||Cervical And Self-Sample In Screening Study|Cervical And Self-Sample In Screening (CASSIS) Study: Diagnostic Performance of Molecular HPV Testing With the Eve Medical Self-collection System© for Detecting Cervical Intraepithelial Neoplasia|Completed||N/A|1225|Actual|McGill University||3|||f||||t||||||||||2017-10-10 23:27:37.149091|2017-10-10 23:27:37.149091
NCT02397239|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-04-05|||March 2015||2015-03-01|April 2015|2015-04-01||||December 2018|Anticipated|2018-12-01||Observational|||Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer||Active, not recruiting||Phase 2|122|Anticipated|National Cheng-Kung University Hospital|||2||f||||t||||||Samples Without DNA|"     Blood hemoglobin, white blood cell, absolute neutrophil count, platelet count, total     bilirubin, aspartate aminotransferase, alanine aminotransferase, creatinine   "|||2017-10-10 23:27:37.272092|2017-10-10 23:27:37.272092
NCT02397226|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-10-31|||September 2014||2014-09-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery|Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery. A 5-year Follow-up Using Duplex Ultrasound, Plethysmography, VCSS, AVVQ and EQ-5D|Recruiting||N/A|200|Anticipated|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-10 23:27:37.361123|2017-10-10 23:27:37.361123
NCT02397213|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-10-12|||April 2015||2015-04-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|CiPRICS||Ciclosporin to Protect Renal Function In Cardiac Surgery|Ciclosporin to Protect Renal Function In Cardiac Surgery: CiPRICS A Phase II Double Blind Randomized Placebo Controlled Study|Completed||Phase 2|155|Actual|Region Skane||2|||f||||t||||||||||2017-10-10 23:27:37.482547|2017-10-10 23:27:37.482547
NCT02397200|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-03-09|||June 2015||2015-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls|Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls|Recruiting||N/A|160|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:27:37.603765|2017-10-10 23:27:37.603765
NCT02397187|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-23|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|LOOP-PersDis||Efficacy of a Structured, Dimension-based, STI in De-compensated Personality-disorder, Hospitalized, Patients|The Assessment of the Efficacy of a Structured, Dimension-based, STI (Short Term Intervention) in De-compensated Personality-disorder, Hospitalized, Patients|Unknown status|Not yet recruiting|N/A|20|Anticipated|Shalvata Mental Health Center||2|||f||||f||||||||||2017-10-10 23:27:37.729629|2017-10-10 23:27:37.729629
NCT02397174|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-04-18|||June 2015||2015-06-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Mediterranean Diet Versus Hypocaloric Diet in PCOS|Mediterranean Diet Versus Hypocaloric Diet: What is the Best Choice for the Treatment of Polycystic Ovary Syndrome (PCOS)?|Recruiting||N/A|100|Anticipated|Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona||2|||f||||f||||||||||2017-10-10 23:27:37.812429|2017-10-10 23:27:37.812429
NCT02397161|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-12-13|||July 2016||2016-07-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Mental Attention-neuromuscular Training for Children With Developmental Coordination Disorder|Improving Mental Attention, Timing of Muscle Activation and Reactive Balance Control in Children With Developmental Coordination Disorder: A Randomized Controlled Trial|Not yet recruiting||N/A|172|Anticipated|The University of Hong Kong||4|||f||||t||||||||||2017-10-10 23:27:37.91765|2017-10-10 23:27:37.91765
NCT02397148|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-10-24|||August 2013||2013-08-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|COSINUS||Assessment of the Morphological Concordance Between CT and Cone Beam in Sinus Imagery|Assessment of the Morphological Concordance Between CT and Cone Beam in Sinus Imagery|Completed||N/A|50|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 23:27:38.016181|2017-10-10 23:27:38.016181
NCT02397135|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-18|||January 2015||2015-01-01|March 2015|2015-03-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Observational|COST2||Control Ovarian Stimulation Timing Test|Control Ovarian Stimulation Timing Test|Unknown status|Recruiting|N/A|200|Anticipated|Laval University|||1||f||||f||||||Samples With DNA|"     Granulosa cells as aspirated from the pre-ovulatory follicles   "|||2017-10-10 23:27:38.102909|2017-10-10 23:27:38.102909
NCT02397109|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-10-28|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|DDX||mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)|Study Of The Agreement Between The mDixon TSE Sequence And Conventional MRI Sequences In The Evaluation Of Dysimmune Orbitopathies|Recruiting||N/A|300|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 23:27:38.265011|2017-10-10 23:27:38.265011
NCT02397096|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-09-27|||June 9, 2015|Actual|2015-06-09|September 2017|2017-09-01|March 30, 2020|Anticipated|2020-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|DRIVE-SHIFT||Safety and Efficacy of a Switch to MK-1439A in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)|A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs)|Active, not recruiting||Phase 3|660|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 23:27:38.336237|2017-10-10 23:27:38.336237
NCT02397083|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-09-26|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|September 2026|Anticipated|2026-09-01|September 2026|Anticipated|2026-09-01||Interventional|||Phase II Study of Intrauterine Device (IUD) Alone or in Combination With Everolimus in Endometrial Cancer|Phase II Study of the Levonorgestrel Intrauterine Device Alone or in Combination With the mTORC1 Inhibitor, Everolimus, for the Treatment of Complex Atypical Hyperplasia and Stage Ia Grade 1 Endometrial Cancer|Recruiting||Phase 2|270|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 23:27:38.43338|2017-10-10 23:27:38.43338
NCT02397070|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-03-23|||January 2015||2015-01-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|April 2015|Anticipated|2015-04-01||Interventional|||Effectiveness of a Jaw Exercise Program in Temporomandibular Disorders Patients|Effectiveness of a Jaw Exercise Program in Temporomandibular Disorders Patients|Unknown status|Recruiting|N/A|30|Anticipated|Universidade Federal do Ceara||2|||f||||t||||||||||2017-10-10 23:27:38.547105|2017-10-10 23:27:38.547105
NCT02397057|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-07-05|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS|A Double-Blinded, Multi-Center, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Restless Legs Syndrome (RLS)|Active, not recruiting||Phase 3|200|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:27:38.640778|2017-10-10 23:27:38.640778
NCT02397044|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-03-23|||December 2010||2010-12-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2012|Actual|2012-12-01||Observational|||"Prospective Evaluation of Immediate & Early Loading of Zimmer Hydroxyapatite Coated Dental Implants"|Immediate and Early Loading of Hydrothermally Treated, Hydroxyapatite-Coated Dental Implants:a Controlled Randomized Prospective Clinical Study|Active, not recruiting||N/A|48|Actual|Louisiana State University Health Sciences Center in New Orleans|||2||f||||f||||||||||2017-10-10 23:27:38.763903|2017-10-10 23:27:38.763903
NCT02397031|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-23|||September 2011||2011-09-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder|Randomized, Active-controlled, Clinical Trial Comparing Effects of Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder|Completed||N/A|64|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 23:27:38.82834|2017-10-10 23:27:38.82834
NCT02397018|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-03-30|||May 2015||2015-05-01|March 2017|2017-03-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||Cord Blood Infusion for Ischemic Stroke|Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke|Completed||Phase 1|10|Actual|Duke University||1|||f||||t||||||||Undecided||2017-10-10 23:27:38.901898|2017-10-10 23:27:38.901898
NCT02397005|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-06-13|||March 2015|Actual|2015-03-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|April 2016|Actual|2016-04-01||Interventional|||Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects|Randomized, Double-blind, Placebo-controlled Study of the Tolerability and Pharmacokinetics of Ascending Single and 14-day Repeated Oral Doses of ZL-2102 With a Pilot Investigation of Food Effect in Healthy Male Subjects|Active, not recruiting||Phase 1|120|Actual|Zai Lab Pty. Ltd.||2|||f||||t||||||||||2017-10-10 23:27:38.989428|2017-10-10 23:27:38.989428
NCT02396992|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-03-24|||March 2014||2014-03-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|MMI||Minimal-Massive Intervention in Elderly Patients With Dysphagia|Evaluation of a Minimal-massive Intervention in Elderly Hospitalized Patients With Oropharyngeal Dysphagia|Unknown status|Active, not recruiting|N/A|62|Actual|Hospital de Mataró||1|||f||||f||||||||||2017-10-10 23:27:39.105175|2017-10-10 23:27:39.105175
NCT02396979|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-05-01|||January 2010||2010-01-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Harapan||Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia|Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia|Completed||Phase 4|300|Actual|Yale University||4|||f||||f|f|f|||f|||Undecided||2017-10-10 23:27:39.177942|2017-10-10 23:27:39.177942
NCT02396966|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-05-29|||December 2014||2014-12-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|ACRO QLQ||Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.|A Prospective, Non-interventional, Observational, Multi-centre Study to Document QoL of Subjects With Acromegaly Under Lanreotide Autogel® Treatment.|Active, not recruiting||N/A|150|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 23:27:39.25159|2017-10-10 23:27:39.25159
NCT02396953|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-08-28|||March 2015||2015-03-01|August 2017|2017-08-01|November 28, 2017|Anticipated|2017-11-28|November 28, 2017|Anticipated|2017-11-28||Interventional|||Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly|Phase IIa, Open Label, Dose Ascending Study to Determine the Maximum Tolerated Dose, Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Lanreotide PRF in Subjects With Acromegaly Previously Treated and Controlled With Either Octreotide LAR or Lanreotide Autogel|Active, not recruiting||Phase 1/Phase 2|28|Actual|Ipsen||1|||f||||t||||||||||2017-10-10 23:27:39.340798|2017-10-10 23:27:39.340798
NCT02396940|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-02-26|||March 2015||2015-03-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||3D HD Versus 2D HD in Laparoscopic Inguinal Hernia Repair: a Randomized Controlled Trial|Three-dimensional High-definition (3DHD) Laparoscopy Versus Two-dimensional High-definition (2DHD) Laparoscopy in Inguinal Hernia Repair.|Recruiting||N/A|30|Anticipated|Herlev Hospital||2|||f||||f||||||||No||2017-10-10 23:27:39.458417|2017-10-10 23:27:39.458417
NCT02396927|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-02-26|||March 2015||2015-03-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||3D HD Versus 2D HD in Cholecystectomy|Three-dimensional High-definition (3DHD) Laparoscopy Versus Two-dimensional High-definition (2DHD) Laparoscopy in Cholecystectomy: a Clinical Controlled Randomized Double Blinded Trial.|Recruiting||N/A|30|Anticipated|Herlev Hospital||2|||f||||f||||||||No||2017-10-10 23:27:39.538228|2017-10-10 23:27:39.538228
NCT02396914|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-08-28|||September 2017||2017-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:27:39.652836|2017-10-10 23:27:39.652836
NCT02396901|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-17|||April 2015||2015-04-01|March 2015|2015-03-01|April 2017|Anticipated|2017-04-01|December 2015|Anticipated|2015-12-01||Interventional|GDT-AKI||Goal Direct Therapy to Prevent Acute Kidney Injury|Goal Direct Therapy to Prevent Acute Kidney Injury After Cardiac Surgery|Unknown status|Not yet recruiting|N/A|214|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:27:41.439545|2017-10-10 23:27:41.439545
NCT02396888|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-03-18|||October 2014||2014-10-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||Effects of Local Insulin on Wound Angiogenesis|Effects of Local Insulin on Angiogenesis in Acute Wounds in Non-diabetic Patients|Unknown status|Active, not recruiting|Phase 3|20|Anticipated|"Hospital Central Dr. Ignacio Morones Prieto"||2|||f||||t||||||||||2017-10-10 23:27:41.538318|2017-10-10 23:27:41.538318
NCT02396875|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-03-18|||April 2015||2015-04-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|MicroCRT||Selective Coronary Vein Sampling in Left Bundle Branch Block and CRT|Selective Coronary Vein Sampling in Dyssynchronous Heart Failure and Cardiac Resynchronisation Therapy to Assess Physiological Response to Exercise and Characterise Regional Release of Novel Biomarkers|Unknown status|Not yet recruiting|N/A|70|Anticipated|Guy's and St Thomas' NHS Foundation Trust||6|||f||||t||||||||||2017-10-10 23:27:41.623395|2017-10-10 23:27:41.623395
NCT02396862|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-09-25|||December 9, 2015|Actual|2015-12-09|September 2017|2017-09-01|March 31, 2021|Anticipated|2021-03-31|December 4, 2020|Anticipated|2020-12-04||Observational|ECHO||Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment|A Prospective, International, Longitudinal, Observational Disease Registry of Patient-reported Outcomes (PROs) and the Association With Hemophilia A and Its Treatment in Patients With Moderate to Severe Hemophilia A|Recruiting||N/A|2000|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 23:27:41.714003|2017-10-10 23:27:41.714003
NCT02396849|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-05-04|||January 2015||2015-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Modulation Of Airway Reactivity With Chronic Mechanical Strain|Modulation Of Airway Reactivity With Chronic Mechanical Strain|Active, not recruiting||N/A|120|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 23:27:41.865702|2017-10-10 23:27:41.865702
NCT02396836|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-03-23|||November 2013||2013-11-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|SHoRT||Randomised Controlled Trial (RCT) of 6 Versus 3 Steps for Hand Hygiene|Randomised Controlled Trial of the Effectiveness of Two Hand Hygiene Techniques Using Alcohol Based Hand Rub on Hand Surface Coverage and Reducing Bacterial Hand Contamination|Completed||N/A|120|Actual|Glasgow Caledonian University||2|||f||||f||||||||||2017-10-10 23:27:41.931298|2017-10-10 23:27:41.931298
NCT02396823|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-03-31|||June 2016|Actual|2016-06-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Respiratory Motor Control and Blood Pressure Regulation After Spinal Cord Injury|Respiratory Motor Control and Blood Pressure Regulation After Spinal Cord Injury|Active, not recruiting||N/A|60|Anticipated|University of Louisville||2|||f||||f|f|f||||||Yes||2017-10-10 23:27:42.00749|2017-10-10 23:27:42.00749
NCT02396810|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-01-20|||March 2015||2015-03-01|January 2016|2016-01-01||||March 2018|Anticipated|2018-03-01||Interventional|||Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas||Recruiting||N/A|75|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||||||||||||2017-10-10 23:27:42.087813|2017-10-10 23:27:42.087813
NCT02396797|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-05-12|||January 2015||2015-01-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|atWork||Effect Evaluation of a Workplace Intervention Targeting Subjective Health Complaints|Effect Evaluation of a Workplace Intervention Targeting Subjective Health Complaints on Sick Leave, Coping, Health, Job Satisfaction and Social Support|Active, not recruiting||N/A|1000|Anticipated|Uni Research||2|||f||||f||||||||No||2017-10-10 23:27:42.262536|2017-10-10 23:27:42.262536
NCT02396784|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-02-22|||January 2011|Actual|2011-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|EarlySTOPP-CN||Early Stockholm Obesity Prevention Program (EarlySTOPP-China)|A Randomised Controlled Trial for Overweight and Obese Parents to Prevent Childhood Obesity - China|Active, not recruiting||N/A|300|Anticipated|Huazhong University of Science and Technology|||2||f||||f||||||||||2017-10-10 23:27:42.361972|2017-10-10 23:27:42.361972
NCT02396771|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-03-23|||January 2015||2015-01-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||Effect of Uterine Massage Versus Sustained Uterine Compression on Blood Loss After Vaginal Delivery|Effect of Uterine Massage Versus Sustained Uterine Compression on Blood Loss and Maternal Pain After Vaginal Delivery: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|990|Anticipated|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-10 23:27:42.454218|2017-10-10 23:27:42.454218
NCT02396758|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-03-17|||June 12, 2015|Actual|2015-06-12|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 30, 2016|Actual|2016-11-30||Interventional|OPTALYSE PE||Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism|Study of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in the Treatment of Acute Submassive Pulmonary Embolism|Active, not recruiting||N/A|100|Actual|EKOS Corporation||5|||f||||f||||||||||2017-10-10 23:27:42.550229|2017-10-10 23:27:42.550229
NCT02396745|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2015-03-23|||March 2015||2015-03-01|March 2015|2015-03-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||TECR & ECM Placement for Esophageal High Grade Dysplasia|A Prospective Feasibility Study to Evaluate the Safety and Efficacy of Transoral Endoscopic Circumferential Esophageal Resection With Extracellular Matrix (ECM) Placement to Treat Barrett's Esophagus With High-grade Dysplasia (HGD)|Recruiting||N/A|10|Anticipated|Allegheny Singer Research Institute||1|||f||||f||||||||||2017-10-10 23:27:42.683798|2017-10-10 23:27:42.683798
NCT02396732|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-03-08|||February 2016||2016-02-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Aspirin and Enoxaparin for VTE in Trauma|The Role Of Combined Therapy With Aspirin and Enoxaparin In Prevention Of Venous Thromboembolism In Trauma Patients: A Randomized-Controlled Trial|Active, not recruiting||Phase 4|800|Anticipated|University of Miami||2|||f||||t||||||||No||2017-10-10 23:27:42.786504|2017-10-10 23:27:42.786504
NCT02396719|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-06-03|||March 2015||2015-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||A Real-World Registry to Investigate the Performance of LenSx® Laser in Chinese Patients|A Prospective, Single-Arm, Multicenter, Registry Study to Investigate the Performance of Femtosecond Laser-Assisted Cataract Surgery in Chinese Cataract Patients|Completed||N/A|1541|Actual|Alcon Research|||1||f||||f||||||||||2017-10-10 23:27:42.865718|2017-10-10 23:27:42.865718
NCT02396706|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-09-02|||January 2015||2015-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||RCT to Evaluate the Efficacy and Safety of Ivy Leaves Cough Liquid vs. Placebo in the Treatment of Acute Cough|Randomized, Controlled, Double-blind, Multi-center Trial to Evaluate the Efficacy and Safety of a Liquid Containing Ivy Leaves Dry Extract vs. Placebo in the Treatment of Acute Cough|Completed||Phase 2|181|Actual|Engelhard Arzneimittel GmbH & Co.KG||2|||f||||||||||||||2017-10-10 23:27:42.947106|2017-10-10 23:27:42.947106
NCT02396693|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-02-02|||August 2012||2012-08-01|February 2016|2016-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Successful Extubation and Noninvasive Ventilation in Preterm ≤ 1500g Terms|Successful Extubation and Noninvasive Ventilation in Preterm Infants ≤ 1500g Terms|Completed||N/A|101|Actual|Federal University of Minas Gerais||3|||f||||t||||||||Undecided||2017-10-10 23:27:43.029339|2017-10-10 23:27:43.029339
NCT02396680|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2016-03-22|||April 2015||2015-04-01|March 2016|2016-03-01||||February 2016|Actual|2016-02-01||Observational|||Ragweed-SPIRE Follow-On Study|An Observational Follow-On Field Study to Evaluate the Continued Efficacy and Safety of Ragweed-SPIRE Treatment in Ragweed Allergic Subjects Approximately One Year After the Completion of Treatment|Completed||N/A|249|Actual|Circassia Limited|||1||f||||f||||||||||2017-10-10 23:27:43.114643|2017-10-10 23:27:43.114643
NCT02396667|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-07-16|||March 2015||2015-03-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Accuracy of 5D LB Ultrasound in Prediction of Birth Weight in Macrosomic Babies : A Pilot Study|Accuracy of 5D LB Ultrasound in Prediction of Birth Weight in Macrosomic Babies: A Pilot Study|Recruiting||N/A|60|Anticipated|Ain Shams University|||1||f||||||||||||||2017-10-10 23:27:43.185187|2017-10-10 23:27:43.185187
NCT02396654|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-19|2017-08-04|||March 2015||2015-03-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||5D LB Ultrasound in Determination of Fetal Weight in Normal Pregnancy : A Pilot Study|Accuracy of Five Dimensional Ultrasound Long Bones Fetal Biometry (5DUS LB ) for Prediction of Fetal Weight Compared to Two Dimensional Ultrasound: a Pilot Study|Completed||N/A|56|Actual|Ain Shams University|||1||f||||||||||||||2017-10-10 23:27:43.25986|2017-10-10 23:27:43.25986
NCT02396641|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-12-23|||March 2015||2015-03-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PCRC BSC||PCRC Best Supportive Care (PCRC BSC)|Implementation of Consensus-based Standards for Best Supportive Care in a Clinical Trial: a Pilot Study|Completed||N/A|40|Actual|Duke University||1|||f||||f||||||||||2017-10-10 23:27:43.320887|2017-10-10 23:27:43.320887
NCT02396628|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-09-26|||June 29, 2017|Actual|2017-06-29|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|September 2019|Anticipated|2019-09-01||Interventional|RIG||Ruxolitinib In GvHD|Multicentre Phase 2 Trial to Evaluate the Efficacy of Ruxolitinib in Steroid-refractory Acute Multicenter, Randomized Phase 2 Trial to Determine the Response Rate of Ruxolitinib and Best Available Treatment (BAT) Versus BAT in Steroid-refractory Acute Graft-versus-Host Disease (aGvHD)|Recruiting||Phase 2|148|Anticipated|University Hospital Freiburg||2|||f||||t|f|f||||||||2017-10-10 23:27:43.386655|2017-10-10 23:27:43.386655
NCT02396615|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-04-21|||February 2015||2015-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SATIN||SATIN WP4 Acute Effect on Appetite of Pineapple Juice With Viscofiber and Red Ginseng|SATIN WP4 - The Acute Effect on Appetite of Pineapple Juice With Viscofiber and Red Ginseng|Completed||N/A|30|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:27:43.535754|2017-10-10 23:27:43.535754
NCT02396602|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-08-24|||February 2015||2015-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||miPlan: A Trial of miPlan Intervention vs. Standard of Care|miPlan: A Randomized Controlled Trial of miPlan Intervention vs. Standard of Care|Completed||N/A|225|Actual|University of Chicago||2|||f||||f||||||||||2017-10-10 23:27:43.612873|2017-10-10 23:27:43.612873
NCT02396589|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-12-11|||December 2014||2014-12-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|COMPASS||Community Participation Transition After Stroke|Feasibility of a Novel Intervention to Improve Participation After Stroke|Recruiting||N/A|40|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:27:43.679219|2017-10-10 23:27:43.679219
NCT02396563|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-03-08|||June 2016||2016-06-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Effect of Epidural Analgesia on the Length of Labor and Delivery and Fetal Outcomes||Not yet recruiting||N/A|100|Anticipated|University of Cagliari|||2||f||||f||||||||||2017-10-10 23:27:44.05776|2017-10-10 23:27:44.05776
NCT02396550|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|January 2016|Actual|2016-01-01||Interventional|||Influence of Patient Expectations With Lateral Epicondylalgia in Applying Mobilization With Movement|Influence of Patient Expectations With Lateral Epicondylalgia in Applying Mobilization With Movement. Clinical Trial|Completed||N/A|66|Anticipated|University of Alcala||2|||f||||t||||||||||2017-10-10 23:27:44.164375|2017-10-10 23:27:44.164375
NCT02396004|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-02-09|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||NIRS in PDA VLBW Infants|Near-Infrared Red Spectroscopy (NIRS) to Measure Cerebral Perfusion During and After Patent Ductus Arteriosus (PDA) Treatment in Very Low Birth Weight (VLBW) Infants|Completed||N/A|30|Actual|Singapore General Hospital|||1||f||||f||||||||||2017-10-10 23:27:50.381241|2017-10-10 23:27:50.381241
NCT02396537|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-01-04|2016-08-09||January 2014||2014-01-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration|Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration: A Double-blind, Randomized, Placebo-controlled Trial|Completed||N/A|77|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 23:27:44.295142|2017-10-10 23:27:44.295142
NCT02396524|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-09-27|||April 2015||2015-04-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|August 2015|Actual|2015-08-01||Interventional|||Hockey Fans in Training (Hockey FIT): A Pilot Pragmatic Randomized Controlled Trial|Hockey Fans in Training (Hockey FIT): A Pilot Pragmatic Randomized Controlled Trial of an Exercise and Healthy Living Program for Middle-aged, Overweight and Obese Men|Completed||N/A|80|Actual|Western University, Canada||2|||f||||f||||||||||2017-10-10 23:27:44.771859|2017-10-10 23:27:44.771859
NCT02396511|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-05-16|||January 2015||2015-01-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|November 2015|Actual|2015-11-01||Interventional|||Single Patient Treatment Protocol of TRC105 Combined With Standard-dose Bevacizumab for a Single Patient With Metastatic And Refractory Choriocarcinoma|Single Patient Treatment Protocol of TRC105 Combined With Standard-dose Bevacizumab for a Single Patient With Metastatic And Refractory Choriocarcinoma|Active, not recruiting||Phase 2|1|Actual|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||||2017-10-10 23:27:44.882925|2017-10-10 23:27:44.882925
NCT02396498|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-03-17|||April 2014||2014-04-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||SP Intravenous Chemotherapy Versus SP by HIPEC in Stage Ⅲ Patients After D2 Gastrectomy|S-1 With Cisplatin Intravenous Chemotherapy Versus S-1 Plus Cisplatin Hyperthermic Intraperitoneal Chemotherapy in Stage Ⅲ Patients After D2 Gastrectomy：a Randomized Controlled Study|Unknown status|Recruiting|Phase 3|270|Anticipated|Tang-Du Hospital||2|||f||||t||||||||||2017-10-10 23:27:44.972043|2017-10-10 23:27:44.972043
NCT02396485|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-18|||March 2014||2014-03-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Early Feeding After A Cesarean Delivery Hastens Recovery Time for Bowel Function|Early Versus Late Feeding After Cesarean Delivery: A Randomized Controlled Trial|Completed||N/A|177|Actual|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-10 23:27:45.09275|2017-10-10 23:27:45.09275
NCT02396472|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-30|||June 2016|Actual|2016-06-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Mental Health Pathways in Internet Support Groups|Internet Support Groups: Identifying and Improving Pathways for Mental Health|Recruiting||N/A|200|Anticipated|Carnegie Mellon University||5|||f||||f||||||||||2017-10-10 23:27:45.172129|2017-10-10 23:27:45.172129
NCT02396459|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2016-01-25|||July 2016||2016-07-01|January 2016|2016-01-01|December 2022|Anticipated|2022-12-01|July 2022|Anticipated|2022-07-01||Interventional|||Triac Trial II in MCT8 Patients|Effects of the Thyroid Hormone Analog Triac on the Neurocognitive Phenotype in Patients With Severe Psychomotor Retardation Caused by Mutations in the MCT8 Thyroid Hormone Transporter: The Triac Trial II|Not yet recruiting||Phase 2|30|Anticipated|Erasmus Medical Center||1|||f||||t||||||||||2017-10-10 23:27:45.271223|2017-10-10 23:27:45.271223
NCT02396446|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-08-24|||June 2017||2017-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||AbStats at the Bedside: Improving Patient Feeding Decisions Using an Abdominal Acoustic Score|AbStats at the Bedside: Improving Patient Feeding Decisions Using an Abdominal Acoustic Score|Not yet recruiting||N/A|50|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 23:27:45.379206|2017-10-10 23:27:45.379206
NCT02396433|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-08-21|||April 2015||2015-04-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers|Phase I/II Clinical Trial of the Combination of Carboplatin, Eribulin Mesylate, and E7449 in Patients With BRCA-Related Cancers|Withdrawn||Phase 1/Phase 2|0|Actual|The University of Texas Health Science Center at San Antonio||1||lack of funding.|f||||t||||||||||2017-10-10 23:27:45.456273|2017-10-10 23:27:45.456273
NCT02396420|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-07-12|||July 2015||2015-07-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|November 2016|Actual|2016-11-01||Interventional|||Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams|Phase II, Single Center, Single Arm, Open Label Investigation of Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams|Active, not recruiting||Phase 2|2|Actual|South Florida Medical Imaging, PA||1|||f||||f||||||||||2017-10-10 23:27:45.536205|2017-10-10 23:27:45.536205
NCT02396407|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health|Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health|Completed||N/A|1789|Actual|University of California, Berkeley||2|||f||||t||||||||||2017-10-10 23:27:45.635147|2017-10-10 23:27:45.635147
NCT02396394|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-04-07|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|March 2017|Actual|2017-03-01||Interventional|WiseMama||Improving ART Retention and Adherence in Uganda: The WiseMama Study|Improving ART Retention and Adherence in Uganda: The WiseMama Study|Active, not recruiting||N/A|165|Actual|Boston University||1|||f||||f|f|f||||||Undecided||2017-10-10 23:27:45.743465|2017-10-10 23:27:45.743465
NCT02396381|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-08-09|||March 12, 2015|Actual|2015-03-12|August 2017|2017-08-01|September 13, 2016|Actual|2016-09-13|September 13, 2016|Actual|2016-09-13||Interventional|||Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 Weeks|A Randomized, Controlled, 2-arm Parallel Group, Multi-center Study, to Evaluate Biological and Functional Changes in Healthy Smokers Switching to Tobacco Heating System 2.2 (THS 2.2) Compared to Continuing Smoking Conventional Cigarettes for 26 Weeks in an Ambulatory Setting|Completed||N/A|984|Actual|Philip Morris Products S.A.||2|||f||||f|f|f||||||||2017-10-10 23:27:45.84164|2017-10-10 23:27:45.84164
NCT02396368|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-11-17|||March 2015||2015-03-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|Radium-223||A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer|A Phase I/Ib Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer|Withdrawn||Phase 1|0|Actual|Sidney Kimmel Comprehensive Cancer Center||1||"Phase III study results for the drug Tesquinimod were not promising so it was a drug   development decision to stop using the drug"|f||||t||||||||||2017-10-10 23:27:45.960865|2017-10-10 23:27:45.960865
NCT02396342|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-02-02|||May 2015||2015-05-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B|A Phase I/II, Open-label, Uncontrolled, Single-dose, Dose-ascending, Multi-centre Trial Investigating an Adeno-associated Viral Vector Containing a Codon-optimized Human Factor IX Gene (AAV5-hFIX) Administered to Adult Patients With Severe or Moderately Severe Hemophilia B|Active, not recruiting||Phase 1/Phase 2|10|Anticipated|UniQure Biopharma B.V.||2|||f||||t||||||||No||2017-10-10 23:27:46.128415|2017-10-10 23:27:46.128415
NCT02396329|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-03-23|||June 2014||2014-06-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Chlorhexidine Versus Povidone-Iodine Antisepsis for Reduction of Post Cesarean Section Surgical Site Infection|Chlorhexidine Versus Povidone-iodine Antisepsis for Reduction of Post Cesarean Section Surgical Site Infection Rate:a Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|410|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 23:27:46.232014|2017-10-10 23:27:46.232014
NCT02396316|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-08-17|2017-06-15||April 2, 2015|Actual|2015-04-02|August 2017|2017-08-01|September 6, 2016|Actual|2016-09-06|June 16, 2016|Actual|2016-06-16||Interventional|VEGA||Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients|A Randomized, Double-masked, and Controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravitreal Administration of Aflibercept in Japanese Patients With Neovascular Glaucoma|Completed||Phase 3|54|Actual|Bayer||2|||f||||f|t|f|||t|||||2017-10-10 23:27:46.322424|2017-10-10 23:27:46.322424
NCT02396303|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2015-03-23|||June 2015||2015-06-01|March 2015|2015-03-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage||Unknown status|Not yet recruiting|Early Phase 1|100|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||t||||||||||2017-10-10 23:27:46.819355|2017-10-10 23:27:46.819355
NCT02396290|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-17|||March 2013||2013-03-01|July 2013|2013-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Clinical Effect of Platelet Rich Plasma Combined With Laser on Scar|Clinical Study on Efficacy and Safety of Platelet Rich Plasma Combined With Laser for Scar Treatment|Completed||N/A|29|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:27:46.910551|2017-10-10 23:27:46.910551
NCT02396277|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-23|||March 2015||2015-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|NRP||Structural and Functional Nerve Changes Following Immobilisation After Distal Radius Fracture - a Pilot Study (NRP)|Structural and Functional Nerve Changes Following Immobilisation After Distal Radius Fracture - a Pilot Study (NRP)|Unknown status|Not yet recruiting|N/A|6|Anticipated|University of Tromso|||1||f||||f||||||||||2017-10-10 23:27:46.992798|2017-10-10 23:27:46.992798
NCT02396264|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2016-04-18|||June 2015||2015-06-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Mediterranean Diet as Treatment for Normal Weight Women With PCOS|Mediterranean Diet: A New Nutritional Approach for the Treatment of Normal Weight Women With Polycystic Ovary Syndrome (PCOS)?|Recruiting||N/A|100|Anticipated|Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona||2|||f||||f||||||||||2017-10-10 23:27:47.06791|2017-10-10 23:27:47.06791
NCT02396251|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-02-07|||February 2015||2015-02-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2016|Actual|2016-12-01||Interventional|||Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation||Active, not recruiting||N/A|72|Anticipated|Q-Med AB||2|||f||||f||||||||||2017-10-10 23:27:47.156129|2017-10-10 23:27:47.156129
NCT02396238|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-06-07|||July 2015||2015-07-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|STAR||Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)|Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR): A Randomized, Double-Blind, Placebo-Controlled Trial With Incomplete Crossover|Active, not recruiting||N/A|88|Actual|Cytori Therapeutics||2|||f||||t||||||||No||2017-10-10 23:27:47.231862|2017-10-10 23:27:47.231862
NCT02396225|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-05-08|||March 2015||2015-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration||Terminated||N/A|12|Actual|University of Aarhus||2||"results obtained at interrim analysis after 12 patients would not be changed by recruiting   another twelwe participants"|f||||t||||||||||2017-10-10 23:27:47.359355|2017-10-10 23:27:47.359355
NCT02396212|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-09-27|||May 2015||2015-05-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA|An Open-label, Single-arm, Active-treatment, Efficacy and Safety Study of Canakinumab (ACZ885) Administered for at Least 48 Weeks in Japanese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)|Active, not recruiting||Phase 3|19|Actual|Novartis||1|||f||||f||||||||||2017-10-10 23:27:47.433948|2017-10-10 23:27:47.433948
NCT02396199|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-02-14|||August 2015||2015-08-01|September 2016|2016-09-01|November 2024|Anticipated|2024-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Zenith® p-Branch® Endovascular Graft Pivotal Study|Zenith® p-Branch® Pivotal Study|Recruiting||N/A|82|Anticipated|Cook Group Incorporated||1|||f||||||||||||||2017-10-10 23:27:47.527585|2017-10-10 23:27:47.527585
NCT02396186|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-04-12|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Days|Observational [Patient Registry]|ANTELOPE||An Assessment of the Glider Balloon in Complex Lesions|An Assessment of the Glider Balloon in Complex Lesions|Recruiting||N/A|500|Anticipated|TriReme Medical, LLC|||1||f||||f||||||||||2017-10-10 23:27:47.67876|2017-10-10 23:27:47.67876
NCT02396173|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-27|||March 2015||2015-03-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|WORRK||"Does the Knowledge of a Non-return to Work Predictive Score Influence Vocational Rehabilitation?"|"Does the Knowledge of a Non-return to Work Predictive Score Influence Vocational Rehabilitation After Orthopaedic Trauma?"|Recruiting||N/A|280|Anticipated|Clinique Romande de Readaptation||2|||f||||t||||||||||2017-10-10 23:27:47.770339|2017-10-10 23:27:47.770339
NCT02395991|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|October 2016|Actual|2016-10-01||Observational|||Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI|Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI|Active, not recruiting||N/A|60|Actual|Seoul National University Hospital|||1||f||||t||||||||No||2017-10-10 23:27:50.453249|2017-10-10 23:27:50.453249
NCT02396160|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-04-03|2015-12-22||August 2013||2013-08-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional||This data includes all those who met criteria (minimum of 2 of the following symptoms per day for 6 months - Urinary Day Frequency ≥10 daytime micturitions; Nocturia ≥2 night time micturitions; Urinary Urgency ≥2 episodes and/or Incontinence ≥1 episode) and were entered into randomisation at the commencement of their enrollment into the study|The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary Incontinence|The Effect of Urox™(Crateva, Horsetail and Lindera Combination) in the Treatment of Overactive Bladder and Urinary Incontinence|Completed||N/A|150|Actual|The University of Queensland|Limitations of this study include the relatively short duration and lack of long-term follow up. As a phase 2 clinical trial, there was no active comparator and a smaller sample size was also utilized.|2|||f||||t||||||||No|As data was analysed de-identified, it is not possible to have individual participant data available associated with their name and details.|2017-10-10 23:27:47.871146|2017-10-10 23:27:47.871146
NCT02396147|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-06-09|2016-06-09||March 2015||2015-03-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional||Safety population: all participants who received at least 1 dose of study drug.|Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants|A Phase 1, Open-Label, Randomized, Three-Way Crossover Study Evaluating the Relative Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Subjects|Completed||Phase 1|54|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:27:48.312953|2017-10-10 23:27:48.312953
NCT02396134|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-07-27|||May 21, 2015|Actual|2015-05-21|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant|A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant|Recruiting||Phase 2|96|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-10 23:27:49.269462|2017-10-10 23:27:49.269462
NCT02396121|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-03-17|||November 2012||2012-11-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|Reboot||Micronutrient and Malnourished Elderly|Évaluation de l'évolution du Statut Nutritionnel en Micronutriment Chez Les Patients âgés dénutris bénéficiant d'Une complémentation Nutritionnelle Orale|Completed||N/A|67|Actual|Nestlé||1|||f||||f||||||||||2017-10-10 23:27:49.384859|2017-10-10 23:27:49.384859
NCT02396108|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2017-02-02|||March 2015||2015-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer|Phase Ib Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by an Open-label Phase II Study in Patients With Stage I-III HER2 Positive Breast Cancer|Recruiting||Phase 1/Phase 2|55|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-10 23:27:49.438336|2017-10-10 23:27:49.438336
NCT02396095|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-17|||August 2008||2008-08-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Oocyte Cryopreservation Study (Egg Banking)|Live Birthrate Following Oocyte Cryopreservation|Terminated||N/A|24|Actual|University of Pennsylvania|||1|American Society of Reproductive Medicine guidelines, October 2012.|f||||f||||||Samples Without DNA|"     oocytes   "|||2017-10-10 23:27:49.515541|2017-10-10 23:27:49.515541
NCT02396082|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-03-16|||August 2014||2014-08-01|March 2016|2016-03-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|MIND at Home||MIND: Care Coordination for Community-living Person With Dementia|MIND: An RCT of Care Coordination for Community-living Person With Dementia|Recruiting||Phase 3|300|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:27:49.574886|2017-10-10 23:27:49.574886
NCT02396069|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-06-23|||March 2015||2015-03-01|March 2015|2015-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers|A Phase I Clinical Study, Randomized, Double-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers.|Completed||Phase 1|24|Actual|Jeil Pharmaceutical Co., Ltd.||2|||f||||t||||||||No||2017-10-10 23:27:49.808443|2017-10-10 23:27:49.808443
NCT02396056|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-10-13|||December 2014||2014-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Enhancing Guided Bone Regeneration by Modifying a Resorbable Membrane|Enhanced Guided Bone Regeneration in Localized Osseous Alveolar Defects by Using a Novel Perforated Resorbable Barrier Membrane|Recruiting||N/A|10|Anticipated|Stony Brook University||2|||f||||t||||||||||2017-10-10 23:27:49.888462|2017-10-10 23:27:49.888462
NCT02396030|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-12-19|||March 2015||2015-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|MGSO4||Different Schemes of Magnesium Sulfate for Preeclampsia|Effectiveness and Safety of 1g/Hour vs. 2g/Hour of Magnesium Sulfate Maintenance Dose for Eclampsia Prevention: Randomized Clinical Trial|Terminated||Phase 4|62|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2||"After recommendation because of the impossibility to end study with 1 center only. Outcomes of   patients already included will be evaluated."|f||||t||||||||||2017-10-10 23:27:50.138471|2017-10-10 23:27:50.138471
NCT02396017|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-03-23|||March 2015||2015-03-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Split-dose Versus Single-dose Polyethylene Glycol Regimen for Capsule Endoscopy|Split-dose Versus Single-dose Polyethylene Glycol Regimen for Capsule Endoscopy Is Timing of Preparation for Capsule Endoscopy the Key for the Best Small-bowel Cleansing?|Unknown status|Recruiting|Phase 4|50|Anticipated|Centro Hospitalar Lisboa Ocidental||2|||f||||t||||||||||2017-10-10 23:27:50.251827|2017-10-10 23:27:50.251827
NCT02395978|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-04-12|||March 2015||2015-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder||Recruiting||Phase 2|100|Anticipated|BioLite, Inc.||3|||f||||f||||||||||2017-10-10 23:27:50.540414|2017-10-10 23:27:50.540414
NCT02395965|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-03-18|||July 2011||2011-07-01|January 2014|2014-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||OMM Utilization in the Clinical Setting|Use and Effectiveness of Osteopathic Manipulative Medicine (OMM) in the Clinical Setting|Completed||N/A|1960|Actual|A.T. Still University of Health Sciences|||1||f||||f||||||||||2017-10-10 23:27:50.662395|2017-10-10 23:27:50.662395
NCT02395952|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-09-12|||March 2015||2015-03-01|September 2016|2016-09-01||||February 2018|Anticipated|2018-02-01||Interventional|||Healing of Persistent Epithelial Defects|Comparison of Standard of Care Treatments for Post-operative Non-healing Epithelial Defects|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center||4||No patients recruited|f||||f||||||||||2017-10-10 23:27:50.780507|2017-10-10 23:27:50.780507
NCT02395939|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-10-09|||July 2015||2015-07-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CT-CROP||Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL|Randomised Controlled Trial Comparing the Diagnostic Yield of Radial Endo-Bronchial Ultra-Sound (R-EBUS) Guided Cryo-biopsy Vs. CT-guided Transthoracic Biopsy in Patients With Parenchymal Lung Lesion, Suspected of Lung Cancer (CT-CROP)|Recruiting||Phase 3|158|Anticipated|Middlemore Hospital, New Zealand||2|||f||||t||||||||||2017-10-10 23:27:50.879022|2017-10-10 23:27:50.879022
NCT02395926|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-03-23|||October 2013||2013-10-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers||Completed||Phase 1|24|Actual|Hyundai Pharmaceutical Co., LTD.||3|||f||||||||||||||2017-10-10 23:27:50.999481|2017-10-10 23:27:50.999481
NCT02395913|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-03-17|||July 2013||2013-07-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)||Completed||Phase 1|72|Actual|Hyundai Pharmaceutical Co., LTD.||4|||f||||f||||||||||2017-10-10 23:27:51.078395|2017-10-10 23:27:51.078395
NCT02395900|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2016-03-21|||March 2014||2014-03-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease|The Effects of Flaxseed Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease|Completed||Phase 2/Phase 3|50|Actual|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-10 23:27:51.15457|2017-10-10 23:27:51.15457
NCT02395887|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-24|||April 2015||2015-04-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Observational|||Postural Balance and Stability Among Patients With Cervical and Back Pain|Postural Balance and Stability Among Patients With Cervical and Back Pain|Unknown status|Not yet recruiting|N/A|80|Anticipated|Meir Medical Center|||2||f||||f||||||||||2017-10-10 23:27:51.236203|2017-10-10 23:27:51.236203
NCT02395874|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-09-12|||May 2015||2015-05-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|MP-LOGA||tDCS and Speech Therapy to Improve Aphasia|MP-LoGa: Bi-hemispheral Transcranial Direct Current Stimulation to Improve the Severe Aphasia in Subacute Stroke Patients: a Randomized, Placebo-controlled, Double Blinded Multi-center Trial|Recruiting||N/A|96|Anticipated|Medical Park AG||2|||f||||t||||||||||2017-10-10 23:27:51.308189|2017-10-10 23:27:51.308189
NCT02395861|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-11-18|||July 2015||2015-07-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|PRORETRO||Prognosis of Brain Reflexes|Evaluation of the Clinical and Electrophysiological Responses of the Brainstem in Patients With Alteration of Consciousness in Relation or Not With Sedation: Prognostic Study of Brain Reflexes|Recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:27:51.413261|2017-10-10 23:27:51.413261
NCT02395848|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-09-12|||July 2015||2015-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection|Prospective, Open-label Trial to Evaluate Efficacy of 30-day Duration of Fidaxomicin in Patients With Recurrent C. Difficile Infection|Active, not recruiting||Phase 3|50|Anticipated|McMaster University||1|||f||||t||||||||||2017-10-10 23:27:51.481385|2017-10-10 23:27:51.481385
NCT02395835|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-17|||September 2009||2009-09-01|March 2015|2015-03-01|March 2011|Actual|2011-03-01|August 2010|Actual|2010-08-01|1 Year|Observational [Patient Registry]|||Methylation of the PPARg Promoter Region in Pregnancy|Methylation Evaluation of the PPARg Promoter Region (-351 to -260) in Pregnancy|Completed||N/A|41|Actual|Materno-Perinatal Hospital of the State of Mexico|||2||f||||f||||||Samples With DNA|"     Leukocytes were obtained according to the ACK-lysing buffer (LONZA) protocol. Briefly, a     peripheral blood sample was placed in EDTA tube and then centrifuged at 2500 rpm for 10 min.     All samples were kept at -80°C until further analysis.      DNA was extracted from leukocytes (4000-10,000 cells) in the MagnaPure (Roche) using the     MagNAPure LC DNA Isolation Kit 1 (Roche, Germany).   "|||2017-10-10 23:27:51.565374|2017-10-10 23:27:51.565374
NCT02395822|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-08-23|||October 1, 2015|Actual|2015-10-01|August 2017|2017-08-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients|MT2014-25: Haploidentical Donor Natural Killer (NK) Cell Infusion With Subcutaneous Recombinant Human IL-15 (rhIL-15) in Adults With Refractory or Relapsed Acute Myelogenous Leukemia (AML)|Completed||Phase 2|17|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-10 23:27:51.629172|2017-10-10 23:27:51.629172
NCT02395809|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-17|||July 2012||2012-07-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Transcutaneous Posterior Tibial Nerve Stimulation for Treatment of Chronic Anal Fissure|Randomized Clinical Trial of Transcutaneous Electrical Posterior Tibial Nerve Stimulation Versus Lateral Internal Sphincterotomy for Treatment of Chronic Anal Fissure.|Completed||N/A|94|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:27:51.709918|2017-10-10 23:27:51.709918
NCT02395796|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-02-24|||July 2015||2015-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pulsatile Pressure Waveform to Confirm Correct Placement of the Epidural in Laboring Patients|Efficacy of the Presence of a Pulsatile Pressure Waveform to Confirm Correct Placement of the Epidural Needle and Catheter in Laboring Pregnant Patients: a Feasibility Study|Terminated||N/A|15|Actual|Lawson Health Research Institute||1||Negative results were obtained in all subjects that were analyzed (n=10)|f||||f||||||||No||2017-10-10 23:27:51.789978|2017-10-10 23:27:51.789978
NCT02395783|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-08-12|||March 2015||2015-03-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PREMELIP||Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease|Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease in Very Preterm Infants|Recruiting||Phase 2/Phase 3|60|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 23:27:51.870869|2017-10-10 23:27:51.870869
NCT02395770|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-17|||June 2013||2013-06-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|MTforSPS||Effects of a Movement Training for Subacromial Pain Syndrome|Effects of a Movement Training Oriented Rehabilitation Program on Symptoms, Functional Limitations and Acromiohumeral Distance in Individuals With Subacromial Pain Syndrome|Completed||N/A|29|Actual|Laval University||1|||f||||f||||||||||2017-10-10 23:27:51.971186|2017-10-10 23:27:51.971186
NCT02395757|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-10-04|||September 2015||2015-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|PREVISION||Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)|Assessment Using Microperimetry of the Risk of a Fellow Eye Progressing From Stage 3 to Stage 4 (AREDS Classification) Age-related Macular Degeneration (AMD)|Recruiting||N/A|300|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:27:52.046987|2017-10-10 23:27:52.046987
NCT02395744|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-02-24|||March 11, 2015|Actual|2015-03-11|February 2017|2017-02-01|February 23, 2017|Actual|2017-02-23|August 15, 2016|Actual|2016-08-15||Interventional|COPPER-B||The COPPER-B Trial|The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Below the Knee|Completed||N/A|11|Actual|Horizons International Peripheral Group||1|||f||||f||||||||||2017-10-10 23:27:52.123192|2017-10-10 23:27:52.123192
NCT02395731|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-03-16|||March 2015||2015-03-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comprehensive Home-based Dementia Care Coordination for Medicare-Medicaid Dual Eligibles in Maryland|Comprehensive Home-based Dementia Care Coordination for Medicare-Medicaid Dual Eligibles in Maryland|Recruiting||N/A|600|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 23:27:52.203286|2017-10-10 23:27:52.203286
NCT02395718|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-02-02|||January 2015||2015-01-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ELDER||Acute Medical Admissions of ELDERly Patients (ELDER)|Acute Medical Admission of ELDERly Patients (≥75yrs) to Either Fast Track or Traditional Inward Hospitalisation. A Randomised Controlled Trial|Completed||N/A|430|Actual|Holbaek Sygehus||2|||f||||t||||||||||2017-10-10 23:27:52.306251|2017-10-10 23:27:52.306251
NCT02395705|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-07-09|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|||Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma|A Phase III, Multicenter Randomized Controlled Study of Neo-adjuvant Chemotherapy Paclitaxel + Cisplatin Versus Surgery Alone for Stage IIA-IIIB Esophageal Squamous Cell Carcinoma|Recruiting||Phase 3|528|Anticipated|Henan Cancer Hospital||2|||f||||t||||||||||2017-10-10 23:27:52.394884|2017-10-10 23:27:52.394884
NCT02395692|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-23|2017-09-12|||December 18, 2015|Actual|2015-12-18|September 2017|2017-09-01||||March 31, 2018|Anticipated|2018-03-31||Interventional|||Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma|Phase II Study of TRC102 in Combination With Temozolomide for Recurrent Glioblastoma|Active, not recruiting||Phase 2|66|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-10 23:27:52.538121|2017-10-10 23:27:52.538121
NCT02395679|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-03-17|||January 2015||2015-01-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|MesoCancerVa||Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients|A Phase I Study on Dendritic Cells Loaded With Allogeneous Cell Lysate in Patients With Mesothelioma as Maintenance Treatment After Chemotherapy|Unknown status|Recruiting|Phase 1|9|Anticipated|Erasmus Medical Center||1|||f||||t||||||||||2017-10-10 23:27:52.642834|2017-10-10 23:27:52.642834
NCT02395666|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-04-25|||March 2015||2015-03-01|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission|A Phase II Preventative Trial of DFMO (Eflornithine HCl) as a Single Agent in Patients With High Risk Neuroblastoma in Remission|Active, not recruiting||Phase 2|142|Actual|Spectrum Health Hospitals||1|||f||||t||||||||||2017-10-10 23:27:52.724378|2017-10-10 23:27:52.724378
NCT02395653|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-08-16|2017-08-16||June 29, 2015|Actual|2015-06-29|August 2017|2017-08-01|September 12, 2016|Actual|2016-09-12|September 12, 2016|Actual|2016-09-12||Interventional||The Safety Population included all participants who received ≥1 dose of fentanyl from the SSEC.|Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants|An Open Label Evaluation of the Safety and Clinical Utility of the Active, Separated System With Enhanced Controller (SSEC) Fentanyl 40 mcg for the Management of Acute Postoperative Pain in Pediatric Patients 12 to Less Than 18 Years of Age|Completed||Phase 3|71|Actual|The Medicines Company||1|||f||||f|t|f||||||||2017-10-10 23:27:52.838809|2017-10-10 23:27:52.838809
NCT02395640|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-17|||March 2015||2015-03-01|March 2015|2015-03-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer|The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer: An Open-label, Multi-center, Prospective and Randomised Study|Recruiting||Phase 3|438|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 23:27:53.111281|2017-10-10 23:27:53.111281
NCT02395627|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-02-14|||March 2015||2015-03-01|February 2017|2017-02-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||Reversing Therapy Resistance With Epigenetic-Immune Modification|Reversing Therapy Resistance With Epigenetic-immune Modification: Phase II Trial of Vorinostat, Tamoxifen and Pembrolizumab in Hormone Receptor Expressing Advanced Breast Cancer|Recruiting||Phase 2|87|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-10 23:27:53.216203|2017-10-10 23:27:53.216203
NCT02395614|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-06-26|||December 2015||2015-12-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation|Incidence of Surgical Site Infection After Irrigation of Surgical Pocket With 0.05% Chlorhexidine Compared to Triple Antibiotic Solution in Post-mastectomy Breast Reconstruction|Recruiting||N/A|60|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-10 23:27:53.309433|2017-10-10 23:27:53.309433
NCT02395601|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-11-22|||March 2015||2015-03-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas|A Phase 1 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, in Patients With B-Cell Lymphomas|Recruiting||Phase 1|41|Anticipated|Constellation Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:27:53.54713|2017-10-10 23:27:53.54713
NCT02395588|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-09-22|||April 2014||2014-04-01|September 2017|2017-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|IHO Rural||Improving Heart Failure Outcomes Rural|Improving Heart Failure Outcomes (IHO)|Completed||N/A|26|Actual|University of Maryland|||1||f||||f||||||||||2017-10-10 23:27:53.692451|2017-10-10 23:27:53.692451
NCT02395562|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-07-11|||January 2008||2008-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|||Viral Reactivation and Skin Cancer|Association of Viral Reactivation and Skin Cancer in Organ Transplant Recipients|Completed||N/A|1200|Actual|University of Zurich|||1||f||||f||||||||Yes|shared with Swiss Transplant Cohort Study. Future projects can obtain data after having a project request approved.|2017-10-10 23:27:53.854834|2017-10-10 23:27:53.854834
NCT02395549|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-06-14|||April 2015||2015-04-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris||Active, not recruiting||Phase 2|364|Actual|Mimetica Pty Limited||4|||f||||||||||||||2017-10-10 23:27:53.934811|2017-10-10 23:27:53.934811
NCT02395536|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-05-09|2017-05-09||March 30, 2015|Actual|2015-03-30|May 2017|2017-05-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Interventional|RIO 2|The baseline analysis population is the number of randomized subjects that had a REVEAL LINQ insertion attempt|Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States|Reveal LINQ™ In-Office 2 (RIO 2) Study United States|Completed||N/A|525|Actual|Medtronic Cardiac Rhythm and Heart Failure|It was not possible to blind either the subject or implanting physician. The study exit rate after randomization but prior to REVEAL LINQ procedure was relatively high, but not unexpected given randomization needed to occur prior to the procedure.|2|||f||||f||||||||No||2017-10-10 23:27:54.119291|2017-10-10 23:27:54.119291
NCT02395523|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-10-05|||March 2015||2015-03-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma|A Phase II Study Using Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|45|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-10-10 23:27:54.677715|2017-10-10 23:27:54.677715
NCT02395510|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-07-22|||May 2015||2015-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder|A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With Panic Disorder|Completed||Phase 4|27|Actual|Siyan Clinical Corporation||1|||f||||f||||||||||2017-10-10 23:27:54.778081|2017-10-10 23:27:54.778081
NCT02395497|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-10-03|||June 2014|Actual|2014-06-01|October 2017|2017-10-01|June 2024|Anticipated|2024-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Human Penile Allotransplantation|Human Penile Allotransplantation|Recruiting||Phase 2/Phase 3|60|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 23:27:54.861893|2017-10-10 23:27:54.861893
NCT02395484|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-05-01|||March 2015||2015-03-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Observational|||Metagenome Analysis of Gut Microbiota in CC Patients|Species and Metagenome Analysis of Gut Microbiota in Chronic Constipation Patients|Unknown status|Recruiting|N/A|50|Anticipated|Jinling Hospital, China|||2||f||||t||||||||||2017-10-10 23:27:54.978126|2017-10-10 23:27:54.978126
NCT02395471|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-01-31|||August 2015||2015-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|CASEII||Cytosponge Adequacy Study Evaluation II|Assessment of a Minimally Invasive Esophageal Cytology Collection System in Patients With Barrett's Esophagus or GERD Symptoms|Recruiting||N/A|175|Anticipated|Medtronic - MITG|||2||f||||f||||||Samples With DNA|"     Tissue samples will be retained at the clinical sites   "|||2017-10-10 23:27:55.062658|2017-10-10 23:27:55.062658
NCT02395458|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-17|||March 2013||2013-03-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens|Efficacy on Helicobacter Pylori Eradication With Sequential Antibiotic Compared to Triple Therapy for 14 Days|Completed||Phase 4|142|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||||2017-10-10 23:27:55.176101|2017-10-10 23:27:55.176101
NCT02395445|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-11-04|||September 2015||2015-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Routine Airway Management|A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Routine Airway Management: a Randomised, Controlled Clinical Trial|Completed||N/A|205|Actual|Complexo Hospitalario Universitario de A Coruña||2|||f||||f||||||||||2017-10-10 23:27:55.266729|2017-10-10 23:27:55.266729
NCT02395432|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-10-11|||September 2015||2015-09-01|October 2016|2016-10-01||||October 2016|Actual|2016-10-01||Interventional|||A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Difficult Airway|A Comparison of Tracheal Intubation Using the Totaltrack vs the Macintosh Laryngoscope in Difficult Airway: a Randomised, Controlled Clinical Trial|Completed||N/A|133|Actual|Complexo Hospitalario Universitario de A Coruña||2|||f||||f||||||||||2017-10-10 23:27:55.353692|2017-10-10 23:27:55.353692
NCT02395419|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-10-13|||October 2016||2016-10-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Interventional|||A Comparison of Tracheal Intubation Using the Totaltrack vs the Airtraq Laryngoscope in Routine Airway Management||Recruiting||N/A|48|Anticipated|Complexo Hospitalario Universitario de A Coruña||2|||f||||f||||||||||2017-10-10 23:27:55.444075|2017-10-10 23:27:55.444075
NCT02395406|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-10-18|||October 2016||2016-10-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Interventional|||A Comparison of Tracheal Intubation Using the Totaltrack vs the Airtraq Laryngoscope in Difficult Airway Management||Recruiting||N/A|48|Anticipated|Complexo Hospitalario Universitario de A Coruña||2|||f||||f||||||||||2017-10-10 23:27:55.527082|2017-10-10 23:27:55.527082
NCT02395393|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-07-19|||October 1, 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation|Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation|Not yet recruiting||N/A|20|Anticipated|Boston Children’s Hospital||1|||f||||t|f|f||||||||2017-10-10 23:27:55.614018|2017-10-10 23:27:55.614018
NCT02395380|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-06-16|||July 6, 2015|Actual|2015-07-06|June 2017|2017-06-01|June 13, 2017|Actual|2017-06-13|March 11, 2017|Actual|2017-03-11||Interventional|CRP-Track||Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection (CRP-Track)|Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection|Completed||N/A|176|Actual|Centre Hospitalier Departemental Vendee||1|||f||||t||||||||||2017-10-10 23:27:55.684724|2017-10-10 23:27:55.684724
NCT02395367|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-09-28|||March 2015||2015-03-01|September 2017|2017-09-01|March 2025|Anticipated|2025-03-01|March 2025|Anticipated|2025-03-01|5 Years|Observational [Patient Registry]|||A Prospective, Observational, Real-world Study Based on the Register System of Oral and Maxillofacial Malignant Tumors|A Prospective, Observational, Real-world Study Based on the Register System of Oral and Maxillofacial Malignant Tumors.|Recruiting||N/A|1000|Anticipated|Beijing Stomatology Hospital|||1||f||||||||||Samples With DNA|"     Investigators plan to retrieve the fresh and paraffin-embedded tissue specimens after primary     tumors are resected from the biobank in Department of Oral and Maxillofacial-Head and Neck     Oncology, Beijing Stomatological Hospital, Capital Medical University during the whole study     phase. The total number of fresh and paraffin-embedded tissue specimens are approximately     1000. Specimen types include non-cancerous matched tissues and cancer tissues. These     specimens will be used to complete the analysis of genetics and epigenetics in the further     study.   "|||2017-10-10 23:27:55.749809|2017-10-10 23:27:55.749809
NCT02395354|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-04-13|||September 2013||2013-09-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Interventional|||PROTDILAT (PROtesis DILATation)|Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease: Metal Self-expanding Prosthesis Balloon Dilatation|Recruiting||N/A|122|Anticipated|Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa||2|||f||||f||||||||||2017-10-10 23:27:55.835589|2017-10-10 23:27:55.835589
NCT02395341|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-08-19|||May 2007||2007-05-01|August 2016|2016-08-01|April 2013|Actual|2013-04-01|February 2009|Actual|2009-02-01||Observational|||The Longitudinal Ovarian Reserve Study|The Effects of Cancer Treatment on Ovarian Function: A Longitudinal Study by the Oncofertility Consortium|Completed||N/A|20|Actual|University of Pennsylvania|||1||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-10 23:27:55.94261|2017-10-10 23:27:55.94261
NCT02395328|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-03-10|||June 2014||2014-06-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Home Visiting for OVC in Tshwane Townships of South Africa|The Impact of Future's Families Orphans and Vulnerable Children Home Visiting Program in Tshwane Townships of South Africa|Completed||N/A|481|Actual|Tulane University||2|||f||||f||||||||Undecided||2017-10-10 23:27:56.008537|2017-10-10 23:27:56.008537
NCT02395315|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-08-23|||December 2015|Actual|2015-12-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|ABCD||Alveolar Bone Changes in Diabetes (ABCD) Study|Placement of Hydrophilic TiZr Implants to Enhance Implant Survival in Diabetic Patients: A Prospective, Two-arm, Cohort Study|Recruiting||N/A|42|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||||||2017-10-10 23:27:56.079586|2017-10-10 23:27:56.079586
NCT02395302|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-02-23|2017-01-03||December 2014||2014-12-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional||Demographic information for 27 of the 28 study subjects was collected. One study subject was withdrawn from the study before demographic information was collected.|Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)|Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort in Patients With Venous Leg Ulcers|Completed||N/A|28|Actual|Tactile Medical||1|||f||||f||||||||No||2017-10-10 23:27:56.210101|2017-10-10 23:27:56.210101
NCT02395289|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-01-30|||March 2016||2016-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Cognitive-Based Compassion Training (CBCT) for People Living With HIV (PLHIV)|The Efficacy of Cognitive-Based Compassion Training for Enhancing Immune Restoration and Psychological Adaptation in Individuals Living With HIV Disease|Completed||N/A|54|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:27:56.400354|2017-10-10 23:27:56.400354
NCT02395276|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-21|||April 2015||2015-04-01|March 2015|2015-03-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Interventional|Coolheart||Hypothermia Therapy in Pediatric Cardiac Intensive Care Unit for Suspected for Brain Injury|Efficacy of Hypothermia Therapy in Pediatric Cardiac Intensive Care Unit in Children Suspected for Brain Injury|Not yet recruiting||N/A|75|Anticipated|Sheba Medical Center||3|||f||||t||||||||||2017-10-10 23:27:56.480799|2017-10-10 23:27:56.480799
NCT02395263|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-20|||March 2015||2015-03-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison of Yuxintine With Placebo in Treatment of MDD|Proof Of Concept Study of Yuxintine in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial|Unknown status|Not yet recruiting|Phase 2|160|Anticipated|Shanghai Mental Health Center||4|||f||||t||||||||||2017-10-10 23:27:56.565999|2017-10-10 23:27:56.565999
NCT02395250|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-04-25|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Anti-GPC3 CAR T for Treating Patients With Advanced HCC|Autologous T Cells Redirected to GPC3 for Treating Patients With Advanced HCC|Terminated||Phase 1|13|Actual|RenJi Hospital||1||For reason NOT related to safety, efficacy, feasibility, or funding issues.|f||||f||||||||No||2017-10-10 23:27:56.677123|2017-10-10 23:27:56.677123
NCT02394509|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-02-06|||March 2015||2015-03-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||HOBSCOTCH Phase II|HOBSCOTCH Phase II: A Pragmatic Study of HOBSCOTCH in New England.|Recruiting||N/A|88|Anticipated|Dartmouth-Hitchcock Medical Center||3|||f||||f||||||||||2017-10-10 23:28:07.505654|2017-10-10 23:28:07.505654
NCT02395237|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2015-03-20|||April 2015||2015-04-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.|An Open-label, Randomized, Two-treatment Crossover Bioequivalence Study Comparing Two Batches of the Same Fixed Dose Combinations Amaryl® M IR 2/1000 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.|Unknown status|Not yet recruiting|Phase 1|50|Anticipated|Pharmaceutical Research Unit, Jordan||2|||f||||f||||||||||2017-10-10 23:27:56.740795|2017-10-10 23:27:56.740795
NCT02395211|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-02-02|||January 2015||2015-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Proprioceptive Stimulation Under Visual Feedback in Patient With CRPS|Effects of Proprioceptive Stimulation Under Visual Feedback in Patient With CRPS: An Exploratory Study|Recruiting||N/A|20|Anticipated|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-10 23:27:58.73441|2017-10-10 23:27:58.73441
NCT02395198|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-05-29|||August 2014||2014-08-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|April 2017|Actual|2017-04-01|12 Months|Observational [Patient Registry]|ECHO||Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients|Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients: Factors Influencing Treatment Initiation and Seroconversion|Active, not recruiting||N/A|2467|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||Undecided||2017-10-10 23:27:58.847824|2017-10-10 23:27:58.847824
NCT02395172|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-09-21|||March 31, 2015|Actual|2015-03-31|September 2017|2017-09-01|January 31, 2023|Anticipated|2023-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)|A Phase III Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Docetaxel in Subjects With Non-small Cell Lung Cancer That Has Progressed After a Platinum-containing Doublet|Active, not recruiting||Phase 3|795|Actual|EMD Serono||2|||f||||t||||||||||2017-10-10 23:27:59.099929|2017-10-10 23:27:59.099929
NCT02395159|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-07-03|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|IMS||Reduction of Groin Wound Infections After Vascular Surgery by Using an Incision Management System (IMS)|Reduction of Groin Wound Infections After Vascular Surgery in Patients With Risk Factors by the Use a Negative Pressure Wound Incision Management System (KCI Prevena)|Active, not recruiting||N/A|204|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-10 23:27:59.823857|2017-10-10 23:27:59.823857
NCT02395146|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-04-10|||August 2015||2015-08-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Neural Monitoring of the Superior Laryngeal Nerve in Thyroid Surgery|Intra-operative Monitoring of the External Branch of the Superior Laryngeal Nerve (EBSLN) During Thyroid Surgery: Does it Improve Voice Preservation?|Recruiting||N/A|60|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 23:27:59.91385|2017-10-10 23:27:59.91385
NCT02395133|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-01|||March 2015||2015-03-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|SOLO-Continue||A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Multiple Dupilumab Dose Regimens Administered as Monotherapy for Maintaining Treatment Response in Patients With Atopic Dermatitis|Completed||Phase 3|475|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:27:59.993729|2017-10-10 23:27:59.993729
NCT02395120|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2016-02-08|||August 2015||2015-08-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|FADS||Family Access to Dentist Study|Family Intervention With Caregivers of Children With Dental Needs|Active, not recruiting||N/A|402|Actual|Case Western Reserve University||5|||f||||t||||||||No||2017-10-10 23:28:00.08461|2017-10-10 23:28:00.08461
NCT02395107|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-09-26|||January 2014||2014-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|LAVIAS||Left Atrial Volume Index in Asymptomatic Aortic Stenosis|Left Atrial Volume Index - Impact on LV Remodeling, LV Function and Functional Capacity in Asymptomatic Aortic Valve Stenosis|Completed||N/A|100|Actual|Odense University Hospital|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 23:28:00.180923|2017-10-10 23:28:00.180923
NCT02395094|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-06-28|||April 2015||2015-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|ChildLife||Study to Examine the Effects of Child Life Interventions on Children's Anxiety Levels at Induction of Anesthesia|Study to Examine the Effects of Child Life Interventions on Children's Anxiety Levels at Induction of Anesthesia|Completed||N/A|72|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:28:00.260769|2017-10-10 23:28:00.260769
NCT02395081|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-01-18|||February 2015||2015-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Trial of Vitamin D Supplements to Raise Calcidiol Levels of Pregnant Women in Mongolia|Trial of Vitamin D Supplements to Raise Calcidiol Levels of Pregnant Women in Mongolia|Completed||N/A|360|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-10 23:28:00.845896|2017-10-10 23:28:00.845896
NCT02395068|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-08-17|||November 2012||2012-11-01|October 2012|2012-10-01|December 2015|Anticipated|2015-12-01|November 2014|Actual|2014-11-01||Interventional|||Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors|Pharmacokinetics Study of Nimotuzumab Single-dose and Multiple-dose in Combination With Irinotecan in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|Biotech Pharmaceutical Co., Ltd.||3|||f||||t||||||||||2017-10-10 23:28:01.076098|2017-10-10 23:28:01.076098
NCT02395055|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-08-31|2016-03-31||June 2015||2015-06-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||Population for all type of analysis included 84 patients who received at least one study drug injection.|Comparative Clinical Trial to Evaluate Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Volunteers|"Single Center Comparative Double Blind Randomized Clinical Study of Pharmacokinetics, Tolerance and Safety of Single Subcutaneous Injection of BCD-057 (JSC BIOCAD, Russia) and Humira in Healthy Volunteers"|Completed||Phase 1|94|Actual|Biocad||2|||f||||f||||||||||2017-10-10 23:28:01.20957|2017-10-10 23:28:01.20957
NCT02395042|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-09-11|||April 30, 2015|Actual|2015-04-30|September 2017|2017-09-01|November 11, 2017|Anticipated|2017-11-11|June 29, 2017|Actual|2017-06-29||Interventional|||A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions|A Multicenter, Randomized, Double-blind, Placebo-controlled Study, Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis With Hunner's Lesions|Active, not recruiting||Phase 2|62|Actual|Allergan||3|||f||||f||||||||||2017-10-10 23:28:01.586891|2017-10-10 23:28:01.586891
NCT02395029|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-16|||August 2013||2013-08-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|PMD-MSC-PD-01||Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD|Evaluate the Safety and Feasibility of Injecting Placental Matrix-Derived Mesenchymal Stem Cells Into the Penis to Treat the Symptoms of Peyronie's Disease|Completed||Phase 1|5|Actual|Z Urology||1|||f||||t||||||||||2017-10-10 23:28:01.745741|2017-10-10 23:28:01.745741
NCT02395016|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-17|2015-07-31|||March 2015||2015-03-01|June 2015|2015-06-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer|A Prospective, Randomized, Controlled, Double-blind, Multi-center Clinical Study of Nimotuzumab Combinated With Gemcitabine Contrast to Placebo Combinated With Gemcitabine in K-RAS Wild-type,Locally Advanced and Metastatic Pancreatic Cancer|Recruiting||Phase 3|276|Anticipated|Biotech Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:28:01.880136|2017-10-10 23:28:01.880136
NCT02395003|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-26|||April 2016||2016-04-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01|12 Weeks|Observational [Patient Registry]|||Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents|Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents|Recruiting||N/A|104|Anticipated|Yale University|||4||f||||f||||||Samples Without DNA|"     Basal plasma samples for measurements of glucose and glycerol enrichment, and glucose,     insulin FFAs, leptin, C-peptide, glucagon, adiponectin, cortisol, growth hormone,     catecholamines and amino acids, will be collected.   "|No||2017-10-10 23:28:02.161171|2017-10-10 23:28:02.161171
NCT02394990|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-30|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Violence Brief Intervention Pilot v1.1|A Randomised Controlled Trial to Evaluate a Violence Brief Intervention (VBI) for Adult Male Patients With Facial Injuries Sustained as a Result of Interpersonal Violence|Unknown status|Recruiting|N/A|300|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-10 23:28:02.276961|2017-10-10 23:28:02.276961
NCT02394977|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-17|||January 2014||2014-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|CFA||Effect of the Cardio First Angle Device on CPR Outcomes|Pilot Study of the Effect of Cardio First Angel (CFA) Device on CPR Outcomes:|Completed||N/A|80|Actual|Baqiyatallah Medical Sciences University||1|||f||||t||||||||||2017-10-10 23:28:02.372914|2017-10-10 23:28:02.372914
NCT02394964|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-01-25|||November 2014||2014-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||The Human Microbiome in Immune-Mediated Diseases|The Human Microbiome in Immune-Mediated Diseases|Recruiting||N/A|90|Anticipated|Yale University|||5||f||||f||||||Samples With DNA|"     whole blood, oral swab, skin swab, stool   "|No||2017-10-10 23:28:02.455573|2017-10-10 23:28:02.455573
NCT02394951|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-04-19|||April 2015||2015-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Pregabalin in CIPN|Investigation of Somatosensory Predictors of Response to Pregabalin in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN)|Recruiting||N/A|35|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 23:28:02.547934|2017-10-10 23:28:02.547934
NCT02394938|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-03-24|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|EMSC||Effects of Recorded Music in Heart Failure Patients|A Randomized Controlled Trial of Listen Recorded Music for Hearth Failure Patients|Completed||N/A|150|Actual|Azienda Usl di Bologna||2|||f||||f||||||||||2017-10-10 23:28:02.641314|2017-10-10 23:28:02.641314
NCT02394925|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-04-06|2017-04-06||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|September 1, 2015|Actual|2015-09-01|September 1, 2015|Actual|2015-09-01||Interventional||All subjects that were dispensed the study lens.|Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional Emmetropes|Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional Emmetropes|Completed||N/A|113|Actual|Johnson & Johnson Vision Care, Inc.||1|||f||||f||||||||||2017-10-10 23:28:02.732826|2017-10-10 23:28:02.732826
NCT02394912|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-05-31|||June 2015||2015-06-01|May 2017|2017-05-01|November 9, 2016|Actual|2016-11-09|November 9, 2016|Actual|2016-11-09||Interventional|||Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System|Evaluation of the Technical Success of Intravascular Ultrasound (IVUS) Guided Vena Cava Filter (VCF) Placement Using the LUMIFI™ With Crux® VCF System (LUMIFI Clinical Study)|Terminated||N/A|21|Actual|Volcano Corporation||1||Unsatisfactory filter deployment in several cases|f||||||||||||||2017-10-10 23:28:02.893128|2017-10-10 23:28:02.893128
NCT02394899|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-10-26|||October 2014||2014-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease|Integrating a Parenting Intervention With Routine Care to Improve Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease|Completed||N/A|64|Actual|The University of The West Indies||2|||f||||f||||||||||2017-10-10 23:28:02.963606|2017-10-10 23:28:02.963606
NCT02394886|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-10-15|||November 2014||2014-11-01|March 2015|2015-03-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers|A Phase I Clinical Study to Evaluate the Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers|Completed||Phase 1|5|Actual|Anterogen Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:28:03.053803|2017-10-10 23:28:03.053803
NCT02394873|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-12-28|||March 2015||2015-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound|A Phase 1 Clinical Study to Evaluate the Safety of Allogeneic Adipose-derived Stem Cells in the Subjects With Deep Second-degree Burn Wound|Completed||Phase 1|5|Actual|Anterogen Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:28:03.235152|2017-10-10 23:28:03.235152
NCT02394860|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-09-07|||April 2015|Actual|2015-04-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Influence of Periodontal Diseases on Vascular Parameters in Patients Suffering of Hypertension|Influence of Periodontal Diseases on Hemodynamic and Molecular Vascular Parameters in Patients Suffering of Hypertension|Recruiting||N/A|84|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:28:03.319408|2017-10-10 23:28:03.319408
NCT02394847|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-03-17|||January 2012||2012-01-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Does Repetitive Electroconvulsive Therapies Affect Propofol Induction Dose ?|Does Repetitive Electroconvulsive Therapies Affect Propofol Induction Dose?|Completed||N/A|10|Actual|Ankara University||1|||f||||f||||||||||2017-10-10 23:28:03.449095|2017-10-10 23:28:03.449095
NCT02394834|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-15|||March 1, 2015|Actual|2015-03-01|June 2017|2017-06-01|July 28, 2021|Anticipated|2021-07-28|February 28, 2020|Anticipated|2020-02-28||Interventional|||An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus. mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer.|An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Phase III, Randomized, Controlled Study Comparing the Efficacy and Safety of mFOLFOX6 + Bevacizumab Therapy vs. mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Wild-type RAS(KRAS/NRAS) Unresectable Advanced or Recurrent Colorectal Cancer|Active, not recruiting||Phase 3|766|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 23:28:03.555406|2017-10-10 23:28:03.555406
NCT02394808|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-04-04|2017-04-04||January 1, 2015|Actual|2015-01-01|March 2017|2017-03-01|September 1, 2015|Actual|2015-09-01|September 1, 2015|Actual|2015-09-01||Interventional||All subjects that were dispensed at least one study lens.|2-week Evaluation of Marketed Silicone Hydrogel Contact Lenses in Indian Population|2-week Dispensing Cross-Over Evaluation of Marketed Silicone Hydrogel Contact Lenses in an Indian Population|Completed||N/A|54|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-10 23:28:04.059095|2017-10-10 23:28:04.059095
NCT02394795|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-15|||March 31, 2015|Actual|2015-03-31|June 2017|2017-06-01|February 29, 2020|Anticipated|2020-02-29|February 28, 2020|Anticipated|2020-02-28||Interventional|PARADIGM||Panitumumab and RAS, DIagnostically-useful Gene Mutation for mCRC).|A Phase III, Randomized, Controlled Study of mFOLFOX6 + Bevacizumab Combination Therapy Versus mFOLFOX6 + Panitumumab Combination Therapy in Chemotherapy-naive Patients With KRAS/NRAS Wild-type, Incurable/Unresectable, Advanced/Recurrent Colorectal Cancer|Active, not recruiting||Phase 3|823|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 23:28:04.295048|2017-10-10 23:28:04.295048
NCT02394782|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-04-22|||February 2015||2015-02-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Observational|ADHERQOL||Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)|A Prospective, Observational, International, Multi-center Study to Measure the Relationship Between Relapse and Adherence in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated With Rebismart®2.0 + MSdialog™, Assessing Quality of Life (ADHERQOL)|Terminated||N/A|8|Actual|Merck KGaA|||1|lower than anticipated recruitment rate|f||||||||||||||2017-10-10 23:28:04.688173|2017-10-10 23:28:04.688173
NCT02394769|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-07-24|||June 2015||2015-06-01|July 2017|2017-07-01|July 2028|Anticipated|2028-07-01|September 2018|Anticipated|2018-09-01||Interventional|ASPIRED||ASPirin Intervention for the REDuction of Colorectal Cancer Risk|ASPIRED: ASPirin Intervention for the REDuction of Colorectal Cancer Risk|Enrolling by invitation||N/A|180|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-10 23:28:04.772419|2017-10-10 23:28:04.772419
NCT02394756|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-03-14|2017-03-14||February 2015||2015-02-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All subjects that were dispensed at least one study lens.|Investigation of Ocular Signs & Symptoms in Wearers Fitted With Contact Lenses Following Digital Device Use||Completed||N/A|52|Actual|Johnson & Johnson Vision Care, Inc.||3|||f||||f||||||||||2017-10-10 23:28:04.867153|2017-10-10 23:28:04.867153
NCT02394743|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-09-06|||March 2011||2011-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Correlation Between Estimated Glomerular Filtration Rate(eGFR) and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)||Completed||N/A|360|Actual|Korea University|||3||f||||||||||||||2017-10-10 23:28:05.151322|2017-10-10 23:28:05.151322
NCT02394730|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-20|||September 2015||2015-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADVICE||Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints|A Double Blind Randomised Comparison of Vorapaxar Versus Placebo for the Treatment of HIV Associated Inflammation and Coagulopathy in Patients With Well Controlled HIV Replication|Recruiting||Phase 1/Phase 2|60|Anticipated|Kirby Institute||2|||f||||t||||||||Undecided||2017-10-10 23:28:05.350337|2017-10-10 23:28:05.350337
NCT02394717|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-05-15|||August 2014||2014-08-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Policy to Practice: Statewide Rollout of YMCA Childhood Obesity Standards|Policy to Practice: Statewide Rollout of YMCA Childhood Obesity Standards|Active, not recruiting||N/A|1000|Actual|University of South Carolina||1|||f||||t||||||||||2017-10-10 23:28:05.525236|2017-10-10 23:28:05.525236
NCT02394704|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-09-26|||November 2015||2015-11-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Intervention for Intrusive Negative Thinking|Graduated Sensory Salience as an Intervention for Intrusive Negative Thinking|Recruiting||N/A|95|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:28:05.621471|2017-10-10 23:28:05.621471
NCT02394691|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-03-29|||July 2014||2014-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|June 2016|Actual|2016-06-01||Interventional|rtDCS in DOC||Effect of Repeated tDCS Sessions on Cognitive Improvement in Patients With Disorders of Consciousness|Effect of Daily Left Prefrontal Dorsolateral Transcranial Direct Current Stimulation Sessions on Cognitive Improvement in Patients With Disorders of Consciousness|Completed||N/A|37|Actual|University Hospital of Liege||2|||f|||||f|f||||||||2017-10-10 23:28:05.732123|2017-10-10 23:28:05.732123
NCT02394678|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-04-02|||May 2015||2015-05-01|April 2015|2015-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|rtIVH||Rheolytic Thrombectomy For Adult Intraventricular Haemorrhage|Rheolytic Thrombectomy For Adult Intraventricular Haemorrhage|Unknown status|Not yet recruiting|N/A|20|Anticipated|Cambridge University Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:28:05.833921|2017-10-10 23:28:05.833921
NCT02394665|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-11-08|2016-11-08||March 2015||2015-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional||Data were not analyzed due to insufficient number of evaluable subjects. Only one subject enrolled who was later withdrawn by the Investigator prior to assignment to any treatment group or receiving any protocol therapy.|Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma|Phase II Study of Dose Escalated, Targeted Radiation Therapy Using 3D Magnetic Resonance Spectroscopy Imaging (MRSI) in Newly Diagnosed Glioblastoma|Terminated||Phase 2|1|Actual|University of Miami|Data were not analyzed due to insufficient number of evaluable subjects. Only one subject enrolled who was later withdrawn by the Investigator prior to assignment to any treatment group or receiving any protocol therapy.|2||Lack of Accrual/Enrollment|f||||t||||||||||2017-10-10 23:28:05.937065|2017-10-10 23:28:05.937065
NCT02394652|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-06-21|||May 2015||2015-05-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|||The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial|The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial|Recruiting||Phase 2|48|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:28:06.362888|2017-10-10 23:28:06.362888
NCT02394639|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-12-07|||April 2015||2015-04-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||EEG@HOME (Phase 4 of the Project)||Enrolling by invitation||N/A|10|Anticipated|University Hospital, Ghent||2|||f||||t||||||||||2017-10-10 23:28:06.499485|2017-10-10 23:28:06.499485
NCT02394626|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-06-26|||May 2015||2015-05-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|RESURGE||Surgery for Recurrent Glioblastoma|RESURGE - Randomized Controlled Comparative Phase II Trial on Surgery for Glioblastoma Recurrence|Recruiting||Phase 2|120|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:28:06.577424|2017-10-10 23:28:06.577424
NCT02394613|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-05-25|||May 2015||2015-05-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|November 2015|Actual|2015-11-01||Interventional|||A Phase I Clinical Trial of DARC|A Phase I, Storer Design, Open-label, Cross-sectional, Single Site Trial of ANX776 in Healthy Volunteers, Progressive Glaucoma/Glaucoma-suspect/Ocular Hypertensive Subjects and Non-arteritic Anterior Ischaemic Optic Neuropathy Subjects|Unknown status|Active, not recruiting|Phase 1|16|Actual|University College, London||1|||f||||t||||||||||2017-10-10 23:28:06.69289|2017-10-10 23:28:06.69289
NCT02394587|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-04-25|||April 2015||2015-04-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||MBSR for Pain Catastrophizing in SCD|A Mindfulness-based Intervention For Pain Catastrophizing In Sickle Cell Disease|Completed||N/A|60|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:28:06.873471|2017-10-10 23:28:06.873471
NCT02394574|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-09-19|||September 2012||2012-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|HAP||Household Air Pollution and Pregnancy Outcome|Household Air Pollution and Pregnancy Outcome|Active, not recruiting||N/A|300|Actual|University of Chicago||2|||f||||f||||||||||2017-10-10 23:28:06.966432|2017-10-10 23:28:06.966432
NCT02394561|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-05-11|||April 10, 2015|Actual|2015-04-10|May 2017|2017-05-01|May 28, 2017|Anticipated|2017-05-28|May 28, 2017|Anticipated|2017-05-28||Interventional|SUPREME||A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)|A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)|Active, not recruiting||Phase 3|434|Actual|Novartis||1|||f||||t|f|f||||||Undecided||2017-10-10 23:28:07.053521|2017-10-10 23:28:07.053521
NCT02394548|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-07-19|||June 2015||2015-06-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer|A Phase I Trial Of Intensity-Modulated Radiation Therapy (IMRT) Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Non-Small Cell Lung Cancer (NSCLC) And Limited-Stage Small Cell Lung Cancer (LS-SCLC).|Recruiting||Phase 1|20|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:28:07.220145|2017-10-10 23:28:07.220145
NCT02394535|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-08-15|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Combining Abraxane With Capecitabine and Radiation Therapy for Consolidation of Treatment Following Induction Chemotherapy for Locally Advanced Pancreatic Cancer|Combining Abraxane With Capecitabine and Radiation Therapy for Consolidation of Treatment Following Induction Chemotherapy for Locally Advanced Pancreatic Cancer|Recruiting||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:28:07.321236|2017-10-10 23:28:07.321236
NCT02394522|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-10-05|||March 2016||2016-03-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SR-M-ZM||Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)|Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia|Withdrawn||N/A|0|Actual|University of Notre Dame||2||sponsors|f||||t||||||||||2017-10-10 23:28:07.42571|2017-10-10 23:28:07.42571
NCT02394496|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-06-14|||November 2007||2007-11-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|OVER||Overcoming Endocrine Resistance in Metastatic Breast Cancer|A Randomized Trial With Factorial Design Comparing Fulvestrant ± Lapatinib ± Aromatase Inhibitor in Metastatic Breast Cancer Progressing After Aromatase Inhibitor Therapy|Recruiting||Phase 3|396|Anticipated|Consorzio Oncotech||4|||f||||f||||||||||2017-10-10 23:28:07.62567|2017-10-10 23:28:07.62567
NCT02394483|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-09-16|||October 2015||2015-10-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Single Ascending Oral Dose Study of F901318|F901318 - A Phase I, Double-Blind, Placebo Controlled, Single Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male Subjects|Completed||Phase 1|46|Actual|F2G Ltd.||10|||f||||f||||||||||2017-10-10 23:28:07.977432|2017-10-10 23:28:07.977432
NCT02394470|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-03-31|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|BLUEMOON||BioImpedentiometry, Lung UltraSound and cONgestion in Heart Failure|BioImpedentiometry and Lung UltraSound Examination to MOnitor cONgestion in Heart Failure|Recruiting||N/A|60|Anticipated|Niguarda Hospital||1|||f||||f||||||||||2017-10-10 23:28:08.202578|2017-10-10 23:28:08.202578
NCT02394457|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-09-12|2016-09-12||August 2010||2010-08-01|September 2016|2016-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|PDPH||Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture Headache|Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture Headache (PDPH)|Completed||Phase 4|29|Actual|United States Naval Medical Center, San Diego|Subjects treated with cosyntropin could also receive EBP.Lack of description of patient activity level on follow up.Functional scoring tool not validated.Cost analysis & system utilization not captured.Variations in clinical judgment.Lack of blinding|2|||f||||f||||||||No||2017-10-10 23:28:08.321317|2017-10-10 23:28:08.321317
NCT02394444|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-03-16|||June 2006||2006-06-01|March 2015|2015-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|IDEX||Impact of an Intervention Program on Parenting Stress After Preterm Birth|Impact of a Psychological Post-hospital Intervention Aimed at Facilitating Parents-child Attachment and Preventing the Preterm Infants' Psycho-emotional, Social and Cognitive Disturbances|Completed||N/A|89|Actual|University Hospital, Caen||3|||f||||t||||||||||2017-10-10 23:28:08.712534|2017-10-10 23:28:08.712534
NCT02394431|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-07-25|||November 2013||2013-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease|Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease|Completed||N/A|62|Actual|Brugmann University Hospital|||2||f||||f||||||||||2017-10-10 23:28:08.818479|2017-10-10 23:28:08.818479
NCT02394418|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-07-03|||September 1, 2017|Anticipated|2017-09-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Effect of Sevoflurane, Propofol and Dexmedetomidine on Delirium & Neuroinflammation in Mechanically Ventilated Patients|Comparison of Sedative Effects of Sevoflurane, Propofol and Dexmedetomidine on the Clinical Course of Delirium and Neuroinflammation in Mechanically Ventilated Patients|Not yet recruiting||Phase 4|45|Anticipated|Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy||3|||f||||f|f|f||||||||2017-10-10 23:28:08.919555|2017-10-10 23:28:08.919555
NCT02394405|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-03-16|||March 2015||2015-03-01|March 2015|2015-03-01|October 2015|Anticipated|2015-10-01|March 2015|Anticipated|2015-03-01||Observational|||Myocardial and Cerebral Dysfunction by Oxidative Stress Caused by On-pump Surgery|Myocardial and Cerebral Dysfunction by Oxidative Stress Caused by On-pump Surgery|Unknown status|Not yet recruiting|N/A|60|Anticipated|Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy|||2||f||||f||||||||||2017-10-10 23:28:09.007321|2017-10-10 23:28:09.007321
NCT02394392|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-07-07|||July 2014||2014-07-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Observational|K-HEMS||Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)|Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient: a Prospective, Cross-sectional and Open-label 8 Week Switching Study|Completed||N/A|12691|Actual|Boryung Pharmaceutical Co., Ltd|||1||f||||f||||||||||2017-10-10 23:28:09.072099|2017-10-10 23:28:09.072099
NCT02394379|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-02-08|||March 2015||2015-03-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL|A Prospective, Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber Intraocular Lens (IOL)|Active, not recruiting||N/A|600|Anticipated|Bausch & Lomb Incorporated|||1||f||||f||||||||||2017-10-10 23:28:09.137091|2017-10-10 23:28:09.137091
NCT02394366|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-03-19|||March 2015||2015-03-01|March 2015|2015-03-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|OHS||Topical Salve for Skin Oxygenation and Blood Flow|Effects of Topical Herbal Salve on Cutaneous Oxygenation and Peripheral Blood Flow|Unknown status|Not yet recruiting|Phase 1/Phase 2|16|Anticipated|National University of Natural Medicine||2|||f||||f||||||||||2017-10-10 23:28:09.217375|2017-10-10 23:28:09.217375
NCT02394353|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-03-03|||January 2013||2013-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|May 2015|Actual|2015-05-01||Interventional|||Impact of Bariatric Surgery on the Evolution of Nonalcoholic Fatty Liver Disease: a Comparative Clinical Trial Between Sleeve Gastrectomy and Gastric Bypass||Completed||Phase 1|60|Actual|Ministry of Health, Brazil||2|||f||||t||||||||||2017-10-10 23:28:09.311584|2017-10-10 23:28:09.311584
NCT02394340|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-03-16|||February 2015||2015-02-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|April 2015|Anticipated|2015-04-01||Interventional|||Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris|An Open-Label, Maximal Use Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris|Unknown status|Recruiting|Phase 4|20|Anticipated|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-10 23:28:09.392589|2017-10-10 23:28:09.392589
NCT02394327|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-01-04|||July 2011||2011-07-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Endoscopic Nasogallbladder Drainage Versus Gallbladder Stenting Before Cholecystecomy|Endoscopic Naso-gallbladder Drainage Versus Gallbladder Stenting Before Elective Cholecystectomy in Patients With Acute Cholecystitis and a High Suspicion of Common Bile Duct Stone; A Prospective Randomized Preliminary Study|Completed||N/A|35|Actual|Ajou University School of Medicine||2|||f||||||||||||||2017-10-10 23:28:09.494209|2017-10-10 23:28:09.494209
NCT02394314|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-09-08|||February 2015||2015-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers|A Phase 1, Single-ascending-dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers|Completed||Phase 1|362|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-10 23:28:09.588329|2017-10-10 23:28:09.588329
NCT02394301|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-05-15|||February 2015||2015-02-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|12 Weeks|Observational [Patient Registry]|ENDURE||Efficacy of Novel Drug-combinations for Relief of Psoriasis|Efficacy of Novel Drug-combinations for Relief of Psoriasis (ENDURE)|Suspended||N/A|200|Anticipated|Medimix Specialty Pharmacy, LLC|||1|Poor enrollment|f||||t||||||||||2017-10-10 23:28:09.67814|2017-10-10 23:28:09.67814
NCT02394288|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-03-18|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Perioperative Cardiac Troponin Levels in Healthy Adults|Perioperative High-sensitivity Cardiac Troponin Levels in Healthy Adults Undergoing Elective Trauma Surgery|Completed||N/A|120|Actual|Medical University of Vienna|||1||f||||t||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:28:09.758553|2017-10-10 23:28:09.758553
NCT02394275|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-07-08|||March 2015||2015-03-01|July 2015|2015-07-01|May 2025|Anticipated|2025-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Prospective Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection|A Prospective Open-Labelled Multi-Centre Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection|Recruiting||Phase 2|300|Anticipated|McMaster University||1|||f||||t||||||||||2017-10-10 23:28:09.843645|2017-10-10 23:28:09.843645
NCT02394262|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-03-27|||March 2015||2015-03-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|PARSEC-NET||Sequential Coronary CT-angiography and Biomarkers|Prediction of Atherosclerotic Plaque Burden Progression With Sequential Coronary CT-angiography and Biomarkers|Recruiting||N/A|140|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-10 23:28:09.976087|2017-10-10 23:28:09.976087
NCT02394249|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-03-15|||February 2015||2015-02-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SIT LESS 3||SIT LESS 3: The Effect of Low Intensity Physical Activity on Insulin Sensitivity, Mood and Cognitive Performance|SIT LESS 3: The Effect of Low Intensity Physical Activity on Insulin Sensitivity, Mood and Cognitive Performance|Completed||N/A|24|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:28:10.097368|2017-10-10 23:28:10.097368
NCT02394236|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-19|||September 2012||2012-09-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|October 2013|Actual|2013-10-01||Interventional|||Aerobic Exercise and Oxygen Uptake Efficiency Slope in Coronary Artery Disease|Continuous vs. Interval Exercise Training on Oxygen Uptake Efficiency Slope in Patients With Coronary Artery Disease|Completed||Phase 2|35|Actual|Hospital TotalCor||2|||f||||t||||||||||2017-10-10 23:28:10.222002|2017-10-10 23:28:10.222002
NCT02394223|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-07-05|||January 2016||2016-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|BIOMAGIC01||FFOCT for the Diagnosis of Prostate Cancer|Full Field Optical Coherence Tomography of Prostate Biopsies for the Diagnosis of Prostate Cancer|Recruiting||N/A|150|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:28:10.288494|2017-10-10 23:28:10.288494
NCT02394210|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-07-24|||May 14, 2013|Actual|2013-05-14|July 2017|2017-07-01|October 30, 2022|Anticipated|2022-10-30|April 30, 2022|Anticipated|2022-04-30||Observational|EPA-MMBR||Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma|Post-authorisation Observational Registry to Assess the Clinical Impact of Initiating Anti-tumour Rescue Therapy in Patients With Multiple Myeloma (MM) in Asymptomatic Biological Relapse Compared to Initiating Treatment at the Time of Symptomatic Relapse.|Active, not recruiting||N/A|417|Actual|Celgene|||2||f||||f||||||||||2017-10-10 23:28:10.378979|2017-10-10 23:28:10.378979
NCT02394197|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-19|||February 2008||2008-02-01|March 2015|2015-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|EMTM||Effectiveness of Malaria Treatment in Mexico|Comparison of the Effectiveness of Two Scheme Treatments to Treat Plasmodium Vivax Cases in Patients Living in Communities With Persistence of Transmission in Oaxaca and Chiapas, Mexico|Completed||Phase 4|153|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||t||||||||||2017-10-10 23:28:10.563314|2017-10-10 23:28:10.563314
NCT02394184|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-06-18|||May 2015||2015-05-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|May 2022|Anticipated|2022-05-01||Observational|Bicuspid TAVR||The Bicuspid Aortic Stenosis Following Transcatheter Aortic Valve Replacement Registry|Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement for Patients With Bicuspid Aortic Valve Stenosis|Recruiting||N/A|250|Anticipated|Asan Medical Center|||1||f||||f||||||||No|This is not a publicly funded trial.|2017-10-10 23:28:10.675505|2017-10-10 23:28:10.675505
NCT02394171|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-19|||May 2005||2005-05-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|HIP||Health is Power: An Ecological Theory-based Health Intervention for Women of Color|Health is Power: An Ecological Theory-based Health Intervention for Women of Color|Completed||N/A|410|Actual|Arizona State University||2|||f||||f||||||||||2017-10-10 23:28:10.810906|2017-10-10 23:28:10.810906
NCT02394158|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-11-09|||December 2014||2014-12-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PRoDroME||Preventing Recurrent Gestational Diabetes With Metformin|Preventing Recurrent Gestational Diabetes Mellitus With Early Metformin Intervention|Recruiting||Phase 4|112|Anticipated|Imperial College London||2|||f||||t||||||||No||2017-10-10 23:28:10.891289|2017-10-10 23:28:10.891289
NCT02394145|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-14|2015-03-19|||September 2009||2009-09-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Genotype and Platelet Reactivity in Patients on Hemodialysis|The Relationship Between Genotype and Platelet Reactivity in Patients Treated With Ticagrelor Versus Clopidogrel: PIANO Genotype Study|Unknown status|Recruiting|Phase 3|20|Anticipated|Kyunghee University Medical Center||5|||f||||t||||||||||2017-10-10 23:28:10.99923|2017-10-10 23:28:10.99923
NCT02394132|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-01-04|||May 2015||2015-05-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|May 2018|Anticipated|2018-05-01||Interventional|RADICAL||Radiotherapy or Imiquimod in Complex Lentigo Maligna|A Randomised Controlled Multicentre Trial of Imiquimod Versus Radiotherapy for Lentigo Maligna (LM) When Staged Surgical Excision With 5mm Margins is Not Possible, is Refused, or Fails|Recruiting||Phase 3|266|Anticipated|Australia and New Zealand Melanoma Trials Group||2|||f||||t||||||||||2017-10-10 23:28:11.101538|2017-10-10 23:28:11.101538
NCT02394119|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-05-03|||June 2015||2015-06-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|June 2018|Anticipated|2018-06-01||Interventional|||Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome|Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor-dependent Idiopathic Nephrotic Syndrome: an Open-label, Randomized, Controlled, Superiority Trial.|Recruiting||Phase 2|140|Anticipated|Istituto Giannina Gaslini||2|||f||||t||||||||||2017-10-10 23:28:11.216866|2017-10-10 23:28:11.216866
NCT02394106|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-05-03|||July 2015||2015-07-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome|Ofatumumab in Children With Steroid- and Calcineurin-inhibitor-resistant Nephrotic Syndrome: a Double-blind Randomized, Controlled, Superiority Trial|Recruiting||Phase 2|50|Anticipated|Istituto Giannina Gaslini||2|||f||||t||||||||||2017-10-10 23:28:11.30531|2017-10-10 23:28:11.30531
NCT02394093|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-14|2016-09-16|||February 2015||2015-02-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Icicle||To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults.|An Open Label Crossover Pharmacokinetic Trial of Aspirin Dry Powder Versus Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Bayer||3|||f||||f||||||||||2017-10-10 23:28:11.395319|2017-10-10 23:28:11.395319
NCT02394080|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-06|||February 2015||2015-02-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|May 2017|Actual|2017-05-01||Interventional|||Safety and Efficacy Study of the Treatment of Humerus Fractures|CE Marking Study of the IlluminOss Photodynamic Bone Stabilization System for the Treatment of Humerus Fractures|Active, not recruiting||N/A|44|Actual|IlluminOss Medical, Inc.||1|||f||||||||||||||2017-10-10 23:28:11.488991|2017-10-10 23:28:11.488991
NCT02394067|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-04-21|||August 2016||2016-08-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|August 2017|Anticipated|2017-08-01||Observational|||Magnetic Resonance Venography Pre- and Post-Treatment in Patients With Idiopathic Intracranial Hypertension|Magnetic Resonance Venography Pre- and Post-Treatment in Patients With Idiopathic Intracranial Hypertension|Not yet recruiting||N/A|20|Anticipated|Nova Scotia Health Authority|||1||f||||f||||||||No||2017-10-10 23:28:11.566523|2017-10-10 23:28:11.566523
NCT02394054|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-08|||January 2015||2015-01-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Vasopressin and the Social Brain|Vasopressin's Effect on Behavior and Neural Activity During Social Cognition Tasks|Completed||Early Phase 1|84|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 23:28:11.779699|2017-10-10 23:28:11.779699
NCT02394041|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-19|||November 2012||2012-11-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ACUCESAR||Randomised Controlled Trial of the Efficacy of Acupuncture Versus Placebo on the Caesarean Section Rate in Case of Cervical Dystocia in Full-term Pregnancy|A Randomised Controlled Multicenter Trial Evaluating the Efficacy of Acupuncture Versus Placebo on the Caesarean Section Rate in Case of Cervical Dystocia in Full-term Pregnancy|Terminated||N/A|142|Actual|Assistance Publique - Hôpitaux de Paris||3||insufficient recruitment: 142 patients instead of 2,220 planned|f||||f||||||||||2017-10-10 23:28:11.889168|2017-10-10 23:28:11.889168
NCT02394028|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-03-09|||March 31, 2015|Actual|2015-03-31|March 2017|2017-03-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn's Disease|A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ETROLIZUMAB AS AN INDUCTION AND MAINTENANCE TREATMENT FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE|Recruiting||Phase 3|1250|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 23:28:12.029663|2017-10-10 23:28:12.029663
NCT02394015|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-08-10|||March 2015||2015-03-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|RETRO-ROC||Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC|Multicenter and Retrospective Observational Study to Analyze the Efficacy and Safety of the Combination With Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to Data Sheet|Active, not recruiting||N/A|80|Anticipated|Grupo Español de Investigación en Cáncer de Ovario|||1||f||||f||||||||||2017-10-10 23:28:13.075315|2017-10-10 23:28:13.075315
NCT02394002|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-19|||March 2015||2015-03-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|SEPinBSP||SEP Changes During Deep Anesthesia|The Effect of Burst-suppression-pattern in EEG on Generating Somatosensory Evoked Potentials|Unknown status|Recruiting|N/A|60|Anticipated|Heinrich-Heine University, Duesseldorf||3|||f||||||||||||||2017-10-10 23:28:13.150119|2017-10-10 23:28:13.150119
NCT02393989|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-16|||January 2010||2010-01-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Three-Year Clinical Evaluation of Bonded Posterior Restorations: Amalgam vs Resin Composite|Three-Year Clinical Evaluation of Bonded Posterior Restorations: Amalgam vs Resin Composite|Completed||N/A|50|Actual|Ege University||1|||f||||||||||||||2017-10-10 23:28:13.232314|2017-10-10 23:28:13.232314
NCT02393976|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-03-19|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||IMMUNONUTRITION IN FAST-TRACK SURGERY|NUTRITIONAL EFFECTS AND INFLUENCE IN THE MORBIDITY AND MORTALITY OF DIET IMMUNOMODULATORY IN FAST-TRACK SURGERY|Completed||N/A|120|Actual|Hospital General Universitario Elche||2|||f||||t||||||||||2017-10-10 23:28:13.283604|2017-10-10 23:28:13.283604
NCT02393963|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-04-06|||July 2015|Actual|2015-07-01|September 2016|2016-09-01|December 21, 2016|Actual|2016-12-21|July 2016|Actual|2016-07-01||Interventional|||Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty|Role of Low Dose Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty: A Randomized Placebo Controlled Study|Completed||Phase 2|140|Actual|Orthopaedic Innovation Centre||2|||f||||t||||||||||2017-10-10 23:29:40.222562|2017-10-10 23:29:40.222562
NCT02392325|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-02-02|||March 2015||2015-03-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults|Evaluation of the Clinical and Immune Response Generated by Heterologous Attenuated Dengue Virus Infection|Active, not recruiting||Phase 1|12|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:29:58.362284|2017-10-10 23:29:58.362284
NCT02393950|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-10-28|2016-10-28||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|FIMPAM||Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers|Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Single Escalating Doses of ODM-106: A Randomised, Double-blind, Placebo-controlled Single Centre Study in Healthy Males|Completed||Phase 1|16|Actual|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-10-10 23:29:40.336985|2017-10-10 23:29:40.336985
NCT02393937|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-11-29|||February 2015||2015-02-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea|A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea|Completed||Phase 3|963|Actual|bioRASI, LLC||3|||f||||||||||||||2017-10-10 23:29:41.189958|2017-10-10 23:29:41.189958
NCT02393911|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-03-15|||March 2015||2015-03-01|March 2015|2015-03-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Interventional|DMLPV||Dysbiosis in Localized Provoked Vulvodynia (LPV)|Dysbiosis in the Vaginal Microbiota May be Associated With the Development of Localized Provoked Vulvodynia (LPV)|Unknown status|Not yet recruiting|Phase 3|70|Anticipated|Western Galilee Hospital-Nahariya||3|||f||||f||||||||||2017-10-10 23:29:41.70063|2017-10-10 23:29:41.70063
NCT02393898|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-06-05|||April 25, 2015|Actual|2015-04-25|June 2017|2017-06-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Observational|||BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older|BELOVA: A Non-Interventional Study to Collect Data on the Safety and Efficacy of Frontline Bevacizumab Treatment in Ovarian Cancer Patients 70 Years and Older|Recruiting||N/A|100|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:29:41.778641|2017-10-10 23:29:41.778641
NCT02393885|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-06-20|||February 2015|Actual|2015-02-01|November 2016|2016-11-01|November 2021|Anticipated|2021-11-01|November 2017|Anticipated|2017-11-01||Interventional|DEEP Pivotal||Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach|Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach for Treatment of Subjects With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation|Suspended||Phase 3|220|Anticipated|AtriCure, Inc.||1|||f||||t||||||||||2017-10-10 23:29:41.961699|2017-10-10 23:29:41.961699
NCT02393872|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2016-02-19|||January 2016||2016-01-01|February 2016|2016-02-01|August 2019|Anticipated|2019-08-01|June 2018|Anticipated|2018-06-01||Interventional|Feel4Diabetes||Feel4Diabetes-study|Developing and Implementing a Community-based Intervention to Create a More Supportive Social and Physical Environment for Lifestyle Changes to Prevent Diabetes in Vulnerable Families Across Europe.|Recruiting||N/A|9000|Anticipated|Harokopio University||3|||f||||f||||||||||2017-10-10 23:29:42.077895|2017-10-10 23:29:42.077895
NCT02393859|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-09-20|||November 10, 2015|Actual|2015-11-10|September 2017|2017-09-01|December 1, 2022|Anticipated|2022-12-01|January 30, 2020|Anticipated|2020-01-30||Interventional|||Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HR First Relapse B-precursor ALL|Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Blinatumomab as Consolidation Therapy Versus Conventional Consolidation Chemotherapy in Pediatric Subjects With HR First Relapse B-precursor ALL|Recruiting||Phase 3|320|Anticipated|Amgen||2|||f||||t||||||||||2017-10-10 23:29:42.172396|2017-10-10 23:29:42.172396
NCT02393846|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-07-03|||February 2015||2015-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Topical Ketoprofen Versus Placebo in Patients With Ankle Sprain|Comparison of Topical Dexketoprofen Versus Placebo in Patients Presented With Ankle Sprain to the Emergency Department: A Randomised Placebo Controlled Trial|Completed||Phase 4|100|Actual|Akdeniz University||2|||f||||f||||||||||2017-10-10 23:29:42.428179|2017-10-10 23:29:42.428179
NCT02393833|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-04-12|||June 2002||2002-06-01|April 2016|2016-04-01||||December 2019|Anticipated|2019-12-01||Interventional|||Serum Protein Research Substudy|Assessment of Vascular Endothelial Growth Factor (VEGF), Soluble Her2 Protein (NRP, Neu-Related Protein), and Vascular Cellular Adhesion Molecule-1 (VCAM-1) in Serum Samples of Patients Participating in Trial IBCSG 22-00|Active, not recruiting||Phase 3|136|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-10-10 23:29:42.508247|2017-10-10 23:29:42.508247
NCT02393820|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-06-17|||August 2013||2013-08-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|February 2017|Anticipated|2017-02-01||Interventional|PACSA (ORL02)||Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma|Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma|Active, not recruiting||Phase 2|72|Actual|UNICANCER||1|||f||||t||||||||No|Individual Participant Data (IPD) will not be shared at an individual level. Those data will be part of the study database including all enrolled patients.|2017-10-10 23:29:42.635026|2017-10-10 23:29:42.635026
NCT02393807|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-04-27|||June 2015||2015-06-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation|A Phase 1 Single-dose Open Label 3-way Crossover Study To Evaluate The Bioavailability Of A Spray Dried Dispersion Solid Dose Formulation Of Pf-06260414 Relative To A Suspension Formulation Under Fasted Conditions And The Effect Of Food On The Bioavailability Of The Pf-06260414 Spray Dried Dispersion Solid Formulation In Healthy Subjects|Withdrawn||Phase 1|0|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:29:42.8524|2017-10-10 23:29:42.8524
NCT02393794|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-06-29|||July 17, 2015|Actual|2015-07-17|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)|Phase I/II Study of Cisplatin Plus Romidepsin and Nivolumab in Metastatic Triple Negative Breast Cancer or BRCA Mutation-Associated Locally Recurrent or Metastatic Breast Cancer|Active, not recruiting||Phase 1/Phase 2|54|Anticipated|University of Kansas Medical Center||4|||f||||t|t|f||||||||2017-10-10 23:29:42.945574|2017-10-10 23:29:42.945574
NCT02393781|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-06-03|||June 2015||2015-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|AdrenOSS||Adrenomedullin and Outcome in Severe Sepsis and Septic Shock|Adrenomedullin and Outcome in Severe Sepsis and Septic Shock. The AdrenOSS Study.|Completed||N/A|596|Actual|Sphingotec GmbH|||1||f||||f||||||Samples Without DNA|"     Plasma samples without DNA Blood samples (heparin-, EDTA-, EDTA/aprotinin plasma) and urine     samples will be collected at the admission, day 2, day 3 and the day of discharge for     measuring ADM and other markers   "|||2017-10-10 23:29:43.10103|2017-10-10 23:29:43.10103
NCT02393768|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-04-21|||October 2014||2014-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|||Epigenetic Reprogramming of Monocytes in Patients With Coronary Atherosclerosis|Epigenetic Reprogramming of Monocytes in Patients With Coronary Atherosclerosis|Completed||N/A|40|Actual|Radboud University|||2||f||||f||||||||||2017-10-10 23:29:43.249315|2017-10-10 23:29:43.249315
NCT02393755|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-08-08|||May 8, 2015|Actual|2015-05-08|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer|A Phase I/II Study of Nintedanib and Capecitabine in Refractory Metastatic Colorectal Cancer|Active, not recruiting||Phase 1/Phase 2|39|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-10 23:29:43.323792|2017-10-10 23:29:43.323792
NCT02393742|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-06-01|||March 2015||2015-03-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|NITRITE||Nitrite Supplementation for Improving Physiological Function in Older Adults|Efficacy of Oral Sodium Nitrite for Improving Physiological Functions in Older Adults|Recruiting||N/A|92|Anticipated|University of Colorado, Boulder||2|||f||||f||||||||||2017-10-10 23:29:43.460234|2017-10-10 23:29:43.460234
NCT02393729|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-05-10|||January 2011||2011-01-01|May 2017|2017-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|FMRI-DCD-DD||Functional MRI Study in Children With a Developmental Coordination Disorder (DCD) and/or Developmental Dyslexia (DD)|Functional MRI Study of the Involvement of Cortico-cerebellar and Cortico-striatal Networks in Children With a Developmental Coordination Disorder (DCD) and/or Developmental Dyslexia (DD)|Completed||N/A|65|Actual|University Hospital, Toulouse||4|||f||||f||||||||||2017-10-10 23:29:43.578143|2017-10-10 23:29:43.578143
NCT02393716|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-01-11|||April 2015||2015-04-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Endurant Evo US Clinical Trial|Endurant Evo US Clinical Trial|Active, not recruiting||N/A|139|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-10-10 23:29:43.684196|2017-10-10 23:29:43.684196
NCT02393690|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-10-02|||May 4, 2015|Actual|2015-05-04|October 2017|2017-10-01|August 1, 2020|Anticipated|2020-08-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer|Randomized Double-Blind Phase II Study of Radioactive Iodine (RAI) in Combination With Placebo or Selumetinib for the Treatment of RAI-Avid Recurrent/Metastatic Thyroid Cancers|Recruiting||Phase 2|60|Anticipated|Academic and Community Cancer Research United||2|||f||||t||||||||||2017-10-10 23:29:43.913362|2017-10-10 23:29:43.913362
NCT02393677|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2015-10-06|2015-04-17||July 2011||2011-07-01|October 2015|2015-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Supraclavicular Brachial Plexus Block Using Ropivacaine Alone and With Dexmedetomidine|Supraclavicular Brachial Plexus Block Using Ropivacaine Alone or Combined With Dexmedetomidine for Upper Limb Surgery: A Prospective, Randomized, Double-blinded, Comparative Study|Completed||N/A|80|Actual|Government Medical College, Haldwani||2|||f||||f||||||||||2017-10-10 23:29:44.093466|2017-10-10 23:29:44.093466
NCT02393664|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-07-01|||March 2015||2015-03-01|July 2015|2015-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Effects of Nonintubated Versus Intubated General Anesthesia on Recovery After Thoracoscopic Lung Resection|Effects of Nonintubated Versus Intubated General Anesthesia on Recovery After Thoracoscopic Lung Resection: A Prospective Randomized Trial|Unknown status|Recruiting|Phase 2/Phase 3|300|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:29:44.341986|2017-10-10 23:29:44.341986
NCT02393651|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2016-08-01|||March 2015||2015-03-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Late LTP-like Plasticity Effects of tDCS in Subacute Stroke Patients|Late LTP-like Plasticity Effects of tDCS in Subacute Stroke Patients|Recruiting||N/A|48|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 23:29:44.432322|2017-10-10 23:29:44.432322
NCT02393638|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-03-18|||April 2014||2014-04-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||ERCP Mechanical Simulator (EMS) Practice for Training Endoscopic Sphincterotomy|ERCP Mechanical Simulator (EMS) Practice for Training Endoscopic Sphincterotomy|Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:29:44.51343|2017-10-10 23:29:44.51343
NCT02393612|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-10-31|||October 2012||2012-10-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|DAVICI||Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease|A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase III Clinical Trial to Evaluate in Efficacy and Safety of DP-R202 and Anplag Tab in Patients With Artery Occlusive Disease|Completed||Phase 3|151|Actual|Alvogen Korea||2|||f||||f||||||||No||2017-10-10 23:29:44.73921|2017-10-10 23:29:44.73921
NCT02393599|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-01-10|||May 2015||2015-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin|Phase 1, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin|Completed||Phase 1|20|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-10 23:29:44.816137|2017-10-10 23:29:44.816137
NCT02393586|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-04-03|||February 2015||2015-02-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers|Evaluating Pharmacokinetics and Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Single Doses of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers|Completed||Phase 1|43|Actual|National University Hospital, Singapore||3|||f||||f||||||||||2017-10-10 23:29:44.900228|2017-10-10 23:29:44.900228
NCT02393573|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-09-16|||November 2015||2015-11-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism|Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism In Patients Undergoing Major Lung or Abdominal Surgery|Recruiting||N/A|30|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 23:29:44.991025|2017-10-10 23:29:44.991025
NCT02393560|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2017-01-24|||April 2015||2015-04-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Observational|||DECT Study in Allopurinol-Treated Gout Patients|A Study to Determine the Presence and Volume of Monosodium Urate Crystals as Assessed by Dual-Energy Computed Tomography in Gout Patients Treated With Allopurinol|Completed||N/A|223|Actual|Ardea Biosciences, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood sample may be used for optional genetic testing in subjects who give consent.     Serum aliquots will be collected and may be used for the analysis of potential analytes and     biomarkers, but may not be used for genetic testing without the subject's written consent.   "|||2017-10-10 23:29:45.146356|2017-10-10 23:29:45.146356
NCT02393547|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-05-09|2017-03-29||September 2013|Actual|2013-09-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Lorcaserin for Preventing Weight Gain Among Smokers|Lorcaserin for Preventing Weight Gain Among Smokers Receiving Varenicline: A Pilot Study|Completed||Phase 1/Phase 2|20|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-10 23:29:45.418182|2017-10-10 23:29:45.418182
NCT02393534|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-04-05|||June 2015||2015-06-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Feasibility of Telephone Follow-up Visits in Primary Care|The Feasibility of Replacing Follow-up Visits With Telephone Calls in Primary Care: A Randomized Clinical Trial|Completed||Phase 4|11|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 23:29:45.823953|2017-10-10 23:29:45.823953
NCT02393521|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-03-15|||August 2014||2014-08-01|March 2015|2015-03-01|April 2015|Anticipated|2015-04-01|November 2014|Actual|2014-11-01||Interventional|vibraMTrP||The Effect of Vibration Therapy Over Neck Myofascial Trigger Points|The Effect of Vibration Therapy on Pressure Pain Thresholds Over Neck Myofascial Trigger Points: a Randomized Controlled Study|Unknown status|Active, not recruiting|N/A|13|Actual|University of Valencia||2|||f||||f||||||||||2017-10-10 23:29:45.91427|2017-10-10 23:29:45.91427
NCT02393508|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-12-19|||September 2015||2015-09-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|ABC-TOP||The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient Population|The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient Population|Enrolling by invitation||Phase 3|60|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 23:29:46.023514|2017-10-10 23:29:46.023514
NCT02393495|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-08-30|||February 2015||2015-02-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Ultrasound Guided Intra-uterine Device Insertion|A Further Step Towards Painless Intrauterine Device Insertion, a Randomized Control Trial|Completed||N/A|102|Actual|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-10 23:29:46.124067|2017-10-10 23:29:46.124067
NCT02393482|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-03-08|||June 2016||2016-06-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Psychological Impact of Amenorrhea in Women With Endometriosis|Psychological Impact of Amenorrhea in Women With Endometriosis: Perspective Randomized Study|Not yet recruiting||Phase 4|50|Anticipated|University of Cagliari||2|||f||||||||||||||2017-10-10 23:29:46.20157|2017-10-10 23:29:46.20157
NCT02393469|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-12-02|||January 2014||2014-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Pulmonary Rehabilitation on Respiratory, and Cardiovascular Functional Capacity in COPD|Effects of Pulmonary Rehabilitation on Function Cardiovascular, Respiratory and Functional Capacity of People With Chronic Obstructive Pulmonary Disease in the Municipality of Santa Cruz do Sul - Rio Grande do Sul.|Active, not recruiting||N/A|70|Actual|University of Santa Cruz do Sul||3|||f||||f||||||||||2017-10-10 23:29:46.316663|2017-10-10 23:29:46.316663
NCT02393456|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-08|||January 2015||2015-01-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Oxytocin and the Social Brain|Oxytocin's Effects on Behavior and Neural Activity During Social Cognition Tasks|Completed||Early Phase 1|161|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 23:29:46.454986|2017-10-10 23:29:46.454986
NCT02393443|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-08|||January 2015||2015-01-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Oxytocin and Learning for Teaching|The Effects of Oxytocin on Learning With Social Versus Nonsocial Motivation|Completed||Early Phase 1|161|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 23:29:46.562315|2017-10-10 23:29:46.562315
NCT02393430|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2015-03-15|||May 2012||2012-05-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Clinical Effect of Rebamipide on Chronic Gastritis|Clinical Effect of Rebamipide on Chronic Gastritis|Completed||Phase 4|180|Actual|Tianjin Medical University General Hospital||2|||f||||f||||||||||2017-10-10 23:29:46.654416|2017-10-10 23:29:46.654416
NCT02393417|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-05-15|||March 2015|Actual|2015-03-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)|Active, not recruiting||Phase 2|156|Anticipated|Nielsen BioSciences, Inc.||4|||f||||f||||||||||2017-10-10 23:29:46.736224|2017-10-10 23:29:46.736224
NCT02393404|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-18|||March 2014||2014-03-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Functional Movement-power Training for Children With Developmental Coordination Disorder: A Randomised Controlled Trial|Enhancing Neuromuscular Performance and Central Nervous System Plasticity Through Functional Movement-power Training to Improve Balance Strategies in Children With Developmental Coordination Disorder: A Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|87|Anticipated|The University of Hong Kong||3|||f||||t||||||||||2017-10-10 23:29:46.870401|2017-10-10 23:29:46.870401
NCT02393391|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-03-18|||May 2015||2015-05-01|March 2015|2015-03-01||||May 2015|Anticipated|2015-05-01||Interventional|||A Novel Non Invasive Brain Stimulation Based Treatment for Chronic Low Back Pain (CLBP)|Novel Non Invasive Brain Stimulation Based Treatment for Chronic Low Back|Unknown status|Not yet recruiting|Phase 2/Phase 3|80|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:29:46.967002|2017-10-10 23:29:46.967002
NCT02393378|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2017-01-26||2017-01-26|April 2015||2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|TELLUS||Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate|A 24-week Randomized, Open-Label, Parallel-Group, Active-Controlled, Exploratory, Proof-of-Mechanism Imaging Study Investigating the Efficacy of 150 mg of Namilumab Administered Subcutaneously vs Adalimumab in Patients With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate|Completed||Phase 2|36|Anticipated|Takeda||2|||f||||f||||||||||2017-10-10 23:29:47.042919|2017-10-10 23:29:47.042919
NCT02393365|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-07-25|||September 2015||2015-09-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Prevalence and Screening of Hepatitis C in Belgium in 2015|Prevalence and Screening of Hepatitis C in Belgium in 2015|Recruiting||N/A|10000|Anticipated|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 23:29:47.205203|2017-10-10 23:29:47.205203
NCT02393352|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-21|||March 2016||2016-03-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|||Benefits of Dry Needling in Trigger Points on Autonomic Nervous System and Corporal Composition in Patients With Fibromyalgia Syndrome|Benefits of Dry Needling in Trigger Points on Autonomic Nervous System, Photoelectric Plethysmography, Body Composition in Patients With Fibromyalgia Syndrome.|Completed||N/A|64|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-10 23:29:47.338594|2017-10-10 23:29:47.338594
NCT02393339|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-18|||April 2015||2015-04-01|March 2015|2015-03-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Pre-operative Analgesics for Postoperative Pain Relief After Dental Treatment|Pre-operative Analgesics for Postoperative Pain Relief After Dental Treatment|Unknown status|Not yet recruiting|Early Phase 1|400|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 23:29:47.436396|2017-10-10 23:29:47.436396
NCT02393326|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-18|||May 2015||2015-05-01|March 2015|2015-03-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars|Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars|Not yet recruiting||Early Phase 1|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 23:29:47.507643|2017-10-10 23:29:47.507643
NCT02393313|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-03-18|||April 2015||2015-04-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|Rayner-toric||Rayner Toric IOL Rotational Stability|Examination of Rayner T-flex Toric Intra-Ocular Lens for Spherical and Astigmatic Correction, and Rotational Stability|Not yet recruiting||N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-10 23:29:47.588683|2017-10-10 23:29:47.588683
NCT02393300|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2015-03-25|||September 2014||2014-09-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Comparison of Topical Versus Intravenous Tranexamic Acid in TKA|Comparison of Topical Versus Intravenous Tranexamic Acid in Primary Total Knee Arthroplasty：A Prospective Randomized Study|Unknown status|Recruiting|Phase 3|150|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||||2017-10-10 23:29:47.680831|2017-10-10 23:29:47.680831
NCT02393287|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-03-18|||November 2014||2014-11-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Observational|ReProLine||Retroprospective Real Life Observatory of Eribulin|Activity and Toxicity Profile of Eribulin Mesylate in Pretreated Metastatic Breast Cancer: an Observational Multicentric Retroprospective Study|Unknown status|Recruiting|N/A|753|Anticipated|Institut Cancerologie de l'Ouest|||1||f||||f||||||||||2017-10-10 23:29:47.787338|2017-10-10 23:29:47.787338
NCT02393274|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2016-12-20|||April 2015||2015-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Observational|||Microcirculation in Venoarterial Extracorporeal Membrane Oxygenation Life Support|Investigation of Microcirculation in Patients With Venoarterial Extracorporeal Membrane Oxygenation Life Support|Completed||N/A|48|Actual|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-10 23:29:47.945719|2017-10-10 23:29:47.945719
NCT02393261|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-18|||January 2015||2015-01-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||A Controlled and Multi-Center Study of 2500ml Huaren Peritoneal Dialysate|Validity and Security of 2500ml Huaren Peritoneal Dialysate: A Prospective, Randomized, Controlled, Multi-Center Clinical Trial|Unknown status|Recruiting|N/A|300|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:29:48.021573|2017-10-10 23:29:48.021573
NCT02393248|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-07-17|||January 2015||2015-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Open-Label, Dose-Escalation Study of INCB054828 in Subjects With Advanced Malignancies|A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies|Recruiting||Phase 1/Phase 2|280|Anticipated|Incyte Corporation||1|||f||||f||||||||||2017-10-10 23:29:48.111408|2017-10-10 23:29:48.111408
NCT02393235|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-07-02|||March 2015||2015-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Observational|||A Comparative Analysis of Arterial Blood Flow in Unexplained Infertility, Tubal Infertility and Fertile Groups|A Comparative Analysis of Ovarian, Uterine and Spiral Arterial Blood Flow in Unexplained Infertility, Tubal Infertility and Fertile Groups|Completed||N/A|217|Actual|Suleymaniye Birth And Women's Health Education And Research Hospital|||3||f||||f||||||||||2017-10-10 23:29:48.235756|2017-10-10 23:29:48.235756
NCT02390999|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-05-01|||March 2013||2013-03-01|February 2015|2015-02-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Neurological Prognostication of Patients in Therapeutic Hypothermia After Cardiac Arrest|Neurological Prognostication of Patients in Therapeutic Hypothermia After Cardiac Arrest|Completed||N/A|100|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:30:14.035684|2017-10-10 23:30:14.035684
NCT02393222|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-18|||March 2015||2015-03-01|March 2015|2015-03-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|ACUMEN-HD||Assessing Cognitive fUnction and MEasuring the Cerebral circulatioN on HaemoDialysis|Exploring the Natural History of Cerebrovascular Disease in Patients With End-stage Renal Disease on Haemodialysis|Unknown status|Not yet recruiting|N/A|97|Anticipated|NHS Greater Glasgow and Clyde|||1||f||||t||||||Samples With DNA|"     Samples will be taken with consent for serum biomarkers. Consent will be sought for DNA     testing in the future, following favourable ethical review   "|||2017-10-10 23:29:48.314372|2017-10-10 23:29:48.314372
NCT02393209|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2017-02-16|||June 2015||2015-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Docetaxel With or Without MLN1117 in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer|A Phase 1b/Adaptive Phase 2 Study of Docetaxel With or Without MLN1117 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer|Terminated||Phase 1/Phase 2|14|Actual|Takeda||6||Lack of efficacy in combination.|f||||f||||||||||2017-10-10 23:29:48.401973|2017-10-10 23:29:48.401973
NCT02393196|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-11-16|||March 2015||2015-03-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Colloid Preload Versus Colloid Coload During Cesarean Deliveries|Colloid Preload Versus Colloid Coload in Preventing Spinal Anesthesia-Induced Hypotension During Cesarean Section Deliveries: A Prospective, Randomized, Double-Blind Comparative Study|Recruiting||Phase 4|200|Anticipated|Sifa University||2|||f||||t||||||||||2017-10-10 23:29:48.521754|2017-10-10 23:29:48.521754
NCT02393183|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2017-03-11|||September 2017|Anticipated|2017-09-01|March 2017|2017-03-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)|The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease, a Placebo Controlled Randomized Clinical Trial|Not yet recruiting||Phase 2/Phase 3|235|Anticipated|Iran University of Medical Sciences||3|||f||||f|f|f||||||||2017-10-10 23:29:48.793583|2017-10-10 23:29:48.793583
NCT02393170|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-02-12|||November 2014||2014-11-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|Home-VR||Home-based -Virtual Reality Intervention for Stroke Rehabilitation|Virtual Reality Intervention for Stroke Rehabilitation - Home Based (Stage 2)|Completed||N/A|24|Actual|Sheba Medical Center||2|||f||||f||||||||No||2017-10-10 23:29:48.938196|2017-10-10 23:29:48.938196
NCT02393157|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2016-10-04|||February 2015||2015-02-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|O-ICE||Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL|Chemoimmunotherapy With Obinutuzumab, Ifosfamide, Carboplatin and Etoposide (O-ICE) in Children, Adolescents and Young Adults With Recurrent Refractory CD20+ Mature B-NHL|Recruiting||Phase 2|25|Anticipated|New York Medical College||2|||f||||t||||||||||2017-10-10 23:29:49.070075|2017-10-10 23:29:49.070075
NCT02393144|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-03-14|||February 2015||2015-02-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Analysis of Contemporary Labor Patterns Measured Via Transperineal Ultrasonography|Analysis of Contemporary Labor Patterns Measured Via Transperineal Ultrasonography|Unknown status|Recruiting|N/A|1000|Anticipated|Ankara University||2|||f||||f||||||||||2017-10-10 23:29:49.237712|2017-10-10 23:29:49.237712
NCT02393131|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-03-27|||February 2015||2015-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain Metastases|Neurocognitive Outcome of Conformal Whole Brain Radiotherapy With or Without Hippocampal Avoidance for Brain Metastases: A Phase II Single Blind Randomized Trial|Recruiting||N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||No||2017-10-10 23:29:49.366818|2017-10-10 23:29:49.366818
NCT02393118|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-03-01|||September 2014||2014-09-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury|Safety and Efficacy of the BrainPort V200 Device in Individuals Blinded by Traumatic Injury|Active, not recruiting||N/A|20|Actual|Wicab||1|||f||||f||||||||||2017-10-10 23:29:49.548067|2017-10-10 23:29:49.548067
NCT02393105|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-03-22|||January 2015||2015-01-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Sense of Hope Alleviates Fatigue in Breast Cancer Survivors|The Sense of Hope Alleviates Fatigue in Breast Cancer Survivors|Unknown status|Recruiting|N/A|180|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:29:49.693348|2017-10-10 23:29:49.693348
NCT02393092|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-10-31|||July 2015||2015-07-01|October 2016|2016-10-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Violence Prevention Study for Youth Age 10-15|A Youth Violence Prevention Initiative: A VCUHS and Boys and Girls Club of Metro Richmond Initiative|Terminated||N/A|22|Actual|Virginia Commonwealth University||3||"It was determined that internal resources to support this population would be better utilized   in other Injury and Violence Prevention Programs."|f||||f||||||||||2017-10-10 23:29:49.815492|2017-10-10 23:29:49.815492
NCT02393079|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-03-13|||January 2015||2015-01-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Analysis of TCLT in TBI Patients: a Prospective, Randomized Controlled Trial|The Effects of Transcranial LED Therapy (TCLT) in Patients With Traumatic Brain Injury (TBI): a Prospective, Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:29:49.907988|2017-10-10 23:29:49.907988
NCT02393066|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-08-03|||October 2014||2014-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Hemodynamics Between Dexmedetomidine and Propofol for Sedation in Patients With Abdominal Surgery|A Comparison of Hemodynamic Effects Between Dexmedetomidine and Propofol for Sedation in Patients With Major Abdominal Tumor Surgery|Completed||Phase 4|60|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:29:50.0317|2017-10-10 23:29:50.0317
NCT02393053|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-03-18|||November 2010||2010-11-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|February 2011|Actual|2011-02-01||Interventional|||Non-Pedicled Buccal Fat Pad Graft in the Treatment of Gingival Recessions|Innovation Technique With Non-pedicled Buccal Fat Pad Graft in the Treatment of Gingival Recessions: a Randomized Controlled Clinical Trial|Completed||N/A|12|Actual|Universidade Positivo||2|||f||||f||||||||||2017-10-10 23:29:50.145476|2017-10-10 23:29:50.145476
NCT02393027|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-05-24|||March 2015||2015-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|November 2016|Actual|2016-11-01||Interventional|LBT 999||Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999|Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999|Terminated||Early Phase 1|16|Actual|University Hospital, Tours||2||Enough inclusions for interpretation|f||||t||||||||||2017-10-10 23:29:50.410161|2017-10-10 23:29:50.410161
NCT02393014|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-09-21|||April 2015||2015-04-01|February 2015|2015-02-01||||June 2016|Actual|2016-06-01||Interventional|AGIR||Physical Activity and Fall Prevention in Geriatric Inpatients in Acute caRe: Feasibility Study|Activité Physique et prévention de la Chute du Patient âGé hospItalisé en Court séjouR: Etude de faisabilité (AGIR)|Completed||N/A|278|Actual|University Hospital, Angers||3|||f||||||||||||||2017-10-10 23:29:50.53097|2017-10-10 23:29:50.53097
NCT02393001|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-08-28|||May 2015||2015-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques|Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques|Active, not recruiting||N/A|50|Actual|University of Florida|||1||f||||f||||||||||2017-10-10 23:29:50.613189|2017-10-10 23:29:50.613189
NCT02392988|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-18|||May 2015||2015-05-01|February 2015|2015-02-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Does Acupuncture Therapy Reduce the Need for Labor Induction After Postdate (Week 41)|Randomised ,Single Blind, Placebo Controlled in Meir Medical Center. Study the Potential of Acupuncture Therapy to Reduce the Need for Labor Induction After Postdate (Week 41)|Not yet recruiting||N/A|600|Anticipated|Meir Medical Center||3|||f||||f||||||||||2017-10-10 23:29:50.712318|2017-10-10 23:29:50.712318
NCT02392975|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-06-06|||April 2015||2015-04-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Fast MR for Young Children With Traumatic Brain Injury|Fast MR for Young Children With Traumatic Brain Injury|Recruiting||N/A|400|Anticipated|University of Colorado, Denver||1|||f||||f||||||||||2017-10-10 23:29:50.821758|2017-10-10 23:29:50.821758
NCT02392962|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-18|||December 2014||2014-12-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Dynamic and Static Stretching on Postural Stability, Reaction Time and Countermovement Jump of Sprinters|Efectos de la Fatiga en el Rendimiento físico en el Ejercicio de Sentadillas|Completed||N/A|24|Actual|Universidad Católica San Antonio de Murcia||2|||f||||t||||||||||2017-10-10 23:29:50.923904|2017-10-10 23:29:50.923904
NCT02392949|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-06-11|||April 2015||2015-04-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Does Passive Spinal Mobilization Improve Shoulders Strength in Healthy Adults?|Does Passive Spinal Mobilization Improve Shoulders Strength in Healthy Adults?|Completed||N/A|22|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||No||2017-10-10 23:29:51.005317|2017-10-10 23:29:51.005317
NCT02392936|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-18|||March 2015||2015-03-01|March 2015|2015-03-01|November 2017|Anticipated|2017-11-01|March 2017|Anticipated|2017-03-01|2 Years|Observational [Patient Registry]|PRISCCA||Evaluation of Peri-operative Risk Factors for Surgery Site Infection in Cardiac Surgery||Not yet recruiting||N/A|1000|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||Samples Without DNA|"     Blood samples during and after intervention, for routine tests, and eventually dosing     plasmatic concentration of the antibiotic administered for prophylaxis. Microbiological     analyses concerning wound and blood samples.   "|||2017-10-10 23:29:51.080196|2017-10-10 23:29:51.080196
NCT02392923|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-02-09|||June 2014||2014-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|Normalen||Quality of Life in a Representative Swedish Population|Quality of Life and Body Functions in a Representative Swedish Population|Completed||N/A|3000|Anticipated|Göteborg University|||1||f||||f||||||||||2017-10-10 23:29:51.149937|2017-10-10 23:29:51.149937
NCT02392910|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-15|2015-03-18|||March 2006||2006-03-01|March 2015|2015-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.|Hospitalization and Mortality in Iron Deficient, Anemic Patients With Chronic Kidney (CKD) and Heart Failure Receiving Intravenous Iron Therapy: A Five Year Follow-up From a Pilot Study|Completed||Phase 4|40|Actual|Hospital Aleman||2|||f||||t||||||||||2017-10-10 23:29:51.227128|2017-10-10 23:29:51.227128
NCT02392897|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-02-07|||April 2015||2015-04-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||theFRESHstudy: FRequency of Eating and Its Influence on Satiety and Health|Eating Frequency and Its Influence on Satiety and Biomarkers of Health & Disease|Recruiting||N/A|50|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||No||2017-10-10 23:29:51.332404|2017-10-10 23:29:51.332404
NCT02392884|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-18|||September 2014||2014-09-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||HIV Medication Adherence in Underserved Populations|A Cognitive Rehabilitation Program to Promote Treatment Adherence for Individuals Who Are HIV Positive With Mild Neurocognitive Difficulties|Unknown status|Recruiting|N/A|60|Anticipated|Cedars-Sinai Medical Center||3|||f||||t||||||||||2017-10-10 23:29:51.434883|2017-10-10 23:29:51.434883
NCT02392871|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-06-27|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|CombiRT||Radiotherapy & Combi in Metastatic Melanoma|An Open-label, Single-arm, Phase I/II, Multicentre Study to Evaluate the Safety and Efficacy of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients With Unresectable (Stage IIIc) and Metastatic (Stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma|Recruiting||Phase 1/Phase 2|30|Anticipated|Australia and New Zealand Melanoma Trials Group||1|||f||||t||||||||||2017-10-10 23:29:51.561999|2017-10-10 23:29:51.561999
NCT02392858|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-08-12|||January 2015||2015-01-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|ANTIGRIPPE||Severe Influenza Cohort|Identification, in Patients Admitted to Intensive Care for Severe Influenza Respiratory Infection, of a Predictive Biomarker of Respiratory Distress|Recruiting||N/A|200|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:29:51.719177|2017-10-10 23:29:51.719177
NCT02392845|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-13|||June 2005||2005-06-01|March 2015|2015-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|MODEL1||A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study|A Pilot Dose Escalation Phase I Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study|Completed||Phase 1|17|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:29:51.854175|2017-10-10 23:29:51.854175
NCT02392832|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-03-01|||April 2015||2015-04-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|LLML||Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria Incidence|Impact and Cost-Effectiveness of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria Incidence: a Cluster-Randomized Controlled Trial in Western Kenya|Recruiting||N/A|240000|Anticipated|University of California, Irvine||2|||f||||f||||||||Yes|We use aggregated publically available clinical records from hospitals, these records can be obtained freely from hospitals or Ministry of Health. We can provide these aggregated data upon request once they are published.|2017-10-10 23:29:51.939704|2017-10-10 23:29:51.939704
NCT02392819|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-09-02|||January 2015||2015-01-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Effects on Metabolism and Cognitive Functions of a Commonly Used Commercial Food Supplement|Food Design for Improved Cognitive Performance|Completed||N/A|22|Actual|Lund University||2|||f||||f||||||||||2017-10-10 23:29:52.020982|2017-10-10 23:29:52.020982
NCT02392793|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-03-31|||March 25, 2015|Actual|2015-03-25|February 2017|2017-02-01|March 31, 2020|Anticipated|2020-03-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies|A Phase I Study of Talazoparib (BMN 673) Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies|Recruiting||Phase 1|60|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|t|f||||||||2017-10-10 23:29:52.178431|2017-10-10 23:29:52.178431
NCT02392780|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-18|||April 2015||2015-04-01|March 2015|2015-03-01||||April 2018|Anticipated|2018-04-01||Interventional|||Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease|Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease|Not yet recruiting||Phase 2|10|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-10 23:29:52.301667|2017-10-10 23:29:52.301667
NCT02392767|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-03-29|2015-10-16||October 2014||2014-10-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function|Effect of a Dietary Supplement on Endothelial Function in Volunteers With Light to Moderate Hypertension - a Randomised, Double-blind, Placebo Controlled Cross-over Study|Completed||N/A|25|Actual|Dr. Loges & Co. GmbH||2|||f||||f||||||||Undecided|Undecided|2017-10-10 23:29:52.396524|2017-10-10 23:29:52.396524
NCT02392754|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-09-27|||April 1, 2015|Actual|2015-04-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Interventional|SCREEN-AF||Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older|"Program for Identification of Actionable Atrial Fibrillation (PIAAF): Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older: the SCREEN-AF Randomized Trial"|Recruiting||N/A|822|Anticipated|Population Health Research Institute||2|||f||||f||||||||||2017-10-10 23:29:54.224024|2017-10-10 23:29:54.224024
NCT02392741|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-18|||March 2015||2015-03-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of a Physical Exercise Program on Microcirculation and Pregnancy Outcomes in Obese Pregnant Women|Effects of a Physical Exercise Program on Microcirculation and Pregnancy Outcomes in Obese Pregnant Women: Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|60|Anticipated|Professor Fernando Figueira Integral Medicine Institute||2|||f||||f||||||||||2017-10-10 23:29:54.403806|2017-10-10 23:29:54.403806
NCT02392728|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-09-13|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|VE||Virtual Environments in Patients Receiving Treatment for Lung Cancer|The Effectiveness of Virtual Environment on the Adverse Psychological Effects in Patients Receiving Treatment for Lung Cancer|Not yet recruiting||N/A|50|Anticipated|Cyprus University of Technology||2|||f||||t|f|f||||||||2017-10-10 23:29:54.504689|2017-10-10 23:29:54.504689
NCT02392715|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-03-27|||April 2015||2015-04-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|IMTGET||Inspiratory Muscle Training Combined With General Exercise Training in COPD|Inspiratory Muscle Training Combined With General Exercise Training, Compared to General Exercise Training Alone in Patients With COPD: Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|80|Anticipated|Hôpital Riviera-Chablais, Vaud-Valais||2|||f||||f||||||||||2017-10-10 23:29:54.58769|2017-10-10 23:29:54.58769
NCT02392702|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-09-22|||March 2015||2015-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects|A Two-Part Open-Label, Randomized, Sequential, Crossover, Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of C-10355 and C-10358 in Healthy Volunteers, With a PK Comparison to Kalydeco®|Completed||Phase 1|15|Actual|Concert Pharmaceuticals||6|||f||||f||||||||||2017-10-10 23:29:54.672154|2017-10-10 23:29:54.672154
NCT02392689|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-08-01|||March 2015||2015-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|IMPACT-EU||Improve Management of Heart Failure With Procalcitonin|Improve Management of Heart Failure With Procalcitonin - Biomarkers in Cardiology 18|Recruiting||N/A|792|Anticipated|Brahms AG||2|||f||||t||||||||||2017-10-10 23:29:54.848198|2017-10-10 23:29:54.848198
NCT02392676|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-04-29|||July 2016||2016-07-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations|A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients With Platinum Sensitive Relapsed Ovarian Cancer Who Are in Complete or Partial Response Following Platinum Based Chemotherapy and Whose Tumours Carry Loss of Function Somatic BRCA Mutation(s) or Loss of Function Mutation(s) in Tumour Homologous Recombination Repair -Associated Genes|Withdrawn||Phase 3|0|Actual|AstraZeneca||2||"Study is unlikely to be feasible given the evolving ovarian cancer landscape and alternative   studies have the potential to meet future clinical demand."|f||||t||||||||||2017-10-10 23:29:55.084426|2017-10-10 23:29:55.084426
NCT02392663|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-11-11|||March 2015||2015-03-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis|Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis: a Randomized, Double-blind, Crossover Trial|Completed||N/A|24|Actual|Hospital Clinic of Barcelona||3|||f||||f||||||||||2017-10-10 23:29:55.24816|2017-10-10 23:29:55.24816
NCT02392650|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-08-08|||June 2014|Actual|2014-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|BaBs||Microbiome And Multi'Omics In Preterm Birth: The Bacteria And Birth Study|Microbiome And Multi'Omics In Preterm Birth: The Bacteria And Birth Study (BaBs)|Recruiting||N/A|526|Anticipated|Baylor College of Medicine|||1||f||||f||||||Samples With DNA|"     Samples with DNA, RNA and metabolites   "|||2017-10-10 23:29:55.361651|2017-10-10 23:29:55.361651
NCT02392637|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-07-19|||April 2, 2015|Actual|2015-04-02|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers|A Phase II Study of Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers|Active, not recruiting||Phase 2|62|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:29:55.460314|2017-10-10 23:29:55.460314
NCT02392624|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-09-11|||May 18, 2015|Actual|2015-05-18|September 2017|2017-09-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Interventional|||A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria|XTEND-CIU (Xolair Treatment Efficacy of Longer Duration in Chronic Idiopathic Urticaria): A Phase IV, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Omalizumab Through 48 Weeks in Patients With Chronic Idiopathic Urticaria|Completed||Phase 4|206|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-10 23:29:55.589897|2017-10-10 23:29:55.589897
NCT02392611|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-06-07|||March 16, 2015|Actual|2015-03-16|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 in Adults With Advanced Solid Tumors and Lymphomas|A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Monotherapy in Subjects With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Subjects With Estrogen Receptor Positive Breast Cancer|Active, not recruiting||Phase 1|33|Actual|Gilead Sciences||3|||f||||f|t|f||||||||2017-10-10 23:29:55.773855|2017-10-10 23:29:55.773855
NCT02392598|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-08-03|||August 2015||2015-08-01|August 2015|2015-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|HBHS||A Hepatitis B With Hepatic Steatosis Study|Effect of Hepatic Steatosis on Prognosis and Outcomes of Patients With Chronic Hepatitis B|Not yet recruiting||N/A|3000|Anticipated|Fatty Liver and Alcoholic Liver Disease Study Group, China|||1||f||||f||||||Samples With DNA|"     Liver tissue   "|||2017-10-10 23:29:55.862077|2017-10-10 23:29:55.862077
NCT02392585|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-05-28|||March 2015||2015-03-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|March 2016|Actual|2016-03-01||Interventional|||Single or Triple Uterine Tourniquet at Myomectomy|Triple Tourniquet vs. Single Tourniquet to Reduce Haemorrhage During Myomectomy: a Prospective Randomised Controlled Trial|Active, not recruiting||N/A|60|Actual|Ataturk University||2|||f||||f||||||||||2017-10-10 23:29:55.967593|2017-10-10 23:29:55.967593
NCT02392572|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-06-07|||November 2015|Actual|2015-11-01|June 2017|2017-06-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|||ONC201 in Relapsed/Refractory Acute Leukemias and High-Risk Myelodysplastic Syndromes (HR-MDS)|Phase I/II Study of Oral ONC201 in Patients With Relapsed or Refractory Acute Leukemias and High-Risk Myelodysplastic Syndromes|Recruiting||Phase 1/Phase 2|120|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 23:29:56.055047|2017-10-10 23:29:56.055047
NCT02392559|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-08-31|||March 24, 2016|Actual|2016-03-24|August 2017|2017-08-01|June 21, 2019|Anticipated|2019-06-21|June 21, 2019|Anticipated|2019-06-21||Interventional|HAUSER-RCT||Trial Assessing Efficacy, Safety and Tolerability of PCSK9 Inhibition in Paediatric Subjects With Genetic LDL Disorders|Double-blind, Randomized, Multicenter, Placebo-Controlled Study to Characterize the Efficacy, Safety, and Tolerability of 24 Weeks of Evolocumab for LDL-C Reduction in Pediatric Subjects 10 to 17 Years of Age With HeFH|Recruiting||Phase 3|150|Anticipated|Amgen||2|||f||||t||||||||||2017-10-10 23:29:56.143684|2017-10-10 23:29:56.143684
NCT02392546|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-06-02|||April 2015||2015-04-01|June 2015|2015-06-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Elobixibat Colonic Motor Function Study|A Single Center, Placebo-controlled Trial to Evaluate the Effects of Elobixibat in Colonic Motor Functions in Patients With Chronic Idiopathic Constipation|Withdrawn||Phase 2|0|Actual|Ferring Pharmaceuticals||4||Business reasons|f||||f||||||||||2017-10-10 23:29:56.426588|2017-10-10 23:29:56.426588
NCT02392533|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-10-26|||August 2015||2015-08-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|May 2016|Actual|2016-05-01||Observational|USPREG||Ultrasound and Neuraxial Anesthesia in Pregnancy|Ultrasound Confirmation of Neuraxial Anesthetic Vertebral Level in Post-partum Patients|Suspended||N/A|450|Actual|University of Chicago|||2|the fellow completed the program and the project stopped when he left|f||||f||||||||No||2017-10-10 23:29:56.518493|2017-10-10 23:29:56.518493
NCT02392520|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-03-18|||May 2015||2015-05-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)|GnRH Antagonist in the Luteal Phase Compared to Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) in Whom All Embryos Are Cryopreserved|Unknown status|Not yet recruiting|N/A|40|Anticipated|Eugonia||2|||f||||f||||||||||2017-10-10 23:29:56.625262|2017-10-10 23:29:56.625262
NCT02392507|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2017-10-03|||October 2015||2015-10-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC|A Single-Arm, Multicenter, Open-Label, Phase 2 Study of Nab®-Paclitaxel (Abraxane®) and Carboplatin Chemotherapy Plus Necitumumab (LY3012211) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|50|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 23:29:56.746173|2017-10-10 23:29:56.746173
NCT02392494|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-16|2015-08-24|||April 2015||2015-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002)|A Single Rising Dose Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MK-1075 in HCV-Infected Patients|Completed||Phase 1|9|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-10 23:29:56.905227|2017-10-10 23:29:56.905227
NCT02392481|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-09-07|||July 16, 2015|Actual|2015-07-16|September 2017|2017-09-01|January 3, 2017|Actual|2017-01-03|January 3, 2017|Actual|2017-01-03||Observational|||Asthma Biomarker Study|An Exploratory, Prospective, Non-interventional Study Comparing Biomarker Signatures Between Patients With Asthma and Healthy Volunteers and to Investigate Biomarkers Associated With Known Phenotypes Across Asthma Severities|Completed||N/A|85|Anticipated|Boehringer Ingelheim|||4||f||||||||||Samples With DNA|"     Blood and sputum   "|||2017-10-10 23:29:56.994934|2017-10-10 23:29:56.994934
NCT02392468|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-08-23|||April 15, 2015|Actual|2015-04-15|August 2017|2017-08-01|August 28, 2017|Anticipated|2017-08-28|August 10, 2017|Actual|2017-08-10||Interventional|||Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers|Randomised, Parallel-group, Double-blind Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Age-comparable Healthy Volunteers|Active, not recruiting||Phase 1|60|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:29:57.084514|2017-10-10 23:29:57.084514
NCT02392455|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-08-22|||March 23, 2015|Actual|2015-03-23|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)|Vargatef in 2nd-line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung|Recruiting||N/A|400|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:29:57.167135|2017-10-10 23:29:57.167135
NCT02392442|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-06-30|||February 25, 2015||2015-02-25|May 4, 2017|2017-05-04|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Effects of Bronchial Segmental Endotoxin Instillation in Humans|Pulmonary Effects of Bronchial Segmental Endotoxin Instillation in Humans|Recruiting||Phase 2|58|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:29:57.259853|2017-10-10 23:29:57.259853
NCT02392429|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-18|2017-10-02|||December 8, 2015|Actual|2015-12-08|May 2017|2017-05-01||||January 1, 2100|Anticipated|2100-01-01||Interventional|||FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia|Early Assessment of Treatment Response in AML Using FLT PET/CT Imaging|Recruiting||Phase 2|57|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-10 23:29:57.37735|2017-10-10 23:29:57.37735
NCT02392416|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-05-17|||April 2015||2015-04-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|ANTLER||Atorvastatin Study in Cardiovascular Disease Risk|Non-interventional, Multicenter Clinical Study to Assess the Treatment With Atorvastatin in Patient Compliance With Hyperlipidemia and Other Cardiovascular Risk Factors|Completed||N/A|900|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-10 23:29:57.579579|2017-10-10 23:29:57.579579
NCT02392390|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2016-04-06|||October 2015||2015-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PDT-Bactério||Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic Wounds|Effects of Topical Dynamic Phototherapy (TDP) on the Microbiota of Chronic Wounds: a Pilot Study|Completed||N/A|10|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 23:29:57.809785|2017-10-10 23:29:57.809785
NCT02392377|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2015-12-18|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy|Pilot Study of Correlation Between Molecular Phenotype and Response to Two Independent Treatment Regimens, Carboplatin and Paclitaxel vs. 5-Fluorouracil and Oxaliplatin Chemotherapy in Patients With Localized Esophageal Adenocarcinoma|Terminated||Phase 2|1|Actual|Case Comprehensive Cancer Center||2||Slow accrual|f||||f||||||||||2017-10-10 23:29:57.945457|2017-10-10 23:29:57.945457
NCT02392364|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-12-13|||March 2015||2015-03-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|EVADE||Variable Interval Versus Set Interval Aflibercept for DME|Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)|Active, not recruiting||Phase 4|50|Actual|California Retina Consultants||2|||f||||f||||||||||2017-10-10 23:29:58.063585|2017-10-10 23:29:58.063585
NCT02392338|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-02-02|||November 2014||2014-11-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Hybrid Procedure in Patients With Persistent Atrial Fibrillation|Comparison of Success Rate of Totally Thoracoscopic Ablation Versus Hybrid Procedure in Patients With Persistent Atrial Fibrillation|Completed||N/A|60|Actual|Samsung Medical Center||2|||f||||t||||||||No||2017-10-10 23:29:58.271557|2017-10-10 23:29:58.271557
NCT02392312|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-13|2017-05-18|||January 22, 2015|Actual|2015-01-22|May 2017|2017-05-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients|Safety and Efficacy of Individual Batches of ATG-F in Kidney Transplant Recipients: Multicentre, Prospective, Observational Study|Recruiting||N/A|1440|Anticipated|Astellas Pharma Inc|||1||f||||f||||||||Undecided||2017-10-10 23:29:58.454735|2017-10-10 23:29:58.454735
NCT02392299|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-10-03|||September 2015||2015-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Observational|||Risk of Falling in Chronic Kidney Disease 5|Frailty, Cardiovascular Function and Risk of Falling in Patients Receiving Haemodialysis Treatment|Recruiting||N/A|60|Anticipated|Queen Margaret University|||1||f||||f||||||||||2017-10-10 23:29:58.568735|2017-10-10 23:29:58.568735
NCT02392286|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-07-11|||March 2015||2015-03-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Corticosteroid Dosage for Crohn's Disease Flare|A Prospective, Randomized Trial Comparing the Efficacy of Body-weight Based Versus Fixed Corticosteroid Dosage on Remission in Patients With Moderate to Severe Crohn's Disease Flares|Recruiting||Phase 4|182|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 23:29:58.635788|2017-10-10 23:29:58.635788
NCT02392273|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-12-23|||February 2015||2015-02-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||A Prospective Observational Registry of Primary Headache Patients Treated With Ausanil|A Prospective Observational Registry of Primary Headache Patients Treated With Ausanil|Terminated||N/A|20|Actual|VR1 Corporation|||1|Study unable to recruit|f||||f||||||||||2017-10-10 23:29:58.859588|2017-10-10 23:29:58.859588
NCT02392260|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-17|||April 2015||2015-04-01|March 2015|2015-03-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|NISTAS1||Non-invasive Screening of the Status of the Vascular System: Feasibility Test|Non-invasive Screening of the Status of the Vascular System: Feasibility Test|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Pavia||1|||f||||f||||||||||2017-10-10 23:29:58.95229|2017-10-10 23:29:58.95229
NCT02392247|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-06-01|2016-02-25||April 2015||2015-04-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Hemosonics- VCU Cardiac Surgery Clinical Study|Hemosonics- VCU Cardiac Surgery Clinical Study Protocol|Completed||N/A|52|Actual|Virginia Commonwealth University|This is a descriptive, single-cohort study, not an hypothesis-testing trial. The objective was device performance comparison. As there is no gold standard technology, this study could not determine which method was 'best' or 'superior'.||1||f||||f||||||||No||2017-10-10 23:29:59.025457|2017-10-10 23:29:59.025457
NCT02392234|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-04-12|||March 2015||2015-03-01|June 2016|2016-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation, and a Second Allele With a CFTR Mutation Predicted to Have Residual Function|Completed||Phase 3|246|Actual|Vertex Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-10-10 23:29:59.28726|2017-10-10 23:29:59.28726
NCT02392221|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-01-30|||May 2015||2015-05-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|Inspired||Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2008).|Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2008).|Recruiting||N/A|966|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||||||2017-10-10 23:29:59.530893|2017-10-10 23:29:59.530893
NCT02392208|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-03-29|2017-01-18||July 2015||2015-07-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5|Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5|Completed||Phase 4|8|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:29:59.6415|2017-10-10 23:29:59.6415
NCT02392195|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-10-03|||February 2013|Actual|2013-02-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|July 2015|Actual|2015-07-01||Observational|||Brain Characteristics Noted Prior to and Following Treatment|Brain Characteristics Noted Prior to and Following Treatment of Deformational Plagiocephaly With a Helmet|Active, not recruiting||N/A|10|Actual|Boston Children’s Hospital|||1||f||||t||||||||||2017-10-10 23:29:59.96953|2017-10-10 23:29:59.96953
NCT02392182|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-09-14|||October 2009||2009-10-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|LHMP||Lung HIV Microbiome Project (Michigan Site)|Understanding the Lung Microbiome in HIV-Infected & HIV-Uninfected Individuals|Completed||N/A|59|Actual|University of Michigan|||1||f||||t||||||Samples Without DNA|"     Oral rinse Nasal swap Bronchoalveolar lavage   "|Yes|deidentified data and biological specimens deposited with NIH BioLNCC|2017-10-10 23:30:00.072735|2017-10-10 23:30:00.072735
NCT02392169|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-12|||August 2013||2013-08-01|March 2015|2015-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Neuroendocrine Substrates, Candidate Genes and Endophenotypes in ADHD|Relationship Between the Neuroendocrine Substrates, Candidate Genes and Endophenotypes in Patients With Attention-deficit/Hyperactivity Disorder|Unknown status|Recruiting|N/A|300|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||Samples With DNA|"     oral mucosal cells   "|||2017-10-10 23:30:00.203556|2017-10-10 23:30:00.203556
NCT02392156|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-02-27|||July 2015||2015-07-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|FORWARD||Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes|A Global, Multicenter, Observational Study Evaluating the Impact of rFVIIIFc and rFIXFc on Patient-reported Treatment Burden and Health Economic Outcomes|Terminated||N/A|3|Actual|Bioverativ Therapeutics Inc.|||4|Study terminated due to recruitment challenges.|f||||f||||||||||2017-10-10 23:30:00.281863|2017-10-10 23:30:00.281863
NCT02392143|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-17|||January 2009||2009-01-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Promoting CRC Screening in an Urban Minority Population|Promoting CRC Screening in a Hard-To-Reach, Low-Income Minority Population|Completed||N/A|564|Actual|Teachers College, Columbia University||3|||f||||f||||||||||2017-10-10 23:30:00.398945|2017-10-10 23:30:00.398945
NCT02392130|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-05-01|||March 2015||2015-03-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin|A Prospective, Randomised, Investigator-Blinded, Vehicle-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin|Completed||Phase 1|40|Actual|LEO Pharma||3|||f||||f||||||||||2017-10-10 23:30:00.479941|2017-10-10 23:30:00.479941
NCT02392117|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-08-18|||March 16, 2015|Actual|2015-03-16|August 2017|2017-08-01|March 16, 2018|Anticipated|2018-03-16|March 16, 2018|Anticipated|2018-03-16||Observational|ReFLeCT||Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus|A Multi-centre, Prospective, Non-interventional Study of Insulin Degludec Investigating the Safety and Effectiveness in a Real World Population With Type 1 and 2 Diabetes Mellitus|Active, not recruiting||N/A|1216|Anticipated|Novo Nordisk A/S|||1||f||||f|t|f|||t|||||2017-10-10 23:30:00.56732|2017-10-10 23:30:00.56732
NCT02392104|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-05-11|||February 2015||2015-02-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service|Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service|Enrolling by invitation||N/A|75|Anticipated|William S. Middleton Memorial Veterans Hospital||1|||f||||t||||||||||2017-10-10 23:30:00.663122|2017-10-10 23:30:00.663122
NCT02392091|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-17|||April 2011||2011-04-01|March 2015|2015-03-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Observational|||Renal Tubular Acidosis is Highly Prevalent in Critically Ill Patients|Renal Tubular Acidosis is Highly Prevalent in Critically Ill Patients|Completed||N/A|100|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 23:30:00.733263|2017-10-10 23:30:00.733263
NCT02392078|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-10-02|||October 2015||2015-10-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Observational|LAANTERN||Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System|Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry|Recruiting||N/A|1000|Anticipated|Monteris Medical|||1||f||||f||||||||||2017-10-10 23:30:00.796283|2017-10-10 23:30:00.796283
NCT02392065|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-03-14|||March 2015||2015-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Chronic Obstructive Pulmonary Disease as a Predictor of Mortality in Cardiac Surgery|Chronic Obstructive Pulmonary Disease as a Predictor of 2-year Mortality in Patients Undergoing Coronary Artery Bypass Graft Surgery|Recruiting||N/A|1100|Anticipated|Meshalkin Research Institute of Pathology of Circulation|||1||f||||f||||||||||2017-10-10 23:30:00.954657|2017-10-10 23:30:00.954657
NCT02392052|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-07-19|||November 2015||2015-11-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Enhancing Self-Efficacy for Caregivers of Family Members With Spinal Cord Injury|Enhancing Self-Efficacy for Caregivers of Family Members With Spinal Cord Injury|Recruiting||N/A|65|Anticipated|Craig Hospital||2|||f||||f||||||||||2017-10-10 23:30:01.024411|2017-10-10 23:30:01.024411
NCT02392039|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-05-26|||December 14, 2015|Actual|2015-12-14|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma|Randomized, Placebo Controlled Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma|Active, not recruiting||Early Phase 1|1|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 23:30:01.120991|2017-10-10 23:30:01.120991
NCT02392026|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-05-17|||August 11, 2015|Actual|2015-08-11|May 2017|2017-05-01|November 4, 2016|Actual|2016-11-04|October 4, 2016|Actual|2016-10-04||Interventional|||Safety and Tolerability of Metronidazole Gel 1.3%|A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Metronidazole Vaginal Gel 1.3% in Adolescent Female Subjects With Bacterial Vaginosis|Completed||Phase 4|60|Actual|Allergan||1|||f||||f||||||||||2017-10-10 23:30:01.22122|2017-10-10 23:30:01.22122
NCT02392013|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-12-11|||December 2014||2014-12-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|HARP||Home Hazard Removal Program to Reduce Falls|Removing Home Hazards for Older Adults|Recruiting||N/A|300|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:30:01.352367|2017-10-10 23:30:01.352367
NCT02392000|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-05-22|||October 20, 2015|Actual|2015-10-20|May 2017|2017-05-01|November 15, 2017|Anticipated|2017-11-15|November 16, 2016|Actual|2016-11-16||Interventional|||Mobile Sleep Intervention for OEF, OIF and OND Veterans|Mobile Sleep and Pain Intervention for OEF, OIF and OND Veterans|Active, not recruiting||Phase 1|40|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||Undecided||2017-10-10 23:30:01.448396|2017-10-10 23:30:01.448396
NCT02391987|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-06-01|||May 2015||2015-05-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|Tele-HC||Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure|A Randomized Study of the Effectiveness of an Integrated Tele-monitoring and Patient-centric Health Coaching Strategy (Tele-HC) in Adult Patients Recently Hospitalized With Acute Decompensated Heart Failure (ADHF) Compared to Standard Care|Recruiting||Phase 3|304|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:30:01.544435|2017-10-10 23:30:01.544435
NCT02391974|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-06-09|||February 2015||2015-02-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy and Safety of a Commercially Available Injectable Hyaluronic Acid Dental Filler for Periodontal Pockets|Filling of Periodontal Pockets With a Commercially Available Injectable Cross-linked Hyaluronic Acid Dental Filler Versus Oral Hygiene Alone, After Scaling and Root Planing and Chlorhexidine Disinfection, for the Treatment of Periodontitis: A Single-blinded, Multi Center, Prospective, Randomized Controlled Trial|Recruiting||Phase 4|30|Anticipated|Teoxane SA||2|||f||||f||||||||||2017-10-10 23:30:01.658301|2017-10-10 23:30:01.658301
NCT02391961|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-04-06|||April 1, 2015|Actual|2015-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis|Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis|Recruiting||Phase 2|30|Anticipated|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-10 23:30:01.774677|2017-10-10 23:30:01.774677
NCT02391012|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-06-13|||April 2015||2015-04-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|June 2016|Actual|2016-06-01||Interventional|FMT IBD||Fecal Transplantation for Inflammatory Bowel Disease|Fecal Transplantation for Inflammatory Bowel Disease|Terminated||Phase 1|9|Actual|Meir Medical Center||1||unable to recruit enough patients|f||||f||||||||||2017-10-10 23:30:13.93845|2017-10-10 23:30:13.93845
NCT02391922|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-05-03|||October 2014||2014-10-01|May 2017|2017-05-01|March 2017|Anticipated|2017-03-01|June 2016|Anticipated|2016-06-01||Interventional|||Better First Aid With First Aid Training and Dispatcher Central Instructions?|Bedre førstehjelp Med førstehjelpstrening og AMK-veiledning?|Withdrawn||N/A|0|Actual|University of Tromso||4||Could not recruit eligible PhD-candidate to take on the project|f||||f||||||||||2017-10-10 23:30:02.336998|2017-10-10 23:30:02.336998
NCT02391909|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-03-08|||August 26, 2015|Actual|2015-08-26|March 2017|2017-03-01|February 21, 2017|Actual|2017-02-21|October 6, 2016|Actual|2016-10-06||Observational|||Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers|Phase 4 Observational Prospective Cohort Study to Assess the Safety of Vivotif at Different Release Titers Among Travelers|Completed||N/A|855|Actual|PaxVax, Inc.|||2||f||||f||||||||||2017-10-10 23:30:02.439041|2017-10-10 23:30:02.439041
NCT02391896|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-04-13|||March 2015||2015-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Design and Evaluation of Mobile X-ray for Rapid and Accurate Diagnosis of Thoracic Disease|Design and Evaluation of Innovative Mobile X-Ray Technology for Rapid and Accurate Diagnosis of Thoracic Disease in Critically Ill Patients|Recruiting||N/A|100|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:30:02.559862|2017-10-10 23:30:02.559862
NCT02391883|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-17|||January 2011||2011-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|December 2013|Actual|2013-12-01||Observational|||Hip-Fracture Surgery on Patients in Clopidogrel Therapy||Completed||N/A|356|Actual|Hvidovre University Hospital|||2||f||||t||||||||||2017-10-10 23:30:02.737959|2017-10-10 23:30:02.737959
NCT02391870|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-12|||November 2008||2008-11-01|March 2015|2015-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression|Phase One: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression|Completed||N/A|49|Actual|University of Colorado, Boulder||1|||f||||t||||||||||2017-10-10 23:30:02.878434|2017-10-10 23:30:02.878434
NCT02391857|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-12|||March 2015||2015-03-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|EGD_ACLS||Early Gastric Decompression During Advanced Cardiopulmonary Resuscitation (EGD_ACLS)|The Clinical Study for the Identifying the Effect of Early Gastric Decompression on Improvement of Circulation During Advanced Cardiopulmonary Resuscitation|Unknown status|Recruiting|N/A|40|Anticipated|Konkuk University Medical Center||1|||f||||t||||||||||2017-10-10 23:30:03.03128|2017-10-10 23:30:03.03128
NCT02391844|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-01-05|||May 2014||2014-05-01|November 2015|2015-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Open-Label Study of Oxycodone/APAP to Treat Post-Operative Pain Following Arthroscopic Knee Surgery|Open-Label Parallel Group Flexible Dosing & Titration Study to Evaluate the Efficacy, Safety of Oxycodone/APAP Extended Release Formulation Xartemisxr® in the Management of Post-Operative Pain Following Outpatient Arthroscopic Knee Surgery|Completed||Phase 4|50|Actual|International Clinical Research Institute||1|||f||||f||||||||||2017-10-10 23:30:03.127708|2017-10-10 23:30:03.127708
NCT02391818|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-10-07|||February 2015||2015-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|IPMR Balance||The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients|The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients|Recruiting||N/A|44|Anticipated|OSF Healthcare System|||2||f||||f||||||||||2017-10-10 23:30:03.360743|2017-10-10 23:30:03.360743
NCT02391805|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-10-02|||May 17, 2015|Actual|2015-05-17|October 2017|2017-10-01|December 8, 2017|Anticipated|2017-12-08|December 8, 2017|Anticipated|2017-12-08||Interventional|||A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection|A Multiple-Center, Randomized, Partially Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antiviral Effects of 12-Week Treatment With RO6864018 in Virologically Suppressed Patients With Chronic Hepatitis B Virus Infection|Active, not recruiting||Phase 2|31|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-10 23:30:03.599931|2017-10-10 23:30:03.599931
NCT02391792|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-08-23|||March 2013||2013-03-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01|7 Days|Observational [Patient Registry]|||Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical Relevance|Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical Relevance|Recruiting||N/A|300|Anticipated|University Hospital, Strasbourg, France|||3||f||||f||||||Samples With DNA|"     blood   "|||2017-10-10 23:30:03.861475|2017-10-10 23:30:03.861475
NCT02391779|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-11-30|||May 2015||2015-05-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension|Flaxseed Lignan Enriched Complex for Blood Pressure Reduction in Elderly Participants With High Normal Blood Pressure or Stage I Hypertension|Recruiting||Phase 2|100|Anticipated|University of Saskatchewan||4|||f||||f||||||||||2017-10-10 23:30:03.97893|2017-10-10 23:30:03.97893
NCT02391766|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-03-17|||September 2014||2014-09-01|March 2015|2015-03-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Group Intervention Empowerment Dementia|Psychosocial Group Intervention to Enhance Empowerment of People With Dementia and Their Caregivers: Study Protocol for a Randomized Controlled Trial|Unknown status|Enrolling by invitation|Early Phase 1|180|Anticipated|Universidad Nacional de Rosario||2|||f||||f||||||||||2017-10-10 23:30:04.174916|2017-10-10 23:30:04.174916
NCT02391753|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-12|||July 2014||2014-07-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|OTELaPFC||Evaluation of Labor Related Pelvic Floor Changes: A 3D Transperineal Ultrasound Study|Optimal Time For Evaluation of Labor Related Pelvic Floor Changes: A 3D Transperineal Ultrasound Study|Completed||N/A|72|Actual|Bezmialem Vakif University|||1||f||||f||||||||||2017-10-10 23:30:04.316915|2017-10-10 23:30:04.316915
NCT02391740|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-03-03|||February 2015||2015-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|EFFADOL||Therapeutic Patient Education and Cancer Pain|THERAPEUTIC PATIENT EDUCATION AND CANCER PAIN|Completed||N/A|75|Actual|Centre Francois Baclesse|||1||f||||f||||||||||2017-10-10 23:30:04.411127|2017-10-10 23:30:04.411127
NCT02391727|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-08-18|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SYN004_Ph_1||Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors|A Phase 1, Multi-center, Open-Label Dose Escalation Study of SYN004 in Patients With Solid Tumors to Evaluate the Safety, Immunogenicity and Pharmacokinetics of SYN004 Following Administration of Eight Intravenous Doses|Recruiting||Phase 1|18|Anticipated|Synermore Biologics Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:30:04.504316|2017-10-10 23:30:04.504316
NCT02391714|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-01-04|2015-08-26||October 2013||2013-10-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|NIUD||Nitrous Oxide for Pain Management of Intrauterine Device (IUD) Insertion|Nitrous Oxide for Pain Management of Intrauterine Device Insertion|Completed||N/A|80|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-10 23:30:04.620761|2017-10-10 23:30:04.620761
NCT02391701|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-03-18|||March 2014||2014-03-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|GALIAT||Effect of an Atlantic Diet on Anthropometric Indices and Serum Lipid Profile|Effect of an Atlantic Diet on Anthropometric Indices and Serum Lipid Profile in a General Population: a Randomised Controlled Trial|Unknown status|Recruiting|N/A|750|Anticipated|Hospital Clinico Universitario de Santiago||2|||f||||f||||||||||2017-10-10 23:30:04.901634|2017-10-10 23:30:04.901634
NCT02391688|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-02-06|||November 2014||2014-11-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation of the Potential Pharmacokinetic Interactions Between Probe Drugs in the Geneva Phenotyping Cocktail||Completed||Phase 1|30|Actual|University Hospital, Geneva||4|||f||||f||||||||||2017-10-10 23:30:04.985286|2017-10-10 23:30:04.985286
NCT02391675|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-12|||June 2012||2012-06-01|March 2015|2015-03-01|October 2018|Anticipated|2018-10-01|June 2016|Anticipated|2016-06-01|6 Years|Observational [Patient Registry]|HAPPIEST||The Hasselt APPendicitis Immunology and Environmental Cohort STudy|The Hasselt APPendicitis Immunology and Environmental Cohort STudy|Recruiting||N/A|600|Anticipated|Hasselt University|||2||f||||f||||||Samples With DNA|"     Whole blood, plasma, serum, appendix tissue, stool   "|||2017-10-10 23:30:05.087974|2017-10-10 23:30:05.087974
NCT02391662|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-07-06|||May 2015||2015-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Nab-paclitaxel and Gemcitabine, in Elderly Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma|A Phase II Study of Nab-paclitaxel and Gemcitabine, in Elderly Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 2|80|Anticipated|Asociación de Oncología Médica del Hospital de Cruces||1|||f||||f||||||||||2017-10-10 23:30:05.18259|2017-10-10 23:30:05.18259
NCT02391649|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-07-02|||February 2015|Actual|2015-02-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PSBBP||Problem-solving-based Bibliotherapy Program for Family Caregivers|A Randomized Controlled Trial of Problem-solving Based Bibliotherapy Program for Family Caregivers of People With Schizophrenia Spectrum Disorders|Active, not recruiting||N/A|138|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-10 23:30:05.365172|2017-10-10 23:30:05.365172
NCT02391636|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-01-24|||February 2015||2015-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage|Comparison Between Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage: A Randomized Controlled Trial|Completed||Phase 4|264|Actual|Ghamra Military Hospital||2|||f||||f||||||||||2017-10-10 23:30:05.461205|2017-10-10 23:30:05.461205
NCT02391623|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2016-03-01|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Multiple Escalating Oral Doses Of Pf-06427878 Co Administered With And Without Food In Healthy Adult Subjects|Completed||Phase 1|40|Actual|Pfizer||6|||f||||f||||||||||2017-10-10 23:30:05.555712|2017-10-10 23:30:05.555712
NCT02391610|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-03-12|||November 2008||2008-11-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|October 2010|Actual|2010-10-01||Observational|||The China-Anhui Birth Cohort Study (C-ABCS)|A Prospective Population-based Cohort Study That Recruited 16766 Pregnant Women From Six Major Cities of Anhui Province in China|Completed||N/A|16766|Actual|Anhui Medical University|||1||f||||t||||||||||2017-10-10 23:30:05.675443|2017-10-10 23:30:05.675443
NCT02391584|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-07-25|||February 2015||2015-02-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|March 2017|Actual|2017-03-01||Interventional|||XprESS Eustachian Tube Dilation Study|XprESS Eustachian Tube Dilation Study|Active, not recruiting||N/A|70|Actual|Entellus Medical, Inc.||2|||f||||f||||||||||2017-10-10 23:30:05.746907|2017-10-10 23:30:05.746907
NCT02391571|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-08-08||2016-08-08|February 2015||2015-02-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects|A Randomized, Double-Blind, Multiple-Dose, Parallel Group Study to Evaluate the Potential of Withdrawal Effects Following Administration of Oxycodone/Naltrexone Capsules and Oxycodone in Methadone-Maintained Opioid-Dependent Subjects|Completed||Phase 3|26|Actual|Elite Laboratories, Inc||3|||f||||f||||||||||2017-10-10 23:30:05.848702|2017-10-10 23:30:05.848702
NCT02391558|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-03-09|||September 2015||2015-09-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|OCTA||Clinical Evaluation of Noninvasive OCT Angiography Using a Zeiss OCT Prototype to Compare to Fluorescein Angiography|Clinical Evaluation of Noninvasive OCT Angiography Using a Zeiss OCT Prototype to Compare to Fluorescein Angiography|Completed||N/A|62|Actual|Association for Innovation and Biomedical Research on Light and Image|||1||f||||t||||||||||2017-10-10 23:30:05.93142|2017-10-10 23:30:05.93142
NCT02391545|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-07-28|||December 2014||2014-12-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|January 2017|Actual|2017-01-01||Interventional|||A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)|A Two-arm, Phase 1b/2 Study of Duvelisib Administered in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)|Completed||Phase 1/Phase 2|55|Actual|Verastem, Inc.||2|||f||||f||||||||||2017-10-10 23:30:05.986885|2017-10-10 23:30:05.986885
NCT02391532|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-08-10|||September 2013||2013-09-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Probiotic Bacteria on Oral Candida in Frail Elderly|Effect of Probiotic Bacteria (L. Reuteri) on Oral Candida Counts in Frail Elderly|Completed||N/A|215|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:30:06.109983|2017-10-10 23:30:06.109983
NCT02391519|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-08-29|||January 2016||2016-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Effects of High Altitude on AMPK Activation|Effects of High Altitude on 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) Activation and Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Regulation|Recruiting||N/A|84|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples With DNA|"     Myometrial tissue, Cord Blood, Placental Tissue.   "|||2017-10-10 23:30:06.18634|2017-10-10 23:30:06.18634
NCT02391506|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-02-14|||May 2015||2015-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GRIP||Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis|A Prospective Study to Evaluate the Safety and Effectiveness of the Cartiva® Synthetic Cartilage Implant for CMC in the Treatment of First Carpometacarpal Joint Osteoarthritis|Active, not recruiting||N/A|50|Anticipated|Cartiva, Inc.||1|||f||||t||||||||No||2017-10-10 23:30:06.301069|2017-10-10 23:30:06.301069
NCT02391493|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-12-14|||November 2014||2014-11-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NEUROSWITCH||Neural Correlates of Language Control in Bilinguals. Functional MRI and Stimulation Mapping Data in Awake Surgery.|Neural Correlates of Language Control in Bilinguals. Functional MRI and Stimulation Mapping Data in Awake Surgery. (NEUROSWITCH)|Recruiting||N/A|24|Anticipated|University Hospital, Toulouse||3|||f||||f||||||||||2017-10-10 23:30:06.387813|2017-10-10 23:30:06.387813
NCT02391480|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-08-24|||April 29, 2015||2015-04-29|August 2017|2017-08-01|August 21, 2018|Anticipated|2018-08-21|May 7, 2018|Anticipated|2018-05-07||Interventional|||A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer|A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Advanced Cancer|Recruiting||Phase 1|150|Anticipated|AbbVie||3|||f||||f||||||||||2017-10-10 23:30:06.46509|2017-10-10 23:30:06.46509
NCT02391467|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-09-30|||December 2014||2014-12-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|6 Months|Observational [Patient Registry]|||Validity of Elastography During Pregnancy|Validity of Non-invasive Liver Fibrosis Assessment by Ultrasound-based Elastography at the Third Trimester of Pregnancy: a Prospective Study|Suspended||N/A|25|Anticipated|Hopital Lariboisière|||1|issue concerning safety of elastography during pregnancy|f||||f||||||||||2017-10-10 23:30:06.75128|2017-10-10 23:30:06.75128
NCT02391454|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-10-01|||February 2015||2015-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SMART||Self-monitoring Physical Activity With a SMARTphone Application in Cancer Patients: a Feasibility Study (SMART)|Self-monitoring and Empowering Physical Activity With a SMARTphone Application During or After Cancer Treatment in a 12 Week Follow-up: a Randomized Feasibility Study (SMART-trial)|Completed||N/A|32|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-10 23:30:06.830312|2017-10-10 23:30:06.830312
NCT02391441|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-05-17|||March 2015||2015-03-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|6 Months|Observational [Patient Registry]|PAH-LTX||Ventricular Reversed Remodeling After LTX in PAH Patients|Imaging of Ventricular Reversed Remodeling After Double Lung Transplantation in Patients With Pulmonary Arterial Hypertension|Enrolling by invitation||N/A|20|Anticipated|University Medical Center Groningen|||2||f||||t||||||Samples Without DNA|"     Whole blood   "|||2017-10-10 23:30:06.947608|2017-10-10 23:30:06.947608
NCT02391428|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-18|||April 2015||2015-04-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|September 2015|Anticipated|2015-09-01||Interventional|||The Correlation Between Blood omega3 and ADHD|The Correlation Between Blood omega3 and ADHD|Unknown status|Not yet recruiting|Early Phase 1|60|Anticipated|Ziv Hospital||2|||f||||f||||||||||2017-10-10 23:30:07.071286|2017-10-10 23:30:07.071286
NCT02391415|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-11-22|||June 2015||2015-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa|Phase II Double-blind, Randomized, Controlled Study to Evaluate Safety and Immunogenicity of VPM1002 Compared With BCG in HIV-exposed and HIV-unexposed, BCG-naive Newborn Infants|Active, not recruiting||Phase 2|416|Actual|Serum Institute of India Pvt. Ltd.||5|||f||||t||||||||||2017-10-10 23:30:07.184038|2017-10-10 23:30:07.184038
NCT02391402|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-06-14|||May 4, 2015|Actual|2015-05-04|June 2017|2017-06-01|March 18, 2019|Anticipated|2019-03-18|November 30, 2018|Anticipated|2018-11-30||Interventional|CABA||Cognitively Augmented Behavioral Activation for Veterans With Comorbid TBI/PTSD|Cognitively Augmented Behavioral Activation for Veterans With Comorbid TBI/PTSD|Recruiting||N/A|192|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 23:30:07.333798|2017-10-10 23:30:07.333798
NCT02391389|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-01-10|||September 2014||2014-09-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||VentFirst Pilot: Ventilating Preterm Infants During Delayed Cord Clamping|VentFirst Pilot: Ventilating Preterm Infants During Delayed Cord Clamping|Completed||N/A|28|Actual|University of Virginia||1|||f||||f||||||||||2017-10-10 23:30:07.53186|2017-10-10 23:30:07.53186
NCT02391376|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-12|||March 2012||2012-03-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|||Heat Transfer by Three Types of Packs and Its Implication on the Flexibility of the Lower Back|Heat Transfer by Three Types of Packs and Its Implication on the Flexibility of the Lower Back: a Randomized, Controlled Trial|Completed||N/A|45|Actual|Universidad Católica del Maule||3|||f||||t||||||||||2017-10-10 23:30:07.64559|2017-10-10 23:30:07.64559
NCT02390986|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-11|||January 2015||2015-01-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||An Extension Study of LON002 in Patients With Cancer|An Extension Study of LON002 in Patients With Cancer|Unknown status|Recruiting|N/A|50|Anticipated|LondonPharma Ltd.||1|||f||||f||||||||||2017-10-10 23:30:14.114585|2017-10-10 23:30:14.114585
NCT02391363|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-11-07|||November 2014||2014-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Calmer Life: Treating Worry Among Older Adults In Underserved, Low-income, Minority Communities|Calmer Life: Treating Worry Among Older Adults In Underserved, Low-income, Minority Communities|Active, not recruiting||N/A|147|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:30:07.734117|2017-10-10 23:30:07.734117
NCT02391350|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-08-11|||January 2015||2015-01-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Management Strategies for Patients With Low Back Pain and Sciatica||Recruiting||Phase 3|220|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-10 23:30:07.850379|2017-10-10 23:30:07.850379
NCT02391337|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-05-05|||December 5, 2016|Actual|2016-12-05|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|RATE-AF||Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)|Evaluating Different Rate Control Therapies in Permanent Atrial Fibrillation: A Prospective, Randomised, Open-label, Blinded Endpoint Feasibility Pilot Comparing Digoxin and Beta-blockers as Initial Rate Control Therapy|Recruiting||Phase 4|160|Anticipated|University of Birmingham||2|||f||||t|f|f||||||No||2017-10-10 23:30:07.950683|2017-10-10 23:30:07.950683
NCT02391324|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-09-30|||January 2016||2016-01-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy|Evaluation of the Effectiveness of Robotic Gait Training and Gait-focused Physical Therapy Programs for Children and Youth With Cerebral Palsy: A Mixed Methods Randomized Controlled Trial|Recruiting||Phase 4|160|Anticipated|University of Alberta||4|||f||||t||||||||||2017-10-10 23:30:08.079531|2017-10-10 23:30:08.079531
NCT02391311|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-05-12|2017-03-17||March 2015||2015-03-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|HtDCS|n=33 subjects were included in final analyses. Of the 37 that completed the study, 4 were deemed ineligible after they had completed the study due to confirmation with medical records they had conditions that may affect neurocognition (stroke and schizophrenia) although they self reported on the screen they did not have these conditions.|A Novel Neurorehabilitation Approach for Cognitive Aging With HIV|Speed of Processing Training With Transcranial Direct Current Stimulation in Older HIV+ Adults (HtDCS)|Completed||N/A|42|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 23:30:08.211467|2017-10-10 23:30:08.211467
NCT02391298|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2017-04-25|||December 2014||2014-12-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||An Online Self-Guided Meditation Course for Individuals With Multiple Sclerosis|An Examination of Potential Neurochemical and Cognitive Mediators of the Relationship Between Mindfulness and Emotion Regulation in Individuals With Multiple Sclerosis: An Internet Based Self-Guided Pilot Study.|Completed||N/A|26|Actual|Suffolk University||1|||f||||f||||||||||2017-10-10 23:30:08.608727|2017-10-10 23:30:08.608727
NCT02391285|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-04-13|||August 2014||2014-08-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Mitigating Chronic Pelvic Floor Dysfunction Following Childbirth by Pelvic Floor Dynamometry|Mitigating Chronic Pelvic Floor Dysfunction Following Childbirth by Pelvic Floor Dynamometry|Completed||N/A|55|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||No||2017-10-10 23:30:08.707673|2017-10-10 23:30:08.707673
NCT02391272|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-04-18|||January 2015||2015-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy|A Multicenter Open-labeled Pilot Study on Recombinant Human Thrombopoietin in Management of Immune Thrombocytopenia in Pregnancy|Recruiting||Phase 3|30|Anticipated|Shandong University||1|||f||||t||||||||||2017-10-10 23:30:08.79599|2017-10-10 23:30:08.79599
NCT02391259|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-03-27|||November 2006||2006-11-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus|Randomized, Multicenter, Double-Blind, Placebo-Controlled, Rising Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|57|Actual|Amgen||2|||f||||f||||||||||2017-10-10 23:30:08.905572|2017-10-10 23:30:08.905572
NCT02391246|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2017-04-12|||June 2015||2015-06-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|DTPI FDG-PET||Radionecrosis and FDG PET|A Dual Time Point FDG-PET to Differentiate Between Recurrent Brain Tumor and Radionecrosis|Recruiting||N/A|62|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-10 23:30:09.005279|2017-10-10 23:30:09.005279
NCT02391233|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-01-30|||May 2015||2015-05-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|E-WORTH||Multimedia WORTH With Black Drug-Involved Women on Probation|Multimedia HIV/STI Prevention for Black Drug-Involved Women on Probation|Recruiting||N/A|460|Anticipated|Columbia University||2|||f||||t||||||||Undecided||2017-10-10 23:30:09.10275|2017-10-10 23:30:09.10275
NCT02391220|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-07-27|||February 2012||2012-02-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Assessment of the Symbiotic Fermented Milk in Patients With Irritable Bowel Syndrome|The Effect of a Symbiotic LCA Yoghurt on Health-related Quality of Life and the Symptoms of Irritable Bowel Syndrome in Adults: A Randomized, Double-blind, Placebo Controlled, Multicentre Clinical Trial|Completed||N/A|76|Actual|Clinres Farmacija d.o.o.||2|||f||||f||||||||||2017-10-10 23:30:09.205216|2017-10-10 23:30:09.205216
NCT02391207|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-03-17|||January 2009||2009-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Observational|||Hepatic Vein-sparing Hepatectomy for Colorectal Liver Metastases at the Caval Confluence|Hepatic Vein-sparing Hepatectomy for Colorectal Liver Metastases at the Caval Confluence: Validation on Intention-to-treat Analysis of a IOUS-guided Approach|Completed||N/A|50|Actual|University of Milan|||1||f||||f||||||||||2017-10-10 23:30:09.291799|2017-10-10 23:30:09.291799
NCT02391194|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-03-21|||April 2015||2015-04-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery|A Phase 1 Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery|Completed||Phase 1|27|Actual|Avelas Biosciences, Inc.||1|||f||||f||||||||||2017-10-10 23:30:09.366322|2017-10-10 23:30:09.366322
NCT02391181|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-10-01|||November 2014||2014-11-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers|An Open-label, Randomized, Crossover-design Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers Under Fasting Conditions|Completed||Phase 1|30|Actual|Azad Pharma AG||2|||f||||f||||||||||2017-10-10 23:30:09.452737|2017-10-10 23:30:09.452737
NCT02391168|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2015-08-03|||July 2015||2015-07-01|August 2015|2015-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|FLDCR||Fatty Liver Disease Collaborative Research in China|A Multi-center, Prospective Cohort Study on the Natural History of Fatty Liver Disease in China|Recruiting||N/A|3000|Anticipated|Fatty Liver and Alcoholic Liver Disease Study Group, China|||1||f||||f||||||Samples With DNA|"     Liver tissue   "|||2017-10-10 23:30:09.52939|2017-10-10 23:30:09.52939
NCT02391155|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-11-09|||January 2015||2015-01-01|March 2015|2015-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|needles(opu)||Follicular Flushing Outcomes in Singles Versus Double Lumen Oocyte Retrieval Needles in Poor Responding Patients|Follicular Flushing Outcomes in Singles Versus Double Lumen Oocyte Retrieval Needles in Poor Responding Patients:a Randomized Controlled Trial|Completed||N/A|80|Anticipated|Baskent University||2|||f||||f||||||||||2017-10-10 23:30:09.630681|2017-10-10 23:30:09.630681
NCT02391142|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-03-28|||June 2014||2014-06-01|May 2014|2014-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|CSB-CHF||Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure|Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure|Recruiting||N/A|100|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||f||||||||||2017-10-10 23:30:09.703207|2017-10-10 23:30:09.703207
NCT02391129|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-03-17|||January 2014||2014-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Locking Compression Plate Fixation Versus Revision- Prosthesis of Vancouver-B2, B3 and C Periprosthetic Femoral Fractures After Total Hip Replacement|Locking Compression Plate Fixation Versus Revision- Prosthesis of Vancouver-B2, B3 and C Periprosthetic Femoral Fractures After Total Hip Replacement|Completed||N/A|102|Actual|Medical University of Vienna|||3||f||||||||||||||2017-10-10 23:30:09.846163|2017-10-10 23:30:09.846163
NCT02391103|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-07-06|||May 2011||2011-05-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|July 2012|Actual|2012-07-01||Interventional|Catastim 2||Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery|Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery. An Ultrasound-Based Randomized Controlled Trial|Completed||N/A|54|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:30:10.164497|2017-10-10 23:30:10.164497
NCT02391090|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-03-11|||November 2014||2014-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||FeNO After Hypoxia in Asthma Patients|Effects of Intermittent Hypoxia on the Asthmatic Inflammation of Asthma Patients - a Pilot Study|Completed||N/A|21|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-10 23:30:10.266712|2017-10-10 23:30:10.266712
NCT02391077|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-03-11|||April 2015||2015-04-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|RMC-11||A Trial Assessing Efficacy of Various Antimicrobial Techniques for Reducing Bacterial Load|A Randomized, Open Label, Two Phase Trial, to Assess Various Antimicrobial Techniques for Reducing Bacterial Load Prior PrePex Removal|Unknown status|Not yet recruiting|Phase 1|33|Anticipated|Ministry of Health, Rwanda||3|||f||||f||||||||||2017-10-10 23:30:10.38607|2017-10-10 23:30:10.38607
NCT02391064|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-04-05|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BICAFMS||Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS)|Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) - BICAFMS Study (Brief Cognitive Assessment in French MS Patients)|Recruiting||N/A|470|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:30:10.506741|2017-10-10 23:30:10.506741
NCT02391051|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-08-09|||October 2014||2014-10-01|August 2017|2017-08-01|December 2029|Anticipated|2029-12-01|December 2019|Anticipated|2019-12-01||Interventional|FOKAL-BT||"Focal Brachytherapy in Patients With Selected Low-risk Prostate Cancer - a Phase-II-trial"|"Focal Brachytherapy in Patients With Selected Low-risk Prostate Cancer - a Phase-II-trial"|Recruiting||Phase 2|50|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-10-10 23:30:12.203144|2017-10-10 23:30:12.203144
NCT02391038|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-02-08|2016-11-04||December 2014||2014-12-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||Safety population included all participants who received any amount of study drug.|MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C|A Phase 1/2 Trial of MLN0264 in Previously Treated Asian Patients With Advanced Gastrointestinal (GI) Carcinoma (Phase 1) or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma (Phase 2) Expressing Guanylyl Cyclase C (GCC)|Terminated||Phase 1|12|Actual|Takeda||1||"The study was terminated because preliminary PK and overall clinical data demonstrated   compelling similarity between Western and Asian participant populations."|f||||f||||||||||2017-10-10 23:30:12.381363|2017-10-10 23:30:12.381363
NCT02391025|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-06-06|||March 2015||2015-03-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Gallium-68 Citrate PET Used in Prostate Cancer|Gallium-68 Citrate PET To Detect MYC Amplification in Metastatic Castrate Resistant Prostate Cancer|Recruiting||N/A|28|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:30:13.849832|2017-10-10 23:30:13.849832
NCT02390973|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-03-10|||March 2015||2015-03-01|March 2016|2016-03-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|REMISSION||Surgery Versus Best Medical Management for the Long Term Remission of Type 2 Diabetes and Related Diseases (REMISSION)|Surgery Versus Best Medical Management for the Long Term Remission of Type 2 Diabetes and Related Diseases (REMISSION)|Recruiting||Phase 4|408|Anticipated|Laval University||4|||f||||f||||||||||2017-10-10 23:30:14.19048|2017-10-10 23:30:14.19048
NCT02390947|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-05-30|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|November 30, 2017|Anticipated|2017-11-30||Interventional|FACT||Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma（FACT）|A Multicenter，Randomized, Double-blind, Placebo-controlled Trial of Famitinib in Patients With Advanced Colorectal Adenocarcinoma|Active, not recruiting||Phase 3|543|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:30:14.383131|2017-10-10 23:30:14.383131
NCT02390934|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-05-15|||October 2014||2014-10-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RAD-THYR||Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer|Single Arm Phase II Trial Evaluating the Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer|Recruiting||Phase 2|22|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-10 23:30:14.672206|2017-10-10 23:30:14.672206
NCT02390921|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-04-11|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|BARIFER||The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron|The Effectiveness of Oral Treatment With Liposomated Iron in Patients With Previous Bariatric Surgery Which Are Currently Receiving Chronic Parentheral Therapy With Iron|Completed||Phase 4|40|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||No||2017-10-10 23:30:14.772586|2017-10-10 23:30:14.772586
NCT02390908|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-10-03|||August 2013||2013-08-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|PLUS||Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings|Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings|Recruiting||Phase 2|240|Anticipated|Hunter College of City University of New York||3|||f||||t||||||||||2017-10-10 23:30:14.864323|2017-10-10 23:30:14.864323
NCT02390895|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-07-31|||October 2016||2016-10-01|July 2016|2016-07-01|September 2022|Anticipated|2022-09-01|March 2022|Anticipated|2022-03-01||Interventional|ENDOSPIN||Prenatal Endoscopic Repair of Fetal Spina Bifida|Prenatal Endoscopic Repair of Fetal Spina Bifida|Not yet recruiting||N/A|75|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 23:30:14.967607|2017-10-10 23:30:14.967607
NCT02390882|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-10-12|||October 2014||2014-10-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH|A Multicenter, Randomized, Double-blind, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With Benign Prostatic Hyperplasia|Completed||Phase 3|494|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||No||2017-10-10 23:30:15.075458|2017-10-10 23:30:15.075458
NCT02390869|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-11|||April 2014||2014-04-01|March 2015|2015-03-01|September 2019|Anticipated|2019-09-01|January 2017|Anticipated|2017-01-01||Interventional|FIL_RENOIR12||Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-Bendamustine for Relapsed/Refractory FL Patients|A Trial Assessing Efficacy and Toxicity of a Combination of Rituximab and Lenalidomide (R2) vs Rituximab Alone as Maintenance After Chemoimmunotherapy With Rituximab-Bendamustine for Relapsed/Refractory FL Patients Not Eligible for ASCT|Recruiting||Phase 3|253|Anticipated|Fondazione Italiana Linfomi ONLUS||2|||f||||f||||||||||2017-10-10 23:30:15.168702|2017-10-10 23:30:15.168702
NCT02390856|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-06-09|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Volar Plate vs. Conventus DRS Fixation|Randomized Controlled Trial: Volar Plate vs. Conventus DRS Intramedullary Fixation for Distal Radius Fractures|Recruiting||N/A|30|Anticipated|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-10 23:30:15.397433|2017-10-10 23:30:15.397433
NCT02390843|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-08-03|||February 2015||2015-02-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|AflacST1402||Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors|A Phase 1 Study Using Simvastatin in Combination With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors|Recruiting||Phase 1|36|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 23:30:15.540791|2017-10-10 23:30:15.540791
NCT02390830|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-03-11|||March 2011||2011-03-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Falls Prevention and Balance Rehabilitation in Multiple Sclerosis|Falls Prevention and Balance Rehabilitation in Multiple Sclerosis: a Bi-centre Randomized Control Trial|Completed||N/A|119|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||||||||||||2017-10-10 23:30:15.67882|2017-10-10 23:30:15.67882
NCT02390817|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-10-05|||March 2015||2015-03-01|October 2016|2016-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Effect of Sugammadex for Muscle Motor Response and Awareness in Intraoperative Wakeup|Effect of Sugammadex in Wakeup Procedure|Completed||Phase 4|60|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:30:15.761588|2017-10-10 23:30:15.761588
NCT02390804|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-11|||March 2014||2014-03-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Postoperative Pain After Total Laparoscopic Hysterectomy: a Comparison of Single-port and Three-port Laparoscopy|Postoperative Pain After Total Laparoscopic Hysterectomy: a Comparison of Transumbilical Single-port Access and Conventional Three-port Laparoscopic Surgery|Completed||N/A|60|Actual|The Catholic University of Korea||2|||f||||t||||||||||2017-10-10 23:30:15.853488|2017-10-10 23:30:15.853488
NCT02390791|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-03-23|||September 2015|Actual|2015-09-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|||New Technologies to Help Manage ADHD|Developing New Technologies to Improve ADHD Medication Continuity|Active, not recruiting||N/A|80|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||No||2017-10-10 23:30:15.93414|2017-10-10 23:30:15.93414
NCT02390778|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-19|||June 2014||2014-06-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Reducing Secondary Distress in Violence Researchers: a Randomised Trial of the Effectiveness of Group Debriefings.|Reducing Secondary Distress in Violence Researchers: a Randomised Trial of the Effectiveness of Group Debriefings.|Completed||N/A|53|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-10 23:30:16.02503|2017-10-10 23:30:16.02503
NCT02390765|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-07-18|||March 10, 2015||2015-03-10|July 13, 2017|2017-07-13|December 12, 2028|Anticipated|2028-12-12|December 12, 2028|Anticipated|2028-12-12||Observational|||Children s Growth and Behavior Study|Children's Growth and Behavior Study|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:30:16.114759|2017-10-10 23:30:16.114759
NCT02390739|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-17|2017-07-26|||March 2, 2015||2015-03-02|March 22, 2017|2017-03-22|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|||Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer|Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to Patients With Thyroglobulin Expressing Thyroid Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:30:16.278655|2017-10-10 23:30:16.278655
NCT02390726|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-07-25|||December 2015||2015-12-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|FMTUC||Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis|Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis|Active, not recruiting||Early Phase 1|20|Anticipated|University of Vermont||2|||f||||t||||||||||2017-10-10 23:30:16.358314|2017-10-10 23:30:16.358314
NCT02390713|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-09-19|||March 2015||2015-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MODHEP1||Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy|Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy in Non Cirrhotic Patient|Recruiting||Phase 1/Phase 2|12|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:30:16.430547|2017-10-10 23:30:16.430547
NCT02390700|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-11-16|||February 2015||2015-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01|2 Years|Observational [Patient Registry]|GO-IV||Observational Study of Golimumab Intravenous Infusion|Golimumab Intravenous Infusion Registry (GO-IV)|Terminated||Phase 4|78|Actual|Janssen Inc.|||1|Business decision based on lack of enrollment|f||||f||||||||||2017-10-10 23:30:16.523541|2017-10-10 23:30:16.523541
NCT02390687|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-01-09|||April 2015||2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Evaluation of the Efficacy of Probiotics in Chronic Periodontitis Patients|Evaluation of the Efficacy of Probiotics in Chronic Periodontitis Patients-A Randomized Placebo Controlled Study.|Completed||Phase 3|31|Actual|Next Gen Pharma India Pvt. Ltd.||2|||f||||f||||||||||2017-10-10 23:30:16.636603|2017-10-10 23:30:16.636603
NCT02390674|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-03-29|||March 2015||2015-03-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|April 2017|Anticipated|2017-04-01||Interventional|CAPRI||Ciclosporin to Reduce Reperfusion Injury in Primary PCI|Evaluating the Effectiveness of Intravenous Ciclosporin on Reducing Reperfusion Injury in Patients Undergoing Primary Percutaneous Intervention: a Double-blind Randomised Controlled Trial|Active, not recruiting||Phase 2|54|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-10-10 23:30:16.712528|2017-10-10 23:30:16.712528
NCT02390661|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-09-28|||November 2013||2013-11-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Drain Placement for Seroma Prevention After Mammosite/SAVI Catheter Removal|Drain Placement for Seroma Prevention After Mammosite/SAVI Catheter Removal|Unknown status|Recruiting|N/A|100|Anticipated|Michigan State University||2|||f||||t||||||||||2017-10-10 23:30:16.815511|2017-10-10 23:30:16.815511
NCT02390648|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-03-15|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy of Ginger as an Adjunctive Prophylaxis for Chemotherapy-induced Nausea and Vomiting|Efficacy of Ginger as an Adjunctive Prophylaxis for Chemotherapy-induced Nausea and Vomiting: Randomised Double-blind Placebo-control Cross Over Study|Completed||Phase 2|34|Actual|Mahidol University||2|||f||||f||||||||||2017-10-10 23:30:17.029331|2017-10-10 23:30:17.029331
NCT02390635|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-11-02|||May 2016||2016-05-01|November 2016|2016-11-01||||May 2019|Anticipated|2019-05-01||Interventional|||Extramedullary Leukemia (EML) in Newly Diagnosed Acute Myeloid Leukemia (AML) is Underreported|PET/CT and Whole Body Magnetic Resonance Imaging (MRI) in Newly Diagnosed Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|55|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:30:17.112667|2017-10-10 23:30:17.112667
NCT02390622|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-11|||July 2013||2013-07-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Biotherapy for MRSA Enterocolitis|Fecal Microbiota Transplantation Restores Dysbiosis in Patients With Methicillin Resistant Staphylococcus Aureus Enterocolitis|Unknown status|Recruiting|N/A|10|Anticipated|Jinling Hospital, China||1|||f||||t||||||||||2017-10-10 23:30:17.226717|2017-10-10 23:30:17.226717
NCT02390609|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-12-21|||March 2015||2015-03-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy Adults|Open-Label, Randomized, Parallel Group, 3- or 4-Way Crossover Bioavailability Study of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy Adults|Completed||Phase 1|40|Actual|Janssen Research & Development, LLC||10|||f||||f||||||||||2017-10-10 23:30:17.323064|2017-10-10 23:30:17.323064
NCT02390596|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-12-08|||March 2015||2015-03-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|KAWAKINRA||Anakinra and Kawasaki Disease|A Phase IIa Multicenter Trial to Assess the Efficacy, and Safety of Anakinra in Patients With Intravenous Immunoglobulin-resistant Kawasaki Disease|Recruiting||Phase 2|25|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:30:17.463862|2017-10-10 23:30:17.463862
NCT02390583|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-05-14|||September 2016||2016-09-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|ADDICSOM||Internet Addiction and Sleep Disorders|Internet Addiction and Sleep Disorders|Withdrawn||N/A|0|Actual|Assistance Publique - Hôpitaux de Paris||2||no patient|f||||f||||||||No|"At the end of the study, patient could be informed of result of the study if they wish.
No individual result will be communicate."|2017-10-10 23:30:17.574092|2017-10-10 23:30:17.574092
NCT02390570|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-07-17|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|February 22, 2017|Actual|2017-02-22||Interventional|||Incorporating Patient Capacity Into the Clinical Landscape|Incorporating Patient Capacity Into the Clinical Landscape|Active, not recruiting||N/A|490|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:30:17.708274|2017-10-10 23:30:17.708274
NCT02390544|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-10-04|||March 2015||2015-03-01|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||A Pharmacokinetic Study of Melphalan in Children|Melphalan Pharmacokinetics in Children Undergoing Hematopoietic Stem Cell Transplantation: A Pilot Study|Recruiting||Phase 1|40|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 23:30:17.921488|2017-10-10 23:30:17.921488
NCT02390531|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-07-25|||April 28, 2015|Actual|2015-04-28|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ROP1||Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity|Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity|Recruiting||Phase 1|112|Anticipated|Jaeb Center for Health Research||1|||f||||t||||||||||2017-10-10 23:30:18.016841|2017-10-10 23:30:18.016841
NCT02390518|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-07-25|||May 2015||2015-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Stereotactic Radiosurgery Dose Escalation for Brain Metastases|Phase I Study of Stereotactic Radiosurgery Dose Escalation for Brain Metastases|Recruiting||N/A|50|Anticipated|University of Utah||1|||f||||t|f|t|f|f|f|||||2017-10-10 23:30:18.186536|2017-10-10 23:30:18.186536
NCT02390505|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-08-03|||July 2016||2016-07-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|CRPS-VITC||Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery|Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery|Recruiting||Phase 3|1000|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-10 23:30:18.289442|2017-10-10 23:30:18.289442
NCT02390492|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-11-01|||March 2015||2015-03-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Phase I Bioavailability and Pharmacokinetic Study of [14C]-Ipatasertib Single Oral and Intravenous Doses in Healthy Male Subjects|A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Ipatasertib (GDC-0068) Following a Single Oral Dose and to Investigate the Absolute Bioavailability Following Single Oral and Intravenous Doses in a Single Cohort of Healthy Male Subjects|Completed||Phase 1|8|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-10 23:30:18.430819|2017-10-10 23:30:18.430819
NCT02390479|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-09-28|||December 2013||2013-12-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin (OPG) and RANKL in Health, Disease and After Treatment|Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin (OPG) and RANKL in Health, Disease and After Treatment|Completed||Early Phase 1|54|Actual|Bulent Ecevit University||2|||f||||f||||||||||2017-10-10 23:30:18.568676|2017-10-10 23:30:18.568676
NCT02390466|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-06-16|||April 2015||2015-04-01|October 2015|2015-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1|Multicentre, Open-label, Phase I/IIa Clinical Study of an Immunoprotective Therapeutic Vaccine Candidate (VAC-3S) in Human Immunodeficiency Virus Type 1 (HIV-1) Chronically Infected Patients Virologically Controlled on Antiretroviral Therapy (ART) Who Rose an Immune Response to VAC-3S During IVVAC-3S/P1|Unknown status|Active, not recruiting|Phase 1/Phase 2|15|Anticipated|InnaVirVax||1|||f||||t||||||||||2017-10-10 23:30:18.685221|2017-10-10 23:30:18.685221
NCT02390453|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-02-07|||January 2015||2015-01-01|February 2017|2017-02-01||||April 2019|Anticipated|2019-04-01||Interventional|CARB||Cognitive and Aerobic Resilience for the Brain|Cognitive and Aerobic Resilience for the Brain|Recruiting||N/A|160|Anticipated|Indiana University||4|||f||||t||||||||||2017-10-10 23:30:18.78384|2017-10-10 23:30:18.78384
NCT02390440|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-01-17|||April 2015||2015-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Exparel for Pain Control During Care of Rib Fractures|Liposomal Bupivicaine (Exparel) for Pain Control During Care of Rib Fractures|Withdrawn||Phase 4|0|Actual|University of Kansas Medical Center||1||Did not obtain an IND.|f||||f||||||||||2017-10-10 23:30:18.919587|2017-10-10 23:30:18.919587
NCT02390427|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-08-03|||April 2015||2015-04-01|August 2016|2016-08-01|October 2020|Anticipated|2020-10-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer|Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer|Recruiting||Phase 1|76|Anticipated|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-10-10 23:30:19.044524|2017-10-10 23:30:19.044524
NCT02390414|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-06-07|||April 2011||2011-04-01|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|||The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study|The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study|Recruiting||N/A|290|Anticipated|Dana-Farber Cancer Institute|||2||f||||t||||||||||2017-10-10 23:30:19.193164|2017-10-10 23:30:19.193164
NCT02390401|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-07-03|||May 2015||2015-05-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|May 2020|Anticipated|2020-05-01||Interventional|VACCS||Vacuum Assisted Closure for Cesarean Section|Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese|Recruiting||Phase 1|400|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 23:30:19.299375|2017-10-10 23:30:19.299375
NCT02390388|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-08-25|||November 2014||2014-11-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pudendal Block Versus Caudal Block for Hypospadias|A Comparison of Effectiveness of Pudendal Nerve Block vs Caudal Block for Hypospadias Surgery in Children|Completed||Phase 4|80|Actual|Istanbul University||2|||f||||t||||||||||2017-10-10 23:30:19.430647|2017-10-10 23:30:19.430647
NCT02390375|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-10-07|||November 2014||2014-11-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia||Completed||Phase 3|348|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 23:30:19.513474|2017-10-10 23:30:19.513474
NCT02390362|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-02-01|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RAMP||Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome|Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome (RAMP)|Terminated||Phase 3|3|Actual|Nationwide Children's Hospital||2||Sponsor Milestones and Financing Requirements could not be met.|f||||t||||||||||2017-10-10 23:30:19.589772|2017-10-10 23:30:19.589772
NCT02390349|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-06-21|||April 2015||2015-04-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||"CuraMed and Curamin in Osteoarthritis"||Completed||N/A|179|Actual|EuroPharma, Inc.||3|||f||||||||||||||2017-10-10 23:30:19.664845|2017-10-10 23:30:19.664845
NCT02390336|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-05-27|||March 2015||2015-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MWM||Mobilization With Movement in Patients With Osteoarthritis of the Hip|The Immediate Effects of Mulligan Mobilization With Movement Technique in Pain, Range of Motion and Physical Function in Patients With Osteoarthritis of the Hip|Completed||N/A|40|Actual|Escola Superior de Tecnologia da Saúde do Porto||2|||f||||f||||||||||2017-10-10 23:30:19.740016|2017-10-10 23:30:19.740016
NCT02390323|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-05-24|||January 2014||2014-01-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Changes in Skin Conductance Measurement as an Endpoint Monitor for Sympathetic Blocks|Changes in Skin Conductance Measurement as an Endpoint Monitor for Sympathetic Blocks|Completed||N/A|14|Actual|Hospital for Special Surgery, New York||1|||f||||f||||||||||2017-10-10 23:30:19.834698|2017-10-10 23:30:19.834698
NCT02390310|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-08-02|||May 2015||2015-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Simplifying the Shang Ring Technique for Circumcision of Men and Boys|Simplifying the Shang Ring Technique for Circumcision of Men and Boys|Completed||N/A|574|Actual|EngenderHealth||4|||f||||t||||||||||2017-10-10 23:30:19.924748|2017-10-10 23:30:19.924748
NCT02390297|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-07-26|||March 2015||2015-03-01|July 2016|2016-07-01|January 2032|Anticipated|2032-01-01|January 2031|Anticipated|2031-01-01||Observational|||Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients|Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct|Enrolling by invitation||N/A|18|Anticipated|Calimmune, Inc.|||1||f||||f||||||Samples With DNA|"     Cryopreserved white blood cells and DNA and RNA extracted from peripheral blood   "|||2017-10-10 23:30:20.015903|2017-10-10 23:30:20.015903
NCT02390284|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-09-20|||September 2014||2014-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|STOP-RGCD||Stop Retinal Ganglion Cell Dysfunction Study|Stop Retinal Ganglion Cell Dysfunction Study|Recruiting||Phase 3|500|Anticipated|University of Miami||3|||f||||f||||||||||2017-10-10 23:30:20.100866|2017-10-10 23:30:20.100866
NCT02390271|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-10|||June 2010||2010-06-01|March 2015|2015-03-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Interventional|||How Reducing Anxiety in Schizophrenia|Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia|Completed||Phase 4|10|Actual|Institut de Recherche Biomedicale des Armees||1|||f||||t||||||||||2017-10-10 23:30:20.218258|2017-10-10 23:30:20.218258
NCT02390258|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-17|||July 2011||2011-07-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103|A Single Centre, Randomised, Double-blind, Placebo-controlled, Fed-fasted, Single and Multiple Ascending Dose Trial of XEN-D0103 in Healthy Subjects|Completed||Phase 1|87|Actual|Xention Ltd||9|||f||||t||||||||||2017-10-10 23:30:20.288276|2017-10-10 23:30:20.288276
NCT02390245|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-05-02|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study|Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study|Active, not recruiting||N/A|375|Anticipated|Wills Eye||2|||f||||t||||||||Yes|A methods paper with year-1 baseline data is completed and currently being submitted for publication. An additional 8 scientific manuscripts are under development.|2017-10-10 23:30:20.371899|2017-10-10 23:30:20.371899
NCT02390232|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-02-21|||February 2015||2015-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01|1 Day|Observational [Patient Registry]|Coli-NASH||Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH|Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH|Recruiting||N/A|120|Anticipated|University Hospital, Toulouse|||2||f||||f||||||Samples Without DNA|"     feces, liver, blood   "|No||2017-10-10 23:30:20.578281|2017-10-10 23:30:20.578281
NCT02389465|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-08-24|||August 2014||2014-08-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|S&I||Late-Life Stress and Inflammation|Stress and Inflammation in the Pathophysiology of Late Life Depression|Recruiting||N/A|150|Anticipated|University of Pennsylvania||3|||f||||f||||||||||2017-10-10 23:30:32.491288|2017-10-10 23:30:32.491288
NCT02390206|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-09-29|||June 2015||2015-06-01|September 2017|2017-09-01|August 28, 2017|Actual|2017-08-28|August 28, 2017|Actual|2017-08-28||Observational|B-CAUSE||Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients|An Observational, Prospective, Multicentre, National Trial on the Benefit of Botulinum Toxin Type A (BoNT-A) Injections in Untreated Chronic Post-stroke Spastic Brazilian Patients|Completed||N/A|239|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 23:30:20.796421|2017-10-10 23:30:20.796421
NCT02390193|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-11-27|||January 2015||2015-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of Hemodialysis on Upper Airways Collapsibility in Patients With Chronic Kidney Disease|Effect of Hemodialysis on Upper Airways Collapsibility in Patients With Chronic Kidney Disease|Enrolling by invitation||N/A|52|Anticipated|University of Nove de Julho||1|||f||||t||||||||||2017-10-10 23:30:20.896232|2017-10-10 23:30:20.896232
NCT02390180|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-05-11|||October 2014||2014-10-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Sorting of Oral Sensations|Sorting of Oral Sensations|Completed||N/A|107|Actual|Purdue University|||2||f||||f||||||||||2017-10-10 23:30:20.978816|2017-10-10 23:30:20.978816
NCT02390167|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-03-09|2016-12-30||March 2015||2015-03-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation of a Ascensia ONYX NEXT Investigational Blood Glucose Monitoring System|User Performance of the ONYX NEXT Blood Glucose Monitoring System|Completed||N/A|376|Actual|Ascensia Diabetes Care||1|||f||||f||||||||No||2017-10-10 23:30:21.084343|2017-10-10 23:30:21.084343
NCT02390154|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2016-07-14|||April 2015||2015-04-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Roniciclib Mass Balance Study|A Phase I, Single Center, Open-label, Non-randomized, Non-placebo-controlled Study to Investigate the Metabolism, Excretion Pattern, Mass Balance, Safety, Tolerability and Pharmacokinetics of Orally Administered [14C]-Roniciclib (BAY 1000394) in Patients With Solid Tumors|Completed||Phase 1|7|Actual|Bayer||2|||f||||f||||||||||2017-10-10 23:30:21.591813|2017-10-10 23:30:21.591813
NCT02390141|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-11-10|||April 2015||2015-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207|A Randomized, Placebo-controlled, Double-blind Trial of Multiple Ascending Doses of ZP4207 Administered to Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP4207|Completed||Phase 1|24|Actual|Zealand Pharma||2|||f||||f||||||||||2017-10-10 23:30:21.679599|2017-10-10 23:30:21.679599
NCT02390128|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2015-03-16|||January 2015||2015-01-01|March 2015|2015-03-01||||January 2017|Anticipated|2017-01-01||Observational|MABY||Mothers and Babies at Yorkhill Thyroid Health Cohort|Giving Children the Best Start in Life: the Mothers and Babies at Yorkhill Thyroid Health|Unknown status|Recruiting|N/A|697|Anticipated|University of Glasgow|||1||f||||f||||||Samples With DNA|"     urine, blood, hair, breastmilk   "|||2017-10-10 23:30:21.776389|2017-10-10 23:30:21.776389
NCT02390115|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|||Effects of Elastic Tape in Shoulder Movements in Hemiparetic Subjects|Effects of Elastic Tape in Proprioception and Performance of Shoulder Movements in Chronic Hemiparetic Subjects|Active, not recruiting||N/A|40|Anticipated|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-10-10 23:30:21.876222|2017-10-10 23:30:21.876222
NCT02390102|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-03-16|||June 2012||2012-06-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|EPICURE||Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement|Combined ErythroPoietin and Iron Therapy for AnemiC Patients With Severe Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve REplacement- The EPICURE Trial A Prospective Double Blind Randomized Trial|Unknown status|Recruiting|Phase 3|100|Anticipated|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec||2|||f||||f||||||||||2017-10-10 23:30:21.957897|2017-10-10 23:30:21.957897
NCT02390089|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-03-23|||April 2015||2015-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Cough According to Stimulus Type in PD|Airway Protection Deficits According to Stimulus Type in Parkinson's Disease|Recruiting||Phase 1|220|Anticipated|University of Florida||3|||f||||f|t|f||||||||2017-10-10 23:30:22.113436|2017-10-10 23:30:22.113436
NCT02390076|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-16|||January 2013||2013-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Behavioral Study of Effects of Low-Level Light Therapy on Mood and Reaction Time|Influence of Low-Level Light Therapy on Attention Bias Modification and Mood Change in Dysphoric Individuals|Completed||N/A|57|Actual|University of Texas at Austin||3|||f||||f||||||||||2017-10-10 23:30:22.268387|2017-10-10 23:30:22.268387
NCT02390063|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-05-17|||June 2015||2015-06-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||VAccination in Prostate caNCEr (VANCE)|A Randomized Phase I Study to Determine the Safety and Immunogenicity of ChAd-MVA Vaccination Compared to MVA Alone With and Without Low Dose Cyclophosphamide in Low and Intermediate Risk Localised Prostate Cancer|Recruiting||Phase 1|48|Anticipated|University of Oxford||8|||f||||t||||||||||2017-10-10 23:30:22.37098|2017-10-10 23:30:22.37098
NCT02390050|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-02-01||2016-07-11|May 2015||2015-05-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus|A Phase 2b, Multi-center, Double-blind, Placebo-controlled, Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets on HbA1c in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2/Phase 3|292|Actual|Theracos||4|||f||||t||||||||No||2017-10-10 23:30:22.954599|2017-10-10 23:30:22.954599
NCT02390037|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-03-03|||March 2015||2015-03-01|March 2017|2017-03-01|November 4, 2016|Actual|2016-11-04|November 4, 2016|Actual|2016-11-04||Observational|PFLEX||Pipeline™ Flex Embolization Device With Shield Technology™ Clinical Study|Pipeline™ Flex Embolization Device With Shield Technology™ Clinical Study|Completed||N/A|50|Actual|Medtronic Neurovascular Clinical Affairs|||1||f||||||||||||||2017-10-10 23:30:23.285729|2017-10-10 23:30:23.285729
NCT02390024|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-02-09|||June 2015||2015-06-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|PVI-NCOG||Influence of Patient/Ventilador Decoupling in Neurocognitive and Psychopathological Sequelae in ICU Patients|Influence of Persistent Patient / Ventilator Decoupling in Cognitive and Psychopathological Sequelae in Critically Ill Patients: A Multicenter Clinical and Mechanisticstudy|Recruiting||N/A|150|Anticipated|Corporacion Parc Tauli|||1||f||||t||||||||||2017-10-10 23:30:23.370653|2017-10-10 23:30:23.370653
NCT02390011|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-12|||January 8, 2015|Actual|2015-01-08|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Observational|||Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies|A Pilot Study of Novel Magnetic Resonance Coil Arrays to Improve the Characterization of Liver Metastases in Patients With Advanced Solid Tumor Malignancies|Recruiting||N/A|70|Anticipated|University of California, San Francisco|||1||f||||t||||||||||2017-10-10 23:30:23.52328|2017-10-10 23:30:23.52328
NCT02389998|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-08-26|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Placebo||Efficacy of Open Label Placebo in Children With FGIDs|Evaluation of the Efficacy of Open Label Placebo in Children With FGIDs (Functional Gastrointestinal Disorders)|Recruiting||N/A|80|Anticipated|Boston Children’s Hospital||2|||f||||||||||||||2017-10-10 23:30:23.626191|2017-10-10 23:30:23.626191
NCT02389985|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-04-18|||July 2015||2015-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of CRLX101 in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|A PHASE Ib STUDY OF CRLX101 IN COMBINATION WITH WEEKLY PACLITAXEL IN PATIENTS WITH RECURRENT OR PERSISTENT EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|NewLink Genetics Corporation||1|||f||||f||||||||||2017-10-10 23:30:23.729828|2017-10-10 23:30:23.729828
NCT02389972|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-08|||April 11, 2013|Actual|2013-04-11|September 2017|2017-09-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Observational|||Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study|Effectiveness of Dasatinib(Sprycel®) in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study|Completed||N/A|128|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 23:30:23.839032|2017-10-10 23:30:23.839032
NCT02389959|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-04-25|||August 2014||2014-08-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|||Intranasal Bevacizumab for HHT-Related Epistaxis|Intranasal Bevacizumab for HHT-Related Epistaxis|Recruiting||Phase 4|40|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 23:30:23.964079|2017-10-10 23:30:23.964079
NCT02389946|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-14|||May 2015||2015-05-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2017|Actual|2017-04-01||Interventional|BIOFLOW-V||Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions|BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - V|Active, not recruiting||N/A|1334|Anticipated|Biotronik, Inc.||2|||f||||t||||||||||2017-10-10 23:30:24.131869|2017-10-10 23:30:24.131869
NCT02389933|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-10-03||||||October 2017|2017-10-01||||||||Expanded Access|||Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)|Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)|Available||N/A|||Novartis|||||||t||||||||||||2017-10-10 23:30:24.535866|2017-10-10 23:30:24.535866
NCT02389920|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-16|||April 2015||2015-04-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Multicenter, PhaseⅣ, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib||Not yet recruiting||Phase 4|40|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-10 23:30:25.306293|2017-10-10 23:30:25.306293
NCT02389907|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01|14 Days|Observational [Patient Registry]|||Association Between Patients' Perceptions of Success in Post-op Pain Management and Overall Experience With Care|Assessing the Association Between Patients' Perceptions of Success With Post-Operative Pain Management and Overall Experience With Care|Unknown status|Recruiting|N/A|300|Anticipated|The Medicines Company|||2||f||||f||||||||||2017-10-10 23:30:25.415486|2017-10-10 23:30:25.415486
NCT02389894|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-04-12|||March 2015||2015-03-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Neuroprotection in Patients Undergoing Aortic Valve Replacement|Neuroprotection In Patients Undergoing Aortic Valve Replacement|Completed||N/A|383|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||||2017-10-10 23:30:25.558598|2017-10-10 23:30:25.558598
NCT02389881|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-01-03|2016-10-07||February 2015||2015-02-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Safety Set, all enrolled participants who received at least 1 dose of study drug.|Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Safety, Tolerability, and Pharmacokinetic Study in Healthy Subjects After Multiple Oral Doses of TAK-058|Completed||Phase 1|40|Actual|Takeda||7|||f||||t||||||||||2017-10-10 23:30:25.780431|2017-10-10 23:30:25.780431
NCT02389868|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-06-15|||February 2015||2015-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LovaC||Effects of Lovastatin on Human Platelet Proteome||Completed||Phase 2|15|Anticipated|Université de Sherbrooke||1|||f||||||||||||||2017-10-10 23:30:27.668105|2017-10-10 23:30:27.668105
NCT02389855|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-01-31|||February 2015||2015-02-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry|Laser Ablation in Stereotactic Neurosurgery|Completed||N/A|144|Actual|Monteris Medical|||1||f||||f||||||||||2017-10-10 23:30:27.749439|2017-10-10 23:30:27.749439
NCT02389842|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2015-03-16|||February 2015||2015-02-01|March 2015|2015-03-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|PIPA||PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib|PIPA: A Phase Ib Study to Assess the Safety, Tolerability and Efficacy of the PI3K Inhibitors, Taselisib (GDC-0032) or Pictilisib (GDC-0941), in Combination With PAlbociclib, With the Subsequent Addition of Fulvestrant in PIK3CA-mutant Breast Cancers|Unknown status|Recruiting|Phase 1|93|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:30:27.831647|2017-10-10 23:30:27.831647
NCT02389829|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-02-27|||March 2015||2015-03-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine|Hydromorphone Versus Prochlorperazine + Diphenhydramine for Treatment of Acute Migraine. A Randomized, Emergency Department Based, Comparative Efficacy Study|Completed||Phase 4|127|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 23:30:27.934283|2017-10-10 23:30:27.934283
NCT02389816|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-09-28|||April 10, 2015|Actual|2015-04-10|September 2017|2017-09-01|April 22, 2018|Anticipated|2018-04-22|April 22, 2018|Anticipated|2018-04-22||Interventional|||A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase III Study to Assess the Efficacy and Safety of Lu AA21004 in Patients With Major Depressive Disorder|Recruiting||Phase 3|480|Anticipated|Takeda||3|||f||||f|f|f||||||||2017-10-10 23:30:28.037133|2017-10-10 23:30:28.037133
NCT02389803|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-03-09|||June 2015||2015-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys|Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys|Recruiting||N/A|160|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:30:28.273596|2017-10-10 23:30:28.273596
NCT02389790|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-09-01|||August 2015||2015-08-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Extension Study of MT-1303 in Subjects With Crohn's Disease|A Phase II, Open-label, Multicentre Study to Evaluate the Long-term Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease Who Have Completed the MT 1303-E13 Study|Completed||Phase 2|46|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||t||||||||||2017-10-10 23:30:28.380483|2017-10-10 23:30:28.380483
NCT02389777|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-11-29||2016-11-29|March 2015||2015-03-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|ACCS||Amnion-derived Cellular Cytokine Solution in UV-induced Inflammation|Effect of ACCS in UV-induced Inflammation|Completed||Phase 2|10|Actual|Noveome Biotherapeutics, formerly Stemnion||3|||f||||f||||||||No||2017-10-10 23:30:28.480697|2017-10-10 23:30:28.480697
NCT02389764|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-08-16|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)|A Phase II Study of BIBF1120 (Nintedanib) for Patients With Metastatic HER2-Negative Inflammatory Breast Cancer (IBC)|Recruiting||Phase 2|44|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:30:28.552068|2017-10-10 23:30:28.552068
NCT02389751|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-03-13|||April 2015|Actual|2015-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study of Ganetespib in Combination With Chemoradiation|GUARDIAN-1 Trial: A Phase 1 Study of Ganetespib in Combination With Chemoradiation for Stage II-III Esophageal Carcinoma|Active, not recruiting||Phase 1|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:30:28.636|2017-10-10 23:30:28.636
NCT02389738|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-11-24|||February 2015||2015-02-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration|Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration|Recruiting||Early Phase 1|5|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:30:28.728393|2017-10-10 23:30:28.728393
NCT02389725|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-09-13|||March 2015||2015-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Effect of Two Different Tourniquet Techniques on Peripheral IV Access Success Rates|The Effect of Two Different Tourniquet Techniques on Peripheral IV Access Success Rates|Completed||N/A|120|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:30:30.321882|2017-10-10 23:30:30.321882
NCT02389712|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-08-28|||March 2015||2015-03-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|FLAME||16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression|16-week Open Randomized Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression: Pharmacogenomic and Biomarker Predictors of Response|Recruiting||Phase 4|400|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:30:30.444794|2017-10-10 23:30:30.444794
NCT02389699|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-10|||June 2014||2014-06-01|March 2015|2015-03-01|June 2024|Anticipated|2024-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Ductal Carcinoma in Situ|Comparison of the Efficacy of Intra-operative Radiation Therapy After Conserving Surgery With Post-operative Whole Breast Radiotherapy for Women With Ductal Carcinoma in Situ|Active, not recruiting||N/A|74|Anticipated|Guangdong Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:30:30.542388|2017-10-10 23:30:30.542388
NCT02389686|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-10|||October 2014||2014-10-01|March 2015|2015-03-01|October 2024|Anticipated|2024-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Intra-operative Radiotherapy For Breast Cancer Women After NSM|Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer After Nipple-sparing Mastectomy|Recruiting||N/A|110|Anticipated|Guangdong Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:30:30.613959|2017-10-10 23:30:30.613959
NCT02389673|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-10|||October 2014||2014-10-01|March 2015|2015-03-01|June 2026|Anticipated|2026-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer|Intra-operative Radiotherapy After Breast-conversing Surgery in Treating Women With Ductal Carcinoma in Situ Breast Cancer|Recruiting||N/A|222|Anticipated|Guangdong Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:30:30.700018|2017-10-10 23:30:30.700018
NCT02389660|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-06-28|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|E-COMPARED||European Comparative Effectiveness Research on Internet-based Depression Treatment in Poland|European Comparative Effectiveness Research on Internet-based Depression Treatment in Poland [Europejskie Badania Porównawcze Nad Efektywnością Interwencji Internetowej Dla Osób z Depresją] (E-COMPARED)|Active, not recruiting||N/A|84|Actual|University of Social Sciences and Humanities, Warsaw||2|||f||||f||||||||||2017-10-10 23:30:30.780895|2017-10-10 23:30:30.780895
NCT02389647|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-08-09|||March 2015||2015-03-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury|Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury|Active, not recruiting||N/A|100|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix|||3||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 23:30:30.888197|2017-10-10 23:30:30.888197
NCT02385006|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-04|||February 2013||2013-02-01|March 2013|2013-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|TEG-PKT||Thromboelastography and Pancreas-kidney Transplantation|Thromboelastographic Profile During Simultaneous Pancreas-kidney Transplantation|Completed||N/A|152|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:31:21.918946|2017-10-10 23:31:21.918946
NCT02389634|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-01-05|||September 2010||2010-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Identification of Novel Molecular Markers for Vasospasm|Identification of Novel Molecular Markers for Vasospasm From the Cerebrospinal Fluid (CSF) of Patients With Aneurysmal Subarachnoid Hemorrhage|Active, not recruiting||N/A|50|Actual|St. Joseph's Hospital and Medical Center, Phoenix|||1||f||||f||||||Samples With DNA|"     blood and cerebrospinal fluid   "|Undecided||2017-10-10 23:30:30.958903|2017-10-10 23:30:30.958903
NCT02389621|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-04-28|||June 1, 2015||2015-06-01|April 2017|2017-04-01|April 19, 2017|Actual|2017-04-19|April 5, 2017|Actual|2017-04-05||Interventional|L-PLUS 2||Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures|A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)|Completed||Phase 3|200|Actual|Shionogi Inc.||2|||f||||t||||||||||2017-10-10 23:30:31.029776|2017-10-10 23:30:31.029776
NCT02389608|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-10-24|||January 2015||2015-01-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Immediate Effect of Electrical Stimulation Transcranial Direct Current (tDCS) Associated With the Use of FES, in Muscle Activity of the Tibialis Anterior Muscle, Balance and Plantar Pressure Distribution of Individuals With Hemiparesis Due to Stroke|The Immediate Effect of Electrical Stimulation Transcranial Direct Current (tDCS) Associated With the Use of FES, in Muscle Activity of the Tibialis Anterior Muscle, Balance and Plantar Pressure Distribution of Individuals With Hemiparesis Due to Stroke - Randomized, Double Blind|Completed||Phase 1/Phase 2|30|Anticipated|University of Nove de Julho||1|||f||||t||||||||||2017-10-10 23:30:31.50697|2017-10-10 23:30:31.50697
NCT02389595|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-04-14|||May 2015||2015-05-01|April 2017|2017-04-01|May 2024|Anticipated|2024-05-01|May 2023|Anticipated|2023-05-01||Observational|||A T Cell-based HIV Vaccine|Selection of a Protective T Cell-based HIV-1/FIV Vaccine Devoid of Viral Enhancing Epitopes|Recruiting||N/A|180|Anticipated|University of Florida|||2||f||||f|f|f||||Samples With DNA|"     Serum Whole Blood T cells   "|||2017-10-10 23:30:31.61485|2017-10-10 23:30:31.61485
NCT02389582|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-04-28|||May 2014||2014-05-01|August 2014|2014-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease|Effects of LMWH Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease|Completed||Phase 4|29|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:30:31.734602|2017-10-10 23:30:31.734602
NCT02389569|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-04-11||||||April 2017|2017-04-01||||August 1, 2016|Actual|2016-08-01||Interventional|||Clinical Study of Biosilicate Under Resin Composite Restorations in Caries Affected Teeth|A Prospective, Double-blind, Randomized, Group Controlled Clinical Study on the Use of Biosilicate Under Resin Composite Restorations in Caries Affected Teeth|Completed||N/A|66|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-10 23:30:31.824892|2017-10-10 23:30:31.824892
NCT02389556|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-02-29|||January 2006||2006-01-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01|3 Years|Observational [Patient Registry]|||Serum ANGPTL3, ANGPTL8 and Glypican 4 Concentrations in Relation to the Development of Obesity in Korean Children|Serum ANGPTL3, ANGPTL8 and Glypican 4 Concentrations in Relation to the Development of Obesity in Korean Children: a Three Year Prospective Cohort Study|Completed||N/A|457|Actual|Korea University|||1||f||||f||||||Samples Without DNA|"     Serum was obtained from each subject after the subjects had fasted overnight for more than 8     hrs.   "|No||2017-10-10 23:30:31.934503|2017-10-10 23:30:31.934503
NCT02389543|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-09-01|||July 2015||2015-07-01|September 2015|2015-09-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|SLAM||Study of Selinexor (KPT- 330), Lenalidomide, & Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients|A Multi-Center, Phase 1/2, Open-Label Study of Selinexor (KPT- 330), Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma|Withdrawn||Phase 1/Phase 2|0|Actual|Karyopharm Therapeutics Inc||2||Terminated this trial and added a Lenalidomide arm to KCP-330-017|f||||f||||||||||2017-10-10 23:30:32.010375|2017-10-10 23:30:32.010375
NCT02389530|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-10-06|||May 2015||2015-05-01|October 2015|2015-10-01||||June 2018|Anticipated|2018-06-01|1 Month|Observational [Patient Registry]|||Use of Fluorescein Dye for the Removal of Brain Tumors|Use of Fluorescein Dye for the Removal of Brain Tumors|Recruiting||Phase 1/Phase 2|100|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:30:32.095724|2017-10-10 23:30:32.095724
NCT02389517|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-08-07|||March 2, 2015|Actual|2015-03-02|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant|Phase II Randomized Trial of Continuation of Post-Transplant Maintenance With Single-Agent Lenalidomide vs. Consolidation/Maintenance With Ixazomib-Lenalidomide-Dexamethasone in Patients With Residual Myeloma|Recruiting||Phase 2|86|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-10 23:30:32.172426|2017-10-10 23:30:32.172426
NCT02389504|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-06-02|||January 2016||2016-01-01|June 2017|2017-06-01|January 20, 2018|Anticipated|2018-01-20|January 20, 2018|Anticipated|2018-01-20||Interventional|||An Investigation of Return to Play Exertion Protocol in Concussed Adolescents|An Investigation of Return to Play Exertion Protocol in Concussed Adolescents|Recruiting||N/A|100|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:30:32.268856|2017-10-10 23:30:32.268856
NCT02389491|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-11-09|||March 2015||2015-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CHD||Effect of a High Density Formula on Growth and Safety in Congenital Heart Disease Infants|Effect of a High Density Formula on Growth and Safety in Early Postoperative Infants With Congenital Heart Disease Duration of Cardiac Intensive Care Unit（CCU）Stay: a Randomized Clinical Trial|Completed||N/A|64|Actual|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 23:30:32.340114|2017-10-10 23:30:32.340114
NCT02389478|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-11-09|||March 2015||2015-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Oropharyngeal Administration of Colostrum to Very Low Birth Weight Infants|Oropharyngeal Administration of Colostrum to Very Low Birth Weight Infants：Effects on Secretory Immunoglobulin A|Completed||N/A|64|Actual|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 23:30:32.413098|2017-10-10 23:30:32.413098
NCT02389452|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-08-04|2015-05-05||February 2010||2010-02-01|August 2017|2017-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|OASIS|Intent to treat (ITT) population included all participants who received at least one dose of study medication.|Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment|A Multicenter, Prospective, Open-Label Study of the Safety and Efficacy of 6 mL Synvisc-One ® (Hylan G F 20) in Indian Patients With Symptomatic Osteoarthritis of the Knee(s) After Initial and Repeat Treatment|Completed||Phase 4|394|Actual|Sanofi||1|||f||||f||||||||||2017-10-10 23:30:32.630503|2017-10-10 23:30:32.630503
NCT02389439|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-04-22|||March 2015||2015-03-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria|Monitoring and Evaluation of the Therapeutic Efficacy and Safety of Pyronaridine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia, an Area of Artemisinin-resistant Falciparum Malaria|Unknown status|Recruiting|Phase 2|145|Anticipated|University of Oxford||1|||f||||t||||||||||2017-10-10 23:30:33.552668|2017-10-10 23:30:33.552668
NCT02389426|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-04-16|||December 2014||2014-12-01|February 2015|2015-02-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|TRADOMS||Transcranial Doppler in Multiple Sclerosis|Evaluation of Cerebrovascular Hemodynamics With Transcranial Doppler and Near-infrared Spectroscopy in Patients With Multiple Sclerosis|Completed||N/A|30|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-10 23:30:33.668777|2017-10-10 23:30:33.668777
NCT02389413|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-05-31|||March 2015||2015-03-01|January 2017|2017-01-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|SAPHIR||Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease|A Phase 2A Multicentre, Randomised, Double Blind, Placebo-Controlled, Parallel-Group Safety and Tolerability Study of PQ912 in Subjects With Early Alzheimer's Disease|Completed||Phase 2|120|Actual|Probiodrug AG||2|||f||||t||||||||||2017-10-10 23:30:33.786405|2017-10-10 23:30:33.786405
NCT02389400|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-03-10|||January 2014||2014-01-01|March 2015|2015-03-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|MAALCH||Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis|Efficacy and Tolerance of Combination Chemotherapy With Methotrexate and Cytosine Arabinoside in Newly Diagnosed Adult With Langerhans Cell Histiocytosis|Recruiting||Phase 2|30|Anticipated|Peking Union Medical College Hospital||1|||f||||f||||||||||2017-10-10 23:30:33.918726|2017-10-10 23:30:33.918726
NCT02389387|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-10-05|||March 2015||2015-03-01|October 2017|2017-10-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Reducing Disparities in Access to Kidney Transplantation (RaDIANT) Regional Study|Reducing Disparities in Access to Kidney Transplantation: The RaDIANT Regional Study|Active, not recruiting||N/A|140|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 23:30:34.024895|2017-10-10 23:30:34.024895
NCT02389374|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-07-18|2017-01-31||August 2014||2014-08-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh|A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of Glucose-6-dehydrogenase Status in South-east Bangladesh|Completed||Phase 4|181|Actual|Menzies School of Health Research||3|||f||||f||||||||||2017-10-10 23:30:34.120119|2017-10-10 23:30:34.120119
NCT02389361|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-07-18|2015-06-22||April 2011||2011-04-01|July 2015|2015-07-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of Oral Zaldiar With Intravenous Paracetamol and Tramadol|ZIH Study : Comparison of Oral Zaldiar (Combination of Paracetamol and Tramadol) With Intravenous Paracetamol and Tramadol for Postoperative Analgesia After Inguinal Hernia Repair|Completed||Phase 4|51|Actual|Astes||2|||f||||f||||||||||2017-10-10 23:30:34.550329|2017-10-10 23:30:34.550329
NCT02389348|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-10-06|||February 2015||2015-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|OZ/DSMCombo||A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265|A Proof-of-concept Study to Assess the Effect of a Range of Doses of Combined Therapy With OZ439 and DSM265 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants|Completed||Phase 1/Phase 2|13|Actual|Medicines for Malaria Venture||1|||f||||f||||||||||2017-10-10 23:30:34.799389|2017-10-10 23:30:34.799389
NCT02389335|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-16|||April 2013||2013-04-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Observational|||Roles of T Helper 1 Cytokines in Type 1 Diabetes|Roles of Interferon Gamma, Interleukin-2 and Tumor Necrotizan Factor Alpha in the Pathogenesis of Type 1 Diabetes|Completed||N/A|128|Actual|Istanbul Medeniyet University|||4||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 23:30:34.881816|2017-10-10 23:30:34.881816
NCT02389322|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-03-15|||March 2015||2015-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|IIb-healthy||Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65|Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65,Adopting Randomized Blinded and Parallel Controlled Method|Completed||Phase 2|1044|Actual|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.||4|||f||||f||||||||No||2017-10-10 23:30:34.95193|2017-10-10 23:30:34.95193
NCT02389309|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-03-07|||October 5, 2015|Actual|2015-10-05|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Trial of Dasatinib (PDGFR and SRC Inhibitor), Temsirolimus and Cyclophosphamide in Patients With Advanced Solid Tumors|A Phase I Trial of Dasatinib (PDGFR and SRC Inhibitor), Temsirolimus and Cyclophosphamide in Patients With Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:30:35.06442|2017-10-10 23:30:35.06442
NCT02389296|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-03-10|||May 2015||2015-05-01|March 2015|2015-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||The Forensic Psychiatric Nurse - Warden or Empathic Caregiver||Unknown status|Not yet recruiting|N/A|212|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-10-10 23:30:35.166576|2017-10-10 23:30:35.166576
NCT02389283|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-04-17|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|April 2017|Actual|2017-04-01||Observational|||Reduced Ultrasound Counts in Rheumatoid Arthritis|Sensitivity to Change of Different Reduced Ultrasound Counts in Rheumatoid Arthritis|Recruiting||N/A|100|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||f||||||||||2017-10-10 23:30:35.230072|2017-10-10 23:30:35.230072
NCT02389270|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-03-05|||March 2016||2016-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||Urinary Neurotrophin Levels in Healthy Children|Age and Daytime Variations in Urinary Neurotrophin Levels in Healthy Children Without Lower Urinary Tract Symptoms|Not yet recruiting||N/A|150|Anticipated|Children's Hospital Zagreb|||1||f||||f||||||Samples Without DNA|"     Urine ultrafiltrate   "|Undecided||2017-10-10 23:30:35.444889|2017-10-10 23:30:35.444889
NCT02389257|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-09-27|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|July 2017|Actual|2017-07-01||Interventional|MINIMAG||Optically Pumped 4He Magnetometers Performances Compared With Medical Reference Methods (ECG and MEG)|Optically Pumped 4He Magnetometers Performances Compared With Medical Reference Methods : Electrocardiography (ECG) and Magnetoencephalography (MEG)|Terminated||Phase 1|1|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 23:30:35.525984|2017-10-10 23:30:35.525984
NCT02389244|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-06-21|||September 2014||2014-09-01|June 2016|2016-06-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|REGOBONE||A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas|A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas|Recruiting||Phase 2|132|Anticipated|UNICANCER||2|||f||||t||||||||No|no individual participant data is shared|2017-10-10 23:30:35.653768|2017-10-10 23:30:35.653768
NCT02389231|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-05-23|||May 17, 2017|Actual|2017-05-17|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ANEMIL||Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment|" Anemil Trial : Phase I/II Clinical Trial Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment"|Recruiting||Phase 1/Phase 2|10|Anticipated|University Hospital, Bordeaux||1|||f||||t|f|f||||||||2017-10-10 23:30:35.927334|2017-10-10 23:30:35.927334
NCT02389218|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-05-17|||March 3, 2015|Actual|2015-03-03|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|METACSA||A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF|A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation|Recruiting||Phase 4|167|Anticipated|University Hospital, Ghent||2|||f||||t||||||||||2017-10-10 23:30:36.092494|2017-10-10 23:30:36.092494
NCT02389205|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-03-18|||April 2015||2015-04-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||The Effect of Functional Activities and Balance Ability With Taping in Subjects of Hemophilia|Rehabilitation Department of Tri-Service General Hospital|Unknown status|Not yet recruiting|N/A|30|Anticipated|Tri-Service General Hospital||2|||f||||f||||||||||2017-10-10 23:30:36.250762|2017-10-10 23:30:36.250762
NCT02389192|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-11|2017-07-13|||March 9, 2015||2015-03-09|July 12, 2017|2017-07-12|January 31, 2025|Anticipated|2025-01-31|January 31, 2025|Anticipated|2025-01-31||Interventional|||Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers|A Phase 1a Open-Label Study to Assess the Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers|Recruiting||Phase 1|5|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:30:36.363177|2017-10-10 23:30:36.363177
NCT02389179|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-12-14|||August 2014||2014-08-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Determination of Vitamin D Dose to Maintain Sufficiency Amongst Indian and Malay Women in the Tropics|Maintenance of Vitamin D Sufficiency With Oral Vitamin D Supplementation in Malaysian Women of Malay and Indian Ethnicity With Post Menopausal Osteoporosis|Recruiting||Phase 4|150|Anticipated|University of Malaya||3|||f||||t||||||||||2017-10-10 23:30:36.450517|2017-10-10 23:30:36.450517
NCT02389166|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-07-27|||June 2015||2015-06-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|August 2016|Anticipated|2016-08-01||Interventional|VNI-HD||Optiflow in Sequential Non-Invasive Ventilation|Randomized Clinical Trial Comparing High Flow Oxygen Delivery System (Optiflow) With Oxygen Therapy Under High-concentration Mask on Oxygenation of Patients Who Receive Sequential Non-Invasive Ventilation (NIV) Sessions|Recruiting||N/A|100|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||No||2017-10-10 23:30:36.547752|2017-10-10 23:30:36.547752
NCT02389153|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-11-02|||July 2014||2014-07-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Feasability of Collaborative Care in the Secondary Prevention of Coronary Heart Disease|Feasability and Effectiveness of a Collaborative Care Intervention in the Secondary Prevention of Coronary Heart Disease - A Pilot Study|Active, not recruiting||N/A|40|Actual|University of Göttingen||2|||f||||f||||||||||2017-10-10 23:30:36.683381|2017-10-10 23:30:36.683381
NCT02389140|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-30|||March 2015||2015-03-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Blood Flow Within Active Myofascial Trigger Points Following Massage|Blood Flow Within Active Myofascial Trigger Points Following Massage|Completed||N/A|28|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:30:36.782886|2017-10-10 23:30:36.782886
NCT02389127|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-10-31|||July 2015||2015-07-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis|Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis: a Pilot Study to Better Characterize and Standardize the Test|Recruiting||N/A|30|Anticipated|University of Arkansas|||3||f||||t||||||||||2017-10-10 23:30:36.867904|2017-10-10 23:30:36.867904
NCT02389114|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2015-07-28|||June 2013||2013-06-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Soy Protein and Polydextrose on Food Intake in Young Chinese Adult Males||Completed||N/A|27|Actual|Clinical Nutrition Research Centre, Singapore||4|||f||||f||||||||||2017-10-10 23:30:36.962437|2017-10-10 23:30:36.962437
NCT02389101|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-10-20|||October 2014||2014-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|MILY||Molecular and Whole-body MR Imaging in Lymphomas|Molecular and Whole-body MR Imaging in Lymphomas|Completed||N/A|21|Actual|Turku University Hospital||1|||f||||f||||||||||2017-10-10 23:30:37.042871|2017-10-10 23:30:37.042871
NCT02389088|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-02-09|2015-05-26||April 2006||2006-04-01|February 2016|2016-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||9 PCOS women|Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH.|Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH|Completed||N/A|9|Actual|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 23:30:37.160565|2017-10-10 23:30:37.160565
NCT02389075|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-08-30|||March 2015||2015-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis|The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis|Recruiting||N/A|60|Anticipated|University of Colorado, Denver|||3||f||||f||||||Samples With DNA|"     Colon pinch biopsies, white blood cells.   "|||2017-10-10 23:30:37.732327|2017-10-10 23:30:37.732327
NCT02389062|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-03-09|||February 2015||2015-02-01|March 2015|2015-03-01|February 2019|Anticipated|2019-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients|Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients: Prospective, Randomized,Placebo Controlled, Double Blind Clinical Trial|Recruiting||N/A|36|Anticipated|Thomas Jefferson University||3|||f||||t||||||||||2017-10-10 23:30:37.820006|2017-10-10 23:30:37.820006
NCT02389049|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-17|||February 2015||2015-02-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Genetics of Primary Ciliary Dyskinesia|Research Genetic Testing for Primary Ciliary Dyskinesia Using a Panel of Genes|Recruiting||N/A|280|Anticipated|University of North Carolina, Chapel Hill|||1||f||||t||||||Samples With DNA|"     Blood or buccal samples   "|||2017-10-10 23:30:37.937792|2017-10-10 23:30:37.937792
NCT02389036|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-05|||May 1, 2017|Actual|2017-05-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|SuDDICU-ANZ||Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients|A Crossover, Cluster Randomised Controlled Trial of Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients in Australian and New Zealand (SuDDICU-ANZ)|Recruiting||Phase 3|8000|Anticipated|The George Institute||2|||f||||t|f|f||||||||2017-10-10 23:30:38.026898|2017-10-10 23:30:38.026898
NCT02389023|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-08-16|||September 2015||2015-09-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery|Multicenter, Prospective, Randomized Clinical Trial of a Negative Pressure Incision Management System in High Risk Vascular Surgery Patients|Recruiting||N/A|242|Anticipated|University of Vermont Medical Center||2|||f||||f||||||||||2017-10-10 23:30:38.144637|2017-10-10 23:30:38.144637
NCT02389010|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-07-18|||January 2015||2015-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|CBPG-DFU||Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers|Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers|Completed||Phase 3|50|Actual|Centro Nazionale Sangue||2|||f||||f||||||||||2017-10-10 23:30:38.268974|2017-10-10 23:30:38.268974
NCT02388997|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-04|||February 2013||2013-02-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus|An Evaluation of Treatment With Omalizumab to Improve the Asthmatic Response to an Experimental Infection With Rhinovirus|Active, not recruiting||Phase 2|22|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-10 23:30:38.366975|2017-10-10 23:30:38.366975
NCT02388984|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-03-20|||May 2013||2013-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy|A Randomized, Double Blind, Multi-Center Study of Compound Danshen Dripping Pills in Patients With Diabetic Retinopathy (Syndrome Of Qi-Stagnation and Blood Stasis)|Active, not recruiting||Phase 3|480|Anticipated|Tasly Pharmaceuticals, Inc.||2|||f||||t||||||||No||2017-10-10 23:30:38.44053|2017-10-10 23:30:38.44053
NCT02388971|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-12-08|||April 2016||2016-04-01|December 2015|2015-12-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease|A Randomized, Double-Blind Placebo- Controlled Phase 2a Study to Assess the Effect of CCR2 Antagonism by MLN1202 on Atherosclerotic Inflammation in Subjects With Stable Atherosclerotic Cardiovascular Disease Using FDG PET/CT Imaging|Withdrawn||Phase 2|0|Actual|Takeda||2||Study has withdrawn.|f||||f||||||||||2017-10-10 23:30:38.53335|2017-10-10 23:30:38.53335
NCT02388958|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-01-18|||June 2014||2014-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Weight Changes During and After Pregnancy in Women With Gestational Diabetes|Weight Changes During and After Pregnancy in Women With Gestational Diabetes|Completed||N/A|89|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||||2017-10-10 23:30:38.601818|2017-10-10 23:30:38.601818
NCT02388945|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-03-09|||January 2015||2015-01-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||A Study of Domestic Automated Peritoneal Dialysis Machine|Validity and Security of Domestic Automated Peritoneal Dialysis Machine: A Prospective, Randomized, Controlled, Multi-Center Clinical Trial|Unknown status|Recruiting|N/A|600|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:30:38.666041|2017-10-10 23:30:38.666041
NCT02388932|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-03-07|||March 3, 2015|Actual|2015-03-03|March 2017|2017-03-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer|Phase I Dose Escalation Study of Stereotactic Body Radiotherapy for Carcinoma of the Head and Neck in High Risk Patients Who Are Ineligible/Refuse Standard of Care Therapy|Terminated||N/A|3|Actual|Case Comprehensive Cancer Center||1||Slow Accrual|f||||f|f|t|f|f|f|||||2017-10-10 23:30:38.838656|2017-10-10 23:30:38.838656
NCT02388919|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-09-15|||February 26, 2015|Actual|2015-02-26|January 2017|2017-01-01|January 6, 2017|Actual|2017-01-06|January 5, 2017|Actual|2017-01-05||Interventional|ALTER0303||Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）|A Registered Randomized, Double-Blind, Placebo-Controlled (2:1), Multi-Centered Clinical Trial of Anlotinib as a Treatment for Advanced Non-Small Cell Lung Cancer|Completed||Phase 2/Phase 3|439|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t|f|f|||f|||||2017-10-10 23:30:38.971775|2017-10-10 23:30:38.971775
NCT02388724|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-08-28|||March 16, 2015|Actual|2015-03-16|August 2017|2017-08-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Interventional|||Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis|A Randomized, Double-Blind, Double-Dummy Phase 3 Study to Evaluate the Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Compared to Lansoprazole 30 mg in the Treatment of Subjects With Erosive Esophagitis|Completed||Phase 3|480|Anticipated|Takeda||2|||f||||f|f|f||||||||2017-10-10 23:30:41.42616|2017-10-10 23:30:41.42616
NCT02388906|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-10-04|||March 12, 2015|Actual|2015-03-12|October 2017|2017-10-01|November 26, 2019|Anticipated|2019-11-26|November 29, 2018|Anticipated|2018-11-29||Interventional|||Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma (CheckMate 238)|A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy With Nivolumab Versus Ipilimumab After Complete Resection of Stage IIIb/c or Stage IV Melanoma in Subjects Who Are at High Risk for Recurrence (CheckMate 238: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 238)|Active, not recruiting||Phase 3|800|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 23:30:39.190749|2017-10-10 23:30:39.190749
NCT02388893|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-05-01|||January 2013|Actual|2013-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|1 Year|Observational [Patient Registry]|||Endocarditis Registry of the University Hospital of Cologne (ER-UHC)|Endocarditis Registry of the University Hospital of Cologne (ER-UHC)|Recruiting||N/A|500|Anticipated|University of Cologne|||1||f||||f||||||||||2017-10-10 23:30:39.586414|2017-10-10 23:30:39.586414
NCT02388880|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-12-29|||February 2015||2015-02-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)|Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology (4 Hour Use)|Terminated||N/A|4|Actual|Advanced Circulatory Systems||1||Slower than anticipated enrollment|f||||t||||||||||2017-10-10 23:30:39.709241|2017-10-10 23:30:39.709241
NCT02388867|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-13|||January 2012||2012-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|ROMAMETA||Matrix Metalloproteinases in Patients With Critical Limb Ischemia Undergoing Surgical Revascularization|Predictive Role of Matrix Metalloproteinases for the Outcome of Surgical Revascularization in Patients With Critical Limb Ischemia|Completed||N/A|30|Actual|University of Cantanzaro||2|||f||||t||||||||||2017-10-10 23:30:39.817258|2017-10-10 23:30:39.817258
NCT02388854|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-03-08|||December 2016||2016-12-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||Influence of Genetic Polymorphisms in the Pathogenesis of Endometriosis in Sardinian Population|Influence of Genetic Polymorphisms in the Pathogenesis of Endometriosis in Sardinian Population: an Observational Case Control Study|Not yet recruiting||N/A|100|Anticipated|University of Cagliari|||2||f||||f||||||Samples With DNA|"     EDTA blood samples   "|||2017-10-10 23:30:39.908735|2017-10-10 23:30:39.908735
NCT02388841|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-15|||January 2012||2012-01-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Thrombus Localization and Accompaying Disorders and Risk Factors|Assessment of the Association Between Thrombus Localization and Accompaying Disorders ,Rısk Factors, D-Dimer and Red Cells Distribution Witdh In Pulmonary Embolisim|Completed||N/A|148|Actual|Yuzuncu Yıl University|||2||f||||t||||||||||2017-10-10 23:30:40.033328|2017-10-10 23:30:40.033328
NCT02388828|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2017-04-21|||March 2015||2015-03-01|April 2017|2017-04-01|March 2025|Anticipated|2025-03-01|March 2025|Anticipated|2025-03-01||Observational|||CART-meso Long-term Follow-up|Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-meso Gene Therapy Products in Cancer Studies|Active, not recruiting||N/A|50|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 23:30:40.136213|2017-10-10 23:30:40.136213
NCT02388815|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-07-11|2016-03-14||March 2015||2015-03-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|BEAGLE||Abbott Sensor Based Glucose Monitoring System Paediatric Study|Evaluation of the Accuracy of the Abbott Sensor Based Glucose Monitoring System - Paediatric Label Extension Study (CE)|Completed||N/A|89|Actual|Abbott Diabetes Care||1|||f||||f||||||||||2017-10-10 23:30:40.216408|2017-10-10 23:30:40.216408
NCT02388802|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-11-07|||January 2017||2017-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Human Clinical Trial of Uterine Transplantation in the United Kingdom|The First Human Clinical Trial of Uterine Transplantation in the United Kingdom|Not yet recruiting||N/A|10|Anticipated|Womb Transplant UK||1|||f||||t||||||||||2017-10-10 23:30:40.433785|2017-10-10 23:30:40.433785
NCT02388789|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-06-08|||February 2015||2015-02-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Foot Skin Temperature and Balance Control|Effects of Changes in Foot Skin Temperature on Plantar-surface Mechanoreceptor Sensitivity and Balance Control|Completed||N/A|8|Actual|Wilfrid Laurier University||1|||f||||f||||||||||2017-10-10 23:30:40.531666|2017-10-10 23:30:40.531666
NCT02388776|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-01-17|||January 2015||2015-01-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Use of Rotational Thromboelastometry (ROTEM) to Characterize Coagulation Abnormalities in Burn Patients|Use of Rotational Thromboelastometry (ROTEM) to Characterize Coagulation Abnormalities in Burn Patients: A Prospective Pilot Study|Terminated||N/A|2|Actual|Weill Medical College of Cornell University||1||Subject recruitment unable to be completed due to study feasibility issues.|f||||f||||||||No|There is no plan to share IPD|2017-10-10 23:30:40.622143|2017-10-10 23:30:40.622143
NCT02388763|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-10|2016-10-21|2016-08-25||April 2015||2015-04-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||This reporting group includes all randomized participants.|Clinical Evaluation of MyDay™ and 1-DAY ACUVUE® TruEye®|Clinical Evaluation of MyDay™ Daily Disposable Silicone Hydrogel Contact Lenses|Completed||N/A|66|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:30:40.713827|2017-10-10 23:30:40.713827
NCT02388750|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-10-05|||April 2015||2015-04-01|October 2017|2017-10-01|August 7, 2017|Actual|2017-08-07|August 7, 2017|Actual|2017-08-07||Interventional|||Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)|Prospective Study of Palonosetron in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting (RINV) - a Phase II Study|Completed||Phase 2|96|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-10 23:30:40.999013|2017-10-10 23:30:40.999013
NCT02388737|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-09-26|||April 1, 2015|Actual|2015-04-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis|A Randomized, Double-Blind, Double-Dummy, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of Oral Once-Daily Administration of TAK-438 10 or 20 mg Compared to Lansoprazole 15 mg in the Maintenance Treatment of Subjects With Endoscopic Healing of Erosive Esophagitis|Recruiting||Phase 3|693|Anticipated|Takeda||3|||f||||f||||||||||2017-10-10 23:30:41.121892|2017-10-10 23:30:41.121892
NCT02388711|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-05-02|||March 2015||2015-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Trial of the C-TraC Intervention for Dementia Patients|A Randomized Control Trial of the Coordinated-Transitional Care (C-TraC) Intervention for Dementia Patients|Recruiting||N/A|1100|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 23:30:41.706478|2017-10-10 23:30:41.706478
NCT02388698|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-07-11|||November 23, 2016|Actual|2016-11-23|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||FDG-PET and Circulating HPV in Patients With Cervical Cancer|FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation|Recruiting||N/A|20|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 23:30:41.805754|2017-10-10 23:30:41.805754
NCT02388685|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-20|||July 2014||2014-07-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Comprehensive Magnetic Resonance in Peripheral Arterial Disease.3|Comprehensive Magnetic Resonance in Peripheral Arterial Disease.3|Recruiting||N/A|80|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-10 23:30:41.889516|2017-10-10 23:30:41.889516
NCT02388672|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-01-25|||March 2015||2015-03-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Effects of Green Coffee Bean Extract (GCE) on Physiological and Psychological Variables|Evaluation of Effects of Green Coffee Bean Extract (GCE) on Physiological and Psychological Variables- a Randomized, Placebo-controlled and Double-blinded Study in Healthy Subjects|Withdrawn||N/A|0|Actual|University Hospital Tuebingen||5||Personnel changes|f||||f||||||||||2017-10-10 23:30:41.976038|2017-10-10 23:30:41.976038
NCT02388659|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-10-20|||February 2014||2014-02-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas|Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas|Recruiting||N/A|105|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||No||2017-10-10 23:30:42.04792|2017-10-10 23:30:42.04792
NCT02388646|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-04-03|||March 2015||2015-03-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Energy Dispersive Bracing for Conservative Treatment of Knee Osteoarthritis||Completed||N/A|60|Actual|Orthopaedic Research Foundation||3|||f||||f||||||||No|Individual participant data will not be shared, only averages and summaries where all participant data is combined.|2017-10-10 23:30:42.252814|2017-10-10 23:30:42.252814
NCT02388633|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-09-26|||March 2015||2015-03-01|September 2016|2016-09-01||||April 2017|Anticipated|2017-04-01||Observational|||Acute Microvascular Changes With LDL Apheresis||Recruiting||N/A|12|Anticipated|Oregon Health and Science University|||1||f||||t||||||||||2017-10-10 23:30:42.350091|2017-10-10 23:30:42.350091
NCT02388620|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-25|||March 25, 2015|Actual|2015-03-25|September 2017|2017-09-01|January 9, 2017|Actual|2017-01-09|January 9, 2017|Actual|2017-01-09||Interventional|||Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011|A Phase I, Open Label, Multi-center, Parallel Cohort, Single Dose Study to Evaluate the Pharmacokinetics of LEE011 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function.|Completed||Phase 1|29|Actual|Novartis||4|||f||||f|t|f||||||||2017-10-10 23:30:42.471299|2017-10-10 23:30:42.471299
NCT02388607|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-09-07|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|ACCRAS||Sustained Attention Abilities in Schizophrenia|Sustained Attention Abilities, Attentional Resources and Cognitive Control Mechanisms in Schizophrenia|Recruiting||N/A|80|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:30:42.57172|2017-10-10 23:30:42.57172
NCT02388594|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-08-21|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients|A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients, With or Without the CCR5 Delta-32 Mutation, Pre-treated With Cyclophosphamide|Active, not recruiting||Phase 1|15|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:30:42.67101|2017-10-10 23:30:42.67101
NCT02388581|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-03-23|||December 2014||2014-12-01|December 2015|2015-12-01|December 2024|Anticipated|2024-12-01|December 2017|Anticipated|2017-12-01||Interventional|||First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL|Multicentre, Prospective Study of First-line Antibiotic Therapy for Early-stage H. Pylori-Positive Gastric Pure (de Novo) Diffuse Large B-cell Lymphoma and Potential Predicting Factor for Treatment Outcome|Recruiting||Phase 2|30|Anticipated|National Health Research Institutes, Taiwan||1|||f||||t||||||||||2017-10-10 23:30:42.759837|2017-10-10 23:30:42.759837
NCT02388568|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-08-28|||January 2015||2015-01-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Lifestyle Modification and Lorcaserin for Weight Loss Maintenance|A Randomized Controlled Trial of Lifestyle Modification and Lorcaserin for Weight Loss Maintenance|Completed||N/A|137|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:30:42.871354|2017-10-10 23:30:42.871354
NCT02388555|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-04-07|||January 2010||2010-01-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Observational|||Perspective Analysis of Coronal Imbalance in Degenerative Scoliosis|Coronal Imbalance in Degenerative Lumbar Scoliosis|Completed||N/A|284|Actual|Nanjing University School of Medicine|||2||f||||t||||||||||2017-10-10 23:30:42.963449|2017-10-10 23:30:42.963449
NCT02388542|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-13|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PROGRESS||Effect of Peer-mentor Mediated Interventions on Cardiovascular Risk Factors at Worksites|Policy and Peer Mentor Intervention Programs on Cardiovascular Disease at Small to Medium Sized Worksites in 3 South Asian Countries - a Pilot Study for a Definitive Large International Cluster Randomized Trial|Active, not recruiting||N/A|334|Actual|St. John's Research Institute||1|||f||||f||||||||||2017-10-10 23:30:43.050469|2017-10-10 23:30:43.050469
NCT02388529|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-10-14|||May 2015||2015-05-01|October 2015|2015-10-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure|A Randomized, Double-Blinded, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure Due to Reduced Left Ventricular Ejection Fraction|Withdrawn||Phase 1|0|Actual|Stealth BioTherapeutics Inc.||4|||f||||t||||||||||2017-10-10 23:30:43.169758|2017-10-10 23:30:43.169758
NCT02388516|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-18|||December 2014||2014-12-01|April 2017|2017-04-01|August 21, 2016|Actual|2016-08-21|August 21, 2016|Actual|2016-08-21||Interventional|MDARI||Maternal Vitamin D for Acute Respiratory Infections in Infancy|Maternal Vitamin D for Acute Respiratory Infections in Infancy (MDARI): a Nested Sub-study in a Randomized Controlled Trial of Vitamin D Supplementation During Pregnancy and Lactation in Dhaka, Bangladesh|Completed||Phase 3|1214|Actual|The Hospital for Sick Children||5|||f||||t||||||||||2017-10-10 23:30:43.280015|2017-10-10 23:30:43.280015
NCT02388503|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-04-30|||February 2015||2015-02-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of a Natural Extract on the Post-prandial Blood Glucose Response After Bread Consumption: a Dose-response of Efficacy|The Effect of a Natural Extract on the Post-prandial Blood Glucose Response After Bread Consumption: a Dose-response of Efficacy|Completed||N/A|64|Actual|Unilever R&D||5|||f||||f||||||||||2017-10-10 23:30:43.401071|2017-10-10 23:30:43.401071
NCT02388490|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-06-28|||August 2015||2015-08-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|Bretuximab||Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas|A Phase II Study of Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas|Recruiting||Phase 2|25|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 23:30:43.519686|2017-10-10 23:30:43.519686
NCT02388477|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-05-06||||||May 2016|2016-05-01||||May 2016|Anticipated|2016-05-01||Interventional|||Trial of the Use of Doxycycline After Rotator Cuff Repair|Randomized Controlled Trial of the Use of Doxycycline After Rotator Cuff Repair|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center||2||Research idea tabled at this point.|f||||f||||||||||2017-10-10 23:30:43.675885|2017-10-10 23:30:43.675885
NCT02388464|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-09-16|||July 2014||2014-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure|A Phase 1 Clinical Pharmacology Study of the Effects of a Single 4 Hour Intravenous Infusion of Bendavia™ (MTP-131) in Subjects With Stable New York Heart Association Class II-III Congestive Heart Failure Due to Left Ventricular Systolic Dysfunction|Completed||Phase 1|36|Actual|Stealth BioTherapeutics Inc.||4|||f||||t||||||||||2017-10-10 23:30:43.786824|2017-10-10 23:30:43.786824
NCT02388451|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-09-13|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Benefits of the Use of the Feuerstein Cognitive Training Method on Cognitive Function in Community-dwelling Older Patients With Mild Cognitive Impairment: a Pilot Study|The Benefits of the Use of the Feuerstein Cognitive Training Method on Cognitive Function in Community-dwelling Older Patients With Mild Cognitive Impairment: a Pilot Study|Active, not recruiting||Phase 4|11|Actual|Meir Medical Center||1|||f||||t||||||||||2017-10-10 23:30:43.893318|2017-10-10 23:30:43.893318
NCT02388438|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-09|||April 2013||2013-04-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|August 2014|Actual|2014-08-01||Interventional|DBM||Demineralized Bone Matrix in Opening Wedge Osteotomy for Hallux Valgus Deformity|Efficiency and Safety of Demineralized Bone Matrix in the Proximal Opening Wedge Osteotomy for Hallux Valgus Deformity|Unknown status|Active, not recruiting|Phase 4|30|Actual|Severance Hospital||1|||f||||f||||||||||2017-10-10 23:30:43.981241|2017-10-10 23:30:43.981241
NCT02387333|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2016-05-18|||February 2015||2015-02-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Role of Mesh Stoma Reinforcement Technique (MSRT) in Prevention of Parastomal Hernia After Ileal Conduit Urinary Diversion|Role of Mesh Stoma Reinforcement Technique (MSRT) in Prevention of Parastomal Hernia After Ileal Conduit Urinary Diversion: A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|40|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 23:30:44.086015|2017-10-10 23:30:44.086015
NCT02387320|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-05-10|||July 2014||2014-07-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluation of a Self-Care Toolkit in Surgical Breast Cancer Patients|Evaluation of a Self-Care Toolkit in Surgical Breast Cancer Patients|Recruiting||N/A|100|Anticipated|Samueli Institute for Information Biology||2|||f||||f||||||||No||2017-10-10 23:30:44.204403|2017-10-10 23:30:44.204403
NCT02387307|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-12-10|||May 2013||2013-05-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|rSIFN-01||A Study of rSIFN-co in Subjects With Advanced Solid Tumors|A Phase I Open-Label, Non-Randomized, Dose-Escalation Study of rSIFN-co in Subjects With Advanced Solid Tumors and With an Expansion Cohort at Recommended Dose (RD) in Subjects With Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma, Melanoma, Hepatocellular Carcinoma or Colon Cancer|Recruiting||Phase 1|42|Anticipated|Sichuan Huiyang Life Science and Technology Corporation||1|||f||||f||||||||Undecided||2017-10-10 23:30:44.323084|2017-10-10 23:30:44.323084
NCT02387294|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-03-06|||October 2014||2014-10-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents|Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection (Trivalent, Seasonal Influenza Vaccine, Active Ingredient Content: 6 μg HA/Strain/0.5 ml) for Children and Adolescents|Completed||Phase 3|120|Actual|Fluart Innovative Vaccine Ltd, Hungary||1|||f||||t||||||||||2017-10-10 23:30:44.418998|2017-10-10 23:30:44.418998
NCT02387281|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-03-17|||March 2015||2015-03-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|FOG||Freezing of Gait: Clinical, Cognitive, and Imaging Features|Freezing of Gait: Clinical, Cognitive, and Imaging Features|Active, not recruiting||N/A|112|Anticipated|Emory University|||4||f||||t||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:30:44.487749|2017-10-10 23:30:44.487749
NCT02387268|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-22|2015-10-06||May 2015||2015-05-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|||Evaluation of the Performance of the CleanC System-Israel|"Evaluation of the Performance of the CleanC System"|Completed||N/A|10|Actual|Motus GI Medical Technologies Ltd||1|||f||||t|f|f||||||||2017-10-10 23:30:44.584096|2017-10-10 23:30:44.584096
NCT02387255|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-09-26|||October 2014||2014-10-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|AAA-MRE||Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms|Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms|Recruiting||N/A|165|Anticipated|Ohio State University|||3||f||||f||||||Samples Without DNA|"     We will collect a small aortic tissue sample for biomechanical testing from patients     undergoing standard of care surgical repair of their abdominal aortic aneurysm.   "|||2017-10-10 23:30:44.783821|2017-10-10 23:30:44.783821
NCT02387242|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-04-12|||February 2015||2015-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers|Evaluating Pharmacokinetics and Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Single 'High' Doses of Rifampicin in Healthy Volunteers|Suspended||Phase 1|18|Anticipated|National University Hospital, Singapore||3||New relevant data published|f||||f||||||||||2017-10-10 23:30:44.879743|2017-10-10 23:30:44.879743
NCT02387229|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-03-23|||March 2015||2015-03-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|BRAIN-AF||Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF|Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)|Recruiting||Phase 3|6396|Anticipated|Montreal Heart Institute||2|||f||||t||||||||||2017-10-10 23:30:44.969296|2017-10-10 23:30:44.969296
NCT02387216|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-08-04|||February 2015||2015-02-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC|A Phase 2 Study of MM-121 in Combination With Docetaxel or Pemetrexed Versus Docetaxel or Pemetrexed Alone in Patients With Heregulin Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Recruiting||Phase 2|280|Anticipated|Merrimack Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:30:45.116455|2017-10-10 23:30:45.116455
NCT02387203|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-02-16|||January 2015||2015-01-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin|Clinical Trial to Define the Effect of Perioperative H. Pylori Eradication With Antibiotic Treatment on the Long Term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)|Recruiting||Phase 2|80|Anticipated|Mercy Medical Center||2|||f||||f||||||||||2017-10-10 23:30:45.399395|2017-10-10 23:30:45.399395
NCT02388425|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-04-21|||February 2015||2015-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:30:45.56691|2017-10-10 23:30:45.56691
NCT02388412|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-02-21|||March 2015||2015-03-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01|12 Months|Observational [Patient Registry]|NaF-PET||18F-NaF-PET for Identification of TCFA|Evaluating the Diagnostic Accuracy of 18F-sodium Fluoride Positron Emission Tomography for Identification of High-risk Vulnerable Coronary Atherosclerotic Plaque in Patients With Coronary Artery Disease|Recruiting||N/A|96|Anticipated|Seoul National University Hospital|||2||f||||t||||||||||2017-10-10 23:30:45.601749|2017-10-10 23:30:45.601749
NCT02388399|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-09|||March 2015||2015-03-01|March 2015|2015-03-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Observational|REASSURE||Invasive Measurement of Axial Plaque Stress, the Pilot Study|Relevance of Invasively Measured Axial Plaque Stress and Wall Shear Stress Using Invasive Coronary Imaging and Hemodynamic Data|Not yet recruiting||N/A|100|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-10 23:30:45.684804|2017-10-10 23:30:45.684804
NCT02388386|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-11-22|||February 2015||2015-02-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Monitoring Medication Adherence in Left Ventricular Assist Device Recipients|Pilot Study of Wireless Observed Therapy With an Ingestible Micro-Sensor Among Patients With Heart Failure and Left Ventricular Assist Devices|Recruiting||Phase 1|10|Anticipated|Scripps Translational Science Institute||1|||f||||t||||||||Yes|Data will be made available upon request|2017-10-10 23:30:45.794269|2017-10-10 23:30:45.794269
NCT02388373|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2016-06-20|||July 2014||2014-07-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down|A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down|Completed||Phase 4|225|Actual|Research in Real-Life Ltd||3|||f||||t||||||||No|Individual participant data will not be publically released as this was not covered by patient consent. Patients have consented for anonymised data to be used for future medical research by Research in Real-Life.|2017-10-10 23:30:45.871065|2017-10-10 23:30:45.871065
NCT02388360|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2015-03-09|||May 2013||2013-05-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma|The Impact of Topical Prostaglandin Analogs on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma|Unknown status|Recruiting|Phase 4|35|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||t||||||||||2017-10-10 23:30:47.457241|2017-10-10 23:30:47.457241
NCT02388347|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-13|2017-02-27||March 2015||2015-03-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional||As Treated Population included all randomized participants and treated with MEDI7836 or placebo.|A Study to Assess the Safety of MEDI7836 in Healthy Adults.|A Phase 1a, Randomised, Placebo-controlled, Single-ascending Dose Study to Evaluate the Safety and Tolerability of MEDI7836 in Healthy Adults|Completed||Phase 1|79|Actual|MedImmune LLC||5|||f||||f||||||||||2017-10-10 23:30:47.63755|2017-10-10 23:30:47.63755
NCT02388334|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-13|||March 2015||2015-03-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|December 2015|Anticipated|2015-12-01||Observational|AQUASEP||Impact of Multiple Sclerosis From the Viewpoint of the Caregivers|Impact of Multiple Sclerosis From the Viewpoint of the Caregivers : Exploring Their Quality Of Life and Their Expectations Concerning the Quality of Professional Management|Unknown status|Not yet recruiting|N/A|730|Anticipated|Rennes University Hospital|||1||f||||t||||||||||2017-10-10 23:30:48.483391|2017-10-10 23:30:48.483391
NCT02387970|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-02-27|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Immediate or Delayed Provisionalization in Posterior Healed Sites|Non-inferiority Study of Immediate or Delayed Provisionalization at Posterior Healed Sites Using NobelParallelCC Implants|Recruiting||N/A|50|Anticipated|Columbia University||2|||f||||f|f|t|f|f|f|||Undecided||2017-10-10 23:30:55.4203|2017-10-10 23:30:55.4203
NCT02388321|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-02|||January 2015||2015-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pediatric Ketamine Study for Pain Management|Comparison of Sub-dissociative Dose Intranasal Ketamine to Intranasal Fentanyl for Treatment of Moderate to Severe Pain in Pediatric Patients Presenting to the Emergency Department: a Prospective, Randomized, Double-blind Study|Active, not recruiting||Phase 4|22|Actual|Maimonides Medical Center||2|||f||||f||||||||||2017-10-10 23:30:48.575544|2017-10-10 23:30:48.575544
NCT02388308|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-06-02|||May 2015||2015-05-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|Clarity-Pro||Evaluation of Clarity Ultrasound Guidance for Prostate Therapy|Evaluation of Clarity Ultrasound Guidance for Prostate Therapy|Recruiting||N/A|53|Anticipated|Institute of Cancer Research, United Kingdom|||4||f||||f||||||||||2017-10-10 23:30:48.689128|2017-10-10 23:30:48.689128
NCT02388295|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-08-18|2017-06-23||April 27, 2015|Actual|2015-04-27|July 2017|2017-07-01|September 19, 2016|Actual|2016-09-19|September 19, 2016|Actual|2016-09-19||Interventional||Safety population, includes only 58 of 59 randomized subjects, those taking at least 1 dose of investigational product|AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients|A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy|Completed||Phase 2|59|Actual|AstraZeneca|Biomarker samples were included if testing done within 6 months of collection, recommendation changed to 3 months of collection during study. Included based on 6 months as per protocol to include as many samples as possible.|2|||f||||t||||||||||2017-10-10 23:30:48.915299|2017-10-10 23:30:48.915299
NCT02388282|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-12-28|||April 2015||2015-04-01|August 2015|2015-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|echoPEEPi||A New Method for Estimating Dynamic Intrinsic PEEP|A New Method for Estimating Dynamic Positive End-expiratory Pressure. Description and Validation With PEEPi Dyn Measured With Transdiaphragmatic Pressure|Completed||N/A|10|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||t||||||||||2017-10-10 23:30:50.063369|2017-10-10 23:30:50.063369
NCT02388256|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-06-25|||March 2015||2015-03-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection|Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection|Completed||N/A|30|Actual|Korean Medicine Hospital of Pusan National University||2|||f||||f||||||||||2017-10-10 23:30:50.304284|2017-10-10 23:30:50.304284
NCT02388243|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-11-10|||September 2014||2014-09-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|eDATA K||The Computer-based Drug and Alcohol Training Assessment in Kenya|The Computer-based Drug and Alcohol Training Assessment in Kenya|Completed||N/A|1212|Actual|Africa Mental Health Foundation||4|||f||||f||||||||No||2017-10-10 23:30:50.42097|2017-10-10 23:30:50.42097
NCT02388230|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-03-01|||October 2015||2015-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|QuaRTUS||Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques|Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel|Recruiting||N/A|64|Anticipated|Institute of Cancer Research, United Kingdom|||2||f||||f||||||||||2017-10-10 23:30:50.59823|2017-10-10 23:30:50.59823
NCT02388217|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2016-03-07|||April 2013||2013-04-01|March 2016|2016-03-01|November 2020|Anticipated|2020-11-01|March 2017|Anticipated|2017-03-01||Observational|||The Effect of Cannabis on Pain and Related Quality Of Life Outcomes In Chronic Pain: A Prospective Open-Label Study|The Effect of Cannabis on Pain and Related Quality Of Life Outcomes In Chronic Pain: A Prospective Open-Label Study|Active, not recruiting||N/A|400|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-10 23:30:50.691348|2017-10-10 23:30:50.691348
NCT02388204|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-03-12|||June 2014||2014-06-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|March 2015|Anticipated|2015-03-01||Interventional|SCSPD||Spinal Cord Stimulation for the Treatment of Motor and Nonmotor Symptoms of Parkinson's Disease|Spinal Cord Stimulation for the Treatment of Motor and Nonmotor Symptoms of Parkinson's Disease|Recruiting||N/A|20|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:30:50.77531|2017-10-10 23:30:50.77531
NCT02388191|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-06-20|2017-04-17||April 2015||2015-04-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Naproxen for Pain Control With Intrauterine Device Insertion|Naproxen for Pain Control With Intrauterine Device Insertion: A Randomized Double-Blind Placebo Controlled Trial|Completed||N/A|119|Actual|Planned Parenthood League of Massachusetts||2|||f||||f||||||||||2017-10-10 23:30:50.897372|2017-10-10 23:30:50.897372
NCT02388178|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-03-06|||April 2015||2015-04-01|February 2015|2015-02-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study|Assessment of 1450 Ppm Fluoride/Arginine Toothpaste Using an Intra-oral Remineralization-demineralization Model.|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Colgate Palmolive||3|||f||||f||||||||||2017-10-10 23:30:51.640655|2017-10-10 23:30:51.640655
NCT02387957|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-04|||February 2015||2015-02-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||An 18 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)||Terminated||Phase 2|64|Actual|Ophthotech Corporation||3|||f||||f||||||||||2017-10-10 23:30:55.579354|2017-10-10 23:30:55.579354
NCT02388152|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-09-06|||March 2015||2015-03-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease|Open-label, Dose-escalation, Multiple Immunisation Study on the Safety, Tolerability and Immunogenicity of Lu AF20513 in Patients With Mild Alzheimer's Disease|Active, not recruiting||Phase 1|35|Anticipated|H. Lundbeck A/S||3|||f||||t||||||||||2017-10-10 23:30:52.575651|2017-10-10 23:30:52.575651
NCT02388139|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-01-12|||October 2014||2014-10-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Observational|REN-ACS||Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)|Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (AMI) Included in the Romanian National Programme of Primary Percutaneous Revascularisation - a Single Center Observational Study|Recruiting||N/A|200|Anticipated|Grigore T. Popa University of Medicine and Pharmacy|||1||f||||f||||||Samples Without DNA|"     serum creatinine, serum urea, lipid profile, glycemia, haemoglobin, etc   "|||2017-10-10 23:30:52.664663|2017-10-10 23:30:52.664663
NCT02388126|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-11-05|||March 2015||2015-03-01|November 2015|2015-11-01||||February 2016|Anticipated|2016-02-01||Interventional|PROMANEG||Prostate Magnetic Resonance Imaging in Patient With Previous Negative Biopsies||Recruiting||N/A|150|Anticipated|Turku University Hospital||1|||f||||f||||||||||2017-10-10 23:30:52.747676|2017-10-10 23:30:52.747676
NCT02388113|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-11-05|||October 2014||2014-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Exercise Frequency on Metabolic Control and Heart Function in Type 2 Diabetes|The Effect of Accumulated Versus Traditional Exercise Training on Metabolic Control and Heart Function in Individuals With Type 2 Diabetes|Completed||N/A|40|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 23:30:52.826739|2017-10-10 23:30:52.826739
NCT02388100|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-12-19|||March 2015||2015-03-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||The GRADE Capillary Blood Collection Pilot Study|The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study) Capillary Blood Collection: A Pilot Study|Completed||N/A|70|Actual|GRADE Study Group|||1||f||||t||||||||||2017-10-10 23:30:52.906709|2017-10-10 23:30:52.906709
NCT02388087|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-03-22|||May 2015||2015-05-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|SHAM-ROX NMS||The Iliac Arterio-venous Fistula for Treatment of Neurally Mediated Syncope Study|The Iliac Arterio-venous Fistula for Treatment of Neurally Mediated Syncope Study|Unknown status|Not yet recruiting|N/A|20|Anticipated|Eastbourne General Hospital||2|||f||||f||||||||||2017-10-10 23:30:53.017115|2017-10-10 23:30:53.017115
NCT02388074|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-06-16|2015-05-05||March 2015||2015-03-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer|Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer|Completed||N/A|25|Actual|bioAffinity Technologies Inc.||1|||f||||t||||||||||2017-10-10 23:30:53.11676|2017-10-10 23:30:53.11676
NCT02388061|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-06-19|||March 2015||2015-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EXTEND-IA TNK||Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke|Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase|Recruiting||Phase 2|202|Anticipated|Neuroscience Trials Australia||2|||f||||t||||||||||2017-10-10 23:30:53.300274|2017-10-10 23:30:53.300274
NCT02388048|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-08-31|||October 2015||2015-10-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia|A Phase II Study of the Combination of Ofatumumab and Ibrutinib Followed by Allogeneic Bone Marrow Transplant or Consolidation for Pretreated High Risk Patients With Chronic Lymphocytic Leukemia|Recruiting||Phase 2|79|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-10 23:30:53.486694|2017-10-10 23:30:53.486694
NCT02388035|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-06-03|||March 2015||2015-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis|Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis|Completed||N/A|254|Actual|Nasser Institute For Research and Treatment||4|||f||||t||||||||||2017-10-10 23:30:53.776132|2017-10-10 23:30:53.776132
NCT02388022|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-08-09|||January 2014||2014-01-01|March 2015|2015-03-01|March 2016|Actual|2016-03-01|January 2015|Actual|2015-01-01||Observational|||A Retrospective Study Using CALIBER® TLIF Expandable Spacer in the Treatment of DDD: 2 Year Follow-up.|A Retrospective Study Using CALIBER® TLIF Expandable Spacer in the Treatment of DDD: 2 Year Follow-up.|Completed||N/A|200|Actual|Globus Medical Inc|||1||f||||f||||||||Yes|Once data collection is complete and analyzed, we will submit to journals for publication|2017-10-10 23:30:53.872729|2017-10-10 23:30:53.872729
NCT02388009|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-12-21|||February 2015||2015-02-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a|Safety and Tolerability of a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a When Administered to Adult Volunteers|Completed||Phase 1|30|Actual|LimmaTech Biologics AG||3|||f||||f||||||||||2017-10-10 23:30:53.942701|2017-10-10 23:30:53.942701
NCT02387983|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-20|2017-04-20||May 6, 2015|Actual|2015-05-06|April 2017|2017-04-01|May 2, 2016|Actual|2016-05-02|May 2, 2016|Actual|2016-05-02||Interventional|||Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)|Pharmacokinetics and Safety of Solid Oral Posaconazole (MK-5592, POS) in Chinese Subjects at High Risk for Invasive Fungal Infections|Completed||Phase 1|65|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:30:55.011549|2017-10-10 23:30:55.011549
NCT02387944|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-12|||March 2015||2015-03-01|March 2015|2015-03-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Observational|POCHEMO||Bedside Evaluation of Coagulation in Children With Congenital Heart Disease|"Point-Of-Care Evaluation of Hemostasis in Children With Congenital Heart Disease"|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire Vaudois|||2||f||||f||||||||||2017-10-10 23:30:55.724899|2017-10-10 23:30:55.724899
NCT02387931|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-11-30|||September 2014||2014-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SAGE||Supplementation in Adolescent Girls With Endometriosis|SAGE: Supplementation in Adolescent Girls With Endometriosis|Completed||Phase 4|69|Actual|Boston Children’s Hospital||3|||f||||t||||||||||2017-10-10 23:30:55.822022|2017-10-10 23:30:55.822022
NCT02387918|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-01-20|||February 2015||2015-02-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Prevention of POV After Paediatric Tonsillectomy|Vomiting After Tonsillectomy in Children: A Comparison of Dexamethasone and Acupuncture|Completed||Phase 4|120|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 23:30:55.934552|2017-10-10 23:30:55.934552
NCT02387905|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-02-07|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Prophylactic Cement Augmentation for Patients at High Risk for Developing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery|Prophylactic Cement Augmentation for Patients at High Risk for Developing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery: A Randomized Phase II Clinical Trial|Recruiting||Phase 2|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 23:30:56.035786|2017-10-10 23:30:56.035786
NCT02387892|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-02-25|||October 2014||2014-10-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|D-KIDS||Fortified Cheese and Yogurt Products and Vitamin D Status in Young Children? Phase 2|Do Vitamin D Fortified Cheese and Yogurt Products Support Vitamin D Status and Functional Outcomes in Young Children? Phase 2|Completed||N/A|51|Actual|McGill University||2|||f||||f||||||||Undecided||2017-10-10 23:30:56.15301|2017-10-10 23:30:56.15301
NCT02387879|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-04-06|||December 25, 2013|Actual|2013-12-25|April 2017|2017-04-01|July 30, 2021|Anticipated|2021-07-30|July 30, 2020|Anticipated|2020-07-30||Observational|||A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR|A Non-interventional, Multi-center, Observational Post Authorization Safety Study of Patients With Relapse/Refractory Multiple Myeloma Treated With Lenalidomide in Turkey|Recruiting||N/A|500|Anticipated|Celgene|||1||f||||f||||||||||2017-10-10 23:30:56.246038|2017-10-10 23:30:56.246038
NCT02387866|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-09-22|||March 2015||2015-03-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects|A Phase 1, Single Ascending Dose, Open-label Study to Evaluate the Pharmacokinetics and Safety of AG-221 in Healthy Male Japanese Subjects Relative to Healthy Male Caucasian Subjects|Completed||Phase 1|62|Actual|Celgene||3|||f||||f||||||||||2017-10-10 23:30:56.402309|2017-10-10 23:30:56.402309
NCT02387853|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-12|2017-05-02|||March 2016||2016-03-01|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis|Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis|Recruiting||Phase 2|100|Anticipated|LEO Pharma||1|||f||||f||||||||||2017-10-10 23:30:56.493323|2017-10-10 23:30:56.493323
NCT02387840|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-01-05|||March 2015||2015-03-01|January 2017|2017-01-01|June 2023|Anticipated|2023-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Feasibility and Clinically Application of Magnetic Resonance Fingerprinting|Feasibility and Clinically Application of Magnetic Resonance Fingerprinting|Recruiting||N/A|80|Anticipated|Case Comprehensive Cancer Center||6|||f||||t||||||||||2017-10-10 23:30:56.629107|2017-10-10 23:30:56.629107
NCT02387827|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-04-03|||February 2015||2015-02-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Comparing of Long Bout and Short Bouts of Similar Volume of Walking in Obese on Weight Loss During a Weight Loss Program||Completed||N/A|60|Actual|Novindiet Clinic||2|||f||||f||||||||||2017-10-10 23:30:56.742319|2017-10-10 23:30:56.742319
NCT02387814|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2015-09-10|||March 2015||2015-03-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment|A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment|Completed||Phase 1|40|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 23:30:56.824517|2017-10-10 23:30:56.824517
NCT02387801|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-03-03|2016-08-29||April 2015||2015-04-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|September 2015|Actual|2015-09-01||Interventional|||A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis|Early Onset of Clinical Improvement With Ixekizumab in Patients With Moderate-to-Severe Plaque Psoriasis|Completed||Phase 3|12|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 23:30:56.925176|2017-10-10 23:30:56.925176
NCT02387788|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-05-23|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO|Phase 2a Open Label Study to Assess the Efficacy and Safety of Subcutaneous 15mg AKB-9778 Administered Twice Daily for 84 Days in Subjects With Retinal Vein Occlusion|Completed||Phase 2|16|Actual|Aerpio Therapeutics||1|||f||||f||||||||No||2017-10-10 23:30:57.41722|2017-10-10 23:30:57.41722
NCT02387775|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-01-13|||December 2015||2015-12-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|E-Chill||Temperature Control With an Esophageal Cooling Device in Post Cardiac Arrest Patients|Temperature Control With an Esophageal Cooling Device: A Feasibility Study in Post Cardiac Arrest Patients|Recruiting||N/A|15|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-10 23:30:57.487294|2017-10-10 23:30:57.487294
NCT02387762|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-08-22|||April 2015||2015-04-01|November 2015|2015-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate|A Phase 2a, 4-Week, Double-Blind, Proof-of-Concept Efficacy and Safety Study of ACP-196 Versus Placebo in Subjects With Active Rheumatoid Arthritis on Background Methotrexate|Completed||Phase 2|31|Actual|Acerta Pharma BV||2|||f||||t||||||||||2017-10-10 23:30:57.594897|2017-10-10 23:30:57.594897
NCT02387736|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-08-04|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|FASTER-DBT||DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical &Cost Effectiveness of a 6 mo. Treatment|Dialectical Behaviour Therapy for Chronically Self-harming Individuals With BPD: Evaluating the Clinical and Cost Effectiveness of a 6-month Treatment|Active, not recruiting||N/A|240|Actual|Centre for Addiction and Mental Health||2|||f||||t||||||||||2017-10-10 23:30:57.805306|2017-10-10 23:30:57.805306
NCT02387723|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-02-01|||December 2014||2014-12-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||CSCC_ASC Therapy in Patients With Severe Heart Failure|Allogeneic Adipose Tissue-derived Stromal/Stem Cell Therapy in Patients With Ischemic Heart Disease and Heart Failure - a Safety Study|Completed||Phase 1|10|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||Yes|Data can be shared for Scientific collaboration|2017-10-10 23:30:57.932515|2017-10-10 23:30:57.932515
NCT02387710|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2017-07-14|2017-05-16||March 2015||2015-03-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|TESSA|18 patients enrolled, 2 did not completed the study, One patient was excluded because of predominantly central sleep apnea on both nights, and another was excluded because of low-quality EEG data. Therefore, 14 subjects were analyzed.|Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea|Inducing Slow Wave Sleep to Treat Obstructive Sleep Apnea|Completed||Phase 2|18|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:30:58.151247|2017-10-10 23:30:58.151247
NCT02387697|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-03-12|||February 2015||2015-02-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL)|Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve|Unknown status|Recruiting|N/A|40|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 23:30:58.365448|2017-10-10 23:30:58.365448
NCT02387684|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-08-17|||April 2012||2012-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients|Efficay of Extended Peginterferon Alpha 2a(PEG-IFN a-2a) Treatment in HBeAg Negative Chronic Hepatitis B Patients|Recruiting||N/A|120|Anticipated|Beijing Ditan Hospital|||1||f||||f||||||||||2017-10-10 23:30:58.457895|2017-10-10 23:30:58.457895
NCT02387671|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-06-29|||February 2015||2015-02-01|January 2015|2015-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Weight Management Among Breast Cancer Survivors|Evaluation of mHealth Counseling for Lifestyle Behaviors Among Breast Cancer Survivors|Completed||N/A|10|Actual|Boston Medical Center||1|||f||||f||||||||||2017-10-10 23:30:58.541715|2017-10-10 23:30:58.541715
NCT02387658|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-03-12|||February 2015||2015-02-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient|Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient|Unknown status|Recruiting|N/A|36|Anticipated|North Texas Veterans Healthcare System|||2||f||||f||||||||||2017-10-10 23:30:58.628512|2017-10-10 23:30:58.628512
NCT02387645|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2015-03-12|||May 2014||2014-05-01|March 2015|2015-03-01||||March 2016|Anticipated|2016-03-01||Interventional|LUDEC||LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma||Unknown status|Recruiting|N/A|80|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-10 23:30:58.72674|2017-10-10 23:30:58.72674
NCT02387632|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2016-03-14|||June 2015||2015-06-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Airway Pressure During Humidified High Flow Nasal Cannula Therapy in Children|Airway Pressure During Humidified High Flow Nasal Cannula Therapy in Children|Recruiting||N/A|40|Anticipated|McMaster University|||1||f||||t||||||||||2017-10-10 23:30:58.810917|2017-10-10 23:30:58.810917
NCT02387619|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-06-23|||February 2015||2015-02-01|March 2015|2015-03-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine|A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine in Healthy Male Volunteers|Completed||Phase 1|41|Actual|Jeil Pharmaceutical Co., Ltd.||4|||f||||f||||||||No||2017-10-10 23:30:58.892294|2017-10-10 23:30:58.892294
NCT02387606|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-09|2016-06-08||2016-06-08|May 2015||2015-05-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection|A Phase 2a, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection in the Virus Challenge Model in Healthy Adult Subjects|Completed||Phase 2|66|Actual|Janssen Sciences Ireland UC||3|||f||||f||||||||||2017-10-10 23:30:58.989557|2017-10-10 23:30:58.989557
NCT02387580|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-01-13|2015-12-09||April 2015||2015-04-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Safety population was to include all subjects who received at least 1 dose of IMP. All 48 subjects met the criteria for inclusion in the safety population|Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets|A Phase I Bioavailability Study of Selected Oral Prototype Granule Formulations of OZ439 in Healthy Subjects, to Evaluate the Pharmacokinetics of OZ439 When Co-Administered With Piperaquine Phosphate Tablets in the Fasted State|Completed||Phase 1|48|Actual|Medicines for Malaria Venture||6|||f||||f||||||||||2017-10-10 23:30:59.250179|2017-10-10 23:30:59.250179
NCT02387567|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-03-12|||January 2007||2007-01-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Paraspinal Block in Nonspecific Low Back Pain|Study on the Effects of Paraspinal Lidocaine Injection on Nonspecific Low Back Pain|Completed||Phase 3|378|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 23:31:00.046885|2017-10-10 23:31:00.046885
NCT02387554|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-06-11|2015-05-22||August 2014||2014-08-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405|A Randomized, Open-label, 4-way Crossover Single Dose Clinical Trial to Investigate the Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 When Administered Alone and in Combination in Healthy Male Volunteers|Completed||Phase 1|33|Actual|Hanmi Pharmaceutical Company Limited||4|||f||||t||||||||||2017-10-10 23:31:00.149669|2017-10-10 23:31:00.149669
NCT02387541|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-05-01|||March 2012||2012-03-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01|1 Week|Observational [Patient Registry]|POCD||Effects of Total Knee Replacement on Early Postoperative Cognitive Function in Elderly Patients|Effects of Total Knee Replacement on Early Postoperative Cognitive Function in Elderly Patients|Completed||N/A|100|Actual|General Hospital of Ningxia Medical University|||1||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:31:00.506132|2017-10-10 23:31:00.506132
NCT02387528|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-07-28|||September 2014||2014-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2014|Actual|2014-09-01||Interventional|MINDFULNESS||Mindfulness, Burnout, Physical and Psychological Well-being of Primary Health Care Professionals|Mindfulness, Burnout, Physical and Psychological Well-being of Primary Health Care Professionals: a Randomized and Controlled Trial.|Enrolling by invitation||N/A|130|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 23:31:00.561712|2017-10-10 23:31:00.561712
NCT02387515|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2017-08-08|||December 2013||2013-12-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Technology-supported Exercise Therapy for Patients With Chronic Low Back Pain|Technology-supported Exercise Therapy for Patients With Chronic Low Back Pain: Pilot Study|Completed||N/A|10|Anticipated|Hasselt University||1|||f||||f||||||||||2017-10-10 23:31:00.647599|2017-10-10 23:31:00.647599
NCT02387502|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-04-28|2015-03-27||January 2014||2014-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Three Laryngoscopes in Difficult Laryngoscopy|Comparative Evaluation of Macintosh, MacCoy and Airtraq Laryngoscope in Simulated Difficult Laryngoscopy Using Rigid Neck Collar|Completed||N/A|120|Actual|Government Medical College, Haldwani|The intubating anesthetist was not blind to the randomization of the laryngoscope. This could have led to bias. However, the primary outcome i.e. time of intubation was well defined and objective.|3|||f||||t||||||||||2017-10-10 23:31:00.78439|2017-10-10 23:31:00.78439
NCT02387489|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-08-30|||October 2, 2015|Actual|2015-10-02|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Clinical Trial of SBIRT Services in School-based Health Centers|A Randomized Clinical Trial of Screening, Brief Intervention, and Referral-to-Treatment (SBIRT) Services in School-based Health Centers|Enrolling by invitation||N/A|300|Anticipated|Friends Research Institute, Inc.||2|||f||||t||||||||||2017-10-10 23:31:01.111674|2017-10-10 23:31:01.111674
NCT02387463|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-08|2017-07-03|||March 2012||2012-03-01|July 2017|2017-07-01|May 21, 2017|Actual|2017-05-21|May 21, 2017|Actual|2017-05-21||Observational|||Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients|Efficacy of Extended Peginterferon Alpha 2a(PEG-IFN a-2a) Treatment in HBeAg Positive Chronic Hepatitis B Patients|Completed||N/A|160|Actual|Beijing Ditan Hospital|||1||f||||f||||||||||2017-10-10 23:31:01.335579|2017-10-10 23:31:01.335579
NCT02387450|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-12|||September 2015||2015-09-01|March 2015|2015-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication|Reduction de la Morbi-mortalité Cardiovasculaire Chez l'artériopathe Claudicant Par le Sildenafil|Unknown status|Not yet recruiting|Phase 2/Phase 3|400|Anticipated|University Hospital, Angers||2|||f||||t||||||||||2017-10-10 23:31:01.438447|2017-10-10 23:31:01.438447
NCT02387437|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-03-12|||November 2014||2014-11-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|DEOTRMOARDS||Different Effects of Three Recruitment Maneuvers on the Lung Heterogeneity of Acute Respiratory Distress Syndrome|Evaluation of Different Effects of Three Recruitment Maneuvers on the Lung Heterogeneity of Acute Respiratory Distress Syndrome|Unknown status|Recruiting|N/A|93|Anticipated|Southeast University, China||3|||f||||f||||||||||2017-10-10 23:31:01.540519|2017-10-10 23:31:01.540519
NCT02387424|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-03-12|||July 2010||2010-07-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depressive Relapse/Recurrence|Phase Two: A Pilot Randomized Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depressive Relapse/Recurrence|Completed||N/A|86|Actual|University of Colorado, Boulder||2|||f||||t||||||||||2017-10-10 23:31:01.638166|2017-10-10 23:31:01.638166
NCT02387411|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-03-12|||May 2010||2010-05-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||High-intensity Interval Versus Combined Exercise Training in CHF|High-intensity Interval Versus Combined High-intensity Interval and Strength Exercise Training in Chronic Heart Failure|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Athens||2|||f||||f||||||||||2017-10-10 23:31:01.72673|2017-10-10 23:31:01.72673
NCT02387398|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-08-25|||December 2015||2015-12-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|PEARL||Early Coronary Angiography Versus Delayed Coronary Angiography|A Pilot Randomized Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography for Post-Cardiac Arrest Patients Without ECG ST Segment Elevation|Recruiting||N/A|240|Anticipated|University of Arizona||2|||f||||t||||||||||2017-10-10 23:31:01.803957|2017-10-10 23:31:01.803957
NCT02387385|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-06-06|||August 2015||2015-08-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|HELIX||Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial|Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial|Recruiting||N/A|408|Anticipated|Thayyil, Sudhin||2|||f||||t||||||||||2017-10-10 23:31:01.920815|2017-10-10 23:31:01.920815
NCT02387372|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-08-02|||February 5, 2015|Actual|2015-02-05|August 2017|2017-08-01|June 16, 2017|Actual|2017-06-16|June 15, 2017|Actual|2017-06-15||Interventional|||Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)|A Phase 1, Prospective, Multi-center, Open-label Study to Assess the Plasma Pharmacokinetics and Lung Penetration of Intravenous (IV) Ceftolozane/Tazobactam in Critically Ill Patients|Completed||Phase 1|37|Actual|Cubist Pharmaceuticals LLC||2|||f||||f||||||||||2017-10-10 23:31:02.052558|2017-10-10 23:31:02.052558
NCT02387359|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-10-03|||December 2014||2014-12-01|October 2017|2017-10-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|IBS-C||The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)|A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|Completed||Phase 3|1050|Anticipated|Synergy Pharmaceuticals Inc.||3|||f||||f||||||||||2017-10-10 23:31:02.15313|2017-10-10 23:31:02.15313
NCT02387346|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-04-08|||April 2015||2015-04-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||The Cerebellum as a Potential Treatment Site for PD Motor Symptoms|The Contribution of the Cerebello-thalamo-cortical Circuit to the Pathology of Non-dopaminergic Responsive Parkinson's Disease Symptoms|Unknown status|Recruiting|N/A|50|Anticipated|Sun Life Financial Movement Disorders Research and Rehabilitation Centre||2|||f||||f||||||||||2017-10-10 23:31:02.631196|2017-10-10 23:31:02.631196
NCT02387177|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-04-02|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype|Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype|Active, not recruiting||N/A|55|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:31:02.772676|2017-10-10 23:31:02.772676
NCT02387164|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-08-23|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|DiAPREV-IT2||Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies|Double-blind, Investigator-initiated Study to Determine the Effect of Alum-GAD (Diamyd) in Combination With Vitamin D3 on the Progression to Type 1 Diabetes in Children With Multiple Islet Autoantibodies|Enrolling by invitation||Phase 2|80|Anticipated|Lund University||2|||f||||t||||||||||2017-10-10 23:31:02.897607|2017-10-10 23:31:02.897607
NCT02387151|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-09-06|||March 2015||2015-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Neptune||Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients|Safety of Allogeneic Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients|Recruiting||Phase 1|10|Anticipated|Leiden University Medical Center||1|||f||||t||||||||||2017-10-10 23:31:03.019926|2017-10-10 23:31:03.019926
NCT02387138|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-08-16|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|SIRINOX||A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan|A Phase I Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan in Patients With Advanced or Metastatic Digestive Adenocarcinoma as First- or Second-line Treatment|Recruiting||Phase 1|24|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-10 23:31:03.131048|2017-10-10 23:31:03.131048
NCT02387125|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2017-06-30|||February 2015||2015-02-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1|A Phase 1b Study Evaluating the Safety, Tolerability and Immunogenicity of CMB305 (Sequentially Administered LV305 and G305) in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1|Recruiting||Phase 1|69|Anticipated|Immune Design||2|||f||||t||||||||||2017-10-10 23:31:03.226298|2017-10-10 23:31:03.226298
NCT02387112|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-07-22|||July 2015||2015-07-01|July 2016|2016-07-01|December 2022|Anticipated|2022-12-01|August 2022|Anticipated|2022-08-01||Interventional|||Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation|Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation|Recruiting||N/A|500|Anticipated|German Heart Institute||2|||f||||t||||||||||2017-10-10 23:31:03.367267|2017-10-10 23:31:03.367267
NCT02387099|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-06-26|||May 2015||2015-05-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|Desiree||Dose EScalation Induction of EvERolimus|A Multicenter, Randomized, Double-blind, Phase II Study to Evaluate the Tolerability of an Induction Dose Escalation of Everolimus in Patients With Metastatic Breast Cancer|Recruiting||Phase 2|156|Anticipated|German Breast Group||2|||f||||t||||||||||2017-10-10 23:31:03.567583|2017-10-10 23:31:03.567583
NCT02387086|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-11|||May 2015||2015-05-01|March 2015|2015-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Gefitinib Combined With Thalidomide to Treat NSCLC|A Phase III, Multi Center, Randomized, Placebo Controlled Study to Evaluate the Efficacy of the Combination Gefitinib With Thalidomide in Patients With Locally Advanced and Metastatic Non-Small-Cell-Lung-Cancer With EGFR Mutation|Unknown status|Not yet recruiting|Phase 2/Phase 3|380|Anticipated|Shaanxi Provincial People's Hospital||2|||f||||t||||||||||2017-10-10 23:31:03.74346|2017-10-10 23:31:03.74346
NCT02387073|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-07-06|||September 2013||2013-09-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01|1 Month|Observational [Patient Registry]|||The Efficacy of Electrical Version of Patient Reported Outcome|The Efficacy of Electrical Version of Patient Reported Outcome: Patient Survey|Completed||N/A|100|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-10 23:31:03.834981|2017-10-10 23:31:03.834981
NCT02387060|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-07|||August 2014||2014-08-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean|Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean|Unknown status|Recruiting|Phase 4|80|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-10 23:31:03.929479|2017-10-10 23:31:03.929479
NCT02387047|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-11-03|||November 2014||2014-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|PACTE-q||Validity of a Self-administered Questionnaire to Screen Phobia of Falling in the Elderly|Screening for Phobia of Falling in the Elderly: Validity and Feasibility of a Self-administered Questionnaire|Completed||N/A|41|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:31:04.052162|2017-10-10 23:31:04.052162
NCT02387034|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-06-16|||June 2010||2010-06-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Swedish PAP in Osteoarthritis - a RCT Study|The Effect on Swedish Physical Activity on Prescription (PAP) in Patients in Primary Care With Osteoarthritis in Knee or Hip - a RCT-study.|Recruiting||N/A|140|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-10 23:31:04.13565|2017-10-10 23:31:04.13565
NCT02387021|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-07|||March 2015||2015-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia|Prospective Comparison Between Continuous Femoral Nerve Block and the Association of Adductor Canal Block and Sciatic Nerve Block in Total Knee Arthroplasty.|Unknown status|Not yet recruiting|N/A|80|Anticipated|Institut Kassab d'Orthopédie||2|||f||||t||||||||||2017-10-10 23:31:04.25036|2017-10-10 23:31:04.25036
NCT02387008|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-09-13|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane in the Bound Edentulous Space|Prospective, Comparative Assessment of Alveolar Bone Augmentation Using Guidor Membrane in the Bound Edentulous Space|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill||3|||f||||f|f|t|f|||||||2017-10-10 23:31:04.359642|2017-10-10 23:31:04.359642
NCT02386995|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-03-06|||July 2013||2013-07-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||BIS and Entropy in Deep Brain Simulation|Comparison of Bispectral Index and Entropy Monitoring in Patients Undergoing Internalization of Deep Brain Simulation|Completed||N/A|30|Actual|University Health Network, Toronto|||1||f||||t||||||||||2017-10-10 23:31:04.473337|2017-10-10 23:31:04.473337
NCT02386982|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-05-13|||March 2015||2015-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients|A Single-centre, Randomized, Open-label, 2-arm, 4-week Treatment Study to Investigate the Beta Cell Function and Related Pharmacodynamics in Type 2 Diabetes Mellitus (T2DM) Patients|Completed||Phase 1|24|Actual|Hua Medicine Limited||2|||f||||t||||||||||2017-10-10 23:31:04.56243|2017-10-10 23:31:04.56243
NCT02386969|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-01-11|||November 2015||2015-11-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Repetitive Transcranial Magnetic Stimulation in Central Neuropathic Pain|Long-term Efficacy of Repetitive Transcranial Magnetic Stimulation on the Primary Motor Cortex (M1) in Central Neuropathic Pain|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 23:31:04.632132|2017-10-10 23:31:04.632132
NCT02386956|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-09-17|||April 2015||2015-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|STRETCH-HAMS||Hamstring Stretch Effect (STRETCH-HAMS)|Evaluation of Hamstrings Elongation After Different Physiotherapy Stretching Techniques|Completed||N/A|66|Actual|Universidad Miguel Hernandez de Elche||3|||f||||f||||||||||2017-10-10 23:31:04.740943|2017-10-10 23:31:04.740943
NCT02386943|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-03-11|||December 2013||2013-12-01|March 2015|2015-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp|An Open-label, Randomized,Three-way Cross-over, Single Dose Study to Explore the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp|Unknown status|Recruiting|Phase 4|12|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||t||||||||||2017-10-10 23:31:04.838841|2017-10-10 23:31:04.838841
NCT02386930|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-03-07|||July 2013||2013-07-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Behavioral Lifestyle Intervention Study (BLIS) in Patients With Type 2 Diabetes in UAE: A Randomized Controlled Trial in Real Life Setting||Completed||N/A|35|Actual|Rashid Centre for Diabetes and Research||2|||f||||f||||||||||2017-10-10 23:31:04.932396|2017-10-10 23:31:04.932396
NCT02386917|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-05-05|||March 2015||2015-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|COCKTAIL||Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers|Impact of Body Weight, Low Calorie Diet and Gastric Bypass on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers|Recruiting||N/A|100|Anticipated|The Hospital of Vestfold||3|||f||||f||||||||Undecided||2017-10-10 23:31:05.02113|2017-10-10 23:31:05.02113
NCT02386904|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-03-16|||March 2015||2015-03-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Safety and Therapeutic Efficacy of Phosphate Enema (Kleen Enema) in Patients Undergoing Sigmoidoscopy|Prospective, Interventional, Single Arm Study in Outpatients Undergoing Sigmoidoscopy for Evaluation of Efficacy and Safety of Kleen Enema 120ml (Phosphate Enema)|Unknown status|Recruiting|Phase 4|40|Anticipated|Nabiqasim Industries (Pvt) Ltd||1|||f||||f||||||||||2017-10-10 23:31:05.101715|2017-10-10 23:31:05.101715
NCT02386891|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-03-11|||March 2014||2014-03-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Influence of Ambient Temperature on Food Intake Through a Randomized Control Trial in an Office Setting|Influence of Ambient Temperature on Food Intake Through a Randomized Control Trial in an Office Setting|Completed||N/A|20|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:31:05.193566|2017-10-10 23:31:05.193566
NCT02386878|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-03-10|||January 2012||2012-01-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PHE||HIV/AIDS Orphaned and Vulnerable Children Public Health Evaluation|The Effectiveness of Two Promising Interventions for Reducing HIV Risk and Improving the Wellbeing of Orphaned and Vulnerable Adolescents in the Eastern Cape of South Africa|Completed||N/A|2302|Actual|Tulane University||4|||f||||f||||||||||2017-10-10 23:31:05.263741|2017-10-10 23:31:05.263741
NCT02386865|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-03-11|||January 2008||2008-01-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|January 2009|Actual|2009-01-01||Observational|||Risk Factors Predicting Prognosis and Outcome of Elderly Patients With Isolated Traumatic Brain Injury|Risk Factors Predicting Prognosis and Outcome of Elderly Patients With Isolated Traumatic Brain Injury|Completed||N/A|292|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-10 23:31:05.40552|2017-10-10 23:31:05.40552
NCT02386852|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-03-11|||March 2014||2014-03-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity|Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity|Completed||Early Phase 1|48|Actual|Sunway University||3|||f||||||||||||||2017-10-10 23:31:05.642487|2017-10-10 23:31:05.642487
NCT02386839|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-11-17|||March 2015||2015-03-01|November 2016|2016-11-01|September 2021|Anticipated|2021-09-01|August 2021|Anticipated|2021-08-01||Observational|PEDAL||Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROP-2008-01 for the Prevention of ROP|Long-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated With rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal Care|Enrolling by invitation||N/A|98|Anticipated|Shire|||2||f||||t||||||||||2017-10-10 23:31:05.725675|2017-10-10 23:31:05.725675
NCT02386826|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-05-11|||September 22, 2015|Actual|2015-09-22|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|September 2018|Anticipated|2018-09-01||Interventional|||INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme|Phase Ib Study Evaluating the c-Met Inhibitor INC280 in Combination With Bevacizumab in Patients With Glioblastoma Multiforme (GBM)|Recruiting||Phase 1|63|Anticipated|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-10 23:31:05.828675|2017-10-10 23:31:05.828675
NCT02386813|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-04-08|||January 2013||2013-01-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|PINK||International Extranodal NK/T-cell Lymphoma Project|International Extranodal NK/T-cell Lymphoma Project: Prognostic Factors in the Era of Nonanthracycline-based Treatment|Completed||N/A|770|Actual|Samsung Medical Center|||2||f||||t||||||||||2017-10-10 23:31:05.920657|2017-10-10 23:31:05.920657
NCT02386800|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-10-03|||March 7, 2015|Actual|2015-03-07|October 2017|2017-10-01|September 15, 2021|Anticipated|2021-09-15|September 15, 2021|Anticipated|2021-09-15||Interventional|||CINC424A2X01B Rollover Protocol|An Open Label, Multi-center, Phase IV Roll-over Protocol for Patients Who Have Completed a Prior Global Novartis or Incyte Sponsored Ruxolitinib (INC424) Study and Are Judged by the Investigator to Benefit From Continued Treatment|Recruiting||Phase 4|171|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 23:31:06.015828|2017-10-10 23:31:06.015828
NCT02386787|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-05-24|||May 2014||2014-05-01|March 2016|2016-03-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|ECHO-GAST||Ultrasound Assessment of Gastric Content for Semi Emergency Surgery|Ultrasound Assessment of Gastric Content for Semi Emergency Surgery|Completed||N/A|300|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:31:06.168414|2017-10-10 23:31:06.168414
NCT02386774|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-04-07|||March 2016||2016-03-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|INNOV-EYE||Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa|Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa : Study of a Handheld in Vivo Confocal Microscope and of a Fluorescent in Vivo Confocal Microscope|Recruiting||N/A|130|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-10 23:31:06.246413|2017-10-10 23:31:06.246413
NCT02386761|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-10-28|||November 2014||2014-11-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CHF6001Ext||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001|A Phase 1, Randomised Double-blind, Placebo-controlled STUDY of Single and Repeated Ascending doseS in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF 6001|Completed||Phase 1|48|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-10 23:31:06.331969|2017-10-10 23:31:06.331969
NCT02386748|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-03-09|||March 2015||2015-03-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Chewing Gums to Stimulate Intestinal Motility After Cesarean Section|Chewing Gums to Stimulate Intestinal Motility After Cesarean Section: A Randomized Controlled Trial|Completed||N/A|450|Actual|Ain Shams University||3|||f||||f||||||||||2017-10-10 23:31:06.406597|2017-10-10 23:31:06.406597
NCT02386735|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-08-04|||March 2015||2015-03-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|September 2019|Anticipated|2019-09-01||Interventional|RECUT||Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD|"Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD - a Randomized, Double-blind, Non-inferiority Study (The RECUT-Trial)"|Recruiting||N/A|470|Anticipated|Cantonal Hosptal, Baselland||2|||f||||t||||||||||2017-10-10 23:31:06.48337|2017-10-10 23:31:06.48337
NCT02386722|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-08-04|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Intervention to Improve Inhalative Adherence|Impact of a Pharmaceutical Care Intervention to Improve Adherence of Inhaled Medication in Asthma and COPD Patients|Completed||N/A|169|Anticipated|Cantonal Hosptal, Baselland||2|||f||||||||||||||2017-10-10 23:31:06.576244|2017-10-10 23:31:06.576244
NCT02386709|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-06-19|||March 2015||2015-03-01|June 2017|2017-06-01|March 2025|Anticipated|2025-03-01|March 2020|Anticipated|2020-03-01||Interventional|TREN||Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer|Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Treatment in Patients With Mammary Gland Cancer|Recruiting||N/A|275|Anticipated|Centre Georges Francois Leclerc||1|||f||||||||||||||2017-10-10 23:31:06.651981|2017-10-10 23:31:06.651981
NCT02386696|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-07|2015-03-23|||January 2015||2015-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|VALMUL||Pleural Sliding During Valsalva and Muller Maneuvers|Pleural Sliding and Contraction of Intercostal Muscles: Ultrasound Findings During Valsalva and Muller Maneuvers|Completed||N/A|20|Actual|Catholic University of the Sacred Heart||1|||f||||f||||||||||2017-10-10 23:31:06.748252|2017-10-10 23:31:06.748252
NCT02386683|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2017-09-29|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||Intraoperative Lung-Protective Ventilation in Neurosurgery|Intraoperative Lung-Protective Ventilation in Neurosurgery|Recruiting||N/A|360|Anticipated|Capital Medical University||2|||f||||t||||||||||2017-10-10 23:31:06.825816|2017-10-10 23:31:06.825816
NCT02386670|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-09-30|||January 2015||2015-01-01|September 2016|2016-09-01|February 2021|Anticipated|2021-02-01|December 2019|Anticipated|2019-12-01||Interventional|PACt-MD||Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)|Prevention of Alzheimer's Dimentia With Cognitive Remediation Plus Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Depression|Recruiting||N/A|375|Anticipated|Centre for Addiction and Mental Health||2|||f||||t||||||||No||2017-10-10 23:31:06.917577|2017-10-10 23:31:06.917577
NCT02386657|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-07-20|||November 2012||2012-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|February 2015|Actual|2015-02-01||Observational|||Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department|Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department|Completed||N/A|104|Actual|Brugmann University Hospital|||1||f||||f||||||||||2017-10-10 23:31:08.564179|2017-10-10 23:31:08.564179
NCT02386644|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2015-04-11|||February 2015||2015-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Transperineal Ultrasonography and Premature Rupture of Membranes|Premature Rupture of Membranes Assessment Via Transperineal Ultrasonography as an Alternative to Speculum Examinations|Completed||N/A|105|Actual|Ankara University||1|||f||||f||||||||||2017-10-10 23:31:08.646694|2017-10-10 23:31:08.646694
NCT02386631|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-06-08|||January 2015||2015-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Hallux Valgus and Custom Orthotic Prescription|Hallux Valgus and the Effects of Custom Orthotic Prescription on the Efficacy of Forward Propulsion|Completed||N/A|10|Anticipated|Wilfrid Laurier University||1|||f||||f||||||||||2017-10-10 23:31:08.717525|2017-10-10 23:31:08.717525
NCT02386618|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-10-04|||October 2013||2013-10-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Endoscopic Treatment for Local Residual Neoplasia|Endoscopic Treatment for Local Residual Neoplasia After Endoscopic Mucosal Resection of the Colorectal Lateral Spreading Tumors (LST)|Completed||N/A|25|Actual|Vitkovice Hospital||1|||f||||t||||||||||2017-10-10 23:31:08.781008|2017-10-10 23:31:08.781008
NCT02386605|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-08-30|||March 28, 2016|Actual|2016-03-28|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|June 29, 2019|Anticipated|2019-06-29||Interventional|||Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers|Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers|Recruiting||N/A|100|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:31:08.85272|2017-10-10 23:31:08.85272
NCT02386592|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-07-27|||September 1, 2015|Actual|2015-09-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|April 15, 2017|Actual|2017-04-15||Interventional|||Prevention of Nosocomial Bacteremia Among Zambian Neonates|Prevention of Nosocomial Bacteremia and Mortality Among Neonates at a Tertiary Referral Center in Zambia|Completed||N/A|9410|Actual|Boston University||1|||f||||t|f|f|||f|||||2017-10-10 23:31:08.942364|2017-10-10 23:31:08.942364
NCT02386579|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-03-06|||February 2015||2015-02-01|March 2015|2015-03-01||||June 2017|Anticipated|2017-06-01||Observational|||Characterization of Local and Systemic Bone Markers in Diabetes Patients With Charcot Osteoarthropathy||Unknown status|Enrolling by invitation|N/A|16|Anticipated|Bispebjerg Hospital|||2||f||||t||||||Samples Without DNA|"     blood serum samples   "|||2017-10-10 23:31:09.028069|2017-10-10 23:31:09.028069
NCT02386566|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-09-01|||March 20, 2015|Actual|2015-03-20|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|PROTYS||Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab|A Prospective, Multicenter, Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Patients Treated With Natalizumab|Active, not recruiting||N/A|48|Actual|Biogen|||1||f||||f||||||||||2017-10-10 23:31:09.093819|2017-10-10 23:31:09.093819
NCT02386553|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-08-15|||May 20, 2015|Actual|2015-05-20|August 2017|2017-08-01|January 26, 2022|Anticipated|2022-01-26|January 26, 2022|Anticipated|2022-01-26||Interventional|NURTURE||A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy|An Open-Label Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ISIS 396443 Delivered Intrathecally to Subjects With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy.|Active, not recruiting||Phase 2|25|Actual|Biogen||1|||t||||t||||||||||2017-10-10 23:31:09.185937|2017-10-10 23:31:09.185937
NCT02386540|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2017-06-27|||February 2015||2015-02-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Health Coach Program to Improve Chronic Disease Outcomes Following an Emergency Department Visit||Recruiting||N/A|300|Anticipated|Alameda County Medical Center||2|||f||||||||||||Undecided||2017-10-10 23:31:09.407455|2017-10-10 23:31:09.407455
NCT02386527|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-03-20|||December 2014||2014-12-01|March 2017|2017-03-01||||December 2020|Anticipated|2020-12-01|3 Years|Observational [Patient Registry]|CATCH-US||Consortium of Early Arthritis Cohorts USA|Consortium of Early Arthritis Cohorts USA - A Prospective Cohort Study of Adults With New Consent Inflammatory Arthritis Symptoms to Understand Predictors of Optimal Outcomes|Recruiting||N/A|2400|Anticipated|Hospital for Special Surgery, New York|||1||f||||||||||Samples With DNA|"     Maximum of 7 tubes of blood will be collected   "|||2017-10-10 23:31:09.511286|2017-10-10 23:31:09.511286
NCT02386514|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-01-02|||June 2016||2016-06-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|ED-RASTI||Emergency Department, Rapid Assessment for Sexually Transmitted Infection||Completed||N/A|1200|Actual|Henry Ford Health System|||1||f||||f||||||||||2017-10-10 23:31:09.578638|2017-10-10 23:31:09.578638
NCT02386501|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-01-18|||September 2015||2015-09-01|January 2017|2017-01-01||||August 2018|Anticipated|2018-08-01||Interventional|||Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors|A Phase 1b Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors|Recruiting||Phase 1/Phase 2|98|Anticipated|Advaxis, Inc.||1|||f||||f||||||||||2017-10-10 23:31:09.644812|2017-10-10 23:31:09.644812
NCT02386488|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-05-18|||March 2015||2015-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women|A Randomised, Open-label, Single-centre, Single- and Multiple-dose Interventional Study Investigating the Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women|Completed||Phase 1|64|Actual|H. Lundbeck A/S||4|||f||||f||||||||||2017-10-10 23:31:09.752893|2017-10-10 23:31:09.752893
NCT02292004|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-04-20|||January 2015||2015-01-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|February 2016|Actual|2016-02-01||Interventional|BEAR||Bridge-Enhanced ACL Repair-Safety Study (BEAR Trial)|Bridge-Enhanced ACL Repair-Safety Study|Completed||Phase 1|20|Actual|Boston Children’s Hospital||2|||f||||t||t|t|f||||No||2017-10-10 23:49:10.686504|2017-10-10 23:49:10.686504
NCT02386475|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-08-11|||January 2015||2015-01-01|August 2017|2017-08-01|December 30, 2018|Anticipated|2018-12-30|March 2017|Actual|2017-03-01||Interventional|SELEIS||Effect of Serotonin and Levodopa in Ischemic Stroke|Effect of Serotonin and Levodopa Functional Recovery in Patients With Cerebral Infarction|Recruiting||Phase 4|240|Anticipated|Hospital de Granollers||4|||f||||f||||||||||2017-10-10 23:31:09.850036|2017-10-10 23:31:09.850036
NCT02386462|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-03-11|||November 2014||2014-11-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Determine the ED50 of Dexmedetomidine to Facilitate LMA Insertion During Anaesthesia Induction|To Determine the Median Effective Dose (ED50) of Dexmedetomidine to Facilitate LMA Insertion During Anaesthesia Induction With Propofol 2.0 mg/kg|Unknown status|Recruiting|Phase 4|30|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||1|||f||||f||||||||||2017-10-10 23:31:09.969874|2017-10-10 23:31:09.969874
NCT02386449|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-01-11|||February 2015||2015-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CLEAR PREP||A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy|A Randomized, Controlled, Parallel Group, Assessor-Blinded Study To Compare The Efficacy, Tolerability, And Safety Of Oral Sodium Picosulfate (PicoPrep®) Versus Oral Mannitol and Bisacodyl, For Colon Cleansing In Colonoscopy Preparation Of Adult Outpatients|Completed||Phase 4|184|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:31:10.071095|2017-10-10 23:31:10.071095
NCT02386436|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-05-12|||April 21, 2015|Actual|2015-04-21|May 2017|2017-05-01|April 11, 2016|Actual|2016-04-11|April 11, 2016|Actual|2016-04-11||Interventional|||A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects|A Phase I, Randomised, Double-blind (Sponsor Open), Placebo-Controlled Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330811 in Healthy Subjects|Completed||Phase 1|41|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-10 23:31:10.15445|2017-10-10 23:31:10.15445
NCT02386423|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-05|||April 2009||2009-04-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|April 2011|Actual|2011-04-01||Interventional|RESTIFFIC||RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome|Efficacy and Safety of the RESTIFFIC™ Brand Pressure Application System, the Restless Leg Relaxer to Reduce the Symptoms of Moderate to Severe Restless Leg Syndrome|Completed||N/A|30|Actual|Lake Erie Research Institute||1|||f||||t||||||||||2017-10-10 23:31:10.246131|2017-10-10 23:31:10.246131
NCT02386410|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-11-07|||August 2015||2015-08-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Selective Prevention of Anxiety Disorders in Children: A Parent Training Intervention for Anxious Parents|Selective Prevention of Anxiety Disorders in Children: A Randomized Controlled Preliminary Study of a Parent Training Intervention for Anxious Parents|Active, not recruiting||Phase 1|60|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-10 23:31:10.323903|2017-10-10 23:31:10.323903
NCT02386397|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-10|||September 2014||2014-09-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|BREGO||Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer|Activity of Regorafenib in Combination With Modified Gemcitabine - Oxaliplatin Chemotherapy (mGEMOX) in Patients With Advanced Biliary Tract Cancer (BTC): A Phase Ib-II Trial (BREGO)|Recruiting||Phase 1/Phase 2|63|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||t||||||||||2017-10-10 23:31:10.40211|2017-10-10 23:31:10.40211
NCT02386384|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-07-25|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure|TNFα (Tumor Necrosis Factor Alpha) and MFG-E8 (Milk Fat Globule-Epidermal Growth Factor 8): Novel Biomarkers to Predict Implantation Failure|Completed||N/A|15|Actual|Eastern Virginia Medical School|||3||f||||f||||||||||2017-10-10 23:31:10.477897|2017-10-10 23:31:10.477897
NCT02386371|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-16|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|May 2018|Anticipated|2018-05-01||Interventional|RE-IORT01||Intraoperative Radiotherapy After Local Recurrence in Breast Cancer|Feasibility Clinical Trial of Intraoperative Radiotherapy (IORT) and Second Breast-conserving-surgery After Local Recurrence of Breast Carcinoma|Recruiting||Phase 2|51|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||t||||||||||2017-10-10 23:31:10.576268|2017-10-10 23:31:10.576268
NCT02386358|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-03-05|||March 1999||1999-03-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|TRAENA||Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial|Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Double Blind Clinical Trial|Completed||Phase 3|910|Actual|Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben||2|||f||||t||||||||||2017-10-10 23:31:10.671962|2017-10-10 23:31:10.671962
NCT02386345|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-17|||March 2015||2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Topera E-FIRM Registry|EU Focal Impulse and Rotor Modulation Registry -Topera E-FIRM Registry-|Active, not recruiting||N/A|300|Anticipated|I-Med-Pro GmbH|||1||f||||f||||||||||2017-10-10 23:31:10.772229|2017-10-10 23:31:10.772229
NCT02386332|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-05|||March 2015||2015-03-01|March 2015|2015-03-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Observational|||A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies|A Randomized Multicenter Study Comparing Unrelated Umbilical-cord Blood Transplant Versus Human Leukocyte Antigen (HLA)-Haploidentical Related Hematopoietic Stem Cell Transplant for Adult Patients With Hematologic Malignancies|Not yet recruiting||Phase 3|206|Anticipated|Instituto de Investigacion Sanitaria La Fe|||2||f||||f||||||||||2017-10-10 23:31:10.849386|2017-10-10 23:31:10.849386
NCT02386319|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-02-17|||August 2016||2016-08-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Analgesic and Anxiolytic Effects of Melatonin: a Randomized, Double-blinded, Placebo-controlled Clinical Study|Analgesic and Anxiolytic Effects of Melatonin: a Randomized, Double-blinded, Placebo-controlled Clinical Study|Not yet recruiting||Phase 3|84|Anticipated|Herlev Hospital||2|||f||||t||||||||||2017-10-10 23:31:10.910922|2017-10-10 23:31:10.910922
NCT02386306|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-02-01|||February 2015||2015-02-01|July 2015|2015-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled; Phase 1b, Safety, Tolerability, and Pharmacokinetic Study of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|39|Actual|GliaCure, Inc.||6|||f||||||||||||||2017-10-10 23:31:11.107583|2017-10-10 23:31:11.107583
NCT02386293|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-12-07|||September 2014||2014-09-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|Avapro3||Effectiveness of Avapro in Obese Normotensive/Hypertensive African Americans|Effectiveness of Avapro in the Treatment of Salt Sensitivity in Both Normotensive and Untreated Hypertensive Obese African Americans: A Randomized Double Blind Placebo Controlled Trial|Recruiting||Phase 2|30|Anticipated|Augusta University||2|||f||||t||||||||Yes|Dissemination will be carried out in a variety of ways that will be accessible to other scientists studying psychosocial stress, hypertension, and the control of fluid-electrolyte balance and blood pressure. These include publications made available through PubMed-cited journals and presentations at scientific meetings and various organizations.|2017-10-10 23:31:11.216676|2017-10-10 23:31:11.216676
NCT02386280|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-03-05|||August 2014||2014-08-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Prevention of Drug Use in Adolescence: Intervening in Parenting Styles|Prevention of Drug Use in Adolescence: Intervening in Parenting Styles|Unknown status|Recruiting|Phase 1/Phase 2|200|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||||2017-10-10 23:31:11.345946|2017-10-10 23:31:11.345946
NCT02386267|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-03-05|||September 2014||2014-09-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|||L-leucine in Diamond Blackfan Anemia Patients|Therapeutic Use of the Amino Acid Leucine in the Treatment of Transfusion-Dependent Diamond Blackfan Anemia Patients|Unknown status|Recruiting|Phase 2|30|Anticipated|Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogache||1|||f||||f||||||||||2017-10-10 23:31:11.423724|2017-10-10 23:31:11.423724
NCT02386254|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-08-25|||January 2015||2015-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|ECOG||Adaptation of a Premorbid Function Scoring System as a Predictor for Intensive Care Unit Mortality|Adaptation of a Premorbid Function Scoring System as a Predictor for Intensive Care Unit Mortality|Recruiting||N/A|300|Anticipated|University of Oklahoma|||1||f||||f||||||||||2017-10-10 23:31:11.501979|2017-10-10 23:31:11.501979
NCT02386241|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-01-04|||March 2015||2015-03-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Observational|||Identification of Genomic Changes in Families Having Multiple Members With Tumors|Identification of Genomic Changes in Families Having Multiple Members With Tumors|Recruiting||N/A|60|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix|||1||f||||t||||||Samples With DNA|"     A single saliva or blood sample measuring 10mL for genomic analysis.   "|||2017-10-10 23:31:11.568234|2017-10-10 23:31:11.568234
NCT02386228|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-01-05|||March 2015||2015-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Micro Ribonucleic Acid (miRNA) Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)|miRNA Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)|Terminated||N/A|1|Actual|St. Joseph's Hospital and Medical Center, Phoenix|||1||f||||t||||||Samples With DNA|"     CSF and blood   "|||2017-10-10 23:31:11.649163|2017-10-10 23:31:11.649163
NCT02386215|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-06-03|||June 2015||2015-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Use of HIV Self-tests to Promote Partner and Couples Testing: a Randomized Trial|The Use of HIV Self-tests to Promote Partner and Couples Testing: a Randomized Trial|Completed||N/A|600|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:31:11.722979|2017-10-10 23:31:11.722979
NCT02386202|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-12-01|||January 2015||2015-01-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||ARC in Hemorrhagic Stroke|Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit|Completed||N/A|80|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-10 23:31:11.806053|2017-10-10 23:31:11.806053
NCT02386189|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-05-22|||March 2, 2015|Actual|2015-03-02|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|March 1, 2017|Actual|2017-03-01||Interventional|||Veteran Dual Use of Health Systems|Dual Health Systems Users: Strategies to Implement Optimal Care Coordination|Completed||N/A|63|Actual|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 23:31:11.883588|2017-10-10 23:31:11.883588
NCT02386176|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-07-24|||August 2015||2015-08-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Observational|||Assessment of Automated Breast Ultrasound|The Assessment of the Role of Automated Breast Ultrasound (ABUS) in Screening Women With Dense Breasts for Early Detection of Breast Cancer|Recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:31:11.971978|2017-10-10 23:31:11.971978
NCT02386163|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-09-08|||May 2014||2014-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Large-scale ex Vivo Expansion and Characterization of Two Kinds of MSC From Knee for Clinical Application|Large-scale ex Vivo Expansion and Characterization of Synovial Membrane MSC (SM-MSC) and Infrapatellar Fat Pad MSC (IF-MSC) for Clinical Application|Completed||N/A|6|Actual|EMO Biomedicine Corporation|||1||f||||f||||||Samples Without DNA|"     MSC from synovial membrane and infrapatellar fat pad   "|||2017-10-10 23:31:12.050897|2017-10-10 23:31:12.050897
NCT02386150|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-05-02|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ — 3-Dose Primary Series With Boost|Phase 1b Escalating Study to Evaluate the Safety and Immunogenicity of Recombinant Ricin Toxin A-Chain 1-33/44-198 (rRTA 1-33/44-198) Vaccine (RVEc™) Administered Intradermally to Healthy Adults as a 3-Dose Primary Series and Booster|Withdrawn||Phase 1|0|Actual|U.S. Army Medical Research and Materiel Command||2||lack of funding|f||||f|t|f||||||||2017-10-10 23:31:12.115515|2017-10-10 23:31:12.115515
NCT02386124|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-01-12|||December 2014||2014-12-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|FRASER||Frailty in Elderly Patients Receiving Cardiac Interventional Procedures|Frailty Assessment in eldeRly Admitted to hoSpital for acutE caRdiac Disease Prospective Study|Active, not recruiting||N/A|402|Actual|University Hospital of Ferrara||1|||f||||t||||||||Undecided||2017-10-10 23:31:12.304547|2017-10-10 23:31:12.304547
NCT02386111|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-08-22|||May 2015||2015-05-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Actual|2017-08-01||Interventional|||A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma|A Phase l/ll Study of Varlilumab in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma|Terminated||Phase 1/Phase 2|17|Actual|Celldex Therapeutics||1||Portfolio re-prioritization|f||||f||||||||||2017-10-10 23:31:12.395731|2017-10-10 23:31:12.395731
NCT02386098|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-09-25|||July 8, 2015|Actual|2015-07-08|September 2017|2017-09-01|June 7, 2017|Actual|2017-06-07|June 7, 2017|Actual|2017-06-07||Interventional|||Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults|A Phase 2b Randomized, Active-Controlled, Staged, Open-label Trial to Investigate Safety and Efficacy of BMS-955176 in Combination With Dolutegravir and Atazanavir (With or Without Ritonavir) in Treatment-Experienced HIV-1 Infected Adults|Terminated||Phase 2|84|Actual|ViiV Healthcare||5||The trial ended early due to GI intolerability.|f||||f|t|f||||||||2017-10-10 23:31:12.517571|2017-10-10 23:31:12.517571
NCT02386085|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2016-07-11|||February 2015||2015-02-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Patient-reported Adverse Events From Osteopathic Manipulative Treatment|Patient-reported Adverse Events From Osteopathic Manipulative Treatment|Enrolling by invitation||N/A|1000|Anticipated|A.T. Still University of Health Sciences|||1||f||||f||||||||Undecided||2017-10-10 23:31:12.758924|2017-10-10 23:31:12.758924
NCT02386072|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2017-06-29|||January 5, 2015|Actual|2015-01-05|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|PERSPECTIVE||A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)|A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder (OAB)|Active, not recruiting||N/A|1524|Actual|Astellas Pharma Inc|||2||f||||f||||||||||2017-10-10 23:31:12.839414|2017-10-10 23:31:12.839414
NCT02386059|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-10|||March 2015||2015-03-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Vitrectomy Under Local Anesthesia|A Multicenter Randomized Trial to Evaluate the Efficacy and Safety of Three Different Prophylactic Treatments of Postoperative Nausea and Vomiting in Patients Undergoing Vitrectomy Under Local Anesthesia|Unknown status|Not yet recruiting|Phase 4|1200|Anticipated|University of Catania||4|||f||||f||||||||||2017-10-10 23:31:13.209731|2017-10-10 23:31:13.209731
NCT02386046|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-12-08|||February 2015||2015-02-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|OCPDPS||Oxygen Saturation and Caffeine Post-Discharge||Recruiting||N/A|180|Anticipated|University of Calgary|||3||f||||f||||||||||2017-10-10 23:31:13.338521|2017-10-10 23:31:13.338521
NCT02386033|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2015-03-05|||November 2013||2013-11-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects|Clinical Efficacy of Subgingivally Delivered Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects: A Randomized Controlled Clinical Trial .|Completed||Phase 2/Phase 3|60|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||t||||||||||2017-10-10 23:31:13.425416|2017-10-10 23:31:13.425416
NCT02386020|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-03-05|||June 2014||2014-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Aloe Vera in Chronic Periodontitis With Type 2 Diabetes Mellitus|Clinical Efficacy of Locally Delivered Aloe Vera Gel as an Adjunct to Non-surgical Periodontal Therapy in Chronic Periodontitis Subjects With Type 2 Diabetes Mellitus: a Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|60|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||t||||||||||2017-10-10 23:31:13.510246|2017-10-10 23:31:13.510246
NCT02386007|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-10-11||||||October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Interventional|||Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients|A Double-blind, Multicenter, Randomized Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Korean Patients With Gastric Inflammation|Not yet recruiting||Phase 2|60|Anticipated|Daewon Pharmaceutical Co., Ltd.||4|||f||||||||||||||2017-10-10 23:31:13.588469|2017-10-10 23:31:13.588469
NCT02385994|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-01-30|||April 2015||2015-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Prospective Multi-Center Study Using Laser for the Treatment of Melasma and Lentigines in Asian Skin|A Prospective Multi-Center Study of a Novel Dual-Wavelength, Dual-Pulse Duration Laser for the Treatment of Melasma and Lentigines in Asian Skin|Completed||N/A|80|Anticipated|Cutera Inc.||2|||f||||f||||||||Undecided||2017-10-10 23:31:13.663096|2017-10-10 23:31:13.663096
NCT02385981|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-03-10|||April 2014||2014-04-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Vagal-stimulation-PAVK-tcpO2-study|Clinical Study to Review the Effects of an Auricular and Percutaneous Electric Stimulation of Nervus Vagus on the Oxygen Supply of Skin of Patients With Severe Claudicatio Intermittens|Unknown status|Recruiting|N/A|12|Anticipated|Payrits, Thomas, M.D.||1|||f||||t||||||||||2017-10-10 23:31:13.754174|2017-10-10 23:31:13.754174
NCT02385968|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-10-03|||October 2014||2014-10-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Detection of Bacteria in Herniated Nucleus Material in Lumbar Disc Herniations by Culture and PCR|Detection of Bacteria in Herniated Nucleus Material in Lumbar Disc Herniations by Culture and PCR|Recruiting||N/A|30|Anticipated|Sygehus Lillebaelt|||1||f||||f||||||Samples Without DNA|"     Biopsies of Nucleus   "|||2017-10-10 23:31:13.836823|2017-10-10 23:31:13.836823
NCT02385955|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-03-10|||April 2015||2015-04-01|March 2015|2015-03-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients|Prospective Multicenter Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients With Hematologic Malignancies|Not yet recruiting||Phase 2|39|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:31:13.910896|2017-10-10 23:31:13.910896
NCT02385942|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-10|||July 2012||2012-07-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||KT(KT Corporation)-SNUBH(Seoul National University Bundang Hospital) U-health Cooperative Research|KT-SNUBH U-health Cooperative Research: Target Selection and Consumers' Intention Research for Commercialization of the Pressure Ulcer Management u-Health Solution|Completed||N/A|60|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 23:31:13.997533|2017-10-10 23:31:13.997533
NCT02385929|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-03-08|||May 11, 2015|Actual|2015-05-11|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|SYNK||Pre-habilitation of Patients With Head and Neck Cancer|Bimodal Pre-habilitation Program to Improve Symptom Control After Treatment for Head and Neck Cancer|Recruiting||N/A|240|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||No||2017-10-10 23:31:14.085236|2017-10-10 23:31:14.085236
NCT02385916|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-05-30|||April 2015||2015-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||The Effects of EstroSense®/MD vs Placebo in Improving the Estrogen Profile in Females|A Randomised, Double Blind, Placebo Controlled, Cross-over Trial Evaluating the Effects of EstroSense®/MD (PNO) vs Placebo in Increasing 2:16α Ratio and Improving the Estrogen Profile in Females|Recruiting||N/A|120|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:31:14.215717|2017-10-10 23:31:14.215717
NCT02385903|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-11-30|||September 2009||2009-09-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|Flammacérium||Randomized Controlled Trial on the Use of Flammacerium in Necrotic Arterial Wounds of the Lower Limb Versus Standard Treatment||Terminated||Phase 2|55|Actual|University Hospital, Montpellier||2||Decision of the Independent Review Committee|f||||t||||||||||2017-10-10 23:31:14.306539|2017-10-10 23:31:14.306539
NCT02385890|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-09-26|||October 2016||2016-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||PERFECT Project - Part 1 - Study 3|Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 1 - Acute Effects of Pulse Ingredients in Snack Products on Appetite, Blood Glucose, and Food Intake in Adults - Study 3|Recruiting||N/A|30|Anticipated|University of Manitoba||6|||f||||||||||||||2017-10-10 23:31:14.396815|2017-10-10 23:31:14.396815
NCT02385877|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-06-30|||March 2015|Actual|2015-03-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines|Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines for Quantification of Regional Cardiac Sympathetic Nerve Density With PET|Completed||Early Phase 1|16|Actual|University of Michigan||3|||f||||f||||||||||2017-10-10 23:31:14.507367|2017-10-10 23:31:14.507367
NCT02385864|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-03-04|||September 2015||2015-09-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Observational|POP-ART||CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension|Effect of the Continuous Positive Airway Pressure on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension|Recruiting||N/A|166|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 23:31:14.614338|2017-10-10 23:31:14.614338
NCT02385851|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-08-10|||February 2015||2015-02-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim)|A Randomized, Double-Blind, Crossover Study to Compare the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® in Healthy Subjects|Completed||Phase 1|116|Actual|Coherus Biosciences, Inc.||2|||f||||f||||||||||2017-10-10 23:31:14.711729|2017-10-10 23:31:14.711729
NCT02385838|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-05-10|||December 2014||2014-12-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Impact of Nutrition Labels on Consumer Purchasing Intentions|Impact of Different Front-of-pack Nutrition Labels on Consumer Purchasing Intentions: Randomized Trial in the NutriNet-Santé Study|Completed||N/A|11981|Actual|University of Paris 13||5|||f||||||||||||||2017-10-10 23:31:14.806647|2017-10-10 23:31:14.806647
NCT02385825|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-02-28|||April 2016||2016-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||IM Recombinant Ricin Toxin Vaccine (RVEc) — 3-Dose Primary Series With Boost|Phase 1b Escalating Study to Evaluate the Safety and Immunogenicity of Recombinant Ricin Toxin A-Chain 1-33/44-198 (rRTA 1-33/44-198) Vaccine (RVEc™) Administered Intramuscularly to Healthy Adults as a 3-Dose Primary Series and Booster|Withdrawn||Phase 1|0|Actual|U.S. Army Medical Research and Materiel Command||3||lack of funding|f||||f||||||||||2017-10-10 23:31:14.902728|2017-10-10 23:31:14.902728
NCT02385812|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-10-05|||April 2015||2015-04-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma|Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma|Recruiting||Phase 2|200|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 23:31:15.012145|2017-10-10 23:31:15.012145
NCT02385799|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-28|||February 2015||2015-02-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Sert2||A Trial of Sertraline in Young Children With Autism Spectrum Disorder|A Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder|Recruiting||Phase 2|60|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-10-10 23:31:15.11433|2017-10-10 23:31:15.11433
NCT02385786|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-05|||November 2011||2011-11-01|March 2015|2015-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Mindfulness-Based Cognitive Therapy Effect on Depression and C-Reactive Protein Levels After 8 Weeks of Treatment|Mindfulness-Based Cognitive Therapy Depression Efficacy and Effects on Inflammatory Biomarker Levels|Completed||N/A|43|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:31:15.231205|2017-10-10 23:31:15.231205
NCT02385773|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-01-04|||March 2015||2015-03-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Impact of the Nutritional Product PTM202 on Acute and Long-Term Recovery From Childhood Diarrheal Disease|A Double Blind, Randomized, Placebo-Controlled Trial to Assess the Impact of the Nutritional Product PTM202 on Acute and Long-Term Recovery From Childhood Diarrheal Disease|Completed||N/A|321|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:31:15.320333|2017-10-10 23:31:15.320333
NCT02385760|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-08-01|||April 2015||2015-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris|A Multi-centre, Double-blind, Randomized, Parallel Group, Placebo Controlled Efficacy and Safety Study of Oral CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris|Completed||Phase 2|124|Actual|Celtaxsys, Inc.||2|||f||||f||||||||||2017-10-10 23:31:15.418941|2017-10-10 23:31:15.418941
NCT02384993|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-12-29|||January 2015||2015-01-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|REACH||aeRobic Exercise and Cognitive Health|Aerobic Exercise for Alzheimer's Disease Prevention in At-Risk Middle-Aged Adults|Completed||N/A|24|Actual|University of Wisconsin, Madison||2|||f||||f||||||||No||2017-10-10 23:31:22.022647|2017-10-10 23:31:22.022647
NCT02385747|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-03-18|||March 2015||2015-03-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Uterine Cavity Assessment and Endometrial Hormonal Receptors in Women With Peri and Post Menopausal Bleeding|Assessment of Uterine Cavity and Endometrial Steroid Receptors in Women With Peri- and Post Menopausal Bleeding|Completed||N/A|100|Actual|Cairo University||1|||f||||t||||||||||2017-10-10 23:31:15.515391|2017-10-10 23:31:15.515391
NCT02385734|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-05|||April 2013||2013-04-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||Concentrated Growth Factor in the Treatment of Gingival Recessions|Concentrated Growth Factor Membrane in the Treatment of Adjacent Multiple Gingival Recessions: A Split Mouth Randomized Clinical Study|Completed||N/A|20|Actual|Bulent Ecevit University||2|||f||||f||||||||||2017-10-10 23:31:15.596417|2017-10-10 23:31:15.596417
NCT02385721|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-07-25|||May 2013|Actual|2013-05-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|12 Months|Observational [Patient Registry]|||A Prospective, Observational, Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)|A Prospective, Observational, Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan) During 1 Year Among 20 and Older Diagnosed With Essential Hypertension|Active, not recruiting||N/A|601|Actual|Boryung Pharmaceutical Co., Ltd|||1||f||||f||||||||||2017-10-10 23:31:15.678811|2017-10-10 23:31:15.678811
NCT02385708|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-10-05|||August 2015|Actual|2015-08-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections|A Randomized Controlled Trial of 2% Chlorhexidine Gluconate Skin Preparation Cloths for the Prevention of Post-Operative Surgical Site Infections in Colorectal Patients|Recruiting||N/A|150|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 23:31:15.736175|2017-10-10 23:31:15.736175
NCT02385695|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-09-24|||March 2015||2015-03-01|September 2015|2015-09-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Observational|MLIDH||Study to Evaluate Safety and Effectiveness of Dynamic Stabilization Versus Lumbar Fusion in Treatment of Multilevel Lumbar Disc Degeneration Disease|A Prospective Comparative Study to Evaluate Safety and Effectiveness of Dynamic Stabilization Versus Lumbar Fusion in Treatment of Multilevel Lumbar Disc Degeneration Disease|Recruiting||N/A|102|Anticipated|Third Military Medical University|||2||f||||f||||||||||2017-10-10 23:31:15.829087|2017-10-10 23:31:15.829087
NCT02385682|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-04-16|||January 2004||2004-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|5 Years|Observational [Patient Registry]|COREA-AMI||CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction|CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Korean Patients With Acute Myocardial Infarction Registry (COREA-AMI)|Completed||N/A|4748|Actual|Seoul St. Mary's Hospital|||2||f||||f||||||||||2017-10-10 23:31:15.923244|2017-10-10 23:31:15.923244
NCT02385669|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-09-14|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|Mel62; 6PAC||A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma|A Phase I/II Trial to Evaluate the Safety and Immunogenicity of a Helper Peptide Vaccine Plus CTLA-4 Blockade in Melanoma Patients (Mel62; 6PAC)|Recruiting||Phase 1/Phase 2|27|Anticipated|University of Virginia||1|||f||||t|t|f||||||||2017-10-10 23:31:16.012159|2017-10-10 23:31:16.012159
NCT02385656|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-10|||March 2013||2013-03-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study|The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study|Unknown status|Recruiting|Phase 4|20|Anticipated|Seoul National University Bundang Hospital||1|||f||||f||||||||||2017-10-10 23:31:16.102272|2017-10-10 23:31:16.102272
NCT02385643|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-05|||September 2013||2013-09-01|March 2015|2015-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients||Unknown status|Recruiting|N/A|100|Anticipated|Taipei City Hospital||2|||f||||f||||||||||2017-10-10 23:31:16.180303|2017-10-10 23:31:16.180303
NCT02385630|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-02-09|||March 2015||2015-03-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer|Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer|Active, not recruiting||N/A|40|Actual|St. James's Hospital, Ireland||2|||f||||f||||||||||2017-10-10 23:31:16.395942|2017-10-10 23:31:16.395942
NCT02385617|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-02-09|||January 2014||2014-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer|Food Intake and Gut Hormone Release in Patients in Cancer Remission Who Have Undergone Upper Gastrointestinal Surgery|Enrolling by invitation||N/A|80|Anticipated|St. James's Hospital, Ireland||4|||f||||f||||||||||2017-10-10 23:31:16.571486|2017-10-10 23:31:16.571486
NCT02385604|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-03-09|||January 2014||2014-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||The Predictive Value of CT-PET in Esophageal Cancer|CT-PET for Prediction of Histopathologic Response, Nodal Status and Oncologic Outcome Following Neoadjuvant Chemoradiation for Esophageal Cancer|Completed||N/A|250|Actual|St. James's Hospital, Ireland|||1||f||||f||||||||||2017-10-10 23:31:16.737043|2017-10-10 23:31:16.737043
NCT02385591|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-11-11|||September 2014||2014-09-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SMS-Stanford||Innovative Physical Activity Interventions for Overweight Latinos|Innovative Physical Activity Interventions for Overweight Latinos|Recruiting||N/A|376|Anticipated|Stanford University||3|||f||||t||||||||||2017-10-10 23:31:16.831932|2017-10-10 23:31:16.831932
NCT02385578|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-03-10|||March 2015||2015-03-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer|An Educational Intervention, the First Step of the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer:Prospective Study With Historical Control|Unknown status|Not yet recruiting|N/A|16000|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-10 23:31:16.96504|2017-10-10 23:31:16.96504
NCT02385565|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-10|||February 2004||2004-02-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|MITOX||Effect Of The System In The Enriched Fat Metabolism Of The Child Reached Mitochondrial Cytopathy|Effect Of The System In The Enriched Fat Metabolism Of The Child Reached Mitochondrial Cytopathy|Completed||N/A|36|Actual|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 23:31:17.075961|2017-10-10 23:31:17.075961
NCT02385552|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-04-14|||March 2011||2011-03-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01|8 Years|Observational [Patient Registry]|||Development of Quality Indicators and Quality Improvement Plan of Colonoscopy in Experienced Endoscopist|Seoul National University Hospital Healthcare System Gangnam Center Colonoscopy Quality Upgrade Project (Gangnam-CUP): Development of Quality Indicators and Quality Improvement Plan of Colonoscopy in Experienced Endoscopist.|Recruiting||N/A|17|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-10 23:31:17.183153|2017-10-10 23:31:17.183153
NCT02385539|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-04-02|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Intrathecal Administration of Levobupivacaine and Opioids in Elderly|Intrathecal Anesthesia for Elderly Patients Undergoing Surgery Lasting >45 Minutes: A Randomized, Controlled, Dose and Combination Finding Study|Completed||N/A|240|Actual|Šarić, Jadranka Pavičić, M.D.||3|||f||||f||||||||||2017-10-10 23:31:17.334031|2017-10-10 23:31:17.334031
NCT02385513|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-10-13|||May 2015||2015-05-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||PCV10 Immunogenicity Study Nepal 2015|A Randomised Controlled Trial Comparing Two-Dose Priming With the 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks to 6 and 14 Weeks in Nepali Children|Recruiting||Phase 4|304|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 23:31:17.638292|2017-10-10 23:31:17.638292
NCT02385500|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-03-15|||March 2015||2015-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Fesoterodine on Urgency Episodes in Parkinson's Disease Population|Randomized Cross-Over Study of Fesoterodine on Urgency Episodes in Parkinson's Disease Population|Recruiting||Phase 4|60|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||t||||||||No||2017-10-10 23:31:17.757224|2017-10-10 23:31:17.757224
NCT02385487|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-07-01|||March 2015||2015-03-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Observational|||Inflammation in Type 2 Myocardial Infarction|Inflammation in Type 2 Myocardial Infarction|Withdrawn||N/A|0|Actual|New York University School of Medicine|||2|Logistics and feasibility|f||||f||||||Samples With DNA|"     Venous blood samples   "|||2017-10-10 23:31:17.876188|2017-10-10 23:31:17.876188
NCT02385474|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-05-12|||March 2013||2013-03-01|May 2016|2016-05-01||||March 2016|Actual|2016-03-01||Interventional|||Effectiveness of SDF in Arresting Dental Caries in Preschool Children|Effectiveness of Silver Diamine Fluoride in Arresting Dental Caries in Preschool Children: a Randomized Clinical Trial With Different Periodicity and Concentration.|Completed||Phase 3|888|Actual|The University of Hong Kong||4|||f||||f||||||||||2017-10-10 23:31:17.965764|2017-10-10 23:31:17.965764
NCT02385461|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-08-04|||January 2012||2012-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|10 Months|Observational [Patient Registry]|OTTILIA||Study on Antithrombotic Prevention in Thrombophilia and Pregnancy Loss|A Proposal of a Prospective Study on Prevention of Pregnancy Loss in Women Carrying Inherited Thrombophilia|Recruiting||N/A|108|Anticipated|Casa Sollievo della Sofferenza IRCCS|||3||f||||t||||||||||2017-10-10 23:31:18.080877|2017-10-10 23:31:18.080877
NCT02385448|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-04-28|||February 2015||2015-02-01|March 2015|2015-03-01|February 2019|Anticipated|2019-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery|A Prospective, Randomized Controlled Trial Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery|Recruiting||Phase 4|144|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:31:18.174714|2017-10-10 23:31:18.174714
NCT02385435|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-10|||January 2014||2014-01-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Caudal Bupivacaine vs Bupivacaine Plus Two Doses of Dexmedetomidine for Postoperative Analgesia in Children|Comparison of Caudal Bupivacaine Alone With Bupivacaine Plus Two Doses of Dexmedetomidine for Postoperative Analgesia in Pediatric Patients Undergoing Infra-umbilical Surgery: A Randomized Controlled Double Blinded Study|Completed||Phase 2/Phase 3|91|Actual|University of Jordan||3|||f||||t||||||||||2017-10-10 23:31:18.287745|2017-10-10 23:31:18.287745
NCT02385422|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-09|||March 2015||2015-03-01|March 2015|2015-03-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding|The Effect of Carvedilol Vs Propranolol in Patients With Cirrhosis Related Esophagogastric Varices After Multiple Endoscopic Treatments For Secondary Prophylaxis:A Randomized Controlled Trial|Recruiting||Phase 4|480|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-10 23:31:18.398113|2017-10-10 23:31:18.398113
NCT02385409|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-03-05|||May 2013||2013-05-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2014|Actual|2014-05-01||Observational|||Incidence and Reasons for Preoperative Anemia in Elective Lower Joint Arthroplasty|Incidence and Reasons for Preoperative Anemia in Elective Lower Joint Arthroplasty - A Descriptive Study|Unknown status|Active, not recruiting|N/A|900|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-10 23:31:18.526943|2017-10-10 23:31:18.526943
NCT02385396|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-03-11||||||March 2015|2015-03-01||||October 2014|Actual|2014-10-01||Interventional|||Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment|Evaluation Concerning the Influence of Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment|Completed||Phase 2|217|Actual|Medical University of Lublin||3|||f||||||||||||||2017-10-10 23:31:18.614446|2017-10-10 23:31:18.614446
NCT02385383|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-03-10|||October 2014||2014-10-01|March 2015|2015-03-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Observational|||An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study|An Intravenous Iron Based Protocol for Optimizing Haemoglobin in Anaemic Patients Prior to Fast-track Hip and Knee Arthroplasty - An Observational Follow up Study|Unknown status|Recruiting|N/A|300|Anticipated|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-10 23:31:18.727284|2017-10-10 23:31:18.727284
NCT02385370|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-10|||December 2014||2014-12-01|December 2014|2014-12-01||||December 2015|Anticipated|2015-12-01||Interventional|conj mmc||Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method|Bleb Function and Morphology With Intratendon Injection of 0.1 mg MMC in Comparison With Conventional Subtenon Application of 0.02% MMC Soaked Sponges in Trabeculectomy|Unknown status|Recruiting|Phase 3|126|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:31:18.855681|2017-10-10 23:31:18.855681
NCT02385357|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-03-10|||February 2015||2015-02-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SPORTEUS||Effect of a Protein-enriched Drink on Muscle Function|Effect of a Protein-enriched Drink on Muscle Function Recovery Following an Acute High Intensity Exercise Bout|Unknown status|Recruiting|Early Phase 1|12|Anticipated|Puleva Biotech||2|||f||||t||||||||||2017-10-10 23:31:18.937037|2017-10-10 23:31:18.937037
NCT02385344|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-05-12|||April 2015||2015-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Weeks|Observational [Patient Registry]|REQUEST||Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery|Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery|Recruiting||N/A|1000|Anticipated|Medistim ASA|||1||f||||f||||||||||2017-10-10 23:31:19.031604|2017-10-10 23:31:19.031604
NCT02385331|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-10|||March 2015||2015-03-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|September 2015|Anticipated|2015-09-01||Observational|MMNNIRP||Molecular Mechanism of Neutrophil Necroptosis and Its Roles in RA Pathogenesis|Molecular Mechanism of Neutrophil Necroptosis and Its Roles in RA Pathogenesis|Unknown status|Recruiting|N/A|30|Anticipated|The Third Affiliated Hospital of Southern Medical University|||1||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-10 23:31:19.130449|2017-10-10 23:31:19.130449
NCT02385318|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-06-27||2016-06-27|February 2015||2015-02-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis||Completed||Phase 3|515|Actual|Perrigo Company||3|||f||||f||||||||||2017-10-10 23:31:19.211312|2017-10-10 23:31:19.211312
NCT02385305|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-01-15|||March 2015||2015-03-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Pressure Support Ventilation on Spontaneous Breathing in Anesthetized Subjects|The Effect of Pressure Support Ventilation on Minute Alveolar Ventilation and End-tidal Carbon Dioxide in Anesthetized Spontaneously Breathing Subjects|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:31:19.290384|2017-10-10 23:31:19.290384
NCT02385292|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-04-07|||May 2015||2015-05-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation|Randomized, Controlled, Crossover, Multicenter Trial Comparing Quality of Tears Produced by Nasal Neurostimulation Versus Sham for Dry Eye|Completed||N/A|23|Actual|Oculeve, Inc.||2|||f||||f|f|t|t|f|f|||No||2017-10-10 23:31:19.36963|2017-10-10 23:31:19.36963
NCT02385279|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-08-10|||March 2015||2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Interventional|DESSOLVE III||Study Comparing the MiStent SES Versus the XIENCE EES Stent|Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries|Active, not recruiting||N/A|1404|Actual|ECRI bv||2|||f||||t||||||||||2017-10-10 23:31:19.462783|2017-10-10 23:31:19.462783
NCT02385266|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-09-29|||September 2013||2013-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|UCPPS||Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain|Brain Imaging-based Strategies for Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain|Completed||Phase 4|20|Actual|Northwestern University||2|||f||||f||||||||Yes|Following publication of primary analyses, de-identified scan and clinical data will be posted to NIH-sponsored Open Pain database.|2017-10-10 23:31:19.609682|2017-10-10 23:31:19.609682
NCT02385253|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-09-12|||September 15, 2015|Actual|2015-09-15|September 2017|2017-09-01|July 23, 2017|Actual|2017-07-23|July 23, 2017|Actual|2017-07-23||Interventional|||Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance|Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance|Completed||N/A|89|Actual|Northwestern University||2|||f||||t||||||||||2017-10-10 23:31:19.705169|2017-10-10 23:31:19.705169
NCT02385240|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-06-27||2016-06-27|March 2015||2015-03-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea||Completed||Phase 3|552|Actual|Perrigo Company||3|||f||||f||||||||||2017-10-10 23:31:19.782465|2017-10-10 23:31:19.782465
NCT02385214|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-07-14|||December 2014||2014-12-01|July 2016|2016-07-01|December 2029|Anticipated|2029-12-01|December 2029|Anticipated|2029-12-01||Interventional|MelmarT||MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma|A Phase III, Multi-centre, Multi-national Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma|Recruiting||Phase 3|400|Anticipated|Australia and New Zealand Melanoma Trials Group||2|||f||||t||||||||||2017-10-10 23:31:19.960891|2017-10-10 23:31:19.960891
NCT02385019|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-03-06|||March 2015||2015-03-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|TREGeneration||A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease|A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease|Recruiting||Phase 1/Phase 2|22|Anticipated|Instituto de Medicina Molecular||4|||f||||t||||||||||2017-10-10 23:31:21.80155|2017-10-10 23:31:21.80155
NCT02385201|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-07-25|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|June 2017|Actual|2017-06-01||Interventional|SENZA-ULN||Clinical Trial of the Senza™ SCS System in the Treatment of Chronic Upper Limb and Neck Pain|Multi-Center, Prospective, Clinical Trial of the Senza™ Spinal Cord Stimulation (SCS) System in the Treatment of Chronic Upper Limb and Neck Pain|Active, not recruiting||N/A|100|Actual|Nevro Corp||1|||f||||f||||||||||2017-10-10 23:31:20.147945|2017-10-10 23:31:20.147945
NCT02385188|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-06-07|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Topical 5% Imiquimod Cream for Vulvar Paget's Disease|Topical 5% Imiquimod Cream for Vulvar Paget's Disease: Clinical Efficacy, Safety and Immunological Response|Enrolling by invitation||Phase 3|25|Actual|University Medical Center Nijmegen||1|||f||||f||||||||||2017-10-10 23:31:20.210129|2017-10-10 23:31:20.210129
NCT02385175|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-01-23|||February 2016|Actual|2016-02-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|||The Accuracy of Tests of Eustachian Tube Function|The Accuracy of Tests of Eustachian Tube Function|Recruiting||N/A|250|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||5||f||||||||||||||2017-10-10 23:31:20.335816|2017-10-10 23:31:20.335816
NCT02385162|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-07-03|||March 2015||2015-03-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|March 2020|Anticipated|2020-03-01||Observational|BioGlycogen||Biomarker for Glycogen Storage Diseases|Biomarker for Glycogen Storage Diseases - AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|100|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry7,5 ml EDTA     blood, saliva tube and a dry blood spot filter card are taken. To prove the correct diagnosis     in those patients where up to the enrollment in the study no genetic testing has been done,     sequencing will be done. The analyses are done in the Centogene AG,Schillingallee 68, 18055     Rostock (Germany)   "|||2017-10-10 23:31:20.422941|2017-10-10 23:31:20.422941
NCT02385149|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-11-19|||January 2015||2015-01-01|March 2015|2015-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Graandioos||Improving Resilience With Whole Grain Wheat|Improving Resilience With Whole Grain Wheat|Completed||N/A|50|Actual|Wageningen University||2|||f||||f||||||||||2017-10-10 23:31:20.615245|2017-10-10 23:31:20.615245
NCT02385136|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-10|||April 2015||2015-04-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases|Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases: A Randomized Trial|Not yet recruiting||Phase 1/Phase 2|135|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-10 23:31:20.737006|2017-10-10 23:31:20.737006
NCT02385123|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-09-14|||April 1, 2015|Actual|2015-04-01|July 19, 2017|2017-07-19|April 1, 2022|Anticipated|2022-04-01|April 1, 2021|Anticipated|2021-04-01||Interventional|||Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers|Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers|Recruiting||Phase 4|50|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f|||||f|f|||f|||||2017-10-10 23:31:20.833824|2017-10-10 23:31:20.833824
NCT02385110|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-08-10|||September 23, 2015|Actual|2015-09-23|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis|Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-10 23:31:20.949141|2017-10-10 23:31:20.949141
NCT02385097|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-09-21|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Chloroprocaine 2% - Axillary Block|A Prospective, Randomised, Non-inferiority Study of Chloroprocaine 2% and the Active Control Ropivacaine 0.75% (AstraZeneca) in Ultrasound-guided Axillary Nerve Block for Short-duration Distal Upper Limb Surgery|Completed||Phase 3|211|Actual|Sintetica SA||2|||f||||t||||||||||2017-10-10 23:31:21.132361|2017-10-10 23:31:21.132361
NCT02385084|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-06-09|||March 2015||2015-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study of LY2409021 Formulations in Healthy Participants|A Single Dose Pharmacokinetic Study of LY2409021 in Healthy Subjects to Bridge Formulations From Capsules to Commercial Tablets|Completed||Phase 1|72|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-10 23:31:21.266943|2017-10-10 23:31:21.266943
NCT02385071|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-09-04|||April 28, 2015|Actual|2015-04-28|September 2017|2017-09-01|September 9, 2015|Actual|2015-09-09|September 9, 2015|Actual|2015-09-09||Interventional|||A Crossover Study to Evaluate Relative Bioavailability of Simeprevir Age-appropriate Oral Formulation Candidates Compared With 150-milligram (mg) Oral Capsule in Healthy Adult Participants|A Phase 1, Open-label, Randomized, 2-panel, 3-way Crossover Study in Healthy Adult Subjects to Assess the Relative Bioavailability of Simeprevir Following Single Dose Administration of Age-appropriate Oral Formulation Candidates, Compared to the 150-mg Oral Capsule, and to Assess the Effect of Food on the Bioavailability of Simeprevir Following Single Dose Administration of a Selected Age-appropriate Oral Formulation Candidate|Completed||Phase 1|48|Actual|Janssen Sciences Ireland UC||12|||f||||f||f||||||||2017-10-10 23:31:21.366208|2017-10-10 23:31:21.366208
NCT02385058|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-04-13|||October 2005||2005-10-01|April 2015|2015-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population|Double-Blind, Placebo-Controlled, Randomized, Prospective, Two-Stage, Two-Arm Study to Evaluate the Efficaciousness and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population|Completed||Phase 4|100|Actual|Janssen-Cilag Ltd.||2|||f||||f||||||||||2017-10-10 23:31:21.522964|2017-10-10 23:31:21.522964
NCT02385045|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-13|||October 2014||2014-10-01|March 2015|2015-03-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|||i-Scan for the Detection of Helicobacter Pylori|i-Scan for the Detection of Helicobacter Pylori|Unknown status|Recruiting|Phase 2|250|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-10 23:31:21.624665|2017-10-10 23:31:21.624665
NCT02385032|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-05-05|||February 2015||2015-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Comparative Bioavailability Study of UDCA||Completed||Phase 1|50|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-10 23:31:21.72157|2017-10-10 23:31:21.72157
NCT02384980|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-08-15|||September 2014||2014-09-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Saving Life and Limb: FES for the Elderly With PAD|Saving Life and Limb: Functional Electrical Stimulation for the Elderly With Peripheral Artery Disease|Completed||Phase 1|43|Actual|MultiCare Health System Research Institute||2|||f||||t||||||||||2017-10-10 23:31:22.132155|2017-10-10 23:31:22.132155
NCT02384967|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-01-23|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|DARULIGHT||Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients|Phase II Trial Assessing the Efficacy of a Reduced Dose Strategy of Darunavir to 400 mg/d in HIV-1 Infected Patients Virologically Suppressed Under a Once Daily Regimen Including Darunavir 800 mg/d and Two Nucleoside Reverse Transcriptase Inhibitors (NRTI), to Maintain the Viral Load Lower Than 50 Copies / mL at 48 Weeks of Treatment|Completed||Phase 2|100|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-10 23:31:22.221714|2017-10-10 23:31:22.221714
NCT02384954|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-08-25|||March 2015||2015-03-01|August 2017|2017-08-01|June 2023|Anticipated|2023-06-01|March 2018|Anticipated|2018-03-01||Interventional|||QUILT-3.002: ALT-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab|A Phase 1/2 Study of ALT-803 in Patients With Relapse/Refractory Indolent B Cell Non-Hodgkin Lymphoma in Conjunction With Rituximab|Recruiting||Phase 1/Phase 2|86|Anticipated|Altor BioScience||1|||f||||t||||||||||2017-10-10 23:31:22.324951|2017-10-10 23:31:22.324951
NCT02384928|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-03-27|||September 9, 2015|Actual|2015-09-09|March 2017|2017-03-01|March 16, 2017|Actual|2017-03-16|January 31, 2017|Actual|2017-01-31||Interventional|||Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation|Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation: a Three-armed, Randomized, Double-blind Controlled Pilot Study|Completed||N/A|60|Actual|Jaseng Medical Foundation||3|||f||||f||||||||No||2017-10-10 23:31:23.23565|2017-10-10 23:31:23.23565
NCT02384915|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-05-07|||January 2015||2015-01-01|March 2015|2015-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Spinal Anesthesia Versus Combined Sciatic-femoral Nerve Block for Outpatient Knee Arthroscopy|Spinale Unilaterale o Blocco Nervoso Periferico Per le Artroscopie di Ginocchio in Day Surgery. Confronto Prospettico Randomizzato|Completed||Phase 4|100|Actual|ASST Gaetano Pini-CTO||2|||f||||f||||||||||2017-10-10 23:31:23.381848|2017-10-10 23:31:23.381848
NCT02384902|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2015-03-09|||May 2014||2014-05-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients|Effect of Dietary Glycemic Index/Load on Kidney-related Biomarkers and Inflammation in Diabetic Nephropathy Patients|Completed||N/A|90|Actual|Isfahan University of Medical Sciences||3|||f||||f||||||||||2017-10-10 23:31:23.507202|2017-10-10 23:31:23.507202
NCT02384889|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-03-30|||April 2015||2015-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||DFMO in Children With Type 1 Diabetes|Targeting Polyamines Using DFMO in Persons With Type 1 Diabetes: A Randomized, Double-Masked, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, and Initial Pharmacodynamics of Multiple Ascending Doses|Recruiting||Phase 1|42|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 23:31:23.613664|2017-10-10 23:31:23.613664
NCT02384876|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-08-18|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|EPHEDRINE||Determination of the Optimal Dose of Ephedrine in Intraoperative Arterial Hypotension of Newborns and Infants up to 6 Months of Age.|Determination of the Optimal Dose of Ephedrine in Intraoperative Arterial Hypotension of Newborns and Infants up to 6 Months of Age. A Randomized, Controlled, Open-label, Dose Escalation Study.|Recruiting||Phase 2|120|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:31:23.789814|2017-10-10 23:31:23.789814
NCT02384863|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-09|||October 2014||2014-10-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|1 Year|Observational [Patient Registry]|||The Evaluation and Management of Patients With Acute Chest Pain in China|The Evaluation and Management of Patients With Acute Chest Pain in China|Unknown status|Recruiting|N/A|18000|Anticipated|Qilu Hospital of Shandong University|||1||f||||t||||||||||2017-10-10 23:31:23.943865|2017-10-10 23:31:23.943865
NCT02384850|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-03-01|||March 2015||2015-03-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|June 2017|Anticipated|2017-06-01||Interventional|SENTINEL||Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer|An Investigator Initiated Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor (KPT-330), An Oral Selective Inhibitor Of Nuclear Export (SINE), In Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 1|27|Anticipated|GSO Global Clinical Research BV||1|||f||||f||||||||||2017-10-10 23:31:24.103709|2017-10-10 23:31:24.103709
NCT02384837|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2016-12-04|||December 2014||2014-12-01|January 2015|2015-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up|Effect of TCFA on Neointimal Coverage After EXCEL Biodegradable Polymer-coated Sirolimus-eluting Stents Implantation at 9 Months Follow-up: Evaluated by Optical Coherence Tomography and Fractional Flow Reserve|Completed||N/A|33|Actual|General Hospital of Chinese Armed Police Forces|||2||f||||t||||||||||2017-10-10 23:31:24.193949|2017-10-10 23:31:24.193949
NCT02384824|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-03-09|||April 2015||2015-04-01|March 2015|2015-03-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Observational|STEMI-OCT||Delayed Plaque Morphology in Patients With STEMI After Thrombus Aspiration During Primary PCI|Evaluation of Delayed Plaque Morphology by Optical Coherence Tomography (OCT) in Patients With Acute ST Segment Elevated Myocardial Infarction (STEMI) After Thrombus Aspiration During Primary Percutaneous Intervention (PCI)|Unknown status|Not yet recruiting|N/A|100|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University|||1||f||||f||||||||||2017-10-10 23:31:24.280662|2017-10-10 23:31:24.280662
NCT02384811|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-04|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2017|Actual|2017-07-01||Interventional|||Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma|Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal|Active, not recruiting||Phase 2|70|Actual|Fudan University||1|||f||||t||||||||||2017-10-10 23:31:24.400134|2017-10-10 23:31:24.400134
NCT02384798|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-03-04|||January 2014||2014-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|SVNI||Ventilatory Support Associated With Exercise in Heart Failure|Noninvasive Ventilatory Support Associated With Concurrent Training in Improved Functional Capacity and Quality of Life in Patients With Heart Failure|Completed||N/A|60|Actual|Federal University of Bahia||2|||f||||f||||||||||2017-10-10 23:31:24.482136|2017-10-10 23:31:24.482136
NCT02384785|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-04-26|||May 2013||2013-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Effectiveness of of Therapeutic Currents in Clinical Dimension and Penetration Depth Dimension in Lower Back|Effectiveness of Different Types of Therapeutic Currents in Clinical Dimension and Penetration Depth Dimension in Lower Back|Enrolling by invitation||N/A|25|Anticipated|Sheba Medical Center|||1||f||||f||||||||No||2017-10-10 23:31:24.567228|2017-10-10 23:31:24.567228
NCT02384772|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-06-09|||January 2015||2015-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Survey of Patients Taking IOP-Lowering Eye Drops|A Multi-Site Questionnaire-Based Study to Assess Attitudes Regarding Current IOP-Lowering Eye Drops and Products in Development for Sustained Release of Medication in Glaucomatous and Ocular Hypertensive Subjects|Completed||N/A|160|Actual|ForSight Vision5, Inc.|||1||f||||f||||||||||2017-10-10 23:31:24.649058|2017-10-10 23:31:24.649058
NCT02384759|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-08-02|||May 2015||2015-05-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|FOLFA||Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers|Phase II Randomized Trial Evaluting Aflibercept Associated With LV5FU2 Regimen as First Line Treatment of Non-resectalbe Metastatic Colorectal Cancers|Recruiting||Phase 2|118|Anticipated|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||||2017-10-10 23:31:24.724423|2017-10-10 23:31:24.724423
NCT02384746|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-03-25|||March 2015||2015-03-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|Millennium||Phase I Study of the Combination of MLN9708 and Fulvestrant|Phase I Study of the Combination of MLN9708 and Fulvestrant in Patients With Advanced Estrogen Receptor Positive Breast Cancer|Recruiting||Phase 1|18|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-10 23:31:26.833917|2017-10-10 23:31:26.833917
NCT02384733|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-07-31|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|March 2036|Anticipated|2036-03-01|March 2036|Anticipated|2036-03-01||Interventional|||Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost|The Skagen Trial 1, Moderately Hypofractionated Loco-regional Adjuvant Radiation Therapy of Early Breast Cancer Combined With a Simultaneous Integrated Boost: a Randomised Clinically Controlled Trial|Recruiting||N/A|2000|Anticipated|Danish Breast Cancer Cooperative Group||2|||f||||t||||||||||2017-10-10 23:31:26.932456|2017-10-10 23:31:26.932456
NCT02384720|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-10-07||||||October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Observational|||Study of Freefol-MCT PKPD in Healthy Volunteers||Not yet recruiting||Phase 4|60|Anticipated|Daewon Pharmaceutical Co., Ltd.|||3||f||||||||||||||2017-10-10 23:31:27.036895|2017-10-10 23:31:27.036895
NCT02384707|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-03-09|||May 2011||2011-05-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|June 2011|Actual|2011-06-01||Interventional|MANOE||Master Allergen Child Nutrition. Reintroduction of Small Doses|Reintroduction of Small Doses of Food in Allergic Children to Lightening the Elimination Diet.|Unknown status|Recruiting|N/A|400|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-10 23:31:27.11123|2017-10-10 23:31:27.11123
NCT02384694|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-03-04|||May 2014||2014-05-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ZumBeat||Effects of a Zumba Dance Program for Postmenopausal Women With Metabolic Syndrome|ZumBeat: Effekte Eines Rhythmusorientierten Aeroben Tanz-Bewegungsprogrammes für Postmenopausale Frauen Mit Metabolischem Syndrom|Completed||N/A|17|Actual|University of Basel||1|||f||||t||||||||||2017-10-10 23:31:27.207547|2017-10-10 23:31:27.207547
NCT02384681|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-09|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|October 2015|Anticipated|2015-10-01||Observational|EchoSam||Evaluation of Auditory Fatigue in Medical Regulation Assistants|Effects of Auditory Fatigue in Medical Regulation Assistants Working With Headset: Objective Measures|Unknown status|Not yet recruiting|N/A|36|Anticipated|Central Hospital, Nancy, France|||2||f||||t||||||||||2017-10-10 23:31:27.286758|2017-10-10 23:31:27.286758
NCT02384668|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-12-15|||March 2015||2015-03-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|DAGMAR||D-vitamin And Graves' Disease; Morbidity And Relapse Reduction|The DAGMAR Study. D-vitamin And Graves' Disease; Morbidity And Relapse Reduction: A Randomised, Clinical Trial.|Recruiting||N/A|260|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:31:27.382196|2017-10-10 23:31:27.382196
NCT02384655|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-04|||April 2015||2015-04-01|March 2015|2015-03-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Fenugreek Use in Mothers of Preterm on Breast Milk Production and Macronutrient Content|Effect of Fenugreek Use in Mothers of Preterm on Breast Milk Production and Macronutrient Content|Unknown status|Not yet recruiting|Phase 1/Phase 2|30|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-10 23:31:27.613362|2017-10-10 23:31:27.613362
NCT02384642|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-12-06|||June 2015||2015-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|COMPASS||Creating Opportunities Through Mentoring, Parenting and Safe Spaces - Democratic Republic of Congo|Creating Opportunities Through Mentoring, Parenting and Safe Spaces - a Randomized Controlled Trial in Democratic Republic of Congo|Completed||N/A|1633|Actual|Columbia University||2|||f||||f||||||||Undecided||2017-10-10 23:31:27.72088|2017-10-10 23:31:27.72088
NCT02384629|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-07-26|||March 2015||2015-03-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||PCI With AXXESS Biolimus A9 Eluting Bifurcation Stent in Treating Coronary Artery Bifurcation Disease|PCI With AXXESS Biolimus A9 Eluting Bifurcation Stent in Treating Coronary Artery Bifurcation Disease|Withdrawn||Phase 4|0|Actual|Yonsei University||4||Problem with medical device provider|f||||t||||||||||2017-10-10 23:31:27.809883|2017-10-10 23:31:27.809883
NCT02384616|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-10-30|||May 2015||2015-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|OXPED||Hyperoxygenation in Anesthetized Children|Impact of Intraoperative High Inspired OXygen Fraction on Pulmonary Function, Surgical Site Infection, Postoperative Nausea and Vomiting in PEDiatric Anesthesia, the OXPED Study|Recruiting||N/A|60|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-10 23:31:27.886791|2017-10-10 23:31:27.886791
NCT02384603|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-08-30|||February 2015||2015-02-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of Physical Therapy in Pain and Posture of Fibromyalgia Patients|Effects of Two Physiotherapeutic Treatments in Pain and Posture of Fibromyalgia Patients: Randomized Controlled Trial|Recruiting||N/A|46|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:31:27.993827|2017-10-10 23:31:27.993827
NCT02384590|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-01-23|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|January 17, 2017|Actual|2017-01-17|January 2017|Actual|2017-01-01||Interventional|CaRISMA||Cognitive Behavioral Therapy and Real-time Self-management Intervention for SCD Via Mobile Applications|Feasibility of Implementing Mental Health Treatment in Routine Adult Sickle Cell Disease Care Using Online Cognitive Behavioral Therapy and a Mobile Technology-Based Intervention|Completed||N/A|30|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:31:28.108803|2017-10-10 23:31:28.108803
NCT02384577|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-11-03|||July 2014||2014-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Observational|||Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment|Multicenter, Open-label, Non-interventional Study (NIS) to Evaluate Patient's Satisfaction and Preference, the Usability of DuoResp® SPIROMAX® and the Impact on Clinical Effects, in the Daily Routine of Asthma and COPD Treatment|Completed||N/A|4034|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-10-10 23:31:28.18436|2017-10-10 23:31:28.18436
NCT02384564|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-07-27|||August 2015||2015-08-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||King Vision Video Laryngoscope aBlade vs. Direct Laryngoscopy in Children|A Randomized Comparison of the King Vision Video Laryngoscope aBlade vs. Direct Laryngoscopy in Children|Unknown status|Not yet recruiting|N/A|140|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-10 23:31:28.262869|2017-10-10 23:31:28.262869
NCT02384551|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-13|||January 25, 2016|Actual|2016-01-25|July 2017|2017-07-01|December 31, 2020|Anticipated|2020-12-31|January 31, 2020|Anticipated|2020-01-31||Interventional|DietGERD||Dietary Carbohydrate and GERD in Veterans|Dietary Carbohydrate Effects on GERD in Obese Veterans: Nutritional or Hormonal?|Recruiting||Early Phase 1|200|Anticipated|VA Office of Research and Development||4|||f||||t|f|f|||f|||||2017-10-10 23:31:28.353985|2017-10-10 23:31:28.353985
NCT02384538|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-07-13|2017-06-12||March 2015|Actual|2015-03-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional||Modified intent-to-treat (mITT) population: all randomized participants who received at least 1 dose of study drug.|A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis|A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-981 to Placebo in Subjects With Erosive Hand Osteoarthritis|Completed||Phase 2|132|Actual|AbbVie||2|||f||||t||||||||||2017-10-10 23:31:28.482591|2017-10-10 23:31:28.482591
NCT02384525|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-07-07|||January 1, 2017|Actual|2017-01-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Assessment of Volume Status by BIA and Lung Ultrasound in Septic AKI Patients Undergoing CRRT||Recruiting||N/A|218|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:31:29.105316|2017-10-10 23:31:29.105316
NCT02384512|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-04-09|||January 2014||2014-01-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|AIWO||Azilect® In Wearing-Off (AIWO)|Azilect® In Wearing-Off (AIWO) Non-interventional Study on Efficacy and Tolerability of Rasagiline (1mg/d) add-on in Ambulatory Parkinson's Disease Patients With Wearing-off Symptoms Diagnosed by Wearing-off Questionnaire (WOQ-32)|Completed||N/A|261|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-10-10 23:31:29.227045|2017-10-10 23:31:29.227045
NCT02384499|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-04|||December 2014||2014-12-01|February 2015|2015-02-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study|Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study|Unknown status|Recruiting|Phase 1|21|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-10 23:31:29.676203|2017-10-10 23:31:29.676203
NCT02384486|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-05-16|||April 2015||2015-04-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Training Programme to Reduce Stress|Evaluating the Efficacy of a Proposed Training Programme to Reduce Stress in Mothers of Children With Autism Spectrum Disorder (ASD) in Saudi Arabia: A Pilot Study|Completed||N/A|67|Actual|University of Nottingham||2|||f||||t||||||||No||2017-10-10 23:31:29.778958|2017-10-10 23:31:29.778958
NCT02384473|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-04-18|||December 24, 2014|Actual|2014-12-24|April 2017|2017-04-01|December 24, 2019|Anticipated|2019-12-24|December 24, 2017|Anticipated|2017-12-24||Interventional|||Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma|Real-Time Contrast Enhanced Ultrasound and Ultrasound-Based Elastography: Novel Quantitative Imaging Techniques for Early Therapy Response Assessment in Sarcomas|Recruiting||Early Phase 1|20|Anticipated|University of Southern California||1|||f||||t|t|t|f|||||||2017-10-10 23:31:29.857443|2017-10-10 23:31:29.857443
NCT02384460|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-08-03|||March 2015||2015-03-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||ESSENCE Study: Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa|A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa|Completed||Phase 3|150|Anticipated|Scioderm, Inc.||2|||f||||f||||||||||2017-10-10 23:31:29.978459|2017-10-10 23:31:29.978459
NCT02383888|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-06|2015-08-12|||May 2015||2015-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 425809 in Healthy Japanese and Chinese Male Subjects (Randomized, Double-blind, Placebo-controlled Design Within Dose Groups)|Completed||Phase 1|49|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:31:35.245944|2017-10-10 23:31:35.245944
NCT02384447|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-03-04|||June 2014||2014-06-01|August 2014|2014-08-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Observational|||Comparing the Ultrasound Appearance of the Sciatic Nerve With Its Appearance Under a Microscope|Correlation of the Ultrasound Appearance of the Sciatic Nerve With Its Histologic Appearance in Pathology Specimens Obtained From Patients Undergoing Above Knee Amputation|Withdrawn||N/A|0|Actual|University of Toledo Health Science Campus|||1||f||||f||||||Samples Without DNA|"     Amputated extremity for histologic examination of the sciatic nerve.   "|||2017-10-10 23:31:30.2458|2017-10-10 23:31:30.2458
NCT02384434|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-04-24|||April 2015||2015-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma|Utilization of Low Level Laser Therapy for Radiation Induced Dermatitis in Patients With Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|37|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:31:30.339724|2017-10-10 23:31:30.339724
NCT02384421|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-10-12|||January 2015||2015-01-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|aDBS||Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's Disease|Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's Disease|Enrolling by invitation||N/A|20|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 23:31:30.469998|2017-10-10 23:31:30.469998
NCT02384408|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-10-11|||November 2014||2014-11-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Hormone Replacement Therapy on the Postmenopausal Endometrium|Comparative Effects of Drospirenone and Tibolone on the Postmenopausal Endometrium|Completed||Phase 4|100|Actual|Universidade do Vale do Sapucai||2|||f||||t||||||||||2017-10-10 23:31:30.589567|2017-10-10 23:31:30.589567
NCT02384395|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-05-15|||September 2015||2015-09-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|PHI 05||Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection|IGHID 11417 - The Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection: Impact on the Latent HIV Reservoir and Long-Term Immunologic Effect|Recruiting||N/A|40|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||No||2017-10-10 23:31:30.743364|2017-10-10 23:31:30.743364
NCT02384369|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-04-14|||June 2016||2016-06-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|PTSD||Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder|Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Efficacy, Safety, and Pharmacokinetics of Orally Administered SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder Concomitantly Treated With Prazosin|Withdrawn||Phase 2|0|Actual|Synchroneuron Inc.||2||Insufficient|f||||f||||||||||2017-10-10 23:31:31.078323|2017-10-10 23:31:31.078323
NCT02384356|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-05-31|||June 2014||2014-06-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||A Longitudinal Survey of Health in Bolivia|A Longitudinal Survey of Health in Bolivia|Enrolling by invitation||N/A|2000|Anticipated|University of Michigan|||1||f||||f||||||||No||2017-10-10 23:31:31.166264|2017-10-10 23:31:31.166264
NCT02384343|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-04-23|||April 2015||2015-04-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Intravenous Dexmedetomidine for Treatment of Shivering During Cesarean Section Under Neuraxial Anesthesia|Intravenous Dexmedetomidine for Treatment of Shivering During Cesarean Section Under Neuraxial Anesthesia: A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 3|80|Anticipated|St. Justine's Hospital||2|||f||||f||||||||||2017-10-10 23:31:31.243392|2017-10-10 23:31:31.243392
NCT02384330|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-13|||November 2014||2014-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|P_Dysport_CS||Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke|Cost Determination Study For Different Botulinum Toxin A Preparations In The Treatment Of Upper Limb Spasticity Post-Stroke In Portugal|Active, not recruiting||N/A|57|Actual|Ipsen|||3||f||||f||||||||||2017-10-10 23:31:31.338648|2017-10-10 23:31:31.338648
NCT02384317|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-12-19|||February 2015||2015-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With Immunoglobulin A Nephropathy on Stable RAAS Blockade|An Open-Label Phase 2 Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With Immunoglobulin A Nephropathy on Stable RAAS Blockade|Completed||Phase 2|5|Actual|ChemoCentryx||1|||f||||f||||||||||2017-10-10 23:31:31.415789|2017-10-10 23:31:31.415789
NCT02384304|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-08-31|||December 2012||2012-12-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Guided and Unguided Internet Treatment for Problematic Alcohol Use|Guided and Unguided Internet Treatment for Problematic Alcohol Use: A Randomized Pilot Study|Completed||N/A|80|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-10 23:31:31.500199|2017-10-10 23:31:31.500199
NCT02384291|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-01-24|||May 2014||2014-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sinus Floor Elevation Using Alpha-Bio's GRAFT Natural Bovine Bone vs. Commercially Available Bone Graft|Sinus Floor Elevation Using Alpha-Bio's GRAFT Natural Bovine Bone Versus Commercially Available Bone Graft. A Prospective Randomized Clinical Trial|Active, not recruiting||N/A|44|Actual|Alpha - Bio Tec Ltd.||2|||f||||t||||||||||2017-10-10 23:31:31.585534|2017-10-10 23:31:31.585534
NCT02384278|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-04-26|||March 2015||2015-03-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|November 2015|Actual|2015-11-01||Interventional|ICBT-AP||Internet Based Cognitive Behavior Treatment for Alcohol Problems|Internet Based Cognitive Behavior Treatment for Alcohol Problems: A Pilot Study|Enrolling by invitation||N/A|40|Anticipated|Karolinska Institutet||1|||f||||f||||||||Undecided||2017-10-10 23:31:31.650143|2017-10-10 23:31:31.650143
NCT02384265|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-05-01|||December 2015||2015-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|FRIENDS-Text||Financial Incentives and Text Messaging to Improve African American Womens' Glycemic Control|Financial Incentives and SMS to Improve African American Womens' Glycemic Control: Friends & Relatives Improving the Effectiveness of Networks for Diabetes Support Through Text Messaging (FRIENDS Text)|Recruiting||N/A|124|Anticipated|University of California, Los Angeles||2|||f||||f||||||||Undecided||2017-10-10 23:31:31.737517|2017-10-10 23:31:31.737517
NCT02384252|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-05-17|||June 3, 2013|Actual|2013-06-03|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Characterization of Obesity-related Cardiomyopathy Through Exploration of Human Atrial Trabeculae Contraction|Characterization of Obesity-related Cardiomyopathy Through Exploration of Human Atrial Trabeculae Contraction|Recruiting||N/A|144|Anticipated|University Hospital, Lille|||2||f||||f||||||Samples Without DNA|"     Right atrial tissue obtained during cannulation of the right atrium in preparation for     cardiac surgery with extracorporeal circulation.   "|||2017-10-10 23:31:31.87241|2017-10-10 23:31:31.87241
NCT02384239|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-12-28|||October 2015||2015-10-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer|Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Hormone Receptor Positive Metastatic Breast Cancer Previously Exposed to Inhibitors of the PI3K Pathway: A Phase II Study With Pharmacodynamics Markers|Recruiting||Phase 2|70|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:31:32.058875|2017-10-10 23:31:32.058875
NCT02384226|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-06-28|||September 2015||2015-09-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study|User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study|Active, not recruiting||N/A|200|Anticipated|University of Colorado, Denver|||1||f||||f||||||||No||2017-10-10 23:31:32.221705|2017-10-10 23:31:32.221705
NCT02384213|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-04|||March 2015||2015-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|iHF||Incidence of and Prognostic Factors Associated With Heart Failure Following Myocardial Infarction: a CALIBER Study|Incidence of and Prognostic Factors Associated With Heart Failure Following Myocardial Infarction (iHF): a CALIBER Study|Unknown status|Active, not recruiting|N/A|55000|Anticipated|University College, London|||1||f||||t||||||||||2017-10-10 23:31:32.29071|2017-10-10 23:31:32.29071
NCT02384200|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-05-31|||March 2015||2015-03-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])|The EDGE Consortium: A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Percutaneous Nephrolithotomy: Part 1|Recruiting||Phase 4|80|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-10 23:31:32.37288|2017-10-10 23:31:32.37288
NCT02384187|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-12-22|||January 2015||2015-01-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Gabapentin Premedication and Adenotonsillectomy in Pediatric Patients|The Effects of Oral Gabapentin Premedication on Postoperative Nausea and Vomiting and Early Postoperative Recovery Profile in Pediatric Patients Undergoing Adenotonsillectomy|Completed||Phase 3|140|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:31:32.538975|2017-10-10 23:31:32.538975
NCT02384174|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-11-25|||May 2015||2015-05-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||Resistant Starch and Non-starch Polysaccharide (Dietary Fibre) Intake and the Colonic Microbiome in Older People|Resistant Starch and Non-starch Polysaccharide (Dietary Fibre) Intake in Relation to the Structure and Metabolic Activities of the Colonic Microbiome in Older People|Withdrawn||N/A|0|Actual|University of Dundee||2|||f||||t||||||||||2017-10-10 23:31:32.637052|2017-10-10 23:31:32.637052
NCT02384161|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-12-07|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Exercise Intermittent Isometric Handgrip and Blood Flow Restriction|Exercise Intermittent Isometric Handgrip Associated With Different Levels of External Vascular Compression: Acute Effects on Neuromuscular Response|Completed||N/A|18|Actual|Universidade Federal de Pernambuco||3|||f||||f||||||||||2017-10-10 23:31:32.734465|2017-10-10 23:31:32.734465
NCT02384148|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-12-01|||June 2011||2011-06-01|December 2015|2015-12-01||||December 2017|Anticipated|2017-12-01||Observational|||Study of Circadian Clock Properties in Healthy Subjects, Obese and Type 2 Diabetic Patients.|Measure and Comparison of Molecular Circadian Clock Properties in Healthy Subjects, Obese and Type 2 Diabetic Patients.|Active, not recruiting||N/A|300|Anticipated|University Hospital, Geneva|||4||f||||||||||||||2017-10-10 23:31:32.844384|2017-10-10 23:31:32.844384
NCT02384135|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-10|||March 2015||2015-03-01|March 2015|2015-03-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|ADJUST-DVT||Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study|Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study|Not yet recruiting||N/A|3300|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-10-10 23:31:32.924093|2017-10-10 23:31:32.924093
NCT02384122|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-10-17|||September 2015||2015-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|OCEAN||Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Angiodysplasias|A Multicenter, Randomized, Open-label Clinical Trial Assessing the Efficacy of Octreotide in Decreasing Blood and Iron Requirements in Patients With Refractory Anaemia Due to Angiodysplasias|Recruiting||Phase 2/Phase 3|62|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-10 23:31:33.019997|2017-10-10 23:31:33.019997
NCT02384109|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-11-01|||June 2015||2015-06-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Pharmacist-Coordinated Implementation of the Diabetes Prevention Program|A Pharmacist-Coordinated Implementation of the Diabetes Prevention Program|Recruiting||N/A|700|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 23:31:33.176438|2017-10-10 23:31:33.176438
NCT02384083|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-12-08|||September 2015||2015-09-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients|Phase I/II, Multicenter, Open Label, Clinical Trial of Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients|Recruiting||Phase 1/Phase 2|56|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-10 23:31:33.468833|2017-10-10 23:31:33.468833
NCT02384070|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-12-10|2016-04-10||January 2009||2009-01-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|SMART-FFR||Simplified Anti-Thrombotic Therapy for FFR|Evaluation of Simplified Anti-Thrombotic Therapy for Coronary Fractional Flow Reserve|Completed||N/A|300|Actual|Odessa Heart Institute||3|||f||||t||||||||||2017-10-10 23:31:33.62384|2017-10-10 23:31:33.62384
NCT02384057|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-10-23|||December 2014||2014-12-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Cognitive Rehabilitation With C8 Sciences|Cognitive Rehabilitation for Participants With Stroke or Brain Injury Using C8 Sciences|Recruiting||N/A|64|Anticipated|National Rehabilitation Center, Seoul, Korea||2|||f||||t||||||||||2017-10-10 23:31:33.959293|2017-10-10 23:31:33.959293
NCT02384044|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-30|||February 2015||2015-02-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Pilot Clinical Study to Evaluate the Safety and Efficacy of Marketed Oxalate Strips Compared to a Marketed Safety Pen||Completed||N/A|30|Actual|Procter and Gamble||2|||f||||||||||||||2017-10-10 23:31:34.066291|2017-10-10 23:31:34.066291
NCT02384031|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-05-20|||February 2012||2012-02-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|||Post-dural Puncture Headache - Needles and Biomarkers in CSF|Quincke vs. Sprotte and Post-dural Puncture Headache - a Randomised Controlled Trial|Recruiting||N/A|300|Anticipated|Nordlandssykehuset HF||2|||f||||f||||||||||2017-10-10 23:31:34.14124|2017-10-10 23:31:34.14124
NCT02384018|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-03-23|||December 2014||2014-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Mesenchymal Stem Cell and Islet Co-transplantation|A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow-derived Mesenchymal Stromal Cells in Chronic Pancreatitis Patients Who Undergo Total Pancreatectomy and Islet Autotransplantation.|Recruiting||Phase 1|24|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:31:34.246862|2017-10-10 23:31:34.246862
NCT02384005|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-05-10|||February 2015||2015-02-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Feasibility of Self or Partner-assisted Digital Anal Exam Screening|The Feasibility of Self or Partner-assisted Digital Anal Exam Screening|Completed||N/A|201|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 23:31:34.340479|2017-10-10 23:31:34.340479
NCT02383992|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-12-05|||October 2015||2015-10-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Postoperative Care of Sutured Wounds|Comparing the Efficacy of Hydrogen Peroxide Versus Normal Saline in Postoperative Care of Sutured Wounds|Enrolling by invitation||N/A|120|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 23:31:34.417211|2017-10-10 23:31:34.417211
NCT02383979|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-08-18|||August 2010||2010-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Perioperative Mirror Therapy and Phantom Limb Pain|Perioperative Visual Therapy May Help Prevent Phantom Limb Pain|Recruiting||Phase 4|115|Anticipated|United States Naval Medical Center, San Diego||3|||f||||t||||||||||2017-10-10 23:31:34.491145|2017-10-10 23:31:34.491145
NCT02383966|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-10-04|||July 31, 2015|Actual|2015-07-31|October 2017|2017-10-01|November 30, 2018|Anticipated|2018-11-30|January 19, 2018|Anticipated|2018-01-19||Interventional|CHANGE2||Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Subjects With Head and Neck Cancer|A Multicenter, Randomized, Open-label, Phase III Trial to Assess Efficacy and Safety of Cetuximab When Given in Combination With Cisplatin Plus 5 Fluorouracil Versus Cisplatin Plus 5-fluorouracil Alone for the First-line Treatment of Chinese Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 3|240|Anticipated|Merck KGaA||2|||f||||t||||||||||2017-10-10 23:31:34.595851|2017-10-10 23:31:34.595851
NCT02383953|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-06-16|||May 2015||2015-05-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins|Non Genetic Factors in the Pathogenesis of Inflammatory Bowel Disease in Twins|Recruiting||N/A|200|Anticipated|St Stephens Aids Trust|||1||f||||f||||||Samples With DNA|"     Blood (plasma), stool, urine   "|||2017-10-10 23:31:34.682363|2017-10-10 23:31:34.682363
NCT02383940|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-08-23||2017-08-23|March 2015||2015-03-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX4211 in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C|Completed||Phase 2|87|Actual|Lexicon Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:31:34.765427|2017-10-10 23:31:34.765427
NCT02383914|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-04|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Clinical Study on Diagnostics and Outcome of Ruptures of the Subscapularis After Arthroscopic Refixation|Prospective Multicenter Trial on Diagnostics and Outcome of Ruptures of the Subscapularis After Arthroscopic Refixation|Active, not recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||||||||||||2017-10-10 23:31:34.987771|2017-10-10 23:31:34.987771
NCT02383901|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-09-02|||September 2014||2014-09-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|September 2015|Actual|2015-09-01||Observational|FORTO||A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX|A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX|Completed||N/A|116|Actual|Isofol Medical AB|||1||f||||f||||||||Yes|Publication in relevant forum planned after finalization of study report|2017-10-10 23:31:35.092725|2017-10-10 23:31:35.092725
NCT02383875|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-03|||September 2012||2012-09-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|Opticourses||An Interventional Study to Reduce Social Disparities in Diet Quality in the Northern Districts of Marseille|An Interventional Study to Reduce Social Disparities in Diet Quality in the Northern Districts of Marseille (Opticourses)|Completed||N/A|189|Actual|Institut National de la Recherche Agronomique||1|||f||||f||||||||||2017-10-10 23:31:35.335173|2017-10-10 23:31:35.335173
NCT02383862|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-04-03|2017-02-03||March 2015||2015-03-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional||Patients with 1 or more SPADE symptoms who completed enrollment (e.g., consent, authorization, baseline questionnaire, randomization)|PROMIS Measures in Primary Care Practice|Incorporating PROMIS Symptom Measures Into Primary Care Practice|Completed||N/A|300|Actual|Indiana University|A convenience sample was obtained from urban primary care clinics. Further studies in different primary care populations are needed.|2|||f||||t||||||||||2017-10-10 23:31:35.42373|2017-10-10 23:31:35.42373
NCT02383849|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-02-24|||July 2015||2015-07-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants|IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants|Enrolling by invitation||N/A|158|Anticipated|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|||6||f||||t||||||Samples With DNA|"     Cell pellets from PK sampling once will be combined and stored for a DNA extraction,     amplification, and gel electrophoresis. The genotype analysis will be completed one time per     study participant. All subjects receiving INH will be genotyped for NAT2. All subjects     receiving NVP will be genotyped for CYP 2B6. These genotypes will be used as covariates in     the population PK analyses of NVP and INH to determine their impact on CL/F (clearance     [apparent]).   "|||2017-10-10 23:31:36.154267|2017-10-10 23:31:36.154267
NCT02383836|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-03-03|||March 2015||2015-03-01|March 2015|2015-03-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01||Observational|||Influence of Position on Detection of Patent Foramen Ovale by Simultaneous Transesophageal Echo and Transcranial Doppler|Influence of Position on Detection of Patent Foramen Ovale by Simultaneous Transesophageal Echo and Transcranial Doppler|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-10 23:31:36.230552|2017-10-10 23:31:36.230552
NCT02383823|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-02-22|||August 2017|Anticipated|2017-08-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects|Postprandial Lipidemia and Glucose Metabolism After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects|Not yet recruiting||N/A|64|Anticipated|Herning Hospital||5|||f||||f|f|f||||||No||2017-10-10 23:31:36.303187|2017-10-10 23:31:36.303187
NCT02383810|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-04-01||2016-03-03|February 2015||2015-02-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)|Randomized, Double-blind, Parallel Group, Placebo-controlled, Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Different Doses of s.c. Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)|Completed||Phase 2|498|Actual|Helsinn Healthcare SA||8|||f||||f||||||||||2017-10-10 23:31:36.405798|2017-10-10 23:31:36.405798
NCT02383797|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-03-01|||February 2015||2015-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox|Immunodeficiency in Cartilage-hair Hypoplasia: Correlation With Pulmonary Disease, Infections and Malignancy|Enrolling by invitation||Phase 4|5|Anticipated|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-10 23:31:36.618403|2017-10-10 23:31:36.618403
NCT02383784|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-03|||March 2007||2007-03-01|March 2015|2015-03-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|||Effects of Low- or High-glycemic Index Diets on Metabolic and Inflammatory Responses in Diabetics|Effects of Low- or High-glycemic Index Diets in Metabolic and Inflammatory Responses in Type 2 Diabetics|Completed||N/A|18|Actual|Federal University of Vicosa||2|||f||||t||||||||||2017-10-10 23:31:36.685035|2017-10-10 23:31:36.685035
NCT02383771|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-08-14|||March 2015||2015-03-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|REVERSAL||Reversal of the Anti-platelet Effects of Ticagrelor|Reversal of the Anti-platelet Effects of Ticagrelor in Healthy Persons and Patients With Coronary Artery Disease|Completed||Phase 4|64|Actual|The First Affiliated Hospital with Nanjing Medical University||4|||f||||f||||||||||2017-10-10 23:31:36.75623|2017-10-10 23:31:36.75623
NCT02383758|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-04-12|||February 1, 2015|Actual|2015-02-01|April 2017|2017-04-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders|An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders|Completed||N/A|22|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:31:36.866763|2017-10-10 23:31:36.866763
NCT02383745|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-10-14|||December 2014||2014-12-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||EEG in In-hospital Patients With Seizure or Altered Mental State|Integrating EEG Into Acute Medicine: EEG in In-hospital Patients With Seizure or Altered Mental State Who Have Been Consulted by Medical Emergency Team|Unknown status|Recruiting|N/A|50|Anticipated|Kuopio University Hospital|||1||f||||||||||||||2017-10-10 23:31:36.964269|2017-10-10 23:31:36.964269
NCT02383732|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-03-28|||February 2015||2015-02-01|March 2017|2017-03-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||A Study of the Elopement Prevention and Safety Training Program|A Feasibility Study of the Elopement Prevention and Safety Training Program|Completed||N/A|24|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:31:37.038591|2017-10-10 23:31:37.038591
NCT02383719|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-04-11|2016-01-13||March 2015||2015-03-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|mask||A Feasibility Study Evaluating the Use of a Non-invasive Ventilation Mask|Oro-nasal Mask Patient Comfort Evaluation|Completed||N/A|18|Actual|Convergent Engineering, Inc.||1|||f||||||||||||||2017-10-10 23:31:37.122909|2017-10-10 23:31:37.122909
NCT02383706|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-08-28|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|May 2017|Actual|2017-05-01||Observational|OSAinPreg||Obstructive Sleep Apnea in Pregnancy|Obstructive Sleep Apnea in Pregnancy: Development of a Pregnancy-Specific Screening Tool|Active, not recruiting||N/A|150|Anticipated|Duke University|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:31:37.265444|2017-10-10 23:31:37.265444
NCT02383693|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-03|||January 2007||2007-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|TMS/DEP||Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled Study|Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled Study|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Centre hospitalier de Ville-Evrard, France||2|||f||||f||||||||||2017-10-10 23:31:37.355669|2017-10-10 23:31:37.355669
NCT02383680|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-03|||December 2014||2014-12-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Observational|MTX_YF||Yellow Fever Vaccination Under Low Dose Methotrexate Therapy|Yellow Fever Vaccination Under Low Dose Methotrexate Therapy - a Multi-Center Prospective Observational Controlled Pilot Study|Unknown status|Recruiting|N/A|30|Anticipated|University of Zurich|||2||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:31:37.458489|2017-10-10 23:31:37.458489
NCT02383667|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-03|||February 1999||1999-02-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Observational|Orbital||Clinical Comparison of Electrocardiograms Collected Using an Ambulatory Holter||Unknown status|Recruiting|N/A|20|Anticipated|University of Toledo Health Science Campus|||1||f||||f||||||||||2017-10-10 23:31:37.567608|2017-10-10 23:31:37.567608
NCT02383654|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-01-29|||January 2015||2015-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis|An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis With Brain Transplants of Autologous Adipose-Tissue Derived Stem Cells (ADSCs)|Completed||Phase 1|1|Actual|China Medical University Hospital||1|||f||||t||||||||||2017-10-10 23:31:37.639236|2017-10-10 23:31:37.639236
NCT02383641|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-07-03|||March 2015||2015-03-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|BioWolman||Biomarker for Wolman Disease|Biomarker for Wolman Disease - AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|100|Anticipated|University of Rostock|||1||f||||t|f|f||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry 7,5 ml EDTA     blood, saliva tube and a dry blood spot filter card are taken. To prove the correct diagnosis     in those patients where up to the enrollment in the study no genetic testing has been done,     sequencing will be done. The analyses are done in the Centogene AG, Schillingallee 68, 18055     Rostock (Germany)   "|||2017-10-10 23:31:37.721931|2017-10-10 23:31:37.721931
NCT02383628|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-06-05|||October 2015||2015-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ICG||Endoscopic Perfusion Utilizing ICG Fluorescence Technology|Endoscopic Perfusion Utilizing ICG Fluorescence Technology|Recruiting||N/A|200|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:31:37.81037|2017-10-10 23:31:37.81037
NCT02383615|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-02|||April 2013||2013-04-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparison of Two Different Ultrasound Guided Techniques for Saphenous Nerve Block|A Comparison of Two Different Ultrasound-Guided Approaches to the Saphenous Nerve Block - Adductor Canal vs. Distal Trans-sartorial: A Prospective, Randomized, Blinded, Non-Inferiority Trial|Completed||N/A|120|Actual|University of Iowa||2|||f||||f||||||||||2017-10-10 23:31:37.877867|2017-10-10 23:31:37.877867
NCT02383602|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-05-08|||August 2014||2014-08-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|August 2018|Anticipated|2018-08-01|18 Months|Observational [Patient Registry]|||Study to Evaluate the Feasibility of Community-based Test and Treat Strategies Among Men Who Have Sex With Men and Transgender Women to Increase the Uptake of HIV Testing and Treatment Services in Thailand|Thai Red Cross AIDS Research Centre (TRC-ARC)|Enrolling by invitation||N/A|6000|Anticipated|Thai Red Cross AIDS Research Centre|||1||f||||t||||||||||2017-10-10 23:31:37.942516|2017-10-10 23:31:37.942516
NCT02383589|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-10-02|||May 26, 2015|Actual|2015-05-26|October 2017|2017-10-01|September 7, 2019|Anticipated|2019-09-07|September 30, 2018|Anticipated|2018-09-30||Interventional|||A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)|A Randomized, Double-Blind, Double-Dummy, Active-Comparator, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab Versus MMF in Patients With Pemphigus Vulgaris|Recruiting||Phase 3|124|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:31:38.010581|2017-10-10 23:31:38.010581
NCT02383563|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-03-03|||February 2015||2015-02-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Metformin for HIV Inflammation|Open-Label, Randomized, 24-Week Pilot Study of Metformin vs Observation for Persistent Immune Activation in Chronic HIV Infection|Unknown status|Recruiting|Phase 2|12|Anticipated|University of Hawaii||2|||f||||f||||||||||2017-10-10 23:31:38.349605|2017-10-10 23:31:38.349605
NCT02383550|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-07-26|||December 2014||2014-12-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Observational|CogMS-Ext||Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension|Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension|Active, not recruiting||N/A|47|Anticipated|Clinique Neuro-Outaouais|||1||f||||f||||||||||2017-10-10 23:31:38.549187|2017-10-10 23:31:38.549187
NCT02383537|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-09-01|||April 2017||2017-04-01|March 2015|2015-03-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Observational|||Biological Changes in the Adipose Tissue Among Pregnant Women With Diabetes|Biological Changes in the Adipose Tissue (RNA Profile) Among Pregnant Women With Diabetes|Not yet recruiting||N/A|150|Anticipated|Hadassah Medical Organization|||2||f||||f||||||||||2017-10-10 23:31:38.632466|2017-10-10 23:31:38.632466
NCT02382757|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-03|||September 2011||2011-09-01|February 2015|2015-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|CDiC||Changing Diabetes in Children|Changing Diabetes in Children (CDiC): Type 1 Diabetes in Economically Underprivileged Children in India|Terminated||N/A|3089|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 23:31:47.618676|2017-10-10 23:31:47.618676
NCT02383524|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-10|||February 2015||2015-02-01|March 2015|2015-03-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Observational|||Genetic Predictors of Responsiveness to Radiofrequency Denervation in Chronic Low Back Pain|Does the Brain-derived Neurotrophic Factor Val66Met Gene Polymorphism Predict Inter-individual Variation in Responsiveness Following Lumbar Radiofrequency Denervation? A Single-centre, Prospective, Exploratory Study in Subjects Diagnosed With Zygapophysial Joint Pain|Unknown status|Recruiting|N/A|70|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:31:38.713825|2017-10-10 23:31:38.713825
NCT02383511|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-08-25|||February 2015||2015-02-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet|A Phase 1b Placebo-controlled, Multi-centre, Randomized, Double-blind Dose Escalation Study to Evaluate the Pharmacokinetics (PK) and Safety of SMT C1100 in Patients With Duchenne Muscular Dystrophy (DMD) Who Follow a Balanced Diet|Completed||Phase 1|12|Actual|Summit Therapeutics||3|||f||||t||||||||||2017-10-10 23:31:38.804752|2017-10-10 23:31:38.804752
NCT02383498|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-18|||April 15, 2015||2015-04-15|July 10, 2017|2017-07-10|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||The National Cancer Institute Opens A Randomized, Double-Blind, Phase 2 Trial of GI-6301 (Yeast-Brachyury Vaccine) Versus Placebo in Combination With Standard of Care Definitive Radiotherapy in Locally Advanced, Unresectable, Chordoma|A Randomized, Double-Blind, Phase 2 Trial of GI-6301 (Yeast-Brachyury Vaccine) Versus Placebo in Combination With Standard of Care Definitive Radiotherapy in Locally Advanced, Unresectable, Chordoma|Recruiting||Phase 2|55|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:31:38.910281|2017-10-10 23:31:38.910281
NCT02383485|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-04|||May 2008||2008-05-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Interventional|SMART||Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children|Exercise and Overweight Children's Cognition (Supplement)|Completed||N/A|175|Actual|Augusta University||2|||f||||f||||||||||2017-10-10 23:31:39.024132|2017-10-10 23:31:39.024132
NCT02383472|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-09-22|||September 2012||2012-09-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||LED Therapy for the Treatment of Concussive Brain Injury|Transcranial LED Therapy for the Treatment of Chronic Mild Traumatic Brain Injury|Completed||N/A|48|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-10 23:31:39.143632|2017-10-10 23:31:39.143632
NCT02383459|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2015-03-06|||January 2005||2005-01-01|March 2015|2015-03-01|July 2011|Actual|2011-07-01|June 2009|Actual|2009-06-01||Observational|||Observatory of Food Preferences in Infants and Children|Longitudinal Study of Food Liking in Eatrly Childhood|Completed||N/A|319|Actual|Centre des Sciences du Goût et de l'Alimentation|||1||f||||f||||||Samples Without DNA|"     Saliva   "|||2017-10-10 23:31:39.290102|2017-10-10 23:31:39.290102
NCT02383446|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-01-21|||February 2015||2015-02-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficiency of Hydraulic Microprocessor Prosthetic Foot for Traumatic Transtibial Amputees|Evaluation of the Efficiency of Hydraulic Microprocessor Prosthetic Foot for Traumatic Transtibial Amputees|Completed||N/A|13|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:31:39.361373|2017-10-10 23:31:39.361373
NCT02383433|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-07-17|||June 14, 2016|Actual|2016-06-14|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer|A Phase II Study of Second-Line Therapy With Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer|Active, not recruiting||Phase 2|2|Actual|Case Comprehensive Cancer Center||1|||f||||f|t|f|||f|||||2017-10-10 23:31:39.452841|2017-10-10 23:31:39.452841
NCT02383420|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-04-14|2015-11-20||February 2015||2015-02-01|March 2015|2015-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors|Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors|Completed||N/A|23|Actual|Carestream Health, Inc.||3|||f||||f||||||||No||2017-10-10 23:31:39.551679|2017-10-10 23:31:39.551679
NCT02383407|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-02-16|||December 2013||2013-12-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|MTLE-DBS||Low Frequency Electrical Stimulation of the Fornix in Intractable Mesial Temporal Lobe Epilepsy (MTLE)|Low Frequency Electrical Stimulation of the Fornix in Intractable Mesial Temporal Lobe Epilepsy (MTLE)|Recruiting||N/A|20|Anticipated|George Washington University||2|||f||||t||||||||||2017-10-10 23:31:39.831704|2017-10-10 23:31:39.831704
NCT02383394|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-04-04|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Factors Associated With Pregnancy Loss in IVF Women|Factors Associated With Second-Trimester Pregnancy Loss in Women With Normal Uterine Anatomy Undergoing In Vitro Fertilization|Recruiting||N/A|500|Anticipated|Cairo University|||2||f||||f||||||||Yes||2017-10-10 23:31:39.939057|2017-10-10 23:31:39.939057
NCT02383381|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-03|||February 2014||2014-02-01|February 2014|2014-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||Lateral Rectus Muscle and Anterior Segment Optical Coherence Tomography (AS-OCT)|Pre and Post-operative Rectus Muscle Insertion Site Changing Using Anterior Segment Optical Coherence Tomography in Strabismus Patients|Completed||N/A|30|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 23:31:40.030558|2017-10-10 23:31:40.030558
NCT02383355|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-05-13|||March 2015||2015-03-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|RAPID||Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation|Switch From an NNRTI or PI-based Regimen to a RAltegravir-based Regimen in Virologically Suppressed HIV-infected Patients: Effects on Platelet Reactivity, Platelet-monocyte Aggregation and the Inflammatory anD Thrombotic State of Monocytes|Unknown status|Enrolling by invitation|Phase 4|40|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-10 23:31:40.211411|2017-10-10 23:31:40.211411
NCT02383342|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-03-06|||March 2015||2015-03-01|March 2015|2015-03-01|March 2027|Anticipated|2027-03-01|March 2025|Anticipated|2025-03-01|2 Years|Observational [Patient Registry]|||Pain Processing and Chronic Pain in Humans: Exploring Genetic Factors and Biomarkers|Pain Processing and Chronic Pain in Humans: Exploring Genetic Factors and Biomarkers|Not yet recruiting||N/A|10000|Anticipated|Radboud University|||1||f||||t||||||None Retained|"     Blood for DNA, RNA and serum   "|||2017-10-10 23:31:40.316244|2017-10-10 23:31:40.316244
NCT02383329|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-23|||December 2015||2015-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MIntS||Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight|Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight|Recruiting||N/A|213|Anticipated|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-10 23:31:40.421633|2017-10-10 23:31:40.421633
NCT02383316|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-04-24|||January 2015||2015-01-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MetabNoonan||Study of Metabolic Modifications in Children With Noonan Syndrome|Study of Metabolic Modifications in Children With Noonan Syndrome|Completed||N/A|20|Actual|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-10 23:31:40.612703|2017-10-10 23:31:40.612703
NCT02383303|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-05-10|||January 2013||2013-01-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|AFI||Assets for Independence Evaluation|Assets for Independence (AFI) Program Evaluation: a Randomized Control Trial of Matched Savings Accounts (Individual Development Accounts or IDAs) for Low-income Households.|Active, not recruiting||N/A|808|Actual|Urban Institute||2|||f||||f||||||||||2017-10-10 23:31:40.708277|2017-10-10 23:31:40.708277
NCT02383290|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-12-17|||April 2015||2015-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|IPPC||The Implementation of Pharmacogenomics Into Primary Care in British Columbia|The Implementation of Pharmacogenomics Into Primary Care in British Columbia|Completed||N/A|190|Actual|University of British Columbia||1|||f||||||||||||||2017-10-10 23:31:40.789911|2017-10-10 23:31:40.789911
NCT02383277|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-08-07|||November 2014||2014-11-01|August 2015|2015-08-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Acute Effects of a Stretching Program of the Rib Cage Muscles on Patients With COPD During Exercise|Acute Effects of a Stretching Program of the Rib Cage Muscles on the Regional Distribution of Ventilation and the Diaphragmatic Mobility of Patients With COPD During Exercise: a Randomized Crossover Clinical Trial|Unknown status|Active, not recruiting|N/A|20|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 23:31:40.875376|2017-10-10 23:31:40.875376
NCT02383264|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2016-11-19|||February 2013||2013-02-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|NIRS-SO||Splanchnic Oxygenation After the First Enteral Feed in Preterm Infants: Prediction of Feeding Tolerance.|Splanchnic Oxygenation Patterns in Response to the First Enteral Feed in Preterm Infants: Prediction of Feeding Tolerance and Correlation With Abnormal Antenatal Doppler.|Completed||N/A|61|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||2||f||||f||||||||Undecided||2017-10-10 23:31:40.950113|2017-10-10 23:31:40.950113
NCT02383251|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-08-23|||June 15, 2015|Actual|2015-06-15|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|TAPAZ||Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer|A Randomized Phase II Study of Pazopanib and Weekly Paclitaxel in Patients With Platinum Resistant/Refractory Ovarian Cancer Who Relapse During Bevacizumab Maintenance|Recruiting||Phase 2|117|Anticipated|ARCAGY/ GINECO GROUP||2|||f||||t||||||||||2017-10-10 23:31:41.02156|2017-10-10 23:31:41.02156
NCT02383238|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-12-01|||March 2014||2014-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Dapa||Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content|Randomized, Placebo Controlled, Crossover Clinical Study to Analyse the Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content|Completed||Phase 3|63|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-10 23:31:41.171065|2017-10-10 23:31:41.171065
NCT02383212|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-09-14|||January 2015||2015-01-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies|A First-in-Human Study of Repeat Dosing With REGN2810, a Monoclonal, Fully Human Antibody to Programmed Death - 1 (PD-1), as Single Therapy and in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies|Active, not recruiting||Phase 1|398|Actual|Regeneron Pharmaceuticals||4|||f||||f||||||||||2017-10-10 23:31:41.644492|2017-10-10 23:31:41.644492
NCT02383199|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-03-26|||September 2013||2013-09-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Observational|||Polypropylene Mesh in Prolapse Surgery|Polypropylene Mesh in Prolapse Surgery; Long-term Outcome and Complications.|Completed||N/A|161|Actual|Turku University Hospital|||1||f||||f||||||||||2017-10-10 23:31:43.337787|2017-10-10 23:31:43.337787
NCT02383186|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-07-17|||May 28, 2014|Actual|2014-05-28|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dermal Suturing Only Versus Layered Cutaneous Closure|Dermal Suturing Only Versus Layered Cutaneous Closure: A Randomized Split Wound Comparative Effectiveness Trial|Completed||N/A|50|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 23:31:43.386155|2017-10-10 23:31:43.386155
NCT02383173|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-06-26|||March 1, 2015|Actual|2015-03-01|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|December 31, 2018|Anticipated|2018-12-31||Interventional|BEACON II||Evaluation of Methods for Implementation of a Comfort Care Order Set|Evaluation of Methods for Implementation of a Comfort Care Order Set|Recruiting||N/A|48|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 23:31:43.448757|2017-10-10 23:31:43.448757
NCT02383160|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-08-22|||September 2014||2014-09-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Scaphoid Non-union and Low-intensity Pulsed Ultrasound|A Randomized Controlled Trial Comparing Low-Intensity, Pulsed Ultrasound to Placebo in the Treatment of Operatively Managed Scaphoid Non-Unions|Recruiting||N/A|154|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 23:31:43.526901|2017-10-10 23:31:43.526901
NCT02383147|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-10-28|||March 2015||2015-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy Study for Development and Use of Neurofeedback-trainings for Patients Suffering From Chronic Tinnitus|A Monocentric Study for Development and Use of Tomographic Neurofeedback Protocols for Patients Suffering From Chronic Tinnitus|Enrolling by invitation||N/A|52|Anticipated|University of Zurich||2|||f||||||||||||No||2017-10-10 23:31:43.630516|2017-10-10 23:31:43.630516
NCT02383134|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-05-12|||May 2015||2015-05-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Observational|||Maximal Distance for Successful Supraclavicular Block|The Maximum Effective Needle-to-Nerve Distance for Anesthetic Ultrasound-Guided Supraclavicular Brachial Plexus Block|Unknown status|Not yet recruiting|N/A|44|Anticipated|Tunisian Military Hospital|||1||f||||||||||||||2017-10-10 23:31:43.713982|2017-10-10 23:31:43.713982
NCT02383121|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-05-15|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Observational|MISP||Midodrine for Ischemic Stroke With Penumbra|Midodrine for Ischemic Stroke With Penumbra|Withdrawn||N/A|0|Actual|University of Utah|||1|Changed study to an observational study|f||||f|t|f||||||Yes||2017-10-10 23:31:43.770802|2017-10-10 23:31:43.770802
NCT02383108|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-09-15|||June 2016||2016-06-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|SMILE||Strategy for Maintenance of HIV Suppression With Elvitegravir + Darunavir/Ritonavir in Children|A Phase 2/3 Multicentre, Open-label, Randomised Study Evaluating Safety and Antiviral Effect of Elvitegravir (EVG) Administered With Darunavir/Ritonavir (DRV/r)Compared to Current Standard Antiretroviral Therapy in HIV-1 Infected, Virologically Suppressed Paediatric Participants.|Recruiting||Phase 2/Phase 3|300|Anticipated|PENTA Foundation||2|||f||||t||||||||||2017-10-10 23:31:43.838058|2017-10-10 23:31:43.838058
NCT02383095|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-10-04|||May 2015|Actual|2015-05-01|October 2017|2017-10-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Efficiency of Art-therapy in Psychotic Disorders|Efficiency of Art-therapy in Psychotic Disorders|Recruiting||N/A|40|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:31:43.917694|2017-10-10 23:31:43.917694
NCT02383082|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-03-06|||September 2013||2013-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:31:43.990919|2017-10-10 23:31:43.990919
NCT02383069|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-05-20|||February 2015||2015-02-01|May 2015|2015-05-01|June 2017|Anticipated|2017-06-01|July 2016|Anticipated|2016-07-01||Interventional|||Pulmonary Rehabilitation in Asthmatic Patient|Pulmonary Rehabilitation in Asthmatic Pediatric Patients: Randomized Clinical Trial|Unknown status|Recruiting|N/A|66|Anticipated|University of Nove de Julho||2|||f||||f||||||||||2017-10-10 23:31:44.122266|2017-10-10 23:31:44.122266
NCT02383056|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-12-16|||December 2012||2012-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Doubleblinded RCT of the Omnilux on Lower Extremity Surgical Wounds Left to Heal by Second Intention|Doubleblinded, Randomized, Controlled Trial to Study the Effect of Omnilux Light Emitting Diode on Wound Healing Following Lower Extremity Surgical Wounds Left to Heal by Second Intention|Recruiting||N/A|40|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 23:31:44.232993|2017-10-10 23:31:44.232993
NCT02383043|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-02-01|||February 2015||2015-02-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer||Recruiting||Early Phase 1|18|Anticipated|University of Kentucky||2|||f||||f||||||||||2017-10-10 23:31:44.32868|2017-10-10 23:31:44.32868
NCT02383030|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-06-14|||November 2015||2015-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|FUMANCE||Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients|Randomized Phase III Study of Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 Negative Postmenopausal Metastatic Breast Cancer Patients|Recruiting||Phase 3|156|Anticipated|Consorzio Oncotech||2|||f||||f||||||||No||2017-10-10 23:31:44.410106|2017-10-10 23:31:44.410106
NCT02383004|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-01-13|||February 2015||2015-02-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement|Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement|Completed||N/A|100|Actual|Oregon Health and Science University||2|||f||||t||||||||No||2017-10-10 23:31:44.680495|2017-10-10 23:31:44.680495
NCT02382991|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-12-11|||March 2015||2015-03-01|June 2015|2015-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Assessment of Disability Compensation With the C-LEG COMPACT 2 Knee (Ref. 3C60 et 3C60=ST)|Randomized, Cross-over Study Comparing the Efficacy of the 3C60 Knee Against Non-microprocessor Controlled Knees on the Risk of Falling and Locomotor Skills of Moderately Active Persons With Leg Amputation Above Knee or Knee Disarticulation|Completed||N/A|35|Actual|Otto Bock France SNC||2|||f||||f||||||||||2017-10-10 23:31:44.778644|2017-10-10 23:31:44.778644
NCT02382978|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-03-06|||April 2015||2015-04-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Feasibility Study of Nurse-Provided Well Child Care|Feasibility Study of Nurse-Provided Well Child Care in Family Health Team in Ontario, Canada|Unknown status|Not yet recruiting|N/A|30|Anticipated|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-10-10 23:31:44.932399|2017-10-10 23:31:44.932399
NCT02382965|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-05-01|||May 2015||2015-05-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Ultrasound in Deep Brain Stimulation|Transcranial Focused Ultrasound for Deep Brain Stimulation in Humans|Completed||N/A|40|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 23:31:45.000091|2017-10-10 23:31:45.000091
NCT02382952|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-08-03|||March 2015||2015-03-01|July 2016|2016-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Pilot Study Differential Dissector™ for Blunt Dissection|Pilot Study Differential Dissector™ for Blunt Dissection|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 23:31:45.070695|2017-10-10 23:31:45.070695
NCT02382939|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-01-24||2016-12-20|February 2015||2015-02-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|REAL 2||A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency|A Multicentre, Multinational, Randomised, Open-labelled, Parallel-group, Active-controlled Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency|Completed||Phase 3|92|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 23:31:45.148376|2017-10-10 23:31:45.148376
NCT02382926|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-12|||October 2014||2014-10-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|RehaDrivecECG||Reha Drive: Capacitive Electrocardiography in Car Seat in Cardiological Patients|Capacitive Electrocardiography in the Driver`s Seat and Elevation of Vital Signs Via Camera During Cardiac Rehabilitation|Completed||N/A|10|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-10 23:31:45.297149|2017-10-10 23:31:45.297149
NCT02382913|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-02-24|2016-01-14||April 2015||2015-04-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)|Phase 1 Extension Study to Evaluate Antibody Persistence Approximately 3 Years After Administration of Different Dosages of Acellular Pertussis or Tetanus-Diphtheria-acellular Pertussis Booster Vaccines in Healthy Adult Subjects Enrolled in Study V113_01|Completed||Phase 1|315|Actual|Novartis||10|||f||||f||||||||||2017-10-10 23:31:45.399528|2017-10-10 23:31:45.399528
NCT02382900|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-06|||February 2015||2015-02-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City|Evaluation of a Two-dose Schedule of Quadrivalent Human Papilloma Virus (Types 6, 11, 16, 18) Recombinant Vaccine in 11-year-old Boys in Mexico City (Gardasil® Merck and Co.).|Unknown status|Recruiting|Phase 3|500|Anticipated|Universidad Nacional Autonoma de Mexico||3|||f||||t||||||||||2017-10-10 23:31:46.487755|2017-10-10 23:31:46.487755
NCT02382887|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-06|||March 2009||2009-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Comparison by Neuromonitoring of Two Techniques of Tracheal Intubation in Patients With Unstable Cervical Spine|Comparison by Neuromonitoring of Two Techniques of Tracheal Intubation in Patients With Unstable Cervical Spine|Unknown status|Recruiting|N/A|40|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-10 23:31:46.583374|2017-10-10 23:31:46.583374
NCT02382874|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-12-03|||May 2015||2015-05-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)|Allogenic Adipose Derived Mesenchymal Stromal Cells Transplantation to Improve Kidney Function in Refractory Primary Nephrotic Syndrome (Focal Segmental Glomerulosclerosis,FSGS) ,a Phase I Clinical Trial|Recruiting||Phase 1|5|Anticipated|Royan Institute||1|||f||||t||||||||||2017-10-10 23:31:46.689707|2017-10-10 23:31:46.689707
NCT02382861|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-06|||February 2015||2015-02-01|March 2015|2015-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|SENA||A Randomized Controlled Trial of Conventional vs. Neurally Adjusted Ventilatory Assist in Difficult Weaning From Mechanical Ventilation|A Prospective, Randomized and Controlled Study Estimating the Neurally Adjusted Ventilatory Assist (NAVA) Versus the Pressure Support Ventilatory (PSV) in Difficult Weaning From Mechanical Ventilation|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 23:31:46.799825|2017-10-10 23:31:46.799825
NCT02382848|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-08-23|||July 2015||2015-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD|Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD|Recruiting||N/A|10|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 23:31:46.914065|2017-10-10 23:31:46.914065
NCT02382835|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-04-04|||March 2015||2015-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|HipLink||Metal-on-metal Hip Prostheses: Do They Have Systemic Effects?|Metal-on-metal Hip Prostheses: Do They Have Systemic Effects?|Completed||N/A|800000|Actual|Royal National Orthopaedic Hospital NHS Trust|||2||f||||f||||||||||2017-10-10 23:31:47.037016|2017-10-10 23:31:47.037016
NCT02382822|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-04-24|||March 2015||2015-03-01|April 2017|2017-04-01|March 2025|Anticipated|2025-03-01|March 2025|Anticipated|2025-03-01||Observational|COCOMO||Copenhagen Co-morbidity in HIV Infection Study|Copenhagen Co-morbidity in HIV Infection Study|Active, not recruiting||N/A|1500|Anticipated|Rigshospitalet, Denmark|||2||f||||t||||||Samples With DNA|"     Routine biochemistry, whole blood, plasma, peripheral blood mononuclear cells (PBMCs), DNA     and RNA from buffy coat, plasma, and red blood cells (RBC).   "|||2017-10-10 23:31:47.118735|2017-10-10 23:31:47.118735
NCT02382809|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-03-08|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction|Efficacy of DC071 Mouthwash (0.2% Chlorhexidine Digluconate) in Peri-surgical Care for Preventing Alveolar Osteitis After Third Molar Extraction|Completed||Phase 4|414|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-10 23:31:47.201463|2017-10-10 23:31:47.201463
NCT02382796|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-09-28|||July 10, 2015|Actual|2015-07-10|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||A Rollover Protocol of Dacomitinib For Patients In Japan|Treatment Access Protocol For Patients Previously Treated With Dacomitinib On A Clinical Trial In Japan|Recruiting||Phase 2|5|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-10 23:31:47.332315|2017-10-10 23:31:47.332315
NCT02382783|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-07-26|||March 2015||2015-03-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|February 2018|Anticipated|2018-02-01||Interventional|||Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)|Optimization of the Flare Management in Rheumatoid Arthritis (RA) by Implementing Patient-driven Systematic Changes to the RA Ambulatory Care Stream|Active, not recruiting||N/A|178|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:31:47.428014|2017-10-10 23:31:47.428014
NCT02382770|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-01-26|||February 2015||2015-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|IROA||International Register of Open Abdomen|International Register of Open Abdomen|Recruiting||N/A|300|Anticipated|A.O. Ospedale Papa Giovanni XXIII|||1||f||||||||||||||2017-10-10 23:31:47.511315|2017-10-10 23:31:47.511315
NCT02382731|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-06-07|||September 2015||2015-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|ISLAND||Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction|Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction|Active, not recruiting||N/A|2742|Actual|Women's College Hospital||3|||f||||f||||||||No||2017-10-10 23:31:47.839569|2017-10-10 23:31:47.839569
NCT02382718|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-06-09|||October 2015||2015-10-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|FASTIIb||FAST Fish Phase IIb Clinical Trial for the Treatment of Fish Allergy by Subcutaneous Immunotherapy|A Multinational Phase IIb Study to Investigate the Efficacy and Safety of Subcutaneous Immunotherapy With a Modified Fish- Parvalbumin Given in Single Rising and Maintenance Doses to Subjects Allergic to Fish|Completed||Phase 2|45|Actual|University of Athens||2|||f||||t||||||||No||2017-10-10 23:31:47.940935|2017-10-10 23:31:47.940935
NCT02382705|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-06-14|||February 2015||2015-02-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Observational|||SB3 Battery Life Observational Study|Clinical Impact of Longer Battery Life on Small Bowel Capsule Endoscopy: a Prospective Observational Study|Enrolling by invitation||N/A|200|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-10 23:31:48.051236|2017-10-10 23:31:48.051236
NCT02382692|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-05-03|||February 2015||2015-02-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Cerebrospinal Fluid Rhinorrhea After Functional Endoscopic Sinus Surgery|Auftreten Von Okkultem Asymptomatischem Liqourverlust Nach Nebenhöhlenoperationen Eine Prospektive Kohortenstudie|Completed||N/A|31|Actual|University of Zurich|||1||f||||f||||||Samples Without DNA|"     RNA Samples   "|No||2017-10-10 23:31:48.105671|2017-10-10 23:31:48.105671
NCT02382679|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-01-05|||March 2015||2015-03-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Vitamin Therapy in Concussion Management: A Randomized Control Trial|Vitamin Therapy in Concussion Management: A Randomized Control Trial|Active, not recruiting||N/A|132|Anticipated|Thomas Jefferson University||2|||f||||||||||||||2017-10-10 23:31:48.16555|2017-10-10 23:31:48.16555
NCT02382666|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-08-21|||January 2015||2015-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers|A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers|Completed||Phase 1|100|Actual|Tesaro, Inc.||6|||f||||f||||||||||2017-10-10 23:31:48.236178|2017-10-10 23:31:48.236178
NCT02382653|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-05-11|||December 2014||2014-12-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain|The Analgesic Efficacy of Oral Piroxicam Versus Buccal Fentanyl in Cancer Breakthrough Pain in Patients With Bone Metastases|Completed||N/A|100|Actual|Tanta University||2|||f||||f||||||||||2017-10-10 23:31:48.430976|2017-10-10 23:31:48.430976
NCT02382640|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-03-28|2016-03-28||March 2015||2015-03-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||The safety set was defined as all participants who were enrolled and received at least 1 dose of study drug.|Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule|A Phase 1, Open-Label, Single Center, Single-Dose, Randomized, 4-Way Crossover Study to Assess the Effect of an Antacid on the Bioavailability of Febuxostat After Oral Administration of a 80 mg Febuxostat Extended-Release (XR) Capsule Formulation|Completed||Phase 1|36|Actual|Takeda||4|||f||||f||||||||||2017-10-10 23:31:48.529431|2017-10-10 23:31:48.529431
NCT02382627|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-04-17|||March 2015||2015-03-01|April 2017|2017-04-01||||August 2017|Anticipated|2017-08-01||Observational|||Choroidal Thickness in Optic Neuropathy|Choroidal Thickness in Optic Neuropathy|Recruiting||N/A|250|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 23:31:49.40011|2017-10-10 23:31:49.40011
NCT02382614|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-04-25|||May 2015||2015-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VAST||Spiration Valves Against Standard Therapy|Safety and Effectiveness of the Spiration Valve System (SVS) in Air Leaks|Recruiting||N/A|200|Anticipated|Spiration, Inc.||2|||f||||t||||||||||2017-10-10 23:31:49.479642|2017-10-10 23:31:49.479642
NCT02382601|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-29|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|||Longitudinal Study of Intra-Uterine Growth Restriction|Longitudinal Study of Intra-Uterine Growth Restriction (IUGR)|Recruiting||N/A|200|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     Maternal peripheral blood and umbilical cord blood   "|||2017-10-10 23:31:49.707663|2017-10-10 23:31:49.707663
NCT02382588|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-10-13|||January 2015||2015-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis|A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Gancyclovir Gel (Zirgan) Versus 0.3% Hypromellose Gel (Genteal Gel; Placebo) for the Treatment of Herpes Zoster Keratitis|Recruiting||Phase 2|100|Anticipated|Northwestern University||2|||f||||f||||||||Yes|Once the study is completed study results will be shared with the study subjects.|2017-10-10 23:31:49.876489|2017-10-10 23:31:49.876489
NCT02382575|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-09-16|||March 2015||2015-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome|Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome|Recruiting||Phase 4|120|Anticipated|Nilratan Sircar Medical College||2|||f||||t||||||||||2017-10-10 23:31:49.989523|2017-10-10 23:31:49.989523
NCT02382562|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-03-06|||May 2015||2015-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Interventional|||Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients|Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients|Active, not recruiting||N/A|18|Actual|University of Mississippi Medical Center||1|||f||||f||||||||||2017-10-10 23:31:50.129354|2017-10-10 23:31:50.129354
NCT02382549|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-11-10|||April 2016||2016-04-01|November 2016|2016-11-01||||June 2019|Anticipated|2019-06-01||Interventional|Mel61||A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib|A Trial to Evaluate the Safety, Immunogenicity, and Clinical Activity of a Helper Peptide Vaccine Plus Combination of BRAF Inhibition and MEK Inhibition (Mel61)|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Virginia||1|||f||||t||||||||||2017-10-10 23:31:50.230847|2017-10-10 23:31:50.230847
NCT02382536|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-02-08|||August 2014||2014-08-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Monitoring the Infusion Pressure in Insulin Infusion Sets in Healthy Adults|Infusion Pressure Delivering Insulin Diluent - BD's Scarlett vs. Medtronic's (MDT) Quickset in Healthy Adults|Completed||N/A|60|Actual|Becton, Dickinson and Company|||1||f||||f||||||||No||2017-10-10 23:31:50.340038|2017-10-10 23:31:50.340038
NCT02382523|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-03|||February 2015||2015-02-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Acthar on Proteinuria in IgA Nephropathy Patients|Impact of Acthar on Proteinuria and Disease Progression in IgA Nephropathy Patients With Nephrotic Range Proteinuria|Withdrawn||Phase 4|0|Actual|Baylor College of Medicine||2||"There were no subjects enrolled locally on this study since it opened. Local IRB closure has   been requested."|f||||t||||||||||2017-10-10 23:31:50.428737|2017-10-10 23:31:50.428737
NCT02382510|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-05-08||2017-05-05|April 2015||2015-04-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics|Completed||Phase 2|59|Actual|Theron Pharmaceuticals, Inc.||3|||f||||||||||||||2017-10-10 23:31:50.543286|2017-10-10 23:31:50.543286
NCT02382497|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-03-03|||July 2014||2014-07-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||New Treatment Perspectives in Eating Disorders: the Efficacy of Non-invasive Brain-directed Treatment|New Treatment Perspectives in Eating Disorders: the Efficacy of Non-invasive Brain-directed Treatment|Unknown status|Recruiting|N/A|160|Anticipated|Bambino Gesù Hospital and Research Institute||4|||f||||f||||||||||2017-10-10 23:31:50.647331|2017-10-10 23:31:50.647331
NCT02382484|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-03-05|||March 2011||2011-03-01|March 2015|2015-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Impact of Pacing Site and AV Delay on Blood Pressure in Hypertensive Patients|Impact of Pacing Site and AV Delay on Blood Pressure in Hypertensive Patients: An Acute Study in Patients Undergoing an Electrophysiology Study or Pacemaker Implant|Completed||N/A|19|Actual|BackBeat Medical Inc||1|||f||||f||||||||||2017-10-10 23:31:50.791561|2017-10-10 23:31:50.791561
NCT02382471|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-03-02|||December 2011||2011-12-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Assessing the Effects of Omega-3 Supplementation on Some Serum BDNF، Follistatin، Irisin Levels in Men With CAD|Assessing the Effects of Omega-3 Supplementation on Some Serum BDNF، Follistatin، Irisin Levels in Men With Coronary Artery Disease|Completed||Phase 4|21|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:31:50.864336|2017-10-10 23:31:50.864336
NCT02382458|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-18|||May 2015||2015-05-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|IMAGINE||Developing the Dietary Inflammatory Index for Clinical Application|Developing the Dietary Inflammatory Index for Clinical Application|Active, not recruiting||Phase 1|97|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-10 23:31:50.951788|2017-10-10 23:31:50.951788
NCT02382445|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-05-08|||January 2014||2014-01-01|May 2017|2017-05-01|May 8, 2017|Actual|2017-05-08|May 8, 2017|Actual|2017-05-08||Interventional|BIS & Dementia||Anesthesia Depth Increases the Degree of Postoperative Dementia, Delirium, and Cognitive Dysfunction|Anesthesia Depth Increases the Degree of Postoperative Dementia, Delirium, and Cognitive Dysfunction by a Higher Load of Neurotrophic Drugs|Completed||N/A|138|Actual|Universitätsmedizin Mannheim||2|||f||||f||||||||||2017-10-10 23:31:51.036921|2017-10-10 23:31:51.036921
NCT02382432|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-03|||December 2013||2013-12-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Dexmedetomidine in Post Spinal Anesthesia Shivering|Safety and Efficacy of Dexmedetomidine in Treating Post Spinal Anesthesia Shivering: A Clinically Controlled Dose-finding Study.|Completed||Phase 2|120|Actual|Assiut University||4|||f||||f||||||||||2017-10-10 23:31:51.12015|2017-10-10 23:31:51.12015
NCT02382419|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-20|||August 2014||2014-08-01|March 2015|2015-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants|Expanded Phase II Trial of a Carrageenan-Containing Gel for Prevention of HPV Infection|Unknown status|Recruiting|Phase 2|200|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-10 23:31:51.20046|2017-10-10 23:31:51.20046
NCT02382406|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-03-28|||June 2015||2015-06-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC|A Phase I/II Study of Carboplatin/Nab-Paclitaxel and Pembrolizumab for Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|67|Anticipated|Hoosier Cancer Research Network||2|||f||||t||||||||No||2017-10-10 23:31:51.291633|2017-10-10 23:31:51.291633
NCT02382393|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-11-11|||March 2015||2015-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Reliability and Validity of Online Cognitive Assessments|Reliability and Validity of Online Cognitive Assessments|Completed||N/A|1152|Actual|Lumos Labs, Inc.||2|||f||||f||||||||||2017-10-10 23:31:51.426454|2017-10-10 23:31:51.426454
NCT02382380|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-03-21|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Gadoterate in Patients With Decreased Kidney Function|Evaluation of Gadoterate in Patients With Renal Dysfunction|Recruiting||Phase 4|280|Anticipated|Loyola University||2|||f||||f||||||||||2017-10-10 23:31:51.517522|2017-10-10 23:31:51.517522
NCT02382367|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-12-04|||December 2014||2014-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|DysA||Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema||Completed||N/A|190|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:31:51.740211|2017-10-10 23:31:51.740211
NCT02381574|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-03-02|||June 2014||2014-06-01|February 2015|2015-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|PTDL||French Lumbar Total Disk Replacement Observational Study|French Lumbar Total Disk Replacement Observational Study (FLTDR Observational Study)|Recruiting||N/A|600|Anticipated|Medtronic France SAS|||1||f||||f||||||||||2017-10-10 23:31:58.033767|2017-10-10 23:31:58.033767
NCT02382354|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-10-13|||March 2015||2015-03-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Remifentanil for the I-gel and Laryngeal Mask Airway Insertion|Comparison of the Effect-site Concentration of Remifentanil for Insertion of the I-gel and Laryngeal Mask Airway During Propofol Anesthesia|Completed||Phase 4|41|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-10 23:31:51.823967|2017-10-10 23:31:51.823967
NCT02382341|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-04-25|||September 12, 2014|Actual|2014-09-12|April 2017|2017-04-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Observational|||BIOSURE™ HEALICOIL™ PK Bone In-growth Study|A Radiographic Study of Patients Treated With the BIOSURE™ HEALICOIL™ PK Interference Screw for ACL Repair With Soft Tissue Fixation|Completed||N/A|12|Actual|Smith & Nephew, Inc.|||1||f||||f||||||||||2017-10-10 23:31:51.922392|2017-10-10 23:31:51.922392
NCT02382328|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-08-08|||February 2016||2016-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Alpha Lipoic Acid on Clinical and Electrophysiological Recovery in Carpal Tunnel Syndrome Undergoing Surgical Release|Effectiveness of Alpha Lipoic Acid on Clinical and Electrophysiological Recovery in Patients With Carpal Tunnel Syndrome Surgical Release|Completed||Phase 2|40|Actual|Hospital Civil de Guadalajara||2|||f||||f||||||||Yes||2017-10-10 23:31:51.989817|2017-10-10 23:31:51.989817
NCT02382315|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-04-05|||March 2015||2015-03-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Therapy Intervention to Address Fear of Recurrence in Men and Women With Cancer|Efficacy of a Cognitive-Existential Therapy Intervention to Address Fear of Recurrence in Men and Women With Cancer: A Randomized Clinical Trial|Completed||N/A|19|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 23:31:52.073799|2017-10-10 23:31:52.073799
NCT02382302|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-03-02|||July 2011||2011-07-01|March 2015|2015-03-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Research to Evaluate Efficiency in U-health Solution Service for the Chronic Wound Management|A Smart Phone-based Tele-consultation System in the Management of Chronic Pressure Ulcer|Completed||N/A|20|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 23:31:52.182005|2017-10-10 23:31:52.182005
NCT02382289|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-08-31|||September 2014||2014-09-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|RFSIBIMONO6||Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points|Radiofrequency Ablation for the Treatment of Chronic Sacroiliac Joint Arthropathy; Comparing the Use of Bipolar RF at Six Points Versus Monopolar RF at Six Points and Three Points|Completed||N/A|60|Actual|King Hamad University Hospital, Bahrain||3|||f||||t||||||||||2017-10-10 23:31:52.259404|2017-10-10 23:31:52.259404
NCT02382276|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-11-21|||December 2014||2014-12-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence||Active, not recruiting||Phase 3|400|Anticipated|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:31:52.336509|2017-10-10 23:31:52.336509
NCT02382263|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-07-05|||April 2013||2013-04-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|FRAGANCE||Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer|Phase I/II Study to Assess the Efficacy and Safety of Nab-paclitaxel in Combination With Gemcitabine for the Treatment of Fragile Patients With Advanced or Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|224|Actual|PH Research, S.L.||4|||f||||f||||||||||2017-10-10 23:31:52.423886|2017-10-10 23:31:52.423886
NCT02382250|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-06|||February 1, 2015|Actual|2015-02-01|September 2017|2017-09-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Observational|||Relationship Between Diet, Lifestyle, and the Severity of Coronary Artery Disease|The Relationship Between Diet, Perception of Healthy Lifestyle and the Severity of Coronary Artery Disease in Patients Referred for Coronary Angiography.|Completed||N/A|440|Actual|New York University School of Medicine|||1||f||||f|f|f||||||||2017-10-10 23:31:52.560936|2017-10-10 23:31:52.560936
NCT02382237|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-08-16|||October 2013|Actual|2013-10-01|August 2017|2017-08-01|August 9, 2017|Actual|2017-08-09|November 2015|Actual|2015-11-01||Interventional|PETANC||Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition|Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition Assessed by F-FDG Petscan|Completed||N/A|20|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||t||||||||||2017-10-10 23:31:52.637116|2017-10-10 23:31:52.637116
NCT02382224|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2017-05-26|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Worry Exposure for Generalized Anxiety Disorder|Worry Exposure for Generalized Anxiety Disorder|Recruiting||N/A|60|Anticipated|University of Texas at Austin||2|||f||||t||||||||||2017-10-10 23:31:52.723061|2017-10-10 23:31:52.723061
NCT02382211|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-09-26|||January 2015||2015-01-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|PROTECT||T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays|A Prospective Observational Trial to Evaluate the Correlation of T-SPOT® Response to CMV Infection and T Cell-mediated Acute Graft Rejection|Active, not recruiting||N/A|600|Actual|Oxford Immunotec|||1||f||||f||||||||||2017-10-10 23:31:52.809884|2017-10-10 23:31:52.809884
NCT02382198|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-09-13|||July 2016||2016-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|GLYCOPAR||Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease|A Randomized, Placebo-controlled, 2-arm Parallel-group Superiority Phase II Study of GLYCOpyrrolate for Moderate-to-severe Sialorrhea in PARkinson's Disease|Recruiting||Phase 2|28|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-10 23:31:52.958986|2017-10-10 23:31:52.958986
NCT02382185|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-01-24|||January 2015||2015-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|ClearNOF||Non Invasive Cardiac Output Monitoring to Guide Goal Directed Fluid Therapy in High Risk Patients Undergoing Urgent Surgical Repair of Proximal Femoral Fractures|Non Invasive Cardiac Output Monitoring to Guide Goal Directed Fluid Therapy in High Risk Patients Undergoing Urgent Surgical Repair of Proximal Femoral Fractures|Recruiting||N/A|250|Anticipated|York Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:31:53.059592|2017-10-10 23:31:53.059592
NCT02382172|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-04-21|||January 2015||2015-01-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SCIT-A||Social Cognition and Interaction Training for Autism|Social Cognition and Interaction Training for Autism (SCIT-A)|Completed||N/A|44|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:31:53.160199|2017-10-10 23:31:53.160199
NCT02382159|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-07-15|||October 2010||2010-10-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|||A Observational Study to Evaluate Lipid-lowering Drug Its Effect on Parameters in Dyslipidemia of Type 2 Diabetes.|Observational, Retrospective, Multi-center Study for Therapeutic Practice Pattern of Lipid-lowering Drug and Its Effect on Parameters in Dyslipidemia of Type 2 Diabetes.|Completed||N/A|1000|Actual|Yooyoung Pharmaceutical Co.,Ltd.|||1||f||||t||||||||||2017-10-10 23:31:53.245222|2017-10-10 23:31:53.245222
NCT02382146|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-02|||April 2012||2012-04-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Prevention of Postoperative Nausea and Vomiting|A Prospective Randomize Study: Prevention of Nausea and Vomiting in Plastic Surgery|Completed||Phase 4|60|Actual|Yeditepe University Hospital||2|||f||||f||||||||||2017-10-10 23:31:53.320945|2017-10-10 23:31:53.320945
NCT02382133|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-05-08|2017-02-20||October 2014||2014-10-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Comparison of Nasal and Forehead Oximetry in Critically Ill Patients at Risk for Decreased Peripheral Perfusion|Comparison of Nasal and Forehead Oximetry in Critically Ill Patients at Risk for Decreased Peripheral Perfusion|Completed||N/A|43|Actual|Washington University School of Medicine|50% the patients expired after being placed on comfort care prior to final collection|1|||f||||f||||||||No||2017-10-10 23:31:53.411456|2017-10-10 23:31:53.411456
NCT02382120|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-03-17|||March 2015||2015-03-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Accuracy of Non-invasive Effective Pulmonary Perfusion Measurement by CO2|Accuracy and Precision of Non-invasive Effective Pulmonary Perfusion Measurement Using Volumetric Capnography|Recruiting||N/A|30|Anticipated|Hospital Privado de Comunidad de Mar del Plata|||1||f||||t||||||||Yes||2017-10-10 23:31:53.612128|2017-10-10 23:31:53.612128
NCT02382107|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-08-31|||March 2015||2015-03-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|May 2016|Actual|2016-05-01||Observational|||A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania|A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania|Completed||N/A|400|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||t||||||Samples Without DNA|"     Blood, urine, sputum   "|||2017-10-10 23:31:53.690816|2017-10-10 23:31:53.690816
NCT02382094|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-05|||June 2005||2005-06-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|April 2009|Actual|2009-04-01||Interventional|||Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy||Completed||Phase 3|110|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-10 23:31:53.768079|2017-10-10 23:31:53.768079
NCT02382081|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-05|||March 2015||2015-03-01|March 2015|2015-03-01||||February 2018|Anticipated|2018-02-01||Interventional|||A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With Psoriasis||Recruiting||N/A|150|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-10 23:31:53.8581|2017-10-10 23:31:53.8581
NCT02382068|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-07-14|||August 2014||2014-08-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Interventional|||Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin|Prevention of Cisplatin-Induced Ototoxicity by Intratympanic Dexamethasone|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center||1||No patients were enrolled to trial|f||||t||||||||||2017-10-10 23:31:53.957263|2017-10-10 23:31:53.957263
NCT02382055|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-09-12|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|REACH||Changing Habits in Anorexia Nervosa: Novel Treatment Development|Changing Habits in Anorexia Nervosa|Completed||N/A|20|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-10 23:31:54.045522|2017-10-10 23:31:54.045522
NCT02382042|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-03-02|||September 2013||2013-09-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|IRI||Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans|Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans|Unknown status|Active, not recruiting|N/A|450|Actual|VA Nebraska Western Iowa Health Care System||2|||f||||t||||||||||2017-10-10 23:31:54.154124|2017-10-10 23:31:54.154124
NCT02382029|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-03-02|||March 2014||2014-03-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|ACUCLONBMS||Acupuncture Versus Clonazepam in Burning Mouth Syndrome|The Effectiveness of Acupuncture Versus Clonazepam in the Patients With Burning Mouth Syndrome|Completed||Early Phase 1|4|Actual|University of Zagreb||2|||f||||t||||||||||2017-10-10 23:31:54.226642|2017-10-10 23:31:54.226642
NCT02382016|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-09-01|||June 1, 2015||2015-06-01|September 2017|2017-09-01|February 20, 2018|Anticipated|2018-02-20|October 17, 2017|Anticipated|2017-10-17||Interventional|PORTICO||PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial|A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension|Active, not recruiting||Phase 4|84|Anticipated|Actelion||2|||f||||f||||||||||2017-10-10 23:31:54.308981|2017-10-10 23:31:54.308981
NCT02382003|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-05-10|||April 2016||2016-04-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Web-based Interpretation Training For Anxiety|Testing Target Engagement and Effectiveness of Web-based Interpretation Training For Anxiety|Recruiting||Phase 2|233|Anticipated|University of Virginia||6|||f||||t||||||||||2017-10-10 23:31:54.501045|2017-10-10 23:31:54.501045
NCT02381990|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-03-24|||July 2013||2013-07-01|March 2015|2015-03-01|June 2023|Anticipated|2023-06-01|June 2019|Anticipated|2019-06-01|10 Years|Observational [Patient Registry]|FIPC||Fuse Image MRI Guided Prostate Cryotherapy|Office Based Fuse Image MRI Guided Prostate Cryotherapy: Outcomes Registry|Recruiting||N/A|5000|Anticipated|Urological Research Network, LLC|||1||f||||t||||||||||2017-10-10 23:31:54.601952|2017-10-10 23:31:54.601952
NCT02381977|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-03-02|||November 2011||2011-11-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|October 2012|Actual|2012-10-01||Observational|PANGEA||Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment|Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment|Completed||N/A|922|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:31:54.703256|2017-10-10 23:31:54.703256
NCT02381964|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-03-02|||March 2012||2012-03-01|March 2015|2015-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||The Effects of Differing Cognitive Task Demands on Whole-body Energy Metabolism and Cerebral Blood-flow: Modulation by Multivitamins/Minerals and Coenzyme Q10|Pilot, Randomized, Placebo-controlled, Double-blind, 3-arm Parallel Groups Trial in Healthy Females to Assess Cerebral Haemodynamics and Energy Expenditure During Cognitive Performance After Supplementation With Two Different Multivitamin / Mineral Preparations.|Completed||Phase 4|106|Actual|Northumbria University||3|||f||||||||||||||2017-10-10 23:31:54.766654|2017-10-10 23:31:54.766654
NCT02381951|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-07-26|||November 24, 2015|Actual|2015-11-24|July 2017|2017-07-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|STIMUPARK||Spinal Cord Stimulation in the Treatment of Parkinson's Disease||Completed||N/A|5|Actual|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||f||||||||||2017-10-10 23:31:54.88233|2017-10-10 23:31:54.88233
NCT02381938|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-05-04|||March 2015||2015-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Care2BWell: Worksite Wellness for Child Care|Care2bWell: A Worksite Physical Activity & Wellness Program for Child Care Staff|Active, not recruiting||N/A|555|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 23:31:55.154006|2017-10-10 23:31:55.154006
NCT02381925|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-09-17||||||September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01|6 Months|Observational [Patient Registry]|||Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism|Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism|Withdrawn||N/A|0|Actual|Duke University|||1|The study never opened due to funding issues|f||||f||||||||||2017-10-10 23:31:55.264843|2017-10-10 23:31:55.264843
NCT02381912|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-03-08|||March 2015||2015-03-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer|Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer|Completed||N/A|210|Actual|Herlev Hospital|||2||f||||f||||||||||2017-10-10 23:31:55.342328|2017-10-10 23:31:55.342328
NCT02381899|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-05|||January 2015||2015-01-01|March 2015|2015-03-01|March 2018|Anticipated|2018-03-01|March 2016|Anticipated|2016-03-01||Observational|||Observational Study in CLL Patients Receiving BR|Observational Study in Chronic Lymphocytic Leukemia Patients Receiving Bendamustine and Rituximab|Recruiting||N/A|100|Anticipated|Czech CLL Study Group|||1||f||||f||||||||||2017-10-10 23:31:55.440529|2017-10-10 23:31:55.440529
NCT02381886|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-08-01|||March 6, 2015|Actual|2015-03-06|August 2017|2017-08-01|December 26, 2018|Anticipated|2018-12-26|February 2, 2018|Anticipated|2018-02-02||Interventional|||A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations|A Phase I Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations|Suspended||Phase 1|180|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 23:31:55.584606|2017-10-10 23:31:55.584606
NCT02381873|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2017-03-06|||February 2015||2015-02-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Determinants of Early Functional Outcome After Reconstructive Surgery|Exploratory Study of Determinants of Early Functional Outcome Following Reconstructive Knee Surgery|Completed||N/A|36|Actual|Queen Margaret University|||1||f||||f||||||Samples With DNA|"     blood serum samples   "|||2017-10-10 23:31:55.724062|2017-10-10 23:31:55.724062
NCT02381860|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-11-02|||March 2015||2015-03-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Investigate the Effect of Tart Montmorency Cherry Juice (Prunus Cerasus) on Cerebral Blood Flow and Cognitive Function|Investigate the Effect of Tart Montmorency Cherry Juice (Prunus Cerasus) on Cerebral Blood Flow and Cognitive Function|Completed||N/A|28|Actual|Northumbria University||2|||f||||t||||||||||2017-10-10 23:31:55.812392|2017-10-10 23:31:55.812392
NCT02381847|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-03-04|||January 2015||2015-01-01|February 2015|2015-02-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Radical Gastrectomy With/Without HIPEC in Advanced Gastric Cancer Patients|Prospective Phase III Trial Using Radical Gastrectomy With/Without HIPEC in Advanced Gastric Cancer Patients Including Adenocarcinoma of the Esophagogastric Junction|Recruiting||Phase 3|60|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||||2017-10-10 23:31:55.900149|2017-10-10 23:31:55.900149
NCT02381834|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-01-08|||March 2015||2015-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of a Novel Midstream Urine Collection Technique for Infants in the Emergency Department|Evaluation of a Novel Midstream Urine Collection Technique for Infants in the Emergency Department|Completed||N/A|150|Actual|Children's Hospital of Eastern Ontario||1|||f||||f||||||||||2017-10-10 23:31:56.023734|2017-10-10 23:31:56.023734
NCT02381821|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-05|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||3D Measurement of Junctional Zone and Its Relation to Implantation|Thickness of the Junctional Zone Measured by 3D Ultrasound and Its Relation to the Success/Failure Implantation Rates in Assisted Reproduction Techniques|Unknown status|Not yet recruiting|N/A|100|Anticipated|Cairo University|||2||f||||f||||||||||2017-10-10 23:31:56.127411|2017-10-10 23:31:56.127411
NCT02381808|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-06-05|||December 2014||2014-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 24, 2017|Anticipated|2017-06-24||Observational|||Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China|Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China|Active, not recruiting||N/A|150|Anticipated|Guangdong Association of Clinical Trials|||1||f||||t||||||Samples With DNA|"     Frozen tissue or tissue block   "|Undecided||2017-10-10 23:31:56.204023|2017-10-10 23:31:56.204023
NCT02381795|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-04-12|||July 2015||2015-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Pilot Study Evaluating the Use of Nasal Carbon Dioxide for the Treatment of Cluster Headache|An Open Label, Pilot Study Evaluating the Efficacy and Safety of the Use of Nasal Carbon Dioxide for the Treatment of Episodic Cluster Headache|Terminated||Phase 2|10|Actual|Cady, Roger, M.D.||1||Terminated at the request of the financial sponsor.|f||||f||||||||||2017-10-10 23:31:56.279773|2017-10-10 23:31:56.279773
NCT02381782|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-07-28|||December 2014||2014-12-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|UHEAR||Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Elderly Cancer Patients Within a Comprehensive Geriatric Assessment|Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Elderly Cancer Patients Within a Comprehensive Geriatric Assessment|Completed||N/A|33|Actual|General Hospital Groeninge|||1||f||||||||||||||2017-10-10 23:31:56.364812|2017-10-10 23:31:56.364812
NCT02381769|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-09-09|||June 2013||2013-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.|THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.|Completed||N/A|55|Actual|Institute of Liver and Biliary Sciences, India||1|||f||||f||||||||||2017-10-10 23:31:56.453602|2017-10-10 23:31:56.453602
NCT02381756|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-10-26|||November 2015||2015-11-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|EFESE||Ultrasound and Left Ventricular Systolic Function|Ultrasound Evaluation of the Left Ventricular Systolic Function in Intensive Care Unit.|Suspended||N/A|100|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-10 23:31:56.548286|2017-10-10 23:31:56.548286
NCT02381743|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-01-11|||May 2015||2015-05-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|mCME project||The mCME Project:Delivering Continuing Medical Education for Community Health Workers Via SMS Text Messages|The mCME Project:Delivering Continuing Medical Education for Community Health Workers Via SMS Text Messages|Completed||N/A|638|Actual|Boston University||3|||f||||f||||||||||2017-10-10 23:31:56.628634|2017-10-10 23:31:56.628634
NCT02381730|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-02-07|||January 2014||2014-01-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PCV||Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment||Active, not recruiting||N/A|37|Actual|Fondation Ophtalmologique Adolphe de Rothschild||1|||f||||f||||||||||2017-10-10 23:31:56.721841|2017-10-10 23:31:56.721841
NCT02381717|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-09-25|||August 2015||2015-08-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Ultrasound Guided Femoral Nerve Block|Comparison of Ultrasound Guided Femoral Nerve Blockade and Standard Parenteral Opioid Pain Management Alone in Patients With Hip Fracture in the Emergency Department|Recruiting||N/A|60|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-10 23:31:56.804187|2017-10-10 23:31:56.804187
NCT02381704|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-05|||April 2008||2008-04-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Cost Analysis of Bariatric Surgery in an Employee-based Healthcare System Following Surgery Coverage|Cost Analysis of Bariatric Surgery in an Employee-based Healthcare System|Completed||N/A|100|Actual|Florida Hospital|||1||f||||f||||||||||2017-10-10 23:31:56.933339|2017-10-10 23:31:56.933339
NCT02381691|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-09-29|||January 2013||2013-01-01|September 2015|2015-09-01||||January 2016|Anticipated|2016-01-01||Interventional|||Analgesic Effect of Maternal Breast Milk Odor in Preterm Neonates: a Randomised Controlled Trial|Analgesic Effect of Maternal Breast Milk Odor in Preterm Neonates: a Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||||||||||||2017-10-10 23:31:57.059994|2017-10-10 23:31:57.059994
NCT02381678|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2016-08-22|2016-05-26||May 2014||2014-05-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Observational||This is one-arm study, all 225 subjects included in the Full Analysis Set.|A Retrospective Study to Collect the Data From the Patients Who Had the Perimount Heart Valve Replacement Surgery in China During 2001 to 2007||Completed||N/A|225|Actual|Edwards (Shanghai) Lifesciences Medical Supplies Co.,Ltd.|||1||f||||||||||||||2017-10-10 23:31:57.143303|2017-10-10 23:31:57.143303
NCT02381665|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-03-02|||March 2015||2015-03-01|March 2015|2015-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|CON-COUR||Efficacy of Interferential Therapy in Chronic Constipation (CON-COUR)|INTERFERENTIAL THERAPY IN THE TREATMENT OF CHRONIC CONSTIPATION IN ADULTS: A RANDOMIZED MULTI-CENTER TRIAL|Not yet recruiting||N/A|200|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:31:57.439866|2017-10-10 23:31:57.439866
NCT02381652|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-06-19|||February 2015||2015-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Repeat Injection of Cingal® for Osteoarthritis of the Knee|Cingal 13-02: An Open-Label, Follow-On Study to Cingal 13-01 to Evaluate the Safety of a Repeat Injection of Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee|Completed||Phase 3|242|Actual|Anika Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:31:57.518368|2017-10-10 23:31:57.518368
NCT02381639|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-07|||June 11, 2015||2015-06-11|September 2017|2017-09-01|August 16, 2017|Actual|2017-08-16|August 16, 2017|Actual|2017-08-16||Interventional|CoCA||Impairment of Central Coherence in Restrictive Anorexia Nervosa (CoCA)|Impairment of Central Coherence in Restrictive Anorexia Nervosa: Single-center and Case-control Study|Completed||N/A|122|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-10 23:31:57.607031|2017-10-10 23:31:57.607031
NCT02381626|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-10-03|||December 2014||2014-12-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)|DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)|Enrolling by invitation||N/A|42|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-10 23:31:57.676144|2017-10-10 23:31:57.676144
NCT02381613|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2015-03-05|||January 2012||2012-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2013|Actual|2013-01-01||Interventional|||Postprandial Differences After Herring and Beef|Postprandial Plasma Nutrient Differences Between Baked Beef, Baked Herring and Pickled Herring.|Completed||N/A|17|Actual|Chalmers University of Technology||3|||f||||f||||||||||2017-10-10 23:31:57.762218|2017-10-10 23:31:57.762218
NCT02381600|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-09-13|||October 2015||2015-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||An Evaluation of the Effect of Vitamin D Supplementation on the Cognitive Function of Older Subjects With Low Levels of This Vitamin|An Evaluation of the Effects of Vitamin D Supplementation on Specific Cognitive Functions and Depressive Symptoms of Older Subjects With Low Levels of This Vitamin|Recruiting||N/A|30|Anticipated|Meir Medical Center||1|||f||||t||||||||||2017-10-10 23:31:57.831523|2017-10-10 23:31:57.831523
NCT02381587|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-03-02|||April 2015||2015-04-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|HAS||the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients|Retrospective Study That Evaluate the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Patients With Primary Sjogren Syndrome|Unknown status|Not yet recruiting|N/A|500|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-10 23:31:57.922457|2017-10-10 23:31:57.922457
NCT02381561|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-06-30|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01||||July 1, 2017|Anticipated|2017-07-01||Interventional|||Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy|Phase I and Pharmacology Study of Oral 5-Iodo-2-Pyrimidinone-2'- Deoxyribose (IPdR) as a Prodrug for IUdR-Mediated Tumor Radiosensitization in Gastrointestinal Cancers|Recruiting||Phase 1|30|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:31:58.288826|2017-10-10 23:31:58.288826
NCT02381535|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-05|2017-09-15|||September 21, 2015|Actual|2015-09-21|September 2017|2017-09-01||||September 30, 2018|Anticipated|2018-09-30||Interventional|||Hsp90 Inhibitor AT13387 in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin|A Phase I Trial of AT13387 in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) Receiving Concurrent Radiation and Cisplatin|Active, not recruiting||Phase 1|36|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:31:58.503543|2017-10-10 23:31:58.503543
NCT02381522|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-05-02|||March 2015||2015-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RIPC-SAH||Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage|Remote Ischemic Pre-conditioning in Subarachnoid Hemorrhage|Recruiting||N/A|100|Anticipated|Loma Linda University||2|||f||||f||||||||||2017-10-10 23:32:00.285836|2017-10-10 23:32:00.285836
NCT02381509|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-03-23|||October 2015||2015-10-01|October 2015|2015-10-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|PRESERVE||Predicting the Safety and Effectiveness of Inferior Vena Cava Filters|Predicting the Safety and Effectiveness of Inferior Vena Cava Filters|Recruiting||N/A|1800|Anticipated|New England Research Institutes|||1||f||||t||||||||||2017-10-10 23:32:00.393597|2017-10-10 23:32:00.393597
NCT02381496|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2015-03-05|||December 2011||2011-12-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)|A Three-part Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) of ACT-453859 in Healthy Male Subjects, of Ascending Multiple Doses of ACT-453859 in Healthy Male and Female Subjects, and of Multiple Doses of Setipiprant (ACT-129968) in Healthy Male and Female Subjects|Completed||Phase 1|88|Actual|Actelion||11|||f||||f||||||||||2017-10-10 23:32:00.67136|2017-10-10 23:32:00.67136
NCT02381483|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2017-05-25|||February 2014||2014-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vitamin A in Brown Fat Activity|The Role of Vitamin A in Brown Fat Activity and Energy Metabolism|Recruiting||N/A|82|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-10 23:32:00.809661|2017-10-10 23:32:00.809661
NCT02381470|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-03-30|||July 2017|Anticipated|2017-07-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Bactericidal Activity Study of Faropenem(With Amoxicillin/Clavulanic Acid)in Patients With Pulmonary Tuberculosis|Trial of Faropenem (in Combination With Amoxicillin/Clavulanic Acid) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity, Whole Blood Bactericidal Activity and Effects on Novel Biomarkers|Not yet recruiting||Phase 2|28|Anticipated|National University Hospital, Singapore||3|||f||||t|f|f||||||||2017-10-10 23:32:00.99229|2017-10-10 23:32:00.99229
NCT02381457|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-20|||April 2015||2015-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01|2 Years|Observational [Patient Registry]|SMART||SNP-based Microdeletion and Aneuploidy RegisTry (SMART)|SNP-based Microdeletion and Aneuploidy RegisTry|Recruiting||N/A|10000|Anticipated|Natera, Inc.|||1||f||||f||||||Samples With DNA|"     -  Maternal residual blood sample        -  Placental tissue        -  Child dried blood spot        -  Child buccal sample   "|||2017-10-10 23:32:01.129914|2017-10-10 23:32:01.129914
NCT02381444|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2017-08-24|||April 17, 2015||2015-04-17|August 2017|2017-08-01|December 16, 2018|Anticipated|2018-12-16|December 16, 2018|Anticipated|2018-12-16||Observational|BALANCE||Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy|Health Related Quality of Life in LCIG Patients and LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy. A Multicenter Post Marketing Observational Study for LCIG in Germany and Switzerland - BALANCE|Recruiting||N/A|266|Anticipated|AbbVie|||2||f||||f||||||||||2017-10-10 23:32:01.34003|2017-10-10 23:32:01.34003
NCT02381431|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-01-12|||March 2015||2015-03-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Use of Mobile Phones for Thermal Imaging of the Chest to Save Lives of Children With Pneumonia in Nagpur, India|Use of Mobile Phones for Thermal Imaging of the Chest to Save Lives of Children With Pneumonia in Nagpur, India|Completed||N/A|75|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:32:01.540012|2017-10-10 23:32:01.540012
NCT02381418|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-10-31|2016-03-11||March 2015||2015-03-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season|Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Southern Hemisphere Season 2015. An Open-Label, Baseline-Controlled Study in Two Age Groups: Adult Subjects ≥ 18 and ≤ 60 Years and Elderly Subjects ≥ 61 Years of Age|Completed||Phase 3|120|Actual|Abbott||1|||f||||f||||||||||2017-10-10 23:32:01.638198|2017-10-10 23:32:01.638198
NCT02381405|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-03|2016-07-13|||February 2015||2015-02-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®)- for Maintaining Bowel Regularity in Patients With GI Toxicity From Any Combination of Therapy Including Tyrosine Kinase Inhibitors (TKI)|A Randomized Open Label Study Evaluating a Proprietary Amino Acid Mixture (Enterade®)- for Maintaining Bowel Regularity in Patients With GI Toxicity From Any Combination of Therapy Including Tyrosine Kinase Inhibitors (TKI)|Terminated||N/A|7|Actual|21st Century Oncology||2|||f||||||||||||||2017-10-10 23:32:01.916146|2017-10-10 23:32:01.916146
NCT02381392|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2017-03-12|||August 2014||2014-08-01|March 2017|2017-03-01|November 19, 2016|Actual|2016-11-19|November 19, 2016|Actual|2016-11-19||Interventional|||A Comparison of Accuvein to Standard IV Access in Children 0 to 24 Months of Age in the Pediatric ED|A Comparison of Accuvein to Standard Intravenous Access in Children 0 to 24 Months of Age in the Pediatric Emergency Department|Terminated||N/A|24|Actual|Los Angeles Biomedical Research Institute||2||Insufficient enrollment, investigator left institution|f||||t||||||||No||2017-10-10 23:32:01.992529|2017-10-10 23:32:01.992529
NCT02381379|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-09-20|||March 2015||2015-03-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|MSIT||Malaysia Stop Tyrosine Kinase Inhibitor Trial|A Randomized Control Trial Comparing Peginterferon-α-2a Versus Observation After Stopping Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia With Deep Molecular Response for at Least Two Years|Recruiting||Phase 3|118|Anticipated|Ministry of Health, Malaysia||2|||f||||f||||||||||2017-10-10 23:32:02.0791|2017-10-10 23:32:02.0791
NCT02381366|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2017-01-18|||March 2015||2015-03-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|September 2016|Actual|2016-09-01||Interventional|||Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study|A Phase I/II, Open-Label Dose Escalation Trial to Evaluate the Safety and Efficacy of Two Dose Levels of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD)|Active, not recruiting||Phase 1/Phase 2|12|Actual|Medipost America Inc.||1|||f||||t||||||||Undecided||2017-10-10 23:32:02.204294|2017-10-10 23:32:02.204294
NCT02381353|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-03-17|||February 2015||2015-02-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Exparel Injection for Postoperative Orbital Pain|Postoperative Pain Control After Enucleation or Evisceration, a Double-Masked Randomized Controlled Trial of Standard Versus Slow-release Bupivacaine|Recruiting||Phase 4|44|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:32:02.318115|2017-10-10 23:32:02.318115
NCT02381340|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-02|||June 2012||2012-06-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||ACE Stapler Sub Study|Effect of the BaroSense ACE Stapler Procedure on Food Intake, Food Reward, Gastric Emptying, Hormone Release, Inflammatory Profile, Gut Microbiota and Behaviour Towards Food.|Completed||N/A|10|Actual|Maastricht University Medical Center|||1||f||||f||||||Samples Without DNA|"     plasma samples, faeces   "|||2017-10-10 23:32:02.47107|2017-10-10 23:32:02.47107
NCT02381327|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-11-25|||February 2015||2015-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Reduction of the Speed of Eating as an Intervention in Obesity|Phase 1 Study of the Effect of Mandometer on Speed of Eating and Body Weight in Patients With Binge Eating Disorder|Completed||Phase 1|386|Actual|Mando Group AB||2|||f||||t||||||||||2017-10-10 23:32:02.539008|2017-10-10 23:32:02.539008
NCT02381314|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-04-11|||March 2015||2015-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer|A Phase 1, Open-Label, Dose Escalation Study of MGA271 in Combination With Ipilimumab in Patients With Melanoma, Non-Small Cell Lung Cancer, and Other Cancers|Recruiting||Phase 1|59|Anticipated|MacroGenics||1|||f||||f||||||||Undecided||2017-10-10 23:32:02.637403|2017-10-10 23:32:02.637403
NCT02381301|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-03-27|||February 2015||2015-02-01|March 2017|2017-03-01|December 2029|Anticipated|2029-12-01|December 2029|Anticipated|2029-12-01||Observational|||Biomarkers and Cardiac CT|Biomarkers and Cardiac Computed Tomography: Relationship Between Cardiovascular Biomarkers and Coronary Artery Disease in Patients Undergoing Cardiac Computed Tomography|Recruiting||N/A|5000|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-10 23:32:02.773875|2017-10-10 23:32:02.773875
NCT02381288|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-04-07|2017-04-07|2017-02-02|September 10, 2015|Actual|2015-09-10|April 2017|2017-04-01|April 8, 2016|Actual|2016-04-08|April 8, 2016|Actual|2016-04-08||Interventional||Safety analysis set included all randomized participants who received at least 1 dose of study drug or placebo.|Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone|A Randomized, Single-Blind, Placebo-Controlled Phase 2a Study to Evaluate the Stimulatory Effects of TAK-448, a Kisspeptin Analog, Administered Intermittently in Middle-aged and Older Men With Low Testosterone|Terminated||Phase 2|17|Actual|Takeda||4||Sponsor decision to terminate the study because the study did not meet the primary endpoint.|f||||t||||||||||2017-10-10 23:32:02.880199|2017-10-10 23:32:02.880199
NCT02381275|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-05|||August 2014||2014-08-01|March 2015|2015-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|LighTen||The Lighthouse Tenofovir Cohort Study|Baseline Characteristics and Long Term Clinical Outcomes of Patients Using Malawi's New First Line Antiretroviral Regimen at Lighthouse: The Lighthouse Tenofovir Cohort|Recruiting||N/A|1500|Anticipated|Lighthouse Trust|||1||f||||f||||||||||2017-10-10 23:32:03.664382|2017-10-10 23:32:03.664382
NCT02381262|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-10-03|||October 2015||2015-10-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Fitbit / Healthy Weight Management Study|Fitbit / Healthy Weight Management Study|Recruiting||N/A|213|Anticipated|Lancaster General Hospital||3|||f||||f||||||||||2017-10-10 23:32:03.743553|2017-10-10 23:32:03.743553
NCT02381249|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-02-09|||March 2015||2015-03-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery|The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery|Enrolling by invitation||N/A|80|Anticipated|St. James's Hospital, Ireland||4|||f||||f||||||||||2017-10-10 23:32:03.826757|2017-10-10 23:32:03.826757
NCT02381236|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-02-22|||February 2016||2016-02-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer|G-202-005: An Open-Label, Single-Arm, Phase II Study to Evaluate the Safety and Activity of G-202 Administered in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Adenocarcinoma of the Prostate|Completed||Phase 2|1|Actual|GenSpera, Inc.||1|||f||||f||||||||||2017-10-10 23:32:03.918433|2017-10-10 23:32:03.918433
NCT02381223|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-04-28|||March 2015||2015-03-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Simplified Medical Abortion Screening: A Pilot Demonstration Project|Simplified Medical Abortion Screening: A Pilot Demonstration Project|Completed||N/A|409|Actual|Gynuity Health Projects|||1||f||||f||||||||||2017-10-10 23:32:03.982243|2017-10-10 23:32:03.982243
NCT02381210|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-03-22|||July 2016||2016-07-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and Mexico|Diagnosis and Prediction of Preeclampsia: A Case Control Study of the Clinical Utility of Congo Red Dot Test in Bangladesh and Mexico|Recruiting||N/A|400|Anticipated|Gynuity Health Projects|||2||f||||t||||||Samples Without DNA|"     urine samples collected   "|Undecided||2017-10-10 23:32:04.03984|2017-10-10 23:32:04.03984
NCT02381197|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-03-22|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Longitudinal Study: Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and Mexico|Diagnosis and Prediction of Preeclampsia: A Longitudinal Study of the Clinical Utility of Congo Red Dot Test in Bangladesh and Mexico|Recruiting||N/A|2000|Anticipated|Gynuity Health Projects|||1||f||||t||||||Samples Without DNA|"     urine samples collected   "|No|Individual participant data will not be made available to the public.|2017-10-10 23:32:04.123249|2017-10-10 23:32:04.123249
NCT02381184|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2016-08-20|||June 2014||2014-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome|Extended Clomiphene Citrate Regimen Versus Laparoscopic Ovarian Drilling for Ovulation Induction in Clomiphene Citrate-resistant Women With Polycystic Ovary Syndrome|Completed||Phase 2/Phase 3|160|Actual|Benha University||2|||f||||f||||||||||2017-10-10 23:32:04.205241|2017-10-10 23:32:04.205241
NCT02381171|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-03-05|||February 2012||2012-02-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Transcranial Magnetic Stimulation and/or Neurofunctional Electrical Acupuncture in Myofascial Chronic Pain Patients|Transcranial Magnetic Stimulation and/or Neurofunctional Electrical Acupuncture in the Rehabilitation of Patients With Myofascial Chronic Pain|Unknown status|Recruiting|N/A|80|Anticipated|Hospital de Clinicas de Porto Alegre||4|||f||||f||||||||||2017-10-10 23:32:04.283417|2017-10-10 23:32:04.283417
NCT02381158|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-01-19|||February 2015||2015-02-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing|Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing|Completed||Phase 4|12|Actual|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy||1|||f||||f|f|f||||||||2017-10-10 23:32:04.391072|2017-10-10 23:32:04.391072
NCT02381145|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-03-02|||August 2012||2012-08-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Dietary Polyphenols and Insulin Sensitivity in Overweight and Obese Humans|Long-term Supplementation of Dietary Polyphenols as Modulators of Lipid Oxidation and Mitochondrial Function in Overweight Volunteers|Completed||N/A|42|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:32:04.45082|2017-10-10 23:32:04.45082
NCT02381132|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-03-23|||November 2014||2014-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain|A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain|Terminated||Phase 3|99|Actual|Lotus Clinical Research, LLC||2|||f||||f||||||||||2017-10-10 23:32:04.640391|2017-10-10 23:32:04.640391
NCT02381119|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-01-10|||May 2015||2015-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|PDA(4)T2D||Effects of Personalized Dietary Advice on Health Status of Diabetes Type 2 Patients|The Personalized Dietary Advice Services: Effects of Use by the Dietician on Health Status of Diabetes Type 2 Patients|Completed||N/A|28|Actual|TNO||2|||f||||f||||||||||2017-10-10 23:32:04.729699|2017-10-10 23:32:04.729699
NCT02381106|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-11-25|||November 2014||2014-11-01|November 2015|2015-11-01||||December 2015|Anticipated|2015-12-01||Observational|||The ADRB3 Receptor in Pregnancy|The ADRB3 Adrenergic Receptor - a Possible New Target for Controlling Pre-eclampsia and Hypertension in Pregnancy and Uterine Contractions in Non-pregnant and Pregnant Myometrium|Recruiting||N/A|80|Anticipated|Karolinska Institutet|||4||f||||f||||||Samples With DNA|"     uterine specimen placental specimen   "|||2017-10-10 23:32:04.84435|2017-10-10 23:32:04.84435
NCT02381093|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Does Contextual Interference Improve Retention of Basic Life Support Skills? A Randomized Controlled Trial|Does Contextual Interference Improve Retention of Basic Life Support Skills? A Randomized Controlled Trial|Recruiting||N/A|84|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 23:32:04.924374|2017-10-10 23:32:04.924374
NCT02381080|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-06-23|||May 19, 2015|Actual|2015-05-19|June 2017|2017-06-01|June 24, 2016|Actual|2016-06-24|June 24, 2016|Actual|2016-06-24||Interventional|||Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy|A Drug-drug Interaction Study of Ibrutinib With Moderate and Strong CYP3A Inhibitors in Patients With B-cell Malignancy|Completed||Phase 1|26|Actual|Janssen Research & Development, LLC||2|||f||||f||f||||||||2017-10-10 23:32:05.007094|2017-10-10 23:32:05.007094
NCT02381067|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-01-19|||March 2015||2015-03-01|January 2017|2017-01-01|December 15, 2016|Actual|2016-12-15|December 1, 2016|Actual|2016-12-01||Interventional|||A Prospective Study of NuCel® in Cervical Spine Fusion|A Prospective, Efficacy Study of NuCel® in Patients Undergoing Fusion for One, Two or Three Level Degenerative Disease of the Cervical Spine|Terminated||N/A|61|Actual|NuTech Medical, Inc||1||Departure of PI from the study facility|f||||f||||||||No||2017-10-10 23:32:05.129442|2017-10-10 23:32:05.129442
NCT02381054|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-06-27|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|June 22, 2017|Actual|2017-06-22|February 2017|Actual|2017-02-01||Observational|PRO-CTCAE||Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients|Translation, Cross-Cultural Adaptation and Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for Italian-speaking Cancer Patients|Completed||N/A|233|Actual|Italian PRO-CTCAE Study Group|||2||f||||f|f|f||||||||2017-10-10 23:32:05.219156|2017-10-10 23:32:05.219156
NCT02381028|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-03-04|||October 2008||2008-10-01|March 2015|2015-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children|Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children: A Small, Randomized, Split Body, Controlled, Blinded Pilot Study|Completed||N/A|9|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:32:05.399778|2017-10-10 23:32:05.399778
NCT02381002|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-03-05|||March 2012||2012-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|"ironobese"||Effect of Weight Reduction Program on Overweight and Obese Children|EVALUATION OF DIETARY REGIMEN AND PHYSICAL ACTIVITY ON IRON AND LIPID STATUS IN OVERWEIGHT AND OBESE CHILDREN 6 Months Prospective Study|Completed||N/A|150|Actual|Ain Shams University||1|||f||||t||||||||||2017-10-10 23:32:05.55824|2017-10-10 23:32:05.55824
NCT02380989|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-03-04|||September 2014||2014-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Integrative Ayurveda Healing Relieves Minor Sports Injury Pain|Integrative Ayurveda Healing Relieves Minor Sports Injury Pain:Results of a Multicenter Controlled Clinical Trial|Completed||Phase 2|210|Actual|Adwin Life Care||2|||f||||t||||||||||2017-10-10 23:32:05.631456|2017-10-10 23:32:05.631456
NCT02380976|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-10-11|||October 2015||2015-10-01|October 2016|2016-10-01||||October 2015|Actual|2015-10-01||Interventional|||Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers||Completed||Phase 1|24|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 23:32:05.704801|2017-10-10 23:32:05.704801
NCT02380963|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-09-28|||February 2015||2015-02-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of Soy Protein and Colorado Diet on Weight Loss and Maintenance|The Effect of Incorporating Soy Protein Foods in the Colorado Diet for Weight Loss and Maintenance|Unknown status|Active, not recruiting|N/A|72|Anticipated|DuPont Nutrition and Health||2|||f||||||||||||||2017-10-10 23:32:05.77604|2017-10-10 23:32:05.77604
NCT02380950|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-03-02|||June 2013||2013-06-01|March 2015|2015-03-01||||September 2013|Actual|2013-09-01||Interventional|||Effect of Moderate Alcohol Consumption to Cognitive Functioning After Roux-en Y Gastric Bypass||Completed||N/A|28|Actual|eSwiss Medical & Surgical Center||1|||f||||||||||||||2017-10-10 23:32:05.856853|2017-10-10 23:32:05.856853
NCT02380937|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-11-14|||January 2015||2015-01-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Radio Frequency Ablation for Atrial Flutter With Magnetic Resonance Guidance and Tracking|Radio Frequency Ablation for Atrial Flutter With Magnetic Resonance Guidance and Tracking: Pilot Study Using a Combination Imricor and Philips Interventional System|Terminated||N/A|8|Actual|Heartcenter Leipzig GmbH||1||"The study was terminated prematurely on 05May 2015 because of the unavailability of study   devices."|f||||f||||||||||2017-10-10 23:32:05.921168|2017-10-10 23:32:05.921168
NCT02380924|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-01-29|||January 2015||2015-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Recovery and Survival of EryDex in Non-patient Volunteers|Determination of the in Vivo Recovery and Survival of EryDex (Dexamethasone Sodium Phosphate Encapsulated in Autologous Erythrocytes) in Non-patient Volunteers|Completed||Phase 1|10|Actual|Erydel||2|||f||||f||||||||||2017-10-10 23:32:06.003045|2017-10-10 23:32:06.003045
NCT02380911|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-08-14|||April 2015||2015-04-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|EPRINA||Statins at the Primary Care Level|An Educational Intervention to Improve Effectiveness in the Detection, Treatment and Control of Patients With High Cardiovascular Risk in Low-resource Settings in Argentina: Rationale and Study Design of a Cluster Randomized Controlled Trial.|Completed||N/A|357|Actual|Institute for Clinical Effectiveness and Health Policy||2|||f||||f||||||||||2017-10-10 23:32:06.090629|2017-10-10 23:32:06.090629
NCT02380898|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2017-09-12|||March 2015||2015-03-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Preemptive Ketorolac for Shoulder Tip Pain During Cesarean Section|Preemptive Ketorolac for Intraoperative Shoulder Tip Pain During Cesarean Section: A Double‑Blind Randomized Clinical Trial.|Completed||Phase 4|200|Actual|Assiut University||2|||f||||||||||||||2017-10-10 23:32:06.188673|2017-10-10 23:32:06.188673
NCT02380885|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2017-05-26|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|RCT SCIT||RCT Social Cognition Training and Therapeutic Alliance Focused Therapy for Persons With Severe Mental Illness|Randomized Controlled Trial of Social Cognition Training and Therapeutic Alliance Focused Therapy for Persons With Severe Mental Illness|Completed||N/A|158|Actual|Bar-Ilan University, Israel||3|||f||||f||||||||||2017-10-10 23:32:06.26112|2017-10-10 23:32:06.26112
NCT02380872|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2015-03-02|||October 2012||2012-10-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Cytokine and MMP Levels in Gingival Crevicular Fluid in the Treatment of Localized Gingival Recessions|Cytokine (IL-1ß) and Matrix Metalloproteinase (MMP) Levels in Gingival Crevicular Fluid After Use of Platelet Rich Fibrin or Connective Tissue Graft in the Treatment of Localized Gingival Recessions|Completed||N/A|24|Actual|Ege University||2|||f||||f||||||||||2017-10-10 23:32:06.365447|2017-10-10 23:32:06.365447
NCT02380859|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-08-01|||February 2015||2015-02-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Visual Adaptation Study|Treatment of Gait Disturbance in Parkinson's Disease With Visual Adaptation|Active, not recruiting||N/A|30|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-10 23:32:06.452316|2017-10-10 23:32:06.452316
NCT02380846|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-02-03|||September 2013||2013-09-01|February 2017|2017-02-01|January 26, 2018|Anticipated|2018-01-26|January 26, 2018|Anticipated|2018-01-26||Interventional|||The Metabolic Effects of Consuming Carbohydrate With Different Protein Types|The Metabolic Effects of Consuming Carbohydrate With Different Protein Types|Active, not recruiting||N/A|15|Actual|Clinical Nutrition Research Centre, Singapore||5|||f||||f||||||||||2017-10-10 23:32:06.531346|2017-10-10 23:32:06.531346
NCT02378142|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-11-17|||March 2015||2015-03-01|November 2015|2015-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||Pazopanib for Treating Uterine Leiomyosarcoma|A Phase II Evaluation of Pazopanib in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Withdrawn||Phase 2|0|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-10 23:32:35.230805|2017-10-10 23:32:35.230805
NCT02380833|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-11-15|||April 2015||2015-04-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness of a Paleolithic Based Diet Compared to MyPlate Guidelines, With and Without Exercise, in Women.|The Effectiveness of a Paleolithic Based Diet Compared to MyPlate Guidelines, With and Without Exercise, on Physical Conditioning in Women: a Randomized Controlled Trial.|Completed||N/A|20|Actual|Clemson University||4|||f||||f||||||||||2017-10-10 23:32:06.616711|2017-10-10 23:32:06.616711
NCT02380820|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-04-08|||June 2015||2015-06-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SPA2-INVACARE||Comparative Measurements of Interface Pressures Between Two Pressure-ulcer Prevention Mattresses: Softform Premier and Airsoft Duo|Comparative Measurements of Interface Pressures Between Two Pressure-ulcer Prevention Mattresses: Softform Premier and Airsoft Duo|Completed||N/A|60|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 23:32:06.721706|2017-10-10 23:32:06.721706
NCT02380807|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2016-01-19|||March 2015||2015-03-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Dry Needling on Spinal Mobility and Trigger Points in Patients With Fibromyalgia Syndrome.|Effects of Dry Needling on Posture, Spinal Mobility and Trigger Points on Spinal Muscles in Patients With Fibromyalgia Syndrome.|Completed||N/A|66|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-10 23:32:06.804754|2017-10-10 23:32:06.804754
NCT02380794|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-07-18|||October 28, 2015|Actual|2015-10-28|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|June 2, 2017|Actual|2017-06-02||Interventional|||Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule|Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule|Recruiting||Phase 2|102|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:32:06.884753|2017-10-10 23:32:06.884753
NCT02380781|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2017-05-01|||March 2015||2015-03-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Contraceptive Counseling in the Postpartum Period|Contraceptive Counseling in the Postpartum Period|Recruiting||N/A|250|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||No||2017-10-10 23:32:06.973201|2017-10-10 23:32:06.973201
NCT02380768|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-07-17|||March 2015||2015-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Comparison of the Ambu AuraGain Versus LMA Supreme in Children|A Randomized Comparison of the Ambu AuraGain™ and LMA Supreme™ in Infants and Children|Completed||N/A|100|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-10 23:32:07.164361|2017-10-10 23:32:07.164361
NCT02380755|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-04-10|||April 2015||2015-04-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism|Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism: Metabolic and Cardiovascular Effects.|Recruiting||Phase 2|78|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:32:07.268073|2017-10-10 23:32:07.268073
NCT02380742|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-01-03|2016-10-05||July 2015||2015-07-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Topical Anesthetic Use In Pessary Management|Topical Anesthetic Use In Pessary Management: A Randomized Double Blinded Placebo Controlled Trial|Completed||Phase 2|54|Actual|Loyola University|There are no limitations or caveats to report.|2|||f||||f||||||||Yes||2017-10-10 23:32:07.395773|2017-10-10 23:32:07.395773
NCT02380729|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-03-02|||January 2015||2015-01-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|MENDEL||Mutation Exploration in Non-acquired, Genetic Disorders and Its Impact on Health Economy and Life Quality|Mutation Exploration in Non-acquired, Genetic Disorders and Its Impact on Health Economy and Life Quality|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||Samples With DNA|"     DNA extracted from peripheral blood cells of the index patient and of his/her parents.   "|||2017-10-10 23:32:08.252705|2017-10-10 23:32:08.252705
NCT02380716|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-11-02|||August 2015||2015-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:32:08.362071|2017-10-10 23:32:08.362071
NCT02380703|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2017-01-28|||February 2014||2014-02-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|APT||Aggression Prevention Training for Caregivers of Persons With Dementia (APT)|Aggression Prevention Training for Caregivers of Persons With Dementia (APT)|Enrolling by invitation||N/A|220|Anticipated|Baylor College of Medicine||2|||f||||t||||||||Yes|"The information generated in this proposal aims to prevent the development of aggression in persons with dementia. Clinician and participant manuals are developed for the intervention and will be widely shared through abstracts, presentation, publication and personal communication if the intervention is efficacious. In addition, if the intervention is found to be evidence-based, we will pursue placement on the websites of:
1) Substance Abuse and Mental Health Services Administration (SAMHSA) National Registry for Evidence-based Programs and 2) Rosalynn Carter Institute for Caregiving (RCI) Caregiver Intervention Database. Information about the study will also be available to interested investigators through NIH CRISP, and the Baylor College of Medicine Section of Health Services Research website. Requests to use the information will be considered on a case-by-case basis, following written request to the principal investigator."|2017-10-10 23:32:08.405162|2017-10-10 23:32:08.405162
NCT02380690|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-09-11|||May 1, 2015|Actual|2015-05-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|April 30, 2019|Anticipated|2019-04-30||Interventional|ECLIPSE||Evaluation of a Peer Coach-Led Intervention to Improve Pain Symptoms|Evaluation of a Peer Coach-Led Intervention to Improve Pain Symptoms (ECLIPSE)|Recruiting||N/A|295|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:32:08.499362|2017-10-10 23:32:08.499362
NCT02380677|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-04-18|||April 2015||2015-04-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors|Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumor Malignancies|Active, not recruiting||Phase 1/Phase 2|42|Actual|NewLink Genetics Corporation||1|||f||||f||||||||||2017-10-10 23:32:08.589656|2017-10-10 23:32:08.589656
NCT02380092|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-08-30|||September 2015||2015-09-01|August 2017|2017-08-01|September 2027|Anticipated|2027-09-01|September 2027|Anticipated|2027-09-01||Observational|||Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™|A Multicentre, Prospective, Post Market Clinical Follow Up Study of the LEGION™ Primary Total Knee System With VERILAST™ Bearing Surface|Recruiting||N/A|158|Anticipated|Smith & Nephew, Inc.|||1||f||||f||||||||||2017-10-10 23:32:14.606835|2017-10-10 23:32:14.606835
NCT02380664|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-27|||January 2012||2012-01-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Swimming Training Repercussion on Metabolic and Structural Bone Development; Benefits of the Incorporation of Whole Body Vibration or Plyometric Training: The RENACIMIENTO Project|Swimming Training Repercussion on Metabolic and Structural Bone Development; Benefits of the Incorporation of Whole Body Vibration or Plyometric Training. The RENACIMIENTO Project|Unknown status|Active, not recruiting|N/A|180|Actual|Universidad de Zaragoza||4|||f||||||||||||||2017-10-10 23:32:08.669579|2017-10-10 23:32:08.669579
NCT02380651|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2017-08-14|||December 2015||2015-12-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|||Functional Outcomes and HRQoL in Upper-extremity Sarcoma Patients After Limb Salvage|Functional Outcomes and Health Related Quality of Life in Upper-extremity Sarcoma Patients After Limb Salvage: a Prospective Study|Recruiting||N/A|70|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 23:32:08.744433|2017-10-10 23:32:08.744433
NCT02380638|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-02-27|||January 2010||2010-01-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Effects of Whole-body Vibration Training on Body Composition in Adolescents With and Without Down Syndrome|Effects of Whole-body Vibration Training on Bone Mass and Bone Metabolism in Adolescents With Down Syndrome / Efectos Del Entrenamiento Vibratorio en la Masa ósea y el Metabolismo óseo de Adolescentes Con síndrome de Down|Completed||N/A|58|Actual|Universidad de Zaragoza||4|||f||||||||||||||2017-10-10 23:32:08.84424|2017-10-10 23:32:08.84424
NCT02380625|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2015-03-01|||April 2015||2015-04-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Multiple Treatments for Ebola Virus Disease (EVD)|An Adaptive Randomized Trial Comparing Multiple Treatments for Ebola Virus (EBOV) Infected Children and Adults|Unknown status|Not yet recruiting|Phase 1/Phase 2|150|Anticipated|Clinical Research Management, Inc.||4|||f||||t||||||||||2017-10-10 23:32:08.928053|2017-10-10 23:32:08.928053
NCT02380612|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-03-06|||January 2015||2015-01-01|June 2016|2016-06-01|February 2017|Actual|2017-02-01|April 2016|Actual|2016-04-01||Interventional|||ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries|Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries|Completed||N/A|30|Actual|Avita Medical||2|||f||||f||||||||||2017-10-10 23:32:09.039267|2017-10-10 23:32:09.039267
NCT02380599|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2015-04-14|||January 2015||2015-01-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study of the Effects of Mid-Thoracic Spinal Manipulation and Spinal Mobilization on Heart Rate Variability|A Comparative Study of the Effects of Mid-Thoracic Spinal Manipulation and Spinal Mobilization on Heart Rate Variability|Unknown status|Enrolling by invitation|N/A|45|Anticipated|Mount St. Mary's College, Los Angeles, CA||1|||f||||f||||||||||2017-10-10 23:32:09.130285|2017-10-10 23:32:09.130285
NCT02380586|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2016-07-22|||November 2015||2015-11-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|OBAAMA-INT||Obstetric Anaesthesia And Analgesia Month Attributes - International|A National Survey on Obstetric Anesthesia and Analgesia Care - International|Completed||N/A|3040|Actual|Brno University Hospital|||1||f||||t||||||||||2017-10-10 23:32:09.209081|2017-10-10 23:32:09.209081
NCT02380573|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-07-21|||July 2015||2015-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|MB2||Cognitive and Functional Connectivity Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease|Cognitive and Functional Connectivity Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease|Recruiting||Phase 2|240|Anticipated|The University of Texas Health Science Center at San Antonio||8|||f||||t||||||||||2017-10-10 23:32:09.287822|2017-10-10 23:32:09.287822
NCT02380560|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-02|||March 2015||2015-03-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|||Myometrial Thickness as a Predictor for the Latency Interval in PPROM|Sonographic Assessment of Myometrial Thickness as a Predictor for the Latency Interval in Women With Preterm Premature Rupture of Membranes|Unknown status|Not yet recruiting|N/A|100|Anticipated|Cairo University|||3||f||||f||||||||||2017-10-10 23:32:09.427893|2017-10-10 23:32:09.427893
NCT02380547|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-10-04|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ECHODIA||Sonographic Evaluation of Diaphragmatic Function in Critical Care Patients With Use of Non Invasive Ventilation|Sonographic Evaluation of Diaphragmatic Function in Critical Care Patients With Use of Non Invasive Ventilation|Active, not recruiting||N/A|25|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:32:09.527115|2017-10-10 23:32:09.527115
NCT02380534|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-27|||February 2015||2015-02-01|February 2015|2015-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Use of Apheretic Technologies in Cardiovascular Disease|Use of H.E.L.P. Apheresis in Patients With High Cardiovascular Disease Lp(a)-Related|Recruiting||N/A|16|Anticipated|University of Pavia||1|||f||||f||||||||||2017-10-10 23:32:09.599223|2017-10-10 23:32:09.599223
NCT02380521|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-11-06|||January 2015||2015-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|||Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes|Effect of Exenatide Once Weekly on Cardiovascular Risk Markers in Patients With Type-2 Diabetes|Completed||Phase 4|60|Actual|University of Palermo||1|||f||||f||||||||||2017-10-10 23:32:09.674239|2017-10-10 23:32:09.674239
NCT02380508|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-11-29|||February 2015||2015-02-01|October 2016|2016-10-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Heterologous Effects of BCG in Healthy UK Adults|Evaluation of the Heterologous Effects of Bacille Calmette-Guérin (BCG) Vaccination in Healthy UK Adults|Completed||N/A|36|Actual|University of Oxford||2|||f||||f||||||||||2017-10-10 23:32:09.764355|2017-10-10 23:32:09.764355
NCT02380495|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-05-18|||March 2015||2015-03-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||"Studio NaVA - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without Asthma"|Studio NaVA - Studio Nazionale Sulla Qualità Della Vita in Adolescenti Con Rinite Allergica Con e Senza Asma|Completed||N/A|1200|Actual|Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy|||2||f||||f||||||||||2017-10-10 23:32:09.868028|2017-10-10 23:32:09.868028
NCT02379208|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-26|||April 2015||2015-04-01|February 2015|2015-02-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Observational|||Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma||Enrolling by invitation||N/A|60|Anticipated|Turku University Hospital|||1||f||||f||||||||||2017-10-10 23:32:24.306223|2017-10-10 23:32:24.306223
NCT02380482|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-12-08|||December 2014||2014-12-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|Echo-TC||Myocardial Dysfunction at Early Phase of Traumatic Brain Injury : Evaluation by Two Dimensional and Speckle Tracking Transthoracic Echocardiography|Myocardial Dysfunction at Early Phase of Traumatic Brain Injury : Evaluation by Two Dimensional and Speckle Tracking Transthoracic Echocardiography|Completed||N/A|40|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 23:32:09.939132|2017-10-10 23:32:09.939132
NCT02380469|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-03-02|||April 2015||2015-04-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Improvement of Information to Cancer Patients' Caregivers|Improvement of Information to Cancer Patients' Caregivers: a Randomised Intervention Study|Unknown status|Not yet recruiting|N/A|200|Anticipated|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-10 23:32:10.039852|2017-10-10 23:32:10.039852
NCT02380443|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-10-19|||September 2016||2016-09-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Increased Frequency of AlloStim® Immunotherapy Dosing in Combination With Cryoablation in Metastatic Colorectal Cancer|In-Situ Cancer Vaccine: Phase I/IIb, Open-Label Study to Assess the Safety of AlloStim® Immunotherapy in Combination With Cryoablation as Third Line Therapy for Metastatic Colorectal Cancer|Recruiting||Phase 2|18|Anticipated|Immunovative Therapies, Ltd.||6|||f||||t||||||||No||2017-10-10 23:32:10.132562|2017-10-10 23:32:10.132562
NCT02380430|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-07-28|||April 2014||2014-04-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|OPERA||Medical Management Survey : Organization of Perioperative Practices in Anesthesia and Ambulatory Surgery|Organisation PERiopératoire de l'anesthésie et de la Chirurgie Ambulatoire|Completed||N/A|2174|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 23:32:10.251222|2017-10-10 23:32:10.251222
NCT02380417|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-27|||October 2013||2013-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Paravertebral Catheter for Lung Transplant|Paravertebral Catheter Use for Postoperative Pain Control in Patients After Lung Transplant Surgery: A Prospective Observational Study|Completed||N/A|33|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-10 23:32:10.817281|2017-10-10 23:32:10.817281
NCT02380404|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-04-13|||June 2014||2014-06-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|March 2016|Actual|2016-03-01|5 Years|Observational [Patient Registry]|LOC||Effectiveness of Removable Prosthesis Retained by 4 Implant-supported Locator-Attachments|Clinical Outcomes of a Cost-effective Implant Treatment in the Edentulous Upper Maxilla: Effectiveness of Removable Prosthesis Retained by 4 Implant-supported Locator-Attachments.|Active, not recruiting||N/A|30|Actual|University Hospital of Liege|||1||f||||f||||||||||2017-10-10 23:32:10.897482|2017-10-10 23:32:10.897482
NCT02380391|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-02-28|||December 2013||2013-12-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|EVERE2ST-HIV||EValuation of REsidual Platelet REactivity After Acute Coronary Syndrome (ST+/ST-) in HIV|EValuation of REsidual Platelet REactivity After Acute Coronary Syndrome in HIV-infected Patients. The EVERE2ST-HIV Study.|Completed||N/A|260|Actual|Saint Antoine University Hospital|||2||f||||t||||||Samples With DNA|"     Each blood sample is composed of 5 tubes, for a total volume of 25 ml of blood :        -  1 x 4.5 ml citrated tube : standard light transmission aggregometry        -  1 x 4.5 ml citrated tube : Bedside test VerifyNow        -  2 x 4.5 ml citrated tubes : flow cytometry        -  1 x 7 ml EDTA tube : genetic analysis of cytochrome P450 2C19      Blood samples do not require fasting.   "|||2017-10-10 23:32:10.992911|2017-10-10 23:32:10.992911
NCT02380378|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-11-07|||March 2015||2015-03-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|MPN||Registry of Philadelphia-Negative Myeloproliferative Neoplasms|Registry of Philadelphia-Negative Myeloproliferative Neoplasms|Recruiting||N/A|500|Anticipated|Hospital Israelita Albert Einstein|||1||f||||t||||||||||2017-10-10 23:32:11.089597|2017-10-10 23:32:11.089597
NCT02380365|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-02|||April 2015||2015-04-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Observational|TX-QTC||QT-Prolongation in Lung Transplantation|QT-Prolongation in Lung Transplantation|Unknown status|Not yet recruiting|N/A|720|Anticipated|Hannover Medical School|||1||f||||f||||||||||2017-10-10 23:32:11.444269|2017-10-10 23:32:11.444269
NCT02380352|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-12-05|||September 2016||2016-09-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|SAFER||Short-course Antimicrobial Therapy for Paediatric Respiratory Infections|Short-course Antimicrobial Therapy for Paediatric Respiratory Infections|Recruiting||Phase 4|270|Anticipated|Hamilton Health Sciences Corporation||2|||f||||t||||||||||2017-10-10 23:32:11.566956|2017-10-10 23:32:11.566956
NCT02380339|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-02-28|||July 2015||2015-07-01|February 2017|2017-02-01||||April 2018|Anticipated|2018-04-01||Interventional|||A Combined Biofeedback-virtual Reality System for Reduction of Fear of Hypoglycemia||Recruiting||N/A|20|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 23:32:11.693669|2017-10-10 23:32:11.693669
NCT02380326|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-12-29|||October 2015||2015-10-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Innovation in Endobronchial Sampling|Innovation in Endobronchial Sampling : Integration of Virtual Bronchoscopic Navigation in the Current Diagnostic Algorithm and the Use of Micro-CT for Tissue Analysis|Recruiting||N/A|20|Anticipated|Katholieke Universiteit Leuven|||2||f||||f||||||Samples Without DNA|"     transbronchial biopsy   "|||2017-10-10 23:32:11.767118|2017-10-10 23:32:11.767118
NCT02380313|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-10-05|||October 2015||2015-10-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone|A Phase I, Open-Label, Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide (Xtandi) or Abiraterone (Zytiga) in Male Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||10||Study cancelled: Withdrawn before enrollment of any participants|f||||f||||||||||2017-10-10 23:32:11.84869|2017-10-10 23:32:11.84869
NCT02380300|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2015-03-04|||March 2015||2015-03-01|March 2015|2015-03-01||||December 2019|Anticipated|2019-12-01|2 Years|Observational [Patient Registry]|||Registry Study of Clinical Application of MRI Compatible CIED||Not yet recruiting||N/A|2500|Anticipated|Biotronik (Beijing) Medical Device Ltd.|||1||f||||||||||||||2017-10-10 23:32:11.963063|2017-10-10 23:32:11.963063
NCT02380287|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-04-15|2016-03-31||March 2015||2015-03-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||First-in-human Study to Evaluate Safety, Tolerability and Pharmacokinetics of Various Doses of BCD-085 in Healthy Subjects|Open-label, Phase I Dose-escalation Clinical Study of the Safety, Tolerability and Pharmacokinetics of Single Subcutaneus Dose of BCD-085, Monoclonal Antibody Against IL-17, in Healthy Subjects|Completed||Phase 1|22|Actual|Biocad||8|||f||||f||||||||||2017-10-10 23:32:12.03432|2017-10-10 23:32:12.03432
NCT02380274|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-09-27|||March 27, 2015|Actual|2015-03-27|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|TRUMPET||Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)|A Prospective Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) in the United States|Recruiting||N/A|1200|Anticipated|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 23:32:12.607593|2017-10-10 23:32:12.607593
NCT02380261|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-09-29|2016-08-09||September 2015||2015-09-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||This analysis population includes all enrolled participants.|A Clinical Study of Systane® Lid Wipes in Brazil|Assessment Of The Skin And Ocular Tolerance Of The Product Systane® Lid Wipes (050343-01) And Assessment Of The Study Subject Acceptance, Under Normal Use Conditions|Completed||N/A|35|Actual|Alcon Research||1|||f||||f||||||||||2017-10-10 23:32:13.160153|2017-10-10 23:32:13.160153
NCT02380248|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-05-10|2017-03-27||May 14, 2015|Actual|2015-05-14|May 2017|2017-05-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional||This analysis population includes all subjects who were exposed to investigational product (Safety Analysis Set).|Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects|Clinical Evaluation of Systane® Gel Drops on Corneal Staining in Indian Subjects With Dry Eye|Completed||N/A|207|Actual|Alcon Research||1|||f||||f|f|f||||||||2017-10-10 23:32:13.317108|2017-10-10 23:32:13.317108
NCT02380235|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-06-14|||December 2014||2014-12-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)||Recruiting||Phase 4|600|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:32:13.482377|2017-10-10 23:32:13.482377
NCT02380222|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-01-06|||July 2014||2014-07-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Patient-Reported Outcome Questionnaire for Systemic Mastocytosis|Patient-Reported Outcome Questionnaire Development for Symptoms of Systemic Mastocytosis|Completed||N/A|5|Actual|Adelphi Values LLC|||5||f||||f||||||||||2017-10-10 23:32:13.582033|2017-10-10 23:32:13.582033
NCT02380209|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-10-25|||August 2014||2014-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer|An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer|Terminated||Early Phase 1|8|Actual|University of Arizona||1||"PI has terminated study as the sequencing on patients and volunteers didn't yield the results   expected. PI has no plans for scholarly/scientific presentations."|f||||t||||||||||2017-10-10 23:32:13.667098|2017-10-10 23:32:13.667098
NCT02380196|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-04-11|||March 2015||2015-03-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Observational|||The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer|The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer|Recruiting||N/A|100|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     Blood Collection   "|||2017-10-10 23:32:13.745223|2017-10-10 23:32:13.745223
NCT02380183|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-01-22|||October 2014||2014-10-01|February 2015|2015-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Needle-Guided vs Free-Hand Technique in Performing Brachial Plexus Blockade|A Randomized Controlled Study Comparing Needle-Guided vs Free-Hand Technique in Performing Brachial Plexus Blockade|Completed||Phase 4|70|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 23:32:13.804859|2017-10-10 23:32:13.804859
NCT02380170|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-07-31|||September 2014||2014-09-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|SERPENS||Epidemiology and Outcomes of Gram Negative Urosepsis|Epidemiology and Outcomes of Gram Negative Urosepsis|Recruiting||N/A|600|Anticipated|European Association of Urology Research Foundation|||1||f||||f||||||||||2017-10-10 23:32:13.873557|2017-10-10 23:32:13.873557
NCT02380157|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-01-05|||March 2015||2015-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Blood Pressure Regulation - Role of Potassium|Oral Potassium Supplementation in Healthy Men - Interactions With the Renin-angiotensin-aldosterone System and the Sympathetic Nervous System|Completed||Phase 4|25|Actual|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-10-10 23:32:13.988572|2017-10-10 23:32:13.988572
NCT02380144|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-10-30|||January 2014||2014-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|May 2014|Actual|2014-05-01||Interventional|||Bioavailability of Carotenoids and Flavonoids From Fresh Oranges and Orange Juice.|Bioavailability of Carotenoids and Flavonoids From Fresh Oranges and Orange Juice.|Active, not recruiting||N/A|12|Actual|University of Hohenheim||2|||f||||f||||||||||2017-10-10 23:32:14.082252|2017-10-10 23:32:14.082252
NCT02380131|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-03-04|||February 2013||2013-02-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis|Phase IV Multi-Institutional Randomized Trial of Capecitabine Plus Oxaliplatin With Herceptin in Patients With Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis|Recruiting||Phase 4|60|Anticipated|Hebei Medical University||1|||f||||f||||||||||2017-10-10 23:32:14.159406|2017-10-10 23:32:14.159406
NCT02380118|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-10-03|||December 2014||2014-12-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||IM Olanzapine Versus Haloperidol or Midazolam|Intramuscular Olanzapine Versus Haloperidol or Midazolam for the Management of Acute Agitation in the Emergency Department - a Multicentre Randomised Clinical Trial|Recruiting||Phase 4|282|Anticipated|The University of Hong Kong||3|||f||||t||||||||||2017-10-10 23:32:14.25376|2017-10-10 23:32:14.25376
NCT02380105|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-02-27|||March 2012||2012-03-01|February 2015|2015-02-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness of a Counseling Program for Temporomandibular Disorders (TMD) Treatment|Effectiveness of a Counseling Program for TMD Treatment|Completed||N/A|50|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||||2017-10-10 23:32:14.538829|2017-10-10 23:32:14.538829
NCT02380079|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-04-11|||February 2015||2015-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose-Escalation Study of SCD-101 in Sickle Cell Disease|Part A: Phase IB, Single Site, Dose-Escalation of SCD-101 and Part B: Randomized, Double-Blind, Placebo-Controlled Crossover of SCD-101 in Adults With Homozygous Sickle Cell Disease or S/Beta 0 Thalassemia.|Recruiting||Phase 1|60|Anticipated|Invenux, LLC||2|||f||||f|t|f||||||No||2017-10-10 23:32:14.70825|2017-10-10 23:32:14.70825
NCT02380066|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-03-05|||March 2015||2015-03-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Comparison of Anyu Peibo With Placebo in Treatment of MDD|Proof Of Concept Study of Anyu Peibo in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial|Unknown status|Not yet recruiting|Phase 2|120|Anticipated|Shanghai Mental Health Center||5|||f||||f||||||||||2017-10-10 23:32:14.802867|2017-10-10 23:32:14.802867
NCT02380053|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-06-09|||June 2016||2016-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CPET1||Chronic Beta-blockade and Cardiopulmonary Exercise in COPD|Proof of Concept Study to Assess the Differential Effects of Chronic Beta-blockade (Celiprolol Versus Bisoprolol) on Cardiopulmonary Outcomes at Rest and During Exercise in Chronic Obstructive Pulmonary Disease|Recruiting||Phase 4|10|Anticipated|University of Dundee||2|||f||||f||||||||||2017-10-10 23:32:14.914417|2017-10-10 23:32:14.914417
NCT02380040|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-09-04|||March 2015||2015-03-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Observational|||Plethismographic Perfusion Index in Neonates|Examination of Perfusion Index in Term and Preterm Newborns Through Plethismography|Recruiting||N/A|100|Anticipated|Shaare Zedek Medical Center|||4||f||||f||||||||Undecided||2017-10-10 23:32:15.072549|2017-10-10 23:32:15.072549
NCT02380027|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-01-14|||January 2016||2016-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|PRECISION||PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not?|A Randomized Control Trial of Magnetic Resonance Imaging-targeted Biopsy Compared to Standard Trans-rectal Ultrasound Guided Biopsy for the Diagnosis of Prostate Cancer in Men Without Prior Biopsy|Recruiting||Phase 3|470|Anticipated|University College, London||2|||f||||t||||||||||2017-10-10 23:32:15.193138|2017-10-10 23:32:15.193138
NCT02378922|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-01-09|||June 2016||2016-06-01|January 2017|2017-01-01||||June 2019|Anticipated|2019-06-01||Interventional|||Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma|Autologous Transplantation and Stem Cell-Based Gene Therapy With LVsh5/C46 (CAL-1), a Dual Anti-HIV Lentiviral Vector, for the Treatment of HIV-Associated Lymphoma|Suspended||Phase 1|5|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-10 23:32:15.429595|2017-10-10 23:32:15.429595
NCT02378909|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-24|||April 2015||2015-04-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|Geko||Wound Healing Process in Diabetic Neuropathy and Diabetic Neuroischemia|Diabetic Wound Healing and Its Relationship to Vascular Circulation.|Unknown status|Not yet recruiting|Phase 1|60|Anticipated|University of Manchester||4|||f||||t||||||||||2017-10-10 23:32:15.585822|2017-10-10 23:32:15.585822
NCT02378896|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-12-22|||February 2015||2015-02-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Personalized Computerized Inhibitory Control Training for OCD|Personalized Computerized Inhibitory Control Training for OCD|Active, not recruiting||N/A|11|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-10 23:32:15.695893|2017-10-10 23:32:15.695893
NCT02378883|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-08-24|||May 18, 2015|Actual|2015-05-18|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study|Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety Study|Active, not recruiting||Phase 4|112|Actual|Medtronic Neurovascular Clinical Affairs||1|||f||||f||||||||||2017-10-10 23:32:15.788856|2017-10-10 23:32:15.788856
NCT02378870|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-06-29|||January 2015||2015-01-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC|A Randomised, Double-blind, Placebo-controlled Multicentre Phase II Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)|Terminated||Phase 2|3|Actual|DexTech Medical AB||2||Poor patient recruitment|f||||t||||||||||2017-10-10 23:32:15.882665|2017-10-10 23:32:15.882665
NCT02378857|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-04-18|||March 2015||2015-03-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|December 2018|Anticipated|2018-12-01||Observational|||Fontan Circulation and Cardiopulmonary Function: Prognostic Factors, Hemodynamics and Long-term Effects|Fontan Circulation and Cardiopulmonary Function: Prognostic Factors, Hemodynamics and Long-term Effects|Recruiting||N/A|80|Anticipated|Oslo University Hospital|||2||f||||t||||||Samples Without DNA|"     EDTA, citrate and serum samples for analysis for vitamin status, biochemical analysis,     inflammation markers and organ specific markers.   "|No||2017-10-10 23:32:15.987124|2017-10-10 23:32:15.987124
NCT02380014|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2016-07-25|||February 2015||2015-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:32:16.06748|2017-10-10 23:32:16.06748
NCT02380001|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-08-12|||January 2015||2015-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Analgesic Preoperative/Postoperative Dexketoprofen Trometamol in Third Molar Surgery|Analgesic Efficacy of Preoperative Oral Administration of Dexketoprofen Trometamol in Third Molar Surgery, Compared to Postoperative Administration|Completed||Phase 4|60|Actual|Universidad Autonoma de San Luis Potosí||2|||f||||t||||||||||2017-10-10 23:32:16.112753|2017-10-10 23:32:16.112753
NCT02379988|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-11-03|||November 2014||2014-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy|Pilot Study For Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy|Recruiting||Early Phase 1|10|Anticipated|University of Arizona||1|||f||||t||||||||||2017-10-10 23:32:16.236051|2017-10-10 23:32:16.236051
NCT02379975|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2015-03-01|||February 2013||2013-02-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of Non-surgical Periodontal Therapy in Patients With Rheumatoid Arthritis|Evaluation of Non-surgical Periodontal Therapy in Patients With Rheumatoid Arthritis|Completed||N/A|56|Actual|Santos Metropolitan University||2|||f||||t||||||||||2017-10-10 23:32:16.316703|2017-10-10 23:32:16.316703
NCT02379962|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-03-01|||November 2014||2014-11-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Public Perception and Attitude of Chinese Towards Biomedical Research and Biobanking in China|Public Perception and Attitude of Chinese Towards Biomedical Research and Biobank in China|Completed||N/A|478|Actual|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||||||2017-10-10 23:32:16.393345|2017-10-10 23:32:16.393345
NCT02379949|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-03-04|||August 2004||2004-08-01|February 2015|2015-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|FOPSII||Virtual Reality Exposure Therapy for the Treatment of Social Phobia|Virtual Reality Exposure Therapy for the Treatment of Social Phobia|Completed||N/A|97|Actual|Georgia State University||3|||f||||t||||||||||2017-10-10 23:32:16.456239|2017-10-10 23:32:16.456239
NCT02379936|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-03-04|||August 2013||2013-08-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|November 2013|Actual|2013-11-01||Interventional|HildaNeoHan||Evaluation of Lactate Dehydrogenase as Decision Support for Admissions to Neonatal Ward|Evaluation of a Point of Care Analyzer for Lactate Dehydrogenase, HildaNeo, as Support for Decisions When Admitting Newborn to the Neonatal Wards at NPH|Completed||N/A|122|Actual|National Hospital of Pediatrics, Vietnam||2|||f||||t||||||||||2017-10-10 23:32:16.585251|2017-10-10 23:32:16.585251
NCT02379923|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-04-19|||June 2015||2015-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CTO-PCI||The Asahi Intecc PTCA Chronic Total Occlusion Study|The Asahi Intecc PTCA Chronic Total Occlusion Study|Completed||N/A|163|Actual|Asahi Intecc USA Inc||1|||f||||t||||||||||2017-10-10 23:32:16.685059|2017-10-10 23:32:16.685059
NCT02379910|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-12-10|||November 2014||2014-11-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis|AM1030: A Phase I/II, Double-Blind, Placebo-Controlled, Single and Multiple Ascending (Topical) Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Patients (Male and Female) With Atopic Dermatitis|Completed||Phase 1/Phase 2|36|Actual|AnaMar AB||5|||f||||f||||||||||2017-10-10 23:32:16.839264|2017-10-10 23:32:16.839264
NCT02379897|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2015-02-27|||September 2000||2000-09-01|February 2015|2015-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Diet, Obesity and Cardiovascular Risk Study|Diet, Obesity and Cardiovascular Risk Study|Completed||N/A|107|Actual|Tufts University||4|||f||||f||||||||||2017-10-10 23:32:16.940138|2017-10-10 23:32:16.940138
NCT02379884|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2017-09-12|||March 2015||2015-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|VentWise||Mechanical Ventilation in Internal Medicine Elderly Patients - Choosing Wisely|Mechanical Ventilation in Internal Medicine Elderly Patients - Choosing Wisely|Active, not recruiting||N/A|619|Actual|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-10 23:32:17.029442|2017-10-10 23:32:17.029442
NCT02379871|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-02-28|||January 2014||2014-01-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effects of Mid-thoracic Manipulation on Heart Rate Variability.|The Effects of Mid-thoracic Manipulation on Heart Rate Variability.|Unknown status|Enrolling by invitation|N/A|90|Anticipated|Mount St. Mary's College, Los Angeles, CA||2|||f||||f||||||||||2017-10-10 23:32:17.095019|2017-10-10 23:32:17.095019
NCT02379858|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2016-12-09|||July 2015||2015-07-01|December 2016|2016-12-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Gastrointestinal Tract Recovery in Patients Undergoing Open Ventral Hernia Repair|Gastrointestinal Tract Recovery in Patients Undergoing Open Ventral Hernia Repair: A Multi-Center, Randomized, Double-Blind, Trial of Alvimopan and Placebo|Recruiting||N/A|140|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||No||2017-10-10 23:32:17.166774|2017-10-10 23:32:17.166774
NCT02379845|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-04-24|||February 2015||2015-02-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|November 2017|Anticipated|2017-11-01||Interventional|||NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating and Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall|MULTICENTER RANDOMIZED, OPEN-LABEL PHASE II/III STUDY, TO COMPARE EFFICACY OF NBTXR3 IMPLANTED AS INTRATUMOR INJECTION AND ACTIVATED BY RADIOTHERAPY, VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMA (EXTREMITY AND TRUNK WALL)|Recruiting||Phase 2/Phase 3|180|Anticipated|Nanobiotix||2|||f||||t||||||||||2017-10-10 23:32:17.28428|2017-10-10 23:32:17.28428
NCT02379832|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-02|2017-07-20|||March 2015||2015-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01|8 Months|Observational [Patient Registry]|PEARL||Pre-Eclampsia And Growth Restriction: a Longitudinal Study|Pré-Eclampsie et Retard de Croissance: Une étude Longitudinale Évaluative (PERLE)|Active, not recruiting||N/A|76|Actual|CHU de Quebec-Universite Laval|||2||f||||f||||||Samples Without DNA|"     Maternal serum Cord blood   "|||2017-10-10 23:32:17.477878|2017-10-10 23:32:17.477878
NCT02379819|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-03-28|||February 2015||2015-02-01|March 2017|2017-03-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|HNE||Hybrid L24 New Enrollment Post Approval Study|Nucleus Hybrid L24 Implant System: New Enrollment Study|Recruiting||N/A|100|Anticipated|Cochlear||1|||f||||f||||||||||2017-10-10 23:32:17.551132|2017-10-10 23:32:17.551132
NCT02379806|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-05-30|||September 2015||2015-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|SYMPTOMS||The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study|Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study|Recruiting||Phase 3|5030|Anticipated|University Hospital, Brest||2|||f||||t||||||||||2017-10-10 23:32:17.696593|2017-10-10 23:32:17.696593
NCT02379793|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-06-13|||March 2015||2015-03-01|February 2015|2015-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects|Skin Irritation Test of LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects|Completed||Phase 1|33|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-10 23:32:18.233394|2017-10-10 23:32:18.233394
NCT02379780|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-03-05|||September 2014||2014-09-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy|Comparison of the Effects of Perioperative Anesthesia Consumption of Ultrasound Guided Subcostal Transversus Abdominis Plane and Paravertebral Block in Laparoscopic Cholecystectomy|Completed||N/A|50|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:32:18.310153|2017-10-10 23:32:18.310153
NCT02379767|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-01|2016-09-12|||March 2015||2015-03-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Effects of ECT on Monoamine Oxidase A in Depression Investigated With PET|Effects of Electroconvulsive Therapy on Monoamine Oxidase A Distribution Volume in Treatment-Resistant Depression Investigated With PET|Recruiting||N/A|36|Anticipated|Medical University of Vienna|||2||f||||t||||||||||2017-10-10 23:32:18.393634|2017-10-10 23:32:18.393634
NCT02379754|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2016-09-06|||January 2015||2015-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function|Gentamicin Treatment Prior to Vestibular Schwannoma Surgery in Patients With Definite Remaining Vestibular Function|Recruiting||Phase 4|40|Anticipated|Lund University||2|||f||||f||||||||||2017-10-10 23:32:18.476532|2017-10-10 23:32:18.476532
NCT02379741|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-03-23|||April 2015||2015-04-01|March 2017|2017-03-01|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Interventional|||ADC-1013 First-in-Human Study|A First-in-human, Multicenter, Open-label, Multiple Ascending Dose Phase I Study in Patients With Advanced Solid Tumors to Determine the Safety, Pharmacokinetics and Pharmacodynamics of Intratumorally or Intravenously Administered ADC-1013|Completed||Phase 1|24|Actual|Alligator Bioscience AB||2|||f||||f||||||||||2017-10-10 23:32:18.594296|2017-10-10 23:32:18.594296
NCT02379728|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-07-12|||September 2015||2015-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Ghana PrenaBelt Trial|A Maternal Device to Reduce the Risk of Stillbirth and Low Birth-Weight|Completed||N/A|200|Actual|IWK Health Centre||4|||f||||f||||||||||2017-10-10 23:32:18.761998|2017-10-10 23:32:18.761998
NCT02379715|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-08-17|||December 2014||2014-12-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect-site Concentration of Remifentanil for Smooth Induction With Desflurane|Effect-site Concentration of Remifentanil for Smooth Induction With Desflurane|Completed||Phase 4|26|Actual|Ajou University School of Medicine||1|||f||||||||||||||2017-10-10 23:32:18.93856|2017-10-10 23:32:18.93856
NCT02379702|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-03-02|||June 2014||2014-06-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01|10 Years|Observational [Patient Registry]|||Metabolic Syndrome Prevalence Study|Turkey Metabolic Syndrome Prevalence Study - METSAR II|Completed||N/A|1659|Actual|Abdi Ibrahim Ilac San. ve Tic A.S.|||1||f||||f||||||||||2017-10-10 23:32:19.019816|2017-10-10 23:32:19.019816
NCT02379689|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-11-16|||December 2014||2014-12-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Intradiscal Injection of Viable Placental Tissue Extract in Subjects With One or Two Level, Symptomatic Lumbar Intervertebral Disc Degeneration|A Randomized, Double-Blinded, Placebo-Controlled With Crossover Study to Evaluate the Efficacy of Intradiscal Injection of Viable Placental Tissue Extract in Subjects With One or Two Level, Symptomatic Lumbar Intervertebral Disc Degeneration|Recruiting||N/A|30|Anticipated|Semmes-Murphey Foundation||2|||f||||||||||||||2017-10-10 23:32:19.103198|2017-10-10 23:32:19.103198
NCT02379676|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2016-07-03|||January 2015||2015-01-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation|Comparison of the Effects of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation in Patients With Prior Non-ST-segment Acute Coronary Syndrome|Recruiting||Phase 4|38|Anticipated|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-10 23:32:19.196043|2017-10-10 23:32:19.196043
NCT02379663|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-03-04|||January 2012||2012-01-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty|Efficacy and Safety for Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty|Completed||Phase 4|639|Actual|Samsung Medical Center||3|||f||||f||||||||||2017-10-10 23:32:19.305943|2017-10-10 23:32:19.305943
NCT02379650|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-28|2016-08-10|||July 2016||2016-07-01|August 2016|2016-08-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss|RCT Assessing Hydroxychloroquine for Unexplained Recurrent Pregnancy Loss|Withdrawn||Phase 2|0|Actual|University of Utah||2||"Testing required by FDA for IND approval was too expensive to move forward with conduct of the   study."|f||||t||||||||||2017-10-10 23:32:19.400293|2017-10-10 23:32:19.400293
NCT02379637|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-05-31|2016-03-30||January 2015||2015-01-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|NAC cold cough||Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough|A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multiple-Dose, Proof-of-Concept Study to Evaluate the Efficacy of N-acetylcysteine Capsules in the Treatment of the Common Cold (Viral URTI) Associated With Cough in an Adult Population|Completed||Phase 2|70|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:32:19.508562|2017-10-10 23:32:19.508562
NCT02379624|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-30|2015-03-04|||August 2014||2014-08-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pectin Start Early Enteral Nutritional Support in Critically Ill Patients|Pectin Start Early Enteral Nutritional Support in Critically Ill Patients|Completed||Phase 1/Phase 2|125|Actual|Nanjing University||2|||f||||t||||||||||2017-10-10 23:32:19.798891|2017-10-10 23:32:19.798891
NCT02379611|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-08-23|||September 2015||2015-09-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|Implaneuro||Study of Neurologic Development of Temporal Voice Area (TVA) in Deaf Infant|Clinical Trial Comparing Neurologic Development of Temporal Voice Area in Cochlear Implanted Deaf Infant and in Normally Hearing Infant.|Recruiting||N/A|80|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:32:19.896415|2017-10-10 23:32:19.896415
NCT02379598|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-27|||May 2012||2012-05-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|||Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy|Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy|Completed||N/A|50|Actual|Federico II University|||2||f||||f||||||||||2017-10-10 23:32:20.000558|2017-10-10 23:32:20.000558
NCT02379572|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-05-08|||June 2015||2015-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas|Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas - A Prospective Multicenter Parallel Group Clinical Trial|Recruiting||N/A|276|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-10 23:32:20.177479|2017-10-10 23:32:20.177479
NCT02379559|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-02-17|||July 2013||2013-07-01|September 2014|2014-09-01|February 16, 2017|Actual|2017-02-16|February 16, 2017|Actual|2017-02-16||Interventional|STRONG||Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men|An Exercise Intervention on Metabolic Syndrome and Prostate Cancer Risk Among Black Men|Completed||N/A|10|Actual|Georgetown University||2|||f||||t||||||||||2017-10-10 23:32:20.316176|2017-10-10 23:32:20.316176
NCT02379546|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-05-27|||August 2013||2013-08-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of Anaesthesia Depth on Oculo-cardiac Reflex|The Effect of Anaesthesia Depth on Oculo-cardiac Reflex in Strabismus Surgery|Completed||Phase 4|64|Actual|Tokat Gaziosmanpasa University||2|||f||||t||||||||||2017-10-10 23:32:20.399228|2017-10-10 23:32:20.399228
NCT02379533|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-03-24|||August 2009||2009-08-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|HBCKD||Effects of Home-based or Center-based Aerobic Exercise in Patients With Chronic Kidney Disease|Effects of Home-based or Center-based Aerobic Exercise on Physical Function, Nutritional Status Ans Cardiopulmonary Parameters in Patients With Chronic Kidney Disease|Completed||N/A|45|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-10-10 23:32:20.477008|2017-10-10 23:32:20.477008
NCT02379520|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-06-13|||September 2015||2015-09-01|June 2017|2017-06-01|October 2033|Anticipated|2033-10-01|October 2018|Anticipated|2018-10-01||Interventional|HESTIA||HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA|HPV-16/18 E6/E7-Specific T Lymphocytes in Patients With Relapsed HPV-Associated Cancers|Recruiting||Phase 1|32|Anticipated|Baylor College of Medicine||2|||f||||t|t|f||||||||2017-10-10 23:32:20.54316|2017-10-10 23:32:20.54316
NCT02379507|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-03-04|||January 2014||2014-01-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study|DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study|Completed||Phase 1|20|Actual|Medicus Research, LLC||1|||f||||f||||||||||2017-10-10 23:32:20.644631|2017-10-10 23:32:20.644631
NCT02379494|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-08-18|||March 2013||2013-03-01|February 2016|2016-02-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Observational|||First Trimester Prediction of Preeclampsia and Fetal Growth Restriction|First Trimester Prediction of Preeclampsia and Fetal Growth Restriction Using Uterine Artery Doppler, Maternal Blood Pressure, Maternal Characteristics, Placental Volume and Maternal Serum Factors|Completed||N/A|1200|Actual|Fetal Medicine Foundation|||1||f||||t||||||Samples Without DNA|"     A 5cc maternal blood sample will be obtained through standard blood draw. The blood will     first be transferred onto a dry blood requisition form card. The blood sample will be     refrigerated and the serum and dried blood spot samples will be sent to Perkin Elmer     Laboratories (see attachment C for collection protocols). The maternal serum levels of     PAPP-A, PLGF, AFP, and free β hCG will be measured according to a protocol established by     Perkin Elmer Laboratories.   "|||2017-10-10 23:32:20.700555|2017-10-10 23:32:20.700555
NCT02379481|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-06-30|||July 2013||2013-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Deer Bone Extract NS on Improvement in Cognitive-Bio-Markers of Cognitive Functions||Completed||N/A|75|Actual|Ewha Womans University||3|||f||||||||||||||2017-10-10 23:32:20.759785|2017-10-10 23:32:20.759785
NCT02379468|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-03-04|||April 2013||2013-04-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|PEDFUT||Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment|Phase IIIb, A Prospective, Open Label, Randomized, Controlled, Parallel Group, Multicenter Clinical Trial of 3 Months Duration Comparing Topical Application of Royal Jelly and Panthenol (PEDYPHAR® Ointment) to Panthenol Ointment Only for Diabetic Foot Ulcers Treatment.|Completed||Phase 3|80|Actual|European Egyptian Pharmaceutical Industries||2|||f||||f||||||||||2017-10-10 23:32:20.995716|2017-10-10 23:32:20.995716
NCT02379455|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-09-19|||March 2015||2015-03-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|August 2017|Actual|2017-08-01||Interventional|COOP||Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study|Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study|Active, not recruiting||N/A|190|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:32:21.080923|2017-10-10 23:32:21.080923
NCT02379442|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-10-05|||February 19, 2015||2015-02-19|August 28, 2017|2017-08-28|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids|A Pilot Study of Early Treatment of Acute Graft Versus Host Disease With Bone Marrow- Derived Mesenchymal Stem Cells and Corticosteroids: Correlation of Disease Severity and Response With Biomarkers|Recruiting||Phase 1/Phase 2|25|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:32:21.201666|2017-10-10 23:32:21.201666
NCT02379429|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-06-30|||February 19, 2015||2015-02-19|January 4, 2017|2017-01-04|January 1, 2025|Anticipated|2025-01-01|January 1, 2025|Anticipated|2025-01-01||Observational|||Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue|Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens From Healthy Volunteers and Urothelial Cancer Patients|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:32:21.285118|2017-10-10 23:32:21.285118
NCT02379416|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-09-12|||February 20, 2015||2015-02-20|August 14, 2017|2017-08-14|December 23, 2017|Anticipated|2017-12-23|December 23, 2017|Anticipated|2017-12-23||Interventional|||Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors|Phase I Trial of the Combination of Nilotinib and Paclitaxel in Adults With Refractory Solid Tumors|Recruiting||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:32:21.367424|2017-10-10 23:32:21.367424
NCT02379195|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-02-22|||November 2014||2014-11-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Peginterferon and TIL Therapy for Metastatic Melanoma|T Cell Therapy in Combination With Peginterferon for Patients With Metastatic Melanoma|Recruiting||Phase 1/Phase 2|12|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-10-10 23:32:24.377826|2017-10-10 23:32:24.377826
NCT02379403|ClinicalTrials.gov processed this data on October 10, 2017|2015-03-04|2017-10-05|||February 19, 2015||2015-02-19|May 9, 2017|2017-05-09|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Observational|||Effects of Tart Cherry and Aroniaberry Supplementation on Endothelial Function and Cardiovascular Measures in Healthy Older Adults: Interactions With Genotype and Proteome|Effects of Tart Cherry and Aroniaberry Supplementation on Endothelial Function and Cardiovascular Measures in Healthy Older Adults:Interactions With Genotype and Proteome|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:32:21.453813|2017-10-10 23:32:21.453813
NCT02379390|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-06-15|||June 2015||2015-06-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PRIMCAB||Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide|Phase II, Randomized, Open-label, Multicenter Study in Chemotherapy-naïve Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Who Have PRIMary Resistance to Abiraterone Acetate or Enzalutamide Treatment Comparing the Anti-tumor Effect of CABazitaxel to Alternative Androgen Receptors (AR) Targeted Therapy|Terminated||Phase 2|5|Actual|Sanofi||2||Unsatisfactory patient accrual|f||||f||||||||||2017-10-10 23:32:21.521005|2017-10-10 23:32:21.521005
NCT02379377|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-11-02|||March 2015||2015-03-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant|PET Imaging of Hepatocellular Carcinoma With 18F-FSPG|Recruiting||N/A|90|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 23:32:21.656782|2017-10-10 23:32:21.656782
NCT02379364|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-05-10|||May 2015||2015-05-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Diacutaneous Fibrolysis and Patellofemoral Pain Syndrome|Effectiveness of Diacutaneous Fibrolysis Technique on Pain, Range of Motion, Strength and Function in Patients With Patellofemoral Pain Syndrome|Completed||Phase 3|60|Actual|Universidad de Zaragoza||1|||f||||f||||||||||2017-10-10 23:32:21.753471|2017-10-10 23:32:21.753471
NCT02379351|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-05-17|||July 2015||2015-07-01|August 2016|2016-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring|Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring In A Local High-Risk Obstetric Population|Completed||N/A|60|Actual|University of Utah||1|||f||||f||||||||No||2017-10-10 23:32:21.81865|2017-10-10 23:32:21.81865
NCT02379338|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-06-13|||January 2015||2015-01-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT|Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluotriopride ([18F]FTP) by PET/CT|Recruiting||Phase 1|20|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:32:21.887294|2017-10-10 23:32:21.887294
NCT02379325|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-03-03|||April 2014||2014-04-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Text Message Stop Smoking Among Young Population|4-Weeks Intervention of Mobile Phone Text Messaging (Let's Quit!) on Smoking Cessation Among University Students: A Non Randomized Controlled Trial|Completed||N/A|60|Actual|Universiti Kebangsaan Malaysia Medical Centre||2|||f||||t||||||||||2017-10-10 23:32:21.966212|2017-10-10 23:32:21.966212
NCT02379312|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-02-26|||October 2011||2011-10-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparison of the Satiety Effect of a Very Low Energy Foam With Normal Energy Foams|Comparison of the Satiety Effect of a Very Low Energy Foam With Normal Energy Foams|Completed||N/A|72|Actual|Unilever R&D||4|||f||||f||||||||||2017-10-10 23:32:22.040761|2017-10-10 23:32:22.040761
NCT02379299|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-08-08||||||August 2016|2016-08-01||||July 22, 2017|Actual|2017-07-22||Interventional|||DiaCon Dual-Hormone Closed-Loop Glucose Control|Dual-Hormone Closed-Loop Glucose Control in Type 1 Diabetes|Withdrawn||Phase 2/Phase 3|0|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 23:32:22.106119|2017-10-10 23:32:22.106119
NCT02379286|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-02-27|||September 2014||2014-09-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|IMAJE||Impact of Media Images, Alcohol and Tobacco to Youth|Impact of Media Images, Alcohol and Tobacco to youthImpact Study and Development of a Prevention Program|Completed||N/A|1000|Actual|Institut de Cancérologie de la Loire|||1||f||||f||||||||||2017-10-10 23:32:22.174098|2017-10-10 23:32:22.174098
NCT02379273|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-09-01|||February 2015||2015-02-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|HED||Nucleus Hybrid L24 Extended Duration Post Approval Study|The Nucleus Hybrid L24 Implant System: Extended Duration Post Approval Study|Enrolling by invitation||N/A|42|Anticipated|Cochlear||1|||f||||f||||||||||2017-10-10 23:32:22.22847|2017-10-10 23:32:22.22847
NCT02379260|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-02-25|||May 2015||2015-05-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PEPs PROSTATE||Development of a Therapeutic Education Program for Patients Operated for Prostate Cancer|Development of a Therapeutic Education Intervention Improving Sexuality in Patients With Prostate Cancer Treated With Radical Prostatectomy|Completed||N/A|19|Actual|Institut de Cancérologie de la Loire||2|||f||||f||||||||||2017-10-10 23:32:22.290367|2017-10-10 23:32:22.290367
NCT02379247|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-07-20|||February 2015||2015-02-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer|Phase I/II Study of BYL719 and Nab-Paclitaxel in Subjects With Locally Recurrent or Metastatic HER-2 Negative Breast Cancer|Recruiting||Phase 1/Phase 2|54|Anticipated|University of Kansas Medical Center||4|||f||||t||||||||||2017-10-10 23:32:22.361434|2017-10-10 23:32:22.361434
NCT02379234|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-26|||January 2014||2014-01-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|SIMHeR||Simulation for Continuous Veno-venous Hemofiltration in Intensive caRe|SIMulation for HEmofiltration in Intensive caRe Unit|Unknown status|Recruiting|N/A|130|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 23:32:24.136153|2017-10-10 23:32:24.136153
NCT02379182|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-08-26|||October 2014||2014-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|VITAL||Effect Of Vitalstim In Patients With Chronic Post-stroke Oropharyngeal Dysphagia|Randomized Controlled Trial To Evaluate The Effect Of Vitalstim In Patients With Chronic Post-stroke Oropharyngeal Dysphagia|Completed||N/A|90|Actual|Hospital de Mataró||3|||f||||||||||||||2017-10-10 23:32:24.512688|2017-10-10 23:32:24.512688
NCT02379169|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-02-26|||February 2015||2015-02-01|November 2014|2014-11-01|August 2018|Anticipated|2018-08-01|February 2017|Anticipated|2017-02-01||Interventional|SBEYE||Effects of Sea Buckthorn Oil and Lutein on Eye Health||Not yet recruiting||N/A|90|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-10 23:32:24.60783|2017-10-10 23:32:24.60783
NCT02379156|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-04-21|||April 2015||2015-04-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia|Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia|Recruiting||Phase 4|30|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-10 23:32:24.691573|2017-10-10 23:32:24.691573
NCT02379143|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-02-26|||September 2013||2013-09-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Practice of the Short Wave Diathermy (SWD) Application|A Probe Into Practice of the Short Wave Diathermy (SWD) Application in Private Physiotherapy Clinics: a Survey From Ethical Practice & Safety Perspective.|Completed||N/A|49|Actual|TPCT's Terna College of Physiotherapy|||1||f||||t||||||||||2017-10-10 23:32:24.814856|2017-10-10 23:32:24.814856
NCT02379130|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-07-26|||February 2015||2015-02-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|EBI||Early Behavioral Intervention for Preterm Infants|FNI Between Mothers and Preschool Age Children|Terminated||N/A|36|Actual|Columbia University||2||Insufficient enrollment/retention|f||||f||||||||Undecided||2017-10-10 23:32:24.881985|2017-10-10 23:32:24.881985
NCT02379117|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-01-04|||April 2015||2015-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Eating Behaviour in Crohn's Disease|Eating Behaviour in Crohn's Disease|Completed||N/A|42|Actual|University of Nottingham|||2||f||||t||||||||||2017-10-10 23:32:25.101816|2017-10-10 23:32:25.101816
NCT02379104|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-05-10|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|ROSI-EVA||ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals|ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals|Recruiting||N/A|240|Anticipated|Tem Innovations GmbH|||2||f||||t||||||||No||2017-10-10 23:32:25.205589|2017-10-10 23:32:25.205589
NCT02379091|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-02-06|||February 2015||2015-02-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|NEXUS||Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)|A 24-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Finding Study to Evaluate the Efficacy and Safety of 3 Doses of Namilumab (20 mg, 80 mg and 150 mg) in Combination With Methotrexate (MTX) in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)|Completed||Phase 2|108|Actual|Takeda||4|||f||||f||||||||||2017-10-10 23:32:25.343523|2017-10-10 23:32:25.343523
NCT02379078|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-04-22|||March 2016||2016-03-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Impact of an Interprofessional Shared Decision-making and Goal-setting Decision Aid for Patients With Diabetes|Impact of an Interprofessional Shared Decision-making and Goal-setting Decision Aid for Patients With Diabetes - A Pilot Cluster Randomized Controlled Trial|Active, not recruiting||N/A|273|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-10-10 23:32:25.517155|2017-10-10 23:32:25.517155
NCT02379065|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-03-03|||February 2015||2015-02-01|February 2015|2015-02-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Aerogen Nebuliser Versus Standard Nebulised Therapy in Acute Chronic Obstructive Pulmonary Disease|Mesh Nebuliser Versus Standard Jet Nebuliser Therapy in Acute Chronic Obstructive Pulmonary Disease in the Emergency Department|Unknown status|Recruiting|N/A|40|Anticipated|Chelsea and Westminster NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:32:25.616598|2017-10-10 23:32:25.616598
NCT02379052|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-05-02|||January 2015||2015-01-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|March 6, 2017|Actual|2017-03-06||Interventional|||Study of Dupilumab in Adult Patients With Active Eosinophilic Esophagitis (EoE)|A Randomized, Double-Blind, Parallel, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Dupilumab in Adult Patients With Active Eosinophilic Esophagitis|Active, not recruiting||Phase 2|47|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:32:25.715188|2017-10-10 23:32:25.715188
NCT02379039|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-05-13|||May 2015||2015-05-01|May 2016|2016-05-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Observational|MORRIS||Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer|Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer in Head & Neck, Lung, Oesophagus, Anal Canal and Uterine Cervix - a Basis for Personalised Radiotherapy|Recruiting||N/A|412|Anticipated|Umeå University|||1||f||||t||||||Samples With DNA|"     Tumour biopsies, plasma   "|Yes|If relevant, anonymized data may be shared.|2017-10-10 23:32:25.832867|2017-10-10 23:32:25.832867
NCT02379026|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-04-02|||October 2014||2014-10-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Lifestyle Modifications for the Treatment of Sarcopenic Obesity|Improving Body Composition, Strength, Function and Health Related Quality of Life in Older Individuals With Sarcopenic Obesity Through Lifestyle Modifications|Active, not recruiting||N/A|18|Actual|Queen Margaret University||2|||f||||f||||||||||2017-10-10 23:32:25.916738|2017-10-10 23:32:25.916738
NCT02379013|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-02-10|||February 2015||2015-02-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|FATIGUE||Measure of Fatigue in Functional MRI|Development and Evaluation of a Cognitive-motor System for a Quantitative and Objective Measure of Fatigue in Functional MRI|Completed||N/A|37|Actual|Centre Hospitalier René Dubos||1|||f||||f||||||||No||2017-10-10 23:32:26.013667|2017-10-10 23:32:26.013667
NCT02379000|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-02-06|||January 2015||2015-01-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy|Transpupillary Thermotherapy (TTT) Alone Versus the Combined Therapy Consisting of TTT and Intravitreal Injection of Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy|Active, not recruiting||Phase 4|50|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:32:26.083564|2017-10-10 23:32:26.083564
NCT02378987|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-10|||October 2010||2010-10-01|August 2010|2010-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Observational|||The Follow Study of Speech Functions in Preschool Children With Cerebral Palsy: Clinical Measures and Acoustic Analysis|The Follow Study of Speech Functions in Preschool Children With Cerebral Palsy: Clinical Measures and Acoustic Analysis|Completed||N/A|46|Actual|Chang Gung Memorial Hospital|||3||f||||t||||||||||2017-10-10 23:32:26.16105|2017-10-10 23:32:26.16105
NCT02378974|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-10-30|||February 2015||2015-02-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of Cordstem-ST in Patients With Cerebral Infarction|A Randomized, Double-blind, Placebo-controlled, Phase I / IIa Clinical Trial for Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of Human Umbilical Cord-derived Mesenchymal Stem Cells in Patients With Cerebral Infarction|Active, not recruiting||Phase 1/Phase 2|18|Anticipated|CHABiotech CO., Ltd||2|||f||||f||||||||||2017-10-10 23:32:26.230926|2017-10-10 23:32:26.230926
NCT02378961|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-08-16|2017-08-16|2016-05-23|February 16, 2015|Actual|2015-02-16|August 2017|2017-08-01|January 26, 2016|Actual|2016-01-26|September 21, 2015|Actual|2015-09-21||Interventional||Safety Analysis Set: participants who received at least 1 dose of study drug.|Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection|A Phase 2, Global, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of GS-9857 Plus Sofosbuvir/GS-5816 Fixed Dose Combination in Subjects With Chronic Non-Genotype 1 HCV Infection|Completed||Phase 2|128|Actual|Gilead Sciences||7|||f||||f|t|f||||||||2017-10-10 23:32:26.327932|2017-10-10 23:32:26.327932
NCT02378948|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-02-10|||October 2015||2015-10-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|NUTRIENTII||Nutritional Route In Esophageal Resection Trial II|Nutritional Route in Esophageal Resection Trial II (NUTRIENT II): a Randomized Controlled Trial|Enrolling by invitation||N/A|148|Anticipated|Catharina Ziekenhuis Eindhoven||2|||f||||f||||||||Undecided||2017-10-10 23:32:27.442313|2017-10-10 23:32:27.442313
NCT02378844|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-05-03|||June 2015||2015-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||A Randomized, Multicentre, Double-blind, Parallel, Sham-controlled Study of the gammaCore|A Randomized, Multicentre, Double-blind, Parallel, Sham-controlled Study of the gammaCore®, a Non-invasive Neurostimulator Device, for the Prevention of Episodic Migraine|Recruiting||N/A|400|Anticipated|ElectroCore LLC||2|||f||||f||||||||Yes|Results will be presented|2017-10-10 23:32:27.773004|2017-10-10 23:32:27.773004
NCT02378831|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-08-25|||March 2016||2016-03-01|February 2015|2015-02-01||||July 2016|Anticipated|2016-07-01||Observational|||Comparison of In-lab PSG to WP200 for Assessing Sleep Parameters|Testing for Sleep Apnea in Adolescence Subjects With the WP200/WP200U Compared to an In-lab Overnight PSG Testing|Withdrawn||N/A|0|Actual|Itamar-Medical, Israel|||1|has not begun yet.|f||||f||||||||||2017-10-10 23:32:28.051572|2017-10-10 23:32:28.051572
NCT02378818|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-02-11|||November 2014||2014-11-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|SCHIZOBAT||Characterization of the Motivational Deficit in Schizophrenia and Depression|SCHIZOBAT/DEPBAT : Characterization of the Motivational Deficit in Schizophrenia and Depression|Recruiting||N/A|140|Anticipated|Centre Hospitalier St Anne||4|||f||||f||||||||||2017-10-10 23:32:28.121834|2017-10-10 23:32:28.121834
NCT02378805|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-10-24|||July 1995||1995-07-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2010|Actual|2010-07-01|10 Years|Observational [Patient Registry]|||European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome|European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome: Current and Novel Therapies|Recruiting||N/A|500|Anticipated|University Hospital Goettingen|||6||f||||f||||||Samples Without DNA|"     Urine and serum-samples.   "|||2017-10-10 23:32:28.249794|2017-10-10 23:32:28.249794
NCT02378792|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-10-11|||August 2014||2014-08-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|VNSRE||Clinical Trial of Vagus Nerve Stimulation for Treatment of Refractory Epilepsy|The Clinical Research on TsingHua Vagus Nerve Stimualtor for Treatment of Refractory Epilepsy|Recruiting||Early Phase 1|300|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:32:28.38479|2017-10-10 23:32:28.38479
NCT02378779|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-05-11|||April 2016||2016-04-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|GETUP||Consultations Reason for Genital, Urinary or Psychological Humans in General Practice|Consultations Reason for Genital, Urinary or Psychological Humans in General Practice|Recruiting||N/A|600|Anticipated|University Hospital, Brest||2|||f||||t||||||||No||2017-10-10 23:32:28.513864|2017-10-10 23:32:28.513864
NCT02378766|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-08-03|||December 2015||2015-12-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|LHIVEHEALTHY||Evaluation of Web-based Interventions to Support People Living With HIV in the Adoption of Health Behaviors|Evaluation of a Tailored Virtual Intervention as an Instrument of Prevention and Support to Improve the Health of PLHIV and Reduce Comorbidity Associated With HIV (MP-02-2015-5853)|Recruiting||N/A|750|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-10 23:32:28.69529|2017-10-10 23:32:28.69529
NCT02378740|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-06-14|||April 2015||2015-04-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Ketamine in Patients Undergoing Anterior Cervical Discectomy and Fusion|A Prospective, Block Randomized, Double-Blind Placebo-Controlled Trial of Ketamine in Patients Undergoing Anterior Cervical Discectomy and Fusion|Withdrawn||Phase 4|0|Actual|Northwestern University||2||PI has left the University|f||||f||||||||No||2017-10-10 23:32:28.919692|2017-10-10 23:32:28.919692
NCT02378727|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-07-01|||January 2015||2015-01-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|COMPASS||CompuFlo® Assessment Study for the Epidural Space Verification|CompuFlo® Assessment Study (COMPASS): A Randomized, Controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Effectiveness of the Epidural Space Verification With the CompuFlo® Epidural Computer Controlled System|Active, not recruiting||N/A|400|Actual|Milestone Scientific, Inc||2|||f||||t||||||||Undecided||2017-10-10 23:32:29.022997|2017-10-10 23:32:29.022997
NCT02378714|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-09-12|||June 2015||2015-06-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers|Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers|Recruiting||Phase 4|576|Anticipated|Northwestern University||4|||f||||t||||||||||2017-10-10 23:32:29.10887|2017-10-10 23:32:29.10887
NCT02378701|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-07-17|||February 2015|Actual|2015-02-01|July 2017|2017-07-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Observational|||Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease|Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease|Recruiting||N/A|240|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-10 23:32:29.230079|2017-10-10 23:32:29.230079
NCT02378688|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-10-12|||March 2015||2015-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease|A Phase II, Multicentre, Randomised, Double-Blind, Parallel Group, Placebo Controlled Study to Evaluate Safety, Tolerability and Clinical Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease|Completed||Phase 2|78|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||t||||||||||2017-10-10 23:32:29.457138|2017-10-10 23:32:29.457138
NCT02378675|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-03-03|||August 2012||2012-08-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Adipocytokines, Gestational Diabetes Mellitus and Lipid Metabolism|Influence of the Adipocytokines Apelin, Omentin, Resistin and Visfatin on Lipid Metabolism and Gestational Diabetes Mellitus|Completed||N/A|300|Actual|Medical University of Vienna|||2||f||||f||||||Samples With DNA|"     Serum   "|||2017-10-10 23:32:29.573512|2017-10-10 23:32:29.573512
NCT02378649|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-10-23|||March 2015||2015-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|||PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension|A Randomized, Placebo Controlled, Single Center Clinical Trial for Evaluation of Efficacy and Safety of Sildenafil Administration in the Cardiac ICU Following Mitral Valve Surgery in Patients With Pulmonary Hypertension|Recruiting||Phase 4|60|Anticipated|Sheba Medical Center||2|||f||||||||||||||2017-10-10 23:32:29.72313|2017-10-10 23:32:29.72313
NCT02378636|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-06-11|||June 2015||2015-06-01|June 2015|2015-06-01|August 2017|Anticipated|2017-08-01|January 2016|Anticipated|2016-01-01||Interventional|||Clinical Investigation of the Modified Rayner Monofocal Aspheric 600C (With Axis Marks) Intraocular Lens|Clinical Investigation of the Modified Rayner Monofocal Aspheric 600C (With Axis Marks) Intraocular Lens|Unknown status|Not yet recruiting|Phase 4|125|Anticipated|Rayner Intraocular Lenses Limited||1|||f||||f||||||||||2017-10-10 23:32:29.815071|2017-10-10 23:32:29.815071
NCT02378623|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-07-19|||May 2015||2015-05-01|July 2016|2016-07-01||||January 2020|Anticipated|2020-01-01||Interventional|PARADOX||Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli|PARADOX Trial: A Prospective, Double-Blind, Randomized Controlled Trial in Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli|Withdrawn||Phase 2|0|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:32:29.930508|2017-10-10 23:32:29.930508
NCT02378610|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-09-06|||February 2015||2015-02-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|||Relationship Between the Gut Microbiota and Stress|Relationship Between the Gut Microbiota and Stress|Completed||N/A|59|Actual|Lund University|||2||f||||f||||||Samples With DNA|"     Fecal samples   "|||2017-10-10 23:32:30.137341|2017-10-10 23:32:30.137341
NCT02378597|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-03-03|||January 2014||2014-01-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|CARE||Resiliency Program for Medical Interpreters|Developing a Resiliency Program for Medical Interpreters in Cancer Care|Completed||Phase 1/Phase 2|28|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:32:30.226431|2017-10-10 23:32:30.226431
NCT02378584|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-01-27|||February 2015||2015-02-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Natural Cycle Versus Endometrial Preparation for Healthy Blastocyst Transfer|The Clinical Results After Frozen-thawed Healthy Blastocyst Transfer in Natural Cycle Versus Cycle With Endometrial Preparation|Completed||N/A|236|Actual|European Hospital||2|||f||||t||||||||||2017-10-10 23:32:30.30768|2017-10-10 23:32:30.30768
NCT02378571|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-01-28|||December 2014||2014-12-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|TEAM-HF||Medication Adherence Telemonitoring to Reduce Heart Failure Readmissions|Telemonitoring Adherence to Medications to Reduce Heart Failure Readmissions: A Pilot Randomized Clinical Trial|Completed||N/A|40|Actual|Columbia University||2|||f||||t||||||||||2017-10-10 23:32:30.412309|2017-10-10 23:32:30.412309
NCT02378558|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-02-08|||March 2015||2015-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Trial of a New Magnetic Breast Marking Clip|Phase 1 Study of Magnetic Breast Marking Clip System MagneMark|Recruiting||N/A|42|Anticipated|Maimonides Medical Center||1|||f||||f||||||||Undecided||2017-10-10 23:32:30.516633|2017-10-10 23:32:30.516633
NCT02378363|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-02-27|||September 2012||2012-09-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|RISCOLAIRE||Representations and Prevention of Cancers in Schools|Representations and Prevention of Cancers in Schools|Completed||N/A|191|Actual|Institut de Cancérologie de la Loire|||1||f||||f||||||||||2017-10-10 23:32:32.924723|2017-10-10 23:32:32.924723
NCT02378545|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-09-18|||October 2015||2015-10-01|October 2016|2016-10-01|November 10, 2016|Actual|2016-11-10|October 2016|Actual|2016-10-01||Interventional|HO2T or NO2T||Trial of Hyperoxic O2 Therapy vs. Normoxic O2 Therapy in Sepsis|(Feasibility) Open Label Randomised Controlled Trial of Hyperoxic O2 Therapy vs. Normoxic O2 Therapy in Sepsis|Completed||Phase 4|50|Actual|Plymouth Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 23:32:30.636001|2017-10-10 23:32:30.636001
NCT02378532|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-08-17|||August 2016|Actual|2016-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|CHLOROBRAIN||The Addition of Chloroquine to Chemoradiation for Glioblastoma|A Phase I Trial for the Addition of Chloroquine, an Autophagy Inhibitor, to Concurrent Chemoradiation for Newly Diagnosed Glioblastoma|Active, not recruiting||Phase 1|7|Actual|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-10-10 23:32:30.764001|2017-10-10 23:32:30.764001
NCT02378519|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-09-22|||September 2014||2014-09-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|June 2016|Actual|2016-06-01||Interventional|||Interactive Web-based Program and CBT-coaching With Physiotherapy for Patients With Chronic Musculoskeletal Pain|Individualised Interactive Web-based Self-help Program and CBT-coaching in Combination With Physiotherapy for Patients With Persistent Musculoskeletal Pain|Active, not recruiting||N/A|12|Actual|Luleå Tekniska Universitet||2|||f||||f||||||||||2017-10-10 23:32:30.89275|2017-10-10 23:32:30.89275
NCT02378506|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-05-10|2017-03-21||April 2015||2015-04-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional||Safety population included all participants who had taken at least 1 dose of study medication.|Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects|A Single-arm, Open-label Study To Assess The Immunogenicity, Safety, And Efficacy Of Etanercept Manufactured Using The High Capacity Process Administered To Subjects With Rheumatoid Arthritis|Completed||Phase 3|188|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:32:31.037548|2017-10-10 23:32:31.037548
NCT02378493|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-06-16|||December 16, 2015|Actual|2015-12-16|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|BioFilm PieDia||Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections|Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections|Recruiting||N/A|40|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||Samples Without DNA|"     The S aureus strains encountered will be maintained in a collection for future ancillary     studies.   "|||2017-10-10 23:32:31.663868|2017-10-10 23:32:31.663868
NCT02378480|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-07-06|||June 2015||2015-06-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)|A Phase 3 Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline IV/PO to Linezolid IV/PO for Treating Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)|Completed||Phase 3|650|Anticipated|Paratek Pharmaceuticals Inc||2|||f||||t||||||||||2017-10-10 23:32:31.810316|2017-10-10 23:32:31.810316
NCT02378467|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-08-21|||March 2015||2015-03-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|SHIP||Saline Hypertonic in Preschoolers|Saline Hypertonic in Preschoolers|Active, not recruiting||N/A|150|Actual|University of Washington, the Collaborative Health Studies Coordinating Center||2|||f||||t||||||||||2017-10-10 23:32:32.028216|2017-10-10 23:32:32.028216
NCT02378454|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-07-29|||August 2014||2014-08-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children|Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children: A Comparison of Two Commercially Available Devices|Completed||N/A|100|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||2||f||||f||||||||||2017-10-10 23:32:32.179394|2017-10-10 23:32:32.179394
NCT02378441|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-12-29|||February 2015||2015-02-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg|A Randomized, Open-labeled, Single-dose, Crossover Design Clinical Trial to Evaluate Pharmacokinetics and Safety of CJ-30056 20/750mg and Co-administration of Lipitor® 20mg and Glucophage SR 750mg in Fed Healthy Male Subjects|Completed||Phase 1|42|Actual|CJ HealthCare Corporation||2|||f||||f||||||||No||2017-10-10 23:32:32.361067|2017-10-10 23:32:32.361067
NCT02378428|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-03-15|||March 2014||2014-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MIBG||MIBG Therapy for Patients With MIBG Avid Tumors|A Phase II Study of <131>I-Metaiodobenzyguanidine (<131>I-MIBG) Therapy for Patients With MIBG Avid Tumors|Recruiting||Phase 2|65|Anticipated|Nationwide Children's Hospital||1|||f||||t||||||||||2017-10-10 23:32:32.452772|2017-10-10 23:32:32.452772
NCT02378415|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-03-03|||December 2011||2011-12-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression|Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression|Terminated||Phase 1|20|Actual|United States Naval Medical Center, San Diego||2||Discrepancies in medication orders|f||||f||||||||||2017-10-10 23:32:32.547358|2017-10-10 23:32:32.547358
NCT02378402|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-08-12|||January 2014||2014-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Myocardial Lipid and Creatine of Heart Failure on MRS|Exploring Myocardial Lipid and Creatine as Imaging Biomarkers for Patients of Heart Failure|Recruiting||N/A|180|Anticipated|Chang Gung Memorial Hospital|||3||f||||t||||||||||2017-10-10 23:32:32.642746|2017-10-10 23:32:32.642746
NCT02378389|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-27|||September 2014||2014-09-01|February 2015|2015-02-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer|A Phase I Study of Pyrotinib In Combination With Docetaxel In Patients With HER2 Positive Advanced Gastric Cancer|Unknown status|Recruiting|Phase 1|28|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:32:32.753336|2017-10-10 23:32:32.753336
NCT02378376|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-02-27|||July 2013||2013-07-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||In Vivo Quantification of Short Chain Fatty Acids Production in the Human Colon|In Vivo Quantification of Short Chain Fatty Acids Production in the Human Colon After Consumption of Different Cereal Fractions.|Completed||N/A|10|Actual|Katholieke Universiteit Leuven||2|||f||||||||||||||2017-10-10 23:32:32.855671|2017-10-10 23:32:32.855671
NCT02378155|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-08-18|||February 2015||2015-02-01|August 2015|2015-08-01||||June 2015|Actual|2015-06-01||Interventional|||Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation||Completed||N/A|60|Anticipated|Hasselt University||2|||f||||f||||||||||2017-10-10 23:32:34.64114|2017-10-10 23:32:34.64114
NCT02378350|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-07|||March 26, 2014|Actual|2014-03-26|September 2017|2017-09-01|September 18, 2017|Anticipated|2017-09-18|September 18, 2017|Anticipated|2017-09-18||Interventional|||Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China|A Multicenter, Randomized, Open-Label Study of Quality of Life in Peritoneal Dialysis and Conventional In-Center Hemodialysis (ChinaQ Study)|Active, not recruiting||Phase 4|668|Actual|Baxter Healthcare Corporation||2|||f||||t||||||||||2017-10-10 23:32:33.005984|2017-10-10 23:32:33.005984
NCT02378337|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-08-19|||September 2014||2014-09-01|August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Observational|pet-ct||Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality||Completed||N/A|335|Actual|Hospital Sao Rafael|||2||f||||f||||||||||2017-10-10 23:32:33.132942|2017-10-10 23:32:33.132942
NCT02378324|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-02-27|||January 2013||2013-01-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Fee on Attendance in Cervical Cancer Screening|Effect of Fee on Attendance in Cervical Cancer Screening-results From ScreenFee a Swedish Population Based Randomised Trial|Completed||N/A|3124|Actual|Göteborg University||2|||f||||f||||||||||2017-10-10 23:32:33.222445|2017-10-10 23:32:33.222445
NCT02378311|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-01-13|||March 2015||2015-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|GRIP||Handlebar Grip Related Injury Prevention (GRIP) Study: Are Exposed Metal Handlebar Ends a Risk Factor for Injury?|A Multicentre Observational Case-controlled Feasibility Study: In Children Who Ride Bikes or Scooters, is the Risk of Sustaining a Serious Injury Greater When Metal Handlebar Ends Are Exposed Than When They Are Covered by Intact Grips?|Completed||N/A|50|Actual|Birmingham Women's and Children's NHS Foundation Trust|||2||f||||f||||||||No||2017-10-10 23:32:33.311986|2017-10-10 23:32:33.311986
NCT02378298|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-08-21|||December 2011||2011-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Rituximab (RTX) Therapy in Patients With Active TAO|Rituximab (RTX) Therapy in Steroid Resistant Patients or Patients Relapsing After Intravenous Steroids With Active TAO|Recruiting||Phase 4|50|Anticipated|Göteborg University||5|||f||||t||||||||||2017-10-10 23:32:33.442993|2017-10-10 23:32:33.442993
NCT02378285|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-26|||October 2010||2010-10-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Treatment of Epicondylitis by Ultrasound-guided Local Injections of PRP (Platelet Rich Plasma)|Treatment of Epicondylitis by Ultrasound-guided Local Injections of Autologous Conditioned Plasma (ACP®): a Double-blind Placebo-controlled Randomized Clinical Trial With One-year Follow-up|Completed||N/A|50|Actual|Arthrex SAS||2|||f||||f||||||||||2017-10-10 23:32:33.562875|2017-10-10 23:32:33.562875
NCT02378272|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-02-01|||December 2014||2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIM-CARE||Care Manager - Coordinating Care for Person Centered Management of Depression in Primary Care|RCT on Care Manager Organization for Management of Mild-moderate Depression in the Primary Care Setting, Sweden|Enrolling by invitation||N/A|400|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 23:32:33.672424|2017-10-10 23:32:33.672424
NCT02378259|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-07-03|||September 2014||2014-09-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|December 2017|Anticipated|2017-12-01||Interventional|AMOS-RCT||Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity|AMOS-RCT (Adolescent Morbid Obesity Surgery)|Recruiting||Phase 3|50|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 23:32:33.793966|2017-10-10 23:32:33.793966
NCT02378246|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-03-13|||November 2012|Actual|2012-11-01|March 2017|2017-03-01|June 2032|Anticipated|2032-06-01|June 2025|Anticipated|2025-06-01||Interventional|SWIDDICH||Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study|The Importance of Iodine During Pregnancy for Future Brain Function : a Randomized Placebo-controlled Trial. Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study|Recruiting||N/A|1275|Anticipated|Göteborg University||2|||f||||f||||||||Undecided|This has not yet been discussed by the study group.|2017-10-10 23:32:33.914285|2017-10-10 23:32:33.914285
NCT02378233|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-12-19|||October 2011||2011-10-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Iodine Status in Swedish Lactating Women - Effect of Iodine Supplementation in the Thyroid Function of Mother and Infant|A Double-blinded Randomised Study of Iodine Supplementation to Lactating Women in an Iodine-sufficient Area in Sweden and Evaluation of Maternal and Neonatal Iodine Levels and Thyroid Function|Recruiting||N/A|221|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 23:32:34.08845|2017-10-10 23:32:34.08845
NCT02378207|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-01-23|||May 2015||2015-05-01|January 2017|2017-01-01|December 9, 2016|Actual|2016-12-09|October 31, 2016|Actual|2016-10-31||Interventional|A-042||Phase 1b Safety and Immunogenicity Trial of BCG Revaccination, H4:IC31, and H56:IC31 in Healthy, HIV-1-Uninfected Adolescents|A Randomized, Placebo-controlled, Partially Blinded Phase 1b Clinical Trial to Evaluate the Safety and Immunogenicity of BCG Revaccination, H4:IC31, and H56:IC31 in Healthy, HIV-1-Uninfected Adolescent Participants|Completed||Phase 1|84|Actual|Aeras||4|||f||||t||||||||Undecided||2017-10-10 23:32:34.294505|2017-10-10 23:32:34.294505
NCT02378194|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-06-15|||January 2010|Actual|2010-01-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug||Completed||Phase 2|62|Actual|Hyundai Pharmaceutical Co., LTD.||3|||f||||f||||||||||2017-10-10 23:32:34.389889|2017-10-10 23:32:34.389889
NCT02378181|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-07-14|||August 16, 2016|Actual|2016-08-16|April 2017|2017-04-01|April 15, 2017|Actual|2017-04-15|April 15, 2017|Actual|2017-04-15||Interventional|||Testing the Effectiveness of a Graphic Novel Health Education Curriculum for Patients With Addiction|Testing the Effectiveness of a Graphic Novel Health Education Curriculum for Patients With Addiction|Completed||N/A|49|Actual|Treatment Research Institute||2|||f||||t||||||||||2017-10-10 23:32:34.463828|2017-10-10 23:32:34.463828
NCT02378168|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-11-02|||April 2014||2014-04-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|||6-month Follow up After Sevoflurane Postconditioning|Late Postconditioning After Cardiac Surgery - Bridge From Surrogate Markers to Clinical Outcome|Completed||N/A|108|Actual|University of Zurich|||1||f||||f||||||||||2017-10-10 23:32:34.551197|2017-10-10 23:32:34.551197
NCT02378129|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-03-03|||April 2014||2014-04-01|February 2015|2015-02-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Interventional|||Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements|Evaluation of the Effectiveness of Dentin Hypersensitivity Treatment Using Glass Ionomer Cements: A Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 2/Phase 3|20|Anticipated|Federal University of Pelotas||2|||f||||f||||||||||2017-10-10 23:32:35.319564|2017-10-10 23:32:35.319564
NCT02378116|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-03-03|||October 2011||2011-10-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|LAACS||Left Atrial Appendage Closure During Open Heart Surgery|Can We Protect the Brain Against Thrombus Embolism by Closing the Left Atrial Appendage During Open Heart Surgery|Unknown status|Recruiting|N/A|200|Anticipated|Frederiksberg University Hospital||2|||f||||f||||||||||2017-10-10 23:32:35.416843|2017-10-10 23:32:35.416843
NCT02378103|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2016-02-03|||February 2015||2015-02-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01||Observational|||A Single-center Trial of Patients With Aortic Dissection in the Chinese XinJiang Province||Active, not recruiting||N/A|100|Anticipated|First Affiliated Hospital of Xinjiang Medical University|||2||f||||||||||||||2017-10-10 23:32:35.510365|2017-10-10 23:32:35.510365
NCT02378090|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-11-09|||January 2015||2015-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||A Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico|An Observational Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico: The Mexican Emerging Infectious Disease Clinical Research Network (La Red)|Completed||N/A|888|Actual|Mexican Emerging Infectious Diseases Clinical Research Network|||1||f||||f||||||Samples With DNA|"     Samples will only be identified by the unique identifier assigned to each participant for the     study. All repository samples will be stored for a maximum of 15 years after the last     enrollment into the study; any remaining samples after this time will be destroyed, following     Mexican and United States of America (USA) Federal regulations.   "|||2017-10-10 23:32:35.569312|2017-10-10 23:32:35.569312
NCT02378077|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-10-19|||August 2014||2014-08-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Understanding the Relationship Between Inflammation and Insulin Resistance in the Adipose Tissue|Immunomodulatory Role of Eosinophils in Determining Inflammation and Insulin Sensitivity in Human Adipose Tissue- Aims 1&2|Recruiting||N/A|35|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:32:35.653654|2017-10-10 23:32:35.653654
NCT02378064|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-12-07|||May 2015||2015-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|FACE||Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation|Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation|Recruiting||Phase 4|50|Anticipated|Asan Medical Center||4|||f||||t||||||||||2017-10-10 23:32:35.787344|2017-10-10 23:32:35.787344
NCT02378051|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-01-09|||September 2014||2014-09-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Staying Strong With Schools - A School-Based Resilience Support Intervention for Military-Connected Children|Staying Strong With Schools - A School-Based Resilience Support Intervention for Military-Connected Children: A Preliminary Examination of Efficacy|Completed||N/A|190|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:32:35.891485|2017-10-10 23:32:35.891485
NCT02378038|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-01-20|||August 2015||2015-08-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)|A Phase II Study of PNT2258 in Patients With Richter's Transformation (RT)|Terminated||Phase 2|5|Actual|Sierra Oncology, Inc.||1|||f||||t||||||||No||2017-10-10 23:32:35.975823|2017-10-10 23:32:35.975823
NCT02378025|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-09-14|||October 2014||2014-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Treating Chronic Pain in Gulf War Illness|A Multimodal Evaluation of the Comparative Efficacy of Yoga Versus a Patient Centered Support Group for Treating Chronic Pain in Gulf War Illness|Active, not recruiting||N/A|100|Anticipated|Palo Alto Veterans Institute for Research||2|||f||||f||||||||||2017-10-10 23:32:36.066683|2017-10-10 23:32:36.066683
NCT02378012|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-09-28|||March 2014||2014-03-01|September 2017|2017-09-01|September 2014||2014-09-01|September 2014|Actual|2014-09-01||Interventional|BUCKiPAD||iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant|Project BUCKiPAD: The Evaluation of an iPAD Distribution Program on Anxiety and Depression in Bone and Marrow Transplant Patients|Terminated||N/A|124|Anticipated|Ohio State University Comprehensive Cancer Center||3||Competing study|f||||t||||||||||2017-10-10 23:32:36.155846|2017-10-10 23:32:36.155846
NCT02377999|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-05-01|||February 2015||2015-02-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts|Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts|Completed||Phase 2|40|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-10 23:32:36.247705|2017-10-10 23:32:36.247705
NCT02377986|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-02-09|||February 2015||2015-02-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Augmenting Buried in Treasures Workshop (BIT) With In-home Decluttering Practice for Individuals With Hoarding Disorder|Augmenting Buried in Treasures Workshop (BIT) With In-home Decluttering Practice for Individuals With Hoarding Disorder|Completed||N/A|8|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-10 23:32:36.32036|2017-10-10 23:32:36.32036
NCT02377973|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-03-03|||January 2011||2011-01-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|SKOT II||Diet and Well-being of Young Danish Children Born by Obese Mothers|The SKOT II Cohort - a Prospective Cohort Study of Diet and Well-being in Young Danish Children Born by Obese Mothers|Completed||N/A|184|Actual|University of Copenhagen|||1||f||||f||||||Samples With DNA|"     Urine, faeces, white cells, plama/serum   "|||2017-10-10 23:32:36.385019|2017-10-10 23:32:36.385019
NCT02377960|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-05-18|||February 2015||2015-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Check and Support -Enhancing the Treatment of Hypertension in Outpatient Care, a Multicenter Study|Check and Support -Pragmatic Randomized Controlled Study of the Effectiveness of 12 Month SMS-Text Message Support and IMB-based Initiation of Medication in Adults With Hypertension for Better Blood Pressure Control and Medication Adherence|Active, not recruiting||N/A|180|Anticipated|Kuopio University Hospital||3|||f||||f||||||||||2017-10-10 23:32:36.497385|2017-10-10 23:32:36.497385
NCT02377934|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-09-14|||September 2012||2012-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|MRI-HART||Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study|Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study|Completed||N/A|9|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-10 23:32:37.46332|2017-10-10 23:32:37.46332
NCT02377921|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-09-14|||May 27, 2015|Actual|2015-05-27|September 2017|2017-09-01|June 9, 2017|Actual|2017-06-09|June 9, 2017|Actual|2017-06-09||Interventional|GNEM||Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)|Completed||Phase 3|89|Actual|Ultragenyx Pharmaceutical Inc||2|||f||||t||||||||||2017-10-10 23:32:37.549012|2017-10-10 23:32:37.549012
NCT02377908|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-02-26|||October 2013||2013-10-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|June 2014|Actual|2014-06-01||Observational|||European Postgraduate Training in Geriatric Medicine|European Postgraduate Training in Geriatric Medicine|Unknown status|Recruiting|N/A|47|Anticipated|Klinikum Nürnberg|||1||f||||f||||||||||2017-10-10 23:32:37.697667|2017-10-10 23:32:37.697667
NCT02377895|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2017-01-25||2017-01-25|March 2015||2015-03-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis|A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Allergen BioCube Study Evaluating the Efficacy and Safety of Nasapaque Nasal Solution in a Population of Adult Subjects With Seasonal Allergic Rhinitis|Completed||Phase 1/Phase 2|73|Actual|3E Therapeutics Corporation||2|||f||||f||||||||||2017-10-10 23:32:37.777506|2017-10-10 23:32:37.777506
NCT02377882|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-08|2015-02-26|||January 2009||2009-01-01|February 2015|2015-02-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Observational|IONM||The Optimal Dosage of Rocuronium for Intraoperative Neuromonitoring During Thyroid Surgery|The Optimal Dosage of Neuromuscular Blocking Agent for Intraoperative Neuromonitoring During Thyroid Surgery|Completed||N/A|80|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||||||2017-10-10 23:32:37.886164|2017-10-10 23:32:37.886164
NCT02377869|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-02-25|||January 2015||2015-01-01|February 2015|2015-02-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Observational|||Heavy Light Chain in Chronic Lymphocytic Leukemia|Heavy Light Chain in Chronic Lymphocytic Leukemia|Recruiting||N/A|130|Anticipated|Bnai Zion Medical Center|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:32:37.983209|2017-10-10 23:32:37.983209
NCT02377856|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-02-29|||June 2007||2007-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection|Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection|Completed||Phase 4|20|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:32:38.08078|2017-10-10 23:32:38.08078
NCT02377843|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2016-09-09|||March 2015||2015-03-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Making Effective Human Papillomavirus (HPV) Vaccine Recommendations|Making Effective HPV Vaccine Recommendations|Completed||N/A|30|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||No||2017-10-10 23:32:38.189538|2017-10-10 23:32:38.189538
NCT02377830|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-04-04|||January 2015||2015-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CYCLE Pilot||CYCLE Pilot Randomized Trial|CYCLE Pilot: A Pilot Randomized Study of Early Cycle Ergometry Versus Routine Physiotherapy in Mechanically Ventilated Patients|Recruiting||Phase 2|60|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 23:32:38.342143|2017-10-10 23:32:38.342143
NCT02377817|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-02-19|||March 15, 2016|Actual|2016-03-15|February 2017|2017-02-01|January 28, 2017|Actual|2017-01-28|January 28, 2017|Actual|2017-01-28||Interventional|||Halifax PrenaBelt Trial|A Maternal Device for the Prevention of Stillbirth and Low Birth-Weight|Completed||N/A|23|Actual|IWK Health Centre||2|||f||||f||||||||||2017-10-10 23:32:38.501607|2017-10-10 23:32:38.501607
NCT02377804|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-27|2015-04-05|||January 2014||2014-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Dry Needling for Spasticity in Stroke|Changes in Spasticity, Range of Motion and Pressure Pain Sensitivity in Patients With Stroke After the Application of Dry Needling in the Shoulder Musculature|Completed||N/A|20|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-10 23:32:38.641799|2017-10-10 23:32:38.641799
NCT02377791|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-03|||July 2014||2014-07-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Observational|||Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients|Impact of CYP3A5 Genetic Polymorphisms on Tacrolimus Concentration and Transplant Outcomes During The Early Stage Post-Transplantation in Thai Kidney Transplant Recipients|Unknown status|Enrolling by invitation|N/A|170|Anticipated|Mahidol University|||1||f||||f||||||Samples With DNA|"     DNA for polymorphism CYP3A5   "|||2017-10-10 23:32:38.745542|2017-10-10 23:32:38.745542
NCT02377778|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-03|||January 2009||2009-01-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparative Effect of Theipoental and Propofol in IVF Outcome||Completed||Phase 4|180|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-10 23:32:38.824607|2017-10-10 23:32:38.824607
NCT02377206|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-06-22|||March 2015||2015-03-01|June 2015|2015-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|NICAD||Neuroinflammation and Cognitive Decline in Alzheimer Disease|Neuroinflammation and Cognitive Decline in Alzheimer Disease (AD) : Pilot Study of Translocator Proteins Ligand PET Imaging With [18F]DPA-714|Unknown status|Recruiting|Phase 1|45|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 23:32:45.181192|2017-10-10 23:32:45.181192
NCT02377765|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-10-19|||February 2014||2014-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement.|A Single Blind, Randomised, Controlled Trial to Evaluate the Effectiveness of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Overactive Bladder (OAB) Symptoms in Women Responders to Posterior Tibial Nerve Stimulation (PTNS)|Completed||N/A|24|Actual|Liverpool Women's NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 23:32:38.917672|2017-10-10 23:32:38.917672
NCT02377752|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-06-22|||March 23, 2015|Actual|2015-03-23|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|January 24, 2017|Actual|2017-01-24||Interventional|||A Study of Olaratumab in Japanese Participants With Advanced Cancer|A Phase 1 Study of Olaratumab in Japanese Patients With Advanced Soft Tissue Sarcoma or Advanced Solid Tumors|Active, not recruiting||Phase 1|18|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-10-10 23:32:39.010047|2017-10-10 23:32:39.010047
NCT02377739|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-10-07|||February 2015||2015-02-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study|Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study|Recruiting||N/A|30|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||1|||f||||f||||||||||2017-10-10 23:32:39.123356|2017-10-10 23:32:39.123356
NCT02377726|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-08-29|||April 2015||2015-04-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Anonymous Treatment on the Internet for Alcohol Dependence: A Randomised, Controlled Trial|Internet Based Treatment for Alcohol Dependence Among Anonymous Help Seekers on the Internet : A Randomized Controlled Trial|Recruiting||N/A|2400|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-10 23:32:39.217414|2017-10-10 23:32:39.217414
NCT02377713|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-12-06|||March 2015||2015-03-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.|A Phase 1 Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.|Completed||Phase 1|20|Actual|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||||2017-10-10 23:32:39.352264|2017-10-10 23:32:39.352264
NCT02377700|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-01-20|||June 2014||2014-06-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|September 2015|Actual|2015-09-01||Interventional|XEL-CR-06||Safety and Performance of a Vascular Patch in Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis|Initial Safety and Performance of the COR-VP-001 Vascular Patch in Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis|Active, not recruiting||N/A|5|Actual|Xeltis||1|||f||||f||||||||||2017-10-10 23:32:39.432545|2017-10-10 23:32:39.432545
NCT02377687|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-02-23|||November 2014||2014-11-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Is Life Worth Living After Major Emergency GI Surgery? Patient Reported Outcome in Elderly Emergency Surgery Patients|Is Life Worth Living After Major Emergency GI Surgery? Patient Reported Outcome in Elderly Emergency Surgery Patients|Completed||N/A|52|Actual|Hvidovre University Hospital|||1||f||||f||||||||No||2017-10-10 23:32:39.505953|2017-10-10 23:32:39.505953
NCT02377674|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-01-20|||October 2013||2013-10-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2015|Actual|2015-09-01||Interventional|EC-TCPC||Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection|To Assess the Initial Safety and Performance of COR-VG-001 Conduit in Pediatric Patients Undergoing Extracardiac Total Cavopulmonary Connection (EC-TCPC)|Active, not recruiting||N/A|5|Actual|Xeltis||1|||f||||f||||||||||2017-10-10 23:32:39.574585|2017-10-10 23:32:39.574585
NCT02377661|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-08-15|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|Low BP Vienna||Lowering Blood Pressure in Primary Care in Vienna|Lowering Blood Pressure in Primary Care in Vienna|Completed||Phase 4|229|Actual|Wilhelminenspital Vienna||2|||f||||f||||||||||2017-10-10 23:32:39.64278|2017-10-10 23:32:39.64278
NCT02377648|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-05-12|||January 2015||2015-01-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Interventional|CART||Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy|Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study|Recruiting||Phase 4|30|Anticipated|Universita di Verona||1|||f||||f||||||||||2017-10-10 23:32:39.730932|2017-10-10 23:32:39.730932
NCT02377635|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-05-13|||February 2015||2015-02-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|SEASP||Selenium and Arsenic Pharmacodynamics|Selenium and Arsenic Pharmacodynamics|Recruiting||Phase 1/Phase 2|40|Anticipated|University of Saskatchewan||2|||f||||t||||||||||2017-10-10 23:32:39.898362|2017-10-10 23:32:39.898362
NCT02377622|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-08-25|||February 2015||2015-02-01|February 2015|2015-02-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Performance Comparison of 2 THERANOVA 400 Dialyzer Prototypes in HD With High-Flux Dialyzers in HD and hv HDF Mode|Comparison of the Clinical Performance of 2 THERANOVA 400 Dialyzer Prototypes in HD With a High-Flux Dialyzer in HD and a High-Flux Dialyzer in hvHDF - A Pilot Study|Completed||N/A|20|Actual|Baxter Healthcare Corporation||4|||f||||f||||||||||2017-10-10 23:32:40.003842|2017-10-10 23:32:40.003842
NCT02377609|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-05-14|||October 2013||2013-10-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks|Cross-validation of the Finger Prick Dried Blood Spot Assay Method With the Established Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patients|Terminated||N/A|108|Actual|Astellas Pharma Inc|||1|"DBS method not be validated against the standard of care venepuncture method due to quality of   blood sample and variable tacrolimus extraction"|f||||f||||||Samples With DNA|"     Dried blood spot and blood collected by venepuncture   "|||2017-10-10 23:32:40.089392|2017-10-10 23:32:40.089392
NCT02377596|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-02-25|||December 2011||2011-12-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|FDDT||Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children With Oral Feeding Resistance|Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children With Oral Feeding Resistance|Withdrawn||N/A|0|Actual|Children's Research Institute|||1|Not enough participants|f||||f||||||||||2017-10-10 23:32:40.232186|2017-10-10 23:32:40.232186
NCT02377583|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-02-25|||August 2012||2012-08-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|CORTICODIAB||Hypothalamo-pituitary Adrenal Axis Activity and Neuropsychological Consequences in Type 1 Diabetes in Childhood|Hypothalamo-pituitary Adrenal Axis Activity: Relation With Neuropsychological Consequences in Type 1 Diabetes in Childhood. The CORTICODIAB Study|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Bordeaux|||2||f||||t||||||Samples With DNA|"     20ml blood sample in order to evaluate:        -  NR3C1 (GR) gene        -  NR3C2 (MR) gene        -  FKBP5 gene        -  CRH gene        -  CRHR1 gene        -  CBG gene   "|||2017-10-10 23:32:40.303182|2017-10-10 23:32:40.303182
NCT02377570|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-07-09|||March 2015||2015-03-01|October 2014|2014-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes With a High-Flux Dialyzer in Hemodialysis Mode|Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes With a High-Flux Dialyzer in Hemodialysis Mode - A Pilot Study|Completed||N/A|20|Actual|Baxter Healthcare Corporation||4|||f||||t||||||||||2017-10-10 23:32:40.38898|2017-10-10 23:32:40.38898
NCT02377557|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-08-15|||February 2015||2015-02-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01|6 Months|Observational [Patient Registry]|||Observational Study to Assess Safety and Utility Pattern of Topical Steroids|Topical Steroid Registry: Observational Study to Assess Safety and Use Pattern in Korea|Completed||N/A|1175|Actual|Hanyang University|||1||f||||f||||||||No||2017-10-10 23:32:40.470492|2017-10-10 23:32:40.470492
NCT02377544|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-02-24|||December 2014||2014-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Role of Bifidobacterium Animalis Ssp Lactis DR10 Supplementation in Women During Pregnancy and Lactation on Breast Milk IL-8 and Gut Mucosa Integrity in Infant|The Role of Bifidobacterium Animalis Ssp Lactis DR10 Supplementation in Women During Pregnancy and Lactation on Breast Milk IL-8 and Gut Mucosa Integrity in Infant|Completed||N/A|70|Actual|Indonesia University||2|||f||||t||||||||||2017-10-10 23:32:40.536563|2017-10-10 23:32:40.536563
NCT02377531|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-04-14|||March 2015||2015-03-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Early Screen and Treatment for Gestational Diabetes|Gestational Diabetes Mellitus: Does Early Screening and Treatment for Patients at Increased Risk for Gestational Diabetes Impact Perinatal Outcomes? A Randomized Controlled Trial|Recruiting||N/A|1020|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-10 23:32:40.601061|2017-10-10 23:32:40.601061
NCT02377518|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-04-04|||June 2015||2015-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||DECT Ventilation Imaging|Quantitative Ventilation Imaging With Dual Energy Computed Tomography|Recruiting||N/A|20|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:32:40.688309|2017-10-10 23:32:40.688309
NCT02377505|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-02-23|||January 2013||2013-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|DBS-SCHIZO||Deep Brain Stimulation in Treatment Resistant Schizophrenia|Deep Brain Stimulation in Treatment Resistant Schizophrenia: Randomized, Controlled, Crossover Pilot Study|Recruiting||N/A|8|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||Undecided||2017-10-10 23:32:40.780363|2017-10-10 23:32:40.780363
NCT02377492|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-02|||March 2015||2015-03-01|February 2015|2015-02-01||||March 2017|Anticipated|2017-03-01||Interventional|||Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy|Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy: A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-10 23:32:40.879283|2017-10-10 23:32:40.879283
NCT02377479|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-02|||March 2015||2015-03-01|February 2015|2015-02-01||||March 2017|Anticipated|2017-03-01||Interventional|||Endocrinology Profile in Patients Undergoing Clomiphene, Letrozole, and Combination Clomiphene and Letrozole Cycles||Unknown status|Not yet recruiting|N/A|10|Anticipated|University Hospitals Cleveland Medical Center||3|||f||||f||||||||||2017-10-10 23:32:42.576805|2017-10-10 23:32:42.576805
NCT02377453|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-10-03|||April 2014||2014-04-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|||A Longitudinal Study of Function and Participation in Patients With Stroke|A Longitudinal Study of Function and Participation in Patients With Stroke: An Integrated Brain Imaging and Biomechanical Analysis|Recruiting||N/A|300|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||||No||2017-10-10 23:32:42.879412|2017-10-10 23:32:42.879412
NCT02377440|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-12-03|||October 2013||2013-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Effects of ACEI on Bone Turnover|Effects of Angiotensin Converting Enzyme Inhibitors (ACEI) on Bone Turnover|Completed||N/A|32|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples Without DNA|"     serum samples   "|||2017-10-10 23:32:42.956363|2017-10-10 23:32:42.956363
NCT02377414|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-05-05|||March 2, 2015|Actual|2015-03-02|May 2017|2017-05-01|April 17, 2015|Actual|2015-04-17|April 17, 2015|Actual|2015-04-17||Interventional|||Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women|A Phase I, Subject and Investigator Blind Randomized, Study to Investigate the Pharmacokinetics, Safety and Tolerability of Retosiban in Healthy Japanese Women|Completed||Phase 1|32|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:32:43.233411|2017-10-10 23:32:43.233411
NCT02377401|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-05-05|||April 28, 2015|Actual|2015-04-28|May 2017|2017-05-01|June 19, 2015|Actual|2015-06-19|June 19, 2015|Actual|2015-06-19||Interventional|||Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults|A Randomized, Double Blinded, Parallel Study to Evaluate the Pharmacokinetics of Zanamivir After Single and Repeated Dose (300 mg and 600 mg) Infusion Administration in Healthy Chinese Adults|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:32:43.331278|2017-10-10 23:32:43.331278
NCT02377388|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-04-10|||February 7, 2017|Actual|2017-02-07|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Saxagliptin and Acute Myocardial Infarction:Effects on Platelet Function|Saxagliptin in Patients With Type 2 Diabetes and Acute Myocardial Infarction:Effects on Platelet Function|Recruiting||Phase 3|80|Anticipated|University of Sao Paulo General Hospital||2|||f||||t|t|f|||f|||Undecided||2017-10-10 23:32:43.433546|2017-10-10 23:32:43.433546
NCT02377375|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-01-26|||January 2015||2015-01-01|January 2016|2016-01-01||||December 2019|Anticipated|2019-12-01||Interventional|||Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD): Improving Targeting Precision|Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD) in the Bed Nucleus of the Stria Terminalis (BNST): Improving Targeting Precision|Recruiting||N/A|10|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-10 23:32:43.583008|2017-10-10 23:32:43.583008
NCT02377362|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-08-11|||March 2015||2015-03-01|August 2017|2017-08-01|November 9, 2016|Actual|2016-11-09|November 9, 2016|Actual|2016-11-09||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01|A 3-Part, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose, and Proof of Concept Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01|Terminated||Phase 1|74|Actual|GLWL Research Inc.||6||Insufficient efficacy for this indication|f||||f||||||||||2017-10-10 23:32:43.677032|2017-10-10 23:32:43.677032
NCT02377336|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-06-04|||May 2015||2015-05-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of GS-6615 in Subjects With Chronic Stable Angina and Coronary Artery Disease|Withdrawn||Phase 2|0|Actual|Gilead Sciences||2||Anticipated recruitment challenges|f||||f||||||||||2017-10-10 23:32:43.979197|2017-10-10 23:32:43.979197
NCT02377323|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-05-23|||January 2014|Actual|2014-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|May 2015|Actual|2015-05-01||Interventional|RLO||Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif|Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif on Employment Status, Quality of Life and Cognition: a Pilot Study|Completed||N/A|296|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-10 23:32:44.069206|2017-10-10 23:32:44.069206
NCT02377310|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-08-11|||September 2013||2013-09-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|VERIFY2||Pd/Pa vs iFR™ in an Unselected Population Referred for Invasive Angiography|A Comparative Study of Resting Coronary Pressure Gradient, Instantaneous Wave-free Ratio and Fractional Flow Reserve in an Unselected Population Referred for Invasive Angiography: The VERIFY 2 Study|Completed||N/A|197|Actual|Golden Jubilee National Hospital|||1||f||||f||||||||||2017-10-10 23:32:44.170993|2017-10-10 23:32:44.170993
NCT02377297|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-09-22|||November 2014||2014-11-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|March 2015|Actual|2015-03-01||Interventional|||Occlusal ART Restorations in Primary Molars Using 3 Different GIC|Survival Rate and Cost Effectiveness of Occlusal ART Restorations in Primary Molars Using 3 Different Glass Ionomers Cements - a Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 23:32:44.255022|2017-10-10 23:32:44.255022
NCT02377284|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-08-16|||October 2013||2013-10-01|August 2017|2017-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Prevention and Management of Food Allergies|Engaging Food Service Workers in the Prevention of Food Allergy-related Adverse Events|Completed||N/A|187|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:32:44.3583|2017-10-10 23:32:44.3583
NCT02377271|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-10-04|||March 2015||2015-03-01|October 2017|2017-10-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|ENDOTHELION||ENDOTHELION Study Group: Effect of Bosentan in NAION Patients|Effect of Bosentan in Patients With Non Arteritic Ischemic Optic Neuropathy|Recruiting||Phase 3|86|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-10 23:32:44.427254|2017-10-10 23:32:44.427254
NCT02377258|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-04-11|||March 2016||2016-03-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|I-CARE||IBD Cancer and Serious Infection in Europe|IBD Cancer and Serious Infection in Europe|Recruiting||N/A|17600|Anticipated|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives|||5||f||||t||||||||||2017-10-10 23:32:44.559531|2017-10-10 23:32:44.559531
NCT02377245|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-06-10|||January 2014||2014-01-01|June 2016|2016-06-01|December 2023|Anticipated|2023-12-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|JIR-cohorte||Juvenile Inflammatory Rheumatism (JIR) Cohorte|Setting up a Pediatric Cohort for Inflammatory Rheumatic Diseases|Enrolling by invitation||N/A|1000|Anticipated|University of Lausanne Hospitals|||1||f||||t||||||||||2017-10-10 23:32:44.756825|2017-10-10 23:32:44.756825
NCT02377232|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-06-22|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CRCSreening||Simultaneous Improvement in Colon Cancer Screening Rates and Patient-Centered Care|Simultaneous Improvement in Colon Cancer Screening Rates and Patient-Centered Care|Completed||N/A|424|Actual|University of Colorado, Denver||2|||f||||f|f|f||||||No||2017-10-10 23:32:44.928087|2017-10-10 23:32:44.928087
NCT02377219|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-05-17|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|FIVPHENOL||Bisphenol A Exposure, Ovarian Function and Assisted Reproductive Technology Outcome.|Bisphenol A Exposure, Ovarian Function and Assisted Reproductive Technology Outcome.|Recruiting||N/A|1388|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 23:32:45.014511|2017-10-10 23:32:45.014511
NCT02377193|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-05-06|||September 2013||2013-09-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|SATIR||Simulect Versus ATG in Sensitized Renal Transplant Patient|Prospective, Multicenter, Randomized, Evaluating Two Induction Therapies With Simulect® Versus ATG® Fresenius Associated With Tacrolimus and Myfortic® in the Prevention of Treatment Failure, in Sensitized Renal Transplant|Recruiting||Phase 4|60|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-10 23:32:45.317901|2017-10-10 23:32:45.317901
NCT02377180|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-01-16|||September 2014||2014-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Capsaicin-induced Muscle Pain in Humans|Capsaicin-induced Muscle Pain in Humans: From Investigating Central Pain Processing to Developing Clinical Applications|Completed||N/A|72|Actual|University Hospital Inselspital, Berne||3|||f||||f||||||||||2017-10-10 23:32:45.436865|2017-10-10 23:32:45.436865
NCT02377167|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-08-28|||May 2015||2015-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|SETPOINT2||Early Tracheostomy in Ventilated Stroke Patients 2|Stroke-Related Early Tracheostomy Versus Prolonged Orotracheal Intubation in Neurocritical Care Trial 2|Recruiting||N/A|380|Anticipated|University Hospital Heidelberg||2|||f||||t|f|f||||||||2017-10-10 23:32:45.542572|2017-10-10 23:32:45.542572
NCT02377154|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-06-01|||February 2015||2015-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparability of Keratometry of VERION Image Guided System With Established Measuring Devices|Comparability of Keratometry and Intraocular Lens (IOL) Calculation of VERION Image Guided System With Established Measuring Devices in Ophthalmologically Healthy Individuals|Completed||N/A|150|Actual|Heidelberg University||1|||f||||f||||||||||2017-10-10 23:32:45.651863|2017-10-10 23:32:45.651863
NCT02377141|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-12-01|||April 2011||2011-04-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Early TIPSS||Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding|Early Use of Transjugular Intrahepatic Portosystemic Shunt (TIPSS) in Patients With Cirrhosis and Variceal Bleeding|Recruiting||N/A|96|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-10-10 23:32:45.751443|2017-10-10 23:32:45.751443
NCT02377128|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-04-28|||March 2015||2015-03-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section||Enrolling by invitation||N/A|45|Anticipated|Wolfson Medical Center||3|||f||||||||||||||2017-10-10 23:32:45.882308|2017-10-10 23:32:45.882308
NCT02377115|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2016-05-09|||March 2015||2015-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|RAPID||Risk Assessment for Postoperative Delirium|Risk Assessment for Postoperative Delirium: Derivation of a Self-Administered Tablet Computer-based Clinical Screening Tool|Completed||N/A|54|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||No||2017-10-10 23:32:45.959544|2017-10-10 23:32:45.959544
NCT02377102|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-10-26|||February 2015||2015-02-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Does Physical Therapy Prevent Total Knee Arthroplasty in Patients With End Stage Osteoarthritis|Does Physical Therapy Prevent Total Knee Arthroplasty in Patients With End Stage Osteoarthritis|Recruiting||N/A|260|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:32:46.077348|2017-10-10 23:32:46.077348
NCT02377089|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-10-27|||May 2015||2015-05-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Neuromodulation for Post-Traumatic Stress Disorder|Neuromodulation as a New Treatment for Post-Traumatic Stress Disorder in Veterans: Evaluating the Effectiveness of Trigeminal Nerve Stimulation|Recruiting||Early Phase 1|74|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 23:32:46.16973|2017-10-10 23:32:46.16973
NCT02377076|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-03|||September 2014||2014-09-01|March 2015|2015-03-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Dietary Calcium Supplementation, Gut Permeability and Microbiota in Type 2 Diabetics||Unknown status|Recruiting|N/A|20|Anticipated|Federal University of Vicosa||2|||f||||f||||||||||2017-10-10 23:32:46.245246|2017-10-10 23:32:46.245246
NCT02377050|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-08-16|||January 2015||2015-01-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates|Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates|Recruiting||N/A|224|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 23:32:46.40154|2017-10-10 23:32:46.40154
NCT02377037|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-02-24|||November 2014||2014-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Metabolic Cost of Sitting, Standing, and Transitions|What is the Metabolic Cost of Sitting, Standing, and Sit/Stand Transitions? A Randomized Controlled Trial|Completed||N/A|50|Actual|Technical University of Lisbon||3|||f||||t||||||||||2017-10-10 23:32:46.480659|2017-10-10 23:32:46.480659
NCT02377024|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-06-30|||February 2014||2014-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Functions|Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Functions in Healthy Adults With Subjective Cognitive Impairment: An 8-Week Prospective Randomized Double-Blind Placebo-Controlled Trial With Multimodal Neuroimaging and Neurocognitive Assessments|Completed||N/A|75|Actual|Ewha Womans University||3|||f||||||||||||||2017-10-10 23:32:46.567911|2017-10-10 23:32:46.567911
NCT02377011|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-06-21|||January 2014||2014-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|eDASH||RCT of the Clinical and Cost Effectiveness of Cognitive Behaviour Therapy (CBT) Delivered Remotely Versus Treatment as Usual in Adolescents and Young Adults With Depression Who Repeatedly Self-harm|Randomised Controlled Trial of the Clinical and Cost Effectiveness of NICE Recommended Problem Solving Cognitive Behaviour Therapy (PS CBT) Delivered Remotely Versus Treatment as Usual in Adolescents and Young Adults With Depression Who Repeatedly Self-harm|Active, not recruiting||N/A|22|Actual|University of Nottingham||2|||f||||t||||||||||2017-10-10 23:32:46.649447|2017-10-10 23:32:46.649447
NCT02376998|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-08-15|2016-05-24||November 2002||2002-11-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|ERRATA||Endovascular Repair for the Descending Thoracic Aorta|Endovascular Repair for Acute Traumatic Transection of the Descending Thoracic Aorta|Completed||N/A|20|Actual|University of Cantanzaro||1|||f||||t||||||||No||2017-10-10 23:32:46.739558|2017-10-10 23:32:46.739558
NCT02376985|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-07-31|||March 26, 2015|Actual|2015-03-26|July 2017|2017-07-01|May 31, 2019|Anticipated|2019-05-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT|Evaluation of Oral Care to Prevent Oral Mucositis in Estrogen Receptor Positive Metastatic Breast Cancer Patients Treated With Everolimus: Phase III Randomized Control Trial|Recruiting||Phase 3|200|Anticipated|Comprehensive Support Project for Oncology Research||2|||f||||t||||||||||2017-10-10 23:32:46.872144|2017-10-10 23:32:46.872144
NCT02376972|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-10-07|||April 2015||2015-04-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|VARIANT||Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Rifaximin Vaginal Tablets in the Treatment of Bacterial Vaginosis|Terminated||Phase 2|392|Actual|Alfa Wassermann S.p.A.||4||According to the Recommendation of the Indipendent Data Monitoring Committee|f||||t||||||||Undecided||2017-10-10 23:32:47.050762|2017-10-10 23:32:47.050762
NCT02376959|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-02-25|||September 2014||2014-09-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||"Effect of Spiritist Passe Energy Therapy in Reducing Anxiety in Volunteers"|"Effect of Spiritist Passe Energy Therapy in Reducing Anxiety in Volunteers"|Unknown status|Recruiting|N/A|60|Anticipated|Associação Médico Espírita de Botucatu||2|||f||||f||||||||||2017-10-10 23:32:47.165397|2017-10-10 23:32:47.165397
NCT02376946|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-01-19|||January 2014||2014-01-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|PEMF||Third Molar Extraction and Pulsed Electromagnetic FieldTherapy|Evaluation of Postoperative Edema and Pain Following Third Molar Extraction With Application of Pulsed Electromagnetic Field (PEMF) Therapy|Terminated||N/A|49|Actual|Tufts University School of Dental Medicine||2||Sponsor decision|f||||f||||||||||2017-10-10 23:32:47.256991|2017-10-10 23:32:47.256991
NCT02376933|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-12-06|||August 2013||2013-08-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer|Phase 2 Study of Vertebral Augmentation and Radiotherapy in Painful or at Risk of Collapse Spinal Metastatic Cancer/Multiple Myeloma|Active, not recruiting||Phase 2|11|Actual|University of Arizona||1|||f||||t||||||||||2017-10-10 23:32:47.347117|2017-10-10 23:32:47.347117
NCT02376920|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-07-29|||March 2010||2010-03-01|July 2016|2016-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01|10 Years|Observational [Patient Registry]|CLEAR||5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes|CLEAR Registry Study: An Open, 5-year Registry Study to Track Clinical Application of DecisionDx-UM Multigene Assay Results and Associated Patient Outcomes.|Enrolling by invitation||N/A|2800|Anticipated|Castle Biosciences Incorporated|||1||f||||f||||||||||2017-10-10 23:32:47.435535|2017-10-10 23:32:47.435535
NCT02376907|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-02-25|||January 2010||2010-01-01|February 2015|2015-02-01|September 2017|Anticipated|2017-09-01|June 2014|Actual|2014-06-01||Observational|||Biliary Drainage in Patients With Duodenal Metal Stent|Multinational Study on Endoscopic Management of Distal Malignant Biliary Obstruction Combined With Gastric Outlet Obstruction|Unknown status|Active, not recruiting|N/A|200|Anticipated|Tokyo University|||1||f||||f||||||||||2017-10-10 23:32:47.500019|2017-10-10 23:32:47.500019
NCT02376894|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-02-25|||February 2015||2015-02-01|February 2015|2015-02-01||||June 2015|Anticipated|2015-06-01||Observational|||An Epidemiological Survey of Cancer-related Fatigue Among Taiwanese Cancer Patients|An Epidemiological Survey of Cancer-related Fatigue Among Taiwanese Cancer Patients|Unknown status|Recruiting|N/A|1200|Anticipated|Taiwan Cancer Palliative Medicine|||1||f||||f||||||||||2017-10-10 23:32:47.643104|2017-10-10 23:32:47.643104
NCT02376881|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-05-12|||March 2015||2015-03-01|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study)|Erythropoietin in Methanol Associated Optic Neuropathy|Recruiting||Phase 3|30|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 23:32:47.727964|2017-10-10 23:32:47.727964
NCT02376868|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-10-07|||May 2015||2015-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Maestro Agreement and Precision Study II|Topcon 3D OCT-1 Maestro Agreement and Precision Study II|Completed||N/A|101|Actual|Topcon Medical Systems, Inc.||3|||f||||f||||||||||2017-10-10 23:32:47.80827|2017-10-10 23:32:47.80827
NCT02376855|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2015-03-02|||October 2011||2011-10-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||"A Study of the Implementation of an Electronic Consultation (eConsult) Platform"|"A Study of the Implementation of an Electronic Consultation (eConsult) Platform to Increase Specialist Access for Patients in Underserved Populations: Impact on Provider Experience, Wait Times and Cost"|Completed||N/A|36|Actual|Community Health Center, Inc.||2|||f||||f||||||||||2017-10-10 23:32:47.885437|2017-10-10 23:32:47.885437
NCT02376842|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-11-16|||November 2014||2014-11-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study of an Electronic Health Record-embedded Severe Sepsis Early Warning Alert|Single-blind Randomized Trial of a Commercially Sold Electronic Health Record Based Severe Sepsis Early Warning Best Practice Alert.|Completed||N/A|1149|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:32:47.976108|2017-10-10 23:32:47.976108
NCT02376829|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-01-23|||March 2015||2015-03-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Class II Correction Study Using the Invisalign System|Class II Correction Study Using the Invisalign System|Active, not recruiting||N/A|110|Anticipated|Align Technology, Inc.||1|||f||||f||||||||||2017-10-10 23:32:48.062715|2017-10-10 23:32:48.062715
NCT02376816|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-11-21|||March 2015||2015-03-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy|Phase I Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.Micro-dystrophin|Active, not recruiting||Phase 1|2|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-10 23:32:48.157381|2017-10-10 23:32:48.157381
NCT02376803|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-04-05|||February 2015||2015-02-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||"The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The INRange RCT"|"The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The INRange RCT"|Active, not recruiting||Phase 4|217|Actual|University of Alberta||2|||f||||f||||||||Yes|Upon publication of all planned manuscripts stemming from this work, anonymized patient level trial data will be posted on www.PragmaticTrials.ca|2017-10-10 23:32:48.260181|2017-10-10 23:32:48.260181
NCT02376790|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-07-25|||March 3, 2015|Actual|2015-03-03|July 2017|2017-07-01|July 30, 2018|Anticipated|2018-07-30|January 15, 2018|Anticipated|2018-01-15||Interventional|||Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis|A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis|Active, not recruiting||Phase 3|851|Actual|Amgen||3|||f||||f||||||||||2017-10-10 23:32:48.387314|2017-10-10 23:32:48.387314
NCT02376777|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-06-27|||April 2014|Actual|2014-04-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Observational|CACAO||Comparison of Accidents and Their Circumstances With Oral Anticoagulants|Comparison of Accidents and Their Circumstances With Oral Anticoagulants. The CACAO Study|Completed||N/A|4162|Actual|CNGE IRMG Association|||2||f||||f||||||||||2017-10-10 23:32:48.768996|2017-10-10 23:32:48.768996
NCT02376764|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-02|||February 2012||2012-02-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Observational|BIPOSTO||Biomarkers in Post Thrombotic Syndrome|New Biomarkers in Post Thrombotic Syndrome|Completed||N/A|235|Actual|University of Cantanzaro|||1||f||||t||||||||||2017-10-10 23:32:48.929746|2017-10-10 23:32:48.929746
NCT02376751|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-06-06||||||November 2015|2015-11-01||||||||Expanded Access|||An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency|AN EXPANDED ACCESS PROTOCOL FOR SEBELIPASE ALFA FOR PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY|No longer available||N/A|||Alexion Pharmaceuticals|||||||||||||||||||2017-10-10 23:32:48.984836|2017-10-10 23:32:48.984836
NCT02376738|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-02-25|||July 2007||2007-07-01|February 2015|2015-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|REAL-CAD||Regional Activation of Leukocytes in Coronary Artery Disease|Regional Activation of Leukocytes in Coronary Artery Disease|Completed||N/A|97|Actual|Sint Franciscus Gasthuis|||1||f||||f||||||||||2017-10-10 23:32:49.037859|2017-10-10 23:32:49.037859
NCT02376725|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-25|||June 2011||2011-06-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Comparing Phaco/IOL Versus Phaco/IOL + Goniosynechialysis in Subjects With PACG|A Randomized Clinical Trial Comparing Phacoemulsification and Goniosynechialysis With Phacoemulsification Alone in the Management of Primary Angle Closure|Completed||N/A|80|Actual|Singapore National Eye Centre||2|||f||||t||||||||||2017-10-10 23:32:49.100478|2017-10-10 23:32:49.100478
NCT02376712|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-03-02|||January 2015||2015-01-01|February 2015|2015-02-01||||May 2015|Anticipated|2015-05-01||Observational|||Diagnostic Value of Urinary Indices in Differentiating Pre-renal and Renal Acute Kidney Injury||Unknown status|Recruiting|N/A|40|Anticipated|Peking Union Medical College Hospital|||2||f||||t||||||Samples Without DNA|"     Serum, urine   "|||2017-10-10 23:32:49.170846|2017-10-10 23:32:49.170846
NCT02376699|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-09-28|||February 2015||2015-02-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|April 2020|Anticipated|2020-04-01||Interventional|||Safety Study of SEA-CD40 in Cancer Patients|A Phase 1, Open-label, Dose-escalation Study of SEA-CD40 in Adult Patients With Advanced Malignancies|Recruiting||Phase 1|290|Anticipated|Seattle Genetics, Inc.||3|||f||||f||||||||||2017-10-10 23:32:49.240674|2017-10-10 23:32:49.240674
NCT02376686|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-11-10|||April 2014||2014-04-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Music Intervention in the Treatment of Sleep Disorders for Depressed Patients|Musik Als Nicht-pharmakologische Intervention Zur Behandlung Von Schlafstörungen Bei Patienten Mit Depressiven Erkrankungen|Recruiting||N/A|50|Anticipated|Sanatorium Kilchberg AG||2|||f||||f||||||||Undecided|Partial availability is possible|2017-10-10 23:32:49.505251|2017-10-10 23:32:49.505251
NCT02376673|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-02-01|||June 2014|Actual|2014-06-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Comparing Children's Book to Brochures for Safe Sleep Education in a Home Visiting Program|A Randomized Controlled Trial Comparing a Children's Book to Brochures for Safe Sleep Education in an At-Risk Population Enrolled in a Home Visitation Program|Completed||N/A|282|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-10 23:32:49.603092|2017-10-10 23:32:49.603092
NCT02376660|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-02-25|||December 2012||2012-12-01|February 2015|2015-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effect of Oats on Lipid Profile|A Randomized Controlled Trial to Evaluate the Efficacy of 3 g of Soluble Fiber From Oats on the Lipid Profile of Men and Women With Elevated Lipid Levels Aged Between 20 and 50 Years|Completed||N/A|80|Actual|PepsiCo Global R&D||2|||f||||f||||||||||2017-10-10 23:32:49.744662|2017-10-10 23:32:49.744662
NCT02376647|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-03-03|||March 2015||2015-03-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|ART-3pilot||ART-3 Pilot - Driving Pressure Limited Ventilation for Patients Without ARDS (ART3pilot)|ART-3 Pilot: A Randomized Controlled Trial to Assess the Feasiblity of a Driving Pressure Limited Ventilation vs.Standard Strategy in Patients Without ARDS|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hospital do Coracao||2|||f||||f||||||||||2017-10-10 23:32:49.818964|2017-10-10 23:32:49.818964
NCT02376634|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2016-09-08|||June 2016||2016-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Hypnotherapy in Major Surgical Procedures|The Effectiveness of Clinical Hypnotherapy in Reducing Anxiety and Pain in Major Surgical Procedures (Nuss and Scoliosis Repair)|Withdrawn||N/A|0|Actual|Nationwide Children's Hospital||2||PI left Nationwide Children's Hosp.|f||||f||||||||||2017-10-10 23:32:49.919748|2017-10-10 23:32:49.919748
NCT02376621|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-25|||October 2014||2014-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Bioavailability of Omega-3 Food Supplements in Healthy Subjects|Nutrition Products - An Open-Label, Randomised, Single-Dose Study to Evaluate the Bioavailability of Omega-3 Based Dietary Supplements Under Fasting Conditions in Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|Pronova BioPharma||5|||f||||f||||||||||2017-10-10 23:32:50.000839|2017-10-10 23:32:50.000839
NCT02289781|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-12-05|||April 2013||2013-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Wear of Enamel Against Polished Zirconia Crowns|Wear of Enamel Antagonists by Polished Ceramic Surfaces|Recruiting||N/A|30|Anticipated|University of Florida|||2||f||||f||||||||No||2017-10-10 23:49:37.142532|2017-10-10 23:49:37.142532
NCT02376608|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-25|||August 2014||2014-08-01|August 2014|2014-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bioavailability of Omega-3 Food Supplement in Healthy Subjects|Pronovum - An Open-label, Randomized, Single-dose Study to Evaluate the Bioavailability of Omega-3 Food Supplements in Healthy Male and Female Subjects.|Completed||Phase 1|24|Actual|Pronova BioPharma||4|||f||||f||||||||||2017-10-10 23:32:50.103964|2017-10-10 23:32:50.103964
NCT02376595|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-25|||March 2013||2013-03-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|November 2013|Actual|2013-11-01||Observational|||Pharmacokinetic and Pharmacodynamic of Rocuronium|Pharmacokinetic and Pharmacodynamic of Rocuronium Bromide Measured in Adductor Pollicis and Masseter Muscles.|Completed||N/A|10|Actual|Pontificia Universidad Catolica de Chile|||1||f||||t||||||Samples Without DNA|"     Plasma samples.   "|||2017-10-10 23:32:50.198671|2017-10-10 23:32:50.198671
NCT02376582|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-01-21|||September 2014||2014-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|EV06||Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS|A Phase I Double Blind Placebo-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of the Combination of DNA-HIV-PT123 and AIDSVAX®B/Ein HIV-1-uninfected Adult Participants With or Without Underlying Schistosoma Mansoni Infection|Completed||Phase 1|72|Actual|EuroVacc Foundation||2|||f||||t||||||||||2017-10-10 23:32:50.312247|2017-10-10 23:32:50.312247
NCT02376569|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-02-25|||October 2014||2014-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||An Observational Pilot Study to Characterize Relationships Between Self-reported Information, Game Performance, and Passive Physiology Measures Throughout a Daily Cycle|An Observational Pilot Study to Characterize Relationships Between Self-reported Information, Game Performance, and Passive Physiology Measures Throughout a Daily Cycle|Completed||N/A|1500|Actual|PepsiCo Global R&D|||1||f||||||||||||||2017-10-10 23:32:50.430461|2017-10-10 23:32:50.430461
NCT02376556|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2015-06-14|||March 2015||2015-03-01|June 2015|2015-06-01||||March 2017|Anticipated|2017-03-01||Observational|||The Effect of Eyelid Surgery on Dry Eye - a Prospective Study|The Prevalence of Dry Eye Syndrome Among Patients Who Underwent Upper Eyelids Blepharoplasty With and Without Muller Muscle Resection|Unknown status|Not yet recruiting|N/A|60|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-10 23:32:50.485413|2017-10-10 23:32:50.485413
NCT02376543|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-09-19|||January 15, 2018|Anticipated|2018-01-15|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Comparison Study in Pancreatic Fiducial Placement|Comparison Study in Pancreatic Fiducial Placement|Not yet recruiting||N/A|30|Anticipated|Parkview Health||2|||f||||f|f|t|f|f|f|||||2017-10-10 23:32:50.578745|2017-10-10 23:32:50.578745
NCT02376530|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-01-11|2016-04-27||September 2012||2012-09-01|February 2015|2015-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Price Changes and Nutrient Profiling Among Adult Grocery Shoppers|Price Changes and Nutrient Profiling Among Adult Grocery Shoppers|Completed||N/A|788|Actual|State University of New York at Buffalo||4|||f||||f||||||||No||2017-10-10 23:32:50.681501|2017-10-10 23:32:50.681501
NCT02376517|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-09-16|||May 2015||2015-05-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Helping All Children be Safe Outdoors With Sun Protection|Helping All Children be Safe Outdoors With Sun Protection|Completed||N/A|300|Actual|Northwestern University||2|||f||||f||||||||||2017-10-10 23:32:51.183584|2017-10-10 23:32:51.183584
NCT02376504|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-03-27|||April 2014||2014-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Modifying the Workplace to Decrease Sedentary Behavior and Improve Health|Modifying the Workplace to Decrease Sedentary Behavior and Improve Health|Completed||N/A|66|Actual|Northeastern University||3|||f||||f||||||||||2017-10-10 23:32:51.259843|2017-10-10 23:32:51.259843
NCT02376491|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-05-18|||June 2015||2015-06-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|THETA-DEP||Efficacy of Intermittent ThetaBurst Stimulation Compared to 10 Hz Stimulation on Dorsolateral Prefrontal Cortex in Treatment Resistant Major Depressive Disorder: a Double-blind Randomized Study|Efficacy of Intermittent ThetaBurst Stimulation Compared to 10 Hz Stimulation on Dorsolateral Prefrontal Cortex in Treatment Resistant Major Depressive Disorder: a Double-blind Randomized Study|Recruiting||N/A|60|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-10 23:32:51.327963|2017-10-10 23:32:51.327963
NCT02376478|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-02-25|||December 2009||2009-12-01|February 2015|2015-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection|On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection|Completed||N/A|222|Actual|Medical University of Vienna|||4||f||||f||||||Samples With DNA|"     Swab samples to detect mucosal HPV DNA using a FDA-approved Assay (Digene Hybrid Capture 2     kit).      Cervical PAP smears were collected by cytobrush. Whole blood to obtain peripheral blood     mononuclear cells and serum   "|||2017-10-10 23:32:51.421033|2017-10-10 23:32:51.421033
NCT02376465|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2016-07-18||2016-07-18|January 2015||2015-01-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy||Completed||Phase 2|45|Actual|Braintree Laboratories||3|||f||||f||||||||||2017-10-10 23:32:51.516193|2017-10-10 23:32:51.516193
NCT02376452|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-03-02|||September 2014||2014-09-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients|Phase II Study of 2-weekly Raltitrexed Plus Irinotecan Regimen (RAILIRI) Versus Fluorouracil, Leucovorin, and Irinotecan Regimen (FOLFIRI) as Second-line Treatment in Advanced Colorectal Cancer Patients|Unknown status|Recruiting|Phase 2|100|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 23:32:51.592434|2017-10-10 23:32:51.592434
NCT02376439|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-02-24|||April 2010||2010-04-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Discordance of Obesity in Adolescent Sibilngs|Non-shared Environments and Discordance of Obesity in Adolescent Sibilngs|Completed||N/A|176|Actual|State University of New York at Buffalo|||1||f||||t||||||||||2017-10-10 23:32:51.692233|2017-10-10 23:32:51.692233
NCT02375659|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-06-22|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|March 2017|Actual|2017-03-01||Observational|||Black Patients' Lived Experiences and Perceptions of Skin of Color Clinics|Black Patients' Lived Experiences and Perceptions of Skin of Color Clinics|Active, not recruiting||N/A|19|Actual|Northwestern University|||1||f||||t||||||||||2017-10-10 23:32:58.479886|2017-10-10 23:32:58.479886
NCT02376426|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-12-07|||March 2015||2015-03-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants|A Phase 1 Study to Evaluate the Safety, Tolerability and Immunogenicity of Heterologous Prime-Boost Regimens Using MVA-BN®-Filo and Ad26.ZEBOV Administered in Different Sequences and Schedules in Healthy Adults|Completed||Phase 1|72|Actual|Crucell Holland BV||4|||f||||t||||||||||2017-10-10 23:32:51.767894|2017-10-10 23:32:51.767894
NCT02376413|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-12-02|||March 2015||2015-03-01|December 2015|2015-12-01|December 2022|Anticipated|2022-12-01|March 2022|Anticipated|2022-03-01||Observational|||Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients|Prospective Non-randomized Evaluation of Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients|Withdrawn||N/A|0|Actual|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|||2|Unavailable to recruit patients.|f||||t||||||||||2017-10-10 23:32:51.858156|2017-10-10 23:32:51.858156
NCT02376400|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-12-07|||April 2015||2015-04-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants|A Phase 1 Study to Evaluate the Safety, Tolerability and Immunogenicity of Heterologous Prime-Boost Regimens Using MVA-BN®-Filo and Ad26.ZEBOV Administered in Different Sequences and Schedules in Healthy Adults|Completed||Phase 1|78|Actual|Crucell Holland BV||4|||f||||||||||||||2017-10-10 23:32:51.941854|2017-10-10 23:32:51.941854
NCT02376387|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-02-24|||March 2015||2015-03-01|February 2015|2015-02-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01|5 Years|Observational [Patient Registry]|DHS||Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation|Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation|Enrolling by invitation||N/A|5000|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-10 23:32:52.047177|2017-10-10 23:32:52.047177
NCT02376374|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-07-10|||February 2015||2015-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||OPV Transmissibility in Communities After Cessation of Routine OPV Immunization|OPV Transmissibility in Communities After Cessation of Routine OPV Immunization|Active, not recruiting||N/A|1828|Actual|Stanford University||3|||f||||f||||||||||2017-10-10 23:32:52.135182|2017-10-10 23:32:52.135182
NCT02376348|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-10-05|||February 3, 2014|Actual|2014-02-03|October 2017|2017-10-01|February 28, 2017|Actual|2017-02-28|May 4, 2015|Actual|2015-05-04||Interventional|||Male Circumcision Against HIV Hukomboa|Increasing Uptake of Voluntary Medical Male Circumcision Among Men Aged 20-34 Years in Njombe & Tabora Regions, Tanzania: A Cluster Randomised Controlled Trial|Completed||N/A|10782|Actual|National Institute for Medical Research, Tanzania||2|||f||||t||||||||||2017-10-10 23:32:52.277192|2017-10-10 23:32:52.277192
NCT02376335|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-01-12|||October 2012||2012-10-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|RITPBC||B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis|B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis|Completed||Phase 2|71|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-10-10 23:32:52.351414|2017-10-10 23:32:52.351414
NCT02376322|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-10-04|||July 2014||2014-07-01|October 2017|2017-10-01|July 30, 2016|Actual|2016-07-30|July 30, 2016|Actual|2016-07-30||Interventional|||Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS|A Phase II Trial of Hypofractionated Radiotherapy (16 Gy in 2 Fractions With an Interval of One Week) for the Palliation of Complicated Bone Metastases in Patients With Poor Performance Status|Completed||Phase 2|50|Actual|Santa Casa de Porto Alegre||1|||f||||f||||||||||2017-10-10 23:32:52.434293|2017-10-10 23:32:52.434293
NCT02376309|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-08-28|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2016|Actual|2016-08-01||Interventional|Le-Na||The Effect of Nandrolone Decanoate and Leucine on Muscle Loss|The Effect of Nandrolone Decanoate Injection and Leucine Supplementation on Muscle Loss|Completed||N/A|30|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:32:52.517331|2017-10-10 23:32:52.517331
NCT02376296|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-11-01|||February 2015||2015-02-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|November 2017|Anticipated|2017-11-01||Observational|||Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients|Observational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay|Recruiting||N/A|80|Anticipated|Saladax Biomedical, Inc.|||2||f||||f||||||Samples Without DNA|"     Plasma   "|No||2017-10-10 23:32:52.601092|2017-10-10 23:32:52.601092
NCT02376283|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-03-14|||March 2015||2015-03-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||P3AMI Antiplatelet Trial|Pharmacokinetics and Pharmacodynamics of Platelet P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction: A Pilot Study|Recruiting||Phase 4|90|Anticipated|The Royal Wolverhampton Hospitals NHS Trust||6|||f||||f||||||||||2017-10-10 23:32:52.927515|2017-10-10 23:32:52.927515
NCT02376270|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-07-14|||March 2015||2015-03-01|October 2015|2015-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Pectin, Aging and Intestinal Barrier Function|The Effects of Pectin on Aging-related Changes in Intestinal Barrier Function, Immune Function and Microbial Composition|Completed||Phase 4|100|Actual|Maastricht University Medical Center||2|||f||||||||||||||2017-10-10 23:32:53.041763|2017-10-10 23:32:53.041763
NCT02376257|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-04-28|||September 16, 2014|Actual|2014-09-16|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|April 21, 2017|Actual|2017-04-21||Interventional|||Improving Therapeutic Learning in Depression: Proof of Concept|Improving Therapeutic Learning in Depression: Proof of Concept|Active, not recruiting||Phase 2|85|Anticipated|Boston University Charles River Campus||3|||f||||t||||||||||2017-10-10 23:32:53.129718|2017-10-10 23:32:53.129718
NCT02376244|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-08-17|||September 2015||2015-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation|A Randomised Controlled Trial on the Efficacy of High Intensity Interval Training Compared With Moderate Intensity Interval Training for Patients Undergoing Cardiac Rehabilitation|Completed||N/A|34|Actual|Liverpool Heart and Chest Hospital NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 23:32:53.214078|2017-10-10 23:32:53.214078
NCT02376231|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2015-02-24|||March 2013||2013-03-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|PJEOC||To Evaluate Plasmajet in Achieving Complete Cytoreduction of Advanced EOC- Initial Feasibility Study|A Pilot Single Blinded Randomized Controlled Trial to Evaluate the Utility and Efficacy of Neutral Argon Plasma as a New Technology in Achieving Complete Cytoreduction of Advanced Epithelial Ovarian Carcinoma- Initial Feasibility Study|Recruiting||N/A|150|Anticipated|Royal Surrey County Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:32:53.317381|2017-10-10 23:32:53.317381
NCT02376218|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-02-08|||April 2015||2015-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PLUG||Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial.|Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial.|Completed||N/A|10|Actual|Lawson Health Research Institute||1|||f||||||||||||||2017-10-10 23:32:53.403927|2017-10-10 23:32:53.403927
NCT02376205|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-08-29|||February 2015||2015-02-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery|The Effectiveness of Postoperative Local Retropharyngeal Space Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery|Recruiting||N/A|60|Anticipated|Justin Parker Neurological Institute||2|||f||||f||||||||||2017-10-10 23:32:53.46827|2017-10-10 23:32:53.46827
NCT02376192|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-02-25|||January 2014||2014-01-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Maternal Microcirculation & SDF Imaging|Maternal Microcirculation & SDF Imaging: A Novel Assessment of the Microcirculation During Cesarean Delivery With Spinal Anesthesia and the Impact of Phenylephrine Prophylaxis to Prevent Spinal Anesthesia-induced Hypotension.|Completed||Phase 4|32|Actual|IWK Health Centre||2|||f||||t||||||||||2017-10-10 23:32:53.555365|2017-10-10 23:32:53.555365
NCT02376179|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-11-04|||August 2014||2014-08-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Endotracheal Tube Intracuff Pressure and Leak Around the Cuff During Retractor Placement for Tonsillectomy and/or Adenoidectomy||Enrolling by invitation||N/A|200|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 23:32:53.649034|2017-10-10 23:32:53.649034
NCT02376166|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-01-09|||July 2014||2014-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|M-RePoRT||Metformin for Rising PSA Remote Trial|M-RePoRT: Metformin - Rising PSA Remote Trial|Completed||N/A|15|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-10 23:32:53.715142|2017-10-10 23:32:53.715142
NCT02376153|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-03-27|||April 2015||2015-04-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Air Barrier System for the Prevention of Prosthesis-related Infections|Air Barrier System for the Prevention of Prosthesis-related Infections|Recruiting||N/A|816|Anticipated|Nimbic Systems, LLC||2|||f||||t||||||||No|There is no current plan.|2017-10-10 23:32:53.79813|2017-10-10 23:32:53.79813
NCT02376140|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2015-02-25|||June 2010||2010-06-01|February 2015|2015-02-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Observational|||Food Consumption and Iron Status Survey in Two Provinces of Rural Burkina Faso|Food Consumption and Iron Status Survey in Two Provinces of Rural Burkina Faso|Completed||N/A|480|Actual|Institut de Recherche pour le Developpement|||2||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:32:53.896504|2017-10-10 23:32:53.896504
NCT02376127|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-02-15|||February 24, 2015|Actual|2015-02-24|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion|Evaluation of Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:32:53.974064|2017-10-10 23:32:53.974064
NCT02376114|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-03-02|||August 2011||2011-08-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma|The Effect of Ginkgo Biloba on Ocular Blood Flow in Primary Open-Angle Glaucoma Patients: A Double-Blind Randomized Crossover Trial|Completed||Phase 2|19|Actual|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-10 23:32:54.059966|2017-10-10 23:32:54.059966
NCT02376101|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-09-12|||October 2014||2014-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Minimal Occlusive Pressure With Cuffed ETT: the Effect of Size on Intracuff Pressure|Minimal Occlusive Pressure With Cuffed ETT: the Effect of Size on Intracuff Pressure|Completed||N/A|100|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-10 23:32:54.146929|2017-10-10 23:32:54.146929
NCT02376088|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-02-24|||June 2011||2011-06-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease|Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease|Completed||N/A|328|Actual|Qilu Hospital of Shandong University|||7||f||||f||||||||||2017-10-10 23:32:54.210728|2017-10-10 23:32:54.210728
NCT02376075|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-25|||January 2013||2013-01-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria|Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Comparison to Placebo in Patients With Hypertension and Albuminuria|Completed||Phase 3|43|Actual|ikfe-CRO GmbH||2|||f||||f||||||||||2017-10-10 23:32:54.28553|2017-10-10 23:32:54.28553
NCT02376062|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-02-24|||June 2015||2015-06-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Improving Knowledge, Awareness, and Practices of Primary Care Providers in Rural Nepal About Mental Illness.|Assessing Impact of Online Educational Modules to Improve Knowledge, Awareness, and Practices of Primary Care Providers in Rural Nepal About Mental Illness|Unknown status|Not yet recruiting|N/A|45|Anticipated|Possible||1|||f||||f||||||||||2017-10-10 23:32:54.37667|2017-10-10 23:32:54.37667
NCT02376049|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-05-01|||February 2015||2015-02-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)|An Explorative Clinical Trial to Evaluate an Intra Patient Comparison Design of Topical Agents in Adults With Mild to Moderate Atopic Dermatitis|Completed||Phase 1|30|Actual|LEO Pharma||4|||f||||f||||||||||2017-10-10 23:32:54.484796|2017-10-10 23:32:54.484796
NCT02376036|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-03-28|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Phase 1 Study of MGD010 in Healthy Subjects|A Phase 1, First-in-Human, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MGD010, a CD32B x CD79B Dual Affinity Re-Targeting (DART®) Bi-specific Antibody-Based Molecule, in Healthy Subjects|Completed||Phase 1|73|Actual|MacroGenics||4|||f||||t||||||||||2017-10-10 23:32:54.594956|2017-10-10 23:32:54.594956
NCT02376023|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-02-07|||February 22, 2016|Actual|2016-02-22|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Messages For Your Health: A Cancer Screening Prevention Study|Development of Mobile Technologies for the Prevention of Cervical Cancer in Santiago, Chile: A Randomized Controlled Trial.|Recruiting||N/A|400|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||No||2017-10-10 23:32:54.691707|2017-10-10 23:32:54.691707
NCT02376010|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-06-29|||February 2, 2015|Actual|2015-02-02|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|||Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium|Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium|Recruiting||Phase 4|110|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||f||||||||||2017-10-10 23:32:54.811743|2017-10-10 23:32:54.811743
NCT02375997|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-02-24|||October 2014||2014-10-01|February 2015|2015-02-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Early Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric Cancer|Early Palliative Care With Standard Oncology Care Versus Standard Oncology Care Alone in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric Cancer|Recruiting||Phase 3|592|Anticipated|Peking University||2|||f||||t||||||||||2017-10-10 23:32:54.905957|2017-10-10 23:32:54.905957
NCT02375984|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-08-15|||March 16, 2016|Actual|2016-03-16|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|TIL||A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas|A Phase II Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) Plus IL-2 Followed by Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanomas|Terminated||Phase 2|1|Actual|John Wayne Cancer Institute||1||PI changed institutions|f||||t|t|f||||||||2017-10-10 23:32:54.988157|2017-10-10 23:32:54.988157
NCT02375958|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-14|||April 15, 2015|Actual|2015-04-15|September 2017|2017-09-01|December 25, 2018|Anticipated|2018-12-25|June 14, 2018|Anticipated|2018-06-14||Interventional|||PCA062 in pCAD-positive Tumors.|A Phase 1 Multi-center, Open-label Dose Escalation and Expansion Study of PCA062 Administered Intravenously in Adult Patients With p-CAD Positive Tumors|Recruiting||Phase 1|90|Anticipated|Novartis||3|||f||||f|t|f||||||||2017-10-10 23:32:55.35678|2017-10-10 23:32:55.35678
NCT02375945|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2016-09-26|||March 2015||2015-03-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Comparison Between a Non-elastic Falcro Device and Current Method After Total Knee Arthroplasty|"Prospective, Randomized Controlled Trial Comparing the Effect of a Non-elastic Compression Device Juxta Reduction Kit (Medi ®) Versus Elastic Class 1 Stockings (BSN Medical® in Patients Undergoing Total Knee Arthroplasty"|Completed||Phase 4|40|Actual|Nij Smellinghe Hosptial||2|||f||||f||||||||||2017-10-10 23:32:55.48494|2017-10-10 23:32:55.48494
NCT02375919|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-07-24|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|PROPER||PERC Rule to Exclude Pulmonary Embolism in the Emergency Deparment|The Pulmonary Embolism Rule Out Criteria (PERC) Rule to Exclude the Diagnosis of Pulmonary Embolism in Emergency Low Risk Patients: a Non-inferiority Randomized Controlled Trial|Completed||N/A|1922|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:32:55.647372|2017-10-10 23:32:55.647372
NCT02375906|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-08-25|||November 2013||2013-11-01|August 2017|2017-08-01|November 2023|Anticipated|2023-11-01|December 2018|Anticipated|2018-12-01|10 Years|Observational [Patient Registry]|HDIN||The Hepatitis Delta International Network|Hepatitis Delta Registry and Research Network- Observational Study|Recruiting||N/A|1000|Anticipated|HepNet Study House, German Liverfoundation|||1||f||||f||||||||||2017-10-10 23:32:55.731981|2017-10-10 23:32:55.731981
NCT02375893|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-12-15|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|MABAC||Bile Acids and Gut Microbiota as Potent Coronary Atheroma Risk Factors: a Prospective Study in Human|The Official Title is in French: Microbiote, Acides Biliaires et Athérome Coronaire (MABAC)|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||||||2017-10-10 23:32:55.864391|2017-10-10 23:32:55.864391
NCT02375880|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder|A Dose Escalation and Cohort Expansion Study of DKN-01 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Carcinoma Primary to the Intra- or Extra-hepatic Biliary System or Gallbladder|Active, not recruiting||Phase 1|51|Actual|Leap Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 23:32:55.962388|2017-10-10 23:32:55.962388
NCT02375867|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2017-07-27|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Steroids in Fulminant Hepatic Failure in the Pediatric Age Group|Safety and Efficacy of Steroids in the Management of Fulminant Hepatic Failure in the Pediatric Age Group|Recruiting||Phase 4|30|Anticipated|National Liver Institute, Egypt||3|||f||||t||||||||||2017-10-10 23:32:56.143704|2017-10-10 23:32:56.143704
NCT02375854|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-09-21|||November 2014||2014-11-01|September 2015|2015-09-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|||Outcomes of Neonatal Acute Kidney Injury In Premature Infants|Outcomes of Neonatal Acute Kidney Injury and Prematurity: An Observational Study and Einstein-Montefiore Neonatal Acute Kidney Injury Clinical Registry and Biorepository|Recruiting||N/A|200|Anticipated|Montefiore Medical Center|||1||f||||f||||||Samples Without DNA|"     Blood and urine samples   "|||2017-10-10 23:32:56.343096|2017-10-10 23:32:56.343096
NCT02375841|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-03-07|||February 2015|Actual|2015-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers|Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers|Recruiting||N/A|400|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:32:56.473467|2017-10-10 23:32:56.473467
NCT02375828|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-08-25|||March 2015||2015-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|NEOGLI||Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels|Tolerance and Acceptability of Glibentek in Patients With Neonatale Diabetes Secondary to Mutations in K+-ATP Channels|Completed||Phase 3|10|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:32:56.598408|2017-10-10 23:32:56.598408
NCT02375815|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-03-23|||January 2015||2015-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|SCIP1||Statin Choice Decision Aid Implementation First Phase|The Statin Choice Implementation Project: Phase 1|Completed||N/A|313|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:32:56.717071|2017-10-10 23:32:56.717071
NCT02375802|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-09-27|||July 2015||2015-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Adipose-Derived Stromal Cells (ASC's) and Pressure Ulcers|A PILOT STUDY: EVALUATING THE SAFETY AND FEASIBILITY OF USING AUTOLOGOUS ADIPOSE-DERIVED STROMAL CELLS (ASCs) ON ADULTS WITH STAGE III OR IV PRESSURE ULCERS|Recruiting||Phase 1|12|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:32:56.91495|2017-10-10 23:32:56.91495
NCT02375789|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-02-02|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|COOLHEAD2||Intranasal Cooling for Symptomatic Relief of Migraine|"Intranasal Evaporative COOLing for the Symptomatic Relief of Migraine HEADache - A Randomized, Double Blind, Placebo Controlled Study"|Terminated||N/A|27|Actual|Cumbria Partnership NHS Foundation Trust||2||Due to insolvency of sponsor|f||||t||||||||||2017-10-10 23:32:57.051802|2017-10-10 23:32:57.051802
NCT02375776|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-02-27|||March 2015||2015-03-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CORA||Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention|Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal mHealth Intervention|Recruiting||N/A|104|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:32:57.199108|2017-10-10 23:32:57.199108
NCT02375763|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-03-22|||February 2015||2015-02-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Dietary Analysis for Caries Prevention in Children Using a Computer Software|Dietary Analysis for Caries Prevention in Children Using a Computer Software|Completed||N/A|100|Actual|Marquette University||2|||f||||||||||||||2017-10-10 23:32:57.312275|2017-10-10 23:32:57.312275
NCT02375750|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-08-08|||September 2014||2014-09-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Treatment of Peri-implantitis Lesions by Using Biomaterial|Surgical Treatment of Peri-implantitis Lesions, With or Without the Placement of a Bone Substitute and a Collagen Membrane. A Randomized Clinical Trial|Active, not recruiting||Phase 4|90|Anticipated|Geistlich Pharma AG||2|||f||||f||||||||No||2017-10-10 23:32:57.389524|2017-10-10 23:32:57.389524
NCT02375737|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-08-11|||January 2015||2015-01-01|January 2016|2016-01-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|CVDMAT||Evaluating CVD Medication Adherence Program in Low SES|Evaluating CVD Medication Adherence Program in Low SES|Completed||N/A|100|Actual|Duke University||1|||f||||f||||||||||2017-10-10 23:32:57.476991|2017-10-10 23:32:57.476991
NCT02375724|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-26|2017-03-09|2016-10-27||March 2015||2015-03-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|M-34273-46||BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH|A RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL STUDY TO ASSESS THE BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH WHEN ADMINISTERED TO PATIENTS WITH COPD|Completed||Phase 4|300|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:32:57.574735|2017-10-10 23:32:57.574735
NCT02375711|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-04-25|||March 2014||2014-03-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|IVVI||Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient|Evaluation of Immunosenescence as a Predictive Biomarker of HBV Vaccine Efficacy in Chronic Renal Disease Patient|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||No||2017-10-10 23:32:58.005211|2017-10-10 23:32:58.005211
NCT02375698|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-08-24|||November 21, 2014|Actual|2014-11-21|August 2017|2017-08-01|October 24, 2016|Actual|2016-10-24|June 24, 2016|Actual|2016-06-24||Interventional|C-037-456||A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB|A Phase I, Double-blind, Randomized, Placebo-controlled, Study to Evaluate the Safety and Immunogenicity of AERAS-456 in HIV Negative Adults Successfully Treated for Drug-susceptible Pulmonary Tuberculosis|Completed||Phase 1|22|Actual|Aeras||2|||f||||t||||||||||2017-10-10 23:32:58.131388|2017-10-10 23:32:58.131388
NCT02375685|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-06-01|||August 2014||2014-08-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|EYEGUARD-X||Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)|A Safety Open-label Study of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis Disease, an eXtension Study. The EYEGUARD-X Study|Terminated||Phase 3|71|Actual|Servier||1|||f||||f||||||||||2017-10-10 23:32:58.238041|2017-10-10 23:32:58.238041
NCT02375672|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-09-05|||April 2015||2015-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer|A Multi-Center, Single Arm, Phase II Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer: HCRN GI14-186|Active, not recruiting||Phase 2|30|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-10-10 23:32:58.373794|2017-10-10 23:32:58.373794
NCT02375646|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-02-27|||May 2015||2015-05-01|February 2015|2015-02-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients|Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients: a Prospective Single-blinded Multicenter Study Comparing Warfarin vs. Low Molecular Weight Heparin Based Bridging Anticoagulation|Unknown status|Not yet recruiting|N/A|286|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 23:32:58.55534|2017-10-10 23:32:58.55534
NCT02375633|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-10-07|||April 2014||2014-04-01|October 2016|2016-10-01||||November 2014|Actual|2014-11-01||Interventional|||Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients||Completed||Phase 3|166|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 23:32:58.656087|2017-10-10 23:32:58.656087
NCT02375620|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2015-02-24|||October 2014||2014-10-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature||Recruiting||Phase 2|96|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:32:58.732981|2017-10-10 23:32:58.732981
NCT02375607|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-24|||February 2012||2012-02-01|February 2015|2015-02-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Could Algometric Assessment be Effective to Adjust Postoperative Analgesic Requirement?|Could Algometric Assessment be Effective to Adjust Postoperative Analgesic Requirement?|Unknown status|Recruiting|N/A|80|Anticipated|Tokat Gaziosmanpasa University||1|||f||||t||||||||||2017-10-10 23:32:58.851855|2017-10-10 23:32:58.851855
NCT02375594|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-24|||December 2014||2014-12-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Exercise Park Equipment for Improving Physical Function and Physical Activity Levels in the Elderly|Sustained Effect of a 12 Week Guided Exercise Program Conducted in an Exercise Park Equipment in the Physical Function and Physical Activity Levels of Physically Inactive Elderly: Randomized Clinical Trial|Unknown status|Recruiting|N/A|88|Anticipated|Fundacio Salut i Envelliment UAB||2|||f||||f||||||||||2017-10-10 23:32:58.945486|2017-10-10 23:32:58.945486
NCT02375581|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-03-18|||January 2015||2015-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer|A Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer|Recruiting||Phase 2|130|Anticipated|First People's Hospital of Hangzhou||2|||f||||f||||||||||2017-10-10 23:32:59.053744|2017-10-10 23:32:59.053744
NCT02375568|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-24|||May 2014||2014-05-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Large-scale Expansion and Characterization of Mesenchymal Stem Cells for Clinical Application|Large-scale ex Vivo Expansion and Characterization of Synovial Membrane Mesenchymal Stem Cells (SM-MSC) and Infrapatellar Fat Pad Mesenchymal Stem Cells (IF-MSC) for Clinical Application|Unknown status|Recruiting|N/A|6|Anticipated|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-10 23:32:59.138538|2017-10-10 23:32:59.138538
NCT02375555|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-07-27|||May 7, 2015|Actual|2015-05-07|July 2017|2017-07-01|June 2022|Anticipated|2022-06-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM|An Open-Label, Single Arm, Phase 2a Study of Bortezomib, Lenalidomide, Dexamethasone and Elotuzumab in Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|41|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:32:59.230212|2017-10-10 23:32:59.230212
NCT02375542|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-01-25|||February 2015||2015-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Characterization of Aortic Tissue at Reoperation|Clinical Observation and Pathological Characterization of Aortic Tissue at Reoperation|Recruiting||N/A|10|Anticipated|CryoLife Europa|||1||f||||f||||||Samples Without DNA|"     Samples of aortic tissue which are removed as standard practice during surgery   "|||2017-10-10 23:32:59.339444|2017-10-10 23:32:59.339444
NCT02375529|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-02-24|||May 2011||2011-05-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|||A Trial of Single Incision Versus Four Ports Laparoscopic Cholecystectomy|Estudio Prospectivo Aleatorizado de la colecistectomía laparoscópica Por Puerto único vs colecistectomía laparoscópica Por Cuatro Puertos en Pacientes Con Colelitiasis sintomática y régimen de cirugía Sin Ingreso.|Completed||N/A|73|Actual|Consorci Sanitari Integral||2|||f||||f||||||||||2017-10-10 23:32:59.406488|2017-10-10 23:32:59.406488
NCT02375516|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-07-22|||September 2012||2012-09-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Preventing Drug Abuse Among Hispanic Adolescents|Drug Abuse Prevention Programming for Hispanic Adolescents|Active, not recruiting||N/A|678|Actual|Columbia University||2|||f||||f||||||||Undecided||2017-10-10 23:32:59.467588|2017-10-10 23:32:59.467588
NCT02375503|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-05-12|||April 2015||2015-04-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy of a Once Daily Calcium and Vitamin D Fortified Food Product to Improve Bone Microarchitecture|Efficacy of a Once Daily Calcium and Vitamin D Fortified Food Product to Improve Bone Microarchitecture in Response to Army Basic Combat Training|Completed||N/A|175|Actual|United States Army Research Institute of Environmental Medicine||2|||f||||f||||||||Undecided||2017-10-10 23:32:59.545877|2017-10-10 23:32:59.545877
NCT02375490|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-05-09|||September 2013||2013-09-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Healthy Start to Increase Physical Activity and Improve Healthy Eating in Early Childcare Centres|A Multilevel Intervention to Increase Physical Activity and Improve Healthy Eating Among Young Children (Ages 3-5) Attending Early Childcare Centres: the Healthy Start Study|Recruiting||N/A|735|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-10 23:32:59.637782|2017-10-10 23:32:59.637782
NCT02375477|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-09-15|||January 2015||2015-01-01|September 2016|2016-09-01||||January 2016|Actual|2016-01-01||Interventional|||Improved Adherence to C. Difficile Isolation Protocols Through Improved Education Methods|Improved Adherence to C. Difficile Isolation Protocols Though Improved Inter-disciplinary Educational Methods|Active, not recruiting||N/A|38|Actual|Case Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 23:32:59.758529|2017-10-10 23:32:59.758529
NCT02375464|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-11-04|||April 2015||2015-04-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Expanded Access|||Gallium-68 DOTATOC for Management of Neuroendocrine Tumors|Gallium-68 DOTATOC for Management of Neuroendocrine Tumors|No longer available||N/A|||Northwell Health|||||||||||||||||||2017-10-10 23:32:59.854245|2017-10-10 23:32:59.854245
NCT02375451|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-06-23|||September 2014||2014-09-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Effect of Childhood Radioiodine Therapy on Salivary Function|Effect of Childhood Radioiodine Therapy on Salivary Function|Completed||N/A|70|Actual|Boston Children’s Hospital|||2||f||||f||||||||||2017-10-10 23:32:59.963477|2017-10-10 23:32:59.963477
NCT02375438|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-04-05|||December 2014||2014-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|NAMITO||Nutritional Assessment in Mitochondrial Cytopathy|Nutritional Assessment in Patients Affected by Mitochondrial Cytopathy|Completed||N/A|26|Actual|University Hospital Inselspital, Berne|||2||f||||t||||||Samples With DNA|"     Whole blood, urine. All samples collected in this study (blood and urinary) will be sent to a     central biobank for long term storage.   "|||2017-10-10 23:33:00.05066|2017-10-10 23:33:00.05066
NCT02375425|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-08-08|||June 2015||2015-06-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Optimization of the ex Vivo Challenge: Reproductive Infections and Contraception|Optimization of the ex Vivo Challenge: Reproductive Infections and Contraception|Completed||N/A|294|Actual|University of Pittsburgh|||4||f||||f||||||||||2017-10-10 23:33:00.131844|2017-10-10 23:33:00.131844
NCT02375412|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-03-07|||February 2015||2015-02-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Preoperative Measurement of Heart Rate Variability as a Predictor of Postoperative Outcome|Preoperative Evaluation of Autonomic Nervous System by Heart Rate Variability as a Predictor of Postoperative Outcome in the Patient Undergoing Major Elective Abdominal Surgery|Completed||N/A|65|Actual|University Hospital Ostrava|||1||f||||f||||||||No||2017-10-10 23:33:00.204242|2017-10-10 23:33:00.204242
NCT02375399|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-06-02|||March 2015||2015-03-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|NEW-CRT||New Echocardiographic Parameters for Prediction of Response to Cardiac Resynchronization Therapy|New Approaches to Echocardiography Assessment of Cardiac Dyssynchrony: Relevance Concerning Response Rate to Cardiac Resynchronization Therapy|Terminated||N/A|15|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-10 23:33:00.280149|2017-10-10 23:33:00.280149
NCT02375386|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-09-14|||February 2015||2015-02-01|September 2017|2017-09-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Feasibility Assessment of Neurophysiological Measurement in Veterans With LBP|CENTRAL MECHANISMS OF BODY BASED INTERVENTION FOR MUSCULOSKELETAL LOW BACK PAIN: Feasibility Assessment of Neurophysiological Measurement in Veterans With Low Back Pain|Completed||N/A|3|Actual|University of Florida||2|||f||||t||||||||||2017-10-10 23:33:00.983839|2017-10-10 23:33:00.983839
NCT02375373|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-01-22|2015-12-01||April 2015||2015-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Effects of Adding Chickpeas to the American Diet (Long Term Study)|Effects of Adding Chickpeas to the American Diet on Fecal Microbiota Composition and Markers of Inflammation|Completed||N/A|12|Actual|University of Florida|||1||f||||f||||||Samples With DNA|"     Fecal   "|||2017-10-10 23:33:01.073343|2017-10-10 23:33:01.073343
NCT02375360|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-02-27|||July 2014||2014-07-01|February 2015|2015-02-01||||December 2016|Anticipated|2016-12-01||Observational|||OIT Effect on FAQLQ|Quality of Life in Food Allergic Patients Before, During and After Oral Immunotherapy|Unknown status|Recruiting|N/A|500|Anticipated|Assaf-Harofeh Medical Center|||7||f||||||||||||||2017-10-10 23:33:01.269701|2017-10-10 23:33:01.269701
NCT02375347|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-05-24|2015-11-23||March 2015||2015-03-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effects of Adding Chickpeas to the American Diet on Fecal Microbiota Composition and Markers of Inflammation|Effects of Adding Chickpeas to the American Diet on Fecal Microbiota Composition and Markers of Inflammation|Completed||N/A|13|Actual|University of Florida||1|||f||||f||||||||||2017-10-10 23:33:01.396193|2017-10-10 23:33:01.396193
NCT02375334|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-07-11|||February 2015||2015-02-01|July 2017|2017-07-01||||January 2017|Actual|2017-01-01||Observational|||Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy|Comparative Development of Data Driven Systems for Insuring Timely Monitoring for Brain Tumor Patients for Management of Myelosuppression|Terminated||N/A|18|Actual|Wake Forest University Health Sciences|||1|Support Staff Left Institution|f||||f|f|f||||||||2017-10-10 23:33:03.295173|2017-10-10 23:33:03.295173
NCT02375321|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-06-23|||May 2014||2014-05-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|QUOLOSA||Quality of Life in Patients With Obstructive Sleep Apnea: The Role of CPAP Associated to Psychological Support|Quality of Life in Patients With Obstructive Sleep Apnea: The Role of CPAP Associated to Psychological Support|Unknown status|Enrolling by invitation|N/A|104|Actual|Careggi Hospital||2|||f||||f||||||||||2017-10-10 23:33:03.376974|2017-10-10 23:33:03.376974
NCT02375308|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-06-27|||April 2015||2015-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression|Efficacy of Activation-focussed Cognitive Treatment of Depression (ACDT) to Hypnotherapeutic Treatment of Depression (HDT) in Mild to Moderate Major Depression|Recruiting||N/A|160|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-10 23:33:03.459774|2017-10-10 23:33:03.459774
NCT02375295|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-04-06|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Struvite Stones Antibiotic Study|A Prospective Randomized Trial of 2 Weeks vs 3 Months of Antibiotics Post Percutaneous Nephrolithotomy for the Prevention of Infection-Related Kidney Stones|Recruiting||Phase 4|28|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-10 23:33:03.554512|2017-10-10 23:33:03.554512
NCT02375282|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-09-09|||March 2015||2015-03-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|July 2015|Actual|2015-07-01||Interventional|||Physical and Functional Recovery From Cardiac Surgery in Hospitalized Patients: A Feasibility Pilot Study|Physical and Functional Recovery From Cardiac Surgery in Hospitalized Patients: A Feasibility Pilot Study|Unknown status|Active, not recruiting|N/A|40|Anticipated|Baystate Medical Center||2|||f||||f||||||||||2017-10-10 23:33:03.704201|2017-10-10 23:33:03.704201
NCT02375269|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-02-27|||March 2015||2015-03-01|January 2015|2015-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|RIPC||Effect of Remote Ischemic Preconditioning on Postoperative Complications in Visceral Surgery|A Randomized, Double- Blind Multicentric Study of the Effect of Remote Ischemic Preconditioning on Postoperative Complications in Patients Undergoing Major Minimal and Open Visceral Surgery|Not yet recruiting||N/A|526|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-10 23:33:03.799854|2017-10-10 23:33:03.799854
NCT02375256|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-02-27|||October 2009||2009-10-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2010|Actual|2010-12-01||Interventional|C-021-402||A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402|A Phase I, Double-Blind, Randomized, Placebo-controlled Leukapheresis Study to Obtain Lymphocytes for the Study of Immune Responses in Healthy Adult Volunteers in the U.S. Who Receive BCG Vaccination Followed by Boosting With AERAS-402|Completed||Phase 1|11|Actual|Aeras||2|||f||||f||||||||||2017-10-10 23:33:03.892127|2017-10-10 23:33:03.892127
NCT02375243|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2017-02-11|||February 2014||2014-02-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Use of Dexmedetomidine in Children Undergoing Cardiac Surgery|Use of Dexmedetomidine in Children Undergoing Cardiac Surgery|Completed||Phase 2|60|Anticipated|Bambino Gesù Hospital and Research Institute||2|||f||||f||||||||||2017-10-10 23:33:03.969651|2017-10-10 23:33:03.969651
NCT02375230|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-03-13|||May 2015||2015-05-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|MRSOPA||MRSOPA-Drills to Improve Mask Ventilation in the Delivery Room|MRSOPA-Drills to Improve Mask Ventilation in the Delivery Room|Completed||N/A|56|Actual|University of Alberta||2|||f||||f||||||||Yes|data will be shared after request from researchers|2017-10-10 23:33:04.052897|2017-10-10 23:33:04.052897
NCT02375217|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-24|||October 2014||2014-10-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"|"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"|Unknown status|Recruiting|Phase 4|56|Anticipated|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-10 23:33:04.285121|2017-10-10 23:33:04.285121
NCT02375204|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-08-15|||March 2015||2015-03-01|August 2017|2017-08-01||||March 2018|Anticipated|2018-03-01||Interventional|||Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors|A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors|Recruiting||Phase 3|420|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 23:33:04.418093|2017-10-10 23:33:04.418093
NCT02375191|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-08-16|||January 2015||2015-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Comparative Study of the Effect of Epidural Dexmedetomidine Versus Fentanyl Added to Ropivacaine in Pediatric Orthopedic Surgery||Completed||N/A|58|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:33:04.816074|2017-10-10 23:33:04.816074
NCT02375178|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-01-09|||August 2014||2014-08-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|October 2014|Actual|2014-10-01||Interventional|||Antimicrobial Activity of Two Mouthwashes|Antimicrobial Activity of Two Mouthwashes|Completed||N/A|30|Actual|Universidade do Vale do Sapucai||3|||f||||t||||||||||2017-10-10 23:33:04.932509|2017-10-10 23:33:04.932509
NCT02375165|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-03-09|||September 2009||2009-09-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2024|Anticipated|2024-12-01||Observational|Biomarkers||Biomarkers for the Detection of Lymphatic Insufficiency|Biomarkers for the Detection of Lymphatic Insufficiency|Enrolling by invitation||N/A|600|Anticipated|Stanford University|||3||f||||f||||||Samples With DNA|"     Serum, plasma, tissue   "|Undecided|unknown at this time.|2017-10-10 23:33:05.059422|2017-10-10 23:33:05.059422
NCT02375152|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-04-25|||April 2015||2015-04-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Effectiveness of Capsulotomy in Refractory OCD|Safety and Effectiveness of Capsulotomy in Refractory Obsessive-Compulsive Disorder|Recruiting||Phase 2/Phase 3|30|Anticipated|Ruijin Hospital||1|||f||||t||||||||||2017-10-10 23:33:05.144875|2017-10-10 23:33:05.144875
NCT02375139|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-07-21|||April 2015||2015-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers|A Randomized, Open-label, Crossover, Single Dose Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 (Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg After Single Oral Administration in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:33:05.229145|2017-10-10 23:33:05.229145
NCT02375126|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-10-04|||March 2014||2014-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|NormalEEG||Normal Quantitative EEG (qEEG) Dataset|Normal Quantitative EEG (qEEG) Dataset for the Use in Comparison With Patients Suffering Carbon Monoxide (CO) Poisoning|Recruiting||N/A|80|Anticipated|Intermountain Health Care, Inc.|||3||f||||f||||||||||2017-10-10 23:33:05.318036|2017-10-10 23:33:05.318036
NCT02375113|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-02-27|||September 2012||2012-09-01|January 2013|2013-01-01|December 2014|Actual|2014-12-01|August 2013|Actual|2013-08-01||Interventional|||Soy as an Innovative Dietary Component in Abdominal Obesity Management Amongst Peri- and Early Menopausal Women|Soy as an Innovative Dietary Component in Abdominal Obesity Management|Completed||Phase 2/Phase 3|12|Actual|The University of Texas at San Antonio||2|||f||||f||||||||||2017-10-10 23:33:05.419505|2017-10-10 23:33:05.419505
NCT02375100|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-10-27|||February 2015||2015-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Transversus Abdominis Plane Block Versus Ilioinguinal Nerve Block for Pain Management in Inguinal Herniorraphy|Comparison of Efficacy of Transversus Abdominis Plane Block and Ilioinguinal Nerve Block for Postoperative Pain Management in Patients Undergoing Inguinal Herniorraphy With Spinal Anesthesia|Completed||N/A|90|Actual|Bozyaka Training and Research Hospital||3|||f||||f||||||||||2017-10-10 23:33:05.50218|2017-10-10 23:33:05.50218
NCT02375087|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-11-10|||May 2014||2014-05-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|STAR||Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ?|Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ?|Recruiting||N/A|70|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-10 23:33:05.63445|2017-10-10 23:33:05.63445
NCT02375074|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-12-27|||May 2014||2014-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SEED||Supported Employment and Preventing Early Disability|Supported Employment and Preventing Early Disability (SEED)|Active, not recruiting||N/A|98|Actual|Uni Research||2|||f||||t||||||||||2017-10-10 23:33:05.72909|2017-10-10 23:33:05.72909
NCT02375061|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-06-10|||October 2013||2013-10-01|April 2016|2016-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BPS_FM||A Positive Psychology Intervention for Fibromyalgia Patients Using ICT´s|A Positive Psychology Intervention for Fibromyalgia Patients to Promote Physical and Psychological Wellbeing Using Information and Communication Technologies|Completed||N/A|80|Actual|Universitat Jaume I||2|||f||||t||||||||||2017-10-10 23:33:05.824758|2017-10-10 23:33:05.824758
NCT02375048|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-02-27|||January 2015||2015-01-01|September 2014|2014-09-01|January 2025|Anticipated|2025-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI|Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation (WBI) Versus Accelerated Partial Breast Irradiation (APBI)|Recruiting||Phase 2|700|Anticipated|Istituto Clinico Humanitas||2|||f||||t||||||||||2017-10-10 23:33:05.957701|2017-10-10 23:33:05.957701
NCT02375035|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-02-24|||January 2015||2015-01-01|February 2015|2015-02-01|September 2019|Anticipated|2019-09-01|December 2015|Anticipated|2015-12-01||Observational|CAMPROBE||Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer|Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer|Recruiting||N/A|50|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:33:06.176518|2017-10-10 23:33:06.176518
NCT02375022|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-03-23|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations|A Study to Evaluate the Efficacy of Rh-Endostatin (Endostar®) in Combination With Icotinib for Advanced Non-Small Cell Lung Cancer With EGFR Mutations|Unknown status|Recruiting|Phase 2|10|Anticipated|Zhejiang University||1|||f||||f||||||||||2017-10-10 23:33:06.261304|2017-10-10 23:33:06.261304
NCT02375009|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-06-20|||March 2015||2015-03-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Glaucoma Management in the African-Derived Developing World Using Trabeculoplasty|Glaucoma Management in the African-Derived Developing World Using Trabeculoplasty|Enrolling by invitation||N/A|129|Actual|West Virginia University||1|||f||||t||||||||Undecided||2017-10-10 23:33:06.369487|2017-10-10 23:33:06.369487
NCT02374996|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-01-12|||November 2015||2015-11-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Observational|||Pharmacoepigenetics of Bipolar Disorder Treatment|Pharmacoepigenetics of Second Generation Antipsychotic-Induced Insulin Resistance in Bipolar Disorder|Recruiting||N/A|105|Anticipated|Wayne State University|||3||f||||||||||||||2017-10-10 23:33:06.451302|2017-10-10 23:33:06.451302
NCT02374983|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-02-27|||October 2013||2013-10-01|February 2015|2015-02-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Observational|||Gamma Knife Dosimetric Differences, TMR 10 Versus Convolution Algorithm|Evaluation of Dosimetric Differences Between the TMR 10 and Convolution Algorithm for Gamma Knife Radiosurgery Planning|Unknown status|Recruiting|N/A|100|Anticipated|University College, London|||1||f||||f||||||||||2017-10-10 23:33:06.549157|2017-10-10 23:33:06.549157
NCT02374970|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-02-27|||February 2015||2015-02-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Transversus Abdominis Muscular Training and Chronic Low Back Pain|Effectiveness of Transversus Abdominis Muscular Training in Patients With Chronic Low Back Pain|Unknown status|Recruiting|N/A|50|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-10 23:33:06.645674|2017-10-10 23:33:06.645674
NCT02374957|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-06-01|||February 2015||2015-02-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CLEAR||Cilostazol After Lower Extremity Arterial Revascularization Trial|Cilostazol After Lower Extremity Arterial Revascularization Trial (CLEAR)|Active, not recruiting||Phase 4|20|Anticipated|Wake Forest University Health Sciences||2|||f||||t|t|f||||||No||2017-10-10 23:33:06.733326|2017-10-10 23:33:06.733326
NCT02374944|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-11-30|||November 2015||2015-11-01|November 2015|2015-11-01||||December 2020|Anticipated|2020-12-01||Interventional|FIRM||Fixation Insitu Versus Removal for Midfoot Lisfranc Injuries|A Randomized Clinical Trial Evaluating Fixation Insitu Versus Removal for Midfoot Lisfranc Injuries|Active, not recruiting||N/A|94|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-10 23:33:06.814794|2017-10-10 23:33:06.814794
NCT02374931|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-01-12|||April 2015||2015-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||18F-FES PET/CT in Imaging Patients With Desmoid Tumors|Pilot Investigation of 18F-FES PET/CT Imaging of Desmoid Tumors|Recruiting||N/A|10|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 23:33:06.928354|2017-10-10 23:33:06.928354
NCT02374918|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bright Light Therapy for Treatment of Sleep Problems Following Mild Traumatic Brain Injury|Bright Light Therapy for Treatment of Sleep Problems Following Mild Traumatic Brain Injury|Recruiting||N/A|69|Anticipated|University of Arizona||4|||f||||f||||||||||2017-10-10 23:33:07.049413|2017-10-10 23:33:07.049413
NCT02374905|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-09-08|||October 2014||2014-10-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|March 2016|Anticipated|2016-03-01||Interventional|||Testing Interventions to Reduce Alcohol Consumption Among Outpatients in a Dental Setting|Assess and Improve Patient's Self-reported Alcohol Consumption While Attending the Oral Medicine Clinic|Unknown status|Recruiting|N/A|40|Anticipated|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-10 23:33:07.164956|2017-10-10 23:33:07.164956
NCT02374892|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||The CHAPTER III Study of Young Adolescents|The CHAPTER III Study of Young Adolescents: Congenital Heart Adolescents Participating in Transition Evaluation Research|Recruiting||N/A|60|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:33:07.27992|2017-10-10 23:33:07.27992
NCT02374879|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-08-14|||February 1, 2015|Actual|2015-02-01|August 2017|2017-08-01|February 1, 2015|Actual|2015-02-01|February 1, 2015|Actual|2015-02-01||Interventional|||User Performance and System Accuracy Evaluations Using Glucose Adjustment|User Performance and System Accuracy Evaluations Using Glucose Adjustment|Completed||N/A|12|Actual|LifeScan||1|||f||||f||||||||||2017-10-10 23:33:07.375273|2017-10-10 23:33:07.375273
NCT02374866|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-09-02|||March 2015||2015-03-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SUIVIOBESITE||Monitoring Obese Patients : Impact on the Frequency of Monitoring Weight|Monitoring Obese Patients: Impact on the Frequency of Monitoring Weight, Quality of Life, Dietary Behavior, Physical Ability and Comorbidities|Completed||N/A|96|Actual|University Hospital, Limoges||2|||f||||f||||||||||2017-10-10 23:33:07.450521|2017-10-10 23:33:07.450521
NCT02374853|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-09-26|||March 2015||2015-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|SWI||Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)|Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)|Enrolling by invitation||Phase 2|1552|Anticipated|University of Alberta||2|||f||||t||||||||||2017-10-10 23:33:07.537062|2017-10-10 23:33:07.537062
NCT02374840|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-07-20||||||July 2015|2015-07-01||||February 2019|Anticipated|2019-02-01|90 Days|Observational [Patient Registry]|PREACT||Pharmacogenomics Registry to Assess Clinical Utility|Pharmacogenomics Registry to Assess Clinical Utility|Not yet recruiting||N/A|340778|Anticipated|Companion Dx Reference Lab, LLC|||1||f||||f||||||||||2017-10-10 23:33:07.621977|2017-10-10 23:33:07.621977
NCT02374827|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-10-03|||April 2015|Actual|2015-04-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|April 2017|Actual|2017-04-01||Interventional|SCORE||Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)|Complete Salpingectomy Versus Standard Postpartum Tubal Ligation at the Time of Cesarean Delivery- a Randomized Controlled Study|Completed||N/A|80|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 23:33:07.693174|2017-10-10 23:33:07.693174
NCT02374814|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-05-01|||March 24, 2015|Actual|2015-03-24|May 2017|2017-05-01|September 22, 2016|Actual|2016-09-22|September 22, 2016|Actual|2016-09-22||Interventional|RABVAX||Immunogenicity of Rabies Vaccine for Pre Exposure|Immunogenicity of a Two vs Three Dose, Intradermal (ID) vs Intramuscular (IM) Administration of a Licensed Rabies Vaccine for Pre-Exposure Vaccination|Completed||Phase 4|60|Actual|State University of New York - Upstate Medical University||6|||f||||f||||||||||2017-10-10 23:33:07.788212|2017-10-10 23:33:07.788212
NCT02374801|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-10-12|||April 2015||2015-04-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D (CAS RESPOND CRT)|Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D|Recruiting||N/A|200|Anticipated|Sorin Group USA, Inc.||1|||f||||t||||||||||2017-10-10 23:33:07.892436|2017-10-10 23:33:07.892436
NCT02374788|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-10-02|||November 2013||2013-11-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Sophia Step Study - a Behaviour Change Program on Physical Activity in Persons With Pre- and Type 2 Diabetes|Health Promotion in the Primary Care Setting- an Evaluation of the Sophia Step Study- a Structured Behaviour Change Program Focusing on Physical Activity in Persons With Pre- and Type 2 Diabetes|Recruiting||N/A|310|Anticipated|Sophiahemmet University||3|||f||||f||||||||||2017-10-10 23:33:07.993836|2017-10-10 23:33:07.993836
NCT02374775|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-04-02|||September 2014||2014-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|EMERALD||Exploring the MEchanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and computationaL Fluid Dynamic|Exploring the MEchanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and computationaL Fluid Dynamics (EMERALD)|Active, not recruiting||N/A|77|Actual|Seoul National University Hospital|||2||f||||t||||||||Yes|After acceptance of first manuscript, the data will be shared upon request and permission of principal investigator and participants of the study|2017-10-10 23:33:08.132932|2017-10-10 23:33:08.132932
NCT02374762|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-02-22|||March 2015||2015-03-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Hemodialysis Vascular Access Imaging Study|Contact-Free Video Imaging of Arteriovenous Fistulas In Chronic Hemodialysis Patients|Completed||N/A|41|Actual|Renal Research Institute|||1||f||||f||||||||||2017-10-10 23:33:08.22019|2017-10-10 23:33:08.22019
NCT02374749|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2016-07-05|||March 2015||2015-03-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|COMEDSPA||COMorbidities and EDucation in SPondyloArthritis Study|COmorbidities and EDucation in SpondyloArthritis Study (COMEDSPA) Evaluation of Standardized Follow-up in Axial Spondyloarthritis|Recruiting||N/A|500|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:33:08.30926|2017-10-10 23:33:08.30926
NCT02374736|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-08-28|||February 2015||2015-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|InAuGuRAL||Effect of Privigen Against Graft Loss|A Pilot Study on the Effect of Privigen Against Graft Loss: Interventional Study of Kidney Transplant Recipients at Risk for Graft Loss Through Antibody-mediated Rejection|Recruiting||Phase 3|15|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:33:08.399716|2017-10-10 23:33:08.399716
NCT02374723|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-04-14|||June 2015||2015-06-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of Biosynthetic Constructs to Replace Donor Corneas|Evaluation of Biosynthetic Constructs as Replacement for Donor Corneas as Graft Material for Corneal Transplantation|Withdrawn||Phase 1|0|Actual|Region Östergötland||2||This study was withdrawn to be replaced with a multi-site Phase I trial.|f||||t||||||||||2017-10-10 23:33:08.486451|2017-10-10 23:33:08.486451
NCT02374710|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-04-16|||April 2015||2015-04-01|April 2015|2015-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Tibial Tunnel Placement for ACL Reconstruction|Tibial Tunnel Placement for ACL Reconstruction: A Prospective, Randomized Clinical Trial|Recruiting||N/A|90|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-10 23:33:08.562489|2017-10-10 23:33:08.562489
NCT02374697|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-12-08|||September 2013||2013-09-01|June 2015|2015-06-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Observational|||Assessment of Tele-expertise for Second Medical Opinion on Pathological Diagnosis|Assessment of Tele-expertise for Second Medical Opinion on Pathological Diagnosis|Completed||N/A|470|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     Fixed tissue   "|||2017-10-10 23:33:08.659491|2017-10-10 23:33:08.659491
NCT02374476|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-06-28|||February 2015||2015-02-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Bipolar Ventricular Tachycardia (VT) Study|Bipolar Catheter Ablation for the Treatment of Refractory Scar-Related Ventricular Arrhythmia|Recruiting||N/A|200|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|f|t|f|||||No||2017-10-10 23:33:11.015686|2017-10-10 23:33:11.015686
NCT02374684|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-02-17|||February 2015||2015-02-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Tolerability, Safety and Pharmacokinetic Study Of Methosulide in Healthy Adult Subjects|A Within-group Randomized, Double-Blind, Placebo-Controlled, Single/ Multiple Dose Study to Assess the Safety , Tolerability, Pharmacokinetics and Food Effect of Methosulide After Oral Administration In Healthy Adult Subjects.|Completed||Phase 1|92|Actual|Hubei Biological Medicine Industrial Technology Institute Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:33:08.930633|2017-10-10 23:33:08.930633
NCT02374671|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-02-24|||November 2014||2014-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients|A Prospective, Multicenter Clinical Trial Of The VisAbility Micro Insert System For Improvement Of Near Visual Acuity In Presbyopic Patients|Active, not recruiting||N/A|360|Anticipated|Refocus Group, Inc.||1|||f||||t||||||||No||2017-10-10 23:33:09.054427|2017-10-10 23:33:09.054427
NCT02374658|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-27|||February 2015||2015-02-01|February 2015|2015-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|ARTS-REHAB||The ARTS-REHAB Project Research Study|The Royal Conservatory's ARTS-REHAB Project Research Study|Unknown status|Recruiting|N/A|188|Anticipated|The Royal Conservatory of Music||2|||f||||f||||||||||2017-10-10 23:33:09.162509|2017-10-10 23:33:09.162509
NCT02374645|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-06-19|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|November 28, 2017|Anticipated|2017-11-28||Interventional|||A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC|A Phase Ib, Open-label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumour Activity of Volitinib in Combination With Gefitinib (Iressa®) in Patients With Epidermal Growth Factor Receptor-mutated Non-small Cell Lung Cancer Who Have Progressed on Epidermal Growth Factor Receptor Inhibitor Treatment|Active, not recruiting||Phase 1|64|Actual|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-10 23:33:09.255495|2017-10-10 23:33:09.255495
NCT02374632|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-02-06|||October 2014||2014-10-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass||Active, not recruiting||Phase 4|40|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 23:33:09.354856|2017-10-10 23:33:09.354856
NCT02374619|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-04-12|||December 2011||2011-12-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Iron Supplementation and Eccentric Exercise|The Effect of Eccentric Exercise and Iron Supplementation on Blood Redox Status and Muscle Performance in Different Age Groups|Completed||N/A|28|Actual|University of Thessaly||2|||f||||f||||||||||2017-10-10 23:33:09.454076|2017-10-10 23:33:09.454076
NCT02374606|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-02-01|||March 2015||2015-03-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Accurate Test of Limb Isometric Strength (ATLIS) in ALS|Accurate Test of Limb Isometric Strength (ATLIS) in ALS|Recruiting||N/A|100|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||No||2017-10-10 23:33:09.578635|2017-10-10 23:33:09.578635
NCT02374580|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-06-15|||February 2015||2015-02-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Partnership and Dignity: a Mixed-methods Survey on Supporting and Retaining Uganda's Village Health Teams|Partnership and Dignity: a Mixed-methods Survey on Supporting and Retaining Uganda's Village Health Teams|Completed||N/A|143|Actual|George Washington University|||1||f||||t||||||||||2017-10-10 23:33:09.946967|2017-10-10 23:33:09.946967
NCT02374567|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-02-23|||January 2015||2015-01-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|GAP||Pharmacovigilance in Gerontopsychiatric Patients|Pharmacovigilance in Gerontopsychiatric Patients|Recruiting||Phase 3|2000|Anticipated|Hannover Medical School||1|||f||||f||||||||No||2017-10-10 23:33:10.052573|2017-10-10 23:33:10.052573
NCT02374554|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-03-05|||February 2015||2015-02-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Thora-3Di™ Respiratory Rate Validation|Thora-3Di™ Respiratory Rate Validation|Unknown status|Recruiting|N/A|43|Anticipated|Pneumacare Ltd||1|||f||||f||||||||||2017-10-10 23:33:10.412256|2017-10-10 23:33:10.412256
NCT02374541|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-08-29|||February 16, 2015|Actual|2015-02-16|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|SaLSA||Screening and Linkage to Services for Autism|Screening and Linkage to Services for Autism|Recruiting||N/A|982|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:33:10.535666|2017-10-10 23:33:10.535666
NCT02374528|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-27|||March 2015||2015-03-01|February 2015|2015-02-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Negative Pressure Wound Therapy for Skin Grafts|Clinical Randomized Controlled Trials on Negative Pressure Wound Therapy for Skin Grafts|Unknown status|Not yet recruiting|N/A|80|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-10 23:33:10.661792|2017-10-10 23:33:10.661792
NCT02374515|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-06-13|||February 2015||2015-02-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Safety and Efficacy of Endocuff-assisted Colonoscopy for Adenoma Detection.|Endocuff-assisted Colonoscopy: a Randomized Back-to-back Colonoscopy Study of Adenoma Detection.|Completed||N/A|275|Actual|University of Naples||2|||f||||t||||||||||2017-10-10 23:33:10.749703|2017-10-10 23:33:10.749703
NCT02374502|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-03-08|||March 2015||2015-03-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|INPACT-AS||Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial|Increasing Physical Activity in Ankylosing Spondylitis (INPACT-AS): a Randomised Controlled Trial|Completed||N/A|40|Actual|University of Dublin, Trinity College||2|||f||||f||||||||||2017-10-10 23:33:10.828526|2017-10-10 23:33:10.828526
NCT02374489|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-10-12|||March 2015||2015-03-01|October 2015|2015-10-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma|A Phase II Trial of LDK378 as the First or Second-line Therapy in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma|Recruiting||Phase 2|34|Anticipated|National Health Research Institutes, Taiwan||1|||f||||t||||||||||2017-10-10 23:33:10.922|2017-10-10 23:33:10.922
NCT02374463|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-08-01|||June 1, 2015|Actual|2015-06-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|MMBI||Improving Balance and Mobility|Improving Balance and Mobility in Older Veterans|Active, not recruiting||N/A|56|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 23:33:11.134908|2017-10-10 23:33:11.134908
NCT02374450|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-03-30|||October 5, 2015|Actual|2015-10-05|March 2017|2017-03-01|May 30, 2022|Anticipated|2022-05-30|May 30, 2022|Anticipated|2022-05-30||Interventional|||A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine|A Prospective Study to Estimate the Incidence of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Infants and Young Children in Sub-Saharan Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine|Recruiting||N/A|47074|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-10 23:33:11.229466|2017-10-10 23:33:11.229466
NCT02374437|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-02-23|||April 2014||2014-04-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy Volunteers|Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy Volunteers|Completed||Phase 1|66|Actual|Galmed Pharmaceuticals Ltd||8|||f||||||||||||||2017-10-10 23:33:11.350989|2017-10-10 23:33:11.350989
NCT02374424|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-06-16|||June 2014||2014-06-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|October 2018|Anticipated|2018-10-01||Interventional|GIOTTO||Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients|Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Before High-Dose Chemotherapy BEAM With Autologous Stem Cell Transplantation (ASCT)|Recruiting||Phase 2|78|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||No||2017-10-10 23:33:11.433225|2017-10-10 23:33:11.433225
NCT02374411|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-02-06|||September 2014||2014-09-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients|A Survey of the Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients|Completed||N/A|55|Actual|Edward-Elmhurst Health System|||1||f||||f||||||||||2017-10-10 23:33:11.567752|2017-10-10 23:33:11.567752
NCT02374398|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-11-18|2016-08-10||March 2011||2011-03-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Clinical Trial Comparing Tranexamic Acid (TXA) With Aquamantys Sealer in Total Knee Arthroplasty (TKA)|A Randomized, Controlled Clinical Trial Comparing the Use of Intravenous Tranexamic Acid With Aquamantys Bipolar Sealer for Blood Loss Reduction in Primary Total Knee Arthroplasty|Completed||Phase 4|127|Actual|Eastern Maine Medical Center||4|||f||||f||||||||Undecided||2017-10-10 23:33:11.640279|2017-10-10 23:33:11.640279
NCT02374385|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-02-08|||November 2014||2014-11-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|VSVΔG-ZEBOV||Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine|A Phase 1 Randomized, Single-Center, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of the BPSC-1001 (VSVΔG-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Subjects|Completed||Phase 1|40|Actual|Dalhousie University||4|||f||||t||||||||||2017-10-10 23:33:12.051553|2017-10-10 23:33:12.051553
NCT02374372|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-02-14|||January 2011||2011-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2015|Actual|2015-12-01||Interventional|PHARMACO-$||Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit|Prospective Randomized Study Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit|Active, not recruiting||N/A|140|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-10 23:33:12.143064|2017-10-10 23:33:12.143064
NCT02374359|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-26|||January 2015||2015-01-01|February 2015|2015-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||Atrial Tachycardia as a Predictor of Atrial Fibrillation, Stroke and Mortality in Cryptogenic Stroke|Atrial Tachycardia as a Predictor of Atrial Fibrillation, Stroke and Mortality in Cryptogenic Stroke|Unknown status|Active, not recruiting|N/A|210|Anticipated|Corporacion Parc Tauli|||2||f||||t||||||||||2017-10-10 23:33:12.241357|2017-10-10 23:33:12.241357
NCT02374346|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2015-11-29|2015-06-28||September 2008||2008-09-01|November 2015|2015-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational||"A total number of 446 adult patients admitted for elective surgery were included in the study.
Exclusion criteria: patient refusal, age under 18 years, cognitive dysfunction, head trauma or neurological disorders, difficulty with language comprehension or any other inability to communicate verbally with the interviewer."|Postoperative Headache in Elective Surgery Patients|Factors Associated With the Presence of Postoperative Headache in Elective Surgery Patients: a Prospective Single Center Cohort Study|Completed||N/A|494|Actual|Attikon Hospital|||1||f||||f||||||||||2017-10-10 23:33:12.543069|2017-10-10 23:33:12.543069
NCT02374333|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-09-06|||March 2014||2014-03-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy|Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 Attached to TCRζ and 4-1BB Signaling Domains in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy|Recruiting||Phase 1|50|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:33:12.814046|2017-10-10 23:33:12.814046
NCT02374320|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-04-03|||November 2014||2014-11-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Exparel as a Nerve Block for Severe Hand Pain|Chemical Sympathectomy Following Peripheral Nerve Block With Liposomal Bupivacaine|Terminated||Phase 2/Phase 3|14|Actual|Ochsner Health System||1||PI leaving institution|f||||t||||||||No||2017-10-10 23:33:12.906939|2017-10-10 23:33:12.906939
NCT02374307|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-03-20|||February 2016||2016-02-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Falls-prevention in Older People Receiving Home-help Services|Effect of a Falls-prevention Program on Quality of Life in Older People Receiving Home-help Services. A Randomized Controlled Clinical Trial|Active, not recruiting||N/A|155|Actual|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||Undecided||2017-10-10 23:33:13.004512|2017-10-10 23:33:13.004512
NCT02374294|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-09-29|||September 2015||2015-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||TCOT Effectiveness in Preventing Wound Infections in Perineal Resections|A Prospective, Randomized, Parallel Study Comparing Transdermal, Continuous Oxygen Therapy (TCOT) to Standard of Care to Assess Postoperative Wound Infection Rate in Perineal Resections|Withdrawn||Phase 2|0|Actual|Neogenix, LLC dba Ogenix||2||could not come to budget agreement|f||||t||||||||||2017-10-10 23:33:13.161186|2017-10-10 23:33:13.161186
NCT02374281|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-03-29|||December 2014||2014-12-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|BBSUCROSE||Autonomic Nervous System Reactivity of the Newborn After a Nociceptive Stress: Interest of Sucrose and Non-nutritive Sucking|Autonomic Nervous System Reactivity of the Newborn After a Nociceptive Stress: Interest of Sucrose and Non-nutritive Sucking : A Controlled Randomized Single-center Study.|Completed||Phase 3|180|Actual|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||No||2017-10-10 23:33:13.243764|2017-10-10 23:33:13.243764
NCT02374268|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-07-18|||March 2015||2015-03-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia|Intervention for Sarcopenia Among Older Chinese Adults: A Randomized Controlled Trial Assessing the Role of Exercise Program and Nutrition Supplement|Recruiting||N/A|135|Anticipated|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-10 23:33:13.365851|2017-10-10 23:33:13.365851
NCT02374255|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-08-23|||February 2015||2015-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Improving Goals of Care Discussion in Advanced Cancer Patients|Improving Advanced Cancer Patient-Centered Care by Enabling Goals of Care Discussions|Recruiting||N/A|280|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 23:33:13.498646|2017-10-10 23:33:13.498646
NCT02374242|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-08-28|||October 2014||2014-10-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|April 2018|Anticipated|2018-04-01||Interventional|ABC||Anti‐PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases|A Phase II Study of Nivolumab and Nivolumab Combined With Ipilimumab in Patients With Melanoma Brain Metastases|Active, not recruiting||Phase 2|76|Actual|Melanoma Institute Australia||3|||f||||t||||||||||2017-10-10 23:33:13.6346|2017-10-10 23:33:13.6346
NCT02374229|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-09-21|||February 2015||2015-02-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Ablation of the Pulmonary Artery With High Pulmonary Hypertension During Mitral Valve Surgery|Surgical Ablation of Ganglion Plexuses of the Pulmonary Artery in Patients With Valvular Heart Disease, Complicated by High Pulmonary Hypertension May Reduce Its Degree.|Unknown status|Recruiting|Phase 1|30|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-10 23:33:13.784872|2017-10-10 23:33:13.784872
NCT02374216|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-09-12|||September 2014||2014-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Prospective Analysis of Failures of Oral Implants|A Prospective Analysis of Failures/Complications With Oral Implants|Recruiting||N/A|200|Anticipated|Malmö University||1|||f||||f||||||||||2017-10-10 23:33:13.907587|2017-10-10 23:33:13.907587
NCT02374203|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-04-12|||December 2014||2014-12-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Nutritional Intervention Study in the Critically Ill Ventilated Patient|Clinical Dietitian, Dietetic Service, Mackay Memorial Hospital|Enrolling by invitation||N/A|500|Anticipated|Mackay Memorial Hospital||1|||f||||t||||||||||2017-10-10 23:33:14.014635|2017-10-10 23:33:14.014635
NCT02374190|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-09-22|||February 2016||2016-02-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Observational|||Examining How Acute Treatment Contributes to Variations in AMI Mortality Across the English NHS|Examining How Acute Treatment Contributes to Variations in Acute Myocardial Infarction (AMI) Mortality Across the English National Health Service (NHS): An Observational Study Using the Myocardial Ischaemia National Audit Project|Active, not recruiting||N/A|600000|Anticipated|London School of Economics and Political Science|||1||f||||||||||||||2017-10-10 23:33:14.105206|2017-10-10 23:33:14.105206
NCT02374177|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-23|||November 2014||2014-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||The Effects of Anaesthetic Agents on Postoperative Delirium|The Effects of Anaesthetic Agents on Postoperative Delirium in the Patients Undergoing Off-pump Coronary Artery Bypass Grafting Surgery|Completed||N/A|292|Actual|Konkuk University Medical Center|||2||f||||f||||||||||2017-10-10 23:33:14.167462|2017-10-10 23:33:14.167462
NCT02374164|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-03-25|2016-03-25||February 2015||2015-02-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional||Safety Set included all participants who were enrolled and received at least 1 dose of study drug.|Food Effect Study of Febuxostat XR in Healthy Participants|A Phase 1, Open-Label, Single-Center, Randomized, 3-Way Crossover Study to Assess the Effect of Food on the Bioavailability of a Single Oral Dose of 80 mg Febuxostat Extended-Release Formulation and the Pharmacokinetics of a Single Oral Dose of 40 mg and 80 mg Febuxostat Extended-Release Formulation in Healthy Subjects|Completed||Phase 1|36|Actual|Takeda||3|||f||||f||||||||||2017-10-10 23:33:14.247537|2017-10-10 23:33:14.247537
NCT02374151|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-06-17|||June 2016||2016-06-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|EHG||Accuracy of Electrohysterography in Assessing Intrauterine Pressure|Accuracy of Electrohysterography in Assessing Intrauterine Pressure Compared to Invasive Intrauterine Pressure Catheter|Recruiting||N/A|50|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-10 23:33:14.925761|2017-10-10 23:33:14.925761
NCT02374138|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-07-19|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|November 2016|Actual|2016-11-01||Interventional|||Breathe With Ease: A Unique Approach to Managing Stress (BEAMS)|Improving Asthma Outcomes Through Stress Management|Completed||N/A|217|Actual|Children's Research Institute||2|||f||||t||||||||||2017-10-10 23:33:15.027164|2017-10-10 23:33:15.027164
NCT02374125|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-23|||November 2014||2014-11-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Teres Major Muscle and Subacromial Impingement Syndrome|Effectiveness of Teres Major Muscle Specific Treatment in Patients Diagnosed With Subacromial Impingement Syndrome|Unknown status|Recruiting|N/A|96|Anticipated|Jordi Gol i Gurina Foundation||3|||f||||f||||||||||2017-10-10 23:33:15.132476|2017-10-10 23:33:15.132476
NCT02289066|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-11-30|||November 2013||2013-11-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Impact of Periodontal Disease on Outcomes in Diabetes|Impact of Periodontal Disease on Outcomes in Diabetes|Completed||N/A|250|Anticipated|University of Nevada, Reno|||1||f||||t||||||||||2017-10-10 23:49:44.853354|2017-10-10 23:49:44.853354
NCT02374112|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-07-26|||January 2016||2016-01-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CREFAS||Creatine Supplementation in Chronic Fatigue Syndrome|The Effects of Medium-term Creatine Supplementation in Adults With Chronic Fatigue Syndrome|Active, not recruiting||Phase 2|60|Anticipated|Center for Health, Exercise and Sport Sciences, Serbia||2|||f||||f||||||||||2017-10-10 23:33:15.240646|2017-10-10 23:33:15.240646
NCT02374099|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-05-31|||March 13, 2015|Actual|2015-03-13|May 2017|2017-05-01|October 12, 2017|Anticipated|2017-10-12|December 13, 2016|Actual|2016-12-13||Interventional|||Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant|A Phase 2, Randomized, Open-label, Two-arm Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant in Postmenopausal Women With ER+, HER2- Metastatic Breast Cancer Who Have Progressed on an Aromatase Inhibitor|Active, not recruiting||Phase 2|97|Actual|Celgene||2|||f||||t||||||||||2017-10-10 23:33:15.327864|2017-10-10 23:33:15.327864
NCT02374086|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-06-12|||January 2016||2016-01-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Benefits of Exercise Training in Women With Ischemic Syndrome|A Pilot Study to Test the Benefits of Exercise Training in Women With Ischemic Syndrome|Withdrawn||N/A|0|Actual|Cedars-Sinai Medical Center||1||Enrollment slower than usual.|f||||||||||||Yes||2017-10-10 23:33:15.488607|2017-10-10 23:33:15.488607
NCT02374073|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-26|||January 2014||2014-01-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Functional Massage of Teres Major Muscle|Effectiveness of Functional Massage of the Teres Major Muscle in Patients With Subacromial Impingement Syndrome. A Randomized Controlled Pilot Study|Completed||N/A|58|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-10 23:33:15.573485|2017-10-10 23:33:15.573485
NCT02374060|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-07-26|||March 2015||2015-03-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|POINT||PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial|PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial|Suspended||Phase 4|267|Anticipated|JHSPH Center for Clinical Trials||3||non-safety reasons|f||||t||||||||||2017-10-10 23:33:15.646838|2017-10-10 23:33:15.646838
NCT02374047|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-03-21|||January 2015||2015-01-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects||Completed||Phase 1|118|Actual|Catabasis Pharmaceuticals||12|||f||||f||||||||||2017-10-10 23:33:15.846964|2017-10-10 23:33:15.846964
NCT02374034|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-23|||April 2014||2014-04-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Egoscue Corrective Exercise Prescription on Acute and Short-term Chronic Knee and Hip Pain|Effect of Egoscue Corrective Exercise Prescription on Acute and Short-term Chronic Knee and Hip Pain|Completed||N/A|40|Actual|Brigham Young University||2|||f||||f||||||||||2017-10-10 23:33:15.967497|2017-10-10 23:33:15.967497
NCT02374021|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-09-13|||July 2016||2016-07-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|TARGET||Treatments Against RA and Effect on FDG-PET/CT|Treatments Against RA and Effect on FDG-PET/CT (The TARGET Trial)|Recruiting||Phase 4|200|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 23:33:16.04276|2017-10-10 23:33:16.04276
NCT02374008|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-11-25|||March 2015||2015-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|HOBSALIplus||The Analgesic Effect of Combined Nerve Block and Systemic High Dose Glucocorticoid After Total Knee Arthroplasty.|The Effect of Saphenous Nerve and Obturator Nerve Block Combined With Systemic High Dose Glucocorticoid Versus Local Infiltration Analgesia Combined With a Systemic High Dose Glucocorticoid on Opioid Consumption and Pain After Total Knee Arthroplasty|Completed||Phase 4|74|Anticipated|Regionshospitalet Silkeborg||2|||f||||t||||||||||2017-10-10 23:33:16.227725|2017-10-10 23:33:16.227725
NCT02373995|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-26|||February 2015||2015-02-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|July 2015|Anticipated|2015-07-01||Interventional|Indigo||Role of the Microbiome in Graves' Orbitopathy|Investigation of Novel Biomarkers and Definition of the Role of the Microbiome In Graves' Orbitopathy|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||t||||||||||2017-10-10 23:33:16.325776|2017-10-10 23:33:16.325776
NCT02373982|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-04-10|||January 2013||2013-01-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|December 2014|Actual|2014-12-01||Observational|LAGO-FA||Left Atrial Geometry and Outcomes After Atrial Fibrillation Ablation|External Validation of the Left Atrial Sphericity as Predictor of Recurrence After Atrial Fibrillation Ablation: A Multicenter Observational Study.|Completed||N/A|417|Actual|Hospital Clinic of Barcelona|||1||f||||f||||||||||2017-10-10 23:33:16.41225|2017-10-10 23:33:16.41225
NCT02373969|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-04-05|||August 2011||2011-08-01|April 2016|2016-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Thromboelastogram During Total Knee Replacement|Thromboelastogram During Surgery for Total Knee Replacement With Tourniquet Application and Single Dose Tranexamic Acid|Completed||N/A|30|Actual|Rambam Health Care Campus|||1||f||||f||||||||No||2017-10-10 23:33:16.487339|2017-10-10 23:33:16.487339
NCT02373956|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-01-31|||November 20, 2015|Actual|2015-11-20|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MeliCare||Efficacy and Tolerance of Honey-impregnated Dressings in the Local Management of Pressure Ulcers|Evaluation of the Efficacy and Tolerance of Honey-impregnated Dressings Versus Non-impregnated Dressings in the Local Management of Pressure Ulcers: A Randomized Single-blind Trial|Recruiting||N/A|70|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 23:33:16.676137|2017-10-10 23:33:16.676137
NCT02373943|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-03-24|||September 2015||2015-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|MAIZE||The MULTINUTRIENT Maize Project: Results of Human Feeding Trial|Bioavailability of Vitamin A From β-carotene-Biofortified Maize Porridge Consumed by Women and Men: Results of a Randomized Crossover Trial|Completed||N/A|20|Actual|Institut de Recerca Biomèdica de Lleida||3|||f||||f||||||||||2017-10-10 23:33:16.865412|2017-10-10 23:33:16.865412
NCT02373930|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-06-24|||February 2015||2015-02-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects|A Phase I, 2-part Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Fasted and Fed Healthy Subjects|Completed||Phase 1|63|Actual|ViiV Healthcare||15|||f||||f||||||||||2017-10-10 23:33:16.977218|2017-10-10 23:33:16.977218
NCT02373917|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-03-07|||May 2016||2016-05-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Characterization of Methylation Patterns in Lung Cancer|Characterization of Methylation Patterns in Lung Cancer|Not yet recruiting||N/A|430|Anticipated|Nucleix Ltd.|||2||f||||f||||||Samples Without DNA|"     1. Blood samples        2. Sputum samples        3. saliva samples   "|||2017-10-10 23:33:17.199162|2017-10-10 23:33:17.199162
NCT02373904|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-07-31|||February 2015||2015-02-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||A Safety and Efficacy Study of the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease|A Prospective, Multi-Center Study of the IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease|Completed||N/A|14|Actual|IlluminOss Medical, Inc.||1|||f||||||||||||||2017-10-10 23:33:17.283814|2017-10-10 23:33:17.283814
NCT02373891|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-23|||April 2014||2014-04-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study to Evaluate the Effect of Food on the Pharmacokinetics of Surfolase CR Tablet in Healthy Volunteers||Completed||Phase 1|25|Actual|Hyundai Pharmaceutical Co., LTD.||2|||f||||f||||||||||2017-10-10 23:33:17.397904|2017-10-10 23:33:17.397904
NCT02373878|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-26|||May 2011||2011-05-01|February 2015|2015-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Telecoaching Plus a Portion Control Device for Weight Management in the Primary Care Setting|Telecoaching Plus a Portion Control Device for Weight Care Management|Completed||N/A|90|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:33:17.487047|2017-10-10 23:33:17.487047
NCT02373852|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-02-22|||October 2014||2014-10-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Observational|||PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention|Post Marketing Surveillance (PMS) Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention|Unknown status|Recruiting|N/A|20|Anticipated|Gardia Medical|||1||f||||f||||||||||2017-10-10 23:33:17.703023|2017-10-10 23:33:17.703023
NCT02373839|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-04-07|||June 2014||2014-06-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MAP||Role of Placental Growth Factor (PlGF) in the Management of Non-Severe Preeclampsia|Role of Placental Growth Factor (PlGF) in the Management of Non-Severe Preeclampsia, a Randomized Study|Recruiting||N/A|300|Anticipated|Fetal Medicine Research Center, Spain||2|||f||||t||||||||||2017-10-10 23:33:17.776576|2017-10-10 23:33:17.776576
NCT02373826|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-03-09|||March 2015||2015-03-01|March 2015|2015-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Novel Method for Real Time Co-Registration of IVUS and Coronary Angiography||Unknown status|Recruiting|N/A|40|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-10 23:33:17.873977|2017-10-10 23:33:17.873977
NCT02373813|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-10-04|||February 20, 2015|Actual|2015-02-20|October 2017|2017-10-01|May 18, 2020|Anticipated|2020-05-18|May 18, 2020|Anticipated|2020-05-18||Interventional|||Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission|A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis|Recruiting||Phase 3|465|Anticipated|Amgen||3|||f||||f||||||||||2017-10-10 23:33:17.966406|2017-10-10 23:33:17.966406
NCT02373800|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-06-16|||February 4, 2016|Actual|2016-02-04|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|ElastoDéclench||Elastography for Evaluating Cervical Maturity in Preparation for Labor Induction at 37 to 42 Weeks of Gestation|Elastography for Evaluating Cervical Maturity in Preparation for Labor Induction at 37 to 42 Weeks of Gestation|Recruiting||N/A|220|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 23:33:18.330869|2017-10-10 23:33:18.330869
NCT02373787|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-03-29|||July 2013||2013-07-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|August 31, 2017|Anticipated|2017-08-31||Interventional|CXP||A 5 Year Clinical Investigation on Creos Xenoprotect|A 5 Year Clinical Investigation on Creos Xenoprotect|Active, not recruiting||N/A|40|Anticipated|Nobel Biocare||2|||f||||f||||||||||2017-10-10 23:33:18.433816|2017-10-10 23:33:18.433816
NCT02373774|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2016-09-13|||July 2015||2015-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Ultrasound vs Palpation for Infant Lumbar Puncture|Sonographic Visualization vs Palpation Technique for Infant Lumbar Puncture|Completed||N/A|81|Actual|Columbia University||2|||f||||t||||||||||2017-10-10 23:33:18.519325|2017-10-10 23:33:18.519325
NCT02373761|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-02-26|||February 2015||2015-02-01|February 2015|2015-02-01||||February 2019|Anticipated|2019-02-01|2 Years|Observational [Patient Registry]|||A Prospective Radiostereometric Analysis (RSA) and Clinical Evaluation of the Triathlon Tritanium Total Knee Replacement|A Prospective Radiostereometric Analysis (RSA) and Clinical Evaluation of the Triathlon Tritanium Total Knee Replacement|Not yet recruiting||N/A|27|Anticipated|Central DuPage Hospital|||1||f||||f||||||||||2017-10-10 23:33:18.625675|2017-10-10 23:33:18.625675
NCT02373748|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-06-03|||March 2015||2015-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Performance of the BioGaming Device (YuGo) in the Support of Physical Rehabilitation|A Prospective, Single Site, Single-arm Study Designed to Evaluate the Performance of the BioGaming Device (YuGo) in the Support of Physical Rehabilitation|Completed||N/A|20|Actual|BioGaming Ltd.||1|||f||||f||||||||||2017-10-10 23:33:18.690806|2017-10-10 23:33:18.690806
NCT02373735|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-12-28|||March 2015||2015-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes|Effect of Stroke Volume Variation Guided Fluid Therapy on the Blood Loss and Postoperative Outcomes in Radical Cystectomy|Completed||N/A|64|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-10 23:33:18.7472|2017-10-10 23:33:18.7472
NCT02373722|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-08-14|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery|Web App Based Patient Education in Mohs Surgery|Completed||N/A|90|Actual|Wake Forest University Health Sciences||4|||f||||f|f|f||||||||2017-10-10 23:33:18.835569|2017-10-10 23:33:18.835569
NCT02373709|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-09-28|||October 2010||2010-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression|Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression|Recruiting||N/A|750|Anticipated|KK Women's and Children's Hospital|||2||f||||t||||||Samples With DNA|"     Saliva samples for DNA extraction   "|||2017-10-10 23:33:18.945393|2017-10-10 23:33:18.945393
NCT02373696|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-09-03|||April 2010||2010-04-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Chronic Pain Dynamic Psychophysical Tests and Genetic Screening|Prediction of Chronic Pain in the Asian Population- Comprehensive Programme Encompassing Dynamic Psychophysical Tests and Genetic Screening to Determine and Prevent Persistent Post-caesarean Pain|Completed||N/A|178|Actual|KK Women's and Children's Hospital|||1||f||||f||||||Samples With DNA|"     Blood sampling   "|||2017-10-10 23:33:19.022957|2017-10-10 23:33:19.022957
NCT02373683|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-23|||December 2014||2014-12-01|February 2015|2015-02-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Helium-oxygen Gas Mixtures Delivered by a High Flow Nasal Cannula in Bronchiolitis|Helium-oxygen Gas Mixtures Delivered by a High Flow Nasal Cannula in Bronchiolitis|Unknown status|Recruiting|N/A|20|Anticipated|Case Western Reserve University||2|||f||||t||||||||||2017-10-10 23:33:19.079156|2017-10-10 23:33:19.079156
NCT02373670|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-03-11|||January 2015||2015-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Parent Mentors Using Positive Deviance in Childhood Obesity||Completed||N/A|60|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 23:33:19.162551|2017-10-10 23:33:19.162551
NCT02373657|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-02-14|||April 2014||2014-04-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|WUHA||Water Uptake for Health in Amhara Pilot||Active, not recruiting||Phase 4|4068|Actual|Francis I. Proctor Foundation||2|||f||||t||||||||||2017-10-10 23:33:19.223503|2017-10-10 23:33:19.223503
NCT02373644|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-05-24|||February 2015||2015-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Spinal Manipulation and Dry Needling Versus Conventional Physical Therapy in Patients With Sacroiliac Dysfunction|Spinal Manipulation and Dry Needling Versus Conventional Physical Therapy in Patients With Sacroiliac Dysfunction: a Multi-center Randomized Clinical Trial|Recruiting||N/A|95|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||f||||||||||2017-10-10 23:33:19.294665|2017-10-10 23:33:19.294665
NCT02373631|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-05-22|||February 2015||2015-02-01|May 2017|2017-05-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||Dry Needling Versus Conventional Physical Therapy in Patients With Knee Osteoarthritis|Dry Needling Versus Conventional Physical Therapy in Patients With Knee Osteoarthritis: a Multi-center Randomized Clinical Trial|Completed||N/A|105|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||f||||||||||2017-10-10 23:33:19.374106|2017-10-10 23:33:19.374106
NCT02373618|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-05-22|||December 2015||2015-12-01|July 2016|2016-07-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|||Dry Needling Versus Conventional Physical Therapy in Patients With Plantar Fasciitis|Dry Needling Versus Conventional Physical Therapy in Patients With Plantar Fasciitis: a Multi-center Randomized Clinical Trial|Completed||N/A|108|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||f||||||||||2017-10-10 23:33:19.48565|2017-10-10 23:33:19.48565
NCT02373605|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-05-23|||February 2015||2015-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Spinal Manipulation and Dry Needling Versus Conventional Physical Therapy in Patients With Cervicogenic Headache|Spinal Manipulation and Dry Needling Versus Conventional Physical Therapy in Patients With Cervicogenic Headache: a Multi-center Randomized Clinical Trial|Recruiting||N/A|110|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||f||||||||||2017-10-10 23:33:19.558149|2017-10-10 23:33:19.558149
NCT02373592|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-08-24|||September 2015||2015-09-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Implementation of Foot Thermometry and SMS and Voice Messaging to Prevent Diabetic Foot Ulcer|Implementation of Foot Thermometry and SMS and Voice Messaging to Prevent Diabetic Foot Ulcer|Active, not recruiting||N/A|172|Actual|Universidad Peruana Cayetano Heredia||2|||f||||f||||||||||2017-10-10 23:33:19.64487|2017-10-10 23:33:19.64487
NCT02373579|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-23|||June 2012||2012-06-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia|Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia|Completed||Phase 2|70|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:33:19.726192|2017-10-10 23:33:19.726192
NCT02373566|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-09-25|||February 2015||2015-02-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|February 2016|Anticipated|2016-02-01||Interventional|||A Study to Evaluate the Efficacy of an Acellular Dermal Template for the Treatment of Full Thickness Skin Defects|A Phase 2, Intra-patient Randomised Controlled Multicentre International Study to Evaluate the Efficacy of an Acellular Dermal Template Novomaix for the Treatment of Full Thickness Skin Defects|Unknown status|Recruiting|Phase 2|20|Anticipated|Association of Dutch Burn Centres||2|||f||||f||||||||||2017-10-10 23:33:19.794883|2017-10-10 23:33:19.794883
NCT02373553|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-03-02|||October 2014||2014-10-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|February 2015|Actual|2015-02-01||Interventional|||Impact of Physical Therapy Program in Mouthbreathing Children After Adenotonsillectomy|Impact of Physical Therapy Program in Mouthbreathing Children After Adenotonsillectomy: Randomized Clinical Trial.|Unknown status|Enrolling by invitation|Phase 1/Phase 2|45|Anticipated|Federal University of Minas Gerais||3|||f||||f||||||||||2017-10-10 23:33:19.892653|2017-10-10 23:33:19.892653
NCT02373540|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-05-16|||June 2015||2015-06-01|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|September 2018|Anticipated|2018-09-01||Observational|||Algovita Post-Market Clinical Study: Spinal Cord Stimulation to Treat Chronic Pain|Real-world Evaluation of Outcome Data Under a Prospective, Observational, Post-Market Clinical Study, Using the Algovita SCS System to Treat Patients With Chronic Pain of the Trunk and/or Limbs Per the Applicable Indications for Use|Recruiting||N/A|200|Anticipated|Nuvectra|||1||f||||f||||||||||2017-10-10 23:33:19.972404|2017-10-10 23:33:19.972404
NCT02373527|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2016-11-28|||March 2015||2015-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Strict Versus No Fasting Prior to Cardiac Catheterization: A Prospective Evaluation of Safety and Clinical Outcomes|Strict Versus No Fasting Prior to Cardiac Catheterization: A Prospective Evaluation of Safety and Clinical Outcomes|Recruiting||N/A|600|Anticipated|The Guthrie Clinic||2|||f||||f||||||||||2017-10-10 23:33:20.049079|2017-10-10 23:33:20.049079
NCT02373514|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-26|||January 2015||2015-01-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||IV Paracetamol Versus IV Dexketoprofen in Dysmenorrhea|Intravenous Paracetamol Versus Intravenous Dexketoprofen in Patients Presented With Dysmenorrhea in Emergency Department|Unknown status|Recruiting|Phase 4|100|Anticipated|Akdeniz University||2|||f||||f||||||||||2017-10-10 23:33:20.159743|2017-10-10 23:33:20.159743
NCT02373501|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-06-17|||January 2013||2013-01-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|EKAM||Extra - Abdominal Versus Intra - Abdominal Repair of the Uterine Incision at Cesarean Section|Extra - Abdominal Versus Intra - Abdominal Repair of the Uterine Incision at Cesarean Section|Recruiting||N/A|500|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:33:21.779664|2017-10-10 23:33:21.779664
NCT02373488|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-02-26|||November 2014||2014-11-01|February 2015|2015-02-01||||July 2016|Anticipated|2016-07-01||Interventional|||The Effects of Connective Tissue Manipulation and Abdominal Massage in Patients With Chronic Constipation||Unknown status|Recruiting|N/A|45|Anticipated|Hacettepe University||3|||f||||f||||||||||2017-10-10 23:33:21.892842|2017-10-10 23:33:21.892842
NCT02373475|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-06-13|||February 2015||2015-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Perioperative Lung Protective Strategies on the Occurrence of Postoperative Pulmonary Complications in Patients Undergoing Lumbar Spinal Surgery in the Prone Position||Completed||Phase 4|78|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:33:21.98727|2017-10-10 23:33:21.98727
NCT02373462|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2015-02-22|||February 2015||2015-02-01|February 2015|2015-02-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)||Recruiting||Phase 4|208|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:33:22.062542|2017-10-10 23:33:22.062542
NCT02373449|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-07-13|||February 2015||2015-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Ketamine and fMRI for Neuropathic Pain|Functional Magnetic Resonance Imaging to Predict and Correlate Clinical Outcomes of Ketamine Infusions for Refractory Neuropathic Pain|Recruiting||N/A|40|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:33:22.145231|2017-10-10 23:33:22.145231
NCT02373436|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2015-05-27|||January 2015||2015-01-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|February 2016|Anticipated|2016-02-01||Interventional|||Effects of Constraint-induced Therapy for the Scapular Kinematics in Patients With Severe Chronic Hemiparesis|Effects of Constraint-induced Therapy for the Scapular Kinematics and Related to the Quality of Movement in Patients With Severe Chronic Hemiparesis|Unknown status|Recruiting|N/A|50|Anticipated|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-10 23:33:22.237601|2017-10-10 23:33:22.237601
NCT02373423|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2017-05-02|||December 2013||2013-12-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Trial to Determine the Effects of a Behavioural Communication Strategy on Salt Levels in Foods|Protocol for a Cluster-randomized Trial to Determine the Effects of a Behavioural Communication Strategy on the Salt Levels of Processed Foods|Completed||N/A|45|Actual|The George Institute||2|||f||||f||||||||||2017-10-10 23:33:22.324655|2017-10-10 23:33:22.324655
NCT02373410|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-02-26|||September 2014||2014-09-01|September 2014|2014-09-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of the Height of the Operating Table During Spinal Anesthesia|Effect of the Height of the Operating Table During Spinal Anesthesia|Unknown status|Recruiting|N/A|60|Anticipated|Seoul National University Hospital||4|||f||||f||||||||||2017-10-10 23:33:22.390009|2017-10-10 23:33:22.390009
NCT02373397|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-04-25|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CACICOL-PTK||Cacicol20® in Corneal Wound Healing and Nerve Regeneration After Phototherapeutic Keratectomy|Cacicol20® in Corneal Wound Healing and Nerve Regeneration After Phototherapeutic Keratectomy of the Anterior Cornea: A Randomized Double-Blinded Placebo-Controlled Study|Terminated||Phase 4|40|Actual|Region Östergötland||2||Study terminated due to poor patient recruitment|f||||f||||||||||2017-10-10 23:33:22.482605|2017-10-10 23:33:22.482605
NCT02373384|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-05-18|||February 2015||2015-02-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||The Predictors of Successful Oral Dissolution Therapy in Radiolucent Renal Stones; A Prospective Evaluation|The Predictors of Successful Oral Dissolution Therapy in Radiolucent Renal Stones; A Prospective Evaluation|Recruiting||Phase 4|150|Anticipated|Mansoura University||1|||f||||t||||||||||2017-10-10 23:33:22.68053|2017-10-10 23:33:22.68053
NCT02373371|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-08-31|||March 2015||2015-03-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Actinic Keratoses Treatment With Metvix® in Combination With Light|Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses|Unknown status|Recruiting|Phase 3|26|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-10 23:33:22.789847|2017-10-10 23:33:22.789847
NCT02373358|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-10-13|||May 2015||2015-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evaluation of Effectiveness of a Group Yoga Intervention as Trauma Therapy for Adolescent Girls|A Mixed Methods Evaluation of Effectiveness of a Group Yoga Intervention as an Adjunctive Trauma Therapy for Adolescent Girls|Completed||N/A|34|Actual|Hamilton Health Sciences Corporation||1|||f||||t||||||||||2017-10-10 23:33:22.879421|2017-10-10 23:33:22.879421
NCT02373345|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2016-05-13|||February 2013||2013-02-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Clinical and Neuromechanical Predictors for the Evolution of Chronic Non-specific Low Back Pain|Clinical and Neuromechanical Predictors for the Evolution of Chronic Non-specific Low Back Pain|Completed||N/A|100|Actual|Université du Québec à Trois-Rivières|||1||f||||f||||||||||2017-10-10 23:33:22.977574|2017-10-10 23:33:22.977574
NCT02373332|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-03-09|||August 2013||2013-08-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Fatty Acid Regulation of Platelet Function in Diabetes|Fatty Acid Regulation of Platelet Function in Diabetes|Recruiting||N/A|200|Anticipated|University of Michigan|||2||f||||f||||||Samples With DNA|"     Platelets, plasma, and whole blood will be assessed for platelet reactivity and thrombosis     and stored for later analysis of protein expression. DNA will be stored for assessment of     levels of gene products throught to play a role in platelet reactivity.   "|||2017-10-10 23:33:23.045545|2017-10-10 23:33:23.045545
NCT02373319|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-09-20|||March 2016||2016-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|April 2017|Actual|2017-04-01||Interventional|ACRISC||Self-screening of Cardiovascular Risk|Validity and Effectiveness of a Method for Self-screening of Cardiovascular Risk|Active, not recruiting||N/A|960|Actual|Parc de Salut Mar||4|||f||||f||||||||||2017-10-10 23:33:23.142685|2017-10-10 23:33:23.142685
NCT02373306|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-10-25|||November 2013||2013-11-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|NIPS-ICD||NIPS to Identify High-risk Patients With ICD|Non-invasive Programmed Stimulation to Identify High-risk Patients With Implanted Cardioverter-defibrillator|Completed||N/A|150|Anticipated|St. Joseph's Centre, Poland||2|||f||||||||||||||2017-10-10 23:33:23.256903|2017-10-10 23:33:23.256903
NCT02373293|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-07-26|||January 18, 2015||2015-01-18|July 2017|2017-07-01|August 31, 2017|Anticipated|2017-08-31|January 30, 2015|Actual|2015-01-30||Observational|AT-PROPANC||Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC)|Epidemiologic , Observational, Prospective Study to Assess the Prognostic Value of the Antithrombin III in the Development of Moderate or Severe Acute Pancreatitis (AT-PROPANC)|Recruiting||N/A|400|Anticipated|Corporacion Parc Tauli|||1||f||||f||||||||||2017-10-10 23:33:23.361851|2017-10-10 23:33:23.361851
NCT02373280|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-04-19|||August 2014||2014-08-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection|A Prospective, Single-center, Open-label, Clinical Trial to Compare the 10-day Sequential Therapy and 7-day Culture Based Tailored Therapy for the Eradication of Helicobacter Pylori|Enrolling by invitation||N/A|400|Actual|Seoul National University Bundang Hospital||4|||f||||f||||||||||2017-10-10 23:33:23.462898|2017-10-10 23:33:23.462898
NCT02373267|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2015-02-20|||March 2015||2015-03-01|February 2015|2015-02-01|February 2019|Anticipated|2019-02-01|February 2017|Anticipated|2017-02-01||Observational|Adamscreen||Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)|Screening of TMA Patients for ADAMTS13 Activity and the Description of Systematic Organ Damage and/or Organ Failure in Different Entities of Thrombotic Microangiopathies (TMA)|Not yet recruiting||N/A|100|Anticipated|University of Cologne|||1||f||||t||||||Samples Without DNA|"     -  2x 5 ml citrate blood        -  2x 3 ml EDTA blood        -  1x 5 ml lithium heparin blood        -  1x 5 ml serum blood        -  1x 3 ml stool        -  1x 9 ml urine        -  1x blood smear   "|||2017-10-10 23:33:23.572571|2017-10-10 23:33:23.572571
NCT02373254|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-07-11|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||NSAIDS Versus Opioids in Acute SER II Ankle Fractures|Pain Management With NSAIDS in Acute Ankle Fractures Type Supination, External Rotation (SER) II: A Prospective Randomized, Single Blinded Controlled Study|Completed||Early Phase 1|1|Actual|University of California, Davis||3|||f||||t||||||||||2017-10-10 23:33:24.052814|2017-10-10 23:33:24.052814
NCT02373241|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-04-27|||April 2015||2015-04-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Preventing Sickle Cell Kidney Disease|Chronobiology and Chronopharmacology to Prevent Sickle Cell Kidney Disease|Recruiting||Phase 2|40|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 23:33:24.146177|2017-10-10 23:33:24.146177
NCT02373215|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-02-20|||April 2013||2013-04-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus|A Phase 1, Open-Label, Non-Randomized, Parallel-Group Study to Characterize and Compare the Pharmacokinetics, Safety, and Tolerability of Escalating Oral Doses of Nalbuphine Hydrochloride Extended Release Tablets in End-Stage Renal Disease Patients on Hemodialysis and Matched Healthy Control Subjects|Completed||Phase 1|22|Actual|Trevi Therapeutics||3|||f||||f||||||||||2017-10-10 23:33:24.312275|2017-10-10 23:33:24.312275
NCT02373202|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-12-08|||February 2015||2015-02-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)|A Randomized, Double-blind, Multicenter Study Evaluating the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis|Completed||Phase 3|91|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 23:33:24.384182|2017-10-10 23:33:24.384182
NCT02373189|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-09-26|||August 2014||2014-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Interventional|||Bright Light Treatment At Home To Manage Chronic Pain In U.S. Veterans||Active, not recruiting||N/A|46|Anticipated|Rush University Medical Center||1|||f||||f||||||||||2017-10-10 23:33:24.543811|2017-10-10 23:33:24.543811
NCT02373176|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-20|||July 2014||2014-07-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||[14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study|[14C] PRC-4016 (Icosabutate) - A Phase I, Open-label Study of the Absorption, Metabolism and Excretion Following Oral Dosing to Healthy Male Subjects.|Completed||Phase 1|6|Actual|Pronova BioPharma||1|||f||||f||||||||||2017-10-10 23:33:24.623245|2017-10-10 23:33:24.623245
NCT02373163|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-10-19|||September 2014||2014-09-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|INTERVENCION||INTERVENCION Trial|Characterization of Arterial Hypertension and Efficacy of Blood-pressure Lowering Therapy at Different Altitudes Above Sea Level|Unknown status|Recruiting|Phase 4|120|Anticipated|Prevencion||3|||f||||f||||||||||2017-10-10 23:33:24.81925|2017-10-10 23:33:24.81925
NCT02373150|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-02-09|||February 2015||2015-02-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety, Tolerability and PK of Imeglimin in Japanese Volunteers|A Phase 1, Randomised, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Imeglimin in Healthy Japanese Subjects|Completed||Phase 1|48|Actual|Poxel SA||3|||f||||f||||||||||2017-10-10 23:33:24.914286|2017-10-10 23:33:24.914286
NCT02373137|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-04-14|||January 2015||2015-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Interventional|DETECT||Descemets Endothelial Thickness Comparison Trial||Active, not recruiting||Phase 4|50|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-10 23:33:25.022018|2017-10-10 23:33:25.022018
NCT02373124|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-08-07|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial||Completed||Phase 1/Phase 2|6|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-10 23:33:25.169632|2017-10-10 23:33:25.169632
NCT02373111|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-06-11|||March 2015||2015-03-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Isoflavone Combined With Astaxanthin on Skin Aging|Effects of Isoflavone Combined With Astaxanthin on Skin Aging|Completed||N/A|90|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:33:25.245212|2017-10-10 23:33:25.245212
NCT02373098|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-10-05|||March 31, 2015|Actual|2015-03-31|October 2017|2017-10-01|January 18, 2017|Actual|2017-01-18|January 18, 2017|Actual|2017-01-18||Interventional|||Fingolimod Effect on Cytokine and Chemokine Levels|Effects of Fingolimod (Gilenya®) on Cytokine and Chemokine Levels in Relapsing Remitting Multiple Sclerosis Patients|Completed||Phase 4|66|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-10 23:33:25.340192|2017-10-10 23:33:25.340192
NCT02373085|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-02-20|||January 2011||2011-01-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||Prospective Comparative Study About Treatment of Asymptomatic Bacteriuria in Kidney Transplant Recipients.|Effect of Systematic Search and Antimicrobial Treatment of Asymptomatic Bacteriuria in Kidney Transplant Recipients in the Incidence of Acute Pyelonephritis: a Pragmatic Prospective Randomized Controlled Study.|Completed||N/A|112|Actual|López-Medrano, Francisco, M.D.||2|||f||||f||||||||||2017-10-10 23:33:25.444821|2017-10-10 23:33:25.444821
NCT02373072|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-02-03|||March 2015||2015-03-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease|A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo-controlled, Single Ascending Dose Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06649751 In Subjects With Idiopathic Parkinson's Disease|Completed||Phase 1|18|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 23:33:25.533084|2017-10-10 23:33:25.533084
NCT02373059|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-05-06|||February 2015||2015-02-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SDMPC||Shared Decision Making With Pharmaceutical Care|Examining the Use of a Shared Decision Making Tool With Pharmaceutical Care in Type 2 Diabetes|Completed||N/A|15|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:33:25.638043|2017-10-10 23:33:25.638043
NCT02373046|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-09-30|||February 2015||2015-02-01|September 2015|2015-09-01||||April 2015|Actual|2015-04-01||Interventional|||Bioequivalence Study Between 400 mg LX4211 Tablets and 2 X 200 mg LX4211 Tablets|A Phase 1, Randomized, Single-center, Open-label, 2-sequence, 2-period, Single-dose Crossover Study to Evaluate Bioequivalence (Pharmacokinetics) and to Compare Total 24-hour Urinary Glucose Excretion (Pharmacodynamics) When 400 mg LX4211 is Administered as a Single 400-mg Tablet and 2 × 200-mg Tablets in Healthy Male and Female Subjects|Completed||Phase 1|30|Actual|Lexicon Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:33:25.708651|2017-10-10 23:33:25.708651
NCT02373033|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-20|||March 2013||2013-03-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Folatefood||Folate-Rich Foods Improve Folate Status|The Effects of a 3-months Dietary Intervention With Folate Enhanced Foods on Folate Status in Healthy Egyptian Women|Completed||N/A|57|Actual|Mansoura University||3|||f||||f||||||||||2017-10-10 23:33:25.793202|2017-10-10 23:33:25.793202
NCT02373020|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-04-07|||January 2011||2011-01-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|6 Months|Observational [Patient Registry]|EPEC||Enteropathogenic Escherichia Coli (EPEC): Does it Have a Role in Colorectal Tumourigenesis?|ROLE OF E COLI IN Colorectal Tumourigenesis|Completed||N/A|500|Actual|Mansoura University|||2||f||||||||||||||2017-10-10 23:33:25.888898|2017-10-10 23:33:25.888898
NCT02373007|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-04-26|||July 2014||2014-07-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of Two Surgical Scopinaro Techniques in the Treatment of Obesity|Evaluation of Safety and Effectiveness Modified Scopinaro Technique in the Surgical Treatment of Obesity Compared to Classical Scopinaro Technique|Active, not recruiting||Phase 3|28|Actual|Instituto Paulo Reis||2|||f||||f||||||||||2017-10-10 23:33:25.971343|2017-10-10 23:33:25.971343
NCT02372994|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-08-15|||January 2015||2015-01-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Loop||My Team of Care: a Pilot Randomized Controlled Trial of an Online Communication Tool for Collaborative Care|My Team of Care (MyTOC) Trial: a Pilot Randomized Controlled Trial of an Online Communication Tool (Loop) for Collaborative Care in Complex Patients|Completed||N/A|49|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-10 23:33:26.051143|2017-10-10 23:33:26.051143
NCT02372981|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-02-20|||October 2010||2010-10-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Doppler-guided Haemorrhoidal Artery Ligation With Suture Mucopexy vs. Suture Mucopexy Alone|Doppler-guided Haemorrhoidal Artery Ligation With Suture Mucopexy vs. Suture Mucopexy Alone for the Treatment of Grade III Haemorrhoids: A Prospective-randomised Controlled Trial|Completed||N/A|40|Actual|Medical University Innsbruck||2|||f||||t||||||||||2017-10-10 23:33:26.148287|2017-10-10 23:33:26.148287
NCT02372968|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-20|||April 2008||2008-04-01|February 2015|2015-02-01|October 2010|Actual|2010-10-01|April 2009|Actual|2009-04-01||Observational|||Use of Metabonomics and Body Imaging for Metabolic Health Assessment|Use of Metabonomics and Body Imaging for Metabolic Health Assessment|Completed||N/A|225|Actual|Nestlé|||1||f||||f||||||||||2017-10-10 23:33:26.213344|2017-10-10 23:33:26.213344
NCT02288468|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-08-04|||July 2015||2015-07-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|March 2020|Anticipated|2020-03-01||Interventional|OPINION||One Pass thalamIc aNd subthalamIc stimulatiON|One Pass thalamIc aNd subthalamIc stimulatiON|Recruiting||N/A|18|Anticipated|University Hospital Freiburg||3|||f||||f||||||||||2017-10-10 23:49:51.613278|2017-10-10 23:49:51.613278
NCT02372955|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-02-20|||February 2015||2015-02-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|February 2016|Anticipated|2016-02-01||Interventional|||Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes|Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes|Unknown status|Recruiting|Phase 4|21|Anticipated|Gulf Regional Research & Educational Services, LLC||2|||f||||f||||||||||2017-10-10 23:33:26.278754|2017-10-10 23:33:26.278754
NCT02372942|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2017-02-15|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Lactoferrin or Progesterone for Prevention of Preterm Delivery|Lactoferrin or Progesterone for Prevention of Preterm Delivery|Recruiting||Phase 4|1030|Anticipated|University of Padua||2|||f||||t||||||||Yes||2017-10-10 23:33:26.376669|2017-10-10 23:33:26.376669
NCT02372929|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-02-13|||April 2012||2012-04-01|February 2017|2017-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|ESOCA||Relationship Between Endoscopic Ultrasound Staging and Degree of Stricture in Esophageal Cancer|Relationship Between Endoscopic Ultrasound Staging and Degree of Stricture in Esophageal Cancer|Completed||N/A|100|Actual|Florida Hospital|||1||f||||f||||||||Yes|A manuscript will be developed upon completion of the study|2017-10-10 23:33:26.470388|2017-10-10 23:33:26.470388
NCT02372916|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-02-25|||November 2014||2014-11-01|February 2015|2015-02-01||||November 2016|Anticipated|2016-11-01||Observational|||Geographic Atrophy and Intravitreal Ranibizumab Injections|Progression of Geographic Atrophy and Intravitreal Injections of Ranibizumab Among Treated for Age-related Macular Degeneration|Unknown status|Recruiting|N/A|90|Anticipated|University Health Network, Toronto|||3||f||||||||||||||2017-10-10 23:33:26.541026|2017-10-10 23:33:26.541026
NCT02372903|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-11-03|||October 2013||2013-10-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis|Pilot Study About Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Laparoscopic Diagnosis of Endometriosis|Completed||N/A|30|Actual|University of Cagliari||1|||f||||f||||||||||2017-10-10 23:33:26.61578|2017-10-10 23:33:26.61578
NCT02372890|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-07-11|||July 2012||2012-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck Cancer|Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck Cancer|Recruiting||N/A|150|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 23:33:26.677602|2017-10-10 23:33:26.677602
NCT02372877|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-01-22|||May 2015||2015-05-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of the AMICUS RBCx System in Sickle Cell Patients|Evaluation of the AMICUS Red Blood Cell Exchange (RBCx) System in Sickle Cell Patients|Recruiting||N/A|62|Anticipated|Fenwal, Inc.||1|||f||||t||||||||No||2017-10-10 23:33:26.759743|2017-10-10 23:33:26.759743
NCT02372864|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-11-30|||February 2015||2015-02-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|PURSUE||Psychosexual Consequences of Risk-reducing Salpingo-oophorectomy|PURSUE - Psychosexual Consequences of Risk-reducing Salpingooophorectomy in BRCA1/2 Mutation Carriers|Active, not recruiting||N/A|66|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-10-10 23:33:26.875573|2017-10-10 23:33:26.875573
NCT02372851|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-09-09|||January 2015||2015-01-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Assessing the Effectiveness of a Water Filter Technology as an Arsenic Mitigation Strategy in West Bengal|Assessing the Effectiveness of a Point-of-use Water Filter Technology as an Arsenic Mitigation Strategy in West Bengal|Completed||N/A|362|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-10 23:33:26.955385|2017-10-10 23:33:26.955385
NCT02372838|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2015-08-17|||June 2014||2014-06-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Reconstruction of Extensive Upper Extremity Long Bone Defects With a Microvascular Fibula Flap|Reconstruction of Extensive Upper Extremity Long Bone Defects With a Microvascular Fibula Flap: a Cross-sectional Study of Long-term Outcomes|Completed||N/A|13|Actual|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 23:33:27.044722|2017-10-10 23:33:27.044722
NCT02372825|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-05-12|||June 2014||2014-06-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01|4 Years|Observational [Patient Registry]|||Role of Free Iliac Crest Flap in Heel and Ankle Reconstruction|Role of Free Iliac Crest Flap in Heel and Ankle Reconstruction|Completed||N/A|7|Actual|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 23:33:27.099643|2017-10-10 23:33:27.099643
NCT02372812|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-04-22|||July 2014||2014-07-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|DOPP||Analgesic Effects Of Dexamethasone; Its Use To Reduce Post Operative Pain Scores|Analgesic Effects Of Dexamethasone; Its Use To Reduce Post Operative Pain Scores: A Double Blinded Randomised Controlled Clinical Trial|Completed||Phase 2|173|Actual|Makerere University||2|||f||||t||||||||||2017-10-10 23:33:27.162276|2017-10-10 23:33:27.162276
NCT02372799|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2017-02-07|||February 2015||2015-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|VLZ-MD-22||Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)|A Multicenter, Double-blind, Placebo- and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder|Recruiting||Phase 3|400|Anticipated|Forest Laboratories||3|||f||||t||||||||||2017-10-10 23:33:27.340433|2017-10-10 23:33:27.340433
NCT02372786|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-01-19|||November 2014||2014-11-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|OPTICA||7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream|A Double Blind Randomized Controlled Trial Comparing the Efficacy of 7% Lidocaine / 7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream for Local Anaesthesia During Laser Treatment of Acne Keloidalis Nuchae and Tattoo Removal|Completed||Phase 4|30|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 23:33:27.564522|2017-10-10 23:33:27.564522
NCT02372383|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-07-25|||October 2014||2014-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis|Pharmacokinetic Evaluation of Nontuberculous Mycobacterial Antibiotics in Cystic Fibrosis Versus Controls|Completed||N/A|32|Actual|University of Colorado, Denver||3|||f||||t||||||||Undecided||2017-10-10 23:33:30.859822|2017-10-10 23:33:30.859822
NCT02372773|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-03-21|||April 2015||2015-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|LEFFTDS||Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects|Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects|Recruiting||N/A|300|Anticipated|Mayo Clinic|||4||f||||t||||||Samples With DNA|"     Blood - DNA, Plasma, Serum, Peripheral blood mononuclear cells, RNA, Cerebrospinal Fluid   "|Yes|De-identified data can be shared following a formal request and approval by the executive committee overseeing the protocol.|2017-10-10 23:33:27.672209|2017-10-10 23:33:27.672209
NCT02372760|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-12-01|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||For A More Comfortable Bronchoscopy: Is Spray Catheter The Answer?|For A More Comfortable Bronchoscopy: Is Spray Catheter The Answer?|Withdrawn||N/A|0|Actual|University of Florida||2||The PI has relocated and the study has been closed.|f||||f||||||||||2017-10-10 23:33:27.813351|2017-10-10 23:33:27.813351
NCT02372747|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-02-21|||October 2012||2012-10-01|February 2006|2006-02-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Interventional|TLDG||Comparison of Delta-Shaped and Billroth II After TLDG|Comparison of Delta-Shaped and Billroth II for Intracorporeal Anastomosis After Totally Laparoscopic Distal Gastrectomy for Gastric Cancer|Completed||N/A|78|Actual|First Hospital of Jilin University||2|||f||||t||||||||||2017-10-10 23:33:27.917757|2017-10-10 23:33:27.917757
NCT02372734|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-06-01|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Long Term Cognitive Impact of Pediatric Acute Renal Injury|Long Term Cognitive Impact of Pediatric Acute Renal Injury|Recruiting||N/A|400|Anticipated|University of Florida|||2||f||||f||||||||||2017-10-10 23:33:28.018117|2017-10-10 23:33:28.018117
NCT02372721|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-10-29|||March 2015||2015-03-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|IMPRESS||Long Term Impact of Pediatric Acute Renal Injury in Severe Sepsis|Long Term Impact of Pediatric Acute Renal Injury in Severe Sepsis|Withdrawn||N/A|0|Actual|University of Florida|||3|The IRB required this protocol to be split into two different protocols|f||||f||||||Samples Without DNA|"     serum and urine   "|||2017-10-10 23:33:28.123711|2017-10-10 23:33:28.123711
NCT02372708|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-02-25|||August 2008||2008-08-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2012|Actual|2012-05-01||Observational|||Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy|Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy|Completed||Phase 2|72|Actual|Chinese PLA General Hospital|||2||f||||f||||||||||2017-10-10 23:33:28.203748|2017-10-10 23:33:28.203748
NCT02372695|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2015-02-20|||July 2012||2012-07-01|February 2015|2015-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MICROBUB||Effect of Paricalcitol Over Vessel Wall|Effect of Paricalcitol Over Vessel Wall: Pleiotropic Analogues Vitamin D Effects|Terminated||Phase 4|50|Actual|Effice Servicios Para la Investigacion S.L.||2||Protocol showed to be inappropriate for the evaluation of the selected patients|f||||t||||||||||2017-10-10 23:33:28.286524|2017-10-10 23:33:28.286524
NCT02372682|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-06-16|||May 2015||2015-05-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Observational|||Shear Wave Sonoelastography in Pediatric Liver Fibrosis|Shear Wave Sonoelastography for the Noninvasive Evaluation of Hepatic Fibrosis in the Pediatric Population|Recruiting||N/A|200|Anticipated|St. Louis University|||2||f||||f||||||||||2017-10-10 23:33:28.371343|2017-10-10 23:33:28.371343
NCT02372669|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2017-07-11|||March 2015||2015-03-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2017|Actual|2017-07-01||Interventional|CNT||Chitosan Nerv Tube for Primary Repair of Traumatic Sensory Nerve Lesions of the Hand|Chitosan Nerv Tube for Primary Repair of Traumatic Sensory Nerve Lesions of the Hand - a Clinical Randomized Controlled Multicenter Trial|Recruiting||N/A|100|Anticipated|BG Unfallklinik||2|||f||||t||||||||||2017-10-10 23:33:28.472451|2017-10-10 23:33:28.472451
NCT02372656|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2015-02-20|||December 2013||2013-12-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Simvastatin and Metformin in Chronic Periodontitis|Comparison Of Efficacy Of Locally Delivered 1.2% Simvastatin And 1% Metformin Gel In Chronic Periodontitis: A Randomized Placebo Controlled Clinical Trial|Completed||Phase 2/Phase 3|98|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||t||||||||||2017-10-10 23:33:28.598066|2017-10-10 23:33:28.598066
NCT02372643|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Ultrasound and Psychobiological Correlates of Female Sexual Function|Pilot Interventional Study on Clitoral Ultrasound Measures and Psychobiological Correlates of Female Sexual Function|Active, not recruiting||N/A|20|Anticipated|University of Florence||1|||f||||f||||||||||2017-10-10 23:33:28.696741|2017-10-10 23:33:28.696741
NCT02372630|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-05-10|||May 2014||2014-05-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|1971||The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects|The Effect of TRADJENTA ® (LINAGLIPTIN) on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects|Recruiting||Phase 4|40|Anticipated|University at Buffalo||2|||f||||t||||||||||2017-10-10 23:33:28.790187|2017-10-10 23:33:28.790187
NCT02372617|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2016-07-11|||January 2012||2012-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2012|Actual|2012-06-01||Observational|||Hip Reconstruction in Cerebral Palsy With Pelvic Osteotomy||Active, not recruiting||N/A|30|Actual|Associação de Assistência a Criança Deficiente|||2||f||||f||||||||||2017-10-10 23:33:28.889266|2017-10-10 23:33:28.889266
NCT02372604|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-02-25|||March 2015||2015-03-01|February 2015|2015-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|LEVURE PLUS||Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria|Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria Resistant to the Licensed Dosage|Unknown status|Not yet recruiting|Phase 3|224|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:33:28.974478|2017-10-10 23:33:28.974478
NCT02372591|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-09-07|||August 2015||2015-08-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|1401||Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain|Analgesic Effects and Abuse Liability of Intravenous Hydromorphone and Buprenorphine in Opioid Dependent Participants With Chronic Musculoskeletal Pain|Completed||Phase 1|14|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-10-10 23:33:29.065915|2017-10-10 23:33:29.065915
NCT02372578|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2017-05-10||2017-05-10|May 27, 2015|Actual|2015-05-27|April 2017|2017-04-01|May 20, 2016|Actual|2016-05-20|May 20, 2016|Actual|2016-05-20||Interventional|||Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy|A Phase 2a Randomized, Double-Blind, Multicenter, Placebo and Active Controlled Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy|Terminated||Phase 2|116|Actual|Astellas Pharma Inc||3||The study was terminated due to futility analysis.|f||||t||||||||Undecided||2017-10-10 23:33:29.168629|2017-10-10 23:33:29.168629
NCT02372565|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-02-25|||March 2014||2014-03-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Facebook to Promote Physical Activity in Black Women African American Women|Using Mass Media to Promote Physical Activity in African American Women|Completed||N/A|30|Actual|Arizona State University||2|||f||||f||||||||||2017-10-10 23:33:29.342346|2017-10-10 23:33:29.342346
NCT02372552|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-07-25|||August 2015||2015-08-01|February 2016|2016-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Microwave Coagulation Using CROMA Electrosurgical System|Clinical Evaluation of the Safety and Performance of Microwave Coagulation by the CROMA Electrosurgical System During Resection of Complex Colorectal Polyps|Completed||N/A|30|Actual|Creo Medical Limited||1|||f||||f||||||||||2017-10-10 23:33:29.419989|2017-10-10 23:33:29.419989
NCT02372539|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-11-11|||January 2015||2015-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Glucose Variability in Cancer Patients Receiving Dexamethasone|Pilot Project to Evaluate Hyperglycemia and Glucose Variability in Cancer Patients Receiving Dexamethasone|Recruiting||N/A|50|Anticipated|University of Colorado, Denver|||2||f||||t||||||||||2017-10-10 23:33:29.508928|2017-10-10 23:33:29.508928
NCT02372526|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-02-06|||January 2015||2015-01-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|August 2016|Actual|2016-08-01||Observational|||The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation|The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation|Active, not recruiting||N/A|18|Actual|Hvidovre University Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma and serum.   "|||2017-10-10 23:33:29.601801|2017-10-10 23:33:29.601801
NCT02372513|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-21|2016-02-17|||January 2015||2015-01-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Observational|LAL-D||National Lysosomal Acid Lipase Deficiency Study|The Frequency of Cholesteryl Ester Storage Disease in Children With Unexplained Transaminase Elevation and Chronic Liver Disease|Recruiting||N/A|1700|Anticipated|Ankara University|||1||f||||f||||||Samples Without DNA|"     whole blood   "|||2017-10-10 23:33:29.719493|2017-10-10 23:33:29.719493
NCT02372500|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-20|||March 2015||2015-03-01|February 2015|2015-02-01|October 2016|Anticipated|2016-10-01|March 2016|Anticipated|2016-03-01||Interventional|||Trial of Chewing Gum to Reduce Post Operative Ileus in Elective Colorectal Surgery|Randomised Controlled Trial of Chewing Gum to Reduce Post Operative Ileus in Elective Colorectal Surgery|Unknown status|Not yet recruiting|N/A|130|Anticipated|Countess of Chester NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:33:29.79892|2017-10-10 23:33:29.79892
NCT02372487|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-02-02|||March 2015||2015-03-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Sildenafil Citrate Therapy for Oligohydramnios|Sildenafil Citrate Therapy for Oligohydramnios|Recruiting||N/A|184|Anticipated|Al Hayat National Hospital||2|||f||||t||||||||||2017-10-10 23:33:29.885334|2017-10-10 23:33:29.885334
NCT02372474|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-02-25|||March 2012||2012-03-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||"It is a Real The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure"|"It is a Real The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure"|Completed||Phase 1/Phase 2|112|Actual|Al-Azhar University||1|||f||||t||||||||||2017-10-10 23:33:29.993972|2017-10-10 23:33:29.993972
NCT02372461|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-12-02|||November 2014||2014-11-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|RETAPP||Randomized Trial of Amoxicillin Versus Placebo for (Fast Breathing) Pneumonia|A Double Blind Community-based Randomized Trial of Amoxicillin Versus Placebo for Fast Breathing Pneumonia in Children Aged 2-59 Months in Karachi, Pakistan|Recruiting||N/A|4000|Anticipated|Aga Khan University||2|||f||||t||||||||Undecided||2017-10-10 23:33:30.093175|2017-10-10 23:33:30.093175
NCT02372448|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-03-05|||July 2014||2014-07-01|February 2015|2015-02-01||||July 2016|Anticipated|2016-07-01||Interventional|STALKLUNG01||Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients|Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients|Unknown status|Recruiting|N/A|224|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 23:33:30.186589|2017-10-10 23:33:30.186589
NCT02372435|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-20|||May 2015||2015-05-01|February 2015|2015-02-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|Fast-track||Short Interval in Treatment of PJI|Efficacy and Safety of Fast-track Treatment for Prosthetic Joint Infection (PJI)|Not yet recruiting||N/A|418|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 23:33:30.262368|2017-10-10 23:33:30.262368
NCT02372422|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-02-20|||October 2002||2002-10-01|February 2015|2015-02-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Transvaginal Ultrasound Cervical Length Measurements in Twin Gestations|Use of Transvaginal Ultrasound Cervical Length Measurements in Twin Gestations|Completed||N/A|125|Actual|Wilford Hall Medical Center||2|||f||||f||||||||||2017-10-10 23:33:30.344332|2017-10-10 23:33:30.344332
NCT02372409|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-27|||August 14, 2015|Actual|2015-08-14|September 2017|2017-09-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|||Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors|A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors|Recruiting||Phase 1|12|Anticipated|Washington University School of Medicine||2|||f||||t|t|t|f|f|f|||||2017-10-10 23:33:30.424265|2017-10-10 23:33:30.424265
NCT02372396|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-05-08|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||Compassion Meditation for PTSD|A Proof of Concept and Feasibility Trial of Compassion Meditation for PTSD|Recruiting||N/A|40|Anticipated|Veterans Medical Research Foundation||2|||f||||t||||||||||2017-10-10 23:33:30.738835|2017-10-10 23:33:30.738835
NCT02372370|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-20|||December 2014||2014-12-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pretreatments of the Skin Prior to PDT|Pretreatments of the Skin to Enhance MAL-induced Protoporphyrin IX (PpIX) Accumulation Prior to Photodynamic Therapy (PDT)|Completed||Phase 1|12|Actual|Bispebjerg Hospital||1|||f||||f||||||||||2017-10-10 23:33:30.993757|2017-10-10 23:33:30.993757
NCT02372357|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-03-02|||February 2012||2012-02-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area|A New Dosing Regimen for Posaconazole Prophylaxis in Children Based in Body Surface Area|Completed||Phase 4|14|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-10 23:33:31.106515|2017-10-10 23:33:31.106515
NCT02372344|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-04-11|2016-04-11||March 2015||2015-03-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||All randomized subjects (n = 42) were included in the baseline analysis.|A Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA of AZD0585 in Healthy Male Japanese Subjects|A Phase I, Single Centre, Randomized, Open-Label, Three-Period Crossover Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA With a Single 4 g Dose of AZD0585 in Healthy Male Japanese Subjects|Completed||Phase 1|72|Actual|AstraZeneca|Statistical analysis is not provided for the treatment comparisons of AUC for the parameter total DHA (not possible to calculate in majority of subjects). Therefore, AUC(0-72) alone represents total plasma exposure in the bioavailability comparison.|3|||f||||f||||||||||2017-10-10 23:33:31.224906|2017-10-10 23:33:31.224906
NCT02372331|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-06-08|||March 4, 2015|Actual|2015-03-04|June 2017|2017-06-01|May 26, 2017|Actual|2017-05-26|May 10, 2017|Actual|2017-05-10||Interventional|ERAS||The Effect of ERAS on Pancreaticoduodenectomy|The Effect of ERAS (Enhanced Recovery After Surgery) on Pancreaticoduodenectomy|Completed||N/A|276|Actual|Asan Medical Center||2|||f||||f||||||||No|At initial status of this study, IRB was approved at limited data access only.|2017-10-10 23:33:31.631129|2017-10-10 23:33:31.631129
NCT02372318|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-06-28|||April 2015||2015-04-01|January 2016|2016-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|NALCUE||Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity|Nalmefene Challenge to Modulate Neural Reactivity to Alcohol-related and Emotional Cues in Non-treatment Seeking Alcohol Dependent Participants|Terminated||Early Phase 1|23|Actual|Central Institute of Mental Health, Mannheim||2||"Anticipated nr of 25 probands was not reached in terms of full data sets (missing data, low   fMRI data quality), but time frame for recruitment ended."|f||||f||||||||||2017-10-10 23:33:31.741243|2017-10-10 23:33:31.741243
NCT02372305|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-11-23|||March 2016||2016-03-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery|Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery|Active, not recruiting||Phase 4|200|Actual|University of Arkansas||2|||f||||t||||||||No||2017-10-10 23:33:31.837927|2017-10-10 23:33:31.837927
NCT02372292|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-06-22|||February 2013||2013-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Value of Renal Vascular Doppler Sonography in Management of Decompensated Heart Failure|Value of Renal Vascular Doppler Sonography in Management of Decompensated Heart Failure|Completed||N/A|60|Actual|Ankara University||2|||f||||f||||||||||2017-10-10 23:33:31.92457|2017-10-10 23:33:31.92457
NCT02372279|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-02-29|||February 2014||2014-02-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|PROdE||Prospective Randomized Study to Evaluate the Effect of Embryonic Observation on the Gestation (PROdE)|Prospective Randomized Study to Evaluate the Effect of Embryonic Observation on the Implantation Rates and Ongoing Gestation|Recruiting||N/A|130|Anticipated|Instituto Bernabeu||2|||f||||t||||||||||2017-10-10 23:33:32.00817|2017-10-10 23:33:32.00817
NCT02372266|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-19|||April 1997||1997-04-01|February 2015|2015-02-01|August 2001|Actual|2001-08-01|January 2001|Actual|2001-01-01||Interventional|||Safety and Cost-Effectiveness of Early Maternal Newborn Infant Discharge|A Randomized Controlled Trial to Assess the Safety and Cost-Effectiveness of Early Maternal Newborn Infant Discharge|Completed||N/A|2223|Actual|Wilford Hall Medical Center||2|||f||||f||||||||||2017-10-10 23:33:32.106028|2017-10-10 23:33:32.106028
NCT02372253|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-09-05|||January 2015||2015-01-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes|Repurposing of Verapamil as a Beta Cell Survival Therapy in Type 1 Diabetes|Recruiting||Phase 2|52|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:33:32.209298|2017-10-10 23:33:32.209298
NCT02372240|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-06-01|||April 8, 2015|Actual|2015-04-08|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of VLX1570 and Dexamethasone in Myeloma Patients|VLX1570 and Low-Dose Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma: A Clinical and Correlative Phase 1/2 Study|Suspended||Phase 1/Phase 2|70|Anticipated|Vivolux AB||1||Dose limiting tox is observed. Study put on hold to assess the safety profile.|f||||f||||||||||2017-10-10 23:33:32.320936|2017-10-10 23:33:32.320936
NCT02372227|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-01-26|||January 2015||2015-01-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma|A Phase 1 Dose Escalation Study of VS-5584, a Dual PI3K/mTOR Inhibitor, Administered With a Fixed Dose of VS-6063, a Focal Adhesion Kinase Inhibitor, in Subjects With Relapsed Malignant Mesothelioma|Terminated||Phase 1|21|Actual|Verastem, Inc.||1|||f||||f||||||||||2017-10-10 23:33:32.401442|2017-10-10 23:33:32.401442
NCT02372214|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-25|||March 2014||2014-03-01|January 2015|2015-01-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|||Production of a Patient-specific Simulator for Endovascular Aneurysm Repair Training|Impact of a Patient-specific Simulation on the Learning Curve of Infra-renal Aneurysm Endovascular Repair|Unknown status|Recruiting|N/A|60|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:33:32.486808|2017-10-10 23:33:32.486808
NCT02372201|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-02-25|||January 2013||2013-01-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|MicFFGAH2013||Effects of Fasting and Hydro Colon Therapy Plus Probiotics on GI Microbiota in Intolerances and Irritable Bowel Syndrome|Effects of Fasting and Hydro Colon Therapy Plus Probiotics on Abundance and Diversity of GI Microbiota in Intolerances and Irritable Bowel Syndrome|Completed||N/A|68|Actual|University of Vienna||1|||f||||f||||||||||2017-10-10 23:33:32.582092|2017-10-10 23:33:32.582092
NCT02372188|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-02-19|||September 2013||2013-09-01|February 2015|2015-02-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Influence of a Bitter Compound and Bittermasking Compound on Gastric pH|Effect of Caffeine With and Without a Bitter Masking Compound on Gastric pH, Taking Into Account the Effect on Satiety Hormones in Blood Plasma and on Food Intake|Unknown status|Active, not recruiting|N/A|25|Actual|University of Vienna||4|||f||||||||||||||2017-10-10 23:33:32.666126|2017-10-10 23:33:32.666126
NCT02372162|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-05-10|||July 2015||2015-07-01|May 2016|2016-05-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Observational|e:Med-HCC-1||Fingerprint Characterization of Advanced HCC|Fingerprint Characterization of Advanced HCC to Optimize Treatment Decisions and Enable an Early Prediction of Therapy Resistance (HCC Multiscale Trial-1)|Recruiting||N/A|40|Anticipated|University Hospital Tuebingen|||2||f||||f||||||Samples With DNA|"     Biospecimens that will be investigated are tumor tissue and blood.   "|||2017-10-10 23:33:32.889435|2017-10-10 23:33:32.889435
NCT02372149|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-11-10|||February 2015||2015-02-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|IDIDM||IVIg for Demyelination in Diabetes Mellitus|Treatment With Gamunex 10% Intravenous Immunoglobulin (IVIg) for Patients With Demyelination and Diabetes Mellitus: A Blinded, Placebo-Controlled Crossover Pilot Study|Recruiting||Phase 4|25|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-10 23:33:33.023377|2017-10-10 23:33:33.023377
NCT02372136|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-02-11|||January 2016||2016-01-01|February 2017|2017-02-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants|Individualizing and Optimizing Nutrition to Prevent Metabolic Syndrome and To Improve Neurodevelopment in Preterm and Small for Gestational Age Infants|Recruiting||N/A|150|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||Undecided||2017-10-10 23:33:33.162782|2017-10-10 23:33:33.162782
NCT02372123|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-12-09|||February 2015||2015-02-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Connective Tissue Massage in Women With Primary Dysmenorrhoea||Completed||N/A|40|Actual|Hacettepe University||2|||f||||f||||||||||2017-10-10 23:33:33.293123|2017-10-10 23:33:33.293123
NCT02372110|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-11-30|||March 2015||2015-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response|Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response|Completed||Phase 4|120|Actual|University of Texas at Austin||2|||f||||f||||||||||2017-10-10 23:33:33.394032|2017-10-10 23:33:33.394032
NCT02372097|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-04-08|2016-04-08||March 2015||2015-03-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||The pharmacokinetic (PK) analysis set included all participants who received study drug, satisfied the minimum requirements of the protocol with no significant deviations, and were assessable for PK.|A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets|A Randomized, Open-label, Crossover Phase 1 Study to Evaluate the Bioequivalence Following a Single Oral Dose Administration of SYR-472 25mg and 50mg Tablets in Healthy Adult Male Subjects|Completed||Phase 1|24|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:33:33.500294|2017-10-10 23:33:33.500294
NCT02372084|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-06-14|||April 21, 2015|Actual|2015-04-21|June 2017|2017-06-01|May 19, 2016|Actual|2016-05-19|May 19, 2016|Actual|2016-05-19||Interventional|||A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function|A Phase I, Open-label, Multi-center, Single Dose, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of Osilodrostat (LCI699) in Subjects With Impaired Hepatic Function Compared to Subjects With Normal Hepatic Function|Completed||Phase 1|33|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-10 23:33:34.060514|2017-10-10 23:33:34.060514
NCT02372071|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-08-13|2015-08-13||April 2014||2014-04-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Transcutaneous Bilirubinometry in Neonates With the BiliCare System Compared to the Invasive TSB Test|Transcutaneous Bilirubinometry in Neonates With the BiliCare System Compared to the Invasive TSB Test|Completed||N/A|111|Actual|Gerium Medical||1|||f||||f||||||||||2017-10-10 23:33:34.135109|2017-10-10 23:33:34.135109
NCT02372058|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-22|2015-08-13|2015-08-13||September 2014||2014-09-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Number of participants who completed the study|Transcutaneous Bilirubinometry in Neonates With Bilicare System|Transcutaneous Bilirubinometry in Neonates With Bilicare System|Completed||N/A|103|Actual|Gerium Medical||1|||f||||f||||||||||2017-10-10 23:33:34.271586|2017-10-10 23:33:34.271586
NCT02372032|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-07-12|||February 2015||2015-02-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Trial of Percutaneous Lumbar Discectomy Combined With Ozone for Treatment of LDH|Percutaneous Lumbar Discectomy (PLD) Combined With Ozone Versus Percutaneous Lumbar Discectomy (PLD) for Treatment of Lumbar Disc Herniation:A Single-Blind Prospective Randomized Controlled Trial|Active, not recruiting||Phase 3|70|Anticipated|Zhongda Hospital||2|||f||||f||||||||||2017-10-10 23:33:34.435118|2017-10-10 23:33:34.435118
NCT02372019|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-08-31|||February 2015||2015-02-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Augmentation Study of A Computerized Treatment for Social Anxiety Disorder|Augmenting Interpretative Cognitive Bias Modification Using Memory Reconsolidation Updating|Unknown status|Recruiting|N/A|122|Anticipated|University of Texas at Austin||3|||f||||f||||||||||2017-10-10 23:33:34.504293|2017-10-10 23:33:34.504293
NCT02372006|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2017-10-03|||April 29, 2015|Actual|2015-04-29|October 2017|2017-10-01|February 15, 2019|Anticipated|2019-02-15|February 15, 2019|Anticipated|2019-02-15||Interventional|||Trial of Afatinib in Pediatric Tumours|Phase I/II Open Label, Dose Escalation Trial to Determine the MTD, Safety, PK and Efficacy of Afatinib Monotherapy in Children Aged ≥1 Year to <18 Years With Recurrent/Refractory Neuroectodermal Tumours, Rhabdomyosarcoma and/or Other Solid Tumours With Known ErbB Pathway Deregulation Regardless of Tumour Histology|Recruiting||Phase 1/Phase 2|55|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:33:34.616989|2017-10-10 23:33:34.616989
NCT02371993|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-10-28|||January 2015||2015-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Asthma in the Elderly: A Study of Choline Supplementation|Asthma in the Elderly: A Study of Choline Supplementation|Completed||Phase 3|30|Actual|Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.||2|||f||||t||||||||||2017-10-10 23:33:34.855232|2017-10-10 23:33:34.855232
NCT02371980|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-08-03|||February 18, 2015|Actual|2015-02-18|August 2017|2017-08-01|February 1, 2019|Anticipated|2019-02-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder|Recruiting||Phase 4|228|Anticipated|Takeda||5|||f||||f|t|f||||||||2017-10-10 23:33:34.959545|2017-10-10 23:33:34.959545
NCT02371967|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-09-07|||April 8, 2015|Actual|2015-04-08|September 2017|2017-09-01|December 19, 2020|Anticipated|2020-12-19|December 19, 2020|Anticipated|2020-12-19||Observational|ROSETT||A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)|A Prospective Observational Study of Erivedge® Treatment, Effectiveness, and Safety Outcomes in Patients With Advanced Basal Cell Carcinoma|Recruiting||N/A|50|Anticipated|Hoffmann-La Roche|||3||f||||||||||||||2017-10-10 23:33:35.290439|2017-10-10 23:33:35.290439
NCT02371954|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-09-20|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Exercise to Prevent Depression and Anxiety in Older Hispanics|Exercise to Prevent Depression and Anxiety in Older Hispanics|Active, not recruiting||N/A|60|Actual|University of Miami||2|||f||||||||||||||2017-10-10 23:33:35.398358|2017-10-10 23:33:35.398358
NCT02371941|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-03-11|||December 2014||2014-12-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis|A Randomized, Double-blind, Placebo-controlled Study of the Use of Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis|Unknown status|Recruiting|Phase 4|24|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-10 23:33:35.504275|2017-10-10 23:33:35.504275
NCT02371928|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-06-22|||February 2015||2015-02-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|SINEX||A Neuromuscular Exercise Program for Patients With Anterior Shoulder Instability|A Neuromuscular Exercise Program for Patients With Anterior Shoulder Instability: A Randomized Controlled Trial|Active, not recruiting||N/A|80|Anticipated|University of Southern Denmark||2|||f||||f||||||||||2017-10-10 23:33:35.611396|2017-10-10 23:33:35.611396
NCT02371915|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-10-25|||June 2014||2014-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Interprofessional Care Models Using Videoconferencing for Patients With Inflammatory Arthritis|Addressing Rural and Remote Access Disparities for Patients With Inflammatory Arthritis Through Telehealth/Videoconferencing and Innovative Inter-professional Care Models|Completed||N/A|85|Actual|University of Saskatchewan||2|||f||||f||||||||No||2017-10-10 23:33:35.736354|2017-10-10 23:33:35.736354
NCT02371902|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-19|||June 2011||2011-06-01|February 2015|2015-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||ESWT vs Cryo-US Therapy in the Treatment of Chronic Lateral Epicondylitis: One Year Follow up Study|Extracorporeal Shock Wave Therapy vs Cryoultrasound Therapy in the Treatment of Chronic Lateral Epicondylitis: One Year Follow up Study|Completed||N/A|80|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-10 23:33:35.830692|2017-10-10 23:33:35.830692
NCT02371889|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-10-04|||January 2015||2015-01-01|October 2017|2017-10-01|January 2021|Anticipated|2021-01-01|November 2020|Anticipated|2020-11-01||Interventional|TOPG||A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers|A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers|Recruiting||Phase 2|200|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:33:35.940978|2017-10-10 23:33:35.940978
NCT02371876|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2016-11-18|2016-09-29||February 2015||2015-02-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of an Ascensia Diabetes Care ONYX PLUS Investigational Blood Glucose Monitoring System|User Performance of the ONYX PLUS Blood Glucose Monitoring System|Completed||N/A|134|Actual|Ascensia Diabetes Care||1|||f||||f||||||||Yes||2017-10-10 23:33:36.07213|2017-10-10 23:33:36.07213
NCT02371863|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-12-27|||December 2014||2014-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|SEP||Normal Values in Stress Echocardiographic Parameters in Patients After Successful Mitral Valve Repair for Organic MR|SEP-study; The Assessment of Normal Values in Stress Echocardiographic Parameters in Patients After Successful Mitral Valve Repair for Organic Mitral Valve Regurgitation|Completed||N/A|25|Actual|UMC Utrecht|||1||f||||f||||||||||2017-10-10 23:33:36.3835|2017-10-10 23:33:36.3835
NCT02371850|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-07-18|2017-04-11||October 2014||2014-10-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers|Determination of Plasma Nicotine Levels After Using Reference and Generic Transdermal Nicotine Patches With and Without Standardized Heat Application in Adult Smokers|Completed||Phase 4|10|Actual|University of Maryland||1|||f||||t||||||||||2017-10-10 23:33:36.4599|2017-10-10 23:33:36.4599
NCT02371837|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-06-11|||February 2015||2015-02-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Pilates in Risk Fall in Older Population|Effects of 6 Week of Pilates in Fall Prevention|Completed||N/A|103|Actual|University of Jaén||2|||f||||f||||||||||2017-10-10 23:33:36.780508|2017-10-10 23:33:36.780508
NCT02371824|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-02-19|||April 2014||2014-04-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|PERFOS||Study of Normal Hip and Lumbar Bone Marrow With Dynamic Contrast Enhancement Magnetic Resonance Imaging|Study of Normal Hip and Lumbar Bone Marrow With Dynamic Contrast Enhancement Magnetic Resonance Imaging|Completed||N/A|60|Actual|University Hospital, Lille|||1||f||||f||||||||||2017-10-10 23:33:36.896551|2017-10-10 23:33:36.896551
NCT02371811|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-07-30|||February 2016||2016-02-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Use of v Care in Abdominal Hysterectomy||Completed||N/A|60|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 23:33:37.019778|2017-10-10 23:33:37.019778
NCT02370329|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-09-12|||August 2015||2015-08-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||P1101 in Treating Patients With Myelofibrosis|Phase II Study of P1101 in Early Myelofibrosis|Recruiting||Phase 2|19|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 23:33:56.122321|2017-10-10 23:33:56.122321
NCT02371798|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-11-30|||February 2015||2015-02-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?|Diagnosing Endolymphatic Hydrops in Patients With Meniere Disease Using Magnetic Resonance Imaging With Intravenous Gadolinium Administration|Withdrawn||N/A|0|Actual|Emory University||1|||f||||f||||||||||2017-10-10 23:33:37.110844|2017-10-10 23:33:37.110844
NCT02371785|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-06-12|||February 2015||2015-02-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|RAPID||Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease|Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease|Completed||N/A|20|Actual|Corindus Inc.||1|||f||||f||||||||||2017-10-10 23:33:37.194202|2017-10-10 23:33:37.194202
NCT02371772|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-19|||August 2008||2008-08-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Self-management of Anticoagulation Treatment|Comparison Between Conventional Anticoagulation Treatment and Self-management of Anticoagulation Treatment|Completed||N/A|23|Actual|University of Bergen||2|||f||||f||||||||||2017-10-10 23:33:37.278655|2017-10-10 23:33:37.278655
NCT02371759|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-03-22|2016-12-26||June 2013||2013-06-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|LCIOADMT2||Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2|Efficacy and Safety of Intraoral Local Anesthesia by Lidocaine + Clonidine in Patients With Diabetes Mellitus Type 2|Completed||Phase 3|256|Actual|University of Belgrade||8|||f||||f||||||||||2017-10-10 23:33:37.382218|2017-10-10 23:33:37.382218
NCT02371746|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-08-17|||January 1, 2015||2015-01-01|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|January 2, 2018|Anticipated|2018-01-02||Interventional|||Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma|A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma|Recruiting||Phase 2|46|Anticipated|Envisia Therapeutics||7|||f||||f||||||||||2017-10-10 23:33:39.558826|2017-10-10 23:33:39.558826
NCT02371733|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2017-09-07|||April 2015||2015-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Aerobic Exercise Training in Pulmonary Arterial Hypertension|Effects of Upper Extremity Aerobic Exercise Training on Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension|Recruiting||N/A|30|Anticipated|Gazi University||2|||f||||f||||||||||2017-10-10 23:33:39.672243|2017-10-10 23:33:39.672243
NCT02371720|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-07-18|||June 2014||2014-06-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|SCD Mobile Dot||Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease|Patient Centered Comprehensive Medication Adherence Management System to Improve Effectiveness of Disease Modifying Therapy With Hydroxyurea in Patients With Sickle Cell Disease|Active, not recruiting||N/A|160|Anticipated|Emory University||4|||f||||f||||||||||2017-10-10 23:33:41.374749|2017-10-10 23:33:41.374749
NCT02371707|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-20|2015-05-06|||March 2015||2015-03-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Bioequivalence Study of Idalopirdine Tablets 60 mg|Interventional, Randomised, Open-label, Two-way Crossover, Single-dose Bioequivalence Study of Idalopirdine in Healthy Subjects Comparing the 60 mg Commercial Tablet (Test) to the 60 mg Clinical Tablet (Reference)|Completed||Phase 1|30|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-10 23:33:41.508042|2017-10-10 23:33:41.508042
NCT02371694|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-04-12|||February 2015||2015-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|REQINSOIL||What is the Dose Response of Varying Meal Content of Fat on Postprandial Glycaemia in Children With T1DM?|What is the Dose Response of Varying Meal Content of Fat on Postprandial Glycaemia in Children With Type 1 Diabetes Mellitus?|Recruiting||N/A|30|Anticipated|Cork University Hospital||6|||f||||f||||||||Undecided||2017-10-10 23:33:41.576734|2017-10-10 23:33:41.576734
NCT02371681|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-09-12|||January 17, 2015||2015-01-17|August 18, 2017|2017-08-18|March 1, 2018|Anticipated|2018-03-01|November 29, 2017|Anticipated|2017-11-29||Interventional|||NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis|NexGen EBA Radiologic and Immunologic Biomarkers to Enhance Early Bactericidal Activity Measurements of Sterilizing Drug Activity in Tuberculosis|Recruiting||Phase 2|350|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:33:41.677014|2017-10-10 23:33:41.677014
NCT02371668|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-25|2017-10-05|||January 14, 2015||2015-01-14|August 2, 2017|2017-08-02|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Human Challenge Model|Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Human Challenge Model|Suspended||Phase 2|71|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:33:41.761547|2017-10-10 23:33:41.761547
NCT02371655|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-05-11|||October 1, 2015|Actual|2015-10-01|May 2017|2017-05-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|DIETSAN||Different Bowel Preparations in CT Colonography: is Diet Necessary? A Randomized Controlled Trial|Different Bowel Preparations in CT Colonography: is Diet Necessary? A Randomized Controlled Trial|Completed||N/A|100|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-10 23:33:41.837927|2017-10-10 23:33:41.837927
NCT02371642|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-10-31|||January 2015||2015-01-01|October 2016|2016-10-01||||January 2017|Anticipated|2017-01-01||Observational|Strain Echo||Strain Echo in Acute Heart Failure|The Utility of Strain Echocardiography in the Management of Acute Heart Failure|Recruiting||N/A|120|Anticipated|Wayne State University|||1||f||||||||||||||2017-10-10 23:33:41.926658|2017-10-10 23:33:41.926658
NCT02371629|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-03-29|||June 2015||2015-06-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD|A Randomized, Double-blind, Parallel Group, 26-week Study Evaluating the Efficacy, Safety and Tolerability of NVA237 Given Once or Twice Daily, in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 4|776|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:33:42.010095|2017-10-10 23:33:42.010095
NCT02367378|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-06-19|||February 2015||2015-02-01|June 2017|2017-06-01|June 13, 2016|Actual|2016-06-13|June 13, 2016|Actual|2016-06-13||Observational|||Minimally Invasive Surgery (MIS) for Spine Metastases|Minimally Invasive Surgery for Spine Metastases - A Prospective Study|Completed||N/A|14|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||||||2017-10-10 23:34:32.508223|2017-10-10 23:34:32.508223
NCT02371603|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-05-05|||February 11, 2015|Actual|2015-02-11|May 2017|2017-05-01|August 12, 2015|Actual|2015-08-12|August 12, 2015|Actual|2015-08-12||Interventional|||Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers|An Open Label, Randomized, Two Part Study to Evaluate the CYP2C8- and OATP1B1-Mediated Drug-Drug Interaction Potential of GSK1278863 With Pioglitazone and Rosuvastatin as Victims and Trimethoprim as Perpetrator in Healthy Adult Volunteers|Completed||Phase 1|70|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 23:33:42.4565|2017-10-10 23:33:42.4565
NCT02371590|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-03-13|||December 2017|Anticipated|2017-12-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Lenalidomide and Obinutuzumab for Previously Untreated CLL|A Phase 2 Clinical Trial To Evaluate Lenalidomide And Obinutuzumab For The Treatment Of Patients With Not Previously Treated Chronic Lymphocytic Leukemia|Not yet recruiting||Phase 2|25|Anticipated|University of California, San Diego||1|||f||||t|t|f||||||||2017-10-10 23:33:42.549107|2017-10-10 23:33:42.549107
NCT02371577|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-04-26|||February 1, 2017|Anticipated|2017-02-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|Revlimid||Evaluation of the Immune Restoration Potential Of Lenalidomide|A Phase 2 Clinical Trial To Evaluate The Immune Restoration Potential Of Lenalidomide For Patients With CLL-Associated Immunodeficiency|Withdrawn||Phase 2|0|Actual|University of California, San Diego||1||withdrawn|f||||t|t|f||||||||2017-10-10 23:33:42.651975|2017-10-10 23:33:42.651975
NCT02371564|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-02-24|||February 2015||2015-02-01|February 2015|2015-02-01||||December 2015|Anticipated|2015-12-01||Interventional|Oh BPCO||High Flow Oxygen Therapy in Patients Suffering From Chronic Obstructive Pulmonary Disease Exacerbation: Effects and Mechanisms of Action|High Flow Oxygen Therapy in Patients Suffering From Chronic Obstructive Pulmonary Disease Exacerbation: Effects and Mechanisms of Action|Unknown status|Recruiting|N/A|15|Anticipated|University Hospital, Angers||2|||f||||||||||||||2017-10-10 23:33:42.739282|2017-10-10 23:33:42.739282
NCT02371551|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-08-29|||August 2014||2014-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT|Evaluation of Complex Renal Cystic Lesions With Contrast Enhanced Ultrasound (CEUS) and Functional MRI Versus the Gold Standard: Computer Tomography (CT)|Recruiting||N/A|60|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 23:33:42.827589|2017-10-10 23:33:42.827589
NCT02371538|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-09-18|||October 2014||2014-10-01|September 2017|2017-09-01|July 2, 2016|Actual|2016-07-02|July 2, 2016|Actual|2016-07-02||Interventional|||Human Breastmilk in Young Children With Norovirus Infection of the Gut|A Pilot Study of Enteral Donor Human Milk in Young Children With Norovirus Infection of the Gut|Terminated||Phase 1/Phase 2|4|Actual|Children's Hospital Medical Center, Cincinnati||1||Slow accrual.|f||||f||||||||||2017-10-10 23:33:42.919317|2017-10-10 23:33:42.919317
NCT02371525|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Enhancing PrEP in Community Settings (EPIC)|Enhancing PrEP in Community Settings (EPIC)|Active, not recruiting||N/A|121|Actual|University of California, San Francisco||2|||f||||||||||||||2017-10-10 23:33:43.004983|2017-10-10 23:33:43.004983
NCT02371512|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-07-31|||February 2015||2015-02-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|MATTERHORN||A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN|A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN|Recruiting||N/A|210|Anticipated|Universitätsklinikum Köln||2|||f||||t||||||||||2017-10-10 23:33:43.085556|2017-10-10 23:33:43.085556
NCT02371499|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-02-01|||December 2014||2014-12-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study|Effect of Lactobacillus Casei dg (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: Multicenter, Randomized, Double-blind, Cross-over, Placebo Controlled, Pilot Study|Completed||N/A|44|Actual|SOFAR S.p.A.||2|||f||||f||||||||No||2017-10-10 23:33:43.175433|2017-10-10 23:33:43.175433
NCT02371486|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-10-12|||April 2016||2016-04-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?|Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?|Recruiting||N/A|150|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:33:43.276821|2017-10-10 23:33:43.276821
NCT02371473|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2016-10-22|||November 2014||2014-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption|Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption|Enrolling by invitation||Phase 4|12|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:33:43.359393|2017-10-10 23:33:43.359393
NCT02371460|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-06-08|||May 2015||2015-05-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|MOBYDIck||Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia|Maternal Omega-3 Supplementation to Reduce BronchopulmonarY Dysplasia in Very Preterm Infants (MOBYDIck Trial)|Recruiting||Phase 3|800|Anticipated|CHU de Quebec-Universite Laval||2|||f||||t||||||||||2017-10-10 23:33:43.450882|2017-10-10 23:33:43.450882
NCT02371447|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-08-25|||September 7, 2015|Actual|2015-09-07|August 2017|2017-08-01|December 31, 2022|Anticipated|2022-12-31|October 30, 2019|Anticipated|2019-10-30||Interventional|||VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer|A Phase I/II Open Label Clinical Trial Assessing Safety and Efficacy of Intravesical Instillation of VPM1002BC in Patients With Recurrent Non-muscle Invasive Bladder Cancer After Standard BCG Therapy|Recruiting||Phase 1/Phase 2|45|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-10 23:33:43.623051|2017-10-10 23:33:43.623051
NCT02371434|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-09-01|||January 2015||2015-01-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|ONEnTreg13||The ONE Study nTreg Trial (ONEnTreg13)|The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation - nTregs Trial|Enrolling by invitation||Phase 1/Phase 2|9|Actual|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-10-10 23:33:43.90445|2017-10-10 23:33:43.90445
NCT02371421|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-07-24|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|GOUT-H||Genetics of Hyperuricemia Therapy in Hmong|Genomic Guided Assessment of Drug Therapy Effectiveness in Managing Hmong Adults With Hyperuricemia or Gout.|Completed||Phase 2|80|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 23:33:43.980719|2017-10-10 23:33:43.980719
NCT02371408|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2016-04-06|||January 2015||2015-01-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4|A Phase IIb/IIIa, Randomized Study to Evaluate the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4|Unknown status|Active, not recruiting|Phase 2/Phase 3|300|Anticipated|Pharco Pharmaceuticals||6|||f||||f||||||||||2017-10-10 23:33:44.065473|2017-10-10 23:33:44.065473
NCT02371382|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-03-16|||March 2013||2013-03-01|March 2017|2017-03-01|March 2025|Anticipated|2025-03-01|March 2025|Anticipated|2025-03-01||Observational|Sirius||Multicentre Prospective Study to Evaluate Long-term Clinical Outcomes of the Sirius Cemented Femoral Stem|Multicentre Prospective Study to Evaluate Long-term Clinical Outcomes of the Sirius Cemented Femoral Stem|Recruiting||N/A|250|Anticipated|Zimmer Biomet|||1||f||||f||||||||No||2017-10-10 23:33:44.25995|2017-10-10 23:33:44.25995
NCT02371369|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-09-29|||March 2015||2015-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ENLIVEN||PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)|A Double-blind, Randomized, Placebo-controlled Phase 3 Study of Orally Administered PLX3397 in Subjects With Pigmented Villonodular Synovitis or Giant Cell Tumor of the Tendon Sheath|Active, not recruiting||Phase 3|120|Actual|Daiichi Sankyo, Inc.||2|||f||||t||||||||||2017-10-10 23:33:44.340026|2017-10-10 23:33:44.340026
NCT02371356|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-06-19|||May 2014||2014-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|January 31, 2017|Actual|2017-01-31||Observational|PCORIPTD||Comparing Effectiveness of Treating Depression With & Without Comorbidity to Improve Fetal Health|Comparing Effectiveness of Treating Depression With & Without Comorbidity to Improve Fetal Health|Active, not recruiting||N/A|88000|Actual|Kaiser Permanente|||9||f||||f||||||||No||2017-10-10 23:33:44.511902|2017-10-10 23:33:44.511902
NCT02371330|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-08-29|||April 2015||2015-04-01|August 2016|2016-08-01||||June 2017|Anticipated|2017-06-01||Observational|Neo-HAT||The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study|The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study - Neo-HAT Study|Recruiting||N/A|72|Anticipated|Karolinska Institutet|||1||f||||||||||||||2017-10-10 23:33:44.68067|2017-10-10 23:33:44.68067
NCT02371317|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-02-01|||May 2015||2015-05-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Stress Management for High Blood Pressure||Recruiting||N/A|180|Anticipated|Kent State University||3|||f||||t||||||||||2017-10-10 23:33:44.772212|2017-10-10 23:33:44.772212
NCT02371304|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-09-11|||October 2015||2015-10-01|September 2017|2017-09-01|January 2023|Anticipated|2023-01-01|June 2022|Anticipated|2022-06-01||Interventional|TESAR||Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers|Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers|Recruiting||Phase 3|302|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-10 23:33:44.881977|2017-10-10 23:33:44.881977
NCT02371291|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-07|||January 2015||2015-01-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Memory Flexibility Training for Depression|A Randomized Controlled Trial Comparing Memory Flexibility Training to Psychoeducation in the Treatment of Major Depressive Disorder|Completed||Phase 1/Phase 2|60|Actual|Medical Research Council Cognition and Brain Sciences Unit||2|||f||||f||||||||||2017-10-10 23:33:44.964705|2017-10-10 23:33:44.964705
NCT02371278|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-03-14|||May 2015||2015-05-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Leucine Co-ingestion and Myofibrillar Protein Synthesis in Older Adults|Influence of Leucine Co-ingestion With Mixed Meals on Integrative Myofibrillar Protein Synthesis in Older Adults|Completed||N/A|20|Actual|McMaster University||2|||f||||f||||||||||2017-10-10 23:33:45.063761|2017-10-10 23:33:45.063761
NCT02371265|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-05-11|||April 2012||2012-04-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique|Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique|Completed||N/A|761|Actual|University of Washington||2|||f||||f||||||||||2017-10-10 23:33:45.160816|2017-10-10 23:33:45.160816
NCT02371252|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2016-09-13|||April 2014||2014-04-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment|Randomized Trial Comparing Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment|Recruiting||Phase 4|120|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-10 23:33:45.236367|2017-10-10 23:33:45.236367
NCT02371239|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-03-15|||February 2015||2015-02-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SIT LESS 2||SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2|SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2|Completed||N/A|19|Actual|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-10 23:33:45.329569|2017-10-10 23:33:45.329569
NCT02371226|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-03-03|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|February 2017|Actual|2017-02-01||Interventional|||Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I|A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human Alpha-L-iduronidase (HIRMAb-IDUA) Fusion Protein, AGT-181 in Adult Patients With Mucopolysaccharidosis I (MPS I, Hurler Syndrome)|Active, not recruiting||Phase 1|3|Actual|ArmaGen, Inc||3|||f||||t||||||||||2017-10-10 23:33:45.439709|2017-10-10 23:33:45.439709
NCT02371213|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-07-26|||April 2015||2015-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HISONET||Social Networking on Mobile Phone to Improve Maternal and Neonatal Outcomes|Antenatal Care Health Education Intervened by Social Networking on Mobile Phone Compared With Usual Care to Improve Maternal and Neonatal Outcomes: Randomized Controlled Trial|Recruiting||N/A|1160|Anticipated|Nopparatrajathanee Hospital||2|||f||||f||||||||||2017-10-10 23:33:45.538641|2017-10-10 23:33:45.538641
NCT02371174|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-02-20|||September 3, 2014|Actual|2014-09-03|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.|An Observational Post-Marketing Surveillance Study on the Status and Factors for the Development of Peripheral Neuropathy in Patients With HER2-Negative Inoperable or Recurrent Breast Cancer in Japan.|Active, not recruiting||N/A|651|Actual|Eisai Inc.|||2||f||||f||||||||||2017-10-10 23:33:45.776592|2017-10-10 23:33:45.776592
NCT02371161|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-09-15|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|February 2023|Anticipated|2023-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy|A Phase II Prospective Study of High-dose Myeloablative Therapy, With Stem Cell Devices Support in Elderly Patients (≥65 and ≤ 75 Years) With Relapsed Aggressive Non-Hodgkin Lymphoma or Resistant to First Line Therapy|Recruiting||Phase 2|135|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-10 23:33:45.840959|2017-10-10 23:33:45.840959
NCT02371148|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-15|||June 2014||2014-06-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|April 2018|Anticipated|2018-04-01||Interventional|FIL_BRB||Fase II Study With BRB for Non-Hodgkin Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia's|Fase II Study With Bortezomib, Rituximab and Bendamustin-BRB- for Non-Hodgkin Lymphoplasmocytic Lymphoma/Waldenstrom Macroglobulinemia's Patients at First Relapse|Recruiting||Phase 2|38|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-10 23:33:46.15379|2017-10-10 23:33:46.15379
NCT02371135|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-03-29|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes|Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes|Recruiting||N/A|75|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     tissue stool   "|||2017-10-10 23:33:46.348584|2017-10-10 23:33:46.348584
NCT02371122|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2015-07-09|||June 2015||2015-06-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Spinal Cord Stimulation (SCS) Therapy Study|Spinal Cord Stimulation (SCS) Therapy Study|Withdrawn||N/A|0|Actual|MedtronicNeuro||4|||f||||f||||||||||2017-10-10 23:33:46.46551|2017-10-10 23:33:46.46551
NCT02371109|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-19|||February 2015||2015-02-01|February 2015|2015-02-01||||May 2016|Anticipated|2016-05-01||Observational|||SYSTEMATIC: NAATS of Pooled Selftaken Versus Clinicantaken Swabs 1||Unknown status|Recruiting|N/A|2350|Anticipated|The Leeds Teaching Hospitals NHS Trust|||1||f||||f||||||||||2017-10-10 23:33:46.577365|2017-10-10 23:33:46.577365
NCT02371096|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-19||||||February 2015|2015-02-01||||June 2016|Anticipated|2016-06-01||Interventional|||Comparative Pharmacokinetic Trial of RGB-03 and MabThera||Unknown status|Not yet recruiting|Phase 1|||Gedeon Richter Plc.||2|||f||||f||||||||||2017-10-10 23:33:46.668333|2017-10-10 23:33:46.668333
NCT02371083|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-08-15|||January 2015||2015-01-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Timing of Pessary Care|Timing of Pessary Care|Recruiting||N/A|126|Anticipated|Hartford Hospital||2|||f||||f||||||||||2017-10-10 23:33:46.758652|2017-10-10 23:33:46.758652
NCT02371070|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-06-30|||December 2013||2013-12-01|February 2015|2015-02-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Observational|POCT-DOAC 2||Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2|Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2|Completed||N/A|60|Actual|University Hospital Tuebingen|||3||f||||f||||||Samples Without DNA|"     Whole blood samples and citrated plasma samples   "|||2017-10-10 23:33:46.871203|2017-10-10 23:33:46.871203
NCT02371057|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-19|||August 2014||2014-08-01|February 2015|2015-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Acromegaly & Sleep Apnoea|The Prevalence of Acromegaly in the Sleep Apnoea Clinic|Unknown status|Recruiting|N/A|1000|Anticipated|The Leeds Teaching Hospitals NHS Trust|||2||f||||f||||||||||2017-10-10 23:33:46.941642|2017-10-10 23:33:46.941642
NCT02371044|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-02-25|||May 2013||2013-05-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|POCT-DOAC 1||Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1|Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1|Completed||N/A|60|Actual|University Hospital Tuebingen|||3||f||||f||||||Samples Without DNA|"     Whole blood samples and citrated plasma samples   "|||2017-10-10 23:33:47.030032|2017-10-10 23:33:47.030032
NCT02371031|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-11-29|||March 2015||2015-03-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas|FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas|Terminated||Phase 1|11|Actual|Washington University School of Medicine||1||Funding source for study ended.|f||||f||||||||||2017-10-10 23:33:47.111183|2017-10-10 23:33:47.111183
NCT02371018|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-09-19|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acute Effects of Nutrition Supplementation on Treatment Efficiency and Hemodynamics During Dialysis|Acute Effects of Nutrition Supplementation on Treatment Efficiency and Hemodynamics During Dialysis|Active, not recruiting||N/A|20|Anticipated|University of Illinois at Urbana-Champaign||3|||f||||f||||||||||2017-10-10 23:33:47.216592|2017-10-10 23:33:47.216592
NCT02371005|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-09-07|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Oral Manifestations of Systemic Sclerosis|Oral Manifestations of Systemic Sclerosis: Toward the Identification of New Prognostic Markers|Recruiting||N/A|90|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:33:47.308791|2017-10-10 23:33:47.308791
NCT02370992|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-19|||July 2011||2011-07-01|February 2015|2015-02-01||||July 2016|Anticipated|2016-07-01||Observational|||I125 Brachytherapy After TURP|Prospective Multi-centre Study of Low-dose Rate Iodine125 (I-125) Prostate Brachytherapy Performed After Transurethral Resection|Unknown status|Recruiting|N/A|100|Anticipated|The Leeds Teaching Hospitals NHS Trust|||1||f||||f||||||||||2017-10-10 23:33:47.42024|2017-10-10 23:33:47.42024
NCT02370979|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-08-06|||February 2015||2015-02-01|August 2015|2015-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|DRONE||Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients|Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients|Unknown status|Recruiting|Phase 4|202|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 23:33:47.499797|2017-10-10 23:33:47.499797
NCT02370966|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-09-26|||February 2015||2015-02-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Berry Intake - Effects on Systemic and Oral Inflammation|Berry Intake - Effects on Systemic and Oral Inflammation|Active, not recruiting||Phase 1/Phase 2|16|Anticipated|Kristianstad University||2|||f||||f||||||||||2017-10-10 23:33:47.604169|2017-10-10 23:33:47.604169
NCT02370953|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2016-03-15|||May 2015||2015-05-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||VERION Versus Conventional, Manual Ink-marking in Toric IOL Implantation|VERION Versus Conventional, Manual Ink-marking in Toric IOL Implantation|Completed||N/A|34|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:33:47.701098|2017-10-10 23:33:47.701098
NCT02370940|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-19|||January 2013||2013-01-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Regular Consumption of High Phytate Reduces Inhibitory Effect of Phytate on Iron Absorption|Regular Consumption of High Phytate Diet Reduces Inhibitory Effect of Phytate on Nonheme Iron Absorption in Female Subjects|Completed||N/A|32|Actual|Iowa State University||2|||f||||f||||||||||2017-10-10 23:33:47.795352|2017-10-10 23:33:47.795352
NCT02370927|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-09-26|||May 2016||2016-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|||PERFECT Project - Part 2 - Study 2|Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 2|Active, not recruiting||N/A|30|Anticipated|University of Manitoba||6|||f||||||||||||||2017-10-10 23:33:47.862684|2017-10-10 23:33:47.862684
NCT02370914|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-09|2015-06-02||August 2011||2011-08-01|March 2017|2017-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Concussion Testing: A Novel Non-invasive Concussion Detection Device|Concussion Testing: A Novel Non-invasive Concussion Detection Device|Completed||N/A|84|Actual|Jan Medical, Inc.|This is a pilot study only. Only 15 concussions were observed from a single gender teenage population from one high school football team over one season. Further data from a broader population is needed to confirm results.|2|||f||||f||||||||No||2017-10-10 23:33:47.961254|2017-10-10 23:33:47.961254
NCT02370901|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-01-06|||July 2017||2017-07-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|July 2018|Anticipated|2018-07-01||Interventional|CRANIO||Cranial Orthotic Device Versus Repositioning Techniques for the Management of Plagiocephaly: the CRANIO Randomized Trial|Cranial Orthotic Device Versus Repositioning Techniques for the Management of Plagiocephaly: the CRANIO Randomized Trial|Not yet recruiting||N/A|200|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-10 23:33:48.134274|2017-10-10 23:33:48.134274
NCT02370888|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-08-03|||May 16, 2016|Actual|2016-05-16|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|UF-BMT-MRD-101||Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease|A Phase I Clinical Trial to Evaluate the Maximally Tolerated Dose (MTD), Dose Limiting Toxicities (DLTs) and Safety Profiles of Increasing Doses of Lenalidomide After Allo-HCT in AML and MDS Subjects With Minimal Residual Disease (MRD) Detected by the CD34+ Mixed Chimerism Analysis (UF-BMT-MRD-101)|Recruiting||Phase 1|24|Anticipated|University of Florida||1|||f||||t|t|f||||||||2017-10-10 23:33:48.204052|2017-10-10 23:33:48.204052
NCT02370875|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-08-18|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|June 2017|Actual|2017-06-01||Interventional|||rTMS and Botulinum Toxin in Benign Essential Blepharospasm|Combined Effects of rTMS and Botulinum Toxin in Benign Essential Blepharospasm: A Novel Approach|Active, not recruiting||N/A|25|Actual|University of Florida||2|||f||||t|f|f||||||||2017-10-10 23:33:48.286382|2017-10-10 23:33:48.286382
NCT02370862|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-19|2017-03-06|||February 2013||2013-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI|A Novel Application of Iontophoresis in the Transcutaneous Delivery of a Prokinetic Agent for the Promotion of Bowel Evacuation|Completed||Early Phase 1|28|Actual|James J. Peters Veterans Affairs Medical Center||1|||f||||f||||||||||2017-10-10 23:33:48.364431|2017-10-10 23:33:48.364431
NCT02370849|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-02-19|||October 2009||2009-10-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2012|Actual|2012-02-01||Interventional|||Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma|Cisplatin and S-1 With or Without Nimotuzumab for Patients With Previously Untreated Advanced Gastric Adenocarcinoma: a Single-center, Randomised, Open-label, Parallel-group, Controlled Phase 2 Clinical Trial|Completed||Phase 2|2|Actual|Chinese Academy of Medical Sciences||2|||f||||||||||||||2017-10-10 23:33:48.43768|2017-10-10 23:33:48.43768
NCT02370836|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-11-17|||May 2015||2015-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Evaluating the Effects of Psycho-oncological Education on Distress and Quality of Life in Solid Tumor Cancer Patients|Evaluating the Effects of Psycho-oncological Education on Distress and Quality of Life in Solid Tumor Patients Who Have Received and Completed Chemotherapy Treatment With Curative Intent. A Pilot Study.|Completed||N/A|28|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 23:33:48.509679|2017-10-10 23:33:48.509679
NCT02370823|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-04-10|||February 2015||2015-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment|A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment|Active, not recruiting||N/A|20|Anticipated|Regenerative Sciences, LLC|||1||f||||f||||||Samples With DNA|"     Synovial Fluid an QC bone marrow sample may be retained.   "|No||2017-10-10 23:33:48.5676|2017-10-10 23:33:48.5676
NCT02370810|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-06-26|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||A CBT-based Internet Intervention for Adults With Tinnitus in the United Kingdom|Study Protocol for a CBT-based Internet Intervention for Adults With Tinnitus in the United Kingdom: A Randomise Controlled Trial|Active, not recruiting||N/A|160|Actual|Anglia Ruskin University||2|||f||||t||||||||||2017-10-10 23:33:48.635795|2017-10-10 23:33:48.635795
NCT02370797|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-06-22|||February 2015||2015-02-01|June 2016|2016-06-01|May 2029|Anticipated|2029-05-01|February 2029|Anticipated|2029-02-01||Interventional|||Node Negative, Invasive Breast Cancer Single Fraction IOERT|Lumpectomy Followed by Intraoperative Electron Radiation Therapy (IOERT) as a Single Full Dose Partial Breast Irradiation for Early Stage, Node Negative, Invasive Breast Cancer|Recruiting||N/A|100|Anticipated|Avera McKennan Hospital & University Health Center||1|||f||||t||||||||||2017-10-10 23:33:48.705966|2017-10-10 23:33:48.705966
NCT02370784|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-07-19|||February 2015||2015-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|TAMER||Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma|The Effect of Atorvastatin on Microvascular Endothelial Function and Raynaud in Early Diffuse Systemic Sclerosis|Recruiting||Phase 2|30|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 23:33:48.783814|2017-10-10 23:33:48.783814
NCT02370771|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-12-06|||June 2015||2015-06-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PASEO||Proteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis|Proteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis|Recruiting||N/A|30|Anticipated|University Hospital, Rouen||1|||f||||t||||||||||2017-10-10 23:33:48.869765|2017-10-10 23:33:48.869765
NCT02370758|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-09-20|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|June 16, 2017|Actual|2017-06-16|September 2016|Actual|2016-09-01||Interventional|Q-CMV||Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients|Cell Mediated Immunity as a Guide for Secondary Prophylaxis in SOT Patients With CMV Infection|Completed||N/A|32|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:33:48.941206|2017-10-10 23:33:48.941206
NCT02370745|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-05-10|||November 2014||2014-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|Incretin||Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle|Characterizing the Incretin Effect of Amino Acids (AA) and Defining the Effect of GLP-1 on Muscle Microvascular Blood Flow and Muscle Protein and Glucose Metabolism in Older Age.|Enrolling by invitation||N/A|32|Anticipated|University of Nottingham||8|||f||||t||||||||Undecided||2017-10-10 23:33:49.011051|2017-10-10 23:33:49.011051
NCT02370732|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-09-26|||February 2015||2015-02-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Alcohol Related Impairment and Reinforcement: Pre to Post Roux en Y Gastric Bypass Surgery|Alcohol Related Impairment and Reinforcement After Gastric Bypass Surgery|Recruiting||N/A|60|Anticipated|Neuropsychiatric Research Institute, Fargo, North Dakota||1|||f||||f||||||||||2017-10-10 23:33:49.107871|2017-10-10 23:33:49.107871
NCT02370719|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-12-21|||June 2015||2015-06-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes|Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes Mellitus|Recruiting||Phase 3|150|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:33:49.193086|2017-10-10 23:33:49.193086
NCT02370693|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-01-20|||March 2016||2016-03-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis|Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis Grant Number: R34HL122558|Recruiting||Phase 2|30|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 23:33:49.518788|2017-10-10 23:33:49.518788
NCT02370680|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-08-04|||February 2015||2015-02-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|DURATION||Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease|Durability of Antiplatelet Effect of a Novel Extended-Release Formulation of Acetylsalicylic Acid, Durlaza in CVD (Cardiovascular Disease) Patients at Risk of High Platelet Turnover|Completed||Phase 1|41|Actual|New Haven Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:33:49.624974|2017-10-10 23:33:49.624974
NCT02370667|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-01-18|2016-09-14||August 2015||2015-08-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional||All participants met the diagnostic criteria for clinical knee OA according to the American College of Rheumatology (Altman et al., 1986).|A Biomechanical Exercise Program for Knee OA|Clinical and Tissue Outcomes of a Biomechanical Exercise Program for Knee Osteoarthritis|Completed||N/A|31|Actual|McMaster University|"The sample was statistically underpowered to detect all potential differences between and within groups
This study involved only women thus limiting the generalizability"|3|||f||||t||||||||No||2017-10-10 23:33:49.734512|2017-10-10 23:33:49.734512
NCT02370654|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-03-24|||March 2014||2014-03-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease|Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease|Recruiting||N/A|40|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 23:33:50.571243|2017-10-10 23:33:50.571243
NCT02370641|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-02-27|||October 2012||2012-10-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|PomX||Effects of Pomegranate Extract on Intestinal Flora|Variations in Urolithin Production by the Microbiome After Pomegranate Extract Administration: Understanding Metabolism and Responsiveness to Pomegranate Ellagitannins|Completed||N/A|26|Actual|University of California, Los Angeles||2|||f||||f||||||||No|No plan to share IPD with other researchers.|2017-10-10 23:33:50.666025|2017-10-10 23:33:50.666025
NCT02370628|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-08-02|||April 2015||2015-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|VITTA||Vertebroplasty In The Treatment Of Acute Fracture Trial - The VITTA Trial|Vertebroplasty In The Treatment Of Acute Fracture Trial (The VITTA Trial)|Recruiting||N/A|495|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-10 23:33:50.74169|2017-10-10 23:33:50.74169
NCT02370615|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-04-14|2016-04-14||February 2015||2015-02-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||The pharmacokinetic analysis set was defined as the set of participants treated with the study drug that had no significant protocol deviation, satisfied the minimum protocol provisions, and could be evaluated for pharmacokinetics.|Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam|A Phase 1, Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of TAK-272 and the Effect of TAK-272 on the Pharmacokinetics of Digoxin or Midazolam In the Healthy Adult Participants|Completed||Phase 1|34|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:33:50.87553|2017-10-10 23:33:50.87553
NCT02370602|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-03-11|2015-03-11||October 2013||2013-10-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063|An Open-Label [^11C]T-773 Positron Emission Tomography Study to Determine Phosphodiesterase10A Occupancy by TAK-063 After a Single Oral Dose in Human Volunteers|Completed||Phase 1|13|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:33:51.614975|2017-10-10 23:33:51.614975
NCT02370589|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-09-20|||February 2015||2015-02-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects|A Phase 1, Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Nanoparticle Vaccine, With or Without Matrix-M™ Adjuvant, in Healthy Subjects ≥18 to <50 Years of Age|Completed||Phase 1|230|Actual|Novavax||13|||f||||f||||||||||2017-10-10 23:33:53.054983|2017-10-10 23:33:53.054983
NCT02370576|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-02-24|||March 2015||2015-03-01|February 2015|2015-02-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01|1 Month|Observational [Patient Registry]|||The Effect of Traumatic Childbirth on the Incidence of PTSD and Other Major Postpartum Psychopathology|The Effect of Traumatic Childbirth on the Incidence of Postpartum PTSD, MDD and Anxiety Disorders|Not yet recruiting||N/A|500|Anticipated|Rambam Health Care Campus|||2||f||||t||||||||||2017-10-10 23:33:53.162934|2017-10-10 23:33:53.162934
NCT02370563|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-08-31|||November 2014||2014-11-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||PET Imaging of Intracranial Cancers With 18F-FSPG|An Open-Label Study of the Efficacy of 18F-FSPG PET/CT in Subjects With Intracranial Cancers|Terminated||Phase 1|26|Actual|Piramal Imaging SA||1||Business decision|f||||f||||||||||2017-10-10 23:33:53.336083|2017-10-10 23:33:53.336083
NCT02370550|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-02-18|||March 2015||2015-03-01|February 2015|2015-02-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|CTRIPS||Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome|Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome(CTRIPS): A Prospective, Randomized, Multicenter, Double-Blind Placebo-Controlled Trial|Unknown status|Not yet recruiting|Phase 4|240|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-10 23:33:53.421871|2017-10-10 23:33:53.421871
NCT02370537|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-24|2016-11-25|2016-09-13||March 2015||2015-03-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PRECISE|All patients enrolled in Part A that had available serum TG and FEC data (Full Analysis Set) were included in the baseline analysis.|A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI|A Two-part, Open-label, Randomised, Crossover, Multicentre, Phase II Study to Investigate the Presence of Pancreatic Exocrine Insufficiency (PEI) in Patients With Type 2 Diabetes Mellitus, and to Investigate the Pharmacokinetics of EPANOVA® and OMACOR® Following a Single Oral Dose in Patients With Different Degrees of PEI|Completed||Phase 2|490|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:33:53.515406|2017-10-10 23:33:53.515406
NCT02370524|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-03-07|||January 2015||2015-01-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease|Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease|Completed||Phase 1|16|Actual|Molecular NeuroImaging||1|||f||||f||||||||||2017-10-10 23:33:54.278827|2017-10-10 23:33:54.278827
NCT02370511|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-09-27|||February 2015||2015-02-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|December 2017|Anticipated|2017-12-01||Interventional|MITRAL||Mitral Implantation of TRAnscatheter vaLves|The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.|Recruiting||Phase 1|90|Anticipated|NorthShore University HealthSystem||3|||f||||t||||||||||2017-10-10 23:33:54.366258|2017-10-10 23:33:54.366258
NCT02370498|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2017-08-28|||May 11, 2015|Actual|2015-05-11|August 2017|2017-08-01|July 26, 2019|Anticipated|2019-07-26|October 26, 2017|Anticipated|2017-10-26||Interventional|||A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061)|A Phase III, Randomized, Open-label Clinical Trial of Pembrolizumab (MK-3475) Versus Paclitaxel in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine|Active, not recruiting||Phase 3|592|Actual|Merck Sharp & Dohme Corp.||2|||f||||t|t|f||||||||2017-10-10 23:33:54.545048|2017-10-10 23:33:54.545048
NCT02370485|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-23|2015-06-18|||February 2015||2015-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children|Relative Bioavailability and the Effect of Food on the Bioavailability of LY2801653 in Healthy Subjects|Completed||Phase 1|23|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 23:33:54.672238|2017-10-10 23:33:54.672238
NCT02370472|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-02-07|||July 2014||2014-07-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of a New Training Model for Ultrasound Guided Regional Anesthesia - A Feasibility Study|Evaluation of a New Training Model for Ultrasound Guided Regional Anesthesia - A Feasibility Study|Completed||N/A|30|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 23:33:54.757831|2017-10-10 23:33:54.757831
NCT02370459|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-02-23|||April 2015||2015-04-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|AFIX||AFIX to Improve HPV Vaccination|Adolescent AFIX: A Multi-state RCT to Increase Adolescent Vaccination by Facilitating Providers' Adoption of Best Practices|Completed||N/A|223|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||No|No raw data will be shared with the general public or other researchers.|2017-10-10 23:33:54.878466|2017-10-10 23:33:54.878466
NCT02370446|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-01-10|||January 2015||2015-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Testing a Personalize Medication Log for Patients With Lymphoma|Testing a Personalize Medication Log for Patients With Lymphoma|Completed||N/A|5|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-10 23:33:55.002346|2017-10-10 23:33:55.002346
NCT02370433|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-08-28|||December 2012||2012-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Use of Prokinetics During Inpatient Bowel Care for SCI Patients||Recruiting||Phase 1|20|Anticipated|James J. Peters Veterans Affairs Medical Center||3|||f||||||||||||||2017-10-10 23:33:55.103529|2017-10-10 23:33:55.103529
NCT02370407|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-07-26|2017-05-23||November 2014||2014-11-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Assessment of the Transferability of Skills From Robotic to Laparoscopic Simulation Platforms|Assessment of the Transferability of Skills From Robotic to Laparoscopic Simulation Platforms in Surgical Skill Naive Participants|Completed||N/A|40|Actual|Johns Hopkins University|We modified three previously validated scales to create a 35-point scale to evaluate participants; therefore, the validity of these scales may have been impacted.|2|||f||||f||||||||||2017-10-10 23:33:55.314946|2017-10-10 23:33:55.314946
NCT02370394|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-11-02|||March 2015||2015-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Intervention for IPV Perinatal Women|Computer-Based Intervention for Victimized Perinatal Women With Mental Illness (Phase 1)|Completed||N/A|54|Actual|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||No||2017-10-10 23:33:55.710978|2017-10-10 23:33:55.710978
NCT02370381|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-12-01|||February 2015||2015-02-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Hemoglobin and INR Out of Nose Blood|Vergleich Zwischen Hb Und INR Aus Nsaenblut Und venösem Blut|Completed||N/A|20|Actual|University of Zurich|||1||f||||f||||||Samples Without DNA|"     Nose blood   "|||2017-10-10 23:33:55.81376|2017-10-10 23:33:55.81376
NCT02370355|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-04-13|||December 23, 2014|Actual|2014-12-23|April 2017|2017-04-01|June 8, 2016|Actual|2016-06-08|June 8, 2016|Actual|2016-06-08||Observational|||Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer|Assessment of Novel Biomarkers in Patients With Metastatic Castration Resistant Prostate Cancer|Terminated||N/A|24|Actual|University of Southern California|||2|Sponsor decided not to pursue study|f||||f|f|f||||Samples With DNA|"     Blood, plasma, and tissue (optional)   "|||2017-10-10 23:33:55.948513|2017-10-10 23:33:55.948513
NCT02370342|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-08-04|||October 16, 2017|Anticipated|2017-10-16|August 2017|2017-08-01|October 16, 2019|Anticipated|2019-10-16|October 16, 2018|Anticipated|2018-10-16||Interventional|||Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing Surgery|Robot-Assisted Laparoscopic HIFU (High-Intensity Focused Ultrasound) for Thermal Ablative Therapy of Small Renal Mass: Corroborating With Robot-Assisted Laparoscopic Partial Nephrectomy Specimens|Not yet recruiting||N/A|20|Anticipated|University of Southern California||1|||f||||t|f|t|f|||||||2017-10-10 23:33:56.020955|2017-10-10 23:33:56.020955
NCT02370316|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-03-01|||December 2015|Actual|2015-12-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|CLIMAMITHE||Biomarkers of Change in BPD After Metacognitive Interpersonal Therapy-standard Approach|Neuroimaging and Clinical Markers of Change in Borderline Personality Disorder After Metacognitive Interpersonal Therapy - Standard Approach|Recruiting||N/A|80|Anticipated|IRCCS Centro San Giovanni di Dio Fatebenefratelli||2|||f||||f|f|f||||||Undecided||2017-10-10 23:33:56.20848|2017-10-10 23:33:56.20848
NCT02370303|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-03-01|||August 2014||2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System|A Pilot Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System|Active, not recruiting||N/A|40|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Preoperative blood sample, tumor tissue from lung resection, postoperative blood sample   "|||2017-10-10 23:33:56.29284|2017-10-10 23:33:56.29284
NCT02370290|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-03-01|||April 2014||2014-04-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer|CT Metrology: Quantitative Imaging Metrics With Advanced Visualization Tools for Cancer Imaging|Completed||N/A|74|Actual|University of Southern California|||1||f||||t||||||||||2017-10-10 23:33:56.365574|2017-10-10 23:33:56.365574
NCT02370277|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-04-18|||December 16, 2014|Actual|2014-12-16|April 2017|2017-04-01|December 16, 2019|Anticipated|2019-12-16|December 16, 2018|Anticipated|2018-12-16||Observational|||Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer|Changes in Intestinal Microbiota in Association With Chemotherapy Treatment|Recruiting||N/A|45|Anticipated|University of Southern California|||3||f||||t|f|f||||Samples With DNA|"     Stool, blood, and urine   "|||2017-10-10 23:33:56.438292|2017-10-10 23:33:56.438292
NCT02370264|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-04-11|||October 1, 2012|Actual|2012-10-01|April 2017|2017-04-01|October 21, 2016|Actual|2016-10-21|September 2, 2015|Actual|2015-09-02||Interventional|||Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer|Screening for Musculoskeletal Impairments and Quality of Life in Individuals Post-Treatment for Breast Cancer|Terminated||N/A|36|Actual|University of Southern California||1||Study not progressing toward scientific goals|f||||t|f|f||||||||2017-10-10 23:33:56.527574|2017-10-10 23:33:56.527574
NCT02370251|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-11-18|||June 2015||2015-06-01|November 2016|2016-11-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Compassionate Use of Omegaven in Children|Fish Oil Lipid Emulsion for the Treatment of Parenteral-Nutrition-Associated Liver Disease in Infants|Recruiting||Phase 2|200|Anticipated|University of Oklahoma||2|||f||||t||||||||||2017-10-10 23:33:56.60219|2017-10-10 23:33:56.60219
NCT02370238|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-05-10|||June 2015||2015-06-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|FRIDA||A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer|A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Paclitaxel in Combination With Reparixin Compared to Paclitaxel Alone as Front-line Therapy for Metastatic Triple- Negative Breast Cancer (FRIDA)|Recruiting||Phase 2|156|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||t||||||||No||2017-10-10 23:33:56.700041|2017-10-10 23:33:56.700041
NCT02370225|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-08-10|||March 2015||2015-03-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|AEPSS||Aerobic Exercise in Primary Sjögren's Syndrome|Effects of Aerobic Exercise on Fatigue in Women With Primary Sjögren's Syndrome: Randomized Controlled Trial|Completed||N/A|45|Actual|Federal University of Espirito Santo||2|||f||||f||||||||Undecided||2017-10-10 23:33:57.565493|2017-10-10 23:33:57.565493
NCT02370212|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-01-15|||March 2015||2015-03-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Cr + HIIT||Interval Training Plus Creatine Effects on Performance and Glucose Tolerance|Interval Training Plus Creatine Effects on Performance and Glucose Tolerance|Completed||N/A|18|Actual|University of British Columbia||2|||f||||||||||||||2017-10-10 23:33:57.770333|2017-10-10 23:33:57.770333
NCT02370199|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2016-08-19|||November 2014||2014-11-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Peripheral Blood Flow Responses to Electromagnetic Energy|Peripheral Blood Flow Responses to Electromagnetic Energy|Recruiting||N/A|40|Anticipated|Medical College of Wisconsin||1|||f||||f||||||||||2017-10-10 23:33:57.864968|2017-10-10 23:33:57.864968
NCT02370186|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-04-11|||February 2015||2015-02-01|April 2017|2017-04-01|March 12, 2017|Actual|2017-03-12|March 12, 2017|Actual|2017-03-12||Observational|||The Role of Dysfunctional HDL in Severe Sepsis|The Role of Dysfunctional HDL in Severe Sepsis|Completed||N/A|110|Actual|University of Florida|||1||f||||f||||||Samples With DNA|"     Serum Plasma   "|No||2017-10-10 23:33:57.961175|2017-10-10 23:33:57.961175
NCT02370173|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-08-01|||September 2014||2014-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Method for Enhancing Sleep in PTSD|A Non-Pharmacologic Method for Enhancing Sleep in PTSD|Recruiting||N/A|90|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-10 23:33:58.049005|2017-10-10 23:33:58.049005
NCT02370160|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-10-04|||December 21, 2015|Actual|2015-12-21|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma|HM2014-26 DT2219 Immunotoxin for the Treatment of Relapsed or Refractory CD19 (+) and/or CD 22 (+) B-lineage Leukemia or Lymphoma|Recruiting||Phase 1/Phase 2|44|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-10 23:33:58.174001|2017-10-10 23:33:58.174001
NCT02370147|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-23|||March 2015||2015-03-01|February 2015|2015-02-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Very Brief Smoking Reduction Intervention|The Effect of Very Brief Smoking Reduction Intervention in Smokers Who Having no Intention to Quit: Study Protocol for a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|500|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-10 23:33:58.266397|2017-10-10 23:33:58.266397
NCT02370134|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-02-23|||February 2015||2015-02-01|February 2015|2015-02-01|May 2017|Anticipated|2017-05-01|January 2016|Anticipated|2016-01-01||Interventional|||Development of Parkinson's Glove for Detection and Suppression of Hand Tremor|Development of Parkinson's Glove for Detection and Suppression of Hand Tremor at Rest Among the Tremor-predominant Parkinson's Disease Patients With Medically Intractable Tremor|Unknown status|Not yet recruiting|Phase 1|50|Anticipated|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 23:33:58.352675|2017-10-10 23:33:58.352675
NCT02370121|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-06-10|2016-03-27||February 2013||2013-02-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Gymnema Sylvestre on Metabolic Syndrome and Insulin|Effect of Gymnema Sylvestre Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion|Completed||Phase 2|24|Actual|University of Guadalajara||2|||f||||t||||||||Undecided||2017-10-10 23:33:58.490004|2017-10-10 23:33:58.490004
NCT02370108|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-23|||February 2015||2015-02-01|February 2015|2015-02-01|May 2017|Anticipated|2017-05-01|January 2016|Anticipated|2016-01-01||Interventional|||The Study of Rest Tremor Suppression by Using Electrical Muscle Stimulation|The Study of Rest Tremor Suppression by Using Electrical Muscle Stimulation|Unknown status|Not yet recruiting|Phase 1|60|Anticipated|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 23:33:59.485026|2017-10-10 23:33:59.485026
NCT02370095|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-04-17|||February 2015||2015-02-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Treprostinil Sodium Inhalation for Patients At High Risk for ARDS|Treprostinil Sodium Inhalation for Patients At High Risk for ARDS: Effect on Oxygenation and Disease-related Biomarkers|Recruiting||Phase 2|30|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 23:33:59.562745|2017-10-10 23:33:59.562745
NCT02370082|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-03-05|||February 2015||2015-02-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||SAVI SCOUT Clinical Evaluation Study|A Prospective, Single-Arm, Multi-Site, Clinical Evaluation of the SAVI SCOUT® Surgical Guidance System for the Location of Non-Palpable Breast Lesions During Excision|Unknown status|Enrolling by invitation|N/A|150|Anticipated|Cianna Medical, Inc.||1|||f||||f||||||||||2017-10-10 23:33:59.666375|2017-10-10 23:33:59.666375
NCT02370069|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-07-10|||June 2015||2015-06-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13|The Effect of Previous Pneumococcal Immunization on the Immune Response of Adult Patients With Severe Chronic Kidney Disease to Prevnar 13|Recruiting||Phase 4|138|Anticipated|Lakehead University||2|||f||||f||||||||||2017-10-10 23:33:59.725439|2017-10-10 23:33:59.725439
NCT02370056|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-04-01|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|3Dvs2DforUC||Evaluation of 3D Visualization for Total Colectomy|Comparative Assessment of Three-dimensional vs. Conventional Laparoscopy in a Total Colectomy Model for Ulcerative Colitis|Recruiting||N/A|54|Anticipated|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-10 23:33:59.803462|2017-10-10 23:33:59.803462
NCT02370030|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-08-26|||November 2014||2014-11-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|CITRUSEP||Effect of Citrulline on the Clinical and Biochemical Evolution of Patients With Sepsis.|Controlled Randomized Multi-centric Clinical Trial on the Effect of Citrulline on the Clinical and Biochemical Evolution of Patients With Sepsis.|Unknown status|Recruiting|Phase 1/Phase 2|160|Anticipated|Instituto Mexicano del Seguro Social||2|||f||||f||||||||||2017-10-10 23:33:59.975014|2017-10-10 23:33:59.975014
NCT02370017|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2017-02-01|||February 2015||2015-02-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|August 2018|Anticipated|2018-08-01||Interventional|ANKL-2||Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment|Combined Effect of Autologous Ex-vivo Expanded Activated NK Cell-lymphocytes (ANKL) and Doublet Chemotherapy in Patients With Advanced NSCLC as the 1st Line Treatment; Phase II|Recruiting||Phase 2|68|Anticipated|The Catholic University of Korea||1|||f||||t||||||||||2017-10-10 23:34:00.081154|2017-10-10 23:34:00.081154
NCT02369991|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-05-12|||June 2014||2014-06-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01|5 Years|Observational [Patient Registry]|||Treatment of Compound Tibia Fracture With a Microvascular Latissimus Dorsi Flap and the Ilizarov Technique|Treatment of Compound Tibia Fracture With a Microvascular Latissimus Dorsi Flap and the Ilizarov Technique: a Cross-sectional Study of Long-term Outcomes|Completed||N/A|9|Actual|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-10 23:34:00.226101|2017-10-10 23:34:00.226101
NCT02369978|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-07-18|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|CHICAMOCHA-3||CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)|Cardiovascular Health Investigation and Collaboration From Countries of America to Assess the Markers and Outcomes of Chagas Disease (CHICAMOCHA-3) - EQUITY (Equivalence of Usual Interventions for Trypanosomiasis)|Recruiting||Phase 2/Phase 3|500|Anticipated|Universidad Autónoma de Bucaramanga||3|||f||||f||||||||||2017-10-10 23:34:00.291083|2017-10-10 23:34:00.291083
NCT02369965|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2015-02-18|||January 2014||2014-01-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|TALENT||Test Albuvirtide in Experienced Patients|Efficacy and Safety of Albuvirtide Plus Lopinavir-ritonavir in HIV-1-infected Adults Failed Standard First-line ART Regimen|Unknown status|Recruiting|Phase 3|420|Anticipated|Frontier Biotechnologies Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:34:00.387664|2017-10-10 23:34:00.387664
NCT02369939|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-08-09|||December 2014||2014-12-01|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|December 2017|Anticipated|2017-12-01||Interventional|HYCAN||Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy|Randomized Trial to Evaluate Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy|Recruiting||Phase 3|118|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-10 23:34:00.597803|2017-10-10 23:34:00.597803
NCT02363088|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-06-29|||February 2015||2015-02-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Can Text Reminders Improve Uptake of Cervical Screening?|Can Text Reminders Improve Uptake of Cervical Screening? A RCT.|Completed||N/A|14597|Actual|Imperial College Healthcare NHS Trust||9|||f||||f||||||||No||2017-10-10 23:35:17.178577|2017-10-10 23:35:17.178577
NCT02369913|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-04-24|||March 2017|Anticipated|2017-03-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||A Metabolomic Approach to Probing Myocardial Fuel Shifts in Human Heart Failure|A Metabolomic Approach to Probing Myocardial Fuel Shifts in Human Heart Failure|Withdrawn||N/A|0|Actual|University of Florida|||2|The Study has been officially closed with the IRB|f||||f||||||||||2017-10-10 23:34:00.775359|2017-10-10 23:34:00.775359
NCT02369900|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-03-03|||March 2015||2015-03-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Esmolol to Treat the Hemodynamic Effects of Septic Shock|Esmolol to Treat the Hemodynamic Effects of Septic Shock|Recruiting||Phase 2|104|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-10 23:34:00.839906|2017-10-10 23:34:00.839906
NCT02369887|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-10-19|||September 2014||2014-09-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01|12 Months|Observational [Patient Registry]|PrEP||Evaluation of a Facility-based Test, Treat, and Prevent HIV Program Among Men Who Have Sex With Men and Transgender Women in Thailand|Bureau AIDS, TB, and STI, Thailand Ministry of Public Health|Enrolling by invitation||N/A|2000|Anticipated|Thai Red Cross AIDS Research Centre|||1||f||||t||||||||||2017-10-10 23:34:00.918458|2017-10-10 23:34:00.918458
NCT02369874|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-18|2017-08-07|||September 9, 2015|Actual|2015-09-09|August 2017|2017-08-01|February 20, 2018|Anticipated|2018-02-20|February 20, 2018|Anticipated|2018-02-20||Interventional|EAGLE||Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer|A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy and MEDI4736 in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Active, not recruiting||Phase 3|736|Actual|AstraZeneca||3|||f||||t||||||||||2017-10-10 23:34:00.989799|2017-10-10 23:34:00.989799
NCT02369861|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-11-29|||March 2015||2015-03-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Study of ACCS Eye Drops in Treating Dry Eye|A Randomized, Masked, Active Placebo-controlled Phase 1 Study of Amnion-derived Cellular Cytokine Solution (ACCS) Eye Drops in the Treatment of Dry Eye|Completed||Phase 1|30|Actual|Noveome Biotherapeutics, formerly Stemnion||2|||f||||f||||||||||2017-10-10 23:34:02.911644|2017-10-10 23:34:02.911644
NCT02369835|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-05-24|||May 2015||2015-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy|A Randomized Study of Topical Dilute Hypochlorite (Modified Dakin's Solution) Treatment for the Prevention of Radiation Dermatitis in Head and Neck Cancer|Recruiting||Phase 3|170|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-10 23:34:03.091455|2017-10-10 23:34:03.091455
NCT02369822|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-23|||February 2015||2015-02-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|September 2015|Anticipated|2015-09-01||Interventional|||Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy|Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:34:03.203215|2017-10-10 23:34:03.203215
NCT02369809|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-02-26|||September 2012||2012-09-01|February 2015|2015-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|NVG-LIGHT||Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia|International Postmarketing Surveillance Study of Pl-VEGF165 Safety and Efficacy in 210 Patients With Peripheral Arterial Disease|Completed||Phase 4|210|Actual|Human Stem Cell Institute, Russia||2|||f||||f||||||||||2017-10-10 23:34:03.285544|2017-10-10 23:34:03.285544
NCT02369796|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-02-13|2016-11-01||February 2015||2015-02-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional||Safety analysis set included all participants who were enrolled and received at least 1 dose of study drug, including participants who did not complete all scheduled study visits.|A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism|An Open-Label, Phase 2a Study to Evaluate the Pharmacodynamics of Different Dosing Regimens of TAK-448, a Kisspeptin Agonist, in Male Overweight/Obese Participants With Hypogonadotropic Hypogonadism|Terminated||Phase 2|15|Actual|Takeda||5||"Sponsor decision to terminate the study because the study did not achieve the primary efficacy   objective."|f||||t||||||||||2017-10-10 23:34:03.448336|2017-10-10 23:34:03.448336
NCT02369783|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-02-25|||July 2014||2014-07-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|DEFCOCANCERO||Screening for Social Weaknesses and Coordination Course of Cancer Patients|Screening for Social Weaknesses and Coordination Course of Cancer Patients: A New Approach by an Expert System IT|Completed||N/A|71|Actual|Institut de Cancérologie de la Loire||1|||f||||f||||||||||2017-10-10 23:34:04.412075|2017-10-10 23:34:04.412075
NCT02369770|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2015-02-17|||October 2014||2014-10-01|February 2015|2015-02-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Sensory-Motor Rehabilitation Post Stroke|Sensory-Motor Rehabilitation Post Stroke|Recruiting||N/A|90|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-10 23:34:04.468626|2017-10-10 23:34:04.468626
NCT02369757|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-02-26|||October 2012||2012-10-01|November 2014|2014-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|COLONAV||Patients Navigator for Organized Colorectal Cancer Screening|Patients Navigator for Organized Colorectal Cancer Screening in Underserved Population|Completed||N/A|40774|Actual|Institut de Cancérologie de la Loire||2|||f||||f||||||||||2017-10-10 23:34:04.54883|2017-10-10 23:34:04.54883
NCT02369744|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-05-08|||March 2013||2013-03-01|May 2017|2017-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Silodosin Versus Tamsulosin for Treatment of Ureteral Stones|Comparison of Silodosin vs. Tamsulosin on Spontaneous Passage of Acutely Obstructing Ureteral Calculi in Medical Expulsive Therapy|Terminated||Phase 4|1|Actual|Albert Einstein Healthcare Network||2||due to lack of suitable patient population|f||||f||||||||No||2017-10-10 23:34:04.60716|2017-10-10 23:34:04.60716
NCT02369731|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-02-13|||April 2015||2015-04-01|February 2017|2017-02-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01|5 Years|Observational [Patient Registry]|||Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy|Long-Term Observational Study of Translarna Safety and Effectiveness in Usual Care|Recruiting||N/A|200|Anticipated|PTC Therapeutics|||1||f||||f||||||||||2017-10-10 23:34:04.702192|2017-10-10 23:34:04.702192
NCT02369718|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-02-14|||November 2014||2014-11-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Cochlear Implants : Influence of Microphone Aging and Dirtying|Consequences of Aging and Dirtying of Microphones on the Performances of Cochlear Implants. Influence of Signal Coding|Completed||N/A|81|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:34:04.858846|2017-10-10 23:34:04.858846
NCT02369705|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-07-14|||June 2015||2015-06-01|April 2016|2016-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Validation of Ambulatory Sleep Test (WP200/U) Compared In-lab Sleep Testing in Cardiac Subjects|Diagnosis of Sleep-related Respiratory Disorders in Patients With Cardiac Disorders Such as Atrial Fibrillation, Heart Failure and Other Comorbidities|Completed||N/A|200|Anticipated|Itamar-Medical, Israel|||1||f||||f||||||||||2017-10-10 23:34:04.926031|2017-10-10 23:34:04.926031
NCT02369692|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-09-10|||April 2014||2014-04-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01|30 Days|Observational [Patient Registry]|||Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System|Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System|Unknown status|Recruiting|N/A|50|Anticipated|Hansen Medical|||1||f||||f||||||||||2017-10-10 23:34:05.098017|2017-10-10 23:34:05.098017
NCT02369679|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-04-05|||October 13, 2014|Actual|2014-10-13|April 2017|2017-04-01|April 5, 2017|Actual|2017-04-05|January 19, 2016|Actual|2016-01-19||Interventional|||Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema|Comparison of the Effectiveness of a Precast Adjustable Compression Wrap With the Multilayer Compression Bandage in Upper Limb Lymphedema|Completed||N/A|47|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-10 23:34:05.179062|2017-10-10 23:34:05.179062
NCT02369666|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-07-15|||November 2014||2014-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||LycoRed 40051 Product as a Countermeasure to Exercise Stress|Effects of 4-weeks Ingestion of LycoRed 40051 Product on Exercise-Induced Inflammation, Muscle Damage, and Oxidative Stress in Endurance Runners|Completed||N/A|20|Actual|Appalachian State University||2|||f||||f||||||||||2017-10-10 23:34:05.272943|2017-10-10 23:34:05.272943
NCT02369653|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-09-14|||April 9, 2015|Actual|2015-04-09|September 2017|2017-09-01|May 28, 2020|Anticipated|2020-05-28|May 28, 2020|Anticipated|2020-05-28||Interventional|||A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Pegylated (PEG) L-Asparaginase|A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Thromboembolism Prevention Versus No Systemic Anticoagulant Prophylaxis During Induction Chemotherapy in Children With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoma (T or B Cell) Treated With Pegylated L-Asparaginase|Recruiting||Phase 3|500|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 23:34:05.378493|2017-10-10 23:34:05.378493
NCT02369640|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-10-26|||February 2015||2015-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Learning From Errors During Simulation-based Ultrasound Training|Learning From Errors During Simulation-based Ultrasound Training|Completed||N/A|60|Actual|Rigshospitalet, Denmark||2|||f||||||||||||||2017-10-10 23:34:05.663818|2017-10-10 23:34:05.663818
NCT02369614|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-02-17|||August 2014||2014-08-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Low -vs- High-Frequency Repetitive TMS of the Right Dorsolateral Prefrontal Cortex in PTSD|Low-Frequency Versus High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in Posttraumatic Stress Disorder|Unknown status|Enrolling by invitation|N/A|268|Anticipated|United States Naval Medical Center, San Diego||4|||f||||f||||||||||2017-10-10 23:34:05.800641|2017-10-10 23:34:05.800641
NCT02369601|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-09-28|||August 2015||2015-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|(PROMComplete||PROMComplete for Determination of Rupture of Fetal Membranes|Clinical Evaluation of PRO-MComplete as an Aid in Determination of Rupture of Fetal Membranes|Recruiting||N/A|600|Anticipated|Pro-Lab Diagnostics|||1||f||||f||||||||||2017-10-10 23:34:05.891482|2017-10-10 23:34:05.891482
NCT02369588|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-02-17|||March 2013||2013-03-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Portion Size of Multiple Items at a Meal on Food Intake of Adults||Completed||N/A|51|Actual|Penn State University||4|||f||||f||||||||||2017-10-10 23:34:06.007231|2017-10-10 23:34:06.007231
NCT02369575|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-01-18|||February 2015||2015-02-01|January 2017|2017-01-01|February 2030|Anticipated|2030-02-01|February 2020|Anticipated|2020-02-01||Observational|||Identification of Novel Markers of Human Lung Disease|Identification of Novel Markers of Human Lung Disease|Recruiting||N/A|100|Anticipated|Ohio State University|||1||f||||f||||||Samples With DNA|"     lung cells   "|||2017-10-10 23:34:06.083117|2017-10-10 23:34:06.083117
NCT02369562|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-03-21|||September 2014||2014-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2015|Actual|2015-09-01||Observational|||A Retrospective Analysis of Failures of Oral Implants|A Retrospective Analysis of Failures/Complications With Oral Implants|Enrolling by invitation||N/A|1200|Anticipated|Malmö University|||1||f||||f||||||||No||2017-10-10 23:34:06.169827|2017-10-10 23:34:06.169827
NCT02369549|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-03-20|||September 2015||2015-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|MPAC-CKD||Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease|Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease|Recruiting||Phase 3|750|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||No||2017-10-10 23:34:06.253347|2017-10-10 23:34:06.253347
NCT02369536|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-07-12|||September 2015||2015-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|NUTRAFAST||Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)|Clinical Trial on the Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)|Recruiting||N/A|150|Anticipated|Neuromed IRCCS||2|||f||||f||||||||No||2017-10-10 23:34:06.361501|2017-10-10 23:34:06.361501
NCT02369523|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-08-30|||September 2014||2014-09-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Multimodal Pain Management Following Primary TKA|Periarticular Infusion With Liposomal Bupivacaine or a Ropivacaine Cocktail Versus Continuous Femoral Nerve Catheters for Multimodal Pain Management Following Primary TKA: A Randomized Controlled Trial|Terminated||Early Phase 1|84|Actual|University of Utah||3||Adequate enrollment was not reached for this study.|f||||t||||||||||2017-10-10 23:34:06.465801|2017-10-10 23:34:06.465801
NCT02369510|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-08-28|2017-05-01||February 2015||2015-02-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Does the Addition of Epinephrine Prolong the Duration of Spinal Anesthesia for Repeat Cesarean Section?|Does the Addition of Epinephrine Increase the Duration of Intrathecal Hyperbaric Bupivacaine for Repeat Cesarean Section?|Completed||Phase 4|68|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||f||||||||||2017-10-10 23:34:06.564226|2017-10-10 23:34:06.564226
NCT02369497|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-02-17|||December 2007||2007-12-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|HRA||Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study|Ascension® Humeral Resurfacing Arthroplasty HRA Follow-Up Study|Terminated||N/A|59|Actual|Integra LifeSciences Corporation|||1|PI left institution and site did not have resources to continue study|f||||f||||||||||2017-10-10 23:34:07.062681|2017-10-10 23:34:07.062681
NCT02369484|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-01-03|||June 2015||2015-06-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|NICHE||Afatinib in NSCLC With HER2 Mutation|Afatinib in Pretreated Patients With Advanced NSCLC Harbouring HER2 Exon 20 Mutations|Suspended||Phase 2|22|Anticipated|European Thoracic Oncology Platform||1||"Interim analysis showed that fewer pts than anticipated profited from trial treatment. No   safety concerns led to decision to close accrual."|f||||t||||||||No||2017-10-10 23:34:07.200877|2017-10-10 23:34:07.200877
NCT02369471|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-06-02|||March 2015||2015-03-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||A Study of GWP42006 in People With Focal Seizures - Part A|A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.|Completed||Phase 2|32|Actual|GW Research Ltd||6|||f||||t||||||||||2017-10-10 23:34:07.306627|2017-10-10 23:34:07.306627
NCT02369458|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-05-18|||April 14, 2015|Actual|2015-04-14|May 2017|2017-05-01|February 28, 2019|Anticipated|2019-02-28|October 31, 2018|Anticipated|2018-10-31||Interventional|||Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Platin, 5-FU, Cetuximab, and Taxane|Phase II Trial of Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Platin, 5-FU, Cetuximab, and Taxane|Recruiting||Phase 2|70|Anticipated|Washington University School of Medicine||2|||f||||t|t|f|||f|||No||2017-10-10 23:34:07.413815|2017-10-10 23:34:07.413815
NCT02369419|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-11-30|||January 2013||2013-01-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|FRAILTY||Frailty Score Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy|Frailty Score Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy|Completed||N/A|150|Actual|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||||||2017-10-10 23:34:07.72643|2017-10-10 23:34:07.72643
NCT02369406|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-03-13|||February 2015||2015-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|EIT||Early Infant HIV Treatment in Botswana|BHP Early Infant Treatment Study: A Clinical Treatment Trial of HIV+ Infants in Botswana|Recruiting||Phase 2/Phase 3|70|Anticipated|Harvard School of Public Health||3|||f||||t||||||||||2017-10-10 23:34:07.810861|2017-10-10 23:34:07.810861
NCT02369393|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-05-17|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|PROMETEOII||Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical Activity|Treatment of Depression: Efficacy and Efficiency of Two Self-administered Online Intervention Protocols Based on Behavioral Activation and Physical Activity|Not yet recruiting||N/A|300|Anticipated|Universitat Jaume I||3|||f||||t|f|f||||||||2017-10-10 23:34:07.975067|2017-10-10 23:34:07.975067
NCT02369380|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-11-09|||November 2014||2014-11-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ELFE||Volume Restoration of Plantar Pad With a Hyaluronic Acid Dermal Filler in Metatarsalgia|Volume Restoration of Plantar Pad With a Hyaluronic Acid Dermal Filler in Treatment of Metatarsalgia of Forefeet Further Use of High Heel Shoes|Completed||N/A|15|Actual|Galderma||1|||f||||f||||||||||2017-10-10 23:34:08.118571|2017-10-10 23:34:08.118571
NCT02369367|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-02-23|||April 2008||2008-04-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme (Phase II)|Phase II Trial of Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Original study did not progress to Phase 2.|f||||f||||||||||2017-10-10 23:34:08.193427|2017-10-10 23:34:08.193427
NCT02369354|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-06-22|||September 2015|Actual|2015-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TALKS||Transplant Social Worker Support for Live Kidney Donation in African Americans|Transplant Social Worker Support for Live Kidney Donation in African Americans|Recruiting||N/A|570|Anticipated|Duke University||3|||f||||t||||||||||2017-10-10 23:34:08.283922|2017-10-10 23:34:08.283922
NCT02369328|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-08-23|||February 2015||2015-02-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Multimodal MRI Study of Ischemic Stroke|Multimodal MRI Study of Ischemic Stroke|Recruiting||N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:34:09.513425|2017-10-10 23:34:09.513425
NCT02369315|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2016-12-06|||February 2012||2012-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Randomized Trial of the Effects of Musical Training on Child Development in the Venezuela Orchestra Program (El Sistema)|Design of a Multi-site Cluster Randomized Trial to Study the Effects of Musical Training on Child Development in the National System of Child and Youth Orchestras in Venezuela (El Sistema)|Completed||N/A|2914|Actual|Inter-American Development Bank||2|||f||||f||||||||No||2017-10-10 23:34:09.573556|2017-10-10 23:34:09.573556
NCT02369302|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-02-27|||January 2015||2015-01-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers|An Open-label, Randomized, 6-Sequence, 3-Period Crossover Study to Evaluate a Drug Interaction Between DWC20141 and DWC20142 in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Daewoong Pharmaceutical Co. LTD.||3|||f||||f||||||||||2017-10-10 23:34:09.645515|2017-10-10 23:34:09.645515
NCT02369289|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-02-16|||March 2015||2015-03-01|February 2015|2015-02-01||||February 2016|Anticipated|2016-02-01||Observational|||Bone Mineral Density in Israeli Female Vegans and Omnivores|Bone Mineral Density in Israeli Female Vegans and Omnivores|Unknown status|Not yet recruiting|N/A|240|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||f||||||||||2017-10-10 23:34:09.711366|2017-10-10 23:34:09.711366
NCT02369276|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-02-01|||April 2015||2015-04-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Safety Study of Musculoskeletal Ultrasonographic to Assess Disabilities Arm of Head and Neck Cancer Patient|Musculoskeletal Ultrasonographic Assessment for the Soft Tissue Injury of Ipsilateral Shoulder of Head and Neck Cancer Patient Following Selective Neck Dissection|Recruiting||N/A|100|Anticipated|Chang Gung Memorial Hospital|||5||f||||t||||||||No|No result now.|2017-10-10 23:34:09.769222|2017-10-10 23:34:09.769222
NCT02369263|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-02-17|||May 2013||2013-05-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Observational|||DVT Ultrasound in the Emergency Department|An Observational Study of Emergency Medicine Resident Performed Ultrasonography for DVT.|Completed||N/A|288|Actual|Emergency Medicine Physicians, Nevada|||1||f||||f||||||||||2017-10-10 23:34:09.870852|2017-10-10 23:34:09.870852
NCT02369250|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-02-17|||November 2013||2013-11-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Rosuvastatin Gel With 1:1 Mixture of Platelet-rich Fibrin and Bone Graft in Mandibular Degree II Furcation Defects|Rosuvastatin 1.2mg in Situ Gel Combined With 1:1 Mixture of Autologous Platelet-rich Fibrin and Porus- Hydroxyappatite Bone Graft in Surgical Treatment of Mandibular Degree II Furcation Defects: A Randomized Clinical Control Trial|Completed||Phase 4|110|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||t||||||||||2017-10-10 23:34:09.931774|2017-10-10 23:34:09.931774
NCT02369237|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-02-17|||April 2012||2012-04-01|February 2012|2012-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Non-invasive Determination of Anemia in Children With Renal Failure|A Non-invasive Device to Determine Iron Deficiency Anemia in Children of Different Age Groups With Renal Failure|Completed||N/A|54|Actual|Center for Studies of Sensory Impairment, Aging and Metabolism|||1||f||||||||||||||2017-10-10 23:34:10.13057|2017-10-10 23:34:10.13057
NCT02369224|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-01-31|||January 2015||2015-01-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|EMST-LE||Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics|Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics|Completed||N/A|27|Actual|Brown, Theodore R., M.D., MPH|||1||f||||f||||||||||2017-10-10 23:34:10.187727|2017-10-10 23:34:10.187727
NCT02369211|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-01-10|||September 2015||2015-09-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)|Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV) in Patients Undergoing Robotic-assisted Laparoscopic Prostatectomy|Recruiting||Phase 4|80|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 23:34:10.275805|2017-10-10 23:34:10.275805
NCT02369198|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-04-05|||September 2014||2014-09-01|April 2017|2017-04-01|January 4, 2017|Actual|2017-01-04|January 4, 2017|Actual|2017-01-04||Interventional|||MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC|MesomiR 1: A Phase I Study of Intravenously Administered Epidermal Growth Factor Receptor -Targeted, EnGeneIC Delivery Vehicle (EDV)-Packaged, miR-16 Mimic (TargomiRs) for Patients With Malignant Pleural Mesothelioma (MPM) and Advanced Non-Small Cell Lung Cancer (NSCLC) Failing on Std Therapy|Completed||Phase 1|27|Actual|Asbestos Diseases Research Foundation||1|||f||||t||||||||||2017-10-10 23:34:10.377374|2017-10-10 23:34:10.377374
NCT02369172|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-08-17|||February 2015||2015-02-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Drug-Drug Interaction Study: ASP2151 and Bupropion|A Single-centre, Open-label Study in Healthy Men to Investigate the Effect of Repeated Oral Doses of ASP2151 on the Pharmacokinetics of Bupropion|Completed||Phase 1|24|Actual|Maruho Europe Limited||1|||f||||f||||||||||2017-10-10 23:34:10.489714|2017-10-10 23:34:10.489714
NCT02369159|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-01-30|||February 2015||2015-02-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza|A Phase 3, Randomized, Open Label, Active-controlled Study to Evaluate the Safety, Pharmacokinetics and Effectiveness of IV Peramivir Compared to Oral Oseltamivir in Pediatric Subjects With Acute Uncomplicated Influenza|Recruiting||Phase 3|140|Anticipated|BioCryst Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:34:10.604714|2017-10-10 23:34:10.604714
NCT02369146|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-08-02|||June 2015||2015-06-01|May 2016|2016-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults|A Phase II, Open-label, Multiple-dose Trial to Investigate the Safety and Efficacy of UB-421 Monotherapy in Substitution for Stable Antiretroviral Therapy in HIV Infected Adults|Completed||Phase 2|28|Actual|United BioPharma||2|||f||||t||||||||||2017-10-10 23:34:10.745108|2017-10-10 23:34:10.745108
NCT02369133|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-02-20|||November 2013||2013-11-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|||Preemptive Analgesia With Intravenous Paracetamol for Post-cesarean Section Pain Control|Preemptive Analgesia With Intravenous Paracetamol for Post-cesarean Section Pain Control : A Randomized Controlled Trial|Completed||Phase 4|60|Actual|Baskent University||2|||f||||t||||||||||2017-10-10 23:34:10.847675|2017-10-10 23:34:10.847675
NCT02369120|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-12-08|||January 2015||2015-01-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Influence of a Biopsychosocial Educational Internet-based Intervention in Chronic Low Back Pain Patients: A Mixed Methods Approach|The Influence of a Biopsychosocial Educational Internet-based Intervention on Pain, Dysfunction, Quality of Life, and Pain Cognition in Chronic Low Back Pain Patients in Primary Care: a Mixed Methods Approach|Recruiting||N/A|60|Anticipated|Universitat de Lleida||2|||f||||||||||||||2017-10-10 23:34:10.924834|2017-10-10 23:34:10.924834
NCT02369107|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-02-17|||February 2015||2015-02-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting|A Multi-center,Randomized Controlled Clinical Trial: the Effect of Acupuncture in Prevention and Treatment of Chemotherapy-induced Nausea and Vomiting on Patients With Malignancy|Unknown status|Not yet recruiting|N/A|136|Anticipated|Beijing Hospital of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-10 23:34:11.03144|2017-10-10 23:34:11.03144
NCT02369094|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-07-13|||December 2014||2014-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||A Study on Effects of Acupressure Among the Frail Elderly in the Community Dwellings|A Study on Effects of Acupressure Among the Frail Elderly in the Social Centers for the Elderly and Neighbourhood Elderly Centers of Yan Chai Hospital, Social Services Department (YCHSS)|Completed||N/A|106|Actual|The University of Hong Kong||2|||f||||t||||||||Undecided||2017-10-10 23:34:11.12884|2017-10-10 23:34:11.12884
NCT02369081|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-07-01|||May 2009||2009-05-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|PATHWAY2||Optimum Treatment for Drug-Resistant Hypertension|Optimum Treatment for Drug-Resistant Hypertension|Unknown status|Active, not recruiting|Phase 4|348|Actual|University of Cambridge||4|||f||||f||||||||||2017-10-10 23:34:11.236326|2017-10-10 23:34:11.236326
NCT02369068|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-09-15|||August 2015||2015-08-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain|A Double-Blind, Randomized Study to Compare Onabotulinumtoxin A Versus Kenalog for Intravaginal Trigger Point Injections in the Treatment of Chronic Pelvic Pain|Recruiting||N/A|40|Anticipated|William Beaumont Hospitals||2|||f||||f||||||||||2017-10-10 23:34:11.416228|2017-10-10 23:34:11.416228
NCT02369055|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-02-21|||March 2014|Actual|2014-03-01|January 2017|2017-01-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30|12 Months|Observational [Patient Registry]|||Quality of Life and Rehabilitation Pathway in Northern Norway and Denmark.|Relationship Between Quality of Life and Rehabilitation Pathway One Year Post Stroke in Northern Norway and Denmark. A Mixed Method Study.|Active, not recruiting||N/A|500|Anticipated|University Hospital of North Norway|||1||f||||f||||||||||2017-10-10 23:34:11.537407|2017-10-10 23:34:11.537407
NCT02369042|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-07-18|||October 2014||2014-10-01|February 2015|2015-02-01|April 19, 2017|Actual|2017-04-19|March 20, 2016|Actual|2016-03-20||Interventional|Ease||KYMA Device: External Measure of Thoracic Fluid and Vital Signs|KYMA Device: External Measure of Thoracic Fluid and Vital Signs|Completed||N/A|17|Actual|The Christ Hospital||2|||f||||t||||||||||2017-10-10 23:34:11.612424|2017-10-10 23:34:11.612424
NCT02369029|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2016-03-07|||March 2015||2015-03-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||BAY1238097, First in Man|An Open-label, Non-randomized, Multicenter Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY 1238097 in Subjects With Advanced Malignancies|Terminated||Phase 1|8|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:34:11.707849|2017-10-10 23:34:11.707849
NCT02369016|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-09-03|||September 22, 2015|Actual|2015-09-22|September 2017|2017-09-01|May 7, 2018|Anticipated|2018-05-07|May 7, 2018|Anticipated|2018-05-07||Interventional|CHRONOS-2||Phase III Copanlisib in Rituximab-refractory iNHL|A Randomized, Double-blind Phase III Study of Copanlisib Versus Placebo in Patients With Rituximab-refractory Indolent Non-Hodgkin's Lymphoma (iNHL) - CHRONOS-2|Active, not recruiting||Phase 3|25|Actual|Bayer||1|||f||||t|t|f||||||||2017-10-10 23:34:11.846791|2017-10-10 23:34:11.846791
NCT02369003|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-03-08|||February 2015||2015-02-01|March 2016|2016-03-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|APNG2||Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS|Continuation of a Pilot Study to Evaluate the Safety and Feasibility of Implanting Autologous Peripheral Nerve Grafts in Subjects With Parkinson's Disease Undergoing Deep Brain Stimulation Surgery and Treatment|Enrolling by invitation||Phase 1|24|Anticipated|University of Kentucky||1|||f||||f||||||||||2017-10-10 23:34:12.221799|2017-10-10 23:34:12.221799
NCT02368990|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-07-06|||June 2015||2015-06-01|July 2015|2015-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|T-STAR||T790M Mutation Positive 2nd Line STandard of cAre Registry|T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry|Withdrawn||N/A|0|Actual|AstraZeneca|||1|"Since the conception of the study, the competitive environment has developed and as a result   this study is no longer able to generate the necessary information."|f||||f||||||||||2017-10-10 23:34:12.329153|2017-10-10 23:34:12.329153
NCT02368977|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-06-26|||November 12, 2013|Actual|2013-11-12|June 2017|2017-06-01|October 11, 2017|Anticipated|2017-10-11|October 11, 2017|Anticipated|2017-10-11||Interventional|||Third Eye Panoramic Device Feasibility Evaluation|Third Eye Panoramic Device Feasibility Evaluation|Enrolling by invitation||N/A|40|Anticipated|Avantis Medical Systems||1|||f||||f||||||||No||2017-10-10 23:34:12.508643|2017-10-10 23:34:12.508643
NCT02368964|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-06-17|||February 2015||2015-02-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||IVF Treatment in Women With Immature Oocytes in Previous Cycle|Treatment for Final Follicular Maturation Induction in Patients With Previous High Ratio of Immature Oocytes|Recruiting||N/A|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:34:12.58303|2017-10-10 23:34:12.58303
NCT02368951|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-07-10|||March 24, 2015|Actual|2015-03-24|July 2017|2017-07-01|July 27, 2016|Actual|2016-07-27|July 27, 2016|Actual|2016-07-27||Interventional|||Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)|An Open-label,Phase I, Dose-escalation Trial to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Pharmacokinetic, and Pharmacodynamics of the Anti-FGFR2 Antibody Drug Conjugate BAY1187982 in Subjects With Advanced Solid Tumors Known to Express FGFR2.|Terminated||Phase 1|20|Actual|Bayer||1|||f||||f|t|f||||||||2017-10-10 23:34:12.760651|2017-10-10 23:34:12.760651
NCT02368938|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-02-20|||August 2014||2014-08-01|February 2015|2015-02-01||||September 2017|Anticipated|2017-09-01||Observational|NSS||Prognosis in the Elderly Chinese: the Northern Shanghai Study|Prognosis Factors of Mortality and Cardiovascular Diseases in the Elderly Chinese: the Northern Shanghai Study|Unknown status|Enrolling by invitation|N/A|5000|Anticipated|Shanghai 10th People's Hospital|||1||f||||f||||||Samples With DNA|"     Pasting venous blood sample and urine sample were collected for each participant.   "|||2017-10-10 23:34:12.856767|2017-10-10 23:34:12.856767
NCT02368925|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-04-14|||March 2015||2015-03-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Clinical Trial to Evaluate Safety and Efficacy of Ultherapy™ System for Lifting Skin on the Neck|Clinical Trial to Evaluate Safety and Efficacy of Ultherapy™ System for Lifting Skin|Completed||N/A|18|Actual|Seoul National University Hospital||1|||f||||f||||||||No||2017-10-10 23:34:12.910548|2017-10-10 23:34:12.910548
NCT02368912|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-02-17|||June 2010||2010-06-01|February 2015|2015-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in Healthy Male and Pre-menopausal Female Subjects, Including a Comparison of the Effects Under Fasted and Fed Conditions in Healthy Young Male Subjects|A Double Blind, Randomized, Placebo-controlled, Ascending Single and Multiple Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1707 in Healthy Young and Elderly Male Subjects and in Healthy Pre-menopausal Female Subjects Including an Open-label Comparison of Pharmacokinetics Under Fasted and Fed Conditions in Healthy Young Male Subjects|Completed||Phase 1|176|Actual|Astellas Pharma Inc||10|||f||||f||||||||||2017-10-10 23:34:12.979446|2017-10-10 23:34:12.979446
NCT02368899|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2017-05-08|||November 2016||2016-11-01|May 2017|2017-05-01|April 17, 2017|Actual|2017-04-17|April 17, 2017|Actual|2017-04-17||Interventional|CAMI||Computerized Alcohol Misuse Intervention System for Health Care|Micro-targeted Computerized Alcohol Misuse Intervention System for Health Care|Completed||N/A|61|Actual|Research Circle Associates, LLC||2|||f||||f||||||||No||2017-10-10 23:34:13.091687|2017-10-10 23:34:13.091687
NCT02368886|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-07-11|||March 2015||2015-03-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer|Regorafenib Dose Optimization Study (ReDOS): A Phase II Randomized Study of Lower Dose Regorafenib Compared to Standard Dose Regorafenib in Patients With Refractory Metastatic Colorectal Cancer (mCRC)|Active, not recruiting||Phase 2|123|Actual|Academic and Community Cancer Research United||4|||f||||t||||||||||2017-10-10 23:34:13.177359|2017-10-10 23:34:13.177359
NCT02368873|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-02-20|||January 2010||2010-01-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||the Use of a IPOM Mesh for Prevention of Parastomal Hernia|Prospective, Randomized Study on the Use of a Intraperitoneal Onlay Mesh for Prevention of Parastomal Hernia of Permanent Colostomy|Completed||N/A|74|Actual|Oulu University Hospital||2|||f||||f||||||||||2017-10-10 23:34:13.42324|2017-10-10 23:34:13.42324
NCT02368860|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-03-21|||September 2013||2013-09-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|OXIRI||OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma|Phase I Trial of OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] Treatment in Patients With Advanced and/or Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 1|28|Anticipated|National Cancer Centre, Singapore||1|||f||||f||||||||||2017-10-10 23:34:13.503817|2017-10-10 23:34:13.503817
NCT02368847|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-17|||March 2015||2015-03-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|UTI_UCP||Urinary Tract Infections in Older Persons Admitted to a Psychogeriatric Ward|Optimizing and Validating the Clinical Algorithm for Diagnosing Urinary Tract Infections in Older Persons Admitted to a Psychogeriatric Ward|Unknown status|Not yet recruiting|N/A|120|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-10 23:34:13.606286|2017-10-10 23:34:13.606286
NCT02368834|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-04-27|||August 2014||2014-08-01|April 2015|2015-04-01||||April 2015|Actual|2015-04-01||Interventional|||Psychoeducation for the Parents of Attention Deficit Hyperactivity Disorder (ADHD) Children|Evaluation of a Psychoeducation Program for the Parents of Attention Deficit Hyperactivity Disorder|Completed||N/A|89|Actual|Peking University||2|||f||||t||||||||||2017-10-10 23:34:13.70319|2017-10-10 23:34:13.70319
NCT02368821|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-02-22|||March 2015||2015-03-01|January 2015|2015-01-01||||January 2017|Anticipated|2017-01-01||Observational|||From Cytotrophoblast to Syncytiotrophoblast|From Cytotrophoblast to Syncytiotrophoblast - Telomere Length, Aggregate Formation and Senescence in Placenta From Complicated Pregnancies Compare to Placenta From Normal Pregnancies.|Unknown status|Not yet recruiting|N/A|300|Anticipated|Meir Medical Center|||2||f||||t||||||Samples Without DNA|"     paraffin blocks placenta cell cultures   "|||2017-10-10 23:34:13.792288|2017-10-10 23:34:13.792288
NCT02368808|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-03-10|||January 2015||2015-01-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Adolescent Bereavement Initiative in the Free State, South Africa|Coping With Loss: A Bereavement Initiative for Adolescent Girls in the Free State, South Africa|Completed||N/A|843|Actual|Tulane University||2|||f||||f||||||||Undecided||2017-10-10 23:34:13.86584|2017-10-10 23:34:13.86584
NCT02368795|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-11-05|||February 2015||2015-02-01|November 2015|2015-11-01||||January 2017|Anticipated|2017-01-01||Interventional|||Non-inferiority of Pharmacological Prevention Alone Versus Pancreatic Stents to Prevent Post-ERCP Pancreatitis|Non-inferiority Trial Comparing Pharmacological Prevention Alone Versus Pancreatic Stents Plus Pharmacological Prevention to Prevent Post-ERCP Pancreatitis|Recruiting||N/A|400|Anticipated|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:34:13.95861|2017-10-10 23:34:13.95861
NCT02368782|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-02-15|||December 2013||2013-12-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|OAE||Effects of Ketamine and Propofol in Otoacoustic Emissions (OAE) in Children|Effects of Ketamine and Propofol in Otoacoustic Emissions (OAE) in Children With Normal Hearing Tests Undergoing Adenoidectomy and Tonsillectomy|Completed||N/A|30|Actual|Istanbul University|||2||f||||t||||||||||2017-10-10 23:34:14.067338|2017-10-10 23:34:14.067338
NCT02368769|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-12-08|||January 2013||2013-01-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|Télé-extempo||Assessment of Tele-expertise for Frozen Section Diagnosis|Multidimensional Assessment of Tele-expertise for Frozen Section Diagnosis|Completed||N/A|253|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     Tissue   "|||2017-10-10 23:34:14.164464|2017-10-10 23:34:14.164464
NCT02368756|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-06-21|||December 2014||2014-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial (The Endurance 2 Trial)|Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial (The Endurance 2 Trial)|Active, not recruiting||Phase 4|25|Anticipated|Palmetto Retina Center, LLC||1|||f||||f||||||||Undecided||2017-10-10 23:34:14.292481|2017-10-10 23:34:14.292481
NCT02368730|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-06-01|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|RAPID||Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures|Documentation of the Efficacy of Desmopressin (MINIRIN Parenteral 4 Microgram/ml Solution for Injection) Within the Context of Surgical Procedures|Completed||N/A|23|Actual|Ferring Pharmaceuticals|||1||f||||||||||||||2017-10-10 23:34:14.486895|2017-10-10 23:34:14.486895
NCT02368704|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-04-15|||November 2012||2012-11-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|GLUCOSTRESS||Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes|Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes|Active, not recruiting||N/A|40|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     blood samples. These samples will be anonymized, frozen and stored in the INSERM UMR-S 872 in     the Cordeliers Research Center (Madame Fabienne Foufelle) under the responsibility of     Professor Jean-François Gautier for a maximum period of 15 years, beyond which they will be     destroyed. These samples will be destroyed at any time at the request of the patient. This     DNA storage will be used to study genes related to the secretion of insulin and to identify     other genes involved in the onset of diabetes.   "|||2017-10-10 23:34:14.69615|2017-10-10 23:34:14.69615
NCT02368691|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-25|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|September 22, 2017|Actual|2017-09-22|September 22, 2017|Actual|2017-09-22||Interventional|||Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)|A Phase 2 Open Label, Multi-Center, Multinational Study Investigating The Efficacy and Safety Of GTx-024 On Advanced, Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)|Terminated||Phase 2|55|Anticipated|GTx||1||Lack of Efficacy|f||||t||||||||||2017-10-10 23:34:14.783288|2017-10-10 23:34:14.783288
NCT02368678|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-02-20|||April 2013||2013-04-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|HACP||"Study of Halitosis in Patients With Advanced Chronic Periodontitis"|Effect Off Full Mouth Disinfection And Scaling Root Planing Per Quadrant In Halitosis in Patients With Advanced Chronic Periodontitis: Randomized Controlled Clinical Trial|Completed||N/A|30|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-10 23:34:14.902255|2017-10-10 23:34:14.902255
NCT02368665|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-02-16|||October 2014||2014-10-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy|A Randomized, Double-blind, Multi-center, Phase III Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil Combination in Patients With Essential Hypertension Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy|Unknown status|Recruiting|Phase 3|158|Anticipated|CJ HealthCare Corporation||3|||f||||f||||||||||2017-10-10 23:34:15.017118|2017-10-10 23:34:15.017118
NCT02368652|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2015-02-16|||October 2014||2014-10-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy|A Randomized, Double-blind, Multi-center, Phase III Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil Combination in Patients With Essential Hypertension Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy|Unknown status|Recruiting|Phase 3|160|Anticipated|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-10 23:34:15.154242|2017-10-10 23:34:15.154242
NCT02368639|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2017-08-09|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing|Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing|Terminated||N/A|14|Actual|Fisher and Paykel Healthcare||1||The study was terminated due to recruitment slower than anticipated|f||||f||||||||||2017-10-10 23:34:15.267016|2017-10-10 23:34:15.267016
NCT02368626|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-02-20|||March 2015||2015-03-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|||Safety and Efficacy of the EndyMed Pro System Using RF Micro-needles Fractional Skin Remodeling|Evaluation of the Safety and Efficacy of the EndyMed Pro™ System Using Radiofrequency (RF) Micro-needles Fractional Skin Remodeling Handpiece (Intensif) for Wrinkle Reduction and Lifting - a Post Marketing Study|Unknown status|Not yet recruiting|N/A|48|Anticipated|EndyMed||1|||f||||t||||||||||2017-10-10 23:34:15.324499|2017-10-10 23:34:15.324499
NCT02368613|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-10-07||||||October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients||Not yet recruiting||Phase 2|64|Anticipated|Daewon Pharmaceutical Co., Ltd.||4|||f||||||||||||||2017-10-10 23:34:15.380355|2017-10-10 23:34:15.380355
NCT02368600|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2017-02-02|||April 21, 2015|Actual|2015-04-21|February 2017|2017-02-01|December 30, 2016|Actual|2016-12-30|June 28, 2016|Actual|2016-06-28||Interventional|||Lifestyle Intervention and Prevention of Gestational Diabetes Mellitus|A Randomized Controlled Trial Examining the Effectiveness of a Lifestyle Intervention in Reducing Gestational Diabetes Mellitus in High Risk Chinese Pregnant Women in Hong Kong|Completed||N/A|220|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:34:15.525446|2017-10-10 23:34:15.525446
NCT02368587|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-20|||March 2015||2015-03-01|January 2015|2015-01-01|October 2017|Anticipated|2017-10-01|August 2016|Anticipated|2016-08-01||Interventional|WJ-ICMP Tria||Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy|Randomised, Double-blind, Placebo-controlled, Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy|Unknown status|Not yet recruiting|Phase 2|160|Anticipated|Navy General Hospital, Beijing||2|||f||||t||||||||||2017-10-10 23:34:15.595786|2017-10-10 23:34:15.595786
NCT02368574|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-02-15|||March 2015||2015-03-01|February 2015|2015-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Class II and Class III Hysterectomy in Early Stage Cervical Cancer Cervical Cancer|Comparison of Class II and Class III Hysterectomy in Early Stage Cervical Cancer Cervical Cancer|Not yet recruiting||N/A|500|Anticipated|Chinese Gynecological Oncology Group||2|||f||||t||||||||||2017-10-10 23:34:15.672003|2017-10-10 23:34:15.672003
NCT02368561|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-16|||March 2015||2015-03-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Treatment of Insertional Achilles Tendinopathy by Hyaluronic Acid Injection|A Pilot Study of the Effects of 3 Retro-calcaneal Hyalin G-F 20 Injection on the Clinical and Radiological Changes in 20 Adult Patients With Changes in Insertional Achilles Tendinopathy.|Unknown status|Not yet recruiting|Early Phase 1|20|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-10 23:34:15.73703|2017-10-10 23:34:15.73703
NCT02368548|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-02-16|||January 2012||2012-01-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Interventional|||Randomized Clinical Trial of a Pharmaceutical Care Program in Chronic Patients Users of an Emergency Department||Completed||N/A|100|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-10 23:34:15.817642|2017-10-10 23:34:15.817642
NCT02368522|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-03-03|||December 2014||2014-12-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)|Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe|Completed||N/A|920|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 23:34:15.961111|2017-10-10 23:34:15.961111
NCT02368509|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-04-18|||November 2014||2014-11-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Sensory Approach of Food Modifications Led by Chemotherapy|Sensory Approach of Food Modifications Led by Chemotherapy|Recruiting||N/A|88|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:34:16.033306|2017-10-10 23:34:16.033306
NCT02368496|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-07-20|||March 2014||2014-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|August 2015|Actual|2015-08-01||Interventional|||APOSTrophe Study (Parenteral Nutrition and Bone Trophicity) Impact of a Long-term Parenteral Nutrition on Bone Metabolism Measured by High Resolution Peripheral Quantitative Computer Tomography (HR-pQCT) in Children and Young Adults|Parenteral Nutrition and Bone Trophicity|Completed||N/A|17|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:34:16.140241|2017-10-10 23:34:16.140241
NCT02368483|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-04-25|||October 2014||2014-10-01|April 2016|2016-04-01||||October 2016|Anticipated|2016-10-01||Interventional|||Conservative Treatment in Patients With Symptomatic Femoroacetabular Impingement|The Effectiveness of Neuromuscular Training of the Lower Limb Muscles in Reducing the Hip Symptoms in Patients With Symptomatic Femoroacetabular Impingement: a Prospective Intervention Study|Recruiting||N/A|30|Anticipated|Schulthess Klinik||1|||f||||||||||||||2017-10-10 23:34:16.200274|2017-10-10 23:34:16.200274
NCT02368470|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-22|||February 2015||2015-02-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection|Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection|Unknown status|Recruiting|Phase 3|252|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 23:34:16.270798|2017-10-10 23:34:16.270798
NCT02368457|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-10-25|2016-02-18||February 2016||2016-02-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|February 2016|Actual|2016-02-01||Interventional|PENTO||Management of Mandibular ORN: PENTO as Medical Treatment|Advances in the Management of Mandibular Osteoradionecrosis: Pentoxifylline and Tocopherol as Medical Treatment|Active, not recruiting||Phase 4|24|Actual|Hospital Vall d'Hebron||2|||f||||t||||||||Undecided||2017-10-10 23:34:16.348936|2017-10-10 23:34:16.348936
NCT02368444|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-01-19|||May 2014||2014-05-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms|A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms|Completed||N/A|45|Actual|Georgetown University||1|||f||||f||||||||No||2017-10-10 23:34:16.584722|2017-10-10 23:34:16.584722
NCT02368431|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2017-04-24|||March 1, 2015|Actual|2015-03-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|||Effectiveness of Zonisamide in Alcohol Dependent Veterans|Effectiveness of Zonisamide in the Treatment of Alcohol Dependent Veterans|Recruiting||Phase 3|160|Anticipated|VA Office of Research and Development||2|||f||||t||||||||No||2017-10-10 23:34:16.653479|2017-10-10 23:34:16.653479
NCT02368418|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-02-23|||September 2014||2014-09-01|January 2016|2016-01-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Observational|CRHIFU||China Rural Health Initiative Follow up Study|China Rural Health Initiative Follow up Study|Completed||N/A|9164|Anticipated|The George Institute for Global Health, China|||4||f||||t||||||||||2017-10-10 23:34:16.738187|2017-10-10 23:34:16.738187
NCT02368405|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-02-01|||February 2015|Actual|2015-02-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Nutrition Education for Cardiovascular Disease Prevention in Spinal Cord Injury|Nutrition Education for Cardiovascular Disease Prevention in Individuals With Spinal Cord Injury|Recruiting||N/A|200|Anticipated|Carolinas Healthcare System||2|||f||||f||||||||||2017-10-10 23:34:16.816362|2017-10-10 23:34:16.816362
NCT02368392|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2016-02-16|||July 2014||2014-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|NCAS||National Cardiac Arrest Survey|National Cardiac Arrest Survey of Sri Lanka|Completed||N/A|537|Actual|Ministry of Health, Sri Lanka|||2||f||||t||||||||||2017-10-10 23:34:16.89637|2017-10-10 23:34:16.89637
NCT02368379|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-16|||March 2014||2014-03-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome|Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome|Unknown status|Recruiting|N/A|25|Anticipated|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-10 23:34:18.355752|2017-10-10 23:34:18.355752
NCT02368366|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-07-28|||November 2014||2014-11-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI|Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI|Recruiting||N/A|120|Anticipated|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-10-10 23:34:18.452809|2017-10-10 23:34:18.452809
NCT02368353|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-09-02|||February 2015||2015-02-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|START||"Stress in At Risk Mental State: Efficacy of Stress Management Cognitive Behavioral Therapy : a Randomized Controlled Trial"|Stress in At Risk Mental State: Efficacy of Stress Management Cognitive Behavioral Therapy : a Randomized Controlled Trial|Unknown status|Recruiting|N/A|120|Anticipated|Centre Hospitalier St Anne||2|||f||||f||||||||||2017-10-10 23:34:18.577577|2017-10-10 23:34:18.577577
NCT02368340|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-01-23|||March 2015||2015-03-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis|A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis|Recruiting||N/A|150|Anticipated|Vanderbilt University Medical Center|||4||f||||t||||||Samples With DNA|"     blood, urine, lymphocytes   "|||2017-10-10 23:34:18.673404|2017-10-10 23:34:18.673404
NCT02368327|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-08-07|||February 2015||2015-02-01|February 2015|2015-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Gene Expression Profiles in Muscle After Immunisation|Clinical Study to Generate Exploratory Training Set of Data on the Time Course of Gene Expression Profile at Site of Antigen Deposition Compared With Whole Blood Following IM Injection With Alum or MF59-adjuvanted Protein Subunit Vaccines|Completed||N/A|45|Anticipated|University of Surrey||3|||f||||||||||||||2017-10-10 23:34:18.77957|2017-10-10 23:34:18.77957
NCT02368314|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-08-31|2016-03-31||January 2015||2015-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Population for analysis of safety: all patient who received at least 1 study drug injection.|A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries|International Multicenter Randomized Double-blind Comparative Clinical Trial of Safety and Efficacy of BCD-080 (JSC BIOCAD, Russia) and Clexan® (Sanofi Aventis France, France) for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries|Completed||Phase 3|124|Actual|Biocad||2|||f||||f||||||||||2017-10-10 23:34:18.860365|2017-10-10 23:34:18.860365
NCT02368301|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-10-05||||||October 2016|2016-10-01||||||||Expanded Access|||Expanded Access Treatment Protocol CA204-143|An Expanded Access Program for Elotuzumab in Combination With Lenalidomide Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Approved for marketing||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-10 23:34:19.294246|2017-10-10 23:34:19.294246
NCT02368288|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2016-08-17|||January 2013||2013-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment|Efficacies of Entecavir Add on Chronic Hepatitis B Patients With HBV DNA Load ≥1000 Copies/ml After 6 Months Treatment of Peginterferon Alpha 2a|Recruiting||Phase 4|200|Anticipated|Beijing Ditan Hospital||2|||f||||f||||||||||2017-10-10 23:34:19.424817|2017-10-10 23:34:19.424817
NCT02287545|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-08-20|||February 2013||2013-02-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|TE-biomech||Biomechanical Changes After Trabeculectomy|Corneal Biomechanical Changes Following Trabeculectomy|Completed||N/A|30|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-10-10 23:50:07.058297|2017-10-10 23:50:07.058297
NCT02368275|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-05-11|||March 1, 2017|Actual|2017-03-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Observational|||Genetic, Neurophysiological and Psychological Risk Factors for Neuropathic Pain|Role of Genetic, Neurophysiological and Psychological Factors in the Development of Postsurgical Neuropathic Pain After Breast Surgery for Cancer|Recruiting||N/A|400|Anticipated|Hospital Ambroise Paré Paris|||2||f||||f||||||Samples With DNA|"     The samples will use GWAS to detect potential genetic risk factors for neuropathic pain.     These data will be analysed in Oxford laboratory (McCarthy).   "|Undecided||2017-10-10 23:34:19.514476|2017-10-10 23:34:19.514476
NCT02368262|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-01-03|||September 2014||2014-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Observational|||Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy|Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy|Completed||N/A|79|Actual|University Hospital, Ghent|||4||f||||f||||||||||2017-10-10 23:34:19.597124|2017-10-10 23:34:19.597124
NCT02368249|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-05-02|||January 2020|Anticipated|2020-01-01|May 2017|2017-05-01|February 2025|Anticipated|2025-02-01|February 2025|Anticipated|2025-02-01||Interventional|TIROL||Does Terlipressin Improve Renal Outcome After Liver Surgery|Does Terlipressin Improve Renal Outcome After Liver Surgery - A Double-Blinded Randomized Control Trial (TIROL-Trial)|Withdrawn||Phase 2|0|Actual|University of Zurich||2||no focus on this topic|f||||t|f|f||||||||2017-10-10 23:34:19.681271|2017-10-10 23:34:19.681271
NCT02368236|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-06-21|||December 2008||2008-12-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2012|Actual|2012-02-01||Interventional|||Facilitating Risk-Appropriate Colorectal Cancer Testing - Testing the Cancer Risk Intake System (CRIS)|Facilitating Risk-Appropriate Colorectal Cancer Testing - Testing the Cancer Risk Intake System (CRIS)|Active, not recruiting||N/A|1012|Actual|University of Texas Southwestern Medical Center||3|||f||||f||||||||No||2017-10-10 23:34:19.758864|2017-10-10 23:34:19.758864
NCT02368223|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-07-23|||October 2014||2014-10-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|YouGrabber||Feasibility of the Portable YouGrabber System|Feasibility of a Home-based Interactive System for Upper Limb Therapy (YouGrabber)|Completed||N/A|15|Actual|University Children's Hospital, Zurich||1|||f||||f||||||||||2017-10-10 23:34:19.824491|2017-10-10 23:34:19.824491
NCT02368210|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-02-16||2017-02-16|January 2015||2015-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|September 2015|Actual|2015-09-01||Interventional|||A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)|A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)|Completed||Phase 3|151|Actual|Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:34:19.903871|2017-10-10 23:34:19.903871
NCT02368197|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-07-26|||July 2015||2015-07-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Drug Eluting Balloon Angioplasty for Recurrent Cephalic Arch Stenosis in Dialysis Fistulas|Prospective Randomized Trial Comparing Drug Eluting Balloon Versus Conventional Balloon Angioplasty for Recurrent Cephalic Arch Stenosis in Dialysis Fistulas.|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-10 23:34:19.989011|2017-10-10 23:34:19.989011
NCT02368184|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-05-23|||February 2015||2015-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|CoVa||Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure|Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure|Withdrawn||N/A|0|Actual|Scripps Translational Science Institute|||1|Sponsor decided not to go forward with study. No subjects were enrolled.|f||||f||||||||No||2017-10-10 23:34:20.073596|2017-10-10 23:34:20.073596
NCT02368171|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-12|||March 2015||2015-03-01|February 2015|2015-02-01||||March 2016|Anticipated|2016-03-01||Observational|||Role of Heme-oxygenase (HO) and Nitric Oxide (NO) Pathway in Patients With Obstructive Sleep Apnea (OSA) and Pulmonary Hypertension (PH)||Unknown status|Not yet recruiting|N/A|60|Anticipated|Southern California Institute for Research and Education|||3||f||||||||||||||2017-10-10 23:34:20.132222|2017-10-10 23:34:20.132222
NCT02368158|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-09-15|||October 2013||2013-10-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|RehaDrive||Reha Drive: Predictors of Fitness to Drive a Car for Cardiologic Patients and Determination of Vital Signs|Reha Drive: Predictors of Fitness to Drive a Car for Cardiologic Patients in Rehabilitation and Acute Clinic and Contactless Determination of Vital Signs Via Camera|Unknown status|Recruiting|N/A|40|Anticipated|RWTH Aachen University||2|||f||||f||||||||||2017-10-10 23:34:20.196861|2017-10-10 23:34:20.196861
NCT02368132|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-06-07|||May 13, 2016|Actual|2016-05-13|June 2017|2017-06-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Delivery Models of Caregiver Support and Education|Comparative Effectiveness of Delivery Methods for Caregiver Support and Education|Recruiting||N/A|405|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||No||2017-10-10 23:34:20.379348|2017-10-10 23:34:20.379348
NCT02368119|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-04-11|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|||Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)|"A PHASE IB, DOUBLE-BLIND, CLINICAL TRIAL TO EVALUATE THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF TWO DIFFERENT DOSAGE LEVELS OF EBOLA CHIMPANZEE ADENOVIRUS VECTOR VACCINE VRC-EBOADC069-00-VP (cAd3-EBO) AND THE HETEROLOGOUS PRIME-BOOST CANDIDATE VACCINE REGIMEN OF cAD3-EBO FOLLOWED BY MVA-VECTORED VACCINE IN HEALTHY ADULTS, 18-65 YEARS OF AGE, IN BAMAKO, MALI"|Active, not recruiting||Phase 1|60|Anticipated|University of Maryland||2|||f||||t||||||||No||2017-10-10 23:34:20.489364|2017-10-10 23:34:20.489364
NCT02368106|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-09-26|||December 2017|Anticipated|2017-12-01|September 2017|2017-09-01|December 2030|Anticipated|2030-12-01|January 2025|Anticipated|2025-01-01|5 Years|Observational [Patient Registry]|GCC 1490||Prospective Patient Registry for Radiation Oncology Techniques and Quality|Patient Registry for Prospective Research on Evolving Radiation Oncology Techniques and Quality|Not yet recruiting||N/A|5000|Anticipated|University of Maryland|||1||f||||t|f|f||||||||2017-10-10 23:34:20.581722|2017-10-10 23:34:20.581722
NCT02368093|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-03-22|2015-03-22||January 2010||2010-01-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis|A Double-blind, Placebo-controlled, Therapeutic Trial With Antitussive Drug-Dextromethorphan: Aimed to Determine Its Therapeutic Effect in Patients With Rheumatoid Arthritis|Completed||N/A|48|Actual|Taichung Veterans General Hospital||2|||f||||f||||||||||2017-10-10 23:34:20.660382|2017-10-10 23:34:20.660382
NCT02368080|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-07-29|||April 2013||2013-04-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|||Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults|Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults: a Comparison of Two Commercially Available Devices|Completed||N/A|95|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||2||f||||f||||||||||2017-10-10 23:34:20.979507|2017-10-10 23:34:20.979507
NCT02368067|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-02-13|||June 2014||2014-06-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|SITs||Improved Method of Detecting Cancer Metastases|Study of Instillation Technique Using The Modified Intra- Uterine Manipulator Catheter With Methylene Blue, Isosulfan Blue or Indocyanine Green Dyes, Compared to Cervical Injection, For Sentinel Lymph Node Detection in Endometrial Carcinoma|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Southeastern Regional Medical Center||2|||f||||f||||||||||2017-10-10 23:34:21.073444|2017-10-10 23:34:21.073444
NCT02368054|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-08-18|||May 2015||2015-05-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|HSBAPCB||Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization|Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization During General Anesthesia: A Randomized Controlled Double Blinded Study|Completed||Phase 4|34|Actual|Helse Fonna||2|||f||||t||||||||||2017-10-10 23:34:21.17533|2017-10-10 23:34:21.17533
NCT02368041|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-01-10|||May 2015||2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure|Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure|Recruiting||N/A|130|Anticipated|University of Florida|||1||f||||f||||||||No|Individual participant will not be shared to avoid risk of loss of confidentiality.|2017-10-10 23:34:21.297934|2017-10-10 23:34:21.297934
NCT02368028|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-09-14|||March 2015||2015-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Oral Alkali Production and Caries Prevention in Children (Cross-sectional Component)|Oral Alkali Production and Caries Prevention in Children (Cross-sectional Component)|Completed||N/A|131|Actual|University of Florida|||2||f||||f||||||Samples With DNA|"     Saliva and Dental Plaque   "|||2017-10-10 23:34:21.382717|2017-10-10 23:34:21.382717
NCT02368015|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-02-02|||December 2014||2014-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|PENTAC||Penetration of Cefazolin Into Hepatic Cysts|An Explorative Study Determining the Hepatic Cyst Penetration of Cefazolin and Factors Affecting Penetration.|Completed||N/A|8|Actual|Radboud University||1|||f||||f||||||||||2017-10-10 23:34:21.467378|2017-10-10 23:34:21.467378
NCT02368002|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-09-26|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||BestFIT: a Personalized Weight Loss Program|Evaluating Options for Non-Responders: A SMART Approach to Enhancing Weight Loss|Active, not recruiting||N/A|500|Anticipated|HealthPartners Institute||3|||f||||t||||||||||2017-10-10 23:34:21.566844|2017-10-10 23:34:21.566844
NCT02367989|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-10-02|||March 2018|Anticipated|2018-03-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Effects of Barley on Glucose Control|A Dose-response, Double-blind, Randomized, Controlled, Cross-over Trial Examining the Effect of Barley Beta-glucan on Post-prandial Glucose Response in Healthy Adults|Not yet recruiting||N/A|24|Anticipated|St. Boniface General Hospital Research Centre||4|||f||||f|f|f||||||||2017-10-10 23:34:21.686916|2017-10-10 23:34:21.686916
NCT02367976|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-02-24|||January 2015||2015-01-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety on Prouk for STEMI Patients in China|A Phase III Study to Research the Efficacy and Safety on Prouk for ST Elevated Mycadial Infarction Patients in China|Recruiting||Phase 3|450|Anticipated|Suzhou RxD Biopharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-10 23:34:21.805203|2017-10-10 23:34:21.805203
NCT02367963|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-01-24|||September 2013||2013-09-01|February 2016|2016-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Fifty-Fifty||Peer-group-based Intervention Program|Evaluation of Comprehensive Lifestyle Peer-group-based Intervention on Cardiovascular Risk Factor, a Randomized Controlled Trial: Fifty-Fifty Program|Completed||N/A|543|Actual|Foundation for Science, Health and Education, Spain||2|||f||||f||||||||||2017-10-10 23:34:21.891536|2017-10-10 23:34:21.891536
NCT02367950|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-13|||January 2015||2015-01-01|February 2015|2015-02-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Exercise as an Intervention in Endometrial Cancer Survivors|Feasibility and Acceptability of Exercise as a Lifestyle Intervention in Endometrial Cancer Survivors.|Unknown status|Recruiting|N/A|50|Anticipated|Royal Cornwall Hospitals Trust||1|||f||||f||||||||||2017-10-10 23:34:21.996886|2017-10-10 23:34:21.996886
NCT02367937|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-13|||August 2014||2014-08-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||PRC-4016 (Icosabutate) Phase I Drug-drug Interaction Study|A Phase I, Open-Label Study to Assess the Effects of PRC-4016 (Icosabutate) on the Pharmacokinetics of Midazolam, Omeprazole, Flurbiprofen and Simvastatin in Healthy Male/Female Subjects|Completed||Phase 1|16|Actual|Pronova BioPharma||1|||f||||f||||||||||2017-10-10 23:34:22.077436|2017-10-10 23:34:22.077436
NCT02367924|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-09-27|||November 2014||2014-11-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|YonSar||Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma|Non-interventional Study to Investigate Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma|Recruiting||N/A|100|Anticipated|PharmaMar, Spain|||1||f||||f||||||||Undecided||2017-10-10 23:34:22.166463|2017-10-10 23:34:22.166463
NCT02367911|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-02-16||2017-02-16|January 2015||2015-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|September 2015|Actual|2015-09-01||Interventional|||A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis|A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis|Completed||Phase 3|144|Actual|Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:34:22.275716|2017-10-10 23:34:22.275716
NCT02367898|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-09-09|||April 2013||2013-04-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Enhancing Cognitive Abilities With Comprehensive Training|Enhancing Cognitive Abilities With Comprehensive Training: A Large, Online, Randomized, Active-Controlled Trial|Completed||N/A|11470|Actual|Lumos Labs, Inc.||2|||f||||f||||||||||2017-10-10 23:34:22.368205|2017-10-10 23:34:22.368205
NCT02367885|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-03-08|2016-03-08||February 2015||2015-02-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Safety analysis set included all participants who received at least 1 dose of study vaccination.|Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants|An Open-label, Multi-center, Phase 1/2 Study to Evaluate the Safety and Immunogenicity of an Intramuscular Injection of TAK-850 in Healthy Pediatric Subjects|Completed||Phase 1/Phase 2|99|Actual|Takeda||3|||f||||f||||||||||2017-10-10 23:34:22.519142|2017-10-10 23:34:22.519142
NCT02367872|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-04-25|2017-04-25||March 2015||2015-03-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional||The plasma pharmacokinetic (PK) set included all participants treated with the study drug who had no significant protocol deviation, satisfied the minimum protocol provisions, and could be evaluated for plasma PK.|Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment|Phase I Open-label, Parallel-group, Comparative Study to Evaluate the Effects of Renal or Hepatic Impairment on TAK-272 Pharmacokinetics With a Single Oral Administration of TAK-272 in Patients With Renal or Hepatic Impairment|Completed||Phase 1|48|Actual|Takeda||8|||f||||f||||||||||2017-10-10 23:34:24.466346|2017-10-10 23:34:24.466346
NCT02367859|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-07-31|||July 17, 2017|Actual|2017-07-17|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|October 2019|Anticipated|2019-10-01||Interventional|||Dabrafenib in Treating Patients With BRAF Mutated Ameloblastoma|A Pilot Study of Dabrafenib for Patients With BRAF Mutated Ameloblastoma|Recruiting||Phase 2|17|Anticipated|Stanford University||1|||f||||t|t|f||||||||2017-10-10 23:34:26.90353|2017-10-10 23:34:26.90353
NCT02367846|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-03|||January 2015||2015-01-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Assessing the Impact of Contraceptives on Bone Health Using 41Ca|The Effect of Oral vs. Non-oral Contraceptive Therapy on Bone Turnover Using 41Ca Methodology|Active, not recruiting||Phase 4|6|Anticipated|Penn State University||2|||f||||f||||||||||2017-10-10 23:34:27.014906|2017-10-10 23:34:27.014906
NCT02367833|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-03|||January 2015||2015-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis|Primary Mechanisms Underlying the Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis and Bone Metabolism in Young Women|Active, not recruiting||Phase 4|48|Anticipated|Penn State University||4|||f||||f||||||||||2017-10-10 23:34:27.133299|2017-10-10 23:34:27.133299
NCT02367820|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-15|||March 2015||2015-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|SUMMIT-LTS||Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain|A Phase 3 Multicenter, Open-Label, 52-Week Study To Evaluate the Long-Term Safety and Tolerability of NKTR-181 in Subjects With Moderate to Severe Chronic Low Back Pain or Chronic Non-cancer Pain|Active, not recruiting||Phase 3|638|Actual|Nektar Therapeutics||1|||f||||f||||||||||2017-10-10 23:34:27.228347|2017-10-10 23:34:27.228347
NCT02367807|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-10-10|||February 2015||2015-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color|Pre-Exposure Prophylaxis With TDF/FTC to Prevent HIV-1 Acquisition in Young Men and Transgender Women of Color Who Have Sex With Men|Completed||N/A|50|Actual|Philadelphia Fight|||1||f||||f||||||Samples Without DNA|"     urine and plasma samples for measurement of tenofovir concentration, blood samples for     measurement of safety labs, and urine/plasma samples and rectal/pharyngeal swabs for sexually     transmitted infection screening   "|||2017-10-10 23:34:27.536404|2017-10-10 23:34:27.536404
NCT02367794|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-06|||June 11, 2015|Actual|2015-06-11|September 2017|2017-09-01|February 15, 2023|Anticipated|2023-02-15|January 1, 2018|Anticipated|2018-01-01||Interventional|||A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]|A Phase III, Open-Label, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) in Combination With Carboplatin+Paclitaxel or Atezolizumab in Combination With Carboplatin+Nab-Paclitaxel Versus Carboplatin+Nab-Paclitaxel in Chemotherapy-Naive Patients With Stage IV Squamous Non-Small Cell Lung Cancer|Active, not recruiting||Phase 3|1021|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 23:34:27.639357|2017-10-10 23:34:27.639357
NCT02367768|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-03-09|||February 2015||2015-02-01|March 2015|2015-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Long-term Outcome Related Prognostic Factor and Biomarkers of Major Trauma Database Analysis|Long-term Outcome Related Prognostic Factor and Biomarkers of Major Trauma Database Analysis|Recruiting||N/A|500|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     CRP, IL-6, cortisol / prolactin / growth hormone   "|||2017-10-10 23:34:29.333718|2017-10-10 23:34:29.333718
NCT02367755|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-03-26|||August 2013||2013-08-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Therapeutic Hypothermia With Propofol in Survival and Neurological Prognoses After Cardiac Arrest|Combining Propofol With Therapeutic Hypothermia for Improving Survival and Neurological Prognoses in Patients Resuscitated From Cardiac Arrest|Recruiting||Phase 4|30|Anticipated|Far Eastern Memorial Hospital||2|||f||||f||||||||No|Not share data|2017-10-10 23:34:29.423033|2017-10-10 23:34:29.423033
NCT02367729|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2017-01-22|||September 2015|Actual|2015-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy of Ear Neurostimulation for Adolescents With Functional Abdominal Pain|Efficacy of Auricular Neurostimulation for Adolescents With Pain-Associated Functional Gastrointestinal Disorders|Completed||N/A|115|Actual|Medical College of Wisconsin||2|||f||||f||||||||No||2017-10-10 23:34:29.6258|2017-10-10 23:34:29.6258
NCT02367716|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-07-28|||December 2014||2014-12-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|MVLV||Post-market Study of Multi-Vector LV Lead Performance in Chinese Patients With Chronic Heart Failure|Post-market Study of Multi-Vector LV Lead Performance in Chinese Patients With Chronic Heart Failure|Active, not recruiting||N/A|121|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-10 23:34:29.707061|2017-10-10 23:34:29.707061
NCT02367703|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-09-18|||March 2015||2015-03-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Feasibility and Benefit of Laparoscopic Hysterectomy With Less Than 3 Millimeter Diameter's Instruments in Current Practice|Assessment of Feasibility and Benefit of the Use of Less Than 3 Millimeter Diameter's Instruments Compared to Standard Size Instruments in Laparoscopic Hysterectomy: a Randomized Single-center Comparative Study|Unknown status|Recruiting|N/A|96|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:34:29.780397|2017-10-10 23:34:29.780397
NCT02367690|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-03-23|||January 2015||2015-01-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients|Phase 1/2, Multi-Dose, Evaluator-Blinded, Randomized, Vehicle & Standard Of Care-Controlled Dose-Escalation Study To Assess Safety, Tolerability, Pharmacokinetics Of Topical Selinexor In Patients With Diabetic Foot Ulcers|Withdrawn||Phase 1/Phase 2|0|Actual|Karyopharm Therapeutics Inc||3||"Due to enrollment challenges & improved SOC during run-in phase; no patients received KPT-330.   Withdrawal is not a consequence of any safety concern."|f||||f||||||||Yes||2017-10-10 23:34:29.865332|2017-10-10 23:34:29.865332
NCT02367677|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-02-01|||November 2013||2013-11-01|August 2016|2016-08-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Observational|||Digital Photographs to Evaluate Blepharoptosis|Comparison Between Clinical Measurements and Computer-based Measurements on Digital Photographs to Evaluate Blepharoptosis|Completed||N/A|36|Actual|CHU de Quebec-Universite Laval|||3||f||||f||||||||Undecided||2017-10-10 23:34:29.950449|2017-10-10 23:34:29.950449
NCT02367664|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-08-30|||October 2014||2014-10-01|August 2015|2015-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants|A Single-centre Phase III Clinical Trial for Vero Cell-derived Inactivated Japanese Encephalitis Vaccine Produced by Shandong Hengye Biotech Co., Ltd. in Healthy Chinese Infants Aged 6-11 Months, Aimed to Evaluate Immunogenicity and Safety|Completed||Phase 3|900|Actual|Jiangsu Province Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-10 23:34:30.022544|2017-10-10 23:34:30.022544
NCT02367651|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-10-11|||June 2015||2015-06-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma|A Randomized, Double-blind, Placebo-controlled Phase II Study of Pazopanib Versus Placebo as Maintenance Therapy for Patients Who Have Not Progressed After First-line Chemotherapy for Advanced Soft Tissue Sarcoma (STS)|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||2||Study cancelled: Withdrawn before enrollment of any participants|f||||f||||||||||2017-10-10 23:34:30.105587|2017-10-10 23:34:30.105587
NCT02367638|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-04-25|||March 2015||2015-03-01|April 2017|2017-04-01||||July 2015|Actual|2015-07-01||Interventional|||Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults|A Single-center, Dose Block-randomized, Single-blind, Active-controlled, Dose Escalation Phase 1 Clinical Trial to Evaluate the Safety and Efficacy (Immunogenicity) of MG1111 in Healthy Adults|Completed||Phase 1|39|Anticipated|Green Cross Corporation||2|||f||||t||||||||||2017-10-10 23:34:30.178203|2017-10-10 23:34:30.178203
NCT02367625|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-27|2017-01-30|||January 2016||2016-01-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Performance, Safety, and Efficacy of a New Cyrotherapy Device for Cervical Dysplasia|Performance, Safety, and Efficacy of a New Cyrotherapy Device for Cervical Dysplasia|Recruiting||N/A|40|Anticipated|Jhpiego||2|||f||||f||||||||Yes||2017-10-10 23:34:30.404297|2017-10-10 23:34:30.404297
NCT02367612|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-06-24|||December 2014||2014-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Fermented Milk on the Appearance of Common Winter Infectious Diseases|Fermented Milk on the Appearance of Common Winter Infectious Diseases|Completed||Phase 2|140|Actual|Federico II University||2|||f||||f||||||||||2017-10-10 23:34:30.485398|2017-10-10 23:34:30.485398
NCT02367599|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-02-24|||November 2014|Actual|2014-11-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|April 2016|Actual|2016-04-01||Interventional|CCTG595VitD||Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM|Effect of Vitamin D Supplementation on Bone Turnover Markers During Tenofovir-Emtricitibine Pre-Exposure Prophylaxis in Men Who Have Sex With Men; A Sub-study of CCTG 595|Active, not recruiting||Phase 4|50|Anticipated|California Collaborative Treatment Group||2|||f||||f||||||||||2017-10-10 23:34:30.556273|2017-10-10 23:34:30.556273
NCT02367573|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-04-22|||January 2015||2015-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||3D vs 2D HD Laparoscopy in Inguinal Hernia Repair|3D Versus 2D HD Laparoscopy in Inguinal Hernia Repair: a Prospective, Single Blinded, Randomized, Controlled Trial|Recruiting||N/A|274|Anticipated|Helsinki University Central Hospital||2|||f||||||||||||||2017-10-10 23:34:30.635014|2017-10-10 23:34:30.635014
NCT02367560|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-07-10|||July 2015||2015-07-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||Calcific Tendinitis: Comparing Minimally Invasive Modalities|Calcific Tendinitis: Comparing Minimally Invasive Modalities|Recruiting||N/A|60|Anticipated|Lakehead University||2|||f||||f||||||||||2017-10-10 23:34:30.718848|2017-10-10 23:34:30.718848
NCT02367547|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2016-09-08|||March 2015||2015-03-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitises: HAL and BF-200 ALA Versus MAL|Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitises: Hexylaminolevulinate and Aminolevulinic Acid Nano Emulsion Versus Methylaminolevulinate|Recruiting||Phase 1/Phase 2|99|Anticipated|Joint Authority for Päijät-Häme Social and Health Care||3|||f||||t||||||||||2017-10-10 23:34:30.812857|2017-10-10 23:34:30.812857
NCT02367534|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-12|||June 2008||2008-06-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Islet Transplantation Through an Indwelling Catheter in the Umbilical Vein|Islet Transplantation Through an Indwelling Catheter in the Umbilical Vein|Completed||Phase 1/Phase 2|12|Actual|Fuzhou General Hospital||1|||f||||t||||||||||2017-10-10 23:34:30.908984|2017-10-10 23:34:30.908984
NCT02367521|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-06-27|||March 2015||2015-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|rTMS TBI||Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression & Other Neuropsychiatric Symptoms After Traumatic Brain Injury (TBI)|Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression & Other Neuropsychiatric Symptoms After Traumatic Brain Injury (TBI)|Active, not recruiting||Phase 2/Phase 3|70|Actual|Johns Hopkins University||2|||f||||t|f|t||||||||2017-10-10 23:34:30.96983|2017-10-10 23:34:30.96983
NCT02367508|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2016-07-27|||February 2014||2014-02-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|April 2014|Actual|2014-04-01||Interventional|MODEL Care||Mindfully Optimizing Delivery of End-of-Life Care|Mindfully Optimizing Delivery of End-of-Life Care (MODEL Care): Feasibility of a Synergistic Intervention for Patients, Family Caregivers, and Providers|Completed||N/A|31|Actual|Indiana University||1|||f||||t||||||||||2017-10-10 23:34:31.049074|2017-10-10 23:34:31.049074
NCT02367495|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-11-18|||January 2015||2015-01-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|ISAR-DESIRE 3A||Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES|Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue Drug-eluting Coronary Stents|Active, not recruiting||N/A|125|Actual|Deutsches Herzzentrum Muenchen||1|||f||||f||||||||||2017-10-10 23:34:31.244695|2017-10-10 23:34:31.244695
NCT02367482|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-11-11|||July 2014||2014-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Tryptophan Metabolism in Human Brain Tumors|Tryptophan Metabolism in Human Brain Tumors: For Patients Whose Clinical Treatment Includes NovoTTF|Recruiting||N/A|10|Anticipated|Wayne State University|||1||f||||t||||||Samples Without DNA|"     we will collect and analyze the tumor specimens obtained prior to NovoTTF therapy (as well as     any tissue specimens available if a patient undergoes surgical resection after initiating     NovoTTF therapy) for various histopathologic features (e.g., proliferative activity, vessel     density, expression of L-type amino acid transporter), and correlate with neuroimaging     findings and clinical response to NovoTTF. This may provide additional useful information on     potential mechanisms of treatment failure.   "|No||2017-10-10 23:34:31.35722|2017-10-10 23:34:31.35722
NCT02367469|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-11-11|||February 2014||2014-02-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Observational|||Tryptophan Metabolism in Human Brain Tumors|Tryptophan Metabolism in Human Brain Tumors|Recruiting||N/A|105|Anticipated|Wayne State University|||1||f||||f||||||Samples Without DNA|"     We will collect and analyze tumor specimens obtained after AMT-PET during tumor resection (if     not used for routine histopathology). Various histopathologic features will be studied, e.g.,     tumor proliferative activity, expression of amino acid transporter as well as enzymes and     metabolites of the kynurenine pathway, and these will also be correlated with neuroimaging     findings.   "|No||2017-10-10 23:34:31.469293|2017-10-10 23:34:31.469293
NCT02367456|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-28|||April 28, 2015|Actual|2015-04-28|September 2017|2017-09-01|November 6, 2021|Anticipated|2021-11-06|November 7, 2019|Anticipated|2019-11-07||Interventional|||A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In 1st Line MDS, AML and CMML Patients|A Randomized, Double-blind Phase 1b/2 Study Of Pf-04449913 (Glasdegib) In Combination With Azacitidine In Patients With Previously Untreated Intermediate-2 Or High-risk Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Blasts And Multi-lineage Dysplasia, Or Chronic Myelomonocytic Leukemia|Recruiting||Phase 1|170|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 23:34:31.571891|2017-10-10 23:34:31.571891
NCT02367443|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-11-05|||March 2014||2014-03-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC|Hypofractionated Accelerated Radiotherapy With Concomitant Full Dose Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Phase I/II Study|Recruiting||Phase 1/Phase 2|100|Anticipated|Independent Public Care Health Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre||1|||f||||f||||||||||2017-10-10 23:34:31.728789|2017-10-10 23:34:31.728789
NCT02367430|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-08-31|||January 2013||2013-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|CTI-HD||Critical Time Intervention for Individuals With Hoarding Disorder|Critical Time Intervention for Individuals With Hoarding Disorder|Completed||N/A|28|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-10 23:34:31.81516|2017-10-10 23:34:31.81516
NCT02367417|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-08-17|||August 14, 2017|Actual|2017-08-14|August 2017|2017-08-01|May 2025|Anticipated|2025-05-01|November 2024|Anticipated|2024-11-01||Observational|||Prospective Clinical 5-year Follow-up of the LINK® Endo-Model® SL®|Prospective Clinical 5-year Follow-up of the LINK® Endo-Model® SL® Rotational and Hinge Knee Prosthesis|Recruiting||N/A|150|Anticipated|Waldemar Link GmbH & Co. KG|||1||f||||f|f|f||||||||2017-10-10 23:34:31.883038|2017-10-10 23:34:31.883038
NCT02367404|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-09-12|||May 2015||2015-05-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Prospective RCT on Post Prostatectomy Urine Leak|A Prospective Randomized Controlled Study Comparing the Efficacy of Pelvic Floor Muscle Training and Oral Duloxetine in the Recovery of Continence After Robotic Assisted Radical Prostatectomy|Recruiting||Phase 3|240|Anticipated|Institut Mutualiste Montsouris||4|||f||||f||||||||||2017-10-10 23:34:31.969886|2017-10-10 23:34:31.969886
NCT02367391|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-05-24|2017-01-18||January 2015||2015-01-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Penn State TXT2Quit Study|Pilot Randomized Trial of an Automated Smoking Cessation Intervention Via Mobile Phone Text Messages as an Adjunct to Varenicline in Primary Care|Completed||N/A|152|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 23:34:32.055515|2017-10-10 23:34:32.055515
NCT02367365|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-01-25|||December 2014||2014-12-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD|Neovascular Morphology and Persistent Disease Activity Among Patients With Neovascular Age-Related Macular Degeneration|Active, not recruiting||N/A|75|Actual|Duke University|||2||f||||f||||||||||2017-10-10 23:34:32.57784|2017-10-10 23:34:32.57784
NCT02367352|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-06-07|||March 25, 2015|Actual|2015-03-25|June 2017|2017-06-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|||Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors|A Phase 1b Study of Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors|Completed||Phase 1|9|Actual|Takeda||3|||f||||f|f|f||||||||2017-10-10 23:34:32.666297|2017-10-10 23:34:32.666297
NCT02367339|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-19|||February 2015||2015-02-01|February 2015|2015-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|REASSE||Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff|Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:34:32.765666|2017-10-10 23:34:32.765666
NCT02367326|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-08-21|||June 2014|Actual|2014-06-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Observational|SCORE1||Identification of Scores Associated With a Favorable Clinical Response With Thiopurines in IBD Patients|Identification of Composite Clinical and Lab Scores Associated With a Favorable Clinical Response With Thiopurines in Patients With IBD (Inflammatory Bowel Disease): an International Clinical Trial|Completed||N/A|400|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-10 23:34:32.833038|2017-10-10 23:34:32.833038
NCT02367313|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-03-17||2017-03-17|February 2015||2015-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SPIRITUS||A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection|Completed||Phase 2|455|Actual|Aviragen Therapeutics||3|||f||||f||||||||||2017-10-10 23:34:32.921726|2017-10-10 23:34:32.921726
NCT02367300|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-06-17|||February 2015||2015-02-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|B-AHEAD III||Validation Of TBI Detection System For Head Injured Patients|Validation Of Point-Of-Care TBI Detection System For Head Injured Patients|Completed||N/A|981|Actual|BrainScope Company, Inc.|||1||f||||f||||||||||2017-10-10 23:34:33.091792|2017-10-10 23:34:33.091792
NCT02367287|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-03-21|||May 2015||2015-05-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||USDA Western Human Nutrition Research Center (WHNRC) Cross-Sectional Nutritional Phenotyping Study|Assessing the Impact of Diet on Inflammation in Healthy and Obese Adults in a Cross-Sectional Phenotyping Study|Recruiting||N/A|436|Anticipated|USDA, Western Human Nutrition Research Center|||1||f||||f||||||Samples With DNA|"     Whole blood, stool   "|||2017-10-10 23:34:33.338059|2017-10-10 23:34:33.338059
NCT02367274|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-04-18|||January 2015||2015-01-01|December 2015|2015-12-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Observational|READ-TBI||Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department|Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department|Completed||N/A|421|Actual|BrainScope Company, Inc.|||1||f||||f||||||||||2017-10-10 23:34:33.431111|2017-10-10 23:34:33.431111
NCT02367261|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-06-27|||November 2014||2014-11-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|SPI||A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of SPI Implant|An Open, Prospective, Multi-center Study to Evaluate Bone Loss, the Survival Rate of SPI Implant System and Implant Stability Over a 24 Months, in Patients With Tooth Loss Requiring up to 4 Implants, in Staged Loading Protocol.|Completed||Phase 4|88|Actual|Alpha - Bio Tec Ltd.||1|||f||||t||||||||||2017-10-10 23:34:33.528581|2017-10-10 23:34:33.528581
NCT02367248|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-05-14|||March 2015||2015-03-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage|Safety and Effectiveness Study of Deferoxamine and Xingnaojing Injection in Intracerebral Hemorrhage|Unknown status|Recruiting|Phase 1/Phase 2|180|Anticipated|Capital Medical University||3|||f||||t||||||||||2017-10-10 23:34:33.603681|2017-10-10 23:34:33.603681
NCT02367235|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-04-18|||January 2015||2015-01-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ACRAS||Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial|Analysis of Robotic Procedural Times Using the Colpassist Vaginal Positioning Device for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial|Recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 23:34:33.72372|2017-10-10 23:34:33.72372
NCT02367222|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-05-10|||August 2014||2014-08-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Observational|H1N1-014VS||A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada|An Observational Retrospective Database Analysis to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada|Completed||N/A|1|Anticipated|University of Manitoba|||2||f||||t||||||||||2017-10-10 23:34:33.81486|2017-10-10 23:34:33.81486
NCT02367209|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-07-10|||February 2015||2015-02-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Observational|FD-COPD||Assessment of Lung Perfusion in Patients With Chronic Obstructive Pulmonary Disease Using FD MRI|Non-contrast-enhanced Perfusion Imaging of the Lung Using Fourier Decomposition Magnetic Resonance Imaging (FD MRI): Assessment of Feasibility in Patients With COPD in Correlation With Perfusion Scintigraphy, SPECT/CT and DCE MRI|Completed||N/A|14|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-10 23:34:33.924696|2017-10-10 23:34:33.924696
NCT02367196|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-28|||March 12, 2015|Actual|2015-03-12|September 2017|2017-09-01|June 13, 2019|Anticipated|2019-06-13|June 13, 2019|Anticipated|2019-06-13||Interventional|||A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers|A Phase I, Open-Label, Dose Finding Study of CC-90002, a Monoclonal Antibody Directed Against CD47, in Subjects With Advanced Solid and Hematologic Cancers|Recruiting||Phase 1|65|Anticipated|Celgene||1|||f||||t||||||||||2017-10-10 23:34:34.05725|2017-10-10 23:34:34.05725
NCT02367183|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-06-21|||April 8, 2015|Actual|2015-04-08|June 2017|2017-06-01|September 18, 2019|Anticipated|2019-09-18|September 6, 2016|Actual|2016-09-06||Interventional|||A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease|A Randomized, Double-blind, Multicenter Study to Explore the Effect of GED-0301 on Endoscopic and Clinical Outcomes in Subjects With Active Crohn's Disease.|Active, not recruiting||Phase 1|64|Actual|Celgene||3|||f||||t||||||||||2017-10-10 23:34:34.194396|2017-10-10 23:34:34.194396
NCT02367170|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-04-25|2016-12-01||March 2015||2015-03-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Project 4A: Inspiratory Muscle Training and Diaphragm Strength|Study: Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care: Project 4A: Inspiratory Muscle Training and Diaphragm Strength|Terminated||Phase 1/Phase 2|1|Actual|University of Florida||2||Unable to recruit sufficient number of patients|f||||t||||||||No||2017-10-10 23:34:34.38363|2017-10-10 23:34:34.38363
NCT02367157|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-09-30|||March 2016||2016-03-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|||Effectiveness of Kinesio Tape in Morning Stiffness and Functional Capacity in Patients With Rheumatoid Arthritis.||Recruiting||N/A|20|Anticipated|CEU San Pablo University||2|||f||||f||||||||||2017-10-10 23:34:34.660481|2017-10-10 23:34:34.660481
NCT02367118|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-06-02|||June 2015||2015-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Prednisone in Chronic Rhinosinusitis Without Nasal Polyps|Prednisone in Chronic Rhinosinusitis Without Nasal Polyps. A Double-blind, Randomized, Placebo-controlled Trial|Unknown status|Recruiting|Phase 3|90|Anticipated|University of Chile||2|||f||||f||||||||||2017-10-10 23:34:34.989219|2017-10-10 23:34:34.989219
NCT02367105|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-08-04|||February 1, 2015|Actual|2015-02-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|LITROS||Lifestyle Intervention and Testosterone Replacement in Obese Seniors|Testosterone Replacement to Augment Lifestyle Therapy in Obese Older Veterans|Recruiting||Phase 3|72|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 23:34:35.107421|2017-10-10 23:34:35.107421
NCT02367092|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2017-07-31|||July 2016||2016-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Exercise Intervention in Liver Transplant Patients|Exercise Intervention in Liver Transplant Patients|Recruiting||N/A|500|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:34:35.241884|2017-10-10 23:34:35.241884
NCT02367079|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-12|||April 2014||2014-04-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Diathermy Compared With Sham Diathermy in Doms Management|Diathermy Compared With Sham Diathermy in Doms Management|Terminated||Phase 4|25|Actual|Studi Fisioterapici di Montagna||2||1 day data collection|f||||t||||||||||2017-10-10 23:34:35.348958|2017-10-10 23:34:35.348958
NCT02367066|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2016-05-17|2016-03-22||March 2015||2015-03-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)|A Single Centre, Double-blind, Randomised, Placebo-controlled, Cross-over Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX After Administration of Repeated Doses for 3 Days in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|30|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:34:35.449085|2017-10-10 23:34:35.449085
NCT02367053|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-01-21|||December 2014||2014-12-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator|A Randomized, Double-blinded Trial of Single Ascending Doses of ZP4207 Administered s.c. or i.m. to HV and a SD of ZP4207 Administered s.c. to Hypoglycemic T1D to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207 as Compared to an Active Comparator|Completed||Phase 1|111|Actual|Zealand Pharma||2|||f||||f||||||||||2017-10-10 23:34:36.409936|2017-10-10 23:34:36.409936
NCT02367027|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-06-09|||February 2015||2015-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions|Single-dose, Open-label, Randomized, 4-way Crossover Study to Compare a Dry Powder Oral Suspension (10 mg and 20 mg Dose of Rivaroxaban) With an Oral Suspension (10 mg of Rivaroxaban) and 10 mg of an Immediate Release Tablet Under Fasting Conditions (10 mg Doses) and Under Fed Conditions (20 mg Dose) in Healthy Male Subjects|Completed||Phase 1|18|Actual|Bayer||4|||f||||f||||||||||2017-10-10 23:34:37.439199|2017-10-10 23:34:37.439199
NCT02367014|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-05-27|||February 2015||2015-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|MMPOWER||A Study Investigating the Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy|A Phase 1/2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending-Dose Clinical Study Investigating the Safety, Tolerability, and Efficacy of Intravenous MTP-131 for the Treatment of Mitochondrial Myopathy in Subjects With Genetically Confirmed Mitochondrial Disease|Completed||Phase 1/Phase 2|36|Actual|Stealth BioTherapeutics Inc.||4|||f||||t||||||||||2017-10-10 23:34:37.540746|2017-10-10 23:34:37.540746
NCT02367001|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-09-30|||February 2014||2014-02-01|February 2015|2015-02-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|GPs||Randomized Trial Evaluating the Effectiveness of the General Practitioner Involvement in Cancer Screening Invitations|"Randomized Trial Evaluating the Effectiveness of a Targeted Communication With the General Practitioner Involvement in Cancer Screening Invitation Letters"|Completed||N/A|53978|Actual|University Hospital, Tours||3|||f||||f||||||||||2017-10-10 23:34:37.635385|2017-10-10 23:34:37.635385
NCT02366988|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-03-02|||February 2015||2015-02-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|PASTEC||The PASTEC Study: Endoscopic Stenting Versus Surgery for the Treatment of Bile Duct Stricture in Chronic Pancreatitis|Phase 3 Prospective, Multicentric Randomized Study of Endoscopic Versus Surgical Treatment of Bile Duct Stricture in Chronic Pancreatitis|Recruiting||N/A|86|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-10 23:34:37.734896|2017-10-10 23:34:37.734896
NCT02366975|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-10-24|||November 2012||2012-11-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|PROTEST||TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST|Effectiveness of Testosterone Replacement Therapy (TRT) on Prostatic Gland in Hypogonadal Patients Affected by Benign Prostatic Hyperplasia (BPH) and Metabolic Syndrome (MetS). Florence-PROTEST|Active, not recruiting||Phase 4|144|Anticipated|University of Florence||3|||f||||f||||||||||2017-10-10 23:34:37.850679|2017-10-10 23:34:37.850679
NCT02366962|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-09-27|||February 2015||2015-02-01|September 2017|2017-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older|Phase III Study of ASP7374－Open-label Study of Subcutaneous Vaccination of Quadrivalent ASP7374 in Adult Subjects Aged 20 or Older|Completed||Phase 3|55|Actual|UMN Pharma Inc.||1|||f||||f||||||||||2017-10-10 23:34:37.946926|2017-10-10 23:34:37.946926
NCT02366936|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-03-07|2017-03-07||June 2015||2015-06-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Treatment of Cranial Molding Deformities in Preterm Infants|Effectiveness of Tortle Midliner Positioning System on the Prevention and Treatment of Cranial Molding Deformities in Preterm Infants|Completed||N/A|32|Actual|Duke University|Study used the original design of the Tortle Midliner (TM). TM's new design adjustments (multiple velcro attachments, material to prevent slippage inside the cap, and doesn't cover head) may result in different outcomes based on our study protocol.|1|||f||||t||||||||||2017-10-10 23:34:38.128228|2017-10-10 23:34:38.128228
NCT02366923|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-03-28|2016-01-18||April 2015||2015-04-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Dehydration of Stenfilcon A Contact Lenses Versus Delefilcon A Contact Lenses|Dehydration of Stenfilcon A Contact Lenses Versus Delefilcon A Contact Lenses|Completed||N/A|28|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 23:34:38.360901|2017-10-10 23:34:38.360901
NCT02366910|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-03-28|2016-01-18||March 2015||2015-03-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Dehydration of Omafilcon A Contact Lenses Versus Delefilcon A Contact Lenses|Dehydration of Omafilcon A Contact Lenses Versus Delefilcon A Contact Lenses|Completed||N/A|26|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 23:34:38.615387|2017-10-10 23:34:38.615387
NCT02366897|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-11|||February 2015||2015-02-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Extrapyramidal Side-Effects in Antipsychotic Drug Therapeutics|Extrapyramidal Side-Effects in Antipsychotic Drug Therapeutics|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Edinburgh||1|||f||||f||||||||||2017-10-10 23:34:38.806195|2017-10-10 23:34:38.806195
NCT02366884|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-02-18|||July 2011||2011-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Evaluation of a New Form of Cancer Therapy Based on the Principles of Atavistic Metamorphosis|Atavistic Chemotherapy and Immunotherapy in Advanced, Metastatic, and Otherwise Incurable and Lethal Cancers Under Conventional Treatments|Enrolling by invitation||Phase 2|100|Anticipated|Dr. Frank Arguello Cancer Clinic||4|||f||||f||||||||||2017-10-10 23:34:38.873714|2017-10-10 23:34:38.873714
NCT02366871|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-05-01|||May 14, 2015|Actual|2015-05-14|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy|The Safety of Oral Apixaban (Eliquis) Versus Subcutaneous Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy; a Prospective Randomized Open Blinded End-point (PROBE) Design|Recruiting||Phase 2|171|Anticipated|University of Colorado, Denver||2|||f||||t||||||||No||2017-10-10 23:34:38.955911|2017-10-10 23:34:38.955911
NCT02366858|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-02-13|||October 2013||2013-10-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures|Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures|Withdrawn||N/A|0|Actual|Florida Hospital||2||PI decision was made to discontinue the study|f||||t||||||||No||2017-10-10 23:34:39.041277|2017-10-10 23:34:39.041277
NCT02366845|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-01-26|||January 2012||2012-01-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|January 2016|Actual|2016-01-01||Interventional|||Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease|Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease|Active, not recruiting||Phase 4|50|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:34:39.10538|2017-10-10 23:34:39.10538
NCT02366832|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-03-21|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|December 16, 2016|Actual|2016-12-16|December 16, 2016|Actual|2016-12-16||Interventional|||Cryoablation for Phantom Limb Pain|Percutaneous Image Guided Cryoablation for the Treatment of Refractory Phantom Limb Pain|Completed||N/A|23|Actual|Emory University||1|||f||||f|f|f||||||Undecided||2017-10-10 23:34:39.303787|2017-10-10 23:34:39.303787
NCT02366819|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-01|||December 2014||2014-12-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer|A Pilot Trial of Perioperative Genotype-Guided Irinotecan Dosing of mFOLFIRINOX for Locally Advanced Gastroesophageal Adenocarcinoma|Recruiting||Phase 4|36|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 23:34:39.379241|2017-10-10 23:34:39.379241
NCT02366806|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-06-14|||April 2014||2014-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer|Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer|Recruiting||N/A|80|Anticipated|University of California, Davis|||1||f||||f||||||||||2017-10-10 23:34:39.489892|2017-10-10 23:34:39.489892
NCT02366793|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-17|2015-09-15|||September 2013||2013-09-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Accessory Joint and Neural Mobilizations in Shoulder After Breast Cancer Surgery. Randomized Clinical Trial.|Accessory Joint and Neural Mobilizations in Shoulder Range of Motion Restriction After Breast Cancer Surgery. A Pilot Randomized Clinical Trial.|Completed||N/A|18|Actual|University of Alcala||2|||f||||f||||||||||2017-10-10 23:34:39.557976|2017-10-10 23:34:39.557976
NCT02366780|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-09-02|||November 2012||2012-11-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Breast Milk Content Expressed Manually Compared to Electric Pump|Breast Milk Content Expressed Manually Compared to Electric Pump|Completed||N/A|50|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:34:39.619158|2017-10-10 23:34:39.619158
NCT02366767|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-02-09|2015-10-28||June 2014||2014-06-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||type 1 diabetes attending a diabetes summer camp|Assessment of an Automatic Closed-loop Insulin Delivery System|Assessment of an Automatic Closed-loop Insulin Delivery System|Completed||N/A|21|Actual|Stanford University|This study was in a closely supervised diabetes camp setting. There was close supervision of fingerstick testing using the second drop of blood. Research staff did not assist subjects in carbohydrate counting and meal sizes were unrestricted.|2|||f||||t||||||||No||2017-10-10 23:34:39.694635|2017-10-10 23:34:39.694635
NCT02366754|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-02-05|||February 2016||2016-02-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||rTMS: A Treatment to Restore Function After Severe TBI|rTMS: A Treatment to Restore Function After Severe TBI|Recruiting||N/A|58|Anticipated|Edward Hines Jr. VA Hospital||2|||f||||t||||||||||2017-10-10 23:34:39.948799|2017-10-10 23:34:39.948799
NCT02366741|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-04-18|||January 2015||2015-01-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study|Neurocognitive Function Changes in Patients With LD Small Cell Lung Cancer Undergoing Prophylactic Whole Brain Radiotherapy With Hippocampal Sparing - a Pilot Study|Recruiting||N/A|5|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:34:40.042457|2017-10-10 23:34:40.042457
NCT02366728|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-06-13|||September 2015||2015-09-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|March 2019|Anticipated|2019-03-01||Interventional|ELEVATE||DC Migration Study for Newly-Diagnosed GBM|Evaluation of Overcoming Limited Migration and Enhancing Cytomegalovirus-specific Dendritic Cell Vaccines With Adjuvant TEtanus Pre-conditioning in Patients With Newly-diagnosed Glioblastoma|Recruiting||Phase 2|100|Anticipated|Duke University||3|||f||||t||||||||||2017-10-10 23:34:40.132348|2017-10-10 23:34:40.132348
NCT02366715|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-11-23|||September 2015||2015-09-01|October 2015|2015-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment Of Bronchiolitis With Heated Humidified High Flow Nasal Cannula - Prospective And Retrospective Research|IMLEMENTATION OF High Flow Nasal Cannulae Therapy FOR THE TREATMENT OF BRONCHIOLITIS IN A GENERAL PEDIATRIC WARD - A RETROSPECTIVE AND PROSPECTIVE CLINICAL TRIAL|Recruiting||Phase 3|200|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-10 23:34:40.238884|2017-10-10 23:34:40.238884
NCT02366702|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-05-02|||February 2015||2015-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Kinematic, Kinetic, and Metabolic Comparison of Bilateral Transfemoral Ambulation With Passive Versus Powered Prosthetic Devices|Kinematic, Kinetic, and Metabolic Comparison of Bilateral Transfemoral Ambulation With Passive Versus Powered Prosthetic Devices|Active, not recruiting||N/A|3|Actual|Southern California Institute for Research and Education|||1||f||||f||||||||||2017-10-10 23:34:40.309526|2017-10-10 23:34:40.309526
NCT02366689|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-02-29|2016-01-28||June 2014||2014-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Study Comparing Dental Plaque and Gingivitis Reduction After Using One of Three Oral Hygiene Multi-component Regimens (Using of a Manual Toothbrush, a Toothpaste and a Mouthwash)|Clinical Efficacy in Reducing Established Dental Plaque and Gingivitis of a Toothpaste Containing 0.3% Triclosan, 2% Copolymer / Sodium Fluoride and a Manual Toothbrush as Compared to an Oral Hygiene Multi-component Regimen Encompassing the Use of a Manual Toothbrush, a Toothpaste Containing Stannous Fluoride / Sodium Hexametaphosphate and a Mouthwash Containing 0.07% Cetylpyridinium Chloride|Completed||Phase 4|179|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-10-10 23:34:40.405217|2017-10-10 23:34:40.405217
NCT02366676|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-18|||January 2014||2014-01-01|December 2013|2013-12-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract|Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract: a Multicenter, Prospective Study|Unknown status|Recruiting|Phase 4|164|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:34:40.760944|2017-10-10 23:34:40.760944
NCT02366650|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-10-19|||February 2015||2015-02-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01||Observational|HERO||Help in the Emergency Room to Detect Organ Dysfunction|Help in the Emergency Room to Detect Organ Dysfunction - The HERO Study|Unknown status|Recruiting|N/A|600|Anticipated|Region Skane|||4||f||||f||||||Samples With DNA|"     Plasma and blood samples   "|||2017-10-10 23:34:42.467071|2017-10-10 23:34:42.467071
NCT02366637|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-05-24|2016-03-03||January 2015||2015-01-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease|A Randomized, Double-blind, Placebo-controlled 2-way Crossover Study To Evaluate The Efficacy, Safety And Tolerability Of Pf-03715455 Administered Twice Daily By Inhalation For 4 Weeks In Subjects With Moderate To Severe Chronic Obstructive Pulmonary Disease (Copd)|Terminated||Phase 2|13|Actual|Pfizer|As this study was prematurely terminated by the sponsor for business reasons, no formal safety or efficacy conclusions can be drawn due to insufficient participant numbers. In addition, PK analysis was not conducted.|2||"Study terminated on 7 April 2015 for business reasons. No safety and/or efficacy concerns   contributed to the termination of the study"|f||||t||||||||||2017-10-10 23:34:42.560655|2017-10-10 23:34:42.560655
NCT02366624|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-06-25|||February 2013||2013-02-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01|1 Year|Observational [Patient Registry]|||Effect of Bariatric Surgery on Bile Acid Homeostasis|Effect of Gastric Bypass, Sleeve Gastrectomy and Duodenal-jejunal Bypass on Bile Acid Homeostasis|Completed||Phase 3|104|Actual|Pontificia Universidad Catolica de Chile|||1||f||||t||||||Samples Without DNA|"     -  Blood samples (serum and plasma).        -  Stool samples.        -  Liver samples.   "|||2017-10-10 23:34:43.041581|2017-10-10 23:34:43.041581
NCT02366611|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-11-08|||November 2014||2014-11-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer|Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Locally Advanced Head and Neck Cancer|Active, not recruiting||N/A|40|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 23:34:43.103845|2017-10-10 23:34:43.103845
NCT02366598|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-26|||May 2015||2015-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||A FINEH Protein Trial - Part 1|Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 1 - Acute Effects of Hemp Protein on Blood Glucose, Appetite, Blood Pressure and Food Intake.|Active, not recruiting||N/A|31|Actual|University of Manitoba||5|||f||||f||||||||||2017-10-10 23:34:43.176461|2017-10-10 23:34:43.176461
NCT02366585|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-04-06|||March 2015||2015-03-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal Pockets|The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal Pockets|Completed||Phase 2|23|Actual|PerioC Limited||1|||f||||f||||||||||2017-10-10 23:34:43.378543|2017-10-10 23:34:43.378543
NCT02366572|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-09-26|||March 2016||2016-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||PERFECT Project - Part 1 - Study 2|Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 1 - Acute Effects of Pulse Ingredients in Snack Products on Appetite, Blood Glucose, and Food Intake in Adults - Study 2|Active, not recruiting||N/A|26|Actual|University of Manitoba||6|||f||||f||||||||||2017-10-10 23:34:43.462215|2017-10-10 23:34:43.462215
NCT02366559|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-01-11|||August 2015||2015-08-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Electrocautery vs Q-switch for Seborrheic Keratosis|Comparing the Efficacy and Risk of Adverse Events of Electrocautery Versus 532 nm Qswitched Neodymium-doped Yttrium Aluminium Garnet Laser for the Treatment of Flat Seborrheic Keratoses: A Randomized Control Trial|Withdrawn||N/A|0|Actual|Northwestern University||2|||f||||t||||||||||2017-10-10 23:34:43.565878|2017-10-10 23:34:43.565878
NCT02366546|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-07-31|||March 2015||2015-03-01|July 2017|2017-07-01||||March 2018|Anticipated|2018-03-01||Interventional|||Investigator Initiated Phase 1 Study of TBI-1301|Multi-center, Investigator Initiated Phase 1 Study of NY-ESO-1 Specific TCR Gene Transferred T Lymphocytes With Solid Tumors|Recruiting||Phase 1|12|Anticipated|Mie University||4|||f||||t||||||||||2017-10-10 23:34:43.635474|2017-10-10 23:34:43.635474
NCT02366533|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-02-27|||May 2010||2010-05-01|March 2016|2016-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|SMILES and LTC||CDC-ATN Linkage Evaluation|CDC-ATN/NICHD Testing and Linkage to Care Project|Completed||N/A|2133|Actual|University of North Carolina, Chapel Hill|||1||f||||t||||||||||2017-10-10 23:34:43.769893|2017-10-10 23:34:43.769893
NCT02366520|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-03-28|||May 2015||2015-05-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Handheld Mirror to Improve Child's Behavior During Dental Treatment|Using a Handheld Mirror to Improve Child's Behavior During Dental Treatment|Recruiting||N/A|60|Anticipated|Case Western Reserve University||2|||f||||f||||||||||2017-10-10 23:34:43.871753|2017-10-10 23:34:43.871753
NCT02366507|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-02-04|||July 2014||2014-07-01|February 2016|2016-02-01||||September 2015|Actual|2015-09-01||Observational|||Systolic Blood Pressure Measurement in Critically-ill Patients|Systolic Blood Pressure Measurement in Critically-ill Patients|Completed||N/A|12|Actual|Carolinas Healthcare System|||1||f||||f||||||||||2017-10-10 23:34:43.969312|2017-10-10 23:34:43.969312
NCT02366494|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-06-22|||March 2015||2015-03-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|February 2018|Anticipated|2018-02-01||Observational|||Micro RNAs to Predict Response to Androgen Deprivation Therapy|Utility of Exosomal microRNAs to Predict Response to Androgen Deprivation Therapy in Prostate Cancer Patients|Recruiting||N/A|60|Anticipated|Medical College of Wisconsin|||2||f||||f||||||Samples With DNA|"     Whole blood collection at pre treatment (at enrollment), 3 months post treatment, and at the     time of disease progression (or at 2 years post treatment).   "|Undecided||2017-10-10 23:34:44.046248|2017-10-10 23:34:44.046248
NCT02366481|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-06-27|||February 2015||2015-02-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes (Vita-K 'n' Adults Study)|Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes|Recruiting||Phase 1/Phase 2|60|Anticipated|Augusta University||3|||f||||t||||||||||2017-10-10 23:34:44.166966|2017-10-10 23:34:44.166966
NCT02366455|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-10-07|||August 2012||2012-08-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Observational|ATB||New Measures for Tracheobronchial Anatomy|Knowing the Right Upper Lobe Anatomy Allows for the Efficient Use of the Right-sided Double Lumen Endobronchial Tube|Unknown status|Active, not recruiting|N/A|106|Actual|Laval University|||1||f||||f||||||||||2017-10-10 23:34:44.409456|2017-10-10 23:34:44.409456
NCT02366442|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-18|||February 2015||2015-02-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Exploring Relationships Among Balance Performance, Cognitive Dysfunction, Affective Dysregulation, and Community Integration in Veterans With Traumatic Brain Injury (TBI)|Exploring Relationships Among Balance Performance, Cognitive Dysfunction, Affective Dysregulation, and Community Integration in Veterans With Traumatic Brain Injury (TBI)|Unknown status|Not yet recruiting|N/A|80|Anticipated|Washington D.C. Veterans Affairs Medical Center|||1||f||||t||||||||||2017-10-10 23:34:44.492668|2017-10-10 23:34:44.492668
NCT02366429|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-09-02|||February 2015||2015-02-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||ICBT for Antenatal Depression|Psychological Treatment Via the Internet for Antenatal Depression|Completed||N/A|60|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:34:44.564998|2017-10-10 23:34:44.564998
NCT02366416|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-07-31|||April 2015||2015-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Physical Exercise on Blood Glucose and Pain From the Muskuloskeletal System in Patients With Type 2 Diabetes|Effects of Physical Exercise on Blood Glucose and Pain From the Muskuloskeletal System in Patients With Type 2 Diabetes and Diabetes Related Complications|Recruiting||N/A|80|Anticipated|Nordsjaellands Hospital||1|||f||||f||||||||||2017-10-10 23:34:44.655523|2017-10-10 23:34:44.655523
NCT02366403|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-09-07|||October 14, 2015|Actual|2015-10-14|September 2017|2017-09-01|April 1, 2019|Anticipated|2019-04-01|March 31, 2019|Anticipated|2019-03-31||Interventional|||Breathing Meditation Intervention for Post Traumatic Stress Disorder|Breathing Meditation Intervention for Post-Traumatic Stress Disorder|Recruiting||N/A|76|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:34:44.735441|2017-10-10 23:34:44.735441
NCT02366390|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-06-22|||February 2015||2015-02-01|October 2015|2015-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|DIACOL||Dialogue Aimed at Reducing Anxiety in Patients With Severe COPD|Efficacy of a Minimal Homebased Psychoeducative Intervention Versus Usual Care for the Management of Anxiety and Dyspnea in Patients With Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 4|66|Actual|Nordsjaellands Hospital||2|||f||||f||||||||||2017-10-10 23:34:44.818007|2017-10-10 23:34:44.818007
NCT02366377|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-18|||February 2015||2015-02-01|February 2015|2015-02-01||||March 2016|Anticipated|2016-03-01||Interventional|||The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients|An Efficacy, Safety, and Tolerability Study of SHR3824 in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy|Unknown status|Not yet recruiting|Phase 1|168|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||4|||f||||||||||||||2017-10-10 23:34:44.887554|2017-10-10 23:34:44.887554
NCT02366364|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-02-18|||February 2015||2015-02-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|NRX-1074||Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled Multiple Oral Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers|Completed||Phase 1|15|Actual|Naurex, Inc||4|||f||||f||||||||||2017-10-10 23:34:45.137086|2017-10-10 23:34:45.137086
NCT02366351|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-18|||February 2015||2015-02-01|February 2015|2015-02-01||||January 2016|Anticipated|2016-01-01||Interventional|||The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Clinical Trial to Evaluate the Pharmacokinetics/Pharmacodynamics, Efficacy and Safety of SHR3824 as Monotherapy in Chinese Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Unknown status|Recruiting|Phase 1|168|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||4|||f||||||||||||||2017-10-10 23:34:45.280066|2017-10-10 23:34:45.280066
NCT02366338|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-04-30|2015-04-30||August 2014||2014-08-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01|1 Day|Observational [Patient Registry]|PROPER||PRescriptiOn PattERns Of Oral Anticoagulants|PRescriptiOn PattERns Of Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Single Center Experience From Turkey (PROPER)|Completed||N/A|148|Actual|Muğla Sıtkı Koçman University|||1||f||||f||||||||||2017-10-10 23:34:45.374537|2017-10-10 23:34:45.374537
NCT02366325|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-12|||July 2014||2014-07-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis|A Phase 2, Open-Label, Multi-Center , Dose-Finding Study of the Safety and Efficacy of Pegol-Sihematide (EPO-018B) for the Treatment of Anemia in Patients With End-Stage Renal Disease Receiving Maintenance Hemodialysis (HD)|Unknown status|Recruiting|Phase 2|60|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||3|||f||||t||||||||||2017-10-10 23:34:45.641475|2017-10-10 23:34:45.641475
NCT02366312|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-07-22|||June 2016||2016-06-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|KCOT||A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors|A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors|Active, not recruiting||Phase 2|2|Actual|The Bluestone Center for Clinical Research||1|||f||||t||||||||||2017-10-10 23:34:45.726163|2017-10-10 23:34:45.726163
NCT02366299|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-11|||February 2015||2015-02-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS.|Comparison of Sedative Effects of Sevoflurane and Dexmedetomidine on the Clinical Course of Delirium and Neuroinflammation in Patients With SIRS.|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy||2|||f||||f||||||||||2017-10-10 23:34:45.807902|2017-10-10 23:34:45.807902
NCT02366104|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-18|||December 2008||2008-12-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2011|Actual|2011-12-01||Observational|BSHA||Brasília Study on Healthy Aging|Brasília Study on Healthy Aging|Unknown status|Active, not recruiting|N/A|230|Anticipated|University of Campinas, Brazil|||1||f||||f||||||Samples With DNA|"     Plasma Leukocyte DNA   "|||2017-10-10 23:34:48.032026|2017-10-10 23:34:48.032026
NCT02366286|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-11-05|||November 2010||2010-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Identification of Chronic Hepatitis B Infections Among Somali Immigrants in Minnesota Through Community-wide Screening|Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in Somali Immigrants: Role of Viral Genetics and the Immune Response|Recruiting||N/A|1000|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     A blood draw of 45 ml. will be taken for serum, plasma and buffy coat   "|||2017-10-10 23:34:45.877817|2017-10-10 23:34:45.877817
NCT02366273|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-10-08|||February 2015||2015-02-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Observational|||Diabetes and Psoriasis|Diabetes and Psoriasis: Study on Prevalence, Role of Inflammation and Insulin-resistance|Recruiting||N/A|300|Anticipated|University of Pavia|||1||f||||f||||||||||2017-10-10 23:34:45.946746|2017-10-10 23:34:45.946746
NCT02366247|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-12|||August 2013||2013-08-01|January 2015|2015-01-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|PEG-Tα1||Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B|Combination Treatment of Polyethylene Glycol Thymosin alpha1 (PEG-Tα1) and Adefovir for Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B: A Multi-center Randomized, Double-blind, Parallel-controlled Phase Ⅲ Trial|Unknown status|Active, not recruiting|Phase 3|463|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:34:46.041053|2017-10-10 23:34:46.041053
NCT02366234|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-12-20|||January 2015||2015-01-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Symptomatic Treatment of Distal Tubercle Fractures of the Scaphoid|Symptomatic Treatment of Distal Tubercle Fractures of the Scaphoid|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||1|The investigator left the institution so the study was terminated.|f||||f||||||||||2017-10-10 23:34:46.204649|2017-10-10 23:34:46.204649
NCT02366221|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-12-07|||January 1998||1998-01-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Observational|||Upper-Extremity Bone or Joint Surgery: Long Term Outcome|Upper-Extremity Bone or Joint Surgery: Long Term Outcome|Enrolling by invitation||N/A|750|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-10 23:34:46.268257|2017-10-10 23:34:46.268257
NCT02366208|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2015-02-12|||May 2011||2011-05-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|PEG-Tα1||Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B|Combination Treatment of Polyethylene Glycol Thymosin alpha1 (PEG-Tα1) and Adefovir for Hepatitis B e Antigen (HBeAg) -Positive Chronic Hepatitis B: A Multi-center Randomized, Double-blind, Parallel-controlled Phase II Trial|Completed||Phase 2|116|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:34:46.338667|2017-10-10 23:34:46.338667
NCT02366195|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-07-04|||April 7, 2015|Actual|2015-04-07|June 2017|2017-06-01|June 29, 2018|Anticipated|2018-06-29|June 26, 2017|Actual|2017-06-26||Interventional|TVEC-325||Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma|Phase 2, Open-Label, Single-arm Trial to Evaluate the Correlation Between ORR and Baseline Intratumoral CD8+ Cell Density in Subjects With Unresected Stage IIIB to IVM1c Melanoma With Talimogene Laherparepvec|Active, not recruiting||Phase 2|112|Actual|Amgen||1|||f||||f||||||||||2017-10-10 23:34:46.456651|2017-10-10 23:34:46.456651
NCT02366182|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-07-02|||January 2015||2015-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Does Neck Circumference Help to Predict Difficult Airway in Obstetric Patients?|Does Neck Circumference Help to Predict Difficult Airway in Obstetric Patients?|Completed||N/A|94|Actual|Corniche Hospital|||1||f||||t||||||||||2017-10-10 23:34:46.62486|2017-10-10 23:34:46.62486
NCT02366169|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-03-31|||March 2015||2015-03-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01|3 Years|Observational [Patient Registry]|||Medigus Ultrasonic Surgical Endostapler (MUSE) Registry|A Worldwide Post-Market Surveillance Registry to Assess the Medigus Ultrasonic Surgical Endostapler (MUSE™) System for the Treatment of GERD|Recruiting||N/A|200|Anticipated|Medigus Ltd|||1||f||||f||||||||||2017-10-10 23:34:46.688914|2017-10-10 23:34:46.688914
NCT02366156|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-03-11|||July 2014||2014-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism|A Randomized, Double-Blind, 3-Period Crossover Study to Evaluate the Effects of a Dietary Supplement Containing Botanical Extracts on Fasting and Postprandial Lipid Metabolism in Apparently Healthy, Overweight and Obese Individuals|Completed||N/A|93|Actual|Access Business Group||3|||f||||f||||||||||2017-10-10 23:34:46.867465|2017-10-10 23:34:46.867465
NCT02366130|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-07-07|||February 2015|Actual|2015-02-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer|Phase II Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer|Recruiting||Phase 2|36|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:34:47.809167|2017-10-10 23:34:47.809167
NCT02366117|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-11|||April 2012||2012-04-01|February 2015|2015-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health Problems|Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health Problems|Unknown status|Active, not recruiting|N/A|240|Anticipated|Universidade Nova de Lisboa||2|||f||||f||||||||||2017-10-10 23:34:47.946235|2017-10-10 23:34:47.946235
NCT02366091|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-07-14|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Inflammation and Coronary Endothelial Function|Inflammation and Coronary Endothelial Function in Patients With Coronary Artery Disease|Recruiting||Phase 2|120|Anticipated|Johns Hopkins University||4|||f||||t||||||||||2017-10-10 23:34:48.112279|2017-10-10 23:34:48.112279
NCT02366078|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-03-23|||June 2015||2015-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Stress Management Training for School Staff|The Efficacy of Using Blended Learning With the Stress Management and Resilience Training (SMART) Program to Decrease Stress and Enhance Resilience in Public School Staff|Completed||N/A|105|Actual|Mayo Clinic||1|||f||||f||||||||No||2017-10-10 23:34:48.239012|2017-10-10 23:34:48.239012
NCT02366065|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-06-03|||January 2015||2015-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Does Oral Acetaminophen Lower Intraocular Pressure?|Does Oral Acetaminophen Lower Intraocular Pressure?|Completed||Early Phase 1|11|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 23:34:48.318047|2017-10-10 23:34:48.318047
NCT02366052|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-05-15|||February 1, 2015|Actual|2015-02-01|May 2017|2017-05-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|NucesNASH||Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study|Nutritional Counseling Versus Nutritional Supplements for the Treatment of NASH - a Randomized Prospective, Open Label Pilot Study (Nuces NASH)|Completed||Phase 2|42|Actual|Johannes Gutenberg University Mainz||3|||f||||t||||||||||2017-10-10 23:34:48.398258|2017-10-10 23:34:48.398258
NCT02366039|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-01-24|||September 2014||2014-09-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|VLE EMR||Probe-based Volumetric Laser Endomicroscopy (pVLE) of Endoscopic Mucosal Resection (EMR) Tissue in Patients With Barrett's Dysplasia|Probe-based Volumetric Laser Endomicroscopy (pVLE) of Endoscopic Mucosal Resection (EMR) Tissue in Patients With Barrett's Dysplasia|Enrolling by invitation||N/A|25|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 23:34:48.488122|2017-10-10 23:34:48.488122
NCT02366026|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-02-22|||June 2017||2017-06-01|February 2016|2016-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|RAISE||REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study|REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study|Not yet recruiting||Phase 3|500|Anticipated|Immune Response BioPharma, Inc.||2|||f||||t||||||||||2017-10-10 23:34:48.554524|2017-10-10 23:34:48.554524
NCT02366013|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-11-18|||January 2015||2015-01-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine|A Phase 1 Clinical Trial of the Safety and Immunogenicity of an Oral, Replicating Adenovirus 26 Vector Vaccine for HIV-1 (rcAd26.MOS1.HIV-Env) in Healthy HIV-1-uninfected Adults|Completed||Phase 1|22|Actual|International AIDS Vaccine Initiative||4|||f||||t||||||||||2017-10-10 23:34:48.641486|2017-10-10 23:34:48.641486
NCT02366000|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-02-11|||September 2010||2010-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|September 2012|Actual|2012-09-01||Interventional|||An Intervention Study: Shaping a Healthier Child|A Randomized Controlled Trial of a Brief Intervention by Parents to Prevent Their Children From Experimenting With Health Risk Behavior: a Pilot Study|Completed||N/A|88|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-10 23:34:48.731767|2017-10-10 23:34:48.731767
NCT02365987|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-03-07|||February 2015||2015-02-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|INTERFAT||The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety|The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety: a Randomised Controlled Trial. The INTER-FAT Study|Completed||N/A|12|Actual|King's College London||2|||f||||f|f|f||||||No||2017-10-10 23:34:48.817338|2017-10-10 23:34:48.817338
NCT02365974|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-08-15|||January 2017||2017-01-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TENS||Transcutaneous Electrical Nerve Stimulation (TENS) on Arterial Stiffness and Blood Pressure|Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on Arterial Stiffness and Blood Pressure in Resistant Hypertensive Individuals|Not yet recruiting||N/A|64|Anticipated|Hospital de Base||2|||f||||t||||||||No||2017-10-10 23:34:48.917684|2017-10-10 23:34:48.917684
NCT02365961|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-04-06|||April 2015||2015-04-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Hip Scope Fascia-iliaca (FI) Block Study|Reduction of Hip Arthroscopy Post-operative Pain Using Ultrasound-guided Fascia-iliaca Block|Recruiting||Phase 4|95|Anticipated|The Hawkins Foundation||2|||f||||f||||||||||2017-10-10 23:34:49.012669|2017-10-10 23:34:49.012669
NCT02365948|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-08-13|||March 2015||2015-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects|A Randomized, Double-blind, Placebo-controlled, Single Escalating Dose Study of Subcutaneous Certolizumab Pegol (CZP) to Evaluate the Pharmacokinetics and Safety of CZP in Healthy Chinese Subjects|Completed||Phase 1|36|Actual|UCB Pharma||4|||f||||f||||||||||2017-10-10 23:34:49.118455|2017-10-10 23:34:49.118455
NCT02365935|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-18|||February 2007||2007-02-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|January 2013|Actual|2013-01-01||Interventional|||4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery|Phase II Randomized Controlled Trial on the Safety and Efficacy of 4 Versus 6 Courses of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients Previously Treated With Neoadjuvant Chemotherapy Plus Radical Surgery|Completed||N/A|215|Actual|Campus Bio-Medico University||2|||f||||f||||||||||2017-10-10 23:34:49.22268|2017-10-10 23:34:49.22268
NCT02365922|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-08-23|||September 2014||2014-09-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|September 2020|Anticipated|2020-09-01||Observational|ARTFL||Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)|Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2|Recruiting||N/A|1560|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     Plasma, serum, cell lines and cerebrospinal fluid will be retained by study investigators and     stored at NIH-funded repositories.   "|||2017-10-10 23:34:49.328639|2017-10-10 23:34:49.328639
NCT02364440|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-05-07|||February 2015||2015-02-01|February 2015|2015-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Efficacy Evaluation of Ultherapy™ System in Aging Hand|Safety and Efficacy Evaluation of Ultherapy™ System in Aging Hand|Completed||N/A|7|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 23:35:04.969728|2017-10-10 23:35:04.969728
NCT02365909|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-09-15|||June 29, 2015|Actual|2015-06-29|September 2017|2017-09-01|August 30, 2016|Actual|2016-08-30|August 30, 2016|Actual|2016-08-30||Interventional|PDPH||Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)|A Prospective Randomized Double-Blind Placebo Controlled Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)|Terminated||Early Phase 1|6|Actual|University of Arkansas||2||Study stopped due to difficulty recruiting patients|f||||t||||||||||2017-10-10 23:34:49.495917|2017-10-10 23:34:49.495917
NCT02365896|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-04-24|||June 2015||2015-06-01|January 2015|2015-01-01||||May 2017|Anticipated|2017-05-01||Interventional|||Comparison of Short Term Outcomes Between Totally Laparoscopic and Laparoscopy-Assisted Distal Gastrectomy With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer||Unknown status|Not yet recruiting|N/A|176|Anticipated|Fujian Cancer Hospital||1|||f||||||||||||||2017-10-10 23:34:49.561438|2017-10-10 23:34:49.561438
NCT02365883|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-10-04|||September 2011||2011-09-01|October 2017|2017-10-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Observational|||Transrectal Photoacoustic Imaging of the Prostate|Transrectal Photoacoustic Imaging of the Prostate|Recruiting||N/A|10|Anticipated|Stanford University|||1||f|||||f|t|f|f||||||2017-10-10 23:34:49.638977|2017-10-10 23:34:49.638977
NCT02365870|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|ANXPD||Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment|Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment|Recruiting||Phase 4|60|Anticipated|Johns Hopkins University||2|||f||||f||||||||Undecided|Will determine how data will be shared once study is complete.|2017-10-10 23:34:49.705096|2017-10-10 23:34:49.705096
NCT02365857|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-01-30|||December 2014||2014-12-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Intrathecal Dexmedetomidine With Bupivacaine for Spinal Anesthesia in Cesarean Section|Effects of Intrathecal Dexmedetomidine on the Perioperative Clinical Profile of Bupivacaine-induced Spinal Anesthesia for Cesarean Section|Completed||Phase 4|120|Actual|Cairo University||4|||f||||f||||||||||2017-10-10 23:34:49.978539|2017-10-10 23:34:49.978539
NCT02365844|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-05-18|||February 2015||2015-02-01|May 2017|2017-05-01|May 18, 2018|Anticipated|2018-05-18|May 18, 2018|Anticipated|2018-05-18||Observational|||Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer|Multispectral Imaging to Characterize Patterns of Vascular Supply Within the Lymphoepithelial Mucosa of Patients With Known or Suspected Oropharyngeal Carcinoma (OPC)|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||||||||||||2017-10-10 23:34:50.089814|2017-10-10 23:34:50.089814
NCT02365831|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-06-14|||May 2015||2015-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|AMBRA||Observation of Medical Treatments in MBC HER2-negative Patients|Evaluation of Medical Treatments in MBC HER2 Negative Patients in Italy - Observational Study|Recruiting||N/A|1500|Anticipated|Consorzio Oncotech|||2||f||||t||||||Samples With DNA|"     Histologic samples for the evaluation of metastatic breast cancer according to biological     subtype definition (Luminal A, Luminal B, HER2 positive, triple-negative).   "|No||2017-10-10 23:34:50.181249|2017-10-10 23:34:50.181249
NCT02365818|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-08-08|||June 2, 2015|Actual|2015-06-02|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|BOND2||Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure|An Open Label, Single Arm, Phase II, Multicenter Study of the Safety and Efficacy of CG0070 Oncolytic Vector Regimen in Patients With Non-Muscle Invasive Bladder Carcinoma Who Have Failed BCG Therapy and Refused Cystectomy|Active, not recruiting||Phase 2|66|Actual|Cold Genesys, Inc.||1|||f||||t|t|f||||||||2017-10-10 23:34:50.301247|2017-10-10 23:34:50.301247
NCT02365805|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-03-09|||April 2014||2014-04-01|March 2017|2017-03-01|October 10, 2016|Actual|2016-10-10|October 10, 2016|Actual|2016-10-10||Interventional|BERNAQ||Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer|Randomized Open-label, Multicentric, Phase II Clinical Trial to Evaluate the Efficacy of a Neoadjuvant Chemotherapy Scheme Customized by Levels of BRCA1 in Women With Primary HER2 Negative Breast Cancer (The BERNAQ Clinical Trial)|Completed||Phase 2|30|Actual|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||3|||f||||f||||||||||2017-10-10 23:34:50.441119|2017-10-10 23:34:50.441119
NCT02365792|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2015-02-11|||May 2015||2015-05-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|ProDEms||Professional Development in Emergency Medical Services|Efficacy of a Clinical Decision Support System in Prehospital Care: Single Blind, Randomized Clinical Trial.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Katholieke Universiteit Leuven||3|||f||||f||||||||||2017-10-10 23:34:50.564338|2017-10-10 23:34:50.564338
NCT02365779|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-09-04|||January 2015||2015-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|FALLOPTIC||Optical Biopsy and Fallopian Tube|Dynamic Real-time in Vivo Confocal Laser Endomicroscopy Cellvizio® of the Fallopian Tube During Laparoscopy|Completed||N/A|40|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:34:50.659792|2017-10-10 23:34:50.659792
NCT02365766|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-09-06|||May 2015||2015-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects|Phase Ib/II Study of Neoadjuvant Pembrolizumab With Gemcitabine-Cisplatin (Cisplatin-Eligible) or Gemcitabine (Cisplatin-Ineligible) in Subjects With T2-4aN0M0 Urothelial Cancer: HCRN GU14-188|Recruiting||Phase 1/Phase 2|81|Anticipated|Hoosier Cancer Research Network||3|||f||||t||||||||||2017-10-10 23:34:50.728489|2017-10-10 23:34:50.728489
NCT02365753|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-09-13|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Effect of Pulsed Electromagnetic Field Therapy on Pain After Cesarean Delivery|Effect of Pulsed Electromagnetic Field Therapy on Pain After Cesarean Delivery|Enrolling by invitation||N/A|50|Anticipated|New York City Health and Hospitals Corporation||2|||f||||f||||||||||2017-10-10 23:34:50.864896|2017-10-10 23:34:50.864896
NCT02365740|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-18|||November 2014||2014-11-01|November 2014|2014-11-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options|Postprandial Blood Glucose Control and Gastric Emptying in Patients With Type 1 Diabetes: Pathogenetic Factors, Clinical Relevance and Possible Therapeutic Options|Unknown status|Recruiting|N/A|80|Anticipated|Federico II University||2|||f||||||||||||||2017-10-10 23:34:50.953262|2017-10-10 23:34:50.953262
NCT02365727|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2016-01-13|||April 2015||2015-04-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Exparel vs Exparel Plus ACB in TKAs|Two-arm, Double-blind Randomized Study Comparing Exparel and Exparel Plus an Adductor Canal Block in Total Knee Arthroplasty|Withdrawn||Phase 4|0|Actual|The Hawkins Foundation||2||Protocol not feasible as written|f||||f||||||||||2017-10-10 23:34:51.076284|2017-10-10 23:34:51.076284
NCT02365714|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-01-17|||February 2015||2015-02-01|June 2016|2016-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|CK-SAPBI||CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)|A Pilot Study of Stereotactic Accelerated Partial Breast Irradiation (SAPBI) for Post-Menopausal Women (>50 y/o) With Ductal Carcinoma in Situ (DCIS) or Early Stage Breast Cancer|Terminated||Phase 1/Phase 2|2|Actual|Georgetown University||1||Slow accrual|f||||t||||||||No||2017-10-10 23:34:51.173658|2017-10-10 23:34:51.173658
NCT02365701|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-08-15|||March 2015||2015-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Motilitone to Treat Functional Dyspepsia|Double-blind, Placebo-controlled, Randomized, 4-week, Phase II Clinical Trial for Assessment of Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia|Recruiting||Phase 2|42|Anticipated|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:34:51.258936|2017-10-10 23:34:51.258936
NCT02365688|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-06-20|2016-03-07||September 2014||2014-09-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Self hemodynamic baseline before surgical incision.|Hemodynamic Response During Goal Directed Fluid Therapy in the OR|Correlation of Multiple Invasive and Non-Invasive Hemodynamic Monitored Modalities to Support Goal Directed Fluid Therapy During Open Abdominal Surgery|Terminated||N/A|18|Actual|Medtronic - MITG|Reference devices did not agree so trial terminated.|1||Lack of consistent reference devices|f||||f||||||||No|Data collected for new algorithm development|2017-10-10 23:34:51.348719|2017-10-10 23:34:51.348719
NCT02365675|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-18|||January 2015||2015-01-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Wound Dressings for Pemphigus and Pemphigoid|An Open Randomized Comparative Trial of Four Different Dressings for Cutaneous Coverage in Pemphigus and Pemphigoid|Unknown status|Recruiting|N/A|12|Anticipated|Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C.||4|||f||||f||||||||||2017-10-10 23:34:51.500338|2017-10-10 23:34:51.500338
NCT02365662|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-08-18|||January 16, 2015||2015-01-16|August 2017|2017-08-01|November 25, 2018|Anticipated|2018-11-25|February 9, 2018|Anticipated|2018-02-09||Interventional|||A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor|A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor|Recruiting||Phase 1|90|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-10 23:34:51.636329|2017-10-10 23:34:51.636329
NCT02365649|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-16|2017-09-01|||March 17, 2015||2015-03-17|September 2017|2017-09-01|August 4, 2017|Actual|2017-08-04|November 25, 2016|Actual|2016-11-25||Interventional|||A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy|Completed||Phase 2|219|Actual|AbbVie||9|||f||||t||||||||||2017-10-10 23:34:51.748498|2017-10-10 23:34:51.748498
NCT02365636|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-08-29|||February 28, 2015|Actual|2015-02-28|August 2017|2017-08-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|(PHN)||A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 (4% and 8% w/w Ointment) in Patients With Postherpetic Neuralgia|Completed||Phase 2|300|Actual|Teva Pharmaceutical Industries||3|||f||||f|t|f||||||||2017-10-10 23:34:52.057435|2017-10-10 23:34:52.057435
NCT02365623|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-05-09|||February 18, 2015|Actual|2015-02-18|May 2017|2017-05-01|September 12, 2020|Anticipated|2020-09-12|July 31, 2018|Anticipated|2018-07-31||Interventional|||An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)|An Open-Label Study to Explore the Safety, Efficacy and Pharmacokinetics of TMC207 in Japanese Patients With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)|Recruiting||Phase 2|5|Anticipated|Janssen Pharmaceutical K.K.||1|||f||||f||f||||||||2017-10-10 23:34:52.272515|2017-10-10 23:34:52.272515
NCT02365610|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-04|||March 2016|Actual|2016-03-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of GWP42006 in People With Focal Seizures - Part B|A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.|Active, not recruiting||Phase 2|162|Actual|GW Research Ltd||2|||f||||t||||||||||2017-10-10 23:34:52.356968|2017-10-10 23:34:52.356968
NCT02365584|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-07-25|||January 2015||2015-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|QoL in IMBO||Quality of Life in Patients With Inoperable Malignant Bowel Obstruction|A Phase II, Multicentre, Randomized Controlled Study Evaluating The Quality Of Life In Patients With Inoperable Malignant Bowel Obstruction Treated With Lanreotide Autogel 120 mg in Combination With Standard Care vs. Standard Care Alone (QOL IN IMBO STUDY)|Recruiting||Phase 2|84|Anticipated|Ipsen||2|||f||||f||||||||||2017-10-10 23:34:52.940022|2017-10-10 23:34:52.940022
NCT02365571|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2015-06-09|||February 2015||2015-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study of LY3154207 in Healthy Participants|Single-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Cytochrome P450 Interaction Study of LY3154207 in Healthy Subjects|Completed||Phase 1|64|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-10 23:34:53.084932|2017-10-10 23:34:53.084932
NCT02365558|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-06-01|||January 2015||2015-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants|Evaluation of the Impact of Increased Gastric pH Following Omeprazole Administration on the Pharmacokinetics of Evacetrapib in Healthy Subjects|Completed||Phase 1|36|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:34:53.196431|2017-10-10 23:34:53.196431
NCT02365545|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-03-23|||February 2015||2015-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:34:53.283065|2017-10-10 23:34:53.283065
NCT02365532|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2015-05-19|||February 2015||2015-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Subjects|Completed||Phase 1|60|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-10 23:34:53.32882|2017-10-10 23:34:53.32882
NCT02365506|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2016-07-11|||July 2015||2015-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Eleclazine on QT, Safety, and Tolerability in Adults With Long QT2 Syndrome|A Double-blind, Placebo-controlled Study to Evaluate the Effect of GS-6615 on QT, Safety and Tolerability in Subjects With Long QT2 Syndrome|Completed||Phase 1|13|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-10 23:34:53.530281|2017-10-10 23:34:53.530281
NCT02365493|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-04-13|||August 2015||2015-08-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|CAMERA2||Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection|CAMERA 2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection - An Investigator-initiated, Multi-centre, Parallel Group, Open Labelled Randomised Controlled Trial|Recruiting||Phase 3|440|Anticipated|Menzies School of Health Research||2|||f||||t||||||||||2017-10-10 23:34:53.64782|2017-10-10 23:34:53.64782
NCT02365480|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-17|2017-09-22|||June 16, 2016|Actual|2016-06-16|September 2017|2017-09-01||||March 15, 2018|Anticipated|2018-03-15||Interventional|||Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission|Phase I Trial of Berberine in Subjects With Ulcerative Colitis|Recruiting||Phase 1|18|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-10 23:34:53.915636|2017-10-10 23:34:53.915636
NCT02365467|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-09-05|||April 2015||2015-04-01|September 2017|2017-09-01|October 2025|Anticipated|2025-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Evaluation of Valiant Mona LSA|Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending Thoracic Aortic Aneurysms and Chronic Dissections|Suspended||N/A|44|Anticipated|Medtronic Endovascular||1||"Paused enrollment to complete assessment of factors that could improve the procedure and   outcomes"|f||||t||||||||||2017-10-10 23:34:54.023989|2017-10-10 23:34:54.023989
NCT02365454|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-18|||August 2014||2014-08-01|February 2015|2015-02-01|August 2021|Anticipated|2021-08-01|August 2016|Anticipated|2016-08-01||Interventional|||NEXUS™ Aortic Arch Stent Graft System First In Man Study|Feasibility Clinical Study to Evaluate the Safety and Performance of the NEXUS™ Aortic Arch Stent Graft System|Recruiting||N/A|10|Anticipated|Endospan Ltd.||1|||f||||f||||||||||2017-10-10 23:34:54.101162|2017-10-10 23:34:54.101162
NCT02365441|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-09-29|||February 2015||2015-02-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|ALT GIST||A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)|A Randomised Phase II Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)|Recruiting||Phase 2|240|Anticipated|Australasian Gastro-Intestinal Trials Group||2|||f||||t||||||||||2017-10-10 23:34:54.212446|2017-10-10 23:34:54.212446
NCT02365428|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-07-03|||July 2014||2014-07-01|February 2015|2015-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evidence-based Websites to Increase Physical Activity for Pregnant Women|Pregnancy and Physical Activity: Text-message Referral to Evidence-based Websites|Completed||N/A|82|Actual|Arizona State University||4|||f||||f||||||||||2017-10-10 23:34:54.405422|2017-10-10 23:34:54.405422
NCT02365415|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2017-04-11|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement|Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement|Recruiting||Phase 2|20|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||No||2017-10-10 23:34:54.469822|2017-10-10 23:34:54.469822
NCT02365402|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2016-08-17|||January 2013||2013-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment|Efficacies of Entecavir Add on HBeAg Negative Chronic Hepatitis B Patients With HBV DNA Load ≥1000 Copies/ml After 3 Months of Peginterferon Alpha 2a Treatment|Recruiting||Phase 4|180|Anticipated|Beijing Ditan Hospital||2|||f||||f||||||||||2017-10-10 23:34:54.573541|2017-10-10 23:34:54.573541
NCT02365389|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-15|2015-02-17|||May 2014||2014-05-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|MNZ||Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis|Assiut University Hospital - Women Health Hospital|Completed||Phase 2/Phase 3|64|Actual|Assiut University||2|||f||||||||||||||2017-10-10 23:34:54.653747|2017-10-10 23:34:54.653747
NCT02365376|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-11|2015-02-11|||June 2013||2013-06-01|February 2015|2015-02-01||||||||Observational|||Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions|Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions|Unknown status|Recruiting|N/A|||BioMarin Pharmaceutical|||1||f||||f||||||||||2017-10-10 23:34:54.754548|2017-10-10 23:34:54.754548
NCT02365363|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-09-26|||October 2016||2016-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||PERFECT Project - Part 2 - Study 3|Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 3|Recruiting||N/A|30|Anticipated|University of Manitoba||6|||f||||||||||||||2017-10-10 23:34:54.81305|2017-10-10 23:34:54.81305
NCT02365350|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-11-17|||January 2015||2015-01-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Randomized Clinical Trial on Follicular Flushing in IVF|A Randomized, Controlled, Open Trial Comparing a 17 G Single Lumen Aspiration Needle With a Modified Double Lumen Needle System (STEINER-TAN Needle®) for Follicular Flushing During Oocyte Pick-up in IVF Patients With Poor Ovarian Response|Completed||N/A|80|Actual|University of Luebeck||2|||f||||f||||||||||2017-10-10 23:34:54.905792|2017-10-10 23:34:54.905792
NCT02365337|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-01-27|||April 2015||2015-04-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|||Influence of Serum Vitamin D Levels on Embryo Morphokinetic Parameters|Influence of Serum Vitamin D Levels on Embryo Morphokinetic Parameters in Women Undergoing Controlled Ovarian Hyperstimulation|Recruiting||N/A|100|Anticipated|Bahceci Clinic|||2||f||||t||||||||||2017-10-10 23:34:54.982853|2017-10-10 23:34:54.982853
NCT02365324|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-11-14|||May 2015||2015-05-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|PAWS||Peer Education About Weight Steadiness|PAWS CLUB: Peer Education About Weight Steadiness|Recruiting||Phase 1/Phase 2|480|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 23:34:55.069865|2017-10-10 23:34:55.069865
NCT02365311|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-04-15|||September 2014||2014-09-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Echocardiographic Evaluation of the Change on Pulmonary Blood Flow and Cardiac Function During One-lung Ventilation||Completed||N/A|25|Actual|Yonsei University||1|||f||||f||||||||||2017-10-10 23:34:55.165422|2017-10-10 23:34:55.165422
NCT02365298|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-06-12|2017-06-12||January 1, 2015|Actual|2015-01-01|June 2017|2017-06-01|June 1, 2015|Actual|2015-06-01|June 1, 2015|Actual|2015-06-01||Interventional||All subjects dispensed at least one study lens during the duration of the study.|Clinical and Laboratory Study of Lysozyme Deposition on Daily Disposable Contact Lenses||Completed||N/A|28|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f|f|t|f|f|t|||||2017-10-10 23:34:55.233652|2017-10-10 23:34:55.233652
NCT02365285|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-02-22|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|RDVCGH||Racial Differences in Vagal Control of Glucose Homeostasis|Racial Differences in Vagal Control of Glucose Homeostasis|Recruiting||Phase 1/Phase 2|24|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 23:34:56.992033|2017-10-10 23:34:56.992033
NCT02365272|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-02-10|||December 2012||2012-12-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department|Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of Amikacin in Patients With Severe Sepsis or Septic Shock Admitted at the Emergency Department(ED)|Completed||Phase 4|100|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-10 23:34:57.072597|2017-10-10 23:34:57.072597
NCT02365259|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-10|||January 2015||2015-01-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Phototherapy in Persons With Multiple Sclerosis|Effect of UVB Phototherapy on Serum Vitamin D in Persons With Multiple Sclerosis; a Placebo Controlled Study|Unknown status|Active, not recruiting|Phase 1|20|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 23:34:57.142296|2017-10-10 23:34:57.142296
NCT02365246|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2015-02-17|||August 2014||2014-08-01|May 2014|2014-05-01|June 2017|Anticipated|2017-06-01|December 2015|Anticipated|2015-12-01||Interventional|IGEIAAD||Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)|Interventional Trial With IgE-specific Immunoadsorption in Severe Atopic Dermatitis. Interventional Trial With IgE-specific Immunoadsorption in Severe Atopic Dermatitis.|Unknown status|Recruiting|Phase 2|15|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||t||||||||||2017-10-10 23:34:57.213933|2017-10-10 23:34:57.213933
NCT02365233|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-05-10|||May 2013||2013-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Fatty Liver Study in Patients With Type II Diabetes|A Phase IV, Open Label, Randomized Trial on the Effect of Metformin Plus Lantus Insulin, Pioglitazone, or DPP4 Inhibitor on Fatty Liver in Patients With Type II Diabetes|Recruiting||Phase 4|75|Anticipated|The University of Texas Medical Branch, Galveston||3|||f||||t||||||||||2017-10-10 23:34:57.297721|2017-10-10 23:34:57.297721
NCT02365220|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-03-30|||February 2015||2015-02-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Smartphone Application, Mood and Stress|Smartphone Application, Mood and Stress|Completed||N/A|132|Actual|University Hospital, Basel, Switzerland||4|||f||||f||||||||||2017-10-10 23:34:57.396395|2017-10-10 23:34:57.396395
NCT02365207|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-09-01|||November 2013||2013-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intravesical BCG Administration to Patients With Invasive Bladder Cancer|Evaluating Local and Regional Immune Responses to Intravesical BCG Administration to Patients With Invasive Bladder Cancer|Recruiting||N/A|25|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-10 23:34:57.470824|2017-10-10 23:34:57.470824
NCT02365194|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-08-25|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|||Modifying Risk in Ventral Hernia Patients|Modifying Risk in Ventral Hernia Patients|Active, not recruiting||N/A|284|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:34:57.545043|2017-10-10 23:34:57.545043
NCT02365181|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-08-02|||September 2014||2014-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|LIA||A Trial Between the Intra-articular Local Anesthetic Infiltration With Catheter and Interscalene Block With Catheter in Postoperative Analgesia After Shoulder Prosthesis|A Randomized Controlled Non-inferiority Trial Between the Intra-articular Local Anesthetic Infiltration With Catheter and Interscalene Block With Catheter in Postoperative Analgesia After Shoulder Prosthesis|Completed||Phase 4|98|Actual|Hospital Ambroise Paré Paris||2|||f||||f||||||||||2017-10-10 23:34:57.624374|2017-10-10 23:34:57.624374
NCT02365168|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-12-14|||September 2014||2014-09-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|TRO-FAST||Allergy Against Different Species of Fish in Children and Adolescents Allergic to Fish|Allergy Against Different Species of Fish in Children and Adolescents Allergic to Fish|Completed||N/A|44|Actual|University Hospital of North Norway||4|||f||||f||||||||||2017-10-10 23:34:57.704434|2017-10-10 23:34:57.704434
NCT02365155|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-03-07|||October 2014||2014-10-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|TIHFEP||Training Intervention in Heart Failure and Frail Elderly Population|Effectiveness of an Interdisciplinary Intervention on Frailty Geriatric Patients With Heart Failure.|Active, not recruiting||N/A|150|Anticipated|Hospital de la Ribera||2|||f||||f||||||||||2017-10-10 23:34:57.904303|2017-10-10 23:34:57.904303
NCT02365142|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-02-17|||June 2014||2014-06-01|July 2014|2014-07-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|CMM-PRGF/ART||Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma|Phase I/II. Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma(PRGF)|Unknown status|Recruiting|Phase 1/Phase 2|38|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||t||||||||||2017-10-10 23:34:58.009857|2017-10-10 23:34:58.009857
NCT02365129|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-10|||February 2015||2015-02-01|February 2015|2015-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ACTIBATE||Activating Brown Adipose Tissue Through Exercise|Activating Brown Adipose Tissue Through Exercise: Randomized Controlled Trial|Unknown status|Recruiting|N/A|180|Anticipated|Universidad de Granada||3|||f||||f||||||||||2017-10-10 23:34:58.123786|2017-10-10 23:34:58.123786
NCT02365116|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-08-11|||August 19, 2015|Actual|2015-08-19|August 2017|2017-08-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||Peer Mentorship to Reduce Suicide Risk Following Psychiatric Hospitalization|Peer Mentorship to Reduce Suicide Risk Following Psychiatric Hospitalization|Completed||N/A|79|Actual|University of Michigan||2|||f||||t||||||||||2017-10-10 23:34:58.237472|2017-10-10 23:34:58.237472
NCT02365103|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-05-02|||November 2014||2014-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|||Tea Consumption and Iron Bioavailability in Women Using a Stable Isotope|Investigation Into the Inhibitory Effects of Tea Consumption on Iron Bioavailability in a Cohort of Healthy UK Women, Using a Stable Iron Isotope|Active, not recruiting||N/A|12|Anticipated|University of Chester||4|||f||||f||||||||Yes|The results are in the writing phase, and will be available in thesis form and possibly publication. It will be available in thesis form in 2017 and publication expected to be in 2018.|2017-10-10 23:34:58.314319|2017-10-10 23:34:58.314319
NCT02365090|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-18|||February 2015||2015-02-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Binocular iPad Sub-Study|Binocular iPad Sub-Study; Suppression in Amblyopia|Recruiting||N/A|96|Anticipated|Retina Foundation of the Southwest||2|||f||||f||||||||||2017-10-10 23:34:58.408912|2017-10-10 23:34:58.408912
NCT02365077|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-10|||January 2015||2015-01-01|February 2015|2015-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|||GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population|Genome-wide Association Study Identified Susceptibility Loci for Glucocorticoid-induced Femur Head Necrosis in the Chinese Population|Recruiting||N/A|2500|Anticipated|Xijing Hospital|||2||f||||t||||||Samples With DNA|"     We will collect 4ml whole blood samples under the consent of patient and extract the genome     from the samples. During the process the blood samples will be collected strickly according     the international guide clinical blood specimen collection.   "|||2017-10-10 23:34:58.50192|2017-10-10 23:34:58.50192
NCT02365064|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-11-02|||February 2015||2015-02-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|P2P||CPAP vs ASV for Insomnia|PAP to PAP: CPAP vs ASV for Insomnia|Recruiting||Phase 4|50|Anticipated|ResMed||2|||f||||f||||||||||2017-10-10 23:34:58.57673|2017-10-10 23:34:58.57673
NCT02365051|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-07-06|||May 2015||2015-05-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|COPECT||Translation of COPE for Publicly-Funded Home Care Clients and Their Families|Translation of COPE for Publicly-Funded Home Care Clients and Their Families|Recruiting||N/A|580|Anticipated|UConn Health||2|||f||||f||||||||||2017-10-10 23:34:58.662062|2017-10-10 23:34:58.662062
NCT02365038|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-02-17|||February 2015||2015-02-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|ART2pilot||ART-2 Pilot - Driving Pressure Limited Ventilation for Patients With ARDS|ART-2 Pilot: A Controlled, Randomized Trial to Assess the Feasiblity of a Driving Pressure Limited Ventilation vs. Standard Strategy (ARDSNet) in Patients With ARDS|Unknown status|Not yet recruiting|N/A|20|Anticipated|Hospital do Coracao||2|||f||||f||||||||||2017-10-10 23:34:58.755507|2017-10-10 23:34:58.755507
NCT02365025|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2015-02-10|||February 2011||2011-02-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of a Parental Intervention on Electronic Media Exposure and Sleep Patterns in Adolescents|The Effects of a Parental Intervention on Electronic Media Exposure and Sleep Patterns in Adolescents|Completed||Phase 4|70|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-10 23:34:58.840891|2017-10-10 23:34:58.840891
NCT02365012|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-08-25|||April 2014||2014-04-01|August 2015|2015-08-01||||June 2017|Anticipated|2017-06-01||Interventional|||Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine|Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine|Unknown status|Recruiting|N/A|50|Anticipated|Corporal Michael J. Crescenz VA Medical Center||2|||f||||f||||||||||2017-10-10 23:34:58.90757|2017-10-10 23:34:58.90757
NCT02364999|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-28|||April 20, 2015|Actual|2015-04-20|September 2017|2017-09-01|December 8, 2017|Anticipated|2017-12-08|May 8, 2017|Actual|2017-05-08||Interventional|||A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC|A Phase 3 Randomized, Double-blind Study Of Pf- 06439535 Plus Paclitaxel-carboplatin And Bevacizumab Plus Paclitaxel -Carboplatin For The First-line Treatment Of Patients With Advanced Non-squamous Non-small Cell Lung Cancer.|Active, not recruiting||Phase 3|719|Actual|Pfizer||2|||f||||t||||||||||2017-10-10 23:34:59.0217|2017-10-10 23:34:59.0217
NCT02362360|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-08-18|2016-08-18||February 2015||2015-02-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Investigation of a New 2-piece Ostomy Product in People With an Ileostomy or Colostomy|Investigation of a New 2-piece Ostomy Product in People With an Ileostomy or Colostomy|Completed||N/A|52|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-10 23:35:24.828653|2017-10-10 23:35:24.828653
NCT02364986|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-06-02|||January 2015||2015-01-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|RESI||Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis|Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis|Recruiting||Phase 1|50|Anticipated|University Hospital, Bonn||1|||f||||f||||||||||2017-10-10 23:34:59.683355|2017-10-10 23:34:59.683355
NCT02364973|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-11-03|||November 2014||2014-11-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study|Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study|Recruiting||N/A|50|Anticipated|Turku University Hospital|||1||f||||f||||||||||2017-10-10 23:34:59.777991|2017-10-10 23:34:59.777991
NCT02364960|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-08-10|||January 2015||2015-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01|10 Years|Observational [Patient Registry]|TARGIT||Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)|Implementation of the Target Intraoperative Therapy Registry at Bethesda North TriHealth Hospital (TARGIT)|Terminated||N/A|16|Actual|TriHealth Inc.|||1|Study site will join the TARGIT-US trial in lieu of this trial|f||||f||||||||No||2017-10-10 23:34:59.852757|2017-10-10 23:34:59.852757
NCT02364947|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-06-05|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)||Completed||Phase 3|678|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-10 23:34:59.924096|2017-10-10 23:34:59.924096
NCT02364934|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-02-24|||March 2015||2015-03-01|February 2015|2015-02-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|||Pharmacokinetics and Pharmacodynamics of Rocuronium in Closed－Loop Infusion System|Effect of Different Anesthetics on Pharmacokinetics and Pharmacodynamics of Rocuronium in Closed－Loop Muscle Relaxant Infusion System|Not yet recruiting||N/A|240|Anticipated|Tianjin Medical University General Hospital|||8||f||||f||||||||||2017-10-10 23:35:00.017223|2017-10-10 23:35:00.017223
NCT02364921|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-08-11|||June 2014||2014-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Double-layer Compression Therapy in the Healing of Chronic Venous Ulcers in Primary Health Care|Effectiveness of Double-layer Compression Therapy in the Healing of Chronic Venous Ulcers in Primary Health Care. Randomized Clinical Trial|Recruiting||N/A|90|Anticipated|Gerencia de Atención Primaria, Madrid||2|||f||||f||||||||||2017-10-10 23:35:00.104192|2017-10-10 23:35:00.104192
NCT02364908|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-08-22|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ESSTIM||Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus|Prospective Evaluation of Adherence to Antimalarials in Patients With Systemic Lupus and Role of Therapeutic Education|Recruiting||N/A|160|Anticipated|University Hospital, Lille||1|||f||||f|f|f||||||||2017-10-10 23:35:00.204164|2017-10-10 23:35:00.204164
NCT02364895|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-02-10|||November 2013||2013-11-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||ColonCancerCheck Mailed Invitations: An Evaluation|ColonCancerCheck Mailed Invitations: An Evaluation|Completed||N/A|75317|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 23:35:00.317224|2017-10-10 23:35:00.317224
NCT02364882|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-06-19|||January 2015||2015-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women|A Phase 1, Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Vulvar-Vaginal Safety and Pharmacokinetic Profile of SST-6006, a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women|Completed||Phase 1|21|Actual|Strategic Science & Technologies, LLC||4|||f||||f||||||||||2017-10-10 23:35:00.387143|2017-10-10 23:35:00.387143
NCT02364869|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-06|||May 2015||2015-05-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Prebiotic in Chronic Kidney Disease Patients|Effect of Prebiotic (Fructooligosaccharide) on Uremic Toxins and Cardiovascular Markers of Chronic Kidney Disease Patients|Completed||N/A|50|Actual|Federal University of São Paulo||2|||f||||t||||||||Undecided||2017-10-10 23:35:00.484969|2017-10-10 23:35:00.484969
NCT02364856|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-06-06|||April 24, 2015|Actual|2015-04-24|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Pain Assessment in Children With Cerebral Palsy Through Parasympathetic Tone Analysis.|Assessment of Pain Through Parasympathetic Tone Analysis : Applicability in Children With Cerebral Palsy.|Recruiting||N/A|40|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||No||2017-10-10 23:35:00.586228|2017-10-10 23:35:00.586228
NCT02364843|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-01-30|||February 2016|Actual|2016-02-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|INFORALTHR||A Physiological Study to Determine the Enteral Threonine Requirements in Infants Aged 1 to 6 Months|A Physiological Study to Determine the Enteral Threonine Requirements in Infants Aged 1 to 6 Months|Enrolling by invitation||N/A|18|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||No||2017-10-10 23:35:00.695145|2017-10-10 23:35:00.695145
NCT02364830|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-10|||April 2013||2013-04-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|IBS-Anise||Clinical Effectiveness of Enteric Coated(E.C.) Anise-oil on Irritable Bowel Syndrome|Randomised Clinical Trial: Enteric-coated Anise-oil Capsules vs. Placebo & Active Controlled in Irritable Bowel Syndrome - A 4 Week Double-blind Study With 2 Weeks Follow-up|Completed||Phase 3|120|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-10-10 23:35:00.803261|2017-10-10 23:35:00.803261
NCT02364817|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-08-22|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|AGADIR||ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse|Impact of Attention Deficit/Hyperactivity Disorder on the Post-detoxification Alcohol Relapse Rate|Recruiting||N/A|132|Anticipated|University Hospital, Lille|||1||f||||f|f|f||||||||2017-10-10 23:35:00.885427|2017-10-10 23:35:00.885427
NCT02364804|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-09-21|||April 2012||2012-04-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|March 2015|Actual|2015-03-01||Observational|||A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer|A Study to Evaluate the Efficacy of Anti-emetic Drug Aprepitant Upon the Combination Chemotherapy of Nedaplatin and Docetaxel for Non-small Cell Lung Cancer|Unknown status|Active, not recruiting|N/A|10|Anticipated|Shiga University|||1||f||||f||||||||||2017-10-10 23:35:00.988691|2017-10-10 23:35:00.988691
NCT02364791|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-03-28|||February 2015||2015-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|Hemopatch||A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures|A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (> 5 Days - PAL).|Recruiting||Phase 2|120|Anticipated|National Cancer Institute, Naples||2|||f||||f||||||||||2017-10-10 23:35:01.054502|2017-10-10 23:35:01.054502
NCT02364778|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-05-25|2016-04-20||December 2014||2014-12-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|1 Year|Observational [Patient Registry]||The study group consisted of 30 patients with 30 bifurcation coronary lesions that did not involve SB ostium.|Single-centre, Registry Trial, the Patients Presented With Stable Coronary Artery Disease|ORBID Trial: Three-Dimensional (3D) Optical Coherence Tomography Guided Assessment of Side Branch Vessel After Provisional Main Vessel Stenting in Coronary Artery Stenting|Completed||N/A|30|Actual|Icahn School of Medicine at Mount Sinai|Small number of cases. Results represent a hypothesis-generating pilot study rather than a definitive result.||1||f||||f||||||||||2017-10-10 23:35:01.290561|2017-10-10 23:35:01.290561
NCT02364765|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-10|||August 2010||2010-08-01|February 2015|2015-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Assessment of Hematologic Parameters Before and After Bimaxillary Orthognathic Surgery|Assessment of Changes of Hematological Parameters and Need for Blood Transfusion in Bimaxillary Orthognathic Surgery|Completed||N/A|53|Actual|Federal University of Minas Gerais||1|||f||||f||||||||||2017-10-10 23:35:01.873405|2017-10-10 23:35:01.873405
NCT02364752|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-03-10|||September 2015||2015-09-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|March 2016|Anticipated|2016-03-01||Interventional|||A Study Evaluating Biomarkers in Participants With Heart Failure (MK-0000-344)|A Clinical Trial to Evaluate Circulating and Imaging Biomarkers in Heart Failure Patients|Withdrawn||Phase 1|0|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-10 23:35:01.953829|2017-10-10 23:35:01.953829
NCT02364739|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-02-17|||January 2014||2014-01-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|QUESE2||Evaluate Educational Interventions for Increasing Fertility Knowledge and Awareness|A Randomized Controlled Trial to Evaluate Two Educational Interventions for Increasing Fertility Knowledge and Awareness in Oocyte Donors|Completed||N/A|201|Actual|Fundació Privada Eugin||3|||f||||f||||||||||2017-10-10 23:35:02.05388|2017-10-10 23:35:02.05388
NCT02364726|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-07-25|||February 2015|Actual|2015-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients|Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients: A Pilot Study|Active, not recruiting||N/A|28|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:35:02.148754|2017-10-10 23:35:02.148754
NCT02364713|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-04-19|||March 2015||2015-03-01|December 2016|2016-12-01|February 2025|Anticipated|2025-02-01|February 2025|Anticipated|2025-02-01||Interventional|||MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer|A Randomized Phase II Trial of a Genetically Engineered NIS-Expressing Strain of Measles Virus Versus Investigator's Choice Chemotherapy for Patients With Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer|Recruiting||Phase 2|134|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:35:02.243448|2017-10-10 23:35:02.243448
NCT02364700|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-06-13|2017-02-07||March 2015||2015-03-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Portable EMG-triggered Hand Robot for Individuals After Stroke|Hand Training Utilizing an Electromyography-triggered Hand Robot for Individuals After Chronic Stroke|Completed||N/A|12|Actual|Rehab-Robotics Company Limited||1|||f||||f||||||||||2017-10-10 23:35:02.415547|2017-10-10 23:35:02.415547
NCT02364687|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-11-16|||October 2013||2013-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Observational|||Optimisation and Quantification of Contrast Enhanced Computed Tomography Myocardial Fibrosis Imaging|Optimisation and Quantification of Contrast Enhanced Computed Tomography|Active, not recruiting||N/A|40|Anticipated|University of Edinburgh|||1||f||||f||||||||||2017-10-10 23:35:02.686543|2017-10-10 23:35:02.686543
NCT02364674|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-03-28|||February 2015||2015-02-01|February 2016|2016-02-01|January 9, 2017|Actual|2017-01-09|January 9, 2017|Actual|2017-01-09||Interventional|TROFI||Transplant Optimization Using Functional Imaging|Transplant Optimization Using Functional Imaging|Completed||N/A|8|Actual|FLUIDDA nv||1|||f||||f||||||||||2017-10-10 23:35:02.753722|2017-10-10 23:35:02.753722
NCT02364661|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-10|||March 2015||2015-03-01|February 2015|2015-02-01||||March 2016|Anticipated|2016-03-01||Interventional|||The Influence of Short-term Starvation on Hepatitis B Virus Load|The Influence of Short-term Starvation on Disease Severity and Viral Replication Among Hepatitis B Virus Patients|Unknown status|Not yet recruiting|N/A|60|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-10 23:35:02.85045|2017-10-10 23:35:02.85045
NCT02364648|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-08-30|||July 1, 2017|Actual|2017-07-01|August 2017|2017-08-01|February 28, 2019|Anticipated|2019-02-28|January 30, 2019|Anticipated|2019-01-30||Interventional|||Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease|Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease|Recruiting||Phase 4|24|Anticipated|University of Delaware||2|||f||||t|f|f||||||||2017-10-10 23:35:02.930579|2017-10-10 23:35:02.930579
NCT02364635|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-09-28|||February 2015||2015-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects|PRC 4016 (Icosabutate) - A Phase I, Single-Blind, Placebo Controlled, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects|Completed||Phase 1|32|Actual|Pronova BioPharma||5|||f||||f||||||||||2017-10-10 23:35:03.042498|2017-10-10 23:35:03.042498
NCT02364622|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-17|||October 2013||2013-10-01|October 2013|2013-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effects of Flexible Intubating Stylet in the Accurate Placement of Double-lumen Endobronchial Tube|The Effects of Flexible Trachway(R) Intubating Stylet in the Accurate Placement of Left-sided Double-lumen Endobronchial Tube|Completed||N/A|120|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||f||||||||||2017-10-10 23:35:03.132022|2017-10-10 23:35:03.132022
NCT02364609|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-13|||September 2015||2015-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib|A Phase I/Ib Trial of MK-3475 (Pembrolizumab) and Afatinib in EGFR-Mutant Non-small Cell Lung Cancer With Resistance to Erlotinib|Recruiting||Phase 1|38|Anticipated|University of California, Davis||2|||f||||t|t|f||||||||2017-10-10 23:35:03.233495|2017-10-10 23:35:03.233495
NCT02364596|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-04-01|||January 2015||2015-01-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years|A Phase 1, Single-arm, Open-label Study To Confirm The Safety, Tolerability, And Immunogenicity Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years|Completed||Phase 1|100|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:35:03.357011|2017-10-10 23:35:03.357011
NCT02364583|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2015-10-12|||June 2010||2010-06-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection|Safety, Tolerability and Pilot Efficacy of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection|Unknown status|Recruiting|Phase 4|150|Anticipated|Papua New Guinea Institute of Medical Research||3|||f||||f||||||||||2017-10-10 23:35:03.441927|2017-10-10 23:35:03.441927
NCT02364570|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-09-06|||January 2015||2015-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cardioprotective Activities Of Whole Eggs On Vascular Endothelial Function In Prediabetic Adults|Cardioprotective Activities Of Whole Eggs On Vascular Endothelial Function In Prediabetic Adults|Active, not recruiting||N/A|20|Actual|Ohio State University||4|||f||||f||||||||||2017-10-10 23:35:03.562839|2017-10-10 23:35:03.562839
NCT02364557|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-06-17|||December 2014||2014-12-01|June 2016|2016-06-01||||December 2022|Anticipated|2022-12-01||Interventional|||Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer|A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer|Recruiting||Phase 2/Phase 3|402|Anticipated|NRG Oncology||2|||f||||||||||||||2017-10-10 23:35:03.685829|2017-10-10 23:35:03.685829
NCT02364544|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-03-22|||April 2013||2013-04-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ICRC||Improving Care and Reducing Cost Study|The Improving Care and Reducing Cost (ICRC) Program|Completed||N/A|461|Actual|Northwell Health||1|||f||||t||||||||||2017-10-10 23:35:03.988891|2017-10-10 23:35:03.988891
NCT02364531|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-06-01|||September 30, 2014|Actual|2014-09-30|June 2017|2017-06-01|October 30, 2018|Anticipated|2018-10-30|August 15, 2017|Anticipated|2017-08-15||Observational|COSMiC||A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting|A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting. The COSMiC Prospective Prostate Cancer Registry|Recruiting||N/A|260|Anticipated|Janssen Inc.|||1||f||||f||||||||||2017-10-10 23:35:04.219167|2017-10-10 23:35:04.219167
NCT02364518|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-02-10|||February 2014||2014-02-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||TranQuill™ Sling Snoreplasty for Snoring and Mild Obstructive Sleep Apnea:|TranQuill™ Sling Snoreplasty for Snoring and Mild Obstructive Sleep Apnea: A Single-arm, Pilot Study for Safety and Effectiveness|Completed||N/A|20|Actual|Medical University of South Carolina||1|||f||||f||||||||||2017-10-10 23:35:04.415239|2017-10-10 23:35:04.415239
NCT02364505|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-08-02|||September 2014||2014-09-01|January 2016|2016-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||A Telemedicine Mindfulness-based Intervention for People With Multiple Sclerosis and Their Caregivers|Improving the Quality of Life of People With Multiple Sclerosis and Their Caregivers With a Telemedicine Mindfulness-Based Intervention|Completed||N/A|156|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||||2017-10-10 23:35:04.494793|2017-10-10 23:35:04.494793
NCT02364492|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-05-30|||February 2015||2015-02-01|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|December 2017|Anticipated|2017-12-01||Interventional|MAGTRIVACSEIN||A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse|An Open Label First-in-Human Adjuvant Phase I Study of a Synthetic Multiple Antigenic Glycopeptide Displaying a Tri Tn Glycotop (MAG-Tn3) Plus AS15, as a Therapeutic Vaccine Candidate in Patients With Non Metastatic, HER2 Negative Localized Breast Cancer at High-Risk of Relapse|Recruiting||Phase 1|30|Anticipated|Institut Pasteur||1|||f||||t||||||||||2017-10-10 23:35:04.591496|2017-10-10 23:35:04.591496
NCT02364479|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-04-13|||July 2014||2014-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein|Treatment of Active Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein Injection: a Randomized, Double-blind, Multicentral Clinical Trial to Investigate the Efficacy and Safety of Yisaipu®|Active, not recruiting||Phase 4|180|Anticipated|Sun Yat-sen University||3|||f||||f||||||||||2017-10-10 23:35:04.679886|2017-10-10 23:35:04.679886
NCT02364466|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-10|||January 2015||2015-01-01|February 2015|2015-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|2019 Years|Observational [Patient Registry]|||Cohort of Peripheral T Cell Lymphoma|Multicenter Prospective Cohort Study of Peripheral T Cell Lymphoma|Recruiting||N/A|200|Anticipated|Korea Cancer Center Hospital|||1||f||||f||||||||||2017-10-10 23:35:04.762485|2017-10-10 23:35:04.762485
NCT02364453|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-02-10|||February 2015||2015-02-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients|The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients|Unknown status|Recruiting|N/A|18|Anticipated|Danish Headache Center||3|||f||||t||||||||||2017-10-10 23:35:04.886081|2017-10-10 23:35:04.886081
NCT02364427|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-09-11|||April 2015||2015-04-01|February 2015|2015-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|Heart-AKI||Arterial Stiffness and AKI Post-CABG|Arterial Stiffness and Acute Kidney Injury Post-Coronary Artery Bypass Graft Surgery|Unknown status|Recruiting|Phase 1/Phase 2|200|Anticipated|King's College Hospital NHS Trust||1|||f||||f||||||||||2017-10-10 23:35:05.051207|2017-10-10 23:35:05.051207
NCT02364414|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-09-23|||December 2014||2014-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||The Accuracy of Direct Digital Intra-oral Scanning Measurements Compared to Measurements on Study Models|The Accuracy of Direct Digital Intra-oral Scanning Measurements Compared to Measurements on Study Models|Completed||N/A|22|Actual|Kettering General Hospital NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:35:05.138257|2017-10-10 23:35:05.138257
NCT02364401|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-08-16|||February 2015||2015-02-01|August 2016|2016-08-01|December 15, 2016|Actual|2016-12-15|November 15, 2016|Actual|2016-11-15||Interventional|||Impedance vs. Contact Force Guided Atrial Fibrillation Ablation Using Automated Annotation System|Comparison of Efficacy Between Impedance Guided and Contact Force Guided Atrial Fibrillation Ablation Using Automated Annotation System|Completed||N/A|50|Actual|Keimyung University Dongsan Medical Center||2|||f||||t||||||||||2017-10-10 23:35:05.220167|2017-10-10 23:35:05.220167
NCT02364375|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2016-11-06|||March 2017||2017-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:35:05.379689|2017-10-10 23:35:05.379689
NCT02364362|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-02-10|||November 2014||2014-11-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|June 2015|Anticipated|2015-06-01||Interventional|||A Study of Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)|Docetaxel Plus Famitinib Versus Docetaxel Plus Placebo in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 1|22|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:35:05.417922|2017-10-10 23:35:05.417922
NCT02364349|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-08-30|||January 2015||2015-01-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Comparative Study on Local Allergic Responses of Bee Venom and Essential Bee Venom Pharmacopuncture|A Comparative Study on Local Allergic Responses of Bee Venom and Essential Bee Venom Pharmacopuncture|Completed||Phase 1|20|Actual|Jaseng Hospital of Korean Medicine||2|||f||||f||||||||No||2017-10-10 23:35:05.507604|2017-10-10 23:35:05.507604
NCT02364336|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-14|2017-10-04|||February 6, 2015||2015-02-06|September 26, 2017|2017-09-26|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B|Mechanisms Associated With Favorable Response to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B|Recruiting||Phase 2|60|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:35:05.603357|2017-10-10 23:35:05.603357
NCT02364323|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-01-26|||February 2015||2015-02-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Genetic Testing and Counseling to Reduce Diabetic Complications|A Randomized Clinical Trial to Compare a Strategy Utilizing Genetic Testing and Personalized Risk Counseling With Standard Care on Patient Empowerment, Risk Factors Control and the Risk of Diabetic Complications|Recruiting||N/A|400|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:35:05.693632|2017-10-10 23:35:05.693632
NCT02364310|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-08-31|||March 2015||2015-03-01|August 2015|2015-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|ESTIM-rHTN||Economic Evaluation of Baroreceptor STIMulation for the Treatment of Resistant HyperTensioN|Evaluation médico-économique de la Stimulation unilatérale du Sinus Carotidien Dans le Traitement de l'Hypertension artérielle résistante: Essai Multicentrique contrôlé, randomisé, Ouvert Avec évaluation d'efficacité Tensionnelle et de sécurité|Recruiting||N/A|128|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 23:35:05.802983|2017-10-10 23:35:05.802983
NCT02364297|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-06-16|||September 2015||2015-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|TFB||TIPS in Fundal Variceal Bleeding (the TFB Study)|Efficacy of Early-TIPS in the Treatment of Acute Variceal Bleeding From Gastric Fundal Varices: a RCT vs Standard Therapy|Recruiting||N/A|60|Anticipated|Institut d'Investigacions Biomèdiques August Pi i Sunyer||2|||f||||t||||||||||2017-10-10 23:35:05.954546|2017-10-10 23:35:05.954546
NCT02364284|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-09-01|||February 2015||2015-02-01|September 2017|2017-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|RECOMMEND||Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP|Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With Complicated Urinary Tract Infection,Complicated Intra-abdominal Infection and Nosocomial Pneumonia Including Ventilator-associated Pneumonia.|Completed||N/A|1322|Actual|Pfizer|||3||f||||f||||||||||2017-10-10 23:35:06.056695|2017-10-10 23:35:06.056695
NCT02364258|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-07-18|||July 2014||2014-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SD2||Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients|Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients: Clinical Impact of Genetic Variation in Statin Disposition|Recruiting||Phase 1|34|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-10-10 23:35:06.302402|2017-10-10 23:35:06.302402
NCT02364245|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-08-01|||November 2014||2014-11-01|November 2014|2014-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluation the Feasibility and Effects of Kinect-based Computer Games as UE Training Tool in Cerebral Palsy Children|Design and Evaluation the Feasibility, Effects of Kinect-based Computer Games as Upper Extremity Training Tool in Children With Cerebral Palsy|Completed||N/A|13|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-10 23:35:06.414565|2017-10-10 23:35:06.414565
NCT02364232|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-05-17|||September 2014||2014-09-01|November 2016|2016-11-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|||Effects of Home-based vs. Clinic-based Rehabilitation on Sensorimotor, Cognition, Daily Function, and Participation|Effects of Home-based vs. Clinic-based Rehabilitation on Sensorimotor, Cognition, Daily Function, and Participation: Bilateral Training With and Without Mirror Feedback Program|Completed||N/A|24|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:35:06.51939|2017-10-10 23:35:06.51939
NCT02364219|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-02-19|||February 2015||2015-02-01|February 2015|2015-02-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|PREWARM||Impact of Prewarming on Perioperative Body Core Temperature and the Outcomes of Cytoreductive- and Major Open Abdominal Surgery: A Randomised Trial|Impact of Prewarming on Perioperative Body Core Temperature and the Outcomes of Cytoreductive- and Major Open Abdominal Surgery: A Randomised Trial (PREWARM)|Unknown status|Recruiting|N/A|48|Anticipated|Charite University, Berlin, Germany||4|||f||||f||||||||||2017-10-10 23:35:06.607003|2017-10-10 23:35:06.607003
NCT02364206|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-07-18|||June 8, 2015|Actual|2015-06-08|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|GLYRad||Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma|Phase I/II Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma|Recruiting||Phase 1/Phase 2|50|Anticipated|Centre Jean Perrin||1|||f||||t||||||||||2017-10-10 23:35:06.694512|2017-10-10 23:35:06.694512
NCT02364193|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-01-27|||March 2015||2015-03-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Thoracic Fluid Assessment by Contrast-enhanced Magnetic Resonance Imaging and Bioimpedance|Thoracic Fluid Assessment by Dynamic Contrast-enhanced Magnetic Resonance Imaging and Bioimpedance Spectroscopy: An Explorative Study in Healthy Subjects|Completed||N/A|14|Actual|Catharina Ziekenhuis Eindhoven||1|||f||||f||||||||||2017-10-10 23:35:06.791845|2017-10-10 23:35:06.791845
NCT02364180|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-03-31|2016-11-21||December 2013||2013-12-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Electromyography in Patients on Chronic Pyridostigmine Therapy|Electromyography With Repetitive Nerve Stimulation in Patients on Chronic Pyridostigmine Therapy|Completed||N/A|11|Actual|University of Toledo Health Science Campus||1|||f||||f||||||||No||2017-10-10 23:35:06.862084|2017-10-10 23:35:06.862084
NCT02364167|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-06-27|||January 2015||2015-01-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|ACUSEC||Acupuncture for Pain Control After Elective Caesarean Section|Acupuncture vs. Placebo Acupuncture and vs. Standard Therapy for Pain Control After Elective Caesarean Section - a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|180|Anticipated|University Medicine Greifswald||3|||f||||f||||||||||2017-10-10 23:35:06.991054|2017-10-10 23:35:06.991054
NCT02364154|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-16|||December 2014||2014-12-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01|3 Weeks|Observational [Patient Registry]|BIOCOR||Colorectal Cancer Detected by 1H-NMR Spectroscopy|Metabolic Phenotyping of Blood Plasma by Means of 1H-NMR Spectroscopy: a New Tool to Detect Colorectal Cancer?|Unknown status|Recruiting|N/A|100|Anticipated|Hasselt University|||2||f||||f||||||Samples Without DNA|"     -  blood plasma for NMR spectroscopy        -  blood sample for free circulating miRNA   "|||2017-10-10 23:35:07.083356|2017-10-10 23:35:07.083356
NCT02364141|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-13|||August 2004||2004-08-01|February 2015|2015-02-01|July 2008|Actual|2008-07-01|November 2007|Actual|2007-11-01||Interventional|||Trunk Restraint Therapy in Post-stroke Patients.|Trunk Restraint Therapy: the Continuous Use of the Harness Could Promote Feedback Dependence in Post-stroke Patients. A Randomized Trial.|Completed||N/A|40|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-10 23:35:07.298673|2017-10-10 23:35:07.298673
NCT02364128|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-04-26|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PCORI||Improving Patient Decisions About Bariatric Surgery|Patient-Centered Outcomes Research Institute (PCORI)- Improving Patient Decisions About Bariatric Surgery|Active, not recruiting||Phase 2|1000|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 23:35:07.403838|2017-10-10 23:35:07.403838
NCT02364115|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2016-07-04|||January 2015||2015-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|VERTICAL||Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy in Patients With Bone Metastases - VERTICAL Study|Randomized Controlled Trial Comparing Conventional Radiotherapy With Stereotactic Body Radiotherapy in Patients With Bone Metastases - VERTICAL Study|Recruiting||N/A|110|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-10 23:35:07.492886|2017-10-10 23:35:07.492886
NCT02364102|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-08-25|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Effect of Hypothyroidism on Brown Adipose Tissue|Effect of Restoration of Euthyroidism in Patients With Primary Hypothyroidism on Brown Adipose Tissue Thermogenesis - the ThyroBAT Study|Completed||N/A|42|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:35:07.604473|2017-10-10 23:35:07.604473
NCT02364089|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-13|||January 2015||2015-01-01|February 2015|2015-02-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|CHIRACIC||Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas|Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas|Recruiting||N/A|110|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 23:35:07.680186|2017-10-10 23:35:07.680186
NCT02364076|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-07-07|||March 2015||2015-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||MK-3475 in Patients With Thymic Carcinoma|A Phase II Study of MK-3475 in Patients With Thymic Carcinoma|Active, not recruiting||Phase 2|41|Actual|Georgetown University||1|||f||||t||||||||||2017-10-10 23:35:07.846113|2017-10-10 23:35:07.846113
NCT02364063|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-01-03|||September 2014||2014-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Micturition Reeducation in Children With Cerebral Palsy|Micturition Reeducation in Children With Cerebral Palsy|Completed||N/A|40|Actual|University Hospital, Ghent||3|||f||||f||||||||||2017-10-10 23:35:07.92811|2017-10-10 23:35:07.92811
NCT02364050|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-15|||September 2013||2013-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||Prospective Data Collection of Elderly Patients With DLBCL Receiving at the Time of Diagnosis VGM|Prospective Data Collection of Elderly Patients (≥ 65 Years) With Diffuse Large B-cell Lymphoma (DLBCL) Receiving at the Time of Diagnosis Multidimensional Geriatric Assessment (VGM)|Recruiting||N/A|1300|Anticipated|Fondazione Italiana Linfomi ONLUS|||1||f||||f||||||||||2017-10-10 23:35:08.027038|2017-10-10 23:35:08.027038
NCT02364037|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-06-24|||August 2013||2013-08-01|June 2015|2015-06-01||||July 2016|Anticipated|2016-07-01||Observational|IMPACCT||Innovative Model of Patient-Centered ConTraception|Implementation of Patient-Centered Contraception Provision in Community Settings|Unknown status|Recruiting|N/A|960|Anticipated|Washington University School of Medicine|||2||f||||f||||||||||2017-10-10 23:35:08.371181|2017-10-10 23:35:08.371181
NCT02364024|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-05-27|||November 2005||2005-11-01|May 2016|2016-05-01||||May 2009|Actual|2009-05-01||Observational|CD3-OncoQuant||Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal Carcinomas|Biomarker Validation Study of Linear Quantification of CD3 Positive Cells in Localized Colorectal Carcinomas, Based on the Cohort of Patient Included in PETACC8 International Phase III Trial (NCT00265811)|Completed||N/A|856|Actual|Federation Francophone de Cancerologie Digestive|||2||f||||f||||||Samples With DNA|"     Tissues: colorectal carcinoma and adjacent non-tumor tissues are collected in formalin fixed     paraffin embedded blocks.   "|||2017-10-10 23:35:08.484419|2017-10-10 23:35:08.484419
NCT02364011|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-15|||November 2014||2014-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Outcomes Following Total Knee Arthroplasty|Clinical and Biomechanical Outcomes Following Total Knee Arthroplasty|Enrolling by invitation||N/A|1100|Anticipated|University of Utah|||1||f||||t||||||||||2017-10-10 23:35:08.550305|2017-10-10 23:35:08.550305
NCT02363998|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-05-01||2016-10-04|February 2015||2015-02-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|NU LEAF||Open-Label, Safety Study of Lofexidine|A Phase 3, Open-Label, Safety Study of Lofexidine|Completed||Phase 3|286|Actual|US WorldMeds LLC||1|||f||||t||||||||||2017-10-10 23:35:08.616121|2017-10-10 23:35:08.616121
NCT02363985|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-02-14|||November 2015||2015-11-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection|Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection in Ethiopia|Unknown status|Not yet recruiting|N/A|110|Anticipated|Ethiopian Public Health Institute||2|||f||||t||||||||||2017-10-10 23:35:08.739486|2017-10-10 23:35:08.739486
NCT02363972|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-07-11|||February 2015||2015-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD|Ellipsys Vascular Access Catheter System Clinical Trial|Completed||Phase 3|118|Actual|Avenu Medical||1|||f||||f||||||||||2017-10-10 23:35:08.815419|2017-10-10 23:35:08.815419
NCT02363959|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-11-28|||February 2015||2015-02-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Hyperbaric Oxygen Therapy for Lung Transplantation|Hyperbaric Oxygen Therapy for Lung Transplantation-Associated Pseudomembranes and Central Airway Stenosis|Recruiting||Phase 2|40|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:35:08.885376|2017-10-10 23:35:08.885376
NCT02363946|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-01-04|||February 2015||2015-02-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)|A Double-Blind, Placebo-Controlled, Dose-Escalating, Phase 1 Study to Determine the Safety, Tolerability, Pharmacokinetics and Effect of Circulating Alpha-1 Antitrypsin Levels of ARC-AAT in Healthy Volunteer Subjects and in Patients With Alpha-1 Antitrypsin Deficiency (AATD)|Terminated||Phase 1|65|Actual|Arrowhead Pharmaceuticals||2||Company decision to terminate the trial|f||||f||||||||||2017-10-10 23:35:08.967214|2017-10-10 23:35:08.967214
NCT02363933|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-13|||April 7, 2015|Actual|2015-04-07|September 2017|2017-09-01|April 10, 2017|Actual|2017-04-10|March 14, 2017|Actual|2017-03-14||Interventional|||Perampanel in Seizure Patients With Primary Glial Brain Tumors|Phase II Feasibility Study to Evaluate the Efficacy and Safety of Perampanel in Seizure Patients With Primary Glial Brain Tumors|Completed||Phase 4|9|Actual|Duke University||1|||f||||f||||||||||2017-10-10 23:35:09.055058|2017-10-10 23:35:09.055058
NCT02363920|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-10-08|||March 2015||2015-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Short Term Physiological Effects of Nasal High Flow Oxygen on Respiratory Mechanics|Short Term Physiological Effects of Nasal High Oxygen Flow vs Low Oxygen Flow and Noninvasive Ventilation (NIV) on Respiratory Mechanics|Completed||Phase 4|14|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||4|||f||||t||||||||||2017-10-10 23:35:09.119894|2017-10-10 23:35:09.119894
NCT02363907|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-07-25|2017-02-07||September 2012||2012-09-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in Pediatrics|Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4|Completed||N/A|30|Actual|DexCom, Inc.|||1||f||||f||||||||||2017-10-10 23:35:09.191042|2017-10-10 23:35:09.191042
NCT02363894|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2016-02-01|||March 2015||2015-03-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||DEFINITIVE AR Two Year Follow-up Extension Study|Directional AthErectomy Followed by a PaclItaxel-Coated BalloN to InhibiT RestenosIs and Maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment - Two Year Follow-up Extension Study|Completed||N/A|53|Actual|Medtronic Endovascular|||1||f||||f||||||||||2017-10-10 23:35:09.347217|2017-10-10 23:35:09.347217
NCT02363868|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-07-03|||February 2014||2014-02-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population|Costs and Outcome Among Patients With Chronic Myelogenous Leukemia (CML) Receiving Dasatinib or Nilotinib as First or Second Line Therapy in a Commercial and Medicare Population|Completed||N/A|186|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 23:35:09.405993|2017-10-10 23:35:09.405993
NCT02363283|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-28|||September 16, 2015|Actual|2015-09-16|September 2017|2017-09-01||||October 28, 2017|Anticipated|2017-10-28||Interventional|||Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma|A Phase 2 Study of CDX-011 (Glembatumumab Vedotin) for Metastatic Uveal Melanoma|Recruiting||Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:35:15.375729|2017-10-10 23:35:15.375729
NCT02363855|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-09-21|||February 23, 2015|Actual|2015-02-23|September 2017|2017-09-01|April 27, 2018|Anticipated|2018-04-27|November 19, 2015|Actual|2015-11-19||Interventional|||Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects|An Open Label Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BAY 1841788 in Japanese Subjects With Metastatic Castration-resistant Prostate Cancer|Active, not recruiting||Phase 1|9|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:35:09.467433|2017-10-10 23:35:09.467433
NCT02363842|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2015-08-12|||April 2015||2015-04-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Trial Comparing SOC +Skin IQ MCM vs SOC for Pressure Ulcer (PU)|A Randomized, Controlled Trial Assessing Use of Skin IQ™ MCM Compared to Current Standard of Care for the Management of Moisture and Temperature at the Patient/Surface Interface for Prevention of Pressure Ulcer Development|Unknown status|Recruiting|N/A|160|Anticipated|Arjohuntleigh||2|||f||||t||||||||||2017-10-10 23:35:09.575983|2017-10-10 23:35:09.575983
NCT02363829|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-10|2017-07-31|||February 2015||2015-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)|A Phase I Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)|Recruiting||Phase 1|6|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 23:35:09.663089|2017-10-10 23:35:09.663089
NCT02363816|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-05-05|||January 2016||2016-01-01|May 2016|2016-05-01||||December 2018|Anticipated|2018-12-01||Observational|||Beta-carotene and Oxidative Stress in Pediatric Second Generation Antipsychotic Use||Withdrawn||N/A|0|Actual|Wayne State University|||1||f||||f||||||||||2017-10-10 23:35:09.723691|2017-10-10 23:35:09.723691
NCT02363803|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-04-19|||February 2015||2015-02-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Lidocaine for Diabetic Peripheral Neuropathy|Predicting Individual Response to Analgesic Treatment in Painful Diabetic Neuropathy|Recruiting||N/A|35|Anticipated|Washington University School of Medicine||2|||f||||f||||||||No||2017-10-10 23:35:09.765278|2017-10-10 23:35:09.765278
NCT02363790|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-08-25|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial|Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial|Active, not recruiting||N/A|189|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:35:09.840321|2017-10-10 23:35:09.840321
NCT02363777|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-30|||August 2012||2012-08-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Paravertebral Catheters for Pancreatic Surgery|Ultrasound Guided Bilateral Paravertebral Catheters Versus Thoracic Epidural Analgesia for Post- Operative Pain Control in Open Pancreatic Surgery: A Prospective Outcomes Study|Completed||N/A|50|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 23:35:09.918923|2017-10-10 23:35:09.918923
NCT02363764|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-10-02|||January 2015||2015-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Observational|||The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients|The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients|Completed||N/A|175|Actual|Universitair Ziekenhuis Brussel|||3||f||||t||||||||No|All data will be analysed and shared as an original article, individual data will only be available upon motivated request|2017-10-10 23:35:09.9889|2017-10-10 23:35:09.9889
NCT02363751|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-06-22|||December 2014||2014-12-01|June 2016|2016-06-01||||July 2019|Anticipated|2019-07-01||Interventional|BEVABEL||Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL)|Prospective Phase II Study of Gemcitabine Plus Platinium Salt in Combination With Bevacizumab (Avastin®) for Metastatic Collecting Duct Carcinoma|Recruiting||Phase 2|41|Anticipated|UNICANCER||1|||f||||t||||||||||2017-10-10 23:35:10.079864|2017-10-10 23:35:10.079864
NCT02363738|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-05-02|||September 2015||2015-09-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression|A Multisite, Fixed Dose, Randomized, Double-Blind, Placebo-Controlled 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for the Treatment of Bipolar I/II Depression|Recruiting||Phase 2|60|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:35:10.167826|2017-10-10 23:35:10.167826
NCT02363725|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-01-16|||December 2014||2014-12-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|COLIN||Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response|Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response|Completed||Phase 2|44|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:35:11.776491|2017-10-10 23:35:11.776491
NCT02363712|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-01-10|||May 2015||2015-05-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|BIOTOK||APOS Therapy for Osteoarthritis of the Knee: a Randomized Controlled Trial BIOTOK|Biomechanical Therapy for Osteoarthritis of the Knee: a Randomized Controlled Trial(BIOTOK)|Active, not recruiting||N/A|220|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 23:35:11.876261|2017-10-10 23:35:11.876261
NCT02363699|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-09|||July 2013||2013-07-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Endovenous Lidocaine and Serum Cytokines Concentration|Effect of Endovenous Lidocaine on Analgesia and Serum Cytokines Concentration: Randomized and Double-blind Trial|Completed||Phase 4|44|Actual|Universidade Federal de Santa Maria||2|||f||||f||||||||||2017-10-10 23:35:11.962144|2017-10-10 23:35:11.962144
NCT02363686|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-05-03|||February 2012||2012-02-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Aspiration in Acute Respiratory Failure Survivors|Aspiration in Acute Respiratory Failure Survivors|Recruiting||N/A|350|Anticipated|University of Colorado, Denver||1|||f||||f||||||||||2017-10-10 23:35:12.0412|2017-10-10 23:35:12.0412
NCT02363673|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-05-18|||February 2015||2015-02-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Individualised Homoeopathic Treatment of Autism Spectrum Disorder in Children|The Effect of Individualised Homoeopathic Treatment of Autism Spectrum Disorder in Children|Completed||Phase 2|10|Actual|University of Johannesburg||1|||f||||f||||||||No||2017-10-10 23:35:12.154769|2017-10-10 23:35:12.154769
NCT02363660|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-01-17|||January 2014||2014-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|GINI||Gardasil Immunogenicity With Needle-Free Injection|A Randomized, Parallel Design Study to Compare the Safety and Effectiveness of Gardasil When Delivered Per Standard Practice (Full Dose, Intramuscular (IM) Delivery Using a Needle and Syringe) vs. Full Dose, IM Delivery Via Needle-free Jet Injection or Reduced Dose, Intradermal Delivery Via Needle-free Jet Injection|Enrolling by invitation||Phase 2|150|Anticipated|Thai Red Cross AIDS Research Centre||3|||f||||t||||||||||2017-10-10 23:35:12.23121|2017-10-10 23:35:12.23121
NCT02363647|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-07-03|||January 2015||2015-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer|Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer|Enrolling by invitation||N/A|55|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|f|f||||||||2017-10-10 23:35:12.300953|2017-10-10 23:35:12.300953
NCT02363634|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-13|||August 2012||2012-08-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Clinical Trial to Evaluate Magtein in Older Adults|A Randomized Double Blind Parallel Group Placebo Controlled Clinical Trial Evaluating the Effects of Magtein on Anxiety, Mood and Sleep Quality in Older Adults|Completed||N/A|50|Actual|Miami Research Associates||2|||f||||f||||||||||2017-10-10 23:35:12.405445|2017-10-10 23:35:12.405445
NCT02363621|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs. Aflibercept in Patients With Diabetic Macular Edema|Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs. Aflibercept in Patients With Diabetic Macular Edema|Recruiting||Phase 2|100|Anticipated|Sierra Eye Associates||2|||f||||||||||||||2017-10-10 23:35:12.486516|2017-10-10 23:35:12.486516
NCT02363608|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-01-12|||January 2015||2015-01-01|January 2017|2017-01-01||||January 2017|Actual|2017-01-01||Observational|||Animal Assisted Activity Program on Patients and Staff on an Inpatient Surgical Oncology Unit|Caring Canines: Outcomes From an Animal Assisted Activity Program on Patients and Staff on an Inpatient Surgical Oncology Unit|Completed||N/A|146|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-10-10 23:35:12.66923|2017-10-10 23:35:12.66923
NCT02363595|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-08-14|||December 2014||2014-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Genomic Predictors of Papillary Microcarcinoma Disease Progression|Genomic Predictors of Papillary Microcarcinoma Disease Progression|Recruiting||N/A|325|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     Tissue   "|||2017-10-10 23:35:12.752359|2017-10-10 23:35:12.752359
NCT02363582|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2016-04-20|||June 2014||2014-06-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||The Impact of a Prebiotics and Lactoferrin Containing Infant Formula on Stool Characteristics in Healthy Term Infants|The Impact of a Prebiotics and Lactoferrin Containing Infant Formula on Stool Characteristics in Healthy Term Infants|Completed||N/A|65|Actual|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||No||2017-10-10 23:35:12.83611|2017-10-10 23:35:12.83611
NCT02363569|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-13|||February 2015||2015-02-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01|2 Years|Observational [Patient Registry]|||The Prognosis of Early Pregnancy With Post Coital Bleeding|The Prognosis of Early Pregnancy With Post Coital Bleeding Compared to Early Pregnancy With Spontaneous Bleeding|Unknown status|Not yet recruiting|N/A|120|Anticipated|Meir Medical Center|||2||f||||t||||||||||2017-10-10 23:35:12.916516|2017-10-10 23:35:12.916516
NCT02363556|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-28|||January 2015||2015-01-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|July 2016|Actual|2016-07-01||Interventional|||Comparing Misoprostol Alone to Dilapan With Misoprostol and Comparing Buccal to Vaginal Misoprostol|A Factorial-Design Randomized Controlled Trial Comparing Misoprostol Alone to Dilapan With Misoprostol and Comparing Buccal to Vaginal Misoprostol for Same-Day Cervical Preparation Prior to Dilation & Evacuation|Completed||N/A|160|Actual|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-10 23:35:12.99959|2017-10-10 23:35:12.99959
NCT02363543|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-08-29|||February 2016||2016-02-01|August 2017|2017-08-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|Hyalomatrix||Comparison of Hyalomatrix and Integra Wound Matrix on Burn Wounds||Withdrawn||Phase 4|0|Actual|Medline Industries||2||Sponsor decision to not to proceed|f||||f||||||||||2017-10-10 23:35:13.088422|2017-10-10 23:35:13.088422
NCT02363530|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-11-19|||November 2014||2014-11-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|CPUDCS||Corneal Protect Used During Cataract Surgery|Influence of 2% HPMC Used During Cataract Surgery for Intraoperative Corneal Optical Clarity and Post-operation Xerophthalmia.|Recruiting||N/A|100|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||f||||||||||2017-10-10 23:35:13.157581|2017-10-10 23:35:13.157581
NCT02363517|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2017-09-20|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|TAP||The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach|The Treatment And Prevention (TAP) Study: Treating People Who Inject Drugs (PWID) in Community-based Settings Using a Social Network Approach|Recruiting||Phase 3|420|Anticipated|Macfarlane Burnet Institute for Medical Research and Public Health Ltd||3|||f||||t||||||||||2017-10-10 23:35:13.266382|2017-10-10 23:35:13.266382
NCT02363504|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-09-12|||October 2016||2016-10-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01|2 Months|Observational [Patient Registry]|LOCUS||The Locus Coeruleus and Memory|Focus on the Locus Coeruleus Network With 7 T MRI: Link to Memory (Dys)Function|Not yet recruiting||N/A|70|Anticipated|Maastricht University Medical Center|||2||f||||t||||||Samples Without DNA|"     Saliva samples   "|||2017-10-10 23:35:13.375686|2017-10-10 23:35:13.375686
NCT02363491|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-03-31|||January 2015||2015-01-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome|A Prospective, Open Label Phase I/II Study to Assess the Safety and Efficacy of Cycles of Intravenously Infused Doses of OPN-305 in Second-line Lower (Low and Intermediate-1) Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1/Phase 2|40|Anticipated|Opsona Therapeutics Ltd.||1|||f||||t||||||||||2017-10-10 23:35:13.463101|2017-10-10 23:35:13.463101
NCT02363478|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-08-31|2016-01-11||December 2014||2014-12-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc)|Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc)|Completed||Early Phase 1|22|Actual|Laikon General District Hospital, Athens||1|||f||||t||||||||||2017-10-10 23:35:13.564515|2017-10-10 23:35:13.564515
NCT02363465|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-10-05|||January 2015||2015-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Echographic Measurement of Skin Thickness|Echographic Measurement of Skin Thickness at the Deltoid and Proximal Forearm in Adults|Completed||N/A|100|Actual|Novosanis NV|||4||f||||f||||||||||2017-10-10 23:35:13.808419|2017-10-10 23:35:13.808419
NCT02363452|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-05-17|||September 2015||2015-09-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|RTIs in AGS||Reverse Transcriptase Inhibitors in AGS|A Pilot Clinical Trial of Reverse Transcriptase Inhibitors in Children With Aicardi-Goutières Syndrome (AGS)|Recruiting||Phase 2|24|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||No||2017-10-10 23:35:13.889891|2017-10-10 23:35:13.889891
NCT02363426|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-01-18|||January 2013||2013-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation|Randomized Controlled Open-Label Non-Inferiority Trial Comparing Day 5 Embryos Derived From Intravaginal Culture Using the Medical Device INVOcell to Traditional In Vitro Fertilization|Completed||Phase 3|40|Actual|Invaron Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-10 23:35:14.061913|2017-10-10 23:35:14.061913
NCT02363413|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-08-05|||February 2015||2015-02-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|OVNI-Dom||Initiation of Non- Invasive Ventilation at Home Versus Hospital Among Patients With Overlap Syndrome|Initiation of Non- Invasive Ventilation at Home Versus Hospital Among Patients With Overlap Syndrome: Randomized Controlled Non-inferiority Study|Unknown status|Recruiting|N/A|80|Anticipated|IP Santé Domicile||2|||f||||f||||||||||2017-10-10 23:35:14.14778|2017-10-10 23:35:14.14778
NCT02363400|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-02-09|||November 2014||2014-11-01|November 2014|2014-11-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA|Phase III Randomized Trial of Immediate Adjuvant Chemotherapy or Delayed Salvage Chemotherapy in Nasopharyngeal Carcinoma Patients With Post-radiation Detectable Plasma EBV DNA|Enrolling by invitation||Phase 3|147|Anticipated|National Health Research Institutes, Taiwan||2|||f||||t||||||||||2017-10-10 23:35:14.417225|2017-10-10 23:35:14.417225
NCT02363387|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-08-14|||November 2015||2015-11-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Suppression of HIV 1 RNA in People Living With HIV|Suppression of HIV 1 RNA in People Living With HIV|Recruiting||N/A|200|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:35:14.512356|2017-10-10 23:35:14.512356
NCT02363374|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-16|||February 2015||2015-02-01|August 2017|2017-08-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|CAOAROAIO-12||Induction Chemotherapy Before or After Preoperative Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer|Induction Chemotherapy Before or After Preoperative Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer: A Randomized Phase II Trial of the German Rectal Cancer Study Group|Recruiting||Phase 2|304|Anticipated|Goethe University||2|||f||||t||||||||||2017-10-10 23:35:14.605589|2017-10-10 23:35:14.605589
NCT02363361|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-09|||March 2015||2015-03-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Cervical Spinal Cord Injury With Imatinib - a Safety and Feasibility Study|Treatment of Acute Cervical Spinal Cord Injury With Imatinib (Glivec®) - a Safety and Feasibility Study (EudraCT no 2014-002170-36)|Unknown status|Not yet recruiting|Phase 2|10|Anticipated|Karolinska University Hospital||1|||f||||f||||||||||2017-10-10 23:35:14.785379|2017-10-10 23:35:14.785379
NCT02363348|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-03-03|||August 2010||2010-08-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy and Safety of L Arginine to Prevent Preeclampsia|Efficacy and Safety of L Arginine to Prevent Preeclampsia in High Risk Pregnancies|Completed||Phase 3|96|Actual|Hospital Civil Juan I. Menchaca||2|||f||||t||||||||||2017-10-10 23:35:14.858607|2017-10-10 23:35:14.858607
NCT02363335|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-09-12|||January 26, 2015||2015-01-26|August 30, 2017|2017-08-30|September 19, 2016|Actual|2016-09-19|September 19, 2016|Actual|2016-09-19||Interventional|||The Role of Phosphodiesterase Inhibitors in Incretin Secretion|The Role of Phosphodiesterase Inhibitors in Incretin Secretion|Completed||Phase 1|100|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 23:35:14.954355|2017-10-10 23:35:14.954355
NCT02363322|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-10-05|||February 11, 2015||2015-02-11|July 12, 2017|2017-07-12|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection|A Multicenter Randomized Safety and Efficacy Study of Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection|Active, not recruiting||Phase 1/Phase 2|1|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:35:15.056714|2017-10-10 23:35:15.056714
NCT02363309|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-07-06|||February 4, 2015||2015-02-04|May 9, 2017|2017-05-09|January 31, 2020|Anticipated|2020-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)|Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:35:15.185672|2017-10-10 23:35:15.185672
NCT02363296|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-13|2017-10-03|||January 8, 2015||2015-01-08|September 20, 2017|2017-09-20|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Influence on Plasticity of Brain Temperature|Influence on Plasticity of Brain Temperature|Recruiting||N/A|35|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:35:15.281824|2017-10-10 23:35:15.281824
NCT02363270|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-05-03|2017-03-18||January 2015||2015-01-01|September 2016|2016-09-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Interventional|||Ketamine: Comparison of IV Push vs. IV Drip|Comparison of Intravenous Push Dose of Low Dose Ketamine to Short Infusion of Low Dose Ketamine for Treatment of Moderate to Severe Pain in the Emergency Department: A Prospective, Randomized, Double-Blind Study|Completed||N/A|48|Actual|Maimonides Medical Center||2|||f||||f||||||||Undecided||2017-10-10 23:35:15.592584|2017-10-10 23:35:15.592584
NCT02363257|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-05-21|||June 2015||2015-06-01|May 2015|2015-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01|1 Week|Observational [Patient Registry]|||Smoke Free Policy Among BEST Bus Employees and Commuters in Mumbai|Compliance, Perceptions and Attitudes of Bus Employees and Commuters Towards Smoke Free Bus Policy (as Part of Smoke Free Public Places) in Mumbai, India|Unknown status|Not yet recruiting|N/A|1025|Anticipated|Tata Memorial Hospital|||1||f||||t||||||||||2017-10-10 23:35:15.899902|2017-10-10 23:35:15.899902
NCT02363244|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-09|||March 2015||2015-03-01|February 2015|2015-02-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Pap and HPVDNA Before and After Acetic Acid|A Pilot Study on Comparative Evaluation of Results of Pap Smears and HPV Hybrid Capture 2 Performed on Cervical Samples Before and After Application of Acetic Acid|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tata Memorial Hospital|||2||f||||t||||||Samples With DNA|"     HPV DNA TEST will be collected in stored as per protocol of storage and will be analysed by     hybridisation method in microbiologt Dept of Tata Memorial hospital.   "|||2017-10-10 23:35:15.96951|2017-10-10 23:35:15.96951
NCT02363231|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-01-08|||January 2014||2014-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Maximal Inspiratory Pressure at Extubation: Relationship With Mortality||Completed||N/A|124|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-10 23:35:16.031096|2017-10-10 23:35:16.031096
NCT02363218|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-10-05|||May 2014||2014-05-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife|An Open-Label, Multi-Center, Single-Arm Study on Effectiveness and Safety of Stereotactic Body Radiotherapy (SBRT) Treating Hepatocellular Carcinoma Patients With CyberKnife|Recruiting||Phase 2|117|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t||||||||||2017-10-10 23:35:16.089968|2017-10-10 23:35:16.089968
NCT02363205|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-03|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Internet-Delivered Cognitive Behaviour Therapy for Adolescent Depression|Guided Internet-Delivered and Tailored Cognitive Behaviour Therapy for Adolescents With Depression: a Randomized Controlled Trial|Active, not recruiting||N/A|150|Anticipated|Linkoeping University||2|||f||||f||||||||||2017-10-10 23:35:16.183231|2017-10-10 23:35:16.183231
NCT02363192|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-12|||May 2012||2012-05-01|February 2015|2015-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effectiveness of Pharmacist Interventions in Difficult Asthma|The Effectiveness of Pharmacist Interventions in Improving Asthma Control and Quality of Life in Patients With Difficult Asthma|Completed||N/A|52|Actual|The Leeds Teaching Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 23:35:16.257541|2017-10-10 23:35:16.257541
NCT02363179|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-07-03|||May 2015|Actual|2015-05-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|MUES||Music in the Emergency Department (ED): Phase II|Music in Urgent and Emergent Settings (MUES) Trial: Phase Two|Completed||N/A|1107|Actual|University of Florida||2|||f||||f|f|f||||||||2017-10-10 23:35:16.337911|2017-10-10 23:35:16.337911
NCT02363166|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-05-16|||August 2015||2015-08-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Analysis of CA-MRSA Transmission: An ED Population Sampling Strategy|Molecular Epidemiology and Phylodynamic and Phylogeographic Analysis of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) Transmission: An Emergency Department Population Sampling Strategy|Recruiting||N/A|575|Anticipated|University of Florida|||1||f||||f|f|f||||Samples With DNA|"     Genomic DNA (gDNA) will be isolated from pelleted bacteria using the Roche High Pure PCR kit     following the standard protocol for isolation of nucleic acids from bacteria. The quality of     the extracted gDNA will be determined through gel electrophoresis and the quantity through     Nanodrop2000.   "|||2017-10-10 23:35:16.434268|2017-10-10 23:35:16.434268
NCT02363140|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-02-18|||June 2012||2012-06-01|February 2016|2016-02-01||||June 2015|Actual|2015-06-01||Interventional|MOVE||Magnetic Resonance Imaging to Assess Changes in Meniscus Vascularity||Active, not recruiting||N/A|48|Anticipated|The Leeds Teaching Hospitals NHS Trust||4|||f||||f||||||||||2017-10-10 23:35:16.657156|2017-10-10 23:35:16.657156
NCT02363127|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-03-01|||February 2015|Actual|2015-02-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients|Subcutaneous Progesterone (Prolutex) Versus Vaginal Progesterone Capsules (Progeffik) for Endometrial Preparation in Fresh Donated Oocytes Recipients: a Randomised, Prospective, Single-blind, Pilot Study|Completed||Phase 4|120|Actual|Instituto Bernabeu||2|||f||||t||||||||||2017-10-10 23:35:16.734173|2017-10-10 23:35:16.734173
NCT02363114|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-11-23|||April 2014||2014-04-01|November 2015|2015-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|1 Year|Observational [Patient Registry]|||DOC Utility: Screening of Depression, Obstructive Sleep Apnea and Cognitive Impairment|DOC Utility: Simple Screening of Depression, Obstructive Sleep Apnea and Cognitive Impairment to Identify Stroke Clinic Patients at Risk of Adverse Outcomes|Recruiting||N/A|8000|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-10-10 23:35:16.972097|2017-10-10 23:35:16.972097
NCT02363101|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-03-03|||March 2015||2015-03-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Observational|HOC-LC||Health Outcomes and Costs (HOC) in Lung Cancer (LC)|Health Outcomes and Costs (HOC) in Brazilian Public Health Care System - The HOC Study in Lung Cancer|Unknown status|Not yet recruiting|N/A|300|Anticipated|Instituto Nacional de Cancer, Brazil|||1||f||||f||||||||||2017-10-10 23:35:17.089336|2017-10-10 23:35:17.089336
NCT02363075|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-09-14|||April 2013||2013-04-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|DXA||Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia|A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial|Recruiting||Phase 3|58|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:35:17.293897|2017-10-10 23:35:17.293897
NCT02363062|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-08-28|||February 2, 2015|Actual|2015-02-02|August 2016|2016-08-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Observational|FTLD-Exome||Identification of New FTLD Genes|Identification of New Genes Causing Frontotemporal Lobar Degeneration by Whole Exome Sequencing and Characterization of the Associated Phenotypes|Recruiting||N/A|440|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Blood samples will be collected by a nurse, during a single consultation or hospitalization   "|||2017-10-10 23:35:17.406257|2017-10-10 23:35:17.406257
NCT02363049|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-02-20|||July 2014||2014-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CLIMAT||Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer|Randomized Phase III Study Assessing the Interest of Primary Tumor Resection in Patients With Asymptomatic Colon Cancer and Unresectable Synchronous Liver Metastases.|Recruiting||Phase 3|278|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:35:17.497927|2017-10-10 23:35:17.497927
NCT02363036|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-09|||March 2015||2015-03-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||The Shift From Monocytes to Neutrophils in Blood Samples of Women in Labor|The Shift From Monocytes to Neutrophils in Blood Samples of Women in Labor|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||Samples Without DNA|"     Blood samples   "|||2017-10-10 23:35:17.605073|2017-10-10 23:35:17.605073
NCT02363023|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-02-12|||February 2015||2015-02-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Observational|||Study of Different Etiologic Diagnostic Methods in Ventilator Associated Pneumonia (VAP)|Prospective Comparative Study of Different Etiologic Diagnostic Methods in Ventilator Associated Pneumonia (VAP)|Unknown status|Not yet recruiting|N/A|72|Anticipated|Federal University of Uberlandia|||1||f||||f||||||Samples Without DNA|"     All positive cultures.   "|||2017-10-10 23:35:17.677033|2017-10-10 23:35:17.677033
NCT02363010|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-07-28|||August 2014||2014-08-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Project Impact: An Innovative Approach to Weight Loss Maintenance|1R01DK100345-01A1: An Innovative, Physical Activity-focused Approach to Weight Loss Maintenance|Active, not recruiting||N/A|350|Anticipated|Drexel University||3|||f||||f||||||||||2017-10-10 23:35:17.774101|2017-10-10 23:35:17.774101
NCT02362997|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-12-28|||April 2015||2015-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL|A Phase 2 Study of Pembrolizumab (MK-3475) After Autologous Stem Cell Transplantation in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma and, Diffuse Large B Cell Lymphoma and T- Cell Non-Hodgkin Lymphoma|Recruiting||Phase 2|60|Anticipated|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-10 23:35:17.872992|2017-10-10 23:35:17.872992
NCT02362984|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-05-02|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||DLBS1033 for the Treatment of Acute Ischemic Stroke|The Role of DLBS1033 in the Management of Acute Ischemic Stroke Patients: A Randomized Controlled Study|Terminated||Phase 3|9|Actual|Dexa Medica Group||2||Major technical hindrance in recruitment.|f||||t||||||||||2017-10-10 23:35:18.023403|2017-10-10 23:35:18.023403
NCT02362971|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-08-29|||September 2009||2009-09-01|August 2016|2016-08-01|October 2027|Anticipated|2027-10-01|October 2018|Anticipated|2018-10-01||Observational|EXVAL||External Validity of a Randomized Trial in Patients With a Femoral Neck Fracture|External Validity of a Randomized Controlled Trial in Patients With a Femoral Neck Fracture|Active, not recruiting||N/A|900|Anticipated|Danderyd Hospital|||3||f||||f||||||||||2017-10-10 23:35:18.165464|2017-10-10 23:35:18.165464
NCT02362958|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-12-19|||February 2015||2015-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer|Sun Yat-sen University Cancer Center|Recruiting||Phase 2|159|Anticipated|Sun Yat-sen University||1|||f||||t||||||||Yes||2017-10-10 23:35:18.298311|2017-10-10 23:35:18.298311
NCT02362945|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-09-07|||October 2015||2015-10-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Hexakaprone Treatment for Post-Partum Hemorrhage Prophylactic|Hexakaprone Treatment for Post-Partum Hemorrhage Prophylactic|Unknown status|Not yet recruiting|Phase 3|1000|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-10 23:35:18.401429|2017-10-10 23:35:18.401429
NCT02362932|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-05-31|||February 2015||2015-02-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MapSan||The Effect of an Urban Sanitation Intervention on Child Health|A Controlled Before and After Study to Measure the Effect of an Urban Sanitation Intervention on Child Health, in Low-income Neighborhoods of Maputo, Mozambique|Recruiting||N/A|2000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-10 23:35:18.489069|2017-10-10 23:35:18.489069
NCT02362919|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-08|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Influenza Vaccination Among the Elderly Individuals|Determinants of Vaccine Response to Influenza Vaccination Among Individuals Over 65 Years of Age - a Population-based Study|Completed||N/A|200|Actual|Helmholtz Centre for Infection Research|||1||f||||f||||||||||2017-10-10 23:35:18.574394|2017-10-10 23:35:18.574394
NCT02362906|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-02-12|||April 2014||2014-04-01|February 2015|2015-02-01||||August 2015|Anticipated|2015-08-01||Interventional|||Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia|Assessing the Effectiveness of Integrative Treatment That Combines Interior and Exterior Treatment Plans in Pediatric Pneumonia: a Program by the Special Scientific Research Fund of Public Welfare Profession of China|Unknown status|Recruiting|N/A|1500|Anticipated|Liaoning University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-10 23:35:18.638108|2017-10-10 23:35:18.638108
NCT02362139|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-02-11|||February 2015||2015-02-01|February 2015|2015-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||The Impact of Papaverine on First Stage of Labor|The Impact of Papaverine on First Stage of Labor|Unknown status|Not yet recruiting|Phase 3|400|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-10 23:35:27.137744|2017-10-10 23:35:27.137744
NCT02362893|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-18|||April 2015||2015-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|DRIVE||Treatment of Hypertension: an Interventional Approach to Improve Blood Pressure Control|Treatment of Hypertension: an Interventional Approach to Improve Blood Pressure Control|Recruiting||N/A|20|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:35:18.799091|2017-10-10 23:35:18.799091
NCT02362880|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-08-02|||February 2015||2015-02-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study|Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease: 18F-Florbetaben Positron Emission Tomography Study|Recruiting||Phase 2/Phase 3|40|Anticipated|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-10 23:35:18.894245|2017-10-10 23:35:18.894245
NCT02362867|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-09|||January 2003||2003-01-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Balanced Knee System Clinical Protocol for IRB Approval|Balanced Knee System Clinical Protocol for IRB Approval|Unknown status|Active, not recruiting|N/A|500|Anticipated|Ortho Development Corporation||1|||f||||f||||||||||2017-10-10 23:35:18.977541|2017-10-10 23:35:18.977541
NCT02362854|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-02-12|||February 2010||2010-02-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy of Diode Laser in Peri-implantitis|A Randomized Clinical Trial of an Adjunct Diode Laser Application in the Treatment of Peri-implantitis.|Completed||N/A|10|Actual|Istanbul University||2|||f||||f||||||||||2017-10-10 23:35:19.075527|2017-10-10 23:35:19.075527
NCT02362841|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-09|||January 2012||2012-01-01|February 2015|2015-02-01||||September 2013|Actual|2013-09-01||Observational|||Assessment of the Evolutions of Transcutaneous CO2 With the Modification of Blood Flow During On-pump Cardiac Surgery|Assessment of the Evolutions of Transcutaneous CO2 With the Modification of Blood Flow During On-pump Cardiac Surgery|Completed||N/A|41|Actual|European Georges Pompidou Hospital|||1||f||||f||||||||||2017-10-10 23:35:19.164051|2017-10-10 23:35:19.164051
NCT02362828|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-07-27|||January 2016||2016-01-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|April 30, 2018|Anticipated|2018-04-30||Observational|EPiMAP||EPiMAP Obstetrics: European Practices in the Management of Accidental Dural Puncture in Obstetrics|EPiMAP Obstetrics: European Practices in the Management of Accidental Dural Puncture in Obstetrics: European Prospective Multicentre Observational Audit to MAP Out Current Practices in the Management of Patients Who Had Accidental Dural Puncture During EPIdural Insertion|Recruiting||N/A|1200|Anticipated|European Society of Anaesthesiology|||1||f||||f||||||||||2017-10-10 23:35:19.225598|2017-10-10 23:35:19.225598
NCT02362815|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2016-09-21|||February 2014||2014-02-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|EGTO||Ultrasound Assessment of Clear Liquid Intake During Labour|Fluid Intake During Labour, Ultrasound Evaluation|Recruiting||N/A|260|Anticipated|Hopital Foch||2|||f||||t||||||||||2017-10-10 23:35:19.311174|2017-10-10 23:35:19.311174
NCT02362802|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2017-06-12|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|May 31, 2017|Actual|2017-05-31||Interventional|MyDate||Myocardial Minimal Damage After Rapid Ventricular Pacing|Myocardial Minimal Damage After Rapid Ventricular Pacing|Active, not recruiting||N/A|149|Actual|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||||2017-10-10 23:35:19.409226|2017-10-10 23:35:19.409226
NCT02362776|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-02-09|||October 2009||2009-10-01|February 2015|2015-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01|1 Day|Observational [Patient Registry]|||Metabolic Changes as a Diagnostic Indicator for Cancer|Metabolic Changes as a Diagnostic Indicator for Cancer|Completed||N/A|426|Actual|Hasselt University|||3||f||||f||||||Samples Without DNA|"     Metabolic phenotype of cancer   "|||2017-10-10 23:35:19.609227|2017-10-10 23:35:19.609227
NCT02362763|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-09|||June 2006||2006-06-01|February 2015|2015-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||The Use of Acupuncture for the Treatment of Vulvar Vestibulitis|The Use of Acupuncture for the Treatment of Vulvar Vestibulitis|Completed||N/A|42|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 23:35:19.685871|2017-10-10 23:35:19.685871
NCT02362750|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-12-20|||July 2013||2013-07-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Evaluating Cancer Survivorship Care Models|Evaluating Cancer Survivorship Care Models|Completed||N/A|992|Actual|George Washington University|||3||f||||f||||||||||2017-10-10 23:35:19.755222|2017-10-10 23:35:19.755222
NCT02362737|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-08-02|||January 2015||2015-01-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|July 2017|Actual|2017-07-01||Interventional|||Active and Healthy Brotherhood: A Program for Chronic Disease Self-Management for Black Men||Active, not recruiting||N/A|332|Actual|Gramercy Research Group||2|||f||||||||||||||2017-10-10 23:35:19.848152|2017-10-10 23:35:19.848152
NCT02361632|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-16|||August 2013||2013-08-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||Does Adding Milk to Coffee Change Gastric Volume?|Does Adding Milk to Coffee Change Gastric Volume?|Completed||N/A|30|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-10 23:35:19.920062|2017-10-10 23:35:19.920062
NCT02361619|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-02-26|||February 2015||2015-02-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|D-cocktail||Dabigatran in an Interaction Probe Drug Cocktail|An Open-label Crossover Trial Assessing the Value of Dabigatran in a Drug Interaction Cocktail in Healthy Young Volunteers|Unknown status|Recruiting|Phase 1|16|Anticipated|Turku University Hospital||1|||f||||f||||||||||2017-10-10 23:35:20.010232|2017-10-10 23:35:20.010232
NCT02362724|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-12-03|||February 2015||2015-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:35:20.10559|2017-10-10 23:35:20.10559
NCT02362711|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-12|||February 2015||2015-02-01|February 2015|2015-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea|Phase3, Placebo Controlled, Randomized, Double-blinded, Long-Term, NSAID-Add-on, Clinical Trial of NPC-16 for Treatment of Dysmenorrhea|Unknown status|Not yet recruiting|Phase 3|240|Anticipated|Nobelpharma||3|||f||||f||||||||||2017-10-10 23:35:20.151163|2017-10-10 23:35:20.151163
NCT02362698|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-02-12|||January 2010||2010-01-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||Clinical Research of Electro-acupuncture Combined Psychological Intervention on Internet Addiction Disorder|Clinical Research of Electro-acupuncture Combined Psychological Intervention on Internet Addiction Disorder|Completed||N/A|32|Actual|Chengdu University of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-10 23:35:20.231385|2017-10-10 23:35:20.231385
NCT02362685|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-01-30|||September 2008||2008-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|RANNOU||Metabolic Exercise Testing|Exercise Testing in Metabolic Myopathies|Recruiting||N/A|1000|Anticipated|University Hospital, Brest|||1||f||||f||||||Samples With DNA|"     Blood sample Urine sample Muscle tissue DNA   "|||2017-10-10 23:35:20.298382|2017-10-10 23:35:20.298382
NCT02362672|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-03-14|||February 2015||2015-02-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|SUMMIT-07||Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain|A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain|Completed||Phase 3|610|Actual|Nektar Therapeutics||2|||f||||f||||||||||2017-10-10 23:35:20.503389|2017-10-10 23:35:20.503389
NCT02362659|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-01-17|||April 2015||2015-04-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|12 Months|Observational [Patient Registry]|||Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry|Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI|Recruiting||N/A|2500|Anticipated|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||||||2017-10-10 23:35:20.693653|2017-10-10 23:35:20.693653
NCT02362646|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-14|||July 2015||2015-07-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients|Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients|Active, not recruiting||Phase 2|159|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:35:20.791579|2017-10-10 23:35:20.791579
NCT02362633|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-02-03|||February 2015||2015-02-01|February 2016|2016-02-01||||October 2015|Actual|2015-10-01||Interventional|||Effect of Long-term Transcranial Direct Current Stimulation (tDCS) on Appetite Control Related Brain Regions|Effect of Long-term Transcranial Direct Current Stimulation (tDCS) on Appetite Control Related Brain Regions|Completed||N/A|27|Actual|Chungbuk National University||2|||f||||||||||||||2017-10-10 23:35:20.987938|2017-10-10 23:35:20.987938
NCT02362620|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-03-26|||May 2014||2014-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|PROSTAC||PROSTAC: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Docetaxel or Cabazitaxel|Prospective Multi-centre Study of Prognostic Factors in Castration Resistant PROState Cancer Treated With doceTaxel or Cabazitaxel|Recruiting||N/A|402|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III|||2||f||||f||||||Samples With DNA|"     Paxgene and tempus tubes on baeline, pre-cycle 3 and progression Tumor paraffine sample at     baseline   "|||2017-10-10 23:35:21.071043|2017-10-10 23:35:21.071043
NCT02362607|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-02-03|||February 2015||2015-02-01|February 2016|2016-02-01||||October 2015|Actual|2015-10-01||Interventional|||Integrated Diabetes Management Protocol Using Smartphone|Integrated Diabetes Management Protocol Using Smartphone|Completed||N/A|40|Actual|Chungbuk National University||2|||f||||||||||||||2017-10-10 23:35:21.254232|2017-10-10 23:35:21.254232
NCT02362594|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-08-29|||July 16, 2015|Actual|2015-07-16|August 2017|2017-08-01|July 19, 2025|Anticipated|2025-07-19|May 31, 2018|Anticipated|2018-05-31||Interventional|||Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/KEYNOTE-054)|Adjuvant Immunotherapy With Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK- 3475) Versus Placebo After Complete Resection of High-risk Stage III Melanoma: A Randomized, Double- Blind Phase 3 Trial of the EORTC Melanoma Group|Active, not recruiting||Phase 3|900|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 23:35:21.329402|2017-10-10 23:35:21.329402
NCT02362581|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-09|||December 2012||2012-12-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A|Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A|Completed||N/A|15|Actual|Chulalongkorn University||1|||f||||f||||||||||2017-10-10 23:35:21.421469|2017-10-10 23:35:21.421469
NCT02362568|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-08-30|||October 2013||2013-10-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|TUBECHO||Study of Interest on Cervical Ultrasound Exploration for Association With Difficult Intubation|Human Study of Interest on Cervical Ultrasound Exploration for Association With Criteria of Difficult Intubation in General Surgery|Completed||N/A|462|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-10 23:35:21.506736|2017-10-10 23:35:21.506736
NCT02362555|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-11-10|||April 2014||2014-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||The Effect of Nuchal Ligament Calcification on Cervical Function in Patients With Neck Pain|The Effect of Nuchal Ligament Calcification on Cervical Function in Patients With Neck Pain|Completed||N/A|68|Actual|Changhua Christian Hospital|||2||f||||t||||||||||2017-10-10 23:35:21.602935|2017-10-10 23:35:21.602935
NCT02362542|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-02-03|||February 2015||2015-02-01|February 2016|2016-02-01||||October 2015|Actual|2015-10-01||Interventional|||Effect of Transcranial Direct Current Stimulation (tDCS) on Appetite Control Related Brain Regions|Effect of Transcranial Direct Current Stimulation (tDCS) on Appetite Control Related Brain Regions|Completed||N/A|15|Actual|Chungbuk National University||2|||f||||||||||||||2017-10-10 23:35:21.695258|2017-10-10 23:35:21.695258
NCT02361944|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-10-18|||April 2016||2016-04-01|October 2016|2016-10-01||||March 2019|Anticipated|2019-03-01||Interventional|ROCS||Risk of Oxygen During Cardiac Surgery Trial|Risk of Oxygen During Cardiac Surgery (ROCS) Trial|Recruiting||N/A|200|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-10-10 23:35:28.558106|2017-10-10 23:35:28.558106
NCT02362529|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-07-20|||February 2015||2015-02-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01||Interventional|||Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder|Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder|Recruiting||Early Phase 1|115|Anticipated|Centre for Addiction and Mental Health||3|||f||||t||||||||||2017-10-10 23:35:21.769332|2017-10-10 23:35:21.769332
NCT02362516|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-07-01|||February 2015||2015-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809|Non-randomised, Open Label, Sequential-group Study to Assess the Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809 in Healthy Male Volunteers|Completed||Phase 1|25|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:35:21.87038|2017-10-10 23:35:21.87038
NCT02362490|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-09-12|||January 2013||2013-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues|HBsAg Clearance of Peginterferon Treatment in Patients Who Had Chronic Hepatitis B and Were on the Treatment of Nucleoside(Acid) Analogues|Recruiting||Phase 4|200|Anticipated|Beijing Ditan Hospital||2|||f||||f||||||||||2017-10-10 23:35:22.348213|2017-10-10 23:35:22.348213
NCT02362477|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-09|||September 2010||2010-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Telemental Health and Cognitive Processing Therapy for Female Veterans With Military-related PTSD|Telemental Health and Cognitive Processing Therapy for Female Veterans With Military-related PTSD|Completed||Phase 3|126|Actual|VA Pacific Islands Health Care System||2|||f||||f||||||||||2017-10-10 23:35:22.438269|2017-10-10 23:35:22.438269
NCT02362464|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-10-05|||January 28, 2015||2015-01-28|September 5, 2017|2017-09-05|March 1, 2019|Anticipated|2019-03-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139|A Pilot Study of Long Term TARP Vaccination Using A Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccine in Previously Vaccinated Men on NCI 09-C-0139|Enrolling by invitation||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:35:22.510164|2017-10-10 23:35:22.510164
NCT02362451|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-10-05|||January 25, 2015||2015-01-25|September 1, 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer|A Randomized, Placebo-Controlled Phase II Study of Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer|Recruiting||Phase 2|75|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 23:35:22.592521|2017-10-10 23:35:22.592521
NCT02362425|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-12|2017-09-21|||January 21, 2015||2015-01-21|September 13, 2017|2017-09-13|December 18, 2017|Anticipated|2017-12-18|December 18, 2017|Anticipated|2017-12-18||Interventional|||Antioxidant Therapy in RYR1-Related Congenital Myopathy|Antioxidant Therapy in RYR1-Related Congenital Myopathy|Recruiting||Phase 1/Phase 2|200|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:35:22.765821|2017-10-10 23:35:22.765821
NCT02362412|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-07-12|2017-01-26||February 18, 2015|Actual|2015-02-18|July 2017|2017-07-01|February 6, 2016|Actual|2016-02-06|February 6, 2016|Actual|2016-02-06||Interventional|||Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes|Study of FK949E - An Open-label, Two-way Crossover Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes|Completed||Phase 3|22|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-10 23:35:22.861796|2017-10-10 23:35:22.861796
NCT02362399|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-04-03|||March 2015||2015-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses|Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses|Completed||N/A|54|Actual|Al Hayat National Hospital||2|||f||||t||||||||||2017-10-10 23:35:23.397592|2017-10-10 23:35:23.397592
NCT02362386|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-04-04|||June 2015||2015-06-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System|Feasibility of Obtaining Adipose Derived Regenerative Cells (ADRCs) From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System for Autologous Treatment of Thermal Burn Injury (The FAST Trial)|Completed||N/A|17|Actual|Cytori Therapeutics|||1||f||||f||||||Samples Without DNA|"     Adipose tissue and adipose derived regenerative cells (ADRCs) will be obtained for     microbiological testing and for non-DNA-based cell characterization.   "|||2017-10-10 23:35:23.50257|2017-10-10 23:35:23.50257
NCT02362373|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-12-14|2015-12-14||August 2011||2011-08-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|WESAIL||Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users|Women With Epilepsy: a Pilot Study of Pharmacokinetic and Pharmacodynamic Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users|Completed||Phase 4|20|Actual|Columbia University||1|||f||||f||||||||||2017-10-10 23:35:23.585034|2017-10-10 23:35:23.585034
NCT02267928|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-08-01|||October 2014||2014-10-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Information Presentation Formats|Information Presentation Formats and Pursuit of Diagnostic Information|Completed||N/A|305|Actual|Carnegie Mellon University||4|||f||||f||||||||||2017-10-10 23:54:02.765286|2017-10-10 23:54:02.765286
NCT02362347|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-11|||February 2015||2015-02-01|February 2015|2015-02-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Investigating Novel Treatments for Concussion: Impact of Compression Vest on Rehabilitation Outcomes|Investigating Novel Treatments for Concussion: Impact of Compression Vest on Rehabilitation Outcomes|Unknown status|Recruiting|N/A|160|Anticipated|Western University, Canada||3|||f||||f||||||||||2017-10-10 23:35:25.128689|2017-10-10 23:35:25.128689
NCT02362334|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-15|||October 2014||2014-10-01|October 2014|2014-10-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||IOL Power Calculation Using Dual Schiempflug Analyzer|Precision of Optical Biometry and Intraocular Lens Power Calculation Using Dual Schiempflug Analyzer|Unknown status|Recruiting|N/A|140|Anticipated|Chuncheon Sacred Heart Hospital|||1||f||||f||||||||||2017-10-10 23:35:25.283146|2017-10-10 23:35:25.283146
NCT02362321|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2016-02-01|2015-02-12||January 2007||2007-01-01|February 2016|2016-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Role of Dexamethasone in the Conservative Treatment of Chronic Subdural Hematoma|Role of Dexamethasone in the Conservative Treatment of Chronic Subdural Hematoma: a Double-blind Randomized Controlled Pilot Study|Terminated||Phase 4|20|Actual|CHU de Quebec-Universite Laval||2||Due to serious adverse events|f||||t||||||||No||2017-10-10 23:35:25.385853|2017-10-10 23:35:25.385853
NCT02362308|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-06-26|||January 2015||2015-01-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas|Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas|Recruiting||N/A|20|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 23:35:25.772135|2017-10-10 23:35:25.772135
NCT02362295|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2015-02-23|||May 2011||2011-05-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Observational|PARME||Prospective National Survey of the Palliative Situation Among Inmates in French Prisons|Prospective National Survey of the Palliative Situation Among Inmates in French Prisons|Completed||N/A|15|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||t||||||||||2017-10-10 23:35:25.917767|2017-10-10 23:35:25.917767
NCT02362269|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-05-13|||October 2015||2015-10-01|May 2016|2016-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Personalized Vitamin D Supplementation in European and African Americans|Personalized Vitamin D Supplementation in European and African Americans|Recruiting||N/A|334|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-10 23:35:26.146604|2017-10-10 23:35:26.146604
NCT02362256|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-02-11|||May 2014||2014-05-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism|The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism With Naltrexone and Sedation|Completed||N/A|60|Actual|Vilnius University||2|||f||||f||||||||||2017-10-10 23:35:26.270345|2017-10-10 23:35:26.270345
NCT02362243|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-03-01|||March 2016||2016-03-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Worksite Exercise Interventions for Low Back Injury Prevention in Firefighters|Worksite Exercise Interventions for Low Back Injury Prevention in Firefighters|Enrolling by invitation||N/A|345|Anticipated|University of South Florida||3|||f||||f||||||||Undecided|To be determined.|2017-10-10 23:35:26.395409|2017-10-10 23:35:26.395409
NCT02362230|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-12-19|||January 2015||2015-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy|Sun Yat-sen University Cancer Center|Recruiting||Phase 2|67|Anticipated|Sun Yat-sen University||1|||f||||t||||||||Yes||2017-10-10 23:35:26.526236|2017-10-10 23:35:26.526236
NCT02362217|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-05-02|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination|A Phase I Study to Evaluate the Safety and Immunogenicity of Simultaneous Prime-Boost Immunisations With Candidate HCV and HIV-1 Vaccines, AdCh3NSmut1 / ChAdV63.HIVconsv and MVA-NSmut / MVA.HIVconsv, in Healthy Volunteers|Active, not recruiting||Phase 1|33|Actual|University of Oxford||3|||f||||t||||||||Undecided||2017-10-10 23:35:26.618655|2017-10-10 23:35:26.618655
NCT02362204|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2015-02-07|||January 2015||2015-01-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|LCN-II||Lung Cancer Nurse Model: a Phase II Study|Development and Feasibility of a Lung Cancer Nurse Model During Early Treatment: a Phase II Study|Unknown status|Recruiting|N/A|71|Anticipated|University of Freiburg|||1||f||||f||||||||||2017-10-10 23:35:26.713547|2017-10-10 23:35:26.713547
NCT02362191|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2017-04-17|||March 2015||2015-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD|Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD|Enrolling by invitation||N/A|20|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 23:35:26.792061|2017-10-10 23:35:26.792061
NCT02362178|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-11|||February 2011||2011-02-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Thromboelastographic Guide for Blood Products in Cirrhotics|USE OF THROMBOELASTOGRAPHY TO GUIDE BLOOD PRODUCTS REPLACEMENT IN DECOMPENSATED CIRRHOTIC PATIENTS UNDERGOING INVASIVE PROCEDURES|Completed||Phase 2|60|Actual|University of Modena and Reggio Emilia||2|||f||||||||||||||2017-10-10 23:35:26.863077|2017-10-10 23:35:26.863077
NCT02362165|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-04-18|||April 2015||2015-04-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma|A Phase 3 Trial Comparing Cyclophosphamide,Bortezomib,and Dexamethasone (CyBorD) and Bortezomib,Doxorubicin,and Dexamethasone (PAD) in the Treatment of Newly Diagnosed Multiple Myeloma|Recruiting||Phase 3|236|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:35:26.945284|2017-10-10 23:35:26.945284
NCT02362152|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2016-02-23|||July 2014||2014-07-01|August 2015|2015-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|RAPID-ACT||The Real Life Topical Field Treatment of Actinic Keratosis Study|The Real Life Topical Field Treatment of Actinic Keratosis Study. An Observational Study Focusing on Patient Reported Outcomes|Completed||N/A|1168|Actual|LEO Pharma|||4||f||||f||||||||||2017-10-10 23:35:27.051382|2017-10-10 23:35:27.051382
NCT02362126|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2015-02-11|||February 2015||2015-02-01|February 2015|2015-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|WALL-RESECT||"Endoscopic Full Thickness Resection in the Lower GI Tract With the Full Thickness Resection Device"|"Endoscopic Full Thickness Resection in the Lower GI Tract With the Full Thickness Resection Device- A Prospective Multicenter Trial"|Unknown status|Recruiting|N/A|80|Anticipated|Kliniken Ludwigsburg-Bietigheim gGmbH|||1||f||||f||||||||||2017-10-10 23:35:27.206338|2017-10-10 23:35:27.206338
NCT02362113|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-07|||December 2014||2014-12-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Observational|||Glycemic Index/ Load and Mental Disorders|Glycemic Index, Glycemic Load and Common Psychological Disorders|Unknown status|Active, not recruiting|N/A|3000|Anticipated|Isfahan University of Medical Sciences|||1||f||||f||||||||||2017-10-10 23:35:27.34103|2017-10-10 23:35:27.34103
NCT02362100|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-11-17|||September 2015||2015-09-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Proximal Humerus Fractures Randomized Control Trial|Proximal Humerus Fractures Randomized Control Trial|Recruiting||N/A|155|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-10 23:35:27.410337|2017-10-10 23:35:27.410337
NCT02362087|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-09-15|||March 2015||2015-03-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|TAPSOTT14-06||Taxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane Chemotherapy for Breast or Prostate Cancer|A Multi-Centre Study to Investigate the Natural History of Taxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane Chemotherapy for Breast or Prostate Cancer|Recruiting||N/A|141|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||Samples With DNA|"     Serum, plasma and buffy coat will be collected and archived tissure.   "|||2017-10-10 23:35:27.522299|2017-10-10 23:35:27.522299
NCT02362061|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2017-03-22|||February 2014|Actual|2014-02-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||3D Ultrasound Measurement of Junctional Zone Thickness and Its Relation to Implantation Success|Thickness of the Junctional Zone Measured by 3D Ultrasound and Its Relation to the Success/Failure Implantation Rates in Assisted Reproduction Techniques|Completed||N/A|100|Actual|Cairo University|||2||f||||f||||||||||2017-10-10 23:35:27.837199|2017-10-10 23:35:27.837199
NCT02362048|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-09-11|||April 2015||2015-04-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|KEYNOTE144||ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic Cancer|A Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic Cancer|Active, not recruiting||Phase 2|73|Actual|Acerta Pharma BV||2|||f||||f||||||||||2017-10-10 23:35:27.904077|2017-10-10 23:35:27.904077
NCT02362035|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-07|2017-05-19|||February 2015||2015-02-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|KEYNOTE145||ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies|A Phase 1b/2 Proof-of-Concept Study of the Combination of ACP-196 (Acalabrutinib) and Pembrolizumab in Subjects With Hematologic Malignancies|Active, not recruiting||Phase 1/Phase 2|159|Actual|Acerta Pharma BV||1|||f||||f||||||||||2017-10-10 23:35:27.992838|2017-10-10 23:35:27.992838
NCT02362022|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-12-02|||September 2007||2007-09-01|June 2015|2015-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effects of Morphine on Desflurane Consumption and Recovery Time|Comparison of Two Different Doses of Intravenous Morphine on Desflurane Consumption and Recovery Time in Patients Undergoing Total Abdominal Hysterectomy|Completed||Phase 4|90|Actual|Baskent University||3|||f||||f||||||||||2017-10-10 23:35:28.083089|2017-10-10 23:35:28.083089
NCT02362009|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-03-29|||February 2015||2015-02-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|12 Months|Observational [Patient Registry]|||South Miami Hospital Fibroid Registry|South Miami Hospital Fibroid Registry|Terminated||N/A|52|Actual|Baptist Health South Florida|||1|Policy approved describing all procedures as standard of care|f||||t||||||||||2017-10-10 23:35:28.156422|2017-10-10 23:35:28.156422
NCT02361996|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-02-07|||February 2015||2015-02-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Observational|CCT/MPERF||Quantitative Measurement of Myocardial Perfusion by Cardiac CT in Patients|Quantitative Measurement of Myocardial Perfusion by Cardiac CT in Patients Before and After Coronary-bypass-surgery, Before and After Dilating/Stenting and Before and After Aortic-valve-replacement.|Not yet recruiting||N/A|690|Anticipated|Bakulev Scientific Center of Cardiovascular Surgery|||3||f||||t||||||||||2017-10-10 23:35:28.218242|2017-10-10 23:35:28.218242
NCT02361983|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-02-07|||July 2012||2012-07-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|AIRTHOR||Airway Management in Thoracic Anesthesia in Italy|Airway Management in Thoracic Surgery and Incidence Rate of Dislocation and Related Intraoperative Hypoxemia: State of the Art in Italy|Completed||N/A|2129|Actual|Azienda Ospedaliera S. Maria della Misericordia|||1||f||||t||||||||||2017-10-10 23:35:28.3073|2017-10-10 23:35:28.3073
NCT02361970|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-20|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism||Completed||N/A|84|Actual|West China Hospital|||3||f||||f||||||Samples Without DNA|"     Peripheral blood sample was collected to examine extra-cell expression of gamma delta T cells     and their intracellular cytokines with or without immuno-stimulants using flow cytometry.   "|||2017-10-10 23:35:28.377056|2017-10-10 23:35:28.377056
NCT02361957|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-08-27|||November 2014||2014-11-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|CUPIDO||The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis Patients|The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis Patients|Suspended||N/A|40|Anticipated|Wageningen University||2||"We recruited 25 of the 40 participants from intended study population. Recruitment in new   populations requires an METC amendment."|f||||f||||||||||2017-10-10 23:35:28.450785|2017-10-10 23:35:28.450785
NCT02361931|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2016-04-10|||April 2015||2015-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Safety and Efficacy of a Novel Topical Formulation Containing Erythropoietin|SAFETY AND EFFICACY OF A NOVEL TOPICAL FORMULATION CONTAINING ERYTHROPOIETIN FOR THE TREATMENT OF CHRONIC DIABETIC ULCERS. A DOUBLE-BLIND RANDOMIZED PLACEBO CONTROLLED PILOT STUDY|Recruiting||Phase 2|20|Anticipated|Remedor Biomed Ltd||2|||f||||f||||||||||2017-10-10 23:35:30.599403|2017-10-10 23:35:30.599403
NCT02361918|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2015-02-08|||March 2012||2012-03-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Predictive Value of Procalcitonin, CRP, Drain Fluid Culture, Il-6 and Tnf-α in Anastomotic Leakage|Predicting Value of Serum Procalcitonin, C-reactive Protein, and Drain Fluid Culture, Fluid Il-6 and Tnf-α Levels in Anastomotic Leakage Following Rectal Resection|Completed||N/A|50|Actual|Istanbul University|||2||f||||||||||||||2017-10-10 23:35:30.703156|2017-10-10 23:35:30.703156
NCT02361905|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-11-17|||February 2015||2015-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas|Advantages of Ulipristal Acetate for the Preoperative Treatment of Hypoechoic Cellular Leiomyomas|Recruiting||Phase 4|42|Anticipated|University Magna Graecia||2|||f||||t||||||||||2017-10-10 23:35:30.765172|2017-10-10 23:35:30.765172
NCT02361892|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-11-17|||February 2015||2015-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|UPA_ovAge||The Effect of Ulipristal Acetate (UPA) on Women Ovarian Reserve|The Effect of UPA on Women Ovarian Reserve|Recruiting||Phase 4|73|Anticipated|University Magna Graecia||1|||f||||t||||||||||2017-10-10 23:35:30.85493|2017-10-10 23:35:30.85493
NCT02361879|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-11-17|||February 2015||2015-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma|Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma|Recruiting||Phase 4|146|Anticipated|University Magna Graecia||2|||f||||t||||||||||2017-10-10 23:35:30.938854|2017-10-10 23:35:30.938854
NCT02361866|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-02-11|||May 2014||2014-05-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults|Randomized, Double Blind, Multicenter, Phase III Study to Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults|Completed||Phase 3|376|Actual|Green Cross Corporation||2|||f||||f||||||||||2017-10-10 23:35:31.055587|2017-10-10 23:35:31.055587
NCT02361853|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-02-11|||March 2015||2015-03-01|January 2015|2015-01-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Observational|||The Role of Immature Myeloid Cells, Monocytes, Dentritic Cells and Neutrophils in Human Pregnancies as Markers for Mature Pregnancy and Spontaneous Labor|The Role of Immature Myeloid Cells, Monocytes, Dentritic Cells and Neutrophils in Human Pregnancies as Markers for Mature Pregnancy and Spontaneous Labor|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hillel Yaffe Medical Center|||3||f||||t||||||Samples Without DNA|"     Blood sample.   "|||2017-10-10 23:35:31.142328|2017-10-10 23:35:31.142328
NCT02361840|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-02-11|||October 2012||2012-10-01|February 2015|2015-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||Predictive Value of Troponin I for Acute Respiratory Distress Syndrome in Children With Shock|Predictive Value of Troponin I for Acute Respiratory Distress Syndrome in Children With Shock|Unknown status|Recruiting|N/A|65|Anticipated|Hospital Civil de Guadalajara|||2||f||||t||||||||||2017-10-10 23:35:31.218732|2017-10-10 23:35:31.218732
NCT02361827|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2015-02-11|||January 2015||2015-01-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|||The Effect of Vitamin D on in Vitro Fertilization Outcome|The Effect of Vitamin D on in Vitro Fertilization Outcome, a Prospective Observational Study|Unknown status|Recruiting|N/A|800|Anticipated|The First Affiliated Hospital of Zhengzhou University|||3||f||||t||||||Samples With DNA|"     Serum   "|||2017-10-10 23:35:31.300697|2017-10-10 23:35:31.300697
NCT02361814|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-06-25|||March 2015||2015-03-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Effect of Human Amniotic Membrane Allograft on Functional Recovery After Flexor Tendon Repair|The Effect of Human Amniotic Membrane Allograft on Functional Recovery After Flexor Tendon Repair: a Pilot Study|Terminated||N/A|5|Actual|University of Tampere||1||Unfavorable results|f||||f||||||||||2017-10-10 23:35:31.401941|2017-10-10 23:35:31.401941
NCT02361801|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-06|||February 2015||2015-02-01|February 2015|2015-02-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|DOBUTACS||Liberal Versus Restrictive Use of Dobutamine in Cardiac Surgery|Liberal Versus Restrictive Dobutamine in Cardiac Surgery (DOBUTACS): a Prospective Randomized Non-inferiority Clinical Trial|Unknown status|Active, not recruiting|Phase 3|154|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:35:31.64458|2017-10-10 23:35:31.64458
NCT02361788|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-03-02|||February 2015||2015-02-01|February 2015|2015-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)|A Prospective Cohort Study on the Etiology of Neonatal Hyperbilirubinemia in a Migrant and Refugee Population on the Thai-Myanmar Border|Unknown status|Recruiting|N/A|1887|Anticipated|University of Oxford|||1||f||||f||||||||||2017-10-10 23:35:31.75949|2017-10-10 23:35:31.75949
NCT02361775|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-11|||July 2012||2012-07-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Paravertebral Catheters for VATS Procedures|Ultrasound Guided Paravertebral Catheter Versus Patient Controlled Analgesia for Postoperative Pain Control in Video Assisted Thoracoscopic Surgery: A Prospective Outcomes Study|Completed||Early Phase 1|50|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 23:35:31.849174|2017-10-10 23:35:31.849174
NCT02361762|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-06-22|||February 2015||2015-02-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|GAMES||Gaming for Autism to Mold Executive Skills Project|Electrophysiological Response to Executive Control Training|Recruiting||N/A|80|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-10 23:35:31.939488|2017-10-10 23:35:31.939488
NCT02361749|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-07-26|||September 2014||2014-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation|Comparative Study Between Botulinum Toxin Injection and Myectomy in Treatment of Idiopathic Constipation in Children|Active, not recruiting||Phase 4|40|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:35:32.04143|2017-10-10 23:35:32.04143
NCT02361736|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-02-23|2016-01-25||March 2015||2015-03-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional||Ages Eligible for Study: ≥65 Years； Both Genders；No Healthy Volunteers|Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery|Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients|Completed||N/A|120|Actual|Tianjin Medical University General Hospital|We may have to prolong the follow-up visit for patients.|2|||f||||t||||||||Undecided||2017-10-10 23:35:32.147444|2017-10-10 23:35:32.147444
NCT02361723|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-05-11|||July 2014||2014-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of the Safety and Pharmacokinetics of BGB-290 in Subjects With Solid Tumors|A Phase IA/IB, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Food Effect, and Antitumor Activities of BGB-290 in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|85|Anticipated|BeiGene||1|||f||||f||||||||Undecided||2017-10-10 23:35:32.608414|2017-10-10 23:35:32.608414
NCT02361710|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-08|2016-01-27|||April 2015||2015-04-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|||Serum Vitamin D Levels and Pregnancy Rates in Women Undergoing Elective Frozen Embryo Transfer (eFET)|Comparing the Serum Vitamin D Levels and Pregnancy Rates in Women Undergoing Elective Frozen Embryo Transfer (eFET)|Recruiting||N/A|200|Anticipated|Bahceci Clinic|||2||f||||t||||||||||2017-10-10 23:35:32.686723|2017-10-10 23:35:32.686723
NCT02361697|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-05-18|||December 2014||2014-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||DTI in Children With Multiple Sclerosis|Monitoring of Neurodegenerative Processes in Children With Multiple Sclerosis by Diffusion-weighed Magnetic Resonance Imaging (DTI)|Recruiting||N/A|15|Anticipated|University Hospital Muenster||1|||f||||f||||||||||2017-10-10 23:35:32.793445|2017-10-10 23:35:32.793445
NCT02361684|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-05-22|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|E-COMPARED_S||e-Compared-S: Comparative Effectiveness Research on Internet-based Depression Treatment - Spanish Trial|European Comparative Effectiveness Research on Internet-based Depression Treatment - Spanish Trial|Recruiting||N/A|150|Anticipated|Universitat Jaume I||2|||f||||t||||||||||2017-10-10 23:35:32.891107|2017-10-10 23:35:32.891107
NCT02361671|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-05-01|||February 2015||2015-02-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Optic Nerve Sheath Diameter in Patients With Intracranial Pathology|Ultrasonographic Assessment of the Optic Nerve Sheath Diameter in Patients With Intracranial Pathology|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:35:33.040494|2017-10-10 23:35:33.040494
NCT02361658|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-06-02|||January 2015||2015-01-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Optic Nerve Sheath Diameter (ONSD) With the Raised PCO2 and Internal Jugular Venous Occlusion|Ultrasonographic Assessment of the Optic Nerve Sheath Diameter During Variations in PetCO2 and Controlled Internal Jugular Venous Occlusion: A Volunteer Study|Completed||N/A|11|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:35:33.144305|2017-10-10 23:35:33.144305
NCT02361645|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-02-06|||March 2014||2014-03-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||NSAIDs and PGE2 Levels in Vitrectomy Patients|Vitreous Nonsteroidal Antiinflammatory Drus Concentrations And Prostaglandin E2 Levels in Vitrectomy Patients Treated With Indomethacin 0.5%, Bromfenac 0.09%, and Nepafenac 0.1%|Completed||Phase 3|70|Actual|Università degli Studi di Brescia||5|||f||||f||||||||||2017-10-10 23:35:33.233011|2017-10-10 23:35:33.233011
NCT02361606|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-06|||March 2009||2009-03-01|February 2015|2015-02-01|January 2013|Actual|2013-01-01|February 2011|Actual|2011-02-01||Interventional|||An Internet Cognitive-Behavioral Intervention for Youth With Type 1 Diabetes - Participation and Efficacy|An Internet Cognitive-Behavioral Intervention for Youth With Type 1 Diabetes - Participation and Efficacy|Completed||N/A|89|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:35:33.322753|2017-10-10 23:35:33.322753
NCT02361580|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-02-08|2017-02-08||January 2015|Actual|2015-01-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Impact of Keeping a Personal Recovery Diary on Upper Extremity Disability|Impact of Keeping a Personal Recovery Diary on Upper Extremity Disability|Terminated||N/A|9|Actual|Massachusetts General Hospital||2||"The Principal Investigator left the institution so the study was stopped before completing   enrollment."|f||||f||||||||||2017-10-10 23:35:33.62197|2017-10-10 23:35:33.62197
NCT02361567|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-02-06|||April 2015||2015-04-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison of Tramacet Versus Percocet in Post Surgical Patients|Comparison of Tramacet Versus Percocet in Post Surgical Patients|Unknown status|Not yet recruiting|Phase 4|160|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:35:33.904826|2017-10-10 23:35:33.904826
NCT02361554|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-08-15|||June 2012||2012-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Deep Brain Stimulation in Treatment Resistant Schizophrenia|Deep Brain Stimulation in Treatment Resistant Schizophrenia|Recruiting||N/A|3|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 23:35:33.998685|2017-10-10 23:35:33.998685
NCT02361541|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-05-13|||November 2014||2014-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|HCV-Epi||Determination of HCV Prevalence in a HIV Patient Cohort in Phnom Penh, Cambodia|Determination of Hepatitis C Prevalence, Genetic Diversity and Treatment Eligibility in an HIV Patient Cohort in Phnom Penh, Cambodia|Completed||N/A|3045|Actual|Institute of Tropical Medicine, Belgium|||1||f||||f||||||Samples Without DNA|"     Left over biological samples (whole blood plasma and serum)   "|||2017-10-10 23:35:34.085183|2017-10-10 23:35:34.085183
NCT02361528|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-09-08|||September 2015||2015-09-01|September 2016|2016-09-01||||September 2018|Anticipated|2018-09-01||Interventional|GRID||GM-CSF to Decrease ICU Acquired Infections|A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression|Recruiting||Phase 3|488|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:35:34.179984|2017-10-10 23:35:34.179984
NCT02361515|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-10-04|||March 2015||2015-03-01|October 2016|2016-10-01||||March 2020|Anticipated|2020-03-01||Interventional|RPAH2||Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid|Moderate Hypofractionated Radiotherapy (62 Gy in 20 Fractions of 3.1 Gy) Versus Stereotactic Radiotherapy (37.5 Gy in 5 Fractions of 7.5 Gy) With Hyaluronic Acid Injection Between the Prostate and the Rectum for Prostate Cancer of Low- to Intermediate Risk; RPAH2|Active, not recruiting||Phase 2|96|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:35:34.399088|2017-10-10 23:35:34.399088
NCT02361502|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-02-06|||February 2015||2015-02-01|February 2015|2015-02-01||||January 2016|Anticipated|2016-01-01||Interventional|||MIrabegron With oveRACtive bLadder Symptoms in mEn|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Comparison Clinical Study to Investigate the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron With Overactive Bladder Symptoms in Men|Unknown status|Recruiting|Phase 4|462|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 23:35:34.51275|2017-10-10 23:35:34.51275
NCT02361489|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-02-06|||February 2015||2015-02-01|February 2015|2015-02-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|TITRATE||Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices|Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices (Short Title: TITRATE)|Unknown status|Recruiting|Phase 4|90|Anticipated|Valeritas, Inc.||2|||f||||f||||||||||2017-10-10 23:35:34.690569|2017-10-10 23:35:34.690569
NCT02361476|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2015-12-29|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Does Intraoperative Clonidine Reduce Post Operative Agitation in Children?|Does Intraoperative Clonidine Reduce Post Operative Agitation in Children Anaesthetised With Sevoflurane? A RCT Including Pharmacokinetic Investigation.|Completed||Phase 4|379|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:35:34.791887|2017-10-10 23:35:34.791887
NCT02361463|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-06|||February 2015||2015-02-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||2D Versus 3D Laparoscopic Training on a Virtual Reality Simulator|2D Versus 3D Laparoscopic Training on a Virtual Reality Simulator - A Randomised Trial|Unknown status|Enrolling by invitation|N/A|32|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:35:34.904905|2017-10-10 23:35:34.904905
NCT02361450|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-08-21|||March 16, 2015|Actual|2015-03-16|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|IRRICO||Retrograde Colonic Irrigation to Manage Spina Bifida Functional Digestive Sequelae: a Multicenter, Prospective, Randomized Controlled Trial|Retrograde Colonic Irrigation to Manage Spina Bifida Functional Digestive Sequelae: a Multicenter, Prospective, Randomized Controlled Trial|Recruiting||N/A|108|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-10 23:35:35.012841|2017-10-10 23:35:35.012841
NCT02361437|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-10-19|||February 2015||2015-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Efficacy of Vasculera® in the Healing of Diabetic Skin Ulcers|Safety and Efficacy of Vasculera® in the Healing of Diabetic Skin Ulcers and Improving Insulin Sensitivity: A Pilot Study|Completed||N/A|40|Anticipated|Primus Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:35:35.164389|2017-10-10 23:35:35.164389
NCT02361424|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-02-12|||February 2013||2013-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PLEODIAL-I||Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)|First Single-blind Sequential Placebo-controlled Prospective Phase IIA Pilot Study Assessing the Effects of PXT00864 in Mild AD Patients|Completed||Phase 2|47|Actual|Pharnext SA||4|||f||||t||||||||||2017-10-10 23:35:35.250016|2017-10-10 23:35:35.250016
NCT02361411|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-06|||February 2015||2015-02-01|February 2015|2015-02-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Observational|||Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy|A Research of the Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy|Unknown status|Not yet recruiting|N/A|1000|Anticipated|Peking University Third Hospital|||1||f||||t||||||Samples With DNA|"     blood brain tissure   "|||2017-10-10 23:35:35.348649|2017-10-10 23:35:35.348649
NCT02361398|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-02-06|||January 2015||2015-01-01|February 2015|2015-02-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Lung Alveolar Recruitment and Individualized PEEP Setting in Patients With ARDS|Lung Alveolar Recruitment and Individualized Positive End Expiratory Pressure(PEEP) Setting in Patients With Acute Respiratory Distress Syndrome(ARDS)|Recruiting||N/A|100|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-10 23:35:35.412232|2017-10-10 23:35:35.412232
NCT02361385|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-05-03|||April 2015||2015-04-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||PBR28 PET and Inflammatory Arthritis|Pilot Study to Evaluate the Feasibility of [11C]PBR28 PET-CT to Image Inflammation in the Joints of Arthritis Patients|Active, not recruiting||N/A|22|Actual|University of Oxford|||1||f||||t||||||Samples With DNA|"     A single blood sample will be taken for a genotyping test, to ascertain whether or not     individuals are suitable to undergo PET-CT with the PBR28 PET tracer. Further, blood samples     will be taken for serum and RNA, and synovial biopsy will be done.   "|||2017-10-10 23:35:35.490935|2017-10-10 23:35:35.490935
NCT02361372|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-08-30|||May 2010||2010-05-01|August 2015|2015-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Kefir on Bone Mineral Density and Bone Metabolism in Osteoporotic Patients|Short-term Effect of Kefir-fermented Milk Consumption on Bone Mineral Density and Bone Metabolism in Osteoporotic Patients|Completed||N/A|69|Actual|Ministry of Science and Technology, Taiwan||2|||f||||t||||||||||2017-10-10 23:35:35.561441|2017-10-10 23:35:35.561441
NCT02361359|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-05-01|||January 2014||2014-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Preoperative Catastrophizing Predicts Pain Outcome After Shoulder, Knee and Hip Arthroplasty|Preoperative Catastrophizing Predicts Pain Outcome After Shoulder, Knee and Hip Arthroplasty|Completed||N/A|300|Actual|Hospital Ambroise Paré Paris|||1||f||||f||||||||||2017-10-10 23:35:35.625507|2017-10-10 23:35:35.625507
NCT02361151|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-12-07|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|mFIT||The mFIT Study (Motivating Families With Interactive Technology)|Enhancing Parent-Child Communication and Promoting Physical Activity and Healthy Eating Through Mobile Technology: the mFIT Study (Motivating Families With Interactive Technology)|Completed||Phase 1|200|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-10 23:35:37.043416|2017-10-10 23:35:37.043416
NCT02361346|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-08|||February 2015||2015-02-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|MT-3724NHL001||PK, PD, Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Non-Hodgkin's B-Cell Lymphoma and B-Cell Chronic Lymphocytic Leukemia|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Non-Hodgkin's B-Cell Lymphoma and B-Cell Chronic Lymphocytic Leukemia|Recruiting||Phase 1|40|Anticipated|Molecular Templates, Inc.||7|||f||||t||||||||||2017-10-10 23:35:35.688784|2017-10-10 23:35:35.688784
NCT02361333|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-02-10|||October 2012||2012-10-01|February 2015|2015-02-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Barriers to Use of Remote Monitoring in Patients With Implantable Cardioverter Defibrillators|Barriers to Use of Remote Monitoring in Patients With Implantable Cardioverter Defibrillators|Unknown status|Enrolling by invitation|N/A|86|Anticipated|Yale University||2|||f||||||||||||||2017-10-10 23:35:35.797566|2017-10-10 23:35:35.797566
NCT02361320|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-01-10|||March 2015||2015-03-01|January 2017|2017-01-01||||March 2019|Anticipated|2019-03-01||Interventional|||Imaging Biomarkers in Pancreatic and Hepatobiliary Cancers|Imaging Biomarkers in Pancreatic and Hepatobiliary Cancers|Recruiting||N/A|259|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:35:35.856138|2017-10-10 23:35:35.856138
NCT02361307|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-04-11|||February 2015||2015-02-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||The Outcomes of Seamless ADL Training Between Occupational Therapist and Nurse in Stroke Patients|The Outcomes of Seamless ADL Training Between Occupational Therapist and Nurse in Stroke Patients|Unknown status|Recruiting|Phase 4|36|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-10 23:35:35.936369|2017-10-10 23:35:35.936369
NCT02361294|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-02-10|||December 2014||2014-12-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Observational|iPLATELET||Immature Plateletes in the Etiopathology of Deep Venous Thrombosis|Prospective Study to Generate Hypotheses About the Role of Platelets and Immature Platelets in the Pathogenesis of Idiopathic Venous Thromboses and Pulmonary Embolisms|Unknown status|Recruiting|N/A|100|Anticipated|Technische Universität München|||2||f||||f||||||Samples With DNA|"     thrombophilia screening   "|||2017-10-10 23:35:36.141038|2017-10-10 23:35:36.141038
NCT02361281|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-06|||December 2014||2014-12-01|February 2015|2015-02-01|July 2015|Anticipated|2015-07-01|March 2015|Anticipated|2015-03-01||Observational|||Validation of a Non-invasive Diagnostic Method for Sarcoidosis Using Exhaled Breath|Validation of a Previously Performed Study on Non-invasive Diagnostic Method for Sarcoidosis Using Exhaled Breath|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Maastricht University|||2||f||||f||||||||||2017-10-10 23:35:36.226437|2017-10-10 23:35:36.226437
NCT02361268|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-07-13|||July 2015||2015-07-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|END-IDLE||End-Stage Renal Disease Intra-dialysis Lifestyle Education Study|End-Stage Renal Disease Intra-dialysis Lifestyle Education Study|Completed||N/A|67|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 23:35:36.287462|2017-10-10 23:35:36.287462
NCT02361255|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2015-08-25|||February 2015||2015-02-01|August 2015|2015-08-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Observational|||Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism|Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism|Unknown status|Recruiting|N/A|40|Anticipated|Corporal Michael J. Crescenz VA Medical Center|||2||f||||||||||||||2017-10-10 23:35:36.385122|2017-10-10 23:35:36.385122
NCT02361242|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-02-12|||June 2013||2013-06-01|December 2014|2014-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PLEODIAL-II||24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion|24-week Open-label Extension Study Evaluating the Effect of PXT00864 in Mild Alzheimer's Disease Patients Further to PLEODIAL-I Completion|Completed||Phase 2|45|Actual|Pharnext SA||3|||f||||t||||||||||2017-10-10 23:35:36.459638|2017-10-10 23:35:36.459638
NCT02361229|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-07-11|||January 2008||2008-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|SCSTCS||Skin Cancer in Swiss Transplant Cohort Study|Skin Cancer in Swiss Transplant Cohort Study|Recruiting||N/A|4000|Anticipated|University of Zurich|||1||f||||f||||||||Yes|Share data with Swiss Transplant Cohort Study. Future projects can obtain data after project request is approved.|2017-10-10 23:35:36.555563|2017-10-10 23:35:36.555563
NCT02361216|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-04-12||2017-04-11|April 2015||2015-04-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest|Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp or Approximately 250 cm2 on the Chest|Completed||Phase 3|729|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 23:35:36.636381|2017-10-10 23:35:36.636381
NCT02361203|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-02-01|||February 2015||2015-02-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Exercise and Virtual Reality Exposure Therapy for Acrophobia|Exercise and Virtual Reality Exposure Therapy for Acrophobia|Completed||N/A|60|Actual|University of Texas at Austin||2|||f||||f||||||||||2017-10-10 23:35:36.713219|2017-10-10 23:35:36.713219
NCT02361190|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-06-09|||February 2015||2015-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Fast Acting Testosterone Nasal Spray on Anxiety|Effects of Fast Acting Testosterone Nasal Spray on Anxiety|Completed||N/A|96|Actual|University of Texas at Austin||2|||f||||f||||||||||2017-10-10 23:35:36.805697|2017-10-10 23:35:36.805697
NCT02361177|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-06-09|||January 2016||2016-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Role of Oxytocin in Telling and Detecting Lies|Role of Oxytocin in Telling and Detecting Lies|Withdrawn||Early Phase 1|0|Actual|University of Texas at Austin||2||Drug not available|f||||f||||||||||2017-10-10 23:35:36.888013|2017-10-10 23:35:36.888013
NCT02361164|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-01-10|||July 2012||2012-07-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|September 2016|Actual|2016-09-01||Observational|||Birth Cohort Study for Respiratory Infections|Prospective Two-year Observational Study to Evaluate the Effect of Bacterial Colonisation of the Nasopharynx on the Occurence of Acute Respiratory Infections in a Birth Cohort of Children and Their Mothers|Active, not recruiting||N/A|300|Anticipated|Nestlé|||1||f||||f||||||Samples With DNA|"     Blood samples, clinical samples for bacterial and viral isolates   "|No||2017-10-10 23:35:36.975278|2017-10-10 23:35:36.975278
NCT02361138|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2015-02-06|||December 2013||2013-12-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Study Following Multiple Dose of SHR3824 in Healthy Subjects|Completed||Phase 1|48|Actual|Jiangsu HengRui Medicine Co., Ltd.||6|||f||||f||||||||||2017-10-10 23:35:37.125966|2017-10-10 23:35:37.125966
NCT02361125|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-08-17|||August 2002|Actual|2002-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate|Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue|Recruiting||Phase 1|36|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:35:37.236542|2017-10-10 23:35:37.236542
NCT02361112|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-06-07|||August 2014||2014-08-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|BLTN-Ic||Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer|A Phase I Study of Pyrotinib In Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer|Recruiting||Phase 1|38|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:35:37.340938|2017-10-10 23:35:37.340938
NCT02361099|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-03-03|||June 2014||2014-06-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|SENTINEL||SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse|"Phase 3 Multicentric Randomized Study Assessing Self-reported Symptoms Transmitted Via an Internet Web-application  Sentinel  Versus Conventional Follow-up in Patients With High Risk Lung Cancer (SENTINEL)"|Terminated||Phase 3|133|Actual|Institut Cancerologie de l'Ouest||2|||f||||f||||||||||2017-10-10 23:35:37.421806|2017-10-10 23:35:37.421806
NCT02361086|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-02-28|||June 2014||2014-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer|A Phase 1/2 Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Once-Daily VT-464 in Patients With Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|21|Actual|Innocrin Pharmaceutical||6|||f||||f||||||||||2017-10-10 23:35:37.529669|2017-10-10 23:35:37.529669
NCT02361073|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-02-10|||June 2011||2011-06-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01|6 Months|Observational [Patient Registry]|||The Role of Emotional Stress in Patients With Stress-induced Cardiomyopathy|Event-related Potentials in Patients With Takotsubo Cardiomyopathy|Unknown status|Recruiting|N/A|30|Anticipated|University of Magdeburg|||3||f||||t||||||||||2017-10-10 23:35:37.648997|2017-10-10 23:35:37.648997
NCT02361060|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-02-21|||February 2015||2015-02-01|February 2017|2017-02-01|July 4, 2016|Actual|2016-07-04|July 4, 2016|Actual|2016-07-04||Interventional|||Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery|Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery - A Randomized Controlled Trial|Completed||Phase 4|130|Actual|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa||2|||f||||f||||||||||2017-10-10 23:35:37.731235|2017-10-10 23:35:37.731235
NCT02361047|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-11-17|||February 2015||2015-02-01|August 2016|2016-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Let's Play! Healthy Kids After Cancer|Healthy Kids After Cancer: A Physical Activity and Nutrition Intervention|Completed||N/A|42|Actual|HealthPartners Institute||2|||f||||t||||||||||2017-10-10 23:35:37.826635|2017-10-10 23:35:37.826635
NCT02361034|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-12-14|||January 2015||2015-01-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||To Evaluate Safety, Tolerability and Pharmacokinetics of GRC 27864 in Healthy Subjects and Elderly Healthy Subjects|A Two-Part, Phase I Study of Orally Administered GRC 27864, a Novel, Microsomal Prostaglandin E Synthase-1 Enzyme (mPGES-1) Inhibitor, to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses in Healthy Subjects (Part 1), and of Multiple Doses in Elderly Subjects (Part 2)|Completed||Phase 1|32|Actual|Glenmark Pharmaceuticals S.A.||2|||f||||f||||||||||2017-10-10 23:35:37.934384|2017-10-10 23:35:37.934384
NCT02361021|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-07-23|||July 2015||2015-07-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|IWEAN||Lung Aeration During WEANing From Mechanical Ventilation Determined by Electrical Impedance Tomography and Lung Ultrasound|Lung Aeration During WEANing From Mechanical Ventilation Determined by Electrical Impedance Tomography and Lung Ultrasound|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:35:38.014999|2017-10-10 23:35:38.014999
NCT02361008|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-06|||December 2012||2012-12-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect|TEE-guided Perventricular Device Closure Through Minithoracotomy vs Traditional Surgery Repair Via CBP in Treatment of Infundibular Ventricular Septal Defect：A Two-center Clinical Randomized Controlled Trial|Completed||N/A|20121212|Actual|The First Affiliated Hospital of Nanchang University||2|||f||||f||||||||||2017-10-10 23:35:38.088785|2017-10-10 23:35:38.088785
NCT02360995|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2016-02-29|2016-02-01||June 2014||2014-06-01|May 2014|2014-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Clinical Investigation of Toothpaste as Compared to Toothpaste and Mouthwash in Reducing Plaque and Gingivitis: A Six-week Clinical Study in the US|The Clinical Investigation of Colgate Total Toothpaste as Compared to Crest Pro-Health Toothpaste and Crest Pro-Health Mouthwash, and Crest Cavity Protection Toothpaste and Crest Fluoride Mouthwash in Reducing Plaque and Gingivitis: A Six-week Clinical Study in the US|Completed||Phase 4|129|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-10-10 23:35:38.189506|2017-10-10 23:35:38.189506
NCT02360982|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-06|||March 2012||2012-03-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|||The Comparison of Incidence and Risk Factors of Postoperative Delirium in Elderly Patients After Lower Extremity Surgery|Cukurova University Faculty of Medicine|Completed||N/A|120|Actual|Cukurova University|||2||f||||f||||||||||2017-10-10 23:35:38.591921|2017-10-10 23:35:38.591921
NCT02360969|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-01-24|||November 2010|Actual|2010-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|STRABO||Effect of Neuromuscular Blockade on the Oculomotor by Not Squinting Child|Effect of Neuromuscular Blockade on the Oculomotor by Not Squinting Child|Completed||N/A|60|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-10 23:35:38.667454|2017-10-10 23:35:38.667454
NCT02360956|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-02-06|||December 2014||2014-12-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)|Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis Progression and Epicardial Adipose Tissue(EAT) Volume Reduction in Patients With Coronary Atherosclerosis Detected by Coronary CT Angiography(CCTA)|Unknown status|Recruiting|Phase 4|100|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-10 23:35:38.726469|2017-10-10 23:35:38.726469
NCT02360943|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-03-23|||July 2014||2014-07-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|PEAGE||Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE|Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE|Recruiting||N/A|1500|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-10 23:35:38.813718|2017-10-10 23:35:38.813718
NCT02360917|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-01-12|||May 2015||2015-05-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|Haze||Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment|Emerging From the Haze™-A Multi-center, Randomized Controlled Trial to Measure Impact of a Multi-dimensional Psycho-educational Program on Subjective Cognitive Complaints After Breast Cancer Treatment Using Virtual Technology|Active, not recruiting||N/A|50|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-10 23:35:39.066626|2017-10-10 23:35:39.066626
NCT02360904|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-06|2017-01-06|||April 2014||2014-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy|A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy: Effects on Quality of Life and Chemotherapy-associated Symptoms|Recruiting||N/A|50|Anticipated|Beth Israel Medical Center||2|||f||||f||||||||No||2017-10-10 23:35:39.122017|2017-10-10 23:35:39.122017
NCT02360891|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-05-17|||January 12, 2015|Actual|2015-01-12|May 2017|2017-05-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01|10 Years|Observational [Patient Registry]|PULSE||Study of Predictive Factors of Progression of Lateral Amyotrophic Sclerosis|Study of Predictive Factors of Progression of Lateral Amyotrophic Sclerosis Prognosis and Endophenotype Biomarkers French Database Set up|Recruiting||N/A|1000|Anticipated|University Hospital, Lille|||3||f||||t|f|f||||Samples With DNA|"     whole blood, serum, white cells, platelets, cerebrospinal fluid,skin, muscle, brains   "|No||2017-10-10 23:35:39.333003|2017-10-10 23:35:39.333003
NCT02360878|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-08-08|||February 2013||2013-02-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Observational|||The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones|The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones|Completed||N/A|25|Actual|University Hospital, Gentofte, Copenhagen|||2||f||||f||||||Samples With DNA|"     whole blood feces   "|||2017-10-10 23:35:39.487079|2017-10-10 23:35:39.487079
NCT02360865|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-06-15|||February 2015||2015-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|COPD||Mechanisms of Exercise Intolerance in Chronic Obstructive Pulmonary Disease|Mechanisms of Exercise Intolerance in Chronic Obstructive Pulmonary Disease|Completed||N/A|18|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:35:39.63625|2017-10-10 23:35:39.63625
NCT02360852|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-02-21|||January 2015||2015-01-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||IBAT Inhibitor A4250 for Cholestatic Pruritus|An Exploratory, Phase IIa Study to Demonstrate the Safety and Efficacy of A4250 in Patients With Primary Biliary Cirrhosis and Cholestatic Pruritus|Terminated||Phase 2|9|Actual|Sahlgrenska University Hospital, Sweden||1||(Expected) side effects|f||||f||||||||No||2017-10-10 23:35:39.733831|2017-10-10 23:35:39.733831
NCT02360839|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-01-25|||July 2009||2009-07-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Use of FNA and FNB in the Optimization of EUS-assisted Tissue Sampling|The Use of FNA and FNB in the Optimization of EUS-assisted Tissue Sampling|Recruiting||N/A|1000|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-10 23:35:39.82747|2017-10-10 23:35:39.82747
NCT02360826|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-07-18|||June 17, 2014|Actual|2014-06-17|July 2017|2017-07-01|July 5, 2016|Actual|2016-07-05|July 5, 2016|Actual|2016-07-05||Interventional|||Statin Distribution|Pharmacokinetics of Pravastatin and Simvastatin in Pediatric Dyslipidemia Patients: Clinical Impact of Genetic Variation in Statin Disposition|Completed||Phase 1|32|Actual|Children's Mercy Hospital Kansas City||2|||f||||t||||||||||2017-10-10 23:35:39.926419|2017-10-10 23:35:39.926419
NCT02360813|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-07-24|||August 2014||2014-08-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Cognitive Remediation Therapy Within a Secure Forensic Setting|Randomised Controlled Trial to Evaluate the Efficacy of Cognitive Remediation Within a Secure Forensic Setting for Schizophrenia Spectrum Patients|Completed||N/A|65|Actual|Central Mental Hospital||2|||f||||f||||||||||2017-10-10 23:35:40.053181|2017-10-10 23:35:40.053181
NCT02360800|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-09-27|||February 2, 2017|Actual|2017-02-02|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|RETICO||Trial Comparing Tisseel as an Adjunct to Traditional Hemostasis After Redo Cardiac Surgery|Randomized Prospective Comparison of Tisseel Or Control to Diminish Blood Loss After Redo Redo Cardiac Surgery: the Study|Recruiting||N/A|200|Anticipated|Cardiochirurgia E.H.||2|||f||||f|f|f||||||||2017-10-10 23:35:40.196068|2017-10-10 23:35:40.196068
NCT02360787|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-07-13|||October 2012||2012-10-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|May 2016|Actual|2016-05-01||Interventional|||The Effects of Including Almonds in a Weight Loss Trial|The Effects of Including Almonds in an Energy-restricted Diet on Weight, Abdominal Fat Loss, Blood Pressure, and Cognitive Function|Active, not recruiting||N/A|80|Anticipated|Purdue University||2|||f||||t||||||||||2017-10-10 23:35:40.284363|2017-10-10 23:35:40.284363
NCT02360774|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-02-22|||February 2015||2015-02-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Mechanisms of Weight Loss With SGLT2 Inhibition|Mechanisms of Weight Loss With SGLT2 Inhibition|Recruiting||Phase 4|42|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f|t|f||||||No||2017-10-10 23:35:40.37391|2017-10-10 23:35:40.37391
NCT02360761|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2016-09-17|||January 2016||2016-01-01|September 2016|2016-09-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|STEPS||Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy|Surgical Treatment of Elderly Patients With Early Stage Non-small Cell Lung Cancer (STEPS): Comparison Between Sublobar Resection and Lobectomy - an Open, Multicenter, Randomized Phase III Clinical Trial|Recruiting||Phase 3|339|Anticipated|Peking University People's Hospital||2|||f||||f||||||||||2017-10-10 23:35:40.46998|2017-10-10 23:35:40.46998
NCT02360748|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-04-06|||October 2015||2015-10-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|January 2017|Anticipated|2017-01-01||Interventional|LOPSIE||A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients|A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients|Enrolling by invitation||N/A|10|Anticipated|Ochsner Health System||1|||f||||f||||||||||2017-10-10 23:35:40.589132|2017-10-10 23:35:40.589132
NCT02360735|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-06-27|||January 2015||2015-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|MLD||Manual Lymph Drainage|Manual Lymph Drainage for Patients With Acute Total Knee Replacement|Terminated||N/A|4|Actual|Anne Arundel Health System Research Institute||2||Lack of enrollment|f||||f||||||||||2017-10-10 23:35:40.675572|2017-10-10 23:35:40.675572
NCT02360722|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-11-30|||October 2016||2016-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly|Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly|Withdrawn||Phase 4|0|Actual|Abbott Nutrition||2||The study was cancelled due to change in food registration regulations in China.|f||||f||||||||No||2017-10-10 23:35:40.757733|2017-10-10 23:35:40.757733
NCT02360709|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-03-23|||November 2014||2014-11-01|March 2015|2015-03-01|April 2021|Anticipated|2021-04-01|January 2017|Anticipated|2017-01-01|5 Years|Observational [Patient Registry]|||Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions|A Prospective, Multi-center, Single-arm Observational Registry Trial Evaluating the Safety and Efficacy of CRE8 Sirolimus-Eluting Stent in the Treatment of Patients With De Novo Coronary Artery Lesions|Recruiting||N/A|800|Anticipated|CID S.p.A.|||1||f||||t||||||||||2017-10-10 23:35:40.837906|2017-10-10 23:35:40.837906
NCT02360696|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-02-05|||August 2014||2014-08-01|February 2015|2015-02-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Observational|||Functional Dyspepsia (FD) - Clinical Response to Montelukast in Children|Predictors of Clinical Response to Montelukast in Children With Functional Dyspepsia|Unknown status|Recruiting|N/A|50|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"     Samples retained, with potential for extraction of DNA from at least one of the types of     samples retained.   "|||2017-10-10 23:35:40.926223|2017-10-10 23:35:40.926223
NCT02360683|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-05-17|||November 18, 2013|Actual|2013-11-18|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|May 2019|Anticipated|2019-05-01||Observational|PREDI-STIM||Predictive Factors and Subthalamic Stimulation in Parkinson's Disease|Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease|Recruiting||N/A|1000|Anticipated|University Hospital, Lille|||1||f||||t|f|f||||||No||2017-10-10 23:35:41.042449|2017-10-10 23:35:41.042449
NCT02360670|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-10-23|||February 2015||2015-02-01|October 2015|2015-10-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|PRACTISE||Penumbra and Recanalisation Acute Computed Tomography in Ischaemic Stroke Evaluation|Penumbra and Recanalisation Acute Computed Tomography in Ischaemic Stroke Evaluation|Unknown status|Recruiting|N/A|400|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||t||||||||||2017-10-10 23:35:41.181309|2017-10-10 23:35:41.181309
NCT02360657|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-01-22|||February 2015||2015-02-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia|A Double-blind, Placebo-controlled, Randomized, 4-Week, Multiple-dose, Proof of Mechanism (POM) Study in Japanese Subjects Asymptomatic at Risk for Alzheimer Dementia (ARAD) Investigating the Effects of JNJ-54861911 on A-beta Processing in Cerebrospinal Fluid (CSF) and Plasma|Completed||Phase 1|18|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-10-10 23:35:41.276378|2017-10-10 23:35:41.276378
NCT02360644|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-09-01|||October 2014||2014-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Interventional|||Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease|Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease|Recruiting||N/A|120|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:35:41.372728|2017-10-10 23:35:41.372728
NCT02360618|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-07-07|||October 2015||2015-10-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Metformin and Simvastatin Use in Bladder Cancer|A Window of Opportunity Study to Evaluate the Role of the Combination of Metformin and Simvastatin as a Neoadjuvant Therapy in Invasive Bladder Cancer|Recruiting||Phase 2|44|Anticipated|London Health Sciences Centre||1|||f||||t||||||||No||2017-10-10 23:35:41.557208|2017-10-10 23:35:41.557208
NCT02360605|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-02-23|||February 2015||2015-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Health Literacy Interventions to Overcome Disparities in CRC Screening|Health Literacy Interventions to Overcome Disparities in CRC Screening|Active, not recruiting||N/A|620|Actual|Louisiana State University Health Sciences Center Shreveport||2|||f||||t||||||||No||2017-10-10 23:35:41.650463|2017-10-10 23:35:41.650463
NCT02261272|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-09-20|||November 2013||2013-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|SHUTiNorse||Internet-based Treatment for Insomnia|Internet-based Treatment for Insomnia in Norway.|Completed||N/A|200|Actual|Norwegian Institute of Public Health||2|||f||||||||||||||2017-10-10 23:56:36.47751|2017-10-10 23:56:36.47751
NCT02360592|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-06-15|||April 2014||2014-04-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients|Combination Therapy of Interferon Alfa-2b Plus Interleukin 2 and Hepatitis B Vaccine in Entecavir-experienced Chronic Hepatitis B Patients With HBeAg Seroclearance: a Prospective, Randomized Open-label Trial (Endeavor Study, a Pilot Study)|Active, not recruiting||Phase 4|100|Anticipated|Tongji Hospital||3|||f||||t||||||||||2017-10-10 23:35:41.753171|2017-10-10 23:35:41.753171
NCT02360579|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-07-14|||September 2015||2015-09-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|June 2018|Anticipated|2018-06-01||Interventional|LN-144||Study of LN-144, Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma|A Phase 2, Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients With Metastatic Melanoma|Recruiting||Phase 2|60|Anticipated|Iovance Biotherapeutics, Inc.||3|||f||||t||||||||||2017-10-10 23:35:41.888327|2017-10-10 23:35:41.888327
NCT02360566|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-09-07|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Participatory Video as a Recovery-Oriented Intervention in Early Psychosis|The Novel Use of Participatory Video as a Recovery-Oriented Intervention in Early Psychosis: A Pilot Study|Completed||N/A|10|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-10 23:35:41.995823|2017-10-10 23:35:41.995823
NCT02360553|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-03-27|||July 2013||2013-07-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||The Effect of ObeseGO! Towards Adolescent Obesity|The Effect of Internet Based Intervention (OBESEGO!) Towards Obesity Among Adolescents|Completed||N/A|47|Actual|Universiti Kebangsaan Malaysia Medical Centre||2|||f||||t||||||||||2017-10-10 23:35:42.089131|2017-10-10 23:35:42.089131
NCT02360540|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-09-21|||May 2015||2015-05-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|3 Months|Observational [Patient Registry]|PERCEPIC||PERCEPIC: PERC Rule Combined With Implicit Low Clinical Probability|Performance of the Pulmonary Embolism Rule-out Criteria (the PERC Rule) Combined With Implicit Low Clinical Probability (Gestalt) to Rule-out PE Without Further Exams|Completed||N/A|1773|Actual|University Hospital, Angers|||1||f||||||||||||||2017-10-10 23:35:42.148833|2017-10-10 23:35:42.148833
NCT02360527|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-04-11|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01|12 Months|Observational [Patient Registry]|DIALRET||Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease|Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease|Completed||N/A|126|Actual|Hospital Universitari Vall d'Hebron Research Institute|||4||f||||f||||||Samples With DNA|"     Biochemical evaluation including Hba1c, lipidic profile, renal and hepatic function. We will     also determine the APOE genotype and plasmatic beta-amyloidal fractions (Aβ1-40 and Aβ1-42)     as previously described (Hixson JE and Vernier DT. Restriction isotyping of human     apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8.)   "|No||2017-10-10 23:35:42.235104|2017-10-10 23:35:42.235104
NCT02360514|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-09|||December 2007||2007-12-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS|Non-comparable and Open Clinical Research to Evaluate Long-term Immunity by Neutralizing Antibody Test of Adults in High Risk Population of HFRS (Hemorrhagic Fever With Renal Syndrome) After Vaccination and Booster Vaccination of Hantavax|Completed||Phase 3|226|Actual|Green Cross Corporation||1|||f||||f||||||||||2017-10-10 23:35:42.29465|2017-10-10 23:35:42.29465
NCT02360501|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-04-18|||January 2008||2008-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma|Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Locally Advanced or Metastatic Nasopharyngeal Carcinoma: a Prospective, Phase 2 Study|Completed||Phase 2|50|Actual|Sun Yat-sen University||1|||f||||f||||||||||2017-10-10 23:35:42.350165|2017-10-10 23:35:42.350165
NCT02360488|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-08-10|||September 2015||2015-09-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With Stroke|Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With Stroke An Assessor-blind, Randomized, Non-inferiority Trial|Recruiting||Phase 1|124|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-10-10 23:35:42.439675|2017-10-10 23:35:42.439675
NCT02360475|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-07-14|2016-11-29||March 20, 2015||2015-03-20|June 2017|2017-06-01|June 21, 2016|Actual|2016-06-21|July 2, 2015|Actual|2015-07-02||Interventional|||Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women|An Observer-blind Study to Assess the Safety, Reactogenicity and Immunogenicity of Different Formulations of GSK Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women|Completed||Phase 2|507|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-10-10 23:35:42.576583|2017-10-10 23:35:42.576583
NCT02360462|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-07-14|||December 2014|Actual|2014-12-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|||The Effect of tDCS in the Preoperative Period of Hallux Valgus Surgical Treatment|The Effect of tDCS in the Preoperative Period of Hallux Valgus Surgical Treatment|Completed||N/A|40|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:35:43.785083|2017-10-10 23:35:43.785083
NCT02360449|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-06-01|||January 2015||2015-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Social Motivation Intervention for Children With Autism Spectrum Disorder: Improving Peer Initiation|Social Motivation Intervention for Children With Autism Spectrum Disorder: Improving Peer Initiation|Active, not recruiting||N/A|44|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:35:43.904269|2017-10-10 23:35:43.904269
NCT02360436|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-01-19|||March 2015||2015-03-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Observational|||Analysis of the Glutathione Cycle in Children With Rett Syndrome|EPITRA-14-001: Analysis of the Glutathione Cycle in Children With Rett Syndrome|Withdrawn||N/A|0|Actual|Edison Pharmaceuticals Inc|||1|Priorities other studies|f||||f||||||||||2017-10-10 23:35:44.006076|2017-10-10 23:35:44.006076
NCT02360228|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-03-07|||May 2015||2015-05-01|March 2016|2016-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|STILL 2||STimulation to Improve Auditory haLLucinations|Targeting Auditory Hallucinations With Alternating Current Stimulation|Completed||N/A|33|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-10 23:35:45.63211|2017-10-10 23:35:45.63211
NCT02360423|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-03-23|||November 2014||2014-11-01|March 2015|2015-03-01|April 2021|Anticipated|2021-04-01|October 2016|Anticipated|2016-10-01||Interventional|||Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions|A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent Versus the RESOLUTE Zotarolimus-Eluting Stent in the Treatment of Patients With De Novo Coronary Artery Lesions|Recruiting||Phase 3|430|Anticipated|CID S.p.A.||2|||f||||t||||||||||2017-10-10 23:35:44.098186|2017-10-10 23:35:44.098186
NCT02360410|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-04-27|||February 2015||2015-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Check Yourself Study|Promoting Adolescent Health Through Personalized Feedback|Completed||N/A|300|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-10 23:35:44.223371|2017-10-10 23:35:44.223371
NCT02360397|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-09-01|||December 2014||2014-12-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ranolazine Mediated PVC Reduction in Ischemic Heart Disease|Ranolazine Mediated Premature Ventricular Contraction Reduction in Ischemic Heart Disease|Recruiting||Phase 2|5|Anticipated|Kent Hospital, Rhode Island||1|||f||||f||||||||||2017-10-10 23:35:44.324768|2017-10-10 23:35:44.324768
NCT02360384|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2016-11-02|||November 2015||2015-11-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Caecal pH as a Biomarker for Irritable Bowel Syndrome|A Randomised Controlled Trial to Validate the Use of Caecal pH Measurement as a Biomarker in Irritable Bowel Syndrome|Enrolling by invitation||N/A|48|Anticipated|Wingate Institute of Neurogastroenterology||3|||f||||f||||||||||2017-10-10 23:35:44.459749|2017-10-10 23:35:44.459749
NCT02360358|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-01-06|||August 2012||2012-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Autologous Skin Substitute for Chronic Leg/Foot Ulcers.|A Phase II Randomized Multicenter Study on Efficacy and Safety of Cultured Autologous Skin (Tiscover®) and Acellular Dermal Matrix (AS210) in Chronic (Arterio-)Venous Ulcers|Terminated||Phase 1/Phase 2|8|Actual|VU University Medical Center||2||slow inclusion|f||||f||||||||||2017-10-10 23:35:44.705232|2017-10-10 23:35:44.705232
NCT02360345|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-09|||September 2013||2013-09-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|ONX-0801||Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly|A Phase I Trial of ONX-0801 (a Novel α-folate Receptor-mediated Thymidylate Synthase Inhibitor) Exploring Once Weekly and Alternate Week Dosing Regimens in Patients With Solid Tumours|Unknown status|Recruiting|Phase 1|66|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:35:44.826267|2017-10-10 23:35:44.826267
NCT02360332|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-02-04|||October 2009||2009-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|September 2013|Actual|2013-09-01||Interventional|ProjSEARCH1||A Collaborative Public/Private Employment Training and Placement Model ASD Transition Age Youth With Autism Spectrum Disorder (ASD)|A Collaborative Public/Private Employment Training and Placement Model for Transition Age Youth With Autism Spectrum Disorder (ASD)|Completed||N/A|54|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-10 23:35:44.925443|2017-10-10 23:35:44.925443
NCT02360319|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-02-07|||December 11, 2014|Actual|2014-12-11|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PRELAPSE||Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics|A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia|Active, not recruiting||Phase 4|488|Actual|Vanguard Research Group||2|||f||||t||||||||||2017-10-10 23:35:45.034535|2017-10-10 23:35:45.034535
NCT02360306|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-02-05|||January 2013||2013-01-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Analysis of the EBUS Scope as a Hybrid Bronchoscope|The Analysis of the EBUS Scope as a Hybrid Bronchoscope|Completed||N/A|62|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:35:45.210152|2017-10-10 23:35:45.210152
NCT02360293|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-06-01|||June 5, 2017|Anticipated|2017-06-05|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|January 14, 2019|Anticipated|2019-01-14||Interventional|||Stay Strong: A Physical Activity Program for Afghanistan and Iraq Veterans|Stay Strong: A Physical Activity Program for Afghanistan and Iraq Veterans|Not yet recruiting||N/A|455|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 23:35:45.275664|2017-10-10 23:35:45.275664
NCT02360280|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-08-21|||April 1, 2015|Actual|2015-04-01|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression|Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant Depression|Recruiting||Phase 2|56|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-10 23:35:45.358903|2017-10-10 23:35:45.358903
NCT02360267|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-04-26|||May 2013||2013-05-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|2 Years|Observational [Patient Registry]|PBR||Pediatric Bipolar Registry|Pediatric Bipolar Registry|Enrolling by invitation||N/A|500|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-10 23:35:45.435507|2017-10-10 23:35:45.435507
NCT02360254|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-08-14|||January 2015||2015-01-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|Basal21||Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes|Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetic Patients. An Observational Study.|Completed||N/A|26|Actual|University of Padova|||2||f||||f||||||||||2017-10-10 23:35:45.500638|2017-10-10 23:35:45.500638
NCT02360241|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-11-27|||February 2015||2015-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|LPRobacus||Light Needle Positioning Robot Under MRI Guidance|LPRobacus: Light Needle Positioning Robot Under MRI Guidance|Completed||N/A|20|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 23:35:45.570386|2017-10-10 23:35:45.570386
NCT02360215|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-05-19|||July 2015|Actual|2015-07-01|May 2017|2017-05-01||||September 2018|Anticipated|2018-09-01||Interventional|||Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases|A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases|Recruiting||Phase 3|510|Anticipated|NRG Oncology||2|||f||||t||||||||||2017-10-10 23:35:45.737636|2017-10-10 23:35:45.737636
NCT02360202|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-08-29|||April 2015||2015-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|RECOPB||Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid|Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid in Patients With Bullous Pemphigoid|Recruiting||Phase 4|35|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 23:35:46.359533|2017-10-10 23:35:46.359533
NCT02360189|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-11-04|||March 2015||2015-03-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|August 2016|Actual|2016-08-01||Observational|||Mechanisms of Social Inequalities in Post-hospitalization Rehabilitation in Patients With Acute Coronary Syndrome|Mechanisms of Social Inequalities in Post-hospitalization Rehabilitation in Patients With Acute Coronary Syndrome|Active, not recruiting||N/A|310|Actual|Nordsjaellands Hospital|||1||f||||f||||||||||2017-10-10 23:35:46.435882|2017-10-10 23:35:46.435882
NCT02360176|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-03-21|||January 2017||2017-01-01|August 2016|2016-08-01|January 2021|Anticipated|2021-01-01|August 2019|Anticipated|2019-08-01||Interventional|MINIOB||Benefit of Single Port-surgery in Sleeve Gastrectomy|Evaluation of Minimally Invasive Bariatric Surgery Using a Single Laparoscopic Trocar (Single Incision of 2.5 to 3 cm) Versus 4 to 7 Trocars in Sleeve Gastrectomy|Recruiting||N/A|388|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-10 23:35:46.484846|2017-10-10 23:35:46.484846
NCT02360163|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-08-20|||February 2015||2015-02-01|August 2015|2015-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|PAUSE||"The Peripheral Access Utilizing Sonographic Evaluation Study"|"The Peripheral Access Utilizing Sonographic Evaluation Study"|Unknown status|Recruiting|N/A|200|Anticipated|Hackensack University Medical Center||2|||f||||f||||||||||2017-10-10 23:35:46.561741|2017-10-10 23:35:46.561741
NCT02360150|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-08-16|||February 2015||2015-02-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|InfarctusGSI||Evaluation of Myocardial Viability : Dual Energy Cardiac CT vs. Cardiac MRI|Evaluation of Myocardial Viability in Late Presentation Myocardial Infarction: Dual Energy Cardiac CT vs. Cardiac MRI.|Recruiting||N/A|45|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 23:35:46.632277|2017-10-10 23:35:46.632277
NCT02360137|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-07-24|||April 2015||2015-04-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|ANTIQUE||Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke|Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque and a Risk of Stroke in Patients With the carotId Bifurcation Plaque Study|Recruiting||N/A|413|Anticipated|University Hospital Ostrava|||2||f||||f||||||Samples Without DNA|"     atherosclerotic plaque   "|Undecided||2017-10-10 23:35:48.697909|2017-10-10 23:35:48.697909
NCT02360124|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-06-13|2016-04-13||January 2012||2012-01-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Preventing and Arresting Dental Root Surface Caries in Community-dwelling Older Adults|Randomized Clinical Trial on Preventing and Arresting Dental Root Surface Caries Using Silver Diamine Fluoride Solution in Community-dwelling Older Adults|Completed||Phase 2/Phase 3|323|Actual|The University of Hong Kong|It should be noted that the water in Hong Kong is fluoridated at an optimal concentration of 0.5 ppm, and whether SDF or SDF/KI is effective among elders living in non-fluoridated areas needs to be investigated in future clinical studies.|3|||f||||f||||||||No|We consider individual request case by case|2017-10-10 23:35:48.78532|2017-10-10 23:35:48.78532
NCT02360111|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-09-27|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant|A Pilot Trial of GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant|Terminated||N/A|3|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-10 23:35:49.074978|2017-10-10 23:35:49.074978
NCT02360098|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-03-10|||December 2014||2014-12-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Emergence From Anesthesia in Anterior Temporal Lobectomy and Amygdalohippocampectomy Patients|Determinants of the Pattern of Emergence From Anesthesia in Patients Undergoing Anterior Temporal Lobectomy and Amygdalohippocampectomy|Completed||N/A|35|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:35:49.144|2017-10-10 23:35:49.144
NCT02360085|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-05-01|||January 2015||2015-01-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Observational|||Does Heart Rate Variablity (HRV) Predict Hypotension in Patients Undergoing Cervical Myelopathy Surgery ?|Does Heart Rate Variablity (HRV) Predict Hypotension on Induction in Patients Undergoing Surgery for Cervical Myelopathy ?|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:35:49.197246|2017-10-10 23:35:49.197246
NCT02360072|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2016-08-15|||September 2014||2014-09-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma|To Delineate the Characteristics of Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma and Sought to Explore a Possible Predictor in the Progression of Allergic Rhinitis to Asthma|Completed||N/A|200|Actual|Guangzhou Institute of Respiratory Disease|||4||f||||f||||||Samples Without DNA|"     serum ,nasal lavage fluid ,induced sputum   "|||2017-10-10 23:35:49.263491|2017-10-10 23:35:49.263491
NCT02360059|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-07-19|2017-07-19||October 2015|Actual|2015-10-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer|Metformin for Reduction of Paclitaxel Treatment-Related Neuropathy in Patients With Breast Cancer: A Randomized Pilot Study|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||2||Low Accrual|f||||t||||||||||2017-10-10 23:35:49.337717|2017-10-10 23:35:49.337717
NCT02360046|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-08-19|||January 2015||2015-01-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|Hydrocort||The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids in Patients With Corticotropic Hypopituitarism|The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids (Intrahepatocellular IHCL and Intramyocellular IMCL) in Patients With Corticotropic Hypopituitarism, a Randomised Placebo-controlled Double-blind Trial|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 23:35:49.598386|2017-10-10 23:35:49.598386
NCT02360033|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-04|||January 2015||2015-01-01|February 2015|2015-02-01|August 2016|Anticipated|2016-08-01|January 2016|Anticipated|2016-01-01||Interventional|||Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders|Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders With Adults: Manual Development and Randomized-Controled Feasibility Study|Unknown status|Recruiting|N/A|32|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-10 23:35:49.794437|2017-10-10 23:35:49.794437
NCT02360020|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-05-09|||August 2014||2014-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||The XLIMUS-DES in Very Complex Lesions|Performance of the XLIMUS Sirolimus-eluting Coronary Stent In Very Complex Lesions|Completed||Phase 4|200|Actual|Clinica Mediterranea||1|||f||||t||||||||Yes|We plan to present and publish the results in an international journal of interventional cardiology|2017-10-10 23:35:49.898073|2017-10-10 23:35:49.898073
NCT02360007|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-09|||January 2015||2015-01-01|February 2015|2015-02-01||||March 2016|Anticipated|2016-03-01||Interventional|IBT||Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access||Unknown status|Recruiting|Phase 2|70|Anticipated|University of Vermont Medical Center||2|||f||||f||||||||||2017-10-10 23:35:49.995348|2017-10-10 23:35:49.995348
NCT02359994|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-31|||April 2015||2015-04-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|CLOT||Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System|Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System|Recruiting||N/A|324|Anticipated|CryoLife, Inc.||3|||f||||t||||||||||2017-10-10 23:35:50.103918|2017-10-10 23:35:50.103918
NCT02359981|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-10|||May 2013||2013-05-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||MyBehavior: Persuasion by Adapting to User Behavior and User Preference|MyBehavior: Persuasion by Adapting to User Behavior and User Preference|Completed||N/A|17|Actual|Cornell University||2|||f||||f||||||||||2017-10-10 23:35:50.200023|2017-10-10 23:35:50.200023
NCT02359968|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-02-09|||January 2015||2015-01-01|February 2015|2015-02-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|PROTECT||PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer|PReoperative Chemoradiation With Paclitaxel-carboplatin or With Fluorouracil-oxaliplatine-acide Folinique (FOLFOX) for Resectable Esophageal and Junctional Cancer - A Randomized Phase II Trial|Recruiting||Phase 2|106|Anticipated|Centre Oscar Lambret||2|||f||||t||||||||||2017-10-10 23:35:50.28778|2017-10-10 23:35:50.28778
NCT02359955|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-05-01|2015-03-07||June 2014||2014-06-01|May 2015|2015-05-01||||May 2015|Anticipated|2015-05-01||Interventional|||Comparison of Masticatory Efficiency Between Complete Denture With Zero-degree Teeth and Anatomic Teeth in Patients With Severely Resorbed Ridge|Comparison of Masticatory Efficiency and EMG Activity Between Complete Denture With Zero-degree Teeth and Anatomic Teeth in Patients With Severely Resorbed Ridge|Unknown status|Active, not recruiting|N/A|20|Actual|Shanghai 9th People's Hospital||2|||f||||||||||||||2017-10-10 23:35:50.413051|2017-10-10 23:35:50.413051
NCT02359942|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2016-04-26|||March 2015||2015-03-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||The Diagnostic Validity of the Urea Breath Test|The Effect of Citric Acid as the Test Meal on the Diagnostic Accuracy of the 13C-Urea Breath Test in Korean, Randomized Controlled, Open Label Prospective Study|Recruiting||N/A|1200|Anticipated|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-10-10 23:35:50.720418|2017-10-10 23:35:50.720418
NCT02359929|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-07-14|||January 2015||2015-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||BMT Auto MSCs GvHD Ph 1|A Phase I Study of Mesenchymal Stromal Cells for the Treatment of Acute and Chronic Graft Versus Host Disease|Recruiting||Phase 1|24|Anticipated|Emory University||3|||f||||t||||||||||2017-10-10 23:35:50.801329|2017-10-10 23:35:50.801329
NCT02359903|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-05-03|2016-04-03||February 2015||2015-02-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||All patients who received at least 1 injection of study drug|Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis|International Multicenter Comparative Double Blind Study of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis|Completed||Phase 1|90|Actual|Biocad||2|||f||||f||||||||||2017-10-10 23:35:50.991255|2017-10-10 23:35:50.991255
NCT02359877|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-04-07|2016-03-31||July 2014||2014-07-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional||Presented baseline measures relate to all volunteers who participated in Stage 1.|Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif® and Avonex® in Healthy Volunteers||Completed||Phase 1|60|Actual|Biocad||3|||f||||f||||||||||2017-10-10 23:35:51.412222|2017-10-10 23:35:51.412222
NCT02359864|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-07-15|||July 2016||2016-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease|Phase I Feasibility Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease|Recruiting||Phase 1|30|Anticipated|Beaumont Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:35:52.976153|2017-10-10 23:35:52.976153
NCT02359851|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-02-08|||May 2015||2015-05-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pembrolizumab in Treating Patients With Advanced Uveal Melanoma|A Multicenter Phase II Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) in Patients With Advanced Uveal Melanoma|Active, not recruiting||Phase 2|29|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 23:35:53.063603|2017-10-10 23:35:53.063603
NCT02359825|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-05-16|||September 2015||2015-09-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function|Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function|Recruiting||Phase 1|18|Anticipated|Vanderbilt University Medical Center||6|||f||||f||||||||||2017-10-10 23:35:53.280995|2017-10-10 23:35:53.280995
NCT02359812|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-04-29|||January 2015||2015-01-01|April 2016|2016-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|RAR1||Robot Aided Rehabilitation - Multi-point Evaluations|Robot Aided Diagnosis, Passive-Active Arm Motor and Sensory Rehabilitation Post Stroke - Multi-point Evaluations|Recruiting||N/A|24|Anticipated|Shirley Ryan AbilityLab|||1||f||||f||||||||||2017-10-10 23:35:53.358275|2017-10-10 23:35:53.358275
NCT02359799|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-04|||January 2011||2011-01-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Robotic Rehabilitation of Cerebral Palsy|Home- and Lab-Based Passive and Active Movement Rehabilitation of Ankle Impairments in Children With Cerebral Palsy - A Randomized Controlled Trial|Unknown status|Recruiting|N/A|76|Anticipated|Shirley Ryan AbilityLab||2|||f||||t||||||||||2017-10-10 23:35:53.456375|2017-10-10 23:35:53.456375
NCT02359786|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-04|||January 2011||2011-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||RAHM Foundation Retrospective Study of Various Diseases|Retrospective Registry To Enhance the Understanding of the Variability, Progression and Treatment of Various Disorders|Unknown status|Active, not recruiting|N/A|10000|Anticipated|Rahm Foundation|||6||f||||f||||||||||2017-10-10 23:35:53.558074|2017-10-10 23:35:53.558074
NCT02359773|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-08-03|||February 2015||2015-02-01|February 2015|2015-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|||Magnetocardiography as a Tool for Patients Presenting With Chest Pain - Pilot Study|Two Cohort, Pilot Study, to Identify Magnetocardiogram Characteristics That Can be Used to Classify Non Ischemic Chest Pain Patients and Myocardial Infarction Patients.|Completed||N/A|41|Actual|Quantum Imaging Limited|||2||f||||t||||||||||2017-10-10 23:35:53.611821|2017-10-10 23:35:53.611821
NCT02359760|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-09|||February 2015||2015-02-01|February 2015|2015-02-01|May 2017|Anticipated|2017-05-01|June 2016|Anticipated|2016-06-01||Interventional|||Assessment of Piezoelectric Periodontal Surgery Effects on Orthodontic Treatment: a Prospective Pilot Study|Assessment of Piezoelectric Periodontal Surgery Effects on Orthodontic Treatment: a Prospective Pilot Study|Unknown status|Not yet recruiting|N/A|20|Anticipated|Université de Montréal||2|||f||||t||||||||||2017-10-10 23:35:53.687112|2017-10-10 23:35:53.687112
NCT02359747|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-01-30|||January 2015||2015-01-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Analysis of Human Genomic DNA in Embryo's Culture Media Targeting on a Single Gene Disease and Point Mutations||Recruiting||N/A|100|Anticipated|Cervesi Hospital, Cattolica, Italy|||1||f||||||||||||||2017-10-10 23:35:53.776661|2017-10-10 23:35:53.776661
NCT02359734|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-08-23|||April 2012||2012-04-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Observational|||A National Study of Intravenous Medication Errors|A National Study of Intravenous Medication Errors: Understanding How to Improve Intravenous Safety With Smart Pumps|Completed||N/A|900|Actual|Brigham and Women's Hospital|||10||f||||f||||||||||2017-10-10 23:35:53.854069|2017-10-10 23:35:53.854069
NCT02359708|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-04-03|||February 2014||2014-02-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Recolonisation of Bacteria in Hands and Possible Bacterial Leakage From Glove Cuff in Cardiac Surgery|Recolonisation of Bacteria in Hands and Possible Bacterial Leakage From Glove Cuff in Cardiac Surgery. Differences in Microbial Flora and Recolonisation Between Hospital and Non-hospital Persons. A Controlled Clinical Trial.|Completed||N/A|28|Actual|Örebro University, Sweden||2|||f||||f||||||||||2017-10-10 23:35:54.167395|2017-10-10 23:35:54.167395
NCT02359695|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-05-09|||October 2013|Actual|2013-10-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||Low-dose GH Supplementation Increases Clinical Pregnancy Rate|Low-dose Growth Hormone Supplementation Increases Clinical Pregnancy Rate in Poor Responders Undergoing in Vitro Fertilisation.|Completed||Phase 1|64|Actual|Centro de Infertilidad y Reproducción Humana||1|||f||||f||||||||||2017-10-10 23:35:54.238502|2017-10-10 23:35:54.238502
NCT02359682|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-08-11|||October 2014||2014-10-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Population Research of Sublingual Microcirculation Data of Healthy Volunteers|Population Research of Sublingual Microcirculation Data of Healthy Volunteers|Completed||N/A|90|Actual|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-10 23:35:54.322872|2017-10-10 23:35:54.322872
NCT02359669|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-05-12|||January 2015||2015-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Stimulearn||Effect of a Nutritional Approach in Combination With Cognitive Stimulation on Child Cognitive Abilities|Effect of a Nutritional Approach in Combination With Cognitive Stimulation on Child Cognitive Abilities|Completed||N/A|200|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 23:35:54.397598|2017-10-10 23:35:54.397598
NCT02359656|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2015-02-04|||January 2006||2006-01-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2013|Actual|2013-01-01||Interventional|||Recent and Non United Odontoid Fractures|Recent and Non United Odontoid Fractures: Clinical and Biomechanical Aspects|Completed||N/A|45|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:35:54.475875|2017-10-10 23:35:54.475875
NCT02359643|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-01-31|||May 2013||2013-05-01|May 2013|2013-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease|Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease|Unknown status|Enrolling by invitation|N/A|300|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:35:54.541835|2017-10-10 23:35:54.541835
NCT02359630|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2017-05-08|||January 2005||2005-01-01|May 2017|2017-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|EasyTube||Multicenter Study of EasyTube® Compared to Endotracheal Tube in General Anesthesia|The EasyTube® in General Anesthesia: A Multicenter Study Comparing EasyTube and Endotracheal Tube|Completed||Phase 3|400|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:35:54.630154|2017-10-10 23:35:54.630154
NCT02359617|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-04-24|||February 2013||2013-02-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration|Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration: Evaluation of a Novel Single-Port Treatment Approach in Type 1 Diabetic Patients During a 1-Day Stay in a Clinical Research Center and a 6-Day Period at Home|Completed||N/A|10|Actual|Medical University of Graz||1|||f||||t||||||||||2017-10-10 23:35:54.701458|2017-10-10 23:35:54.701458
NCT02359604|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-02-06|||October 2014||2014-10-01|February 2017|2017-02-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Interventional|||The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study|The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study|Completed||N/A|12|Actual|Medical University of Graz||1|||f||||t||||||||Undecided||2017-10-10 23:35:54.777711|2017-10-10 23:35:54.777711
NCT02359591|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-07-25|||March 2014||2014-03-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|||The Development of Child Development Checklist Multimedia System and Its Clinical Evaluation|The Development of Child Development Checklist Multimedia System and Its Clinical Evaluation|Completed||N/A|390|Actual|Chang Gung Memorial Hospital|||1||f||||||||||||||2017-10-10 23:35:54.8648|2017-10-10 23:35:54.8648
NCT02359578|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2015-02-12|||August 2014||2014-08-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|Occlusion||Determining Occlusion Pressure in Lymphatic Vessels|The Occlusion Pressure of Superficial Lymphatics in the Upper Extremity of Healthy Volunteers: A Near Infrared Lymphofluoroscopy Approach|Completed||Early Phase 1|32|Actual|Centre Hospitalier Universitaire Saint Pierre||1|||f||||f||||||||||2017-10-10 23:35:54.929053|2017-10-10 23:35:54.929053
NCT02359565|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-09|2017-09-12|||May 22, 2015|Actual|2015-05-22|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, or Hypermutated Brain Tumors|A Safety and Preliminary Efficacy Trial of MK-3475 (Pembrolizumab; Anti-PD-1) in Children With Recurrent, Progressive or Refractory High-Grade Gliomas (HGG) and DIPGs and Hypermutated Brain Tumors|Recruiting||Phase 1|75|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:35:55.00247|2017-10-10 23:35:55.00247
NCT02359552|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-05|2017-03-07|||May 2015||2015-05-01|August 2016|2016-08-01|February 15, 2019|Anticipated|2019-02-15|February 15, 2018|Anticipated|2018-02-15||Interventional|R2||Rasagiline Rescue in Alzheimer's Disease Clinical Trial|A 24-week, Three-site, Randomized, Double Blind, Placebo Controlled, Parallel Group, Proof-of-concept Study to Evaluate Rasagiline in the Regional Brain Metabolism on FDG PET in Patients With Mild to Moderate Alzheimer's Disease|Recruiting||Phase 2|50|Anticipated|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-10 23:35:55.159815|2017-10-10 23:35:55.159815
NCT02359539|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2015-02-09|||August 2009||2009-08-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|April 2012|Actual|2012-04-01||Interventional|||Marginal Periosteal Pedicle Flap - Platelet Rich Fibrin Barriers in Treating Periodontal Intrabony Defects|Marginal Periosteal Pedicle Flap and Platelet Rich Fibrin Barriers for the Treatment of Periodontal Intrabony Defects -Randomized Clinical Trial|Completed||Phase 2|10|Actual|Al-Azhar University||2|||f||||t||||||||||2017-10-10 23:35:55.247131|2017-10-10 23:35:55.247131
NCT02359526|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-03-09|||October 2014||2014-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|RESPOND||A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients|A Non-randomised, Open-label, Multicenter Phase 4 Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies With or Without Intravitreal Corticosteroid Therapy (RESPOND)|Completed||Phase 4|12|Actual|Association for Innovation and Biomedical Research on Light and Image||1|||f||||f||||||||||2017-10-10 23:35:55.317026|2017-10-10 23:35:55.317026
NCT02359513|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-04-07|||November 9, 2015|Actual|2015-11-09|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.|Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF - a Multicenter Study|Recruiting||Phase 4|45|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:35:55.645113|2017-10-10 23:35:55.645113
NCT02359500|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-05-01|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|January 23, 2017|Actual|2017-01-23|January 23, 2017|Actual|2017-01-23||Interventional|||68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)|Safety and Efficacy Study of 68Ga-Dotatoc Positron Emission Tomography for Diagnosis for Staging, Restaging and Assessment of Response to Treatment in Somatostatin Receptor-Positive Neuroendocrine Tumors|Terminated||Phase 1|71|Actual|Icahn School of Medicine at Mount Sinai||1||compound no longer available|f||||t|t|f||||||||2017-10-10 23:35:55.770522|2017-10-10 23:35:55.770522
NCT02359487|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-06|||February 2011||2011-02-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Behavioral Counseling Intervention Trial to Reduce Alcohol-related Sexual Risk Behavior Among HIV-negative Men in Namibia|Behavioral Counseling Intervention Trial to Reduce Alcohol-related Sexual Risk Behavior Among HIV-negative Men in Namibia|Completed||N/A|550|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 23:35:55.865459|2017-10-10 23:35:55.865459
NCT02359474|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-10-22|||January 2015||2015-01-01|October 2015|2015-10-01||||July 2018|Anticipated|2018-07-01||Interventional|HyperTET||Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin|Trabectedin Combined With Regional Hyperthermia as Second Line Treatment for Adult Patients With Advanced Soft-tissue Sarcoma|Recruiting||N/A|120|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||||||||||||2017-10-10 23:35:55.94451|2017-10-10 23:35:55.94451
NCT02359461|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-07-28|||November 2014||2014-11-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|STENDO3||Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2|Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:35:56.035679|2017-10-10 23:35:56.035679
NCT02359448|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-04|||April 2015||2015-04-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Melatonin for Nocturia in Parkinson's Disease|Single-centre Open Label Exploratory Phase IIb Pilot Study of Exogenous Oral Melatonin for the Treatment of Nocturia in Adults With Parkinson's Disease|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|University College, London||1|||f||||t||||||||||2017-10-10 23:35:56.145515|2017-10-10 23:35:56.145515
NCT02359435|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2017-03-21|2016-01-11||October 2012||2012-10-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|REHYTRI||Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection|Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection — a Randomized Controlled Trial (REHYTRI Study)|Completed||N/A|440|Actual|Kaohsiung Veterans General Hospital.|The trial was performed in a single country|2|||f||||t||||||||||2017-10-10 23:35:56.233595|2017-10-10 23:35:56.233595
NCT02359422|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-11-19|||April 2014||2014-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MASH||Evaluation of a Middle School Comprehensive Sexual Health Media Literacy Education Program|Randomized Control Trial Efficacy Study of a Comprehensive Sexual Health Media Literacy Education Program for Middle School Students|Completed||N/A|1017|Actual|Innovation Research & Training||2|||f||||f||||||||||2017-10-10 23:35:56.518802|2017-10-10 23:35:56.518802
NCT02359409|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-04-27|||July 2014||2014-07-01|April 2017|2017-04-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|||Use of Goggle Balloon to Improve Cecal Intubation During Colonoscopy|Use of Goggle Balloon to Improve Cecal Intubation During Colonoscopy|Withdrawn||N/A|0|Actual|Indiana University||2||no subjects consented due to competing studies|f||||f||||||||No||2017-10-10 23:35:56.704053|2017-10-10 23:35:56.704053
NCT02359396|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-08-19|||November 2014||2014-11-01|February 2015|2015-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics|Effects of Oral Administration of a Chinese Proprietary Medicine, MZRW on Tolerability, Exposure and Pharmacokinetics in Healthy Subjects|Completed||Phase 1|23|Actual|Hong Kong Baptist University||3|||f||||t||||||||||2017-10-10 23:35:56.778056|2017-10-10 23:35:56.778056
NCT02359383|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-09-15|||January 2014||2014-01-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|FISIOPLEURA||Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion|Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion|Unknown status|Recruiting|N/A|26|Anticipated|Hospital de Granollers||2|||f||||f||||||||||2017-10-10 23:35:56.853174|2017-10-10 23:35:56.853174
NCT02359370|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2015-02-09|||September 2014||2014-09-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effects of Lidocaine and Magnesium Sulphate on the Attenuation of the Hemodynamic Response to Tracheal Intubation|The Effects of Lidocaine and Magnesium Sulphate on the Attenuation of the Hemodynamic Response to Tracheal Intubation: Single Center, Prospective, Double-Blind and Randomized Study|Completed||Phase 4|49|Actual|Hospital de Base||2|||f||||f||||||||||2017-10-10 23:35:56.941989|2017-10-10 23:35:56.941989
NCT02359357|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-04-07|||January 2015||2015-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers|A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalation First-Time-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of Single and Repeat Oral Doses of FDL169 in Healthy Volunteers|Completed||Phase 1|130|Actual|Flatley Discovery Lab LLC||22|||f||||f||||||||||2017-10-10 23:35:57.02916|2017-10-10 23:35:57.02916
NCT02359331|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-04-19|||August 2014||2014-08-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection|A Prospective, Single-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare the 14-day Bismuth Quadruple Therapy and 7-day Culture Based Tailored Therapy for the Eradication of Helicobacter as a Rescue 2nd Therapy.|Recruiting||N/A|370|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-10 23:35:57.218535|2017-10-10 23:35:57.218535
NCT02359318|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-09-28|||May 2015||2015-05-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|March 2017|Anticipated|2017-03-01||Interventional|||De-bonding Following Infiltration|Enamel Damages Following De-bracketing of Demineralised Teeth With or Without Prior Infiltration Compared to Sound Enamel: A Single-center, Randomized, Single Blinded, Split-mouth Controlled Clinical Trial|Recruiting||N/A|30|Anticipated|DMG Dental Material Gesellschaft mbH||3|||f||||f||||||||||2017-10-10 23:35:57.317062|2017-10-10 23:35:57.317062
NCT02359292|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-04-05|||February 2015||2015-02-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers|Cross-over Clinical Pharmacology Study, to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination Across Two Different Dose Strengths, Administered With and Without Activated Charcoal, in Healthy Volunteers|Completed||Phase 1|50|Actual|Chiesi Farmaceutici S.p.A.||5|||f||||f||||||||||2017-10-10 23:35:57.476265|2017-10-10 23:35:57.476265
NCT02359279|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-06-15|||August 2015||2015-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Radiographic Contrast To Differentiate Cavitated From Non-cavitated Tooth Decay|Radiographic Contrast To Differentiate Cavitated From Non-cavitated Tooth Decay|Completed||N/A|30|Actual|Creighton University||1|||f||||t||||||||No||2017-10-10 23:35:57.571157|2017-10-10 23:35:57.571157
NCT02359266|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-06|||December 2011||2011-12-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CLDVitD||Vitamin D Improves Depression in Liver Patients|Clinical Trial Investigating the Role of Vitamin D in the Treatment of Depression in Patients With Chronic Liver Disease|Completed||N/A|111|Actual|Saarland University||2|||f||||f||||||||||2017-10-10 23:35:57.640406|2017-10-10 23:35:57.640406
NCT02359253|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-05-05|||February 2015||2015-02-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|RAR2||Robot Aided Rehabilitation - Intervention|Robot Aided Diagnosis, Passive-Active Arm Motor and Sensory Rehabilitation Post Stroke - Intervention|Recruiting||N/A|72|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-10 23:35:57.728334|2017-10-10 23:35:57.728334
NCT02359240|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-04|||December 2014||2014-12-01|February 2015|2015-02-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Observational|||HO-1 and Muscle Mitochondrial Dysfunction in Sepsis|Skeletal Muscle Wasting in Patients With Sepsis|Unknown status|Active, not recruiting|N/A|50|Anticipated|Changhai Hospital|||2||f||||t||||||Samples With DNA|"     skeletal muscle   "|||2017-10-10 23:35:57.852704|2017-10-10 23:35:57.852704
NCT02359227|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-01-31|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|April 2, 2015|Actual|2015-04-02|April 2, 2015|Actual|2015-04-02||Interventional|||Safety Study of Cenderitide in Stable Chronic Heart Failure|A Study Assessing the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Open-Label, Continuous, Stepwise, Dose Increasing, Subcutaneous Infusion of Cenderitide Via the Insulet Drug Delivery System in Subjects With Stable, Chronic Heart Failure|Completed||Phase 2|14|Actual|Capricor Inc.||1|||f||||f||||||||||2017-10-10 23:35:57.929152|2017-10-10 23:35:57.929152
NCT02359214|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-06-07|||April 2014||2014-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Vitamin D3 Supplementation on Cardiometabolic Risk|Effect of Vitamin D3 Supplementation on Cardiometabolic Risk Factors in a Cohort of Overweight and Obese Adults in the UK|Active, not recruiting||N/A|49|Actual|University of Chester||2|||f||||f||||||||Yes|I intend to report IPD including participant characteristics, laboratory measurements and details of randomisation in my thesis after writing is complete by February 2017. IPD will possibly be published in nutrition and medical journals by September 2017.|2017-10-10 23:35:58.004788|2017-10-10 23:35:58.004788
NCT02359201|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-04-20|||February 2015||2015-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Assessment of V0018 1.5 mg Effect on Craving|Double-blind, Randomized, Placebo-controlled, Cross-over Study of the Effect of a 1.5 mg Nicotine Lozenge on Smoking Craving|Completed||Phase 2|30|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-10 23:35:58.103346|2017-10-10 23:35:58.103346
NCT02359188|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-11-30|||August 2016||2016-08-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|EpimiRNA_D||Transcutaneous Vagal Nerve Stimulation: Influence on miRNA, Inflammation, Cerebral Resting State and Gastric Motility|Influence of Transcutaneous Vagal Nerve Stimulation on Expression of microRNA, Cytokines, Chemokines and Neuropeptides as Well as Cerebral Resting State and Gastric Motility|Recruiting||Phase 1/Phase 2|60|Anticipated|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-10-10 23:35:58.181561|2017-10-10 23:35:58.181561
NCT02359175|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-10-28|||February 2015||2015-02-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|SEAVATS||Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS Study|Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS Study|Recruiting||Phase 4|134|Anticipated|Odense University Hospital||2|||f||||t||||||||No||2017-10-10 23:35:58.269321|2017-10-10 23:35:58.269321
NCT02359149|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-04-27|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Intravitreal Injections by Nurses and Physicians Compared|Intravitreal Injections by Nurses or Physicians: a Randomized Controlled Trial Comparing Efficacy, Patient Satisfaction and Health Economy|Completed||N/A|328|Actual|St. Olavs Hospital||2|||f||||f|f|f||||||No||2017-10-10 23:35:58.482332|2017-10-10 23:35:58.482332
NCT02359136|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-03-30|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Local Infiltration Anesthesia With Ropivacaine on Pain After Primary Total Hip Arthroplasty|Effect of Local Infiltration Anesthesia With Ropivacaine on Pain After Primary Total Hip Arthroplasty|Completed||N/A|116|Actual|St. Olavs Hospital||2|||f||||f|f|f||||||||2017-10-10 23:35:58.572656|2017-10-10 23:35:58.572656
NCT02359123|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-08-01|||November 2016||2016-11-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients|Cannabics Capsules as Treatment to Improve Cancer Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients- Pilot Study|Recruiting||N/A|40|Anticipated|Cannabics Pharmaceuticals Inc.||1|||f||||f||||||||||2017-10-10 23:35:58.660253|2017-10-10 23:35:58.660253
NCT02359110|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-01-19|||June 2015||2015-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|Gabapentin||Administration of Pre-Operative Gabapentin to Patients Undergoing Laparoscopy|Administration of Pre-Operative Gabapentin to Patients Undergoing Laparoscopy: A Prospective Double-blinded, Placebo Controlled Randomized Study|Completed||Phase 4|112|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-10 23:35:58.895743|2017-10-10 23:35:58.895743
NCT02359097|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-06-19|||January 6, 2015|Actual|2015-01-06|June 2017|2017-06-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma|High Resolution Steady State Blood Volume Maps in Glioblastoma Using MRI ? A Multicenter Study|Recruiting||N/A|90|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 23:35:58.98486|2017-10-10 23:35:58.98486
NCT02359084|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2017-06-21|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|||Project EARLY: Engagement, Assessment, Referral, & Linkage for Young Children|Early Identification and Service Linkage for Urban Children With Autism|Recruiting||N/A|250|Anticipated|Boston University||2|||f||||t|f|f||||||Yes|Data will be shared with the National Database for Autism Research biannually.|2017-10-10 23:35:59.104136|2017-10-10 23:35:59.104136
NCT02359071|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-11-19|||September 2013||2013-09-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|Handover||Shift Characteristics Affect Handover Duration and Rates.|Which Shift Characteristics Affect Handover Duration and Rates? A Prospective Multicentric Study|Completed||N/A|267|Actual|Ataturk University|||2||f||||f||||||||||2017-10-10 23:35:59.216813|2017-10-10 23:35:59.216813
NCT02359045|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-03-21|2016-07-25||February 12, 2015|Actual|2015-02-12|March 2017|2017-03-01|July 27, 2015|Actual|2015-07-27|July 27, 2015|Actual|2015-07-27||Interventional|||Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions|A Randomized, Open-label, Single-center, Cross-over Study in Healthy Subjects to Assess the Relative Bioavailability of EPA and DHA Delivered by Three New Capsule Formulation Prototypes in Relation to the Current Epanova® Capsule Under Fasting (Part 1) and Fed (Part 2) Conditions|Completed||Phase 1|137|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:35:59.449171|2017-10-10 23:35:59.449171
NCT02359032|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-06-17|||January 2015||2015-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects|A Phase 1 Combined Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6858 in Healthy Subjects|Completed||Phase 1|88|Actual|Astellas Pharma Inc||5|||f||||f||||||||||2017-10-10 23:36:02.067207|2017-10-10 23:36:02.067207
NCT02359019|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-09-14|||February 2015||2015-02-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy|Phase II Study of MK-3475 as Maintenance Therapy in Extensive Stage Small Cell Lung Cancer (SCLC) Patients|Active, not recruiting||Phase 2|54|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-10 23:36:02.189835|2017-10-10 23:36:02.189835
NCT02358993|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-10-05|||December 2014||2014-12-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|NO-UTI||Short-course Methenamine Hippurate for Prevention of Post-operative UTI|The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection|Recruiting||N/A|240|Anticipated|University of Pennsylvania||2|||f||||f||||||||Undecided||2017-10-10 23:36:02.366833|2017-10-10 23:36:02.366833
NCT02358980|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-02-06|||July 2014||2014-07-01|February 2015|2015-02-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Observational|KEEPER||Kidney Therapy for Free Light Chain Removal in Patients With Multiple Myeloma & Cast Nephropathy|KIDNEY THERAPY FOR FREE LIGHT CHAIN REMOVAL IN PATIENTS WITH MULTIPLE MYELOMA & CAST NEPHROPATHY|Unknown status|Recruiting|N/A|20|Anticipated|Arcispedale Santa Maria Nuova-IRCCS|||1||f||||t||||||||||2017-10-10 23:36:02.541864|2017-10-10 23:36:02.541864
NCT02358967|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-05-08|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|PATCH||Palm Tocotrienols in Chronic Hemodialysis (USA)|Palm Tocotrienols in Chronic Hemodialysis (PATCH Study)|Enrolling by invitation||N/A|400|Anticipated|Wayne State University||2|||f||||t|f|f||||||||2017-10-10 23:36:02.621396|2017-10-10 23:36:02.621396
NCT02358954|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-07-11|||January 2015||2015-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|VPI||Vestibular Pain Interactions|Modulation of Pain Responses by Vestibular Stimulation. A Contact Heat Evoked Potential Study.|Completed||N/A|26|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 23:36:02.886296|2017-10-10 23:36:02.886296
NCT02358941|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-02-03|||December 2013||2013-12-01|February 2015|2015-02-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD|Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD)|Unknown status|Recruiting|N/A|80|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 23:36:02.989549|2017-10-10 23:36:02.989549
NCT02357589|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-27|||January 2015||2015-01-01|August 2017|2017-08-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|||3D vs 2D HD Laparoscopy in Cholecystectomy|3 Versus 2 Dimensional HD Laparoscopy in Cholecystectomy: a Prospective, Single Blinded, Randomized, Controlled Trial|Completed||N/A|210|Actual|Helsinki University Central Hospital||2|||f||||||||||||||2017-10-10 23:36:21.699319|2017-10-10 23:36:21.699319
NCT02358928|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-03|||July 2014||2014-07-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|NAFLD||Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome|Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome|Unknown status|Recruiting|N/A|54|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 23:36:03.071777|2017-10-10 23:36:03.071777
NCT02358915|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-04-04|||February 2015||2015-02-01|April 2017|2017-04-01|August 31, 2016|Actual|2016-08-31|August 2016|Actual|2016-08-01||Interventional|||A Two-step Training Paradigm for Voluntary Control of the Peri-auricular Muscles|A Two-step Training Paradigm for Voluntary Control of the Peri-auricular Muscles|Completed||Early Phase 1|10|Anticipated|University of Southern California||1|||f||||f||||||||Undecided||2017-10-10 23:36:03.158991|2017-10-10 23:36:03.158991
NCT02358902|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-02-03|||March 2013||2013-03-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Transcranial Direct Current Stimulation Associated With Aerobic Exercise Training for Patients With Fibromyalgia|Effect of Transcranial Direct Current Stimulation Associated With Aerobic Exercise Training for Patients With Fibromyalgia|Completed||Phase 2/Phase 3|45|Actual|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-10 23:36:03.231539|2017-10-10 23:36:03.231539
NCT02358889|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-05-11|||February 2015||2015-02-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|EMERGE||Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration|A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration|Completed||Phase 2|88|Actual|Iconic Therapeutics, Inc.||3|||f||||||||||||||2017-10-10 23:36:03.319483|2017-10-10 23:36:03.319483
NCT02358876|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-08-15|2016-06-27||February 2015||2015-02-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||BradyXplore Phase II: Bradykinesia Feature Extraction System|BradyXplore Phase II: Bradykinesia Feature Extraction System|Completed||N/A|32|Actual|Great Lakes NeuroTechnologies Inc.|||1||f||||f||||||||||2017-10-10 23:36:03.519161|2017-10-10 23:36:03.519161
NCT02358863|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-08-30|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|mEGA||Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach|A Pilot Study of Molecular Profile-Directed Chemotherapy for Metastatic HER2(-) Esophagogastric Adenocarcinoma|Terminated||N/A|13|Actual|Georgetown University||1||Issues with recruitment.|f||||t||||||||||2017-10-10 23:36:03.735141|2017-10-10 23:36:03.735141
NCT02358850|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-12-13|||January 2016||2016-01-01|December 2015|2015-12-01||||June 2019|Anticipated|2019-06-01||Interventional|||Post-tonsillectomy Pain Control in Adults|Post-tonsillectomy Pain Control in Adults: a Randomized Prospective Study|Not yet recruiting||Phase 4|39|Anticipated|University of Nebraska||3|||f||||f||||||||||2017-10-10 23:36:03.846716|2017-10-10 23:36:03.846716
NCT02358837|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-04-14|||August 2011||2011-08-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01|7 Days|Observational [Patient Registry]|RadioUS||Improving Breast Cancer Diagnostic by Novel sonographicTechniques Study|Improving Breast Cancer Diagnostics by Novel Sonographic Techniques|Completed||N/A|236|Actual|University Hospital, Basel, Switzerland|||2||f||||t||||||||||2017-10-10 23:36:03.984127|2017-10-10 23:36:03.984127
NCT02358824|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2015-07-06|||February 2015||2015-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|CKD-828||CKD-828 (80/5mg) Pharmacokinetic Study|A Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of CKD-828(Telmisartan 80mg/S-amlodipine 5mg Combination Tablet) to Coadministration of Telmisartan 80mg and S-amlodipine 5mg in Healthy Male Volunteers|Completed||Phase 1|48|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:36:04.075498|2017-10-10 23:36:04.075498
NCT02358811|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-06-30|||June 30, 2015|Actual|2015-06-30|June 2017|2017-06-01|August 31, 2020|Anticipated|2020-08-31|June 30, 2020|Anticipated|2020-06-30||Observational|VOILAGE||Evaluation of the Impact of Sleep Apnea on Cerebral Volumetry According to Age|Evaluation of the Impact of Sleep Apnea on Cerebral Volumetry According to Age|Recruiting||N/A|106|Anticipated|Centre Hospitalier Universitaire de Saint Etienne|||4||f||||f||||||||||2017-10-10 23:36:04.190003|2017-10-10 23:36:04.190003
NCT02358798|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-09-03|||August 2014||2014-08-01|September 2015|2015-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|REVOLMUCO||Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period||Recruiting||N/A|40|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:36:04.311668|2017-10-10 23:36:04.311668
NCT02358785|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-08-10|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|November 1, 2015|Actual|2015-11-01|October 1, 2015|Actual|2015-10-01||Observational|||Evaluation of a Powered Stapler System on Surgical Interventions Required During Laparoscopic Sleeve Gastrectomy|Evaluation of a Powered Stapler System on Surgical Interventions Required During Laparoscopic Sleeve Gastrectomy|Completed||N/A|100|Anticipated|Ethicon Endo-Surgery|||1||f||||f|f|t|f|f|t|||||2017-10-10 23:36:04.436085|2017-10-10 23:36:04.436085
NCT02358772|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2016-08-08|||February 2011||2011-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2015|Actual|2015-06-01|3 Months|Observational [Patient Registry]|||Comparison of Pre-hospital and In-hospital Iv-tPA Stroke Treatment||Completed||N/A|658|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-10 23:36:04.520637|2017-10-10 23:36:04.520637
NCT02358759|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-01-11|||June 2014||2014-06-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Management of Abnormally Fertilized Zygotes? InVitro Correction of 3PN|Treatment of Abnormally Multinucleated Zygotes Before Before Division Starting.|Completed||Early Phase 1|22|Actual|Al Baraka Fertility Hospital||2|||f||||f||||||||||2017-10-10 23:36:04.606224|2017-10-10 23:36:04.606224
NCT02358746|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-02-06|||May 2015||2015-05-01|February 2015|2015-02-01|December 2019|Anticipated|2019-12-01|May 2019|Anticipated|2019-05-01||Interventional|EPILOGUE||Ventricular Tachycardia in Ischemic Cardiomyopathy; a Combined Endo-Epicardial Ablation Within the First Procedure Versus a Stepwise Approach|Ventricular Tachycardia in Ischemic Cardiomyopathy; a Combined Endo-Epicardial Ablation Within the First Procedure Versus a Stepwise Approach a Randomized Controlled Trial|Not yet recruiting||N/A|125|Anticipated|Erasmus Medical Center||2|||f||||t||||||||||2017-10-10 23:36:04.690361|2017-10-10 23:36:04.690361
NCT02358733|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-05-09|||February 2015||2015-02-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Use of IMSI in Poor Responders to IVF|Use of Intra-Cytoplasmic Morphologically Selected Sperm Injection (IMSI) in Poor Responders to In Vitro Fertilization (IVF): a Prospective, Double-blind, Randomized, Controlled Trial|Recruiting||N/A|200|Anticipated|Centro de Infertilidad y Reproducción Humana||2|||f||||f||||||||||2017-10-10 23:36:04.776845|2017-10-10 23:36:04.776845
NCT02358720|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-02-06|||December 2014||2014-12-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|SMART||Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases|Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-10 23:36:04.886255|2017-10-10 23:36:04.886255
NCT02358707|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-02-06|||May 2014||2014-05-01|February 2015|2015-02-01|May 2015|Anticipated|2015-05-01|March 2015|Anticipated|2015-03-01||Interventional|||Is Phonophoresis Treatment Effective?|Is Phonophoresis Treatment Effective? Determination of Ibuprofen Levels by Microextraction and HPLC (High Liquid Pressure Chromatography) Method in the Tissues of the Patients With Knee Osteoarthritis?|Unknown status|Recruiting|N/A|18|Anticipated|Cukurova University||1|||f||||||||||||||2017-10-10 23:36:04.984206|2017-10-10 23:36:04.984206
NCT02358694|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-02-13|||February 2015||2015-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS|Safety and Tolerability of Serum-Derived Bovine Immunoglobulin in Children With Diarrhea-Predominant Irritable Bowel Syndrome|Active, not recruiting||N/A|20|Anticipated|Connecticut Children's Medical Center||2|||f||||f||||||||||2017-10-10 23:36:05.077537|2017-10-10 23:36:05.077537
NCT02358681|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-07-14|||May 2015||2015-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children|Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children: A Randomized Non-inferiority Clinical Trial|Recruiting||Phase 3|80|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-10 23:36:05.167755|2017-10-10 23:36:05.167755
NCT02358668|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-03-14|2017-01-25||March 30, 2015|Actual|2015-03-30|March 2017|2017-03-01|February 19, 2016|Actual|2016-02-19|February 2016|Actual|2016-02-01||Interventional|||BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-Diabetes|A Study to Evaluate the Effect of BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in High Risk Chinese Subjects With Pre-Diabetes|Completed||Phase 2|60|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-10 23:36:05.623813|2017-10-10 23:36:05.623813
NCT02358655|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-09-18|||June 1, 2015|Actual|2015-06-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2016|Actual|2016-10-31||Interventional|C-CUSP ED||Canadian Community Utilization of Stroke Prevention Study - Emergency Department|Canadian Community Utilization of Stroke Prevention Study - Emergency Department|Active, not recruiting||N/A|360|Anticipated|Population Health Research Institute||3|||f||||f||||||||||2017-10-10 23:36:07.843471|2017-10-10 23:36:07.843471
NCT02358642|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-02-06|||September 2010||2010-09-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Drug to Prevent Pneumonia in the Tube Fed|A Randomized Placebo Controlled Trial of Low Dose Angiotensin Converting Enzyme Inhibitor to Prevent Pneumonia in Older People Who Require Tube Feeding Because of Neurological Dysphagia|Terminated||Phase 4|93|Actual|Chinese University of Hong Kong||2||"The interim analysis suggested that low dose lisinopril given to be tube fed older patients   with neuroligical dysphagia had increased mortality."|f||||||||||||||2017-10-10 23:36:07.940644|2017-10-10 23:36:07.940644
NCT02358629|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-09-20|||February 2015||2015-02-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).||Completed||N/A|14|Actual|Nitiloop Ltd.||1|||f||||f||||||||||2017-10-10 23:36:08.017205|2017-10-10 23:36:08.017205
NCT02358616|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-08-28|||December 2012||2012-12-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003)|An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial|Completed||N/A|219|Actual|Microbicide Trials Network|||1||f||||t||||||||||2017-10-10 23:36:08.087162|2017-10-10 23:36:08.087162
NCT02358590|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-09-22|||February 2015||2015-02-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||The Effect of Theory Menu-Based Intervention on Vitamin D Adherence in People With Osteoporosis-Pilot Study|The Effect of Health Action Process Approach Menu-Based Intervention on Vitamin D Adherence in Older Adult With Osteoporosis-Pilot Study|Unknown status|Enrolling by invitation|N/A|20|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 23:36:08.270937|2017-10-10 23:36:08.270937
NCT02358577|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-03-03|||September 2015||2015-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|wEECycle||Early In-bed Cycling in Critically Ill Children|Early Exercise in Critically Ill Youth and Children, a preLiminary Evaluation.|Recruiting||Phase 1/Phase 2|40|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 23:36:08.384004|2017-10-10 23:36:08.384004
NCT02358564|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-09-14|||February 2015||2015-02-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|GPSS||Gut Permeability, Sensitivity and Symptomatology|Gut Permeability, Sensitivity and Symptomatology: Is There a Link and Explanation for Exacerbation of Symptoms Post Meals|Recruiting||Early Phase 1|39|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:36:08.50148|2017-10-10 23:36:08.50148
NCT02358551|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2015-02-03|||June 2014||2014-06-01|February 2015|2015-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Comparison of Axillary Vein Puncture With Subclavian Vein Puncture in Pacemaker Implantation|Comparison of Axillary Vein Puncture With Subclavian Vein Puncture in Pacemaker Implantation|Unknown status|Recruiting|N/A|220|Anticipated|China-Japan Friendship Hospital||2|||f||||t||||||||||2017-10-10 23:36:08.592134|2017-10-10 23:36:08.592134
NCT02358538|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-09-21|||March 2015||2015-03-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies|A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies Followed by 52 Week Open-Label Treatment|Active, not recruiting||Phase 2|50|Anticipated|Marinus Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:36:08.674263|2017-10-10 23:36:08.674263
NCT02358525|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-03-01|||January 2015||2015-01-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Effects of a Rehabilitation Program on Immune Activation and Mood in Heart Failure Patients|Effects of a Multi-Modality Rehabilitation Program on Immune Activation, Depressive Symptoms and Quality of Life in Heart Failure Patients. A Pilot Study|Completed||N/A|16|Actual|Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-10 23:36:08.990228|2017-10-10 23:36:08.990228
NCT02358512|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-02-22|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Intermittent Versus Continuous Feeding in ICU Patients|A Phase 2 Pilot Physiological Randomised Clinical Trial to Investigate the Effect of Intermittent Versus Continuous Enteral Nutrition on Muscle Wasting in Critical Illness|Recruiting||Phase 2|116|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||Undecided||2017-10-10 23:36:09.060593|2017-10-10 23:36:09.060593
NCT02358499|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-07-31|||January 2015||2015-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children|Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children|Active, not recruiting||Phase 1|40|Anticipated|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-10-10 23:36:09.15379|2017-10-10 23:36:09.15379
NCT02358486|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-08-15|||January 2015||2015-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect and Mechanism of Acupuncture on Functional Dyspepsia|Effect and Mechanism of Acupuncture on Patients With Functional Dyspepsia: a Protocol for a Randomized, Assessor-blind, Sham-controlled Trial|Recruiting||N/A|70|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-10 23:36:09.257048|2017-10-10 23:36:09.257048
NCT02358473|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-11|||January 2015||2015-01-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer|Open-label, Multicenter Phase 1 Study of Mogamulizumab (KW-0761) in Combination With Docetaxel in Previously Treated Subjects With Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1|13|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||t||||||||||2017-10-10 23:36:09.395275|2017-10-10 23:36:09.395275
NCT02358460|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-02-03|||May 2011||2011-05-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Pressure-limited Ventilation Versus Volume-targeted Ventilation in Term Newborns|Randomised Controlled Trial Comparing Volume-targeted to Pressure-limited Ventilation in Infants Born at or Near Term|Completed||N/A|40|Actual|King's College London||2|||f||||f||||||||||2017-10-10 23:36:09.515767|2017-10-10 23:36:09.515767
NCT02358447|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-03-05|||April 2010||2010-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||SPECT-CT for Assessment of Total Knee Arthroplasty in Navigated and Non-navigated Total Knee Arthroplasty|SPECT-CT for Assessment of Patients Before and After Navigated and Conventional Total Knee Arthroplasty.|Recruiting||N/A|210|Anticipated|Kantonsspital Baselland Bruderholz|||2||f||||t||||||||||2017-10-10 23:36:09.615971|2017-10-10 23:36:09.615971
NCT02358434|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-01-25|||July 2015||2015-07-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Observational|||ATTUNE TM Video-fluoroscopy Study|Kinematics Analysis: Cruciate Retaining, Fixed Bearing Primary Total Knee Arthroplasty With the ATTUNE TM Knee System|Completed||N/A|5|Actual|Institute for Biomechanics, ETH Zürich|||1||f||||f||||||||||2017-10-10 23:36:09.734459|2017-10-10 23:36:09.734459
NCT02358421|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-02-03|||October 2013||2013-10-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01|30 Months|Observational [Patient Registry]|HighART||Prediction of High Ovarian Response After Assisted Reproductive Techniques|High Response Predictive Parameters After Controlled Ovarian Stimulation in Women Undergoing Assisted Reproductive Techniques|Unknown status|Recruiting|N/A|300|Anticipated|Instituto de Investigacion Sanitaria La Fe|||1||f||||f||||||||||2017-10-10 23:36:09.861897|2017-10-10 23:36:09.861897
NCT02358408|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-01-27|||January 2015||2015-01-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||System Accuracy Evaluation of Karajishi Contour and Karajishi TS Blood Glucose Monitoring Systems Following ISO 15197:2013|System Accuracy Evaluation of Karajishi Contour and Karajishi TS Blood Glucose Monitoring Systems Following ISO 15197:2013|Completed||N/A|136|Actual|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm|||||f||||||||||||||2017-10-10 23:36:09.954701|2017-10-10 23:36:09.954701
NCT02358395|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-03-06|||February 2015||2015-02-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma|A Phase I Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 1|12|Anticipated|Sumitomo Dainippon Pharma Co., Ltd.||1|||f||||||||||||||2017-10-10 23:36:10.040367|2017-10-10 23:36:10.040367
NCT02358382|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-08-22|||March 2016||2016-03-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||The Management of Systemic-Pulmonary Collateral Blood Flow in Cyanotic Children During Cardiopulmonary Bypass - Pilot Study|The Management of Systemic-Pulmonary Collateral Blood Flow in Cyanotic Children During Cardiopulmonary Bypass - Pilot Study|Recruiting||N/A|20|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:36:10.120553|2017-10-10 23:36:10.120553
NCT02358369|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-10-24||2016-10-21|January 2015||2015-01-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||Dose-Ranging Study of the Bimatoprost Ocular Insert|A Phase 2 Prospective, Multicenter, Randomized, Double-masked, Controlled Study to Evaluate the Efficacy and Safety and Dose-response of the Bimatoprost Ocular Insert (2.2mg, 13mg) With and Without Concomitant Artificial Tears Compared to a Placebo Ocular Insert With and Without Concomitant Timolol (0.5%) Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension.|Completed||Phase 2|156|Actual|ForSight Vision5, Inc.||3|||f||||f||||||||||2017-10-10 23:36:10.214035|2017-10-10 23:36:10.214035
NCT02358356|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-09-18|||November 2015||2015-11-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|CONTROL NETS||Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study|Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study|Recruiting||Phase 2|165|Anticipated|Australasian Gastro-Intestinal Trials Group||3|||f||||t||||||||||2017-10-10 23:36:10.307882|2017-10-10 23:36:10.307882
NCT02358343|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-05-03|||February 2015||2015-02-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|ASCEND||A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}|ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression|Recruiting||Phase 3|800|Anticipated|University of Washington||5|||f||||t||||||||||2017-10-10 23:36:10.445427|2017-10-10 23:36:10.445427
NCT02358330|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-10-26|||February 2015||2015-02-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Observational|EHR Project||Project 1: Evaluating EHR-Based Health System Modifications for the Chronic Care of Smoking|Project 1: Evaluating EHR-Based Health System Modifications for the Chronic Care of Smoking|Recruiting||N/A|28|Anticipated|University of Wisconsin, Madison|||2||f||||t||||||||||2017-10-10 23:36:10.593053|2017-10-10 23:36:10.593053
NCT02358317|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-05-16|||March 2015|Actual|2015-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Motor Learning and Brain Changes in Autism|The Effects of Video Game Learning on the Brain in Adolescents With Autism: A Pilot Study|Recruiting||N/A|30|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 23:36:10.703294|2017-10-10 23:36:10.703294
NCT02358304|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-05-20|||September 2007||2007-09-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma|Treatment of Aggressive Central Giant Cell Granuloma|Completed||Phase 2|24|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:36:10.799522|2017-10-10 23:36:10.799522
NCT02358291|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-06|||March 2015||2015-03-01|February 2015|2015-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Microendoscopic Discectomy Vs Transforaminal Endoscopic Lumbar Discectomy Vs Open Discectomy|Microendoscopic Discectomy Vs Transforaminal Endoscopic Lumbar Discectomy Vs Open Discectomy for the Treatment of Lumbar Disc Herniation|Unknown status|Not yet recruiting|Phase 1/Phase 2|240|Anticipated|Southeast University, China||3|||f||||t||||||||||2017-10-10 23:36:10.889064|2017-10-10 23:36:10.889064
NCT02358278|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-03|||March 2013||2013-03-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|September 2013|Actual|2013-09-01||Observational|||"Evaluation and Implementation of the Paediatric Anesthesia Emergence Delirium Scale (PAED) in the PACU in Children Under 14 Years of Age"|"Evaluation and Implementation of the Paediatric Anesthesia Emergence Delirium Scale (PAED) in the PACU in Children Under 14 Years of Age"|Completed||N/A|821|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 23:36:10.978435|2017-10-10 23:36:10.978435
NCT02358265|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-09-09|||December 2014||2014-12-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Chronic Urticaria - Long Term Assessment of Effects of Rupatadine|A Multi-center, Randomized, Double Blind, Dose Escalating Phase III Study on the Efficacy, Safety and Long Term Outcome of Continuous vs. on Demand Treatment of Chronic Spontaneous Urticaria With Rupatadine.|Recruiting||Phase 3|192|Anticipated|Charite University, Berlin, Germany||4|||f||||f||||||||||2017-10-10 23:36:11.058276|2017-10-10 23:36:11.058276
NCT02358252|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-11-10|||January 2014||2014-01-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Heart Rate Variability and Orthostatic Hypotension in Stroke Patients Evaluated by Intelligent Biosensor System|Changhua Christian Hospital|Recruiting||N/A|120|Anticipated|Changhua Christian Hospital|||2||f||||t||||||||||2017-10-10 23:36:11.168212|2017-10-10 23:36:11.168212
NCT02358239|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-03|||February 2013||2013-02-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy and Safety of Acupuncture for Dizziness and Vertigo in Emergency Department: a Clinical Control Trial||Completed||N/A|60|Actual|Changhua Christian Hospital||1|||f||||||||||||||2017-10-10 23:36:11.242556|2017-10-10 23:36:11.242556
NCT02358226|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-08-25|||July 2015||2015-07-01|August 2016|2016-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||HIV & Drug Abuse Prevention for South African Men|HIV & Drug Abuse Prevention for South African Men|Recruiting||Phase 3|1200|Anticipated|University of California, Los Angeles||3|||f||||f||||||||||2017-10-10 23:36:11.298862|2017-10-10 23:36:11.298862
NCT02358213|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-12-15|||March 2015||2015-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ETREINTE||Evaluation of the Reproducibility Inter-observer of the Ultrasound Anomalies of the Salivary Glands in Sjogren's Disease|Evaluation of the Reproducibility Inter-observer of the Ultrasound Anomalies of the Salivary Glands in Sjogren's Disease : Etude ETREINTE.|Completed||N/A|21|Actual|University Hospital, Brest||1|||f||||t||||||||||2017-10-10 23:36:11.424724|2017-10-10 23:36:11.424724
NCT02358200|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-02|||February 23, 2015|Actual|2015-02-23|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|January 1, 2016|Actual|2016-01-01||Interventional|||Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer|Phase I Study to Evaluate the Tolerability, Safety and Efficacy of BMN-673 in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumor Malignancies That Have BRCA Mutations or Triple Negative Metastatic Breast Cancer|Active, not recruiting||Phase 1|23|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:36:11.521809|2017-10-10 23:36:11.521809
NCT02358187|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-03-29|||January 2015||2015-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A Vaccine Trial for Low Grade Gliomas|A Phase II Study of Vaccinations With HLA-A2 Restricted Glioma Antigen Peptides in Combination With Poly-ICLC for Children With Recurrent Unresectable Low-Grade Gliomas (LGG)|Recruiting||Phase 2|25|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:36:11.623792|2017-10-10 23:36:11.623792
NCT02358174|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-02-03|||September 2013||2013-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|HeMe||Hemorrhoids and Metalloproteinases, Observational Study|Hemorrhoids and Metalloproteinases, Observational Study|Completed||N/A|187|Actual|University of Cantanzaro||2|||f||||t||||||||||2017-10-10 23:36:11.727008|2017-10-10 23:36:11.727008
NCT02358161|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-02-03|||September 2013||2013-09-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|MATRIX||Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer|Phase I/II Study of LDE225 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Locally Advanced or Metastasized Pancreatic Cancer|Unknown status|Recruiting|Phase 1/Phase 2|56|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-10 23:36:11.816829|2017-10-10 23:36:11.816829
NCT02358148|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-07-18|||February 2015||2015-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SACS||Validation of Simple Acute Coronary Syndrome (SACS) Score|Validation of the Simple Acute Coronary Syndrome (SACS) Score and Head-to-Head Comparison of the SACS vs. Modified TIMI vs. HEART ACS Scores|Enrolling by invitation||N/A|200|Anticipated|Bayfront Health St Petersburg|||2||f||||t||||||||||2017-10-10 23:36:11.934248|2017-10-10 23:36:11.934248
NCT02358135|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-07-11|||February 2015||2015-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|PCORI||Collaborative Connected Health (CCH) for PCORI|Collaborative Connected Health (CCH): A Pragmatic Trial Evaluating Effectiveness of CCH in Psoriasis Management Compared to In-person Visits.|Active, not recruiting||N/A|300|Anticipated|University of Southern California||2|||f||||f||||||||||2017-10-10 23:36:12.031546|2017-10-10 23:36:12.031546
NCT02358122|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-03|||September 2014||2014-09-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|RIGHT||Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh|Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh|Unknown status|Active, not recruiting|N/A|75|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-10 23:36:12.119462|2017-10-10 23:36:12.119462
NCT02358109|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Interventional|FLAMENCO||The Flamenco (Fitness League Against MENopause COsts) Project|Cost-Effectiveness of an Exercise Program in Midlife Women|Completed||N/A|160|Actual|Universidad de Granada||2|||f||||t||||||||||2017-10-10 23:36:12.199145|2017-10-10 23:36:12.199145
NCT02358096|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-03-27|||February 2015||2015-02-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|October 2016|Actual|2016-10-01||Interventional|ALBUM||A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease|A Phase 2, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease|Completed||Phase 2|125|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 23:36:12.344227|2017-10-10 23:36:12.344227
NCT02358083|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-05|||August 2014||2014-08-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents|Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents|Completed||Phase 3|1165|Actual|Indiana University||12|||f||||f||||||||||2017-10-10 23:36:12.745747|2017-10-10 23:36:12.745747
NCT02358070|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-10-18|||April 2015||2015-04-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Epidemiologic Study of Hepatocellular Carcinoma in the US|Epidemiologic Study of Hepatocellular Carcinoma in the US|Active, not recruiting||N/A|45|Actual|Stanford University|||2||f||||||||||Samples With DNA|"     saliva samples   "|||2017-10-10 23:36:12.832129|2017-10-10 23:36:12.832129
NCT02358057|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-07-05|||February 2015||2015-02-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Can we Get Conscious Sedation by Combining Dexmedetomidine With Alfentanil?|Can we Get Conscious Sedation in Optimal Safety Conditions in an Emergency Department, by Combining Dexmedetomidine With Alfentanil?|Completed||Phase 4|40|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-10-10 23:36:12.899045|2017-10-10 23:36:12.899045
NCT02358044|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-03-28|2016-09-15||February 27, 2015|Actual|2015-02-27|March 2017|2017-03-01|February 16, 2016|Actual|2016-02-16|November 26, 2015|Actual|2015-11-26||Interventional||Full Analysis Set (FAS); all randomized participants who receive at least one dose of study treatment. Two participants in the SOF + PR arm withdrew from study prior to treatment and were excluded from analysis.|Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)|A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 Versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR Prior Treatment Failure Subjects With Chronic HCV GT1, 4 or 6 Infection|Completed||Phase 3|257|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:36:12.983035|2017-10-10 23:36:12.983035
NCT02358031|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-10-03|||March 19, 2015|Actual|2015-03-19|September 2017|2017-09-01|January 15, 2019|Anticipated|2019-01-15|March 15, 2018|Anticipated|2018-03-15||Interventional|||A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)|A Phase 3 Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma|Active, not recruiting||Phase 3|825|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||t|t|f||||||||2017-10-10 23:36:13.490102|2017-10-10 23:36:13.490102
NCT02358018|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-11-01||||||November 2016|2016-11-01||||||||Expanded Access|||68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial|68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial|No longer available||N/A|||Memorial Sloan Kettering Cancer Center|||||||||||||||||||2017-10-10 23:36:13.584701|2017-10-10 23:36:13.584701
NCT02358005|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-02|||February 2015||2015-02-01|February 2015|2015-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity||Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-10 23:36:13.735391|2017-10-10 23:36:13.735391
NCT02357368|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-09-12|||February 2015||2015-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk|Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk|Recruiting||N/A|120|Anticipated|Emory University||4|||f||||f||||||||||2017-10-10 23:36:23.892603|2017-10-10 23:36:23.892603
NCT02357992|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-05-01|||April 2010|Actual|2010-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy|STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy|Recruiting||N/A|130|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:36:13.844789|2017-10-10 23:36:13.844789
NCT02357979|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-05-08|||June 2017|Anticipated|2017-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|LaserFissure||Fissure Caries Inhibition Study With Solea CO2-9.3μm Short-pulsed Laser|Fissure Caries Inhibition Study With Solea CO2-9.3μm Short-pulsed Laser - A Randomized, Single Blind, Prospective, Split Mouth Controlled, Clinical Trial|Not yet recruiting||N/A|80|Anticipated|University of California, San Francisco||2|||f||||f|f|t|f|f||||Undecided||2017-10-10 23:36:13.96149|2017-10-10 23:36:13.96149
NCT02357966|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-02-22|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus|A Phase I-II Study of the Safety and Efficacy of a True Human Antibody, 514G3, in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus|Completed||Phase 1/Phase 2|52|Actual|XBiotech, Inc.||2|||f||||f||||||||No||2017-10-10 23:36:14.129425|2017-10-10 23:36:14.129425
NCT02357953|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-06-08|||October 2012||2012-10-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|ThermoD-PAC||Transpulmonary Thermodilution Using an Implented Central Venous Access Port|Measurement of Cardiac Index by Transpulmonary Thermodilution Using an Implanted Central Venous Access Port: a Prospective Study in Patients Scheduled for Oncologic High-risk Surgery|Completed||N/A|20|Actual|Gustave Roussy, Cancer Campus, Grand Paris|||1||f||||f||||||||||2017-10-10 23:36:14.270328|2017-10-10 23:36:14.270328
NCT02357940|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-11-18|2016-07-26||January 2015||2015-01-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema|Clinical Trial to Evaluate the Tolerance of a Nighttime Moisturizing Balm on Babies and Adults With Mild to Moderate Atopic Dermatitis|Completed||N/A|41|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||t||||||||||2017-10-10 23:36:14.432252|2017-10-10 23:36:14.432252
NCT02357927|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-01-19|||March 2015||2015-03-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Mini-AFTER||A Single Session Intervention For Fear Of Recurrence In Breast Cancer Patients|A Single Session Intervention For Fear Of Recurrence In Breast Cancer Patients (The Mini AFTERc): A Controlled Trial|Completed||Phase 1/Phase 2|16|Actual|University of St Andrews||2|||f||||f||||||||||2017-10-10 23:36:17.35229|2017-10-10 23:36:17.35229
NCT02357914|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-12-06|||April 2015||2015-04-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|FUS||Freehand Ultrasound to Evaluate Scapular Kinematics in People With Paraplegia|Freehand Ultrasound to Evaluate Scapular Kinematics in People With Paraplegia|Recruiting||N/A|40|Anticipated|Shirley Ryan AbilityLab|||1||f||||f||||||||Undecided||2017-10-10 23:36:17.425383|2017-10-10 23:36:17.425383
NCT02357901|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-07-27||2017-01-29|January 28, 2015|Actual|2015-01-28|July 2017|2017-07-01|April 29, 2016|Actual|2016-04-29|April 29, 2016|Actual|2016-04-29||Interventional|||Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine|Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Efficacy of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP 6000) Over 24 Weeks in Treatment-Seeking Participants With Opioid Use Disorder|Completed||Phase 3|505|Actual|Indivior Inc.||4|||f||||t||||||||||2017-10-10 23:36:17.506288|2017-10-10 23:36:17.506288
NCT02357888|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-10-07|||February 2015||2015-02-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Assessment of V0018 2.5 mg Effect on Craving|Double-blind, Randomized, Placebo-controlled, Cross-over Study of the Effect of a 2.5 mg Nicotine Lozenge on Smoking Craving|Completed||Phase 2|45|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-10 23:36:17.653207|2017-10-10 23:36:17.653207
NCT02357862|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-07-22|||January 2015||2015-01-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|June 2016|Anticipated|2016-06-01||Observational|||Changes in the Tricuspid Valve Complex Induced by Mitral Valve Annuloplasty|Impact of Isolated Mitral Valve Annuloplasty on the Geometry and the Function of the Tricuspid Valve Complex|Unknown status|Recruiting|N/A|50|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:36:17.715921|2017-10-10 23:36:17.715921
NCT02357849|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-08-24|||July 2014||2014-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|FACT||Fluoxetine vs Aripiprazole Comparative Trial (FACT)|The Role of Antidepressants or Antipsychotics in Preventing Psychosis: Fluoxetine vs Aripiprazole Comparative Trial (FACT)|Recruiting||Phase 4|48|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-10 23:36:17.804511|2017-10-10 23:36:17.804511
NCT02357836|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-05-31|||June 2015||2015-06-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Neoadjuvant Itraconazole in Non-small Cell Lung Cancer|Phase 0 Pharmacodynamic Study of the Effects of Itraconazole on Tumor Angiogenesis and the Hedgehog Pathway in Early-stage Non-small Cell Lung Cancer|Recruiting||Early Phase 1|15|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 23:36:17.885113|2017-10-10 23:36:17.885113
NCT02357823|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-01-09|||January 2015||2015-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults|Long Term Serological Response and Memory Cells Role After Different Pneumococcal Vaccine Strategies in HIV Adults|Withdrawn||N/A|0|Actual|University of Siena|||5||f||||f||||||Samples Without DNA|"     Microbes isolated from nasopharingeal swab; blood for analysis of immune response   "|||2017-10-10 23:36:17.968124|2017-10-10 23:36:17.968124
NCT02357810|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-12-13|||February 2015||2015-02-01|December 2016|2016-12-01||||July 2017|Anticipated|2017-07-01||Interventional|||Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas|A Phase II Study of Pazopanib With Oral Topotecan in Patients With Metastatic and Non-resectable Soft Tissue and Bone Sarcomas|Recruiting||Phase 2|136|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 23:36:18.103758|2017-10-10 23:36:18.103758
NCT02357784|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-08-18|||January 2015||2015-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SaNDI||Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment|Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment|Recruiting||N/A|15|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-10 23:36:20.136907|2017-10-10 23:36:20.136907
NCT02357771|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-09-22|||April 2015||2015-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Probiotic Lozenge Reduce Streptococcus Mutans in Plaque in Orthodontic Bracket Patients|Topical Application of Probiotic Lozenge to Reduce Streptococcus Mutans in Plaque Around Orthodontic Brackets|Completed||Phase 3|30|Actual|Next Gen Pharma India Pvt. Ltd.||2|||f||||f||||||||||2017-10-10 23:36:20.224917|2017-10-10 23:36:20.224917
NCT02357758|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-05|||September 2012||2012-09-01|February 2015|2015-02-01||||October 2015|Anticipated|2015-10-01||Interventional|||Effects of Antibiotic Prophylaxis on Recurrent UTI in Children|Recurrent Urinary Tract Infections in Children: Bacterial Identification, Antibiotic Susceptibility Profiling and Cytokine Levels Associated With Antibiotic Prophylaxis|Unknown status|Recruiting|Phase 4|60|Anticipated|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-10 23:36:20.293153|2017-10-10 23:36:20.293153
NCT02357745|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-05|||February 2015||2015-02-01|January 2015|2015-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|ENLPPMNS||Evaluation of Neopterin Levels in Pre and Post-menopausal Women With Periodontitis Following Non Surgical Therapy|Biochemical Evaluation of Plasma,Urine and Salivary Neopterin Levels in Pre and Post-menopausal Women With Periodontitis Following Non-surgical Therapy|Unknown status|Not yet recruiting|N/A|30|Anticipated|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||2||f||||t||||||||||2017-10-10 23:36:20.384387|2017-10-10 23:36:20.384387
NCT02357732|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-12-09|||August 2015||2015-08-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib|A Phase I Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib in Patients With BRAF or NRAS-mutated Metastatic Melanoma|Withdrawn||Phase 1|0|Actual|University of Pittsburgh||3||PI decided not to proceed|f||||t||||||||||2017-10-10 23:36:20.47201|2017-10-10 23:36:20.47201
NCT02357719|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-02-24|||March 2015||2015-03-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|VISTAO2_FLUX||Effectiveness of VistaO2 FLUX Device in Screening of Sleep Apnea/Hypopnea Syndrome|Effectiveness of VistaO2 Device in Screening of Sleep Apnea/Hypopnea Syndrome|Recruiting||N/A|182|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||No||2017-10-10 23:36:20.549327|2017-10-10 23:36:20.549327
NCT02357693|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2015-08-24|||February 2015||2015-02-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|PONV||Neurokinin Receptor Antagonist Associated to Ondansetron in PONV|Effect of the Association of Neurokinin-1 Receptor Antagonist Aprepitant to Dexamethasone/Ondansetron in the Incidence of Postoperative Nausea and Vomiting in High Risk Apfel Score Patients|Completed||Phase 4|90|Actual|Instituto do Cancer do Estado de São Paulo||2|||f||||t||||||||||2017-10-10 23:36:20.726255|2017-10-10 23:36:20.726255
NCT02357680|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-04-27|||March 2015||2015-03-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Diaries for Critically Ill Patients Written by Relatives|Dagbøger Til Kritisk Syge Patienter Skrevet af pårørende: Betydning for Patient og pårørende Samt Effekt i Forhold Til Udvikling af Symptomer på Posttraumatisk Stress|Recruiting||N/A|400|Anticipated|Hospitalsenheden Vest||2|||f||||f||||||||||2017-10-10 23:36:20.829449|2017-10-10 23:36:20.829449
NCT02357667|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-05-01|||March 2015||2015-03-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Observational|SCOPE||The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study|The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study|Recruiting||N/A|80|Anticipated|University of Pennsylvania|||2||f||||f||||||Samples Without DNA|"     Evaluation of angiogenic factors, markers of heart failure, and evaluation of extracellular     RNAs will specifically be used for discovery. The investigators will not be evaluating DNA.   "|||2017-10-10 23:36:21.074953|2017-10-10 23:36:21.074953
NCT02357654|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||GnRH for Luteal Support in IVF/ICSI/FET Cycles|GnRH for Luteal Support in IVF/ICSI/FET Cycles|Recruiting||Phase 4|350|Anticipated|University Reproductive Associates||2|||f||||f||||||||||2017-10-10 23:36:21.177142|2017-10-10 23:36:21.177142
NCT02357641|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-03|||November 2013||2013-11-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|ACS-Strain||Acute Coronary Disease (ACS)- Strain|Analysis of Myocardial Deformation in Patients With Acute Coronary Disease|Completed||N/A|300|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-10 23:36:21.27059|2017-10-10 23:36:21.27059
NCT02357628|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-02-05|||March 2015||2015-03-01|February 2015|2015-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Effect of Regulated Oxygen-Enriched Negative Pressure Therapy (RO-NPT) On Soft Tissue Wound Repair||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||3||f||||t||||||||||2017-10-10 23:36:21.348955|2017-10-10 23:36:21.348955
NCT02357615|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-02-03|||December 2014||2014-12-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure||Unknown status|Recruiting|Phase 4|244|Anticipated|Shanghai Shyndec Pharmaceutical Co.,Ltd.||2|||f||||||||||||||2017-10-10 23:36:21.446031|2017-10-10 23:36:21.446031
NCT02357602|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-11-29|||March 2015||2015-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2015|Actual|2015-10-01||Interventional|||Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women|Dose Proportionality of TFV-DP in Mucosal Tissue, and Endogenous Nucleotide Quantification, After a Single Dose of GS-7340 in Women|Completed||Phase 1|24|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-10 23:36:21.568943|2017-10-10 23:36:21.568943
NCT02357576|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-09-14|||May 21, 2016|Actual|2016-05-21|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD|Phase 3 Study of Standard Lipid Therapy Versus Intravenous Fat Emulsion Minimization for the Prevention of Parenteral Nutrition-Associated Liver Disease|Active, not recruiting||Phase 3|60|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-10 23:36:21.79465|2017-10-10 23:36:21.79465
NCT02357563|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-11-17|||February 2015||2015-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation|Ulipristal Acetate Versus GnRH Analogue for Myometrial Preservation in Patients With Submucosal Uterine Leiomyoma G2|Recruiting||Phase 4|110|Anticipated|University Magna Graecia||2|||f||||t||||||||||2017-10-10 23:36:21.891245|2017-10-10 23:36:21.891245
NCT02357550|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-01-15|||March 2015||2015-03-01|January 2015|2015-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Ketones Influence on Glucose Metabolism in Brain. A Human Positron Emission Tomography (PET) Study|Ketones Influence on Glucose Metabolism in Brain. A Human Positron Emission Tomography (PET) Study|Completed||N/A|9|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:36:21.997116|2017-10-10 23:36:21.997116
NCT02357524|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-03-16|||January 2015||2015-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers|A Single Center, Open-label Study to Evaluate the Effects of a Single 1200mg IV Dose of Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers|Completed||Phase 1|20|Actual|The Medicines Company||1|||f||||f||||||||||2017-10-10 23:36:22.171333|2017-10-10 23:36:22.171333
NCT02357511|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-07-28|||February 2015||2015-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Validation of Pulse Waveform Analysis-based Continuous Noninvasive Blood Pressure Measurement Sensor|Validation of Pulse Waveform Analysis-based Continuous Noninvasive Blood Pressure Measurement Sensor|Completed||N/A|30|Actual|Tampere University Hospital||1|||f||||f||||||||||2017-10-10 23:36:22.241978|2017-10-10 23:36:22.241978
NCT02357498|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-09-30|||February 2015||2015-02-01|September 2016|2016-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|TRANSSPHER||Transsphenoidal Extent of Resection Study|Prospective Multicenter Cohort Study Comparing Extent of Tumor Resection Between Microscopic Transsphenoidal Surgery and Fully Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas|Recruiting||N/A|700|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||f||||||||||2017-10-10 23:36:22.325794|2017-10-10 23:36:22.325794
NCT02357485|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2015-06-26|2015-02-13||March 2014||2014-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Six (6) participants with eight (8) knees - Two (2) participants with bilateral OA (4 knees) Four (4) participant with unilateral OA (4 knees)|ADSC Injections for Pain Management of Osteoarthritis in the Human Knee Joint|Adipose Derived Stromal Cell (ADSC) Injections for Pain Management of Osteoarthritis in the Human Knee Joint|Completed||Phase 1|6|Actual|Fodor, Peter B, M.D.||1|||f||||f||||||||||2017-10-10 23:36:22.496921|2017-10-10 23:36:22.496921
NCT02357459|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-08-08||2017-01-27|February 2015||2015-02-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee|A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee|Completed||Phase 3|486|Actual|Flexion Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 23:36:22.97395|2017-10-10 23:36:22.97395
NCT02357433|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-05-05|||February 2015||2015-02-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|ROMPA||Mortality Reduction in Septic Shock by Plasma Adsorption|Reduccion de la Mortalidad Mediante Plasma-Adsorción en Shock séptico (ROMPA)|Recruiting||N/A|190|Anticipated|Hospital Universitario San Juan de Alicante||2|||f||||||||||||||2017-10-10 23:36:23.140837|2017-10-10 23:36:23.140837
NCT02357420|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-09-22||2016-02-16|January 2015||2015-01-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis|A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis|Completed||Phase 2|393|Actual|Motus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:36:23.285246|2017-10-10 23:36:23.285246
NCT02357407|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-09-05|||June 2015||2015-06-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|FLUO-POP||Development of an Adjustment Assistance Tool Dosage of Fluoroquinolones in a Population Pharmacokinetic Model|Development of an Adjustment Assistance Tool Dosage of Fluoroquinolones in a Population Pharmacokinetic Model|Recruiting||Phase 4|60|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-10 23:36:23.565165|2017-10-10 23:36:23.565165
NCT02357394|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-14|||May 2015||2015-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:36:23.689902|2017-10-10 23:36:23.689902
NCT02357381|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2015-10-09|||January 2015||2015-01-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Observational|ESPOUSE||eNeura SpringTMS Post-Market Observational US Study of Migraine|eNeura SpringTMS Post-Market Observational U.S. Study of Migraine|Unknown status|Recruiting|N/A|250|Anticipated|eNeura, Inc.|||1||f||||f||||||||||2017-10-10 23:36:23.740737|2017-10-10 23:36:23.740737
NCT02357316|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-10-04|||November 2013||2013-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Observational|||Heritability and Genetics of Fat Taste|Heritability and Genetics of Fat Taste|Active, not recruiting||N/A|2500|Anticipated|Purdue University|||1||f||||f||||||Samples With DNA|"     Buccal cells   "|||2017-10-10 23:36:25.608496|2017-10-10 23:36:25.608496
NCT02357303|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-01-07|||April 2015||2015-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Simethicone and N-acetylcysteine in Upper Endoscopy - Prospective Double-blinded Randomized Controlled Trial|Premedication With Simethicone and N-acetylcysteine in Improving Mucosal Visibility During Upper Endoscopy - a Prospective Double-blinded Randomized Controlled Trial|Completed||Phase 4|300|Actual|Portuguese Oncology Institute, Coimbra||3|||f||||f||||||||||2017-10-10 23:36:25.700178|2017-10-10 23:36:25.700178
NCT02357290|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-06-28|||January 2014||2014-01-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders|Open-Label Study of N-Acetylcysteine in Children and Adolescents Ages 5-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Recruiting||Phase 4|40|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 23:36:25.826603|2017-10-10 23:36:25.826603
NCT02357277|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-07-14|||March 2015||2015-03-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton|The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton|Withdrawn||Phase 4|0|Actual|Columbia University||3||Lack of funding|f||||f||||||||||2017-10-10 23:36:25.914058|2017-10-10 23:36:25.914058
NCT02357264|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2017-05-03|2017-01-09||February 2015||2015-02-01|September 2016|2016-09-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Thoracic Ultrasonography for Pulmonary Edema in Patients With Pre-Eclampsia|Thoracic Ultrasonography for the Assessment of Pulmonary Edema in Patients With Pre-Eclampsia|Completed||N/A|186|Actual|Maimonides Medical Center|||2||f||||f||||||||No||2017-10-10 23:36:26.012845|2017-10-10 23:36:26.012845
NCT02357251|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-07-10|||December 12, 2014|Actual|2014-12-12|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Interventional|||Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients|Enhanced Recovery After Surgery: A Randomized Control Trial of Perioperative Management of Gynecologic Patients|Completed||N/A|40|Actual|Case Comprehensive Cancer Center||2|||f||||f|f|f||||||||2017-10-10 23:36:26.279317|2017-10-10 23:36:26.279317
NCT02357238|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2017-01-10|||January 2011||2011-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01|10 Years|Observational [Patient Registry]|||Genetics of Uveitis|Genetics of Uveitis|Recruiting||N/A|1500|Anticipated|The Cleveland Clinic|||1||f||||f||||||Samples With DNA|"     Whole blood serum will be collected   "|No||2017-10-10 23:36:26.388989|2017-10-10 23:36:26.388989
NCT02357225|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-07-27|||August 2015|Actual|2015-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Pilot Study of Pyridostigmine in Pompe Disease|Evaluation of Respiratory and Skeletal Muscle Functions in Response to Acetylcholinesterase Inhibitors in Pompe Disease|Recruiting||Early Phase 1|16|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-10 23:36:26.62398|2017-10-10 23:36:26.62398
NCT02357212|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-12|||April 2009||2009-04-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|Lady Gator||Early Invasive Versus Conservative Therapy in Women With an Acute Coronary Syndrome|Early Invasive Versus Conservative Therapy in Women With an Acute Coronary Syndrome|Completed||N/A|40|Actual|University of Florida||2|||f||||f||||||||||2017-10-10 23:36:26.756253|2017-10-10 23:36:26.756253
NCT02357199|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-08-28|||January 2015||2015-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Interventional Study Targeting Oral Infections in Patients With Chronic Kidney Disease|Interventional Study Targeting Oral Infections in Patients With Chronic Kidney Disease|Completed||N/A|93|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-10 23:36:26.891077|2017-10-10 23:36:26.891077
NCT02357186|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-08-09|||November 16, 2015|Actual|2015-11-16|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|EVEACE||Broad Validation Study of a Management Algorithm Mild Head Injury in Children|Multicenter Prospective Broad Validation of a Management Algorithm Mild Head Injury in Children|Recruiting||N/A|10300|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 23:36:27.056963|2017-10-10 23:36:27.056963
NCT02357160|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-09-12|||November 2014||2014-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|VIVA||The Value of Integrating Visual Arts: Evaluating the Benefits of Hospital Room Artwork on Inpatient Wellbeing|The Value of Integrating Visual Arts (VIVA): Evaluating the Benefits of Hospital Room Artwork on Inpatient Wellbeing|Completed||N/A|184|Actual|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-10-10 23:36:27.310332|2017-10-10 23:36:27.310332
NCT02357147|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-02-08|||November 4, 2015||2015-11-04|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|ARTEMIS||Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM).|A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma.|Active, not recruiting||Phase 2|108|Actual|Morphotek||2|||f||||t||||||||||2017-10-10 23:36:27.400462|2017-10-10 23:36:27.400462
NCT02357134|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-05-01|||March 2015|Actual|2015-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||High-Flow Oxygen for Exertional Dyspnea in Cancer Patients|High-Flow Oxygen for Exertional Dyspnea in Cancer Patients|Recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||4|||f||||t|f|f||||||||2017-10-10 23:36:27.602947|2017-10-10 23:36:27.602947
NCT02357121|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-04-25|||April 2015||2015-04-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|March 2018|Anticipated|2018-03-01||Interventional|FLA||Focal Laser Ablation of Prostate Tissue|Focal Laser Ablation of Prostate Tissue: A Pilot Feasibility Study Using MRI/US Image Fusion for Guidance|Active, not recruiting||N/A|12|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:36:27.712281|2017-10-10 23:36:27.712281
NCT02357108|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-07-14|||May 2013||2013-05-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Message: Study of Patients' Perception of Physician's Compassion|A Trial on Patient's Evaluation of a Physician Conveying Two Different Messages|Completed||N/A|103|Actual|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-10-10 23:36:27.797774|2017-10-10 23:36:27.797774
NCT02357095|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-02-02|||June 2010||2010-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|UACECSP||UACE Followed by Uterine Suction Curettage for the Treatment of Caesarean Scar Pregnancy|Evaluation of the Efficacy and Complications of UACE Combined With Suction Curettage Under Different Kind of Monitoring Methods for the Treatment of Caesarean Scar Pregnancy|Completed||N/A|144|Actual|Maternal and Child Health Hospital of Hubei Province||3|||f||||t||||||||||2017-10-10 23:36:27.907773|2017-10-10 23:36:27.907773
NCT02357082|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-02-20|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|January 2020|Anticipated|2020-01-01|6 Months|Observational [Patient Registry]|||Mayo Clinic Cardiac Implantable Electronic Device MRI Registry|Mayo Clinic Cardiac Implantable Electronic Device (CIED) Magnetic Resonance Imaging (MRI) Registry; Determining the Risks of of MRI in the Presence of Cardiac Implantable Electronic Devices|Enrolling by invitation||N/A|6000|Anticipated|Mayo Clinic|||1||f||||f|f|t|f|||||No||2017-10-10 23:36:28.00886|2017-10-10 23:36:28.00886
NCT02357069|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-01-05|||February 2015||2015-02-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Multi-center (in Korea and Japan), Double-blind, Randomized, Parallel-group Study to Evaluate Similarity of Efficacy and Safety of LBEC0101 50mg Subcutaneous Weekly Injection to Enbrel® 50mg Subcutaneous Weekly Injection, as Adjunctive Therapy to Methotrexate (MTX), in Patients With Active Rheumatoid Arthritis Who Had an Inadequate Response to MTX|Active, not recruiting||Phase 3|372|Anticipated|LG Life Sciences||2|||f||||||||||||||2017-10-10 23:36:28.089871|2017-10-10 23:36:28.089871
NCT02357056|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-02|||February 2015||2015-02-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Randomized Controlled Evaluation of Robotic Cardiac Surgery Training Modalities|Randomized Controlled Evaluation of Robotic Cardiac Surgery Training Modalities|Unknown status|Not yet recruiting|N/A|40|Anticipated|Lawson Health Research Institute||4|||f||||f||||||||||2017-10-10 23:36:28.172157|2017-10-10 23:36:28.172157
NCT02357030|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2015-10-13|||January 2015||2015-01-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Methylphenidate Plus GWI-Nutrient Formula as a Treatment for Patients With Gulf War Illness|Phase IIa Open Label Study to Evaluate the Safety, Tolerability, and Efficacy of KPAX 002 (Methylphenidate Hydrochloride + K-PAX Synergy) as a Treatment for Gulf War Illness in Patients Meeting the Kansas Case Definition|Unknown status|Recruiting|Phase 2|30|Anticipated|K-PAX Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:36:28.342093|2017-10-10 23:36:28.342093
NCT02357017|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-31|||February 2015||2015-02-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Mechanisms of Refractory Hypertension (High and Low Salt Diet)|Mechanisms of Refractory Hypertension (High and Low Salt Diet)|Recruiting||N/A|40|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:36:28.444124|2017-10-10 23:36:28.444124
NCT02357004|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-31|||February 2015||2015-02-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Mechanisms of Refractory Hypertension (Carvedilol)||Recruiting||N/A|100|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:36:28.528052|2017-10-10 23:36:28.528052
NCT02356991|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-02-02|||October 2014||2014-10-01|February 2015|2015-02-01||||January 2016|Anticipated|2016-01-01||Interventional|||A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)|A Randomized,Double-Blind, Placebo-Controlled, Multicenter, Phase II Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|144|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:36:28.625939|2017-10-10 23:36:28.625939
NCT02356978|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-09-11|||December 2014||2014-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DRAP||New Phototherapy Device to Treat Patients With Crigler-Najjar Disease|Trial of a New Phototherapy Device for Treating Hyperbilirubinemia in Crigler-Najjar Patients : a New Concept|Recruiting||N/A|6|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:36:28.727796|2017-10-10 23:36:28.727796
NCT02356965|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-03-24|||December 2014||2014-12-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Dose Ranging Study to Assess the Analgesic Efficacy, Tolerability, Safety and Pharmacokinetic/Pharmacodynamic Properties of A Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction|Completed||Phase 2|80|Actual|iX Biopharma Ltd.||3|||f||||t||||||||||2017-10-10 23:36:28.82412|2017-10-10 23:36:28.82412
NCT02356952|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-07-25|||September 2014||2014-09-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Effect of a Low Glycemic Index on Metabolic Syndrome|A Low Glycemic Index Mediterranean Diet in the Treatment of Metabolic Syndrome. A Randomized Controlled Trial.|Completed||N/A|163|Actual|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis||3|||f||||t||||||||Undecided||2017-10-10 23:36:28.911494|2017-10-10 23:36:28.911494
NCT02356939|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-06-13|||April 2015||2015-04-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|BILIDRAINT||Removable Intraductal Stenting in Duct-to-duct Biliary Reconstruction in Liver Transplantation|Efficacy Of A Removable Intraductal Stent In Duct-To-Duct Biliary Reconstruction To Prevent Biliary Complications In Liver Transplantation: A Randomized Controlled Trial|Recruiting||N/A|380|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:36:29.003745|2017-10-10 23:36:29.003745
NCT02356926|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-02-20|||February 2016||2016-02-01|June 2016|2016-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|Charmed||Cross Checking to Reduce Adverse Events in the Emergency Department|Cross Checking to Reduce Adverse Events Resulting From Medical Errors in the Emergency Department|Completed||N/A|1680|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 23:36:29.105834|2017-10-10 23:36:29.105834
NCT02356913|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-02|||April 2014||2014-04-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum|A Pilot, Open Label, Randomised, Single Dose, Four-Period, Four-Treatment, Four-Sequence, Four Way Crossover Comparative Pharmacokinetic Study of Three Different 4 mg Nicotine Chewing Gum Test Formulations of Fertin Pharma A/S, Denmark With Nicorette Freshmint 4 mg Medicated Chewing Gum of McNeil Denmark ApS as Reference Formulation in Healthy, Adult, Human Smokers Under Fasting Conditions|Completed||Phase 1|15|Actual|Fertin Pharma A/S||4|||f||||||||||||||2017-10-10 23:36:29.1725|2017-10-10 23:36:29.1725
NCT02356900|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-04-12|2017-03-01||February 2015||2015-02-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Hyperbaric VO2max Study|Effects of High Intensity Interval Training in a Hyperoxic-hyperbaric Environment on Exercise Performance at Altitude|Terminated||Phase 2|25|Actual|Duke University||2||Lack of funding required to enroll target subject number|f||||f||||||||||2017-10-10 23:36:29.248593|2017-10-10 23:36:29.248593
NCT02356887|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-05-10|||February 2015||2015-02-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Internal Jugular Vein Flow in the Sitting Position|Measurement of Flow in Internal Jugular Vein in the Sitting Position: an Ultrasound Study on Healthy Volunteers|Completed||N/A|10|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:36:29.605629|2017-10-10 23:36:29.605629
NCT02356874|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-02-06|||August 2015||2015-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|ESpA||The Effect of Exercise on Disease Activity and Cardiovascular Risk for Patients With Axial SpondyloArthritis|Exercise for SpondyloArthritis (SpA) - the ESpA Study The Effect of a Supervised Exercise Intervention on Disease Activity and Cardiovascular Risk in Patients With SpA - A Multicenter Randomized Controlled Trial|Active, not recruiting||N/A|100|Actual|Diakonhjemmet Hospital||2|||f||||||||||||||2017-10-10 23:36:29.661363|2017-10-10 23:36:29.661363
NCT02356861|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-07-27|||March 1, 2016|Actual|2016-03-01|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|||LED Light Therapy to Improve Cognitive & Psychosocial Function in TBI-PTSD Veterans|LED Light Therapy to Improve Cognitive/Psychosocial Function in TBI-PTSD Veterans|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:36:29.73977|2017-10-10 23:36:29.73977
NCT02356848|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-08-04|||September 3, 2015|Actual|2015-09-03|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|November 30, 2018|Anticipated|2018-11-30||Interventional|STEP UP||STEP UP to Avert Amputation in Diabetes|STEP UP to Avert Amputation in Diabetes|Recruiting||N/A|238|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:36:29.929178|2017-10-10 23:36:29.929178
NCT02356835|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-03|2016-03-15|||February 2015||2015-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|APT-14-002||APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults|A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer|Completed||N/A|10|Actual|Origin Inc.||2|||f||||f||||||||||2017-10-10 23:36:30.046921|2017-10-10 23:36:30.046921
NCT02356822|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-05-02|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|December 2024|Anticipated|2024-12-01|December 2018|Anticipated|2018-12-01|10 Years|Observational [Patient Registry]|||Sarah Cannon Outcomes Registry|Sarah Cannon Outcomes Registry|Recruiting||N/A|10000|Anticipated|SCRI Development Innovations, LLC|||1||f||||||||||||||2017-10-10 23:36:30.146353|2017-10-10 23:36:30.146353
NCT02356809|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-02|||March 2015||2015-03-01|January 2015|2015-01-01|August 2015|Anticipated|2015-08-01|March 2015|Anticipated|2015-03-01||Interventional|||Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon|Safety and Efficacy Study of Pl-vegf165 to Treat Secondary Raynaud's Phenomenon Caused by Systemic Scleroderma|Unknown status|Not yet recruiting|Phase 1/Phase 2|30|Anticipated|Human Stem Cell Institute, Russia||2|||f||||||||||||||2017-10-10 23:36:30.219832|2017-10-10 23:36:30.219832
NCT02356796|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-10-27|||February 2015||2015-02-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|CPP||Chronic Pelvic Pain in Women - Conservative Group Treatment Compared to Standard Conservative Treatment.|Chronic Pelvic Pain in Women - Conservative Multidisciplinary Group Treatment Compared to Standard Conservative Treatment. A Randomised Controlled Trial.|Recruiting||N/A|50|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-10-10 23:36:30.306416|2017-10-10 23:36:30.306416
NCT02356783|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-07-26|||February 2015||2015-02-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Implementation of Pedometer for Monitoring Step Count Pre and Post Lumbar ESI for Radicular Pain|Implementation of Wireless Pedometer for Monitoring Step Count Before and After Lumbar Epidural Steroid Injection for Radicular Pain.|Completed||N/A|43|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-10 23:36:30.391804|2017-10-10 23:36:30.391804
NCT02356770|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-02-02|||February 2012||2012-02-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Clinical Study to Investigate Collagen Matrix 10808 for Soft Tissue Volume Augmentation Around Single Implants|Randomized Controlled Clinical Study to Investigate Effectiveness and Safety of a Collagen Matrix 10808 for Soft Tissue Volume Augmentation After Implant Placement in Single Tooth Gaps|Completed||N/A|20|Actual|Geistlich Pharma AG||2|||f||||f||||||||||2017-10-10 23:36:30.478554|2017-10-10 23:36:30.478554
NCT02356757|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-08-04|||August 24, 2015|Actual|2015-08-24|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|October 31, 2018|Anticipated|2018-10-31||Interventional|PATRIOT||Primary Prevention of Foot Complications in Diabetes|Preventing Amputations by Tailored Risk-based Intervention to Optimize Therapy|Recruiting||N/A|404|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:36:30.566689|2017-10-10 23:36:30.566689
NCT02356744|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-04|||February 2015||2015-02-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Maternal and Neonatal Outcome in Pregnant Women Before and After 1 Year Since Bariatric Operation|Comparison of Maternal and Neonatal Outcome Before and After 1 Year of Bariatric Surgery|Unknown status|Not yet recruiting|N/A|100|Anticipated|Cairo University|||2||f||||t||||||||||2017-10-10 23:36:30.668432|2017-10-10 23:36:30.668432
NCT02356731|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-01-16|||March 2015||2015-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|LIBERTY||LevetIracetam in Patients Being Treated for Epilepsy|The Diagnosis and Management of Patients With Epilepsy: Nationwide, Multicenter Study of Recordings for the Diagnosis and Management of Patients With Epilepsy and Treatment With Levetiracetam in Daily Clinical Practice in Greece|Completed||N/A|450|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||Undecided||2017-10-10 23:36:30.742121|2017-10-10 23:36:30.742121
NCT02356718|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-07-25|||January 2015||2015-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Cognitive Training in Inpatient Treatment for Substance Use Disorders|Cognitive Training in Inpatient Treatment for Substance Use Disorders|Completed||N/A|111|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-10 23:36:30.824695|2017-10-10 23:36:30.824695
NCT02356705|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-01-06|||January 2015||2015-01-01|January 2017|2017-01-01||||January 2017|Anticipated|2017-01-01||Interventional|||Intranasal Midazolam in Children as a Pre-Operative Sedative - Part 2|Intranasal Midazolam in Children as a Pre-Operative Sedative - Part 2|Recruiting||Phase 4|45|Anticipated|Bassett Healthcare||3|||f||||f||||||||||2017-10-10 23:36:30.902458|2017-10-10 23:36:30.902458
NCT02356692|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-02-04|||April 2012||2012-04-01|February 2015|2015-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Clinical Comfort Evaluation of Two Marketed Spherical Contact Lenses|Clinical Comfort Evaluation of Two Marketed Spherical Contact Lenses|Completed||N/A|60|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 23:36:30.997301|2017-10-10 23:36:30.997301
NCT02356679|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-08-21|||August 2014||2014-08-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients|A Phase 4, Multicenter, Randomized, Open, Active Drug Comparative Trial to Evaluated the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients|Completed||Phase 4|230|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:36:31.085967|2017-10-10 23:36:31.085967
NCT02356666|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-02-25|||December 2014||2014-12-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|TcCO2||Prevalence of Nocturnal Hypoventilation in Neuromuscular Diseases According to Different Definitions|Prevalence of Nocturnal Hypoventilation in Neuromuscular Diseases According to Different Definitions|Completed||N/A|232|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-10 23:36:31.1903|2017-10-10 23:36:31.1903
NCT02356653|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-11-14|||December 2013||2013-12-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|ExpMACs||Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC|Expanded Access Protocol Using CD3+/CD19+ Depleted Unrelated Donor or Partially Matched Related Donor Peripheral Stem Cells|Recruiting||Early Phase 1|100|Anticipated|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-10-10 23:36:31.257068|2017-10-10 23:36:31.257068
NCT02356640|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2015-02-04|||August 2014||2014-08-01|February 2015|2015-02-01||||August 2019|Anticipated|2019-08-01||Interventional|||EUS-guided CGN for Inoperable Cancer|A Randomized Controlled Trial on Endoscopic Ultrasound-guided Celiac Ganglion Neurolysis Versus Percutaneous Celiac Plexus Neurolysis in Patients With Inoperable Cancer|Recruiting||Phase 2/Phase 3|66|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:36:31.350902|2017-10-10 23:36:31.350902
NCT02356627|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2017-05-09|||February 1, 2015|Actual|2015-02-01|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|October 31, 2016|Actual|2016-10-31||Interventional|||The Cancer Home Life Intervention Study. A Randomised, Controlled Multicentre Trial and a Health Economic Evaluation|The Cancer Home Life Intervention Study Protocol: Effectiveness on Everyday Activities and Quality of Life in People With Advanced Cancer Living at Home. A Randomised, Controlled Multicentre Trial and a Health Economic Evaluation|Completed||N/A|242|Actual|University of Southern Denmark||2|||f||||f||||||||No||2017-10-10 23:36:31.453772|2017-10-10 23:36:31.453772
NCT02356614|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-06-01|||March 2015||2015-03-01|January 2017|2017-01-01|May 2027|Anticipated|2027-05-01|March 2027|Anticipated|2027-03-01||Observational|||A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study|A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study|Active, not recruiting||N/A|325|Anticipated|Apollo Endosurgery, Inc.|||1||f||||f||||||||||2017-10-10 23:36:31.55153|2017-10-10 23:36:31.55153
NCT02356601|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-02|||April 2013||2013-04-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Lumbar Neuraxial Ultrasound Corrrelation With MRI|Lumbar Neuraxial Ultrasound Corrrelation With MRI|Completed||N/A|20|Actual|The Adelaide and Meath Hospital|||1||f||||f||||||||||2017-10-10 23:36:31.653083|2017-10-10 23:36:31.653083
NCT02356588|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-12-21|2016-06-20||February 2015||2015-02-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for the Treatment of Post-Operative Pain in Patients After Abdominal Surgery|Completed||Phase 3|161|Actual|AcelRx Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:36:31.729475|2017-10-10 23:36:31.729475
NCT02356562|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-07-12|||February 3, 2015||2015-02-03|July 2017|2017-07-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|||A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection|An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection|Completed||Phase 2|29|Actual|AbbVie||1|||f||||f||||||||||2017-10-10 23:36:32.503953|2017-10-10 23:36:32.503953
NCT02259686|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-05-29|||November 2014||2014-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Cardiovascular Effects of Apelin In Healthy Volunteers|Cardiovascular Effects of Apelin In Healthy Volunteers|Completed||Early Phase 1|14|Actual|University of Edinburgh||3|||f||||f||||||||||2017-10-10 23:56:54.040116|2017-10-10 23:56:54.040116
NCT02356549|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-05-03|||May 1, 2015||2015-05-01|May 2017|2017-05-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||African American Cancer Clinical Trial Decisions: Testing Tailored Messages|African American Cancer Clinical Trial Decisions: Testing Tailored Messages|Recruiting||N/A|948|Anticipated|Virginia Commonwealth University||4|||f||||t|f|f||||||||2017-10-10 23:36:32.628635|2017-10-10 23:36:32.628635
NCT02356536|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-08-10|||October 2013||2013-10-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CuePed||The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease|The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease|Completed||Phase 1|20|Actual|The University of Queensland||1|||f||||f||||||||||2017-10-10 23:36:32.750544|2017-10-10 23:36:32.750544
NCT02356523|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-04|||February 2015||2015-02-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|||Incidence and Prognostic Value of Delirium in Cardiac Intensive Care Unit Patients||Recruiting||N/A|1000|Anticipated|Ospedale San Donato|||1||f||||f||||||||||2017-10-10 23:36:32.833135|2017-10-10 23:36:32.833135
NCT02356510|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2015-02-04|||June 2014||2014-06-01|February 2015|2015-02-01||||February 2015|Actual|2015-02-01||Observational|||Which One Should be Treated in the Setting of Acute ST Elevation Myocardial Infarction - Culprit Lesion or Culprit Vessel?||Completed||N/A|637|Actual|Samsun Education and Research Hospital|||2||f||||||||||||||2017-10-10 23:36:32.906985|2017-10-10 23:36:32.906985
NCT02356497|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2016-07-04|||June 2013||2013-06-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|3 Years|Observational [Patient Registry]|PRESENT||Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort|Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort|Recruiting||N/A|1470|Anticipated|UMC Utrecht|||1||f||||f||||||||||2017-10-10 23:36:32.972086|2017-10-10 23:36:32.972086
NCT02356484|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2015-12-29|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Surgical Stress Markers for Postoperative Complications: a Prospective Study|Predictive Value of Surgical Stress Markers for Postoperative Complications: a Prospective Study|Completed||N/A|150|Actual|University of Lausanne Hospitals|||4||f||||t||||||||||2017-10-10 23:36:33.049374|2017-10-10 23:36:33.049374
NCT02356471|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-05-25|||March 2015||2015-03-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery|Pilot Study of a Consumer-Based Activity Monitor (Fitbit Zip) in Evaluating Perioperative Activity of Older Adults Undergoing Major Oncologic Surgery|Completed||N/A|34|Actual|Wake Forest University Health Sciences||1|||f||||f|f|t||||||||2017-10-10 23:36:33.109738|2017-10-10 23:36:33.109738
NCT02356458|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-03-03|||August 2015|Actual|2015-08-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma|Combination of Ibrutinib and Bortezomib Followed by Ibrutinib Maintenance to Treat Patients With Relapsed and Refractory Mantle Cell Lymphoma; a Multicenter Phase I/II Trial.|Recruiting||Phase 1/Phase 2|73|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||No||2017-10-10 23:36:33.185038|2017-10-10 23:36:33.185038
NCT02356445|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-08-10|||November 2014||2014-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|||Use of Immunosuppressive Therapy for Sarcoidosis|Outcome of Use of Cytotoxic Drugs for Inflammatory Lung Diseases|Recruiting||N/A|2000|Anticipated|University of Cincinnati|||1||f||||f||||||Samples Without DNA|"     serum in some cases   "|||2017-10-10 23:36:33.313822|2017-10-10 23:36:33.313822
NCT02356432|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2016-10-18|||March 2015||2015-03-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01|1 Year|Observational [Patient Registry]|CMB-NOW||Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)|Cerebral Microbleeds as Predictor of Future Intra-Cerebral Hemorrhage During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)|Active, not recruiting||N/A|86|Actual|Tokai University|||2||f||||t||||||||Undecided||2017-10-10 23:36:33.394787|2017-10-10 23:36:33.394787
NCT02356419|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-02-01|||September 2014||2014-09-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics|rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics for Healthy Subjects in the Phase Ⅰ Clinical Study|Unknown status|Recruiting|Phase 1|40|Anticipated|Shenyang Sunshine Pharmaceutical Co., LTD.||4|||f||||t||||||||||2017-10-10 23:36:33.480941|2017-10-10 23:36:33.480941
NCT02356406|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-05|||January 2014||2014-01-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Celiac Plexus Radiosurgery for Pain Management|Celiac Plexus Radiosurgery for Pain Management in Advanced Cancer Patients - a Phase II Trial|Unknown status|Recruiting|Phase 2|52|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:36:33.582602|2017-10-10 23:36:33.582602
NCT02356393|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-10-19|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Serum Magnesium Levels in Desalination Tap Water and Outcomes in Acute Myocardial Infarction Patients|The Effect of Magnesium Serum Levels on Clinical Outcomes in Patients With Acute Myocardial Infarction by Considering Desalination Drinking Water Levels Patients Fed From.|Recruiting||N/A|450|Anticipated|Sheba Medical Center|||1||f||||f||||||||No||2017-10-10 23:36:33.692682|2017-10-10 23:36:33.692682
NCT02356380|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-02-04|||January 2015||2015-01-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|THSPMOBS||The Effects of Thoracic Spine Mobilizations in Individuals With Neck Pain.|The Effects of Thoracic Spine Mobilizations in Individuals With Neck Pain.|Unknown status|Recruiting|N/A|60|Anticipated|Chatham University||1|||f||||f||||||||||2017-10-10 23:36:33.790504|2017-10-10 23:36:33.790504
NCT02356367|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2017-04-11|||May 2016||2016-05-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|FACE||French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS, AirCurve 10CS): Predictive Factors of Poor Compliance (FACE)|French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS, AirCurve 10 CS): Predictive Factors of Poor Compliance|Withdrawn||N/A|0|Actual|ResMed|||1||f||||f||||||||||2017-10-10 23:36:34.132606|2017-10-10 23:36:34.132606
NCT02356354|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-09-07|||August 2015||2015-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|NERVAL||Study of the Cutaneous Reinnervation After Burn|Study of the Cutaneous Reinnervation After Burn With the Aim of a Better Care of Neuropathic Pain and Pruritus After Healing|Terminated||N/A|6|Actual|University Hospital, Brest||1||Difficulty to recruit all the patients|f||||t||||||||||2017-10-10 23:36:34.261747|2017-10-10 23:36:34.261747
NCT02356341|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-03-08|||January 2015||2015-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||NovaTears® Eye Drops Observational Study NT-002|NovaTears® Observational Study NT-002|Completed||N/A|72|Actual|Novaliq GmbH|||1||f||||f||||||||||2017-10-10 23:36:34.377969|2017-10-10 23:36:34.377969
NCT02356328|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-03-08|||January 2015||2015-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||NovaTears® Eye Drops Observational Study NT-003|NovaTears® Observational Study NT-003|Completed||N/A|25|Actual|Novaliq GmbH|||1||f||||f||||||||||2017-10-10 23:36:34.513919|2017-10-10 23:36:34.513919
NCT02356315|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-12-18|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Brain, Brainstem, and Spinal Cord fMRI|Investigating Pain Processing in the Brain, Brainstem, and Spinal Cord With fMRI|Completed||N/A|13|Actual|Northwestern University|||2||f||||t||||||||||2017-10-10 23:36:34.622076|2017-10-10 23:36:34.622076
NCT02356302|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2016-03-15|||May 2015||2015-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Safety and Pharmacokinetics of Intravaginal Rings Containing Vicriviroc (MK-4176) and/or MK-2048|Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-10 23:36:34.739934|2017-10-10 23:36:34.739934
NCT02356289|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-02|2015-09-21|||January 2015||2015-01-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Single Ascending Dose Study of MYK-461 in Healthy Volunteers|Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Healthy Volunteers|Completed||Phase 1|48|Actual|MyoKardia, Inc.||2|||f||||t||||||||||2017-10-10 23:36:34.844607|2017-10-10 23:36:34.844607
NCT02356276|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-03-19|||February 2015||2015-02-01|March 2015|2015-03-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|HIPEC-01||Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer|A Phase III Study of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2|Recruiting||Phase 3|584|Anticipated|Affiliated Tumor Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-10 23:36:34.943173|2017-10-10 23:36:34.943173
NCT02356263|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-08-05|||March 2015||2015-03-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Observational|||Adaptation and Validation of Recent Life Changes Questionnaire for Measuring Stress Among Adults in Karachi, Pakistan|Adaptation and Validation of Recent Life Changes Questionnaire (RLCQ) to Measure Stress Among Adult Population of Karachi, Pakistan.|Completed||N/A|300|Actual|Aga Khan University|||1||f||||f||||||||||2017-10-10 23:36:35.069228|2017-10-10 23:36:35.069228
NCT02356250|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2017-03-21|||February 18, 2015||2015-02-18|March 2017|2017-03-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Observational|||A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic Patients|A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive|Withdrawn||N/A|0|Actual|Carmel Medical Center|||1|no participants enrolled|f||||t||||||||||2017-10-10 23:36:35.135721|2017-10-10 23:36:35.135721
NCT02356237|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2017-04-02|||June 2015||2015-06-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||The Effect of Episiotomy on Maternal and Fetal Outcomes (EPITRIAL)|The Effect of Episiotomy on Advanced Perineal Tears and Other Maternal and Fetal Outcomes - Randomized Controlled Multicentric Trial (EPITRIAL)|Recruiting||N/A|6006|Anticipated|Carmel Medical Center||2|||f||||f||||||||Undecided||2017-10-10 23:36:35.207071|2017-10-10 23:36:35.207071
NCT02356224|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-04|||June 2013||2013-06-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SHR3824||The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Study Following Single Dose of SHR3824 in Healthy Subjects|Completed||Phase 1|84|Actual|Jiangsu HengRui Medicine Co., Ltd.||7|||f||||||||||||||2017-10-10 23:36:35.321321|2017-10-10 23:36:35.321321
NCT02356185|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-02-15|||September 2015||2015-09-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Substance Use Disorders in HIV People of Cameroon|Prevalence, Socio-demographic Correlates of Substance Use Disorders Among HIV-infected Adults in Cameroon, and Their Influence on Adherence to Antiretroviral Therapy and Immunological Feature: Study Protocol for a Retrospective Cohort Study|Unknown status|Not yet recruiting|N/A|1000|Anticipated|Goulfey Health District Unit|||1||f||||f||||||||||2017-10-10 23:36:35.653291|2017-10-10 23:36:35.653291
NCT02356172|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-06-30|||January 27, 2015||2015-01-27|December 7, 2016|2016-12-07|November 18, 2017|Anticipated|2017-11-18|November 18, 2017|Anticipated|2017-11-18||Observational|||Psychological Outcomes in Isolated GnRH Deficiency|Psychological Outcomes in Isolated GNRH Deficiency|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:36:35.768085|2017-10-10 23:36:35.768085
NCT02355964|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-07-27|||January 2015||2015-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|EFFORT||EFFORT Asthma: Effects of Diet and Exercise in Asthma|EFFORT Asthma: Effects of a High Protein/Low Glycemic Index Diet and Physical Exercise in Sedentary Non-obese Asthmatics.|Completed||N/A|149|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-10 23:36:37.543329|2017-10-10 23:36:37.543329
NCT02356159|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-04|2017-07-26|||January 9, 2015||2015-01-09|July 14, 2017|2017-07-14|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation|A Phase I/II Open Label, Dose Escalation Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation|Recruiting||Phase 1/Phase 2|50|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:36:35.852168|2017-10-10 23:36:35.852168
NCT02356146|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2015-02-01|||January 2012||2012-01-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Observational|||First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction|First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction|Unknown status|Recruiting|N/A|60|Anticipated|Chulalongkorn University|||1||f||||f||||||Samples Without DNA|"     Blood level for tacrolimus was took 12 hours after first dose.   "|||2017-10-10 23:36:35.972212|2017-10-10 23:36:35.972212
NCT02356133|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2015-02-01|||March 2015||2015-03-01|August 2014|2014-08-01||||August 2015|Anticipated|2015-08-01||Observational|||The Relationship Among rSO2, MAP, et al by Near-Infrared Spectroscopy in Endovascular Neurosurgery|The Relationship Among rSO2, MAP,CAM Value, Vital Organ Disfunction and the Outcome of Patients After Operation by Near-Infrared Spectroscopy in Endovascular Neurosurgery|Unknown status|Not yet recruiting|N/A|50|Anticipated|China International Neuroscience Institution|||1||f||||||||||||||2017-10-10 23:36:36.07029|2017-10-10 23:36:36.07029
NCT02356120|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-12-15|||February 2015||2015-02-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Inter-Observer Reliability and Accuracy of Tricuspid Annular Plane Systolic Excursion in Patients With Suspected PE in the ED|The Inter-observer Reliability and Diagnostic Accuracy of Tricuspid Annular Plane Systolic Excursion in Patients With Suspected Pulmonary Embolus in the Emergency Department|Withdrawn||N/A|0|Actual|Yale University|||1||f||||f||||||||||2017-10-10 23:36:36.126391|2017-10-10 23:36:36.126391
NCT02356107|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-08-09|||April 2015||2015-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females|5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females|Completed||Phase 4|15|Actual|University of Utah||1|||f||||f||||||||||2017-10-10 23:36:36.200754|2017-10-10 23:36:36.200754
NCT02356094|ClinicalTrials.gov processed this data on October 10, 2017|2015-02-01|2015-02-01|||January 2015||2015-01-01|February 2015|2015-02-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Posterior Cornea in Primary Open Angle Glaucoma|Posterior Cornea in Primary Open Angle Glaucoma|Unknown status|Recruiting|N/A|100|Anticipated|Centro Hospitalar do Baixo Vouga|||2||f||||f||||||||||2017-10-10 23:36:36.281985|2017-10-10 23:36:36.281985
NCT02356081|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-12-08|||February 2015||2015-02-01|January 2015|2015-01-01||||February 2019|Anticipated|2019-02-01||Interventional|||eSMART Trial to Evaluate ASyMS|eSMART: Randomised Controlled Trial to Evaluate Electronic Symptom Management Using the Advanced Symptom Management System (ASyMS) Remote Technology for Patients With Cancers|Recruiting||N/A|1108|Anticipated|University of Surrey||2|||f||||t||||||||||2017-10-10 23:36:36.379258|2017-10-10 23:36:36.379258
NCT02356068|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2015-02-12|||January 2015||2015-01-01|January 2015|2015-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01|1 Week|Observational [Patient Registry]|||Predictions of Bleeding During Liver Transplantation With Thromboelastometry|Thromboelastometry as a Tool to Predict Bleeding and Transfusion Requirement During Liver Transplantation|Unknown status|Recruiting|N/A|70|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-10-10 23:36:36.509723|2017-10-10 23:36:36.509723
NCT02356055|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-11-18|||October 2014||2014-10-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|STOMP||Mass Practice of Activities of Daily Living in Dementia (STOMP)|High-dose Mass Practice Intervention to Reduce ADL Disability in Dementia|Completed||N/A|32|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-10 23:36:36.591421|2017-10-10 23:36:36.591421
NCT02356042|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-04|||February 2014||2014-02-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Effects of Geriatric Inclusive Art Activity in Nursing Home Residents (GIA)|Effects of Geriatric Inclusive Art Activity in Nursing Home Residents (GIA)|Completed||N/A|24|Actual|University Hospital, Angers|||2||f||||||||||||||2017-10-10 23:36:36.682182|2017-10-10 23:36:36.682182
NCT02356029|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-30|||January 2015||2015-01-01|January 2015|2015-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|REAppropriate||Perception of Inappropriate CPR: a Multicenter International Cross-sectional Survey|The REAppropriate Study: Perception of Inappropriate CPR: a Multicenter International Cross-sectional Survey|Unknown status|Recruiting|N/A|3000|Anticipated|University Hospital, Ghent|||1||f||||f||||||||||2017-10-10 23:36:36.772547|2017-10-10 23:36:36.772547
NCT02356016|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-05-20|||August 2013||2013-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||"Effects of Whole-body Electromyostimulation and Dietary Supplements on Sarcopenic Obesity"|"Effects of Whole-body Electromyostimulation and Dietary Supplements on Sarcopenic Obesity in Elderly Females Living in the Community"|Completed||Phase 2/Phase 3|75|Actual|University of Erlangen-Nürnberg Medical School||3|||f||||f||||||||||2017-10-10 23:36:36.877181|2017-10-10 23:36:36.877181
NCT02356003|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2016-09-14|||May 2015||2015-05-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|TICS||Transcranial Magnetic Stimulation for Children With Tourette's Syndrome|TICS: Transcranial Magnetic Stimulation for Children With Tourette's Syndrome|Recruiting||Phase 1|11|Anticipated|University of Calgary||1|||f||||f||||||||||2017-10-10 23:36:36.976527|2017-10-10 23:36:36.976527
NCT02355990|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2015-02-03|||February 2015||2015-02-01|January 2015|2015-01-01|February 2016|Anticipated|2016-02-01|October 2015|Anticipated|2015-10-01||Interventional|||Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study|Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study|Unknown status|Not yet recruiting|N/A|6|Anticipated|Sanoculis Ltd||1|||f||||f||||||||||2017-10-10 23:36:37.054531|2017-10-10 23:36:37.054531
NCT02355977|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-31|2015-10-29|2015-09-26||June 2013||2013-06-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||The Response of Pathogens to the Respective or Combined Treatment of SRP and Local Minocycline in Chronic Periodontitis|The Response of Periodontal Pathogens to the Respective or Combined Treatment of Scaling and Root Planning and Locally Delivered Minocycline in Patients With Chronic Periodontitis- a Short-term Randomized Clinical Trial|Completed||Phase 4|70|Actual|Zhejiang University||3|||f||||f||||||||||2017-10-10 23:36:37.131754|2017-10-10 23:36:37.131754
NCT02355951|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-02-01|||December 2014||2014-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection||Completed||N/A|166|Actual|Transgene|||||f||||f||||||||||2017-10-10 23:36:37.618237|2017-10-10 23:36:37.618237
NCT02355938|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-10-12|||February 2014||2014-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury|Role of Fidaxomicin in a Patient Population With Problematic Clostridium Difficile Infection|Terminated||Phase 4|12|Actual|Baylor College of Medicine||2||Lost funding due to low enrollment.|f||||f||||||||No|Enrollment to low for statistical analysis.|2017-10-10 23:36:37.692501|2017-10-10 23:36:37.692501
NCT02355925|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-05-23|||October 2014||2014-10-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes|Evaluation the Effect of Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Implantation, Clinical Pregnancy and Miscarriage Rates: Double Blind Randomized Clinical Trial ,Phase 3|Recruiting||Phase 3|150|Anticipated|Royan Institute||3|||f||||t||||||||||2017-10-10 23:36:37.767304|2017-10-10 23:36:37.767304
NCT02355912|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-07-07|||January 2015||2015-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Adaptive Recalibration of Prosthetic Leg Neural Control System|Adaptive Recalibration of Prosthetic Leg Neural Control System|Recruiting||N/A|35|Anticipated|Shirley Ryan AbilityLab||1|||f||||f||||||||||2017-10-10 23:36:37.862271|2017-10-10 23:36:37.862271
NCT02355899|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-09-18|||January 2015||2015-01-01|September 2017|2017-09-01|August 23, 2017|Actual|2017-08-23|August 23, 2017|Actual|2017-08-23||Interventional|||Evaluation of the Suitability of PD P 506 A in the PDT of Distal Subungual Onychomycosis (DSO) of the Great Toenail.|Evaluation of the Suitability of PD P 506 A in the Photodynamic Therapy of Distal Subungual Onychomycosis (DSO) of the Great Toenail.|Completed||Phase 2|25|Actual|photonamic GmbH & Co. KG||1|||f||||f||||||||||2017-10-10 23:36:37.934531|2017-10-10 23:36:37.934531
NCT02355886|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-05-10|||April 2015||2015-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy|Randomized Placebo Control Trial of Perioperative Gabapentin to Reduce Total Analgesic Requirements in Patients Undergoing Radical Cystectomy|Recruiting||Phase 2/Phase 3|44|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-10 23:36:38.022609|2017-10-10 23:36:38.022609
NCT02355873|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-06|||February 2015||2015-02-01|February 2015|2015-02-01||||July 2015|Anticipated|2015-07-01||Interventional|||Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients|Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients Continuous Renal Replacement Therapy Patients|Unknown status|Recruiting|Phase 4|60|Anticipated|Peking University First Hospital||2|||f||||f||||||||||2017-10-10 23:36:39.663345|2017-10-10 23:36:39.663345
NCT02355860|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-01-30|||May 2010||2010-05-01|January 2015|2015-01-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Observational|||Female Sexual Function and Socioeconomic Status|Female Sexual Function and Socioeconomic Status|Completed||N/A|268|Actual|Ohio State University|||1||f||||t||||||||||2017-10-10 23:36:39.781292|2017-10-10 23:36:39.781292
NCT02355847|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-01-30|||January 2012||2012-01-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PROM||Cultural Competency, Risk Management, and Patient Safety Internet-Based Curriculum for OB/GYN Resident Physicians|Cultural Competency, Risk Management, and Patient Safety Internet-Based Curriculum for OB/GYN Resident Physicians and Adverse Patient Events|Completed||N/A|76|Actual|Ohio State University||1|||f||||f||||||||||2017-10-10 23:36:39.837562|2017-10-10 23:36:39.837562
NCT02355834|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-09-26|||May 2015||2015-05-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|FINS||Faecal Incontinence iNtervention Study|Improving Continence in People With Inflammatory Bowel Disease: Active Case Finding and a Randomised Controlled Trial|Recruiting||N/A|186|Anticipated|London North West Healthcare NHS Trust||2|||f||||f||||||||No||2017-10-10 23:36:39.899477|2017-10-10 23:36:39.899477
NCT02355821|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-03-29|||April 2015||2015-04-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|COMPASS||Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women|Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)|Recruiting||N/A|114|Anticipated|National Research Center for Preventive Medicine||2|||f||||f||||||||Undecided||2017-10-10 23:36:40.031796|2017-10-10 23:36:40.031796
NCT02355808|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-01-30|||October 2012||2012-10-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Interventional|SUPFASTEHEALTH||Do Superfast Broadband and Tailored Interventions Improve Use of E-health and Reduce Health Related Travel?|Do Superfast Broadband and Tailored Interventions Improve Use of E-health and Reduce Health Related Travel?|Unknown status|Active, not recruiting|N/A|1044|Actual|University of Plymouth||8|||f||||f||||||||||2017-10-10 23:36:40.128336|2017-10-10 23:36:40.128336
NCT02355795|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2016-11-24|||November 2014||2014-11-01|November 2016|2016-11-01||||October 2015|Actual|2015-10-01||Interventional|||Diets With a Spectrum of Fat Intake for Preventing Obesity: A Randomized Controlled-feeding Trial||Completed||N/A|307|Actual|Zhejiang University||3|||f||||||||||||||2017-10-10 23:36:40.200524|2017-10-10 23:36:40.200524
NCT02355782|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-04-14||||||January 2015|2015-01-01||||||||Expanded Access|||OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy|Provision of OMS721 to Patients With Thrombotic Microangiopathy Under Compassionate Use|Available||N/A|||Medical Universtity of Lodz|||||f||||||||||||||2017-10-10 23:36:40.276289|2017-10-10 23:36:40.276289
NCT02355769|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-10-01|||December 2014||2014-12-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|January 2017|Anticipated|2017-01-01|24 Months|Observational [Patient Registry]|||Complex Pathophysiological Background of Heart Failure Deterioration|Multiparametric Assessment of Complex Pathophysiological Background of Heart Failure Deterioration - Relation to Treatment Effects and Prognosis|Recruiting||N/A|200|Anticipated|Military Institute of Medicine, Poland|||1||f||||f||||||||||2017-10-10 23:36:40.337043|2017-10-10 23:36:40.337043
NCT02355756|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-07-09|||January 2015||2015-01-01|January 2015|2015-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Biomarker Development for Future PAC1 Antagonists With Maxadilan|Development of a Target Engagement Biomarker for Future PAC1 Antagonists With the Use of Intradermal Injected Maxadilan Induced Dermal Blood Flow Changes, Assessed by Laser Doppler Imaging|Completed||Early Phase 1|20|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-10 23:36:40.435896|2017-10-10 23:36:40.435896
NCT02355743|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-12-18|||February 2015||2015-02-01|December 2015|2015-12-01|February 2019|Anticipated|2019-02-01|February 2017|Anticipated|2017-02-01||Interventional|||rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome|Prophylactic Recombinant Tissue Plasminogen Activator in the Prevention of Central Venous Access Device (CVAD)-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome|Recruiting||Phase 4|10|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:36:40.612486|2017-10-10 23:36:40.612486
NCT02355730|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-30|||May 2014||2014-05-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Blood Donation From Warfarin Users for the Development of POC INR Monitor|Blood Donation for the Development and Optimisation of the Second Generation Microvisk International Normalized Ratio (INR) Testing System for the Measurement of Prothrombin Time (PT)/INR in Patients on Warfarin Therapy.|Unknown status|Recruiting|N/A|1560|Anticipated|Microvisk Technologies Ltd||1|||f||||f||||||||||2017-10-10 23:36:40.697687|2017-10-10 23:36:40.697687
NCT02355717|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-06-27|||December 2014||2014-12-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Role of Cardiometabolic Risk Factors in Childhood Bone Development|Role of Cardiometabolic Risk Factors in Childhood Bone Development (Healthy Heart 'N' Bones Study)|Recruiting||N/A|400|Anticipated|Augusta University|||1||f||||t||||||||||2017-10-10 23:36:40.788561|2017-10-10 23:36:40.788561
NCT02355704|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-01-30|||January 2012||2012-01-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney|Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney Transplantation in Vivo|Completed||Phase 3|48|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-10 23:36:40.883683|2017-10-10 23:36:40.883683
NCT02355691|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-06-09|||May 2015||2015-05-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty|Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty|Terminated||N/A|25|Actual|University of North Carolina, Chapel Hill||2||Loss of Personnel|f||||f||||||||||2017-10-10 23:36:40.977695|2017-10-10 23:36:40.977695
NCT02355678|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-08-20|||January 2015||2015-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Dexamethasone Versus Local Infiltration Technique for Tonsillectomy in Children|The Effect of Dexamethasone Versus Local Infiltration Technique on Postoperative Nausea and Vomiting After Tonsillectomy in Children: A Randomized Double-blind Clinical Trial|Completed||N/A|129|Actual|Makassed General Hospital||2|||f||||f||||||||||2017-10-10 23:36:41.062504|2017-10-10 23:36:41.062504
NCT02355665|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-01-17||2016-07-26|January 2015||2015-01-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study Using a Naturalistic Clinical Model to Measure the Efficacy and Safety of a Novel Nicotine Replacement Therapy in Smokers Motivated to Quit|Completed||Phase 3|1200|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||Undecided||2017-10-10 23:36:41.17193|2017-10-10 23:36:41.17193
NCT02355652|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-01-05|||January 2015||2015-01-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|HLS||Cemented Versus Uncemented Total Knee Arthroplasty : a Prospective Randomized Study|Comparison of Two Surgical Strategies of Total Knee Arthroplasty : Cemented Versus Uncemented HLS Knee-Tec Prosthesis System. A Prospective Randomized Study.|Withdrawn||Phase 4|0|Actual|Hospices Civils de Lyon||2||an other study will start with new outcome measures|f||||f||||||||||2017-10-10 23:36:41.422935|2017-10-10 23:36:41.422935
NCT02355639|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-01|||January 2015||2015-01-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin|A Single-Centre, Explorative, Randomised, Investigator-Blinded, Negative-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess Steroid Induced Skin Atrophy on Healthy Skin|Completed||Phase 1|16|Actual|LEO Pharma||3|||f||||f||||||||||2017-10-10 23:36:41.496948|2017-10-10 23:36:41.496948
NCT02355626|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-05-17|||April 2014|Actual|2014-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|PAN-ICU||Prognosis of Anxiety in Intensive Care Unit|Prognosis of Anxiety in Intensive Care Unit|Recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:36:41.57273|2017-10-10 23:36:41.57273
NCT02355613|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-30|||July 2014||2014-07-01|January 2015|2015-01-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Comparative Evaluation of Two Different Radiosurgery|Comparative Evaluation of Two Different Radiosurgery Modalities in Brain Metastatic Patients From Several Solid Tumors|Unknown status|Recruiting|Phase 3|250|Anticipated|Istituto Clinico Humanitas||2|||f||||f||||||||||2017-10-10 23:36:41.6481|2017-10-10 23:36:41.6481
NCT02355600|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-09-21|||November 2014||2014-11-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|6 Years|Observational [Patient Registry]|TAMOXIFERT||Oocyte Recovery During Tamoxifen Adjuvant Therapy|Tamoxifen as Adjuvant Treatment in Breast Cancer and Its Impact on Ovarian Function|Recruiting||N/A|20|Anticipated|Instituto de Investigacion Sanitaria La Fe|||1||f||||f||||||||||2017-10-10 23:36:41.73253|2017-10-10 23:36:41.73253
NCT02355587|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-02-23|||March 2014||2014-03-01|February 2017|2017-02-01|February 2024|Anticipated|2024-02-01|February 2024|Anticipated|2024-02-01|10 Years|Observational [Patient Registry]|EXPAND||Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes|An Open, 5-year Registry Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results and Associated Patient Outcomes|Active, not recruiting||N/A|5000|Anticipated|Castle Biosciences Incorporated|||1||f||||f||||||||||2017-10-10 23:36:41.82885|2017-10-10 23:36:41.82885
NCT02355574|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-02-23|||March 2014||2014-03-01|February 2017|2017-02-01|June 2024|Anticipated|2024-06-01|February 2024|Anticipated|2024-02-01|10 Years|Observational [Patient Registry]|INTEGRATE||5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results|An Ongoing, 5-year Post Market Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile (GEP) Assay Results and the Impact on Patient Outcomes and Health Economics|Active, not recruiting||N/A|1672|Anticipated|Castle Biosciences Incorporated|||1||f||||f||||||||||2017-10-10 23:36:41.899361|2017-10-10 23:36:41.899361
NCT02355561|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-03-02|||January 2015||2015-01-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Crossover Study to Evaluate the Relative Oral Bioavailability and Food Effect After Single Dose Administration of JNJ-54861911 Tablet in Healthy Elderly Participants|An Open-Label, Randomized, Three-Period Crossover Study to Evaluate the Relative Oral Bioavailability and Food Effect of JNJ-54861911 Tablet (1x25mg) After Single Dose Administration in Healthy Elderly Subjects|Completed||Phase 1|12|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-10 23:36:41.963014|2017-10-10 23:36:41.963014
NCT02355548|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-08-28|||December 2012||2012-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|Low Risk PE||Outpatient Treatment of Low-risk Pulmonary Embolism|Rapid Risk Stratification for Outpatient Treatment of Low-risk Pulmonary Embolism|Active, not recruiting||N/A|200|Anticipated|Intermountain Health Care, Inc.|||1||f||||t||||||||||2017-10-10 23:36:42.062229|2017-10-10 23:36:42.062229
NCT02355522|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-03-23|||February 2015||2015-02-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Trial of Local Lidocaine Gel and Intrauterine Lidocaine Infusion for Pain Relief During Saline Infusion Sonohysterography|Randomized Controlled Trial of Local Lidocaine Gel and Intrauterine Lidocaine Infusion for Pain Relief During Saline Infusion Sonohysterography|Completed||N/A|120|Actual|The University of Hong Kong||3|||f||||f||||||||||2017-10-10 23:36:42.371547|2017-10-10 23:36:42.371547
NCT02355509|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-06|||January 2010||2010-01-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients|Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients|Completed||Phase 4|21|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||||2017-10-10 23:36:42.460682|2017-10-10 23:36:42.460682
NCT02355496|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Impact of Charge Displays on Inpatient Laboratory Test Ordering|The Impact of Charge Displays on Inpatient Laboratory Test Ordering|Completed||N/A|98529|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:36:42.560282|2017-10-10 23:36:42.560282
NCT02355483|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-01-30|||May 2012||2012-05-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Impact of Unenhanced Computed Tomography (CT) in Elderly Patients Admitted to the Emergency Department With Acute Abdominal Pain|Accuracy of Unenhanced CT in Elderly Patients Admitted to the Emergency Department With Acute Abdominal Symptoms|Completed||N/A|423|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:36:42.641392|2017-10-10 23:36:42.641392
NCT02355470|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-04-27|||August 2015||2015-08-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|GIFTSS||College Health Center-based Alcohol and Sexual Violence Intervention|GIFTSS (Giving Information for Trauma Support and Safety): A College Health Center-based Alcohol and Sexual Violence Intervention|Active, not recruiting||N/A|2295|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 23:36:42.709395|2017-10-10 23:36:42.709395
NCT02355457|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-01-30|||July 2013||2013-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|4 Years|Observational [Patient Registry]|BACC||Biomarkers in Acute Cardiac Care|Biomarkers in Acute Cardiac Care|Recruiting||N/A|3000|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||Samples With DNA|"     blood samples, white blood cells.   "|Undecided||2017-10-10 23:36:42.813458|2017-10-10 23:36:42.813458
NCT02355444|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-02-23|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|Cardio-Rubus||Effects of Blackberry-derived Polyphenols on Cardiovascular Risk in Adults|Dietary Intervention to Investigate the Effects of Blackberry-derived Polyphenols on Cardio-metabolic Risk Factors in Adults|Completed||N/A|83|Actual|University College Cork||2|||f||||t||||||||Undecided||2017-10-10 23:36:42.909009|2017-10-10 23:36:42.909009
NCT02355431|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-11-16|||December 2014||2014-12-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||INCB039110 in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations|A Randomized, Double-blind Phase 2 Study of INCB039110 in Combination With Erlotinib Versus Erlotinib Alone in Subjects With Stage IIIB/ IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Have Epidermal Growth Factor Receptor (EGFR) Activating Mutations|Withdrawn||Phase 2|0|Actual|Incyte Corporation||2||Study withdrawn before enrolling first patient|f||||t||||||||||2017-10-10 23:36:42.993804|2017-10-10 23:36:42.993804
NCT02355418|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-11-30|||September 2015||2015-09-01|November 2015|2015-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation|A Prospective Observational Study Examining the Role of Myocardial Fibrosis in Outcome Following Mitral Valve Repair in Degenerative Mitral Regurgitation.|Recruiting||N/A|115|Anticipated|University Hospital Birmingham NHS Foundation Trust|||2||f||||f||||||Samples Without DNA|"     Blood samples will be taken from all patients as part of their routine care, including     measurements for full blood count, urea and electrolytes, liver function test, and markers of     cardiac fibrosis.      In patients who chooses to undergo surgical repair of mitral regurgitation, myocardial     biopsies will be taken to look for the degree of diffuse myocardial fibrosis.   "|||2017-10-10 23:36:43.110424|2017-10-10 23:36:43.110424
NCT02258399|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-05-01|||May 2015||2015-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Exercise in the Fasted State, Glucose Metabolism and Energy Balance||Active, not recruiting||N/A|12|Actual|University of Bath||3|||f||||||||||||||2017-10-10 23:57:10.330261|2017-10-10 23:57:10.330261
NCT02355405|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-04-17|||January 2015||2015-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|||Diagnostic Values of Lung Ultrasound for Perioperative Atelectasis|Diagnostic Performance of Lung Ultrasound for Perioperative Atelectasis in Adult Patients Undergoing General Anesthesia|Completed||N/A|46|Actual|The Third Xiangya Hospital of Central South University|||1||f||||t||||||||||2017-10-10 23:36:43.193743|2017-10-10 23:36:43.193743
NCT02355392|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-01-30|||February 2011||2011-02-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Prevalence of Hypertension Using Telemedical Home Blood Pressure Measurements|Prevalence of Hypertension Using Telemedical Home Blood Pressure Measurements|Completed||N/A|3159|Actual|Regional Hospital Holstebro|||1||f||||f||||||||||2017-10-10 23:36:43.266545|2017-10-10 23:36:43.266545
NCT02355379|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-08-02|||January 2015||2015-01-01|August 2016|2016-08-01|August 2025|Anticipated|2025-08-01|August 2023|Anticipated|2023-08-01||Interventional|ADAGE||Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over|Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial: Ffcd, Gercor, Gerico, Unicancer-gi|Recruiting||Phase 3|774|Anticipated|Federation Francophone de Cancerologie Digestive||4|||f||||t||||||||||2017-10-10 23:36:43.342913|2017-10-10 23:36:43.342913
NCT02355366|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-10-12|||April 2015||2015-04-01|October 2016|2016-10-01||||April 2018|Anticipated|2018-04-01||Interventional|||Family Focused Therapy for Teens at Risk for Bipolar Disorder|Family Focused Therapy (FFT) for Adolescents at Familial Risk for Bipolar|Recruiting||N/A|40|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-10 23:36:43.606767|2017-10-10 23:36:43.606767
NCT02355353|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-01-30|||February 2015||2015-02-01|January 2015|2015-01-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|||Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer|Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer Treated With Fluoropyrimidine-based Chemotherapy as Preoperative Treatment|Unknown status|Not yet recruiting|N/A|31|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||t||||||||||2017-10-10 23:36:43.736279|2017-10-10 23:36:43.736279
NCT02355340|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-08-12|||May 2015||2015-05-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture|Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture|Recruiting||N/A|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-10 23:36:43.824539|2017-10-10 23:36:43.824539
NCT02355327|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-06-22|||February 2015||2015-02-01|January 2016|2016-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Vibrating Vaginal Balls After Childbirth|Feasibility Trial on the Effectiveness of Vibrating Vaginal Balls to Improve Pelvic Floor Muscle Performance in Women After Childbirth|Completed||N/A|56|Actual|City, University of London||2|||f||||f||||||||||2017-10-10 23:36:43.928777|2017-10-10 23:36:43.928777
NCT02355314|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-09-19|||December 2013||2013-12-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|R2D2||Doppler-based Renal Resistive Index in Assessing Renal Dysfunction Reversibility in ICU Patients|Doppler-based Renal Resistive Index in Assessing Renal Dysfunction Reversibility in ICU Patients|Completed||N/A|367|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-10 23:36:44.030452|2017-10-10 23:36:44.030452
NCT02355288|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-04-21|||October 1, 2018|Anticipated|2018-10-01|April 2017|2017-04-01|October 1, 2020|Anticipated|2020-10-01|October 1, 2020|Anticipated|2020-10-01||Interventional|LIBERTI||Left Internal Thoracic Artery Bypass Versus Percutaneous Revascularization in Diabetics|Left Internal Thoracic Artery Bypass Versus Percutaneous Revascularization in Diabetics:Is Minimally Invasive Left Internal Thoracic Artery Bypass Superior to Percutaneous Revascularization in Diabetic Patients With Isolated LAD Stenosis?|Not yet recruiting||N/A|100|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t|f|f||||||No|No individual participant data will be shared with other researchers/institutions unless a contract or agreement is determined.|2017-10-10 23:36:44.24345|2017-10-10 23:36:44.24345
NCT02355275|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-01-11|2016-01-11||January 2015||2015-01-01|January 2016|2016-01-01||||January 2016|Actual|2016-01-01||Interventional|TBKT_HEP||Thera-Band® HEP for LBP Secondary Prevention|Thera-Band® Based Home Exercise Program for Low Back Pain Secondary Prevention|Terminated||N/A|22|Actual|Sport and Spine Rehab Clinical Research Foundation||1||large non-response rate|f||||f||||||||||2017-10-10 23:36:44.339299|2017-10-10 23:36:44.339299
NCT02355262|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-07-18|||July 1, 2014|Actual|2014-07-01|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|||CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers|Community-Based HIT Tools for Cancer Screening and Health Insurance Promotion (CATCH-UP)|Recruiting||N/A|200|Anticipated|OHSU Knight Cancer Institute|||2||f||||||||||||||2017-10-10 23:36:44.50106|2017-10-10 23:36:44.50106
NCT02355249|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-03|||September 2014||2014-09-01|January 2015|2015-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer|Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer: a Multi-center, Randomized, and Open-label Trial|Recruiting||Phase 3|648|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:36:44.60897|2017-10-10 23:36:44.60897
NCT02355236|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-03-20|||February 2015||2015-02-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis|A Prospective, Randomized, Double-blinded, Double-dummy, Active-controlled, Multi-center, Interventional Study to Compare Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis|Unknown status|Recruiting|Phase 4|106|Anticipated|Severance Hospital||2|||f||||f||||||||||2017-10-10 23:36:44.897735|2017-10-10 23:36:44.897735
NCT02355223|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-12-28|||January 2016||2016-01-01|December 2015|2015-12-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission|Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission|Not yet recruiting||N/A|6607|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 23:36:45.074057|2017-10-10 23:36:45.074057
NCT02355210|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-05-12|||June 2013||2013-06-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults|Application of a Novel Synbiotic to Modulate the Human Gut Microbiota and Improve Health|Completed||N/A|151|Actual|Rush University Medical Center||6|||f||||f||||||||||2017-10-10 23:36:45.172144|2017-10-10 23:36:45.172144
NCT02355197|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-03-22|||January 2013|Actual|2013-01-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Antioxidants in Gestational Diabetes|Physiological Effects of Gestational Diabetes on the Placenta and Neonatal Outcome; Role of Antioxidant Administration|Completed||Phase 4|200|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:36:45.282884|2017-10-10 23:36:45.282884
NCT02355184|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-02-01|||November 2014||2014-11-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||An Extension of Protocol PRO 140_CD01 TS Study|Extension of Protocol PRO140_CD01 to Evaluate Long-term Suppression of HIV-1 Replication Following Substitution of Stable Combination ART With PRO 140 (Monoclonal CCR5 Antibody) Monotherapy for Additional 160 Weeks in Adult Subjects w/ HIV-1|Active, not recruiting||Phase 2|28|Anticipated|CytoDyn, Inc.||1|||f||||t||||||||||2017-10-10 23:36:45.386807|2017-10-10 23:36:45.386807
NCT02355171|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-09-15|||November 2015||2015-11-01|September 2017|2017-09-01||||March 2018|Anticipated|2018-03-01||Observational|||Personalize my Treatment|A Large-scale Longitudinal Oncology Platform|Recruiting||N/A|10000|Anticipated|Exactis Innovation|||1||f||||f||||||Samples With DNA|"     Tissue (from surgical resection or biopsy) and blood   "|||2017-10-10 23:36:45.486352|2017-10-10 23:36:45.486352
NCT02355158|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-23|2017-03-06||June 2014||2014-06-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy|A Multicenter, Open-label, Single-arm Study to Evaluate the Long-term Use of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy|Completed||Phase 2|197|Actual|BioDelivery Sciences International||1|||f||||f||||||||||2017-10-10 23:36:45.601179|2017-10-10 23:36:45.601179
NCT02355145|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-05-24|||April 2, 2015|Actual|2015-04-02|May 2017|2017-05-01|July 28, 2016|Actual|2016-07-28|July 28, 2016|Actual|2016-07-28||Observational|REALITY||Non-inteRvEntional Study to Observe rAtionaLe to Select add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin.|REALITY: A Non-inteRvEntional Study to Observe the rAtionaLe of selectIng add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin in Real-life Practice at 1 Year Distance|Completed||N/A|1005|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-10 23:36:45.946958|2017-10-10 23:36:45.946958
NCT02355132|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-05-18|||August 2011||2011-08-01|October 2015|2015-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|AMRIC||Assessing a Medicaid Randomized Insurance Experiment Within Community Clinics|Assessing a Medicaid Randomized Insurance Experiment Within Community Clinics|Completed||N/A|308283|Actual|Oregon Health and Science University|||2||f||||f||||||||||2017-10-10 23:36:46.037499|2017-10-10 23:36:46.037499
NCT02355119|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-02-03|||January 2015||2015-01-01|January 2015|2015-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|GIP-2||Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer|Phase III Italian Multicenter Study Comparing the Combination of 5-fluorouracil/Folinic Acid, Oxaliplatin and Irinotecan (Folfoxiri) Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer|Recruiting||Phase 3|310|Anticipated|Azienda Ospedaliero, Universitaria Pisana||2|||f||||t||||||||||2017-10-10 23:36:46.12399|2017-10-10 23:36:46.12399
NCT02355106|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-03-13|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Prospective, Multicenter, Investigation of the Adagio System in Subjects With Atrial Flutter||Recruiting||N/A|50|Anticipated|Adagio Medical||1|||f||||f||||||||||2017-10-10 23:36:46.218665|2017-10-10 23:36:46.218665
NCT02355093|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-30|||July 2014||2014-07-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|March 2015|Anticipated|2015-03-01||Interventional|||Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction Arthroscopically|Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction Arthroscopically|Unknown status|Enrolling by invitation|Phase 4|40|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||2|||f||||t||||||||||2017-10-10 23:36:46.317103|2017-10-10 23:36:46.317103
NCT02355080|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-02-01|||April 2016|Actual|2016-04-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|iKnow2 Project||A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results|A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results|Recruiting||Phase 2/Phase 3|239|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-10 23:36:46.393721|2017-10-10 23:36:46.393721
NCT02355067|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-01-03|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Social Media Intervention for Postpartum Depression|Social Media Intervention to Teach Parenting for Women With Postpartum Depression|Active, not recruiting||N/A|40|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 23:36:46.480437|2017-10-10 23:36:46.480437
NCT02355054|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-01-19||||||January 2017|2017-01-01||||||||Expanded Access|||Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study|Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study|Approved for marketing||N/A|||Washington University School of Medicine|||||||||||||||||||2017-10-10 23:36:46.56565|2017-10-10 23:36:46.56565
NCT02355041|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2016-02-04|||February 2015||2015-02-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Meal Replacement Study|Pilot Meal Replacement-Based Diet Effectiveness Study|Withdrawn||Phase 3|0|Actual|Icahn School of Medicine at Mount Sinai||2||The PI changed institutions|f||||f||||||||||2017-10-10 23:36:46.630396|2017-10-10 23:36:46.630396
NCT02257073|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-03-31|||October 2014||2014-10-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Cognitive-behavioral Treatment for Rheumatoid Arthritis||Enrolling by invitation||N/A|150|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:57:26.960861|2017-10-10 23:57:26.960861
NCT02355015|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-02-20|||March 2014||2014-03-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections|A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections|Recruiting||N/A|200|Anticipated|Singapore General Hospital|||1||f||||f||||||||||2017-10-10 23:36:46.808784|2017-10-10 23:36:46.808784
NCT02355002|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2017-01-11|||May 2015||2015-05-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|TMSOCD||Transcranial Magnetic Stimulation (TMS) in Obsessive Compulsive Disorder (OCD): Mechanisms and Biomarkers|Transcranial Magnetic Stimulation (TMS) in Obsessive Compulsive Disorder (OCD): Mechanisms and Biomarkers|Recruiting||Phase 2|58|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:36:46.879071|2017-10-10 23:36:46.879071
NCT02354989|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-30|2015-11-26|||January 2015||2015-01-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|RESPONSIBLE||Rate RESPONSIVe Pacing in Patients With Permanent AF Underwent AV Node ABLation and bivEntricular Pacing (RESPONSIBLE)|Effect on Exercise Capacity of Fixed Rate Vs Rate RESPONSIve Pacing in Patients With Permanent AF and Left Ventricular Dysfunction Underwent Radiofrequency Atrioventricular Junction aBLation and bivEntricular Pacing (RESPONSIBLE Study)|Completed||N/A|60|Actual|Azienda Ospedaliera Cardinale G. Panico||2|||f||||f||||||||||2017-10-10 23:36:46.963505|2017-10-10 23:36:46.963505
NCT02354963|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-11-17|||November 2014||2014-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|FAPPOR||Follicular Activation in Poor Responders|Follicle Activation in Patients With Poor Ovarian Response Through Fragmentation of the Ovarian Tissue.|Recruiting||N/A|36|Anticipated|Instituto de Investigacion Sanitaria La Fe||2|||f||||t||||||||||2017-10-10 23:36:47.129367|2017-10-10 23:36:47.129367
NCT02354950|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-08-07|||June 22, 2015|Actual|2015-06-22|August 2017|2017-08-01|September 16, 2016|Actual|2016-09-16|September 16, 2016|Actual|2016-09-16||Interventional|||A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers|A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects|Completed||Phase 1|16|Actual|ViiV Healthcare||4|||f||||f|t|f||||||||2017-10-10 23:36:47.208297|2017-10-10 23:36:47.208297
NCT02354937|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-01-16|||July 2015||2015-07-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment|A Phase I, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Severe Renal Impairment and Healthy Matched Control Subjects|Completed||Phase 1|16|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-10 23:36:47.296492|2017-10-10 23:36:47.296492
NCT02354924|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-03-02|2016-11-01||June 2013||2013-06-01|March 2017|2017-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Clinical Evaluation of Two Daily Wear Silicon Hydrogel Contact Lens|A Prospective Randomized Controlled Study to Evaluate the Clinical Performance of VISCO Soft Contact Lens on a Daily Wear Basis|Completed||N/A|60|Actual|Visco Vision Inc.||2|||f||||t||||||||No||2017-10-10 23:36:47.378589|2017-10-10 23:36:47.378589
NCT02354911|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-02-02|||October 2015||2015-10-01|January 2015|2015-01-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes Therapy|A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study of the Safety and Efficacy of Autologous Immunoregulatory Dendritic Cells in Patients With Type 1 Diabetes|Not yet recruiting||Phase 2|24|Anticipated|DiaVacs, Inc.||2|||f||||t||||||||||2017-10-10 23:36:47.609913|2017-10-10 23:36:47.609913
NCT02354898|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-05-08|||March 2015||2015-03-01|August 2016|2016-08-01||||March 2019|Anticipated|2019-03-01||Interventional|||A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma|A Phase I Study of BBI503 Monotherapy in Patients With Advanced Solid Tumors, or BBI503 Plus Sorafenib Combination Therapy in Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 1|60|Anticipated|Sumitomo Dainippon Pharma Co., Ltd.||1|||f||||||||||||||2017-10-10 23:36:47.688994|2017-10-10 23:36:47.688994
NCT02354885|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-29|||December 2014||2014-12-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|TXASRZREGA||TXA in the EMS on the Helicopter and the Ambulance|Administration of Tranexamic Acid in the Preclinical Setting and Its Effect on Coagulation Parameters and Outcome in Multiple Trauma Patients and Isolated TBI in EMS (Schutz Und Rettung Zürich) and Helicopter Rescue(REGA).|Unknown status|Recruiting|Phase 4|50|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:36:47.753393|2017-10-10 23:36:47.753393
NCT02354872|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-09-13|||January 2015||2015-01-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit|Optimized Chronic Care for Smokers: A Comparative Effectiveness Approach; Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit|Recruiting||Phase 4|512|Anticipated|University of Wisconsin, Madison||16|||f||||t||||||||||2017-10-10 23:36:47.845953|2017-10-10 23:36:47.845953
NCT02354859|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-07-18|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)|A Phase 2, Multi-Center, Randomized, Placebo-Controlled Study of IV Gallium Nitrate in Patients With Cystic Fibrosis (IGNITE Study)|Recruiting||Phase 2|120|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-10 23:36:47.968523|2017-10-10 23:36:47.968523
NCT02354846|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2016-10-30|||February 2015||2015-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)||Recruiting||N/A|6|Anticipated|Yonsei University|||1||f||||t||||||||||2017-10-10 23:36:48.262552|2017-10-10 23:36:48.262552
NCT02354833|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-01-03|2016-04-26||August 2014||2014-08-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||We conducted a prospective, observational, randomized, open labeled trial on parturient scheduled for elective cesarean delivery under spinal anesthesia.|Phenylephrine vs. Norepinephrine Infusion After Spinal Anesthesia for Cesarean Delivery|Phenylephrine vs. Norepinephrine Infusion in Preventing Hypotension After Spinal Anesthesia for Cesarean Delivery|Completed||Phase 4|85|Actual|West Virginia University|38 subjects were enrolled in the phenylephrine group and none excluded. 47 subjects were enrolled in the norepinephrine group; 4 patients excluded (2 patients due to monitoring equipment failure, and 2 patients due to emergency cesarean deliveries).|2|||f||||f||||||||||2017-10-10 23:36:48.340453|2017-10-10 23:36:48.340453
NCT02354820|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-03-25|||February 2015||2015-02-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|CHICA-GI||Child Health Improvement Through Computer Automation of Constipation Management in Primary Care|Child Health Improvement Through Computer Automation of Constipation Management in Primary Care|Unknown status|Not yet recruiting|N/A|400|Anticipated|Indiana University||2|||f||||f||||||||||2017-10-10 23:36:48.719268|2017-10-10 23:36:48.719268
NCT02354807|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-05-08|||October 2015||2015-10-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|MiraBAT||Efficacy of Pharmacological Stimulation of BAT and WAT in Lean and Obese Young Adults|Efficacy of Pharmacological Stimulation of Brown and White Fat in Lean and Obese Young Adults|Recruiting||Phase 2|20|Anticipated|Wayne State University||1|||f||||t||||||||||2017-10-10 23:36:48.800911|2017-10-10 23:36:48.800911
NCT02354794|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-01-29|||February 2014||2014-02-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Arginine Supplementation in the Metabolic Syndrome|Effect of Oral Supplementation With One Form of L-arginine on Vascular Endothelial Function in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.|Completed||N/A|36|Actual|Institut National de la Recherche Agronomique||1|||f||||f||||||||||2017-10-10 23:36:48.90322|2017-10-10 23:36:48.90322
NCT02354781|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-03-28|||January 2015||2015-01-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy|Phase I/II Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 1/Phase 2|6|Anticipated|Nationwide Children's Hospital||1|||f||||t||||||||||2017-10-10 23:36:49.075363|2017-10-10 23:36:49.075363
NCT02354768|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-05-30|||October 2015||2015-10-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|ILEHOS||Evaluation of Lanreotide Efficacity in High Output Stoma: a Multicentric Randomized Study|Evaluation of Lanreotide Efficacity in High Output Stoma: a Multicentric Randomized Study|Recruiting||Phase 3|90|Anticipated|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||No||2017-10-10 23:36:49.173957|2017-10-10 23:36:49.173957
NCT02354755|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-01-30|||February 2015||2015-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||The Effect of Temperature on Anesthesia and Surgical Resident's Ability to Perform Clinical and Cognitive Tasks||Completed||N/A|24|Actual|Nationwide Children's Hospital|||3||f||||f||||||||||2017-10-10 23:36:49.310791|2017-10-10 23:36:49.310791
NCT02354742|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-05-03|||December 2014||2014-12-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|ECHO RCT||Echo vs. EGDT in Severe Sepsis and Septic Shock|Echocardiography-Guided Resuscitation in Severe Sepsis and Septic Shock Vs. Early Goal-Directed Therapy: Pilot Study|Recruiting||N/A|80|Anticipated|Intermountain Health Care, Inc.||2|||f||||f||||||||No||2017-10-10 23:36:49.392338|2017-10-10 23:36:49.392338
NCT02354729|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-01-29|||October 2013||2013-10-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Encouraging Allergic Young Adults to Carry Epinephrine|Using Text Messaging and Financial Incentives to Encourage Allergic Young Adults to Carry Epinephrine|Completed||N/A|33|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:36:49.515707|2017-10-10 23:36:49.515707
NCT02354716|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-01-25|||December 2014||2014-12-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|EndoFLIP||EndoFLIP Use in Upper GI Tract Stenosis|Expanding the Clinical Applications of Functional Luminal Imaging (EndoFLIP) in Esophageal Stenoses|Recruiting||N/A|100|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-10 23:36:49.599412|2017-10-10 23:36:49.599412
NCT02354703|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-06-28|||July 2015||2015-07-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder|Recruiting||Phase 2|366|Anticipated|University of Maryland||2|||f||||t||||||||No||2017-10-10 23:36:49.708337|2017-10-10 23:36:49.708337
NCT02354690|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-02-22|||November 2014||2014-11-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Vemurafenib and TIL Therapy for Metastatic Melanoma|T-cell Therapy in Combination With Vemurafenib for Patients With BRAF Mutated Metastatic Melanoma|Recruiting||Phase 1/Phase 2|12|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-10-10 23:36:49.823336|2017-10-10 23:36:49.823336
NCT02354677|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-03-27|||October 17, 2014|Actual|2014-10-17|March 2017|2017-03-01|October 17, 2017|Anticipated|2017-10-17|October 17, 2017|Anticipated|2017-10-17||Interventional|RRR||Repair, Remodeling and Regeneration of the Bronchial Epithelium of COPD Patients|Repair, Remodeling and Regeneration of the Bronchial Epithelium of COPD Patients|Recruiting||N/A|30|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:36:49.933249|2017-10-10 23:36:49.933249
NCT02354651|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-06-15|||May 2013||2013-05-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Response to Diaphragmatic Pacing in Subjects With Pompe Disease|Response to Diaphragmatic Pacing in Subjects With Pompe Disease|Recruiting||N/A|12|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-10 23:36:50.125299|2017-10-10 23:36:50.125299
NCT02354638|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-02-03|||December 2014||2014-12-01|February 2015|2015-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Impact of Smoke Free Public Places (Smoke Free Cabs) on Cab Drivers in Mumbai|Impact of Smoke Free Public Places (Smoke Free Cabs) on Cab Drivers in Mumbai, India|Unknown status|Recruiting|N/A|400|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:36:50.233533|2017-10-10 23:36:50.233533
NCT02354625|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-09-25|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||The Safety of ahSC in Chronic SCI With Rehabilitation|The Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Chronic Spinal Cord Injury (SCI) Receiving Rehabilitation|Recruiting||Phase 1|10|Anticipated|University of Miami||1|||f||||t||||||||||2017-10-10 23:36:50.32711|2017-10-10 23:36:50.32711
NCT02354612|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-07-27|||May 2011||2011-05-01|July 2015|2015-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||An Open Label Continuation Study of TRC105 Therapy for Patients Who Have Completed a Prior TRC105 Trial and Are Judged by the Investigator to Have the Potential to Benefit From Continued TRC105 Therapy|An Open Label Continuation Study of TRC105 Therapy for Patients Who Have Completed a Prior TRC105 Trial and Are Judged by the Investigator to Have the Potential to Benefit From Continued TRC105 Therapy|Enrolling by invitation||Phase 1/Phase 2|50|Anticipated|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||||2017-10-10 23:36:50.432055|2017-10-10 23:36:50.432055
NCT02354599|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-05-12|2016-05-12||November 2014||2014-11-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Safety analysis set (SAS) included all participants who received the study medication.|Single-Dose Study of MT203|A Randomized, Single-center, Double-Blind, Placebo-Controlled Phase 1 Study to Evaluate Safety and Pharmacokinetics of Single Subcutaneous Injection of MT203 in Healthy Adult Japanese and Caucasian Male Participants|Completed||Phase 1|32|Actual|Takeda||8|||f||||f||||||||||2017-10-10 23:36:50.53906|2017-10-10 23:36:50.53906
NCT02354586|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-06-09|||March 2015||2015-03-01|June 2017|2017-06-01||||October 2017|Anticipated|2017-10-01||Interventional|QUADRA||A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens|A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens|Recruiting||Phase 2|500|Anticipated|Tesaro, Inc.||1|||f||||||||||||||2017-10-10 23:36:51.653632|2017-10-10 23:36:51.653632
NCT02354573|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-03|||December 2011||2011-12-01|August 2013|2013-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)|A Mechanistic Study to Assess The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)|Completed||N/A|121|Actual|University of Oxford||2|||f||||t||||||||||2017-10-10 23:36:51.800846|2017-10-10 23:36:51.800846
NCT02354560|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-01-29|||June 2015||2015-06-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version|Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-protocol is Identical to Study No. 0519-10-TLV- Minors' Adjusted Version|Not yet recruiting||Phase 4|15|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-10 23:36:51.884263|2017-10-10 23:36:51.884263
NCT02354547|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-15|||December 2014||2014-12-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors|A Phase I Study of SGT-53, a TfRscFv-Liposome-p53 Complex, in Children With Refractory or Recurrent Solid Tumors|Recruiting||Phase 1|18|Anticipated|SynerGene Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:36:51.95837|2017-10-10 23:36:51.95837
NCT02354534|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-05|||February 2015||2015-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)|A Phase I Study of Intravaginally Administered Artesunate In Women With High Grade Cervical Intraepithelial Neoplasia (CIN2/3)|Recruiting||Phase 1|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||4|||f||||t||||||||No||2017-10-10 23:36:52.088162|2017-10-10 23:36:52.088162
NCT02354521|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-02|||August 2011||2011-08-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Observational|PINS2||Nutrition Support During Pediatric Critical Illness - 2nd Multicenter, International Cohort Study|NUTRITION SUPPORT DURING PEDIATRIC CRITICAL ILLNESS - 2ND MULTICENTER, INTERNATIONAL COHORT STUDY OF BARRIERS AND OUTCOMES|Completed||N/A|1200|Actual|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-10 23:36:52.298376|2017-10-10 23:36:52.298376
NCT02354508|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-10-03|||March 31, 2015|Actual|2015-03-31|October 2017|2017-10-01|August 29, 2018|Anticipated|2018-08-29|August 29, 2018|Anticipated|2018-08-29||Interventional|||Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues|A Phase IIIb Multicenter, Open-label, Single Arm Study to Evaluate the Efficacy and Safety of Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues|Active, not recruiting||Phase 3|99|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-10 23:36:52.391205|2017-10-10 23:36:52.391205
NCT02354495|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-01-26|||August 2013||2013-08-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|NutriCAPE||Individualized Metabolic Assessment and Nutritional Optimization in Children With Chronic Respiratory Insufficiency|Individualized Metabolic Assessment and Nutritional Optimization in Children With Chronic Respiratory Insufficiency on Ventilatory Support at Home|Completed||N/A|16|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-10 23:36:52.629916|2017-10-10 23:36:52.629916
NCT02354482|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-08-08|||January 2015||2015-01-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|ACHIEVE||Achieving Patient-Centered Care and Optimized Health In Care Transitions by Evaluating the Value of Evidence|Achieving Patient-Centered Care and Optimized Health In Care Transitions by Evaluating the Value of Evidence|Enrolling by invitation||N/A|19000|Anticipated|University of Kentucky|||2||f||||f||||||||||2017-10-10 23:36:52.712325|2017-10-10 23:36:52.712325
NCT02354469|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-10-03|||August 2015||2015-08-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||The Effects of Head Trauma on Collegiate Athletes|The Effects of Head Trauma on Biological Markers and Neurologic Function in Collegiate Athletes: a Prospective Investigation|Recruiting||N/A|300|Anticipated|Boston Children’s Hospital|||4||f||||f||||||Samples Without DNA|"     Urine and blood samples will be acquired and stored in a biorepository.   "|||2017-10-10 23:36:52.81715|2017-10-10 23:36:52.81715
NCT02354456|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-01-20|||January 2015||2015-01-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01|1 Year|Observational [Patient Registry]|AFTER-2||Atrial Fibrillation in Turkey: Epidemiologic Registry-2|An Epidemiological Study to Evaluate the Use of Vitamin K Antagonists and New Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients in Turkey|Recruiting||N/A|4100|Anticipated|Dicle University|||1||f||||f||||||||||2017-10-10 23:36:52.926596|2017-10-10 23:36:52.926596
NCT02354443|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-06-22|||June 2015||2015-06-01|October 2015|2015-10-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|PROVIDE||A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders|A Phase 1 Trial of a Single ProHema® CB Product as Part of Single Cord Blood Unit Transplant After Busulfan/Cyclophosphamide/ATG Conditioning for Pediatric Patients With Inherited Metabolic Disorders|Terminated||Phase 1|1|Actual|Fate Therapeutics||1||Business decision|f||||t||||||||||2017-10-10 23:36:53.012527|2017-10-10 23:36:53.012527
NCT02354430|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-09-01|||December 2013||2013-12-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|WAPW||The Effect Water-exercise on Low Back Pain and Sick Leave, Among Healthy Pregnant Women|AquaMama - Testing the Effect of a Public Water-exercise Program on Low Back Pain and Sick Leave Among Healthy Pregnant Women|Completed||N/A|516|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:36:53.089586|2017-10-10 23:36:53.089586
NCT02354417|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-06-22|||December 2014||2014-12-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies|A Phase 1 Trial of a Single ProHema® CB Product (Ex Vivo Modulated Human Cord Blood Cells) Following Myeloablative Conditioning for Pediatric Patients With Hematologic Malignancies|Terminated||Phase 1|3|Actual|Fate Therapeutics||1|||f||||t||||||||||2017-10-10 23:36:53.171336|2017-10-10 23:36:53.171336
NCT02354404|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-04-04|||January 2015||2015-01-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda|Phase 1B, Open-Label, Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of the Investigational Ebola Vaccines, VRC-EBOADC069-00-VP, VRC-EBOADC076-00-VP and VRC-EBOMVA079-00-VP in Healthy Adults in Kampala Uganda|Active, not recruiting||Phase 1|90|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-10 23:36:53.251931|2017-10-10 23:36:53.251931
NCT02354391|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-10-19|||January 2015||2015-01-01|October 2015|2015-10-01||||September 2016|Anticipated|2016-09-01||Interventional|||Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis|Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis.|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Pacific Dermaesthetics||1|||f||||f||||||||||2017-10-10 23:36:53.410795|2017-10-10 23:36:53.410795
NCT02354378|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-02-01|||August 2012||2012-08-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients|A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients|Completed||N/A|64|Actual|Boston Children’s Hospital|||2||f||||f||||||||||2017-10-10 23:36:53.535657|2017-10-10 23:36:53.535657
NCT02354365|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-11-19|||February 2014||2014-02-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|1 Week|Observational [Patient Registry]|||Measuring Lung Pressures in Critically Ill Children Who Are on Mechanical Ventilation|Transpulmonary Pressure and Pressure Rate Product as a Guide to Ventilator Management and Extubation Readiness|Recruiting||N/A|60|Anticipated|Children's Hospital Los Angeles|||3||f||||t||||||||No||2017-10-10 23:36:53.610583|2017-10-10 23:36:53.610583
NCT02354352|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-06-01|||January 2015||2015-01-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy|Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy|Active, not recruiting||Phase 3|52|Anticipated|Ohio State University||2|||f||||t||||||||No||2017-10-10 23:36:53.695833|2017-10-10 23:36:53.695833
NCT02354339|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity|Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity|Completed||Phase 2|24|Actual|University of Guadalajara||2|||f||||f||||||||||2017-10-10 23:36:53.807822|2017-10-10 23:36:53.807822
NCT02354326|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-01-05|||November 2014||2014-11-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer|Evaluation of Bone Metastases With Dual Energy Computed Tomography (CT)|Recruiting||N/A|45|Anticipated|Case Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-10 23:36:53.90053|2017-10-10 23:36:53.90053
NCT02354313|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-08-17|||May 2010||2010-05-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Interventional|MCL-0208||STUDY WITH LENALIDOMIDE (Revlimid®) MAINTENANCE VS OBSERVATION AFTER INTENSIFIED INDUCTION REGIMEN CONTAINING RITUXIMAB FOLLOWED BY HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION AS FIRST LINE TREATMENT IN ADULT PATIENTS WITH ADVANCED MANTLE CELL LYMPHOMA|A PHASE III MULTICENTER, RANDOMIZED STUDY WITH LENALIDOMIDE (Revlimid®) MAINTENANCE VERSUS OBSERVATION AFTER INTENSIFIED INDUCTION REGIMEN CONTAINING RITUXIMAB FOLLOWED BY HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION AS FIRST LINE TREATMENT IN ADULT PATIENTS WITH ADVANCED MANTLE CELL LYMPHOMA.|Active, not recruiting||Phase 3|300|Anticipated|Fondazione Italiana Linfomi ONLUS||2|||f||||f||||||||||2017-10-10 23:36:53.994668|2017-10-10 23:36:53.994668
NCT02354300|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-08-25|||April 2015||2015-04-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|||Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization|A Prospective Study of the Treatment of Intracranial Aneurysms Using Pipeline Flow-Diverter Embolization in Conjunction With Transcranial Dopplers (TCD)|Completed||N/A|2|Actual|University of Florida|||1||f||||f||||||||No||2017-10-10 23:36:54.189191|2017-10-10 23:36:54.189191
NCT02354287|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-12|||February 2015||2015-02-01|April 2017|2017-04-01|September 25, 2015|Actual|2015-09-25|September 25, 2015|Actual|2015-09-25||Observational|||Effectiveness of Cold Biopsy Forceps With Pre-lift for Complete Resection of Colonic Polyps ≤7mm in Size|Effectiveness of Cold Biopsy Forceps With Pre-lift for Complete Resection of Colonic Polyps ≤7mm in Size.|Completed||N/A|64|Actual|Gloucestershire Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-10-10 23:36:54.263794|2017-10-10 23:36:54.263794
NCT02354274|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-05-19|||January 2015||2015-01-01|May 2016|2016-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant Navelbine®|Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant Navelbine®|Recruiting||Phase 3|330|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:36:54.358393|2017-10-10 23:36:54.358393
NCT02354261|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-09-15|||August 2015||2015-08-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)|Phase IIb Open-label Trial of SUBA™-Itraconazole in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)|Active, not recruiting||Phase 2|38|Actual|HedgePath Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-10 23:36:54.460384|2017-10-10 23:36:54.460384
NCT02354248|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-07-25|||July 2014||2014-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Application of the Triple Stimulation Technique to Patients With CNS Disorders Including Stroke|Application of the Triple Stimulation Technique to Patients With CNS Disorders Including Stroke|Active, not recruiting||Phase 4|100|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 23:36:54.549156|2017-10-10 23:36:54.549156
NCT02354235|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-08-05|||January 2015||2015-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)|Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin in Patients With Inadequate Glycemic Control on Teneligliptin)|Completed||Phase 3|138|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-10 23:36:54.627576|2017-10-10 23:36:54.627576
NCT02354222|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-08-05|||January 2015||2015-01-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)|Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin in Patients With Inadequate Glycemic Control on Canagliflozin)|Completed||Phase 3|154|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-10 23:36:54.717907|2017-10-10 23:36:54.717907
NCT02354209|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-05-18|||March 2015||2015-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy|Targeted Clinical Strategies and Low Abundance HIV Viraemia in Boosted-PI Therapy: an Observational Study|Active, not recruiting||N/A|50|Actual|St Stephens Aids Trust|||1||f||||f||||||Samples With DNA|"     Plasma samples   "|||2017-10-10 23:36:54.803132|2017-10-10 23:36:54.803132
NCT02354196|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-03-21|||May 2015||2015-05-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01|24 Months|Observational [Patient Registry]|Big PICTURE 2||Physicians International CT Utilization Registry 2|Big PICTURE 2: Physicians International CT Utilization Registry 2|Withdrawn||N/A|0|Actual|MDDX LLC|||1||f||||f||||||||||2017-10-10 23:36:54.863377|2017-10-10 23:36:54.863377
NCT02354183|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-02-09|||April 2015||2015-04-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Commitment and Motivation in a Brief DBT Intervention for Self Harm|Commitment and Motivation in a Brief DBT Intervention for Self Harm|Completed||N/A|39|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 23:36:54.926173|2017-10-10 23:36:54.926173
NCT02354170|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-07-24|||January 2015||2015-01-01|July 2017|2017-07-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|STOMP-CSC||Short-Term Oral Mifepristone for Central Serous Chorioretinopathy|Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC)|Completed||Phase 2|16|Actual|Bay Area Retina Associates||3|||f||||t||||||||||2017-10-10 23:36:54.993682|2017-10-10 23:36:54.993682
NCT02354157|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-01-29|||March 2013||2013-03-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||The Nutritional Effect of Parental Use of Food as a Reward|Field Observation of Adverse Nutritional Effect of Parental Use of Food as a Reinforcer for Non-food Related Behavior|Completed||N/A|207|Actual|McGill University|||1||f||||f||||||||||2017-10-10 23:36:55.137745|2017-10-10 23:36:55.137745
NCT02354144|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-08-28|||February 2016||2016-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|LIMIT-HPV||Lubricant Investigation in Men to Inhibit Transmission of HPV Infection|A Randomized Controlled Trial of a Carrageenan-Containing Lubricant to Reduce Transmission of Human Papillomavirus Infection Among Men Who Have Sex With Men|Recruiting||Phase 2/Phase 3|380|Anticipated|McGill University||2|||f||||f||||||||||2017-10-10 23:36:55.194033|2017-10-10 23:36:55.194033
NCT02354131|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2017-04-03|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|November 2018|Anticipated|2018-11-01||Interventional|AVANOVA||Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer|Part 1: AVANOVA1 - A Phase I Study to Evaluate the Safety and Tolerability of Bevacizumab-niraparib Combination Therapy and Determine the Recommended Phase 2 Dose (RP2D) in Women With Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Part 2: AVANOVA2 - A Two-arm, Open-label, Phase II Randomized Study to Evaluate the Efficacy of Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer.|Recruiting||Phase 1/Phase 2|108|Anticipated|Nordic Society for Gynaecologic Oncology||2|||f||||t||||||||||2017-10-10 23:36:55.280639|2017-10-10 23:36:55.280639
NCT02354118|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-07-14|||January 2013||2013-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Maintaining Patency in Implanted Port Catheters|Maintaining Patency in Implanted Port Catheters With Saline Only Flushes|Recruiting||Phase 4|396|Anticipated|TriHealth Inc.||2|||f||||f||||||||||2017-10-10 23:36:55.376549|2017-10-10 23:36:55.376549
NCT02354105|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-10-05|||January 2015||2015-01-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|CIMAX||A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life|A Noninterventional Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Practice|Active, not recruiting||N/A|680|Actual|UCB Pharma|||1||f||||f||||||||||2017-10-10 23:36:55.496743|2017-10-10 23:36:55.496743
NCT02354092|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-01-29|||February 2015||2015-02-01|January 2015|2015-01-01||||January 2016|Anticipated|2016-01-01||Interventional|||Paracervical Block for Pain Control With Osmotic Dilator Placement|Paracervical Block for Pain Control During Osmotic Dilator Placement: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|108|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:36:57.421064|2017-10-10 23:36:57.421064
NCT02354079|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-02-05|||February 2016||2016-02-01|February 2016|2016-02-01|December 2028|Anticipated|2028-12-01|December 2019|Anticipated|2019-12-01||Interventional|HYPOCHOL||HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism|HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism|Recruiting||N/A|400|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 23:36:57.532592|2017-10-10 23:36:57.532592
NCT02354066|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-09-21|||June 2013||2013-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Foot Orthoses on the Braking Response Time|The Effect of Different Foot Orthoses (Hallux Valgus Shoe; Forefoot Relief Shoe) on the Brake Response Time After Hallux Valgus and/or Additional Forefoot Surgery|Completed||N/A|42|Actual|Medical University Innsbruck||3|||f||||f||||||||||2017-10-10 23:36:57.612803|2017-10-10 23:36:57.612803
NCT02354053|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-09-20|||November 2015||2015-11-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|TRIIADD||Evaluation of Switching From Current cART to Triumeq With Adherence Support Will Enhance HIV Control in Vulnerable Populations|A Phase IV, Multicentre Randomized Prospective Open Label Study to Evaluate Whether Switching From Current cART to Triumeq in Addition to Adherence Support Will Enhance Virologic Control and Adherence in Vulnerable Populations Relative to Adherence Support Alone|Recruiting||Phase 4|100|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-10 23:36:57.701188|2017-10-10 23:36:57.701188
NCT02354040|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-08-05|||March 2015||2015-03-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|TalkingRx||Using a Tailored Health Information Technology Driven Intervention to Improve Health Literacy and Medication Adherence|Using a Tailored Health Information Technology Driven Intervention to Improve Health Literacy and Medication Adherence in a Pakistani Population With Vascular Disease|Completed||N/A|200|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-10 23:36:57.796256|2017-10-10 23:36:57.796256
NCT02354027|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-07-14|||September 2014||2014-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||The Drug-drug Interaction of SHR3824 and Metformin|Drug Interaction Study of Henagliflozin and Metformin in Healthy Subjects|Completed||Phase 1|12|Actual|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:36:57.867205|2017-10-10 23:36:57.867205
NCT02354014|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-07-18|||May 3, 2016|Actual|2016-05-03|July 2017|2017-07-01|February 26, 2025|Anticipated|2025-02-26|March 11, 2021|Anticipated|2021-03-11||Interventional|||Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB|A Phase 2, Open-label, Multicenter, Single-arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Anti-mycobacterial Activity of TMC207 in Combination With a Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for the Treatment of Children and Adolescents 0 Months to <18 Years of Age Who Have Confirmed or Probable Pulmonary MDR-TB|Recruiting||Phase 2|60|Anticipated|Janssen Research & Development, LLC||1|||f||||t|t|||||||||2017-10-10 23:36:57.936197|2017-10-10 23:36:57.936197
NCT02354001|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-08-07|||April 2011|Actual|2011-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia|Selective Estrogen Receptor Modulators (SERMs) - A Potential New Treatment for Women of Child-bearing Age With Psychotic Symptoms of Schizophrenia|Recruiting||Phase 4|80|Anticipated|The Alfred||2|||f||||f|f|f||||||||2017-10-10 23:36:58.040814|2017-10-10 23:36:58.040814
NCT02353988|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-02-02|||January 2015||2015-01-01|January 2015|2015-01-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|Arbre||AR-inhibitor Bicalutamide in Treating Patients With TNBC|Bicalutamide in Treating Patients With AR-positive Metastatic Triple Negative Breast Cancer|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 23:36:58.23831|2017-10-10 23:36:58.23831
NCT02353975|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-02-02|||May 2014||2014-05-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy Subjects|An Open Label, Randomized, Two-period, Crossover Study to Assess the Effect of Food on SHR3824 and Mass Balance Study in Healthy Volunteers|Completed||Phase 1|12|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:36:58.334362|2017-10-10 23:36:58.334362
NCT02353962|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-02-09|||March 2015||2015-03-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|April 2016|Actual|2016-04-01||Interventional|||Evaluating the Feasibility and Usability of Exergames in Stroke Patients With Visuo-spatial Neglect|Evaluating the Feasibility and Usability of Exergames on Exploring the Hemineglected Space in Stroke Patients With Visuo-spatial Neglect|Completed||N/A|7|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 23:36:58.414427|2017-10-10 23:36:58.414427
NCT02353949|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-10-26|||May 2015||2015-05-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Investigating the Clinical Consequences of Flutemetamol-PET-scanning|Investigating the Clinical Consequences of Flutemetamol-PET-scanning|Recruiting||Phase 3|100|Anticipated|University of Zurich||1|||f||||f||||||||Undecided||2017-10-10 23:36:58.512687|2017-10-10 23:36:58.512687
NCT02353936|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-09-05|||January 2015||2015-01-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus||Recruiting||Phase 2|49|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 23:36:58.628094|2017-10-10 23:36:58.628094
NCT02353923|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-08-14|||September 2014||2014-09-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|||OcuStem Nutritional Supplement in Diabetic Patients With Mild to Moderate Non-proliferative Retinopathy|OcuStem Nutritional Supplement in Diabetic Patients With Mild to Moderate Non-proliferative Retinopathy|Unknown status|Active, not recruiting|N/A|30|Anticipated|Aidan Products LLC||1|||f||||f||||||||||2017-10-10 23:36:58.721192|2017-10-10 23:36:58.721192
NCT02353910|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-02|||July 2009||2009-07-01|January 2015|2015-01-01||||December 2014|Actual|2014-12-01||Observational|||VTE Incidence in Severe Sepsis and Septic Shock|VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock|Completed||N/A|113|Actual|University of Utah|||1||f||||||||||||||2017-10-10 23:36:58.801558|2017-10-10 23:36:58.801558
NCT02353897|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2016-10-24|||October 2014||2014-10-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|APPEAL||Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®|An Assessment of Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®.|Completed||N/A|150|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 23:36:58.869458|2017-10-10 23:36:58.869458
NCT02353884|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2015-01-28|||January 2010||2010-01-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|||Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion||Completed||N/A|150|Actual|Xuanwu Hospital, Beijing|||2||f||||t||||||||||2017-10-10 23:36:58.983396|2017-10-10 23:36:58.983396
NCT02353871|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-05-03|2016-12-28||January 2015||2015-01-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|BTX-A-HAC NG|Randomised population.|Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines|A Phase III, Double Blind, Randomised, Placebo Controlled Study To Assess The Efficacy And Safety Of A Single Treatment Of Clostridium Botulinum Toxin Type A To Improve The Appearance Of Moderate To Severe Glabellar Lines|Completed||Phase 3|185|Actual|Ipsen|Median could not be calculated because insufficient number of participants with events in the placebo group (3 events for ILA and 8 for SSA).|2|||f||||f||||||||||2017-10-10 23:36:59.100523|2017-10-10 23:36:59.100523
NCT02353858|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-12-04|||August 2012||2012-08-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|HT01||Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer|Preoperative Radiochemotherapy With Concurrent Deep Regional Hyperthermia for Locally Advanced Rectal Cancer. A Prospective Phase II Trial|Recruiting||Phase 2|78|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-10 23:37:00.215179|2017-10-10 23:37:00.215179
NCT02353845|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-08-21|||November 2013||2013-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|October 2015|Actual|2015-10-01||Observational|||Construction of Diagnosis System for Early AD Based on Multi-Modality MRI Technology||Completed||N/A|297|Actual|Xuanwu Hospital, Beijing|||4||f||||t||||||||||2017-10-10 23:37:00.322929|2017-10-10 23:37:00.322929
NCT02353832|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-02-23|||January 2015||2015-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer|Phase II Study of Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer|Recruiting||Phase 2|29|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-10 23:37:00.402634|2017-10-10 23:37:00.402634
NCT02353819|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-02-12|||October 2015||2015-10-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer|Phase I Clinical Trial of Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets for Patients With High Risk Prostate Cancer|Recruiting||Phase 1|50|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 23:37:00.505936|2017-10-10 23:37:00.505936
NCT02353806|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation|Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation|Active, not recruiting||Phase 4|16|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-10 23:37:00.601283|2017-10-10 23:37:00.601283
NCT02353793|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-11-26|||April 2015||2015-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Trauma Patients and Hypothermia in the Emergency Room: ReadyHeat® Versus Cotton Wool Blanket|Trauma Patients and Hypothermia in the Emergency Room: a Trial Between Self-warming ReadyHeat® Blanket and Traditional Cotton Wool Blanket|Completed||N/A|60|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-10 23:37:00.695503|2017-10-10 23:37:00.695503
NCT02353780|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2017-08-08|||March 2015||2015-03-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MAZERATI||Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept|Mechanistic Studies of B- and T-Cell Function in Rheumatoid Arthritis Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept|Recruiting||Phase 4|90|Anticipated|University of Pittsburgh||3|||f||||f||||||||||2017-10-10 23:37:00.782294|2017-10-10 23:37:00.782294
NCT02353767|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-02|||January 2011||2011-01-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|METAFIB||Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome||Completed||N/A|478|Actual|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba|||2||f||||f||||||Samples Without DNA|"     plasma, serum   "|||2017-10-10 23:37:00.895993|2017-10-10 23:37:00.895993
NCT02353754|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-05-20|2016-05-20||May 2015||2015-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section|A Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the Transversus Abdominis Plane (TAP) After Bupivacaine Spinal Anesthesia in Subjects Undergoing Elective Cesarean Section|Terminated||Phase 4|15|Actual|Pacira Pharmaceuticals, Inc||2||Slow enrollment. None of the subjects received EXPAREL.|f||||f||||||||||2017-10-10 23:37:00.984971|2017-10-10 23:37:00.984971
NCT02353403|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-30|||January 2014||2014-01-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|GLYCOFOS-cream||Glycaemic and Insulinaemic Responses After Consumption of FOS.|Postprandial Glycaemic and Insulinaemic Responses After Consumption of Dairy Desserts Containing Fructo-oligosaccharides in Adults.|Completed||N/A|27|Actual|Institut Pasteur de Lille||2|||f||||f||||||||||2017-10-10 23:37:04.322127|2017-10-10 23:37:04.322127
NCT02353741|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-01-02|||April 2015||2015-04-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CERTAIN||Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC|Concurrent EGFR-TKIs and Thoracic Radiation Therapy in EGFR Active Mutation for the First Line Treatment of Non-Small Cell Lung Cancer at Stage IV: A Single-arm, Open-label, Single Center, Phase II Trial.|Recruiting||Phase 2|47|Anticipated|Xinqiao Hospital of Chongqing||1|||f||||f||||||||||2017-10-10 23:37:01.277094|2017-10-10 23:37:01.277094
NCT02353728|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-28|||January 2015||2015-01-01|January 2015|2015-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|CAMN107AUS42T||Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy|Detection, Monitoring, and Molecular Characterization of Leukemic Stem Cells From Patients With Chronic Myeloid Leukemia (CML) Undergoing Therapy With Nilotinib|Not yet recruiting||Phase 2|40|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 23:37:01.383803|2017-10-10 23:37:01.383803
NCT02353715|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2017-09-14|||May 2015||2015-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PEAX||Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing|PEAX: Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing|Recruiting||N/A|36|Anticipated|Duke University|||3||f||||f||||||||||2017-10-10 23:37:01.480876|2017-10-10 23:37:01.480876
NCT02353702|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-21|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|CATPAR||Efficacy of Local Anesthesic on Diaphragmatic Function After Upper Abdominal Surgery|Efficacy of Parietal Continuous Infiltration of Local Anesthesic on Diaphragmatic Function After Upper Abdominal Surgery Through a Subcostal Incision|Completed||Phase 3|31|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 23:37:01.565229|2017-10-10 23:37:01.565229
NCT02353689|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-02-04|||October 2013||2013-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement|Identification of the Effect of Fermentable Oligo-, di-, and Mono- Saccharides and Poorly Absorbed Short-chain Carbohydrate (FODMAP) Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement|Completed||Phase 2/Phase 3|84|Actual|Dong-A University||3|||f||||t||||||||||2017-10-10 23:37:01.660301|2017-10-10 23:37:01.660301
NCT02353676|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-29|2015-01-29|||January 2015||2015-01-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Bupivacaine Supplementation For Postoperative Pain Control In Surgical Removal Of Mandibular Third Molars|Bupivacaine For Postoperative Pain Control|Unknown status|Not yet recruiting|N/A|100|Anticipated|Cosmozone Dental Clinic||2|||f||||f||||||||||2017-10-10 23:37:01.739904|2017-10-10 23:37:01.739904
NCT02353663|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-04-05|||April 2014||2014-04-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Observational|||Rheumatic Heart Disease in Peru: Prevalence and Cardiovascular Outcomes Among Schoolchildren|Rheumatic Heart Disease in Peru: Prevalence and Cardiovascular Outcomes Among Schoolchildren|Completed||N/A|1023|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 23:37:01.834451|2017-10-10 23:37:01.834451
NCT02353650|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-04-14|||November 2014||2014-11-01|April 2016|2016-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||The Effect of Coenzyme Q10 on Hearing and Tinnitus Characteristics of Chronic Tinnitus Patients||Recruiting||N/A|||University Hospital, Antwerp|||||f||||||||||||||2017-10-10 23:37:01.910153|2017-10-10 23:37:01.910153
NCT02353637|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-12-20|||November 2014||2014-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Peds Obesity Study|Partial Meal Replacements Providing High Protein, Restricted Carbohydrates in the Treatment of Adolescents With Severe Obesity: A Randomized Controlled Trial|Recruiting||N/A|45|Anticipated|University of Florida||2|||f||||f||||||||Undecided||2017-10-10 23:37:01.983296|2017-10-10 23:37:01.983296
NCT02353624|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-02-02|||May 2011||2011-05-01|January 2015|2015-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Physiological Responses to a Prolonged Cycling Expedition in Older Men|Physiological Responses to a Prolonged Cycling Expedition in Older Men|Completed||N/A|6|Actual|University of Copenhagen|||1||f||||t||||||Samples Without DNA|"     Urine samples, muscle and subcutaneous adipose tissue biopsies and venous blood samples.   "|||2017-10-10 23:37:02.073871|2017-10-10 23:37:02.073871
NCT02353611|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-02-02|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Efficacy of a 6% Hydrogen Peroxide Tooth Bleaching Agent|Safety and Efficacy of a Light-activated 6% Hydrogen Peroxide With Nitrogen-doped Titanium Dioxide Tooth Bleaching Agent|Completed||N/A|31|Actual|University of Chile||2|||f||||t||||||||||2017-10-10 23:37:02.135563|2017-10-10 23:37:02.135563
NCT02353598|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-07-24|||February 26, 2015|Actual|2015-02-26|July 2017|2017-07-01|June 26, 2017|Actual|2017-06-26|November 30, 2016|Actual|2016-11-30||Interventional|||A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease|A Phase Ib, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Arm, Multiple-Dose Study to Assess The Safety, Tolerability, And Pharmacokinetics of Intravenous Crenezumab Administered in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|77|Actual|Genentech, Inc.||5|||f|||||t|f||||||||2017-10-10 23:37:02.371078|2017-10-10 23:37:02.371078
NCT02353585|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-01-11|||December 2014||2014-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|3 Months|Observational [Patient Registry]|NOACISP||Novel Oral Anticoagulants in Stroke Patients|A Registry of Novel Oral AntiCoagulants and Vitamin K-antagonists In Stroke Patients - a Multi-center Audit Addressing a) Intracerebral Haemorrhage and b) Acute Ischemic Stroke in Patients Treated With Oral Anticoagulants|Recruiting||N/A|1000|Anticipated|University Hospital, Basel, Switzerland|||2||f||||f||||||||||2017-10-10 23:37:02.483416|2017-10-10 23:37:02.483416
NCT02353390|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-07-05|||March 2015||2015-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Oral Water Hydration to Prevent Post-Vaccination Presyncope|Feasibility and Impact of Implementing an Oral Water Hydration Strategy to Prevent Post-Vaccination Presyncope and Syncope in Adolescents and Young Adults|Completed||N/A|1820|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:37:04.400744|2017-10-10 23:37:04.400744
NCT02353572|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-23|2015-02-23||November 2009||2009-11-01|January 2015|2015-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||Based on the annual number of referrals made to the Myeloma and Amyloidosis Program, expected accrual to this study was about 20 patients per year.|Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma|A Phase I-II Study of Infusional Melphalan + Bortezomib for Myeloablative Therapy Prior to Autologous Transplant for Patients With Multiple Myeloma|Terminated||Phase 1/Phase 2|3|Actual|University of Colorado, Denver|This study was terminated due to the investigator's departure from the institution.|1||Principle investigator left the institution|f||||t||||||||||2017-10-10 23:37:02.56278|2017-10-10 23:37:02.56278
NCT02353559|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-09-28|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|EASE||Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia|Emotion And Symptom-focused Engagement (EASE): A Randomized Pilot Trial of an Intervention for Individuals With Acute Leukemia|Completed||N/A|47|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:37:02.763215|2017-10-10 23:37:02.763215
NCT02353546|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-12-29|||June 2011||2011-06-01|December 2015|2015-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|CALM||CALM Phase 2b Pilot|Managing Cancer and Living Meaningfully (CALM): Phase 2b Pilot Randomized Psychotherapy Trial in Patients With Advanced Cancer|Completed||Phase 2|60|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:37:02.86489|2017-10-10 23:37:02.86489
NCT02353533|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-11-18|||January 2015||2015-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|FiRE||Endoscopic Full-thickness REsection of Residual Colorectal Lesions - The FiRE Study||Recruiting||N/A|40|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-10 23:37:02.95804|2017-10-10 23:37:02.95804
NCT02353520|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-30|||June 2013||2013-06-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Observational|||"Reliability of Motricity Index Strength Assessments for Upper Extremity in Post Stroke Hemiparesis- a Correlation Study''"|"Reliability of Motricity Index Strength Assessments for Upper Extremity in Post Stroke Hemiparesis- a Correlation Study''"|Completed||N/A|20|Actual|Maharishi Markendeswar University|||1||f||||f||||||||||2017-10-10 23:37:03.055863|2017-10-10 23:37:03.055863
NCT02353507|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-04-25|||February 2015||2015-02-01|February 2015|2015-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Comparison of Chitosan and Carboxymethylcellulose Silver Dressings on Burn Wounds in Pediatric and Adult Subjects|A Multi-Center, Randomized, Comparison Study of a Chitosan (Opticell Ag+) Silver Dressing and a Sodium Carboxymethylcellulose (Aquacel® Ag+) Silver Dressing on Burn Wounds in Pediatrics and Adults Subjects|Withdrawn||Phase 4|0|Actual|Medline Industries||2|||f||||f||||||||||2017-10-10 23:37:03.117048|2017-10-10 23:37:03.117048
NCT02353494|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-01-31|||March 2015||2015-03-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria|Efficacy and Safety of Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum and Plasmodium Vivax Malaria in Timika, Indonesia|Completed||N/A|130|Actual|Menzies School of Health Research|||1||f||||f||||||Samples With DNA|"     Samples for genotyping of Plasmodium vivax and Plasmodium falciparum.   "|||2017-10-10 23:37:03.198719|2017-10-10 23:37:03.198719
NCT02353481|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-02|||April 2012||2012-04-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||1 Year Post Discharge Prognostic Model From the National Heart Failure Audit (NHFA)||Unknown status|Active, not recruiting|N/A|63320|Anticipated|University College, London|||1||f||||f||||||||||2017-10-10 23:37:03.277215|2017-10-10 23:37:03.277215
NCT02353468|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-02-23|2015-02-23||December 2009||2009-12-01|January 2015|2015-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||The study had planned to enroll sixty-two patients in order to achieve sufficient power, 81% to detect an improvement in 3-year event-free survival.|Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant|Phase II Study: Therapy With Bortezomib + Lenalidomide + Dexamethasone With Lenalidomide + Dexamethasone as Post Transplant Consolidation and Maintenance for Patients With Symptomatic Multiple Myeloma Following Autologous Transplantation|Terminated||Phase 2|3|Actual|University of Colorado, Denver|This study was terminated due to the investigator's departure from the institution.|1||Principle investigator left the institution|f||||t||||||||||2017-10-10 23:37:03.360882|2017-10-10 23:37:03.360882
NCT02353455|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-09-08|||March 2013||2013-03-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Observational|||Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity|Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity|Recruiting||N/A|300|Anticipated|Ludwig-Maximilians - University of Munich|||4||f||||f||||||Samples Without DNA|"     PBMC samples, monocyte derived cells   "|||2017-10-10 23:37:03.585438|2017-10-10 23:37:03.585438
NCT02353442|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2017-02-14|2016-08-26||March 2015||2015-03-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Changes in Subjects With Posterior Capsule Tightness|Biomechanical and Neurophysiological Changes in Subjects With Posterior Capsule Tightness - Evaluation and Treatment|Completed||N/A|59|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||No||2017-10-10 23:37:03.700657|2017-10-10 23:37:03.700657
NCT02353429|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-30|||November 2012||2012-11-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets|Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets|Unknown status|Recruiting|Phase 2|25|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-10 23:37:04.148965|2017-10-10 23:37:04.148965
NCT02353416|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-30|||February 2011||2011-02-01|January 2015|2015-01-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|Nutri_AGEs||Effect of Low-Glycemic Index Mediterranean Diet on AGEs|Effect of a Low Glycemic Index Mediterranean Diet on AGEs. A Randomized Clinical Trial|Completed||N/A|50|Actual|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis||2|||f||||t||||||||||2017-10-10 23:37:04.23373|2017-10-10 23:37:04.23373
NCT02353377|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-10-04|||January 2015||2015-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:37:04.486863|2017-10-10 23:37:04.486863
NCT02353364|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-28|||November 2014||2014-11-01|January 2015|2015-01-01|October 2016|Anticipated|2016-10-01|December 2015|Anticipated|2015-12-01||Interventional|BEACON||Blastocyst Euploidy Assessment and Conditioned embryO traNsfer|Prospective Randomised Control Trial of Blastocyst Euploidy Assessment and Conditioned Embryo Transfer for Infertility Patients of Advanced Maternal Age|Unknown status|Recruiting|Phase 1|1000|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:37:04.535748|2017-10-10 23:37:04.535748
NCT02353351|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-05-24|||January 19, 2015|Actual|2015-01-19|May 2017|2017-05-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Observational|ASO 522||ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study|Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study|Terminated||N/A|602|Actual|St. Jude Medical|||1|The sponsor's study closure justification addressed the 522 Order's questions.|f||||t||||||||||2017-10-10 23:37:04.628118|2017-10-10 23:37:04.628118
NCT02353338|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-10-13|||May 2015||2015-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|RIST||Distal Radial Fractures in the Late Middle Aged|Distal Radial Fractures in the Late Middle Aged: Surgical or Conservative Treatment - A Randomized Control Trial|Recruiting||Phase 4|50|Anticipated|Shoulder & Upper Extremity Research Group of Edmonton||2|||f||||f||||||||||2017-10-10 23:37:04.81809|2017-10-10 23:37:04.81809
NCT02353325|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-06-09|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Iron Bioavailability From Encapsulated Ferrous Sulphate|Iron Bioavailability From Salt Fortified With Ferrous Sulphate, Zinc Sulphate and Ascorbic Acid Encapsulated in a Polymer Jacket|Completed||N/A|20|Actual|Swiss Federal Institute of Technology||6|||f||||f||||||||||2017-10-10 23:37:04.890535|2017-10-10 23:37:04.890535
NCT02353312|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-07-18|||March 2015||2015-03-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIDD-HF||Rhode Island Diastolic Dysfunction - Heart Failure|Rhode Island Diastolic Dysfunction - Heart Failure|Recruiting||N/A|30|Anticipated|Providence VA Medical Center||2|||f||||f||||||||||2017-10-10 23:37:04.969789|2017-10-10 23:37:04.969789
NCT02353286|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-10-20|||May 2014||2014-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:37:05.293832|2017-10-10 23:37:05.293832
NCT02353273|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-01-25|||July 2015||2015-07-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers|The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers|Recruiting||Phase 1|12|Anticipated|Oneness Biotech Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:37:05.331411|2017-10-10 23:37:05.331411
NCT02353260|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-30|||December 2014||2014-12-01|January 2015|2015-01-01|September 2017|Anticipated|2017-09-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer|A Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ultrasound Hyperthermia in Combination With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer|Unknown status|Recruiting|Phase 2|120|Anticipated|Shanghai 9th People's Hospital||2|||f||||t||||||||||2017-10-10 23:37:05.421212|2017-10-10 23:37:05.421212
NCT02353247|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-03-24|||August 2015||2015-08-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant|Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant|Recruiting||N/A|30|Anticipated|Norton Healthcare||1|||f||||f||||||||No||2017-10-10 23:37:05.521373|2017-10-10 23:37:05.521373
NCT02353234|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-12-01|||December 2014||2014-12-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Bioavailability of Phenolic Compounds in Bread|Bioavailability of Phenolic Compounds in Wholegrain Bread Compared With White Bread Enriched With Aleurone Fraction|Completed||N/A|15|Actual|University of Parma||3|||f||||f||||||||||2017-10-10 23:37:05.597917|2017-10-10 23:37:05.597917
NCT02353221|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-01-31|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|12 Months|Observational [Patient Registry]|CEUAR||CPMC Early Undifferentiated Arthritis Registry|California Pacific Medical Center Early Undifferentiated Arthritis Registry|Recruiting||N/A|500|Anticipated|California Pacific Medical Center Research Institute|||2||f||||f||||||Samples With DNA|"     Blood samples: Our objective is to create a repository that includes PBMCs and serum samples     suitable for functional assays as well as nucleic acid analysis. These efforts will make our     cohort a unique source to measure PBMC antigen-specific proliferation, cytokine and chemokine     secretion, and activation markers expression among others. Blood will be fractionated for     serum analysis and cell analysis. PBMCs will be sorted into neutrophils, B cells, T cells,     and monocytes. Cells will be used for RNA and DNA extraction and analysis, for functional     assays involving cytokine and chemokine production, cell proliferation, and expression of     surface markers of activation.   "|||2017-10-10 23:37:05.688339|2017-10-10 23:37:05.688339
NCT02353208|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-05-03|||January 2015||2015-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|November 16, 2016|Actual|2016-11-16||Interventional|||The Effect of Sham Feeding on Small Bowel Transit Time in Patients Undergoing Capsule Endoscopy|The Effect of Sham Feeding on Small Bowel Transit Time in Patients Undergoing Capsule Endoscopy: a Prospective Randomized Trial|Completed||N/A|122|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:37:05.769164|2017-10-10 23:37:05.769164
NCT02353195|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-09-27|||October 2013||2013-10-01|September 2016|2016-09-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Radio-frequency in Patients With Myofascial Chronic Neck Pain|"Analgesic Effects of Capacitive Resistive Monopolar Radio-frequency (448 kHz) in Patients With Myofascial Chronic Neck Pain: A Pilot Randomized Controlled Trial."|Completed||N/A|50|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||No||2017-10-10 23:37:05.878075|2017-10-10 23:37:05.878075
NCT02353182|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The T REX Pilot Study: a Study to Investigate the Use of an Alternative Anaesthetic in Infants.|An Open Label Pilot Study of Feasibility of a Dexmedetomidine-Remifentanil-Caudal Anaesthetic for Infant Lower Abdominal/Lower Extremity Surgery: The TREX Pilot Study|Completed||Phase 4|60|Actual|Murdoch Childrens Research Institute||1|||f||||t||||||||No|Data will be presented as group data and no individual will be identified.|2017-10-10 23:37:05.967551|2017-10-10 23:37:05.967551
NCT02353169|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-06-22|||September 2015||2015-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|DexmedQT||The Effects of Dexmedetomidine on the Heart Beat During Elective Surgery in Children|The Effects of Dexmedetomidine on Myocardial Repolarization in Children|Recruiting||Phase 4|60|Anticipated|University of British Columbia||4|||f||||t||||||||Undecided||2017-10-10 23:37:06.094218|2017-10-10 23:37:06.094218
NCT02353156|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-10-16|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Posthemorrhoidectomy Pain Management With Electronic Bidet or Sitz Bath|Single Blind, Randomized Controlled, Multicenter Study to Evaluate the Efficacy and Convenience of Electronic Bidet With Very Low Force Flow Fountain System for Pain Control and Wound Healing After Operation for Anal Disease, Compared to Conventional Sitz Bath|Enrolling by invitation||Phase 2|76|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:37:06.201763|2017-10-10 23:37:06.201763
NCT02353143|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-06-14|||December 2014||2014-12-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|ARMY||Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia|First in Man Study With MEN1112, a CD157 Targeted Monoclonal Antibody, in Relapsed or Refractory Acute Myeloid Leukemia.|Recruiting||Phase 1|50|Anticipated|Menarini Group||1|||f||||f||||||||||2017-10-10 23:37:06.300409|2017-10-10 23:37:06.300409
NCT02353130|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-03|||July 2015||2015-07-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine Treatment|Development Of Cortical Metrics Assessment Outcome Measures in Response to Memantine Treatment in Autism Spectrum Disorders|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill|||1|Protocol did not continue once Investigator relocated to another institution|f||||f||||||||||2017-10-10 23:37:06.425081|2017-10-10 23:37:06.425081
NCT02353117|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-08-11|||January 11, 2016|Actual|2016-01-11|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|PCS||Preventing Congenital Syphilis|Preventing Congenital Syphilis|Recruiting||N/A|6000|Anticipated|Tulane University||2|||f||||t||||||||||2017-10-10 23:37:06.500731|2017-10-10 23:37:06.500731
NCT02353104|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-28|||November 2013||2013-11-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effects of the Onion-Pumpkin Extract on Blood Pressure|The Effects of the Onion-Pumpkin Extract on Blood Pressure: An Open-label, Adaptive-design, Pilot Study|Completed||Phase 2|10|Actual|Medicus Research, LLC||1|||f||||f||||||||||2017-10-10 23:37:06.599106|2017-10-10 23:37:06.599106
NCT02353091|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01||||February 2017|Anticipated|2017-02-01||Interventional|||FM Systems on Children With Auditory Processing Disorders|Effects of Frequency Modulation (FM) Assistive Listening Device Systems on Listening and Related Skills in Children With Auditory Processing Disorders (APD)|Enrolling by invitation||Phase 2|32|Anticipated|University College, London||2|||f||||f||||||||||2017-10-10 23:37:06.6624|2017-10-10 23:37:06.6624
NCT02353065|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2015-01-28|||January 2015||2015-01-01|January 2015|2015-01-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|SONAR||Sonographic Assessment of Reduction in Colles' Fracture|Sonographic Assessment of Reduction in Colles' Fracture|Unknown status|Recruiting|N/A|40|Anticipated|Teesside University||2|||f||||t||||||||||2017-10-10 23:37:06.844404|2017-10-10 23:37:06.844404
NCT02353052|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-17|2015-01-28|||July 2013||2013-07-01|January 2015|2015-01-01||||September 2016|Anticipated|2016-09-01||Observational|||Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST|Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of Primary Gastrointestinal Stromal Tumor|Unknown status|Recruiting|N/A|900|Anticipated|Shanghai Zhongshan Hospital|||2||f||||t||||||Samples Without DNA|"     GIST paraffin specimens   "|||2017-10-10 23:37:06.934657|2017-10-10 23:37:06.934657
NCT02353039|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-07-01|||September 2014||2014-09-01|July 2015|2015-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis|Double Blind, Multicenter, Randomized, Placebo-controlled, Parallel-group, Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis|Unknown status|Recruiting|Phase 2|200|Anticipated|Green Cross Corporation||4|||f||||f||||||||||2017-10-10 23:37:07.040188|2017-10-10 23:37:07.040188
NCT02353026|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-11-17|||January 2015||2015-01-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Phase I Study of Intravenous Artesunate for Solid Tumors|A Phase I Study of Intravenous Artesunate in Patients With Solid Tumors|Completed||Phase 1|19|Actual|Georgetown University||1|||f||||t||||||||||2017-10-10 23:37:07.208407|2017-10-10 23:37:07.208407
NCT02353013|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-03-15|||December 2014||2014-12-01|March 2017|2017-03-01|October 1, 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Protein Intake on Preterm Infant Body Composition|Effect of Protein Intake on Preterm Infant Body Composition|Active, not recruiting||N/A|36|Anticipated|University of Oklahoma||2|||f||||t||||||||No||2017-10-10 23:37:07.281371|2017-10-10 23:37:07.281371
NCT02353000|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-01-27|||July 2016||2016-07-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|WBRTvsSRS||Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases|Whole Brain Radiotherapy vs. Stereotactic Radiosurgery for 4 - 10 Brain Metastases:a Phase III Randomized Multicenter Trial|Recruiting||N/A|260|Anticipated|Maastricht Radiation Oncology||2|||f||||t||||||||No||2017-10-10 23:37:07.371886|2017-10-10 23:37:07.371886
NCT02352987|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-01-11|||March 2015||2015-03-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis|Randomized, Single Blind, Placebo Controlled Clinical Trial to See the Effect of Combination of Neem, Propylene Glycol and Salicylic Acid in the Treatment of Arsenical Palmar Keratosis|Completed||Phase 2|30|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||f||||||||||2017-10-10 23:37:07.499317|2017-10-10 23:37:07.499317
NCT02352974|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-06-05|||January 2015||2015-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|DIAGNODE||GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)|Open Label Pilot Trial in Adults With Recent-onset T1D to Evaluate the Safety, Diabetes Status and Immune Response of GAD-antigen (Diamyd®) Therapy Administered Into Lymph Nodes in Combination With an Oral Vitamin D Regimen|Active, not recruiting||Phase 1|12|Actual|Linkoeping University||1|||f||||f||||||||||2017-10-10 23:37:07.588891|2017-10-10 23:37:07.588891
NCT02352961|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-01-27|||April 2014||2014-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|Imbizo||An Implementation Science Study Investigating Profiles of Men Interested in MMC|An Implementation Science Study Investigating Profiles of Men Interested in Medical Male Circumcision (MMC), Barriers and Methods to Increase the Uptake of MMC Among Older Men in South Africa|Completed||N/A|2817|Actual|The Aurum Institute NPC|||1||f||||f||||||||Yes|Publications will be shared and made available|2017-10-10 23:37:07.685465|2017-10-10 23:37:07.685465
NCT02352948|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-05-01|||January 13, 2015|Actual|2015-01-13|April 2017|2017-04-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|ARCTIC||A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer|A Phase III, Open Label, Randomised, Multi-centre, International Study of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB-IV) Who Have Received at Least Two Prior Systemic Treatment Regimens Including One Platinum Based Chemotherapy Regimen and Do Not Have Known EGFR TK Activating Mutations or ALK Rearrangements (ARCTIC).|Active, not recruiting||Phase 3|597|Actual|AstraZeneca||6|||f||||t||||||||||2017-10-10 23:37:07.766105|2017-10-10 23:37:07.766105
NCT02352935|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function|Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE)|Recruiting||Phase 1/Phase 2|15|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:37:08.146872|2017-10-10 23:37:08.146872
NCT02352922|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-08-22|||July 2015||2015-07-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Randomized Trial of Wound Infiltration With Extended-release Bupivacaine Before Laparoscopic or Robotic Hysterectomy|A Randomized Controlled Trial of Wound Infiltration With Extended-release Versus Short-acting Bupivacaine Before Laparoscopic or Robotic Hysterectomy|Completed||Phase 4|64|Actual|Florida Hospital||2|||f||||f||||||||Yes|There is not a plan to make IPD available, but aggregate data can be made available to interested correspondents|2017-10-10 23:37:08.387044|2017-10-10 23:37:08.387044
NCT02352909|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-09-07|||July 2014||2014-07-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Controlled Trial on Recreational Runners With Patellofemoral Pain|A Randomised Controlled Trial on Recreational Runners With Patellofemoral Pain: Effects of Rehabilitation Approaches Based on Specific Underlying Mechanisms|Completed||N/A|69|Actual|Laval University||3|||f||||t||||||||||2017-10-10 23:37:08.509552|2017-10-10 23:37:08.509552
NCT02352896|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-06-29|||January 2014||2014-01-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome|EPI743-13-023: Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome|Enrolling by invitation||Phase 2|31|Anticipated|Edison Pharmaceuticals Inc||1|||f||||f||||||||||2017-10-10 23:37:08.596369|2017-10-10 23:37:08.596369
NCT02352883|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-09-22|||March 2015||2015-03-01|September 2015|2015-09-01||||November 2027|Anticipated|2027-11-01||Interventional|||MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ|Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)|Recruiting||N/A|350|Anticipated|Eastern Cooperative Oncology Group||5|||f||||||||||||||2017-10-10 23:37:08.738071|2017-10-10 23:37:08.738071
NCT02352857|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-01-28|||October 2013||2013-10-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|GLYCOFOS-cake||Glycaemic and Insulinaemic Responses After Consumption of FOS.|Postprandial Glycaemic and Insulinaemic Responses After Consumption of Minicakes Containing FOS in Adults|Completed||N/A|50|Actual|Institut Pasteur de Lille||2|||f||||f||||||||||2017-10-10 23:37:09.426506|2017-10-10 23:37:09.426506
NCT02352844|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-09-07|||October 7, 2015|Actual|2015-10-07|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|August 15, 2017|Actual|2017-08-15||Interventional|||Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations|Phase II Study of Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations|Active, not recruiting||Phase 2|12|Actual|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 23:37:09.514142|2017-10-10 23:37:09.514142
NCT02352831|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-08-14|||August 31, 2015|Actual|2015-08-31|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma|Phase I/II Study Combining Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 1/Phase 2|42|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||||2017-10-10 23:37:09.604678|2017-10-10 23:37:09.604678
NCT02352805|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-10-04|||January 2015||2015-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Observational|||Coagulopathy and SIRS During ECC in Intensive Care|A Comparative Clinical Study to Understand the Coagulopathy and Systemic Inflammation Associated With the Use of Extracorporeal Circulation in Intensive Care Patients|Active, not recruiting||N/A|65|Actual|University Hospital Tuebingen|||8||f||||f||||||Samples With DNA|"     human whole blood and blood plasma   "|||2017-10-10 23:37:09.817146|2017-10-10 23:37:09.817146
NCT02352792|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-30|||December 2008||2008-12-01|January 2015|2015-01-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck Cancer|Randomized Phase II Study for Dose Escalation in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated With Radiochemotherapy|Recruiting||N/A|90|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 23:37:09.909849|2017-10-10 23:37:09.909849
NCT02352779|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-07-05|2017-02-03||February 2015||2015-02-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors|Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue|Completed||N/A|108|Actual|University of Rochester||3|||f||||t||||||||||2017-10-10 23:37:10.000533|2017-10-10 23:37:10.000533
NCT02352766|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-10-03|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules|Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules|Active, not recruiting||N/A|300|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:37:10.761929|2017-10-10 23:37:10.761929
NCT02352740|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-01-28|||March 2013||2013-03-01|January 2015|2015-01-01||||May 2013|Actual|2013-05-01||Interventional|||Characterization of the Metabolic Fate of an Oral Arginine Form|Characterization of the Metabolic Fate of an Oral L-arginine Form in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.|Completed||N/A|32|Actual|Institut National de la Recherche Agronomique||2|||f||||f||||||||||2017-10-10 23:37:10.989288|2017-10-10 23:37:10.989288
NCT02352727|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-01-28|||May 2014||2014-05-01|January 2015|2015-01-01||||January 2016|Anticipated|2016-01-01||Observational|PD||The Measurement of Nocturnal Hypokinesia in Parkinson's Disease (PD) Patient Compared With Spouse by Wearable Sensors||Unknown status|Enrolling by invitation|N/A|28|Anticipated|Chulalongkorn University|||1||f||||||||||||||2017-10-10 23:37:11.162014|2017-10-10 23:37:11.162014
NCT02352714|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-09-21|||January 2015||2015-01-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SOPHI||Study of Pain Control With Hormonal IUS Insertion|Study of Pain Control With Hormonal IUS Insertion (SOPHI Study)|Completed||Phase 4|98|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-10 23:37:11.23852|2017-10-10 23:37:11.23852
NCT02352701|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-08-26|||December 2012||2012-12-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori|Efficacy and Safety of Basic Triple Therapy Including Ilaprazole, Levofloxacin on the First Line Eradication Treatment of H.Pylori|Completed||Phase 4|320|Actual|Il-Yang Pharm. Co., Ltd.|||1||f||||t||||||||||2017-10-10 23:37:11.335657|2017-10-10 23:37:11.335657
NCT02352688|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-07-18|||May 2015||2015-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Interventional|||RCT on Elderly Patients Undergoing Colorectal Cancer Surgery With Enhanced Geriatric Care|A Randomised Controlled Trial on Preoperative Elderly Patients Undergoing Colorectal Cancer Surgery With Enhanced Geriatric Input|Completed||N/A|74|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-10 23:37:11.40995|2017-10-10 23:37:11.40995
NCT02352675|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-07-28|||April 2015||2015-04-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Determination of the Minimal Concentration of Antifibrinolytics Required to Inhibit t-PA-activated Fibrinolysis|Determination of the Minimal Concentration of Antifibrinolytics Required to Inhibit t-PA-activated Fibrinolysis Using an in Vitro Experimental Model of Fibrinolysis.|Completed||N/A|40|Actual|Boston Children’s Hospital|||2||f||||f||||||Samples Without DNA|"     The doctor will obtain one 13.6 mL blood sample from the arterial catheter or intravenous     catheter at the beginning of the procedure after the patient has been anesthetized.   "|||2017-10-10 23:37:11.475892|2017-10-10 23:37:11.475892
NCT02352662|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-04-07|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Peri-operative Assessment of Coagulopathy in Neonates and Infants Undergoing Cardiac Surgery|Peri-operative Assessment of Coagulopathy in Neonates and Infants Undergoing Cardiac Surgery|Withdrawn||N/A|0|Actual|Boston Children’s Hospital|||1|Competition with another study.|f||||f||||||Samples Without DNA|"     Collect bloods samples at three different time points intraoperatively to look at coagulation     factors   "|||2017-10-10 23:37:11.552102|2017-10-10 23:37:11.552102
NCT02352649|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2015-01-28|||April 2015||2015-04-01|January 2015|2015-01-01|September 2017|Anticipated|2017-09-01|March 2016|Anticipated|2016-03-01||Interventional|||Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury|1-2 Phase of Safety and Efficacy of Patient Intraneural Injections of VEGF165 Plasmid Gene Therapy on Regeneration After Total Severance or Disruption of the Entire Nerve Fiber|Unknown status|Not yet recruiting|Phase 1/Phase 2|45|Anticipated|Human Stem Cell Institute, Russia||3|||f||||f||||||||||2017-10-10 23:37:11.6267|2017-10-10 23:37:11.6267
NCT02352636|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-08-15|||January 2015||2015-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Auriculotherapy for Osteoarthritis Knee|The Experiences for Receiving Auriculotherapy for Osteoarthritis Knee: A Randomised Controlled Feasibility Study.|Completed||Phase 3|44|Actual|The Hong Kong Polytechnic University||4|||f||||t||||||||||2017-10-10 23:37:11.702173|2017-10-10 23:37:11.702173
NCT02352623|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-05-25|||February 2015||2015-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Observational|||Quality of Life and Surgical Late Effects of Melanoma Treatment|Quality of Life and Surgical Late Effects of Melanoma Treatment|Completed||N/A|435|Actual|Herlev Hospital|||1||f||||t||||||||Undecided||2017-10-10 23:37:11.781566|2017-10-10 23:37:11.781566
NCT02352610|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-01-30|||March 2015||2015-03-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study|A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study|Active, not recruiting||N/A|20|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-10 23:37:13.602509|2017-10-10 23:37:13.602509
NCT02352597|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2017-03-22|||January 2013||2013-01-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|PCOS||Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS|Phytoestrogens as an Alternative to Estradiol in Reversing the Antiestrogenic Effect of Clomid on Endometrium in Ovulation Induction in Cases of Polycystic Ovarian Syndrome|Completed||Phase 4|150|Actual|Cairo University||3|||f||||t|t|f|||f|||No||2017-10-10 23:37:13.67728|2017-10-10 23:37:13.67728
NCT02352584|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-10-18|||October 2014||2014-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||A Multicenter, Double-blind, Parallel Phase III Study|A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Phase III Study to Investigate the Efficacy(Immunogenicity) and Safety of GC3110A(Quadrivalent Influenza Vaccine)|Completed||Phase 3|1299|Anticipated|Green Cross Corporation||3|||f||||t||||||||||2017-10-10 23:37:13.753321|2017-10-10 23:37:13.753321
NCT02352571|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-07-04|||January 2015||2015-01-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer|A Prospective, Open-label, Dose Escalation (Part A) and Cohort Expansion (Part B) Phase 1 Study to Investigate the Safety, Tolerability, and Immunogenicity and to Determine Maximum Tolerated Dose and Recommended Phase 2 Dose of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancers|Recruiting||Phase 1|72|Anticipated|Green Cross Corporation||1|||f||||t||||||||Undecided||2017-10-10 23:37:13.860971|2017-10-10 23:37:13.860971
NCT02352558|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-03-25|||May 2015||2015-05-01|March 2017|2017-03-01||||April 2018|Anticipated|2018-04-01||Interventional|||A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies|A Phase Ib Clinical Study of BBI608 for Adult Patients With Advanced, Refractory Hematologic Malignancies|Active, not recruiting||Phase 1|200|Anticipated|Boston Biomedical, Inc||9|||f||||||||||||||2017-10-10 23:37:13.950551|2017-10-10 23:37:13.950551
NCT02352545|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-28|||August 2014||2014-08-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Montelukast for Postinfectious Cough|Montelukast for Postinfectious Cough in Adults|Unknown status|Recruiting|Phase 2|200|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-10 23:37:14.060849|2017-10-10 23:37:14.060849
NCT02352532|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-07-20|||January 2015||2015-01-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|SWE/DN||Using Structural Health Monitoring to Improve Diagnosis and Treatment of Low Back Injury in U.S. Service Members- Phase 2|Using Structural Health Monitoring to Improve Diagnosis and Treatment of Low Back Injury in U.S. Service Members- Phase 2|Completed||N/A|90|Actual|Baylor University||3|||f||||f||||||||||2017-10-10 23:37:14.144497|2017-10-10 23:37:14.144497
NCT02352519|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-07-20|||April 2011||2011-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Comparison of UGBRS Block and Local Infiltration|A Randomized Comparison of Ultrasound Guided Bilateral Rectus Sheath Block and Local Anesthetic Infiltration for Postoperative Pain Control in Children With Acute Appendicitis|Completed||Phase 4|50|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:37:14.235463|2017-10-10 23:37:14.235463
NCT02352506|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2016-10-26|||January 2015||2015-01-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Serum MIF in Acute Kidney Injury|Macrophage Migration Inhibitory Factor in the Serum of Critically Ill Patients as an Early Marker for Acute Kidney Injury|Recruiting||N/A|500|Anticipated|Medical University of Vienna|||2||f||||||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:37:14.312308|2017-10-10 23:37:14.312308
NCT02352493|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-09-04|||January 2015||2015-01-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|April 2016|Actual|2016-04-01||Interventional|||A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH|A Phase 1/2 Single-ascending and Multiple-ascending Dose, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Subcutaneously Administered ALN-CC5 in Healthy Adult Volunteers and Patients With Paroxysmal Nocturnal Hemoglobinuria|Completed||Phase 1/Phase 2|62|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:37:14.484012|2017-10-10 23:37:14.484012
NCT02352441|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-12-06|||June 2016||2016-06-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ACTION||Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction|Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction|Recruiting||Phase 2|28|Anticipated|Allina Health System||2|||f||||f||||||||No||2017-10-10 23:37:15.048771|2017-10-10 23:37:15.048771
NCT02352428|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-06-26|||February 2015||2015-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|SCSES||Skin Cancer Screening Education Study|Skin Cancer Screening Education Study|Active, not recruiting||N/A|113|Actual|Association of Dermatological Prevention, Germany||2|||f||||f||||||||||2017-10-10 23:37:15.143709|2017-10-10 23:37:15.143709
NCT02352402|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-04-28|||March 2015||2015-03-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|POPular CABG||The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery|A Randomized, Double-Blind, Placebo-Controlled Trial Investigating The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery (The POPular CABG Study)|Recruiting||Phase 3|720|Anticipated|St. Antonius Hospital||2|||f||||t||||||||||2017-10-10 23:37:15.233476|2017-10-10 23:37:15.233476
NCT02352376|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-01-28|||March 2013||2013-03-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|Physiotherapy||Noninvasive Ventilation After Coronary Bypass Grafting|Effects of Non Invasive Ventilation on Heart Rate Variability After Coronary Bypass Grafting: Comparison Between Different Ventilator|Completed||Phase 4|10|Actual|Federal University of Uberlandia||2|||f||||t||||||||||2017-10-10 23:37:15.467755|2017-10-10 23:37:15.467755
NCT02352363|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-05-25|||March 2015||2015-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Randomized Safety Study of CVT-301 Compared to an Observational Control Group|A Phase 3, Randomized Study Investigating the Safety of CVT-301 (Levodopa Inhalation Powder) in Parkinson's Disease (PD) Patients With Motor Response Fluctuations (OFF Phenomena) Compared to an Observational Cohort Control|Completed||Phase 3|408|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-10-10 23:37:15.563373|2017-10-10 23:37:15.563373
NCT02352350|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-08-16|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Observational|||Lactate in Cardiac Arrest|The Predictive Value of Prehospital Blood Lactate Measurement Following Out of Hospital Cardiac Arrest (OHCA) and Return of Spontaneous Circulation (ROSC).|Not yet recruiting||N/A|365|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-10 23:37:15.972204|2017-10-10 23:37:15.972204
NCT02352337|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-02-20|||December 23, 2014|Actual|2014-12-23|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|PANOPTIMOX||First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem|Randomised Phase II Study in Metastatic Pancreatic Cancer Evaluating FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem in First-line|Active, not recruiting||Phase 2|276|Actual|Federation Francophone de Cancerologie Digestive||3|||f||||t||||||||Undecided||2017-10-10 23:37:16.077524|2017-10-10 23:37:16.077524
NCT02352324|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-01-27|||June 2014||2014-06-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Cardiac Output Monitoring With Estimated Continuous Cardiac Output (esCCO) vs. Transpulmonary Thermodilution (TPTD)|Continuous Cardiac Output Monitoring Using esCCO: a Validation vs. Transpulmonary Thermodilution in Off-pump Coronary Artery Bypass Grafting|Completed||N/A|20|Actual|Northern State Medical University||1|||f||||f||||||||||2017-10-10 23:37:16.288582|2017-10-10 23:37:16.288582
NCT02352311|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-02-01|||January 2015||2015-01-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Safety and Pharmacokinetic Characteristics of DKF-313|A Randomized, Open-label, Single-dose, 2-treatment, 2-way, 2-period Crossover Study to Evaluate the Safety and the Pharmacokinetic Characteristics of DKF-313 in Healthy Male Volunteers|Unknown status|Recruiting|Phase 1|54|Anticipated|Dongkook Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:37:16.378696|2017-10-10 23:37:16.378696
NCT02352298|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-05-05|2015-03-19||February 2015||2015-02-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude|Protocol for the Evaluation of Dario™ Blood Glucose Monitor (BGMS) Performance at Elevated Altitude|Completed||N/A|52|Actual|LabStyle Innovations Ltd.||2|||f||||f||||||||No||2017-10-10 23:37:16.486076|2017-10-10 23:37:16.486076
NCT02352285|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-06-12|||December 2012|Actual|2012-12-01|November 2016|2016-11-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|AQUATIC||Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure|Assessment of Clinical Outcome and Treatment Quality Under Adequate Use of Tolvaptan In Correction of Hyponatremia in Patients Hospitalized With Worsening Heart Failure and Hyponatremia|Terminated||Phase 4|58|Actual|Korea Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:37:16.70059|2017-10-10 23:37:16.70059
NCT02352272|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-27|||January 2014||2014-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|BankingSleep||Benefits of Sleep Extension on Performances During Total Sleep Deprivation (BankingSleep)|Benefits of Sleep Extension on Cognitive and Physical Performances During Baseline, Total Sleep Deprivation and Recovery (BankingSleep)|Completed||N/A|14|Actual|Institut de Recherche Biomedicale des Armees||2|||f||||t||||||||||2017-10-10 23:37:16.792764|2017-10-10 23:37:16.792764
NCT02352259|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-01-27|||September 2013||2013-09-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II|Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II|Unknown status|Recruiting|Phase 2|15|Anticipated|Institute of Oncology Ljubljana||1|||f||||t||||||||||2017-10-10 23:37:16.898686|2017-10-10 23:37:16.898686
NCT02352246|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-30|||February 2015||2015-02-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||HIIE and Abdominal Fat Mass in DT2 Postmenopausal Women|Effect of High-Intensity Intermittent Exercise on Abdominal Fat Mass in Type 2 Diabetes Postmenopausal Women.|Not yet recruiting||N/A|30|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:37:17.028246|2017-10-10 23:37:17.028246
NCT02351830|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-04-20|||January 2015||2015-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Clinical Validation of Birch Pollen in the EEU|Controlled Birch Pollen Challenge in the Environmental Exposure Unit (EEU); Clinical Validation and Biomarker Exploration|Completed||N/A|59|Actual|Queen's University|||||f||||f||||||||||2017-10-10 23:37:20.991497|2017-10-10 23:37:20.991497
NCT02352233|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-01-27|||January 2014||2014-01-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Observational|REVCOR||Retroview Colonoscope for the Evaluation of Colon Mucosa Study|Pentax Retroview Colonoscope for the Evaluation of Colon Mucosa in Forward and Retro Viewing: a Safety and Feasibility Pilot Study|Completed||N/A|48|Actual|Instituto Ecuatoriano de Enfermedades Digestivas|||1||f||||t||||||Samples Without DNA|"     biopsies, tissue from colonic mucosa: inflammatory, polyps   "|||2017-10-10 23:37:17.13783|2017-10-10 23:37:17.13783
NCT02352220|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-08-25|||January 2015||2015-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|EARLY COPD||Determinants of Onset and Progression of COPD in Young Adults|Early COPD: Determinants of Onset and Progression of COPD in Young Adults|Active, not recruiting||N/A|310|Actual|Hospital Son Espases|||1||f||||||||||||||2017-10-10 23:37:17.222225|2017-10-10 23:37:17.222225
NCT02352207|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-06-30|||March 2015||2015-03-01|June 2016|2016-06-01|January 2021|Anticipated|2021-01-01|July 2020|Anticipated|2020-07-01||Observational|MALFPULM||Risk Factors of Neonatal Respiratory Distress for Newborns With Prenatally Diagnosed Congenital Lung Malformations|Prospective Identification of Predictors of Neonatal Respiratory Distress for Newborns With Prenatally Diagnosed Congenital Lung Malformations : A Population-based, Nationally Representative Study|Recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     A portion of tissue malformation   "|||2017-10-10 23:37:17.288219|2017-10-10 23:37:17.288219
NCT02352194|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-27|||July 2014||2014-07-01|May 2014|2014-05-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Observational|REHABSEP||Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis|Observational Study of the Physical Capacity of Patients With Multiple Sclerosis and Evaluation of the Effects of Usual Rehabilitation in the Day Hospital|Unknown status|Recruiting|N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 23:37:17.364403|2017-10-10 23:37:17.364403
NCT02352181|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-01-04|||December 2014||2014-12-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.|Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.|Completed||N/A|82|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:37:17.460281|2017-10-10 23:37:17.460281
NCT02352168|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-08-15|||September 2014||2014-09-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Airway Inflammation in Children With Allergic Rhinitis and Intervention|To Evaluate Airway Inflammation in Children With Allergic Rhinitis and To Examine the Effects of Nasal Corticosteroids Therapy on Lower Airway Inflammation of Rhinitis.|Completed||N/A|60|Actual|Guangzhou Institute of Respiratory Disease||2|||f||||f||||||||||2017-10-10 23:37:17.535958|2017-10-10 23:37:17.535958
NCT02352155|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-04-06|||February 2015||2015-02-01|January 2016|2016-01-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes|Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes|Recruiting||N/A|314|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||No||2017-10-10 23:37:17.623817|2017-10-10 23:37:17.623817
NCT02352142|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-09-23|||January 2015||2015-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Family Nurture Intervention in the CHoNJ NICU|Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit|Terminated||N/A|54|Actual|Columbia University||3||insufficient enrollment numbers|f||||f||||||||||2017-10-10 23:37:17.714106|2017-10-10 23:37:17.714106
NCT02352129|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-07-26|||December 2011||2011-12-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy|Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy|Recruiting||N/A|330|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:37:17.807838|2017-10-10 23:37:17.807838
NCT02352116|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-07-25|||June 2013||2013-06-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Post-PACU Pain Management in Pediatric Surgery|Evaluation of Post-PACU Pain Management Experiences in Pediatric Ambulatory Surgery Patients|Recruiting||N/A|900|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-10 23:37:17.883411|2017-10-10 23:37:17.883411
NCT02352103|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-15|||January 2015||2015-01-01|August 2017|2017-08-01|May 2027|Anticipated|2027-05-01|May 2016|Actual|2016-05-01||Interventional|||Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery|The Impact of Retzius-sparing Approach for Robot-assisted Laparoscopic Radical Prostatectomy on Short-term Continence Recovery: Randomized Controlled Trial|Active, not recruiting||Phase 3|120|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-10-10 23:37:18.001354|2017-10-10 23:37:18.001354
NCT02352090|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-02-23|||February 2015||2015-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SYLVI||Synthetic vs Natural Estrogen in Combined Oral Contraception|Synthetic vs Natural Estrogen in Combined Oral Contraception- Effect on Insulin Sensitivity, Coagulation, Inflammation and Endometrium - a Comparison With a Progestin-only Preparation.|Recruiting||Phase 4|60|Anticipated|Helsinki University Central Hospital||3|||f||||t||||||||||2017-10-10 23:37:18.17534|2017-10-10 23:37:18.17534
NCT02352077|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-10-08|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||NeuroRegen Scaffold™ With Stem Cells for Chronic Spinal Cord Injury Repair|Safety and Efficacy of NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells or Mesenchymal Stem Cells for Chronic Spinal Cord Injury Repair|Enrolling by invitation||Phase 1|30|Actual|Chinese Academy of Sciences||1|||f||||f||||||||||2017-10-10 23:37:18.311167|2017-10-10 23:37:18.311167
NCT02352064|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-01-31|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|TEP-GVH||Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)|EVALUATION OF THE DIAGNOSTIC VALUE OF PET (18F-FDG) IN CHRONIC GRAFT VERSUS HOST DISEASE (cGVH)|Recruiting||N/A|26|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:37:18.409198|2017-10-10 23:37:18.409198
NCT02352051|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-30|||February 2014||2014-02-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effects of Atx and Oros-mph on Executive Functions|Effects of Atomoxetine and Oros-mph on Executive Functions in Patients With Combined Type Attention Deficit Hyperactivity Disorder|Completed||Phase 4|43|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-10 23:37:18.491252|2017-10-10 23:37:18.491252
NCT02352038|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-05-12|||April 2014||2014-04-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Randomized Controlled Trial of a Novel Laser-aided Orthodontic-periodontal Treatment Strategy|Randomized Controlled Trial of a Novel Laser-aided Orthodontic-periodontal Treatment Strategy|Recruiting||N/A|35|Anticipated|The University of Hong Kong||2|||f||||t||||||||Undecided|The sharing of individual participant data has not been decided yet.|2017-10-10 23:37:18.573068|2017-10-10 23:37:18.573068
NCT02352025|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-09-15|||April 15, 2015|Actual|2015-04-15|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||S-equol in Women With Triple Negative Breast Cancer|A Pre-surgical Clinical Trial of Therapy With S-equol in Women With Triple Negative Breast Cancer.|Recruiting||Early Phase 1|45|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-10 23:37:18.652702|2017-10-10 23:37:18.652702
NCT02352012|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-01-04|||February 2015||2015-02-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|February 2015|Actual|2015-02-01||Interventional|||Interventional Treatment of Refractory Pneumothorax by Bronchoscope|A Multi-site Randomized Controlled Study of Interventional Treatment of Refractory Pneumothorax by Bronchoscope|Recruiting||N/A|269|Anticipated|Tang-Du Hospital||3|||f||||t||||||||||2017-10-10 23:37:18.733377|2017-10-10 23:37:18.733377
NCT02351999|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-04-21|||February 2015||2015-02-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Clinical Study of the TSP Crosser System for Transseptal Access and Left Atrial Catheter Navigation|Clinical Study of the TSP Crosser System For Transseptal Access and Left Atrial Catheter Navigation in Patients Undergoing Atrial Fibrillation Ablation|Recruiting||N/A|30|Anticipated|Transseptal Solutions Ltd.||1|||f||||f||||||||Undecided||2017-10-10 23:37:18.848086|2017-10-10 23:37:18.848086
NCT02351986|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-03-21|||June 2014||2014-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Effects of Cryotherapy on Joint Function and Pressure Pain Threshold in Patients With Subacromial Impingement Syndrome.|Effects of Cryotherapy on Inflammatory Mediators, Joint Function and Pressure Pain Threshold in Patients With Subacromial Impingement Syndrome.|Completed||N/A|30|Actual|Universidade Federal de Sao Carlos||2|||f||||||||||||||2017-10-10 23:37:18.938849|2017-10-10 23:37:18.938849
NCT02351973|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-07-01|||November 2009||2009-11-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|PATHWAY3||Comparison of Single and Combination Diuretics in Low-Renin Hypertension|Comparison of Single and Combination Diuretics in Low-Renin Hypertension|Unknown status|Active, not recruiting|Phase 4|423|Actual|University of Cambridge||3|||f||||t||||||||||2017-10-10 23:37:19.033328|2017-10-10 23:37:19.033328
NCT02351960|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-05-12|2017-05-12||March 19, 2015|Actual|2015-03-19|May 2017|2017-05-01|July 13, 2016|Actual|2016-07-13|June 22, 2016|Actual|2016-06-22||Interventional||Safety analysis set (SAF) included all participants who received at least 1 dose of study drug.|Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease|A Phase 4, Open-Label Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole|Completed||Phase 4|296|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:37:19.163336|2017-10-10 23:37:19.163336
NCT02351947|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-03-16|||January 2010||2010-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Structural and Functional Brain Changes in Response to Post-Stroke Rehabilitation|Structural and Functional Brain Changes in Response to Post-Stroke Rehabilitation|Active, not recruiting||N/A|24|Anticipated|Louis Stokes VA Medical Center||2|||f||||f||||||||||2017-10-10 23:37:19.882821|2017-10-10 23:37:19.882821
NCT02351934|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-08-28|2017-06-02||February 2015|Actual|2015-02-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Intention to treat analysis|Early Diuresis Following Colorectal Surgery|A Prospective, Randomized Study Evaluating the Efficacy and Safety of Early Diuresis Following Colorectal Surgery|Completed||Phase 4|123|Actual|Mayo Clinic||2|||f||||f|t|f||||||||2017-10-10 23:37:19.985668|2017-10-10 23:37:19.985668
NCT02351921|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-01-29|||February 2015||2015-02-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Repetitive Transcranial Magnetic Stimulation in Individuals With Spinal Cord Injury: A Pilot Study|Repetitive Transcranial Magnetic Stimulation in Individuals With Spinal Cord Injury: A Pilot Study|Unknown status|Not yet recruiting|N/A|20|Anticipated|McMaster University||3|||f||||f||||||||||2017-10-10 23:37:20.369359|2017-10-10 23:37:20.369359
NCT02351908|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-06-26|||March 2015||2015-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2016|Actual|2016-04-01||Interventional|||Renal Integrase Study|A Phase IV, Open-label Three-arm Study Investigating the Impact of a Combination of Tenofovir Disoproxil Fumarate/Emtricitabine With Raltegravir or Dolutegravir or Elvitegravir/Cobicistat on Renal Tubular Function and Renal Transporters in HIV-1 Antiretroviral naïve Patients|Completed||Phase 4|60|Actual|St Stephens Aids Trust||3|||f||||f||||||||||2017-10-10 23:37:20.44543|2017-10-10 23:37:20.44543
NCT02351895|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-08-04|||January 2014||2014-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Effect of Copper Impregnated Textiles on Healthcare Associated Infections and Antibiotic Use|Effect of Copper Impregnated Textiles on Healthcare Associated Infections and Antibiotic Use in a Single Intensive Care Unit|Completed||N/A|1302|Actual|Eastern Virginia Medical School|||1||f||||f||||||||||2017-10-10 23:37:20.534796|2017-10-10 23:37:20.534796
NCT02351882|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-10-04|||January 2015||2015-01-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety and Efficacy of Nabilone in Alzheimer's Disease|Safety and Efficacy of Nabilone in Alzheimer's Disease: a Pilot Study|Recruiting||Phase 2/Phase 3|40|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-10 23:37:20.62101|2017-10-10 23:37:20.62101
NCT02351869|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-01-23|||August 2015||2015-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolar Disorder|Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolar Disorder|Recruiting||Phase 2|40|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-10 23:37:20.710424|2017-10-10 23:37:20.710424
NCT02351804|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-08-31|||February 2015||2015-02-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Does Perineural Dexamethasone Prolong Duration of a Nerve Block?|Does Perineural Dexamethasone Prolong Duration of an Adductor Canal Block When Controlling for a Systemic Effect? A Paired, Randomized, Blinded, Study in Healthy Volunteers|Completed||Phase 2|20|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:37:21.40084|2017-10-10 23:37:21.40084
NCT02351791|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-08-06|||February 2015||2015-02-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||An Exploratory Study Investigating Human Skin Reaction to Output|An Exploratory Study Investigating Human Skin Reaction to Output|Completed||N/A|24|Actual|Coloplast A/S||2|||f||||||||||||||2017-10-10 23:37:21.503108|2017-10-10 23:37:21.503108
NCT02351778|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2015-01-29|||January 2014||2014-01-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|||Quality of Life of Stable Stroke Survivors in Pakistan|Quality of Life of Stable Stroke Survivors and Their Caregivers in an Low and Middle Income Country|Completed||N/A|350|Actual|Aga Khan University|||1||f||||f||||||||||2017-10-10 23:37:21.62024|2017-10-10 23:37:21.62024
NCT02351765|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-07-24|||January 2016||2016-01-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|ABC-08||ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers|A Phase Ib, Multi-centre, Open-label Study of a First-in-class Nucleotide Analogue Acelarin (NUC-1031) in Combination With Cisplatin in Patients With Locally Advanced/Metastatic Biliary Tract Cancers|Recruiting||Phase 1|24|Anticipated|The Christie NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 23:37:21.684155|2017-10-10 23:37:21.684155
NCT02351752|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-12-15|||January 2015||2015-01-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study|Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease|Completed||Phase 4|20|Actual|Peking University First Hospital||1|||f||||f||||||||||2017-10-10 23:37:21.825688|2017-10-10 23:37:21.825688
NCT02351739|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-28|2017-09-11|||April 2015||2015-04-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|KEYNOTE143||Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer|Randomized Phase 2 Trial of ACP-196 and Pembrolizumab Immunotherapy Dual CHECKpoint Inhibition In Platinum Resistant Metastatic Urothelial Carcinoma (RAPID CHECK Study)|Active, not recruiting||Phase 2|75|Actual|Acerta Pharma BV||2|||f||||t||||||||||2017-10-10 23:37:21.916485|2017-10-10 23:37:21.916485
NCT02351726|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-05-29|||March 2015||2015-03-01|May 2017|2017-05-01|December 2024|Anticipated|2024-12-01|October 2024|Anticipated|2024-10-01||Interventional|||Mitroflow DL Post Approval Study- North America|Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study|Active, not recruiting||N/A|186|Actual|Sorin Group USA, Inc.||1|||f||||t||||||||||2017-10-10 23:37:22.020768|2017-10-10 23:37:22.020768
NCT02351713|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-01-30|||May 2014||2014-05-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of Exercise Intensity Prescription|Is a Threshold-Based Model a Superior Method to the Relative Percent Concept for Establishing Individual Exercise Intensity? A Randomized Controlled Trial|Completed||Phase 2|42|Actual|Western State Colorado University||3|||f||||f||||||||||2017-10-10 23:37:22.123292|2017-10-10 23:37:22.123292
NCT02351687|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-11-09|||April 2014||2014-04-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Package of Interventions After Recovering From Moderate Acute Malnutrition|Randomized Controlled Trial of the Impact of Offering a Nutrition and Health Intervention to Children Recovered From Moderate Acute Malnutrition|Completed||N/A|1499|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:37:22.306809|2017-10-10 23:37:22.306809
NCT02351674|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-01-27|||January 2015||2015-01-01|January 2015|2015-01-01||||September 2015|Anticipated|2015-09-01||Observational|||Retrospective Cohort Study on Post Analysis on the Link Between the Clinical Heart Rate and Outcomes During PCI|A Single Centre, Retrospective Cohort Study on Post Analysis on the Link Between the Clinical Heart Rate and Outcomes During PCI|Unknown status|Not yet recruiting|N/A|15000|Anticipated|Chinese PLA General Hospital|||4||f||||f||||||||||2017-10-10 23:37:22.410934|2017-10-10 23:37:22.410934
NCT02351661|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-01-27|||August 2010||2010-08-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|CMTF||The Nutrition Care in Canadian Hospitals Study; 2010-2013.|The Nutrition Care In Canadian Hospitals Study: 2010-2013|Completed||N/A|1022|Actual|Canadian Malnutrition Task Force|||1||f||||f||||||||||2017-10-10 23:37:22.489498|2017-10-10 23:37:22.489498
NCT02351648|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-01-29|||October 2012||2012-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Randomised Control Trial of a Transitional Care Model in Singapore General Hospital|A Randomised Control Trial of a Transitional Care Model in Singapore General Hospital|Completed||N/A|840|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-10-10 23:37:22.552307|2017-10-10 23:37:22.552307
NCT02351635|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-07-12|||January 2015||2015-01-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS|Clinical Study of the BÜHLMANN fCAL™ ELISA as an Aid in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome|Recruiting||N/A|390|Anticipated|Bühlmann Laboratories AG|||5||f||||f||||||Samples With DNA|"     Stool samples collected before start of specific medication   "|||2017-10-10 23:37:22.637685|2017-10-10 23:37:22.637685
NCT02351622|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-04-18|||September 2012||2012-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Caffeic Acid Tablets as a Second-line Therapy for ITP|A Multicentre Randomized Study of Caffeic Acid Tablets as a Second-line Therapy for the Treatment of Immune Thrombocytopenia (ITP)|Completed||Phase 3|103|Actual|Shandong University||2|||f||||t||||||||||2017-10-10 23:37:22.760493|2017-10-10 23:37:22.760493
NCT02351609|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-10-04|||May 1, 2015|Actual|2015-05-01|October 2017|2017-10-01|October 1, 2017|Actual|2017-10-01|March 3, 2017|Actual|2017-03-03||Interventional|||Patient Navigation and Financial Incentives to Promote Smoking Cessation|Patient Navigation and Financial Incentives to Promote Smoking Cessation|Completed||N/A|352|Actual|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-10 23:37:22.853374|2017-10-10 23:37:22.853374
NCT02351596|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-02-02|||August 2014||2014-08-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|April 2015|Anticipated|2015-04-01||Interventional|||Do Core Stability Exercise Classes Help Children With Cerebral Palsy Improve Their Balance|The Effect of a 'Core Stability' Physiotherapy Group Intervention Programme on Balance in Ambulant Children With Cerebral Palsy: A Randomised Control Trial|Unknown status|Recruiting|N/A|48|Anticipated|Royal College of Surgeons, Ireland||4|||f||||f||||||||||2017-10-10 23:37:22.982711|2017-10-10 23:37:22.982711
NCT02351583|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-05-03|||January 2015||2015-01-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Microcirculatory and Tissue and Cerebral Oxygenation in Preeclampsia and Normal Pregnancy: An Observation Study|Microcirculatory and Tissue and Cerebral Oxygenation Differences Between Preeclampsia and Normal Pregnancy: An Observation Study|Recruiting||N/A|20|Anticipated|University of Virginia|||2||f||||f||||||||No||2017-10-10 23:37:23.105988|2017-10-10 23:37:23.105988
NCT02351570|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-01-29|||November 2010||2010-11-01|January 2015|2015-01-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Observational|||Health Prevention Programmes to Patients Through Their General Practitioners|Offer and Mediation of §20 SGB V Health Prevention Programmes to Patients Through Their Treating General Practitioner - a Mixed Methods Study|Completed||N/A|474|Actual|Berlin School of Public Health|||1||f||||f||||||||||2017-10-10 23:37:23.203864|2017-10-10 23:37:23.203864
NCT02351557|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-02-01|||October 2013||2013-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Pharmacokinetic Study of Effect of Cardiac Output on the Uptake of Isoflurane|Effect of Cardiac Output on Uptake of Isoflurane|Completed||N/A|33|Actual|Postgraduate Institute of Medical Education and Research|||2||f||||t||||||||||2017-10-10 23:37:23.266422|2017-10-10 23:37:23.266422
NCT02351544|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-01-14|||September 2015||2015-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches||Recruiting||N/A|100|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-10 23:37:23.338006|2017-10-10 23:37:23.338006
NCT02351531|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-01-27|||November 2013||2013-11-01|January 2015|2015-01-01||||December 2014|Actual|2014-12-01||Interventional|COMETE||Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy|Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy|Completed||Phase 3|32|Actual|United Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:37:23.465196|2017-10-10 23:37:23.465196
NCT02351518|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-10-03|||November 2015||2015-11-01|October 2017|2017-10-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Cerebral Autoregulation and Vasospasm in Patients With TBI|Cerebral Autoregulation and Vasospasm in Patients With Traumatic Brain Injury|Completed||N/A|25|Actual|University of Maryland|||1||f||||f||||||||||2017-10-10 23:37:23.548749|2017-10-10 23:37:23.548749
NCT02351505|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-05-12|2016-03-21||May 2015||2015-05-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer|An Investigator-Sponsored Phase 2 Study of Single Agent Selinexor (KPT-330) in Patients With Relapsed Small Cell Lung Cancer|Terminated||Phase 2|1|Actual|Ohio State University Comprehensive Cancer Center|Trial was closed early due to slow accrual.|1||Low patient accrual|f||||t||||||||||2017-10-10 23:37:23.624149|2017-10-10 23:37:23.624149
NCT02351479|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-11-07|||September 2013||2013-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hula, a Physical Activity Intervention for Female-Cancer Survivors|Hula, a Physical Activity Intervention for Female-Cancer Survivors|Active, not recruiting||N/A|73|Actual|University of Hawaii||1|||f||||t||||||||No||2017-10-10 23:37:24.06365|2017-10-10 23:37:24.06365
NCT02351466|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-06-05|||March 2015||2015-03-01|June 2015|2015-06-01||||June 2019|Anticipated|2019-06-01||Observational|||Type 1 Diabetes and the Brain in Children|Type 1 Diabetes and the Brain in Children: Metabolic Interventions. Protocol #1: Longitudinal Assessment|Enrolling by invitation||N/A|220|Anticipated|Nemours Children's Clinic|||2||f||||t||||||||||2017-10-10 23:37:24.162872|2017-10-10 23:37:24.162872
NCT02351453|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-29|||August 2011||2011-08-01|November 2011|2011-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study)|Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study)|Completed||N/A|207|Actual|University Hospital, Angers|||1||f||||f||||||||||2017-10-10 23:37:24.255496|2017-10-10 23:37:24.255496
NCT02351440|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-04-22|||April 2016||2016-04-01|April 2016|2016-04-01||||August 2017|Anticipated|2017-08-01||Interventional|||Effect of Preoperative Duloxetine on Quality of Recovery After Outpatient Laparoscopic Surgery|Effect of Preoperative Duloxetine on Quality of Recovery After Outpatient Laparoscopic Surgery|Recruiting||Phase 4|70|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:37:24.310923|2017-10-10 23:37:24.310923
NCT02351427|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-02-03|||February 2015||2015-02-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation|Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney|Unknown status|Recruiting|Phase 3|30|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-10 23:37:24.383202|2017-10-10 23:37:24.383202
NCT02351414|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-06-02|||June 15, 2015|Actual|2015-06-15|June 2017|2017-06-01|December 2028|Anticipated|2028-12-01|June 2027|Anticipated|2027-06-01||Observational|AMETHYST||Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts|Post Market Clinical Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts|Recruiting||N/A|150|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||No||2017-10-10 23:37:24.464415|2017-10-10 23:37:24.464415
NCT02351401|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-27|||November 2011||2011-11-01|January 2015|2015-01-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Interventional|RAEUS||Rheumatoid Arthritis Through Education and US Study (RAEUS)|Improvement in Patient Awareness and Ability to Assess Disease in Rheumatoid Arthritis: Rheumatoid Arthritis Through Education and US Study (RAEUS)|Completed||N/A|101|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-10 23:37:24.558328|2017-10-10 23:37:24.558328
NCT02351388|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-01-03|||December 2014||2014-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|ADAPT||Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research|Ameliorating Depression in Alzheimer's Disease Patients by Transcranial Direct Current Stimulation (ADAPT) - Preliminary Research|Recruiting||Phase 1/Phase 2|20|Anticipated|National Center of Neurology and Psychiatry, Japan||2|||f||||t||||||||||2017-10-10 23:37:24.629108|2017-10-10 23:37:24.629108
NCT02351375|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-03-02|||November 2014||2014-11-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|MICRO||MICRO-study: The IntelliCap® System as a Gastrointestinal Fluid Sampling Tool|MICRO-study: The IntelliCap® System as a Gastrointestinal Fluid Sampling Tool|Completed||N/A|12|Actual|NIZO Food Research||2|||f||||f||||||||||2017-10-10 23:37:24.733349|2017-10-10 23:37:24.733349
NCT02351362|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-07-11|||February 2015||2015-02-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Voucher Incentive for Improving Retention in Postpartum HIV Care in South Africa|A Pilot Study of a Voucher Incentive System for Improving Retention in Postpartum HIV Care in South Africa|Active, not recruiting||N/A|100|Actual|Boston University||2|||f||||f|f|f||||||||2017-10-10 23:37:25.614366|2017-10-10 23:37:25.614366
NCT02351349|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-10-06|||January 2016||2016-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|FRED-CKD||Chronic Kidney Disease Among Frail Elderly|MULTIDISCIPLINARY INTERVENTION FOR FRAIL ELDERLY PATIENTS WITH STAGE 4 or 5 Chronic Kidney Disease (Not on Dialysis)|Recruiting||N/A|110|Anticipated|McGill University Health Center||2|||f||||f||||||||No||2017-10-10 23:37:25.720229|2017-10-10 23:37:25.720229
NCT02351336|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-02-15|||August 2014||2014-08-01|February 2015|2015-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||Fetal Adrenal Gland Volume Estimation Compared to Cervical Length Assessment in Prediction of Preterm Birth|Three - Dimensional Ultrasound Estimation of Fetal Adrenal Gland Enlargement Compared to Assessment of Cervical Changes Alone & Prediction of Impending Preterm Birth|Unknown status|Recruiting|N/A|78|Anticipated|Ain Shams Maternity Hospital|||1||f||||t||||||||||2017-10-10 23:37:25.854677|2017-10-10 23:37:25.854677
NCT02351323|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-01-27|||May 2010||2010-05-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Novel Type 2 Diabetes Mellitus Preventive Therapies|Novel Type 2 Diabetes Mellitus Preventive Therapies|Completed||Phase 1|12|Actual|Boston Medical Center||2|||f||||t||||||||||2017-10-10 23:37:25.978111|2017-10-10 23:37:25.978111
NCT02351310|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-03-11|||November 2015||2015-11-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effectiveness of ACS in Extreme Preemies|Effects of Antenatal Corticosteroids in Patients With Early (22 - 23w6d) Threatened Preterm Birth|Withdrawn||Phase 3|0|Actual|Mednax Center for Research, Education and Quality||2||Company decided not to pursue this study.|f||||t||||||||No||2017-10-10 23:37:26.090829|2017-10-10 23:37:26.090829
NCT02351297|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-01-20|||January 2015||2015-01-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effects of High Protein Diet on the Large Intestine in Overweight Humans|Effects of High Protein Diet on the Large Intestine in Overweight Humans|Completed||N/A|42|Actual|Hospital Avicenne||3|||f||||f||||||||||2017-10-10 23:37:26.196087|2017-10-10 23:37:26.196087
NCT02351284|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-07-19|||June 2016||2016-06-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01|18 Months|Observational [Patient Registry]|PuraVIHta||Impact of Hypovitaminosis D on Bone Disease in HIV Infected Patients|Impact of Hypovitaminosis D in Metabolic Disturbances and Bone Metabolism, and Changes in Patients Receiving Vitamin D Supplementation|Active, not recruiting||N/A|300|Anticipated|Asociacion para el Estudio de las Enfermedades Infecciosas|||1||f||||f||||||||||2017-10-10 23:37:26.304312|2017-10-10 23:37:26.304312
NCT02351258|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-10-02|||November 2015||2015-11-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CCLIP||Community Central Line Infection Prevention Trial|Community Central Line Infection Prevention Trial|Active, not recruiting||N/A|10000|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:37:26.512707|2017-10-10 23:37:26.512707
NCT02351232|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2016-10-20|||February 2015||2015-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Lira Pump Trial|The Lira Pump Trial. The Effects of Liraglutide in Patients With Insulin Pump Treated Type 1 Diabetes: A Randomized Placebo-Controlled Trial|Completed||Phase 2/Phase 3|44|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 23:37:26.753474|2017-10-10 23:37:26.753474
NCT02351219|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-27|||December 2012||2012-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|FLAP||FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer|Phase II Study of FOLFOXIRI as Primary Treatment for Stage III Unresectable Locally Advanced Pancreatic Cancer|Completed||Phase 2|50|Actual|Azienda Ospedaliero, Universitaria Pisana||1|||f||||f||||||||||2017-10-10 23:37:26.86445|2017-10-10 23:37:26.86445
NCT02351206|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-01-29|||January 2010||2010-01-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|||Lumbar Disc Space Height in Young Disc Herniation and Degeneration Patients|Lumbar Intervertebral Disc Space Height in Disc Herniation and Degeneration Patients in Their Early 20s|Completed||N/A|389|Actual|Jaseng Hospital of Korean Medicine|||2||f||||f||||||||||2017-10-10 23:37:26.96347|2017-10-10 23:37:26.96347
NCT02351193|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-01-30|||January 2011||2011-01-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||a Predictive Scheme for Poor Responders in IVF Cycles|A Predictive Scheme to Assess the Outcome of IVF/ICSI Cycles in Poor Responders. an Observational Study in Egypt|Completed||N/A|928|Actual|Woman's Health University Hospital, Egypt|||2||f||||f||||||||||2017-10-10 23:37:27.060565|2017-10-10 23:37:27.060565
NCT02351180|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-02-13|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients|A Randomized Placebo Controlled Trial of Inhaled Beclomethasone After Community-acquired Respiratory Viral Infection in Lung Transplant Recipients|Recruiting||Phase 1/Phase 2|80|Anticipated|Washington University School of Medicine||2|||f||||f|t|f|||f|||No|There is no plan to share IPD|2017-10-10 23:37:27.150295|2017-10-10 23:37:27.150295
NCT02351167|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-09-20|||May 2015||2015-05-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|GISC||Genetically Informed Smoking Cessation Trial|Genetically Informed Smoking Cessation Trial|Recruiting||Phase 4|720|Anticipated|Washington University School of Medicine||3|||f||||t||||||||||2017-10-10 23:37:27.294375|2017-10-10 23:37:27.294375
NCT02351154|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-01-29|||September 2014||2014-09-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Grading Atrophic Gastritis by Confocal Laser Endomicroscopy Probe (p-CLE)|Grading Atrophic Gastritis by a New Quantitative Method Using Confocal Laser Endomicroscopy Probe (p-CLE): First Results of a Prospective Cohort Study|Completed||N/A|30|Actual|Instituto Ecuatoriano de Enfermedades Digestivas||1|||f||||t||||||||||2017-10-10 23:37:27.407698|2017-10-10 23:37:27.407698
NCT02351141|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-05-08|||January 2015||2015-01-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Structure and Function MRI of Asthma|Structure and Function MRI of Asthma|Recruiting||N/A|120|Anticipated|Western University, Canada||1|||f||||f||||||||||2017-10-10 23:37:27.503107|2017-10-10 23:37:27.503107
NCT02351128|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-02-21|||April 2015||2015-04-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|PHRC-Merkel||Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues|Traitement Des Carcinomes à Cellules de Merkel inopérables et/ou métastatiques Par Analogue de la Somatostatine - Etude Nationale Multicentrique Mono-bras de Phase II.|Recruiting||Phase 2|35|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 23:37:27.604818|2017-10-10 23:37:27.604818
NCT02351115|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-03-13|||January 2015||2015-01-01|January 2016|2016-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Staccato Alprazolam and Photoparoxysmal Response|Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy|Completed||Phase 2|5|Actual|Alexza Pharmaceuticals, Inc.||5|||f||||f|t|f||||||Yes|IPD submitted to regulatory authorities. Others may contact Alexza Pharmaceuticals, Inc. Please send your request to ClinicalTrialsInfo@alexza.com|2017-10-10 23:37:27.717884|2017-10-10 23:37:27.717884
NCT02351102|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2017-04-12|||November 2015||2015-11-01|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|April 2020|Anticipated|2020-04-01||Interventional|||Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy|Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy|Recruiting||Phase 2/Phase 3|100|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:37:27.820242|2017-10-10 23:37:27.820242
NCT02351089|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-11-28|||February 2015||2015-02-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|ProRad||Probiotics in Radiation-treated Gynecologic Cancer|Probiotics in Radiation-treated Gynecologic Cancer|Recruiting||N/A|200|Anticipated|Probi AB||3|||f||||t||||||||||2017-10-10 23:37:27.915542|2017-10-10 23:37:27.915542
NCT02351076|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-09-07|||August 2014||2014-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Observational|||Correlation of Right-left Shunt Detection in Cardioembolism Etiology in Stroke Patient.|Correlation of Right-left Shunt Detection in Cardioembolism Etiology in Stroke Patient. Pilot Study.|Completed||N/A|44|Actual|University Hospital Ostrava|||1||f||||f||||||||No||2017-10-10 23:37:27.984867|2017-10-10 23:37:27.984867
NCT02351063|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-29|||April 2014||2014-04-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|HABIT-II||HF Assessment With BNP in the Home: Part II|HF Assessment With BNP in the Home: Part II|Terminated||N/A|1|Actual|Alere San Diego||1||Sponsor's discretion to terminate study prematurely for further evaluation.|f||||t||||||||||2017-10-10 23:37:28.049506|2017-10-10 23:37:28.049506
NCT02351050|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-07-24|||April 2015||2015-04-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting|Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring|Recruiting||Phase 3|120|Anticipated|University Hospital Ostrava||2|||f||||t||||||||Undecided||2017-10-10 23:37:28.169049|2017-10-10 23:37:28.169049
NCT02351037|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-05-18|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Study of Ibrutinib in Subjects With Acute Myeloid Leukemia|A Multicenter Open-Label Phase 2a Study of Ibrutinib Monotherapy or in Combination With Either Cytarabine or Azacitidine in Subjects With Acute Myeloid Leukemia|Terminated||Phase 2|36|Actual|Pharmacyclics LLC.||3||Study data do not support development in AML.|f||||f||||||||No||2017-10-10 23:37:28.255767|2017-10-10 23:37:28.255767
NCT02351024|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-03-31|||February 2015||2015-02-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase I Study PK Study With OXP005 and Naprosyn|Study to Assess the Comparative Bioavailability and Pharmacokinetics of Naproxen From OXP005 Tablets (Test) And Naprosyn® Tablets (Reference) in Normal, Healthy, Adult Subjects|Completed||Phase 1|||Oxford Pharmascience Ltd||2|||f||||f||||||||||2017-10-10 23:37:28.350874|2017-10-10 23:37:28.350874
NCT02351011|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-01-05|||February 2015||2015-02-01|January 2017|2017-01-01|February 2021|Anticipated|2021-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA|Human Autologous Mesenchymal Stromal Cells for the Treatment of Mid to Late Stage Knee Osteoarthritis|Active, not recruiting||Phase 1/Phase 2|12|Actual|University Health Network, Toronto||3|||f||||t||||||||||2017-10-10 23:37:28.41941|2017-10-10 23:37:28.41941
NCT02350998|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-03-09|||January 2015||2015-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration|A 1-Month, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Trans-Tympanic Tube Administration for Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects With Otitis Media Requiring Tympanostomy Tube Placement|Completed||Phase 3|33|Actual|Otonomy, Inc.||1|||f||||f||||||||||2017-10-10 23:37:28.508861|2017-10-10 23:37:28.508861
NCT02350985|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2015-01-29|||January 2014||2014-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine|Effectivity of Propranolol and Venlafaxine in Treatment of Vestibular Migraine: A Randomized Controlled Clinical Trial|Completed||Phase 4|73|Actual|Haseki Training and Research Hospital||2|||f||||f||||||||||2017-10-10 23:37:28.643468|2017-10-10 23:37:28.643468
NCT02350972|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-26|||July 1978||1978-07-01|January 2015|2015-01-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Inducing Systemic Immunity and Regressions in Metastatic Melanoma|Inducing Systemic Immunity and Regressions in Metastatic Melanoma|Completed||Phase 1|88|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 23:37:28.732876|2017-10-10 23:37:28.732876
NCT02350959|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-10-05|||January 2015||2015-01-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|CITRUS||Adverse Plaque Characteristics in CCTA and TVC Imaging|Evaluation of Adverse Plaque Characteristics in Coronary Computed Tomography Angiography Using Combined Near Infrared Spectroscopy With Intravascular Ultrasound [CITRUS Study]|Unknown status|Recruiting|Phase 4|100|Anticipated|National Health Insurance Service Ilsan Hospital||2|||f||||f||||||||||2017-10-10 23:37:28.797195|2017-10-10 23:37:28.797195
NCT02350946|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-26|||January 2015||2015-01-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Effects of Oxytocin on Emotion Recognition and Response Inhibition|Effects of Oxytocin on Emotion Recognition and Response Inhibition|Unknown status|Recruiting|Phase 2|40|Anticipated|RWTH Aachen University||2|||f||||f||||||||||2017-10-10 23:37:28.88381|2017-10-10 23:37:28.88381
NCT02350933|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-28|||September 2011|Actual|2011-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Endoscopic Evaluation of the Paediatric Airway After Prior Prolonged (>24 h) Tracheal Intubation|Endoscopic Evaluation of the Paediatric Airway After Prior Prolonged (>24 h) Tracheal Intubation|Recruiting||N/A|1000|Anticipated|University Children's Hospital, Zurich||1|||f||||f||||||||||2017-10-10 23:37:28.978397|2017-10-10 23:37:28.978397
NCT02350920|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-05-02|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease|A Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease|Completed||N/A|95|Actual|University College Dublin||2|||f||||t|f|f||||||Yes|Publication in medical journal|2017-10-10 23:37:29.072424|2017-10-10 23:37:29.072424
NCT02350907|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-09-12|||February 2015||2015-02-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Observational|RaDAR-Go||Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea|Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea: RaDAR-Go|Completed||N/A|261|Actual|University of Bern|||1||f||||f||||||Samples With DNA|"     Swabs from the urethra, rectum, oropharynx, vagina and endocervix   "|||2017-10-10 23:37:29.150703|2017-10-10 23:37:29.150703
NCT02350894|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Microstructural Changes in the Brain During Recovery After Mild Traumatic Brain Injury|Microstructural Changes in the Brain During Recovery After Mild Traumatic Brain Injury|Recruiting||N/A|50|Anticipated|University of Aarhus|||1||f||||t||||||||No||2017-10-10 23:37:29.22399|2017-10-10 23:37:29.22399
NCT02350881|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-09-12|2016-05-02||May 2013||2013-05-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Observational||64 patients who received 70 implants (6 bilateral)|Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.|A Post-Market Observational Study to Evaluate Safety and Performance of Primus™ FGT Implant at a Minimum of 5 Years Follow-up|Completed||N/A|70|Actual|Tornier, Inc.|"inclusion of patients from only 1 site, operated by a single surgeon
lack of control group for comparison with another treatment option
inability to compare preoperative and postoperative AOFAS scores"||1||f||||f||||||||||2017-10-10 23:37:29.324536|2017-10-10 23:37:29.324536
NCT02350868|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-06-01|||January 2015||2015-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose-Seeking Study of MPT0E028 in Subjects With Advanced Solid Malignancies Without Standard Treatment|A Phase 1, First-In-Human, Dose-Seeking Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Orally Administered MPT0E028 in Subjects With Advanced Solid Malignancies Without Standard Treatment|Recruiting||Phase 1|30|Anticipated|Taipei Medical University||1|||f||||t||||||||Undecided||2017-10-10 23:37:31.694575|2017-10-10 23:37:31.694575
NCT02350855|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-01-29|||December 2013||2013-12-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Impact of Nutritional Intervention in Indian Female Cancer Cachexia Patients|To Study the Impact of Nutritional Intervention in Delaying the Progression of Cachexia to Refractory Cachexia in Female Cancer Patients: A Study Based in India|Completed||Phase 2|62|Actual|University of Westminster||2|||f||||t||||||||||2017-10-10 23:37:31.804362|2017-10-10 23:37:31.804362
NCT02350842|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-09-12|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|TRIUMPH-CRT||Triple-site Biventricular Stimulation in the Optimization of CRT|Triple-site Biventricular Stimulation in the Optimization of Cardiac Resynchronization Therapy (CRT)|Active, not recruiting||Phase 3|30|Actual|LivaNova||2|||f||||f||||||||||2017-10-10 23:37:31.936073|2017-10-10 23:37:31.936073
NCT02350829|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-04-15|||February 2014||2014-02-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||T1 Mapping of Diffuse Myocardial Fibrosis in Congenital Heart Disease|Quantification of Diffuse Myocardial Fibrosis in Children With Cardiomyopathy or Congenital Heart Disease by T1 Mapping Cardiac Magnetic Resonance|Unknown status|Recruiting|N/A|200|Anticipated|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-10 23:37:32.105887|2017-10-10 23:37:32.105887
NCT02241408|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2017-04-18|||September 2014||2014-09-01|April 2017|2017-04-01||||September 2017|Anticipated|2017-09-01||Observational|||Outcomes Data of Adipose Stem Cells to Treat Osteoarthritis|Autologous Adipose Stromal Vascular Fraction Outcomes in Osteoarthritis Research Study|Recruiting||N/A|50|Anticipated|StemGenex|||1||f||||||||||||||2017-10-11 00:00:47.507022|2017-10-11 00:00:47.507022
NCT02350816|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-03-08|||April 2015||2015-04-01|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.|An Open-Label Extension of Study HGT-SAN-093 Evaluating the Safety and Efficacy Study of HGT-1410 (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Mucopolysaccharidosis Type IIIA Disease|Enrolling by invitation||Phase 2|18|Anticipated|Shire||4|||f||||t||||||||||2017-10-10 23:37:32.22121|2017-10-10 23:37:32.22121
NCT02350803|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-26|||February 2011||2011-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|March 2013|Actual|2013-03-01||Interventional|||Does Use of Rigid Fixation After Removing Distraction Osteogenesis Device Reduce the Relapse?|Dose Use of Rigid Fixation After Removing the Distraction Device Reduce the Anterior-posterior Relapse or Not?|Completed||Phase 2|20|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:37:32.318039|2017-10-10 23:37:32.318039
NCT02350790|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-01-19|||December 2013||2013-12-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Robotic Surgical Management of Endometriosis: Excision Versus Ablation|Robotic Surgical Management of Endometriosis: Excision Versus Ablation With Argon Beam Coagulator (ABC)|Completed||N/A|73|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 23:37:32.389596|2017-10-10 23:37:32.389596
NCT02350777|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-12-13|||January 2015||2015-01-01|December 2016|2016-12-01||||January 2020|Anticipated|2020-01-01||Interventional|||T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation|Phase II Trial of T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|47|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:37:32.581539|2017-10-10 23:37:32.581539
NCT02350764|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-05-09|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs|An Exploratory Study to Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs|Recruiting||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:37:32.673096|2017-10-10 23:37:32.673096
NCT02350751|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-07-10|||January 2015||2015-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MEDI8852||Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults|A Phase 1 Double-blind, Single-dose, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Healthy Adults|Completed||Phase 1|94|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-10 23:37:32.7775|2017-10-10 23:37:32.7775
NCT02350738|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-07-24|||February 2014||2014-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia|Effects of Multimodal Cognitive Enhancement Therapy (MCET) for People With Mild Cognitive Impairment and Early Stage Dementia: a Randomized, Controlled, Double-blind, Cross-over Trial|Completed||Phase 3|64|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-10 23:37:32.871313|2017-10-10 23:37:32.871313
NCT02350725|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-06-30|||December 2014||2014-12-01|December 2014|2014-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|FUROPHARM-HF||Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration|A Single Center, Randomized, Open-label, Cross-over Exploratory Study to Evaluate the Pharmacodynamic and Pharmacokinetic Response to a Subcutaneous Administration or Oral Administration of Furosemide in Subjects With Heart Failure Presenting With Chronic Fluid Overload|Completed||Phase 1/Phase 2|10|Actual|scPharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:37:32.979787|2017-10-10 23:37:32.979787
NCT02350712|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-04-20|||December 2014||2014-12-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer|An Open Label, Phase 1B Safety Evaluation of Patritumab (U31287) in Combination With Cetuximab Plus Platinum Containing Therapy In Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|15|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-10 23:37:33.088434|2017-10-10 23:37:33.088434
NCT02350699|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-03-09|||January 2015||2015-01-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Control Study of Nautilus BrainPulse for the Detection of Concussion|Non Blinded Control Study of High School Athletes in Non Contact Sports|Active, not recruiting||N/A|22|Actual|Jan Medical, Inc.|||1||f||||f||||||||No||2017-10-10 23:37:33.212288|2017-10-10 23:37:33.212288
NCT02350686|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-02-15|||May 14, 2015|Actual|2015-05-14|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy|Phase II Study of Second Line Capecitabine Plus Oxaliplatin (XELOX) in Patients With Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy|Recruiting||Phase 2|67|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:37:33.291766|2017-10-10 23:37:33.291766
NCT02350673|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-09-11|||June 29, 2015|Actual|2015-06-29|September 2017|2017-09-01|December 4, 2018|Anticipated|2018-12-04|December 4, 2018|Anticipated|2018-12-04||Interventional|||A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors|A Phase 1b, Open-Label, Multi-Center, Dose Escalation Study of the Safety, Pharmacokinetics, and Therapeutic Activity of Cergutuzumab Amunaleukin, an Immunocytokine, Which Consists of a Variant of Interleukin 2 (IL 2v), That Targets Carcinoembryonic Antigen (CEA), and Atezolizumab, an Antibody That Targets Programmed Death-Ligand 1 (PD-L1), Administered Intravenously, in Patients With Locally Advanced and/or Metastatic Solid Tumors|Recruiting||Phase 1|75|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:37:33.394445|2017-10-10 23:37:33.394445
NCT02350647|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-04-06|||May 2014||2014-05-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Suture Anchor Comparison in Rotator Cuff Repairs|TWO-ARM, SINGLE BLIND, RANDOMIZED POST-MARKET STUDY ON THE USE OF HEALICOIL™ REGENESORB SUTURE ANCHOR IN THE REPAIR OF TEARS OF THE ROTATOR CUFF|Recruiting||N/A|68|Anticipated|The Hawkins Foundation||2|||f||||f||||||||||2017-10-10 23:37:33.635668|2017-10-10 23:37:33.635668
NCT02350621|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-01-26|||February 2015||2015-02-01|January 2015|2015-01-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Cervical Foraminal Stenosis and Radiculopathy - ACDF Versus Minimal Invasive Posterior Cervical Foraminotomy.|Cervical Foraminal Stenosis and Radiculopathy - Anterior Cervical Discectomy and Fusion (ACDF) Versus Minimal Invasive Posterior Cervical Foraminotomy miPCF).|Not yet recruiting||N/A|80|Anticipated|Stockholm Spine Center AB||2|||f||||f||||||||||2017-10-10 23:37:33.789061|2017-10-10 23:37:33.789061
NCT02350608|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-11-03|||March 2015||2015-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Pulse Waveform and ECG Analysis in Postoperative Cardiac Surgical Patients|Pulse Waveform and ECG Analysis in Postoperative Cardiac Surgical Patients|Completed||N/A|20|Actual|Tampere University Hospital|||1||f||||f||||||||||2017-10-10 23:37:33.871414|2017-10-10 23:37:33.871414
NCT02350595|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-10-28|||August 2011||2011-08-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|FISK2||A Study on the Possible Health Effects of Lean Fish and Fatty Fish Intake in Overweight or Obese Adults|Fiskespisestudiene 2011-2014. Spiseforsøk Med Fisk. Delstudie 2: Studie av Mulige Effekter av Fet og Mager Fisk på Glukosemetabolismen og inflammasjonsmarkører i Overvektige Voksne.|Completed||N/A|76|Actual|University of Bergen||3|||f||||f||||||||||2017-10-10 23:37:33.939664|2017-10-10 23:37:33.939664
NCT02350582|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-07-21|||April 2012||2012-04-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|June 2015|Actual|2015-06-01||Interventional|e-CUIDACHEMO||e-CUIDACHEMO: Telerehabilitation During Chemotherapy in Breast Cancer|e-CUIDACHEMO: Telerehabilitation During Chemotherapy in Breast Cancer Patients|Completed||N/A|60|Actual|Universidad de Granada||2|||f||||f||||||||||2017-10-10 23:37:34.018652|2017-10-10 23:37:34.018652
NCT02350569|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-03-27|2017-03-27||May 22, 2015|Actual|2015-05-22|March 2017|2017-03-01|April 22, 2016|Actual|2016-04-22|March 28, 2016|Actual|2016-03-28||Interventional||Safety Analysis Set: participants who were enrolled into the study and received at least 1 dose of study drug during the Main Study|Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting|A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic HCV for Use in the Peri-Operative Liver Transplantation Setting|Completed||Phase 2|17|Actual|Gilead Sciences||1|||f||||t|t|f||||||||2017-10-10 23:37:34.125911|2017-10-10 23:37:34.125911
NCT02350556|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-05-29|||March 9, 2015|Actual|2015-03-09|May 2017|2017-05-01|November 23, 2016|Actual|2016-11-23|June 3, 2016|Actual|2016-06-03||Interventional|EQHEM||Interest of Evaluating the Movement of the Center of Mass in a Dynamic Avoidance Task as the Endpoint of the Dynamic Equilibrium of Hemiplegic Patients|Interest of Evaluating the Movement of the Center of Mass in a Dynamic Avoidance Task as the Endpoint of the Dynamic Equilibrium of Hemiplegic Patients|Completed||N/A|63|Actual|Rennes University Hospital||2|||f||||||||||||||2017-10-10 23:37:35.575168|2017-10-10 23:37:35.575168
NCT02350543|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-10-08|||February 2015||2015-02-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Peri-operative Aspirin Continuation Versus Discontinuation|Must Aspirin be Discontinued Prior to TURBT: a Prospective, Randomized, Non-inferiority Trial Comparing Peri-operative Aspirin Continuation Versus Discontinuation.|Enrolling by invitation||Phase 4|114|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:37:35.666689|2017-10-10 23:37:35.666689
NCT02350530|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2016-09-19|||January 2015||2015-01-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|FORBES||FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type|A Phase II Study to Evaluate the Surgical Conversion Rate in Patients With RAS Mutation-type Receiving FOLFOXIRI +/- Bevacizumab for Unresectable Colorectal Liver-Limited Metastases|Recruiting||Phase 2|138|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:37:35.776517|2017-10-10 23:37:35.776517
NCT02350517|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2016-11-08|||January 2015||2015-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer|A Phase II Trial of Recombinant Human Endostatin Injection (Endostar) Combined With Paclitaxel and Nedaplatin as First-line Therapy in Treating Patients With Recurrent or Metastatic Esophageal Cancer|Recruiting||Phase 2|52|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 23:37:35.884927|2017-10-10 23:37:35.884927
NCT02350504|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2015-06-18|||December 2013||2013-12-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Impact of Childrens Preparation Before MRI on Anxiety and Need for Anesthesia: a Prospective Randomized Clinical Trial|IMPACT OF CHILDREN&Apos;S PREPARATION BEFORE MRI ON ANXIETY AND NEED FOR ANESTHESIA: A PROSPECTIVE RANDOMIZED CLINICAL TRIAL.|Completed||N/A|131|Actual|Soroka University Medical Center||2|||f||||t||||||||||2017-10-10 23:37:35.982803|2017-10-10 23:37:35.982803
NCT02350491|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-05-15|||February 16, 2015|Actual|2015-02-16|May 2017|2017-05-01|July 16, 2019|Anticipated|2019-07-16|July 16, 2019|Anticipated|2019-07-16||Observational|SPIRALE||Study During Pregnancy of Expression of miRNAs in RA or SLE|Study During Pregnancy of miRNAs in Rheumatoid Arthritis or Systemic Lupus Erythematosus|Recruiting||N/A|40|Anticipated|University Hospital, Strasbourg, France|||3||f||||f||||||Samples With DNA|"     The samples that will be analyzed in the present application are serum, urine, placenta,     blood monocytes.   "|||2017-10-10 23:37:36.07729|2017-10-10 23:37:36.07729
NCT02350101|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-23|||January 2010||2010-01-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Massive Transfusion Protocol With Coagulation Algorithm|Introduction of a Massive Transfusion Protocol - Evaluation Over Three Years|Completed||N/A|243|Actual|University of Zurich|||1||f||||f||||||||||2017-10-10 23:37:39.49696|2017-10-10 23:37:39.49696
NCT02350478|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-03-21|||July 2013||2013-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Effects of Linagliptin on Endothelial Function|Effects of Linagliptin on Endothelial Function and Global Arginine Bioavailability Ratio in Coronary Artery Disease Patients With Early Diabetes|Completed||Phase 4|42|Actual|Medical University of Graz||2|||f||||t||||||||No||2017-10-10 23:37:36.206434|2017-10-10 23:37:36.206434
NCT02350465|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-06-01|||March 1, 2015|Actual|2015-03-01|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Detection and Treatment of Sarcopenia and Myosteatosis in Older African Americans|Detection and Treatment of Sarcopenia and Myosteatosis in Older African Americans|Recruiting||N/A|140|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-10 23:37:36.325978|2017-10-10 23:37:36.325978
NCT02350452|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-04-21|||January 2015||2015-01-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|||Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Endometriomas|The Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Inner Lining of Ovarian Endometriomas After Laparoscopic Cystectomy: a Randomized Clinical Trial.|Completed||N/A|50|Actual|University of Cagliari||2|||f||||f||||||||||2017-10-10 23:37:36.882364|2017-10-10 23:37:36.882364
NCT02350439|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-01-08|||January 2015||2015-01-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Differential Effect of High (200μg/kg/Min) Adenosine Dose on Fractional Flow Reserve in Patients Presenting Variation of FFR ≥0.05 During the Usual Dose of Adenosine Infusion (140μg/kg/Min).|Differential Effect of High (200μg/kg/Min) Adenosine Dose on Fractional Flow Reserve in Patients Presenting Variation of FFR ≥0.05 During the Usual Dose of Adenosine Infusion (140μg/kg/Min).|Completed||Phase 3|30|Actual|University of Patras||1|||f||||f||||||||||2017-10-10 23:37:36.965678|2017-10-10 23:37:36.965678
NCT02350426|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-01-16|||August 2015||2015-08-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques|An Adaptive Design Open Label Pilot Study in Rheumatoid Arthritis Patients to Assess Inflammation Using Molecular Imaging Techniques|Terminated||Phase 1|13|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:37:37.056885|2017-10-10 23:37:37.056885
NCT02350413|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-11-22|||May 2014||2014-05-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01|3 Months|Observational [Patient Registry]|||Multicenter Italian Validation of EHP-30|Multicenter Italian Validation of EHP-30 at Centres Located in the Territory|Recruiting||N/A|200|Anticipated|University of Cagliari|||1||f||||f||||||||||2017-10-10 23:37:37.154478|2017-10-10 23:37:37.154478
NCT02350400|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-02-12|||June 2014||2014-06-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI).|Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI) in the Treatment of Hepatic Colorectal Metastases|Completed||Phase 1|5|Actual|Singapore General Hospital||1|||f||||t||||||||||2017-10-10 23:37:37.239486|2017-10-10 23:37:37.239486
NCT02350387|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-02-25|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Eccentric Resistance Training in Persons With Knee Osteoarthritis|Efficacy of Eccentric Resistance Training in Persons With Knee Osteoarthritis|Completed||N/A|32|Actual|Regis University||2|||f||||f||||||||||2017-10-10 23:37:37.322952|2017-10-10 23:37:37.322952
NCT02350374|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-07-20|||November 2014||2014-11-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Carbohydrate Counting in Children and Adolescents With Type 1 Diabetes|Analysis of the Individual Variation of the Carbohydrate Amount at Each Meal in Children and Adolescents With Type 1 Diabetes Using the Carbohydrate Counting Method|Unknown status|Recruiting|N/A|87|Anticipated|Fondation Lenval||1|||f||||f||||||||||2017-10-10 23:37:37.407745|2017-10-10 23:37:37.407745
NCT02350361|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-25|||January 2014||2014-01-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|July 2015|Anticipated|2015-07-01||Interventional|||Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.|A Study of Endostar Combination With Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer Rechallenging Treatment After Resistance of EGFR-TKI and Tumor Progression|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Peking University Third Hospital||2|||f||||f||||||||||2017-10-10 23:37:37.495073|2017-10-10 23:37:37.495073
NCT02350348|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-03-15|||March 2016||2016-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|NECTARINE||NEonate-Children sTudy of Anaesthesia pRactice IN Europe Epidemiology of Morbidity and Mortality in Neonatal Anaesthesia|NECTARINE: NEonate-Children sTudy of Anaesthesia pRactice IN Europe Epidemiology of Morbidity and Mortality in Neonatal Anaesthesia: A European Prospective Multicentre Observational Study|Recruiting||N/A|5000|Anticipated|European Society of Anaesthesiology|||1||f||||f||||||||Undecided||2017-10-10 23:37:37.583805|2017-10-10 23:37:37.583805
NCT02350335|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-04-11|||January 2011||2011-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|NRT-SAH||Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid Hemorrhage|Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid Hemorrhage|Completed||N/A|200|Actual|Oslo University Hospital||3|||f||||f||||||||No||2017-10-10 23:37:37.716297|2017-10-10 23:37:37.716297
NCT02350322|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-01-11|||January 2015||2015-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Diet and Learning Abilities in Norwegian Youths|Diet and Learning Abilities in Norwegian Youths|Completed||N/A|478|Actual|National Institute of Nutrition and Seafood Research, Norway||3|||f||||f||||||||||2017-10-10 23:37:37.843057|2017-10-10 23:37:37.843057
NCT02350309|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-11-02|||January 2015||2015-01-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Study to Evaluate the Effect of 2 Dosage Strengths of E2006 on a Multiple Sleep Latency Test in Subjects With Insomnia Disorder|A Randomized, Double-Blind, Placebo-Controlled, 3-Way Crossover Study to Evaluate the Effect of 2 Dosage Strengths of E2006 on a Multiple Sleep Latency Test in Subjects With Insomnia Disorder|Completed||Phase 1|123|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-10 23:37:38.00667|2017-10-10 23:37:38.00667
NCT02350296|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-06-24|||November 2014||2014-11-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Two-way Crossover, Single Dose Randomized, Two-stage Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Granules Oral Solution|Two-way Crossover, Randomised, Single Dose and Two-stage Bioequivalence Phase I Study of Ketoprofen Lysine Salt as Immediate Release Tablets Formulation (40 mg) Versus Ketoprofen Lysine Salt as Granules for Oral Solution (80 mg Bipartite Sachet, Half Sachet) After Oral Administration to Healthy Volunteers of Both Sexes|Completed||Phase 1|30|Actual|Dompé Farmaceutici S.p.A||2|||f||||f||||||||||2017-10-10 23:37:38.100488|2017-10-10 23:37:38.100488
NCT02350283|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-06-20|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|EAST||Endovascular Therapy for Acute Ischemic Stroke Trial|A Multicenter, Prospective, Control Study to Evaluate of Thrombectomy With Solitaire in Patients With Acute Ischemic Stroke|Completed||Phase 3|225|Actual|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-10-10 23:37:38.20028|2017-10-10 23:37:38.20028
NCT02350270|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-01-28|||January 2015||2015-01-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Observational|||Gait, cOgnitiOn & Decline (GOOD)|Gait, cOgnitiOn & Decline (GOOD)|Unknown status|Recruiting|N/A|2800|Anticipated|University Hospital, Angers|||3||f||||||||||||||2017-10-10 23:37:38.290019|2017-10-10 23:37:38.290019
NCT02350257|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-11-29|||March 2015||2015-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Internet-Based CBT for Children With Anxiety Disorders: Implementation in Clinical Settings|Internet-Based CBT for Children With Anxiety Disorders: Implementation in Clinical Settings|Active, not recruiting||N/A|131|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:37:38.377332|2017-10-10 23:37:38.377332
NCT02350244|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-26|||June 2014||2014-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|I-Preventive||Active Prevention of MSDs (Musculoskeletal Disorders, Upper and Spine Members) in the Context of Computer Screen Work|Active Prevention of MSDs (Musculoskeletal Disorders, Upper and Spine Members) in the Context of Computer Screen Work|Completed||Phase 1|200|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:37:38.452678|2017-10-10 23:37:38.452678
NCT02350231|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-01-21|||February 1, 2014|Actual|2014-02-01|January 2017|2017-01-01|January 15, 2017|Actual|2017-01-15|January 1, 2017|Actual|2017-01-01||Interventional|PPPTP||Progesterone Vaginal Pessary for Prevention of Preterm Twin Birth||Completed||Phase 2/Phase 3|100|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 23:37:38.523289|2017-10-10 23:37:38.523289
NCT02350218|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-06-29|||March 2015||2015-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PROVISION||Safety, Efficacy of Eglandin® in Living Donor Liver Transplanted Patient (PROVISION)|Open-label, Single Center, Randomized Clinical Trial to Evaluate Safety, Efficacy of Eglandin® (Alprostadil) 360㎍, 720㎍ in Living Donor Liver Transplanted Patient|Recruiting||Phase 2|76|Anticipated|Asan Medical Center||2|||f||||t||||||||No||2017-10-10 23:37:38.590985|2017-10-10 23:37:38.590985
NCT02350205|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-02-08|||January 2015||2015-01-01|February 2017|2017-02-01||||January 2020|Anticipated|2020-01-01||Interventional|||SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma|SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma.|Recruiting||Phase 1/Phase 2|17|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-10 23:37:38.686147|2017-10-10 23:37:38.686147
NCT02350192|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-07-26|||June 2013||2013-06-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effectiveness of an E-health Educational Intervention for Cardiovascular Disease Adults in Improving Outcomes|A Randomized Controlled Trial of the Effectiveness of a Home-based Interactive E-health Educational Intervention for Middle-aged Cardiovascular Disease Adults in Improving Total Exercise, Adherence Rate, Exercise Efficacy and Outcomes|Completed||N/A|438|Actual|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-10 23:37:38.780366|2017-10-10 23:37:38.780366
NCT02350179|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-02-07|||June 2014||2014-06-01|February 2015|2015-02-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||Efficacy of Tranexamic Acid in Reducing Blood Loss During and After Caesarean Section|Efficacy of Tranexamic Acid in Reducing Blood Loss During and After Caesarean Section|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Ain Shams University||2|||f||||f||||||||||2017-10-10 23:37:38.877903|2017-10-10 23:37:38.877903
NCT02350166|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-11-15|||November 2013||2013-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Short-term Effects of LASI Surgery Versus Conventional Laparotomy for Colorectal Liver Metastasis|Short-term Effects of Laparoscopic-assisted Small-incision Surgery Versus Conventional Laparotomy in Treatment of Resectable Colorectal Liver Metastasis|Recruiting||Phase 3|40|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-10 23:37:38.982788|2017-10-10 23:37:38.982788
NCT02350153|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-08-23|||September 2013||2013-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|||Cushing´s Disease Epidemiology in Sweden|National Swedish Study in Cushing´s Disease Incidence and Outcomes|Active, not recruiting||N/A|400|Anticipated|Vastra Gotaland Region|||1||f||||f||||||||||2017-10-10 23:37:39.089217|2017-10-10 23:37:39.089217
NCT02350140|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-05-12|||January 2015||2015-01-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|TextIT||Texting to Improve Testing (TextIT):|Texting to Improve Testing (TextIT): A Cluster Randomized Stepped Wedge Trial of Text Messaging to Improve Postpartum Retention in Care and Early Infant Diagnosis of HIV|Recruiting||N/A|2508|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 23:37:39.17016|2017-10-10 23:37:39.17016
NCT02350127|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-06-28|||May 4, 2015|Actual|2015-05-04|June 2017|2017-06-01|January 31, 2019|Anticipated|2019-01-31|August 31, 2018|Anticipated|2018-08-31||Interventional|PLIE-VA||Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia|Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia|Recruiting||Phase 2/Phase 3|120|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-10 23:37:39.277898|2017-10-10 23:37:39.277898
NCT02350114|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2016-06-30|||November 2014||2014-11-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||An Observational Study of the Functional Capacity of Heart Failure|An Observational Study of the Functional Capacity of Heart Failure Patients With Reduced Ejection Fraction Admitted With Acute Heart Failure|Completed||N/A|51|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-10 23:37:39.396859|2017-10-10 23:37:39.396859
NCT02350088|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-17|2015-01-24|||January 2014||2014-01-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|Fast-track||Fast-track Surgery in the Treatment of Hirschsprung's Disease|Fast-track Surgery in the Treatment of Hirschsprung's Disease|Unknown status|Recruiting|N/A|100|Anticipated|Tongji Hospital||2|||f||||t||||||||||2017-10-10 23:37:39.55279|2017-10-10 23:37:39.55279
NCT02350075|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-07-24|||March 2015||2015-03-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Clinical Success of Short Dental Implants Alone and Standard Dental Implants Combined With Osteotome Sinus Floor Elevation in Posterior Maxillae||Recruiting||N/A|250|Anticipated|Shanghai 9th People's Hospital||2|||f||||t||||||||||2017-10-10 23:37:39.644688|2017-10-10 23:37:39.644688
NCT02350062|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-01-28|||January 2014||2014-01-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01||Observational|NMT-STIMPOD||Comparison of Two Neuromuscular Monitors|Comparison of Two Neuromuscular Monitors|Completed||N/A|17|Actual|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 23:37:39.74749|2017-10-10 23:37:39.74749
NCT02350049|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-01-23|||November 2014||2014-11-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|March 2016|Actual|2016-03-01||Observational|GK10||Cementless Oxford Partial Knee Controlled Observational Study|Cementless Oxford Partial Knee Retrospective and Prospective Controlled Multi-center Observational Study|Active, not recruiting||N/A|391|Actual|Zimmer Biomet|||2||f||||f||||||||Yes|The primary analysis data is patient level data; collected in anticipation of potential PMA submission.|2017-10-10 23:37:39.801015|2017-10-10 23:37:39.801015
NCT02350036|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-03-18|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|9 Months|Observational [Patient Registry]|||Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia|Maternal Serum Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia and Relation to Maternal and Neonatal Outcome|Completed||N/A|50|Actual|Cairo University|||2||f||||f||||||||||2017-10-10 23:37:39.876758|2017-10-10 23:37:39.876758
NCT02350023|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-11-29|||September 2014||2014-09-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|COLA||Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata|A Randomized Comparative Study of Efficacy and Safety of Topical Latanoprost Versus Topical Corticosteroid in the Treatment of Localized Alopecia Areata|Completed||Phase 4|50|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 23:37:39.955378|2017-10-10 23:37:39.955378
NCT02350010|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-26|||January 2015||2015-01-01|January 2015|2015-01-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Observational|||Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing|The Research of Etiology and Risk Factors Related to Prognosis of Intracerebral Hemorrhage in Beijing|Unknown status|Not yet recruiting|N/A|1500|Anticipated|Beijing Neurosurgical Institute|||1||f||||t||||||||||2017-10-10 23:37:40.05929|2017-10-10 23:37:40.05929
NCT02349997|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2017-07-26|||January 2015||2015-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Fluid Shift on Obstructive and Central Sleep Apnea|The First Affiliated Hospital of Nanjing Medical University|Recruiting||N/A|40|Anticipated|Nanjing Medical University|||2||f||||f||||||||||2017-10-10 23:37:40.163525|2017-10-10 23:37:40.163525
NCT02349971|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-07-19|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Feasibility of MR-Guided High Intensity Focused Ultrasound (MR-HIFU) Ablation of Osteoid Osteoma in Children|Safety and Feasibility of MR-Guided High Intensity Focused Ultrasound (MR-HIFU) Ablation of Osteoid Osteoma in Children|Recruiting||N/A|14|Anticipated|Children's Research Institute||1|||f||||t||||||||||2017-10-10 23:37:40.249254|2017-10-10 23:37:40.249254
NCT02349958|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-01-30|||September 2006||2006-09-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|HIPEC/IPHC||Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy|Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy Using Cisplatin, Mitomycin, and Adriamycin in Peritoneal Surface Malignancies Also Known as Hyperthermic Intraperitoneal Chemotherapy.|Recruiting||Phase 2|200|Anticipated|Bay Area Gynecology Oncology||4|||f||||t||||||||||2017-10-10 23:37:40.324765|2017-10-10 23:37:40.324765
NCT02349945|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-07-11|||January 2011||2011-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy|Significance of the FSH Receptor Polymorphism p.N680S for the Efficacy of FSH Therapy of Idiopathic Male Infertility: a Pharmacogenetic Approach|Completed||Phase 2/Phase 3|88|Actual|Azienda USL Modena||2|||f||||t||||||||||2017-10-10 23:37:40.431689|2017-10-10 23:37:40.431689
NCT02349932|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-09-18|||July 2018|Anticipated|2018-07-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||The Influence of Histo-blood Group Antigen Polymorphism on the Composition of the Microbiota|The Influence of Histo-blood Group Antigen Polymorphism on the Composition of the Microbiota|Not yet recruiting||N/A|100|Anticipated|University of Florida|||1||f||||f||||||Samples With DNA|"     Blood, saliva, and fecal material will be collected from subjects. The blood and saliva will     be used for typing sugar expression. DNA will be extracted from stool samples and used for     characterization of the gut flora.   "|||2017-10-10 23:37:40.527105|2017-10-10 23:37:40.527105
NCT02349919|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-03-21|||March 2015||2015-03-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Oral Procaterol on Postinfectious Persistent Cough|Effect of Oral Procaterol on Chronic Persistent Cough Following Upper Respiratory Tract Infection: Double-Blind Randomized Placebo-Controlled Trial|Recruiting||N/A|74|Anticipated|Mahidol University||2|||f||||t|f|f||||||Yes||2017-10-10 23:37:40.61139|2017-10-10 23:37:40.61139
NCT02349906|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-06-13|||April 2015||2015-04-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases|Clinical Phase II Trial to Compare Treosulfan-based Conditioning Therapy With Busulfan-based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Paediatric Patients With Non-malignant Diseases|Recruiting||Phase 2|100|Anticipated|medac GmbH||2|||f||||t||||||||Undecided||2017-10-10 23:37:40.713106|2017-10-10 23:37:40.713106
NCT02348398|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-08-15|||August 2016||2016-08-01|August 2016|2016-08-01||||August 2019|Anticipated|2019-08-01||Interventional|||Phase II Study of Pazopanib and Topotecan in Cervical Cancer|A Phase II Study of Pazopanib and Oral Topotecan in Women With Recurrent Cervical Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:37:59.022952|2017-10-10 23:37:59.022952
NCT02349893|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2017-07-12|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea: A Single-arm, Multicenter Study|Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea: A Single-arm, Multicenter Study|Recruiting||N/A|40|Anticipated|Olympus Surgical Technologies Europe||1|||f||||f||||||||||2017-10-10 23:37:40.982515|2017-10-10 23:37:40.982515
NCT02349880|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-01-23|||October 2011||2011-10-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||A Shared Decision-making Training for Inpatients With Schizophrenia|A Shared Decision-making Training for Inpatients With Schizophrenia|Unknown status|Active, not recruiting|N/A|240|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-10 23:37:41.080989|2017-10-10 23:37:41.080989
NCT02349867|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-07-17|||January 29, 2015|Actual|2015-01-29|July 2017|2017-07-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer|A Phase 1 Study of Neoadjuvant Chemotherapy, Followed by Concurrent Chemoradiation With Gemcitabine, Sorafenib, and Vorinostat in Pancreatic Cancer|Recruiting||Phase 1|36|Anticipated|Virginia Commonwealth University||1|||f||||t|t|f|||t|||||2017-10-10 23:37:41.151853|2017-10-10 23:37:41.151853
NCT02349854|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-03-23|||February 2013|Actual|2013-02-01|March 2017|2017-03-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Observational|||Neurobiology of the Scalp in Seborrheic Dermatitis|Neurobiology of the Scalp in Seborrheic Dermatitis|Completed||N/A|32|Actual|Boston University|||2||f||||f|f|f||||Samples Without DNA|"     Scalp biopsy   "|No||2017-10-10 23:37:41.29409|2017-10-10 23:37:41.29409
NCT02349841|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-01-28|||September 2014||2014-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis|A Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem, Administered Intravenously, Plus Amoxycillin/CA and Faropenem, Administered Orally, Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed, Smear-positive Pulmonary Tuberculosis.|Completed||Phase 2|46|Actual|Task Foundation NPC||3|||f||||f||||||||||2017-10-10 23:37:41.401554|2017-10-10 23:37:41.401554
NCT02349828|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-04-19|||September 2015||2015-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Antiviral Prophylaxis in a Burn Population|A Prospective, Randomized Trial of Antiviral Prophylaxis in a Population of Burn Patients|Withdrawn||Phase 2/Phase 3|0|Actual|Southern Illinois University||2||PI decided to stop due to divisional reorganization. No pts enrolled.|f||||t||||||||||2017-10-10 23:37:41.515263|2017-10-10 23:37:41.515263
NCT02349815|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2017-09-28|||January 1, 2017|Actual|2017-01-01|September 2017|2017-09-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|||JAYDESS Drug Utilization Study in Sweden|Pharmacoepidemiological Study (Drug Utilization Study) of JAYDESS Use in Routine Clinical Practice in Sweden|Recruiting||N/A|10000|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 23:37:41.593556|2017-10-10 23:37:41.593556
NCT02349802|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-01-29|||February 2013||2013-02-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|BCB119||Autoinjector Device Assessment Study|Evaluation of the Single-Use Pre-Filled Autoinjector|Completed||Phase 1|3052|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-10 23:37:41.677858|2017-10-10 23:37:41.677858
NCT02349789|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2016-08-08|||January 2015||2015-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Role of Cerebellar Hyperactivity in Parkinson's Disease|Stimulating the Little Brain to Make Big Steps: Improving Gait in Parkinson's Disease Patients by Non-invasive Electrical Stimulation of the Cerebellum.|Active, not recruiting||N/A|20|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|||1||f||||f||||||||||2017-10-10 23:37:41.778566|2017-10-10 23:37:41.778566
NCT02349776|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-26|2015-01-26|||January 2015||2015-01-01|January 2015|2015-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Experiencing Transplant With Stories From Survivors|How do Stories of Survival Help Patients Going Through Bone Marrow Transplant?|Recruiting||N/A|40|Anticipated|The Leeds Teaching Hospitals NHS Trust||1|||f||||f||||||||||2017-10-10 23:37:41.850844|2017-10-10 23:37:41.850844
NCT02349763|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-01-28|||February 2015||2015-02-01|January 2015|2015-01-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|DEPARO||Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction|Intravenous Versus Oral Regimens of Dexamethasone for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction in Primary Ovarian, Fallopian Tube and Peritoneal Cancer Patients: a Double-blind Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 3|260|Anticipated|Rajavithi Hospital||2|||f||||t||||||||||2017-10-10 23:37:41.925556|2017-10-10 23:37:41.925556
NCT02349750|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2015-01-28|||January 2010||2010-01-01|January 2015|2015-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Endometrial Scratch Injury in Women With Unexplained Infertility Undergoing IUI|Endometrial Scratch Injury Induced Higher Pregnancy Rate for Women With Unexplained Infertility Undergoing IUI With Ovarian Stimulation|Completed||N/A|154|Actual|Cairo University||2|||f||||f||||||||||2017-10-10 23:37:42.012343|2017-10-10 23:37:42.012343
NCT02349737|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-01-28|||October 2014||2014-10-01|January 2015|2015-01-01||||January 2015|Actual|2015-01-01||Observational|||Evaluation of Interference Between Bioelectrical Impedance Analysis and Implantable Cardioverter Defibrillators|Use of Bioelectrical Impedance Analysis in the Nutritional Assessment of Patients With CHF Equipped With Implantable Cardioverter Defibrillators|Unknown status|Recruiting|N/A|70|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-10 23:37:42.111265|2017-10-10 23:37:42.111265
NCT02349724|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2017-04-24|||December 2014||2014-12-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Clinical Research of CAR T Cells Targeting CEA Positive Cancer|A Clinical Research of Chimeric Antigen Receptor(CAR) T Cells Targeting CEA Positive Cancer|Recruiting||Phase 1|75|Anticipated|Southwest Hospital, China||5|||f||||f||||||||||2017-10-10 23:37:42.213876|2017-10-10 23:37:42.213876
NCT02349711|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-05-09|2016-05-24||January 2015||2015-01-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|JEN||Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies|Probiotics (Lactobacillus Gasseri KS-13, Bifidobacterium Bifidum G9-1, Bifidobacterium Longum MM-2) and Health-related Quality of Life in Individuals With Seasonal Allergies|Completed||N/A|224|Actual|University of Florida||2|||f||||f||||||||||2017-10-10 23:37:42.316092|2017-10-10 23:37:42.316092
NCT02349698|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2016-10-13|||December 2014||2014-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma|A Clinical Research of Chimeric Antigen Receptor (CAR) T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma|Recruiting||Phase 1/Phase 2|45|Anticipated|Southwest Hospital, China||3|||f||||f||||||||Undecided||2017-10-10 23:37:42.634785|2017-10-10 23:37:42.634785
NCT02349685|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-25|2016-08-09|2016-04-26||January 2010||2010-01-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori|The Efficacy of the Culture Based Tailored Therapy for Helicobacter Pylori Eradication Comparing With the Traditional 2nd Line Rescue Therapy in Korean|Completed||N/A|219|Actual|Seoul National University Bundang Hospital|Early termination leading to small number of subjects analyzed|3|||f||||f||||||||||2017-10-10 23:37:42.747337|2017-10-10 23:37:42.747337
NCT02349672|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-07-03|||March 2016|Actual|2016-03-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Observational|||Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)|Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (HIE) Control Levels|Completed||N/A|41|Actual|University of Florida|||2||f||||f|f|f||||Samples Without DNA|"     blood samples   "|||2017-10-10 23:37:43.117939|2017-10-10 23:37:43.117939
NCT02349659|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-01-30|||December 2014||2014-12-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|SMASHING||A Multi-Centre RCT of the Axium® Neurostimulator for the Treatment of Chronic Inguinal Pain Following Surgery|A Randomised Controlled Trial to Evaluate the Efficacy of the Spinal Modulation Axium® NeuroStimulator THerapy as a Treatment for Persistent INGuinal Pain Following Surgical Intervention: SMASHING|Terminated||N/A|18|Actual|Maxima Medical Center||2||Sponsor withdrawn due to low inclusion rate|f||||f||||||||||2017-10-10 23:37:43.207364|2017-10-10 23:37:43.207364
NCT02349620|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2015-01-23|||September 2014||2014-09-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Effect of Platelet-rich Factor on Implant Stability and Bone Resorption in the Lower Posterior Mandible|Platelet-rich Factot in Implant Dentistry|Unknown status|Recruiting|Phase 2|30|Anticipated|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:37:43.443068|2017-10-10 23:37:43.443068
NCT02349607|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-04-22|||January 2015||2015-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints|A Double Blind, Double Dummy, Randomized, Placebo-controlled, 5 Period Cross-over Study To Examine The Effect Of Pf-05089771 Alone And In Combination With Pregabalin On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin And Ibuprofen As Positive Controls|Completed||Phase 1|25|Actual|Pfizer||5|||f||||f||||||||||2017-10-10 23:37:43.52857|2017-10-10 23:37:43.52857
NCT02349594|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-11-09|||January 2014||2014-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease|Modulation of Immune Function by Parenteral Fish Oil in Patients With Crohn's Disease and High Inherent Tumor Necrosis Factor-alpha Production: a Randomized, Single Blinded, Cross-over Study|Completed||Phase 4|6|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-10 23:37:43.630825|2017-10-10 23:37:43.630825
NCT02349581|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-23|||November 2014||2014-11-01|January 2015|2015-01-01||||May 2015|Anticipated|2015-05-01||Interventional|PPBCS||Ultrasound Guided Pectoral Nerves Blockade for Persistent Pain After Breast Cancer Surgery|Ultrasound Guided Pectoral Nerves (Pecs) Blockade in Persistent Pain After Breast Cancer Surgery|Unknown status|Recruiting|Phase 2|6|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:37:43.722358|2017-10-10 23:37:43.722358
NCT02349568|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-23|||May 2012||2012-05-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||The Cost Effectiveness of Endoscopic Ultrasound ( EUS ) Based Strategy in Diagnosis of Common Bile Duct Stones|The Cost Effectiveness Between EUS-based Strategy Versus Endoscopic Retrograde Cholangiopancreatography ( ERCP )-Based Strategy in Diagnosis of Common Bile Duct Stones in Patients With Intermediate Risk: a Study in Developing Country.|Completed||N/A|141|Actual|Prince of Songkla University|||2||f||||t||||||||||2017-10-10 23:37:43.813318|2017-10-10 23:37:43.813318
NCT02349555|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-09-26|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Nutritional Supplement Impact on Metabolic Parameters|An Open-Label Single-Center Study to Determine Safety and Effects of Novel Nutritional Blend on Inflammatory Balance Markers and Metabolic Parameters|Completed||N/A|41|Actual|Pharmanex||1|||f||||f||||||||||2017-10-10 23:37:43.91271|2017-10-10 23:37:43.91271
NCT02349542|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-08-01|2017-07-07||January 2015|Actual|2015-01-01|August 2017|2017-08-01|November 21, 2016|Actual|2016-11-21|November 1, 2016|Actual|2016-11-01||Interventional|||Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty|The Safety of Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty|Completed||Phase 4|20|Actual|OrthoCarolina Research Institute, Inc.||1|||f||||f|t|f|||f|||||2017-10-10 23:37:44.014739|2017-10-10 23:37:44.014739
NCT02349529|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-23|||February 2015||2015-02-01|January 2015|2015-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|PIE||An Exploratory RCT of a Psychosocial Group Intervention for Epilepsy|An Exploratory Randomised Controlled Trial of a Manualised Psychosocial Group Intervention for Young People With Epilepsy (PIE)|Unknown status|Not yet recruiting|N/A|200|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-10 23:37:44.216174|2017-10-10 23:37:44.216174
NCT02349516|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-05-31|||February 2015||2015-02-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)|A Randomized, Controlled Study of the Safety and Efficacy of Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema|Withdrawn||Phase 2|0|Actual|NJ Retina||4||Study cancelled as of 9/12/15. 0 subjects enrolled.|f||||f||||||||No|Study cancelled, no data|2017-10-10 23:37:44.295843|2017-10-10 23:37:44.295843
NCT02349503|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-06-09|||February 2015||2015-02-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia|A Phase 1, Open-Label, Single-Dose, Sequential Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia|Withdrawn||Phase 1|0|Actual|Neurocrine Biosciences||3|||f||||t||||||||||2017-10-10 23:37:44.404371|2017-10-10 23:37:44.404371
NCT02349490|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-01-23|||November 2011||2011-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|July 2013|Actual|2013-07-01||Interventional|||Seraseal for Endoscopic Hemostasis|A Multi-centre Proof of Concept Study to Assess Efficacy and Safety of a New Liquid Endoscopic Hemostatic Agent (Seraseal / Fastact ®) in Patients With Active Gastrointestinal Bleeding|Completed||Phase 4|37|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:37:44.524512|2017-10-10 23:37:44.524512
NCT02349477|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-12-01|||November 2014||2014-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Gabapentin for Alcohol Relapse Prevention|Gabapentin for Relapse Prevention: Alcohol Withdrawal Effects|Recruiting||Phase 2|90|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:37:44.599265|2017-10-10 23:37:44.599265
NCT02349464|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-01-23|||December 2014||2014-12-01|January 2015|2015-01-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|PLEASE||Promoting Lactation Education, Access, and Support Efforts for Preterm Infants|Promoting Lactation Education, Access, and Support Efforts for Preterm Infants|Unknown status|Enrolling by invitation|N/A|70|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:37:44.675072|2017-10-10 23:37:44.675072
NCT02349451|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-08-02|2017-06-27||April 28, 2015|Actual|2015-04-28|August 2017|2017-08-01|July 4, 2016|Actual|2016-07-04|July 4, 2016|Actual|2016-07-04||Interventional||Full Analysis Set: randomized participants who received at least 1 dose of study medication.|A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)|A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate|Completed||Phase 2|240|Actual|AbbVie||4|||f||||f||||||||||2017-10-10 23:37:44.885114|2017-10-10 23:37:44.885114
NCT02349438|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-11-27|2016-11-27||December 2014||2014-12-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||All subjects that were dispensed at least 1 study lens throughout the duration of the study.|Assessment of Contact Lens Wettability Using Wavefront Aberrometry||Completed||N/A|25|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-10 23:37:46.522376|2017-10-10 23:37:46.522376
NCT02349425|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-04-14|||March 31, 2015|Actual|2015-03-31|April 2017|2017-04-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29||Interventional|||A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough|A Dose Escalation Study to Assess the Efficacy and Tolerance of AF-219 in Subjects With Refractory Chronic Cough|Completed||Phase 2|30|Actual|Afferent Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:37:46.734651|2017-10-10 23:37:46.734651
NCT02349412|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-04-19|||April 2015||2015-04-01|April 2017|2017-04-01||||June 2018|Anticipated|2018-06-01||Interventional|||Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers|Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies|Active, not recruiting||Phase 3|405|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 23:37:46.833125|2017-10-10 23:37:46.833125
NCT02349399|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-04-04|||May 1, 2015|Actual|2015-05-01|April 2017|2017-04-01|March 1, 2016|Actual|2016-03-01|March 1, 2016|Actual|2016-03-01||Observational|||Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases|Drug Utilization Study on Diane®-35 (and Generics) in European Healthcare Databases|Completed||N/A|26065|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:37:46.969917|2017-10-10 23:37:46.969917
NCT02349386|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-07-11|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 14, 2017|Actual|2017-06-14||Interventional|MASTERS||Maintaining Suppression of Testosterone With Transdermal Estradiol Gel|A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer|Terminated||Phase 2|34|Actual|BHR Pharma, LLC||4||Inability to recruit patients|f||||f|t|f||||||||2017-10-10 23:37:47.046251|2017-10-10 23:37:47.046251
NCT02349373|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-04-28|||April 2015||2015-04-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|March 2016|Actual|2016-03-01||Interventional|||Focus of a Running Schedule and Risk of Running Injuries|The Focus of a Running Schedule and Its Association With the Risk of Running Injuries? A Randomized Trial.|Active, not recruiting||N/A|839|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-10 23:37:47.165814|2017-10-10 23:37:47.165814
NCT02349360|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-12-23|||August 2015||2015-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|LJ||Safety, Tolerability and Host Response to Lactobacillus Johnsonii|Safety, Tolerability and Host Response to Lactobacillus Johnsonii|Completed||N/A|42|Actual|University of Florida||2|||f||||t||||||||Undecided||2017-10-10 23:37:47.291219|2017-10-10 23:37:47.291219
NCT02349347|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-01-27|||December 2012||2012-12-01|January 2015|2015-01-01||||November 2017|Anticipated|2017-11-01||Interventional|MEL-CAP||A Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles in Patients With Castration-resistant Prostate Cancer (CRPC)|A Single Arm Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles in Patients With Castration-resistant Prostate Cancer (CRPC)|Recruiting||Phase 2|39|Anticipated|Queen Mary University of London||1|||f||||f||||||||||2017-10-10 23:37:47.381141|2017-10-10 23:37:47.381141
NCT02349334|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-01-27|||January 2012||2012-01-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Interventional|CONFIDeNT||UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence|CONtrol of Faecal Incontinence Using Distal NeuromodulaTion (CONFIDeNT)|Completed||Phase 3|227|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-10-10 23:37:47.464464|2017-10-10 23:37:47.464464
NCT02349321|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-07-28|||February 9, 2013|Actual|2013-02-09|July 2017|2017-07-01|May 30, 2016|Actual|2016-05-30|September 30, 2013|Actual|2013-09-30||Interventional|||Skhokho Supporting Success: A Cluster RCT of a Multi-faceted, School-based IPV Prevention Intervention in South Africa|Skhokho Supporting Success: A Cluster Randomised Controlled Trial of a Multi-faceted, School-based Intimate Partner Violence Primary Prevention Intervention in Gauteng, South Africa|Completed||N/A|3192|Anticipated|Medical Research Council, South Africa||3|||f||||f||||||||||2017-10-10 23:37:47.540296|2017-10-10 23:37:47.540296
NCT02349308|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-09-02|||October 2013||2013-10-01|January 2015|2015-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|MCENPS||Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter|Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter for Dialysis|Completed||Phase 4|10|Actual|Merit Medical Systems, Inc.|||1||f||||f||||||||||2017-10-10 23:37:47.617608|2017-10-10 23:37:47.617608
NCT02349282|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-01-08|||December 2014||2014-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|D-Fit||The Effect of Calcifediol (Hy.D 25 SD/S) and Vitamin D3 on Muscle Strength in a Frail Elderly Population|The Effect of Calcifediol (Hy.D 25 SD/S) and Vitamin D3 on Muscle Strength in a Frail Elderly Population: a Randomized, Double-blind, Placebo-controlled Trial.|Completed||N/A|78|Actual|Wageningen University||3|||f||||f||||||||||2017-10-10 23:37:49.829231|2017-10-10 23:37:49.829231
NCT02349269|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-01-23|||January 2012||2012-01-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|December 2012|Actual|2012-12-01|105 Months|Observational [Patient Registry]|POAF||Postoperative Atrial Fibrillation and Long-term Survival|Postoperative Atrial Fibrillation After Cardiac Surgery is Not an Independent Risk Factor for Long-term Cardiovascular Morbidity and Mortality in Anticoagulated Patients|Completed||N/A|519|Actual|Kuopio University Hospital|||1||f||||f||||||||||2017-10-10 23:37:49.930677|2017-10-10 23:37:49.930677
NCT02349256|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-01-22|||December 2014||2014-12-01|January 2015|2015-01-01||||May 2015|Anticipated|2015-05-01||Observational|||Somatoform Disorder in British South Asians|Somatoform Disorder in British South Asians - What Are the Patients' Views?|Unknown status|Recruiting|N/A|16|Anticipated|Global Health Primary Care Research and Innovation and Network|||1||f||||f||||||||||2017-10-10 23:37:49.991063|2017-10-10 23:37:49.991063
NCT02349243|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-01-30|||January 2015||2015-01-01|January 2015|2015-01-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|||Effect of Entacapone on Bodyweight Loss in Obese Population|Effect of Entacapone on Bodyweight Loss in Obese Population: A Randomized, Double-blind, Placebo-controlled, Pilot Trial|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-10 23:37:50.08436|2017-10-10 23:37:50.08436
NCT02349230|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-23|||June 2014||2014-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|Astym||The Effect of Astym Treatment on Muscle Performance|The Effect of Astym Treatment on Acute Changes in Muscle Performance|Completed||N/A|59|Actual|Duquesne University||3|||f||||f||||||||||2017-10-10 23:37:50.183645|2017-10-10 23:37:50.183645
NCT02349217|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-03-08|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Mindfulness Based Couples Therapy|Mindfulness Based Couples Therapy for Breast Cancer Survivors: A Pilot Study|Active, not recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:37:50.249061|2017-10-10 23:37:50.249061
NCT02349204|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-07-20|||January 2015||2015-01-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Music on Surgical Skill in the Setting of Simulated Intraocular Surgery|The Effect of Music on Surgical Skill in the Setting of Simulated Intraocular Surgery|Completed||N/A|26|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-10 23:37:50.446213|2017-10-10 23:37:50.446213
NCT02349191|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-03-21|||March 2016||2016-03-01|March 2016|2016-03-01|May 2019|Anticipated|2019-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Omental Transposition Surgery for Mild Alzheimer's Disease|A Prospective, Single Site, Single Arm, Non-randomized, Interventional Study to Evaluate the Safety and Effectiveness of Omental Transposition Surgery for Patients With Alzheimer's Disease.|Not yet recruiting||N/A|25|Anticipated|Bariatric Medicine Institute, Salt Lake City, UT||1|||f||||t||||||||||2017-10-10 23:37:50.533233|2017-10-10 23:37:50.533233
NCT02349178|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-05-05|||December 2014||2014-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT|Bridging Study: A Phase 2 Study Investigating Clofarabine, Cyclophosphamide and Etoposide for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia and Minimal Residual Disease|Terminated||Phase 2|5|Actual|Medical College of Wisconsin||1||Low accrual|f||||t||||||||||2017-10-10 23:37:50.631873|2017-10-10 23:37:50.631873
NCT02349165|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-17|2015-01-27|||May 2011||2011-05-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Standard Versus Transepithelial Corneal Crosslinking|Standard Versus Transepithelial Corneal Crosslinking for Treatment of Progressive Keratoconus|Completed||N/A|61|Actual|UMC Utrecht||2|||f||||f||||||||||2017-10-10 23:37:50.727923|2017-10-10 23:37:50.727923
NCT02349152|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-09-20|||January 2016||2016-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Remifentanil and Glycemic Response in Cardiac Surgery|The Effect of Intraoperative Continuous Remifentanil Infusion on Glycemic Response and Variability in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Prospective, Randomized, Open Label Clinical Trial|Active, not recruiting||Phase 4|116|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 23:37:50.836388|2017-10-10 23:37:50.836388
NCT02349139|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-08-09|||January 19, 2015|Actual|2015-01-19|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer|A Phase 1/2, Open-Label, Uncontrolled, Multiple-Dose Escalation, Cohort Expansion And Extension Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of ASN001 In Subjects With Metastatic Progressive Castrate Resistant Prostate Cancer|Active, not recruiting||Phase 1|27|Actual|Asana BioSciences||1|||f||||f||||||||||2017-10-10 23:37:50.971846|2017-10-10 23:37:50.971846
NCT02349126|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-08-12|||February 2015||2015-02-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Study of ARC-520 in Patient With Chronic Hepatitis B Virus||Withdrawn||Phase 2|0|Actual|Arrowhead Pharmaceuticals||1||Company decision to pursue alternative clinical trial|f||||f||||||||||2017-10-10 23:37:51.072143|2017-10-10 23:37:51.072143
NCT02349113|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-02-13|||February 2012||2012-02-01|February 2015|2015-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Acute Estrogen Therapy on Bone Formation|Effects of Acute Estrogen Therapy on Bone Formation|Completed||Phase 1|20|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:37:51.16713|2017-10-10 23:37:51.16713
NCT02349100|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-04-10|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|August 30, 2016|Actual|2016-08-30|July 13, 2016|Actual|2016-07-13||Observational|||PET-CT After Nellix Implantation|Clinical Relevance of Positron Emission Tomography (PET) Imaging Following Endovascular Aneurysm Repair Using the Nellix Endoprosthesis|Completed||N/A|10|Actual|Rijnstate Hospital|||1||f||||f||||||||||2017-10-10 23:37:51.243675|2017-10-10 23:37:51.243675
NCT02349087|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2015-08-31|||December 2014||2014-12-01|May 2015|2015-05-01||||December 2015|Anticipated|2015-12-01||Observational|||EEG in Resuscitated In-hospital Patients|Integrating EEG Into Acute Medicine: EEG in Resuscitated In-hospital Patients|Unknown status|Recruiting|N/A|50|Anticipated|Kuopio University Hospital|||1||f||||||||||||||2017-10-10 23:37:51.315339|2017-10-10 23:37:51.315339
NCT02349074|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-12-13|||November 2014||2014-11-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|ENTRACT||Digestive ENdoscopy afTeR Out-of-hospitAl Cardiac arresT|Digestive ENdoscopy afTeR Out-of-hospitAl Cardiac arresT|Recruiting||N/A|270|Anticipated|Versailles Hospital||1|||f||||f||||||||||2017-10-10 23:37:51.389245|2017-10-10 23:37:51.389245
NCT02349061|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-09-05|||October 15, 2015|Actual|2015-10-15|September 2017|2017-09-01|March 21, 2019|Anticipated|2019-03-21|May 15, 2017|Actual|2017-05-15||Interventional|||A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus|A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus|Active, not recruiting||Phase 2|102|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-10 23:37:51.503089|2017-10-10 23:37:51.503089
NCT02349048|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-01-11|2017-01-11||January 2015||2015-01-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|ACCORDION-1||Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection|A Phase 2, Randomized, Open-label Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of 6 or 8 Weeks of Treatment With Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Subjects With Chronic Hepatitis C Virus Genotype 1 Infection|Completed||Phase 2|68|Actual|Janssen Research & Development, LLC|The sample size in Arm B (participants with cirrhosis) was small (n=9).|2|||f||||t||||||||||2017-10-10 23:37:51.725926|2017-10-10 23:37:51.725926
NCT02349035|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-02-13|||December 2014||2014-12-01|February 2017|2017-02-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Application of Targeted Reinnervation for People With Transradial Amputation|Application of Targeted Reinnervation for People With Transradial Amputation|Recruiting||N/A|12|Anticipated|Shirley Ryan AbilityLab||1|||f||||f||||||||||2017-10-10 23:37:52.465648|2017-10-10 23:37:52.465648
NCT02349022|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-08-02|||January 2015||2015-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Comparison of PET With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-Prostatectomy|A Phase 2 Study - Comparison Of Positron Emission Tomography (PET/CT) With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-prostatectomy|Completed||Phase 2|19|Actual|ImaginAb, Inc.||1|||f||||f||||||||Yes||2017-10-10 23:37:52.572685|2017-10-10 23:37:52.572685
NCT02349009|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2017-08-16|||June 2015||2015-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial|A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial|Completed||Phase 1/Phase 2|17|Actual|Prism Pharma Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:37:52.652703|2017-10-10 23:37:52.652703
NCT02348996|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-01-22|||February 2014||2014-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study Comparing Dryweight Determination in Hemodialysis Patients With Two Methods|Randomized Study Comparing Analysis With Bioeletric Impedance and Clinical Evaluation to Determine Dry Weight in Hemodialyis Patients|Completed||N/A|57|Actual|Pontificia Universidade Católica do Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 23:37:52.743166|2017-10-10 23:37:52.743166
NCT02348983|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-28|||January 2013||2013-01-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|WHEEL-Pilot||Weight Loss Intervention in Long-Haul Truck Drivers: A Pilot Study|Weight Loss Intervention in Long-Haul Truck Drivers: A Pilot Study|Completed||N/A|13|Actual|University of Utah||1|||f||||f||||||||||2017-10-10 23:37:52.826747|2017-10-10 23:37:52.826747
NCT02348970|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-06-01|||January 2015||2015-01-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|IRIS||Efficacy and Compliance of the Mandibular Advancement Devices ONIRIS® vs. Custom Made Devices|Multicenters, Randomised Clinical Trial, to Evaluate Efficacy and Compliance of Mandibular Advancement Devices ONIRIS® vs. Laboratory Devices TALI in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas|Active, not recruiting||N/A|204|Anticipated|ONIRIS||2|||f||||f||||||||No||2017-10-10 23:37:52.914004|2017-10-10 23:37:52.914004
NCT02348957|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-04-19|||October 2014||2014-10-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Observational|DasPAQT||Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib|Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib PCR-Monitoring, Adherence, Quality of Life, Therapy Satisfaction|Active, not recruiting||N/A|300|Anticipated|Onco Medical Consult GmbH|||1||f||||t||||||||||2017-10-10 23:37:53.059169|2017-10-10 23:37:53.059169
NCT02348944|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-23|||August 2013||2013-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|COVAR||Biological Variability in Cartilage Specific Biomarkers in Healthy Volunteers.|Evaluation of Biological Variability in Cartilage Specific Biomarkers (Coll2-1, Coll2-1NO2, FIB3-1 and FIB 3-2) in Healthy Volunteers.|Completed||N/A|15|Actual|Artialis|||1||f||||f||||||Samples With DNA|"     Serum and urine samples   "|||2017-10-10 23:37:53.303177|2017-10-10 23:37:53.303177
NCT02348931|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-01-27|||December 2013||2013-12-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Clinical Effect of a Nasal Former in Nasal Deformities|Investigation of the Effect of a Customized Nasal Brace on Nasal Deformities With or Without Prior Surgery|Unknown status|Recruiting|Phase 3|100|Anticipated|University of Zurich||3|||f||||t||||||||||2017-10-10 23:37:53.384109|2017-10-10 23:37:53.384109
NCT02348918|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-23|||October 2014||2014-10-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® and Focal Laser Photocoagulation in the Treatment of Diabetic Macular Edema|A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® and Focal Laser Photocoagulation in the Treatment of Diabetic Macular Edema|Unknown status|Recruiting|Phase 2|150|Anticipated|Allegro Ophthalmics, LLC||5|||f||||t||||||||||2017-10-10 23:37:53.484123|2017-10-10 23:37:53.484123
NCT02348905|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-01-23|||March 2015||2015-03-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|July 2015|Anticipated|2015-07-01||Interventional|||ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial|ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial|Unknown status|Not yet recruiting|Phase 2/Phase 3|10|Anticipated|Albany Medical College||2|||f||||f||||||||||2017-10-10 23:37:53.632038|2017-10-10 23:37:53.632038
NCT02348892|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-22|||December 2014||2014-12-01|January 2015|2015-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|PROCOPES||Evaluation Program of the Benefit of the Coordination of the Course of the Elderly Patient in Health Establishment - Pilot Study.|Evaluation Program of the Benefit of the Coordination of the Course of the Elderly Patient in Health Establishment - Pilot Study.|Unknown status|Recruiting|N/A|100|Anticipated|Nantes University Hospital|||2||f||||f||||||||||2017-10-10 23:37:53.720872|2017-10-10 23:37:53.720872
NCT02348879|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-01-28|||January 2005||2005-01-01|January 2015|2015-01-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject|A Placebo Controlled, Randomized, Double-blind, Sequential, Rising, Single Dose Study to Examine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous and Subcutaneous AMG 403 in Healthy Young and Older Adult Subjects|Completed||Phase 1|51|Actual|Amgen||2|||f||||f||||||||||2017-10-10 23:37:53.788156|2017-10-10 23:37:53.788156
NCT02348866|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-01-13|||January 2015||2015-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|||Bacterial Contamination on Obstetric Resident Surgical Scrubs|Bacterial Contamination on Obstetric Resident Surgical Scrubs: a Randomized Trial|Completed||N/A|18|Actual|Greenville Health System||4|||f||||f||||||||||2017-10-10 23:37:53.858214|2017-10-10 23:37:53.858214
NCT02348853|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-11-09|||January 2015||2015-01-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|February 2018|Anticipated|2018-02-01||Interventional|HF2||Healthy Families Healthy Forces Study|Intervention for Sustainable Weight Loss in Military Families|Recruiting||N/A|580|Anticipated|Tufts University||2|||f||||t||||||||||2017-10-10 23:37:53.921558|2017-10-10 23:37:53.921558
NCT02348840|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-04-19|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Perinatal mHealth Intervention in Guatemala|Mobile Health Intervention to Improve Perinatal Continuum of Care in Guatemala|Recruiting||N/A|1050|Anticipated|Emory University||3|||f||||f|f|f||||||Yes|Data will be de-identified and shared through PhysioNet.org|2017-10-10 23:37:54.016604|2017-10-10 23:37:54.016604
NCT02348827|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-04-27|||January 2015||2015-01-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Family Psychoeducation for Major Depressive Disorder|Family Psychoeducation for Major Depressive Disorder - a Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Mental Health Services in the Capital Region, Denmark||2|||f||||f||||||||||2017-10-10 23:37:54.096893|2017-10-10 23:37:54.096893
NCT02348814|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-05-05|||May 2015||2015-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Development of a Novel Biomarker for Liver Fibrosis|Development of a Novel Biomarker for Liver Fibrosis|Recruiting||N/A|125|Anticipated|University of California, Los Angeles|||8||f||||f||||||Samples Without DNA|"     Biospecimens include inflammatory markers (cytokines) and markers of metabolic dysfunction     (adipokines):      leptin, adiponectin, TNF-alpha, PAI-1, IL-6, MCP-1, and retinoids   "|No||2017-10-10 23:37:54.318513|2017-10-10 23:37:54.318513
NCT02348801|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|LISD||Lifestyle Intervention for Senior Diabetics|Lifestyle Intervention Strategy to Treat Diabetes in Older Adults|Recruiting||Phase 3|100|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:37:54.423676|2017-10-10 23:37:54.423676
NCT02348788|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2017-01-31|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIMAL||Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia|Artemether-lumefantrine vs Chloroquine in Patients With Acute Non-severe P. Vivax Malaria in Sabah, Malaysia|Recruiting||Phase 3|98|Anticipated|Menzies School of Health Research||2|||f||||f||||||||Undecided||2017-10-10 23:37:54.548289|2017-10-10 23:37:54.548289
NCT02348775|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-05|||November 2014||2014-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Glutathione and Function in HIV Patients|Glutathione and Function in HIV Patients|Active, not recruiting||Phase 1|16|Actual|Baylor College of Medicine||1|||f||||f||||||||Yes|Data from the study will be submitted for publication once analyses are completed|2017-10-10 23:37:54.684403|2017-10-10 23:37:54.684403
NCT02348762|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-05|||November 2014||2014-11-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Energetics and Function in Older Humans|Energetics and Function in Older Humans|Recruiting||Phase 1|20|Anticipated|Baylor College of Medicine||1|||f||||f||||||||No||2017-10-10 23:37:54.780635|2017-10-10 23:37:54.780635
NCT02348749|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-03-21|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies|A Phase I/IIA Study of 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies|Recruiting||Phase 1/Phase 2|70|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:37:54.882651|2017-10-10 23:37:54.882651
NCT02348736|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-11-16|||January 2015||2015-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SensaScope||Comparison of SensaScope Intuboscope and McGrath Series 5 for Endotracheal Intubation|Comparative Study Between SensaScope Intuboscope and McGrath Series 5 Videolaryngoscope to Tracheal Intubation: a Prospective Randomised Study|Completed||N/A|75|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-10 23:37:54.987257|2017-10-10 23:37:54.987257
NCT02348723|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-03-07|||April 2015||2015-04-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)|Randomized Evaluation of Dabigatran Etexilate Compared to warfarIn in pulmonaRy Vein Ablation: Assessment of an Uninterrupted periproCedUral alntIcoagulation sTrategy (The RE-CIRCUIT Trial)|Completed||Phase 4|678|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:37:55.13593|2017-10-10 23:37:55.13593
NCT02348710|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-01-26|||June 2015|Actual|2015-06-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Exercise Intervention for Cancer Survivors|Exercise Outcome Expectations Among Breast Cancer Survivors|Completed||N/A|64|Actual|Duke University||2|||f||||t||||||||||2017-10-10 23:37:55.466334|2017-10-10 23:37:55.466334
NCT02348697|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-06-23|||June 2015||2015-06-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|NISANIK||Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects|Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects|Active, not recruiting||N/A|82|Actual|Tetec AG|||1||f||||f||||||||No||2017-10-10 23:37:55.555331|2017-10-10 23:37:55.555331
NCT02348684|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-10-10|||March 2012||2012-03-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation|Pilot Study to Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation in Women Treated for Node Positive Breast Cancer With Three- Dimensional Conformal Radiation Therapy (3DCRT)|Completed||N/A|20|Actual|Medical College of Wisconsin|||1||f||||f||||||||Yes|Data available upon request after publication of findings.|2017-10-10 23:37:55.645543|2017-10-10 23:37:55.645543
NCT02348671|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-09-22|||March 2015||2015-03-01|January 2015|2015-01-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Evaluation of Wound Dressings in the Reduction of Shear- Force|Evaluation of Wound Dressings to Reduce the Harmful Effects of Shear- Force at the Skin|Completed||N/A|10|Actual|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-10 23:37:55.735553|2017-10-10 23:37:55.735553
NCT02348658|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-03-24|2016-03-24||January 2015||2015-01-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Pharmacokinetic (PK) analysis set included all participants who received the study drug, completed the minimum protocol-specified procedures without any major protocol deviations, and who were evaluable for the food-effect.|A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet|A Phase 1, Randomized, Open-Label, Crossover Study to Evaluate the Food-Effect of Single Oral Dose of TAK-536TCH Final Formulation Tablet in Healthy Adult Male Subjects|Completed||Phase 1|12|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:37:55.809402|2017-10-10 23:37:55.809402
NCT02348645|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-10-27|||October 2014||2014-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Decompression vs. Fusion for Stable Degenerative Spondylolisthesis|Decompression Alone vs. Decompression and Instrumented Fusion for the Management of Lumbar Spinal Stenosis Associated With Stable Degenerative Spondylolisthesis: A Pragmatic Randomized Clinical Pilot Trial|Recruiting||N/A|130|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:37:56.341331|2017-10-10 23:37:56.341331
NCT02348632|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-10-03|||May 2015||2015-05-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"|A Long-Term Safety and Maintenance of Efficacy Study ofJZP-110 [(R)-2-amino-3 Phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or Obstructive Sleep Apnea|Active, not recruiting||Phase 3|645|Actual|Jazz Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:37:56.531924|2017-10-10 23:37:56.531924
NCT02348619|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-09-16|||May 2015||2015-05-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|August 2016|Actual|2016-08-01||Interventional|OSA||"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"|A Six-Week, Double-Blind, Placebo-Controlled, Randomized- Withdrawal, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)|Active, not recruiting||Phase 3|191|Actual|Jazz Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:37:56.748814|2017-10-10 23:37:56.748814
NCT02348606|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-09-06|||May 2015||2015-05-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|OSA||"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"|A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Obstructive Sleep Apnea (OSA)|Active, not recruiting||Phase 3|440|Anticipated|Jazz Pharmaceuticals||5|||f||||f||||||||||2017-10-10 23:37:56.980857|2017-10-10 23:37:56.980857
NCT02348593|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-11-30|||May 2015||2015-05-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"|A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy|Active, not recruiting||Phase 3|240|Actual|Jazz Pharmaceuticals||4|||f||||f||||||||||2017-10-10 23:37:57.181915|2017-10-10 23:37:57.181915
NCT02348580|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-07-30|||September 2013||2013-09-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Effectiveness Study of Teacher Training and Social and Financial Education in Rwanda's Primary and Secondary Schools|Active Learning Methods for Social and Financial Education in Rwanda's Primary and Secondary Schools: A Cluster Randomized Controlled Trial|Completed||N/A|1750|Actual|Stichting Child Savings International||2|||f||||f||||||||||2017-10-10 23:37:57.362452|2017-10-10 23:37:57.362452
NCT02348567|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-08-04|||August 2014||2014-08-01|August 2015|2015-08-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Unannounced Periodic Surveys on Public Hospitals|Unannounced or Announced Periodic Hospital Surveys: A Study Protocol for a Nationwide Cluster-randomised, Controlled Trial|Unknown status|Active, not recruiting|N/A|23|Anticipated|Danish Center for Healthcare Improvement||2|||f||||f||||||||||2017-10-10 23:37:57.450373|2017-10-10 23:37:57.450373
NCT02348554|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-01-22|||October 2013||2013-10-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|eMouve3||A Smartphone Application to Evaluate Energy Expenditure and Duration of Activities for Overweight and Obese People|A Smartphone Application to Evaluate Energy Expenditure and Duration of Activities in Free-living Conditions for Overweight and Obese People (eMouve3)|Completed||N/A|43|Actual|Institut National de la Recherche Agronomique||2|||f||||t||||||||||2017-10-10 23:37:57.538376|2017-10-10 23:37:57.538376
NCT02348541|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-06-10|||December 2014||2014-12-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||CollaGUARD Adhesion Barrier|A Post-Market Clinical Follow-up Study to Investigate the Usability of the CollaGUARD Adhesion Barrier Following Hysteroscopic Adhesiolysis|Completed||Early Phase 1|9|Actual|Innocoll||1|||f||||f||||||||||2017-10-10 23:37:57.643403|2017-10-10 23:37:57.643403
NCT02348528|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2016-11-03|||September 2012||2012-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year|A Multi-center, Open-label Extended Access Program of Lenalidomide Plus Low-dose Dexamethasone in Chinese Subjects With Relapsed/Refactory Multiple Myeloma Who Participated in Study CC-5013-MM-021 for at Least One Year.|Completed||Phase 2|65|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-10 23:37:57.725018|2017-10-10 23:37:57.725018
NCT02348515|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-10-20|||June 2013||2013-06-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Observational|||Cardiovascular Disease Protection Tissue|Effects of ACE2/Ang-(1-7) on Cardiac Progenitor Cells From Heart Failure Patients and Explant Control|Recruiting||N/A|180|Anticipated|University of Florida|||4||f||||f||||||Samples With DNA|"     Blood samples and discarded heart tissue.   "|No||2017-10-10 23:37:57.835171|2017-10-10 23:37:57.835171
NCT02348502|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2016-08-17|||January 2013||2013-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment|Sustained Viral Response and HBsAg Level Changes in Chronic Hepatitis B Patients Who Achieved HBsAg Level≤100 IU/ml After Completed Interferon Therapy|Recruiting||N/A|160|Anticipated|Beijing Ditan Hospital|||1||f||||f||||||||||2017-10-10 23:37:57.949732|2017-10-10 23:37:57.949732
NCT02348489|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-01-04|||March 2015||2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction|A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 Versus Treatment Choice (TC) in Adults With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy|Active, not recruiting||Phase 3|815|Actual|Astex Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:37:58.049895|2017-10-10 23:37:58.049895
NCT02348476|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-09-17|||November 2014||2014-11-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension||Completed||N/A|150|Actual|Allergan|||1||f||||f||||||||||2017-10-10 23:37:58.437298|2017-10-10 23:37:58.437298
NCT02348463|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-01-27|||January 2007||2007-01-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|||Treatment of Bacterial Vaginosis in Early Pregnancy in Skaraborg and the Effect on Spontaneous Preterm Delivery|Treatment of Bacterial Vaginosis in Early Pregnancy in Skaraborg County in Sweden and the Effect on Spontaneous Preterm Delivery|Completed||N/A|540|Actual|Skaraborg Hospital|||1||f||||f||||||||||2017-10-10 23:37:58.513327|2017-10-10 23:37:58.513327
NCT02348450|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-12-02|||February 2015||2015-02-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer|Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer: a Multi-center, Randomized, Open Label Study|Recruiting||Phase 4|308|Anticipated|Guangdong Association of Clinical Trials||2|||f||||f||||||||No||2017-10-10 23:37:58.58855|2017-10-10 23:37:58.58855
NCT02348437|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-31|||February 2015||2015-02-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Repair vs Non-repair of the Pronator Quadratus Muscle in Distal Radius Fractures. RCT.|Clinical Outcome After Repair of the Pronator Quadratus Muscle in Volar Locked Plating of the Distal Radius. A Randomised Clinical Trial.|Completed||N/A|72|Actual|Nordsjaellands Hospital||2|||f||||f||||||||||2017-10-10 23:37:58.778235|2017-10-10 23:37:58.778235
NCT02348424|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-04-06|||May 5, 2015|Actual|2015-05-05|April 5, 2017|2017-04-05|January 13, 2017|Actual|2017-01-13|January 13, 2017|Actual|2017-01-13||Interventional|||Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin|Phase 1 Open Label Trial of the Safety, Tolerability, and Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-10 23:37:58.863824|2017-10-10 23:37:58.863824
NCT02348411|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-08-18|||December 2014||2014-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Bilateral Anterior Capsulotomy in the Treatment of Medication-Refractory MDD||Recruiting||N/A|5|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-10 23:37:58.937405|2017-10-10 23:37:58.937405
NCT02348385|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-12-15|||December 2012||2012-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers|Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers|Recruiting||N/A|80|Anticipated|Yale University|||2||f||||t||||||Samples Without DNA|"     Samples will be obtained for hormones and amphetamine drug levels   "|No||2017-10-10 23:37:59.113041|2017-10-10 23:37:59.113041
NCT02348372|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-06-21|||March 31, 2011|Actual|2011-03-31|June 2017|2017-06-01|June 3, 2011|Actual|2011-06-03|June 3, 2011|Actual|2011-06-03||Interventional|||Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects|A Phase I, Randomized, Single-Blind, Placebo-Controlled, Dose-Escalation (Part 1), Fixed Sequence and Open-Label (Part 2), Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects|Completed||Phase 1|34|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 23:37:59.199643|2017-10-10 23:37:59.199643
NCT02348359|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-01-12|||March 2015||2015-03-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2017|Actual|2017-01-01||Interventional|||X-82 to Treat Age-related Macular Degeneration|A Randomized, Double-Masked, Placebo-Controlled, Dose- Finding, Non-Inferiority Study of X-82 Plus Prn Intravitreal (Ivt) Anti-VEGF Compared to Prn Ivt Anti-VEGF Monotherapy in Neovascular AMD|Active, not recruiting||Phase 2|132|Anticipated|Tyrogenex||4|||f||||t||||||||||2017-10-10 23:37:59.28808|2017-10-10 23:37:59.28808
NCT02348346|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-08-26|||March 2015||2015-03-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|July 2015|Actual|2015-07-01||Observational|TITANIC||Effect of MVX (Titanium Dioxide) on the Microbial Colonization of Surfaces in an Intensive Care Unit|Effect of MVX (Titanium Dioxide) on the Microbial Colonization of Surfaces in an Intensive Care Unit|Completed||N/A|35|Actual|Gelderse Vallei Hospital|||1||f||||f||||||||||2017-10-10 23:37:59.430498|2017-10-10 23:37:59.430498
NCT02348333|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-01-22|||September 2013||2013-09-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Repeated Dose Phase I Study of FYU-981|Seven-day Repeated Dose Clinical Pharmacological Study of FYU-981 Administered to Healthy Male Adults (Phase I Study).|Completed||Phase 1|18|Actual|Fuji Yakuhin Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:37:59.502629|2017-10-10 23:37:59.502629
NCT02348320|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-08-24|||June 17, 2015|Actual|2015-06-17|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy|Recruiting||Phase 1|30|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 23:37:59.563717|2017-10-10 23:37:59.563717
NCT02348307|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-01-22|||March 2013||2013-03-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Single Dose Phase I Study of FYU-981|Single Dose Clinical Pharmacological Study of FYU-981 Administered to Healthy Male Adults (Phase I Study).|Completed||Phase 1|54|Actual|Fuji Yakuhin Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:37:59.638286|2017-10-10 23:37:59.638286
NCT02348294|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-01-27|||February 2015||2015-02-01|January 2015|2015-01-01||||January 2016|Anticipated|2016-01-01||Interventional|||The Effect of Shear- Force at the Skin in Patients With Diabetes Mellitus|Measurement of Cytokines, Bloodflow and Erythema Index After Pressure and Shear- Force Loading in Patients With Diabetes Mellitus Type 2|Unknown status|Not yet recruiting|N/A|40|Anticipated|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-10 23:37:59.702531|2017-10-10 23:37:59.702531
NCT02348281|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2017-01-03|||January 2015||2015-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients|A Prospective, Single Center, Phase II Study of Bicalutamide as A Treatment in Androgen Receptor (AR)-Positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients|Terminated||Phase 2|1|Actual|Fudan University||1||it's too slow to enroll suitable patients into this study|f||||t||||||||||2017-10-10 23:37:59.773186|2017-10-10 23:37:59.773186
NCT02348268|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-22|||January 2010||2010-01-01|January 2015|2015-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Myofascial Release Therapy and Mechanical Neck Pain|Myofascial Release Therapy in the Treatment of Occupational Mechanical Neck Pain: a Randomized Parallel Group Study.|Completed||N/A|59|Actual|FREMAP Mutual Insurance Company for Occupational Accidents and Diseases||2|||f||||f||||||||||2017-10-10 23:37:59.983177|2017-10-10 23:37:59.983177
NCT02348255|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-01-31|||January 2016|Actual|2016-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse|A Phase II, Multi-institutional Trial of NOVO-TTF-100A, BCNU and Bevacizumab for GBM in First Relapse|Withdrawn||Phase 2|0|Actual|University of California, Davis||1||Poor Accrual|f||||t||||||||||2017-10-10 23:38:00.193829|2017-10-10 23:38:00.193829
NCT02348242|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-02-10|||December 2014||2014-12-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|OCUREA2||Ocular Surface Disorders in Patients in Intensive Care Units, a Comparative Study of Three Preventive Approaches|Ocular Surface Disorders in Patients in Intensive Care Units, a Comparative Study|Completed||N/A|49|Actual|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f||||||||||2017-10-10 23:38:00.843309|2017-10-10 23:38:00.843309
NCT02348229|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-17|2015-01-27|||September 2013||2013-09-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|ERASAG||Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins|Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins in Patients With Advanced Gastric Cancer|Completed||N/A|149|Actual|First Hospital of Jilin University||2|||f||||f||||||||||2017-10-10 23:38:00.958901|2017-10-10 23:38:00.958901
NCT02348216|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-09-11|||January 2015||2015-01-01|August 2017|2017-08-01||||March 2017|Actual|2017-03-01||Interventional|ZUMA-1||A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1)|A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)|Recruiting||Phase 1/Phase 2|142|Anticipated|Kite Pharma, Inc.||1|||f||||t||||||||||2017-10-10 23:38:01.090214|2017-10-10 23:38:01.090214
NCT02348203|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-27|2017-09-29|||January 13, 2016|Actual|2016-01-13|September 2017|2017-09-01||||January 31, 2019|Anticipated|2019-01-31||Interventional|||Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers|Clinical Study of the Effect of Combined Treatment of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers|Recruiting||Phase 2|66|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-10 23:38:01.322574|2017-10-10 23:38:01.322574
NCT02348190|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-11-23|||June 2003||2003-06-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Fat Induced Insulin Resistance and Atherosclerosis|Fat Induced Insulin Resistance and Atherosclerosis|Completed||N/A|86|Actual|Temple University||2|||f||||f||||||||||2017-10-10 23:38:01.505697|2017-10-10 23:38:01.505697
NCT02348177|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-05-10|||January 2013||2013-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB|A Pharmacokinetics Study Comparing Lopinavir Plasma Exposure When Given as Lopinavir/Ritonavir (1:1) in the Presence of Rifampicin and Lopinavir/Ritonavir (4:1) Without Rifampicin in HIV and TB Co-infected Children in South Africa.|Completed||Phase 4|96|Actual|Drugs for Neglected Diseases||1|||f||||t||||||||||2017-10-10 23:38:01.598429|2017-10-10 23:38:01.598429
NCT02348164|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-01-27|||December 2007||2007-12-01|January 2015|2015-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Human Lycopene and Beta-cryptoxanthin Absorption From Citrus Fruit|Human Lycopene and Beta-cryptoxanthin Absorption From Citrus Fruit|Completed||N/A|23|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 23:38:01.794913|2017-10-10 23:38:01.794913
NCT02348151|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-03-09|||January 2014||2014-01-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|March 2015|Actual|2015-03-01||Interventional|(SWTiCOPD)||Shuttle Walk Test Performed on a Treadmill Versus a Corridor in Patients With COPD|Analysis of Metabolic and Ventilatory Demands During the Shuttle Walk Test Performed on a Treadmill Versus a Corridor in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Recruiting|N/A|47|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 23:38:01.901003|2017-10-10 23:38:01.901003
NCT02348138|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-10-02|||June 2015||2015-06-01|October 2017|2017-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Isometric Handgrip Training on Cardiovascular Risk in Hypertensives|Effect of Isometric Handgrip Training on Cardiovascular Risk in Hypertensives|Completed||N/A|72|Actual|University of Pernambuco||3|||f||||t||||||||||2017-10-10 23:38:02.048637|2017-10-10 23:38:02.048637
NCT02348125|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-04-12|||March 2016||2016-03-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MitoASD||Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?|Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?|Recruiting||Phase 1|50|Anticipated|Drexel University||1|||f||||f||||||||||2017-10-10 23:38:02.17615|2017-10-10 23:38:02.17615
NCT02348112|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-03-13|||January 2015||2015-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence|A Post-Market Evaluation of the Altis® Single Incision Sling System Versus Transobturator or Retropubic Mesh Sling in the Treatment of Female Stress Urinary Incontinence|Recruiting||N/A|356|Anticipated|Coloplast A/S|||2||f||||f||||||||No||2017-10-10 23:38:02.277922|2017-10-10 23:38:02.277922
NCT02348099|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-04-20|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes|Ultrasound Guided Detection and Characterization of Subclinical Lipohypertrophy in Type 1 and Type 2 Diabetes Mellitus|Recruiting||N/A|100|Anticipated|University of British Columbia|||1||f||||f|f|f||||||No||2017-10-10 23:38:02.52115|2017-10-10 23:38:02.52115
NCT02348086|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-04-18|||January 2015||2015-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Outcomes Data of Adipose Stem Cells to Treat Rheumatoid Arthritis|Autologous Adipose Stromal Vascular Fraction Outcomes in Rheumatoid Arthritis Research Study|Recruiting||N/A|50|Anticipated|StemGenex|||1||f||||f||||||||||2017-10-10 23:38:02.596023|2017-10-10 23:38:02.596023
NCT02348073|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2015-09-21|||March 2015||2015-03-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AGPIn3||Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy|Efficacy of Phosphatidylserine Enriched With Polyunsaturated n-3 Fatty Acid Supplementation on Attention Deficit Disorders in Children With Epilepsy. A Randomized Double-blind Placebo-controlled Trial|Recruiting||Phase 3|272|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:38:02.661546|2017-10-10 23:38:02.661546
NCT02348060|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-04-18|||November 2015||2015-11-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Outcomes Data of Adipose Stem Cells to Treat Chronic Obstructive Pulmonary Disease|Autologous Adipose Stromal Vascular Fraction Outcomes in Chronic Obstructive Pulmonary Disease Research Study|Recruiting||N/A|75|Anticipated|StemGenex|||1||f||||f||||||||||2017-10-10 23:38:02.796063|2017-10-10 23:38:02.796063
NCT02348047|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-05-11|||March 11, 2015|Actual|2015-03-11|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2015|Actual|2015-04-01||Interventional|S5-SAMU||(S5-SAMU) Randomized Study Comparing the ASV (Adaptative Support Ventilation) to Conventional Ventilation|Randomized Study Comparing the ASV to Conventional Ventilation for Intubated Patients During Inter-hospital Transfers. Controlled Randomized Monocentric Prospective Study Comparing ASV Versus Conventional Ventilation Modes|Terminated||Phase 4|27|Actual|Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer||2||PI resignation|f||||f||||||||||2017-10-10 23:38:02.860294|2017-10-10 23:38:02.860294
NCT02348034|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-04-25|||November 2015||2015-11-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Randomized Controlled Trial Exploring the Ability of Negative Pressure Wound Therapy (NPWT) to Reduce Colorectal Surgical Site Infections (SSI)|A Randomized Controlled Trial Exploring the Ability of Negative Pressure Wound Therapy (NPWT) to Reduce Colorectal Surgical Site Infections (SSI)|Recruiting||N/A|398|Anticipated|University of Saskatchewan||2|||f||||t||||||||||2017-10-10 23:38:02.93255|2017-10-10 23:38:02.93255
NCT02348021|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-09-28|||July 2014||2014-07-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|April 2016|Anticipated|2016-04-01||Interventional|||Leaders Free Japan|BF-14J01 Drug Coated Stent (DCS) Clinical Trial|Unknown status|Active, not recruiting|Phase 3|139|Anticipated|Biosensors Europe SA||1|||f||||f||||||||||2017-10-10 23:38:03.061883|2017-10-10 23:38:03.061883
NCT02348008|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-08-02|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:|Phase Ib and Phase II Studies of Anti-PD-1 Antibody MK-3475 in Combination With Bevacizumab for the Treatment of Metastatic Renal Cell Carcinoma: Big Ten Cancer Research Consortium GU14-003|Active, not recruiting||Phase 1/Phase 2|61|Actual|Big Ten Cancer Research Consortium||2|||f||||t||||||||||2017-10-10 23:38:03.157915|2017-10-10 23:38:03.157915
NCT02347995|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-06-06|||August 24, 2015|Actual|2015-08-24|June 2017|2017-06-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|REPS||Resistive Training Combined With Nutritional Therapy After Stroke|Resistive Training Combined With Nutritional Therapy After Stroke|Recruiting||N/A|150|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-10 23:38:03.374162|2017-10-10 23:38:03.374162
NCT02347982|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-04-20|||June 2015||2015-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|1 Day|Observational [Patient Registry]|ELDER-TURK||Epidemiology of Cardiovascular Disease in Elderly Turkish Population|Epidemiology of Cardiovascular Disease in Elderly Turkish Population|Completed||N/A|2500|Actual|Turkish Society of Cardiology|||1||f||||f||||||||||2017-10-10 23:38:03.502975|2017-10-10 23:38:03.502975
NCT02347969|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-09-20|||October 2014||2014-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of the Effect of the Dietary Supplement X34 on Skin Radiance of Healthy Volunteers With Dull Complexion|Evaluation of the Effect of the Dietary Supplement X34 on Skin Radiance of Healthy Volunteers With Dull Complexion|Completed||N/A|35|Actual|Nutratech Conseils||1|||f||||f||||||||||2017-10-10 23:38:03.562818|2017-10-10 23:38:03.562818
NCT02347956|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-11-12|||January 2015||2015-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer||Completed||Phase 1/Phase 2|19|Actual|Yonsei University||1|||f||||f||||||||||2017-10-10 23:38:03.639101|2017-10-10 23:38:03.639101
NCT02347930|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-03-28|||April 2014||2014-04-01|October 2015|2015-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury|Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury|Unknown status|Recruiting|N/A|300|Anticipated|RenJi Hospital|||1||f||||f||||||Samples Without DNA|"     only plasma and urine   "|||2017-10-10 23:38:03.830726|2017-10-10 23:38:03.830726
NCT02347917|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-08-02|||February 2015||2015-02-01|July 2017|2017-07-01||||November 2017|Anticipated|2017-11-01||Interventional|||A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma|A Phase I/II Clinical Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma|Active, not recruiting||Phase 1/Phase 2|24|Actual|Sumitomo Dainippon Pharma Co., Ltd.||1|||f||||||||||||||2017-10-10 23:38:03.927413|2017-10-10 23:38:03.927413
NCT02347904|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-07-26|||December 2014||2014-12-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SOX||Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer|Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer|Recruiting||Phase 1|40|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-10 23:38:04.028475|2017-10-10 23:38:04.028475
NCT02347891|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-18|||January 2015||2015-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|BIM||Belimumab in Myositis|Belimumab for Maintenance Therapy in Idiopathic Inflammatory Myositis|Recruiting||Phase 2/Phase 3|60|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-10 23:38:04.123211|2017-10-10 23:38:04.123211
NCT02347878|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-01-26|||April 2015||2015-04-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)|Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)|Unknown status|Not yet recruiting|Phase 4|85|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:38:06.077045|2017-10-10 23:38:06.077045
NCT02347865|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-05-30|||June 16, 2015|Actual|2015-06-16|May 2017|2017-05-01|July 20, 2018|Anticipated|2018-07-20|March 22, 2017|Actual|2017-03-22||Observational|PILOTE||Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France|Prospective Observational Study to Describe Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France and Its Use in Routine Clinical Practice|Active, not recruiting||N/A|777|Actual|Amgen|||2||f||||f||||||||||2017-10-10 23:38:06.173256|2017-10-10 23:38:06.173256
NCT02347852|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-08-29|||January 20, 2015|Actual|2015-01-20|August 2017|2017-08-01|September 8, 2016|Actual|2016-09-08|September 8, 2016|Actual|2016-09-08||Observational|REGO-ACT||Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer|Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer|Completed||N/A|25|Actual|Bayer|||1||f||||t||||||||||2017-10-10 23:38:06.261359|2017-10-10 23:38:06.261359
NCT02347826|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-01-27|||January 2014||2014-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Observational|SCW||Evaluation of Satisfaction in Patients Undergoing Non Surgical Lifting by Means of Coned Wires.|Evaluation of Aesthetic Satisfaction in Patients Undergoing Non Surgical Face and Neck Lift by Means of Coned Wires.|Completed||N/A|243|Actual|AQ-DE|||1||f||||f||||||||||2017-10-10 23:38:06.448928|2017-10-10 23:38:06.448928
NCT02347813|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-08-25|||November 2014||2014-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preventing Squamous Cell Skin Cancer|Chemoprevention of Squamous Cell Cancer of the Skin in High Risk Patients|Enrolling by invitation||Phase 2|40|Anticipated|University of Rochester||2|||f||||t||||||||No||2017-10-10 23:38:06.507903|2017-10-10 23:38:06.507903
NCT02347787|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-05-02|||January 2015||2015-01-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2016|Actual|2016-12-01||Interventional|IMPaCT||A Multi-center Trial of IMPaCT CHW Support for Chronically-ill Patients|A Multi-center Trial of Clinician Versus Community Health Worker Support to Help Low Socioeconomic, Chronically-ill Patients Achieve Health Goals|Active, not recruiting||N/A|444|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:38:06.580703|2017-10-10 23:38:06.580703
NCT02347774|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-05-16||2016-03-18|February 2015||2015-02-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|GOLDEN-4||Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer|Completed||Phase 3|641|Actual|Sunovion Respiratory Development Inc.||3|||f||||f||||||||||2017-10-10 23:38:06.657215|2017-10-10 23:38:06.657215
NCT02347761|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-05-16||2016-03-18|February 2015||2015-02-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|GOLDEN-3||Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-3 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)|Completed||Phase 3|653|Actual|Sunovion Respiratory Development Inc.||3|||f||||f||||||||||2017-10-10 23:38:07.02053|2017-10-10 23:38:07.02053
NCT02347748|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-10-04|||January 2015||2015-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comfort Talk for Pediatric Cardiac Catheterization|The Impact of Comfort Talk on Anxiety Levels and Procedural Experience in a Pediatric Population Undergoing Cardiac Catheterization: A Prospective Randomized Controlled Trial|Recruiting||N/A|160|Anticipated|The Hospital for Sick Children||4|||f||||t||||||||||2017-10-10 23:38:07.239999|2017-10-10 23:38:07.239999
NCT02347735|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-08-03|||August 2015||2015-08-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|REVEAL||Predictive Factors for Anastomotic Leakage After Colorectal Surgery|Predictive Factors for Anastomotic Leakage After Colorectal Surgery: The REVEAL Study|Recruiting||N/A|628|Anticipated|Maastricht University Medical Center|||2||f||||t||||||Samples With DNA|"     Buccal swab   "|Undecided||2017-10-10 23:38:07.375907|2017-10-10 23:38:07.375907
NCT02347722|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-06-26|||May 2015||2015-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Biomarkers to Classify Heart Failure|Evaluation of Existing Biomarker Candidates to Accurately Classify the Etiology of Heart Failure|Recruiting||N/A|825|Anticipated|Ottawa Heart Institute Research Corporation|||3||f||||f||||||Samples Without DNA|"     Serum and plasma for biomarkers   "|No|Data will be presented as the mean and standard deviation for the main cohort and sub-groups.|2017-10-10 23:38:07.503135|2017-10-10 23:38:07.503135
NCT02347709|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-01-05|||December 2014||2014-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Differential Characteristics of Neuropathy in Type 2 Diabetics With and Without Lower Extremity Wounds|Differential Clinical, Molecular, and Pathological Characteristics of Neuropathy in Type 2 Diabetics With and Without Lower Extremity Wounds-a Pilot Study|Recruiting||N/A|30|Anticipated|Winthrop University Hospital|||3||f||||f||||||Samples Without DNA|"     Tissue samples will be obtained via 3mm punch biopsy during standard of care wound     debridement.   "|||2017-10-10 23:38:07.597662|2017-10-10 23:38:07.597662
NCT02347696|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-07-25|||March 2015||2015-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Diet and Physical Activity on NAFLD and Erytrocyte Membrane Lipid Profile.|Effect of Two Programs of Physical Activity of Different Intensity, Mediterranean Diet and the Combination of Both on NAFLD and Erytrocyte Membrane Lipid Profile.|Recruiting||N/A|240|Anticipated|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis||6|||f||||t||||||||Yes|When data analysis will finish|2017-10-10 23:38:07.704087|2017-10-10 23:38:07.704087
NCT02347683|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy|Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy|Completed||N/A|50|Actual|University of Nebraska|||2||f||||f||||||||||2017-10-10 23:38:07.802911|2017-10-10 23:38:07.802911
NCT02347670|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-11-26|||August 2014||2014-08-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population|Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population|Completed||N/A|155|Actual|Wills Eye||4|||f||||f||||||||Yes|A manuscript has been published.|2017-10-10 23:38:07.868319|2017-10-10 23:38:07.868319
NCT02347657|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-02-07|||January 2015||2015-01-01|February 2017|2017-02-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor|A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation|Completed||Phase 3|509|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||t||||||||||2017-10-10 23:38:07.958464|2017-10-10 23:38:07.958464
NCT02347644|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-12-02|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|PSUUKR||Prevention of Substance Use in Youth in Ukraine|Pilot Study of Prevention of Alcohol and Other Drug Use Using Motivational Interviewing Among Youth in Ukraine|Completed||N/A|121|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:38:08.289066|2017-10-10 23:38:08.289066
NCT02347293|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-05-26|||October 2014||2014-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Over-night Effect of Dietary Fiber on Glucose Metabolism and Satiety|Indigestible Carbohydrates in an Over-night Design as Means to Modulate Colonic Events, With Specific Focus on Metabolism and Satiety|Completed||Early Phase 1|21|Actual|Lund University||2|||f||||f||||||||||2017-10-10 23:38:11.029055|2017-10-10 23:38:11.029055
NCT02347631|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-05-02|||April 2016||2016-04-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|TruEyeTotal1||DAILIES TOTAL1 Versus ACUVUE TruEye|A Comparison of the Effects of Alcon DAILIES TOTAL1 and a Control High Oxygen Permeable Silicone Hydrogel Daily Disposable Contact Lens, the ACUVUE TruEye, on the Biology of the Ocular Surface and Lid Margin|Recruiting||N/A|94|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 23:38:08.392418|2017-10-10 23:38:08.392418
NCT02347618|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-04-25|||December 2014||2014-12-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer|Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer|Recruiting||N/A|12|Anticipated|University of Rochester||1|||f||||t||||||||||2017-10-10 23:38:08.492172|2017-10-10 23:38:08.492172
NCT02347592|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-01-21|||November 2007||2007-11-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Peritoneal Dialysis Catheter Function|Comparison of Self-locating Catheter Versus a Straight Catheter for Outflow Problems.|Completed||N/A|62|Actual|University Hospital, Umeå||2|||f||||f||||||||||2017-10-10 23:38:08.662549|2017-10-10 23:38:08.662549
NCT02347579|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-04-06|||June 2014||2014-06-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BrainEXPain||Neurophysiological Basis of Rehabilitation in Complex Regional Pain Syndrome, Type I and Chronic Low Back Pain|Neurophysiological Basis of Rehabilitation in Complex Regional Pain Syndrome, Type I and Chronic Low Back Pain|Recruiting||N/A|60|Anticipated|Maastricht University Medical Center|||3||f||||f||||||||||2017-10-10 23:38:08.738661|2017-10-10 23:38:08.738661
NCT02347566|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-04-18|||February 2015||2015-02-01|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|PAEP||Physical Activity Enhancing Programme in COPD|The Efficacy of a Physical Activity Enhancing Programme Using Activity Monitors With Set Targets and Feedback for Enhancing Physical Activity Levels in Patients With COPD Attending Pulmonary Rehabilitation.|Completed||N/A|46|Actual|University of Edinburgh||2|||f||||t||||||||||2017-10-10 23:38:08.819821|2017-10-10 23:38:08.819821
NCT02347553|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-04-06|||August 2014||2014-08-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Effect of Hypoglycaemia on Social Cognition and Cardiac Conduction|The Effect of Hypoglycaemia on Social Cognition and Cardiac Conduction in Adults With Type 1 Diabetes|Completed||N/A|16|Actual|University of Edinburgh|||1||f||||f||||||||No||2017-10-10 23:38:08.946819|2017-10-10 23:38:08.946819
NCT02347540|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-21|||December 2014||2014-12-01|January 2015|2015-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|QoH||Heart Failure and Related Risk-factors After Preeclampsia|Queen of Hearts Research Program|Recruiting||N/A|2580|Anticipated|Maastricht University Medical Center|||2||f||||t||||||Samples With DNA|"     The investigators will perform an unbiased screen for the human genome content of circulating     microRNAs. Standard HF biomarkers will be included so that the added value of these novel     HFpEF miRNAs can be directly compared to established HF biomarkers. In this cohort of women     who experienced pre-eclampsia and matched controls the investigators will profile miRNAs on a     genome wide scale using total RNA from plasma. Differentially expressed miRNAs will be     further investigated in relation to the pathogenesis of micro- and macrovascular disease.     Selected miRNAs will be placed on a custom megaplex array and used to screen a cohort of     patients with HFpEF. In patients with HFpEF the investigators will relate miRNA expression     level to the circulating levels of angiopoietin-2/ang-1ratio's and micro-albuminuria. Part of     the obtained blood and urine will be stored at the Biobank in Maastricht for future studies.   "|||2017-10-10 23:38:09.018524|2017-10-10 23:38:09.018524
NCT02347527|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-08-29|||May 2013||2013-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Neuronal and Behavioral Effects of Implicit Priming in Obese Individuals|Neuronal and Behavioral Effects of Implicit Priming in Obese Individuals|Recruiting||N/A|100|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:38:09.110354|2017-10-10 23:38:09.110354
NCT02347514|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-01-17|||November 2014||2014-11-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Implementing Diabetes Group Visits in Community Health Centers|Implementing Diabetes Group Visits in Community Health Centers|Active, not recruiting||N/A|343|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 23:38:09.210114|2017-10-10 23:38:09.210114
NCT02347501|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-27|||November 2013||2013-11-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|DINUP||Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)|Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP): A Randomised Clinical Trial|Completed||Phase 2|118|Actual|University College Dublin||2|||f||||t||||||||||2017-10-10 23:38:09.29068|2017-10-10 23:38:09.29068
NCT02347488|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-03-20|2016-11-03||February 2015||2015-02-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||Endotracheal Tube Holder and Bite Guard Research|Testing a Novel Combined Endotracheal Tube Holder and Bite Guard in Neurosurgical Patients, Thoracic Surgery Patients, and Orthopedic and Neurosurgical Spine Surgery Patients.|Completed||Phase 4|30|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-10-10 23:38:09.428022|2017-10-10 23:38:09.428022
NCT02347475|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-09-12|||January 2015||2015-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SPARTAN||SMA Flow Patterns in Neonatal Transfusion|Impact of Red Cell Transfusion on Superior Mesenteric Artery Flow Patterns and Intestinal Oxygenation in Fed Preterm Neonates (SPARTAN: Sma PAttern Related to TrAnsfusion in Neonates)|Recruiting||N/A|70|Anticipated|University of Calgary|||1||f||||f||||||||||2017-10-10 23:38:09.67864|2017-10-10 23:38:09.67864
NCT02347280|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-08-15|||January 2015||2015-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Loop Ileostomy With Colonic Lavage for Fulminant Clostridium Difficile Colitis|Less May be More: Loop Ileostomy With Colonic Lavage for Fulminant Clostridium Difficile Colitis A Prospective National Multi-Center Cohort Study|Recruiting||N/A|126|Anticipated|Jewish General Hospital||2|||f||||t||||||||||2017-10-10 23:38:11.108609|2017-10-10 23:38:11.108609
NCT02347462|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-09-19|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Bilevel Positive Airway Pressure (BiPAP) for the Treatment of Moderate to Severe Acute Asthma Exacerbations|A Prospective Open Randomized Clinical Trial Comparing Bilevel Positive Airway Pressure (BiPAP) Therapy Against Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma Unresponsive to Inhaled Bronchodilators.|Withdrawn||N/A|0|Actual|University of British Columbia||2||we were not able to work through the logistics of the study to support enrolment in ER|f||||f||||||||||2017-10-10 23:38:09.749563|2017-10-10 23:38:09.749563
NCT02347449|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-01-04|||October 2014||2014-10-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population|The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population of Patients With Estrogen Receptor- Positive Early Breast Cancer With 1-3 Positive Lymph Nodes|Recruiting||N/A|100|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-10 23:38:09.836886|2017-10-10 23:38:09.836886
NCT02347436|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-02-27|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Does Benign Prostatic Obstruction Cause Hypertension?|Effect of Transurethral Prostate Resection on 24 Hour Blood Pressure Measurement|Recruiting||N/A|80|Anticipated|St. Olavs Hospital|||2||f||||f||||||||||2017-10-10 23:38:09.920967|2017-10-10 23:38:09.920967
NCT02347423|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-05|||February 2015||2015-02-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants|Immunogenicity and Safety of 3 Adjuvated Reduced Dose Inactivated Polio Vaccines (IPV-Al SSI) and Non-adjuvated Full Dose IPV SSI, Given as Primary Vaccinations to Infants at 6, 10 and 14 Weeks of Age|Completed||Phase 2|824|Actual|Statens Serum Institut||4|||f||||t||||||||No||2017-10-10 23:38:09.99251|2017-10-10 23:38:09.99251
NCT02347410|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-11-29|||February 2015||2015-02-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|SCOUT||Spineology Clinical Outcomes Trial: An IDE Investigation|Spineology Clinical Outcomes Trial: An Investigation Device Exempt (IDE) Performance Goal Clinical Investigation|Recruiting||N/A|102|Anticipated|Spineology, Inc||1|||f||||t||||||||||2017-10-10 23:38:10.113358|2017-10-10 23:38:10.113358
NCT02347397|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-25|||April 29, 2015|Actual|2015-04-29|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Project JAY HAP Registration Study|A Prospective, Randomized, Multicenter Clinical Study in Elderly Chinese Subjects to Compare the Safety and Efficacy of the SS Bipolar Head and SL-TWIN Stem With Bipolar Head and SL-PLUS Stem in Hemiarthroplasty of the Hip|Active, not recruiting||N/A|134|Actual|Smith & Nephew Orthopaedics (Beijing) Limited||2|||f||||f|f|f||||||No||2017-10-10 23:38:10.247251|2017-10-10 23:38:10.247251
NCT02347384|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-25|||April 20, 2015||2015-04-20|April 2017|2017-04-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional|||Project JAY THA Registration Study|A Prospective, Randomized, Multicenter Clinical Study in Chinese Subjects to Compare the Safety and Efficacy of the Delta PLUS Femoral Head and SL-TWIN Stem With BIOLOX Forte Ball Head and SL-PLUS Stem in Total Hip Arthroplasty|Completed||N/A|100|Actual|Smith & Nephew Orthopaedics (Beijing) Limited||2|||f||||f|f|f||||||No||2017-10-10 23:38:10.338347|2017-10-10 23:38:10.338347
NCT02347371|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-04-14|||January 2015||2015-01-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01|5 Years|Observational [Patient Registry]|||Heart Transplant Registry of Városmajor|Follow-up Registry of Heart Transplant Recipients, to Determine Long Term Outcome and Need for Further Interventional and Non-interventional Procedures|Recruiting||N/A|20|Anticipated|Semmelweis University Heart and Vascular Center|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-10 23:38:10.420055|2017-10-10 23:38:10.420055
NCT02347358|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2015-01-26|||February 2015||2015-02-01|January 2015|2015-01-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke|Mechanical Opening Device Implantation Following Intravenous r-tPA and Recanalization Outcome Evaluation in Stroke Disease (MODIFIED) Trial|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|The Second Artillery General Hospital||2|||f||||t||||||||||2017-10-10 23:38:10.594051|2017-10-10 23:38:10.594051
NCT02347345|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-02-23|||January 2015||2015-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs|The Immunologic Effects of HCV Therapy With Fixed Dose Combination Ledipasvir/Sofosbuvir (HARVONI) in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs.|Active, not recruiting||Phase 4|36|Actual|Rockefeller University||3|||f||||f||||||||No||2017-10-10 23:38:10.702694|2017-10-10 23:38:10.702694
NCT02347332|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-02-17|||April 2014|Actual|2014-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer|Phase III Study of IV Vinflunine in Combination With Methotrexate Versus Methotrexate Alone in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-based Chemotherapy|Active, not recruiting||Phase 3|459|Actual|Pierre Fabre Medicament||2|||f||||t|f|f||||||||2017-10-10 23:38:10.799921|2017-10-10 23:38:10.799921
NCT02347319|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-01-26|||April 2012||2012-04-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease|A Double-Blind, Randomized, Multicenter Trial Examining the Efficacy of Biphenyl Dimethyl Dicarboxylate Combined With Garlic Oil in Patients With Transaminase Elevated Chronic Liver Disease|Completed||Phase 4|262|Actual|PharmaKing||3|||f||||f||||||||||2017-10-10 23:38:10.880943|2017-10-10 23:38:10.880943
NCT02347306|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-26|||January 2015||2015-01-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Observational|||Prospective Identification of High-risk Coronary Plaques Through Non-invasive Imaging|Prospective Identification of High-risk Coronary Plaques Through Non-invasive Imaging|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Papworth Hospital NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:38:10.965389|2017-10-10 23:38:10.965389
NCT02347267|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-26|||May 2012||2012-05-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|August 2012|Actual|2012-08-01||Interventional|||Reduction in Consumption of Sweetened Beverages on Weight, Body Composition and Blood Pressure in Young Adults|The Impact of Reduction in Consumption of Caloric and no Caloric Sweetened Beverages on Weight, Body Composition and Blood Pressure in Young Adults.|Completed||N/A|148|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||3|||f||||f||||||||||2017-10-10 23:38:11.191791|2017-10-10 23:38:11.191791
NCT02347254|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-05-17|||September 2014||2014-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease|Feasibility Trial Evaluating the Safety and Efficacy of ExAblate Transcranial Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for Unilateral Pallidotomy for the Treatment of L-Dopa Induced Dyskinesia (LID) of Parkinson's Disease.|Recruiting||N/A|6|Anticipated|InSightec||1|||f||||f||||||||||2017-10-10 23:38:11.290026|2017-10-10 23:38:11.290026
NCT02347241|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-09-30|||January 2014||2014-01-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|January 2015|Actual|2015-01-01||Interventional|INSPIRE-D||Infant Special Program for In Hospital Resuscitation Education in the Delivery Room|Infant Special Program for In Hospital Resuscitation Education in the Delivery Room - INSPIRE-D|Completed||N/A|435|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 23:38:11.371464|2017-10-10 23:38:11.371464
NCT02347228|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2017-01-25|||July 2017||2017-07-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies|A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies|Not yet recruiting||Phase 1|30|Anticipated|Oneness Biotech Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:38:11.457463|2017-10-10 23:38:11.457463
NCT02347215|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-12-02|||August 2014||2014-08-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|CIAO||Changes in Ischemia and Angina Over 1 Year Among ISCHEMIA Trial Screen Failures With no Obstructive CAD on Coronary CT Angiography|Changes in Ischemia and Angina Over One Year Among ISCHEMIA Trial Screen Failures|Recruiting||N/A|300|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 23:38:11.571911|2017-10-10 23:38:11.571911
NCT02347202|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-19|||October 2015||2015-10-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention|Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention|Recruiting||N/A|240|Anticipated|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-10 23:38:11.654591|2017-10-10 23:38:11.654591
NCT02347176|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-05-11|2017-05-11|2017-02-14|January 23, 2015|Actual|2015-01-23|April 2017|2017-04-01|February 5, 2016|Actual|2016-02-05|November 27, 2015|Actual|2015-11-27||Interventional|D2213C00001||Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis|A Phase 2b, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Tralokinumab in Adult Subjects With Moderate-to-Severe Atopic Dermatitis|Completed||Phase 2|306|Actual|MedImmune LLC||4|||f||||f||||||||||2017-10-10 23:38:11.850289|2017-10-10 23:38:11.850289
NCT02347163|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-12-06|||January 2015||2015-01-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Pre-operative Zoledronate in Triple Negative Breast Cancer|A Multicenter, Single-arm, Phase II Study to Evaluate the Activity of Pre-operative Zoledronate in Triple Negative Breast Cancer Patients, According to p53 Level|Recruiting||Phase 2|40|Anticipated|Mario Negri Institute for Pharmacological Research||1|||f||||f||||||||No|The final clinical study report will be sent to the participating researchers|2017-10-10 23:38:12.740112|2017-10-10 23:38:12.740112
NCT02347150|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-08-17|||March 2015||2015-03-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01|6 Months|Observational [Patient Registry]|||International Multicenter Study of In-hospital Outcome of Patients After ICU Discharge|International Multicenter Study of In-hospital Outcome of Patients After ICU Discharge|Unknown status|Recruiting|N/A|3000|Anticipated|Hospital Vila Franca de Xira|||1||f||||f||||||||||2017-10-10 23:38:12.854144|2017-10-10 23:38:12.854144
NCT02347137|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-21|||July 2012||2012-07-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Influence of Reduced Daily Step Count and Anabolic Interventions on Muscle Protein Metabolism in Older Persons|Efficacy of Isolated Whey and Micellar Whey Protein (+/-Citrulline) to Stimulate Protein Synthesis in 'Healthy' and 'Anabolically Resistant' Elderly Muscle|Completed||N/A|30|Actual|McMaster University||3|||f||||t||||||||||2017-10-10 23:38:12.924364|2017-10-10 23:38:12.924364
NCT02347124|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-08-05|||February 2015||2015-02-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Oral Health Randomized Trial|Promoting Oral Health Among Tobacco Quitline Callers|Active, not recruiting||N/A|718|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-10 23:38:12.994509|2017-10-10 23:38:12.994509
NCT02347111|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-10-31|||February 2015||2015-02-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Pilot Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation|A Pilot and Feasibility Study to Determine If a Common Atrial Fibrillation Risk Locus Modulates Differential Response to Antiarrhythmic Drugs|Active, not recruiting||Phase 4|10|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-10-10 23:38:13.075691|2017-10-10 23:38:13.075691
NCT02347098|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-08-16|||March 30, 2015|Actual|2015-03-30|August 2017|2017-08-01|March 30, 2018|Anticipated|2018-03-30|July 31, 2017|Actual|2017-07-31||Interventional|PREMIER||Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II|Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II|Active, not recruiting||Phase 3|128|Anticipated|VA Office of Research and Development||2|||f||||t|t|t|f|f|f|||||2017-10-10 23:38:13.144724|2017-10-10 23:38:13.144724
NCT02347085|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-06-01|2016-06-03||February 2015||2015-02-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||The MITT Population was a subset of the ITT Population including the subjects who received treatment and had post-treatment efficacy data from both treatment periods.|24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDI|A Randomized, Phase IIIb, Two-period, Two-treatment Double-blind, Multi-center, Crossover Study to Evaluate the 24-hour Lung Function Profile in Subjects With Moderate to Very Severe COPD After 4 Weeks of Treatment With PT003 and Placebo MDI|Completed||Phase 3|43|Actual|Pearl Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:38:13.233714|2017-10-10 23:38:13.233714
NCT02347072|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-03-07|2016-08-19||February 1, 2015|Actual|2015-02-01|March 2017|2017-03-01|March 1, 2016|Actual|2016-03-01|August 1, 2015|Actual|2015-08-01||Interventional||MITT population was a subset of the ITT Population including subjects who received treatment and had post treatment efficacy data from at least 2 treatment periods and this population is used for baseline characteristics. Participant Flow includes all patients randomized, regardless of treatment received.|24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo|A Randomized, Phase IIIb, Three-period, Three-treatment, Double-blind, Multi-center, Crossover Study to Evaluate the 24-hour Lung Function Profile in Subjects With Moderate to Very Severe COPD After 4 Weeks of Treatment With PT003, Open-Label Spiriva® Respimat® (Tiotropium Bromide) as an Active Control, and Placebo|Completed||Phase 3|80|Actual|Pearl Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 23:38:13.639145|2017-10-10 23:38:13.639145
NCT02347059|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-26|||January 2015||2015-01-01|January 2015|2015-01-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease|A Randomized, Single-blind Trial on the Efficacy and Safety of L-dopa Monotherapy Versus Dopamine Agonists Monotherapy After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease|Unknown status|Recruiting|Phase 2|40|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-10 23:38:14.100267|2017-10-10 23:38:14.100267
NCT02347046|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-03-05|||January 2015||2015-01-01|January 2015|2015-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)|Clinical Pharmacology Study of FYU-981 for Subjects With Renal Insufficiency.|Completed||Phase 1|18|Actual|Fuji Yakuhin Co., Ltd.||3|||f||||||||||||||2017-10-10 23:38:14.195142|2017-10-10 23:38:14.195142
NCT02347033|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-07-08|||August 2014||2014-08-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ToSCA||Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety|RCT of Sertraline Versus Cognitive Behavioural Therapy for Anxiety Symptoms in People With Generalised Anxiety Disorder Who Have Failed to Respond to Low Intensity Psychological Interventions as Defined by the NICE GAD Guidelines|Terminated||Phase 4|5|Actual|University College, London||2||Difficulties with recruitment during the internal pilot phase|f||||t||||||||Undecided|To be discussed and decided by the Data Monitoring Committee|2017-10-10 23:38:14.282129|2017-10-10 23:38:14.282129
NCT02347020|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-05-10|||October 2014||2014-10-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Impact of Sleep and Meal Timing on Food Intake Regulation|Impact of Sleep and Meal Timing on Food Intake Regulation|Completed||N/A|6|Actual|Columbia University||4|||f||||t||||||||||2017-10-10 23:38:14.391646|2017-10-10 23:38:14.391646
NCT02347007|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-01-30|||October 2014|Actual|2014-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults|Impact of Almond Supplementation, Relative to a Low-fat, High Carbohydrate Control, on Body Composition in Overweight and Obese Black and Hispanic Adults|Active, not recruiting||N/A|26|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-10 23:38:14.484192|2017-10-10 23:38:14.484192
NCT02346994|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-01-30|||January 2013||2013-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Development of Melt Organic Baking Fat for Reducing Child Obesity|Development and Expansion of Melt Organic Baking Fat for Oxidative Stability and Reducing Child Obesity|Completed||N/A|15|Actual|Columbia University||2|||f||||t||||||||Undecided||2017-10-10 23:38:14.611427|2017-10-10 23:38:14.611427
NCT02346981|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-26|||February 2008||2008-02-01|January 2015|2015-01-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Resistance Training and Post-exercise Blood Pressure in Normotensive Older Women|Chronic Resistance Training and Post-exercise Blood Pressure in Normotensive Older Women|Completed||N/A|28|Actual|Universidade Estadual de Londrina||2|||f||||f||||||||||2017-10-10 23:38:14.69806|2017-10-10 23:38:14.69806
NCT02346968|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-08-29|||October 2014||2014-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Evaluation of CAF22 After Renal Transplantation|Evaluation of Serum and Urinary C-terminal Agrin Fragment-22 (CAF22) as Novel Renal Function Marker in Kidney Transplant Recipients - A Prospective Observational Study|Recruiting||N/A|60|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||Samples Without DNA|"     Serum, urine   "|||2017-10-10 23:38:14.769372|2017-10-10 23:38:14.769372
NCT02346955|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-03-15|||February 2015||2015-02-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)|A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies|Terminated||Phase 1|27|Actual|Merck Sharp & Dohme Corp.||9|||f||||t||||||||||2017-10-10 23:38:14.873178|2017-10-10 23:38:14.873178
NCT02346942|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-02-03|||June 2006||2006-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Factors Associated With Biologic DMARD Switching|Factors Associated With Biologic Disease Modifying Antirheumatic Drugs Switching and Impact of Healthcare Resource Utilization in a Managed Care Setting|Completed||N/A|4099|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 23:38:14.985896|2017-10-10 23:38:14.985896
NCT02346929|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-09-25|||August 2014|Actual|2014-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|Hematoma Block||Hematoma Block for Distal Radius Fracture|"Comparison of Ultrasound-guided Hematoma Block and Blind Hematoma Block for Analgesia in Distal Radius Fractures"|Recruiting||N/A|115|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-10 23:38:15.091268|2017-10-10 23:38:15.091268
NCT02346916|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-08-27|||October 2013||2013-10-01|August 2015|2015-08-01||||August 2015|Anticipated|2015-08-01||Interventional|||Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac Ischemia|Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac Ischemia|Unknown status|Active, not recruiting|N/A|75|Anticipated|Bassett Healthcare||1|||f||||f||||||||||2017-10-10 23:38:15.216463|2017-10-10 23:38:15.216463
NCT02346903|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-08-27|||April 2013||2013-04-01|August 2015|2015-08-01||||August 2015|Anticipated|2015-08-01||Interventional|||Chest Pain Perception and Capsaicin Sensitivity|Chest Pain Perception and Capsaicin Sensitivity|Unknown status|Active, not recruiting|N/A|100|Anticipated|Bassett Healthcare||1|||f||||f||||||||||2017-10-10 23:38:15.297231|2017-10-10 23:38:15.297231
NCT02346890|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-01-26|||April 2013||2013-04-01|January 2015|2015-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722|A Phase 1, Single-center, Randomized, 2-way Crossover, Open Label Study to Evaluate the Effect of Renvela on the Pharmacodynamics of AZD1722 in Healthy Volunteeers|Completed||Phase 1|16|Actual|Ardelyx||2|||f||||f||||||||||2017-10-10 23:38:15.374595|2017-10-10 23:38:15.374595
NCT02346877|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-03-23|2016-10-20||April 2015||2015-04-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis|A Multicenter, Historical Control Study to Evaluate the Effects of Personalized Patient Counselling on Persistence to Enbrel® Therapy in Subjects With Rheumatoid Arthritis (PerSuit)|Terminated||Phase 4|19|Actual|Amgen||2||Business Decision|f||||f||||||||||2017-10-10 23:38:15.472767|2017-10-10 23:38:15.472767
NCT02346864|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2015-01-20|||December 2013||2013-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Three-Stair-Position on Improvement of Apnea of Prematurity|Effect of Three-Stair-Position on Improvement of Apnea of Prematurity and Feeding Performance in Prematurity: A Randomized Control Trial|Completed||N/A|144|Actual|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 23:38:15.706591|2017-10-10 23:38:15.706591
NCT02346851|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-01-20|||October 2012||2012-10-01|January 2015|2015-01-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||The Effects of Accelerometer Triggered Functional Electrical Stimulation on Post-Stroke Hemiplegic Shoulder Subluxation||Unknown status|Recruiting|N/A|60|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-10 23:38:15.788428|2017-10-10 23:38:15.788428
NCT02346838|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-06-01|||January 2014||2014-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Prebiotics, Gut Microbiota, and Cardiometabolic Health|The Effect of Prebiotics on Insulin Sensitivity, Metabolic Flexibility, and Cardiovascular Health in Prediabetic Adults.|Active, not recruiting||N/A|22|Actual|Virginia Polytechnic Institute and State University||2|||f||||t||||||||||2017-10-10 23:38:15.902207|2017-10-10 23:38:15.902207
NCT02346825|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-11-02|||January 2014||2014-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|The Baby CHAMP||The Baby CHAMP Study (Children With Hemiparesis Arm and Movement Project)|Multisite RCT of 3 Neurorehabilitation Therapies for Infants With Asymmetrical Cerebral Palsy|Recruiting||Phase 1/Phase 2|72|Anticipated|Virginia Polytechnic Institute and State University||3|||f||||f||||||||||2017-10-10 23:38:15.99641|2017-10-10 23:38:15.99641
NCT02346812|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-04-29|||January 2015||2015-01-01|January 2015|2015-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Brassica Intake and Isothiocyanate Absorption|Brassica Intake and Isothiocyanate Absorption: Intake Patterns May Have Implications for Cancer Prevention by Dietary Brassica Vegetables|Completed||N/A|18|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 23:38:16.119916|2017-10-10 23:38:16.119916
NCT02346799|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-08-18|||January 2015||2015-01-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|Routines||Creating Exercise Habits Through Incentives for Routines|Creating Exercise Habits Through Incentives for Routines|Completed||N/A|2702|Actual|University of Pennsylvania||5|||f||||f||||||||||2017-10-10 23:38:16.185096|2017-10-10 23:38:16.185096
NCT02346786|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-02-08|||April 2015||2015-04-01|February 2015|2015-02-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Interventional|||Epidemiology of Incidents and Accidents in Sport. Influence of Moisture.|Epidemiology of Incidents and Accidents in Sport. Influence of Moisture.|Unknown status|Not yet recruiting|Phase 3|50|Anticipated|Centre de Recherche Rhumatologique et Thermal||2|||f||||f||||||||||2017-10-10 23:38:16.263592|2017-10-10 23:38:16.263592
NCT02346773|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-12-08|||November 2008||2008-11-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.|Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.|Completed||N/A|40|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-10 23:38:16.335789|2017-10-10 23:38:16.335789
NCT02346760|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-02-07|||December 2015||2015-12-01|October 2016|2016-10-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers|A Phase I, Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Subcutaneous Dose of UB-621 in Healthy Volunteers|Completed||Phase 1|15|Actual|United BioPharma||1|||f||||t||||||||||2017-10-10 23:38:16.415255|2017-10-10 23:38:16.415255
NCT02346747|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-09-26|||February 2015||2015-02-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|VITAL||Phase 2 Trial of Maintenance Vigil for High Risk Stage IIIb-IV Ovarian Cancer|A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell Immunotherapy in Subjects With Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy|Active, not recruiting||Phase 2/Phase 3|89|Actual|Gradalis, Inc.||2|||f||||t||||||||||2017-10-10 23:38:16.482508|2017-10-10 23:38:16.482508
NCT02346734|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-05-02|||July 2012||2012-07-01|May 2017|2017-05-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|||Physical Telerehabilitation in Veterans With Multiple Sclerosis|Physical Telerehabilitation in Veterans With Multiple Sclerosis|Completed||N/A|74|Actual|University of Maryland||2|||f||||t||||||||||2017-10-10 23:38:16.606369|2017-10-10 23:38:16.606369
NCT02346539|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-12-28|||February 2015||2015-02-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Nicotine on Brain Reward Pathways|Effect of Nicotine on Brain Reward Pathways|Recruiting||Phase 1|50|Anticipated|Mclean Hospital||2|||f||||f||||||||No||2017-10-10 23:38:18.467175|2017-10-10 23:38:18.467175
NCT02346721|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2017-03-23|2017-03-23||February 23, 2015|Actual|2015-02-23|March 2017|2017-03-01|June 15, 2016|Actual|2016-06-15|March 23, 2016|Actual|2016-03-23||Interventional||Safety Analysis Set included participants who took at least 1 dose of study drug.|Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection|An Open Label Study of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects With Chronic HCV Infection|Completed||Phase 3|111|Actual|Gilead Sciences||1|||f||||f|t|f||||||||2017-10-10 23:38:16.703439|2017-10-10 23:38:16.703439
NCT02346708|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-02-01|||January 2014||2014-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Cognitive Dysfunction in Parkinson's Disease|Cortical Physiology as a Therapeutic Target in Parkinson's Disease Related Dementia and Cognitive Dysfunction|Active, not recruiting||N/A|150|Anticipated|University of Colorado, Denver||2|||f||||f||||||||Yes|De-identified data will be made available to the scientific community upon request.|2017-10-10 23:38:17.31648|2017-10-10 23:38:17.31648
NCT02346695|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-01-20|||June 2012||2012-06-01|January 2015|2015-01-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Observational|||Association Between Left Ventricular Deformation and Aerobic Exercise Capacity in Untreated Arterial Hypertension|Vascular and Biochemical Determinants of Left Ventricular Deformation and Twisting-untwisting and Their Interrelation With Aerobic Exercise Capacity in Untreated Arterial Hypertension|Unknown status|Recruiting|N/A|480|Anticipated|University of Athens|||2||f||||f||||||Samples Without DNA|"     Plasma in serum for fibrosis and inflammatory markers   "|||2017-10-10 23:38:17.406284|2017-10-10 23:38:17.406284
NCT02346682|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-04-23|||February 2015||2015-02-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|NMNTDM||Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder|Neurochemical,Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder|Recruiting||Phase 4|75|Anticipated|Zhejiang Provincial Tongde Hospital||3|||f||||t||||||||||2017-10-10 23:38:17.501026|2017-10-10 23:38:17.501026
NCT02346669|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-06-08|||April 2016||2016-04-01|June 2016|2016-06-01||||January 2018|Anticipated|2018-01-01||Interventional|||Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients|Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients|Recruiting||Phase 2|30|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||||||||||||2017-10-10 23:38:17.617229|2017-10-10 23:38:17.617229
NCT02346656|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-12-15|||May 2013||2013-05-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|BRAVO||a BavaRiAn eValuatiOn of Dorsal Root Ganglion (DRG) Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin|BRAVO: a BavaRiAn eValuatiOn of DRG Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin|Terminated||N/A|7|Actual|St. Jude Medical|||1|Inadequate Enrolment|f||||f||||||||||2017-10-10 23:38:17.723873|2017-10-10 23:38:17.723873
NCT02346630|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-04-25|||March 2015|Anticipated|2015-03-01|April 2017|2017-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation|The Effect of Combining Robotic-Assisted Therapy With Levodopa/Carbidopa in Chronic Post-Stroke Upper-Limb Hemiparesis|Withdrawn||Phase 4|0|Actual|Spaulding Rehabilitation Hospital||2||We didn't receive the expected funding to support the study.|f||||f||f||||||No|No sharing of IPD|2017-10-10 23:38:17.855236|2017-10-10 23:38:17.855236
NCT02346617|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-11-17|||January 2016||2016-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection|Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection in Allogeneic Hematopoietic Cell Transplant Recipients|Not yet recruiting||Phase 1/Phase 2|5|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 23:38:17.959765|2017-10-10 23:38:17.959765
NCT02346604|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-11-19|||July 2013||2013-07-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Pulmonary Gas Exchange Abnormalities in Patients With Mild COPD|Pulmonary Gas Exchange Abnormalities in Patients With Mild COPD|Completed||N/A|22|Actual|Queen's University|||2||f||||f||||||||||2017-10-10 23:38:18.052343|2017-10-10 23:38:18.052343
NCT02346591|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-21|2015-01-26|||February 2013||2013-02-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|Emotions||Mobile-Web Emotion Self-management Tool|Emotion Management Training: An Innovative Stress Reduction Program|Completed||Phase 2|298|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 23:38:18.124696|2017-10-10 23:38:18.124696
NCT02346578|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-12-16|||January 2015||2015-01-01|December 2016|2016-12-01||||September 2018|Anticipated|2018-09-01||Interventional|||Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.|Multicenter, Prospective, Randomised and Comparative Study of AA Therapy and Early Administrating Enzalutamide in Participants With CRPC Previously Treated With CAB Therapy Using Bicalutamide.|Recruiting||N/A|100|Anticipated|Osaka City University||2|||f||||||||||||||2017-10-10 23:38:18.21195|2017-10-10 23:38:18.21195
NCT02346565|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-08-14|||January 2015||2015-01-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Stress Echocardiography Versus Exercise ECG (ExECG) in Women With Chest Pain|The Role of Contemporary Stress Echocardiography Techniques in the Initial Assessment of Women With No Previous History of Coronary Artery Disease (CAD) Who Present With Chest Pain of Recent Onset. Stress Echocardiography vs Exercise ECG as First Line Investigation in This Population. Potential for Higher Diagnostic Accuracy Cost Saving.|Recruiting||N/A|450|Anticipated|London North West Healthcare NHS Trust||2|||f||||f||||||||||2017-10-10 23:38:18.295856|2017-10-10 23:38:18.295856
NCT02346552|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-09-15|||January 2015||2015-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Usability and Performance Evaluation of the AutoLap System - a Feasibility Study|Usability and Performance Evaluation of the AutoLap System - a Feasibility Study|Recruiting||N/A|40|Anticipated|M.S.T. Medical Surgery Technology LTD.||2|||f||||f||||||||||2017-10-10 23:38:18.384085|2017-10-10 23:38:18.384085
NCT02346526|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-08-04|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer|A Single-arm Open Label Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer|Recruiting||Phase 2|22|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:38:18.552605|2017-10-10 23:38:18.552605
NCT02346513|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-01-20|||February 2014||2014-02-01|January 2015|2015-01-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01|3 Months|Observational [Patient Registry]|CoM||Serum Level of Cobalt and Chromium After Ceramic on Metal Articulation Total Hip Arthroplasty|Serum Level of Cobalt and Chromium After Ceramic on Metal Articulation Total Hip Arthroplasty|Unknown status|Recruiting|N/A|228|Anticipated|Korea University Guro Hospital|||3||f||||f||||||||||2017-10-10 23:38:18.665373|2017-10-10 23:38:18.665373
NCT02346500|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-08-10|||December 2012||2012-12-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|||Ultrasound-Guided Photoselective Vaporization of the Prostate|Ultrasound-Guided Photoselective Vaporization of the Prostate|Recruiting||Early Phase 1|10|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 23:38:18.764814|2017-10-10 23:38:18.764814
NCT02346487|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-11-10|||September 2015||2015-09-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|LIVING||Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally (LIVING Study)|Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally|Recruiting||Phase 3|3000|Anticipated|Drugs for Neglected Diseases||1|||f||||t||||||||||2017-10-10 23:38:18.85746|2017-10-10 23:38:18.85746
NCT02346474|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2017-07-11|||December 23, 2014||2014-12-23|June 27, 2017|2017-06-27|July 28, 2016|Actual|2016-07-28|July 28, 2016|Actual|2016-07-28||Observational|||Cross Calibration of Two Dual Energy Densitometers and Comparison of Regional Adipose Tissue Measurements by iDXA and MRI|Cross Calibration of Two Dual Energy Densitometers and Comparison of Regional Adipose Tissue Measurements by iDXA and MRI.|Completed||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:38:18.983246|2017-10-10 23:38:18.983246
NCT02346461|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-24|2017-09-12|||January 14, 2015||2015-01-14|September 5, 2017|2017-09-05|August 30, 2018|Anticipated|2018-08-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy|An Open-Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy|Active, not recruiting||Phase 1/Phase 2|14|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:38:19.067026|2017-10-10 23:38:19.067026
NCT02346448|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-02-28|||February 2015||2015-02-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Endoscopic Sphincterotomy vs. Balloon Dilation for Assessment of Pancreatitis|Endoscopic Sphincterotomy vs. Balloon Dilation for Assessment of Pancreatitis: A Prospective Randomized Multicenter Trial|Recruiting||N/A|600|Anticipated|Helios Albert-Schweitzer-Klinik Northeim||3|||f||||t||||||||||2017-10-10 23:38:19.203251|2017-10-10 23:38:19.203251
NCT02346435|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-03-14|||January 2009||2009-01-01|March 2016|2016-03-01||||January 2017|Anticipated|2017-01-01|5 Years|Observational [Patient Registry]|DISSRM||The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry|The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry|Recruiting||N/A|600|Anticipated|Johns Hopkins University|||3||f||||t||||||||||2017-10-10 23:38:19.353008|2017-10-10 23:38:19.353008
NCT02346422|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-30||2017-01-30|April 2015||2015-04-01|January 2017|2017-01-01||||June 26, 2015|Actual|2015-06-26||Interventional|||A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure|A Phase 1/2 Study of the Safety and Preliminary Activity of MYDICAR® at a Dose of 2.5 x 10^13 DNase Resistant Particles (DRP) in Subjects With Advanced Heart Failure Divided Into 2 Phases: Phase 1 Open-label and Phase 2 Randomized, Double-blind, Placebo-controlled|Terminated||Phase 1/Phase 2|9|Actual|Celladon Corporation||2||Sponsor has suspended clinical development of MYDICAR for heart failure.|f||||t||||||||||2017-10-10 23:38:19.471059|2017-10-10 23:38:19.471059
NCT02346409|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-08-29|||February 4, 2015|Actual|2015-02-04|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|CERESTIM||Cerebello-thalamo-cortical Coupling in Essential Tremor|Cerebello-thalamo-cortical Coupling in Essential Tremor: Effects of High Frequency tACS of the Cerebellum|Recruiting||N/A|28|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-10 23:38:19.623431|2017-10-10 23:38:19.623431
NCT02346396|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-28|||January 2015||2015-01-01|January 2015|2015-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|STIMATHOME||CORTICAL STIMULATION BY DIRECT CURRENT FOR THE TREATMENT OF CHRONIC PAIN : PILOT-STUDY OF A STIMULATION DEVICE AT HOME|Non-invasive Analgesic Stimulation of the Motor Cortex at Home|Recruiting||N/A|45|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:38:19.725093|2017-10-10 23:38:19.725093
NCT02346383|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-07-19|||September 2013||2013-09-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Optimal Stimulation Programming for Spinal Peripheral Neuromodulation|Optimal Stimulation Programming for Spinal Peripheral Neuromodulation|Completed||N/A|42|Actual|Carolinas Center for Advanced Management of Pain||3|||f||||f||||||||||2017-10-10 23:38:19.836922|2017-10-10 23:38:19.836922
NCT02346370|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-05-04|||November 30, 2014|Actual|2014-11-30|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|February 2, 2017|Actual|2017-02-02||Interventional|PRIMAL||A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC|PRIMAL STUDY: A Phase 1b, Open-label, Multicenter, Multinational Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel (PDoc) in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|15|Actual|Halozyme Therapeutics||1||Changing standard of care therapy regimen|f||||f||||||||No||2017-10-10 23:38:19.965854|2017-10-10 23:38:19.965854
NCT02346357|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-01-26|||May 2014||2014-05-01|January 2015|2015-01-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Ultrasound-Guided Obturator Nerve Block for Ambulatory Hip Arthroscopy|Ultrasound-Guided Obturator Nerve Block for Ambulatory Hip Arthroscopy: A Prospective, Randomized Controlled Trial|Unknown status|Recruiting|N/A|70|Anticipated|Benaroya Research Institute||2|||f||||t||||||||||2017-10-10 23:38:20.083492|2017-10-10 23:38:20.083492
NCT02346344|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-01-20|||April 2014||2014-04-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus|Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus|Completed||N/A|20|Actual|Foundation for the National Institutes of Health|||1||f||||f||||||||||2017-10-10 23:38:20.176302|2017-10-10 23:38:20.176302
NCT02346331|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-12-01|||January 2015||2015-01-01|December 2016|2016-12-01||||August 2016|Actual|2016-08-01||Interventional|||Epidemiology, Acute Management, and Outcomes of Patients With Sepsis Presenting to a Referral Hospital in Western Kenya|Epidemiology, Acute Management, and Outcomes of Patients With Sepsis Presenting to a Referral Hospital in Western Kenya|Active, not recruiting||N/A|198|Actual|Duke University||2|||f||||t||||||||||2017-10-10 23:38:20.247061|2017-10-10 23:38:20.247061
NCT02346318|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-07-20|||November 2014||2014-11-01|October 2014|2014-10-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||The Randomized Controlled Clinical Trial of Kushen Injection|The Randomized Controlled Clinical Trial of Kushen Injection Reducing Radiotherapy Related Adverse Reactions in Lung Cancer|Unknown status|Recruiting|Phase 4|240|Anticipated|Beijing Zheng Ju Medical Technology Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:38:20.352116|2017-10-10 23:38:20.352116
NCT02346305|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-07-02|||January 2015||2015-01-01|July 2015|2015-07-01||||April 2017|Anticipated|2017-04-01|2 Years|Observational [Patient Registry]|||Cohort of Respiratory Failure Patients Treated for the First Time With Non-Invasive Ventilation at Home|Multicenter Prospective and Observational Cohort of Respiratory Failure Patients Treated for the First Time With Non-invasive Ventilation (NIV) at Home|Unknown status|Recruiting|N/A|3000|Anticipated|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche|||1||f||||||||||||||2017-10-10 23:38:20.440036|2017-10-10 23:38:20.440036
NCT02346292|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-01-19|||March 2015||2015-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|CLOUD||Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care Basement|Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care Basement|Completed||N/A|1250|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:38:20.553359|2017-10-10 23:38:20.553359
NCT02346279|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-24|||April 2011||2011-04-01|January 2015|2015-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Responsiveness and Minimal Clinical Important Difference of the Multiple Sclerosis Questionnaire for Physiotherapists|Study to Evaluate the Responsiveness and Minimal Clinical Important Difference (MCID) of the 'Multiple Sclerosis Questionnaire for Physiotherapists' (MSQPT)|Completed||N/A|81|Actual|Institut fuer Physiotherapieforschung|||1||f||||f||||||||||2017-10-10 23:38:20.664797|2017-10-10 23:38:20.664797
NCT02346266|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-23|||November 2014||2014-11-01|January 2015|2015-01-01|November 2015|Anticipated|2015-11-01|June 2015|Anticipated|2015-06-01||Interventional|SMART||SMART (School-aged Children Making Healthy Choices And Recognizing sTroke)|SMART (School-aged Children Making Healthy Choices And Recognizing sTroke): A Pilot Trial of a Stroke Awareness Program|Unknown status|Enrolling by invitation|N/A|480|Anticipated|Los Amigos Research and Education Institute||2|||f||||f||||||||||2017-10-10 23:38:20.738434|2017-10-10 23:38:20.738434
NCT02346253|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-05-24|||January 2015||2015-01-01|May 2017|2017-05-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01||Interventional|||High-Dose Brachytherapy in Treating Patients With Prostate Cancer|A Phase I/II Study of High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer|Recruiting||Phase 1/Phase 2|163|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 23:38:20.796926|2017-10-10 23:38:20.796926
NCT02346240|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-09-28||2016-12-15|February 11, 2015|Actual|2015-02-11|September 2017|2017-09-01|December 3, 2018|Anticipated|2018-12-03|March 22, 2016|Actual|2016-03-22||Interventional|CIMPACT||Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)|A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled Study Followed by a Placebo-Controlled Maintenance Period and Open-Label Follow-Up to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Active, not recruiting||Phase 3|559|Actual|UCB Pharma||4|||f||||f|t|f|||f|||||2017-10-10 23:38:20.9321|2017-10-10 23:38:20.9321
NCT02346227|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2016-12-07|||January 2015||2015-01-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|KINVAV||Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix|Efficiency of AV2 Antiviral Drug in the Treatment of Human Papillomavirus-associated Precancerous Lesions of the Uterine Cervix: a Randomized Clinical Trial in Kinshasa, Democratic Republic of the Congo|Recruiting||Phase 3|400|Anticipated|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-10 23:38:21.377349|2017-10-10 23:38:21.377349
NCT02346214|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-09-07|||July 2016|Actual|2016-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 30, 2017|Anticipated|2017-09-30||Observational|||Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age|Smartphone Ophthalmoscope Lens Vascularity Estimated Gestational Age (SOLVE-GA)|Recruiting||N/A|420|Anticipated|RTI International|||1||f||||f||||||||||2017-10-10 23:38:21.513816|2017-10-10 23:38:21.513816
NCT02346201|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-08-16|||January 2016||2016-01-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|ADMET2||Apathy in Dementia Methylphenidate Trial 2|Apathy in Dementia Methylphenidate Trial 2|Recruiting||Phase 3|200|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-10 23:38:21.625729|2017-10-10 23:38:21.625729
NCT02346188|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-01-23|||January 2000||2000-01-01|January 2015|2015-01-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Effects of Iron and/or Zinc Supplementation in Mexican School Children Exposed to Lead|Effects of Iron and Zinc Supplementation on Neuropsychological and Educational Achievement in Lead-exposed School Children|Completed||N/A|602|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||||2017-10-10 23:38:21.779879|2017-10-10 23:38:21.779879
NCT02346175|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-02-01|||June 2014||2014-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients|Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients|Completed||Phase 1|30|Actual|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-10 23:38:21.909439|2017-10-10 23:38:21.909439
NCT02346162|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-06-21|||June 2015||2015-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||PREPARE: A Randomized Trial of a Pre-pregnancy Weight Loss Intervention|PREPARE: A Randomized Trial of a Pre-pregnancy Weight Loss Intervention|Active, not recruiting||N/A|326|Actual|Kaiser Permanente||2|||f||||t||||||||No|Any information from this study we present in reports or publications will not identify any individual.|2017-10-10 23:38:21.995161|2017-10-10 23:38:21.995161
NCT02346149|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-01-28|||June 2015||2015-06-01|January 2016|2016-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|Glucox||Effect of Acute Hyperglycemia on Renal Tissue Oxygenation|Effect of Acute Hyperglycemia on Renal Tissue Oxygenation as Measured By BOLD-MRI in Individuals With Impaired Glucose Tolerance and Controls|Recruiting||Phase 4|60|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-10 23:38:22.0916|2017-10-10 23:38:22.0916
NCT02346136|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-01-13|||July 2015||2015-07-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|Mi-WISH||Health Outcomes of Tai Chi in Subsidized Senior Housing|Health Outcomes of Tai Chi in Subsidized Senior Housing|Recruiting||N/A|320|Anticipated|Hebrew Rehabilitation Center, Boston||2|||f||||t||||||||||2017-10-10 23:38:22.201858|2017-10-10 23:38:22.201858
NCT02346123|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-10-09|||June 2015||2015-06-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy|Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy|Completed||N/A|55|Actual|Hospital Sao Rafael|||1||f||||f||||||Samples With DNA|"     Plasma, Serum, Whole Blood   "|||2017-10-10 23:38:22.352885|2017-10-10 23:38:22.352885
NCT02346110|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-02-11|||April 2015||2015-04-01|October 2015|2015-10-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|PEUSB||Protracted Effect of the Ultrasound-guided Saphenous Block|Comparison of the Effect of a Single Shot Saphenous Block With Plain Bupivacaine vs. Protracted Bupivacaine Mixture as a Supplement to Continuous Sciatic Catheter After Major Ankle and Foot Surgery|Completed||Phase 4|40|Actual|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-10 23:38:22.474645|2017-10-10 23:38:22.474645
NCT02346097|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-10-27|||February 2015||2015-02-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|ElectroCRT||Electrophysiological Optimization of Left Ventricular Lead Placement in CRT|ElectroCRT - Left Ventricular Lead Implant and Optimization Guided by Electrocardiography in Cardiac Resynchronization Therapy|Recruiting||N/A|122|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:38:22.616406|2017-10-10 23:38:22.616406
NCT02346084|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-09-05|||January 2015||2015-01-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults|CHARM-03: A Randomized, Open Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel Administered Rectally and Vaginally to HIV-1 Seronegative Adults|Completed||Phase 1|19|Actual|International Partnership for Microbicides, Inc.||2|||f||||t||||||||||2017-10-10 23:38:22.751035|2017-10-10 23:38:22.751035
NCT02346071|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-05-18|||January 2015||2015-01-01|January 2015|2015-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Acceptance and Commitment Group Therapy for Adolescents With a Range of Functional Somatic Syndromes|Acceptance and Commitment Group Therapy for Adolescents With a Range of Functional Somatic Syndromes: Randomized Trial|Recruiting||N/A|120|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:38:22.845017|2017-10-10 23:38:22.845017
NCT02346058|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-19|||October 2013||2013-10-01|June 2013|2013-06-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins|Evaluate the Efficacy and Safety of Esarin Gel in the Treatment of Chronic Venous Insufficiency or Varicose Vein Combine With Superficial Vein Thrombophlebitis in Outpatient|Completed||Phase 4|53|Actual|Ten Sun Pharma Company Limited||1|||f||||f||||||||||2017-10-10 23:38:22.973436|2017-10-10 23:38:22.973436
NCT02346045|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-01-19|||September 2014||2014-09-01|January 2015|2015-01-01|October 2018|Anticipated|2018-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension|Effects of Catheter Based Renal Sympathetic Denervation on Resistant Hypertension in End Stage Renal Disease in Korea|Recruiting||Phase 3|40|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-10 23:38:23.061198|2017-10-10 23:38:23.061198
NCT02346032|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-04-24|||June 30, 2015|Actual|2015-06-30|April 2017|2017-04-01|October 13, 2016|Actual|2016-10-13|September 30, 2016|Actual|2016-09-30||Interventional|||Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma|Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma|Completed||Phase 2|4|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:38:23.176278|2017-10-10 23:38:23.176278
NCT02346019|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-10-03|||August 2014||2014-08-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Thigh Reduction Surgery of Above Knee Amputee Residual Limbs to Improve Prosthesis Fit and Patient Outcomes|Thighplasty of Transfemoral Amputee Residual Limbs to Improve Prosthesis Fit and Patient Functional Outcomes|Active, not recruiting||N/A|3|Anticipated|Shirley Ryan AbilityLab||1|||f||||f||||||||||2017-10-10 23:38:23.245091|2017-10-10 23:38:23.245091
NCT02346006|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-03|||February 1, 2015|Actual|2015-02-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||CHAMPS Eye Study - Myopia and Retinal Vascular Geometry in Relation to Physical Activity|CHAMPS Eye Study - Myopia and Retinal Vascular Geometry in Relation to Physical Activity.|Completed||N/A|307|Actual|Odense University Hospital||1|||f||||t||||||||||2017-10-10 23:38:23.316602|2017-10-10 23:38:23.316602
NCT02345993|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-04-01|||January 2015||2015-01-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|||Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis|Extra-fine Formoterol/Beclomethasone in the Treatment of Asthmatic Crisis|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|National Institute of Respiratory Diseases, Mexico||2|||f||||f||||||||||2017-10-10 23:38:23.409947|2017-10-10 23:38:23.409947
NCT02345980|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-06-27|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Randomized Controlled Trial Evaluating Sildenafil Citrate in Relieving Ureteral Stent Related Symptoms|A Randomized Controlled Trial Evaluating Sildenafil Citrate in Relieving Ureteral Stent Related Symptoms|Completed||Phase 4|94|Actual|Mansoura University||2|||f||||t||||||||||2017-10-10 23:38:23.490304|2017-10-10 23:38:23.490304
NCT02345954|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-11-07|||January 2015||2015-01-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|September 2018|Anticipated|2018-09-01||Interventional|HysPex||Laparoscopic Supracervical Hysterectomy and Sacropexy Versus Hysteropexy Study|Laparoscopic Supracervical Hysterectomy and Sacropexy Compared to Uterus Conserving Hysteropexy: a Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|Kantonsspital Aarau||2|||f||||f||||||||||2017-10-10 23:38:23.628737|2017-10-10 23:38:23.628737
NCT02345941|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-12-22|||July 2014||2014-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|||Safety in Seconds 2.0: An App to Increase Car Seat Use|Evaluating a Web-based Child Passenger Safety Program: Safety in Seconds 2.0|Completed||N/A|1129|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 23:38:23.717234|2017-10-10 23:38:23.717234
NCT02345928|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-04-21|||August 5, 2014|Actual|2014-08-05|April 2017|2017-04-01|March 16, 2017|Actual|2017-03-16|March 16, 2017|Actual|2017-03-16||Interventional|||A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Subjects and Multiple Ascending Dose Study of CNTO 7160 in Subjects With Asthma and Subjects With Atopic Dermatitis|Completed||Phase 1|108|Actual|Janssen Research & Development, LLC||13|||f||||f||f||||||||2017-10-10 23:38:23.783989|2017-10-10 23:38:23.783989
NCT02345915|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-09-01|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|LEA-JA||Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia|Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia-LEA-JA-IPC 2014-005|Recruiting||N/A|90|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 23:38:23.899976|2017-10-10 23:38:23.899976
NCT02345902|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-04-20|||January 2016||2016-01-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|THDOM||Treatment of Hypoactive Delirium and Outcome Measures|Randomized Double-Blind Clinical Trial to Compare Haloperidol and Non-Pharmacologic Treatment Versus Non-Pharmacologic Treatment and Placebo, in Elderly Hospitalized Patients With Hypoactive Delirium|Recruiting||Phase 3|60|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||Undecided||2017-10-10 23:38:23.978828|2017-10-10 23:38:23.978828
NCT02345889|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-12-06|||February 2015||2015-02-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy|A 4-arm Randomized Controlled Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy|Enrolling by invitation||N/A|1600|Anticipated|Indiana University||4|||f||||f||||||||||2017-10-10 23:38:24.081784|2017-10-10 23:38:24.081784
NCT02345876|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-08-26|||March 2014||2014-03-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|ASTRAUCOLE||Maturation of Auditory Processing in Children With Dyslexia Compared to Average-reading Children|Asymmetry, Auditory Processing and Reading Skills in Phonological Dyslexic Children Compared to Average-reading Children|Recruiting||N/A|160|Anticipated|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-10 23:38:24.189085|2017-10-10 23:38:24.189085
NCT02345863|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-09-23|||January 2015||2015-01-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients|A Prospective, Open-label, Multicenter Phase-II Trial to Evaluate the Efficacy and Safety of a Sequential Regimen of Bendamustine Followed by GA101 and Ibrutinib (BIG) Followed by GA101 and Ibrutinib Maintenance in CLL Patients (CLL2-BIG Protocol)|Active, not recruiting||Phase 2|66|Actual|German CLL Study Group||1|||f||||f||||||||No||2017-10-10 23:38:24.272891|2017-10-10 23:38:24.272891
NCT02345850|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-28|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)|A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN #1301; Progress II)|Recruiting||Phase 3|345|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||t||||||||||2017-10-10 23:38:24.364422|2017-10-10 23:38:24.364422
NCT02345837|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-04-04|||February 2014||2014-02-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of Local Endometrial Injury on Pregnancy Outcomes During Ovulation Induction Cycles|Effect of Local Endometrial Injury on Pregnancy Outcomes During Ovulation Induction Cycles|Recruiting||N/A|160|Anticipated|Al Hayat National Hospital||2|||f||||t||||||||||2017-10-10 23:38:24.532545|2017-10-10 23:38:24.532545
NCT02345824|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-10-27|||March 2016||2016-03-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma|Early-Phase Study to Assess Tumor Pharmacokinetics and Efficacy of the CDK4/6 Inhibitor Ribociclib (LEE011) in Patients With Recurrent Glioblastoma or Anaplastic Glioma|Recruiting||Phase 1|20|Anticipated|University of Virginia||1|||f||||t||||||||No||2017-10-10 23:38:24.610391|2017-10-10 23:38:24.610391
NCT02344719|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-09-24|||October 2010||2010-10-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis|The Effect of Oral Taurine on Portal Hemodynamics in Patients With Advanced|Completed||Phase 4|30|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:38:24.694344|2017-10-10 23:38:24.694344
NCT02344706|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-09-07|||December 2017||2017-12-01|September 2016|2016-09-01||||February 2018|Anticipated|2018-02-01||Observational|||Diagnostic Value of Prehospital EEG in Non-convulsive Status Epilepticus|Diagnostic Value of Prehospital EEG in Non-convulsive Status Epilepticus|Not yet recruiting||N/A|30|Anticipated|Helsinki University Central Hospital|||1||f||||t||||||||||2017-10-10 23:38:24.771682|2017-10-10 23:38:24.771682
NCT02344693|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-09-07|||February 2017||2017-02-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01|1 Month|Observational [Patient Registry]|||Electroencephalography in Patients Resuscitated From Cardiac Arrest|Electroencephalography in Patients Resuscitated From Cardiac Arrest|Not yet recruiting||N/A|40|Anticipated|Helsinki University Central Hospital|||1||f||||t||||||||||2017-10-10 23:38:26.544046|2017-10-10 23:38:26.544046
NCT02344680|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-05-22|||October 2015||2015-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Liver Fibrosis in Zambian HIV-HBV Co-infected Patients|Liver Fibrosis in Zambian HIV-HBV Co-infected Patients: a Long-term Prospective Cohort Study|Recruiting||N/A|400|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||||||2017-10-10 23:38:26.652098|2017-10-10 23:38:26.652098
NCT02344667|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-18|||March 2015||2015-03-01|January 2015|2015-01-01||||July 2016|Anticipated|2016-07-01||Interventional|||Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT|Randomized Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. Volume Modulated Arc Therapy|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Juravinski Cancer Center||2|||f||||t||||||||||2017-10-10 23:38:26.776275|2017-10-10 23:38:26.776275
NCT02344654|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-11-10|||May 2015||2015-05-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Fluorescence Cholangiography During Cholecystectomy - a RCT|Fluorescence Cholangiography Versus X-ray Cholangiography During Laparoscopic Cholecystectomy for Complicated Gallstone Disease|Enrolling by invitation||N/A|120|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 23:38:26.858631|2017-10-10 23:38:26.858631
NCT02344641|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-26|||January 2015||2015-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients|Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients|Unknown status|Not yet recruiting|N/A|234|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-10 23:38:26.934401|2017-10-10 23:38:26.934401
NCT02344628|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-17|2017-03-06|||June 2015||2015-06-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of Two Different Doses of Azithromycin for Treatment of Yaws|Randomized Controlled Trial Comparing Efficacy of Single Dose Treatment of Yaws With 20mg/kg Versus 30mg/kg of Azithromycin|Completed||Phase 3|583|Actual|London School of Hygiene and Tropical Medicine||2|||f||||||||||||||2017-10-10 23:38:27.009225|2017-10-10 23:38:27.009225
NCT02344615|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2016-01-27|||May 2014||2014-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Nerve Stimulator Versus Ultrasound-guided Infraclavicular Block|A Randomized Comparison of Nerve Stimulator and Ultrasound-guided Infraclavicular Block for Upper Extremity Surgery|Completed||N/A|44|Anticipated|Cheju Halla General Hospital||2|||f||||f||||||||||2017-10-10 23:38:27.10128|2017-10-10 23:38:27.10128
NCT02344602|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-01-16|||December 2012||2012-12-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effect of Uric Acid Lowering in Type 1 Diabetes|A Deep Phenotyping Approach to Assess the Effect of Uric Acid Lowering in Patients With Uncomplicated Type 1 Diabetes Mellitus|Unknown status|Recruiting|Phase 4|72|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:38:27.189312|2017-10-10 23:38:27.189312
NCT02344589|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-27|||January 2015||2015-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of Local Anesthetic Volume Within the Adductor Canal on Quadriceps Function Evaluated by Electromyography|The Effect of Local Anesthetic Volume Within the Adductor Canal on Quadriceps Function Evaluated by Electromyography: A Randomized, Observer-Masked, Placebo-Controlled Study in Volunteers.|Completed||Phase 4|20|Actual|University Hospital, Gentofte, Copenhagen||5|||f||||t||||||||||2017-10-10 23:38:27.292875|2017-10-10 23:38:27.292875
NCT02344576|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-03-02|||May 2015||2015-05-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|DECIDE-LVAD||PCORI-1310-06998 Trial of a Decision Support Intervention for Patients and Caregivers Offered Destination Therapy Heart Assist Device|A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for End-Stage Heart Failure|Active, not recruiting||N/A|445|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:38:27.390733|2017-10-10 23:38:27.390733
NCT02345811|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-03-30|||January 2015||2015-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:38:27.613649|2017-10-10 23:38:27.613649
NCT02345798|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-05-31|||February 11, 2015|Actual|2015-02-11|May 2017|2017-05-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||Video-Assisted Intervention in Improving Recovery in Patients With Cancer Undergoing Lung Surgery and Caregivers|Preparing Patients and Informal Caregivers for Lung Surgery: Pilot Study of a Video-Assisted Intervention to Enhance Post-Operative Recovery|Completed||N/A|73|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-10-10 23:38:27.660201|2017-10-10 23:38:27.660201
NCT02345785|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-23|||January 2015||2015-01-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Evaluation of the Change of Penile Corpus Cavernosum After Caudal Block Using Ultrasonography in Children||Unknown status|Not yet recruiting|N/A|20|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-10 23:38:27.750654|2017-10-10 23:38:27.750654
NCT02345759|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-01-24|||January 2013||2013-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|KetoPsy||Psychological Aspects and Patients Compliance to Restricted-protein Regimens in Chronic Kidney Disease|Psychological Aspects Related to Compliance of Patients on Restricted-protein Regimens in Chronic Kidney Disease|Recruiting||N/A|120|Anticipated|Anemia Working Group Romania|||2||f||||t||||||||||2017-10-10 23:38:27.926174|2017-10-10 23:38:27.926174
NCT02345746|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-08-22|||December 2012||2012-12-01|August 2017|2017-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis|Phase 2 Study of Hepatic Arterial Infusion With Oxaliplatin, Folinic Acid and 5 Fluorouracil Alone or in Combination With Intravenous Chemotherapy in Heavily Pre-Treated Patients With Liver-Predominant Metastasis From Colorectal Cancer|Withdrawn||Phase 2|0|Actual|Western Regional Medical Center||1||patient population|f||||f||||||||||2017-10-10 23:38:28.023674|2017-10-10 23:38:28.023674
NCT02345733|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-09-19|||September 2015||2015-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis|Use of a Novel Diet (UC DIET) Targeting the Microbiota for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis: An Open Label Pilot Study|Recruiting||Phase 4|20|Anticipated|Wolfson Medical Center||2|||f||||f||||||||||2017-10-10 23:38:28.112679|2017-10-10 23:38:28.112679
NCT02345720|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-10-05|2016-06-20||December 2014||2014-12-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||All subjects that were dispensed a study lens.|Effects of Multifocal Contact Lens on Ocular Tissue|Effects on Ocular Tissues of Vistakon® Investigational Multifocal Contact Lenses - Asian Population Study|Completed||N/A|23|Actual|Johnson & Johnson Vision Care, Inc.||1|||f||||f||||||||||2017-10-10 23:38:28.235705|2017-10-10 23:38:28.235705
NCT02345707|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-07-09|||March 2015||2015-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir|A Phase 1, Single-center, Randomized, Open-label, Crossover Study to Assess the Relative Bioavailability of Phase III Tablet Formulation Candidates in Healthy Adult Subjects|Completed||Phase 1|37|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-10 23:38:28.419096|2017-10-10 23:38:28.419096
NCT02345694|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-01-12|||January 2015||2015-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|CIH-Gait||Non-automatic Control of Gait and Posture in Obstructive Sleep Apnea Syndrome (CIH-Gait)|Non-automatic Control of Gait and Posture in Obstructive Sleep Apnea Syndrome : a Randomised Controlled Trial of Continuous Positive Airway Pressure Effectiveness (CIH - Gait)|Recruiting||N/A|24|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 23:38:28.515683|2017-10-10 23:38:28.515683
NCT02345681|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-03-17|||May 2015||2015-05-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|IRIHS-REA||Impact of Rational Control of Fluid Balance in the Intensive Care Unit|Impact of Rational Control of Fluid Balance in the Intensive Care Unit.IRIHS-REA|Recruiting||Phase 3|172|Anticipated|Nantes University Hospital||2|||f||||||||||||||2017-10-10 23:38:28.643931|2017-10-10 23:38:28.643931
NCT02345668|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-05-30|||April 2015||2015-04-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of a Transdiagnostic Internet-based Treatment for Emotional Disorders|Effectiveness of a Transdiagnostic Internet-based Treatment for Emotional Disorders vs Treatment as Usual in Specialized Care: a Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Universitat Jaume I||2|||f||||t||||||||||2017-10-10 23:38:28.744401|2017-10-10 23:38:28.744401
NCT02345655|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-02-21|||January 2016||2016-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|ESUB-MG||On-site Evaluation of Substances Consumption on Opiate Maintenance|Impact of On-site Evaluation of Substances Consumption on Opiate Maintenance in the Context of Family Practice|Recruiting||N/A|400|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-10 23:38:28.850383|2017-10-10 23:38:28.850383
NCT02345629|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-03-28|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Cordotomy for Refractory Cancer Pain|Minimally Invasive Cordotomy for Refractory Cancer Pain|Recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 23:38:29.021012|2017-10-10 23:38:29.021012
NCT02345616|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-07-25|||February 2015||2015-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NOCaPH||Role of the Nitric Oxide (NO) in Pre-oxygenation Before Anesthetic Induction in Patients With a Pulmonary Hypertension in Cardiac Surgery. Pilot Study of Feasibility|Role of the Nitric Oxide (NO) in Pre-oxygenation Before Anesthetic Induction in Patients With a Pulmonary Hypertension in Cardiac Surgery. Pilot Study of Feasibility|Recruiting||Phase 2|30|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 23:38:29.107751|2017-10-10 23:38:29.107751
NCT02345603|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-02|||December 2014||2014-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRASDEN||Pilot Study of of Renal Arterial Sympathetic Denervation by Cryotherapy|Pilot Study of of Renal Arterial Sympathetic Denervation by Cryotherapy During Open Surgery for Aortic Aneurysm|Active, not recruiting||Phase 4|9|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-10 23:38:29.307397|2017-10-10 23:38:29.307397
NCT02345590|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2016-01-13|||May 2015||2015-05-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Eplerenone in the Management of Abdominal Aortic Aneurysms|Eplerenone in the Management of Abdominal Aortic Aneurysms: A Proof-Of-Concept Randomised Controlled Trial|Recruiting||Phase 4|172|Anticipated|Bayside Health||2|||f||||f||||||||||2017-10-10 23:38:29.387905|2017-10-10 23:38:29.387905
NCT02345577|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-03-29|||January 2015||2015-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Whole-body Vibration Physiotherapy in Kidney Transplantation|Effects of Stochastic Whole-body Vibration Physiotherapy-WBV (Stochastic Resonance Physiotherapy-SRT) on Muscle Strength in Patients After Kidney Transplantation: a Pilot Study|Recruiting||N/A|20|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:38:29.494277|2017-10-10 23:38:29.494277
NCT02345564|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-07-21|||March 2012||2012-03-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Clinical and Radiological Results of Osteochondral Repair Using MaioRegen in Knee and Ankle Surgery|Clinical and Radiological Results of Osteochondral Repair Using MaioRegen in Knee and Ankle Surgery|Unknown status|Active, not recruiting|N/A|15|Anticipated|Barmherzige Brüder Eisenstadt||1|||f||||f||||||||||2017-10-10 23:38:29.617096|2017-10-10 23:38:29.617096
NCT02345551|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-12-02|||February 2015||2015-02-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|SWPA||A Physical Activity Intervention for Female Shift Workers|The Feasibility of a Telephone and Web-based Physical Activity Intervention for Female Shift Workers.|Completed||N/A|20|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-10 23:38:29.708902|2017-10-10 23:38:29.708902
NCT02345538|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-06-17||||||June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Use of a Perineometer to Assess Pelvic Muscle Tone|Use of a Perineometer to Assess Resting Pelvic Muscle Tone in Patients With Pelvic Pain|Withdrawn||N/A|0|Actual|Duke University|||2|"Investigator did not start the project in time; study team decided it was not feasible to begin   study as resident was soon graduating. No patients enrolled."|f||||f||||||||No|study withdrawn|2017-10-10 23:38:29.823882|2017-10-10 23:38:29.823882
NCT02345525|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-05-02|||August 2014||2014-08-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Constraint-Induced Movement Therapy in Chronic Stroke Patients|The Feasibility of a Home-based Constraint-Induced Movement Therapy Program in Chronic Stroke Survivors.|Recruiting||N/A|20|Anticipated|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-10 23:38:29.904895|2017-10-10 23:38:29.904895
NCT02345499|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-19|||January 2014||2014-01-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|OvsL||Open Versus Laparoscopic Radical Cystectomy|Open Versus Laparoscopic Radical Cystectomy for Invasive Bladder Cancer in the Elderly Patient. A Multicenter Randomized Clinical Trial.|Unknown status|Recruiting|Phase 2|80|Anticipated|Azienda Ospedaliero-Universitaria Consorziale||2|||f||||t||||||||||2017-10-10 23:38:30.110324|2017-10-10 23:38:30.110324
NCT02345486|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-04-19|||February 2015||2015-02-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SALT||Isotonic Solution Administration Logistical Testing|Isotonic Solution Administration Logistical Testing: Pilot Study for the Isotonic Solutions and Major Adverse Renal Events Trial|Completed||Phase 2|974|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 23:38:30.221799|2017-10-10 23:38:30.221799
NCT02345473|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-19|||January 2005||2005-01-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|CirCanCell||Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy|Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy|Completed||N/A|59|Actual|Azienda Ospedaliero-Universitaria Consorziale|||2||f||||t||||||Samples With DNA|"     Peripheral blood samples   "|||2017-10-10 23:38:30.346947|2017-10-10 23:38:30.346947
NCT02345460|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2016-10-19|||September 2015||2015-09-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study|Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study|Terminated||Phase 2|1|Actual|Case Comprehensive Cancer Center||1||Competing studies|f||||f||||||||||2017-10-10 23:38:30.467243|2017-10-10 23:38:30.467243
NCT02345447|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-05-10|||October 2013||2013-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|October 2015|Actual|2015-10-01||Interventional|OTV_PRE_01||Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence|Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Placebo Controlled, Randomized, Double-blinded Parallel-Group Comparison for Superiority|Active, not recruiting||Phase 3|296|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 23:38:30.593637|2017-10-10 23:38:30.593637
NCT02345434|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-09-28|||August 2014||2014-08-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances|The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances|Completed||N/A|1525|Actual|Abdul Latif Jameel Poverty Action Lab||2|||f||||f||||||||||2017-10-10 23:38:30.699194|2017-10-10 23:38:30.699194
NCT02345421|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-05-23|||December 2014||2014-12-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||A Study to Identify and Characterize LAL-D Patients in High-risk Populations|A Study to Identify the Frequency of Lysosomal Acid Lipase Deficiency in At-Risk Patient Populations|Terminated||N/A|640|Actual|Alexion Pharmaceuticals|||1||f||||f||||||||||2017-10-10 23:38:30.780758|2017-10-10 23:38:30.780758
NCT02345395|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-23|||September 2013||2013-09-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|MININCRUSP||Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms|Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms|Unknown status|Recruiting|N/A|120|Anticipated|University of Sao Paulo General Hospital||3|||f||||f||||||||||2017-10-10 23:38:31.00668|2017-10-10 23:38:31.00668
NCT02345382|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-08-22|||February 19, 2015|Actual|2015-02-19|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|September 14, 2016|Actual|2016-09-14||Interventional|||Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia|An Open-label Phase I Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY1143572 Given in a Once-daily or an Intermittent Dosing Schedule in Subjects With Advanced Acute Leukemia|Completed||Phase 1|42|Actual|Bayer||2|||f||||f|t|f||||||||2017-10-10 23:38:31.137268|2017-10-10 23:38:31.137268
NCT02345369|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2017-01-20|||January 2015||2015-01-01|January 2017|2017-01-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Locked Versus Unlocked Set Screws in Intramedullary Fixation of Intertrochanteric Fractures|Does Static Locking of Set Screws in Intramedullary Fixation of Intertrochanteric Fractures Prevent Shortening of Intertrochanteric Hip Fractures?|Terminated||N/A|3|Actual|Bassett Healthcare||2||change in surgical implant use, loss of subinvestigator|f||||f||||||||||2017-10-10 23:38:31.270633|2017-10-10 23:38:31.270633
NCT02344862|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-01-22|||January 2014||2014-01-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Study of FYU-981 in Hyperuricemia With or Without Gout|Exploratory Study of FYU-981 for Hyperuricemia With or Without Gout (Phase II (IIa) Study)|Completed||Phase 2|80|Actual|Fuji Yakuhin Co., Ltd.||4|||f||||f||||||||||2017-10-10 23:38:37.087019|2017-10-10 23:38:37.087019
NCT02345356|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-11-28|||January 2016||2016-01-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics|A Randomized, Double-blind Clinical Trial of Anticoagulation Therapy With Warfarin in Caribbean Hispanics: Comparison Between an Admixture-adjusted Pharmacogenetic-driven Warfarin Dose Refinement Algorithm and the Standard of Care|Recruiting||N/A|300|Anticipated|University of Puerto Rico|||2||f||||f||||||Samples With DNA|"     Buccal swabs   "|Yes|Data sharing plan is fully described in the corresponding section of the protocol. A thorough description of appropriate use of the data to be shared in this study is provided in informed consent documents. Limitations on data use are also described therein and in this Institutional Certification. Safeguards to protect the data according to Federal standards for information protection will be implemented. As stated by guidelines, data will be made available in the database of Genotype and Phenotype (dbGaP) http://www.ncbi.nlm.nih.gov/gap through controlled-access. This research involves individual-level human data. We expect to share both genotypes and phenotype data as well as additional information necessary to interpret such data, and we propose a data sharing plan that complies with NIH guidelines for NIH-funded studies (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088.html) and the new NIH Genomic Data Sharing (GDS) Policy's scope (http://gds.nih.gov/03policy2.html).|2017-10-10 23:38:31.357099|2017-10-10 23:38:31.357099
NCT02345343|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-06-27|||May 4, 2015|Actual|2015-05-04|June 2017|2017-06-01|October 7, 2015|Actual|2015-10-07|October 7, 2015|Actual|2015-10-07||Observational|||Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico|Early Post-Marketing Study of Eliquis (Apixaban), in Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE in Adults|Completed||N/A|100|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 23:38:31.504773|2017-10-10 23:38:31.504773
NCT02345330|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-12-12|||May 2015||2015-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)|A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Treatment-Refractory Metastatic and Unresectable SCC of the Head and Neck|Completed||Phase 2|4|Actual|OncoSec Medical Incorporated||1|||f||||f||||||||||2017-10-10 23:38:31.603914|2017-10-10 23:38:31.603914
NCT02345317|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-19|||December 2014||2014-12-01|January 2015|2015-01-01||||July 2017|Anticipated|2017-07-01||Observational|||Reticular Pseudodrusen Progression Study|Reticular Pseudodrusen Progression Study|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital Muenster|||1||f||||t||||||||||2017-10-10 23:38:31.699222|2017-10-10 23:38:31.699222
NCT02345304|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-20|2015-03-08|||March 2015||2015-03-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin|A Study to Investigate the Effects of BI 1181181 on the Pharmacokinetics of Midazolam, Warfarin, Omeprazole and Digoxin in Healthy Male Subjects|Withdrawn||Phase 1|0|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-10 23:38:31.788661|2017-10-10 23:38:31.788661
NCT02345278|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-12-01|||May 2015||2015-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|DTS||SUBLIVAC FIX Mite Mixture Dose Tolerability Study|A Randomized, Double-blind, Placebo-controlled Study to Determine Tolerability and Safety of Different Dosages of SUBLIVAC FIX Mite Mixture in Patients With Allergic Rhinitis / Rhinoconjunctivitis Caused by House Dust Mites|Completed||Phase 1/Phase 2|81|Actual|HAL Allergy||5|||f||||t||||||||||2017-10-10 23:38:32.021179|2017-10-10 23:38:32.021179
NCT02345265|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-23|2017-09-04|||December 4, 2015|Actual|2015-12-04|July 2017|2017-07-01||||February 1, 2019|Anticipated|2019-02-01||Interventional|||Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Phase 2 Study of Olaparib and Cediranib for the Treatment of Recurrent Ovarian Cancer|Active, not recruiting||Phase 2|70|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:38:32.263774|2017-10-10 23:38:32.263774
NCT02345239|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-22|||February 2015||2015-02-01|January 2015|2015-01-01||||June 2015|Anticipated|2015-06-01||Interventional|||Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes|Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion Inpatients With Type 2 Diabetes|Unknown status|Not yet recruiting|Phase 3|14|Anticipated|McGill University||1|||f||||f||||||||||2017-10-10 23:38:32.814346|2017-10-10 23:38:32.814346
NCT02345213|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-12-01|||March 2015||2015-03-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)|A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)|Recruiting||Phase 4|140|Anticipated|Eisai Inc.||2|||f||||t||||||||||2017-10-10 23:38:33.361578|2017-10-10 23:38:33.361578
NCT02345200|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-22|||April 2013||2013-04-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Body Composition and Hormonal Status in Ataxia Telangiectasia|Body Composition, Muscle Strength and Hormonal Status in Patients With Ataxia Telangiectasia Compared to Healthy Controls|Completed||N/A|52|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-10 23:38:33.466172|2017-10-10 23:38:33.466172
NCT02345187|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-04-23|||October 2014||2014-10-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||fMRI Study to Investigate Hemodynamic Changes in Brain Resulting From Supplementation of Bacopa Monnieri Extract and Multiple Micronutrient Supplementation.|Impact of a Multiple Micronutrient (MMN) Fortified Powder Supplemented With Bacopa Monnieri Extract (EBM) on Hemodynamic Responses as Measured by Functional Magnetic Resonance Imaging (fMRI) in Indian School Children (11-12 Yrs; Inclusive) After Approximately 4 Months of Intervention: an Exploratory, Randomized, Double-blind, Controlled Trial|Completed||N/A|80|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-10 23:38:33.590549|2017-10-10 23:38:33.590549
NCT02345174|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-04-28|||March 19, 2015|Actual|2015-03-19|April 2017|2017-04-01|June 2, 2016|Actual|2016-06-02|June 2, 2016|Actual|2016-06-02||Interventional|||Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors|An Open Label Positron Emission Tomography (PET) Imaging Study Using 89Zirconium to Investigate the Biodistribution of Anti-HER3 Monoclonal Antibody (mAb) GSK2849330 and Characterize Its Dose-receptor Occupancy Relationship in Subjects With Advanced HER3-Positive Solid Tumors|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:38:33.69306|2017-10-10 23:38:33.69306
NCT02345148|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-03-02|||December 2014||2014-12-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult Participants|An Open-Label, Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Elderly (>= 75 Years of Age) and Healthy Younger Adult Subjects (18 to 55 Years of Age, Inclusive)|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 23:38:34.316828|2017-10-10 23:38:34.316828
NCT02345135|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-22|||September 2012||2012-09-01|January 2015|2015-01-01||||January 2016|Anticipated|2016-01-01||Interventional|||Susceptibility to Infections in Ataxia Telangiectasia|Susceptibility to Infections in Patients With Ataxia Telangiectasia : A Prospective Follow-up Study|Unknown status|Enrolling by invitation|N/A|41|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-10 23:38:34.400164|2017-10-10 23:38:34.400164
NCT02345122|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-09-05|||November 2014||2014-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PARTNERs||CAMH PARTNERs Integrated Care Study|CAMH PARTNERs: Integrated Care for Better Outcomes|Enrolling by invitation||N/A|600|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-10 23:38:34.485189|2017-10-10 23:38:34.485189
NCT02345109|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-01-22|||December 2014||2014-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|15001Analy||Clinical Trial of Transtek Body Fat Analyzer (GBF-835-N2 & Other 7 Models)|Verify the Functions and Efficiency of Transtek (Trade Mark) Body Fat Analyzer, 8 Models|Completed||N/A|60|Actual|BTS International||2|||f||||f||||||||||2017-10-10 23:38:34.640377|2017-10-10 23:38:34.640377
NCT02345096|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-12-02|||January 2015||2015-01-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis|A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis|Terminated||N/A|22|Actual|Lesaffre International||2||Recruitment difficulties|f||||t||||||||||2017-10-10 23:38:34.734461|2017-10-10 23:38:34.734461
NCT02345083|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2015-08-24|||June 2015||2015-06-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01|1 Year|Observational [Patient Registry]|INA-FRAGILE||Indonesia Frailty, Aging, and Longitudinal Study|Indonesia Frailty, Aging, and Longitudinal Study|Unknown status|Recruiting|N/A|300|Anticipated|Indonesia University|||1||f||||t||||||||||2017-10-10 23:38:34.816246|2017-10-10 23:38:34.816246
NCT02345070|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-09-15|||May 1, 2015||2015-05-01|September 2017|2017-09-01|August 14, 2017|Actual|2017-08-14|August 14, 2017|Actual|2017-08-14||Interventional|ESTAIR||Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis|Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis (IPF): A Randomized, Double-blind, Placebo-controlled, 52-week Dose-ranging Study|Completed||Phase 2|327|Actual|Sanofi||3|||f||||t||||||||||2017-10-10 23:38:34.931207|2017-10-10 23:38:34.931207
NCT02345057|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-09-22|||January 2015||2015-01-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria|A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Subjects With Type 2 Diabetes Mellitus and Microalbuminuria|Completed||Phase 2|365|Actual|Daiichi Sankyo, Inc.||5|||f||||t||||||||||2017-10-10 23:38:35.207067|2017-10-10 23:38:35.207067
NCT02345044|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2016-02-11|||January 2015||2015-01-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects|A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Subjects With Hypertension|Completed||Phase 2|426|Actual|Daiichi Sankyo, Inc.||5|||f||||f||||||||||2017-10-10 23:38:35.310051|2017-10-10 23:38:35.310051
NCT02345031|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-08-21|2017-04-19||January 2015||2015-01-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|CLARITY-1||Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss|A Balanced, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss [CLARITY-1 Study]|Completed||Phase 2|78|Actual|Autifony Therapeutics Limited||2|||f||||f||||||||||2017-10-10 23:38:35.423965|2017-10-10 23:38:35.423965
NCT02344992|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-19|2017-05-31|||January 2015||2015-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal|Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal|Completed||Phase 1|38|Actual|Adocia||2|||f||||f||||||||||2017-10-10 23:38:36.101463|2017-10-10 23:38:36.101463
NCT02344979|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-01-22|||May 2009||2009-05-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC|The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC Receiving Gemcitabine and Cisplatin or Carboplatin Chemotherapy|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Shenyang Sunshine Pharmaceutical Co., LTD.|||2||f||||f|||||||"     Randomized, open label, controlled, parallel, multi-center Study   "|||2017-10-10 23:38:36.190943|2017-10-10 23:38:36.190943
NCT02344966|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-18|||February 2011||2011-02-01|February 2011|2011-02-01|February 2021|Anticipated|2021-02-01|December 2020|Anticipated|2020-12-01||Observational|||Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia||Recruiting||N/A|1100|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-10 23:38:36.285726|2017-10-10 23:38:36.285726
NCT02344953|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-18|||January 2011||2011-01-01|January 2011|2011-01-01|January 2021|Anticipated|2021-01-01|December 2020|Anticipated|2020-12-01||Observational|||Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort)||Recruiting||N/A|1000|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-10 23:38:36.360943|2017-10-10 23:38:36.360943
NCT02344940|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-09-20|||December 2014||2014-12-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|TTOS||Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer|Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer: A Randomized, Controlled, Prospective, Observational Study|Active, not recruiting||Phase 4|126|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 23:38:36.434052|2017-10-10 23:38:36.434052
NCT02344927|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-03-14|||February 2015||2015-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||CRT Hydration in the Last Days of Life (Feasibility Study)|A Cluster Randomised Trial of Alternative Forms of Hydration in Cancer Patients in the Last Days of Life (Feasibility Study)|Completed||N/A|200|Actual|University of Surrey||2|||f||||t||||||||No||2017-10-10 23:38:36.536863|2017-10-10 23:38:36.536863
NCT02344914|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2015-05-17|||June 2015||2015-06-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Dental Support and the Second Stage of Labor Among Multiparous Women|Dental Support and the Second Stage of Labor Among Multiparous Women|Unknown status|Not yet recruiting|Phase 3|300|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-10 23:38:36.650964|2017-10-10 23:38:36.650964
NCT02344901|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-09-22|||February 2015||2015-02-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01|1 Day|Observational [Patient Registry]|RAMSES||ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)|ReAl-life Multicentre Survey Evaluating the Status of Stroke Prevention Strategies in Patients With Non-Valvular Atrial Fibrillation in TurKey (RAMSES)|Completed||N/A|6273|Actual|Muğla Sıtkı Koçman University|||1||f||||f||||||||||2017-10-10 23:38:36.756438|2017-10-10 23:38:36.756438
NCT02344888|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2017-05-08|||February 2015||2015-02-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Adding Prednisolone During Ovulation Induction With CC in Lean Women With CC Resistant PCOS|Adding Prednisolone During Ovulation Induction With Clomiphene Citrate in Lean Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome|Recruiting||Phase 4|100|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 23:38:36.926989|2017-10-10 23:38:36.926989
NCT02344875|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-18|2015-01-22|||May 2014||2014-05-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Clinical Pharmacology of FYU-981 (Elder Subjects)|Clinical Pharmacological Study of FYU-981 Administered to Male and Female Elder or Non-elder Subjects|Completed||Phase 1|24|Actual|Fuji Yakuhin Co., Ltd.||4|||f||||f||||||||||2017-10-10 23:38:37.017502|2017-10-10 23:38:37.017502
NCT02344849|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-01-05|||July 2015||2015-07-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction|An Open, Single-center, Phase 1 Study to Evaluate Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cell in Erectile Dysfunction.|Active, not recruiting||Phase 1|10|Anticipated|Pharmicell Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:38:37.157796|2017-10-10 23:38:37.157796
NCT02344836|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-06-23|||January 2015||2015-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SocialPOD||The Social Pounds Off Digitally (Social POD) Study|Refining and Pilot Testing Social Networks for Encouraging Healthy Behaviors: The Social Pounds Off Digitally (Social POD) Study|Completed||Phase 1|57|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-10 23:38:37.318566|2017-10-10 23:38:37.318566
NCT02344823|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-09-24|||June 2012||2012-06-01|September 2015|2015-09-01||||June 2016|Anticipated|2016-06-01||Interventional|||Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis|Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis|Unknown status|Recruiting|Phase 4|30|Anticipated|Medical University of Vienna||4|||f||||t||||||||||2017-10-10 23:38:37.392072|2017-10-10 23:38:37.392072
NCT02344810|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-16|||January 2015||2015-01-01|January 2015|2015-01-01||||June 2016|Anticipated|2016-06-01||Interventional|||C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer|A Phase I and Randomized Phase II Double Blinded Placebo Controlled Study of mFOLFOX6 +/- AMG 337 in the First Line Treatment of Patients With Her2/Neu Negative and High MET Expressing Advanced Gastric and Esophageal Adenocarcinoma|Unknown status|Not yet recruiting|Phase 1/Phase 2|308|Anticipated|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-10 23:38:37.503994|2017-10-10 23:38:37.503994
NCT02344797|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-19|||February 2015||2015-02-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|PIXIE||Prevention of Myocardial Injury in Non-cardiac Surgery|Prevention of Myocardial Injury by Remote Ischemic Preconditioning in Emergent or Urgent Non-cardiac Surgery: a Randomized Clinical Trial|Recruiting||N/A|540|Anticipated|University Hospital Koge||2|||f||||f||||||||||2017-10-10 23:38:37.624926|2017-10-10 23:38:37.624926
NCT02344784|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-08-22|||January 2015||2015-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|PPI||The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder|The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder: With and Without Medication.|Active, not recruiting||N/A|46|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-10 23:38:37.856167|2017-10-10 23:38:37.856167
NCT02344771|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-06-24|||March 2015||2015-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Perioperative Endothelial Dysfunction|Perioperative Endothelial Dysfunction in Patients Undergoing Non-cardiac Surgery|Completed||N/A|32|Actual|University Hospital Koge|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:38:37.958649|2017-10-10 23:38:37.958649
NCT02344758|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-22|||April 2013||2013-04-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Gluten-free Diet Monitoring in Urine|Non-invasive Gluten-free Diet Adherence Monitoring in Celiac Patients: Detection of Gluten Immunogenic Peptides in Urine|Completed||Early Phase 1|134|Actual|University of Seville||4|||f||||t||||||||||2017-10-10 23:38:38.033519|2017-10-10 23:38:38.033519
NCT02344745|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-10-24|2016-06-01||October 2014||2014-10-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Lavender Aromatherapy for Anxiety During Urodynamics|The Use of Lavender Aromatherapy to Decrease Women's Anxiety and Perception of Pain During Multi-channel Urodynamics Procedure|Completed||N/A|80|Actual|University of Southern California||2|||f||||f||||||||||2017-10-10 23:38:38.147605|2017-10-10 23:38:38.147605
NCT02344732|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-22|||October 2013||2013-10-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Systemic Oxygen on Corneal Epithelial Wound Healing in Diabetic Patients Undergoing Pars Plana Vitrectomy|Effect of Systemic Oxygen on Corneal Epithelial Wound Healing in Diabetic Patients Undergoing Pars Plana Vitrectomy|Completed||N/A|32|Actual|University of Science Malaysia||2|||f||||f||||||||||2017-10-10 23:38:38.547651|2017-10-10 23:38:38.547651
NCT02344563|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-22|||September 2014||2014-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Bioequivalence of Two Formulations of Meropenem Intravenous Injection|A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Meropenem In Healthy Volunteers(Meropenem Intravenous Injection) After Intravenous Infusion|Completed||Phase 4|14|Actual|Yung Shin Pharm. Ind. Co., Ltd.||2|||f||||||||||||||2017-10-10 23:38:38.651796|2017-10-10 23:38:38.651796
NCT02344550|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-08-26|||February 2014||2014-02-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|LEO||Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer|Ovarian Suppression Plus Letrozole Plus Everolimus for Hormone Receptor-Positive, Tamoxifen and Ovarian Suppression Pretreated, Premenopausal Women With Recurrent or Metastatic Breast Cancer[LEO]|Recruiting||Phase 2|137|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-10 23:38:38.732752|2017-10-10 23:38:38.732752
NCT02344537|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-26|||January 2015||2015-01-01|January 2015|2015-01-01||||January 2017|Anticipated|2017-01-01||Interventional|LMS||Meditation and Stretching for Post Treatment Lyme Disease Syndrome|Meditation and Stretching for Post Treatment Lyme Disease Syndrome|Unknown status|Not yet recruiting|N/A|40|Anticipated|Research Foundation for Mental Hygiene, Inc.||2|||f||||f||||||||||2017-10-10 23:38:38.859848|2017-10-10 23:38:38.859848
NCT02344524|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-17|||November 2012||2012-11-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Drainage of Traumatic Hemothorax and Pneumothorax: Small Bore Versus Large Bore Chest Drain|Drainage of Traumatic Hemothorax and Pneumothorax: Small Bore Versus Large Bore Chest Drain- a Randomized Controlled Trial|Completed||N/A|60|Actual|Delhi University||2|||f||||f||||||||||2017-10-10 23:38:38.978034|2017-10-10 23:38:38.978034
NCT02344121|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-06|||January 2015||2015-01-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Intra- and Inter-fraction Changes in Radiation Therapy|Intra- and Inter-fraction Changes in Radiation Therapy|Recruiting||N/A|500|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-10-10 23:38:43.759676|2017-10-10 23:38:43.759676
NCT02344511|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2016-09-22|||March 2016||2016-03-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|AHOM||Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis|A Phase 3, Multicenter, Double-Blind, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis of the Long Bones Known or Suspected to be Due to Gram-Positive Organisms|Withdrawn||Phase 3|0|Actual|Durata Therapeutics Inc., an affiliate of Allergan plc||2|||f||||t||||||||||2017-10-10 23:38:39.076556|2017-10-10 23:38:39.076556
NCT02344498|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-04-05|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa|Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa|Active, not recruiting||N/A|1350|Actual|Oslo University Hospital|||2||f||||f||||||||||2017-10-10 23:38:39.176501|2017-10-10 23:38:39.176501
NCT02344472|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2017-06-06|||September 2015||2015-09-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Detect V / CHEVENDO (Chemo vs. Endo)|DETECT V / CHEVENDO CHemo- Versus ENDOcrine Therapy in Combination With Dual HER2-targeted Therapy of Herceptin® (Trastuzumab) and Perjeta® (Pertuzumab) in Patients With HER2 Positive and Hormone-receptor Positive Metastatic Breast Cancer|Recruiting||Phase 3|270|Anticipated|University of Ulm||9|||f||||t||||||||||2017-10-10 23:38:39.427318|2017-10-10 23:38:39.427318
NCT02344459|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-01-16|||January 2010||2010-01-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening|Randomized Controlled Trial: Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening|Completed||N/A|105|Actual|University of Washington||2|||f||||f||||||||||2017-10-10 23:38:39.583534|2017-10-10 23:38:39.583534
NCT02344446|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-02-24|||November 2014||2014-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Physical Therapy Intervention for Extended Physical Symptoms After a Sports-related Concussion|Physical Therapy Intervention for Extended Physical Symptoms After a Sports-related Concussion|Completed||N/A|10|Actual|Walsh University||1|||f||||f||||||||||2017-10-10 23:38:39.663582|2017-10-10 23:38:39.663582
NCT02344433|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-03-14|||November 2016|Actual|2016-11-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|VICKY||Using Virtual Counselors to Overcome Genetic Literacy Barriers|Using Virtual Counselors to Overcome Genetic Literacy Barriers: Project VICKY|Enrolling by invitation||N/A|500|Anticipated|Boston University||2|||f||||f|f|f||||||No||2017-10-10 23:38:39.759214|2017-10-10 23:38:39.759214
NCT02344420|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-05-05|||June 2015||2015-06-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|BIOWOMEN||Clinical Investigation on Differences in the Magnitude of CRT Response in WOmen Versus MEN|Study to Compare the Cardiac Resynchronization Therapy (CRT) Response Rate in a Heart Failure (HF) Population With an Equal Distribution of Men and Women.|Recruiting||Phase 4|494|Anticipated|Biotronik SE & Co. KG||1|||f||||t||||||||||2017-10-10 23:38:39.838503|2017-10-10 23:38:39.838503
NCT02344407|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-22|2017-08-03|2017-05-25||January 20, 2015||2015-01-20|August 2017|2017-08-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)|Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)|Active, not recruiting||Phase 2|1500|Actual|National Institutes of Health Clinical Center (CC)||3|||||||t||||||||||2017-10-10 23:38:39.939825|2017-10-10 23:38:39.939825
NCT02344394|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-09-08|||September 2014||2014-09-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation|Prospective, Randomized Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone Versus Hybrid Ablation With Pulmonary Vein Isolation Plus Catheter Ablation for CFAE and Linear Lesions|Recruiting||N/A|254|Anticipated|Aurora Health Care||2|||f||||f||||||||||2017-10-10 23:38:40.537346|2017-10-10 23:38:40.537346
NCT02344381|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-10-22|||January 2015||2015-01-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Impact of Sucrose Ingestion Post-Exercise on Liver and Muscle Glycogen Repletion.||Completed||N/A|15|Actual|Northumbria University||2|||f||||t||||||||||2017-10-10 23:38:40.636159|2017-10-10 23:38:40.636159
NCT02344368|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-07-15|||January 2015||2015-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Sucrose on Pain Relief During Venous Blood Sampling in Preterm Infants|The Effect of Sucrose on Pain Relief During Venous Blood Sampling in Preterm Infants: a Comparison of Two Different Doses|Completed||N/A|50|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 23:38:40.719166|2017-10-10 23:38:40.719166
NCT02344355|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-04-19|||March 13, 2017|Actual|2017-03-13|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|April 2020|Anticipated|2020-04-01||Interventional|||A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme|Pharmacological Ascorbate Combined With Radiation and Temozolomide in Glioblastoma Multiforme: A Phase 2 Trial|Recruiting||Phase 2|90|Anticipated|University of Iowa||1|||f||||t|t|f||||||Yes|Data will be made available after completion of the trial on on clinicaltrials.gov as well as Project Data Sphere and/or NIH equivalent.|2017-10-10 23:38:40.800375|2017-10-10 23:38:40.800375
NCT02344342|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-03-21|2016-10-04||February 2015||2015-02-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|Manifold-HF|Group Number of subjects TM_YES_AND_FD_YES 13 TM_YES_AND_FD_NO 11 TM_NO_AND_FD_YES 14 TM_NO_AND_FD_NO 13|University of Michigan Advanced Heart Failure Tele-Monitoring and Flexible Diuretic Project|Michigan Advanced Heart Failure TelemoNItoring and FLexible Diuretic Trial - MANIFOLD-HF|Terminated||N/A|51|Actual|University of Michigan|Early termination leading to a small number of subjects analyzed. We have enrolled a total of 51 patients when our target was to enroll 400 patients.|2||The industry sponsor has discontinued the product under evaluation in the study.|f||||t||||||||No||2017-10-10 23:38:40.918686|2017-10-10 23:38:40.918686
NCT02344329|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-05-05|||August 2014||2014-08-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TAD||A Comparison of TCC-EZ Using Human Amnion Allograft vs TCC-EZ and Standard Wound Care in Treating Diabetic Foot Ulcers.|A Comparison of Total Contact Casting (TCC-EZ) Using Human Amnion Allograft (AmnioExcel) Versus Total Contact Casting (TCC-EZ) and Standard Wound Care in Treating Diabetic Foot Ulcers (TAD)|Active, not recruiting||Phase 4|12|Actual|University of North Dakota||2|||f||||f||||||||Undecided||2017-10-10 23:38:41.421673|2017-10-10 23:38:41.421673
NCT02344303|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-05-11|||December 2014||2014-12-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals|A Single-dose, Open-label, Fixed Sequence, Two Period Cross Over Study to Assess the Tolerability of a Supra Therapeutic Dose of TRV130 Followed by A Single Dose, Randomized, Double Blind, Comparative, Positive and Placebo Controlled, Four Period Cross-over Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on the QTc Intervals in Healthy Subjects|Completed||Phase 1|63|Actual|Trevena Inc.||2|||f||||f||||||||||2017-10-10 23:38:41.572361|2017-10-10 23:38:41.572361
NCT02344290|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-09-05|||March 2015||2015-03-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|REPRIEVE||Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults|Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE|Recruiting||Phase 4|6500|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:38:41.658879|2017-10-10 23:38:41.658879
NCT02344277|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-08-09|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Observational|S-ICD Brugada||Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients|Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients|Recruiting||N/A|200|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 23:38:42.43641|2017-10-10 23:38:42.43641
NCT02344264|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-09-24|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Nervus Cutaneous Femoris Lateralis-Blockade on Moderate Pain Responders After Total Hip Arthroplasty|Effect of Nervus Cutaneous Femoris Lateralis-Blockade on Moderate Pain Responders After Total Hip Arthroplasty|Completed||Phase 4|60|Actual|Naestved Hospital||2|||f||||t||||||||||2017-10-10 23:38:42.65828|2017-10-10 23:38:42.65828
NCT02344251|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-08-29|||June 1, 2016|Actual|2016-06-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|December 7, 2016|Actual|2016-12-07||Interventional|||Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence|A Phase II Randomized Trial to Assess the Effectiveness and Safety of the ID-Cap System for Medication Ingestion Monitoring and Enhancing Adherence|Active, not recruiting||N/A|40|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-10 23:38:42.772293|2017-10-10 23:38:42.772293
NCT02344238|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-07-08|||July 2015||2015-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Smart Capsule for Automatic Adherence Monitoring|Smart Capsule for Automatic Adherence Monitoring|Completed||N/A|60|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-10-10 23:38:42.869797|2017-10-10 23:38:42.869797
NCT02344225|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-10-03|||January 2015||2015-01-01|October 2017|2017-10-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|SPIPROP||The Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)|The Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP STUDY)|Recruiting||Phase 2|120|Anticipated|State University of New York - Downstate Medical Center||3|||f||||t||||||||||2017-10-10 23:38:42.972846|2017-10-10 23:38:42.972846
NCT02344212|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-21|||February 2008||2008-02-01|January 2015|2015-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Weight Loss and Prevention in Latina Immigrants: Advancing Methods of Community-Based Intervention Delivery|Weight Loss and Prevention in Latina Immigrants: Advancing Methods of Community-Based Intervention Delivery|Completed||N/A|35|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-10 23:38:43.095984|2017-10-10 23:38:43.095984
NCT02344199|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-05-17|||March 2015||2015-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|INOSET||Eplerenone in Heart Failure Treatment|A Non-interventional, Multicenter, Observational Clinical Trial to Assess Eplerenone Treatment in Patients With Heart Failure.|Completed||N/A|450|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-10 23:38:43.172807|2017-10-10 23:38:43.172807
NCT02344186|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-01-07|||May 2014||2014-05-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes|Effects of Liraglutide on Endoplasmic (ER) Stress in Obese Patients With Type 2 Diabetes|Active, not recruiting||Phase 4|12|Anticipated|Temple University||2|||f||||f||||||||||2017-10-10 23:38:43.275939|2017-10-10 23:38:43.275939
NCT02344173|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-07-21|||November 2014||2014-11-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01|12 Months|Observational [Patient Registry]|ABLATOR||ABLATOR Ablation Observational Registry|ABLATOR Ablation Observational Registry|Active, not recruiting||N/A|2007|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-10 23:38:43.400973|2017-10-10 23:38:43.400973
NCT02344160|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-12-15|||December 2014||2014-12-01|December 2016|2016-12-01|December 2028|Anticipated|2028-12-01|December 2028|Anticipated|2028-12-01||Observational|||REDAPT Revision System Study to Assess 5 Year Revision Rate & up to 10 Year Revision Rate and Safety and Effectiveness|A Prospective, Multi-center Consecutive Series Study of Subjects Treated With the REDAPT™ Revision Femoral System|Withdrawn||N/A|0|Actual|Smith & Nephew, Inc.|||1|Unable to recruit subjects|f||||f||||||||||2017-10-10 23:38:43.596747|2017-10-10 23:38:43.596747
NCT02344134|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-01-16|||September 2013||2013-09-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional|||Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects|A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess the Immunogenicity and Safety of NBP607 (Trivalent Inactivated Cell Culture-derived Influenza Vaccine) in Healthy Adults and Elderly Subjects|Completed||Phase 3|1155|Actual|SK Chemicals Co.,Ltd.||2|||f||||t||||||||||2017-10-10 23:38:43.67602|2017-10-10 23:38:43.67602
NCT02344108|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-06-30|||February 2015||2015-02-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Pilot Study to Evaluate the Safety and Efficacy of the Hypoglossal Nerve Stimulator in Adolescents With Down Syndrome and Obstructive Sleep Apnea|A Pilot Study to Evaluate the Safety and Efficacy of the Hypoglossal Nerve Stimulator in Adolescents and Young Adults With Down Syndrome and Obstructive Sleep Apnea|Recruiting||N/A|21|Anticipated|Massachusetts Eye and Ear Infirmary||1|||f||||f||||||||||2017-10-10 23:38:43.850481|2017-10-10 23:38:43.850481
NCT02344095|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-01|2015-01-22|||December 2014||2014-12-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|POPOPO||A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer|A Randomized Phase 1 Trial Evaluating the Safety of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Unknown status|Recruiting|Phase 1|12|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:38:44.005829|2017-10-10 23:38:44.005829
NCT02344082|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-27|||January 2015||2015-01-01|January 2015|2015-01-01||||April 2015|Anticipated|2015-04-01||Interventional|||Pharmacists Provide Telemedicine in Addition to Clinic Visits to Improve Diabetes Management||Unknown status|Enrolling by invitation|N/A|40|Anticipated|Johns Hopkins University||2|||f||||||||||||||2017-10-10 23:38:44.108167|2017-10-10 23:38:44.108167
NCT02344069|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-04-10|||February 2015|Actual|2015-02-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage|Effect of Immediate, Pre-emptive Fibrinogen Concentrate in Patients With Trauma Haemorrhage Needing Haemostatic Resuscitation - a Randomized, Controlled, Double-blinded Investigator-initiated Pilot Trial|Completed||Phase 2|40|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||No||2017-10-10 23:38:44.171983|2017-10-10 23:38:44.171983
NCT02344056|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-04-28|||October 2014||2014-10-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Coco||Cognition Intervention Study Dortmund- Continued (Coco)||Completed||N/A|154|Actual|Research Institute of Child Nutrition, Dortmund||2|||f||||||||||||||2017-10-10 23:38:44.262021|2017-10-10 23:38:44.262021
NCT02344043|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-11-25|||March 2014||2014-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|CONFOCAL||Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness|Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness|Completed||N/A|116|Actual|Queen's University|||1||f||||f||||||||Yes|We will publish our data in a peer reviewed scientific journal|2017-10-10 23:38:44.336031|2017-10-10 23:38:44.336031
NCT02344030|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-03-10|||January 2015||2015-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|KingVision||Comparsion of King Vision® Standard Blade and King Vision® Channeled Blade in Patients Scheduled for Tracheal Intubation|Comparative Study of King Vision® Standard Blade and King Vision® Channeled for Tracheal Intubation: a Prospective Randomised Study|Completed||N/A|44|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-10 23:38:44.410981|2017-10-10 23:38:44.410981
NCT02344017|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-01-03|||February 2015||2015-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DUALIDES||Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer|Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer (CRPC): Open, Non-Randomised, Uncontrolled, Multicentre, Dose Escalation, First-in-man Study With a Dose Expansion|Active, not recruiting||Phase 1/Phase 2|75|Anticipated|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-10-10 23:38:44.477406|2017-10-10 23:38:44.477406
NCT02344004|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-02-03|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|October 2017|Anticipated|2017-10-01||Interventional|CONVERT||Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone|A Randomized, Open-label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult Patients With Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC) That Are Refractory to Treatment|Active, not recruiting||Phase 3|350|Anticipated|Insmed Incorporated||2|||f||||t||||||||||2017-10-10 23:38:44.565569|2017-10-10 23:38:44.565569
NCT02343991|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-12-09|||October 2014||2014-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound|A Study to Evaluate the Safety and Feasibility of Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound With Intravenous Ultrasound Contrast Agents in the Treatment of Brain Tumours With Doxorubicin|Recruiting||N/A|10|Anticipated|InSightec||1|||f||||f||||||||||2017-10-10 23:38:44.927548|2017-10-10 23:38:44.927548
NCT02343978|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-05-18|||December 26, 2014|Actual|2014-12-26|May 2017|2017-05-01||||May 1, 2015|Actual|2015-05-01||Interventional|||Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC)|Phase II, Randomized, Open-label Study of KWA-0711 Administrated Orally for 2 Weeks to Evaluate Its Safety and Efficacy in Patients With Chronic Constipation (CC)|Completed||Phase 2|37|Actual|Kissei Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 23:38:44.991309|2017-10-10 23:38:44.991309
NCT02343965|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-01-20|||January 2015||2015-01-01|January 2015|2015-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TANDHEMS||The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study|The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study|Completed||N/A|62|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-10-10 23:38:45.059969|2017-10-10 23:38:45.059969
NCT02343952|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-09-06|||March 2015||2015-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC|A Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab for the Treatment of Inoperable or Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC): HCRN LUN14-179|Active, not recruiting||Phase 2|93|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-10-10 23:38:45.118653|2017-10-10 23:38:45.118653
NCT02342639|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-04-26|||May 2015||2015-05-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Rifaximin Therapy in Chronic Kidney Disease|Impact of Rifaximin Therapy on Intestinal Byproducts in Chronic Kidney Disease|Recruiting||Phase 4|30|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 23:39:01.308973|2017-10-10 23:39:01.308973
NCT02343926|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-05-17|||December 2014||2014-12-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin|A Multicentre, National, Randomized, Parallel-group, Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin|Completed||Phase 3|443|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 23:38:45.335239|2017-10-10 23:38:45.335239
NCT02343913|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-03-02|||June 2014||2014-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan|Simplifying Menstrual Regulation (MR): Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service Provision in Pakistan: Post Abortion Care (PAC)|Completed||N/A|329|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-10-10 23:38:47.06557|2017-10-10 23:38:47.06557
NCT02343887|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-10-22|||November 2014||2014-11-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|CogStim||CogStim, a Pilot Study : Cognitive Rehabilitation Management of HIV-1 Mild Cognitively Impaired Patients Controlled With Antiretroviral Therapy|CogStim, a Pilot Study : Cognitive Rehabilitation Management of HIV-1 Mild Cognitively Impaired Patients Controlled With Antiretroviral Therapy|Unknown status|Recruiting|N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||t||||||||||2017-10-10 23:38:47.159246|2017-10-10 23:38:47.159246
NCT02343874|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-16|||December 2012||2012-12-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|||Impact of Alcohol Consumption on Use of Health Care Resources|Impact of Alcohol Consumption of the General Population Who Visited Primary Health Care Centers on the Use of Health Care Resources in Catalonia.|Completed||N/A|1911771|Actual|Hospital Clinic of Barcelona|||1||f||||f||||||||||2017-10-10 23:38:47.251245|2017-10-10 23:38:47.251245
NCT02343861|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-11-16|||January 2015||2015-01-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis|The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis: A Pilot Study|Completed||N/A|24|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:38:47.350988|2017-10-10 23:38:47.350988
NCT02343848|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2016-04-12|||July 2015||2015-07-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|PEDPTB||Physical Activity and Gestational Complications|Physical Activity and Gestational Complications|Recruiting||N/A|200|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:38:47.423494|2017-10-10 23:38:47.423494
NCT02343835|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-03-27|||January 2015||2015-01-01|December 2015|2015-12-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer|IRE: Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer|Recruiting||Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:38:47.485482|2017-10-10 23:38:47.485482
NCT02343822|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-06-06|||March 2015||2015-03-01|June 2017|2017-06-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|PRPLE||Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection|Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection in a Double-Blinded Randomized Controlled Study (PRPLE)|Suspended||N/A|532|Anticipated|Kaiser Permanente||3|||f||||t||||||||||2017-10-10 23:38:47.566896|2017-10-10 23:38:47.566896
NCT02343809|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-21|||October 2014||2014-10-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|||Diacutaneous Fibrolysis on Lateral Epicondylitis|Effectiveness of Diacutaneous Fibrolysis on Chronic Lateral Epicondylitis. A Randomized Controlled Trial.|Unknown status|Recruiting|Phase 3|60|Anticipated|Jordi Gol i Gurina Foundation||3|||f||||f||||||||||2017-10-10 23:38:47.660162|2017-10-10 23:38:47.660162
NCT02343796|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-02-09|||June 2003||2003-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Follow-up of Direct/Indirect Bridge, Orthodontic and Periodontal Splint by Using Fibre-reinforced Composite|Clinical Follow-up of Direct/Indirect Bridge, Orthodontic and Periodontal Splint Applications by Using Fibre-reinforced Composite.|Active, not recruiting||N/A|200|Actual|Ege University||1|||f||||f||||||||Undecided|IPD would be considered for sharing with other reseachers during manuscript preparation.|2017-10-10 23:38:47.782141|2017-10-10 23:38:47.782141
NCT02343783|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-10-02|||January 2015||2015-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants|A Phase 0 Study Exploring the Use of Induced Skin Blisters in Adult Subjects With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Subjects.|Completed||Early Phase 1|46|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 23:38:47.946494|2017-10-10 23:38:47.946494
NCT02343770|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-09-04|||June 2015||2015-06-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Biomarkers in Idiopathic Juvenile Arthritis|Usefulness of Protoarray®Microarray for Identifying Biomarkers in Idiopathic Juvenile Arthritis Antinuclear Antibodies Positive.|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:38:48.06295|2017-10-10 23:38:48.06295
NCT02343757|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2015-01-21|||October 2013||2013-10-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid|Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid|Unknown status|Recruiting|N/A|30|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-10-10 23:38:48.149858|2017-10-10 23:38:48.149858
NCT02343744|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-06-16|||January 19, 2015|Actual|2015-01-19|June 2017|2017-06-01|September 21, 2018|Anticipated|2018-09-21|August 31, 2018|Anticipated|2018-08-31||Interventional|||An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis|A Phase 3, Multicenter, Open-Label Study Evaluating the Efficacy and Safety of CNTO1959 (Guselkumab) in the Treatment of Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis|Active, not recruiting||Phase 3|21|Actual|Janssen Pharmaceutical K.K.||1|||f||||t||f||||||||2017-10-10 23:38:48.238279|2017-10-10 23:38:48.238279
NCT02343731|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-01-08|||January 2015||2015-01-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Dogs as Probiotics|Dogs as Probiotics to Enhance the Health and Emotional Well-Being of Elderly Adults|Completed||Phase 2|20|Actual|University of Arizona||1|||f||||f||||||||||2017-10-10 23:38:48.379377|2017-10-10 23:38:48.379377
NCT02343718|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-03-31|||June 2, 2015|Actual|2015-06-02|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|February 2019|Anticipated|2019-02-01||Interventional|||Vinblastine and Temsirolimus in Pediatric Patients With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours|A Study of Vinblastine and Temsirolimus in Pediatric Patients With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours|Active, not recruiting||Phase 1|7|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-10 23:38:48.476109|2017-10-10 23:38:48.476109
NCT02343705|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-04-26|||January 2015||2015-01-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Evaluation of the Latella Knee Implant System for Medial Osteoarthritis Pain Reduction (Latella-2 Study)|Evaluation of the Latella Knee Implant System for Medial Osteoarthritis Pain Reduction (Latella-2 Study)|Terminated||N/A|67|Actual|Cotera, Inc.||1||Sponsor election|f||||f||||||||||2017-10-10 23:38:48.58196|2017-10-10 23:38:48.58196
NCT02343692|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-02-20|||March 2016|Actual|2016-03-01|January 2015|2015-01-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|RADIOCYST01||A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas|A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas (RADIOCYST01)|Recruiting||Phase 2|97|Anticipated|University College, London||1|||f||||f||||||||||2017-10-10 23:38:48.690444|2017-10-10 23:38:48.690444
NCT02343679|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-01-30|||May 2015||2015-05-01|January 2017|2017-01-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies|A Phase II Study of the ALK Inhibitor, Ceritinib (LDK378), in Relapsed/Refractory ALK+ Hematologic Malignancies|Withdrawn||Phase 2|0|Actual|Duke University||1||No accrual due to rarity of disease.|f||||f||||||||||2017-10-10 23:38:48.809986|2017-10-10 23:38:48.809986
NCT02343666|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-06-27|||August 15, 2016|Actual|2016-08-15|June 2017|2017-06-01||||August 1, 2020|Anticipated|2020-08-01||Interventional|||HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection|A Clinical Trial of Gene-Modified Stem Cells to Generate HIV-Resistant Cells in Conjunction With Standard Chemotherapy for Treatment of Lymphoma in Patients With HIV Infection|Recruiting||Phase 1|13|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-10 23:38:48.89398|2017-10-10 23:38:48.89398
NCT02343653|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-12-01|||January 2015||2015-01-01|November 2015|2015-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Resistance Training on Muscle Strength and Nutritional Status in Patients With Liver Cirrhosis|The Effect of Resistance Training on Muscle Strength and Nutritional Status in Patients With Liver Cirrhosis|Recruiting||N/A|40|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:38:49.026499|2017-10-10 23:38:49.026499
NCT02343640|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-08-04|||January 2015||2015-01-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|1 Year|Observational [Patient Registry]|||Ultrasound Study of Season-Long Joint Changes to College Baseball Players|Ultrasound Study of Season-Long Joint Changes to College Baseball Players|Completed||N/A|10|Actual|California State University, Northridge|||1||f||||f||||||||||2017-10-10 23:38:49.137752|2017-10-10 23:38:49.137752
NCT02343627|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-27|2017-05-03|||December 2014||2014-12-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail|A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Assess the Safety and Efficacy of NVXT Solution in Patients With Mild-to-Moderate Fungal Infection of the Toe Nail|Completed||Phase 2|48|Actual|Taro Pharmaceuticals USA||2|||f||||f||||||||No||2017-10-10 23:38:49.223138|2017-10-10 23:38:49.223138
NCT02343614|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-01-21|||March 2003||2003-03-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer|Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer|Completed||Phase 2|58|Actual|Azienda Ospedaliero-Universitaria Consorziale||1|||f||||t||||||||||2017-10-10 23:38:49.323742|2017-10-10 23:38:49.323742
NCT02343601|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-12-03|||December 2014||2014-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|PANEX3||Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery|Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery : A Randomized Controlled Study|Recruiting||Phase 3|160|Anticipated|University Hospital, Caen||2|||f||||t||||||||||2017-10-10 23:38:49.40303|2017-10-10 23:38:49.40303
NCT02343588|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-22|||September 2013||2013-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||A National School-based Health Lifestyles Interventions Among Chinese Children and Adolescents Against Obesity|Development and Application of Appropriate Technology for Obesity Prevention and Control in Seven Centers in China|Completed||N/A|70000|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:38:49.605703|2017-10-10 23:38:49.605703
NCT02343575|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-04-20|||January 2015||2015-01-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU|Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU|Suspended||Phase 4|30|Anticipated|Stanford University||2||The research assistant has left the position and we are recruiting a new one.|f||||t||||||||||2017-10-10 23:38:49.705323|2017-10-10 23:38:49.705323
NCT02343562|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-07-26|||October 2014||2014-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis|Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis|Recruiting||Phase 4|40|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:38:49.814713|2017-10-10 23:38:49.814713
NCT02343549|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-07-31|||January 2015||2015-01-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)|A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)|Recruiting||Phase 2|46|Anticipated|Carolinas Healthcare System||1|||f||||t||||||||||2017-10-10 23:38:49.921888|2017-10-10 23:38:49.921888
NCT02343536|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-05-09|||April 29, 2015|Actual|2015-04-29|May 2017|2017-05-01|March 1, 2020|Anticipated|2020-03-01|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma|A Phase 1, Open-label, Multicenter Trial of Oral Azacitidine (CC-486) Plus R-CHOP in Subjects With High Risk (IPI 3 or More) Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3B Follicular Lymphoma.|Recruiting||Phase 1|50|Anticipated|Celgene||2|||f||||t||||||||||2017-10-10 23:38:50.015026|2017-10-10 23:38:50.015026
NCT02343523|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-05-04|||January 2015||2015-01-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Pilot Study of the QI Device for Monitoring of Patients With Congestive Heart Failure|Pilot Study of the Quanttus Device for Monitoring of Patients With Congestive Heart Failure|Completed||N/A|13|Actual|Scripps Translational Science Institute|||1||f||||f||||||||No||2017-10-10 23:38:50.160179|2017-10-10 23:38:50.160179
NCT02343510|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2017-07-16|||January 2015||2015-01-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study|Detection of Chlamydia DNA by Polymerase Chain Reaction ( PCR ) in Tumours Tissue of Primary Tubal and Ovarian Cancers : a Pilot Study|Completed||N/A|70|Actual|Ain Shams University|||4||f||||t||||||Samples With DNA|"     Archival Paraffin blocks for cases of primary tubal cancers , high grade serous ovarian     cancers , low grade serous ovarian cancers and normal Fallopian tubes removed during     Hysterectomy operations for benign Gynecological indications   "|||2017-10-10 23:38:50.229763|2017-10-10 23:38:50.229763
NCT02343497|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-09-08|||August 2014||2014-08-01|September 2015|2015-09-01||||September 2015|Anticipated|2015-09-01||Interventional|LLAX||Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia|Randomized, Double-blind, Placebo-controlled, Parallel-group Design, Monocentric Study on Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidemia|Unknown status|Active, not recruiting|N/A|68|Anticipated|Ajinomoto Foods Europe SAS||2|||f||||f||||||||||2017-10-10 23:38:50.318031|2017-10-10 23:38:50.318031
NCT02343484|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-09-30|||March 2013||2013-03-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Intradiscal Gelified Ethanol and Pulsed Radiofrequency Versus Gelified Ethanol Injection for Discogenic Low Back Pain|Intradiscal Combination of Gelified Ethanol and Pulsed Radiofrequency Versus Gelified Ethanol Injection for the Treatment of Chronic Discogenic Low Back Pain. A Randomized Controlled Trial.|Completed||N/A|40|Actual|Attikon Hospital||2|||f||||f||||||||||2017-10-10 23:38:50.419559|2017-10-10 23:38:50.419559
NCT02343471|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2015-05-04|||March 2015||2015-03-01|January 2015|2015-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PREMEAL 3||The Effect of Whey Protein Consumed as a Pre-meal on Postprandial Lipemia in Healthy and Subjects With Type 2 Diabetes|Whey Protein, Postprandial Lipemia and Cardiovascular Disease: Evaluation of the Effect of a Pre-meal of Whey Protein on Postprandial Lipiemia in Subjects With the Metabolic Syndrome and Type 2 Diabetes|Completed||N/A|26|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-10-10 23:38:50.513309|2017-10-10 23:38:50.513309
NCT02343458|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-09-05|||March 30, 2015|Actual|2015-03-30|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD|A Randomized, Double-Blind, Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo|Completed||Phase 3|1759|Actual|Pearl Therapeutics, Inc.||4|||f||||t|t|f||||||||2017-10-10 23:38:50.626564|2017-10-10 23:38:50.626564
NCT02343445|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-08-08|||April 2015||2015-04-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|CLEAN-CF||Clearing Lungs With ENAC Inhibition in Cystic Fibrosis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)|Completed||Phase 2|142|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||f||||||||Undecided||2017-10-10 23:38:50.834972|2017-10-10 23:38:50.834972
NCT02343419|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-11-08|||November 2014||2014-11-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||Diagnostic Utility of Different Airway Resistance Assessment Techniques in the Methacholine Challenge Test|Diagnostic Utility of Different Airway Resistance Assessment Techniques in the Evaluation of Bronchial Hyperreactivity by Methacholine Challenge Testing|Completed||N/A|46|Actual|Medical University of Warsaw||1|||f||||f||||||||No||2017-10-10 23:38:51.111549|2017-10-10 23:38:51.111549
NCT02343406|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-08-16|||February 11, 2015||2015-02-11|August 2017|2017-08-01|June 11, 2020|Anticipated|2020-06-11|December 27, 2019|Anticipated|2019-12-27||Interventional|INTELLANCE 2||Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas|Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma: A Randomized Phase II Study of the EORTC Brain Tumor Group (EORTC Protocol 1410-BTG) Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas|Recruiting||Phase 2|260|Anticipated|AbbVie||5|||f||||t||||||||||2017-10-10 23:38:51.235441|2017-10-10 23:38:51.235441
NCT02343393|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-01-15|||January 2015||2015-01-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|NICHE||Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study|Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study|Unknown status|Recruiting|Phase 3|100|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-10 23:38:51.667626|2017-10-10 23:38:51.667626
NCT02343380|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-11-27|2015-08-20||May 2014||2014-05-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Timing of Caloric Intake, Diet-induced Thermogenesis and Hormonal Pattern|Is the Timing of Caloric Intake Associated With Variation in Diet-induced Thermogenesis and Hormonal Pattern?|Completed||N/A|20|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-10-10 23:38:51.782039|2017-10-10 23:38:51.782039
NCT02343367|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-08-07|||January 2015||2015-01-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|H4K||Health4Kids Intervention Trial for Hispanic Families|Pediatric Obesity Management Intervention Trial for Hispanic Families|Recruiting||N/A|460|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-10 23:38:52.04385|2017-10-10 23:38:52.04385
NCT02343354|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-08-31|||November 2014||2014-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|MoMMii||The MoMMii Study. Diabetes Prevention Intervention on Families With Past Gestational Diabetes|The MoMMii Study: Effects of a Multimodal Diabetes Prevention Intervention on Families With a History of Gestational Diabetes|Active, not recruiting||N/A|118|Actual|McGill University Health Center||1|||f||||f||||||||||2017-10-10 23:38:52.161507|2017-10-10 23:38:52.161507
NCT02343341|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-19|||November 2015||2015-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|FAMILIA||Family-based Approach to Promotion of Health|Family-based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health (FAMILIA)|Recruiting||N/A|600|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|f||||||||2017-10-10 23:38:52.280738|2017-10-10 23:38:52.280738
NCT02343328|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-09-12|||January 2015||2015-01-01|September 2017|2017-09-01|July 29, 2016|Actual|2016-07-29|July 29, 2016|Actual|2016-07-29||Interventional|||Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a First or Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum|Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a First or Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum|Terminated||Phase 1|3|Actual|Massachusetts General Hospital||2||Not enough interest|f||||||||||||||2017-10-10 23:38:52.407292|2017-10-10 23:38:52.407292
NCT02343315|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-01-21|||February 2015||2015-02-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Interventional|||Are Supervised Exercises and TENS Necessary Along With Prescribed Home Exercises for Chronic Low Back Pain?|Effectiveness of TENS and Supervised Motor Control Exercises Compared To Unsupervised Exercises in Subjects With Chronic Low Back Pain: A Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|135|Anticipated|Kathmandu University School of Medical Sciences||3|||f||||t||||||||||2017-10-10 23:38:52.493764|2017-10-10 23:38:52.493764
NCT02343302|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-01-15|||February 2013||2013-02-01|January 2015|2015-01-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Prospective Trial Evaluating the Effect of Closed Suction Drainage Versus Straight Drainage After Distal Pancreatectomy|Prospective Trial Evaluating the Effect of Closed Suction Drainage Versus Straight Drainage After Distal Pancreatectomy|Unknown status|Recruiting|N/A|300|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:38:52.606764|2017-10-10 23:38:52.606764
NCT02343289|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-09-25|||January 2015||2015-01-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy Participants|An Open-Label Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy Subjects|Completed||Phase 1|18|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-10 23:38:52.717843|2017-10-10 23:38:52.717843
NCT02343276|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-02-22|||February 2015||2015-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs|Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs.|Completed||Phase 3|328|Actual|Instituto de Cardiologia de Santa Catarina||2|||f||||f||||||||||2017-10-10 23:38:52.825329|2017-10-10 23:38:52.825329
NCT02343263|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-02-28|||March 2015||2015-03-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage|Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage: a Clinical Trial.|Terminated||Phase 2|10|Actual|Indiana University||3||insufficient manpower|f||||f||||||||No||2017-10-10 23:38:52.917366|2017-10-10 23:38:52.917366
NCT02343250|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-01-11|||March 2015||2015-03-01|January 2016|2016-01-01||||March 2015|Actual|2015-03-01||Interventional|IDCV||A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan|A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers|Completed||Phase 1|54|Actual|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||||2017-10-10 23:38:53.040053|2017-10-10 23:38:53.040053
NCT02343237|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-07-05|||December 2015||2015-12-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|FIBROPATHIC||Osteopathic Medicine in Fibromyalgia Syndrome|A Multicenter, Randomized Study, Against Credible Factitious Intervention That Evaluates the Interest of Osteopathic Medicine in the Management of Fibromyalgia Syndrome|Recruiting||N/A|150|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 23:38:53.115512|2017-10-10 23:38:53.115512
NCT02343224|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-08-04|||November 2014||2014-11-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|Peg Interferon||Phase II Pegylated Interferon|A Phase II Study Of Pegylated Interferon ALFA-2b in Children With Recurrent or Refractory and Radiographically or Clinically Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas|Recruiting||Phase 2|20|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 23:38:53.226355|2017-10-10 23:38:53.226355
NCT02343211|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-24|||November 2013||2013-11-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|June 2016|Actual|2016-06-01||Interventional|IaSON||Immunotherapy and Paraneoplastic Neurological Syndromes|Early Onset Immunotherapy by Intravenous Immunoglobulin in Well-characterized Onconeural-antibody-positive Paraneoplastic Neurological Syndromes|Active, not recruiting||Phase 2|17|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:38:53.330321|2017-10-10 23:38:53.330321
NCT02343198|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-08-21|||August 2014||2014-08-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Use of NMES as a Home-based Therapy Following Total Knee Arthroplasty|The Use of NMES as a Home-based Therapy Following Total Knee Arthroplasty|Unknown status|Recruiting|N/A|50|Anticipated|National University of Ireland, Galway, Ireland||2|||f||||f||||||||||2017-10-10 23:38:53.432028|2017-10-10 23:38:53.432028
NCT02343185|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-08-07|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effects of Diaphragmatic Manual Therapy in Chronic Low Back Pain|Effects of Diaphragmatic Manual Therapy in Chronic Low Back Pain|Completed||N/A|64|Actual|Cardenal Herrera University||2|||f||||t||||||||||2017-10-10 23:38:53.533008|2017-10-10 23:38:53.533008
NCT02343172|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-09-29|||March 14, 2015|Actual|2015-03-14|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma|A Phase Ib/II, Open-label, Multicenter Study of Oral HDM201 in Combination With Oral LEE011 in Adult Patients With Liposarcoma|Recruiting||Phase 1/Phase 2|108|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-10 23:38:53.643607|2017-10-10 23:38:53.643607
NCT02343159|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-11|2017-04-11||February 28, 2015|Actual|2015-02-28|April 2017|2017-04-01|April 15, 2016|Actual|2016-04-15|April 15, 2016|Actual|2016-04-15||Interventional||The Intent-to-treat (ITT) population will be used for analysis. ITT is defined as all participants who were randomized and received at least one dose of study treatment.|Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.|A Multicenter, Open-label Phase IV Study to Evaluate Whether a Medication Event Monitoring System (MEMS®) Can Improve Adherence to Tecfidera® (Delayed-release Dimethyl Fumarate) Treatment in Multiple Sclerosis Patients.|Terminated||Phase 4|84|Actual|Biogen||3||Sponsor Decision|f||||t||||||||||2017-10-10 23:38:53.784451|2017-10-10 23:38:53.784451
NCT02343146|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-03-28|||October 2015||2015-10-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Healthy Eating, Physical Activity, and Glycemic Control in Young Children With T1D|Healthy Eating, Physical Activity, and Glycemic Control in Young Children With T1D|Enrolling by invitation||N/A|70|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-10 23:38:54.475686|2017-10-10 23:38:54.475686
NCT02343133|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-08-02|||January 2015||2015-01-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome|A Phase 2 Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects|Completed||Phase 2|200|Actual|Neumedicines Inc.||2|||f||||t||||||||||2017-10-10 23:38:54.547514|2017-10-10 23:38:54.547514
NCT02343120|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-09-02|||August 2014||2014-08-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies|A Phase I, Open-Label, Multiple-Dose, Dose Escalation and Expansion Study to Investigate the Safety and Pharmacokinetics of the BTK Inhibitor BGB-3111 in Subjects With B-Cell Lymphoid Malignancies|Recruiting||Phase 1|235|Anticipated|BeiGene||1|||f||||t||||||||||2017-10-10 23:38:54.819177|2017-10-10 23:38:54.819177
NCT02343107|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-07-02|||March 2014||2014-03-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ANODE||E-coaching for Type 2 Diabetes|E-coaching for Patients With Abdominal Obesity and Type 2 Diabetes : the A.N.O.D.E. Study|Completed||N/A|120|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:38:54.932936|2017-10-10 23:38:54.932936
NCT02343094|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-08-25|||February 2015||2015-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|PIRATE||Phenylbutyrate in Proteinuric Nephropathies|Phenylbutyrate Effect on Lcn2 Urianry Expression in Proteinuric Patients|Completed||Phase 2/Phase 3|26|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:38:55.042207|2017-10-10 23:38:55.042207
NCT02343081|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-03-20|2015-02-23||January 2012||2012-01-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Not specified|Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System|A Randomized, Open Label, Two-way Crossover, Single Dose Bioequivalence Study Comparing Dralitem® Capsules to the Reference Drug Temodal® Capsules in Patients With Primary Tumors of the Central Nervous System Under Fasting Conditions|Completed||Phase 4|24|Actual|Monte Verde SA||2|||f||||f||||||||||2017-10-10 23:38:55.138694|2017-10-10 23:38:55.138694
NCT02343068|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-12-14|||June 2014||2014-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:38:55.626118|2017-10-10 23:38:55.626118
NCT02343055|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-04-30|||October 2011||2011-10-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||COPE With COPD Trial|Collaborative Self-Management Patient Education Will Improve Health Outcomes in COPD|Completed||N/A|182|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:38:55.669034|2017-10-10 23:38:55.669034
NCT02343042|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-09-14|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|STOMP||Selinexor and Backbone Treatments of Multiple Myeloma Patients|A Phase 1b/2 Study of Selinexor (KPT-330) in Combination With Backbone Treatments for Relapsed/Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|262|Anticipated|Karyopharm Therapeutics Inc||4|||f||||f||||||||||2017-10-10 23:38:55.789948|2017-10-10 23:38:55.789948
NCT02343029|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-08-31|||June 2014||2014-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SMART||Physical Activity and Cerebral Metabolism in the Elderly: a Randomised Controlled Trial|Physical Activity and Cerebral Metabolism in the Elderly: a Randomised Controlled Trial|Completed||N/A|60|Actual|Goethe University||2|||f||||f||||||||||2017-10-10 23:38:56.002889|2017-10-10 23:38:56.002889
NCT02342834|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-15|||January 2015||2015-01-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Interventional|||Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis|Mechanisms Through Which a Small Protein and Lipid Preload Improves Glucose Tolerance in Subjects With Impaired Glucose Homeostasis|Unknown status|Enrolling by invitation|N/A|35|Actual|Azienda Ospedaliero, Universitaria Pisana||2|||f||||f||||||||||2017-10-10 23:38:58.864244|2017-10-10 23:38:58.864244
NCT02343016|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-01-15|||February 2015||2015-02-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|NIRS||NIRS as a Continuous Noninvasive Monitoring System of Liver/Kidney Graft Perfusion|Evaluation of NIRS as a Continuous Noninvasive Monitoring System of Liver/Kidney Graft Perfusion in the Early Postoperative Period in Pediatric Patients. Pilot Study|Unknown status|Not yet recruiting|N/A|15|Anticipated|Bambino Gesù Hospital and Research Institute|||1||f||||f||||||Samples Without DNA|"     -  Blood count        -  Coagulation: INR, PT,PTT, ATIII, fibrinogen        -  Electrolytes        -  Albumine, proteins        -  Liver function specific markers: GOT/GPT, total and direct bilirubin, urea nitrogen,          lactic acid        -  Renal function specific markers: NGAL, creatinine, urea nitrogen   "|||2017-10-10 23:38:56.112426|2017-10-10 23:38:56.112426
NCT02342990|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2016-02-23|||March 2014||2014-03-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Telerehabilitation of Working Memory in Children With Periventricular Leukomalacia and Bilateral Cerebral Palsy|Telerehabilitation of Working Memory in Children With Periventricular Leukomalacia and Bilateral Cerebral Palsy, a Neuropsychological and Electrophysiological (High-density EEG) Study|Completed||N/A|20|Actual|IRCCS Fondazione Stella Maris||2|||f||||f||||||||||2017-10-10 23:38:56.788476|2017-10-10 23:38:56.788476
NCT02342977|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-08-25|||November 2014||2014-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty:|Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty: A Randomized Double -Blinded, Placebo-controlled Pilot Study.|Withdrawn||Phase 2|0|Actual|Indiana University||2||We were unable to enroll any patients into the study.|f||||t||||||||||2017-10-10 23:38:56.923654|2017-10-10 23:38:56.923654
NCT02342964|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-08-25|||January 2015||2015-01-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|MUCO-FIBRO||Comparison of Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic Fibrosis|Comparative Study of Different Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic Fibrosis|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:38:57.686235|2017-10-10 23:38:57.686235
NCT02342951|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-08-25|||April 2014||2014-04-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|LCI||Evaluation of the Lung Clearance Index|Evaluation of Lung Clearance Index for Early Detection of Lung Disease in Young Children With Cystic Fibrosis|Recruiting||N/A|50|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:38:57.798809|2017-10-10 23:38:57.798809
NCT02342938|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-10-12|||September 2013||2013-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|SEMAINE||Simultaneous MEG or fMRI And INtracranial EEG||Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:38:57.899724|2017-10-10 23:38:57.899724
NCT02342925|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-11-01|||February 2015||2015-02-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study of the Effect of RG1662 on Metformin in Healthy Volunteers||Completed||Phase 1|17|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:38:57.996444|2017-10-10 23:38:57.996444
NCT02342912|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-12-15|||February 2015||2015-02-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|||Social Media Obesity Treatment for College Students|Translation of Social Media Obesity Treatment Into Two College Campus Communities|Recruiting||N/A|450|Anticipated|George Washington University||3|||f||||t||||||||||2017-10-10 23:38:58.094824|2017-10-10 23:38:58.094824
NCT02342899|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-11-24|||March 2015||2015-03-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|OPIP||Cost Effectiveness of Outpatient Set-up of Automated NIV in Obese Patients With Chronic Respiratory Failure|Medium Cost Effectiveness of Automated Non-Invasive Ventilation Outpatient Set Up vs Standard Fixed Level Non-Invasive Ventilation Inpatient Set Up In Obese Patients With Chronic Respiratory Failure|Recruiting||Phase 3|82|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||No|No plan to share individual participant data|2017-10-10 23:38:58.232281|2017-10-10 23:38:58.232281
NCT02342886|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-08-18|||February 2015||2015-02-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|STAND||Shortening Treatment by Advancing Novel Drugs|A Phase 3 Open-Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin Plus PA-824 Plus Pyrazinamide After 4 and 6 Months of Treatment in Adult Subjects With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis and After 6 Months of Treatment in Adult Subjects With Multi-Drug Resistant, Smear-Positive Pulmonary Tuberculosis.|Active, not recruiting||Phase 3|1500|Anticipated|Global Alliance for TB Drug Development||5|||f||||t||||||||||2017-10-10 23:38:58.401552|2017-10-10 23:38:58.401552
NCT02342873|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-07-13|||March 2014||2014-03-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Nerve Stimulator Versus Ultrasound-guided Interscalene Block for Shoulder Surgery|A Randomized Comparison of Nerve Stimulator-guided and Ultrasound-guided Interscalene Block for Shoulder Surgery|Completed||N/A|53|Actual|Cheju Halla General Hospital||2|||f||||f||||||||||2017-10-10 23:38:58.568446|2017-10-10 23:38:58.568446
NCT02342860|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-06-07|||September 2014||2014-09-01|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||The Impact of Improved WASH in Schools on Absence, Diarrhea and Helminth Infection in Lao PDR|Measuring the Impact of WASH in Schools in the Lao People's Democratic Republic|Completed||N/A|8873|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:38:58.662018|2017-10-10 23:38:58.662018
NCT02342847|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-07-20|||December 10, 2014|Actual|2014-12-10|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|November 9, 2016|Actual|2016-11-09||Observational|aLIVE||Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer|Observational Cohort Study of Health-related Quality of Life in Patients Initiating Treatment With Chemotherapy for Metastatic Pancreatic Cancer|Active, not recruiting||N/A|120|Actual|Celgene|||1||f||||f||||||||||2017-10-10 23:38:58.743658|2017-10-10 23:38:58.743658
NCT02342821|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-16|2017-03-26|||February 2015||2015-02-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||Empowering Immigrants in the Greater Boston Area to Connect to HBV Care|Empowering Immigrants in the Greater Boston Area to Connect to HBV Care|Active, not recruiting||N/A|100|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-10 23:38:58.940745|2017-10-10 23:38:58.940745
NCT02342808|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-08-31|||June 2015||2015-06-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TRIUMPH||Lifestyle Interventions in Treatment-Resistant Hypertension|Treating Resistant Hypertension Using Lifestyle Modification to Promote Health|Recruiting||N/A|150|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:38:59.000251|2017-10-10 23:38:59.000251
NCT02342795|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-09-05|||June 2015||2015-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation|Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation|Recruiting||Phase 1/Phase 2|520|Anticipated|Virginia Commonwealth University||4|||f||||t||||||||||2017-10-10 23:38:59.090436|2017-10-10 23:38:59.090436
NCT02342782|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-10-02|||June 8, 2015||2015-06-08|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma|Phase I Study of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Plus Standard BEAM Conditioning for Autologous Hematopoietic Cell Transplantation in Patients With Mature T-Cell Non-Hodgkin Lymphoma: the aTAC BEAM Regimen|Recruiting||Phase 1|24|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:38:59.33346|2017-10-10 23:38:59.33346
NCT02342769|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-09-26|||February 19, 2015|Actual|2015-02-19|September 2017|2017-09-01|October 15, 2018|Anticipated|2018-10-15|October 15, 2018|Anticipated|2018-10-15||Observational|TRIUMPH||Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany|Prospective Non-Interventional Observational Study of Use of Triumeq® and Corresponding Monitoring Measures in Clinical Practice in Germany|Active, not recruiting||N/A|403|Actual|ViiV Healthcare|||1||f||||f||||||||||2017-10-10 23:38:59.497695|2017-10-10 23:38:59.497695
NCT02342756|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-01-29|||January 2015||2015-01-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EPOCH||Esophageal Pressure-Guided Optimal PEEP/mPaw in CMV and HFOV: The EPOCH Study|Esophageal Pressure-Guided Optimal PEEP/mPaw in CMV and HFOV: The EPOCH Study|Active, not recruiting||N/A|20|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-10 23:38:59.672657|2017-10-10 23:38:59.672657
NCT02342743|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-04-28|||February 2, 2015|Actual|2015-02-02|April 2017|2017-04-01|April 11, 2017|Actual|2017-04-11|April 11, 2017|Actual|2017-04-11||Interventional|||Open-trial on the Prevention of Chronic Migraines With the CEFALY Device|Open-trial on the Prevention of Chronic Migraines With the CEFALY Device|Completed||N/A|73|Actual|Cefaly Technology||1|||f||||f||||||||||2017-10-10 23:38:59.793882|2017-10-10 23:38:59.793882
NCT02342730|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-03-16|||December 17, 2014||2014-12-17|March 2017|2017-03-01|September 18, 2017|Anticipated|2017-09-18|May 18, 2015|Actual|2015-05-18||Interventional|||Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia|Referral of Obese Endometrial Cancer Survivors to a Bariatric Specialist and a Healthier Survivorship: A Prospective Intervention Cohort Study|Active, not recruiting||N/A|127|Actual|Case Comprehensive Cancer Center||1|||f||||f|f|f||||||||2017-10-10 23:38:59.887199|2017-10-10 23:38:59.887199
NCT02342717|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2015-04-01|||January 2015||2015-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects|Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects (an Open-label, Two-period, Fixed-sequence Trial)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:39:00.03469|2017-10-10 23:39:00.03469
NCT02342704|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-05-17|2017-05-17||November 30, 2014|Actual|2014-11-30|May 2017|2017-05-01|May 18, 2016|Actual|2016-05-18|May 18, 2016|Actual|2016-05-18||Interventional|REVEAL||Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants|A Multicenter, Randomized, Open-Label Study to Assess the Impact of Natalizumab Versus Fingolimod on Central Nervous System Tissue Damage and Recovery in Active Relapsing-Remitting Multiple Sclerosis Subjects|Terminated||Phase 4|111|Actual|Biogen||2||Business Decision|f||||||||||||||2017-10-10 23:39:00.159085|2017-10-10 23:39:00.159085
NCT02342691|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-08-03|||September 2016||2016-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|BLXA4||Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis|A Phase 1 / 2 Clinical Trial to Assess the Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis|Recruiting||Phase 1/Phase 2|125|Anticipated|The Forsyth Institute||3|||f||||t||||||||||2017-10-10 23:39:00.828808|2017-10-10 23:39:00.828808
NCT02342678|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-01-23|||January 2015||2015-01-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|LILA||Lessening Incontinence Through Low-impact Activity|Lessening Incontinence Through Low-impact Activity, a.k.a. Yoga to Enhance Behavioral Self-Management of Urinary Incontinence in Women|Active, not recruiting||N/A|80|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:39:00.924918|2017-10-10 23:39:00.924918
NCT02342665|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-09-21|||April 21, 2015|Actual|2015-04-21|September 2017|2017-09-01|October 31, 2021|Anticipated|2021-10-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL|Open-label, Uncontrolled, Single-arm, Phase Ib/II Study of Intravenous Copanlisib in Japanese Patients With Indolent B-cell Non Hodgkin's Lymphomas Relapsed After or Refractory to Standard Therapy|Recruiting||Phase 1/Phase 2|26|Anticipated|Bayer||1|||f||||f||||||||||2017-10-10 23:39:01.015498|2017-10-10 23:39:01.015498
NCT02342652|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-10-31|||October 2014||2014-10-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects|A Phase 1, Randomised, Single Blind, Placebo Controlled, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects|Completed||Phase 1|7|Actual|Aslan Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:39:01.183901|2017-10-10 23:39:01.183901
NCT02342626|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-03-29|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer|CDC SIP: Rochester Prevention Research Center: Development and Evaluation of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer|Active, not recruiting||N/A|140|Anticipated|University of Rochester||2|||f||||f||||||||No||2017-10-10 23:39:01.427305|2017-10-10 23:39:01.427305
NCT02342613|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-10-12|||February 2015||2015-02-01|October 2016|2016-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation|Adoptive Immunotherapy Utilizing Activated Marrow Infiltrating Lymphocytes Derived From Patients With Bone Marrow Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Graft-Versus-Host Disease Prophylaxis.|Recruiting||Phase 1|27|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:39:01.51495|2017-10-10 23:39:01.51495
NCT02342587|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-02-16|||December 3, 2014|Actual|2014-12-03|February 2017|2017-02-01|August 21, 2016|Actual|2016-08-21|January 2016|Actual|2016-01-01||Interventional|||Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer|Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer: A Phase II Single Arm Prospective Study|Completed||Phase 2|7|Actual|Samsung Medical Center||1|||f||||||||||||||2017-10-10 23:39:01.706336|2017-10-10 23:39:01.706336
NCT02342574|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2016-09-16|||February 2015||2015-02-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||F901318 Multiple Ascending Dose Study|F901318 - A Phase I, Double-Blind, Placebo Controlled, Single and Multiple Ascending Intravenous Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male Subjects|Completed||Phase 1|72|Actual|F2G Ltd.||18|||f||||f||||||||||2017-10-10 23:39:01.80664|2017-10-10 23:39:01.80664
NCT02342561|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-11-08|2015-09-01||September 2014||2014-09-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional||The intervention and control groups are the knees of the same patients assigned to either draping or no draping (split-person design). The avoid double-counting we report each unique participant here (each receiving both interventions). However in outcomes, each knee is considered as separate in the analysis.|Iodine Impregnated Incision Drapes and Bacterial Recolonization in Simulated Knee Surgery. A Controlled Randomized Experimental Trial.|Iodine Impregnated Incision Drapes and Bacterial Recolonization in Simulated Total Knee Arthroplasty. A Controlled Randomized Experimental Trial.|Completed||N/A|20|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:39:01.92575|2017-10-10 23:39:01.92575
NCT02342548|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-03-09|||February 25, 2015|Actual|2015-02-25|March 2017|2017-03-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021|An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021|Terminated||Phase 2|188|Actual|Pfizer||2||"Study terminated on 15DEC2016 due to study A8241021 showing no significant difference on   primary endpoint between PF-02545920 & placebo. No safety concerns."|f||||t||||||||||2017-10-10 23:39:02.230649|2017-10-10 23:39:02.230649
NCT02342535|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-04-10|2016-05-13||September 2014||2014-09-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional||30 South Asian adult women were the participants whose data is being analyzed. No research data was obtained from the children. The children have only assented to be in the study.|Community-Clinic Partnership to Promote Physical Activity in South Asian Women|Community-Clinic Partnership to Promote Physical Activity in South Asian Women|Completed||N/A|68|Actual|Northwestern University|Limitations of this pilot study are inclusion of a single site in Chicago, lack of a control arm, and that we were only able to recruit and enroll 20% of the individuals we approached.|1|||f||||f||||||||||2017-10-10 23:39:02.456124|2017-10-10 23:39:02.456124
NCT02342522|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-05-13|||November 2015||2015-11-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|February 2018|Anticipated|2018-02-01||Interventional|ERIC-PPCI||Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI|Effect of Remote Ischaemic Conditioning on Clinical Outcomes in ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention (ERIC-PPCI): A Multicentre Randomised Controlled Clinical Trial|Recruiting||Phase 3|2000|Anticipated|University College, London||2|||f||||t||||||||Undecided||2017-10-10 23:39:02.599561|2017-10-10 23:39:02.599561
NCT02342509|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-14|||September 2014||2014-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MIRCONTROL||Automated Control of End-tidal Volatile Anesthetic Concentration|Automated Control of End-tidal Volatile Anesthetic Concentration Using the MIRUS System: A Comparison of Isoflurane, Sevoflurane and Desflurane in Anesthesia.|Completed||N/A|63|Actual|Ruhr University of Bochum||3|||f||||t||||||||||2017-10-10 23:39:02.683279|2017-10-10 23:39:02.683279
NCT02342496|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-10-20|||January 2015||2015-01-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly|Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly.|Unknown status|Recruiting|Early Phase 1|60|Anticipated|Probi AB||3|||f||||||||||||||2017-10-10 23:39:02.759023|2017-10-10 23:39:02.759023
NCT02342483|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-14|||July 2014||2014-07-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||MSM Product on Attenuating Nasal Provocation With a Standardized Allergenic Challenge|The Efficacy of the MSM Product on Attenuating Nasal Provocation With a Standardized Allergenic Challenge A Randomized, Double-blind, Adaptive-design Study|Completed||Phase 2|15|Actual|Medicus Research, LLC||3|||f||||f||||||||||2017-10-10 23:39:02.834676|2017-10-10 23:39:02.834676
NCT02342470|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-03-29|||September 2014||2014-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users|A Multiple-center, Randomized, Double-blind, Parallel, Placebo-controlled, Dose-selection Phase II Study to Evaluate the Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users|Recruiting||Phase 2|160|Anticipated|PharmaKing||4|||f||||f||||||||||2017-10-10 23:39:02.898888|2017-10-10 23:39:02.898888
NCT02342457|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-01-20|||March 2015||2015-03-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Electrophysiological Activity of the Anorectum in Children Suspected of Hirschsprung Disease|The Elactrophysiological Response of the Colon, in Normal Bowel, and Large Bowel Lacking Ganglia in Children With Suspected Hirschsprungs Disease.|Not yet recruiting||N/A|20|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-10 23:39:04.744634|2017-10-10 23:39:04.744634
NCT02342444|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-01-14|||March 2014||2014-03-01|January 2015|2015-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)|A Prospective Randomized Trial Comparing Two Standard Doses of Enoxaparin for the Prevention of Thromboembolism in Surgical Patients|Unknown status|Recruiting|N/A|100|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 23:39:04.822114|2017-10-10 23:39:04.822114
NCT02342431|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-01-14|||October 2010||2010-10-01|January 2015|2015-01-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|||Comparison of a Patient Warming System Using a Forced-air, Non-compressible Under-body Mattress Versus a Regular Forced-air Underbody Mattress System During Pediatric Cardiac Catheterization|Comparison of a Patient Warming System Using a Forced-air, Non-compressible Under-body Mattress Versus a Regular Forced-air Underbody Mattress System During Pediatric Cardiac Catheterization|Withdrawn||Phase 4|0|Actual|Medical University of Vienna||2||"Cardiac Catheterization no longer part of the anesthesia department A (no belonging to cardiac   anesthesia, which is a different department)"|f||||f||||||||||2017-10-10 23:39:04.913268|2017-10-10 23:39:04.913268
NCT02342418|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-01-25|2016-10-17||March 2015||2015-03-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults|Single Dose Pharmacokinetics of Intravenous Tedizolid Phosphate in Morbidly Obese and Age-, Sex-, and Ideal Body Weight-Matched Non-Obese Adults|Completed||Phase 4|19|Actual|Albany College of Pharmacy and Health Sciences|Most of the participants were below 130 kg and so these data should not be extrapolated to adults above 130 kg.|2|||f||||f||||||||No|Summative data have been published|2017-10-10 23:39:04.987458|2017-10-10 23:39:04.987458
NCT02342405|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-05-26|||January 2015||2015-01-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||High Inspiratory Oxygen Fraction on Endothelial Function in Healthy Volunteers|Effect of High Inspiratory Oxygen Fraction on Endothelial Function in Healthy Volunteers: a Randomized Controlled Cross-over Trial|Completed||N/A|25|Actual|University Hospital Koge||2|||f||||f||||||||||2017-10-10 23:39:05.224608|2017-10-10 23:39:05.224608
NCT02342392|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-14|||September 2012||2012-09-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study|Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study|Completed||Phase 2/Phase 3|36|Actual|University of Science Malaysia||2|||f||||f||||||||||2017-10-10 23:39:05.296784|2017-10-10 23:39:05.296784
NCT02342366|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-19|||February 2012||2012-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Characterization of the Prosocial and Prosexual Effects of GHB|Multimodal Characterization of the Prosocial and Prosexual Effects of GHB Assessing Behavior, fMRI, EEG, and Neuroendocrine Mechanisms|Completed||N/A|19|Actual|University of Zurich||2|||f||||f||||||||||2017-10-10 23:39:05.464117|2017-10-10 23:39:05.464117
NCT02342353|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-08-23|||May 18, 2015|Actual|2015-05-18|August 2017|2017-08-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2023|Anticipated|2023-03-31||Interventional|||Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)|A Phase I/II Study of Pacritinib in Patients With EGFR Mutant NSCLC After EGFR TKI|Recruiting||Phase 1/Phase 2|35|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||||2017-10-10 23:39:05.654983|2017-10-10 23:39:05.654983
NCT02342340|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-05-12|||January 2015||2015-01-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|BBB-2014||Bioavailability of Compounds From Different Bean Varieties in Healthy Individuals.|A Blinded, Randomized, Controlled Study to Examine the Bioavailability of Compounds From Different Bean Varieties in Healthy Individuals.|Completed||N/A|8|Actual|University of Manitoba||6|||f||||f||||||||||2017-10-10 23:39:05.785272|2017-10-10 23:39:05.785272
NCT02342327|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-03-29|||October 2014||2014-10-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Smoking Cessation in Menthol Flavored Cigarette Smokers||Recruiting||N/A|120|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:39:05.892032|2017-10-10 23:39:05.892032
NCT02342314|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-09-23|||January 2015||2015-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study of LY3143753 and LY3185643 in Healthy Participants|A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3143753 and LY3185643 in Healthy Subjects|Completed||Phase 1|64|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-10 23:39:06.000174|2017-10-10 23:39:06.000174
NCT02342301|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-05-10|||September 2014||2014-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Cardiometabolic Response to Sit-stand Workstations.|Cardiometabolic Response to Sit-stand Workstations.|Completed||N/A|25|Actual|University of Prince Edward Island||2|||f||||f||||||||No||2017-10-10 23:39:06.090637|2017-10-10 23:39:06.090637
NCT02342288|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-01-27|2015-04-09||July 2008||2008-07-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|IOP|no significant differences in baseline demographics between the groups|Intraoperative Ocular Pressure in Lumbar Spine Fusion Patients|Intraoperative Ocular Pressure in Lumbar Spine Fusion Patients|Completed||N/A|79|Actual|West Virginia University|The main limitation of our trial is that these were not consecutive cases, due to availability of the technician and a limited number of anesthesiologists on the protocol.|2|||f||||f||||||||No|Group data will be published. Not individual data.|2017-10-10 23:39:06.193802|2017-10-10 23:39:06.193802
NCT02342275|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-10-05|||October 2013||2013-10-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma|Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma|Recruiting||Phase 3|300|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-10 23:39:06.556785|2017-10-10 23:39:06.556785
NCT02342262|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-01-14|||August 2014||2014-08-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|Promi2||The Effect of Probiotics on the Frequency and Intensity of Migraine Attacks and Intestinal Permeability|The Effects of Probiotics on the Frequency and Intensity of Migraine Attacks and Intestinal Permeability. A Placebo-controlled Trial|Unknown status|Enrolling by invitation|N/A|80|Anticipated|Wageningen University||2|||f||||f||||||||||2017-10-10 23:39:06.682731|2017-10-10 23:39:06.682731
NCT02342249|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-06-09||2017-05-24|December 11, 2014|Actual|2014-12-11|June 2017|2017-06-01|May 25, 2016|Actual|2016-05-25|May 25, 2016|Actual|2016-05-25||Interventional|||Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects|A Phase 2b, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study of 2 Dose Levels of VX 787 Administered as Monotherapy and One Dose Level of VX-787 Administered in Combination With Oseltamivir for the Treatment of Acute Uncomplicated Seasonal Influenza A in Adult Subjects|Completed||Phase 2|292|Actual|Janssen Research & Development, LLC||4|||f||||t|t|f||||||||2017-10-10 23:39:06.766867|2017-10-10 23:39:06.766867
NCT02342236|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-09-12|||June 2014||2014-06-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Cerebral Regional Oxygen Saturation and Markers of Brain Damage During Primary Hip Arthroplasty|The Regional Cerebral Oxygen Saturation and Both S100B and GFAP Proteins Serum Concentration in Patients Undergoing Primary Hip Arthroplasty.|Completed||N/A|18|Actual|Military Institute of Medicine, Poland||2|||f||||f||||||||||2017-10-10 23:39:07.403504|2017-10-10 23:39:07.403504
NCT02342223|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-11-21|2016-08-04||February 2015||2015-02-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy|Voluma Treatment of HIV Facial Lipoatrophy|Completed||Phase 1|20|Actual|VA Northern California Health Care System||1|||f||||f||||||||||2017-10-10 23:39:07.495794|2017-10-10 23:39:07.495794
NCT02342210|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-09-07|||May 2015||2015-05-01|September 2017|2017-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Mindfulness Group-based Intervention for Early Psychosis: A Pilot Study|Mindfulness Group-based Intervention for Early Psychosis: A Pilot Study|Completed||N/A|21|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:39:07.763485|2017-10-10 23:39:07.763485
NCT02342197|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2015-01-19|2015-01-19||January 2011||2011-01-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation|Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation for Poor Responders in ICSI Cycles|Completed||Phase 3|60|Actual|Kasr El Aini Hospital||2|||f||||f||||||||||2017-10-10 23:39:07.867143|2017-10-10 23:39:07.867143
NCT02342184|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2016-02-03|||August 2014||2014-08-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome|Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome|Completed||Phase 3|21|Actual|Japan Blood Products Organization||1|||f||||f||||||||||2017-10-10 23:39:08.109271|2017-10-10 23:39:08.109271
NCT02342171|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-02-07|||February 2015||2015-02-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Ebola-Tx||Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea|Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea|Completed||Phase 2/Phase 3|102|Actual|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||||2017-10-10 23:39:08.208121|2017-10-10 23:39:08.208121
NCT02342158|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-06-27|||November 2014||2014-11-01|June 2016|2016-06-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|PERMED01||Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors|Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors-PERMED01-IPC 2014-003|Recruiting||N/A|460|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 23:39:08.320082|2017-10-10 23:39:08.320082
NCT02342145|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-16|||June 2014||2014-06-01|January 2015|2015-01-01|December 2018|Anticipated|2018-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major|Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major Treatment: a Multi-center, Open, Randomized, Controlled Clinical Study|Recruiting||Phase 4|40|Anticipated|First Affiliated Hospital of Guangxi Medical University||2|||f||||t||||||||||2017-10-10 23:39:08.424074|2017-10-10 23:39:08.424074
NCT02342132|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-09-19|||August 2014|Actual|2014-08-01|September 2017|2017-09-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Methods to Improve Expiratory Cough Flow and Lung Volume in Children With NMDs|A Comparison of Three Methods for Improving Expiratory Cough Flow and Lung Volume in Children With Neuromuscular Diseases|Completed||N/A|40|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-10 23:39:08.55599|2017-10-10 23:39:08.55599
NCT02342119|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation|Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation|Recruiting||N/A|1289|Anticipated|University of Pittsburgh||2|||f||||f||||||||Undecided||2017-10-10 23:39:08.645222|2017-10-10 23:39:08.645222
NCT02342106|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2015-01-14|||January 2015||2015-01-01|January 2015|2015-01-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Observational|||Assessment of Myeloid Cell Constitution in the Follicular Fluid of Women Undergoing In-vitro Fertilization|Assessment of Myeloid Cell Constitution in the Follicular Fluid of Women Undergoing In-vitro Fertilization (IVF)|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||2||f||||f||||||Samples Without DNA|"     Follicular fluid   "|||2017-10-10 23:39:08.753965|2017-10-10 23:39:08.753965
NCT02342093|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-14|||January 2011||2011-01-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|July 2013|Actual|2013-07-01||Interventional|||Contraceptives Containing Drospirenone and Blood Pressure|Effects of Two Contraceptives Containing Drospirenone on Blood Pressure in Normotensive Women: a Randomized Controlled Trial|Completed||Phase 4|44|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:39:08.830799|2017-10-10 23:39:08.830799
NCT02342080|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-05-08|||March 2013||2013-03-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional|||Effects of System Suspended Robotic Lokomat Gait in Patients With Incomplete Spinal Cord Injury|Effects of System Suspended Robotic Lokomat Gait in Patients With Incomplete Spinal Cord Injury|Completed||N/A|15|Actual|University of Sao Paulo General Hospital||1|||f||||t||||||||||2017-10-10 23:39:08.90207|2017-10-10 23:39:08.90207
NCT02342067|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-05-11|||December 2014||2014-12-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination|A Phase 1, Multiple-Dose, Open-Label, Randomized, Crossover Study in Healthy Subjects to Assess the Effect of Pioglitazone (PGZ) on the Pharmacokinetics (PK) of Cenicriviroc Mesylate (CVC) and the Effect of CVC on the PK of PGZ|Completed||Phase 1|20|Actual|Tobira Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:39:08.965022|2017-10-10 23:39:08.965022
NCT02342054|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-16|||October 2014||2014-10-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|October 2015|Anticipated|2015-10-01||Interventional|SINFRA_PROST||Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer|Prospective Phase II Trial of Single Fraction Real-time High-Dose-Rate (19-HDR) Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer|Recruiting||Phase 2|49|Anticipated|Hospital de Cruces||1|||f||||t||||||||||2017-10-10 23:39:09.036527|2017-10-10 23:39:09.036527
NCT02342041|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2016-10-13|||September 2014||2014-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects|A Single-center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SUVN-G3031 After Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects|Completed||Phase 1|64|Actual|Suven Life Sciences Limited||2|||f||||t||||||||||2017-10-10 23:39:09.123748|2017-10-10 23:39:09.123748
NCT02342028|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-23|||January 2015||2015-01-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||The Number and Function of Regular T Cell in Patients With Obstructive Sleep Apnea|Impact of Intermittent Hypoxia on the Number and Function of Regular T Cell in Patients With Obstructive Sleep Apnea|Unknown status|Recruiting|N/A|80|Anticipated|Taipei Veterans General Hospital, Taiwan|||2||f||||f||||||Samples Without DNA|"     the whole blood of enrollees   "|||2017-10-10 23:39:09.199323|2017-10-10 23:39:09.199323
NCT02342015|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-01-14|||September 2009||2009-09-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|November 2011|Actual|2011-11-01||Interventional|||Effect of Atorvastatin on Bone-vascular Axis||Completed||Phase 4|20|Actual|University of Padova||1|||f||||f||||||||||2017-10-10 23:39:09.27914|2017-10-10 23:39:09.27914
NCT02342002|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-07-15|||January 2015||2015-01-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial|Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial|Recruiting||Phase 4|416|Anticipated|Gynuity Health Projects||2|||f||||t||||||||||2017-10-10 23:39:09.371206|2017-10-10 23:39:09.371206
NCT02341989|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-10-13|||April 2015||2015-04-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|SWENOTECA-ABC||Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer|A Randomized Phase III Study Comparing One Course of Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) and One Course of Carboplatin AUC7 in Clinical Stage I Seminomatous Testicular Cancer|Recruiting||Phase 3|348|Anticipated|St. Olavs Hospital||2|||f||||f||||||||||2017-10-10 23:39:09.552223|2017-10-10 23:39:09.552223
NCT02341976|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Whole Body Vibration Training for Pelvic Floor Muscle|Study of Pelvic Floor Muscle and Urinary Sphincter Activity by Electromyography During Whole Body Vibration Training|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||1||PI left University and no study was ever done|f||||t||||||||||2017-10-10 23:39:09.65049|2017-10-10 23:39:09.65049
NCT02341963|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-11-08|||January 2015||2015-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery|A Prospective, Open-Label Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery|Recruiting||Phase 1|10|Anticipated|Rush University Medical Center||1|||f||||t||||||||||2017-10-10 23:39:09.722891|2017-10-10 23:39:09.722891
NCT02341950|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-05-15|||February 5, 2015|Actual|2015-02-05|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Trial of a Serious Game for Individuals With SCI/D|Evaluating the Effectiveness of a Serious Game to Enhance Self-Management Skills Among Adolescents and Young Adults With Spinal Cord Dysfunction|Active, not recruiting||N/A|178|Actual|University of Michigan||2|||f||||f||||||||No|Individual patient data is not planned to be released.|2017-10-10 23:39:09.810678|2017-10-10 23:39:09.810678
NCT02341937|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-12-02|||December 2014||2014-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs|D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs|Recruiting||N/A|420|Anticipated|G. d'Annunzio University|||1||f||||f||||||||||2017-10-10 23:39:09.934983|2017-10-10 23:39:09.934983
NCT02341924|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-09-19|||September 2015||2015-09-01|September 2017|2017-09-01|December 20, 2017|Anticipated|2017-12-20|December 2017|Anticipated|2017-12-01||Interventional|||"Validating the Foods for Health Portfolio of Functional Food Products"|"Validating the Foods for Health Portfolio of Functional Food Products: Effects on Lipid and Blood Glucose Management in Individuals Intolerant of Statin (HMG-CoA Reductase Inhibitor) Therapy"|Active, not recruiting||N/A|60|Actual|University of Manitoba||2|||f||||||||||||||2017-10-10 23:39:10.068077|2017-10-10 23:39:10.068077
NCT02341911|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-05-26|||January 2015||2015-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|TNBC||Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC)|A Phase II, Single-center, Open-Label, Randomized Study of Gemcitabine Plus Cisplatin (GP) Versus Gemcitabine Plus Carboplatin (GC) as First-Line Treatment in Patients With Advanced Triple-Negative Breast Cancer|Recruiting||Phase 2|150|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 23:39:10.16239|2017-10-10 23:39:10.16239
NCT02341898|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-05-02|||March 2015||2015-03-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|IMPRINT||Implementation of a Multicomponent Intervention to Prevent Physical Restraints in Nursing Home Residents (IMPRINT)|Implementation of a Multicomponent Intervention to Prevent Physical Restraints in Nursing Home Residents: a Cluster-randomized Controlled Trial|Completed||N/A|10800|Actual|University of Luebeck||3|||f||||t||||||||||2017-10-10 23:39:10.271895|2017-10-10 23:39:10.271895
NCT02341885|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-01-21|||March 2015||2015-03-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Observational|PEACE||PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy|PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy in the ICU Environment|Completed||N/A|2000|Actual|European Society of Intensive Care Medicine|||1||f||||f||||||||||2017-10-10 23:39:10.377803|2017-10-10 23:39:10.377803
NCT02341872|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-07-20|||August 2013||2013-08-01|May 2016|2016-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Compare the Efficacy of the Remineralization Agents on the White Enamel Lesions|Compare the Efficacy of the Remineralization Agents on the White Enamel Lesions|Completed||N/A|32|Actual|Ege University||4|||f||||t||||||||No||2017-10-10 23:39:10.501883|2017-10-10 23:39:10.501883
NCT02341859|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-01-30|2016-04-19||January 2015||2015-01-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®|Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®|Completed||N/A|22|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-10 23:39:10.657086|2017-10-10 23:39:10.657086
NCT02341846|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-01-20|||February 2015||2015-02-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Exploring New Technologies to Manage Cancer Pain in the Community|Exploring the Desirability, Feasibility and Practicalities of Using Information and Communication Technology (ICT) to Improve Cancer Pain Management in the Community|Completed||N/A|50|Actual|University of Aberdeen|||3||f||||f||||||||||2017-10-10 23:39:12.635587|2017-10-10 23:39:12.635587
NCT02341833|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-01-20|||January 2015||2015-01-01|January 2015|2015-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effects of Preconditioning With Sevoflurane During Organ Procurement From Brain Dead Donors: Impact on Early Function of Liver Allografts||Not yet recruiting||Phase 4|240|Anticipated|University Hospital of Liege||2|||f||||||||||||||2017-10-10 23:39:12.709968|2017-10-10 23:39:12.709968
NCT02341820|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-03-16|||April 2014|Actual|2014-04-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Observational|PICTURE L||PICTURE Breast L: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Longitudinal|PICTURE Breast L: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Longitudinal|Completed||N/A|83|Actual|University College, London|||1||f||||f||||||||Yes|All requests for data sharing will adhere to the UCL Surgical & Interventional Trials Unit (SITU) data sharing agreement policy. UCL Medical School is supportive of data sharing and will endeavour to assist in requests for data sharing. These data will be held at UCL on secure servers and will not be released to any third parties until the final study report has been published. All requests for access to the data will be formally requested through the use of a SITU data request form which will state the purpose, analysis and publication plans together with the named collaborators. All requests are dealt with on a case by case basis. All requests will be logged and those successful will have a data transfer agreement which will specify appropriate acknowledgement of the Royal Free Hospital, the sponsor, and funders.|2017-10-10 23:39:12.815205|2017-10-10 23:39:12.815205
NCT02341807|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-09-28|||January 2015||2015-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Dose Escalation Study of AAV2-hCHM in Subjects With CHM (Choroideremia) Gene Mutations|A Phase 1/2 Safety Study in Subjects With CHM (Choroideremia) Gene Mutations Using an Adeno-Associated Virus Serotype 2 Vector to Deliver the Normal Human CHM Gene [AAV2-hCHM] to the Retina|Active, not recruiting||Phase 1/Phase 2|15|Actual|Spark Therapeutics||2|||f||||t||||||||||2017-10-10 23:39:12.890012|2017-10-10 23:39:12.890012
NCT02341794|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-01-17|||January 2015||2015-01-01|January 2015|2015-01-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography|Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography|Recruiting||N/A|60|Anticipated|Tokyo Medical University||1|||f||||f||||||||||2017-10-10 23:39:13.101775|2017-10-10 23:39:13.101775
NCT02341781|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-01-25|||April 2015||2015-04-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|MCL-004||Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment|A Multicenter, Observational Study to Evaluate the Effectiveness of Lenalidomide (Revlimid®) in Subjects With Mantle Cell Lymphoma Who Have Relapsed or Progressed After Treatment With Ibrutinib or Are Refractory or Intolerant to Ibrutinib.|Completed||N/A|30|Actual|Celgene|||1||f||||f||||||||||2017-10-10 23:39:13.202307|2017-10-10 23:39:13.202307
NCT02341768|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-09-12|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|November 2019|Anticipated|2019-11-01||Observational|CARAT||Clinical and Device Functional Assessment of Real World ICD Patients|Clinical and Device Functional Assessment of Real World ICD Patients|Recruiting||N/A|2058|Anticipated|LivaNova|||1||f||||f||||||||||2017-10-10 23:39:13.304975|2017-10-10 23:39:13.304975
NCT02341755|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-01-16|||May 2012||2012-05-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Observational|||Dual Energy Computerized Tomography (DE-CT) in Patients With Crohn's Disease|Dual Energy Computerized Tomography (DE-CT) for Evaluation of Obstructive Intestinallesions in Patients With Crohn's Disease|Terminated||N/A|38|Actual|Shaare Zedek Medical Center|||1|Interim analysis was sufficient to demonstrate accuracy of the evaluated test|f||||f||||||||||2017-10-10 23:39:13.730692|2017-10-10 23:39:13.730692
NCT02341742|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-07-31|||October 2014|Actual|2014-10-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|PHYSICOSMICI||Physical Activity and Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease|Relationship Between Physical Activity and Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease|Active, not recruiting||N/A|84|Actual|University Hospital, Lille|||1||f||||f||||||||||2017-10-10 23:39:13.797707|2017-10-10 23:39:13.797707
NCT02341729|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-01-16|||January 2015||2015-01-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Interventional|ticagrelor||Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome|Evaluation of the Effects and Plasma Concentration of the Potent Platelet Inhibitor Ticagrelor, After Crushed and Non-crushed Intake, After Semi-urgent Coronary Bypass and in Patients After Cardiac Arrest.|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-10 23:39:13.91282|2017-10-10 23:39:13.91282
NCT02341716|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|SUNFIT||Hospital- and Home-based Supervised Exercise Versus UNsupervised Walk Advice For Patients With InTermittent Claudication|Hospital- or Home-based Supervised Exercise Therapy or Unsupervised Walk Advice for Patients With Intermittent Claudication|Recruiting||N/A|165|Anticipated|Sahlgrenska University Hospital, Sweden||3|||f||||f||||||||||2017-10-10 23:39:14.021592|2017-10-10 23:39:14.021592
NCT02341703|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-07-27|||February 2015||2015-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Ovulation Induction in Clomiphene Citrate Resistant PCO Women|Letrozole-metformin Versus Letrozole-metformin-pioglitazone in PCO Clomiphene Citrate Resistant Women|Completed||Early Phase 1|100|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:39:14.157594|2017-10-10 23:39:14.157594
NCT02341690|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-03-28|||January 2015||2015-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intervention Study - Effectiveness of Smartphone Delivered Interval Walking Training to Patients With Type 2 Diabetes|The Effectiveness of Smartphone Delivered Interval Walking Training on Physical Activity and Glycemic Control in Patients With Type 2 Diabetes: a Pragmatic Randomized Controlled Trial - Part of The InterWalk Study|Active, not recruiting||N/A|513|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:39:14.254218|2017-10-10 23:39:14.254218
NCT02341677|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-01-14|||November 2014||2014-11-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||SmartTarget: BIOPSY|SmartTarget - A Magnetic Resonance Image to Ultrasound Fusion System for Targeted Prostate Intervention: Biopsy|Unknown status|Recruiting|N/A|80|Anticipated|University College, London||1|||f||||f||||||||||2017-10-10 23:39:14.374473|2017-10-10 23:39:14.374473
NCT02341664|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-02-15|||May 2015||2015-05-01|January 2016|2016-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01|1 Day|Observational [Patient Registry]|PALM||Patient and Provider Assessment of Lipid Management Registry|Patient and Provider Assessment of Lipid Management Registry|Completed||N/A|7658|Actual|Duke University|||1||f||||f||||||||||2017-10-10 23:39:14.479722|2017-10-10 23:39:14.479722
NCT02341651|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2015-11-19|||August 2014||2014-08-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|COBRA-BPS||Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility Study|Feasibility Study for a Cluster Randomized Trial on Integrated Primary Care Strategies to Reduce High Blood Pressure (Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility Study)|Completed||N/A|453|Actual|Duke-NUS Graduate Medical School||2|||f||||t||||||||||2017-10-10 23:39:14.620498|2017-10-10 23:39:14.620498
NCT02341638|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-03-29|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects|Randomized, Double-Blinded, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects|Completed||Phase 1|148|Actual|Bristol-Myers Squibb||17|||f||||f||||||||||2017-10-10 23:39:14.714172|2017-10-10 23:39:14.714172
NCT02341625|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-09-15|||June 17, 2015|Actual|2015-06-17|September 2017|2017-09-01|August 29, 2022|Anticipated|2022-08-29|June 14, 2021|Anticipated|2021-06-14||Interventional|||A Study of BMS-986148 in Patients With Select Advanced Solid Tumors|A Phase I/IIa Study of BMS-986148, a Mesothelin Directed Antibody Drug Conjugate, in Subjects With Select Advanced Solid Tumors|Active, not recruiting||Phase 1/Phase 2|407|Anticipated|Bristol-Myers Squibb||4|||f||||f|t|f||||||||2017-10-10 23:39:14.867398|2017-10-10 23:39:14.867398
NCT02341612|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-01-16|||December 2013||2013-12-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Cold Therapy in the Treatment of Exercise-induced Muscle Damage|Effects of Different Cold Therapy Modalities on Muscular Recovery and Inflammatory Responses Following Exercise-induced Muscle Damage in Healthy Men|Completed||N/A|65|Actual|University of Brasilia||5|||f||||t||||||||||2017-10-10 23:39:15.005577|2017-10-10 23:39:15.005577
NCT02341599|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-13|||December 11, 2014|Actual|2014-12-11|September 2017|2017-09-01|April 20, 2015|Actual|2015-04-20|April 13, 2015|Actual|2015-04-13||Interventional|||Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects|A Phase 1, Non-randomized, Parallel-group, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects|Completed||Phase 1|40|Actual|Cubist Pharmaceuticals LLC||5|||||||||||||||||2017-10-10 23:39:15.11982|2017-10-10 23:39:15.11982
NCT02341586|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-06-10|||April 2015||2015-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Lucky Iron Fish Home Fortification of Iron|A Randomized Control Trial of the Lucky Iron Fish to Improve Hemoglobin Concentration in Women in Preah Vihear, Cambodia|Completed||Phase 1|340|Actual|University of British Columbia||3|||f||||f||||||||Yes||2017-10-10 23:39:15.210593|2017-10-10 23:39:15.210593
NCT02341573|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-08-10|||March 2013||2013-03-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Experienced Chinese Herbal Formulas on Pediatric Asthma|Effect of Experienced Chinese Herbal Formulas Based on Different Stages and Different Symptoms on Pediatric Asthma: a Single-blinded Randomized Controlled Trial|Completed||N/A|182|Actual|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-10 23:39:15.309559|2017-10-10 23:39:15.309559
NCT02341560|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-07-06|||October 2015||2015-10-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)|A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)|Recruiting||Phase 2/Phase 3|530|Anticipated|Quark Pharmaceuticals||5|||f||||t||||||||||2017-10-10 23:39:15.42067|2017-10-10 23:39:15.42067
NCT02341547|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-18|||February 2015||2015-02-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|||Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'|A Prospective, Observational, Non-inferiority Study to Assess the Effectiveness of a Biosimilar Epoetin Alfa in Maintaining Haemoglobin Levels in Stable 'End Stage Renal Failure' Patients on Haemodialysis|Unknown status|Not yet recruiting|N/A|44|Anticipated|Penang Hospital, Malaysia|||1||f||||f||||||||||2017-10-10 23:39:16.078326|2017-10-10 23:39:16.078326
NCT02341534|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-07-12|||June 2015||2015-06-01|July 2017|2017-07-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|"BIO|GUARD-MI"||BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Acute Myocardial Infarction|BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Acute Myocardial Infarction|Recruiting||N/A|2900|Anticipated|Biotronik SE & Co. KG||2|||f||||t||||||||||2017-10-10 23:39:16.171908|2017-10-10 23:39:16.171908
NCT02341521|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2015-05-22|||March 2015||2015-03-01|March 2015|2015-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation of Metabolic Profile of OC000459|An Evaluation of the Plasma and Urine Pharmacokinetics of Parent Compound and a Metabolite of OC000459 in Healthy Male and Female Subjects|Completed||Phase 1|18|Actual|Atopix Therapeutics, Ltd.||1|||f||||f||||||||||2017-10-10 23:39:16.293874|2017-10-10 23:39:16.293874
NCT02341508|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-05-04|||September 2015||2015-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers|A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Lpathomab Administered Intravenously to Healthy Volunteers|Completed||Phase 1|36|Actual|Lpath, Inc.||2|||f||||t||||||||||2017-10-10 23:39:16.378041|2017-10-10 23:39:16.378041
NCT02341495|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-04-12|||February 2013||2013-02-01|April 2016|2016-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|EXJADE||Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65|A Phase II Study Examining the Use of Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed Acute Myelogenous Leukemia (AML) in Elderly Patients|Recruiting||Phase 2|29|Anticipated|Loyola University||1|||f||||t||||||||||2017-10-10 23:39:16.476708|2017-10-10 23:39:16.476708
NCT02341482|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-05-23|2016-02-25||February 2015||2015-02-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects|A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Pharmacokinetics Of Pf 04958242 In Healthy Adult Subjects|Completed||Phase 1|13|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:39:16.62795|2017-10-10 23:39:16.62795
NCT02341469|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-07-14|||September 2014||2014-09-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|IeDA||A Trial of an Integrated E-diagnosis Assessment to Improve the Management of Childhood Illnesses in Burkina Faso|Integrated eDiagnosis Assessment (IeDA) for Children Under Five Years Old: a Stepped-wedge Randomized Cluster Trial of a Quality Improvement of the Management of Children Illnesses in Burkina Faso at the Primary Health Care Level|Recruiting||N/A|7200|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-10 23:39:17.14558|2017-10-10 23:39:17.14558
NCT02341456|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-09-08|||January 16, 2015|Actual|2015-01-16|August 2017|2017-08-01|September 29, 2017|Anticipated|2017-09-29|December 14, 2016|Actual|2016-12-14||Interventional|||Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours|A Phase Ib, Dose Finding Study Evaluating AZD1775 in Monotherapy, in Combination With Carboplatin and Paclitaxel, and in Combination With Only Carboplatin in Adult Asian Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|19|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 23:39:17.23813|2017-10-10 23:39:17.23813
NCT02341443|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-07-07|||April 2015||2015-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|DMFx||A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures|A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures|Recruiting||N/A|314|Anticipated|AO Clinical Investigation and Documentation||2|||f||||f||||||||||2017-10-10 23:39:17.353076|2017-10-10 23:39:17.353076
NCT02341430|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-06-29|||January 2016||2016-01-01|June 2017|2017-06-01|September 1, 2017|Anticipated|2017-09-01|July 1, 2017|Anticipated|2017-07-01||Interventional|||A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh|A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh|Recruiting||Phase 4|50|Anticipated|Anne Arundel Health System Research Institute||1|||f||||f||||||||||2017-10-10 23:39:17.511227|2017-10-10 23:39:17.511227
NCT02341417|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-03-21|||June 10, 2015|Actual|2015-06-10|March 2017|2017-03-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||Single-arm Extension Study on the Safety of Cinacalcet Treatment in SHPT in Pediatric Subjects With CKD on Dialysis|A Multicenter Single-arm Extension Study to Characterize the Long-term Safety of Cinacalcet Hydrochloride in the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects With Chronic Kidney Disease on Dialysis|Completed||Phase 3|28|Actual|Amgen||1|||f||||f||||||||||2017-10-10 23:39:17.605496|2017-10-10 23:39:17.605496
NCT02341404|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-03-10|||May 2012||2012-05-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer|An Open, Single Dose, Antitumour Effect Study of 2-hydroxy-flutamide as a Controlled Release Product (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer|Completed||Phase 2|23|Actual|Lidds AB||1|||f||||f||||||||||2017-10-10 23:39:17.766344|2017-10-10 23:39:17.766344
NCT02341391|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-21|||February 2007||2007-02-01|January 2015|2015-01-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Biological Efficacy Study of TisssueGene-C to Degenerative Arthritis|A Dose-escalating, Single-center, Phase I Clinical Trial to Investigate the Safety and Biological Efficacy of TissueGene-C in Degenerative Arthritis Patients.|Completed||Phase 1|12|Actual|Kolon Life Science||3|||f||||t||||||||||2017-10-10 23:39:17.845127|2017-10-10 23:39:17.845127
NCT02341378|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-21|||August 2009||2009-08-01|January 2015|2015-01-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis|A Multicenter, Single-blind, Phase 2A Clinical Trial to Evaluate the Efficacy and Safety of TissueGene-C, a Cell-mediated Gene Therapy, in Degenerative Arthritis Patients|Completed||Phase 2|28|Actual|Kolon Life Science||2|||f||||t||||||||||2017-10-10 23:39:17.92639|2017-10-10 23:39:17.92639
NCT02341365|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-01-16|||June 2013||2013-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||Vitamin D Influence on Oocyte Donation|Impact of Vitamin D Levels on Ovarian Reserve and Ovarian Response to Controlled Stimulation in Egg Donors|Completed||N/A|269|Actual|IVI Madrid|||1||f||||f||||||||||2017-10-10 23:39:18.035816|2017-10-10 23:39:18.035816
NCT02341339|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-08-10||||||August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Interventional|||Utility of Fallopian Tube Cocultures in Assisted Reproductive Technology|Utility of Fallopian Tube Cocultures in Assisted Reproductive Technology|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-10 23:39:18.285886|2017-10-10 23:39:18.285886
NCT02341326|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-05-23|||July 2014||2014-07-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD|Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD|Recruiting||N/A|120|Anticipated|Weill Medical College of Cornell University|||3||f||||f||||||Samples With DNA|"     Biospecimens, in particular SAE BC and stem/progenitor cell will be obtained from     bronchoscopic brushings. In vitro assays will be performed to assess SAE BC stem/progenitor     capacities relevant to the maintenance of small airway architecture.   "|Undecided||2017-10-10 23:39:18.351025|2017-10-10 23:39:18.351025
NCT02341313|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2015-01-16|||March 2014||2014-03-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|POCKET||Point of Care Ketone Measurement in the Newborn|Feasibility of the Use of Point of Care Technology to Measure Ketone and Lactate Levels in the Newborn at Risk From Hypoglycaemia Due to Impaired Perinatal Counter Regulation|Unknown status|Recruiting|N/A|50|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:39:18.429013|2017-10-10 23:39:18.429013
NCT02341300|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-02-27|||August 2014||2014-08-01|February 2017|2017-02-01|November 2020|Anticipated|2020-11-01|August 30, 2019|Anticipated|2019-08-30||Interventional|||Use of Cast Iron Pots to Improve Maternal Anemia|Use of Cast Iron Pots to Improve Maternal Anemia|Recruiting||N/A|128|Anticipated|Weill Medical College of Cornell University||2|||f||||f|f|f||||||Undecided|Deidentified data may be shared. No biologic specimens are being collected in this study|2017-10-10 23:39:18.498571|2017-10-10 23:39:18.498571
NCT02341287|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-01-06|||May 2015||2015-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Temperature Manipulating Gloves for the Treatment of Insomnia|Temperature Manipulating Gloves for the Treatment of Insomnia|Recruiting||Early Phase 1|30|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||No||2017-10-10 23:39:18.589417|2017-10-10 23:39:18.589417
NCT02341274|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-09-06|||November 2016||2016-11-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ASDBioequiv||Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers|Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteers|Recruiting||Phase 1|24|Anticipated|Indiana University||4|||f||||t||||||||||2017-10-10 23:39:18.671876|2017-10-10 23:39:18.671876
NCT02341261|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-08-11|||November 2015||2015-11-01|August 2016|2016-08-01||||April 2020|Anticipated|2020-04-01||Interventional|ADAPT||Activity for Diabetic Polyneuropathy|Activity for Diabetic Polyneuropathy: the ADAPT Study|Recruiting||N/A|140|Anticipated|University of Utah||2|||f||||||||||||||2017-10-10 23:39:18.782991|2017-10-10 23:39:18.782991
NCT02341248|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-08-16|||July 18, 2014|Actual|2014-07-18|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|BIG||Bacteria & Inflammation in the Gut (BIG) Study|Gut Microbial Taxonomy and Metabolism in Paediatric Crohn's Disease During Exclusive and Supplementary Enteral Nutrition Using -Omics Technologies|Recruiting||N/A|200|Anticipated|NHS Greater Glasgow and Clyde|||3||f||||f||||||Samples Without DNA|"     Blood, faecal, urine and mucosal samples retained.   "|||2017-10-10 23:39:18.856842|2017-10-10 23:39:18.856842
NCT02341235|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-05-10|||February 2015||2015-02-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|SMARTGOAL||Self-monitoring Activity: a Randomized Trial of Game-oriented Applications|Self-monitoring Activity: a Randomized Trial of Game-oriented Applications (SMARTGOAL)|Recruiting||N/A|120|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-10 23:39:18.946025|2017-10-10 23:39:18.946025
NCT02341222|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-01-13|||January 2008||2008-01-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|DM108/2008-B||BP as a Super-light Mesh and as a New Fixation Device for General Surgery -DM108/2008-B|"BP as a Super-light Mesh and as a New Fixing Device for General, Emergency and Prosthetic Surgery. The BP Implantation Effects on Immunity System, on the Metabolism and on Sealing. Preliminary Experimentation of Small Feasibility Study"|Unknown status|Active, not recruiting|Early Phase 1|30|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-10 23:39:19.048027|2017-10-10 23:39:19.048027
NCT02341209|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-12|||November 2017|Anticipated|2017-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|CTCL||Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma|Doxycycline in Patients With Relapsed Cutaneous T-cell Lymphoma|Not yet recruiting||Phase 2|20|Anticipated|Rochester General Hospital||1|||f||||f|t|f||||||||2017-10-10 23:39:19.149078|2017-10-10 23:39:19.149078
NCT02341196|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2015-01-13|||January 1995||1995-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|January 2004|Actual|2004-01-01||Interventional|||Randomized Clinical Trial of Polyester vs. Polyurethane Patch for Carotid Endarterectomy|Randomized Clinical Trial of Polyester vs. Polyurethane Patch for Carotid Endarterectomy. Long-term Results|Completed||N/A|450|Actual|University of Poitiers||2|||f||||t||||||||||2017-10-10 23:39:19.234105|2017-10-10 23:39:19.234105
NCT02341183|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-06-22|||May 2016||2016-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|tPAD||Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects|Novel Therapies for Muco-Obstructive Lung Diseases: A Study of Tolerability and MCC Effect of Hypertonic Saline Delivered Via the tPAD in Patients With Chronic Bronchitis|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||2|||f||||f||t|f|||||||2017-10-10 23:39:19.298934|2017-10-10 23:39:19.298934
NCT02341170|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-12-02|||January 2016||2016-01-01|December 2015|2015-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|HIPPO-S||HS-PCI in Locally Advanced Adenocarcinoma of the Lung|A Phase III Trial of Hippocampal-sparing Prophylactic Cranial Irradiation (HS-PCI) in Locally Advanced (Stage IIIA/IIIB) Adenocarcinoma of the Lung|Not yet recruiting||Phase 3|438|Anticipated|Universitätsmedizin Mannheim||2|||f||||f||||||||||2017-10-10 23:39:19.377575|2017-10-10 23:39:19.377575
NCT02341157|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-04-07|||January 2015||2015-01-01|January 2015|2015-01-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|ICE||ICE COPD PikoLogic® Cohort Study.Implementation, Compliance, and Effectiveness of Integrating the PikoLogic®|Implementation, Compliance, and Effectiveness of Integrating the PikoLogic® Into Disease Management Discharge Care for Patients With COPD Exacerbation: A Prospective Cohort Study.|Withdrawn||N/A|0|Actual|University of Louisville|||1|Principal Investigator left the University of Louisville.|f||||f||||||||||2017-10-10 23:39:19.455761|2017-10-10 23:39:19.455761
NCT02341144|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-04-13|2017-03-02||December 2014||2014-12-01|April 2017|2017-04-01|April 1, 2016|Actual|2016-04-01|March 1, 2016|Actual|2016-03-01||Interventional|||Percutaneous Rectus Sheath Block Versus Intra-operative Rectus Sheath Block for Pediatric Umbilical Hernia Repair|Percutaneous Rectus Sheath Block Versus Intra-operative Rectus Sheath Block for Pediatric Umbilical Hernia Repair: A Prospective, Randomized Study|Completed||N/A|61|Actual|Johns Hopkins All Children's Hospital||2|||f||||t||||||||No||2017-10-10 23:39:19.515733|2017-10-10 23:39:19.515733
NCT02341131|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-02-15|||January 2012||2012-01-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels|BDNF as a Potential Biomarker for Cognitive Remediation Therapy in Schizophrenia|Completed||N/A|70|Actual|Hospital Clinic of Barcelona||3|||f||||f||||||||Undecided||2017-10-10 23:39:21.664235|2017-10-10 23:39:21.664235
NCT02341118|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-09-19|||May 2014||2014-05-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.|Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.|Recruiting||N/A|1000|Anticipated|University Health Network, Toronto|||1||f||||t||||||||||2017-10-10 23:39:21.773145|2017-10-10 23:39:21.773145
NCT02341105|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2016-12-09|||January 2016||2016-01-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|March 2017|Anticipated|2017-03-01||Interventional|AmioCAAF||AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation|AMIOCAAF (AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation): a Randomized Controlled Trial - Vanguard Phase|Recruiting||Phase 4|50|Anticipated|Population Health Research Institute||2|||f||||f||||||||No||2017-10-10 23:39:21.868012|2017-10-10 23:39:21.868012
NCT02341092|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-13|||February 2013||2013-02-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|February 2015|Anticipated|2015-02-01||Observational|AVEC-TC||Analysis and Valuation of the Expertise of Use of the Close Friends of People Victims of Traumatic Brain Injury|AVEC-TC : Post-traumatic Behavioral Disorders : Analysis and Valuation of the Expertise of Use of the Close Relations of People Victims of Traumatic Brain Injury|Unknown status|Recruiting|N/A|130|Anticipated|University Hospital, Angers|||1||f||||f||||||||||2017-10-10 23:39:21.992362|2017-10-10 23:39:21.992362
NCT02341079|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-03-07|||March 2015||2015-03-01|March 2017|2017-03-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty|Prospective Randomized Trial Comparing Intraoperative Liposomal Bupivacaine Injection With Indwelling Femoral Nerve Blockade in Early Postoperative Pain Control for Primary Total Knee Arthroplasty|Withdrawn||Phase 2/Phase 3|0|Actual|United States Naval Medical Center, San Diego||2||Principal no longer interested in conducting study|f||||t||||||||||2017-10-10 23:39:22.095863|2017-10-10 23:39:22.095863
NCT02341066|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2016-02-25|||July 2015||2015-07-01|February 2016|2016-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|EDRA||Endothelial Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis (EDRA Study)|Evaluation of a New Score Incorporating Endothelial Dysfunction for the Assessment of Coronary Heart Disease Risk in Patients With Rheumatoid Arthritis: a 3-year Prospective Study.|Recruiting||N/A|3000|Anticipated|Azienda Ospedaliero Universitaria di Sassari|||1||f||||f||||||||||2017-10-10 23:39:22.231225|2017-10-10 23:39:22.231225
NCT02341053|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-09-06|||September 2015||2015-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy|Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy|Active, not recruiting||N/A|6|Anticipated|Gillette Children's Specialty Healthcare||1|||f||||t||||||||||2017-10-10 23:39:22.362137|2017-10-10 23:39:22.362137
NCT02341040|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-09-01|||November 2014||2014-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Evaluation of Potential Allergenicity of New Wheat Varieties|Evaluation of Potential Allergenicity of New Wheat Varieties|Recruiting||N/A|30|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     Subjects may opt to have extra blood drawn. This sample will be de-identified and sent to the     sponsor, Monsanto, for future study that is yet to be determined.   "|||2017-10-10 23:39:22.464639|2017-10-10 23:39:22.464639
NCT02341027|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-07-15|||January 2015||2015-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial|Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial|Completed||Phase 4|205|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:39:22.650826|2017-10-10 23:39:22.650826
NCT02341014|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-02-08|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas|Phase Ib/IIa Study of Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas|Active, not recruiting||Phase 1/Phase 2|31|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:39:22.756495|2017-10-10 23:39:22.756495
NCT02341001|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-10-28|||January 2015||2015-01-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Does Text Message Support After Discharge Improve Outcomes Following Bariatric Surgery? A Randomised Trial.|Does Text Message Support After Discharge Improve Outcomes Following Bariatric Surgery? A Randomised Trial and Sub-study of the BOBS Study (Better Outcomes Following Bariatric Surgery)|Unknown status|Recruiting|N/A|100|Anticipated|University of Auckland, New Zealand||2|||f||||f||||||||||2017-10-10 23:39:22.851595|2017-10-10 23:39:22.851595
NCT02340988|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-11-02|||April 2015||2015-04-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects|An Open-Label Study to Assess the Drug-Drug Interaction Potential of a Single 1200 mg IV Dose of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects.|Completed||Phase 1|36|Actual|The Medicines Company||2|||f||||f||||||||||2017-10-10 23:39:22.938099|2017-10-10 23:39:22.938099
NCT02340975|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-09-26|||March 31, 2015|Actual|2015-03-31|September 2017|2017-09-01|September 7, 2018|Anticipated|2018-09-07|September 7, 2018|Anticipated|2018-09-07||Interventional|||A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma|A Phase 1b/2 Study of MEDI4736 in Combination With Tremelimumab, MEDI4736 Monotherapy, and Tremelimumab Monotherapy in Subjects With Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma|Recruiting||Phase 1/Phase 2|135|Anticipated|MedImmune LLC||5|||f||||f||||||||||2017-10-10 23:39:23.030538|2017-10-10 23:39:23.030538
NCT02340949|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-02-02|||January 2015||2015-01-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|September 2017|Anticipated|2017-09-01||Interventional|RIA||Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer|Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer. Phase II Randomized, Multicenter, Open Label Trial|Active, not recruiting||Phase 2|180|Actual|Grupo Espanol Multidisciplinario del Cancer Digestivo||2|||f||||f||||||||No||2017-10-10 23:39:23.304381|2017-10-10 23:39:23.304381
NCT02340936|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-11-18|||January 2011||2011-01-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma|National, Open-label, Multicentre Phase I-II Study of Combination R-ESHAP With Lenalidomide as Salvage Therapy for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Candidates to Stem-cell Transplantation|Active, not recruiting||Phase 1/Phase 2|53|Actual|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||4|||f||||f||||||||||2017-10-10 23:39:23.420987|2017-10-10 23:39:23.420987
NCT02340923|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-08-10|||January 2015||2015-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01|12 Months|Observational [Patient Registry]|||A Device for Rapid, Painless, Bedside Muscle Evaluation of Children|A Device for Rapid, Painless, Bedside Muscle Evaluation of Children|Completed||N/A|327|Actual|Skulpt, Inc.|||2||f||||t||||||||||2017-10-10 23:39:23.564759|2017-10-10 23:39:23.564759
NCT02340910|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-05-22|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|March 2020|Anticipated|2020-03-01||Interventional|WBV||Dose-Response Effects of Whole Body Vibration on Spasticity and Walking in SCI||Recruiting||N/A|57|Anticipated|Shepherd Center, Atlanta GA||1|||f||||f||||||||||2017-10-10 23:39:23.643512|2017-10-10 23:39:23.643512
NCT02340897|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-27|2016-04-18|||December 2014||2014-12-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|||Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CT|Diagnostic Accuracy and Inter-rater Agreement of Chest Computed Tomography in the Diagnosis of Nontuberculous Mycobacterial Lung Disease|Completed||N/A|132|Actual|Seoul National University Hospital|||3||f||||f||||||||||2017-10-10 23:39:23.729395|2017-10-10 23:39:23.729395
NCT02340884|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-24|||January 2015||2015-01-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|January 31, 2017|Actual|2017-01-31||Interventional|||A Pilot RCT of the PRISM Intervention for AYAs With Cancer|A Pilot Randomized Controlled Trial of the Promoting Resilience in Stress Management (PRISM) Intervention for Adolescents and Young Adults With Cancer|Recruiting||Phase 2|100|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-10 23:39:23.800002|2017-10-10 23:39:23.800002
NCT02340871|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-13|||March 2015||2015-03-01|December 2014|2014-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|NGS||Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases|Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases|Not yet recruiting||N/A|75|Anticipated|Rabin Medical Center|||1||f||||t||||||Samples With DNA|"     Samples with DNA   "|||2017-10-10 23:39:23.896766|2017-10-10 23:39:23.896766
NCT02238041|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-09-29|||December 2014||2014-12-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||GlucoClear ICU Study|An ICU Study of Safety and Accuracy Using the GlucoClear CGM System|Withdrawn||N/A|0|Actual|Edwards Lifesciences|||1|Discontinued program|f||||f||||||||||2017-10-11 00:01:36.220232|2017-10-11 00:01:36.220232
NCT02340858|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Percutaneous Irreversible Electroportion for Unresectable Breast Cancer|Safety and Efficacy of Irreversible Electroporation (IRE) for Breast Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:39:23.986873|2017-10-10 23:39:23.986873
NCT02340832|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-01-20|||November 2014||2014-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:39:24.18083|2017-10-10 23:39:24.18083
NCT02340819|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-04-13|||March 2015||2015-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)|A 4-Stage, Open-label, Multicenter Study Including Long-term Extension to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome|Active, not recruiting||Phase 3|11|Anticipated|Shire||1|||f||||f||||||||||2017-10-10 23:39:24.350438|2017-10-10 23:39:24.350438
NCT02340806|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-01-20|||January 2015||2015-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Association Between Bolus Rate and Duration of Adequate Labor Analgesia|Association Between Bolus Rate and the Adequacy of Labor Analgesia Using Timed-intermittent Boluses for Maintenance of Labor Analgesia|Recruiting||N/A|220|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-10 23:39:24.474539|2017-10-10 23:39:24.474539
NCT02340793|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-01-10|||January 2015||2015-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|BEYOND||BEYOND Weight Loss Study|Body Composition and Energy Expenditure With Total Diet Replacement During Weight Loss and Maintenance|Active, not recruiting||N/A|23|Actual|NHS Greater Glasgow and Clyde||1|||f||||f||||||||||2017-10-10 23:39:24.589042|2017-10-10 23:39:24.589042
NCT02340780|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-09-11|||January 30, 2015|Actual|2015-01-30|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia|A Phase II Study of Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 2|14|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-10 23:39:24.695464|2017-10-10 23:39:24.695464
NCT02340767|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-01-12|||December 2014||2014-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|June 2015|Actual|2015-06-01||Interventional|SOCL||Decision Aids for the Management of Suspicious Occlusal Caries Lesions|Decision Aids for the Management of Suspicious Occlusal Caries Lesions|Completed||N/A|108|Actual|The National Dental Practice-Based Research Network||3|||f||||t||||||||No||2017-10-10 23:39:24.792554|2017-10-10 23:39:24.792554
NCT02340754|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2016-09-12|||May 2015||2015-05-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Mindfulness-based Stress Reduction for Multiple Sclerosis||Active, not recruiting||N/A|60|Anticipated|National University of Natural Medicine||2|||f||||t||||||||||2017-10-10 23:39:24.907808|2017-10-10 23:39:24.907808
NCT02340741|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-03-19|||September 2014||2014-09-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Insufflation of Carbon Dioxide During Cardiac Surgery as Prevention Neurologic Complications|Assessing of Carbon Dioxide Insufflation on the Neurological Complications During Open Heart Operations|Recruiting||N/A|334|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 23:39:25.021951|2017-10-10 23:39:25.021951
NCT02340728|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-02-06|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies|A Randomized Trial of Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies|Active, not recruiting||Phase 3|170|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:39:25.144219|2017-10-10 23:39:25.144219
NCT02340702|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-13|||August 2014||2014-08-01|January 2015|2015-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01|5 Weeks|Observational [Patient Registry]|COPD||Chronic Obstructive Pulmonary Disease (COPD) in Patients Hospitalized for Acute Decompensated Heart Failure.|COPD in Patients Hospitalized for Acute Decompensated Heart Failure.|Unknown status|Active, not recruiting|N/A|105388|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-10 23:39:25.89134|2017-10-10 23:39:25.89134
NCT02340689|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-08-04|||October 2013||2013-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Primary Hyperoxaluria Mutation Genotyping/Phenotyping|Genetic Characterization and Genotype/Phenotype Correlations in Primary Hyperoxaluria|Recruiting||N/A|1250|Anticipated|Mayo Clinic|||1||f||||t||||||Samples With DNA|"     DNA samples retained for potential future use, with consent of subjects only.   "|||2017-10-10 23:39:25.993004|2017-10-10 23:39:25.993004
NCT02233257|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-12-08||||||December 2016|2016-12-01||||||||Expanded Access|||Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy|Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy|Available||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||||||||||||||||2017-10-11 00:02:33.297972|2017-10-11 00:02:33.297972
NCT02340676|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-10-03|||February 2015||2015-02-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|August 2017|Actual|2017-08-01||Interventional|||A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease|A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease|Active, not recruiting||Phase 2|25|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:39:26.192573|2017-10-10 23:39:26.192573
NCT02340663|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-05-10|||November 2015||2015-11-01|May 2017|2017-05-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|SISU-SOVA||Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV|Preliminary Phase IV Trial Comparing the SOVA Night Guard With the Clinical Standard Acrylic Orthotic|Completed||Phase 4|67|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:39:26.312353|2017-10-10 23:39:26.312353
NCT02340650|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-10-24|||April 2015||2015-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|HRME_Bladder||High Resolution Imaging for Early and Better Detection of Bladder Cancer|High Resolution Imaging for Early and Better Detection of Bladder Cancer|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||Undecided||2017-10-10 23:39:26.466022|2017-10-10 23:39:26.466022
NCT02340637|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-01-09|||January 2014||2014-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|TIM||Coping Kids: Early Intervention for Anxiety and Depression|Coping Kids: A Randomized Controlled Study of a New Indicated Preventive Intervention for Children With Symptoms of Anxiety and Depression|Active, not recruiting||N/A|700|Anticipated|Regionsenter for barn og unges psykiske helse||2|||f||||t||||||||||2017-10-10 23:39:26.608844|2017-10-10 23:39:26.608844
NCT02340624|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-15|||January 2015||2015-01-01|January 2015|2015-01-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study.|Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Wayne State University||8|||f||||f||||||||||2017-10-10 23:39:26.732759|2017-10-10 23:39:26.732759
NCT02340611|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-04-28|||June 2015||2015-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib|A Proof of Concept Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on Olaparib in Ovarian Cancer|Recruiting||Phase 2|5|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-10 23:39:26.850562|2017-10-10 23:39:26.850562
NCT02340598|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-05-02|||January 2015||2015-01-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Pilot Study of Effects of Cold Vests on Cardiovascular Risk Markers|Prospective Randomized Pilot Study of the Effects of Cold Vests on Cardiovascular Risk Markers and Basal Metabolic Rate|Active, not recruiting||N/A|50|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-10 23:39:26.973033|2017-10-10 23:39:26.973033
NCT02340585|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-09-07|||June 2015||2015-06-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Neuroform Atlas IDE Study|Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms With the Next Generation Neuroform Stent System|Recruiting||N/A|360|Anticipated|Stryker Neurovascular||1|||f||||t||||||||||2017-10-10 23:39:27.077801|2017-10-10 23:39:27.077801
NCT02340572|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-08-07|||November 2014||2014-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRS-080|A First-in-Human, Randomized, Dose-Escalation, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Establish Safety, Lack of Immunogenicity, Tolerability, Pharmacokinetic Parameters, Target Engagement and Pharmacodynamic Effects|Completed||Phase 1|48|Actual|Pieris Pharmaceuticals GmbH||2|||f||||t||||||||||2017-10-10 23:39:27.31722|2017-10-10 23:39:27.31722
NCT02340559|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-20|||August 2012||2012-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|September 2013|Actual|2013-09-01||Interventional|||Effectiveness of Meta-Cognitive Training (EMC) in People With Psychosis of Brief Evolution.|Effectiveness of Meta-Cognitive Training (EMC) on Symptmos, Metacognition, Social and Neuropsychological Functioning in People With Psychosis of Brief Evolution|Completed||N/A|122|Actual|Fundació Sant Joan de Déu||2|||f||||f||||||||||2017-10-10 23:39:27.404253|2017-10-10 23:39:27.404253
NCT02340546|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-02-12|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|TRAJECTORIES||Trajectory Changes of Coronary Sinus Lead Tip and Cardiac Resynchronization Therapy Outcome|Trajectory Changes of Coronary Sinus Lead Tip and Cardiac Resynchronization Therapy Outcome|Recruiting||N/A|100|Anticipated|Ospedale Santa Maria delle Croci|||1||f||||f||||||||||2017-10-10 23:39:27.495562|2017-10-10 23:39:27.495562
NCT02340533|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-07-26|||January 2015||2015-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Histopathological Diagnosis of Adenomyosis|The Diagnostic Accuracy of Hysteroscopic Endomyometrial Biopsy in Adenomyosis|Completed||N/A|200|Anticipated|Woman's Health University Hospital, Egypt||1|||f||||t||||||||||2017-10-10 23:39:27.592758|2017-10-10 23:39:27.592758
NCT02340520|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-08-16|||December 2014||2014-12-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Enhancement of Corticosteroid Efficacy in COPD|Enhancement of Corticosteroid Efficacy in COPD|Completed||Phase 3|13|Actual|UConn Health||1|||f||||f||||||||||2017-10-10 23:39:27.657988|2017-10-10 23:39:27.657988
NCT02340507|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-03-31|||May 2013||2013-05-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|May 2014|Actual|2014-05-01||Interventional|||The Impact of the Glycaemic Index (GI) on Daily Blood Glucose Profiles and Food Intake in Young Chinese Adult Males||Completed||N/A|15|Actual|Clinical Nutrition Research Centre, Singapore||2|||f||||f||||||||||2017-10-10 23:39:27.719314|2017-10-10 23:39:27.719314
NCT02340494|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-13|||April 2015||2015-04-01|January 2015|2015-01-01||||March 2016|Anticipated|2016-03-01||Interventional|||An Online Enhanced Education Tool for Young Women Newly Diagnosed With Breast Cancer|An Online Enhanced Education Tool for Young Women Newly Diagnosed With Breast Cancer|Unknown status|Not yet recruiting|N/A|200|Anticipated|Women's College Hospital||2|||f||||f||||||||||2017-10-10 23:39:27.891461|2017-10-10 23:39:27.891461
NCT02337491|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-08-30|||February 2015||2015-02-01|August 2016|2016-08-01||||August 2016|Actual|2016-08-01||Interventional|||Pembrolizumab +/- Bevacizumab for Recurrent GBM|Phase II Study of Pembrolizumab (MK-3475) With and Without Bevacizumab for Recurrent Glioblastoma|Active, not recruiting||Phase 2|82|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 23:40:01.571234|2017-10-10 23:40:01.571234
NCT02340481|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-01-06|||July 2005||2005-07-01|January 2016|2016-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety Study of Loperamide Hydrochloride/Simethicone Chewable Tablet in Treatment of Acute Diarrhea With Abdominal Discomfort and Flatulence|A Multi-center, Randomized, Double-blind, Double-dummy, and Parallel Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Loperamide Hydrochloride/Simethicone Chewable Tablet in the Treatment of Acute Diarrhea With Abdominal Discomfort and Flatulence|Completed||Phase 3|217|Actual|Xian-Janssen Pharmaceutical Ltd.||2|||f||||f||||||||||2017-10-10 23:39:27.97854|2017-10-10 23:39:27.97854
NCT02340468|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-02-08|||April 2015||2015-04-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Breast Tumor Oxygenation During Exercise|Breast Tumor Oxygenation During Exercise|Recruiting||N/A|30|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-10 23:39:28.090545|2017-10-10 23:39:28.090545
NCT02340455|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-07-06|||December 2014||2014-12-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of Oral Pregabalin on Hyperalgesia and Post-operative Pain in Patients Undergoing Nephrectomy Surgery: Sex Differential Study||Unknown status|Recruiting|N/A|252|Anticipated|Yonsei University||4|||f||||f||||||||||2017-10-10 23:39:28.17417|2017-10-10 23:39:28.17417
NCT02340442|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-08-31|||October 2013||2013-10-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Observational|||DVA Risk Pregnancy|Retinal Vessel Analysis in Low Risk and High Risk Pregnant Women|Unknown status|Recruiting|N/A|120|Anticipated|Medical University of Vienna|||3||f||||||||||||||2017-10-10 23:39:28.269084|2017-10-10 23:39:28.269084
NCT02340429|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-07-13|||January 2015||2015-01-01|January 2015|2015-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Using a Video Otoscope in Pediatric Ear Examination: A Prospective Randomized Controlled Study:|The Impact of Using a Video Otoscope on Parents' Satisfaction in Pediatric Ear Examination: A Prospective Randomized Controlled Study:|Completed||N/A|60|Actual|Ziv Hospital||2|||f||||t||||||||||2017-10-10 23:39:28.372465|2017-10-10 23:39:28.372465
NCT02340416|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-03-24|||August 2014||2014-08-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Observational|||Tissue Oxygen Index and Pulsatility Index in Orthopedic Surgery: a NIRS and TCD Pilot Trial|Tissue Oxygen Index and Pulsatility Index in Orthopedic Surgery: a NIRS and TCD Pilot Trial|Completed||N/A|50|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-10 23:39:28.452663|2017-10-10 23:39:28.452663
NCT02340403|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-07-25|||September 2014||2014-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|INSULOX||Exploration by NMR Spectroscopy of the Choline Concentrations in the Insular Cortex of Patients Suffering of Neuropathic Pain Induced by Oxaliplatin|Exploration by NMR Spectroscopy of the Choline Concentrations in the Insular Cortex of Patients Suffering of Neuropathic Pain Induced by Oxaliplatin|Recruiting||N/A|46|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:39:28.521726|2017-10-10 23:39:28.521726
NCT02340390|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-03-28|||May 2015||2015-05-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|June 2016|Actual|2016-06-01||Interventional|G7||G7 Acetabular System vs. Exceed ABT Acetabular System in THA|A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED TRIAL TO EVALUATE G7 Acetabular System With CoC ARTICULATION COMPARED TO EXCEED ABT Acetabular System With CoC ARTICULATION IN TOTAL HIP ARTHROPLASTY|Active, not recruiting||N/A|160|Actual|Zimmer Biomet||2|||f||||t||||||||Undecided||2017-10-10 23:39:28.636941|2017-10-10 23:39:28.636941
NCT02340377|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-08-06|||January 2015||2015-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Pill Study Hyperthermia Device (Heckel HT 3000): Monitoring Core Body Temperature Using Wireless Technology|Core Body Temperature During Hyperthermia in a Whole Body Hyperthermia Device (Heckel HT 3000): Monitoring Core Body Temperature Using Wireless Technology|Terminated||N/A|30|Anticipated|University of Arizona|||1|investigator transferred institutions|f||||f||||||||||2017-10-10 23:39:28.742005|2017-10-10 23:39:28.742005
NCT02340364|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-08-31|||March 2015||2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|NAVI-HF||Patient NAVIgation to Reduce Readmissions Among Black Men With Heart Disease|Patient NAVIgation to Reduce Readmissions Among Black Men With Heart Disease|Recruiting||N/A|416|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:39:28.82481|2017-10-10 23:39:28.82481
NCT02340338|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-12-01|2016-08-05||July 2014||2014-07-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|rTSST-1||rTSST-1 Variant Vaccine Phase 1 First-in-man Trail|Phase 1 Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults|Completed||Phase 1|46|Actual|Biomedizinische Forschungs gmbH||7|||f||||t||||||||No||2017-10-10 23:39:29.013384|2017-10-10 23:39:29.013384
NCT02340325|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-02-01|||May 2015||2015-05-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||FS2 Safety and Tolerability Study in Healthy Volunteers|The Safety of Topically Delivered FS2 in Humans. Phase 1 Clinical Trial|Completed||Phase 1|20|Actual|British Columbia Professional Firefighters' Burn and Wound Healing Laboratory||2|||f||||f||||||||||2017-10-10 23:39:29.681281|2017-10-10 23:39:29.681281
NCT02340312|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-01-13|||January 2015||2015-01-01|January 2015|2015-01-01||||January 2020|Anticipated|2020-01-01||Observational|||Functional Dyspepsia Microbiome Study|Evaluation of the Duodenal Microbiome in Pediatric Functional Dyspepsia|Recruiting||N/A|200|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"     Collection of .5 aggregate of doudenal tissue. Collection of stool samples.   "|||2017-10-10 23:39:29.771516|2017-10-10 23:39:29.771516
NCT02340299|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2015-01-20|||January 2015||2015-01-01|January 2015|2015-01-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Nasal High Frequency Oscillation Ventilation Versus Nasal Continuous Positive Airway Pressure to Reduce Post-extubation pCO2|Nasal High Frequency Oscillation Ventilation Versus Nasal Continuous Positive Airway Pressure to Reduce Post-extubation pCO2 in Very Low Birth Weight Infants: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|68|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 23:39:29.88273|2017-10-10 23:39:29.88273
NCT02340286|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-06-28|||September 2014||2014-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 2015|Actual|2015-05-01||Observational|||Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children|Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children.|Active, not recruiting||N/A|10|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-10-10 23:39:30.007195|2017-10-10 23:39:30.007195
NCT02340273|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-01-29|||December 2014||2014-12-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Long Duration Therapeutic Ultrasound on Tendon Injuries|Long Duration Therapeutic Ultrasound on Tendon Injuries|Terminated||N/A|13|Actual|ZetrOZ, Inc.||2|||f||||f||||||||||2017-10-10 23:39:30.075511|2017-10-10 23:39:30.075511
NCT02340260|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-06-13|||August 2013||2013-08-01|June 2016|2016-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Time Efficient Exercise in Type 2 Diabetes|Effects of Time Efficient Low-volume Interval Exercise on Cardiometabolic Risk Factors in Individuals With Type 2 Diabetes|Completed||N/A|21|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 23:39:30.172987|2017-10-10 23:39:30.172987
NCT02340247|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-06-29|||November 2014||2014-11-01|June 2016|2016-06-01||||April 2015|Actual|2015-04-01||Interventional|||Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass|Effects of Ursodeoxycholic Acid and Chenodeoxycholic Acid on GLP-1 Secretion After Roux-en-Y Gastric Bypass|Completed||Phase 4|11|Actual|Hvidovre University Hospital||3|||f||||t||||||||||2017-10-10 23:39:30.270514|2017-10-10 23:39:30.270514
NCT02340234|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-09-28|||May 2015||2015-05-01|September 2017|2017-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lebrikizumab in Patients With Persistent Moderate to Severe Atopic Dermatitis That is Inadequately Controlled by Topical Corticosteroids|Completed||Phase 2|212|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-10 23:39:30.387217|2017-10-10 23:39:30.387217
NCT02340221|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-09-21|||April 9, 2015|Actual|2015-04-09|September 2017|2017-09-01|July 6, 2019|Anticipated|2019-07-06|July 6, 2019|Anticipated|2019-07-06||Interventional|SANDPIPER||A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy|A Phase III, Double-Blind, Placebo-Controlled, Randomized Study of Taselisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy|Recruiting||Phase 3|600|Anticipated|Hoffmann-La Roche||2|||f||||t|t|f||||||||2017-10-10 23:39:30.668493|2017-10-10 23:39:30.668493
NCT02340208|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-08-11|||May 2012||2012-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47|A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47 as a Monotherapy in Non-Squamous Non-Small Cell Lung Cancer Patients|Active, not recruiting||Phase 1/Phase 2|76|Actual|Helix BioPharma Corporation||1|||f||||t||||||||||2017-10-10 23:39:31.317922|2017-10-10 23:39:31.317922
NCT02340195|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-11-06|||January 2015||2015-01-01|November 2015|2015-11-01||||September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function|Interventional, Single-site, Open-label, Reduced/Staged, Multiple-dose Study Investigating the Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Patients With Renal Impairment and in Healthy Subjects|Completed||Phase 1|16|Actual|H. Lundbeck A/S||4|||f||||f||||||||||2017-10-10 23:39:31.420957|2017-10-10 23:39:31.420957
NCT02340182|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-01-15|||March 2013||2013-03-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|MISSION-1||The Role of the Microbiota in the Systemic Immune Response|The Role of the Microbiota in the Systemic Immune Response|Completed||N/A|12|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 23:39:31.506534|2017-10-10 23:39:31.506534
NCT02340169|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2017-05-03|||January 23, 2015|Actual|2015-01-23|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|||Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis|An Open Label, Safety Study to Assess the Potential for Adrenal Suppression and Pharmacokinetics Following Maximal Use Treatment With Topicort® (Desoximetasone) Topical Spray, 0.25% in Pediatric Patients With Plaque Psoriasis.|Recruiting||Phase 4|100|Anticipated|Taro Pharmaceuticals USA||1|||f||||f||||||||No||2017-10-10 23:39:31.600457|2017-10-10 23:39:31.600457
NCT02340156|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-13|||December 2014||2014-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma|Phase II Study of Combined Temozolomide and Targeted P53 Gene Therapy (SGT-53) for Treatment of Patients With Recurrent Glioblastoma|Recruiting||Phase 2|26|Anticipated|SynerGene Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:39:31.704793|2017-10-10 23:39:31.704793
NCT02340143|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-09-13|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Assessing Early Behavioral Indicators of Formula Tolerance|Assessing Early Behavioral Indicators of Formula Tolerance|Completed||N/A|71|Actual|Mead Johnson Nutrition||2|||f||||f||||||||||2017-10-10 23:39:31.837743|2017-10-10 23:39:31.837743
NCT02340130|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-06-17|||September 2014||2014-09-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma|A Multicentre, Open Label, Phase IIb Clinical Trial to Evaluate Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites Mixes at 200 DPP/ml (DP/MG/14-1 Dermatophagoides Pteronyssinus / Lepidoglyphus Destructor and DP/MG/14-2 Dermatophagoides Pteronyssinus /Blomia Tropicalis) in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma|Recruiting||Phase 2|57|Anticipated|Laboratorios Leti, S.L.||2|||f||||t||||||||||2017-10-10 23:39:31.917664|2017-10-10 23:39:31.917664
NCT02340117|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-04-25|||January 2015||2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer|Phase II Study of Combined Targeted p53 Gene Therapy (SGT-53) Plus Gemcitabine/Nab-Paclitaxel for Treatment of Metastatic Pancreatic Cancer|Recruiting||Phase 2|28|Anticipated|SynerGene Therapeutics, Inc.||1|||f||||f||||||||Undecided||2017-10-10 23:39:32.023012|2017-10-10 23:39:32.023012
NCT02340104|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-05-26|2017-03-10||January 2015||2015-01-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants|An Absolute Bioavailability Study of Baricitinib in Healthy Subjects Using the Intravenous Tracer Method|Completed||Phase 1|8|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 23:39:32.130202|2017-10-10 23:39:32.130202
NCT02340065|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2016-07-13|||January 2015||2015-01-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Endocuff-assisted vs. Standard Colonoscopy|Endocuff-assisted vs. Standard Colonoscopy: a Randomized, Back-to-Back Study|Completed||N/A|200|Actual|Attikon Hospital||2|||f||||f||||||||||2017-10-10 23:39:32.461907|2017-10-10 23:39:32.461907
NCT02340052|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-01-26|||April 2014||2014-04-01|January 2017|2017-01-01|June 1, 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Pain Map DK: a Prospective Cohort Study of Pain Treatment in 500 Hip Arthroplasty Patients at Different Danish Hospitals||Completed||N/A|501|Actual|Zealand University Hospital|||5||f||||t||||||||||2017-10-10 23:39:32.5998|2017-10-10 23:39:32.5998
NCT02340039|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-08-23|||January 2015||2015-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|GLU-FRU||Effects of Fruit Extracts on Glycaemia: The GLU-FRU Study|The Acute Effects of Blackcurrant and Apple Extracts on Postprandial Glycaemia: a Randomised Controlled Trial. The GLU-FRU Study|Completed||N/A|34|Actual|King's College London||3|||f||||f||||||||||2017-10-10 23:39:32.70333|2017-10-10 23:39:32.70333
NCT02340026|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-10-13|||December 2014||2014-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|iMOVE||Cerebral Palsy Early Mobility Training|Dynamic Supported Mobility for Infants and Toddlers With Cerebral Palsy|Recruiting||Phase 2|42|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 23:39:32.813779|2017-10-10 23:39:32.813779
NCT02340013|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-11-11|||July 2013||2013-07-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Endometrial Shedding Prior to Ovulation Induction Pilot Study|The Effect of Endometrial Shedding With Medroxyprogesterone Acetate Prior to Ovulation Induction With Clomiphene Citrate in Oligo-ovulatory and Anovulatory Women: a Pilot Study|Completed||Phase 4|50|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-10 23:39:32.924219|2017-10-10 23:39:32.924219
NCT02340000|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2017-08-22|2017-07-16||November 18, 2014|Actual|2014-11-18|August 2017|2017-08-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate|Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate|Completed||Phase 4|315|Actual|Albany Medical College|"Initial formulation of high-dose amox/clav (extended release) became unavailable, so had to switch after participant #180 to immediate-release.
The medical students and residents had trouble reaching some participants for follow-up."|2|||f||||f|t|f|||f|||||2017-10-10 23:39:33.032143|2017-10-10 23:39:33.032143
NCT02339987|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-08-15|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration|Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration|Recruiting||N/A|60|Anticipated|John Wayne Cancer Institute|||1||f||||f|f|f||||Samples With DNA|"     Tissue from resection of a metastatic melanoma lesion   "|||2017-10-10 23:39:33.567557|2017-10-10 23:39:33.567557
NCT02339974|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-06-19|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|HOVER||Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)|Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation HOVER Trial|Recruiting||Phase 4|15|Anticipated|Temple University||1|||f||||t|f|t|f|||||No||2017-10-10 23:39:33.645523|2017-10-10 23:39:33.645523
NCT02339961|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-11-29|||February 2015||2015-02-01|September 2014|2014-09-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis|Evaluation of Lung Doppler Signals (LDS) in Detecting Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis (SSc)|Withdrawn||N/A|0|Actual|Echosense Ltd.||1||No patients|f||||f||||||||||2017-10-10 23:39:33.735129|2017-10-10 23:39:33.735129
NCT02339948|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-06-12|||June 2006||2006-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma|A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With or Without Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Patients With Clinically Confined Prostate Adenocarcinoma|Recruiting||N/A|350|Anticipated|21st Century Oncology||2|||f||||f||||||||||2017-10-10 23:39:33.793215|2017-10-10 23:39:33.793215
NCT02339935|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-04-26|||January 2015||2015-01-01|September 2015|2015-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Improving Hospitalizations for Children With ASD|Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention|Completed||N/A|36|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-10 23:39:33.904579|2017-10-10 23:39:33.904579
NCT02339922|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-01-11|||May 2016||2016-05-01|January 2017|2017-01-01||||December 2021|Anticipated|2021-12-01||Interventional|||Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma|A Window Study of Ixazomib in Untreated Indolent B-NHL|Recruiting||Phase 2|36|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 23:39:33.987212|2017-10-10 23:39:33.987212
NCT02339896|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-15|||February 2014||2014-02-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|March 2015|Anticipated|2015-03-01|365 Days|Observational [Patient Registry]|||Observation Study an Immunogenicity Modified TRC-ID Regimen With CPRV With or Without Rabies Immunoglobulin in Children|Observation an Immunogenicity and Safety Study of Modified TRC-ID Regimen With A New Chromatographically Purified Vero Cell Rabies Vaccine (SPEEDA®) With or Without Rabies Immunoglobulin in Children|Unknown status|Enrolling by invitation|N/A|45|Actual|Queen Saovabha Memorial Institute|||2||f||||f||||||Samples Without DNA|"     Rabies Neutralizing antibody   "|||2017-10-10 23:39:34.187347|2017-10-10 23:39:34.187347
NCT02339883|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-15|2017-08-22|||December 23, 2014||2014-12-23|August 9, 2017|2017-08-09|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Physiological and Psychosomatic Effects of Exposure to MRI Scanning Environment|Physiological and Psychosomatic Effects of Exposure to MRI Scanning Environment|Not yet recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:39:34.269657|2017-10-10 23:39:34.269657
NCT02339870|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-02-11|||April 2015||2015-04-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Expressive Writing in Improving the Wellbeing or Comforting Capacity of Caregivers of Patients With Cancer|Caring for Caregivers: Increasing Cancer Caregiver Wellbeing and Comforting Sensitivity|Completed||N/A|100|Anticipated|University of Washington||3|||f||||||||||||||2017-10-10 23:39:34.341815|2017-10-10 23:39:34.341815
NCT02339857|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-15|||November 2011||2011-11-01|January 2015|2015-01-01||||June 2013|Actual|2013-06-01||Observational|||The Long-term Results of the No-touch Vein Graft to the Left Anterior Descending Artery.|The Long-term Results of Coronary Artery Bypass Surgery When the No-touch Vein Graft is Anastomised to the Left Anterior Descending Artery.|Completed||N/A|97|Actual|Örebro County Council|||1||f||||f||||||||||2017-10-10 23:39:34.554042|2017-10-10 23:39:34.554042
NCT02339844|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-01-17|||January 2014||2014-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|PECANSII||Pan European Collaboration on Antipsychotic Naïve Schizophrenia II|Pan European Collaboration on Antipsychotic Naïve Schizophrenia II|Recruiting||Phase 4|200|Anticipated|University of Copenhagen||2|||f||||t||||||||No||2017-10-10 23:39:34.649147|2017-10-10 23:39:34.649147
NCT02339831|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-01-31|2015-07-22||March 2007||2007-03-01|January 2017|2017-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||137 patients agreed to participate, 27 did not meet the inclusion criteria and 110 signed the informed consent form. Following allocation to their group, we excluded 24 patients (20 using CAM and 7 CPM) who did not finish the study due to non-compliance, leaving a total of 83 patients.|Active Versus Passive Motion Device Following Knee Replacement Surgery|A Prospective, Randomized, Controlled, Single Center Study Evaluating the Clinical Performance of CAMOPED Following Knee Replacement|Completed||N/A|110|Actual|Brigham and Women's Hospital|We ran into an unexpected problem in recruiting patients for this study. Many did not want to participate in this study, as they did not want to use the passive device and were not willing to use it 4 hours each day.|2|||f||||f||||||||No||2017-10-10 23:39:34.822171|2017-10-10 23:39:34.822171
NCT02339818|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-03-06|||August 2015||2015-08-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries|Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries|Completed||N/A|126|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-10 23:39:35.350017|2017-10-10 23:39:35.350017
NCT02339805|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-07-05|||November 1, 2014|Actual|2014-11-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|LymphoSeq||Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS|Assessment of the Minimal Residual Disease in Diffuse Large B-Cell Lymphomas (DLBCL) From Cell-free Circulating DNA by Next Generation Sequencing (NGS)|Completed||N/A|30|Actual|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-10 23:39:35.43438|2017-10-10 23:39:35.43438
NCT02339792|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-01-12|||November 2012||2012-11-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|||E-learning to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients|Effect of an Integrated E-learning Intervention, Focused on Comprehensive Geriatric Assessment to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients|Completed||N/A|697|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||t||||||||||2017-10-10 23:39:35.541917|2017-10-10 23:39:35.541917
NCT02339779|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-03-03|||October 2015||2015-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|BREAST||Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy|the Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy Trial|Recruiting||N/A|196|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 23:39:35.634437|2017-10-10 23:39:35.634437
NCT02339766|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-02-11|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Quadratus Lumborum Block for Post-Cesarean Analgesia|Comparison of Intrathecal Morphine With Quadratus Lumborum Block for Post-Cesarean Delivery Analgesia:|Recruiting||N/A|75|Anticipated|Lawson Health Research Institute||3|||f||||f||||||||Undecided||2017-10-10 23:39:35.759072|2017-10-10 23:39:35.759072
NCT02339753|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-15|||January 2015||2015-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation|Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|24|Anticipated|The Korean Society of Pediatric Hematology Oncology||1|||f||||t||||||||||2017-10-10 23:39:35.905575|2017-10-10 23:39:35.905575
NCT02339740|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-07-18|||June 2015||2015-06-01|July 2017|2017-07-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|||Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia|A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-trans Retinoic Acid|Recruiting||Phase 3|158|Anticipated|Children's Oncology Group||1|||f||||t||||||||||2017-10-10 23:39:35.997558|2017-10-10 23:39:35.997558
NCT02339363|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-01-14|||March 2013||2013-03-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Sitting Meditation and Hatha Yoga in Adolescents|Differential Effects of Sitting Meditation and Hatha Yoga on Working Memory, Stress, and Mindfulness Among Adolescents in a School Setting|Completed||Phase 1/Phase 2|198|Actual|Alliant International University||3|||f||||f||||||||||2017-10-10 23:39:41.82908|2017-10-10 23:39:41.82908
NCT02339727|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-01-12|||July 2010||2010-07-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|November 2013|Actual|2013-11-01||Interventional|||Omega-6/Omega-3 Ratio and Neural Development in Preterm Infants.|Clinical Trial of the Relation Between Omega-6/Omega-3 Ratio in Formula of Preterm Infants Less Than 1500 Grams and/or Less Than 32 Weeks Gestational Ages and Brunet Lezine Score at 2 Years of Live. Anuvis Study|Completed||Phase 1/Phase 2|40|Actual|Health Research Institute of Santiago||2|||f||||f||||||||||2017-10-10 23:39:36.207538|2017-10-10 23:39:36.207538
NCT02339714|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-07-19|||March 2015||2015-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis|Effect Comparison of Acupuncture Combined With Moxibustion and Loratadine for Perennial Allergic Rhinitis: a Randomized Controlled Trial|Recruiting||Phase 2|96|Anticipated|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-10 23:39:36.279504|2017-10-10 23:39:36.279504
NCT02339701|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-07-05|||January 2015||2015-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer|A Randomized, Open Label, Phase II Study: Stereotactic Body Radiotherapy (SBRT) vs Conventional Intensity-modulated Radiotherapy (IMRT) for Low or Intermediate Risk Prostate Cancer in Asia Population|Recruiting||N/A|68|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:39:36.394532|2017-10-10 23:39:36.394532
NCT02339688|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-06-13|||October 2014||2014-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|MCS-III-MOB||Psychometric Properties Mobility Measures MS|Psychometric Properties of Mobility, Beyond Walking Speed, in Multiple Sclerosis: a Multi-center Study.|Completed||N/A|254|Actual|Hasselt University||1|||f||||f||||||||||2017-10-10 23:39:36.499827|2017-10-10 23:39:36.499827
NCT02339675|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-06-13|||October 2014||2014-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|MCS-III-UL||Psychometric Properties Upper Limb Function Measures Multiple Sclerosis|Psychometric Properties of Outcome Measures for Upper Limb Function, in Multiple Sclerosis: a Multi-center Study|Completed||N/A|136|Actual|Hasselt University||1|||f||||f||||||||||2017-10-10 23:39:36.603964|2017-10-10 23:39:36.603964
NCT02339662|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2015-10-18|||February 2015||2015-02-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Prospective, Cross Over Gabapentin vs Amitriptyline Study on Patients Suffering From Masticatory Muscle Pain|Prospective, Cross Over Gabapentin vs Amitriptyline Study on Patients Suffering From Masticatory Muscle Pain|Unknown status|Recruiting|Phase 4|50|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-10 23:39:36.697268|2017-10-10 23:39:36.697268
NCT02339649|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-07-28|||September 2013||2013-09-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|BonSEP||Long-term Cognitive and Cerebral Changes in Sepsis Survivors and Their Predictors|Long-term Cognitive and Cerebral Changes in Sepsis Survivors and Their Predictors|Recruiting||N/A|308|Anticipated|German Center for Neurodegenerative Diseases (DZNE)||3|||f||||t||||||||||2017-10-10 23:39:36.806509|2017-10-10 23:39:36.806509
NCT02339636|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-14|||March 2015||2015-03-01|August 2013|2013-08-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|||A Clinical Study of Subclinical Enthesitis and Synovitis in Patients With Vulgaris Psoriasis|A Clinical Study of Subclinical Enthesitis and Synovitis in Patients With Vulgaris Psoriasis|Unknown status|Not yet recruiting|N/A|200|Anticipated|The 306 Hospital of People's Liberation Army|||2||f||||t||||||||||2017-10-10 23:39:36.953302|2017-10-10 23:39:36.953302
NCT02339623|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2015-01-13|||August 2014||2014-08-01|January 2015|2015-01-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Observational|||Fetal Adrenal Gland Volume Estimation in Prediction of Preterm Birth|Three - Dimensional Ultrasound Estimation of Fetal Adrenal Gland Enlargement Compared to Assessment of Cervical Changes Alone & Prediction of Impending Preterm Birth|Unknown status|Recruiting|N/A|78|Anticipated|Ain Shams Maternity Hospital|||1||f||||t||||||||||2017-10-10 23:39:37.035553|2017-10-10 23:39:37.035553
NCT02339610|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-21|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Post-Operative Recovery in ATTUNE® Total Knee Arthroplasty|Multi-Center Evaluation of Post-Operative Recovery in ATTUNE Primary, Cemented Total Knee Arthroplasty|Active, not recruiting||N/A|200|Actual|DePuy Orthopaedics||1|||f||||f||||||||||2017-10-10 23:39:37.128807|2017-10-10 23:39:37.128807
NCT02339597|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-01-12|||January 2014||2014-01-01|January 2015|2015-01-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Therapy Adherence of APAP Therapy Initiation in Sleep-lab Versus at Home|Therapy Adherence in Different Settings of Automatic Positive Airway Pressure (APAP) Therapy Initiation in Patients With Obstructive Sleep Apnea (OSA): Comparison Between in Sleep-lab vs. at Home Environment.|Unknown status|Recruiting|N/A|224|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:39:37.206429|2017-10-10 23:39:37.206429
NCT02339584|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-08-07|2017-08-07||April 14, 2015|Actual|2015-04-14|August 2017|2017-08-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional||This analysis population includes all subjects who received study medication, satisfied pre-randomization inclusion/exclusion criteria, and had at least 1 scheduled on-therapy study visit (Per Protocol (PP) Analysis Set).|Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)|Efficacy and Safety of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension Plus Brimonidine 2 mg/mL Eye Drops, Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|493|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:39:37.290002|2017-10-10 23:39:37.290002
NCT02335788|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-02-09|||February 2015||2015-02-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|May 2015|Anticipated|2015-05-01||Interventional|EPED||"EMBA Peripheral Embolization Device (EPED) Study"|"EMBA Peripheral Embolization Device (EPED) Study"|Unknown status|Recruiting|N/A|10|Anticipated|EMBA Medical, Inc.||1|||f||||t||||||||||2017-10-10 23:40:20.91697|2017-10-10 23:40:20.91697
NCT02339558|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-09-12|||July 21, 2015|Actual|2015-07-21|September 2017|2017-09-01||||December 31, 2018|Anticipated|2018-12-31||Interventional|||Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer|Multicenter Phase II Study of Nivolumab in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma|Active, not recruiting||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:39:40.231779|2017-10-10 23:39:40.231779
NCT02339545|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-08-10|||February 2015||2015-02-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Coronary Flow Reserve Following Orbital Atherectomy|Coronary Flow Reserve Following Orbital Atherectomy and Percutaneous Revascularization in Severely Calcified Coronary Lesions|Completed||N/A|15|Actual|Cardiovascular Systems Inc||1|||f||||f||||||||No||2017-10-10 23:39:40.361674|2017-10-10 23:39:40.361674
NCT02339532|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2015-08-31|||January 2015||2015-01-01|August 2015|2015-08-01|June 2023|Anticipated|2023-06-01|June 2018|Anticipated|2018-06-01||Interventional|NeoTOP||Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status|Neoadjuvant Phase II Trial Combining [3 FEC 100 Followed by 3 Docetaxel Associated With Trastuzumab Plus Pertuzumab] or [6 Docetaxel, Carboplatin Associated With Trastuzumab Plus Pertuzumab] According to TOP2A Status in Patients With T1c Operable, HER2-positive Breast Cancer|Recruiting||Phase 2|90|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-10 23:39:40.444187|2017-10-10 23:39:40.444187
NCT02339519|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-12-07|||January 2015||2015-01-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Comparison of Supraglottic Airway Devices|A Comparison of Supraglottic Airway Devices; Lma Classic, Lma Fastrach and Lma Supreme; a Prospective, Randomized, Clinical Trial of Efficacy, Safety and Complications|Completed||Phase 4|90|Actual|Umraniye Education and Research Hospital||3|||f||||f||||||||||2017-10-10 23:39:40.589636|2017-10-10 23:39:40.589636
NCT02339493|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-11-02|||May 2016||2016-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter|Randomized Controlled Trial of Electronic Alerts to Increase Anticoagulation Prescription for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter|Recruiting||N/A|1000|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-10 23:39:40.764164|2017-10-10 23:39:40.764164
NCT02339480|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-13|2017-08-08|||July 2015||2015-07-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Research on Mechanism of Massage Therapy on Energy Metabolism Disorder of Simple Obesity||Completed||N/A|38|Actual|Guiyang College of Traditional Chinese Medicine||2|||f||||||||||||||2017-10-10 23:39:40.964752|2017-10-10 23:39:40.964752
NCT02339467|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-05-16|||February 2015||2015-02-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|GO-OUT||Getting Older Adults OUT-of -Doors|Getting Older Adults OUT-of-doors (GO-OUT): A Randomized Controlled Trial of a Community-based Outdoor Walking Program|Completed||N/A|9|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-10 23:39:41.064892|2017-10-10 23:39:41.064892
NCT02339454|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-03-14|||May 2012||2012-05-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris|Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris - A Randomized, Double Blind, Placebo Controlled, Multicenter Study|Recruiting||Phase 3|80|Anticipated|Moscow State University of Medicine and Dentistry||2|||f||||f||||||||||2017-10-10 23:39:41.180092|2017-10-10 23:39:41.180092
NCT02339441|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-05-12|||June 2010||2010-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|ESOS||Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis|Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis|Completed||N/A|320|Actual|University of Manchester|||4||f||||f||||||||||2017-10-10 23:39:41.308874|2017-10-10 23:39:41.308874
NCT02339428|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy|Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy: a Randomized Controlled Study|Completed||Phase 3|90|Actual|University Hospital Rijeka||2|||f||||f||||||||||2017-10-10 23:39:41.405765|2017-10-10 23:39:41.405765
NCT02339415|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-09-13|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|TACTICAL-HIV||Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease|Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease|Active, not recruiting||Phase 2|44|Actual|Minneapolis Medical Research Foundation||2|||f||||t||||||||||2017-10-10 23:39:41.489786|2017-10-10 23:39:41.489786
NCT02339402|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-01-12|||June 2014||2014-06-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|||Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders|NON-INVASIVE PRENATAL TESTING (NIPT) OF FETAL SINGLE-GENE DISORDERS IN MATERNAL BLOOD|Recruiting||N/A|160|Anticipated|Maastricht University Medical Center|||1||f||||f||||||Samples With DNA|"     Foetal DNA is isolated from the blood of pregnant women and their partners   "|||2017-10-10 23:39:41.572666|2017-10-10 23:39:41.572666
NCT02339376|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-02-04|||January 2015||2015-01-01|February 2017|2017-02-01||||January 2018|Anticipated|2018-01-01||Interventional|||Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation|Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation|Recruiting||N/A|30|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||||||||||||2017-10-10 23:39:41.727021|2017-10-10 23:39:41.727021
NCT02334293|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-07|||October 2013||2013-10-01|January 2015|2015-01-01||||July 2017|Anticipated|2017-07-01||Interventional|||Omegaven® as Parenteral Nutrition|Omegaven® as Parenteral Nutrition|Unknown status|Recruiting|N/A|25|Anticipated|Carle Foundation Hospital||1|||f||||f||||||||||2017-10-10 23:40:38.248897|2017-10-10 23:40:38.248897
NCT02339350|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-15|||January 2015||2015-01-01|January 2015|2015-01-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|||Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children|Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children|Recruiting||Phase 2|110|Anticipated|The Korean Society of Pediatric Hematology Oncology||2|||f||||t||||||||||2017-10-10 23:39:41.926435|2017-10-10 23:39:41.926435
NCT02339337|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-12|||June 2010||2010-06-01|January 2015|2015-01-01||||June 2014|Actual|2014-06-01||Interventional|||A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection|A Randomized-Controlled, Comparative Study, To Evaluate the Efficacy of Tailored Regimen of Peginterferon Alfa Plus Ribavirin According to Rapid Virological Response and Baseline Viral Loads in the Treatment of Patients With Chronic Hepatitis C/Hepatitis B Co-Infection: A Pilot Study (Pioneer)|Completed||Phase 4|203|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:39:42.017382|2017-10-10 23:39:42.017382
NCT02339324|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2017-09-22|||June 2015||2015-06-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b|Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b in Patients With Locally/Regionally Advanced/Recurrent Melanoma: Safety, Efficacy and Biomarker Study|Active, not recruiting||Phase 1|30|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:39:42.09344|2017-10-10 23:39:42.09344
NCT02339311|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-14|||June 2012||2012-06-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|ZHI-CDE||Zuni Health Initiative - Chronic Disease Education|A Home-based Educational Intervention Improves Patient Activation Measures and Diabetes Health Indicators Among Zuni Indians|Completed||N/A|60|Actual|University of New Mexico|||1||f||||f||||||||||2017-10-10 23:39:42.188063|2017-10-10 23:39:42.188063
NCT02339298|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-11-09|||July 2009||2009-07-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Intraoperative Music Application and Postoperative Behaviour in Children and Adolescents.|Impact of Intraoperative Music Application on Postoperative Behaviour in Children and Adolescents.|Completed||N/A|140|Actual|University Children's Hospital, Zurich||2|||f||||f||||||||||2017-10-10 23:39:42.261207|2017-10-10 23:39:42.261207
NCT02339285|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-04-26|||April 2015||2015-04-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|MDD||Transcranial Alternating Current Stimulation for Major Depressive Disorder|Pilot Clinical Trial for the Evaluation of Feedback Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder|Active, not recruiting||N/A|90|Anticipated|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-10 23:39:42.366126|2017-10-10 23:39:42.366126
NCT02339272|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-14|||January 2008||2008-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility|Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility|Completed||N/A|50|Actual|Igenomix|||2||f||||f||||||Samples Without DNA|"     Fixed slides with paraformaldehide, and metanol-acetic acid   "|||2017-10-10 23:39:42.473008|2017-10-10 23:39:42.473008
NCT02339259|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-04-27|||October 2014||2014-10-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Causes of Fever in Bangladeshi Patients|Rickettsial Disease in Febrile Hospitalised Patients in a Tertiary Referral Hospital in Bangladesh|Recruiting||N/A|330|Anticipated|University of Oxford|||2||f||||f||||||Samples With DNA|"     Blood, swab and crust specimen.   "|||2017-10-10 23:39:42.558244|2017-10-10 23:39:42.558244
NCT02339246|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-12-11|2015-11-06||January 2015||2015-01-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ASTCOFF||Pharmacokinetic Comparison Of All FK-506 Formulations|A Steady-state Pharmacokinetic Comparison Of All FK-506 Formulations|Completed||Phase 3|32|Actual|Veloxis Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:39:42.672447|2017-10-10 23:39:42.672447
NCT02339233|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-04-12|||January 2010||2010-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Epi Stim to Facilitate Standing and Stepping|Spinal Epidural Electrode Array to Facilitate Standing and Stepping After Spinal Cord Injury|Recruiting||N/A|10|Anticipated|University of Louisville||1|||f||||t||||||||||2017-10-10 23:39:43.029867|2017-10-10 23:39:43.029867
NCT02339220|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-09-28|||September 2016||2016-09-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|TBI||The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment|Harnessing Neuroplasticity to Promote Rehabilitation: Constraint-Induced (CI) Therapy for Traumatic Brain Injury (TBI)|Recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||4|||f||||t||||||||||2017-10-10 23:39:43.127524|2017-10-10 23:39:43.127524
NCT02339207|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-10-20|||December 2014||2014-12-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1|A Randomized, Double-blind, Placebo-controlled, First-in-human, 3 Part Study of Orally Administered AL-335 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosing and Food-effect in Healthy Volunteers, and Multiple Ascending Dosing in Subjects With Chronic Hepatitis C Genotype 1 Infection|Completed||Phase 1|112|Actual|Alios Biopharma Inc.||2|||f||||||||||||||2017-10-10 23:39:43.251906|2017-10-10 23:39:43.251906
NCT02339194|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-12-03|||January 2014||2014-01-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Application of a Simplified Method of Complete Denture Fabrication for Severely Resorbed Mandibular Ridges|Application of a Simplified Method of Complete Denture Fabrication for Severely Resorbed Mandibular Ridges|Recruiting||Phase 3|72|Anticipated|Universidade Federal do Ceara||2|||f||||f||||||||||2017-10-10 23:39:43.488263|2017-10-10 23:39:43.488263
NCT02339168|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-04-26|||June 2016||2016-06-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer|Enzalutamide and Metformin Combination Therapy to Overcome Autophagy Resistance in Castration Resistant Prostate Cancer|Recruiting||Phase 1|24|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 23:39:43.610833|2017-10-10 23:39:43.610833
NCT02333864|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-05-26|||December 2014||2014-12-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||POGO® Automatic Blood Glucose Monitoring System Clinical Study||Completed||N/A|287|Actual|Intuity Medical, Inc|||1||f||||f||||||||||2017-10-10 23:40:41.898213|2017-10-10 23:40:41.898213
NCT02339155|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-08-21|||February 24, 2015|Actual|2015-02-24|August 2017|2017-08-01|June 6, 2017|Actual|2017-06-06|January 3, 2017|Actual|2017-01-03||Interventional|||Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed|A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)|Completed||Phase 4|573|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:39:43.736148|2017-10-10 23:39:43.736148
NCT02339142|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-14|||January 2015||2015-01-01|January 2015|2015-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CRISEPTED||Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease|Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease|Not yet recruiting||Phase 4|100|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:39:43.850994|2017-10-10 23:39:43.850994
NCT02339129|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-09-07||2016-02-25|November 2014||2014-11-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|DIS DOMS||Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness|A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Dosing Interval, Efficacy, and Safety of SST-0225, a Topical Ibuprofen Cream, in the Treatment of Delayed Onset Muscle Soreness (DOMS)|Completed||Phase 2|72|Actual|Strategic Science & Technologies, LLC||2|||f||||f||||||||Undecided||2017-10-10 23:39:43.940828|2017-10-10 23:39:43.940828
NCT02339116|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-09-13|||January 2015||2015-01-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|May 15, 2017|Actual|2017-05-15||Interventional|TRIBE2||Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC|FIRST-LINE FOLFOXIRI PLUS BEVACIZUMAB FOLLOWED BY REINTRODUCTION OF FOLFOXIRI PLUS BEVACIZUMAB AT PROGRESSION Versus FOLFOX PLUS BEVACIZUMAB FOLLOWED BY FOLFIRI PLUS BEVACIZUMAB AT PROGRESSION IN FIRST- AND SECOND-LINE TREATMENT OF UNRESECTABLE METASTATIC COLORECTAL CANCER.|Active, not recruiting||Phase 3|654|Anticipated|Gruppo Oncologico del Nord-Ovest||2|||f||||f||||||||||2017-10-10 23:39:44.040518|2017-10-10 23:39:44.040518
NCT02339077|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-01-09|||October 2014||2014-10-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01|1 Day|Observational [Patient Registry]|Stillborn||Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting|Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting|Unknown status|Recruiting|N/A|300|Anticipated|University of Witwatersrand, South Africa|||1||f||||f||||||Samples Without DNA|"     Cord blood Placenta skin swab from fetus Gastric/ tracheal aspirate   "|||2017-10-10 23:39:44.531125|2017-10-10 23:39:44.531125
NCT02339064|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-07-31|||February 2015||2015-02-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|March 2018|Anticipated|2018-03-01||Interventional|INFUS-ON||Infusion of Apomorphine: Long-term Safety Study|A Phase 3, Open-Label Study of the Safety, Efficacy and Tolerability of Apomorphine Administered by Continuous Subcutaneous Infusion in Advanced Parkinson's Disease Patients With Unsatisfactory Control on Available|Recruiting||Phase 3|100|Anticipated|US WorldMeds LLC||1|||f||||f||||||||||2017-10-10 23:39:44.628577|2017-10-10 23:39:44.628577
NCT02339051|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-07-07|||January 2015||2015-01-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Mechanical Loading on Bone Material Strength and Microarchitecture in Postmenopausal Women||Completed||N/A|20|Actual|Sahlgrenska University Hospital, Sweden||1|||f||||||||||||||2017-10-10 23:39:44.789726|2017-10-10 23:39:44.789726
NCT02339038|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-06-15|2017-06-15||January 7, 2015||2015-01-07|June 2017|2017-06-01|August 1, 2025|Anticipated|2025-08-01|June 15, 2016|Actual|2016-06-15||Interventional|||Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia|A Phase IV Pilot Study to Assess Community-Based Treatment Efficacy in Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia|Active, not recruiting||Phase 4|600|Actual|National Institutes of Health Clinical Center (CC)|Although primary outcome is complete, the study remains active for prolonged observation and numerous secondary outcomes, with a projected closure date in 2025.|1|||f||||f|t|f||||||No||2017-10-10 23:39:44.874799|2017-10-10 23:39:44.874799
NCT02339025|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-10-05|||January 7, 2015||2015-01-07|March 23, 2017|2017-03-23|September 20, 2021|Anticipated|2021-09-20|September 20, 2021|Anticipated|2021-09-20||Observational|||DoD-NCI TRICARE Feasibility Study|The NCI-DoD TriCare Feasibility Study|Not yet recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:39:45.15749|2017-10-10 23:39:45.15749
NCT02339012|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-07-26|||January 7, 2015||2015-01-07|July 24, 2017|2017-07-24|December 31, 2036|Anticipated|2036-12-31|November 4, 2036|Anticipated|2036-11-04||Observational|||Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)|The Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:39:45.246116|2017-10-10 23:39:45.246116
NCT02338999|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-08-22|||December 29, 2014||2014-12-29|August 9, 2017|2017-08-09|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)|The Role of PPAR-Gamma Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)|Recruiting||Phase 1/Phase 2|70|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:39:45.333499|2017-10-10 23:39:45.333499
NCT02338986|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-10-05|||December 22, 2014||2014-12-22|September 22, 2017|2017-09-22|December 2, 2040|Anticipated|2040-12-02|November 2, 2040|Anticipated|2040-11-02||Observational|||Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases|Collection of Plasma From Subjects That Recovered From or Were Vaccinated To Emerging Infectious Diseases|Enrolling by invitation||N/A|10|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:39:45.421227|2017-10-10 23:39:45.421227
NCT02338973|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-14|2017-10-05|||December 17, 2014||2014-12-17|May 12, 2017|2017-05-12|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)|Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)|Suspended||Phase 1/Phase 2|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:39:45.50195|2017-10-10 23:39:45.50195
NCT02338960|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-06-30|||January 2015||2015-01-01|June 2017|2017-06-01|June 29, 2017|Actual|2017-06-29|August 2016|Actual|2016-08-01||Interventional|||A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial With an Open-label Extension|Phase 3, Randomized, Double-blind, Placebo-controlled, Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Subcutaneously Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)|Completed||Phase 3|714|Actual|Palatin Technologies||2|||f||||t||||||||||2017-10-10 23:39:45.600926|2017-10-10 23:39:45.600926
NCT02338947|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-03-21|||March 2016||2016-03-01|January 2016|2016-01-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|FRAGILE||Off Pump Versus On Pump Coronary Artery Bypass Grafting in Frailty Patients (FRAGILE)|Off Pump Versus On Pump Coronary Artery Bypass Grafting in Frailty Patients: A National, Multicenter, Prospective, Randomized Clinical Trial|Not yet recruiting||N/A|330|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:39:45.865434|2017-10-10 23:39:45.865434
NCT02338934|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-01-13|||January 2015||2015-01-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients|An Open-label Study of Combination of Cinacalcet and Active Vitamin D Analogue in the Management of Severe Secondary Hyperparathyroidism in Haemodialysis Patients|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Penang Hospital, Malaysia||1|||f||||f||||||||||2017-10-10 23:39:46.030711|2017-10-10 23:39:46.030711
NCT02338908|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2016-03-14|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Dry Needling and Exercises in Shoulder Pain|Effectiveness of Dry Needling and Eccentric Exercises in Unspecific Shoulder Pain|Completed||N/A|50|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-10 23:39:46.362719|2017-10-10 23:39:46.362719
NCT02338895|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-01-22|||September 2014||2014-09-01|January 2015|2015-01-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|AMOSS||Algorithm for Oliguria in Septic Shock|An Ultrasound- Guided Algorithm for the Management of Oliguria in Septic Shock|Unknown status|Recruiting|N/A|40|Anticipated|King Faisal Specialist Hospital & Research Center|||1||f||||f||||||||||2017-10-10 23:39:46.448836|2017-10-10 23:39:46.448836
NCT02338882|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-13|||January 2015||2015-01-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Clinical Investigation of the Bi Flex M Multifocal IOL|Randomised Clinical Investigation of the Bi Flex M Multifocal Intraocular Lens|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|University of Plymouth||2|||f||||f||||||||||2017-10-10 23:39:46.547379|2017-10-10 23:39:46.547379
NCT02338869|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2017-07-06|||December 2014||2014-12-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|December 2018|Anticipated|2018-12-01||Interventional|PsychoStroke||Psycho-Social Well Being Following Stroke|Psycho-Social Well Being Following Stroke - A Randomized Controlled Trial|Recruiting||N/A|330|Anticipated|University of Oslo||2|||f||||t||||||||||2017-10-10 23:39:46.635608|2017-10-10 23:39:46.635608
NCT02338856|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-03-30|||January 2015||2015-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers|A Phase I Clinical Trial to Evaluate the Pharmacokinetics and Safety of MB12066 in Healthy Male Volunteers|Completed||Phase 1|11|Actual|KT&G Life Sciences Corp||2|||f||||f||||||||||2017-10-10 23:39:46.725924|2017-10-10 23:39:46.725924
NCT02338843|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2017-04-06|||March 2015||2015-03-01|April 2017|2017-04-01|February 18, 2017|Actual|2017-02-18|December 1, 2016|Actual|2016-12-01||Interventional|ATHOS-3||A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension|A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)|Completed||Phase 3|344|Actual|La Jolla Pharmaceutical Company||2|||f||||t||||||||||2017-10-10 23:39:46.810153|2017-10-10 23:39:46.810153
NCT02338830|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-01-13|||June 2012||2012-06-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix|Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix|Completed||Phase 4|182|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:39:47.120489|2017-10-10 23:39:47.120489
NCT02338817|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-10-03|||December 2015||2015-12-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population|Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population|Terminated||N/A|9|Actual|University of Florida|||2|"The device often failed to detect hypoglycemic episodes in glycogen storage disease patients   and the rate of false positive alarms was high."|f||||f||||||||||2017-10-10 23:39:47.212566|2017-10-10 23:39:47.212566
NCT02338804|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-09-08|||January 2015||2015-01-01|January 2015|2015-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient|Safety Issue and Efficacy Study of Combining Mix Vaccine and Standard Therapy in the Treatment of Breast Carcinoma Patient|Completed||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:39:47.299503|2017-10-10 23:39:47.299503
NCT02216006|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-05-12|||September 2014||2014-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||High Fresh Gas Flow After Intubation|High Fresh Gas Flow After Intubation - A Randomized Clinical Trial|Completed||N/A|24|Actual|Landstinget Västmanland||2|||f||||f||||||||||2017-10-11 00:06:38.540135|2017-10-11 00:06:38.540135
NCT02338791|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-11-04|||April 2012||2012-04-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Rehabilitative Ultrasound Imaging: Measurements of Articular Movement of the Shoulder|Rehabilitative Ultrasound Imaging: Measurements of Articular Movement of the Shoulder|Active, not recruiting||N/A|200|Anticipated|University of Cincinnati||1|||f||||f||||||||No||2017-10-10 23:39:47.383801|2017-10-10 23:39:47.383801
NCT02338778|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-09-08|||January 2015||2015-01-01|January 2015|2015-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient|Safety Issue and Efficacy Study of Combining Mix Vaccine and Standard Therapy in the Treatment of Hepatocyte Carcinoma Patient|Completed||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:39:47.463017|2017-10-10 23:39:47.463017
NCT02338765|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-06-08|||January 2015||2015-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||MoTHER Buddy Program|With Help From Buddies: The Impact of Social Support Using Mobile Technology on Physical Activity Among Women With Young Children|Completed||N/A|54|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:39:47.554776|2017-10-10 23:39:47.554776
NCT02338752|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-09-08|||January 2015||2015-01-01|January 2015|2015-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient|Safety Issue and Efficacy Study of Combining Mix Vaccine and Standard Therapy in the Treatment of Pancreatic Carcinoma Patient|Completed||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:39:47.640126|2017-10-10 23:39:47.640126
NCT02338739|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-05-09|||March 2015||2015-03-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|AdaPT-R||An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R) in Nyanza, Kenya|An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R)|Recruiting||N/A|2500|Anticipated|University of California, San Francisco||15|||f||||f||||||||||2017-10-10 23:39:47.730086|2017-10-10 23:39:47.730086
NCT02338726|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-10-20|||September 2015||2015-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Pelvic Floor Symptoms and Quality of Life in Elderly Women - a Population-based Pilot Study|Pelvic Floor Symptoms and Quality of Life in Elderly Women - a Population-based Pilot Study|Completed||N/A|143|Actual|Turku University Hospital|||1||f||||f||||||||||2017-10-10 23:39:47.865869|2017-10-10 23:39:47.865869
NCT02338713|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-04-03|2016-03-08||January 2015||2015-01-01|April 2017|2017-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||The safety analysis set included all participants who were enrolled and received at least 1 dose of dummy treatment.|Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption|A Single-Sequence, 2-Period, Open-Label Study of a Novel Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet Dosed for 3 Days to Investigate the Effect on Intestinal Calcium Absorption in Healthy Postmenopausal Women and Healthy Men|Completed||Phase 1|27|Actual|Takeda||1|||f||||f||||||||||2017-10-10 23:39:47.951982|2017-10-10 23:39:47.951982
NCT02338700|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2015-09-08|||January 2015||2015-01-01|January 2015|2015-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient|Safety Issue and Efficacy Study of Combining Mix Vaccine and Standard Therapy in the Treatment of Prostate Carcinoma Patient|Completed||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:39:48.325581|2017-10-10 23:39:48.325581
NCT02338687|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2016-02-02|||October 2014||2014-10-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|AMCAL||Low Dose Calcium to Prevent Preeclampsia|Low Dose Calcium Supplementation to Prevent Preeclampsia: a Cluster Randomized Study|Recruiting||Phase 4|1040|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 23:39:48.403008|2017-10-10 23:39:48.403008
NCT02338674|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-11|2017-08-21|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||TDF and LdT in Patients With HBV Infection Awaiting Assisted Reproduction|Double Therapy of Tenofovir and Telbivudine for Elimination of Virus in Patients With Chronic Hepatitis B Virus Infection Awaiting Assisted Reproduction|Active, not recruiting||Phase 1/Phase 2|120|Actual|Fuzhou General Hospital||2|||f||||t||||||||||2017-10-10 23:39:48.502856|2017-10-10 23:39:48.502856
NCT02338661|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-02-21|||January 2004||2004-01-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Clinical Observation Study With the SBG Stem|Clinical Observation Study With the SBG Stem|Active, not recruiting||N/A|148|Actual|Smith & Nephew, Inc.|||1||f||||||||||||||2017-10-10 23:39:48.576978|2017-10-10 23:39:48.576978
NCT02338648|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-08-09||2017-06-05|October 2014||2014-10-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN 131 Transdermal System (TDS) as Compared to Placebo TDS in Adult Patients With a Chalazion|Completed||Phase 2|60|Actual|Senju USA, Inc.||2|||f||||f||||||||||2017-10-10 23:39:48.635942|2017-10-10 23:39:48.635942
NCT02338635|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-05-13|||July 2015||2015-07-01|May 2015|2015-05-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis|Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis|Not yet recruiting||Phase 4|55|Anticipated|Ewha Womans University||2|||f||||f||||||||||2017-10-10 23:39:48.737307|2017-10-10 23:39:48.737307
NCT02338622|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-01-16|||March 2014||2014-03-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|ComPAKT||Trial of Olaparib in Combination With AZD5363 (ComPAKT)|A Phase I Multi-centre Trial of the Combination of Olaparib (PARP Inhibitor) and AZD5363 (AKT Inhibitor) in Patients With Advanced Solid Tumours|Unknown status|Recruiting|Phase 1|58|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:39:48.834426|2017-10-10 23:39:48.834426
NCT02338440|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-04-26|||January 2015||2015-01-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT|Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT|Active, not recruiting||Phase 2/Phase 3|30|Anticipated|Seoul National University Hospital||1|||f||||t||||||||Undecided||2017-10-10 23:39:50.656294|2017-10-10 23:39:50.656294
NCT02338609|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-05-04|||December 17, 2014|Actual|2014-12-17|May 2017|2017-05-01|September 25, 2026|Anticipated|2026-09-25|September 25, 2026|Anticipated|2026-09-25||Interventional|EXIST-LT||Long-term Follow-up for Growth and Development of Pediatric Patients From CRAD001M2301|Long-term Follow-up Study to Monitor the Growth and Development of Pediatric Patients Previously Treated With Everolimus in Study CRAD001M2301|Active, not recruiting||Phase 4|15|Actual|Novartis||2|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-10 23:39:48.952774|2017-10-10 23:39:48.952774
NCT02338596|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-13|||June 2001||2001-06-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old|Comparison of the Outcomes of Ultra-Short Anatomic and Conventional Cementless Stems in Patients Younger Than Fifty-Five Years Old|Completed||Phase 4|111|Actual|Ewha Womans University||2|||f||||t||||||||||2017-10-10 23:39:49.051856|2017-10-10 23:39:49.051856
NCT02338583|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-08-10|||December 1, 2014|Actual|2014-12-01|August 2017|2017-08-01|May 1, 2015|Actual|2015-05-01|April 1, 2015|Actual|2015-04-01||Observational|||Powered Surgical Stapler in VATS Lung Resection Procedures in China|A Prospective, Multi-Center Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in China|Completed||N/A|95|Actual|Ethicon Endo-Surgery|||1||f||||f|f|t|f|f|t|||||2017-10-10 23:39:49.117408|2017-10-10 23:39:49.117408
NCT02338570|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-11-28|||July 2015||2015-07-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ORCHIDEE||Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)|Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus After Failure of a First-line Treatment With VEGF Inhibitor|Terminated||Phase 4|31|Actual|Mario Negri Institute for Pharmacological Research||1||Stopped on November 16th 2016, because of recruitment failure.|f||||f||||||||||2017-10-10 23:39:49.184158|2017-10-10 23:39:49.184158
NCT02338557|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-09|||January 2010||2010-01-01|January 2015|2015-01-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Motor Relearning Programme and Mirror Therapy Along for Improving Hand Function In Patients With Stroke.|Effectiveness of Motor Relearning Programme and Mirror Therapy Along With Conventional Physiotherapy Treatment for Improving Hand Function In Patients With Stroke.|Completed||N/A|12|Actual|Maharishi Markendeswar University||2|||f||||||||||||||2017-10-10 23:39:49.391757|2017-10-10 23:39:49.391757
NCT02338544|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-02-15|||January 2015||2015-01-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|PUMP-it||Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne|Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne|Completed||N/A|1388|Actual|Galderma Laboratorium GmbH|||1||f||||f||||||||No||2017-10-10 23:39:49.479715|2017-10-10 23:39:49.479715
NCT02338531|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-04-28|||June 2015||2015-06-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|RHEA||Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer|Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer|Withdrawn||Phase 2|0|Actual|Jules Bordet Institute||1||Due to the discontinuation of the development of the Notch inhibitor PF-03084014-04|f||||f||||||||||2017-10-10 23:39:49.563985|2017-10-10 23:39:49.563985
NCT02338518|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-10-27|||January 2015||2015-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SVOSA||Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients|Comparison of SEEOX and SOX Chemotherapeutic Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients|Recruiting||Phase 3|320|Anticipated|Jinling Hospital, China||2|||f||||f||||||||||2017-10-10 23:39:49.666775|2017-10-10 23:39:49.666775
NCT02338505|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-13|||February 2015||2015-02-01|January 2015|2015-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|OB-ALFX||Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX||Unknown status|Not yet recruiting|Phase 2|50|Anticipated|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-10 23:39:49.798776|2017-10-10 23:39:49.798776
NCT02338492|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-07-31|||March 2015||2015-03-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Efficacy Study of the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease|A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease|Completed||N/A|81|Actual|IlluminOss Medical, Inc.||1|||f||||||||||||||2017-10-10 23:39:49.95221|2017-10-10 23:39:49.95221
NCT02338479|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-09-28|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies|Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies|Recruiting||N/A|340|Anticipated|Center for International Blood and Marrow Transplant Research|||1||f||||t||||||||||2017-10-10 23:39:50.10345|2017-10-10 23:39:50.10345
NCT02338466|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2016-09-22|||November 2016||2016-11-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|DIVA||Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion|Randomized Therapeutic Study Assessing the Superiority of a Sequential Intravenous Thrombolysis Treatment (Rt-PA + Tenecteplase) in Comparison With Rt-PA Standard Treatment in Proximal Middle Cerebral Artery Occlusion (DIVA).|Not yet recruiting||Phase 2|60|Anticipated|University Hospital Center of Martinique||2|||f||||f||||||||No||2017-10-10 23:39:50.459002|2017-10-10 23:39:50.459002
NCT02338453|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-08-17|||March 2015||2015-03-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|ABMT+CBGT||Attention Bias Modification Treatment (ABMT) and Cognitive-Behavioral Group Therapy (CBGT) in Social Anxiety Disorder|Examining the Effects of a Combined Attention Bias Modification Treatment (ABMT) and Cognitive-Behavioral Group Therapy (CBGT) for Social Anxiety Disorder|Completed||N/A|50|Actual|Tel Aviv University||2|||f||||f||||||||||2017-10-10 23:39:50.557379|2017-10-10 23:39:50.557379
NCT02338427|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2017-01-10|||May 2016||2016-05-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|November 2017|Anticipated|2017-11-01||Interventional|IPA||Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis|Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis. Multicenter Prospective|Recruiting||N/A|130|Anticipated|Centre Hospitalier Departemental Vendee||1|||f||||t||||||||||2017-10-10 23:39:50.740185|2017-10-10 23:39:50.740185
NCT02338414|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-11|||January 2015||2015-01-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP|An Observational Study to Evaluate the Efficacy of Romiplostim Administered at Every Other Week in Adult Patients With Chronic Immune Thrombocytopenia (ITP) Who Attained Platelet Counts ≥ 50 x 109/L After Weekly Doses of Romiplostim|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-10 23:39:50.825921|2017-10-10 23:39:50.825921
NCT02338401|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2017-05-01|||December 2015||2015-12-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Fish Oil Supplementation, Resting Energy Expenditure, Skeletal Muscle Membrane Composition and Metabolism in Elderly Subjects.|Effect of Fish Oil Supplementation on Resting Energy Expenditure, Skeletal Muscle Membrane Composition and Metabolism in Elderly Subjects.|Active, not recruiting||N/A|30|Anticipated|University of Guelph||2|||f||||f||||||||||2017-10-10 23:39:50.911851|2017-10-10 23:39:50.911851
NCT02338388|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-12|2015-01-13|||January 2012||2012-01-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Cesarean-scar Thickness and Closure Technique|Longitudinal Transvaginal Ultrasound Evaluation of Cesarean-scar Thickness in the First Two Years After Single- or Double-layer Uterotomy Closure: a Prospective Randomized Study|Completed||N/A|435|Actual|Charite University, Berlin, Germany||3|||f||||t||||||||||2017-10-10 23:39:51.001249|2017-10-10 23:39:51.001249
NCT02338375|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-01-11|||December 2012||2012-12-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|Cartistem||Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product|Clinical Trial of the Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product With Microfracture for Osteochondral Lesion of Talus Patients|Unknown status|Enrolling by invitation|Early Phase 1|28|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 23:39:51.068501|2017-10-10 23:39:51.068501
NCT02338349|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-03-02|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer|A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer|Active, not recruiting||Phase 1|75|Anticipated|Radius Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:39:51.241179|2017-10-10 23:39:51.241179
NCT02338336|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2016-10-06|2016-05-30||February 2015||2015-02-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts|A Phase I/II, Two- Staged Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Nowarta110 in Patients With Plantar Warts and Clinical Recovery Successfully Completed|Completed||Phase 1/Phase 2|54|Actual|Nowarta Biopharma Inc||4|||f||||t||||||||Yes||2017-10-10 23:39:51.31231|2017-10-10 23:39:51.31231
NCT02338323|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-10|2016-05-05|||January 2015||2015-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Compare the Renal Protective Effects of Febuxostat and Benzbromarone|Compare the Renal Protective Effects of Febuxostat and Benzbromarone in Chronic Kidney Disease Patients With GFR 20-50ml/Min|Recruiting||N/A|200|Anticipated|Shanghai 10th People's Hospital||2|||f||||t||||||||||2017-10-10 23:39:51.65284|2017-10-10 23:39:51.65284
NCT02338310|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-01-09|||September 2008||2008-09-01|January 2015|2015-01-01||||April 2024|Anticipated|2024-04-01||Interventional|POETIC||Trial of Perioperative Endocrine Therapy - Individualising Care||Active, not recruiting||Phase 3|4486|Actual|Institute of Cancer Research, United Kingdom||2|||f||||t||||||||||2017-10-10 23:39:51.748749|2017-10-10 23:39:51.748749
NCT02338297|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-03-31|||February 2016||2016-02-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC|A Randomized Controlled Trial of Ethanol-gelfoam Mixture(EGM) Versus Gelfoam for the Treatment of Arterioportal Shunts (APS) in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolization (TACE)|Recruiting||Phase 3|236|Anticipated|Nanjing Medical University||2|||f||||t||||||||||2017-10-10 23:39:52.093452|2017-10-10 23:39:52.093452
NCT02338284|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-06-14|||October 2014||2014-10-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|||Optic Nerve Sheath Diameter as a Screening Test for Increased Intracranial Pressure|Optic Nerve Sheath Diameter Measured by Bedside Ultrasound May be a Simple Screening Test for Increased Intracranial Pressure in the Comatose Critically Ill Patient|Unknown status|Recruiting|N/A|100|Anticipated|King Faisal Specialist Hospital & Research Center|||1||f||||f||||||||||2017-10-10 23:39:52.201522|2017-10-10 23:39:52.201522
NCT02338271|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-13|||January 2015||2015-01-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Autologous Adipose Derived Stem Cell Therapy for Intervertebral Disc Degeneration|Safety and Efficacy Study of Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration|Recruiting||Phase 1|10|Anticipated|Bundang CHA Hospital||1|||f||||f||||||||||2017-10-10 23:39:52.291848|2017-10-10 23:39:52.291848
NCT02338076|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-07|2016-07-06||June 2013||2013-06-01|April 2017|2017-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin|A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin|Completed||N/A|20|Actual|Rockefeller University||1|||f||||f||||||||Undecided||2017-10-10 23:39:55.658458|2017-10-10 23:39:55.658458
NCT02338258|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2015-01-11|||June 2014||2014-06-01|January 2015|2015-01-01|June 2017|Anticipated|2017-06-01|September 2016|Anticipated|2016-09-01||Interventional|||The Study of the Nonunion of Long Tubular Bone|The Prospective、Randomized、Comparative Clinical Study About the Two Operation Methods Between Anti-rotational Plate Group and Exchanged Intramedullary Nailgroup to Treat the Nonunion of Long Tubular Bone After Intramedullary Nail Fixation|Unknown status|Recruiting|Phase 1|82|Anticipated|Beijing Jishuitan Hospital||2|||f||||t||||||||||2017-10-10 23:39:52.374569|2017-10-10 23:39:52.374569
NCT02338245|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-02-01|||December 2014||2014-12-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|February 2017|Actual|2017-02-01||Interventional|||Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab|Randomized Phase 2A/2B Study to Compare the Efficacy and Safety of ASLAN001 + Capecitabine to Lapatinib + Capecitabine in Patients With HER 2-Positive MBC That Has Failed on Prior Trastuzumab Therapy|Active, not recruiting||Phase 2|200|Anticipated|Aslan Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:39:52.440294|2017-10-10 23:39:52.440294
NCT02338232|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-08-08|||July 7, 2015|Actual|2015-07-07|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pilot Study of Telmisartan (Micardis) For the Prevention of Acute Graft vs. Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation|Pilot Study of Telmisartan (Micardis) For the Prevention of Acute Graft vs. Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||N/A|60|Anticipated|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-10 23:39:54.146396|2017-10-10 23:39:54.146396
NCT02338219|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2015-01-11|||May 2013||2013-05-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Pregnancy and Childbirth on Pelvic Floor Morphology and Sexual Function in Egyptian Women|Effects of Pregnancy and Childbirth on Pelvic Floor Morphology and Sexual Function in Egyptian Women|Completed||Phase 1/Phase 2|120|Actual|Al-Azhar University||3|||f||||t||||||||||2017-10-10 23:39:54.282682|2017-10-10 23:39:54.282682
NCT02338206|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-08-30|||January 2015||2015-01-01|August 2015|2015-08-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Long Protocol in Poor Responders|Can the Addition of Growth Hormone to the Long Down Regulation Protocol Improve the Outcome of In Vitro Fertilization Cycles in Poor Responders?|Unknown status|Recruiting|Phase 2|150|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-10 23:39:54.35938|2017-10-10 23:39:54.35938
NCT02338193|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-05-08|||August 2015||2015-08-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|DAPA-GDM||Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women|A Randomized Study Evaluating Dapagliflozin and Metformin, Alone and in Combination, in Overweight Women With a Recent History of Gestational Diabetes Mellitus: Effects on Anthropometric Measurements and Cardiometabolic Abnormalities|Recruiting||Phase 3|72|Anticipated|Woman's||3|||f||||f||||||||No|Will publish findings. Individual patient information will be revealed only to patient|2017-10-10 23:39:54.450392|2017-10-10 23:39:54.450392
NCT02338180|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-09-23|||March 2009||2009-03-01|September 2016|2016-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|PTPS||Preventive and Therapeutic Proximal Sealants|A Randomized Clinical Trial on Preventive and Therapeutic Proximal Sealants|Completed||Phase 4|390|Actual|Universidad de Valparaiso||3|||f||||t||||||||||2017-10-10 23:39:54.592581|2017-10-10 23:39:54.592581
NCT02338167|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-08-24|||June 2014||2014-06-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01|36 Months|Observational [Patient Registry]|PRAEGNANT||Praegnant Breast Cancer|Prospective Academic Translational Research Network for the Optimization of the Oncological Health Care Quality in the Adjuvant and Advanced/Metastatic Setting: Health Care Research, Pharmacogenomics, Biomarkers, Health Economics|Recruiting||N/A|3500|Anticipated|University Hospital Tuebingen|||1||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:39:54.717498|2017-10-10 23:39:54.717498
NCT02338154|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-07-21|||July 2012||2012-07-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|FOUNDATION||EDWARDS INTUITY Valve System FOUNDATION Study|Assessing Standard oF Care and Clinical Outcomes UsiNg the EDWARDS INTUITY VAlve SysTem in a European multI-center, Active, pOst-market surveillaNce Study.|Completed||N/A|517|Actual|Edwards Lifesciences|||1||f||||t||||||||||2017-10-10 23:39:55.073513|2017-10-10 23:39:55.073513
NCT02338141|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-04-27|||August 2015||2015-08-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women|Evaluating the Accuracy of Portable Colposcopy and Prevalent HPV Genotypes Among HIV Positive Women in Haiti|Terminated||N/A|132|Actual|Duke University||2||Funding unavailable to perform study.|f||||f|f|t|t|f|t|||||2017-10-10 23:39:55.20297|2017-10-10 23:39:55.20297
NCT02338128|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-05-05|||January 2015||2015-01-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients|The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients: a Prospective Cohort Study|Active, not recruiting||N/A|50|Anticipated|Shanghai 10th People's Hospital|||1||f||||t||||||||||2017-10-10 23:39:55.309249|2017-10-10 23:39:55.309249
NCT02338115|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-05-01|||May 2014||2014-05-01|May 2017|2017-05-01|December 20, 2016|Actual|2016-12-20|December 20, 2016|Actual|2016-12-20||Observational|||Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients|Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients|Completed||N/A|60|Actual|University of Michigan Cancer Center|||1||f||||t||||||Samples With DNA|"     Serum at end of first infusion and 24 hours after Whole blood prior to infusion, at end of     infusion and 24 hours after, and every 3-4 weeks   "|||2017-10-10 23:39:55.378256|2017-10-10 23:39:55.378256
NCT02338102|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-11-02|||January 2013||2013-01-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer|Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer: A Pilot Study|Completed||N/A|36|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 23:39:55.465535|2017-10-10 23:39:55.465535
NCT02338089|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-09-02|||January 2015||2015-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Investigating the Effect of Pulsatile Administration of Oxytocin on the Desensitization of Human Myometrium In-vitro|Investigating the Effect of Pulsatile Administration of Oxytocin on the Desensitization of Human Myometrium In-vitro|Completed||N/A|18|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||3|||f||||f||||||||||2017-10-10 23:39:55.563381|2017-10-10 23:39:55.563381
NCT02338050|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-09-15|||May 2015||2015-05-01|September 2015|2015-09-01||||May 2020|Anticipated|2020-05-01||Interventional|||Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell Transplantation|A Phase II Study of the Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell Transplantation|Terminated||Phase 2|1|Actual|Center for International Blood and Marrow Transplant Research||1|||f||||t||||||||||2017-10-10 23:39:56.041929|2017-10-10 23:39:56.041929
NCT02338037|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-08-07|||May 19, 2015|Actual|2015-05-19|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors|An Intracerebral Microdialysis Study to Determine the Neuropharmacokinetics of Eribulin in Patients With Brain Tumors|Active, not recruiting||N/A|8|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:39:56.142955|2017-10-10 23:39:56.142955
NCT02338024|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-25|||October 2015||2015-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|MARTAS||Enhancing Linkage to HIV Care for Newly Detected HIV-positive Persons in Ukraine|Enhancing Linkage to HIV Care for Newly Detected HIV-positive Persons in Ukraine|Recruiting||N/A|276|Anticipated|Ukrainian Institute on Public Health Policy||2|||f||||f||||||||||2017-10-10 23:39:56.24656|2017-10-10 23:39:56.24656
NCT02338011|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-01-23|||November 2014||2014-11-01|January 2015|2015-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|EGFR||Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)|Gefitinib Alone or With Concomitant Whole Brain Radiotherapy for Patients Harboring an EGFR Mutation With Multiple Brain Metastases From Non-Small-cell Lung Cancer: a Phase II/III Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|210|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||||2017-10-10 23:39:56.371308|2017-10-10 23:39:56.371308
NCT02337998|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-05-01|||January 2015||2015-01-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Effect of Load Carriage on Upper Limb Performance||Completed||N/A|10|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:39:56.478364|2017-10-10 23:39:56.478364
NCT02337985|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-08-10|||August 3, 2015|Actual|2015-08-03|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma|Safety and Feasibility of Stem Cell Gene Transfer Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patients Using Peripheral Blood Stem/Progenitor Cells Treated With a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs|Recruiting||N/A|10|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:39:56.555377|2017-10-10 23:39:56.555377
NCT02337972|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-02-19|||January 2015||2015-01-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients|Conjunctival Flora Patterns After Serial Intravitreal Injections Without Postinjection Topical Antibiotics in Diabetic Patients|Unknown status|Recruiting|N/A|50|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:39:56.796904|2017-10-10 23:39:56.796904
NCT02337959|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-04-15|2015-05-01||January 2015||2015-01-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors|Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors|Completed||N/A|27|Actual|Carestream Health, Inc.||3|||f||||f||||||||No||2017-10-10 23:39:56.899327|2017-10-10 23:39:56.899327
NCT02337946|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-07|||September 17, 2014|Actual|2014-09-17|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|March 31, 2017|Actual|2017-03-31||Interventional|SAPPHIRE||Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Patients With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma|SAPPHIRE Study - A Phase II Randomized Study Comparing the Efficacy and Safety of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in the Patients With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma of KRAS Wild-type After 6 Cycles of Combination Therapy With mFOLFOX6 +|Completed||Phase 2|164|Actual|Takeda||2|||f||||f|f|f||||||||2017-10-10 23:39:57.205808|2017-10-10 23:39:57.205808
NCT02337933|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-11-02|||September 2014||2014-09-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome|Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome|Completed||Phase 2|24|Actual|University of Guadalajara||2|||f||||f||||||||||2017-10-10 23:39:57.448904|2017-10-10 23:39:57.448904
NCT02337920|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-07-19|||February 2015|Actual|2015-02-01|July 2015|2015-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|TEA-NIRS||Prediction of Femoral Revascularization Quality Using the Somatic NIRS Signal|Prediction of Femoral Revascularization Quality Using the Somatic NIRS Signal|Completed||N/A|31|Actual|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 23:39:57.556436|2017-10-10 23:39:57.556436
NCT02337907|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-07-25|||January 21, 2015|Actual|2015-01-21|July 2017|2017-07-01|October 9, 2017|Anticipated|2017-10-09|September 11, 2017|Anticipated|2017-09-11||Interventional|||BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.|A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease|Active, not recruiting||Phase 2|295|Anticipated|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 23:39:57.623282|2017-10-10 23:39:57.623282
NCT02337894|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-01-03|||January 2017||2017-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children|Effects of Nutritional Supplementation With Amino Acids on Liver Lipid Content, Whole-body Protein Turnover, and Body Composition in Obese Pre-pubertal Children|Not yet recruiting||N/A|32|Anticipated|Arkansas Children's Hospital Research Institute||2|||f||||t||||||||||2017-10-10 23:39:57.849798|2017-10-10 23:39:57.849798
NCT02337504|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-01-09|||January 2015||2015-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ARTCo-ops||Developing and Assessing a Community Based Model of Antiretroviral Care|Developing and Assessing a Community Based Model of Antiretroviral Care|Unknown status|Not yet recruiting|N/A|360|Anticipated|Moi University||2|||f||||t||||||||||2017-10-10 23:40:01.458406|2017-10-10 23:40:01.458406
NCT02337881|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-06-21|||January 2015||2015-01-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Management of Acute Preterm Labor: Nifedipen Alone or Combined With Cildenafil Citrate|Combined Nifedipine and Sildenafil Citrate Versus Nifedipine Alone in Acute Tocolysis of Preterm Labor: A Randomized Clinical Trial|Recruiting||Phase 1|227|Anticipated|Al Hayat National Hospital||2|||f||||t||||||||||2017-10-10 23:39:57.958183|2017-10-10 23:39:57.958183
NCT02337868|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-12-22|||March 2015||2015-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase 1 Trial of Inactivated West Nile Virus Vaccine|A Double Blind, Randomized, Placebo-Controlled, Phase I Dose Escalation Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001, in Healthy Adults|Completed||Phase 1|96|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-10 23:39:58.067037|2017-10-10 23:39:58.067037
NCT02337855|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-06-22|||February 4, 2015|Actual|2015-02-04|December 7, 2016|2016-12-07|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|||A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults|A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults|Completed||Phase 1|72|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||9|||f|||||t|f|||f|||||2017-10-10 23:39:58.163368|2017-10-10 23:39:58.163368
NCT02337842|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-06-02|||September 2015||2015-09-01|August 2015|2015-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)|Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-10 23:39:58.279071|2017-10-10 23:39:58.279071
NCT02337829|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-12-02|||December 2014||2014-12-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL|A Phase II Study Using ACP-196 in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL: Pharmacodynamic Assessment of BTK Inhibition and Anti-Tumor Response|Recruiting||Phase 2|48|Anticipated|Acerta Pharma BV||2|||f||||f||||||||||2017-10-10 23:39:58.379353|2017-10-10 23:39:58.379353
NCT02337816|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-01-09|||December 2014||2014-12-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01||Interventional|||Role of Metabolomics in the Diagnosis of Endometriosis|Role of Metabolomics in the Diagnosis of Endometriosis|Active, not recruiting||N/A|40|Anticipated|University of Cagliari||2|||f||||||||||||||2017-10-10 23:39:58.489399|2017-10-10 23:39:58.489399
NCT02337790|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-12-28|||January 2015||2015-01-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals|Necklace-Shaped Sensor for Non-Invasive Monitoring of Fluids, Heart Rate, Heart Rate Variability, and Respiration Rate in Patients With a Pacemaker, Implanted Cardioverter-Defibrillator, or Ventricular Assist Device|Completed||N/A|109|Actual|toSense, Inc.|||1||f||||f||||||||||2017-10-10 23:39:58.639397|2017-10-10 23:39:58.639397
NCT02337777|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-01-15|||July 2014||2014-07-01|January 2015|2015-01-01||||June 2017|Anticipated|2017-06-01||Observational|||The Study of Functional Magnetic Resonance Imaging in Abdominal and Pelvic Diseases|The Study of Functional Magnetic Resonance Imaging in Abdominal and Pelvic Diseases|Unknown status|Recruiting|N/A|1000|Anticipated|Tongji Hospital|||1||f||||||||||||||2017-10-10 23:39:58.707723|2017-10-10 23:39:58.707723
NCT02337751|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-03-30|||July 31, 2015|Actual|2015-07-31|March 2017|2017-03-01|March 16, 2017|Actual|2017-03-16|March 16, 2017|Actual|2017-03-16||Interventional|||A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants|A Multicenter, Open-label, Long-term, Extension, Phase 3 Study to Evaluate the Safety and Efficacy of TVP-1012 at 1 mg in Early Parkinson's Disease Patients Not Treated With Levodopa|Completed||Phase 3|198|Actual|Takeda||1|||f||||f||||||||||2017-10-10 23:39:59.055693|2017-10-10 23:39:59.055693
NCT02337712|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-04-15|||January 2015||2015-01-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer|Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy Compared With Twice-daily Radiotherapy in Limited Small-cell Lung Cancer Treated Concurrently With Cisplatin and Etoposide|Recruiting||Phase 2|204|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:39:59.719953|2017-10-10 23:39:59.719953
NCT02337699|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-08-25|||January 2015||2015-01-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|GASPA||Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain|DORSAL ROOT GANGLION STIMULATION AS TREATMENT FOR POSTSURGICAL GROIN PAIN (GASPA Study)|Terminated||N/A|1|Actual|St. Jude Medical|||2|"The Principal investigator retired without replacement. Only one patient was enrolled and   completed the entire study without adverse events."|f||||f||||||||||2017-10-10 23:39:59.829757|2017-10-10 23:39:59.829757
NCT02337686|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-09-28|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Pharmacodynamic Study of Pembrolizumab in Patients With Recurrent Glioblastoma|Pharmacodynamic Study of Pembrolizumab in Patients With Recurrent Glioblastoma|Recruiting||Phase 2|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:39:59.920532|2017-10-10 23:39:59.920532
NCT02337673|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2016-03-22|||May 2014||2014-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|7 Days|Observational [Patient Registry]|||Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography|Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography in Intensive Care Patients Undergoing Epigastric Surgery|Completed||N/A|130|Actual|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-10 23:40:00.023425|2017-10-10 23:40:00.023425
NCT02337660|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-06-04|||January 2015||2015-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia|Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia|Completed||N/A|30|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-10-10 23:40:00.126666|2017-10-10 23:40:00.126666
NCT02337647|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-09-20|||June 2014|Actual|2014-06-01|January 2015|2015-01-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of the Distortion Correction Data Collection (DCDC) App Software|Evaluation of the Distortion Correction Data Collection (DCDC) App Software to Repair Visual Distortions for Low Vision Age-related Macular Degeneration, and the Correlation of the Distortions With Clinical Examination|Completed||N/A|5|Actual|University of Nebraska||1|||f||||f||||||||||2017-10-10 23:40:00.23341|2017-10-10 23:40:00.23341
NCT02337634|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-07-28|||January 2015||2015-01-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Milk Thistle in Pathological Gambling|Silymarin Treatment of Pathological Gambling: A Double-Blind, Placebo-Controlled Study|Recruiting||Phase 2|80|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-10 23:40:00.302563|2017-10-10 23:40:00.302563
NCT02337621|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-04-03|||May 2015||2015-05-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|PEP||Pain, Exercise and Psychological Well-being in Pectus Excavatum|Evaluating Outcomes for Pectus Excavatum: Pain, Exercise, and Psychological Well-being|Recruiting||N/A|10|Anticipated|Phoenix Children's Hospital|||1||f||||f||||||||Undecided||2017-10-10 23:40:00.398735|2017-10-10 23:40:00.398735
NCT02337608|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-11-18|||December 2014||2014-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|ORIGIN||Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis|Phase II, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Patients With Moderate to Severe Ulcerative Colitis|Completed||Phase 2|64|Actual|Galapagos NV||2|||f||||t||||||||||2017-10-10 23:40:00.50531|2017-10-10 23:40:00.50531
NCT02337595|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-04-21|||August 2014||2014-08-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Interventional|45RA_NEG_DLI||Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation|Transfusion of CD45RA-depleted Donor Lymphocytes to Improve Regeneration of Antimicrobial Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation|Completed||Phase 1/Phase 2|30|Actual|Federal Research Institute of Pediatric Hematology, Oncology and Immunology||1|||f||||f||||||||||2017-10-10 23:40:00.681789|2017-10-10 23:40:00.681789
NCT02337582|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-01-09|||January 2007||2007-01-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|December 2012|Actual|2012-12-01||Interventional|||Colombian Screening Mammography Project|Pilot Study for Implementing Breast Cancer Early Detection Programs in Colombia|Completed||N/A|15855|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-10 23:40:00.761691|2017-10-10 23:40:00.761691
NCT02337569|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-01-12|||January 2015||2015-01-01|January 2015|2015-01-01||||December 2015|Anticipated|2015-12-01||Interventional|||A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency|A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency|Unknown status|Recruiting|Phase 3|50|Anticipated|Nobelpharma||2|||f||||||||||||||2017-10-10 23:40:00.834882|2017-10-10 23:40:00.834882
NCT02337556|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-05-03|||November 2014|Actual|2014-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU|The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU|Completed||N/A|208|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-10 23:40:00.923764|2017-10-10 23:40:00.923764
NCT02337543|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-03-09|||January 2015||2015-01-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||NEO6860, a TRPV1 Antagonist, First in Human Study|NEO6860: A Phase I, Double-Blind, Placebo-Controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Healthy Male and Female Subjects|Completed||Phase 1|64|Actual|Neomed Institute||2|||f||||t||||||||||2017-10-10 23:40:01.023511|2017-10-10 23:40:01.023511
NCT02337530|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-05-25|||February 5, 2015|Actual|2015-02-05|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous Non-Small Cell Lung Cancer|A Randomized Phase II Trial of Selumetinib in Patients Receiving Standard Pemetrexed and Platinum-based Chemotherapy for the Treatment of Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|62|Actual|Canadian Cancer Trials Group||3|||f||||t||||||||||2017-10-10 23:40:01.148485|2017-10-10 23:40:01.148485
NCT02337517|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-09-04|||September 8, 2015|Actual|2015-09-08|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|August 1, 2020|Anticipated|2020-08-01||Interventional|||Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease|Pilot Study for the Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD) With GDC-0449 (GDC-0449)|Recruiting||N/A|12|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:40:01.300265|2017-10-10 23:40:01.300265
NCT02337478|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-09-18|||May 2015||2015-05-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|An Open Label, Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 2|5|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-10 23:40:01.708922|2017-10-10 23:40:01.708922
NCT02337465|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-08-03|||September 22, 2015|Actual|2015-09-22|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer|Integrated 3D X-ray and Ultrasound Guided Radiation Therapy of Soft Tissue Targets|Recruiting||N/A|16|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|f|t|f|f|f|||||2017-10-10 23:40:02.029734|2017-10-10 23:40:02.029734
NCT02337452|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-05-26|||April 10, 2015|Actual|2015-04-10|May 2017|2017-05-01|April 2048|Anticipated|2048-04-01|April 2048|Anticipated|2048-04-01|40 Years|Observational [Patient Registry]|||The Patient-Driven Self-Navigated Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families|The Patient-Driven Self-Navigated Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families|Active, not recruiting||N/A|10000|Anticipated|M.D. Anderson Cancer Center|||3||f||||f|f|f||||||||2017-10-10 23:40:02.195945|2017-10-10 23:40:02.195945
NCT02337439|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-08-02|||August 2014||2014-08-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Perceptual Deficits in Schizophrenia|Cognitive Remediation for Perceptual Deficits in Schizophrenia|Unknown status|Recruiting|N/A|60|Anticipated|VA Connecticut Healthcare System||2|||f||||f||||||||||2017-10-10 23:40:02.328451|2017-10-10 23:40:02.328451
NCT02337426|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-05-03|||February 13, 2015||2015-02-13|May 2017|2017-05-01|September 21, 2018|Anticipated|2018-09-21|November 8, 2016|Actual|2016-11-08||Interventional|||Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I Trial of Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Glioblastoma Multiforme|Active, not recruiting||Phase 1|12|Actual|Virginia Commonwealth University||1|||f||||t|t|f||||||||2017-10-10 23:40:02.432465|2017-10-10 23:40:02.432465
NCT02337413|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-10-26|||January 2016||2016-01-01|October 2015|2015-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis|A Controlled Randomized, Physician Blinded Study to Assess Isolated Uro-therapy vs. Urotherapy With Constipation Treatment for Patients With Moderate-severe Monosymptomatic Nocturnal Enuresis (MNE) Not Meeting ROME-III Constipation Criteria|Not yet recruiting||Phase 4|110|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:40:02.55523|2017-10-10 23:40:02.55523
NCT02337400|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-08-29|||January 2015||2015-01-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Evaluation of a Cognitive Behavioral Smoking Reduction Program|"Das Verhaltenstherapeutische Therapiemanual Smoke_less Zur Reduktion Des Tabakkonsums: Eine Evaluationsstudie Mit Ambulanten Patienten"|Completed||N/A|155|Actual|Ludwig-Maximilians - University of Munich||3|||f||||f||||||||||2017-10-10 23:40:02.688826|2017-10-10 23:40:02.688826
NCT02337374|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2015-01-09|||June 2010||2010-06-01|January 2015|2015-01-01||||February 2012|Actual|2012-02-01||Observational|UPMUSF||Predictive Role of Urodynamics on Mid-urethral Sling Failure|Do Urodynamics Superior to 25 Years of Clinical Expertise Predict Mid-Urethral Sling Failure?|Completed||N/A|242|Actual|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||f||||||||||2017-10-10 23:40:02.932404|2017-10-10 23:40:02.932404
NCT02337361|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-07|||February 2016||2016-02-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Computerized Tool for Preventing Prenatal Drinking|Preparing a Computerized Tool for Preventing Prenatal Drinking for a Larger Trial|Active, not recruiting||N/A|200|Anticipated|Public Health Institute, California||2|||f||||t||||||||||2017-10-10 23:40:03.005001|2017-10-10 23:40:03.005001
NCT02337348|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-12-15|||August 2014||2014-08-01|December 2015|2015-12-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|PROCTOR||Prospective Randomized Optical Coherence Tomography Oslo tRial|Optical Coherence Tomography (OCT) Guided Compared to Conventional Angiography Guided Coronary Intervention in Stentfailure|Recruiting||N/A|200|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 23:40:03.091789|2017-10-10 23:40:03.091789
NCT02337335|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-01-08|||November 2014||2014-11-01|January 2015|2015-01-01|April 2015|Anticipated|2015-04-01|December 2014|Actual|2014-12-01||Observational|||Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients|Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients|Unknown status|Recruiting|N/A|268|Anticipated|NephroCare Spain|||1||f||||f||||||||||2017-10-10 23:40:03.192813|2017-10-10 23:40:03.192813
NCT02337322|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-10-19|||April 2015||2015-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir|Immune Reconstitution in Severely Immunosuppressed Antiretroviral-naive HIV-1-Infected Patients (<100 CD4+ T Cells/μL) Taking Antiretroviral Regimens Based on Dolutegravir or Ritonavir-boosted Darunavir (the Advanz-4 Trial).|Recruiting||Phase 4|108|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-10 23:40:03.271981|2017-10-10 23:40:03.271981
NCT02337309|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-01|||July 2015||2015-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||SF1126 for Patients With Relapsed or Refractory Neuroblastoma|Phase I Study of SF1126 for Patients With Relapsed or Refractory Neuroblastoma|Recruiting||Phase 1|28|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-10-10 23:40:03.38594|2017-10-10 23:40:03.38594
NCT02337296|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-03-14|||January 2014||2014-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE|An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE|Completed||N/A|59|Actual|Michigan State University||3|||f||||f||||||||||2017-10-10 23:40:03.523589|2017-10-10 23:40:03.523589
NCT02337283|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2016-03-17|||January 2015||2015-01-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)|Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets Given Orally Once Daily for 12 Days to Young and Elderly Healthy Male and Female Volunteers (Randomised, Double-blind, Placebo-controlled Within Dose Groups Phase I Study)(Part 1) and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 After Oral Administration in the Morning Versus Oral Administration in the Evening in Young Healthy Male and Female Volunteers (Randomised, Two-sequence, Open, Two Period, Two-way Cross Over) (Part 2)|Completed||Phase 1|96|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-10 23:40:03.632115|2017-10-10 23:40:03.632115
NCT02337270|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-09-06|||September 5, 2017|Actual|2017-09-05|September 2017|2017-09-01|April 30, 2020|Anticipated|2020-04-30|December 31, 2019|Anticipated|2019-12-31||Interventional|||Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol|Phase 1, Open-label Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol|Recruiting||Phase 1|36|Anticipated|McMaster University||4|||f||||t|f|f||||||||2017-10-10 23:40:03.721146|2017-10-10 23:40:03.721146
NCT02337244|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-08-31|||November 2013||2013-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Zimmer POLAR Persona - TKA (EMEA Study)|Persona Outcomes Led Assessment Research in Total Knee Arthroplasty (POLAR - TKA)|Recruiting||N/A|600|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-10 23:40:03.955911|2017-10-10 23:40:03.955911
NCT02337231|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-05-18|||June 24, 2014|Actual|2014-06-24|May 2017|2017-05-01|December 15, 2015|Actual|2015-12-15|December 15, 2015|Actual|2015-12-15||Interventional|||Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils|Role of Fatty Acid Desaturase(s) (FADS) Polymorphisms in Determining the In Vivo Metabolism of Polyunsaturated Fatty Acids (PUFAs) in Botanical Oils in Humans.|Completed||N/A|66|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||Yes|Study recruitment has just been completed. Samples are beginning to be analysed and data will be shared when available|2017-10-10 23:40:04.113146|2017-10-10 23:40:04.113146
NCT02337218|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-06-21|||November 2014||2014-11-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Electrical Stimulation for Improving Balance in Diabetes|Electrical Stimulation for Improving Balance in Diabetes|Active, not recruiting||N/A|80|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-10 23:40:04.202194|2017-10-10 23:40:04.202194
NCT02337205|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-12-15|||December 2014||2014-12-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis|A Phase 1, Single-Center, Safety, Tolerability, and Pharmacokinetic Study of KX2 391 Ointment in Subjects With Actinic Keratosis|Completed||Phase 1|29|Actual|Kinex Pharmaceuticals Inc||1|||f||||f||||||||No||2017-10-10 23:40:04.293248|2017-10-10 23:40:04.293248
NCT02337192|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-01-08|||January 2014||2014-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Antimicrobial Photodynamic Therapy Applied in Orthodontic. Orthodontic Patients.|Oral Decontamination Using Antimicrobial Photodynamic Therapy Applied in Orthodontic Patients.|Completed||Phase 1|24|Actual|University of Sao Paulo||7|||f||||t||||||||||2017-10-10 23:40:04.382216|2017-10-10 23:40:04.382216
NCT02337179|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-05-01|||February 2011|Actual|2011-02-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|June 2014|Actual|2014-06-01||Interventional|||Male Circumcision Services for HIV Prevention in the Dominican Republic|A Pilot Study to Introduce Male Circumcision (MC) Services to Prevent HIV Infection in Two High Prevalence Areas of the Dominican Republic (DR)|Completed||N/A|539|Actual|University of Illinois at Chicago||1|||f||||f||||||||||2017-10-10 23:40:04.492764|2017-10-10 23:40:04.492764
NCT02337166|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||December 2002||2002-12-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Regeneration of Human Intrabony Defects With rhFGF-2/HA|Regeneration of Human Intrabony Defects With Recombinant Human Fibroblast Growth Factor 2 in a Hyaluronic Acid Gel Carrier - a Longitudinal, Prospective, Randomized Controlled Clinical Trial|Completed||Phase 1/Phase 2|30|Actual|Universidade Federal Fluminense||2|||f||||t||||||||||2017-10-10 23:40:04.594849|2017-10-10 23:40:04.594849
NCT02337153|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-11-19|||April 2014||2014-04-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|OBS||Ankylosed Teeth Treatment by Bone Orthodontic Treatment|Study of Validation of Measurements of the Movement of Stiff Treated Teeth and Orthodontic Corticotomy|Recruiting||N/A|40|Anticipated|University Hospital, Montpellier|||1||f||||f||||||||||2017-10-10 23:40:04.67285|2017-10-10 23:40:04.67285
NCT02337140|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-11-30|||August 2014||2014-08-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|TAVISTIM||Indication of Permanent Cardiac Parcing After Tanscatheter Aortic Valve Implantation|Indication of Permanent Cardiac Parcing After Tanscatheter Aortic Valve Implantation : Contribution of Electrophysioly Study|Completed||N/A|165|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:40:04.752416|2017-10-10 23:40:04.752416
NCT02337127|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-01-08|||June 2011||2011-06-01|January 2015|2015-01-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents|A Prospective, Open-label, Multicenter Study of Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents|Unknown status|Recruiting|Phase 4|500|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:40:04.842911|2017-10-10 23:40:04.842911
NCT02337114|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-12-09|||January 2015||2015-01-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|REACT||Recovery Enhancement From Traumatic Brain Injury Using Acceptance and Commitment Therapy - a Pilot Study.|REACT - Recovery Enhancement From TBI Using ACT. A Pilot Study.|Completed||Early Phase 1|47|Actual|University of Glasgow||2|||f||||f||||||||||2017-10-10 23:40:04.940079|2017-10-10 23:40:04.940079
NCT02337101|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-06-10|||March 2015||2015-03-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Early Intervention Programme for Young Patients (Aged 15 - 30 Years) With Symptoms Following Concussion.|Early Intervention Programme for Impairing Post-concussional Symptoms in Adolescents and Young Adults: Randomised Trial|Recruiting||N/A|120|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:40:05.022502|2017-10-10 23:40:05.022502
NCT02337088|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-08-28|||April 16, 2015|Actual|2015-04-16|August 2017|2017-08-01|August 28, 2017|Actual|2017-08-28|May 17, 2017|Actual|2017-05-17||Interventional|DCC||Delayed Cord Clamping in Very Low Birth Weight Infants|Delayed Cord Clamping at 30 vs. 60 Seconds for Very Low Birth Weight Infants: A Randomized Controlled Trial|Terminated||N/A|39|Actual|University of Chicago||2||Logistical reasons|f||||f||||||||||2017-10-10 23:40:05.121783|2017-10-10 23:40:05.121783
NCT02337075|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-06-27|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|PATH||PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities in Indigenous Communities|PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities Using Digital Technology in Indigenous Communities|Completed||N/A|60|Actual|University of British Columbia||2|||f||||f|f|f||||||No||2017-10-10 23:40:05.19846|2017-10-10 23:40:05.19846
NCT02337062|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-08-03|2017-07-07||February 2015||2015-02-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Phase IIIb Study of APD421 in Combination as PONV Prophylaxis|Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients|Completed||Phase 3|1147|Actual|Acacia Pharma Ltd|There were no limitations and caveats that occurred during the duration of this study.|2|||f||||t||||||||||2017-10-10 23:40:05.283438|2017-10-10 23:40:05.283438
NCT02337049|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-08|||September 2014||2014-09-01|January 2015|2015-01-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Observational|||Preeclampsia Subtypes and Surrogate Markers of CVD Risk||Unknown status|Recruiting|N/A|120|Anticipated|University of Aarhus|||3||f||||t||||||Samples With DNA|"     Blood serum. Blood plasma. Urine.   "|||2017-10-10 23:40:05.608497|2017-10-10 23:40:05.608497
NCT02337036|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-10-26|||December 2013||2013-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|TACTHEP||Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients|Building a Population Pharmacokinetic Model of Tacrolimus in Paediatric Liver Transplant Patients|Recruiting||N/A|80|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:40:05.685783|2017-10-10 23:40:05.685783
NCT02337023|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-07-20|||May 2011||2011-05-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|SCINTIK||Brain Scintigraphy in Normal Versus Kleine-Levin Syndrome Subjects|Brain Scintigraphy in Normal Versus Kleine-Levin Syndrome Subjects|Completed||N/A|56|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 23:40:05.771397|2017-10-10 23:40:05.771397
NCT02337010|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-08|||October 2010||2010-10-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Continuous Central Venous Oxygen Saturation Assisted Intraoperative Hemodynamic Management|Continuous Central Venous Oxygen Saturation Assisted Intraoperative Hemodynamic Management During Major Abdominal Surgery|Completed||N/A|79|Actual|Szeged University||2|||f||||f||||||||||2017-10-10 23:40:05.837536|2017-10-10 23:40:05.837536
NCT02336997|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2016-04-18|||January 2015||2015-01-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of the Effect of Autologous Fat and SVF Transplantation in Promoting Mechanical-stretch Induced in Vivo Skin Regeneration||Recruiting||Phase 1/Phase 2|60|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||||||||||||2017-10-10 23:40:06.034042|2017-10-10 23:40:06.034042
NCT02336984|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-09-22|||June 2014|Actual|2014-06-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS|A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS|Active, not recruiting||Phase 1/Phase 2|5|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-10 23:40:06.1487|2017-10-10 23:40:06.1487
NCT02336971|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-10-06|||November 2011||2011-11-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Individual PE vs Couples' CBT for Combat-Related Posttraumatic Stress Disorder|Individual Prolonged Exposure (PE) Versus Couples' Cognitive-Behavioral Therapy for Combat-Related Posttraumatic Stress Disorder (PTSD)|Completed||Phase 3|64|Actual|Ryerson University||2|||f||||t||||||||||2017-10-10 23:40:06.245513|2017-10-10 23:40:06.245513
NCT02336958|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-03-12|2015-03-12||September 2013||2013-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Ultrasound Guided Intermediate Cervical Plexus Block and Additional Perivascular Local Anesthetic Infiltration|Ultrasound Guided Intermediate Cervical Plexus Block -Randomized Evaluation Concerning the Significance of Additional Perivascular Local Anesthetic Infiltration|Completed||N/A|40|Actual|Helios Research Center||2|||f||||f||||||||||2017-10-10 23:40:06.361491|2017-10-10 23:40:06.361491
NCT02336945|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-09|2017-01-23|||January 2015||2015-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional|Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-Professional|Completed||N/A|146|Actual|Abbott Diabetes Care|||1||f||||f||||||||||2017-10-10 23:40:06.795999|2017-10-10 23:40:06.795999
NCT02336932|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-01-20|||February 2015||2015-02-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|February 2015|Actual|2015-02-01||Observational|||Vitamin D and the Free Hormone Hypothesis|Vitamin D and the Free Hormone Hypothesis: Lessons From Surgical Stress|Active, not recruiting||N/A|20|Actual|Rigshospitalet, Denmark|||1||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-10 23:40:06.909245|2017-10-10 23:40:06.909245
NCT02336919|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-04-24|||April 2015||2015-04-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|Txt2Prevent||The Use of Texting Messaging to Improve the Hospital-to-community Transition Period in Cardiovascular Disease Patients|The Use of Text Messaging to Improve the Hospital-community Transition and Prevent Readmission in Patients With Cardiovascular Disease (Txt2Prevent)|Completed||N/A|76|Actual|Simon Fraser University||2|||f||||f||||||||Undecided||2017-10-10 23:40:07.020256|2017-10-10 23:40:07.020256
NCT02336906|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-01-08|||January 2015||2015-01-01|January 2015|2015-01-01||||December 2018|Anticipated|2018-12-01||Interventional|||Urotherapy vs. Urotherapy With Constipation Treatment for Children With Lower Urinary Tract Dysfunction|A Controlled Randomized, Physician Blinded Study to Assess Isolated Uro-therapy vs. Urotherapy With Constipation Treatment for Patients With Lower Urinary Tract Dysfunction (LUTD) Not Meeting ROME-III Constipation Criteria|Not yet recruiting||Phase 4|110|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:40:07.136916|2017-10-10 23:40:07.136916
NCT02336893|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||August 2013||2013-08-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PACIENTE||A Semi-structured Interview PACIENTE Improves Communication With Family Members at the Intensive Care Unit|Result of an Intervention for the Group of Physicians Responsible for Providing Information on the Satisfaction of the Relatives of Patients Hospitalized in an Intensive Care Unit|Completed||N/A|245|Actual|Fundación Universitaria de Ciencias de la Salud||2|||f||||t||||||||||2017-10-10 23:40:07.25457|2017-10-10 23:40:07.25457
NCT02336880|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-08-19|||January 2015||2015-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2015|Actual|2015-03-01||Interventional|||Internet-delivered CBT for NCCP-patients - a Pilot Trial|Short-term Internet-delivered Cognitive Behavioural Therapy for Treatment of Cardiac Anxiety and Fear of Body Sensations in Patients With Non-cardiac Chest Pain - a Pilot Randomized Controlled Study|Completed||N/A|15|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-10 23:40:07.34983|2017-10-10 23:40:07.34983
NCT02336867|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-09-18|||January 2015||2015-01-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Interventional|FISCLOSE||Therapeutic Management of Complex Anal Fistulas by Installing a Closure Clip: Multicentre Randomized Controlled Trial|Therapeutic Management of Complex Anal Fistulas by Installing a Closure Clip: Multicentre Randomized Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|92|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:40:07.438912|2017-10-10 23:40:07.438912
NCT02336854|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-08-07|||January 12, 2015|Actual|2015-01-12|January 2015|2015-01-01|March 19, 2015|Actual|2015-03-19|February 2, 2015|Actual|2015-02-02||Interventional|||Tacrobell tab_Phase1_PK||Completed||Phase 1|50|Actual|Chong Kun Dang Pharmaceutical||2|||f||||||||||||||2017-10-10 23:40:07.529636|2017-10-10 23:40:07.529636
NCT02336841|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||January 2015||2015-01-01|January 2015|2015-01-01|October 2017|Anticipated|2017-10-01|December 2016|Anticipated|2016-12-01||Interventional|SHARED||Self-Help And Recovery Guide in Eating Disorders|A Study of the Feasibility and Effectiveness of the Addition of Self Help And Recovery Guide for Eating Disorders (SHARED) to Treatment as Usual for Anorexia Nervosa|Unknown status|Not yet recruiting|Early Phase 1|150|Anticipated|King's College London||2|||f||||f||||||||||2017-10-10 23:40:07.622019|2017-10-10 23:40:07.622019
NCT02336828|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-23|||January 2015||2015-01-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Observational|MEWS||Validation of Modified Early Warning Score (MEWS) in Predicting Outcomes in Clinical Oncology Ward Adult Patients|Validation of Modified Early Warning Score (MEWS) in Predicting Outcomes in Clinical Oncology Ward Adult Patients|Unknown status|Recruiting|N/A|171|Anticipated|Chinese University of Hong Kong|||1||f||||f||||||||||2017-10-10 23:40:07.723944|2017-10-10 23:40:07.723944
NCT02336815|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-09-22|||May 2015||2015-05-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|April 2018|Anticipated|2018-04-01||Interventional|STORM||Selinexor Treatment of Refractory Myeloma|A Phase 2b, Open-Label, Single-Arm Study of Selinexor (KPT-330) Plus Low-‑Dose Dexamethasone (Sd) in Patients With Multiple Myeloma Previously Treated With Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib, and an Anti-CD38 Monoclonal Antibody (mAb) Daratumumab, and Refractory to Prior Treatment With Glucocorticoids, an Immunomodulatory Agent, a Proteasome Inhibitor, and an the Anti-CD38 mAb Daratumumab|Recruiting||Phase 2|210|Anticipated|Karyopharm Therapeutics Inc||1|||f||||t||||||||||2017-10-10 23:40:07.817662|2017-10-10 23:40:07.817662
NCT02336802|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-02-05|||January 2016||2016-01-01|January 2015|2015-01-01|December 2018|Anticipated|2018-12-01|March 2017|Anticipated|2017-03-01||Observational|AVOID||Threat-Avoidance Learning in Anxiety Patients|The Experimental Study of Threat-Avoidance in Anxiety Patients: Behavioral, Emotional, and Neural Correlates|Not yet recruiting||N/A|80|Anticipated|Katholieke Universiteit Leuven|||4||f||||f||||||||||2017-10-10 23:40:08.119471|2017-10-10 23:40:08.119471
NCT02336789|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||December 2014||2014-12-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Proposal to Examine the Effect of Fecal Transplantation on Obesity|Proposal to Examine the Effect of Fecal Transplantation on Obesity.|Unknown status|Recruiting|N/A|20|Anticipated|Kaplan Medical Center||2|||f||||f||||||||||2017-10-10 23:40:08.211518|2017-10-10 23:40:08.211518
NCT02336776|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-08|||May 2014||2014-05-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||Functional Electrical Stimulation in Chronic Kidney Disease|Effects of Functional Electrical Stimulation on Muscle Architecture of Patients With Chronic Kidney Disease: Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|21|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||||2017-10-10 23:40:08.294804|2017-10-10 23:40:08.294804
NCT02336763|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-03-11|2016-02-12||October 2014||2014-10-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||only two subjects were enrolled|Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases|Prophylactic Hepatic Irradiation for Uveal Melanoma|Terminated||N/A|2|Actual|Jonsson Comprehensive Cancer Center||1||Closed due to lack of accrual|f||||t||||||||||2017-10-10 23:40:08.375945|2017-10-10 23:40:08.375945
NCT02336750|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2017-01-03|||December 2014||2014-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis|A Phase III Trial Comparing Dexamethasone, Aprepitant With or Without Mirtazapine in Delayed Emesis Control and Appetite Improvement|Recruiting||Phase 3|212|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-10 23:40:08.578632|2017-10-10 23:40:08.578632
NCT02336737|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-02-06||2017-02-06|January 2015||2015-01-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SentiMagIC||SentiMag® Intraoperative Comparison in Breast Cancer|A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure|Completed||N/A|160|Actual|Endomagnetics Inc||1|||f||||f||||||||||2017-10-10 23:40:08.671931|2017-10-10 23:40:08.671931
NCT02336724|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-01-31|||March 2012||2012-03-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor|A Single Arm, Open Label, Multicenter, Phase II Study of Famitinib in Patients With Gastrointestinal Stromal Tumor|Active, not recruiting||Phase 2|88|Actual|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:40:08.776679|2017-10-10 23:40:08.776679
NCT02336711|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-06-01|||November 2014||2014-11-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced SCC of the Oropharynx|Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced Squamous Cell Carcinoma of the Oropharynx: a Phase-I Study.|Recruiting||N/A|10|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-10 23:40:08.848129|2017-10-10 23:40:08.848129
NCT02336698|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-09-25||2017-09-06|July 13, 2015|Actual|2015-07-13|September 2017|2017-09-01|September 15, 2016|Actual|2016-09-15|September 15, 2016|Actual|2016-09-15||Interventional|||Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002|Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee|Completed||Phase 3|18|Actual|Janssen Research & Development, LLC||3|||f||||t|t|f||||||||2017-10-10 23:40:08.986397|2017-10-10 23:40:08.986397
NCT02336685|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-09-25||2017-09-06|July 7, 2015|Actual|2015-07-07|September 2017|2017-09-01|September 16, 2016|Actual|2016-09-16|September 16, 2016|Actual|2016-09-16||Interventional|||Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001|Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Adjunctive Therapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee|Completed||Phase 3|79|Actual|Janssen Research & Development, LLC||3|||f||||t|t|f||||||||2017-10-10 23:40:09.13855|2017-10-10 23:40:09.13855
NCT02336672|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-08-31|||November 2014||2014-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||EUS-Guided Cryothermal Ablation in Patients With Stage III Pancreatic Adenocarcinoma (HybridTherm Study)|EUS-Guided Cryothermal Ablation in Patients With Stage III (Locally Advanced and Borderline Resectable) Pancreatic Adenocarcinoma|Recruiting||Phase 2/Phase 3|66|Anticipated|IRCCS San Raffaele||2|||f||||t||||||||||2017-10-10 23:40:09.318115|2017-10-10 23:40:09.318115
NCT02336659|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-06-20|||April 2014||2014-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery|Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery|Completed||N/A|12|Actual|Hvidovre University Hospital||4|||f||||t||||||||||2017-10-10 23:40:09.391201|2017-10-10 23:40:09.391201
NCT02336646|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||July 2014||2014-07-01|January 2015|2015-01-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease|Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease|Unknown status|Recruiting|Phase 1|18|Anticipated|Taiwan Bio Therapeutics Co., Ltd.||3|||f||||t||||||||||2017-10-10 23:40:11.354147|2017-10-10 23:40:11.354147
NCT02336633|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-08-11|||July 2015||2015-07-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|REVHD||Resveratrol and Huntington Disease|Metabolic Intervention Using Resveratrol in Patients With Huntington Disease|Recruiting||Phase 3|102|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:40:11.50093|2017-10-10 23:40:11.50093
NCT02336620|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-04-25|||December 2014||2014-12-01|April 2017|2017-04-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||Balanced Salt Solution VS. Normal Saline Solution in Septic Shock|Balanced Salt Solution Versus Normal Saline Solution During Initial Resuscitation in Severe Sepsis or Septic Shock Children: A Randomized Controlled Trial|Completed||Phase 3|60|Actual|Ramathibodi Hospital||2|||f||||t||||||||||2017-10-10 23:40:11.582039|2017-10-10 23:40:11.582039
NCT02336607|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-03-13|2015-01-12||December 2005||2005-12-01|March 2015|2015-03-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional||Baseline characteristics are based on ITT group.|The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.|A Randomized, Open-label Study to Evaluate the Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release, Alone and in Combination With Metoprolol, Lisinopril or Hydrochlorothiazide, in Chinese Patients With Mild to Moderate Essential Hypertension.|Completed||N/A|529|Actual|AstraZeneca||4|||f||||||||||||||2017-10-10 23:40:11.680921|2017-10-10 23:40:11.680921
NCT02336581|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-09-18|||March 2015||2015-03-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|REACH||Researching the Effectiveness of Acceptance-Based Coping During Hospitalization|Effectiveness of Psychosocial Treatment for Inpatients With Psychosis|Completed||N/A|62|Actual|Butler Hospital||2|||f||||f||||||||||2017-10-10 23:40:12.480316|2017-10-10 23:40:12.480316
NCT02336568|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||March 2015||2015-03-01|January 2015|2015-01-01|March 2018|Anticipated|2018-03-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of 21-Days Intranasal Oxytocin on Patients With Post Traumatic Stress Disorder (PTSD)|The Effect of 21-Days Intranasal Oxytocin on Clinical Symptoms and Social Function in Patients With Post Traumatic Stress Disorder (PTSD), a Randomized Controled Trail|Not yet recruiting||Phase 4|40|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-10 23:40:12.71573|2017-10-10 23:40:12.71573
NCT02336555|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-03-11|||March 2015||2015-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012)|A Randomized Clinical Trial to Study the Efficacy, Safety, and Tolerability of MK-8291 in Subjects With Post-Herpetic Neuralgia With Allodynia|Completed||Phase 1|35|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 23:40:12.848436|2017-10-10 23:40:12.848436
NCT02336542|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-03-21|||November 2014||2014-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10|For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase IIb Clinical Research|Completed||Phase 2|192|Actual|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.||2|||f||||f||||||||No||2017-10-10 23:40:12.965322|2017-10-10 23:40:12.965322
NCT02336529|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-10-26|||July 2016||2016-07-01|October 2015|2015-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Nerveblocks for Persistent Pain After Breast Cancer Surgery|Tenderpoint and Ultrasound Guided Nerveblocks for Persistent Pain After Breast Cancer Surgery|Unknown status|Not yet recruiting|Phase 3|48|Anticipated|Rigshospitalet, Denmark||4|||f||||f||||||||||2017-10-10 23:40:13.098196|2017-10-10 23:40:13.098196
NCT02336516|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-10-07|||July 2015||2015-07-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|ZITHROSHU||Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome|Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome|Recruiting||N/A|148|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:40:13.183592|2017-10-10 23:40:13.183592
NCT02336503|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-12-17|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis|A Multicenter, Randomized, Double Blind, Vehicle-Controlled Study to Evaluate the Safety and Effect on Sweat Production of 3 Concentrations of Topically Applied BBI-4000 in Subjects With Axillary Hyperhidrosis|Completed||Phase 2|189|Actual|Brickell Biotech, Inc.||4|||f||||f||||||||||2017-10-10 23:40:13.290939|2017-10-10 23:40:13.290939
NCT02336490|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-10-28|||January 2015||2015-01-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Randomized Pilot Trial of the Impact of Bedside Delivery of Discharge Medications to Pediatric Patients With Asthma|Randomized Pilot Trial of the Impact of Bedside Delivery of Discharge Medications|Completed||N/A|23|Actual|Boston Medical Center||2|||f||||f||||||||||2017-10-10 23:40:13.422368|2017-10-10 23:40:13.422368
NCT02336477|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||June 2011||2011-06-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|MYOMEX||Mexiletine and Non Dystrophic Myotonias|Efficacy and Safety of Mexiletine in Non-dystrophic Myotonias|Completed||Phase 3|24|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:40:13.510983|2017-10-10 23:40:13.510983
NCT02336464|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-03-21|||January 2016||2016-01-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|DYSTRESS||Impact of Dyspnea on Patients in the Intensive Care Unit|Impact of DYSpnea on the ouTcome of Patients Admitted for an Acute RESpiratory Failure in the intenSive Care Unit|Recruiting||N/A|622|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-10 23:40:13.613604|2017-10-10 23:40:13.613604
NCT02336438|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-01-31|2015-07-24||May 2013||2013-05-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery|The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With RNY Gastric Bypass Surgery|Completed||Phase 4|10|Actual|Bassett Healthcare||2|||f||||f||||||||No||2017-10-10 23:40:14.01091|2017-10-10 23:40:14.01091
NCT02336425|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-08-07|2017-02-21||September 2015||2015-09-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma|A Multi-Center, Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of 52 Weeks Treatment With QGE031 Subcutaneous (s.c). in Asthma Patients Not Adequately Controlled by Medium- or High-dose Inhaled Corticosteroid (ICS) Plus Long Acting β2-agonist (LABA) With or Without Oral Corticosteroid (OCS)|Terminated||Phase 2|10|Actual|Novartis|Study was terminated due to the efficacy results from the Phase II study CQGE031B2201 (NCT01716754). Data analyses were not performed due to the very limited dataset (only 10 participants received study medication of the 440 participants planned).|4||"This study was terminated due to the efficacy results from an interim analysis (at the end of   treatment epoch) of the Phase II study CQGE031B2201 (NCT01716754)."|f||||t||||||||||2017-10-10 23:40:14.26307|2017-10-10 23:40:14.26307
NCT02336412|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-01-29|||January 2015||2015-01-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Short Message Service (SMS) Reminders for Stroke Secondary Preventative Medications|The Use of Short Message Service (SMS) as a Reminder for Continuation of Treatment With Secondary Preventative Medications After Stroke or TIA|Completed||N/A|10|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-10 23:40:14.954709|2017-10-10 23:40:14.954709
NCT02336399|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||January 2012||2012-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment|Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment|Unknown status|Active, not recruiting|N/A|120|Anticipated|Beijing Ditan Hospital|||1||f||||f||||||||||2017-10-10 23:40:15.034867|2017-10-10 23:40:15.034867
NCT02336386|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-01-12|||December 2014||2014-12-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma|Study of Cyclophosphamide，Liposome Doxorubicin Dexamethasone（CDD) Plus Bortezomib Compared With CDD in the Relapsed or Refractory Multiple Myeloma Combined With Extramedullary Plasmacytoma Patients|Unknown status|Recruiting|Phase 3|100|Anticipated|Beijing Chao Yang Hospital||2|||f||||f||||||||||2017-10-10 23:40:15.099851|2017-10-10 23:40:15.099851
NCT02336373|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2017-08-25|||December 2014||2014-12-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|February 2017|Actual|2017-02-01||Interventional|SCYTHE||Treatment of Hemoglobin SC Disease|SC Youth Treatment With Hydroxyurea Effects|Completed||Phase 2|32|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 23:40:15.209712|2017-10-10 23:40:15.209712
NCT02336360|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2016-01-21|||January 2015||2015-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Augmenting 18F-AV-1451 Dosimetry Estimates|A Multicenter Study to Obtain Data to Assist in Radiation Dosimetry Calculations From Subjects Enrolled in Human Studies Employing 18F-AV-1451|Completed||Phase 1|6|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-10 23:40:15.297985|2017-10-10 23:40:15.297985
NCT02336347|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-08|2015-07-10|||May 2014||2014-05-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||A Phase 1 Study Comparing AVP-786 With AVP-923|A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, 2-way Crossover Study Comparing AVP-786 With AVP-923|Completed||Phase 1|62|Actual|Avanir Pharmaceuticals||4|||f||||f||||||||||2017-10-10 23:40:15.37429|2017-10-10 23:40:15.37429
NCT02336334|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-07-18|||October 2014||2014-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of Posturing-Adherence in Patients After Intraocular Surgery|Measurement and Logging of Posturing Adherence of Patients After Intraocular Surgery With Gasendotamponades Using a Sensorsystem With Different Feedback-Methods|Completed||N/A|48|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 23:40:15.46736|2017-10-10 23:40:15.46736
NCT02336321|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-05-13|||April 2014||2014-04-01|March 2014|2014-03-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||Daily-life Brain Control Of A Hand Exoskeleton After Cervical Spinal Cord Injury|Restoration of Daily-life Hand Function Using a Brain/Neural-Computer Interaction (BNCI) System in Paralysis After Cervical Spinal Cord Injury|Completed||Phase 1|6|Actual|University Hospital Tuebingen||1|||f||||t||||||||||2017-10-10 23:40:15.555902|2017-10-10 23:40:15.555902
NCT02336308|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-11-24|||January 2015||2015-01-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients|A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients|Withdrawn||Phase 4|0|Actual|University of Colorado, Denver||2||Standard of care for dressing changes at the institution now includes treatment intervention|f||||f||||||||||2017-10-10 23:40:15.632888|2017-10-10 23:40:15.632888
NCT02336295|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-01-07|||February 2015||2015-02-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Developing and Validating a Food Frequency Questionnaires (FFQ) for the Vegan Population in Israel|Developing and Validating a Food Frequency Questionnaires (FFQ) for the Vegan Population in Israel|Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||||||||||||2017-10-10 23:40:15.732942|2017-10-10 23:40:15.732942
NCT02336282|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-06-21|||January 12, 2015|Actual|2015-01-12|January 2017|2017-01-01|June 9, 2017|Actual|2017-06-09|June 9, 2017|Actual|2017-06-09||Interventional|||Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia|Feasibility and Efficacy of Transcranial Direct Current Stimulation (tDCS) and Cognitive Training for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia|Completed||N/A|53|Actual|St. Jude Children's Research Hospital||2|||f||||f|f|t|f|f|t|||||2017-10-10 23:40:15.799249|2017-10-10 23:40:15.799249
NCT02336269|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-07|||October 2013||2013-10-01|January 2015|2015-01-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Observational|||Evaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics|Protocol For The Evaluation of Primex's PGX Assay|Recruiting||N/A|100000|Anticipated|Primex Clinical Laboratories, Inc.|||1||f||||t||||||Samples With DNA|"     Buccal swab   "|||2017-10-10 23:40:15.91028|2017-10-10 23:40:15.91028
NCT02336256|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-01-07|||January 2013||2013-01-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Plasma Total Antioxidant Status and Thiobarbituric Acid-reacting Substances in Patients With Inguinal Hernia|Plasma Total Antioxidant Status and Thiobarbituric Acid-reacting Substances in Patients With Inguinal Hernia Operated by Totally Extraperitoneal (TEP) or Single Incision Laparoscopic Surgery (SILS)|Completed||N/A|34|Actual|Poznan University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:40:15.973114|2017-10-10 23:40:15.973114
NCT02336243|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2015-11-03|||May 2015||2015-05-01|November 2015|2015-11-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders|Docosahexaenoic Acid (DHA) Supplementation During Pregnancy to Prevent Deep Placentation Disorders: A Randomized Clinical Trial and a Study of the Molecular Pathways of Abnormal Placentation Prevention|Recruiting||Phase 3|2400|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||||2017-10-10 23:40:16.042306|2017-10-10 23:40:16.042306
NCT02336230|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-08-01|||January 2015||2015-01-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD||Recruiting||Phase 3|60|Anticipated|Mesoblast, Ltd.||1|||f||||t||||||||||2017-10-10 23:40:16.182662|2017-10-10 23:40:16.182662
NCT02336217|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-06-06|||September 2014||2014-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|GEMApp||Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations|Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations|Recruiting||N/A|60|Anticipated|Marshall University||2|||f||||f||||||||||2017-10-10 23:40:16.351658|2017-10-10 23:40:16.351658
NCT02336204|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-01-07|||September 2011||2011-09-01|January 2015|2015-01-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Observational|||Alcohol Consumption Relation With Nutritional Knowledge and Body Weight|Effect of Alcohol Consumption and Nutritional Knowledge on Body Weight and Composition in a Group of Piacenza Students|Completed||N/A|104|Actual|Catholic University of the Sacred Heart|||1||f||||||||||||||2017-10-10 23:40:16.445808|2017-10-10 23:40:16.445808
NCT02336191|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2017-03-24|||June 2014||2014-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Observational|TGF||Monitoring Living Donor Liver Functions by Thromboelastometry|Monitoring Post-transplant Living Donor Liver Functions by Thromboelastometry. A Prospective Observational Study.|Completed||N/A|50|Actual|Mansoura University|||1||f||||f||||||||No||2017-10-10 23:40:16.494469|2017-10-10 23:40:16.494469
NCT02335996|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-08-31|||December 2014||2014-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Hyper-Cor||Hypercortisolism and Epicardial Adipose Tissue|Impact Hypercortisolism on Adipose Epicardial and on Myocardial Function|Recruiting||N/A|42|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:40:19.019086|2017-10-10 23:40:19.019086
NCT02336178|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-03-23|2017-01-09||January 2015|Actual|2015-01-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional||The baseline analysis population included all enrolled participants who received the study drug.|Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China|An Open-label, Single-arm, Post-authorization Pragmatic Clinical Trial On The Safety And Efficacy Of Benefix (Nonacog Alfa, Recombinant Factor Ix) In Subjects With Hemophilia B In Usual Care Settings In China|Completed||Phase 4|70|Actual|Pfizer||1|||f||||t||||||||||2017-10-10 23:40:16.680389|2017-10-10 23:40:16.680389
NCT02336165|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-02-14|||February 26, 2015||2015-02-26|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Phase 2 Study of MEDI4736 in Patients With Glioblastoma|Phase 2 Study to Evaluate the Clinical Efficacy and Safety of MEDI4736 in Patients With Glioblastoma (GBM)|Active, not recruiting||Phase 2|159|Actual|Ludwig Institute for Cancer Research||5|||f||||f||||||||||2017-10-10 23:40:17.59987|2017-10-10 23:40:17.59987
NCT02336152|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-07|||January 2015||2015-01-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Use of Onepiece Suit or Forced Warm Air for Perioperative Temperature Conservation.|Use of Onepiece Suit or Forced Warm Air for Perioperative Temperature Conservation.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:40:17.738923|2017-10-10 23:40:17.738923
NCT02336139|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2017-08-16|||March 2016||2016-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2017|Actual|2017-01-01||Interventional|SIMPLIFY||A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use|A Phase II, Open-label, Single Arm, Multicentre, International Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use|Active, not recruiting||Phase 2|103|Actual|Kirby Institute||1|||f||||t||||||||||2017-10-10 23:40:17.819006|2017-10-10 23:40:17.819006
NCT02336126|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-04-15|||October 2014||2014-10-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Biopsychological Intervention in Chronic Fatigue Syndrome - a Pilot Study||Completed||N/A|8|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-10 23:40:17.905513|2017-10-10 23:40:17.905513
NCT02336113|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-05-12|||August 2014||2014-08-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|OPERA||Effect of Pharmacist Intervention on Hospital Readmissions|Effect of Pharmacist Intervention on Hospital Readmissions|Recruiting||N/A|400|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:40:17.992117|2017-10-10 23:40:17.992117
NCT02336100|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-07|||June 2011||2011-06-01|January 2015|2015-01-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis|Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis|Completed||N/A|36|Actual|King Chulalongkorn Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:40:18.085434|2017-10-10 23:40:18.085434
NCT02336087|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-08-18|||January 2016||2016-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery|A Pilot Study of Gemcitabine, Abraxane, Metformin and a Standardized Dietary Supplement (DS) in Patients With Unresectable Pancreatic Cancer|Recruiting||Phase 1|21|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:40:18.16889|2017-10-10 23:40:18.16889
NCT02336074|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-03-13|||November 27, 2015|Actual|2015-11-27|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIVER||Research In Viral Eradication of HIV Reservoirs|Research In Viral Eradication of HIV Reservoirs|Active, not recruiting||Phase 2|59|Actual|Imperial College London||2|||f||||t||||||||||2017-10-10 23:40:18.298998|2017-10-10 23:40:18.298998
NCT02336061|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-12-28|||February 2015||2015-02-01|December 2015|2015-12-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Observational|IMPULSO||Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer|Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer.|Recruiting||N/A|1250|Anticipated|Asociación para la Investigación del Cáncer de Pulmón en Mujeres|||2||f||||t||||||||||2017-10-10 23:40:18.455922|2017-10-10 23:40:18.455922
NCT02336035|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-10-15|||January 2015||2015-01-01|October 2015|2015-10-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|DROC||Distal Radius Fractures in Patients Over 65 Years, Operation or Cast?|Unstable Distal Radius Fractures in Patients Over 65 Years. Conservative Treatment With Cast Immobilization Versus Volar Locking Plate. A Prospective Randomized Controlled Trial.|Recruiting||N/A|100|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:40:18.770738|2017-10-10 23:40:18.770738
NCT02336022|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-07-26|||March 2015||2015-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||The Evaluation of a Noninvasive Respiratory Monitor in Pediatric Patients Undergoing General Anesthesia|The Evaluation of a Noninvasive Respiratory Monitor in Pediatric Patients Undergoing General Anesthesia|Completed||N/A|90|Actual|Boston Children’s Hospital|||1||f||||||||||||||2017-10-10 23:40:18.854528|2017-10-10 23:40:18.854528
NCT02336009|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-10-05|||October 2014||2014-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Patient Perceived Outcome After Total Wrist Arthroplasty With a New Total Wrist Arthroplasty Implant|Clinical, Radiological and Patient Perceived Outcome After Total Wrist Arthroplasty With a New Total Wrist Arthroplasty Implant|Recruiting||Phase 2/Phase 3|20|Anticipated|Örebro University, Sweden||1|||f||||f||||||||||2017-10-10 23:40:18.932639|2017-10-10 23:40:18.932639
NCT02335983|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-04-26|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Phase 1b Study of Carfilzomib Administered Once Weekly in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma|Phase 1b Study of Carfilzomib Administered Once Weekly in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma|Recruiting||Phase 1|114|Anticipated|Amgen||6|||f||||f||||||||No||2017-10-10 23:40:19.091556|2017-10-10 23:40:19.091556
NCT02335970|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-12|||September 2005||2005-09-01|January 2015|2015-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery|Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery -a Randomized Controlled Trial|Completed||Phase 2|64|Actual|Göteborg University||2|||f||||f||||||||||2017-10-10 23:40:19.248153|2017-10-10 23:40:19.248153
NCT02335957|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-09-15|||April 2015||2015-04-01|September 2015|2015-09-01|April 2022|Anticipated|2022-04-01|December 2021|Anticipated|2021-12-01||Interventional|OPTIMAL||OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)|OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)|Recruiting||N/A|1422|Anticipated|Grupo de Investigación Clínica en Oncología Radioterapia||2|||f||||t||||||||||2017-10-10 23:40:19.320605|2017-10-10 23:40:19.320605
NCT02335931|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-01-11|||September 2014||2014-09-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|||Characterization of the Charcot Foot|Follow-up on Cross-sectional Study of Known Population With Charcot Osteoarthropathy - Metabolic, Physiologic and Pathologic Changes|Enrolling by invitation||N/A|49|Anticipated|Bispebjerg Hospital|||2||f||||f||||||Samples Without DNA|"     Frozen full blood samples   "|||2017-10-10 23:40:19.808679|2017-10-10 23:40:19.808679
NCT02335918|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-25|||January 2015||2015-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|April 2019|Anticipated|2019-04-01||Interventional|||A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors|A Phase l/ll Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered in Combination With Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors|Recruiting||Phase 1/Phase 2|205|Anticipated|Celldex Therapeutics||1|||f||||f||||||||||2017-10-10 23:40:19.892818|2017-10-10 23:40:19.892818
NCT02335905|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2016-06-24|||January 2015||2015-01-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children|Phase 1/2 Trial of Ceftaroline for the Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children|Recruiting||Phase 1/Phase 2|18|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-10 23:40:20.079387|2017-10-10 23:40:20.079387
NCT02335892|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-05-24|||November 11, 2014|Actual|2014-11-11|May 2017|2017-05-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Observational|PROFILE||PROFILE - Evaluation of QoL and PRO Outcomes in Patients Taking Fingolimod|Patient Reported Outcomes With Fingolimod in Local Experience (PROFILE)|Completed||N/A|114|Actual|Novartis|||1||f||||f||||||||||2017-10-10 23:40:20.17274|2017-10-10 23:40:20.17274
NCT02335879|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-09|||May 2008||2008-05-01|January 2015|2015-01-01||||August 2009|Actual|2009-08-01||Interventional|||Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation||Completed||Phase 3|534|Actual|GeneScience Pharmaceuticals Co., Ltd.||1|||f||||||||||||||2017-10-10 23:40:20.263304|2017-10-10 23:40:20.263304
NCT02335866|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2015-01-07|||January 2014||2014-01-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Interventional|||Platelet-Rich Fibrin in the Treatment of Multiple Gingival Recessions|Platelet Rich Fibrin Against Connective Tissue Graft in Treatment of Gingival Recessions|Completed||Early Phase 1|20|Actual|Necmettin Erbakan University||2|||f||||t||||||||||2017-10-10 23:40:20.337103|2017-10-10 23:40:20.337103
NCT02335853|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-09|||January 2015||2015-01-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|NGF||Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder|Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder|Unknown status|Recruiting|N/A|90|Anticipated|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||3||f||||f||||||||||2017-10-10 23:40:20.414011|2017-10-10 23:40:20.414011
NCT02335840|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-01-07|||March 2011||2011-03-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Doses of Coffee and Blood Pressure Response Post-exercise|Influence of Different Doses of Coffee in the Blood Pressure Response Post-exercise|Completed||N/A|12|Actual|Federal University of Paraíba||4|||f||||t||||||||||2017-10-10 23:40:20.493051|2017-10-10 23:40:20.493051
NCT02335827|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Renal Tumors|Irreversible Electroporation (IRE) for Unresectable Renal Tumors: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|15|Anticipated|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:40:20.57769|2017-10-10 23:40:20.57769
NCT02335814|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-09-21|||January 2015||2015-01-01|September 2017|2017-09-01||||March 2018|Anticipated|2018-03-01||Interventional|||First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia|Phase 1/1b, First-in-Human, Dose-Escalation and Expansion Study of FLX925 Administered Orally to Subjects With Relapsed or Refractory Acute Myeloid Leukemia|Terminated||Phase 1|123|Anticipated|FLX Bio, Inc.||1||Dose escalation completed; Sponsor decision|f||||f||||||||||2017-10-10 23:40:20.678569|2017-10-10 23:40:20.678569
NCT02335801|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-01-09|||April 2013||2013-04-01|December 2014|2014-12-01|January 2018|Anticipated|2018-01-01|June 2015|Anticipated|2015-06-01|30 Months|Observational [Patient Registry]|TOSCA||The TOSCA Registry: Hormonal and Metabolic Deficiencies in Chronic Heart Failure|The TOSCA Registry: Epidemiology, Clinical and Prognostic Value of Hormonal and Metabolic Deficiencies in Chronic Heart Failure|Recruiting||N/A|650|Anticipated|Federico II University|||1||f||||t||||||Samples Without DNA|"     serum for determination of hormonal levels   "|||2017-10-10 23:40:20.777254|2017-10-10 23:40:20.777254
NCT02335775|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-01-20|||July 2008||2008-07-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Observational|||Lymph Node Counts in Endometrial Cancer Staging|A Prospective Study of the Impact of Surgical and Pathologic Tissue Sampling Methods on Lymph Node Counts and Detection of Lymph Node Metastasis in Endometrial Cancer Staging|Completed||N/A|120|Actual|Duke University|||1||f||||||||||||||2017-10-10 23:40:20.991209|2017-10-10 23:40:20.991209
NCT02335762|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-01-13|||January 2012||2012-01-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Observational|||Dietary Conjugated Linoleic Acid (CLA) Intake Among Students in Italy|Dietary Intake of Conjugated Linoleic Acid in a Cohort of Healthy Students in Italy|Completed||N/A|40|Actual|Catholic University of the Sacred Heart|||1||f||||||||||||||2017-10-10 23:40:21.049651|2017-10-10 23:40:21.049651
NCT02335749|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-06-20|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|DST||Distal Thigh Study|CoolSculpting the Distal Thigh|Completed||N/A|40|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-10 23:40:21.099916|2017-10-10 23:40:21.099916
NCT02335736|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-02-12|||January 2015||2015-01-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|August 2015|Actual|2015-08-01||Interventional|||Antagonist Protocol in IVF|Can Antagonist Protocol be the Protocol of Choice in in Vitro Fertilization Patients?|Recruiting||Phase 2|200|Anticipated|Woman's Health University Hospital, Egypt||3|||f||||t||||||||||2017-10-10 23:40:21.174418|2017-10-10 23:40:21.174418
NCT02335723|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-06-27|||September 2015||2015-09-01|June 2017|2017-06-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|ASSET||ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber|Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber|Terminated||N/A|15|Actual|Alteco Medical AB||2||Problem to find eligible patients to include|f||||f||||||||No||2017-10-10 23:40:21.280181|2017-10-10 23:40:21.280181
NCT02335710|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-09-09|2016-07-15||July 2014||2014-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Optimized Loading Response by JOURNEY II BCS Knee Increases Daily Physical Activity and Functions|In Vivo Comparison of Knee Kinematics for Subjects Implanted With a Smith & Nephew Journey Posterior Stabilizing (PS) Total Knee Arthroplasty (TKA) and Subjects Having a Normal Knee|Completed||N/A|50|Actual|The University of Tennessee, Knoxville|||2||f||||f||||||||No||2017-10-10 23:40:21.395751|2017-10-10 23:40:21.395751
NCT02335697|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-04-28|||November 2014||2014-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Community-based Participatory Intervention to Change Attitudes Towards Female Circumcision Among Somali Immigrants in Sweden|A Community-based Participatory Intervention to Change Attitudes Towards Female Circumcision Among Somali Immigrants in Sweden: a Cluster Randomized Controlled Trial|Completed||N/A|372|Actual|Uppsala University||2|||f||||t||||||||||2017-10-10 23:40:21.854671|2017-10-10 23:40:21.854671
NCT02335684|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-10-26|||November 2013||2013-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effects of Increased CF-LVAD Pump Speed During Sustained Submaximal Exercise|Improving Functional Capacity in Heart Failure Patients Supported With Continuous-flow Left Ventricular Assist Devices. -Effects of Increased Pump Speed During Sustained Submaximal Exercise|Completed||N/A|31|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 23:40:21.93404|2017-10-10 23:40:21.93404
NCT02335671|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-08-01|||February 2015||2015-02-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy|Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy|Recruiting||Phase 2|43|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:40:22.027076|2017-10-10 23:40:22.027076
NCT02335658|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-07-23|||December 2014||2014-12-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Long-term Study of DSP-5423P in Patients With Schizophrenia|Long-term Study of DSP-5423P in Patients With Schizophrenia <Phase 3>|Completed||Phase 3|203|Actual|Sumitomo Dainippon Pharma Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:40:22.120272|2017-10-10 23:40:22.120272
NCT02335645|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-11-18|||January 2015||2015-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||AlterG ACL Return to Running Case Series|AlterG ACL Return to Running Case Series|Completed||N/A|5|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 23:40:22.190172|2017-10-10 23:40:22.190172
NCT02335619|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-04-14|||February 2015||2015-02-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Early Integrated Supportive Care Study for Gastrointestinal Cancer Patients|Early Integrated Supportive Care Study for Gastrointestinal Cancer Patients|Unknown status|Recruiting|N/A|152|Anticipated|British Columbia Cancer Agency||2|||f||||f||||||||||2017-10-10 23:40:22.344011|2017-10-10 23:40:22.344011
NCT02335606|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-09-26|||October 6, 2013|Actual|2013-10-06|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31|2 Years|Observational [Patient Registry]|||Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan|Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Multi-center Observational Study in Taiwan|Active, not recruiting||N/A|318|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 23:40:22.413304|2017-10-10 23:40:22.413304
NCT02335593|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-01-09|||December 2014||2014-12-01|January 2015|2015-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Efficacy Study of Zinc Supplementation on Anemia, Oxidative Stress and Inflammation in Hemodialysis Patients|Evaluation of the Effect of Zinc Supplementation on the Health Status of Hemodialysis Patients|Unknown status|Recruiting|Phase 2|60|Anticipated|Ain Shams University||2|||f||||f||||||||||2017-10-10 23:40:22.481602|2017-10-10 23:40:22.481602
NCT02335580|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-08-08|||January 2015||2015-01-01|August 2016|2016-08-01||||December 2016|Anticipated|2016-12-01||Observational|||Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis|Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis: A Single-center, Prospective, Cohort Study|Recruiting||N/A|200|Anticipated|General Hospital of Shenyang Military Region|||1||f||||f||||||||||2017-10-10 23:40:22.566911|2017-10-10 23:40:22.566911
NCT02335567|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-09-15|||June 2012||2012-06-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|3TMR||Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms|Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms|Completed||N/A|162|Actual|Michigan State University|||1||f||||f||||||||||2017-10-10 23:40:22.662045|2017-10-10 23:40:22.662045
NCT02335554|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-09|||August 2012||2012-08-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|WorkDep||Internet Program for Workers With Subthreshold Depression|Multimedia Internet-Based Program for Workers With Subthreshold Depression|Completed||N/A|300|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 23:40:22.724744|2017-10-10 23:40:22.724744
NCT02335528|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-08|||October 2012||2012-10-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||SimCoach Evaluation: A Virtual Human Intervention to Encourage Servicemember Help-seeking for PTSD and Depression|SimCoach Evaluation: A Virtual Human Intervention to Encourage Servicemember Help-seeking for PTSD and Depression|Completed||N/A|333|Actual|RAND||3|||f||||t||||||||||2017-10-10 23:40:22.934166|2017-10-10 23:40:22.934166
NCT02335515|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-08|||September 2014||2014-09-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||The Gastric Residence Time (GRT) of Soctec Capsule After a Standardized Breakfast|Gastric Retention Time of Floating Gastro-Retentive Capsules in Male Healthy Subjects After Breakfast as Measured by Magnetic Resonance Imaging (MRI)|Unknown status|Active, not recruiting|Early Phase 1|15|Anticipated|SkyePharma AG||1|||f||||f||||||||||2017-10-10 23:40:23.018811|2017-10-10 23:40:23.018811
NCT02335502|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-08-10|2017-03-06||April 2012||2012-04-01|August 2017|2017-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||A Post Market Study to Assess the Spinal Modulation Neurostimulator System for Chronic Intractable Pain|A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Intractable Pain|Completed||N/A|66|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-10 23:40:23.104401|2017-10-10 23:40:23.104401
NCT02335489|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-08-28|2017-04-24||March 2013||2013-03-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg|A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg|Terminated||N/A|10|Actual|St. Jude Medical|||1|"A significant local issue has to led to the suspension of recruitment, this study will be   terminated in the coming months"|f||||f||||||||||2017-10-10 23:40:23.364647|2017-10-10 23:40:23.364647
NCT02335476|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-10-13|||March 2015||2015-03-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Automatic Early Melanoma Detection by Ultrahigh Resolution Three Dimensional Optical Coherence Tomography|Automatic Early Melanoma Detection by Ultrahigh Resolution Three Dimensional Optical Coherence Tomography|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:40:23.582252|2017-10-10 23:40:23.582252
NCT02335463|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-10-13|||May 2014||2014-05-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||3D Single Cell Analysis Using Cell Morphology and Organelle Scattering Texture|3D Single Cell Analysis Using Cell Morphology and Organelle Scattering Texture|Recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:40:23.67937|2017-10-10 23:40:23.67937
NCT02335450|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-03-28|||January 2015||2015-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Theory Based Intervention Program to Support Physical Activity for Individuals With Multiple Sclerosis: a Case Series|Theory Based Intervention Program to Support Physical Activity for Individuals With Multiple Sclerosis: a Case Series|Completed||N/A|5|Actual|Oakland University||1|||f||||f||||||||Yes|Manuscript in process|2017-10-10 23:40:23.765748|2017-10-10 23:40:23.765748
NCT02335437|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-06-27|||March 2015|Actual|2015-03-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Observational|CEBA||Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents|Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents|Completed||N/A|270|Anticipated|University Hospital, Akershus|||2||f||||f||||||||||2017-10-10 23:40:23.873054|2017-10-10 23:40:23.873054
NCT02335424|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-08-18|||February 24, 2015|Actual|2015-02-24|August 2017|2017-08-01|June 21, 2018|Anticipated|2018-06-21|June 21, 2018|Anticipated|2018-06-21||Interventional|||Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)|A Phase II Clinical Trial of Pembrolizumab (MK-3475) in Subjects With Advanced/Unresectable or Metastatic Urothelial Cancer|Active, not recruiting||Phase 2|350|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 23:40:23.962503|2017-10-10 23:40:23.962503
NCT02335411|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-03-07|||February 2015||2015-02-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|November 2016|Actual|2016-11-01||Interventional|||A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)|A Phase II Clinical Trial of Pembrolizumab as Monotherapy and in Combination With Cisplatin+5-Fluorouracil in Subjects With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (KEYNOTE-059)|Active, not recruiting||Phase 2|253|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:40:24.073363|2017-10-10 23:40:24.073363
NCT02335398|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-07|||July 2011||2011-07-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management|Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management|Completed||Phase 4|34|Actual|Mahidol University||1|||f||||t||||||||||2017-10-10 23:40:24.185446|2017-10-10 23:40:24.185446
NCT02335385|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-07|||June 2009||2009-06-01|January 2015|2015-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Single Incision Laparoscopic Varicocelectomy|Single Incision Transumbilical Laparoscopic Varicocelectomy: Comparison With the Conventional Laparoscopic Approach.|Completed||N/A|90|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:40:24.29395|2017-10-10 23:40:24.29395
NCT02335372|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-04-25|||June 2013|Actual|2013-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Cervical Cancer Screening Study in Brazil|A Pilot Study of a Low-Cost Optical Imaging Tool for Cervical Cancer Screening in Brazil|Active, not recruiting||N/A|300|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:40:24.380425|2017-10-10 23:40:24.380425
NCT02335359|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-03-04|||March 2015||2015-03-01|March 2015|2015-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Tranexamic Acid in Major Vascular Surgery|Tranexamic Acid in Major Vascular Surgery. A Randomized Placebo-controlled Trial.|Unknown status|Recruiting|Phase 4|100|Anticipated|IRCCS San Raffaele||2|||f||||||||||||||2017-10-10 23:40:24.486671|2017-10-10 23:40:24.486671
NCT02335333|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-03-06|||January 2015||2015-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Biomarkers of Aging as Predictors of Kidney Transplant Function|Clinical Utility of Biomarkers of Aging as Predictors of Kidney Graft Function in Extended Criteria Organ Recipients|Completed||N/A|35|Actual|HealthSpan Dx|||1||f||||f||||||Samples With DNA|"     T lymphocytes, plasma and white blood cells isolated from peripheral blood sample will be     stored.   "|||2017-10-10 23:40:24.697865|2017-10-10 23:40:24.697865
NCT02335320|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-03-20|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|ANRS HC POC||Qualification of Point-of-Care Assays for Management of HCV Patients|Qualification of Point-of-Care Assays for Management of HCV Patients|Unknown status|Recruiting|N/A|250|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f||||||||||2017-10-10 23:40:24.785774|2017-10-10 23:40:24.785774
NCT02335307|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-09-22|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|January 30, 2018|Anticipated|2018-01-30||Observational|||Implementing Genomics in Practice (IGNITE) Proof of Concept Study: Genotyping in Family Medicine Clinics|Implementing Genomics in Practice (IGNITE) Proof of Concept Study: Genotyping in Family Medicine Clinics|Recruiting||N/A|600|Anticipated|University of Florida|||3||f||||f|f|f||||Samples With DNA|"     genotype   "|||2017-10-10 23:40:24.862575|2017-10-10 23:40:24.862575
NCT02335294|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-09-02|||December 2014||2014-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||A Study of TRV130 for the Treatment of Pain After Abdominoplasty|A Phase 2, Randomized, Double-Blind, Placebo- and Active-controlled Study of TRV130 for the Treatment of Acute Postoperative Pain Following Abdominoplasty|Completed||Phase 2|200|Actual|Trevena Inc.||3|||f||||f||||||||||2017-10-10 23:40:24.990873|2017-10-10 23:40:24.990873
NCT02335281|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2015-01-08|||January 2015||2015-01-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|SFMT-IBD||Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease|Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Inflammatory Bowel Disease|Recruiting||Phase 2|40|Anticipated|Third Military Medical University||2|||f||||t||||||||||2017-10-10 23:40:25.093053|2017-10-10 23:40:25.093053
NCT02335268|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-05-09|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|July 2018|Anticipated|2018-07-01||Interventional|EUROPE||VALIDATION OF A PREDICTIVE MODEL OF RESPONSE TO ROMIPLOSTIM IN PATIENTS WITH IPSS LOW OR INTERMEDIATE-1 RISK MDS AND THROMBOCYTOPENIA|PROSPECTIVE VALIDATION OF A PREDICTIVE MODEL OF RESPONSE TO ROMIPLOSTIM IN PATIENTS WITH IPSS LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROME (MDS) AND THROMBOCYTOPENIA - THE EUROPE-TRIAL|Recruiting||Phase 2|90|Anticipated|Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH||3|||f||||t||||||||||2017-10-10 23:40:25.189585|2017-10-10 23:40:25.189585
NCT02335255|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-05-03|||June 2014||2014-06-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis|A Multi-Center, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® (Naftifine Hydrochloride) Gel 2% in Patients With Tinea Pedis.|Completed||Phase 1|690|Actual|Taro Pharmaceuticals USA||3|||f||||f|t|f|||f|||No||2017-10-10 23:40:25.32003|2017-10-10 23:40:25.32003
NCT02335242|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-05-09|||May 23, 2015|Actual|2015-05-23|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|April 2021|Anticipated|2021-04-01||Interventional|||Sildenafil for the Treatment of Lymphatic Malformations|Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations|Recruiting||Phase 2|40|Anticipated|Stanford University||2|||f||||t|t|f||||||No|The IPD will only be shared de-identified to our study staff and human subjects approved subsites. These results will eventually be published, but will be completed around 2022.|2017-10-10 23:40:25.430477|2017-10-10 23:40:25.430477
NCT02335190|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-05-08|||September 2015||2015-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study|Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study|Active, not recruiting||N/A|31|Actual|Western University, Canada||1|||f||||f||||||||||2017-10-10 23:40:26.812226|2017-10-10 23:40:26.812226
NCT02335177|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-05-24|||February 2015||2015-02-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|T4H||Technology and Human Help at Home After Hospitalisation|Technology and Human Help at Home After Hospitalisation (T4H): a Randomized Clustered Controlled Trial|Completed||N/A|36|Actual|Ages et Vies Association||2|||f||||f||||||||||2017-10-10 23:40:26.91271|2017-10-10 23:40:26.91271
NCT02335164|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2017-05-10|||July 2015||2015-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|FLU003||A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults|A Randomised, Controlled, Blinded Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian H5 Influenza Vaccine in Adults|Recruiting||Phase 1|270|Anticipated|Vaxine Pty Ltd||9|||f||||f||||||||Undecided||2017-10-10 23:40:27.020453|2017-10-10 23:40:27.020453
NCT02335151|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2016-11-02|||October 2016||2016-10-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||CTC Pancreatic Adenocarcinoma|Resectable Pancreatic Adenocarcinoma - Does the Type of Anesthesia Have an Impact on Circulating Tumor Cells?|Recruiting||Phase 4|56|Anticipated|University of Zurich||2|||f||||f||||||||No|Data will not be shared|2017-10-10 23:40:27.151489|2017-10-10 23:40:27.151489
NCT02335138|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-06-09|||April 2016||2016-04-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Project Nexus: Providing Online Counseling for Home-Based HIV Testing|Project Nexus: Providing Online Counseling for Home-Based HIV Testing|Recruiting||N/A|350|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-10 23:40:27.269906|2017-10-10 23:40:27.269906
NCT02335125|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-04-22|||February 2015||2015-02-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|August 2015|Actual|2015-08-01||Interventional|TSOS 6||A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot||Active, not recruiting||N/A|80|Anticipated|University of Washington||4|||f||||t||||||||||2017-10-10 23:40:27.384236|2017-10-10 23:40:27.384236
NCT02335112|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms|Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|15|Anticipated|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:40:27.464988|2017-10-10 23:40:27.464988
NCT02335099|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis|Randomized, Placebo-controlled, Single Blind, Trial to Determine the Safety and Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis|Recruiting||Phase 1/Phase 2|88|Anticipated|University of Virginia||2|||f||||f||||||||No||2017-10-10 23:40:27.561084|2017-10-10 23:40:27.561084
NCT02335086|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-02-21|||September 2014||2014-09-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|DECODE||DNA Damage & Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease|DNA Damage and Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease|Completed||N/A|126|Actual|University of Surrey|||2||f||||f||||||Samples With DNA|"     Whole blood, plasma, serum, white blood cells   "|||2017-10-10 23:40:27.684061|2017-10-10 23:40:27.684061
NCT02335073|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-08-08|||January 2015||2015-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis|Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis: A Single-center, Prospective, Observational Study|Completed||N/A|108|Actual|General Hospital of Shenyang Military Region|||1||f||||f||||||None Retained|"     Venous blood   "|No||2017-10-10 23:40:29.962196|2017-10-10 23:40:29.962196
NCT02335060|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-04-25|||March 2014||2014-03-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||N-acetylcysteine Effects on Tetrahydrocannabinol|Effect of N-acetylcysteine on the Acute Cognitive Effects of Delta-9-Tetrahydrocannabinol|Active, not recruiting||Phase 1|36|Anticipated|Yale University||4|||f||||t||||||||||2017-10-10 23:40:30.03185|2017-10-10 23:40:30.03185
NCT02335047|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-10-01|||January 2015||2015-01-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Investigation of the Putative Correlation Between Involuntary Psoas Activity During Passive Flexion of the Trunk at the Hips|The Putative Correlation Between Impaired Hip Flexor Passivity and Common Lower Back Pain: a Pilot Study.|Completed||Phase 4|90|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 23:40:30.120539|2017-10-10 23:40:30.120539
NCT02335034|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-11-01|||December 2014||2014-12-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Project Arthritis Recovering Quality of Life by Means Education II (PARQVE II)|Project Osteoarthritis: Recovering Quality of Life by Means Education II (PARQVE II) - A Prospective Randomized Study Comparing the Multidisciplinary Care Associated With Education to Multidisciplinary Treatment Without Education.|Active, not recruiting||N/A|152|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:40:30.187214|2017-10-10 23:40:30.187214
NCT02335021|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-10-09|||January 2015||2015-01-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|AFS-adult||The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adults|The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adults|Recruiting||N/A|120|Anticipated|Yale University||4|||f||||t||||||||Undecided||2017-10-10 23:40:30.279447|2017-10-10 23:40:30.279447
NCT02335008|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-07-14|||September 2014||2014-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|AFS_pilot||The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity and Preference - Pilot|The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity and Preference - Pilot Study|Completed||N/A|30|Actual|Yale University||2|||f||||t||||||||||2017-10-10 23:40:30.364031|2017-10-10 23:40:30.364031
NCT02334995|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2016-01-24|||January 2014||2014-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||The Biofeedback Therapy in Solitery Rectal Ulser Patients BIOFEEDBACK THERAPY|The Biofeedback Therapy in Solitery Rectal Ulser Patients|Recruiting||N/A|40|Anticipated|Ege University|||1||f||||f||||||||||2017-10-10 23:40:30.431063|2017-10-10 23:40:30.431063
NCT02334982|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-29|2015-01-29||June 2013||2013-06-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single Doses of TAK-137 in Healthy Subjects|Completed||Phase 1|47|Actual|Takeda||7|||f||||f||||||||||2017-10-10 23:40:30.518402|2017-10-10 23:40:30.518402
NCT02334969|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-06-17|||April 2016||2016-04-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM|A Multi-center, Randomized, Double-blind and Placebo-controlled Clinical Research of 2200 Cases in Improving Curative Effect of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM|Recruiting||Phase 4|2200|Anticipated|ShuGuang Hospital||2|||f||||t||||||||Yes||2017-10-10 23:40:32.436034|2017-10-10 23:40:32.436034
NCT02334956|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-08-08|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|MobiCogIm||Linking fMRI to Mobile Technologies in Addiction Research: Pathophysiology of Executive Deficits, Craving and Substance Use|Linking fMRI to Mobile Technologies in Addiction Research: Pathophysiology of Executive Deficits, Craving and Substance Use|Recruiting||N/A|120|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:40:32.607064|2017-10-10 23:40:32.607064
NCT02334943|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-11-19|||March 2015||2015-03-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ACTIVIH||Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment|Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment: Etiologic Factors, Forms and Potential Association With Chronic Comorbidities Unrelated to Immune Deficiency.|Completed||N/A|140|Actual|University Hospital, Montpellier||3|||f||||t||||||||||2017-10-10 23:40:32.707702|2017-10-10 23:40:32.707702
NCT02334930|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-08-19|||April 2015||2015-04-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|PEC-Hem||Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors|Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors|Completed||N/A|13|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 23:40:32.798663|2017-10-10 23:40:32.798663
NCT02334917|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-01-06|||January 2015||2015-01-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Comparison of Fast-Absorbing Sutures for Mohs Surgery|Comparison of Fast-Absorbing Sutures for Mohs Surgery Repair on the Face (ComFAS): a Randomized Controlled Split-scar Study|Unknown status|Not yet recruiting|Early Phase 1|100|Anticipated|University of British Columbia||1|||f||||t||||||||||2017-10-10 23:40:33.020875|2017-10-10 23:40:33.020875
NCT02334904|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-05-30|||July 2014||2014-07-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|CARB||Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI|Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI|Recruiting||N/A|60|Anticipated|University of British Columbia|||3||f||||f||||||Samples With DNA|"     Participants will be offered the option of taking part in an optional biobanking component of     the main study. Eight milliliters of whole blood samples will be collected and stored at -80     degrees Celsius for genotyping to determine if certain genetic polymorphisms predispose     individuals to brain changes while taking antipsychotic medications.   "|||2017-10-10 23:40:33.116274|2017-10-10 23:40:33.116274
NCT02334891|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2017-03-14|||October 2014||2014-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|1 Year|Observational [Patient Registry]|KCHF||Kyoto Congestive Heart Failure Study|Kyoto Congestive Heart Failure Study|Recruiting||N/A|2000|Anticipated|Kyoto University, Graduate School of Medicine|||1||f||||f||||||||||2017-10-10 23:40:33.245415|2017-10-10 23:40:33.245415
NCT02334878|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2017-09-07|||October 1, 2015|Actual|2015-10-01|September 2017|2017-09-01|December 1, 2016|Actual|2016-12-01|October 30, 2016|Actual|2016-10-30||Interventional|||Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence|Autologous Bone Marrow-derived Mesenchymal Stem Cells Versus Tension-free Vaginal Tape for Treatment of Female Stress Urinary Incontinence: An Open-label Clinical Trial|Completed||Phase 3|50|Actual|Ain Shams Maternity Hospital||2|||f||||f||||||||||2017-10-10 23:40:33.349735|2017-10-10 23:40:33.349735
NCT02334865|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-07-08|||March 9, 2016|Actual|2016-03-09|July 2017|2017-07-01|November 9, 2019|Anticipated|2019-11-09|November 9, 2018|Anticipated|2018-11-09||Interventional|||SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy|A Phase I Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH in Patients With Multiple Myeloma Receiving Lenalidomide Maintenance Therapy|Recruiting||Phase 1|18|Anticipated|Roswell Park Cancer Institute||2|||f||||f||||||||||2017-10-10 23:40:33.442114|2017-10-10 23:40:33.442114
NCT02334852|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-04-10|||December 2014||2014-12-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01|2 Years|Observational [Patient Registry]|CARMEN-AF||Registry of Atrial Fibrillation and Embolic Risk in Mexico|Registry of Atrial Fibrillation and Embolic Risk in Mexico|Completed||N/A|1200|Actual|Registro de Fibrilación Auricular y Riesgo Embólico en México|||1||f||||f||||||||||2017-10-10 23:40:33.556027|2017-10-10 23:40:33.556027
NCT02334839|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-06|||September 2014||2014-09-01|January 2015|2015-01-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|||The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction|The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction|Unknown status|Recruiting|N/A|150|Anticipated|Rabin Medical Center|||3||f||||t||||||||||2017-10-10 23:40:33.623387|2017-10-10 23:40:33.623387
NCT02334826|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-11-24|||February 2015||2015-02-01|November 2016|2016-11-01|August 2022|Anticipated|2022-08-01|September 2017|Anticipated|2017-09-01||Interventional|RELEASE-BVS||Revascularization With BVS or CABG in Patients With Advanced CAD|Revascularization With the Use of Biodegradable Scaffolds Compared to CABG in Patients With Advanced Stable Ischemic Heart Disease|Terminated||Phase 4|11|Actual|Poznan University of Medical Sciences||2||"slow enrollment in one site and withdrawal of the second site prior to enrollment of first   participant;"|f||||t||||||||||2017-10-10 23:40:33.718018|2017-10-10 23:40:33.718018
NCT02334813|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-05-04|2017-05-04||July 2002||2002-07-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|EIS2002||Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia|A Randomized Trial of Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia|Completed||Phase 3|26|Actual|University Hospital, Essen||2|||f||||f||||||||No||2017-10-10 23:40:33.810045|2017-10-10 23:40:33.810045
NCT02334787|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-08-09|2016-06-07||January 2015||2015-01-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects|A Single-center, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Assess the Safety and Pharmacokinetics of OPA-15406 Ointment in Healthy Adult Male Subjects (Phase 1 Trial)|Completed||Phase 1|32|Actual|Otsuka Pharmaceutical Co., Ltd.||8|||f||||f||||||||||2017-10-10 23:40:34.159108|2017-10-10 23:40:34.159108
NCT02334774|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-08-07|||January 2015||2015-01-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of An Oral Swallowing Care Program on Swallowing and Oral Intake Status in Patients Following Prolonged Endotracheal Intubation|Effects of An Oral Swallowing Care Program on Swallowing and Oral Intake Status in Patients Following Prolonged Endotracheal Intubation|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-10 23:40:34.598551|2017-10-10 23:40:34.598551
NCT02334761|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-09-19|||January 2014||2014-01-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|December 2018|Anticipated|2018-12-01||Observational|||Biopsies in Oncology - Prospective Study of Impact on Patient's Quality of Life.|Biopsies in Oncology - Prospective Study of Impact on Patient's Quality of Life.|Recruiting||N/A|400|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:40:34.677723|2017-10-10 23:40:34.677723
NCT02334748|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-04-05|||November 3, 2014|Actual|2014-11-03|April 2017|2017-04-01|December 22, 2018|Anticipated|2018-12-22|December 22, 2018|Anticipated|2018-12-22||Interventional|||A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies|A French Open-label Extension Study of Canakinumab in Patients Who Participated in International Phase III Studies CACZ885G2301E1 or CACZ885G2306 in Systemic Juvenile Idiopathic Arthritis and CACZ885N2301 in Hereditary Periodic Fevers (TRAPS, HIDS, or crFMF)|Recruiting||Phase 3|41|Anticipated|Novartis||1|||f||||f||||||||||2017-10-10 23:40:34.879809|2017-10-10 23:40:34.879809
NCT02334735|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-02-10|||July 2015||2015-07-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence|A Phase II Open Label, Randomized Study of Poly-ICLC Matured DC as an Adjuvant for NY-ESO-1 and Melan-A/MART-1 Peptide Vaccination Compared to Montanide® ISA-51 VG, in Study Subjects With Melanoma in Complete Clinical Remission But at High Risk of Disease Recurrence|Recruiting||Phase 2|50|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:40:34.957448|2017-10-10 23:40:34.957448
NCT02334709|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-01-09|||February 2014||2014-02-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.|Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.|Completed||Phase 1/Phase 2|13|Actual|University Hospital, Ghent||1|||f||||||||||||||2017-10-10 23:40:35.159726|2017-10-10 23:40:35.159726
NCT02334696|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-06|||January 2015||2015-01-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Observational|IMPROVA||Improving Outcomes in Vascular Access|Improving Outcomes in Vascular Access|Unknown status|Not yet recruiting|N/A|200|Anticipated|University Hospital Birmingham|||1||f||||f||||||||||2017-10-10 23:40:35.239476|2017-10-10 23:40:35.239476
NCT02334683|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2016-09-14|||December 2014||2014-12-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia|Comparison of Electrophysiologic And Ultrasound Guidance For Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia And Spasticity|Recruiting||N/A|30|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 23:40:35.295914|2017-10-10 23:40:35.295914
NCT02334670|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-09-12|||August 14, 2015|Actual|2015-08-14|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|CRICS||Vietnam Cryptococcal Retention in Care Study Version 1.0|Evaluation of a Public Health Strategy to Improve Survival of HIV Infected Patients|Active, not recruiting||N/A|2612|Anticipated|National Hospital for Tropical Diseases, Hanoi, Vietnam|||3||f||||f|f|f||||Samples With DNA|"     Complete blood samples   "|||2017-10-10 23:40:35.399399|2017-10-10 23:40:35.399399
NCT02215278|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-08-12|||February 2014||2014-02-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||A Multiple Meal Stable Iron Isotope Study in Iron Deficient Rwandese Women to Investigate the Performance of Low Phytic Acid Bean Seeds||Completed||N/A|25|Actual|GroundWork||3|||f||||f||||||||||2017-10-11 00:06:45.198324|2017-10-11 00:06:45.198324
NCT02334657|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-05-03|||November 2013||2013-11-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01|15 Years|Observational [Patient Registry]|||Prospective Study of Long-term Outcome After Non-aneurysmal Subarachnoid Hemorrhage|Prospective Study of Long-term Outcome After Non-aneurysmal Subarachnoid Hemorrhage|Completed||N/A|173|Actual|University Clinic Frankfurt|||5||f||||f||||||||||2017-10-10 23:40:35.574879|2017-10-10 23:40:35.574879
NCT02334644|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-12-12|||April 2015||2015-04-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Probiotic Treatment in Adult Obsessive-Compulsive Disorder|A 12-week Randomized Controlled Trial of Probiotic Treatment (Lactobacillus Helveticus R0052 and Bifidobacterium Longum R0175) vs Placebo in Adult Obsessive Compulsive Disorder|Recruiting||Phase 4|64|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 23:40:35.661879|2017-10-10 23:40:35.661879
NCT02334631|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-01-23|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||High Volume Simethicone VCE Clinical Trial|A Double Blind Randomized Controlled Trial of High Volume Simethicone to Improve Visualization During Capsule Endoscopy|Recruiting||Phase 4|164|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||Undecided||2017-10-10 23:40:35.811011|2017-10-10 23:40:35.811011
NCT02334618|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-02-24|||August 2014||2014-08-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Insole Sensor to Determine Optimal Limb Loading in the Rehabilitation of Ankle Fractures|Clinical Trial of an Insole Sensor to Determine Optimal Limb Loading in the Rehabilitation of Ankle Fractures|Enrolling by invitation||N/A|30|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-10 23:40:35.914075|2017-10-10 23:40:35.914075
NCT02334605|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-12-02|||January 2015||2015-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Cold Dry Air Exposure, Discs and Capsaicin|Comparison of Cold Dry Air Exposure, Hyperosmolar Sponge and Capsaicin Nasal Spray for Objective Evaluation of Nasal Hyperreactivity|Recruiting||N/A|36|Anticipated|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||||2017-10-10 23:40:35.991793|2017-10-10 23:40:35.991793
NCT02334592|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-07|||January 2014||2014-01-01|December 2013|2013-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Vitamin D Production Levels Achieved by Sunbed Tanning|The Impact of Health Canada's Sunbed Exposure Time Guidelines on Serum 25(OH)D Concentrations|Completed||N/A|87|Actual|Vitamin D Society||4|||f||||f||||||||||2017-10-10 23:40:36.08543|2017-10-10 23:40:36.08543
NCT02334579|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-04-25|||December 2014||2014-12-01|April 2017|2017-04-01|December 2024|Anticipated|2024-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer|Function-Preserving Stereotactic Body Radiotherapy for Clinical State I-III Prostate Cancer|Recruiting||N/A|146|Anticipated|Swedish Medical Center||1|||f||||f||||||||||2017-10-10 23:40:36.159503|2017-10-10 23:40:36.159503
NCT02334566|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-07-30|||August 2015||2015-08-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|LHOF||Lending a Hand to Our Future: PTSD in Refugee Children and Youth|Lending a Hand to Our Future: Documenting, Assessing and Treating Posttraumatic Stress Disorder in Refugee Children and Youth|Unknown status|Not yet recruiting|N/A|300|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 23:40:36.256135|2017-10-10 23:40:36.256135
NCT02334553|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-11-06|||January 2015||2015-01-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|S-1226(8%)||Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma|Phase IIa, Placebo-controlled, Randomized, Double-blind, Crossover Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of S-1226 (8%) Administered by Nebulization in Subjects With Mild Atopic Asthma.|Recruiting||Phase 2|16|Anticipated|SolAeroMed Inc.||2|||f||||t||||||||||2017-10-10 23:40:36.333914|2017-10-10 23:40:36.333914
NCT02334540|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-05-12|||January 2015||2015-01-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Satiety Effects of Pulses Compared to Matched Protein Smoothie|Satiety Effects of Pulses Compared to Matched Protein Smoothie|Completed||N/A|40|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 23:40:36.428365|2017-10-10 23:40:36.428365
NCT02334527|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-03-10|||March 2015||2015-03-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy|Phase II Trial of Palbociclib (PD-0332991) in Patients With Metastatic Urothelial Cancer (UC) After Failure of First-Line Chemotherapy|Recruiting||Phase 2|40|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:40:36.506217|2017-10-10 23:40:36.506217
NCT02334514|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2017-09-27|||November 2014||2014-11-01|September 2017|2017-09-01|July 30, 2017|Actual|2017-07-30|May 30, 2017|Actual|2017-05-30||Observational|||The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza Infection|The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza Infection Among Adults - a Prospective, Cohort Study.|Completed||N/A|215|Actual|Rambam Health Care Campus|||1||f||||t||||||Samples Without DNA|"     Nasopharyngeal swabs taken after start of oseltamivir treatment in patients diagnosed with     influenza   "|||2017-10-10 23:40:36.61519|2017-10-10 23:40:36.61519
NCT02334501|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-05-09|||August 2014||2014-08-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects|An Open-Label, 2-Period, Fixed Sequence Study to Evaluate the Effect of Lansoprazole on the Pharmacokinetics of Neratinib in Healthy Subjects|Completed||Phase 1|15|Actual|Puma Biotechnology, Inc.||1|||f||||f||||||||||2017-10-10 23:40:36.688395|2017-10-10 23:40:36.688395
NCT02334488|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-07-24|||December 2014|Actual|2014-12-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function|Prospective Multicenter Randomized Openlabel Study to Evaluate the Benefit on Renal Function at 12months Post-transplantation of Immunosuppressive Treatment With Withdrawal of Calcineurin Inhibitor at 3months and Combining Mycophenolate Sodium-Everolimus Versus Tacrolimus-Everolimus, in Patients With de Novo Kidney Transplant|Recruiting||Phase 3|390|Anticipated|Poitiers University Hospital||2|||f||||t||||||||||2017-10-10 23:40:36.770593|2017-10-10 23:40:36.770593
NCT02334475|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-01-07|||July 2013||2013-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Steroid Versus Platelet Rich Plasma Injection for Chronic Low Back Pain|Steroid Versus Platelet Rich Plasma in Ultrasound Guided Sacroiliac Joint Injection for Chronic Low Back Pain|Completed||N/A|40|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-10 23:40:36.897038|2017-10-10 23:40:36.897038
NCT02334462|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-07|2017-10-04|||December 10, 2014||2014-12-10|August 21, 2017|2017-08-21|September 30, 2018|Anticipated|2018-09-30|March 31, 2016|Actual|2016-03-31||Interventional|||Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali|Phase 1 Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel, a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria in Adults in the US and Mali|Active, not recruiting||Phase 1|54|Actual|National Institutes of Health Clinical Center (CC)||7|||f||||||||||||||2017-10-10 23:40:36.981889|2017-10-10 23:40:36.981889
NCT02334449|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-10-26|||February 2015||2015-02-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|LML134||First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers|A First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Oral Dose Study, to Assess the Safety, Tolerability and Pharmacokinetics of LML134 in Healthy Volunteers|Completed||Phase 1|133|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:40:37.099699|2017-10-10 23:40:37.099699
NCT02334436|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-03-20||2017-02-01|January 2015||2015-01-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|EV-002||A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002|A Phase III, Multi-center, Randomized, Double Blind, Placebo-controlled, Single Dose, Trial to Demonstrate the Safety and Efficacy of DWP-450 in Adult Subjects for Treatment of Moderate-to-severe Glabellar Lines|Completed||Phase 3|330|Actual|Evolus, Inc.||2|||f||||f||||||||Undecided||2017-10-10 23:40:37.213969|2017-10-10 23:40:37.213969
NCT02334423|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-03-20||2017-02-01|January 2015||2015-01-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001|A Phase III, Multi-center, Randomized, Double Blind, Placebo-controlled, Single Dose, Trial to Demonstrate the Safety and Efficacy of DWP-450 in Adult Subjects for Treatment of Moderate-to-severe Glabellar Lines|Completed||Phase 3|324|Actual|Evolus, Inc.||2|||f||||f||||||||Undecided|We are developing a plan|2017-10-10 23:40:37.299235|2017-10-10 23:40:37.299235
NCT02334410|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-06|||February 2015||2015-02-01|January 2015|2015-01-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Early Intervention to Reduce Bone Loss After Spinal Cord Injury||Not yet recruiting||N/A|60|Anticipated|University of Strathclyde||2|||f||||f||||||||||2017-10-10 23:40:37.382664|2017-10-10 23:40:37.382664
NCT02334397|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-08-18|||February 2016||2016-02-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Bump on the Ball: Impact of a Prenatal Exercise & Education Program on Birth Outcomes & Maternal Quality of Life|Bump on the Ball: Impact of a Prenatal Exercise & Education Program on Birth Outcomes & Maternal Quality of Life|Recruiting||N/A|120|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:40:37.455803|2017-10-10 23:40:37.455803
NCT02334384|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-07|||April 2015||2015-04-01|January 2015|2015-01-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess|Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|Eastern Virginia Medical School||2|||f||||f||||||||||2017-10-10 23:40:37.54193|2017-10-10 23:40:37.54193
NCT02334371|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-03-14|||April 2015||2015-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study|MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study|Completed||N/A|10|Actual|Maastricht University Medical Center||1|||f||||t||||||||No||2017-10-10 23:40:37.616876|2017-10-10 23:40:37.616876
NCT02334358|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-09-09|||September 2014||2014-09-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Observational|||Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s|A Multi-center, Prospective and Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s Injected Into the Nasolabial Folds|Unknown status|Active, not recruiting|N/A|500|Anticipated|LG Life Sciences|||1||f||||f||||||||||2017-10-10 23:40:37.692031|2017-10-10 23:40:37.692031
NCT02334345|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-08-31|||January 2015||2015-01-01|August 2015|2015-08-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|EVOSKIN||Skin Protection During Radiotherapy in Patients With Breast Cancer|Skin Protection During Radiotherapy in Patients With Breast Cancer: A Comparative Study of Evoskin® Verus Trixéra®|Unknown status|Recruiting|N/A|25|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-10 23:40:37.75891|2017-10-10 23:40:37.75891
NCT02334332|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-09-23|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery|Pilot Study of an Educational Brochure to Prepare Patients and Informal Caregivers for Recovery Following Gastrectomy|Withdrawn||N/A|0|Actual|City of Hope Medical Center||2||No accrual|f||||t||||||||||2017-10-10 23:40:37.838283|2017-10-10 23:40:37.838283
NCT02334319|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-07-22|||December 2014||2014-12-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Ganetespib Window of Opportunity Study in Head and Neck Cancers|A Molecularly Driven Pilot Study of Preoperative Ganetespib in Resectable Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Terminated||Phase 1|3|Actual|Emory University||1||Lack of funding|f||||t||||||||||2017-10-10 23:40:38.040466|2017-10-10 23:40:38.040466
NCT02334306|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-14|||June 8, 2015|Actual|2015-06-08|September 2017|2017-09-01|August 16, 2018|Anticipated|2018-08-16|February 7, 2018|Anticipated|2018-02-07||Interventional|||A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome|A Phase 2a, Randomized, Placebo Controlled, Proof of Mechanism Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome|Recruiting||Phase 2|42|Anticipated|MedImmune LLC||2|||f||||f|t|f||||||||2017-10-10 23:40:38.134595|2017-10-10 23:40:38.134595
NCT02334280|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-07|||September 2009||2009-09-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI|Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI|Completed||N/A|120|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 23:40:38.326714|2017-10-10 23:40:38.326714
NCT02334267|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-01-18|2016-02-10||November 2014||2014-11-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|February 2015|Actual|2015-02-01||Interventional|ABChD||Acid-Base Composition With Use of hemoDialysates|Acid-Base Composition With Use of hemoDialysates: the ABChD Trial|Completed||N/A|11|Actual|Fresenius Medical Care North America||2|||f||||t|f|t|f|f|f|||No||2017-10-10 23:40:38.530319|2017-10-10 23:40:38.530319
NCT02334254|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-07|||August 2013||2013-08-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention|Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 4|420|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||||2017-10-10 23:40:39.083932|2017-10-10 23:40:39.083932
NCT02334241|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-08-30|||October 2014||2014-10-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|September 2016|Actual|2016-09-01||Interventional|ADHOC||The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study)|The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study)|Completed||N/A|200|Actual|INRESA Pharma||2|||f||||f||||||||||2017-10-10 23:40:39.187026|2017-10-10 23:40:39.187026
NCT02334228|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-07|||September 2006||2006-09-01|January 2015|2015-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness|Promoting Health and Functioning in Persons With SMI|Completed||N/A|133|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 23:40:39.308642|2017-10-10 23:40:39.308642
NCT02334215|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-03-07|||December 2014||2014-12-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|SOMATICS FRI||A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail|A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail|Recruiting||N/A|300|Anticipated|Friends Research Institute, Inc.||3|||f||||t||||||||||2017-10-10 23:40:39.406981|2017-10-10 23:40:39.406981
NCT02334202|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-08-17|||November 2011||2011-11-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|POMC-A||Preventing Obesity in Military Communities, Adolescents|Preventing Obesity in Military Communities, Adolescents (POMC-Adolescents)|Unknown status|Active, not recruiting|N/A|48|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-10-10 23:40:39.525361|2017-10-10 23:40:39.525361
NCT02334189|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-07|||January 2015||2015-01-01|January 2015|2015-01-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Targeted Letters to Reduce Avoidable Emergency Department Attendances|Targeted Letters to Reduce Avoidable Emergency Department Attendances|Unknown status|Not yet recruiting|N/A|25000|Anticipated|The Behavioural Insights Team||2|||f||||f||||||||||2017-10-10 23:40:39.634357|2017-10-10 23:40:39.634357
NCT02334176|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-07|||January 2015||2015-01-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||US Guided Axillary Block With Only One Injection|A Prospective, Randomized Comparison Between Single and Double Injection Ultrasound-Guided Axillary Brachial Plexus Block|Unknown status|Not yet recruiting|N/A|320|Anticipated|Institut Kassab d'Orthopédie||2|||f||||t||||||||||2017-10-10 23:40:39.699303|2017-10-10 23:40:39.699303
NCT02334163|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-07|||December 2014||2014-12-01|January 2015|2015-01-01|April 2015|Anticipated|2015-04-01|February 2015|Anticipated|2015-02-01||Interventional|||The Effects of Nitazoxanide in Hepatic Encephalopathy|The Clinical Effects of Nitazoxanide in Hepatic Encephalopathy Patients: A Pilot Study|Unknown status|Recruiting|Phase 2|36|Anticipated|Ain Shams University||3|||f||||f||||||||||2017-10-10 23:40:39.791416|2017-10-10 23:40:39.791416
NCT02334150|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-01-07|||June 2013||2013-06-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Epidural Analgesia on Electrophysiological Function|Effects of Combined Spinal-epidural Analgesia During Labor on Postpartum Electrophysiological Function of Maternal Pelvic Floor Muscle: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|308|Actual|Nanjing Maternity and Child Health Care Hospital||2|||f||||f||||||||||2017-10-10 23:40:39.898516|2017-10-10 23:40:39.898516
NCT02334137|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2016-07-25|||November 2014||2014-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|LionsDMed||A Pilot Project to Assess the Impact of Diabetes Education During Ophthalmology Visits|Providing Diabetes Services in the Lions Eye Clinic: a Pilot Project to Assess the Impact of Diabetes Education During Ophthalmology Visits|Completed||N/A|36|Actual|California Pacific Medical Center Research Institute|||3||f||||f||||||||||2017-10-10 23:40:40.006068|2017-10-10 23:40:40.006068
NCT02334124|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2017-08-29|||January 2015||2015-01-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|June 2017|Actual|2017-06-01||Interventional|CHOICE||Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital|CHOICE Trial: Cellulitis at Home Or Inpatient in Children From ED|Active, not recruiting||N/A|190|Actual|Murdoch Childrens Research Institute||2|||f||||t|f|f||||||||2017-10-10 23:40:40.123874|2017-10-10 23:40:40.123874
NCT02334111|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-01-13|||July 2013||2013-07-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|RESPECT-Plus||RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure|Project RESPECT-Plus: Recovery, Empowerment, Social Services, Prenatal Care, Education and Community Treatment-Plus|Completed||N/A|200|Actual|Boston Medical Center||2|||f||||f||||||||No||2017-10-10 23:40:40.225926|2017-10-10 23:40:40.225926
NCT02334098|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-06-08|||February 2015||2015-02-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Omega-3 Supplementation and Behavior Problems|Omega-3 Supplementation and Behavior Problems in Children and Adolescents|Recruiting||Phase 2/Phase 3|300|Anticipated|City University of Hong Kong||3|||f||||t||||||||||2017-10-10 23:40:40.317277|2017-10-10 23:40:40.317277
NCT02334085|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-01-06|||August 2009||2009-08-01|January 2015|2015-01-01|August 2031|Anticipated|2031-08-01|August 2029|Anticipated|2029-08-01||Observational|HOW||The Health of Women Study|The Health of Women (HOW) Study|Recruiting||N/A|100000|Anticipated|Dr. Susan Love Research Foundation|||1||f||||f||||||||||2017-10-10 23:40:40.421229|2017-10-10 23:40:40.421229
NCT02334072|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-06-22|||January 2015||2015-01-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||The Effects of Different Airway Devices on Middle Ear Pressure in Pediatric Patients|The Effects of Different Airway Devices on Middle Ear Pressure in Pediatric Patients|Unknown status|Recruiting|N/A|100|Anticipated|Adiyaman University Research Hospital||5|||f||||f||||||||||2017-10-10 23:40:40.495927|2017-10-10 23:40:40.495927
NCT02334059|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-01-10|||November 2015||2015-11-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery|Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery|Recruiting||N/A|108|Anticipated|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-10-10 23:40:40.591501|2017-10-10 23:40:40.591501
NCT02334046|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-12-16|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Remifentanil for Smooth Emergence in Elderly Patients|Effect-site Concentration of Remifentanil for Preventing Cough During Emergence in Elderly Patients|Completed||Phase 4|47|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-10 23:40:40.691976|2017-10-10 23:40:40.691976
NCT02334033|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-24|||January 2014||2014-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Cystatin C and Uncontrolled Hypertension|Cystatin C and Uncontrolled Hypertension|Completed||N/A|903|Actual|Ankara University|||1||f||||||||||||||2017-10-10 23:40:40.769889|2017-10-10 23:40:40.769889
NCT02334020|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-04-25|||September 2013||2013-09-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Investigating the Impact of the Mental Health First-Aid Training Course in Danish Employees|Effectiveness of Mental Health First-Aid Training in Denmark. A Randomized Controlled Trial With a Six-Month Follow-Up Supplemented With a Qualitative Study|Unknown status|Active, not recruiting|N/A|538|Actual|Mental Health Services in the Capital Region, Denmark||2|||f||||f||||||||||2017-10-10 23:40:40.83201|2017-10-10 23:40:40.83201
NCT02334007|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-13|||September 2015||2015-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery|Extended Low-Molecular Weight Heparin VTE Prophylaxis in the Thoracic Surgery Population, a Prospective, Randomized Controlled Study|Recruiting||Phase 1/Phase 2|120|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 23:40:40.903749|2017-10-10 23:40:40.903749
NCT02333994|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-01-07|||March 2013||2013-03-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of Education With Balance Exercise in Improving Balance and Reducing the Fear of Falls in Elderly|Efficacy of Education With Balance Exercise in Improving Balance and Reducing the Fear of Falls in Elderly|Completed||N/A|60|Actual|Maharishi Markendeswar University||2|||f||||f||||||||||2017-10-10 23:40:40.99655|2017-10-10 23:40:40.99655
NCT02333981|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-01-07|||August 2012||2012-08-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of Passive Oral Motor Therapy on Drooling in Children With Multiple Disabilities|Efficacy of Passive Oral Motor Therapy on Drooling in Children With Multiple Disabilities|Completed||N/A|7|Actual|Maharishi Markendeswar University||1|||f||||||||||||||2017-10-10 23:40:41.07078|2017-10-10 23:40:41.07078
NCT02333968|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-01-07|||February 2014||2014-02-01|January 2015|2015-01-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Self-management Support in Cancer Pain|Effects of a Multifaceted Teleguided Pain Care Program in Patients With Cancer Pain|Unknown status|Recruiting|N/A|174|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:40:41.132|2017-10-10 23:40:41.132
NCT02333955|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-01-13|||January 2015||2015-01-01|January 2015|2015-01-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Phase 2 Extension of Study GCS-100-CS-4003|A Phase 2 Extension of Study GCS-100-CS-4003|Withdrawn||Phase 2|0|Actual|La Jolla Pharmaceutical Company||1||Corporate decision|f||||f||||||||||2017-10-10 23:40:41.207043|2017-10-10 23:40:41.207043
NCT02333942|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-06-02|||May 2014||2014-05-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|February 2015|Actual|2015-02-01||Observational|||Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia|A Non-Blinded, Non-Significant Risk Study With a Non-Invasive, Passive Pressure Wave Method of Diagnosing Brain Pathologies to Develop a Diagnostic Algorithm for Alzheimer Disease and Other Dementias.|Unknown status|Active, not recruiting|N/A|40|Anticipated|Jan Medical, Inc.|||4||f||||f||||||||||2017-10-10 23:40:41.280549|2017-10-10 23:40:41.280549
NCT02333929|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-02-13|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Validation of Rivaroxaban Assay for US Registration|Validation of Rivaroxaban Assay for US Registration|Completed||N/A|100|Actual|Diagnostica Stago|||3||f||||f||||||Samples Without DNA|"     Plasma samples   "|||2017-10-10 23:40:41.361106|2017-10-10 23:40:41.361106
NCT02333916|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-09-22|||June 2014||2014-06-01|April 2015|2015-04-01||||April 2015|Actual|2015-04-01||Interventional|FeedEX||Effect of Exercise and Training on Fat Oxidation During Overfeeding - the FeedEX Study|Effects of Short-term Overfeeding With or Without Exercise on 24-hour Fat Oxidation and Fat Balance Before and After 10 Weeks of Training - The FeedEX Study|Terminated||N/A|5|Actual|Maastricht University Medical Center||1||Recruitment target could not be met|f||||t||||||||||2017-10-10 23:40:41.438209|2017-10-10 23:40:41.438209
NCT02333903|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-07-27|||January 2015||2015-01-01|January 2015|2015-01-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|PEEPSO||Adapted Physical Activity Program After Sleeve Gastrectomy|Effects of an Adapted Physical Activity Program on Health and Physical Condition After Sleeve Gastrectomy|Withdrawn||N/A|0|Actual|Lille Catholic University||2|||f||||t||||||||||2017-10-10 23:40:41.531244|2017-10-10 23:40:41.531244
NCT02333890|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-11-17|||July 2015||2015-07-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|CUBiC||A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer|A Phase 2 Randomized, Double-blind, Window of Opportunity Trial Evaluating Clinical and Correlative Effects of Chloroquine as a Novel Therapeutic Strategy in Breast Cancer|Recruiting||Phase 2|60|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 23:40:41.721247|2017-10-10 23:40:41.721247
NCT02333877|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2016-05-17|||January 2015||2015-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|Skinlink||Comparison of Skinlink With Suture for ED Patients|Comparison of Skinlink With Suture for ED Patients: a Randomized Controlled Trial|Completed||N/A|49|Actual|Hallym University Kangnam Sacred Heart Hospital||2|||f||||||||||||||2017-10-10 23:40:41.816832|2017-10-10 23:40:41.816832
NCT02333851|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2015-01-05|||June 2013||2013-06-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PININ||Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)|Comparison of Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)|Terminated||Phase 4|72|Actual|Hospital Universitario Central de Asturias||2||Safety reasons|f||||f||||||||||2017-10-10 23:40:42.00175|2017-10-10 23:40:42.00175
NCT02333838|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-10-17|||March 2015||2015-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TBF-Cord||Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies|Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies|Recruiting||Phase 2|57|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:40:42.092243|2017-10-10 23:40:42.092243
NCT02333825|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-01-11|||December 2015||2015-12-01|January 2017|2017-01-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Interventional|PAPI||Pediatric and Adolescent Patellar Instability|Pediatric and Adolescent Patellar Instability|Enrolling by invitation||N/A|240|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-10 23:40:42.197651|2017-10-10 23:40:42.197651
NCT02333812|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-01-05|||January 2015||2015-01-01|September 2014|2014-09-01||||December 2015|Anticipated|2015-12-01||Observational|||Prevalence of Malignant and Premalignant Lesions in the Head & Neck in Patients With Chronic Obstructive Pulmonary Disease||Unknown status|Not yet recruiting|N/A|250|Anticipated|Hadassah Medical Organization|||3||f||||f||||||||||2017-10-10 23:40:42.380458|2017-10-10 23:40:42.380458
NCT02333799|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-02-28|||March 2015||2015-03-01|August 2016|2016-08-01|October 2021|Anticipated|2021-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis|A Phase 3 Open-label Trial Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB) or Treatment Intolerant / Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB).|Recruiting||Phase 3|200|Anticipated|Global Alliance for TB Drug Development||1|||f||||t||||||||||2017-10-10 23:40:42.464454|2017-10-10 23:40:42.464454
NCT02333786|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-10-06|||January 2015||2015-01-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Ultrasound-guided Arterial Catheterization in Pediatric Patients|Comparison of Long-axis/In-plane and Short-axis/Out-of-plane Methods During the Ultrasound-guided Arterial Cannulation in Pediatric Patients|Completed||N/A|108|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:40:42.598781|2017-10-10 23:40:42.598781
NCT02333773|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|IRE||Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli|Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial|Recruiting||Phase 1/Phase 2|15|Anticipated|Fuda Cancer Hospital, Guangzhou||3|||f||||t||||||||||2017-10-10 23:40:42.687753|2017-10-10 23:40:42.687753
NCT02333760|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-08-16|||September 2014||2014-09-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|WAS FUP||Gene Therapy for WAS Follow-up|Long Term Safety Follow up of Patients Enrolled in the Phase I/II Clinical Trial of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome (GTG002-07 and GTG003-08).|Recruiting||Phase 1/Phase 2|10|Anticipated|Genethon||1|||f||||f||||||||||2017-10-10 23:40:42.795705|2017-10-10 23:40:42.795705
NCT02333747|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-02-21|||January 2015||2015-01-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Can Transcutaneous Electrical Acupoint Stimulation Improve the Quality of Recovery After Thyroidectomy?|The Effects of Transcutaneous Electrical Acupoint Stimulation on the Quality of Recovery After Thyroidectomy Surgery|Completed||N/A|84|Actual|Fujian Provincial Hospital||2|||f||||t||||||||No||2017-10-10 23:40:42.915489|2017-10-10 23:40:42.915489
NCT02333734|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2015-02-02|||July 2014||2014-07-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|DIATRAIN||Investigation of the Effect of 8-week Controlled High Intense Interval Training in Type 2 Diabetic Patients|Investigation of the Effect of 8-week Controlled High Intense Interval Training in Type 2 Diabetic Patients|Completed||N/A|23|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-10-10 23:40:43.043182|2017-10-10 23:40:43.043182
NCT02333721|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2017-01-11|||January 2015||2015-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|LSPLN||Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer|Study on Long-term Outcome of Laparoscopic Spleen-Preserving D2 Lymphadenectomy With and Without No. 10 Lymph Node Dissection for Advanced Gastric Cancer|Active, not recruiting||Phase 3|536|Anticipated|Fujian Medical University||2|||f||||t||||||||No||2017-10-10 23:40:43.144567|2017-10-10 23:40:43.144567
NCT02333708|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-09-12|||September 2015||2015-09-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|MicroGiant||Study of Circulating Microparticles in Giant Cell Arteritis|Study of Circulating Microparticles in Giant Cell Arteritis|Recruiting||N/A|75|Anticipated|University Hospital, Caen|||3||f||||||||||||||2017-10-10 23:40:43.299511|2017-10-10 23:40:43.299511
NCT02333695|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-06|||January 2015||2015-01-01|January 2015|2015-01-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|SCIMAG||Medical Device for Magnetic Therapy for Spinal Cord Injuries (SCI)|Medical Device for Magnetic Therapy for Spinal Cord Injuries (SCIMAG)|Unknown status|Recruiting|N/A|50|Anticipated|American Society Of Thermalism And Climatology Inc||1|||f||||t||||||||||2017-10-10 23:40:43.393471|2017-10-10 23:40:43.393471
NCT02333682|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-04-12|||November 2014||2014-11-01|January 2015|2015-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics of Calcifediol and Cholecalciferol|The Response of Serum 25-hydroxyvitamin D to Different Doses of Calcifediol Hy.D Compared to Vitamin D3 Supplementation: A Randomized, Controlled, Double Blind, Long Term Pharmacokinetic Study|Completed||N/A|93|Actual|DSM Nutritional Products, Inc.||4|||f||||t||||||||||2017-10-10 23:40:43.49653|2017-10-10 23:40:43.49653
NCT02333669|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-01-06|||January 2012||2012-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome|Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome|Completed||N/A|249|Actual|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University|||2||f||||t||||||||||2017-10-10 23:40:43.602746|2017-10-10 23:40:43.602746
NCT02333656|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2017-01-03|||January 2015||2015-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Management of Hip and Knee Osteoarthritis in Primary Health Care|Improved Management of Patients With Hip and Knee Osteoarthritis in Primary Health Care|Active, not recruiting||N/A|388|Anticipated|Diakonhjemmet Hospital||2|||f||||f||||||||||2017-10-10 23:40:43.706129|2017-10-10 23:40:43.706129
NCT02333643|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-07-25||2016-07-25|January 2015||2015-01-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.|A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Study to Evaluate Efficacy and Safety of Topical Ionic Contra-viral Therapy (ICVT) Comprised of CLS003 in Cutaneous Warts|Completed||Phase 2|81|Actual|Cutanea Life Sciences, Inc.||4|||f||||f||||||||||2017-10-10 23:40:43.84223|2017-10-10 23:40:43.84223
NCT02333630|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-01-30|||November 2014||2014-11-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|November 2016|Actual|2016-11-01||Interventional|AsthmaCare||Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management|Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management|Enrolling by invitation||N/A|200|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-10 23:40:43.953247|2017-10-10 23:40:43.953247
NCT02333617|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-01-30|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Manual Therapy to Treat Gluteus Medius Trigger Points|Manual Therapy to Treat Gluteus Medius Trigger Points to Improve Hip Abduction Strength in Patients With Anterior Knee Pain.|Recruiting||N/A|60|Anticipated|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-10 23:40:44.052752|2017-10-10 23:40:44.052752
NCT02333604|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-06|||January 2013||2013-01-01|January 2015|2015-01-01||||January 2035|Anticipated|2035-01-01|10 Years|Observational [Patient Registry]|CER||Cancer Experience Registry|Cancer Experience Registry|Recruiting||N/A|15000|Anticipated|Cancer Support Community, Research and Training Institute, Philadelphia|||1||f||||||||||||||2017-10-10 23:40:44.216569|2017-10-10 23:40:44.216569
NCT02333591|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-11-04|||July 2016||2016-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults|Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults|Recruiting||Phase 4|20|Anticipated|Bispebjerg Hospital||3|||f||||t||||||||Undecided||2017-10-10 23:40:44.300078|2017-10-10 23:40:44.300078
NCT02333578|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-05|||November 2014||2014-11-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|EVD001||Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment|A Phase I/II Pilot Clinical Trial to Evaluate the Efficacy and Safety of Ebola Virus Disease (EVD) Convalescent Plasma (ECP) for Treatment of EVD|Unknown status|Recruiting|N/A|70|Anticipated|Clinical Research Management, Inc.||1|||f||||f||||||||||2017-10-10 23:40:44.421375|2017-10-10 23:40:44.421375
NCT02333565|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-06|||January 2015||2015-01-01|January 2015|2015-01-01||||January 2018|Anticipated|2018-01-01||Interventional|CEVOREM||Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas|Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas.|Recruiting||Phase 2|20|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:40:44.550852|2017-10-10 23:40:44.550852
NCT02333552|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-06|||March 2013||2013-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Observational|||Frailty Status and Quality of Life in Elderly|A Cohort Study of Frailty Status Transition and Its Impact to Quality of Life in Outpatient Elderly|Completed||N/A|269|Actual|Indonesia University|||1||f||||f||||||||||2017-10-10 23:40:44.665104|2017-10-10 23:40:44.665104
NCT02333539|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-08-22|||September 2012||2012-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|Pump It Up!||Adherence Intervention to Promote Optimal Use of Insulin Pumps in Adolescents With Type 1 Diabetes|Adherence Intervention to Promote Optimal Use of Insulin Pumps in Adolescents|Active, not recruiting||N/A|100|Anticipated|University of Colorado, Denver||3|||f||||t|f|f||||||||2017-10-10 23:40:44.767462|2017-10-10 23:40:44.767462
NCT02333526|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-08-09|||December 2017|Anticipated|2017-12-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01|2 Days|Observational [Patient Registry]|||Syndecan 1 as Biomarker for Inflammation|Soluble Syndecan 1 as Biomarker for Acute and Chronic Bowel Inflammation|Not yet recruiting||N/A|44|Anticipated|Helios Albert-Schweitzer-Klinik Northeim|||1||f||||f||||||Samples Without DNA|"     blood serum for soluble Syndecan 1 and CRP Leucocyte cound Blood panel Stool analysis for     calprotectin   "|||2017-10-10 23:40:44.880963|2017-10-10 23:40:44.880963
NCT02333513|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-04-08|||February 2015||2015-02-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation|A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation|Not yet recruiting||N/A|100|Anticipated|Hebei Yanda Hospital||1|||f||||t||||||||||2017-10-10 23:40:45.006329|2017-10-10 23:40:45.006329
NCT02333500|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2015-09-30|||January 2015||2015-01-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa|Pilot Study: a Comparative Study Between Serum Levels of Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa in Adolescents|Unknown status|Recruiting|N/A|60|Anticipated|Fondation Lenval||3|||f||||f||||||||||2017-10-10 23:40:45.167174|2017-10-10 23:40:45.167174
NCT02333487|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-02-12|||December 2014||2014-12-01|February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Interventional|||Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700|Interventional, Open-label, Positron Emission Tomography (PET) Study Investigating D1 Dopamine, D2 Dopamine, and 5-HT6 Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700 in Male Patients With Schizophrenia|Completed||Phase 1|22|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-10-10 23:40:45.283457|2017-10-10 23:40:45.283457
NCT02333474|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-09-08|||January 2015||2015-01-01|January 2015|2015-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient|Safety Issue and Efficacy of Combining Mix Vaccine and Standard Therapy in the Treatment of Lung Carcinoma Patient|Completed||Phase 1/Phase 2|20|Anticipated|Fuda Cancer Hospital, Guangzhou||2|||f||||t||||||||||2017-10-10 23:40:45.362456|2017-10-10 23:40:45.362456
NCT02333461|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2015-01-06|||May 2012||2012-05-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Evaluation of Botanicals for Mechanisms Related to Appetite and Fat Metabolism|Study to Evaluate Botanicals for Mechanisms Related to Appetite and Fat Metabolism in Healthy, Overweight and Obese Individuals|Completed||N/A|90|Actual|Access Business Group||5|||f||||f||||||||||2017-10-10 23:40:45.603332|2017-10-10 23:40:45.603332
NCT02333448|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-01-05|||October 2014||2014-10-01|October 2014|2014-10-01||||January 2017|Anticipated|2017-01-01||Observational|EMPIRICAND||"Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis."|Diagnostic Value of PCR Genetic Amplification and Mannan Antigenemia Coupled With Antimannan Antibodies in Intensive Care Patients With Suspected Invasive Candidiasis|Unknown status|Recruiting|N/A|40|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-10 23:40:45.723101|2017-10-10 23:40:45.723101
NCT02333435|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-09-06|||January 2015||2015-01-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|RCT-EPA||Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life|Étude randomisée, contrôlée, de Phase II, Effets d'un Supplement d'oméga-3 (EPA) Sur l'Inflammation, la prolifération Cellulaire et la qualité de Vie Chez Des Patients Avec Cancer de la Prostate traités Par Prostatectomie Radicale|Recruiting||Phase 2|130|Anticipated|CHU de Quebec-Universite Laval||2|||f||||t||||||||Undecided||2017-10-10 23:40:45.844733|2017-10-10 23:40:45.844733
NCT02333422|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-06|||July 2014||2014-07-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||NIRS Neurofeedback as a Treatment for Attention Deficit Hyperactivity Disorder|Clinical Trial Using NIRS Neurofeedback on Children With Attention Deficit Hyperactivity Disorder (ADHD)|Unknown status|Recruiting|Phase 2|10|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||f||||||||||2017-10-10 23:40:45.982083|2017-10-10 23:40:45.982083
NCT02333409|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-01-05|||March 2015||2015-03-01|January 2015|2015-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Acupuncture for Pain Control in Patients With Inoperable Pancreatic Cancer|Electroacupuncture Analgesia in Patients With Inoperable Pancreatic Cancer: A Randomized, Sham-controlled Study|Not yet recruiting||Phase 3|60|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:40:46.100527|2017-10-10 23:40:46.100527
NCT02333396|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-05-01|||April 6, 2015|Actual|2015-04-06|May 2017|2017-05-01|March 7, 2017|Actual|2017-03-07|March 7, 2017|Actual|2017-03-07||Interventional|||Improving Communication in the PICU: The Navigate Study|Improving Communication in the Pediatric Intensive Care Unit for Patients Facing Life-Changing Decisions: The Navigate Study|Completed||N/A|506|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||No||2017-10-10 23:40:46.17865|2017-10-10 23:40:46.17865
NCT02333383|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-08-14|||December 31, 2014||2014-12-31|August 2017|2017-08-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Observational|AS PMOS||Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients|A Prospective, Mono-Country, Multi-Center Study to Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis Patients on Adalimumab Therapy|Completed||N/A|201|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 23:40:46.291597|2017-10-10 23:40:46.291597
NCT02333370|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-08-01|||February 4, 2015|Actual|2015-02-04|August 2017|2017-08-01|October 5, 2018|Anticipated|2018-10-05|September 6, 2018|Anticipated|2018-09-06||Interventional|||A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer|A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer|Active, not recruiting||Phase 1|88|Actual|Novartis||3|||f||||f|f|f||||||||2017-10-10 23:40:46.384128|2017-10-10 23:40:46.384128
NCT02333357|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-05-11|||March 2011||2011-03-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Multimedia Toolkits to Implement 12-Step Recovery Concepts in Group Counseling|Multimedia Toolkits to Implement 12-Step Recovery Concepts in Group Counseling|Completed||N/A|3483|Actual|Treatment Research Institute||2|||f||||f||||||||||2017-10-10 23:40:46.501375|2017-10-10 23:40:46.501375
NCT02333344|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2016-10-27|||July 2015||2015-07-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA|The Efficacy Study of Aclasta (Zoledronic Acid 5mg) on Prosthetic Fixation in Postmenopausal Women After Cementless Total Hip Arthroplasty (THA): a 24 Months, Single Center, Open- Label, Randomized, Parallel Controlled Study|Recruiting||Phase 4|198|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 23:40:46.622873|2017-10-10 23:40:46.622873
NCT02333331|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-04-12|||December 9, 2014|Actual|2014-12-09|April 2017|2017-04-01|January 13, 2019|Anticipated|2019-01-13|December 16, 2018|Anticipated|2018-12-16||Interventional|||Dose Range Finding Study of Bimagrumab in Sarcopenia|A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)|Recruiting||Phase 2|280|Anticipated|Novartis||4|||f||||t||||||||||2017-10-10 23:40:46.735817|2017-10-10 23:40:46.735817
NCT02333318|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-01-05|||July 2014||2014-07-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||A Single Ascending Dose Escalation to Investigate Safety and PK of VVZ-149 Injection in Healthy Older Male Volunteers|A Single Ascending Dose Escalation Clinical Trial to Investigate Safety and Pharmacokinetics of VVZ-149 Injection in Healthy Older Male Volunteers|Completed||Phase 1|24|Actual|Vivozon, Inc.||3|||f||||f||||||||||2017-10-10 23:40:49.269752|2017-10-10 23:40:49.269752
NCT02333305|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-05-14|||June 2013||2013-06-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|January 2017|Actual|2017-01-01||Interventional|AOA1||Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10|Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10|Recruiting||Phase 3|19|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 23:40:49.364763|2017-10-10 23:40:49.364763
NCT02332369|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-08-29|||February 2005|Actual|2005-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CTR||EyeKon Medical Inc. Capsular Tension Ring Study|EyeKon Medical, Inc. Capsular Tension Ring Clinical Study|Recruiting||N/A|125|Anticipated|EyeKon Medical, Inc.||1|||f|||||f|t||f||||||2017-10-10 23:41:00.673485|2017-10-10 23:41:00.673485
NCT02333292|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-10-14|||December 2014||2014-12-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Observational|FPSMON201401||Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions|Efficacy and Safety of Treatment Against Hepatitis C Virus Infection Based on Direct-acting Antivirals in Real-life Conditions: The GEHEP Cohort|Recruiting||N/A|1000|Anticipated|Valme University Hospital|||2||f||||f||||||Samples With DNA|"     whole blood samples   "|||2017-10-10 23:40:49.460121|2017-10-10 23:40:49.460121
NCT02333279|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-08-02|||May 2008||2008-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01|5 Years|Observational [Patient Registry]|||Cancer Development In Organ Transplant Recipients|Cancer Development In Organ Transplant Recipients|Recruiting||N/A|4000|Anticipated|University of Zurich|||1||f||||t||||||||||2017-10-10 23:40:49.610053|2017-10-10 23:40:49.610053
NCT02333266|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-05-11|||June 2016||2016-06-01|December 2015|2015-12-01||||December 2017|Anticipated|2017-12-01||Observational|||Bio-assay Development and Implementation for Fungal Infection Detection|Bio-assay Development and Implementation for Fungal Infection Detection|Withdrawn||N/A|0|Actual|Universitaire Ziekenhuizen Leuven|||1|The bioassay development is too difficult.|f||||f||||||Samples With DNA|"     Whole blood samples   "|||2017-10-10 23:40:49.690203|2017-10-10 23:40:49.690203
NCT02333253|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-01-26|||January 2015||2015-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase|Delayed Start vs Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase.|Completed||Phase 3|60|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:40:49.76354|2017-10-10 23:40:49.76354
NCT02333240|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-11-29|||April 2015||2015-04-01|May 2016|2016-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SNAP-HT||Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study|Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study|Completed||N/A|101|Actual|University of Oxford||2|||f||||t||||||||No||2017-10-10 23:40:49.859289|2017-10-10 23:40:49.859289
NCT02333227|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-08-08|||May 2015||2015-05-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|July 2018|Anticipated|2018-07-01||Interventional|PPaX||Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi|Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi (Prevention of Prematurity and Xylitol)|Recruiting||N/A|9365|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 23:40:49.994534|2017-10-10 23:40:49.994534
NCT02333214|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-10-25|||October 2014||2014-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness of a Program Using Video Games Associated With Conventional Physiotherapy in Physical Functioning in Frail Elderly Compared to Conventional Physiotherapy|The Effectiveness of an Exercise Program Using Video Games Associated With Conventional Physiotherapy in Physical Functioning in Frail Elderly Compared to Conventional Physiotherapy: Randomized Clinical Trial|Recruiting||N/A|82|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t||||||||||2017-10-10 23:40:50.219664|2017-10-10 23:40:50.219664
NCT02333201|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-03-07|||April 2015||2015-04-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|DYnAMICS||DYsphAgia In Mechanically Ventilated ICU patientS|DYsphAgia In Mechanically Ventilated ICU patientS (DYnAMICS) - a Prospective Multicentre Observational Analysis|Completed||N/A|2000|Actual|University Hospital Inselspital, Berne|||1||f||||||||||||||2017-10-10 23:40:50.360733|2017-10-10 23:40:50.360733
NCT02333188|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-07-10|||December 2014||2014-12-01|July 2017|2017-07-01||||November 2017|Anticipated|2017-11-01||Interventional|||Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer|A Genotype-Guided Dosing Study of FOLFIRABRAX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies|Recruiting||Phase 1/Phase 2|51|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-10 23:40:50.457837|2017-10-10 23:40:50.457837
NCT02333175|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-11-03|||September 2014||2014-09-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|CLaSP||Care for Late Stage Parkinsonism|Care for Late Stage Parkinsonism|Recruiting||Phase 4|184|Anticipated|University College, London||2|||f||||f||||||||||2017-10-10 23:40:50.617532|2017-10-10 23:40:50.617532
NCT02333162|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-07-24|||December 5, 2014|Actual|2014-12-05|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant|A Phase I Study of Intensity Modulated Total Marrow Irradiation (IMTMI) in Addition to Fludarabine/Melphalan Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies|Recruiting||Phase 1|30|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-10 23:40:50.768915|2017-10-10 23:40:50.768915
NCT02333149|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-09-15|||December 2015||2015-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MYNAP||Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population|Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population|Active, not recruiting||Phase 3|300|Actual|University of Alberta||2|||f||||t||||||||||2017-10-10 23:40:50.932343|2017-10-10 23:40:50.932343
NCT02333136|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-12-30|||August 2012||2012-08-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|IVRS||In Vivo Raman Spectroscopy of Human Capillary Beds|In Vivo Raman Spectroscopy (IVRS) of Human Fingertip Capillary Beds|Active, not recruiting||N/A|5|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-10-10 23:40:51.013064|2017-10-10 23:40:51.013064
NCT02333123|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-06-26|||July 10, 2015|Actual|2015-07-10|June 2017|2017-06-01|November 11, 2016|Actual|2016-11-11|August 18, 2016|Actual|2016-08-18||Interventional|AVURT||Aspirin for Venous Ulcers: Randomised Trial (AVURT)|Aspirin for Venous Ulcers: Randomised Trial (AVURT)|Terminated||Phase 2|26|Actual|St George's, University of London||2||"Recruitment halted following TSC meeting due to poor recruitment and study unlikely to   complete. Funders withdrew continued support"|f||||t||||||||||2017-10-10 23:40:51.092609|2017-10-10 23:40:51.092609
NCT02333110|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-10-03|||January 2015||2015-01-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors|Spatially Fractionated Radiation (SFR) Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors|Recruiting||N/A|50|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||1|||f||||f||||||||||2017-10-10 23:40:51.195993|2017-10-10 23:40:51.195993
NCT02333097|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-04-19|||January 2015||2015-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|CAPA||Non Syndromic Congenital Heart Defect and Array-CGH in Prenatal Diagnosis|Prospective Study for Diagnosis Utility of Array-CGH Screening in Case of Non Syndromic Congenital Heart Defect in Prenatal Diagnosis (CAPA)|Recruiting||N/A|80|Anticipated|Rennes University Hospital|||1||f||||||||||||||2017-10-10 23:40:51.294344|2017-10-10 23:40:51.294344
NCT02333084|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-08-02|||July 2014||2014-07-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||The Influence Of a Natural Anti-Inflammatory Product On Levels Of Inflammatory Markers In Cases With Osteoarthritis Of Knee|The Influence Of a Natural Anti-Inflammatory Product On Levels Of Inflammatory Markers In Cases With Osteoarthritis Of Knee|Active, not recruiting||Phase 2/Phase 3|120|Anticipated|Physician Recommended Nutriceuticals||3|||f||||||||||||||2017-10-10 23:40:51.405286|2017-10-10 23:40:51.405286
NCT02333071|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2017-07-05|||December 2014||2014-12-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|July 2016|Actual|2016-07-01||Interventional|||A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial With an Open-label Extension|Phase 3, Randomized, Double-blind, Placebo-controlled, Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Subcutaneously Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)|Completed||Phase 3|723|Actual|Palatin Technologies||2|||f||||t||||||||||2017-10-10 23:40:51.527708|2017-10-10 23:40:51.527708
NCT02333058|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-01-20|||July 2014||2014-07-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies|Clinical Phase II Trial to Describe the Safety and Efficacy of Treosulfan-based Conditioning Therapy Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Paediatric Patients With Haematological Malignancies|Active, not recruiting||Phase 2|70|Actual|medac GmbH||1|||f||||t||||||||||2017-10-10 23:40:51.989758|2017-10-10 23:40:51.989758
NCT02333045|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-08-04|||January 2015||2015-01-01|August 2016|2016-08-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|MIP||Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women|Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women|Recruiting||N/A|40|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 23:40:52.169811|2017-10-10 23:40:52.169811
NCT02333032|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-03-21|||February 2015||2015-02-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|Hemislope||Effects of a Positive Slope Treadmill Training in Individuals After Stroke. (Hemislope)|Evaluation of Biomechanical and Functional Effects of a Positive Slope Treadmill Training in Individuals After Stroke.|Completed||N/A|15|Actual|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||No||2017-10-10 23:40:52.27218|2017-10-10 23:40:52.27218
NCT02333019|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-11-09|||January 2013||2013-01-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|PPP_2||A Parent Child Program to Prevent Adolescent Pregnancy|A Parent Child Program to Prevent Adolescent Pregnancy|Completed||N/A|395|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 23:40:52.348762|2017-10-10 23:40:52.348762
NCT02333006|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-07-20|||February 2015||2015-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ANOSOGNOSIA||Anosognosia Evaluation After Cranocerebral Trauma Moderate to Severe|Anosognosia Evaluation After Cranocerebral Trauma Moderate to Severe|Recruiting||N/A|80|Anticipated|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||||2017-10-10 23:40:52.441536|2017-10-10 23:40:52.441536
NCT02332993|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-01-20|||December 2014||2014-12-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|FPP3||Nutritional Regulation of Wound Inflammation: Part III|Nutritional Regulation of Wound Inflammation: Part III|Recruiting||N/A|30|Anticipated|Ohio State University|||2||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 23:40:52.531339|2017-10-10 23:40:52.531339
NCT02332980|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-06-30|||February 19, 2015|Actual|2015-02-19|May 2017|2017-05-01|January 5, 2020|Anticipated|2020-01-05|January 5, 2020|Anticipated|2020-01-05||Interventional|||Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas|A Phase II Study of Anti-PD-1 Antibody (MK-3475) in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Other Low Grade B Cell Non-Hodgkin Lymphoma (NHL)|Recruiting||Phase 2|68|Anticipated|Mayo Clinic||1|||||||t||||||||||2017-10-10 23:40:52.665845|2017-10-10 23:40:52.665845
NCT02332967|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-01-12|||July 2007||2007-07-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Efficacy of Addition of Structured Lipids in Starter Formulas|Safety and Efficacy of Addition of Structured Lipids in Starter Formulas|Completed||N/A|488|Actual|Nestlé||3|||f||||t||||||||||2017-10-10 23:40:52.870223|2017-10-10 23:40:52.870223
NCT02332954|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-01-09|||February 2015||2015-02-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|AtWoRC||Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine|Interventional, Open-Label, Single Cohort, Canadian Study to Describe the Relationship Between Cognitive Symptoms and Work Productivity in Working Adults Treated With Vortioxetine for Major Depressive Disorder (MDD)|Active, not recruiting||Phase 4|226|Actual|Lundbeck Canada Inc.||2|||f||||f||||||||||2017-10-10 23:40:52.983858|2017-10-10 23:40:52.983858
NCT02332941|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-06-01|||August 2014||2014-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Rituximab||Treatment -Resistant Neovascular Age-Related Macular Degeneration|Intravitreal Rituximab|Completed||Phase 1|5|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-10 23:40:53.16135|2017-10-10 23:40:53.16135
NCT02332928|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-07-10|||March 25, 2015|Actual|2015-03-25|July 2017|2017-07-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy|Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: A Double Blind Placebo-Controlled Trial|Recruiting||Phase 3|142|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f||||||||2017-10-10 23:40:53.246007|2017-10-10 23:40:53.246007
NCT02332915|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-09-20|||May 1, 2015|Actual|2015-05-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Treatment Intensity - Apraxia of Speech|Effect of Intensity of Treatment on Rehabilitation of Acquired Apraxia of Speech|Recruiting||N/A|36|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:40:53.365357|2017-10-10 23:40:53.365357
NCT02332902|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-05-16|2017-05-09||February 2015||2015-02-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|DCLNF1||Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T|Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1- CRAD001CUS232T|Completed||Phase 2|24|Actual|The University of Texas Health Science Center, Houston||1|||f||||f||||||||||2017-10-10 23:40:53.460567|2017-10-10 23:40:53.460567
NCT02332889|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-05-08|||April 2015||2015-04-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs|A Phase I/Pilot II Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed or Refractory Pediatric High Grade Gliomas, Medulloblastomas, and CNS PNETs|Terminated||Phase 1/Phase 2|1|Actual|University of Louisville||1||Transition to a different immunotherapy strategy in the future at our institution|f||||t||||||||||2017-10-10 23:40:53.665209|2017-10-10 23:40:53.665209
NCT02332876|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-05-26|||August 2014||2014-08-01|May 2016|2016-05-01||||August 2017|Anticipated|2017-08-01||Interventional|||Physical Activity and Neuropsychological Outcomes in a Cancer Population||Active, not recruiting||N/A|87|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:40:53.750802|2017-10-10 23:40:53.750802
NCT02332863|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-04-13|||April 2016||2016-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.|Comparison of Traditional Back-loaded Fiducial Needles With Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement for Image-guided Radiation Therapy in Patients With Pancreatic Cancer: A Multicenter Randomized Controlled Trial.|Recruiting||N/A|40|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:40:53.820646|2017-10-10 23:40:53.820646
NCT02332850|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-15|||December 2014||2014-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma|A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination With Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1|42|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:40:53.9271|2017-10-10 23:40:53.9271
NCT02332837|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2016-11-04|||January 2018||2018-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|I-TIC||Interactive Tool for Informed Consent|Interactive Tool for Informed Consent: A Randomized Controlled Trial|Not yet recruiting||N/A|9600|Anticipated|ThinkWell||3|||f||||t||||||||||2017-10-10 23:40:54.009124|2017-10-10 23:40:54.009124
NCT02332811|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-12-22|||October 2013||2013-10-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TOSCANA||An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients|An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic Chronic Kidney Disease Patients|Completed||Phase 3|96|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 23:40:54.441076|2017-10-10 23:40:54.441076
NCT02332798|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-05-06|2016-03-02||January 2015||2015-01-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|MAD||Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia|A Randomized, Double-blind, Placebo Controlled, Sponsor Open, Parallel Group Phase 1b Study To Examine The Safety, Tolerability And Pharmacokinetics Of Multiple Ascending Doses Of Pf-04958242 In Subjects With Stable Schizophrenia|Completed||Phase 1|39|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 23:40:54.550946|2017-10-10 23:40:54.550946
NCT02332785|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-07-21|||November 2014|Actual|2014-11-01|July 2017|2017-07-01|November 2026|Anticipated|2026-11-01|November 2026|Anticipated|2026-11-01||Observational|||Prospective Study of Colon Serrated Polyps|Prospective Study of Colon Serrated Polyps|Recruiting||N/A|10000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-10 23:40:55.400745|2017-10-10 23:40:55.400745
NCT02332772|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-10-26|||April 2015||2015-04-01|October 2016|2016-10-01||||April 2025|Anticipated|2025-04-01||Observational|||Prospective Study of Colonoscopic Resection of Large Polyps and Flat Lesions|Prospective Study of Colonoscopic Resection of Large Polyps and Flat Lesions|Recruiting||N/A|10000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-10 23:40:55.491518|2017-10-10 23:40:55.491518
NCT02332759|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-12-20|||July 2014||2014-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device|A PILOT STUDY TO EVALUATE THE PRELIMINARY SAFETY AND FEASIBILITY OF THE MATERNA MEDICAL DEVICE FOR THE PREVENTION OF PERINEAL LACERATIONS AND OCCULT DISRUPTION OF THE PELVIC FLOOR AND ASSOCIATED SEQUELA DURING VAGINAL DELIVERY.|Completed||N/A|61|Actual|Baylor College of Medicine||1|||f||||f||||||||No||2017-10-10 23:40:55.579913|2017-10-10 23:40:55.579913
NCT02332746|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-01-05|||September 2013||2013-09-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Observational|||Exploring Temporal Relationships Between Self-worth and Physical Activity Middle-aged Women|Novel Exploration of Temporal Relationships Between Self-worth and Physical Activity in Middle-aged Women|Completed||N/A|67|Actual|Arizona State University|||1||f||||f||||||||||2017-10-10 23:40:55.6553|2017-10-10 23:40:55.6553
NCT02332733|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2016-09-21|||November 2014||2014-11-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand|Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Immunogenicity of Two Doses of the LID/NIAID Live-Attenuated Tetravalent Dengue Vaccine, TV003, Administered Six Months Apart, to Healthy Adults, Adolescents, and Children in Thailand|Recruiting||Phase 2|266|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:40:55.731053|2017-10-10 23:40:55.731053
NCT02332707|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-05-25|||January 22, 2015|Actual|2015-01-22|May 2017|2017-05-01|December 6, 2016|Actual|2016-12-06|September 16, 2016|Actual|2016-09-16||Interventional|||Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)|A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 With Either MK-8742 or MK-8408 in Subjects With Chronic HCV GT1 and GT2 Infection|Completed||Phase 2|443|Actual|Merck Sharp & Dohme Corp.||16|||f||||f||||||||||2017-10-10 23:40:56.029822|2017-10-10 23:40:56.029822
NCT02332694|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-07-23|||February 2015||2015-02-01|July 2015|2015-07-01||||December 2015|Anticipated|2015-12-01||Interventional|Fibro and WBH||Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia|Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia|Withdrawn||N/A|0|Actual|University of Arizona||1||Investigator transferred to the University of Wisconsin - Madison|f||||f||||||||||2017-10-10 23:40:56.180325|2017-10-10 23:40:56.180325
NCT02332681|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-05|||December 2014||2014-12-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Osteoporosis and Knee Insufficiency Fracture|Osteoporosis and Knee Insufficiency Fracture|Recruiting||N/A|300|Anticipated|University of Sao Paulo General Hospital|||2||f||||t||||||||||2017-10-10 23:40:56.266312|2017-10-10 23:40:56.266312
NCT02332668|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-06|2017-09-20|||March 18, 2015|Actual|2015-03-18|September 2017|2017-09-01|September 1, 2022|Anticipated|2022-09-01|January 2, 2019|Anticipated|2019-01-02||Interventional|||A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)|A Phase I/II Study of Pembrolizumab (MK-3475) in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma (KEYNOTE-051)|Recruiting||Phase 1/Phase 2|310|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||f|t|f||||||||2017-10-10 23:40:56.368979|2017-10-10 23:40:56.368979
NCT02332655|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-09-11|||December 2014||2014-12-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome|Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome|Active, not recruiting||Phase 1/Phase 2|10|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||f||||||||||2017-10-10 23:40:56.560849|2017-10-10 23:40:56.560849
NCT02332642|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-03-06|||November 2014||2014-11-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 2016|Actual|2016-12-01||Observational|ImmunoPAX||Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy|Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy|Completed||N/A|12|Actual|Universitätsmedizin Mannheim|||1||f||||f||||||||||2017-10-10 23:40:56.648716|2017-10-10 23:40:56.648716
NCT02332629|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-04-07|||January 2015||2015-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Methylprednisolone on Endothelial Function in Patients Undergoing Total Knee-arthroplasty|Effect of Preoperative Intravenous High Dose Methylprednisolone on Endothelial Function in Patients Scheduled for Total Knee-arthroplasty|Completed||Phase 3|70|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-10 23:40:56.712353|2017-10-10 23:40:56.712353
NCT02332616|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-04-07|||January 2015||2015-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Methylprednisolone on Complement Activation in Patients Undergoing Total Knee-arthroplasty|Effect of Preoperative Intravenous High Dose Methylprednisolone on Complement Activation in Patients Scheduled for Total Knee-arthroplasty|Completed||Phase 3|70|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-10 23:40:56.801089|2017-10-10 23:40:56.801089
NCT02332603|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-01-17|||January 2015||2015-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Methylprednisolone on Glucose Homeostasis in Patients Undergoing Total Hip- and Knee-arthroplasty|Effect of Preoperative Intravenous High Dose Methylprednisolone on Glucose Homeostasis in Patients Scheduled for Total Hip- and Knee-arthroplasty|Completed||Phase 3|134|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:40:56.896977|2017-10-10 23:40:56.896977
NCT02332590|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-09-14|2017-05-24|2016-12-07|February 2015||2015-02-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)|A Randomized, Double-blind, Parallel-group Study Assessing the Efficacy and Safety of Sarilumab Monotherapy Versus Adalimumab Monotherapy in Patients With Rheumatoid Arthritis|Active, not recruiting||Phase 3|369|Actual|Sanofi||2|||f||||t||||||||||2017-10-10 23:40:57.052376|2017-10-10 23:40:57.052376
NCT02332577|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-04-19|||April 2015||2015-04-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia|A Multi-centre, Non-inferiority, Randomized, Double-blind, Phase IV Study Comparing Pristinamycin (2g x 2 Per Day for 2 Days Then 1g x 3 Per Day for 5 to 7 Days) to Amoxicillin (1g x 3 Per Day) for 7 to 9 Days in Adults With Acute Community Acquired Pneumonia With a PORT Score of II or III|Recruiting||Phase 4|500|Anticipated|Sanofi||2|||f||||t||||||||||2017-10-10 23:40:58.912682|2017-10-10 23:40:58.912682
NCT02332564|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-03-23|||December 2014||2014-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CIMA||Coronary Steal Via Natural Internal Mammary Artery-To-Coronary Artery Bypasses|Coronary Steal Via Natural Internal Mammary Artery-To-Coronary Artery Bypasses|Suspended||N/A|100|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-10 23:40:59.134257|2017-10-10 23:40:59.134257
NCT02332382|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-01-04|||February 2015||2015-02-01|January 2015|2015-01-01||||April 2016|Anticipated|2016-04-01|3 Months|Observational [Patient Registry]|Breast Milk||The Influence of Mother Nutrition on Breast Milk Microbiome|The Influence of Mother Nutrition on the Composition of Fatty Acid, Oligosacharides and Its Effect on Breast Milk Microbiome|Unknown status|Not yet recruiting|N/A|20|Anticipated|Sheba Medical Center|||1||f||||||||||||||2017-10-10 23:41:00.58492|2017-10-10 23:41:00.58492
NCT02332551|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-03-27|||January 2015||2015-01-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Pilot Study of Percutaneous Irreversible Electroporation to Treat Unresectable Hepatic Carcinoma Close to the Gallbladder|A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:40:59.227454|2017-10-10 23:40:59.227454
NCT02332538|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-27|2017-09-03|||September 2014||2014-09-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH|Randomized Trial Comparing Holmium Laser Enucleation of the Prostate vs. Greenlight 532nm-laser Vapo-Enucleation of the Prostate vs. Bipolar Transurethral Resection of the Prostate in Management of Moderate/Large Benign Prostate Hyperplasia|Active, not recruiting||N/A|182|Actual|Mansoura University||3|||f||||t||||||||||2017-10-10 23:40:59.305599|2017-10-10 23:40:59.305599
NCT02332525|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-01-03|||January 2015||2015-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|OVSCF||The Influence of Oral Vibrational Stimulation on Cognitive Function of Elderly Individuals|The Influence of Oral Vibrational Stimulation on Brain Activity and Cognitive Function of Elderly Individuals With Mild Cognitive Impairment|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Seoul National University Bundang Hospital||1|||f||||t||||||||||2017-10-10 23:40:59.388633|2017-10-10 23:40:59.388633
NCT02332512|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2017-02-23|||January 2015||2015-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|ANSWER||Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)|A Randomized, Double-blind, Placebo-controlled, Phase III Trial of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)|Recruiting||Phase 3|417|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:40:59.478275|2017-10-10 23:40:59.478275
NCT02332499|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-09-15|||December 2014||2014-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALTER0703||Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)|Randomized,Double-blind,Placebo-controlled,Multicenter Study to Compare the Efficacy and Safety of Anlotinib Plus BSC Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies(ALTER0703)|Active, not recruiting||Phase 2/Phase 3|450|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-10 23:40:59.573722|2017-10-10 23:40:59.573722
NCT02332486|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-03|||January 2015||2015-01-01|January 2015|2015-01-01||||December 2017|Anticipated|2017-12-01||Interventional|OLP||Based on Metabonomics Dryness Pathogen Type of OLP: a Dynamic Study|Based on Metabonomics Dryness Pathogen Type of Oral Lichen Planus of Dynamic|Not yet recruiting||N/A|25|Anticipated|Heilongjiang University of Chinese Medicine||2|||f||||||||||||||2017-10-10 23:40:59.705557|2017-10-10 23:40:59.705557
NCT02332473|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2017-01-23|||June 2014||2014-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|||A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B|A Prospective Phase 2 Clinical Trial to Assess the Efficacy and Safety of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis Patients.|Completed||Phase 2|110|Actual|Xiamen Amoytop Biotech Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:40:59.78474|2017-10-10 23:40:59.78474
NCT02332460|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2016-10-06|||February 2015||2015-02-01|October 2016|2016-10-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01||Observational|||Infusion Related Reactions in Patients Receiving Infliximab|Incidence, Risk Factors and Immunologic Mechanisms of Infusion Related Reactions in Patients With Chronic Inflammatory Disease Receiving Infliximab|Recruiting||N/A|100|Anticipated|Haukeland University Hospital|||1||f||||f||||||Samples With DNA|"     immunological and biochemical biomarkers, autoimmune antibodies, antibodies to infliximab,     allergy analysis, concentrations of drugs (Infliximab, Metothrexat, and Imurel), HLA type   "|No||2017-10-10 23:40:59.873906|2017-10-10 23:40:59.873906
NCT02332447|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-10-04|||January 2015||2015-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2015|Actual|2015-03-01||Interventional|ENALEPSY||Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy|Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy|Recruiting||Phase 3|700|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:40:59.947282|2017-10-10 23:40:59.947282
NCT02332434|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-11-16|||March 2015||2015-03-01|November 2015|2015-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|MISTRAL||Effects of Various Bariatric Surgical Procedures on Intestinal TRL Metabolism in Obese Type 2 Diabetic Patients|Effects of Various Bariatric Surgical Procedures on Intestinal Triglyceride-rich-lipoprotein (TRL) Metabolism in Obese Type 2 Diabetic Patients|Recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:41:00.037774|2017-10-10 23:41:00.037774
NCT02332421|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-09-26|||June 2014||2014-06-01|January 2015|2015-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||The Use of a Modified Dentoalveolar Distractor to Retract Maxillary Canines|A Comparison Of The Short-Term Therapeutic Effects Between Two Distractors Used For The Retraction Of Maxillary Canines By Dentoalveolar Distraction Osteogenesis|Completed||N/A|8|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 23:41:00.120506|2017-10-10 23:41:00.120506
NCT02332408|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-01-04|||September 2014||2014-09-01|January 2015|2015-01-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|CKHRTVH||CyberKnife Based Hypofractionated Radiotherapy for Vertebral Hemangiomas|CyberKnife Based Hypofractionated Radiotherapy Versus Conventional Linac Based Radiotherapy for Painful Vertebral Hemangiomas - Controlled Randomized Clinical Trial.|Recruiting||Phase 3|80|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||t||||||||||2017-10-10 23:41:00.255486|2017-10-10 23:41:00.255486
NCT02332395|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-04-18|||December 2013||2013-12-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||The Evaluation of Postoperative Pain After Caesarean Section|The Evaluation of Postoperative Pain After Emergency and Elective Caesarean Section Operations|Completed||N/A|115|Actual|Tokat Gaziosmanpasa University|||2||f||||f||||||||Undecided||2017-10-10 23:41:00.494829|2017-10-10 23:41:00.494829
NCT02332356|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-01-04|||September 2014||2014-09-01|January 2015|2015-01-01||||March 2019|Anticipated|2019-03-01||Interventional|||Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease|Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease|Recruiting||Phase 3|100|Anticipated|Tokyo Medical and Dental University||4|||f||||||||||||||2017-10-10 23:41:00.794955|2017-10-10 23:41:00.794955
NCT02332343|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2017-05-05|||October 2014||2014-10-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|SIGHT||Sparing of the Fovea in Geographic Atrophy Progression|Sparing of the Fovea in Geographic Atrophy Progression|Completed||N/A|26|Actual|University Hospital, Bonn|||1||f||||f||||||||||2017-10-10 23:41:00.907046|2017-10-10 23:41:00.907046
NCT02332330|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2016-04-27|||January 2015||2015-01-01|October 2015|2015-10-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|VEST II||CD0104 VEST II Post Marketing Surveillance Study|A Post-market Prospective Study of the VGS VEST (Venous External Support), Supporting Saphenous Vein Grafts for Coronary Bypass Graft Surgery in Patients With Severe Coronary Heart Disease|Completed||N/A|30|Actual|Vascular Graft Solutions Ltd.||1|||f||||f||||||||||2017-10-10 23:41:00.985988|2017-10-10 23:41:00.985988
NCT02332317|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-05-31|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Early, Integrated, Specialized Palliative Rehabilitation|A Randomized, Controlled Phase III Study of Integrated, Specialized Palliative Rehabilitation for Patients With Newly Diagnosed Non-resectable Cancer.|Recruiting||N/A|300|Anticipated|Vejle Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:41:01.06918|2017-10-10 23:41:01.06918
NCT02332304|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-01-04|||May 2014||2014-05-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.|Amniotic Fluid Optical Density Determination Between 28 and 36 6/7 Weeks of Pregnancy and Its Relationship With the Diagnosis of Neonatal Respiratory Distress Syndrome.|Completed||Phase 3|200|Actual|Saint Thomas Hospital, Panama||1|||f||||f||||||||||2017-10-10 23:41:01.206927|2017-10-10 23:41:01.206927
NCT02332291|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-06-27|||April 2015||2015-04-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|CAARE||Connectivity Affecting the Antidepressant REsponse Study|Connectivity Affecting the Antidepressant REsponse (The CAARE Study)|Recruiting||Phase 4|130|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 23:41:01.30228|2017-10-10 23:41:01.30228
NCT02332278|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-01-04|||June 2014||2014-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Early Oral Feeding Versus Traditional Postoperative Care After Cesarean Section.|Early Oral Feeding Versus Traditional Postoperative Care After Uncomplicated Cesarean Section. A Randomized Controlled Trial.|Completed||N/A|444|Actual|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-10 23:41:01.427849|2017-10-10 23:41:01.427849
NCT02332265|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2015-01-02|||February 2009||2009-02-01|January 2015|2015-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|SAGE4Health||Evaluation of the Effects of a Structural Economic and Food Security Intervention on HIV Vulnerability in Rural Malawi|Pathways Linking Poverty, Food Insecurity, and HIV in Rural Malawi|Completed||N/A|1901|Actual|University of Wisconsin, Milwaukee|||3||f||||f||||||||||2017-10-10 23:41:01.514346|2017-10-10 23:41:01.514346
NCT02332252|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-01-05|||February 2015||2015-02-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Electrocautery Versus Scalpel for Surgical Skin Incisions in Cesarean Section.|Electrocautery Versus Scalpel for Surgical Skin Incisions in Cesarean Section. A Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|1000|Anticipated|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-10 23:41:01.638228|2017-10-10 23:41:01.638228
NCT02332226|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-11-04|||January 2015||2015-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|PIFBO||The PIFBO-study: Person-centred Information to Parents in Paediatric Oncology|The PIFBO-study: Person-centred Information to Parents in Paediatric Oncology - A Randomized Controlled Trial Based Upon a Conceptual Framework for Patient Education|Enrolling by invitation||N/A|130|Anticipated|Umeå University||2|||f||||f||||||||||2017-10-10 23:41:01.880209|2017-10-10 23:41:01.880209
NCT02332213|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-02|||January 2014||2014-01-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|VOLGACORE||Volatile Markers in Digestive Cancer|Volatile Marker Testing for Digestive Cancer and Precancerous Lesion Detection, Evaluation of Confounding Factors|Recruiting||N/A|2000|Anticipated|University of Latvia|||9||f||||f||||||Samples With DNA|"     Exhaled air samples being stored in specific adsorbent media Plasma/serum samples for group     stratification Faecal samples for occult blood testing and microbiota analysis Biopsy samples     from stomach and colon   "|||2017-10-10 23:41:01.979683|2017-10-10 23:41:01.979683
NCT02332200|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-01-30|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Rest Before Physical Therapy in Adolescents With Active Spondylolysis and Spondylolisthesis|Rest Before Physical Therapy in Adolescents With Active Spondylolysis and Spondylolisthesis.|Recruiting||N/A|250|Anticipated|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-10 23:41:02.197868|2017-10-10 23:41:02.197868
NCT02332187|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-04-25|||December 2014||2014-12-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of All-Stim 2 Quadriceps Treatments on Limb Muscle Strength In Mechanically Ventilated Patients|Effect of All-Stim 2 Quadriceps Treatments on Limb Muscle Strength In Mechanically Ventilated Patients.|Recruiting||N/A|20|Anticipated|University of Kentucky||2|||f||||t||||||||Yes|We will provide de-identified data to other researchers on request. We cannot, however, under the terms of our IRB approval, provide primary data which contains information that may identify participants. Data will be released once the paper is accepted for publication.|2017-10-10 23:41:02.31921|2017-10-10 23:41:02.31921
NCT02332174|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-01-03|||March 2014||2014-03-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects|Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects|Completed||Phase 1|40|Actual|Wuhan Union Hospital, China||4|||f||||t||||||||||2017-10-10 23:41:02.430458|2017-10-10 23:41:02.430458
NCT02332161|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-05-17|||January 2014||2014-01-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Leg Function and ADL After ALT Reconstruction for Head and Neck Cancer|Does Harvesting an Anterolateral Thigh (ALT) Flap Impact Lower Extremity Function and Activities of Daily Living (ADL) in Patients Undergoing Reconstructive Surgery for Head and Neck Cancer|Recruiting||N/A|20|Anticipated|University of Chicago|||1||f||||f||||||||||2017-10-10 23:41:02.515165|2017-10-10 23:41:02.515165
NCT02332148|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-08-19|||February 2015||2015-02-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|October 2015|Anticipated|2015-10-01||Interventional|||Assessment of the Safety and Efficacy of 3VM1001 Cream for Treatment of Chronic Pain Caused by Knee Osteoarthritis.|A Double-blind, Placebo-controlled, Randomized Study to Assess the Safety and Efficacy of 3VM1001 Cream for the Treatment of Chronic Pain Caused by Osteoarthritis of the Knee: A Proof of Concept Study|Unknown status|Not yet recruiting|Phase 1|50|Anticipated|CDA Research Group, Inc.||2|||f||||f||||||||||2017-10-10 23:41:02.596736|2017-10-10 23:41:02.596736
NCT02332122|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-08-21|||January 2015||2015-01-01|August 2015|2015-08-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Observational|||Detection of Aspergillus Fumigatus and Sensitization in COPD Patients With Bronchiectasis vs Without Bronchiectasis|Detection of Aspergillus Fumigatus and Sensitization in COPD Patients With Bronchiectasis vs COPD Patients Without Bronchiectasis|Unknown status|Recruiting|N/A|100|Anticipated|Katholieke Universiteit Leuven|||2||f||||f||||||Samples With DNA|"     Sputum sample obtained through induction   "|||2017-10-10 23:41:02.762657|2017-10-10 23:41:02.762657
NCT02332109|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-06-06|||September 2015||2015-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy|ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy|Completed||N/A|29|Actual|TRB Chemedica AG|||1||f||||f||||||||||2017-10-10 23:41:02.851711|2017-10-10 23:41:02.851711
NCT02332096|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-07-27|||June 2015||2015-06-01|July 2017|2017-07-01||||May 2020|Anticipated|2020-05-01||Observational|||Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation|Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation|Recruiting||N/A|100|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-10 23:41:02.937194|2017-10-10 23:41:02.937194
NCT02332083|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-07-22|||August 2014||2014-08-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Innovative Training Program for Elderly in Need of Care|Skilling-up Exercise for Elderly in Need of Care|Completed||Phase 4|20|Actual|Bern University of Applied Sciences||2|||f||||f||||||||||2017-10-10 23:41:03.02485|2017-10-10 23:41:03.02485
NCT02332070|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-07-19|||January 2015||2015-01-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|MARCE||Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac Events (MARCE)|Timing of Coronary Angiography and Multivariate Risk for Cardiac Surgery Associated Acute Kidney Injury and Major Adverse Renal and Cardiac Events (MARCE)|Active, not recruiting||N/A|1750|Anticipated|Baylor Research Institute|||1||f||||f||||||||||2017-10-10 23:41:03.106422|2017-10-10 23:41:03.106422
NCT02332057|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2016-07-26|||February 2015||2015-02-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Diclofenac Plus Lidocaine Gel for Pain Relief During Intrauterine Device Insertion(IUD).|Diclofenac Plus Lidocaine Gel for Pain Relief During Intrauterine Device (IUD) Insertion. A Randomized Double Blinded Placebo-controlled Study|Completed||Phase 2|90|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:41:03.183767|2017-10-10 23:41:03.183767
NCT02332044|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-04|2015-01-04|||April 2014||2014-04-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|||Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers|A Randomized, Open-label, Single Dose, Three-treatment, Three-period, Six-sequence Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Erdosteine and Bepotastine Besilate After Oral Administration in Healthy Volunteers|Completed||Phase 1|36|Actual|Daewoong Pharmaceutical Co. LTD.||3|||f||||f||||||||||2017-10-10 23:41:03.255115|2017-10-10 23:41:03.255115
NCT02332031|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-10-09|||February 2015||2015-02-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Sorafenib Drug Drug Interaction Study in Healthy Male Subjects|An Open-label Study in Healthy Male Subjects to Assess the Effect of Hyperthyroidism Mimicked by Oral Dosing of Levothyroxine on the Pharmacokinetics of Sorafenib|Completed||Phase 1|25|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:41:03.319796|2017-10-10 23:41:03.319796
NCT02332018|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2017-02-17|||July 2014||2014-07-01|February 2017|2017-02-01|January 6, 2016|Actual|2016-01-06|January 6, 2016|Actual|2016-01-06||Observational|||Measurements Of Lower Limbs And Spine Based On Biplanar Radiographs: Microdose Compared To Standard Dose Protocol|Two-dimensional And Three-dimensional Measurements Of Torsion And Length Of Lower Limbs And Spine Based On Biplanar Radiographs: Microdose Imaging Protocol Compared To Standard Dose Imaging Protocol|Completed||N/A|100|Actual|Balgrist University Hospital|||3||f||||t||||||||||2017-10-10 23:41:03.445703|2017-10-10 23:41:03.445703
NCT02332005|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-04-04|||November 2014||2014-11-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|March 2017|Anticipated|2017-03-01||Interventional|DE-DPN||12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study|Twelve-Month Chronic Efficacy and Safety of Diepalrestat in Adult Subjects With Diabetic Peripheral Neuropathy (DPN), A Randomized, Double-Blind, Placebo-Controlled Study|Recruiting||Phase 2/Phase 3|330|Anticipated|NeuromaxBionevia||3|||f||||f||||||||Yes||2017-10-10 23:41:03.516234|2017-10-10 23:41:03.516234
NCT02331979|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2016-01-26|||September 2015||2015-09-01|January 2016|2016-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Improving Bladder Function in SCI by Neuromodulation|Improving Bladder Function in SCI by Neuromodulation|Recruiting||Early Phase 1|24|Anticipated|University of California, Los Angeles||3|||f||||t||||||||||2017-10-10 23:41:03.754657|2017-10-10 23:41:03.754657
NCT02331966|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2015-01-05|||September 2014||2014-09-01|January 2015|2015-01-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia|Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors|Unknown status|Recruiting|N/A|10|Anticipated|AHEPA University Hospital|||1||f||||t||||||Samples Without DNA|"     RNA extraction from bone marrow and tissue samples from patients with tumor -induced     osteomalacia   "|||2017-10-10 23:41:03.836703|2017-10-10 23:41:03.836703
NCT02331953|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-03-09|||September 2014||2014-09-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Predictors of Postoperative Delirium in Elder Patients After Spine Surgery: Regional Cerebral Oxygen Saturation||Completed||N/A|109|Actual|Yonsei University|||2||f||||f||||||||||2017-10-10 23:41:03.910354|2017-10-10 23:41:03.910354
NCT02331940|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2017-02-12|2016-05-10||March 2010||2010-03-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional|||Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients|Tiotropium Respimat Soft Mist Inhaler Versus HandiHaler to Improve Sleeping Oxygen Saturation and Sleep Quality in COPD.|Completed||N/A|200|Actual|University of Crete||2|||f||||f||||||||No||2017-10-10 23:41:03.983881|2017-10-10 23:41:03.983881
NCT02331927|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-12-02|||March 2015||2015-03-01|December 2015|2015-12-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|PERMAD||PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer|Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer (PERMAD-Trial) - a Multicenter, Multinational, Two Part, Phase II Trial|Recruiting||Phase 2|200|Anticipated|University of Ulm||2|||f||||t||||||||||2017-10-10 23:41:05.947879|2017-10-10 23:41:05.947879
NCT02331914|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-04-20|||November 2014||2014-11-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||GIST: Assessment of Tumor Mutations and TKI Plasma Exposure|Gastrointestinal Stromal Tumors: Assessment of Mutations in Tumors and in Circulating Tumor DNA and Measurement of TKI Plasma Exposure to Optimize Treatment|Recruiting||N/A|300|Anticipated|University Medical Center Groningen|||1||f||||f||||||Samples With DNA|"     Tumor biopsy after disease progression   "|||2017-10-10 23:41:06.107069|2017-10-10 23:41:06.107069
NCT02331901|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Cerebral Microstructural Changes Following Mild Traumatic Brain Injury|Cerebral Microstructural Changes Following Mild Traumatic Brain Injury|Completed||N/A|50|Actual|University of Aarhus|||2||f||||t||||||||No||2017-10-10 23:41:06.234385|2017-10-10 23:41:06.234385
NCT02331888|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-09-07|||May 2014||2014-05-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|EUM||To Compare the Efficacy Between 3 Fetal Monitoring Methods|A Prospective, Blinded Clinical Study to Compare the Efficacy Between Three Fetal Monitoring Methods: Electro Uterine Monitor (EUM), Fetal Doppler and Scalp Electrode.|Unknown status|Recruiting|Phase 3|100|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-10 23:41:06.302013|2017-10-10 23:41:06.302013
NCT02331875|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-01-02|||December 2014||2014-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity|Open Label Single Arm Phase Ib-II Study of Pre-operative IPH2201 in Patients With Locally Advanced Resectable Squamous Cell Carcinoma of the Oral Cavity|Terminated||Phase 1/Phase 2|3|Actual|Innate Pharma||1||lack of recruitment|f||||||||||||||2017-10-10 23:41:06.377643|2017-10-10 23:41:06.377643
NCT02331862|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-01-04|||January 2015||2015-01-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||To Study the Effect of Adjunctive Oral Methylprednisolone Therapy in Pediatric Urinary Tract Infection|To Study the Effect of Adjunctive Oral Methylprednisolone Therapy in Pediatric Urinary Tract Infection|Unknown status|Not yet recruiting|Phase 3|160|Anticipated|National Cheng-Kung University Hospital||2|||f||||t||||||||||2017-10-10 23:41:06.456552|2017-10-10 23:41:06.456552
NCT02331849|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-01-02|||October 2013||2013-10-01|January 2015|2015-01-01||||February 2015|Anticipated|2015-02-01||Interventional|HIMEOS||Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry.|Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry - Effect on Esophageal Motility of Standard Therapy.|Unknown status|Recruiting|N/A|20|Anticipated|Technische Universität München||1|||f||||f||||||||||2017-10-10 23:41:06.537882|2017-10-10 23:41:06.537882
NCT02331836|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-08-09|||February 2015||2015-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|EC-Cap-SC||Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy|Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy for Adenoma Detection: A Randomized Controlled European Multicenter Study|Recruiting||N/A|561|Anticipated|Helios Albert-Schweitzer-Klinik Northeim||3|||f||||f||||||||||2017-10-10 23:41:06.621968|2017-10-10 23:41:06.621968
NCT02331823|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-01-02|||June 2013||2013-06-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Research on New Regimens for Retreatment Pulmonary Tuberculosis|New Super-short Course Regimen for Retreatment Pulmonary Tuberculosis|Unknown status|Recruiting|Phase 4|864|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||t||||||||||2017-10-10 23:41:06.861938|2017-10-10 23:41:06.861938
NCT02331810|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-06-02|||April 2016||2016-04-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients|A Randomized, Double-blind, Placebo-controlled Study Of Safety, Tolerability, And Pharmacokinetics Of Repeated Ascending Subcutaneous Doses Of SAR113244 And Pharmacodynamics Of Single Dose Of SAR113244 In Male And Female Lupus Patient|Withdrawn||Phase 1|0|Actual|Sanofi||2|||f||||t||||||||||2017-10-10 23:41:06.98527|2017-10-10 23:41:06.98527
NCT02330666|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-09-30|||August 2004||2004-08-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|MP||Parent-child Communication and Health-risk Behavior|Parent-child Communication and Health-risk Behavior|Completed||N/A|604|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-10 23:41:18.18052|2017-10-10 23:41:18.18052
NCT02331797|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2015-01-02|||December 2014||2014-12-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Endoscopic Transcanal Lateral Graft Tympanoplasty|Endoscopic Transcanal Lateral Graft Tympanoplasty: a Minimally Invasive Otologic Surgery|Unknown status|Recruiting|N/A|21|Anticipated|Prince of Songkla University||2|||f||||t||||||||||2017-10-10 23:41:07.080174|2017-10-10 23:41:07.080174
NCT02331784|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-19|||April 2015||2015-04-01|May 2017|2017-05-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|PACR-AD||Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease|Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease|Completed||N/A|66|Actual|Posit Science Corporation||2|||f||||t||||||||||2017-10-10 23:41:07.189603|2017-10-10 23:41:07.189603
NCT02331771|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-04-05|||June 2015||2015-06-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Donepezil Memory Preservation Post ECT|Can Donepezil Preserve Autobiographical Memory Post Electroconvulsive Therapy? A Randomized, Placebo-Controlled Trial|Recruiting||N/A|162|Anticipated|Porter Adventist Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:41:07.272432|2017-10-10 23:41:07.272432
NCT02331758|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-01-02|||January 2015||2015-01-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||The Influence Factors of Ovarian Response in PCOS Patients With IVF-ET Treatment|The Influence Factors of Ovarian Response in Polycystic Ovary Syndrome Patients(PCOS) With In Vitro Fertilization and Embryo Transfer (IVF-ET) Treatment|Unknown status|Not yet recruiting|N/A|1000|Anticipated|Peking University Third Hospital||2|||f||||f||||||||||2017-10-10 23:41:07.367077|2017-10-10 23:41:07.367077
NCT02331745|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2016-08-04|||October 2013||2013-10-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|April 2016|Actual|2016-04-01||Interventional|||RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure|Granulocyte Colony-stimulating Factor(G-CSF) in the Treatment of Hepatic Failure: a Prospective Randomized Controlled Clinical Study|Recruiting||Phase 4|140|Anticipated|Beijing 302 Hospital||2|||f||||f||||||||||2017-10-10 23:41:07.440656|2017-10-10 23:41:07.440656
NCT02331732|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2015-09-23|||October 2015||2015-10-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Virtually Observed Treatment (VOT) for Tuberculosis Patients in Moldova||Unknown status|Not yet recruiting|N/A|400|Anticipated|The Behavioural Insights Team||2|||f||||f||||||||||2017-10-10 23:41:07.544166|2017-10-10 23:41:07.544166
NCT02331719|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-01-25|||August 2014||2014-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|90 Days|Observational [Patient Registry]|MiSPACE||Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation|Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation|Recruiting||N/A|50|Anticipated|Aurora Health Care|||2||f||||f||||||||No||2017-10-10 23:41:07.631089|2017-10-10 23:41:07.631089
NCT02331706|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-09-23|||December 2014||2014-12-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Interventional|||IFN-DLI for Relapsed Acute Leukemia After Allo-SCT|A Pilot Study to Determine the Feasibility of Conventional Induction Chemotherapy Followed by G-CSF Mobilized Donor Leukocyte Infusion (DLI) and IFN-α (IFN-DLI) for Relapsed Acute Leukemia After Allogeneic Stem Cell Transplantation.|Recruiting||Early Phase 1|48|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:41:07.751443|2017-10-10 23:41:07.751443
NCT02331693|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-05|||December 2014||2014-12-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR|Genetically Modified T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR|Unknown status|Recruiting|Phase 1|10|Anticipated|RenJi Hospital||1|||f||||||||||||||2017-10-10 23:41:07.835914|2017-10-10 23:41:07.835914
NCT02331680|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-03-09|||December 2014||2014-12-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration|A Phase 2, Multicenter, Placebo-controlled, Double-blind, Randomized, Parallel-group Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration|Completed||Phase 2|120|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-10 23:41:07.940452|2017-10-10 23:41:07.940452
NCT02331667|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-12-16|||December 2014||2014-12-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Diet on Learning Abilities for Children in Kindergarden|The Effect of Diet on Learning Abilities for Children in Kindergarden|Completed||N/A|233|Actual|National Institute of Nutrition and Seafood Research, Norway||2|||f||||t||||||||Yes|The results will be published in international journals.|2017-10-10 23:41:08.028999|2017-10-10 23:41:08.028999
NCT02331654|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-01-05|||November 2013||2013-11-01|January 2015|2015-01-01|February 2016|Anticipated|2016-02-01|June 2015|Anticipated|2015-06-01||Interventional|||Spinal Direct Current Stimulation Effects on Pain in Multiple Sclerosis|Spinal Direct Current Stimulation Effects on Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment and Evaluation of Endocannabinoid System Activity|Unknown status|Recruiting|N/A|60|Anticipated|"IRCCS National Neurological Institute C. Mondino Foundation"||2|||f||||f||||||||||2017-10-10 23:41:08.130299|2017-10-10 23:41:08.130299
NCT02331641|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-01-05|||January 2005||2005-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.|Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases. A Propensity Score-matched Dual-institution Analysis.|Completed||N/A|554|Actual|University of Milan|||2||f||||f||||||||||2017-10-10 23:41:08.231754|2017-10-10 23:41:08.231754
NCT02331628|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-09-26|||October 2014||2014-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ESWT as a Treatment for Chronic NHO in TBI Patients|Effect of Extracorporeal Shock Wave Therapy on Chronic Neurogenic Heterotopic Ossification in Traumatic Brain Injured Patients|Recruiting||N/A|12|Anticipated|Loewenstein Hospital||2|||f||||t||||||||||2017-10-10 23:41:08.335191|2017-10-10 23:41:08.335191
NCT02331615|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-09-26|||March 2013||2013-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Application of Trans Cranial Direct Current Stimulation for Executive Dysfunction After Traumatic Brain Injury|Feasibility of the Use of Electrical Stimulation Using tDCS to Influence Executive Abilities After Traumatic Brain Injury Patients|Recruiting||N/A|90|Anticipated|Loewenstein Hospital||3|||f||||t||||||||||2017-10-10 23:41:08.42864|2017-10-10 23:41:08.42864
NCT02331602|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2015-08-04|||July 2013||2013-07-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|RIVAL-AF||Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran|Comparison of Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran in Patients With Non-valvular Atrial Fibrillation (RIVAL-AF Study) -Multicenter Randomized Study-|Unknown status|Recruiting|Phase 4|200|Anticipated|Yokohama City University Medical Center||2|||f||||t||||||||||2017-10-10 23:41:08.524905|2017-10-10 23:41:08.524905
NCT02331589|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-02-08|2015-01-07||August 2011||2011-08-01|December 2014|2014-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis|Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis|Completed||Phase 4|75|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||||2017-10-10 23:41:08.801429|2017-10-10 23:41:08.801429
NCT02331576|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-07-25|||January 2015||2015-01-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Analgesic Effect of Perineural Fentanyl Additive to Local Anesthetics in Femoral Nerve Block|Femoral Nerve Block in Patient With Total Knee Arthroplasty; Analgesic Effect of Perineural Fentanyl Additive to Local Anesthetics|Recruiting||N/A|100|Anticipated|Chonnam National University Hospital||2|||f||||t||||||||||2017-10-10 23:41:09.123379|2017-10-10 23:41:09.123379
NCT02331563|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-09-03|||October 2014||2014-10-01|January 2015|2015-01-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|USG||Adjuvant Effect of Dexmedetomidine in Ultrasound (USG) Guided Transvers Abdominis Plane Block|Adjuvant Effect of Dexmedetomidine for the Ultrasound Guided Transversus Abdominis Plane Block in Patients Undergoing Laparascopic Cholecystectomy: a Randomized Controlled Clinical Trial.|Withdrawn||Phase 3|0|Actual|Kırıkkale University||2||patients should have assurance to attend this study, money is the main problem|f||||f||||||||||2017-10-10 23:41:09.224219|2017-10-10 23:41:09.224219
NCT02331550|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2016-09-25|||January 2014||2014-01-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Observational vs. Ablative Treatment for Low-grade Squamous Intraepithelial Lesions.|Observational vs. Ablative Treatment for Low-grade Squamous Intraepithelial Lesions. Retrospective Paired Cohort Study.|Completed||N/A|250|Actual|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-10 23:41:09.327829|2017-10-10 23:41:09.327829
NCT02331537|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-08-31|||January 2015||2015-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Internet-based Exposure Therapy for Excessive Worry|Internet-based Exposure Therapy for Excessive Worry: A Randomized Trial|Completed||N/A|140|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:41:09.42091|2017-10-10 23:41:09.42091
NCT02331524|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-27|2017-02-22|||October 2014||2014-10-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Interventions to Improve Daily Activity in Heart Failure|Exercise and Psychosocial-Based Interventions to Improve Daily Activity in Heart Failure|Completed||N/A|16|Actual|Grand Valley State University||3|||f||||f||||||||||2017-10-10 23:41:09.507172|2017-10-10 23:41:09.507172
NCT02331511|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-10-28|||October 2015||2015-10-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator|Effect of Aspirin and Clopidogrel in Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator|Unknown status|Recruiting|N/A|100|Anticipated|Shahid Beheshti University of Medical Sciences||3|||f||||t||||||||||2017-10-10 23:41:09.601443|2017-10-10 23:41:09.601443
NCT02331498|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-02-21|||June 2015||2015-06-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|PAZOGLIO||Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I/II Study of Pazopanib in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme After Surgery and RT-CT|Recruiting||Phase 1/Phase 2|51|Anticipated|Centre Antoine Lacassagne||1|||f||||t||||||||||2017-10-10 23:41:09.712812|2017-10-10 23:41:09.712812
NCT02331485|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-01-03|||August 2014||2014-08-01|January 2015|2015-01-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Randomised Control Study to Asses the Role of Negative Pressure Wound Therapy (NPWT) in the Management of Wound in Surgical Patient|RANDOMISED CONTROL STUDY TO ASSES THE ROLE OF NEGATIVE PRESSURE WOUND THERAPY (NPWT) IN THE MANAGEMENT OF WOUND IN SURGICAL PATIENT|Unknown status|Recruiting|N/A|150|Anticipated|St James Connolly Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:41:09.827102|2017-10-10 23:41:09.827102
NCT02331472|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2017-07-06|||January 2015||2015-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Month|Observational [Patient Registry]|||The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)|The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome|Recruiting||N/A|75|Anticipated|Asan Medical Center|||2||f||||t||||||Samples With DNA|"     RNA in urine specimen   "|||2017-10-10 23:41:09.957582|2017-10-10 23:41:09.957582
NCT02331459|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2015-01-31|||December 2013||2013-12-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|EMTIFE||Training Intervention in a Controlled Population of Frail Elderly|Effect of a Multicomponent Training Intervention on Cognition, Mood, and Function in a Controlled Population of Community-dwelling Frail Elderly Patients.|Completed||N/A|100|Actual|Hospital de la Ribera||2|||f||||f||||||||||2017-10-10 23:41:10.066777|2017-10-10 23:41:10.066777
NCT02331446|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-08-22|2016-07-13||March 2014||2014-03-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ProAFIM|The number of baseline participants is not consistent with number provided in the Participant Flow module because two of the beginning participants did not arrived on the first data collection. Due to this, these participants (one of the 90 min/week, and other of the 150 min/week group) were lost to follow-up before the baseline data collection.|The Effect of Different Volumes of Physical Exercise on the Immune System|Dose-response Effects of Different Volumes of Structured Exercise in the Inflammatory and Oxidative Stress Parameters in Postmenopausal Women: a Randomized Clinical Trial|Completed||N/A|42|Actual|Federal University of Pelotas|The test performed to estimate the cardiorespiratory fitness was not specific to measure physical activity performed by the women. The test was done walking (six-minute walking test) and the aerobic training was carried out on cycle-ergometers.|4|||f||||t||||||||||2017-10-10 23:41:10.246815|2017-10-10 23:41:10.246815
NCT02331433|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2016-04-07|||December 2014||2014-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects|A Phase 1 Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APN1125 in Healthy Normal Subjects|Completed||Phase 1|58|Actual|CoMentis||2|||f||||f||||||||||2017-10-10 23:41:11.615874|2017-10-10 23:41:11.615874
NCT02331420|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-05|||February 2015||2015-02-01|January 2015|2015-01-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|BASTA||Effect of BAriatric Surgery Versus Optimal Medical Therapy on Cardiovascular Health and Atherosclerosis in Obese, Type II Diabetic Patients|Prospective Randomized Controlled Trial on the Effect of BAriatric Surgery Versus Optimal Medical Therapy on Cardiovascular Health and Progression of Atherosclerosis in Obese, Type II Diabetic Patients|Unknown status|Not yet recruiting|N/A|58|Anticipated|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-10 23:41:11.700434|2017-10-10 23:41:11.700434
NCT02331407|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-01-02|||October 2008||2008-10-01|January 2015|2015-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Robot Rehabilitation Exercise Training on Motor Control After Stroke|Effect of Robot Rehabilitation Exercise Training on Motor Control After Stroke|Completed||N/A|9|Actual|Columbia University||1|||f||||f||||||||||2017-10-10 23:41:11.766344|2017-10-10 23:41:11.766344
NCT02331394|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-03|2017-03-08|||October 2015||2015-10-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CH||A Feasibility Study of Chinese Herbs to Manage Cancer-related Symptoms in Patients With Advanced NSCLC|A Feasibility Study of Chinese Herbs to Manage Cancer-related Symptoms in Patients With Advanced Non-small-cell- Lung Cancer|Recruiting||N/A|15|Anticipated|Lady Davis Institute||1|||f||||f||||||||Yes|Publication in peer-reviewed journal|2017-10-10 23:41:11.828467|2017-10-10 23:41:11.828467
NCT02331381|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-02-16|||December 26, 2013|Actual|2013-12-26|February 2017|2017-02-01|September 7, 2016|Actual|2016-09-07|December 23, 2015|Actual|2015-12-23||Interventional|||Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device|A Pilot Study of Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device|Terminated||Phase 1|15|Actual|Washington University School of Medicine||1||Low accrual|f||||t|f|t|f|f|f|||No||2017-10-10 23:41:12.090591|2017-10-10 23:41:12.090591
NCT02331368|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-09-06|||June 2015||2015-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma|Phase 2 Multi-center Study of Anti-Programmed-Death-1 [Anti-PD-1] During Lymphopenic State After High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplant [HDT/ASCT] for Multiple Myeloma|Active, not recruiting||Phase 2|32|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:41:12.17977|2017-10-10 23:41:12.17977
NCT02331355|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-10-24|||April 2016||2016-04-01|October 2016|2016-10-01|January 2025|Anticipated|2025-01-01|February 2021|Anticipated|2021-02-01||Observational|||Hand Transplantation: Functional and Quality of Life Outcomes|VCA (Hand Transplantation): Functional and Quality of Life Outcomes|Recruiting||N/A|5|Anticipated|University of Michigan|||1||f||||f||||||||||2017-10-10 23:41:12.277025|2017-10-10 23:41:12.277025
NCT02331342|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-05|||July 2013||2013-07-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Comparison of NICOM and Innocor for Non-Invasive Determination of Cardiac Output||Completed||N/A|36|Actual|Universitätsmedizin Mannheim|||1||f||||f||||||||||2017-10-10 23:41:12.361158|2017-10-10 23:41:12.361158
NCT02331329|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2015-01-05|||July 2013||2013-07-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Evaluation of NICOM (Bioreactance) for the Non-invasive Determination of Cardiac Output||Completed||N/A|41|Actual|Universitätsmedizin Mannheim|||1||f||||f||||||||||2017-10-10 23:41:12.435697|2017-10-10 23:41:12.435697
NCT02331316|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2016-11-04|||January 2018||2018-01-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Drinking Water to Reach or Maintain a Healthier Weight|Drinking Water To Prevent or Reduce Weight Gain - An Online Randomized Controlled Trial With Adult Participants|Not yet recruiting||N/A|9600|Anticipated|ThinkWell||4|||f||||t||||||||||2017-10-10 23:41:12.500861|2017-10-10 23:41:12.500861
NCT02331303|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2017-08-21|||April 15, 2015|Actual|2015-04-15|August 2017|2017-08-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||A Drug Utilization Study of Radium-223 in Sweden|A Drug Utilization Study of Xofigo Use in Sweden|Active, not recruiting||N/A|200|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 23:41:12.621289|2017-10-10 23:41:12.621289
NCT02331290|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-05-10|||May 2016||2016-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen|Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen|Recruiting||N/A|20|Anticipated|University of Manitoba|||1||f||||f||||||Samples Without DNA|"     Blood (2 x 10 ml) at 2 and 4 hours after amantadine ingestion. Saliva (2 x 5ml) immediately     after the blood samples. Urine specimen between the time of the 2 blood samples.      The sampling protocol will be repeated 3 weeks later with the second cycle of chemotherapy.   "|||2017-10-10 23:41:12.706985|2017-10-10 23:41:12.706985
NCT02331277|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-05|2016-05-31|||September 2015||2015-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Safety and Pharmacokinetics of Multiple Doses of BI 655064 in Healthy Chinese Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Doses of BI 655064 in Healthy Chinese Male Volunteers (Randomised, Double-blind, Placebo-controlled, Clinical Phase I Study)|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:41:12.803086|2017-10-10 23:41:12.803086
NCT02331264|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-02|2016-04-04|||November 2014||2014-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Observational|||Cardiac Assessment of Patients With Hip Implants|Cardiac Assessment of Patients With Hip Implants|Completed||N/A|90|Actual|Royal National Orthopaedic Hospital NHS Trust|||3||f||||f||||||||Yes|publication submitted|2017-10-10 23:41:12.924786|2017-10-10 23:41:12.924786
NCT02331251|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2017-08-08|||December 2014||2014-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)|A Phase Ib/II Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)|Active, not recruiting||Phase 1/Phase 2|90|Anticipated|Western Regional Medical Center||6|||f||||f||||||||||2017-10-10 23:41:13.059694|2017-10-10 23:41:13.059694
NCT02331238|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2017-02-24|||March 2015||2015-03-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Trial of a Middle School Coach Gender Violence Prevention Program|Cluster-Randomized Trial of a Middle School Coach Gender Violence Prevention Program|Active, not recruiting||N/A|973|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 23:41:13.19677|2017-10-10 23:41:13.19677
NCT02331225|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-12-15|||December 2014||2014-12-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Observational|||Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension|Endothelial Mircroparticles as a Biomarker of Pulmonary Hypertension in Systemic Sclerosis|Completed||N/A|30|Actual|Louisiana State University Health Sciences Center in New Orleans|||3||f||||f||||||Samples Without DNA|"     Blood will be retained.   "|||2017-10-10 23:41:13.289134|2017-10-10 23:41:13.289134
NCT02331212|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-07-11|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer|Role of Hyaluronic Acid in Cancer Stem Cell Niche|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences|||1|Logistical Issues|f||||f|f|f||||||||2017-10-10 23:41:13.397733|2017-10-10 23:41:13.397733
NCT02331199|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-01-20|||December 2014||2014-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Comparison Between Amniotic Fluid Lamellar Body Count and Fetal Pulmonary Artery Doppler Indices in Predicting Fetal Lung Maturity|Comparison Between Amniotic Fluid Lamellar Body Count and Fetal Pulmonary Artery Doppler Indices in Predicting Fetal Lung Maturity|Recruiting||Phase 3|200|Anticipated|Cairo University||1|||f||||t||||||||||2017-10-10 23:41:13.497646|2017-10-10 23:41:13.497646
NCT02331186|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2015-01-02|||December 2014||2014-12-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Effects of Bariatric Surgery on Pelvic Floor Fonctions in Obese Women|Effects of Bariatric Surgery on Pelvic Floor in Obese Women|Unknown status|Recruiting|N/A|60|Anticipated|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||1||f||||f||||||||||2017-10-10 23:41:13.639888|2017-10-10 23:41:13.639888
NCT02331160|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2017-02-23|||March 2015||2015-03-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|RECeiVe||Rebozo and External Cephalic Version in Breech Presentation.|Rebozo Som Vendingsmetode Ved sædepræsentation (in Danish)|Recruiting||N/A|378|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-10 23:41:13.821899|2017-10-10 23:41:13.821899
NCT02331147|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-08-14|||December 2014||2014-12-01|August 2016|2016-08-01||||January 2017|Anticipated|2017-01-01||Interventional|||Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers|A Prospective, Randomized, Comparative Parallel Study of Allogenic Dermis Graft in the Management of Diabetic Foot Ulcers|Recruiting||N/A|80|Anticipated|Professional Education and Research Institute||2|||f||||f||||||||||2017-10-10 23:41:13.921746|2017-10-10 23:41:13.921746
NCT02331134|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2017-07-06|||May 13, 2015|Actual|2015-05-13|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Tissue and Hematopoietic Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer|Pilot Study of Tissue and Hematopoietic Stem Cell Collection for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer|Recruiting||N/A|20|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-10 23:41:14.041073|2017-10-10 23:41:14.041073
NCT02331121|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2016-10-12|||June 2012||2012-06-01|October 2016|2016-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|FirstAid_2||Multimedia First Aid Program for Families|Multimedia First Aid Program for Families|Completed||N/A|182|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 23:41:14.122017|2017-10-10 23:41:14.122017
NCT02331108|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-04-12|2017-02-06||August 2014|Actual|2014-08-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|INHvsIV||A Comparison of Inhalation vs. Intravenous Induction|A Comparison of the Effect on Temperature Between Patients Induced With Intravenous Propofol vs Inhalation Induction With Sevoflurane|Completed||N/A|331|Actual|Albert Einstein Healthcare Network||6|||f||||f||||||||Undecided||2017-10-10 23:41:14.206979|2017-10-10 23:41:14.206979
NCT02331095|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-03-28|||January 2015||2015-01-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|||Statin Use in Patients With Acute VTE|A Pilot Study of Using Statins in Patients With Acute Venous Thromboembolism (VTE)|Recruiting||Phase 1/Phase 2|80|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-10 23:41:14.705563|2017-10-10 23:41:14.705563
NCT02331082|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-02-24|||November 2014||2014-11-01|February 2015|2015-02-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Integrating Pediatric Care Delivery in Rural Healthcare Systems|Integrating Pediatric Care Delivery in Rural Healthcare Systems|Recruiting||N/A|7000|Anticipated|Possible||2|||f||||f||||||||||2017-10-10 23:41:14.812717|2017-10-10 23:41:14.812717
NCT02331069|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-03-13|||January 2015||2015-01-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Delto-Tricipital Compression Syndrome: Treated With Injection of Dextrose|Delto-Tricipital Compression Syndrome: A Randomized Treatment Comparison Trial of Dextrose Injection Versus Physical Therapy.|Unknown status|Recruiting|N/A|80|Anticipated|Universidad Abierta Interamericana||2|||f||||f||||||||||2017-10-10 23:41:14.929459|2017-10-10 23:41:14.929459
NCT02331056|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-10-06|||July 2014||2014-07-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01|1 Week|Observational [Patient Registry]|||Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?|Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?|Completed||N/A|79|Actual|Samsung Medical Center|||2||f||||t||||||||||2017-10-10 23:41:15.039706|2017-10-10 23:41:15.039706
NCT02331043|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-01-07|||March 2013||2013-03-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Serum Cholesterol Reduction Efficacy of Biscuit With Plant Stanol Ester|Serum Cholesterol Reduction Efficacy of Biscuit With Added Plant Stanol Ester|Completed||N/A|119|Actual|Raisio Group||2|||f||||||||||||||2017-10-10 23:41:15.138346|2017-10-10 23:41:15.138346
NCT02331030|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-07-17|||December 2014||2014-12-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting|A Randomised Controlled Trial Comparing Ultrasound-guided Supraclavicular Brachial Plexus Block With Combined Supraclavicular and Pecs II Block in Patients Undergoing Arteriovenous Grafting Surgery|Completed||N/A|36|Actual|Changi General Hospital||2|||f||||f||||||||||2017-10-10 23:41:15.226495|2017-10-10 23:41:15.226495
NCT02331017|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-01-02|||December 2014||2014-12-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Assessment of Bimodal Contribution in Adult Cochlear Implant Users|Assessment of the Contribution of the Combined Acoustic Hearing Via a Hearing Aid and Electric Hearing Via a Cochlear Implant in Adult Bimodal Users With Moderate to Severe Residual Hearing in the Implanted and Non Implanted Ear.|Unknown status|Recruiting|N/A|20|Anticipated|Bnai Zion Medical Center||1|||f||||f||||||||||2017-10-10 23:41:15.334696|2017-10-10 23:41:15.334696
NCT02331004|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-05-28|||May 2014||2014-05-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effectiveness of an Intervention Program for Fine Motor Skills|Effectiveness of an Intervention Program for Fine Motor Skills in Institutionalized Elderly Residents: a Randomized Clinical Trial|Completed||N/A|40|Actual|Universidad de Granada||2|||f||||t||||||||||2017-10-10 23:41:15.424343|2017-10-10 23:41:15.424343
NCT02330991|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-01-01|||January 2015||2015-01-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse||Not yet recruiting||Phase 2|204|Anticipated|Beijing Sanbo Brain Hospital||2|||f||||||||||||||2017-10-10 23:41:15.5013|2017-10-10 23:41:15.5013
NCT02330978|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2016-07-04|||January 2014||2014-01-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.|Intravitreal Autologous Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Patients With Advanced Glaucoma. Phase I: Safety Study.|Recruiting||Phase 1|10|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-10 23:41:15.570288|2017-10-10 23:41:15.570288
NCT02330965|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-04-26|||December 2014||2014-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis|Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis (AMS04)|Active, not recruiting||N/A|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||f|f|f||||Samples With DNA|"     Blood & Cerebrospinal Fluid Samples   "|||2017-10-10 23:41:15.790916|2017-10-10 23:41:15.790916
NCT02330952|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2016-10-24|||February 2015||2015-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|BECOMEG||Efficacy of Corticosteroids to Treat Outpatients With Acute Exacerbations of COPD|Efficacy and Safety of Oral Corticosteroids for the Treatment of Acute Exacerbations of COPD in General Practice|Recruiting||Phase 4|500|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:41:15.924234|2017-10-10 23:41:15.924234
NCT02330939|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-01-02|||June 2014||2014-06-01|January 2015|2015-01-01||||December 2014|Actual|2014-12-01||Interventional|FACILE||Fats And Carbohydrates Quality on Postprandial glycemIc Response in Type 1 Diabetes|Impact of Fats And Carbohydrates Quality on Postprandial glycemIc Response in People With Type 1 diabEtes on Insulin Pump (FACILE Study)|Unknown status|Active, not recruiting|N/A|14|Anticipated|Federico II University||6|||f||||||||||||||2017-10-10 23:41:16.045924|2017-10-10 23:41:16.045924
NCT02330926|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-06-22|||April 2015||2015-04-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|MENAC||Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy|A Randomised, Open-label Trial of a Multimodal Intervention (Exercise, Nutrition and Antiinflammatory Medication) Plus Standard Care Versus Standard Care Alone to Prevent/Attenuate Cachexia in Advanced Cancer Patients Undergoing Chemotherapy|Recruiting||N/A|240|Anticipated|Norwegian University of Science and Technology||2|||f||||t||||||||Undecided||2017-10-10 23:41:16.149899|2017-10-10 23:41:16.149899
NCT02330913|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-12-24|||December 2014||2014-12-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy|Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy: π-shape Esophagojejunostomy, Three-in-one Technique|Completed||N/A|10|Actual|Keimyung University Dongsan Medical Center||1|||f||||f||||||||||2017-10-10 23:41:16.331425|2017-10-10 23:41:16.331425
NCT02330900|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-05-10|||November 2014||2014-11-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation of Interference Between Cell Phones and Implantable Cardioverter Defibrillators|Evaluation of Interference Between Cell Phones and Implantable Cardioverter Defibrillators|Completed||N/A|54|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-10-10 23:41:16.422041|2017-10-10 23:41:16.422041
NCT02330887|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2014-12-31|||November 2014||2014-11-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Group Antenatal Care: The Power of Peers for Increasing Skilled Birth Attendance in Achham, Nepal|Group Antenatal Care: The Power of Peers for Increasing Skilled Birth Attendance in Achham, Nepal|Unknown status|Recruiting|N/A|1800|Anticipated|Possible||2|||f||||f||||||||||2017-10-10 23:41:16.535923|2017-10-10 23:41:16.535923
NCT02330874|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2015-01-02|||April 2014||2014-04-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Observational|||Validation of the SD-ICU. A Risk Assessment Tool of Unplanned ICU Readmission|Assessment of the Risk of Unplanned Readmission to the Intensive Care Unit Using the Safe Discharge From ICU (SD-ICU) Score: A Validation Study.|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Hospital Sao Domingos|||1||f||||t||||||||||2017-10-10 23:41:16.669399|2017-10-10 23:41:16.669399
NCT02330861|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-01-05|||December 2014||2014-12-01|January 2015|2015-01-01||||December 2015|Anticipated|2015-12-01||Interventional|||Relationship Between Pressure and Flow Velocity on Coronary Physiology|Relationship Between Pressure and Flow Velocity on Coronary Physiology|Unknown status|Recruiting|N/A|15|Anticipated|Hyogo College of Medicine||1|||f||||||||||||||2017-10-10 23:41:16.749374|2017-10-10 23:41:16.749374
NCT02328794|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-05-01|||January 1, 2015|Actual|2015-01-01|May 2017|2017-05-01|April 20, 2017|Actual|2017-04-20|November 5, 2016|Actual|2016-11-05||Interventional|||Randomized Clinical Trial to Reduce Harm From Tobacco|Randomized Clinical Trial to Reduce Harm From Tobacco|Completed||N/A|6006|Actual|University of Pennsylvania||5|||f||||f||||||||||2017-10-10 23:41:40.750135|2017-10-10 23:41:40.750135
NCT02330848|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-01-02|||February 2012||2012-02-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|Walnut3||Walnut Ingestion in Adults at Risk for Diabetes: Effects on Body Composition, Diet Quality, and Cardiac Risk Measures|Walnut Ingestion in Adults at Risk for Diabetes: Effects on Body Composition, Diet Quality, and Cardiac Risk Measures|Completed||N/A|112|Actual|Griffin Hospital||2|||f||||f||||||||||2017-10-10 23:41:16.83159|2017-10-10 23:41:16.83159
NCT02330835|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-01-02|||January 2007||2007-01-01|December 2014|2014-12-01|July 2007|Actual|2007-07-01|May 2007|Actual|2007-05-01||Interventional|BUS_2||Multimedia Program to Promote Positive Bus Behavior|Multimedia Program to Promote Positive Bus Behavior|Completed||Phase 2|710|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 23:41:16.932155|2017-10-10 23:41:16.932155
NCT02330822|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-09-26|||December 2014||2014-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Role of Hyaluronic Acid in Bone Healing After Dental Extraction|A Clinical and Experimental Study to Evaluate the Efficacy of Locally Applied Hyaluronic Acid in Bone Healing Following Dental Extraction|Completed||N/A|20|Actual|Damascus University||2|||f||||t||||||||||2017-10-10 23:41:17.036368|2017-10-10 23:41:17.036368
NCT02330809|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-11-04|||February 2018||2018-02-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|||Drinking Extra Water for to Prevent or Decrease Headaches|Drinking Extra Water To Prevent or Decrease Headaches - A Feasibility Online Randomized Controlled Trial With Adult Participants|Not yet recruiting||N/A|9600|Anticipated|ThinkWell||4|||f||||t||||||||||2017-10-10 23:41:17.13064|2017-10-10 23:41:17.13064
NCT02330796|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2016-10-04|||April 2015||2015-04-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout|A RANDOMIZED, MULTICENTRE PHASE IIa OPEN-LABEL, ACTIVE-COMPARATOR TRIAL TO ASSESS THE EFFICACY AND SAFETY OF TWO REGIMENS OF BUCILLAMINE 100 MG TABLETS AS COMPARED TO COLCHICINE 0.6 MG TABLETS FOR THE TREATMENT OF AN ACUTE GOUT FLARE IN SUBJECTS WITH MODERATE TO SEVERE GOUT.|Completed||Phase 2|66|Actual|Revive Therapeutics, Ltd.||3|||f||||t||||||||||2017-10-10 23:41:17.259144|2017-10-10 23:41:17.259144
NCT02330783|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-05-07|||December 2014||2014-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients|A Randomized, Open-label, Multi-center Phase II Study to Compare Bevacizumab Plus Sorafenib Versus Sorafenib for the Third-line Treatment of Patients With Metastatic Renal Cell Carcinoma|Recruiting||Phase 2|106|Anticipated|Beijing Cancer Hospital||2|||f||||t||||||||||2017-10-10 23:41:17.356281|2017-10-10 23:41:17.356281
NCT02330770|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2017-05-08|||January 2015||2015-01-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration|Dual Trigger Versus Gonadotropin Releasing Hormone Agonist Trigger Combined With Luteal Human Chorionic Gonadotropin Administration|Recruiting||Phase 4|225|Anticipated|Mansoura University||3|||f||||f||||||||Undecided||2017-10-10 23:41:17.49119|2017-10-10 23:41:17.49119
NCT02330757|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2017-05-08|||January 2015||2015-01-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients|Hormone Replacement Therapy Versus Minimal Ovarian Stimulation for Endometrial Preparation Prior to Frozen-thawed Embryo Transfer in Non Polycystic Ovarian Syndrome Patients|Recruiting||Phase 4|150|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 23:41:17.611586|2017-10-10 23:41:17.611586
NCT02330744|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-08-31|||July 2014||2014-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|April 2017|Actual|2017-04-01||Interventional|ACTIV8||The Neurobiology of Approach Avoidance Training in Depression|The Neurobiology of Approach Avoidance Training in Depression|Completed||N/A|40|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:41:17.716903|2017-10-10 23:41:17.716903
NCT02330731|ClinicalTrials.gov processed this data on October 10, 2017|2015-01-01|2015-01-02|||January 2012||2012-01-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||N-butyl-2-cyanoacrylate, Iso-amyl-2-cyanoacrylate and Hypertonic Glucose With 72% Chromated Glycerin in Gastric Varices|N-butyl-2-cyanoacrylate, Iso-amyl-2-cyanoacrylate and Hypertonic Glucose With 72% Chromated Glycerin in Gastric Varices|Completed||N/A|90|Actual|Ain Shams University||3|||f||||t||||||||||2017-10-10 23:41:17.795866|2017-10-10 23:41:17.795866
NCT02330718|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2014-12-31|||May 2014||2014-05-01|December 2014|2014-12-01|January 2020|Anticipated|2020-01-01|April 2019|Anticipated|2019-04-01|5 Years|Observational [Patient Registry]|||Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia||Recruiting||N/A|1500|Anticipated|Yonsei University|||1||f||||f||||||Samples Without DNA|"     peripheral blood and bone marrow aspirates have been collected and stored for the study   "|||2017-10-10 23:41:17.862725|2017-10-10 23:41:17.862725
NCT02330705|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-05-08|||January 2015||2015-01-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Timing of HCG Administration in IUI Cycles|Timing of Human Chorionic Gonadotropin Administration in Intrauterine Insemination Cycles|Recruiting||Phase 4|225|Anticipated|Mansoura University||3|||f||||f||||||||Undecided||2017-10-10 23:41:17.923212|2017-10-10 23:41:17.923212
NCT02330692|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2014-12-31|||September 2013||2013-09-01|December 2014|2014-12-01|September 2023|Anticipated|2023-09-01|July 2023|Anticipated|2023-07-01|10 Years|Observational [Patient Registry]|||Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome||Recruiting||N/A|1000|Anticipated|Yonsei University|||1||f||||f||||||Samples Without DNA|"     Acquisition and storage of blood and bone marrow samples at diagnosis, at response evaluation     and at times of relapse or refractory period.   "|||2017-10-10 23:41:18.013285|2017-10-10 23:41:18.013285
NCT02330679|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-01-02|||December 2014||2014-12-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis|Prediction of Individual Treatment Response Based on Brain Changes at the Early Phase of Antidepressant Treatment in Major Depressive Disorder Using Machine Learning Classification Analysis|Unknown status|Recruiting|Phase 4|61|Anticipated|University of Calgary||1|||f||||f||||||||||2017-10-10 23:41:18.08079|2017-10-10 23:41:18.08079
NCT02330653|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-06-16|||March 2016|Actual|2016-03-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis|A Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Ulcerative Colitis|Recruiting||Phase 1/Phase 2|60|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f||||||||2017-10-10 23:41:18.243848|2017-10-10 23:41:18.243848
NCT02330640|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-05-06|||January 2016||2016-01-01|May 2017|2017-05-01|October 1, 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ATCCC||A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting|A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting|Completed||Phase 4|137|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||3|||f||||f||||||||||2017-10-10 23:41:18.332132|2017-10-10 23:41:18.332132
NCT02330627|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2016-10-27|||April 2014||2014-04-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|||Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes|Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes|Completed||N/A|29|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:41:18.4151|2017-10-10 23:41:18.4151
NCT02330601|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-11-15|||August 2014||2014-08-01|November 2015|2015-11-01||||October 2017|Anticipated|2017-10-01||Interventional|||Effect of Endoscopic Papillary Large Balloon Dilation on Recurrent Rate of Patients With Recurrentstones in Bile Duct||Recruiting||N/A|1500|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-10 23:41:18.578843|2017-10-10 23:41:18.578843
NCT02330588|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-03-05|2016-11-16||October 2014||2014-10-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|RIPPLE||The Resource Information Program for Parents on Lifestyle and Education|Working With Parents to Prevent Childhood Obesity: A Primary Care-based Study|Completed||N/A|226|Actual|University of Alberta|(1) The SBIRT did not include data collection of parents’ self-reported concern and intention pre- and post-intervention, and (2) the study was developmental in nature and was not sufficiently powered to detect group differences.|5|||f||||f||||||||No||2017-10-10 23:41:18.675001|2017-10-10 23:41:18.675001
NCT02330575|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|ACE||Alberta Cancer Exercise Pilot Randomized Trial|Alberta Cancer Exercise Community-based Program: A Pilot Randomized Controlled Trial|Active, not recruiting||N/A|80|Actual|University of Alberta||2|||f||||f||||||||No|No plan in place|2017-10-10 23:41:19.198132|2017-10-10 23:41:19.198132
NCT02330562|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2017-09-22|||March 2015||2015-03-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab|A Phase 1, Multicenter, Open-label, Dose-escalation, Combination Study of Marizomib and Bevacizumab in Bevacizumab-Naïve Subjects With WHO Grade IV Malignant Glioma Followed by a Phase 2 Studies of Single Agent Marizomib and Combination Marizomib and Bevacizumab|Recruiting||Phase 1/Phase 2|106|Anticipated|Triphase Research and Development I Corporation||1|||f||||f||||||||||2017-10-10 23:41:19.297386|2017-10-10 23:41:19.297386
NCT02330549|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-09-18||2017-09-18|June 29, 2015|Actual|2015-06-29|September 2017|2017-09-01|September 8, 2016|Actual|2016-09-08|August 26, 2016|Actual|2016-08-26||Interventional|||ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD|ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)|Completed||Phase 2|45|Actual|Tobira Therapeutics, Inc.||2|||f||||f||||||||||2017-10-10 23:41:19.423557|2017-10-10 23:41:19.423557
NCT02330536|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-01-02|||December 2014||2014-12-01|December 2014|2014-12-01||||September 2016|Anticipated|2016-09-01||Interventional|||Cardiopulmonary Effects of Intrathoracic Pressure Overshoot During Carbon Dioxide Insufflation in Thoracoscopic Surgery|Cardiopulmonary Effects of Intrathoracic Pressure Overshoot During Carbon Dioxide Insufflation in Thoracoscopic Surgery|Unknown status|Active, not recruiting|N/A|20|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-10 23:41:19.512786|2017-10-10 23:41:19.512786
NCT02330523|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2016-01-21|2015-12-10||April 2014||2014-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||An RCT Comparing Xenograft and Allograft for Ridge Preservation|A Prospective, Randomized, Controlled, Multi-center Study With Direct Measure and Histological Evaluation Comparing Xenograft and Allograft for Posterior Buccal Dehiscence Extraction Site Ridge Preservation|Completed||N/A|40|Actual|McGuire Institute||2|||f||||f||||||||||2017-10-10 23:41:19.57394|2017-10-10 23:41:19.57394
NCT02330510|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-09-23|||August 2014||2014-08-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|MITNEC C6||Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease|Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease|Unknown status|Recruiting|N/A|150|Anticipated|Sunnybrook Health Sciences Centre|||2||f||||t||||||Samples With DNA|"     Whole blood will be collected to better understand the possible contribution of genetics to     white matter disease. DNA will be extracted from blood samples to assess the Apolipoprotein     (ApoE) gene type, as ApoE e4 genotype may influence the rate of disease progression.   "|||2017-10-10 23:41:19.833694|2017-10-10 23:41:19.833694
NCT02330497|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2015-11-23|||February 2015||2015-02-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor|Efficacy and Safety of Radiofrequency Ablation Under Endoscopic Ultrasonography Guidance in Pancreatic Neuroendocrine and Cystic Tumor|Recruiting||Phase 3|30|Anticipated|Société Française d'Endoscopie Digestive||1|||f||||f||||||||||2017-10-10 23:41:19.913121|2017-10-10 23:41:19.913121
NCT02330484|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2014-12-31|||March 2014||2014-03-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Affect of Incentive Strategy on the Adherence to Medication Among Patients With Type 2 Diabetes|Affect of Incentive Strategy on the Adherence to Medication Among Patients With Type 2 Diabetes|Unknown status|Active, not recruiting|N/A|400|Anticipated|Shanghai Jiao Tong University School of Medicine||4|||f||||t||||||||||2017-10-10 23:41:20.00817|2017-10-10 23:41:20.00817
NCT02330471|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-27|2015-04-16|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CONE-1||Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial|Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial|Completed||Phase 3|160|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-10 23:41:20.114543|2017-10-10 23:41:20.114543
NCT02330458|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-07-18|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2017|Actual|2017-05-01||Observational|||The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients|The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients|Active, not recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 23:41:20.360284|2017-10-10 23:41:20.360284
NCT02330445|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-04-18||2017-04-18|February 2015||2015-02-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SPARTA-II||6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection|Phase I/II Open Label Evaluation of Safety and Feasibility of 6 Months IV PRTX-100 Administrations in Previous Rheumatoid Arthritis Study Participants and Development of Immunological Samples for Assay Development From Normal Volunteers|Completed||Phase 1/Phase 2|13|Actual|Protalex, Inc.||2|||f||||t||||||||No||2017-10-10 23:41:20.470452|2017-10-10 23:41:20.470452
NCT02330432|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2015-07-24|||May 2015||2015-05-01|July 2015|2015-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|MISS||Mycobacterium w in Patients With Severe Sepsis|Phase IIb Randomized, Double Blind, Two Arm, Controlled Clinical Trial of Mycobacterium W in Combination With Standard Therapy Versus Standard Therapy Alone in Sepsis|Unknown status|Recruiting|Phase 2/Phase 3|150|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-10 23:41:20.592532|2017-10-10 23:41:20.592532
NCT02330419|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-09-28|||April 2015||2015-04-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|Say When||Say When: Targeting Heavy Alcohol Use With Naltrexone Among MSM|Say When: Targeting Heavy Alcohol Use With Naltrexone Among MSM|Recruiting||Phase 2|120|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:41:20.722629|2017-10-10 23:41:20.722629
NCT02330406|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-05-26|||January 2015||2015-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|REASON||Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial|Effect of Anagliptin and Sitagliptin on Low-density Lipoprotein Cholesterol in Patients With Type 2 Diabetes and Cardiovascular Risk Factors: Randomized Controlled Trial|Recruiting||Phase 4|300|Anticipated|Institute for Clinical Effectiveness, Japan||2|||f||||t||||||||Undecided||2017-10-10 23:41:20.848685|2017-10-10 23:41:20.848685
NCT02330367|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-09-29|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC|Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Patients With EGFR T790M Positive Advanced Non Small Cell Lung Cancer Who Progressed on Prior Therapy With EGFR TKIs|Recruiting||Phase 1|294|Anticipated|Hangzhou ACEA Pharmaceutical Research Co.,Ltd.||1|||f||||f||||||||||2017-10-10 23:41:21.254591|2017-10-10 23:41:21.254591
NCT02330354|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-08-10|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Interventional|||Our Year of Healthy Living (Formative Research & Intervention)|Our Year of Healthy Living: A Social Marketing Intervention for Child Care & Home|Active, not recruiting||N/A|2160|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 23:41:21.469323|2017-10-10 23:41:21.469323
NCT02330341|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-11-30|||December 2014||2014-12-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Artemisia Dracunculus on Glucose Intolerance, Insulin Sensitivity and Insulin Secretion|Effect of Artemisia Dracunculus on Glucose Intolerance, Insulin Sensitivity and Insulin Secretion|Completed||Phase 2|24|Actual|University of Guadalajara||2|||f||||t||||||||||2017-10-10 23:41:21.558201|2017-10-10 23:41:21.558201
NCT02330328|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2017-07-17|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Evaluation of the Utility of Telemetry in Patients Admitted for Chest Pain Who Are at Low Risk for Acute Coronary Syndrome||Completed||N/A|3000|Actual|Carilion Clinic||2|||f||||t||||||||||2017-10-10 23:41:21.681369|2017-10-10 23:41:21.681369
NCT02330315|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-03-17|||March 2015||2015-03-01|March 2017|2017-03-01||||June 2016|Actual|2016-06-01||Interventional|||Effects of tDCS and tUS on Pain Perception in OA of the Knee|Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS) on the Perception of Pain and Functional Limitations Due to Osteoarthritis of the Knee.|Active, not recruiting||N/A|28|Actual|Spaulding Rehabilitation Hospital||2|||f||||f||||||||||2017-10-10 23:41:21.791888|2017-10-10 23:41:21.791888
NCT02330302|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-31|2015-07-27|||August 2014||2014-08-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Single Shot Fascia Iliaca Block vs Femoral Nerve Block for Analgesia for Surgical Fixation of Hip Fractures|A Randomized Controlled Trial Comparing Single Shot Fascia Iliaca Block With Femoral Nerve Block for Analgesia Following Surgical Fixation of Hip Fractures|Unknown status|Recruiting|N/A|30|Anticipated|Changi General Hospital||2|||f||||f||||||||||2017-10-10 23:41:21.907555|2017-10-10 23:41:21.907555
NCT02211430|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-08-06|||October 2002||2002-10-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|ACS||Smoking Cessation for Low-Income Pregnant Women|Smoking Cessation for Low-Income Pregnant Women|Completed||N/A|277|Actual|Fox Chase Cancer Center||2|||f||||f||||||||||2017-10-11 00:07:41.414999|2017-10-11 00:07:41.414999
NCT02330289|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-04-28|||December 2015||2015-12-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|ENLITen||Effect of Norms on Laboratory and Imaging Testing (ENLITen)|The Effect of Norms on Laboratory and Imaging Testing (ENLITen): a Pragmatic Randomized Controlled Trial|Completed||N/A|154|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:41:22.010899|2017-10-10 23:41:22.010899
NCT02330276|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-03-03|2016-01-08||September 2014||2014-09-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|Epicatechin||Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin|(+)-Epicatechin: Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin|Completed||Phase 1|12|Actual|Veterans Medical Research Foundation||3|||f||||t||||||||No||2017-10-10 23:41:22.104|2017-10-10 23:41:22.104
NCT02330263|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-08-15|||January 2015||2015-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Preoperative Oral Carbohydrates on Postoperative Insulin Resistance in Patients Undergoing OPCAB(Off- Pump Coronary Artery Bypass Surgery)||Completed||N/A|57|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:41:22.756458|2017-10-10 23:41:22.756458
NCT02330250|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-06-23|||July 2014||2014-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|ADELES||Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment|Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment in Rio de Janeiro: a Randomized Clinical Trial|Completed||N/A|131|Actual|Oswaldo Cruz Foundation||2|||f||||t||||||||||2017-10-10 23:41:22.836426|2017-10-10 23:41:22.836426
NCT02330237|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-04-19|||January 2015||2015-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Natural Gels for Treatment of Plaque Psoriasis|Safety and Efficacy of Natural Gel Combination and Hair Mask of Plant Origin in Patients With Psoriasis: A Randomized, Double-Blind, Placebo (Vehicle) Controlled|Recruiting||Phase 1/Phase 2|52|Anticipated|Secret of Youth||2|||f||||t||||||||||2017-10-10 23:41:22.933774|2017-10-10 23:41:22.933774
NCT02330224|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2014-12-31|||July 2014||2014-07-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health|Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health - A Cluster Randomized Pilot Trial in SingHealth Polyclinics, Singapore|Completed||N/A|100|Actual|Duke-NUS Graduate Medical School||2|||f||||t||||||||||2017-10-10 23:41:23.021357|2017-10-10 23:41:23.021357
NCT02330211|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-06-16|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Fecal Microbiota Transplant (FMT) in Pediatric Active Crohn's Colitis|A Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Crohn's Colitis|Recruiting||Phase 1/Phase 2|60|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f||||||||2017-10-10 23:41:23.103583|2017-10-10 23:41:23.103583
NCT02330198|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2015-11-04|||March 2015||2015-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01|3 Months|Observational [Patient Registry]|FAAM-Fi||Validation of the Foot and Ankle Ability Measure Tool in Finnish|Evidence for Validity and Reliability of the Finnish Version of the Foot and Ankle Ability Measure|Completed||N/A|84|Actual|Turku University Hospital|||1||f||||t||||||||||2017-10-10 23:41:23.199888|2017-10-10 23:41:23.199888
NCT02330185|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2015-08-04|||January 2015||2015-01-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Comparison of Two Anatomic Landmarks With Ultrasonography in Spinal Anesthesia|Phase IV Study of Landmarks for Spinal Anesthesia|Completed||Phase 4|80|Actual|Diskapi Yildirim Beyazit Education and Research Hospital||1|||f||||f||||||||||2017-10-10 23:41:23.273453|2017-10-10 23:41:23.273453
NCT02330172|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-03-02|2016-12-15||May 2014||2014-05-01|July 2015|2015-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Sugammadex Provide Better Surgical Condition Compared With Neostigmine in Laryngeal Microsurgery.|Comparison Sugammadex With Neostigmine in Laryngeal Microsurgery.|Completed||N/A|44|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:41:23.377302|2017-10-10 23:41:23.377302
NCT02330159|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-11-17|||February 2015||2015-02-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Feasibility of a Novel Technique for Pilonidal Wound Healing|A Feasibility Study of a Novel Technique for Pilonidal Wound Healing on Patient, Financial, and Quality of Life Outcomes|Recruiting||N/A|20|Anticipated|Southeast Clinical Research Associates, Houston, Texas|||1||f||||f||||||||||2017-10-10 23:41:23.670159|2017-10-10 23:41:23.670159
NCT02330146|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-26|||May 2015||2015-05-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|ReaCT||Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis|Terminated||Phase 1/Phase 2|8|Actual|RepliCel Life Sciences, Inc.||2||"-  slower than anticipated rate of enrollment      -  need to obtain safety and efficacy data in a timely manner      -  pending expiry of manufacturing materials/reagents"|f||||t||||||||||2017-10-10 23:41:23.756516|2017-10-10 23:41:23.756516
NCT02330133|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-04|2014-12-30|||May 2008||2008-05-01|December 2014|2014-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|FemRepro_2||Mid-life Women: Preventing Unintended Pregnancy and STIs|Mid-life Women: Preventing Unintended Pregnancy and STIs|Completed||Phase 2|333|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 23:41:23.840218|2017-10-10 23:41:23.840218
NCT02330120|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-12-09|||January 2011||2011-01-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effects of Dexmedetomidine and Propofol on Pulmonary Mechanics||Completed||Phase 4|64|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:41:23.970026|2017-10-10 23:41:23.970026
NCT02330107|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2017-08-08|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men|Effectiveness of Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men: A Randomized Controlled Feasibility Study.|Completed||N/A|102|Actual|The Hong Kong Polytechnic University||3|||f||||f||||||||||2017-10-10 23:41:24.070111|2017-10-10 23:41:24.070111
NCT02330094|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2016-03-19|||December 2014||2014-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage|Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage|Recruiting||Phase 4|20|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:41:24.168881|2017-10-10 23:41:24.168881
NCT02330068|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-09-03|||December 2014|Actual|2014-12-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Microbiome of Depression & Treatment Response to Citalopram|Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study|Recruiting||N/A|80|Anticipated|Mayo Clinic|||2||f||||f||||||Samples With DNA|"     Blood, saliva and stool samples will be collected at three time points.   "|||2017-10-10 23:41:24.352018|2017-10-10 23:41:24.352018
NCT02330055|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-03-29|||May 2014||2014-05-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Determination of the Predictors of Nocturnal Desaturation in Postpartum Women|Determination of the Predictors of Nocturnal Desaturation in Postpartum Women|Recruiting||N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||||||||||||2017-10-10 23:41:24.451226|2017-10-10 23:41:24.451226
NCT02330042|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2014-12-30|||September 2014||2014-09-01|December 2014|2014-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||OCT Biomarkers for Diabetic Retinopathy|Functional Optical Coherence Tomography-Derived Biomarkers for Diabetic Retinopathy|Unknown status|Active, not recruiting|N/A|215|Anticipated|Oregon Health and Science University|||3||f||||||||||||||2017-10-10 23:41:24.549096|2017-10-10 23:41:24.549096
NCT02330029|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-11-18|||August 2012||2012-08-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|November 2014|Actual|2014-11-01||Interventional|||Pinaverium and Herbs for Irritable Bowel Syndrome Treatment: an Onset and Offset Study (PHIBEST)|A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome|Active, not recruiting||N/A|800|Anticipated|Macrohard Institute of Health||3|||f||||t||||||||||2017-10-10 23:41:24.648717|2017-10-10 23:41:24.648717
NCT02330016|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-06-17|||December 2014||2014-12-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|VolumaChin||Juvederm Voluma® XC for the Treatment of Hypoplastic Chin|Juvederm Voluma® XC for the Treatment of Hypoplastic Chin|Unknown status|Recruiting|N/A|30|Anticipated|Beer, Kenneth R., M.D., PA||1|||f||||f||||||||||2017-10-10 23:41:24.791948|2017-10-10 23:41:24.791948
NCT02330003|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2014-12-30|||May 2013||2013-05-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer|A Randomized, Active-Comparator, Open-Label, Phase 1 Clinical Trial to Assess the Safety of the 'IL-YANG Inactivated Split Influenza Vaccine' and Fluarix Prefilled Syringe in Healthy Korean Male Volunteer|Completed||Phase 1|100|Actual|Il-Yang Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:41:27.078765|2017-10-10 23:41:27.078765
NCT02329990|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-01-07|||June 2013||2013-06-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Phosphorus Supplementation on Body Weight|Premeal Phosphorus Supplementation for Reducing Energy Intake and Body Weight|Completed||N/A|71|Actual|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-10 23:41:27.559036|2017-10-10 23:41:27.559036
NCT02329977|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2015-12-01|||June 2013||2013-06-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|||Rate of Duodenal-biliary Reflux Increases in Patients With Recurrent Common Bile Duct Stones|Rate of Duodenal-biliary Reflux Increases in Patients With Recurrent Common Bile Duct Stones: Direct Evidence From Barium Meal Examination|Completed||N/A|64|Actual|Fourth Military Medical University|||2||f||||t||||||||||2017-10-10 23:41:27.636132|2017-10-10 23:41:27.636132
NCT02329964|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-27|2015-08-31|2015-08-04||February 2015||2015-02-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|August 2015|Actual|2015-08-01||Interventional|||Effectiveness of Sugammadex in LMS Surgery|Comparison of the Effectiveness of Rocuronium - Sugammadex With Succinylcholine-Cisatracurium-Neostigmine in Patients Undergoing Laser Microlaryngeal Surgery|Unknown status|Active, not recruiting|Phase 4|80|Actual|Korea University Anam Hospital|The surgical rating score was assessed on the basis of the degree of laryngx exposure. This was influenced not only by neuromuscular relaxation but also by anatomical factors.|2|||f||||t||||||||||2017-10-10 23:41:27.778315|2017-10-10 23:41:27.778315
NCT02329951|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2016-11-04|||December 2014||2014-12-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Predictive Factors for LBP Interventional Treatment Outcomes|Prospective, Observational Study Evaluating the Ability of Clinical Factors to Predict Interventional Treatment Outcomes for Low Back Pain (LBP)|Recruiting||N/A|346|Anticipated|Johns Hopkins University|||3||f||||f||||||||||2017-10-10 23:41:28.247564|2017-10-10 23:41:28.247564
NCT02329938|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2014-12-30|||December 2010||2010-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Interventional|||Desarda Repair for Inguinal Hernia|Desarda Versus Lichtenstein's Repair for Inguinal Hernia: a Comparative Study|Completed||N/A|155|Actual|Mansoura University||2|||f||||||||||||||2017-10-10 23:41:28.399945|2017-10-10 23:41:28.399945
NCT02329925|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-06-12|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Efficacy of Tongue Stabilizing Device in Patients With Obstructive Sleep Apnea|The Efficacy of Tongue Stabilizing Device in Patients With Obstructive Sleep Apnea|Active, not recruiting||Phase 1|60|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-10 23:41:28.512712|2017-10-10 23:41:28.512712
NCT02329912|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-12-01|||December 2014||2014-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|PIDuSA||Postoperative Ileus: Duration and Severity Assessment With the SmartPill®|The SmartPill® as an Objective Parameter to Evaluate Severity and Duration of Postoperative Ileus|Recruiting||N/A|55|Anticipated|University Hospital, Bonn||2|||f||||f||||||||||2017-10-10 23:41:28.657334|2017-10-10 23:41:28.657334
NCT02329899|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-11-03|||July 2012||2012-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|MBD||Standardisation of Investigations of Mild Bleeding Disorders|Standardisation of Investigations of Mild Bleeding Disorders|Completed||N/A|208|Actual|University Hospital, Geneva|||2||f||||f||||||Samples With DNA|"     2 aliquots of plasma from 2x 6 ml EDTA blood 2 aliquots of plasma from 2 x 2.7 ml citrate     blood 2 aliquots of plasma from 1 x 4 ml heparin blood Storage at -80°C   "|||2017-10-10 23:41:28.988465|2017-10-10 23:41:28.988465
NCT02329886|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2016-08-10|||March 2013||2013-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||The Qingdao Port Health Study|The Qingdao Port Health Study|Completed||N/A|25000|Actual|China National Center for Cardiovascular Diseases|||1||f||||t||||||Samples With DNA|"     In 2013, whole blood samples were collected for future genetic studies. And saliva and urine     samples were also collected for future analysis.   "|||2017-10-10 23:41:29.102392|2017-10-10 23:41:29.102392
NCT02329873|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-30|||November 2011||2011-11-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Respiratory Rehabilitation Exercises in Older Adults With Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Efficacy of the Respiratory Rehabilitation Exercise Training Package in Hospitalized Elderly Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Randomized Control Trial|Completed||N/A|61|Actual|Chest Hospital, Ministry of Health and Welfare, Taiwan||2|||f||||f||||||||||2017-10-10 23:41:29.207115|2017-10-10 23:41:29.207115
NCT02329860|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-07-04|||January 13, 2014|Actual|2014-01-13|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)|A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Study (AHELP) of Apatinib in Patients With Hepatocellular Carcinoma After Systemic Therapy（Chemotherapy and/or Targeted Therapy）|Active, not recruiting||Phase 3|400|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:41:29.345005|2017-10-10 23:41:29.345005
NCT02329834|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-02-16||2017-02-16|April 2015||2015-04-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure|Open-label, Single-dose, Randomized, Two-way (Two-period) Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80mg) Administered Intravenously in Subjects With Chronic Heart Failure|Completed||Phase 2/Phase 3|16|Actual|scPharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-10 23:41:29.67691|2017-10-10 23:41:29.67691
NCT02329821|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-07-09|||November 2014||2014-11-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Observational|||Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection|Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection|Completed||N/A|72|Actual|Samsung Medical Center|||2||f||||t||||||||||2017-10-10 23:41:29.769785|2017-10-10 23:41:29.769785
NCT02329808|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-05-29|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PROTECT||Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics|Clinical Validation of a Dried Blood Spot (DBS) Method for the Analysis of Immunosuppressive and Antifungal Drugs in Pediatric Patients (Part of the PROTECT Study).|Recruiting||N/A|126|Anticipated|Radboud University|||9||f||||t||||||Samples With DNA|"     Plasma without DNA, blood with DNA and dried blood spot (with DNA)   "|No||2017-10-10 23:41:29.862106|2017-10-10 23:41:29.862106
NCT02329782|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-09-27|||February 2015||2015-02-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|March 2019|Anticipated|2019-03-01||Interventional|START||Supporting Treatment Adherence Readiness Through Training (START)|Controlled Evaluation of the Adherence Readiness Program for ART Adherence|Recruiting||N/A|240|Anticipated|RAND||2|||f||||t||||||||No||2017-10-10 23:41:30.083033|2017-10-10 23:41:30.083033
NCT02329769|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-10-27|||December 2014||2014-12-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)|A Phase II, Open Label, Extension Study to Assess the Effect of PRO044 in Patients With Duchenne Muscular Dystrophy|Terminated||Phase 2|15|Actual|BioMarin Pharmaceutical||3|||f||||t||||||||||2017-10-10 23:41:30.195297|2017-10-10 23:41:30.195297
NCT02329756|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-02-04|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||Tranexamic Acid in Adherent Placenta (TAP)|Tranexamic Acid in Adherent Placenta (TAP), a Randomized Clinical Trial|Not yet recruiting||Phase 3|20|Anticipated|Baylor College of Medicine||2|||f||||t|t|f|||t|||No||2017-10-10 23:41:30.296442|2017-10-10 23:41:30.296442
NCT02329743|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-12-28|||December 2014||2014-12-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery|A Multicenter, Double-Masked, Parallel-Group, Vehicle-Controlled Study to Assess the Efficacy and Safety of RX-10045 Nanomicellar Ophthalmic Solution for Treatment of Ocular Inflammation and Pain in Subjects Undergoing Cataract Surgery|Completed||Phase 2|256|Actual|A.T. Resolve SARL||3|||f||||f||||||||||2017-10-10 23:41:30.390174|2017-10-10 23:41:30.390174
NCT02329730|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-03-26|2015-01-14||February 2014||2014-02-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional||Each group of baseline analysis population apply full analysis set (FAS).FAS are the participant, following the principle of ITT, who receive at least once drug and have curative effect evaluation of drug treatment .Missing data of the curative effect part in FAS population use Last observation carried forward(LOCF)method to supplement.|Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10|Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Antigen ESAT6-CFP10|Completed||Phase 2|144|Actual|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.||3|||f||||f||||||||||2017-10-10 23:41:30.51346|2017-10-10 23:41:30.51346
NCT02329717|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-09-28|||April 2015||2015-04-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma|A Phase II, Single-arm, Open-label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|50|Anticipated|Phoenix Biotechnology, Inc||1|||f||||t||||||||||2017-10-10 23:41:31.716474|2017-10-10 23:41:31.716474
NCT02329704|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2014-12-30|||May 2007||2007-05-01|December 2014|2014-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Evaluation Study Between Density Gradient and Swimming Down for Semen Processing|Evaluation Study Between Density Gradient and Swimming Down for Semen Processing|Completed||N/A|100|Actual|Al Baraka Fertility Hospital|||2||f||||f||||||Samples With DNA|"     Semen samples   "|||2017-10-10 23:41:31.836091|2017-10-10 23:41:31.836091
NCT02329691|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-03-20|||December 2014||2014-12-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01||Observational|||Team, Competence and Safety Climate in the Operating Room|Team, Competence and Safety Climate in the Operating Room|Completed||N/A|125|Actual|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||||2017-10-10 23:41:32.026911|2017-10-10 23:41:32.026911
NCT02329678|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-31|||January 2012||2012-01-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy of Guided Tissue Regeneration Membrane in the Healing of Apicomarginal Defects|Efficacy of Guided Tissue Regeneration Membrane in the Healing of Apicomarginal Defects - A Prospective, Controlled Clinical Trial.|Completed||N/A|23|Actual|Postgraduate Institute of Dental Sciences Rohtak||2|||f||||t||||||||||2017-10-10 23:41:32.118447|2017-10-10 23:41:32.118447
NCT02329665|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2014-12-31|||February 2015||2015-02-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Data Collection in Patients Undergoing CT-Guided Needle Interventions for NeedleWays System Development|A Prospective Data Collection, Single-Center, Open Label Study in Patients Undergoing CT-Guided Needle Interventions for the Development of the NeedleWays System|Unknown status|Not yet recruiting|N/A|50|Anticipated|NeedleWays||1|||f||||t||||||||||2017-10-10 23:41:32.212971|2017-10-10 23:41:32.212971
NCT02329652|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-07-30|||December 2014||2014-12-01|July 2017|2017-07-01|December 2027|Anticipated|2027-12-01|May 2020|Anticipated|2020-05-01||Interventional|NNP-UE+T||Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury|Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury|Recruiting||N/A|10|Anticipated|MetroHealth Medical Center||1|||f||||f||||||||||2017-10-10 23:41:32.280162|2017-10-10 23:41:32.280162
NCT02329639|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-05-10|||April 2014||2014-04-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|BEVAPROS||Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy|Prospective Evaluation of VEGFR-2 rs11133360/IL-8 rs4073 Genetic Interaction in Metastatic Breast Cancer Patients Treated With Paclitaxel and Bevacizumab vs. Chemotherapy Alone (BEVAPROS)|Recruiting||N/A|189|Anticipated|University of Pisa|||2||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-10 23:41:32.37522|2017-10-10 23:41:32.37522
NCT02329626|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-06-16|||January 29, 2016|Actual|2016-01-29|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Observational|HYCORE||Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder|Evaluation Via PET Scan of Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||Samples Without DNA|"     Blood samples will be taken at baseline, 3 months and 6 months.   "|||2017-10-10 23:41:32.483791|2017-10-10 23:41:32.483791
NCT02329613|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-05-23|||April 2015||2015-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IRCAR||Introduction of an Enriched Evening Meal on the Feeding Behavior of Institutionalized Residents|Impact of the Introduction of a New Qualitative Composition of the Evening Meal on the Feeding Behavior of Institutionalized Residents of a Long-term Care Unit: a Randomized, Single Center Study|Completed||N/A|48|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 23:41:32.606524|2017-10-10 23:41:32.606524
NCT02329600|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-09-25|2016-07-28||June 2013||2013-06-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus|Evaluation of Systemic Administration of Green Tea Polyphenols as a Supportive Antioxidant Agent in the Management of Oral Lichen Planus|Completed||Phase 3|40|Actual|Cairo University||3|||f||||f||||||||||2017-10-10 23:41:32.72886|2017-10-10 23:41:32.72886
NCT02329587|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-08-30|||January 2015||2015-01-01|August 2017|2017-08-01||||February 2017|Actual|2017-02-01||Interventional|||Transcranial Direct Current Stimulation Augmented Exposure and Response Prevention for Obsessive-Compulsive Disorder|tDCS for Inhibitory Control Deficits: A Test in OCD|Completed||N/A|32|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-10 23:41:33.057126|2017-10-10 23:41:33.057126
NCT02329574|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-07-11|||October 2014||2014-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Prediction of Persistent Post-Mastectomy Pain|Prediction of Persistent Post-Mastectomy Pain|Recruiting||N/A|200|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"     saliva   "|||2017-10-10 23:41:33.147996|2017-10-10 23:41:33.147996
NCT02329561|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2014-12-30|||January 2007||2007-01-01|December 2014|2014-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects|Comparative, Randomized, Double-Blind, Single-Dose, 2-way Crossover Study to Evaluate the Pharmacokinetics and Analgesic Effect of Labopharm Tramadol Contramid® OAD 200 mg Tablets or Placebo in Healthy Young and Elderly Adult Volunteers|Completed||Phase 1|35|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-10 23:41:33.216079|2017-10-10 23:41:33.216079
NCT02329548|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-01-28|||December 2014||2014-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Qualitative Sweat Distribution During Tilt Table Procedure|Qualitative Sweat Distribution Among Youth With Postural Tachycardia Syndrome (POTS), Syncope, or Anxiety|Completed||N/A|95|Actual|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-10 23:41:33.30075|2017-10-10 23:41:33.30075
NCT02210299|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-06-09|||September 2014||2014-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|TEXTO||TEXTO : Total EXposure To Organic Pollutants|TEXTO : Total EXposure To Organic Pollutants|Withdrawn||N/A|0|Actual|Rennes University Hospital||1||No participants enrolled|f||||f||||||||||2017-10-11 00:07:54.660284|2017-10-11 00:07:54.660284
NCT02329535|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2017-08-16|||January 2015||2015-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Comparing Double Dose of Vaginal Progesterone to no Treatment for Prevention of Preterm Birth in Twins and Short Cervix|Comparing a Double Dose of Vaginal Progesterone to no Treatment for the Prevention of Preterm Birth in Twins Pregnancy and Short Cervix|Terminated||N/A|15|Actual|HaEmek Medical Center, Israel||2||Results from similar research were already published|f||||t||||||||||2017-10-10 23:41:33.378127|2017-10-10 23:41:33.378127
NCT02329522|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-09-28|||February 2014||2014-02-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|October 2014|Actual|2014-10-01||Observational|||USCOM For Assessing Patients With COPD|Non-Invasive Doppler Ultrasound For Assessing Patients With Chronic Obstructive Pulmonary Disease: A Prospective Observational Study|Active, not recruiting||N/A|200|Anticipated|Chinese University of Hong Kong|||4||f||||f||||||||||2017-10-10 23:41:33.465454|2017-10-10 23:41:33.465454
NCT02329509|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-12-01|||January 2010||2010-01-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of Facial Growth in Two Primary Protocols Used in the Surgical Treatment of Unilateral Cleft Lip and Palate Patients|Evaluation of Facial Growth in Two Primary Protocols Used in the Surgical Treatment of Unilateral Cleft Lip and Palate Patients. A Prospective Randomized Trial|Completed||N/A|64|Actual|Professor Fernando Figueira Integral Medicine Institute||2|||f||||t||||||||||2017-10-10 23:41:33.57202|2017-10-10 23:41:33.57202
NCT02329496|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-04-05|||December 3, 2014|Actual|2014-12-03|April 2017|2017-04-01|October 21, 2017|Anticipated|2017-10-21|October 6, 2016|Actual|2016-10-06||Interventional|NGDS||REPRISE Next Generation Delivery System|REPRISE NGDS: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LotuS™ ValvE With the Next Generation Delivery System|Active, not recruiting||N/A|38|Actual|Boston Scientific Corporation||1|||f||||f||||||||No||2017-10-10 23:41:33.648795|2017-10-10 23:41:33.648795
NCT02329483|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-04-04|||December 2014||2014-12-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Observational|||Monitoring the Early Follicular Phase With Androstenedione in Low-dose Step-up Ovulation Induction in High Responders|Early Follicular Phase Androstenedione Monitoring During Low-dose Step-up Induction of Ovulation in High Responders|Unknown status|Recruiting|N/A|50|Anticipated|Bagcilar Training and Research Hospital|||1||f||||f||||||||||2017-10-10 23:41:33.764159|2017-10-10 23:41:33.764159
NCT02329470|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-11-03|||March 2012||2012-03-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Obstructive Sleep Apnea and Arterial Stiffness|Cardiovascular Effects of CPAP Treatment for Obstructive Sleep Apnea|Completed||N/A|100|Actual|Umeå University||2|||f||||f||||||||||2017-10-10 23:41:33.852155|2017-10-10 23:41:33.852155
NCT02329457|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-07-27|||December 2014||2014-12-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|VZIDST||VZV Vaccine for Hematopoietic Stem Cell Transplantation|Efficacy and Safety of a Novel Intradermal Live-attenuated Varicella Zoster Vaccine in Hematopoietic Stem Cell Transplantation Donors: a Randomized Double Blind Placebo-controlled Trial|Recruiting||N/A|120|Anticipated|The University of Hong Kong||5|||f||||t||||||||||2017-10-10 23:41:34.053804|2017-10-10 23:41:34.053804
NCT02329444|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-04-19|||August 2014||2014-08-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of Remote Ischemic Preconditioning on Elective Percutaneous Coronary Intervention in Diabetic Nephropathy|Remote Ischemic Preconditioning for the Prevention of Contrast-induced Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention|Completed||N/A|100|Actual|Ulsan University Hospital||2|||f||||t||||||||||2017-10-10 23:41:34.156902|2017-10-10 23:41:34.156902
NCT02329431|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-04-12|2016-10-29||August 2013||2013-08-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional||Completed a baseline interview|Padres Efectivos (Parent Activation): Skills Latina Mothers Use to Get Healthcare for Their Children|Padres Efectivos (Parent Activation): Skills Latina Mothers Use to Get Healthcare for Their Children|Completed||N/A|181|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||Undecided||2017-10-10 23:41:34.241568|2017-10-10 23:41:34.241568
NCT02329418|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-01-17|||September 2014||2014-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|LATA||Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit|Impact of a Written Document on Post Traumatic Stress Disorder (PTSD) Diagnosed in Family Members After Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 23:41:34.67877|2017-10-10 23:41:34.67877
NCT02329405|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-05-18|||December 2014||2014-12-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effects of PXR Activation on Hepatic Fat Content|PXR-aktivaation Vaikutus Maksan Rasvoittumiseen|Recruiting||Phase 4|16|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-10 23:41:34.772754|2017-10-10 23:41:34.772754
NCT02329392|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-04-28|||December 2014||2014-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Assessment of Skin Perfusion Pressure as an Indicator of Tissue Oxygenation in Cardiac Surgery Patients Undergoing Cardiopulmonary Bypass||Completed||N/A|72|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 23:41:34.865823|2017-10-10 23:41:34.865823
NCT02329379|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-04-13|||May 2015||2015-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|TGAUS||The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance|Therapeutic Role of Levothyroxine on the Patients With Atypia of Undetermined Significance (AUS) Goiter|Unknown status|Not yet recruiting|Phase 4|1200|Anticipated|National Defense Medical Center, Taiwan||8|||f||||f||||||||||2017-10-10 23:41:34.928878|2017-10-10 23:41:34.928878
NCT02329366|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2016-11-01|||December 2014||2014-12-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Development of a Cellular Biomarker for the Diagnosis and Treatment of Diabetic Foot Ulcers||Recruiting||N/A|30|Anticipated|Winthrop University Hospital|||2||f||||f||||||Samples Without DNA|"     In this study, diabetic patients undergoing Diabetic Foot Ulcer debridement under the     standard of care will be asked for their permission to collect the debrided tissue for use in     scientific research.   "|||2017-10-10 23:41:35.028248|2017-10-10 23:41:35.028248
NCT02328417|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-08-10|||December 2014||2014-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Observational|||Enhanced Recovery After Radical Cystectomy Study|Enhanced Recovery After Radical Cystectomy Study|Active, not recruiting||N/A|241|Actual|Hospital Universitario Fundación Alcorcón|||2||f||||f||||||||||2017-10-10 23:41:43.705326|2017-10-10 23:41:43.705326
NCT02329353|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-01-09|||February 2015||2015-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers|Clinical And Microbiological Analysis Of Orally Administered Lactobacillus Probiotic Lozenges In Chronic Periodontitis Patients Among Smokers And Non-smokers And Its Correlation With Clinical Parameters - A Clinico-Microbiological Study|Completed||Phase 3|60|Actual|Next Gen Pharma India Pvt. Ltd.||2|||f||||f||||||||||2017-10-10 23:41:35.115115|2017-10-10 23:41:35.115115
NCT02329340|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2014-12-29|||September 2009||2009-09-01|December 2014|2014-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|SAS_2||Safety Skills Training: Parents of School-Aged Children|Safety Skills Training: Parents of School-Aged Children|Completed||Phase 2|175|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 23:41:35.19596|2017-10-10 23:41:35.19596
NCT02329327|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-04-03|||January 2015||2015-01-01|April 2017|2017-04-01||||November 2022|Anticipated|2022-11-01||Interventional|||A Study in Patients With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants|Prospective, Open-Label Study of Andexanet Alfa in Patients Receiving a Factor Xa Inhibitor Who Have Acute Major Bleeding (ANNEXA-4)|Recruiting||Phase 3|350|Anticipated|Portola Pharmaceuticals||1|||f||||t||||||||||2017-10-10 23:41:35.295671|2017-10-10 23:41:35.295671
NCT02329314|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2014-12-30|||November 2014||2014-11-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||The Evaluation of Glycyrrhizic Acid's Pesticide Effect in Treating Liver Damage (Retrospective Study）|The Evaluation of Glycyrrhizic Acid's Pesticide Effect in Treating Liver Damage (Retrospective Study）|Unknown status|Recruiting|N/A|60|Anticipated|ShuGuang Hospital|||1||f||||t||||||||||2017-10-10 23:41:35.546662|2017-10-10 23:41:35.546662
NCT02329301|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-09-20|||September 2014||2014-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|June 2016|Actual|2016-06-01||Interventional|||Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia|Assessing the Effectiveness of Mass Drug Administration (MDA) With Dihydroartemisinin + Piperaquine for Reducing Malaria Parasite Infection Prevalence and Incidence in Southern Province Zambia|Active, not recruiting||N/A|2430|Actual|PATH||3|||f||||t||||||||||2017-10-10 23:41:35.617747|2017-10-10 23:41:35.617747
NCT02329288|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2015-03-27|||May 2015||2015-05-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION|Retrobulbar Triamcinolone Acetonide Injection in the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Second Military Medical University||2|||f||||f||||||||||2017-10-10 23:41:35.724125|2017-10-10 23:41:35.724125
NCT02329275|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-10-03|||December 2014||2014-12-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Observational|||HPV as a Possible Cause of Azoospermia||Recruiting||N/A|140|Anticipated|Odense University Hospital|||2||f||||t||||||||||2017-10-10 23:41:35.799263|2017-10-10 23:41:35.799263
NCT02329262|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-10-03|||September 2015||2015-09-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|March 2019|Anticipated|2019-03-01||Interventional|||A Skills-based RCT for Physical Activity Using Peer Mentors|A Skills-based RCT for Physical Activity Using Peer Mentors|Recruiting||N/A|1720|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-10 23:41:35.893922|2017-10-10 23:41:35.893922
NCT02329249|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2014-12-31|||February 2001||2001-02-01|December 2014|2014-12-01|January 2006|Actual|2006-01-01|January 2005|Actual|2005-01-01||Interventional|NRT_2||Pharmacological Aids for Interactive Smoking Cessation|Pharmacological Aids for Interactive Smoking Cessation|Completed||N/A|500|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-10 23:41:36.038954|2017-10-10 23:41:36.038954
NCT02329236|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2014-12-30|||January 2015||2015-01-01|December 2014|2014-12-01||||January 2016|Anticipated|2016-01-01||Observational|||Prevalence of Attention Deficit Disorder Among Patients With Constitutional Growth Delay||Unknown status|Not yet recruiting|N/A|100|Anticipated|Meir Medical Center|||2||f||||t||||||||||2017-10-10 23:41:36.126001|2017-10-10 23:41:36.126001
NCT02329223|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-09-20|2016-08-01||December 2014||2014-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients|A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Omalizumab in Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite H1 Antihistamine Therapy|Completed||Phase 3|218|Actual|Novartis||3|||f||||f||||||||||2017-10-10 23:41:36.214713|2017-10-10 23:41:36.214713
NCT02329210|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2016-09-12|||June 2014||2014-06-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01|10 Years|Observational [Patient Registry]|CRIBBS||Clinical Registry Investigating Bardet-Biedl Syndrome|Clinical Registry Investigating Bardet-Biedl Syndrome|Recruiting||N/A|500|Anticipated|Marshfield Clinic Research Foundation|||1||f||||f||||||||Yes|De-identified data is shared the NIH/NCATS GRDR® Program.|2017-10-10 23:41:36.883298|2017-10-10 23:41:36.883298
NCT02329197|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2014-12-30|||October 2014||2014-10-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|October 2015|Anticipated|2015-10-01||Interventional|||Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure||Unknown status|Recruiting|Phase 4|380|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-10 23:41:36.959742|2017-10-10 23:41:36.959742
NCT02329184|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-09-12|||December 2014||2014-12-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461|Safety, Tolerability, Preliminary Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of MYK-461 in Patient Volunteers With Hypertrophic Cardiomyopathy|Completed||Phase 1|15|Actual|MyoKardia, Inc.||1|||f||||t||||||||||2017-10-10 23:41:37.047821|2017-10-10 23:41:37.047821
NCT02329171|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-06-20|||December 2014||2014-12-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TOPIC||Imiquimod Treatment of CIN Lesions|TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasm: a Randomized Controlled Trial.|Terminated||Phase 3|9|Actual|Maastricht University Medical Center||2||Insufficient number of participants.|f||||t||||||||||2017-10-10 23:41:37.264852|2017-10-10 23:41:37.264852
NCT02329158|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2014-12-30|||May 2015||2015-05-01|December 2014|2014-12-01|April 2018|Anticipated|2018-04-01|April 2016|Anticipated|2016-04-01||Observational|||Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery|Clinical Impact of Disinvestment in Hydroxyl-ethyl Starches (HES) for Patients Undergoing Cardiac Surgery|Not yet recruiting||N/A|2000|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||||2017-10-10 23:41:37.377096|2017-10-10 23:41:37.377096
NCT02329145|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||July 2013||2013-07-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Renal Denervation in Patients With Chronic Heart Failure and Resynchronization Therapy|Renal Denervation in Patients With Chronic Heart Failure and Resynchronization Therapy|Unknown status|Recruiting|Phase 2|20|Anticipated|Jagiellonian University||2|||f||||f||||||||||2017-10-10 23:41:37.448494|2017-10-10 23:41:37.448494
NCT02329132|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2016-09-22|||November 2015||2015-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema|Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema|Recruiting||N/A|30|Anticipated|Kagawa University|||1||f||||f||||||Samples Without DNA|"     Aqueous humor is obtained at the initial injection of Lucentis.   "|||2017-10-10 23:41:37.531121|2017-10-10 23:41:37.531121
NCT02329119|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2015-08-20|||September 2015||2015-09-01|August 2015|2015-08-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|ERPs-PSY||Psychiatric Disorders and Electrophysiological Markers|Psychiatric Disorders and Electrophysiological Markers|Not yet recruiting||N/A|200|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:41:37.612992|2017-10-10 23:41:37.612992
NCT02329106|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2016-03-27|||December 2014||2014-12-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome|Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome|Recruiting||Phase 1/Phase 2|30|Anticipated|Fuda Cancer Hospital, Guangzhou||1|||f||||t||||||||||2017-10-10 23:41:37.690145|2017-10-10 23:41:37.690145
NCT02329080|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-03-01|||December 2014||2014-12-01|March 2017|2017-03-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement|An International Phase II Trial Assessing Tolerability and Efficacy of Sequential Methotrexate-Aracytin-based Combination and R-ICE Combination, Followed by HD Chemotherapy Supported by ASCT, in Patients With Systemic B-cell Lymphoma With CNS Involvement at Diagnosis or Relapse (MARIETTA Regimen)|Recruiting||Phase 2|76|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||f||||||||||2017-10-10 23:41:37.849364|2017-10-10 23:41:37.849364
NCT02329067|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-08-28|||December 2014||2014-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2016|Actual|2016-07-01||Interventional|WALDI||The Metabolic Effect of Walnuts in Healthy Subjects|The Metabolic Effect of Walnut Consumption in Healthy Men and Healthy Postmenopausal Women Substituting Walnuts for Different Food Components|Completed||N/A|180|Actual|Ludwig-Maximilians - University of Munich||4|||f||||f||||||||||2017-10-10 23:41:38.132817|2017-10-10 23:41:38.132817
NCT02329054|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-11-14|||December 2014||2014-12-01|March 2015|2015-03-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|JIKI||Efficacy of Favipiravir Against Ebola (JIKI)|Efficacy of Favipiravir in Reducing Mortality in Individuals With Ebola Virus Disease in Guinea|Completed||Phase 2|126|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-10 23:41:38.229993|2017-10-10 23:41:38.229993
NCT02329041|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2017-04-03|||January 2015||2015-01-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Comparison of McGrath Series 5 and Airtraq Videolaryngoscope for Double-lumen Tube (DLT) Intubation|A Randomised Controlled Trial Comparing of McGrath Series 5 and Airtraq Videolaryngoscope for Double-lumen Tube Intubation in Patients With Low Airway Risk Index Score|Completed||N/A|90|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||No|Because the article has not been published.|2017-10-10 23:41:38.35774|2017-10-10 23:41:38.35774
NCT02329028|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-09-07|||January 2015||2015-01-01|September 2016|2016-09-01||||September 2016|Actual|2016-09-01|4 Weeks|Observational [Patient Registry]|||Feasibility of Mini-EEG in the Prehospital Setting|Feasibility of Mini-EEG in the Prehospital Setting|Completed||N/A|23|Actual|Helsinki University Central Hospital|||1||f||||t||||||||||2017-10-10 23:41:38.454913|2017-10-10 23:41:38.454913
NCT02329015|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2016-09-17|2016-04-25||September 2014||2014-09-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools|Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools|Completed||Phase 1|112|Actual|Long Island University|This study had several limitations including the lack of blinding of tester and an excessive reliance on self-report. Analysis limited by an inability to test effects due to clustering. Novelty, Pygmalion, or motivational effect cannot be ruled out.|2|||f||||f||||||||||2017-10-10 23:41:38.549003|2017-10-10 23:41:38.549003
NCT02329002|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-29|||October 2014||2014-10-01|December 2014|2014-12-01|October 2023|Anticipated|2023-10-01|October 2018|Anticipated|2018-10-01||Observational|||SPT Screening in Irradiated Hereditary Retinoblastoma Survivors|Multicenter Implementation of MR Imaging Studies in Irradiated Hereditary Retinoblastoma Survivors for Assessment of the Value of Craniofacial MRI Screening for Early Detection of Second Craniofacial Primary Tumors and to Enhance Survival|Recruiting||N/A|400|Anticipated|VU University Medical Center|||1||f||||f||||||||||2017-10-10 23:41:39.045179|2017-10-10 23:41:39.045179
NCT02328989|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-02-21|||November 2014||2014-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|PESSAR'ONE||Pessary to Prevent Prematurity in Twins in Case of Short Cervix|Pessary to Prevent Prematurity in Twins in Case of Short Cervix|Recruiting||N/A|324|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-10 23:41:39.124634|2017-10-10 23:41:39.124634
NCT02328976|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-08-21|||May 2014||2014-05-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|January 2016|Actual|2016-01-01||Interventional|HYPOTHAMIG||Hypothalamus Connectivity in Chronic and Episodic Migraine|Hypothalamus Connectivity in Chronic and Episodic Migraine in Headache-free Period: A Resting State Functional Magnetic Resonance Imaging Study|Completed||N/A|53|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:41:39.252876|2017-10-10 23:41:39.252876
NCT02328963|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-06-11|||May 2014||2014-05-01|June 2015|2015-06-01||||May 2017|Anticipated|2017-05-01||Interventional|EVERCMV||Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A|A Multicenter, Two Arms, Randomized, Open Label Clinical Phase IV Study Investigating the Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection Within the First 6 Months Post-transplantation When Treated With an Immunosuppressive Regimen Including Everolimus (Certican®) and Reduced Dose of Cyclosporine A (Neoral®) Versus an Immunosuppressive Regimen With Mycophenolic Acid (Myfortic®) and Standard Dose of Cyclosporine A (Neoral®).|Unknown status|Recruiting|Phase 4|226|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-10 23:41:39.341419|2017-10-10 23:41:39.341419
NCT02328950|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2016-02-16|||December 2014||2014-12-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|September 2016|Anticipated|2016-09-01||Observational|||A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome|A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome|Recruiting||N/A|50|Anticipated|Fujian Medical University|||1||f||||f||||||||||2017-10-10 23:41:39.498016|2017-10-10 23:41:39.498016
NCT02328937|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-12-02|2016-08-04||November 2014||2014-11-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All subjects that were dispensed at least one study lens.|Central Corneal Swelling With Silicone Hydrogel Materials|Daily Wear Central Corneal Swelling With Etafilcon A and 2 Silicone Hydrogel Materials|Completed||N/A|41|Actual|Johnson & Johnson Vision Care, Inc.||6|||f||||f||||||||||2017-10-10 23:41:39.58992|2017-10-10 23:41:39.58992
NCT02328924|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2014-12-29|||May 2012||2012-05-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||There is a Value of Luteinizing Hormone Predictive of in Vitro Fertilization Treatment Outcome in Antagonist Protocols?|There is a Cut Off Value of Luteinizing Hormone Predictive of in Vitro Fertilization Treatment Outcome? A Randomized Controlled Trial in Fixed Versus Flexible Gonadotropin-releasing Hormone Antagonist Protocols.|Completed||Phase 4|213|Actual|U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti||2|||f||||t||||||||||2017-10-10 23:41:39.862941|2017-10-10 23:41:39.862941
NCT02328911|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2015-09-25|||January 2015||2015-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Laser Therapy for Diabetic Peripheral Neuropathic Pain|Laser Therapy Treatment of Peripheral Neuropathic Pain in Individuals With Diabetes|Withdrawn||Phase 2|0|Actual|University of Miami||2||Difficulty recruiting qualified subjects.|f||||f||||||||||2017-10-10 23:41:39.924915|2017-10-10 23:41:39.924915
NCT02328898|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||"Randomized All-comer Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent"|A Prospective, Single Center, Open Label, Randomized Controlled, Two Arm Study Evaluating Safety and Efficacy of the Permanent Polymer Zotarolimus Eluting Stent Resolute Integrity Compared to the Polymer Free Amphilimus Eluting Stent Cre8|Recruiting||Phase 4|1532|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-10 23:41:40.001941|2017-10-10 23:41:40.001941
NCT02328885|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-07-07|||July 2014||2014-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation|Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Banc de Sang i Teixits||1|||f||||f||||||||||2017-10-10 23:41:40.098767|2017-10-10 23:41:40.098767
NCT02328872|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-11-05|||January 2015||2015-01-01|November 2016|2016-11-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Interventional|Compass||Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia|Compass - Randomized Controlled Trial of 5-yearly Cervical Screening With Primary HPV Testing Versus Cervical Screening With 2.5-yearly Liquid Based Cytology Testing, in HPV-Unvaccinated and HPV-Vaccinated Women in Australia|Recruiting||N/A|121000|Anticipated|Victorian Cytology Service||2|||f||||t||||||||||2017-10-10 23:41:40.225439|2017-10-10 23:41:40.225439
NCT02328859|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-06-27|||April 1, 2016|Actual|2016-04-01|June 2017|2017-06-01|June 27, 2017|Actual|2017-06-27|June 23, 2017|Actual|2017-06-23||Interventional|||Virtual Reality Rehabilitation for Individuals With Lower Limb Amputation|Virtual Reality for Rehabilitation for Individuals With Lower Limb Amputation|Completed||Early Phase 1|4|Actual|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 23:41:40.323864|2017-10-10 23:41:40.323864
NCT02328846|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-04|||January 2018|Anticipated|2018-01-01|October 2016|2016-10-01|February 2020|Anticipated|2020-02-01|January 2019|Anticipated|2019-01-01||Observational|||Transcutaneous-Arterial Carbon Dioxide and Microcirculatory Dysfunction|Transcutaneous-Arterial Carbon Dioxide Gradient Predicts Microcirculatory Dysfunction And The Development of Organ Failure After Cardiac Surgery|Not yet recruiting||N/A|300|Anticipated|University of Virginia|||1||f||||f||||||||||2017-10-10 23:41:40.407725|2017-10-10 23:41:40.407725
NCT02328833|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2014-12-29|||January 2015||2015-01-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|GPC-DEPc||Controlled Study About Implementation of a Computerized Depression Guideline in Primary Care|Controlled Study About Implementation of a Computerized Depression Guideline in Primary Care|Unknown status|Not yet recruiting|N/A|10|Anticipated|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-10 23:41:40.471902|2017-10-10 23:41:40.471902
NCT02328820|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-05-12|||October 2014||2014-10-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DEFINE-FLOW||Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses|DEFINE-FLOW (Distal Evaluation of Functional Performance With Intravascular Sensors to Assess the Narrowing Effect - Combined Pressure and Doppler FLOW Velocity Measurements)|Enrolling by invitation||N/A|450|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-10 23:41:40.567934|2017-10-10 23:41:40.567934
NCT02328807|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-29|2017-07-28|||December 29, 2014|Actual|2014-12-29|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Focal Prostate Radio-Frequency Ablation|Focal Prostate Radio-Frequency Ablation for the Treatment of Prostate Cancer|Recruiting||N/A|30|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t|f|||||||||2017-10-10 23:41:40.663053|2017-10-10 23:41:40.663053
NCT02328781|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2016-06-03|||August 2014||2014-08-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|PESS||Prospective Evaluation of Safety and Efficacy Vertebral Drug-eluting Stent System|Prospective Multi-center Single-arm Target Value Clinical Trial for Evaluating Clinical Use Safety and Efficacy of the Firehorus Vertebral Artery Rapamycin-target-eluting Stent System|Active, not recruiting||Phase 2|150|Actual|Beijing Tiantan Hospital||1|||f||||t||||||||||2017-10-10 23:41:40.835423|2017-10-10 23:41:40.835423
NCT02328768|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-09-21|||April 2015||2015-04-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children|Compassionate Use of an Intravenous Fish Oil Lipid Emulsion (Omegaven®) for the Treatment of Intestinal Failure Associated Liver Disease in Children|Enrolling by invitation||Phase 2|20|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-10 23:41:40.909645|2017-10-10 23:41:40.909645
NCT02328755|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-12-15|||January 2015||2015-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia|Targeting Cross-presentation With Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in High Risk Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|35|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-10 23:41:40.979317|2017-10-10 23:41:40.979317
NCT02328742|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-26|2017-01-31|||November 2015||2015-11-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Observational|PréSynUT-1||Development of a Bioabsorbable Medical Device for the Prevention of Postoperative Intra-uterine Adhesions.|Pathophysiology of Intrauterine Synechia - Exploratory Study. Development of a Bioabsorbable Medical Device for the Prevention of Postoperative Intra-uterine Adhesions.|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes|||3|Feasibility issues require solutions.|f||||f||||||Samples Without DNA|"     Endometrial biopsies.   "|||2017-10-10 23:41:41.190539|2017-10-10 23:41:41.190539
NCT02328729|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2014-12-25|||January 2015||2015-01-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Observational|||Incident and Extent of Pulse Alteration During Local Anesthesia in Children|Incident and Extent of Pulse Alteration During Administration of Various Modes of Local Anesthesia in Children During Routine Dental Treatment|Unknown status|Not yet recruiting|N/A|300|Anticipated|Tel Aviv University|||6||f||||t||||||||||2017-10-10 23:41:41.320333|2017-10-10 23:41:41.320333
NCT02328716|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-03-11|||February 2012||2012-02-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|September 2014|Actual|2014-09-01||Interventional|CARCINOHIPEC||Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma|Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma : Randomized Clinical Trial.|Unknown status|Active, not recruiting|Phase 3|32|Anticipated|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||2|||f||||t||||||||||2017-10-10 23:41:41.441913|2017-10-10 23:41:41.441913
NCT02328703|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-25|||May 2013||2013-05-01|May 2017|2017-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Reiki4Pain||Reiki for the Management of Neuropathic Pain|Reiki for the Management of Neuropathic Pain in Service Members With Extremity Trauma|Terminated||N/A|2|Actual|Fort Belvoir Community Hospital||2||Study closed due to substantial decrease in the desired patient population.|f||||f||||||||||2017-10-10 23:41:41.537792|2017-10-10 23:41:41.537792
NCT02328690|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-25|||June 2012||2012-06-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Sound Mind Warrior Study|Binaural Beat Technology: A Complementary Path to Post Deployment Wellness (The Sound Mind Warrior Study)|Completed||N/A|74|Actual|Fort Belvoir Community Hospital||2|||f||||f||||||||||2017-10-10 23:41:41.638319|2017-10-10 23:41:41.638319
NCT02328677|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-08-10|||March 2007||2007-03-01|August 2016|2016-08-01|October 2030|Anticipated|2030-10-01|October 2030|Anticipated|2030-10-01||Observational|||ColoCare Study - Colorectal Cancer Cohort|ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis|Recruiting||N/A|5000|Anticipated|Fred Hutchinson Cancer Research Center|||4||f||||f||||||Samples With DNA|"     blood, urine, feces, saliva, FFPE and fresh frozen tissue (multiple sources/locations), DNA,     RNA, miRNA   "|||2017-10-10 23:41:41.772423|2017-10-10 23:41:41.772423
NCT02328664|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-08-04|||August 2015||2015-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|SCAPURA||SCar-biopsies After Malignant Colorectal Polypectomy of Uncertain RAdicality|The Sensitivity of Scar-biopsies for Residual Colorectal Adenocarcinoma After Endoscopic Resection With Uncertain Radicality|Recruiting||N/A|1356|Anticipated|Deventer Ziekenhuis||1|||f||||t||||||||No|Data collection is within current OpenClinica standard and not shared|2017-10-10 23:41:41.894835|2017-10-10 23:41:41.894835
NCT02328651|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-07-25|||October 2014||2014-10-01|July 2017|2017-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease|Effect and Safety of Xiao'er Jiebiao Oral Liquid in Combination With Standard Treatment on Hand-foot-mouth Disease in Pediatric Patients|Recruiting||Phase 4|398|Anticipated|Children's Hospital of Fudan University||2|||f||||||||||||||2017-10-10 23:41:42.037207|2017-10-10 23:41:42.037207
NCT02328638|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-01-19|||December 2014||2014-12-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Development of a Manual-based, Interdisciplinary Intervention for Youth With ASD and Obesity|Development of a Manual-based, Interdisciplinary Intervention for Youth With ASD and Obesity|Completed||N/A|10|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:41:42.138435|2017-10-10 23:41:42.138435
NCT02328625|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-03-15|||April 2015||2015-04-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|August 2016|Anticipated|2016-08-01|1 Year|Observational [Patient Registry]|STAR||Scleroderma Treatment With Celution Processed ADRCs Registry|Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (ADRCs) Registry|Withdrawn||N/A|0|Actual|Cytori Therapeutics|||1|Corporate decision|f||||f||||||||||2017-10-10 23:41:42.237863|2017-10-10 23:41:42.237863
NCT02328430|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2014-12-30|||January 2015||2015-01-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Feasibility and Validity of Remote Lung Function Assessment|Comparison of Remote Camera Measures of Lung Function Compared to Standard Spirometry|Unknown status|Not yet recruiting|N/A|100|Anticipated|North Bristol NHS Trust|||1||f||||f||||||||||2017-10-10 23:41:43.641062|2017-10-10 23:41:43.641062
NCT02328612|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-04-01|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CELLULA||Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers|Phase I, Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers|Completed||Phase 1|32|Actual|Cellerix||4|||f||||f||||||||||2017-10-10 23:41:42.314741|2017-10-10 23:41:42.314741
NCT02328599|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-07-21|||February 2015||2015-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ARMMS-T2D||Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes|A Prospective Consortium Evaluating the Long-term Follow-up of Patients With Type 2 Diabetes Enrolled In a Randomized Controlled Trial Comparing Bariatric Surgery Versus Medical Management|Enrolling by invitation||N/A|302|Anticipated|The Cleveland Clinic|||2||f||||t||||||Samples Without DNA|"     Study specific blood and urine specimens will be analyzed at a central laboratory.     Participation in the research repository is optional. Blood will be drawn and stored at each     site for later analysis.   "|||2017-10-10 23:41:42.404211|2017-10-10 23:41:42.404211
NCT02328586|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-11-30|||July 2014||2014-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|GAP||Group Acupuncture for Pain|Group Acupuncture for Pain|Completed||N/A|114|Actual|Beth Israel Medical Center||1|||f||||f||||||||||2017-10-10 23:41:42.54316|2017-10-10 23:41:42.54316
NCT02328573|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-09-12|||April 2014||2014-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers|The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers|Recruiting||N/A|80|Anticipated|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-10 23:41:42.628214|2017-10-10 23:41:42.628214
NCT02328560|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-10-28|||January 2016||2016-01-01|February 2016|2016-02-01||||October 2016|Actual|2016-10-01||Observational|ANNONCEP||Impact of the Paramedic Announced Consultation on the Use of Patient Care With Cancer and Treated With Chemotherapy|Impact of the Paramedic Announced Consultation on the Use of Patient Care With Cancer and Treated With Chemotherapy|Terminated||N/A|44|Actual|Centre Francois Baclesse|||2|Loss of recrutement|f||||t||||||||||2017-10-10 23:41:42.717023|2017-10-10 23:41:42.717023
NCT02328547|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-06-19|||May 2015||2015-05-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome|Multicenter, Randomized, Double-blinded, Placebo-controlled Trial of Fecal Microbiota Transplantation (FMT) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|Active, not recruiting||Phase 2|110|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-10 23:41:42.797607|2017-10-10 23:41:42.797607
NCT02328534|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-28|2014-12-30|||March 2007||2007-03-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Observational|||Semen Processing for ICSI Using Swim-down and Density Gradient Methods|Novel Approach of Semen Preparation to Improve ICSI Outcome.|Completed||N/A|890|Actual|Al Baraka Fertility Hospital|||2||f||||f||||||Samples With DNA|"     Semen samples Embryos processed after ICSI and IVF cycles.   "|||2017-10-10 23:41:42.913071|2017-10-10 23:41:42.913071
NCT02328521|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-01-17|||December 2014||2014-12-01|January 2015|2015-01-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy Study of Nicorandil on Neointima|Efficacy Study of Nicorandil on Neointima After Coronary Drug-eluting Stent Implantation in Patients With Diabetic Mellitus|Unknown status|Recruiting|Phase 4|48|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:41:43.030191|2017-10-10 23:41:43.030191
NCT02328508|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2014-12-30|||June 2011||2011-06-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Hyperbaric Oxygen Therapy in Diabetics With Chronic Foot Ulcers and Improvement of Quality of Life|Hyperbaric Oxygen Therapy in Diabetics With Chronic Foot Ulcers and Improvement of Quality of Life|Completed||Phase 1|38|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:41:43.143522|2017-10-10 23:41:43.143522
NCT02328495|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-07-26|||January 2015||2015-01-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Misoprostol Versus Uterine Striating by Bladder Filling for Pain Relief During Office Hysteroscopy|Misoprostol Versus Uterine Striating by Bladder Filling for Pain Relief During Office Hysteroscopy. A Randomized Controlled Trial|Completed||Phase 2|76|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:41:43.229413|2017-10-10 23:41:43.229413
NCT02328482|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2016-11-21|||January 2015||2015-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|HOPEMD||Continuation Protocol to Protocol BBCO-001|A Pivotal, Multicenter, Open-label, Randomized Withdrawal, Non-Treatment Concurrent Control Study to Assess the Safety, Tolerability, and Efficacy of Cabaletta® in Oculopharyngeal Muscular Dystrophy (OPMD) Patients Who Participated in Study BBCO-001|Active, not recruiting||Phase 3|9|Actual|Bioblast Pharma Ltd.||2|||f||||t||||||||||2017-10-10 23:41:43.314659|2017-10-10 23:41:43.314659
NCT02328469|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-05-11|||June 2014||2014-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Aseptic Meningoencephalitis in Slovenia|Prospective Study of the Etiology, Pathogenesis, Clinical Picture and Outcome of Aseptic Meningitis in Slovenia|Recruiting||N/A|800|Anticipated|University Medical Centre Ljubljana|||5||f||||f||||||Samples With DNA|"     Samples of full blood, serum and plasma will be collected and retained in deep freezer for     further analyses.   "|||2017-10-10 23:41:43.389552|2017-10-10 23:41:43.389552
NCT02328456|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-04-14|||December 2014||2014-12-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of SMS Reminder and Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China|A Randomized Controlled Trail to Determine the Impact of a SMS Reminder Associated With Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China|Completed||N/A|209|Actual|Sun Yat-sen University||2|||f||||t||||||||No||2017-10-10 23:41:43.49348|2017-10-10 23:41:43.49348
NCT02328443|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-04-15|||January 2014||2014-01-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|CYP3A_weak||Evaluation and Validation of Metabolic Markers for the Assessment of CYP3A Activity and Prediction of DDI|Evaluation and Validation of Metabolic Markers for the Assessment of CYP3A Activity and Prediction of Drug-drug Interaction in Korean Healthy Subjects|Completed||Phase 1|24|Actual|Seoul National University Hospital||3|||f||||f||||||||||2017-10-10 23:41:43.562737|2017-10-10 23:41:43.562737
NCT02328404|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2016-06-23|2015-01-28||February 2014||2014-02-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional||Number of participants in each arm had been randomly allocated.|The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)|The Effect of Vitamin D Supplementation on Chromium Serum Levels and Insulin Resistance Among Overweight Jordanian Women With Polycystic Ovary Syndrome in Irbid|Completed||Phase 3|60|Actual|Hayat Pharmaceutical Co. PLC|"The study was conducted only in the north of Jordan
Body composition was measured by bioelectrical impedance
Insulin resistance was assessed using the indirect method of assessment (HOMA)
The study was done exclusively on overweight women"|2|||f||||t||||||||No||2017-10-10 23:41:43.81084|2017-10-10 23:41:43.81084
NCT02328391|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-12-30|||September 2013||2013-09-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01|8 Months|Observational [Patient Registry]|GGCP 055/12||STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE|MULTICENTER, PROSPECTIVE, OBSERVATIONAL OF ERLOTINIB AS SECOND-LINE TREATMENT IN PATIENTS WITH NON-SMALL CELL (NSCLC) LUNG CANCER WITH PREDOMINANTLY SQUAMOUS HISTOLOGY AND CARRIERS OF THE GENE (EGFR) EPIDERMAL GROWTH FACTOR RECEPTOR NATIVE|Unknown status|Recruiting|N/A|51|Anticipated|Grupo Gallego de Cancer de Pulmon|||1||f||||t||||||||||2017-10-10 23:41:44.634735|2017-10-10 23:41:44.634735
NCT02328378|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2016-05-22|||September 2014||2014-09-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Postoperative Pain Relief After Cesarean Section: Is There a Role for the Quadratus Lumborum Block?|Postoperative Pain Relief After Cesarean Section: Is There a Role for the Quadratus Lumborum Block?|Completed||N/A|50|Actual|Corniche Hospital||2|||f||||f||||||||||2017-10-10 23:41:44.708404|2017-10-10 23:41:44.708404
NCT02328365|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-08-07|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Screening and Systematic Follow-up for Cardiopulmonary Comorbidity in Patients Having Surgery for Colorectal Cancer|Screening and Systematic Follow-up for Cardiopulmonary Comorbidity in Patients Having Surgery for Colorectal Cancer|Active, not recruiting||N/A|202|Actual|Vejle Hospital||2|||f||||f||||||||||2017-10-10 23:41:44.775339|2017-10-10 23:41:44.775339
NCT02328352|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-12-30|||October 2010||2010-10-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|DM159||"BP as a New Device for Surgery and Solid Cancer and Hematopoietic System Tumors Treatment. Effects of BP Implantation"|The Buckypaper as a New Device in the Treatment of Some Solid Cancer and Hematopoietic System Tumors and as a New Fixing Device for Prosthetic Surgery. In Vivo Study on Effects of BP Implantation, Preliminary to Human Surgical Applications|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|University of Roma La Sapienza||4|||f||||t||||||||||2017-10-10 23:41:44.846399|2017-10-10 23:41:44.846399
NCT02328339|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-08-28|||January 2015||2015-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Tea and Forearm Blood Flow|Forearm Blood Flow Response to Acute Consumption of Black Tea|Completed||N/A|20|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-10 23:41:44.948785|2017-10-10 23:41:44.948785
NCT02328326|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-08-18|||January 1, 2017|Actual|2017-01-01|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|November 30, 2018|Anticipated|2018-11-30||Interventional|CO-IMPACT||Caring Others Increasing EngageMent in PACT|Engaging Veterans and Family Supporters in PACT to Improve Diabetes Management|Enrolling by invitation||N/A|480|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:41:45.030853|2017-10-10 23:41:45.030853
NCT02328313|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-12-22|||October 2014||2014-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older|LCCC 1410: Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older|Recruiting||N/A|100|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:41:45.122952|2017-10-10 23:41:45.122952
NCT02328300|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-10-03|||May 7, 2014|Actual|2014-05-07|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions|FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions|Recruiting||N/A|15|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-10 23:41:46.825039|2017-10-10 23:41:46.825039
NCT02328287|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-01-31|||November 2014||2014-11-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Study on Allogeneic Osteoblastic Cells Implantation in Rescue Interbody Fusion|A Pilot Phase 2a, Multicentre, Open, Proof-of-concept Study on the Safety and the Efficacy of Allogeneic Osteoblastic Cells (ALLOB®) Implantation in Rescue Interbody Fusion|Recruiting||Phase 2|23|Anticipated|Bone Therapeutics S.A||1|||f||||f||||||||||2017-10-10 23:41:46.909767|2017-10-10 23:41:46.909767
NCT02328274|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2014-12-25|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Observational|||A Modified Technique for Laparoscopic Subtotal Hysterectomy||Completed||N/A|19|Actual|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-10 23:41:46.983893|2017-10-10 23:41:46.983893
NCT02328261|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-26|||November 2014||2014-11-01|November 2014|2014-11-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|||A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma|Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma: A Phase II, Multi-center, Open-label Study|Unknown status|Active, not recruiting|Phase 2|66|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||f||||||||||2017-10-10 23:41:47.035124|2017-10-10 23:41:47.035124
NCT02328248|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2014-12-26|||July 2014||2014-07-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Usage of Biological Patch Versus Plastic in the Laparoscopic Repair of Hiatal Hernias|Randomized Control Trial (RCT) That the Usage With Biological Patch Versus Plastic in the Laparoscopic Repair|Unknown status|Active, not recruiting|Phase 2/Phase 3|150|Anticipated|Xijing Hospital of Digestive Diseases||2|||f||||f||||||||||2017-10-10 23:41:47.109157|2017-10-10 23:41:47.109157
NCT02328235|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-10-03|||January 2013||2013-01-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of High Fat Diet on Muscle Metabolism|Effect of High Fat Diet on Muscle Metabolism|Active, not recruiting||N/A|11|Actual|Virginia Polytechnic Institute and State University||1|||f||||t||||||||||2017-10-10 23:41:47.196199|2017-10-10 23:41:47.196199
NCT02328222|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-12-26|||June 2010||2010-06-01|December 2014|2014-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|ESWMEX001||ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION|PHASE 4, STUDY OF THE EFFECT OF EARLY STEROID WITHDRAWAL IN RENAL TRANSPLANT RECEPIENTS OF A LIVING-RELATED DONOR|Completed||Phase 4|71|Actual|Unidad de Investigacion Medica en Enfermedades Renales||2|||f||||f||||||||||2017-10-10 23:41:47.269659|2017-10-10 23:41:47.269659
NCT02328209|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2014-12-26|||June 2014||2014-06-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration|Evaluation of the Efficacy and Continuance Rate of Treatment in Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration|Unknown status|Recruiting|N/A|50|Anticipated|Mie University||1|||f||||t||||||||||2017-10-10 23:41:47.356851|2017-10-10 23:41:47.356851
NCT02328196|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-03-15|||August 2014||2014-08-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Validation of a Revised Version of the Danish McGill Ingestive Skills Assessment|Validation of a Revised Version of the Danish McGill Ingestive Skills Assessment for Measuring Dysphagic Clients' Performance During Meals|Completed||N/A|328|Actual|Metropolitan University College|||1||f||||f||||||||No|Individuel participant data are not available for other than the principal Investigator. This is approved by the Danish Data Protection Authority.|2017-10-10 23:41:47.445879|2017-10-10 23:41:47.445879
NCT02328183|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-08-31|||December 2014||2014-12-01|August 2015|2015-08-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|XDR||Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative Bacteria|Efficacy of Polymyxin B Against Infections Caused by Extensively Drug-resistant (XDR) Gram-Negative Bacteria|Unknown status|Recruiting|Phase 4|100|Anticipated|Mahidol University||1|||f||||t||||||||||2017-10-10 23:41:47.514172|2017-10-10 23:41:47.514172
NCT02328170|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-03-21|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Observational|||Comparative Study of Specific IgE Levels to Common Foods and Aeroallergens Measured by EUROIMMUN Allergy and ImmunoCap|Comparative Study of Specific IgE Levels to Common Foods and Aeroallergens Among Thai Children Measured by EUROIMMUN Allergy and ImmunoCap|Completed||N/A|235|Actual|Mahidol University|||2||f||||f|f|f||||Samples Without DNA|"     Clotted blood 3 mL   "|No||2017-10-10 23:41:47.736453|2017-10-10 23:41:47.736453
NCT02328157|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2016-09-22|||January 2015||2015-01-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Combined 25-gauge Vitrectomy and Cataract Surgery With Toric Intraocular Lens With Idiopathic Epiretinal Membrane.|Combined 25-gauge Vitrectomy and Cataract Surgery With Toric Intraocular Lens With Idiopathic Epiretinal Membrane.|Recruiting||N/A|30|Anticipated|Kagawa University||1|||f||||f||||||||||2017-10-10 23:41:47.84657|2017-10-10 23:41:47.84657
NCT02328144|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2014-12-26|||July 2013||2013-07-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Effectiveness of Metronidazole in Pain Control Posthemorrhoidectomy|Effectiveness of Metronidazole Versus Homologated Placebo in Pain Control Posthemorrhoidectomy|Completed||Phase 3|44|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-10 23:41:47.931314|2017-10-10 23:41:47.931314
NCT02328131|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-02-10|||June 2013||2013-06-01|February 2016|2016-02-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Observational|||European Registry on the Management of Helicobacter Pylori Infection|European Registry on the Management of Helicobacter Pylori Infection|Recruiting||N/A|10000|Anticipated|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa|||1||f||||f||||||||Undecided||2017-10-10 23:41:48.029727|2017-10-10 23:41:48.029727
NCT02328118|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2016-08-23|||February 2015||2015-02-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|RaTAPDR||25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China|25-Gauge Vitrectomy Combine With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in Chinese Patients|Recruiting||Phase 2/Phase 3|120|Anticipated|The First People's Hospital of Xuzhou||2|||f||||f||||||||Undecided||2017-10-10 23:41:48.252952|2017-10-10 23:41:48.252952
NCT02328105|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-06-20|||December 2014||2014-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer|LCI-LUN-ABR-001: A Pilot Study of Carboplatin With Nab-Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer of Squamous Histology|Active, not recruiting||Phase 2|11|Actual|Carolinas Healthcare System||1|||f||||t||||||||||2017-10-10 23:41:48.377602|2017-10-10 23:41:48.377602
NCT02328092|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-26|||May 2013||2013-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Double-blind Randomized Clinical Trial on the Efficacy of Magnetic Sacral Roots Stimulation for the Treatment of Nocturnal Enuresis|Therapeutic Effect of Sacral Root Stimulation on Nocturnal Enuresis|Completed||N/A|41|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 23:41:48.456776|2017-10-10 23:41:48.456776
NCT02328079|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-26|||April 2013||2013-04-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy|Antiviral Treatment in Facial Palsy. Randomized Control Trial|Completed||N/A|50|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 23:41:48.528415|2017-10-10 23:41:48.528415
NCT02328066|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-26|||July 2014||2014-07-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|NICE||Diagnostic Accuracy of NICE Classification to Predict Deep Submucosal Invasion|Diagnostic Accuracy of NICE Classification to Predict Deep Submucosal Invasion in Colon Lesions. Prospective Multicenter Study in Routine Clinical Practice|Unknown status|Recruiting|N/A|1921|Anticipated|Asociación Española de Gastroenterología||1|||f||||f||||||||||2017-10-10 23:41:48.604951|2017-10-10 23:41:48.604951
NCT02328053|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2014-12-26|||February 2014||2014-02-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Clinical & Visual Outcomes of Collagen Cross Linking for Fungal Keratitis|Clinical & Visual Outcomes of Collagen Cross Linking for Fungal Keratitis|Unknown status|Recruiting|N/A|20|Anticipated|Aravind Eye Care System||2|||f||||f||||||||||2017-10-10 23:41:48.703648|2017-10-10 23:41:48.703648
NCT02328040|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-08-05|||September 2014||2014-09-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop|Double-blinded, Randomized, Controlled Paired Trial Comparing Sitagliptin to Placebo in Closed Loop.|Completed||Phase 1|15|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-10 23:41:48.79008|2017-10-10 23:41:48.79008
NCT02328027|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-01-23|||December 2014||2014-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)|A Phase I-IIa Study of Safety, Tolerance, Pharmacokinetics, Dosimetry and Benefice of Early Nuclear Medicine Imaging of 99mTc-rhAnnexin V-128 in Patients With Rheumatoid Arthritis or Ankylosing Spondylitis|Recruiting||Phase 1/Phase 2|20|Anticipated|Advanced Accelerator Applications||1|||f||||t||||||||||2017-10-10 23:41:48.873636|2017-10-10 23:41:48.873636
NCT02328014|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-02-23|||December 2014||2014-12-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||ACP-196 in Combination With ACP-319, for Treatment of B-Cell Malignancies|A Phase 1/2 Proof-of-Concept Study of the Combination of ACP-196 and ACP-319 in Subjects With B-cell Malignancies|Recruiting||Phase 1/Phase 2|126|Anticipated|Acerta Pharma BV||2|||f||||f||||||||||2017-10-10 23:41:48.95854|2017-10-10 23:41:48.95854
NCT02328001|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-04-06|||December 2014||2014-12-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Cost-Minimization Analysis After a Targeted Intervention for EGD and Colonoscopy|Cost-Minimization Analysis and Its Impact on Resource Utilization After a Targeted Intervention for EGD and Colonoscopy|Completed||N/A|969|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-10 23:41:49.055642|2017-10-10 23:41:49.055642
NCT02327988|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-25|||March 2013||2013-03-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CLMD||Cryotherapy and Laser Therapy on Muscle Damage|Cryotherapy and Laser Therapy do Not Interfere in the Response to Eccentric Exercise-induced Muscle Damage: a Randomized Clinical Trial.|Completed||Phase 4|60|Actual|Universidade Federal do Rio Grande do Norte||3|||f||||t||||||||||2017-10-10 23:41:49.130555|2017-10-10 23:41:49.130555
NCT02327975|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2015-02-27|||November 2012||2012-11-01|February 2015|2015-02-01||||September 2013|Actual|2013-09-01||Interventional|PEME||Prescription of Physical Exercise Through Mobile Application in Elderly|Effects of a Training Program of Physical Exercise Administered Through Mobile Application in Elderly|Completed||N/A|48|Actual|University of the Balearic Islands||3|||f||||f||||||||||2017-10-10 23:41:49.215479|2017-10-10 23:41:49.215479
NCT02327962|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2014-12-25|||January 2011||2011-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Comparing an Automatic PWV Analyser to Pulse Pressure in Hemodialysis|A Prospective Observational Study Comparing a Non-operator Dependent Automatic PWV Analyser to Pulse Pressure, in Assessing Arterial Stiffness in Hemodialysis|Completed||N/A|143|Actual|Ospedale Regionale di Locarno|||2||f||||f||||||||||2017-10-10 23:41:49.318559|2017-10-10 23:41:49.318559
NCT02327949|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2016-08-15|||December 2014||2014-12-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||W-Shaped Acetabular Angular Plate (WAAP) Versus Reconstruction Plate|Prospective Comparison Between W-Shaped Acetabular Angular Plate (WAAP) and Reconstruction Plate for the Treatment of Posterior Acetabular Wall Fracture|Active, not recruiting||Phase 4|40|Anticipated|Hebei Medical University Third Hospital||2|||f||||f||||||||||2017-10-10 23:41:49.48523|2017-10-10 23:41:49.48523
NCT02327936|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-12-17|||December 2014||2014-12-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|FOXY||Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children|Efficacy and Tolerability of Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children: a Comparative Study.|Enrolling by invitation||Phase 3|60|Anticipated|CHU de Quebec-Universite Laval||2|||f||||t||||||||Yes|Publication to be submitted in peer reviewed journal, end of 2017|2017-10-10 23:41:49.580848|2017-10-10 23:41:49.580848
NCT02327923|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2016-11-06|||October 2014||2014-10-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy|Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy: a Randomized Clinical Trial|Completed||Phase 4|90|Actual|B.P. Koirala Institute of Health Sciences||2|||f||||t||||||||No||2017-10-10 23:41:49.668061|2017-10-10 23:41:49.668061
NCT02327910|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2016-03-22|||October 2014||2014-10-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||The Clinical Value of Applying TOF and TcPO2 to Guide Elderly Patients Extubation|The Clinical Value of Applying Qualitative TOF Monitoring and Transcutaneous Partial Pressure of Carbon Dioxide to Guide Elderly Patients Extubation|Enrolling by invitation||N/A|300|Anticipated|Beijing Municipal Science & Technology Commission||3|||f||||t||||||||Yes||2017-10-10 23:41:49.819502|2017-10-10 23:41:49.819502
NCT02327897|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-06-30|||December 23, 2014||2014-12-23|June 2, 2017|2017-06-02|January 1, 2030|Anticipated|2030-01-01|December 30, 2029|Anticipated|2029-12-30||Observational|||NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)|Natural History of Asthma With Longitudinal Environmental Sampling|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:41:49.895648|2017-10-10 23:41:49.895648
NCT02327884|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-30|2017-07-11|||December 18, 2014||2014-12-18|June 30, 2017|2017-06-30|January 1, 2025|Anticipated|2025-01-01|January 1, 2025|Anticipated|2025-01-01||Observational|||Characterization of Diseases With Salivary Gland Involvement|Characterization of Diseases With Salivary Gland Involvement|Recruiting||N/A|1050|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:41:49.975429|2017-10-10 23:41:49.975429
NCT02327871|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-05-03|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|THE-COOL||Esophageal Temperature Management After Cardiac Arrest|Targeted Temperature Management With Therapeutic Hypothermia Using Esophageal COOLing After Cardiac Arrest: THE COOL STUDY|Completed||N/A|15|Actual|IST cardiology||1|||f||||f||||||||||2017-10-10 23:41:50.069737|2017-10-10 23:41:50.069737
NCT02327858|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2016-08-04|||July 2015||2015-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Supportive Text Messages to Reduce Mood Symptoms and Problem Drinking- Randomised Controlled Pilot Trials|Supportive Text Messages to Reduce Mood Symptoms and Problem Drinking in Patients With Primary Depression or Alcohol Use Disorder - Randomised Controlled Pilot Trials|Completed||N/A|131|Actual|University of Alberta||2|||f||||t||||||||||2017-10-10 23:41:50.151392|2017-10-10 23:41:50.151392
NCT02327845|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-06-30|||April 2015||2015-04-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Phenotype, Genotype & Biomarkers in ALS and Related Disorders|Phenotype, Genotype & Biomarkers in ALS and Related Disorders|Recruiting||N/A|700|Anticipated|University of Miami|||2||f||||f||||||Samples With DNA|"     DNA, serum, urine and CSF   "|||2017-10-10 23:41:50.26035|2017-10-10 23:41:50.26035
NCT02327832|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2014-12-29|||December 2014||2014-12-01|December 2014|2014-12-01||||March 2017|Anticipated|2017-03-01||Interventional|||Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs|Safety Study of a Less Invasive Liver Regeneration Therapy Using Cultured Autologous Bone Marrow-derived Mesenchymal Stem Cells for Compensated Liver Cirrhotic Patient|Unknown status|Recruiting|Phase 1|10|Anticipated|Yamaguchi University Hospital||1|||f||||f||||||||||2017-10-10 23:41:50.432731|2017-10-10 23:41:50.432731
NCT02327819|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2014-12-24|||January 2015||2015-01-01|December 2014|2014-12-01||||December 2015|Anticipated|2015-12-01||Interventional|||The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer||Unknown status|Not yet recruiting|N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-10 23:41:50.52586|2017-10-10 23:41:50.52586
NCT02327806|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2014-12-24|||January 2015||2015-01-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||The Effect of Pullsed Magnetic Field Induction on Improving the Forearm Tissue Muscle Performance|The Effect of Pullsed Magnetic Field Induction on Improving the Forearm Tissue Muscle Performance|Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||||||||||||2017-10-10 23:41:50.599944|2017-10-10 23:41:50.599944
NCT02327793|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2016-04-04|||June 2009||2009-06-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|PATIS||Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke|Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke|Completed||Phase 2|65|Actual|University of Alberta||3|||f||||f||||||||||2017-10-10 23:41:50.674675|2017-10-10 23:41:50.674675
NCT02327780|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2014-12-29|||January 2015||2015-01-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||The Effectivness of FODMAP Diet in Israel in Relieving Symptoms of Patients With Irritable Bowel Syndrome|The Effectivness of FODMAP Diet in Israel in Relieving Symptoms of Patients With Irritable Bowel Syndrome|Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||||||||||||2017-10-10 23:41:50.755986|2017-10-10 23:41:50.755986
NCT02327767|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-01-02|||January 2015||2015-01-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Use of a Mechanically Passive Rehabilitation Device in Vietnam: Impact on Upper Extremity Hemiparesis After Stroke|Use of a Mechanically Passive Rehabilitation Device as a Training Tool in Vietnam: Impact on Upper Extremity Hemiparesis After Stroke|Unknown status|Not yet recruiting|N/A|30|Anticipated|California State University, Northridge||2|||f||||f||||||||||2017-10-10 23:41:50.823845|2017-10-10 23:41:50.823845
NCT02327754|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-04-10||||||November 2015|2015-11-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|UPWARD||Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout|Effect of Topiroxostat on Urinary Albumin Excretion in Patients With eARly Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout: a Randomized, Placebo-controlled, Double-blind Phase 2a Trial (UPWARD).|Completed||Phase 2|60|Anticipated|Sanwa Kagaku Kenkyusho Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:41:50.923897|2017-10-10 23:41:50.923897
NCT02327741|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2014-12-29|||October 2012||2012-10-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy of Long Term Plavix Therapy Post Angioplasty|Evaluation of Safety, Benefits and Complications of Long-term Dual Antiplatelet Therapy in Patients With Angioplasty|Completed||N/A|1010|Actual|Shiraz University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:41:51.005025|2017-10-10 23:41:51.005025
NCT02327728|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-24|||February 2013||2013-02-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm|Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm|Unknown status|Recruiting|N/A|120|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:41:51.095383|2017-10-10 23:41:51.095383
NCT02327715|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||January 2015||2015-01-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients|Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Asian-Pacific Alliance of Liver Disease, Beijing||1|||f||||t||||||||||2017-10-10 23:41:51.203202|2017-10-10 23:41:51.203202
NCT02327702|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||January 2015||2015-01-01|December 2014|2014-12-01|July 2017|Anticipated|2017-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients|Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Asian-Pacific Alliance of Liver Disease, Beijing||1|||f||||t||||||||||2017-10-10 23:41:51.298164|2017-10-10 23:41:51.298164
NCT02327689|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||January 2015||2015-01-01|December 2014|2014-12-01|July 2017|Anticipated|2017-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients|Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients|Unknown status|Not yet recruiting|Phase 4|400|Anticipated|Asian-Pacific Alliance of Liver Disease, Beijing||2|||f||||t||||||||||2017-10-10 23:41:51.412733|2017-10-10 23:41:51.412733
NCT02327676|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||January 2015||2015-01-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients|Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Asian-Pacific Alliance of Liver Disease, Beijing||1|||f||||t||||||||||2017-10-10 23:41:51.518361|2017-10-10 23:41:51.518361
NCT02327663|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||December 2014||2014-12-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Emtricitabine for Naive Chinese Chronic Hepatitis B Patients|Emtricitabine for Naive Chinese Chronic Hepatitis B Patients|Not yet recruiting||Phase 4|2000|Anticipated|Asian-Pacific Alliance of Liver Disease, Beijing||2|||f||||t||||||||||2017-10-10 23:41:51.60893|2017-10-10 23:41:51.60893
NCT02327650|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2016-04-12|||November 2015||2015-11-01|April 2016|2016-04-01||||April 2016|Actual|2016-04-01||Observational|||To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations|The Examinations Whether or Not the Primary Causes of Osteoarthritis or Rheumatoid Arthritis in Joints Might be Bone Alterations|Recruiting||Phase 2|200|Anticipated|Shinshu University|||1||f||||f||||||||||2017-10-10 23:41:51.70515|2017-10-10 23:41:51.70515
NCT02327637|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2014-12-23|||December 2014||2014-12-01|December 2014|2014-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|PACT||A Comparison of Bed Rest Versus Moderate Activity in Preterm Premature Rupture of Membranes (PPROM)|A Comparison of Bed Rest Versus Moderate Activity Among Inpatient Antepartum Patients With Preterm Premature Rupture of Membranes (PPROM): A Randomized Controlled Trial|Unknown status|Recruiting|N/A|130|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:41:51.7742|2017-10-10 23:41:51.7742
NCT02327624|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-04-24|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|STEEL-PCI||STEEL Percutaneous Coronary Intervention|Study of Two Regimens of TicagrElor Compared to Clopidogrel in Patients Undergoing ELective Percutaneous Coronary Intervention|Active, not recruiting||Phase 4|180|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||3|||f||||f||||||||Undecided||2017-10-10 23:41:51.861853|2017-10-10 23:41:51.861853
NCT02327611|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-10-04|||February 2015||2015-02-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||CUstodiol Versus RInger: whaT Is the Best Agent?|CUstodiol Versus RInger: whaT Is the Best Agent? A Randomized Double Blind Trial.|Active, not recruiting||Phase 4|90||Scientific Institute San Raffaele||2|||f||||||||||||||2017-10-10 23:41:51.936529|2017-10-10 23:41:51.936529
NCT02327598|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2015-12-05|||January 2015||2015-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:41:52.113555|2017-10-10 23:41:52.113555
NCT02327585|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2014-12-30|||June 2013||2013-06-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD)|Study on the Psychological Behavior Intervention Technology of Attention Deficit Hyperactivity Disorder|Unknown status|Recruiting|Phase 1|80|Anticipated|Peking University||1|||f||||t||||||||||2017-10-10 23:41:52.163321|2017-10-10 23:41:52.163321
NCT02327572|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-10-24|||March 2014||2014-03-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2015|Actual|2015-06-01||Observational|IMAGE||Age-related Changes in the Immune System and Their Impact on Elderly Breast Cancer|Age-related Changes in the Immune System and Their Impact on Elderly Breast Cancer|Completed||N/A|60|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     Blood samples (two 10-mL EDTA tubes) will be collected from each patient immediately prior to     surgery for assessing ageing/immunosenescence biomarkers   "|||2017-10-10 23:41:52.256169|2017-10-10 23:41:52.256169
NCT02327559|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-05-23|||October 2011||2011-10-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Interventional|PEARLS||Prenatal Education About Reducing Labor Stress (PEARLS)|Randomized Controlled Trial of a Mindfulness Intervention for Labor-Related Pain and Fear|Completed||N/A|33|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:41:52.331175|2017-10-10 23:41:52.331175
NCT02327546|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-04-10|||December 2014||2014-12-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548|An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.|Completed||Phase 1|10|Actual|Akebia Therapeutics||2|||f||||f||||||||||2017-10-10 23:41:52.432787|2017-10-10 23:41:52.432787
NCT02327520|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2014-12-24|||January 2010||2010-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2010|Actual|2010-12-01||Observational|||Clostridium Difficile Infection: the First Report in Southeast Asia by 2010 Nationwide Study|The Burden of Clostridium Difficile Infection in Thai Population: the First Report in Southeast Asia by 2010 Nationwide Study|Completed||N/A|204666|Actual|King Chulalongkorn Memorial Hospital|||1||f||||t||||||||||2017-10-10 23:41:52.615168|2017-10-10 23:41:52.615168
NCT02327507|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||June 2014||2014-06-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Everybody Brush: A Community-wide Toothpaste Distribution Campaign|Bending the Oregon Health Plan (OHP) Dentistry Cost Curve in Central Oregon by Reducing the Burden of Oral Disease|Unknown status|Active, not recruiting|N/A|21731|Anticipated|Advantage Dental Services, LLC|||2||f||||f||||||||||2017-10-10 23:41:52.689343|2017-10-10 23:41:52.689343
NCT02327494|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-01-06|||January 2015||2015-01-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|June 2016|Anticipated|2016-06-01|90 Days|Observational [Patient Registry]|OXYMUBLOC||Study to Evaluate Oxygen Monitoring at Different Stages of Neuromuscular Blockade in Colorectal Surgery|Prospective Study to Evaluate the Central Venous Oxygen Saturation and the Regional Cerebral Oxygen Saturation Monitoring at Different Stages of Neuromuscular Blockade in High-risk Patients Scheduled for Colorectal Surgery|Unknown status|Not yet recruiting|N/A|70|Anticipated|Hospital Universitari de Bellvitge|||1||f||||t||||||||||2017-10-10 23:41:52.775143|2017-10-10 23:41:52.775143
NCT02327481|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-01-11|||January 2015||2015-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2016|Actual|2016-06-01||Interventional|||Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer|Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer|Active, not recruiting||Phase 3|438|Anticipated|Fujian Medical University||2|||f||||t||||||||No||2017-10-10 23:41:52.862232|2017-10-10 23:41:52.862232
NCT02327455|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-06-21|||July 2017||2017-07-01|June 2016|2016-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Integrated RF and B-mode Deformation Analysis for 4D Stress Echocardiography|Integrated RF and B-mode Deformation Analysis for 4D Stress Echocardiography|Not yet recruiting||N/A|20|Anticipated|Yale University||1|||f||||f||||||||||2017-10-10 23:41:52.958936|2017-10-10 23:41:52.958936
NCT02327442|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||June 2014||2014-06-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|GNNGB||68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients|Prospective Imaging Study of 68Ga-NOTA-NFB in Tumors|Unknown status|Recruiting|N/A|46|Anticipated|Xijing Hospital|||3||f||||f||||||||||2017-10-10 23:41:53.032479|2017-10-10 23:41:53.032479
NCT02327429|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-06-01|2016-12-09||February 2015||2015-02-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Program completes only|Pilot Test of a Chinese Menu Plan for Type 2 Diabetes|Pilot Test of a Chinese Menu Plan for Type 2 Diabetes|Completed||N/A|19|Actual|University of Alberta||1|||f||||f||||||||||2017-10-10 23:41:53.145392|2017-10-10 23:41:53.145392
NCT02327416|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-08-11|||October 2014||2014-10-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)|A Prospective Randomized Clinical Trial of Combination Sequential Treatment With Y Peginterferon Alfa-2b and ETV (Entecavir) in CHB (Chronic Hepatitis B) Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)|Recruiting||Phase 3|300|Anticipated|Tongji Hospital||3|||f||||t||||||||||2017-10-10 23:41:53.538139|2017-10-10 23:41:53.538139
NCT02327403|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-03-30|||October 2015|Actual|2015-10-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Belatacept Conversion in Proteinuric Kidney Transplant Recipients|"The B7-1 Study: Belatacept Conversion in Proteinuric Renal Transplant Recipients and B7-1 Positivity Status on Biopsy: an Interventional Multi-Center Trial"|Active, not recruiting||Phase 2|36|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:41:53.678162|2017-10-10 23:41:53.678162
NCT02327390|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-06-09|||March 17, 2015|Actual|2015-03-17|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV Melanoma|Phase I Study Using Autologous Ex Vivo-Activated (X-ACT) Lymph Node Lymphocytes as Adoptive Immunotherapy in Advanced Malignant Melanoma Patients|Suspended||Phase 1|24|Anticipated|Case Comprehensive Cancer Center||1||Administrative hold|f||||t|t|f||||||||2017-10-10 23:41:53.781131|2017-10-10 23:41:53.781131
NCT02327377|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-05-08|||April 2014||2014-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Web-based Management of Pediatric Functional Abdominal Pain|Predicting Treatment Outcomes in Pediatric Functional Abdominal Pain|Recruiting||N/A|300|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 23:41:53.889862|2017-10-10 23:41:53.889862
NCT02327364|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-02-10|||March 2014||2014-03-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|3 Years|Observational [Patient Registry]|||Natural History of Pearson Syndrome|Rare Disease Clinical Research Network Natural History of Pearson Syndrome North American Mitochondrial Disease Consortium (NAMDC)|Enrolling by invitation||N/A|25|Anticipated|The Cleveland Clinic|||1||f||||f||||||Samples With DNA|"     Blood samples will be obtained for analyses of mtDNA deletions and hematologic parameters   "|||2017-10-10 23:41:54.004428|2017-10-10 23:41:54.004428
NCT02327351|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-07-23|||July 2012||2012-07-01|July 2016|2016-07-01||||December 2018|Anticipated|2018-12-01||Interventional|||TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID|Phase II/III Study of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated and Haploidentical Donors After TCR Alfa Beta Negative Selection in Pediatric Patients With Primary Immunodeficiency Diseases|Recruiting||Phase 2/Phase 3|60|Anticipated|Federal Research Institute of Pediatric Hematology, Oncology and Immunology||1|||f||||t||||||||||2017-10-10 23:41:54.066548|2017-10-10 23:41:54.066548
NCT02327338|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-07-28|||November 2014||2014-11-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Use of ThermaCare Heat Wraps and Ibuprofen as an Adjunct to Physical Therapy for Neck Pain|Use of ThermaCare Heat Wraps and Ibuprofen as an Adjunct to Physical Therapy for Neck Pain|Completed||Phase 4|90|Actual|Future Sciene Technology||4|||f||||f||||||||||2017-10-10 23:41:54.175681|2017-10-10 23:41:54.175681
NCT02327325|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-07-12|||May 21, 2015|Actual|2015-05-21|July 2017|2017-07-01|March 1, 2017|Actual|2017-03-01|November 30, 2016|Actual|2016-11-30||Interventional|PACe-LBP||Physical Activity for Older Adults Chronic Low Back Pain|Physical Activity for Older Adults With Chronic Low Back Pain: PACe-LBP|Completed||N/A|60|Actual|VA Office of Research and Development||3|||f||||f|f|f|||f|||||2017-10-10 23:41:54.274986|2017-10-10 23:41:54.274986
NCT02327312|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2015-06-16|||November 2014||2014-11-01|June 2015|2015-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty||Recruiting||N/A|1200|Anticipated|Glaukos Corporation||2|||f||||t||||||||||2017-10-10 23:41:54.365891|2017-10-10 23:41:54.365891
NCT02327299|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-23|||October 2014||2014-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Fe Bouillon||Iron Bioavailability From Cubes|Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Women|Completed||N/A|24|Actual|Swiss Federal Institute of Technology||4|||f||||t||||||||||2017-10-10 23:41:54.476158|2017-10-10 23:41:54.476158
NCT02327286|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-09-01|||January 2015||2015-01-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|LINDA-Brasil||Randomized Clinical Trial of Lifestyle Interventions to Prevent Diabetes in Women With Previous Gestational Diabetes|Prevenção do Diabetes em Mulheres Com Diabetes Gestacional prévio: Estudo multicêntrico de mudanças Intensivas de Estilo de Vida: LINDA-Brasil|Recruiting||Phase 3|740|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 23:41:54.564131|2017-10-10 23:41:54.564131
NCT02327273|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2015-07-21|||October 2014||2014-10-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects|Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects|Completed||Phase 1|88|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:41:54.692599|2017-10-10 23:41:54.692599
NCT02327260|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-08-31|||February 2015||2015-02-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|||Increasing Adherence to Treatment Recommendations Following a Cardiac Event|Increasing Adherence to Treatment Recommendations Following a Cardiac Event|Active, not recruiting||N/A|61|Actual|University of Missouri, Kansas City||2|||f||||f||||||||||2017-10-10 23:41:54.775135|2017-10-10 23:41:54.775135
NCT02326896|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2014-12-29|||November 2013||2013-11-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||MACOCHA Score Predicts Intubation Failure|The New MACOCHA Score Predicts Intubation Failure of Non-anesthesiologist ICU Trainees|Completed||N/A|134|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-10 23:41:58.343962|2017-10-10 23:41:58.343962
NCT02327247|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-23|||September 2008||2008-09-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover, Bioequivalence Study Comparing Felodipine Extended Release Tablet (Containing Felodipine 10 mg) of OHM Laboratories Inc (A Subsidiary of Ranbaxy Pharmaceuticals Inc) With PLENDIL® Extended Release Tablet (Containing Felodipine 10 mg) Manufactured by Merck & Co. Inc. for AstraZeneca in Healthy, Adult, Male, Human Subjects Under Fasting Condition.|Completed||N/A|48|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-10 23:41:54.84626|2017-10-10 23:41:54.84626
NCT02327234|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-04-19|||December 2014||2014-12-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Airway Response to Repeat Allergen Challenge and the Effect of Ibuprofen in Mild Atopic Asthma|Assessment of Repeated Allergen Challenge and the Effects of Ibuprofen on the Inflammatory Process|Completed||N/A|13|Actual|University of Saskatchewan||2|||f||||f||||||||Yes|journal publication|2017-10-10 23:41:54.91596|2017-10-10 23:41:54.91596
NCT02327221|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-04-24|||December 2014|Actual|2014-12-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|CATS29||Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease|A Phase IIb, Multicentre, Randomised, Double-blinded, Placebo-controlled, Multi-dose and Multi-injection, Parallel Groups Study to Evaluate the Efficacy and the Safety of Ovasave in Patients With Active Refractory Crohn's Disease|Terminated||Phase 2|32|Actual|TxCell||4|||f||||t||||||||||2017-10-10 23:41:54.992302|2017-10-10 23:41:54.992302
NCT02327208|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-07-19|||January 2015||2015-01-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Lean Body Mass Response to Higher-protein Diets During Winter Military Training|Effects of Carbohydrate and Protein Supplementation on Whole-body Protein Balance and Skeletal Muscle Mass During Winter Military Training: a Randomized Controlled Trial|Completed||N/A|73|Actual|United States Army Research Institute of Environmental Medicine||3|||f||||f||||||||||2017-10-10 23:41:55.236447|2017-10-10 23:41:55.236447
NCT02327195|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-01-18|||March 2014||2014-03-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MPOrtho||General Anesthesia Emergence Induced by Methylphenidate|Active Emergence of From Isoflurane General Anesthesia Induced by Methylphenidate|Recruiting||Phase 1|54|Anticipated|Ohio State University||2|||f||||t||||||||No||2017-10-10 23:41:55.322037|2017-10-10 23:41:55.322037
NCT02327182|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-11-12|||December 2014||2014-12-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Safety Study of MT-4666 in Subjects With Alzheimer's Disease|A Long-Term Safety Study of MT-4666 in Patients With Mild to Moderate Alzheimer's Disease (AD)|Terminated||Phase 3|117|Actual|Mitsubishi Tanabe Pharma Corporation||2||This study was terminated due to the benefit-risk balance of MT-4666.|f||||f||||||||||2017-10-10 23:41:55.413802|2017-10-10 23:41:55.413802
NCT02327169|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-09-21|||February 2, 2015|Actual|2015-02-02|September 2017|2017-09-01|December 23, 2017|Anticipated|2017-12-23|December 23, 2017|Anticipated|2017-12-23||Interventional|||A Phase 1B Study of MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Patients With Advanced Nonhematologic Malignancies|A Multiarm, Open-label, Phase 1b Study of MLN2480 (an Oral A-, B-, and CRAF Inhibitor) in Combination With MLN0128 (an Oral mTORC 1/2 Inhibitor), or Alisertib (an Oral Aurora A Kinase Inhibitor), or Paclitaxel, or Cetuximab, or Irinotecan, in Adult Patients With Advanced Nonhematologic Malignancies|Recruiting||Phase 1|125|Anticipated|Takeda||5|||f||||t|t|f||||||||2017-10-10 23:41:55.492135|2017-10-10 23:41:55.492135
NCT02327143|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2015-02-24|||January 2015||2015-01-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of LY2835219 in Healthy Participants|An Absolute Bioavailability Study of LY2835219 in Healthy Subjects Using the Intravenous Tracer Method|Completed||Phase 1|15|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:41:55.834162|2017-10-10 23:41:55.834162
NCT02327130|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-03-06|||April 2015||2015-04-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients|Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients|Recruiting||Phase 2|110|Anticipated|Isomark, LLC||1|||f||||t||||||||||2017-10-10 23:41:55.910068|2017-10-10 23:41:55.910068
NCT02327117|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2016-06-12|2016-06-12||January 2013||2013-01-01|June 2016|2016-06-01||||January 2015|Actual|2015-01-01||Interventional|||Low Dose Peri- Operative Intra Venous Teranexamic Acid Reduces Blood Loss After Total Knee Arthroplasty: A Double Blind Randomized Placebo Controlled Clinical Trial||Completed||N/A|90|Actual|Isfahan University of Medical Sciences||2|||f||||||||||||||2017-10-10 23:41:56.009228|2017-10-10 23:41:56.009228
NCT02327104|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2015-05-01|||October 2012||2012-10-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Effectiveness of Mindfulness Based Relapse Prevention for Tobacco Dependents|Evaluation of the Effectiveness of the Program of Mindfulness - Based Relapse Prevention (MBRP) as an Assistant Strategy to the Treatment of Tobacco Dependence|Unknown status|Recruiting|N/A|60|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 23:41:56.228932|2017-10-10 23:41:56.228932
NCT02327091|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-12-29|||April 2012||2012-04-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||The Effect of Alfacalcidol on Muscle Strength in Elderly Indonesian Women : A Randomized Controlled Trial|Phase 3 Study of Vitamin D Analog (Alfacalcidol) on Muscle Strength in Elderly Indonesian Women Who Have Low Handgrip Strength|Completed||Phase 3|122|Actual|Indonesia University||2|||f||||t||||||||||2017-10-10 23:41:56.33151|2017-10-10 23:41:56.33151
NCT02327078|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-09-20|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)|A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)|Recruiting||Phase 1/Phase 2|485|Anticipated|Incyte Corporation||3|||f||||t||||||||||2017-10-10 23:41:56.434029|2017-10-10 23:41:56.434029
NCT02327065|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-29|||December 2014||2014-12-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|August 2015|Anticipated|2015-08-01||Interventional|||Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion|Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB（Endoscopic Ultrasonography-Fine Needle Biopsy ） and EUS-FNA（Endoscopic Ultrasonography-Fine Needle Aspiration ） on Solid Occupying Lesion|Unknown status|Recruiting|N/A|408|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:41:56.601687|2017-10-10 23:41:56.601687
NCT02327039|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-01-02|||March 2015||2015-03-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|DAPA-HDL||The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients|The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients. A 12 Weeks Randomized Placebo-controlled Phase IV Study|Completed||Phase 4|33|Actual|University of Padova||2|||f||||f||||||||||2017-10-10 23:41:56.869949|2017-10-10 23:41:56.869949
NCT02327026|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-23|2017-05-09|||March 9, 2015|Actual|2015-03-09|May 2017|2017-05-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|CAAM||Tracheal Intubation vs. Bag-valve-mask Ventilation in Patients With Out-of-Hospital Cardiac Arrest _ CAAM STUDY|Initial Airway Management in Patients With Out-of-Hospital Cardiac Arrest: Tracheal Intubation vs. Bag-valve-mask Ventilation - CAAM STUDY|Completed||N/A|2043|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:41:56.995604|2017-10-10 23:41:56.995604
NCT02327000|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-23|||October 2014||2014-10-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers|A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers|Completed||Phase 1|40|Actual|GL Pharm Tech Corporation||4|||f||||f||||||||||2017-10-10 23:41:57.360783|2017-10-10 23:41:57.360783
NCT02326987|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-23|||October 2013||2013-10-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS-NF1 Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects|A Randomized, Open, Single-dose, 3-treatment, 3-period, 6-sequence Crossover Study in Healthy Male Subjects to Evaluate the Pharmacokinetics of GLA5PR GLARS-NF1 Tablet 150mg and LYRICA® Capsule 75mg|Completed||Phase 1|30|Actual|GL Pharm Tech Corporation||3|||f||||f||||||||||2017-10-10 23:41:57.481255|2017-10-10 23:41:57.481255
NCT02326974|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-07-29|||December 2014||2014-12-01|July 2017|2017-07-01|April 2022|Anticipated|2022-04-01|August 2018|Anticipated|2018-08-01||Interventional|||T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA|The Impact of HER2 Heterogeneity on the Treatment of Early-stage HER2-positive Breast Cancer: a Phase II Study of T-DM1 in Combination With Pertuzumab in the Preoperative Setting|Recruiting||Phase 2|160|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:41:57.601869|2017-10-10 23:41:57.601869
NCT02326961|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-10-26|||January 2015||2015-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|ACT-OA Knee||Celution Prepared Adipose Derived Regenerative Cells in the Treatment of Osteoarthritis of the Knee|Celution Prepared Adipose Derived Regenerative Cells in the Treatment of Osteoarthritis of the Knee: A Double-blind, Placebo Controlled, Multi-center Safety and Feasibility Study|Completed||Phase 2|94|Actual|Cytori Therapeutics||3|||f||||t||||||||||2017-10-10 23:41:57.7773|2017-10-10 23:41:57.7773
NCT02326948|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2014-12-29|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Alcohol Consumption and Gallbladder Cancer|Alcohol Consumption and Gallbladder Cancer: Case-control Study in Jeju Island, Korea.|Completed||N/A|156|Actual|Cheju Halla General Hospital|||2||f||||f||||||||||2017-10-10 23:41:57.915681|2017-10-10 23:41:57.915681
NCT02326935|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-02-13|||November 2014||2014-11-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis|Proposal for a Non-randomized, Patient Sponsored, Multi-center Study Studying the Impact and Safety of the Utilization of Culture Expanded Autologous, Adipose-derived Mesenchymal Stem Cells Deployed Via Intravenous Injection for the Treatment of Multiple Sclerosis|Recruiting||Phase 1|100|Anticipated|American CryoStem Corporation||1|||f||||f||||||||||2017-10-10 23:41:58.009158|2017-10-10 23:41:58.009158
NCT02326922|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2016-03-11|||June 2014||2014-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding|The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding|Completed||Phase 1/Phase 2|61|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:41:58.141908|2017-10-10 23:41:58.141908
NCT02326909|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-12-29|||December 2011||2011-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma|a Prospective In-vivo Human Study to Assess the Diagnostic Accuracy of Optical Coherence Tomography for Diagnosis and Staging of Upper Urinary Tract Urothelial Carcinoma|Completed||N/A|26|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-10 23:41:58.228542|2017-10-10 23:41:58.228542
NCT02205671|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-04-24|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|July 2015|Actual|2015-07-01||Interventional|||Building Better Caregivers: Development and Evaluation|Building Better Caregivers: Development and Evaluation|Completed||N/A|128|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 00:09:02.906887|2017-10-11 00:09:02.906887
NCT02326870|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2016-09-15|||December 2014||2014-12-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of the Follow Me Mode of the AutoLap System - A Feasibility Study|Evaluation of the Follow me Mode of the AutoLap System - a Feasibility Study|Completed||N/A|33|Actual|M.S.T. Medical Surgery Technology LTD.||1|||f||||f||||||||||2017-10-10 23:41:58.556929|2017-10-10 23:41:58.556929
NCT02326857|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2017-06-30|||December 23, 2014||2014-12-23|November 7, 2016|2016-11-07|December 31, 2018|Anticipated|2018-12-31|December 23, 2014|Actual|2014-12-23||Observational|||Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment|Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment|Active, not recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:41:58.696266|2017-10-10 23:41:58.696266
NCT02326844|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-25|2017-04-24|2017-01-12||March 2, 2015|Actual|2015-03-02|April 2017|2017-04-01|April 14, 2016|Actual|2016-04-14|April 14, 2016|Actual|2016-04-14||Interventional|||BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment|A Phase 2 Pilot Study of BMN 673 (Talazoparib), an Oral PARP Inhibitor, in Patients With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment|Terminated||Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)||1||Study was closed by the Cancer Therapy Evaluation Program (CTEP)|f||||f|t|f||||||No||2017-10-10 23:41:58.814014|2017-10-10 23:41:58.814014
NCT02326818|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-06-30|||December 2, 2014||2014-12-02|May 31, 2017|2017-05-31|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity|Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity|Recruiting||Phase 3|30|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-10 23:41:59.132596|2017-10-10 23:41:59.132596
NCT02326805|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-24|2017-09-04|||June 3, 2015|Actual|2015-06-03|July 2017|2017-07-01|May 30, 2019|Anticipated|2019-05-30|May 30, 2019|Anticipated|2019-05-30||Interventional|||PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance|Phase II Randomized, Placebo-Controlled Trial of PROSTVAC® (PSA-TRICOM) in Patients With Clinically Localized Prostate Cancer Undergoing Active Surveillance|Recruiting||Phase 2|150|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-10 23:41:59.254872|2017-10-10 23:41:59.254872
NCT02326792|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-11-30|||January 2015||2015-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|Training||Effect of Volume Training on Back Endurance|Effect of Volume Training on Endurance of Trunk Extensor Muscles in Healthy Subjects: A Randomized Control Trial.|Completed||N/A|42|Actual|Universidade Norte do Paraná||3|||f||||t||||||||||2017-10-10 23:41:59.415603|2017-10-10 23:41:59.415603
NCT02326779|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-01-02|||March 2016||2016-03-01|January 2016|2016-01-01||||October 2018|Anticipated|2018-10-01||Interventional|||Low-dose Aspirin Therapy for Esophageal Cancer|Low-dose Aspirin Therapy for Stage II-III Esophageal Cancer- A Multi-Center, Open Label, Randomized Controlled Phase III Trial|Not yet recruiting||Phase 3|600|Anticipated|Zhejiang University||2|||f||||||||||||||2017-10-10 23:41:59.508817|2017-10-10 23:41:59.508817
NCT02326766|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2014-12-26|||November 2011||2011-11-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Blood Pressure Lowering Effect of Supplementation With Korea Red Ginseng Associated With Reductions in Circulating Lp-PLA2 Activity and Lysophospatidylcholines and an Increase in Dihydrobiopterin in Prehypertensive Subjects||Completed||Phase 3|62|Actual|Yonsei University||2|||f||||t||||||||||2017-10-10 23:41:59.585461|2017-10-10 23:41:59.585461
NCT02326753|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-07-30|||December 2014||2014-12-01|November 2014|2014-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Gender and Proper Size of Oropharyngeal Airway: Pilot Study||Completed||N/A|36|Actual|Yonsei University||3|||f||||f||||||||||2017-10-10 23:41:59.666834|2017-10-10 23:41:59.666834
NCT02326740|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-04-25|||December 2014||2014-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum|Terminated||Phase 3|9|Actual|XOMA (US) LLC||3|||f||||t||||||||||2017-10-10 23:41:59.766209|2017-10-10 23:41:59.766209
NCT02326727|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-22|||April 2015||2015-04-01|December 2014|2014-12-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery||Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-10 23:41:59.90985|2017-10-10 23:41:59.90985
NCT02326714|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-03-29|||June 2015||2015-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Auricular Acupressure (AA) For Overweight/Obese Adolescent and Young Polycystic Ovary Syndrome ( PCOS)|Effect of Auricular Acupressure on Weight Loss in Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome.|Recruiting||N/A|80|Anticipated|Heilongjiang University of Chinese Medicine||2|||f||||f||||||||||2017-10-10 23:41:59.999911|2017-10-10 23:41:59.999911
NCT02326701|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-12-22|||December 2014||2014-12-01|October 2014|2014-10-01||||December 2016|Anticipated|2016-12-01||Observational|||RV Function Evaluation Assessed by Strain and Validated by MRI|RV Function by Strain and MRI|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-10 23:42:00.104638|2017-10-10 23:42:00.104638
NCT02326688|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-22|||December 2014||2014-12-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Quantification of Arm Non-Use After a Stroke|Reliability of Kinematic Analysis in Assessment and Rehabilitation of the Upper Arm of Stroke Patients Following a Cerebral Vascular Accident, Hemiparetic Subjects|Unknown status|Recruiting|N/A|144|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-10 23:42:00.172252|2017-10-10 23:42:00.172252
NCT02326675|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-07-03|||March 2015||2015-03-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant|Randomized Controlled, Open-Label Study on the Use of Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant Patients|Recruiting||N/A|48|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-10 23:42:00.257983|2017-10-10 23:42:00.257983
NCT02326662|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2015-10-26|||July 2014||2014-07-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Neural Stem Cell Transplantation in Traumatic Spinal Cord Injury|Safety and Efficacy of Autologous Neural Stem Cell Transplantation in Patients With Traumatic Spinal Cord Injury|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Federal Research Clinical Center of Federal Medical & Biological Agency, Russia||6|||f||||t||||||||||2017-10-10 23:42:00.593359|2017-10-10 23:42:00.593359
NCT02326649|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-02-28|2017-02-28||December 2014||2014-12-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|||Noninvasive Measurement of CO Using Impedance Cardiography in Patients With CHD|Noninvasive Measurement of Cardiac Output Using Impedance Cardiography in Patients With Congenital Heart Disease|Completed||N/A|21|Actual|University of California, San Diego|||1||f||||f||||||||||2017-10-10 23:42:00.733802|2017-10-10 23:42:00.733802
NCT02326636|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-10-25|||April 2014||2014-04-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|FMT||Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection|Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection|Recruiting||N/A|76|Anticipated|University of California, Irvine|||1||f||||t||||||Samples Without DNA|"     A donor stool sample will be kept for future testing in case of contamination.   "|||2017-10-10 23:42:00.965654|2017-10-10 23:42:00.965654
NCT02326623|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-02-21|||October 2015||2015-10-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Distraction to Reduce Pain and Distress in the Pediatric Emergency Department|Distraction to Reduce Pain and Distress: A Randomized Controlled Trial of Children Undergoing Intravenous Placement in the Pediatric Emergency Department|Active, not recruiting||N/A|80|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:42:01.091428|2017-10-10 23:42:01.091428
NCT02326610|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-26|||December 2014||2014-12-01|December 2014|2014-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|hGH||Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae|Early hGH Treatment of Symmetrically Born Small for Gestational Age Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae|Not yet recruiting||Phase 2|20|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:42:01.208532|2017-10-10 23:42:01.208532
NCT02326584|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-08-03|||December 2014||2014-12-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|January 30, 2017|Actual|2017-01-30||Interventional|||A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML|A Phase 1b Dose-escalation Study of SGN-CD33A in Combination With Standard-of-care for Patients With Newly Diagnosed Acute Myeloid Leukemia|Active, not recruiting||Phase 1|116|Actual|Seattle Genetics, Inc.||4|||f||||f||||||||||2017-10-10 23:42:01.501409|2017-10-10 23:42:01.501409
NCT02326571|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-04-10|||December 2014||2014-12-01|April 2017|2017-04-01|June 20, 2016|Actual|2016-06-20|June 20, 2016|Actual|2016-06-20||Observational|||Multimodal Monitoring in Patients With Spontaneous Intracerebral Hemorrhage|Multimodal Monitoring in Patients With Spontaneous Intracerebral Hemorrhage|Completed||N/A|8|Actual|Rigshospitalet, Denmark|||1||f||||t||||||Samples Without DNA|"     For later miRNA analysis.   "|||2017-10-10 23:42:01.684355|2017-10-10 23:42:01.684355
NCT02326558|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-04-03|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|October 2015|Actual|2015-10-01||Interventional|||Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma|Comparison of Zero Ischemia Laparoscopic Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma|Completed||N/A|183|Actual|RenJi Hospital||2|||f||||t||||||||||2017-10-10 23:42:01.807735|2017-10-10 23:42:01.807735
NCT02326532|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-03-27|||February 2015||2015-02-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|PRO||Incorporation of Patient Reported Outcomes Data in the Care of US Veterans With Rheumatoid Arthritis|Incorporation of Patient Reported Outcomes Data in the Care of US Veterans With Rheumatoid Arthritis|Active, not recruiting||N/A|143|Actual|North Florida Foundation for Research and Education||2|||f||||t||||||||||2017-10-10 23:42:02.163901|2017-10-10 23:42:02.163901
NCT02326519|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-22|||September 2014||2014-09-01|December 2014|2014-12-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|E20PC||Electrical Signal Collection From a 20 Pole Catheter During Routine Cardiac Procedures|Electrical Signal Collection From a 20 Pole Catheter During Routine Cardiac Procedures|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-10-10 23:42:02.276486|2017-10-10 23:42:02.276486
NCT02326506|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-03-15|||September 2014||2014-09-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of Drainable Volume Measurements During VA-ELS|Evaluation of Drainable Volume Measurements and Their Usage for Predicting Optimal Cardiac Support in Patients Supported by Veno-arterial Extracorporeal Life Support|Recruiting||N/A|10|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-10 23:42:02.363433|2017-10-10 23:42:02.363433
NCT02326493|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-02-22|||November 2014||2014-11-01|September 2016|2016-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Tailor-CRT: Better Application of Cardiac Resynchronization Therapy|Tailor-CRT: Better Application of Cardiac Resynchronization Therapy by Automated and Improved Selection of Location and Timing of Stimulation|Completed||N/A|28|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-10 23:42:02.452258|2017-10-10 23:42:02.452258
NCT02326480|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-05-02|||January 2015||2015-01-01|May 2016|2016-05-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|OSV||Genetic Analysis of Childhood Obesity|Genetic Analysis of Childhood Obesity|Recruiting||N/A|300|Anticipated|Lille Catholic University|||3||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 23:42:02.564554|2017-10-10 23:42:02.564554
NCT02326467|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-05-08|||February 2016||2016-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study: Safety of Chlorhexidine (CHG) Baths in Patients Less Than 2 Months of Age|Pilot Study: Safety of Chlorhexidine (CHG) Baths in Patients Less Than 2 Months of Age|Recruiting||Phase 1|50|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||Undecided||2017-10-10 23:42:02.669031|2017-10-10 23:42:02.669031
NCT02326454|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-09-23|||November 2014||2014-11-01|September 2017|2017-09-01|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29||Interventional|||A Placebo Controlled Study of MR901 for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia|A Phase 2 Randomised, Double-blind, Placebo Controlled, Study of MR901 in Patients With Moderate to Severe Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)|Completed||Phase 2|225|Actual|Light Sciences Oncology||4|||f||||f||||||||||2017-10-10 23:42:02.789411|2017-10-10 23:42:02.789411
NCT02326441|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-11-16|||December 2014||2014-12-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies|A Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KX2-361 in Subjects With Advanced Malignancies That Are Refractory to Conventional Therapies|Recruiting||Phase 1|76|Anticipated|Kinex Pharmaceuticals Inc||1|||f||||f||||||||Undecided||2017-10-10 23:42:03.021657|2017-10-10 23:42:03.021657
NCT02326428|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-02-21|||March 2014||2014-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|SITS Open||SITS (Safe Implementation of Treatments in Stroke) Open Artery by Thrombectomy in Acute Occlusive Stroke Study|SITS Open Artery by Thrombectomy in Acute Occlusive Stroke Study: an Open Prospective International Multicentre Controlled Study of Safety and Efficacy of Thrombectomy in Acute Occlusive Stroke Following IV Thrombolysis With Alteplase|Recruiting||N/A|600|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 23:42:03.124296|2017-10-10 23:42:03.124296
NCT02326415|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-26|||May 2013||2013-05-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|January 2014|Actual|2014-01-01||Interventional|CLIPUA||"Clinical Pathway With Fast-Track In Uncomplicated Acute Appendicitis"|"Prospective Randomised Study Comparing Clinical Pathway With Fast-Track Versus Usual Protocol In Uncomplicated Acute Appendicitis"|Unknown status|Recruiting|N/A|300|Anticipated|Hospital Universitario Virgen de la Arrixaca||2|||f||||t||||||||||2017-10-10 23:42:03.236575|2017-10-10 23:42:03.236575
NCT02326402|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-08-16|||December 2014||2014-12-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Observational|THEME||TandemHeart Experiences and MEthods (THEME Registry)|THEME Registry: TandemHeart Experiences and MEthods (THEME Registry)|Recruiting||N/A|200|Anticipated|CardiacAssist, Inc.|||1||f||||f||||||||||2017-10-10 23:42:03.331113|2017-10-10 23:42:03.331113
NCT02326389|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-08-09|||May 2015||2015-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Exercise and Cognitive Training|Exercise and Cognitive Training|Active, not recruiting||N/A|30|Anticipated|Boston University Charles River Campus||2|||f||||f||||||||||2017-10-10 23:42:03.459604|2017-10-10 23:42:03.459604
NCT02326376|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-08-23|||April 2015||2015-04-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Kineret CAPS Post Authorisation Study|Non-interventional PASS to Evaluate Safety of Kineret in Treatment of CAPS in Routine Clinical Care With Regard to Serious Infections, Malignancies, Injection Site Reactions, Allergic Reactions, Medication Errors Including Re-use of Syringe|Active, not recruiting||N/A|13|Actual|Swedish Orphan Biovitrum|||1||f||||f||||||||||2017-10-10 23:42:03.533689|2017-10-10 23:42:03.533689
NCT02326363|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-09-20|||March 16, 2015|Actual|2015-03-16|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|March 1, 2018|Anticipated|2018-03-01||Interventional|MBR-Veterans||Mindfulness-Based Recovery in Veterans|Mindfulness-Based Recovery in Veterans With Substance Use Disorders|Recruiting||N/A|308|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 23:42:03.615542|2017-10-10 23:42:03.615542
NCT02326350|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-02-04|||January 2015||2015-01-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|STAR||ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial|ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial|Enrolling by invitation||Phase 2|60|Anticipated|Belfast Health and Social Care Trust||2|||f||||t||||||||||2017-10-10 23:42:03.728495|2017-10-10 23:42:03.728495
NCT02326337|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-11-08|||October 2014||2014-10-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|TWO2DFU||Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers|A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers|Recruiting||N/A|220|Anticipated|AOTI Ltd.||2|||f||||t||||||||||2017-10-10 23:42:03.809666|2017-10-10 23:42:03.809666
NCT02326324|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2014-12-22|||December 2014||2014-12-01|December 2014|2014-12-01|December 2029|Anticipated|2029-12-01|December 2029|Anticipated|2029-12-01||Observational|UHSM CMR||The UHSM Cardiovascular Magnetic Resonance Study|The University Hospital of South Manchester Cardiovascular Magnetic Resonance Study|Recruiting||N/A|10000|Anticipated|University Hospital of South Manchester NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Peripheral blood sampling will be performed on the same day as CMR scanning   "|||2017-10-10 23:42:03.896344|2017-10-10 23:42:03.896344
NCT02326311|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response|Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) - and Quality of Life (QoL) in Elderly Patients (≥60 Years) With Ph+ Chronic Myeloid Leukemia (CML) and MR3.0 / MR4.0 Stable Molecular Response|Recruiting||Phase 3|502|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||t||||||||||2017-10-10 23:42:04.036587|2017-10-10 23:42:04.036587
NCT02326298|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-09-28||2016-12-15|December 16, 2014|Actual|2014-12-16|September 1, 2017|2017-09-01|October 30, 2018|Anticipated|2018-10-30|March 8, 2016|Actual|2016-03-08||Interventional|CIMPASI-1||An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)|A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Study Followed by a Dose-Blind Period and Open-Label Follow-Up to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Active, not recruiting||Phase 3|234|Actual|UCB Pharma||3|||f||||f|t|f|||f|||||2017-10-10 23:42:04.128552|2017-10-10 23:42:04.128552
NCT02326285|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-08-18|||November 2015||2015-11-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|March 28, 2017|Actual|2017-03-28||Interventional|NeoIntercal||Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB|Induction Therapy With Gefitinib Followed by Taxane Platinum Chemotherapy and Intercalated Gefitinib in NSCLC Stages II-IIIB With Activating EGFR Mutation - A Single Arm Phase II Trial.|Terminated||Phase 2/Phase 3|1|Actual|AIO-Studien-gGmbH||1||"Due to low patient enrollment was stopped. Only one patient could be enrolled. 37 patients were   pre-screened, but not into the inclusion criteria (wt-EGFR)"|f||||f||||||||||2017-10-10 23:42:04.276869|2017-10-10 23:42:04.276869
NCT02326272|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-09-28||2016-12-15|December 15, 2014|Actual|2014-12-15|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|January 5, 2016|Actual|2016-01-05||Interventional|CIMPASI-2||A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)|A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Study Followed by a Dose-Blind Period and Open-Label Follow-Up to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Active, not recruiting||Phase 3|227|Actual|UCB Pharma||3|||f||||f|t|f|||f|||||2017-10-10 23:42:04.392383|2017-10-10 23:42:04.392383
NCT02326259|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-05-01|||March 2015||2015-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia|Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia|Recruiting||N/A|30|Anticipated|Temple University|||1||f||||f||||||||||2017-10-10 23:42:04.516896|2017-10-10 23:42:04.516896
NCT02326246|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-03-20|||October 2014||2014-10-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||MRI in Active Surveillance of Prostate Cancer|Multi-parametric Magnetic Resonans Imaging in the Diagnosis and Surveillance of Low-risk Prostate Cancer|Completed||N/A|85|Actual|Aarhus University Hospital Skejby||1|||f||||t||||||||||2017-10-10 23:42:04.589569|2017-10-10 23:42:04.589569
NCT02326233|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-07-10|||June 2015||2015-06-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetics, Safety, and Tolerability Study of the Pen and PFS of SB5 in Healthy Subjects|A Randomised, Open-labelled, Two-arm, Parallel Group, Single-dose Study to Compare the Pharmacokinetics, Safety, and Tolerability of the Pre-filled Pen and PFS of SB5 in Healthy Subjects|Completed||Phase 1|190|Actual|Samsung Bioepis Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:42:04.670733|2017-10-10 23:42:04.670733
NCT02326220|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-02-06||2017-01-20|March 2015||2015-03-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|ODYSSEY ESCAPE||Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia Undergoing Lipid Apheresis Therapy|Completed||Phase 3|62|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:42:06.436782|2017-10-10 23:42:06.436782
NCT02326207|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-09-26|||April 2015||2015-04-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Weekly Versus no Routine Ventilator Circuit Changes in NICU|Weekly Versus no Routine Ventilator Circuit Changes in Neonatal Intensive Care Unit: Prospective, Randomized Study|Terminated||Phase 1|19|Actual|Prince of Songkla University||2||very low enrolled participants|f||||t||||||||||2017-10-10 23:42:06.560564|2017-10-10 23:42:06.560564
NCT02326194|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-08-27|||December 2014||2014-12-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.|A Phase 1 Double-blind, Dose-escalation, Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults in China|Completed||Phase 1|120|Actual|Jiangsu Province Centers for Disease Control and Prevention||4|||f||||t||||||||||2017-10-10 23:42:06.640068|2017-10-10 23:42:06.640068
NCT02326181|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2014-12-24|||January 2015||2015-01-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Inspiratory and Expiratory Pressure Training Methods in Patients With Chronic Obstructive Pulmonary Disease|Effects of Inspiratory and Respiratory Pressure Threshold Training in Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Not yet recruiting|N/A|80|Anticipated|Zhujiang Hospital||3|||f||||t||||||||||2017-10-10 23:42:06.742122|2017-10-10 23:42:06.742122
NCT02326168|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-01-23|||October 2013||2013-10-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer|A Study Evaluating the Safety and Tolerability of Percutaneous Vaccination Prior to Intravesical Instillation of Bacillus Calmette-Guerin (BCG) Mycobacteria for Non-Muscle Invasive Bladder Cancer|Completed||Early Phase 1|25|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-10 23:42:06.844322|2017-10-10 23:42:06.844322
NCT02326155|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-06-05|||April 2014||2014-04-01|June 2017|2017-06-01|June 2026|Anticipated|2026-06-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)|An Observational, Prospective Cohort Study to Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)|Recruiting||N/A|500|Anticipated|Celltrion|||1||f||||t||||||Samples Without DNA|"     Blood samples will be collected for IGRA assessment and immunogenicity analysis (optional).     Where appropriate, the serum should be transferred into a sufficient number of transfer vials     prior to freezing. Additionally, blood samples for immunogenicity should be retained at the     central laboratory (PPD Global Central Labs) up to the End of the Study, in case additional     analysis is required.   "|||2017-10-10 23:42:06.920179|2017-10-10 23:42:06.920179
NCT02326142|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-01-17|||March 2015||2015-03-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|October 2016|Actual|2016-10-01||Interventional|TERM||A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth|A Phase 2, Double-blind, Parallel Group, Randomised, Placebo Controlled, Proof of Concept Study to Assess the Safety and Efficacy of OBE001 After Oral Administration in Pregnant Women With Threatened Preterm Labour.|Terminated||Phase 2|10|Actual|ObsEva SA||2||Enrolment difficulties.|f||||t||||||||||2017-10-10 23:42:06.991051|2017-10-10 23:42:06.991051
NCT02326129|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-01-31|||February 2015||2015-02-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Novel Biomarker for Development of T2D|A Novel Biomarker for Development of Type 2 Diabetes: 11Beta-Hydroxy Steroid Dehydrogenase Type 1 Activity|Recruiting||N/A|150|Anticipated|Duke University|||3||f||||f||||||Samples Without DNA|"     24 hour urine samples.   "|||2017-10-10 23:42:07.231207|2017-10-10 23:42:07.231207
NCT02326116|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2017-07-13|||November 2014||2014-11-01|July 2017|2017-07-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|||TTE and Dysphagia in Anterior Cervical Surgery|Investigating the Role of Tracheal Traction Exercises (TTE) in Reducing Dysphagia Following Anterior Cervical Surgery|Recruiting||N/A|120|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-10 23:42:07.336667|2017-10-10 23:42:07.336667
NCT02326103|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-01-18|||April 2015||2015-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis|Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis in Addition to Prednisolon Therapy|Completed||Early Phase 1|22|Actual|Helsinki University||2|||f||||f||||||||No|No IPD will be shared with other researchers during the study or during the analysis of the results.|2017-10-10 23:42:07.421445|2017-10-10 23:42:07.421445
NCT02326090|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-09-07|||December 2014||2014-12-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye|A Phase 2, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1.0% and 2.5% Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye|Completed||Phase 2|161|Actual|Herantis Pharma Plc.||3|||f||||f||||||||||2017-10-10 23:42:07.524402|2017-10-10 23:42:07.524402
NCT02326077|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2016-12-16|||December 2012||2012-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|SONOLABOR||Sonopartogram. The Next Step in the Delivery Room|Intrapartum Ultrasonography - Sonopartogram. Longitudinal Evaluation of the Mechanism of Active Labor Using Ultrasound Parameters|Recruiting||N/A|4000|Anticipated|University of Medicine and Pharmacy Craiova|||1||f||||t||||||||Undecided||2017-10-10 23:42:07.617575|2017-10-10 23:42:07.617575
NCT02326064|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-07-18|||May 2015||2015-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|TORCH||Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4|Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI (Risk of Malignancy Index) and Tumor Markers Such as CA125 (Cancer Antigen 125) and HE4 (Human Epididymal Protein 4)|Completed||N/A|250|Actual|Centre Hospitalier Departemental Vendee|||1||f||||f||||||||||2017-10-10 23:42:07.746919|2017-10-10 23:42:07.746919
NCT02326051|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-06-03|||December 2014||2014-12-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|||Timing of Initiation of LMWH Administration in Pregnant Women With APS|Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome|Completed||Phase 4|100|Actual|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 23:42:07.816203|2017-10-10 23:42:07.816203
NCT02326038|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2014-12-24|||November 2014||2014-11-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Ritalin, Memory and Attention in MCI: a Behaviour-EEG Study|Can Methylphenidate (Ritalin) Improve Memory and Attention in Mild Cognitive Impairment? A Combined Behaviour-EEG Study|Unknown status|Recruiting|Phase 4|40|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:42:07.922719|2017-10-10 23:42:07.922719
NCT02326012|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-01-03|||March 2014||2014-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study|Emotion Regulation Individual Therapy for Adolescents With NSSI - An Open Pilot Study|Completed||N/A|17|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 23:42:08.143956|2017-10-10 23:42:08.143956
NCT02325999|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-12-21|||December 2013||2013-12-01|December 2014|2014-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection for Early Gastric Cancer|Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection:a New Therapy for Early Gastric Cancer|Recruiting||Early Phase 1|200|Anticipated|Beijing Friendship Hospital||2|||f||||t||||||||||2017-10-10 23:42:08.220074|2017-10-10 23:42:08.220074
NCT02325986|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-11-19|||March 2015||2015-03-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer|Concurrent Radiotherapy and Weekly Chemotherapy of 5-fluorouracil and Cisplatin for Postoperative Locoregional Recurrence of Oesophageal Squamous Cell Carcinoma|Recruiting||Phase 2|46|Anticipated|Sun Yat-sen University||1|||f||||f||||||||||2017-10-10 23:42:08.308729|2017-10-10 23:42:08.308729
NCT02325973|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-10-21|||June 2013||2013-06-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|AMICRO||Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI|Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI (AMICRO)|Recruiting||N/A|242|Anticipated|St. Jude Medical||1|||f||||f||||||||||2017-10-10 23:42:08.422183|2017-10-10 23:42:08.422183
NCT02325960|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-02-21|||January 2015||2015-01-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||A Comparison of Exenatide and Insulin Glargine|A Comparison of Exenatide and Insulin Glargine on Glycemic Variability in T2DM Patients Inadequately Controlled With Metformin Monotherapy|Completed||Phase 4|44|Actual|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||Undecided||2017-10-10 23:42:08.563861|2017-10-10 23:42:08.563861
NCT02325947|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-27|||January 2015||2015-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|iMove||Efficacy of Hand Exoskeleton Controlled by BCI in Post Stroke Patients|A Multicentre Randomized Single Blind Placebo Controlled Study to Assess Efficacy of Hand Exoskeleton Controlled by Motor Imagery Based BCI for Post Stroke Patients Movement Rehabilitation|Completed||N/A|75|Actual|Russian Academy of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:42:08.653153|2017-10-10 23:42:08.653153
NCT02325934|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-05-06|||February 2015||2015-02-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|CRUSTRI||Bioequivalence of Crushed Stribild With a Normal Breakfast or With Drip Feed Compared to the Whole Tablet|Bioequivalence of Crushed Stribild With a Normal Breakfast or With Drip Feed Compared to the Whole Tablet|Completed||Phase 1|24|Actual|Radboud University||3|||f||||f||||||||||2017-10-10 23:42:08.735253|2017-10-10 23:42:08.735253
NCT02325921|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-10-12|||October 2014||2014-10-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01|1 Week|Observational [Patient Registry]|||MRI in Renal Tumors|Advanced MRI in Renal Tumors.|Active, not recruiting||N/A|48|Actual|Radboud University|||1||f||||f||||||||||2017-10-10 23:42:08.805189|2017-10-10 23:42:08.805189
NCT02325908|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-02-22|||April 2008||2008-04-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||Body Fluid Dynamics in Hemodialysis Patients, an Estimation of Dry Weight|Evaluation of Body Hydration Status in Hemodialysis Patients Using Segmental Bioimpedance Analysis|Terminated||N/A|89|Actual|Renal Research Institute|||2||f||||f||||||Samples Without DNA|"     During every study day, 1 tube (3.5mL) will be collected before and 1 tube (3.5mL) after HD.     This will be done at each study day until the subject reaches optimal hydration status. These     samples will be used to assess Na+, K+, Ca++ concentrations and conductivity of the blood.     We'll also measure aldosterone monthly.In case of technical issues (which may include device     malfunction, transportation of samples, or scheduling of personnel), samples may be frozen     temporarily. Samples may also be frozen and kept for future biochemical studies (see Consent     form for future biochemical studies).   "|||2017-10-10 23:42:08.988753|2017-10-10 23:42:08.988753
NCT02325895|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-24|||August 2012||2012-08-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Dried Plums for Bone Health in Older Postmenopausal Women|Effect of Dried Plum on Bone and Bone Biomarkers in Older Women|Completed||N/A|48|Actual|San Diego State University||3|||f||||f||||||||||2017-10-10 23:42:09.075829|2017-10-10 23:42:09.075829
NCT02325882|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2016-03-27|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Postoperative Analgesic Effect of Combination With Dexmedetomidine in Fentanyl-based Intravenous Patient Controlled Analgesia Compared With Conventional Thoracic Epidural and Intravenous Patient Controlled Analgesia After Radical Open Gastrectomy||Completed||N/A|171|Actual|Yonsei University||3|||f||||f||||||||||2017-10-10 23:42:09.149749|2017-10-10 23:42:09.149749
NCT02325869|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-07-26|||July 2015||2015-07-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|DESIRE-ACS||Clinical Study Protocol - Debris Interventional Removal in ACS (DESIRE-ACS)|DebriS Interventional REmoval in ACS (DESIRE-ACS) Study to Assess the Safety and Performance of the ECA Bell Balloon in Subjects Undergoing Coronary Percutaneous Interventions.|Unknown status|Recruiting|N/A|30|Anticipated|Angioslide Ltd.||1|||f||||t||||||||||2017-10-10 23:42:09.236443|2017-10-10 23:42:09.236443
NCT02325856|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-12-29|2015-06-24||October 2013||2013-10-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients|Effect of Post-dialysis Weight Evaluated With Bioimpedance Spectroscopy on Dialysis Morbidities and Clinical Outcomes in Hemodialysis Patients: A Randomized Controlled Trial|Completed||N/A|298|Actual|An Hsin QingShui Clinic||2|||f||||t||||||||||2017-10-10 23:42:09.325534|2017-10-10 23:42:09.325534
NCT02325843|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-20|||July 2015||2015-07-01|December 2014|2014-12-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn|The Subconjunctival Injection of Human Bone Marrow Mesenchymal Stem Cells for Ocular Corneal Burn: Prospective,Double-blind, Randomized, Controlled Trial|Not yet recruiting||Phase 2|100|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:42:09.556192|2017-10-10 23:42:09.556192
NCT02325830|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-01-26|||March 2015||2015-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|REDUCE FMR||CARILLON Mitral Contour System® for Reducing Functional Mitral Regurgitation|The REDUCE FMR Trial: Safety and Efficacy of the CARILLON Mitral Contour System® in Reducing Functional Mitral Regurgitation (FMR) Associated With Heart Failure|Recruiting||N/A|180|Anticipated|Cardiac Dimensions Pty Ltd||2|||f||||t||||||||No||2017-10-10 23:42:09.664658|2017-10-10 23:42:09.664658
NCT02325817|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2017-08-23|||December 3, 2014|Actual|2014-12-03|August 2017|2017-08-01|January 13, 2017|Actual|2017-01-13|November 29, 2016|Actual|2016-11-29||Interventional|||Bingo Drug-eluting Balloon in Bifurcation|A Multicenter, Superior, Randomized Controlled Clinical Trial to Observe the Safety and Efficacy of Bingo Drug-eluting Balloon vs. Yinyi Balloon Dilatation Catheter in the Treatment of Patients With Bifurcation Stenosis Lesions of Coronary Artery|Completed||N/A|222|Actual|Liaoning Biomedical Materials R&D Center Co., Ltd.||2|||f|||||f|f||||||||2017-10-10 23:42:09.913103|2017-10-10 23:42:09.913103
NCT02325804|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-04-26|||December 2014||2014-12-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Specific Diet and Physical Activity on Weight and/or Fat Loss|Effect of Specific Diet and Circuit-based Exercise on Weight and/or Fat Loss|Recruiting||N/A|60|Anticipated|Slovak Academy of Sciences||2|||f||||f||||||||Undecided||2017-10-10 23:42:09.998701|2017-10-10 23:42:09.998701
NCT02325622|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-24|||December 2013||2013-12-01|December 2014|2014-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Relationships Between Mean Plasma Glucose and HbA1c in Cirrhotic Patients With Hepatogenous Diabetes|Relationships Between Mean Plasma Glucose and HbA1c in Compensated and Decompensated Cirrhotic Patients With Hepatogenous Diabetes|Unknown status|Recruiting|N/A|48|Anticipated|Yonsei University|||1||f||||t||||||Samples Without DNA|"     LSP, fructosamine   "|||2017-10-10 23:42:13.82101|2017-10-10 23:42:13.82101
NCT02325791|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2017-03-09|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Study to Evaluate the Efficacy and Safety of REGN2222, for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically Attended RSV Infection in Preterm Infants|Active, not recruiting||Phase 3|1538|Anticipated|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:42:10.132196|2017-10-10 23:42:10.132196
NCT02325778|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-08-04|||January 2010||2010-01-01|August 2016|2016-08-01||||July 2016|Actual|2016-07-01||Interventional|||Comparison of CTI Ablation Prior to or After LA Ablation for AF|Randomized, Single-blind, Comparative Trial of Two AF Ablation Strategies (CTI Ablation Prior to LA Ablation Versus CTI After LA Ablation) to Eliminate Persistent AF|Completed||Phase 3|132|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 23:42:10.567342|2017-10-10 23:42:10.567342
NCT02325765|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-11-28|||April 2014||2014-04-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Study of the Corelation Between Circulating Nuclearsome and SIRS Happened After Congential Cardiac Surgery|Corelation Between Circulating Nuclearsome and SIRS Happened After Congential Cardiac Surgery|Completed||N/A|100|Actual|Shanghai Children's Medical Center|||2||f||||t||||||Samples Without DNA|"     Whole Blood, plasma, serum   "|||2017-10-10 23:42:10.741021|2017-10-10 23:42:10.741021
NCT02325752|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2017-02-09|||August 2011||2011-08-01|February 2017|2017-02-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||A Prospective Randomised Control Trial to Study the Effectiveness of a Health Service Innovation Using a Modified Virtual Ward Model to Prevent Unscheduled Readmission of High Risk Patients|A Prospective Randomised Control Trial to Study the Effectiveness of a Health Service Innovation Using a Modified Virtual Ward Model to Prevent Unscheduled Readmission of High Risk Patients|Completed||N/A|840|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-10-10 23:42:10.819698|2017-10-10 23:42:10.819698
NCT02325739|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-06-30|||December 29, 2014|Actual|2014-12-29|June 2017|2017-06-01|May 15, 2019|Anticipated|2019-05-15|December 31, 2018|Anticipated|2018-12-31||Interventional|||FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression|A Phase I/II, Multicenter, Open-label Study of Oral FGF401 in Adult Patients With Hepatocellular Carcinoma or Solid Malignancies Characterized by Positive FGFR4 and KLB Expression|Recruiting||Phase 1/Phase 2|238|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 23:42:10.894457|2017-10-10 23:42:10.894457
NCT02325726|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2015-10-30|||September 2014||2014-09-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.|Renal Resistive Index Compared With NephroCheckTM to Predict Postoperative Acute Renal Failure in Patients Undergoing Cardiac Surgery.|Completed||N/A|51|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-10 23:42:11.077879|2017-10-10 23:42:11.077879
NCT02325713|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-01-03|2017-01-03||January 2015||2015-01-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional||The safety population included all randomized subjects who received at least 1 dose of the trial medication and who had follow-up safety assessments.|Relative Bioavailability Trial of Oral Dispersible Praziquantel Tablets in Healthy Volunteers|A Phase I, Open-label, Randomized, Four-period, Crossover, Single Center Trial to Assess the Relative Bioavailability of a Single Oral Dose of the New 150 mg Oral Dispersible Tablet (ODT) Formulation of Praziquantel (PZQ), MSC1028703A, at Different Dose Levels vs the Current Commercial 500 mg Tablet Formulation of PZQ in Healthy Male Volunteers|Completed||Phase 1|32|Actual|Merck KGaA||16|||f||||||||||||||2017-10-10 23:42:11.181422|2017-10-10 23:42:11.181422
NCT02325700|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2014-12-21|||January 2006||2006-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|January 2010|Actual|2010-01-01|6 Years|Observational [Patient Registry]|||Total Laparoscopic Versus Open Aortic Surgery for Abdominal Aortic Disease|Total Laparoscopic Versus Open Aortic Surgery for Abdominal Aortic Disease. A Prospective Study With Propensity Analysis|Completed||N/A|228|Actual|University of Poitiers|||2||f||||t||||||||||2017-10-10 23:42:13.200948|2017-10-10 23:42:13.200948
NCT02325687|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-02-22|||January 2015||2015-01-01|September 2016|2016-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|Cytokine OSA||A Pilot Study of Biomarkers in Obstructive Sleep Apnea|A Pilot Study of Biomarkers in Obstructive Sleep Apnea (OSA): Is There a Correlation Between Cerebrospinal Fluid and Serum Markers of Inflammation in OSA?|Completed||N/A|50|Actual|Hospital for Special Surgery, New York||3|||f||||f||||||||||2017-10-10 23:42:13.271109|2017-10-10 23:42:13.271109
NCT02325674|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2015-06-17|||January 2016||2016-01-01|June 2015|2015-06-01|October 2029|Anticipated|2029-10-01|October 2029|Anticipated|2029-10-01|10 Years|Observational [Patient Registry]|||Post Authorisation Safety Registry for US Patients With Generalised Lipodystrophy Treated With Metreleptin|Metreleptin Safety Registry|Not yet recruiting||N/A|100|Anticipated|Aegerion Pharmaceuticals, Inc.|||1||f||||f||||||||||2017-10-10 23:42:13.363236|2017-10-10 23:42:13.363236
NCT02325661|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-24|||October 2014||2014-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|AKQOLVS||Open Uncontrolled Validation Study for the German Version of the Actinic Keratosis Quality of Life Questionnaire (AKQoL)|Open Uncontrolled Validation Study for the German Version of the Actinic Keratosis Quality of Life Questionnaire (AKQoL)|Completed||N/A|34|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 23:42:13.436744|2017-10-10 23:42:13.436744
NCT02325648|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2016-11-01|||December 2014||2014-12-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||The Intraoperative Physiologic Changes of Patients Under Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Cytoreductive Surgery; Prospective Observational Study||Completed||N/A|22|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 23:42:13.506736|2017-10-10 23:42:13.506736
NCT02325635|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-11-12|||November 2013||2013-11-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|Equip 2||A Prospective Trial of an Endoscopic Quality Improvement Project|A Prospective Randomized Controlled Trial of an Endoscopic Quality Improvement Project-2 (EQUIP-2) to Improve Adenoma Detection in Screening and Surveillance Colonoscopy|Completed||N/A|10|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:42:13.578801|2017-10-10 23:42:13.578801
NCT02325609|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-03-03|||December 2014||2014-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:42:13.909379|2017-10-10 23:42:13.909379
NCT02325596|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-24|||July 2014||2014-07-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|July 2015|Anticipated|2015-07-01||Observational|ITROMICRFDTA||Investigate the Role of microRNA in Chronic Rhinosinusitis From DC-Th Axis|Investigate the Role of microRNA in Chronic Rhinosinusitis From DC-Th Axis|Unknown status|Enrolling by invitation|N/A|70|Anticipated|First Affiliated Hospital of Chongqing Medical University|||4||f||||f||||||||||2017-10-10 23:42:13.962817|2017-10-10 23:42:13.962817
NCT02325583|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-25|||January 2014||2014-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Intraoral 30% Glucose Effect In Newborns|Baskent University Institutional Review Board|Completed||Phase 3|19|Actual|Baskent University||1|||f||||t||||||||||2017-10-10 23:42:14.047982|2017-10-10 23:42:14.047982
NCT02325570|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-02-22|||November 2014||2014-11-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of the KLOX BioPhotonic OraLum Gel With a LED Curing Lamp in Moderate to Severe Chronic Periodontitis|The Evaluation of the Clinical Effects of the KLOX BioPhotonic OraLum Gel With a LED Curing Lamp as an Adjunct to the Non-Surgical Treatment of Moderate to Severe Chronic Periodontitis|Completed||N/A|30|Actual|KLOX Technologies Inc.||2|||f||||f||||||||||2017-10-10 23:42:14.135118|2017-10-10 23:42:14.135118
NCT02325557|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2017-01-18|||January 2015||2015-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|||ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Patients With Prostate Cancer - KEYNOTE-046|A Phase 1-2 Dose-Escalation and Safety Study of ADXS31-142 Alone and of ADXS31-142 in Combination With Pembrolizumab (MK-3475) in Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 1/Phase 2|51|Anticipated|Advaxis, Inc.||2|||f||||f||||||||||2017-10-10 23:42:14.219145|2017-10-10 23:42:14.219145
NCT02325544|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-07-10|||October 2014||2014-10-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|CODES||Comparing Different Treatments in Reducing Dissociative Seizure Occurrence|COgnitive Behavioural Therapy Versus Standardised Medical Care for Adults With Dissociative Non-Epileptic Seizures: A Multicentre Randomised Controlled Trial (CODES)|Active, not recruiting||N/A|368|Actual|King's College London||2|||f||||t||||||||||2017-10-10 23:42:14.337913|2017-10-10 23:42:14.337913
NCT02325531|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-12-06|||September 2014||2014-09-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|SPREAD-NET||SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET|SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET|Active, not recruiting||N/A|20000|Anticipated|Kaiser Permanente||3|||f||||f||||||||||2017-10-10 23:42:14.516946|2017-10-10 23:42:14.516946
NCT02325518|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-22|2016-10-13|2016-10-13||December 2014||2014-12-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||This analysis population includes all randomized subjects who received study medication and completed at least 1 scheduled on-therapy study visit (Full Analysis Set).|Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution|The Efficacy and Safety of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 1%/Timolol 0.5% in Patients With Open-Angle Glaucoma and Ocular Hypertension|Completed||Phase 4|218|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:42:14.602574|2017-10-10 23:42:14.602574
NCT02325505|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2017-08-19|||April 2016||2016-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|2 Years|Observational [Patient Registry]|||Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma|Clinical Profile Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Followed at Hospital Das Clínicas, University of Sao Paulo Medical School|Recruiting||N/A|200|Anticipated|InCor Heart Institute|||1||f||||t||||||||||2017-10-10 23:42:14.881865|2017-10-10 23:42:14.881865
NCT02325492|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-10-01|||October 2014||2014-10-01|December 2014|2014-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study|Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study|Terminated||Phase 2|10|Actual|Galmed Pharmaceuticals Ltd||3||Protocol redesign|f||||f||||||||||2017-10-10 23:42:15.023761|2017-10-10 23:42:15.023761
NCT02325479|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-02-17|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)|Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI) a Randomised Controlled Pilot Study|Completed||Phase 1|120|Actual|The Egyptian IVF-ET Center||2|||f||||f||||||||||2017-10-10 23:42:15.115673|2017-10-10 23:42:15.115673
NCT02325466|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-09-26|||November 2014||2014-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes|Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease (PAD) Patients With Type 2 Diabetes (T2D)|Recruiting||Phase 3|90|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||f||||||||||2017-10-10 23:42:15.210014|2017-10-10 23:42:15.210014
NCT02325453|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-08-15|||May 2015||2015-05-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Robotic, Laparoscopic and Open Surgery for Gastric Cancer Compared on Surgical, Clinical and Oncological Outcomes|A Multi-Institutional Chart Review to Compare the Outcomes of Robotic, Laparoscopic and Open Surgery for Gastric Cancer.|Recruiting||N/A|7000|Anticipated|International Study Group on Minimally Invasive Surgery for Gastric Cancer|||3||f||||f||||||||||2017-10-10 23:42:15.318142|2017-10-10 23:42:15.318142
NCT02325440|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-12-19|||March 2014||2014-03-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|ToFingo2||Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya|A 32-week, Monocentric, Exploratory, Single Arm Study to Assess Immune Function and MRI Disease Activity in Patients With RRMS Transferred From Previous Treatment With Natalizumab to Gilenya® (Fingolimod)|Unknown status|Recruiting|Phase 4|15|Anticipated|University Hospital Muenster||1|||f||||f||||||||||2017-10-10 23:42:15.582965|2017-10-10 23:42:15.582965
NCT02325258|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2014-12-29|||August 2012||2012-08-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Assessment of a Proposed Microbiological Alert and Its Impact on a Sepsis Campaign|Assessment of a Proposed Microbiological Alert and Its Impact on a Sepsis Campaign|Completed||N/A|300|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-10 23:42:16.942557|2017-10-10 23:42:16.942557
NCT02325427|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2017-03-30|||November 2014||2014-11-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Changes in Brain Activity Associated With Upper Limb Motor Recovery|Changes in Cortical Excitability Associated With Upper Limb Motor Recovery - a Study of Neural Strategies Employed in Motor Recovery|Suspended||N/A|119|Anticipated|National University Hospital, Singapore||3||The study team is in the process of ordering new TMS machine for the study.|f||||t||||||||Undecided||2017-10-10 23:42:15.684067|2017-10-10 23:42:15.684067
NCT02325414|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-21|2016-12-16|||February 2015||2015-02-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Prevention of Bone Loss After Acute SCI by Zoledronic Acid|Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength, and Use of Biomarkers to Guide Therapy|Recruiting||Phase 2|60|Anticipated|Northwestern University||4|||f||||t||||||||||2017-10-10 23:42:15.763738|2017-10-10 23:42:15.763738
NCT02325401|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-01-13|||March 2015||2015-03-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma|A Phase I Dose-finding Study of Metformin in Combination With Concurrent Cisplatin and Radiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 1|30|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-10 23:42:15.871109|2017-10-10 23:42:15.871109
NCT02325375|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-05-13|||December 2014||2014-12-01|December 2014|2014-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||sCD163 in ALS Patients|Inflammation in Amyotrophic Lateral Sclerosis - a Study of Soluble Cluster of Differentiation 163 in the Cerebrospinal Fluid|Completed||N/A|20|Actual|University of Aarhus|||3||f||||t||||||Samples Without DNA|"     spinal fluid and blood sample for identification of different factors   "|||2017-10-10 23:42:16.056755|2017-10-10 23:42:16.056755
NCT02325362|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-07-31|||March 2015||2015-03-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|MIGLUSTAT-CF||Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation|Single Center, Double-blind, Randomized, Placebo-controlled, Two-period/Two-treatment Crossover, Proof-of-mechanism Study Investigating the Effect of Miglustat on the Nasal Potential Difference in Adult Patients With Cystic Fibrosis Homozygous for the F508del Mutation|Recruiting||Phase 2/Phase 3|20|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 23:42:16.150691|2017-10-10 23:42:16.150691
NCT02325349|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2017-05-02|||March 20, 2015|Actual|2015-03-20|April 2017|2017-04-01|September 20, 2018|Anticipated|2018-09-20|September 20, 2018|Anticipated|2018-09-20||Interventional|MLAPOCHI||PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents|PET/CT Molecular Imaging of Angiogenesis in Pulmonary or Head and Neck Cancers Prior to or During Chemotherapy Including Agent With Antiangiogenic Effect. A Prospective Multicentric Study of Efficacy and Tolerability.|Recruiting||Phase 2|70|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:42:16.266203|2017-10-10 23:42:16.266203
NCT02325336|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-05-30|||September 2016||2016-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DREAM||Detection Medication Administration Errors Using Bar-code and RFID Technology (DREAM)|Effect of Bar-code-assisted Medication Administration on Medication Error Rates: a Controlled Randomized Multicentre Trial|Not yet recruiting||N/A|6000|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:42:16.351397|2017-10-10 23:42:16.351397
NCT02325323|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2014-12-19|||May 2014||2014-05-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Observational|GASTRIMED||Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia|Prospective Cohort Study: Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia|Unknown status|Recruiting|N/A|2000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     Biopsy slides.   "|||2017-10-10 23:42:16.421091|2017-10-10 23:42:16.421091
NCT02325310|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-07-31|||February 2015||2015-02-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|BREMEAVAC||Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR|Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With a Combined Measles-mumps-rubella (MMR) Vaccine|Active, not recruiting||Phase 4|14|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:42:16.577857|2017-10-10 23:42:16.577857
NCT02325297|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-06-23|||December 2014||2014-12-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|Famirea 22||"Impacts of the Letter of Condolence to the Bereaved Families Experience After a Death in ICU  - Study Famirea 22"|"Impacts of the Letter of Condolence to the Bereaved Families Experience After a Death in ICU  - Study Famirea 22"|Completed||N/A|242|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:42:16.686337|2017-10-10 23:42:16.686337
NCT02325284|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-04-10|||September 2014||2014-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Observational|||Objective Measurement of Pain Using the Algometer|Phase 1 Pilot Study of an Apparatus and Method to Objectively Measure Pain in Normal Healthy Adults.|Completed||N/A|20|Actual|Children's Research Institute|||1||f||||f||||||||||2017-10-10 23:42:16.761946|2017-10-10 23:42:16.761946
NCT02325271|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-09-04|||February 2015||2015-02-01|September 2017|2017-09-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Observational|||Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers|Intra-individual Variability and Circadian Rhythm of Systemic Vascular Endothelial Growth Factor (VEGF) Levels and Interaction With Biomarkers of Inflammation in Subjects With Normal Glucose Tolerance (NGT) and Patients With Type 2 Diabetes Without Diabetic Macular Edema (DME)|Completed||N/A|40|Actual|GWT-TUD GmbH|||2||f||||f||||||||||2017-10-10 23:42:16.846036|2017-10-10 23:42:16.846036
NCT02325232|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-08-26|||February 2012||2012-02-01|July 2015|2015-07-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|||Enteroscopy for Early Diagnosis of Tumors in Celiac Disease|A Capsule Endoscopy and Double Balloon Enteroscopy Sequential Approach for Early Detection of Gastrointestinal Tumors in Celiac Disease: a Prospective Trial|Recruiting||N/A|200|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||1|||f||||f||||||||||2017-10-10 23:42:17.143478|2017-10-10 23:42:17.143478
NCT02325219|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-10-03|||December 19, 2014|Actual|2014-12-19|October 2017|2017-10-01|September 21, 2018|Anticipated|2018-09-21|September 21, 2018|Anticipated|2018-09-21||Interventional|||An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis|Recruiting||Phase 3|226|Anticipated|Janssen Pharmaceutical K.K.||3|||f||||t||f||||||||2017-10-10 23:42:17.244534|2017-10-10 23:42:17.244534
NCT02325206|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-02-18|||December 2014||2014-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|DAPA-IIT1||Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes|Randomized, Double-blind, Placebo-controlled, Single-center Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin as Add-on to Intravenous Insulin-infusion in Adolescents and Adults With Type 1 Diabetes|Completed||Phase 1|36|Actual|Kinderkrankenhaus auf der Bult||2|||f||||t||||||||No||2017-10-10 23:42:17.444921|2017-10-10 23:42:17.444921
NCT02325193|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-03-02|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||"MiniMed 640G System User Evaluation With the Question of Reducing the Rate of Hypoglycemia"|Prevention of Hypoglycaemia Using the Minimed®640G System|Completed||N/A|24|Actual|Kinderkrankenhaus auf der Bult|||1||f||||f||||||||No||2017-10-10 23:42:17.528067|2017-10-10 23:42:17.528067
NCT02325180|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-09-01|||January 2015||2015-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia|Clinical Efficacy of Artemisinin-based Combination Therapy for Treatment of Uncomplicated Plasmodium Falciparum Malaria in North Sumatera, Indonesia and the Association of Molecular Markers With Treatment Outcomes|Completed||Phase 4|338|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-10 23:42:17.59542|2017-10-10 23:42:17.59542
NCT02325167|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-09-06|||January 2015||2015-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Short-term Existential Behavioural Therapy for Informal Caregivers of Palliative Patients: a Randomised Controlled Trial|Short-term Existential Behavioural Therapy for Informal Caregivers of Palliative Patients: a Randomised Controlled Trial|Recruiting||Phase 3|120|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-10 23:42:17.693809|2017-10-10 23:42:17.693809
NCT02325154|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-05-12|||December 2014||2014-12-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|THANIRS||Cerebral Oxygenation in Total Hip Arthroplasty Patients|Cerebral Near-Infrared Spectroscopy and Hypotensive Anesthesia in Patients Undergoing Total Hip Arthroplasty|Completed||N/A|100|Actual|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-10 23:42:17.794847|2017-10-10 23:42:17.794847
NCT02325141|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2014-12-19|||January 2011||2011-01-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Laparoscopic Sleeve Gasterectomy With or Without Pyloric Botulinum Neurotoxin Injection|Laparoscopic Sleeve Gasterectomy With or Without Pyloric Sphincter Botulinum Neurotoxin Injection: a Comparative Study|Completed||N/A|130|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:42:17.875713|2017-10-10 23:42:17.875713
NCT02325128|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-09-12|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|SANAP||Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps|Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps|Completed||N/A|35|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:42:17.938655|2017-10-10 23:42:17.938655
NCT02325115|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-19|||January 2014||2014-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Observational|||Validation of the French Warwick-Edinburgh Mental Well-being Scale (WEMWBS)|Validation of the French Warwick-Edinburgh Mental Well-being Scale (WEMWBS) in Both Non-clinical and Clinical Populations|Completed||N/A|515|Actual|Hôpital le Vinatier|||3||f||||t||||||||||2017-10-10 23:42:18.037291|2017-10-10 23:42:18.037291
NCT02325102|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-19|||June 2014||2014-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children Hospitalized in Pediatric Department|Potential Clinical and Biological Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children in Pediatric Department|Completed||N/A|400|Actual|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-10 23:42:18.10045|2017-10-10 23:42:18.10045
NCT02325089|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-03-01|||July 2014||2014-07-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Interventional|ORACLE||ORal ApplianCes for sLeep Apnea of the Elderly|Effect of Treating Sleep Apnea With Oral Appliances in the Elderly: ORACLE Study|Recruiting||Phase 4|500|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||Undecided||2017-10-10 23:42:18.183547|2017-10-10 23:42:18.183547
NCT02325076|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-02-10|||December 2013||2013-12-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Association Between Pulmonary Function Tests and Difficult Airway|The Association Between Pulmonary Function Tests and Difficult Airway|Completed||N/A|202|Actual|Tokat Gaziosmanpasa University||1|||f||||f||||||||||2017-10-10 23:42:18.288439|2017-10-10 23:42:18.288439
NCT02324894|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-06-15|||February 2015||2015-02-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.|Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.|Recruiting||N/A|1000|Anticipated|Brugmann University Hospital||1|||f||||f||||||||||2017-10-10 23:42:19.861477|2017-10-10 23:42:19.861477
NCT02325063|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-06-16|||December 17, 2015|Actual|2015-12-17|June 2017|2017-06-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|LET||Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia|Leukocyte and Platelet Rich Plasma Versus Type A Botulinum Toxin Versus Glucocorticoids for the Treatment of Lateral Epicondylalgia: a Randomized, Multicenter, Double-blind, Therapeutic Trial With Three Parallel Arms|Terminated||N/A|13|Actual|Centre Hospitalier Universitaire de Nīmes||3||Stop production PRB kit|f||||t||||||||||2017-10-10 23:42:18.364992|2017-10-10 23:42:18.364992
NCT02325050|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-06-12|||January 8, 2015|Actual|2015-01-08|June 2017|2017-06-01|May 8, 2017|Actual|2017-05-08|July 2, 2015|Actual|2015-07-02||Interventional|||A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants|A Phase 1, Randomized, Placebo-Controlled, Observer-Blind Study to Evaluate the Safety, Tolerability and Immunogenicity of Heterologous and Homologous Prime-Boost Regimens Using MVA-BN-Filo® and Ad26.ZEBOV Administered in Different Doses, Sequences and Schedules in Healthy Adult Subjects|Completed||Phase 1|164|Actual|Janssen Vaccines & Prevention B.V.||10|||f||||t||f||||||||2017-10-10 23:42:18.460077|2017-10-10 23:42:18.460077
NCT02325037|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-09-07|||December 2014||2014-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||First-in-Human Single and Multiple Dose of GLPG1837|Randomized, Double-blind, Placebo-controlled, Dose-escalation Study for the Assessment of Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of GLPG1837 in Healthy Subjects|Completed||Phase 1|64|Actual|Galapagos NV||4|||f||||f||||||||||2017-10-10 23:42:18.564206|2017-10-10 23:42:18.564206
NCT02325024|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-08-10|||January 2016||2016-01-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.|An Open-Label, Single-Dose Study to Compare the Pharmacokinetics (PK) of an Oromucosal Dose of Four Sprays of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease (ESRD), Not Requiring Dialysis, Compared to Matched Subjects With Normal Renal Function.|Withdrawn||Phase 1|0|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-10-10 23:42:18.642837|2017-10-10 23:42:18.642837
NCT02325011|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-08-13|||November 2014||2014-11-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.|An Open-Label, Randomized, Single-Dose, Two-Sequence, Two-Treatment, Four-Period, Crossover Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.|Completed||Phase 1|14|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-10-10 23:42:18.726296|2017-10-10 23:42:18.726296
NCT02324998|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-01-06|||December 2016||2016-12-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|CaNCaP03||Studying the Effects of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Radical Prostatectomy|A Study Into the Pharmacodynamic Biomarker Effects of Olaparib (a PARP Inhibitor) ± Degarelix (a GnRH Antagonist) Given Prior to Radical Prostatectomy|Recruiting||Phase 1|20|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 23:42:18.979858|2017-10-10 23:42:18.979858
NCT02324985|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-01-12|||January 2015||2015-01-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Phase II Study of AP0302 5% Versus a Vehicle Comparator|Phase II Study of the Effects of AP0302 5% Versus the Vehicle Control on Delayed Onset Muscle Soreness of the Elbow Flexors|Unknown status|Recruiting|Phase 2|144|Anticipated|Aponia Laboratories, Inc.||2|||f||||f||||||||||2017-10-10 23:42:19.084948|2017-10-10 23:42:19.084948
NCT02324959|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-19|||November 2014||2014-11-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|ACoTrain||Acupuncture and Computer-based Training to Improve Attention Deficits in Patients After Stroke|Evaluation of Acupuncture and Attention Training Effects on Patients After Stroke: a Study Protocol of an International Multicentre Study Using a Randomized Single Blinded Three-group Design|Unknown status|Recruiting|N/A|60|Anticipated|Fujian University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-10 23:42:19.284792|2017-10-10 23:42:19.284792
NCT02324946|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-06-28|||October 2014||2014-10-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|||Comparison of STOP-BANG and DES-OSA as Predictive Score for Difficult Intubation.|Comparison of STOP-BANG and DES-OSA as Predictive Score for Difficult Intubation Among Patients Scheduled for Bariatric Surgery.|Completed||N/A|200|Actual|Astes|||1||f||||f||||||||||2017-10-10 23:42:19.386135|2017-10-10 23:42:19.386135
NCT02324933|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-10-30|||August 2014||2014-08-01|October 2015|2015-10-01||||January 2016|Anticipated|2016-01-01||Interventional|||Post-Operative Pain Control in Opioid Tolerant Patients: Fentanyl Challenge Protocol Versus Standard of Care|Post-Operative Pain Control in Opioid Tolerant Patients: Fentanyl Challenge Protocol Versus Standard of Care|Withdrawn||Phase 4|0|Actual|Bassett Healthcare||2||insufficient population, unable to recruit|f||||f||||||||||2017-10-10 23:42:19.466869|2017-10-10 23:42:19.466869
NCT02324920|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-08-03|||October 2015||2015-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|BIOSync CLS||Benefit of Dual-chamber Pacing With Closed Loop Stimulation (CLS) in Tilt-induced Cardioinhibitory Reflex Syncope|Benefit of Dual-chamber Pacing With Closed Loop Stimulation (CLS) in Tilt-induced Cardioinhibitory Reflex Syncope. A Randomized Double-blind Parallel Trial.|Recruiting||N/A|128|Anticipated|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-10-10 23:42:19.547941|2017-10-10 23:42:19.547941
NCT02324907|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-07-27|||January 2015||2015-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis|The Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis|Recruiting||N/A|30|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 23:42:19.704165|2017-10-10 23:42:19.704165
NCT02324881|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-07-12|||December 2014||2014-12-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy|A Pilot Study for a Pain Management Smartphone Application for Patients Undergoing Radiation Therapy for Locally Advanced Head and Neck Cancer|Completed||N/A|24|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||f||||||||||2017-10-10 23:42:19.961304|2017-10-10 23:42:19.961304
NCT02324868|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-03-29|||January 2016||2016-01-01|January 2016|2016-01-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|ISIC||Impact of Availability of Showerpatch for Patients With Intravenous Catheters|Comparison of Showerpatch Versus Other Measures to Protect Intravenous Catheter Entry Site During Bathing Activities|Terminated||N/A|18|Actual|Universitaire Ziekenhuizen Leuven||2||logistic problems|f||||f||||||||||2017-10-10 23:42:20.057189|2017-10-10 23:42:20.057189
NCT02324855|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-05-15|||October 2015||2015-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Long-term Airway Clearance Therapy in Non-cystic Fibrosis Bronchiectasis|Long Term Airway Clearance Therapy in Non Cystic Fibrosis Bronchiectasis: a Randomized Controlled Trial|Enrolling by invitation||N/A|26|Anticipated|Universidad San Jorge||2|||f||||t||||||||||2017-10-10 23:42:20.151501|2017-10-10 23:42:20.151501
NCT02324842|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-07|||November 2014||2014-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients|Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients|Recruiting||N/A|90|Anticipated|The University of Texas Health Science Center at San Antonio||3|||f||||f||||||||||2017-10-10 23:42:20.244702|2017-10-10 23:42:20.244702
NCT02324829|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-06-16|||November 2012||2012-11-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|July 2013|Actual|2013-07-01||Observational|||Automatic Physiotherapy and Rehabilitation System for Lower Body Total Joint Replacement|Automatic Physiotherapy and Rehabilitation System for Lower Body Total Joint Replacement|Completed||N/A|18|Actual|University of Waterloo|||1||f||||f||||||||No||2017-10-10 23:42:20.357409|2017-10-10 23:42:20.357409
NCT02324816|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-20|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|OTC||Colder Outer Thigh Study|Non-Invasive Fat Layer Reduction in the Lateral Thighs With a Cryolipolysis System Using a Colder Treatment Parameter|Completed||N/A|19|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-10 23:42:20.448856|2017-10-10 23:42:20.448856
NCT02324790|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-04-12|||November 2014||2014-11-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Pilot Study of Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea|A Multicenter Pilot Study on the Indications of Negative Pressure Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA)|Terminated||N/A|25|Actual|Somnics, Inc.||1|||f||||f||||||||||2017-10-10 23:42:20.620742|2017-10-10 23:42:20.620742
NCT02324777|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-07-14|||June 2015||2015-06-01|July 2017|2017-07-01||||January 2018|Anticipated|2018-01-01||Interventional|CAPRI||Cannabinoid Profile Investigation of Vapourized Cannabis in Patients With Osteoarthritis of the Knee|A Randomized Double Blind Placebo Controlled, Proof-of-concept, Crossover Clinical Trial of Vapourized Cannabis in Adults With Painful Osteoarthritis of the Knee|Recruiting||Phase 2|40|Anticipated|Prairie Plant Systems Inc.||6|||f||||t||||||||||2017-10-10 23:42:20.717112|2017-10-10 23:42:20.717112
NCT02324764|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-04-22|||December 2014||2014-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CAPITAL-PRO||Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography|Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography|Recruiting||N/A|400|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-10 23:42:20.852331|2017-10-10 23:42:20.852331
NCT02324751|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-09-29|||September 2015||2015-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|VAST||Vaccines Against Salmonella Typhi|A Phase IIb, Observer-blind, Randomised Controlled Trial to Assess the Immunogenicity and Protective Efficacy of Vi Conjugated (Vi-TCV) and Unconjugated (Vi-PS) Polysaccharide Vaccines in Preventing Typhoid Infection Compared to a Control Vaccine (Meningococcal ACWY), Using a Human Challenge Model of Typhoid Infection|Active, not recruiting||Phase 2|112|Actual|University of Oxford||3|||f||||t||||||||||2017-10-10 23:42:20.965092|2017-10-10 23:42:20.965092
NCT02324738|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-11-02|||January 2015||2015-01-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of Mefloquine and Dihydroartemisinin-Piperaquine in Healthy Subjects|Open-Label Study to Evaluate Potential Pharmacokinetic and Pharmacodynamic Interactions of Orally Administered Mefloquine and Dihydroartemisinin-Piperaquine in Healthy Adult Subjects|Completed||Phase 4|16|Actual|University of Oxford||1|||f||||f||||||||||2017-10-10 23:42:21.076659|2017-10-10 23:42:21.076659
NCT02324725|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-08-07|||October 2011||2011-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Biomarkers of Injectable Extended Release Naltrexone Treatment|Biomarkers of Disease and Response to Treatment in Opioid Addiction|Active, not recruiting||Phase 4|32|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:42:21.170256|2017-10-10 23:42:21.170256
NCT02324712|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-02-22||||||February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Interventional|||Cytokine and Growth Factor Changes and Correlation With Clinical Outcomes Following Acupuncture for TMD|Cytokine and Growth Factor Changes and Correlation With Clinical Outcomes Following Acupuncture for TMD|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||2||PI relocated to another institution; study may be resubmitted at a later date.|f||||f||||||||||2017-10-10 23:42:21.264334|2017-10-10 23:42:21.264334
NCT02324699|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-06-13|||April 2016||2016-04-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Corticosteroids With Vedolizumab in Crohn's Disease|Corticosteroids as Co-Induction Agents With Vedolizumab in Crohn's Disease: a Double-blind Placebo Controlled Randomized Trial|Recruiting||Phase 4|123|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:42:21.369771|2017-10-10 23:42:21.369771
NCT02324686|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-05-02|||January 2014||2014-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|VISTA||Vitamin K Supplementation in Patients on Hemodialysis|Vitamin K Supplementation to Improve INR Stability in Patients on Hemodialysis Taking Warfarin for Atrial Fibrillation|Recruiting||Phase 2|15|Anticipated|University Health Network, Toronto||1|||f||||f||||||||Undecided|When the study is complete aggregate data of the study will be published and shared. Individual participant data that may identify participants will not be shared. If a participant requests information on his/her individual participant data, it will be provided to the requesting participant.|2017-10-10 23:42:21.483868|2017-10-10 23:42:21.483868
NCT02324673|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-05-30|2017-05-30||April 13, 2015|Actual|2015-04-13|May 2017|2017-05-01|May 9, 2016|Actual|2016-05-09|May 9, 2016|Actual|2016-05-09||Interventional||Safety Analysis Population (SAF), all participants who received ≥1 dose of the investigational product.|Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders|A Phase 1/2 Study to Assess the Pharmacokinetics and Safety of Multiple Doses of Pharmaceutical Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Seizure Disorders|Completed||Phase 1/Phase 2|61|Actual|INSYS Therapeutics Inc||3|||f||||t||||||||||2017-10-10 23:42:21.659665|2017-10-10 23:42:21.659665
NCT02324660|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-01|2016-08-10||December 2014||2014-12-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|SCAP||Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary Syndromes|Prospective Evaluation of a Screening Methodology for Chronic Obstructive Pulmonary Disease in Patients Admitted to Hospital for Acute Coronary Syndromes.|Completed||N/A|137|Actual|University Hospital of Ferrara||1|||f||||t||||||||||2017-10-10 23:42:22.989447|2017-10-10 23:42:22.989447
NCT02324647|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-06-20|||January 2015||2015-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|2 Years|Observational [Patient Registry]|SERENDIPITY||Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield|Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield|Recruiting||N/A|1000|Anticipated|University Medical Center Groningen|||1||f||||f||||||Samples Without DNA|"     Urine samples and serum or plasma samples   "|Undecided|undecided|2017-10-10 23:42:23.180505|2017-10-10 23:42:23.180505
NCT02324634|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-05-02|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ESCAPS||Early Electrical Stimulation to Prevent Complications in the Arm Post-stroke - a Feasibility Study|Early Electrical Stimulation to the Wrist Extensors and Wrist Flexors to Prevent the Post-stroke Complications of Pain and Contractures in the Paretic Arm - a Feasibility Study|Active, not recruiting||N/A|40|Actual|University of Nottingham||2|||f||||f||||||||No||2017-10-10 23:42:23.461837|2017-10-10 23:42:23.461837
NCT02324621|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-09-21|||February 2015||2015-02-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors|A Continuation Clinical Trial of Every Three-Week Dosing of Oral ONC201 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|30|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 23:42:23.548588|2017-10-10 23:42:23.548588
NCT02324608|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-01-19|||January 2015||2015-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer|A Pilot Study of Neoadjuvant Cetuximab in Advanced Squamous Cell Carcinomas of Skin (SCCS)|Recruiting||N/A|20|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 23:42:23.646531|2017-10-10 23:42:23.646531
NCT02324595|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-04-11|||December 2013||2013-12-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|MISSION||Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study|Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study|Completed||Phase 2|30|Actual|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-10 23:42:23.741005|2017-10-10 23:42:23.741005
NCT02324582|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-06-27|||June 2015||2015-06-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|MARC||MK-3475/BCG in High Risk Superficial Bladder Cancer|Phase I Study of MK-3475 in Combination With BCG for Patients With High Risk Superficial Bladder Cancer|Recruiting||Phase 1|15|Anticipated|Southern Illinois University||1|||f||||t||||||||||2017-10-10 23:42:23.835948|2017-10-10 23:42:23.835948
NCT02324569|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-01-25|||December 2014||2014-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study to Evaluate the Safety and Efficacy of SYR-472 When Orally Administered at a Dose of 100 mg Once Weekly as an add-on to Insulin Therapy in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Treatment With Insulin Preparations in Addition to Diet and/or Exercise Therapy|Completed||Phase 3|240|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:42:23.956374|2017-10-10 23:42:23.956374
NCT02324556|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-03-20|||January 2015||2015-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|LATA||A LAparoscopic and TransAnal Total Mesorectal Excision (TME) for Rectal Cancer Trial|A LAparoscopic and TransAnal Total Mesorectal Excision (TME for Rectal Cancer Trial|Recruiting||N/A|40|Anticipated|Sahlgrenska University Hospital, Sweden|||2||f||||f||||||||||2017-10-10 23:42:24.255592|2017-10-10 23:42:24.255592
NCT02324543|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-10-05|||February 2015||2015-02-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 1/2 Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer|Phase 1/2 Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:42:24.351942|2017-10-10 23:42:24.351942
NCT02324530|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-18|||December 2013||2013-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy|Evaluation of CPAP (Continuous Positive Airway Pressure) in the Planning of Radiation Treatments for Lung, Upper Abdomen and Left Breast Cancers|Unknown status|Recruiting|Phase 2|30|Anticipated|Sheba Medical Center||3|||f||||f||||||||||2017-10-10 23:42:24.467323|2017-10-10 23:42:24.467323
NCT02324517|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2014-12-18|||March 2010||2010-03-01|December 2014|2014-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders|Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders, Including Hemophilia With Inhibitors|Unknown status|Recruiting|N/A|300|Anticipated|Sheba Medical Center|||10||f||||f||||||||||2017-10-10 23:42:24.565291|2017-10-10 23:42:24.565291
NCT02324504|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-09-14|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|ECG-PICC||Evaluation of Electrocardiographic Guidance in Accurate Peripherally Inserted Central Catheter Placement in Children.|Evaluation of Electrocardiographic Guidance in Accurate Peripherally Inserted Central Catheter Placement in Children.|Active, not recruiting||N/A|192|Anticipated|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-10 23:42:24.664909|2017-10-10 23:42:24.664909
NCT02324491|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-01-04|||December 2014||2014-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus|Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Type 2 Diabetes Mellitus to Evaluate Weight Reduction, Glycemic Control, Safety, and Tolerability|Terminated||Phase 2|152|Actual|Zafgen, Inc.||3||Sponsor decision to analyze available safety and efficacy data|f||||t||||||||||2017-10-10 23:42:24.77424|2017-10-10 23:42:24.77424
NCT02324478|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2015-06-23|||March 2015||2015-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Exploration of Autonomic Nervous System by Photoplethysmography||Completed||N/A|52|Anticipated|ASST Fatebenefratelli Sacco|||1||f||||f||||||||||2017-10-10 23:42:24.922525|2017-10-10 23:42:24.922525
NCT02324465|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-14|||April 2013||2013-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||King Vision Video Laryngoscope Versus Glidescope Video Laryngoscope|King Vision Video Laryngoscope Versus Glidescope Video Laryngoscope: A Comparative Study in Ambulatory Surgery Center Patients|Recruiting||N/A|122|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 23:42:25.005011|2017-10-10 23:42:25.005011
NCT02324452|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-08-16|||March 2015||2015-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines|Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines|Recruiting||N/A|1250|Anticipated|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-10-10 23:42:25.143418|2017-10-10 23:42:25.143418
NCT02324439|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-30|||March 2015||2015-03-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission|Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission|Recruiting||Phase 1|90|Anticipated|Southern Illinois University||1|||f||||f||||||||||2017-10-10 23:42:25.301091|2017-10-10 23:42:25.301091
NCT02324426|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-04-29|||December 2014||2014-12-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||CNS Uptake of Intranasal Glutathione|Central Nervous System Uptake of Intranasal Glutathione in Parkinson's Disease|Completed||Phase 1|15|Actual|University of Washington||1|||f||||f||||||||||2017-10-10 23:42:25.398838|2017-10-10 23:42:25.398838
NCT02324413|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-12-23|||October 2013||2013-10-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pilot Study: Intraoperative Clonidine and Postoperative Behaviour|Randomised Controlled Pilot Study: Does Intraoperative Clonidine Reduce the Incidence of Post-hospitalisation Negative Behaviour Changes in Children Who Are Distressed During the Induction of General Anaesthesia?|Completed||Phase 3|45|Actual|University Hospitals Bristol NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:42:25.501353|2017-10-10 23:42:25.501353
NCT02324400|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-18|||January 2015||2015-01-01|December 2014|2014-12-01||||January 2016|Anticipated|2016-01-01||Interventional|||Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure Patients||Unknown status|Not yet recruiting|Phase 1/Phase 2|36|Anticipated|Nephera Ltd.||2|||f||||f||||||||||2017-10-10 23:42:25.584636|2017-10-10 23:42:25.584636
NCT02324387|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-08-02|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Tc99m Sestamibi Molecular Breast Imaging|Assessment of the Tumor Response to Neoadjuvant Chemotherapy in Women With Locoregional Invasive Breast Cancer Using Tc99m Sestamibi Molecular Breast Imaging: A Prospective Study|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|||||||||2017-10-10 23:42:25.686587|2017-10-10 23:42:25.686587
NCT02324374|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-01-25|||June 2011||2011-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Endocytoscopy and Colorectal Neoplasia|The Role of in Vivo Real Time Endocytoscopy in Diagnosing Colorectal Neoplasia|Completed||N/A|50|Actual|University of Pennsylvania||1|||f||||||||||||||2017-10-10 23:42:25.768972|2017-10-10 23:42:25.768972
NCT02324348|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-11-16|||June 2013||2013-06-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|INNOVATION||Efficacy and Safety Study of Deferred Stenting in Patients With STEMI|Impact of Immediate Stent Implantation Versus Deferred Stent Implantation on Infarct Size and Microvascular Perfusion in Patients With ST-segment Elevation Myocardial Infarction|Completed||N/A|114|Actual|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-10 23:42:25.935443|2017-10-10 23:42:25.935443
NCT02324335|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-08-25|||May 2015||2015-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Brilacidin||Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer|Phase 2 Study to Evaluate the Efficacy & Safety of Brilacidin Oral Rinse Administered Daily for 7 Weeks in Attenuating Oral Mucositis in Patients With Head & Neck Cancer Receiving Chemoradiation|Active, not recruiting||Phase 2|61|Actual|Cellceutix Corporation||2|||f||||t|t|f||||||||2017-10-10 23:42:26.021776|2017-10-10 23:42:26.021776
NCT02324322|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-03-20|||October 2013||2013-10-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Non-Ambulatory SCI Walk Using a Robotic Exoskeleton: Effect on Bone and Muscle|Non-Ambulatory SCI Walk Using a Robotic Exoskeleton: Effect on Bone and Muscle|Recruiting||N/A|13|Anticipated|Kessler Foundation||1|||f||||t||||||||Yes||2017-10-10 23:42:26.150659|2017-10-10 23:42:26.150659
NCT02324309|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-01-15||2016-01-15|May 2014||2014-05-01|January 2016|2016-01-01||||November 2014|Actual|2014-11-01||Interventional|||BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance|A Single-blind Crossover Study of the Pharmacokinetic and Postprandial Glucose Dynamics of BIOD-531 Compared to Humulin® R U-500 and Humalog® Mix75/25™ in Subjects With Type 2 DM Who Are Treated With ≥ 150 Units of Insulin Per Day|Completed||Phase 1/Phase 2|12|Actual|Biodel||4|||f||||f||||||||||2017-10-10 23:42:26.235904|2017-10-10 23:42:26.235904
NCT02324296|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-19|||December 1998||1998-12-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|January 2009|Actual|2009-01-01||Observational|||PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases|PEI REGIMEN: A THERAPEUTIC OPTION IN SMALL CELL LUNG CANCER? A MONOINSTITUTIONAL EXPERIENCE OF 46 CONSECUTIVE CASES|Completed||N/A|46|Actual|Arcispedale Santa Maria Nuova-IRCCS|||1||f||||||||||||||2017-10-10 23:42:26.316637|2017-10-10 23:42:26.316637
NCT02324283|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-08-31|||October 2012||2012-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia|Comparison of Emergence and Recovery Time, and Evaluation of Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia in Lung Surgery- A Pilot Study|Active, not recruiting||N/A|80|Anticipated|Juntendo University||2|||f||||f||||||||||2017-10-10 23:42:26.378819|2017-10-10 23:42:26.378819
NCT02324270|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-19|||May 2014||2014-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain|Randomized, Double-Blind, Multiple-Center, Placebo-Controlled Study Comparing the Safety and Efficacy of Generic Diclofenac Epolamine to Flector® Patch in the Treatment of Acute Pain Due to Minor Ankle Sprain|Completed||Phase 3|658|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-10 23:42:26.467113|2017-10-10 23:42:26.467113
NCT02324244|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-23|||October 2012||2012-10-01|December 2014|2014-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||CMV Intensive Care Units|A Prospective Monitoring Study of Cytomegalovirus Infection in Immunocompetent Critical Heart Surgery Patients|Completed||N/A|150|Actual|Hospital General Universitario Gregorio Marañon|||1||f||||f||||||Samples With DNA|"     plasma samples   "|||2017-10-10 23:42:26.788029|2017-10-10 23:42:26.788029
NCT02324231|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-27|||April 2016||2016-04-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia|SPOG 2015 FN Definition. A Swiss Pediatric Oncology Group (SPOG) Initiated Multi-center Open-label Randomized Controlled Multiple Crossover Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia (FN)|Recruiting||N/A|400|Anticipated|Swiss Pediatric Oncology Group||2|||f||||t|f|f||||||||2017-10-10 23:42:27.093909|2017-10-10 23:42:27.093909
NCT02324218|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-07-18|||October 2014||2014-10-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age|Incidence of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age, in the United Kingdom Clinical Practice Research Datalink (CPRD)|Completed||N/A|161429|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-10-10 23:42:27.259223|2017-10-10 23:42:27.259223
NCT02324205|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-09-21|||March 2015||2015-03-01|September 2017|2017-09-01|August 29, 2017|Actual|2017-08-29|August 29, 2017|Actual|2017-08-29||Interventional|ADAPT||Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)|Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT Trial) ADAPT-BX: Recruitment Plan for Initially Asymptomatic Women Referred for Breast Biopsy|Terminated||N/A|196|Actual|GE Healthcare||2||Sponsor met enroll. need for planned second study before meeting enroll. ceiling in protocol|f||||f||||||||||2017-10-10 23:42:27.806633|2017-10-10 23:42:27.806633
NCT02324192|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-23|||August 2011||2011-08-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2012|Actual|2012-08-01||Interventional|||Hand Ultrasonography: Clinical and Functional Correlation in Symptomatic Osteoarthritis (OA)|Hand Ultrasonography: Clinical and Functional Correlation in Symptomatic Osteoarthritis (OA)|Completed||N/A|60|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-10 23:42:27.949287|2017-10-10 23:42:27.949287
NCT02324179|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-03-06|||August 2014||2014-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Use of EndoPAT for Measurements of Endothelial Dysfunction in HIV Infected Children and Healthy Controls|Use of EndoPAT for Measurements of Endothelial Dysfunction in HIV Infected Children and Healthy Controls|Completed||N/A|76|Actual|University Hospitals Cleveland Medical Center|||2||f||||f||||||Samples Without DNA|"     plasma and serum   "|||2017-10-10 23:42:28.086876|2017-10-10 23:42:28.086876
NCT02324166|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-23|||January 2015||2015-01-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain|Cefazolin-Lidocaine Solution for Reducing Pain Associated With Subconjunctival Antibiotic Prophylaxis in Vitreo-Retinal Surgery|Unknown status|Not yet recruiting|Phase 4|54|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:42:28.219726|2017-10-10 23:42:28.219726
NCT02324153|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-08-28|||March 24, 2017|Actual|2017-03-24|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|RECOVER||A Randomized Double Blind Placebo Controlled Trial of Ramelteon in the Prevention of Post-operative Delirium|A Randomized Double Blind Placebo Controlled Trial of Ramelteon in the Prevention of Post-operative Delirium in Older Patients Undergoing Orthopedic Surgery|Recruiting||Phase 2|80|Anticipated|Johns Hopkins University||2|||f||||t|t|f|||f|||||2017-10-10 23:42:28.351537|2017-10-10 23:42:28.351537
NCT02324140|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-07-13|||June 2012||2012-06-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Observational|||Inflammatory Response in Aortic Valve Replacement|The Impact of Genetic Variability on Perioperative Morbidity and Mortality. Substudy: Inflammatory Response in Patients Undergoing Aortic Valve Replacement.|Completed||N/A|101|Actual|University Hospital Inselspital, Berne|||4||f||||t||||||Samples With DNA|"     whole blood analysis   "|||2017-10-10 23:42:28.495445|2017-10-10 23:42:28.495445
NCT02324127|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2014-12-23|||October 2012||2012-10-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer|Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer|Unknown status|Active, not recruiting|N/A|1100|Anticipated|Protgen Ltd||1|||f||||f||||||||||2017-10-10 23:42:28.614035|2017-10-10 23:42:28.614035
NCT02324114|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2014-12-22|||September 2012||2012-09-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer|Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer|Unknown status|Recruiting|N/A|1100|Anticipated|Protgen Ltd||1|||f||||f||||||||||2017-10-10 23:42:28.723743|2017-10-10 23:42:28.723743
NCT02324101|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2014-12-22|||April 2013||2013-04-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer|Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer|Unknown status|Recruiting|N/A|1100|Anticipated|Protgen Ltd||1|||f||||f||||||||||2017-10-10 23:42:28.835385|2017-10-10 23:42:28.835385
NCT02324088|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2017-05-03|||October 2000||2000-10-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|December 2012|Actual|2012-12-01||Interventional|PEGASE07||Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer|PHASE III TRIAL ASSESSING THE INTEREST OF A MAINTENANCE CHEMOTHERAPY COMBINING DOCETAXEL (TAXOTERE) 5-FU AFTER INDUCTION TREATMENT BY AINTENSIVE CHEMOTHERAPY FOR INFLAMMATORY BREAST CANCERS|Completed||Phase 3|174|Actual|UNICANCER||2|||f||||t||||||||||2017-10-10 23:42:28.941338|2017-10-10 23:42:28.941338
NCT02324075|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-01-15|||December 2014||2014-12-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|WSUP||Using Behaviour Change Messaging to Improve Communal Toilets in Dhaka, Bangladesh|Using Behaviour Change Messaging to Improve Communal Toilets in Dhaka, Bangladesh|Completed||N/A|4200|Actual|Stanford University||2|||f||||t||||||||||2017-10-10 23:42:29.050377|2017-10-10 23:42:29.050377
NCT02324062|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2017-04-08|||June 12, 2014|Actual|2014-06-12|April 2017|2017-04-01|January 5, 2017|Actual|2017-01-05|January 5, 2017|Actual|2017-01-05||Observational|HCP||Cancer Genetics Hereditary Cancer Panel Testing|University of Southern California (USC) Norris Comprehensive Cancer Center and Stanford Cancer Institute Cancer Genetics Hereditary Cancer Panel Testing|Completed||N/A|1511|Actual|University of Southern California|||4||f||||t||||||Samples With DNA|"     Blood and Saliva   "|||2017-10-10 23:42:29.157756|2017-10-10 23:42:29.157756
NCT02324036|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-11-30|||December 2014||2014-12-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|EMPATHy||The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence|The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence|Completed||Early Phase 1|190|Actual|University of California, Irvine||2|||f||||f||||||||||2017-10-10 23:42:29.359441|2017-10-10 23:42:29.359441
NCT02324023|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-11-28|||November 2014||2014-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|January 2016|Actual|2016-01-01||Interventional|||Endoscopic Ultrasound and Contrast Enhancement for Staging and Evaluation of Angiogenesis of Left Sided Colon Cancers|Endoscopic Ultrasound Scanning and Contrast Enhancement for Staging and Evaluation of Angiogenesis of Left Sided Colon Cancers|Completed||N/A|35|Actual|Zealand University Hospital||1|||f||||t||||||||No||2017-10-10 23:42:29.4427|2017-10-10 23:42:29.4427
NCT02324010|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-07-05|||July 2015||2015-07-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes|Effects of Sitagliptin on Postprandial Glycaemia, Incretin Hormones and Blood Pressure in Type 2 Diabetes - Relationship to Gastric Emptying|Completed||Phase 2|14|Actual|Royal Adelaide Hospital||2|||f||||f||||||||||2017-10-10 23:42:29.534668|2017-10-10 23:42:29.534668
NCT02323997|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-07-25|||January 2015||2015-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Observational|CIN3+plus||Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study|Human Papillomavirus‐Associated Cervical Neoplasia in Switzerland at the Start of a National Vaccination Programme: Crosssectional Study|Completed||N/A|767|Actual|University of Bern|||1||f||||f|||||||"     Histologically confirmed CIN3+ lesions, i.e. CIN3, adenocarcinoma in situ and invasive     carcinoma of the cervix.   "|||2017-10-10 23:42:29.650698|2017-10-10 23:42:29.650698
NCT02323984|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-01-18|||January 2014||2014-01-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|mRNAOrtho||Postoperative Delirium in Hip Arthroplasty Patients|Postoperative Delirium in Patients Undergoing Hip Arthroplasty|Completed||N/A|49|Actual|Ohio State University|||3||f||||f||||||||||2017-10-10 23:42:31.556681|2017-10-10 23:42:31.556681
NCT02323971|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-03-11|||December 2014||2014-12-01|December 2014|2014-12-01||||June 2015|Anticipated|2015-06-01||Observational|Ticagrelor||Impact of Renal Function on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients|Impact of Renal Function on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients|Unknown status|Recruiting|N/A|80|Anticipated|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia|||1||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-10 23:42:31.644337|2017-10-10 23:42:31.644337
NCT02323958|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-07-25|||December 2014||2014-12-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|TIGER||TEAS to Improve Outcome During Emergence From General Anesthesia After Robotic Surgery|Effect of Transcutaneous Electrical Acupoint Stimulation on Outcome During Emergence From Anesthesia in Patients Undergoing Robotic Laparoscopic Gynecologic Surgery|Completed||N/A|150|Actual|Fourth Military Medical University||3|||f||||t||||||||||2017-10-10 23:42:31.729979|2017-10-10 23:42:31.729979
NCT02323945|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-10-17|||October 2014||2014-10-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury|Mechanisms of Intermittent Hypoxia-induced Motor Recovery in Persons With SCI|Recruiting||Phase 1/Phase 2|44|Anticipated|Emory University||26|||f||||f||||||||||2017-10-10 23:42:31.855781|2017-10-10 23:42:31.855781
NCT02323932|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-23|||December 2014||2014-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Perception of Intonation by Bimodal and Bilateral Cochlear Implant Users|Perception of Intonation by Bimodal and Bilateral Cochlear Implant Users|Unknown status|Recruiting|N/A|30|Anticipated|Bnai Zion Medical Center||2|||f||||f||||||||||2017-10-10 23:42:32.102402|2017-10-10 23:42:32.102402
NCT02323919|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-01-26|||April 2006||2006-04-01|January 2016|2016-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Long-term Exercise in Older Cardiac Patients|Improving Long Term Exercise in Older Cardiac Patients|Completed||N/A|379|Actual|Case Western Reserve University||3|||f||||t||||||||||2017-10-10 23:42:32.225508|2017-10-10 23:42:32.225508
NCT02323906|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-03-17|||January 16, 2015|Actual|2015-01-16|March 2017|2017-03-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|||Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer|A Phase 1b, Multi-Center, Open-Label, Dose Finding Study of CC-122 in Combination With Sorafenib in Subjects With Unresectable Hepatocellular Carcinoma|Terminated||Phase 1|12|Actual|Celgene||1||Slow enrollment and business decision. No safety concerns were identified for the study drugs.|f||||t||||||||||2017-10-10 23:42:32.307192|2017-10-10 23:42:32.307192
NCT02323893|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-05-01|||February 2015||2015-02-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Study of Kinetics, Dosimetry & Safety of [18F]F-AraG, a Positron Emission Tomography Imaging Tracer in Healthy Humans|Study of the Kinetics, Dosimetry and Safety of [18F]F-AraG, a Positron Emission Tomography Tracer for Imaging the Activation of the Immune System in Healthy Humans|Recruiting||Phase 1|30|Anticipated|CellSight Technologies, Inc.||1|||f||||f||||||||||2017-10-10 23:42:32.424897|2017-10-10 23:42:32.424897
NCT02323880|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-09-08|||October 2015||2015-10-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas|A Phase 1 Study of Selinexor (KPT-330), a Selective XPO1 Inhibitor, in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors|Recruiting||Phase 1|81|Anticipated|Children's Oncology Group||1|||f||||t|t|f||||||||2017-10-10 23:42:34.075865|2017-10-10 23:42:34.075865
NCT02323867|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-11-14|||October 2014||2014-10-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|October 2019|Anticipated|2019-10-01||Interventional|AB-CliniMACs||Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies|UNRELATED AND PARTIALLY MATCHED RELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH Alpha/Beta T CELL AND B CELL DEPLETION FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES|Recruiting||Phase 2|60|Anticipated|Children's Hospital of Philadelphia||3|||f||||t||||||||||2017-10-10 23:42:34.908561|2017-10-10 23:42:34.908561
NCT02323854|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2017-02-22|||January 2015||2015-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|EMPRESS||The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)|The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)|Active, not recruiting||N/A|30|Anticipated|Medtronic - MITG||1|||f||||f||||||||Undecided||2017-10-10 23:42:34.997188|2017-10-10 23:42:34.997188
NCT02323841|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-12-23|||March 2014||2014-03-01|February 2014|2014-02-01|March 2015|Anticipated|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Feasibility Study: Conservative Treatment in Cervical Cancer|Feasibility Study: Conservative Treatment in Cervical Cancer FIGO Stage IB1-IIA1 > 2cm|Unknown status|Active, not recruiting|Early Phase 1|30|Anticipated|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-10 23:42:35.135924|2017-10-10 23:42:35.135924
NCT02323828|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-01-26|||January 2013||2013-01-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|RS||High Resistant Starch (RS) Cookies and Appetite Control|Effect of High Resistant Starch-cookies on Food Ingestion and Appetite Control in a Cohort of Healthy Students|Completed||Early Phase 1|18|Actual|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-10 23:42:35.266681|2017-10-10 23:42:35.266681
NCT02323815|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-08-16|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|PROMIS-Mali||The Effect of Integrated Prevention and Treatment on Child Malnutrition and Health in Mali: a Cluster Randomized Intervention Study|The Effect of Integrated Prevention and Treatment on Child Malnutrition and Health in Mali: a Cluster Randomized Intervention Study|Active, not recruiting||Phase 4|2304|Anticipated|International Food Policy Research Institute||2|||f||||f||||||||||2017-10-10 23:42:35.369089|2017-10-10 23:42:35.369089
NCT02323802|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-18|||July 2013||2013-07-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Diet Therapy Versus Prescriptive Educational Group Intervention in Overweight / Obese Patients at First Episode of AMI: a Randomized Controlled Trial|Diet Therapy Versus Prescriptive Educational Group Intervention in Overweight / Obese Patients at First Episode of AMI: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|90|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||||||||||||2017-10-10 23:42:35.494702|2017-10-10 23:42:35.494702
NCT02323789|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-03-01|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ADSTEM||Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa|A Phase I/II Study Evaluating Allogeneic Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa|Active, not recruiting||Phase 1/Phase 2|10|Actual|King's College London||1|||f||||t||||||||||2017-10-10 23:42:35.584283|2017-10-10 23:42:35.584283
NCT02323776|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-03-17|||December 2014||2014-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Observational|||Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients|Correlation of Radiotherapy-related Features With Postoperative Complications in Patients With Esophageal Cancer Treated With Trimodality Therapy|Terminated||N/A|150|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-10 23:42:35.792782|2017-10-10 23:42:35.792782
NCT02323763|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-02-08|||July 14, 2014|Actual|2014-07-14|February 2017|2017-02-01|August 29, 2016|Actual|2016-08-29|August 29, 2016|Actual|2016-08-29||Observational|||An fMRI Study on Temporal Discounting in Bipolar Disorder|Reconceptualizing Suicide as Impaired Temporal Discounting: an fMRI Study in Bipolar Disorder|Completed||N/A|28|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-10 23:42:35.876979|2017-10-10 23:42:35.876979
NCT02323750|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-05|||December 2014||2014-12-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|||TransitionCHF Systolic Dysfunction to Congestive Heart Failure Cohort Study|Systolic Dysfunction to Congestive Heart Failure Cohort Study|Recruiting||N/A|1500|Anticipated|University of Göttingen|||1||f||||f||||||||||2017-10-10 23:42:35.968602|2017-10-10 23:42:35.968602
NCT02323737|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-29|||July 2010||2010-07-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer|Cisplatin Combined With Irinotecan or Etoposide for Untreated Extensive-stage Small Cell Lung Cancer: a Multicenter Randomized Control Clinical Trial|Completed||Phase 2|62|Actual|Chinese Academy of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:42:36.044825|2017-10-10 23:42:36.044825
NCT02323724|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-09-21|||February 2015||2015-02-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.|APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.|Completed||N/A|25|Anticipated|Corporacion Parc Tauli|||1||f||||||||||||||2017-10-10 23:42:36.143318|2017-10-10 23:42:36.143318
NCT02323711|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-03-09|||January 2015||2015-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Dressing Versus Glue (2-Octyl Cyanoacrylate) for Coverage of the Skin Incision After Closure During Cesarean Delivery|A Randomized Controlled Trial of Dressing Versus Glue (2-Octyl Cyanoacrylate) for Coverage of the Skin Incision After Closure During Cesarean Delivery|Withdrawn||N/A|0|Actual|Danbury Hospital||2||Investigator Preference.|f||||||||||||||2017-10-10 23:42:36.241446|2017-10-10 23:42:36.241446
NCT02323698|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-10-17|||October 2014||2014-10-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects of Caffeine and Low Oxygen Therapy on Leg Function in Human Spinal Cord Injury|The Effects of Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury (Caffeine Substudy)|Recruiting||Phase 1/Phase 2|20|Anticipated|Emory University||4|||f||||f||||||||||2017-10-10 23:42:37.163054|2017-10-10 23:42:37.163054
NCT02323685|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-10-26|||December 2014||2014-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Effect of SANGUINATE™ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH)|Single Escalating-dose, Open-label Study to Assess the Safety and Effect of SANGUINATE™ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) After Acute Aneurysmal Subarachnoid Hemorrhage (SAH)|Completed||Phase 2|12|Actual|Prolong Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:42:37.30114|2017-10-10 23:42:37.30114
NCT02323672|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-02-09|||February 2014||2014-02-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions|Salivary and Serum Levels of Chemerin and MMP-9 in Oral Precancer and Oral Squamous Cell Carcinoma.|Completed||N/A|45|Actual|Cairo University|||3||f||||f||||||Samples Without DNA|"     serum and whole unstimulated saliva   "|||2017-10-10 23:42:37.42293|2017-10-10 23:42:37.42293
NCT02323659|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-07-12|||June 2014||2014-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas|Comparison of Methotrexate Versus Interferon-alfa 2b on Efficacy, Safety and Quality of Life in Patients With Primary Cutaneous T-cell Lymphomas|Recruiting||Phase 4|100|Anticipated|Polish Lymphoma Research Group||2|||f||||t||||||||||2017-10-10 23:42:37.539264|2017-10-10 23:42:37.539264
NCT02323646|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-07-25|||December 2014||2014-12-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Phase 2, Study to Evaluate the Safety and Efficacy Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Uterine Fibroids|A Phase 2, Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids|Completed||Phase 2|42|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-10-10 23:42:37.656681|2017-10-10 23:42:37.656681
NCT02323633|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-22|||January 2015||2015-01-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||Phase IIa Exploratory Clinical Trial, to Examine the Safety and Efficacy of tPCS on Paediatric ADHD Participants|A Single-blind, Randomised, Sham Controlled, Phase IIa Exploratory Clinical Trial, to Examine the Safety and Efficacy of BGX-3006 (tPCS) on Paediatric ADHD Participants.|Unknown status|Not yet recruiting|Phase 2|48|Anticipated|Braingear Technologies GmbH||2|||f||||t||||||||||2017-10-10 23:42:37.756897|2017-10-10 23:42:37.756897
NCT02323620|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-18|||March 2015||2015-03-01|December 2014|2014-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|RACE-STEMI||Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI|The Impact of Repeated Intracoronary Injection of Autologous Bone-marrow Derived Mononuclear Cells for Left Ventricle Contractility and Remodeling in Patients With STEMI.Prospective Randomized Study.|Not yet recruiting||Phase 3|200|Anticipated|American Heart of Poland||2|||f||||t||||||||||2017-10-10 23:42:37.854015|2017-10-10 23:42:37.854015
NCT02323607|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-07-06|||January 2016|Actual|2016-01-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations|Phase I Study of Pacritinib and Chemotherapy in Patients With Acute Myeloid Leukemia and FLT3 Mutations|Suspended||Phase 1|60|Anticipated|Ohio State University Comprehensive Cancer Center||2||per FDA|f||||t||||||||||2017-10-10 23:42:37.949027|2017-10-10 23:42:37.949027
NCT02323594|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-02-23|||December 2014||2014-12-01|December 2014|2014-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir|A Bioequivalence Study of the 90-mg Daclatasvir Tablet Relative to the 3 × 30-mg Daclatasvir Phase 3 Tablets, and Relative Bioavailability Studies of Chewable Pediatric Tablets of Daclatasvir and Asunaprevir in Healthy Adult Subjects|Completed||Phase 1|88|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-10 23:42:38.060384|2017-10-10 23:42:38.060384
NCT02323581|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-06-01|||January 2014||2014-01-01|May 2016|2016-05-01||||December 2021|Anticipated|2021-12-01||Interventional|TAAA IDE||Feasibility and Safety of Endovascular Thoracoabdominal Aortic Aneurysm Repair Using a Standard-Configuration Stent Graft With Branches and Fenestrations in Patients at High Risk for Open Surgical Repair|Feasibility and Safety of Endovascular Thoracoabdominal Aortic Aneurysm Repair Using a Standard-Configuration Stent Graft With Branches and Fenestrations in Patients at High Risk for Open Surgical Repair|Recruiting||N/A|100|Anticipated|New York Presbyterian Hospital||1|||f||||t||||||||||2017-10-10 23:42:38.144704|2017-10-10 23:42:38.144704
NCT02323568|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-02-09|||December 2014||2014-12-01|September 2015|2015-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|VIVROVAIRE 2||Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.|Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.|Completed||N/A|179|Actual|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-10 23:42:38.240502|2017-10-10 23:42:38.240502
NCT02323555|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-02-09|||March 2014||2014-03-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Optimize the Requirements and Preparations in Outpatient Chemotherapy|Optimize the Requirements and Preparations in Outpatient Chemotherapy|Completed||N/A|624|Actual|Centre Francois Baclesse||1|||f||||f||||||||||2017-10-10 23:42:38.510953|2017-10-10 23:42:38.510953
NCT02323542|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-13|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Plasma Glucose Kinetics and Cereal Product Content in Slowly Digestible Starch (SDS) in Healthy Volunteers|Plasma Glucose Kinetics Following Ingestion of Two Cereal Products With a Different Content in Slowly Digestible Starch (SDS) in Healthy Males and Females|Completed||N/A|41|Actual|Mondelēz International, Inc.||2|||f||||f||||||||||2017-10-10 23:42:38.632954|2017-10-10 23:42:38.632954
NCT02323529|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2015-11-10|||December 2014||2014-12-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|HT-1||Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1|Open-label, Multicentre, Multiple-dose Trial to Evaluate Pharmacokinetics, Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Orfadin in Patients Diagnosed With Hereditary Tyrosinemia Type 1|Completed||Phase 3|18|Actual|Swedish Orphan Biovitrum||1|||f||||f||||||||||2017-10-10 23:42:38.732434|2017-10-10 23:42:38.732434
NCT02323516|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-12-07|||December 2014||2014-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ASPIDIA||Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.|Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.|Withdrawn||Phase 2|0|Actual|Centre Francois Baclesse||2|||f||||t||||||||||2017-10-10 23:42:38.846606|2017-10-10 23:42:38.846606
NCT02323503|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-07-19|||June 2015||2015-06-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01|2 Years|Observational [Patient Registry]|BioCONTINUE||Assessment of Ventricular Arrhythmia Risk After CRT-D Replacement for Patients With Primary Prevention Indication|BIOtronik Study to Assess the CONTINUation of Existing Risk of Ventricular Arrhythmias After CRT-D Replacement for Patients With Primary Prevention Indication|Recruiting||N/A|277|Anticipated|Biotronik SE & Co. KG|||1||f||||t||||||||||2017-10-10 23:42:38.960833|2017-10-10 23:42:38.960833
NCT02323490|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-07-22|||July 2012||2012-07-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|February 2016|Actual|2016-02-01||Interventional|men_micro||Augmentation of Meniscal Repair With Marrow Stimulation Techniques (Microfractures)|Augmentation of Meniscal Repair With Bone Marrow Stimulation Techniques (Microfractures): a Double Blind, Prospective, Randomized Clinical Trial of Efficacy and Safety.|Completed||N/A|40|Actual|Centre of Postgraduate Medical Education||2|||f||||f||||||||||2017-10-10 23:42:39.177003|2017-10-10 23:42:39.177003
NCT02323477|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-01-24|||February 2015||2015-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|HUC-HEART||Human Umbilical Cord Stroma MSC in Myocardial Infarction|The Efficacy and Safety Assessment of Human Umbilical Cord Stroma-derived Multipotent Stromal Cells in Myocardial Infarction; a Phase 1/2 Clinical Trial (HUC-HEART Study)|Recruiting||Phase 1/Phase 2|79|Anticipated|Ankara University||3|||f||||t||||||||||2017-10-10 23:42:39.289877|2017-10-10 23:42:39.289877
NCT02323464|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-11-03|||January 2013||2013-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Prevalence of Sleep Apnea in Patients Undergoing Surgery for Colorectal Cancer|Prevalence of Sleep Apnea in Patients Undergoing Surgery for Colorectal Cancer|Recruiting||N/A|300|Anticipated|Umeå University|||3||f||||t||||||||||2017-10-10 23:42:39.389956|2017-10-10 23:42:39.389956
NCT02323451|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-23|||December 2014||2014-12-01|December 2014|2014-12-01|April 2017|Anticipated|2017-04-01|August 2016|Anticipated|2016-08-01||Interventional|||Medical Chitosan or Sodium Hyaluronate for Knee Osteoarthritis (CHOOSE)|A Multicentre, Randomized, Double-blinded, Parallel-controlled, Non-inferiority Clinical Study Of Safety and Efficacy Of Medical Chitosan for Knee Osteoarthritis Compared With Sodium Hyaluronate Injection|Unknown status|Recruiting|Phase 4|270|Anticipated|Shanghai Qisheng Biological Preparation Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:42:39.487639|2017-10-10 23:42:39.487639
NCT02323100|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|June 2019|Anticipated|2019-06-01||Interventional|GPBA||Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)|A Double Blind, Placebo Controlled, Dose Escalation Trial of Glycerol Phenylbutyrate Corrector Therapy for Cystic Fibrosis|Not yet recruiting||Phase 1/Phase 2|36|Anticipated|National Jewish Health||3|||f||||t|t|f||||||||2017-10-10 23:42:42.915207|2017-10-10 23:42:42.915207
NCT02323438|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-01-19|||December 2014||2014-12-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum|A Randomized, Controlled Study to Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum|Completed||N/A|153|Actual|R.J. Reynolds Vapor Company||4|||f||||f||||||||No||2017-10-10 23:42:39.590185|2017-10-10 23:42:39.590185
NCT02323425|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-02-01|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|EPIC-sICAS||Effects of Limb Ischemic Postconditioning in Young sICAS|Effects of Upper Limb Ischemic Postconditioning on Collateral Circulation in Young Symptomatic Intracranial Atherosclerosis|Recruiting||N/A|100|Anticipated|Health Science Center of Xi’an Jiaotong University||2|||f||||f||||||||Undecided||2017-10-10 23:42:39.745447|2017-10-10 23:42:39.745447
NCT02323412|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-01-18|||June 2015||2015-06-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|AIM||Antibiotics In Modic Changes|Antibiotic Treatment in Patients With Chronic Low Back Pain and Modic Changes: a Randomized Double-blind Placebo Controlled Trial|Recruiting||Phase 3|160|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 23:42:39.850721|2017-10-10 23:42:39.850721
NCT02323399|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-05-11|||February 2015||2015-02-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV|Phase 4 Open Label Study to Determine Pharmacokinetics of Phenylephrine and Pharmacodynamic Effects on BP Via IV Admin of Phenylephrine Hydrochloride Inj in Ped Subjects (≥12 to 16 Years of Age) Undergoing Gen and Neuraxial Anesthesia|Recruiting||Phase 4|100|Anticipated|West-Ward Pharmaceutical||1|||f||||t||||||||||2017-10-10 23:42:39.976071|2017-10-10 23:42:39.976071
NCT02323386|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-04-10|||January 2015||2015-01-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|July 2015|Actual|2015-07-01||Interventional|Attune-RSA||Kinematic Analysis of a PS, FB Primary Total Knee Arthroplasty (ATTUNE Knee System) Using Dynamic RSA|Anatomo-functional Correlation Between Intra-operative Passive Kinematics Recorded by Navigation and Post-operative Kinematics Analyzed by Dynamic Weight Bearing RSA of the Operated Knee.|Completed||N/A|20|Actual|Istituto Ortopedico Rizzoli||1|||f||||f||||||||No|The IPd are to be shared by papers|2017-10-10 23:42:40.103513|2017-10-10 23:42:40.103513
NCT02323373|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-01-12|||June 2014||2014-06-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|TRANEXTKA||Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty|Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty: a Randomized Clinical Trial With 90 Patients|Completed||Phase 2|90|Actual|Irmandade da Santa Casa de Misericordia de Sao Paulo||3|||f||||f||||||||||2017-10-10 23:42:40.206224|2017-10-10 23:42:40.206224
NCT02323360|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-22|||November 2014||2014-11-01|December 2014|2014-12-01|May 2018|Anticipated|2018-05-01|November 2016|Anticipated|2016-11-01||Interventional|||A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC|A Randomised Phase III Trial on Stereotactic Body Radiotherapy (SBRT) After Incomplete Transcatheter Arterial Embolization (TAE) or Chemoembolization (TACE) Versus Exclusive TAE or TACE for Inoperable Hepatocellular Carcinoma (HCC)|Recruiting||Phase 3|80|Anticipated|Istituto Clinico Humanitas||2|||f||||f||||||||||2017-10-10 23:42:40.286742|2017-10-10 23:42:40.286742
NCT02323347|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-22|||January 2009||2009-01-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer|Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer|Completed||N/A|1901|Actual|Institut Universitari Dexeus|||1||f||||f||||||||||2017-10-10 23:42:40.386193|2017-10-10 23:42:40.386193
NCT02323334|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-02-25|||December 2014||2014-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease|Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3202626|Completed||Phase 1|136|Actual|Eli Lilly and Company||11|||f||||f||||||||||2017-10-10 23:42:40.449866|2017-10-10 23:42:40.449866
NCT02323321|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-03-29|||September 2015||2015-09-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|October 2016|Anticipated|2016-10-01||Interventional|EXPANDHeart||International EXPAND Heart Pivotal Trial|International Trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System (OCS™) Heart For Preserving and Assessing Expanded Criteria Donor Hearts for Transplantation (EXPAND Heart Trial)|Recruiting||Phase 3|75|Anticipated|TransMedics||1|||f||||t||||||||||2017-10-10 23:42:40.542253|2017-10-10 23:42:40.542253
NCT02323308|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-12-22|||December 2010||2010-12-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|ANRSHBEP03||Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination|Study of Immunological, Virological, Serological Characteristics of HIV+ Patients Harboring Isolated Anti-HBc Profile and Response to Hepatitis B Vaccination|Completed||N/A|55|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||t||||||||||2017-10-10 23:42:40.627996|2017-10-10 23:42:40.627996
NCT02323295|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of High Doses of Radiation on Bone Structure and Metabolism|Pilot Study of the Effect of High Doses of Radiation on Bone Metabolism and Structure in Patients Treated With Adjuvant Radiotherapy and Surgery for Sacral Tumors|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:42:40.699243|2017-10-10 23:42:40.699243
NCT02323282|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-12-18|||October 2014||2014-10-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Study of Ropivacaine Median Effective Concentration in Ultrasound-guided Supraclavicular Brachial Plexus Block|The Study of Ropivacaine Median Effective Concentration in Ultrasound-guided Supraclavicular Brachial Plexus Block|Unknown status|Recruiting|Phase 4|60|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||1|||f||||||||||||||2017-10-10 23:42:40.810282|2017-10-10 23:42:40.810282
NCT02323087|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-05-02|||March 2015||2015-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Point of Care Susceptibility Testing in Primary Care|Reducing Antibiotic Resistance: Improved Diagnostics and Treatment for Uncomplicated Urinary Tract Infection in General Practice, Denmark|Completed||N/A|377|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:42:43.031989|2017-10-10 23:42:43.031989
NCT02323269|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-04-07|||May 2015||2015-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|IMPROVE||Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)|A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing-Remitting Multiple Sclerosis, Who Are Either Treatment-Naïve or Switching From an Interferon or Glatiramer Acetate After Suboptimal Response (ImPROve)|Terminated||N/A|24|Actual|Biogen|||2|"109MS415 ImPROve study was terminated due to patient enrollment challenges and feasibility .   The decision was not a result of safety concerns."|f||||f||||||||||2017-10-10 23:42:40.89627|2017-10-10 23:42:40.89627
NCT02323256|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-07-26|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|NEUROSYLLABIC||Neurophysiological Measures of Auditory Perception and Rehabilitation in Cochlear Implanted Patients|Neurophysiological Measures During Sound and Speech Perception in Cochlear Implanted Patients and Development of New Speech Rehabilitation Tools|Recruiting||N/A|456|Anticipated|Hospices Civils de Lyon||4|||f||||f||||||||||2017-10-10 23:42:41.174742|2017-10-10 23:42:41.174742
NCT02323243|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-08-02|||September 2015|Actual|2015-09-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ALLIUM||"Clinical Interest of the Temporary Urethral Stent Allium  Bulbar Urethral Stent  in the Treatment of Detrusor Sphincter Dyssynergia"|"Clinical Interest of the Temporary Urethral Stent Allium  Bulbar Urethral Stent  in the Treatment of Detrusor Sphincter Dyssynergia"|Completed||Phase 1/Phase 2|9|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:42:41.325258|2017-10-10 23:42:41.325258
NCT02323230|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-07-17|||January 2015||2015-01-01|December 2015|2015-12-01|February 2018|Anticipated|2018-02-01|June 2017|Actual|2017-06-01||Interventional|||A Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCL|Phase 2 Study of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide in Patients With Recurrent Survivin-Expressing Diffuse Large B-Cell Lymphoma (DLBCL)|Active, not recruiting||Phase 2|24|Anticipated|ImmunoVaccine Technologies, Inc.||1|||f||||f||||||||||2017-10-10 23:42:41.411517|2017-10-10 23:42:41.411517
NCT02323217|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-08-17|||January 2015||2015-01-01|February 2016|2016-02-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|I2PETHV||I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers|I2PETHV - Quantification and Localisation of Imidazoline2 Binding Sites in Healthy Volunteers Using [11C]BU99008 a Positron Emission Tomography Study|Completed||Early Phase 1|20|Actual|Imperial College London||1|||f||||f||||||||||2017-10-10 23:42:41.511958|2017-10-10 23:42:41.511958
NCT02323204|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-02-09|||January 2015||2015-01-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury|PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury|Recruiting||N/A|300|Anticipated|University of Iowa||2|||f||||f|f|f||||||Undecided||2017-10-10 23:42:41.617178|2017-10-10 23:42:41.617178
NCT02323191|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-04-13|||January 19, 2015|Actual|2015-01-19|April 2017|2017-04-01|September 21, 2018|Anticipated|2018-09-21|September 21, 2018|Anticipated|2018-09-21||Interventional|||A Study of Emactuzumab and Atezolimumab Administered in Combination in Participants With Advanced Solid Tumors|Open-Label, Multicenter, Dose Escalation Phase Ib Study With Expansion Phase to Evaluate the Safety, Pharmacokinetics, and Activity of RO5509554 (Emactuzumab) and MPDL3280A (Atezolizumab) Administered in Combination in Patients With Advanced Solid Tumors|Recruiting||Phase 1|310|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:42:41.766946|2017-10-10 23:42:41.766946
NCT02323178|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-07-11|||August 7, 2014|Actual|2014-08-07|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Eltrombopag in Patients With CMML and Thrombocytopenia|A Phase I/II Study of Eltrombopag in Patients With Chronic Myelomonocytic Leukemia and Thrombocytopenia|Recruiting||Phase 1/Phase 2|25|Anticipated|Groupe Francophone des Myelodysplasies||1|||f||||t||||||||||2017-10-10 23:42:41.931722|2017-10-10 23:42:41.931722
NCT02323165|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-03-23|||January 2015||2015-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||A New Method for Detection of Bacteria in the Bloodstream|A New Method for Detection of Bacteria in the Bloodstream|Recruiting||N/A|200|Anticipated|University of Florida|||1||f||||f|f|f||||||No||2017-10-10 23:42:42.196634|2017-10-10 23:42:42.196634
NCT02323152|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-22|||September 2012||2012-09-01|December 2014|2014-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|PROGEA||PREVENTION OF POSTPARTUM DEPRESSION DEVELOPMENT IN WOMEN WITH VERY HIGH RISK|PREVENTION OF POSTPARTUM DEPRESSION DEVELOPMENT IN WOMEN WITH VERY HIGH RISK|Unknown status|Enrolling by invitation|N/A|135|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-10 23:42:42.280933|2017-10-10 23:42:42.280933
NCT02323139|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-07-11|||February 10, 2015|Actual|2015-02-10|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|LDE255||A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients|A Single-arm Dose Finding Phase Ib Multicenter Study of the Oral Smoothened Antagonist LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients|Recruiting||Phase 1|36|Anticipated|Groupe Francophone des Myelodysplasies||1|||f||||t||||||||||2017-10-10 23:42:42.386998|2017-10-10 23:42:42.386998
NCT02323126|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-29|||February 9, 2015|Actual|2015-02-09|September 2017|2017-09-01|April 10, 2022|Anticipated|2022-04-10|June 17, 2021|Anticipated|2021-06-17||Interventional|EGF816||Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer|A Phase II, Multicenter, Open-label Study of EGF816 in Combination With Nivolumab in Adult Patients With EGFR Mutated Non-small Cell Lung Cancer and of INC280 in Combination With Nivolumab in Adult Patients With cMet Positive Non-small Cell Lung Cancer|Recruiting||Phase 2|68|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-10 23:42:42.618976|2017-10-10 23:42:42.618976
NCT02323113|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-06-08|||February 19, 2015|Actual|2015-02-19|June 2017|2017-06-01|November 16, 2020|Anticipated|2020-11-16|May 16, 2020|Anticipated|2020-05-16||Interventional|||Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML)|An Open-Label, Phase 1b/2 Study Investigating Recommended Phase 2 Dose, Safety, Tolerability, and Preliminary Efficacy of TAK-659 in Adult Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)|Recruiting||Phase 1|81|Anticipated|Takeda||2|||f||||f|t|f||||||||2017-10-10 23:42:42.780986|2017-10-10 23:42:42.780986
NCT02323074|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2016-07-04|||January 2014||2014-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brain Training System Using Electroencephalography (EEG) for Neurorehabilitation of Hand Function After Stroke|Brain Training System Using Electroencephalography (EEG) for Neurorehabilitation of Hand Function After Stroke|Recruiting||N/A|45|Anticipated|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-10 23:42:43.101361|2017-10-10 23:42:43.101361
NCT02323061|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-09-15|||May 1, 2015|Actual|2015-05-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Brain Computer Interface（BCI） System for Stroke Rehabilitation|Brain Computer Interface（BCI） System for Stroke Rehabilitation|Completed||N/A|25|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-10 23:42:43.173696|2017-10-10 23:42:43.173696
NCT02323035|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-06-20|||December 2014||2014-12-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Investigative Headgear With CPAP Mask|Investigative Headgear With CPAP Mask|Enrolling by invitation||N/A|300|Anticipated|Fisher and Paykel Healthcare||1|||f||||t||||||||||2017-10-10 23:42:43.312585|2017-10-10 23:42:43.312585
NCT02323022|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-10-07|||December 2014||2014-12-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)|IAC Regimen Versus IA Regimen as Induction Treatment for Initially Diagnosed AML Patients: a Randomized Controlled Phase III Clinical Trial|Recruiting||Phase 3|840|Anticipated|The First Affiliated Hospital of Soochow University||3|||f||||f||||||||||2017-10-10 23:42:43.380225|2017-10-10 23:42:43.380225
NCT02323009|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2014-12-17|||January 2011||2011-01-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Esophageal Balloon Guided Weaning of the Morbidly Obese Patient|Esophageal Balloon Guided Weaning of the Morbidly Obese Patient|Terminated||N/A|25|Actual|East Carolina University||3||Minimal recruitment. very few patients available with eligibility criteria|f||||f||||||||||2017-10-10 23:42:43.481448|2017-10-10 23:42:43.481448
NCT02322996|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-08-06|||September 2015||2015-09-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|||Phenotyping Acute Pain for Discovery Research and Directed Therapeutics|Phenotyping Acute Pain for Discovery Research and Directed Therapeutics|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|East Carolina University|||1||f||||f||||||||||2017-10-10 23:42:43.57785|2017-10-10 23:42:43.57785
NCT02322983|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2014-12-22|||February 2011||2011-02-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|December 2012|Actual|2012-12-01||Interventional|||Conscious Sedation With Nitrous Oxide in Control of Stress During Dental Care for Individuals With Cerebral Palsy|Effect Evaluation of Conscious Sedation With Nitrous Oxide at Control of Stress During Dental Care in Individuals With Cerebral Palsy.|Completed||N/A|77|Actual|Universidade Cruzeiro do Sul||1|||f||||t||||||||||2017-10-10 23:42:43.64876|2017-10-10 23:42:43.64876
NCT02322970|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-07-02|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|IMPRESSIT||Invasive Versus Non Invasive Measurement of Intracranial Pressure in Brain Injury Trial (IMPRESSIT)|Invasive Versus Non Invasive Measurement of Intracranial Pressure in Brain Injury Trial|Recruiting||N/A|490|Anticipated|Università degli Studi di Brescia|||1||f||||f|f|f||||||||2017-10-10 23:42:43.722285|2017-10-10 23:42:43.722285
NCT02322957|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-09-30|||February 2015||2015-02-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers|A Phase 1 Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers|Completed||Phase 1|24|Anticipated|ContraVir Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:42:43.799994|2017-10-10 23:42:43.799994
NCT02322944|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-10-21|||December 2014||2014-12-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|PEACE-QI-AMI||China PEACE II: Quality Improvement for Acute Myocardial Infarction|China Patient-centered Evaluative Assessment of Cardiac Events II: Quality Improvement for Acute Myocardial Infarction|Completed||N/A|8000|Actual|China National Center for Cardiovascular Diseases||3|||f||||t||||||||||2017-10-10 23:42:43.856962|2017-10-10 23:42:43.856962
NCT02322931|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-01-29|||January 2015||2015-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|C-arm||C-arm Cone-beam CT in Prostate Brachytherapy|Intra-operative Use of C-arm Cone-beam CT for Quality Assurance of Low-dose-rate Prostate Brachytherapy Dose Delivery|Recruiting||N/A|35|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-10 23:42:43.945103|2017-10-10 23:42:43.945103
NCT02322918|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-05-30|||July 2014||2014-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|6 Months|Observational [Patient Registry]|BCPP BIODA||The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder|BC Psychosis Program Biobank and Database for Investigating Genetic Polymorphisms of Brain-derived Neurotrophic Factor and Catechol-o-methyl Transferase and Their Associations With Psychosis Disorder|Recruiting||N/A|200|Anticipated|University of British Columbia|||1||f||||f||||||Samples With DNA|"     We will be collecting and retaining whole blood samples and saliva samples for genomic     testing.   "|||2017-10-10 23:42:44.038952|2017-10-10 23:42:44.038952
NCT02322905|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-19|||August 2015|Actual|2015-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ERT-ICs||Cancer Caregiver Burden: Targeting Emotion Regulation in a Trial|Cancer Caregiver Burden: Targeting Emotion Regulation in a Randomized Controlled Trial|Recruiting||N/A|80|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:42:44.127042|2017-10-10 23:42:44.127042
NCT02322892|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2017-03-03|2016-04-07||January 2015||2015-01-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Modified intention to treat analysis|Thiamine as an Adjunctive Therapy in Cardiac Surgery|Thiamine as an Adjunctive Therapy in Cardiac Surgery|Completed||Phase 2|64|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-10 23:42:44.380225|2017-10-10 23:42:44.380225
NCT02322879|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-08-02|2017-03-29||May 2013||2013-05-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|APAPII||Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing|Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing|Completed||Phase 4|21|Actual|Beth Israel Deaconess Medical Center||2|||f||||t|t|f|||f|||||2017-10-10 23:42:44.906981|2017-10-10 23:42:44.906981
NCT02322866|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-02-15|||December 2014||2014-12-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne|A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 1.5 mg/kg Per Day of Sarecycline Compared to Placebo in the Treatment of Acne Vulgaris|Completed||Phase 3|1034|Actual|Warner Chilcott||2|||f||||f||||||||||2017-10-10 23:42:45.310853|2017-10-10 23:42:45.310853
NCT02322853|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-05-23|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|OLYMPE||A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors|A Randomized Open-label Phase II Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors|Terminated||Phase 2|8|Actual|Centre Francois Baclesse||2||lack of recruitment|f||||t||||||||||2017-10-10 23:42:45.548666|2017-10-10 23:42:45.548666
NCT02322827|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-10-26|||November 2014||2014-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|HOST||Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART|Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed a Single Tablet Regimen (STR) Versus Multi Tablet Regimen (MTR).|Completed||N/A|445|Actual|Triple O Research Institute PA|||2||f||||f||||||||Undecided||2017-10-10 23:42:45.762738|2017-10-10 23:42:45.762738
NCT02322814|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-09-27|||November 25, 2014|Actual|2014-11-25|September 2017|2017-09-01|July 1, 2020|Anticipated|2020-07-01|July 31, 2018|Anticipated|2018-07-31||Interventional|||A Study of Cobimetinib in Combination With Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, and Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as First-line Treatment for Participants With Metastatic Triple-Negative Breast Cancer|A Multistage, Phase II Study Evaluating the Safety and Efficacy of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as First-Line Treatment for Patients With Metastatic Triple-Negative Breast Cancer|Recruiting||Phase 2|162|Anticipated|Hoffmann-La Roche||4|||f||||||||||||||2017-10-10 23:42:45.891068|2017-10-10 23:42:45.891068
NCT02322801|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-11-01|||March 2009||2009-03-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Observational Safety Study of Rituximab in Patients Diagnosed With Rheumatoid Arthritis (RA) Who Did Not Respond Adequately to TNF-alpha Blocker||Completed||N/A|209|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:42:46.248989|2017-10-10 23:42:46.248989
NCT02322788|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-11-23|2016-09-16||March 2015||2015-03-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Full analysis set|Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3|A Randomised, Double-blind, Double-dummy, Multi-site, Phase III, Single Dose, 4-way Cross-over Pharmacodynamic Study Evaluating the Efficacy of Bricanyl Turbuhaler M3 Compared to Bricanyl Turbuhaler M2 by Studying the Protective Effect on Methacholine Induced Bronchoconstriction in Patients With Stable, Mild to Moderate Asthma|Completed||Phase 3|95|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-10 23:42:46.433023|2017-10-10 23:42:46.433023
NCT02322775|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-08-14|2016-09-29||February 2, 2015|Actual|2015-02-02|August 2017|2017-08-01|October 7, 2015|Actual|2015-10-07|October 7, 2015|Actual|2015-10-07||Interventional|||Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma|A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.|Completed||Phase 3|211|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:42:46.845412|2017-10-10 23:42:46.845412
NCT02322762|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-09-04|||December 30, 2014|Actual|2014-12-30|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Observational|DISCOVER||DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings|DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings|Active, not recruiting||N/A|13350|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:42:47.718961|2017-10-10 23:42:47.718961
NCT02322749|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-07-20|2016-04-28||February 2015||2015-02-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All randomized subjects (n = 48) were included in the baseline analysis|A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers|A Phase I, Single Centre, Randomised, Open Label, Crossover Study to Assess the Bioequivalence or Relative Bioavailability of Variants of Selumetinib (AZD6244, Hyd-Sulfate) Blue Capsules in Healthy Male Volunteers Aged 18 to 45 Years|Completed||Phase 1|48|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-10 23:42:49.367556|2017-10-10 23:42:49.367556
NCT02322736|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-06-14|||November 21, 2014|Actual|2014-11-21|June 2017|2017-06-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Observational|VISION||Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR|A Prospective Observational Study of 1st and 2nd Line Vectibix® Use in KRAS/NRAS-wt mCRC Patients to Evaluate Pattern of Use and Overall Response Rates|Recruiting||N/A|218|Anticipated|Amgen|||1||f||||f||||||||||2017-10-10 23:42:50.300294|2017-10-10 23:42:50.300294
NCT02322723|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2016-02-17|||February 2016||2016-02-01|February 2016|2016-02-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|ORIENT||Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA|Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA|Withdrawn||N/A|0|Actual|AbbVie|||1|No enrollment|f||||f||||||||||2017-10-10 23:42:50.464971|2017-10-10 23:42:50.464971
NCT02322554|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-05-18|||January 2005||2005-01-01|May 2016|2016-05-01||||January 2020|Anticipated|2020-01-01|2 Months|Observational [Patient Registry]|CTPR||Cellular and Tissue Based Therapy Registry|The Registry of Cellular and Tissue Based Therapies for Chronic Wounds and Ulcers|Recruiting||N/A|50000|Anticipated|U.S. Wound Registry|||1||f||||t||||||||||2017-10-10 23:42:51.757778|2017-10-10 23:42:51.757778
NCT02322697|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-12-23|||August 2013||2013-08-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Carnitine on Uremic Cardiomyopathy|Effects of Chronic Intravenous Administration of L-carnitine on Myocardial Fatty Acid Metabolism in Hemodialysis Patients|Completed||N/A|60|Actual|Toujinkai Hospital||2|||f||||f||||||||||2017-10-10 23:42:50.693711|2017-10-10 23:42:50.693711
NCT02322684|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-10-17|||January 2015||2015-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Endotracheal Intubation Using a Bougie Through the Air-Q Intubating Laryngeal Airway|Bougie-guided Tracheal Tube Placement Through the Air-Q® Intubating Laryngeal Airway: Clinical Evaluation|Completed||N/A|140|Actual|Theodor Bilharz Research Institute||2|||f||||f||||||||||2017-10-10 23:42:50.77174|2017-10-10 23:42:50.77174
NCT02322671|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2017-05-12|||February 23, 2015|Actual|2015-02-23|May 2017|2017-05-01|April 20, 2015|Actual|2015-04-20|April 20, 2015|Actual|2015-04-20||Interventional|||Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects|An Open-label, Randomised, Single Dose, Three-Way Crossover, Six Sequence, Pilot Study to Determine the Relative Bioavailability of Montelukast Sodium 5mg From Two Candidate Chewable Tablet Formulations of GW483100 Relative to One 5mg Chewable Tablet of Reference Montelukast Sodium in Healthy Adult Subjects Under Fasting Conditions|Completed||Phase 1|18|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 23:42:50.890384|2017-10-10 23:42:50.890384
NCT02322658|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-18|||September 2008||2008-09-01|December 2014|2014-12-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed Conditions|An Open Label, Balanced, Randomized, Two-Treatment, Two Period, Two-Sequence, Single Dose, Crossover, Oral Bioequivalence Study of Eszopiclone Tablets 3 mg of Dr. Reddy's Laboratories Limited, and 'LUNESTA' Tablets 3 mg, Mfg For Sepracor Inc. USA In Healthy Adult Human Subjects Under Fed Conditions.|Completed||Phase 1|46|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:42:51.024208|2017-10-10 23:42:51.024208
NCT02322645|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-18|||August 2008||2008-08-01|December 2014|2014-12-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-Treatment, Two Period, Two-Sequence, Single Dose, Crossover, Oral Bioequivalence Study Of Eszopiclone Tablets 3 mg of Dr. Reddy's Laboratories Limited, and 'LUNESTA' Tablets 3 mg, Mfg For Sepracor Inc. USA In Healthy Adult Human Subjects Under Fasting Conditions.|Completed||Phase 1|46|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:42:51.147567|2017-10-10 23:42:51.147567
NCT02322632|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-18|||November 2010||2010-11-01|December 2014|2014-12-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions|An Open-label, Balanced, Randomized, Two-treatment, Two-sequence, Two-period, Single-dose, Crossover Oral Bioequivalence Study of Paricalcitol Capsules 4 mcg of Dr. Reddy's Laboratories Limited and Zemplar Capsules, 4 mcg of Abbott Laboratories, USA in Healthy, Adult, Human Subjects Under Fasting Conditions.|Completed||Phase 1|69|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:42:51.217971|2017-10-10 23:42:51.217971
NCT02322619|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-18|2014-12-18|||November 2012||2012-11-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study of Moxifloxacin Tablets, 400 mg of Dr. Reddy's Laboratories Limited, Comparing With Avelox® Tablets 400 mg of Bayer Healthcare Pharmaceuticals Inc. in Healthy, Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|26|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:42:51.314893|2017-10-10 23:42:51.314893
NCT02322606|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-11-24|||November 2014||2014-11-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Phase 1, Single and Multiple Dose Study of TAK-137|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of TAK-137 in Healthy Subjects|Withdrawn||Phase 1|0|Actual|Takeda||6|||f||||f||||||||||2017-10-10 23:42:51.390707|2017-10-10 23:42:51.390707
NCT02322593|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-08-02|||December 2014||2014-12-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|SOLAR||Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer|An Open-label Randomized Multi-center Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer|Active, not recruiting||Phase 3|686|Actual|Taiho Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:42:51.494834|2017-10-10 23:42:51.494834
NCT02322580|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-12-01|||January 2015||2015-01-01|May 2016|2016-05-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Observational|DERM||An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients|Intermittent Versus Continuous Treatment: an Observational Monocentric Study Investigating the Association Between Trough Levels of Enbrel and Therapy Regimen|Completed||N/A|56|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||||||||||||2017-10-10 23:42:51.612692|2017-10-10 23:42:51.612692
NCT02322567|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-02-24|||January 2012||2012-01-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Left Ventricular Diastolic Dysfunction in Kidney Recipients|Influence of Left Ventricular Diastolic Dysfunction on Graft Function and Postoperative Complication in Patients Undergoing Elective Kidney Transplantation|Completed||N/A|242|Actual|Severance Hospital|||2||f||||f||||||||||2017-10-10 23:42:51.676121|2017-10-10 23:42:51.676121
NCT02322541|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-06-02|||September 2016||2016-09-01|June 2017|2017-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Dietary Absorption of Garlic Metabolites Following Garlic Consumption||Withdrawn||N/A|0|Actual|USDA Beltsville Human Nutrition Research Center||1||This study was suspended due to additional time needed for method development.|f||||f||||||||||2017-10-10 23:42:51.84421|2017-10-10 23:42:51.84421
NCT02322528|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-09-17|2015-09-17||April 2014||2014-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax|Evaluation of Ocular Surface Inflammatory Mediators and Ocular Surface Metrology Effected by Lotemax|Completed||N/A|10|Actual|University of Rochester||1|||f||||f||||||||||2017-10-10 23:42:51.917169|2017-10-10 23:42:51.917169
NCT02322515|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-11-30|||January 2015||2015-01-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|Tapping||Patellar Taping on Proprioceptive Exercises in Young Women With Patellofemoral Pain Syndrome|The Effect of a Patellar Taping on Proprioceptive Exercises in Young Women With Patellofemoral Pain Syndrome: A Single-blinded Randomized Controlled Trial.|Completed||N/A|40|Actual|Universidade Norte do Paraná||2|||f||||t||||||||||2017-10-10 23:42:53.805245|2017-10-10 23:42:53.805245
NCT02322502|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-10-05|||February 2015||2015-02-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia|Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia: a Randomized Multicenter Controlled Trial (ACC Baxter)|Completed||Phase 3|352|Actual|RWTH Aachen University||3|||f||||f||||||||||2017-10-10 23:42:53.881158|2017-10-10 23:42:53.881158
NCT02322489|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2015-06-08|||January 2015||2015-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy of Microcurrent Therapy After Eccentric Exercise|Efficacy of Microcurrent Therapy After Eccentric Exercise|Completed||N/A|15|Actual|University Hospital of Liege||2|||f||||f||||||||||2017-10-10 23:42:53.971043|2017-10-10 23:42:53.971043
NCT02322476|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-12-22|||January 2015||2015-01-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01||Observational|||Herpes Simplex Reactivation in Adult Critical Care Patients|Herpes Simplex Reactivation in Adult Critical Care Patients|Unknown status|Not yet recruiting|N/A|140|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     blood tracheal secretions   "|||2017-10-10 23:42:54.047386|2017-10-10 23:42:54.047386
NCT02322463|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2015-02-02|||December 2014||2014-12-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Ethnicity and Analgesic Practice in a Pediatric Emergency Department|Ethnicity and Analgesic Practice in a Pediatric Emergency Department|Unknown status|Recruiting|N/A|5000|Anticipated|Rambam Health Care Campus|||2||f||||f||||||||||2017-10-10 23:42:54.101561|2017-10-10 23:42:54.101561
NCT02322450|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-09-27|||January 2015||2015-01-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|2QG1||Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension|Multicenter, Randomized, Double-blind, Two-period, Placebo Controlled, Forced-titration Proof of Concept Crossover Study to Compare QGC001 With Placebo in Patients With Grade I or II Essential Hypertension|Completed||Phase 2|34|Actual|Quantum Genomics SA||2|||f||||f||||||||||2017-10-10 23:42:54.188976|2017-10-10 23:42:54.188976
NCT02322437|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-03-28|||April 2015||2015-04-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Home Treatment for Acute Psychiatric Care|Home Treatment for Acute Psychiatric Care in the Canton of Aargau (Switzerland): A Randomized Controlled Trial|Recruiting||N/A|500|Anticipated|Psychiatric Services Aargau AG||2|||f||||f||||||||||2017-10-10 23:42:54.278213|2017-10-10 23:42:54.278213
NCT02322424|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-17|||December 2014||2014-12-01|December 2014|2014-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|42 Months|Observational [Patient Registry]|||Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy|Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy: Prospective Large Observational Study|Unknown status|Recruiting|N/A|3000|Anticipated|Wakayama Medical University|||1||f||||t||||||||||2017-10-10 23:42:54.373349|2017-10-10 23:42:54.373349
NCT02322411|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-09-30|||January 2015||2015-01-01|December 2014|2014-12-01||||June 2016|Anticipated|2016-06-01||Interventional|StrokeStrong||Effects of Oropharyngeal Strengthening on Dysphagia in Patients Post-stroke|Effects of Device-Facilitated Isometric Progressive Resistance Oropharyngeal (I-PRO) Therapy on Dysphagia Related Outcomes in Patients Post-stroke|Unknown status|Not yet recruiting|N/A|30|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-10 23:42:54.46401|2017-10-10 23:42:54.46401
NCT02322398|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-17|||March 2010||2010-03-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization|Controlled Ovarian Stimulation With Recombinant Follicle Stimulating Hormone Plus Recombinant Luteinizing Hormone vs. Human Menopausal Gonadotropin in In Vitro Fertilization: Retrospective Analysis of Real Life Data|Completed||N/A|848|Actual|University of Turin, Italy|||2||f||||f||||||||||2017-10-10 23:42:54.694042|2017-10-10 23:42:54.694042
NCT02322385|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-02-28|||January 2014||2014-01-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|DNAAA||Clinical Implications of DNA Analysis on ADPKD|Mutational Types and Phenotypes Relationship in Autosomal Dominant Polycystic Kidney Disease|Completed||N/A|80|Actual|Kyorin University|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-10 23:42:54.807572|2017-10-10 23:42:54.807572
NCT02322372|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2015-02-15|||July 2014||2014-07-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Femoral Blockade and Low-dose Spinal Anesthesia in Outpatient Knee Arthroscopy|Comparison of Conventional Dose Spinal Anesthesia With Low-dose Spinal Anesthesia and Femoral Blockade Combination in Outpatient Knee Arthroscopy|Completed||Phase 4|50|Actual|Ankara University||2|||f||||f||||||||||2017-10-10 23:42:54.899347|2017-10-10 23:42:54.899347
NCT02322359|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-19|||August 2014||2014-08-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|CILICA-FS||Compression Is Life In Cardiac Arrest - Fatigue Study|Impact of a Feedback Device, CPRmeter®, on Chest Compression Quality During Extend Cardio-pulmonary Resuscitation. A Manikin Study.|Completed||N/A|60|Actual|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 23:42:55.012342|2017-10-10 23:42:55.012342
NCT02322346|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2014-12-22|||August 2008||2008-08-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain|Peritonsillar Infiltration With Levobupivacaine for Relief of Posttonsillectomy Pain: Does Concentration Have Any Effect?|Completed||Phase 4|70|Actual|Ankara University||3|||f||||f||||||||||2017-10-10 23:42:55.110396|2017-10-10 23:42:55.110396
NCT02322333|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-07-13|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||MLD10 in the Prevention of Migraine in Adults|A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of MLD10 in the Prevention of Migraine Headache in Adults|Completed||Phase 2/Phase 3|157|Actual|Pharmalyte Solutions LLC||2|||f||||f||||||||||2017-10-10 23:42:55.212956|2017-10-10 23:42:55.212956
NCT02322320|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-08-24|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)|Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN #07LT)|Recruiting||Phase 3|450|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||t||||||||||2017-10-10 23:42:55.353844|2017-10-10 23:42:55.353844
NCT02322307|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-06-27|||February 2015||2015-02-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life|A Pragmatic Randomized Controlled Trial to Evaluate the Impact of HealthPROMISE Platform on Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease|Active, not recruiting||N/A|320|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|f||||||||2017-10-10 23:42:55.640496|2017-10-10 23:42:55.640496
NCT02322294|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-06-08|||January 2015||2015-01-01|June 2016|2016-06-01||||March 2016|Actual|2016-03-01||Interventional|14GGHF||Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight|A Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Effects of 8 Weeks Use of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight as Compared to Placebo|Completed||Phase 2|50|Actual|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-10 23:42:55.742487|2017-10-10 23:42:55.742487
NCT02322281|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-06-02|||February 2015||2015-02-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy|TIGER-3: A Phase 3, Open-label, Multicenter, Randomized Study of Oral Rociletinib (CO-1686) Monotherapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC) After Failure of at Least 1 Previous EGFR-directed Tyrosine Kinase Inhibitor (TKI) and Platinum-doublet Chemotherapy|Active, not recruiting||Phase 3|149|Actual|Clovis Oncology, Inc.||3|||f||||t||||||||||2017-10-10 23:42:55.847892|2017-10-10 23:42:55.847892
NCT02322268|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2015-11-30|||August 2014||2014-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||RCT Evaluating Effects of Cosmos Caudatus (Ulam Raja) in T2DM Patients|Metabolomic Profiling on The Effect of Cosmos Caudatus (Ulam Raja) Supplementation in Patients With Type 2 Diabetes: A Randomized Controlled Trial|Completed||N/A|101|Actual|Universiti Putra Malaysia||2|||f||||t||||||||||2017-10-10 23:42:56.198601|2017-10-10 23:42:56.198601
NCT02322255|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-03-22|||December 2014||2014-12-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)|A Natural History, Non-Interventional, Two-Part Study in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)|Active, not recruiting||N/A|100|Anticipated|Clementia Pharmaceuticals Inc.|||1||f||||f||||||Samples With DNA|"     Blood and urine samples for biomarker and proteomic analysis.   "|||2017-10-10 23:42:56.311763|2017-10-10 23:42:56.311763
NCT02322242|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-02-03|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ISB-Dex||The Effects of Dexamethasone on Low Dose Interscalene Brachial Plexus Block|Comparison of the Effects of Perineural Versus Systemic Dexamethasone on Low Dose Interscalene Brachial Plexus Block: A Randomized Control Trial|Recruiting||Phase 4|180|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||No||2017-10-10 23:42:56.424708|2017-10-10 23:42:56.424708
NCT02322216|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-10-12|2016-08-22||December 2014||2014-12-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||This analysis population includes all participants who were randomized, received drug, had at least one on-therapy visit, satisfied inclusion/exclusion criteria, and had no major protocol deviations (Per Protocol Set).|Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects|A Comparative Study of Olopatadine Hydrochloride Ophthalmic Solution 0.2% QD vs Olopatadine Hydrochloride Ophthalmic Solution 0.1% BID in the Treatment of Allergic Conjunctivitis in Chinese Subjects|Completed||Phase 3|383|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:42:56.620059|2017-10-10 23:42:56.620059
NCT02322190|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-20|2017-09-30|||December 4, 2014||2014-12-04|September 29, 2017|2017-09-29|October 1, 2027|Anticipated|2027-10-01|October 1, 2025|Anticipated|2025-10-01||Interventional|||Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD|Biomarkers in Acute Graft-Versus-Host Disease (GVHD) and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD|Suspended||Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:42:57.027292|2017-10-10 23:42:57.027292
NCT02322177|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-08-16|||December 10, 2014||2014-12-10|August 15, 2017|2017-08-15|October 1, 2024|Anticipated|2024-10-01|October 1, 2024|Anticipated|2024-10-01||Observational|||Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol|Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol|Suspended||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:42:57.113016|2017-10-10 23:42:57.113016
NCT02322164|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-09-22|||December 11, 2014||2014-12-11|September 21, 2017|2017-09-21|September 21, 2017|Actual|2017-09-21|September 21, 2017|Actual|2017-09-21||Observational|||Psychophysical Correlates of Pain Reduction by Topical Analgesic Compounds|Psychophysical Correlates of Pain Reduction by Topical Analgesic Compounds|Completed||N/A|40|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:42:57.190273|2017-10-10 23:42:57.190273
NCT02322151|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-19|2017-06-30|||December 12, 2014||2014-12-12|October 14, 2016|2016-10-14|October 14, 2016|Actual|2016-10-14|November 9, 2015|Actual|2015-11-09||Observational|||Pharmacokinetics of Granulocyte Colony Stimulating Factor in the Breast Milk of Volunteer Peripheral Blood Stem Cell Donor|Pharmacokinetics of Granulocyte Colony Stimulating Factor in the Breast Milk of Volunteer Peripheral Blood Stem Cell Donor|Completed||N/A|4|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:42:57.272348|2017-10-10 23:42:57.272348
NCT02322138|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-07-22|||January 2015||2015-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Gastrointestinal Tolerance of Infant Formula|Gastrointestinal Tolerance of Formula Supplemented With Prebiotics|Completed||N/A|131|Actual|Abbott Nutrition||3|||f||||f||||||||||2017-10-10 23:42:57.353482|2017-10-10 23:42:57.353482
NCT02322125|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-06-13|||June 2014||2014-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Restoring Walking With a Powered Exoskeleton After Spinal Cord Injury|Restoring Walking With a Powered Exoskeleton After Spinal Cord Injury|Recruiting||N/A|15|Anticipated|University of Alberta||1|||f||||f|f|t|f|f|t|||No||2017-10-10 23:42:57.467059|2017-10-10 23:42:57.467059
NCT02322112|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-09-01|||August 2015|Actual|2015-08-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Alberta FYBER (Feed Your Gut Bacteria morE fibeR) Study|The Alberta FYBER (Feed Your Gut Bacteria morE fibeR) Study: Exploring the Significance of Structure-function Relationships Between Dietary Fiber and the Gut Microbiota in Human Health.|Recruiting||N/A|200|Anticipated|University of Alberta||3|||f||||f||||||||||2017-10-10 23:42:57.584384|2017-10-10 23:42:57.584384
NCT02322099|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-11-29|||May 2016||2016-05-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|APART||Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss|A Multi-centre, Prospective, Randomised Trial of Short Course Alendronate Therapy or Placebo Combined With Vitamin D and Calcium to Prevent Loss of Bone Mineral Density in Antiretroviral-naïve, HIV-1 Infected Subjects Initiating Antiretroviral Therapy|Recruiting||Phase 4|80|Anticipated|University College Dublin||2|||f||||t||||||||||2017-10-10 23:42:57.68017|2017-10-10 23:42:57.68017
NCT02322086|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-09-15|||January 2015||2015-01-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10|A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Provectus Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:42:57.794278|2017-10-10 23:42:57.794278
NCT02322073|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-02-01|||December 2014||2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Adipos2||Inflammation and Obesity-associated Disease|Inflammation and Obesity-associated Disease|Recruiting||N/A|80|Anticipated|Göteborg University|||4||f||||f||||||||||2017-10-10 23:42:57.875152|2017-10-10 23:42:57.875152
NCT02322060|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-01-11|||September 2014||2014-09-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01|2 Years|Observational [Patient Registry]|IVADFPOI||In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency|Ovarian Tissue Cryopreservation and Auto-transplantation for in Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency|Unknown status|Recruiting|N/A|100|Anticipated|The First Affiliated Hospital of Zhengzhou University|||1||f||||t||||||Samples With DNA|"     Serum, ovary tissue   "|||2017-10-10 23:42:57.954499|2017-10-10 23:42:57.954499
NCT02322047|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-12-23|||November 2014||2014-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|PaN||Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders|Effect of Prazosin and Naltrexone on Personalized Script-Induced Alcohol Craving in Individuals With Alcohol Use Disorders With and Without Comorbid PTSD|Recruiting||Phase 2|120|Anticipated|Seattle Institute for Biomedical and Clinical Research||4|||f||||t||||||||||2017-10-10 23:42:58.039137|2017-10-10 23:42:58.039137
NCT02322034|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-07-29|||January 2015||2015-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Interval Training and Hormones in Chronic Heart Failure|Effects of Interval Training on Hormonal Pathways in Chronic Heart Failure|Recruiting||N/A|80|Anticipated|Federico II University||2|||f||||t||||||||||2017-10-10 23:42:58.138961|2017-10-10 23:42:58.138961
NCT02322021|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-06-19|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Dose-Finding Study To Evaluate the Safety and Tolerability of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease|A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Dose-Finding Study To Evaluate the Safety and Tolerability of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease|Active, not recruiting||Phase 2|71|Actual|Eisai Inc.||8|||f||||t||||||||Undecided||2017-10-10 23:42:58.233602|2017-10-10 23:42:58.233602
NCT02322008|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-22|||September 2009||2009-09-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice|Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice|Completed||N/A|1035|Actual|Regionshospitalet Viborg, Skive|||1||f||||f||||||||||2017-10-10 23:42:58.495344|2017-10-10 23:42:58.495344
NCT02173210|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-05-02|||June 2014||2014-06-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|PRoMISE||Precision Medicine for Preterm Birth|Precision Medicine In Segregating Endotypes in Preterm Birth|Recruiting||N/A|150|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 00:17:08.906895|2017-10-11 00:17:08.906895
NCT02321995|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-06-28|||June 2016|Actual|2016-06-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||A Quantitative Optical Sensor to Monitor Vascular Physiology; A Healthy Volunteer Study|A Quantitative Optical Sensor to Monitor Vascular Physiology; A Healthy Volunteer Study|Completed||N/A|10|Actual|Zenalux Biomedical, Inc.|||1||f||||f|f|f||||||||2017-10-10 23:42:58.571984|2017-10-10 23:42:58.571984
NCT02321982|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-07-03|||February 2015||2015-02-01|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery|Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery|Withdrawn||N/A|0|Actual|Dartmouth-Hitchcock Medical Center||2||Study topic is no longer being pursued by study team members|f||||||||||||||2017-10-10 23:42:58.660917|2017-10-10 23:42:58.660917
NCT02321969|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-10-26|||August 2010||2010-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||Green Tea Extracts for the Prevention of Colorectal Adenomas and Colorectal Cancer|Green Tea Extracts for the Prevention of Colorectal Adenomas and Colorectal Cancer|Completed||N/A|176|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:42:58.740716|2017-10-10 23:42:58.740716
NCT02321956|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-06-04|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Ultrasound Study of the Airway to Predict Endotracheal Tube Size in Anesthetized Pediatric Patients|Ultrasound Study of the Airway to Predict Endotracheal Tube Size in Anesthetized Pediatric Patients|Completed||N/A|93|Actual|Siriraj Hospital||2|||f||||||||||||||2017-10-10 23:42:58.82012|2017-10-10 23:42:58.82012
NCT02321943|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-04-26|||February 2015||2015-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study|Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study|Completed||N/A|56|Actual|Sykehuset Innlandet HF|||1||f||||f||||||Samples Without DNA|"     Blood tests including cardiovascular risk factors and immunological parameters (cytokines).   "|||2017-10-10 23:42:58.907841|2017-10-10 23:42:58.907841
NCT02321930|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-08-26|||January 2016||2016-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients|Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients|Recruiting||Phase 4|25|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-10 23:42:58.982213|2017-10-10 23:42:58.982213
NCT02321917|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-02-02|||April 2013||2013-04-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|RheoMECC||Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)|Coagulation, Inflammation and Cerebral Embolism Using a Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC): Differences to the Conventional MECC System|Active, not recruiting||Phase 4|50|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:42:59.064776|2017-10-10 23:42:59.064776
NCT02321904|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-08-23|||June 2008||2008-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|August 2014|Actual|2014-08-01||Observational|CCM||Corneal Confocal Microscopy to Detect Diabetic Neuropathy in Children|Corneal Confocal Microscopy to Detect Diabetic Neuropathy in Children|Active, not recruiting||N/A|176|Actual|University of Calgary|||2||f||||f||||||||||2017-10-10 23:42:59.146065|2017-10-10 23:42:59.146065
NCT02321891|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-16|||December 2014||2014-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||A Pilot Study to Determine a Candidate Protocol for Transcranial Electrical Stimulation in the Treatment of Anxiety|Optimizing Transcranial Electrical Stimulation for Clinical Applications (the OptES Study): A Pilot Study to Determine a Candidate Protocol for Treatment of Anxiety (OptES-Anx)|Unknown status|Recruiting|N/A|14|Anticipated|University of Eastern Finland||2|||f||||f||||||||||2017-10-10 23:42:59.237781|2017-10-10 23:42:59.237781
NCT02321878|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-08-31|||December 15, 2014|Actual|2014-12-15|August 2017|2017-08-01|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Observational|||Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)|Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)|Completed||N/A|1092|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 23:42:59.315858|2017-10-10 23:42:59.315858
NCT02321865|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-07-22|||January 2015||2015-01-01|July 2015|2015-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency|Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency|Unknown status|Active, not recruiting|Phase 3|40|Anticipated|Nobelpharma||1|||f||||f||||||||||2017-10-10 23:42:59.396662|2017-10-10 23:42:59.396662
NCT02321852|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-11-09|||January 2015||2015-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|Tribunal-Basel||Influence of Triflusal on Cognitive Functions in Healthy Subjects|Randomized Placebo Controlled Phase II Cross Over Study on the Influence of Triflusal on Cognitive Functions in Healthy Participants|Completed||Phase 2|40|Actual|University of Basel||2|||f||||f||||||||||2017-10-10 23:42:59.471498|2017-10-10 23:42:59.471498
NCT02321839|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-10-19|||January 2014||2014-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.|Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration.|Recruiting||Phase 4|100|Anticipated|Nagoya City University||1|||f||||t||||||||No||2017-10-10 23:42:59.572814|2017-10-10 23:42:59.572814
NCT02321826|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-09-29|||April 2015||2015-04-01|April 2017|2017-04-01|September 29, 2017|Actual|2017-09-29|September 29, 2017|Actual|2017-09-29||Interventional|||Music for Insomnia|Better Night - Better Day: a Randomized Controlled Trial of Listening to Music for Improving Insomnia|Completed||N/A|57|Actual|University of Aarhus||3|||f||||t||||||||||2017-10-10 23:42:59.669858|2017-10-10 23:42:59.669858
NCT02321813|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-09-21|||January 2014||2014-01-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|November 2016|Actual|2016-11-01||Interventional|DIQOL||Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Randomised Trial in Colorectal Cancer Patients|Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Protocol of a Randomised Clinical Trial in Colorectal Cancer Patients|Completed||N/A|220|Actual|Tumorzentrum Regensburg e.V.||2|||f||||t||||||||||2017-10-10 23:42:59.770055|2017-10-10 23:42:59.770055
NCT02321800|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-07-11||2017-07-11|December 1, 2014||2014-12-01|July 2017|2017-07-01|August 16, 2016|Actual|2016-08-16|July 26, 2016|Actual|2016-07-26||Interventional|APEKS-cUTI||A Study of Efficacy/Safety of Intravenous S-649266 Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections|A Multicenter, Double-blind, Randomized, Clinical Study to Assess the Efficacy and Safety of Intravenous S-649266 in Complicated Urinary Tract Infections With or Without Pyelonephritis or Acute Uncomplicated Pyelonephritis Caused by Gram-Negative Pathogens in Hospitalized Adults in Comparison With Intravenous Imipenem/Cilastatin|Completed||Phase 2|450|Actual|Shionogi Inc.||2|||f||||t||||||||||2017-10-10 23:42:59.861068|2017-10-10 23:42:59.861068
NCT02321787|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-01-14|||December 2014||2014-12-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ultrasonography for Confirmation of Caudal Injection|Utility of Ultrasonography for Confirmation of Successful Caudal Epidural Injection|Completed||N/A|100|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-10 23:42:59.962134|2017-10-10 23:42:59.962134
NCT02321774|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-05-19|||November 2014||2014-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Observational|||Validation of a Wearable Sensor for Stress Response in a Virtual Reality Environment|Validation of a Wearable Sensor for Stress Response in a Virtual Reality Environment|Completed||N/A|53|Actual|Scripps Translational Science Institute|||1||f||||f||||||||||2017-10-10 23:43:00.046948|2017-10-10 23:43:00.046948
NCT02321761|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-09-26|||June 2014||2014-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Amantadine Administration on Spatial Functioning Following Traumatic Brain Injury|Effect of Amantadine Administration on Spatial Functioning Following Traumatic Brain Injury|Recruiting||Phase 4|10|Anticipated|Loewenstein Hospital||1|||f||||t||||||||||2017-10-10 23:43:00.119646|2017-10-10 23:43:00.119646
NCT02321748|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-08-17|||December 2014||2014-12-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Drug-Drug Interaction Study: ASP2151 and Montelukast|A Single-centre, Open-label, Randomised, Crossover, Drug-drug Interaction Study in Healthy Men to Investigate the Effect of a Single Dose of ASP2151 on the Pharmacokinetics of Montelukast|Completed||Phase 1|24|Actual|Maruho Europe Limited||2|||f||||f||||||||||2017-10-10 23:43:00.223297|2017-10-10 23:43:00.223297
NCT02321735|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-03-15|||September 2014||2014-09-01|March 2016|2016-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|LTSOC||DOD Long-Term Survivors of Ovarian Cancer|The Genomic, Epigenomic, and Psychosocial Characteristics of Long-Term Survivors of Ovarian Cancer - Recruitment|Recruiting||N/A|400|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||Undecided|the study is still at a very early stage to understand how data will be shared|2017-10-10 23:43:00.91379|2017-10-10 23:43:00.91379
NCT02321722|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-09-22|||January 2015||2015-01-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Observational|||The Effect of Colonoscopy on Intralocular Pressure|The Effect of Colonoscopy on Intralocular Pressure|Unknown status|Recruiting|N/A|100|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-10 23:43:01.024009|2017-10-10 23:43:01.024009
NCT02321709|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-04-29|||November 2014||2014-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients|A Randomized, Double-blind, Placebo-controlled Study Of Safety, Tolerability, And Pharmacokinetics Of Repeated Ascending Subcutaneous Doses Of SAR113244 And Pharmacodynamics Of Single Dose Of SAR113244 In Male And Female Lupus Patients|Completed||Phase 1|21|Actual|Sanofi||3|||f||||t||||||||||2017-10-10 23:43:01.108592|2017-10-10 23:43:01.108592
NCT02321696|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-01-19|||February 2015||2015-02-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Physiotherapy or Acupuncture for Lateral Epicondylitis|Clinical Comparative Effect of Physiotherapy or Acupuncture Treatment of Lateral Epicondylitis; a Randomized Controlled Pilot Trial|Recruiting||N/A|36|Anticipated|Oslo University Hospital||3|||f||||f||||||||||2017-10-10 23:43:01.208651|2017-10-10 23:43:01.208651
NCT02321683|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-17|||December 2003||2003-12-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|June 2005|Actual|2005-06-01||Interventional|||Evaluation of a New Coating in Cement Less Femoral Stems|No Mid-term Advantage by Electrochemical Deposition of Hydroxyl-apatite in Cementless Femoral Stems. 5-year RSA and DXA Results From a Randomized Controlled Trial|Completed||Phase 4|55|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:43:01.338198|2017-10-10 23:43:01.338198
NCT02321670|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-10-12|||September 2015||2015-09-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|SUPS||Scandinavian Urethroplasty Study|Scandinavian Urethroplasty Study. A Multicentre, Prospective, Randomized Study Comparing Bulbar Urethroplasty With Excision and Primary Anastomosis or With an Onlay Grafting Procedure Using Buccal Mucosa.|Recruiting||N/A|300|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:43:01.470348|2017-10-10 23:43:01.470348
NCT02321657|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-10-26|||March 2015||2015-03-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|RELAX-A||RELAX Anaesthetics: the Effect of a Bespoke Relaxation App on Stress Levels in Children Undergoing Anaesthesia|RELAX Anaesthetics: the Effect of a Bespoke Relaxation App on Stress Levels in Children Undergoing Anaesthesia|Completed||N/A|100|Anticipated|Royal College of Music||2|||f||||f||||||||||2017-10-10 23:43:01.595662|2017-10-10 23:43:01.595662
NCT02321644|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-08-17|||November 2014||2014-11-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study|A Two-Part, Phase 1 Study to Evaluate Pharmacokinetics and Pharmacodynamics of Multiple Dose CC-90001 and to Evaluate the Effects of Food and Formulation on Pharmacokinetics of Single Dose CC-90001 in Healthy Subjects|Completed||Phase 1|26|Actual|Celgene||4|||f||||f||||||||||2017-10-10 23:43:01.687499|2017-10-10 23:43:01.687499
NCT02321631|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-08-23|||January 2015||2015-01-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy of EPA-enriched Supplement in Malnourished Head and Neck Cancer Patients Undergone Surgery|Efficacy of EPA-enriched Supplement Compared With Standard Formula on Body Weight Changing in Malnourished Head and Neck Cancer Patients Undergone Surgery: A Randomized Study|Recruiting||Phase 3|70|Anticipated|Prince of Songkla University||2|||f||||t||||||||||2017-10-10 23:43:01.781139|2017-10-10 23:43:01.781139
NCT02172833|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2014-12-30|||January 2014||2014-01-01|December 2014|2014-12-01||||July 2015|Anticipated|2015-07-01||Observational|||Antibiotic-associated Coagulopathy|Antibiotic-associated Coagulopathy|Unknown status|Recruiting|N/A|500|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:17:13.105668|2017-10-11 00:17:13.105668
NCT02321618|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-08-21|||February 17, 2015|Actual|2015-02-17|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|December 31, 2016|Actual|2016-12-31||Interventional|||Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study|Barber-Pharmacist Coordination to Improve Blood Pressure Management in Black Men|Active, not recruiting||N/A|500|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-10 23:43:01.877507|2017-10-10 23:43:01.877507
NCT02321605|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2014-12-19|||January 2013||2013-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy of Best Possible Self Intervention Over Time|Efficacy of Best Possible Self Intervention Over Time: A Randomized Control Trial|Completed||N/A|78|Actual|Universitat Jaume I||2|||f||||t||||||||||2017-10-10 23:43:01.963342|2017-10-10 23:43:01.963342
NCT02321592|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-11-07|||May 2015||2015-05-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|August 2017|Anticipated|2017-08-01||Interventional|GHSG-AFM13||GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma|GHSG-AFM13 An Open-label, Randomized, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma|Recruiting||Phase 2|39|Anticipated|University of Cologne||2|||f||||t||||||||||2017-10-10 23:43:02.060773|2017-10-10 23:43:02.060773
NCT02321579|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-19|||December 2014||2014-12-01|December 2014|2014-12-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities|The Effects of Vitamin B-6 and Glutathione on Inflammatory Responses, Homocysteine Metabolism, Oxidative Stress and Antioxidant Capacities in Patients With Liver Cirrhosis or Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|25|Anticipated|Taichung Veterans General Hospital||4|||f||||f||||||||||2017-10-10 23:43:02.158472|2017-10-10 23:43:02.158472
NCT02321566|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-08-29|||February 2015||2015-02-01|August 2016|2016-08-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.|Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.|Recruiting||Phase 1|36|Anticipated|Johns Hopkins University||1|||f||||||||||||||2017-10-10 23:43:02.496531|2017-10-10 23:43:02.496531
NCT02321553|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-05-13|||April 2014||2014-04-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effect of Brown Rice on the Risk Factors for Metabolic Syndrome|Biological Functions of Brown Rice on Metabolic Syndrome: A Randomized Cross-over Pilot Study|Completed||N/A|7|Actual|Tufts University||2|||f||||f||||||||||2017-10-10 23:43:02.581188|2017-10-10 23:43:02.581188
NCT02321540|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-02-15|||March 31, 2015|Actual|2015-03-31|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer|A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1/Phase 2|13|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:43:02.671678|2017-10-10 23:43:02.671678
NCT02321527|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-05-24|2017-05-24||July 2015||2015-07-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients|Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Ultrasound Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients|Completed||N/A|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:43:02.776368|2017-10-10 23:43:02.776368
NCT02321514|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-05-18|||November 2014||2014-11-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Early Feasibility Study of the Tendyne Mitral Valve System|Expanded Clinical Study of Tendyne Mitral Valve System|Recruiting||N/A|110|Anticipated|Tendyne Holdings, LLC||1|||f||||t||||||||||2017-10-10 23:43:02.996452|2017-10-10 23:43:02.996452
NCT02321501|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-08-04|||June 2016|Actual|2016-06-01|August 2017|2017-08-01|June 2023|Anticipated|2023-06-01|June 2023|Anticipated|2023-06-01||Interventional|||Phase I/Ib Dose Escalation & Biomarker Study of Ceritinib (LDK378) + Everolimus for Locally Advanced or Metastatic Solid Tumors With an Expansion in Non-Small Cell Lung Cancer (NSCLC) Characterized by Abnormalities in Anaplastic Lymphoma Kinase (ALK) Expression|A Phase I/Ib Dose Escalation and Biomarker Study of Ceritinib (LDK378) in Combination With Everolimus in Patients With Locally Advanced or Metastatic Solid Tumors With an Expansion in Non-Small Cell Lung Cancer (NSCLC) Characterized by Abnormalities in Anaplastic Lymphoma Kinase (ALK) Expression|Recruiting||Phase 1|66|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-10 23:43:03.157785|2017-10-10 23:43:03.157785
NCT02321475|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-06-29|||June 2014||2014-06-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|TAYPES||EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders|Non-interventional Prospective Observational Survey to Describe EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders.|Completed||N/A|54|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 23:43:03.278181|2017-10-10 23:43:03.278181
NCT02321462|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2016-09-30|||March 2015||2015-03-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ESTOS||Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy|Efficacy, Safety and Tolerability of a Split-dose of a New Bowel Cleansing Preparation (Eziclen) in Adult Subjects Undergoing Colonoscopy: A Phase III, Multicentre, Randomised, 2 Parallel Group, Comparative Versus Fortrans®, Non-inferiority, Investigator-blinded Study|Completed||Phase 3|305|Actual|Ipsen||2|||f||||f||||||||||2017-10-10 23:43:03.369204|2017-10-10 23:43:03.369204
NCT02321449|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2015-06-29|||June 2014||2014-06-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|QUALISLEEP||The Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over|Open-label, Post-marketing Observational Study to Evaluate the Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over|Completed||N/A|40|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 23:43:03.454456|2017-10-10 23:43:03.454456
NCT02321280|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-05-04|||February 2015||2015-02-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||The Efficacy of Denosumab in Active Crohn's Disease|Denosumab (A Monoclonal Antibody to Receptor Activator of Nuclear Factor-Kappa B Ligand (RANKL) in Crohn's Disease|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-10-10 23:43:05.799279|2017-10-10 23:43:05.799279
NCT02321436|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-05-22|2017-03-23||December 2014||2014-12-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ONTIME Pilot|Baseline characteristics are reported for the 42 subjects with UL spasticity who were enrolled and treated with either Dysport® 500 U or placebo.|Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression|Asian Multicentre, Double Blind, Randomised, Placebo Controlled Pilot Study, to Assess the Impact of Dysport® Intramuscular Injections When Administered Within the First 12 Weeks After Stroke on the Time to Spasticity Progression in Adult Subjects With Upper Limb Spasticity.|Completed||Phase 4|42|Actual|Ipsen||2|||f||||f||||||||||2017-10-10 23:43:03.543|2017-10-10 23:43:03.543
NCT02321423|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-09-14|||April 2004||2004-04-01|September 2016|2016-09-01||||December 2058|Anticipated|2058-12-01|1 Year|Observational [Patient Registry]|IPCRR||International Pachyonychia Congenita Research Registry||Recruiting||N/A|1800|Anticipated|Pachyonychia Congenita Project|||1||f||||f||||||||||2017-10-10 23:43:04.620557|2017-10-10 23:43:04.620557
NCT02321410|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-04-25|||February 2014||2014-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PLAVASC||"In Vivo Comparison in Human Carotid Atherosclerosis: Plaque Neovascularization"|"Plaque Neovascularization Assessment by Contrast Ultrasounds and Plaque Magnetic Resonance: in Vivo Comparison in Human Carotid Atherosclerosis"|Completed||N/A|45|Actual|Ospedale San Giovanni Bellinzona||1|||f||||t||||||||||2017-10-10 23:43:04.736755|2017-10-10 23:43:04.736755
NCT02321397|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-11-03|||November 2014||2014-11-01|December 2015|2015-12-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain|Randomised, Double-blind, Double-dummy, Cross-over Multicenter Study to Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Taking Oxycodone Equivalents of 120 & 160 mg Per Day as Achieved With the Higher OXN PR Tablet Strengths (OXN60/30 mg PR, OXN80/40 mg PR) BID Compared to the Identical Daily Dose Taken as a Combination of Lower Tablet Strengths in Subjects With Non-malignant or Malignant Pain That Requires Around-the-clock Opioid Therapy.|Completed||Phase 2/Phase 3|155|Actual|Mundipharma Research GmbH & Co KG||2|||f||||||||||||||2017-10-10 23:43:04.830114|2017-10-10 23:43:04.830114
NCT02321384|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-04-03|||December 15, 2014|Actual|2014-12-15|April 2017|2017-04-01|November 26, 2015|Actual|2015-11-26|November 26, 2015|Actual|2015-11-26||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RO6889678 and the Combination of RO6889678 With Ritonavir in Healthy Participants|A Single-Center, Randomized, Double-Blind, Single and Multiple Ascending Dose, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of RO6889678 and the Combination of RO6889678 With Ritonavir Following Oral Administration, the Effect of Food on the Pharmacokinetics of RO6889678 and the Effect of Multiple Oral Dosing of RO6889678 and the Combination of RO6889678 With Ritonavir on the Pharmacokinetics of Midazolam in Healthy Subjects|Terminated||Phase 1|100|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 23:43:04.928219|2017-10-10 23:43:04.928219
NCT02321371|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-01-26|||October 2014||2014-10-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.||Completed||N/A|73|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:43:05.07594|2017-10-10 23:43:05.07594
NCT02321358|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-04-05|||September 2014||2014-09-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|OutPACE||Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer Survivors|Randomized Controlled Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer Survivors: The OutPACE Trial|Recruiting||N/A|120|Anticipated|Memorial University of Newfoundland||3|||f||||t||||||||||2017-10-10 23:43:05.172226|2017-10-10 23:43:05.172226
NCT02321345|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2017-06-08|||February 2015||2015-02-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Pretransplant Evaluation by Supportive Care Team for Patients Undergoing HCT for Hematological Malignancies|Feasibility of Implementing Pretransplant Evaluation by the Supportive Care Team for Patients Undergoing Hematopoietic Cell Transplantation for Hematological Malignancies|Active, not recruiting||N/A|7|Actual|Medical College of Wisconsin||1|||f||||f||||||||||2017-10-10 23:43:05.278352|2017-10-10 23:43:05.278352
NCT02321332|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-16|||June 2010||2010-06-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ETS||Unilateral Sequential Sympathectomy for Palmar Hyperhidrosis|Unilateral Sequential Versus Bilateral Simultaneous Sympathectomy for Palmar Hyperhidrosis: a Study of 407 Cases.|Completed||N/A|400|Actual|Mansoura University||2|||f||||||||||||||2017-10-10 23:43:05.359231|2017-10-10 23:43:05.359231
NCT02321319|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-06-02|||December 2014||2014-12-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients|An Open-Label, Safety and Pharmacokinetic Study of Hydromorphone Hydrochloride Extended-Release Tablets (Once-Daily Hydromorphone) in Opioid-Tolerant Pediatric Subjects With Chronic Pain|Recruiting||Phase 3|100|Anticipated|Mallinckrodt||1|||f||||f||||||||||2017-10-10 23:43:05.44924|2017-10-10 23:43:05.44924
NCT02321306|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-07-27|||May 2015||2015-05-01|July 2015|2015-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CASCADE||An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis|An Open-label, Multicenter Extension Study to Evaluate the Long-term Safety and Tolerability of LUM001, an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTi), in Patients With Primary Biliary Cirrhosis|Withdrawn||Phase 2|0|Actual|Shire||1||The study stopped early, before enrolling its first participant.|f||||f||||||||||2017-10-10 23:43:05.544813|2017-10-10 23:43:05.544813
NCT02321293|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-09-01|||August 2015||2015-08-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|CURCUMIN||A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC|A Phase 1 Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors for Epidermal Growth Factor Receptor (EGFR)-Mutant Advanced Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 1|20|Anticipated|Lady Davis Institute||1|||f||||f||||||||||2017-10-10 23:43:05.666924|2017-10-10 23:43:05.666924
NCT02321267|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-09-22|||December 2014||2014-12-01|September 2016|2016-09-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|||Cohort Study of the Clinical Course of Macular Diseases in Kagawa|Cohort Study of the Clinical Course of Macular Diseases in Kagawa (Kagawa Macula Cohort Study)|Recruiting||Phase 4|1000|Anticipated|Kagawa University||1|||f||||f||||||||||2017-10-10 23:43:05.895803|2017-10-10 23:43:05.895803
NCT02321254|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-06-30|||May 2014||2014-05-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MyoReArm||Myoelectric Robot-assisted Rehabilitation for the Upper Limb After Stroke|A Pilot Study of Active, Robot-assisted Therapy for Shoulder Rehabilitation After Stroke, Using Myoelectric Signals|Completed||Phase 1|10|Anticipated|IRCCS San Camillo, Venezia, Italy||1|||f||||||||||||||2017-10-10 23:43:05.98121|2017-10-10 23:43:05.98121
NCT02321241|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-08-21|||February 1, 2016|Actual|2016-02-01|August 2017|2017-08-01|August 18, 2017|Actual|2017-08-18|January 18, 2017|Actual|2017-01-18||Observational|TITAN||Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD|A retrospecTive and Prospective Non-Interventional Study to Assess the Clinical pracTice in Real Life for Patients With Wet AMD Refractory to raNibizumab and Switching to Aflibercept|Completed||N/A|236|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:43:06.074139|2017-10-10 23:43:06.074139
NCT02321228|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-08-22|||January 2015||2015-01-01|August 2016|2016-08-01|January 2035|Anticipated|2035-01-01|January 2025|Anticipated|2025-01-01||Interventional|TUBA||Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers|Early Salpingectomy (Tubectomy) With Delayed Oophorectomy to Improve Quality of Life as Alternative for Risk Reducing Salpingo-oophorectomy in BRCA1/2 Gene Mutation Carriers|Recruiting||N/A|510|Anticipated|University Medical Center Nijmegen||2|||f||||t||||||||||2017-10-10 23:43:06.16247|2017-10-10 23:43:06.16247
NCT02321215|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-05-20|||January 2015||2015-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness and Feasibility of Delivering an Education Program to Patients With an Acute Exacerbation of COPD|Effectiveness and Feasibility of Delivering an Introductory Education Program to Patients Admitted to Hospital With an Acute Exacerbation of COPD - a Pilot Randomized Controlled Trial|Completed||N/A|31|Actual|West Park Healthcare Centre||2|||f||||f||||||||||2017-10-10 23:43:06.2904|2017-10-10 23:43:06.2904
NCT02321202|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2014-12-19|||March 2010||2010-03-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer|Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer|Completed||Phase 4|320|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:43:06.376066|2017-10-10 23:43:06.376066
NCT02321189|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2015-04-02|||October 2014||2014-10-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness|The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness|Unknown status|Recruiting|N/A|34|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:43:06.47676|2017-10-10 23:43:06.47676
NCT02321176|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2014-12-16|||March 2014||2014-03-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood|Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood|Unknown status|Recruiting|N/A|20|Anticipated|Huazhong University of Science and Technology||1|||f||||t||||||||||2017-10-10 23:43:06.710897|2017-10-10 23:43:06.710897
NCT02321163|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-02-24|||February 2016||2016-02-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Electrical Stimulation for Attenuating Muscle Atrophy|A New Paradigm of Neuromuscular Electrical Stimulation in Attenuating Muscle Atrophy: a Randomised Controlled Trial|Recruiting||N/A|105|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-10 23:43:06.81394|2017-10-10 23:43:06.81394
NCT02321150|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-26|||December 2013||2013-12-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Novel Technique for the Removal of Pterygiums|A Novel Technique for the Removal of Pterygiums|Unknown status|Active, not recruiting|N/A|50|Anticipated|The University of The West Indies||2|||f||||t||||||||||2017-10-10 23:43:06.926456|2017-10-10 23:43:06.926456
NCT02321137|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|December 2027|Anticipated|2027-12-01|December 2018|Anticipated|2018-12-01||Interventional|LAA-CLOSURE||Left Atrial Appendage CLOSURE for the Prevention of Thromboembolisms in Patients Undergoing Aortic Bioprosthesis Surgery|A Randomized Prospective Multicenter Trial for Stroke Prevention by Surgical Occlusion of the Left Atrial Appendage in Patients Undergoing Aortic Bioprosthetic Surgery|Recruiting||N/A|1040|Anticipated|University of Turku||2|||f||||t||||||||||2017-10-10 23:43:07.029469|2017-10-10 23:43:07.029469
NCT02321124|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-19|||August 2012||2012-08-01|December 2014|2014-12-01||||August 2015|Anticipated|2015-08-01||Interventional|||Connective Tissue Manipulation Improves Symptoms and Quality of Life in Patients With Chronic Constipation||Unknown status|Recruiting|N/A|50|Anticipated|Hacettepe University||2|||f||||||||||||||2017-10-10 23:43:07.1683|2017-10-10 23:43:07.1683
NCT02321111|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-06|||January 2015||2015-01-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|Eritoran1||The Role of TLR4 on Lipid-induced Insulin Resistance|The Role of TLR4 on Lipid-Induced Insulin Resistance|Suspended||Phase 2|20|Anticipated|The University of Texas Health Science Center at San Antonio||3||Study drug expired, pending receipt of drug availability from supplier.|f||||f||||||||||2017-10-10 23:43:07.307676|2017-10-10 23:43:07.307676
NCT02321098|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-02-10|||February 2014||2014-02-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|COOL||Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic Varnish|Determination of Antifungal Activity of Loceryl Nail Lacquer 5% When Used Concomitantly With a Cosmetic Nail Varnish Compared to a Loceryl Nail Lacquer 5% Alone in Treatment of Toenail Distal Subungual Onychomycosis|Completed||Phase 4|50|Actual|Galderma||3|||f||||f||||||||||2017-10-10 23:43:07.403103|2017-10-10 23:43:07.403103
NCT02321085|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-12-19|||November 2014||2014-11-01|November 2014|2014-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||The Comparison With Clinical Impacts on Functional Capacity and Symptom Improvement According to the Rhythm Control in Patients With Heart Failure and Recent Onset Atrial Fibrillation||Recruiting||N/A|150|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-10 23:43:07.512999|2017-10-10 23:43:07.512999
NCT02321072|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-15|||February 2015||2015-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|O2-ICU||Optimal Oxygenation in the Intensive Care Unit|The Effects of Hyperoxia on Organ Dysfunction and Outcome in Critically Ill Patients With SIRS|Recruiting||Phase 4|385|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-10-10 23:43:07.618832|2017-10-10 23:43:07.618832
NCT02321059|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-06-25|||November 2014||2014-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|VAGSI||Validation of the Goodstrength System for Assessment of Abdominal Wall Strength in Patients With Incisional Hernia|Validation of the Goodstrength System for Assessment of Abdominal Wall Strength in Patients With Incisional Hernia|Completed||N/A|20|Actual|Bispebjerg Hospital|||2||f||||t||||||||||2017-10-10 23:43:07.750581|2017-10-10 23:43:07.750581
NCT02321046|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-09-15|||September 2, 2015|Actual|2015-09-02|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|ORTUS||An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).|An epidemiOlogy Study to deteRmine the Prevalence of EGFR muTations in RUSsian Patients With Advanced NSCLC (ORTUS)|Recruiting||N/A|80|Anticipated|AstraZeneca|||1||f||||f||||||Samples With DNA|"     Cytology and plasma samples   "|||2017-10-10 23:43:07.838528|2017-10-10 23:43:07.838528
NCT02321033|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-11-17|||August 2014||2014-08-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Influence of Daylong Glycemia on Detraining Induced Metabolic Changes|Einfluss Der Postprandialen Glykämie Auf Inaktivitäts-induzierte Veränderungen im Stoffwechsel|Completed||N/A|16|Actual|University of Hohenheim||2|||f||||f||||||||||2017-10-10 23:43:07.977928|2017-10-10 23:43:07.977928
NCT02321020|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2014-12-18|||January 2002||2002-01-01|December 2014|2014-12-01||||December 2014|Actual|2014-12-01||Observational|||Follow up of Radiofrequency Maze in Mitral Patients|Sinus Rhythm and Atrial Contractility Recovery After Radiofrequency Maze in Mitral Patients|Completed||N/A|168|Actual|Centro Cardiologico Monzino|||1||f||||||||||||||2017-10-10 23:43:08.072991|2017-10-10 23:43:08.072991
NCT02321007|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-08-29|||September 2014||2014-09-01|August 2017|2017-08-01|September 2064|Anticipated|2064-09-01|September 2064|Anticipated|2064-09-01||Observational|||Study of Placental Function in Healthy and Pathological Pregnancies|Study of Placental Function in Healthy and Pathological Pregnancies|Recruiting||N/A|1250|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 23:43:08.148627|2017-10-10 23:43:08.148627
NCT02320994|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-06-12|||November 2014||2014-11-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|MAS-I||Managing Aftercare for Stroke (MAS): MAS-I - a Cross Sectional Study of Post-rehabilitation Stroke Burden and Patients' Needs|Managing Aftercare for Stroke (MAS): MAS-I - a Cross Sectional Study of Post-rehabilitation Stroke Burden and Patients' Needs|Completed||N/A|64|Actual|Charite University, Berlin, Germany|||1||f||||f||||||Samples Without DNA|"     blood samples   "|||2017-10-10 23:43:08.225371|2017-10-10 23:43:08.225371
NCT02320981|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-04-27|||August 2014||2014-08-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Mucosal Impedance in Pediatric Population|Assessment of Esophageal Epithelium Integrity With Mucosal Impedance in Pediatric Patients|Completed||N/A|127|Actual|Vanderbilt University Medical Center|||1||f||||t|f|f|||f|||No||2017-10-10 23:43:08.315081|2017-10-10 23:43:08.315081
NCT02320968|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-04-27|||December 2014||2014-12-01|April 2017|2017-04-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||Sleep Position May Reduce Acid Reflux Symptoms at Night|Sleep Position Reduces Acid Reflux and Decreases Extraesophageal Reflux Symptoms: A Non-randomized Prospective Study of the Amenity Health MedclineTM Sleep Assist Device|Terminated||N/A|10|Actual|Vanderbilt University Medical Center||1||low recruitment|f||||f|f|f||||||No||2017-10-10 23:43:08.410981|2017-10-10 23:43:08.410981
NCT02320955|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-05-02|||January 2015||2015-01-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|SPARS||Swiss Prospective Autologous Bone Flap Resorption Study|Swiss Prospective Autologous Bone Flap Resorption Study|Recruiting||N/A|125|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 23:43:08.49986|2017-10-10 23:43:08.49986
NCT02320942|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-08-24|||October 2014||2014-10-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ExP-BMT||Exercise Post Bone Marrow Transplant|Implementation of a Physician-prescribed Exercise Program as Standard of Care in Allogeneic Stem Cell Transplant Patients in British Columbia: a Pilot Study.|Unknown status|Recruiting|N/A|20|Anticipated|University of British Columbia||1|||f||||t||||||||||2017-10-10 23:43:08.603781|2017-10-10 23:43:08.603781
NCT02320929|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-06-25|||March 2015||2015-03-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Treatment of Purulent Flexor Tenosynovitis|The Treatment of Purulent Flexor Tenosynovitis - Is Postoperative Catheter Irrigation Necessary? A Prospective Randomized Trial.|Recruiting||N/A|48|Anticipated|University of Tampere||2|||f||||f||||||||||2017-10-10 23:43:08.694416|2017-10-10 23:43:08.694416
NCT02320916|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-08-16|||April 2013||2013-04-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Randomized Controlled Trial on the Effect of Needle Gauge on the Pain and Anxiety Experienced During Arterial Puncture|A Randomized Controlled Trial on the Effect of Needle Gauge on the Pain and Anxiety Experienced During Arterial Puncture|Completed||N/A|200|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-10 23:43:08.793723|2017-10-10 23:43:08.793723
NCT02320890|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-16|||December 2014||2014-12-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|||Study of tDCS for Mild Cognitive Impairment|A Study for the Short- and Long-term Improvement of Cognitive Function (Evaluated by PET-CT and SNSB) After Transcranial Direct Current Stimulation in Mild Cognitive Impairment|Unknown status|Recruiting|N/A|24|Anticipated|Incheon St.Mary's Hospital||2|||f||||f||||||||||2017-10-10 23:43:08.930951|2017-10-10 23:43:08.930951
NCT02320526|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-04-26|||November 2014||2014-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Interval-training in Type 2 Diabetics|Interval-training in Type 2 Diabetics - Mechanisms Behind Increased Glucose Disposal and Effects on Systemic Inflammation|Completed||N/A|14|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-10 23:43:16.054126|2017-10-10 23:43:16.054126
NCT02320877|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-03-28|||December 2014||2014-12-01|March 2017|2017-03-01||||May 2018|Anticipated|2018-05-01||Interventional|||Evaluation of the Cardiovascular Effects of the MAS in the Treatment of Obstructive Sleep Apnea|Evaluation of the Overall Effectiveness Including Cardiovascular Effects of the Custom-made, Titratable Duoblock Flex SomnoDent® MAS in the Treatment of Obstructive Sleep Apnea|Recruiting||N/A|50|Anticipated|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-10 23:43:09.028309|2017-10-10 23:43:09.028309
NCT02320864|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-07-03|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||The Strong Brain Study|A Pilot Study to Evaluate the Role of Brain Integrity on Post-hospital Sarcopenia|Completed||N/A|18|Actual|University of Florida|||2||f||||t|f|f||||||||2017-10-10 23:43:09.132517|2017-10-10 23:43:09.132517
NCT02320851|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-18|||January 2015||2015-01-01|December 2014|2014-12-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Tailored Care for Somatoform Vertigo/Dizziness|Tailored Care for Somatoform Vertigo/Dizziness - From Diagnostics to Therapy|Unknown status|Not yet recruiting|N/A|216|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-10-10 23:43:09.217386|2017-10-10 23:43:09.217386
NCT02320838|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-07-03|2016-12-21||November 2014||2014-11-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Unmodulated 5 Kilohertz Currents Versus TENS: Effect on Pain Thresholds, Tactile Threshold, and Nerve Conduction|Unmodulated 5 Kilohertz Alternating Currents Versus TENS: Effect on Mechanical and Thermal Pain Thresholds, Tactile Threshold, and Peripheral Nerve Conduction in Humans.|Completed||N/A|38|Actual|University of Castilla-La Mancha||3|||f||||f||||||||||2017-10-10 23:43:09.309969|2017-10-10 23:43:09.309969
NCT02320825|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-08-23|||December 2014||2014-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases|Phase III Multicenter Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases|Active, not recruiting||Phase 3|16|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:43:10.060548|2017-10-10 23:43:10.060548
NCT02320812|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-08-15|||June 2015||2015-06-01|March 2017|2017-03-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|||Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa|A Prospective, Multicenter, Open-Label, Single-Arm Study of the Safety and Tolerability of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP)|Completed||Phase 1/Phase 2|28|Actual|jCyte, Inc||1|||f||||t||||||||||2017-10-10 23:43:10.159364|2017-10-10 23:43:10.159364
NCT02320799|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-09-29|||September 2015||2015-09-01|September 2015|2015-09-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya|Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV-infected Women Exposed to Gender Based Violence in Kenya|Recruiting||N/A|250|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:43:10.233746|2017-10-10 23:43:10.233746
NCT02320786|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-11-01|||October 2016||2016-10-01|November 2016|2016-11-01||||February 2017|Anticipated|2017-02-01||Interventional|CoPILOT||Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 1)|Collaborative Power Mobility Innovative Learning OpporTunity (CoPILOT) - A Pilot Study of a New Training Approach (Phase 1)|Recruiting||Phase 1|10|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:43:10.326578|2017-10-10 23:43:10.326578
NCT02320773|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-09-08|||November 25, 2014|Actual|2014-11-25|September 2017|2017-09-01|July 27, 2016|Actual|2016-07-27|July 27, 2016|Actual|2016-07-27||Observational|BELIEVE||A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice|Non-Interventional Study Assessing Quality of Life, Treatment Satisfaction, Resource Utilisation, and Persistence With Treatment in Overactive Bladder (OAB) Patients Prescribed Betmiga® - A Multicenter Non-interventional Post Authorisation Study (PAS)|Completed||N/A|863|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 23:43:10.433982|2017-10-10 23:43:10.433982
NCT02320760|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-16|||January 2005||2005-01-01|December 2014|2014-12-01|May 2009|Actual|2009-05-01|January 2007|Actual|2007-01-01||Interventional|||Physical Activity on Prescription in Overweight Older Adults|Physical Activity in Prevention and Treatment of Overweight, Central Obesity and the Metabolic Syndrome - a Randomised Controlled Study in Overweight 65 Year Old Women and Men|Completed||N/A|102|Actual|Karolinska Institutet||2|||f||||||||||||||2017-10-10 23:43:12.318048|2017-10-10 23:43:12.318048
NCT02320747|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-04-06|||September 2014||2014-09-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Immediate Effect of Tai Chi Exercise in Healthy Volunteers|Immediate Effect of Tai Chi Exercise in Healthy Volunteers:Randomized Controlled Study|Completed||N/A|64|Actual|Adwin Life Care||2|||f||||t||||||||||2017-10-10 23:43:12.384283|2017-10-10 23:43:12.384283
NCT02320734|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-09-16|||February 2015||2015-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|DEPTH||Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy|A Randomized Controlled Double-blinded Trial Comparing the Effect of on Demand vs Deep Neuromuscular Relaxation on Rating of Surgical and Anesthesia Conditions in Patients Undergoing Thoraco-laparoscopic Esophagectomy|Completed||Phase 4|66|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-10 23:43:12.455076|2017-10-10 23:43:12.455076
NCT02320721|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-06-12|2017-05-18||January 2015||2015-01-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|SENIOR|Baseline population included all randomized participants.|Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications|A Randomized, Open-label, 2-arm Parallel-group, Multicenter, 26-week Study Assessing the Safety and Efficacy of H0E901-U300 Versus Lantus in Older Patients With Type 2 Diabetes Inadequately Controlled on Antidiabetic Regimens Either Including no Insulin, or With Basal Insulin as Their Only Insulin|Completed||Phase 3|1014|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 23:43:12.605654|2017-10-10 23:43:12.605654
NCT02304874|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-27|||July 2011||2011-07-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|June 2013|Actual|2013-06-01||Interventional|FERNORM||Evaluation of Body Iron Stores in Overweight Healthy Volunteers|Evaluation of Body Iron Stores in Overweight Healthy Volunteers|Completed||N/A|14|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-10 23:46:34.371025|2017-10-10 23:46:34.371025
NCT02320708|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-01-17||2016-04-29|December 2014||2014-12-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study of Acetaminophen (ACE) in Post-operative Dental Pain|A Randomized, Double-Blind, Placebo- and Active- Controlled, Single-Dose, Efficacy, Safety, and Pharmacokinetics Proof of Concept Study of a Test Acetaminophen 500 mg Tablet in Postoperative Dental Pain|Completed||Phase 2|240|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||f||||||||Undecided||2017-10-10 23:43:14.263698|2017-10-10 23:43:14.263698
NCT02320695|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-12-04|2015-09-08||March 2015||2015-03-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Trial to Test if Antibiotic Ointments & Cream Will Sting After Application on a Minor Wound After Tape Stripping Injury|Evaluation of Perception of Sting Sensation Following Application of Antibiotic Ointment and Cream Formulations After Tape Stripping Injury|Completed||N/A|60|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||6|||f||||f||||||||||2017-10-10 23:43:14.398217|2017-10-10 23:43:14.398217
NCT02320682|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-18|||December 2014||2014-12-01|December 2014|2014-12-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|Fp-III||Bone Metabolism Adjacent to Hip Prosthetic Surfaces. A Clinical F-PET/CT Study|Bone Metabolism Adjacent to Hip Prosthetic Surfaces. A Randomized Clinical F-PET/CT Study.|Recruiting||N/A|32|Anticipated|Uppsala University||4|||f||||t||||||||||2017-10-10 23:43:14.917381|2017-10-10 23:43:14.917381
NCT02320669|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|TRICC-2||Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass|Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass|Recruiting||Phase 3|220|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-10 23:43:15.029651|2017-10-10 23:43:15.029651
NCT02320656|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-07|||May 2014|Actual|2014-05-01|June 2017|2017-06-01|May 2023|Anticipated|2023-05-01|May 2018|Anticipated|2018-05-01||Interventional|HEMATO-BIO||Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015|Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015|Recruiting||N/A|300|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-10 23:43:15.139357|2017-10-10 23:43:15.139357
NCT02320643|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-04-27|||December 2014|Actual|2014-12-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|November 2016|Actual|2016-11-01||Interventional|||A Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh in Patients With Pelvic Organ Prolapsed|A Prospective Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh(Seratom PA®) in Patients With Pelvic Organ Prolapsed|Completed||N/A|50|Actual|Samyang Biopharmaceuticals Corporation||1|||f||||f||||||||||2017-10-10 23:43:15.224419|2017-10-10 23:43:15.224419
NCT02320630|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-10-26|||October 2014||2014-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Combination Therapy Prevents the Relapse of RA|Rheumatology and Immunology Department，Peking University First Hospital，China|Unknown status|Recruiting|N/A|240|Anticipated|Peking University First Hospital||3|||f||||t||||||||||2017-10-10 23:43:15.312408|2017-10-10 23:43:15.312408
NCT02320617|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-19|||December 2014||2014-12-01|December 2014|2014-12-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer|Application of Diffusion Weighted Magnetic Resonance Imaging Versus CT in Evaluation of the Effect of Treating Lung Cancer|Unknown status|Recruiting|N/A|80|Anticipated|Fourth Military Medical University||1|||f||||t||||||||||2017-10-10 23:43:15.425074|2017-10-10 23:43:15.425074
NCT02320604|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-08-02|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)|Pharmacokinetics of Liposomal Amphotericin B (AmBisome®) Given Intravenously to Patients Undergoing Bariatric Surgery|Not yet recruiting||Phase 4|16|Anticipated|Radboud University||2|||f||||f|f|f||||||||2017-10-10 23:43:15.524695|2017-10-10 23:43:15.524695
NCT02320591|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-03-16|||July 2012||2012-07-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|CPC||Evaluation of the Comprehensive Primary Care Initiative|Evaluation of the Comprehensive Primary Care Initiative|Active, not recruiting||N/A|365076|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-10 23:43:15.617216|2017-10-10 23:43:15.617216
NCT02320578|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-06-05|||October 2014||2014-10-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial|Prospective Randomized Trial on2D Versus 3D Laparoscopic Radical Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Early Stage Cervical Cancer (FIGO Stages IA2-IB1-IIA<2cm) and Advanced Stage Cervical Cancer (FIGO Stages IB2-IIA>2 Cm-IIB) Submitted to NACT With Complete Clinical Response.|Completed||N/A|26|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-10 23:43:15.701472|2017-10-10 23:43:15.701472
NCT02320565|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-06-05|||October 2014||2014-10-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial|Prospective Randomized Trial on 2D Versus 3D Laparoscopic Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Endometrial Cancer FIGO Stage IB-II|Completed||N/A|36|Actual|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-10 23:43:15.780837|2017-10-10 23:43:15.780837
NCT02320552|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-15|||February 2014||2014-02-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Prevalence of Protein-energy Wasting and Obesity Among Danish Dialysis Patients|Prevalence of Protein-energy Wasting and Obesity Among Danish Dialysis Patients|Completed||N/A|105|Actual|Zealand University Hospital|||2||f||||t||||||||||2017-10-10 23:43:15.879764|2017-10-10 23:43:15.879764
NCT02320539|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-05-25|||November 2014||2014-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|6 Months|Observational [Patient Registry]|||MicroRNA Diagnostics in Subarachnoid Hemorrhage 2|MicroRNA Diagnostics in Subarachnoid Hemorrhage 2|Completed||N/A|70|Actual|Rigshospitalet, Denmark|||4||f||||t||||||Samples With DNA|"     MicroRNA profiles from blood and cerebrospinal fluid are investigated.   "|||2017-10-10 23:43:15.964126|2017-10-10 23:43:15.964126
NCT02320513|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-09-29|||October 2014||2014-10-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|IAM||A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients|A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients|Completed||N/A|33|Actual|Renal Research Institute|||2||f||||f||||||||||2017-10-10 23:43:16.153999|2017-10-10 23:43:16.153999
NCT02320500|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-01-28|||September 2013||2013-09-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis|Prospective Randomized Controlled Trial Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis|Recruiting||Phase 4|50|Anticipated|Queen's University||2|||f||||t||||||||||2017-10-10 23:43:16.244913|2017-10-10 23:43:16.244913
NCT02320474|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-10-10|||November 2014||2014-11-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Interventional|ATTRACT||Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)|Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)|Recruiting||Phase 4|26|Anticipated|Poitiers University Hospital||1|||f||||f||||||||||2017-10-10 23:43:16.55048|2017-10-10 23:43:16.55048
NCT02320461|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-18|||August 2008||2008-08-01|December 2014|2014-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|ELSA-Brasil||Estudo Longitudinal de Saúde do Adulto (Brazilian Longitudinal Study of Adult Health )|Estudo Longitudinal de Saúde do Adulto|Active, not recruiting||N/A|15105|Actual|Federal University of Rio Grande do Sul|||1||f||||f||||||Samples With DNA|"     Frozen serum and urine samples   "|||2017-10-10 23:43:16.627452|2017-10-10 23:43:16.627452
NCT02320448|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-09-09|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Treating Peritoneal Carcinomatosis With PIPAC|Implementation and Evaluation of PIPAC for the Treatment of Patients With Peritoneal Carcinomatosis - a Feasibility Study.|Completed||Phase 2|35|Actual|Odense University Hospital||1|||f||||t||||||||||2017-10-10 23:43:16.699676|2017-10-10 23:43:16.699676
NCT02320422|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-12-08|||January 2015||2015-01-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ALTER||Adult Liver Transplant Enhanced Care|An Intervention to Improve Adherence to Medications in Adults With Liver Transplants|Completed||N/A|8|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-10 23:43:17.027794|2017-10-10 23:43:17.027794
NCT02320409|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-07-13|||December 2014||2014-12-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||A Food Effect Phase I Study of the Sufatinib in Healthy Subjects (HMPL-012)||Completed||Phase 1|24|Actual|Hutchison Medipharma Limited||2|||f||||f||||||||||2017-10-10 23:43:17.106311|2017-10-10 23:43:17.106311
NCT02320396|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-03-13|2016-04-12||January 2015||2015-01-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All Randomized Participants|Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)|A Phase III, Multi-Center, Randomized, Placebo-Controlled, Double-Blind Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|449|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:43:17.241817|2017-10-10 23:43:17.241817
NCT02320383|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2017-09-06|||September 2014||2014-09-01|October 2016|2016-10-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|||CLLR3: Bendamustine + GA101 (BG) in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients|A Prospective, Multicenter, Phase-II Trial Evaluating Efficacy and Safety of Bendamustine + GA101 (BG) in Patients With Relapsed CLL Followed by Maintenance Therapy With GA101 for Responding Patients|Recruiting||Phase 2|60|Anticipated|Munich Municipal Hospital||1|||f||||f||||||||||2017-10-10 23:43:18.158265|2017-10-10 23:43:18.158265
NCT02320370|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-18|||January 2015||2015-01-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|OptesStressP||Transcranial Electrical Stimulation in the Treatment of Acute Anxiety Induced by Stressful Life Events: A Pilot Study|Optimizing Electrical Stimulation for Clinical Applications (the OptES Study): Severe Psychological Stress - a Pilot Study (OptES-Stress-pilot)|Unknown status|Not yet recruiting|N/A|14|Anticipated|University of Eastern Finland||2|||f||||f||||||||||2017-10-10 23:43:18.305791|2017-10-10 23:43:18.305791
NCT02320357|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-12-22|||August 2015||2015-08-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CLOPUS||Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous|Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous|Recruiting||Phase 1/Phase 2|30|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 23:43:18.402479|2017-10-10 23:43:18.402479
NCT02320344|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-16|||July 2013||2013-07-01|December 2014|2014-12-01||||February 2016|Anticipated|2016-02-01||Interventional|||Partnerships to Improve Lifestyle Interventions (PILI) 'Ohana Dissemination Project Partners in Care||Unknown status|Recruiting|N/A|150|Anticipated|University of Hawaii||1|||f||||||||||||||2017-10-10 23:43:18.551594|2017-10-10 23:43:18.551594
NCT02320331|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-16|||July 2013||2013-07-01|December 2014|2014-12-01||||February 2016|Anticipated|2016-02-01||Interventional|||Partnerships to Improve Lifestyle Interventions (PILI) 'Ohana Dissemination Project||Unknown status|Recruiting|N/A|150|Anticipated|University of Hawaii||1|||f||||||||||||||2017-10-10 23:43:18.668808|2017-10-10 23:43:18.668808
NCT02320318|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-05-18|||October 2015||2015-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|IRIS-05||12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)|A 12-week Double-blind, Randomised, Placebo-controlled, Parallel Group Phase III Study, Followed by a 4-week Randomised Withdrawal Period to Evaluate the Efficacy and Safety of Oral Ibodutant 10 mg Once Daily in Female Patients With Irritable Bowel Syndrome With Diarrhoea (IBS-D).|Withdrawn||Phase 3|0|Actual|Menarini Group||2|||f||||f||||||||||2017-10-10 23:43:18.760651|2017-10-10 23:43:18.760651
NCT02320305|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-09-12|||January 2015||2015-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery|Peptide Vaccine With Glucopyranosyl Lipid A - Stable Oil-in-Water Emulsion (GLA-SE) for Patients With Resected Melanoma: A Pilot Study|Active, not recruiting||N/A|23|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:43:18.902189|2017-10-10 23:43:18.902189
NCT02320292|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-12-20|||February 2015||2015-02-01|December 2016|2016-12-01||||January 2026|Anticipated|2026-01-01||Interventional|||Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma|The Asymptomatic Follicular Lymphoma (AFL) Trial: A Phase III Study of Single-agent Rituximab Immunotherapy Versus Zevalin Radioimmunotherapy for Patients With New, Untreated Follicular Lymphoma Who Are Candidates for Observation|Recruiting||Phase 3|128|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:43:19.02129|2017-10-10 23:43:19.02129
NCT02320279|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2014-12-18|||October 2013||2013-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|1 Day|Observational [Patient Registry]|||The Fetal EKG Study|The Fetal EKG Study|Unknown status|Recruiting|N/A|100|Anticipated|Mindchild Medical Inc.|||1||f||||f||||||||||2017-10-10 23:43:19.172844|2017-10-10 23:43:19.172844
NCT02320266|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-09-27|||December 2014||2014-12-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||Sensory Gating Measured With Microelectrode Recording (MER) During Deep Brain Stimulation (DBS) Surgery|Sensory Gating Measured With Microelectrode Recording During Deep Brain Stimulation Surgery|Recruiting||N/A|150|Anticipated|University of Colorado, Denver|||5||f||||f||||||||||2017-10-10 23:43:19.263025|2017-10-10 23:43:19.263025
NCT02320253|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-07-11|||November 2014||2014-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||REAL HEALTH-Diabetes: Reach Ahead for Lifestyle and Health-Diabetes|REAL HEALTH-Diabetes: Reach Ahead for Lifestyle and Health-Diabetes|Active, not recruiting||N/A|270|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-10 23:43:19.354513|2017-10-10 23:43:19.354513
NCT02320240|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-03-11|||June 2013||2013-06-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|SNRI-AKI||Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury|Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury|Completed||N/A|3255526|Actual|Canadian Network for Observational Drug Effect Studies, CNODES|||2||f||||f||||||||||2017-10-10 23:43:19.471342|2017-10-10 23:43:19.471342
NCT02320227|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-01-30|2016-07-28||December 2014||2014-12-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Single-Center, Clinical Study to Evaluate the Safety of a Non-Fragranced Personal Lubricant in Healthy Female Subjects||Completed||N/A|30|Actual|Church & Dwight Company, Inc.||1|||f||||||||||||||2017-10-10 23:43:19.581492|2017-10-10 23:43:19.581492
NCT02320214|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-10-19|2016-07-28||December 2014||2014-12-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects||Completed||N/A|30|Actual|Church & Dwight Company, Inc.||1|||f||||||||||||||2017-10-10 23:43:19.720246|2017-10-10 23:43:19.720246
NCT02320201|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-08-30|||September 2014||2014-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Foot Neuromodulation for Overactive Bladder in Children|Foot Neuromodulation for Overactive Bladder in Children|Enrolling by invitation||Phase 1|20|Anticipated|Children's Hospital of Pittsburgh||1|||f||||f||||||||||2017-10-10 23:43:19.869878|2017-10-10 23:43:19.869878
NCT02320188|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-07-25|||December 2014||2014-12-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|EECRA||Eccentric Exercise and Cachexia in Rheumatoid Arthritis|Effect of Eccentric Exercise Training in Rheumatoid Cachexia|Recruiting||N/A|48|Anticipated|University Hospital, Clermont-Ferrand||3|||f||||||||||||||2017-10-10 23:43:19.960215|2017-10-10 23:43:19.960215
NCT02320175|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-08|||December 15, 2014|Actual|2014-12-15|September 2017|2017-09-01|January 3, 2017|Actual|2017-01-03|January 3, 2017|Actual|2017-01-03||Interventional|||Bringing I-PASS to the Bedside: A Communication Bundle to Improve Patient Safety and Experience|Bringing I-PASS to the Bedside: A Communication Bundle to Improve Patient Safety and Experience|Completed||N/A|3372|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-10 23:43:20.150885|2017-10-10 23:43:20.150885
NCT02320162|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-08-28|||February 2010||2010-02-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||School-based Oral Health Education Program Using Experiential Learning|"School-based Oral Health Education Program Using Experiential Learning or Traditional Lecturing in Children and Adolescents: a Clinical Trial"|Completed||N/A|351|Actual|Marquette University||2|||f||||||||||||||2017-10-10 23:43:20.232638|2017-10-10 23:43:20.232638
NCT02320149|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-02-15|||December 2014||2014-12-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne|A Randomized, Multicenter, Double-blind, Placebocontrolled Study to Evaluate the Efficacy and Safety of 1.5 mg/kg Per Day of Sarecycline Compared to Placebo in the Treatment of Acne Vulgaris|Completed||Phase 3|968|Actual|Warner Chilcott||2|||f||||f||||||||||2017-10-10 23:43:20.456373|2017-10-10 23:43:20.456373
NCT02320136|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-05-27|||June 2014||2014-06-01|May 2016|2016-05-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Observational|HFO||Recording High Frequency Oscillations in Patients With Tumors and Epilepsy|Recording High Frequency Oscillations in Patients With Tumors and Epilepsy.|Enrolling by invitation||N/A|120|Anticipated|University of Zurich|||3||f||||f||||||||||2017-10-10 23:43:20.647772|2017-10-10 23:43:20.647772
NCT02320123|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-23|||September 2013||2013-09-01|December 2014|2014-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||End-of-Life Care for African Americans|End-of-Life Care for African Americans: Intervention Design and Implementation|Active, not recruiting||N/A|116|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-10 23:43:20.713481|2017-10-10 23:43:20.713481
NCT02320110|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-15|||September 2014||2014-09-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Correlation of Irisin and Adipokine Levels With Body Mass Index and Risk Factors for Metabolic Syndrome in Hispanic Children|Correlation of Circulating Irisin and Adipokine Levels Across a Broad Spectrum of Body Mass Index Ranging From Undernourished to Obese and With Insulin Resistance and Risk Factors for the Metabolic Syndrome in Hispanic Children|Completed||N/A|40|Actual|Instituto Tecnologico y de Estudios Superiores de Monterey|||1||f||||||||||||||2017-10-10 23:43:20.809227|2017-10-10 23:43:20.809227
NCT02320097|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-10-01|||January 2015||2015-01-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of the Impact of Head Position on Foot Pressure in Stance|A Study of the Impact of Head Position on Foot Pressure in Stance.|Completed||N/A|87|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 23:43:20.906509|2017-10-10 23:43:20.906509
NCT02320084|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-05-29|||September 2013||2013-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|OPAL||Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care|A Non-interventional Post Authorization Study (PASS) to Evaluate Long-term Safety of Orfadin Treatment in Hypertyrosinemia Type 1 (HT-1) Patients in Standard Care|Enrolling by invitation||N/A|400|Anticipated|Swedish Orphan Biovitrum|||1||f||||f||||||||Undecided|Discussions ongoing with regards to data sharing/registry.|2017-10-10 23:43:20.987043|2017-10-10 23:43:20.987043
NCT02320071|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2015-09-02|||January 2015||2015-01-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Observational|QualiFunc||Abdominal Wall Function and Quality of Life and Before and After Incisional Hernia Repair|Abdominal Wall Function and Quality of Life and Before and After Incisional Hernia Repair|Unknown status|Recruiting|N/A|25|Anticipated|Bispebjerg Hospital|||1||f||||t||||||||||2017-10-10 23:43:21.257374|2017-10-10 23:43:21.257374
NCT02320058|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-09-14|||January 5, 2015|Actual|2015-01-05|September 2017|2017-09-01|November 4, 2022|Anticipated|2022-11-04|November 3, 2022|Anticipated|2022-11-03||Interventional|CheckMate204||An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself|A Multi-Center Phase 2 Open-Label Study to Evaluate Safety and Efficacy in Subjects With Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy|Recruiting||Phase 2|110|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 23:43:21.361526|2017-10-10 23:43:21.361526
NCT02320045|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-06-02|||November 2014||2014-11-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects|A Phase 1 Study to Evaluate the Pharmacokinetics of ITCA 650 in Subjects With Mild and Moderate Renal Impairment Compared to the Pharmacokinetics of Subjects With Normal Renal Function|Completed||Phase 1|38|Actual|Intarcia Therapeutics||4|||f||||f||||||||||2017-10-10 23:43:21.600864|2017-10-10 23:43:21.600864
NCT02320032|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2016-05-02|||December 2014||2014-12-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia|A Phase 1, Randomized, Open-Label Study Evaluating the Pharmacokinetics of Various Dosing Regimens of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia|Completed||Phase 1|140|Actual|Alkermes, Inc.||4|||f||||f||||||||||2017-10-10 23:43:21.703733|2017-10-10 23:43:21.703733
NCT02320019|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-11-08|||March 2015||2015-03-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Clinical Trial of YH14618 in Patients With Degenerative Disc Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2b Trial to Evaluate the Efficacy and Safety of YH14618 in Patients With Lumbar Degenerative Disc Disease|Completed||Phase 2|326|Actual|Yuhan Corporation||5|||f||||f||||||||||2017-10-10 23:43:21.845698|2017-10-10 23:43:21.845698
NCT02320006|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2014-12-18|||December 2014||2014-12-01|December 2014|2014-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effect of Acupuncture on Incomplete Fallopian Tube Obstructive Infertility: Study Protocol for Trial||Unknown status|Recruiting|Early Phase 1|120|Anticipated|First Affiliated Hospital of Heilongjiang Chinese Medicine University||2|||f||||f||||||||||2017-10-10 23:43:21.95944|2017-10-10 23:43:21.95944
NCT02319993|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2016-01-18|||May 2013||2013-05-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Traditional Chinese Medicine Suan Tsao Jen Tang and Tian-Wang-Bu-Xin Dan in Patients With Primary Insomnia.|Traditional Chinese Medicine Suan Tsao Jen Tang and Tian-Wang-Bu-Xin Dan in Patients With Primary Insomnia. A Multi-center Clinical Trial|Completed||Phase 2|128|Actual|Chung Shan Medical University||3|||f||||t||||||||||2017-10-10 23:43:22.050855|2017-10-10 23:43:22.050855
NCT02319980|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2016-02-13|||May 2015||2015-05-01|February 2016|2016-02-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|AHMSS||The Adult Hemorrhagic Moyamoya Surgery Study|The Adult Hemorrhagic Moyamoya Surgery Study|Active, not recruiting||Phase 3|360|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-10 23:43:22.130112|2017-10-10 23:43:22.130112
NCT02319967|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-12-03|||March 2015||2015-03-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|CHICAGO||Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes|Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes (CHICAGO Trial)|Recruiting||N/A|640|Anticipated|University of Illinois at Chicago||3|||f||||t||||||||||2017-10-10 23:43:22.216278|2017-10-10 23:43:22.216278
NCT02319954|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2015-01-18|||January 2015||2015-01-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Intra-operative Nasal Compression After Lateral Osteotomy to Minimize Post-operative Peri-orbital Ecchymosis and Edema|Intra-operative Nasal Compression After Lateral Osteotomy to Minimize Post-operative Peri-orbital Ecchymosis and Edema|Unknown status|Not yet recruiting|N/A|16|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:43:22.341318|2017-10-10 23:43:22.341318
NCT02319941|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-06-15|||May 20, 2015|Actual|2015-05-20|June 2017|2017-06-01|March 10, 2017|Actual|2017-03-10|February 14, 2017|Actual|2017-02-14||Interventional|OPTIMA||Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes|Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes; Pharmacodynamics and Pharmacokinetics Study|Completed||Phase 2|65|Actual|Asan Medical Center||3|||f||||t||||||||||2017-10-10 23:43:22.438974|2017-10-10 23:43:22.438974
NCT02319928|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-11-23|||June 2015||2015-06-01|November 2015|2015-11-01|December 2028|Anticipated|2028-12-01|December 2028|Anticipated|2028-12-01||Interventional|EPoS||European Polyp Surveillance Trial|Randomized Controlled Trial of Comparison Between Surveillance Intervals After Excision of Colonic Adenomas|Recruiting||N/A|28000|Anticipated|Asociación Española de Gastroenterología||2|||f||||t||||||||||2017-10-10 23:43:22.54784|2017-10-10 23:43:22.54784
NCT02319915|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-11-15|||February 2014||2014-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation.|Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation.|Recruiting||Early Phase 1|20|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 23:43:22.647958|2017-10-10 23:43:22.647958
NCT02319902|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2014-12-14|||December 2014||2014-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Standard Carbon Dioxide Gas Versus Heated Humidified Gas in Gynaecological Laparoscopy|The Effects of Using Heated Humidified Carbon Dioxide Gas on Post Operative Pain Scores, Nausea and Analgesic Requirements in Patients Undergoing Gynaecological Laparoscopy: a Randomised Controlled Trial.|Unknown status|Recruiting|N/A|88|Anticipated|Royal Surrey County Hospital||2|||f||||t||||||||||2017-10-10 23:43:22.800415|2017-10-10 23:43:22.800415
NCT02319889|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-01-31|||February 2, 2016|Actual|2016-02-02|January 2017|2017-01-01|January 19, 2017|Actual|2017-01-19|July 6, 2016|Actual|2016-07-06||Interventional|||Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma|Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma|Terminated||Early Phase 1|3|Actual|Case Comprehensive Cancer Center||1||Funding unavailable|f||||t|t|f|||f|||||2017-10-10 23:43:22.885372|2017-10-10 23:43:22.885372
NCT02319876|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-07-27|||February 2014||2014-02-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Expression of TIM-3 on Lymphocytes in Sepsis|Expression and the Clinical Significance of TIM-3 on Lymphocytes During Sepsis|Unknown status|Recruiting|N/A|80|Anticipated|Changhai Hospital|||3||f||||f||||||Samples Without DNA|"     Peripheral blood sample was collected to examine TIM-3 on CD4+ and CD8+ lymphocytes, and     CD14+ monocytes. Monocyte HLA-DR will also be determined.   "|||2017-10-10 23:43:22.986147|2017-10-10 23:43:22.986147
NCT02319863|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-15|||February 1994||1994-02-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Rapid Ligating the Corresponding Inflow and Outflow Vessels Without Hilus Dissection During Hepatectomy|A Simple Technique of Rapid Ligating the Corresponding Inflow and Outflow Vessels Without Hilus Dissection During Hepatectomy|Unknown status|Recruiting|N/A|600|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:43:23.090069|2017-10-10 23:43:23.090069
NCT02319850|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-05-14|||February 2014||2014-02-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|MUSCLED||Muscle Ultrasound for Sarcopenia Leading to Early Detection|Revisiting the Sarcopenia Diagnosis: New Approaches to Rapid Screening and Preventative Healthcare|Unknown status|Active, not recruiting|N/A|30|Anticipated|George Washington University|||2||f||||f||||||||||2017-10-10 23:43:23.228531|2017-10-10 23:43:23.228531
NCT02319837|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2017-09-28|||December 17, 2014|Actual|2014-12-17|September 2017|2017-09-01|December 13, 2024|Anticipated|2024-12-13|September 30, 2021|Anticipated|2021-09-30||Interventional|||Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)|A Phase 3, Randomized, Efficacy And Safety Study Of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, And Placebo Plus Leuprolide In Men With High-risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy|Recruiting||Phase 3|1860|Anticipated|Pfizer||3|||f||||t||||||||||2017-10-10 23:43:23.378824|2017-10-10 23:43:23.378824
NCT02319824|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-04-18|2017-04-18||January 2015||2015-01-01|April 2017|2017-04-01||||June 2015|Actual|2015-06-01||Interventional|||NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy|A Pilot Trial of NY-ESO-1-Specific T Cells in Patients With Metastatic NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation|Completed||Phase 1|2|Actual|Fred Hutchinson Cancer Research Center|"This trial was ended early as persistence was not at the level we had hoped and we had the opportunity to pursue a more promising strategy.
The data is limited by having only 2 patients."|1|||f||||t||||||||||2017-10-10 23:43:24.279336|2017-10-10 23:43:24.279336
NCT02319811|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-04-11|||November 1995||1995-11-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Observational|||Cryopreserved Human Meniscus Transplantation|Meniscus Transplantation in Symptomatic Patients Under Fifty Years of Age: Survivorship Analysis|Completed||N/A|76|Actual|Cincinnati Sportsmedicine Research and Education Foundation|||1||f||||f||||||||Yes|Published results in Journal of Bone and Joint Surgery, 2015 and American Journal of Sports Medicine 2016|2017-10-10 23:43:24.673406|2017-10-10 23:43:24.673406
NCT02319798|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-12-15|||July 2010||2010-07-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease|Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation.|Completed||N/A|86|Actual|Central Manchester University Hospitals NHS Foundation Trust||2|||f||||||||||||||2017-10-10 23:43:24.76226|2017-10-10 23:43:24.76226
NCT02319785|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-12-15|||August 2014||2014-08-01|December 2014|2014-12-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of Robot-Assisted Combined Therapy in Upper Limb Rehabilitation in Stroke Patients|Effects of Robot-Assisted Combined Therapy in Upper Limb Rehabilitation in Stroke Patients|Recruiting||N/A|120|Anticipated|Cathay General Hospital||6|||f||||f||||||||||2017-10-10 23:43:24.864899|2017-10-10 23:43:24.864899
NCT02319772|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-07-06|||December 2014||2014-12-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430|A Phase 1 Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BCX4430 Administered Via Intramuscular Injection (IM) in Healthy Subjects|Completed||Phase 1|94|Actual|BioCryst Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:43:25.007923|2017-10-10 23:43:25.007923
NCT02318628|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2014-12-16|||December 2014||2014-12-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|March 2015|Anticipated|2015-03-01||Observational|AAA||Advanced Approach to Arterial Stiffness|Advanced Approach to Arterial Stiffness (AAA Study - Triple A Study)|Unknown status|Recruiting|N/A|1500|Anticipated|International Society for Vascular Health|||1||f||||f||||||||||2017-10-10 23:43:40.54245|2017-10-10 23:43:40.54245
NCT02319759|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-04-06||2017-03-07|March 27, 2015|Actual|2015-03-27|April 2017|2017-04-01|January 17, 2017|Actual|2017-01-17|May 31, 2016|Actual|2016-05-31||Interventional|||Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)|A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab in the Treatment of Subjects With Active Psoriatic Arthritis|Completed||Phase 2|149|Actual|Janssen Research & Development, LLC||2|||f||||t|t|||||||||2017-10-10 23:43:25.115784|2017-10-10 23:43:25.115784
NCT02319746|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-07-19|||September 2013||2013-09-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSE|COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSE|Recruiting||N/A|100|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-10 23:43:25.304731|2017-10-10 23:43:25.304731
NCT02319733|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2017-02-11|||December 2014||2014-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold|Plaque Stabilization and Restoration of Vascular Function by Bioresorbable Vascular Scaffold in Acute Coronary Syndrome Prone Patients|Terminated||N/A|1|Actual|Canisius-Wilhelmina Hospital||1||insufficient eligable subjects and new data on BVS|f||||f||||||||||2017-10-10 23:43:25.392745|2017-10-10 23:43:25.392745
NCT02319720|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-17|||July 2008||2008-07-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|March 2013|Actual|2013-03-01||Interventional|||Study to Evaluate Bone Marrow Cells in the Treatment of Chronic Wounds|A Randomized Study to Evaluate the Safety of Bone Marrow Aspirate Plus Cultured Bone Marrow Cells vs. Bone Marrow Aspirate Alone vs. Cultured Bone Marrow Cells Alone in the Treatment of Chronic Wounds.|Terminated||Phase 1|11|Actual|University of Miami||4||Lack of funds|f||||t||||||||||2017-10-10 23:43:25.461|2017-10-10 23:43:25.461
NCT02319707|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-14|2015-09-07|||September 2015||2015-09-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Management of the Third Stage of Labor|Management of the Third Stage of Labor|Unknown status|Not yet recruiting|Phase 3|500|Anticipated|Rabin Medical Center||3|||f||||t||||||||||2017-10-10 23:43:25.548438|2017-10-10 23:43:25.548438
NCT02319694|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-04-24|||July 2013||2013-07-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Intraoperative Analysis of Reward and Impulsivity in the Basal Ganglia|Intraoperative Analysis of Reward and Impulsivity in the Basal Ganglia|Enrolling by invitation||N/A|30|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 23:43:25.631772|2017-10-10 23:43:25.631772
NCT02319681|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-06-25|||January 2015||2015-01-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Reminiscence, Anxiety and Early Alzheimer's Disease|Reminiscence, Anxiety and Early Alzheimer's Disease|Withdrawn||N/A|0|Actual|Emory University||2||PI relocated to UNCP; Study is not being transferred|f||||f||||||||||2017-10-10 23:43:25.701791|2017-10-10 23:43:25.701791
NCT02319668|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-06-21|2017-03-02||February 1, 2015|Actual|2015-02-01|June 2017|2017-06-01|February 29, 2016|Actual|2016-02-29|June 1, 2015|Actual|2015-06-01||Interventional||Safety population: defined as all the participants who were randomised and received at least one dose of study treatment during the study.|Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity|A Clinical Study to Evaluate the Efficacy of Pre-procedural and Pre-surgical Rinsing With an Antimicrobial Agent in Reducing Bacteria in Dental Aerosols and in the Oral Cavity|Completed||Phase 4|38|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:43:25.792863|2017-10-10 23:43:25.792863
NCT02319655|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-02-12|||June 2014||2014-06-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Morphologic Changes After Membrane Peeling With Air Tamponade and Balanced Salt Solution|Changes of the Subfoveal Hyporeflective Zone After Membrane Peeling With Air Tamponade and Balanced Salt Solution - a Pilot Study|Recruiting||N/A|57|Anticipated|Vienna Institute for Research in Ocular Surgery||2|||f||||f||||||||Undecided||2017-10-10 23:43:26.322877|2017-10-10 23:43:26.322877
NCT02319642|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-01-16|||November 2014||2014-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|RAPID-C OLE||An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044|A Phase 3, Multicenter, Open-label Extension Study To Assess The Safety And Efficacy Of Certolizumab Pegol As Additional Medication To Methotrexate In Chinese Subjects With Active Rheumatoid Arthritis Who Participated In RA0044.|Completed||Phase 3|347|Actual|UCB Pharma||1|||f||||t||||||||||2017-10-10 23:43:26.417208|2017-10-10 23:43:26.417208
NCT02319629|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-03-26|||December 2014||2014-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preventive Therapy With Ursodiol to Reduce the Incidence of Gallstones Formation in Patients After Bariatric Surgery|Preventive Therapy With Ursodiol to Reduce the Incidence of Gallstones Formation in Patients After Bariatric Surgery|Recruiting||N/A|266|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||Yes||2017-10-10 23:43:26.564691|2017-10-10 23:43:26.564691
NCT02319616|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-10-03|||November 2016|Actual|2016-11-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|TEN||Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis|A Randomized Placebo Controlled Split-body Double-blind Phase II Clinical Trial to Investigate the Safety and Efficacy of Clobetasol 0.05% Ointment for the Treatment of Toxic Epidermal Necrolysis (TEN)|Recruiting||Phase 1/Phase 2|15|Anticipated|University of California, Davis||2|||f||||t|t|f|||f|||||2017-10-10 23:43:26.659403|2017-10-10 23:43:26.659403
NCT02319603|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-07-22|||January 2015||2015-01-01|July 2015|2015-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||To Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats|A Randomized, Double-blind, Two Dose Group, Parallel-control Multi-center, Post-marketing Clinical Trial,to Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats.|Unknown status|Recruiting|Phase 4|288|Anticipated|Beijing Bozhiyin T&S Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:43:26.742773|2017-10-10 23:43:26.742773
NCT02319590|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2017-06-27|||December 2014||2014-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|T-CARD||Anti-Angiotensin-Receptor 1 (ATR1)-, Anti-Endothelin-Receptor A (ETRA)-Antibodies and T Cells in Cardiomyopathy|The Role of Functional Active Anti-Angiotensin-Receptor 1 (ATR1)- and Anti-Endothelin-Receptor A (ETRA)-Antibodies and Autoreactive T Cells in Cardiomyopathy|Recruiting||N/A|80|Anticipated|Zurich Regional Health Center|||4||f||||t||||||Samples With DNA|"     T cells   "|||2017-10-10 23:43:26.817688|2017-10-10 23:43:26.817688
NCT02319577|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-17|||March 2012||2012-03-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial|Randomized, Phase II Study With Gefitinib Plus Vinorelbine Versus Gefitinib Alone in Patients Affected by Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of EGFR|Unknown status|Recruiting|Phase 2|80|Anticipated|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||2|||f||||f||||||||||2017-10-10 23:43:26.892519|2017-10-10 23:43:26.892519
NCT02319564|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2016-11-11|||April 2016||2016-04-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|CONjuGATE||Combined Glucocorticoid Adrenergic Therapy For Wheezy Preschool Children|Randomized Trial Assessing the Effectiveness of Beclomethasone and Combination Beclomethasone and Salbutamol as Compared With Placebo in Preschool Aged Children With Wheeze|Withdrawn||Phase 4|0|Actual|University of Calgary||3||Study population too narrow - unable to recruit any patients.|f||||t||||||||No||2017-10-10 23:43:28.811373|2017-10-10 23:43:28.811373
NCT02319538|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-17|||February 2012||2012-02-01|December 2014|2014-12-01|February 2016|Anticipated|2016-02-01|March 2015|Anticipated|2015-03-01||Interventional|||Hashimoto - a Surgical Disease. Absolute Total Thyroidectomy Makes Antibodies Disappear and Ameliorates Symptoms|Surgical Treatment of Hashimotos Disease. Effect on Antibodies and Clinical Symptoms.|Unknown status|Recruiting|N/A|150|Anticipated|Sykehuset Telemark||2|||f||||t||||||||||2017-10-10 23:43:28.919925|2017-10-10 23:43:28.919925
NCT02319525|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-07-17|2016-12-29||January 2014|Actual|2014-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus|Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus|Completed||N/A|301|Actual|University of Alabama at Birmingham|"Study findings may not be generalizable to men with lupus, since we studied only women
It remains to be seen whether our decision-aid can be used by lupus patients with non-renal manifestations"|2|||f||||f|f|f||||||||2017-10-10 23:43:29.044452|2017-10-10 23:43:29.044452
NCT02319512|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-13|||January 2012||2012-01-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Effects of Chewing Gum Against Postoperative Ileus|Effects of Chewing Gum Against Postoperative Ileus After Pancreaticoduodenectomy - a Randomized Controlled Trial|Terminated||Phase 3|65|Actual|Sahlgrenska University Hospital, Sweden||2||Due to a radical change in postoperative care as well as surgical technique.|f||||t||||||||||2017-10-10 23:43:29.679221|2017-10-10 23:43:29.679221
NCT02319499|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-13|||August 1998||1998-08-01|December 2014|2014-12-01||||February 1999|Actual|1999-02-01||Interventional|||Zinc, Iron, Vitamin A and Psychosocial Care for Child Growth and Development|Zinc, Iron and Vitamin A Supplementation for Infant Growth and Development, and the Contributing Role of Psychosocial Care|Completed||Phase 3|800|Actual|Indonesia University||4|||f||||f||||||||||2017-10-10 23:43:29.763023|2017-10-10 23:43:29.763023
NCT02319486|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2015-03-11|2014-12-18||January 2009||2009-01-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma|CEV With/Without Periocular Carboplatin Chemotherapy for Nonmetastatic Extraocular Retinoblastoma Carboplatin--A Single Center, Retrospective Study to Evaluate the Efficacy of Carboplatin in Subjects With Retinoblastoma|Completed||Phase 4|26|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 23:43:29.998405|2017-10-10 23:43:29.998405
NCT02319473|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-05-03|||January 2007||2007-01-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|JAC Registry||Jakarta Acute Coronary Syndrome Registry|Jakarta Acute Coronary Syndrome Registry|Recruiting||N/A|28812|Anticipated|National Cardiovascular Center Harapan Kita Hospital Indonesia|||1||f||||f||||||||||2017-10-10 23:43:30.261261|2017-10-10 23:43:30.261261
NCT02319447|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Increasing Kidney Transplant Among Blacks on the Transplant Waiting List|Increasing Kidney Transplant Among Blacks on the Transplant Waiting List|Enrolling by invitation||N/A|500|Anticipated|St. Barnabas Medical Center||2|||f||||t||||||||No|There are no plans to share individual participant data.|2017-10-10 23:43:30.474571|2017-10-10 23:43:30.474571
NCT02319434|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-08-29|||November 2015|Actual|2015-11-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Ostom-i Alert Sensor Quality of Life Validation|Validating the Use of a Novel Wearable Device in Improving Quality of Life of Ostomy Patients|Recruiting||N/A|20|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-10 23:43:30.574883|2017-10-10 23:43:30.574883
NCT02319421|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-04-18|||March 2015||2015-03-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|March 2016|Actual|2016-03-01||Interventional|||Reducing the Risk of Alarm Fatigue Through the Use of Focused Management in Safety Huddles|Reducine the Risk of Alarm Fatigue Through the Use of Focused Management in Safety Huddles|Completed||N/A|812|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-10 23:43:30.662735|2017-10-10 23:43:30.662735
NCT02319408|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-09-08|||April 2016||2016-04-01|September 2016|2016-09-01|August 2020|Anticipated|2020-08-01|March 2018|Anticipated|2018-03-01||Interventional|RadImmune||Immune Boost In Non-Small Cell Lung Cancer|A Randomized Phase II Study of Radiation Induced Immune Boost in Operable Non-small Cell Lung Cancer|Recruiting||Phase 2|36|Anticipated|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-10 23:43:30.74606|2017-10-10 23:43:30.74606
NCT02319200|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2017-01-10|||June 2015||2015-06-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|METFOVIR||Primary Prevention Hepatocellular Carcinoma by Metformin|PRIMARY PREVENTION OF HEPATOCELLULAR CARCINOMA BY METFORMIN IN PATIENTS WITH VIRAL C CIRRHOSIS : PROSPECTIVE MULTICENTER STUDY, RANDOMIZED CONTROL TRIAL. Ancillary Study of the ANRS CO12 CirVir Cohort|Terminated||Phase 3|11|Actual|Assistance Publique - Hôpitaux de Paris||2||Decision of investigator|f||||t||||||||Undecided||2017-10-10 23:43:32.824563|2017-10-10 23:43:32.824563
NCT02319395|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-01-24|||November 2011||2011-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Observational|BADGE-PD||Behavioural Addiction and Genetics in Parkinson's Disease|Behavioural Addiction and Genetics in Parkinson's Disease|Completed||N/A|332|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     One blood sampling during the study. A small number (1 to 5) of markers type tag SNPs or     coding SNP will be selected for each of the selected genes, for a total of 50 markers     (representing 20 to 25 genes). Non-silent coding SNP, that may have a functional effect, will     be included as a priority. Genotyping is carried out by the method of genotyping VeraCode     Goldengate.   "|||2017-10-10 23:43:30.842949|2017-10-10 23:43:30.842949
NCT02319382|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-07-13|||June 2012||2012-06-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|INFLAPARK||Measure of Microglial Activation in the Brain of Parkinson Disease Patients With PET|High Resolution PET Imaging of Microglial Activation in Parkinson's Disease (PD) With a New Tracer [18F]DPA-714|Unknown status|Recruiting|N/A|46|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:43:30.957565|2017-10-10 23:43:30.957565
NCT02319369|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-09-19|||November 2014||2014-11-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|||Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-3032b in Hematological Malignancies|A Phase 1 Dose Escalation Study of DS-3032b, an Oral Murine Double Minute (mdm2) Oncogene Inhibitor, in Subjects With Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) in Blast Phase, or High-Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1|100|Anticipated|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-10 23:43:31.060579|2017-10-10 23:43:31.060579
NCT02319356|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2014-12-17|||March 2015||2015-03-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Does Dietary Nitrate Supplementation Improve Aerobic Performance|Does Dietary Nitrate Supplementation Improve Aerobic Performance in Colorectal Cancer? A Pilot Study|Unknown status|Not yet recruiting|Early Phase 1|70|Anticipated|Royal Surrey County Hospital NHS Foundation Trust||2|||f||||||||||||||2017-10-10 23:43:31.153596|2017-10-10 23:43:31.153596
NCT02319343|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-04-07|||January 2015||2015-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Methylprednisolone on Quadriceps Muscle Function in Patients Undergoing Total Knee-arthroplasty|Effect of Preoperative Intravenous High Dose Methylprednisolone on Quadriceps Muscle Function in Patients Scheduled for Total Knee-arthroplasty|Completed||Phase 3|70|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-10 23:43:31.267501|2017-10-10 23:43:31.267501
NCT02319330|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-10-18|||September 2013||2013-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|MAHILA||Preventing & Treating HIV Comorbidities in India: Multi-tiered Strategy for Women|Preventing & Treating HIV Comorbidities in India: Multi-tiered Strategy for Women|Active, not recruiting||N/A|120|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-10 23:43:31.371543|2017-10-10 23:43:31.371543
NCT02319317|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-05|2017-09-05||April 2015||2015-04-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|August 2016|Actual|2016-08-01||Interventional|||Web-based Intervention to Prevent Risky Driving|Promoting Teen Health: A Web-based Intervention to Prevent Risky Driving|Completed||N/A|61|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:43:31.505454|2017-10-10 23:43:31.505454
NCT02319304|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-07-28|||March 2015||2015-03-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|GCC 1314||Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma|Phase II Trial of Low Dose Whole Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed T3N0M0, T2N1M0, or T3N1M0 Rectal Adenocarcinoma|Recruiting||Phase 2|30|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-10 23:43:31.8562|2017-10-10 23:43:31.8562
NCT02319291|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-01-27|||February 2015||2015-02-01|January 2017|2017-01-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01|5 Years|Observational [Patient Registry]|||PS150 Total Knee Arthroplasty Outcomes Registry|Outcomes of Total Knee Arthroplasty (TKA) Using the Sigma PS150 Primary Total Knee System|Active, not recruiting||N/A|175|Actual|DePuy Orthopaedics|||1||f||||f||||||||||2017-10-10 23:43:31.979038|2017-10-10 23:43:31.979038
NCT02319278|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-05-02|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|DECIFER||DEtection of Cellular Inflammation With FERumoxytol in the HEART|DEtection of Cellular Inflammation With FERumoxytol in the HEART|Completed||Phase 2/Phase 3|58|Actual|University of Edinburgh||4|||f||||f||||||||||2017-10-10 23:43:32.069467|2017-10-10 23:43:32.069467
NCT02319265|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-04-20|||April 2017|Anticipated|2017-04-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|DAMSEL2||Dose Assessment of Melatonin in Sepsis Trial|Dose Assessment of Melatonin in Sepsis Trial|Withdrawn||Phase 1/Phase 2|0|Actual|University of Aberdeen||2||Study registered elsewhere and is not covered by FDA|f||||t|f|f||||||No||2017-10-10 23:43:32.335525|2017-10-10 23:43:32.335525
NCT02319252|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-05-02|||January 2015||2015-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases|Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases|Recruiting||N/A|40|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:43:32.43051|2017-10-10 23:43:32.43051
NCT02319239|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-12-18|||May 2014||2014-05-01|December 2014|2014-12-01|May 2018|Anticipated|2018-05-01|May 2015|Anticipated|2015-05-01||Interventional|ESKO||Prostate Cancer Stereotactic Radiotherapy|Development of Prostate Cancer Stereotactic Radiotherapy in Tampere Using Intra-fractional Movement Detector and Diffusion-weighted Magnetic Resonance Imaging.|Recruiting||N/A|80|Anticipated|Tampere University Hospital||3|||f||||f||||||||||2017-10-10 23:43:32.533167|2017-10-10 23:43:32.533167
NCT02319226|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2016-11-18|||May 2014||2014-05-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Observational|BioGvHD||Toward Immune Biomarkers for Tolerance and GvHD in Humans|Toward Immune Biomarkers for Tolerance and GvHD in Humans|Recruiting||N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||||||||||||2017-10-10 23:43:32.646663|2017-10-10 23:43:32.646663
NCT02319213|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-17|||March 2008||2008-03-01|December 2014|2014-12-01|November 2009|Actual|2009-11-01|January 2009|Actual|2009-01-01||Interventional|||This Study Performed to Develop a New Technique for Measuring the Intra Abdominal Pressure|The Increase of Intra-abdominal Pressure Can Affect Intra-ocular Pressure.|Completed||N/A|40|Actual|Selcuk University||4|||f||||f||||||||||2017-10-10 23:43:32.724595|2017-10-10 23:43:32.724595
NCT02319187|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-07-30|||December 2014||2014-12-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial|Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Squamous Cell Carcinoma (ESWN 01 Trial): a Phase 3, Prospective,Multicenter, Randomised Study|Unknown status|Recruiting|Phase 3|240|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:43:32.935206|2017-10-10 23:43:32.935206
NCT02319161|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2014-12-13|||June 2014||2014-06-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Comparison of Calcium Channel Blockers and Beta Blockers on Tourniquet-induced Hypertension During Intravenous Regional Anesthesia|Comparison of Calcium-channel Blockers and Beta Blockers in Tourniquet-induced Hypertension During Intravenous Regional Anesthesia|Completed||N/A|50|Actual|Ankara University|||2||f||||f||||||||||2017-10-10 23:43:33.176391|2017-10-10 23:43:33.176391
NCT02319148|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-07-28|2015-10-05||July 2014||2014-07-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||The baseline analysis population included all eligible participants who received a single dose of PF-00489791 20 mg tablet orally.|A Study to Estimate the Effect of CYP3A4 Inhibitors (Itraconazole, Diltiazem or Verapamil) on the Pharmacokinetics of Single Dose PF- 00489791 in Healthy Volunteers|A Phase 1, Randomized, Open-label, 3-sequence, 4-treatment, Incomplete Block Design To Estimate The Effect Of Steady State Cyp3a4 Inhibitors (Itraconazole, Diltiazem Or Verapamil) On The Pharmacokinetics Of Singe Dose Pf-00489791 In Healthy Volunteers|Completed||Phase 1|22|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 23:43:33.288898|2017-10-10 23:43:33.288898
NCT02319135|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-12-08|||October 2014||2014-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|FLUGAZA||Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia|A PHASE III, MULTICENTRE, RANDOMIZED, OPEN LABEL CLINICAL TRIAL OF AZACYTIDINE (VIDAZA®) VERSUS FLUDARABINE AND CYTARABINE (FLUGA SCHEME) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA.|Recruiting||Phase 3|350|Anticipated|PETHEMA Foundation||2|||f||||t||||||||||2017-10-10 23:43:34.478362|2017-10-10 23:43:34.478362
NCT02319122|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-07-17|||January 2015||2015-01-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||A Prospective Study of Two Home Based Muscle Strengthening Programs for Children With Cerebral Palsy|A Prospective Study of Two Home Based Muscle Strengthening Programs for Children With Cerebral Palsy|Recruiting||N/A|22|Anticipated|Medical University of Graz||2|||f||||t||||||||||2017-10-10 23:43:34.595877|2017-10-10 23:43:34.595877
NCT02319109|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-01-21|||December 2014||2014-12-01|December 2014|2014-12-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|REF01||PT/INR Reference Interval IN Healthy Volunteers|A Prospective, Single-Center Study, in Healthy Volunteers to Establish a PT/INR Reference Interval for the Microvisk INR Test System|Completed||N/A|154|Actual|Microvisk Technologies Ltd|||1||f||||f||||||||||2017-10-10 23:43:34.706384|2017-10-10 23:43:34.706384
NCT02319083|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2015-07-03|||January 2015||2015-01-01|July 2015|2015-07-01|December 2025|Anticipated|2025-12-01|December 2015|Anticipated|2015-12-01||Observational|E-CABG||Outcome After Coronary Artery Bypass Grafting|E-CABG: European Multicenter Study on the Outcome After Coronary Artery Bypass Grafting|Recruiting||N/A|4000|Anticipated|University of Oulu|||1||f||||t||||||||||2017-10-10 23:43:34.856981|2017-10-10 23:43:34.856981
NCT02319070|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-08|||January 13, 2015|Actual|2015-01-13|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|May 28, 2017|Actual|2017-05-28||Observational|HAMLET||2-cohort Study of Adult Patients With Severe Hemophilia A in Greece|Prospective, Observational, 2-cohort Study of Adult Patients With Severe Hemophilia A in Greece. Cost,Clinical Outcomes and Quality of Life Comparison Between on Demand and Secondary Prophylaxis Treatment Strategies|Active, not recruiting||N/A|72|Actual|Bayer|||2||f||||f||||||||||2017-10-10 23:43:34.968441|2017-10-10 23:43:34.968441
NCT02319057|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-05-05|||September 2014||2014-09-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Nebula PK 1||Pharmacokinetic Study of Single Doses of ORM-12741|Pharmacokinetic Study of Modified Release Formulations and an Immediate Release Formulation of ORM-12741 After Single Oral Doses|Completed||Phase 1|23|Actual|Orion Corporation, Orion Pharma||6|||f||||t||||||||||2017-10-10 23:43:35.057755|2017-10-10 23:43:35.057755
NCT02319044|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-04-28|||April 15, 2015|Actual|2015-04-15|April 2017|2017-04-01|March 30, 2018|Anticipated|2018-03-30|September 26, 2016|Actual|2016-09-26||Interventional|||Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck|A Phase II, Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination With Tremelimumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Active, not recruiting||Phase 2|267|Actual|AstraZeneca||3|||f||||t||f||||||||2017-10-10 23:43:35.280075|2017-10-10 23:43:35.280075
NCT02319031|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-12-05|2016-12-05||February 2015||2015-02-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional||Treated Population: All enrolled participants who received at least 1 dose of study drug|Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis|Open-Label, Randomized Study of Daclatasvir, Sofosbuvir, and Ribavirin for 12 vs. 16 Weeks in Treatment Naive and Treatment Experienced Patients With Genotype 3 Chronic Hepatitis C Infection Subjects With Compensated Advanced Fibrosis/Cirrhosis (F3/F4)|Completed||Phase 3|53|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:43:35.60578|2017-10-10 23:43:35.60578
NCT02319018|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-17|2017-05-23|||August 27, 2015|Actual|2015-08-27|May 2017|2017-05-01||||June 1, 2017|Anticipated|2017-06-01||Interventional|||Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors|A Phase 1 Study of Alisertib (MLN8237) in Combination With mFOLFOX in Gastrointestinal Tumors|Active, not recruiting||Phase 1|30|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-10 23:43:36.054505|2017-10-10 23:43:36.054505
NCT02319005|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-05-23|||December 2014||2014-12-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|October 2016|Actual|2016-10-01||Interventional|||ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)|A Phase 3 Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALN TTRSC in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)|Completed||Phase 3|206|Actual|Alnylam Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:43:36.241106|2017-10-10 23:43:36.241106
NCT02318992|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-04-18|||September 2013||2013-09-01|November 2016|2016-11-01||||April 2018|Anticipated|2018-04-01||Interventional|||Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea|Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea|Recruiting||Phase 1/Phase 2|106|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||t||||||||||2017-10-10 23:43:36.478358|2017-10-10 23:43:36.478358
NCT02318979|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-11-08|||October 2013||2013-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||What is the Optimal Stiffness and Height of a Running-specific Prosthesis?|What is the Optimal Stiffness and Height of a Running-specific Prosthesis?|Active, not recruiting||N/A|30|Actual|VA Eastern Colorado Health Care System||2|||f||||t||||||||||2017-10-10 23:43:36.626831|2017-10-10 23:43:36.626831
NCT02318966|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-04-13|||February 2016||2016-02-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|Glyde||Glycosade v UCCS in the Dietary Management of Hepatic GSD|A Comparison of Glycosade® and Uncooked Cornstarch (UCCS) for the Dietary Management of Hepatic Glycogen Storage Diseases (GSD)|Recruiting||N/A|70|Anticipated|Vitaflo International, Ltd||2|||f||||f||||||||Undecided||2017-10-10 23:43:36.744813|2017-10-10 23:43:36.744813
NCT02318953|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-10-06|||January 2015||2015-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Mobile App Home Monitoring on the Number of In-Person Visits Following Ambulatory Surgery|The Effect of Mobile App Home Monitoring on the Number of In-Person Visits Following Ambulatory Surgery: A Randomized Control Trial|Completed||N/A|70|Actual|Women's College Hospital||2|||f||||f||||||||||2017-10-10 23:43:36.878038|2017-10-10 23:43:36.878038
NCT02318940|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-02-12|2016-10-20||December 2014||2014-12-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Femoral Central Venous Access Comparison of 2 Methods|Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters in Pediatric Intensive Care Units : Anatomical Method vs Ultrasound in Real Time.|Completed||N/A|99|Actual|University of Chile||2|||f||||f||||||||No||2017-10-10 23:43:36.973249|2017-10-10 23:43:36.973249
NCT02318927|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-20|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|November 3, 2016|Actual|2016-11-03||Interventional|||A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's Disease|A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's Disease|Active, not recruiting||N/A|5|Actual|University of Florida||1|||f||||t|f|t|f|f||||||2017-10-10 23:43:37.31167|2017-10-10 23:43:37.31167
NCT02318914|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-04-25|||November 2014||2014-11-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum|A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients With Pyoderma Gangrenosum|Terminated||Phase 3|15|Actual|XOMA (US) LLC||1|||f||||f||||||||||2017-10-10 23:43:37.414571|2017-10-10 23:43:37.414571
NCT02318901|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-06-23|||October 2014||2014-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PembroMab||Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer|A Phase Ib/II Study of Pembrolizumab and Monoclonal Antibody Therapy in Patients With Advanced Cancer (PembroMab|Active, not recruiting||Phase 1/Phase 2|90|Anticipated|Western Regional Medical Center||3|||f||||f||||||||Undecided||2017-10-10 23:43:37.710171|2017-10-10 23:43:37.710171
NCT02318888|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-06-26|||December 2009|Actual|2009-12-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Does Icodextrin Reduce the Risk of Small Bowel Obstruction?|Does Icodextrin Reduce the Risk of Small Bowel Obstruction?|Active, not recruiting||N/A|1808|Actual|Uppsala University||2|||f||||t||||||||||2017-10-10 23:43:37.823775|2017-10-10 23:43:37.823775
NCT02318875|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-11|||June 2012||2012-06-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Easykrill||Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles Disorders|Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles Disorders|Completed||Phase 3|154|Actual|Vivatech||2|||f||||f||||||||||2017-10-10 23:43:37.927086|2017-10-10 23:43:37.927086
NCT02318862|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-04-27|||July 2013||2013-07-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Assessment of Esophageal Epithelium Integrity With Mucosal Impedance|Assessment of Esophageal Epithelium Integrity With Mucosal Impedance|Completed||N/A|15|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||No||2017-10-10 23:43:38.006309|2017-10-10 23:43:38.006309
NCT02318849|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-10-25|||November 2014||2014-11-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|iDecide||Online Intervention for ANHPI College Students|Social and Behavioral Interventions to Increase Solid Organ Donation|Recruiting||N/A|4500|Anticipated|University of Hawaii||2|||f||||f||||||||Undecided||2017-10-10 23:43:38.082001|2017-10-10 23:43:38.082001
NCT02318836|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-05-01|||July 2014||2014-07-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects|Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects|Completed||Phase 1|24|Actual|US WorldMeds LLC||4|||f||||f||||||||||2017-10-10 23:43:38.244864|2017-10-10 23:43:38.244864
NCT02318823|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2015-09-24|||December 2014||2014-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Beer (Alcohol) on Social Cognition|Effects of Beer (Alcohol) on Social Cognition|Completed||N/A|60|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-10 23:43:38.362048|2017-10-10 23:43:38.362048
NCT02318810|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-05-02|||March 2015||2015-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Influence of the Neuromuscular Blockade on Mask Ventilation|The Influence of the Neuromuscular Blockade on Mask Ventilation; a Placebo Controlled, Randomized Trial With Three Different Dosages of Rocuronium (0.3 mg/kg, 0.6 mg/kg and 0.9 mg/kg)|Completed||N/A|300|Actual|University of Rostock||4|||f||||t||||||||Undecided||2017-10-10 23:43:38.473061|2017-10-10 23:43:38.473061
NCT02318784|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-05-31|||July 15, 2015|Actual|2015-07-15|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers|Phase II Study of Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers|Active, not recruiting||Phase 2|62|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-10 23:43:38.76084|2017-10-10 23:43:38.76084
NCT02318771|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-10-18|||February 2015||2015-02-01|October 2016|2016-10-01||||January 2020|Anticipated|2020-01-01||Interventional|||Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer|An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer|Recruiting||Phase 1|40|Anticipated|Thomas Jefferson University||4|||f||||t||||||||||2017-10-10 23:43:38.865667|2017-10-10 23:43:38.865667
NCT02318758|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-03-20|||September 2014||2014-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|TDE-PH-125||Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers|Randomized, Single Dose, 4-Way Cross-over Study to Investigate the Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers|Completed||Phase 1|32|Actual|United Therapeutics||4|||f||||f||||||||||2017-10-10 23:43:39.031533|2017-10-10 23:43:39.031533
NCT02318745|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-11|||June 2007||2007-06-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|CIFFTA-P||Preventing Health Disparities in Hispanic Youth|Preventing Health Disparities in Hispanic Youth|Completed||N/A|200|Actual|University of Miami||2|||f||||f||||||||||2017-10-10 23:43:39.133241|2017-10-10 23:43:39.133241
NCT02318732|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-05-24|||February 2015||2015-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|APPS||Evaluation of California's Armed and Prohibited Persons System|Prospective Evaluation of California's Armed and Prohibited Persons System|Active, not recruiting||N/A|20000|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 23:43:39.235807|2017-10-10 23:43:39.235807
NCT02318719|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-06-14|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||DS-5565 Phase III Study for Post-herpetic Neuralgia|An Asian, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled 14-Week Study of DS-5565 in Patients With Post-herpetic Neuralgia Followed by a 52-Week Open-label Extension|Completed||N/A|765|Actual|Daiichi Sankyo, Inc.||4|||f||||f||||||||||2017-10-10 23:43:39.318268|2017-10-10 23:43:39.318268
NCT02318706|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-08-21|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain|An Asian, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled 14-Week Study of DS-5565 in Patients With Diabetic Peripheral Neuropathic Pain Followed by a 52-Week Open-label Extension|Completed||Phase 3|825|Actual|Daiichi Sankyo, Inc.||4|||f||||f|f|f||||||||2017-10-10 23:43:39.422185|2017-10-10 23:43:39.422185
NCT02318693|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-05-11|2016-11-21||February 4, 2015|Actual|2015-02-04|May 2017|2017-05-01|December 15, 2015|Actual|2015-12-15|December 15, 2015|Actual|2015-12-15||Interventional||Baseline data is provided for the Full Analysis Set (FAS) population consisting of all randomized participants who received at least one dose of study treatment, with at least one post-randomization/post-treatment observation for analysis, and with applicable baseline data.|Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)|A Randomized, Open-label, Comparative Clinical Trial to Study the Efficacy of Sitagliptin and Glibenclamide in a Short Term Treatment on the Daily Glucose Variability Using Continuous Glucose Monitoring (CGM) in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|53|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:43:39.518462|2017-10-10 23:43:39.518462
NCT02318680|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-01-09|||January 2013||2013-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Follow Home Visits After Discharge|Follow Home Visits by Hospital and Municipality After Discharge of Frail Elderly Patients From Nykøbing Falster Hospital - a Randomized Controlled Trial|Completed||N/A|545|Actual|Zealand University Hospital||2|||f||||f||||||||||2017-10-10 23:43:40.17089|2017-10-10 23:43:40.17089
NCT02318667|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-09-08|||February 27, 2015|Actual|2015-02-27|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|June 21, 2017|Actual|2017-06-21||Interventional|EVOLUTION||Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).|An Open Label, Single Group Assignment Design Study to Correlate Soluble ST2 With Clinical, Endoscopic and Histological Activity in Moderate to Severe Ulcerative Colitis Patients Under Golimumab.|Completed||Phase 4|38|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-10 23:43:40.260727|2017-10-10 23:43:40.260727
NCT02318654|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-02-07|||December 2014||2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ice Versus EMLA for Pain in Laser Hair Removal|Comparing the Efficacy of Ice Pack Versus Topical EMLA for Pain Control in Laser Axillary Hair Removal: A Randomized Control Trial|Active, not recruiting||N/A|30|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 23:43:40.348538|2017-10-10 23:43:40.348538
NCT02318641|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-09-22|||December 2014||2014-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Measurement of the Oxygen Saturation in the Retinal Vessels With Oxymap|Measurement of the Oxygen Saturation in the Retinal Vessels With Oxymap|Recruiting||N/A|300|Anticipated|Kagawa University|||1||f||||f||||||||||2017-10-10 23:43:40.4655|2017-10-10 23:43:40.4655
NCT02318615|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-11-19|||December 2015||2015-12-01|November 2015|2015-11-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema Prevention|The Efficacy and Safety of Immediate Axillary Plasty With Pedicled Partial Latissimus Dorsi Muscle Flap for Lymphedema Prevention in Breast Cancer Patients Who Undergoing Axillary Dissection: a Prospective, Corhort Study|Not yet recruiting||N/A|450|Anticipated|Peking University People's Hospital||2|||f||||f||||||||||2017-10-10 23:43:40.628477|2017-10-10 23:43:40.628477
NCT02318602|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-10-04|||January 2016|Actual|2016-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder|A Multicenter, Open-label, Flexible Dose Study to Assess the Long-term Safety of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Treatment for Pediatric and Adult Subjects With a Treatment-resistant Seizure Disorder Who Complete INS011-14-029 or Part A of INS011-15-054|Active, not recruiting||Phase 3|54|Anticipated|INSYS Therapeutics Inc||1|||f||||t|t|f||||||||2017-10-10 23:43:40.705762|2017-10-10 23:43:40.705762
NCT02318589|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-10-14|||August 2015||2015-08-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase I of Eribulin and Oral Irinotecan for Relapsed or Refractory Solid Tumors|A Phase I Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors|Recruiting||Phase 1|18|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-10-10 23:43:40.81422|2017-10-10 23:43:40.81422
NCT02318576|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-10-25|||March 2015||2015-03-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|C3PO||Computerized Cognition Testing and Cognitive Motor Interference in MS|Computerized Cognition Testing and Cognitive Motor Interference in MS|Completed||N/A|29|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 23:43:40.891513|2017-10-10 23:43:40.891513
NCT02318563|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-10-04|||November 30, 2017|Anticipated|2017-11-30|October 2017|2017-10-01|June 17, 2018|Anticipated|2018-06-17|June 17, 2018|Anticipated|2018-06-17||Interventional|||Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome|A Multicenter, Randomized, Double-blind, Placebo- Controlled, Interventional Study to Assess the Safety and Efficacy of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Dravet Syndrome|Not yet recruiting||Phase 3|86|Anticipated|INSYS Therapeutics Inc||2|||f||||t|t|f||||||||2017-10-10 23:43:40.97722|2017-10-10 23:43:40.97722
NCT02318550|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-10-03|||December 2014||2014-12-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|6 Months|Observational [Patient Registry]|||Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD|A Single Institution Registry Trial Evaluating the Safety of MRI for Patients With Non-MRI Conditional Pacemakers and ICD|Recruiting||N/A|500|Anticipated|Lancaster General Hospital|||1||f||||t||||||||||2017-10-10 23:43:41.052222|2017-10-10 23:43:41.052222
NCT02318537|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-10-03|||November 30, 2017|Anticipated|2017-11-30|October 2017|2017-10-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome|A Multicenter, Randomized, Double-blind, Placebo-controlled, Interventional Study to Assess the Safety and Efficacy of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Lennox-Gastaut Syndrome|Not yet recruiting||Phase 3|86|Anticipated|INSYS Therapeutics Inc||2|||f||||t|t|f||||||||2017-10-10 23:43:41.127197|2017-10-10 23:43:41.127197
NCT02318524|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-05-17|||August 2011||2011-08-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|FungiCOPD||Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients|Circulation of Pathogenic Fungi in the Domestic Environment: Clinical Impact of Mould and Pneumocystis Jirovecii Exposure on COPD Patients|Recruiting||N/A|90|Anticipated|University Hospital, Lille|||1||f||||t||||||Samples Without DNA|"     Sputum, serum, oropharyngeal washing, Dust catchers   "|No||2017-10-10 23:43:41.203035|2017-10-10 23:43:41.203035
NCT02318511|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-08-24|||June 2015||2015-06-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis|An Investigation of ReNu™ Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis|Active, not recruiting||N/A|200|Anticipated|NuTech Medical, Inc||3|||f||||f||||||||||2017-10-10 23:43:41.27392|2017-10-10 23:43:41.27392
NCT02318498|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-03-06|||November 2014||2014-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|SMINC-2||Stockholm Myocardial Infarction With Normal Coronaries (SMINC)-2 Study on Diagnosis Made by Cardiac MRI|Stockholm Myocardial Infarction With Normal Coronaries (SMINC)-2|Recruiting||N/A|150|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:43:41.371366|2017-10-10 23:43:41.371366
NCT02318485|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-08-30|||April 2015||2015-04-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|MLEC||Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter Trial|Translational Stem Cell Research in Ophthalmology - Regenerating the Anterior Cornea Through Standardized Transplantation of Limbal Epithelial Stem Cells: a Phase II Multicenter Trial|Recruiting||Phase 2|60|Anticipated|University Hospital, Antwerp||1|||f||||||||||||||2017-10-10 23:43:41.442682|2017-10-10 23:43:41.442682
NCT02318472|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-03-24|||November 2013||2013-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|EarlyM-Achil||Early Mobilization After Achilles Tendon Rupture|Effects of Direct Functional Mobilization After Achilles Tendon Rupture on Healing and Outcome|Recruiting||N/A|150|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-10 23:43:41.542256|2017-10-10 23:43:41.542256
NCT02318459|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-11-02|||May 2014||2014-05-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|HIITERGY||High Intensity Interval Training in Geriatrics|High Intensity Interval Training for thE Rehabilitation of Geriatric Patients - a Feasibility Pilot studY.|Completed||N/A|100|Actual|University Hospital, Geneva||2|||f||||f||||||||No||2017-10-10 23:43:41.749512|2017-10-10 23:43:41.749512
NCT02317523|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-05-01|||September 2014||2014-09-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Alzheimer's Caregiver Coping: Mental and Physical Health|Alzheimer's Caregiver Coping: Mental and Physical Health|Recruiting||N/A|200|Anticipated|University of California, San Diego||2|||f||||f||||||||Undecided||2017-10-10 23:43:52.153386|2017-10-10 23:43:52.153386
NCT02318446|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-16|||March 2015||2015-03-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics|Efficacy Study of Folic Acid Supplementation on Homocysteine Levels in Adolescent Epileptics Taking Antiepileptic Drugs: A Single Blind Randomized Controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 3|36|Anticipated|Maharashtra University of Health Sciences||2|||f||||f||||||||||2017-10-10 23:43:41.819438|2017-10-10 23:43:41.819438
NCT02318433|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-12-31|||December 2014||2014-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Intra-Articular Dexamethasone to Prevent Post-Traumatic Osteoarthritis: A Pilot Study|Intra-Articular Dexamethasone to Prevent Post-Traumatic Osteoarthritis: A Pilot Study|Enrolling by invitation||Early Phase 1|40|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:43:41.915744|2017-10-10 23:43:41.915744
NCT02318420|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-06-28|||October 1, 2014||2014-10-01|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|March 1, 2016|Actual|2016-03-01||Interventional|PartoMa||The PartoMa Project: For Improving Monitoring, Action and Triage During Labour|The PartoMa Project for Saving Lives at Birth - An Intervention Based Study to Strengthen the Quality of Monitoring, Action and Triage During Labour at an East African Referral Hospital|Active, not recruiting||N/A|3087|Actual|University of Copenhagen||2|||f||||f||||||||Undecided||2017-10-10 23:43:41.996669|2017-10-10 23:43:41.996669
NCT02318407|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-12|||December 2006||2006-12-01|December 2014|2014-12-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Subjects With Osteoarthritis Knee Pain|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Younger and Older Subjects With Osteoarthritis Knee Pain|Completed||Phase 1|24|Actual|Amgen||2|||f||||f||||||||||2017-10-10 23:43:42.07936|2017-10-10 23:43:42.07936
NCT02318394|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-09-07|||March 2, 2015|Actual|2015-03-02|September 2017|2017-09-01|March 2, 2020|Anticipated|2020-03-02|March 2, 2020|Anticipated|2020-03-02||Interventional|||A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors|A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Activity of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors|Active, not recruiting||Phase 1|56|Actual|MedImmune LLC||1|||f||||f||||||||||2017-10-10 23:43:42.164755|2017-10-10 23:43:42.164755
NCT02318381|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-03-05|||January 2014||2014-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|SupraCufTear||Suprascapular Neuropathy in the Setting of Rotator Cuff Tears: Results of Arthroscopic Treatment|Suprascapular Neuropathy in the Setting of Rotator Cuff Tears; Results of Arthroscopic Treatment|Recruiting||N/A|42|Anticipated|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-10 23:43:42.401312|2017-10-10 23:43:42.401312
NCT02318368|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-06-08|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FOCAL||A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label|A Phase 2, Multicenter, Randomized, Double-blind Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label|Terminated||Phase 2|10|Actual|AVEO Pharmaceuticals, Inc.||2||Sponsor's decision|f||||f||||||||No||2017-10-10 23:43:42.544162|2017-10-10 23:43:42.544162
NCT02318355|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-12|||November 2013||2013-11-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Proving Hemodilution in a Human Model for Class I Hemorrhage|Resuscitative Effect of Two Liters of Crystalloid on Hemodilution and Base Deficit in Healthy Volunteer Blood Donors With Class I Hemorrhage.|Completed||N/A|165|Actual|Carolinas Healthcare System||3|||f||||||||||||||2017-10-10 23:43:42.792901|2017-10-10 23:43:42.792901
NCT02318342|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-12-06|||December 2014||2014-12-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|RESOLVE||Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation|Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Dysfunction With Multimodality Imaging and Its TrEatment With Anticoagulation|Recruiting||N/A|1000|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-10 23:43:42.901754|2017-10-10 23:43:42.901754
NCT02318329|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-01-24|||November 2014||2014-11-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors|A Phase 1 Open-Label, Dose-Finding Study Evaluating Safety and Pharmacokinetics of FPA144 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|210|Anticipated|Five Prime Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 23:43:43.024142|2017-10-10 23:43:43.024142
NCT02318316|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-16|||December 2014||2014-12-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Observational|||"Exhaled Breath Condensate in Allogeneic Stem Cell Recipients and the Value in Follow-up"|"Exhaled Breath Condensate in Allogeneic Stem Cell Recipients and Value in Follow-up"|Unknown status|Not yet recruiting|N/A|80|Anticipated|Gazi University|||1||f||||f||||||||||2017-10-10 23:43:43.261513|2017-10-10 23:43:43.261513
NCT02318303|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-05-26|2017-04-18||December 2014||2014-12-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||To Study GSP 301 in Patients With Seasonal Allergic Rhinitis|A Double-blind, Randomized, Parallel-group, Comparative Study to Evaluate the Efficacy, Safety and Tolerability of Two Different Strengths and Regimens of a Fixed Dose Combination GSP 301 Nasal Spray Compared With Placebo Nasal Spray and Individual Monotherapy Formulations (Comparators), in Subjects (12 Years of Age and Older) With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 2|1111|Actual|Glenmark Pharmaceuticals Ltd. India||7|||f||||f||||||||||2017-10-10 23:43:43.358735|2017-10-10 23:43:43.358735
NCT02318290|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-02-17|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|WAAICUP||Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort Study|Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort Study|Completed||N/A|54|Actual|Hopital du Sacre-Coeur de Montreal|||1||f||||f||||||||||2017-10-10 23:43:43.889337|2017-10-10 23:43:43.889337
NCT02317328|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2017-09-12|||November 12, 2014||2014-11-12|August 29, 2017|2017-08-29|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Observational|||Adaptive Optics Retinal Imaging|Adaptive Optics Retinal Imaging|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:43:54.011824|2017-10-10 23:43:54.011824
NCT02318277|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-08-23|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)|A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)|Recruiting||Phase 1/Phase 2|192|Anticipated|Incyte Corporation||1|||f||||f||||||||||2017-10-10 23:43:43.984142|2017-10-10 23:43:43.984142
NCT02318264|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-04-26|||February 2015||2015-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Influence of Elastic Tape on Activation of the Quadriceps Muscle During Selected Resisted and Weight Bearing Exercises|Influence of Elastic Tape on Activation of the Quadriceps Muscle During Selected Resisted and Weight Bearing Exercises|Completed||N/A|15|Actual|State University of New York - Upstate Medical University||2|||f||||f||||||||No|No individual participant data will be shared.|2017-10-10 23:43:44.119785|2017-10-10 23:43:44.119785
NCT02318251|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-02-08|||January 2015||2015-01-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|||Stress Urinary Incontinence Physiotherapy|Stress Urinary Incontinence Physiotherapy (SUIP) - A Randomized Controlled Trial With 6-Months Follow-up|Recruiting||N/A|96|Anticipated|Bern University of Applied Sciences||2|||f||||t||||||||No||2017-10-10 23:43:44.189958|2017-10-10 23:43:44.189958
NCT02318238|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-11|||February 2014||2014-02-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|||Comparison Between 6 Minute Walk Test, 6 Minute Step Test and 4 Metre Gait Speed||Completed||N/A|74|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f||||f||||||||||2017-10-10 23:43:44.286969|2017-10-10 23:43:44.286969
NCT02318225|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-09-19|||January 2015||2015-01-01|September 2015|2015-09-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Misoprostol Prior to Office Hysteroscopy in Patients With no Risk Factors for Experiencing Unacceptable Pain|Cervical Priming With Misoprostol Before Diagnostic Office Hysteroscopy in Patients With no Risk Factors for Experiencing Unacceptable Pain. A Randomized Double Blinded Placebo-controlled Study|Unknown status|Recruiting|Phase 2|100|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:43:44.377912|2017-10-10 23:43:44.377912
NCT02318212|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-18|||March 2015||2015-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|DSREGISTRYIA||Dilapan-S / Dilasoft E-Registry in Induced Abortion|International Observational E-Registry on the Use of Dilapan-S/Dilasoft Osmotic Dilators for Cervical Priming Prior to Induced Abortion|Completed||N/A|439|Actual|Medicem International CR s.r.o.|||1||f||||f||||||||||2017-10-10 23:43:44.479484|2017-10-10 23:43:44.479484
NCT02318199|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-08-04|||January 2015||2015-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Observational|||Emergence Agitation in Adult Patients After Intracranial Surgery|Emergence Agitation During Recovery From Intracranial Surgery Under General Anesthesia: a Prospective Multicenter Cohort Study|Completed||N/A|400|Actual|Capital Medical University|||2||f||||t||||||||||2017-10-10 23:43:44.577221|2017-10-10 23:43:44.577221
NCT02318186|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-10-03|||October 2013||2013-10-01|October 2017|2017-10-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Observational|PKRemodulin||Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)|Multi-center, Open-label Pharmacokinetic Study of Subcutaneously and Intravenously Administered Treprostinil in Children With Pulmonary Arterial Hypertension (PAH)|Completed||N/A|51|Actual|Stanford University|||5||f||||t||||||Samples Without DNA|"     2 mL blood sample in K3-EDTA tube and immediately place on ice; Place plasma into 2 aliquots;     Freeze at -20 degrees or lower. Store until batch is complete; Batch ship all samples on dry     ice to pharmacokinetic analytical laboratory   "|||2017-10-10 23:43:44.655686|2017-10-10 23:43:44.655686
NCT02318173|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-18|||May 2015||2015-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|DSREGISTRYIL||Dilapan-S/Dilasoft E-Registry in Induction of Labor|International Observational E-Registry on the Use of Dilapan-S / Dilasoft Osmotic Dilators for Cervical Ripening Prior to Labour Induction|Completed||N/A|444|Actual|Medicem International CR s.r.o.|||1||f||||f||||||||||2017-10-10 23:43:44.731951|2017-10-10 23:43:44.731951
NCT02318160|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-12|||January 2014||2014-01-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01|3 Months|Observational [Patient Registry]|||Oxidative Status in Children With Autoimmune Thyroiditis|Oxidative Status in Children and Adolescents With Autoimmune Thyroiditis: A Tertiary Center Study From Upper Egypt|Completed||N/A|64|Actual|Assiut University|||1||f||||f||||||||||2017-10-10 23:43:44.839409|2017-10-10 23:43:44.839409
NCT02318147|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2014-12-16|||January 2015||2015-01-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)|Fecal Microbiota Transplantation in SAP（Severe Acute Pancreatitis）Patients With Infectious Complications|Unknown status|Not yet recruiting|Phase 1|60|Anticipated|The First Affiliated Hospital of Nanchang University||2|||f||||f||||||||||2017-10-10 23:43:44.892068|2017-10-10 23:43:44.892068
NCT02318134|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2014-12-16|||January 2015||2015-01-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|FMTP||Fecal Microbiota Transplantation for Pancreatitis|Fecal Microbiota Transplantation in SAP（Severe Acute Pancreatitis）Patients With Intestinal Barrier Dysfunction|Unknown status|Not yet recruiting|Phase 1|60|Anticipated|The First Affiliated Hospital of Nanchang University||2|||f||||f||||||||||2017-10-10 23:43:45.116859|2017-10-10 23:43:45.116859
NCT02318121|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-12-16|||April 2014||2014-04-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|September 2014|Actual|2014-09-01||Interventional|AOAL||Amniotomy and Oxytocin for Augmentation of Labour|Concurrent Versus Sequential Administration of Amniotomy and Oxytocin for Augmentation of Labour: a Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 2|150|Actual|Assiut University||3|||f||||f||||||||||2017-10-10 23:43:45.218441|2017-10-10 23:43:45.218441
NCT02318108|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-03-21|||July 2012|Actual|2012-07-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|SPARC||Supporting Practices to Adopt Registry-Based Care|Redesigning Diabetes Work Processes for Population-Based Primary Care: Supporting Practices to Adopt Registry-Based Care|Active, not recruiting||N/A|30|Anticipated|Mathematica Policy Research, Inc.||2|||f||||t||||||||||2017-10-10 23:43:45.282972|2017-10-10 23:43:45.282972
NCT02318082|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-07-06|||February 2015||2015-02-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic Graft-versus-Host-Disease|A Phase I Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic Graft-versus-Host-Disease|Recruiting||Phase 1|20|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:43:45.436142|2017-10-10 23:43:45.436142
NCT02318069|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2017-04-26|||January 2015||2015-01-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|February 2016|Actual|2016-02-01||Interventional|||New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly|Humoral Response to TBE Vaccine in Elderly (50+ Year Olds) After Changed Dosage Intervals/Number of Doses?|Active, not recruiting||Phase 2/Phase 3|250|Actual|Sormland County Council, Sweden||5|||f||||t||||||||||2017-10-10 23:43:45.521999|2017-10-10 23:43:45.521999
NCT02318056|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-07-20|||December 2015||2015-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Burn Glove Trial - Hand Burn Dressing Pilot|The Burn Glove Trial-A Randomized Controlled Trial of Dressings for Partial Thickness Hand Burns|Withdrawn||N/A|0|Actual|Southern Illinois University||3||Due to reorganization.|f||||t||||||||No||2017-10-10 23:43:45.606277|2017-10-10 23:43:45.606277
NCT02318043|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-11|||January 2007||2007-01-01|December 2014|2014-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|AMPHis||AMP-BPT and His-BPT for Assessment of Asthma|Is Adenosine Monophosphate Superior to Histamine for Bronchial Provocation Test in Evaluation of Asthma?|Completed||N/A|84|Actual|Guangzhou Institute of Respiratory Disease||2|||f||||f||||||||||2017-10-10 23:43:45.705259|2017-10-10 23:43:45.705259
NCT02318030|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-10-03|||April 2014||2014-04-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||CNTRP POSITIVE Study|CNTRP Paediatric Outcomes in Transplant: Personalising Immunosuppression to Improve Efficacy (POSITIVE Study)|Recruiting||N/A|600|Anticipated|The Hospital for Sick Children|||2||f||||f||||||Samples With DNA|"     Immune function testing: blood Pharmacokinetic testing: blood EBV/PTLD viral sequencing:     blood EBV/PTLD immunoassays: blood   "|||2017-10-10 23:43:45.812309|2017-10-10 23:43:45.812309
NCT02318004|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-11|||December 2014||2014-12-01|December 2014|2014-12-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of EarlySense Home Care Tele-monitoring Device|Study Protocol for Evaluation of EarlySense Home Care Tele-monitoring Device - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion For Early Detection of Deterioration For Cardiac Patients at Home|Unknown status|Not yet recruiting|N/A|50|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:43:46.003944|2017-10-10 23:43:46.003944
NCT02317991|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-16|||May 5, 2015|Actual|2015-05-05|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer|Phase II Study of Nab-Paclitaxel and Ramucirumab for the Second-line Treatment of Patients With Metastatic Gastroesophageal Cancer|Recruiting||Phase 2|65|Anticipated|SCRI Development Innovations, LLC||1|||f||||f|t|f||||||||2017-10-10 23:43:46.083507|2017-10-10 23:43:46.083507
NCT02317978|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-12|2016-09-17|||December 2014||2014-12-01|September 2016|2016-09-01||||February 2017|Anticipated|2017-02-01||Observational|||Evaluation of the Role of Follicular Sensitivity Index in the Prediction of IVF/ICSI Outcome||Recruiting||N/A|10000|Anticipated|Cairo University|||1||f||||||||||||||2017-10-10 23:43:46.197842|2017-10-10 23:43:46.197842
NCT02317965|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-09-18|||March 2015||2015-03-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|||Non-Invasive Screening for Fetal Aneuploidy|A Prospective Clinical Study to Evaluate a Novel Non-invasive Prenatal Screening Method for Characterizing Fetal Whole Chromosome Aberrations and Other Major Defects and Deletions Found in the Maternal Blood.|Active, not recruiting||N/A|340|Anticipated|Progenity, Inc.|||1||f||||f||||||Samples With DNA|"     plasma, PBMCs   "|||2017-10-10 23:43:46.275336|2017-10-10 23:43:46.275336
NCT02317952|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-06-07|||May 2014||2014-05-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Formula for Children With Cow's Milk Allergy|A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein|Completed||N/A|90|Actual|Perrigo Nutritionals||2|||f||||f|f|f||||||||2017-10-10 23:43:46.361823|2017-10-10 23:43:46.361823
NCT02317939|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-04-04|||December 2014||2014-12-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|ELECTOR_I||Home Monitoring of Patients With Rheumatoid Arthritis - an eHealth Development Study|Home Monitoring of Patients With Rheumatoid Arthritis - an eHealth Development Study|Recruiting||N/A|240|Anticipated|Parker Research Institute||2|||f||||f||||||||||2017-10-10 23:43:48.225312|2017-10-10 23:43:48.225312
NCT02317926|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-05-05|||May 2015||2015-05-01|May 2015|2015-05-01||||May 2018|Anticipated|2018-05-01||Interventional|||Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism||Recruiting||N/A|81|Anticipated|Walter Reed National Military Medical Center||3|||f||||||||||||||2017-10-10 23:43:48.310347|2017-10-10 23:43:48.310347
NCT02317913|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-03-08|||April 2013||2013-04-01|March 2015|2015-03-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Observational|||Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012|Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012|Completed||N/A|2402|Actual|Children's Hospital of Fudan University|||1||f||||t||||||||||2017-10-10 23:43:48.388003|2017-10-10 23:43:48.388003
NCT02317900|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-15|2017-01-31|||December 2014||2014-12-01|January 2017|2017-01-01||||November 2016|Actual|2016-11-01||Interventional|||Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults|A Phase 1 Evaluation of the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169|Completed||Phase 1|48|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:43:48.456939|2017-10-10 23:43:48.456939
NCT02317887|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-10-03|||December 3, 2014||2014-12-03|September 20, 2017|2017-09-20|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis|A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis|Recruiting||Phase 1/Phase 2|24|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 23:43:48.543326|2017-10-10 23:43:48.543326
NCT02317874|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-16|2017-10-05|||July 24, 2015|Actual|2015-07-24|September 2017|2017-09-01|November 22, 2017|Anticipated|2017-11-22|November 22, 2017|Anticipated|2017-11-22||Interventional|||Talazoparib, Carboplatin, and Paclitaxel in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|A Phase 1 Study of BMN 673 in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumors|Recruiting||Phase 1|66|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-10 23:43:48.633295|2017-10-10 23:43:48.633295
NCT02317848|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-21|||December 2014||2014-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|PROVE-SAS-AHF||PRevalence, Persistence and prOgnostic ValuE of Sleep Apnea Syndrome in Acute Heart Failure|PRevalence, Persistence and prOgnostic ValuE of Sleep Apnea Syndrome in Acute Heart Failure.|Recruiting||N/A|194|Anticipated|French Cardiology Society||1|||f||||f||||||||||2017-10-10 23:43:48.857367|2017-10-10 23:43:48.857367
NCT02317835|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-06-08|||July 2015||2015-07-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|DFUPS||Diabetic Foot Ulcer Prevention System|An Innovative System for the Early Identification, Monitoring, Evaluation and Diagnosis of Diabetic Foot Ulcers|Completed||Phase 1|105|Actual|King's College Hospital NHS Trust||1|||f||||||||||||||2017-10-10 23:43:49.054037|2017-10-10 23:43:49.054037
NCT02317809|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-10-18|2016-10-18||January 2015||2015-01-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||Safety analysis set included all subjects who received at least 1 dose of the investigational medicinal product (IMP) (that is, either liquid formulation or freeze-dried formulation).|Bioequivalence Trial of Liquid Versus Freeze-Dried Pergoveris® in Pituitary Suppressed Healthy Premenopausal Female Subjects|An Open-label, Randomized, Two-period, Two-sequence Crossover Trial to Assess the Bioequivalence of the Liquid Formulation Versus the Freeze-dried Formulation of 900 IU r-hFSH and 450 IU r-hLH in Pergoveris®, Administered Subcutaneously in Pituitary Suppressed Healthy Premenopausal Female Subjects|Completed||Phase 1|34|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-10 23:43:49.169295|2017-10-10 23:43:49.169295
NCT02317796|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-09-23|||December 2014||2014-12-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Adult Subjects With Uncontrolled Type 2 Diabetes|A Multi-center, Double Blind, Randomized, Placebo-controlled, Parallel Group Phase IIa Study of MLR-1023 in Adult Subjects With Uncontrolled Type 2 Diabetes|Completed||Phase 2|149|Actual|Melior Pharmaceuticals||5|||f||||t||||||||Undecided|Undecided|2017-10-10 23:43:49.954887|2017-10-10 23:43:49.954887
NCT02317783|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-06-06|||December 2015||2015-12-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment|Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment|Recruiting||N/A|15|Anticipated|University of Utah||1|||f||||t||||||||||2017-10-10 23:43:50.064242|2017-10-10 23:43:50.064242
NCT02317770|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-03-15|||November 2013||2013-11-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of Topical and Nebulized Anesthesia in Patients Undergoing Esophago-Gastro-Duodenoscopy|Comparison of Topical and Nebulized Anesthesia in Patients Undergoing Esophago-Gastro-Duodenoscopy|Recruiting||Phase 4|110|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-10 23:43:50.145446|2017-10-10 23:43:50.145446
NCT02317757|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-03-31|||January 2015||2015-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients|Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients: A Prospective Study|Recruiting||N/A|150|Anticipated|Mahidol University|||1||f||||f||||||||No||2017-10-10 23:43:50.243172|2017-10-10 23:43:50.243172
NCT02317731|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-04-15|||December 2014||2014-12-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation|Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation|Terminated||N/A|20|Actual|Yale University||2||PI relocated|f||||f||||||||||2017-10-10 23:43:50.402989|2017-10-10 23:43:50.402989
NCT02317718|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-11|||December 2014||2014-12-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01|6 Months|Observational [Patient Registry]|||Serum Vitamin D Level and Its Association With Ovarian Reserve and IVF Outcome|Serum Vitamin D Level in Subfertile Women and Its Association With Ovarian Reserve and IVF Outcome.|Unknown status|Recruiting|N/A|500|Anticipated|Fakih IVF Fertility Center|||2||f||||t||||||||||2017-10-10 23:43:50.469688|2017-10-10 23:43:50.469688
NCT02317705|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-07-25|||December 2014||2014-12-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer|A Phase 2, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer|Completed||Phase 2|48|Actual|On Target Laboratories, LLC||1|||f||||f||||||||||2017-10-10 23:43:50.555531|2017-10-10 23:43:50.555531
NCT02317679|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-12-15|||April 2014||2014-04-01|December 2014|2014-12-01|February 2015|Anticipated|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot Study|Treatment of Port-wine Stains by Bosentan in Addition to Pulsed Dye Laser (PDL) in Children or Young Adults Who Previously Failed to Respond to PDL Alone: a Monocentric Pilot Study|Unknown status|Active, not recruiting|Phase 2|4|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 23:43:50.82703|2017-10-10 23:43:50.82703
NCT02317666|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-11-05|||December 2014||2014-12-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||DBI - Tool for Medication Reviews in Older People|Decreasing the Load? The Drug Burden Index - A Tool for Medication Reviews in Older People (the DBI TMO Study)|Completed||N/A|157|Actual|University of Groningen||2|||f||||f||||||||||2017-10-10 23:43:50.917284|2017-10-10 23:43:50.917284
NCT02317653|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-04-19|||February 2015||2015-02-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|Mom2Baby Pilot||Understanding the Influence of Pregnancy on Breast Milk|Mom2Baby Pilot: Understanding the Influence of Pregnancy on Breast Milk|Completed||N/A|18|Actual|Louisiana State University Health Sciences Center in New Orleans|||2||f||||f||||||Samples Without DNA|"     Maternal Blood Collection: approximately 60 mL of blood will be collected over 2 timepoints      Breast Milk Collection: approximately 50-100 mL of breast milk will be collected at 1     timepoint      Infant Stool Collection: 1 fresh infant stool sample will be collected at 1 timepoint   "|||2017-10-10 23:43:51.002687|2017-10-10 23:43:51.002687
NCT02317640|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2017-08-18|||March 15, 2017|Actual|2017-03-15|August 2017|2017-08-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males|Testosterone Replacement Therapy in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males.|Recruiting||Phase 1/Phase 2|56|Anticipated|Kessler Foundation||4|||f||||t|t|t|f|||||||2017-10-10 23:43:51.076454|2017-10-10 23:43:51.076454
NCT02317627|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-04-06||2016-04-06|December 2014||2014-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy|A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy|Completed||Phase 2|38|Actual|Kadmon Corporation, LLC||3|||f||||t||||||||||2017-10-10 23:43:51.188801|2017-10-10 23:43:51.188801
NCT02317614|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-08-15|||May 2, 2016|Actual|2016-05-02|August 2017|2017-08-01|February 18, 2018|Anticipated|2018-02-18|February 18, 2018|Anticipated|2018-02-18||Interventional|||SteadyRx: Smartphone ART Adherence Intervention for Drug Users||Recruiting||N/A|50|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:43:51.297038|2017-10-10 23:43:51.297038
NCT02317601|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-07-15|||December 2014||2014-12-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Preoperative Single Glucocorticoid Hip Fracture Hip Fracture Surgery|Preoperative Single-high Dose Glucocorticoid for Patients Undergoing Hip Fracture Surgery and the Effect on Postoperative Delirium.|Completed||Phase 4|122|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 23:43:51.394851|2017-10-10 23:43:51.394851
NCT02317588|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-03-09|||December 2014||2014-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|OXGEN-2014||Gender Effects of Dietary Omega-3 Fatty Acids From Plant and Marine Sources on Oxylipins in Healthy Humans|Gender Effects of Dietary Omega-3 Fatty Acids From Plant and Marine Sources on Oxylipins in Healthy Humans|Completed||Phase 1|12|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-10 23:43:51.490106|2017-10-10 23:43:51.490106
NCT02317575|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-09-17|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|||A Study of LY900014 Formulations in Healthy Participants|Safety, Tolerability, Pharmacokinetics and Glucodynamics of Multiple LY900014 Formulations|Completed||Phase 1|29|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-10 23:43:51.588224|2017-10-10 23:43:51.588224
NCT02317562|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-09-12|||November 2015||2015-11-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PRISM2||Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302|"International, Multicentre, Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Extension of PRISM Study I10E-1302"|Recruiting||Phase 3|15|Anticipated|Laboratoire français de Fractionnement et de Biotechnologies||1|||f||||f||||||||||2017-10-10 23:43:51.684644|2017-10-10 23:43:51.684644
NCT02317536|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2015-09-17|||December 2014||2014-12-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|15CAHL||A Pilot Clinical Trial on the Efficacy of Two Carnitine-Based Products on Muscle Function in Healthy Older Adults|A Randomized Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Relative Efficacy of Two Carnitine-Based Products Purported to Promote Muscle Anabolism in Healthy Older Adults|Completed||Phase 2|42|Actual|KGK Synergize Inc.||3|||f||||f||||||||||2017-10-10 23:43:52.042431|2017-10-10 23:43:52.042431
NCT02317510|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-02-17|2015-05-17||December 2014||2014-12-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Combined Spinal Epidural Anesthesia and General Anesthesia for Laparoscopic Cholecystectomy|Combined Spinal Epidural Anesthesia and General Anesthesia for Laparoscopic Cholecystectomy: a Prospective, Randomized Study|Completed||N/A|50|Actual|Lütfiye Nuri Burat Government Hospital|one patients had dural injury. Because of this that patient had released.|2|||f||||f||||||||||2017-10-10 23:43:52.270472|2017-10-10 23:43:52.270472
NCT02317497|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-06-20|||September 2016||2016-09-01|June 2016|2016-06-01|November 2018|Anticipated|2018-11-01|January 2018|Anticipated|2018-01-01||Interventional|MODERNISE||Sedation Depth in Neurocritical Care|MOderate vs DEep Regimen in NeuroIntensive Care SEdation|Not yet recruiting||Phase 2|100|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-10 23:43:52.751253|2017-10-10 23:43:52.751253
NCT02317484|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-10-17|||November 2014||2014-11-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|HARUKAS||Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes|Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes|Active, not recruiting||N/A|231|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||f||||||||||2017-10-10 23:43:52.840496|2017-10-10 23:43:52.840496
NCT02317471|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-06-02|||November 2014||2014-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96|Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96|Recruiting||Phase 1/Phase 2|45|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:43:52.905339|2017-10-10 23:43:52.905339
NCT02317458|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-07-07|||June 2017||2017-06-01|July 2016|2016-07-01||||March 2020|Anticipated|2020-03-01||Interventional|CHART-2||Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL|EFFICACY AND SAFETY OF BONE MARROW-DERIVED MESENCHYMAL CARDIOPOIETIC CELLS (C3BS-CQR-1) FOR THE TREATMENT OF CHRONIC ISCHEMIC HEART FAILURE|Not yet recruiting||Phase 3|400|Anticipated|Celyad (formerly named Cardio3 BioSciences)||2|||f||||t||||||||||2017-10-10 23:43:53.086196|2017-10-10 23:43:53.086196
NCT02317445|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-12-15|||January 2008||2008-01-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|December 2010|Actual|2010-12-01||Observational|||Relationship of Helicobacter Pylori Eradication Therapy and Long-term Outcome in Acute Coronary Syndrome|Beijing Tiantan Hospital,Capital Medical University.|Completed||N/A|472|Actual|Capital Medical University|||1||f||||t||||||||||2017-10-10 23:43:53.158134|2017-10-10 23:43:53.158134
NCT02317432|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-03-22|||July 2015||2015-07-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)|Building Community Capacity for Disability Prevention for Minority Elders|Recruiting||N/A|360|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:43:53.225239|2017-10-10 23:43:53.225239
NCT02317419|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2016-07-22|||December 2014||2014-12-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid Tumors|PHASE IA/IB, OPEN-LABEL, MULTICENTER, MULTIPLE ASCENDING DOSE STUDY FOLLOWED BY AN EXTENSION PHASE TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND ACTIVITY OF RO6927005, AN ANTI-MESOTHELIN (MSLN) RECOMBINANT CYTOLYTIC FUSION PROTEIN (cFP), ADMINISTERED EITHER ALONE (PART A) OR IN COMBINATION WITH GEMCITABINE AND NAB-PACLITAXEL (PART B) IN PATIENTS WITH MESOTHELIN-POSITIVE METASTATIC AND/OR LOCALLY ADVANCED MALIGNANT SOLID TUMORS|Terminated||Phase 1|15|Actual|Hoffmann-La Roche||5||"The study was prematurely terminated because the emerging benefit:risk ratio did not justify   continuing dosing patients."|f||||||||||||||2017-10-10 23:43:53.34037|2017-10-10 23:43:53.34037
NCT02317406|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-07-18|||December 2014||2014-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Probiotics on the Digestibility and Immunity in Infants|Effect of Probiotics on the Digestibility and Immunity in Infants|Completed||N/A|133|Actual|Biostime Institute of Nutrition and Care||2|||f||||f||||||||||2017-10-10 23:43:53.441105|2017-10-10 23:43:53.441105
NCT02317380|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2017-06-30|||November 25, 2014||2014-11-25|November 2, 2016|2016-11-02|November 10, 2015|Actual|2015-11-10|November 10, 2015|Actual|2015-11-10||Observational|||Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close Other|Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close Other|Completed||N/A|1100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:43:53.669557|2017-10-10 23:43:53.669557
NCT02317367|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2017-08-08|||November 22, 2014||2014-11-22|August 3, 2017|2017-08-03|December 13, 2017|Anticipated|2017-12-13|December 13, 2017|Anticipated|2017-12-13||Observational|||Self-Affirmation: Construct Validity|Self-Affirmation: Construct Validity|Recruiting||N/A|3634|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:43:53.749673|2017-10-10 23:43:53.749673
NCT02317354|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2017-06-30|||December 8, 2014||2014-12-08|November 15, 2016|2016-11-15|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial|Patient Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial|Enrolling by invitation||N/A|13|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:43:53.830438|2017-10-10 23:43:53.830438
NCT02317341|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-13|2017-06-30|||December 2, 2014||2014-12-02|June 5, 2017|2017-06-05|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Effect of Ketamine on Fatigue Following Cancer Therapy|Effect of Ketamine on Fatigue Following Cancer Therapy|Recruiting||Early Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:43:53.903388|2017-10-10 23:43:53.903388
NCT02317315|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-05-16|||January 2013||2013-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Biomarkers Associated With Spontaneous Preterm Birth Less Than 32 Wks Gestation|Non-Invasive Sampling of Inflammatory Mediators Associated With Spontaneous Preterm Birth Less Than 32 Weeks Gestation|Recruiting||N/A|240|Anticipated|Winthrop University Hospital|||1||f||||t||||||Samples Without DNA|"     1. Saliva - We will collect saliva in a sterile container.        2. Maternal Blood - Blood samples will be collected during routine blood draws and into          serum separator tubes, spun, and the serum stored at -80°C.        3. Urine - Urine samples will be collected into a sterile container.        4. Cervical and vaginal secretions - During speculum exam, we will simultaneously insert          two Weck-Cell Sponges directly into the cervical os for collection of cervical          secretions then another two sponges will be applied in the posterior fornix for          collection of vaginal fluid.   "|||2017-10-10 23:43:54.096705|2017-10-10 23:43:54.096705
NCT02317302|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-02-21|||June 28, 2011|Actual|2011-06-28|February 2017|2017-02-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer|FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients With Cervical Cancer|Active, not recruiting||Phase 1|48|Actual|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||No||2017-10-10 23:43:54.195748|2017-10-10 23:43:54.195748
NCT02317289|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-04-26|||July 2014||2014-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|demarpark||Assisted Device for Freezing in Parkinson Disease|Development of a Multimodal Controlled Device for Improvement and Monitoring of Freezing in Parkinsonian Patients|Recruiting||N/A|40|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-10 23:43:54.300567|2017-10-10 23:43:54.300567
NCT02317276|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-04-10|||December 2014||2014-12-01|April 2017|2017-04-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|GNE-AD||A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal|A Study in Atopic Dermatitis to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal|Completed||Phase 4|11|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:43:54.391633|2017-10-10 23:43:54.391633
NCT02317263|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-08-02||||||August 2016|2016-08-01|January 2099|Anticipated|2099-01-01|January 2099|Anticipated|2099-01-01||Interventional|||A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis||Withdrawn||Phase 2|0|Actual|University of California, Los Angeles||2||NIH did not fund the study so it never started|f||||t||||||||||2017-10-10 23:43:54.486288|2017-10-10 23:43:54.486288
NCT02317250|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-02-04|||June 2018||2018-06-01|January 2016|2016-01-01|December 2022|Anticipated|2022-12-01|October 2022|Anticipated|2022-10-01||Interventional|||Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II|Early and Long-Term Health Outcomes of Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II|Not yet recruiting||N/A|1500|Anticipated|University of California, Los Angeles||4|||f||||t||||||||||2017-10-10 23:43:54.556742|2017-10-10 23:43:54.556742
NCT02317237|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-05-02|||March 8, 2015|Actual|2015-03-08|November 2015|2015-11-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|GOLIATH||"GOLIATH - General Or Local Anaestesia in Intra Arterial THerapy"|Anaesthetic Strategy During Endovascular Therapy: General Anaesthesia or Conscious Sedation ?|Completed||Phase 3|128|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:43:54.65804|2017-10-10 23:43:54.65804
NCT02317224|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-10|||August 2014||2014-08-01|December 2014|2014-12-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|3-Hole||"The Safety and Efficacy of 3-Hole Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor"|"Comparison of Safety and Efficacy Among 3-Hole Subxiphorid Approach, Trans Sternal Approach and VATS in Surgical Treatment of Anterior Mediastinal Tumor"|Recruiting||Phase 2|240|Anticipated|Tang-Du Hospital||3|||f||||t||||||||||2017-10-10 23:43:54.735992|2017-10-10 23:43:54.735992
NCT02317211|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2015-11-16|||February 2014||2014-02-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Purified Anthocyanins Supplementation in Type 2 Diabetes Mellitus|Effect of Purified Anthocyanin on Oxidative Stress and Glycemic Control in Subjects With Type 2 Diabetes Mellitus: A Randomized, Double-Blinded, Placebo-Controlled Trial|Completed||Early Phase 1|70|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:43:54.838662|2017-10-10 23:43:54.838662
NCT02317198|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-04-24|||June 2013||2013-06-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|POPular AGE||Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly|Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly|Recruiting||Phase 4|1000|Anticipated|St. Antonius Hospital||2|||f||||t||||||||||2017-10-10 23:43:54.92379|2017-10-10 23:43:54.92379
NCT02317185|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-10|||December 2014||2014-12-01|December 2014|2014-12-01||||December 2016|Anticipated|2016-12-01||Observational|||Clinical Evaluation of GENEX® DS in Instrumented Posterolateral Fusion|CLINICAL EVALUATION OF GENEX® DS IN INSTRUMENTED POSTEROLATERAL FUSION|Unknown status|Recruiting|N/A|30|Anticipated|Spine Wave|||1||f||||f||||||||||2017-10-10 23:43:55.039974|2017-10-10 23:43:55.039974
NCT02317172|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-11|||October 2012||2012-10-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases|Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases|Completed||N/A|120|Actual|Dental Innovation Foundation Under Royal Patronage||1|||f||||f||||||||||2017-10-10 23:43:55.128154|2017-10-10 23:43:55.128154
NCT02317159|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2014-12-12|||February 2015||2015-02-01|December 2014|2014-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia|Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Cttq||1|||f||||t||||||||||2017-10-10 23:43:55.206059|2017-10-10 23:43:55.206059
NCT02317146|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-01-31|||November 2013||2013-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|MAG-PP||Magnesium Sulfate in Pregnancy and Postpartum|A Novel Protocol for Postpartum Magnesium Sulfate in Severe Preeclampsia When the Woman Received Less That 8 Hours Before Delivery. Six Versus Twenty-four Hours Postpartum|Completed||Phase 2/Phase 3|280|Actual|Complejo Hospitalario Dr. Arnulfo Arias Madrid||2|||f||||f||||||||No||2017-10-10 23:43:55.270012|2017-10-10 23:43:55.270012
NCT02317133|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-06-16|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|FOX-TREG||Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura|Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura|Recruiting||N/A|120|Anticipated|Centre Hospitalier Universitaire de Nīmes|||3||f||||f||||||Samples With DNA|"     Stool samples: DNA extractions for microbiota analysis. Blood samples: DNA extractions for     bacterial translocation analysis Blood samples: samples remaining will be kept for further     analysis   "|||2017-10-10 23:43:55.351168|2017-10-10 23:43:55.351168
NCT02317120|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-01-31|||February 2015||2015-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||BRCA1 and BRCA2 Mutation in Romanian Population: a Study of Genotype - Phenotype Correlation at Diagnosis With Prospective Disease Outcome and Survival|BRCA1 and BRCA2 Mutation in Romanian Population: a Study of Genotype - Phenotype Correlation at Diagnosis With Prospective Disease Outcome and Survival|Completed||N/A|250|Actual|Prof. Dr. I. Chiricuta Institute of Oncology|||1||f||||||||||||||2017-10-10 23:43:55.45292|2017-10-10 23:43:55.45292
NCT02317107|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-10-03|||June 30, 2015|Actual|2015-06-30|October 2017|2017-10-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Examination of Balance, Vestibular, and Ocular Functions and Activity Following Concussion|A Longitudinal Examination of Dynamic Balance Control, Vestibular/Ocular Motor Function, and Activity Participation Following Concussion|Recruiting||N/A|60|Anticipated|Boston Children’s Hospital|||2||f||||f||||||||||2017-10-10 23:43:55.511539|2017-10-10 23:43:55.511539
NCT02317094|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-10-19|||January 2015||2015-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Blood-flow Restricted Exercise in Inclusion Body Myositis|Low-intensity Blood-flow Restricted Muscle Exercise in Patients With Sporadic Inclusion Body Myositis: a Randomised Controlled Trial|Completed||N/A|22|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-10 23:43:55.592744|2017-10-10 23:43:55.592744
NCT02317081|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-06-25|||February 2014||2014-02-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Axetis Inert Coronary Stent System First In Man Clinical Investigation (AXETIS FIM)|Axetis Inert Coronary Stent System First In Man Clinical Investigation (AXETIS FIM)|Unknown status|Recruiting|N/A|35|Anticipated|Axetis AG||1|||f||||t||||||||||2017-10-10 23:43:55.686834|2017-10-10 23:43:55.686834
NCT02317068|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-10-20|||January 2014||2014-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation||Completed||Phase 3|200|Actual|Urmia University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:43:55.777564|2017-10-10 23:43:55.777564
NCT02317055|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-01-17|||June 2014||2014-06-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|June 2014|Actual|2014-06-01||Interventional|GADOXY||Magnetic Resonance Imaging Evaluation of the Tissular Oxygen Saturation in Brain||Terminated||N/A|14|Actual|University Hospital, Grenoble||2||enrollment problem|f||||f||||||||||2017-10-10 23:43:55.852038|2017-10-10 23:43:55.852038
NCT02317029|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-05-29|||September 2013||2013-09-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|December 2014|Actual|2014-12-01||Interventional|CODE||Comparison of Oxygen Interventions and Defibrillator Efficiency|A Comparison of Two Biphasic Waveforms and Impact of Oxygen on Myocardial Injury Following Cardioversion|Terminated||N/A|134|Actual|Randers Regional Hospital||4||A major adverse event occured (pulsed biphasic waveform arm).|f||||t||||||||||2017-10-10 23:43:56.00487|2017-10-10 23:43:56.00487
NCT02317016|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-05-30|2016-06-06||March 10, 2015|Actual|2015-03-10|May 2017|2017-05-01|January 4, 2018|Anticipated|2018-01-04|July 11, 2015|Actual|2015-07-11||Interventional||All patients in the safety analysis set who received at least one dose of AZD9291 or rosuvastatin (n = 44) were included in the baseline analysis.|Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer|A Phase I, Open-Label, Non-Randomised, Multicentre Study to Assess the Effect of AZD9291 on the Pharmacokinetics of Rosuvastatin (a Sensitive BCRP Substrate) in Patients With EGFRm Positive NSCLC Whose Disease Has Progressed on an EGFR TKI|Active, not recruiting||Phase 1|55|Actual|AstraZeneca|At end of Part B, the CAP allowed patients to continue receiving AZD9291 if still deriving clinical benefit. No clinical data was databased during the CAP; thus AE data is presented to end of Part B only.|1|||f||||f||||||||||2017-10-10 23:43:56.113218|2017-10-10 23:43:56.113218
NCT02317003|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-02-11|||March 2015||2015-03-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|April 2016|Anticipated|2016-04-01||Interventional|PEPPER||Physical Exercise Prescription With PEdometeR in General Practice for Patients With Cardiovascular Risk Factors - The PEPPER Pragmatic Trial|Physical Exercise Prescription With PEdometeR in General Practice for Patients With Cardiovascular Risk Factors - The PEPPER Pragmatic Randomised Controlled Trial|Recruiting||N/A|140|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-10 23:43:57.061287|2017-10-10 23:43:57.061287
NCT02316990|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-02-27|||January 2015||2015-01-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|SUP||China Survey of Stress Ulcer Bleeding in Critically Ill Neurosurgical Patients|China Survey of Stress Ulcer Bleeding in Critically Ill Neurosurgical Patients|Completed||N/A|1416|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:43:57.652064|2017-10-10 23:43:57.652064
NCT02316977|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-10-26|||December 2014||2014-12-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|eRehab||Home Monitoring of Patients With Chronic Diseases - an eRehab Test-retest Study|Home Monitoring of Patients With Chronic Diseases - an eRehab Test-retest Study|Unknown status|Recruiting|N/A|240|Anticipated|Parker Research Institute|||1||f||||f||||||||||2017-10-10 23:43:57.752828|2017-10-10 23:43:57.752828
NCT02316964|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-12-02|||April 2015||2015-04-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|||Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|Pilot Study of Decitabine and Haplo-identical Natural Killer Cells in Acute Myeloid Leukemia (AML)|Recruiting||N/A|10|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:43:57.836799|2017-10-10 23:43:57.836799
NCT02316951|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-12-23|||July 2015||2015-07-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Monitoring Postoperative Pain and Recovery Following Orthopedic Surgery|Monitoring Postoperative Pain and Recovery Following Orthopedic Surgery|Recruiting||N/A|30|Anticipated|University of Florida|||1||f||||f||||||||No||2017-10-10 23:43:57.986341|2017-10-10 23:43:57.986341
NCT02316938|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-09-23|||February 2015||2015-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADVISE||Assessing DSA Formation, Diabetes, Viral Infections, Structural Kidney Changes With an Everolimus-based Regimen (ADVISE)|Exploring the Impact of de Novo Everolimus on Key Determinants of Long Term Outcome After Kidney Transplantation: NODAT, Viral Infection, DSA, Proteinuria and Graft Histology|Recruiting||Phase 4|90|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 23:43:58.094168|2017-10-10 23:43:58.094168
NCT02316925|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-05-04|||May 2015||2015-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||GSH Supplementation on Cold/Flu Symptoms in Older Healthy Adults|Oral Glutathione Supplementation on Cold/Flu Symptoms in Older Healthy Adults|Withdrawn||N/A|0|Actual|University of Florida||2||This study will never recruit. The protocol was renamed and will be resubmitted.|f||||f||||||||||2017-10-10 23:43:58.233451|2017-10-10 23:43:58.233451
NCT02316912|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-07-18|||February 2015||2015-02-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||First in Man Evaluation of Single and Multiple Doses of Oral ATX2417|Double Blind Randomised Placebo Controlled Evaluation of Single and Multiple Oral Doses of ATX2417 in Man and Effect of Food|Completed||Phase 1|64|Actual|Atopix Therapeutics, Ltd.||18|||f||||f||||||||||2017-10-10 23:43:58.327984|2017-10-10 23:43:58.327984
NCT02316899|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-06-14|||October 2014||2014-10-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome|Phase III Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study and Long-term Study in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|Completed||Phase 3|500|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-10 23:43:58.484152|2017-10-10 23:43:58.484152
NCT02316886|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-08-21|||October 2015||2015-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|PREVENT||The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Vulnerable Plaque|The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Stenosis With Vulnerable Plaque Characteristics|Recruiting||Phase 4|1600|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-10 23:43:58.727526|2017-10-10 23:43:58.727526
NCT02316873|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-11|||September 2011||2011-09-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|ReMus||Rhythm and Music to Rehabilitate Reading Disorders|Rhythm and Music to Rehabilitate Reading Disorders|Completed||N/A|48|Actual|Aix Marseille Université||2|||f||||f||||||||||2017-10-10 23:43:59.028554|2017-10-10 23:43:59.028554
NCT02316860|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2014-12-11|||October 2014||2014-10-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Diagnostic Performance of Tilt Test in Athletes|The Diagnostic Performance of Tilt Test in Athletes and a Novel Strategy for Its Improvement|Unknown status|Recruiting|N/A|140|Anticipated|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-10 23:43:59.100168|2017-10-10 23:43:59.100168
NCT02316847|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-02-17|||December 2014||2014-12-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray in Adolescents and Adults With Cluster Seizures|Multi-center, Open-label, Study of Safety and Tolerability of Chronic Intermittent Usage of Diazepam Nasal Spray in Epilepsy Patients With Cluster Seizures, Including Assessment of Olfaction and Reported Changes in Taste.|Terminated||Phase 2|126|Actual|Acorda Therapeutics||1|||f||||t||||||||||2017-10-10 23:43:59.195755|2017-10-10 23:43:59.195755
NCT02316834|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-02-24|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||POSITION: A PilOt Study of InducTion PARP InhibitiON in Ovarian Cancer|POSITION: A PilOt Study of InducTion PARP InhibitiON in Ovarian Cancer|Active, not recruiting||Early Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:43:59.33649|2017-10-10 23:43:59.33649
NCT02316821|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-04-12|||December 2014||2014-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study|RTA 402 Phase 2 Clinical Trial (A Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients With Chronic Kidney Disease and Type 2 Diabetes)|Active, not recruiting||Phase 2|108|Anticipated|Kyowa Hakko Kirin Co., Ltd||2|||f||||t||||||||||2017-10-10 23:43:59.417338|2017-10-10 23:43:59.417338
NCT02316808|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-19|||August 2011||2011-08-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Cholesterol-lowering Effects of Plant Stanol Ester||Completed||N/A|91|Actual|Raisio Group||2|||f||||||||||||||2017-10-10 23:43:59.488227|2017-10-10 23:43:59.488227
NCT02316795|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-12-17|||February 2014||2014-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma|Evaluation of Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma|Completed||Early Phase 1|20|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 23:43:59.556095|2017-10-10 23:43:59.556095
NCT02316782|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-12-10|||October 2008||2008-10-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2010|Actual|2010-12-01||Observational|BLAST||Bifurcation Lesion Analysis and STenting / BLAST|Bifurcation Lesion Analysis and STenting / BLAST|Completed||N/A|195|Actual|Volcano Corporation|||2||f||||f||||||||||2017-10-10 23:43:59.652648|2017-10-10 23:43:59.652648
NCT02152657|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-04-25|||January 2015||2015-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of Autologous Mesenchymal Stem Cell Transplantation in Chronic Spinal Cord Injury: a Pilot Study||Completed||N/A|5|Actual|Hospital Sao Rafael||1|||f||||t||||||||||2017-10-11 00:22:04.971343|2017-10-11 00:22:04.971343
NCT02316769|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-01-19|2015-07-24||August 2012||2012-08-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison Study of the McGrath MAC Video Laryngoscope With the King Vision|Randomized Controlled Trial Comparing the McGrath MAC Video Laryngoscope With the King Vision Video Laryngoscope in Adult Patients.|Completed||N/A|66|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||Undecided||2017-10-10 23:43:59.741765|2017-10-10 23:43:59.741765
NCT02316756|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-06-08|||December 2014||2014-12-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects|A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo-controlled First-in-human Trial To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06648671 After Administration Of Single Ascending Doses To Fasted And Fed Healthy Subjects|Completed||Phase 1|18|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 23:43:59.959478|2017-10-10 23:43:59.959478
NCT02316743|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-12-13|||December 2014||2014-12-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism|Beneficial Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism|Unknown status|Recruiting|Phase 4|40|Anticipated|Université de Sherbrooke||1|||f||||f||||||||||2017-10-10 23:44:00.038866|2017-10-10 23:44:00.038866
NCT02316730|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-04-30|||June 2014||2014-06-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||A Bioequivalence Study of Sanchi-Tongshu Capsule (Enteric Coated Pellets)|Single-dose, Open, Randomized, Two-period, Crossover Comparative Bioavailability Study of Sanchi-Tongshu Capsule and Sanchi-Tongshu Capsule (Enteric Coated Pellets) in Chinese Healthy Adult Male Subjects|Completed||Phase 1|23|Actual|Pharmaceutical Factory of Chengdu HuaSun Group Inc., Ltd.||2|||f||||f||||||||||2017-10-10 23:44:00.135207|2017-10-10 23:44:00.135207
NCT02316717|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-02-14|||December 2014||2014-12-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis|A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.|Active, not recruiting||Phase 2|130|Anticipated|Immuron Ltd.||3|||f||||f||||||||||2017-10-10 23:44:00.217319|2017-10-10 23:44:00.217319
NCT02316704|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2017-02-24|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Fixation of OsseoTi™ Porous Structure Versus PPS (Porous Plasma Spray) Coating on the G7™ Acetabular Component for Primary Total Hip Arthroplasty|Fixation of OsseoTi™ Porous Structure Versus PPS (Porous Plasma Spray) Coating on the G7™ Acetabular Component for Primary Total Hip Arthroplasty: A Single-Blinded Randomized Controlled Trial Evaluating Implant Migration, Acetabular Liner Wear, and Patient Reported Outcome|Active, not recruiting||N/A|98|Anticipated|Hvidovre University Hospital||4|||f||||t||||||||||2017-10-10 23:44:00.362178|2017-10-10 23:44:00.362178
NCT02316691|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-07-10|||January 2016||2016-01-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|BetTeRTED||B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease|B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease|Recruiting||N/A|28|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"     Samples will be used to determine longitudinal effect of B cell depletion on frequencies and     functions of T helper subsets and memory B cells in blood. Any unused PBMC as well as serum     obtained from these blood draws will be banked for future use in in vitro experiments.   "|||2017-10-10 23:44:00.583855|2017-10-10 23:44:00.583855
NCT02316678|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-04-17|2017-01-20||September 2014||2014-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PPOD||Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics|Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics|Completed||N/A|9573|Actual|University of Pennsylvania|||2||f||||f||||||||||2017-10-10 23:44:00.714308|2017-10-10 23:44:00.714308
NCT02316665|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-01-05|||April 2013||2013-04-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|DIADEME||Effect of Sleep Apnea Treatment on Type 1 Diabetes|Effect of Continuous Positive Airway Pressure Treatment on Nocturnal Glycemia of Patients Having Type 1 Diabetes and Sleep Apnea Syndrome: a Randomized Controlled Trial|Completed||N/A|81|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 23:44:00.99682|2017-10-10 23:44:00.99682
NCT02316652|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-10|||October 2013||2013-10-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Effect of Disinfective Solution as an Adjunct to Maintenance Therapy of Inflamed Periodontal Pockets|Using Chemical Pocket Disinfection as an Adjunct to Non-surgical Maintenance Therapy of Inflamed Periodontal Pockets|Unknown status|Active, not recruiting|N/A|33|Actual|University of Nebraska||3|||f||||f||||||||||2017-10-10 23:44:01.108493|2017-10-10 23:44:01.108493
NCT02316639|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-08-12|||August 2015||2015-08-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effectiveness of Neuromuscular Training in Healthy and ACL-Injured Adolescent Females|The Effectiveness of Neuromuscular Training in Healthy and ACL-Injured Adolescent Females|Unknown status|Recruiting|N/A|40|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-10 23:44:01.210538|2017-10-10 23:44:01.210538
NCT02316626|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2016-11-21|||December 2014||2014-12-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support|Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Gonadotropin Ovarian Stimulation for Intrauterine Insemination: a Pilot Randomized Controlled Study|Completed||Phase 4|246|Actual|University Magna Graecia||2|||f||||t||||||||||2017-10-10 23:44:01.324332|2017-10-10 23:44:01.324332
NCT02316613|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2016-01-28|2015-11-18||February 2007||2007-02-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational||Overall population: All the participants (except duplicate cases and participants without data available) meeting all the inclusion/exclusion criteria were included.|Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)|OLYMPE - Prospective Cohort Study on the Management of Patients With Relapsed Follicular Lymphoma|Completed||N/A|260|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:44:01.462662|2017-10-10 23:44:01.462662
NCT02316600|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-08-21|||January 2015||2015-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|RESPECT||Mobility Assessment & Follow-up in Frail Elderly: Clinic-technical Validation of a Smart Insole in Real Life|Mobility Assessment & Follow-up in Frail Elderly: Clinic-technical Validation of a Smart Insole in Real Life|Recruiting||N/A|70|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:44:02.696533|2017-10-10 23:44:02.696533
NCT02316587|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-04-03|||March 2014||2014-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|January 2016|Actual|2016-01-01||Observational|AMFAST||Assessment of Myocardial Fibrosis in Aortic STenosis|Assessment of Myocardial Fibrosis - Impact on Postoperative Outcome i Patients With Severe Aortic STenosis Undergoing Aortic Valve Replacement|Completed||N/A|112|Actual|Odense University Hospital|||1||f||||f||||||Samples Without DNA|"     Plasma saved for biomarkers Endomyocardial biopsy Stenotic aortic valve   "|||2017-10-10 23:44:02.798133|2017-10-10 23:44:02.798133
NCT02316574|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-09-20|||December 2014||2014-12-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||The Role of Neural Systems for Emotion Regulation in Coping With Alcohol Craving|The Role of Neural Systems for Emotion Regulation in Coping With Alcohol Craving|Recruiting||N/A|40|Anticipated|New York State Psychiatric Institute||1|||f||||t||||||||No||2017-10-10 23:44:02.867743|2017-10-10 23:44:02.867743
NCT02316561|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-01-19|||October 2014||2014-10-01|January 2017|2017-01-01|May 2028|Anticipated|2028-05-01|May 2018|Anticipated|2018-05-01||Interventional|ABLATIVE||Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer|Single Dose Ablative Preoperative Radiation Treatment for Early-Stage Breast Cancer in Elderly Patients|Recruiting||N/A|25|Anticipated|UMC Utrecht||1|||f||||t||||||||No||2017-10-10 23:44:02.961105|2017-10-10 23:44:02.961105
NCT02316548|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-02-02|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer|Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer|Terminated||N/A|14|Actual|NRG Oncology||2||Trial will not meet CTEP Early Phase Trial Slow Accrual Guidelines|f||||t||||||||||2017-10-10 23:44:03.057341|2017-10-10 23:44:03.057341
NCT02316535|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-09-10|||November 2014||2014-11-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|LcACEC||Low-dose Capecitabine Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colorectal Cancer|Low-dose Versus Standard-dose Capecitabine Adjuvant Chemotherapy for Chinese Elderly Patients With Stage II/III Colorectal Cancer: A Randomized, Phase 3 Non-inferiority Study|Recruiting||Phase 3|710|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-10 23:44:03.349212|2017-10-10 23:44:03.349212
NCT02316522|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-23|||May 2014||2014-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population|Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population|Recruiting||N/A|240|Anticipated|Weill Medical College of Cornell University|||4||f||||t||||||Samples With DNA|"     Blood Urine   "|Undecided||2017-10-10 23:44:03.43793|2017-10-10 23:44:03.43793
NCT02316496|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-07-29|||September 23, 2015|Actual|2015-09-23|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2016|Actual|2016-01-01||Interventional|REGAIN||Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II Study|A Phase II Study of Cetuximab Rechallenge in Combination With Irinotecan in Advanced Metastatic Colorectal Cancer Without KRAS or NRAS or BRAF Mutation (All Wild Type) for Patients Pretreated With FOLFIRI and Cetuximab in First Line With Stopping Cetuximab for Progressive Disease After a Previous Response (Partial Response or Complete Response) and After Treatment With a Fluoropyrimidine, Oxaliplatin Plus Bevacizumab Regimen|Terminated||Phase 2|2|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||f||||||||||2017-10-10 23:44:03.608992|2017-10-10 23:44:03.608992
NCT02316483|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-23|||December 2013||2013-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes|Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes|Recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University|||3||f||||t||||||Samples With DNA|"     Blood Urine   "|Yes|All results of the proposed studies will be published in international peer-reviewed scientific journals, presented at meetings in Qatar, the regional and international conferences, and disseminated through the local Qatari media, seminars and lectures for high school and college students. The original data will be available to interested investigators using the conventional standards of biomedical science.|2017-10-10 23:44:03.731682|2017-10-10 23:44:03.731682
NCT02316470|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-04-25|2017-01-04||December 2014||2014-12-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study|Dose Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Randomized, Controlled, Observer Blind Phase II Study|Completed||Phase 2|500|Actual|Valneva Austria GmbH||4|||f||||t||||||||||2017-10-10 23:44:05.597193|2017-10-10 23:44:05.597193
NCT02316080|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-12-09|||July 2011||2011-07-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Desensitizing Agents in In-home or In-office Dental Bleaching|Evaluating Remineralizers and Desensitizers Agents in Dental Bleaching Treatment: in Vitro and in Vivo Study|Completed||Phase 4|113|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:44:11.736108|2017-10-10 23:44:11.736108
NCT02316444|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-11-16|||November 2015||2015-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda|Strategies for the Prevention of Hepatitis B Viral Infection Among HIV Infected Adults in Uganda|Active, not recruiting||Phase 4|132|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-10 23:44:08.441183|2017-10-10 23:44:08.441183
NCT02316431|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-12-15|||December 2014||2014-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|Workflow||Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases|Diagnostic Comparison and Workflow Evaluation of Whole Body PET-magnetic Resonance and PET-CT With and Without Contrast Media in Patients With Oncologic Diseases|Completed||N/A|142|Actual|University of Zurich|||1||f||||f||||||||||2017-10-10 23:44:08.519323|2017-10-10 23:44:08.519323
NCT02316418|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-11-30|||January 2017||2017-01-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|HAS-FPHL||Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)|Prospective Safety and Efficacy Evaluation of Hairstetics™ Anchoring System for Hair Extensions in Female Pattern Hair Loss|Not yet recruiting||N/A|10|Anticipated|Hairstetics||1|||f||||f||||||||No||2017-10-10 23:44:08.584669|2017-10-10 23:44:08.584669
NCT02316405|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-11|||July 2011||2011-07-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Can Arm and Leg Cycling Exercise Improve Walking After Stroke|Can Arm and Leg Cycling Exercise Improve Walking After Stroke?|Unknown status|Recruiting|N/A|20|Anticipated|University of Victoria||1|||f||||t||||||||||2017-10-10 23:44:08.78678|2017-10-10 23:44:08.78678
NCT02316392|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-03-08|||December 2014||2014-12-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Imaging and Understanding BOS in Lung Transplantation|Imaging and Understanding BOS in Lung Transplantation|Completed||N/A|6|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     Biopsies of transplanted and explanted lung tissue   "|Undecided|There is no plan to share IPD with other researchers at this time. If this plan changes, no identifiable information will be shared.|2017-10-10 23:44:08.895751|2017-10-10 23:44:08.895751
NCT02316379|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-04-12|||February 2015||2015-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|HpXeMRCal||Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration|Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration|Recruiting||Phase 1/Phase 2|100|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 23:44:08.9699|2017-10-10 23:44:08.9699
NCT02316366|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-07-31|2015-07-31||November 2012||2012-11-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Use of Warmed Saline in Vaso-occlusive Episodes|Clinical Impact of Warmed Intravenous Saline in Sickle Cell Patients With Vaso-Occlusive Episodes|Completed||N/A|80|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-10 23:44:09.057593|2017-10-10 23:44:09.057593
NCT02316353|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-10-02|||December 30, 2015|Actual|2015-12-30|October 2017|2017-10-01|October 10, 2017|Anticipated|2017-10-10|October 10, 2017|Anticipated|2017-10-10||Interventional|||A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema|An Open-label, Randomized Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneous Administration of Human Plasma-derived C1-esterase Inhibitor in the Prophylactic Treatment of Hereditary Angioedema|Active, not recruiting||Phase 3|110|Anticipated|CSL Behring||2|||f||||f||||||||||2017-10-10 23:44:09.307969|2017-10-10 23:44:09.307969
NCT02316327|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-10-04|||July 2013||2013-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab|Phase IV/II Open-label Study to Evaluate Prompt Response to Treatment With Cisplatin, Gemcitabine and Bevacizumab in Patients With Non-small Lung Cancer.|Completed||Phase 4|19|Actual|Fundacion Clinic per a la Recerca Biomédica||1|||f||||f||||||||||2017-10-10 23:44:09.597295|2017-10-10 23:44:09.597295
NCT02316314|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-05-23|||December 2014||2014-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)|Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)|Recruiting||N/A|45|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||Samples With DNA|"     Blood Amount: Up to 88 mL of blood will be collected for the entire study and up to 57 mL of     blood will be collected for a single visit. (CBC = 5 mL per visit; Clotting = 6 mL per visit;     Chemistry = 7 mL per visit; Liver function = 5 mL per visit; Cardiac enzymes = 5 mL per     visit; Future serum = 3 mL per visit; Genetic analysis = 4 mL; HbA1c = 5mL; HIV test = 7 mL;     and Anti-AAVrh.10 = 10 mL)      Urine Amount: Approximately 24 mL of urine will be collected for the entire study and     approximately 12 mL of urine will be collected for a single visit.   "|Undecided||2017-10-10 23:44:09.693681|2017-10-10 23:44:09.693681
NCT02316301|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-07-26|||January 2015||2015-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Optimal Timing of Misoprostol Administration Prior to Office Hysteroscopy|Optimal Timing of Misoprostol Administration Prior to Office Hysteroscopy; a Randomized Controlled Trial.|Completed||Phase 2|120|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:44:09.79436|2017-10-10 23:44:09.79436
NCT02316288|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-05-11|||December 2014||2014-12-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Development of a Couple-based Mindfulness Intervention for Chronic Pain|Preliminary Test of an Integrative Intervention to Alleviate Chronic Pain and Improve Quality of Life|Completed||N/A|48|Actual|Wayne State University||2|||f||||t||||||||||2017-10-10 23:44:09.885802|2017-10-10 23:44:09.885802
NCT02315885|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-08-15|||July 2015||2015-07-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|||Biomarkers to Measure Treatment Response for Alcohol Dependence|Biomarkers to Measure Treatment Response for Alcohol Dependence|Recruiting||N/A|36|Anticipated|University of Maryland|||1||f||||t|f|f||||||||2017-10-10 23:44:13.258189|2017-10-10 23:44:13.258189
NCT02316275|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-07-28|||December 2011||2011-12-01|July 2015|2015-07-01|December 2031|Anticipated|2031-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery|IMpact of Unrestricted ACTIVity Following Mid-Urethral Sling Surgery (I'M ACTIVe): Quality of Life and Cost Implications|Recruiting||N/A|50|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-10 23:44:09.985898|2017-10-10 23:44:09.985898
NCT02316262|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-02-15|||October 2014||2014-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation|Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation|Recruiting||N/A|50|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 23:44:10.08986|2017-10-10 23:44:10.08986
NCT02316249|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2015-09-30|||April 2015||2015-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Vaginal Creams to Reduce Vaginal Erosion in Pessary Users|Vaginal Creams for Reduction of Vaginal Discharge and Erosion in Patients Using Ring With Support or Gellhorn Pessaries to Reduce Pelvic Organ Prolapse|Withdrawn||Phase 2|0|Actual|Northwell Health||2||the study was not feasible|f||||t||||||||||2017-10-10 23:44:10.209254|2017-10-10 23:44:10.209254
NCT02316236|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-01-13|||December 2014||2014-12-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|DEALS||Dexmedetomidine to Improve Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery|Effect of Dexmedetomidine on Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery|Recruiting||N/A|60|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-10 23:44:10.321191|2017-10-10 23:44:10.321191
NCT02316223|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-02-03|||January 2015||2015-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SAMBA||Supporting Asthma Management Behaviors in Aging Adults|Clinic-based vs. Home-based Support to Improve Care and Outcomes for Older Asthmatics|Active, not recruiting||N/A|406|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||t|f|f||||||||2017-10-10 23:44:10.431406|2017-10-10 23:44:10.431406
NCT02316210|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-03-08|||May 2014||2014-05-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|TURBO||Optimization of Onpulse Technology for Patients With Post Surgical or Vascular Oedema|Optimization of Onpulse Technology for Patients With Post Surgical or Vascular Oedema|Completed||Early Phase 1|25|Actual|Firstkind Ltd||1|||f||||f||||||||||2017-10-10 23:44:10.522892|2017-10-10 23:44:10.522892
NCT02316197|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-09-11|||December 31, 2014|Actual|2014-12-31|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia|A Multicenter, Open-Label, Dose-Escalating Phase I Trial of the DNA-PK Inhibitor MSC2490484A in Subjects With Advanced Solid Tumors or Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|31|Actual|Merck KGaA||1|||f||||f||||||||||2017-10-10 23:44:10.714506|2017-10-10 23:44:10.714506
NCT02316184|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-07-17|||January 2015||2015-01-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|REACH||Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons|Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons|Recruiting||N/A|300|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-10 23:44:10.829965|2017-10-10 23:44:10.829965
NCT02316171|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2017-05-09|||December 2014||2014-12-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CANON||Safety and Clinical Activity of CAVATAK™ Alone or With Low Dose Mitomycin C in Non-muscle Invasive Bladder Cancer|A Phase 1 Study to Evaluate the Safety and Clinical Activity of Intravesicular CAVATAK™ (Coxsackievirus A21, CVA21) Alone and in Sequential Combination With Low Dose Mitomycin C in Patients With Non-Muscle Invasive Bladder Cancer|Completed||Phase 1|15|Actual|Viralytics||2|||f||||f||||||||||2017-10-10 23:44:10.935922|2017-10-10 23:44:10.935922
NCT02316158|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2014-12-09|||March 2009||2009-03-01|September 2011|2011-09-01|May 2010|Actual|2010-05-01|June 2009|Actual|2009-06-01||Interventional|PSYS||PsYoungSupport - Web-based Support to Young Careers to Persons With Mental Illness|PsYoungSupport Internet and Communication Technology Based Health Programmes - Information, Education and Support to Young People Close to Persons With Mental Illness|Completed||N/A|241|Actual|Vardalinstitutet The Swedish Institute for Health Sciences||2|||f||||f||||||||||2017-10-10 23:44:11.025062|2017-10-10 23:44:11.025062
NCT02316145|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-12-09|||September 2008||2008-09-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Internet-based Coaching for Young Adults With Neuropsychiatric Disorders|Internet-based Support and Coaching for Young Adults With Neuropsychiatric Disorders - A Pilot Study|Completed||N/A|12|Actual|Vardalinstitutet The Swedish Institute for Health Sciences||1|||f||||f||||||||||2017-10-10 23:44:11.112932|2017-10-10 23:44:11.112932
NCT02316132|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-12-04|||December 2014||2014-12-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Confocal Laser Endomicroscopy, IBS and Stress|Confocal Endomicroscopy for the Detection of Food Intolerances in Patients With IBS: Add on Control Group: Does Stress Cause Similar Mucosal Changes to Food Antigens?|Recruiting||N/A|30|Anticipated|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-10 23:44:11.188822|2017-10-10 23:44:11.188822
NCT02316119|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-04-25|||January 2013||2013-01-01|June 2014|2014-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|||Mechanistic Study of Bleeding Risk in Coronary Patients With Cerebrovascular Disease|Mechanisms Involved in the Bleeding Risk of Patients With Coronary Artery Diseased Previous Stroke or Transient Ischemic Attack in Use of Antiplatelet Therapy|Completed||N/A|140|Actual|University of Sao Paulo General Hospital|||2||f||||f||||||||||2017-10-10 23:44:11.286986|2017-10-10 23:44:11.286986
NCT02316106|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-05-26|||May 20, 2015|Actual|2015-05-20|May 2017|2017-05-01|November 27, 2020|Anticipated|2020-11-27|November 27, 2017|Anticipated|2017-11-27||Interventional|||A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma|A Randomized Phase 2 Trial to Evaluate Three Daratumumab Dose Schedules in Smoldering Multiple Myeloma|Active, not recruiting||Phase 2|126|Actual|Janssen Research & Development, LLC||3|||f||||t|t|f||||||||2017-10-10 23:44:11.360927|2017-10-10 23:44:11.360927
NCT02316093|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2014-12-10|||March 2013||2013-03-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||The Effects of Obesity on 8-Hydroxy-Deoxyguanosine Levels in Patients With and Without Periodontal Disease||Completed||Phase 1|90|Actual|Bulent Ecevit University|||6||f||||||||||||||2017-10-10 23:44:11.660192|2017-10-10 23:44:11.660192
NCT02316067|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-09|||May 2013||2013-05-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Traumatic Spinal Cord Injury: Effects of Corporal Suspension and Pendulum Exercises|Effect of Corporal Suspension and Pendulum Exercises on Torque, Muscle Activation, Muscle Thickness and Functionality in Patients With Traumatic Spinal Cord Injury|Completed||N/A|26|Actual|Federal University of Rio Grande do Sul||2|||f||||t||||||||||2017-10-10 23:44:11.839712|2017-10-10 23:44:11.839712
NCT02316054|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-12-06|||November 2007||2007-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|EVADIAB||Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)|Long-term Additive Prognostic Value of Heterogeneity Myocardial Perfusion Imaging of SPECT Over Clinical and Ischemia in High-risk Diabetic Patients.|Completed||N/A|170|Actual|University Hospital, Grenoble|||1||f||||t||||||||||2017-10-10 23:44:11.928633|2017-10-10 23:44:11.928633
NCT02316041|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-02|||January 2014||2014-01-01|May 2017|2017-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction|Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction|Recruiting||N/A|220|Anticipated|Tilganga Institute of Ophthalmology||1|||f||||f||||||||||2017-10-10 23:44:12.015804|2017-10-10 23:44:12.015804
NCT02316028|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-05-23|||March 2014||2014-03-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|December 2016|Actual|2016-12-01||Interventional|DECIT||Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)|A Phase I Clinical Trial on Decitabine (5-aza-2'-Deoxycytidine) Administered by Hepatic Arterial Infusion in Patients With Unresectable Liver-predominant Metastases From Colorectal Cancer|Recruiting||Phase 1/Phase 2|6|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-10 23:44:12.130973|2017-10-10 23:44:12.130973
NCT02316015|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-06-15|||December 2014||2014-12-01|June 2015|2015-06-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|PEMIB||Protein-energy Enriched Milk for Infants With Bronchiolitis|Protein-energy Enriched Milk for Infants With Bronchiolitis|Unknown status|Recruiting|N/A|44|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-10 23:44:12.259673|2017-10-10 23:44:12.259673
NCT02316002|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2016-09-23|||December 2014||2014-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer|Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer|Recruiting||Phase 2|42|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:44:12.366778|2017-10-10 23:44:12.366778
NCT02315989|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-11-28|2015-11-30||August 2014||2014-08-01|September 2014|2014-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Early-Phase Safety of Proton Therapy Equipment|A Study of the Early-Phase Safety of Proton Therapy Equipment for Patients Suffering From Solid Cancers, and the Equipment's Operational Effectiveness.|Completed||N/A|6|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||No||2017-10-10 23:44:12.452125|2017-10-10 23:44:12.452125
NCT02315976|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-29|2015-12-04|||April 2014||2014-04-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Acute Episodes in Chronic Stable Angina: Assessment of the Use of the Coronary Vasodilator Propatyl Nitrate.|Avaliação de episódios Agudos na Angina Pectoris crônica estável: Abordagem clínico-laboratorial do Uso do Vasodilatador Coronariano Propatilnitrato.|Active, not recruiting||Phase 4|200|Anticipated|Fundação Educacional Serra dos Órgãos||1|||f||||f||||||||||2017-10-10 23:44:12.651949|2017-10-10 23:44:12.651949
NCT02315963|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-06-27|||April 2016||2016-04-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Feedback and Rewards to Increase Motivation for Therapy in Stroke Rehabilitation|Feedback and Rewards to Increase Motivation for Therapy in Stroke Rehabilitation|Recruiting||N/A|62|Anticipated|Cereneo AG||2|||f||||f||||||||||2017-10-10 23:44:12.728911|2017-10-10 23:44:12.728911
NCT02315950|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-07-28|||December 2014||2014-12-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder|CineMRI/UDS for Evaluating the Physiologic Effect of Botox in Women With Overactive Bladder|Unknown status|Recruiting|N/A|10|Anticipated|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-10-10 23:44:12.821072|2017-10-10 23:44:12.821072
NCT02315937|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-07-25|||September 2016||2016-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|SATE||Hemodynamic Assessment During Spinal Anesthesia Using Transthoracic Echocardiography'|Hemodynamic Assessment During Spinal Anesthesia Using Transthoracic Echocardiography'|Suspended||N/A|35|Anticipated|Catharina Ziekenhuis Eindhoven|||1|logistic reasons; amendment pending with IRB|f||||||||||||||2017-10-10 23:44:12.911507|2017-10-10 23:44:12.911507
NCT02315924|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-07-19|||March 2013||2013-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Combined Coronary and Cerebral Angiography and Intervention for Coronary and Cerebrovascular Atherosclerosis|An Open-label, Single-centre Study Evaluating the Prevalence and Characteristics of Coronary and Cerebrovascular Arteriosclerosis as Measured by Combined Coronary and Cerebral Angiography, and Comparing the Efficacy and Safety of Simultaneous or Staged Coronary and Cerebral Interventional Strategy in Chinese Patients|Recruiting||N/A|300|Anticipated|Capital Medical University||2|||f||||t||||||||||2017-10-10 23:44:12.9758|2017-10-10 23:44:12.9758
NCT02315911|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-02-25|||December 2014||2014-12-01|February 2016|2016-02-01|October 2026|Anticipated|2026-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Randomized Control Trials of Surgery for Pediatric OSA|Randomized Controlled Studies of Sugery for Pediatric OSA: Part 1 Expectancy Compared to Adeno-tonsillectomy for Mild-moderate OSA. Part 2 Adeno-tonsillectomy Compared to Adeno-pharyngoplasty for Severe OSA.|Recruiting||N/A|160|Anticipated|Karolinska University Hospital||4|||f||||t||||||||||2017-10-10 23:44:13.071911|2017-10-10 23:44:13.071911
NCT02315898|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-12|||November 1, 2017|Anticipated|2017-11-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|August 2021|Anticipated|2021-08-01||Interventional|||Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis|Safety and Efficacy of Inhaled Tissue Plasminogen Activator (tPA) for the Acute Treatment of Pediatric Plastic Bronchitis|Not yet recruiting||Phase 2|24|Anticipated|University of Michigan||1|||f||||t|t|f||||||||2017-10-10 23:44:13.186152|2017-10-10 23:44:13.186152
NCT02315872|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-09-26|||December 2014||2014-12-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ACTH||ACTH for Fatigue in Multiple Sclerosis Patients|The Effect of ACTH (Acthar) on Measures of Chronic Fatigue in Patients With Relapsing Multiple Sclerosis.|Recruiting||Phase 3|90|Anticipated|Providence Health & Services||2|||f||||t||||||||No||2017-10-10 23:44:13.334348|2017-10-10 23:44:13.334348
NCT02315859|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-01-06|||December 2014||2014-12-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Validation of New Non-Invasive Parameters of Diastolic Suction in the Left Ventricle|Validation of New Non-Invasive Parameters of Diastolic Suction in the Left Ventricle|Recruiting||N/A|40|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-10 23:44:13.452511|2017-10-10 23:44:13.452511
NCT02315846|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-09|||January 2014||2014-01-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Acetylcholinesterase in Postoperative Delirium|Role of Acetylcholinesterase for the Diagnosis of Postoperative Delirium in Patients Needing Postoperative Monitoring|Completed||N/A|120|Actual|Heidelberg University|||1||f||||f||||||Samples Without DNA|"     blood-serum   "|||2017-10-10 23:44:13.523263|2017-10-10 23:44:13.523263
NCT02315833|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-22|||June 2014||2014-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients|The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients. Randomized Intervention Trial With a Medical Device (Acetium®Capsules)|Recruiting||N/A|200|Anticipated|Biohit Oyj||2|||f||||f||||||||No||2017-10-10 23:44:13.582209|2017-10-10 23:44:13.582209
NCT02315820|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-10|||January 2015||2015-01-01|December 2014|2014-12-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|IOLEMMT||Induction of Labor Versus Expectant Management of Large for Gestational Age/Macrosomic Babies at Term. A Multi-center Trial|Induction of Labor Versus Expectant Management of Large for Gestational Age/Macrosomic Babies at Term. A Multi-center Randomized Trial|Not yet recruiting||N/A|474|Anticipated|The Baruch Padeh Medical Center, Poriya||2|||f||||f||||||||||2017-10-10 23:44:13.701232|2017-10-10 23:44:13.701232
NCT02315807|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-12-04|||December 2015||2015-12-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|NeuroCog||Neurostimulation for Cognitive Rehabilitation in Stroke|Neurostimulation for Cognitive Enhancement After Stroke (NeuroCog)|Recruiting||Phase 2/Phase 3|60|Anticipated|Federal University of Paraíba||3|||f||||||||||||||2017-10-10 23:44:13.781079|2017-10-10 23:44:13.781079
NCT02315794|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2014-12-09|||September 2009||2009-09-01|December 2014|2014-12-01|February 2011|Actual|2011-02-01|January 2010|Actual|2010-01-01||Interventional|||Aesthetic Outcomes of Single Tooth Implant Using Metal Ceramic Restorations With Either Zirconia or Titanium Abutments|Aesthetic Outcomes of Single Tooth Implant-supported Restorations Using Metal Ceramic Restorations With Either Zirconia or Titanium Abutments: A Randomized Controlled Clinical Study|Completed||Phase 2|24|Actual|University of Firenze and Siena, Napoli, Italy||2|||f||||f||||||||||2017-10-10 23:44:13.85515|2017-10-10 23:44:13.85515
NCT02315781|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-11-14|||January 2015||2015-01-01|November 2015|2015-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||tDCS in Parkinson's Disease With Depression|Parkinson's Disease Depression and tDCS|Recruiting||N/A|50|Anticipated|Pacific Parkinson's Research Centre||2|||f||||f||||||||||2017-10-10 23:44:14.066253|2017-10-10 23:44:14.066253
NCT02315768|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-03-23|||November 2015||2015-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.|A Phase Ib/II Study of Ibrutinib in Combination With GA101 - Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients Over 65 Years of Age or With Comorbidities That Preclude the Use of Chemotherapy Based Treatment. GA101+Ibrutinib|Recruiting||Phase 1/Phase 2|32|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-10 23:44:14.154866|2017-10-10 23:44:14.154866
NCT02315755|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-09-11|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|December 31, 2016|Actual|2016-12-31||Observational|||Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC|Observational Study Evaluating The Efficacy Of Targeted Treatments Following Tyrosine Kinase Inhibitors In Metastatic Renal Cell Carcinoma Patients And Effects On Quality Of Life: A National, Multicenter Study|Active, not recruiting||N/A|102|Actual|Pfizer|||1||f||||f||||||||||2017-10-10 23:44:14.246184|2017-10-10 23:44:14.246184
NCT02315742|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-04|||February 2016||2016-02-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 10, 2017|Actual|2017-03-10||Interventional|||Hearts and Minds in HIV|Healing Hearts and Mending Minds in Older Persons Living With HIV|Completed||N/A|25|Anticipated|Emory University||1|||f||||f||||||||||2017-10-10 23:44:14.362627|2017-10-10 23:44:14.362627
NCT02315729|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-08-29|||November 2016||2016-11-01|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|November 2020|Anticipated|2020-11-01||Observational|||Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis|Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis|Recruiting||N/A|380|Anticipated|University of Colorado, Denver|||1||f||||||||||||||2017-10-10 23:44:14.451995|2017-10-10 23:44:14.451995
NCT02315716|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-11-07|||May 2015||2015-05-01|November 2016|2016-11-01|May 2026|Anticipated|2026-05-01|May 2018|Anticipated|2018-05-01||Interventional|Cardamon||Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Multiple Myeloma|Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Untreated Transplant-eligible Patients With Symptomatic MM to Evaluate the Benefit of Upfront ASCT|Recruiting||Phase 2|280|Anticipated|University College, London||2|||f||||t||||||||||2017-10-10 23:44:14.520331|2017-10-10 23:44:14.520331
NCT02315703|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-08-14||2017-02-01|December 22, 2014|Actual|2014-12-22|August 2017|2017-08-01|June 1, 2023|Anticipated|2023-06-01|May 2, 2016|Actual|2016-05-02||Interventional|||Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention|A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention|Active, not recruiting||Phase 1/Phase 2|393|Actual|Crucell Holland BV||8|||f||||t||f||||||||2017-10-10 23:44:14.767593|2017-10-10 23:44:14.767593
NCT02315690|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-02-02|||September 2015|Actual|2015-09-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|fMDA||Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland|Evaluating the Effectiveness and Feasibility of Reactive Focal Mass Drug Administration vs. Reactive Case Detection as a Community Level Intervention in Response to a Passively Identified Index Malaria Case in Swaziland|Recruiting||Phase 3|6000|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:44:14.915792|2017-10-10 23:44:14.915792
NCT02315677|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-01-06|||January 2015||2015-01-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Nasal Intubation Using a Parker Flex-tip Endotracheal Tube Compared to a Nasal RAE Tube|Nasal Intubation Using a Parker Flex-tip Endotracheal Tube With Posteriorly Facing Bevel Compared to a Nasal RAE Tube With Left Facing Bevel: A Randomized Study|Completed||N/A|60|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-10 23:44:15.027644|2017-10-10 23:44:15.027644
NCT02315664|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-07-11|||November 2, 2015|Actual|2015-11-02|July 2017|2017-07-01|May 25, 2017|Actual|2017-05-25|May 17, 2017|Actual|2017-05-17||Interventional|||MONITOR-OA: Using Wearable Activity Trackers to Improve Physical Activity in Knee Osteoarthritis|Improving Physical Activity Using an Online Monitoring Tool: a New Model of Care for Knee Osteoarthritis|Completed||N/A|61|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:44:15.128149|2017-10-10 23:44:15.128149
NCT02315651|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-12-11|||January 2015||2015-01-01|October 2014|2014-10-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Efficacy of Combined Treatment With CoQ10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder|Efficacy of Combined Treatment With Co-enzyme Q10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder|Unknown status|Not yet recruiting|N/A|60|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:44:15.222775|2017-10-10 23:44:15.222775
NCT02315638|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-11-28|||November 2014||2014-11-01|November 2016|2016-11-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Observational|||Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.|Follow-up to Study Protocol B2801001, A Phase I/II, Open-Label Dose Escalation Study to Evaluate the Safety and Efficacy of Single Doses of TT-034 in Patients With Chronic Hepatitis C [CHC] Infection|Active, not recruiting||N/A|9|Actual|Tacere Therapeutics, Inc.|||1||f||||f||||||Samples Without DNA|"     Blood samples will be collected and archived for further testing, should future data suggest     that it is clinically or scientifically indicated.   "|||2017-10-10 23:44:15.31625|2017-10-10 23:44:15.31625
NCT02315625|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-10-05|||December 5, 2014||2014-12-05|August 23, 2017|2017-08-23|September 6, 2021|Anticipated|2021-09-06|September 7, 2020|Anticipated|2020-09-07||Interventional|||Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery|A Phase II Trial of Mutation-Targeted Therapy With Sunitinib or Everolimus in Patients With Advanced Low-or Intermediate Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery|Recruiting||Phase 2|120|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:44:15.393772|2017-10-10 23:44:15.393772
NCT02315599|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-09-07|||November 19, 2014||2014-11-19|September 1, 2017|2017-09-01|August 1, 2050|Anticipated|2050-08-01|August 1, 2034|Anticipated|2034-08-01||Observational|||Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials|Follow-Up Evaluation for Gene-Therapy Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials|Enrolling by invitation||N/A|63|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:44:15.610587|2017-10-10 23:44:15.610587
NCT02315586|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-11|2017-09-12|||November 12, 2014||2014-11-12|August 28, 2017|2017-08-28|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis|Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:44:15.685729|2017-10-10 23:44:15.685729
NCT02315573|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-09|||October 2014||2014-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Lidocaine With Epinephrine vs. Bupivacaine With Epinephrine as Local Anesthetic Agents in Wide-awake Hand Surgery|Lidocaine With Epinephrine vs. Bupivacaine With Epinephrine as Local Anesthetic Agents in Wide-awake Hand Surgery: an Outcome Study of Patients' Pain Perception.|Unknown status|Recruiting|N/A|70|Anticipated|St. Mary's Research Center, Canada||2|||f||||t||||||||||2017-10-10 23:44:15.771224|2017-10-10 23:44:15.771224
NCT02315560|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-02-14|||September 2014||2014-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Foot Neuromodulation for Nocturnal Enuresis|Foot Neuromodulation for Nocturnal Enuresis in Children|Enrolling by invitation||N/A|20|Anticipated|Children's Hospital of Pittsburgh|||1||f||||f||||||||||2017-10-10 23:44:15.897299|2017-10-10 23:44:15.897299
NCT02315547|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-08-08|||January 2015||2015-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|BISER-2||Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of Bronchiectasis|Guangzhou Institute of Respiratory Disease|Recruiting||N/A|120|Anticipated|Guangzhou Institute of Respiratory Disease||1|||f||||f||||||||||2017-10-10 23:44:15.983956|2017-10-10 23:44:15.983956
NCT02315534|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-07-11|||March 2015||2015-03-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma|A Phase Ib/II Clinical Study of BBI608 in Combination With Temozolomide for Adult Patients With Recurrent or Progressed Glioblastoma|Recruiting||Phase 1/Phase 2|60|Anticipated|Boston Biomedical, Inc||2|||f||||f||||||||||2017-10-10 23:44:16.10497|2017-10-10 23:44:16.10497
NCT02315521|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-11-28|||December 2014||2014-12-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01|5 Years|Observational [Patient Registry]|||Standardized Prenatal Clinical Care for LUTO|Validation of the Standardized Prenatal Clinical Management of Fetuses With Lower Urinary Tract Obstruction (LUTO)|Recruiting||N/A|50|Anticipated|Baylor College of Medicine|||4||f||||f||||||||No||2017-10-10 23:44:16.215387|2017-10-10 23:44:16.215387
NCT02315508|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-03-30|||October 2014||2014-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|QUIET-1||Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo|A Balanced Randomised Placebo Controlled Double-blind Phase IIa Study to Investigate the Efficacy and Safety of AUT00063 Versus Placebo in Subjective Tinnitus|Completed||Phase 2|91|Actual|Autifony Therapeutics Limited||2|||f||||t||||||||||2017-10-10 23:44:16.31588|2017-10-10 23:44:16.31588
NCT02315495|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-07-20|||February 2015||2015-02-01|July 2015|2015-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes|Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes|Unknown status|Recruiting|Phase 3|22|Anticipated|Zhongda Hospital||4|||f||||t||||||||||2017-10-10 23:44:16.43272|2017-10-10 23:44:16.43272
NCT02315482|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-06-23|||December 2014||2014-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Pneumoperitoneum and Steep Trendelenburg on Autonomic Nervous System||Completed||N/A|52|Anticipated|ASST Fatebenefratelli Sacco||2|||f||||f||||||||||2017-10-10 23:44:16.526911|2017-10-10 23:44:16.526911
NCT02315469|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-10-25|||February 2015||2015-02-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery|Pre-operative Assessment and Post-Operative Outcomes of Elderly Women With Gynecologic Cancers|Active, not recruiting||N/A|228|Anticipated|NRG Oncology|||1||f||||t||||||||||2017-10-10 23:44:16.645663|2017-10-10 23:44:16.645663
NCT02315456|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-10|||December 2014||2014-12-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser|Prospective Randomized Evaluation of Centration of Intraocular Lens With Two Laser Settings for Capsulorhexis With Femtosecond Laser|Unknown status|Recruiting|N/A|50|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:44:17.690439|2017-10-10 23:44:17.690439
NCT02315443|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-05-04|||March 2015||2015-03-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|FRONTIER||Field Randomization of NA-1 Therapy in Early Responders|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Intravenous NA-1 Initiated by Paramedics in the Field for Acute Cerebral Ischemia Within Three Hours of Symptom Onset|Recruiting||Phase 3|558|Anticipated|NoNO Inc.||2|||f||||t||||||||||2017-10-10 23:44:17.796224|2017-10-10 23:44:17.796224
NCT02315417|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-04-25|||November 2014||2014-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum|Terminated||Phase 3|16|Actual|XOMA (US) LLC||3|||f||||t||||||||||2017-10-10 23:44:18.878509|2017-10-10 23:44:18.878509
NCT02315404|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-12-10|||January 2014||2014-01-01|December 2014|2014-12-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Cap Assisted Balloon Enteroscopy Versus Conventional Balloon Enteroscopy In The Evaluation Of Obscure Gastrointestinal Bleeding: A Randomized Controlled Trial|Cap Assisted Balloon Enteroscopy Versus Conventional Balloon Enteroscopy In The Evaluation Of Obscure Gastrointestinal Bleeding: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|212|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 23:44:18.96304|2017-10-10 23:44:18.96304
NCT02315391|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-12-17|||September 2012||2012-09-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Protein Nutrition for Muscle Hypertrophy in Older Adults|Efficacy of Isolated Whey and Micellar Whey Protein (+/- Citrulline) to Stimulate Protein Synthesis in 'Healthy' and 'Anabolically Resistant' Elderly Muscle|Completed||N/A|30|Actual|Nestlé||3|||f||||f||||||||||2017-10-10 23:44:19.058123|2017-10-10 23:44:19.058123
NCT02315378|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-08-15|||June 2008||2008-06-01|August 2016|2016-08-01|August 2013|Actual|2013-08-01|October 2010|Actual|2010-10-01||Interventional|||Anxiety Reduction Treatment for Acute Trauma|Anxiety Reduction Treatment for Acute Trauma|Terminated||N/A|36|Actual|New York University School of Medicine||2||The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.|f||||f||||||||||2017-10-10 23:44:19.132128|2017-10-10 23:44:19.132128
NCT02315365|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-10-05|||March 2015||2015-03-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|September 2016|Actual|2016-09-01||Observational|||Real-World Outcome Research Study on Quality of Life, Work Productivity and Health Care Resource Utilization in Metastatic Breast Cancer|Real-World Outcome Research Study on Quality of Life, Work Productivity and Health Care Resource Utilization in Metastatic Breast Cancer|Active, not recruiting||N/A|202|Actual|PeriPharm|||1||f||||f||||||||||2017-10-10 23:44:19.205082|2017-10-10 23:44:19.205082
NCT02315352|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-01-12|2017-01-12||April 2015||2015-04-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets (ODTs) of Praziquantel (PZQ) and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years|Randomized, Single Blind, Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets of PZQ and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years|Completed||Phase 1|48|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-10 23:44:19.268604|2017-10-10 23:44:19.268604
NCT02315339|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-10-25|||August 2014||2014-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01|5 Years|Observational [Patient Registry]|EHMVR||European Home Mechanical Ventilation Registry|European Home Mechanical Ventilation Registry|Terminated||N/A|37|Actual|ResMed|||1||f||||f||||||||||2017-10-10 23:44:19.709573|2017-10-10 23:44:19.709573
NCT02315326|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-02-22|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)|A Phase I/II Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)|Recruiting||Phase 1/Phase 2|18|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-10-10 23:44:19.78371|2017-10-10 23:44:19.78371
NCT02315313|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-08|||December 2014||2014-12-01|December 2014|2014-12-01||||December 2015|Anticipated|2015-12-01||Observational|||The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation||Unknown status|Not yet recruiting|N/A|1000|Anticipated|Ruijin Hospital|||4||f||||f||||||||||2017-10-10 23:44:19.887477|2017-10-10 23:44:19.887477
NCT02315300|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-06-14|||November 2014||2014-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|HypoArrhyth||Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease|Predicting Hypoglycaemia and Arrhythmias in the Vulnerable Patient With Diabetes and Chronic Kidney Disease|Completed||N/A|62|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-10 23:44:19.943394|2017-10-10 23:44:19.943394
NCT02315287|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-08-10|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management|Comparison of Therapeutic Efficacy Between Lobeglitazone and Pioglitazone as Initial Triple Therapy With Metformin and Sitagliptin in Drug-naïve Type 2 Diabetic Patients|Recruiting||Phase 4|190|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-10 23:44:20.039403|2017-10-10 23:44:20.039403
NCT02315274|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-09-22|||June 2014||2014-06-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Pilot Study of Between Visit Interaction to Improve Glycemic Control in Pregnancy With Pre-existing Diabetes|Pilot Study of Between Visit Interaction to Improve Glycemic Control in Pregnancy With Pre-existing Diabetes.|Unknown status|Recruiting|N/A|10|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:44:21.943353|2017-10-10 23:44:21.943353
NCT02315248|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-02-08|||December 2014||2014-12-01|December 2014|2014-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study|Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study|Completed||N/A|197|Actual|University of Mississippi Medical Center|||1||f||||f||||||Samples Without DNA|"     Salivary biosamples will be stored for assaying osteocalcin (OC) and deoxypyridinoline (DPD)     levels   "|||2017-10-10 23:44:22.099608|2017-10-10 23:44:22.099608
NCT02315235|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-04-14|||May 2014||2014-05-01|April 2016|2016-04-01|March 2016|Anticipated|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Peripheral Mobilized Mononuclear Cell-based Therapy in Patient With Diabetic Neuropathy|The Efficacy and Safety of Peripheral Mobilized Mononuclear Cell-based Therapy in Patients With Diabetic Painful Neuropathy|Withdrawn||N/A|0|Actual|Seoul National University Hospital||2||Do not have a sutable subjects.|f||||t||||||||No||2017-10-10 23:44:22.167803|2017-10-10 23:44:22.167803
NCT02315222|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-10|||November 2014||2014-11-01|December 2014|2014-12-01||||July 2015|Anticipated|2015-07-01||Interventional|||Dietary Supplements and Periodontal Wound Healing|Impact of Dietary Supplements on Oral and Periodontal Wound Healing|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|University of Milan||2|||f||||t||||||||||2017-10-10 23:44:22.260335|2017-10-10 23:44:22.260335
NCT02315209|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-09|||January 2014||2014-01-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01|1 Year|Observational [Patient Registry]|||Multicentric Evaluation of UPP, UHS and Ultra Pro Comfort Plug for Inguinal Hernia Surgery Including Quality of Life Evaluation||Unknown status|Enrolling by invitation|N/A|4000|Anticipated|University of Magdeburg|||1||f||||t||||||||||2017-10-10 23:44:22.357408|2017-10-10 23:44:22.357408
NCT02315196|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-09-21|||December 26, 2014|Actual|2014-12-26|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer|A Phase 2 Trial of Liposomal Doxorubicin and Carboplatin in Patients With ER, PR, HER2 Negative Breast Cancer (TNBC)|Recruiting||Phase 2|60|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 23:44:22.437092|2017-10-10 23:44:22.437092
NCT02315183|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-05-25|||January 2014||2014-01-01|December 2014|2014-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|MaRACAS||An Observational Case Control Study to Identify the Role of MV and MV Derived Micro-RNA in Post CArdiac Surgery AKI|An Observational Case Control Study to Identify the Role of MV and MV Derived Micro-RNA in Post CArdiac Surgery Acute Kidney Injury: The MaRACAS Study|Completed||N/A|96|Actual|University of Leicester|||1||f||||t||||||Samples Without DNA|"     Blood and Urine samples are taken at numerous timepoints upto 5 days post cardiac surgery.   "|||2017-10-10 23:44:22.551207|2017-10-10 23:44:22.551207
NCT02315170|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-02-02|||September 2014||2014-09-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Assessment of Novel Intraocular Injection Guide|Assessment of Novel Intraocular Injection Guide|Completed||N/A|50|Actual|Maturi, Raj K., M.D., P.C.||2|||f||||f||||||||||2017-10-10 23:44:22.623475|2017-10-10 23:44:22.623475
NCT02315157|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2016-10-19||||||October 2016|2016-10-01||||January 2020|Anticipated|2020-01-01||Interventional|||Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma|Phase I Study of Escalating-Doses of Bendamustine for Patients With Previously Treated Multiple Myeloma|Withdrawn||Phase 1|0|Actual|Thomas Jefferson University||2||Withdrawn by PI|f||||t||||||||||2017-10-10 23:44:22.798865|2017-10-10 23:44:22.798865
NCT02313636|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-12-28|||May 2014||2014-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01|1 Day|Observational [Patient Registry]|DaBlaCa-7||Narrow Band Imaging in Flexible Cystocopy|Narrow Band Imaging in Flexible Cystocopy - DaBlaCa-7|Completed||N/A|892|Anticipated|Aarhus University Hospital|||1||f||||t||||||||||2017-10-10 23:44:40.717992|2017-10-10 23:44:40.717992
NCT02315144|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-08-27|||April 2015||2015-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients|A 2-Stage, Single-Dose Study in Healthy Volunteers and COPD Patients With an Open Label Ipratropium Bromide Reference to Evaluate the Efficacy, Pharmacokinetics, and Safety Profile of Inhaled TV48108|Terminated||Phase 1|61|Actual|Teva Pharmaceutical Industries||5||Business decision|f||||f||||||||||2017-10-10 23:44:22.913527|2017-10-10 23:44:22.913527
NCT02315131|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-08-27|||March 2015||2015-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017|A 2-Stage, Single-Dose Study in Healthy Volunteers and COPD Patients With an Open Label Ipratropium Bromide Reference to Evaluate the Efficacy, Pharmacokinetics, and Safety Profile of Inhaled TV46017|Terminated||Phase 1|53|Actual|Teva Pharmaceutical Industries||6||Business decision|f||||f||||||||||2017-10-10 23:44:23.024287|2017-10-10 23:44:23.024287
NCT02315118|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-06-21|||December 2014||2014-12-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies|Pilot Study of Autologous T Lymphocytes With Antibody-Dependent Cell Cytotoxicity in Patients With CD20-Positive B-Cell Malignancies|Recruiting||Phase 1/Phase 2|18|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-10 23:44:23.13855|2017-10-10 23:44:23.13855
NCT02315105|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2014-12-17|||August 2011||2011-08-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Resolution of Comorbidities & Safety and Efficacy of Greater Curvature Plication in Obese Patients||Unknown status|Recruiting|N/A|75|Anticipated|Singh, Kuldeep, M.D., P.A.||1|||f||||t||||||||||2017-10-10 23:44:23.24224|2017-10-10 23:44:23.24224
NCT02315092|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-05-12|||December 2014||2014-12-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|||Evaluation of Fluorescence-image Guided Wound Assessment vs. Standard Practice|Evaluation of Fluorescence-image Guided Wound Assessment vs. Standard Practice|Unknown status|Enrolling by invitation|N/A|77|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples Without DNA|"     Microbiological samples (skin and wound swabs)   "|||2017-10-10 23:44:23.331031|2017-10-10 23:44:23.331031
NCT02315079|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-08-28|||January 2015||2015-01-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Point of Care Testing of Inflammatory Markers in Tears|Point of Care Testing of Inflammatory Markers in Tears|Completed||N/A|63|Actual|University of Florida|||2||f||||f||||||Samples Without DNA|"     de-identified tear samples   "|||2017-10-10 23:44:23.413812|2017-10-10 23:44:23.413812
NCT02315066|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-09-11|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566|A Phase 1, Open-label, Dose Escalation Study Of Pf-04518600 As A Single Agent And In Combination With Pf-05082566 In Patients With Selected Locally Advanced Or Metastatic Cancers|Recruiting||Phase 1|210|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-10 23:44:23.51366|2017-10-10 23:44:23.51366
NCT02315053|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-09-26|||February 2013||2013-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||PET Response During Chemoradiation of Lung Cancer|Dynamic FDG‐PET/CT Response During Chemoradiation for NSCLC|Recruiting||N/A|42|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-10 23:44:23.739535|2017-10-10 23:44:23.739535
NCT02315040|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2017-06-06|||March 2012||2012-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|EVIE||EVIE-Study: Slow Release Insemination Versus Standard Intrauterine Insemination Study|Testing the Effect of Intrauterine Slow Release Insemination (SRI) on the Pregnancy Rate in Women Designated for Standard Intrauterine Insemination (IUI)|Recruiting||Phase 3|250|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-10 23:44:23.827137|2017-10-10 23:44:23.827137
NCT02315027|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-05-08|||October 2012||2012-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Mesenchymal Stem Cell Therapy in Multiple System Atrophy|Intrathecal Autologous Mesenchymal Stem Cell Therapy in Multiple System Atrophy (MSA) - Effect of Dose and Natural History|Active, not recruiting||Phase 1|30|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-10 23:44:23.931159|2017-10-10 23:44:23.931159
NCT02315014|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-12-10|||March 2013||2013-03-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Daily Protein Intake Distribution and MPS (ARCIII)|Effect of Balanced Daily Protein Distribution Supplemented With Whey Protein on Muscle Protein Synthesis in Overweight Older Men During Calorie Restriction and Exercise (ARC III)|Completed||N/A|20|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 23:44:24.014463|2017-10-10 23:44:24.014463
NCT02315001|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-05-19|||January 2014||2014-01-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|LIONESS||Liraglutide to Improve corONary Haemodynamics During Exercise streSS|The Physiological Effects of GLP-1 on Haemodynamics During Exercise in Patients With Ischaemic Heart Disease|Completed||Phase 2|26|Actual|King's College London||2|||f||||f||||||||||2017-10-10 23:44:24.087822|2017-10-10 23:44:24.087822
NCT02314988|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-08-23|||December 2016||2016-12-01|August 2016|2016-08-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Tranexamic Acid to Reduce Blood Loss in Spine Trauma Surgery|Topical Application of Tranexamic Acid to Reduce Blood Loss During Complex Combat-related Spine Trauma Surgery|Not yet recruiting||Phase 2/Phase 3|252|Anticipated|Columbia University||2|||f||||t||||||||Undecided||2017-10-10 23:44:24.188127|2017-10-10 23:44:24.188127
NCT02314962|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-12-15|||December 2014||2014-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|Perfusion||PET/MRI Perfusion and CT Perfusion in Solid Tumors|Diagnostic and Clinical Accuracy of Integrated Magnetic Resonance Imaging and Computed Tomography Perfusion in PET/MRI in Comparison to PET/CT in Solid Tumors|Terminated||N/A|43|Actual|University of Zurich|||1|Slow enrolment|f||||f||||||||||2017-10-10 23:44:24.370077|2017-10-10 23:44:24.370077
NCT02314949|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-08|||October 2000||2000-10-01|July 2013|2013-07-01||||January 2015|Anticipated|2015-01-01||Observational|LP||Leuven Tolerogenic Protocol for Intestinal Transplantation|A Multifactorial Immunomodulatory Protocol -Promoting T-regulatory Cells- Prolongs Graft and Patient Survival After Intestinal Transplantation|Unknown status|Recruiting|N/A|13|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:44:24.531541|2017-10-10 23:44:24.531541
NCT02314923|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-08-17|||December 5, 2014|Actual|2014-12-05|August 2017|2017-08-01|June 23, 2016|Actual|2016-06-23|June 23, 2016|Actual|2016-06-23||Interventional|||Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)|A Phase 1 Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Response Study to Evaluate the Safety and Immunogenicity of the BPSC-1001 (VSVΔG-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Subjects|Completed||Phase 1|512|Actual|Merck Sharp & Dohme Corp.||8|||f||||t||||||||||2017-10-10 23:44:24.744811|2017-10-10 23:44:24.744811
NCT02314910|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-10-25|||August 2013||2013-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01|5 Years|Observational [Patient Registry]|||Bone Innervation Around Implants|Exploring Bone Innervation Around Osseointegrated Implants|Recruiting||N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"     Implant surrounded by bone material   "|||2017-10-10 23:44:24.875546|2017-10-10 23:44:24.875546
NCT02314897|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-10|||January 2015||2015-01-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study|Left Ventricular Pacing to Prevent Iatrogenic Tricuspid Regurgitation Caused by Conventional Right Ventricular Pacing: a Pilot Study|Unknown status|Not yet recruiting|N/A|20|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-10 23:44:24.980588|2017-10-10 23:44:24.980588
NCT02314884|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-10|||November 2014||2014-11-01|November 2014|2014-11-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours|A Phase I, Open-label, Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Cafusertib Hydrochloride in Patients With Advanced Solid Tumors|Unknown status|Recruiting|Phase 1|40|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:44:25.135975|2017-10-10 23:44:25.135975
NCT02314871|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-02-18|||January 2015||2015-01-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery|Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery|Recruiting||Phase 4|60|Anticipated|The Institute of Molecular and Translational Medicine, Czech Republic||3|||f||||f||||||||||2017-10-10 23:44:25.259244|2017-10-10 23:44:25.259244
NCT02314858|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-06-21|||October 2014||2014-10-01|June 2016|2016-06-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|||Tailored Treatment to Enhance Risk Perception in Sleep Apnea|Tailored Treatment to Enhance Risk Perception in Sleep Apnea.|Recruiting||N/A|300|Anticipated|National Jewish Health||3|||f||||f||||||||||2017-10-10 23:44:25.40009|2017-10-10 23:44:25.40009
NCT02314845|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Optimizing Intraoperative Mechanical Ventilation Using EIT-titrated PEEP|Optimizing Intraoperative Mechanical Ventilation Using EIT-titrated PEEP|Completed||N/A|40|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:44:25.537393|2017-10-10 23:44:25.537393
NCT02314832|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-03-28|||September 2014||2014-09-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Risk of Falling After CFNB Versus ACB|Comparison Between the Risk Falls After Total Knee Arthroplasty With Use of Femoral Nerve Block Versus Adductor Canal Block|Completed||N/A|62|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-10 23:44:25.651002|2017-10-10 23:44:25.651002
NCT02314819|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-01-24|||December 2014||2014-12-01|January 2017|2017-01-01|January 17, 2017|Actual|2017-01-17|January 2017|Actual|2017-01-01||Interventional|FRESCO||A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)|A Randomized, Double-blind and Placebo-controlled Phase III Trial Comparing Fruquintinib Efficacy and Safety vs Best Support Care (BSC) in Advanced Colorectal Cancer Patients Who Have Failed at Least Second Lines of Chemotherapies|Completed||Phase 3|416|Actual|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-10 23:44:25.770416|2017-10-10 23:44:25.770416
NCT02314806|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-09|||January 2013||2013-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Gentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla|Effect of Gentamicin Versus Clindamycin Versus Normal Saline Lavage of the Axillary Surgical Bed After Lymph Node Dissection on Drainage Discharge Volume|Completed||Phase 3|51|Actual|Hospital General Universitario Elche||3|||f||||t||||||||||2017-10-10 23:44:25.915635|2017-10-10 23:44:25.915635
NCT02314793|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-06-17|||November 2014||2014-11-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205|A Phase 1 Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of ASP2205|Terminated||Phase 1|93|Actual|Astellas Pharma Inc||7||The study has been terminated because of operational reasons.|f||||f||||||||||2017-10-10 23:44:26.001087|2017-10-10 23:44:26.001087
NCT02314780|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-03-15|||January 2015||2015-01-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Pilot Trial: The Effects of Intravenous Heme Arginate on HO-1 Expression and Oxidative Stress in the Human Heart||Recruiting||Phase 2|36|Anticipated|Medical University of Vienna||3|||f||||f||||||||||2017-10-10 23:44:26.144848|2017-10-10 23:44:26.144848
NCT02314767|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-09|||February 2004||2004-02-01|December 2014|2014-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Finnish Community Randomized Psychotherapy Effectiveness Study for Major Depression|A Finnish Community Randomized Psychotherapy Effectiveness Study for Major Depression|Completed||N/A|134|Actual|Helsinki University Central Hospital||3|||f||||f||||||||||2017-10-10 23:44:26.237081|2017-10-10 23:44:26.237081
NCT02314754|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-07-13|||December 2014||2014-12-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|XXGA||Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation|Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation: A Non-inferiority Trial|Completed||Phase 4|719|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-10 23:44:26.324388|2017-10-10 23:44:26.324388
NCT02314741|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-05-29|||May 2014||2014-05-01|July 2014|2014-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|POEM||Peroral Endoscopic Myotomy (POEM) for Esophageal Motility|Peroral Endoscopic Myotomy (POEM) for Esophageal Motility in Patients With a Clinical Diagnosis of Achalasia|Completed||N/A|10|Actual|University of Pennsylvania||1|||f||||||||||||||2017-10-10 23:44:26.441562|2017-10-10 23:44:26.441562
NCT02314728|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-03-15|||November 2014||2014-11-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Cervical Ripening in Premature Rupture of Membranes|Cervical Ripening in Premature Rupture of Membranes|Recruiting||N/A|400|Anticipated|Montefiore Medical Center||2|||f||||t||||||||Undecided||2017-10-10 23:44:26.52984|2017-10-10 23:44:26.52984
NCT02314715|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-03-02|||November 2013||2013-11-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|NEKO||Neuromuscular Control in Knee Osteoarthritis|Neuromuscular Control in Knee Osteoarthritis|Completed||N/A|95|Actual|Glasgow Caledonian University|||2||f||||||||||||||2017-10-10 23:44:26.64903|2017-10-10 23:44:26.64903
NCT02314702|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-06-19|||September 2015||2015-09-01|June 2017|2017-06-01|October 2027|Anticipated|2027-10-01|October 2026|Anticipated|2026-10-01||Observational|||Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems|Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems|Recruiting||N/A|30|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||No||2017-10-10 23:44:26.72528|2017-10-10 23:44:26.72528
NCT02314689|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-03-07|2015-12-09||January 2015||2015-01-01|March 2016|2016-03-01||||December 2015|Actual|2015-12-01||Interventional|||A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease||Completed||Phase 1|4|Actual|University of Mississippi Medical Center||1|||f||||t||||||||||2017-10-10 23:44:26.836302|2017-10-10 23:44:26.836302
NCT02314676|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-09|||November 2014||2014-11-01|December 2014|2014-12-01||||July 2017|Anticipated|2017-07-01||Interventional|||Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children||Unknown status|Recruiting|Phase 4|900|Anticipated|GeneScience Pharmaceuticals Co., Ltd.||1|||f||||||||||||||2017-10-10 23:44:27.045309|2017-10-10 23:44:27.045309
NCT02314663|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-09|||January 2013||2013-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|EFESCOM||Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia|Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia: a Randomised Clinical Trial|Unknown status|Active, not recruiting|N/A|358|Anticipated|Gerencia de Atención Primaria, Albacete||2|||f||||t||||||||||2017-10-10 23:44:27.154948|2017-10-10 23:44:27.154948
NCT02314650|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2016-01-27|||April 2014||2014-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TOP||TEAS to Reduce Propofol Consumption During General Anesthesia|Effect of Transcutaneous Electrical Acupoint Stimulation on Propofol Consumption During General Anesthesia|Completed||N/A|81|Actual|Fourth Military Medical University||3|||f||||t||||||||||2017-10-10 23:44:27.280922|2017-10-10 23:44:27.280922
NCT02314637|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-07-29|2014-12-12||August 2009||2009-08-01|July 2015|2015-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients|Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|240|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-10 23:44:27.419202|2017-10-10 23:44:27.419202
NCT02314624|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-02-06|||December 2014||2014-12-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||PracticeGround: Transforming Training and Delivery of Mental Health EBPs|PracticeGround: Transforming Training and Delivery of Mental Health EBPs|Enrolling by invitation||N/A|80|Anticipated|Evidence-Based Practice Institute, Seattle, WA||2|||f||||t||||||||||2017-10-10 23:44:28.713774|2017-10-10 23:44:28.713774
NCT02314611|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-06-19|||December 2014||2014-12-01|June 2017|2017-06-01|December 2027|Anticipated|2027-12-01|December 2026|Anticipated|2026-12-01||Observational|||Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems|Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems|Enrolling by invitation||N/A|150|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||No||2017-10-10 23:44:28.807492|2017-10-10 23:44:28.807492
NCT02314598|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-06-19|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|October 20, 2017|Anticipated|2017-10-20|September 20, 2017|Anticipated|2017-09-20||Observational|TEC||Therapy Coil Electrogram Collection Study|Therapy Coil Electrogram Collection Study|Active, not recruiting||N/A|46|Actual|Medtronic BRC|||1||f||||f||||||||||2017-10-10 23:44:28.907821|2017-10-10 23:44:28.907821
NCT02314585|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2015-08-25|||December 2014||2014-12-01|August 2015|2015-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|FIRMS||Fall Risk Reduction in Multiple Sclerosis (FIRMS)|Fall Risk Reduction in Multiple Sclerosis: Exercise Intervention vs. Attention Control Modification|Recruiting||N/A|100|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 23:44:28.991575|2017-10-10 23:44:28.991575
NCT02314572|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-12-15|||March 2013||2013-03-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Visual Acuity After the Combined Binocular Implantation of +2.5 Diopters and +3.0 Diopters ReSTOR Multifocal Intraocular Lenses.|Evaluation of the Visual Acuity After the Implantation of a ReSTOR +2.5 Diopters Intraocular Lens (ReSTOR SV25T0) in the Distance Dominant Eye, in Combination With a +3.0 Diopters ReSTOR Intraocular Lens (ReSTOR SN6AD1) in the Fellow Eye.|Completed||Phase 4|15|Actual|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-10 23:44:29.096609|2017-10-10 23:44:29.096609
NCT02314559|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-11-15|||February 2015||2015-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Psychomotor Recuperation Study After Deep Sedation for Colonoscopy Between Target Controlled and Manual Titration of Propofol|A Psychomotor Recuperation Study After Deep Sedation for Colonoscopy Between Target Controlled and Manual Titration of Propofol.|Recruiting||Phase 4|160|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 23:44:29.212855|2017-10-10 23:44:29.212855
NCT02314546|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-06-25|2015-01-28||December 2011||2011-12-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||It was determined that a minimum of 15 patients (5 in each group) were necessary for baseline statistical analysis of this pilot study, to be used in performing a formal power analysis and sample size calculation. However, limitations in the number of providers and eligible patients during the two-year study period prevented further recruitment.|Intranasal Midazolam in Children as a Pre-Operative Sedative|Intranasal Midazolam in Children as a Pre-Operative Sedative|Completed||Phase 4|15|Actual|Bassett Healthcare|Limitations in the number of providers and eligible patients during the two-year study period.|3|||f||||f||||||||||2017-10-10 23:44:29.376662|2017-10-10 23:44:29.376662
NCT02314533|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-09|||December 2014||2014-12-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluate the Efficacy of Fenofibrate on Microalbuminuria|A Prospective, Open-label, Parallel, Controlled Study to Evaluate the Efficacy of Fenofibrate on Microalbuminuria in Hypertriglyceridemic Patients With Type 2 Diabetes on Top of Statin Therapy|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Beijing Chao Yang Hospital||1|||f||||t||||||||||2017-10-10 23:44:29.989944|2017-10-10 23:44:29.989944
NCT02314520|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-06-21|2017-05-23||July 13, 2015|Actual|2015-07-13|June 2017|2017-06-01|December 7, 2016|Actual|2016-12-07|December 7, 2016|Actual|2016-12-07||Interventional|NSPVC||Complications Associated With Central Venous Access in the NSICU: PICC vs CVC|Complications Associated With Central Venous Access in the NSICU: PICC vs CVC|Completed||N/A|152|Actual|Milton S. Hershey Medical Center||2|||f||||t|f|t|f|f||||No||2017-10-10 23:44:30.124108|2017-10-10 23:44:30.124108
NCT02314507|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2015-03-17|||July 2014||2014-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Gua Sha for Chronic Low Back Pain in Elderly|Effects of Gua Sha and Hot Pack for Relieving Chronic Low Back Pain in Elderly: A Crossover Randomized Controlled Trial|Completed||N/A|12|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||||2017-10-10 23:44:30.544263|2017-10-10 23:44:30.544263
NCT02314494|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-07-11|||May 2015||2015-05-01|December 2015|2015-12-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|ProAsk||Proactve Assessment of Overweight Risk During Infancy|A Feasibility Study of an Interactive, Educational Programme to Facilitate Proactive Assessment of Overweight Risk During Infancy|Completed||N/A|83|Actual|Anglia Ruskin University|||2||f||||f||||||||||2017-10-10 23:44:30.645381|2017-10-10 23:44:30.645381
NCT02314481|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-16|||May 12, 2017|Actual|2017-05-12|May 2017|2017-05-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|DARWIN II||Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity|Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity - DARWIN II|Recruiting||Phase 2|119|Anticipated|University College, London||4|||f||||t|f|f||||||||2017-10-10 23:44:30.729953|2017-10-10 23:44:30.729953
NCT02314468|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-12-08|||October 2013||2013-10-01|December 2014|2014-12-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|NPWTvsGPA||Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation|Comparative Study of Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation in Necrotising Soft Tissue Infections|Unknown status|Recruiting|N/A|32|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-10 23:44:30.865431|2017-10-10 23:44:30.865431
NCT02314455|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-07-19|||September 2014||2014-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|EoE||Esophageal Absorption in EoE|Esophageal Absorption in Eosinophilic Esophagitis|Terminated||N/A|14|Actual|Mayo Clinic||1||Early analysis showed negative results. It was decided to halt the study.|f||||f||||||||||2017-10-10 23:44:30.966172|2017-10-10 23:44:30.966172
NCT02314442|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-12-16|||December 2014||2014-12-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|||A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)|A Phase 1, Randomized, Single Blind, Placebo Controlled, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN PCSSC in Subjects With Elevated Low Density Lipoprotein Cholesterol|Completed||Phase 1|70|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:44:31.048586|2017-10-10 23:44:31.048586
NCT02314429|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-03-11|||September 2014||2014-09-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|LACRING01||Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis|Phase I Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis|Completed||Phase 1|6|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-10 23:44:31.122921|2017-10-10 23:44:31.122921
NCT02314416|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-05-22|||May 2015||2015-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Stem Cells In Wound Healing With Collagen Matrix as a Carrier|Stem Cells In Wound Healing With Collagen Matrix as a Carrier|Withdrawn||Phase 4|0|Actual|Augusta University||2|||f||||t||||||||||2017-10-10 23:44:31.334239|2017-10-10 23:44:31.334239
NCT02314403|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-04-20|||February 2015||2015-02-01|April 2017|2017-04-01|August 2021|Anticipated|2021-08-01|March 2021|Anticipated|2021-03-01||Interventional|||Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)||Active, not recruiting||Phase 1|5|Anticipated|Massachusetts General Hospital||1|||||||t||||||||||2017-10-10 23:44:31.422346|2017-10-10 23:44:31.422346
NCT02314390|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-08|||September 2013||2013-09-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|G/I-MBCT||Group- Versus Individual-Mindfulness-Based Cognitive Therapy: a Randomized Trial|Group- Versus Individual-Mindfulness-Based Cognitive Therapy for Patients With a Chronic Somatic Disease and Comorbid Depressive Symptoms: a Randomized Trial|Completed||N/A|56|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-10 23:44:31.53418|2017-10-10 23:44:31.53418
NCT02314377|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-06-02|||June 2016||2016-06-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Bevacizumab Therapy for Brain Arteriovenous Malformation|Bevacizumab Therapy for Brain Arteriovenous Malformation|Recruiting||Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-10 23:44:31.619063|2017-10-10 23:44:31.619063
NCT02314364|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-09-22|||December 2014||2014-12-01|September 2017|2017-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC|A Phase II Trial of Integrating Stereotactic Body Radiation Therapy With Selective Targeted Therapy in Stage IV Oncogene-driven Non-Small Cell Lung Cancer|Recruiting||Phase 2|30|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-10 23:44:31.723653|2017-10-10 23:44:31.723653
NCT02314351|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-01-03|||December 2014||2014-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial|Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial|Completed||Phase 4|148|Actual|Kocaeli University||2|||f||||t||||||||||2017-10-10 23:44:31.853817|2017-10-10 23:44:31.853817
NCT02314338|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-12-31|||September 2014||2014-09-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||The Short Physical Performance Battery in Chronic Obstructive Pulmonary Disease (COPD)|The Short Physical Performance Battery in COPD - Possible Impact of a Pulmonary Rehabilitation Program and Relationships to Other Physical Performance Measures, Symptoms, and Quality of Life.|Completed||N/A|50|Actual|LHL Helse||1|||f||||f||||||||||2017-10-10 23:44:32.002756|2017-10-10 23:44:32.002756
NCT02314325|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-12-10|||April 2014||2014-04-01|December 2014|2014-12-01|October 2016|Anticipated|2016-10-01|May 2016|Anticipated|2016-05-01||Interventional|PERSONAL||Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens|Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens|Unknown status|Recruiting|Phase 4|20|Anticipated|St. James's Hospital, Ireland||2|||f||||t||||||||||2017-10-10 23:44:32.132154|2017-10-10 23:44:32.132154
NCT02314312|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-10|||January 2012||2012-01-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors|A 12 Month, Single-center, Open-label, Randomized-controlled Trial to Investigate Efficacy, Safety and Tolerability of Everolimus in Combination With Cyclosporine A and Corticosteroid in de Novo Transplant Recipients of Expanded Criteria Donor Kidneys or Acute Kidney Injury|Unknown status|Active, not recruiting|Phase 3|48|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-10 23:44:32.296232|2017-10-10 23:44:32.296232
NCT02314299|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-10-02||2015-10-02|November 2014||2014-11-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|SPIOC-101||A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration|A Phase 1/2, Open-Label, Dose-Escalation, Single Center, Clinical Study of MTP-131 (Ocuvia™) Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration.|Completed||Phase 1/Phase 2|20|Actual|Stealth BioTherapeutics Inc.||2|||f||||f||||||||||2017-10-10 23:44:32.426607|2017-10-10 23:44:32.426607
NCT02314286|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-12-10|||December 2014||2014-12-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery|Rosuvastatin Use in Order to Induce Preeclampsia Resolution in Severe Preeclampsia Cases up to 48 Hours Following Delivery|Unknown status|Not yet recruiting|Phase 1/Phase 2|100|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-10-10 23:44:32.562964|2017-10-10 23:44:32.562964
NCT02314273|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-12-08|||September 2011||2011-09-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL|Effect of Treatment Using rhIL-11 in Patients With Thrombocytopenia After Chemotherapy for Childhood Acute Lymphoblastic Leukemia|Completed||Phase 4|120|Actual|Shanghai Children's Medical Center||2|||f||||t||||||||||2017-10-10 23:44:32.675968|2017-10-10 23:44:32.675968
NCT02314260|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2015-01-08|2014-12-15||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational||80 primigravidas undergoing induction of labour at our hospital|Modifying Cervical Bishop Scoring System|Bishop Score; Are Further Modifications Needed?|Completed||N/A|80|Actual|Kasr El Aini Hospital|||1||f||||f||||||||||2017-10-10 23:44:32.805396|2017-10-10 23:44:32.805396
NCT02314247|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-03-23|||February 2015||2015-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy & Safety Study of Selinexor in Relapsed/Refractory Peripheral T-cell Lymphoma & Cutaneous T-cell Lymphoma|Multi-center, Phase II, Open-label Study of Efficacy and Safety of the Selective Inhibitor of Nuclear Export (SINE™) Selinexor (KPT-330) in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) and Cutaneous T-cell Lymphoma (CTCL)|Terminated||Phase 2|16|Actual|Karyopharm Therapeutics Inc||1||Due to enrollment challenges. The termination is not a consequence of any safety concern.|f||||f||||||||Yes||2017-10-10 23:44:33.194376|2017-10-10 23:44:33.194376
NCT02314234|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-02-23|||January 2012||2012-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Improvement of Facial Nerve Monitoring in Parotid Surgery by Sugammadex|Influence of Sugammadex on Facial Nerve Monitoring in Parotid Surgery|Completed||Phase 4|50|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||2||f||||t||||||||||2017-10-10 23:44:33.311063|2017-10-10 23:44:33.311063
NCT02314221|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-08-21|||February 2015||2015-02-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|EAWSCI||Exoskeletal-assisted Walking to Improve Mobility, Bowel Function and Cardio-Metabolic Profiles in Persons With SCI|A Randomized, Crossover Clinical Trial of Exoskeletal-assisted Walking to Improve Mobility, Bowel Function and Cardio-Metabolic Profiles in Persons With SCI|Recruiting||N/A|64|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-10 23:44:33.38997|2017-10-10 23:44:33.38997
NCT02314208|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-03-03|||January 2015||2015-01-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SPA-M||Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5|Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5|Active, not recruiting||Phase 2|12|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||f||||||||||2017-10-10 23:44:33.512805|2017-10-10 23:44:33.512805
NCT02314195|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-10|||April 2014||2014-04-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Music Therapy in Obsessive Compulsive Disorder|A Randomized Clinical Trial of Music Therapy as an Adjunct to Standard Treatment for Obsessive Compulsive Disorder and Co-morbid Anxiety and Depression in Iran|Completed||N/A|30|Actual|Islamic Azad University, Marvdasht||2|||f||||f||||||||||2017-10-10 23:44:33.623312|2017-10-10 23:44:33.623312
NCT02314182|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-12-10|||November 2014||2014-11-01|November 2014|2014-11-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|GRECCAR8||GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis|GRECCAR 8 : Impact on Survival of the Primary Tumor Resection in Rectal Cancer With Unresectable Synchronous Metastasis a Randomized Multicenter Study|Recruiting||Phase 3|290|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:44:33.71603|2017-10-10 23:44:33.71603
NCT02314169|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-10|2017-05-23|||May 1, 2015|Actual|2015-05-01|March 2017|2017-03-01||||September 1, 2016|Actual|2016-09-01||Interventional|||Nivolumab in Treating Patients With Refractory Metastatic Anal Canal Cancer|A Multi-Institutional Phase 2 Study of Nivolumab in Refractory Metastatic Squamous Cell Carcinoma of the Anal Canal|Active, not recruiting||Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:44:33.833056|2017-10-10 23:44:33.833056
NCT02314156|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-09|2017-06-28|||October 2015||2015-10-01|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy|Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy|Recruiting||Phase 2|70|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-10 23:44:33.988769|2017-10-10 23:44:33.988769
NCT02314143|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-09-23|||November 13, 2013||2013-11-13|September 2017|2017-09-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|||Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib|Phase II Biomarker Study Evaluating The Upfront Combination Of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus The Combination After Eight Weeks Of Monotherapy With Dabrafenib Or Trametinib In Patients With Metastatic And Unresectable Stage III Or IV Melanoma Harbouring An Activating BRAF Mutation|Completed||Phase 2|47|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:44:34.114957|2017-10-10 23:44:34.114957
NCT02314130|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-12-10|||May 2009||2009-05-01|March 2013|2013-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||No-commercial Enteral Diet for Patients in Home Nutritional Therapy: Effects on Anthropometric and Biochemical Indices|No-commercial Enteral Diet for Patients in Home Nutritional Therapy: Effects on Anthropometric and Biochemical Indices|Completed||N/A|66|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 23:44:34.235512|2017-10-10 23:44:34.235512
NCT02314117|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-03-08|||January 2015||2015-01-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|January 2017|Actual|2017-01-01||Interventional|RAINFALL||A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Capecitabine and Cisplatin With or Without Ramucirumab as First-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (RAINFALL)|Active, not recruiting||Phase 3|616|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 23:44:34.336632|2017-10-10 23:44:34.336632
NCT02314104|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-04-10|2015-04-02||May 2011||2011-05-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||arm 1: 6 baseline data lost, 3 did not report scores, 1 surgery cancelled after TAP, arm 2: 6 did not report scores, 6 baseline data lost, 1 developed allergy, 1 TAP given after surgery, 1 never received TAP arm 3: 6 did not report scores, 2 developed allergy, 2 surgery cancelled after TAP, 1 re-operated, 1 discharged immediately|Efficacy of Transversus Abdominis Plane Block Versus Local Injection of Pain Medication|Analgesic Efficacy of Transversus Abdominis Plane Block Versus Local Injection in Postoperative Pain Management Following Minimally Invasive Gynecological Surgery|Completed||N/A|220|Actual|Liberman, Eric, D.O.||3|||f||||f||||||||||2017-10-10 23:44:34.821219|2017-10-10 23:44:34.821219
NCT02314091|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-09|||January 2011||2011-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2012|Actual|2012-09-01||Interventional|IH01||Long Term Results of Randomized Prospective Comparison of Onlay and Sublay Mesh Repair Techniques for Incisional Hernia|Long Term Results of Randomized Prospective Comparison of Onlay and Sublay Mesh Repair Techniques for Incisional Hernia|Completed||N/A|100|Actual|Konya Training and Research Hospital||2|||f||||f||||||||||2017-10-10 23:44:35.335336|2017-10-10 23:44:35.335336
NCT02314078|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-08|||January 2010||2010-01-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|Crash||Audit of the Response Time of the Anaesthetic and Surgical Techniques for Crash Caesarean Section|Audit of the Response Time of the Anaesthetic and Surgical Techniques for Crash Caesarean Section|Completed||N/A|390|Actual|KK Women's and Children's Hospital|||1||f||||f||||||||||2017-10-10 23:44:35.432666|2017-10-10 23:44:35.432666
NCT02314065|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-09-15|||December 2014||2014-12-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|HA-NonInf||Cognitive Behavioral Therapy for Health Anxiety: Internet Treatment Versus Face-to-Face Therapy|Cognitive Behavioral Therapy for Health Anxiety: a Randomized Controlled Non-inferiority Trial of Internet-delivered and Face-to-Face Therapy|Recruiting||N/A|308|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-10 23:44:35.518366|2017-10-10 23:44:35.518366
NCT02314052|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-08-03|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|August 3, 2017|Actual|2017-08-03||Interventional|||Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma|Phase 1b/2, Multicenter, Dose Escalation Trial to Determine the Safety, Tolerance, Maximum Tolerated Dose and Recommended Phase 2 Dose of DCR-MYC, a Lipid Nanoparticle (LNP)-Formulated Small Inhibitory RNA (siRNA) Oligonucleotide Targeting MYC, in Patients With Hepatocellular Carcinoma (HCC)|Terminated||Phase 1/Phase 2|72|Anticipated|Dicerna Pharmaceuticals, Inc.||1||Sponsor decision|f||||f||||||||||2017-10-10 23:44:35.679152|2017-10-10 23:44:35.679152
NCT02314039|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-09|||January 2015||2015-01-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Psychological Factors in Acne: A Focus on Psychological Trauma|Psychological Factors in Acne: A Focus on Psychological Trauma|Unknown status|Not yet recruiting|N/A|180|Anticipated|Edinburgh Napier University|||1||f||||f||||||||||2017-10-10 23:44:35.781302|2017-10-10 23:44:35.781302
NCT02314026|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-11|||March 2015|Actual|2015-03-01|January 2017|2017-01-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH|Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases|Completed||Phase 2|140|Actual|Exalenz Bioscience LTD.||1|||f||||f||||||||||2017-10-10 23:44:35.854285|2017-10-10 23:44:35.854285
NCT02314013|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-11-14|||April 2014||2014-04-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|November 2016|Actual|2016-11-01||Interventional|||Randomized Clinical Trial for the Uncomplicated Diverticulitis in Right Colon|Prospective Randomized Clinical Trial for the Management of Uncomplicated Diverticulitis in Right Colon; Non-antibiotics Versus Antibiotics|Active, not recruiting||N/A|132|Anticipated|Dongtan Sacred Heart Hospital||2|||f||||t||||||||||2017-10-10 23:44:35.955426|2017-10-10 23:44:35.955426
NCT02314000|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-07-26|||December 2014||2014-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|WHISPER||Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude|WHISPER - A Randomized Controlled Study to Evaluate the Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude|Active, not recruiting||N/A|146|Anticipated|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-10 23:44:36.033764|2017-10-10 23:44:36.033764
NCT02313987|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-02-23|||June 2015||2015-06-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|EndoGET||Endothelial Function-guided Therapy Compared to Usual Care in Patients With NOCAD|The Impact of Endothelial Function-guided Therapy Compared to Usual Care on Major Adverse Cardiovascular Events in Patients With Chest Pain and Non-obstructive Coronary Artery Disease|Withdrawn||N/A|0|Actual|Itamar-Medical, Israel|||3|Study never began|f||||t||||||||Undecided||2017-10-10 23:44:36.129571|2017-10-10 23:44:36.129571
NCT02313974|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-09-12|||January 2014||2014-01-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01|2 Years|Observational [Patient Registry]|LuFla||Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)|Lupus Flares and Histological Renal Activity at the End of the Treatment|Active, not recruiting||N/A|36|Actual|Hospital de Clinicas José de San Martín|||1||f||||t||||||||||2017-10-10 23:44:36.210506|2017-10-10 23:44:36.210506
NCT02313961|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-02-28|||March 2013||2013-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIC-STEMI||Remote Ischemic Conditioning in ST-elevation Myocardial Infarction as Adjuvant to Primary Angioplasty|Evaluation of Remote Ischemic Conditioning in ST-elevation Myocardial Infarction as Adjuvant to Primary Angioplasty|Active, not recruiting||N/A|516|Actual|Hospital de Braga||2|||f||||f||||||||||2017-10-10 23:44:36.284909|2017-10-10 23:44:36.284909
NCT02313935|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-10|||November 2010||2010-11-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|May 2012|Actual|2012-05-01||Interventional|LLM-AUTH||Cognitive/Physical Computer-Game Blended Training of Elderly: Neuroscientific LLM Studies|Effects of Cognitive and/or Physical Exercises Blended by Computer Games in Elderly: The LLM Project Neuroscientific Investigations in Thessaloniki, Greece by the LLM Team at the Aristotle University of Thessaloniki|Completed||N/A|581|Actual|Aristotle University Of Thessaloniki||5|||f||||f||||||||||2017-10-10 23:44:36.391592|2017-10-10 23:44:36.391592
NCT02313922|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-08|||November 2014||2014-11-01|December 2014|2014-12-01||||October 2016|Anticipated|2016-10-01||Interventional|||Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate|Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate: a Phase IV, Multicenter, Randomized, Double-blind, Controlled Trial|Unknown status|Recruiting|Phase 4|488|Anticipated|Zhejiang University||2|||f||||||||||||||2017-10-10 23:44:36.503356|2017-10-10 23:44:36.503356
NCT02313909|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-08|||December 23, 2014|Actual|2014-12-23|September 2017|2017-09-01|January 15, 2018|Anticipated|2018-01-15|January 15, 2018|Anticipated|2018-01-15||Interventional|NAVIGATE ESUS||Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)|Multicenter, Randomized, Double-blind, Double-dummy, Active-comparator, Event-driven, Superiority Phase III Study of Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With a Recent Embolic Stroke of Undetermined Source (ESUS), Comparing Rivaroxaban 15 mg Once Daily With Aspirin 100 mg|Recruiting||Phase 3|7000|Anticipated|Bayer||2|||f||||t|t|f||||||||2017-10-10 23:44:36.643964|2017-10-10 23:44:36.643964
NCT02313896|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-10-13|||July 2014||2014-07-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Cirrhosis Readmission Telehealth Project|Cirrhosis Readmission Telehealth Project|Terminated||N/A|10|Actual|Yale University||2||Poor enrollment|f||||f||||||||||2017-10-10 23:44:38.291564|2017-10-10 23:44:38.291564
NCT02313883|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-05-03|||July 2015|Actual|2015-07-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||A Phase I/II Study to Evaluate the Safety and Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis|A Phase I/II Study to Evaluate the Safety, Tolerability and Efficacy of PerioSept® and Scaling and Root Planing in Subjects With Periodontitis|Recruiting||Phase 1/Phase 2|95|Anticipated|Geistlich Pharma AG||5|||f||||f||||||||||2017-10-10 23:44:38.384584|2017-10-10 23:44:38.384584
NCT02313870|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-11|||January 2008||2008-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|BP/MTX||Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid|Comparison of Monotherapy With Protracted Superpotent Topical Steroids to Superpotent Topical Steroids Associated With Methotrexate in Bullous Pemphigoid|Unknown status|Recruiting|Phase 3|300|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:44:38.54929|2017-10-10 23:44:38.54929
NCT02313857|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-28|||September 2015||2015-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)|A Phase I Study Using Most Closely HLA-matched Cytomegalovirus-specific T Lymphocytes for the Treatment of Cytomegalovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-C)|Recruiting||Phase 1|10|Anticipated|ViraCyte||1|||f||||t||||||||||2017-10-10 23:44:38.698123|2017-10-10 23:44:38.698123
NCT02313844|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-10-31|||January 2017||2017-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)|A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)|Not yet recruiting||Phase 1|10|Anticipated|ViraCyte||1|||f||||t||||||||||2017-10-10 23:44:38.852027|2017-10-10 23:44:38.852027
NCT02313454|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-09-01|||December 2014||2014-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:44:43.836945|2017-10-10 23:44:43.836945
NCT02313831|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-13|||August 2013||2013-08-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|January 2015|Anticipated|2015-01-01||Interventional|||Optimization of Interval Exercise Based-intensity on Ventilatory Anaerobic Threshold in Coronary Artery Disease|Influence of Interval Aerobic Exercise Training on Cardiorespiratory and Metabolic Variables and Inflammatory Markers in Patients With Different Level of Coronary Artery Lesions|Unknown status|Recruiting|N/A|68|Anticipated|Universidade Federal de Sao Carlos||1|||f||||t||||||||||2017-10-10 23:44:38.989379|2017-10-10 23:44:38.989379
NCT02313818|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-07-19|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Variable-length Cognitive Processing Therapy for Combat-Related PTSD|Variable-length Cognitive Processing Therapy for Combat-Related PTSD|Recruiting||N/A|130|Anticipated|Duke University||1|||f||||t||||||||||2017-10-10 23:44:39.099683|2017-10-10 23:44:39.099683
NCT02313805|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-09|||July 2014||2014-07-01|November 2014|2014-11-01||||July 2016|Anticipated|2016-07-01||Interventional|||The Effect of a Checklist on the Quality of Education During Insulin Initiation by Trained Medical Students|The Effect of a Checklist on the Quality of Education During Insulin Initiation by Trained Medical Students: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|100|Anticipated|The University of The West Indies||2|||f||||f||||||||||2017-10-10 23:44:39.208849|2017-10-10 23:44:39.208849
NCT02313792|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2014-12-08|||January 2015||2015-01-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation|Efficacy, Safety and Quality of Life of Palifermin on Reducing Oral Mucositis in Patients With Hematopoietic Stem Cell Transplantation, Prospective Double-blind Randomized Phase III Trial|Unknown status|Not yet recruiting|Phase 3|88|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-10 23:44:39.319483|2017-10-10 23:44:39.319483
NCT02313779|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-07-14|||December 2014||2014-12-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|MDMS3||Meditation and Decision Making Study III|Nonconscious Affective and Physiological Mediators of Behavioral Decision Making Study 3|Completed||N/A|240|Actual|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-10-10 23:44:39.391559|2017-10-10 23:44:39.391559
NCT02313766|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-03-17|2014-12-23||October 2006||2006-10-01|March 2016|2016-03-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|PREOX||Preoxygenation With Positive Inspiratory Pressure During Induction of Anesthesia|Randomized Controlled Trial on Preoxygenation Through Spontaneous Breathing or Non Invasive Positive Pressure Ventilation With and Without Positive End Expiratory Pressure|Completed||N/A|150|Actual|University Hospital, Caen||3|||f||||t||||||||||2017-10-10 23:44:39.494816|2017-10-10 23:44:39.494816
NCT02313753|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-09-14|||December 2014||2014-12-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|CLASP||Evaluation of the Coping Long Term With Active Suicide Program|Evaluation of the Coping Long Term With Active Suicide Program|Recruiting||N/A|232|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-10 23:44:39.925043|2017-10-10 23:44:39.925043
NCT02313740|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-07-20|||April 2015||2015-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly|Prospective Cohort Study to Evaluate Safety and Immunogenicity of Butantan´s Fragmented, Inactivated Trivalent Influenza Vaccine in Healthy Adults and Elderly|Completed||N/A|120|Actual|Butantan Institute|||2||f||||f||||||||||2017-10-10 23:44:40.002008|2017-10-10 23:44:40.002008
NCT02313727|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-08|||December 2014||2014-12-01|November 2014|2014-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression|Combined Treatment With TNF (Tumor Necrosis Factor) Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Bnai Zion Medical Center||2|||f||||f||||||||||2017-10-10 23:44:40.107484|2017-10-10 23:44:40.107484
NCT02313714|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-12-09|||September 2012||2012-09-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of Neuromuscular Electrical Stimulation in Patients With Congestive Heart Failure|Effects of Neuromuscular Electrical Stimulation in Patients With Congestive Heart Failure|Unknown status|Recruiting|N/A|15|Anticipated|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-10 23:44:40.199976|2017-10-10 23:44:40.199976
NCT02313701|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-04|||December 2014||2014-12-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Standardized Consent for Urogynecological Procedures on Patient Satisfaction|Effect of Standardized Consent for Urogynecological Procedures on Patient Satisfaction|Recruiting||N/A|96|Anticipated|Beth Israel Deaconess Medical Center||6|||f||||f||||||||||2017-10-10 23:44:40.290604|2017-10-10 23:44:40.290604
NCT02313688|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-09|||January 2015||2015-01-01|December 2014|2014-12-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors|The Relationship Between the Length of the Proximal Resection Margin and Long-term Survival for Adenocarcinomas of the Esophagogastric Junction (Siewert-II/Siewert-III)- Randomized Controlled Trial|Not yet recruiting||N/A|320|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-10 23:44:40.377952|2017-10-10 23:44:40.377952
NCT02313675|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-05-01|||May 2015||2015-05-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol for Carpal Tunnel and Distal Radius Fracture Surgeries|Comparing Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol Administration for Carpal Tunnel Release and Distal Radius Fracture Surgeries|Completed||Phase 4|74|Actual|University of Pittsburgh||4|||f||||f||||||||||2017-10-10 23:44:40.475571|2017-10-10 23:44:40.475571
NCT02313662|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-12-28|||December 2014||2014-12-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|DaBlaCa-8||Comparison of White Light, PDD and NBI in Detection of Flat Dysplasia and CIS at TURB - a Study of Trimodality|Trimodalitets-studie Hvidt Lys vs. NBI vs. PDD Ved Detektion af Flad Dysplasi og CIS Ved TURB|Completed||N/A|153|Actual|Aarhus University Hospital|||1||f||||t||||||||||2017-10-10 23:44:40.564025|2017-10-10 23:44:40.564025
NCT02313649|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2016-04-18|||December 2014||2014-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B|Evaluation of ShearWave™ Elastography Performances for the Non-Invasive Assessment of Liver Fibrosis in Chinese Patients With Chronic Hepatitis B Infection|Completed||N/A|447|Actual|SuperSonic Imagine|||1||f||||f||||||||||2017-10-10 23:44:40.630812|2017-10-10 23:44:40.630812
NCT02313623|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2016-12-02|||July 2013||2013-07-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research|MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research|Recruiting||N/A|125|Anticipated|Yale University|||1||f||||f||||||Samples Without DNA|"     Research samples will be placed in separate, de-identified specimen jars. Following each     case, investigators on this protocol will provide the de-identified specimen jars to     collaborators to perform single-cell analysis. All clinical specimens will be handled by     pathology according to existing protocols.      Processing of the samples will include disassociated into a single cell suspension and     culturing the sample. This suspension can be then placed onto a microfluidic device for     processing. It is hypothesized that collection of samples in this manner will allow the     comparison of molecular profiles with clinically accepted standards to impact prospective     research on prostate cancer.   "|No||2017-10-10 23:44:40.783219|2017-10-10 23:44:40.783219
NCT02313610|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2016-10-14|||April 2011||2011-04-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis|Efficacy and Safety of Qinbudan as an Adjunct Therapy in Patients Receiving Standard Combination Therapy for Retreatment Pulmonary Tuberculosis: A Randomized, Double-blind, Placebo-controlled Multicenter Clinical Trial|Completed||Phase 2|253|Actual|Shanghai University of Traditional Chinese Medicine||2|||f||||f||||||||Undecided||2017-10-10 23:44:40.855969|2017-10-10 23:44:40.855969
NCT02313597|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-01-26|||August 2014||2014-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||VAAFT Vs SETON in the Management of High Peri Anal Fistula|Comparison of Post Operative Outcome of VAAFT vs SETON Tightening in the Management of High Perianal Fistula|Recruiting||N/A|60|Anticipated|Services Hospital, Lahore||2|||f||||f||||||||||2017-10-10 23:44:40.973964|2017-10-10 23:44:40.973964
NCT02313584|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-09|||December 2014||2014-12-01|December 2014|2014-12-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk||Unknown status|Not yet recruiting|Phase 3|464|Anticipated|Korea University||2|||f||||||||||||||2017-10-10 23:44:41.054376|2017-10-10 23:44:41.054376
NCT02313571|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2015-09-03|||March 2010||2010-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|BTP||Breakthrough Pain Computer Integrated Patient Controlled Epidural Analgesia|Incidence and Characteristics of Breakthrough Pain in Parturients Using Computer Integrated Patient Controlled Epidural Analgesia|Completed||N/A|350|Actual|KK Women's and Children's Hospital|||1||f||||f||||||||||2017-10-10 23:44:41.122817|2017-10-10 23:44:41.122817
NCT02313558|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2015-05-29|2015-01-05||March 2013||2013-03-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy of a Commercial Dentifrice Containing Ilex Rotunda Thunb Extract for Dental Plaque and Gingivitis|Efficacy of a Commercial Dentifrice Containing Ilex Rotunda Thunb Extract for Dental Plaque and Gingivitis: A 3-month Clinical Study in Adults in China|Completed||N/A|100|Actual|Sun Yat-sen University|The major limitation is the lack of a positive control,that is used to determine whether the dentifrice was more or less effective than it. The adoption of an inactive control is possible when the true efficacy of the dentifrice is assessed.|2|||f||||t||||||||||2017-10-10 23:44:41.190705|2017-10-10 23:44:41.190705
NCT02313545|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2016-11-13|||December 2014||2014-12-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV|Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of Atrophic Vaginitis or Desquamative Inflammatory Vaginitis|Recruiting||Phase 1/Phase 2|50|Anticipated|Izun Pharma Ltd||1|||f||||f||||||||Undecided||2017-10-10 23:44:41.48346|2017-10-10 23:44:41.48346
NCT02313532|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-07|||January 2015||2015-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Treatment of Febrile Infectious Disease Among Children in Hadera District Given the Final Diagnosis. Descriptive Study|Treatment of Febrile Infectious Disease Among Children in Hadera District Given the Final Diagnosis. Descriptive Study|Unknown status|Not yet recruiting|N/A|500|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-10 23:44:41.581402|2017-10-10 23:44:41.581402
NCT02313519|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-09|||April 2013||2013-04-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Probiotics in the Prevention of Complications After Colorectal Surgery|A Randomized Clinical Study of the Efficacy of a Formulation of Four Probiotics for the Prevention of Post-operative Complications in Patients Undergoing Colorectal Surgery|Completed||Phase 4|164|Actual|University of Athens||2|||f||||t||||||||||2017-10-10 23:44:43.411309|2017-10-10 23:44:43.411309
NCT02313506|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-06-29|||January 2015||2015-01-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|TRACK-OA||Feasibility of a Wearable-enabled Intervention for Promoting Physical Activity in People Knee OA|Feasibility and Preliminary Efficacy of an Activity Tracker-driven Intervention for Promoting Physical Activity in People Living With Osteoarthritis of the Knee|Completed||N/A|34|Actual|University of British Columbia||2|||f||||f|f|f||||||No||2017-10-10 23:44:43.504362|2017-10-10 23:44:43.504362
NCT02313493|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-09|||September 2012||2012-09-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|July 2015|Anticipated|2015-07-01||Interventional|||Efficacy and Feasibility of Baby Triple P - a Pilot Study|Improving Mental Health in First Time Parents - A Randomized Controlled Pilot Study|Unknown status|Active, not recruiting|N/A|78|Anticipated|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-10 23:44:43.598274|2017-10-10 23:44:43.598274
NCT02313480|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-08|||April 2013||2013-04-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Does the Addition of Massage to Manual Therapy and Exercise Improve Outcome in Chronic Neck Pain?|Does the Addition of Massage to Manual Therapy and Exercise Improve Outcome in Chronic Neck Pain?|Completed||N/A|39|Actual|Society of Musculoskeletal Medicine||2|||f||||f||||||||||2017-10-10 23:44:43.676788|2017-10-10 23:44:43.676788
NCT02313467|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-03-10|||January 2014||2014-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Topical PDT Cream Without Irradiation Source in the Acne Treatment|Topical Application of 1.5% Butenyl ALA Without Light Source Irradiation in the Treatment of Acne: a Double Blinded Randomized Controlled Trial.|Completed||N/A|45|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:44:43.764358|2017-10-10 23:44:43.764358
NCT02313441|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-24|||September 2013||2013-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Cardio- and Renoprotective Effect of Remote Ischemic Preconditioning in Patients Undergoing Percutaneous Coronary Intervention|Cardio- and Reno-protective Effect of Remote Ischemic Preconditioning in Patients Undergoing Percutaneous Coronary Intervention. A Prospective, Non-randomized Controlled Trial.|Completed||N/A|200|Actual|Assiut University||2|||f||||f||||||||||2017-10-10 23:44:43.885188|2017-10-10 23:44:43.885188
NCT02313428|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-08-30|||December 2014||2014-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Topical Oxygen Therapy for Diabetic Wounds|Effects of Topical Oxygen for Diabetic Wounds|Recruiting||N/A|140|Anticipated|Ohio State University||2|||f||||t||||||||||2017-10-10 23:44:43.982414|2017-10-10 23:44:43.982414
NCT02313415|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2017-02-02|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|February 2017|Anticipated|2017-02-01|December 2015|Actual|2015-12-01||Interventional|||Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Blood-derived Mesenchyma Stem Cells|Clinical Study of the Treatment of Infertility Caused by Severe Intrauterine Adhesions by Collagen Scaffold Loaded With Umbilical Cord Blood-derived Mesenchymal Stem Cells|Active, not recruiting||N/A|20|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||f||||||||No||2017-10-10 23:44:44.117892|2017-10-10 23:44:44.117892
NCT02313402|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-11-25|||June 2014||2014-06-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ELY-SLA||A New Eye-based Communication Device for ALS Patients|A Pilot Study Assessing a New Eye-writing Device Allowing Cursive Writing With Smooth Pursuit Eye Movements in Subjects With ALS|Completed||N/A|12|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:44:44.214661|2017-10-10 23:44:44.214661
NCT02313389|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-11-04|||September 2015||2015-09-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|BLOCAGE-01||Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma|Phase III Trial Evaluating Maintenance Treatment Versus Observation in Elderly Patients Suffering From Primary Central Nervous System Lymphoma in Complete Remission After High Dose Methotrexate Based Chemotherapy in First Line|Recruiting||Phase 3|295|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-10 23:44:44.426054|2017-10-10 23:44:44.426054
NCT02313376|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2015-11-17|||December 2014||2014-12-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes|Trial to Assess the Safety, Attenuation and Immunogenicity of Genetically-attenuated p52-/p36-/sap1- Plasmodium Falciparum Parasites (GAP3KO) Administered Via Infected Anopheles Stephensi Mosquitoes to Malaria-Naïve Adults|Completed||Phase 1|10|Actual|Seattle Biomedical Research Institute||1|||f||||t||||||||||2017-10-10 23:44:44.531551|2017-10-10 23:44:44.531551
NCT02313363|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2014-12-09|||December 2013||2013-12-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Patient-Centered Smartphone-Based Diabetes Care|Feasibility of a Patient-Centered Smartphone-Based Diabetes Care System: a Pilot Study|Completed||Early Phase 1|30|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:44:44.607423|2017-10-10 23:44:44.607423
NCT02313350|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-01-03|||September 2017||2017-09-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|EDIS||Intradiscal Discogel® in Resistant Sciatica|Non-inferiority Trial of Intradiscal Discogel® Versus Surgery in Sciatica Resistant to Conservative Treatment|Not yet recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:44:44.695813|2017-10-10 23:44:44.695813
NCT02313337|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-07|||December 2014||2014-12-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Comparison of Different Administration Routes of Pediatric Premedication|The Comparison of Different Administration Routes of Pediatric Premedication-Single Center,Randomized，Controlled Trial|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Second Affiliated Hospital of Xi'an Jiaotong University||4|||f||||f||||||||||2017-10-10 23:44:44.816882|2017-10-10 23:44:44.816882
NCT02313324|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-07|||November 2012||2012-11-01|November 2012|2012-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ESWT||The Effects of Extracorporeal Shock Wave Therapy in Patients With Coccydynia: A Randomized Controlled Trial|The Effects of Extracorporeal Shock Wave Therapy in Patients With Coccydynia: A Randomized Controlled Trial|Completed||N/A|42|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:44:44.945797|2017-10-10 23:44:44.945797
NCT02313311|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2014-12-07|||October 2013||2013-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Observational|SETLSSET||Select Embryos by Time-lapse System for Single Embryo Transfer|Study Embryos of IVF by Time-lapse System|Unknown status|Enrolling by invitation|N/A|500|Anticipated|Nanjing University|||1||f||||t||||||||||2017-10-10 23:44:45.040662|2017-10-10 23:44:45.040662
NCT02313298|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-07|2016-03-21|||June 2013||2013-06-01|March 2016|2016-03-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer|A Phase II Trial of Prostate Stereotactic Radiotherapy|Recruiting||Phase 2|80|Anticipated|National Cancer Centre, Singapore||1|||f||||f||||||||||2017-10-10 23:44:45.131039|2017-10-10 23:44:45.131039
NCT02313285|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-10-04|||January 12, 2015|Actual|2015-01-12|October 2017|2017-10-01|April 15, 2022|Anticipated|2022-04-15|April 15, 2022|Anticipated|2022-04-15||Observational|||A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668|An Open-label, Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668|Recruiting||N/A|72|Anticipated|Sanofi|||2||f||||f|f|f||||||||2017-10-10 23:44:45.228485|2017-10-10 23:44:45.228485
NCT02313272|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-30|||May 5, 2015|Actual|2015-05-05|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas|A Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab in Patients With Recurrent High Grade Gliomas|Recruiting||Phase 1|46|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-10 23:44:45.315912|2017-10-10 23:44:45.315912
NCT02313259|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-02-22|||February 2012|Actual|2012-02-01|September 2015|2015-09-01|February 23, 2015|Actual|2015-02-23|February 23, 2015|Actual|2015-02-23||Observational|||The Impact of Ocular Diseases on Driving: a Prospective Study|The Impact of Ocular Diseases on Driving: a Prospective Study|Completed||N/A|60|Actual|CHU de Quebec-Universite Laval|||4||f||||t||||||||||2017-10-10 23:44:45.467371|2017-10-10 23:44:45.467371
NCT02313246|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-03-24|||August 2015||2015-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|IBS||A Pilot Study of Cognitive-Behaviour Therapy for Irritable Bowel Syndrome and the Gut Microbiome|A Pilot Study of Cognitive-Behaviour Therapy for Irritable Bowel Syndrome and the Gut Microbiome|Terminated||N/A|6|Actual|Hamilton Health Sciences Corporation||1||Principal investigator left the institution|f||||f||||||||No||2017-10-10 23:44:45.56212|2017-10-10 23:44:45.56212
NCT02313233|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-05-17|2015-09-03||December 2013||2013-12-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||The baseline analysis includes the International Prostate Symptom Score (IPSS), quality-of-life (QoL), urinary flow rate (Qmax), postvoided residual volume (PVR), prostate volume, serum PSA level. All the subjects have the history of benigh prostate hyperplasia and have been receiving the medication for this condition.|Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia|Research on Benefit of Umooze as Add-on Therapy in Benign Prostatic Hyperplasia|Completed||N/A|41|Actual|Golden Biotechnology Corporation||2|||f||||f||||||||No||2017-10-10 23:44:45.669883|2017-10-10 23:44:45.669883
NCT02313220|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-11-16|||December 2014||2014-12-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Dapalost||Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight|A 24-week, Single Centre, Randomized, Parallel-group, Double-blind, Placebo Controlled Phase II Study With an Optional 28-week Open-label Extension to Evaluate the Efficacy on Body Weight of Dapagliflozin 10 mg Once Daily in Combination With Exenatide 2 mg Once Weekly in Obese Non-diabetic Subjects.|Completed||Phase 2|50|Actual|Uppsala University||2|||f||||f||||||||||2017-10-10 23:44:46.306122|2017-10-10 23:44:46.306122
NCT02313207|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-03|||November 2014||2014-11-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Confocal Laser Endomicroscopy in IBS Patients|Confocal Endomicroscopy for the Detection of Food Intolerances in Patients With IBS.|Recruiting||N/A|50|Anticipated|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-10 23:44:46.410506|2017-10-10 23:44:46.410506
NCT02313194|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-01-26|||July 2013||2013-07-01|January 2016|2016-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Spinal Cord Neuromodulation for SCI|Enabling Forelimb Function With Agonist Drug and Epidural Stimulation in SCI|Recruiting||Phase 1/Phase 2|12|Anticipated|University of California, Los Angeles||1|||f||||t||||||||||2017-10-10 23:44:46.640213|2017-10-10 23:44:46.640213
NCT02313181|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-02-16|||December 2014||2014-12-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|ELF-TLC||Early Limited Formula for Treating Lactation Concerns|Early Limited Formula for Treating Lactation Concerns|Active, not recruiting||N/A|328|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:44:46.736103|2017-10-10 23:44:46.736103
NCT02313168|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-03-08|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||F.R.O.N.T. Formula for Pre-operative Airway Assessment and Documentation|F.R.O.N.T. Formula for Pre-operative Airway Assessment and Documentation|Completed||N/A|1150|Actual|University of Debrecen|||2||f||||f||||||||||2017-10-10 23:44:46.847167|2017-10-10 23:44:46.847167
NCT02313155|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-01-20|2016-01-20||December 2014||2014-12-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Safety analysis set was defined as all participants who received vaccination with the study drug.|Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults|A Randomized Double Blind Parallel-Group Comparative Phase 1/2 Study to Evaluate the Safety and Immunogenicity of a Single Subcutaneous Injection of TAK-850 in Healthy Adult Subjects|Completed||Phase 1/Phase 2|110|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:44:46.98261|2017-10-10 23:44:46.98261
NCT02313142|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-03-11|||January 2015||2015-01-01|March 2016|2016-03-01||||December 2015|Actual|2015-12-01||Interventional|STAMAS||Responses of the Cardiovascular Systems to Leg Exercises in Microgravity-like Conditions|Responses of the Cardiovascular Systems to Leg Exercises in Microgravity-like Conditions|Active, not recruiting||N/A|10|Anticipated|Swiss Federal Institute of Technology||1|||f||||f||||||||||2017-10-10 23:44:48.413858|2017-10-10 23:44:48.413858
NCT02313129|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-03|||August 2015||2015-08-01|April 2017|2017-04-01|January 24, 2017|Actual|2017-01-24|January 24, 2017|Actual|2017-01-24||Observational|||Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis|Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis|Completed||N/A|150|Actual|Duke University|||2||f||||f||||||Samples With DNA|"     blood tests   "|||2017-10-10 23:44:48.482903|2017-10-10 23:44:48.482903
NCT02313116|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-12-13|||April 2014||2014-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)|Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)|Suspended||N/A|50|Anticipated|Diagnostic Photonics, Inc.|||1||f||||f||||||||||2017-10-10 23:44:48.594714|2017-10-10 23:44:48.594714
NCT02313103|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects|Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects|Completed||Phase 1|16|Actual|US WorldMeds LLC||2|||f||||f||||||||||2017-10-10 23:44:48.674902|2017-10-10 23:44:48.674902
NCT02313090|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2014-12-07|||January 2014||2014-01-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control|Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control|Completed||N/A|100|Actual|First Affiliated Hospital of Zhejiang University||2|||f||||f||||||||||2017-10-10 23:44:48.77243|2017-10-10 23:44:48.77243
NCT02313077|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-04-13|||December 17, 2014|Actual|2014-12-17|April 2017|2017-04-01|March 15, 2016|Actual|2016-03-15|April 17, 2015|Actual|2015-04-17||Interventional|||A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants|A Phase 1, First-in-Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Heterologous Prime-Boost Regimens Using MVA-BN®-Filo and Ad26.ZEBOV Administered in Different Sequences and Schedules in Healthy Adults|Completed||Phase 1|87|Actual|Crucell Holland BV||5|||f||||t|f|||||||||2017-10-10 23:44:48.843278|2017-10-10 23:44:48.843278
NCT02313064|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-05-02|||January 2015||2015-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Oral CXA-10 Study in Healthy Volunteers|A Two-Part, Double-Blind, Third Party Open (Sponsor), Dose-Rising, Placebo-Controlled and Open-Label Exploratory Food Effect Study of the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of CXA-10 in Healthy Volunteers|Completed||Phase 1|40|Actual|Complexa, Inc.||2|||f||||f||||||||No||2017-10-10 23:44:48.936131|2017-10-10 23:44:48.936131
NCT02313051|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-08|||December 2014||2014-12-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|MIRACLE||Everolimus trIal for Advanced prememopausaL Breast Cancer Patients|A Multicenter, Randomized Phase ll Study of Letrozole Versus Letrozole Plus Everolimus for Hormone Receptor-PositivePremenopausal Women With Recurrent or Metastatic Breast Cancer on Goserelin Treatment After Progression on Tamoxifen|Not yet recruiting||Phase 2|200|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:44:49.012651|2017-10-10 23:44:49.012651
NCT02313038|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-08-27|||December 2013||2013-12-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01|1 Year|Observational [Patient Registry]|PEACE-DES||Prospective Assessment of Efficacy and Safety of Drug Eluting Stents|Prospective Assessment of Efficacy and Safety of Drug Eluting Stents|Completed||N/A|6023|Actual|China National Center for Cardiovascular Diseases|||1||f||||t||||||Samples With DNA|"     A venous blood sample of 20mL will be collected at 1-month visit and 12-month visit for     biomarker analysis and storage for future genetic studies; A urine samples of 40mL will be     collected at 1-month visit and 12-month visit for biomarker analysis and storage.   "|||2017-10-10 23:44:49.105051|2017-10-10 23:44:49.105051
NCT02313025|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-08|||January 2015||2015-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||A Speech Sound and Phonemic Awareness Intervention in Flemish Early Childhood Education|Spreken Verfijnen in de Kleuterklas: De Ontwikkeling Van Een Spraakdidactiek Als Uitbreiding op de Gangbare Taaldidactiek in Het Kleuteronderwijs|Unknown status|Not yet recruiting|N/A|200|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-10 23:44:49.173833|2017-10-10 23:44:49.173833
NCT02313012|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-08-18|||January 2015||2015-01-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors|A Phase 1a Multicenter, Open-label Safety, Tolerability and Pharmacokinetic Study of CC-90003, a Selective Extracellular Signal-Regulated Kinase (ERK) Inhibitor, in Subjects With Locally-Advanced or Metastatic, Relapsed, or Refractory BRAF or RAS-Mutated Malignancies|Terminated||Phase 1|19|Actual|Celgene Corporation||1||"The MTD did not offer a sufficiently encouraging profile to proceed with the additional dosing   schedule or to the cohort expansion phase."|f||||f||||||||||2017-10-10 23:44:49.251673|2017-10-10 23:44:49.251673
NCT02312999|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-11-22|||April 2015||2015-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Crystalloids or Colloids for Goal-directed Fluid Therapy With Closed-loop Assistance in Major Surgery|Phase IV, Multicentric, Prospective, Controlled, Randomized, Double Blind Study Comparing a Crystalloid to a Colloid Used in the Perioperatory Hemodynamic Optimisation With a 'Closed Loop' Automatic Filling System, on the Post-surgery Morbidity in Major Abdominal Surgery.|Completed||Phase 4|160|Actual|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 23:44:49.350311|2017-10-10 23:44:49.350311
NCT02312986|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-08-14|||August 2015||2015-08-01|August 2015|2015-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||FMT for Multidrug Resistant Organism Reversal|Use of Fecal Microbiota Transplantation (FMT) to Reverse Multi-Drug Resistant Organism Carriage|Unknown status|Enrolling by invitation|Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-10 23:44:49.63717|2017-10-10 23:44:49.63717
NCT02312973|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-06-14|||January 2015||2015-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects|Investigation of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Single Oral Doses of 75 mg Molidustat in Male and Female Subjects With Renal Impairment Requiring Hemo- or Peritoneal Dialysis Compared to Age- and Weight-matched Healthy Subjects in a Single-center, Non-controlled, Non-blinded Study With Group Stratification|Completed||Phase 1|40|Actual|Bayer||3|||f||||f||||||||||2017-10-10 23:44:49.710429|2017-10-10 23:44:49.710429
NCT02312960|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-09-11|||December 18, 2014|Actual|2014-12-18|September 2017|2017-09-01|September 15, 2025|Anticipated|2025-09-15|September 15, 2025|Anticipated|2025-09-15||Interventional|||Radium-223 Dichloride Long-term Follow-up Program|A Phase 4 Long-term Follow-up Study to Define the Safety Profile of Radium-223 Dichloride|Active, not recruiting||Phase 4|250|Anticipated|Bayer||1|||f||||f|f|f||||||||2017-10-10 23:44:49.815565|2017-10-10 23:44:49.815565
NCT02312947|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2014-12-08|||December 2014||2014-12-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Coblation Versus Cold Adenoidectomy -Safety and Efficiency|Coblation Versus Cold Adenoidectomy -Safety and Efficiency|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-10 23:44:49.947947|2017-10-10 23:44:49.947947
NCT02312934|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-22|||August 2015||2015-08-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study||Recruiting||Phase 2|40|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 23:44:50.024531|2017-10-10 23:44:50.024531
NCT02312921|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-06|2016-08-08|||January 2016||2016-01-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|PREDICT||Population-centered Risk- and Evidence-based Dental Inter-professional Care Team|Reducing Oral Health Disparity Through Outreach, Evidenced-Based Care, Global Budgeting and the Alternative Quality Contract|Enrolling by invitation||N/A|14|Anticipated|Advantage Dental Services, LLC|||2||f||||f||||||||||2017-10-10 23:44:50.123796|2017-10-10 23:44:50.123796
NCT02312908|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-04-21|||March 2015||2015-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism|Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism: a Prospective, Randomized, Double-blind and Placebo-controlled Trial|Completed||Phase 2|40|Actual|Seoul National University Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:44:50.200507|2017-10-10 23:44:50.200507
NCT02312895|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-01-26|||December 2014||2014-12-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparing Dry Needling to Manual Therapy for Patients With Mechanical Low Back Pain|Randomized Controlled Trial Comparing the Use of Dry Needling to Manual Therapy for Patients With Mechanical Low Back Pain.|Recruiting||N/A|100|Anticipated|Youngstown State University||2|||f||||f||||||||||2017-10-10 23:44:50.306163|2017-10-10 23:44:50.306163
NCT02312869|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-26|||September 2015||2015-09-01|June 2017|2017-06-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Observational|LAMiNAR||Local Assessment of Management of Burn Patients|Local Assessment of Management of Burn Patients (LAMiNAR) - a Prospective Observational International Multicenter Cohort Study|Completed||N/A|300|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-10 23:44:50.494546|2017-10-10 23:44:50.494546
NCT02312856|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-07-15|||October 2014||2014-10-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|ANSWER||Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and Reconstruction|Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and|Active, not recruiting||N/A|30|Anticipated|Pulsar Vascular||1|||f||||t||||||||||2017-10-10 23:44:50.590193|2017-10-10 23:44:50.590193
NCT02312843|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-04-19|||March 2013||2013-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|PACE-2||Piedmont Aging, Cognition & Exercise Study-2|A Randomized Controlled Trial to Examine the Effects of Aerobic Exercise on Cognition and Aging-related Biomarkers for Adults With Prediabetes and Mild Cognitive Impairment|Completed||N/A|33|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-10 23:44:50.667093|2017-10-10 23:44:50.667093
NCT02312830|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-06-29|||November 2014||2014-11-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|BE-C@TS||Belgian Cross-sectional Allogeneic Transplant Survivor Study|Belgian Cross-sectional Allogeneic Transplant Survivor Study|Enrolling by invitation||N/A|400|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:44:50.766109|2017-10-10 23:44:50.766109
NCT02312817|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-08-16|||December 2014||2014-12-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System|RCT of Strategies to Improve Screening Rates Among a Cohort of Cirrhotic Patients at High Risk for Developing HCC in a Safety-net Health System|Active, not recruiting||N/A|1800|Actual|University of Texas Southwestern Medical Center||3|||f||||t||||||||||2017-10-10 23:44:50.825184|2017-10-10 23:44:50.825184
NCT02312804|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-02-13|||January 2015||2015-01-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Ph Ib/BGJ398/Cervix and Other Solid Tumors|A Phase Ib Study Evaluating BGJ398 in Combination With Chemotherapeutic Regimen in Patients With Stage IV, Recurrent or Persistent Carcinoma of The Cervix and Other Solid Tumors|Withdrawn||Phase 1|0|Actual|The University of Texas Health Science Center at San Antonio||2||Drug not available.|f||||t||||||||||2017-10-10 23:44:50.923972|2017-10-10 23:44:50.923972
NCT02312791|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-02-22|||December 2014||2014-12-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|PROGRAD||Prognosis of Inpatients Evaluated for Palliative Radiotherapy|Observational Study of Prognosis of Inpatients Evaluated for Palliative Radiotherapy|Active, not recruiting||N/A|362|Actual|University of Sao Paulo|||1||f||||f||||||||||2017-10-10 23:44:51.014589|2017-10-10 23:44:51.014589
NCT02312778|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-05-21|||January 2015||2015-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Immediate Effects of a Spinal Lumbar Manipulation|Immediate Effects of a Spinal Lumbar Manipulation on the Threshold Pressure Pain and the Postural Control in Subjects With Non-specific Low Back Pain|Completed||N/A|24|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 23:44:51.087042|2017-10-10 23:44:51.087042
NCT02312765|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-07-20|||November 2014||2014-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence|Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence|Enrolling by invitation||N/A|20|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:44:51.169376|2017-10-10 23:44:51.169376
NCT02312752|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-06-15|||December 2014||2014-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|IES||Intra-epidermal Stimulation (IES) of Small Nerve Fibers (A-delta Fibers)|Intra-epidermal Stimulation (IES) of Small Nerve Fibers (A-delta Fibers)|Active, not recruiting||N/A|3|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 23:44:51.23594|2017-10-10 23:44:51.23594
NCT02312739|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-05-25|2016-03-02||February 2014||2014-02-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|NEST||Nitrous Oxide for Pain Management During In-office Transcervical Sterilization|Nitrous Oxide for Pain Management During In-office Transcervical Sterilization|Completed||N/A|72|Actual|University of New Mexico|Limitations of the study include the limited ability to truly blind physicians due to the signs and symptoms of N2O/O2 sedation being apparent.|2|||f||||t||||||||||2017-10-10 23:44:51.315904|2017-10-10 23:44:51.315904
NCT02312726|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-03-03|2016-02-04||November 2013||2013-11-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|PIPPI||Postplacental Intrauterine Device Insertion: A Mixed Methods Assessment of Women's Experience|Postplacental Intrauterine Device Insertion: A Mixed Methods Assessment of Women's Experience|Completed||N/A|135|Actual|University of New Mexico|||2||f||||f||||||||||2017-10-10 23:44:51.762724|2017-10-10 23:44:51.762724
NCT02312700|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2014-12-05|||January 2015||2015-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||An Interactive Empowerment Tool for Breast Cancer Patients|Development of an Interactive Empowerment Tool in Support of Patient Empowerment.|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Milan||2|||f||||f||||||||||2017-10-10 23:44:52.293481|2017-10-10 23:44:52.293481
NCT02312687|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-05-02|||December 2014||2014-12-01|May 2017|2017-05-01|August 16, 2018|Anticipated|2018-08-16|August 16, 2018|Anticipated|2018-08-16||Interventional|||Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)|A Phase 2b, Open-Label, Long-Term Extension Study to Evaluate the Safety and Pharmacodynamics of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)|Enrolling by invitation||Phase 2|25|Anticipated|Ultragenyx Pharmaceutical Inc||1|||f||||f||||||||||2017-10-10 23:44:52.370772|2017-10-10 23:44:52.370772
NCT02312674|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-12-08|||January 2015||2015-01-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Prevention of Cancer-associated Malnutrition Through Oral Nutritional Supplements|Prevention of Malnutrition Through Oral Nutritional Supplements in Cancer Patients Receiving Palliative Therapy|Unknown status|Not yet recruiting|N/A|80|Anticipated|University of Hohenheim||2|||f||||f||||||||||2017-10-10 23:44:52.46888|2017-10-10 23:44:52.46888
NCT02312661|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-04-20|||October 2015||2015-10-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|OVMET||Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer|Phase Ib Study of Metformin in Combination With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer|Recruiting||Phase 1|20|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-10-10 23:44:52.546535|2017-10-10 23:44:52.546535
NCT02312648|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2014-12-08|||January 2015||2015-01-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Impact of Mobilization on Cardiac Surgery|Impact of an Early Mobilization Program on Functional Capacity After Coronary Artery Bypass Surgery: a Protocol of Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|52|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||f||||||||||2017-10-10 23:44:52.639708|2017-10-10 23:44:52.639708
NCT02312635|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-12-08|||December 2012||2012-12-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|DCS||Augmentation of Cognitive Training in Children With TBI With D-Cyloserine|Augmentation of Cognitive Training in Children With TBI With D-Cyloserine|Unknown status|Recruiting|Early Phase 1|30|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 23:44:52.708147|2017-10-10 23:44:52.708147
NCT02312622|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-24|||January 2015||2015-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase II Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer|A Phase II Study of Etirinotecan Pegol (NKTR 102) in Patients With Refractory Brain Metastases and Advanced Lung Cancer or Metastatic Breast Cancer (MBC)|Recruiting||Phase 2|15|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 23:44:52.924263|2017-10-10 23:44:52.924263
NCT02312609|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-08|||September 2008||2008-09-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover, Bioequivalence Study Comparing Minocycline Hydrochloride 135 mg Extended Release Tablets (Containing Minocycline Hydrochloride 135 mg) of OHM Laboratories, USA. (A Subsidiary of Ranbaxy Pharmaceuticals Inc., USA) With SolodynTM Extended Release Tablets (Containing Minocycline Hydrochloride 135 mg) of AAI Pharma, Inc. in Healthy, Adult, Male, Human Subjects Under Fed Condition|Completed||N/A|18|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-10 23:44:53.035602|2017-10-10 23:44:53.035602
NCT02312596|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-03-28|||July 2016||2016-07-01|January 2016|2016-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Prospective, Randomized Clinical Trial of ECLIPSE PRP™ Wound Biomatrix in Non-Healing Diabetic Foot Ulcers|A Prospective, Randomized Clinical Trial of ECLIPSE PRP™ Wound Biomatrix in Non-Healing Diabetic Foot Ulcers|Not yet recruiting||Phase 2/Phase 3|250|Anticipated|PRP Concepts, LLC||2|||f||||f||||||||No||2017-10-10 23:44:53.109197|2017-10-10 23:44:53.109197
NCT02312583|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-10-03|||January 2015||2015-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of an Online Program for the Treatment of Mild and Moderate Depression|Efficacy the Online Program iFightDepression for the Treatment of Mild and Moderate Depression|Recruiting||N/A|310|Anticipated|Parc de Salut Mar||2|||f||||f||||||||||2017-10-10 23:44:53.196034|2017-10-10 23:44:53.196034
NCT02312570|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-03-28|||July 2016||2016-07-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Trial of ECLIPSE PRP™ Wound Biomatrix in Chronic Non-Healing Pressure Ulcers|A Prospective, Randomized Clinical Trial of ECLIPSE PRP™ Wound Biomatrix in Chronic Non-Healing Pressure Ulcers|Not yet recruiting||Phase 2/Phase 3|250|Anticipated|PRP Concepts, LLC||2|||f||||f||||||||No||2017-10-10 23:44:53.32105|2017-10-10 23:44:53.32105
NCT02312557|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-08-31|||November 18, 2014|Actual|2014-11-18|August 2017|2017-08-01|January 1, 2020|Anticipated|2020-01-01|January 1, 2019|Anticipated|2019-01-01||Interventional|||Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide|Addition of Pembrolizumab Upon Progression on Enzalutamide in Men With mCRPC|Recruiting||Phase 2|58|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-10 23:44:53.401921|2017-10-10 23:44:53.401921
NCT02312544|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-12-13|||November 2014||2014-11-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension|A Prospective, Multicenter, Randomized, Double-Masked, Parallel-Arm Phase 2b Study Evaluating the Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|72|Actual|Ocular Therapeutix, Inc.||2|||f||||f||||||||||2017-10-10 23:44:53.512638|2017-10-10 23:44:53.512638
NCT02312531|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-08|||May 2012||2012-05-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Prevention for Mother-to-infant Transmission of HBV|HBIG for Prevention of Mother-to-infant HBV Transmission|Completed||N/A|28|Actual|Health Science Center of Xi’an Jiaotong University||2|||f||||t||||||||||2017-10-10 23:44:53.588724|2017-10-10 23:44:53.588724
NCT02312518|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-03-28|||July 2016||2016-07-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Trial of ECLIPSE PRP™ Wound Biomatrix in Chronic Non-Healing Venous Leg Ulcers|A Prospective, Randomized Clinical Trial of ECLIPSE PRP™ Wound Biomatrix in Chronic Non-Healing Venous Leg Ulcers|Not yet recruiting||Phase 2/Phase 3|250|Anticipated|PRP Concepts, LLC||2|||f||||f||||||||No||2017-10-10 23:44:53.674271|2017-10-10 23:44:53.674271
NCT02312505|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-10-24|||March 2012||2012-03-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Comparison of a New Semi-invasive Monitoring System With Transpulmonary Thermodilution in Cardiac Surgery Patients|Estimation of Cardiac Output by a New Semi-invasive Monitoring System: Accuracy and Limitations|Completed||N/A|65|Actual|University of Schleswig-Holstein||1|||f||||t||||||||No||2017-10-10 23:44:53.757583|2017-10-10 23:44:53.757583
NCT02312492|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-04-24|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans|Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans.|Recruiting||N/A|6|Anticipated|Tufts University||3|||f||||f||||||||||2017-10-10 23:44:53.841885|2017-10-10 23:44:53.841885
NCT02312479|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-09-26|||December 2014||2014-12-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Performance Study of the Nyxoah SAT System for Treating OSA|Safety and Performance Study of the Use of the Nyxoah SAT System for the Treatment of Obstructive Sleep Apnea|Terminated||N/A|6|Actual|Nyxoah S.A.||1|||f||||t||||||||||2017-10-10 23:44:53.952564|2017-10-10 23:44:53.952564
NCT02312466|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-01-27|||March 2015||2015-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Observational|SIS||Swiss National Iodine Survey 2015|Swiss National Iodine Survey 2015; A Cross-sectional Study to Assess Iodine Status in School Children, Women of Reproductive Age and Pregnant Women|Completed||N/A|1430|Actual|Swiss Federal Institute of Technology|||3||f||||||||||||||2017-10-10 23:44:54.03078|2017-10-10 23:44:54.03078
NCT02312453|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2014-12-06|||November 2012||2012-11-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Posterior Parasagittal In-Plane Ultrasound-Guided Infraclavicular Brachial Plexus Block|Posterior Parasagittal In-Plane Ultrasound-Guided Infraclavicular Brachial Plexus Block - A Case Series|Completed||N/A|18|Actual|University of Malaya||1|||f||||f||||||||||2017-10-10 23:44:54.10569|2017-10-10 23:44:54.10569
NCT02312440|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-11-28|||October 2014||2014-10-01|May 2015|2015-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty|Comparison of Topical and Intravenous Tranexamic Acid on Blood Loss and Transfusion Rates in Total Hip Arthroplasty|Completed||Phase 3|173|Actual|Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||||2017-10-10 23:44:54.191212|2017-10-10 23:44:54.191212
NCT02312427|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2015-03-29|||January 2015||2015-01-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure|Investigation of the Impact of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Serum B-type Natriuretic Peptide (BNP) Level of Diabetic Patients With Congestive Heart Failure.|Unknown status|Recruiting|Phase 4|50|Anticipated|Mitsui Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:44:54.316167|2017-10-10 23:44:54.316167
NCT02312414|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-05-15|||October 2014||2014-10-01|May 2015|2015-05-01||||March 2015|Actual|2015-03-01||Interventional|||Effects of Carnitine on Oxidative Stress to IVIR Administration to CKD Patients:Impact of Haptoglobin Genotype|Effects of Carnitine on Oxidative Stress and Inflammatory Responses to Intravenous Iron Administration to Patients With CKD: Impact of Haptoglobin Genotype|Unknown status|Recruiting|N/A|25|Anticipated|The Nazareth Hospital, Israel||2|||f||||t||||||||||2017-10-10 23:44:54.417967|2017-10-10 23:44:54.417967
NCT02312401|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-08-02|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy|Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy|Recruiting||Phase 2|165|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:44:54.495053|2017-10-10 23:44:54.495053
NCT02312388|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-08|||July 2013||2013-07-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of the Central Venous Catheter Insertion Techniques|Comparison of the Central Venous Catheter Insertion Techniques: the Thin-wall Needle Versus the Catheter-over-the-needle Technique in Children|Completed||N/A|138|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:44:54.623891|2017-10-10 23:44:54.623891
NCT02312375|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-04-27|||March 2015||2015-03-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients|Effects of Fimasartan on Insulin Secretion, and Interaction With DPP4 Inhibitors in Patients With Type 2 Diabetes|Completed||N/A|46|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:44:54.71423|2017-10-10 23:44:54.71423
NCT02312362|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2014-12-05|||November 2012||2012-11-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|June 2015|Anticipated|2015-06-01||Interventional|HFDS_abinterno||High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP|HFDS ab Interno - to Compare Intraocular Pressure (IOP) Lowering Effect of Combined High Frequency Deep Sclerotomy ab Interno (HFDS ab Interno) With Phacoemulsification and Phacoemulsification Alone, in Primary Open Angle Glaucoma Patients|Unknown status|Recruiting|N/A|108|Anticipated|Oertli Instrumente AG||2|||f||||||||||||||2017-10-10 23:44:54.789035|2017-10-10 23:44:54.789035
NCT02312349|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-08|||September 2011||2011-09-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Assessment of Gluten-Free Availability in Elaborated Food Stores in Three Neighbourhoods of Buenos Aires City|Assessment of Gluten-Free Availability in Elaborated Food Stores in Three Neighbourhoods of Buenos Aires City|Completed||N/A|112|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-10 23:44:54.885119|2017-10-10 23:44:54.885119
NCT02312336|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-07-27|||September 2014||2014-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Pilot Study of Transcoronary Myocardial Cooling|A Safety and Feasibility Study of Transcoronary Myocardial Buffering and Cooling During Primary Coronary Angioplasty to Reduce Myocardial Reperfusion Injury in Acute Myocardial Infarction.|Completed||N/A|10|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:44:54.947685|2017-10-10 23:44:54.947685
NCT02312323|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2014-12-06|||November 2014||2014-11-01|December 2014|2014-12-01||||January 2015|Anticipated|2015-01-01||Interventional|||One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses||Unknown status|Active, not recruiting|N/A|||Contamac Ltd||2|||f||||||||||||||2017-10-10 23:44:55.031658|2017-10-10 23:44:55.031658
NCT02312310|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2016-10-11|||December 2015||2015-12-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Dietary Flavanols and Dentate Gyrus Function|Dietary Cocoa Flavanols and Age-Related Memory Decline|Recruiting||N/A|260|Anticipated|New York State Psychiatric Institute||4|||f||||f||||||||||2017-10-10 23:44:55.163936|2017-10-10 23:44:55.163936
NCT02312297|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-08|||September 2008||2008-09-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover, Bioequivalence Study Comparing Minocycline Hydrochloride 135 mg Extended Release Tablets (Containing Minocycline Hydrochloride 135 mg) of OHM Laboratories, USA (A Subsidiary of Ranbaxy Pharmaceuticals Inc. USA) With SolodynTM Extended Release Tablets (Containing Minocycline Hydrochloride 135 mg) of AAI Pharma, Inc. in Healthy, Adult, Male, Human Subjects Under Fasting Condition.|Completed||N/A|28|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-10 23:44:55.280365|2017-10-10 23:44:55.280365
NCT02312271|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-29|||December 2014||2014-12-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Observational|||Enteral Formula Tolerance of Standard Tube Feedings||Completed||N/A|102|Actual|Nestlé|||1||f||||||||||||||2017-10-10 23:44:55.407528|2017-10-10 23:44:55.407528
NCT02312258|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-05|||April 23, 2015|Actual|2015-04-23|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Study of Oral Ixazomib Maintenance Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation|A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation|Recruiting||Phase 3|761|Anticipated|Takeda||2|||f||||t|t|f||||||||2017-10-10 23:44:55.484393|2017-10-10 23:44:55.484393
NCT02312245|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-27|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Avatar-Directed Chemotherapy in Platinum-Resistant Ovarian, Primary Peritoneal and Fallopian Tube Cancers|Recruiting||Phase 2|240|Anticipated|Mayo Clinic||4|||f||||t||||||||||2017-10-10 23:44:55.732914|2017-10-10 23:44:55.732914
NCT02312232|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-02-17|||November 2014||2014-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|NOCOF||Pharmacokinetic Study in Healthy Males|Pharmacokinetics of Levodopa, Carbidopa, 3-OMD and ODM-104 After Repeated Doses of Different Formulations: an Open, Randomised, Multicentre Study With Crossover Design in Healthy Males|Completed||Phase 1|20|Actual|Orion Corporation, Orion Pharma||5|||f||||f||||||||||2017-10-10 23:44:55.89373|2017-10-10 23:44:55.89373
NCT02312219|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-08-24|||November 2014||2014-11-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 8, 2016|Actual|2016-12-08||Interventional|PET/CTMTX||PET/CT Imaging Companion Study To ACTG A5314|Imaging Companion Study To ACTG A5314: Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection|Active, not recruiting||Phase 2|91|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:44:55.984737|2017-10-10 23:44:55.984737
NCT02312206|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-08-14|||February 2015||2015-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|January 2018|Anticipated|2018-01-01||Interventional|VITAL||The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis|A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care Versus Placebo Plus Standard of Care in Subjects With Light Chain (AL) Amyloidosis|Active, not recruiting||Phase 3|236|Anticipated|Prothena Therapeutics Ltd.||2|||f||||t||||||||||2017-10-10 23:44:56.077119|2017-10-10 23:44:56.077119
NCT02312193|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-03-13|||January 2015||2015-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Observational|||Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects|Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects|Completed||N/A|95|Actual|Neuromed IRCCS|||2||f||||||||||||||2017-10-10 23:44:56.267799|2017-10-10 23:44:56.267799
NCT02312180|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-08-28|||December 2014||2014-12-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency|A Phase 1, Dose Escalation, and Pharmacokinetic Study of ProMetic Plasminogen Administered as Intravenous Infusion in Adults and Children With Hypoplasminogenemia|Completed||Phase 1|7|Actual|ProMetic BioTherapeutics, Inc||2|||t||||t||||||||||2017-10-10 23:44:56.485635|2017-10-10 23:44:56.485635
NCT02312167|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2016-02-10|||October 2014||2014-10-01|December 2014|2014-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|PERSEE||Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE)|Essai de faisabilité Pour Une Endomicroscopie Robotisée Dans la redéfinition Des Stratégies d&Apos;ExérèsE|Completed||N/A|30|Actual|Institut Mutualiste Montsouris||1|||f||||t||||||||||2017-10-10 23:44:56.573181|2017-10-10 23:44:56.573181
NCT02312154|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-03-16|2014-12-09||April 2014||2014-04-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Changing in Skin Physiology After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces|Split-face Study of Changing in Skin Physiology and Clinical Appearance After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces|Completed||Phase 4|25|Actual|Konkuk University Hospital|First, it did not have a double-blind design, and so the GAIS scores of the subjects could have been influenced. Second, the posttreatment follow-up period was relatively short, at 12 weeks. Finally, the patient sample in this study was small.|2|||f||||t||||||||||2017-10-10 23:44:56.69619|2017-10-10 23:44:56.69619
NCT02312141|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-09-23|||October 2014||2014-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:44:57.129273|2017-10-10 23:44:57.129273
NCT02312128|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-08-09|||January 2015||2015-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Early Mobilization of Operatively Stabilized Distal Radius Fractures - a Randomized Controlled Trail|Early Mobilization of Operatively Stabilized Distal Radius Fractures - a Randomized Controlled Trail|Completed||N/A|146|Actual|Ludwig Boltzmann Gesellschaft||2|||f||||f||||||||||2017-10-10 23:44:57.181038|2017-10-10 23:44:57.181038
NCT02312115|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-11-23|||September 2016||2016-09-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|DRAFFT||Delayed Renal Allograft Function and Furosemide Treatment|DRAFFT Trial: Delayed Renal Allograft Function and Furosemide Treatment: A Randomized Prospective Double-blinded Placebo-controlled Clinical Pilot Trial|Withdrawn||Phase 2|0|Actual|Loma Linda University||2||Lack of funding|f||||t||||||||No||2017-10-10 23:44:57.297781|2017-10-10 23:44:57.297781
NCT02312102|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-10|||March 2015||2015-03-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|November 2017|Anticipated|2017-11-01||Interventional|||Phase I Study of Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation|Phase I Dose Escalation Study of Velcade in Combination With Lenalidomide in Patients With Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) After Allogeneic Stem Cell Transplantation|Recruiting||Phase 1|28|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||Undecided||2017-10-10 23:44:57.417999|2017-10-10 23:44:57.417999
NCT02312089|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-08|||December 2014||2014-12-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles|Gonadotropin Releasing Hormone Agonist for Luteal Phase Support in Gonadotropin Releasing Hormone Antagonist Protocol Cycles|Recruiting||Phase 4|200|Anticipated|Mansoura University||2|||f||||f||||||||No||2017-10-10 23:44:57.538281|2017-10-10 23:44:57.538281
NCT02312076|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-05-08|||December 2014||2014-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles|Gonadotropin Releasing Hormone Agonist for Luteal Phase Support in Long Gonadotropin Releasing Hormone Agonist Protocol Cycles|Recruiting||Phase 4|200|Anticipated|Mansoura University||2|||f||||f||||||||No||2017-10-10 23:44:57.647897|2017-10-10 23:44:57.647897
NCT02312063|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-08-30|||February 2015||2015-02-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|DIET||Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes|Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes: a Multicenter, Randomized, Prospective, Open-label, Clinical Trial|Completed||Phase 4|48|Actual|Kansai Electric Power Hospital||2|||f||||f||||||||||2017-10-10 23:44:57.758498|2017-10-10 23:44:57.758498
NCT02312050|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2015-05-16|||March 2015||2015-03-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes|A Phase 2b, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes|Unknown status|Active, not recruiting|Phase 2|375|Anticipated|La Jolla Pharmaceutical Company||4|||f||||f||||||||||2017-10-10 23:44:57.876244|2017-10-10 23:44:57.876244
NCT02312037|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-09-28||||||September 2017|2017-09-01||||||||Expanded Access|AML||Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy|Gemtuzumab Ozogamicin (Mylotarg (Registered)) Expanded Access Protocol For Treatment Of Patients In The United States With Relapsed/Refractory Acute Myelogenous Leukemia Who May Benefit From Treatment And Have No Access To Other Comparable/Alternative Therapy|Available||N/A|||Pfizer|||||||||||||||||||2017-10-10 23:44:58.015097|2017-10-10 23:44:58.015097
NCT02312024|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-06-03|||January 2015||2015-01-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01|30 Days|Observational [Patient Registry]|CytoSorb||International Registry on the Use of the CytoSorb Adsorber|International Registry on the Use of the CytoSorb®-Adsorber in ICU Patients|Recruiting||N/A|3000|Anticipated|Jena University Hospital|||4||f||||f||||||||||2017-10-10 23:44:58.390162|2017-10-10 23:44:58.390162
NCT02312011|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-11-02|||December 2014||2014-12-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1|A Phase 1/2a Blinded, Placebo-Controlled Study to Assess the Safety, Tolerability, and Dose-range Finding of Multiple Ascending Doses of ISIS 598769 Administered Subcutaneously to Adult Patients With Myotonic Dystrophy Type 1|Completed||Phase 1/Phase 2|48|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:44:58.504803|2017-10-10 23:44:58.504803
NCT02311998|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-09-14|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive Philadelphia-Chromosome (PC) Positive Acute Lymphoblastic Leukemia (ALL) and Chronic Myeloid Leukemia (CML)|A Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Lymphoid Blast Phase|Recruiting||Phase 1/Phase 2|80|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:44:58.587208|2017-10-10 23:44:58.587208
NCT02311985|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-01-19|||September 2014||2014-09-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|POCKET||Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial|Point-of-care Versus Standard Coagulation Tests Versus Restrictive Strategy to Guide Transfusion in Chronic Liver Failure Patients Requiring Central Venous Line: Prospective Randomized Trial|Recruiting||N/A|165|Anticipated|Hospital Israelita Albert Einstein||3|||f||||f||||||||Undecided||2017-10-10 23:44:58.682009|2017-10-10 23:44:58.682009
NCT02311972|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-05-15|2017-03-29||November 2014||2014-11-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Temperature Monitoring With InnerSense Esophageal Temperature Sensor/Feeding Tube After Birth Through Stabilization in VLBW Infants|Temperature Monitoring With InnerSense Esophageal Temperature Sensor/Feeding Tube After Birth Through Stabilization in VLBW Infants|Completed||N/A|52|Actual|Duke University||2|||f||||t||||||||||2017-10-10 23:44:58.789246|2017-10-10 23:44:58.789246
NCT02311959|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-08-07|||February 9, 2015|Actual|2015-02-09|August 2017|2017-08-01|February 2024|Anticipated|2024-02-01|February 2019|Anticipated|2019-02-01||Interventional|MAPAM-01||Therapeutic Nipple Sparing Mastectomy.|Therapeutic Nipple Areola Skin-sparing Mastectomy.|Recruiting||Phase 3|450|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||||2017-10-10 23:44:59.238717|2017-10-10 23:44:59.238717
NCT02311764|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-11-24|||February 2015||2015-02-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|PRO-PLAT||Carboplatin in Castration-resistant Prostate Cancer|Single Arm Open Label Phase II Pilot Study of Carboplatin in Patients With Metastatic Castrationresistant Prostate Cancer (CRPC) and PTEN Loss and/or DNA Repair Defects|Recruiting||Phase 2|25|Anticipated|Cantonal Hospital of St. Gallen||1|||f||||t||||||||Undecided||2017-10-10 23:45:07.462832|2017-10-10 23:45:07.462832
NCT02311946|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-05-27|||January 2015||2015-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib|A Phase 1, Open‑Label Fixed‑Sequence 2‑Period Crossover Study Of Palbociclib (pd‑0332991) In Healthy Volunteers To Estimate The Effect Of Antacid Treatment On The Bioavailability Of A 125 Mg Single Dose Of Six Experimental Formulations Of Palbociclib Relative To Palbociclib Administration Alone Under Fasted Conditions|Completed||Phase 1|60|Actual|Pfizer||6|||f||||f||||||||||2017-10-10 23:44:59.418565|2017-10-10 23:44:59.418565
NCT02311920|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-09-12|||April 16, 2015|Actual|2015-04-16|September 2017|2017-09-01||||November 1, 2017|Anticipated|2017-11-01||Interventional|||Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma|Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients With Newly Diagnosed Glioblastoma|Active, not recruiting||Phase 1|42|Anticipated|National Cancer Institute (NCI)||3|||f||||f||||||||||2017-10-10 23:45:02.659931|2017-10-10 23:45:02.659931
NCT02311907|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-08|2017-01-05|2016-07-19||December 2009||2009-12-01|January 2017|2017-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer|The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study|Completed||Phase 3|195|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-10 23:45:02.975557|2017-10-10 23:45:02.975557
NCT02311894|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-03-13|||March 31, 2015|Actual|2015-03-31|March 2017|2017-03-01|November 6, 2017|Anticipated|2017-11-06|October 1, 2017|Anticipated|2017-10-01||Interventional|||A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency|A Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naïve Growth Hormone-Deficient Children (iSTUDY)|Active, not recruiting||Phase 4|82|Actual|Genentech, Inc.||1|||f||||f||||||||||2017-10-10 23:45:04.855164|2017-10-10 23:45:04.855164
NCT02311881|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-02-23|2016-10-10||January 2015||2015-01-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||Baseline data are displayed for the safety population; i.e. for the population of all treated participants. One participant was randomized but did not receive any treatment.|A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis|An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis|Completed||Phase 3|960|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:45:05.051764|2017-10-10 23:45:05.051764
NCT02311868|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-08|||December 2014||2014-12-01|December 2014|2014-12-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Effect of Short-term Synbiotic Treatment on Plasma P-cresol Levels in Hemodialysis Patients||Unknown status|Recruiting|Phase 4|30|Anticipated|Federico II University||2|||f||||||||||||||2017-10-10 23:45:06.544511|2017-10-10 23:45:06.544511
NCT02311855|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-01-05|||August 2014||2014-08-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Duration of Immune Response to Influenza Vaccination in Patients With RA|Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents|Completed||Phase 4|87|Actual|Bassett Healthcare||1|||f||||f||||||||No||2017-10-10 23:45:06.641054|2017-10-10 23:45:06.641054
NCT02311842|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-04|||January 2012||2012-01-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS|To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early Ankylosing Spondylitis|Completed||N/A|68|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-10 23:45:06.728946|2017-10-10 23:45:06.728946
NCT02311829|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-03-07|||January 2014||2014-01-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|EDUQ-CPNE||Evaluation of a Telephone Follow-up Procedure on the Quality of Life in Psychogenic Non-epileptic Seizures|Evaluation d'un Dispositif de Suivi téléphonique Sur la Qualité de Vie Dans Les Crises Psychogènes Non Epileptiques.|Recruiting||N/A|136|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-10-10 23:45:06.813325|2017-10-10 23:45:06.813325
NCT02311816|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-04|||October 2012||2012-10-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Increase in Procalcitonin Kinetics May be a Good Indicator of Starting Empirical Antibiotic Treatment in Critically Ill Patients||Completed||N/A|114|Actual|Szeged University|||2||f||||f||||||||||2017-10-10 23:45:07.026861|2017-10-10 23:45:07.026861
NCT02311803|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-04-24|||February 2015||2015-02-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Preservation Versus Excision of Denonvilliers Fascia in L-PANP Surgery|Preservation Versus Excision of Denonvilliers Fascia in Laparoscopic Pelvic Autonomic Nerve Preserving Surgery for Male Mid-low Rectal Cancer Patients: a Randomized Controlled Clinical Trial|Recruiting||N/A|172|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 23:45:07.123254|2017-10-10 23:45:07.123254
NCT02311790|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-08-31|||July 2015||2015-07-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Palmitoleic Isomer Study|Supplementation With Vegetable Oils Enriched in the Fatty Acids Trans-C16:1 or Cis-C16:1: Dose-response Study|Completed||N/A|17|Actual|Tufts University||2|||f||||f||||||||||2017-10-10 23:45:07.28228|2017-10-10 23:45:07.28228
NCT02311777|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-06-07|||January 2015||2015-01-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Pre-operative Pregabalin and Ketamine to Prevent Phantom Pain|Effects of Pre-operative Pregabalin and Ketamine to Prevent Development of Phantom Pain in Patients Undergoing Lower Extremity Amputation|Recruiting||Phase 3|30|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||Yes||2017-10-10 23:45:07.364479|2017-10-10 23:45:07.364479
NCT02311751|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-06-08|||October 2014|Actual|2014-10-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|June 2017|Actual|2017-06-01||Interventional|||rTMS for Executive Function Deficits in Autism Spectrum Disorder|Repetitive Transcranial Magnetic Stimulation (rTMS) for Executive Function Deficits in Autism Spectrum Disorder and Effects on Brain Structure: A Pilot Study|Active, not recruiting||N/A|40|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-10 23:45:07.578459|2017-10-10 23:45:07.578459
NCT02311738|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-04-05|||January 2015||2015-01-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|EGO||Exercise and Genes in Obese (EGO)|The Effect of Exercise and Genes on Energy Expenditure, Appetite and Quality of Life in Morbidly Obese Patients|Active, not recruiting||N/A|50|Anticipated|Sykehuset i Vestfold HF||2|||f||||t||||||||||2017-10-10 23:45:07.672176|2017-10-10 23:45:07.672176
NCT02311725|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-07-12|||May 1, 2017|Actual|2017-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|sTVi-RCT||Storytelling Video Intervention for Depressed Primary Care Patients - Pilot Trial|Narrative Intervention to Disseminate ACT for Depression in Primary Care|Recruiting||N/A|40|Anticipated|Butler Hospital||2|||f||||f|f|f||||||||2017-10-10 23:45:07.771067|2017-10-10 23:45:07.771067
NCT02311712|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-05-02|||December 2016||2016-12-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|NESP||Non-endoscopic EC Screening Program in Northern Iran|Non-endoscopic Esophageal Cancer Screening Program in Northern Iran|Active, not recruiting||N/A|12000|Anticipated|Tehran University of Medical Sciences||2|||f||||t|||||t|||||2017-10-10 23:45:07.881362|2017-10-10 23:45:07.881362
NCT02311699|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-07-12|||December 2014||2014-12-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Using Cultural Ceremonies to Reduce Intimate Partner Violence and HIV Transmission|Using Cultural Ceremonies to Reduce Intimate Partner Violence and HIV Transmission|Active, not recruiting||N/A|6800|Anticipated|Abdul Latif Jameel Poverty Action Lab||4|||f||||f||||||||||2017-10-10 23:45:07.984439|2017-10-10 23:45:07.984439
NCT02311686|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-05-13|||December 2014||2014-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Non-oxidative Metabolite Profiles After Increasing Doses of Ethanol|Identifying the Profile of the Main Non-oxidative Biomarkers of Alcohol (Ethyl Glucuronide, Ethyl Sulphate, Fatty Acid Ethyl Esters) After the Experimental Exposure to Increasing Doses of Alcohol in Adults.|Completed||Phase 1|54|Actual|Parc de Salut Mar||5|||f||||t||||||||||2017-10-10 23:45:08.084851|2017-10-10 23:45:08.084851
NCT02311673|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-04-19|||February 2015||2015-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome|A Ph 2, Randomized, Double-Blind, Placebo-controlled Pilot Study to Assess the Effects of RM-493, a Melanocortin 4 Receptor (MC4R) Agonist, in Obese Subjects With Prader-Willi Syndrome (PWS) on Safety, Weight Reduction, and Food-Related Behaviors|Completed||Phase 2|40|Actual|Rhythm Pharmaceuticals, Inc.||3|||f||||t|t|f||||||No||2017-10-10 23:45:08.226182|2017-10-10 23:45:08.226182
NCT02311660|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-08-02|||December 2014||2014-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Vagus Nerve Stimulation in Crohn's Disease|Study of the Safety and Efficacy of Neurostimulation of the Cholinergic Anti-Inflammatory Pathway Using a Vagal Nerve Stimulation Device in Patients With Active Refractory Crohn's Disease|Active, not recruiting||N/A|15|Anticipated|SetPoint Medical Corporation||1|||f||||f||||||||||2017-10-10 23:45:08.365397|2017-10-10 23:45:08.365397
NCT02311647|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-22|||January 2015||2015-01-01|December 2014|2014-12-01|February 2017|Anticipated|2017-02-01|January 2017|Anticipated|2017-01-01||Observational|||Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients|Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients|Unknown status|Not yet recruiting|N/A|120|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-10 23:45:08.453765|2017-10-10 23:45:08.453765
NCT02311634|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-08-03|||December 2014||2014-12-01|June 2015|2015-06-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||A Comparison of Electrical Pudendal Nerve Stimulation and Transvaginal Electrical Stimulation for Urge Incontinence|A Comparison of Efficacies of Electrical Pudendal Nerve Stimulation Versus Transvaginal Electrical Stimulation in Treating Urge Incontinence|Completed||N/A|120|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-10 23:45:08.526815|2017-10-10 23:45:08.526815
NCT02311621|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-01-30|||November 2014||2014-11-01|January 2017|2017-01-01||||November 2017|Anticipated|2017-11-01||Interventional|||Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01|A Phase 1 Feasibility and Safety Study of Cellular Immunotherapy for Recurrent/Refractory Neuroblastoma Using Autologous T-cells Lentivirally Transduced to Express CD171-specific Chimeric Antigen Receptors|Recruiting||Phase 1|40|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||Undecided|Current plan will be to present as a combined data set once enrollment and assessments are complete. Individual data may be made available if clinically applicable based on extreme response or toxicity.|2017-10-10 23:45:08.607776|2017-10-10 23:45:08.607776
NCT02311608|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-05|||February 2014||2014-02-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Observational|CER:T||Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails|Comparative Effectiveness Research: Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails to Treat the Patients With Acute Variceal Bleeding|Unknown status|Recruiting|N/A|1320|Anticipated|Shanghai Zhongshan Hospital|||5||f||||t||||||||||2017-10-10 23:45:08.690334|2017-10-10 23:45:08.690334
NCT02311595|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-05|||December 2014||2014-12-01|December 2014|2014-12-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection|A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection for Gastric Cancer Patients|Unknown status|Not yet recruiting|Phase 2|67|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-10 23:45:08.797383|2017-10-10 23:45:08.797383
NCT02311582|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-26|||August 5, 2015|Actual|2015-08-05|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas|A Phase I and Open Label, Randomized, Controlled Phase II Study Testing the Safety, Toxicities, and Efficacy of MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas|Recruiting||Phase 1/Phase 2|52|Anticipated|Washington University School of Medicine||3|||f||||t|t|t|f|f||||No||2017-10-10 23:45:08.873875|2017-10-10 23:45:08.873875
NCT02311569|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-12-28|||April 2015||2015-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation|Effects of Sympathicomimetic Agonists on the Disease Course and Mutant Allele Burden in Patients With JAK2-mutated Myeloproliferative Neoplasms. A Multicenter Phase II Trial.|Completed||Phase 2|39|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||No||2017-10-10 23:45:09.002932|2017-10-10 23:45:09.002932
NCT02311556|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-02-22|||May 7, 2013|Actual|2013-05-07|February 2017|2017-02-01|December 16, 2016|Actual|2016-12-16|July 1, 2016|Actual|2016-07-01||Interventional|||Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging|Assessment of Early Treatment Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging|Completed||Phase 1|23|Actual|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||No||2017-10-10 23:45:09.109916|2017-10-10 23:45:09.109916
NCT02311543|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-07-21|||March 18, 2015|Actual|2015-03-18|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 27, 2017|Actual|2017-06-27||Interventional|||Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer|Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Lymph Node Dissection for Breast Cancer. A Multicenter Randomized Phase III Trial.|Active, not recruiting||Phase 3|142|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-10 23:45:09.174865|2017-10-10 23:45:09.174865
NCT02311530|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-05|||October 2008||2008-10-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover, Bioequivalence Study Comparing Felodipine Extended Release Tablet (Containing Felodipine 10 mg) of OHM Laboratories Inc (A Subsidiary of Ranbaxy Pharmaceuticals Inc) With PLENDIL® Extended Release Tablet (Containing Felodipine 10 mg) Manufactured by Merck & Co. Inc. for AstraZeneca in Healthy, Adult, Male, Human Subjects Under Fed Condition|Completed||N/A|80|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-10 23:45:09.267237|2017-10-10 23:45:09.267237
NCT02311517|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-04|||November 2014||2014-11-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||The Effects of Serratus Anterior Plane Block on Postoperative Quality of Recovery and Analgesia After Video-assisted Thoracoscopic Surgery||Unknown status|Recruiting|N/A|90|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:45:09.529373|2017-10-10 23:45:09.529373
NCT02311504|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-05-27|||January 2014||2014-01-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Observational|DiabCheckophta||Eye Screening in German Secondary Diabetes Care Centers|OCT Screening of Diabetes Patients: Health Care Research in Secondary Diabetes Care Centers|Completed||N/A|831|Actual|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-10 23:45:09.600379|2017-10-10 23:45:09.600379
NCT02311491|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-08-25|||December 2016||2016-12-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Nano-Crystalline Ceramic Coating of Orthodontic Archwires|Nano-Crystalline Ceramic Coating for the Reduction of Sliding Resistance of Orthodontic Archwires|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||2||Funding terminated|f||||f||||||||||2017-10-10 23:45:09.6718|2017-10-10 23:45:09.6718
NCT02311478|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-08-04|||December 2014||2014-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|TRIBE||Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users|(TRIBE) Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users|Active, not recruiting||N/A|80|Anticipated|University of Utah||1|||f||||f||||||||||2017-10-10 23:45:09.744649|2017-10-10 23:45:09.744649
NCT02311465|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2015-12-09|||December 2015||2015-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Randomized Study of Early Palliative Care|A Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Oncology Care Alone in Patients With Non-colorectal Gastrointestinal Malignancies.|Withdrawn||N/A|0|Actual|Vanderbilt University||2||Feasibility issues|f||||f||||||||||2017-10-10 23:45:09.818179|2017-10-10 23:45:09.818179
NCT02311452|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-05|||January 2009||2009-01-01|December 2014|2014-12-01||||December 2012|Actual|2012-12-01||Observational|PIVVOT||Comparative Effectiveness of Intravenous v. Oral Antibiotic Therapy for Serious Bacterial Infections|Comparative Effectiveness of Intravenous v. Oral Antibiotic Therapy for Serious Bacterial Infections|Completed||N/A|15000|Actual|Children's Hospital of Philadelphia|||3||f||||f||||||||||2017-10-10 23:45:09.902045|2017-10-10 23:45:09.902045
NCT02311439|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-05|||October 2014||2014-10-01|December 2014|2014-12-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|||Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas|Induction Chemotherapy, Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan (FOLFIRINOX) Followed With Concurrent Capecitabine and Radiation Therapy in Treatment of Patients With Inoperable Locally Advanced Cancer Pancreas|Unknown status|Recruiting|Phase 2/Phase 3|1|Anticipated|Assiut University||1|||f||||t||||||||||2017-10-10 23:45:09.978035|2017-10-10 23:45:09.978035
NCT02311426|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2014-12-05|||March 2014||2014-03-01|December 2014|2014-12-01||||September 2016|Anticipated|2016-09-01|12 Months|Observational [Patient Registry]|||Stroke in North of Norway and Denmark. A Prospective Cohort Study.||Unknown status|Recruiting|N/A|1000|Anticipated|University Hospital of North Norway|||2||f||||f||||||||||2017-10-10 23:45:10.079706|2017-10-10 23:45:10.079706
NCT02311413|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-10-06|||January 2015||2015-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Fel d 1 Peptide Immunotherapy Clinical Trial|The Effect of Peptide Immunotherapy on Frequency, Memory Phenotype, Chemokine Receptor Expression and Markers of Regulatory T Cell Function Among Allergen-Specific T Cells. A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy (DAIT U19-MMU-02)|Recruiting||Phase 2|48|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:45:10.165333|2017-10-10 23:45:10.165333
NCT02311400|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-30|||November 19, 2014||2014-11-19|September 29, 2016|2016-09-29|September 29, 2016|Actual|2016-09-29|April 1, 2015|Actual|2015-04-01||Observational|||Self-Affirmation, Emotion, and Alcohol Consumption|Self-Affirmation, Emotion, and Alcohol Consumption|Completed||N/A|700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:45:10.267221|2017-10-10 23:45:10.267221
NCT02311387|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-30|||November 18, 2014||2014-11-18|October 31, 2016|2016-10-31|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|||Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali|Study of the Seroprevalence and the Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali|Completed||N/A|601|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:45:10.331776|2017-10-10 23:45:10.331776
NCT02311374|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-30|||November 20, 2014||2014-11-20|May 4, 2017|2017-05-04|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness|Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness|Recruiting||Early Phase 1|66|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:45:10.490834|2017-10-10 23:45:10.490834
NCT02311361|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-10-04|||November 19, 2014||2014-11-19|August 4, 2017|2017-08-04|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer|A Pilot Study of Immune Checkpoint Inhibition (Durvalumab With or Without Tremelimumab) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer|Recruiting||Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-10 23:45:10.572602|2017-10-10 23:45:10.572602
NCT02311348|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-30|||November 20, 2014||2014-11-20|December 21, 2016|2016-12-21|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Observational|||Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy|Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy|Completed||N/A|32|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:45:10.686906|2017-10-10 23:45:10.686906
NCT02311335|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-09-12|||November 18, 2014||2014-11-18|September 1, 2017|2017-09-01|September 1, 2025|Anticipated|2025-09-01|September 1, 2025|Anticipated|2025-09-01||Observational|||Genes Involved in Lipid Disorders|Genes Involved in Lipid Disorders|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:45:10.749671|2017-10-10 23:45:10.749671
NCT02311322|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-05|2017-06-30|||November 14, 2014||2014-11-14|October 19, 2016|2016-10-19|October 31, 2024|Anticipated|2024-10-31|October 31, 2024|Anticipated|2024-10-31||Observational|||Genetic Causes of Growth Disorders|Genetic Causes of Growth Disorders|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:45:10.838682|2017-10-10 23:45:10.838682
NCT02311309|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-03-22|2016-02-09||November 2013||2013-11-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery|Epidemiology of Peroperative Bleeding and Transfusion During Scheduled Surgery.|Completed||N/A|1439|Actual|University Hospital, Caen|||2||f||||f||||||||||2017-10-10 23:45:10.927504|2017-10-10 23:45:10.927504
NCT02311296|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-12-04|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Reduced Ventilator-Free Days and Bacterial Colonization of Sub-Glottic Secretions|Effect of Bacterial Colonization and Extracellular HSP-70 Expression in Sub-Glottic Secretions on Ventilator Free Days in Patients Receiving Mechanical Ventilation for Respiratory Failure or Airway Protection|Not yet recruiting||N/A|100|Anticipated|University of Tennessee, Chattanooga|||1||f||||f||||||||||2017-10-10 23:45:11.344001|2017-10-10 23:45:11.344001
NCT02311283|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-21|||October 2014||2014-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|October 2015|Actual|2015-10-01|1 Year|Observational [Patient Registry]|||Pilot Study: Urea Cycle Disorders Practice Patterns and Outcomes Assessment|Pilot Study: Urea Cycle Disorders Practice Patterns and Outcomes Assessment|Completed||N/A|87|Actual|University of South Florida|||1||f||||f||||||||||2017-10-10 23:45:11.420165|2017-10-10 23:45:11.420165
NCT02311270|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-22|||September 2014||2014-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01|1 Day|Observational [Patient Registry]|||Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation|Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation|Completed||N/A|106|Actual|University of South Florida|||1||f||||f||||||||||2017-10-10 23:45:11.501043|2017-10-10 23:45:11.501043
NCT02311257|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-21|||September 2014||2014-09-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01|1 Day|Observational [Patient Registry]|||Survey on Supplement Use in Mitochondrial Disease|Survey on Supplement Use in Mitochondrial Disease|Completed||N/A|162|Actual|University of South Florida|||1||f||||f||||||||||2017-10-10 23:45:11.581245|2017-10-10 23:45:11.581245
NCT02311244|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-05-02|||February 2014||2014-02-01|May 2017|2017-05-01|February 2023|Anticipated|2023-02-01|February 2018|Anticipated|2018-02-01||Observational|SUMMER||The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes|The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes: Identification of New Molecular Promoters of Mortality and Morbidity in Patients With Type 2 Diabetes Mellitus|Recruiting||N/A|5000|Anticipated|University of Roma La Sapienza|||1||f||||f||||||Samples With DNA|"     Serum and urine   "|||2017-10-10 23:45:11.670141|2017-10-10 23:45:11.670141
NCT02311231|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-05-18|||June 2014||2014-06-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|VALIDATE||Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART|Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on the SWEDEHEART Platform|Completed||Phase 4|6012|Actual|Uppsala University||2|||f||||t||||||||||2017-10-10 23:45:11.772527|2017-10-10 23:45:11.772527
NCT02311218|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2014-12-04|||March 2013||2013-03-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|OMICI||Probiotic Lactobacillus Reuteri and Oral Microbiota|Oral Microbiota Shift After 12-week Supplementation With Lactobacillus Reuteri DSM 17938 and PTA 5289|Completed||Phase 2|44|Actual|Umeå University||2|||f||||f||||||||||2017-10-10 23:45:11.882702|2017-10-10 23:45:11.882702
NCT02311205|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-08|||December 2014||2014-12-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|COTSOM||Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)|A Phase II, Prospective, Open-label, Single Arm Study of the Efficacy and Safety of Concurrent Conventional TACE and Sorafenib in Patients With Hepatocellular Carcinoma and Extrahepatic Metastasis (COTSOM Study)|Unknown status|Recruiting|Phase 2|55|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-10 23:45:11.959408|2017-10-10 23:45:11.959408
NCT02311192|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-04-26|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Grading Scale of Vitreous Haze in Patients With Uveitis Using Ultrasonography|Grading Scale of Vitreous Haze in Patients With Uveitis Using Ultrasonography|Not yet recruiting||N/A|170|Anticipated|University of Nebraska||1|||f||||f|f|f||||||||2017-10-10 23:45:12.07305|2017-10-10 23:45:12.07305
NCT02311179|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-12-05|||January 2013||2013-01-01|December 2014|2014-12-01|March 2020|Anticipated|2020-03-01|January 2015|Anticipated|2015-01-01||Interventional|||The Effect of Implant Coating (BoneMaster) on Migration and Clinical Outcome in Hip Arthoplasty With the Exceed Cup|The Effect of Implant Coating With Hydroxyapatite Deposited Electrochemically (BoneMaster) on Migration and Clinical Outcome in Hip Arthoplasty With the Exceed Cup|Enrolling by invitation||N/A|56|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:45:12.143154|2017-10-10 23:45:12.143154
NCT02311166|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-02-29|||April 2014||2014-04-01|March 2014|2014-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Soft Tissue Pathology in Hip Dysplasia Before and After Periacetabular Osteotomy|Soft Tissue Pathology in 100 Patients With Hip Dysplasia Before and After Periacetabular Osteotomy|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Aarhus|||1||f||||t||||||||Undecided||2017-10-10 23:45:12.239045|2017-10-10 23:45:12.239045
NCT02311153|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-04-18|||November 25, 2014|Actual|2014-11-25|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|July 26, 2016|Actual|2016-07-26||Interventional|||Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery|Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery|Active, not recruiting||N/A|104|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 23:45:12.327428|2017-10-10 23:45:12.327428
NCT02311140|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-10-24|||July 2012||2012-07-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Observational|KPNSI||Effects of Kalydeco on Upper Airway and Paranasal Sinus Inflammation Measured by Nasal Lavage and on Symptoms|Effects of Kalydeco on Upper Airway and Paranasal Sinus Inflammation Measured by Nasal Lavage and on Symptoms|Recruiting||N/A|10|Anticipated|University of Jena|||1||f||||f||||||Samples Without DNA|"     Nasal lavage   "|||2017-10-10 23:45:12.400365|2017-10-10 23:45:12.400365
NCT02311127|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-12-23|||April 2015||2015-04-01|August 2015|2015-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SecurAstaP||SecurAcath Versus Statlock for PICC Securement|Comparing SecurAcath Versus StatLock to Secure Peripherally Inserted Central Catheters: a Randomised, Open Trial|Completed||N/A|105|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 23:45:12.4701|2017-10-10 23:45:12.4701
NCT02311114|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-07-05|||June 2014||2014-06-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|December 2014|Actual|2014-12-01||Observational|TLC||Program Evaluation of Telehomecare: TeLeCare Study|Program Evaluation of Telehomecare for Patients With Heart Failure or Chronic Obstructive Pulmonary Disease: TeLeCare (TLC) Study|Active, not recruiting||N/A|||University of Toronto|||4||f||||f||||||||||2017-10-10 23:45:12.544696|2017-10-10 23:45:12.544696
NCT02311101|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2015-12-01|||March 2012||2012-03-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer|Sequential Intravesical Mitomycin Plus Bacillus Calmette-Guérin for Non-Muscle Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial|Completed||Phase 1|18|Actual|The University of Texas Health Science Center at San Antonio||4|||f||||t||||||||||2017-10-10 23:45:12.639426|2017-10-10 23:45:12.639426
NCT02311088|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-02-05|||December 2014||2014-12-01|February 2016|2016-02-01||||December 2015|Actual|2015-12-01||Interventional|TROCADERO||Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor|Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor - A Double-blinded, Placebo-controlled, Randomized, Multicenter, Development Phase II Study|Terminated||Phase 2|26|Actual|Uppsala University||2||Too low enrolment rate|f||||||||||||||2017-10-10 23:45:12.71652|2017-10-10 23:45:12.71652
NCT02311075|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-06-13|||December 2014||2014-12-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|DIAB-EETs||Mechanisms of Endothelial Dysfunction in Type 2 Diabetes|Determination of the Mechanisms Involved in Conduit Artery Endothelial Dysfunction in Type 2 Diabetes|Completed||N/A|48|Actual|University Hospital, Rouen||3|||f||||f||||||||||2017-10-10 23:45:12.792913|2017-10-10 23:45:12.792913
NCT02311062|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-04|||March 2012||2012-03-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Compatibility of Different Injury Prevention Exercises in Athletes|Effects of Two Different Injury Prevention Resistance Exercise Protocols on the Hamstring Torque-Angle Relationship: A Randomized Controlled Trial|Completed||N/A|32|Actual|University of Greenwich||3|||f||||t||||||||||2017-10-10 23:45:12.860217|2017-10-10 23:45:12.860217
NCT02311049|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2014-12-04|||June 2013||2013-06-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Hypofractionated Radiotherapy for Prostate Cancer|Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer: Randomised Trial Comparing Toxicity Between 2 Different Hypofractionated Schedules|Unknown status|Recruiting|Phase 2|346|Anticipated|University Hospital, Ghent||2|||f||||||||||||||2017-10-10 23:45:12.927426|2017-10-10 23:45:12.927426
NCT02311036|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-05|||December 2014||2014-12-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Functional Recovery Effects on Comprehensive Rehabilitation for Post-acute Care -Cerebrovascular Diseases|Effect and Outcome Predictors on Functional Recovery After Comprehensive Rehabilitation for Post-acute Care -Cerebrovascular Diseases|Unknown status|Enrolling by invitation|N/A|165|Anticipated|Taipei City Hospital||4|||f||||t||||||||||2017-10-10 23:45:13.008399|2017-10-10 23:45:13.008399
NCT02311023|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-11-03|||March 2014||2014-03-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Intermittent Fasting in Refractory Epilepsy|A Single Centre Open Six Months Study of Intermittent Fasting for the Treatment of People With Refractory Epilepsy.|Terminated||Phase 2|4|Actual|University College London Hospitals||1||Difficulties recruiting|f||||f||||||||||2017-10-10 23:45:13.079947|2017-10-10 23:45:13.079947
NCT02311010|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-12-04|||January 2011||2011-01-01|December 2014|2014-12-01|January 2015|Anticipated|2015-01-01|October 2014|Actual|2014-10-01||Interventional|CYRANO||Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism|Influence of Recipient Cytochrome P450 3A5 Polymorphism on the Metabolism of Prolonged Release Tacrolimus Administered de Novo After Renal Transplantation|Unknown status|Active, not recruiting|Phase 4|150|Anticipated|Université Catholique de Louvain||4|||f||||t||||||||||2017-10-10 23:45:13.136721|2017-10-10 23:45:13.136721
NCT02310997|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-05-26|||July 2011||2011-07-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MAC UCBT||Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)|Transplantation Of Umbilical Cord Blood From Unrelated Donors In Patients With Haematological Diseases Using A Myeloablative Conditioning Regimen|Terminated||Phase 2|11|Actual|University College, London||2||Trial closed early due to poor recruitment|f||||t||||||||||2017-10-10 23:45:13.214394|2017-10-10 23:45:13.214394
NCT02310984|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-03-16|||March 2014|Actual|2014-03-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Observational|PICTURE XS||PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional|PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional|Completed||N/A|222|Actual|University College, London|||1||f||||f||||||||Yes|All requests for data sharing will adhere to the UCL Surgical & Interventional Trials Unit (SITU) data sharing agreement policy. UCL Medical School is supportive of data sharing and will endeavour to assist in requests for data sharing. These data will be held at UCL on secure servers and will not be released to any third parties until the final study report has been published. All requests for access to the data will be formally requested through the use of a SITU data request form which will state the purpose, analysis and publication plans together with the named collaborators. All requests are dealt with on a case by case basis. All requests will be logged and those successful will have a data transfer agreement which will specify appropriate acknowledgement of the Royal Free Hospital, the sponsor, and funders.|2017-10-10 23:45:13.311121|2017-10-10 23:45:13.311121
NCT02310971|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2015-04-01|||February 2015||2015-02-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas|A Phase 2 Trial of Cvac (Autologous Dendritic Cells Pulsed With Recombinant Human Fusion Protein [Mucin 1-Glutathione S-Transferase] Coupled to Oxidized Polymannose) in Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas|Withdrawn||Phase 2|0|Actual|Prima BioMed Ltd||1||"The trial has been terminated per Sponsor direction due to longer than expected clinical and   regulatory approvals."|f||||t||||||||||2017-10-10 23:45:13.546232|2017-10-10 23:45:13.546232
NCT02310958|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2014-12-04|||March 2010||2010-03-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|March 2014|Actual|2014-03-01||Observational|||Outcome of Laparoscopic Inguinal Herniorraphy in Children|A Single Center, Retrospective Study of the Outcome of Laparoscopic Inguinal Herniorraphy in Children|Unknown status|Enrolling by invitation|N/A|250|Anticipated|University Children's Hospital Basel|||1||f||||f||||||||||2017-10-10 23:45:13.627824|2017-10-10 23:45:13.627824
NCT02310945|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2014-12-04|||June 2014||2014-06-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01||Observational|||Pain Sensitization and Outcome Following Physiotherapy in Patients With Knee Osteoarthritis|Pain Sensitization and the Risk of Poor Outcome Following Physiotherapy for Knee Osteoarthritis: A Protocol for a Prospective Cohort Study|Unknown status|Recruiting|N/A|140|Anticipated|University College Dublin|||1||f||||f||||||||||2017-10-10 23:45:13.701592|2017-10-10 23:45:13.701592
NCT02310932|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-04-10|||February 2015||2015-02-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Improving Mental Health Through Integration With Primary Care in Rural Karnataka|Improving Mental Health Through Integration With Primary Care in Rural Karnataka|Recruiting||N/A|2500|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:45:13.81528|2017-10-10 23:45:13.81528
NCT02310919|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-01-09|||September 2014||2014-09-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Administration of FSH and Low Dose hCG for Oocyte Maturity While Decreasing hCG Exposure in IVF Cycles|Concomitant Administration of FSH With a Low Dose of hCG (1,500 IU) Has Equivalent Oocyte Developmental Competence While Decreasing the Exposure to hCG in IVF Cycles: A Double Blind Randomized Control Trial|Recruiting||Phase 3|100|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:45:13.91327|2017-10-10 23:45:13.91327
NCT02310906|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-10-02|||December 2014||2014-12-01|October 2017|2017-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Phase I/II Study of SRP-4053 in DMD Patients|A 2-Part, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration, Safety, Tolerability, and Pharmacokinetics Study (Part 1) Followed by an Open-Label Efficacy and Safety Evaluation (Part 2) of SRP-4053 in Patients With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping|Active, not recruiting||Phase 1/Phase 2|39|Actual|Sarepta Therapeutics||4|||f||||t||||||||||2017-10-10 23:45:14.028816|2017-10-10 23:45:14.028816
NCT02310893|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-01-15|||January 2016||2016-01-01|January 2016|2016-01-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Interventional|CHAMPS||Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care|Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care|Recruiting||N/A|660|Anticipated|University of California, Los Angeles||4|||f||||f||||||||||2017-10-10 23:45:14.124698|2017-10-10 23:45:14.124698
NCT02310880|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-05-25|||September 2010||2010-09-01|December 2014|2014-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World|Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World|Completed||N/A|35|Actual|University of Alabama at Birmingham|||2||f||||f||||||||||2017-10-10 23:45:14.302608|2017-10-10 23:45:14.302608
NCT02310867|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-21|||March 2015||2015-03-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy|Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy|Recruiting||Phase 2|50|Anticipated|Duke University||1|||f||||t||||||||||2017-10-10 23:45:14.377188|2017-10-10 23:45:14.377188
NCT02310854|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-04-11|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|November 2029|Anticipated|2029-11-01|December 2016|Actual|2016-12-01||Interventional|ROTOR||Acute Anterior Cruciate Ligament Rupture; RecOnsTruction Or Repair?|Acute Anterior Cruciate Ligament Rupture; RecOnsTruction Or Repair?|Active, not recruiting||N/A|48|Actual|Orthopedisch Centrum Oost Nederland||2|||f||||t||||||||Undecided|to be determined yet|2017-10-10 23:45:14.469575|2017-10-10 23:45:14.469575
NCT02310841|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-04-27|||March 2013||2013-03-01|December 2014|2014-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pilot Study for Patient-cooperative Control Strategies for Actuated Transfemoral Prostheses|Pilotstudie zu Patientenkooperativen Regelungsstrategien für Aktuierte Oberschenkelexoprothesen|Completed||N/A|1|Actual|Swiss Federal Institute of Technology||1|||f||||t||||||||||2017-10-10 23:45:14.579304|2017-10-10 23:45:14.579304
NCT02310828|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-06-22|||June 2014||2014-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Efficacy of L-cysteine in Prevention of Cluster Headache|The Efficacy of L-cysteine in Prevention of Cluster Headache. Randomized Intervention Trial With a Medical Device (Acetium® Capsules)|Recruiting||N/A|100|Anticipated|Biohit Oyj||2|||f||||f||||||||No||2017-10-10 23:45:14.658196|2017-10-10 23:45:14.658196
NCT02310815|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-12-02|||December 2014||2014-12-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Observational|Clinical PAS||ReSure Sealant Post Approval Study|ReSure Sealant Post-Approval Study: A Registry Evaluation of ReSure Sealant for Specified Adverse Ocular Events After Sealing Corneal Incisions in Patients Undergoing Clear Corneal Cataract Surgery|Completed||N/A|626|Actual|Ocular Therapeutix, Inc.|||1||f||||f||||||||||2017-10-10 23:45:14.80006|2017-10-10 23:45:14.80006
NCT02310802|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-09-21||2017-09-21|November 2014||2014-11-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|IMPLANT||OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICSI|A Phase 2, Double-blind, Dose-finding, Placebo-controlled Study to Assess the Safety and Efficacy of a Single Oral Administration of OBE001 to Improve Embryo Implantation Following IVF or ICSI|Completed||Phase 2|247|Actual|ObsEva SA||4|||f||||t||||||||||2017-10-10 23:45:14.875197|2017-10-10 23:45:14.875197
NCT02310789|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-04-23|||July 2015||2015-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||(Study: Vertex IIS) Does Ivacaftor Alter Wild Type CFTR-Open Probability In The Sweat Gland Secretory Coil?|(Study: Vertex IIS) A Study To Access the Effects of Ivacaftor on Wild Type CFTR-Open Probability (PO) In The Sweat Gland Secretory Coil|Active, not recruiting||Early Phase 1|6|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:45:15.036273|2017-10-10 23:45:15.036273
NCT02310776|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-01-07|2015-04-21||June 2012||2012-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|March 2014|Actual|2014-03-01||Interventional|||Lesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound|Breast Lesion Detection Using the Acuson S2000 Automated Breast Volume Scanner (ABVS) Compared With Handheld (HH) Physician-performed Ultrasound (US) Examinations|Completed||N/A|501|Actual|Northwestern University||1|||f||||t||||||||||2017-10-10 23:45:15.127328|2017-10-10 23:45:15.127328
NCT02310763|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-10-03|||November 24, 2014|Actual|2014-11-24|October 2017|2017-10-01|May 24, 2019|Anticipated|2019-05-24|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy|A Phase 2 Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study To Evaluate The Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Pf-06252616 In Ambulatory Boys With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 2|113|Actual|Pfizer||2|||f||||t|t|f||||||||2017-10-10 23:45:15.327964|2017-10-10 23:45:15.327964
NCT02310750|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-01-13|2017-01-13||November 2014||2014-11-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation|A Phase 1, Within Cohort, Randomized, Double Blind, Third-party Open, Placebo-controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06700841 In Healthy Subjects And Subjects With Plaque Psoriasis And Bioavailability Of A Tablet Formulation Relative To Suspension Formulation And The Effect Of Food On A Tablet Formulation Of Pf-06700841|Completed||Phase 1|96|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 23:45:15.66074|2017-10-10 23:45:15.66074
NCT02310737|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-06-07|||September 2014||2014-09-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|fascia||Comparison of Postoperative Pain and Neuropathy at Cesarean Sectio With Blunt or Sharp Fascia Incision|Comparison of Postoperative Pain and Neuropathy at Cesarean Sectio With Blunt or Sharp Fascia Incision: A Prospective Randomized Controlled Double-Blinded Trial|Completed||N/A|123|Actual|Sisli Etfal Training & Research Hospital||2|||f||||f||||||||||2017-10-10 23:45:22.761459|2017-10-10 23:45:22.761459
NCT02310724|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-03-29|||March 2014||2014-03-01|March 2016|2016-03-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Observational|T2P2||TODAY2 Phase 2 Follow-up|Long-term Post-Intervention Follow-up of the TODAY Cohort (Treatment Options for Type 2 Diabetes in Youth and Adolescents)|Enrolling by invitation||N/A|506|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||Samples Without DNA|"     Blood and urine are collected annually and shipped to the study's Central Biospecimen     Laboratory for analysis and storage.   "|Yes|"The TODAY/TODAY2 Study Group engages in a number of methods to disseminate and share resources.
Findings are reported in manuscripts and presentations.
An active Ancillary Studies Committee reviews proposals to access the study cohort, the central database, and stored biospecimens.
Materials from the TODAY lifestyle intervention program and the standard diabetes education manual for adolescents developed by study experts are made available for public access on the website https://today.bsc.gwu.edu/web/today/home.
The study group adheres to the policies of the NIDDK Central Repositories to make data available to other scientific investigators. A TODAY2 de-identified database will be prepared and transferred along with excess stored biospecimens. Appropriate informed consent is required to transfer stored biospecimens.
TODAY establishes collaborative arrangements to work with other federally funded study groups."|2017-10-10 23:45:22.88009|2017-10-10 23:45:22.88009
NCT02310711|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-07-29|||May 2012||2012-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BCT||Multi-scale Modeling of Breast Conserving Therapy|A Pilot Study for the Identification of Targets for Clinical Improvement in Breast Conserving Therapy|Recruiting||N/A|15|Anticipated|The Methodist Hospital System|||1||f||||f||||||||Undecided|Plan to share data to be determined.|2017-10-10 23:45:23.002472|2017-10-10 23:45:23.002472
NCT02310698|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-07-21|||December 2, 2014||2014-12-02|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening|Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening|Recruiting||N/A|800|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:45:23.073074|2017-10-10 23:45:23.073074
NCT02306642|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-05-10|||December 2014||2014-12-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|FANCY||Follow-up of AKI in Neonates During Childhood Years|Long Term Follow-up of Acute Kidney Injury in Very Low Birth Weight Infants|Recruiting||N/A|80|Anticipated|University of Virginia|||3||f||||||||||||||2017-10-10 23:46:12.831301|2017-10-10 23:46:12.831301
NCT02310685|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-09-13|||January 2015||2015-01-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|CHIN-UPS||the Canadian Health Improvement Network to Upgrade Prevention Services|The Canadian Health Improvement Network to Upgrade Prevention Services (CHIN-UPS) - Evaluating a Multidisciplinary Health Promotion Program.|Enrolling by invitation||N/A|1200|Anticipated|McGill University||2|||f||||t||||||||Undecided||2017-10-10 23:45:23.167095|2017-10-10 23:45:23.167095
NCT02310672|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2017-05-19|||June 1, 2015||2015-06-01|May 2017|2017-05-01|May 31, 2019|Anticipated|2019-05-31|October 31, 2018|Anticipated|2018-10-31||Interventional|REPAIR||REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension|A Prospective, Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Effects of Macitentan on Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension Assessed by Cardiac Magnetic Resonance Imaging|Recruiting||Phase 4|100|Anticipated|Actelion||1|||f||||f||||||||||2017-10-10 23:45:23.254752|2017-10-10 23:45:23.254752
NCT02310659|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-03|||March 2009||2009-03-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Observational|||Study to Evaluate the Association of Testosterone Levels With Coronary Artery Calcification|Study to Evaluate the Association of Testosterone Levels With Coronary Artery in Patients With Stable Coronary Artery Disease|Unknown status|Recruiting|N/A|200|Anticipated|Zhejiang University|||2||f||||f||||||||||2017-10-10 23:45:23.656965|2017-10-10 23:45:23.656965
NCT02310646|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-05-01|2016-08-01||January 2015||2015-01-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||One subject in the foam-gel group discontinued from the trial prior to the Week 1 visit and did not complete any on-treatment questionnaires. This subject was excluded from the full analysis set which hence comprised 212 subjects: 108 subjects in the foam-gel group and 104 subjects in the gel-foam group.|Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris|A Clinical Trial Gathering Insight of Patient Reported Factors That Influence Preference Following Once Daily Topical Treatment With LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris|Completed||Phase 3|219|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-10 23:45:23.801045|2017-10-10 23:45:23.801045
NCT02310620|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-05|||December 2012||2012-12-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Computer Games to Prevent Mild Cognitive Impairment and Dementia||Recruiting||N/A|100|Anticipated|Semmelweis University||1|||f||||f||||||||||2017-10-10 23:45:24.904602|2017-10-10 23:45:24.904602
NCT02310607|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-04-07|||June 2013||2013-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Non-invasive Optical Detection of Iron Deficiency|Non-invasive Optical Detection of Iron Deficiency - Evaluation of a Fiber Optic Tissue Fluorescence Measurement to Determine the Erythrocyte Zinc Protoporphyrin-IX/Heme Ratio|Completed||N/A|96|Actual|Klinikum der Universitaet Muenchen, Grosshadern|||1||f||||f||||||||||2017-10-10 23:45:24.994786|2017-10-10 23:45:24.994786
NCT02310594|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-01-18|||July 2010||2010-07-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy|The Effect of Radiation Therapy on Tumor Immunity|Recruiting||N/A|500|Anticipated|Jonsson Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-10 23:45:25.075151|2017-10-10 23:45:25.075151
NCT02310581|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-08-03|2017-06-01|2015-12-07|February 24, 2015|Actual|2015-02-24|June 2017|2017-06-01|March 19, 2015|Actual|2015-03-19|March 19, 2015|Actual|2015-03-19||Interventional||All participants who were randomized.|Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain|A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain|Terminated||Phase 3|40|Actual|INSYS Therapeutics Inc|This study was terminated early by the sponsor due to business reasons (40 participants enrolled out of 312 planned). Due to this early termination 10 outcome measures originally registered as pre-specified secondary are no longer secondaries.|4||Business decision|f||||f||||||||||2017-10-10 23:45:25.240751|2017-10-10 23:45:25.240751
NCT02310568|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-11-16|2016-09-26||November 2014||2014-11-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||POC Study in Partially Responsive Generalized Anxiety Disorder|An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder|Terminated||Phase 2|90|Actual|Pfizer|All 34 centres who enrolled subjects were terminated due to internal sponsor portfolio prioritization. The decision to terminate the study was not due to any safety concern or change in the benefit:risk assessment of PF-06372865|5||"Study recruitment was terminated on 24 June 2015, due to a Pfizer business decision. This study   was not terminated for reasons of safety or efficacy"|f||||t||||||||||2017-10-10 23:45:26.305942|2017-10-10 23:45:26.305942
NCT02310555|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-04|||October 2014||2014-10-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|MSS||Surgical Techniques in Diabetes Mellitus-II and Obesity. Metabolic Surgery Study (MSS)|Prospective Randomised Study Comparing Surgical Techniques in Patients With Diabetes Mellitus-II And Obesity|Unknown status|Recruiting|N/A|90|Anticipated|Hospital Universitario Virgen de la Arrixaca||3|||f||||f||||||||||2017-10-10 23:45:29.430835|2017-10-10 23:45:29.430835
NCT02310542|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-12-28|||December 2011||2011-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MARSPAD||Comparison of Two Liver Dialysis Systems : MARS Versus SPAD in Severe Liver Failure|Comparison of Two Extracorporeal Liver Support System (With or Without Recirculation) : MARS (Molecular Adsorbents Recirculating System) Versus SPAD (Single Pass Albumin Dialysis) in Severe Liver Failure.|Recruiting||N/A|50|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:45:29.544999|2017-10-10 23:45:29.544999
NCT02310529|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2015-08-15|||March 2014||2014-03-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Interpersonal Psychotherapy for Maternal Depression|Randomized Control Trial of an Interpersonal Psychotherapy for Maternal Depression|Completed||N/A|50|Actual|Pakistan Institute of Learning and Living||2|||f||||f||||||||||2017-10-10 23:45:29.648652|2017-10-10 23:45:29.648652
NCT02310516|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-11-16|||September 2014||2014-09-01|August 2015|2015-08-01||||March 2017|Anticipated|2017-03-01||Interventional|EVECHE||Prospective Evaluation of the Impact of Pre-operative Device on the Personal Experience of Brain Awake Surgery|Prospective Evaluation of the Impact of Pre-operative Device on the Personal Experience of Brain Awake Surgery: Comparative Study, Randomized|Unknown status|Recruiting|N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:45:29.75812|2017-10-10 23:45:29.75812
NCT02310503|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-09-11|||July 2013||2013-07-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|4 Years|Observational [Patient Registry]|REGESMOHS||Spanish Registry of Mohs Surgery|Spanish Registry of Mohs Surgery [Registro Español de Cirugía de Mohs]|Recruiting||N/A|6000|Anticipated|Fundación Academia Española de Dermatología|||1||f||||f||||||||No||2017-10-10 23:45:29.861141|2017-10-10 23:45:29.861141
NCT02310490|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-11-02|||December 2014||2014-12-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||DermaVeil Versus Sculptra for the Treatment of Nasolabial Folds Wrinkles|A Controlled, Randomized, Within-subject, Multi-center Prospective Clinical Trial of DermaVeil (Injectable Poly-L-lactic Acid) Versus SCULPTRA® Aesthetic (Injectable Poly-L-lactic Acid) in the Treatment of Nasolabial Fold Wrinkles.|Active, not recruiting||N/A|160|Anticipated|DermAvance||2|||f||||f||||||||||2017-10-10 23:45:30.071866|2017-10-10 23:45:30.071866
NCT02310477|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-08-08|||February 2014||2014-02-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|REBECCA||Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting|REBECCA: A Cohort Study of Regorafenib in the Real-life Setting in Patients Previously Treated for Metastatic Colorectal Cancer.|Completed||N/A|704|Actual|Centre Oscar Lambret|||1||f||||t||||||||No||2017-10-10 23:45:30.186095|2017-10-10 23:45:30.186095
NCT02310464|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-12-01|||December 2015||2015-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects|An Open-Label Study to Assess the Safety and Tolerability of Active Immunotherapy With Escalating Doses of OBI-833/OBI-821 (Globo H-CRM197/OBI-821) in Subjects With Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer|Recruiting||Phase 1|58|Anticipated|OBI Pharma, Inc||1|||f||||t||||||||||2017-10-10 23:45:30.306782|2017-10-10 23:45:30.306782
NCT02310451|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-03-21|||December 2014||2014-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|EXOSOMES||Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes|Pilot Study of Exosomes Before and After BRAF Inhibitor Therapy in Patients With Advanced Unresectable or Metastatic BRAF Mutation-positive Melanoma|Recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 23:45:30.424014|2017-10-10 23:45:30.424014
NCT02310438|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-04|2016-01-04|||January 2014||2014-01-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|TIMPStro||Music Therapy for The Rehabilitation of Upper Limb With Stroke Patients|An Investigation Into Music Therapy for Upper Limb Rehabilitation in Stroke Patients|Completed||Phase 2|10|Actual|Anglia Ruskin University||2|||f||||f||||||||||2017-10-10 23:45:30.547001|2017-10-10 23:45:30.547001
NCT02310425|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-04|||March 2013||2013-03-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|SBP||A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants|A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants|Completed||Phase 3|125|Actual|China Medical University, China||2|||f||||t||||||||||2017-10-10 23:45:30.822868|2017-10-10 23:45:30.822868
NCT02310412|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-10-12|||December 2014||2014-12-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma|A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma|Completed||Phase 2|14|Actual|Cerus Corporation||2|||f||||f||||||||||2017-10-10 23:45:30.942002|2017-10-10 23:45:30.942002
NCT02310386|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-12-04|||September 2014||2014-09-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|Fibromyalgia||BEMER in the Treatment of Pain in Fibromyalgia.|The Efficacy of the BEMER Electromagnetic Field Therapy in the Treatment of Fibromyalgia.|Unknown status|Enrolling by invitation|N/A|110|Anticipated|Central Finland Hospital District||2|||f||||f||||||||||2017-10-10 23:45:31.123673|2017-10-10 23:45:31.123673
NCT02310373|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-01-26|||November 2014||2014-11-01|January 2016|2016-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of Nicotine-Free Hookah Smoking on Blood Flow to the Heart, Muscle and Skin|Effects of Nicotine-Free Hookah Smoking on Blood Flow to the Heart, Muscle and Skin|Recruiting||Phase 1/Phase 2|20|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-10 23:45:31.225089|2017-10-10 23:45:31.225089
NCT02310360|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-10-25|||November 2014||2014-11-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2015|Actual|2015-12-01||Observational|DA-Fallypride||Striatal and Extra-striatal Dopamine Release in Response to Food in Healthy Humans|Measuring Food-induced Striatal and Extra-striatal Dopamine Release Using (18F)Fallypride Positron Emission Tomography|Active, not recruiting||N/A|12|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||||||||||||2017-10-10 23:45:31.325823|2017-10-10 23:45:31.325823
NCT02310347|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-10-25|||December 2014||2014-12-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|September 2016|Actual|2016-09-01||Interventional|||Influence of a Medicinal Cannabinoid Agonist on Responses to Food Images and Food Intake|Influence of a Medicinal Cannabinoid Agonist on Behavioural Responses to Food Images and Food Intake: Role of Gut Peptides|Active, not recruiting||N/A|18|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-10 23:45:31.396646|2017-10-10 23:45:31.396646
NCT02310334|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-02-23|||August 2014||2014-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|||The Pacing (Guided Vs Unguided) Strategies Study|The Impact of Real-Time Physiological Status Based Pacing Guidance on Physiological Strain for Exercising Humans|Completed||N/A|23|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 23:45:31.477915|2017-10-10 23:45:31.477915
NCT02310321|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-09-25|||February 26, 2015|Actual|2015-02-26|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia.|Phase I Study of ASP2215 - A Phase 1 Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia|Recruiting||Phase 1|30|Anticipated|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-10 23:45:31.565946|2017-10-10 23:45:31.565946
NCT02310308|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-05|||April 2012||2012-04-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of a Sugar-Free Chewing Gum Containing Magnolia Bark Extract on Caries Lesions in Healthy Adult Volunteers|Effect of a Sugar-free Chewing Gum Containing Magnolia Bark Extract on the Development of Caries Lesions in Healthy Adult Volunteers: a Randomized Controlled Intervention Trial|Unknown status|Active, not recruiting|N/A|480|Actual|Università degli Studi di Sassari||3|||f||||t||||||||||2017-10-10 23:45:31.684205|2017-10-10 23:45:31.684205
NCT02310295|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-05|||January 2009||2009-01-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|IBeTA||Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema|Bevacizumabe e Acetato de Triancinolona Intra-vítreo Associados à Laserterapia em Pacientes Com Edema Macular diabético (IBeTA)|Completed||N/A|45|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-10 23:45:31.803891|2017-10-10 23:45:31.803891
NCT02310282|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-10-27|||November 2014||2014-11-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|TeleCLASS||Telemedicine for Optimized Collection of CLinical datA in Patients With Suspicion of Acute Stroke|Telemedicine for Optimized Collection of CLinical datA in Patients With Suspicion of Acute Stroke|Active, not recruiting||N/A|50|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||f||||||||||2017-10-10 23:45:31.903385|2017-10-10 23:45:31.903385
NCT02310269|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-01-27|||March 2013||2013-03-01|January 2017|2017-01-01|April 2024|Anticipated|2024-04-01|April 2024|Anticipated|2024-04-01||Observational|||Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease|Non-interventional Study for the Generation of Long Term Safety and Efficacy Data of Pasireotide s.c. in Patients With Cushing's Disease (Post-Authorization Safety Study)|Recruiting||N/A|200|Anticipated|Novartis|||1||f||||f||||||||||2017-10-10 23:45:32.005082|2017-10-10 23:45:32.005082
NCT02310256|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-03-14|||November 2014||2014-11-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||A Clinical Trial on the Effects of Home-based Five Plus Exercise Training|A Randomized Clinical Trial on the Effects of Home-based Five Plus Exercise Training|Completed||N/A|30|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-10 23:45:32.281461|2017-10-10 23:45:32.281461
NCT02310243|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-05-18|||July 2015||2015-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Palbociclib in MLL-rearranged Acute Leukemias|Phase Ib/IIa Study of Palbociclib in MLL-rearranged Acute Leukemias AMLSG 23-14/Palbo-AL-1|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Ulm||1|||f||||t||||||||||2017-10-10 23:45:32.377499|2017-10-10 23:45:32.377499
NCT02310217|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-03-13|||February 2015||2015-02-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||Validation of New Tools for the Assessment of Cognitive Functions and Connectivity Network in Hypertensive Patients|Validation of New Tools for the Assessment of Cognitive Functions and Connectivity Network in Hypertensive Patients|Recruiting||N/A|160|Anticipated|Neuromed IRCCS|||2||f||||||||||||||2017-10-10 23:45:32.880459|2017-10-10 23:45:32.880459
NCT02310204|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-05|||May 2011||2011-05-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|EDUPSO||Therapeutic Education Program in Psoriasis|Evaluation of a Therapeutic Education Program in Patients With Moderate to Severe Psoriasis : a Multicenter Randomized Controlled Study|Completed||N/A|187|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:45:32.980653|2017-10-10 23:45:32.980653
NCT02310191|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-12-03|||July 2012||2012-07-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Correlation Between Laboratory Markers and Origin of New Brain Ischemic Lesions After Carotid Stenting|Correlation Between Laboratory Markers and Origin of New Brain Ischemic Lesions After Carotid Stenting|Completed||N/A|81|Actual|University Hospital Ostrava|||1||f||||t||||||Samples Without DNA|"     Blood samples collecting: hematology + reticulocytes, coagulation markers (PT, APTT, INR,     Fbg, Clauss), vWF antigen, PAI-1 activity, PAI-1 polymorphism 4G/g, Multiplate (ASA and     clopidogrel resistance test) anti Xa activity   "|||2017-10-10 23:45:33.088802|2017-10-10 23:45:33.088802
NCT02310178|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-12-03|||May 2012||2012-05-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|BAREVAL||Obesity Cohort : Medical Follow-up of Severe or Morbid Obese Patients Undergoing Bariatric Surgery|Obesity Cohort : Medical Follow-up of Severe or Morbid Obese Patients Undergoing Bariatric Surgery|Unknown status|Recruiting|Phase 4|750|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-10 23:45:33.170825|2017-10-10 23:45:33.170825
NCT02310165|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-03|||July 2013||2013-07-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Insertion Technique in Large Volume Paracentesis|Z-tract Versus Coaxial Insertion Technique in Large Volume Paracentesis|Completed||N/A|72|Actual|University of Virginia||2|||f||||t||||||||||2017-10-10 23:45:33.257519|2017-10-10 23:45:33.257519
NCT02127658|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-08-21|||February 2016||2016-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MEDiC||MRSA Eradication and Decolonization in Children|MRSA Eradication and Decolonization in Children|Recruiting||N/A|190|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 00:29:48.993692|2017-10-11 00:29:48.993692
NCT02310152|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-06-27|||November 2014||2014-11-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|SPACE||Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)|Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)|Recruiting||N/A|120|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 23:45:33.331589|2017-10-10 23:45:33.331589
NCT02310139|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-12-15|||May 2015||2015-05-01|December 2015|2015-12-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Observational|FoDCO||Failed/Difficult Colonoscopy Outcomes|Outcomes of Patients With Failed or Difficult Colonoscopy at a Tertiary Referral Centre|Recruiting||N/A|150|Anticipated|Western Sydney Local Health District|||1||f||||t||||||||||2017-10-10 23:45:33.437772|2017-10-10 23:45:33.437772
NCT02310126|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-06-13|2016-03-01||November 1, 2014|Actual|2014-11-01|June 2017|2017-06-01|December 1, 2014|Actual|2014-12-01|December 1, 2014|Actual|2014-12-01||Interventional||The analysis population consists of subjects that were dispensed at least one study lens.|Handling Comparison Between Two Contact Lens Types||Completed||N/A|195|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-10 23:45:33.53192|2017-10-10 23:45:33.53192
NCT02310113|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-05|||September 2013||2013-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|||Transfusion and Skeletal Muscle Tissue Oxygenation|Red Blood Cell Transfusion and Skeletal Muscle Tissue Oxygenation in Anaemic Haematologic Outpatients|Completed||N/A|30|Actual|University Medical Centre Ljubljana|||1||f||||f||||||||||2017-10-10 23:45:34.031576|2017-10-10 23:45:34.031576
NCT02310100|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-08-18|||December 2014||2014-12-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2017|Actual|2017-02-01||Interventional|TactiCathPAS||TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study|TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study|Active, not recruiting||N/A|178|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-10 23:45:34.142359|2017-10-10 23:45:34.142359
NCT02310087|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-11-21|||November 2014||2014-11-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|Astax-ART||Oral Astaxanthin and Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures|Effect of Oral Administration of Astaxanthin on Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures|Recruiting||N/A|80|Anticipated|University Medical Centre Ljubljana||2|||f||||t||||||||Undecided||2017-10-10 23:45:34.281701|2017-10-10 23:45:34.281701
NCT02310074|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-01-31|||January 2010||2010-01-01|December 2014|2014-12-01||||June 2014|Actual|2014-06-01||Interventional|||Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism|Study on the Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism|Unknown status|Active, not recruiting|Phase 4|76|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-10 23:45:34.421536|2017-10-10 23:45:34.421536
NCT02310061|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-09-08|||November 2013||2013-11-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|LUST||Lung Water by Ultrasound Guided Treatment in Hemodialysis Patients (The Lust Study).|Lung Water By Ultra-Sound Guided Treatment To Prevent Death and Cardiovascular Complications in High Risk End Stage Renal Disease Patients With Cardiomyopathy (Lust Study)|Recruiting||Phase 3|500|Anticipated|"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"||2|||f||||t||||||||||2017-10-10 23:45:34.525931|2017-10-10 23:45:34.525931
NCT02310048|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-03-13|||November 2014||2014-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Comparative Oral Bioavailability Study of MT-1303|A Randomised, Open-Label, Single-Dose, Parallel Group Study to Assess the Comparative Oral Bioavailability of Two Capsule Formulations of MT-1303 in Healthy Male Subjects|Completed||Phase 1|34|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||||||||||||2017-10-10 23:45:34.748807|2017-10-10 23:45:34.748807
NCT02310035|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-05-12|||April 2014||2014-04-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Observational Study on the Course of Plasma Glutamine Levels During Critical Illness|Observational Study on the Course of Plasma Glutamine Levels During Critial Illness|Completed||N/A|178|Actual|Medical Centre Leeuwarden|||1||f||||f||||||||||2017-10-10 23:45:34.825|2017-10-10 23:45:34.825
NCT02310022|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-03-08|||November 2014||2014-11-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|PK/PD||A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules|A Pharmacokinetic and Pharmacodynamic Study of Two Formulations of Omega-3 One Gram Capsules After Single and Multi-Dose Administrations Under Fed Conditions|Unknown status|Recruiting|Phase 1/Phase 2|48|Anticipated|Matinas Biopharma, Inc||2|||f||||f||||||||||2017-10-10 23:45:34.895796|2017-10-10 23:45:34.895796
NCT02310009|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-02-10|||December 2014||2014-12-01|February 2017|2017-02-01|July 30, 2015|Actual|2015-07-30|June 2015|Anticipated|2015-06-01||Interventional|ANEX||IL-1RA, Acute Exercise, and Beta-cell Function||Withdrawn||N/A|0|Actual|Rigshospitalet, Denmark||4||PI relocated to a different country and coI moved to a different lab.|f||||f||||||||||2017-10-10 23:45:34.991266|2017-10-10 23:45:34.991266
NCT02309996|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-08-22|||December 2014||2014-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||SMART Supervisor Training Program to Prevent Work Disability|A Supervisor Training Program for Work Disability Prevention: A Cluster RCT|Recruiting||N/A|350|Anticipated|Lakehead University||2|||f||||f||||||||||2017-10-10 23:45:35.099416|2017-10-10 23:45:35.099416
NCT02309983|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-03-27|||December 2006||2006-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Activity Dependent Rehabilitation Model to Improve Bone and Muscle Outcomes|Activity Dependent Rehabilitation Model In Incomplete Spinal Cord Injury: Neuromuscular and Skeletal Changes|Recruiting||N/A|21|Anticipated|Kessler Foundation||3|||f||||f||||||||Undecided||2017-10-10 23:45:35.222479|2017-10-10 23:45:35.222479
NCT02309970|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-04|||December 2014||2014-12-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Observational|||Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke||Unknown status|Not yet recruiting|N/A|90|Anticipated|Rabin Medical Center|||3||f||||f||||||||||2017-10-10 23:45:35.364647|2017-10-10 23:45:35.364647
NCT02309957|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-08-02|||May 2011||2011-05-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|EAGLE||EAGLE European Post Market Study|"Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions (EAGLE) European Post Market Study"|Active, not recruiting||N/A|33|Actual|Kensey Nash Corporation|||1||f||||f||||||||||2017-10-10 23:45:35.486584|2017-10-10 23:45:35.486584
NCT02309944|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-08-15|||May 2015||2015-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients|Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients: A Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-10-10 23:45:35.617034|2017-10-10 23:45:35.617034
NCT02309931|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-05-11|||June 2014|Actual|2014-06-01|May 2017|2017-05-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2016|Actual|2016-11-01||Interventional|ISOVANTI||ISOperistaltic Versus ANTIperistaltic Anastomosis After Laparoscopic Right Colectomy for Cancer|Randomized Clinical Trial Comparing Isoperistaltic Versus Antiperistaltic Side to Side Anastomosis After Right Laparoscopic Hemicolectomy for Cancer.|Active, not recruiting||N/A|108|Actual|Hospital Universitario Virgen de la Arrixaca||2|||f||||t||||||||||2017-10-10 23:45:35.704695|2017-10-10 23:45:35.704695
NCT02309918|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-25|||November 2014||2014-11-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection|Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection With Ledipasvir/Sofosbuvir Fixed-Dose Combination - The HepNet Acute HCV IV Study|Completed||Phase 2|20|Actual|HepNet Study House, German Liverfoundation||1|||f||||f||||||||||2017-10-10 23:45:35.794549|2017-10-10 23:45:35.794549
NCT02309905|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-01-14|||June 2014||2014-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|TLM-Inmates||Evaluation of Tele-expertise for Inmates With a Dermatological Lesion|Evaluation of Tele-expertise for Inmates With a Dermatological Lesion|Completed||N/A|100|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||||||2017-10-10 23:45:35.935977|2017-10-10 23:45:35.935977
NCT02309892|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-08-11|||April 2014||2014-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC|A Phase I, Open Label, Dose Escalation Study of Immunoconjugate L-DOS47 in Combination With Pemetrexed/Carboplatin in Patients With Stage IV (TNM M1a and M1b) Recurrent or Metastatic NSCL Lung Cancer|Recruiting||Phase 1|40|Anticipated|Helix BioPharma Corporation||1|||f||||t||||||||||2017-10-10 23:45:36.027157|2017-10-10 23:45:36.027157
NCT02309879|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-08-17|||August 2014||2014-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Infusion of Lidocaine, Magnesium and Remifentanil Perioperatively in Patients Undergoing Mastectomy|Effect of Intravenous Infusion of Lidocaine, Magnesium Sulphate and Remifentanil Perioperatively in Patients Undergoing Mastectomy: a Prospective, Randomized and Double-blind Study|Completed||Phase 4|120|Actual|Hospital de Base||4|||f||||f||||||||||2017-10-10 23:45:36.120948|2017-10-10 23:45:36.120948
NCT02309866|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-03|||January 2015||2015-01-01|November 2014|2014-11-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|||Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases||Not yet recruiting||N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||||||||Samples With DNA|"     genomic DNA   "|||2017-10-10 23:45:36.428817|2017-10-10 23:45:36.428817
NCT02309853|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2014-12-04|||December 2014||2014-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|ViTaTrain||Visual and Tactile Scanning Training in Patients With Neglect After Stroke|Visual and Tactile Scanning Training in Patients With Neglect After Stroke|Unknown status|Recruiting|N/A|16|Anticipated|HES-SO Valais-Wallis||2|||f||||f||||||||||2017-10-10 23:45:36.488452|2017-10-10 23:45:36.488452
NCT02309840|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-12-03|||September 2011||2011-09-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2012|Actual|2012-06-01||Interventional|MEALS||The Modifying Eating and Lifestyles at School Study|The Modifying Eating and Lifestyles at School (MEALS) Study|Completed||N/A|6873|Actual|Harvard School of Public Health||4|||f||||t||||||||||2017-10-10 23:45:36.588584|2017-10-10 23:45:36.588584
NCT02309827|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-09-15|||December 2014||2014-12-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers|A Phase 1, Randomized, Double Blind, Third-party Open, Placebo-controlled, Single And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Pf-06651600 In Healthy Subjects|Completed||Phase 1|80|Actual|Pfizer||9|||f||||f||||||||||2017-10-10 23:45:36.663173|2017-10-10 23:45:36.663173
NCT02309814|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-09-07|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Eyelid Movement Sensor Device- Blinking Characterizing|Eyelid Movement Sensor Device- Blinking Characterizing|Completed||N/A|80|Actual|HaEmek Medical Center, Israel||1|||f||||t||||||||||2017-10-10 23:45:36.788347|2017-10-10 23:45:36.788347
NCT02309801|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-04|||July 2012||2012-07-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|COCADEP/2||Interaction Between a Natural Aldehyde Dehydrogenase 2 (ALDH2) Inhibitor and Alcohol|Human Pharmacology Study to Evaluate the Interaction Between a Natural Inhibitor of Aldehyde Dehydrogenase 2 (ALDH2) and Alcohol in Healthy Volunteers. Pilot Clinical Trial|Completed||Phase 1|10|Actual|Parc de Salut Mar||2|||f||||t||||||||||2017-10-10 23:45:36.849367|2017-10-10 23:45:36.849367
NCT02309788|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-01-23|||January 2016||2016-01-01|January 2016|2016-01-01||||December 2019|Anticipated|2019-12-01||Observational|RHCC||Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis||Recruiting||N/A|100|Anticipated|Guangxi Medical University|||2||f||||||||||||||2017-10-10 23:45:36.93315|2017-10-10 23:45:36.93315
NCT02309775|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-12-05|||January 2012||2012-01-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|||Auriculotherapy in Tension-type Headache Due to Temporomandibular Dysfunction|Auriculotherapy in Tension-type Headache Due to Temporomandibular Dysfunction - A Randomized Study|Completed||N/A|38|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-10 23:45:37.019162|2017-10-10 23:45:37.019162
NCT02309762|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-02-03|||March 2015||2015-03-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of FB825 in Healthy Volunteers|A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Ascending Intravenous Doses of FB825|Completed||Phase 1|54|Actual|Fountain Biopharma Inc.||2|||f||||t||||||||||2017-10-10 23:45:37.08107|2017-10-10 23:45:37.08107
NCT02309749|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-12-04|||April 2013||2013-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||CAP Pilot Study for Obstructive Sleep Apnea (OSA)||Completed||N/A|50|Actual|Fisher and Paykel Healthcare|||1||f||||f||||||||||2017-10-10 23:45:37.143227|2017-10-10 23:45:37.143227
NCT02309736|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-02-14|||January 2016||2016-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||ReSure Sealant Device Exposure Registry|Device Exposure Registry: A Post-Approval Observational Registry of ReSure Sealant to Track the Incidence of Endophthalmitis After Sealing Corneal Incisions in Patients Undergoing Clear Corneal Cataract Surgery|Recruiting||N/A|4857|Anticipated|Ocular Therapeutix, Inc.|||1||f||||f||||||||||2017-10-10 23:45:37.301549|2017-10-10 23:45:37.301549
NCT02309723|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-02-22|2016-09-26||September 2013||2013-09-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional||number of clinicians responded to the email|Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.|A Survey of Clinicians to Assess the Influence of Beta-amyloid Imagining Information on the Diagnosis and Management of Hypothetical Patients With Cognitive Complaints|Completed||N/A|315|Actual|Tufts Medical Center||3|||f||||||||||||||2017-10-10 23:45:37.399556|2017-10-10 23:45:37.399556
NCT02309710|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-01-20|||June 2015||2015-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Male Circumcision (MC) Using the ShangRing™ Device in Malawi|Prospective Study of Male Circumcision Using the ShangRing Device in Routine Clinical Settings in Malawi|Completed||Phase 1|500|Actual|FHI 360||1|||f||||f||||||||||2017-10-10 23:45:37.745138|2017-10-10 23:45:37.745138
NCT02309697|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-01-13|||January 2015||2015-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Neurodevelopmental Outcomes of Preterm and Term Children|Neurodevelopmental Outcomes of Preterm and Term Children|Terminated||N/A|1|Actual|Icahn School of Medicine at Mount Sinai|||2|Study goals rolled into a broader study|f||||f||||||||||2017-10-10 23:45:37.825898|2017-10-10 23:45:37.825898
NCT02309684|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-04|||January 2015||2015-01-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|June 2015|Anticipated|2015-06-01||Observational|||Bio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study|The Clinical & Economic Evaluation of Bio-ConneKt® Wound Dressing in Treating Chronic Foot Ulcers (Diabetic and/or Venous Ulcers).|Unknown status|Not yet recruiting|N/A|20|Anticipated|MLM Biologics Inc.,|||1||f||||f||||||||||2017-10-10 23:45:37.903102|2017-10-10 23:45:37.903102
NCT02309671|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2016-11-04||2016-11-04|December 2014||2014-12-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|November 2015|Actual|2015-11-01||Interventional|||A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment|A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Undergoing an Assisted Reproductive Technology Programme|Completed||Phase 2|159|Actual|Ferring Pharmaceuticals||4|||f||||t||||||||||2017-10-10 23:45:37.976114|2017-10-10 23:45:37.976114
NCT02309658|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-10-14|||September 2013||2013-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients|Safety and Efficacy of Gemcitabine Based Neoadjuvant Chemotherapy Followed by Chemoradiation in Locally Advanced Cervical Cancer Patients and Association With Human Equilibrative Nucleoside Transporter 1 (hENT1) Expression|Completed||Phase 2|50|Actual|Professor Fernando Figueira Integral Medicine Institute||1|||f||||t||||||||||2017-10-10 23:45:38.078941|2017-10-10 23:45:38.078941
NCT02309645|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-06-27|||October 1, 2014|Actual|2014-10-01|June 2017|2017-06-01|July 1, 2019|Anticipated|2019-07-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||The Paediatric EVICEL® Neuro Study|A Prospective Randomized Controlled Study Evaluating the Safety and Efficacy of EVICEL® Used for Suture-Line Sealing in Dura-Mater Closure During Paediatric Neurosurgical Cranial Procedures|Recruiting||Phase 4|42|Anticipated|Ethicon, Inc.||2|||f||||f||||||||Yes||2017-10-10 23:45:38.187573|2017-10-10 23:45:38.187573
NCT02309632|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-06-12|||November 2015||2015-11-01|June 2017|2017-06-01|November 2026|Anticipated|2026-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Pancreatic Cancer Screening of High-Risk Individuals in Arkansas|Pancreatic Cancer Screening of High-Risk Individuals in Arkansas|Active, not recruiting||N/A|100|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-10-10 23:45:38.287073|2017-10-10 23:45:38.287073
NCT02309619|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2015-04-15|||January 2008||2008-01-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE|Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in Minimally Invasive Esophagectomy: a Single-Center Randomized Controlled Trial|Unknown status|Recruiting|N/A|60|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-10 23:45:38.368946|2017-10-10 23:45:38.368946
NCT02309606|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-08-14|||December 2014||2014-12-01|August 2017|2017-08-01||||August 2017|Anticipated|2017-08-01||Observational|||Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography|Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography|Recruiting||N/A|48|Anticipated|Danish Headache Center|||3||f||||||||||||||2017-10-10 23:45:38.46269|2017-10-10 23:45:38.46269
NCT02309593|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-06-19|||December 2014||2014-12-01|June 2017|2017-06-01|December 2026|Anticipated|2026-12-01|December 2025|Anticipated|2025-12-01||Observational|||Post Market Clinical Follow-up Study Protocol for PROFEMUR® Xm Femoral Stems|Post Market Clinical Follow-up Study Protocol for PROFEMUR® Xm Femoral Stems|Recruiting||N/A|143|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||No||2017-10-10 23:45:38.55085|2017-10-10 23:45:38.55085
NCT02309580|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-02-02|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma|A Multicenter Phase I Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma|Recruiting||Phase 1|19|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-10-10 23:45:38.64986|2017-10-10 23:45:38.64986
NCT02309567|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-10-30|||May 2014||2014-05-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Observational|||Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?||Completed||N/A|146|Actual|Cumhuriyet University|||1||f||||||||||||||2017-10-10 23:45:38.757911|2017-10-10 23:45:38.757911
NCT02309554|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-07-29|||December 2014||2014-12-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Postcoital Testing Study of the SILCS Diaphragm Used With 3% N-9 Gel, ContraGel, or No Gel|A Phase I Postcoital Testing Study of the SILCS Diaphragm Used With 3% Nonoxynol-9 Gel, ContraGel, or No Gel|Completed||Phase 1|27|Actual|CONRAD||3|||f||||f||||||||||2017-10-10 23:45:38.833545|2017-10-10 23:45:38.833545
NCT02309528|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-08-27|||September 2014||2014-09-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Chronic Kidney Disease Knowledge and Awareness Among American Indians|Chronic Kidney Disease Knowledge and Awareness Among American Indians|Completed||N/A|70|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-10-10 23:45:39.005662|2017-10-10 23:45:39.005662
NCT02309515|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-06-13|||June 2015||2015-06-01|June 2016|2016-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis|Impact of Short Term Lenalidomide on Immune Response to Prevnar 13® in Individuals With Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL), and Monoclonal B Cell Lymphocytosis (MBL)|Recruiting||Phase 2|58|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:45:39.071477|2017-10-10 23:45:39.071477
NCT02309502|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-12-04|||October 2012||2012-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|PRPhS||Panretinal Photo-stimulation in Proliferative Diabetic Retinopathy|Pascal Pan Retinal Photo-Stimulation in Pre-Proliferative Diabetic Retinopathy: a Safety and Efficacy Study|Unknown status|Recruiting|N/A|30|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||3|||f||||f||||||||||2017-10-10 23:45:39.199988|2017-10-10 23:45:39.199988
NCT02309489|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-08-24|||January 2015||2015-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Involving Men in Maternity Care in Burkina Faso|Involving Men in Maternity Care in Burkina Faso|Active, not recruiting||N/A|1115|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-10 23:45:39.287947|2017-10-10 23:45:39.287947
NCT02309476|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-12-03|||October 2012||2012-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|MEM||Sub-threshold Photocoagulation of Diabetic Macular Oedema|Manchester Pascal Endpoint Management Laser Treatment of Diffuse Diabetic Macular Oedema (DMO): A Safety and Efficacy Study|Unknown status|Recruiting|N/A|30|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||6|||f||||f||||||||||2017-10-10 23:45:39.390272|2017-10-10 23:45:39.390272
NCT02309463|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-03-17|||January 2015||2015-01-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|January 2016|Anticipated|2016-01-01||Observational|LONGACT||Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension|A Prospective Multicenter Study to Assess the Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance and 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension Newly Initiating Endothelin Receptor Antagonist Therapy|Withdrawn||N/A|0|Actual|Actelion|||1|"EC did not accept measurement of patient's activity for the primary end-point with a   non-validated activity tracking device"|f||||f||||||||||2017-10-10 23:45:39.486116|2017-10-10 23:45:39.486116
NCT02309450|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-02-01|||December 2014||2014-12-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|November 2015|Anticipated|2015-11-01||Interventional|QUATTROTURBO||Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin Regimen|Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin Regimen|Withdrawn||Phase 2|0|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1||BMS decision|f||||t||||||||||2017-10-10 23:45:39.55058|2017-10-10 23:45:39.55058
NCT02309437|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-29|2014-12-03|||January 2015||2015-01-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Use of Opioid to Control Local Mucosa Pain Induced by Irradiation in Nasopharyngeal Carcinoma Patients|Influences on the Nutrition Statuses and Clinical Outcomes of Early Use of Opioid to Control Local Mucosa Pain Induced by Irradiation in Nasopharyngeal Carcinoma Patients|Not yet recruiting||N/A|174|Anticipated|Affiliated Tumor Hospital of Guangzhou Medical University||2|||f||||f||||||||||2017-10-10 23:45:39.637401|2017-10-10 23:45:39.637401
NCT02309424|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-04|||July 2008||2008-07-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Vinegar on Glucose and Lipid Metabolism in Subjects With Impaired Glucose Tolerance or Type 2 Diabetes|The Effect of Vinegar on Glucose and Lipid Metabolism in Peripheral Tissues in Subjects With Impaired Glucose Tolerance or Type 2 Diabetes|Completed||N/A|20|Actual|Attikon Hospital||2|||f||||f||||||||||2017-10-10 23:45:39.73611|2017-10-10 23:45:39.73611
NCT02309411|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-06-02|||January 15, 2015|Actual|2015-01-15|June 2017|2017-06-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|EINSTEINJr||EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis|30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Young Children With Various Manifestations of Venous Thrombosis|Completed||Phase 2|47|Actual|Bayer||1|||f||||t|t|f||||||||2017-10-10 23:45:39.805922|2017-10-10 23:45:39.805922
NCT02309398|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2017-02-06|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||CCC Project - Atrial Fibrillation|Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Atrial Fibrillation|Recruiting||N/A|42000|Anticipated|Beijing Institute of Heart, Lung and Blood Vessel Diseases|||1||f||||||||||||||2017-10-10 23:45:40.057764|2017-10-10 23:45:40.057764
NCT02309385|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-04-25|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis|A Randomized, Parallel Group, Double-masked, Active-controlled Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of Dexamethasone Sodium Phosphate Visulex System for the Treatment of Non-infectious Anterior Uveitis|Completed||Phase 1/Phase 2|44|Actual|Aciont Inc||3|||f||||f||||||||Undecided||2017-10-10 23:45:40.137678|2017-10-10 23:45:40.137678
NCT02309372|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-09-27|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Depression Therapy to Improve Cardiovascular Risk in HIV|A Randomized, Controlled Pilot Trial Assessing the Utility of Cognitive Behavioral Therapy to Improve Endothelial Function and Reduce Inflammation in Depressed, Virologically-Suppressed, Antiretroviral-Treated, HIV-infected Adults|Recruiting||N/A|110|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-10 23:45:40.387772|2017-10-10 23:45:40.387772
NCT02309359|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-09-13||2017-09-05|January 2015||2015-01-01|September 2017|2017-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis|A Phase IIb Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-Range Finding Study of ALX-0061 Administered Subcutaneously in Combination With Methotrexate, in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 2|345|Actual|Ablynx||5|||f||||t||||||||||2017-10-10 23:45:40.480222|2017-10-10 23:45:40.480222
NCT02309346|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-06-29|||December 2014||2014-12-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|CLINDA-PRO||Clindamycin Once a Day in Septic Abortion|A Randomized Clinical Trial Between Clindamycin Once and Thrice a Day in Septic Abortion.|Recruiting||Phase 4|190|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-10 23:45:40.761201|2017-10-10 23:45:40.761201
NCT02309333|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-09-20|||November 2014||2014-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2016|Actual|2016-11-01|5 Years|Observational [Patient Registry]|||Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database|Assessing the Impact of a Simplified Patient Care Strategy to Decrease Early Deaths In Acute Promyelocytic Leukemia (APL) By Maintaining A Database|Active, not recruiting||N/A|117|Actual|Emory University|||1||f||||f|f|f||||||||2017-10-10 23:45:40.959194|2017-10-10 23:45:40.959194
NCT02309320|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-03-15|||November 2014||2014-11-01|March 2016|2016-03-01||||February 2016|Actual|2016-02-01||Interventional|||A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171|A Phase I/IIa Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With Respiratory Syncytial Virus Lower Respiratory Tract Infection, Consisting of an Open-label Lead-in Part Followed by a Double-blind, Placebo-controlled Part, to Evaluate the Safety, Tolerability and Clinical Activity of ALX-0171, Administered Via Inhalation, in Addition to Standard of Care.|Completed||Phase 1|53|Actual|Ablynx||2|||f||||t||||||||||2017-10-10 23:45:41.043823|2017-10-10 23:45:41.043823
NCT02309307|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-10-22|||December 2014||2014-12-01|January 2015|2015-01-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|CP-STR-01||Tissue Repair Device (VergenixTM STR) in Patients With Epicondylitis (Tennis Elbow)|A Prospective, Open Label, Single Arm, Multi-center Study to Assess the Safety and Performance of a Soft Tissue Repair Device (VergenixTM STR) in Patients With Epicondylitis (Tennis Elbow)|Unknown status|Recruiting|N/A|20|Anticipated|Collplant||1|||f||||f||||||||||2017-10-10 23:45:41.261591|2017-10-10 23:45:41.261591
NCT02309294|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-10-05|2016-07-28||December 2014||2014-12-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin||Completed||N/A|43|Actual|Church & Dwight Company, Inc.||1|||f||||||||||||||2017-10-10 23:45:41.364797|2017-10-10 23:45:41.364797
NCT02309281|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2014-12-02|||May 2013||2013-05-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab|Intravitreal Aflibercept (VEGF Trap-Eye) in Neovascular Age-related Macular Degeneration With Limited Response to Ranibizumab|Completed||Phase 4|33|Actual|Vista Klinik||1|||f||||f||||||||||2017-10-10 23:45:41.52719|2017-10-10 23:45:41.52719
NCT02309268|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-06-11|||June 2012||2012-06-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|LARIAT||Atrial Appendage Closure Prospective Observational Study|LARIAT: Atrial Appendage Closure Prospective Observational Study|Withdrawn||N/A|0|Actual|Virginia Commonwealth University|||1|"The principal linvestigator decided not to continue the registry. No patient were enrolled.   CLosure to the registry was done October 2014"|f||||f||||||||||2017-10-10 23:45:41.620827|2017-10-10 23:45:41.620827
NCT02309255|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-06-12|||February 2014||2014-02-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||The NOR-COR Study for Coronary Prevention|The NOR-COR (NORwegian CORonary) Study: Identification of CHD Patients With Poor Adherence to Secondary Prevention and Their Perceived Needs for Follow-up|Completed||N/A|975|Actual|Vestre Viken Hospital Trust|||1||f||||f||||||Samples With DNA|"     Salvia for genetic analyses   "|||2017-10-10 23:45:41.697|2017-10-10 23:45:41.697
NCT02309242|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-08-20|||December 2014||2014-12-01|August 2015|2015-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study|Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study|Recruiting||N/A|60|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-10 23:45:41.775435|2017-10-10 23:45:41.775435
NCT02309229|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-12-02|||December 2012||2012-12-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01|6 Months|Observational [Patient Registry]|MucoSpuCo||Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.|Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.|Completed||N/A|30|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-10 23:45:41.853389|2017-10-10 23:45:41.853389
NCT02309216|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-05-08|||November 2014||2014-11-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Whole-Body MRI in Suspected Victims of Abusive Head Trauma|Whole-Body MRI in Suspected Victims of Abusive Head Trauma|Completed||N/A|8|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-10 23:45:41.924417|2017-10-10 23:45:41.924417
NCT02309203|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2015-07-27||||||July 2015|2015-07-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|CanFRED||Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms|Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms - The CanFRED Trial|Withdrawn||N/A|0|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1||Study not initiated at our site.|f||||t||||||||||2017-10-10 23:45:41.982051|2017-10-10 23:45:41.982051
NCT02309190|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-05-12|||December 2016||2016-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Transpulmonary Pressures in Mechanical Ventilated Patients With Morbid Obesity|Transpulmonary Pressures in Mechanical Ventilated Patients With Morbid Obesity|Not yet recruiting||N/A|30|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-10 23:45:42.049485|2017-10-10 23:45:42.049485
NCT02309177|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-09-01|||January 14, 2015|Actual|2015-01-14|September 2017|2017-09-01|October 26, 2018|Anticipated|2018-10-26|October 26, 2018|Anticipated|2018-10-26||Interventional|||Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer|A Phase 1, Open-label, Multicenter, Safety Study of Nivolumab (Bms-936558) in Combination With Nab-pacitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-paclitaxel/Carboplatin in Stage Iiib/iv Non-small Cell Lung Cancer or Nab-paclitaxel in Metastastic Breast Cancer|Recruiting||Phase 1|138|Anticipated|Celgene||6|||f||||t||||||||||2017-10-10 23:45:42.133382|2017-10-10 23:45:42.133382
NCT02309164|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-11-11|||September 2014||2014-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).|The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).|Completed||N/A|32|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:45:42.292842|2017-10-10 23:45:42.292842
NCT02309151|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-10-26|||December 2014||2014-12-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|DISCO||Direct or Subacute Coronary Angiography for Out-of-hospital Cardiac Arrest|Direct or Subacute Coronary Angiography for Out-of-hospital Cardiac Arrest - a Randomized Study|Recruiting||N/A|120|Anticipated|Uppsala University||3|||f||||f||||||||||2017-10-10 23:45:42.372051|2017-10-10 23:45:42.372051
NCT02309125|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-04|||December 2014||2014-12-01|November 2014|2014-11-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|||Comparing the Secondary Stability of Dental Implants: Immediate Gradual Loading Versus Early Loading Protocol in Posterior Maxilla|Split Mouth Clinical Study to Compare the Secondary Stability of Dental Implants Using Immediate Gradual Loading Versus Early Loading Protocol in Posterior Maxilla. A Randomized Controlled Trial|Unknown status|Recruiting|N/A|10|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:45:42.543149|2017-10-10 23:45:42.543149
NCT02309112|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2015-02-09|2014-12-15||April 2014||2014-04-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|Y-ACT|"The sample includes male and female (n=11) adult cancer patients receiving conventional treatment in Vancouver, Canada.
Patients undergoing one or more treatments of chemotherapy, radiation, hormone therapy or active surveillance were included in the study. Baseline data collection included all types of treatment for a primary cancer diagnosis."|Yoga in Adult Cancer: A Feasibility Trial|Yoga for Health-related Quality of Life in Adult Cancer: A Randomized Controlled Feasibility Trial|Completed||N/A|15|Actual|University of Oxford|As a feasibility study, the sample size is underpowered and quantitative results are unreliable.|3|||f||||f||||||||||2017-10-10 23:45:42.644695|2017-10-10 23:45:42.644695
NCT02309099|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-06-06|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach|Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach|Active, not recruiting||N/A|10|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-10 23:45:43.188594|2017-10-10 23:45:43.188594
NCT02309086|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-07-16|||May 2011||2011-05-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C|Phase I-II Vaccination Clinical Trial in Patients With Chronic Hepatitis C by Administration of Autologous Dendritic Cells Transduced With an Adenoviral Vector Encoding NS3 Protein|Completed||Phase 1/Phase 2|5|Actual|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||||2017-10-10 23:45:43.271309|2017-10-10 23:45:43.271309
NCT02309073|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-05-15|||November 2013||2013-11-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01|3 Years|Observational [Patient Registry]|PC||PC Protocol: Preconceptional Screening|PC Protocol: Preconceptional Screening Part 2|Recruiting||N/A|1500|Anticipated|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     Blood will be drawn for later determination of various parameters. DNA will also be     extracted.   "|||2017-10-10 23:45:43.324332|2017-10-10 23:45:43.324332
NCT02309060|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2017-07-12|||September 2016||2016-09-01|July 2017|2017-07-01|March 1, 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|sTVi-Open||Storytelling Video Intervention for Depressed Primary Care Patients - Open Trial|Narrative Intervention to Disseminate ACT for Depression in Primary Care|Completed||N/A|11|Actual|Butler Hospital||1|||f||||f||||||||||2017-10-10 23:45:43.531281|2017-10-10 23:45:43.531281
NCT02309047|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-05-15|||October 2004||2004-10-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|January 2020|Anticipated|2020-01-01||Observational|COLA||The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank|The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank|Recruiting||N/A|5000|Anticipated|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     6 x 500 μL serum, 2 x 500 μL EDTAplasma en 3 x 900 μL celpellet   "|||2017-10-10 23:45:43.604559|2017-10-10 23:45:43.604559
NCT02309034|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2014-12-04|||September 2014||2014-09-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Aquatic and Land Physical Training Effects on Cardiometabolic Risk Factors in Adolescents With Overweight and Obesity|Aquatic and Land Physical Training Effects on Cardiometabolic Risk Factors in Adolescents With Overweight and Obesity: a Randomized Controlled Clinical Trial.|Completed||N/A|75|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||||2017-10-10 23:45:43.689893|2017-10-10 23:45:43.689893
NCT02309021|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-12-10|||November 2014||2014-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PHAST||PHAST: Physical Activity in Substitution Therapy|PHAST: Influence of Exercise Training on Substance Use, Substance Craving, Quality of Life, Mental Health, Sleep, and Physical Health in Patients Suffering From Opiate Dependence While Under Substitution Therapy|Completed||N/A|28|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 23:45:43.772422|2017-10-10 23:45:43.772422
NCT02309008|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-04-20|||November 2014||2014-11-01|April 2016|2016-04-01||||April 2016|Actual|2016-04-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects|A Randomized, Double-blind, Placebo-controlled Multiple Dosing Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream After Transdermal Administration in Healthy Volunteers|Completed||Phase 1|24|Actual|Amorepacific Corporation||2|||f||||f||||||||||2017-10-10 23:45:43.850831|2017-10-10 23:45:43.850831
NCT02308995|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-01-28|||December 2014||2014-12-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Barbed Sutures Versus Conventional Sutures in Laparoscopic Excision of Endometrioma|Barbed Sutures Versus Conventional Sutures in Laparoscopic Excision of Endometrioma . A Randomized Controlled Study|Recruiting||Phase 2|40|Anticipated|Aljazeera Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:45:43.920227|2017-10-10 23:45:43.920227
NCT02308969|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-09-24|||December 2014||2014-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|5HT2A-fMRI||Neuronal Correlates of Altered States of Consciousness|Neuronal Correlates of Altered States of Consciousness|Completed||Early Phase 1|24|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-10 23:45:44.169186|2017-10-10 23:45:44.169186
NCT02308956|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-03|2016-05-23|||March 2015||2015-03-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|TaSCS||Task Sharing for the Care of Severe Mental Disorders in a Low-income Country|Task Sharing for the Care of Severe Mental Disorders in a Low-income Country: a Randomised, Controlled Non-inferiority Trial|Active, not recruiting||Phase 3|324|Actual|University of Cape Town||2|||f||||t||||||||||2017-10-10 23:45:44.247463|2017-10-10 23:45:44.247463
NCT02308930|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2014-12-04|||July 2014||2014-07-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|May 2015|Anticipated|2015-05-01||Interventional|||Effect of DHA Supplementation on Cognitive Performance and Growth in Chinese Children|Effect of Dietary DHA Supplementation on Cognitive Performance and Growth in Chinese School Children: A Randomized Controlled Study|Unknown status|Active, not recruiting|N/A|106|Actual|Sun Yat-sen University||2|||f||||||||||||||2017-10-10 23:45:44.347999|2017-10-10 23:45:44.347999
NCT02308917|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-12-02|||September 2013||2013-09-01|December 2015|2015-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|18 Months|Observational [Patient Registry]|CIDsCaNN||Canadian Children Inflammatory Bowel Disease Network (CIDsCANN)|Canadian Children Inflammatory Bowel Disease Network (CIDsCANN): A Joint Partnership of CIHR and C.H.I.L.D. Foundation: Multi-center Inception Cohort Study|Recruiting||N/A|1200|Anticipated|The Hospital for Sick Children|||1||f||||f||||||Samples With DNA|"     Blood samples Urine Samples Biopsy Samples Colonoscopy Washing Samples Stool Samples   "|||2017-10-10 23:45:44.407|2017-10-10 23:45:44.407
NCT02308904|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-07-21|||June 2013||2013-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Fertility thal||Reproductive Capacity and Iron Burden in Thalassemia|Reproductive Capacity and Association to Iron Burden and Chelation Patterns in Thalassemia Major Patients|Recruiting||N/A|30|Anticipated|Children's Hospital & Research Center Oakland||3|||f||||f||||||||||2017-10-10 23:45:44.517275|2017-10-10 23:45:44.517275
NCT02308891|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-08-04|||November 2014||2014-11-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|August 2015|Actual|2015-08-01||Interventional|||A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis|Multicenter Prospective Randomized Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis|Completed||N/A|510|Anticipated|Dankook University||2|||f||||t||||||||||2017-10-10 23:45:44.624976|2017-10-10 23:45:44.624976
NCT02308878|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-03|||October 2013||2013-10-01|December 2014|2014-12-01||||June 2015|Anticipated|2015-06-01||Interventional|Re@dict||Mobile Health Cognitive Stimulation in Heroin Users|Executive Functioning in Heroin Users Following a Mobile Health Cognitive Stimulation Approach: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|65|Anticipated|Universidade Lusófona de Humanidades e Tecnologias||2|||f||||t||||||||||2017-10-10 23:45:44.712263|2017-10-10 23:45:44.712263
NCT02308865|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-05-18|||October 17, 2014|Actual|2014-10-17|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|July 2020|Anticipated|2020-07-01||Interventional|IMPAQ||Early Palliative Care in Metastatic Lung Cancer in Northern France|Impact of Early Palliative Care on Quality of Life and Survival of Patients With Non-small-cell Metastatic Lung Cancer in Northern France|Recruiting||N/A|144|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||No||2017-10-10 23:45:44.783417|2017-10-10 23:45:44.783417
NCT02308852|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-10-25|||October 2014||2014-10-01|October 2016|2016-10-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Improving Bi-manual Activities in Stroke Patients With Application of Neuro-stimulation||Recruiting||Phase 1/Phase 2|100|Anticipated|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-10-10 23:45:44.89082|2017-10-10 23:45:44.89082
NCT02308839|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-26|||July 2012||2012-07-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|||GORE® EXCLUDER® Endprosthesis French Mandatory Registry|Study of the GORE® EXCLUDER® Endoprosthesis in the Treatment of Infra-renal Abdominal Aortic Aneurysms|Active, not recruiting||N/A|181|Actual|W.L.Gore & Associates|||1||f||||f||||||||||2017-10-10 23:45:44.964367|2017-10-10 23:45:44.964367
NCT02308826|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Multi-Component Early Intervention for Socially Inhibited Preschool Children||Recruiting||N/A|150|Anticipated|University of Maryland||2|||f||||||||||||||2017-10-10 23:45:46.86391|2017-10-10 23:45:46.86391
NCT02308813|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-02-01|||October 2014||2014-10-01|November 2014|2014-11-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Predictability of the Ability to Perform an Emergency Stop With Disorders of the Hip|Predictability of Braking Performance in Patients With Degenerative Disease of the Hip Joint or With Total Hip Arthroplasty|Completed||N/A|100|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-10 23:45:46.955724|2017-10-10 23:45:46.955724
NCT02308800|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-10-19|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADA NPWT||Negative Pressure Wound Therapy as a Drug Delivery System (ADANPWT)|Negative Pressure Wound Therapy as a Drug Delivery System|Recruiting||N/A|150|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-10 23:45:47.046868|2017-10-10 23:45:47.046868
NCT02308787|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-05-10|2016-02-03||November 2014||2014-11-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|PLTD|Eligible subjects had received a minimum of 1 PLTD procedure using the Spectra Optia Apheresis System and had available pre- and post-procedure PLT counts.Data were collected from 20 PLTD procedures performed in 12 subjects, which constituted the Full and Safety Analysis Sets.|Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions|Multicenter, Retrospective Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for Platelet Depletion Procedures.|Completed||N/A|12|Actual|Terumo BCT|||1||f||||f||||||||||2017-10-10 23:45:47.1561|2017-10-10 23:45:47.1561
NCT02308774|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-12-11|||August 2014||2014-08-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Observational|PCT||Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis (PCT)|Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis|Completed||N/A|36|Actual|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples Without DNA|"     Blood and tissue samples   "|||2017-10-10 23:45:47.501208|2017-10-10 23:45:47.501208
NCT02308748|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-06-06|2016-01-13||May 2014||2014-05-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block|Five Period Crossover Study of the Ability of Late Sodium or Calcium Current Block (Mexiletine, Lidocaine, or Diltiazem) to Balance the Electrocardiographic Effects of hERG Potassium Current Block (Dofetilide or Moxifloxacin)|Completed||Phase 1|22|Actual|Food and Drug Administration (FDA)||5|||f||||f||||||||||2017-10-10 23:45:47.676037|2017-10-10 23:45:47.676037
NCT02308735|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-11-18|||March 2014||2014-03-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01|3 Months|Observational [Patient Registry]|FAEE-IDM||Fatty Acid Ethyl Esters in Meconium of Infants of Diabetic Mothers: a Pilot Trial|Fatty Acid Ethyl Esters in Meconium of Infants of Diabetic Mothers: a Pilot Trial|Recruiting||N/A|60|Anticipated|University of Oklahoma|||4||f||||f||||||Samples With DNA|"     Urine sample, meconium sample, placental cord blood sample   "|||2017-10-10 23:45:48.4974|2017-10-10 23:45:48.4974
NCT02308722|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-04-12|||April 2015||2015-04-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|SPARC||SBRT Pre-operatively for Pancreatic Cancer|A Phase I Trial of Pre-operative, Margin Intensive, Stereotactic Body Radiation Therapy for Pancreatic Cancer|Recruiting||Phase 1|24|Anticipated|University of Oxford||1|||f||||f||||||||||2017-10-10 23:45:48.611711|2017-10-10 23:45:48.611711
NCT02308709|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-10-04|||September 2014||2014-09-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Novel Lung Functional Imaging for Personalized Radiotherapy|Novel Lung Functional Imaging for Personalized Radiotherapy|Recruiting||N/A|33|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 23:45:48.726061|2017-10-10 23:45:48.726061
NCT02308696|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-10-19|||March 2015||2015-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Effectiveness of Peer-to-Peer Community Support to Promote Aging in Place|The Effectiveness of Peer-to-Peer Community Support to Promote Aging in Place|Active, not recruiting||N/A|457|Actual|University of Wisconsin, Madison||2|||f||||f||||||||No||2017-10-10 23:45:48.811235|2017-10-10 23:45:48.811235
NCT02308683|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-03|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Effects of Moringa Oleifera on hsCRP and Hgba1c Level of Patients in Ospital ng Maynila Medical Center Diabetic Clinic|The Effects of Moringa Oleifera Supplements on hsCRP and HgbA1c Levels of Patients in Ospital ng Maynila Medical Center Diabetic Clinic: A Prospective Cohort Study|Completed||Phase 1|56|Actual|Ospital ng Maynila Medical Center||1|||f||||f||||||||||2017-10-10 23:45:48.912822|2017-10-10 23:45:48.912822
NCT02308670|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-10-24|||July 2014||2014-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis|An Open-label, Prospective, Observational, Single-blinded, Longitudinal, Cross-over Study to Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week on Thalamic Pathology in Subjects With Relapsing-remitting Multiple Sclerosis|Completed||N/A|150|Actual|University at Buffalo|||1||f||||f||||||||No||2017-10-10 23:45:48.980819|2017-10-10 23:45:48.980819
NCT02308657|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-02-27|||November 2013||2013-11-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|MOS-DM1/POP||Multicenter Observational Study of Myotonic Dystrophy Type 1|A Multicenter Observational Study to Assess the Variability of Molecular Biomarkers and Clinical Measures in Patients With Myotonic Dystrophy Type 1|Active, not recruiting||N/A|120|Actual|University of Rochester|||1||f||||f||||||Samples With DNA|"     Blood samples will be used for routine laboratory testing, such as tests of blood cells,     chemistry, and ability to form blood clots. Blood samples will be used for genetic testing     (DNA testing) and to identify biomarkers. Needle muscle biopsies will be obtained from the     tibialis anterior, a muscle in the front of the leg, next to the shin.   "|||2017-10-10 23:45:49.052729|2017-10-10 23:45:49.052729
NCT02308644|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-01|||February 2009||2009-02-01|December 2014|2014-12-01|February 2013|Actual|2013-02-01|December 2011|Actual|2011-12-01||Interventional|||Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study|Phase 3 Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Pilot Study.|Completed||Phase 3|41|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:45:49.150832|2017-10-10 23:45:49.150832
NCT02308631|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-12-01|||February 2014||2014-02-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|EACC||Endoscopically Assisted Colostomy With Colopexy for Critically Ill Patients Without General Anesthesia or Laparotomy|ENDOSCOPICALLY ASSISTED COLOSTOMY WITH COLOPEXY FOR CRITICALLY ILL PATIENTS WITHOUT GENERAL ANESTHESIA OR LAPAROTOMY. EXPERIMENTAL STUDY|Completed||Phase 1|5|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-10 23:45:49.247295|2017-10-10 23:45:49.247295
NCT02308618|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-02|||March 2008||2008-03-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Rehabilitation Programs After Achilles Tendon Rupture|Achilles Tendon Rupture: Comparative Study Between Two Rehabilitation Programs.|Completed||N/A|47|Actual|Federal University of Rio Grande do Sul||3|||f||||t||||||||||2017-10-10 23:45:49.33508|2017-10-10 23:45:49.33508
NCT02308605|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-04-19|||September 2014||2014-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Observational|SMARTCAP||SMARTCap Stroke Study: A Field Deployable Blood Test for Stroke|A Field Deployable Blood Test for Stroke, Capable of Detecting Brain Ischaemia From the Earliest Stages of Pathology|Completed||N/A|217|Actual|University Hospitals Coventry and Warwickshire NHS Trust|||3||f||||t||||||||||2017-10-10 23:45:49.431192|2017-10-10 23:45:49.431192
NCT02308592|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-05-11|||January 2015||2015-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Patient Decision Aid for Antidepressant Use in Pregnancy|Patient Decision Aid (PDA) for Antidepressant Use In Pregnancy|Completed||N/A|100|Actual|Women's College Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:45:49.62758|2017-10-10 23:45:49.62758
NCT02308579|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-02-11|||July 2014||2014-07-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases|Prevalence of Chronic Cerebrospinal Venous Insufficiency in Patients With Multiple Sclerosis and Other Neurological Diseases. An Ultrasound, Blinded, Case-Controlled, Centralized Reading Assessment|Completed||N/A|499|Actual|University at Buffalo|||4||f||||f||||||||||2017-10-10 23:45:49.744915|2017-10-10 23:45:49.744915
NCT02308566|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-06-29|||June 2011||2011-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|AKE-MECC||Cerebral Embolic Load in Patients Undergoing Surgical Aortic Valve Replacement: A Comparison of the Conventional With the Minimized Extracorporeal Circulation Technique Using Transcranial Doppler Ultrasound|Aortic Valve Replacement Using Closed Extracorporeal Circuit. Minimized Versus Conventional Extracorporeal Circulation Technique: Qualitative Differences|Completed||Phase 4|48|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 23:45:49.814041|2017-10-10 23:45:49.814041
NCT02308553|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-09-12|||January 2015||2015-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|NIPAWILMA||Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma|Phase I/II,Multicenter,Randomized,Double-blind,Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib/Vargatef in Combination With Paclitaxel Chemotherapy for Treatment of Patients With BRAF Wildtype Metastatic Melanoma|Recruiting||Phase 1/Phase 2|126|Anticipated|University Hospital, Essen||2|||f||||f||||||||No||2017-10-10 23:45:49.910271|2017-10-10 23:45:49.910271
NCT02308540|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-12-22|||January 2015||2015-01-01|March 2016|2016-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants|A Phase 1/2, Prospective, Randomized, Double-Blind, Age De-escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 10-Valent Pneumococcal Conjugate Vaccine in Healthy Young Adults, Toddlers, and Infants|Completed||Phase 1/Phase 2|346|Actual|PATH||6|||f||||t||||||||||2017-10-10 23:45:50.059028|2017-10-10 23:45:50.059028
NCT02308527|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-05-05|||July 2013|Actual|2013-07-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|July 2018|Anticipated|2018-07-01||Interventional|BEACON||Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children|A Randomised Phase IIb Trial of Bevacizumab Added to Temozolomide ± Irinotecan for Children With Refractory/Relapsed Neuroblastoma - BEACON-Neuroblastoma Trial|Recruiting||Phase 2|160|Anticipated|University of Birmingham||6|||f||||t|f|f||||||No||2017-10-10 23:45:50.164594|2017-10-10 23:45:50.164594
NCT02308514|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-05-10|||September 2014||2014-09-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2015|Actual|2015-09-01||Interventional|||Does Adding Cryostimulation to Conservative Care Help in Managing Chronic Lateral Epicondylitis? a Pilote Study|Does Adding Cryostimulation to Conservative Care Help in Managing Chronic Lateral Epicondylitis? a Pilote Study|Active, not recruiting||N/A|40|Anticipated|Université du Québec à Trois-Rivières||2|||f||||f||||||||||2017-10-10 23:45:50.341012|2017-10-10 23:45:50.341012
NCT02308501|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-10-21|||December 2014||2014-12-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy||Completed||Phase 4|25|Actual|ORA, Inc.||2|||f||||f||||||||||2017-10-10 23:45:50.467055|2017-10-10 23:45:50.467055
NCT02308488|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-08-14|||August 2009||2009-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Prone Accelerated Breast And Nodal IMRT|PHASE I - II STUDY OF PRONE ACCELERATED BREAST AND NODAL IMRT(Intensity-Modulated Radiation Therapy)|Active, not recruiting||N/A|97|Actual|New York University School of Medicine||1|||f||||t|f|f||||||||2017-10-10 23:45:50.558505|2017-10-10 23:45:50.558505
NCT02308475|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-03-23|||December 2014||2014-12-01|March 2017|2017-03-01||||May 2018|Anticipated|2018-05-01||Interventional|||Myocardial Stress Perfusion Computed Tomography in the Evaluation of Patients With Acute Chest Pain Using a Novel 3rd Generation Dual-source CT System|Myocardial Stress Perfusion Computed Tomography in the Evaluation of Patients With Acute Chest Pain Using a Novel 3rd Generation Dual-source CT System|Suspended||N/A|2|Actual|Medical University of South Carolina||1||Data analysis|f||||f||||||||||2017-10-10 23:45:50.644949|2017-10-10 23:45:50.644949
NCT02308462|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-09-12|||November 2014||2014-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CHIMPs||Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents|Implementation and Evaluation of a Family-based Intervention Program for Children and Adolescents of Mentally Ill Parents - a Randomized Controlled Multicenter Trial|Active, not recruiting||N/A|400|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-10 23:45:50.728337|2017-10-10 23:45:50.728337
NCT02308449|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-10-25|||October 2014||2014-10-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Iron Status and Human Metabolism|Effects of Endogenous Iron Status and Intravenous Iron on Human Skeletal Muscle Metabolism at Rest and During Exercise|Completed||N/A|29|Actual|University of Oxford||4|||f||||f||||||||||2017-10-10 23:45:50.876929|2017-10-10 23:45:50.876929
NCT02308436|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-08-27|||February 2015||2015-02-01|August 2015|2015-08-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide|Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide: a Mono-centre, Not-controlled. Not Blinded, Not-randmised in Situ Study|Withdrawn||N/A|0|Actual|Mibelle AG||1||Study is not realised.|f||||f||||||||||2017-10-10 23:45:50.972274|2017-10-10 23:45:50.972274
NCT02308423|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-10|||January 2015||2015-01-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Observational|||Clinical and Radiologic Follow up of Subchondral Fractures of the Glenoid|Clinical and Radiologic Follow up of Subchondral Fractures of the Glenoid|Unknown status|Enrolling by invitation|N/A|12|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-10 23:45:51.053769|2017-10-10 23:45:51.053769
NCT02308410|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-12-02|||October 2013||2013-10-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01|8 Weeks|Observational [Patient Registry]|||Effect of Tourniquet Application on Postoperative Functional Outcome Following Total Knee Arthroplasty|Effect of Tourniquet Application on Postoperative Functional Outcome Following Total Knee Arthroplasty; a Prospective Cohort Study|Completed||N/A|99|Actual|Medicort Sports & Orthopedic Care|||2||f||||f||||||||||2017-10-10 23:45:51.111375|2017-10-10 23:45:51.111375
NCT02308397|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-05-09|||November 2014||2014-11-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Bakery Products for Non-Coeliac Gluten Sensitive Consumers|Bakery Products for Non-Coeliac Gluten Sensitive Consumers|Recruiting||N/A|40|Anticipated|University of Aberdeen||4|||f||||t||||||||Undecided||2017-10-10 23:45:51.200584|2017-10-10 23:45:51.200584
NCT02308384|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-04-25|||September 2015||2015-09-01|November 2015|2015-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Trial of the Implementation of iFOBT in General Practice|The Use of Immunochemical Faecal Occult Blood Test (iFOBT) in General Practice. A Randomised Trial of the Implementation of iFOBT.|Completed||N/A|825|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:45:51.298911|2017-10-10 23:45:51.298911
NCT02308371|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-11-01|2016-08-03||November 2014||2014-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|PPV|All subjects admitted to the pediatric critical care unit|PPV to Guide Fluid Management in the PICU|Automated Pulse Pressure Variation Guided Fluid Management in the Pediatric Intensive Care Setting|Completed||N/A|100|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-10 23:45:51.392172|2017-10-10 23:45:51.392172
NCT02308358|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-18|||May 2014||2014-05-01|August 2017|2017-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|LongTermOC||Long Term Outcomes of Osteochondral Allografts for Osteochondral Defects of the Knee|Long Term Outcomes of Osteochondral Allografts for Osteochondral Defects of the Knee.|Withdrawn||N/A|0|Actual|University of Missouri-Columbia|||2|New study initiated to replace this one|f||||f||||||||||2017-10-10 23:45:51.80494|2017-10-10 23:45:51.80494
NCT02308345|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-03-29|||December 2014||2014-12-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||MiVideo - Video Visit Summary for Cancer Patients|MiVideo - Video Visit Summary for Cancer Patients|Completed||N/A|58|Actual|University of Michigan||1|||f||||f|f|f||||||Undecided||2017-10-10 23:45:51.869644|2017-10-10 23:45:51.869644
NCT02308332|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-10-24|||February 2015||2015-02-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|ESCAPE||Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning|Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning, ESCAPE Study|Recruiting||Phase 4|60|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-10 23:45:52.082127|2017-10-10 23:45:52.082127
NCT02308319|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-02|||January 2015||2015-01-01|November 2014|2014-11-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|POWER||Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load|A Phase 4, Open-Label Study to Investigate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (Viread(R)) in Preventing Hepatocellular Carcinoma Recurrence in Chronic Hepatitis B Virus Infected Patients With Low Viral Load at Baseline Treated With Radiofrequency Ablation or Resection|Not yet recruiting||Phase 4|124|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-10 23:45:52.194333|2017-10-10 23:45:52.194333
NCT02308306|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-05-11|||October 2014||2014-10-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ABILITY||Predictive Markers of the Effects of Opioid Therapy|Predictive Markers of the Effects of Opioid Therapy in Opioid naïve Patients With Chronic Pain: an International, Multi-centre, Observational Cohort Study (ABILITY)|Completed||N/A|62|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-10 23:45:52.319391|2017-10-10 23:45:52.319391
NCT02308293|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-11-23|||January 2015||2015-01-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia|The Effect of Exercise-induced Hyperlacticacidemia on Counterregulatory Responses, Symptoms, Cognitive Function and Brain Lactate Accumulation During Hypoglycemia in (Hypoglycemic Unaware)Type I Diabetes Patients and Normal Controls|Completed||N/A|30|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 23:45:52.471678|2017-10-10 23:45:52.471678
NCT02308280|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-03-21|||November 2014||2014-11-01|March 2017|2017-03-01|November 2022|Anticipated|2022-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients|A Phase II, Open-label Study of Bortezomib Following Nonmyeloablative Allogeneic Stem Cell Transplant in Patients With High-risk Multiple Myeloma|Recruiting||Phase 2|30|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||t||||||||||2017-10-10 23:45:52.628601|2017-10-10 23:45:52.628601
NCT02308267|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-02-24|||November 2015||2015-11-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Forton2015||Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis|Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis: Contribution to Lung Pathology and Impaired Defence Against Bacterial Infection|Recruiting||N/A|200|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||2||f||||f||||||Samples With DNA|"     1. Lung explants from end-stage CF and control patients, which were obtained for a reason          independent from the study.        2. Sputum, nasal (fluid) and serum samples from CF patients and controls patients (COPD          patients and healthy subjects) will be collected for S-IgA and microbiological assays.          Spontaneous sputum will be collected, while nasal fluid will be sampled through nasal          lavage.        3. Endobronchial biopsies and broncho-alveolar lavage will be sampled in some CF patients          who must have a general anaesthesia for a reason independent from the study. If          possible, nasal and rectal biopsies will also be performed. Control subjects will be          patients without evidence of lung disease and who are undergoing narcosis for an          independent reason.   "|||2017-10-10 23:45:52.753806|2017-10-10 23:45:52.753806
NCT02308254|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-10-27|||November 2013||2013-11-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|Lixi||Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People|Effects of Lixisenatide on Gastric Emptying, Glycaemia and 'Postprandial' Blood Pressure in Type 2 Diabetes and Healthy Subjects.|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Royal Adelaide Hospital||2|||f||||f||||||||||2017-10-10 23:45:52.876177|2017-10-10 23:45:52.876177
NCT02308241|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-05-03|||December 2, 2014|Actual|2014-12-02|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies|A Pilot Study of Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies|Active, not recruiting||N/A|12|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:45:53.044391|2017-10-10 23:45:53.044391
NCT02308228|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-11-10|||September 2014||2014-09-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults|Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults|Recruiting||N/A|100|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-10 23:45:53.157674|2017-10-10 23:45:53.157674
NCT02308215|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-05-16|||July 2010||2010-07-01|May 2017|2017-05-01||||November 2019|Anticipated|2019-11-01||Observational|||Retinal Therapy Guided by 3D OCT Image Analysis|Retinal Therapy Guided by 3D OCT Image Analysis|Recruiting||N/A|200|Anticipated|University of Iowa|||1||f||||f||||||||Yes||2017-10-10 23:45:53.293253|2017-10-10 23:45:53.293253
NCT02308202|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-07-11|||January 2012||2012-01-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||DOXAZOSIN FOR PTSD|DOXAZOSIN AS A TREATMENT FOR POST TRAUMATIC STRESS SYNDROME|Recruiting||Phase 1|30|Anticipated|Baylor College of Medicine||3|||f||||t||||||||||2017-10-10 23:45:53.380945|2017-10-10 23:45:53.380945
NCT02308189|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-10-03|||December 2014||2014-12-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|BEND||The Back Exercises to Neutralize Disability Study|Novel Exercise Interventions to Improve Trunk Muscle Function: A Pilot Study|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Ohio University||2|||f||||t||||||||No||2017-10-10 23:45:53.477569|2017-10-10 23:45:53.477569
NCT02308176|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-01-10|||September 2015||2015-09-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|AD01||Effectiveness of a Mobile Application as an Adjunct to Medical Advice to Promote Healthy Habits|Effectiveness of a Mobile Application as an Adjunct to Medical Advice to Promote Healthy Habits (Diet and Sport) in a Population of Patients Obese or Overweight Adults Patients|Active, not recruiting||N/A|107|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-10 23:45:53.582728|2017-10-10 23:45:53.582728
NCT02308150|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-06-18|||December 2014||2014-12-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|Asian TAVR||The Asian Transcatheter Aortic Valve Replacement Registry|Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement in the Asian Pacific Population|Recruiting||N/A|2000|Anticipated|Asan Medical Center|||1||f||||t||||||||No|This is not a publicly funded trial.|2017-10-10 23:45:54.165731|2017-10-10 23:45:54.165731
NCT02308137|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-05-10|||February 2015||2015-02-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)|Open-label, Single-center, Single-arm Futility Trial Evaluating Oral Domperidone 10mg QID for Reducing Progression of Disability in Patients With Secondary Progressive Multiple Sclerosis (SPMS)|Recruiting||Phase 2|62|Anticipated|University of Calgary||1|||f||||t||||||||||2017-10-10 23:45:54.343659|2017-10-10 23:45:54.343659
NCT02308124|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-03-02|2017-01-04||November 2014||2014-11-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study|Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study|Completed||Phase 4|87|Actual|Seoul National University Hospital|This study lacked a placebo group and a blinding process Compared with previous studies, which focused on primary autonomic degenerative disorders, our study included more patients with peripheral autonomic neuropathy.|3|||f||||t||||||||||2017-10-10 23:45:54.448681|2017-10-10 23:45:54.448681
NCT02308111|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-06-19|||December 2014||2014-12-01|June 2017|2017-06-01|April 2025|Anticipated|2025-04-01|December 2024|Anticipated|2024-12-01||Interventional|COBALT||Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis|A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis|Recruiting||Phase 4|428|Anticipated|Intercept Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:45:54.917769|2017-10-10 23:45:54.917769
NCT02308098|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-06-29|||December 2014||2014-12-01|January 2015|2015-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|BUFODIL||To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product|Study Comparing Bronchodilator Efficacy of Two Dry Powder Inhalers, Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler; a Randomised, Double-blind, Double-dummy, Multicentre, Single Dose, Crossover Study in Asthmatic Subjects|Completed||Phase 3|72|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-10-10 23:45:55.878816|2017-10-10 23:45:55.878816
NCT02308085|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-08|||December 2014||2014-12-01|September 2017|2017-09-01|December 2028|Anticipated|2028-12-01|June 2020|Anticipated|2020-06-01||Interventional|POSITIVE||Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer|A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy|Recruiting||N/A|500|Anticipated|International Breast Cancer Study Group||1|||f||||t||||||||||2017-10-10 23:45:56.021272|2017-10-10 23:45:56.021272
NCT02308072|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-03-20|||September 2015||2015-09-01|March 2017|2017-03-01|June 2022|Anticipated|2022-06-01|June 2019|Anticipated|2019-06-01||Interventional|ORCA-2||Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer|A Phase I Trial of Olaparib in Addition to Cisplatin-based Concurrent Chemoradiotherapy for Patients With High Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NHSCC)|Recruiting||Phase 1|70|Anticipated|University College, London||1|||f||||t||||||||Undecided||2017-10-10 23:45:56.857103|2017-10-10 23:45:56.857103
NCT02308059|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-02|||April 2012||2012-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Ultrasonographic Evaluation of Diabetic Neuropathy|Diabetic Peripheral Neuropathy: Correlation Between Ultrasound Findings and Clinical Features|Completed||N/A|106|Actual|Cukurova University|||2||f||||f||||||||||2017-10-10 23:45:56.961037|2017-10-10 23:45:56.961037
NCT02308046|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-07-18|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|SMART GIVES||Multi-Center Study of New Medications to Treat Vaginal Infections|Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety|Completed||Phase 3|212|Actual|Curatek Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 23:45:57.041219|2017-10-10 23:45:57.041219
NCT02308033|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-07-18|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|SMART GIVES||Multi-Center Study of New Medications to Treat Vaginal Infections|Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety|Completed||Phase 3|204|Actual|Curatek Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 23:45:57.182321|2017-10-10 23:45:57.182321
NCT02308020|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-10-02|||April 2015||2015-04-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain|A Phase 2 Study of Abemaciclib in Patients With Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer, Non-small Cell Lung Cancer, or Melanoma|Recruiting||Phase 2|247|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-10 23:45:57.317525|2017-10-10 23:45:57.317525
NCT02308007|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-07-18|||June 2015||2015-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SMART GIVES||Multi-Center Study of New Medications to Treat Vaginal Infections|Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety|Recruiting||Phase 3|189|Anticipated|Curatek Pharmaceuticals, LLC||3|||f||||f||||||||||2017-10-10 23:45:57.785883|2017-10-10 23:45:57.785883
NCT02307994|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2014-12-04|||August 2014||2014-08-01|August 2014|2014-08-01||||June 2015|Anticipated|2015-06-01||Interventional|||Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH|Effectiveness and Safety of uFSH for Severe Oligospermia or Azoospermia:A Multi-center,Open,Randomized,Interventional,and Phase4 Trial in China|Unknown status|Enrolling by invitation|Phase 4|180|Anticipated|Livzon Pharmaceutical Group Inc.||1|||f||||||||||||||2017-10-10 23:45:58.09096|2017-10-10 23:45:58.09096
NCT02307981|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-08-17|||August 2013||2013-08-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|September 2015|Anticipated|2015-09-01||Observational|NOR-OCCIP||Norwegian Occipital Ischemic Stroke Study|Management and Outcome of Visual Field Defects in Occipital Infarction (NOR-OCCIP)- A Multi-center Prospective Study|Unknown status|Active, not recruiting|N/A|75|Anticipated|Haukeland University Hospital|||2||f||||f||||||||||2017-10-10 23:45:58.186003|2017-10-10 23:45:58.186003
NCT02307968|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-02-03|||October 2014||2014-10-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|CUSTIOT||Comparative Study of Insulin Therapy Between Inner and Outer Upper Thigh|Comparison of Patient's Preference, Pain Perception, and Usability Between Inner and Outer Upper Thigh for Insulin Therapy|Completed||N/A|20|Actual|First Affiliated Hospital of Zhejiang University|||2||f||||f||||||||||2017-10-10 23:45:58.295857|2017-10-10 23:45:58.295857
NCT02307955|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-03-08|||September 2014||2014-09-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Firefly ANKLE Sprain Study|Firefly ANKLE Sprain Study|Completed||Phase 2|24|Actual|Firstkind Ltd||2|||f||||f||||||||||2017-10-10 23:45:58.405261|2017-10-10 23:45:58.405261
NCT02307942|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-03-05|||February 2015||2015-02-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Interventional|ELDSURG||Improvement in Physical Performance and Obesity Surgery in Patients Older Than 60 Years|Does Intense Weight Loss Improve Physical Performance in Obese Patients Older Than 60 Yrs Undergoing Exercise Training? Comparison Between Surgery and Standard of Care.|Recruiting||N/A|180|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||No||2017-10-10 23:45:58.523129|2017-10-10 23:45:58.523129
NCT02307929|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-09-05|||September 2010||2010-09-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|September 2015|Actual|2015-09-01||Observational|QoC NAHC||Evaluation of Quality of Care - Nurse Allied Health Clinic Programme, HA|Evaluation of Quality of Care - Nurse Allied Health Clinic Programme, HA|Completed||N/A|2496|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-10 23:45:58.710376|2017-10-10 23:45:58.710376
NCT02307916|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-10-03|||October 2016||2016-10-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations|Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations|Recruiting||Phase 2|60|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||||2017-10-10 23:45:58.785176|2017-10-10 23:45:58.785176
NCT02307903|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-09-05|||September 2010||2010-09-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|September 2016|Actual|2016-09-01||Observational|QoC HDPPP||Evaluation of Quality of Care - Haemodialysis Public-Private-Partnership, Hospital Authority|Evaluation of Quality of Care - Haemodialysis Public-Private-Partnership, Hospital Authority (HA)|Completed||N/A|125|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-10 23:45:58.901116|2017-10-10 23:45:58.901116
NCT02307890|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-04-06|||August 2014||2014-08-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||The Relationship of Initial Liver Profile and Outcome After Transplantation|The Relationship of Hepatobiliary microRNA Expression Profile and Clinical Outcome in Liver Transplantation|Recruiting||N/A|100|Anticipated|University of Edinburgh|||1||f||||f||||||Samples With DNA|"     Liver and bile duct   "|Undecided||2017-10-10 23:45:58.987087|2017-10-10 23:45:58.987087
NCT02307877|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-07-17|||September 2014||2014-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Observational|||Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate|Comparative Effectiveness of Long Term Fingolimod Versus Glatiramer Acetate on Brain Atrophy Rates, Cognition and Patient Reported Outcomes in Patients With Multiple Sclerosis|Active, not recruiting||N/A|157|Actual|University of Colorado, Denver|||2||f||||f||||||||||2017-10-10 23:45:59.068326|2017-10-10 23:45:59.068326
NCT02307864|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-09-25|||December 2014||2014-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants|A Randomized, Double-Blind, Placebo- and Positive-Controlled, Multiple Dose, Four Way Crossover Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Subjects at Therapeutic and Supratherapeutic Dose Levels|Completed||Phase 1|68|Actual|Janssen Scientific Affairs, LLC||4|||f||||f||||||||||2017-10-10 23:45:59.148435|2017-10-10 23:45:59.148435
NCT02307851|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-09-20||2016-09-20|November 2014||2014-11-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults|A Phase 2 Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Immunogenicity and SAfety of Quadrivalent Seasonal Virus-Like Particle (VLP) Influenza Vaccine (Recombinant) in Healthy Young (18-49) Adults|Completed||Phase 2|400|Actual|Novavax||4|||f||||f||||||||||2017-10-10 23:45:59.275001|2017-10-10 23:45:59.275001
NCT02307838|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-02-02|2016-11-28||June 2014||2014-06-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ACROSS|For baseline characteristics and analyses, participants were grouped according to FTY720 exposure: Continuous >= 8 years of FTY720 and Non-continuous < 8 years of FTY720. Non-continuous groups were broken down according to the high-efficacy DMTs' exposure. DMTs included natalizumab, mitoxantrone, alemtuzumab, rituximab, cladribine or ocrelizumab.|Long-term Follow-up of Fingolimod Phase II Study Patients|Long-term Follow-up at 10 Years of Patients Enrolled in the Fingolimod Phase II Program in Relapsing Multiple Sclerosis (MS)|Completed||Phase 4|177|Actual|Novartis||1|||f||||f||||||||||2017-10-10 23:45:59.38445|2017-10-10 23:45:59.38445
NCT02307825|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-06-15|||November 2014|Actual|2014-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|AZI-CRS||Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy|Azithromycin as add-on Therapy in Patients Failing Medical and Surgical Treatment for Chronic Rhinosinusitis: a Double-blind, Randomized, Placebo-controlled Trial|Active, not recruiting||Phase 4|129|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-10 23:45:59.959953|2017-10-10 23:45:59.959953
NCT02307812|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-07-07||||||July 2015|2015-07-01||||||||Expanded Access|||Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France|Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France|No longer available||N/A|||Eli Lilly and Company|||||f||||||||||||||2017-10-10 23:46:00.077052|2017-10-10 23:46:00.077052
NCT02307799|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-01-11|||June 2012||2012-06-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Observational|RESPECT||A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology|A RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology (RESPECT)|Active, not recruiting||N/A|3133|Actual|Université Catholique de Louvain|||1||f||||f||||||||||2017-10-10 23:46:00.181093|2017-10-10 23:46:00.181093
NCT02307786|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2014-12-03|||June 2014||2014-06-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Long Term Outcomes in β Thalassemia Major|Long Term Outcomes in β Thalassemia Major - Comparing Late Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation and Standard Supportive Care|Unknown status|Recruiting|N/A|150|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||||2017-10-10 23:46:00.26052|2017-10-10 23:46:00.26052
NCT02307773|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-01-12|||November 2013||2013-11-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy|Does Use of Lidocaine Spray on an Endoscope Immediately Before Insertion Improve Patient Tolerance to Endoscopy? A Single Center, Case-Control Study.|Completed||N/A|497|Actual|Cheju Halla General Hospital|||2||f||||t||||||||||2017-10-10 23:46:00.33699|2017-10-10 23:46:00.33699
NCT02307760|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-05-09|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Evaluation of Human Milk Fortifiers in Preterm Infants|Evaluation of Two Human Milk Fortifiers in Preterm Infants|Completed||N/A|164|Actual|Abbott Nutrition||2|||f||||f||||||||Undecided||2017-10-10 23:46:00.448202|2017-10-10 23:46:00.448202
NCT02307747|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-08-20|||February 2015||2015-02-01|August 2015|2015-08-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Disruption of Circadian Rhythm and Healthcare-related Infection in Patients With Severe Trauma|Disruption of Circadian Rhythm and Healthcare-related Infection in Patients With Severe Trauma|Recruiting||N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-10 23:46:00.543807|2017-10-10 23:46:00.543807
NCT02307734|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-07-01|||May 2015||2015-05-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Family-Focused Intervention for Asian American Male Smokers|A Family-Focused Intervention for Asian American Male Smokers|Recruiting||N/A|720|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:46:00.609838|2017-10-10 23:46:00.609838
NCT02307721|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2017-09-19|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|OPI-14-001||Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use|Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use|Completed||Phase 1/Phase 2|12|Actual|Norwegian University of Science and Technology||2|||f||||t|f|f||||||||2017-10-10 23:46:00.711393|2017-10-10 23:46:00.711393
NCT02307708|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-12-01|||December 2014||2014-12-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|TARCI||Reeducation of Chronic Achilles Tendinopathy by Wearing Shoes Inclined Versus Reeducation by Kinesitherapy|Reeducation of Chronic Achilles Tendinopathy by Wearing Shoes Inclined Versus Reeducation by Kinesitherapy|Unknown status|Active, not recruiting|N/A|74|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-10 23:46:00.81579|2017-10-10 23:46:00.81579
NCT02307695|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-07-05|||November 2014||2014-11-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes|The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes|Recruiting||Phase 4|184|Anticipated|Nanjing Medical University||2|||f||||t||||||||||2017-10-10 23:46:00.889345|2017-10-10 23:46:00.889345
NCT02307682|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-07-04|||December 8, 2014|Actual|2014-12-08|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|April 22, 2017|Actual|2017-04-22||Interventional|||Efficacy and Safety of RTH258 Versus Aflibercept|A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 Versus Aflibercept in Subjects With Neovascular Age-Related Macular Degeneration|Active, not recruiting||Phase 3|1600|Anticipated|Alcon Research||3|||f||||t||||||||||2017-10-10 23:46:02.578293|2017-10-10 23:46:02.578293
NCT02307669|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-01-31|||December 2015||2015-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|INCA-SUN||Inhaler Adherence in Severe Unstable Asthma|A Study on Inhaler Adherence to Improve Poor Asthma Control|Recruiting||N/A|190|Anticipated|Beaumont Hospital||2|||f||||t||||||||||2017-10-10 23:46:02.675989|2017-10-10 23:46:02.675989
NCT02307656|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-01|||November 21, 2014|Actual|2014-11-21|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|July 30, 2018|Anticipated|2018-07-30||Interventional|||Taste Properties of Atazanavir and Cobicistat|Assessment of the Taste Properties of Atazanavir and Cobicistat and Pediatric Oral Test Formulations Containing Both Atazanavir and Cobicistat in Healthy Adults|Active, not recruiting||Phase 1|6|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 23:46:02.772355|2017-10-10 23:46:02.772355
NCT02307643|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-06-13|||February 2015||2015-02-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients|An Exploratory Study of MT-1303 in Subjects With Systemic Lupus Erythematosus (a Multicenter, Open-label Study)|Completed||Phase 1|17|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-10-10 23:46:02.877421|2017-10-10 23:46:02.877421
NCT02307630|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-06-08|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study|PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study|Recruiting||N/A|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:46:02.99865|2017-10-10 23:46:02.99865
NCT02307617|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-04-20|||July 2014||2014-07-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|GPII||Glutamate Probes in Adolescent Depression|Glutamate Probes in Adolescent Depression|Recruiting||N/A|100|Anticipated|Mayo Clinic|||4||f||||t||||||||||2017-10-10 23:46:03.085669|2017-10-10 23:46:03.085669
NCT02307604|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-08-07|||May 2016||2016-05-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|5 Years|Observational [Patient Registry]|SPECTAbrain||SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access|Screening Platform of EORTC for Clinical Trials Access in Brain Tumors|Recruiting||N/A|300|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||t||||||Samples With DNA|"     FFPE blocks of tumour tissue Blood samples   "|||2017-10-10 23:46:03.185873|2017-10-10 23:46:03.185873
NCT02307591|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2015-10-05|||December 2014||2014-12-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|EASE||Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)|Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola.|Withdrawn||Phase 2/Phase 3|0|Actual|Emergency NGO Onlus||2||The Study could not be started due to an insufficient number of new EVD cases.|f||||t||||||||||2017-10-10 23:46:03.262823|2017-10-10 23:46:03.262823
NCT02307578|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-09-20||||||September 2017|2017-09-01||||||||Expanded Access|||Extended Access Program for Subjects Completing Perampanel StudyE2007-G000-332|An Extended Access Program for Subjects Completing Perampanel Study E2007-G000-332 (Study 332)|Available||N/A|||Eisai Inc.|||||||||||||||||||2017-10-10 23:46:03.334322|2017-10-10 23:46:03.334322
NCT02307565|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-03-06|||March 2014||2014-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Blood Pressure, Cerebral Blood Flow and Cognition in Spinal Cord Injury|Blood Pressure, Cerebral Blood Flow and Cognition in SCI|Recruiting||Phase 3|60|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-10 23:46:03.538579|2017-10-10 23:46:03.538579
NCT02307552|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-06-26|2016-12-14||June 2013||2013-06-01|June 2017|2017-06-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional||1|Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer|Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer|Terminated||N/A|1|Actual|University of California, Irvine||1||"The probe could not be anchored in place and would rotate about its axis, thus comparison was   difficult."|f||||t||||||||Undecided||2017-10-10 23:46:03.66855|2017-10-10 23:46:03.66855
NCT02307539|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-06-01|||November 2014||2014-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer|Feasibility of an Interdisciplinary Palliative Care Planning Intervention in Pancreatic Cancer|Completed||N/A|10|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:46:03.846872|2017-10-10 23:46:03.846872
NCT02307526|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-07-18|2015-08-31||January 2011||2011-01-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Acetylcholinesterase Inhibition and Orthostatic Hypotension in SCI|Acetylcholinesterase Inhibition: A Novel Approach in the Treatment of Orthostatic Hypotension in Spinal Cord Injury|Completed||Phase 2|10|Actual|James J. Peters Veterans Affairs Medical Center||1|||f||||f||||||||||2017-10-10 23:46:03.97649|2017-10-10 23:46:03.97649
NCT02307513|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2017-07-25|||December 16, 2014|Actual|2014-12-16|July 2017|2017-07-01|September 14, 2018|Anticipated|2018-09-14|August 19, 2018|Anticipated|2018-08-19||Interventional|||A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease|A Phase 3, Multicenter, Randomized, Doubleblind, Placebo-controlled, Parallel Group Study, Followed by an Active-treatment Phase to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Subjects With Active Behcet's Disease|Active, not recruiting||Phase 3|207|Actual|Celgene||2|||f||||t||||||||||2017-10-10 23:46:04.268705|2017-10-10 23:46:04.268705
NCT02307500|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-09-01|||December 2014||2014-12-01|September 2015|2015-09-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Interventional|RESOUND||Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy|An Open-label Phase II Study of Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy - RESOUND|Recruiting||Phase 2|80|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-10-10 23:46:04.495304|2017-10-10 23:46:04.495304
NCT02307487|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-06-15|||December 2014||2014-12-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|April 2016|Actual|2016-04-01||Interventional|||Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients|Evaluation of the Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel Mixed With Mitomycin C (MMC) in Non-muscle Invasive Bladder Cancer (NMIBC) Patients|Completed||Phase 2|14|Actual|UroGen Pharma Ltd.||6|||f||||t||||||||||2017-10-10 23:46:04.591451|2017-10-10 23:46:04.591451
NCT02307474|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2016-03-01|||September 2015||2015-09-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer|CASE 10813: A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Carcinoma|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center||1||Funding Unavailable|f||||f||||||||||2017-10-10 23:46:04.695233|2017-10-10 23:46:04.695233
NCT02307461|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-07-28|||November 2014||2014-11-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145|A Phase 1, Open-label, 2-Part Study to Evaluate the Bioequivalence of the Duvelisib Marker-Image Formulation to the Duvelisib Clinical-Trial Formulation and to Assess the Effect of Food on the Pharmacokinetics of IP Duvelisib in Healthy Adult Subjects|Completed||Phase 1|103|Actual|Verastem, Inc.||3|||f||||f||||||||||2017-10-10 23:46:04.787965|2017-10-10 23:46:04.787965
NCT02307448|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-02|2015-08-12|||August 2015||2015-08-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds|Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds|Unknown status|Recruiting|N/A|1500|Anticipated|ACR Biologics, LLC||2|||f||||f||||||||||2017-10-10 23:46:04.864555|2017-10-10 23:46:04.864555
NCT02307435|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-12-01|||August 2014||2014-08-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AMSC||Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture|Potency of Allogenic Bone Marrow, Umbilical Cord, Adipose Mesenchymal Stem Cell for Non Union Fracture and Long Bone Defect, Directly and Cryopreserved|Recruiting||Early Phase 1|9|Anticipated|Indonesia University||1|||f||||f||||||||||2017-10-10 23:46:04.961243|2017-10-10 23:46:04.961243
NCT02307422|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-12|||November 2014||2014-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Genetic Polymorphisms Associated With CAD|Genetic Polymorphisms Associating With CAD, Inflammatory Biomarkers, and Oxidized Phospholipids in a Greek Population|Active, not recruiting||N/A|1173|Actual|Interleukin Genetics, Inc.|||2||f||||f||||||Samples With DNA|"     DNA has been extracted from previously obtained subject blood samples at the University     General Hospital of Ioannina, Greece study site. DNAs will be labeled by anonymized subject     ID # (de-identified), and shipped to ILI for genotyping and genetic analysis.   "|||2017-10-10 23:46:05.205686|2017-10-10 23:46:05.205686
NCT02307409|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-08-17|||June 2014||2014-06-01|April 2016|2016-04-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Observational|||Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis|Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis|Completed||N/A|114|Actual|Institute of Liver and Biliary Sciences, India|||2||f||||f||||||||||2017-10-10 23:46:05.301956|2017-10-10 23:46:05.301956
NCT02307396|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-02-29|||November 2014||2014-11-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients|Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics for the Prevention of Relapse in Long-term Stabilized Schizophrenic Patients: a Randomized, Single-blind, Longitudinal Trial|Active, not recruiting||Phase 4|25|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-10-10 23:46:05.373117|2017-10-10 23:46:05.373117
NCT02307383|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-12-04|||October 2014||2014-10-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers|Pilot Study of the Effectiveness of Probiotics and Lactitol for the Intestinal Decolonization of People Carriers of Klebsiella Pneumoniae Producers of Carbapenemase OXA-48-type: DesProbiOXA Study|Unknown status|Recruiting|Phase 2|20|Anticipated|Instituto de Investigación Hospital Universitario La Paz||1|||f||||f||||||||||2017-10-10 23:46:05.529828|2017-10-10 23:46:05.529828
NCT02307370|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-04-24|||December 2014|Actual|2014-12-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01||Interventional|ABLATE||Atherectomy By Laser Ablation With Turbo-Elite|Atherectomy By Laser Ablation With Turbo-Elite|Completed||N/A|44|Actual|Spectranetics Corporation||1|||f||||||||||||||2017-10-10 23:46:05.622527|2017-10-10 23:46:05.622527
NCT02307357|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2014-12-01|||December 2014||2014-12-01|December 2014|2014-12-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effects of Newcomball Training on Physical Fitness and Mood State of Middle Age Women in Israel|The Effects of Newcomball Training on Physical Fitness and Mood State of Middle Age Women in Israel|Unknown status|Not yet recruiting|N/A|120|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-10 23:46:05.686137|2017-10-10 23:46:05.686137
NCT02307344|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-12-01|||January 2015||2015-01-01|December 2014|2014-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|NASH NAFLD||Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-10 23:46:05.774674|2017-10-10 23:46:05.774674
NCT02307331|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-08-11|||March 2014||2014-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||RSA Study of Sirius Stem and Exceed Cup|RCT of the Sirius Stem Used in Conjunction With the Exceed ABT Cemented Cup and OptiPac/OptiVac Cement - Model Based RSA, Clinical and Radiographic Outcomes|Active, not recruiting||N/A|48|Anticipated|Region Skane||4|||f||||f||||||||||2017-10-10 23:46:05.868839|2017-10-10 23:46:05.868839
NCT02307318|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-11-15|2016-09-26||November 2014||2014-11-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Heart and Hands Study II: A Retrospective Data Collection & Analysis Project|Heart and Hands Study II: A Retrospective Data Collection & Analysis Project|Completed||Phase 1/Phase 2|51|Actual|HealthEast Care System||1|||f||||f||||||||No||2017-10-10 23:46:05.992381|2017-10-10 23:46:05.992381
NCT02307305|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-02-17|||August 2014||2014-08-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Does Duloxetine Reduce Chronic Pain After Total Knee Arthroplasty?|Does Duloxetine Reduce Chronic Pain After Total Knee Arthroplasty?|Recruiting||Phase 2|168|Anticipated|Hanyang University Seoul Hospital||2|||f||||t||||||||||2017-10-10 23:46:06.211006|2017-10-10 23:46:06.211006
NCT02307292|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-01-09|||December 2014||2014-12-01|January 2015|2015-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01|24 Months|Observational [Patient Registry]|Q3-Registry||Prospective, Post Market Surveillance Q3-registry (POLARIS)|Prospective, Non-randomized Post Market Surveillance Registry to Document the Clinical Performance in Routine Clinical Practice of the POLARIS Peripheral Vascular Self Expanding Stent System.|Unknown status|Recruiting|N/A|250|Anticipated|QualiMed Innovative Medizinprodukte GmbH|||1||f||||f||||||||||2017-10-10 23:46:06.309827|2017-10-10 23:46:06.309827
NCT02307279|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-09-12|||November 2014|Actual|2014-11-01|July 2016|2016-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effect of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes|Completed||N/A|436|Actual|Gelesis, Inc.||2|||f||||t||||||||||2017-10-10 23:46:06.391146|2017-10-10 23:46:06.391146
NCT02307266|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-07-25|2016-06-13||November 2014||2014-11-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Patient Education in Adherence on Acne (PEAce)|Effect of Patient Education on Treatment Adherence and Satisfaction Among Acne Patients Receiving Once-daily Epiduo Gel Treatment in Primary Care Clinics|Completed||Phase 4|97|Actual|Galderma||3|||f||||f||||||||||2017-10-10 23:46:06.558465|2017-10-10 23:46:06.558465
NCT02307253|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-12-01|||June 2013||2013-06-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|March 2015|Anticipated|2015-03-01||Interventional|NIFLEX||EUS GUIDED Transduodenal Biopsy Using the 19G Flex|EUS-guided Fine Needle Tissue Acquisition Using a Newly Developed Nitinol Ultra Flex 19 Gauge Needle for Transduodenal Lesions: a Multicenter Prospective Feasibility Study|Unknown status|Recruiting|N/A|200|Anticipated|Catholic University of the Sacred Heart||1|||f||||f||||||||||2017-10-10 23:46:07.146315|2017-10-10 23:46:07.146315
NCT02307240|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-11-22|||November 2014||2014-11-01|November 2016|2016-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors|Phase I Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered CUDC-907, an HDAC and PI3K Inhibitor, in Subjects With Advanced/Relapsed Solid Tumors|Recruiting||Phase 1|60|Anticipated|Curis, Inc.||3|||f||||t||||||||||2017-10-10 23:46:07.257212|2017-10-10 23:46:07.257212
NCT02307227|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-01|||April 2006||2006-04-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2009|Actual|2009-04-01||Interventional|||Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors|Antitumor Immune Responses in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: a Phase II Study With Trastuzumab and Concomitant Weekly Paclitaxel in Patients With HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors.|Completed||Phase 2|46|Actual|Centro di Riferimento Oncologico - Aviano||2|||f||||t||||||||||2017-10-10 23:46:07.336185|2017-10-10 23:46:07.336185
NCT02307214|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-04-25|||October 2013||2013-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ENDAUT||Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: New Insights Into the Pathophysiology|Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: New Insights Into the Pathophysiology of Two Orphan Cardiac Diseases|Completed||N/A|39|Actual|Ospedale San Giovanni Bellinzona||3|||f||||t||||||||||2017-10-10 23:46:07.413147|2017-10-10 23:46:07.413147
NCT02307201|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-01-31|||December 2014||2014-12-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MAG-PIP||Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia|Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia Receiving Treatment for More Than 8 Hours Before Delivery. A Randomized Multicenter Clinical Trial .|Completed||Phase 2/Phase 3|1114|Actual|Complejo Hospitalario Dr. Arnulfo Arias Madrid||2|||f||||t||||||||||2017-10-10 23:46:07.48788|2017-10-10 23:46:07.48788
NCT02307188|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-02-18|2015-12-04||November 2014||2014-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Due to the paucity and lack of quality of intracardiac electrogram information collected from the one patient for whom the catheter was used in the left atrium, the collected electrogram data were not analyzed further.|Multipolar Mapping and Atrial Arrhythmias|Atrial Signal Analysis Using a Multipolar Catheter in Patients Undergoing Atrial Fibrillation and Flutter Ablations|Completed||N/A|5|Actual|Columbia University||1|||f||||t||||||||||2017-10-10 23:46:07.703075|2017-10-10 23:46:07.703075
NCT02307175|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-04-05|||September 2014||2014-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication|A Phase I Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron (CYCLOTEC) in Patients With Thyroid Scan Indication|Recruiting||Phase 1|30|Anticipated|Centre de recherche du Centre hospitalier universitaire de Sherbrooke|||2||f||||f||||||||||2017-10-10 23:46:07.875579|2017-10-10 23:46:07.875579
NCT02307162|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2015-10-27|||December 2014||2014-12-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||SAD/MAD Study of a New Formulation of Nebulised RPL554 in Healthy Subjects and COPD Subjects|A Phase I, Randomised, Double Blind, Placebo Controlled, 3-part Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Inhaled Doses of RPL554 Administered by Nebuliser to Healthy Male Subjects and Stable COPD Subjects.|Completed||Phase 1|112|Actual|Verona Pharma plc||2|||f||||t||||||||||2017-10-10 23:46:07.961495|2017-10-10 23:46:07.961495
NCT02307149|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-08-18|||February 2015||2015-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MITCI||Melanoma IntraTumoral Cavatak + Ipilimumab|Phase Ib Study of Intratumoral CAVATAK® (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma|Recruiting||Phase 1|59|Anticipated|Viralytics||1|||f||||||||||||||2017-10-10 23:46:08.051001|2017-10-10 23:46:08.051001
NCT02307136|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-02-15|||January 2013||2013-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|SUREA||Evaluation of the Impact of Within-hospital Trajectories of Patients Admitted in Intensive Care Units (ICU) From Emergency Departments|Evaluation of the Impact of Within-hospital Trajectories of Patients Admitted in Intensive Care Units (ICU) From Emergency Departments|Completed||N/A|50000|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:46:08.177558|2017-10-10 23:46:08.177558
NCT02307123|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2016-10-27|2015-12-02||January 2013||2013-01-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Observational|||One-year Outcome After Prehospital Intubation|One-year Outcome After Prehospital Intubation|Completed||N/A|483|Actual|Tampere University Hospital|||1||f||||f||||||||||2017-10-10 23:46:08.263574|2017-10-10 23:46:08.263574
NCT02307110|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2014-12-02|||August 2010||2010-08-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy|A Cross Sectional Study Assessing the Prevalence of Different Stages of Diabetic Retinopathy and Diabetic Macular Edema Among Type 1 Diabetic Patients Treated With Long-term Intensified Insulin Therapy|Unknown status|Recruiting|N/A|150|Anticipated|Vista Klinik||1|||f||||f||||||||||2017-10-10 23:46:08.436581|2017-10-10 23:46:08.436581
NCT02307084|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-11-14|||February 2015||2015-02-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Ultrasound to Prevent Leg Wound Complications in Heart Bypass.|An Investigation Into the Efficacy of Pre-operative Long Saphenous Vein Mapping Using Ultrasound for Use in Coronary Artery Bypass Grafting to Reduce Vein Harvest Site Complications.|Recruiting||N/A|106|Anticipated|University Hospitals Bristol NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 23:46:08.664165|2017-10-10 23:46:08.664165
NCT02307071|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-05-27|||November 2014||2014-11-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|OSCRO||Occipital Transcutaneous Stimulation in Chronic Migraine|Transcutaneous Suboccipital Neurostimulation for the Treatment of Chronic Migraine|Unknown status|Recruiting|Phase 4|20|Anticipated|University Hospital of Liege||1|||f||||f||||||||||2017-10-10 23:46:08.767371|2017-10-10 23:46:08.767371
NCT02307058|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-10-03|||February 5, 2015|Actual|2015-02-05|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|BLaStM||Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy|A Phase II Randomized Trial of MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy - The Miami BLaStM Trial|Recruiting||N/A|164|Anticipated|University of Miami||2|||f||||t||||||||||2017-10-10 23:46:08.872094|2017-10-10 23:46:08.872094
NCT02307045|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-02|||June 2011||2011-06-01|December 2014|2014-12-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Effect of Smoking Reduction on Endothelial Glucocalyx and Vascular Function|Effect of Smoking Reduction on Endothelial Glucocalyx and Arterial Wall Properites During Medically-aided Smoking Cessation Program.|Unknown status|Recruiting|Phase 4|100|Anticipated|University of Athens||2|||f||||t||||||||||2017-10-10 23:46:08.995728|2017-10-10 23:46:08.995728
NCT02307032|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-01-27|||September 2014||2014-09-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|January 2019|Anticipated|2019-01-01||Observational|AFPRET||Atrial Fibrillation Prediction Trial.|Atrial Fibrillation Prediction Trial of the Dynamic Changes Through the Continuous Spectrum of the Arrhythmia Evolution.|Recruiting||N/A|500|Anticipated|University of Athens|||1||f||||f||||||||||2017-10-10 23:46:09.098535|2017-10-10 23:46:09.098535
NCT02307019|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-05-28|||July 2014||2014-07-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|CPA||Intervention on Caregivers Caring for Patients Poststroke With Upper Limb Apraxia|Intervention on Caregivers Caring for Patients Poststroke With Upper Limb Apraxia: Randomized Clinical Trial|Unknown status|Recruiting|N/A|50|Anticipated|Universidad de Granada||2|||f||||t||||||||||2017-10-10 23:46:09.199961|2017-10-10 23:46:09.199961
NCT02307006|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-11-30|||January 2015||2015-01-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|PREVTAROLINE||The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection|IDC 56: A Randomized Double-blinded Study Comparing Ceftaroline to Standard of Care Therapy With Cefazolin and Vancomycin as Surgical Prophylaxis for High Risk Orthopedic and Cardiac Surgeries|Recruiting||Phase 4|500|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-10-10 23:46:09.311235|2017-10-10 23:46:09.311235
NCT02306993|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-07-21|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Sickle Cell Hemoglobinopathies and Bone Health|Sickle Cell Hemoglobinopathies and Bone Heath|Recruiting||N/A|45|Anticipated|UConn Health|||3||f||||t||||||Samples Without DNA|"     Blood will be collected once from each subject by certified study staff at UCHC, CCMC or the     participating approved community sites in a private setting.Subjects will donate ~12-15 cc of     whole blood via venipuncture. Blood will be collected into 3 vacutainer tubes: one 3.5-mL     lavender top tube for CBC and hemoglobin electrophoresis, one 3.5-mL yellow top tube for     serum calcium and phosphate, and one 5-mL red-top tube for 25-OH vitamin D, P1NP, CTX, and     PTH analysis. The   "|||2017-10-10 23:46:09.416163|2017-10-10 23:46:09.416163
NCT02306980|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-07-21|||October 2013||2013-10-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|April 2015|Actual|2015-04-01||Interventional|||Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota|Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota|Completed||N/A|12|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 23:46:09.505818|2017-10-10 23:46:09.505818
NCT02306967|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-05-17|||September 2011||2011-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Fluorescent Visualization in Early Oral Cancer||Active, not recruiting||N/A|40|Actual|University of Calgary||2|||f||||||||||||||2017-10-10 23:46:09.571066|2017-10-10 23:46:09.571066
NCT02306954|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2016-09-26|||December 2014||2014-12-01|September 2016|2016-09-01|June 2025|Anticipated|2025-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer|Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Renal Cancer|Recruiting||Phase 2|84|Anticipated|Providence Health & Services||2|||f||||f||||||||||2017-10-10 23:46:09.64561|2017-10-10 23:46:09.64561
NCT02306941|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2017-05-15|||March 2015||2015-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Internet-delivered CBT for Functional Abdominal Pain in Adolescents - a Pilot|Internet-delivered Cognitive Behavior Therapy for Functional Abdominal Pain in Adolescents - an Open Pilot.|Completed||N/A|31|Actual|Karolinska Institutet||1|||f||||f||||||||No||2017-10-10 23:46:09.754212|2017-10-10 23:46:09.754212
NCT02306928|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-02-09|2015-05-22||September 2014||2014-09-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||PK Analysis of Piperacillin in Septic Shock Patients|Population Pharmacokinetics of Piperacillin in the Early Phase of Septic Shock - Does Standard Dosing Result in Therapeutic Plasma Concentrations?|Completed||N/A|15|Actual|University of Aarhus|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-10 23:46:09.860196|2017-10-10 23:46:09.860196
NCT02306915|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-06-02|||October 2014||2014-10-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants|A Randomized, Double-Blind Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Single Subcutaneous Administration of Lipegfilgrastim (Doses up to 100 μg/kg) in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|48|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-10-10 23:46:10.07809|2017-10-10 23:46:10.07809
NCT02306902|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-01|||October 2009||2009-10-01|December 2014|2014-12-01|April 2010|Actual|2010-04-01|November 2009|Actual|2009-11-01||Interventional|||Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover Bioequivalence Study Comparing Fenofibrate Capsule 130 mg of Ohm Laboratories Inc., USA (A Subsidiary of Ranbaxy Pharmaceuticals Inc., USA) With Antara® Capsule 130 mg (Containing Fenofibrate 130 mg) of Oscient Pharmaceutical Corporation, USA in Healthy, Adult, Male Human Subjects Under Fed Conditions|Completed||N/A|24|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-10 23:46:10.183453|2017-10-10 23:46:10.183453
NCT02306889|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-01|||January 2010||2010-01-01|December 2014|2014-12-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two -Period, Two -Sequence, Crossover Bioequivalence Study Comparing a Single Oral Dose of Fenofibrate 130 mg Capsules of Ohm Laboratories Inc. USA (a Subsidiary of Ranbaxy Pharmaceutical Inc.) With Antara® 130 mg Capsules (Containing Fenofibrate 130 mg) of Oscient Pharmaceuticals Corporation USA, in Healthy, Adult, Male, Human Subjects Under Fasting Condition.|Completed||N/A|48|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-10 23:46:10.255167|2017-10-10 23:46:10.255167
NCT02306876|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-08-14|||January 19, 2015|Actual|2015-01-19|August 2017|2017-08-01|June 14, 2016|Actual|2016-06-14|June 14, 2016|Actual|2016-06-14||Interventional|||A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males|A Randomized,Subject And Investigator Blind, Sponsor Open Placebo Controlled, Parallel Phase 1b Study To Examine The Safety, Pharmacokinetics, And Pharmacodynamic Effects Of Pf‑06412562 On Cognitive And Reward/Motivation Domains In Healthy Male Volunteers Selected By Cognitive Phenotype|Terminated||Phase 1|77|Actual|Pfizer||3||"Study recruitment was terminated on 14 June 2016 due to a Pfizer business decision. This study   was not terminated for reasons of safety."|f||||f|t|f||||||||2017-10-10 23:46:10.320197|2017-10-10 23:46:10.320197
NCT02306863|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-02-13|||January 2015||2015-01-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Whole-body Vibration as a Treatment for Parkinson's Disease|The Efficacy of Long-term Whole-body Vibration in the Treatment of Parkinson's Disease|Unknown status|Recruiting|N/A|60|Anticipated|Sun Life Financial Movement Disorders Research and Rehabilitation Centre||2|||f||||f||||||||||2017-10-10 23:46:10.41234|2017-10-10 23:46:10.41234
NCT02306850|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-05-22|||January 2015||2015-01-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|NeoPembroMel||Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma|Phase 2B Single-site, Open-label, Nonrandomized Study Evaluating the Efficacy of Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma|Recruiting||Phase 2|15|Anticipated|St. Louis University||1|||f||||f||||||||||2017-10-10 23:46:10.512838|2017-10-10 23:46:10.512838
NCT02306434|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-02|||March 2014||2014-03-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Fear of Childbirth - Comparison of Two Treatments|Fear of Childbirth - Comparison of Two Treatment Options: Internet Given Behavioral Therapy and Counseling by Midwife- a Clinical Randomized Controlled Trial|Unknown status|Recruiting|N/A|200|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-10 23:46:14.237124|2017-10-10 23:46:14.237124
NCT02306837|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-09-06|||September 2014||2014-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Consolidation Chemotherapy After Autologous Stem Cell Transplantation for Lymphoid Malignancies|A Phase II Trial of Consolidation Chemothetapy for Patients With Relapse or Refractory Lymphoid Malignancies After Autologous Stem Cell Transplantation|Recruiting||Phase 2|40|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||Undecided||2017-10-10 23:46:10.598508|2017-10-10 23:46:10.598508
NCT02306824|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2016-11-24|||December 2014||2014-12-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01|2 Years|Observational [Patient Registry]|||Berlin Atrial Fibrillation Registry|Berlin Cohort Study on Oral Anticoagulation in Patients With Atrial Fibrillation and Acute Ischemic Stroke|Active, not recruiting||N/A|1080|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 23:46:10.683552|2017-10-10 23:46:10.683552
NCT02306811|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-12-20||2016-12-20|February 2015||2015-02-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839|A Long-Term Follow-up Study Assessing the Safety and Efficacy of Vatelizumab in Multiple Sclerosis (MS) Patients Who Completed Treatment in Study DRI13839|Terminated||Phase 2|62|Actual|Sanofi||4||"Study discontinued based on planned interim analysis of the primary endpoint. Not linked to any   safety concern."|f||||t||||||||||2017-10-10 23:46:10.743693|2017-10-10 23:46:10.743693
NCT02306798|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-12-03|||September 2013||2013-09-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||TP0502-B-Pharmaco-Scintigraphic-Study|An Open Label, Single-site Pharmaco-Scintigraphic Study in Healthy Subjects With Radio-labelled TP05-tablets (Mesalazine) to Evaluate the Gastrointestinal Transit and Release Profile|Completed||Phase 1|9|Actual|Tillotts Pharma AG||1|||f||||f||||||||||2017-10-10 23:46:10.847555|2017-10-10 23:46:10.847555
NCT02306785|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-12-01|||October 2012||2012-10-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||TP0502-Pharmaco-Scintigraphic-Study and Amendment|An Open Label, Single-site Pharmaco-Scintigraphic Study in Healthy Subjects and Patients With Active Ulcerative Colitis With Radio-labelled TP05-tablets to Evaluate the Gastrointestinal Transit and Release Profiles of Two Different Formulations (and Amendment)|Completed||Phase 1|26|Actual|Tillotts Pharma AG||3|||f||||f||||||||||2017-10-10 23:46:11.043926|2017-10-10 23:46:11.043926
NCT02306772|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-12-01|||December 2011||2011-12-01|November 2014|2014-11-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||TP0501 - Pharmaco-Scintigraphic-Study|An Open Label, Single-site Pharmaco-Scintigraphic Study in Healthy Subjects With Radio-labelled TP05-tablets (Mesalazine) to Evaluate the Gastrointestinal Transit and Release Profiles of Two Different Formulations.|Completed||Phase 1|18|Actual|Tillotts Pharma AG||2|||f||||f||||||||||2017-10-10 23:46:11.126382|2017-10-10 23:46:11.126382
NCT02306759|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-07-11|2017-01-31||January 2015||2015-01-01|July 2017|2017-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|KETAFAP||Ketamine For Acute Treatment of Pain in Emergency Department|Ketamine For Acute Treatment of Pain in Emergency Department|Completed||Phase 4|60|Actual|The Brooklyn Hospital Center||2|||f||||f||||||||||2017-10-10 23:46:11.205121|2017-10-10 23:46:11.205121
NCT02306733|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-30|2017-01-20|||November 2014||2014-11-01|January 2017|2017-01-01||||October 2017|Anticipated|2017-10-01||Interventional|||Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally|Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial|Recruiting||Phase 3|200|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:46:12.105125|2017-10-10 23:46:12.105125
NCT02306720|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-08-15|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||An Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)|An Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)|Enrolling by invitation||N/A|500|Anticipated|Alexion Pharmaceuticals|||1||f||||||||||||||2017-10-10 23:46:12.216715|2017-10-10 23:46:12.216715
NCT02306707|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-07-05|||October 2014||2014-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|OERS||Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach|Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach.|Recruiting||N/A|200|Anticipated|Western Sydney Local Health District|||1||f||||t||||||||||2017-10-10 23:46:12.390607|2017-10-10 23:46:12.390607
NCT02306694|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-09-26|||December 2014||2014-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Biomarkers of Bone Metabolism in Hemophilia A|Prospective Biomarkers of Bone Metabolism in Hemophilia A|Recruiting||Phase 3|20|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-10-10 23:46:12.474176|2017-10-10 23:46:12.474176
NCT02306681|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-06-25|||October 2014||2014-10-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes|An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes|Completed||N/A|7315|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 23:46:12.574757|2017-10-10 23:46:12.574757
NCT02306668|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-02|||February 2014||2014-02-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Ocular Surface Dry Eye Microbiome|Microbiome Analysis of the Ocular Surface in Dry Eye Disease|Unknown status|Recruiting|N/A|80|Anticipated|University of Washington|||1||f||||t||||||Samples With DNA|"     Conjunctival swabs   "|||2017-10-10 23:46:12.681346|2017-10-10 23:46:12.681346
NCT02306629|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-29|2015-05-11|||November 2014||2014-11-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood|An Open-label, Parallel-group, Single-dose Escalation Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of Subcutaneous Epratuzumab in Healthy Caucasian and Japanese Subjects|Completed||Phase 1|42|Actual|UCB Pharma||4|||f||||f||||||||||2017-10-10 23:46:12.918369|2017-10-10 23:46:12.918369
NCT02306616|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-29|2017-02-06|||November 2014||2014-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||CCC Project- Acute Coronary Syndrome|Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome|Recruiting||N/A|76500|Anticipated|Beijing Institute of Heart, Lung and Blood Vessel Diseases|||1||f||||||||||||||2017-10-10 23:46:13.003934|2017-10-10 23:46:13.003934
NCT02306603|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-12-15|||October 2014||2014-10-01|December 2015|2015-12-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|OERDA||Long-term Outcomes of Endoscopic Resection (ER) of Lesions of the Duodenum and Ampulla|Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Duodenum and Ampulla|Recruiting||N/A|200|Anticipated|Western Sydney Local Health District|||1||f||||t||||||||||2017-10-10 23:46:13.073308|2017-10-10 23:46:13.073308
NCT02306590|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis||Active, not recruiting||N/A|200|Anticipated|University of Ulm||2|||f||||t||||||||||2017-10-10 23:46:13.158102|2017-10-10 23:46:13.158102
NCT02306577|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-06-01|||November 2014||2014-11-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Observational|SINNR||STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)|STRIBILD in Non-Nucleoside Resistant Patients, An Evaluation of Safety and Efficacy in Vulnerable Population (SINNR STUDY)|Unknown status|Recruiting|N/A|30|Anticipated|Vancouver Infectious Diseases Centre|||1||f||||f||||||||||2017-10-10 23:46:13.256944|2017-10-10 23:46:13.256944
NCT02306564|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-12-03|||December 2014||2014-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection|Effect of Cabergoline on Subendometrial Vascularity During ICSI Cycles and Pregnancy Outcome|Recruiting||Phase 2/Phase 3|150|Anticipated|Kasr El Aini Hospital||3|||f||||f||||||||||2017-10-10 23:46:13.345799|2017-10-10 23:46:13.345799
NCT02306551|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-11-05|||September 2014||2014-09-01|November 2015|2015-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|WARM||Well Being And Resilience: Mechanisms of Transmission of Health and Risk|Well Being And Resilience: Mechanisms of Transmission of Health and Risk in Parents With Complex Mental Health Problems and Their Offspring|Recruiting||N/A|200|Anticipated|University of Copenhagen|||4||f||||f||||||||||2017-10-10 23:46:13.434138|2017-10-10 23:46:13.434138
NCT02306538|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-09-29|||October 2013||2013-10-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Observational|EMBRACE-MRI||Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI|Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI - The EMBRACE MRI Study|Recruiting||N/A|150|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     blood   "|||2017-10-10 23:46:13.533753|2017-10-10 23:46:13.533753
NCT02306525|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-06-14|||December 2014||2014-12-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||Arthroscopic Treatment of Patients in Horsens and Aarhus With FemoroAcetabular Impingement: the HAFAI-cohort|Outcome After Arthroscopic Treatment of Patients in Horsens and Aarhus With FemoroAcetabular Impingement: the HAFAI-cohort|Active, not recruiting||N/A|90|Actual|University of Aarhus|||2||f||||t||||||||||2017-10-10 23:46:13.600183|2017-10-10 23:46:13.600183
NCT02306512|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-12-02|||June 2015||2015-06-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Mohs and Immunofluorescence for Malignant Melanoma In Situ|Mohs Micrographic Surgery for Primary Cutaneous Malignant Melanoma In Situ Using Immunofluorescence|Withdrawn||N/A|0|Actual|University of Miami||2||PI is leaving the University of Miami|f||||f||||||||||2017-10-10 23:46:13.712861|2017-10-10 23:46:13.712861
NCT02306499|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2014-11-30|||June 2014||2014-06-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Outcome of ICSI Using Cryopreserved Testicular Sperm From Infertile Men With Varicocele-associated Azoospermia|Outcome of ICSI Using Cryopreserved Testicular Sperm From Infertile Men With Varicocele-associated Azoospermia|Unknown status|Recruiting|N/A|16|Anticipated|Sohag University||2|||f||||||||||||||2017-10-10 23:46:13.807242|2017-10-10 23:46:13.807242
NCT02306486|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-02|||January 2012||2012-01-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|OxalicAc||The Effect of Oxalic Acid on Cervical Restorations|The Effect of Oxalic Acid on Cervical Restorations on Hypersensitive Teeth, a Double-blind Randomized Controlled Clinical Trial. One Year Follow up|Completed||N/A|31|Actual|University of Chile||4|||f||||t||||||||||2017-10-10 23:46:13.889322|2017-10-10 23:46:13.889322
NCT02306473|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-03-24|||October 2015||2015-10-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||The Leaky Lung Test|A Novel Non-invasive Way to Measure Airway Epithelial Permeability in Human Subjects|Recruiting||Early Phase 1|100|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 23:46:13.957894|2017-10-10 23:46:13.957894
NCT02306460|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-10-12|||July 2014||2014-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01|1 Year|Observational [Patient Registry]|||Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation|Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation|Recruiting||N/A|80|Anticipated|Tampere University Hospital|||4||f||||f||||||||||2017-10-10 23:46:14.047555|2017-10-10 23:46:14.047555
NCT02306447|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-05-12|||August 2014||2014-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|rpms-tinn||Combined Transcranial and Peripheral Muscle Magnetic Stimulation in Chronic Tinnitus|Combined Transcranial and Peripheral Muscle Magnetic Stimulation in Chronic Tinnitus|Completed||N/A|54|Actual|University of Regensburg||1|||f||||f||||||||||2017-10-10 23:46:14.14947|2017-10-10 23:46:14.14947
NCT02306421|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2014-12-18|||August 2014||2014-08-01|November 2014|2014-11-01|May 2015|Anticipated|2015-05-01|March 2015|Anticipated|2015-03-01||Interventional|RPHSMMH||A Multi Center Clinical Trial of Rph With the Simplified Milligan-Morgan Surgery on Treatment of Mixed Hemorrhoids|A Multi Center Clinical Trial of the Efficacy and Safety of Rph With the Simplified Milligan-Morgan Surgery on Treatment of Mixed Hemorrhoids|Unknown status|Enrolling by invitation|N/A|3000|Actual|The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine||5|||f||||t||||||||||2017-10-10 23:46:14.333388|2017-10-10 23:46:14.333388
NCT02306395|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2016-01-04|||December 2014||2014-12-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Endometrial Local Injury to Improve the Outcome of Embryo Transfer|Endometrial Local Injury of Frozen Cycle to Improve the Outcome of Embryo Transfer of Repeated Implantation Failure.|Recruiting||N/A|100|Anticipated|Navy General Hospital, Beijing||2|||f||||t||||||||||2017-10-10 23:46:14.468272|2017-10-10 23:46:14.468272
NCT02306382|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-06-07|||December 2012||2012-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Multicenter Study for Diagnosis and Treatment of Perianal Abscesses|Randomized Controlled Multicenter Study for Diagnosis and Treatment of Perianal Abscesses.|Recruiting||N/A|200|Anticipated|University Hospital, Umeå||2|||f||||t||||||||||2017-10-10 23:46:14.77721|2017-10-10 23:46:14.77721
NCT02306369|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-08-30|||November 2013||2013-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Interventional|||Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents|Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents - a Randomized Controlled Study|Active, not recruiting||N/A|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-10 23:46:14.926513|2017-10-10 23:46:14.926513
NCT02306356|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2016-01-18|||September 2014||2014-09-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting|Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting|Completed||N/A|20|Anticipated|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 23:46:15.066161|2017-10-10 23:46:15.066161
NCT02306343|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-11-30|||November 2011||2011-11-01|November 2014|2014-11-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the Experimental Device|Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the Experimental Device|Unknown status|Recruiting|N/A|100|Anticipated|Insuline Medical Ltd.||2|||f||||f||||||||||2017-10-10 23:46:15.200005|2017-10-10 23:46:15.200005
NCT02306330|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-11-13|||December 2014||2014-12-01|December 2014|2014-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|MALDITOF||MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial|Assessing Time to Reporting and Clinical Management of Patients With Severe Bacterial and Fungal Infections Between Two Diagnostic Approaches: Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial|Completed||N/A|802|Actual|Oxford University Clinical Research Unit, Vietnam||2|||f||||f||||||||||2017-10-10 23:46:15.330543|2017-10-10 23:46:15.330543
NCT02306317|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-10-21|||March 2014||2014-03-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Adding Value of Parents to Nursing Care in the Control of FiO2|Changing the Paradigm for Improving Neonatal Care: Clinical Study on Optimal Oxygen-saturation Time and the Adding Value of Parents to Nursing Care in the Control of Fi02|Recruiting||N/A|46|Anticipated|Hospital Universitario 12 de Octubre||2|||f||||f||||||||No||2017-10-10 23:46:15.494599|2017-10-10 23:46:15.494599
NCT02306304|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-02-07|||January 2015||2015-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Ultra-sound for AAA Screening in Smoking Israeli Arab Men|Ultra-sound for AAA Screening in Smoking Israeli Arab Men|Completed||N/A|913|Actual|Clalit Health Services||1|||f||||f||||||||||2017-10-10 23:46:15.623241|2017-10-10 23:46:15.623241
NCT02306291|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-11-08|||March 2015||2015-03-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML|A Phase I/II, Open-label Multicenter Trial to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in Patients With Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|102|Anticipated|GlycoMimetics Incorporated||3|||f||||t||||||||||2017-10-10 23:46:15.74236|2017-10-10 23:46:15.74236
NCT02306265|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-09-21|||May 2015||2015-05-01|September 2017|2017-09-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|ADAPT||Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography|Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT Trial) ADAPT-SCR: Recruitment Plan for Asymptomatic Women Undergoing Screening Mammography|Completed||N/A|250|Actual|GE Healthcare||2|||f||||f||||||||||2017-10-10 23:46:16.03298|2017-10-10 23:46:16.03298
NCT02306252|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-09-11|||June 2014|Actual|2014-06-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|CARE Program||The CARE Program: CAncer REhabilitation Pilot Study for Older Adults|LCCC 1409: The CARE Program: CAncer REhabilitation Pilot Study for Older Adults|Completed||N/A|67|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:46:16.158032|2017-10-10 23:46:16.158032
NCT02306239|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2014-12-25|||December 2014||2014-12-01|December 2014|2014-12-01||||August 2015|Anticipated|2015-08-01||Interventional|||The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients|the Surgical Intensive Care Unit|Unknown status|Recruiting|N/A|40|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-10 23:46:16.282479|2017-10-10 23:46:16.282479
NCT02306226|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-05-29|||September 2014||2014-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|May 2016|Actual|2016-05-01|12 Months|Observational [Patient Registry]|SAVI TF||Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry|Symetis ACURATE Neo™ Valve Implantation Using TransFemoral Access: SAVI TF Registry|Completed||N/A|1000|Actual|Symetis SA|||1||f||||f||||||||||2017-10-10 23:46:16.380059|2017-10-10 23:46:16.380059
NCT02306213|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-28|||January 2011||2011-01-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Hydroxyethylstarch 6% 130/0.4 Administration on Renal Function After Cardiac Surgery|Effect of Hydroxyethylstarch 6% 130/0.4 Administration on Renal Function After Cardiac Surgery|Completed||N/A|1564|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 23:46:16.452972|2017-10-10 23:46:16.452972
NCT02306200|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-03-24|||August 2013||2013-08-01|March 2017|2017-03-01|August 2054|Anticipated|2054-08-01|August 2053|Anticipated|2053-08-01|40 Years|Observational [Patient Registry]|CHIP||Cardiovascular Health Improvement Project|Cardiovascular Health Improvement Project|Recruiting||N/A|9999|Anticipated|University of Michigan|||2||f||||t||||||Samples With DNA|"     Blood, Tissue   "|Undecided||2017-10-10 23:46:16.527704|2017-10-10 23:46:16.527704
NCT02306187|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-10-12|||December 2014||2014-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis|The Effectiveness of Eldecalcitol in the Osteoporotic Patients Who Are Bisphosphonate Non-responders After Long-term Bisphosphonate Treatment|Recruiting||Phase 1|100|Anticipated|Shinshu University||2|||f||||f||||||||||2017-10-10 23:46:16.626532|2017-10-10 23:46:16.626532
NCT02306174|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-03-31|||September 2014||2014-09-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Cognitive Rehabilitation and Exposure-based Class for Compulsive Hoarding|Cognitive Rehabilitation and Exposure-based Class for Compulsive Hoarding|Active, not recruiting||N/A|200|Anticipated|University of Miami||1|||f||||f||||||||||2017-10-10 23:46:16.737207|2017-10-10 23:46:16.737207
NCT02306148|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-05-15|||April 2015||2015-04-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effects of Foot Strengthening on the Incidence of Injuries in Long Distance Runners|Effects of a Foot Strengthening Program on the Incidence of Injuries, Foot Functionality and Health in Long Distance Runners: a Randomized Controlled Trial.|Recruiting||N/A|111|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||Yes|All files will be available in the database published at http://figshare.com after completion of the study.|2017-10-10 23:46:20.001997|2017-10-10 23:46:20.001997
NCT02306135|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-04-25|||March 2015||2015-03-01|January 2016|2016-01-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01|2 Years|Observational [Patient Registry]|||Identifying Mechanisms of Resistance to mTOR Inhibitors in Cancer|Identifying Mechanisms of Resistance to mTOR Inhibitors in Cancer|Terminated||N/A|2|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||Samples With DNA|"     Tumor biopsy and surgical specimens obtained through routine clinical procedures and archived     in the institution's Pathology tissue bank will be used for DNA extraction for genetic     analysis.      Blood samples collected prospectively will be used to extract plasma and leukocytes, which     will be used to extract DNA for genetic analysis.   "|||2017-10-10 23:46:20.108913|2017-10-10 23:46:20.108913
NCT02306122|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-30|||March 2011||2011-03-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PHARxMOS||Pharmacy Home Adherence Reporting and Monitoring Outcomes Study|Nudging Doctors to Collaborate With Pharmacists to Improve Medication Adherence|Completed||N/A|2697|Actual|Brown University||13|||f||||f||||||||||2017-10-10 23:46:20.304395|2017-10-10 23:46:20.304395
NCT02306109|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-02-19|||July 2013||2013-07-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|ermoSla||Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS)|Effects of Motor Rehabilitation Treatment on Disability and Quality of Life in Amyotrophic Lateral Sclerosis (ALS).|Active, not recruiting||N/A|67|Actual|Azienda Unita' Sanitaria Locale Di Modena||2|||f||||t||||||||||2017-10-10 23:46:20.442118|2017-10-10 23:46:20.442118
NCT02306096|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2016-03-22|||August 2010||2010-08-01|March 2016|2016-03-01|August 2031|Anticipated|2031-08-01|August 2031|Anticipated|2031-08-01||Observational|SCAN-B||Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer|SCAN-B: The Sweden Cancerome Analysis Network - Breast Initiative|Recruiting||N/A|15000|Anticipated|Lund University|||1||f||||f||||||Samples With DNA|"     Tumor tissue, whole blood, serum, plasma. Collected at diagnosis and during follow-up.   "|Undecided|Upon publication, the relevant anonymized individual participant data will be shared.|2017-10-10 23:46:20.549327|2017-10-10 23:46:20.549327
NCT02306083|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-05-07|||July 2014||2014-07-01|March 2014|2014-03-01||||June 2015|Anticipated|2015-06-01||Interventional|||Effect of Glucosamine on Intraocular Pressure||Unknown status|Recruiting|Phase 3|41|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:46:20.691823|2017-10-10 23:46:20.691823
NCT02306070|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2017-09-20|||January 2016||2016-01-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Improving Outcomes With Metformin|Improving Treatment and Liver Fibrosis Outcomes With Metformin in HCV-HIV Co-infected and HCV Mono-infected Patients With Insulin Resistance.|Suspended||Phase 2|60|Anticipated|Ottawa Hospital Research Institute||2||insufficient funding|f||||t||||||||||2017-10-10 23:46:20.779231|2017-10-10 23:46:20.779231
NCT02306057|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-04-08|||November 2014||2014-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Observational|||Fluid Balance in Children Undergoing Fontan Surgery|Interstitial Colloid Osmotic Pressure in Children With Congenital Heart Defect Preparing for Fontan Surgery Undergoing Preoperative Catheterization and Surgery in General Anesthesia|Completed||N/A|39|Actual|Oslo University Hospital|||4||f||||f||||||Samples Without DNA|"     Interstitial fluid Serum   "|||2017-10-10 23:46:20.8737|2017-10-10 23:46:20.8737
NCT02306044|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-12-02|||April 2013||2013-04-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Bleeding Prediction in Thrombocytopenia|Bleeding Prediction in Thrombocytopenia Using Platelet Indices, Platelet Aggregometry and a Standardized Bleeding Questionnaire|Completed||N/A|280|Actual|Odense University Hospital|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-10 23:46:20.96184|2017-10-10 23:46:20.96184
NCT02306031|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2014-11-29|||June 2013||2013-06-01|November 2014|2014-11-01||||June 2014|Actual|2014-06-01||Interventional|diclofenac||Topical Diclofenac on Macular Thickness After Phacoemulsification|The Effect of Topical Sodium Diclofenac on Macular Thickness in Diabetic Eyes After Phacoemulsification: A Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 2|108|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:46:21.026161|2017-10-10 23:46:21.026161
NCT02306018|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-05-07|||October 2014||2014-10-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Evaluation of EV1000™/volumeView™ for Cardiac Output Monitoring in Liver Transplantation|Evaluation of a New Calibrated Pulse Wave Analysis Method(EV1000™/volumeView™) for Cardiac Output Monitoring in Adult Liver Transplantation|Completed||N/A|28|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-10 23:46:21.102205|2017-10-10 23:46:21.102205
NCT02306005|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2014-11-29|||November 2014||2014-11-01|November 2014|2014-11-01||||December 2018|Anticipated|2018-12-01||Observational|InLipoDiab1||Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes.|Insulin Therapy and Quantitive and Qualitive Changes of Plasma Lipoproteins in Patients With Newly Diagnosed Type 1 Diabetes.|Recruiting||N/A|100|Anticipated|Poznan University of Medical Sciences|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-10 23:46:21.201557|2017-10-10 23:46:21.201557
NCT02305992|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-09-14|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Regional Anesthesia for Arteriovenous Fistula|Effect of Sympathetic Blockade on the Success and Survival of Arteriovenous Fistula|Suspended||N/A|105|Anticipated|McMaster University||3||Looking for funding opportunities|f||||f||||||||||2017-10-10 23:46:21.291303|2017-10-10 23:46:21.291303
NCT02305979|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-09-15|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|||Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies|Evaluation of Loratadine for Granulocyte-Colony Stimulating Factor Induced Bone Pain in Patients With Hematologic Malignancies|Completed||N/A|61|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-10 23:46:21.385488|2017-10-10 23:46:21.385488
NCT02305966|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-03-22|||August 1, 2017|Anticipated|2017-08-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Implant Fixation in Reverse Total Shoulder Arthroplasty|Evaluation of Implant Fixation in Reverse Total Shoulder Arthroplasty|Not yet recruiting||Phase 3|40|Anticipated|Lawson Health Research Institute||4|||f||||f|f|||||||||2017-10-10 23:46:21.477957|2017-10-10 23:46:21.477957
NCT02305953|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-28|||October 2014||2014-10-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Cytokines and Vascular Inflammation in Psoriasis|Correlation Between Serum Levels of Cytokines and a Chemokine and Vascular Inflammation in Patients With Moderate to Severe Psoriasis|Completed||N/A|96|Actual|Innovaderm Research Inc.|||1||f||||f||||||||||2017-10-10 23:46:21.554598|2017-10-10 23:46:21.554598
NCT02305940|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-07-24|||July 2014||2014-07-01|April 2017|2017-04-01|July 12, 2017|Actual|2017-07-12|July 12, 2017|Actual|2017-07-12||Interventional|||Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients|A Phase III Double-blind, Randomised, Placebo Controlled Trial of Long Term Therapy on Exacerbation Rate in Patients With Stable COPD Using Doxycycline|Completed||Phase 3|222|Actual|Imperial College London||2|||f||||t||||||||||2017-10-10 23:46:21.637113|2017-10-10 23:46:21.637113
NCT02305927|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-08-22|||June 2015||2015-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ToV5||Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health|Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health|Recruiting||Phase 3|2300|Anticipated|Harvard School of Public Health||2|||f||||t||||||||||2017-10-10 23:46:21.731471|2017-10-10 23:46:21.731471
NCT02305914|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-05-21|||November 2014||2014-11-01|November 2014|2014-11-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Observational|FSCAP||Follow-up Study of Complications of Acute Pancreatitis|A Large Sample Follow-up Study of Long-term Complications of Acute Pancreatitis|Unknown status|Recruiting|N/A|1300|Anticipated|The First Affiliated Hospital of Nanchang University|||1||f||||f||||||Samples With DNA|"     Blood sample faeces sample   "|||2017-10-10 23:46:21.994148|2017-10-10 23:46:21.994148
NCT02305901|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2015-05-10|||December 2014||2014-12-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers|The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion Following Oral Administration in Healthy Male Subjects (an Open-label, One-sequence Trial)|Completed||Phase 1|18|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:46:22.108788|2017-10-10 23:46:22.108788
NCT02305888|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-05-01||2016-08-01|March 2015||2015-03-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively|Safety of LEO 43204 0.018%, 0.037% and 0.1% for Actinic Keratosis Applied Once Daily for Three Consecutive Days on Face/Chest, Scalp and Trunk/Extremities, Respectively|Completed||Phase 2|188|Actual|LEO Pharma||3|||f||||f||||||||||2017-10-10 23:46:22.189976|2017-10-10 23:46:22.189976
NCT02305875|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-05-15|||October 2014||2014-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||The Musculocutaneous Nerve in a High Resolution MRI|The Musculocutaneous Nerve (Mcn) in a High Resolution MRI|Completed||N/A|54|Actual|Diakonhjemmet Hospital||1|||f||||f||||||||||2017-10-10 23:46:22.275238|2017-10-10 23:46:22.275238
NCT02305862|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-07-19|||January 2013||2013-01-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques|An Open-label, Single-centre Randomized Study Evaluating the Effect of Treatment With Rosuvastatin 5/20mg on Atherosclerotic Disease as Measured by High-Resolution Contrast Enhanced Magnetic Resonance Imaging in Patients With Coronary Artery Disease and Hyperlipideimia|Recruiting||N/A|150|Anticipated|Capital Medical University||2|||f||||t||||||||||2017-10-10 23:46:22.351269|2017-10-10 23:46:22.351269
NCT02305667|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-01-20|||May 2015||2015-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Videolaryngoscopes for Double Lumen Tube Intubations|A Comparison of Three Videolaryngoscopes for Double-Lumen Tubes Intubation in Humans. A Randomized Controlled Study|Completed||N/A|133|Actual|Dammam University||4|||f||||t||||||||||2017-10-10 23:46:24.398439|2017-10-10 23:46:24.398439
NCT02305836|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-05-13|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease|The Effect of Electroacupuncture Combined With Donepezil on Cognitive Function in Alzheimer's Disease Patients: Study Protocol for a Randomized Controlled Trial|Recruiting||Phase 2|334|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t|f|f||||||||2017-10-10 23:46:22.964024|2017-10-10 23:46:22.964024
NCT02305823|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-03-13|||October 2005|Actual|2005-10-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|February 2011|Actual|2011-02-01||Interventional|PAFIP2||Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis|Phase IV Study of the Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in the Treatment of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program II (PAFIP II)|Completed||Phase 4|203|Actual|Fundación Marques de Valdecilla||3|||f||||f|f|f||||||No||2017-10-10 23:46:23.084605|2017-10-10 23:46:23.084605
NCT02305810|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-08-09|||September 2013||2013-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus|An Angiogenic Study in Patients With Well/Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors Treated With Everolimus|Recruiting||Phase 2|47|Anticipated|European Institute of Oncology||1|||f||||f||||||||||2017-10-10 23:46:23.233551|2017-10-10 23:46:23.233551
NCT02305797|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-07-14|||January 2015||2015-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)||Completed||Phase 3|495|Actual|Edgemont Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-10 23:46:23.335303|2017-10-10 23:46:23.335303
NCT02305784|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-07-18|||May 2015||2015-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|Kin_YKL_CF||Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis Patients|Chitinase and Cystic Fibrosis Disease Evolution|Recruiting||N/A|200|Anticipated|Institut de Recherches Cliniques de Montreal|||1||f||||f||||||Samples Without DNA|"     We will take a blood and sputum samples at each regular clinic visit (3-4/year-no evidence of     exacerbation in the past two weeks) as well as at the beginning and the end of an     exacerbation treated with IV antibiotics.   "|||2017-10-10 23:46:23.410144|2017-10-10 23:46:23.410144
NCT02305771|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-02-14|||February 27, 2015|Actual|2015-02-27|February 2017|2017-02-01|November 20, 2015|Actual|2015-11-20|November 20, 2015|Actual|2015-11-20||Interventional|BRAINGRAPH||Contributions From the Analysis of Graphs for Identification of Neural Cliques|Contributions From the Analysis of Graphs for Identification of Neural Cliques|Completed||N/A|21|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-10 23:46:23.484889|2017-10-10 23:46:23.484889
NCT02305758|ClinicalTrials.gov processed this data on October 10, 2017|2014-12-01|2017-09-22|||December 2, 2014||2014-12-02|September 2017|2017-09-01|September 21, 2017|Actual|2017-09-21|May 19, 2017|Actual|2017-05-19||Interventional|||Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer|Randomized, Blinded, Multicenter, Phase 2 Study Comparing Veliparib Plus FOLFIRI ± Bevacizumab Versus Placebo Plus FOLFIRI ± Bevacizumab in Previously Untreated Metastatic Colorectal Cancer|Completed||Phase 2|131|Actual|AbbVie||2|||f||||f||||||||||2017-10-10 23:46:23.562608|2017-10-10 23:46:23.562608
NCT02305745|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-09-20|||August 2015||2015-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Observational|DREAM||Determining the Risk Elevation After Maternity|Determining the Risk Elevation After Maternity|Recruiting||N/A|55|Anticipated|Ottawa Hospital Research Institute|||2||f||||f||||||||||2017-10-10 23:46:23.714131|2017-10-10 23:46:23.714131
NCT02305719|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2014-12-02|||July 2014||2014-07-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01|3 Days|Observational [Patient Registry]|RATS||Regional Anesthesia for Thoracoscopic Surgery|Regional Anesthesia for Thoracoscopic Surgery|Unknown status|Recruiting|N/A|150|Anticipated|Ludwig-Maximilians - University of Munich|||3||f||||f||||||||||2017-10-10 23:46:23.985468|2017-10-10 23:46:23.985468
NCT02305706|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2014-12-02|||April 2014||2014-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|ROLCOL||Right or Left for Colonoscopy?|Does Right Rather Than Left Starting Position Lead to Quicker Completion of COLonoscopy?|Completed||N/A|163|Actual|Imperial College Healthcare NHS Trust||2|||f||||f||||||||||2017-10-10 23:46:24.07695|2017-10-10 23:46:24.07695
NCT02305693|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-07-28|||November 2014||2014-11-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||Comparison Between Letrozole and Laparoscopic Ovarian Drilling in Women With Clomiphene Resistant Polycystic Ovarian Syndrome (PCOS)|Comparison Between Letrozole and Laparoscopic Ovarian Drilling in Women With Clomiphene Resistant Polycystic Ovarian Syndrome (PCOS)|Recruiting||Phase 3|140|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:46:24.155232|2017-10-10 23:46:24.155232
NCT02305680|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-05-09|||December 17, 2014|Actual|2014-12-17|May 2017|2017-05-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Observational|EPICOR||Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension|EPICOR Asia-China Extension. Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension|Completed||N/A|2334|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-10 23:46:24.266482|2017-10-10 23:46:24.266482
NCT02305654|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-11-27|||April 2015||2015-04-01|November 2014|2014-11-01||||July 2018|Anticipated|2018-07-01||Interventional|InPACT||International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)|International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)|Not yet recruiting||Phase 3|400|Anticipated|Institute of Cancer Research, United Kingdom||5|||f||||f||||||||||2017-10-10 23:46:24.512835|2017-10-10 23:46:24.512835
NCT02305615|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-09-11|||November 24, 2014|Actual|2014-11-24|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||An Observational Study of Continued Avastin Plus Chemotherapy Until First Progression in Patients With Metastatic Colorectal Cancer||Active, not recruiting||N/A|300|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:46:24.890003|2017-10-10 23:46:24.890003
NCT02305602|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-04-26|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of VentriGel in Post-MI Patients|A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction|Enrolling by invitation||Phase 1|18|Anticipated|Ventrix, Inc.||1|||f||||t||||||||||2017-10-10 23:46:24.998025|2017-10-10 23:46:24.998025
NCT02305589|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-12-14|||September 2014||2014-09-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Observational|||The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium|The Comparison of Sugammadex and Conventional Cholinesterase Inhibitor on the Aspect of Postoperative Delirium in the Elderly Patients Undergoing Hip Surgery|Recruiting||N/A|250|Anticipated|Konkuk University Medical Center|||1||f||||f||||||||||2017-10-10 23:46:25.080819|2017-10-10 23:46:25.080819
NCT02305576|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-02-07|||January 2014||2014-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ANIFACT||Effect of Perioperative Factors on the Analgesia Nociception Index|Effect of Perioperative Factors on the Analgesia Nociception Index|Recruiting||N/A|600|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-10 23:46:25.170927|2017-10-10 23:46:25.170927
NCT02305563|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-10-03|||January 27, 2015|Actual|2015-01-27|October 2017|2017-10-01|September 15, 2021|Anticipated|2021-09-15|February 14, 2019|Anticipated|2019-02-14||Interventional|||An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase 1/2, Open-label Randomized Study of Ulocuplumab (BMS-936564) in Combination With Low Dose Cytarabine in Subjects With Newly Diagnosed Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|126|Anticipated|Bristol-Myers Squibb||4|||f||||t|t|f||||||||2017-10-10 23:46:25.250868|2017-10-10 23:46:25.250868
NCT02305550|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-02-08|||April 2015||2015-04-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for Inhalation|A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for Inhalation|Completed||N/A|12|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:46:25.53946|2017-10-10 23:46:25.53946
NCT02305537|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-03-18|||October 2014||2014-10-01|March 2016|2016-03-01|October 2030|Anticipated|2030-10-01|October 2024|Anticipated|2024-10-01||Interventional|||Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment|Building an Outcomes Assessment Infrastructure to Assess Youth in the McLean Anxiety Mastery Program at McLean Hospital|Recruiting||N/A|45|Anticipated|Mclean Hospital||2|||f||||f||||||||||2017-10-10 23:46:25.629073|2017-10-10 23:46:25.629073
NCT02305524|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-01|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|SLETI||Intubation During Adult Intubation|Evaluation of Chest Compression Effect on Airway Management With he Visualized Tracheoscopic Ventilation Tube and the Macintosh Laryngoscopy by Novice Paramedics: a Randomized Crossover Simulation Study.|Unknown status|Recruiting|N/A|150|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:46:25.723241|2017-10-10 23:46:25.723241
NCT02305511|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-01|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|IOCPR||Intraosseous Access During Pediatric Resuscitation|A Comparison of Four Intraosseous Access Devices With Standard Venous Catheterization During Child Cardiopulmonary Resuscitation Simulation: a Randomized Crossover Trial.|Unknown status|Recruiting|N/A|130|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:46:25.818924|2017-10-10 23:46:25.818924
NCT02305498|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-05-02|||November 2014|Actual|2014-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Yoga Practice for Breast or Ovarian Cancer Patients|Yoga Practice for Breast or Ovarian Cancer Patients: A Pilot Study|Active, not recruiting||N/A|39|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:46:25.906564|2017-10-10 23:46:25.906564
NCT02305485|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-12-07|||November 2014||2014-11-01|December 2016|2016-12-01|June 2020|Anticipated|2020-06-01|December 2016|Actual|2016-12-01||Interventional|||NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial|Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With Denovo Coronary Artery Lesion (NeoVas): Randomized Controlled Trial|Active, not recruiting||N/A|560|Anticipated|Lepu Medical Technology (Beijing) Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:46:25.984051|2017-10-10 23:46:25.984051
NCT02305472|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-03-07|||November 2014||2014-11-01|December 2015|2015-12-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|||NeoVas Bioresorbable Coronary Scaffold Registry Study|Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With de Novo Coronary Artery Lesion (NeoVas): a Single Arm Registry Study|Active, not recruiting||N/A|825|Anticipated|Lepu Medical Technology (Beijing) Co., Ltd.||1|||f||||t||||||||||2017-10-10 23:46:26.14736|2017-10-10 23:46:26.14736
NCT02305459|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-08-17|||November 2014||2014-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01|12 Months|Observational [Patient Registry]|CIRT||CIRSE Registry for SIR-Spheres Therapy|CIRSE Registry for SIR-Spheres Therapy|Recruiting||N/A|1200|Anticipated|Cardiovascular and Interventional Radiological Society of Europe|||1||f||||t||||||||||2017-10-10 23:46:26.276785|2017-10-10 23:46:26.276785
NCT02305446|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-12-03|2015-10-01||December 2014||2014-12-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.|Phase 3b, Open Label, Uncontrolled, Single-arm, Single-centre Study to Evaluate the Safety of Two Doses of Novartis Meningococcal Group B Vaccine When Administered to Healthy Adults From 18 to 50 Years of Age and to Collect Blood Donations to Develop Vaccines Against Neisseria Meningitidis|Completed||Phase 3|55|Actual|Novartis||1|||f||||f||||||||||2017-10-10 23:46:26.526103|2017-10-10 23:46:26.526103
NCT02305433|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-08-02|||December 2014||2014-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effects of Long-term Intensive Home-based Physiotherapy on Older People With an Operated Hip Fracture or Frailty (RCT).|Effects of Long-term Intensive Home-based Physiotherapy on Older People With an Operated Hip Fracture or Frailty (RCT).|Recruiting||N/A|600|Anticipated|South Karelia, Social and Health Care District||4|||f||||f||||||||||2017-10-10 23:46:26.76025|2017-10-10 23:46:26.76025
NCT02305420|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-08-26|||November 2014||2014-11-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|BlastGen||EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage|EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage|Recruiting||Phase 4|100|Anticipated|FertilitySA||2|||f||||t||||||||Undecided||2017-10-10 23:46:26.920768|2017-10-10 23:46:26.920768
NCT02305407|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-08-21|||March 2016||2016-03-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|NRAAMUS||Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery|Neurocognitive and Radiological Assessments in Adult Patients With Moyamoya Disease Undergoing Surgical Revascularization|Recruiting||N/A|80|Anticipated|Huashan Hospital||2|||f||||f||||||||||2017-10-10 23:46:27.05327|2017-10-10 23:46:27.05327
NCT02305394|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-12-01|||January 2015||2015-01-01|November 2014|2014-11-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy|Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy ---a Randomized Control Double-Blind Clinical Trial|Unknown status|Not yet recruiting|Phase 4|132|Anticipated|First Affiliated Hospital of Chongqing Medical University||2|||f||||f||||||||||2017-10-10 23:46:27.22022|2017-10-10 23:46:27.22022
NCT02305381|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-01-12||2016-11-15|December 2014||2014-12-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SUSTAIN™ 5||Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes|Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes|Completed||Phase 3|397|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-10 23:46:27.404724|2017-10-10 23:46:27.404724
NCT02305368|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-26|||March 2011||2011-03-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01|1 Year|Observational [Patient Registry]|Oncogramme||Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4|Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4: a Pilot Study|Completed||N/A|20|Actual|University Hospital, Limoges|||1||f||||f||||||Samples With DNA|"     tumor fragment   "|||2017-10-10 23:46:27.709376|2017-10-10 23:46:27.709376
NCT02305355|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2014-12-01|||February 2009||2009-02-01|November 2014|2014-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia|Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia|Completed||Phase 4|68|Actual|Kuhnil Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:46:27.780643|2017-10-10 23:46:27.780643
NCT02305342|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-03-05|||November 2014||2014-11-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians|"Antibiotic Susceptibility of Bacterial Uro-Pathogens In Patients Attending Family Physicians (In Vitro Study)"|Completed||N/A|350|Actual|Abbott|||1||f||||f||||||||||2017-10-10 23:46:27.872467|2017-10-10 23:46:27.872467
NCT02305329|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-07-22|2015-07-22||February 2014||2014-02-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation|Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation in Healthy Subjects|Completed||Phase 1|56|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-10 23:46:27.958642|2017-10-10 23:46:27.958642
NCT02305316|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-07-22|2015-07-22||February 2014||2014-02-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone|Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone in Healthy Volunteers|Completed||Phase 1|28|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 23:46:28.55776|2017-10-10 23:46:28.55776
NCT02305303|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-08-23|||November 2014||2014-11-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|Qualitrau||Diary for Severe Trauma|Impact of an Intensive Care Unit Diary on Long-term Quality of Life After Severe Trauma|Recruiting||N/A|226|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:46:28.898711|2017-10-10 23:46:28.898711
NCT02305290|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-12-15|||August 2014||2014-08-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|UGI-EMR||Upper GI Outcomes Following EMR|Outcomes of Endoscopic Resection in the Upper Gastrointestinal Tract|Recruiting||N/A|200|Anticipated|Western Sydney Local Health District|||1||f||||f||||||||||2017-10-10 23:46:29.549809|2017-10-10 23:46:29.549809
NCT02305082|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-09-03|||December 2014||2014-12-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Fast-track Giant Ventral Hernia Repair|Fast-track Giant Ventral Hernia Repair|Completed||N/A|32|Actual|Bispebjerg Hospital|||2||f||||t||||||||||2017-10-10 23:46:31.954327|2017-10-10 23:46:31.954327
NCT02305277|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-10-14|2015-07-22||March 2014||2014-03-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers|Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers|Completed||Phase 1|85|Actual|Bial - Portela C S.A.||6|||f||||f||||||||||2017-10-10 23:46:29.684192|2017-10-10 23:46:29.684192
NCT02305264|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-02-20|||February 2012||2012-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|INFLASEP||Imaging of Intracerebral Inflammation in MS|Imaging of Intracerebral Inflammation in the Progressive Phase of Multiple Sclerosis|Recruiting||N/A|65|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:46:30.314359|2017-10-10 23:46:30.314359
NCT02305251|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-05-10|||June 2012||2012-06-01|May 2017|2017-05-01|November 2, 2015|Actual|2015-11-02|March 2014|Actual|2014-03-01||Observational|||Patient Preferences of a Resect and Discard Paradigm|Patient Preferences of a Resect and Discard Paradigm|Completed||N/A|500|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-10 23:46:30.428154|2017-10-10 23:46:30.428154
NCT02305238|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2017-07-16|||December 19, 2014|Actual|2014-12-19|July 2017|2017-07-01|December 28, 2017|Anticipated|2017-12-28|December 22, 2016|Actual|2016-12-22||Interventional|ALTAIR||Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration|A Randomized, Open-label Phase 4 Study Evaluating the Efficacy and Safety of Repeated Doses of Intravitreal Aflibercept With Variable Treatment Intervals in Japanese Subjects With Neovascular Age-related Macular Degeneration|Active, not recruiting||Phase 4|255|Actual|Bayer||2|||f||||f|t|f|||t|||||2017-10-10 23:46:30.491162|2017-10-10 23:46:30.491162
NCT02305225|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-26|||May 2013||2013-05-01|November 2014|2014-11-01||||May 2016|Anticipated|2016-05-01||Interventional|||Cortical Excitability and Decision Making After Total Sleep Deprivation and Sleep Restriction||Unknown status|Recruiting|N/A|14|Anticipated|University of Zurich||2|||f||||||||||||||2017-10-10 23:46:30.63856|2017-10-10 23:46:30.63856
NCT02305212|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-30|||December 2013||2013-12-01|June 2017|2017-06-01|June 2, 2016|Actual|2016-06-02|June 2, 2016|Actual|2016-06-02||Interventional|Cogmed||Cogmed for Working Memory After TBI|Applying Cogmed to Improve Working Memory Abilities After Traumatic Brain Injury|Completed||N/A|12|Actual|Kessler Foundation||2|||f||||f||||||||||2017-10-10 23:46:30.708283|2017-10-10 23:46:30.708283
NCT02305199|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-04-18|||January 1, 2015|Actual|2015-01-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||Hartmann's Solution and Normal Saline in Type II Diabetes Patients|Comparison of Hartmann's Solution and Normal Saline on Postoperative Blood Glucose and Insulin Levels in Type II Diabetic Patients|Withdrawn||N/A|0|Actual|Yeungnam University College of Medicine||2||impossible to enroll participants|f||||t||||||||||2017-10-10 23:46:30.782406|2017-10-10 23:46:30.782406
NCT02305186|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-31|||March 2015||2015-03-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|UVA-PC-PD101||Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer|A Randomized Multicenter Phase Ib/II Study to Assess the Safety and the Immunological Effect of Chemoradiation Therapy (CRT) in Combination With Pembrolizumab (MK-3475) Compared to CRT Alone in Patients With Resectable or Borderline Resectable Pancreatic Cancer|Recruiting||Phase 1/Phase 2|56|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-10 23:46:31.003449|2017-10-10 23:46:31.003449
NCT02305173|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-12-01|||November 2014||2014-11-01|November 2014|2014-11-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|Dexa-mama||Dexamethasone and Respiratory Function After Mastectomy|Effect of the Preoperative Administration of Dexamethasone in the Respiratory Function and Postoperative Symptoms in Women Undergoing Mastectomy for Cancer. Results of a Randomized Clinical Trial.|Unknown status|Recruiting|Phase 3|120|Anticipated|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-10 23:46:31.125569|2017-10-10 23:46:31.125569
NCT02305160|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-11-26|||April 2005||2005-04-01|November 2014|2014-11-01|July 2007|Actual|2007-07-01|May 2006|Actual|2006-05-01||Interventional|||A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm Infants|Phase 3 Multicenter, Randomized, Open Label Trial of a New Low Cost Animal Extracted Surfactant to Treat Respiratory Distress Syndrome in Preterm Infants|Completed||Phase 2/Phase 3|327|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:46:31.241073|2017-10-10 23:46:31.241073
NCT02305147|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-03-08|||November 2014||2014-11-01|March 2017|2017-03-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Observational|ICEBERG||Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson's Disease|Etude Des Facteurs prédictifs de l'Apparition et de l'évolution de la Maladie de Parkinson|Recruiting||N/A|330|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||3||f||||f||||||Samples With DNA|"     Sampling at baseline   "|||2017-10-10 23:46:31.395803|2017-10-10 23:46:31.395803
NCT02305134|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-08-10|||January 2015||2015-01-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial|Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial|Recruiting||Phase 1/Phase 2|80|Anticipated|Chiba University||2|||f||||t||||||||||2017-10-10 23:46:31.486901|2017-10-10 23:46:31.486901
NCT02305121|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2017-01-30|||March 2015||2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Observational|FR TFNA||Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™)|A Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™) - TFNA System in Patients With Proximal Inter-, Per- or Subtrochanteric Fractures|Active, not recruiting||N/A|35|Actual|AO Clinical Investigation and Documentation|||1||f||||t||||||||||2017-10-10 23:46:31.580704|2017-10-10 23:46:31.580704
NCT02305108|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-11-18|||June 2014||2014-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|manifahip||Fascial Manipulation in Patients With Hip Osteoarthritis|Evaluation of the Efficacy of Treatment of the Soft Tissues With Fascial Manipulation for Patients That Are Waiting for Total Hip Arthroplasty in Osteoarthritis|Completed||N/A|60|Actual|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-10 23:46:31.667399|2017-10-10 23:46:31.667399
NCT02305095|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-07-20|||May 2015||2015-05-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|GRAHF-2||Genomic Response Analysis of Heart Failure Therapy in African Americans|Genomic Analysis of the Enhanced Response to Heart Failure Therapy in African Americans|Recruiting||N/A|500|Anticipated|University of Pittsburgh|||2||f||||t||||||Samples With DNA|"     Serum and DNA banked at baseline.   "|||2017-10-10 23:46:31.761453|2017-10-10 23:46:31.761453
NCT02305069|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-27|||October 2009||2009-10-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle|The Effect of Obesity-induced Cytokine Elevation on the Molecular Regulation of Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle|Completed||N/A|26|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-10 23:46:32.0498|2017-10-10 23:46:32.0498
NCT02305056|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CARBONOMIC||Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC)||Recruiting||Phase 1|6|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-10 23:46:32.178853|2017-10-10 23:46:32.178853
NCT02305043|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-27|||March 2014||2014-03-01|November 2014|2014-11-01||||February 2017|Anticipated|2017-02-01|24 Months|Observational [Patient Registry]|VARIANZ||Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer|Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Adenocarcinoma of the Stomach or Gastroesophageal Junction. A Non-interventional Study|Unknown status|Recruiting|N/A|500|Anticipated|University of Leipzig|||1||f||||f||||||||||2017-10-10 23:46:32.264045|2017-10-10 23:46:32.264045
NCT02305017|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-28|2015-10-16|2015-07-22||March 2014||2014-03-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Paracetamol on Opicapone Pharmacokinetics in Healthy Volunteers|Effect of Paracetamol on Opicapone Pharmacokinetics in Healthy Volunteers|Completed||Phase 1|28|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 23:46:32.401508|2017-10-10 23:46:32.401508
NCT02305004|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-12-03|||September 2013||2013-09-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|INTOx||Blood Serum Concentrations of Routine Drugs in Patients Treated in the Intensive Care Unit.|INTOx A Prospective Measurement of Serum Concentrations of Routine Drugs in Patients Treated in the Intensive Care Unit-A Quality Measurement/Improvement for Clinical Treatment and Forensic Assessment|Recruiting||N/A|1000|Anticipated|Uppsala University|||1||f||||f||||||||||2017-10-10 23:46:32.670967|2017-10-10 23:46:32.670967
NCT02304991|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-07-24|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|FARE/SLIT||FARE Peanut SLIT and Early Tolerance Induction|Peanut Sublingual Immunotherapy Induction of Clinical Tolerance of Newly Diagnosed Peanut Allergic 12 to 48 Month Old Children|Active, not recruiting||Phase 2|50|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 23:46:32.741427|2017-10-10 23:46:32.741427
NCT02304978|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-05-17|||June 22, 2009|Actual|2009-06-22|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|TF||Prognostic Value of Tissue Factor (TF) in Blood t in Colorectal Cancer in Adults|Prognostic Value of Tissue Factor (TF) in Blood t in Colorectal Cancer in Adults|Recruiting||Early Phase 1|120|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-10 23:46:32.840916|2017-10-10 23:46:32.840916
NCT02304965|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2015-09-02|||November 2014||2014-11-01|June 2015|2015-06-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Activity at Pulse Pressure Above an Individual Threshold in Patients With LVAD|Daily Physical Activity at Pulse Pressure Above an Individual Threshold in Patients With Continuous Flow Left Ventricular Assist Devices - a Feasibility Study|Completed||N/A|7|Actual|Hannover Medical School||1|||f||||f||||||||||2017-10-10 23:46:32.928538|2017-10-10 23:46:32.928538
NCT02304952|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-07-26|||September 2014||2014-09-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Eccentric Exercise or Radiofrequent Microtenotomy as Treatment of Lateral Epicondylalgia|Eccentric Exercise or Radiofrequent Microtenotomy as Treatment of Chronic Lateral Epicondylalgia - a Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Capio Sankt Görans Hospital||2|||f||||f||||||||||2017-10-10 23:46:32.999442|2017-10-10 23:46:32.999442
NCT02304939|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-05-11|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CHIC||CHangeovers of Norepinephrine in Intensive Care|Prospective, Randomized, Multi-center Trial Aiming to Determined the Impact of Changeovers of Norepinephrine on the Blood Pressure Stability With Patients in Shock in ICU.|Active, not recruiting||N/A|285|Actual|University Hospital, Angers||3|||f||||t||||||||||2017-10-10 23:46:33.089573|2017-10-10 23:46:33.089573
NCT02304926|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-05-05|2015-04-01||January 2009||2009-01-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia|Study of Lipoprotein Subfractions, Inflammation, Oxidative Stress and Endothelial Function After Treatment With Simvastatin and Ezetimibe Administered Alone and in Combination in Hyperlipidemic Patients|Completed||N/A|42|Actual|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||f||||||||||2017-10-10 23:46:33.190696|2017-10-10 23:46:33.190696
NCT02304913|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-02-20|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|OralAcu||Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy|Hypoglossal Acupuncture for Dysgeusia in Gynecologic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial|Recruiting||N/A|75|Anticipated|Universität Duisburg-Essen||3|||f||||||||||||||2017-10-10 23:46:34.113298|2017-10-10 23:46:34.113298
NCT02304900|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-02-23|||December 2009||2009-12-01|February 2017|2017-02-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|IOL et sommeil||Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep|Effect of the Color of the Intra-eye Implant in the Cataract Surgery on the Sleep|Completed||N/A|400|Actual|University Hospital, Tours||2|||f||||f||||||||||2017-10-10 23:46:34.213158|2017-10-10 23:46:34.213158
NCT02304887|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2016-11-23|||January 2006||2006-01-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||The Relationship Between the Residual Renal Function and Osteoporosis Treatment|The Relationship Between the Residual Renal Function and Osteoporosis Treatment|Recruiting||N/A|1000|Anticipated|Tomidahama Hospital|||4||f||||f||||||||||2017-10-10 23:46:34.286293|2017-10-10 23:46:34.286293
NCT02304861|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-01-14|||January 2014||2014-01-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss|Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss|Completed||N/A|80|Actual|Democritus University of Thrace||2|||f||||t||||||||||2017-10-10 23:46:34.444451|2017-10-10 23:46:34.444451
NCT02304848|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-10-12|||October 2012||2012-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|DBS||Effects of Deep Brain Stimulation (DBS) Frequency on Neural Synchrony||Enrolling by invitation||N/A|200|Anticipated|Stanford University||1|||f||||||||||||||2017-10-10 23:46:34.520336|2017-10-10 23:46:34.520336
NCT02304835|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2014-12-04|||May 2013||2013-05-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion|Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion|Completed||N/A|322|Actual|Nordic Pharma SAS|||1||f||||f||||||||||2017-10-10 23:46:34.593714|2017-10-10 23:46:34.593714
NCT02304822|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-04-12|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIRS||Comparison of Multiple-, Single- and Zero-dose of Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery|Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery: a Prospective Randomized Trail in Comparison of Multiple-, Single- and Zero-dose.|Recruiting||N/A|450|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||3|||f||||t||||||||||2017-10-10 23:46:34.651524|2017-10-10 23:46:34.651524
NCT02304809|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-02-15|||July 2014||2014-07-01|February 2016|2016-02-01|February 2022|Anticipated|2022-02-01|February 2016|Anticipated|2016-02-01||Interventional|AcSé||Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations|Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations|Recruiting||Phase 2|500|Anticipated|UNICANCER||1|||f||||t||||||||||2017-10-10 23:46:34.740967|2017-10-10 23:46:34.740967
NCT02304796|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2016-04-13|||January 2015||2015-01-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Unified Cognitive-Behavioral Therapy (CBT) vs. Combined CBT and Dance/Movement Therapy (DMT) for Anxiety Disorders|Randomized Controlled Trial Examining the Effectiveness of Two Group Psychotherapies for Anxiety Disorders: Unified Cognitive-behavioral Therapy vs. Combined Cognitive Behavioral and Dance/Movement Therapy|Active, not recruiting||N/A|24|Anticipated|Shalvata Mental Health Center||2|||f||||f||||||||||2017-10-10 23:46:34.88644|2017-10-10 23:46:34.88644
NCT02304783|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-04-01|||January 2014||2014-01-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ONSAIP-RC||Oral NSAI Versus Placebo as a Second Line Treatment for Renal Colics|The Investigation of the Efficacity and Safety of Oral Non Steroidal Anti Inflammatory (NSAI) Drugs Such as Piroxicam as a Second Line Treatment of Patients Consulting the Emergency Departement for Renal Colics.|Recruiting||Phase 1/Phase 2|500|Anticipated|University of Monastir||2|||f||||f||||||||Undecided||2017-10-10 23:46:35.162347|2017-10-10 23:46:35.162347
NCT02304770|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2017-04-14|||December 2014||2014-12-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia|A Pilot Study of Aminolaevulinic Acid (ALA) Photodynamic Therapy (PDT) in Patients With Cervical Persistent High Risk HPV Infection or Cervical Intraepithelial Neoplasia|Completed||Phase 2|73|Actual|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||3|||f||||f||||||||||2017-10-10 23:46:35.284292|2017-10-10 23:46:35.284292
NCT02304757|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-10-18|||January 2015||2015-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Decreased Bone Mineral Density|Randomized Trial of 99Tc-MDP and Alendronate Sodium in Postmenopausal Women With Differentiated Thyroid Cancer and Decrease in Bone Mineral Density Treated With Supraphysiological Doses of Thyroid Hormone|Recruiting||N/A|206|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||4|||f||||t||||||||No||2017-10-10 23:46:35.382374|2017-10-10 23:46:35.382374
NCT02304744|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2015-03-05|||October 2011||2011-10-01|March 2015|2015-03-01|December 2019|Anticipated|2019-12-01|December 2014|Actual|2014-12-01||Observational|UCORBIO||Utrecht Coronary Biobank (UCORBIO)|Utrecht Coronary Biobank (UCORBIO)|Active, not recruiting||N/A|3000|Anticipated|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     Whole blood and EDTA plasma.   "|||2017-10-10 23:46:35.53306|2017-10-10 23:46:35.53306
NCT02304731|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-11-27|||February 2013||2013-02-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|||Physical Exercise and Pollution: Cardiorrespiratory, Cerebral and Molecular Aspects|Physical Exercise and Pollution: Cardiorrespiratory, Cerebral and Molecular Aspects.|Completed||Phase 4|45|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-10-10 23:46:35.612433|2017-10-10 23:46:35.612433
NCT02304718|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-08-31|||December 2014||2014-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Exercise Intervention to Prevent Gestational Diabetes|Cycle Study:an Exercise Intervention to Prevent Gestational Diabetes in Overweight and Obese Chinese Pregnant Women|Completed||N/A|300|Actual|Peking University First Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:46:35.687947|2017-10-10 23:46:35.687947
NCT02304705|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-06-29|||January 2015||2015-01-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|Sildenafil-HF||Sildenafil in Heart Failure With Reactive Pulmonary Hypertension|Sildenafil in Heart Failure With Reactive Pulmonary Hypertension|Terminated||Phase 4|33|Actual|University of Kentucky||2||Difficulty meeting enrollment goal|f||||f||||||||||2017-10-10 23:46:35.804423|2017-10-10 23:46:35.804423
NCT02304692|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-31|||October 2014||2014-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Interventional|||Clinical Survey of Different Abutment Topologies|C49:Clinical Survey of Different Abutment Topologies Installed With a Minimally Invasive Surgery for Bone Anchored Hearing Systems|Active, not recruiting||N/A|14|Anticipated|Oticon Medical||2|||f||||f||||||||||2017-10-10 23:46:35.9035|2017-10-10 23:46:35.9035
NCT02304679|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-06-17|||September 2015||2015-09-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|Shock-ED||Low Energy Shockwave Therapy for Improving Erectile Dysfunction|The Effectiveness of Low Energy Shockwave Therapy for Improving Erectile Dysfunction in Men: a Double Blind Randomized Controlled Trial|Recruiting||N/A|154|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 23:46:36.008289|2017-10-10 23:46:36.008289
NCT02304666|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-08-28|||November 2014||2014-11-01|August 2015|2015-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|VANIN||Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis.|Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis|Recruiting||N/A|200|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:46:36.200767|2017-10-10 23:46:36.200767
NCT02304653|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-04-30|||February 2013||2013-02-01|April 2015|2015-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01|30 Days|Observational [Patient Registry]|||Acute Appendicitis: The Influence of C-reactive Protein and Leucocytes on Clinical Decision-making|Acute Appendicitis: The Influence of C-reactive Protein and Leucocytes on Clinical Decision-making|Completed||N/A|226|Actual|Odense University Hospital|||1||f||||t||||||||||2017-10-10 23:46:36.292657|2017-10-10 23:46:36.292657
NCT02304640|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-09-20|||October 2014||2014-10-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Observational|||Prevalence, Severity and Determinants of Cancer-related Fatigue (CRF) in Asian Breast Cancer Patients|Prevalence, Severity and Determinants of Cancer-related Fatigue (CRF) in Asian Breast Cancer Patients|Recruiting||N/A|194|Anticipated|National University, Singapore|||2||f||||f||||||||||2017-10-10 23:46:36.370304|2017-10-10 23:46:36.370304
NCT02304627|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-09-01|||November 2014||2014-11-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects|Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects|Completed||Phase 1|45|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-10 23:46:36.4539|2017-10-10 23:46:36.4539
NCT02304614|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2017-03-31|||April 1, 2015|Actual|2015-04-01|March 2017|2017-03-01|March 24, 2018|Anticipated|2018-03-24|April 24, 2017|Anticipated|2017-04-24||Observational|3DBCT||The Use of 3D Surface Imaging in the Objective Assessment of Breast Conserving Therapy|The Use of 3D Surface Imaging in the Objective Assessment of Breast Conserving Therapy|Recruiting||N/A|300|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:46:36.549123|2017-10-10 23:46:36.549123
NCT02304601|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-07-28|||January 2011||2011-01-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Observational|Generik||Development and Testing of a Generic Screening for Use in Application Process of Medical Rehabilitation Services|Entwicklung Und Testung Eines Generischen Screenings für Die Vorabschätzung Von Fallgruppen im Antragsverfahren|Completed||N/A|2736|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-10 23:46:36.650982|2017-10-10 23:46:36.650982
NCT02304588|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-12-01|||January 2013||2013-01-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot|Vascular Occlusive Diseases Such as Diabetic Foot Treated With Mesenchymal Stem Cell|Recruiting||Phase 1|20|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 23:46:36.707215|2017-10-10 23:46:36.707215
NCT02304575|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-03-11|||January 2015||2015-01-01|November 2014|2014-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Quality of Life Among Testicular Cancer Survivors|Quality of Life Among Testicular Cancer Survivors|Recruiting||N/A|330|Anticipated|Rabin Medical Center|||3||f||||f||||||||||2017-10-10 23:46:36.779688|2017-10-10 23:46:36.779688
NCT02304562|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-12-01|||January 2013||2013-01-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair|Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair|Recruiting||Phase 1|50|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 23:46:36.879554|2017-10-10 23:46:36.879554
NCT02304549|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-02-01|||April 2014||2014-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Observational|||A Prospective Investigation Using the Expired Breath Ethanol Test|Is Absorption of Irrigation Fluid a Problem in Thulium Laser Vaporization of the Prostate? A Prospective Investigation Using the Expired Breath Ethanol Test.|Completed||N/A|57|Actual|Cantonal Hospital of St. Gallen|||1||f||||f||||||||||2017-10-10 23:46:36.956961|2017-10-10 23:46:36.956961
NCT02304536|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-01-20|||November 2014||2014-11-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|FSH||Comparison Between Laparoscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.|Comparison Between Laproscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome: A Randomised Controlled Trial|Recruiting||Phase 3|210|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:46:37.049196|2017-10-10 23:46:37.049196
NCT02304523|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2015-09-10|||January 2015||2015-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy|A Prospective, Randomized, Single-blinded (Evaluator), 3-treatment Arm, Parallel, Multi-center, Phase 3 Trial to Evaluate Safety and Efficacy of CDFR0612 and CDFR0613|Completed||Phase 3|310|Actual|CTC Bio, Inc.||3|||f||||f||||||||||2017-10-10 23:46:37.153112|2017-10-10 23:46:37.153112
NCT02304510|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-27|2014-12-02|||November 2014||2014-11-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing|Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing|Unknown status|Recruiting|N/A|2800|Anticipated|Peking University|||1||f||||f||||||||||2017-10-10 23:46:37.247285|2017-10-10 23:46:37.247285
NCT02304497|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-12-01|||March 2013||2013-03-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01|1 Day|Observational [Patient Registry]|||PRF Growth Factors Levels in Diabetic Patients With Chronic Periodontitis|Evaluation of Platelet Rich Fibrin Growth Factors (PRF) in Type 2 Diabetic Patients With Chronic Periodontitis|Completed||N/A|80|Actual|Bulent Ecevit University|||4||f||||f||||||||||2017-10-10 23:46:37.317485|2017-10-10 23:46:37.317485
NCT02304484|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-06-16|||November 24, 2014|Actual|2014-11-24|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab|A Multicenter, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab|Active, not recruiting||Phase 3|770|Actual|Amgen||1|||f||||t||||||||||2017-10-10 23:46:37.401896|2017-10-10 23:46:37.401896
NCT02304471|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-12-01|||November 2014||2014-11-01|November 2014|2014-11-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01||Observational|||Circulating lncRNA and CV Morbidities in CKD and ESRD|Circulating Long Non-coding RNAs and Cardiovascular Morbidities in Chronic Kidney Disease and End-Stage Renal Disease|Recruiting||N/A|360|Anticipated|National Taiwan University Hospital|||3||f||||t||||||Samples With DNA|"     blood   "|||2017-10-10 23:46:37.781257|2017-10-10 23:46:37.781257
NCT02304445|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2015-11-25|||November 2015||2015-11-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TACE-SBRT||Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver Cancer|Trans-Arterial Chemo-Embolization (TACE) Vs. TACE Plus Stereotactic Body Radiosurgery (SBRT) in the Treatment of Hepatocellular Carcinoma (HCC)|Withdrawn||N/A|0|Actual|Midwestern Regional Medical Center||2||Necessary equipment could not be obtained.|f||||f||||||||||2017-10-10 23:46:38.071476|2017-10-10 23:46:38.071476
NCT02304432|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-09-18|2017-07-31||September 27, 2015|Actual|2015-09-27|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|September 30, 2016|Actual|2016-09-30||Interventional|DCS||Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine|Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine|Completed||Early Phase 1|2|Actual|Mclean Hospital||3|||f||||f|f|f||||||||2017-10-10 23:46:38.168486|2017-10-10 23:46:38.168486
NCT02304419|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-10-04|||May 2015||2015-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study of Galunisertib on the Immune System in Participants With Cancer|Phase 1 Study to Determine the Immunomodulatory Activity of LY2157299 Monohydrate in Patients With Solid Tumors|Completed||Phase 1|10|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-10 23:46:41.014645|2017-10-10 23:46:41.014645
NCT02304406|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-09-28|||January 21, 2015|Actual|2015-01-21|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|ALK NSCLC MENA||Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa|Retrospective Epidemiology Study Of Eml4-alk Rearrangement In Non-small Cell Lung Cancer Patients In The Middle East & North Africa.|Recruiting||N/A|700|Anticipated|Pfizer|||1||f||||||||||Samples With DNA|"     The tissue samples of NSCLC cases will be retrieved from tissue banks of the molecular     diagnostic units & pathology departments in these study centers. The histological diagnosis     will be confirmed by the pathologists. The retained samples will then be tested by performing     the Ventana ALK-IHC to assess the absence or presence of the ALK rearrangement by the     detection of the ALK protein in formalin-fixed, paraffin-embedded NSCLC stored tissue samples     using Ventana anti-ALK (D5F3) Rabbit Monoclonal Primary Antibody (Roche Diagnostics GmbH) in     the selected study centers.   "|||2017-10-10 23:46:41.125848|2017-10-10 23:46:41.125848
NCT02304393|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-07-21|||December 12, 2014|Actual|2014-12-12|July 2017|2017-07-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||A Study of RO7009789 in Combination With Atezolizumab in Participants With Locally Advanced and Metastatic Solid Tumors|An Open-Label, Multicenter, Dose-Escalation Phase IB Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Therapeutic Activity of RO7009789 (CD40 Agonist) in Combination With Atezolizumab (Anti PD-L1) in Patients With Locally Advanced and/or Metastatic Solid Tumors|Recruiting||Phase 1|160|Anticipated|Hoffmann-La Roche||5|||f||||||||||||||2017-10-10 23:46:41.309757|2017-10-10 23:46:41.309757
NCT02304380|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-11-09|||March 2015||2015-03-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Care Coordination for Children With Disabilities|Improving Care Coordination for Children With Disabilities Through an Accountable Care Organization|Active, not recruiting||N/A|2118|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||No||2017-10-10 23:46:41.47696|2017-10-10 23:46:41.47696
NCT02304367|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-05-02|||April 23, 2015|Actual|2015-04-23|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of KRN23 in Adult Subjects With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)|A Phase 2 Open-Label Trial to Assess the Efficacy and Safety of KRN23, an Antibody to FGF23, in Subjects With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)-Associated Osteomalacia|Active, not recruiting||Phase 2|17|Actual|Ultragenyx Pharmaceutical Inc||1|||f||||f||||||||||2017-10-10 23:46:41.541283|2017-10-10 23:46:41.541283
NCT02304354|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|LYRITUX||Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX)|Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX)|Recruiting||Phase 3|100|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 23:46:41.64606|2017-10-10 23:46:41.64606
NCT02304341|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-11-02|||September 2012||2012-09-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Observational|||Development of a Modified Pediatric Early Warning Score: a French Prospective Multicentre Regional Study|Development of a Modified Pediatric Early Warning Score: a French Prospective Multicentre Regional Study.|Completed||N/A|3016|Actual|University Hospital, Lille|||1||f||||f||||||||||2017-10-10 23:46:41.783239|2017-10-10 23:46:41.783239
NCT02304328|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-01-11|||December 2015||2015-12-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|July 2018|Anticipated|2018-07-01||Observational|hWFNS||Impact of Herniation on WFNS Grading in Spontaneous Subarachnoid Hemorrhage - a SWISS SOS Observational Trial|Impact of Herniation on WFNS Grading and Outcome in Spontaneous Subarachnoid Hemorrhage - a SWISS SOS Observational Trial|Recruiting||N/A|250|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-10 23:46:41.871251|2017-10-10 23:46:41.871251
NCT02304315|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-06-29|||February 2015||2015-02-01|December 2015|2015-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients|A Randomized, Open-label, Single-center, Phase II Trial to Explore the Safety and Efficacy of GC1102 and Determine Its Optimal Dose After Intravenous Administration in HBV-related Liver Transplant Recipients|Completed||Phase 2|40|Actual|Green Cross Corporation||2|||f||||f||||||||||2017-10-10 23:46:42.009056|2017-10-10 23:46:42.009056
NCT02304302|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-04-14|||October 2014||2014-10-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Down Syndrome Memantine Follow-up Study|Phase II Multicenter 16-Week Randomized Double Blind Placebo-Controlled Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Adolescents and Young Adults With Down Syndrome|Recruiting||Phase 2|200|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 23:46:42.11285|2017-10-10 23:46:42.11285
NCT02304289|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-01-03|||November 2014||2014-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|DESPARTH||Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma|Phase I Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Oral Artesunate (ART) in Patients With Advanced Hepatocellular Carcinoma (HCC).|Completed||Phase 1|2|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-10 23:46:42.278977|2017-10-10 23:46:42.278977
NCT02304276|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-05-12|||January 2015||2015-01-01|May 2016|2016-05-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|18F-FAABULOUS||18F-Fluoride Assessment of Aortic Bioprosthesis Durability and Outcome|18F-Fluoride Assessment of Aortic Bioprosthesis Durability and Outcome|Enrolling by invitation||N/A|180|Anticipated|University of Edinburgh||3|||f||||f||||||||||2017-10-10 23:46:42.368406|2017-10-10 23:46:42.368406
NCT02304263|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-09-22|||February 2015||2015-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Tenofovir Pharmacology in Older HIV Infected Individuals|Assessing Tenofovir Pharmacology in Older HIV Infected Individuals Receiving Tenofovir-based Antiretroviral Therapy|Completed||N/A|45|Actual|University of Colorado, Denver|||2||f||||f||||||||||2017-10-10 23:46:42.44928|2017-10-10 23:46:42.44928
NCT02304250|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-11-25|||October 2013||2013-10-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Dexamethasone and Wound Healing After Thyroid Surgery|The Effect of Dexamethasone on Safety of Thyroid Surgery|Completed||N/A|220|Actual|Shanghai 6th People's Hospital||2|||f||||t||||||||||2017-10-10 23:46:42.529086|2017-10-10 23:46:42.529086
NCT02304237|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2014-11-26|||December 2014||2014-12-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women|A Multicenter, Randomized, Open-label, Investigator Initiated Trial of Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women|Unknown status|Not yet recruiting|Phase 3|360|Anticipated|Ewha Womans University Mokdong Hospital||2|||f||||t||||||||||2017-10-10 23:46:42.608354|2017-10-10 23:46:42.608354
NCT02304224|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-25|||December 2014||2014-12-01|November 2014|2014-11-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||the Relationship of the Use of Eye Masks and Outcomes of Patients With Sepsis in Intensive Care Unit|the Relationship of the Use of Eye Masks and Outcomes of Patients With Sepsis in Intensive Care Unit|Unknown status|Not yet recruiting|N/A|100|Anticipated|Shanghai 10th People's Hospital||2|||f||||t||||||||||2017-10-10 23:46:42.693064|2017-10-10 23:46:42.693064
NCT02304211|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-12-22|||December 2014||2014-12-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|IAM-POC||Intra-Arterial Microdosing: Proof-of-Concept in Humans|Intra-Arterial Microdosing: Proof-of-Concept in Humans|Completed||Early Phase 1|10|Actual|Duke University||2|||f||||f||||||||Yes|PET Imaging data presently being analyzed for presentation and final manuscript publication|2017-10-10 23:46:42.896404|2017-10-10 23:46:42.896404
NCT02304198|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-04-15|||April 2014||2014-04-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH|A Single-arm, Open-label, Extension Study to Evaluate the Long-term Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)|Completed||Phase 2/Phase 3|59|Actual|Dong-A ST Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:46:42.995889|2017-10-10 23:46:42.995889
NCT02304185|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-06-03|||December 2014||2014-12-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers|A First in Human Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Dose Levels of Trimeric gp140 Protein in Healthy Adult Volunteers|Completed||Phase 1|50|Actual|Crucell Holland BV||6|||f||||t||||||||||2017-10-10 23:46:43.094449|2017-10-10 23:46:43.094449
NCT02304172|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-02-12|||November 2014||2014-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|Thunderbeat||The Efficacy and Safety of Thunderbeat in Thyroid Surgery|The Efficacy and Safety of Thunderbeat in Thyroid Surgery: a Prospective Randomized Study|Completed||N/A|50|Actual|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:46:43.194535|2017-10-10 23:46:43.194535
NCT02304159|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-10-04|||January 2015|Actual|2015-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Interventional|||Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics|A Randomized Study to Evaluate the Safety and Efficacy of Adding Daclatasvir to the Combination of Sofosbuvir (SOF) and Ribavirin (RBV) for 16 Weeks Versus 24 Weeks in Cirrhotic Subjects With Chronic Hepatitis C Infection Genotype 3|Active, not recruiting||Phase 4|39|Actual|Southern California Research Center||2|||f||||f||||||||||2017-10-10 23:46:43.297842|2017-10-10 23:46:43.297842
NCT02304146|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-12-01|||November 2014||2014-11-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01|1 Day|Observational [Patient Registry]|||Long-term Ultrasound Guided Foam Sclerotherapy Versus Classical Surgical Stripping Study|Long-term Ultrasound Guided Foam Sclerotherapy Versus Classical Surgical Stripping Study|Unknown status|Recruiting|N/A|460|Anticipated|Maastricht University Medical Center|||2||f||||f||||||||||2017-10-10 23:46:43.406214|2017-10-10 23:46:43.406214
NCT02304133|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-25|||January 2012||2012-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|February 2013|Actual|2013-02-01||Interventional|||Transfer From a Point-of-care Ultrasound Course|Transfer From a Point-of-care Ultrasound Course to Diagnostic Performance on Patients - a Randomized Controlled Trial|Completed||N/A|64|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-10 23:46:43.506171|2017-10-10 23:46:43.506171
NCT02304120|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-04-05|||December 2014||2014-12-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|SeMoPoP||Sensorimotor Training in Low-back Pain Rehabilitation|Effects of a Sensorimotor Training on Postural Control and Pain: A Parallel, Single-blinded Randomised Controlled Trial|Completed||N/A|60|Actual|Reha Rheinfelden||2|||f||||t||||||||||2017-10-10 23:46:43.573633|2017-10-10 23:46:43.573633
NCT02304107|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-07-03|||May 2013||2013-05-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|FSH||Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.|Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome: A Randomised Controlled Trial|Completed||Phase 3|140|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:46:43.670549|2017-10-10 23:46:43.670549
NCT02304094|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-03-28|||October 2015||2015-10-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Morton's Neuroma: Manipulation Versus Steroid Injection|A Randomised Controlled Trial to Compare the Clinical Effectiveness of Lower Extremity Manipulation to That of Steroid Injection in the Treatment of Morton's Neuroma|Recruiting||N/A|64|Anticipated|Queen Margaret University||2|||f||||t||||||||||2017-10-10 23:46:43.75781|2017-10-10 23:46:43.75781
NCT02304081|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-09-26|||January 2015||2015-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function|Effect of Saxagliptin in Addition to Dapagliflozin and Metformin on Insulin Resistance, Islet Cell Dysfunction, and Metabolic Control in Subjects With Type 2 Diabetes Mellitus on Previous Metformin Treatment|Completed||Phase 4|64|Actual|Profil Mainz GmbH & Co KG||2|||f||||f||||||||||2017-10-10 23:46:43.854781|2017-10-10 23:46:43.854781
NCT02304068|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-25|||April 2012||2012-04-01|November 2014|2014-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Accuracy of Home Monitoring for Acute Macular Degeneration (AMD) Disease Activity|The Accuracy of Home Monitoring for Disease Activity During Maintenance Therapy for Neovascular Age-related Macular Degeneration|Completed||N/A|||The Leeds Teaching Hospitals NHS Trust||1|||f||||||||||||||2017-10-10 23:46:43.971409|2017-10-10 23:46:43.971409
NCT02304055|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-01-26|||May 2013||2013-05-01|January 2016|2016-01-01||||December 2014|Actual|2014-12-01||Interventional|||Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial|Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial|Completed||Phase 3|100|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:46:44.035148|2017-10-10 23:46:44.035148
NCT02304042|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2015-07-01|||November 2014||2014-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PPH||Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial|Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial|Completed||Phase 3|200|Actual|Cairo University||2|||f||||t||||||||||2017-10-10 23:46:44.122873|2017-10-10 23:46:44.122873
NCT02304029|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-07-06|||March 2015||2015-03-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|EPISODIUM||Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy|Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy|Recruiting||N/A|90|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||t||||||||||2017-10-10 23:46:44.206593|2017-10-10 23:46:44.206593
NCT02304016|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-02-14|||December 2014||2014-12-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of the Effect of Pelvic Floor Physical Therapy on Patients With 3rd and 4th Degree Obstetrical Lacerations|Evaluation of the Effect of Pelvic Floor Physical Therapy on Patients With 3rd and 4th Degree Obstetrical Lacerations|Recruiting||N/A|40|Anticipated|Boston Urogynecology Associates||2|||f||||f||||||||||2017-10-10 23:46:44.300803|2017-10-10 23:46:44.300803
NCT02304003|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2017-07-14|||April 2014||2014-04-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of an Evidence-based Physiotherapy Regimen for Patients With Rotator Cuff Tendinopathy|The Effect of an Evidence-based Physiotherapy Regimen for Patients on Need for Subacromial Decompression Surgery Due to Rotator Cuff Tendinopathy : a Randomized Controlled Trial.|Recruiting||N/A|80|Anticipated|Bergen University College||2|||f||||t||||||||||2017-10-10 23:46:44.38797|2017-10-10 23:46:44.38797
NCT02303990|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-04-11|||February 2015||2015-02-01|April 2016|2016-04-01||||February 2017|Anticipated|2017-02-01||Interventional|||RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers|RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers|Recruiting||Phase 1|70|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 23:46:44.488156|2017-10-10 23:46:44.488156
NCT02303977|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-26|2016-04-11|||November 2014||2014-11-01|April 2016|2016-04-01||||April 2017|Anticipated|2017-04-01||Interventional|||Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy|Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy|Recruiting||Phase 2|37|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 23:46:44.567552|2017-10-10 23:46:44.567552
NCT02303964|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-02-19|||November 2014||2014-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PUPTH||Pre-Hospital Use of Plasma for Traumatic Hemorrhage|Pre-Hospital Use of Plasma for Traumatic Hemorrhage|Withdrawn||Phase 2/Phase 3|0|Actual|Virginia Commonwealth University||2||Low patient enrollment is the primary reason|f||||t||||||||No|There is no data to share.|2017-10-10 23:46:44.641341|2017-10-10 23:46:44.641341
NCT02303951|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-05-11|||January 2015||2015-01-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Neoadjuvant Vemurafenib + Cobimetinib in Melanoma: NEO-VC|Neoadjuvant Treatment With the Combination of Vemurafenib and Cobimetinib (GDC-0973) in Limited Metastasis of Malignant Melanoma (AJCC Stage IIIC/IV) and Integrated Biomarker Study: a Single Armed Phase II EADO (European Association of Dermato Oncology) Trial|Recruiting||Phase 2|110|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-10 23:46:44.728792|2017-10-10 23:46:44.728792
NCT02303938|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-08-03|||August 2013||2013-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effects of Exercise on Cognitive Function in Glioma Patients|A Pilot Randomized Controlled Trial on the Feasibility and Efficacy of an Exercise Intervention to Improve Cognitive Functioning in Patients With Glioma|Completed||N/A|60|Actual|University of Tilburg||2|||f||||t||||||||||2017-10-10 23:46:44.819239|2017-10-10 23:46:44.819239
NCT02303925|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-08-01|||November 2014||2014-11-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|February 2017|Anticipated|2017-02-01||Interventional|EMBORRHOID||Feasibility of Superior Rectal Artery Embolization for the Treatment of Hemorrhoidal Disease|Feasibility of Superior Rectal Artery Embolization for the Treatment of Hemorrhoidal Disease|Recruiting||N/A|26|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||t||||||||||2017-10-10 23:46:44.889593|2017-10-10 23:46:44.889593
NCT02303912|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-10-19|||November 2014||2014-11-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|ProGem2||Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer|Phase 1B Open Label Study to Assess the Safety, Pharmacokinetics and Clinical Activity of Nuc-1031 Given on Days 1 & 8 With Carboplatin on Day 1, q3-weekly for 6 Cycles in Participants With Recurrent Ovarian Cancer.|Recruiting||Phase 1|36|Anticipated|Imperial College Healthcare NHS Trust||1|||f||||t||||||||||2017-10-10 23:46:44.95873|2017-10-10 23:46:44.95873
NCT02303899|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-02-09|||November 2014||2014-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma|A Phase II Study of the Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Malignant Pleural Mesothelioma|Active, not recruiting||Phase 2|22|Actual|Istituto Clinico Humanitas||1|||f||||f||||||||No|not planned|2017-10-10 23:46:45.066449|2017-10-10 23:46:45.066449
NCT02303886|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-28|||March 2009||2009-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|June 2012|Actual|2012-06-01||Interventional|||Methylene Blue Intravenously and Chronic Neuropathic Pain|Evaluation of the Effects of Methylene Blue on Neuropathic Pain and Protein Biomarkers|Completed||N/A|10|Actual|Uppsala University||2|||f||||f||||||||||2017-10-10 23:46:45.174207|2017-10-10 23:46:45.174207
NCT02303860|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-05-05|||October 2014||2014-10-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2)|Pharmacokinetic Study of ORM-12741 After Multiple Oral Doses|Completed||Phase 1|15|Actual|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-10-10 23:46:45.314048|2017-10-10 23:46:45.314048
NCT02303847|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-05-24|||November 2014||2014-11-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|Ketamine||Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting|Ultra-low Dose Oral Ketamine for Treatment of Chronic Non-cancer Pain in the Primary Care Setting|Unknown status|Active, not recruiting|Phase 3|32|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-10 23:46:45.429167|2017-10-10 23:46:45.429167
NCT02303834|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-10-24|||February 2015||2015-02-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|||CPAP in Preeclampsia|Single Blinded Randomised Control Trial of Treatment of Sleep Disordered Breathing in Preeclampsia With Nasal CPAP|Terminated||N/A|5|Actual|University of Sydney||2||Poor recruitment|f||||t||||||||No|Data is de-identified and analysed as a cohort, no individual data will be published.|2017-10-10 23:46:45.585455|2017-10-10 23:46:45.585455
NCT02303821|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-09-14|||December 2014||2014-12-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia|Phase 1b Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia|Suspended||Phase 1|36|Anticipated|Amgen||1||Enrollment halted while protocol is amended|f||||t||||||||||2017-10-10 23:46:45.670638|2017-10-10 23:46:45.670638
NCT02303808|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-12-01|||December 2014||2014-12-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis|Effect of Introducing a Positive Expiratory Pressure Device During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis: a Randomized Crossover Trial.|Completed||N/A|20|Actual|Universidad San Jorge||2|||f||||t||||||||||2017-10-10 23:46:45.888075|2017-10-10 23:46:45.888075
NCT02303795|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-12-15|||August 2015||2015-08-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial|A Phase 2, Randomized, Open Label, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Rivaroxaban Compared With Vitamin K Antagonism in Patients With Atrial Fibrillation With Bioprosthetic Mitral Valves - RIVER|Recruiting||Phase 2|1000|Anticipated|Hospital do Coracao||2|||f||||t||||||||||2017-10-10 23:46:45.981384|2017-10-10 23:46:45.981384
NCT02303782|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-08-31|||January 2015||2015-01-01|August 2016|2016-08-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||A Study Assessing tOTX015 in Combination With Azacitidine (AZA) or AZA Single Agent in Patients With Newly-diagnosed Acute Myeloid Leukemia (AML) Not Candidate for Standard Intensive Induction Therapy (SIIT)|A Phase Ib/II Study Assessing the BET-bromodomain (BRD) Inhibitor OTX015 in Combination With Azacitidine (AZA) or AZA Single Agent in Patients With Newly-diagnosed Acute Myeloid Leukemia (AML) Not Candidate for Standard Intensive Induction Therapy (SIIT)|Withdrawn||Phase 1/Phase 2|0|Actual|Oncoethix GmbH||2|||||||t||||||||||2017-10-10 23:46:46.093164|2017-10-10 23:46:46.093164
NCT02303769|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-02-24|||March 2014||2014-03-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|GL2702||Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS|A Multicenter, Randomized, Double -Blind, Parallel, Comparative, Phase III Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1 Tablet in BPH Patients With LUTS|Completed||Phase 3|309|Actual|GL Pharm Tech Corporation||2|||f||||f||||||||No||2017-10-10 23:46:46.173244|2017-10-10 23:46:46.173244
NCT02303756|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-10-09|||August 2015||2015-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Colonic Capsule Endoscopy (CCE) for Screening of Neoplasm's A Pilot Study|Colonic Capsule Endoscopy (CCE) for Screening of Neoplasm's|Completed||N/A|250|Actual|Odense University Hospital||1|||f||||t||||||||||2017-10-10 23:46:46.271566|2017-10-10 23:46:46.271566
NCT02303743|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-10-13|2014-12-02||January 2014||2014-01-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Men and women aged 18 and older with scheduled elective colonoscopy. All enrolled outpatients were able to follow instructions and owners of a smartphone|Improving Bowel Cleansing With a Smart Phone Application|Improving the Quality of Colonoscopy Bowel Preparation Using a Smart Phone Application|Completed||Phase 4|260|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-10-10 23:46:46.361081|2017-10-10 23:46:46.361081
NCT02303730|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-09-10|||March 2015||2015-03-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes|Exenatide BID Compared With Insulin Glargine to Change Liver Fat Content in Non-alcoholic Fatty-liver Disease Patients With Type 2 Diabetes|Recruiting||Phase 4|76|Anticipated|Fudan University||2|||f||||f||||||||Undecided||2017-10-10 23:46:46.637775|2017-10-10 23:46:46.637775
NCT02303717|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-25|||December 2014||2014-12-01|November 2014|2014-11-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|IDEAL-LM||Xience Versus Synergy in Left Main PCI|Improved Drug Eluting Stent for Percutaneous Coronary Intervention of the Left Main Artery in a Real World All-comers Population|Not yet recruiting||N/A|818|Anticipated|NHS National Waiting Times Centre Board||2|||f||||t||||||||||2017-10-10 23:46:46.799513|2017-10-10 23:46:46.799513
NCT02303704|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-12-05|2014-11-29||April 2013||2013-04-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|MACBC|All patients who was enrolled for trial age and gender was clearly defined and noted|Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia|Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia and Continuous Controlled Warm Shot Through Vein Grafts During Proximal Ends Anastomosis in Conventional CABG|Completed||Phase 2|448|Actual|Multan Institute of Cardiology||2|||f||||f||||||||||2017-10-10 23:46:46.913996|2017-10-10 23:46:46.913996
NCT02303691|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-03-27|||April 2013||2013-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|January 2017|Actual|2017-01-01||Interventional|||Attention Bias Modification for Transdiagnostic Anxiety|Neural Dimensions of Attention Bias Modification for Transdiagnostic Anxiety|Active, not recruiting||N/A|70|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:46:47.282015|2017-10-10 23:46:47.282015
NCT02303678|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-08-01|||February 2015||2015-02-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||D2C7 for Adult Patients With Recurrent Malignant Glioma|Phase I Single-Center, Dose Escalation Study of D2C7-IT Administered Intratumorally Via Convection-Enhanced Delivery for Adult Patients With Recurrent Malignant Glioma|Recruiting||Phase 1|45|Anticipated|Duke University||1|||f||||f||||||||||2017-10-10 23:46:47.376497|2017-10-10 23:46:47.376497
NCT02303665|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-03-08|||November 2014||2014-11-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Observing the Curative Effect of Assisted Reproduction by TCM Multi-channel Interventional Therapy|TCM Multi-channel Interventional Therapy for Assisting Reproduction|Completed||Phase 2|100|Actual|Chengdu University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-10 23:46:47.517469|2017-10-10 23:46:47.517469
NCT02303652|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-25|||January 2005||2005-01-01|November 2014|2014-11-01||||November 2014|Actual|2014-11-01||Observational|||Biatrial Contractility Recovery After Maze|Surgical Treatment of Concomitant Atrial Fibrillation: a Comprehensive Insight Into Biatrial Contractility Recovery.|Completed||N/A|122|Actual|Centro Cardiologico Monzino|||1||f||||||||||||||2017-10-10 23:46:47.637604|2017-10-10 23:46:47.637604
NCT02303639|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-08-31|||April 2015||2015-04-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|MANTRA-VT||Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias|Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias. A Prospective, Randomized Multicentre Study.|Recruiting||Phase 4|120|Anticipated|Central Finland Hospital District||2|||f||||t||||||||||2017-10-10 23:46:47.735776|2017-10-10 23:46:47.735776
NCT02303613|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-09-27|||November 2014||2014-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01|30 Days|Observational [Patient Registry]|HTPS||A Validation of Current Hospital Triage Performance System Versus RETTS|A Validation of Current Hospital Triage Performance System Versus RETTS and Identify Trauma Patient Outcome at Moi Teaching and Referral Hospital, Kenya.|Completed||N/A|628|Actual|University Hospital, Linkoeping|||1||f||||f||||||||||2017-10-10 23:46:48.097449|2017-10-10 23:46:48.097449
NCT02303600|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-25|||August 2014||2014-08-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough|Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough:A Prospective, Open Label, Randomized and Placebo-Controlled Trial|Unknown status|Recruiting|N/A|200|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-10 23:46:48.160336|2017-10-10 23:46:48.160336
NCT02303587|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-05-08|||December 2014||2014-12-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)|Low Dose Versus High Dose Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia : a Multicenter Randomized Blinded Trial|Recruiting||N/A|630|Anticipated|Beijing Children's Hospital||2|||f||||t||||||||No||2017-10-10 23:46:48.250745|2017-10-10 23:46:48.250745
NCT02303561|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-05-16|||June 2014|Actual|2014-06-01|May 2017|2017-05-01|March 13, 2017|Actual|2017-03-13|March 13, 2017|Actual|2017-03-13||Interventional|CHAMP||The Childhood Health and Asthma Management Program|The Childhood Health and Asthma Management Program|Completed||N/A|56|Actual|University of Florida||2|||f||||f||||||||Undecided||2017-10-10 23:46:48.428444|2017-10-10 23:46:48.428444
NCT02303548|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2017-01-24|||October 2014||2014-10-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Bicarbonate in Patients With Out-of-hospital Cardiac Arrest|Pilot Study of Bicarbonate Injection for Improving Outcome in Patients With Out-of-hospital Cardiac Arrest, Double-blind Randomized Control Trial|Completed||Phase 2|50|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-10 23:46:48.505026|2017-10-10 23:46:48.505026
NCT02303535|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-11-03|||April 2000||2000-04-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||National Congenital Heart Disease Audit|National Congenital Heart Disease Audit|Recruiting||N/A|120000|Anticipated|University College, London|||1||f||||t||||||||||2017-10-10 23:46:48.571466|2017-10-10 23:46:48.571466
NCT02303522|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-04-05|||December 2014||2014-12-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)|A Retrospective Pooled Analysis of Complete Remission Among Pediatric Patients With Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia (ALL)|Completed||N/A|207|Anticipated|Amgen|||1||f||||f||||||||||2017-10-10 23:46:48.696564|2017-10-10 23:46:48.696564
NCT02303509|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2014-11-25|||August 2013||2013-08-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject|A Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study Evaluating The Safety/Tolerability, Pharmacokinetic and Pharmacodynamic Effects of UCB5857 in Healthy and Mild-to-Moderate Psoriatic Subjects|Completed||Phase 1|57|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-10 23:46:48.779961|2017-10-10 23:46:48.779961
NCT02303496|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2014-11-25|||December 2014||2014-12-01|November 2014|2014-11-01|May 2015|Anticipated|2015-05-01|March 2015|Anticipated|2015-03-01||Interventional|||Autologous Platelet-Rich Plasma Cream for Photoaging and Chronological Skin Aging|The Effects of Autologous Platelet-Rich Plasma Cream on Photoaging and Chronological Skin Aging|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Acibadem University||2|||f||||t||||||||||2017-10-10 23:46:48.996739|2017-10-10 23:46:48.996739
NCT02303483|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-06-29|||January 4, 2016|Actual|2016-01-04|June 2017|2017-06-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Interventional|||The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men|The Effect of Nicotinamide Ribose (NR) on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men - a Randomized, Placebo Controlled Clinical Trial|Completed||N/A|40|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-10-10 23:46:49.093518|2017-10-10 23:46:49.093518
NCT02303470|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-09-15|||March 2015||2015-03-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|||Vigorous Exercise Versus Moderate Exercise to Improve Glucose Metabolism and Metabolic Parameters in Women With Polycystic Ovary Syndrome and Insulin Resistance: A Prospective Randomized Pilot Study||Unknown status|Recruiting|N/A|20|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:46:49.180991|2017-10-10 23:46:49.180991
NCT02303457|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2016-01-27|||July 2014||2014-07-01|January 2016|2016-01-01|July 2024|Anticipated|2024-07-01|July 2024|Anticipated|2024-07-01||Interventional|||CO2 Laser and Open Surgery for T1N0 Glottic SCC With Anterior Commissure Involved|Multicenter, Prospective, Randomized and Controlled Clinical Study 0f CO2 Laser and Open Surgery for T1N0 Glottic Squamous Cell Carcinoma With Anterior Commissure Involved|Recruiting||N/A|402|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:46:49.317522|2017-10-10 23:46:49.317522
NCT02303444|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-09-25|||April 8, 2015|Actual|2015-04-08|September 2017|2017-09-01|July 31, 2020|Anticipated|2020-07-31|March 31, 2020|Anticipated|2020-03-31||Observational|RIFTOS MKI||An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors|RIFTOS MKI - Radioactive Iodine reFractory Asymptomatic Patients in Differentiated Thyroid Cancer - an Observational Study to Assess the Use of Multikinase Inhibitors|Recruiting||N/A|700|Anticipated|Bayer|||2||f||||f||||||||||2017-10-10 23:46:49.439371|2017-10-10 23:46:49.439371
NCT02303431|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-03-22|||August 2014||2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study|A Phase 1, Open-Label, Single-Dose, Non-Randomized Study to Evaluate Pharmacokinetics and Pharmacodynamics of Edoxaban in Pediatric Patients|Recruiting||Phase 1|60|Anticipated|Daiichi Sankyo, Inc.||10|||f||||f||||||||||2017-10-10 23:46:49.699752|2017-10-10 23:46:49.699752
NCT02303418|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-01-20|||November 2014||2014-11-01|January 2017|2017-01-01||||November 2017|Anticipated|2017-11-01||Interventional|||Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial|Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial|Recruiting||Phase 3|500|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:46:49.976891|2017-10-10 23:46:49.976891
NCT02303405|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-04-18|||November 2014||2014-11-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus|Comparing the Effects of Hydroxychloroquine (HCQ) to Pioglitazone in Type 2 Diabetic Patients Failing Maximal Doses of Metformin Plus a Sulfonylurea|Recruiting||Phase 2|60|Anticipated|Charles Drew University of Medicine and Science||2|||f||||t||||||||No||2017-10-10 23:46:50.115914|2017-10-10 23:46:50.115914
NCT02303392|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-10-04|||March 11, 2015|Actual|2015-03-11|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma|A Dose Escalation Study of Selinexor (KPT-330), a Selective Inhibitor of Nuclear Export, and Ibrutinib, a Bruton's Tyrosine Kinase Inhibitor, in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma|Recruiting||Phase 1|92|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:46:50.248412|2017-10-10 23:46:50.248412
NCT02303379|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-09-26|||January 2014||2014-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Different Endurance Training Protocols in Cardiac Patients|Effects of Different Endurance Training Protocols on Physical Performance in Cardiac Patients|Active, not recruiting||Phase 4|52|Actual|Paracelsus Medical University||3|||f||||f||||||||||2017-10-10 23:46:50.427758|2017-10-10 23:46:50.427758
NCT02303366|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-11-04|||September 2015||2015-09-01|October 2015|2015-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|BOSTON II||Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475|A Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475.|Recruiting||Phase 1|15|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-10 23:46:50.584276|2017-10-10 23:46:50.584276
NCT02303353|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-02-23|||October 2013||2013-10-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy|Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy|Recruiting||N/A|2000|Anticipated|SPGO Research Mannheim GmbH|||1||f||||f||||||||||2017-10-10 23:46:50.700813|2017-10-10 23:46:50.700813
NCT02303340|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-03-15|||February 2015||2015-02-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Diagnosis of Decreased Bone Density by Dental Cone Beam Computed Tomography|Diagnosis of Decreased Bone Density by Dental Cone Beam Computed Tomography|Recruiting||N/A|50|Anticipated|Soroka University Medical Center|||1||f||||f||||||||||2017-10-10 23:46:50.801741|2017-10-10 23:46:50.801741
NCT02303327|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-03-16|||January 2015||2015-01-01|February 2017|2017-02-01|January 2029|Anticipated|2029-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients|Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy Followed by HDR Brachy Boost for High Risk Adenocarcinoma of the Prostate (PCS-VI)|Recruiting||Phase 3|296|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||f||||||||||2017-10-10 23:46:50.92754|2017-10-10 23:46:50.92754
NCT02303314|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-21|||November 2014||2014-11-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Interventional|||Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease||Completed||Phase 2/Phase 3|35|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:46:51.094326|2017-10-10 23:46:51.094326
NCT02303301|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-10-02|||October 2014||2014-10-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Changes of Oropharyngeal Flora|Changes in the Oropharyngeal Flora in Hospitalised Patients|Recruiting||N/A|128|Anticipated|Region Skane||2|||f||||f||||||||||2017-10-10 23:46:51.173689|2017-10-10 23:46:51.173689
NCT02303288|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2015-05-28|||November 2014||2014-11-01|May 2015|2015-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Post-Market Study of the Argus® II Retinal Prosthesis System - France|Post-Market Study of the Argus® II Retinal Prosthesis System - France|Recruiting||N/A|18|Anticipated|Second Sight Medical Products|||1||f||||t||||||||||2017-10-10 23:46:51.294066|2017-10-10 23:46:51.294066
NCT02303275|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-24|||May 2013||2013-05-01|November 2014|2014-11-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Lifestyle Change Program in Elderly Patients With Heart Failure|Comprehensive 12-week Lifestyle Change Program in Elderly Patients With Heart Failure|Unknown status|Recruiting|N/A|34|Anticipated|Scripps Center for Integrative Medicine||1|||f||||f||||||||||2017-10-10 23:46:51.390732|2017-10-10 23:46:51.390732
NCT02303262|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-27|||September 2015||2015-09-01|August 2016|2016-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma|A Phase II Study of Mocetinostat Administered With Gemcitabine for Patients With Metastatic Leiomyosarcoma With Progression or Relapse Following Prior Treatment With Gemcitabine-Containing Therapy|Completed||Phase 2|20|Actual|Sarcoma Alliance for Research through Collaboration||1|||f||||t||||||||||2017-10-10 23:46:51.503035|2017-10-10 23:46:51.503035
NCT02303249|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-01-09|||July 2013||2013-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|Tele-hjem||Interventional Study of Videoconferences Between Hospital and Municipality - a Randomized Controlled Trial|Interventional Study of Videoconferences Between Hospital and Municipality After Discharge From Roskilde and Køge Hospitals - a Randomized Controlled Trial|Completed||N/A|1387|Actual|Zealand University Hospital||2|||f||||f||||||||||2017-10-10 23:46:51.589419|2017-10-10 23:46:51.589419
NCT02303236|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-10-03|||November 2014|Actual|2014-11-01|October 2017|2017-10-01|December 24, 2016|Actual|2016-12-24|December 2016|Actual|2016-12-01||Observational|||Biological Markers Predicting Exercise Capacity in CF-LVAD Patients.|Biological Markers Predicting Exercise Capacity in Heart Failure Patients Supported With a Continuous-flow Left Ventricular Assist Device.|Completed||N/A|25|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     Blood samples in biological bank.   "|||2017-10-10 23:46:51.674175|2017-10-10 23:46:51.674175
NCT02303223|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2015-01-28|||January 2014||2014-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Propofol Pharmacokinetics in Children After Single Bolus Dose|Propofol Pharmacokinetics in Children After Single Bolus Dose|Completed||N/A|12|Actual|Postgraduate Institute of Medical Education and Research||1|||f||||t||||||||||2017-10-10 23:46:51.735894|2017-10-10 23:46:51.735894
NCT02303210|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-09-20|||December 2014||2014-12-01|September 2017|2017-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of Frequency Lowering Technique|Evaluation of Frequency Lowering Technique|Completed||N/A|30|Actual|Phonak AG, Switzerland||2|||f||||f||||||||||2017-10-10 23:46:51.824267|2017-10-10 23:46:51.824267
NCT02303197|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-12-20|||May 2014||2014-05-01|October 2014|2014-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis|A Randomized,Controlled Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis.|Completed||Phase 3|70|Actual|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-10 23:46:51.91252|2017-10-10 23:46:51.91252
NCT02127060|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2015-11-17|||February 2013||2013-02-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effectiveness of Vitamin C in Postoperative Pain Management of Single-level Posterior Lumbar Interbody Fusion (PLIF)||Completed||N/A|112|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:29:56.622204|2017-10-11 00:29:56.622204
NCT02303184|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-03-02|||January 2015||2015-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|TANZANITE||Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO|TANZANITE: Safety and Efficacy of Suprachoroidal CLS-TA in Combination With Intravitreal Aflibercept in Subjects With Macular Edema Following Retinal Vein Occlusion|Completed||Phase 2|46|Actual|Clearside Biomedical, Inc.||2|||f||||f||||||||||2017-10-10 23:46:52.013223|2017-10-10 23:46:52.013223
NCT02303171|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-05-08|||November 2014||2014-11-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Use of Warfarin After the First Trimester in Pregnant Women With APS|Use of Warfarin After the First Trimester in Pregnant Women With Antiphospholipid Syndrome|Recruiting||Phase 4|100|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 23:46:52.123831|2017-10-10 23:46:52.123831
NCT02303158|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-11-23|||January 2014||2014-01-01|November 2015|2015-11-01|February 2018|Anticipated|2018-02-01|February 2016|Anticipated|2016-02-01||Observational|LIDEAL||Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With Depression|Study of the Relationship Between Protein Biomarkers in Cerebrospinal Fluid and the Risk of Progression to Alzheimer&Apos;s Disease in a Cohort of Patients With Depression|Recruiting||N/A|50|Anticipated|Institut Investigacio Sanitaria Pere Virgili|||1||f||||t||||||Samples With DNA|"     cerebrospinal fluid (CSF), blood serum, blood plasma and whole blood   "|||2017-10-10 23:46:52.228045|2017-10-10 23:46:52.228045
NCT02303145|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-04-30|||September 2014||2014-09-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|BCSurvivorship||Breast Cancer Survivorship & Work-Related Cognitive Limitation|The Relationship Between Biopsychosocial Functioning and Work-Related Cognitive Limitation Among Employed Breast Cancer Survivors: Case Control Study.|Completed||N/A|187|Actual|Palo Alto University|||2||f||||f||||||||||2017-10-10 23:46:52.313994|2017-10-10 23:46:52.313994
NCT02303132|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-07-18|||November 2015||2015-11-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis|Ex Vivo Experiments to Evaluate the Role of Medication on the Colon Permeability in Microscopic Colitis|Completed||N/A|12|Actual|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-10 23:46:52.400867|2017-10-10 23:46:52.400867
NCT02303119|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-09-07|||February 2, 2015|Actual|2015-02-02|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|June 2020|Anticipated|2020-06-01||Interventional|FLIRT||Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT)|A Randomized Phase III Trial Evaluating Two Strategies of Rituximab Administration for the Treatment of First Line/Low Tumor Burden Follicular Lymphoma (Follicular Lymphoma IV/SC Rituximab Therapy)|Recruiting||Phase 3|202|Anticipated|The Lymphoma Academic Research Organisation||2|||f||||f||||||||||2017-10-10 23:46:52.471904|2017-10-10 23:46:52.471904
NCT02303106|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2015-04-21|||November 2014||2014-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Interaction Between Paracetamol and Lamotrigine: A Clinical Interaction Study|Interaction Between Paracetamol and Lamotrigine: A Clinical Interaction Study.|Completed||Phase 4|12|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:46:52.687334|2017-10-10 23:46:52.687334
NCT02303093|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-10-07|||March 2017||2017-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|GAM 10-06||"Non-Interventional Octagam® 10% - GAM10-06 GammaTrack"|"Non-Interventional Study on the Tolerability and Efficacy of Octagam® 10% - GAM10-06 GammaTrack"|Not yet recruiting||Phase 4|1000|Anticipated|Octapharma|||1||f||||f||||||||||2017-10-10 23:46:52.755011|2017-10-10 23:46:52.755011
NCT02303080|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-25|||November 2010||2010-11-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|Thermowhey||Whey Protein Micelles and Thermogenesis in Overweight Subjects|Whey Protein Micelles and Thermogenesis In Overweight Subjects|Completed||N/A|17|Actual|Nestlé||4|||f||||f||||||||||2017-10-10 23:46:52.95289|2017-10-10 23:46:52.95289
NCT02303067|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-10-05|||November 19, 2014||2014-11-19|September 14, 2017|2017-09-14|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)|Prospective International Study of Coronary Subtraction Using 320 Row-Detector CT|Recruiting||N/A|125|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:46:53.060521|2017-10-10 23:46:53.060521
NCT02303041|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-04-24|||February 2015||2015-02-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma|An Open-Label Pilot Study to Evaluate the Efficacy and Safety of a Combination Treatment of Sonidegib (LDE225) and Buparlisib (BKM120) For the Treatment of Advanced Basal Cell Carcinomas|Active, not recruiting||N/A|11|Actual|Stanford University||1|||f||||t||||||||Undecided||2017-10-10 23:46:53.236535|2017-10-10 23:46:53.236535
NCT02303028|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-05-08|||March 2015||2015-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|TOPAZ||Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid and CNS Tumours|A Phase I and Enrichment Study of Low-dose Metronomic Topotecan and Pazopanib in Pediatric Patients With Recurrent or Refractory Solid Tumours Including CNS Tumours|Recruiting||Phase 1/Phase 2|42|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||||2017-10-10 23:46:53.342859|2017-10-10 23:46:53.342859
NCT02303015|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-09-29|||August 2014||2014-08-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Observational|||Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors|Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors|Recruiting||N/A|4000|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     Blood samples and /or saliva.   "|||2017-10-10 23:46:53.480327|2017-10-10 23:46:53.480327
NCT02303002|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-03-08|||December 2014||2014-12-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines||Completed||Phase 2|268|Actual|Revance Therapeutics, Inc.||5|||f||||f||||||||||2017-10-10 23:46:53.560501|2017-10-10 23:46:53.560501
NCT02302989|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-10-18|||May 2015||2015-05-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PROTECT||Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration|Prospective Double-blind Randomized Study to Evaluate Lucentis for Prophylaxis Against the Conversion to Neovascular Age-related Macular Degeneration (AMD) in High-risk Eyes (Let's ProTECT AMD Eyes)|Active, not recruiting||Phase 1/Phase 2|4|Anticipated|NJ Retina (Retina Associates of New Jersey)||2|||f||||f||||||||||2017-10-10 23:46:53.648655|2017-10-10 23:46:53.648655
NCT02302976|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-06-26|||November 2014||2014-11-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration||Recruiting||Phase 1|24|Anticipated|Yale University||4|||f||||t||||||||||2017-10-10 23:46:53.73045|2017-10-10 23:46:53.73045
NCT02302963|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-03-22|||June 2015||2015-06-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D|Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Hypoglycemia Reduction in Type 1 Diabetes|Completed||N/A|85|Actual|University of Virginia||2|||f||||t||||||||Yes|NIH's Data Sharing Policy on sharing research resources for research purposes to the scientific community will be followed. Data will be stored in a Data Archive Database includes CGM-insulin delivery time series, meal content, boluses, & exercise will be deidentified & retrievable only by subject ID number. The data's real value lies in their precise time stamps - each reading is coded by date & time which makes possible the data to be related to the subjects' daily routine. Individual patterns of demographic & insulin treatment parameters leave open a remote possibility of deductive disclosure of subjects with unusual characteristics. Data can be made available only under a Data-Sharing Agreement that includes: (1) a commitment to using the data only for research purposes & not to identify participants; (2) a commitment to securing the data using appropriate computer technology; & (3) a commitment to destroying or returning the data after analyses are completed.|2017-10-10 23:46:53.829772|2017-10-10 23:46:53.829772
NCT02302950|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-05-19|||September 2014||2014-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Observational|||A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas|A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas|Active, not recruiting||N/A|254|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-10 23:46:53.930379|2017-10-10 23:46:53.930379
NCT02302937|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-04-07|||August 2011||2011-08-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|LESSTEP||SIngle Port vs Standard TEP for Primary Inguinal Hernia Repair|A Prospective, Randomized, Controlled Trial to Compare Single Port Laparoscopic TEP Inguinal Hernia Repair Versus Standard Laparoscopic (3 Port) TEP Inguinal Hernia Mesh Repair|Completed||N/A|100|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-10 23:46:54.008046|2017-10-10 23:46:54.008046
NCT02302924|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-06-11|||September 2014||2014-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Observational|FluPRO3||Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III|Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III|Completed||N/A|535|Actual|Uniformed Services University of the Health Sciences|||1||f||||f||||||Samples Without DNA|"     After obtaining informed consent, an oral/nasal swab or wash to confirm or rule out an     influenza etiology will be collected at baseline if the participant does not already have     documented laboratory confirmation of influenza.   "|||2017-10-10 23:46:54.110477|2017-10-10 23:46:54.110477
NCT02302911|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-09-29|||January 2013||2013-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|SwissEIPA||Swiss Early Intervention Project in Autism: An Evaluation of Early Intervention Outcome|Swiss Early Intervention Project in Autism: An Evaluation of Early Intervention Outcome|Recruiting||N/A|90|Anticipated|University of Zurich|||3||f||||t||||||Samples Without DNA|"     no biospecimens are being retained   "|||2017-10-10 23:46:54.202214|2017-10-10 23:46:54.202214
NCT02302898|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-26|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|||Roux-en-Y Gastric Bypass and Weight Regain|Characteristics Associated With Weight Regain After Roux-en-Y Gastric Bypass|Unknown status|Not yet recruiting|N/A|50|Anticipated|Washington University School of Medicine|||2||f||||f||||||||||2017-10-10 23:46:54.336004|2017-10-10 23:46:54.336004
NCT02302885|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-04-11|||November 2014||2014-11-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Healthy Human Control Blood Collection for Validation of Biomarker Assay|Human Blood Collection to Serve as Negative Control for Validation of Circulating Tumor Cell Assay|Recruiting||N/A|70|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     About 20 mL blood will be collected from volunteers up to 20 different timepoints.   "|||2017-10-10 23:46:54.483419|2017-10-10 23:46:54.483419
NCT02302872|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-09-20|||October 2013||2013-10-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|October 2017|Anticipated|2017-10-01||Interventional|MAVERIC||Treatment of Heart Failure and Associated Functional Mitral Valve Regurgitation|Mitral Valve Repair Clinical Trial (MAVERIC Trial)|Recruiting||N/A|45|Anticipated|Mvrx, Inc.||1|||f||||t||||||||||2017-10-10 23:46:54.566914|2017-10-10 23:46:54.566914
NCT02302846|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-06-01|||March 20, 2015|Actual|2015-03-20|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|||Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission|Phase II Study Of Ixazomib As Maintenance Therapy For Patients With Acute Myeloid Leukemia (AML) And High Risk Myelodysplastic Syndrome (MDS) In Remission|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f|t|f||||||||2017-10-10 23:46:54.80189|2017-10-10 23:46:54.80189
NCT02301754|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-03-01|||November 2014||2014-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||INVAC-1 Anti-Cancer hTERT DNA Immunotherapy|A First in Human Phase I Study of INVAC-1 as a Single Agent in Patients With Advanced Cancer|Recruiting||Phase 1|26|Anticipated|Invectys||1|||f||||t||||||||||2017-10-10 23:47:08.633187|2017-10-10 23:47:08.633187
NCT02302833|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-11|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable Metastatic Pheochromocytomas and Paragangliomas|A Phase II Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable Metastatic Pheochromocytomas and Paragangliomas|Recruiting||Phase 2|22|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:46:54.893388|2017-10-10 23:46:54.893388
NCT02302820|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-01-04|||December 2014||2014-12-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ACP||Nurse-led Patient-centered Advance Care Planning: A Pilot Study|Nurse-led Patient-centered Advance Care Planning: A Pilot Study|Completed||N/A|78|Actual|Mayo Clinic||4|||f||||f||||||||||2017-10-10 23:46:54.989724|2017-10-10 23:46:54.989724
NCT02302807|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-08-01|||January 13, 2015|Actual|2015-01-13|August 2017|2017-08-01|November 28, 2017|Anticipated|2017-11-28|March 13, 2017|Actual|2017-03-13||Interventional|||A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]|A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer After Failure With Platinum-Containing Chemotherapy|Active, not recruiting||Phase 3|932|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:46:55.099175|2017-10-10 23:46:55.099175
NCT02302794|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2014-11-25|||August 2014||2014-08-01|July 2014|2014-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery|Prospective Randomized Controlled Multicenter Clinical Trial for Comparison of Long-term Outcomes Between Laparoscopy-assisted and Open Distal Subtotal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer|Unknown status|Recruiting|Phase 3|1056|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:46:55.611124|2017-10-10 23:46:55.611124
NCT02302781|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-04-09|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2020|Anticipated|2020-01-01|3 Years|Observational [Patient Registry]|DOT||Why Subfertile Couples Drop Out|Why Subfertile Couples Drop Out (Drop Out Trial); a Prospective Survey in the Netherlands.|Recruiting||N/A|1000|Anticipated|Isala|||1||f||||t|f|f||||||Undecided||2017-10-10 23:46:55.69537|2017-10-10 23:46:55.69537
NCT02302768|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-26|||December 2012||2012-12-01|November 2014|2014-11-01|January 2015|Anticipated|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT|Effect of Supplementation of Two Doses of L-selenomethionine (Semet; 80 and 160 mcg) Versus Placebo in Patients With Chronic Autoimmune Thyroiditis (AIT) With Normal Thyroid Function.|Unknown status|Active, not recruiting|Phase 2|60|Actual|University of Siena||3|||f||||f||||||||||2017-10-10 23:46:55.81968|2017-10-10 23:46:55.81968
NCT02302755|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-10-25|||November 2014||2014-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||TP10 Use in Patients With C3 Glomerulopathy (C3G)|A Pilot, Open-Label Single Center Trial of TP10 in Pediatric and Adult Patients With C3 Glomerulopathy (C3G)|Withdrawn||Phase 1|0|Actual|University of Iowa||1||no recruitment|f||||t||||||||||2017-10-10 23:46:55.884854|2017-10-10 23:46:55.884854
NCT02302742|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-08-25|||March 2011||2011-03-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01|10 Years|Observational [Patient Registry]|PROGECT||Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry|PROspective Evaluation of GErmline Mutations, Cancer Outcome and Tissue Biomarkers: A Registry for Patients With Triple Negative Breast Cancer and Germline Mutations|Recruiting||N/A|750|Anticipated|University of Kansas Medical Center|||2||f||||f||||||Samples With DNA|"     A baseline blood draw is collected as a part of this registry. If a study participant has a     personal history of cancer and a tumor sample is available, the participant may give consent     for the tissue to be used as a part of the study. Additional optional specimen collection     sub-studies may also be offered to participants.   "|||2017-10-10 23:46:57.764147|2017-10-10 23:46:57.764147
NCT02302729|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-09-28|||February 16, 2015|Actual|2015-02-16|September 2017|2017-09-01|December 8, 2015|Actual|2015-12-08|December 8, 2015|Actual|2015-12-08||Interventional|||Early Child Development and Nutrition in Guatemala|Professor, Department of Pediatrics, University of Maryland School of Medicine|Completed||N/A|1730|Actual|University of Maryland||4|||f||||t||||||||||2017-10-10 23:46:57.875902|2017-10-10 23:46:57.875902
NCT02302703|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-03-02|||May 2015||2015-05-01|November 2014|2014-11-01|January 2017||2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Low FODMAP (Fermentable Oligo-,di-,Mono-saccharides and Polyols) Versus Gluten-free Diet in Pediatric IBS Patients; a Cross-over Randomized Trial.|Low FODMAP (Fermentable Oligo-,di-,Mono-saccharides and Polyols) Versus Gluten-free Diet in Pediatric IBS Patients; a Cross-over Randomized Trial.|Unknown status|Recruiting|N/A|40|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-10 23:46:58.126753|2017-10-10 23:46:58.126753
NCT02302690|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2016-08-17|||November 2014||2014-11-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Immunity Against AAV in Crigler Najjar Patient|Study of the Prevalence of Pre-existing Immunity Against the Adeno-associated Virus (AAV) in Patients With Crigler-Najjar Syndrome|Recruiting||N/A|50|Anticipated|Genethon|||1||f||||f||||||||||2017-10-10 23:46:58.206313|2017-10-10 23:46:58.206313
NCT02302677|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-09-19|||January 2015||2015-01-01|September 2017|2017-09-01|September 20, 2017|Actual|2017-09-20|August 15, 2016|Actual|2016-08-15||Observational|BAS||The Effect of Sleeve Gastrectomy on Post-prandial Serum Bile Acids|The Effect of Sleeve Gastrectomy on Post-prandial Serum Bile Acids|Completed||N/A|40|Actual|University of Nebraska|||1||f||||f||||||Samples Without DNA|"     Serum Urine   "|||2017-10-10 23:46:58.267013|2017-10-10 23:46:58.267013
NCT02302469|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-06-06|||March 2009|Actual|2009-03-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|RV-WM-0426||Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia|A Multicenter Phase I/II Dose Escalation Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia|Completed||Phase 1/Phase 2|17|Actual|University Hospital, Lille||1|||f||||t||||||||No||2017-10-10 23:47:00.397936|2017-10-10 23:47:00.397936
NCT02302664|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-06-19|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|January 2018|Anticipated|2018-01-01||Interventional|PATH-2||PATH-2: Platelet Rich Plasma in Achilles Tendon Healing|A Pragmatic Multi-centre Blinded Randomised Placebo-controlled Trial Comparing Platelet Rich Plasma Injection (PRP) to Placebo (Imitation) Injection in Adults With Achilles Tendon Rupture|Recruiting||N/A|214|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 23:46:58.451089|2017-10-10 23:46:58.451089
NCT02302651|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-24|||June 2010||2010-06-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Non-invasive Focal Therapy for Osteoid Osteoma|Treatment of Osteoid Osteoma With MR Guided High Intensity Focused Ultrasound|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-10 23:46:58.619465|2017-10-10 23:46:58.619465
NCT02302638|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2015-06-08|||November 2014||2014-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Embryo Development Using Two Commercial Single-step Media|Embryo Development and Utilization Using Two Commercial Single-step Media|Completed||N/A|43|Actual|Eugonia||2|||f||||f||||||||||2017-10-10 23:46:58.711361|2017-10-10 23:46:58.711361
NCT02302625|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-03-02|||November 2014||2014-11-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Cognitive Behavior Therapy for Atopic Dermatitis|Exposure-based CBT for Itching in Atopic Dermatitis|Completed||N/A|9|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-10 23:46:58.799061|2017-10-10 23:46:58.799061
NCT02302612|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-01-12|||January 2015||2015-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The CREATE Wellness Study|Multi-Component Behavioral Intervention for Complex Patients With CVD Risk. The Changing Results: Engage and Activate to Enhance Wellness (CREATE Wellness) Study|Recruiting||N/A|588|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-10 23:46:58.893438|2017-10-10 23:46:58.893438
NCT02302599|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-26|||January 2013||2013-01-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|UC-MSCs||Mesenchymal Stem Cells to Treat Type II Diabetes|Mesenchymal Stem Cell Infusion Therapy Between Efficacy and Safety of Chinese Type II Diabetic Subjects of Multicenter, Randomized, Double-blind, Controlled Study|Unknown status|Recruiting|Phase 1|200|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:46:59.049788|2017-10-10 23:46:59.049788
NCT02302586|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-08-02|||September 2014||2014-09-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|VATS||Thoracic Paravertebral Blockade in Video Assisted Thoracoscopic Surgery (VATS)|Effects of Thoracic Paravertebral Blockade on Acute and Chronic Pain After Video Assisted Thoracoscopic Surgery (VATS) - A Randomized, Clinical Trial|Completed||Phase 4|60|Actual|Istanbul University||2|||f||||t||||||||||2017-10-10 23:46:59.142481|2017-10-10 23:46:59.142481
NCT02302573|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-12-05|||May 2009||2009-05-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population|Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population|Completed||N/A|80|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 23:46:59.24925|2017-10-10 23:46:59.24925
NCT02302560|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-07-06|||February 2015||2015-02-01|July 2017|2017-07-01|November 2019|Anticipated|2019-11-01|February 2019|Anticipated|2019-02-01||Observational|||Identification of the Sleep Architecture in Patients With Hip Surgery (TepSo)|Identification of the Sleep Architecture in Patients With Hip Surgery (TepSo)|Active, not recruiting||N/A|40|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-10 23:46:59.330855|2017-10-10 23:46:59.330855
NCT02302547|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-10-05|||December 2014|Actual|2014-12-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 23, 2017|Actual|2017-08-23||Interventional|TRULIGHT||Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy|Randomized Clinical Trial to Evaluate the Interest of a Down-scaled Treatment Strategy Using Dual Therapy (Nucleoside Analogs) in HIV Infected Patients Already Being Treated Using Triple Therapy, Who Present With a Successful Virological Control and for Which the HIV Reservoir is Low to Moderate|Active, not recruiting||Phase 3|224|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-10-10 23:46:59.418939|2017-10-10 23:46:59.418939
NCT02302534|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-08-31|||September 2014||2014-09-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MOR-FO-SIA||Pilot Study of Functional and Morphometric Brain Abnormalities Related to Adolescent Idiopathic Scoliosis (MOR-FO-SIA)|Pilot Study of Functional and Morphometric Brain Abnormalities Related to Adolescent Idiopathic Scoliosis (MOR-FO-SIA)|Completed||N/A|16|Actual|University Hospital, Tours||2|||f||||f||||||||||2017-10-10 23:46:59.569141|2017-10-10 23:46:59.569141
NCT02302521|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-25|2017-08-10|||May 28, 2015|Actual|2015-05-28|July 2016|2016-07-01|November 26, 2016|Actual|2016-11-26|November 26, 2016|Actual|2016-11-26||Observational|||Motion Immune Magnetic Resonance Imaging (MRI)|Examining the Clinical Utility of Motion Immune MRI Across Multiple Patient Populations|Completed||N/A|16|Actual|Duke University|||4||f||||||t|t|f||||||2017-10-10 23:46:59.643992|2017-10-10 23:46:59.643992
NCT02302508|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-08-02|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|PANDDA||Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients|PANDDA Study: Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients|Not yet recruiting||Phase 4|108|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||4|||f||||t|f|f||||||||2017-10-10 23:46:59.731006|2017-10-10 23:46:59.731006
NCT02302495|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-08-21|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|IFM2012-03||Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma|A Multicenter Open Label Phase 2 Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma|Recruiting||Phase 2|80|Anticipated|University Hospital, Lille||1|||f||||f||||||||||2017-10-10 23:46:59.842099|2017-10-10 23:46:59.842099
NCT02302482|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-05-22|||November 2014|Actual|2014-11-01|September 2016|2016-09-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Interventional|MEMORA||Predictive Factors and Autonomy Level Change|Predictive Factors of the Autonomy Level Change Related to Memory Disorders|Recruiting||N/A|6780|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:47:00.289196|2017-10-10 23:47:00.289196
NCT02301546|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-01-13|||March 2015||2015-03-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Cognitive Training and Practice Effects in MCI|Cognitive Training and Practice Effects in MCI|Recruiting||N/A|200|Anticipated|University of Utah||2|||f||||f||||||||Yes||2017-10-10 23:47:10.292164|2017-10-10 23:47:10.292164
NCT02302456|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-09-04|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|TRAAP||Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery|Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery: a Multicenter Randomised Double Blind Placebo Controlled Trial|Completed||Phase 3|4079|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-10 23:47:00.522428|2017-10-10 23:47:00.522428
NCT02302443|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-04-07|||February 2015||2015-02-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470|A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Administration of HM12470 in Subjects With Type 1 (T1DM) and Type 2 Diabetes Mellitus (T2DM)|Recruiting||Phase 1|100|Anticipated|Hanmi Pharmaceutical Company Limited||6|||f||||f||||||||||2017-10-10 23:47:00.63698|2017-10-10 23:47:00.63698
NCT02302430|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-05-18|||October 2015||2015-10-01|May 2017|2017-05-01||||July 2017|Anticipated|2017-07-01||Interventional|ECHO||Intranasal Oxytocin and Enhancement of Team Cohesion|Psychobiological Assessment and Enhancement of Team Cohesion and Psychological Resilience Using a Virtual Team Cohesion Test.|Recruiting||Phase 1|360|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:47:00.74025|2017-10-10 23:47:00.74025
NCT02302404|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-05-05|||January 6, 2015|Actual|2015-01-06|May 2017|2017-05-01|March 5, 2016|Actual|2016-03-05|March 5, 2016|Actual|2016-03-05||Interventional|||A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects|A Single-centre, Randomized, Double-blind (Sponsor Unblinded), Placebo-controlled Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects|Completed||Phase 1|79|Actual|GlaxoSmithKline||7|||f||||f||||||||||2017-10-10 23:47:01.089762|2017-10-10 23:47:01.089762
NCT02302391|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-05-06|||October 2014||2014-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Observational|Morpheus||Pharmacokinetic Analysis of Midazolam and Fentanyl in Pediatric Patients With Long-term Analgosedation|Pharmacokinetic Analysis of Midazolam and Fentanyl in Pediatric Patients With Long-term Analgosedation.|Recruiting||N/A|30|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-10 23:47:01.217142|2017-10-10 23:47:01.217142
NCT02302378|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-12-02|||January 2015||2015-01-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Taylor's Approach vs Lumbar Approach for Spinal Anesthesia|Hypotension in Spinal Anesthesia for Total Knee Joint Arthroplasty: a Comparison of Taylor's Approach With Paramedian Lumbar Approach|Completed||N/A|30|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:47:01.308413|2017-10-10 23:47:01.308413
NCT02302365|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-02-03|2015-11-12||April 2014||2014-04-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|WBCD|Eligible subjects had received a minimum of 1 WBCD procedure using the Spectra Optia Apheresis System.|Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion|Multicenter, Retrospective Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion|Completed||N/A|43|Actual|Terumo BCT|||1||f||||t||||||||||2017-10-10 23:47:01.425522|2017-10-10 23:47:01.425522
NCT02302352|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-24|||December 2014||2014-12-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|April 2015|Anticipated|2015-04-01||Interventional|SSc||Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis|Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis: a Randomized Double-blind Placebo-controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 3|76|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-10 23:47:01.821768|2017-10-10 23:47:01.821768
NCT02302339|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-06-20|||November 2014||2014-11-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma|A Phase 2 Study of Glembatumumab Vedotin, an Anti-gpNMB Antibody-drug Conjugate, as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma|Recruiting||Phase 2|120|Anticipated|Celldex Therapeutics||3|||f||||f||||||||||2017-10-10 23:47:01.918886|2017-10-10 23:47:01.918886
NCT02302326|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-02-14|||January 2013||2013-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PI12/1984||Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome|Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome: Possible Therapeutic Implications of Insulin Sensitizers.|Recruiting||N/A|50|Anticipated|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||3|||f||||f||||||||||2017-10-10 23:47:02.102864|2017-10-10 23:47:02.102864
NCT02302313|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-08-26|||March 2015||2015-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study of the ANI Validity on Evaluation of Nociception in State of Hypnosis|Pilot Study of the ANI (Analgesia Nociception Index) Validity on the Nociception Assessment in Healthy Volunteers in State of Hypnosis, Compared to Painful Numerical Verbal Scale (EVN).|Completed||N/A|35|Actual|University Hospital, Brest||1|||f||||t||||||||||2017-10-10 23:47:02.212004|2017-10-10 23:47:02.212004
NCT02302300|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-01-13|||July 2014||2014-07-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Interventional|CAPVNI||Interest of the Not Invasive Ventilation Used in Meadow and Post-operative of Cardiac Surgery|Interest of the Not Invasive Ventilation Used in Meadow and Post-operative of Cardiac Surgery, in Disease Prevention of the Cardiac and/or Lung Complications at the Patients at Risk.|Recruiting||N/A|216|Anticipated|University Hospital, Brest||2|||f||||t||||||||||2017-10-10 23:47:02.284894|2017-10-10 23:47:02.284894
NCT02302287|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-11-24|||January 2015||2015-01-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|MEDIKA||Renal Effects of Meditarranean Diet and Low-protein Diet With Ketoacids on Physiological Intestinal Mibrobiota in CKD|Gut-kidney Axis: Renal Effects of Meditarranean Diet and Low-protein Diet With Ketoacids to Restore Physiological Intestinal Mibrobiota in Chronic Kidney Disease|Active, not recruiting||Phase 4|60|Anticipated|Azienda Sanitaria ASL Avellino 2||3|||f||||f||||||||||2017-10-10 23:47:02.356568|2017-10-10 23:47:02.356568
NCT02302274|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-03-20|||July 2010||2010-07-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome|Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome|Recruiting||Phase 1/Phase 2|230|Anticipated|New York University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 23:47:02.459552|2017-10-10 23:47:02.459552
NCT02302261|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-07-25|||January 2015||2015-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Pleth Variability and Asthma Severity in Children|Using Pleth Variability to Triage Asthmatics in the Pediatric ED|Completed||N/A|37|Actual|Northwell Health|||1||f||||f||||||||||2017-10-10 23:47:02.54874|2017-10-10 23:47:02.54874
NCT02302248|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-25|||April 2014||2014-04-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effectiveness of a Crowdsourced Cognitive Reappraisal Intervention|A Randomized, Active-Controlled Trial to Investigate the Effectiveness of a Crowdsourced Cognitive Reappraisal Intervention.|Completed||N/A|270|Actual|Massachusetts Institute of Technology||2|||f||||f||||||||||2017-10-10 23:47:02.688147|2017-10-10 23:47:02.688147
NCT02302235|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-03-17|||February 2014||2014-02-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|GBMXRT||Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study|Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study|Recruiting||Phase 2|42|Anticipated|Mid-Atlantic Epilepsy and Sleep Center, LLC||2|||f||||f||||||||||2017-10-10 23:47:02.918881|2017-10-10 23:47:02.918881
NCT02302222|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-06-01|||May 2015|Actual|2015-05-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing|The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing|Recruiting||N/A|102|Anticipated|KCI USA, Inc.||2|||f||||f||||||||||2017-10-10 23:47:03.028023|2017-10-10 23:47:03.028023
NCT02302209|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-05-20|||April 2011||2011-04-01|May 2016|2016-05-01||||June 2016|Anticipated|2016-06-01||Interventional|DOS||Dyad Oxytocin Study (DOS)|Effects of Oxytocin on Familial Interactions|Recruiting||Phase 1|60|Anticipated|University of California, San Francisco||2|||f||||||||||||||2017-10-10 23:47:03.119982|2017-10-10 23:47:03.119982
NCT02302196|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-03-09|||September 2015||2015-09-01|March 2017|2017-03-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects|Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects|Recruiting||N/A|100|Anticipated|Kaiser Permanente|||2||f||||f||||||||No||2017-10-10 23:47:03.224211|2017-10-10 23:47:03.224211
NCT02302183|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-03-02|||December 24, 2014|Actual|2014-12-24|March 2017|2017-03-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|Infant-Free02||Automatic Oxygen Administration During the Respiratory Distress in Infants and Children (Infant-FreeO2)|Automatic Oxygen Administration in Spontaneous Ventilation During the Hypoxemic Acute Respiratory Distress in Infants and Children|Completed||N/A|60|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-10-10 23:47:03.307482|2017-10-10 23:47:03.307482
NCT02302170|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-25|||December 2004||2004-12-01|November 2014|2014-11-01|September 2008|Actual|2008-09-01|September 2006|Actual|2006-09-01||Interventional|||A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children|A Phase Ⅲ Clinical Trial for Efficacy, Immunogenicity, Safety and Immune Persistence of Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children Aged From 6-15 Years Old.|Completed||Phase 3|4464|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-10 23:47:03.387969|2017-10-10 23:47:03.387969
NCT02302157|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-08-17|||March 2015||2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Dose Escalation Study of AST-OPC1 in Spinal Cord Injury|A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury|Recruiting||Phase 1/Phase 2|35|Anticipated|Asterias Biotherapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:47:03.498492|2017-10-10 23:47:03.498492
NCT02302144|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-07-18|||December 2011||2011-12-01|July 2017|2017-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease|A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease|Completed||N/A|32|Actual|Boston University Charles River Campus||2|||f||||f||||||||||2017-10-10 23:47:03.677866|2017-10-10 23:47:03.677866
NCT02302131|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-04-04|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|November 2015|Actual|2015-11-01|24 Months|Observational [Patient Registry]|Pulmonic XT||Pulmonic SAPIEN XT THV|Pulmonic SAPIEN XT™ THV A Multi-center, Observational Registry With Retrospective Enrollment of Patients That Underwent Transcatheter Pulmonic Valve Implantation and a Retrospective or Prospective Follow-up|Completed||N/A|49|Actual|Institut für Pharmakologie und Präventive Medizin|||1||f||||f||||||||||2017-10-10 23:47:03.8129|2017-10-10 23:47:03.8129
NCT02302118|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-12-02|||April 2013||2013-04-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|AEG-II-EG||Esophagogastrectomy Versus Extended Gastrectomy in AEG II|Survival Benefit by Esophagogastrectomy Versus Extended Gastrectomy of Patients With Carcinoma of the Esophagogastric Junction|Completed||N/A|128|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-10 23:47:03.915232|2017-10-10 23:47:03.915232
NCT02302105|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-24|||November 2011||2011-11-01|November 2014|2014-11-01||||January 2021|Anticipated|2021-01-01||Interventional|POP-RT||Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer|Prospective Phase III Randomized Trial of Prostate Only or Whole Pelvic RadioTherapy in High Risk Prostate Cancer (POP-RT) Trial|Recruiting||N/A|224|Anticipated|Tata Memorial Centre||2|||f||||t||||||||||2017-10-10 23:47:04.003891|2017-10-10 23:47:04.003891
NCT02302079|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-08-10||2017-08-01|January 12, 2015|Actual|2015-01-12|August 2017|2017-08-01|August 12, 2016|Actual|2016-08-12|August 12, 2016|Actual|2016-08-12||Interventional|VIDI||A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)|A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema|Completed||Phase 2|96|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-10 23:47:04.202033|2017-10-10 23:47:04.202033
NCT02302066|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-09-08|||December 1, 2014|Actual|2014-12-01|September 2017|2017-09-01|July 12, 2019|Anticipated|2019-07-12|July 12, 2019|Anticipated|2019-07-12||Interventional|||Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants|A Phase II, Double-Blind, Controlled Trial to Assess the Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Subjects Aged Between 2 and <18 Years and Living in Dengue Endemic Countries in Asia and Latin America|Active, not recruiting||Phase 2|1800|Anticipated|Takeda||4|||f||||t||||||||||2017-10-10 23:47:04.353236|2017-10-10 23:47:04.353236
NCT02302053|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-25|||February 2013||2013-02-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Self-Perceived Thinning Hair|Completed||N/A|40|Actual|Ablon Skin Institute Research Center||2|||f||||f||||||||||2017-10-10 23:47:04.456031|2017-10-10 23:47:04.456031
NCT02302040|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-07-03|||December 2015||2015-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|AIM2ACT||Applying Interactive Mobile Health to Asthma Care in Teens (AIM2ACT)|mHealth Approach to Collaborative Asthma Management for Teens & Parents|Recruiting||N/A|240|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 23:47:04.54972|2017-10-10 23:47:04.54972
NCT02302027|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-01-06|||December 2014||2014-12-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|O214||Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache|Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache With or Without Abuse of Painkillers|Recruiting||N/A|30|Anticipated|Association pour la Recherche au Centre d'Urgence des Céphalées||1|||f||||f||||||||||2017-10-10 23:47:04.661933|2017-10-10 23:47:04.661933
NCT02302014|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-12-14|||August 2013||2013-08-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|FLAME||Palliative Care for Patients With Advanced Heart Disease|Randomised Trial of Early Versus Delayed Future Care Planning for Patients and Families Living With Advanced Heart Disease|Completed||Phase 2|50|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-10-10 23:47:04.767315|2017-10-10 23:47:04.767315
NCT02302001|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-07-15|||November 2014||2014-11-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effects of Jet Hydro Dissection in Breast Augmentation Postoperative Pain|Breast Augmentation Using Novel Method of Jet Hydro Dissection Effects on Postoperative Pain|Completed||N/A|21|Actual|Aristocrat Plastic Surgery and MedAesthetics||1|||f||||t||||||||||2017-10-10 23:47:04.845345|2017-10-10 23:47:04.845345
NCT02301988|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-07-11|||February 17, 2015|Actual|2015-02-17|July 2017|2017-07-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer|A Phase II Randomized, Double-Blind, Study of Ipatasertib (GDC-0068), an Inhibitor to AKT, in Combination With Paclitaxel as Neoadjuvant Treatment for Patients With Early Stage Triple Negative Breast Cancer|Active, not recruiting||Phase 2|151|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-10 23:47:04.930512|2017-10-10 23:47:04.930512
NCT02301975|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-05-08|2017-05-08||March 1, 2015||2015-03-01|May 2017|2017-05-01|November 25, 2016|Actual|2016-11-25|November 1, 2016|Actual|2016-11-01||Interventional|||An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma|A Randomized, Double-blind, Double-dummy, Parallel Group, Multicenter Study of Once Daily Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, Twice Daily Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Twice Daily Fluticasone Propionate 250 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents Already Adequately Controlled on Twice-daily Inhaled Corticosteroid and Long-acting beta2 Agonist|Completed||Phase 3|1526|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:47:05.174347|2017-10-10 23:47:05.174347
NCT02301962|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-03-06|||July 2015||2015-07-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer|An Open Label, Multicenter, Non-Comparative, Phase IV Study of Panitumumab to Characterize Its Safety, Tolerability and Activity in Indian Subjects With Previously Treated Wild-Type RAS (KRAS and NRAS), Metastatic Colorectal Cancer|Recruiting||Phase 4|58|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:47:06.433386|2017-10-10 23:47:06.433386
NCT02301949|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-04-19|||December 2015||2015-12-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment|The Study of the Optimal Treatment Strategy for Patients With Gastrointestinal Bleeding Due to Gastrointestinal Vascular Malformation: a Randomized, Double Blind, Placebo Controlled Study|Withdrawn||Phase 2|0|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||||2017-10-10 23:47:06.56868|2017-10-10 23:47:06.56868
NCT02106741|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-10-24|||May 2013||2013-05-01|August 2015|2015-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Acupressure for Fatigue and Low Back Pain|Randomized Pilot Study of Self-Administered Acupressure for Patients With Low Back Pain|Completed||N/A|51|Actual|University of Michigan||3|||f||||f||||||||||2017-10-11 00:35:13.447147|2017-10-11 00:35:13.447147
NCT02301936|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-04-18|2017-04-18||March 2, 2015|Actual|2015-03-02|April 2017|2017-04-01|April 18, 2016|Actual|2016-04-18|April 18, 2016|Actual|2016-04-18||Interventional||Safety Analysis Set: participants who took at least 1 dose of study drug.|Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease|An Open-Label Study of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Subjects With Sickle Cell Disease|Completed||Phase 2|10|Actual|Gilead Sciences||2|||f||||f|t|f||||||||2017-10-10 23:47:06.69906|2017-10-10 23:47:06.69906
NCT02301923|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-25|||November 2014||2014-11-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|November 2014|Actual|2014-11-01||Observational|CPAPcompl||Continuous Positive Airway Pressure (CPAP) Compliance in Obstructive Sleep Apnea|Predictive Factors Determining Continuous Positive Airway Pressure (CPAP) Compliance in Obstructive Sleep Apnea|Unknown status|Not yet recruiting|N/A|450|Anticipated|Saint-Joseph University|||2||f||||t||||||||||2017-10-10 23:47:07.469663|2017-10-10 23:47:07.469663
NCT02301910|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2014-11-25|||October 2014||2014-10-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|FORMAT-1||Single Bolus Recombinant Nonimmunogenic Staphylokinase (FORtelyzin) Versus Single Bolus Tenecteplase (Metalyse) in STEMI|Multicenter Open Lable Randomized Comparative Study of Efficacy and Safety of Single Bolus Injection of Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Tenecteplase (Metalyse) in STEMI Patients|Unknown status|Recruiting|Phase 3|392|Anticipated|Supergene, LLC||2|||f||||f||||||||||2017-10-10 23:47:07.565837|2017-10-10 23:47:07.565837
NCT02301897|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-07-25|||December 2014||2014-12-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids|A Phase 2, Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids|Completed||Phase 2|43|Actual|Repros Therapeutics Inc.||3|||f||||t||||||||||2017-10-10 23:47:07.746749|2017-10-10 23:47:07.746749
NCT02301884|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-03-10|||November 2013||2013-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|pILIT||Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis|Open-labeled Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients|Completed||Phase 1|12|Actual|Gachon University Gil Medical Center||1|||f||||t||||||||||2017-10-10 23:47:07.835341|2017-10-10 23:47:07.835341
NCT02301871|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2014-11-25|||July 2013||2013-07-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||The Effect of Soft Tissue Mobilization in Myofascial Neck Pain|Efficacy of Muscle Energy Technique and Deep Neck Flexors Training in Mechanical Neck Pain- A Randomized Clinical Trial|Completed||N/A|33|Actual|Maharishi Markendeswar University||3|||f||||t||||||||||2017-10-10 23:47:07.912933|2017-10-10 23:47:07.912933
NCT02301858|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-12-06|||December 2013||2013-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases|Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases|Recruiting||N/A|100|Anticipated|Sykehuset i Vestfold HF||1|||f||||f||||||||||2017-10-10 23:47:07.999654|2017-10-10 23:47:07.999654
NCT02301845|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-03-14|||February 2016||2016-02-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Validation of Aspiration Markers|Validation of a Marker for Aspiration and Endotracheal Tube Cuff Leak.|Withdrawn||Phase 1|0|Actual|Massachusetts General Hospital||1||IRB disapproval|f||||f||||||||||2017-10-10 23:47:08.096338|2017-10-10 23:47:08.096338
NCT02301832|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-02-03|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|July 20, 2016|Actual|2016-07-20|July 20, 2016|Actual|2016-07-20||Observational|||Reliability of Sensor Spacing for NIRS in Traumatic Tibia Fractures|Reliability of Sensor Spacing for Near Infrared Spectroscopy in Traumatic Tibia Fractures: An Observational Study|Completed||N/A|14|Actual|Emory University|||1||f||||f||||||||||2017-10-10 23:47:08.167846|2017-10-10 23:47:08.167846
NCT02301819|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-09-25|||September 2014||2014-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|ECMO-CS||ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock|ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock|Recruiting||Phase 4|120|Anticipated|Na Homolce Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:47:08.227655|2017-10-10 23:47:08.227655
NCT02301806|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2016-02-15|||January 2015||2015-01-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM|A Randomized, Prospective, Parallel Design Study to Compare the Effectiveness of Sitagliptin Versus Glimepiride on Endothelial Dysfunction During an Oral Glucose Loading in Drug Naive Patients With Type 2 Diabetes.|Recruiting||Phase 4|30|Anticipated|Dokkyo Medical University||2|||f||||t||||||||||2017-10-10 23:47:08.312874|2017-10-10 23:47:08.312874
NCT02301780|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-11-08|||December 2015||2015-12-01|November 2015|2015-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ASPRE||Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention|Combined Multi-marker Screening and Randomised Patient Treatment With Aspirin for Evidence-based Pre-eclampsia Prevention. University College London - Sponsor of All EU Study Sites.|Completed||Phase 3|2|Actual|Rabin Medical Center||2|||f||||t||||||||No||2017-10-10 23:47:08.475424|2017-10-10 23:47:08.475424
NCT02301767|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-02-13|||November 2014||2014-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study|MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study|Recruiting||N/A|1500|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"     saliva   "|||2017-10-10 23:47:08.543999|2017-10-10 23:47:08.543999
NCT02301741|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-06-09|||January 2015||2015-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Using an Interactive Game to Reduce Fear and Increase Spine Motion in Low Back Pain|Using an Interactive Game to Reduce Fear & Increase Spine Motion in Low Back Pain|Completed||N/A|53|Actual|Ohio University||2|||f||||t||||||||||2017-10-10 23:47:08.713552|2017-10-10 23:47:08.713552
NCT02301728|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2014-11-25|||December 2014||2014-12-01|November 2014|2014-11-01|May 2015|Anticipated|2015-05-01|January 2015|Anticipated|2015-01-01||Observational|||Study on Short Chain Fatty Acids Concentration in Breast Milk and Its Correlation With the Maternal Diet|Short Chain Fatty Acids in Breast Milk|Unknown status|Not yet recruiting|N/A|100|Anticipated|Federico II University|||1||f||||||||||||||2017-10-10 23:47:08.78713|2017-10-10 23:47:08.78713
NCT02301715|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-07-20|||April 2014||2014-04-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|ELOREA||Effects of Intranasal Oxytocin on Emotion Regulation in Adolescents|Effects of Intranasal Oxytocin on Emotion Regulation to Stressful Interaction in Insecure Adolescents: a Study Protocol for a Double Blind Randomized Controlled Trial|Recruiting||Phase 1|60|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-10 23:47:08.996086|2017-10-10 23:47:08.996086
NCT02301702|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2017-08-21|||July 2016||2016-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Maternal Tdap Immunization in Guatemala|Evaluation of Tdap in Pregnancy to Prevent Infant Pertussis|Recruiting||Phase 2|376|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 23:47:09.128925|2017-10-10 23:47:09.128925
NCT02301689|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-11-02|||May 2014||2014-05-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01|5 Years|Observational [Patient Registry]|||SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register|SchlaHF-XF- Register. Sleep Disordered Breathing in Heart Failure Register|Active, not recruiting||N/A|4749|Actual|ResMed|||1||f||||f||||||||||2017-10-10 23:47:09.235894|2017-10-10 23:47:09.235894
NCT02301676|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-12-01|||December 2014||2014-12-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Long Term Postoperative Cognitive Dysfunction in the Elderly Patients|Phase 4 Study of Long Term Postoperative Cognitive Dysfunction After Laparoscopic Cholecystectomy in the Elderly Patients|Unknown status|Not yet recruiting|Phase 4|190|Anticipated|Pusan National University Yangsan Hospital||2|||f||||f||||||||||2017-10-10 23:47:09.299226|2017-10-10 23:47:09.299226
NCT02301663|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2017-08-15|||November 2014||2014-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease|DEVELOPMENT OF A NOVEL STRESS TESTING PROTOCOL TO DEFINE THE RELATIONSHIP BETWEEN CORONARY MICROVASCULAR DYSFUNCTION AND DIASTOLOGY IN WOMEN WITH ANGINA BUT NO EVIDENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE|Recruiting||N/A|30|Anticipated|Cedars-Sinai Medical Center||3|||f||||f||||||||||2017-10-10 23:47:09.376962|2017-10-10 23:47:09.376962
NCT02301650|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-22|||October 2014||2014-10-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children|The Effect of Anti-viral Drugs Used in Late Pregnancy in Mothers With Hepatitis B Virus Infection on Long-term Development of Children|Enrolling by invitation||N/A|400|Anticipated|Beijing Ditan Hospital|||4||f||||f||||||||||2017-10-10 23:47:09.470862|2017-10-10 23:47:09.470862
NCT02301637|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-07-09|||October 2014||2014-10-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|PROSPECT||Eeva System Imaging Study|Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data|Unknown status|Active, not recruiting|N/A|500|Anticipated|Progyny, Inc.|||1||f||||f||||||||||2017-10-10 23:47:09.560743|2017-10-10 23:47:09.560743
NCT02301624|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-22|2017-08-07|||November 2014||2014-11-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||ECU-MG-302: An Extension Trial of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis|ECU-MG-302, A Phase III, Open-label, Extension Trial of ECU-MG-301 to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)|Active, not recruiting||Phase 3|117|Actual|Alexion Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:47:09.642055|2017-10-10 23:47:09.642055
NCT02301598|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-26|||January 2012||2012-01-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||Femtosecond Laser-assisted Anterior Lamellar Keratoplasty|Femtosecond Laser-assisted Anterior Lamellar Keratoplasty|Completed||N/A|13|Actual|The S.N. Fyodorov Eye Microsurgery State Institution||1|||f||||f||||||||||2017-10-10 23:47:09.906059|2017-10-10 23:47:09.906059
NCT02301585|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2016-02-08|||February 2014||2014-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|OFTaPLR||Optimization of Fluid Therapy in Sepsis by a Passive Leg Raising Test|Optimization of Fluid Therapy by a Passive Leg Raising Test in Patients With Septic Shock in the ICU|Terminated||N/A|34|Actual|Karolinska Institutet||2||The study was stopped because of futility due to unexpected low weight gain in both groups.|f||||t||||||||||2017-10-10 23:47:09.981831|2017-10-10 23:47:09.981831
NCT02301572|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-09-01|||August 2014||2014-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical Course|Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical Course|Completed||N/A|750|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-10-10 23:47:10.103738|2017-10-10 23:47:10.103738
NCT02301559|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-25|||September 2014||2014-09-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||The Influence of the Method Pilates in Women With Primary Dysmenorrhea|The Influence of the Method Pilates in Life Quality, Intensity of Pain and Flexibility of Women With Primary Dysmenorrhea|Unknown status|Recruiting|N/A|11|Anticipated|Universidade Estadual do PiauÍ||1|||f||||f||||||||||2017-10-10 23:47:10.190351|2017-10-10 23:47:10.190351
NCT02301533|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-07-10|||June 2015||2015-06-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|Shikamana||Provider and Peer Support Intervention to Improve ART Adherence Among Kenyan Men Who Have Sex With Men|Provider and Peer Support Intervention to Improve ART Adherence Among Kenyan Men Who Have Sex With Men|Completed||N/A|60|Actual|University of Washington||2|||f||||f||||||||||2017-10-10 23:47:10.384523|2017-10-10 23:47:10.384523
NCT02301520|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2015-06-23|||January 2015||2015-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|Haiti||Vitamin D, Iodine, and Lead Levels in Haitian Infants and Children.|Vitamin D Deficiency, Iodine Deficiency and Lead Levels in Haitian Infants and Children.|Completed||N/A|299|Actual|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-10 23:47:10.492935|2017-10-10 23:47:10.492935
NCT02301507|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-05-19|||November 2014||2014-11-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|August 2015|Actual|2015-08-01||Interventional|||Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women|Evaluation of Texting Intervention to Improve Adherence to Antiretroviral Therapy (ART) in Young Women Infected With Human Immunodeficiency Virus (HIV)|Completed||N/A|7|Actual|The University of Texas Health Science Center, Houston||1|||f||||f||||||||||2017-10-10 23:47:10.602747|2017-10-10 23:47:10.602747
NCT02301494|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-09-12|||August 2018|Anticipated|2018-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|CTCL||Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma|Feasibility Study to Determine Effectiveness of 3.75% Topical Imiquimod Cream and Topical Vanos (Fluocinonide) Cream 0.1% in the Treatment of Early Stage Cutaneous T-cell Lymphoma|Not yet recruiting||N/A|40|Anticipated|Rochester General Hospital||2|||f||||t|f|f||||||||2017-10-10 23:47:10.680074|2017-10-10 23:47:10.680074
NCT02301481|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-23|2016-01-04|||January 2014||2014-01-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma|A Prospective, Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Concomitant Boost Intensity-Modulated Radiotherapy With S-1 in Locally Advanced Gastric Adenocarcinoma|Recruiting||Phase 2|60|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:47:10.774712|2017-10-10 23:47:10.774712
NCT02301468|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-12-17|||November 2014||2014-11-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Ischemic Compression Compared With Dry Needling|Ischemic Compression Compared With Dry Needling as a Treatment of Myofascial Trigger Points in the Neck Region in Office Workers.|Completed||N/A|42|Actual|University Ghent||2|||f||||f||||||||||2017-10-10 23:47:10.87887|2017-10-10 23:47:10.87887
NCT02301455|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-04-17|||October 2014||2014-10-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||REACH OUT: to Reduce High Blood Pressure in the Emergency Department||Completed||N/A|104|Actual|University of Michigan||3|||f||||f||||||||||2017-10-10 23:47:10.95232|2017-10-10 23:47:10.95232
NCT02301442|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-05-12|||September 2014||2014-09-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Step it Up: An Exercise and Behaviour Change Programme for People With Multiple Sclerosis|"A Randomised Controlled Trial of an Exercise Plus Behaviour Change Intervention in People With MS: the Step it Up Study Protocol"|Completed||N/A|65|Actual|University of Limerick||2|||f||||f||||||||||2017-10-10 23:47:11.043391|2017-10-10 23:47:11.043391
NCT02301429|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-09-02|2016-09-02||November 2014||2014-11-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Model 20105 Lead Study|Model 20105 Lead Study|Terminated||N/A|16|Actual|Medtronic BRC||1||"Low implant success rate(46%). For the successfull implants, 3month FU and available electrical   data showed an increase in threshold values for the left atrium"|f||||f||||||||||2017-10-10 23:47:11.125827|2017-10-10 23:47:11.125827
NCT02301416|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-07-27|||December 2014||2014-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Qsymia as an Adjunct to Surgical Therapy in the Superobese|Qsymia as an Adjunct to Surgical Therapy in the Superobese|Active, not recruiting||Phase 2|21|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-10 23:47:11.311309|2017-10-10 23:47:11.311309
NCT02301403|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-01-09|||January 2015||2015-01-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Comparative Effectiveness RCT of Optimized Cessation Treatments|A Comparative Effectiveness RCT of Optimized Cessation Treatments|Active, not recruiting||Phase 4|600|Anticipated|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-10 23:47:11.395219|2017-10-10 23:47:11.395219
NCT02301390|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-04-15|||October 2009|Actual|2009-10-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|INTERVENE||INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events|INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events|Terminated||N/A|53|Actual|Icahn School of Medicine at Mount Sinai||2||could not meet enrollment goal|f||||t||||||||No||2017-10-10 23:47:11.496193|2017-10-10 23:47:11.496193
NCT02301377|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2015-06-22|2015-06-03||November 2014||2014-11-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis|Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis|Completed||N/A|5|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:47:11.6019|2017-10-10 23:47:11.6019
NCT02301351|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-04-20|||October 2014||2014-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors|Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors|Recruiting||N/A|360|Anticipated|University of Pennsylvania||2|||f||||f||||||||Yes|de-identified data and measures codebook will be made available after the conclusion of the study.|2017-10-10 23:47:11.981035|2017-10-10 23:47:11.981035
NCT02301338|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-03-08|||November 2014||2014-11-01|March 2017|2017-03-01|March 16, 2016|Actual|2016-03-16|March 16, 2016|Actual|2016-03-16||Observational|||Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing|Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing|Terminated||N/A|2|Actual|Memorial Sloan Kettering Cancer Center|||2|Lack of accrual|f||||||||||||||2017-10-10 23:47:12.073859|2017-10-10 23:47:12.073859
NCT02301312|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-11-24|||January 2015||2015-01-01|November 2014|2014-11-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Study of POSS-PCU Vascular Grafts for Vascular Access|A Clinical Investigation to Assess the Safety and Performance of POSS-PCU Small Diameter Grafts as Conduits in Arteriovenous (AV) Access|Not yet recruiting||N/A|30|Anticipated|University College, London||1|||f||||t||||||||||2017-10-10 23:47:12.227897|2017-10-10 23:47:12.227897
NCT02301299|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-09-27|||October 2014||2014-10-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|CEERIAS||Community Engagement for Early Recognition and Immediate Action in Stroke|Community Engagement for Early Recognition and Immediate Action in Stroke|Recruiting||N/A|1000|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-10 23:47:12.291929|2017-10-10 23:47:12.291929
NCT02301286|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-06-06|||September 2014||2014-09-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|ASPIRIN||A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients|A Phase III Double-blind Placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients|Recruiting||Phase 3|1588|Anticipated|Leiden University Medical Center||2|||f||||t||||||||||2017-10-10 23:47:12.384303|2017-10-10 23:47:12.384303
NCT02301273|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-11-27|||November 2011||2011-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Being Awake, Upright and Moving as the Basis for Early ICU Physiotherapy|Being Awake, Upright and Moving as the Basis for Early ICU Physiotherapy: Comparison of Patient Outcomes Between Enhanced and Conventional ICU Physiotherapy|Completed||N/A|60|Anticipated|Landspitali University Hospital||2|||f||||f||||||||||2017-10-10 23:47:12.584098|2017-10-10 23:47:12.584098
NCT02301260|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-08-15|||April 2014||2014-04-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Speed of Processing Training to Improve Cognition in Multiple Sclerosis|Speed of Processing Training to Improve Cognition in Multiple Sclerosis: A Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|Kessler Foundation||2|||f||||f||||||||||2017-10-10 23:47:12.673718|2017-10-10 23:47:12.673718
NCT02301247|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-06-30|||November 2014||2014-11-01|June 2017|2017-06-01|April 2, 2017|Actual|2017-04-02|April 2, 2017|Actual|2017-04-02||Interventional|||Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)|Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)|Completed||N/A|32|Actual|Kessler Foundation||2|||f||||f||||||||||2017-10-10 23:47:12.755893|2017-10-10 23:47:12.755893
NCT02301234|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-06||2017-09-06|March 25, 2015|Actual|2015-03-25|August 2017|2017-08-01|September 19, 2016|Actual|2016-09-19|September 19, 2016|Actual|2016-09-19||Interventional|||Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007|Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Fulranumab as Adjunctive Therapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee|Completed||Phase 3|111|Actual|Janssen Research & Development, LLC||3|||f||||t||f||||||||2017-10-10 23:47:12.84524|2017-10-10 23:47:12.84524
NCT02301221|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-11-03|||March 2015||2015-03-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Interventional|FMTSTC||Effect of Fecal Microbiota Transplantation in Slow Transit Constipation|A Study of Efficacy, Safety and Durability of Fecal Microbiota Transplantation in Adult Patients With Slow Transit Constipation|Active, not recruiting||Phase 2|60|Anticipated|Jinling Hospital, China||1|||f||||t||||||||||2017-10-10 23:47:13.289716|2017-10-10 23:47:13.289716
NCT02301208|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-12-05|||December 2014||2014-12-01|December 2014|2014-12-01||||December 2016|Anticipated|2016-12-01||Interventional|NPC-RCT-WCRT||Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma|A Randomized Phase III Study of Concurrent Weekly Nedaplatin or Cisplatin With IMRT in NPC Patients|Unknown status|Not yet recruiting|Phase 3|120|Anticipated|Jiangsu Cancer Institute & Hospital||4|||f||||||||||||||2017-10-10 23:47:13.407656|2017-10-10 23:47:13.407656
NCT02301195|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-05-02|||October 2010||2010-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2014|Actual|2014-05-01||Interventional|||Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder|Measuring the Effects of Therapeutic Horseback Riding on School-Age Children and Adolescents With Autism Spectrum Disorders|Active, not recruiting||N/A|127|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:47:13.515929|2017-10-10 23:47:13.515929
NCT02301182|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-11-24|||November 2014||2014-11-01|October 2014|2014-10-01|November 2023|Anticipated|2023-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Comparison of Functional Results of ADM X3-MoP Cup (Stryker) and a CoC Cup (Zimmer) in Young Patients|A Single-Center Randomized, Patient-Blinded, Prospective Five-Year Study to Compare the Functional Results After Insertion of ADM X3-MoP Cup (Stryker) and a CoC Cup (Zimmer) in Primary THA|Enrolling by invitation||N/A|60|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:47:13.628637|2017-10-10 23:47:13.628637
NCT02301169|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-04-11|2015-12-07||March 2014||2014-03-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Investigate the Effects of a New Treatment in Patients With Chronic Pain|A Study to Investigate the Effects of T4P1001 Treatment in Patients With Peripheral Neuropathic Pain|Completed||N/A|42|Actual|Tools4Patient||2|||f||||f||||||||||2017-10-10 23:47:13.726809|2017-10-10 23:47:13.726809
NCT02300987|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-09-14|||February 26, 2015|Actual|2015-02-26|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression|A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression|Active, not recruiting||Phase 2|10|Actual|Novartis||2|||f||||f|t|f||||||||2017-10-10 23:47:15.813821|2017-10-10 23:47:15.813821
NCT02301156|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-12-13|||January 2015||2015-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Patients With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)|A Phase 3, Randomized, Study to Assess the Efficacy and Safety of Ublituximab in Combination With Ibrutinib Compared to Ibrutinib Alone, in Patients With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 3|120|Anticipated|TG Therapeutics, Inc.||2|||f||||t||||||||||2017-10-10 23:47:14.150798|2017-10-10 23:47:14.150798
NCT02301143|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-09-28|||April 21, 2015|Actual|2015-04-21|September 2017|2017-09-01|June 15, 2018|Anticipated|2018-06-15|October 16, 2017|Anticipated|2017-10-16||Interventional|LAPACT||Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)|nab1-paclitaxel (Abraxane) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC): An International, Open-label, Multi-center, Phase 2 Study (LAPACT).|Active, not recruiting||Phase 2|107|Actual|Celgene||1|||f||||f||||||||||2017-10-10 23:47:14.525793|2017-10-10 23:47:14.525793
NCT02301117|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-09-05|||January 2015||2015-01-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment|A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAS-102 in Patients With Advanced Solid Tumors and Varying Degrees of Renal Impairment|Recruiting||Phase 1|48|Anticipated|Taiho Oncology, Inc.||4|||f||||f||||||||||2017-10-10 23:47:14.838303|2017-10-10 23:47:14.838303
NCT02301104|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-10-13|||January 2015||2015-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment|A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAS-102 in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment.|Completed||Phase 1|24|Actual|Taiho Oncology, Inc.||4|||f||||f||||||||||2017-10-10 23:47:14.984603|2017-10-10 23:47:14.984603
NCT02301091|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-04-13|||October 2014||2014-10-01|April 2016|2016-04-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|CORTT||Combine TACE and RFA Versus TACE Alone for HCC With PVTT|Combine Transcatheter Arterial Embolization and Radiofrequency Ablation Versus Transcatheter Arterial Embolization Alone for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus|Recruiting||Phase 3|240|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:47:15.077654|2017-10-10 23:47:15.077654
NCT02301078|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-12-05|||July 2014||2014-07-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|||Short-term Function and Pain After Treatment for Dupuytren's Disease|Comparing Short-term Function and Pain After Treatment With Collagenase Clostridium Histolyticum or Percutaneous Needle Aponeurotomy for Dupuytren's Disease|Recruiting||N/A|60|Anticipated|Sunnybrook Health Sciences Centre|||2||f||||f||||||||||2017-10-10 23:47:15.165469|2017-10-10 23:47:15.165469
NCT02301065|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-07-14|||October 13, 2016|Actual|2016-10-13|July 2017|2017-07-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Observational|||Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors|Analysis of KIR+CD56+ T Cells and FcRg-CD56+CD3- NK Cells in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients and Donors|Completed||N/A|35|Actual|St. Jude Children's Research Hospital|||2||f||||f|f|f||||||||2017-10-10 23:47:15.253311|2017-10-10 23:47:15.253311
NCT02301052|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-24|||September 2014||2014-09-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms|Double Blind Randomized Placebo-control Trial of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms|Unknown status|Recruiting|Phase 1/Phase 2|75|Anticipated|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-10-10 23:47:15.323427|2017-10-10 23:47:15.323427
NCT02301039|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-07-19|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas|SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas|Recruiting||Phase 2|146|Anticipated|Sarcoma Alliance for Research through Collaboration||2|||f||||t||||||||||2017-10-10 23:47:15.407217|2017-10-10 23:47:15.407217
NCT02301026|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-06-13|||September 1, 2014|Actual|2014-09-01|April 2017|2017-04-01|December 9, 2016|Actual|2016-12-09|December 9, 2016|Actual|2016-12-09||Observational|DINO||A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency|A Non-interventional Study of Diafer (5% Iron Isomaltoside 1000) Administered According to Standard Hospital Practice and Product Labelling in Subjects With Chronic Kidney Disease on Haemodialysis for Treatment of Iron Deficiency|Completed||N/A|209|Actual|Pharmacosmos A/S|||1||f||||f||||||||||2017-10-10 23:47:15.514809|2017-10-10 23:47:15.514809
NCT02301013|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-11-24|||March 2013||2013-03-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|||Impact of Urethral Mobility on the Success of Sling Operations|Are Unsatisfying Results After TVT and TOT Operations Associated With Increased Urethral Mobility|Unknown status|Recruiting|N/A|140|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital||1|||f||||f||||||||||2017-10-10 23:47:15.590389|2017-10-10 23:47:15.590389
NCT02301000|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-02-04|||November 2014||2014-11-01|February 2015|2015-02-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||IMT for Primary Clostridium Difficile Infection|Intestinal Microbiota Therapy Versus Metronidazole for Primary Clostridium Difficile Infection: a Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-10 23:47:15.659989|2017-10-10 23:47:15.659989
NCT02300974|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2015-12-14|||December 2015||2015-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:47:15.91147|2017-10-10 23:47:15.91147
NCT02300961|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-11-08|||December 2014||2014-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility Neurocognitive Outcome After Transplant|A Risk Stratification Model for Neurocognitive Outcome After Transplant and Feasibility of an Early Cognitive Intervention Program|Recruiting||N/A|35|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-10 23:47:15.95108|2017-10-10 23:47:15.95108
NCT02300948|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-11-24|||December 2006||2006-12-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||Optimizing Periconceptional and Prenatal Folic Acid Supplementation|Optimizing Periconceptional and Prenatal Folic Acid Supplementation|Completed||Phase 4|83|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-10 23:47:16.05083|2017-10-10 23:47:16.05083
NCT02300935|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-01-14|||January 2016||2016-01-01|January 2016|2016-01-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Trametinib and Nab-paclitaxel in Patients With Melanoma|Phase I Study of Trametinib and Nab-paclitaxel in Patients With Melanoma|Withdrawn||Phase 1|0|Actual|SCRI Development Innovations, LLC||1||Study concept was terminated.|f||||f||||||||||2017-10-10 23:47:16.130965|2017-10-10 23:47:16.130965
NCT02300922|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-01-17|||December 2014||2014-12-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|RITCOLON||Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer|Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer : A Multicentric Phase I/II Study of Fractionated TF2 Plus 90Y-IMP288 (RITCOLON)|Active, not recruiting||Phase 1/Phase 2|7|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-10 23:47:16.211318|2017-10-10 23:47:16.211318
NCT02300909|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-02-17|||November 2014||2014-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||dHACM in Lumbar Decompression and Microdiscectomy Surgery|A Randomized, Single Blind, Controlled Trial of Clinical Outcomes of Dehydrated Human Amnion/Chorion Membrane (dHACM) in Lumbar Decompression and Microdiscectomy Surgery|Active, not recruiting||N/A|143|Actual|MiMedx Group, Inc.||2|||f||||t||||||||||2017-10-10 23:47:16.28815|2017-10-10 23:47:16.28815
NCT02300896|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-09-11|||March 2015||2015-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|September 2017|Actual|2017-09-01||Interventional|||Functional and Cognitive Impairment Prevention for Elderly Hospitalized Patients|Functional and Cognitive Impairment Prevention Through Early Physical Activity for Elderly Hospitalized Patients: a Randomized Clinical Trial|Active, not recruiting||N/A|370|Anticipated|Fundacion Miguel Servet||2|||f||||f||||||||||2017-10-10 23:47:16.378874|2017-10-10 23:47:16.378874
NCT02300883|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-07-20|||April 2011||2011-04-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients|Diagnostic and Prognostic Role of New Inflammation Biomarkers in Patients With Malignant Pleural Mesothelioma|Active, not recruiting||N/A|100|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples Without DNA|"     pleural effusion   "|No|not planned|2017-10-10 23:47:16.452597|2017-10-10 23:47:16.452597
NCT02300870|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-21|||January 2015||2015-01-01|November 2014|2014-11-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|||Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection|Myocardial Perfusion Echocardiography to Detect Human Heart Transplant|Unknown status|Not yet recruiting|N/A|40|Anticipated|Brigham and Women's Hospital|||2||f||||t||||||||||2017-10-10 23:47:16.524881|2017-10-10 23:47:16.524881
NCT02300857|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-07-11|||November 2014|Actual|2014-11-01|July 2017|2017-07-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Effects of Macronutrient Diet on Brain Activity|Effects of Macronutrient Diet Composition on Brain Reward Activity|Completed||N/A|72|Actual|Brigham and Women's Hospital||3|||f||||f||||||||||2017-10-10 23:47:18.459178|2017-10-10 23:47:18.459178
NCT02300844|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-07-25|||December 1, 2014|Actual|2014-12-01|July 2017|2017-07-01|March 21, 2016|Actual|2016-03-21|March 21, 2016|Actual|2016-03-21||Interventional|||Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects|Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects|Completed||Phase 1|54|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 23:47:18.564539|2017-10-10 23:47:18.564539
NCT02300831|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-07-12|||December 1, 2014|Actual|2014-12-01|July 2017|2017-07-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|LUMINIST||LUMINIST: LUng Cancer Molecular Insights Non Interventional Study|LUMINIST: LUng Cancer Molecular Insights Non Interventional Study|Completed||N/A|770|Actual|AstraZeneca|||1||f||||f||||||None Retained|"     All samples used in the study are collected under the auspices of the SELECT 1 study     screening. Luminist provides the clinical data to correlate the with sample results.   "|||2017-10-10 23:47:18.646932|2017-10-10 23:47:18.646932
NCT02300818|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-06-22|||November 2014||2014-11-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|GME||Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion.|Magneto Therapy in the Therapy of Glaucoma|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|American Society Of Thermalism And Climatology Inc||2|||f||||t||||||||||2017-10-10 23:47:18.909814|2017-10-10 23:47:18.909814
NCT02300805|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-01-09|||November 2014||2014-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|VOCAL||Accuracy of Endometrial Volume Measured by VOCAL Versus Office Hysteroscopy for Diagnosis of Endometrial Polyps|Accuracy of Endometrial Volume Measured by Virtual Organ Computer-aided AnaLysis (VOCAL)Versus Office Hysteroscopy for Diagnosis of Endometrial Polyps|Completed||N/A|117|Actual|Ain Shams University|||1||f||||f||||||||||2017-10-10 23:47:19.015356|2017-10-10 23:47:19.015356
NCT02300792|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-24|||November 2013||2013-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A|The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A|Completed||Phase 2|50|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-10 23:47:19.184567|2017-10-10 23:47:19.184567
NCT02300779|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-04-11|||December 2014||2014-12-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|DIMEPREP||Diet for Colonoscopy Preparation in Diabetic Patients|Randomized Clinical Trial on the Efficacy of an Adapted Bowel Preparation for Diabetic Patients Undergoing a Colonoscopy. DIMEPREP Study|Completed||Phase 3|150|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-10 23:47:19.268154|2017-10-10 23:47:19.268154
NCT02300766|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-10-03|||October 2014||2014-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|1 Year|Observational [Patient Registry]|||Cerebellar Mutism Syndrome Study|Nordic Study of the Cerebellar Mutism Syndrome in Children With Brain Tumours of the Posterior Fossa|Recruiting||N/A|500|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||Samples With DNA|"     A blood sample from each patient will be collected in order to make SNP analyses on the DNA     to explore the role of genomic variants on the development, severity and recovery from the     CMS.   "|||2017-10-10 23:47:19.376164|2017-10-10 23:47:19.376164
NCT02300753|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-11-24||||||November 2014|2014-11-01||||||||Expanded Access|||Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]|Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]|No longer available||N/A|||Edison Pharmaceuticals Inc|||||||||||||||||||2017-10-10 23:47:19.574256|2017-10-10 23:47:19.574256
NCT02300740|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-02-26|||December 2014||2014-12-01|November 2014|2014-11-01||||February 2015|Actual|2015-02-01||Interventional|||Pharmacokinetic Analysis of Nicotinamide Riboside||Completed||Early Phase 1|12|Actual|Aarhus University Hospital||2|||f||||||||||||||2017-10-10 23:47:19.648455|2017-10-10 23:47:19.648455
NCT02300727|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-12-27|||February 2015||2015-02-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy|A Phase I/II Study to Determine the Safety and Efficacy of Curcumin in Patients With Oral Mucositis Secondary to Chemotherapy|Recruiting||Phase 1/Phase 2|38|Anticipated|Aurora BayCare Medical Center||3|||f||||f||||||||||2017-10-10 23:47:19.724343|2017-10-10 23:47:19.724343
NCT02300714|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-24|||November 2014||2014-11-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Fluoroscopically-guided Epidural Block in the Midthoracic Region: A Comparison of Anterioposterior Versus Oblique View Approach||Unknown status|Recruiting|N/A|30|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-10 23:47:19.819207|2017-10-10 23:47:19.819207
NCT02300701|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2015-10-22|||December 2014||2014-12-01|August 2015|2015-08-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Interventional|ADAPT||Role of Anti-IgE in Severe Childhood Eczema|The Role of Anti-IgE (Omalizumab) in the Management of Severe Recalcitrant Paediatric Atopic Eczema|Unknown status|Recruiting|Phase 4|62|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:47:19.887136|2017-10-10 23:47:19.887136
NCT02300688|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-01-11|||December 2014||2014-12-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers|An Open Label, Randomized, 2-sequence, 2-period, Single-dose Cross-over Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||||2017-10-10 23:47:19.96785|2017-10-10 23:47:19.96785
NCT02300675|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-09-13|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2016|Actual|2016-08-01||Interventional|PEPs HORMONO||Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy|Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy|Completed||N/A|352|Actual|Institut de Cancérologie de la Loire||2|||f||||f||||||||||2017-10-10 23:47:20.065515|2017-10-10 23:47:20.065515
NCT02300662|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-08-19|||January 2013||2013-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|MoVe-ICU||Early Mobilization for Critical Patients on Invasive Mechanical Ventilation in the Intensive Care Unit|Early Mobilization With a Cycle Ergometer for Critical Patients on Invasive Mechanical Ventilation in the Intensive Care Unit (MoVe-ICU Study): Study Protocol for a Randomized Controlled Trial|Completed||N/A|28|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-10 23:47:20.172565|2017-10-10 23:47:20.172565
NCT02300649|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-04-16|||September 2014||2014-09-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Transesophageal Echocardiographic Evaluation of the Effect of Dexmedetomidine Infusion as an Adjuvant to General Anesthesia on the Cardiac Function||Completed||N/A|30|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:47:20.246247|2017-10-10 23:47:20.246247
NCT02300636|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2015-03-17|||February 2014||2014-02-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Resistive Co-contraction Training After Anterior Cruciate Ligament Reconstruction|Randomized-controlled,Resistive Co-contraction Training Enhances Strength Recovery After Anterior Cruciate Ligament Reconstruction|Completed||N/A|52|Actual|Hacettepe University||3|||f||||f||||||||||2017-10-10 23:47:20.318486|2017-10-10 23:47:20.318486
NCT02300623|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-21|||March 2000||2000-03-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|PHI-IL2||Intermittent ART in Primary HIV Infection|Long Term Follow-up of Patients Experiencing Structured Treatment Interruption (STI) With or Without Low Doses of Interleukin-2 During Primary HIV Infection (PHI)|Completed||Phase 4|12|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-10 23:47:20.413327|2017-10-10 23:47:20.413327
NCT02300610|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-29|||February 11, 2015|Actual|2015-02-11|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer|A Phase I/1b Study of Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer|Active, not recruiting||Phase 1|10|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 23:47:20.509373|2017-10-10 23:47:20.509373
NCT02300597|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-08-11|||September 2010||2010-09-01|May 2015|2015-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Internet-based Support for Young People With ADHD and Autism - a Controlled Study|Internet-based Support and Coaching for Adolescents and Young Adults With ADHD and Autism Spectrum Disorders - a Controlled Study|Completed||N/A|45|Actual|Göteborg University||2|||f||||f||||||||||2017-10-10 23:47:20.603781|2017-10-10 23:47:20.603781
NCT02300584|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-09-07|||November 2014||2014-11-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program|Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program|Completed||N/A|42|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:47:20.804245|2017-10-10 23:47:20.804245
NCT02300571|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-01|||September 2013||2013-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant|An Observational Retrospective/Prospective Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant Using Peripheral Blood Stem Cells (PBSC) From Unrelated or Related, HLA-identical or Partially Mismatched Donors|Recruiting||N/A|60|Anticipated|Fondazione del Piemonte per l'Oncologia|||1||f||||f||||||Samples With DNA|"     PBMC   "|||2017-10-10 23:47:20.911762|2017-10-10 23:47:20.911762
NCT02300558|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-02-24|||December 17, 2014|Actual|2014-12-17|February 2017|2017-02-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3|A Phase 3, Single-Blind Study to Evaluate the Effect of Eleclazine (GS-6615) on Shortening of the QT Interval, Safety, and Tolerability in Subjects With Long QT Syndrome Type 3|Terminated||Phase 3|41|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 23:47:21.024824|2017-10-10 23:47:21.024824
NCT02300545|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-08-31|||April 8, 2015|Actual|2015-04-08|August 2017|2017-08-01|June 30, 2020|Anticipated|2020-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy|A Phase II Study of Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy|Recruiting||Phase 2|56|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 23:47:21.158187|2017-10-10 23:47:21.158187
NCT02300532|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-02-23|||January 10, 2013|Actual|2013-01-10|January 2017|2017-01-01|March 24, 2015|Actual|2015-03-24|July 10, 2014|Actual|2014-07-10||Observational|||Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)|Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)|Completed||N/A|561|Actual|Eisai Inc.|||1||f||||||||||||||2017-10-10 23:47:21.286326|2017-10-10 23:47:21.286326
NCT02300519|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-08-12|||March 2015||2015-03-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Thrombin Generation Numerical Models Validation in Haemophilic Case|Thrombin Generation Numerical Models Validation in Haemophilic Case|Completed||N/A|40|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     blood   "|||2017-10-10 23:47:21.359519|2017-10-10 23:47:21.359519
NCT02300506|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-23|||January 10, 2014|Actual|2014-01-10|August 2017|2017-08-01|March 13, 2017|Actual|2017-03-13|February 28, 2017|Actual|2017-02-28||Observational|||Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma|Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma|Completed||N/A|507|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-10 23:47:21.443302|2017-10-10 23:47:21.443302
NCT02300493|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2014-11-24|||January 2013||2013-01-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Four Year Weight Change of Cornell Students||Unknown status|Active, not recruiting|N/A|200|Actual|Cornell University||2|||f||||t||||||||||2017-10-10 23:47:21.513884|2017-10-10 23:47:21.513884
NCT02300480|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-24|||December 2014||2014-12-01|November 2014|2014-11-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||Effects of Calot's Triangle Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Double-blind, Controlled, Clinical Trial|Effects of Calot's Triangle Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Double-blind, Controlled, Clinical Trial|Unknown status|Not yet recruiting|Phase 4|140|Anticipated|First Affiliated Hospital of Chongqing Medical University||2|||f||||f||||||||||2017-10-10 23:47:21.58818|2017-10-10 23:47:21.58818
NCT02300467|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-08-13|||December 2014||2014-12-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors|A Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of NOV120401 (CKD-516 Tablet) in Patients With Advanced Refractory Solid Tumors|Unknown status|Recruiting|Phase 1|30|Anticipated|National OncoVenture||1|||f||||f||||||||||2017-10-10 23:47:21.699237|2017-10-10 23:47:21.699237
NCT02300454|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-03-22|||June 2015||2015-06-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|ELEGANT||Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions||Active, not recruiting||Phase 4|210|Actual|Mitsui Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:47:21.787369|2017-10-10 23:47:21.787369
NCT02300441|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-03-15|||September 2014||2014-09-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|September 2015|Actual|2015-09-01||Observational|HI-VISION||HI-VISION Pilot Study|HI-VISION - Hypotension Myocardial Ischemia-Vascular Events In Noncardiac Surgery Patients: a Cohort Evaluation: Pilot Study|Active, not recruiting||N/A|133|Actual|McMaster University|||1||f||||f||||||||||2017-10-10 23:47:21.8848|2017-10-10 23:47:21.8848
NCT02300428|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2017-02-03|||November 2014||2014-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Observational|||Health Economics of the Use of Ferrous Iron Salts in Primary Care in the UK.|Health Economics of the Use of Ferrous Iron Salts in Primary Care in the UK.|Active, not recruiting||N/A|406902|Actual|Medical Research Council|||2||f||||f||||||||||2017-10-10 23:47:21.954|2017-10-10 23:47:21.954
NCT02300415|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2016-03-18|||December 2014||2014-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Observational|PREDI||Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.|Comparison of Sensitivity Between Presepsine and Arterial Lactate for the Diagnosis of Severe Sepsis and Sepsis Shock in Emergency Department.|Recruiting||N/A|400|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||||||||Samples Without DNA|"     total blood sample   "|||2017-10-10 23:47:22.038105|2017-10-10 23:47:22.038105
NCT02300402|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-09-07|||October 2014||2014-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|ADAMANTIUS||Detection and Characterization of Residual Masses in Lymphomas|Automatic Detection and Characterization of Residual Masses in Patients With Lymphomas Through Fusion of Whole‐Body Diffusion‐Weighted MRI on 3 Tesla and 18F‐Fluorodeoxyglucose PET/CT|Recruiting||N/A|120|Anticipated|The Lymphoma Academic Research Organisation|||1||f||||f||||||||||2017-10-10 23:47:22.125116|2017-10-10 23:47:22.125116
NCT02300389|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-04-11|||December 2011||2011-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HYPOPROST||Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated|Randomized, Multi-center Clinical Trial Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated in a High Risk Group of Prostate Cancer Patients|Recruiting||N/A|465|Anticipated|The Greater Poland Cancer Centre||2|||f||||t||||||||No||2017-10-10 23:47:22.202039|2017-10-10 23:47:22.202039
NCT02300376|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-08-19|||December 2014||2014-12-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|DFGBay||Designing a Bayesian Model of the Plasma Clearance of Calcium Edetate de Sodium for the Calculation of GFR and Validity Compared to the Renal Clearance of Inulin|Designing a Bayesian Model of the Plasma Clearance of Calcium Edetate de Sodium, With a Limited Sampling Strategy for the Calculation of Glomerular Filtration Rate (GFR) and Validity Assessment Compared to the Renal Clearance of Inulin : DFGBay|Recruiting||Phase 3|32|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-10-10 23:47:22.302539|2017-10-10 23:47:22.302539
NCT02300363|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-07-08|||October 2014||2014-10-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin|A Phase 1, Single-center, Open-label, 2-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Rosuvastatin (Crestor®), a Sensitive Breast Cancer Resistance Protein (BCRP) Substrate, in Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-10-10 23:47:22.377569|2017-10-10 23:47:22.377569
NCT02300350|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-07-08|||October 2014||2014-10-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||DDI Study With Multiple-dose LX4211 and Single Dose Digoxin|A Phase 1, Single-center, Open-label, Two-period, Single-sequence, Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose LX4211 on the Pharmacokinetics of Single-dose Digoxin (Lanoxin®), a Sensitive P-glycoprotein (P-gp) Substrate, in Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-10-10 23:47:22.443406|2017-10-10 23:47:22.443406
NCT02300337|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-01-16|||November 2014||2014-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|LTS||Comparison of Reduced Cuff-pressure of the Laryngeal Tube Under General Anesthesia|Comparative Study of the Tightness of the Laryngeal Tube Under Mechanical Ventilation Before and After Reduction of Cuff Pressure on 60cmH₂O, 50cmH₂O, 40cmH₂O or 30cmH₂O|Completed||N/A|60|Actual|Johannes Gutenberg University Mainz||1|||f||||f||||||||||2017-10-10 23:47:22.516542|2017-10-10 23:47:22.516542
NCT02300324|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-09-16|||October 2014||2014-10-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|BOBS||The Bioavailability Of Sulforaphane From Broccoli Soups Study (BOBS)|An Intervention Study to Assess the Bioavailability of Sulforaphane Delivered by Glucoraphanin-enriched Broccoli Soups in Healthy Subjects|Completed||N/A|11|Actual|Quadram Institute||1|||f||||f||||||||||2017-10-10 23:47:22.579109|2017-10-10 23:47:22.579109
NCT02300311|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-24|2016-07-26|2016-05-24||January 2015||2015-01-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Treated set (TS): All randomised patients who used at least one dose of study medication were included in the treated set.|Efficacy and Safety of Finalgon® Cream Multiple Doses in Acute Low Back Pain|A Multinational, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Multiple Doses of Finalgon® Cream (1.08% Nicoboxil/ 0.17% Nonivamide) in the Treatment of Acute Low Back Pain|Completed||Phase 3|138|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:47:22.658228|2017-10-10 23:47:22.658228
NCT02300285|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-08-19|||February 2015||2015-02-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia|Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia|Recruiting||N/A|20|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-10 23:47:23.170486|2017-10-10 23:47:23.170486
NCT02300272|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-12-23|||March 2015||2015-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|OA-TIME||Health Behaviors and Time-of-Day: Older Adult Cognitive Function|Modifiable Health Behaviors Associated With Time-of-Day Differences in Older Adults' Practice-Related Learning|Completed||N/A|88|Actual|University of Florida|||1||f||||f||||||||No||2017-10-10 23:47:23.267328|2017-10-10 23:47:23.267328
NCT02300259|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-04-16|||November 2014||2014-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study of LY2623091 in Healthy Participants|A Study to Determine the Effect of CYP3A Inhibition on the Pharmacokinetics of LY2623091 and the Effect of LY2623091 on the Pharmacokinetics of CYP3A Substrates in Healthy Subjects|Completed||Phase 1|48|Actual|Eli Lilly and Company||8|||f||||f||||||||||2017-10-10 23:47:23.356062|2017-10-10 23:47:23.356062
NCT02300246|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-21|||July 2014||2014-07-01|November 2014|2014-11-01||||December 2014|Anticipated|2014-12-01||Interventional|||Clinical, Histological and Micro-computed Tomographic Evaluation of Neoformed Tissue in Post-extraction Sockets Covered With Platelet-rich Fibrin (PRF) Membrane: a Randomized Controlled Trial|Clinical, Histological and Micro-computed Tomographic Evaluation of Neoformed Tissue in Post-extraction Sockets Covered With Platelet-rich Fibrin (PRF) Membrane: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 1|30|Anticipated|Universidade Federal Fluminense||2|||f||||t||||||||||2017-10-10 23:47:23.454378|2017-10-10 23:47:23.454378
NCT02300233|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-05-24|||December 2014||2014-12-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia|The COMPASS Study: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of ISIS 304801 Administered Subcutaneously to Patients With Hypertriglyceridemia|Active, not recruiting||Phase 3|114|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-10 23:47:23.5437|2017-10-10 23:47:23.5437
NCT02300220|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-07-24|||June 2014||2014-06-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Targeted Retreatment of COPD Exacerbations|Targeted Retreatment of Incompletely Recovered COPD Exacerbations With Ciprofloxacin: a Double-blind, Randomised, Placebo-controlled, Multicentre Phase III Trial|Recruiting||Phase 3|144|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-10 23:47:23.702891|2017-10-10 23:47:23.702891
NCT02300194|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-03-14|||December 2014||2014-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures|Topical Morphine for Analgesia in Pediatric Procedures. Clinical Trial Randomized, Double-blind, Placebo.|Recruiting||Phase 4|44|Anticipated|Hospital General de Niños Pedro de Elizalde||2|||f||||t||||||||||2017-10-10 23:47:23.909629|2017-10-10 23:47:23.909629
NCT02300181|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-08-17|||October 2014||2014-10-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of the Extract of the Flour Fermented With Bacillus Subtilis Var Natto DC-15 on Postprandial Glucose|A Randomized, Double-blind, Placebo Controlled, Crossover Study to Determine the Effect of the Flour Fermentation Products by Bacillus Subtilis Var Natto DC-15 on Postprandial Glucose Profile in Prediabetic Subjects.|Completed||N/A|20|Actual|Hiroshima University||2|||f||||f||||||||||2017-10-10 23:47:24.019776|2017-10-10 23:47:24.019776
NCT02300155|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-21|||October 2004||2004-10-01|November 2014|2014-11-01|January 2008|Actual|2008-01-01|October 2006|Actual|2006-10-01||Interventional|||Improving Multivitamin Supplementation to Pregnant Women|Improving Multivitamin Supplementation to Pregnant Women|Completed||Phase 4|1370|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-10 23:47:24.164059|2017-10-10 23:47:24.164059
NCT02300129|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-08-29|2015-10-20||April 2014||2014-04-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Intent to Treat population|Effect of CD07805/47 Gel in Rosacea Flushing|Effect of CD07805/47 Gel in Subjects Presenting With Flushing Related to Erythematotelangiectatic or Papulopustular Rosacea|Completed||Phase 2|34|Actual|Galderma R&D||4|||f||||f||||||||||2017-10-10 23:47:24.386056|2017-10-10 23:47:24.386056
NCT02300116|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-05-18|||November 2014||2014-11-01|May 2015|2015-05-01||||March 2015|Actual|2015-03-01||Observational|||Smart Vision Labs Autorefractor||Unknown status|Recruiting|N/A|50|Anticipated|Smart Vision Labs|||1||f||||||||||||||2017-10-10 23:47:24.726208|2017-10-10 23:47:24.726208
NCT02300103|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-06-30|2017-06-30||December 1, 2014|Actual|2014-12-01|June 2017|2017-06-01|September 15, 2016|Actual|2016-09-15|July 2, 2016|Actual|2016-07-02||Interventional||Safety Analysis Set: participants who received at least 1 dose of study drug|Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study|An Open Label Study to Evaluate The Efficacy And Safety Of Sofosbuvir/GS-5816 Fixed Dose Combination With Ribavirin For 24 Weeks In Chronic HCV Infected Subjects Who Participated In A Prior Gilead Sponsored HCV Treatment Study|Completed||Phase 2|69|Actual|Gilead Sciences||1|||f||||f|t|f||||||||2017-10-10 23:47:24.816686|2017-10-10 23:47:24.816686
NCT02300077|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-07-26|||December 2014||2014-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Methadone in Ambulatory Surgery|Methadone in Ambulatory Surgery|Active, not recruiting||N/A|60|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:47:25.311887|2017-10-10 23:47:25.311887
NCT02300064|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-05-28|||January 2009||2009-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Exercise in Health and Chronic Obstructive Pulmonary Disease|Mechanisms of Adaptation to Exercise in Health and Chronic Obstructive Pulmonary Disease (COPD); Oxidative Stress Links Aging, Activity and Mobility|Completed||N/A|185|Actual|University of Utah||2|||f||||t||||||||||2017-10-10 23:47:25.412348|2017-10-10 23:47:25.412348
NCT02300051|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-12-08|||February 2011||2011-02-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||Intervention Study for Individuals With Compulsive Sexual Behavior|Sexual Risk Behavior, Clinical and Psychopathological Aspects of Individuals With Compulsive Sexual Behavior of the Institute of Psychiatry of the General Hospital of the University of São Paulo Medical School, an Intervention Study.|Completed||N/A|135|Actual|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-10 23:47:25.48994|2017-10-10 23:47:25.48994
NCT02300025|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-01-21|2016-01-21||August 2014||2014-08-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Safety population included all participants who received at least one dose of cobimetinib and had at least one post-dose safety assessment.|A Study to Evaluate the Pharmacokinetics and Safety of Cobimetinib in Volunteers With and Without Liver Damage||Completed||Phase 1|28|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-10 23:47:25.657533|2017-10-10 23:47:25.657533
NCT02300012|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-12-14|||February 2015||2015-02-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||A Pilot Study to Investigate Biomarkers in Anterior Cruciate Ligament (ACL) Patients and Healthy Controls|A Pilot Study to Investigate Biomarkers in ACL Patients and Healthy Controls|Recruiting||N/A|60|Anticipated|United Lincolnshire Hospitals NHS Trust||4|||f||||f||||||||||2017-10-10 23:47:26.441162|2017-10-10 23:47:26.441162
NCT02299999|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-05-02|||April 7, 2014|Actual|2014-04-07|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|SAFIR02_Breast||SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer|PERSONALIZED MEDICINE GROUP / UCBG UC-0105/1304: SAFIR02_Breast - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer|Recruiting||Phase 2|1460|Anticipated|UNICANCER||4|||f||||t||||||||Undecided||2017-10-10 23:47:26.557081|2017-10-10 23:47:26.557081
NCT02299986|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-06-23|||April 2013||2013-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|ITAVIDD||An InnovaTive Approach to Ventilator-Induced Diaphragmatic Dysfunction|An InnovaTive Approach to Ventilator-Induced Diaphragmatic Dysfunction|Completed||N/A|56|Actual|University Hospital, Antwerp|||1||f||||f||||||||||2017-10-10 23:47:26.859321|2017-10-10 23:47:26.859321
NCT02299973|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-20|||October 2014||2014-10-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating|Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating: a Double Blind, Placebo Controlled Randomised Clinical Trial|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-10 23:47:26.941283|2017-10-10 23:47:26.941283
NCT02299960|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-06-09|||August 2014||2014-08-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Measurement of Endothelial Function and Cardiac Output: New Methods|Pilot Study: Analysis of Endothelial Function Through Circulating Endothelial Cells and Puls-amplitude-tonometry and of Non-invasive Measurement of Cardiac Output on Exertion in Patients With Heart Failure, Pulmonary Hypertension, Arterial Hypertension and Diabetic Nephropathy|Completed||N/A|101|Actual|Charite University, Berlin, Germany|||4||f||||||||||Samples Without DNA|"     Blood samples, 51,4ml per Patient   "|||2017-10-10 23:47:27.078118|2017-10-10 23:47:27.078118
NCT02299947|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-03-29|||August 2014||2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FIBTEG||Bloodtranfusions After Aortic Surgery|Comparison of a Single Dose Fibrinogen With Placebo and the Number of Blood Transfusions After Ascending Aorta Surgery (FIBTEG Study)|Recruiting||Phase 4|82|Anticipated|St. Antonius Hospital||2|||f||||t||||||||||2017-10-10 23:47:27.170571|2017-10-10 23:47:27.170571
NCT02299934|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-06-06|||July 2014||2014-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||3T MR Angiography of the Hepatic Vasculature|3T MR Angiography of the Hepatic Vasculature: A Pilot Comparison Study of New Noncontrast Techniques to Post-contrast Technique and CT Angiography in Liver Donors.|Enrolling by invitation||N/A|10|Anticipated|University of Colorado, Denver||1|||f||||f||||||||No|Participant data will only be shared to research personnel.|2017-10-10 23:47:27.26534|2017-10-10 23:47:27.26534
NCT02299921|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-08-29|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|||Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure|Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure|Recruiting||N/A|100|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     blood: serum cortisol, Adrenocorticotropic Hormone (ACTH), Corticotropin-Releasing Hormone     (CRH), Arginine Vasopressin (AVP) hair: cortisol urine: Total Protein (TP), Neutrophil     Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1) exhaled breath     condensate: Chemokine ligand 5 (CCL5) Bronchoalveolar lavage (BAL): cell count and     differential, total protein, cytokines/chemokines including CCL5, Tumor Necrosis Factor a     (TNFa), Interferon Gamma (IFNg), Interleukin 6 (IL-6), IL-8, IL-10, alveoloar macrophage     cytokine/chemokine production, alveolar macrophage viability, apoptosis, cytotoxicity,     lymphocyte activation.   "|||2017-10-10 23:47:27.34509|2017-10-10 23:47:27.34509
NCT02299908|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-20|||November 2014||2014-11-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|||Ultrasound-guided Transverses Abdominis Plane Block in Inguinal Herniorrhaphy: Randomized Controlled Clinical Trial|Ultrasound-guided Transverses Abdominis Plane Block in Inguinal Herniorrhaphy: Randomized Controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Universidad de Caldas||2|||f||||f||||||||||2017-10-10 23:47:27.436692|2017-10-10 23:47:27.436692
NCT02299895|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-20|||February 2012||2012-02-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|SCS||Professionals' Perspectives on Facilitating and Hindering Factors of Implementing Health Promotion Programs in Organizational Settings|Professionals' Perspectives on Facilitating and Hindering Factors of Implementing Health Promotion Programs in Organizational Settings: a Qualitative Comparative Study in Austria|Unknown status|Active, not recruiting|N/A|90|Anticipated|Ludwig Boltzmann Gesellschaft|||1||f||||||||||||||2017-10-10 23:47:27.553975|2017-10-10 23:47:27.553975
NCT02299882|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-11-21|||August 2012||2012-08-01|February 2013|2013-02-01|January 2016|Anticipated|2016-01-01|August 2015|Anticipated|2015-08-01||Interventional|||Surgical Infection Rates With Adjunct Vancomycin Compared to Standard Peri-Operative IV Antibiotics|Surgical Infection Rates With Adjunct Vancomycin Compared to Standard Peri-Operative IV Antibiotics|Unknown status|Recruiting|N/A|700|Anticipated|Spectrum Health Hospitals||2|||f||||t||||||||||2017-10-10 23:47:27.60998|2017-10-10 23:47:27.60998
NCT02299869|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-01-30|2016-07-25||October 2014||2014-10-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Comparative Study to Evaluate the Cosmetic Appearance of Two Brands (Coopervision (CVI) vs. Competitor) of Color Soft Contact Lenses.|Comparative Study to Evaluate the Cosmetic Appearance of Two Brands (Coopervision (CVI) vs. Competitor) of Color Soft Contact Lenses.|Completed||N/A|41|Actual|Coopervision, Inc.||4|||f||||f||||||||||2017-10-10 23:47:27.703587|2017-10-10 23:47:27.703587
NCT02299856|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2015-12-09|||March 2014||2014-03-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Observational|||Cardiac Magnetic Resonance in Acute Myocarditis|Cardiac Magnetic Resonance in Acute Myocarditis|Completed||N/A|84|Actual|University Hospital, Bonn|||2||f||||f||||||Samples With DNA|"     Hematocrit is obtained prior to cardiac MR.   "|||2017-10-10 23:47:28.161962|2017-10-10 23:47:28.161962
NCT02299843|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-11-30|||October 2014||2014-10-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||RALPPS Venus ALPPS for Hepatocellular Carcinoma|A Prospective Randomized Controlled Trial of Radio-frequency Assisted ALPPS（RALPPS）and Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy（ALPPS）in the Treatment of Hepatocellular Carcinoma.|Recruiting||N/A|32|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-10 23:47:28.252369|2017-10-10 23:47:28.252369
NCT02299830|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2014-11-20|||December 2014||2014-12-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Interventional Pulmonologic Treatment of Malignant Central Airway Stricture|Prospective, Open, Multicenter Study of Interventional Pulmonologic Treatment of Malignant Central Airway Stricture|Not yet recruiting||N/A|200|Anticipated|Tang-Du Hospital||4|||f||||t||||||||||2017-10-10 23:47:28.335901|2017-10-10 23:47:28.335901
NCT02299817|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-08-29|||August 2015||2015-08-01|August 2016|2016-08-01|February 2021|Anticipated|2021-02-01|January 2021|Anticipated|2021-01-01||Interventional|||Denosumab for Treating Periprosthetic Osteolysis.|Denosumab for Treating Periprosthetic Osteolysis After Uncemented Total Hip Arthroplasty A Randomized, Double-blind, Placebo-controlled Trial Using Volumetric Computed Tomography|Recruiting||Phase 2|110|Anticipated|Danderyd Hospital||2|||f||||f||||||||||2017-10-10 23:47:28.43804|2017-10-10 23:47:28.43804
NCT02299804|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-04-14|||January 2014||2014-01-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo|A Multicenter, Double-Blind, Phase Ⅱ Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo Caused By Posterior Circulation Infarction|Completed||Phase 2|98|Actual|Sihuan Pharmaceutical Holdings Group Ltd.||3|||f||||t||||||||No||2017-10-10 23:47:28.552539|2017-10-10 23:47:28.552539
NCT02299791|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-10-02|2017-03-30||September 2010||2010-09-01|October 2017|2017-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|ALL||Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics|Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics|Completed||N/A|4856|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-10 23:47:28.664356|2017-10-10 23:47:28.664356
NCT02299778|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-10-14|||April 2014||2014-04-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Bacterially-synthesized Folate Absorption Across the Large Intestine|Is Bacterially-Synthesized Folate Absorbed Across the Colon of Humans?|Completed||Phase 1|10|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||||2017-10-10 23:47:29.006101|2017-10-10 23:47:29.006101
NCT02299765|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-01-26|||December 2014||2014-12-01|January 2015|2015-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC|A Randomized, Open-label, Multiple-centre Study of Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced NSCLC With EGFR Mutation Positive|Recruiting||Phase 2|146|Anticipated|Sichuan University||2|||f||||t||||||||||2017-10-10 23:47:29.087881|2017-10-10 23:47:29.087881
NCT02299752|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-20|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Unnoticed Gloves Perforation|Double Gloves: A Randomized Trial to Evaluate a Simple Strategy to Reduce Contamination During Resuscitation|Unknown status|Recruiting|N/A|200|Anticipated|International Institute of Rescue Research and Education||1|||f||||t||||||||||2017-10-10 23:47:29.220222|2017-10-10 23:47:29.220222
NCT02299739|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-20|||December 2005||2005-12-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Liver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine|Liver Enzyme Abnormalities and Its Risk Factors in Taking Traditional Herbal Medicine in Korea|Completed||N/A|6894|Actual|Jaseng Hospital of Korean Medicine|||1||f||||f||||||||||2017-10-10 23:47:29.843447|2017-10-10 23:47:29.843447
NCT02299726|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-04-19|||May 2015||2015-05-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study|Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study|Withdrawn||Phase 2|0|Actual|Indiana University||2||Study was not funded|f||||t||||||||||2017-10-10 23:47:29.920988|2017-10-10 23:47:29.920988
NCT02299713|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-08-11|||January 2015||2015-01-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|February 2017|Actual|2017-02-01||Interventional|EATOAK||Electro-Acupuncture Treatment in Patients With Osteoarthritis Of The Knee (EATOAK)|Randomized, Double-Blind, Placebo-Controlled Trial, Parallel Design Used To Evaluate Pain, Endocrinologic Variations, Life Quality And Medication Use, After Electro-Acupuncture Treatment In Patients With Osteoarthritis Of The Knee|Active, not recruiting||N/A|128|Anticipated|Hospital Son Llatzer||2|||f||||f||||||||||2017-10-10 23:47:29.99511|2017-10-10 23:47:29.99511
NCT02299700|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-10-26|||September 2014||2014-09-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|Mentis||Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder|A Study to Preliminarily Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder|Completed||Early Phase 1|34|Actual|Janssen Research & Development, LLC|||3||f||||f||||||||||2017-10-10 23:47:30.1171|2017-10-10 23:47:30.1171
NCT02299687|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-21|2014-12-31|||September 2014||2014-09-01|December 2014|2014-12-01||||December 2014|Actual|2014-12-01||Interventional|||Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole|A Clinical Trial to Investigate the Influence of CYP2C19 Polymorphism on Pharmacokinetic/Pharmacodynamic Characteristics of Omeprazole in Healthy Korean Volunteers|Completed||Phase 1|24|Actual|Seoul National University Hospital||3|||f||||||||||||||2017-10-10 23:47:30.195716|2017-10-10 23:47:30.195716
NCT02299674|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-05-02|||November 2014|Actual|2014-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|November 2015|Actual|2015-11-01||Observational|||Study of Medial-Lateral Center of Pressure Displacement in Unilateral Transfemoral Amputees|Investigation of Medial Lateral Displacement of Center of Pressure and Center of Mass During Double Support in Men With Unilateral Transfemoral Amputations.|Completed||N/A|3|Actual|Southern California Institute for Research and Education|||1||f||||||||||||||2017-10-10 23:47:30.272038|2017-10-10 23:47:30.272038
NCT02299661|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-06-18|||November 2014||2014-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease|An Open-Label, Randomised, Parallel Group Pilot Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single Doses of DS-1093a in Patients With Chronic Kidney Disease|Completed||Phase 1|31|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||||2017-10-10 23:47:30.341803|2017-10-10 23:47:30.341803
NCT02299648|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-02-15|||July 25, 2014|Actual|2014-07-25|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||The Screening Protocol for The VIKTORY Trial|The Screening Protocol for The VIKTORY Trial- Targeted Agent eValuation in gastrIc Cancer basKeT KORea studY: SMC-AZ GC Basket Trial Screening Protocol|Recruiting||N/A|600|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 23:47:30.429695|2017-10-10 23:47:30.429695
NCT02299635|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-11-17|2016-11-17||February 2015||2015-02-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations|Phase 2 Study Of Single-agent Pf-03084014 In Patients With Advanced Triple-negative Breast Cancer With Or Without Genomic Alterations In Notch Receptors|Terminated||Phase 2|19|Actual|Pfizer|This study was terminated prematurely based on project re-prioritization by the Sponsor and was not due to any safety concerns or regulatory actions.|1||"The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014   development. There were no safety/efficacy concerns behind the decision."|f||||f||||||||||2017-10-10 23:47:30.681278|2017-10-10 23:47:30.681278
NCT02299622|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-04-19|||November 2013||2013-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01||Observational|||Personalized Sequence for Thoracic, Esophageal, and H&N Cancer|Establishment of Personalized Cancer Medicine Using Samsung Cancer Sequencing Platform in Lung Cancer/Mediastinal Tumor/ Head & Neck/Esophageal Cancer/Rare Cancer (PerSeq: Personalized Sequence)|Recruiting||N/A|200|Anticipated|Samsung Medical Center|||1||f||||t||||||Samples With DNA|"     fresh tissue   "|||2017-10-10 23:47:31.321716|2017-10-10 23:47:31.321716
NCT02299609|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-21|||January 2013||2013-01-01|November 2014|2014-11-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI|Therapeutic Effect of Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI|Unknown status|Recruiting|N/A|100|Anticipated|Sakarya University||2|||f||||t||||||||||2017-10-10 23:47:31.414845|2017-10-10 23:47:31.414845
NCT02299596|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-11-29|||January 2015||2015-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Physical Activity in Relation to Surgical Procedures|Physsurg - a Controlled Randomized Trial on the Effect of Physical Activity in Relation to Outcome After Surgery|Recruiting||N/A|620|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||Undecided||2017-10-10 23:47:31.525429|2017-10-10 23:47:31.525429
NCT02299583|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2014-11-21|||October 2014||2014-10-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Controlled Trial of Early Intervention With Children and Adolescents Exposed to Nonrelational Traumatic Events|Protocol for a Controlled Trial of Early Intervention With Children and Adolescents Exposed to Nonrelational Traumatic Events Comparing Trauma-informed and Usual Health Care Practice|Unknown status|Recruiting|N/A|684|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:47:31.649907|2017-10-10 23:47:31.649907
NCT02299570|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-03-22|||November 2014||2014-11-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|November 2015|Actual|2015-11-01||Interventional|PUNCHCD2||Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection|A Phase 2B Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study Demonstrating the Efficacy and Safety of Rebiotix RBX2660 (Microbiota Suspension) for the Treatment of Recurrent Clostridium Difficile Infection|Active, not recruiting||Phase 2|117|Anticipated|Rebiotix Inc.||3|||f||||t||||||||||2017-10-10 23:47:31.81939|2017-10-10 23:47:31.81939
NCT02299557|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-07-26|||November 2014||2014-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients|A Double Blind Study to Examine the Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients|Completed||Phase 1/Phase 2|19|Actual|RDD Pharma Ltd||2|||f||||||||||||||2017-10-10 23:47:31.976962|2017-10-10 23:47:31.976962
NCT02299544|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-10-20|||February 2015||2015-02-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|OAB||BlueWind Medical System for the Treatment of Patients With OAB|Safety and Performance of the BlueWind System for the Treatment of Patients With Overactive Bladder (OAB)|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|Rainbow Medical||1|||f||||f||||||||||2017-10-10 23:47:32.058814|2017-10-10 23:47:32.058814
NCT02299531|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-21|||May 2013||2013-05-01|November 2014|2014-11-01||||August 2014|Actual|2014-08-01||Interventional|||Effects of Portion Size and Energy Density of a Single Meal in Preschool Children||Completed||N/A|131|Actual|Penn State University||6|||f||||f||||||||||2017-10-10 23:47:32.162127|2017-10-10 23:47:32.162127
NCT02299518|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-05-11|||May 18, 2015|Actual|2015-05-18|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|Phase 1 Study of Selinexor in Combination With Topoisomerase-II Inhibition in Acute Myeloid Leukemia|Recruiting||Phase 1|60|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:47:32.260678|2017-10-10 23:47:32.260678
NCT02299505|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-03-01|||April 9, 2015|Actual|2015-04-09|March 2017|2017-03-01|October 25, 2018|Anticipated|2018-10-25|October 25, 2018|Anticipated|2018-10-25||Interventional|||Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)|A Multi-center, Randomized Open Label Study to Assess the Systemic Exposure, Effiacy, and Safety of 450 mg Ceritinib Taken With a Low-fat Meal and 600 mg Ceritinib Taken With a Low-fat Meal as Compared With That of 750 mg Ceritinib Taken in the Fasted State in Adult Patients With ALK Rearranged (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|318|Anticipated|Novartis||3|||f||||f||||||||||2017-10-10 23:47:32.410367|2017-10-10 23:47:32.410367
NCT02299492|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-10-04|||September 2013||2013-09-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PCCP||Person-Centered Care Planning and Service Engagement|Person-Centered Care Planning and Service Engagement|Active, not recruiting||N/A|476|Anticipated|New York University||2|||f||||f||||||||||2017-10-10 23:47:32.765071|2017-10-10 23:47:32.765071
NCT02299466|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-05-10|||December 2003||2003-12-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01|10 Years|Observational [Patient Registry]|HTPN||Registry for Patients Receiving Intravenous Nutrition at Home|Home Total Parenteral Nutrition (HTPN) in Canada: A New Website Based Patient Registry|Recruiting||N/A|600|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:47:32.952501|2017-10-10 23:47:32.952501
NCT02299453|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-21|||December 2011||2011-12-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Tele-IPT for HIV-Infected Rural Persons|Telephone IPT Intervention for HIV-Infected Rural Persons|Unknown status|Active, not recruiting|Phase 1/Phase 2|180|Actual|University of Georgia||2|||f||||t||||||||||2017-10-10 23:47:33.075459|2017-10-10 23:47:33.075459
NCT02299440|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-09-19|||April 2015||2015-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|KETIS||Effects of Ketamine in the Acute Phase of Suicidal Ideation|Evaluation of the Effects of Ketamine in the Acute Phase of Suicidal Ideation: a Multicenter Randomized Double-blind Trial|Recruiting||Phase 3|156|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||No||2017-10-10 23:47:33.15136|2017-10-10 23:47:33.15136
NCT02299427|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-12-08|2016-07-14||March 2015||2015-03-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Website to Teach Children Safety With Dogs|A Website to Teach Children Safety With Dogs|Completed||Phase 1|69|Actual|University of Alabama at Birmingham||2|||f||||f||||||||Undecided|After primary analyses will completed, will provide de-identified data to qualified users who contact us.|2017-10-10 23:47:33.4532|2017-10-10 23:47:33.4532
NCT02299414|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-10-04|||September 2016||2016-09-01|October 2017|2017-10-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|CHAP||Chronic Hypertension and Pregnancy (CHAP) Project|A Pragmatic Multicenter Randomized Clinical Trial (RCT) of Antihypertensive Therapy for Mild Chronic Hypertension During Pregnancy: Chronic Hypertension and Pregnancy (CHAP) Project|Recruiting||Phase 4|4700|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-10 23:47:33.719852|2017-10-10 23:47:33.719852
NCT02299401|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-11-02|||December 2014||2014-12-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of SQPT for At-Home Follow-Up|Assessing the Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of a Semi-Quantitative Pregnancy Test for At-Home Follow-Up|Completed||Phase 2/Phase 3|401|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-10 23:47:34.19174|2017-10-10 23:47:34.19174
NCT02299388|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-12-01|||October 2014||2014-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study|To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study|Completed||Phase 4|15|Actual|Tulane University||2|||f||||t||||||||||2017-10-10 23:47:34.925809|2017-10-10 23:47:34.925809
NCT02299362|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-08-03|||October 2008||2008-10-01|August 2017|2017-08-01|December 2032|Anticipated|2032-12-01|December 2032|Anticipated|2032-12-01|18 Years|Observational [Patient Registry]|GSSG||The Treatment of Progressive Early Onset Spinal Deformities: A Multi-Center Outcome Study|The Treatment of Progressive Early Onset Spinal Deformities: A Multi-Center Outcome Study|Recruiting||N/A|4000|Anticipated|Growing Spine Study Group|||1||f||||f||||||||||2017-10-10 23:47:35.379413|2017-10-10 23:47:35.379413
NCT02299349|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-03-14|2015-04-02||August 2013||2013-08-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional||Men and women aged 18 and up receiving total knee arthroplasty for degenerative joint disease|Bupivacaine Liposome Suspension Versus a Concentrated Multi Drug Periarticular Injection|Bupivacaine Liposome Suspension Versus a Concentrated Multi Drug Periarticular Injection in 70 Patients Undergoing Total Knee Arthroplasty Without Femoral Nerve Block: a Double-blinded, Randomized Clinical Trial|Completed||N/A|70|Actual|TriHealth Inc.||2|||f||||f||||||||||2017-10-10 23:47:35.671002|2017-10-10 23:47:35.671002
NCT02299336|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-05-01|||October 2014||2014-10-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial|Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial.|Completed||Phase 4|26|Anticipated|Greater Houston Retina Research||1|||f||||f||||||||Undecided||2017-10-10 23:47:36.009208|2017-10-10 23:47:36.009208
NCT02299323|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-08-09|||January 2012||2012-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||INDEPENDENCE Spacer for Lumbar Fusion|Circumferential Lumbar Spinal Fusion for Treatment of Degenerative Disc Disease: A Prospective, Non-Randomized Clinical Study|Completed||N/A|30|Actual|Globus Medical Inc|||1||f||||f||||||||||2017-10-10 23:47:36.160501|2017-10-10 23:47:36.160501
NCT02299310|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-29|||November 2014||2014-11-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease|Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:47:36.267398|2017-10-10 23:47:36.267398
NCT02299297|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-07-28|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis|An Open-Label Pilot Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis|Active, not recruiting||Phase 2|15|Anticipated|Columbia University||1|||f||||f|t|f||||||||2017-10-10 23:47:37.024875|2017-10-10 23:47:37.024875
NCT02297607|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-06-03|||November 2014||2014-11-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|November 2019|Anticipated|2019-11-01||Interventional|||Routine Post-Operative Supplemental Nutrition|Routine Post-Operative Supplemental Nutrition: A Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 23:47:54.897089|2017-10-10 23:47:54.897089
NCT02299284|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-05-04|||June 2013||2013-06-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Intensive Home-based Bimanual and Lower-limb Training in Young Children With Hemiplegia|Intensive Home-based Bimanual and Lower-limb Training in Young Children With Hemiplegia|Completed||N/A|24|Actual|Teachers College, Columbia University||2|||f||||f||||||||||2017-10-10 23:47:37.150569|2017-10-10 23:47:37.150569
NCT02299271|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-02-07|||June 2014||2014-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty|Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study|Terminated||Phase 4|72|Actual|The Christ Hospital||2||Preliminary analysis showed no difference between groups.|f||||t||||||||||2017-10-10 23:47:37.26509|2017-10-10 23:47:37.26509
NCT02299258|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-02-10|2014-11-22||May 2009||2009-05-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Gastric Outlet Obstructions Tailored Covered Stents for GOO|A Multicenter Randomized Controlled Trial of Malignant Gastric Outlet Obstruction: Tailored Partially Covered Stents (Placed Fluoroscopically) Versus Standard Uncovered Stents (Placed Endoscopically)|Completed||N/A|63|Actual|The First People's Hospital of Yuhang District||2|||f||||t||||||||||2017-10-10 23:47:37.359778|2017-10-10 23:47:37.359778
NCT02299245|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-07-13|||October 2014||2014-10-01|July 2015|2015-07-01|November 2016|Anticipated|2016-11-01|July 2016|Anticipated|2016-07-01||Interventional|||Rosuvastatin Effect on Telomere-telomerase System in ACS|Different Doses Rosuvastatin Effect on Telomere-telomerase System in Acute Coronary Syndrome Patients After Percutaneous Coronary INtervention: RETAIN Study|Unknown status|Active, not recruiting|Phase 4|400|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:47:37.653425|2017-10-10 23:47:37.653425
NCT02299232|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-19|||February 2014||2014-02-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|DEX||Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation|Comparison of Two Different Intranasal Doses of Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation|Completed||Phase 4|60|Actual|Sisli Etfal Training & Research Hospital||2|||f||||f||||||||||2017-10-10 23:47:37.734421|2017-10-10 23:47:37.734421
NCT02299219|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-03-31|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Teens Taking Charge: Managing Cancer Online|Teens Taking Charge: A Pilot Randomized Controlled Trial of an Online Self-Management and Transitional Care Program for Youth With Cancer|Recruiting||N/A|120|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 23:47:37.819276|2017-10-10 23:47:37.819276
NCT02299206|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-03-24|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants|Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants|Terminated||N/A|3|Actual|Northwestern University||2||Principal Investigator and sponsor agreed to termination.|f||||t||||||||||2017-10-10 23:47:37.928183|2017-10-10 23:47:37.928183
NCT02299193|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-08-29|||August 2014||2014-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Online CBT-I for High Blood Pressure|Online CBT-I for High Blood Pressure|Completed||N/A|58|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:47:38.018412|2017-10-10 23:47:38.018412
NCT02299180|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-08-01|||February 2015||2015-02-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Impact of Advance Care Planning on Care for Patients With Advanced Heart Failure|Impact of Advance Care Planning on Care for Patients With Advanced Heart Failure: A Randomized Controlled Trial|Recruiting||N/A|254|Anticipated|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-10 23:47:38.09641|2017-10-10 23:47:38.09641
NCT02299167|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-20|||January 2014||2014-01-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Minimal Effective Dose of Hyperbaric Spinal Bupivacaine for Saddle Block|The Minimal Effective Dose of Hyperbaric Spinal Bupivacaine for Successful Reliable Saddle Block for Minor Perianal Surgeries|Completed||Phase 3|24|Actual|Dammam University||1|||f||||t||||||||||2017-10-10 23:47:38.179343|2017-10-10 23:47:38.179343
NCT02299154|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-03-07|||December 2014||2014-12-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|REMAD||Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process :|Study of Memory Problems Perceptions With the French Adaptation of the Illness Perception Questionnaire Memory, Among Patients Who Come for the First Time at a Memory Center Until Diagnosis Disclosure Post-visit|Recruiting||N/A|250|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-10-10 23:47:38.332841|2017-10-10 23:47:38.332841
NCT02299141|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-07-20|||May 7, 2015|Actual|2015-05-07|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer|A Pilot Study of Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 23:47:38.41024|2017-10-10 23:47:38.41024
NCT02299128|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-02-24|||September 2014||2014-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness of Early Physical Therapy Intervention for Patients With Dizziness After a Sports-Related Concussion|A Feasibility Study for a Randomized Controlled Trial on the Effectiveness of Early Physical Therapy Intervention for Patients With Dizziness After a Sports-Related Concussion|Completed||N/A|41|Actual|Walsh University||2|||f||||f||||||||No||2017-10-10 23:47:38.496321|2017-10-10 23:47:38.496321
NCT02299115|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-04-16|||September 2016||2016-09-01|April 2016|2016-04-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|PREDVGB||Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms|Prednisolone vs. Vigabatrin in the First-line Treatment of Infantile Spasms|Not yet recruiting||Phase 3|105|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||No||2017-10-10 23:47:38.586815|2017-10-10 23:47:38.586815
NCT02298920|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-06-01|||January 2015||2015-01-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||AZD0914 Phase 1 ADME Study in Healthy Volunteers|A Phase I, Open-Label Study to Assess the Absorption, Metabolism, Excretion, Safety and Tolerability of a Single Oral Dose of Radiolabeled [14C]-AZD0914 in Healthy Male Subjects|Completed||Phase 1|6|Anticipated|Entasis Therapeutics||1|||f||||f||||||||||2017-10-10 23:47:41.733225|2017-10-10 23:47:41.733225
NCT02299102|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-12-05|||December 2014||2014-12-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study Comparing Powered Ported Bone Marrow Aspiration Procedures to Manual Standard Bone Marrow Aspiration Procedures Using Healthy Volunteers|A Study Comparing Powered Ported Bone Marrow Aspiration Procedures to Manual Standard Bone Marrow Aspiration Procedures Using Healthy Volunteers|Completed||N/A|15|Actual|Vidacare Corporation||2|||f||||f||||||||||2017-10-10 23:47:38.704414|2017-10-10 23:47:38.704414
NCT02299076|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-08-11|2017-05-11||January 1, 2016|Actual|2016-01-01|August 2017|2017-08-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Interventional|||Pro-Change Smoking Cessation Intervention|Software to Translate Behavioral Economics Insights to Improve Health (Phase 2b)|Completed||N/A|422|Actual|VAL Health, LLC||2|||f||||f|f|f||||||||2017-10-10 23:47:38.892253|2017-10-10 23:47:38.892253
NCT02299063|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-11-03|||November 2014||2014-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dexmedetomidine Effect on Mitochondrial Function|The Protective Effect of the α2-agonist Dexmedetomidine on Mitochondrial Structure and Function for Children With Non-cyanotic Congenital Heart Defects Having Cardiac Surgery: A Randomized Controlled Trial.|Recruiting||Phase 4|36|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||No||2017-10-10 23:47:39.157958|2017-10-10 23:47:39.157958
NCT02299050|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-14|||June 2014||2014-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Cycloset on Glycemic Control When Added to GLP-1 Analogue Therapy|Effect of Cycloset on Glycemic Control in Type 2 Diabetic Patients Inadequately Controlled on GLP-1 Analogue Therapy|Active, not recruiting||Phase 4|20|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-10 23:47:39.251852|2017-10-10 23:47:39.251852
NCT02299037|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-20|||March 2012||2012-03-01|November 2014|2014-11-01|July 2015|Anticipated|2015-07-01|January 2015|Anticipated|2015-01-01||Observational|||Predicting the Risk of Post-operative Delirium: Use of Neuropsychology, Serum and CSF Biomarkers and Genetics to Predict Risk of Post-operative Delirium||Unknown status|Recruiting|N/A|316|Anticipated|Belfast Health and Social Care Trust|||1||f||||f||||||Samples With DNA|"     serum cerebrospinal fluid DNA extracted from blood   "|||2017-10-10 23:47:39.32967|2017-10-10 23:47:39.32967
NCT02299024|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-21|||October 2012||2012-10-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter|Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter|Completed||N/A|278|Actual|Northwestern University||2|||f||||f||||||||||2017-10-10 23:47:39.385793|2017-10-10 23:47:39.385793
NCT02299011|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-06-11|||February 2014||2014-02-01|June 2015|2015-06-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|BIODEGRADE||Comparison of Biomatrix and Orsiro Drug Eluting Stent|Comparison of Biomatrix and Orsiro Drug Eluting Stent in Angiographic Result in Patients With All-comer Patients With Coronary Artery Disease : A Multicenter, Randomized, Open Label Study (BIODEGRADE Study)|Recruiting||Phase 4|3850|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-10 23:47:39.455783|2017-10-10 23:47:39.455783
NCT02298998|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-11-03|||March 2013||2013-03-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study|Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study|Recruiting||N/A|45|Anticipated|The University of Texas Health Science Center at San Antonio|||2||f||||t||||||Samples With DNA|"     After participant signs the consent form, research staff may ask participant to provide a     urine sample at each study visit for research purposes.   "|||2017-10-10 23:47:39.559678|2017-10-10 23:47:39.559678
NCT02298985|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-01-12|||January 2015||2015-01-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients|Curcumin as add-on to Antipsychotic Treatment in Chronic Schizophrenia Patients: A Randomized, Double-Blind, Placebo-controlled Study|Recruiting||Phase 4|40|Anticipated|Beersheva Mental Health Center||2|||f||||t||||||||||2017-10-10 23:47:39.640285|2017-10-10 23:47:39.640285
NCT02298972|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-10-24|||October 2014||2014-10-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With Cancer|Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With Cancer|Completed||N/A|143|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-10 23:47:39.73308|2017-10-10 23:47:39.73308
NCT02298959|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-09-12|||March 13, 2015|Actual|2015-03-13|September 2017|2017-09-01||||December 31, 2018|Anticipated|2018-12-31||Interventional|||Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors|A Phase 1 Trial of MK-3475 Plus Ziv-Aflibercept in Patients With Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-10 23:47:39.798659|2017-10-10 23:47:39.798659
NCT02298946|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-04|||November 13, 2014||2014-11-13|July 26, 2017|2017-07-26|April 7, 2017|Actual|2017-04-07|July 13, 2016|Actual|2016-07-13||Interventional|||AMP-224, a PD-1 Inhibitor, in Combination With Stereotactic Body Radiation Therapy in People With Metastatic Colorectal Cancer|A Pilot Study of AMP-224, a PD-1 Inhibitor, in Combination With Stereotactic Body Radiation Therapy (SBRT) in Patients With Metastatic Colorectal Cancer|Completed||Phase 1|17|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:47:39.918978|2017-10-10 23:47:39.918978
NCT02298933|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-21|2017-08-22|||November 4, 2014||2014-11-04|August 9, 2017|2017-08-09|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Interventional|||Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia|Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia|Completed||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:47:41.654418|2017-10-10 23:47:41.654418
NCT02298907|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-06-25|||June 2010||2010-06-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01|1 Week|Observational [Patient Registry]|||CPET in Colorectal Surgery|Cardiopulmonary Exercise Variables Are Associated With Postoperative Morbidity After Major Colorectal Surgery - A Validation Study|Completed||N/A|170|Actual|Aintree University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:47:41.804832|2017-10-10 23:47:41.804832
NCT02298881|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-19|||July 2013||2013-07-01|November 2014|2014-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Ocular Surface Microbiome|Diversity and Dynamic Stability of the Ocular Surface Microbiome|Unknown status|Recruiting|N/A|80|Anticipated|University of Washington|||2||f||||f||||||Samples With DNA|"     Swab or scrapings of the cornea   "|||2017-10-10 23:47:41.966451|2017-10-10 23:47:41.966451
NCT02298868|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-02-04|2015-01-06||October 2012||2012-10-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|||Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study|Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study|Completed||Phase 2|10|Actual|University of Virginia||1|||f||||f||||||||||2017-10-10 23:47:42.052237|2017-10-10 23:47:42.052237
NCT02298855|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-11-21|||January 2006||2006-01-01|September 2014|2014-09-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer.|A Randomised Study Comparing Satisfaction With Individualised Follow-up Led by a Trained Cancer Nurse Versus Conventional Medical Follow-up After Primary Treatment for Ovarian Cancer.|Completed||N/A|113|Actual|University College, London||2|||f||||f||||||||||2017-10-10 23:47:42.309821|2017-10-10 23:47:42.309821
NCT02298842|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-07-18|2017-04-05||November 5, 2015||2015-11-05|July 2017|2017-07-01|May 12, 2016|Actual|2016-05-12|May 12, 2016|Actual|2016-05-12||Interventional||The Safety Population includes all participants enrolled in this study who underwent any study related apheresis procedure.|In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution|In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution|Completed||N/A|87|Actual|Terumo BCT||2|||f||||f||||||||||2017-10-10 23:47:42.533777|2017-10-10 23:47:42.533777
NCT02298829|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Observational|||Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease|Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease in Studies AUX-CC-802, AUX-CC-803, AUX-CC-804 and AUX-CC-806|Active, not recruiting||Phase 4|280|Actual|Endo Pharmaceuticals|||1||f||||f||||||Samples Without DNA|"     Blood samples for the determination of antibodies to AUX-I and AUX-II and neutralizing     antibodies to AUX-I and AUX-II will be collected at each long-term follow-up visit.   "|||2017-10-10 23:47:43.124907|2017-10-10 23:47:43.124907
NCT02298816|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-12-28|||August 2014||2014-08-01|December 2016|2016-12-01|December 2025|Anticipated|2025-12-01|December 2024|Anticipated|2024-12-01|10 Years|Observational [Patient Registry]|HMvax-Regist||B-Cell Hematologic Malignancy Vaccination Registry|B-Cell Hematologic Malignancy Vaccination Registry|Enrolling by invitation||N/A|10000|Anticipated|Aurora Health Care|||1||f||||f||||||||||2017-10-10 23:47:43.272726|2017-10-10 23:47:43.272726
NCT02298790|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2017-04-20|||November 2014||2014-11-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effect of Dietary Habits on Metabolic Health|Effect of Dietary Habits on Metabolic Health|Recruiting||N/A|24|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:47:43.449057|2017-10-10 23:47:43.449057
NCT02298777|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-09-07|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|SCLEROMICS||Metabolomic Analysis of Systemic Sclerosis|Metabolomic Analysis of Systemic Sclerosis|Recruiting||N/A|140|Anticipated|University Hospital, Strasbourg, France|||5||f||||f||||||||||2017-10-10 23:47:43.55121|2017-10-10 23:47:43.55121
NCT02298764|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-11-14|||February 2013||2013-02-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Back Pain and PostTraumaticStressDisorder. A Randomized Clinical Trial|Somatic Experiencing for Patients With Comorbid Posttraumatic Stress and Back Pain - A Randomized Controlled Trial.|Completed||N/A|91|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-10 23:47:43.653787|2017-10-10 23:47:43.653787
NCT02298751|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-09-28|||May 2015||2015-05-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Exposure Therapy as Aftercare for Alcohol Use Disorder|Alcohol Cue Exposure: An Investigator-blinded, Randomized, Controlled Study of Exposure-based Aftercare in Alcohol Use Disorder Individuals|Recruiting||N/A|300|Anticipated|University of Southern Denmark||3|||f||||t||||||||||2017-10-10 23:47:43.736511|2017-10-10 23:47:43.736511
NCT02298738|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-21|||January 2012||2012-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Effect of Vit D on New-onset AF in Hypertension|Relation of Low Vitamin D Levels and New-onset AF Among Hypertensive Patients|Completed||N/A|227|Actual|Ankara University|||2||f||||f||||||||||2017-10-10 23:47:43.8387|2017-10-10 23:47:43.8387
NCT02298725|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-08-10|||December 16, 2014|Actual|2014-12-16|August 2017|2017-08-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|iMAPS||Individual Metabolism and Physiology Signature Study|Individual Metabolism and Physiology Signature Study|Completed||N/A|54|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-10 23:47:43.909749|2017-10-10 23:47:43.909749
NCT02298699|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-10-13|||November 2014||2014-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|BioSly||Biomarker for Sly Disease|Biomarker for Sly Disease - AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry 10ml EDTA     blood, sputum tube and a dry blood spot filter card are taken. To proof the correct diagnosis     in those patients where up to the enrollment in the study no genetic testing has been done,     sequencing will be done. The analyses are done in the Albrecht-Kossel-Institute for     Neuroregeneration (AKos), POB 100 888, Gehlsheimer Str. 20, 18055 Rostock (Germany)   "|Undecided||2017-10-10 23:47:44.26788|2017-10-10 23:47:44.26788
NCT02298686|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-10-13|||November 2014||2014-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|BioSanfilippo||Biomarker for Sanfilippo Disease|Biomarker for Sanfilippo Disease - AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry 10ml EDTA     blood, sputum tube and a dry blood spot filter card are taken. To proof the correct diagnosis     in those patients where up to the enrollment in the study no genetic testing has been done,     sequencing will be done. The analyses are done in the Albrecht-Kossel-Institute for     Neuroregeneration (AKos), POB 100 888, Gehlsheimer Str. 20, 18055 Rostock (Germany)   "|Undecided||2017-10-10 23:47:44.378928|2017-10-10 23:47:44.378928
NCT02298673|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-08-28|||November 2014||2014-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|BioML||Biomarker for Mucolipidosis Disorder Type I, II, III or IV|Biomarker for Mucolipidosis Disorder Type I, II, III or IV - AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|50|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry 10ml EDTA     blood, sputum tube and a dry blood spot filter card are taken. To proof the correct diagnosis     in those patients where up to the enrollment in the study no genetic testing has been done,     sequencing will be done. The analyses are done in the Albrecht-Kossel-Institute for     Neuroregeneration (AKos), POB 100 888, Gehlsheimer Str. 20, 18055 Rostock (Germany)   "|||2017-10-10 23:47:44.467473|2017-10-10 23:47:44.467473
NCT02298660|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-11-19|||April 2013||2013-04-01|November 2014|2014-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI|Effect of Botox Treatment for Neurogenic Detrusor Overactivity on the Prevention of Autonomic Dysreflexia Following Spinal Cord Injury|Unknown status|Recruiting|Phase 4|40|Anticipated|Rick Hansen Institute||1|||f||||t||||||||||2017-10-10 23:47:44.555319|2017-10-10 23:47:44.555319
NCT02298621|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-19|||January 2013||2013-01-01|December 2012|2012-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Pomegranate Juice and Metabolic Syndrome|The Effect of Pomegranate Juice Intake on Cardiometabolic Factors in Subjects With Metabolic Syndrome.|Completed||N/A|30|Actual|Urmia University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:47:44.862389|2017-10-10 23:47:44.862389
NCT02298608|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2014-11-21|||January 2014||2014-01-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Efficacy and Safety of IRE for RMs|The Efficacy and Safety of Irreversible Electroporation for the Ablation of Renal Masses: A Prospective, Human, In-Vivo Study.|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-10 23:47:44.943909|2017-10-10 23:47:44.943909
NCT02298595|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-07-05|||August 2016||2016-08-01|July 2016|2016-07-01|August 2024|Anticipated|2024-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma|A Phase I/II Study of BYL719, Cetuximab, and Cisplatin in Transorally Resectable, HPV-Associated Oropharyngeal Squamous Cell Carcinoma|Not yet recruiting||Phase 1/Phase 2|62|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-10 23:47:45.047643|2017-10-10 23:47:45.047643
NCT02298582|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-05-02|||December 8, 2014|Actual|2014-12-08|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FENTA||Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly|Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly With or Without Background Treatment.|Recruiting||Phase 2/Phase 3|60|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-10 23:47:45.148465|2017-10-10 23:47:45.148465
NCT02298569|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-03-23|||September 2014||2014-09-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|SORPRISE||Early Postnatal Discharge in a French Perinatal Network|Early Postnatal Discharge in a French Perinatal Network|Active, not recruiting||N/A|800|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-10 23:47:45.235219|2017-10-10 23:47:45.235219
NCT02298556|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2016-01-22|||October 2014||2014-10-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|HARVEST-TR||An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes|A Prospective Noninterventional, Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Non-dihydropyridine Calcium Channel Blocker Single Pill Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes Mellitus|Active, not recruiting||N/A|270|Actual|Abbott|||1||f||||f||||||||||2017-10-10 23:47:45.358255|2017-10-10 23:47:45.358255
NCT02298543|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-20|2015-12-29|||November 2014||2014-11-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry|The Multicenter Registry to Evaluate the Natural Course of Coronary Spasm Patients Presenting Aborted Sudden Cardiac Death|Completed||N/A|200|Actual|Asan Medical Center|||1||f||||f||||||||||2017-10-10 23:47:45.487451|2017-10-10 23:47:45.487451
NCT02298530|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-12-03|||March 2015||2015-03-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Tea Components, Mental Stress and Blood Pressure|A Study to Determine the Acute Effects of a Tea Component on Blood Pressure and Mental Stress Challenge|Completed||N/A|56|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-10 23:47:45.561542|2017-10-10 23:47:45.561542
NCT02298517|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2015-05-27|||December 2013||2013-12-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Application Breathing Exercises With Load Inspiratory Postoperative Abdominal Surgery|Application of Breathing Exercises With Load Inspiratory Postoperative Abdominal Surgery: a Randomized Clinical Trial Blind|Completed||N/A|114|Actual|Universidade Metodista de Piracicaba||5|||f||||f||||||||||2017-10-10 23:47:45.659056|2017-10-10 23:47:45.659056
NCT02298504|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Vital Pulp Treatment in Primary Teeth|Evaluation of MTA Pulpotomy, Biodentine Pulpotomy, and Glass Ionomer Indirect Pulp Treatment in Primary Teeth|Recruiting||Phase 4|156|Anticipated|University of Maryland Baltimore Dental School||3|||f||||t||||||||||2017-10-10 23:47:45.754391|2017-10-10 23:47:45.754391
NCT02298491|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-05-02|||May 2016||2016-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||CNS Sarcoidosis and Acthar Gel|Clinical Biomarkers of Disease Activity and Treatment Responses in Patients With CNS Sarcoidosis Treated With H.P. Acthar Gel|Recruiting||Phase 4|10|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-10 23:47:45.837579|2017-10-10 23:47:45.837579
NCT02298478|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-05-24|||September 1, 2015|Actual|2015-09-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of an Internet-based Treatment for Flying Phobia: NO-FEAR Airlines|Efficacy of an Internet-based Treatment for Flying Phobia: A Randomized Controlled Trial|Active, not recruiting||N/A|69|Actual|Universitat Jaume I||3|||f||||f||||||||Undecided||2017-10-10 23:47:45.937828|2017-10-10 23:47:45.937828
NCT02298465|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-04-06|||November 2014||2014-11-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||ESWL for Distal Ureteric Stone: Supine Versus Prone|Randomized Controlled Study on Extracorporeal Shockwave Lithotripsy for Distal Ureteric Stone: Transgluteal Versus Traditional Prone Approach|Recruiting||N/A|130|Anticipated|Queen Mary Hospital, Hong Kong||2|||f||||t||||||||No||2017-10-10 23:47:46.041313|2017-10-10 23:47:46.041313
NCT02298452|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-05-02|||May 2013||2013-05-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids|Structured Post Market Clinical Follow-up (PMCF) to Evaluate the Quality of a New Hearing Aid Product Generation.|Completed||N/A|253|Actual|Phonak AG, Switzerland||1|||f||||f||||||||||2017-10-10 23:47:46.152592|2017-10-10 23:47:46.152592
NCT02298439|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-05-10|||October 2013||2013-10-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01|5 Years|Observational [Patient Registry]|||Fatty Liver Patient Registry|Non-Alcoholic Fatty Liver Disease Patient Registry|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-10 23:47:46.227534|2017-10-10 23:47:46.227534
NCT02298426|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2017-04-04|||April 2014||2014-04-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||Body Constitution Classification Based Comprehensive Health Management Intervention on Obese Population|Body Constitution Classification Based Comprehensive Health Management Intervention on Obese Population|Completed||N/A|1452|Actual|Peking University||4|||f||||t||||||||No||2017-10-10 23:47:46.311109|2017-10-10 23:47:46.311109
NCT02298413|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2016-02-03|||May 2013||2013-05-01|February 2016|2016-02-01|May 2021|Anticipated|2021-05-01|November 2016|Anticipated|2016-11-01|5 Years|Observational [Patient Registry]|BVS-RAI||Italian Absorb Registry|Clinical Study on Absorb Polylactic, Reabsorbable Coronary Scaffold (RAI)|Active, not recruiting||N/A|1520|Actual|Ospedale Santa Croce-Carle Cuneo|||1||f||||f||||||||||2017-10-10 23:47:46.389889|2017-10-10 23:47:46.389889
NCT02298400|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-01-05|||August 2014||2014-08-01|November 2014|2014-11-01||||March 2015|Anticipated|2015-03-01||Interventional|||A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses|A Single-Center, Cross-over, Pilot Study Evaluating Acuvue® Oasys® Lenses (Senofilcon A), 30-Day Bausch + Lomb PureVision (Balafilcon A), and Clariti® 1-Day (Somofilcon A) Lenses, for Their Impact on Ocular Discomfort Induced by Exposure to the Turbo Controlled Adverse Environment™|Unknown status|Recruiting|Phase 4|40|Anticipated|ORA, Inc.||3|||f||||f||||||||||2017-10-10 23:47:46.462942|2017-10-10 23:47:46.462942
NCT02298387|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-07-25|||December 2014||2014-12-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors|A Phase 1 Dose Escalation and Expansion Study of OMP-305B83 in Subjects With Solid Tumors|Active, not recruiting||Phase 1|71|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:47:46.532393|2017-10-10 23:47:46.532393
NCT02298374|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-04-20|||November 2014||2014-11-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Evaluation of Homecare Reablement, the Trondheim Model|Evaluation of Homecare Reablement, the Trondheim Model|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||2||no funding|f||||f||||||||||2017-10-10 23:47:46.725033|2017-10-10 23:47:46.725033
NCT02298361|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-04-26|2016-04-26||March 2013||2013-03-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|IMPACCT||IMPACCT for Kids' Care|Innovative Methods for Parents And Clinics to Create Tools (IMPACCT) for Kids' Care|Completed||N/A|27251|Actual|Ochin, Inc.|||3||f||||f||||||||||2017-10-10 23:47:46.821032|2017-10-10 23:47:46.821032
NCT02298348|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-08-11|||April 2015||2015-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|N2013-02||Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma|NANT N2013-02 A Phase I Study of Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma|Recruiting||Phase 1|18|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-10-10 23:47:47.491486|2017-10-10 23:47:47.491486
NCT02298335|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-08-09|||June 2014||2014-06-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational Study|A Prospective Observational Study to Assess the Efficacy an Safety of Glucocorticoid Therapy in the Treatment of Adult Idiopathic Nephrotic Syndrome|Recruiting||N/A|235|Anticipated|Nanjing University School of Medicine||1|||f||||t||||||||||2017-10-10 23:47:47.640109|2017-10-10 23:47:47.640109
NCT02298322|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-09-02|||November 2014||2014-11-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|||Submental IDE Study|Study to Evaluate Non-Invasive Subcutaneous Fat Reduction in the Submental Area Using Cryolipolysis|Unknown status|Active, not recruiting|N/A|60|Anticipated|Zeltiq Aesthetics||1|||f||||f||||||||||2017-10-10 23:47:47.730775|2017-10-10 23:47:47.730775
NCT02298309|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-03-21|||April 2015||2015-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Siyasiza||Test and Treat TB: A Proof of Concept Trial in South Africa||Active, not recruiting||N/A|4809|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:47:47.810538|2017-10-10 23:47:47.810538
NCT02298296|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-04-18|||June 2014||2014-06-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|PEACEIIa||Trajectory of Positive Psychological States in Patients With ACS|Trajectory of Positive Psychological States in Patients With Acute Coronary Syndrome|Completed||N/A|25|Actual|Massachusetts General Hospital|||1||f||||f||||||||No||2017-10-10 23:47:47.930244|2017-10-10 23:47:47.930244
NCT02298283|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-03-08|||April 2015||2015-04-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|August 2020|Anticipated|2020-08-01||Interventional|BRAPP2||Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD|Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II Hodgkin's Lymphoma and FDG-PET Positivity After 2 Cycles of ABVD|Recruiting||Phase 2|40|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-10 23:47:48.030203|2017-10-10 23:47:48.030203
NCT02298270|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-06-21|||March 2014||2014-03-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype|Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype|Completed||N/A|65|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:47:48.40599|2017-10-10 23:47:48.40599
NCT02298257|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-07-11|||June 2015||2015-06-01|July 2017|2017-07-01|June 2022|Anticipated|2022-06-01|June 2018|Anticipated|2018-06-01||Interventional|AMC-085||A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage III-IV HIV-associated Hodgkin Lymphoma|A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage III-IV HIV-associated Hodgkin Lymphoma|Recruiting||Phase 2|20|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||f||||||||||2017-10-10 23:47:48.542073|2017-10-10 23:47:48.542073
NCT02298244|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-19|||January 2015||2015-01-01|November 2014|2014-11-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Safety Procedure Pulmonary Artery Denervation in Addition to Pulmonary Vein Isolation Combined With Ganglionated Plexi Ablation in Patients With Persistent Atrial Fibrillation and Pulmonary Hypertension||Unknown status|Not yet recruiting|N/A|20|Anticipated|Krasnoyarsk Regional Hospital||2|||f||||||||||||||2017-10-10 23:47:48.737851|2017-10-10 23:47:48.737851
NCT02298231|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-10-13|||April 2016||2016-04-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Improving Balance in TBI Using Virtual Reality|Improving Balance in TBI Using a Low-Cost Customized Virtual Reality Rehabilitation Tool|Recruiting||N/A|180|Anticipated|Kessler Foundation||3|||f||||||||||||||2017-10-10 23:47:48.816672|2017-10-10 23:47:48.816672
NCT02298218|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-20|||September 2009||2009-09-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia||Completed||Phase 4|50|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:47:48.904699|2017-10-10 23:47:48.904699
NCT02298205|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-11-28|||February 2015||2015-02-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ASIST||Asthma Symptom Based Adjustment of Inhaled Steroid Therapy in African American Children|Asthma Symptom Based Adjustment of Inhaled Steroid Therapy in African American Children|Active, not recruiting||Phase 4|206|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-10 23:47:48.966396|2017-10-10 23:47:48.966396
NCT02298023|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-19|||November 2014||2014-11-01|November 2014|2014-11-01|April 2017|Anticipated|2017-04-01|July 2015|Anticipated|2015-07-01||Interventional|||Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)|Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells: Phase II Double-Blind Placebo-Controlled Randomized Clinical Trials.|Unknown status|Recruiting|Phase 2|24|Anticipated|Seoul National University Hospital||3|||f||||f||||||||||2017-10-10 23:47:51.278359|2017-10-10 23:47:51.278359
NCT02298192|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-04-24|2016-12-22|2016-12-06|November 21, 2014|Actual|2014-11-21|April 2017|2017-04-01|December 23, 2015|Actual|2015-12-23|December 23, 2015|Actual|2015-12-23||Interventional|DUAL™ VI|Full analysis set (FAS): Included all randomised subjects. The subjects in IDegLira (IWT) and IDegLira are 210 in each arm.|A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms|A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms|Completed||Phase 3|420|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 23:47:49.068017|2017-10-10 23:47:49.068017
NCT02298179|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-06-29|||December 19, 2014|Actual|2014-12-19|June 2017|2017-06-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|||To Evaluate the Safety and Ability of the Medicine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults|A Phase 1 Randomized, Observer Blind, Placebo Controlled, Dosage-Escalation Single Center Study to Evaluate the Safety and Immunogenicity of an RSV Fusion Glycoprotein (F) Subunit Vaccine in Healthy Adults|Completed||Phase 1|288|Actual|GlaxoSmithKline||12|||f||||t||||||||||2017-10-10 23:47:49.58522|2017-10-10 23:47:49.58522
NCT02298166|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-03-15|||November 17, 2016|Actual|2016-11-17|March 2017|2017-03-01|October 2023|Anticipated|2023-10-01|April 2022|Anticipated|2022-04-01||Interventional|||Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations|Dose-Finding Run-in Phase I Followed by a Phase III, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations|Recruiting||Phase 3|276|Anticipated|University of Ulm||2|||f||||t||||||||||2017-10-10 23:47:49.812836|2017-10-10 23:47:49.812836
NCT02298153|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-07-13|||November 2014|Actual|2014-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|February 2020|Anticipated|2020-02-01||Interventional|||A Study of Atezolizumab (MPDL3280A) in Combination With Epacadostat (INCB024360) in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (ECHO-110)|A Phase 1 Study of Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (ECHO-110)|Active, not recruiting||Phase 1|29|Actual|Incyte Corporation||1|||f||||f||||||||||2017-10-10 23:47:49.920722|2017-10-10 23:47:49.920722
NCT02298140|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-07-31|||November 2014||2014-11-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|(PCMT)||Providers' Compliance to Malaria Treatment|Responding to Efficacy Decay Analysis of Artemisinin Based Combination Therapy (ACTs) in Rural Tanzania: Intervening on Provider Compliance and Patient Adherence to Correct Malaria Treatment|Unknown status|Recruiting|N/A|712|Anticipated|Ifakara Health Institute||1|||f||||f||||||||||2017-10-10 23:47:50.019958|2017-10-10 23:47:50.019958
NCT02298127|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-20|||July 2014||2014-07-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Auricular Acupressure for Smoking Cessation|Acceptability and Potential Efficacy of a Randomised, Double-blinded, Sham-controlled Trial of Auricular Acupressure for Smoking Cessation: A Pilot Study|Unknown status|Recruiting|N/A|90|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-10 23:47:50.116071|2017-10-10 23:47:50.116071
NCT02298114|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-12-21|||August 2013||2013-08-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Mobilization With Neuromuscular Electrical Stimulation in Critical Care Patients|The Effects of Early Mobilization With Neuromuscular Electrical Stimulation in Critical Care Patients|Recruiting||N/A|24|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:47:50.218067|2017-10-10 23:47:50.218067
NCT02298101|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-11-16|||September 2014||2014-09-01|November 2015|2015-11-01||||June 2015|Actual|2015-06-01||Interventional|||Comparison of Lung Deposition With the Aeroneb Solo Adapter and a Standard Jet Nebulizer by SPECT-CT||Completed||N/A|6|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-10 23:47:50.304218|2017-10-10 23:47:50.304218
NCT02298088|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-08-23|||August 2015||2015-08-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|TREAT||Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis|Phase III, Randomized, Multicenter, Open Label, Non-Inferiority Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis|Recruiting||Phase 3|3794|Anticipated|Hospital do Coracao||2|||f||||t||||||||||2017-10-10 23:47:50.410504|2017-10-10 23:47:50.410504
NCT02298075|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-05-25|||April 2016||2016-04-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia|Response Rate and Response Duration After Discontinuation of Treatment With Thrombopoietin Receptor Agonists in Patients Affected by Primary Immune Thrombocytopenia (pITP): Retrospective Study|Recruiting||N/A|100|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||No||2017-10-10 23:47:50.782565|2017-10-10 23:47:50.782565
NCT02298062|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-02-02|||January 2013||2013-01-01|December 2014|2014-12-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial|Infliximab for Kawasaki Disease Patients Resistant to Intravenous Immunoglobulin : a Multicentre, Prospective, Randomised Trial|Completed||Phase 3|40|Actual|Fudan University||2|||f||||t||||||||||2017-10-10 23:47:50.933127|2017-10-10 23:47:50.933127
NCT02298049|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-20|||July 2010||2010-07-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||An fMRI Study of Satiation in Healthy Volunteers.|Satiation Attenuates BOLD Activity in Brain Regions Involved in Reward and Increases Activity in an Inhibitory Control Area: an fMRI Study in Healthy Volunteers.|Completed||N/A|16|Actual|University of Birmingham||1|||f||||f||||||||||2017-10-10 23:47:51.029875|2017-10-10 23:47:51.029875
NCT02298036|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-09-12|||January 2014||2014-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Helping Urgent Care Users Cope With Distress About Physical Complaints|Helping Urgent Care Users Cope With Distress About Physical Complaints: A Randomised Controlled Trial|Recruiting||N/A|144|Anticipated|University of Nottingham||2|||f||||t||||||||No||2017-10-10 23:47:51.144171|2017-10-10 23:47:51.144171
NCT02298010|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-11-16|||February 2016||2016-02-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|February 2016|Anticipated|2016-02-01||Observational|||Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial|Pattern and Clinical Implication of Lymph Node Metastasis From Gastric Cancer Which Was Resected by Radical Surgery With Extended Lymphadenectomy|Not yet recruiting||N/A|910|Anticipated|Seoul National University Hospital|||2||f||||f||||||||||2017-10-10 23:47:51.413989|2017-10-10 23:47:51.413989
NCT02297997|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-12-02|||November 2014||2014-11-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy|Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia: An Exploratory Pilot Study|Unknown status|Enrolling by invitation|Early Phase 1|65|Anticipated|Seoul National University Hospital||5|||f||||f||||||||||2017-10-10 23:47:51.504996|2017-10-10 23:47:51.504996
NCT02297984|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-08-11|||October 2013||2013-10-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01|3 Months|Observational [Patient Registry]|||Serum Neuroglobin and HIF-1α in Acute Ischemic Stroke|Changes of Serum Neuroglobin and HIF-1α Concentrations in Early-phase of Acute Ischemic Stroke|Completed||N/A|40|Actual|Shanghai 6th People's Hospital|||1||f||||f||||||||||2017-10-10 23:47:51.625422|2017-10-10 23:47:51.625422
NCT02297971|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-09-26|||September 2013||2013-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|BRILIQUE||Assessment of Coagulation and Thrombocyte Function After Termination of Ticagrelor|Assessment of Coagulation and Thrombocyte Function After Termination of Ticagrelor in Patients Who Have Previously Undergone PCI Procedures and Insertion of Coronary Stents|Completed||N/A|25|Actual|Örebro University, Sweden|||1||f||||t||||||Samples Without DNA|"     Blood for analysis of complement, coagulation factors and other biochemical markers   "|||2017-10-10 23:47:51.689918|2017-10-10 23:47:51.689918
NCT02297958|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-08-16|||January 2015||2015-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Observational|IFFaLCCO||Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma|Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma|Recruiting||N/A|40|Anticipated|Rennes University Hospital|||1||f||||||||||||||2017-10-10 23:47:51.769256|2017-10-10 23:47:51.769256
NCT02297945|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-02-14|||April 2015||2015-04-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|PROMPT||Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome|Prospective, Single Arm, Open-label, Multicenter, International Study to Assess the Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome During a 12-week Treatment Period Followed by an Extension Period of 24 Weeks|Recruiting||Phase 3|70|Anticipated|HRA Pharma||1|||f||||f||||||||||2017-10-10 23:47:51.854596|2017-10-10 23:47:51.854596
NCT02297932|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-15|||November 2014||2014-11-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PHYSACTINMS||Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes|Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes|Completed||N/A|18|Actual|Kessler Foundation||2|||f||||f||||||||||2017-10-10 23:47:52.054246|2017-10-10 23:47:52.054246
NCT02297919|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2015-08-25|||January 2014||2014-01-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Evaluation of the Effectiveness of Internet Based Nutrition and Physical Activity Education Programme in Adolescents|Eskisehir Osmangazi University- Scientific Research Projects|Unknown status|Active, not recruiting|N/A|500|Anticipated|Eskisehir Osmangazi University||2|||f||||f||||||||||2017-10-10 23:47:52.146148|2017-10-10 23:47:52.146148
NCT02297906|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-07-14|||February 2015||2015-02-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pharmacokinetics of Intranasal Ketorolac in Children|Pharmacokinetics of Intranasal Ketorolac in Children|Recruiting||Phase 1|18|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-10 23:47:52.229601|2017-10-10 23:47:52.229601
NCT02297893|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-08-30|||November 2014||2014-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Improving Dexterous Skills in Parkinson's Disease|Improving Dexterous Skills in Parkinson's Disease: A Randomized Controlled Trial|Completed||N/A|103|Actual|Luzerner Kantonsspital||2|||f||||t||||||||||2017-10-10 23:47:52.325805|2017-10-10 23:47:52.325805
NCT02297880|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-02-08|||October 2014||2014-10-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effects of Low Calorie Sweeteners on Dietary Intakes, Hunger, Appetite and Satiety|Effects of Beverages Containing Low Calorie Sweeteners (LCS) on Energy and Macronutrient Intakes and on Hunger, Appetite and Satiety Sensations|Completed||N/A|170|Actual|The Coca-Cola Company||2|||f||||f||||||||||2017-10-10 23:47:52.40517|2017-10-10 23:47:52.40517
NCT02297867|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-07-04|||July 2015||2015-07-01|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|July 4, 2017|Anticipated|2017-07-04||Interventional|||Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis|Adipose-Derived Stem Cells (ADSCs) Injections for Liver Cirrhosis|Active, not recruiting||Phase 1|6|Anticipated|Gwo Xi Stem Cell Applied Technology Co., Ltd.||1|||f||||f|f|f||||||||2017-10-10 23:47:52.476352|2017-10-10 23:47:52.476352
NCT02297854|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2014-11-19|||July 2011||2011-07-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition|Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Cross Over, Single Dose, Oral Bioequivalence Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition|Completed||Phase 1|83|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:47:52.545028|2017-10-10 23:47:52.545028
NCT02297841|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-09-14|2016-07-19||November 2014||2014-11-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Repeated Insult Patch Test of Personal Lubricants||Completed||N/A|209|Actual|Church & Dwight Company, Inc.||1|||f||||||||||||||2017-10-10 23:47:52.62171|2017-10-10 23:47:52.62171
NCT02297828|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-04-23|||October 2014||2014-10-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Boussignac CPAP Ventilation on PaO2 and PaO2/FiO2 Ratio in Morbidly Obese Patients Undergoing Bariatric Surgery|Effect of Boussignac Continuous Positive Airway Pressure Ventilation on PaO2 and PaO2/FiO2 Ratio Immediately After Extubation in Morbidly Obese Patients Undergoing Bariatric Surgery: a Randomized Controlled Trial|Completed||N/A|24|Actual|Centro Hospitalar do Porto||2|||f||||t||||||||||2017-10-10 23:47:52.746383|2017-10-10 23:47:52.746383
NCT02297802|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-11-24|||June 2013||2013-06-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Expanded Access|||A Single Patient IND for PD-0325901|A Phase I Single Patient IND for PD-0325901|No longer available||N/A|||Sharp HealthCare|||||||||f||||||||||2017-10-10 23:47:52.905569|2017-10-10 23:47:52.905569
NCT02297789|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-07-22|||November 2014||2014-11-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluation of a Full Face Mask and Headgear for the Treatment of Obstructive Sleep Apnea|Evaluation of a Full Face Mask and Headgear for the Treatment of Obstructive Sleep Apnea|Completed||N/A|11|Actual|Fisher and Paykel Healthcare||2|||f||||t||||||||||2017-10-10 23:47:53.109013|2017-10-10 23:47:53.109013
NCT02297776|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-21|||August 2014||2014-08-01|November 2014|2014-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|CABNO||Circulating Biomarkers Predict Neurological Outcome After Cardiac Arrest|Circulating Biomarkers Predict Neurological Outcome After Cardiac Arrest|Unknown status|Recruiting|N/A|160|Anticipated|Shanghai 10th People's Hospital|||2||f||||t||||||Samples Without DNA|"     Plasma samples are to be retained.   "|||2017-10-10 23:47:53.201344|2017-10-10 23:47:53.201344
NCT02297763|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-11-18|||March 2015||2015-03-01|July 2014|2014-07-01||||September 2016|Anticipated|2016-09-01||Interventional|||Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients||Unknown status|Not yet recruiting|Phase 3|194|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:47:53.310192|2017-10-10 23:47:53.310192
NCT02297750|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-10-23|||August 2012||2012-08-01|November 2014|2014-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Optimal Timing of Double-Wire Technique For Biliary Cannulation at ERCP|Optimal Timing of Double-Wire Technique For Biliary Cannulation at ERCP|Completed||N/A|161|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:47:53.389988|2017-10-10 23:47:53.389988
NCT02297737|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-05-05|||October 2013||2013-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|HeartChi||Mindful Movement Intervention for Post-MI Patients|Developing a Mindfulness Movement Intervention Program for Post-MI Patients: A Randomized 75-subject Pilot Clinical Trial of Tai Chi Versus Health Education in Post-myocardial Infarction Patients|Enrolling by invitation||N/A|75|Anticipated|San Diego Veterans Healthcare System||2|||f||||t||||||||||2017-10-10 23:47:53.49356|2017-10-10 23:47:53.49356
NCT02297724|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-06-21|||April 2014||2014-04-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Observational|||MRI Assessment of Placental Health|MRI Assessment of Placental Health|Recruiting||N/A|80|Anticipated|Boston Children’s Hospital|||1||f||||||||||||||2017-10-10 23:47:53.628755|2017-10-10 23:47:53.628755
NCT02297711|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-11-19|||October 2014||2014-10-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|SPORT||TEP Versus Open Minimal Suture Repair for the Sportsman's Groin|Total ExtraPeritoneal (TEP) Versus Open Minimal Suture Repair for Treatment of Sportsman's Hernia/Athletic Pubalgia: A Randomized Multi-center Trial.|Unknown status|Recruiting|N/A|100|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:47:53.761642|2017-10-10 23:47:53.761642
NCT02297698|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-14|||October 2014||2014-10-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|HER3+||Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients|Phase II Trial of Combination Immunotherapy With Nelipepimut-S + GM-CSF (NeuVax™) and Trastuzumab in High-risk HER2+ Breast Cancer Patients|Recruiting||Phase 2|100|Anticipated|Cancer Insight, LLC||2|||f||||t||||||||||2017-10-10 23:47:53.880564|2017-10-10 23:47:53.880564
NCT02297685|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-19|||February 2013||2013-02-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|TENBACK||Effectiveness of Electrotherapy Techniques to Treat Low Back Pain|Effectiveness of Two Electrotherapy Techniques to Treat Chronic Low Back Pain|Completed||N/A|60|Actual|Camilo Jose Cela University||3|||f||||f||||||||||2017-10-10 23:47:54.175638|2017-10-10 23:47:54.175638
NCT02297672|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-04|||February 2015||2015-02-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|December 2017|Anticipated|2017-12-01||Interventional|PBSI||Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant|Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant|Recruiting||N/A|25|Anticipated|British Columbia Cancer Agency||1|||f||||t||||||||||2017-10-10 23:47:54.323771|2017-10-10 23:47:54.323771
NCT02297659|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-12-13|||August 2014||2014-08-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of Hypertonic Saline After Damage Control Laparotomy to Improve Early Primary Fascial Closure|Use of Hypertonic Saline After Damage Control Laparotomy to Improve Early Primary Fascial Closure|Recruiting||N/A|312|Anticipated|San Antonio Military Medical Center||2|||f||||t||||||||||2017-10-10 23:47:54.462082|2017-10-10 23:47:54.462082
NCT02297646|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2014-11-20|||August 2012||2012-08-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CHO||Influencing Factors on Training Efficacy in Healthy Adults|The Influence of Carbohydrates on Training Efficacy and Health Status in Healthy Adults|Completed||Early Phase 1|23|Actual|Saarland University||2|||f||||f||||||||||2017-10-10 23:47:54.578116|2017-10-10 23:47:54.578116
NCT02297633|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-19|||October 2014||2014-10-01|November 2014|2014-11-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Observational|||Evaluation of Reactive Oxygen Metabolites in the Value of COPD|System Evaluation of Reactive Oxygen Metabolites in the Value of Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|320|Anticipated|Beijing Chao Yang Hospital|||4||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:47:54.69242|2017-10-10 23:47:54.69242
NCT02297620|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-10-14|||April 2014||2014-04-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|STELLA-ELDER||The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients|Specified Drug Use resulTs survEy of IpragLifLozin treAtment in ELDERly type2 Diabetes Patients (STELLA-ELDER)|Completed||N/A|8687|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-10 23:47:54.80008|2017-10-10 23:47:54.80008
NCT02297594|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-10-19|||October 2014||2014-10-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Safety, Tolerability and PK Study of AK0529 in Healthy Human|A Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of AK0529 When Administered Orally in Healthy Male and Female Adult Subjects|Completed||Phase 1|74|Actual|Ark Biosciences Inc.||2|||f||||t||||||||||2017-10-10 23:47:54.991944|2017-10-10 23:47:54.991944
NCT02297581|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-03-31|||May 2015||2015-05-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Observational|||Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program|A Prospective Multicenter Cohort Study to Evaluate the Benefit of the Geriatric Fracture Center (GFC) Concept|Active, not recruiting||N/A|282|Actual|AO Clinical Investigation and Documentation|||2||f||||f||||||||||2017-10-10 23:47:55.158412|2017-10-10 23:47:55.158412
NCT02297568|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-07-19|||March 2014||2014-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Vitamin D Supplementation During Lactation|Randomized Control Trial of Vitamin D Supplementation During Lactation on Vitamin D in Maternal Milk|Completed||N/A|80|Actual|Rajavithi Hospital||2|||f||||f||||||||||2017-10-10 23:47:55.264463|2017-10-10 23:47:55.264463
NCT02297555|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-12-08|||April 2014||2014-04-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|ENDOMETAB||ENDOBARRIER® and Conventional Therapy in the Management of Metabolic Syndrome in Obese Patients|ENDOBARRIER® vs Conventional Therapy in the Management of Metabolic Syndrome in Obese Patients. Medico-economic Analysis as Part of a Randomized Controlled Multicenter Trial - ENDOMETAB|Suspended||Phase 1/Phase 2|174|Anticipated|University Hospital, Lille||2|||f||||t||||||||||2017-10-10 23:47:55.348285|2017-10-10 23:47:55.348285
NCT02297542|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-12-19|||October 2014||2014-10-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Immune Response to High-Dose vs. Standard Dose Influenza Vaccine|Immune Response to High-Dose vs. Standard Dose Influenza Vaccine|Active, not recruiting||Phase 4|85|Anticipated|Health Sciences North Research Institute||2|||f||||f||||||||||2017-10-10 23:47:55.45316|2017-10-10 23:47:55.45316
NCT02297529|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-08-18||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma|A Phase 3b, Multicenter, Open-label, Single-arm, Expanded Access Protocol of Talimogene Laherparepvec for the Treatment of Subjects in Europe With Unresected Stage IIIB to IVM1c Melanoma|No longer available||N/A|||Amgen|||||f||||||||||||||2017-10-10 23:47:55.533256|2017-10-10 23:47:55.533256
NCT02297516|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-05-08|||November 2014|Actual|2014-11-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment|An Evaluator-blinded Multi-center Study of Combined Treatment With Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster as Compared to Single Treatment With Either Azzalure/Dysport Alone or Restylane/Emervel Filler Alone|Completed||Phase 4|65|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-10 23:47:55.59688|2017-10-10 23:47:55.59688
NCT02297503|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-05-08|||November 2014|Actual|2014-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Efficacy of Treatment With Azzalure, Restylane/Emervel Filler and Restylane Skinbooster|An Evaluator-blinded Multi-center Study of Combined Treatment With Azzalure, Restylane/Emervel Filler and Restylane Skinbooster as Compared to Single Treatment With Either Azzalure Alone or Restylane/Emervel Filler Alone|Completed||Phase 4|61|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-10 23:47:55.684018|2017-10-10 23:47:55.684018
NCT02297490|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-10-15|||January 2014||2014-01-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials|Evaluation of the Utility of an Environmental Exposure Chamber (EEC) for Assessing Efficacy of Specific Immunotherapy (SIT) in Pivotal Clinical Trials|Completed||Phase 2|158|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-10-10 23:47:55.795206|2017-10-10 23:47:55.795206
NCT02297477|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2016-01-10|||December 2014||2014-12-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Interventional|ASAP||The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia|Therapeutic Efficacy of Atovaquone-proguanil and Artesunate-atovaquone-proguanil for the Treatment of Uncomplicated P. Falciparum Malaria in Areas of Multidrug Resistance in Cambodia.|Completed||Phase 4|205|Actual|Armed Forces Research Institute of Medical Sciences, Thailand||2|||f||||f||||||||||2017-10-10 23:47:55.928853|2017-10-10 23:47:55.928853
NCT02297464|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-04-07|||July 2014||2014-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|||Eggs as Part of a Healthy Breakfast|Eggs as Part of a Healthy Breakfast: Lack of Association With Heart Disease Risk|Active, not recruiting||N/A|50|Actual|University of Connecticut||2|||f||||f||||||||||2017-10-10 23:47:56.012019|2017-10-10 23:47:56.012019
NCT02297451|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-07-14|||February 2011||2011-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|STEAL||Trial Comparing the Incidence of Steal Syndrome in the Two Types of anTEcubitaL Fossa Arteriovenous fistuLa AVF|Randomised Controlled Trial Comparing the Incidence of Steal Syndrome in the Two Types of anTEcubitaL Fossa Arteriovenous fistuLa AVF (STEAL Trial)|Recruiting||N/A|110|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:47:56.076034|2017-10-10 23:47:56.076034
NCT02297438|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-09-28|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|March 2019|Anticipated|2019-03-01||Interventional|||A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]|A Multicenter, Randomized, Double-blind Phase 3 Study Of Palbociclib (Oral Cdk 4/6 Inhibitor) Plus Letrozole Versus Placebo Plus Letrozole For The Treatment Of Previously Untreated Asian Postmenopausal Women With Er (+), Her2 (-) Advanced Breast Cancer|Recruiting||Phase 3|330|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-10 23:47:56.172192|2017-10-10 23:47:56.172192
NCT02297425|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-01-09|||January 2015||2015-01-01|January 2015|2015-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer|Phase 1/2 Open Label Study Of Pf 06459988 (Epidermal Growth Factor Receptor T790m Inhibitor) In Patients With Advanced Epidermal Growth Factor Receptor Mutant (Del 19 Or L858r + - T790m) Non Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:47:56.347811|2017-10-10 23:47:56.347811
NCT02297412|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-08|||November 2014||2014-11-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel|Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial|Completed||N/A|47|Actual|Academic and Community Cancer Research United||2|||f||||t||||||||||2017-10-10 23:47:56.428587|2017-10-10 23:47:56.428587
NCT02297399|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-02-21|||December 2, 2014|Actual|2014-12-02|February 2017|2017-02-01|January 26, 2016|Actual|2016-01-26|January 26, 2016|Actual|2016-01-26||Interventional|iDIMEPREP||Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients|Improvement of Tolerability for Bowel Preparation for Colonoscopy in Diabetic Patients. A Randomized Controlled Trial of Two Bowel Preparation Protocols Including 4 Liters PEG vs. 2 Liters PEG Plus Ascorbic Acid. iDIMEPREP Study.|Completed||Phase 3|158|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-10 23:47:56.551058|2017-10-10 23:47:56.551058
NCT02297386|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-10-03|||November 2014||2014-11-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer|Phase I Trial Of [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer|Active, not recruiting||Phase 1|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:47:58.288131|2017-10-10 23:47:58.288131
NCT02297373|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-02-21|||November 2014||2014-11-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|||Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis|Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis|Recruiting||N/A|745|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||Samples Without DNA|"     Serum   "|Undecided||2017-10-10 23:47:58.383211|2017-10-10 23:47:58.383211
NCT02297360|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-19|||August 2013||2013-08-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair|A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Ability Of Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Self-Perceived Thinning Hair|Completed||N/A|60|Actual|Ablon Skin Institute Research Center||2|||f||||f||||||||||2017-10-10 23:47:58.484283|2017-10-10 23:47:58.484283
NCT02297334|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-08-28|||September 2013||2013-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|October 2015|Actual|2015-10-01||Interventional|||Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery|Reduction of Inflammation Reaction to Extracorporeal Circulation in Cardiac Surgery by Interleukin Dialysis|Completed||N/A|40|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-10 23:47:58.644118|2017-10-10 23:47:58.644118
NCT02297321|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-09-16|||November 2014||2014-11-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation of the Safety and Efficacy of the DeScribe™ Patch|Evaluation of the Safety and Efficacy of the DeScribe™ Laser Tattoo Removal Accessory Device|Completed||N/A|30|Actual|ON Light Sciences||1|||f||||f||||||||No||2017-10-10 23:47:58.74857|2017-10-10 23:47:58.74857
NCT02297308|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-01-21|2015-11-30||October 2014||2014-10-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|||A Retrospective Study Evaluating the Use of the SoloPath® Sheath in Reducing Vascular and Bleeding Complications|A Single Center, Retrospective Study Evaluating the Use of the SoloPath® Sheath in Reducing Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation|Completed||N/A|90|Actual|Terumo Medical Corporation|Single center, retrospective data analysis.||1||f||||f||||||||No||2017-10-10 23:47:58.832722|2017-10-10 23:47:58.832722
NCT02297295|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-11-16|||June 2014||2014-06-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Impact of Exercise Medicine on Lower Limb Amputees According to the International Classification of Functioning|Impact of Exercise Medicine on Lower Limb Amputees According to the Three Domains of the International Classification of Functioning|Unknown status|Recruiting|N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-10 23:47:58.985544|2017-10-10 23:47:58.985544
NCT02297282|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-01-18|||October 2014||2014-10-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|BRAVE||A Study to Assess the Effectiveness of Behavioural Activation Group Therapy in Individuals With Depression|A Pragmatic Randomized Trial to Investigate the Effectiveness of BehaviouRal ActiVation Group Therapy in Reducing dEpressive Symptoms and Improving Quality of Life in Patient With Depression: BRAVE Study.|Recruiting||N/A|160|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-10 23:47:59.071769|2017-10-10 23:47:59.071769
NCT02297269|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-19|||December 2014||2014-12-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|June 2015|Anticipated|2015-06-01||Observational|||The Impact of Laparoscopic Versus Open Surgeries on the Incidence of Postoperative Deep Vein Thrombosis in Patients With Gastrointestinal Malignancy ---A Cohort Study|The Impact of Laparoscopic Versus Open Surgeries on the Incidence of Postoperative Deep Vein Thrombosis in Patients With Gastrointestinal Malignancy ---A Cohort Study|Unknown status|Not yet recruiting|N/A|230|Anticipated|First Affiliated Hospital of Chongqing Medical University|||2||f||||f||||||||||2017-10-10 23:47:59.307924|2017-10-10 23:47:59.307924
NCT02297256|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-28|||August 2012|Actual|2012-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BMAC||Prospective Study of Thoracolumbar Spinal Fusion Graft|Prospective Study of Thoracolumbar Spinal Fusion Graft Efficacy: Bone Marrow Aspirate Concentrate Versus Iliac Crest Bone Graft|Active, not recruiting||Phase 3|40|Anticipated|New York University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-10 23:47:59.441891|2017-10-10 23:47:59.441891
NCT02103998|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-04-03|||July 2014||2014-07-01|April 2014|2014-04-01|May 2021|Anticipated|2021-05-01|May 2016|Anticipated|2016-05-01||Interventional|THOP2||Study of Thyroid Hormones in Prematures|Phase III Study of Thyroid Hormones in Prematures|Not yet recruiting||Phase 3|1224|Anticipated|New York Medical College||2|||f||||f||||||||||2017-10-11 00:36:05.924817|2017-10-11 00:36:05.924817
NCT02297243|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-02-11|||March 2015||2015-03-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|SLS||Sinopsys Lacrimal Stent Indicated for Sinus Irrigation|The Sinopsys Lacrimal Stent Indicated for Sinus Irrigation Via Transcaruncular Ethmoid Sinus Access in Patients With Moderate to Severe Chronic Rhinosinusitis With Ethmoid Sinus Involvement|Completed||Early Phase 1|9|Actual|Sinopsys Surgical||1|||f||||f||||||||||2017-10-10 23:47:59.548344|2017-10-10 23:47:59.548344
NCT02297217|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-08-26|||September 2016||2016-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Chemoradiotherapy for Advanced Esophageal Cancer|A Phase 2 Study of Palliative Chemo-Radiotherapy With Carbo-Taxol in Non-Curative Cancer of the Esophagus|Not yet recruiting||Phase 2|50|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-10 23:47:59.772201|2017-10-10 23:47:59.772201
NCT02297204|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2014-11-20|||November 2014||2014-11-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|Endurance||The Endurance 1 Trial|Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial (The Endurance 1 Trial)|Unknown status|Enrolling by invitation|Phase 4|10|Anticipated|Northern California Retina Vitreous Associates||1|||f||||f||||||||||2017-10-10 23:47:59.873561|2017-10-10 23:47:59.873561
NCT02297178|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-10-13|||August 2016||2016-08-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding|A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding|Withdrawn||N/A|0|Actual|Medway NHS Foundation Trust|||2|Unable to recruit resaerch staff for study|f||||f||||||||||2017-10-10 23:48:00.092317|2017-10-10 23:48:00.092317
NCT02297165|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-03-07|||June 2014||2014-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|OLFANOR||Efficacy Study of an Olfactory Stimulation Program for the Recuperation of Autobiographical Memories in Anorexia|Efficacy Study of an Olfactory Stimulation Program in Relaxing Environment for the Recuperation of Autobiographical Memories in Anorexic Patients|Recruiting||N/A|100|Anticipated|Lille Catholic University||2|||f||||f||||||||No||2017-10-10 23:48:00.194279|2017-10-10 23:48:00.194279
NCT02297139|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-09-14|||July 17, 2015|Actual|2015-07-17|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 27, 2018|Anticipated|2018-02-27||Interventional|||Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib|Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib|Active, not recruiting||Phase 2|100|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f|||t|||||2017-10-10 23:48:00.81727|2017-10-10 23:48:00.81727
NCT02297126|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-02-28|||January 2015||2015-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|INGenious||A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program|A Prospective Randomized Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program at Eskenazi Hospital|Recruiting||N/A|6000|Anticipated|Indiana University||2|||f||||f||||||||No||2017-10-10 23:48:00.940807|2017-10-10 23:48:00.940807
NCT02297113|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-03-24|||November 2014||2014-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Rapid Sequence Intubation at the Emergency Department|The C-MAC Videolaryngoscope Compared With Conventional Laryngoscopy for Rapid Sequence Intubation at the Emergency Department|Completed||N/A|150|Actual|University of Zurich||2|||f||||f||||||||||2017-10-10 23:48:01.076202|2017-10-10 23:48:01.076202
NCT02297100|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-10-03|||December 2014||2014-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravesicular Onabotulinumtoxin A in Interstitial Cystitis|The Impact of Injection Location on the Efficacy of Intravesicular Onabotulinumtoxin A in Interstitial Cystitis--Phase 4|Recruiting||Phase 4|40|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-10 23:48:01.180801|2017-10-10 23:48:01.180801
NCT02297087|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-09-25|||October 2014||2014-10-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment|Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment|Active, not recruiting||N/A|12|Anticipated|Western Regional Medical Center||1|||f||||f|f|f||||||||2017-10-10 23:48:01.305183|2017-10-10 23:48:01.305183
NCT02297074|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-18|||January 2013||2013-01-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|BREADGI||Evaluation of Glycemic Index, Glycemic Load and Insulinemic Index of Spanish Breads|Evaluation of Glycemic Index Glycemic Load and Insulinemic Index of Spanish Breads and Their Effect on Incretins and Gastrointestinal Hormones Related With Appetite Regulation|Completed||N/A|22|Actual|Organización Interprofesional Agroalimentaria de Cereales Panificables y Derivados||6|||f||||f||||||||||2017-10-10 23:48:01.387159|2017-10-10 23:48:01.387159
NCT02297061|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-11-18|||December 2013||2013-12-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Observational|||Can Thrombelastography Predict Blood Loss in Patients With Hip Fractures|Study on the Value of Thrombelastogralhy to Pre-operatively Predict Hip Fracture Patients at Risk of Major Blood Loss During and After Surgery.|Completed||N/A|180|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-10 23:48:01.492634|2017-10-10 23:48:01.492634
NCT02297048|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-09-30|||July 2014||2014-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|DEPROGE||Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome)|Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome)|Completed||Phase 4|26|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:48:01.60435|2017-10-10 23:48:01.60435
NCT02297035|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-08-11|||March 2012||2012-03-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|March 2017|Actual|2017-03-01||Interventional|CAPP||Characterisation of Primary Progressives Aphasias|Linguistic, Anatomic/Metabolic and Biologic Characterisation of the Three Main Variants of Primary Progressive Aphasia : Towards the Rationale for Drug Trials and Specific Language Rehabilitations|Recruiting||N/A|155|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:48:01.700819|2017-10-10 23:48:01.700819
NCT02297022|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-12-15|||October 2014||2014-10-01|November 2014|2014-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|DBSPW||Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome|Phase 1 Study of Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome|Unknown status|Recruiting|Phase 1|6|Anticipated|University of Sao Paulo General Hospital||1|||f||||f||||||||||2017-10-10 23:48:02.007094|2017-10-10 23:48:02.007094
NCT02297009|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-01-13|||December 2014||2014-12-01|October 2014|2014-10-01|September 2018|Anticipated|2018-09-01|June 2015|Anticipated|2015-06-01||Observational|||Comparison of the Methylation Pattern of DNA in Buccal Swabs From Different Time Points|Comparison of the Methylation Pattern of DNA in Buccal Swabs From Different Time Points|Recruiting||N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||||||||Samples With DNA|"     Buccal cells   "|||2017-10-10 23:48:02.149926|2017-10-10 23:48:02.149926
NCT02296996|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-05-23|||October 2014||2014-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients|A Phase II Clinical Trial on the Combination of Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients With Advanced BRAF V600 Mutant Melanoma|Active, not recruiting||Phase 2|25|Actual|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-10 23:48:02.264506|2017-10-10 23:48:02.264506
NCT02296983|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-04-13|||December 2014||2014-12-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.|A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSVΔG-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Volunteers in Kilifi, Kenya.|Active, not recruiting||Phase 1|40|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-10 23:48:02.372205|2017-10-10 23:48:02.372205
NCT02296970|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-01-05|||December 2014||2014-12-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence|An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence|Recruiting||N/A|100|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-10-10 23:48:02.494873|2017-10-10 23:48:02.494873
NCT02296957|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-10-07|||November 2014||2014-11-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|HYPAGE||Impact of the Decrease of Exposure to Hypnosedative Drugs in the Elderly Through the Discontinuation of Hospital-initiated Prescription|Decrease of Exposure to Hypnosedative Drugs in the Elderly Through the Discontinuation of Hospital-initiated Prescription: Impact on the Quality of Sleep and Fall Frequency|Recruiting||N/A|240|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:48:02.587048|2017-10-10 23:48:02.587048
NCT02296944|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-06-30|||January 2015||2015-01-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Observational|PERFOPED||Anatomical and Functional Results of Surgery of the Tympanic Membrane Perforation of the Child|Anatomical and Functional Results of Surgery of the Tympanic Membrane Perforation of the Child|Active, not recruiting||N/A|980|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||||||2017-10-10 23:48:02.684811|2017-10-10 23:48:02.684811
NCT02296931|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-08-11|2016-06-24||March 2015||2015-03-01|August 2016|2016-08-01||||October 2015|Actual|2015-10-01||Interventional|||Laboratory and Pilot Clinical Assessment of the Accuracy, Usability, and Function of a Low-cost, Low-power Syringe Pump in Administering Magnesium Sulfate to Pre-eclamptic Women in a Low-resource Hospital|Laboratory and Pilot Clinical Assessment of the Accuracy, Usability, and Function of a Low-cost, Low-power Syringe Pump in Administering Magnesium Sulfate to Pre-eclamptic Women in a Low-resource Hospital|Completed||Phase 1/Phase 2|34|Actual|William Marsh Rice University||2|||f||||f||||||||||2017-10-10 23:48:02.782751|2017-10-10 23:48:02.782751
NCT02296918|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2016-12-02|||November 2014||2014-11-01|December 2016|2016-12-01||||November 2018|Anticipated|2018-11-01||Interventional|||Acalabrutinib in Combination With Obinutuzumab in Relapsed/Refractory or Untreated CLL/SLL/PLL|A Phase 1b Study of ACP-196 in Combination With Obinutuzumab for Patients With Relapsed / Refractory or Untreated CLL/SLL/PLL|Active, not recruiting||Phase 1|45|Actual|Acerta Pharma BV||2|||f||||||||||||||2017-10-10 23:48:03.054995|2017-10-10 23:48:03.054995
NCT02296905|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2015-10-20|||October 2014||2014-10-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function|Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function|Completed||Phase 1|24|Actual|AbbVie||4|||f||||f||||||||||2017-10-10 23:48:03.154672|2017-10-10 23:48:03.154672
NCT02296892|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-08-03|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|March 13, 2017|Actual|2017-03-13|March 2017|Actual|2017-03-01||Interventional|||A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy|A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy|Completed||Phase 3|431|Actual|Paion UK Ltd.||3|||f||||f||||||||||2017-10-10 23:48:03.256527|2017-10-10 23:48:03.256527
NCT02296879|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-02-15|||January 20, 2015|Actual|2015-01-20|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types|A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types|Recruiting||Phase 1|60|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 23:48:03.385076|2017-10-10 23:48:03.385076
NCT02296866|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-12-26|||September 2014||2014-09-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Assessment of Prokinetic Effects of Erythromycin in Emergency Patients With a Full Stomach||Completed||N/A|28|Actual|Hôpital Edouard Herriot|||1||f||||||||||||||2017-10-10 23:48:03.482979|2017-10-10 23:48:03.482979
NCT02296853|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-04-23|||December 2014||2014-12-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Pharmacokinetics of Tenofovir Alafenamide in Adults With Normal Hepatic Function and Severe Hepatic Impairment|A Phase 1, Open-Label, Parallel-Group, Single Dose Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment|Completed||Phase 1|20|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-10 23:48:03.551269|2017-10-10 23:48:03.551269
NCT02296840|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-03-08|||November 2014|Actual|2014-11-01|March 2017|2017-03-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Post-operative Pain Control After Pediatric Adenotonsillectomy|Comparing Narcotics With Non-steroidal Anti-inflammatory Drugs (NSAIDS) Post-operatively in Pediatric Patients Undergoing Adenotonsillectomy|Terminated||Phase 4|53|Actual|Emory University||2|||f||||t|t|f||||||Undecided||2017-10-10 23:48:03.647945|2017-10-10 23:48:03.647945
NCT02296814|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-07-16|||November 2014||2014-11-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|CESAR||Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis|Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis. A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase IV Study (Sinusitis Study)|Completed||Phase 4|314|Actual|Hevert-Arzneimittel GmbH & Co. KG||2|||f||||f||||||||||2017-10-10 23:48:03.784577|2017-10-10 23:48:03.784577
NCT02296801|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-03-27|||January 2015||2015-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|PALLET||A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer|A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer|Recruiting||Phase 2|306|Anticipated|NSABP Foundation Inc||4|||f||||t||||||||||2017-10-10 23:48:03.944434|2017-10-10 23:48:03.944434
NCT02296788|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-01-07|||June 2015||2015-06-01|January 2016|2016-01-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|EGM||Effects of Aerobic Exercise on Gut Microbiota|Effects of Aerobic Exercise on Gut Microbiota (EGM) - P & F Ancillary Study (E-Mechanic)|Withdrawn||N/A|0|Actual|Pennington Biomedical Research Center||3||Study wasn't stopped. It wasn't started. Funding.|f||||f||||||||||2017-10-10 23:48:04.12908|2017-10-10 23:48:04.12908
NCT02296775|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-18|||November 2014||2014-11-01|November 2014|2014-11-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis||Unknown status|Recruiting|Phase 1/Phase 2|276|Anticipated|Dr. Reddy's Laboratories Limited||3|||f||||t||||||||||2017-10-10 23:48:04.20327|2017-10-10 23:48:04.20327
NCT02296762|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-19|||February 2010||2010-02-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition|Open Label, Randomized, Two-treatment, Two-period, Two-sequence, Cross Over, Single Dose, Oral Bioequivalence Study of Sirolimus Tablets 2 mg Under Fed Condition|Completed||Phase 1|36|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:48:04.548318|2017-10-10 23:48:04.548318
NCT02296749|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-19|||January 2010||2010-01-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition|Open Label, Randomized, Two-treatment, Two-period, Two-sequence, Cross Over, Single Dose, Oral Bioequivalence Study of Sirolimus Tablets 2 mg Under Fasting Condition|Completed||Phase 1|60|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:48:04.639199|2017-10-10 23:48:04.639199
NCT02296736|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-05-23|||October 2014||2014-10-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan|The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan|Recruiting||N/A|422|Anticipated|Plymouth Hospitals NHS Trust|||1||f||||f||||||||||2017-10-10 23:48:04.734399|2017-10-10 23:48:04.734399
NCT02296723|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-19|||July 2011||2011-07-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition|Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Cross Over, Single Dose, Oral Bioequivalence Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition|Completed||Phase 1|66|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:48:04.835402|2017-10-10 23:48:04.835402
NCT02296710|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-03-22|||August 2014||2014-08-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|May 2015|Actual|2015-05-01||Interventional|MitralHDZ||Echocardiographic Parameter and Sleep Apnea Changes After Mitral Valve Surgery|Echocardiographic Parameter and Sleep Apnea Changes After Mitral Valve Surgery|Completed||N/A|132|Actual|Heart and Diabetes Center North-Rhine Westfalia||1|||f||||f||||||||||2017-10-10 23:48:04.933799|2017-10-10 23:48:04.933799
NCT02296333|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2015-03-12|||May 2014||2014-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|OOEOPAOA||Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen|Double Blinded Study Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen|Completed||Phase 4|80|Actual|Mustafa Kemal University||2|||f||||t||||||||||2017-10-10 23:48:08.247043|2017-10-10 23:48:08.247043
NCT02296697|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-06-09|||January 2015||2015-01-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Low-level Laser Therapy Versus High Frequency on Pressure Ulcers Treatment|Comparison Between the Effects of Low-level Laser Therapy, High Frequency and Wound Dressing on Pressure Ulcers Treatment: a Clinical Randomized Trial|Recruiting||N/A|75|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||Undecided||2017-10-10 23:48:05.039251|2017-10-10 23:48:05.039251
NCT02296684|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-07-17|||March 25, 2015|Actual|2015-03-25|July 2017|2017-07-01|March 31, 2022|Anticipated|2022-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma|Immunotherapy With MK-3475 in Locoregionally Advanced, Surgically Resectable Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 2|46|Anticipated|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-10 23:48:05.184115|2017-10-10 23:48:05.184115
NCT02296671|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-03-07|||February 2015||2015-02-01|March 2016|2016-03-01|February 2022|Anticipated|2022-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers|Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||2||Was unable to accrue any patients|f||||t||||||||||2017-10-10 23:48:05.353085|2017-10-10 23:48:05.353085
NCT02296645|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-07-12||2016-07-11|November 2014||2014-11-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)|A Pilot Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZuraPrep™|Completed||Phase 2|36|Actual|Zurex Pharma, Inc.||2|||f||||f||||||||||2017-10-10 23:48:05.607605|2017-10-10 23:48:05.607605
NCT02296632|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-08-18|||November 2014||2014-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study|Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study and Preliminary Validation Effort|Completed||N/A|7|Actual|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-10 23:48:05.727252|2017-10-10 23:48:05.727252
NCT02296619|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-02-25|||September 2014||2014-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|TAP||The Effects of Transversus Abdominis Plane Block in Patients Undergoing Total Abdominal Hysterectomy|The Effects of TAP Block on Hemodynamic Variables, Anaesthetic and Analgesic Requirement and Quality of Recovery in Patients Undergoing Total Abdominal Hysterectomy|Completed||Phase 4|66|Actual|Tokat Gaziosmanpasa University||2|||f||||t||||||||||2017-10-10 23:48:05.819945|2017-10-10 23:48:05.819945
NCT02296593|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-03-06|||November 2014||2014-11-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Observational|MONILAG||Continuous MONItoring of Blood LActate and Glucose Levels Using a New Central Veinous Microdialysis Catheter Device|Monitorage Continu du Lactate et de la glycémie Par Microdialyse : Une étude de Validation en Chirurgie Cardiaque.|Completed||N/A|20|Actual|University Hospital, Caen|||1||f||||t||||||Samples With DNA|"     Blood samples for determination of lactate and glucose blood levels   "|||2017-10-10 23:48:05.995111|2017-10-10 23:48:05.995111
NCT02296567|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-08-07|||December 2014||2014-12-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients|Comparison of Pharmacokinetics of and Effect on Systemic Vascular Endothelial Growth Factor (VEGF) Levels Over Time of Intravitreal Ranibizumab and Bevacizumab and Aflibercept in Age Related Macular Degeneration Patients|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|East Florida Eye Institute||10|||f||||f||||||||||2017-10-10 23:48:06.228445|2017-10-10 23:48:06.228445
NCT02296554|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-10-28|||June 2014||2014-06-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|SLAP||Superior Labral Tear From Anterior to Posterior (SLAP) Repair Versus Biceps Tenodesis for SLAP Tears in the Shoulder|SLAP Repair Versus Biceps Tenodesis for SLAP Tears in the Shoulder: A Randomized Outcomes Study|Recruiting||N/A|150|Anticipated|HealthPartners Institute||2|||f||||f||||||||||2017-10-10 23:48:06.375826|2017-10-10 23:48:06.375826
NCT02296541|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-02-27|||December 2014||2014-12-01|February 2017|2017-02-01||||November 2016|Actual|2016-11-01||Interventional|||Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults|A Phase 1 Randomized, Double-Blind, Placebo Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of 3 Different HIV-1 DNA Priming Regimens (Nat-B Env, CON-S Env, and Mosaic Env) With MVA-CMDR Boosts in Healthy, HIV-1-Uninfected Adults|Active, not recruiting||Phase 1|105|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-10 23:48:06.479409|2017-10-10 23:48:06.479409
NCT02296528|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-05-25|||June 2014||2014-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in Patients|Safety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in Patients With Life-threatening Aspiration Secondary to Feeding Tube Dependent Oropharyngeal Dysphagia: A Single-site, Open-label, Phase 1 Human Trial|Recruiting||N/A|5|Anticipated|University of California, Davis||1|||f||||f||||||||||2017-10-10 23:48:06.642221|2017-10-10 23:48:06.642221
NCT02296515|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-04-06|||October 2014||2014-10-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Intrathecal Pump Refill Undergoing Regular Intrathecal Pump Refill|Intrathecal Pump Refill: Reservoir Fill Port Identification by Palpation Versus Ultrasound,a Mono-centre Prospective Comparison Study in Patients Undergoing Regular Intrathecal Pump Refill|Recruiting||N/A|25|Anticipated|Ospedale Regionale di Lugano|||1||f||||f||||||||||2017-10-10 23:48:06.752826|2017-10-10 23:48:06.752826
NCT02296489|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-11-01|||December 2014||2014-12-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||An Association Between Asthma Severity and Capnography Parameters|An Association Between Asthma Severity and Capnography Parameters|Completed||N/A|73|Actual|Medtronic - MITG|||2||f||||f||||||||||2017-10-10 23:48:06.939726|2017-10-10 23:48:06.939726
NCT02296476|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-08-10|||October 2014||2014-10-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|OTX015_107||A Trial With Dose Optimization of OTX015 in Recurrent Glioblastoma Multiforme (GBM) Patients|A Phase IIa Trial With Dose Optimization of OTX015, a Small Molecule Inhibitor of the Bromodomain and Extra-terminal (BET) Proteins, in Recurrent Glioblastoma Multiforme (GBM) Patients|Terminated||Phase 1/Phase 2|12|Actual|Oncoethix GmbH||1|||f||||t||||||||||2017-10-10 23:48:07.017755|2017-10-10 23:48:07.017755
NCT02296463|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2016-04-27|||November 2014||2014-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|September 2015|Actual|2015-09-01||Interventional|||A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age|A Phase I Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) Recombinant Fusion (F) Nanoparticle Vaccine, With or Without Aluminum Adjuvant, in Healthy Subjects 24 to <72 Months of Age|Completed||Phase 1|32|Actual|Novavax||5|||f||||f||||||||||2017-10-10 23:48:07.09833|2017-10-10 23:48:07.09833
NCT02296450|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-08-23|||November 18, 2014|Actual|2014-11-18|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments|Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments|Recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-10 23:48:07.187123|2017-10-10 23:48:07.187123
NCT02296437|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-08-07|||November 2014||2014-11-01|August 2017|2017-08-01||||November 2019|Anticipated|2019-11-01||Interventional|tDCS + CT||Transcranial Direct Current Stimulation (tDCS) and Cognitive Task in Depression|Pilot Study of Transcranial Direct Current Stimulation (tDCS) and Cognitive Task in Depression.|Recruiting||Early Phase 1|30|Anticipated|The University of New South Wales||1|||f||||f||||||||||2017-10-10 23:48:07.281387|2017-10-10 23:48:07.281387
NCT02296424|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-09-23|||November 2014||2014-11-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ß-SPECIFIC 4||ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab|An Open-label Canakinumab (ACZ885) Dose Reduction or Dose Interval Prolongation Efficacy and Safety Study in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)|Recruiting||Phase 3|180|Anticipated|Novartis||2|||f||||t||||||||||2017-10-10 23:48:07.362091|2017-10-10 23:48:07.362091
NCT02296411|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-03-28|||November 2014||2014-11-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|ELITRA||Efficacy of LAMA Added to ICS in Treatment of Asthma|A Multicentre, Randomised, Double-blind, Placebo-controlled, 2-way Cross-over Study to Evaluate the Efficacy and Safety of CHF 5259 (Glycopyrrolate Bromide) pMDI on Top of QVAR® pMDI for the Treatment of Patients With Uncontrolled Asthma on Low-Medium Dose of Inhaled Corticosteroids|Completed||Phase 2|98|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-10 23:48:07.553913|2017-10-10 23:48:07.553913
NCT02296398|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-03-10|||January 2015||2015-01-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|||Long-term Use of Romidepsin in Patients With CTCL|Retrospective and Prospective Study of Long-term Use of Romidepsin in Patients|Completed||N/A|47|Actual|Northwestern University|||1||f||||f||||||||||2017-10-10 23:48:07.788854|2017-10-10 23:48:07.788854
NCT02296385|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-17|||June 2012||2012-06-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Genotype-related Effects of PUFA|Response to PUFA Intervention According to PPAR Genotypes|Completed||N/A|200|Actual|Nestlé||1|||f||||f||||||||||2017-10-10 23:48:07.869396|2017-10-10 23:48:07.869396
NCT02296372|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-02-07|||November 2014||2014-11-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Ill Patients|Pilot Observation of Continuous Glucose Monitoring in Critically Ill Patients Under Consideration of Accuracy, Feasibility and Acceptance by Ward Staff|Completed||N/A|20|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 23:48:07.957354|2017-10-10 23:48:07.957354
NCT02296359|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-08-12|||October 2014||2014-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Vaccination Response in Individual Monozygotic Twins|Vaccination Response in Individual Monozygotic Twins|Terminated||N/A|1|Actual|Michigan State University|||2|Insufficient enrollment|f||||f||||||Samples With DNA|"     If the volunteers agree,tissue is stored for usage in future research without identifiers.     This includes cells from blood and saliva and extracted DNA, RNA and protein. The cells may     be used to grow a new cell line that may be maintained in the laboratory.   "|||2017-10-10 23:48:08.049947|2017-10-10 23:48:08.049947
NCT02296346|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-05-16|||October 2014||2014-10-01|May 2016|2016-05-01||||October 2017|Anticipated|2017-10-01||Interventional|MSECP||Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis|A Randomized, Controlled, Open-Label Study to Evaluate the Efficacy of Extracorporeal Photopheresis (ECP) Versus Corticosteroids in the Treatment of Patients With Secondary Progressive Multiple Sclerosis (SPMS)|Suspended||Phase 1|66|Anticipated|University of Michigan||2||PI Changed sites and we are waiting to open it at the new site.|f||||t||||||||||2017-10-10 23:48:08.136177|2017-10-10 23:48:08.136177
NCT02296320|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-09-22|||October 10, 2014|Actual|2014-10-10|September 2017|2017-09-01|October 14, 2019|Anticipated|2019-10-14|October 14, 2019|Anticipated|2019-10-14||Interventional|SAATELLITE||Study of the Efficacy and Safety of MEDI4893|A Phase 2 Randomised, Double-blind, Placebo-controlled, Single-dose, Dose-ranging Study of the Efficacy and Safety of MEDI4893, a Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects|Recruiting||Phase 2|285|Anticipated|MedImmune LLC||2|||f||||t|t|f||||||||2017-10-10 23:48:08.35591|2017-10-10 23:48:08.35591
NCT02296307|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-08-28|||January 2012||2012-01-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|DOvEE||DOvEE - Diagnosing Ovarian & Endometrial Cancer Early|Diagnosing Ovarian & Endometrial Cancer Early (DOvEE) by Targeting Symptomatic Women|Recruiting||N/A|13600|Anticipated|McGill University|||1||f||||f||||||||||2017-10-10 23:48:08.633757|2017-10-10 23:48:08.633757
NCT02296294|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-07-13|||October 2014||2014-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|BCM_Volunteer||Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy|Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy|Completed||N/A|15|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:48:08.792372|2017-10-10 23:48:08.792372
NCT02296281|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-19|||January 2015||2015-01-01|November 2014|2014-11-01||||June 2016|Anticipated|2016-06-01||Interventional|||Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury||Unknown status|Not yet recruiting|Phase 2|48|Anticipated|Beijing Continent Pharmaceutical Co, Ltd.||1|||f||||||||||||||2017-10-10 23:48:08.873896|2017-10-10 23:48:08.873896
NCT02296268|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2014-11-18|||January 2015||2015-01-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|STROKE-TRIC||Stepping up Aerobic Exercise to Improve Health Outcomes After Stroke|Stepping up Aerobic Exercise to Improve Health Outcomes After Stroke: Translating Research Into Clinical Care|Unknown status|Not yet recruiting|N/A|62|Anticipated|Nova Scotia Health Authority|||3||f||||f||||||||||2017-10-10 23:48:08.95949|2017-10-10 23:48:08.95949
NCT02296255|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-19|||April 2010||2010-04-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|May 2011|Actual|2011-05-01||Interventional|||Effect of HPV Vaccination on Women Aged 25 Years|Effective Surveillance and Impact of HPV Vaccination on Screening for Cervical Cancer in Tuscany|Completed||Phase 4|832|Actual|Cancer Prevention and Research Institute, Italy||2|||f||||t||||||||||2017-10-10 23:48:09.0831|2017-10-10 23:48:09.0831
NCT02296242|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-07-11|||November 2014||2014-11-01|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes|Phase 1/2 Dose-Escalation, Safety, Clinical Activity, Pharmacokinetic and Pharmacodynamic Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes|Completed||Phase 1/Phase 2|53|Actual|BioMed Valley Discoveries, Inc||1|||f||||||||||||||2017-10-10 23:48:09.183187|2017-10-10 23:48:09.183187
NCT02296229|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-09-12|||January 27, 2014|Actual|2014-01-27|September 2017|2017-09-01|January 27, 2021|Anticipated|2021-01-27|January 27, 2020|Anticipated|2020-01-27||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer|Study of Stereotactic Body Radiotherapy (SBRT) for High-Risk Localized Prostrate Cancer|Recruiting||N/A|220|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 23:48:09.272742|2017-10-10 23:48:09.272742
NCT02296216|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-01-02|||December 2014||2014-12-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|LateRAc||Late Effects of Radiosurgery on Acromegaly Study|LateR-Ac Study: Late Effects of Radiosurgery on Acromegaly Study|Recruiting||N/A|80|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-10 23:48:09.382419|2017-10-10 23:48:09.382419
NCT02296203|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-09-13|||October 2014||2014-10-01|July 2017|2017-07-01|December 15, 2017|Anticipated|2017-12-15|June 19, 2017|Actual|2017-06-19||Interventional|CRICKET||Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).|A PHASE II SINGLE-ARM STUDY OF CETUXIMAB PLUS IRINOTECAN AS RECHALLENGE 3RD-LINE TREATMENT OF KRAS, NRAS AND BRAF WILD-TYPE IRINOTECAN-PRETREATED METASTATIC COLORECTAL CANCER PATIENTS PROGRESSING AFTER AN INITIAL RESPONSE TO A 1ST-LINE CETUXIMAB-CONTAINING THERAPY AND A STANDARD 2ND-LINE|Active, not recruiting||Phase 2|27|Actual|Gruppo Oncologico del Nord-Ovest||1|||f||||||||||||||2017-10-10 23:48:09.464194|2017-10-10 23:48:09.464194
NCT02296190|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-01-09|||January 2015||2015-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|NODE-1||Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm|Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia to Sinus Rhythm|Completed||Phase 2|199|Actual|Milestone Pharmaceuticals Inc.||2|||f||||f||||||||Undecided||2017-10-10 23:48:09.568214|2017-10-10 23:48:09.568214
NCT02296177|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-05-10|||July 2015||2015-07-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evidence Based Dissemination for Mammography Adherence in Safety Net Communities|Evidence Based Dissemination for Mammography Adherence in Safety Net Communities|Recruiting||N/A|5000|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:48:09.712658|2017-10-10 23:48:09.712658
NCT02296164|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-11-18|||November 2014||2014-11-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|PROVe||Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma|A PROspective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated With Valchlor®|Recruiting||N/A|300|Anticipated|Actelion|||1||f||||f||||||||No|observational study|2017-10-10 23:48:09.816999|2017-10-10 23:48:09.816999
NCT02296151|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2015-11-26|||January 2015||2015-01-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of Treatment Factors in the Management of Chronic Iliotibial Band Syndrome in Female Distance Runners|Evaluation of Treatment Factors in the Management of Chronic Iliotibial Band Syndrome in Female Distance Runners.|Recruiting||N/A|36|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-10-10 23:48:10.023266|2017-10-10 23:48:10.023266
NCT02296138|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-19|2017-07-28|||January 13, 2015|Actual|2015-01-13|July 2017|2017-07-01|March 29, 2017|Actual|2017-03-29|March 8, 2017|Actual|2017-03-08||Interventional|||Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.|A Randomised, Double-blind, Active-controlled Parallel Group Study to Evaluate the Effect of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared With Tiotropium on Chronic Obstructive Pulmonary Disease (COPD) Exacerbation in Patients With Severe to Very Severe COPD. [DYNAGITO]|Completed||Phase 3|7903|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:48:10.200113|2017-10-10 23:48:10.200113
NCT02296125|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-06-29|||December 3, 2014|Actual|2014-12-03|June 2017|2017-06-01|October 15, 2018|Anticipated|2018-10-15|June 19, 2017|Actual|2017-06-19||Interventional|FLAURA||AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer|A Phase III, Double-blind, Randomised Study to Assess the Safety and Efficacy of AZD9291 Versus a Standard of Care Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as First Line Treatment in Patients With Epidermal Growth Factor Receptor Mutation Positive, Locally Advanced or Metastatic Non Small Cell Lung Cancer.|Active, not recruiting||Phase 3|674|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-10 23:48:12.014974|2017-10-10 23:48:12.014974
NCT02296112|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-11-18|||January 2015||2015-01-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations|A Phase II Open-Label, Two-Arm Study of the MEK Inhibitor, Trametinib, to Investigate the Safety and Anti-Cancer Activity in Subjects With Melanoma With BRAF Non-V600 Mutations|Recruiting||Phase 2|50|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-10 23:48:12.430648|2017-10-10 23:48:12.430648
NCT02296099|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2016-09-07|||November 2014||2014-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence|The Impact of Liposomal Bupivacaine Administered Following Placement of a Retropubic Suburethral Sling for Stress Urinary Incontinence: a Randomized Placebo-controlled Trial|Completed||Phase 4|114|Actual|TriHealth Inc.||2|||f||||f||||||||No||2017-10-10 23:48:12.553703|2017-10-10 23:48:12.553703
NCT02296086|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-09-29|||April 2015||2015-04-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Observational|||MobiChina - A Prospective Multicenter Cohort Study|A Prospective Multicenter Cohort Study to Evaluate the Effect of Early Mobilization of Patients After Hip Fracture Fixation on Functional Outcomes in the Chinese Population|Active, not recruiting||N/A|248|Anticipated|AO Clinical Investigation and Documentation|||2||f||||f||||||||||2017-10-10 23:48:12.641349|2017-10-10 23:48:12.641349
NCT02296073|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-19|||December 2014||2014-12-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Efficacy and the Safety of Dexmedetomidine Sedation on the Pediatric Intensive Unit(PICU) Patients.|The Efficacy and the Safety of Dexmedetomidine Sedation on the PICU Patients-A Randomized, Controlled Study.|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Anhui Provincial Children's Hospital||4|||f||||f||||||||||2017-10-10 23:48:14.331402|2017-10-10 23:48:14.331402
NCT02296060|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-18|||December 2014||2014-12-01|November 2014|2014-11-01||||December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of Exercise Tolerance During Pregnancy||Unknown status|Not yet recruiting|N/A|40|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-10 23:48:14.464851|2017-10-10 23:48:14.464851
NCT02296047|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-07-26|||December 2014||2014-12-01|November 2014|2014-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD|Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|22|Actual|Zhujiang Hospital||2|||f||||t||||||||||2017-10-10 23:48:14.534858|2017-10-10 23:48:14.534858
NCT02296034|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-04-13|||September 2015||2015-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Observational|||Blood Glucose Variability in Obese Youth Participating in a Lifestyle Modification Program|Blood Glucose Variability in Obese Youth Participating in a Lifestyle Modification Program|Withdrawn||N/A|0|Actual|Yale University|||1|Unable to recruit participants|f||||f||||||||||2017-10-10 23:48:14.626704|2017-10-10 23:48:14.626704
NCT02296021|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-09-01|||November 2014||2014-11-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy|Helicobacter Pylori Eradication With Berberine Hydrochloride,Esomeprazole,Amoxicillin and Clarithromycin Versus Bismuth,Esomeprazole,Amoxicillin,and Clarithromycin: a Randomized,Open-label, Non-inferiority, Phase Ⅳ Trail|Completed||Phase 4|612|Actual|Xijing Hospital of Digestive Diseases||2|||f||||t||||||||||2017-10-10 23:48:14.682232|2017-10-10 23:48:14.682232
NCT02296008|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-07-01|||April 2013||2013-04-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||3D High Resolution Anorectal Manometry in Children After Surgery for Anorectal Disorders|3D High Resolution Anorectal Manometry in Children After Surgery for Anorectal Disorders|Unknown status|Recruiting|N/A|40|Anticipated|Medical University of Warsaw||3|||f||||f||||||||||2017-10-10 23:48:14.779933|2017-10-10 23:48:14.779933
NCT02295995|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-05-02|||December 18, 2015|Actual|2015-12-18|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|||Exercise and PTSD in Older Veterans|Exercise as an Adjuvant Therapy for Veterans With PTSD|Recruiting||N/A|40|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 23:48:14.868396|2017-10-10 23:48:14.868396
NCT02295982|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-06-27|||November 2014||2014-11-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence)||Completed||N/A|30|Actual|University Hospital Roskilde||2|||f||||t||||||||||2017-10-10 23:48:14.952118|2017-10-10 23:48:14.952118
NCT02295969|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-07-25|||December 2014||2014-12-01|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Observational|||Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis|An Observational Study of ORALAIR® (Grass Pollen Allergen Extract From: Cocksfoot, Sweet Vernal, Rye Grass, Meadow Grass, Timothy) Tablet for Sublingual Use in Children 5 to 9 Years of Age With Grass-pollen-induced Allergic Rhinitis With or Without Conjunctivitis|Completed||N/A|307|Actual|Stallergenes Greer|||1||f||||f||||||||||2017-10-10 23:48:15.024256|2017-10-10 23:48:15.024256
NCT02295956|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-01-20|||February 2, 2015|Actual|2015-02-02|January 2017|2017-01-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer|Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer: A Pilot Study|Active, not recruiting||Early Phase 1|75|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:48:15.089869|2017-10-10 23:48:15.089869
NCT02295943|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-05-05|||November 2014||2014-11-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Objective Evaluation of Postoperative Positioning in Macular Hole Surgery|Objective Evaluation of Postoperative Positioning in Macular Hole Surgery|Recruiting||N/A|320|Anticipated|Helse Stavanger HF||1|||f||||f||||||||No||2017-10-10 23:48:15.189583|2017-10-10 23:48:15.189583
NCT02295930|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-03-11|||October 2011||2011-10-01|March 2015|2015-03-01||||March 2015|Actual|2015-03-01||Interventional|MACBETH||Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient|Induction Chemotherapy With Folfoxiri Plus Cetuximab and Maintenance With Cetuximab or Bevacizumab Therapy in Unresectable Kras Wild-type Metastatic Colorectal Cancer Patients|Completed||Phase 2|143|Actual|Gruppo Oncologico del Nord-Ovest||2|||f||||t||||||||||2017-10-10 23:48:16.631279|2017-10-10 23:48:16.631279
NCT02295917|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-24|||December 2014||2014-12-01|November 2014|2014-11-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Observational|EMJ||Computerized Evaluation of the Endometrial Myometrial Junction During a Natural Menstrual Cyle.|The Investigators Aim to Evaluate the Width of the Endometrial Myometrial Zone in Participants During Natural Menstrual Cycle by Using Specific Computerized Application on 3 Dimensions Sonographic Images of Their Uteri|Unknown status|Not yet recruiting|N/A|20|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-10 23:48:16.756774|2017-10-10 23:48:16.756774
NCT02295904|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-05-08|||February 2015||2015-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Video Analysis of Vaginal Deliveries|Video Analysis of Vaginal Deliveries to Evaluate the Impact of the Support of the Perineum|Active, not recruiting||N/A|120|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-10 23:48:16.816328|2017-10-10 23:48:16.816328
NCT02295891|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-10-12|||November 2014||2014-11-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|November 2016|Anticipated|2016-11-01||Interventional|MiraDry Tx||Miradry Treatment for Focal Axillary Hyperhidrosis|Microwave Energy-induced Thermolysis of Axillary Apocrine Glands and Hair Follicles Will Result in Improvement of Secondary Psychopathology Related to Hyperhidrosis.|Recruiting||N/A|24|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 23:48:16.876998|2017-10-10 23:48:16.876998
NCT02295878|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-17|||August 2011||2011-08-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|February 2012|Actual|2012-02-01||Interventional|SWAFAX||The Effect of Seaweed Derived Polyphenols on Inflammation and Oxidative Stress in Vivo - The SWAFAX Study|Seaweed Derived Anti-inflammatory Agents and Antioxidants|Completed||N/A|80|Actual|University of Ulster||2|||f||||f||||||||||2017-10-10 23:48:16.951182|2017-10-10 23:48:16.951182
NCT02295865|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-07-06||2016-10-03|November 17, 2014|Actual|2014-11-17|July 2017|2017-07-01|March 11, 2016|Actual|2016-03-11|March 11, 2016|Actual|2016-03-11||Interventional|||A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis|A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis|Completed||Phase 2|62|Actual|Janssen Research & Development, LLC||4|||f||||f||f||||||||2017-10-10 23:48:17.02528|2017-10-10 23:48:17.02528
NCT02295852|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-17|||December 2014||2014-12-01|November 2014|2014-11-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Increasing Calcium Dietary Intake Helps to Control Blood Presure and Body Weight|Effects of Changes in Calcium Dietary Intake on Blood Pressure and Body Weight Control|Unknown status|Not yet recruiting|N/A|150|Anticipated|Federico II University||2|||f||||t||||||||||2017-10-10 23:48:17.136318|2017-10-10 23:48:17.136318
NCT02295839|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-19|||May 2011||2011-05-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|June 2013|Actual|2013-06-01||Interventional|SHARI||Sleep Hygiene and Relaxation Intervention to Improve Sleep and Fatigue for Children Receiving Maintenance Chemotherapy|Feasibility, Acceptability, and Effectiveness of a Sleep Hygiene and Relaxation Intervention to Improve Sleep and Fatigue for Children Receiving Maintenance Chemotherapy for Acute Lymphoblastic Leukemia|Completed||N/A|20|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 23:48:17.341182|2017-10-10 23:48:17.341182
NCT02295826|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-11-22|||January 2015||2015-01-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|DATAS II||Dabigatran Following Transient Ischemic Attack and Minor Stroke|Dabigatran Following Transient Ischemic Attack and Minor Stroke|Recruiting||Phase 2|300|Anticipated|University of Alberta||2|||f||||t||||||||||2017-10-10 23:48:17.488989|2017-10-10 23:48:17.488989
NCT02295813|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-17|||October 2012||2012-10-01|November 2014|2014-11-01||||December 2012|Actual|2012-12-01||Interventional|||Safety and Pharmacokinetics Study of FBF001|A Single Center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetics of One Single Intravenous Dose and 5-day Repeated Intravenous Doses of FBF001 in Healthy Male Subjects|Completed||Phase 1|16|Actual|Fab'entech||2|||f||||||||||||||2017-10-10 23:48:17.610393|2017-10-10 23:48:17.610393
NCT02295800|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-11-20|||April 2013||2013-04-01|November 2014|2014-11-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV|The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV|Unknown status|Enrolling by invitation|N/A|1216|Actual|Elizabeth Glaser Pediatric AIDS Foundation|||3||f||||f||||||Samples With DNA|"     Plasma specimens collected from the adult participants at the time of viral load testing and     dried blood spot (DBS) specimens drawn from the infant participants.   "|||2017-10-10 23:48:17.699352|2017-10-10 23:48:17.699352
NCT02295787|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-03-01|||July 2015||2015-07-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Intranasal Ketamine for Late-Life Depression and Suicidal Ideation|Intranasal Ketamine for Late-Life Depression and Suicidal Ideation|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||2||No funding|f||||t||||||||||2017-10-10 23:48:17.807956|2017-10-10 23:48:17.807956
NCT02295592|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-19|||November 2014||2014-11-01|October 2014|2014-10-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Interventional|||TSTstarr + for Treatment of Severe Prolapsed Hemorrhoids --- a Multi-center Randomized Controlled Clinical Trail||Unknown status|Not yet recruiting|N/A|780|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:48:20.349733|2017-10-10 23:48:20.349733
NCT02295774|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-12-09|2015-12-09||February 2013||2013-02-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||"13 patients were enrolled. 2 withdrew consent. 1 deviated from inclusion criteria.
Analysis populations were:
Analysis set N. subjects
Safety set 10 FAS 10 PP set 10"|Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA|Effect of Oral Administration of Methylene Blue MMX Tablets on Double-stranded DNA Damage Assessed by GammaH2AX Analysis of Colon Biopsy Samples|Completed||Phase 2|10|Actual|Cosmo Technologies Ltd||2|||f||||f||||||||||2017-10-10 23:48:17.90647|2017-10-10 23:48:17.90647
NCT02295761|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-11-30|||January 2012||2012-01-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|June 2012|Actual|2012-06-01||Interventional|||Promoting Overweight Adolescents Physical Activity|Promoting Overweight Adolescents Physical Activity and Adherence to Healthy Lifestyles: a Randomized Controlled Trial|Active, not recruiting||N/A|46|Actual|University of Oulu||2|||f||||f||||||||||2017-10-10 23:48:18.18902|2017-10-10 23:48:18.18902
NCT02295748|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-09-25|||December 2014|Actual|2014-12-01|January 2017|2017-01-01|August 24, 2017|Actual|2017-08-24|August 24, 2017|Actual|2017-08-24||Interventional|||An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort|An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Orally Administrated Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy|Completed||Phase 1|24|Actual|PTC Therapeutics||1|||f||||f||||||||||2017-10-10 23:48:18.343098|2017-10-10 23:48:18.343098
NCT02295735|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-02-09|||June 2015||2015-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Two Silicone Dressings for Sacral and Heel Pressure Ulcer Prevention|A Randomized Controlled Parallel-group Trial to Investigate the Effectiveness of Two Silicone Dressings for Sacral and Heel Pressure Ulcer Prevention Compared to no Dressings|Recruiting||N/A|464|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-10 23:48:18.475545|2017-10-10 23:48:18.475545
NCT02295722|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-06-14|||April 2015||2015-04-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|GEMHDM2014||GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma|Infusional Gemcitabine and High-dose Melphalan (HDM) Conditioning Prior to (ASCT) Autologous Stem Cell Transplantation for Patients With Relapsed/Refractory Lymphoma|Recruiting||Phase 1/Phase 2|200|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||No||2017-10-10 23:48:18.613719|2017-10-10 23:48:18.613719
NCT02295709|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-19|||January 2014||2014-01-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|||Cervical Transforaminal Injection of Steroids Guided by Ultrasound|Cervical Transforaminal Injection of Steroids Guided by Ultrasound|Unknown status|Active, not recruiting|N/A|60|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||3|||f||||t||||||||||2017-10-10 23:48:18.759145|2017-10-10 23:48:18.759145
NCT02295696|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-20|||November 2014||2014-11-01|November 2014|2014-11-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|EMMA||EMMA: Empowerment, Motivation and Medical Adherence|EMMA: Empowerment, Motivation and Medical Adherence|Recruiting||N/A|270|Anticipated|Steno Diabetes Center||2|||f||||f||||||||||2017-10-10 23:48:18.896515|2017-10-10 23:48:18.896515
NCT02295683|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-07-03|||November 2014||2014-11-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01|5 Years|Observational [Patient Registry]|Iberis||Renal Sympathetic Denervation by Iberis System in Patients With Uncontrolled Hypertension - Iberis-HTN Registry|Renal Sympathetic Denervation by Iberis System in Patients With Uncontrolled Hypertension - IBERIS - HTN Registry|Active, not recruiting||N/A|18|Actual|Terumo Europe N.V.|||1||f||||f||||||||||2017-10-10 23:48:19.029515|2017-10-10 23:48:19.029515
NCT02295670|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-18|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|3V-L DL||Pediatric Difficult Intubation|Can the Vividtrac Laryngoscope Rival the Miller Laryngoscope for Child Tracheal Intubation During Chest Compression in a Manikin? A Randomized Crossover Trial.|Unknown status|Recruiting|N/A|180|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:48:19.135106|2017-10-10 23:48:19.135106
NCT02295657|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-18|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|DLETI||Double Lumen Tube Intubation|Comparison of Techniques for Double-lumen Tube Intubation: Standard Double-lumen Tube or VivaSight Double Lumen Tube by Paramedics. A Randomized Crossover Manikin Trial.|Unknown status|Recruiting|N/A|120|Anticipated|International Institute of Rescue Research and Education||1|||f||||t||||||||||2017-10-10 23:48:19.260164|2017-10-10 23:48:19.260164
NCT02295644|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-08-19|2015-12-02||November 2014||2014-11-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional||One in group C and two in group D had pain less that 4.|Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial|Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial|Completed||N/A|28|Actual|State University of New York at Buffalo|Three subjects who met the inclusion criteria on recruitment (bilateral masseter pain of four or more) did not meet the criteria at the time of the experiment so were not analyzed.|4|||f||||f||||||||No||2017-10-10 23:48:19.369722|2017-10-10 23:48:19.369722
NCT02295631|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-26|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||ETI During Spinal Trauma|A Comparison of Conventional Tube and ETView VivaSight SL Tube for Tracheal Intubation in Patients With a Cervical Spine Immobilisation. A Randomized Cross-over Manikin Trial.|Unknown status|Recruiting|N/A|150|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:48:20.023595|2017-10-10 23:48:20.023595
NCT02295618|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2014-11-27|||November 2014||2014-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|SL||ETI During Intubation|Can the ETView VivaSight SL Rival the Macintosh Laryngoscopy With Conventional Tube During Adult Resuscitation by Novice Physicians: a Randomized Crossover Simulation Study.|Completed||N/A|107|Actual|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:48:20.143002|2017-10-10 23:48:20.143002
NCT02295605|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2016-07-31|||August 2014||2014-08-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Comparison Between Land-based and Water-based Exercises for Knee Osteoarthritis: Randomized Controlled Trial|Comparison Between a Land-based and Water-based Muscles Strengthening Program on Patients With Knee Osteoarthritis Randomized Controlled Trial|Completed||Phase 1|46|Actual|University of Nove de Julho||2|||f||||t||||||||Undecided||2017-10-10 23:48:20.241668|2017-10-10 23:48:20.241668
NCT02295579|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-20|||June 2014||2014-06-01|November 2014|2014-11-01|November 2015|Anticipated|2015-11-01|June 2015|Anticipated|2015-06-01|6 Months|Observational [Patient Registry]|||Will Vaginal Colonization of Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida|Vaginal Colonization After Treatment With Lactobacillus in Women With BV or Candida Will That Increase the Cure Rate After Treatment With Clindamycin for BV and Flucnazole for Candida|Unknown status|Recruiting|N/A|50|Anticipated|Skaraborg Hospital|||1||f||||t||||||||||2017-10-10 23:48:20.487899|2017-10-10 23:48:20.487899
NCT02295566|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-11-17|||May 2011||2011-05-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|RATNO||RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study|RATNO (Reducing Antibiotic Tolerance Using NO) Reducing Antibiotic Tolerance Using Low Dose Nitric Oxide in Cystic Fibrosis - a Phase 2 Pilot Study|Completed||Phase 2|12|Actual|University Hospital Southampton NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:48:20.588855|2017-10-10 23:48:20.588855
NCT02295553|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-04-25|||July 2013|Actual|2013-07-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Ketamine and Propofol for Upper Endoscopy|Co-administration of Ketamine and Propofol for Upper Endoscopy in Children: a Dose-finding Study|Completed||Phase 4|56|Actual|The Hospital for Sick Children||4|||f||||f||||||||||2017-10-10 23:48:20.6909|2017-10-10 23:48:20.6909
NCT02295540|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-01-19|||August 2016||2016-08-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity|Preoperative Hypofractionated Radiation Followed by Surgery in Advanced Oral Cavity Squamous Cell Carcinoma|Recruiting||Phase 1/Phase 2|45|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 23:48:20.805736|2017-10-10 23:48:20.805736
NCT02295527|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-05-11|||November 2014||2014-11-01|December 2015|2015-12-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|REATIVE||Functional Later Rehabilitation in Older Adults: Effectiveness of Physical Exercises|Effectiveness of a Physical Exercise Intervention Program in Improving Functional Mobility in Older Adults After Hip Fracture in Later Stage Rehabilitation: a Randomized Clinical Trial|Recruiting||N/A|82|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t||||||||||2017-10-10 23:48:20.959068|2017-10-10 23:48:20.959068
NCT02295514|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|SEPP1B||Correlation Between PTP1B Expression and Organ Failure During Sepsis|Correlation Between PTP1B Expression and Organ Failure During Sepsis|Completed||N/A|54|Actual|University Hospital, Rouen||1|||f||||t||||||||||2017-10-10 23:48:21.103123|2017-10-10 23:48:21.103123
NCT02295501|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-05-04|||December 2014||2014-12-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease|A Prospective, Open Label Observational, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease|Enrolling by invitation||Phase 1|12|Anticipated|Cerus Corporation||1|||f||||f||||||||||2017-10-10 23:48:21.214683|2017-10-10 23:48:21.214683
NCT02295488|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-21|||March 2015||2015-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MAISAVEN||Determinism of the Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy|Determinism of the Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy|Recruiting||N/A|30|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-10 23:48:21.318483|2017-10-10 23:48:21.318483
NCT02295475|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-18|2017-06-21|||February 2015||2015-02-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ASTRO-APS||Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome|Apixaban for the Secondary Prevention of Thromboembolism: A Prospective Randomized Outcome Pilot Study Among Patients With the AntiphosPholipid Syndrome|Recruiting||Phase 4|200|Anticipated|Intermountain Health Care, Inc.||2|||f||||t||||||||No||2017-10-10 23:48:21.423298|2017-10-10 23:48:21.423298
NCT02295462|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-05-02|||December 2014||2014-12-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|EPCentCare||Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial|Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial|Completed||N/A|1158|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||t||||||||||2017-10-10 23:48:21.567222|2017-10-10 23:48:21.567222
NCT02295449|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-08-26|||June 2015||2015-06-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SONOCAP||Quantitative Prostate Cancer Contrast-enhanced Ultrasound||Recruiting||N/A|130|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-10 23:48:21.662169|2017-10-10 23:48:21.662169
NCT02295436|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-19|||August 2014||2014-08-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetics and Tolerability of Minodronic Acid and Food and Age Effects on the Pharmacokinetics|Pharmacokinetics and Tolerability of Minodronic Acid Tablets in Healthy Chinese Subjects and Food and Age Effects on the Pharmacokinetics|Completed||Phase 1|48|Actual|Wuhan Union Hospital, China||4|||f||||t||||||||||2017-10-10 23:48:21.755496|2017-10-10 23:48:21.755496
NCT02295423|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-12-08|||November 2014||2014-11-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Follow-Up Study to Assess Implementation of Ultrasound-Guided Regional Anesthesia Skills|A Long-Term Follow-Up Study to Assess Implementation of Ultrasound-Guided Regional Anesthesia Skills Training by Practicing Anesthesiologists|Completed||N/A|99|Actual|VA Palo Alto Health Care System|||1||f||||t||||||||||2017-10-10 23:48:21.831114|2017-10-10 23:48:21.831114
NCT02295410|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-14|||May 2013||2013-05-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01||Observational|HBTMH||The Effects of Home-Based Telemental Health for Rural Veterans With PTSD|The Effects of Home-Based Telemental Health for Rural Veterans With PTSD|Unknown status|Recruiting|N/A|200|Anticipated|VA Pacific Islands Health Care System|||2||f||||f||||||||||2017-10-10 23:48:21.891099|2017-10-10 23:48:21.891099
NCT02295397|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-05-10|||November 2014||2014-11-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|iFAAM||Integrated Approaches to Food Allergen and Allergy Risk Management|Integrated Approaches to Food Allergen and Allergy Risk Management|Completed||N/A|72|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 23:48:21.981367|2017-10-10 23:48:21.981367
NCT02295384|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-09-08|||November 2014||2014-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Observational|||Use of Concomitant Medications in HIV-1 Infected Patients in a Large Community Practice in Sydney, Australia|Use of Concomitant Medications in HIV-1 Infected Patients in a Large Community Practice in Sydney, Australia|Completed||N/A|1104|Actual|Holdsworth House Medical Practice|||1||f||||||||||||||2017-10-10 23:48:22.062145|2017-10-10 23:48:22.062145
NCT02295371|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-01-11|||January 2015||2015-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|MIPC||Medication Incidents in Primary Care Medicine|Medication Incidents in Primary Care Medicine: A Study by the Swiss Federal Sentinel Reporting System|Completed||N/A|213|Actual|University of Zurich|||1||f||||f||||||||||2017-10-10 23:48:22.145873|2017-10-10 23:48:22.145873
NCT02295358|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2015-07-08|||November 2014||2014-11-01|July 2015|2015-07-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface|The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface|Withdrawn||N/A|0|Actual|University of Colorado, Denver|||1|Project never got initiated|f||||f||||||||||2017-10-10 23:48:22.212494|2017-10-10 23:48:22.212494
NCT02295345|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-04-15|||June 2014||2014-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Open Pilot of Cognitive Behavioural Therapy for Insomnia in Pregnancy|Open Pilot of Cognitive Behavioural Therapy for Insomnia in Pregnancy|Completed||N/A|13|Actual|University of Calgary||1|||f||||||||||||||2017-10-10 23:48:22.270535|2017-10-10 23:48:22.270535
NCT02295332|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-11-01|||December 2014||2014-12-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study of RG7625 in Healthy Volunteers||Completed||Phase 1|17|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:48:22.33992|2017-10-10 23:48:22.33992
NCT02295319|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-12-01|||November 2014||2014-11-01|November 2014|2014-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Impact of Individual-based Discharges From Acute Admission Units to Home|The Impact of Individual-based Discharges From Acute Admission Units to Home on Healthcare Utilization, Quality-of-life and Patient Experience: a Randomized Controlled Study|Completed||N/A|200|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-10 23:48:22.417904|2017-10-10 23:48:22.417904
NCT02295306|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-05-05|||June 2013||2013-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Overnight Polysomnography and Respiratory Volume Monitor|The Evaluation of a Respiratory Volume Monitor in Patients Undergoing Overnight Polysomnography|Active, not recruiting||N/A|80|Anticipated|Tufts Medical Center|||1||f||||f||||||||||2017-10-10 23:48:22.62653|2017-10-10 23:48:22.62653
NCT02295293|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-06-04|||December 2014||2014-12-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|SomaghLipid||The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia|The Effects of Rhus Coriaria L. (Rhus or Somagh) on Serum Lipid Levels of Patients With Hyperlipidemia|Completed||Early Phase 1|74|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:48:22.705963|2017-10-10 23:48:22.705963
NCT02295267|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-05-10|||December 2012||2012-12-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Molecular Analysis of IgE Antibodies in Walnut Allergic Patients|Molecular Analysis of IgE Antibodies in Walnut Allergic Patients|Completed||N/A|61|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 23:48:22.902631|2017-10-10 23:48:22.902631
NCT02295254|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-10-03|||September 2014||2014-09-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Observational|||Microbiome Changes in Travelers to Tropical Destinations|Microbiome Changes in Travelers to Tropical Destinations|Recruiting||N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-10 23:48:22.995307|2017-10-10 23:48:22.995307
NCT02295241|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-03-25|||February 2015||2015-02-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||"Improving Muscle Assessment in Older Adults - The Can We Build a Better Mouse Trap? Study"|"Improving Muscle Assessment in Older Adults - The Can We Build a Better Mouse Trap? Study"|Completed||N/A|112|Actual|University of Wisconsin, Madison|||1||f||||f||||||Samples Without DNA|"     Blood will be drawn to obtain a serum chemistry panel to document health status of the study     participants. For subjects who agree to optional banking, serum aliquots will be obtained and     banked for future study of markers relevant to musculoskeletal health.   "|||2017-10-10 23:48:23.097254|2017-10-10 23:48:23.097254
NCT02295228|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-03-25|||January 2015||2015-01-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Hip Arthroplasty and Vitamin D Status|Hip Arthroplasty and Vitamin D Status|Completed||N/A|43|Actual|University of Wisconsin, Madison|||1||f||||f||||||Samples Without DNA|"     Blood and urine samples will be collected at all time points. Blood and urine aliquots will     also be banked from each visit.   "|||2017-10-10 23:48:23.184716|2017-10-10 23:48:23.184716
NCT02295215|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-11-14|||June 2013||2013-06-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|CH0660/10||Exercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction|Effects of Physical Training on Sensitivity Baroreflex Patients Without Chagas' Heart Ventricular Systolic Dysfunction|Unknown status|Recruiting|N/A|24|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:48:23.269084|2017-10-10 23:48:23.269084
NCT02295202|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-10-01|||March 2015||2015-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|TREATOSA-MS||Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome|Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome: A Randomized Study|Recruiting||Phase 4|100|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:48:23.372874|2017-10-10 23:48:23.372874
NCT02295176|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-10-26|||April 2013||2013-04-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|ARMP-11||Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome|Metabolic and Cardiovascular Effects of a Proprietary Nutraceutical Containing Berberine, Policosanols and Red Yeast in Subjects With Metabolic Syndrome|Completed||N/A|159|Actual|Rottapharm||2|||f||||f||||||||||2017-10-10 23:48:23.579701|2017-10-10 23:48:23.579701
NCT02295163|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-09-25|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Stellate Ganglion Block for Hot Flushes in Men Treated With ADT|Short-term Efficacy of Stellate Ganglion Block in Men to Reduce Hot Flushes Related to Androgen Deprivation Therapy|Recruiting||N/A|50|Anticipated|Rijnstate Hospital||2|||f||||f||||||||||2017-10-10 23:48:23.668559|2017-10-10 23:48:23.668559
NCT02295150|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-19|||March 2013||2013-03-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Prophylaxis of Venous Thromboembolism After Bariatric Surgery|Prospective, Pharmacokinetic Study for Determination of the Relationship Between Lean Body Weight and Anti-Xa Activity 4 Hours After Subcutaneous Injection of 5700 IU Nadroparin in Morbidly Obese Patients After Bariatric Surgery.|Unknown status|Recruiting|Phase 4|50|Anticipated|Rijnstate Hospital||1|||f||||f||||||||||2017-10-10 23:48:23.784035|2017-10-10 23:48:23.784035
NCT02295137|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-11-14|||February 2014||2014-02-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Image Fusion of Preprocedural CTA With Real Time Fluoroscopy to Enhance EVAR Repair|Image Fusion of Pre-procedural CTA With Real-time Fluoroscopy to Guide Proper Renal and Visceral Arteries Catheterization During Advanced Endovascular Aortic Aneurysms Repair: A Feasibility Study|Unknown status|Recruiting|Phase 1|20|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:48:23.882643|2017-10-10 23:48:23.882643
NCT02295124|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-10-27|||August 2012||2012-08-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery|Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery|Active, not recruiting||Phase 4|200|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:48:23.964377|2017-10-10 23:48:23.964377
NCT02295111|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-11-10|||October 2014||2014-10-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|BMEA||Electro-acupuncture (EA) and Chronic Pelvic Pain (CPP)|The BMEA Study: The Impact of Meridian Balanced Method (BM) Electro-acupuncture (EA) Treatment on Women With Chronic Pelvic Pain (CPP): A Three-arm Randomized Controlled Pilot Study.|Completed||N/A|30|Actual|University of Edinburgh||3|||f||||f||||||||||2017-10-10 23:48:24.072259|2017-10-10 23:48:24.072259
NCT02295098|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2016-12-05|||August 2015||2015-08-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Epidural and Paracostal Catheter Placement for Pain Control After Rib Fractures|Comparison of Epidural and Paracostal Catheter Placement for Pain Control After Rib Fractures|Recruiting||N/A|200|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:48:24.174874|2017-10-10 23:48:24.174874
NCT02295085|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-01-27|||September 1990||1990-09-01|January 2017|2017-01-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|FCC||Fernald Community Cohort -18 Year Observational Study|Fernald Community Cohort - 18 Year Observational Study With Bio Banked Blood and Urine Samples|Active, not recruiting||N/A|9782|Actual|University of Cincinnati|||1||f||||f|f|f||||Samples With DNA|"     160,000 archived biosamples available, drawn from 1990-2008 (whole Bood, Plasma, Serum,     Urine, Buffered Urine), extracted DNA. Breast, Renal & Prostate cancer formalin fixed tissue.   "|No||2017-10-10 23:48:24.29113|2017-10-10 23:48:24.29113
NCT02295072|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-05-04|||December 2014||2014-12-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Interventional|ActiveBrains||Effects of an Exercise Program on Cognition and Brain in Overweight/Obese Preadolescent Children|ActiveBrains: Effects of an Exercise-based Randomized Controlled Trial on Cognition, Brain Structure and Brain Function in Overweight/Obese Preadolescent Children|Active, not recruiting||N/A|110|Actual|Universidad de Granada||2|||f||||f||||||||||2017-10-10 23:48:24.383541|2017-10-10 23:48:24.383541
NCT02295059|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-11-01|||August 2014||2014-08-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention|Omega-3 Fatty Acids and ERPR(-) and HER-2/Neu(+/-) Breast Cancer Prevention|Recruiting||Phase 1|80|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-10 23:48:24.476228|2017-10-10 23:48:24.476228
NCT02295046|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-17|||October 2011||2011-10-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition|Open Label, Randomized, Two-treatment, Two-period, Two-sequence,Crossover, Single Dose, Oral Bioequivalence Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10mg/80mg Under Fasting Condition|Completed||Phase 1|80|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:48:24.579791|2017-10-10 23:48:24.579791
NCT02295033|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-18|||May 1989||1989-05-01|November 2014|2014-11-01||||May 2006|Actual|2006-05-01||Interventional|||Randomized Boost Versus no Boost Irradiation of Early Breast Cancer|Phase III Study in the Conservative Management of Breast Carcinoma by Tumorectomy and Radiotherapy: Assessment of the Role of a Booster Dose of Radiotherapy (Joint Study of the European Organisation for Research and Treatment of Cancer Radiotherapy Cooperative Group and Breast Cancer Cooperative Group)|Completed||Phase 3|||European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-10 23:48:24.666549|2017-10-10 23:48:24.666549
NCT02295020|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-06-01|2016-04-08||May 2013||2013-05-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Bioskin||Effect of Bioskin Ten-7 vs. Standard Treatment on Patient Reported Outcomes and Cytokine.|Effect of Bioskin Ten-7 vs. Standard Treatment on Patient Reported Outcomes and Cytokine.|Completed||N/A|40|Actual|Cropper Medical||2|||f||||f||||||||No||2017-10-10 23:48:24.752799|2017-10-10 23:48:24.752799
NCT02295007|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-05-10|||December 2014||2014-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging|Pilot Study to Assess Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging (2014-2015 Season)|Completed||N/A|266|Actual|Columbia University||1|||f||||f||||||||||2017-10-10 23:48:25.432857|2017-10-10 23:48:25.432857
NCT02294994|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-29|||November 2014||2014-11-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease|Randomized Controlled Clinical Study to Compare the Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease|Unknown status|Recruiting|Phase 4|1000|Anticipated|Second Hospital of Jilin University||3|||f||||t||||||||||2017-10-10 23:48:25.512272|2017-10-10 23:48:25.512272
NCT02294981|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-10-07|||January 2016||2016-01-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|Photos||Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis|A Randomized Clinical Trial to Determine Whether a Novel Plaque-based Dosimetry Strategy Can Improve the Speed of Response to Treatment in Patients With Plaque Psoriasis (Photos)|Recruiting||N/A|30|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:48:25.609176|2017-10-10 23:48:25.609176
NCT02294968|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-05-22|||November 2014||2014-11-01|May 2017|2017-05-01|February 2024|Anticipated|2024-02-01|December 2018|Anticipated|2018-12-01||Interventional|FIV||The Family Startup Program. A Randomized Controlled Trial of a Universal Group-based Parenting Support Program|The Family Startup Program. A Randomized Controlled Trial of a Universal Group-based Parenting Support Program|Active, not recruiting||N/A|1719|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:48:25.685137|2017-10-10 23:48:25.685137
NCT02294955|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-05-07|||May 2008||2008-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|CAPTAF||Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)|Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation - a Randomized Multicentre Study Comparing Atrial Fibrillation Ablation Strategy With Optimized Conventional Pharmacological Strategy After 12 Months Follow-up.|Active, not recruiting||N/A|152|Actual|Uppsala University Hospital||2|||f||||t||||||||||2017-10-10 23:48:25.762237|2017-10-10 23:48:25.762237
NCT02294942|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-04-26|||October 2014||2014-10-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Extended-Release RANCAD in the Patients With Stable Angina Pectoris|A Double-blind, Randomized, Placebo-controlled, Parallel Study to Evaluate the Effects of add-on RANCAD on Exercise Tolerance and Angina Frequency in Patients With Stable Angina Pectoris.|Completed||Phase 3|75|Actual|TSH Biopharm Corporation Limited||3|||f||||t||||||||||2017-10-10 23:48:25.894728|2017-10-10 23:48:25.894728
NCT02294929|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-05-07|||September 2013|Actual|2013-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|CRYO-LPAF||Cryoballoon Ablation in Patients With Longstanding Persistent Atrial Fibrillation|Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Longstanding Persistent Atrial Fibrillation (the CRYO-LPAF Study)|Recruiting||N/A|40|Anticipated|Uppsala University Hospital||1|||f||||f||||||||||2017-10-10 23:48:25.976887|2017-10-10 23:48:25.976887
NCT02294916|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-16|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|NURS_ETI||Pediatric Intubation by Nurses|Comparison of Pentax-AWS Airwayscope, Intubrite, AirTraq and Miller Laryngoscope for Tracheal Intubation by Nurses During Chest Compression in a Pediatric Manikin: A Randomised Crossover Trial.|Unknown status|Recruiting|N/A|150|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:48:26.223104|2017-10-10 23:48:26.223104
NCT02294890|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-15|||January 2015||2015-01-01|November 2014|2014-11-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Observational|||Knee Stiffness in Fibrosis Diathesis|Does Fibrosis Diathesis Influence the Recovery of Knee Mobility After Total Knee Replacement?|Unknown status|Not yet recruiting|N/A|60|Anticipated|University Hospital Pellenberg|||2||f||||t||||||||||2017-10-10 23:48:26.432517|2017-10-10 23:48:26.432517
NCT02294877|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-04-19|||September 2014||2014-09-01|January 2017|2017-01-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01|10 Years|Observational [Patient Registry]|MARS||A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)|A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)|Recruiting||N/A|583|Anticipated|BioMarin Pharmaceutical|||1||f||||f||||||Samples Without DNA|"     Blood serum; urine samples   "|No||2017-10-10 23:48:26.527186|2017-10-10 23:48:26.527186
NCT02294864|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-12-22|||April 2014||2014-04-01|December 2015|2015-12-01||||April 2017|Anticipated|2017-04-01||Interventional|||A Controlled Comparison of Pulsed Radiofrequency Vs Physical Therapy on Treating Chronic Knee Osteoarthritis|A Controlled Comparison of Pulsed Radiofrequency Vs Physical Therapy on Treating Chronic Knee Osteoarthritis|Recruiting||N/A|50|Anticipated|VA Long Beach Healthcare System||2|||f||||t||||||||||2017-10-10 23:48:26.932769|2017-10-10 23:48:26.932769
NCT02294851|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-04-12|||December 2014||2014-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Intravenously Administered BMS-986168 in Healthy Subjects||Completed||Phase 1|65|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:48:27.104694|2017-10-10 23:48:27.104694
NCT02294838|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-11-25|||December 2014||2014-12-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|August 2015|Actual|2015-08-01||Interventional|SPIT||Feasibility Study of MRI Imaging on Parotid Gland Stimulation|Feasibility Study of MRI Imaging on Parotid Gland Stimulation|Active, not recruiting||N/A|10|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-10 23:48:27.199399|2017-10-10 23:48:27.199399
NCT02294825|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2017-08-29|||June 2009||2009-06-01|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01|7 Years|Observational [Patient Registry]|CIRENDO||The North-West Inter Regional Female Cohort for Patients With Endometriosis|The North-West Inter Regional Female Cohort for Patients With Endometriosi|Active, not recruiting||N/A|1500|Anticipated|University Hospital, Rouen|||1||f||||f||||||||||2017-10-10 23:48:27.288741|2017-10-10 23:48:27.288741
NCT02294812|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-10-12|||September 2016||2016-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Cognitive Training on Speech Perception|Effects of Cognitive Training on Age-Related Hearing Loss and Speech Perception|Recruiting||N/A|120|Anticipated|Nova Scotia Health Authority||3|||f||||f||||||||No||2017-10-10 23:48:27.388112|2017-10-10 23:48:27.388112
NCT02294799|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-11-16|||November 2014||2014-11-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|August 2015|Anticipated|2015-08-01||Interventional|MRITMJ||Magnetic Ressonance Imaging of Temporomandibular Joint|Magnetic Ressonance Imaging Evaluation of Articular Disc Position in TMD Subjects After Mandibular Mobilization. A Double Blind, Randomized, Placebo-controlled Study|Unknown status|Not yet recruiting|N/A|24|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-10 23:48:27.506826|2017-10-10 23:48:27.506826
NCT02294786|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-09-26|||December 17, 2014|Actual|2014-12-17|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer|A Randomised, Multicentre, Open Label, Phase II Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer|Recruiting||Phase 2|140|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 23:48:27.642313|2017-10-10 23:48:27.642313
NCT02294773|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-11-04|2015-09-27||October 2013||2013-10-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study Evaluating the Timing of Intrauterine Insemination in Relation to Positive Home Ovulation Prediction Kit|Randomized Controlled Trial Evaluating the Timing of Intrauterine Insemination in Relation to the LH Surge|Completed||N/A|13|Actual|Midwest Fertility Specialists||2|||f||||f||||||||||2017-10-10 23:48:27.900822|2017-10-10 23:48:27.900822
NCT02294760|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-04-28|||November 2014||2014-11-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Long-term Sacral Nerve Stimulation for Irritable Bowel Syndrome.|Long-term Efficacy of Sacral Nerve Stimulation for Irritable Bowel Syndrome. A Randomised Controlled Crossover Study|Enrolling by invitation||N/A|22|Anticipated|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-10 23:48:28.386729|2017-10-10 23:48:28.386729
NCT02294747|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-07-10|||November 2014||2014-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trochanteric Hip Fractures (AO A2) SHS With or Without Trochanteric Stabilizing Plate - Rct Using RSA|Trochanteric Hip Fractures (AO A2) Treated With Sliding Hip Screw With or Without Trochanteric Stabilizing Plate - a Randomized Controlled Trial Using Radiostereometry.|Active, not recruiting||N/A|30|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-10 23:48:28.515002|2017-10-10 23:48:28.515002
NCT02294734|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-01-20|2016-10-17||March 2015||2015-03-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease|A Randomised, Double-blind (Sponsor Unblinded), Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Efficacy and Safety of GSK2269557 Administered in Addition to Standard of Care in Adult Subjects Diagnosed With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Completed||Phase 2|126|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:48:28.928832|2017-10-10 23:48:28.928832
NCT02294721|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-16|2014-11-16|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|CPR_NURSE||Pediatric Resuscitation With Feedback Devices|Quality of Pediatric Chest Compression: Comparing Four CPR Feedback Devices With Standard BLS by a Single Rescuer: A Randomised Controlled Manikin Trial|Unknown status|Recruiting|N/A|200|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:48:36.650226|2017-10-10 23:48:36.650226
NCT02294708|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2014-11-16|||January 2014||2014-01-01|November 2014|2014-11-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||The Influence of Postoperative Postures on Persistent Sub-foveal Fluid After Scleral Buckle Surgery|The Influence of Postoperative Postures on the Incidence and Duration of Persistent Sub-foveal Fluid After Scleral Buckle for Macula-off Retinal Detachment|Unknown status|Recruiting|N/A|60|Anticipated|Peking University Third Hospital||2|||f||||t||||||||||2017-10-10 23:48:36.775563|2017-10-10 23:48:36.775563
NCT02294695|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-06-16|||October 2012||2012-10-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients|Early Procalcitonin Kinetics May Indicate Effectiveness of the Empirical Antibiotic Therapy in Sepsis Within Hours|Completed||N/A|209|Actual|Szeged University|||2||f||||f||||||||||2017-10-10 23:48:36.906467|2017-10-10 23:48:36.906467
NCT02294682|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-04-17|2017-02-14||April 15, 2015||2015-04-15|February 2017|2017-02-01|July 27, 2016|Actual|2016-07-27|July 1, 2016|Actual|2016-07-01||Interventional|||A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae|A Phase II, Randomized, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Efficacy, Safety, and Tolerability of Single Doses of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae|Completed||Phase 2|106|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:48:37.156362|2017-10-10 23:48:37.156362
NCT02294669|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-05-08|||February 2015||2015-02-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||A Feasibility Study to Evaluate the TURRIS Facet Fusion System in Lumbar Spinal Surgery|A Feasibility Study to Evaluate the TURRIS Facet Fusion System as an Adjuvant to Unilateral Pedicle Screw Fixation in Lumbar Spinal Surgery|Recruiting||N/A|10|Anticipated|SpineWelding AG||1|||f||||||||||||||2017-10-10 23:48:38.591219|2017-10-10 23:48:38.591219
NCT02294656|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-04-24|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide|Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide|Recruiting||Phase 1|20|Anticipated|Soll Eye||2|||f||||f||||||||Yes|Yes, there a plan to make individual participant data (IPD) available.|2017-10-10 23:48:38.740257|2017-10-10 23:48:38.740257
NCT02066831|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-02-22|||February 2014||2014-02-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|DCS||Diabetes Coaching Study|Diabetes Coaching Study|Completed||N/A|202|Actual|West German Center of Diabetes and Health||2|||f||||f||||||||||2017-10-11 00:44:34.77218|2017-10-11 00:44:34.77218
NCT02294643|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-24|||April 2009||2009-04-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2012|Actual|2012-03-01||Interventional|SERENADE||Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study|A Multicenter Randomized Trial Evaluating the Efficacy of Sarpogrelate on Ischemic Heart Disease After Drug-eluting Stent Implantation in Patients With Diabetes Mellitus or Renal Impairment|Completed||Phase 3|220|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-10 23:48:38.883831|2017-10-10 23:48:38.883831
NCT02294630|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-08-09|||December 2014||2014-12-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|AS-02||Aerosolized Surfactant in Neonatal RDS|Aerosolized Survanta in Neonatal Respiratory Distress Syndrome: Phase I/II Study|Active, not recruiting||Phase 1/Phase 2|220|Anticipated|Sood, Beena G., MD, MS||2|||f||||t||||||||||2017-10-10 23:48:38.99631|2017-10-10 23:48:38.99631
NCT02294617|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-11-14|||August 2012||2012-08-01|November 2014|2014-11-01||||April 2014|Actual|2014-04-01||Interventional|||E-cigarette vs. Nicotine Inhaler Comparisons|Comparative Evaluation of the Perceptions and Utilization of Nicotine Inhalation Devices|Completed||N/A|41|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-10 23:48:39.103077|2017-10-10 23:48:39.103077
NCT02294604|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-01-31|2016-10-12||April 2015||2015-04-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Antiseptic Outcome of Traditional Hand Scrubbing Versus Hand Rubbing in Surgical Room|The Antiseptic Outcome of Traditional Hand Scrubbing Versus Hand Rubbing in Surgical Room|Completed||N/A|236|Actual|Taipei Medical University Shuang Ho Hospital||3|||f||||t||||||||No||2017-10-10 23:48:39.187867|2017-10-10 23:48:39.187867
NCT02294591|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-11-24|||November 2014||2014-11-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|NACOS||NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression|NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression - A Double Blind Randomized Placebo-controlled Trial With Follow up|Completed||Phase 2|80|Actual|Region Syddanmark||2|||f||||t||||||||||2017-10-10 23:48:39.956669|2017-10-10 23:48:39.956669
NCT02294578|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-05-23|||December 2014||2014-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Salivary Biomarkers for Non-small Cell Lung Cancer Detection|Prospective Blinded Evaluation of Salivary Transcriptome Biomarkers for Non-small Cell Lung Cancer Detection|Recruiting||N/A|166|Anticipated|PeriRx|||2||f||||f||||||Samples With DNA|"     Saliva samples   "|Undecided||2017-10-10 23:48:40.060451|2017-10-10 23:48:40.060451
NCT02294565|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-07-23|||June 2014||2014-06-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Interventional|||VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer|A Phase I/II Study of VST-1001 (Dilute Fluorescein) for Lymphatic Mapping and Localization of Lymph Nodes Draining a Primary Tumor Site in Patients With Clinically Node Negative Breast Cancer|Unknown status|Recruiting|Phase 1/Phase 2|147|Anticipated|Vestan, Inc.||1|||f||||f||||||||||2017-10-10 23:48:40.155435|2017-10-10 23:48:40.155435
NCT02294552|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-01-08|||October 2014||2014-10-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT|High-dose Post-transplantation Cyclophosphamide as Graft Versus-host Disease Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation|Active, not recruiting||Phase 2|200|Actual|St. Petersburg State Pavlov Medical University||3|||f||||f||||||||||2017-10-10 23:48:40.269714|2017-10-10 23:48:40.269714
NCT02294539|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-03-14|||August 2014||2014-08-01|March 2017|2017-03-01|May 18, 2016|Actual|2016-05-18|May 18, 2016|Actual|2016-05-18||Interventional|||Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients|Comparison of Effects Between Calcium Channel Blocker and Diuretics in Combination With Angiotensin II Receptor Blocker on 24-hr Central Blood Pressure and Vascular Hemodynamic Parameters in Hypertensive Patients Multicenter, Double-blind, Active-controlled, Phase 4 Randomized Trial|Completed||Phase 4|231|Actual|Kyung Hee University Hospital at Gangdong||4|||f||||f||||||||||2017-10-10 23:48:40.431599|2017-10-10 23:48:40.431599
NCT02294526|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-01-28|||November 2012||2012-11-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|PILCHARDUS||A Sardine Diet Intervention Study to Assess Benefits to the Metabolic Profile in Type 2 Diabetes Mellitus Patients|PILCHARDUS STUDY: A Sardine Diet Intervention Study to Assess Benefits to the Metabolic Profile in Type 2 Diabetes Mellitus Patients|Completed||N/A|35|Actual|Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders||2|||f||||t||||||||||2017-10-10 23:48:40.547849|2017-10-10 23:48:40.547849
NCT02294513|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-04-10|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|HIAD||Hearing Instruments in Alzheimer's Disease|Hearing Intervention for Patients With Early-Stage Alzheimer's Disease: Determining the Benefits for Patients and Family Caregivers|Completed||N/A|25|Actual|Phonak AG, Switzerland|||2||f||||||||||||||2017-10-10 23:48:40.689582|2017-10-10 23:48:40.689582
NCT02294500|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-04-25|||July 2011||2011-07-01|April 2016|2016-04-01|July 2021|Anticipated|2021-07-01|May 2016|Anticipated|2016-05-01|10 Years|Observational [Patient Registry]|||Cohort Study to Evaluate Ovarian Function|Multicenter Cohort Study to Evaluate and to Protect Ovarian Function and Reproductive Function|Recruiting||N/A|6000|Anticipated|Huazhong University of Science and Technology|||1||f||||t||||||Samples With DNA|"     Our biospecimen included blood, serum, plasma and other body fluid and tissues   "|||2017-10-10 23:48:40.86069|2017-10-10 23:48:40.86069
NCT02294487|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-01-23|||December 2014||2014-12-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Study of the Immune Response After Vaccination in Multiple Myeloma Patients|The Immune Response Following Vaccination in Multiple Myeloma Patients: A Prospective Pilot Study|Active, not recruiting||N/A|19|Actual|Aurora Health Care|||1||f||||f||||||||||2017-10-10 23:48:40.966379|2017-10-10 23:48:40.966379
NCT02294474|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-02-09||2017-02-09|January 2015||2015-01-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|SORELLA 2||Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine|Six-month, Randomized, Open-label, Parallel-group Comparison of the Insulin Analog SAR342434 to Humalog® in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine|Completed||Phase 3|505|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 23:48:41.068721|2017-10-10 23:48:41.068721
NCT02294448|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-11-15|||November 2014||2014-11-01|November 2014|2014-11-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||PopPK Profile of Qishe Pill: Study Protocol for a Phase I Clinical Trial|Population Pharmacokinetic Modeling of Qishe Pill in Three Major TCM-defined Constitutional Types of Healthy Chinese Subjects: Study Protocol for a Phase I Clinical Trial|Unknown status|Recruiting|Phase 1|36|Anticipated|Shanghai University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-10 23:48:42.844509|2017-10-10 23:48:42.844509
NCT02294435|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-04-11|||February 2015||2015-02-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms||Recruiting||N/A|25|Anticipated|Sanford Health||2|||f||||t||||||||||2017-10-10 23:48:43.016956|2017-10-10 23:48:43.016956
NCT02294422|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-02|2015-06-29|||April 2014||2014-04-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|LOR-ETCP||Balloon Palpation vs Loss of Resistance Syringe for Safe Endotracheal Tube Cuff Pressure; a Randomized Clinical Trial|Achieving Recommended Endotracheal Tube Cuff Pressure; A Randomized Control Trial Comparing Loss of Resistance Syringe to Pilot Balloon Palpation.|Completed||N/A|178|Actual|Makerere University||2|||f||||t||||||||||2017-10-10 23:48:43.114757|2017-10-10 23:48:43.114757
NCT02294409|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-05-05|||October 2014||2014-10-01|May 2017|2017-05-01||||March 2019|Anticipated|2019-03-01||Interventional|||Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis|Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis: A Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|McGill University||2|||f||||f||||||||||2017-10-10 23:48:43.206793|2017-10-10 23:48:43.206793
NCT02294396|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-31||2017-08-31|October 28, 2014|Actual|2014-10-28|August 2017|2017-08-01|September 7, 2016|Actual|2016-09-07|September 7, 2016|Actual|2016-09-07||Interventional|||Post-marketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.|Post-Marketing Study of Mirabegron - Long-term Add-on Therapy With Anticholinergics in Patients With Overactive Bladder Under Treatment With Mirabegron|Completed||Phase 4|649|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-10 23:48:43.322681|2017-10-10 23:48:43.322681
NCT02294383|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-10-03|||August 2014||2014-08-01|October 2016|2016-10-01||||January 2016|Actual|2016-01-01||Observational|||Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions|Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions|Completed||N/A|138|Actual|Artann Laboratories|||4||f||||f||||||||||2017-10-10 23:48:43.448237|2017-10-10 23:48:43.448237
NCT02294370|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-03-11|||December 2013||2013-12-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Variation of Glucose Values at Early Stages of Diabetes - Continuous Glucose Monitoring|Glucose Excursions at Early Stages of Diabetes, MOSAIC Prospective Study|Completed||N/A|62|Actual|Folkhälsan Researech Center|||1||f||||f||||||Samples With DNA|"     serum, plasma, urine   "|||2017-10-10 23:48:43.52129|2017-10-10 23:48:43.52129
NCT02294357|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-11-17|||December 2014||2014-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib|A Phase 2 Study of Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib|Recruiting||Phase 2|45|Anticipated|Oncotherapeutics||3|||f||||f||||||||||2017-10-10 23:48:43.613591|2017-10-10 23:48:43.613591
NCT02294344|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-05-14|||June 2014|Actual|2014-06-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Clinical Efficacy of DFPP in Patients With AAGN|A Prospective, Controlled Study of Double Filtration Plasmapheresis (DFPP) in Patients With Antineutrophil Cytoplasmic Autoantibody Associated Glomerulonephritis (AAGN)|Terminated||N/A|14|Actual|Nanjing University School of Medicine||2||The recruitment of subject is very difficult.|f||||t||||||||||2017-10-10 23:48:43.746126|2017-10-10 23:48:43.746126
NCT02294331|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-10-04|||August 2014|Actual|2014-08-01|October 2017|2017-10-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|||Attain Performa™ Left Ventricular (LV) Quadripolar Leads Chronic Performance Study|Attain Performa™ Left Ventricular Quadripolar Lead Post-Approval Study|Active, not recruiting||N/A|1916|Actual|Medtronic|||1||f||||f||||||||||2017-10-10 23:48:43.889277|2017-10-10 23:48:43.889277
NCT02294318|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-07-13|||June 2015||2015-06-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics|HealthCall: Brief Intervention to Reduce Drug Use in HIV Primary Care|Unknown status|Recruiting|N/A|50|Anticipated|Research Foundation for Mental Hygiene, Inc.||2|||f||||t||||||||||2017-10-10 23:48:44.19412|2017-10-10 23:48:44.19412
NCT02294292|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-08-17|||July 2014||2014-07-01|February 2016|2016-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its Impact on Morbidity and Mortality|Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its' Impact on Morbidity and Mortality|Completed||N/A|189|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:48:44.392552|2017-10-10 23:48:44.392552
NCT02294097|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-15|2014-11-15|||November 2014||2014-11-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation|The Outcomes of Protocol-Specified Modification of Immunosuppression Directed to Histological Diagnosis by Surveillance Protocol Biopsy|Unknown status|Recruiting|N/A|100|Anticipated|Chulalongkorn University||2|||f||||f||||||||||2017-10-10 23:48:46.006394|2017-10-10 23:48:46.006394
NCT02294279|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-04-24|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|NSRS||The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms|The Evaluation of FeNO for Predicting Response to an Inhaled Corticosteroid in Subjects With Non-specific Respiratory Symptoms|Completed||Phase 4|360|Actual|Research in Real-Life Ltd||2|||f||||f||||||||Undecided|Principal investigator has not made a decision regarding a plan to share data at this point in time.|2017-10-10 23:48:44.491444|2017-10-10 23:48:44.491444
NCT02294266|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-10-07|||December 2014||2014-12-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Mephedrone and Alcohol Interactions in Humans|Mephedrone and Alcohol Interactions After Single-dose Administration in Humans|Completed||Phase 1|12|Actual|Parc de Salut Mar||4|||f||||t||||||||||2017-10-10 23:48:44.579718|2017-10-10 23:48:44.579718
NCT02294253|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-04-17|||September 2014||2014-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone|Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone: An Outpatient Detoxification for Opioid Dependence.|Recruiting||Phase 2/Phase 3|50|Anticipated|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-10 23:48:44.678053|2017-10-10 23:48:44.678053
NCT02294240|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-01-07|||September 2014||2014-09-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Effect of Energy Dense Biscuits in Undernourished Women on Birth Weight of Their Neonates|Effect of Energy Dense Biscuits in Under Nourished Pregnant Women on Birth Weight of Their Newborns in a Low Income Peri-urban Setting of Karachi; a Community Based Randomized Interventional Study|Active, not recruiting||N/A|224|Anticipated|Aga Khan University||2|||f||||f||||||||||2017-10-10 23:48:44.763833|2017-10-10 23:48:44.763833
NCT02294227|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-06-02|||May 2015||2015-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FUTURE 4||16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis|A Phase III, Randomized, Double-blind, Placebo-controlled Multicenter Study of Subcutaneous Secukinumab (150 mg) in Pre-filled Syringe, With or Without Loading Regimen, to Demonstrate Efficacy, Safety and Tolerability up to 2 Years in Patients With Active Psoriatic Arthritis (FUTURE 4)|Active, not recruiting||Phase 3|341|Actual|Novartis||3|||f||||t||||||||||2017-10-10 23:48:44.87329|2017-10-10 23:48:44.87329
NCT02294214|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-10-05|||February 2016||2016-02-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SR-M-Tz||Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania|Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania|Withdrawn||N/A|0|Actual|University of Notre Dame||2||Sponsors|f||||t||||||||||2017-10-10 23:48:45.105299|2017-10-10 23:48:45.105299
NCT02294201|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-10-05|||June 2016||2016-06-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SR-M-KEN||Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya|Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya|Withdrawn||N/A|0|Actual|University of Notre Dame||2||Sponsors|f||||t||||||||||2017-10-10 23:48:45.28182|2017-10-10 23:48:45.28182
NCT02294188|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-10-05|||May 2015||2015-05-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|SR-M-IDR||Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia|Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia|Active, not recruiting||N/A|2000|Anticipated|University of Notre Dame||2|||f||||t||||||||||2017-10-10 23:48:45.361416|2017-10-10 23:48:45.361416
NCT02294175|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-03-27|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm From Chronic Lower Extremity or Diabetic Foot Ulcers|RCT: Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm From Chronic Lower Extremity or Diabetic Foot Ulcers|Recruiting||N/A|296|Anticipated|North Florida Foundation for Research and Education||2|||f||||f||||||||||2017-10-10 23:48:45.44981|2017-10-10 23:48:45.44981
NCT02294162|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-11-14|||April 2015||2015-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect?|Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect?|Recruiting||N/A|50|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||f||||||||||2017-10-10 23:48:45.56064|2017-10-10 23:48:45.56064
NCT02294149|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2015-04-06|||January 2015||2015-01-01|April 2015|2015-04-01|November 2016|Anticipated|2016-11-01|April 2015|Actual|2015-04-01||Interventional|||Vit D3 and Omega 3 in Chemo Induced Neuropathy|A Randomized Controlled Trial of Mammalian Omega 3 With Vitamin D3 in Patients at Risk of Chemotherapy Induced Peripheral Neuropathy.|Unknown status|Recruiting|Phase 3|600|Anticipated|McGill University Health Center||2|||f||||||||||||||2017-10-10 23:48:45.654088|2017-10-10 23:48:45.654088
NCT02294136|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2017-05-01|||December 2013||2013-12-01|May 2017|2017-05-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|||Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection|Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection|Completed||N/A|85|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:48:45.737887|2017-10-10 23:48:45.737887
NCT02294123|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-03-14|||September 2013||2013-09-01|September 2015|2015-09-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|IGIT||Glycemic Index and Insulinemic Index of 3 Types of Tortilla in Mexican Adults|Glycemic Index and Insulinemic Index of 3 Types of Tortilla in Mexican Adults With Overweight or Diabetes or Clinically Healthy|Completed||N/A|81|Actual|Mexican National Institute of Public Health||3|||f||||t||||||||||2017-10-10 23:48:45.829957|2017-10-10 23:48:45.829957
NCT02294110|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2015-08-04|||November 2014||2014-11-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Effect of Diabetes Mellitus on Success of Spinal Anesthesia|Phase IV Study of Diabetes Mellitus for Spinal Anesthesia Failure|Completed||N/A|1000|Actual|Diskapi Yildirim Beyazit Education and Research Hospital|||1||f||||f||||||||||2017-10-10 23:48:45.932965|2017-10-10 23:48:45.932965
NCT02294084|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2016-03-24|||March 2014||2014-03-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|Sita01||Sitagliptin and Brown Adipose Tissue|The Effect of Sitagliptin on Brown Adipose Tissue and Whole-body Metabolism in Overweight Pre-diabetic Men|Recruiting||Phase 4|30|Anticipated|Leiden University Medical Center||2|||f||||t||||||||||2017-10-10 23:48:46.098414|2017-10-10 23:48:46.098414
NCT02294071|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-17|2014-11-17|||December 2014||2014-12-01|November 2014|2014-11-01||||November 2015|Anticipated|2015-11-01||Interventional|||Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children|Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Lawson Health Research Institute||3|||f||||||||||||||2017-10-10 23:48:46.200324|2017-10-10 23:48:46.200324
NCT02294058|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-05-04|||December 3, 2014|Actual|2014-12-03|May 2017|2017-05-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Interventional|||Phase 3 Study of RPC1063 in Relapsing MS|A Phase 3, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of RPC1063 Administered Orally To Relapsing Multiple Sclerosis Patients|Completed||Phase 3|1346|Actual|Celgene||3|||f||||t||||||||||2017-10-10 23:48:46.35205|2017-10-10 23:48:46.35205
NCT02294045|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-09-18|||January 2017||2017-01-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|Joint||Analysis of Joint Sounds in the Diagnosis of Knee Disorders|Analysis of Joint Sounds in the Diagnosis of Knee Disorders|Withdrawn||N/A|0|Actual|Loma Linda University|||1|Unable to get the correct software.|f||||t||||||||||2017-10-10 23:48:46.866689|2017-10-10 23:48:46.866689
NCT02294032|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-11-03|||June 2014||2014-06-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||The Role of B Cells in Kidney Allograft Dysfunction|The Role of B Cells in Kidney Allograft Dysfunction|Recruiting||N/A|180|Anticipated|Loma Linda University|||1||f||||t||||||Samples With DNA|"     Whole blood, and plasma or serum   "|No||2017-10-10 23:48:46.933688|2017-10-10 23:48:46.933688
NCT02294019|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-04-22|2016-04-22||November 2014||2014-11-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||All participants who purchased at least 1 carton of study medication.|Actual Use Trial of Ibuprofen 400 mg|A Multicenter Actual Use And Compliance Study Of Ibuprofen 400 Mg In A Simulated Over-the-counter Environment|Completed||Phase 3|738|Actual|Pfizer||1|||f||||f||||||||||2017-10-10 23:48:47.053394|2017-10-10 23:48:47.053394
NCT02294006|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-11-18|||June 2014||2014-06-01|November 2014|2014-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MetNET1||Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs|Activity and Safety of Everolimus in Combination With Octreotide LAR and Metformin in Patients With Advanced Pancreatic Well-differentiated Neuroendocrine Tumors (pWDNETs): a Phase II, Open, Monocentric, Prospective Study|Unknown status|Recruiting|Phase 2|43|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-10 23:48:47.36127|2017-10-10 23:48:47.36127
NCT02293993|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-02|||October 2014||2014-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia|Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia|Active, not recruiting||Phase 1|21|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-10 23:48:47.46714|2017-10-10 23:48:47.46714
NCT02293980|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-23|||November 2014||2014-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma|A Phase 1, Multiple-Dose, Dose-Escalation Trial of PT2385 Tablets, a HIF-2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma|Active, not recruiting||Phase 1|107|Anticipated|Peloton Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 23:48:47.557525|2017-10-10 23:48:47.557525
NCT02293967|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-03-13|||September 2014||2014-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Mass Balance Study of MT-1303|An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C] MT-1303 After a Single Oral Dose to Healthy Male Subjects.|Completed||Phase 1|8|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||||||||||||2017-10-10 23:48:47.698923|2017-10-10 23:48:47.698923
NCT02293954|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-09-08|||June 8, 2015|Actual|2015-06-08|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer|Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)|Recruiting||N/A|20|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:48:47.785438|2017-10-10 23:48:47.785438
NCT02293941|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-02-03|||May 2014||2014-05-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|May 2017|Anticipated|2017-05-01||Interventional|JKB122||Liver Test Study of Using JKB-122 in HCV-Positive Patients|A Phase 2, Randomized, Multiple-dose, Double-blind, Placebo-controlled Study of JKB-122 to Assess Liver Tests (ALT and AST) in HCV-positive Subjects Who Have Been Nonresponsive to Prior Interferon Based Therapies (Pegylated or Standard) Either Alone or in Combination With Ribavirin|Active, not recruiting||Phase 2|148|Anticipated|TaiwanJ Pharmaceuticals Co., Ltd||4|||f||||t||||||||||2017-10-10 23:48:47.913445|2017-10-10 23:48:47.913445
NCT02293928|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-13|||October 2010||2010-10-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy|Impact of Hybrid Coronary Revascularization on Antiplatelet Effect of Aspirin and Clopidogrel|Completed||N/A|40|Actual|Aarhus University Hospital Skejby|||1||f||||f||||||Samples Without DNA|"     4 ml serum and 4 ml sodium citrate plasma   "|||2017-10-10 23:48:48.008526|2017-10-10 23:48:48.008526
NCT02293915|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-08-08|||April 2014||2014-04-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease|Phase III Study of Sodium Oligo-mannurarate (GV-971) Capsule on Mild to Moderate Alzheimer Disease|Recruiting||Phase 3|788|Anticipated|Shanghai Greenvalley Pharmaceutical Co., Ltd.||2|||f||||f||||||||No||2017-10-10 23:48:48.093923|2017-10-10 23:48:48.093923
NCT02293902|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-12-05|||November 2014||2014-11-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)|A Randomized, Double-blind, Multicenter Study With a Placebo-controlled Period Assessing the Efficacy and Safety of Sarilumab Added to Methotrexate (MTX) in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy|Completed||Phase 3|243|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 23:48:48.321171|2017-10-10 23:48:48.321171
NCT02293889|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-08-03|||March 2015||2015-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Impact of Physical Activity and Vitamin D on Osteoarthritic Knee Pain|The Impact of Physical Activity and Vitamin D on Osteoarthritic Knee Pain in Older Obese People|Completed||N/A|45|Actual|Newcastle University||4|||f||||f||||||||||2017-10-10 23:48:48.636944|2017-10-10 23:48:48.636944
NCT02293876|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2014-11-18|||April 2013||2013-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|CORNEALPREV||Corneal Lesions in Intensive Care Unit (ICU) Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center|Risk for Corneal Injury in Critically Ill Patients and Effect of Nursing Interventions for Its Prevention: Randomized Controlled Trial|Completed||N/A|360|Actual|Hospital Risoleta Tolentino Neves||4|||f||||t||||||||||2017-10-10 23:48:48.769475|2017-10-10 23:48:48.769475
NCT02293863|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-09-08|||January 14, 2015|Actual|2015-01-14|September 2017|2017-09-01|May 23, 2017|Actual|2017-05-23|May 23, 2017|Actual|2017-05-23||Interventional|||A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection||Completed||Phase 2|168|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-10 23:48:48.913643|2017-10-10 23:48:48.913643
NCT02293850|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-08-25|||October 2014||2014-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I/II Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma|A Phase I/II Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma|Recruiting||Phase 1/Phase 2|33|Anticipated|Oncolys BioPharma Inc||2|||f||||t||||||||||2017-10-10 23:48:49.393295|2017-10-10 23:48:49.393295
NCT02293837|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-08-30|||January 2015||2015-01-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|EXTEND||Tocilizumab (TCZ) in New-onset Type 1 Diabetes|Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)|Recruiting||Phase 2|133|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:48:49.490007|2017-10-10 23:48:49.490007
NCT02293824|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-09-11|||December 2014||2014-12-01|June 2017|2017-06-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||Effect of Feedings on Caffeine in Premature Infants|Effect of Feedings on Caffeine Pharmacokinetics and Metabolism in Premature Infants|Completed||N/A|50|Anticipated|Duke University|||1||f||||f||||||||||2017-10-10 23:48:49.678201|2017-10-10 23:48:49.678201
NCT02293811|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2014-11-14|||December 2014||2014-12-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|P2RX7||Decoding of the Expression of Tumor Suppressor P2RX7 in Inflammatory and Malignant Colonic Mucosa|Decoding of the Expression of Tumor Suppressor P2RX7 in Inflammatory and Malignant Colonic Mucosa|Unknown status|Not yet recruiting|N/A|180|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 23:48:49.771007|2017-10-10 23:48:49.771007
NCT02293798|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-09-12|||August 2014||2014-08-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Circumferential Periareolar Mastopexy Using SERI Surgical Scaffold|Circumferential Periareolar Mastopexy Using SERI Surgical Scaffold|Completed||N/A|14|Actual|Mofid, Mehrdad Mark, M.D.||1|||f||||f||||||||||2017-10-10 23:48:49.846897|2017-10-10 23:48:49.846897
NCT02293785|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-03-18|||November 2014||2014-11-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||GREAT - Good Response With Appropriate Treatment|"GREAT (Good Response With Appropriate Treatment) Factors Influencing the Analgesic Response Over Time of the Oxycodone-Naloxone Association in Painful Cancer Patients"|Completed||N/A|200|Actual|Mario Negri Institute for Pharmacological Research|||1||f||||f||||||||||2017-10-10 23:48:49.918079|2017-10-10 23:48:49.918079
NCT02293772|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-09-15|||March 2012||2012-03-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|November 2013|Actual|2013-11-01||Interventional|PlanHab||Planetary Habitat Simulation: Nutrition Studies|Planetary Habitat Simulation: An Investigation Into the Effects of Hypoxia and / or Bedrest on Fuel Metabolism and Appetite (WP5)|Completed||N/A|14|Actual|University of Nottingham||3|||f||||t||||||||No||2017-10-10 23:48:50.026419|2017-10-10 23:48:50.026419
NCT02293759|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-03-27|||October 2014||2014-10-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency|Prospective Non-randomized Trial Comparing Holmium Laser Enucleation of the Prostate Versus Greenlight Laser Photoselective Vaporization of the Prostate in Treating Benign Prostate Hyperplasia in Patients With Bleeding Tendency|Recruiting||Phase 4|60|Anticipated|Mansoura University||2|||f||||f||||||||||2017-10-10 23:48:50.13956|2017-10-10 23:48:50.13956
NCT02293746|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-03-06|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|January 9, 2017|Actual|2017-01-09|December 11, 2016|Actual|2016-12-11||Interventional|||Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study|Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study: CE Certificate Number 562872|Completed||Phase 4|60|Actual|Inspire Medical Systems, Inc.||1|||f||||f||||||||Yes||2017-10-10 23:48:50.220994|2017-10-10 23:48:50.220994
NCT02293733|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-11-17|||January 2014||2014-01-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|EGFR-RETRO||Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)|Retrospective Multicenter Observational Study in NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutation Treated First Line by Tyrosine Kinase Inhibitor (TKI)|Completed||N/A|144|Actual|Groupe Francais De Pneumo-Cancerologie|||1||f||||t||||||||||2017-10-10 23:48:50.308829|2017-10-10 23:48:50.308829
NCT02293720|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-09-13|||April 2015||2015-04-01|November 2014|2014-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|OLE||An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System|An Open-Label Extension to Protocol 09-1, Multi-Center, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects|Withdrawn||N/A|0|Actual|GI Dynamics||1||This was the cross over study for 09-1 which was terminated early|f||||t||||||||No||2017-10-10 23:48:50.453408|2017-10-10 23:48:50.453408
NCT02293525|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-01-20||||||January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain|Investigational Plan for the Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain|Withdrawn||N/A|0|Actual|Vital 5, LLC||2||No subjects were enrolled and the sponsor suspended support at this time|f||||f||||||||||2017-10-10 23:48:53.758386|2017-10-10 23:48:53.758386
NCT02293707|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-31|||November 2014||2014-11-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer|A Randomised, Parallel-group, Open-label Phase II Trial of the Immunological Effects of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer Patients Who Have Achieved Response or Disease Stability With First-line Chemotherapy|Recruiting||Phase 2|120|Anticipated|Laboratoires Leurquin Mediolanum||3|||f||||f||||||||||2017-10-10 23:48:50.515026|2017-10-10 23:48:50.515026
NCT02293694|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-09-15|||September 17, 2015|Actual|2015-09-17|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|January 27, 2017|Actual|2017-01-27||Interventional|||Sayana® Press Self-injection Study in Malawi|A 12-month Open-label Randomized Controlled Trial to Evaluate Sayana® Press Suitability for at Home Subcutaneous Self-injection Procedures in Adult Women|Completed||N/A|735|Actual|FHI 360||2|||f||||f||||||||||2017-10-10 23:48:50.647457|2017-10-10 23:48:50.647457
NCT02293681|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-09-01|||April 10, 2015|Actual|2015-04-10|September 2017|2017-09-01|January 15, 2018|Anticipated|2018-01-15|December 31, 2017|Anticipated|2017-12-31|52 Weeks|Observational [Patient Registry]|RECOVERY||An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement|A Multicenter and Observational Study to Assess the Effectiveness of Infliximab Comparing With Conventional Therapy in Ankylosing Spondylitis Subjects With Hip Involvement|Active, not recruiting||N/A|220|Anticipated|Janssen Research & Development, LLC|||2||f||||f||f||||Samples Without DNA|"     Blood samples will be retained for the assessment of laboratory parameters: CRP = C-reactive     protein; ESR = erythrocyte sedimentation rate.   "|||2017-10-10 23:48:50.716504|2017-10-10 23:48:50.716504
NCT02293668|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-01-07|||November 2014||2014-11-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients||Completed||N/A|95|Actual|Istanbul University||3|||f||||f||||||||||2017-10-10 23:48:50.80914|2017-10-10 23:48:50.80914
NCT02293655|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-04-17|||January 2015||2015-01-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|TEAM||The Effects of ADHD Medication (TEAM) Study|The Effects of ADHD Medication (TEAM) Study: Neurobehavioral Effects of Abrupt Methylphenidate Discontinuation|Recruiting||Phase 4|180|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 23:48:50.883222|2017-10-10 23:48:50.883222
NCT02293642|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2017-08-18|||December 2014||2014-12-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|ARIE||Bone Pain Score Validation Initiative|Prospective Epidemiology Study to Validate the BOMET-QoL-10 in Patients With Bone Metastasis in Germany|Completed||N/A|370|Actual|iOMEDICO AG|||1||f||||f||||||||||2017-10-10 23:48:50.982448|2017-10-10 23:48:50.982448
NCT02293629|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2015-05-18|||October 2014||2014-10-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects|A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects|Completed||Phase 1|8|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-10-10 23:48:52.712405|2017-10-10 23:48:52.712405
NCT02293616|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-08-11|||June 2015||2015-06-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Strength Testing After Nitrate Delivery (STAND) in ICU Patients|Strength Testing After Nitrate Delivery (STAND) in ICU Patients|Active, not recruiting||N/A|20|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-10 23:48:52.801337|2017-10-10 23:48:52.801337
NCT02293603|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-06-17|||November 2014||2014-11-01|June 2016|2016-06-01|April 2020|Anticipated|2020-04-01|May 2015|Actual|2015-05-01||Interventional|DYNAMIC||Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)|A Randomized, Double-blind, Placebo-controlled, Phase I Study of the Safety of Multi-vessel Intra-coronary Delivery of Allogeneic Human Cardiosphere-Derived Stem Cells in Patients With Dilated Cardiomyopathy (DCM)|Active, not recruiting||Phase 1|42|Anticipated|Capricor Inc.||2|||f||||t||||||||||2017-10-10 23:48:52.88437|2017-10-10 23:48:52.88437
NCT02293590|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-08-11|||November 2013||2013-11-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|RICE||RICE: Remission by Intra-articular Injection Plus CErtolizumab|An Open Label, Randomised Study to Compare the Efficacy of Certolizumab Pegol (CZP) Plus a Dynamic or Fixed Dose Treatment Strategy in Patients With Rheumatoid Arthritis, a Phase II Study|Recruiting||Phase 2|48|Anticipated|Cantonal Hospital of St. Gallen||2|||f||||f||||||||||2017-10-10 23:48:52.974583|2017-10-10 23:48:52.974583
NCT02293577|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-01-04|||November 2014||2014-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Continuous Glucose Monitoring in Youth With Type 2 Diabetes|Continuous Glucose Monitoring in Youth With Type 2 Diabetes|Completed||N/A|15|Actual|Yale University|||1||f||||f||||||||||2017-10-10 23:48:53.072663|2017-10-10 23:48:53.072663
NCT02293564|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-02-17|||March 2013||2013-03-01|February 2015|2015-02-01||||January 2015|Actual|2015-01-01||Interventional|||Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand|An Open-label Safety Extension Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand|Completed||N/A|312|Actual|XOMA (US) LLC||1|||f||||f||||||||||2017-10-10 23:48:53.144271|2017-10-10 23:48:53.144271
NCT02293551|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2015-09-08|||December 2014||2014-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of Lispro Formulations in Healthy Participants|Safety, Tolerability, and Pharmacokinetics of Multiple Novel Insulin Lispro Formulations|Completed||Phase 1|54|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-10 23:48:53.258332|2017-10-10 23:48:53.258332
NCT02293538|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-14|2016-10-04|2016-06-28||November 2014||2014-11-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||All participants exposed to any test or control article evaluated in this study (Safety Analysis Set). Note: Two participants inadvertently received investigational product without being randomized, so are included in the safety analysis set only.|Formula Identification (FID) 114657 in Contact Lens Wearers|Evaluation of a Lubricant Eye Drop on Tear Lipid Layer Thickness in Contact Lens Wearers|Completed||N/A|234|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:48:53.34565|2017-10-10 23:48:53.34565
NCT02055521|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-07-17|||October 2013||2013-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|BIOCTA||Search Tolerance Signature in Vascularised Composite Allograft|Search Tolerance Signature in Vascularised Composite Allograft|Completed||N/A|18|Actual|Hospices Civils de Lyon|||||f||||f||||||||||2017-10-11 00:47:28.905127|2017-10-11 00:47:28.905127
NCT02293499|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-11-16|||November 2014||2014-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|May 2018|Anticipated|2018-05-01||Interventional|PLASMA||Peer Led Asthma Self Management for Adolescents: PLASMA|Peer Led Asthma Self Management for Adolescents: PLASMA|Recruiting||Phase 2/Phase 3|420|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-10 23:48:53.974018|2017-10-10 23:48:53.974018
NCT02293486|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-13|||August 2012||2012-08-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Study of Pomegranate Juice in the Modulation of Oxidative Stress Markers in Endurance-based Athletes||Completed||Early Phase 1|20|Actual|Universidad Miguel Hernandez de Elche||3|||f||||t||||||||||2017-10-10 23:48:54.096976|2017-10-10 23:48:54.096976
NCT02293473|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-10-25|||March 2015||2015-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|SOMM||Surgical Outcome and Multimodal Monitoring - SOMM|The Impact of Multimodal Monitoring During Major Surgery on the Morbidity, Mortality and Duration of Hospital Stay in UMC Ljubljana|Suspended||N/A|126|Anticipated|University Medical Centre Ljubljana||2||Funding attempts failed.|f||||f||||||||||2017-10-10 23:48:54.18023|2017-10-10 23:48:54.18023
NCT02293460|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-09-12|||May 2015||2015-05-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PRISM||Efficacy and Safety Study of I10E in Treatment of Patients With CIDP|An International, Multicentre, Efficacy and Safety Study of I10E in Initial and Maintenance Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.|Recruiting||Phase 3|42|Anticipated|Laboratoire français de Fractionnement et de Biotechnologies||1|||f||||f||||||||||2017-10-10 23:48:54.277166|2017-10-10 23:48:54.277166
NCT02293447|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-05-10|||November 2014||2014-11-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization|Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization : a Single-center Prospective Randomized Study|Completed||Phase 4|60|Actual|University Health Network, Toronto||3|||f||||f||||||||||2017-10-10 23:48:54.458636|2017-10-10 23:48:54.458636
NCT02293434|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-11-19|||February 2014||2014-02-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|NUTRI-REAPED||Nutritional Status on Admission to Pediatric Intensive Care|Nutritional Status on Admission to Pediatric Intensive Care: A French Multicentric Study|Completed||N/A|600|Actual|University Hospital, Montpellier|||1||f||||t||||||||||2017-10-10 23:48:54.56457|2017-10-10 23:48:54.56457
NCT02293421|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-10-11|||November 2014||2014-11-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluation of the STOP-BANG Screening Questionnaire in a Sleep Clinic|Evaluation of the STOP-BANG Screening Questionnaire in a Sleep Clinic|Active, not recruiting||N/A|449|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-10-10 23:48:54.63786|2017-10-10 23:48:54.63786
NCT02293408|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-07-12|||September 2014||2014-09-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Natural History Study to Characterise the Course of Disease Progression in Patients With Mucopolysaccharidosis Type IIIB|A Prospective Cross-Sectional and Longitudinal Study With Additional Retrospective Chart Review to Evaluate Clinical and Biochemical Characteristics and Disease Progression in Patients With Mucopolysaccharidosis Type IIIB|Active, not recruiting||N/A|30|Anticipated|Alexion Pharmaceuticals|||2||f||||f||||||Samples With DNA|"     Clinical laboratory tests, including heparan sulfate and exploratory disease biomarkers from     serum and urine.   "|||2017-10-10 23:48:54.706897|2017-10-10 23:48:54.706897
NCT02293382|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-02-02|||July 2013||2013-07-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB|A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB|Completed||N/A|30|Actual|Alexion Pharmaceuticals|||1||f||||f||||||||||2017-10-10 23:48:55.537005|2017-10-10 23:48:55.537005
NCT02293369|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-01-07|||November 2014||2014-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Comparison of Two Methods of Vaginal Cuff Closure at Laparoscopic Hysterectomy|Comparison of Two Methods of Vaginal Cuff Closure at Laparoscopic Hysterectomy and Their Effect on Female Sexual Function and Vaginal Length|Completed||N/A|58|Actual|Istanbul University||2|||f||||f||||||||||2017-10-10 23:48:55.614714|2017-10-10 23:48:55.614714
NCT02293356|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-08-18|||August 2015||2015-08-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma|Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma|Recruiting||Phase 4|2000|Anticipated|Biotech Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:48:55.696884|2017-10-10 23:48:55.696884
NCT02293343|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-05-10|||October 2014||2014-10-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||24 Hrs Histamine Profile in Healthy Persons and Patients With Food Intolerance|24 Hrs Histamine Profile in Healthy Persons and Patients With Food Intolerance: Correlations Between Subjective Affliction and Measured Histamine Parameter|Completed||N/A|65|Actual|University of Erlangen-Nürnberg Medical School|||3||f||||f||||||||||2017-10-10 23:48:55.780385|2017-10-10 23:48:55.780385
NCT02293330|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-11-22|||November 2014||2014-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Continuous Versus Automated Bolus Infusion in Sciatic Nerve Catheters|Continuous Infusion Versus Automated Intermittent Bolus of Levobupivacaine 0,1% in Ultrasound Guided Subparaneural Sciatic Nerve Catheters. A Prospective Double Blind Randomised Study.|Completed||Phase 4|71|Actual|University Hospital, Antwerp||2|||f||||f||||||||||2017-10-10 23:48:55.86633|2017-10-10 23:48:55.86633
NCT02293317|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2016-02-21|||November 2014||2014-11-01|November 2014|2014-11-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|BVX006||Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV|A Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety and Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by a Seasonal Trivalent Influenza Vaccine (TIV)|Completed||Phase 2|37|Actual|BiondVax Pharmaceuticals ltd.||3|||f||||f||||||||||2017-10-10 23:48:55.960854|2017-10-10 23:48:55.960854
NCT02293291|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-06-22|||September 2014||2014-09-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|February 2016|Anticipated|2016-02-01||Interventional|TCTGWI||Thermal Clinic Treatment in Gulf War Illness|Thermal Clinic Treatment in Gulf War Illness|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|American Society Of Thermalism And Climatology Inc||2|||f||||t||||||||||2017-10-10 23:48:56.149814|2017-10-10 23:48:56.149814
NCT02293278|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-11-13|||February 2011||2011-02-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Preschoolers Activity Trial|Preschoolers Activity Trial - a Pilot Randomized Controlled to Increase Physical Activity and Reduce Sedentary Behaviour|Completed||N/A|83|Actual|Healthy Active Living and Obesity Research Group||2|||f||||f||||||||||2017-10-10 23:48:56.263092|2017-10-10 23:48:56.263092
NCT02293252|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-10-24|||March 2009||2009-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|||CardioBBEAT - Randomized Controled Trial to Evaluate the Health Economic Impact of Remote Patient Monitoring|Gesundheitsökonomische Methodenentwicklung am Beispiel Der Evaluation Einer Technologiebasierten, sektorübergreifenden Intervention Zur Versorgung Chronisch Kranker Patienten|Completed||N/A|621|Actual|University of Bayreuth||2|||f||||t||||||||||2017-10-10 23:48:56.7481|2017-10-10 23:48:56.7481
NCT02293239|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-05-10|||August 2013|Actual|2013-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of WB-EMS and Dietetic Treatment on Cancer Patients|Effects of Whole-Body Electromyostimulation (WB-EMS) Combined With Individualized Nutritional Support on Patients With Malignant Disease Undergoing Curative or Palliative Anti-cancer Treatment|Recruiting||N/A|300|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-10 23:48:56.845285|2017-10-10 23:48:56.845285
NCT02293226|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-17|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|VIDEO||Video-laryngoscopy During Chest Compression|Comparison of Four Video-laryngoscopes During Pediatric Intubation During Simulated Resuscitation|Unknown status|Not yet recruiting|N/A|150|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:48:56.972015|2017-10-10 23:48:56.972015
NCT02293213|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-20|||September 2013||2013-09-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT|Utilizing Electronic Medical Record Referrals for Teratogen and Contraceptive Counseling for Women Taking Category D or X Medications: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|120|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:48:57.869282|2017-10-10 23:48:57.869282
NCT02293200|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-17|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||CPR Feedback Devices|TWO METHODS OF TRAINING TO IMPROVE CHEST COMPRESSION EFFECITVENESS BY MEDICAL STUDENTS AND BYSTANDERS: A Randomized Trial|Unknown status|Recruiting|N/A|200|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:48:58.000593|2017-10-10 23:48:58.000593
NCT02293187|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-04-20|||January 2015||2015-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Impact of Vitamin D on 25-hydroxyvitamin D Levels and Physical Function|The Impact of Supplemental Vitamin D on Serum 25-hydroxyvitamin D Levels and Short Term Indicators of Physical Function|Recruiting||N/A|100|Anticipated|Tufts University||2|||f||||f||||||||No||2017-10-10 23:48:58.098132|2017-10-10 23:48:58.098132
NCT02293174|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-11-01|||September 2014||2014-09-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||Retinal Fundus Camera Evaluation|TRC-NW400 Retinal Fundus Camera Image Evaluation and Instrument Comparison Protocol|Completed||N/A|10|Actual|Topcon Medical Systems, Inc.|||1||f||||f||||||||||2017-10-10 23:48:58.205471|2017-10-10 23:48:58.205471
NCT02293161|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-05-05|||November 11, 2014|Actual|2014-11-11|May 2017|2017-05-01|September 1, 2015|Actual|2015-09-01|September 1, 2015|Actual|2015-09-01||Interventional|||Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers|A Randomised, Double-Blind (Sponsor Unblind), Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Single Ascending Doses of a Fully Humanized Anti-IL-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers|Completed||Phase 1|18|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-10 23:48:58.295276|2017-10-10 23:48:58.295276
NCT02292602|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2017-05-08|||February 2014||2014-02-01|May 2017|2017-05-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Developing a Preschool Obesity Intervention for Families Enrolled in WIC|Developing a Preschool Obesity Intervention for Families Enrolled in WIC|Completed||N/A|19|Actual|Wayne State University||2|||f||||f||||||||||2017-10-10 23:49:04.210646|2017-10-10 23:49:04.210646
NCT02293148|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-05-05|||November 17, 2014|Actual|2014-11-17|May 2017|2017-05-01|March 10, 2015|Actual|2015-03-10|March 10, 2015|Actual|2015-03-10||Interventional|||Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers|A Two-part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a High, Single Oral Dose of GSK1278863 (Part A), and a Randomized, Single-blind, Placebo- and Positive-controlled, Four-way Crossover Study to Assess the Effect of Single, Oral Dose of GSK1278863 on Cardiac Repolarization (Part B) in Healthy Volunteers|Completed||Phase 1|61|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:48:58.457261|2017-10-10 23:48:58.457261
NCT02293135|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-05-21|||November 2014||2014-11-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|Diabete_1||Evaluation of Stendo Pulsating Suit on Microcirculation and Endothelial Function in Diabetic Patients|Evaluation of the Action of the Stendo Pulsating Suit on Peripheral Microcirculation and on Endothelial Function in Diabetic Patients Without Complication|Unknown status|Recruiting|N/A|16|Anticipated|Stendo||2|||f||||t||||||||||2017-10-10 23:48:58.625875|2017-10-10 23:48:58.625875
NCT02293122|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2015-07-14|||November 2014||2014-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||To Investigate Agreement Between the EM-3000 and the Predicate Device Noncon Robo Pachy (F&A) (CellChek XL)|To Investigate Agreement Between the EM-3000 and the Predicate Device NonCon Robo Pachy (F&A) (CellChek XL).|Completed||N/A|75|Actual|Tomey Corporation|||1||f||||f||||||||||2017-10-10 23:48:58.738804|2017-10-10 23:48:58.738804
NCT02293109|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-07-05|||December 2015||2015-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma|Phase I Study of Escalating Doses of Carfilzomib With Hyper-CVAD in Patients With Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma|Recruiting||Phase 1|21|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-10 23:48:58.827862|2017-10-10 23:48:58.827862
NCT02293096|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-03-23|||September 2014||2014-09-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01||Interventional|||Pharmacogenetic Prediction of Metoprolol Effectiveness|Pharmacogenetic Prediction of Metoprolol Effectiveness|Recruiting||N/A|500|Anticipated|University of Colorado, Denver||4|||f||||t||||||||||2017-10-10 23:48:59.028764|2017-10-10 23:48:59.028764
NCT02293083|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-13|||April 2010||2010-04-01|November 2014|2014-11-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome|Effect of Hyaluronidase Addition to Lidocaine for Trigger Point Injection in Myofascial Pain Syndrome|Completed||N/A|61|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 23:48:59.158097|2017-10-10 23:48:59.158097
NCT02293070|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-02-28|||December 2013||2013-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|OMM||One More Magnetic Resonance Imaging|One More Magnetic Resonance Imaging|Completed||N/A|32|Actual|Saint Luke's Health System||1|||f||||f||||||||||2017-10-10 23:48:59.239253|2017-10-10 23:48:59.239253
NCT02293057|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-06-30|||September 2014||2014-09-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Interventional|||Gender-Responsive Drug Use Treatment for Juvenile Justice Girls|Gender-Responsive Drug Use Treatment for Juvenile Justice Girls|Recruiting||N/A|212|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:48:59.324197|2017-10-10 23:48:59.324197
NCT02293044|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-10-02|||November 2014||2014-11-01|October 2017|2017-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Evaluate the Safety and Efficacy of an Oxalate Strip on Adjacent Teeth With Dentinal Hypersensitivity|A Pilot Clinical Study to Evaluate the Safety and Efficacy of a Self-Applied Oxalate Strip on Adjacent Teeth With Dentinal Hypersensitivity|Completed||N/A|15|Actual|Procter and Gamble||1|||f||||||||||||||2017-10-10 23:48:59.447497|2017-10-10 23:48:59.447497
NCT02293031|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-03-05|||November 2014||2014-11-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery|"Clinical Trial of Safety and Efficacy of the Medical Item Collagen Plates With Hydroxyapol Inducing Angiogenesis, Nukleostim, for Bone Tissue Regeneration"|Enrolling by invitation||N/A|12|Anticipated|NextGen Company Limited||1|||f||||f||||||||||2017-10-10 23:48:59.522996|2017-10-10 23:48:59.522996
NCT02293018|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-04-16|||August 2014||2014-08-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pharmacokinetic Study of MTC896 Gel in Subjects With Acne|A Randomized, Single-Blind, Phase 2 Study to Determine the Safety, Tolerability, and Systemic Exposure of 3 Dose Regimens of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris|Completed||Phase 1/Phase 2|32|Actual|Mimetica Pty Limited||3|||f||||t||||||||||2017-10-10 23:48:59.621845|2017-10-10 23:48:59.621845
NCT02293005|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-02-15|||May 20, 2015|Actual|2015-05-20|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma|Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma|Active, not recruiting||Phase 2|28|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:48:59.699326|2017-10-10 23:48:59.699326
NCT02292992|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-12-11|||December 2014||2014-12-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Lung Volume Change Between Noninvasive Positive Pressure Ventilation by Nasal Pillow and High Flow Nasal Cannula|The Difference of Lung Volume Change Detected by Electrical Impedance Tomography (EIT) Between Noninvasive Positive-pressure Ventilation (NIPPV) Support by Nasal Pillow and High Flow Nasal Cannula in Post-extubation Patients|Unknown status|Recruiting|N/A|40|Anticipated|Mackay Memorial Hospital||1|||f||||t||||||||||2017-10-10 23:48:59.776469|2017-10-10 23:48:59.776469
NCT02292979|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-03-08|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|August 2022|Anticipated|2022-08-01|December 2016|Actual|2016-12-01||Interventional|BREACH||Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma.|Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Stage I/II Unfavourable Hodgkin Lymphoma. A Randomized Phase II LYSA-FIL-EORTC Intergroup Study|Active, not recruiting||Phase 2|170|Actual|The Lymphoma Academic Research Organisation||2|||f||||t||||||||||2017-10-10 23:48:59.863556|2017-10-10 23:48:59.863556
NCT02292966|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-06-02|||July 2015||2015-07-01|June 2016|2016-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|HEPCOG-II||Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism|Impact of HCV Eradication on Neurocognitive Functions and CNS Metabolism: a Trial of Daclatasvir, Asunaprevir and Beclabuvir for Patients With HCV Genotype 1 Infection|Withdrawn||Phase 4|0|Actual|Kirby Institute||1|||f||||f||||||||||2017-10-10 23:49:00.202836|2017-10-10 23:49:00.202836
NCT02292914|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-02-23|||March 2014||2014-03-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Prospective Analysis of Robot-Assisted Surgery|Prospective Analysis of Robot-Assisted Surgery|Recruiting||N/A|1120|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||t||||||||||2017-10-10 23:49:00.590233|2017-10-10 23:49:00.590233
NCT02292901|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-10-28|||November 2014||2014-11-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Interventional|MGM-Eval||McGrath Mac VideoLaryngoscope vs the Macintosh Laryngoscope|Randomised Controlled Trial of Intubation With the McGrath Mac VideoLaryngoscope vs the Macintosh Laryngoscope|Terminated||N/A|158|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-10 23:49:00.707982|2017-10-10 23:49:00.707982
NCT02292888|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-17|||December 2014||2014-12-01|November 2014|2014-11-01||||December 2015|Anticipated|2015-12-01||Interventional|||Can Changes in Velocity Time Integral Serve as a Sensitive Indicator for Monitoring Changes in Stroke Volume ?|Can Changes in LVOT VTI Before and After Passive Leg Raising (PLR) Test Serve as a Sensitive Indicator for Changes in SV and CO and Hence Volume Responsiveness ?|Unknown status|Not yet recruiting|Early Phase 1|50|Anticipated|Fortis Hospital, India||2|||f||||f||||||||||2017-10-10 23:49:00.80266|2017-10-10 23:49:00.80266
NCT02292875|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-14|||April 2014||2014-04-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||ToleroMune Grass Follow on Study|An Optional Follow-Up Study to Evaluate the Continued Efficacy of ToleroMune Grass in Grass Allergic Subjects Following Challenge With Grass Allergen in an Environmental Exposure Unit.|Completed||Phase 2|84|Actual|Circassia Limited|||1||f||||f||||||||||2017-10-10 23:49:00.893534|2017-10-10 23:49:00.893534
NCT02292862|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-14|||November 2012||2012-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Observational|K-LNMC||Maternal Microchimerism in Lymph Nodes of Infants With Biliary Atresia at Time of Kasai's Operation|Search for Maternal Microchimerism in Swollen Portal Lymph Nodes of Infants With Biliary Atresia.|Completed||N/A|7|Actual|Medizinische Hochschule Brandenburg Theodor Fontane|||1||f||||f||||||Samples With DNA|"     Lymph nodes from children Whole Blood from mother and infant   "|||2017-10-10 23:49:00.980956|2017-10-10 23:49:00.980956
NCT02292849|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-08-03|2017-01-27||November 1, 2013|Actual|2013-11-01|August 2017|2017-08-01|October 7, 2015|Actual|2015-10-07|October 7, 2015|Actual|2015-10-07||Interventional|||Peer to Peer Delivery of Behavioral Activation|Peer to Peer Delivery of Behavioral Activation|Completed||N/A|29|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-10 23:49:01.065243|2017-10-10 23:49:01.065243
NCT02292836|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-11-13|||August 2012||2012-08-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Rosacea Prevalence in General Population - Pilot Study|Rosacea Prevalence in General Population - Pilot Study|Completed||N/A|120|Actual|Galderma|||2||f||||f||||||||||2017-10-10 23:49:01.618763|2017-10-10 23:49:01.618763
NCT02292823|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2015-08-31|||April 2014||2014-04-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01|12 Months|Observational [Patient Registry]|e-MASTER||MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction|e-MASTER Registry: MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction|Terminated||N/A|63|Actual|InspireMD|||1|Enrolment rate|f||||t||||||||||2017-10-10 23:49:01.722122|2017-10-10 23:49:01.722122
NCT02292810|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2014-11-13|||November 2014||2014-11-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Acute Effects of Inspiratory Muscle Exercise on Glucose Level and Glucose Variability in Patients With Type 2 Diabetes.|Acute Effects of Inspiratory Muscle Exercise on Glucose Level and Glucose Variability in Patients With Type 2 Diabetes.|Unknown status|Not yet recruiting|N/A|14|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:49:01.818181|2017-10-10 23:49:01.818181
NCT02292797|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-11-14|||September 2013||2013-09-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|RISE||Assessment of the Rosacea Prevalence in the General Population|Assessment of the Prevalence of Rosacea in the General Population|Completed||N/A|6000|Actual|Galderma|||1||f||||f||||||||||2017-10-10 23:49:01.91053|2017-10-10 23:49:01.91053
NCT02292784|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-09-06|||June 1, 2015|Actual|2015-06-01|September 2017|2017-09-01|July 29, 2022|Anticipated|2022-07-29|July 29, 2022|Anticipated|2022-07-29||Interventional|ARIOS||Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies|Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies|Active, not recruiting||Phase 3|2100|Anticipated|GlaxoSmithKline||4|||f||||t|t|f||||||||2017-10-10 23:49:01.999875|2017-10-10 23:49:01.999875
NCT02292589|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-05-15|||October 2014||2014-10-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|tDCS/PPCS||Brain Stimulation for Mild Traumatic Brain Injury|tDCS in Patients With Mild Traumatic Brain Injury and Persistent Post Concussion Syndrome: Randomized Crossover Trial|Recruiting||Phase 2|20|Anticipated|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-10 23:49:04.301148|2017-10-10 23:49:04.301148
NCT02292745|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-01-31|||November 2014||2014-11-01|January 2017|2017-01-01|November 2020|Anticipated|2020-11-01|May 2020|Anticipated|2020-05-01||Interventional|LAPC-1||Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.|Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.|Recruiting||N/A|51|Anticipated|Foundation for Liver Research||1|||f||||f||||||||||2017-10-10 23:49:02.667516|2017-10-10 23:49:02.667516
NCT02292732|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2016-01-25|||February 2016||2016-02-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors|A Phase I, Open-Label Study to Determine the Effect of Repeat Dosing of Trametinib on the Pharmacokinetics and Safety of a Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) and to Characterize the Pharmacokinetics of Trametinib's Metabolite M5 in Female Subjects With Solid Tumors|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:49:02.754595|2017-10-10 23:49:02.754595
NCT02292719|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-07-18|||December 19, 2014||2014-12-19|July 2017|2017-07-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Interventional|Quartz II/III||A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection|A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of the Co-Administration of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) With Sofosbuvir (SOF) With or Without Ribavirin (RBV) in Subjects With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection or Genotype 3 HCV Infection With or Without Cirrhosis|Completed||Phase 2|70|Actual|AbbVie||6|||f||||f||||||||||2017-10-10 23:49:02.838402|2017-10-10 23:49:02.838402
NCT02292706|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-13|2017-09-28|||December 29, 2014|Actual|2014-12-29|September 2017|2017-09-01|May 2024|Anticipated|2024-05-01|May 2024|Anticipated|2024-05-01|5 Years|Observational [Patient Registry]|||A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection|A Registry for Subjects With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection|Enrolling by invitation||N/A|1637|Anticipated|Gilead Sciences|||1||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:49:02.950565|2017-10-10 23:49:02.950565
NCT02292693|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-14|||November 2014||2014-11-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Direct Laryngoscopy During Cervical Trauma|Comparison Three Different Laryngoscope Blades for Endotracheal Intubation in Pediatric Patients With Cervical Spine Immobilization.|Unknown status|Enrolling by invitation|N/A|80|Anticipated|International Institute of Rescue Research and Education||1|||f||||t||||||||||2017-10-10 23:49:03.514573|2017-10-10 23:49:03.514573
NCT02292680|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-11-04|||January 2017||2017-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Childhood Measures of NICU-based Chemical Exposure|Novel Biomarkers for Exposures in the Neonatal Intensive Care Unit|Not yet recruiting||N/A|65|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||||||2017-10-10 23:49:03.591898|2017-10-10 23:49:03.591898
NCT02292667|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-08-11|||January 2015||2015-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|ETAP||Efficacy of the Ultrasound-guided Transversus Abdominis Plane Block in Open Aortic Abdominal Aneurysm Repair Surgery|Efficacy of the Ultrasound-guidedTransversus Abdominis Plane (TAP) Block on Postoperative Pain Control in Open Aortic Abdominal Aneurysm Repair Surgery|Recruiting||Phase 3|60|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||No||2017-10-10 23:49:03.671979|2017-10-10 23:49:03.671979
NCT02292641|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-03-08|||October 2014||2014-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Assessing Outcomes in Primary or Recurrent Rectal or Sigmoid Cancer With Tumour Extending Beyond the TME Plane (Beyond TME)|Assessing Outcomes in Primary or Recurrent Rectal or Sigmoid Cancer With Tumour Extending Beyond the TME Plane|Recruiting||N/A|70|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 23:49:03.934884|2017-10-10 23:49:03.934884
NCT02292628|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-09-20|||October 2013||2013-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence|Study Phase I/II, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence|Active, not recruiting||Phase 1/Phase 2|16|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||f||||||||||2017-10-10 23:49:04.053121|2017-10-10 23:49:04.053121
NCT02292615|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-12|||April 2014||2014-04-01|November 2014|2014-11-01||||April 2014|Actual|2014-04-01||Observational|||Application of Integrated MR-PET in Patients With Gynecologic Cancers||Unknown status|Recruiting|N/A|220|Anticipated|National Taiwan University Hospital|||3||f||||||||||||||2017-10-10 23:49:04.137446|2017-10-10 23:49:04.137446
NCT02292563|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-10-14|||June 2015||2015-06-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||The Impact of Experienced Endoscopy Nurse Participation on Polyp and Adenoma Detection During Colonoscopy|Can Experienced Endoscopy Nurse Participation During Screening Colonoscopy Increase Polyp and Adenoma Detection Rate?:A Prospective Randomized Trial|Unknown status|Recruiting|N/A|660|Anticipated|Ningbo No. 1 Hospital||2|||f||||f||||||||||2017-10-10 23:49:04.485304|2017-10-10 23:49:04.485304
NCT02292537|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-03-22|||November 2014||2014-11-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|CHERISH||A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)|A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy|Completed||Phase 3|126|Actual|Biogen||2|||t||||t||||||||||2017-10-10 23:49:04.729584|2017-10-10 23:49:04.729584
NCT02292524|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-12|||May 2002||2002-05-01|November 2014|2014-11-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Prostate Biomarkers in Men Consuming Tomato Products|Prostate Biomarkers in Men Consuming Tomato Products|Completed||N/A|33|Actual|Ohio State University Comprehensive Cancer Center||4|||f||||t||||||||||2017-10-10 23:49:04.919554|2017-10-10 23:49:04.919554
NCT02292511|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-03-06|||February 2015||2015-02-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Mind-motor Exercise in Older Adults With Type 2 Diabetes and Self-reported Cognitive Complaints|Mind-motor Exercise in Older Adults With Type 2 Diabetes and Self-reported Cognitive Complaints|Completed||N/A|25|Actual|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-10 23:49:05.005788|2017-10-10 23:49:05.005788
NCT02292498|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-04-28|||November 2014||2014-11-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Thermal Imaging to Diagnose and Monitor Suspected Bacterial Infections|Thermal Imaging to Diagnose and Monitor Suspected Bacterial Infections|Completed||N/A|18|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-10 23:49:05.115425|2017-10-10 23:49:05.115425
NCT02292485|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-08-09|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||PCORI-CER-1306-03385 Lung Cancer Screening Readiness Study|Promoting Informed Decisions About Lung Cancer Screening: Lung Cancer Screening Readiness Study|Recruiting||N/A|1000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-10 23:49:05.197167|2017-10-10 23:49:05.197167
NCT02292472|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-05-26|||August 2014||2014-08-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|||Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy|A Randomized, Double-blind, Multi-center, Phase II Optimal Dose-finding Study to Determine Safety and Efficacy of Medytoxin® in Subjects in Benign Masseteric Hypertrophy|Unknown status|Recruiting|Phase 2|68|Anticipated|Medy-Tox||2|||f||||f||||||||||2017-10-10 23:49:05.288526|2017-10-10 23:49:05.288526
NCT02292459|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-07-15|||December 2015||2015-12-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)|A Multicenter, Open Label, Non-controlled Phase 3 Clinical Trial of the Efficacy and the Safety for the Relief of Constipation of Polyethylene Glycol 3350|Withdrawn||Phase 3|0|Actual|Bayer||2|||f||||f||||||||||2017-10-10 23:49:05.430807|2017-10-10 23:49:05.430807
NCT02292446|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-10-03|||November 23, 2014|Actual|2014-11-23|October 2017|2017-10-01|January 2, 2018|Anticipated|2018-01-02|January 2, 2018|Anticipated|2018-01-02||Interventional|||Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Are Available.|An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Are Available.|Recruiting||Phase 3|200|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-10 23:49:05.522982|2017-10-10 23:49:05.522982
NCT02292433|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-02-16|2016-02-16||January 2015||2015-01-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Safety analysis set included all participants who received at least 1 dose of study medication (including placebo) in at least 1 period.|A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy|A Phase 1, Randomized, Double-blind, Placebo-controlled, 3- Period, Crossover Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Two Dose Levels of Pf-04937319 In Japanese Subjects With Type 2 Diabetes Mellitus as Monotherapy|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 23:49:05.79903|2017-10-10 23:49:05.79903
NCT02292420|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2015-04-27|||October 2014||2014-10-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||The Normal Reference Values of Pulse Oximetry Plethymographic Waveform Parameters|The Normal Reference Values of Pulse Oximetry Plethymographic Waveform Parameters|Completed||N/A|1019|Actual|Peking Union Medical College Hospital|||1||f||||f||||||||||2017-10-10 23:49:06.72172|2017-10-10 23:49:06.72172
NCT02292407|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-11-12|||June 2012||2012-06-01|October 2014|2014-10-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|ANDPrecise||Prospective Pilot Study ANDPrecise|AND Precise! : Axillary Lymph Node Dissection and No Drain With the PRECISE Instrument|Recruiting||Phase 3|20|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-10 23:49:06.785979|2017-10-10 23:49:06.785979
NCT02292394|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-05-10|||November 2014||2014-11-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|RCDS||Brief Telephone Psychological Intervention for Depressive Symptoms in Caregivers|A Study of Randomized Controlled Dismantling of a Brief Telephone Psychological Intervention Applied to Informal Caregivers With Depressive Symptoms|Completed||N/A|180|Actual|University of Santiago de Compostela||3|||f||||t||||||||||2017-10-10 23:49:06.863375|2017-10-10 23:49:06.863375
NCT02292381|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-05-19|||April 2014||2014-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Blood Flow Regulation in Glaucoma||Recruiting||N/A|120|Anticipated|Medical University of Vienna|||2||f||||||||||||||2017-10-10 23:49:07.101842|2017-10-10 23:49:07.101842
NCT02292368|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-01-24|||November 10, 2014|Actual|2014-11-10|January 2017|2017-01-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Neurological Effects of Acupuncture to Prevent Radiation-induced Xerostomia|Neurological Effects of Acupuncture to Prevent Radiation-induced Xerostomia|Active, not recruiting||N/A|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:49:07.22768|2017-10-10 23:49:07.22768
NCT02292355|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-06-21|||March 2015||2015-03-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|January 16, 2017|Actual|2017-01-16||Interventional|||Effect of the Method Pilates in Women With Temporomandibular Disorders|Effect of the Method Pilates in Women With Temporomandibular Disorders - Clinical Trial|Completed||N/A|40|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-10 23:49:07.349207|2017-10-10 23:49:07.349207
NCT02292342|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-05-27|||May 2014||2014-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||An Investigation of the Dose-dependent Vascualr Effects of (-)-Epicatechin in Healthy Men|An Acute, Double-blind, Randomised, Placebo-controlled, Crossover Intervention Trial Investigating the Dose-dependent Vascular Effects of Pure (-)-Epicatechin (≤1 mg/kg BW) in Healthy Men.|Completed||Early Phase 1|21|Actual|University of Reading||4|||f||||f||||||||No||2017-10-10 23:49:07.455663|2017-10-10 23:49:07.455663
NCT02292329|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-05-27|||September 2014||2014-09-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|AF1||Cardiovascular Benefits of Acai Polyphenols in Volunteers at Risk of Metabolic Syndrome|Cardiovascular Benefits of Acai in Volunteers at Risk of Metabolic Syndrome.|Completed||N/A|23|Actual|University of Reading||2|||f||||f||||||||||2017-10-10 23:49:07.570387|2017-10-10 23:49:07.570387
NCT02292316|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-03-11|||December 2011||2011-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CFC||Falls With Fracture : Role of Cognitive Disorders and Comparison With Bone Fragility|Falls With Fracture : Role of Cognitive Disorders and Comparison With Bone Fragility|Recruiting||N/A|300|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:49:07.664899|2017-10-10 23:49:07.664899
NCT02292303|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-12|||October 2014||2014-10-01|November 2014|2014-11-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Clinical Trial to Determine the Bioavailability of Three Different Zinc Preparations|Randomized, Monocentric, Double-blind, 3-way-cross-over Clinical Trial to Determine the Bioavailability of Three Different Zinc Preparations|Unknown status|Active, not recruiting|N/A|26|Anticipated|Lesaffre International||3|||f||||f||||||||||2017-10-10 23:49:07.782456|2017-10-10 23:49:07.782456
NCT02292290|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-16|2014-11-14|||April 2011||2011-04-01|August 2012|2012-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|T4R||Trial for People With Established Type 2 Diabetes During Ramadan|A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan: Liraglutide vs. a Sulphonylurea|Completed||Phase 4|99|Actual|University of Leicester||4|||f||||t||||||||||2017-10-10 23:49:07.873278|2017-10-10 23:49:07.873278
NCT02292277|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-05-20|||October 2014||2014-10-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Observational|||Ticagrelor Pharmacokinetics in NSTEMI|Evaluation of Ticagrelor Pharmacokinetics in Patients With Non-ST Elevation Myocardial Infarction After a 180 mg Ticagrelor Loading Dose|Completed||N/A|63|Actual|Karolinska University Hospital|||2||f||||f||||||Samples Without DNA|"     Samples of venous blood will be collected into lithium-heparin tubes, centrifuged at 1500 g     at 4ºC for 10 min within 30 min of blood sampling at the following time points: pre-dose, 1,     2, 3, 4, 5, and 6 hours post-dose, as shown in the table below. For P2Y12-antagonist naïve     patients and controls, sampling of venous blood into Hirudin tubes for pharmacodynamics     evaluation will be performed for analysis using an ADP-induced platelet aggregation assay.      The resulting plasma samples will then be stored below minus 20ºC until analyzed. Plasma     concentrations of ticagrelor and its active metabolite AR-C124910XX will be determined by     validated methods (high-performance liquid chromatography and tandem mass spectrometry     detection; LC-MS/MS) at a certified laboratory.   "|||2017-10-10 23:49:08.000793|2017-10-10 23:49:08.000793
NCT02292264|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Risk Factors and Complications of Ventral Hernia Repair|Risk Factors and Complications of Ventral Hernia Repair|Completed||N/A|575|Actual|University Hospital Koge|||1||f||||f||||||||||2017-10-10 23:49:08.104164|2017-10-10 23:49:08.104164
NCT02292251|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2016-09-07|||May 2015||2015-05-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|SMARTS2||Study to Enhance Motor Acute Recovery With Intensive Training After Stroke|Study to Enhance Motor Acute Recovery With Intensive Training After Stroke|Recruiting||N/A|48|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-10 23:49:08.174156|2017-10-10 23:49:08.174156
NCT02292238|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-07-18|||November 2014||2014-11-01|July 2016|2016-07-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|Benfotiamine||Benfotiamine in Alzheimer's Disease: A Pilot Study|Benfotiamine in Alzheimer's Disease: A Pilot Study|Recruiting||Phase 2|76|Anticipated|Burke Medical Research Institute||2|||f||||t||||||||||2017-10-10 23:49:08.304346|2017-10-10 23:49:08.304346
NCT02292225|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-07-28|||February 2015||2015-02-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)|A Phase 1b Study of Duvelisib Administered in Combination With Obinutuzumab in Patients With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor (BTKi) (SYNCHRONY)|Terminated||Phase 1|3|Actual|Verastem, Inc.||1||"The scope of the program has been reduced to focus resources on studies which can potentially   enable the registration of duvelisib."|f||||f||||||||||2017-10-10 23:49:08.426464|2017-10-10 23:49:08.426464
NCT02292212|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-07-19|2017-05-31||November 24, 2014|Actual|2014-11-24|July 2017|2017-07-01|November 6, 2015|Actual|2015-11-06|November 6, 2015|Actual|2015-11-06||Interventional|AVID||Clinical Study of Asahi ViE Dialyzer in Canada|Clinical Study of Asahi ViE Dialyzer in Canada (AVID)|Completed||N/A|17|Actual|Asahi Kasei Medical Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:49:08.58699|2017-10-10 23:49:08.58699
NCT02292199|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-14|||August 2014||2014-08-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|January 2015|Anticipated|2015-01-01||Interventional|||Transcutaneous Electrical Nerve Stimulation on Nervous System in Patients With Hypertension.|Effects of Transcutaneous Electrical Nerve Stimulation on Sympathetic and Parasympathetic Nervous System in Patients With Hypertension: a Randomized Clinical Trial|Unknown status|Recruiting|N/A|60|Anticipated|Federal University of Health Science of Porto Alegre||3|||f||||t||||||||||2017-10-10 23:49:09.182811|2017-10-10 23:49:09.182811
NCT02292186|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-05-23|||October 2014||2014-10-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis|A Phase 2, Open-label Extension Study to Evaluate the Long-Term Safety, Clinical Activity, and Pharmacokinetics of ALN-TTRSC in Patients With Transthyretin (TTR) Cardiac Amyloidosis Who Have Previously Received ALN-TTRSC|Completed||Phase 2|25|Actual|Alnylam Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:49:09.287729|2017-10-10 23:49:09.287729
NCT02292173|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-06-30|||December 19, 2014|Actual|2014-12-19|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer|A Phase 1a/1b Trial of Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer|Recruiting||Phase 1|34|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-10 23:49:09.377804|2017-10-10 23:49:09.377804
NCT02292160|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-06-13|||September 2015||2015-09-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?|Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance? Pilot Study to Guide Probabilistic Antibiotic Regimens of Community-acquired Urinary Tract Infections|Completed||N/A|1128|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-10 23:49:09.481226|2017-10-10 23:49:09.481226
NCT02292147|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-08-02|||March 13, 2013|Actual|2013-03-13|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|HANOX||Functional Outcome After Cardiac Arrest|Functional Outcome After Cardiac Arrest; Prediction and Prognosis Factors for Patients Awake Within the First 15 Days|Active, not recruiting||N/A|140|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:49:09.546109|2017-10-10 23:49:09.546109
NCT02292134|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-11-14|||July 2012||2012-07-01|November 2013|2013-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EARS||Improving Sleep Quality in ICU Patients|Benefit of an Individual Protection Against Noise and Light on Sleep Quality in ICU Patients|Completed||Phase 3|64|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:49:09.622008|2017-10-10 23:49:09.622008
NCT02292121|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-02-20|||February 2014||2014-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|LEAKY GUT||Intestinal Permeability in Obesity|Intestinal Permeability in Obesity of Intercellular Tight Junctions to Metabolic Complications|Recruiting||N/A|110|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 23:49:09.711348|2017-10-10 23:49:09.711348
NCT02292108|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-01-24|||September 2014|Actual|2014-09-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|HYPNODIET||Hypnosis, Self-hypnosis and Weight Loss in Obese Patients|Study of the Influence of Erickson's Hypnosis and Self-hypnosis Practice on Food Impulsivity and Weight Loss in Obese Patients: a Pilot Project|Completed||N/A|82|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:49:09.81979|2017-10-10 23:49:09.81979
NCT02292095|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2015-11-05|||January 2016||2016-01-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Effects of Transverse Abdominis Plane Block Guided by Ultrasound on the Postoperative Analgesia and Quality of Lives Among the Patients Undergo Inguinal Hernia Repair|Effects of Transverse Abdominis Plane Block Guided by Ultrasound on the Postoperative Analgesia and Quality of Lives Among the Patients Undergo Inguinal Hernia Repair|Not yet recruiting||Phase 4|260|Anticipated|First Affiliated Hospital of Chongqing Medical University||2|||f||||f||||||||||2017-10-10 23:49:09.925665|2017-10-10 23:49:09.925665
NCT02292082|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-02-28|||November 2014||2014-11-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ACB PAI||The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)|The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)|Completed||Phase 4|111|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||Undecided||2017-10-10 23:49:10.088381|2017-10-10 23:49:10.088381
NCT02292069|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-12|||September 2011||2011-09-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition|Open Label, Randomized, Two-treatment, Two-period, Two-sequence, Oral Bioequivalence Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10mg/80mg Under Fed Condition|Completed||Phase 1|90|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:49:10.199368|2017-10-10 23:49:10.199368
NCT02292056|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-14|||September 2013||2013-09-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|MSRP||Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions|Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions|Unknown status|Recruiting|N/A|50|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-10-10 23:49:10.282551|2017-10-10 23:49:10.282551
NCT02292043|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-12|||May 2013||2013-05-01|November 2014|2014-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction|Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction|Unknown status|Recruiting|N/A|60|Anticipated|Harbin Medical University|||2||f||||f||||||||||2017-10-10 23:49:10.448782|2017-10-10 23:49:10.448782
NCT02292030|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2014-11-12|||November 2014||2014-11-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure|Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure With or Without HTEA|Unknown status|Recruiting|N/A|60|Anticipated|Harbin Medical University|||2||f||||f||||||||||2017-10-10 23:49:10.535785|2017-10-10 23:49:10.535785
NCT02292017|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-08-29|||October 2014||2014-10-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2017|Anticipated|2017-12-01||Interventional|PropackI||Prospective Packing Density With Target Coils I|A Prospective Single Center Trial Investigating the Effects of Prospectively Measuring Packing Density Prior to Choosing Target Coils for the Treatment of Intracranial Saccular Aneurysms.|Recruiting||N/A|25|Anticipated|Tennessee Neurovascular Institute, LLC||1|||f||||f||||||||||2017-10-10 23:49:10.607164|2017-10-10 23:49:10.607164
NCT02291991|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-01-27|||November 2014||2014-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|GX-E2-P1||Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects|A Randomized, Double-blind Placebo Controlled, Single-dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 After Single Intravenous Administration in Healthy Subjects|Completed||Phase 1|10|Actual|Genexine, Inc.||2|||f||||f||||||||||2017-10-10 23:49:10.77031|2017-10-10 23:49:10.77031
NCT02291978|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-11-18|||October 2014||2014-10-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||MR Guided High Intensity Focused Ultrasound for Lumbar Back Pain|A Feasibility Study to Evaluate the Safety and Initial Effectiveness of MR Guided High Intensity Focused Ultrasound (MRgHIFU) in the Treatment of Facetogenic Lumbar Back Pain|Recruiting||N/A|10|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 23:49:10.849844|2017-10-10 23:49:10.849844
NCT02291965|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-10-25|||November 2014||2014-11-01|October 2016|2016-10-01||||June 2019|Anticipated|2019-06-01||Observational|||Blood Samples to Identify Biomarkers of Busulfan|Optimizing Busulfan: Efficacy, Toxicity, and Pharmacometabolomics|Recruiting||N/A|150|Anticipated|Fred Hutchinson Cancer Research Center|||1||f||||f||||||Samples Without DNA|"     Plasma samples from metabolomic and/or pharmacokinetic analysis.   "|||2017-10-10 23:49:10.925901|2017-10-10 23:49:10.925901
NCT02291952|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2016-12-08|||November 2014||2014-11-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Development of Countermeasures Against Adverse Metabolic Effects of Shift Work|Development of Countermeasures Against Adverse Metabolic Effects of Shift Work|Recruiting||N/A|22|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:49:10.992186|2017-10-10 23:49:10.992186
NCT02291939|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-01-23|||January 2015||2015-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Parotidectomy Surgery|Evaluation of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Parotidectomy Surgery|Completed||N/A|5|Actual|Domain Surgical, Inc.|||1||f||||f||||||||||2017-10-10 23:49:11.074864|2017-10-10 23:49:11.074864
NCT02291926|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-05-08|||December 2014||2014-12-01|July 2015|2015-07-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect|Phase I Study of Human Umbilical Cord Mesenchymal Stem Cell Implantation in the Treatment of Articular Cartilage Defect of Knee|Completed||Phase 1|20|Actual|Shenzhen Hornetcorn Bio-technology Company, LTD||1|||f||||t||||||||Undecided||2017-10-10 23:49:11.148941|2017-10-10 23:49:11.148941
NCT02291913|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-07-06|||January 7, 2015|Actual|2015-01-07|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer|Phase II Open Label Study of Everolimus in Combination With Anti-estrogen Therapy in Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer|Active, not recruiting||Phase 2|48|Actual|SCRI Development Innovations, LLC||1|||f||||f|t|f|||f|||||2017-10-10 23:49:12.96451|2017-10-10 23:49:12.96451
NCT02291900|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-15|||February 2014||2014-02-01|November 2014|2014-11-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|TalarAVN||Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression|Talar Avascular Necrosis: Surgical Angiogenesis Compared to Core Decompression With Osseous Auto Grafting|Unknown status|Recruiting|N/A|20|Anticipated|BG Trauma Center Ludwigshafen||2|||f||||f||||||||||2017-10-10 23:49:13.069875|2017-10-10 23:49:13.069875
NCT02291887|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2014-11-12|||November 2014||2014-11-01|November 2014|2014-11-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept|Genetic Analysis of Patients With Neovascular Age-Related Macular Degeneration Responsive to Ranibizumab But Resistant to Aflibercept|Unknown status|Not yet recruiting|N/A|17|Anticipated|Associated Retinal Consultants, Michigan|||1||f||||f||||||Samples With DNA|"     Blood from each patient will be drawn for genetic analysis.   "|||2017-10-10 23:49:13.164967|2017-10-10 23:49:13.164967
NCT02291874|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-07-17|||October 8, 2014|Actual|2014-10-08|July 2017|2017-07-01|July 7, 2016|Actual|2016-07-07|July 7, 2016|Actual|2016-07-07||Interventional|||Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)|An Open-label, Non-comparative Study to Assess the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control With GLP-1 Receptor Agonists|Completed||Phase 4|100|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-10 23:49:13.265685|2017-10-10 23:49:13.265685
NCT02291861|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-03-10|||October 2014||2014-10-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|AIM-TD||Addressing Involuntary Movements in Tardive Dyskinesia|A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia|Completed||Phase 3|298|Actual|Teva Pharmaceutical Industries||4|||f||||t||||||||||2017-10-10 23:49:13.396994|2017-10-10 23:49:13.396994
NCT02291848|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-12|2017-05-26|||April 2015||2015-04-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|TACTAM||TUMOR-ASSOCIATED ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR MULTIPLE MYELOMA|ADMINISTRATION OF TUMOR-ASSOCIATED ANTIGEN (TAA)-SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO PATIENTS WITH ACTIVE MYELOMA (TACTAM)|Recruiting||Phase 1|36|Anticipated|Baylor College of Medicine||2|||f||||t|t|f||||||||2017-10-10 23:49:13.797833|2017-10-10 23:49:13.797833
NCT02291835|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-11-14|||January 2013||2013-01-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Dietary Intakes and Periodontal Outcomes After Sanative Therapy|Dietary Intakes and Periodontal Outcomes After Sanative Therapy|Completed||N/A|129|Actual|Brock University|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:49:13.899767|2017-10-10 23:49:13.899767
NCT02291822|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-07-18|||November 2014||2014-11-01|May 2015|2015-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Retrospective Study of MRI in Pediatric Patients|The Safety and Efficacy of MULTIHANCE at the Dose of 0.10 mmol/kg in Magnetic Resonance Imaging of the Central Nervous System in Pediatric Patients Who Are Less Than 2 Years of Age|Completed||N/A|90|Actual|Bracco Diagnostics, Inc|||1||f||||f||||||||||2017-10-10 23:49:13.958418|2017-10-10 23:49:13.958418
NCT02291809|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-02-22|||November 2017||2017-11-01|February 2016|2016-02-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study|REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study|Not yet recruiting||Phase 2|26|Anticipated|Immune Response BioPharma, Inc.||2|||f||||t||||||||||2017-10-10 23:49:14.021838|2017-10-10 23:49:14.021838
NCT02291796|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-11|||January 2011||2011-01-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|BEZAFIBRAMI||Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction|Early Effect Of Bezafibrate On Fibrinogen Levels, Inflammatory Response And Clinical Impact, In Patients With ST Elevation Acute Myocardial Infarction|Completed||Phase 4|100|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-10 23:49:14.123058|2017-10-10 23:49:14.123058
NCT02291783|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-06-19|||November 2013||2013-11-01|June 2017|2017-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment|A Double-Blind, Placebo-Controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of HTL0009936 in Healthy Subjects|Completed||Phase 1|108|Actual|Heptares Therapeutics Limited||2|||f||||f||||||||No||2017-10-10 23:49:14.218274|2017-10-10 23:49:14.218274
NCT02291770|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-11|||October 2014||2014-10-01|November 2014|2014-11-01|December 2019|Anticipated|2019-12-01|November 2015|Anticipated|2015-11-01||Interventional|MSC-cGvHD||Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells|Treatment of of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells. A Phase III Randomized Open Label Multi-center Study in Southern China.|Recruiting||Phase 3|130|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-10-10 23:49:14.308367|2017-10-10 23:49:14.308367
NCT02291757|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-11|||October 2013||2013-10-01|November 2014|2014-11-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy and Safety of NEM® Brand Eggshell Membrane in Patients With Knee Osteoarthiritis With Joint Pain and Stiffness|Efficacy and Safety of NEM® Brand Eggshell Membrane in Patients With Knee Osteo Arthiritis With Joint Pain and Stiffness. A Multi-center, Randomized, Double-blind, Placebo-controlled, Crossover Study|Unknown status|Recruiting|N/A|200|Anticipated|Generica Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:49:14.435422|2017-10-10 23:49:14.435422
NCT02291744|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-11-10|||October 2014||2014-10-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients|A Randomized Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients With Unresectable Metastatic Lesions|Recruiting||Phase 2|130|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 23:49:14.550126|2017-10-10 23:49:14.550126
NCT02291731|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-09-16|||September 2014||2014-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Autologous Serum Eye Drops With Contact Lenses for Corneal Epithelial Defects|Topical Autologous Serum Eye Drops Combined With Silicone Hydrogen Lenses for theTreatment of Corneal Epithelial Defects|Completed||N/A|21|Actual|E-DA Hospital||1|||f||||t||||||||||2017-10-10 23:49:14.645223|2017-10-10 23:49:14.645223
NCT02291718|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-03-22|2016-09-28||January 2014||2014-01-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Thoracoabdominal Arortic CTA Study|Comparison of High Iodine Concentration Contrast Material (Isovue 370) vs Standard Protocol (Isovue 300) in Thoracoabdominal Aortic Computed Tomographic Angiography (CTA) for Radiation Dose Reduction|Completed||Phase 4|150|Actual|Duke University||3|||f||||f||||||||||2017-10-10 23:49:14.726255|2017-10-10 23:49:14.726255
NCT02291705|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-14|||January 2012||2012-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Ultrasound-guided Rectus Sheath Block In Children||Completed||Phase 4|40|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:49:15.042651|2017-10-10 23:49:15.042651
NCT02291692|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-14|||June 2013||2013-06-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Ultrasound Guided Thoracic Paravertebral Block for Percutaneous Nephrolithotomy Operations in Children|Ultrasound Guided Thoracic Paravertebral Block|Completed||Phase 4|40|Actual|Cukurova University||2|||f||||f||||||||||2017-10-10 23:49:15.137244|2017-10-10 23:49:15.137244
NCT02291679|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-05-22|2017-02-24|2016-08-01|October 2014||2014-10-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Trial of Linaclotide in Patients With Chronic Idiopathic Constipation|A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation|Completed||Phase 3|1223|Actual|Ironwood Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 23:49:15.340628|2017-10-10 23:49:15.340628
NCT02291666|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-07-18|||April 2015||2015-04-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects|Effects of Type 2 Diabetes on CYP450s Activities; Intersubject Variability in Drug Metabolism.|Recruiting||Phase 4|126|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||3|||f||||t||||||||||2017-10-10 23:49:16.34377|2017-10-10 23:49:16.34377
NCT02291653|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-12-04|||November 2014||2014-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|EMS||Pediatric Endotracheal Intubation|Comparing the Novel McGrath MAC EMS Videolaryngoscope With Conventional Direct Laryngoscopy During Child Resuscitation: a Randomized Crossover Mannequin Study of Paramedic Students|Completed||N/A|87|Actual|International Institute of Rescue Research and Education||2|||f||||f||||||||||2017-10-10 23:49:16.47349|2017-10-10 23:49:16.47349
NCT02291640|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-11|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Pediatric Intubation Among Nursing|Coparison of Miller and CoPilot Laryngoscopes for Intubation by Nurses During Child Chest Compression. A Manikin Study|Unknown status|Recruiting|N/A|130|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:49:16.557438|2017-10-10 23:49:16.557438
NCT02291627|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-11|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Pediatric Intubation With Difficult Airway|Comparison of the Macintosh, Coopdech and AirTraq Laryngoscopes Using a Rigid Neck Collar in Pediatric Patients With Simulated Difficult Laryngoscopy.|Unknown status|Recruiting|N/A|120|Anticipated|International Institute of Rescue Research and Education||1|||f||||t||||||||||2017-10-10 23:49:16.692836|2017-10-10 23:49:16.692836
NCT02291614|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-09-18|||November 27, 2014|Actual|2014-11-27|September 2017|2017-09-01|January 30, 2018|Anticipated|2018-01-30|August 31, 2017|Actual|2017-08-31||Interventional|||A Phase 1 Study of AMG 211 in Subjects With Advanced Gastrointestinal Cancer|A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 211 Administered as Continuous Intravenous Infusion in Subjects With Relapsed/Refractory Gastrointestinal Adenocarcinoma|Active, not recruiting||Phase 1|51|Actual|Amgen||1|||f||||f||||||||||2017-10-10 23:49:16.799738|2017-10-10 23:49:16.799738
NCT02291588|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-11|||December 2007||2007-12-01|November 2014|2014-11-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|26|Actual|Amgen||2|||f||||f||||||||||2017-10-10 23:49:16.961995|2017-10-10 23:49:16.961995
NCT02291575|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-06-27|||October 2012||2012-10-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||Improving the Quality of Private Sector Health Care in West Bengal|Improving the Quality of Private Sector Health Care in West Bengal|Completed||N/A|304|Actual|Abdul Latif Jameel Poverty Action Lab||2|||f||||f||||||||||2017-10-10 23:49:17.040174|2017-10-10 23:49:17.040174
NCT02291562|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-01-15|||July 2014||2014-07-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of THC and CBD on Human Episodic Memory Function|Effects of D-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Human Episodic Memory Function|Completed||N/A|20|Actual|Central Institute of Mental Health, Mannheim||3|||f||||f||||||||||2017-10-10 23:49:17.129963|2017-10-10 23:49:17.129963
NCT02291549|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-08-15||2017-03-01|December 2014||2014-12-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|RESOLVEII||Clinical Evaluation of Safety and Efficacy of S8 Sinus Implant in Chronic Sinusitis Patients|RESOLVE II: A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Sinus Obstruction|Completed||Phase 3|300|Actual|Intersect ENT||2|||f||||f||||||||||2017-10-10 23:49:17.204492|2017-10-10 23:49:17.204492
NCT02291536|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-01-15|||February 2014||2014-02-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|AB_THC_CBD||Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)|Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)|Completed||N/A|20|Actual|Central Institute of Mental Health, Mannheim||3|||f||||f||||||||||2017-10-10 23:49:17.366125|2017-10-10 23:49:17.366125
NCT02291523|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|November 2023|Anticipated|2023-11-01|November 2021|Anticipated|2021-11-01||Interventional|FMT_UC||The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis|The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis|Recruiting||Phase 1|101|Anticipated|Children's Hospital Los Angeles||2|||f||||t||||||||No||2017-10-10 23:49:17.555963|2017-10-10 23:49:17.555963
NCT02291510|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-10-19|2015-08-21||October 2012||2012-10-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Randomized (ITT) Population|Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects|A Randomized, Crossover Study Assessing the Pharmacokinetics of EFB0027 Versus ETB0015 and ETB0014 in Healthy Subjects|Completed||Phase 1|20|Actual|Elcelyx Therapeutics, Inc.||4|||f||||f||||||||||2017-10-10 23:49:17.661966|2017-10-10 23:49:17.661966
NCT02291497|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-11-05|||October 2014||2014-10-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Burden of Disease in Hypophosphatasia (HPP)|Non-interventional, Prospective, Single-center Investigation With Exploratory Data Analysis to Delineate the Variability and Frequency of Symptoms and Disease Manifestations in Adult HPP Patients|Completed||N/A|114|Actual|Wuerzburg University Hospital|||1||f||||f||||||Samples With DNA|"     Blood will be stored till 2031   "|Undecided||2017-10-10 23:49:18.317819|2017-10-10 23:49:18.317819
NCT02291484|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-08-03|||August 2013||2013-08-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CRESCENT2||Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)|Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)|Completed||Phase 3|250|Actual|Erasmus Medical Center||2|||f||||t||||||||No||2017-10-10 23:49:18.393325|2017-10-10 23:49:18.393325
NCT02291471|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-06-08|||October 2014||2014-10-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers|An Open, Dose Escalation, Single Dose Study to Assess Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers|Completed||Phase 1|56|Actual|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||1|||f||||f||||||||||2017-10-10 23:49:18.48502|2017-10-10 23:49:18.48502
NCT02291458|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-13|||November 2014||2014-11-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|ArgMB||L-arginine and Brown Adipose Tissue|The Effect of L-arginine on Brown Adipose Tissue Metabolism in South Asian and White Caucasian Subjects|Unknown status|Recruiting|Phase 3|26|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:49:18.561105|2017-10-10 23:49:18.561105
NCT02291445|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-09-21|||March 2015||2015-03-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study|A Randomized, Double Blind, Single Dose, Two Treatment, Two Period Crossover Pharmacokinetic Study Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®) in Healthy Volunteers|Completed||Phase 2|8|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:49:18.663167|2017-10-10 23:49:18.663167
NCT02051166|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-06-14|||February 2014||2014-02-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Clinical Practice of AECOPD Management in China|A Non Interventional, Retrospective Study on AECOPD Treatment Status in China|Completed||N/A|5095|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-11 00:48:31.057912|2017-10-11 00:48:31.057912
NCT02291432|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-06-16|||December 2014||2014-12-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery|Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Cook Group Incorporated||1|||f||||||||||||||2017-10-10 23:49:18.786321|2017-10-10 23:49:18.786321
NCT02291419|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-02-08|2017-02-08||July 2015||2015-07-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|INTREPID||Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery|An Open Label, Randomized Study to Determine the Rate of Cardiovascular Events at 1 yr for Patients With Elevated Troponins Post Major Non-cardiac Surgery and the Impact of Ticagrelor vs Aspirin on the Occurrence of Cardiovascular Events|Terminated||Phase 4|6|Actual|The Cleveland Clinic||2||Enrollment expectations were not met|f||||t||||||||No||2017-10-10 23:49:18.882976|2017-10-10 23:49:18.882976
NCT02291406|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-13|||October 2014||2014-10-01|October 2014|2014-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Importance of Surgical Approach for Gynecological Surgery on Metabolic Effects and Subsequent Recovery|Importance of Surgical Approach for Hysterectomies on Metabolic Effects Regarding Development of Insulin Resistance and Subsequent Recovery. A Randomized Controlled Study.|Unknown status|Recruiting|N/A|20|Anticipated|Region Örebro County||2|||f||||t||||||||||2017-10-10 23:49:19.317255|2017-10-10 23:49:19.317255
NCT02291393|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-05-18|||August 2012||2012-08-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)|The Role of High Density Surface Cardiac Electrographic Mapping in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy :A Pilot Study|Completed||N/A|20|Actual|The Leeds Teaching Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 23:49:19.435438|2017-10-10 23:49:19.435438
NCT02291380|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-09-22|||September 2014||2014-09-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine|A Multi-center, Randomized, Double-blind, Placebo Parallel-Controlled Clinical Study to Evaluate the Safety and Efficacy of Botulinum Toxin Type A for Injection (HengLi ®) for Prophylactic Treatment of Chronic Migraine in Adults|Enrolling by invitation||Phase 3|288|Anticipated|Lanzhou Institute of Biological Products Co., Ltd||2|||f||||t||||||||No||2017-10-10 23:49:19.508859|2017-10-10 23:49:19.508859
NCT02291367|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-13|||May 2008||2008-05-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition|Single Dose Crossover Comparative Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg in Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|76|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:49:19.605498|2017-10-10 23:49:19.605498
NCT02291354|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-02-03|||March 2015||2015-03-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Evaluating the Synergism of Soluble Dietary Fiber With Fecal Microbiota Transplantation in Slow Transit Constipation|A Randomized, Controlled Study of Synergism of Soluble Dietary Fiber With Fecal Microbiota Transplantation in Adult Patients With Slow Transit Constipation|Recruiting||Phase 2|50|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 23:49:19.683823|2017-10-10 23:49:19.683823
NCT02291341|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-13|||May 2008||2008-05-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition|Single Dose Crossover Comparative Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg in Healthy Adult Human Subjects Under Fed Conditions|Completed||Phase 1|76|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-10 23:49:19.798213|2017-10-10 23:49:19.798213
NCT02291328|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-05-01|||September 2014||2014-09-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|EBL||Effects of Brassica on Human Gut Lactobacilli|A Human Intervention Trial Investigating the Effects of Brassica on Gut Lactobacilli|Completed||N/A|10|Actual|Quadram Institute||2|||f||||f||||||||||2017-10-10 23:49:19.879667|2017-10-10 23:49:19.879667
NCT02291315|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-12|||July 2007||2007-07-01|November 2014|2014-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Calcium Absorption in Postmenopausal Thai Women|Calcium Bioavailability of Cassia Leaves in Post-Menopausal Women|Completed||N/A|22|Actual|Cornell University|||1||f||||f||||||||||2017-10-10 23:49:19.95111|2017-10-10 23:49:19.95111
NCT02291302|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-06-21|||January 2015||2015-01-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|SICAS-2||School Inner-City Asthma Intervention Study (SICAS-2)|School Inner-City Asthma Intervention Study|Recruiting||Phase 4|300|Anticipated|Boston Children’s Hospital||4|||f||||t||||||||||2017-10-10 23:49:20.025651|2017-10-10 23:49:20.025651
NCT02291289|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-10-02|||April 17, 2015|Actual|2015-04-17|October 2017|2017-10-01|October 30, 2020|Anticipated|2020-10-30|October 30, 2020|Anticipated|2020-10-30||Interventional|MODUL||A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)|A Multi-Centre Randomised Clinical Trial of Biomarker-Driven Maintenance Treatment for First-Line Metastatic Colorectal Cancer (MODUL)|Recruiting||Phase 2|1400|Anticipated|Hoffmann-La Roche||8|||f||||t||||||||||2017-10-10 23:49:20.144164|2017-10-10 23:49:20.144164
NCT02291276|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-07-18|||November 2014|Actual|2014-11-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|November 2016|Actual|2016-11-01||Observational|||Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study|Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (GynRight) - Pilot Study|Withdrawn||N/A|0|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-10 23:49:20.807982|2017-10-10 23:49:20.807982
NCT02291263|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-08-26|||October 2014||2014-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine|Assessing the Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine Against Type 2 With Bivalent Oral Poliovirus Vaccine in Routine Immunization|Completed||Phase 3|738|Actual|Centers for Disease Control and Prevention||3|||f||||t||||||||||2017-10-10 23:49:20.887003|2017-10-10 23:49:20.887003
NCT02291250|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2016-12-01|||November 2014||2014-11-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Soft Fruit on Postprandial Blood Glucose|Effect of Soft Fruit on Postprandial Blood Glucose|Recruiting||N/A|16|Anticipated|University of Aberdeen||4|||f||||t||||||||Undecided||2017-10-10 23:49:20.979321|2017-10-10 23:49:20.979321
NCT02291237|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-02-24|||February 5, 2015|Actual|2015-02-05|February 2017|2017-02-01|February 17, 2017|Actual|2017-02-17|February 17, 2017|Actual|2017-02-17||Interventional|LIBERTY-HCM||Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy|Study Title: A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of GS-6615 on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy|Terminated||Phase 2/Phase 3|172|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 23:49:21.078963|2017-10-10 23:49:21.078963
NCT02291224|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-03-24|||March 2015||2015-03-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|2Gether||Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens|Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens|Recruiting||N/A|710|Anticipated|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-10 23:49:21.290365|2017-10-10 23:49:21.290365
NCT02291211|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-13|||September 2014||2014-09-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis|Phase Ⅱ Study of S-1 Combined Cisplatin Hyperthermic Intraperitoneal Chemotherapy for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis|Unknown status|Recruiting|Phase 2|60|Anticipated|Tang-Du Hospital||1|||f||||t||||||||||2017-10-10 23:49:21.428482|2017-10-10 23:49:21.428482
NCT02291198|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-11|||October 2014||2014-10-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|January 2016|Actual|2016-01-01||Interventional|||Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy|Open Label, Prospective, Cross-Sectional Clinical Performance Study of the in Vitro Diagnostic Device NK Vue Kit: Measurement of Natural Killer Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy|Completed||N/A|1081|Actual|ATGen Canada Inc||1|||f||||f||||||||||2017-10-10 23:49:21.510175|2017-10-10 23:49:21.510175
NCT02291185|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-08-30|||November 2014||2014-11-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Prediction of Fluid Responsiveness Using Dynamic Preload Indices During Arthroscopic Shoulder Surgery in the Beach Chair Position||Completed||N/A|42|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 23:49:21.579534|2017-10-10 23:49:21.579534
NCT02291172|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-08-10|||September 2014||2014-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comprehensive Communication Intervention for Minimally Verbal Children With Autism|Comprehensive Communication Intervention for Minimally Verbal Children With Autism|Active, not recruiting||N/A|74|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-10 23:49:21.640127|2017-10-10 23:49:21.640127
NCT02291159|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-12-30|||November 2014||2014-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke|Effectiveness of Dry Needling (DNHS Technique) in the Treatment of Upper Limb Spasticity and Function in Stroke Patients: a Randomized Clinical Trial|Completed||N/A|10|Actual|Universidad San Jorge||2|||f||||f||||||||||2017-10-10 23:49:21.723394|2017-10-10 23:49:21.723394
NCT02291146|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2014-11-11|||July 2011||2011-07-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|LA Sprouts||LA Sprouts: The Impact of Gardening and Nutrition Education on Childhood Obesity in Latino Youth|LA Sprouts: The Impact of Gardening and Nutrition Education on Childhood Obesity in Latino Youth|Completed||N/A|421|Actual|University of Southern California||2|||f||||f||||||||||2017-10-10 23:49:21.810247|2017-10-10 23:49:21.810247
NCT02291133|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2014-11-11|||June 2014||2014-06-01|November 2014|2014-11-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|ECT-HCC||Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)|Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)|Unknown status|Recruiting|Phase 1/Phase 2|25|Anticipated|University Medical Centre Ljubljana||1|||f||||t||||||||||2017-10-10 23:49:21.904021|2017-10-10 23:49:21.904021
NCT02291120|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-11-11|||March 2014||2014-03-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|October 2015|Anticipated|2015-10-01||Interventional|||MEDCEM PC and MTA in Pulpotomies of Primary Molars||Unknown status|Recruiting|Phase 4|80|Anticipated|Universitat Internacional de Catalunya||2|||f||||||||||||||2017-10-10 23:49:21.998044|2017-10-10 23:49:21.998044
NCT02291107|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-08-20|||June 2014||2014-06-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Robot-assisted Gait Training in Patients With Multiple Sclerosis: Efficacy and Comparison With Traditional Methods|Robot-assisted Gait Training in Patients Affected by Multiple Sclerosis: Rehabilitative Efficacy Evaluation and Comparison With Traditional Methods|Unknown status|Recruiting|N/A|17|Anticipated|Habilita, Ospedale di Sarnico||2|||f||||t||||||||||2017-10-10 23:49:22.076803|2017-10-10 23:49:22.076803
NCT02291094|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2014-11-23|||August 2013||2013-08-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Intravenous Infusion of Lidocaine and Remifentanil Perioperatively in Patients Undergoing Mastectomy|Effect of Intravenous Infusion of Lidocaine and Remifentanil Perioperatively in Patients Undergoing Mastectomy: a Prospective, Randomized, Double-blind Study|Completed||Phase 4|60|Actual|Hospital de Base||2|||f||||f||||||||||2017-10-10 23:49:22.184548|2017-10-10 23:49:22.184548
NCT02291081|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-11-11|||October 2014||2014-10-01|November 2014|2014-11-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Observational|HIV-HEART10||A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients|A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk, New Cardiovascular Events and the Cardiovascular Diseases in HIV-infected Patients: 10 Year Follow-up|Unknown status|Recruiting|N/A|1500|Anticipated|University Hospital, Essen|||1||f||||f||||||Samples With DNA|"     Stored blood samples   "|||2017-10-10 23:49:22.271886|2017-10-10 23:49:22.271886
NCT02291068|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-11-11|||November 2014||2014-11-01|November 2014|2014-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Psychological Flexibility and Effectiveness of Psychotherapy|Psychological Flexibility and Effectiveness of Psychotherapy Treatment in Patients With Adjustment Disorder|Unknown status|Not yet recruiting|N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||||2017-10-10 23:49:22.407242|2017-10-10 23:49:22.407242
NCT02291055|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-01-18|||April 2015||2015-04-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer|Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combination In Previously Treated Locally Advanced or Metastatic Cervical or HPV+ Head & Neck Cancer|Recruiting||Phase 1/Phase 2|66|Anticipated|Advaxis, Inc.||2|||f||||f||||||||||2017-10-10 23:49:22.483929|2017-10-10 23:49:22.483929
NCT02291042|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-03-27|||October 2015||2015-10-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|SPASMS||Effect of an Anti-spasmodic Suppository to Improve Comfort After Urologic Surgery|Pre-operative Administration of a Muscarinic Antagonist for Elective Cystoscopy Patients|Completed||N/A|50|Actual|Southern New Hampshire Medical Center||2|||f||||t||||||||||2017-10-10 23:49:22.615469|2017-10-10 23:49:22.615469
NCT02291029|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-04-12|||October 22, 2014|Actual|2014-10-22|April 2017|2017-04-01|May 29, 2018|Anticipated|2018-05-29|May 29, 2018|Anticipated|2018-05-29||Interventional|||Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CFZ533 in Patients With Primary Sjögren's Syndrome|Recruiting||Phase 2|42|Anticipated|Novartis||4|||f||||f||||||||||2017-10-10 23:49:22.698804|2017-10-10 23:49:22.698804
NCT02291016|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-02-06|||February 2015||2015-02-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers|A Randomized, Double-Dummy, Crossover, Single-Center Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers in the Treatment of Patients Recovering From Severe Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Recruiting|N/A|30|Anticipated|University of Tennessee Graduate School of Medicine||2|||f||||f||||||||||2017-10-10 23:49:22.816553|2017-10-10 23:49:22.816553
NCT02291003|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-09-22|||December 2014||2014-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Identification of Novel Circadian Biomarkers|Identification of Novel Circadian Biomarkers|Recruiting||N/A|30|Anticipated|Northwestern University|||1||f||||f||||||Samples With DNA|"     Blood, saliva and skin samples   "|No||2017-10-10 23:49:22.948593|2017-10-10 23:49:22.948593
NCT02290990|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-03-31|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2015|Actual|2015-10-01||Interventional|DIMMISI||"Efficacy Study of Imaginative Distention, a Self Managed Tool to Cope With Fatigue,Insomnia and Stress in pw Insomnia and pw MS"|A Randomized Controlled Trial on Integrated Imaginative Distention in MS Ans Insomnia: a Self Managed Tool to Cope With Fatigue, Stress and Insomnia|Completed||N/A|144|Actual|Niguarda Hospital||6|||f||||t||||||||||2017-10-10 23:49:23.021774|2017-10-10 23:49:23.021774
NCT02290977|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2014-12-03|||November 2014||2014-11-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|||Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)|Scheduled Interval Trans-catheter Arterial Chemo-embolization and Radiation Therapy for Hepatocellular Carcinoma Combined With Portal Vein Tumor Thrombosis: Prospective Phase II Trial|Unknown status|Recruiting|Phase 2|40|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 23:49:23.106175|2017-10-10 23:49:23.106175
NCT02290964|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2014-11-13|||March 2010||2010-03-01|November 2014|2014-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|ANH||Effect of Acute Normovolemic Haemodilution on Allogenic Transfusion Needs In Laparotomy|Effect of Acute Normovolemic Haemodilution on Allogenic Transfusion Needs in Patients Undergoing Laparotomy Surgery|Completed||N/A|34|Actual|Universitas Padjadjaran||2|||f||||t||||||||||2017-10-10 23:49:23.179827|2017-10-10 23:49:23.179827
NCT02290951|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-10-17|||November 2014||2014-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 1 Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies|An Open-Label, Multi-Center Phase 1 Study to Investigate the Safety and Tolerability of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, in Patients With CD20+ B-Cell Malignancies Previously Treated With CD20-Directed Antibody Therapy|Recruiting||Phase 1|150|Anticipated|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:49:23.245457|2017-10-10 23:49:23.245457
NCT02290938|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-05-16|||July 2014||2014-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|April 2017|Actual|2017-04-01||Interventional|MICUNAY||Motivational Interviewing and Culture for Urban Native American Youth (MICUNAY)|Motivational Interviewing and Culture for Urban Native American Youth (MICUNAY)|Recruiting||N/A|200|Anticipated|RAND||2|||f||||t||||||||||2017-10-10 23:49:23.448467|2017-10-10 23:49:23.448467
NCT02290925|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-10-03|||May 2014||2014-05-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose Levels in Patients With Diabetes|The Effect of a Biscuit Containing the Extract of Salacia Reticulata on Glycaemia in Patients With Type II Diabetes Mellitus A Two Center Randomized Double Blind Placebo Controlled Two Period Two Sequence Crossover Clinical Trial|Active, not recruiting||Phase 3|195|Actual|Rajarata University, Sri Lanka||2|||f||||t||||||||||2017-10-10 23:49:23.584565|2017-10-10 23:49:23.584565
NCT02290912|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2015-12-02|||April 2014||2014-04-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Gray Matters Alzheimer's Disease Prevention Intervention|Gray Matters: Multi-domain Lifestyle Behavioral Alzheimer's Disease Prevention Randomized Controlled Trial|Completed||N/A|146|Actual|Utah State University||2|||f||||f||||||||||2017-10-10 23:49:23.680241|2017-10-10 23:49:23.680241
NCT02290899|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-08-08|||June 2014||2014-06-01|April 2017|2017-04-01|August 7, 2017|Actual|2017-08-07|August 7, 2017|Actual|2017-08-07||Observational|||Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder|Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder|Completed||N/A|30|Actual|Rhode Island Hospital|||1||f||||||||||||||2017-10-10 23:49:23.785587|2017-10-10 23:49:23.785587
NCT02290886|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-09-19|||July 2014||2014-07-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral|A Multicenter Phase I/II Clinical Trial, Randomized, Controlled With Placebo, Triple Blind to Evaluate Safety, and Indications of Efficiency of the Intravenous Administration of the Therapy With 3 Doses of MSC in Patients With ASL Moderated to Severe|Recruiting||Phase 1/Phase 2|40|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||4|||f||||f||||||||||2017-10-10 23:49:23.857866|2017-10-10 23:49:23.857866
NCT02290873|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-08-03|||March 30, 2015|Actual|2015-03-30|July 2017|2017-07-01|April 19, 2016|Actual|2016-04-19|April 2016|Actual|2016-04-01||Interventional|||A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients|A Prospective, Double-blind, Randomized, Placebo and Active Controlled, Multi-center, Parallel Group Study Comparing Remimazolam to Placebo, With an Additional Open-label Arm For Midazolam, in Patients Undergoing a Colonoscopy for Diagnostic or Therapeutic Reasons.|Completed||Phase 3|461|Actual|Paion UK Ltd.||3|||f||||f||||||||||2017-10-10 23:49:23.986984|2017-10-10 23:49:23.986984
NCT02290860|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-05-08|||December 2014||2014-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|SoL||Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes Mellitus|Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes Mellitus - Stage 2, a Multicentre Trial.|Active, not recruiting||N/A|301|Anticipated|Université de Sherbrooke||1|||f||||f||||||||||2017-10-10 23:49:24.137855|2017-10-10 23:49:24.137855
NCT02290847|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-10-05|||September 2012||2012-09-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Clinical Effectiveness Trial of In-Home Cognitive Processing Therapy for Combat-Related PTSD|Clinical Effectiveness Trial of In-Home Cognitive Processing Therapy for Combat-Related PTSD|Recruiting||N/A|123|Anticipated|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-10-10 23:49:24.231975|2017-10-10 23:49:24.231975
NCT02290834|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-03-27|||March 2015||2015-03-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|January 2020|Anticipated|2020-01-01||Interventional|||Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer|Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer|Active, not recruiting||N/A|200|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||Undecided|No data are yet available|2017-10-10 23:49:24.333221|2017-10-10 23:49:24.333221
NCT02290821|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-03-08|2016-09-20||December 2014||2014-12-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects With Acute Blunt Soft Tissue Injuries/Contusions of the Limbs|Completed||Phase 3|215|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:49:24.444036|2017-10-10 23:49:24.444036
NCT02290808|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2016-07-19|||March 2014||2014-03-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||First-time Parents Physical Activity Intervention|First-time Parents Physical Activity Intervention|Recruiting||N/A|160|Anticipated|University of Victoria||2|||f||||f||||||||||2017-10-10 23:49:24.731627|2017-10-10 23:49:24.731627
NCT02290795|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-01-20|||November 2014||2014-11-01|October 2014|2014-10-01|August 2016|Anticipated|2016-08-01|April 2016|Anticipated|2016-04-01||Observational|||Vitreopapillary Interface and Optic Disc Morphology|Vitreopapillary Traction and Optic Disc Morphology in Healthy Subjects, Vitreomacular Traction Patients and Glaucoma Patients|Unknown status|Recruiting|N/A|350|Anticipated|Universitaire Ziekenhuizen Leuven|||4||f||||f||||||||||2017-10-10 23:49:24.878548|2017-10-10 23:49:24.878548
NCT02290782|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-05-31|||October 2014||2014-10-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|TARGIT-C||TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer|TARGIT-C(Consolidation) Prospective Phase IV Study of Intraoperative Radiotherapy (IORT) in Patients With Small Breast Cancer|Recruiting||Phase 4|387|Anticipated|Universitätsmedizin Mannheim||1|||f||||f||||||||||2017-10-10 23:49:25.000588|2017-10-10 23:49:25.000588
NCT02290769|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-04-07|||January 2018|Anticipated|2018-01-01|April 2017|2017-04-01|October 2021|Anticipated|2021-10-01|September 2020|Anticipated|2020-09-01||Interventional|RELG||Time of Cannulation During Primary ERCP With Short Guide Wire Rapid Exchange or With Long Guide Wire|Evaluation of the Cannulation Time During Primary ERCP With Short Guide Wire Rapid Exchange or With Long Guide Wire. Multicentre Prospective Randomized Trial|Not yet recruiting||N/A|292|Anticipated|Niguarda Hospital||2|||f||||f|f|f||||||||2017-10-10 23:49:25.112464|2017-10-10 23:49:25.112464
NCT02290756|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-11-30|||January 2015||2015-01-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Community Based Implementation of a Toolkit and Parenting Program for Improving Brain Development in Newborns|A Community Based Implementation of a Low Cost Evidence-based Toolkit and Parenting Program for Improving Brain Development in Newborns|Recruiting||N/A|1080|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-10 23:49:25.192671|2017-10-10 23:49:25.192671
NCT02290743|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-01-30|||November 2014||2014-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Kinesio Taping on Muscle Strength in Quadriceps Femoris|The Effect of One Application of Kinesio Tape on Muscle Strength in Quadriceps Femoris on Patients With Knee Problems or Pain and Weak Quadriceps Femoris - a Randomized Controlled Trial|Completed||N/A|57|Actual|Norwegian School of Sport Sciences||2|||f||||t||||||||||2017-10-10 23:49:25.28018|2017-10-10 23:49:25.28018
NCT02290730|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2015-01-30|||November 2014||2014-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Kinesio Taping on Muscle Strength in Lower Trapezius|The Effect of One Application of Kinesio Tape on Muscle Strength in Lower Trapezius on Patients With Shoulder Problems and Weak Lower Trapezius - a Randomized Controlled Trial|Completed||N/A|49|Actual|Norwegian School of Sport Sciences||2|||f||||t||||||||||2017-10-10 23:49:25.360516|2017-10-10 23:49:25.360516
NCT02290717|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-04-15|||May 2015||2015-05-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Fractional Laser in Combination With UVB Therapy in Vitiligo Patients|Fractional Laser Abrasion in Combination With UVB Therapy in Vitiligo Patients: a Randomized Controlled Study.|Withdrawn||N/A|0|Actual|Netherlands Institute for Pigment Disorders||3||Difficulty including patients|f||||||||||||||2017-10-10 23:49:25.497082|2017-10-10 23:49:25.497082
NCT02290704|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-13|||January 2014||2014-01-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People|Changes of Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy Under Different Managing Conditions and in Normal People|Unknown status|Recruiting|N/A|200|Anticipated|Sun Yat-sen University|||2||f||||t||||||||||2017-10-10 23:49:25.63233|2017-10-10 23:49:25.63233
NCT02290678|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-02-18|||February 2015||2015-02-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Pushing Limits - Adventure: Pilot Study|Examining the Feasibility and Efficacy of Adventure Based Therapy as a Treatment Intevention for Depression and Anxiety.|Unknown status|Recruiting|N/A|25|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||||2017-10-10 23:49:25.811962|2017-10-10 23:49:25.811962
NCT02290665|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-04-12|||September 2014||2014-09-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Localized Therapeutics for the Treatment of Gastrointestinal Disorders|Localized Therapeutics for the Treatment of Gastrointestinal Disorders|Recruiting||N/A|30|Anticipated|Stanford University||2|||f||||||||||||||2017-10-10 23:49:25.937987|2017-10-10 23:49:25.937987
NCT02290652|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-10-14|||October 2014||2014-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Sexual Function Questionnaire Total Hip Replacement|Development and Validation of a Sexual Function Questionnaire for Female Patients Undergoing Total Hip Replacement|Recruiting||N/A|200|Anticipated|University Hospital Southampton NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 23:49:26.017683|2017-10-10 23:49:26.017683
NCT02290639|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-01-11|||December 2012||2012-12-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|||Brief Cognitive Behavioral Treatment of Deployment-Related PTSD Symptoms in Primary Care Settings|Brief Cognitive Behavioral Treatment of Deployment-Related PTSD Symptoms in Primary Care Settings: A Randomized Controlled Trial|Completed||N/A|74|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 23:49:26.142571|2017-10-10 23:49:26.142571
NCT02290626|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2015-10-30|||November 2014||2014-11-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation|Randomized Comparison of Elemental Diets and Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation in Bedridden Gastrostomy-fed Patients|Withdrawn||N/A|0|Actual|Showa Inan General Hospital||2||Study protocol was changed.|f||||f||||||||||2017-10-10 23:49:26.236022|2017-10-10 23:49:26.236022
NCT02290613|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-02-04|||December 2014||2014-12-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|EDITA||Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)|Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) A Randomized, Controlled, Double-blind, Parallel Group, Proof-of-concept Trial EDITA|Unknown status|Recruiting|Phase 2|38|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-10 23:49:26.321854|2017-10-10 23:49:26.321854
NCT02290600|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-02-06|||January 2015||2015-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|||Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias|Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias|Completed||N/A|23|Actual|William Sansum Diabetes Center|||1||f||||f|f|t|f|||||||2017-10-10 23:49:26.429102|2017-10-10 23:49:26.429102
NCT02290587|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-03-31|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|SOCOG-MS||Study of Social Cognition by Morphological and Functional Imaging in Multiple Sclerosis Patients|Study of Social Cognition by Morphological and Functional Imaging in Multiple Sclerosis Patients|Completed||N/A|35|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:49:26.495213|2017-10-10 23:49:26.495213
NCT02290574|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2014-11-10|||November 2014||2014-11-01|November 2014|2014-11-01||||October 2015|Anticipated|2015-10-01||Interventional|NEO TREAT||Efficacy of Neoadjuvant Thermo-Radio-chemotherapy for Locally Advanced Rectal Cancer Before Laparoscopic Total Mesorectal Excision: Prospective Phase II Trial|Efficacy of Neoadjuvant Thermo-Radio-chemotherapy for Locally Advanced Rectal Cancer Before Laparoscopic Total Mesorectal Excision: Prospective Phase II Trial|Unknown status|Recruiting|Phase 2|43|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-10 23:49:26.567117|2017-10-10 23:49:26.567117
NCT02290561|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-13|||December 2014||2014-12-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||SmartTarget THERAPY|SmartTarget - A Magnetic Resonance Image to Ultrasound Fusion System for Targeted Prostate Intervention: Therapy|Unknown status|Not yet recruiting|N/A|69|Anticipated|University College, London||1|||f||||f||||||||||2017-10-10 23:49:26.647467|2017-10-10 23:49:26.647467
NCT02290548|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-12-11|||December 2014||2014-12-01|December 2014|2014-12-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of High-flow Nasal Oxygen on Extubation Outcome|Effect of High-flow Nasal Oxygen vs Standard Oxygen Therapy on Extubation Outcome With High Risk of Extubation Failure in Medical ICU Patients|Unknown status|Recruiting|N/A|400|Anticipated|Mackay Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:49:26.713057|2017-10-10 23:49:26.713057
NCT02290535|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2015-07-15|||June 2014||2014-06-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|EIT-Lunge||Electrical Impedance Tomography of Lung in Child and Young Age|Electrical Impedance Tomography of Lung in Child and Young Age|Completed||N/A|192|Actual|RWTH Aachen University|||2||f||||f||||||||||2017-10-10 23:49:26.79981|2017-10-10 23:49:26.79981
NCT02290522|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-10-28|||May 2013||2013-05-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CoPPO||Copenhagen Prospective Personalized Oncology (CoPPO)|A Prospective Study Using Genomic Screening to Select Patients for Targeted Molecular Treatment|Recruiting||N/A|500|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-10 23:49:26.874379|2017-10-10 23:49:26.874379
NCT02290509|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-09-22|2016-06-17||October 2014||2014-10-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||The baseline analysis population includes the Safety Population, all randomized subjects who were immunized and provided any safety data (solicited or unsolicited) following administration of study vaccine.|Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age|Double-Blind, Randomized, Active-Controlled Comparison of the Immunogenicity and Safety of Flublok® Quadrivalent Versus IIV4 in Healthy, Medically Stable Adults 18-49 Years of Age|Completed||Phase 3|1350|Actual|Protein Sciences Corporation||2|||f||||f||||||||||2017-10-10 23:49:28.690779|2017-10-10 23:49:28.690779
NCT02290496|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-08-31|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|SleepWell||CBT Insomnia Teens: Augmenting SSRIs to Improve Youth Depression|CBT Insomnia Teens: Augmenting Usual Care SSRIs to Improve Youth Depression Outcomes|Active, not recruiting||Phase 3|165|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-10 23:49:29.105841|2017-10-10 23:49:29.105841
NCT02290470|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-11-11|||April 2014||2014-04-01|November 2014|2014-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel|Olanzapine for the Prevention of Delayed Nausea and Vomiting in Patients With Gynecologic Cancers Receiving Carboplatin and Paclitaxel-based Chemotherapy and Guideline-directed Prophylactic Anti-emetics|Unknown status|Recruiting|Phase 2|81|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||3|||f||||f||||||||||2017-10-10 23:49:29.18655|2017-10-10 23:49:29.18655
NCT02290457|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-13|||June 2014||2014-06-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Core Strength Training in Youth|Effects of Core Strength Training Using Unstable Surfaces on Physical Fitness in Adolescents|Completed||N/A|27|Actual|University of Potsdam||2|||f||||f||||||||||2017-10-10 23:49:29.291316|2017-10-10 23:49:29.291316
NCT02290444|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-04-24|||August 2013||2013-08-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Effects of Acthar on Recovery From Cognitive Relapses in MS|Effects of Adrenocorticotropic Hormone (ACTHAR Gel) on Recovery From Cognitive Relapses in Multiple Sclerosis|Enrolling by invitation||Phase 3|60|Anticipated|State University of New York at Buffalo||2|||f||||t||||||||||2017-10-10 23:49:29.380444|2017-10-10 23:49:29.380444
NCT02290418|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-10|||January 2012||2012-01-01|November 2014|2014-11-01|December 2018|Anticipated|2018-12-01|June 2016|Anticipated|2016-06-01||Interventional|ROSESS||Roux-en-Y Gastric Bypass (RYGB) Versus Omega-Loop Gastric Bypass (OLGB) Safety and Efficacy Short-term Study|Prospective Randomized Controlled Clinical Study Comparing Two Bariatric Bypass Procedures, Roux-en-Y Gastric Bypass (RYGB) and Omega-Loop Gastric Bypass (OLGB), in Patients With Severe Obesity and Metabolic Disease|Active, not recruiting||N/A|50|Anticipated|Nemocnice Břeclav, p.o.||2|||f||||f||||||||||2017-10-10 23:49:30.182024|2017-10-10 23:49:30.182024
NCT02290405|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-03-28|||October 1, 2014|Actual|2014-10-01|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|October 31, 2017|Anticipated|2017-10-31||Observational|||Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers|Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers|Recruiting||N/A|164|Anticipated|National Jewish Health|||2||f||||f||||||||||2017-10-10 23:49:30.39834|2017-10-10 23:49:30.39834
NCT02290392|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-11|2017-08-08|||October 23, 2014||2014-10-23|August 3, 2017|2017-08-03|July 1, 2030|Anticipated|2030-07-01|July 1, 2030|Anticipated|2030-07-01||Observational|||Minority Health Genomics and Translational Research Bio-Repository Database (MH-GRID)-2.0|The Minority Health Genomics and Translational Research BIo-Repository Database (MH-GRID)-2.0|Active, not recruiting||N/A|1692|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:49:30.547136|2017-10-10 23:49:30.547136
NCT02290379|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-05-16|||November 2014||2014-11-01|November 2014|2014-11-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Phase 1 Single Ascending Dose Safety Study of TNX-201 Capsules in Healthy Volunteers|A Single-Center, Randomized, Double-blind, Placebo-controlled, Phase 1, Single Ascending Dose Safety, Tolerability, and Pharmacokinetic Study of TNX-201 Capsules in Healthy Volunteers.|Completed||Phase 1|27|Actual|Tonix Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-10-10 23:49:30.662052|2017-10-10 23:49:30.662052
NCT02290366|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-06-22|||November 2014||2014-11-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer|Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer|Recruiting||Phase 2|100|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-10 23:49:30.787989|2017-10-10 23:49:30.787989
NCT02290353|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-03-30|||April 2015|Actual|2015-04-01|March 2017|2017-03-01|November 16, 2015|Actual|2015-11-16|November 16, 2015|Actual|2015-11-16||Interventional|FEATHERS||Functional Engagement in Assisted Therapy Through Exercise Robotics|Functional Engagement in Assisted Therapy Through Exercise Robotics|Completed||N/A|10|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:49:30.920783|2017-10-10 23:49:30.920783
NCT02290327|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-02-05|||May 2015||2015-05-01|February 2016|2016-02-01||||January 2016|Actual|2016-01-01||Interventional|REVISE||Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU||Completed||Phase 3|91|Actual|McMaster University||2|||f||||f||||||||||2017-10-10 23:49:31.204884|2017-10-10 23:49:31.204884
NCT02290314|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-03-07|||December 2014||2014-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Midline Lumbar Fusion Versus Posterior Lumbar Interbody Fusion|Minimal Access Midline Lumbar Fusion Versus Traditional Open Posterior Lumbar Interbody Fusion for Degenerative Lumbar Spondylolisthesis|Recruiting||N/A|60|Anticipated|The London Spine Centre||2|||f||||t||||||||||2017-10-10 23:49:31.332953|2017-10-10 23:49:31.332953
NCT02290301|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-01-27|||June 2013||2013-06-01|January 2016|2016-01-01||||December 2017|Anticipated|2017-12-01||Observational|||An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin|An Observational Study to Evaluate Cardiovascular Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Gemigliptin|Active, not recruiting||N/A|5180|Actual|LG Life Sciences|||1||f||||||||||||||2017-10-10 23:49:31.446808|2017-10-10 23:49:31.446808
NCT02290288|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-05-18|||October 2005||2005-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Prospective Study for Vaginal Vault Prolapse After Hysterectomy: Comparison of Two Surgical Methods|Prospective Randomized Study for Vaginal Vault Prolapse After Hysterectomy: Comparison of a Vaginal and Laparoscopic Method With Validation of Translated Questionnaire for Symptoms and Quality of Life by Vaginal Prolapse.|Completed||N/A|138|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-10 23:49:31.515171|2017-10-10 23:49:31.515171
NCT02290275|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-05-12|||January 2015||2015-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Creatine, Exercise and Inflammatory Markers in Knee Osteoarthritis|Creatine, Exercise and Inflammatory Markers in Knee Osteoarthritis|Completed||N/A|30|Actual|University of Manitoba||3|||f||||f||||||||||2017-10-10 23:49:31.601022|2017-10-10 23:49:31.601022
NCT02290262|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-12-30|||November 2014||2014-11-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|SheppHeart||SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting|SheppheartCABG. A Randomised Clinical Trial of a Comprehensive Physical and Psycho-educative Rehabilitation Programme Plus Usual Care Versus Usual Care in Phase 1 Rehabilitation After Coronary Artery Bypass Grafting|Completed||N/A|326|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:49:31.682992|2017-10-10 23:49:31.682992
NCT02290236|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-10-11|||September 2014||2014-09-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|||Monitored Saturation Post-ICU|Monitored Saturation Post-ICU; Correlation to Charted Saturation, Pre-intensive Care Unit Obstructive Sleep Apnea and Outcome|Enrolling by invitation||N/A|500|Anticipated|Karolinska University Hospital|||1||f||||f||||||||||2017-10-10 23:49:31.841991|2017-10-10 23:49:31.841991
NCT02290223|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-09-05|||June 2015||2015-06-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 6, 2017|Actual|2017-08-06||Interventional|||Patient Activation to Address Chronic Pain and Opioid Management in Primary Care|Patient Activation to Address Chronic Pain and Opioid Management in Primary Care|Active, not recruiting||N/A|377|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-10 23:49:31.929587|2017-10-10 23:49:31.929587
NCT02290210|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-03-06|||July 24, 2014|Actual|2014-07-24|March 2017|2017-03-01|August 31, 2015|Actual|2015-08-31|December 2, 2014|Actual|2014-12-02||Interventional|||Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients|A Placebo-controlled, Randomized, Double-blind, Multicenter Phase 2 Study to Assess the Efficacy and Safety of URC102 in Gout Patients|Completed||Phase 2|64|Actual|JW Pharmaceutical||5|||f||||||||||||||2017-10-10 23:49:32.06851|2017-10-10 23:49:32.06851
NCT02290197|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-11-08|||August 2010||2010-08-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|November 2014|Anticipated|2014-11-01||Interventional|||Knee Dislocation - Clinical Evaluation of the Use of Hinged External Fixator After Ligament Reconstruction|Knee Dislocation - Clinical Evaluation of the Use of Hinged External Fixator After Ligament Reconstruction. Randomized Prospective Study.|Unknown status|Active, not recruiting|N/A|40|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:49:32.264703|2017-10-10 23:49:32.264703
NCT02290171|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2016-05-22|||August 2014||2014-08-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Promoting Health in Healthy Living Centres - a Clinical Study Among Children|Promoting Health in Healthy Living Centres - a Clinical Study Among Famililies With Overweight Children|Recruiting||Phase 1|100|Anticipated|University of Bergen||2|||f||||f||||||||||2017-10-10 23:49:32.462959|2017-10-10 23:49:32.462959
NCT02290158|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2015-12-07|||June 2013||2013-06-01|November 2014|2014-11-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Effects of a Finishing Protocol Implementation in Orthodontic Patients|Effects of a Finishing Protocol Implementation on the American Board of Orthodontics - Objective Grading System Score in Patients of Orthodontic Postgraduate Program: A Quasiexperimental Clinical Trial|Completed||N/A|34|Actual|Universidad de Antioquia||2|||f||||f||||||||||2017-10-10 23:49:32.572818|2017-10-10 23:49:32.572818
NCT02289794|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-02-10|||January 2014||2014-01-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Vaccine Against Escherichia Coli Infection|Evaluation of a Candidate Vaccine Against Uropathogenic Escherichia Coli in Women With a Clinical History of Recurrent Urinary Tract Infection|Completed||Phase 1|194|Actual|GlycoVaxyn AG||2|||f||||t||||||||No||2017-10-10 23:49:36.935189|2017-10-10 23:49:36.935189
NCT02290145|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-08-16|||December 2016||2016-12-01|November 2015|2015-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage|Cyclin D1 Based TPF(Docetaxel, Cisplatin and 5-fluorouracil) Induction Chemotherapy for OSCC(Oral Squamous Cell Carcinoma) Patients at cN2(Clinical Node 2) Stage: a Phase II Randomized Controlled Trial|Recruiting||Phase 2|48|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 23:49:32.660454|2017-10-10 23:49:32.660454
NCT02290132|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-11-08|||August 2013||2013-08-01|November 2014|2014-11-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01|4 Years|Observational [Patient Registry]|HSCT||ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors|Hematology , Shanghai Jiaotong University Affiliated Shanghai First People's Hospital, Shanghai, China|Unknown status|Recruiting|Phase 4|63|Anticipated|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||t||||||||||2017-10-10 23:49:32.773115|2017-10-10 23:49:32.773115
NCT02290119|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-04-03|||May 2014||2014-05-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||PILOT STUDY: Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing: A Randomized, Double-Blind, Controlled Trial||Recruiting||N/A|40|Anticipated|Orthosensor, Inc.||2|||f||||f||||||||||2017-10-10 23:49:32.889292|2017-10-10 23:49:32.889292
NCT02290106|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2017-08-28|||March 2, 2015|Actual|2015-03-02|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Pitavastatin on Insulin Sensitivity and Liver Fat|Effects of Pitavastatin on Insulin Sensitivity and Liver Fat|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:49:32.982742|2017-10-10 23:49:32.982742
NCT02290093|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-02-22|||November 2014||2014-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Bowel Preparation for Colonoscopy in the Elderly|Bowel Preparation With Standard 4 Liters of PEG vs. Split-dose of 4 Liters PEG vs. Split-dose of 2 Liters PEG Containing Ascorbic Acid Solutions for Outpatient Elective Colonoscopy in the Elderly: A Randomized, Colonoscopist-blinded Study|Completed||Phase 4|230|Actual|Kyunghee University Medical Center||3|||f||||t||||||||||2017-10-10 23:49:33.093181|2017-10-10 23:49:33.093181
NCT02290080|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2017-03-02|||October 2014|Actual|2014-10-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|December 2015|Actual|2015-12-01||Interventional|DETO2X-bio||Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers|Determination of the Role of Oxygen on Mechanisms Involved in Ischemia-reperfusion Injury in Suspected Acute Myocardial Infarction by Biomarkers. A Sub Study to the DETO2X-AMI Trial.|Active, not recruiting||Phase 3|175|Actual|Karolinska Institutet||2|||f||||f|t|f||||||||2017-10-10 23:49:33.204101|2017-10-10 23:49:33.204101
NCT02290067|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-12-19|||October 2014||2014-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||System Accuracy and User Performance of Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus|EVALUATING SYSTEM ACCURACY AND USER PERFORMANCE OF BLOOD GLUCOSE MONITORING SYSTEMS FOR SELF-TESTING IN MANAGING DIABETES MELLITUS|Completed||N/A|130|Anticipated|B. Braun Melsungen AG||3|||f||||f||||||||||2017-10-10 23:49:33.307265|2017-10-10 23:49:33.307265
NCT02290054|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2017-06-07|||April 2014||2014-04-01|June 2017|2017-06-01|May 23, 2016|Actual|2016-05-23|May 23, 2016|Actual|2016-05-23||Interventional|RUPO||Auriculotherapy for Prevention of Postoperative Urinary Retention|Auriculotherapy for Prevention of Postoperative Urinary Retention in Men Receiving Postoperative Epidural Analgesia After Thoracic Surgery|Completed||N/A|53|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-10 23:49:33.398304|2017-10-10 23:49:33.398304
NCT02290041|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-06-12|||March 2015||2015-03-01|November 2014|2014-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response|Clinical Trial Phase I/II, of Test of Concept, Blind Double, Randomized, Controlled With Placebo, to Assess the Safety and Efficiency of the Treatment With Allogenic Adult Mesenchymal Stem Cells From Adipose Tissue Expanded, in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response|Unknown status|Not yet recruiting|Phase 1/Phase 2|15|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||t||||||||||2017-10-10 23:49:33.526368|2017-10-10 23:49:33.526368
NCT02290028|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-09-18|||January 2015||2015-01-01|August 2017|2017-08-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|QP ExCELs||Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads|Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads|Recruiting||N/A|1754|Anticipated|Biotronik SE & Co. KG||1|||f||||t||||||||||2017-10-10 23:49:33.66022|2017-10-10 23:49:33.66022
NCT02290015|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-11-08|||August 2010||2010-08-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|||Acupuncture as a Treatment for Tinnitus|Effectiveness of Acupuncture as a Treatment for Tinnitus: a Randomized Controlled Trial Using 99mTc-ECD SPECT|Completed||N/A|57|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-10 23:49:33.984503|2017-10-10 23:49:33.984503
NCT02290002|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2017-02-13|||June 2014||2014-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome|Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome|Completed||Phase 2/Phase 3|200|Actual|Benha University||2|||f||||f||||||||Undecided||2017-10-10 23:49:34.049672|2017-10-10 23:49:34.049672
NCT02289989|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-03-29|2017-02-06||November 2014||2014-11-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis|Investigator-Initiated, Randomized, Investigator-Blind, Half-Side Comparison of Topical Oregano Extract Ointment vs .Hydrocortisone 1% for the Treatment of Atopic Dermatitis in Pediatric Patients|Terminated||N/A|1|Actual|Rutgers, The State University of New Jersey|Termination of the trial due to difficulty recruiting patients.|2||Lack of response to recruitment|f||||f||||||||Undecided||2017-10-10 23:49:34.131769|2017-10-10 23:49:34.131769
NCT02289976|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-12|||February 2014||2014-02-01|November 2014|2014-11-01|November 2016|Anticipated|2016-11-01|November 2014|Anticipated|2014-11-01||Interventional|TalarAVN||Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression|Talar Avascular Necrosis: Surgical Angiogenesis Compared to Core Decompression With Osseous Autografting|Unknown status|Recruiting|N/A|20|Anticipated|BG Trauma Center Ludwigshafen||2|||f||||f||||||||||2017-10-10 23:49:34.448773|2017-10-10 23:49:34.448773
NCT02289963|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-06-22|2017-04-24||January 2015||2015-01-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Baseline population included all randomized participants.|Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab in High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy in South Korea and Taiwan|Completed||Phase 3|199|Actual|Sanofi||2|||f||||t|t||||t|||||2017-10-10 23:49:34.674864|2017-10-10 23:49:34.674864
NCT02289950|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-03-06|||March 2015||2015-03-01|February 2017|2017-02-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Subjects With Low CA125 Platinum-Sensitive Ovarian Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Subjects With Low CA125 Platinum-Sensitive Ovarian Cancer|Recruiting||Phase 2|210|Anticipated|Morphotek||2|||f||||t||||||||||2017-10-10 23:49:35.612123|2017-10-10 23:49:35.612123
NCT02289937|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-12|||March 2014||2014-03-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of a Lateral Nerve of the Thigh Block on Postoperative Pain After Total Hip Replacement Surgery|Effect of a Lateral Nerve of the Thigh Block on Postoperative Pain After Total Hip Replacement Surgery: a Clinical Randomized Trial|Completed||Phase 4|100|Actual|Naestved Hospital||2|||f||||t||||||||||2017-10-10 23:49:35.867413|2017-10-10 23:49:35.867413
NCT02289924|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-22|||January 5, 2015|Actual|2015-01-05|August 2017|2017-08-01|April 30, 2019|Anticipated|2019-04-30|December 31, 2018|Anticipated|2018-12-31||Observational|PERSEUS-IT||Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy|PERSEUS-IT. A Prospective Non-intERventional Study to asSEss the Effectiveness of Aflibercept (Eylea®) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy|Active, not recruiting||N/A|912|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:49:35.962391|2017-10-10 23:49:35.962391
NCT02289911|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-10|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|FAST||FAST Learning Methods|Comparison of Two Learning Methods in Focused Assessment With Sonography for Trauma (FAST) Training Among Paramedics|Unknown status|Recruiting|N/A|100|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:49:36.060695|2017-10-10 23:49:36.060695
NCT02289898|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-14|||April 20, 2015|Actual|2015-04-20|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|May 2017|Actual|2017-05-01||Interventional|YOSEMITE||Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma|A 3-Arm Phase 2 Double-Blind Randomized Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma|Active, not recruiting||Phase 2|207|Actual|OncoMed Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-10 23:49:36.16086|2017-10-10 23:49:36.16086
NCT02289885|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-10|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|FAST||FAST Examination During Emergency Practice|Knowledge, Attitude and Practice About Focused Assessment With Sonography in Trauma Among Paramedics. Randomized Crossover Manikin Trial|Unknown status|Recruiting|N/A|100|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:49:36.331131|2017-10-10 23:49:36.331131
NCT02289872|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-01-21|||November 2014||2014-11-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ETICPR||Pediatric Intubation|Comparison of the TruView PCD Video Laryngoscope and Macintosh Laryngoscope for Pediatric Tracheal Intubation by Novice Paramedics: A Randomized Crossover Simulation Trial.|Completed||N/A|120|Actual|International Institute of Rescue Research and Education||3|||f||||t||||||||||2017-10-10 23:49:36.416381|2017-10-10 23:49:36.416381
NCT02289859|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-07-17|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Undermining During Cutaneous Wound Closure|Undermining During Cutaneous Wound Closure: a Randomized Split Wound Comparative Effectiveness Trial|Completed||N/A|50|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-10 23:49:36.485525|2017-10-10 23:49:36.485525
NCT02289846|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-12-01||2016-12-01|October 2014||2014-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Study of Oral IW-9179 Administered Once and Twice Daily for 4 Weeks to Patients With Diabetic Gastroparesis|Completed||Phase 2|90|Actual|Ironwood Pharmaceuticals, Inc.||4|||f||||||||||||||2017-10-10 23:49:36.557544|2017-10-10 23:49:36.557544
NCT02289833|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-04-12|||October 31, 2014|Actual|2014-10-31|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|October 25, 2016|Actual|2016-10-25||Interventional|||A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)|A Phase 2, Multicenter, Single-Arm Study of Trastuzumab Emtansine in Patients With HER2 IHC-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Received At Least One Prior Chemotherapy Regimen|Active, not recruiting||Phase 2|49|Actual|Hoffmann-La Roche||1|||f|||||t|f||||||||2017-10-10 23:49:36.653436|2017-10-10 23:49:36.653436
NCT02289807|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-10|||March 2015||2015-03-01|November 2014|2014-11-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy|Prospective Non-inferior Clinical Trial Comparing Concurrent Chemoradiotherapy or Radiotherapy Alone in Patients With Intermediate Risk Nasopharyngeal Carcinoma in Intensity-modulated Radiotherapy Era|Not yet recruiting||N/A|280|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:49:36.848308|2017-10-10 23:49:36.848308
NCT02289768|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-08-03|||October 2014||2014-10-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses|Multicentre, Randomized, Parallel, Double-Blind, Vehicle Controlled Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In The Field-Directed Treatment Of Actinic Keratoses Grade I To II (Field Cancerization)|Completed||Phase 3|166|Actual|Almirall, S.A.||2|||f||||f||||||||||2017-10-10 23:49:37.237215|2017-10-10 23:49:37.237215
NCT02289755|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-03-25|2015-12-16||September 2014||2014-09-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional||All subjects (N=16) were included in the analysis.|Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria|A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria|Completed||Phase 2|16|Actual|Allena Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:49:37.377931|2017-10-10 23:49:37.377931
NCT02289742|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-06-15|2016-03-31||December 2014||2014-12-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||This analysis population includes all randomized and exposed subjects.|Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric|Characterization of Pre-Lens Tear Film Stability of Daily Disposable Multifocal and Toric Contact Lenses Using Ring Mire Projection|Completed||N/A|48|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:49:37.703195|2017-10-10 23:49:37.703195
NCT02289729|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-12-07|||October 2014||2014-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|ADEQUA||Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease|Study on Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease|Completed||N/A|1|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 23:49:38.101575|2017-10-10 23:49:38.101575
NCT02289716|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-09-06||2017-09-06|July 10, 2015|Actual|2015-07-10|August 2017|2017-08-01|October 10, 2016|Actual|2016-10-10|October 10, 2016|Actual|2016-10-10||Interventional|||Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3003|Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee|Completed||Phase 3|41|Actual|Janssen Research & Development, LLC||3|||f||||t||f||||||||2017-10-10 23:49:38.241004|2017-10-10 23:49:38.241004
NCT02289703|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-01-23|||January 2015||2015-01-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis|An Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of Rivaroxaban in Subjects With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-10 23:49:38.410366|2017-10-10 23:49:38.410366
NCT02289677|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2014-11-12|||November 2014||2014-11-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|ETICPR||Pediatric Intubation During CPR|Comparison of the Atmos Scope, the Coopdech and the AirTraq in Pediatric Patients During Resuscitation. Randomized Crossover Manikin Trial|Unknown status|Enrolling by invitation|N/A|100|Anticipated|International Institute of Rescue Research and Education||1|||f||||t||||||||||2017-10-10 23:49:38.763652|2017-10-10 23:49:38.763652
NCT02289664|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-12|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Videolaryngoscopy During Child Intubation|A Comparison of Coopdech, Intubrite, and CoPilot Video-laryngoscopes With Macintosh Laryngoscope for Tracheal Intubation in Pediatric Patients During Resuscitation. Randomized Crossover Manikin Trial|Unknown status|Recruiting|N/A|80|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:49:38.842785|2017-10-10 23:49:38.842785
NCT02289651|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-12|||November 2014||2014-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|PETI||Effectiveness of Pediatric Intubation|Comparison of the Venner(TM) A.P. Advance(TM) With the Macintosh Laryngoscope for Emergency Intubation in a Standardized Airway Manikin With and Without Chest Compressions by Nurses. A Randomized, Controlled Crossover Trial.|Unknown status|Recruiting|N/A|80|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:49:38.958637|2017-10-10 23:49:38.958637
NCT02289638|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-12|||November 2014||2014-11-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Effectiveness of Child Intubation|First Comparison of the /Intubrite VideoLaryngoscope System Versus the Miller Laryngoscope for Intubations by Non-anaesthetists: a Manikin Study.|Unknown status|Recruiting|N/A|100|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:49:39.075539|2017-10-10 23:49:39.075539
NCT02289625|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-04-26|||October 2010||2010-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Exercise Training on Cognitive Performance and Sympathetic Activity in Obstructive Sleep Apnea|Effects of Exercise Training on Structure and Cerebral Metabolism, Cognition and Neurovascular Control in Individuals With Obstructive Sleep Apnea|Active, not recruiting||N/A|70|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||No||2017-10-10 23:49:39.183117|2017-10-10 23:49:39.183117
NCT02289612|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-05-27|||November 2014||2014-11-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|Pudding||Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products|The Pudding Study: The Effect of Effect of Fibre-enriched Pudding Products on Glycemic and Satiety Response in Adults at Risk for Type 2 Diabetes|Unknown status|Recruiting|N/A|15|Anticipated|University of Guelph||10|||f||||f||||||||||2017-10-10 23:49:39.271545|2017-10-10 23:49:39.271545
NCT02289599|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-01-15|||November 2014||2014-11-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects|A Randomized, Double-blind, Placebo-controlled, Single-Ascending Dose Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects|Completed||Phase 1|24|Actual|Eisai Inc.||8|||f||||f||||||||||2017-10-10 23:49:39.397843|2017-10-10 23:49:39.397843
NCT02289586|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-11-12|||July 2014||2014-07-01|August 2014|2014-08-01||||February 2016|Anticipated|2016-02-01||Interventional|||Interventional Bronchoscopy Under Noninvasive Ventilation|Interventional Bronchoscopy Under Noninvasive Ventilation for Central Airway Stenosis|Unknown status|Recruiting|N/A|40|Anticipated|Futian People's Hospital||2|||f||||t||||||||||2017-10-10 23:49:39.50689|2017-10-10 23:49:39.50689
NCT02289573|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-11-12|||November 2014||2014-11-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Effects of NAVA and PSV to AECOPD Patients' Air Distribution and Dead Space|Effects of NAVA and PSV to AECOPD Patients' Air Distribution and Dead Space|Unknown status|Not yet recruiting|Phase 3|15|Anticipated|Southeast University, China||2|||f||||f||||||||||2017-10-10 23:49:39.601249|2017-10-10 23:49:39.601249
NCT02289560|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-07-06|||April 2015||2015-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors|A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects|Active, not recruiting||N/A|50|Anticipated|InSightec||1|||f||||t||||||||||2017-10-10 23:49:39.665901|2017-10-10 23:49:39.665901
NCT02289547|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-06-13|||May 2015||2015-05-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer|Randomized Phase 3 Study of Xelox(Capecitabine Plus Oxaliplatin) Followed by Maintenance Capecitabine or Observation in Patients With Advanced Gastric Adenocarcinoma|Recruiting||Phase 3|184|Anticipated|The Catholic University of Korea||2|||f||||f||||||||Undecided||2017-10-10 23:49:39.74827|2017-10-10 23:49:39.74827
NCT02289534|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2016-02-12|||February 2014||2014-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:49:39.874392|2017-10-10 23:49:39.874392
NCT02289521|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-10-28|||August 2014||2014-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Stimulation of Dorsolateral Prefrontal Cortex on Language Control|Role of Executive Function on Language: an Experimental and Clinical Approach With Application to Mother Language and Second Language|Active, not recruiting||N/A|28|Actual|University of Fribourg||2|||f||||f||||||||||2017-10-10 23:49:39.910508|2017-10-10 23:49:39.910508
NCT02289508|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-09-28|||November 2014||2014-11-01|September 2017|2017-09-01|November 6, 2017|Anticipated|2017-11-06|November 6, 2017|Anticipated|2017-11-06||Observational|||Role of USCOM in Adult Patients With Heart Failure|Diagnostic and Prognostic Role of USCOM in Adult Patients With Heart Failure-A Prospective Observational Study|Suspended||N/A|280|Anticipated|Chinese University of Hong Kong|||4|Inadequate funding to continue at present. Data being analysed.|f||||f||||||Samples With DNA|"     10ml venous blood will be collected through venipuncture. Blood will be centrifuged, plasma     decanted, and stored pending B-type Natriuretic Peptide (BNP) measurements.   "|||2017-10-10 23:49:39.996351|2017-10-10 23:49:39.996351
NCT02289495|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-05-05|||November 18, 2014|Actual|2014-11-18|May 2017|2017-05-01|June 27, 2015|Actual|2015-06-27|June 27, 2015|Actual|2015-06-27||Interventional|||A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects|A Double Blind, Placebo Controlled, Single and Repeat Dose Escalation Study of GSK2838232 With and Without Ritonavir for 8-11 Days in Healthy Subjects|Terminated||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:49:40.135919|2017-10-10 23:49:40.135919
NCT02289482|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-05-12|||November 17, 2014|Actual|2014-11-17|May 2017|2017-05-01|March 10, 2015|Actual|2015-03-10|March 10, 2015|Actual|2015-03-10||Interventional|||A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects|A Double-Blind, Randomized, Placebo-Controlled, Continuation Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 With and Without Ritonavir, and to Evaluate Different Formulations of GSK2838232, in Healthy Subjects|Terminated||Phase 1|20|Actual|GlaxoSmithKline||2||Study prematurely terminated due to safety concerns leading to clinical hold|f||||f||||||||||2017-10-10 23:49:40.226325|2017-10-10 23:49:40.226325
NCT02289469|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2017-07-05|2017-02-15||April 2015||2015-04-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||PictureRx: Improving Medication Safety in Health Disparity Populations|PictureRx: Improving Medication Safety in Health Disparity Populations|Completed||N/A|488|Actual|PictureRx, LLC||2|||f||||f||||||||||2017-10-10 23:49:40.329481|2017-10-10 23:49:40.329481
NCT02289456|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-05-22|||April 28, 2015|Actual|2015-04-28|May 2017|2017-05-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Interventional|AboundPS2||Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2|A Phase II, Single Arm, Open-Label, Multicenter, Safety and Tolerability Trial With Nab-Paclitaxel (ABRAXANE®) Plus Carboplatin Followed by Nab-Paclitaxel Monotherapy as First-Line Treatment for Subjects With Locally Advanced or Metastatic Nonsmall Cell Lung Cancer (NSCLC) and an Eastern Cooperative Oncology Group Performance Status of 2 (ABOUND.PS2)|Completed||Phase 2|41|Actual|Celgene||1|||f||||t||||||||||2017-10-10 23:49:40.700059|2017-10-10 23:49:40.700059
NCT02289443|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2017-03-27|||September 2012||2012-09-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||a 10-year Follow-up Study of a Randomized Clinical Trial|Comparison of Two Different Procedures Fabrication of Conventional Complete Dentures: a 10-year Follow-up Study of a Randomized Clinical Trial|Completed||N/A|104|Actual|Nihon University|||2||f||||f||||||||No||2017-10-10 23:49:40.793413|2017-10-10 23:49:40.793413
NCT02289430|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2016-03-24|||December 2014||2014-12-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|NVP-1205||to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers|A Phase I Clinical Trial to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers|Completed||Phase 1|59|Actual|Navipharm Corporation||3|||f||||t||||||||No||2017-10-10 23:49:41.036792|2017-10-10 23:49:41.036792
NCT02289417|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-08-31|||December 10, 2014|Actual|2014-12-10|August 2017|2017-08-01|August 29, 2019|Anticipated|2019-08-29|December 21, 2017|Anticipated|2017-12-21||Interventional|UC||Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis|A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Apremilast (CC-10004) for Treatment of Subjects With Active Ulcerative Colitis|Active, not recruiting||Phase 2|171|Actual|Celgene||3|||f||||t||||||||||2017-10-10 23:49:41.175314|2017-10-10 23:49:41.175314
NCT02289404|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2017-04-10|||January 2015||2015-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NVP-1203||Evaluate the Food Effect on the Pharmacokinetics of NVP-1203|Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of NVP-1203 in Healthy Male Volunteers|Suspended||Phase 1|42|Anticipated|Navipharm Corporation||2||Due to operational reasons|f||||t||||||||No||2017-10-10 23:49:41.574594|2017-10-10 23:49:41.574594
NCT02289391|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-10|||December 2014||2014-12-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia|Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia-single Center,Randomized,Double-blind，Controlled Trial|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Second Affiliated Hospital of Xi'an Jiaotong University||4|||f||||f||||||||||2017-10-10 23:49:41.695597|2017-10-10 23:49:41.695597
NCT02289378|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-13|||November 2014||2014-11-01|November 2014|2014-11-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|DaeMon-Plus||Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer|Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 23:49:41.833063|2017-10-10 23:49:41.833063
NCT02289365|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-06-14|||November 2014||2014-11-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients|Phase 2 Study of Orally Administrated JBM-TC4 for the Prevention of Acute Radiation-induced Dermatitis in Breast Cancer Patients|Enrolling by invitation||Phase 2|120|Actual|Joben Bio-Medical Co., Ltd.||3|||f||||t||||||||||2017-10-10 23:49:41.986643|2017-10-10 23:49:41.986643
NCT02289352|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-03-18|||July 2014||2014-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea|A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel-Design Study to Evaluate the Safety and Therapeutic Equivalence of Brimonidine Topical Gel, 0.33% (Watson Laboratories, Inc., USA) to Reference Product Mirvaso® (Brimonidine) Topical Gel, 0.33% (Galderma Laboratories, L.P., USA) in Patients With Moderate to Severe Facial Erythema Associated With Rosacea|Completed||Phase 3|462|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-10 23:49:42.153472|2017-10-10 23:49:42.153472
NCT02289339|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-08|2017-03-08|||November 2007|Actual|2007-11-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|EVERY-TAVI||Everyday Practice With Transcatheter Aortic Valve Implantation|Experience With Percutaneous Transcatheter Aortic Valve Implantation in Patients With Symptomatic Aortic Valve Disease in Two German Centers|Recruiting||N/A|2000|Anticipated|Klinikum der Universitaet Muenchen|||1||f||||f||||||||Undecided||2017-10-10 23:49:42.287595|2017-10-10 23:49:42.287595
NCT02289326|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2015-04-26|||July 2014||2014-07-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|||Biomarker Monitoring in TP53 Mutation Carriers|Biomarker Monitoring for a Young Individual Carrying a TP53 Gene Mutation in a Familial High-Cancer Predisposition Setting|Unknown status|Active, not recruiting|N/A|100|Anticipated|Scripps Health|||1||f||||t||||||Samples With DNA|"     -  DNA and RNA from blood        -  Stool samples for microbiome analysis        -  Urine samples for microbiome and general biomarker analysis        -  Saliva samples for microbiome and general biomarker analysis        -  Blood for general biomarker and metabolite profiling   "|||2017-10-10 23:49:42.415238|2017-10-10 23:49:42.415238
NCT02289313|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2016-03-18|||November 2014||2014-11-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Development of a Youth Healthy Living Program With Underserved Adolescents at Rochester Alternative Learning Center|Development of a Youth Healthy Living Program at the Rochester Alternative Learning Center|Active, not recruiting||N/A|224|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:49:42.499007|2017-10-10 23:49:42.499007
NCT02289300|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2015-12-28|||December 2014||2014-12-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients|A Phase II Randomized, Double-Blind, Placebo Controlled, Parallel Study of DCB-BO1202 for Alleviating Liver Fibrosis in HBV Patients With Intermediate Hepatocellular Carcinoma Receiving Loco-regional Therapies|Suspended||Phase 2|188|Anticipated|A2 Healthcare Taiwan Corporation||3||On hold by FDA|f||||t||||||||||2017-10-10 23:49:42.603434|2017-10-10 23:49:42.603434
NCT02289287|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2017-07-18|||April 17, 2017|Actual|2017-04-17|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of a Self-Management Group-Intervention on Participation in Post-Stroke Patients.|Effects of a Self-Management Group-Intervention on Participation in Post-Stroke Patients.|Recruiting||N/A|90|Anticipated|Clalit Health Services||2|||f||||f|f|f||||||||2017-10-10 23:49:42.721362|2017-10-10 23:49:42.721362
NCT02289274|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-09|2017-04-10|||December 2014||2014-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NVP-1203||Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203|Partial Replicated Crossover Clinical Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203 Treatment to Those of Co-administration of Eperisone Hydrochloride Slow Release and Aceclofenac in Volunteers|Suspended||Phase 1|30|Anticipated|Navipharm Corporation||2||Due to operational reasons|f||||f||||||||No||2017-10-10 23:49:42.839726|2017-10-10 23:49:42.839726
NCT02289261|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-10|2014-11-10|||November 2014||2014-11-01|November 2014|2014-11-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain|A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain|Unknown status|Recruiting|Phase 4|40|Anticipated|Cukurova University||2|||f||||f||||||||||2017-10-10 23:49:42.942273|2017-10-10 23:49:42.942273
NCT02289248|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-02-27|||February 2015||2015-02-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine|Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine|Completed||Phase 1|16|Actual|Yale University||1|||f||||t||||||||||2017-10-10 23:49:43.056296|2017-10-10 23:49:43.056296
NCT02289235|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-02-22|||November 2014||2014-11-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|GinLiv||The Effects of Ginger on Nonalcoholic Fatty Liver Disease|The Effects of Ginger on Biochemical Markers and Imaging Studies of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)|Active, not recruiting||Early Phase 1|90|Anticipated|Shiraz University of Medical Sciences||2|||f||||t||||||||Undecided||2017-10-10 23:49:43.171417|2017-10-10 23:49:43.171417
NCT02289222|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-11-03|||December 2014||2014-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma|1454GCC: Phase I/II Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|48|Actual|University of Maryland||1|||f||||t||||||||||2017-10-10 23:49:43.282934|2017-10-10 23:49:43.282934
NCT02289209|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-03-30|||December 2014||2014-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reirradiation With MK-3475 (Pembrolizumab) in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck|A Phase II Trial of Reirradiation Combined With Open Label MK-3475 in Patients With Locoregional Inoperable Recurrence or Second Primary Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 2|48|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-10 23:49:43.372468|2017-10-10 23:49:43.372468
NCT02289196|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-11-04|||March 2014||2014-03-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|October 2014|Actual|2014-10-01||Interventional|||Safety Study of Vx006 Vaccine in Solid Tumor Patients|A Multicenter, Open Label, Uncontrolled Phase I Trial to Compare Safety, Tolerability and Immunogenicity of Vx-006 Vaccine at 0.5mg, 1mg, 5mg and 10mg Doses in Human Leukocyte Antigen-A02 (HLA-A02) Positive Patients With Solid Tumours|Active, not recruiting||Phase 1|23|Actual|Vaxon Biotech||4|||f||||f||||||||||2017-10-10 23:49:43.497393|2017-10-10 23:49:43.497393
NCT02289183|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-01-11|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MDSG||Prospective Study on Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery for Distal Gastric Cancer|Prospective Randomized Controlled Trial on Clinical Application Value of Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery and Billroth-I Anastomosis in Laparoscopy-assisted Surgery for Distal Gastric Cancer|Active, not recruiting||Phase 3|240|Anticipated|Fujian Medical University||2|||f||||t||||||||No||2017-10-10 23:49:43.580987|2017-10-10 23:49:43.580987
NCT02289170|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-11-09|||September 2014||2014-09-01|November 2014|2014-11-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)|A Randomized, Double-blind, Multicenter, Parallel Designed Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) in Patients With Chronic Low Back Pain|Unknown status|Recruiting|N/A|80|Anticipated|DongGuk University||2|||f||||t||||||||||2017-10-10 23:49:43.65987|2017-10-10 23:49:43.65987
NCT02289157|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-01-27|||January 27, 2015|Actual|2015-01-27|January 2017|2017-01-01|October 21, 2016|Actual|2016-10-21|August 30, 2016|Actual|2016-08-30||Interventional|NPWTCS||Negative Pressure Wound Therapy in Cesarean Section|Negative Pressure Wound Therapy in High Risk Patients Undergoing Cesarean|Completed||N/A|441|Actual|University of Texas Southwestern Medical Center||2|||f||||f|f|t|f|f|t|||No||2017-10-10 23:49:43.745269|2017-10-10 23:49:43.745269
NCT02289144|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-06-07|||June 2015||2015-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer|Ceritinib in Mutation and Oncogene Directed Therapy in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer|Recruiting||Phase 2|10|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-10 23:49:43.815197|2017-10-10 23:49:43.815197
NCT02289131|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-09-06|||December 2014||2014-12-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|FOCIS||Frequency of Oral Care Intervention Study|Oral Care Intervention In Mechanically Ventilated Adults: Renewal|Recruiting||N/A|345|Anticipated|University of South Florida||3|||f||||f||||||||No||2017-10-10 23:49:43.896452|2017-10-10 23:49:43.896452
NCT02289118|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-03-29|||November 2014|Actual|2014-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tau Imaging in Young Onset Dementia|[18F]-T807 PET/CT Imaging of Tau Pathology in Young Onset Focal Dementia|Active, not recruiting||N/A|16|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 23:49:43.975598|2017-10-10 23:49:43.975598
NCT02289105|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-12-01|2016-06-28||November 2014||2014-11-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Impact of Active Choice on Advance Directive Completion Rates|The Impact of Active Choice on Completion Rates of Advanced Directives in New Employees of an Academic University Hospital|Completed||N/A|1279|Actual|University of Pennsylvania|Study population is not ideal - healthy workers may not benefit from AD completion as much as older or seriously ill patients.|2|||f||||f||||||||||2017-10-10 23:49:44.063196|2017-10-10 23:49:44.063196
NCT02289092|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||The Positive Family Support Project - Partnering With Families for a Successful Transition to School|Testing the Efficacy of an Ecological Approach to Family Intervention and Treatment During Early Elementary School to Prevent Problem Behavior and Improve Academic Outcomes|Recruiting||N/A|2100|Anticipated|University of Oregon||2|||f||||f||||||||||2017-10-10 23:49:44.529463|2017-10-10 23:49:44.529463
NCT02289079|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-06-08|2015-12-11||June 2013||2013-06-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy|Ultrasound Guided Subcostal Transversus Abdominis Plane (TAP) Block With Liposomal Bupivacaine vs Bupivacaine in Robotic Hysterectomy Patients: A Prospective Randomized Study.|Completed||Phase 4|60|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:49:44.611266|2017-10-10 23:49:44.611266
NCT02289053|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-05-12|||April 1, 2006|Actual|2006-04-01|May 2017|2017-05-01|June 30, 2014|Actual|2014-06-30|June 30, 2014|Actual|2014-06-30||Observational|||Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer|Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer|Completed||N/A|1623|Actual|University of Michigan|||2||f||||f||||||||||2017-10-10 23:49:44.919805|2017-10-10 23:49:44.919805
NCT02289040|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-11-07|||October 2014||2014-10-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|February 2015|Actual|2015-02-01||Observational|p-MiVAKI||Acute Kidney Injury Following Paediatric Cardiac Surgery|A Feasibility Study to Consider the Role of Microvesicles (MV) and MV Derived microRNA (miRNA) in Acute Kidney Injury (AKI) Following Paediatric Cardiac Surgery: p-MiVAKI Study|Active, not recruiting||N/A|24|Anticipated|University of Leicester|||1||f||||t||||||Samples With DNA|"     -  serum        -  EDTA plasma        -  citrated blood        -  hirudin blood        -  urine   "|||2017-10-10 23:49:45.001983|2017-10-10 23:49:45.001983
NCT02289027|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-01-27|||October 2014||2014-10-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland|A Phase I/II Double-blind, Randomized, Placebo Controlled, Safety and Immunogenicity, Dose-finding Trial of the Monovalent Zaire Ebola Chimpanzee Adenovirus Vector Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland|Completed||Phase 1/Phase 2|120|Actual|Centre Hospitalier Universitaire Vaudois||5|||f||||t||||||||||2017-10-10 23:49:45.110518|2017-10-10 23:49:45.110518
NCT02289014|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-05-05|||January 2014||2014-01-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|STREAM||Web-based Stress Management for Newly Diagnosed Cancer Patients (STREAM-1)|Web-based Stress Management for Newly Diagnosed Cancer Patients (STREAM-1): A Randomized, Wait-list Controlled Intervention Study|Completed||N/A|129|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-10 23:49:47.290393|2017-10-10 23:49:47.290393
NCT02289001|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-05-26|||February 2015||2015-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|SBAR||Simulation Training in Undergraduate Nursing Education as a Means to Improve Awareness of Team Member Roles|Study to Evaluate the Use of the SBAR (Situation-Background-Assessment-Recommendation) Checklist as a Means to Help Undergraduate Nursing Students Understand Team Member Roles and Improve Healthcare Team Communication|Completed||N/A|93|Actual|University of Girona||2|||f||||f||||||||||2017-10-10 23:49:47.375488|2017-10-10 23:49:47.375488
NCT02288988|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-07|||January 1995||1995-01-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|COLLIS-NIS||Minimally Invasive Collis-Nissen for the Treatment of Short Esophagus|Results of the Minimally Invasive Collis-Nissen Technique for the Treatment of True Short Esophagus|Completed||N/A|65|Actual|University of Bologna||1|||f||||t||||||||||2017-10-10 23:49:47.489269|2017-10-10 23:49:47.489269
NCT02288975|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-03-08|||October 2014||2014-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Adsorbtion of Cytokines Early in Septic Shock: the ACESS Study|The Effect of Early Cytokine Absorption on the Systemic Inflammatory Response Syndrome and Organ Dysfunction in the First 48 Hours of Septic Shock|Recruiting||N/A|20|Anticipated|Szeged University|||2||f||||f||||||||||2017-10-10 23:49:47.614689|2017-10-10 23:49:47.614689
NCT02288962|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-12-19|||November 2014||2014-11-01|December 2016|2016-12-01|May 2025|Anticipated|2025-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas|Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas (NFPAs) - a Randomized Controlled Trial|Recruiting||Phase 3|60|Anticipated|St. Olavs Hospital||2|||f||||f||||||||No||2017-10-10 23:49:47.723706|2017-10-10 23:49:47.723706
NCT02288949|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-08-10|||January 2014||2014-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|STANDARDS||Stratification of the Acute Respiratory Distress Syndrome|STratification AND Outcome of Patients With the Acute Respiratory Distress Syndrome|Completed||N/A|600|Actual|Dr. Negrin University Hospital|||2||f||||f||||||||||2017-10-10 23:49:47.828521|2017-10-10 23:49:47.828521
NCT02288923|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-09-26|||March 2015||2015-03-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 1, 2018|Anticipated|2018-04-01||Interventional|LIFT||Trial to Compare Femoral Nerve Block With Local Anaesthetic Injection for Post-operative Pain After Knee Replacement.|A Randomised, Observer Blinded, Controlled Trial Of Femoral Nerve Block Versus Local Infiltration Analgesia for Post Operative Analgesia Following Total Knee Arthroplasty|Recruiting||N/A|162|Anticipated|Royal Devon and Exeter NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:49:48.01018|2017-10-10 23:49:48.01018
NCT02288910|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-04-26|||November 2014||2014-11-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver|Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver|Recruiting||N/A|25|Anticipated|Rush University Medical Center|||1||f||||f||||||||||2017-10-10 23:49:48.164718|2017-10-10 23:49:48.164718
NCT02288897|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-09-25|||April 2015||2015-04-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma|PV-10 Intralesional Injection vs Systemic Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma|Recruiting||Phase 3|225|Anticipated|Provectus Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:49:48.391487|2017-10-10 23:49:48.391487
NCT02288884|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-10-12|||May 2011||2011-05-01|April 2016|2016-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Use of a Silver Containing Dressing (Acticoat) on Wound Complication Rates Post Elective Cesarean Section|The Use of a Silver Containing Dressing (Acticoat) on Wound Complication Rates Post Elective Cesarean Section|Completed||N/A|100|Actual|Regina Qu'Appelle Health Region||2|||f||||f||||||||||2017-10-10 23:49:48.577985|2017-10-10 23:49:48.577985
NCT02288871|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-09-12|||October 2014||2014-10-01|September 2016|2016-09-01||||February 2017|Anticipated|2017-02-01||Interventional|||Pilot Trial: Comparison of Flow Patterns|"Pilot Trial: Comparison of Flow Patterns. Is There a Difference Between sewed-in and Sutureless Bioprosthetic Aortic Heart Valves?"|Recruiting||N/A|20|Anticipated|Medical University of Vienna||2|||f||||||||||||||2017-10-10 23:49:48.667382|2017-10-10 23:49:48.667382
NCT02288858|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-13|||April 2011||2011-04-01|November 2014|2014-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair|A Multi-site, Double-blind, Placebo-controlled Clinical Study to Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair|Completed||N/A|96|Actual|Irish Response t/a Lifes2good||2|||f||||f||||||||||2017-10-10 23:49:48.769386|2017-10-10 23:49:48.769386
NCT02288845|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-03-09||2017-03-09|October 2014||2014-10-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia|An Open-Label Positron Emission Tomography (PET) Study to Demonstrate Receptor Occupancy, Safety, Tolerability and Pharmacokinetics of ITI-007 in Stable Schizophrenia Patients|Completed||Phase 2|14|Actual|Intra-Cellular Therapies, Inc.||1|||f||||f||||||||||2017-10-10 23:49:48.852581|2017-10-10 23:49:48.852581
NCT02288832|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-11-18|||March 2015||2015-03-01|November 2015|2015-11-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|AuTop||"Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by Point-of-care During Pregnancy"|"Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by Point-of-care During Pregnancy"|Recruiting||Phase 2/Phase 3|6800|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-10-10 23:49:48.928801|2017-10-10 23:49:48.928801
NCT02288819|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-10-27|||September 2014||2014-09-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|DIPSTICK||Spot Urinary Analysis to Assess Loop Diuretic Efficiency in Stable Heart Failure|Diuretic Efficiency in Patients With Stable Heart Failure: Ion Excretion Capacity of the Kidneys (DIPSTICK) Study|Completed||N/A|50|Actual|Hasselt University||1|||f||||t||||||||||2017-10-10 23:49:49.048774|2017-10-10 23:49:49.048774
NCT02288793|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-11-07|||November 2014||2014-11-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Observational|FAST||Focused Assessment With Sonography in Trauma|Prepared for Focused Assessment With Sonography in Trauma Examination?|Unknown status|Recruiting|N/A|300|Anticipated|International Institute of Rescue Research and Education|||1||f||||t||||||||||2017-10-10 23:49:49.148076|2017-10-10 23:49:49.148076
NCT02288780|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-10|||November 2014||2014-11-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Transthoracic Echocardiographic Evaluation of the Cardiac Function During Transurethral Resection of Prostate in Elderly Patients||Unknown status|Not yet recruiting|N/A|30|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-10 23:49:49.220687|2017-10-10 23:49:49.220687
NCT02288767|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-09-12|||March 9, 2015|Actual|2015-03-09|September 2017|2017-09-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||The Effect of Fluid Management by SVV of FloTrac/ Vigileo™ Monitoring on Postoperative Recovery in Bowel Resection||Completed||N/A|62|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:49:49.273243|2017-10-10 23:49:49.273243
NCT02288754|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-09-25|||December 2014||2014-12-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Observational|||Detection of Tumor DNA in Blood Samples From Cancer Patients|"Detection of Tumor DNA in Blood Samples From Patients With Late Stage Cancer and Healthy Controls"|Recruiting||N/A|500|Anticipated|Lexent Bio, Inc.|||3||f||||t|f|f||||Samples With DNA|"     Blood 2 x 10 ml of Streck FFPE tumor tissue (optional)   "|||2017-10-10 23:49:49.345861|2017-10-10 23:49:49.345861
NCT02288741|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-11-06|||August 2001||2001-08-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|DSMM-II||Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy|Phase III-study for Evaluation of Induction Therapy Before Stem Cell Mobilization and Tandem High-dose Melphalan in Multiple Myeloma Patients 60 to 70 Years of Age|Completed||Phase 3|549|Actual|WiSP Wissenschaftlicher Service Pharma GmbH||3|||f||||f||||||||||2017-10-10 23:49:49.433328|2017-10-10 23:49:49.433328
NCT02288728|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-11-06|||December 2014||2014-12-01|November 2014|2014-11-01|October 2019|Anticipated|2019-10-01|October 2016|Anticipated|2016-10-01||Interventional|DTA&GTA||Double Tract Anastomosis and Gastric Tube Anastomosis to Proximal Gastrectomy|Remnant Stomach-jejunum Double Tract Anastomosis vs. Gastric Tube Anastomosis to Proximal Gastrectomy of Early Gastric Cancer- a Randomized Controlled Trial|Not yet recruiting||Phase 3|86|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-10 23:49:49.538044|2017-10-10 23:49:49.538044
NCT02288715|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-11-06|||March 2014||2014-03-01|November 2014|2014-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated Encephalopathy|Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated Encephalopathy|Unknown status|Recruiting|N/A|109|Anticipated|West China Hospital|||2||f||||f||||||||||2017-10-10 23:49:49.6216|2017-10-10 23:49:49.6216
NCT02288702|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-01-19|||October 2014|Actual|2014-10-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Comparison of Bispectral Index Values in Patients With and Without Down's Syndrome|Comparison of Bispectral Index Values in Patients With and Without Down's Syndrome|Recruiting||N/A|50|Anticipated|Milton S. Hershey Medical Center|||2||f||||f||||||||||2017-10-10 23:49:49.710643|2017-10-10 23:49:49.710643
NCT02288689|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2015-09-22|||November 2015||2015-11-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|EUC||Clinical and Sonoelasographic Evaluation of the Elasticity of the Uterine Cervix in Pregnant Patients at Term|Clinical and Sonoelasographic Evaluation of the Elasticity of the Uterine Cervix in Pregnant Patients at Term|Unknown status|Not yet recruiting|N/A|50|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-10 23:49:49.790127|2017-10-10 23:49:49.790127
NCT02288676|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-03-21|||January 2014||2014-01-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|DOvEEgene||DOvEEgene: Developing and Validating a Novel Molecular Screening Test for the Early Diagnosis of Cancer of the Endometrium, Tubes and Ovaries|DOvEEgene: Developing and Validating a Novel Molecular Screening Test for the Early Diagnosis of Cancer of the Endometrium, Tubes and Ovaries|Recruiting||N/A|280|Anticipated|McGill University|||2||f||||f||||||||||2017-10-10 23:49:49.846578|2017-10-10 23:49:49.846578
NCT02288663|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-11-06|||November 2014||2014-11-01|November 2014|2014-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FREAGE||Renal Function Assessment in the Elderly Using Plasma Creatinine Assay and Lean Body Mass Measurement|Renal Function Assessment in the Elderly Using Plasma Creatinine Assay and Lean Body Mass Measurement|Unknown status|Not yet recruiting|N/A|220|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-10 23:49:49.959216|2017-10-10 23:49:49.959216
NCT02288650|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-11-06|||July 2013||2013-07-01|November 2014|2014-11-01||||July 2015|Anticipated|2015-07-01||Interventional|||Incidence of Post-operative Vomitings (POV) After Early Refeeding in Pediatric Day Case Surgery.||Unknown status|Recruiting|N/A|808|Anticipated|University Hospital, Strasbourg, France||2|||f||||||||||||||2017-10-10 23:49:50.161511|2017-10-10 23:49:50.161511
NCT02288637|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-03-07|||September 2014||2014-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray Product|Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray Product, Separately and Together, Against Malaria Transmitted by Pyrethroid Resistant Mosquitoes.|Recruiting||N/A|3840|Anticipated|London School of Hygiene and Tropical Medicine||4|||f||||t||||||||Undecided||2017-10-10 23:49:50.248086|2017-10-10 23:49:50.248086
NCT02288624|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-11-10|||April 2012||2012-04-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||The Effects of Whole Versus Processed Orange Consumption on Satiety|A Randomized, Double Blind and Crossover Study Investigating the Effect of Whole Versus Processed Orange Consumption on Satiety in Healthy Volunteers|Completed||N/A|24|Actual|University of Reading||4|||f||||t||||||||||2017-10-10 23:49:50.387855|2017-10-10 23:49:50.387855
NCT02288611|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-06|||May 2012||2012-05-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|AJWA||The Impact of Palm Date Intake on Colon Health Biomarkers|A Randomised, Controlled Intervention Trial to Assess the Impact of Palm Date Intake on Markers of Large Intestinal Health|Completed||N/A|22|Actual|University of Reading||2|||f||||f||||||||||2017-10-10 23:49:50.47975|2017-10-10 23:49:50.47975
NCT02288598|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-01-30|||October 2014||2014-10-01|January 2017|2017-01-01|March 14, 2016|Actual|2016-03-14|March 14, 2016|Actual|2016-03-14||Interventional|||Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering|Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering|Completed||N/A|30|Actual|University of Oxford||2|||f||||f||||||||||2017-10-10 23:49:50.567927|2017-10-10 23:49:50.567927
NCT02288585|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-01-18|||October 2014||2014-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus|The Effect of a Low-fat Spread Enriched With Plant Sterol Esters on the Blood Lipid Profile of Subjects With Established Type 2 Diabetes Mellitus and Subjects at High Risk of Developing Type 2 Diabetes|Completed||N/A|150|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-10 23:49:50.65605|2017-10-10 23:49:50.65605
NCT02288572|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-06|||May 2013||2013-05-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Probiotic Bacteria in Prevention of the Metabolic Syndrome|Mechanisms of Action of Probiotic and Protective Bacteria PCS 20, PCS 26, and LGG in Prevention of the Metabolic Syndrome|Completed||Phase 2|16|Actual|University Maribor||2|||f||||f||||||||||2017-10-10 23:49:50.769051|2017-10-10 23:49:50.769051
NCT02288559|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-09-04|||March 30, 2015|Actual|2015-03-30|September 2017|2017-09-01|June 2, 2017|Actual|2017-06-02|June 2, 2017|Actual|2017-06-02||Interventional|||A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy|A Phase II, Multicenter, Randomized, Single-Masked, Sham Injection-Controlled Exposure-Response Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Patients With Geographic Atrophy|Completed||Phase 2|96|Actual|Genentech, Inc.||4|||f|||||t|f||||||||2017-10-10 23:49:50.892116|2017-10-10 23:49:50.892116
NCT02288546|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-06|||September 2011||2011-09-01|August 2011|2011-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Vegans Health Status and Exposure to Pesticides and Nitrate|Vegans Exposure to Pesticides and Nitrate|Completed||Early Phase 1|41|Actual|University of Eastern Finland|||2||f||||f||||||||||2017-10-10 23:49:51.079174|2017-10-10 23:49:51.079174
NCT02288533|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-02-02|||September 2014||2014-09-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Transcranial Direct Current Stimulation Effects in Patients With Chronic Consciousness Disorders|Transcranial Direct Current Stimulation (tDCS) Effects in Patients With Chronic Consciousness Disorders|Completed||N/A|10|Actual|University Hospital of Ferrara||1|||f||||t||||||||No||2017-10-10 23:49:51.153541|2017-10-10 23:49:51.153541
NCT02288520|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-06-01|||September 2014||2014-09-01|October 2015|2015-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|STRATEGE||Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis|Therapeutic Strategy in Rheumatology When Faced With a Patient Treated With Methotrexate (MTX) for Rheumatoid Arthritis (RA).|Completed||N/A|854|Actual|Nordic Pharma SAS|||1||f||||f||||||||||2017-10-10 23:49:51.233629|2017-10-10 23:49:51.233629
NCT02288507|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-10|||November 2014||2014-11-01|November 2014|2014-11-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer|Phase I Study of Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer|Unknown status|Recruiting|Phase 1|18|Anticipated|University of Hawaii||1|||f||||t||||||||||2017-10-10 23:49:51.301299|2017-10-10 23:49:51.301299
NCT02288494|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-11-07|||October 2013||2013-10-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Observational|STEWALB||Acid Base Balance of ICU Patients With Severe Hypoalbuminemia, Before and After an Albumin Infusion, Using Stewart Approach|Acid Base Balance of ICU Patients With Severe Hypoalbuminemia, Before and After an Albumin Infusion, Using Stewart Approach|Unknown status|Active, not recruiting|N/A|100|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:49:51.417407|2017-10-10 23:49:51.417407
NCT02288481|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-03-11|||January 2015||2015-01-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study With a Food Effect Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects|Completed||Phase 1|48|Actual|Global Alliance for TB Drug Development||12|||f||||f||||||||||2017-10-10 23:49:51.506249|2017-10-10 23:49:51.506249
NCT02288455|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-08-08|||October 2014||2014-10-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|RELIEFII||Clinical Investigation of GT UrologIcal, LLC's Artificial Urinary Sphincter (RELIEF II)|A Prospective, Non-Randomized, Multi-Center Clinical Investigation of the Safety and PeRformancE of GT UroLogIcal, LLC's ArtiFicial Urinary Sphincter (RELIEF II)|Recruiting||Phase 1/Phase 2|80|Anticipated|GT Urological, LLC||1|||f||||t||||||||||2017-10-10 23:49:51.74079|2017-10-10 23:49:51.74079
NCT02288442|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-07-18|||January 2015||2015-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|WHOLEi+12||Whole Muscle Exercise Training (WHOLEi+12) in Pulmonary Hypertension|Exercise Training (WHOLEi+12) in Pulmonary Hypertension|Completed||N/A|40|Actual|Universidad Europea de Madrid||2|||f||||t||||||||||2017-10-10 23:49:51.855855|2017-10-10 23:49:51.855855
NCT02288429|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-08-25|||September 2013||2013-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium|Evaluation of Steady-state Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium in Cystic Fibrosis and Critically Ill Patients|Active, not recruiting||N/A|16|Actual|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:49:51.933858|2017-10-10 23:49:51.933858
NCT02288416|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-10-04|||December 8, 2014||2014-12-08|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening|Pilot Study of a Video-Based Intervention to Reduce Psychological Harm Associated With Lung Cancer Screening|Active, not recruiting||N/A|20|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-10-10 23:49:52.016588|2017-10-10 23:49:52.016588
NCT02288403|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-06-22|||April 2015||2015-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Interval Versus Continuous Training in Healthy Adults|Effects of a High-intensity Interval Training Program Compared to a Moderate Intensity Program in Adults 18-44 Years|Completed||N/A|44|Actual|Universidad de Antioquia||2|||f||||f||||||||||2017-10-10 23:49:52.105918|2017-10-10 23:49:52.105918
NCT02288377|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-08-10|||September 2014||2014-09-01|May 2016|2016-05-01|January 2024|Anticipated|2024-01-01|June 2017|Anticipated|2017-06-01||Interventional|REMINET||A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)|A EUROPEAN, MULTICENTRE, PHASE II/III RANDOMISED DOUBLE-BLIND, PLACEBO CONTROLLED STUDY EVALUATING LANREOTIDE AS MAINTENANCE THERAPY IN PATIENTS WITH NON-RESECTABLE DUODENO-PANCREATIC NEUROENDOCRINE TUMOURS AFTER FIRST-LINE TREATMENT|Recruiting||Phase 2/Phase 3|222|Anticipated|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||||2017-10-10 23:49:52.275433|2017-10-10 23:49:52.275433
NCT02288364|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-03-16|2016-02-16||December 2014||2014-12-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Reducing Pain of Lidocaine Injection|Does Sodium Bicarbonate Reduce the Pain of Lidocaine for Local Anesthesia in Percutaneous Breast Biopsies?|Completed||Phase 4|88|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:49:52.472021|2017-10-10 23:49:52.472021
NCT02288351|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-12-23|||November 2014||2014-11-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass|Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass|Withdrawn||N/A|0|Actual|Duke University||1||The PI decided to withdraw the study. No patient interaction took place.|f||||t||||||||||2017-10-10 23:49:52.982876|2017-10-10 23:49:52.982876
NCT02288338|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-03-09|||November 2014||2014-11-01|November 2014|2014-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers|CKD-391 in Healthy Volunteers to Investigate the Pharmacokinetic Drug Interaction Between Atorvastatin an Ezetimibe After Oral Administration|Completed||Phase 1|36|Actual|Chong Kun Dang Pharmaceutical||6|||f||||t||||||||||2017-10-10 23:49:53.060384|2017-10-10 23:49:53.060384
NCT02288325|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-05-11|||November 2014||2014-11-01|May 2017|2017-05-01|September 16, 2016|Actual|2016-09-16|September 16, 2016|Actual|2016-09-16||Interventional|||A Multicenter, Relapse Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder|A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse Prevention Study With Levomilnacipran ER in Patients With Major Depressive Disorder|Completed||Phase 4|644|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-10 23:49:53.211036|2017-10-10 23:49:53.211036
NCT02288312|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2014-12-19|2014-11-28||May 2007||2007-05-01|December 2014|2014-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate|Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate Market Formulation in Healthy Volunteers|Completed||Phase 1|18|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-10 23:49:53.411355|2017-10-10 23:49:53.411355
NCT02288299|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-07-25|||October 2015||2015-10-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|LIAM||Long-Term Effect of LIAM on Respiratory Performance in NIV Patients Suffering From Neuromuscular Disease|Long-Term Effect of LIAM (Lung Insufflation Assist Maneuver) on Respiratory Performance in Non-invasive Ventilated Patients Suffering From Neuromuscular Disease|Recruiting||N/A|30|Anticipated|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||||2017-10-10 23:49:53.776025|2017-10-10 23:49:53.776025
NCT02288286|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-01-19|||November 2014||2014-11-01|November 2014|2014-11-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Immunogenicity of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans|Safety and Immunogenicity of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans From 10-60 Years Old|Completed||Phase 3|1200|Actual|Beijing Center for Disease Control and Prevention||6|||f||||t||||||||||2017-10-10 23:49:53.876033|2017-10-10 23:49:53.876033
NCT02282735|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-02-02|||May 2013||2013-05-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Parental Decision-Making for Children With Relapsed Neuroblastoma|Parental Decision-Making for Children With Relapsed Neuroblastoma|Recruiting||N/A|160|Anticipated|Dana-Farber Cancer Institute|||1||f||||t||||||||||2017-10-10 23:51:10.069812|2017-10-10 23:51:10.069812
NCT02288273|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2016-12-05|2016-03-23||December 2014||2014-12-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||239 subjects were screened in order to randomize 117 subjects; however, 116 subjects were included in the modified intent to treat population, which consisted of all randomized patients who received at least one dose of randomized study drug.|Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.|A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes|Completed||Phase 4|239|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-10 23:49:53.975478|2017-10-10 23:49:53.975478
NCT02288260|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-07|2017-08-17|||April 13, 2015|Actual|2015-04-13|August 2017|2017-08-01|July 30, 2018|Anticipated|2018-07-30|July 30, 2018|Anticipated|2018-07-30|2 Years|Observational [Patient Registry]|STREAM||RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy|RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy (STREAM)|Active, not recruiting||N/A|5470|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-10 23:49:54.537345|2017-10-10 23:49:54.537345
NCT02288234|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-07-18|||November 2014|Actual|2014-11-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|TOUR||Telavancin Observational Use Registry (TOUR)|Telavancin Observational Use Registry (TOUR)|Active, not recruiting||N/A|1000|Anticipated|Theravance Biopharma Antibiotics, Inc.|||1||f||||f||||||||||2017-10-10 23:49:54.921823|2017-10-10 23:49:54.921823
NCT02288221|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-11-07|||January 2015||2015-01-01|June 2014|2014-06-01||||June 2016|Anticipated|2016-06-01||Interventional|SafEE||Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome|SafEE : Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome|Unknown status|Not yet recruiting|N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-10 23:49:54.993499|2017-10-10 23:49:54.993499
NCT02288208|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-02-04|||November 2014||2014-11-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B|Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability and Pharmacokinetics Study of Birinapant in Subjects With Chronic Hepatitis B|Terminated||Phase 1|7|Actual|TetraLogic Pharmaceuticals||2||Due to cranial nerve palsies observed|f||||f||||||||||2017-10-10 23:49:55.072402|2017-10-10 23:49:55.072402
NCT02288195|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-10-12|||August 2014||2014-08-01|October 2016|2016-10-01|June 2024|Anticipated|2024-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients|Phase III Study of Neoadjuvant Chemotherapy With Capecitabine and Oxaliplatin Versus Chemoradiation for Locally Advanced Rectal Cancer Patients|Recruiting||Phase 3|648|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-10 23:49:55.145036|2017-10-10 23:49:55.145036
NCT02288182|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-12-02|||October 2014||2014-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Randomized, Controlled Study to Compare Straumann® VivOss™ to Geistlich Bio-Oss® in Sinus Floor Augmentation.|A Randomized Controlled Clinical Trial to Investigate the Capability of Straumann® VivOss™ Compared to Geistlich Bio-Oss® in Sinus Floor Augmentation|Active, not recruiting||N/A|50|Actual|Institut Straumann AG||2|||f||||f||||||||No||2017-10-10 23:49:55.245843|2017-10-10 23:49:55.245843
NCT02288156|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2015-12-02|||July 2015||2015-07-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis|Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis|Recruiting||Phase 4|120|Anticipated|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||||2017-10-10 23:49:55.517391|2017-10-10 23:49:55.517391
NCT02288143|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2015-12-01|||January 2015||2015-01-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|COOL-COS||COmbining Oral Letrozole and Clomiphene for Ovarian Stimulation|Evaluation of a Simplified Low-cost and Friendly Controlled Ovarian Stimulation Combining Oral Letrozole and Clomiphene Citrate: a Pilot Study|Completed||Phase 4|28|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-10 23:49:55.645755|2017-10-10 23:49:55.645755
NCT02288130|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-11-02|||December 2014||2014-12-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|MYOMEX||Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy|Ulipristal Versus Gonadotropin-releasing Hormone Agonists Prior to Laparoscopic Myomectomy: a Double Blind Randomized Controlled Trial|Recruiting||Phase 4|100|Anticipated|VU University Medical Center||3|||f||||f||||||||||2017-10-10 23:49:55.730767|2017-10-10 23:49:55.730767
NCT02288117|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-04-19|||July 2015|Actual|2015-07-01|April 2017|2017-04-01|June 2022|Anticipated|2022-06-01|December 2021|Anticipated|2021-12-01||Observational|||Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem|Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem|Active, not recruiting||N/A|240|Actual|Waldemar Link GmbH & Co. KG|||1||f||||f||||||||Undecided||2017-10-10 23:49:55.855691|2017-10-10 23:49:55.855691
NCT02288104|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-08-28|||January 2015||2015-01-01|August 2017|2017-08-01|March 17, 2017|Actual|2017-03-17|March 17, 2017|Actual|2017-03-17||Interventional|||Needle-based Confocal Laser Endomicroscopy in CT-guided Percutaneous Procedures|Needle-based Confocal Laser Endomicroscopy in CT-guided Procedures in Interventional Radiology With Applications in Liver and Kidneys: a Feasibility Study|Completed||N/A|16|Actual|Mauna Kea Technologies||1|||f||||f||||||||||2017-10-10 23:49:55.991468|2017-10-10 23:49:55.991468
NCT02288091|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-05-04|2017-02-08||January 2015||2015-01-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||32 subjects were consented, however, 25 patients were randomized/treated to received the study drug.|A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)|A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 1|32|Actual|Massachusetts General Hospital||1|||f||||f|t|f||||||No||2017-10-10 23:49:56.131096|2017-10-10 23:49:56.131096
NCT02288078|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-11-11|||October 2014||2014-10-01|November 2014|2014-11-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)|A Study of Prophylactic Oral Steroids for Fatigue and Malaise Due to Regorafenib Treatment for Unresectable Metastatic Colorectal Cancer: a Randomized, Placebo-controlled, Double-blind Phase 2 Clinical Study (KSCC1402/HGCSG1402)|Unknown status|Recruiting|Phase 2|74|Anticipated|Clinical Research Support Center Kyush||2|||f||||t||||||||||2017-10-10 23:49:56.462661|2017-10-10 23:49:56.462661
NCT02288065|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-12-29|||January 2014||2014-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Predictive Factors and Outcome in Medical Thoracoscopy|Predictive Factors and Outcome in Medical Thoracoscopy|Completed||N/A|155|Actual|Katholieke Universiteit Leuven|||2||f||||f||||||||||2017-10-10 23:49:56.640053|2017-10-10 23:49:56.640053
NCT02288052|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-01-27|||January 2013||2013-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Consolidation of Motor Learning of Writing Skills and Its Related Brain Activity Changes in Parkinson's Disease|Consolidation of Motor Learning of Writing Skills and Its Related Brain Activity Changes in Parkinson's Disease|Completed||N/A|42|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-10 23:49:56.714549|2017-10-10 23:49:56.714549
NCT02288039|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-03-07|||March 2015|Actual|2015-03-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Quality of Life in Pulmonary Rehabilitation: A Social Identity Based Intervention|A Pilot Study to Assess the Feasibility and Efficacy of a Social Identity Theory Based Intervention to Improve the Quality of Life of Patients Attending Pulmonary Rehabilitation.|Completed||N/A|84|Actual|Liverpool Heart and Chest Hospital NHS Foundation Trust||2|||f||||f||||||||No||2017-10-10 23:49:56.823271|2017-10-10 23:49:56.823271
NCT02288026|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2014-11-07|||September 2014||2014-09-01|November 2014|2014-11-01||||December 2017|Anticipated|2017-12-01||Observational|||Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer||Recruiting||N/A|630|Anticipated|Capital Medical University|||2||f||||t||||||||||2017-10-10 23:49:56.9145|2017-10-10 23:49:56.9145
NCT02288013|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-01-26|||October 2013||2013-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Uterine Closure at C-section by Stratafix Tissue Control Device: Randomized Case-Control Study||Completed||N/A|100|Actual|Cairo University||2|||f||||f||||||||||2017-10-10 23:49:57.016382|2017-10-10 23:49:57.016382
NCT02288000|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-05-17|||September 14, 2016|Actual|2016-09-14|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|WP3_P002||Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases|Effect of a 15-day Memantine Treatment on Biomarkers of AD in Healthy Volunteers|Recruiting||Phase 1|30|Anticipated|University Hospital, Lille||2|||f||||t||||||||||2017-10-10 23:49:57.092296|2017-10-10 23:49:57.092296
NCT02287987|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-01-03|||October 2014||2014-10-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|CLOCK||CLamp vs Off Clamp Kidney During Partial Nephrectomy|Prospective Randomized Trial Comparing Clamp Versus Clampless Robot Assisted Partial Nephrectomy|Enrolling by invitation||N/A|200|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||f||||||||||2017-10-10 23:49:57.204239|2017-10-10 23:49:57.204239
NCT02287974|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-09-19|||September 2011||2011-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin|Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs: Study of the Needs of Insulin|Active, not recruiting||Phase 1/Phase 2|20|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||4|||f||||f||||||||||2017-10-10 23:49:57.294232|2017-10-10 23:49:57.294232
NCT02287961|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-02-27|||December 2014||2014-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|APACHES||Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men|Natural History of Anal Human Papillomavirus Infection and Associated Disease in HIV-infected Men Who Have Sex With Men: Towards an Evidence Base for the Prevention of Anal Cancer.|Active, not recruiting||N/A|500|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-10 23:49:57.374101|2017-10-10 23:49:57.374101
NCT02287948|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-02-02|||September 2014||2014-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis Subjects|Validation Study for Using Wii FIT Balance Board to Recording Balance Parameters in Healthy Subjects and Multiple Sclerosis Subjects|Completed||N/A|40|Actual|University Hospital of Ferrara|||2||f||||t||||||||||2017-10-10 23:49:57.455465|2017-10-10 23:49:57.455465
NCT02287935|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2014-11-07|||January 2009||2009-01-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional|||Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease|Effectiveness of Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease|Completed||N/A|71|Actual|Adana Numune Training and Research Hospital||2|||f||||f||||||||||2017-10-10 23:49:57.542125|2017-10-10 23:49:57.542125
NCT02287922|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-09-05||2017-09-05|February 2015||2015-02-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis|A Phase IIb Multicenter, Randomized, Double-blind Study of ALX-0061 Administered Subcutaneously as Monotherapy, in Subjects With Moderate to Severe Rheumatoid Arthritis Who Are Intolerant to Methotrexate or for Whom Continued Methotrexate Treatment is Inappropriate|Completed||Phase 2|251|Actual|Ablynx||4|||f||||t||||||||||2017-10-10 23:49:57.618088|2017-10-10 23:49:57.618088
NCT02287909|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-03-15|||December 2014||2014-12-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|SWAP-4||Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease|Pharmacodynamic Evaluation of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease|Recruiting||Phase 4|100|Anticipated|University of Florida||4|||f||||t|f|f||||||||2017-10-10 23:49:57.870651|2017-10-10 23:49:57.870651
NCT02287896|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-03-27|||April 2014||2014-04-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Pharmacokinetics and Safety of Roledumab, in RhD-negative Pregnant Women Carrying an RhD-positive Foetus|Pharmacokinetics and Safety of Roledumab, a Fully Human Recombinant Monoclonal Anti-RhD Antibody, in RhD-negative Pregnant Woman Carrying an RhD-positive Foetus: a Phase IIb, Multicenter, Open-label Study|Active, not recruiting||Phase 2/Phase 3|60|Anticipated|Laboratoire français de Fractionnement et de Biotechnologies||1|||f||||t||||||||||2017-10-10 23:49:57.962229|2017-10-10 23:49:57.962229
NCT02287857|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-06|||September 2014||2014-09-01|October 2014|2014-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B||Recruiting||N/A|260|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-10 23:49:58.223712|2017-10-10 23:49:58.223712
NCT02287844|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-14|||October 2008||2008-10-01|November 2014|2014-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PIB||Prebiotics Change Microflora and Decrease LPS|Xylo-oligosaccharide (XOS) in Combination With Inulin Modulates Both the Intestinal Environment and Immune Status in Healthy Subjects, While XOS Alone Only Shows Prebiotic Properties|Completed||N/A|60|Actual|Institut Pasteur de Lille||3|||f||||f||||||||||2017-10-10 23:49:58.348747|2017-10-10 23:49:58.348747
NCT02287831|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2016-02-24|||February 2014||2014-02-01|February 2016|2016-02-01||||June 2016|Anticipated|2016-06-01||Interventional|||Umbilical Cord Mesenchymal Stem Cells Injection for Diabetes Secondary Peripheral Arterial Disease|Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Injection for Diabetes Secondary Peripheral Arterial Disease|Enrolling by invitation||Phase 1/Phase 2|30|Anticipated|Institute of Hematology & Blood Diseases Hospital||1|||f||||f||||||||||2017-10-10 23:49:58.447553|2017-10-10 23:49:58.447553
NCT02287818|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-04-05|||December 2014||2014-12-01|April 2017|2017-04-01|October 27, 2016|Actual|2016-10-27|October 27, 2016|Actual|2016-10-27||Interventional|||A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout||Completed||Phase 2|127|Actual|TWi Biotechnology, Inc.||2|||f||||f||||||||||2017-10-10 23:49:58.528606|2017-10-10 23:49:58.528606
NCT02287805|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-08-25|||October 2014||2014-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Observational|AmAc||Qualitative and Quantitative Study Which Aims to Determine the Specifics of the Announcement for the Diagnosis of Patients With Craniosynostosis and Their Parents to Better Support Them in Their Care|Craniosynostosis: How to Improve the Diagnosis and Assist Patients and Their Families?|Completed||N/A|574|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||||||2017-10-10 23:49:58.598923|2017-10-10 23:49:58.598923
NCT02287792|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-07-24|||April 17, 2015|Actual|2015-04-17|July 2017|2017-07-01|January 2017|Actual|2017-01-01|April 2016|Actual|2016-04-01||Interventional|TEPvENDO||18-FDG PET/CT Imaging and Clinical Decisions in Infective Endocarditis|Effect of 18-FDG PET/CT Imaging on Clinical Decision Making During the Acute Phase of Infective Endocarditis: a Multicenter Prospective Impact Study|Completed||N/A|150|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:49:58.683454|2017-10-10 23:49:58.683454
NCT02287779|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-10-13|2016-06-17||January 2015||2015-01-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Safety analysis set included all participants for whom a randomization number was assigned and who had taken greater than equal (>=) 1 dose of investigational medicinal product (IMP).|Safety and Tolerability Study of SHP626 in Overweight and Obese Adults|A Randomized, Double-blind, Placebo-controlled, Phase 1 Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Multiple Oral Doses of SHP626 in Overweight and Obese Adult Subjects|Completed||Phase 1|84|Actual|Shire|None of the participants in the safety analysis set were included in the pharmacokinetic set because no participant had sufficient and interpretable primary pharmacokinetic data.|2|||f||||||||||||||2017-10-10 23:49:58.800157|2017-10-10 23:49:58.800157
NCT02287753|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-04-19|||November 2013|Actual|2013-11-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Relationship Between Parameters of VOT Using NIRS and Clinical Outcomes in Pediatric Cardiac Surgery|Relationship Between Parameters of Vascular Occlusion Test Using Near Infrared Spectroscopy and Clinical Parameters & Outcomes in Pediatric Cardiac Surgery|Completed||N/A|130|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:50:02.612829|2017-10-10 23:50:02.612829
NCT02287740|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-08-17|||November 2014||2014-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prevention of Falls Among Older Adults in Community Settings|Comparative Effectiveness and Cost-effectiveness of a Fall Prevention Intervention: Tai Ji Quan: Moving for Better Balance|Recruiting||N/A|700|Anticipated|Oregon Research Institute||3|||f||||f||||||||||2017-10-10 23:50:02.703112|2017-10-10 23:50:02.703112
NCT02287727|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-10-11|||March 2015||2015-03-01|October 2016|2016-10-01||||October 2016|Actual|2016-10-01||Interventional|||Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment|(Bayer Study ONC-2013-036) A Phase II Single-Arm Study of Regorafenib Maintenance Therapy in Patients With T3, T4 or Node-Positive Rectal Cancer Patients Who Completed Curative-Intent Treatment|Withdrawn||Phase 2|0|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-10 23:50:02.862007|2017-10-10 23:50:02.862007
NCT02287714|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-03-28|||May 2014||2014-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Instep Plantar Fasciotomy With and Without Gastrocnemius Recession|Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession|Withdrawn||N/A|0|Actual|OhioHealth||2||Low (no) enrollment.|f||||f||||||||||2017-10-10 23:50:02.975966|2017-10-10 23:50:02.975966
NCT02287701|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-08-10|||May 2014||2014-05-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization|Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization|Completed||N/A|24|Actual|New York University School of Medicine||1|||f||||t|f|f||||||||2017-10-10 23:50:03.068603|2017-10-10 23:50:03.068603
NCT02287688|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-05-17|||December 1, 2014|Actual|2014-12-01|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Observational|||Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study|Post-licensure Observational Safety Surveillance Study of Quadrivalent Meningococcal ACWY Conjugate Vaccine MenACWY-CRM (MENVEO®) in Children 2 Months Through 23 Months of Age.|Active, not recruiting||N/A|121|Anticipated|GlaxoSmithKline|||1||f||||f||||||||||2017-10-10 23:50:03.154522|2017-10-10 23:50:03.154522
NCT02287675|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-06-02|||October 2014||2014-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Lymphoseek||Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer|A Randomized, Double-Blinded Trial Comparing Lymphoseek and 99mTc-Sulfur Colloid With Regard to Pre-op Imaging and Imaging Drug Kinetics and Intra-op Lymphatic Mapping and Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer|Active, not recruiting||Phase 4|40|Anticipated|Kettering Health Network||2|||f||||f||||||||No||2017-10-10 23:50:03.238231|2017-10-10 23:50:03.238231
NCT02287662|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-09-20|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2017|Actual|2017-04-01||Interventional|3MTAVR||The Multidisciplinary, Multimodality, But Minimalist Approach to Transfemoral Transcatheter Aortic Valve Replacement|The Vancouver Multidisciplinary, Multimodality, But Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transfemoral Transcatheter Aortic Valve Replacement Centres: The 3M TAVR Study|Active, not recruiting||N/A|411|Anticipated|BC Centre for Improved Cardiovascular Health||1|||f||||t||||||||||2017-10-10 23:50:03.317347|2017-10-10 23:50:03.317347
NCT02287649|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2015-10-18|||September 2012||2012-09-01|October 2015|2015-10-01|January 2016|Anticipated|2016-01-01|July 2015|Actual|2015-07-01||Interventional|Poly-ITP||Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)|Fc Gamma RIIIA V/F158 Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP) and Correlations With Treatment|Unknown status|Active, not recruiting|N/A|43|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:50:03.394056|2017-10-10 23:50:03.394056
NCT02287636|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-04-26|||April 2013||2013-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer|Clinical Evaluation of PET-MRI Versus PET-CT in Pediatric Oncology Patients|Completed||N/A|12|Actual|Case Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-10 23:50:03.460102|2017-10-10 23:50:03.460102
NCT02287623|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-10-12|2015-08-10||May 2013||2013-05-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional||we analyzed patients age, weight and gender.|Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study|Subcostal TAP Block With Liposomal Bupivacaine vs Bupivacaine in Donor Nephrectomy Patients: A Prospective Randomized Study|Completed||Phase 4|60|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:50:03.552121|2017-10-10 23:50:03.552121
NCT02287610|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-02-02|2016-10-19||November 2014||2014-11-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|SUNRAY||A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis|A Non-Interventional Study to Evaluate the Effectiveness of Delayed-Release Prednisone (RAYOS) on Clinical Assessments and Serologic Disease Activity in Patients With Active Rheumatoid Arthritis in the Clinical Practice Setting|Completed||N/A|75|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland|||1||f||||f||||||||||2017-10-10 23:50:05.739064|2017-10-10 23:50:05.739064
NCT02287584|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-03-21|||August 2014||2014-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Confirmatory Study of DSP-5423P in Patients With Schizophrenia|Confirmatory Study of DSP-5423P in Patients With Schizophrenia|Recruiting||Phase 3|501|Anticipated|Sumitomo Dainippon Pharma Co., Ltd.||3|||f||||f||||||||||2017-10-10 23:50:06.511963|2017-10-10 23:50:06.511963
NCT02287571|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-06|||March 2013||2013-03-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Skin Traction Versus Position Splint in Patients With Hip Fracture|The Effects of Preoperative Skin Traction and Position Splint on Pain, Comfort and Satisfaction in Patients With Hip Fracture|Completed||N/A|68|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||2|||f||||t||||||||||2017-10-10 23:50:06.826244|2017-10-10 23:50:06.826244
NCT02287558|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2014-11-06|||November 2014||2014-11-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study|A Phase I Single Arm Study to Assess the Safety and Efficacy of Pomalidomide in Patients With Bleeding Due to Hereditary Hemorrhagic Telangiectasia and Refractory Angiodysplasia|Unknown status|Not yet recruiting|Phase 1|9|Anticipated|The Cleveland Clinic||1|||f||||t||||||||||2017-10-10 23:50:06.968764|2017-10-10 23:50:06.968764
NCT02287532|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-07-25|||February 2013||2013-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TELESAGE||Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen|Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen|Recruiting||N/A|696|Anticipated|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||3|||f||||f||||||||||2017-10-10 23:50:07.186335|2017-10-10 23:50:07.186335
NCT02287519|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-08-01|||November 2014||2014-11-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|February 2018|Anticipated|2018-02-01||Interventional|START-OC||Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention|Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention|Recruiting||N/A|75|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:50:07.863745|2017-10-10 23:50:07.863745
NCT02287506|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2014-11-06|||March 2015||2015-03-01|November 2014|2014-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|StartRIGHT||StartRIGHT:the Right Diabetes Diagnosis and Treatment (Pilot Study)|The StartRIGHT Study; Getting the Right Diagnosis and the Right Treatment From the Start in Young Adult Diabetes- a Pilot Study|Not yet recruiting||N/A|200|Anticipated|NIHR Exeter Clinical Research Facility||2|||f||||f||||||||||2017-10-10 23:50:07.963168|2017-10-10 23:50:07.963168
NCT02287493|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-06-03|||July 2013|Actual|2013-07-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PhA-SLED||Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)|Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)|Completed||N/A|35|Actual|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f||||||||||2017-10-10 23:50:08.041157|2017-10-10 23:50:08.041157
NCT02287480|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2016-03-07|||November 2014||2014-11-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|April 2015|Actual|2015-04-01||Interventional|VSV-ZEBOV||VSV-ZEBOV Geneva Vaccine Trial|A Phase I/II Dose-finding Randomized, Single-center, Double-blind, Placebo-controlled Safety and Immunogenicity Trial of the Vesicular Stomatitis Virus-vectored Zaire Ebola Candidate Vaccine BPSC1001 (VSVΔG-ZEBOV) in Healthy Adults.|Completed||Phase 1/Phase 2|115|Actual|University Hospital, Geneva||3|||f||||t||||||||||2017-10-10 23:50:08.231641|2017-10-10 23:50:08.231641
NCT02287467|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2016-09-21|||January 2015||2015-01-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza|Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG)|Recruiting||Phase 3|320|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:50:08.360337|2017-10-10 23:50:08.360337
NCT02287454|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-11-05|||January 2013||2013-01-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis|Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis: a Randomized Clinical Trial|Completed||N/A|32|Actual|University of Deusto||2|||f||||t||||||||||2017-10-10 23:50:08.554132|2017-10-10 23:50:08.554132
NCT02287441|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-02-06|||November 2014||2014-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|VEG1||Feasibility Study to Increase Vegetable Consumption|Feasibility Study Comparing Dietary Methods to Increase Vegetable Consumption|Active, not recruiting||N/A|24|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||No||2017-10-10 23:50:08.643452|2017-10-10 23:50:08.643452
NCT02287428|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-04-30|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Ph I Personalized NeoAntigen Cancer Vaccine With Radiotherapy for Patients With MGMT Unmethylated, Newly Diagnosed Glioblastoma|A Phase I Study of a Personalized NeoAntigen Cancer Vaccine With Radiotherapy Among MGMT Unmethylated, Newly Diagnosed Glioblastoma Patients|Active, not recruiting||Phase 1|16|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:50:08.753189|2017-10-10 23:50:08.753189
NCT02287415|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2014-11-28|2014-11-28||May 2002||2002-05-01|November 2014|2014-11-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin|The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin in Healthy Volunteers|Completed||Phase 1|13|Actual|Bial - Portela C S.A.||1|||f||||f||||||||||2017-10-10 23:50:08.892485|2017-10-10 23:50:08.892485
NCT02287402|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-04-08|2014-12-09||March 2010||2010-03-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Postmarketing Clinical Study on AO-128|Postmarketing Clinical Study on AO-128|Completed||Phase 4|197|Actual|Takeda||1|||f||||f||||||||||2017-10-10 23:50:09.199565|2017-10-10 23:50:09.199565
NCT02287389|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2014-11-07|||December 2014||2014-12-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Interventional Pulmonologic Treatment of Benign Central Airway Fibrotic Stricture|Prospective, Randomized, Open, Controlled, Multicenter Stucy of Interventional Pulmonologic Treatment of Benign Central Airway Fibrotic Stricture|Not yet recruiting||N/A|160|Anticipated|Tang-Du Hospital||4|||f||||t||||||||||2017-10-10 23:50:09.73857|2017-10-10 23:50:09.73857
NCT02287376|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-07-22|2017-01-24||January 2015||2015-01-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds|A Phase 4, Open-Label Study of the Pharmacokinetics and Safety of Cambia® (Diclofenac Potassium for Oral Solution) for the Acute Treatment of Migraine Attacks With or Without Aura in Pediatric Subjects (Ages 12-17 Years)|Completed||Phase 4|25|Actual|Depomed||1|||f||||||||||||||2017-10-10 23:50:09.886335|2017-10-10 23:50:09.886335
NCT02287363|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-07|||October 2014||2014-10-01|November 2014|2014-11-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Observational|||Genetic and Morphological Analysis of Thyrotoxic Periodic Paralysis|Genetic and Morphological Analysis of Thyrotoxic Periodic Paralysis:an Observational Study of Sichuan Individuals in China.|Unknown status|Active, not recruiting|N/A|160|Anticipated|West China Hospital|||2||f||||t||||||Samples With DNA|"     We intend to draw a 3-5mL whole blood from each participant and extract their genome DNA for     genetic analysis.   "|||2017-10-10 23:50:10.875747|2017-10-10 23:50:10.875747
NCT02050594|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-07-03|||February 2014||2014-02-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Ipilimumab 12-month Intensive Pharmacovigilance Protocol|Ipilimumab 12-month Intensive Pharmacovigilance Protocol|Completed||N/A|6|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 00:48:35.796735|2017-10-11 00:48:35.796735
NCT02287350|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-06-12|2017-01-25||September 2014||2014-09-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain|A Phase 4, Open-Label Study of the Pharmacokinetics and Safety of Diclofenac Potassium Oral Solution in Pediatric Subjects (Ages 2-12 Years) With Mild to Moderate Acute Pain|Completed||Phase 4|51|Actual|Depomed||1|||f||||||||||||||2017-10-10 23:50:10.982504|2017-10-10 23:50:10.982504
NCT02287337|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-11-30|||September 2013||2013-09-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|||Validation of CPR for Manipulation for Neck Pain|Validation of a Clinical Prediction Rule to Identify Patients With Neck Pain Likely to Benefit From Cervical Spine Manipulation: A Randomized Clinical Trial|Recruiting||N/A|200|Anticipated|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-10 23:50:11.854591|2017-10-10 23:50:11.854591
NCT02287324|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-11-05|||January 2014||2014-01-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Cervical Spine Manipulation on Gait|Immediate Effects of Cervical Spine Manipulation on Gait Parameters in Individuals With and Without Mechanical Neck Pain|Completed||N/A|40|Actual|University of Nevada, Las Vegas||2|||f||||t||||||||||2017-10-10 23:50:11.95138|2017-10-10 23:50:11.95138
NCT02287311|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-07-12|||February 2015||2015-02-01|July 2017|2017-07-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|MABEL||Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)|ADMINISTRATION OF MOST CLOSELY MATCHED THIRD PARTY RAPIDLY GENERATED LMP, BARF1 and EBNA1 SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO PATIENTS WITH EBV-POSITIVE LYMPHOMA|Recruiting||Phase 1|42|Anticipated|Baylor College of Medicine||3|||f||||t||||||||||2017-10-10 23:50:12.039403|2017-10-10 23:50:12.039403
NCT02287298|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-04-05|||August 2014||2014-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment|Triple Combination Therapy of Choroidal Neovascularization in Exudative Age-related Macular Degeneration - a Cost Effect and Efficient Therapeutic Treatment|Completed||N/A|400|Actual|The Retina Center of St. Louis County, PC|||2||f||||f||||||||||2017-10-10 23:50:12.15459|2017-10-10 23:50:12.15459
NCT02287285|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-10-11|||October 2014||2014-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Determinants of Diabetes Remission After Gastric Bypass Surgery|Long Term Change of GLP-1 Insulinotropic Effect After GBP Surgery|Recruiting||N/A|38|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-10 23:50:12.251306|2017-10-10 23:50:12.251306
NCT02287272|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-11-17|||May 2014||2014-05-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Drug-drug Interaction Study of CHF5993 With Cimetidine|Open-label, Randomized, Single Dose, 2-sequence, 2-period Cross-over Study to Investigate the Effect of Inhibition of the Organic Cation Transport in the Kidneys by Cimetidine on the Pharmacokinetics of the CHF5993 in Healthy Volunteers|Completed||Phase 1|25|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-10 23:50:12.35357|2017-10-10 23:50:12.35357
NCT02287259|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-07-18|||November 2014|Actual|2014-11-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)|A Randomized, Open Label Trial of Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified.|Recruiting||Phase 4|236|Anticipated|Chiba University||2|||f||||||||||||||2017-10-10 23:50:12.43721|2017-10-10 23:50:12.43721
NCT02287246|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-05-23|||October 2014||2014-10-01|May 2016|2016-05-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Urogynecologic Surgery|Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Pain Management Following Urogynecologic Surgery: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial|Recruiting||Phase 4|120|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||Yes|Planning to publish once completed|2017-10-10 23:50:12.520776|2017-10-10 23:50:12.520776
NCT02287233|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-08-03|||April 4, 2014||2014-04-04|August 2017|2017-08-01|May 10, 2019|Anticipated|2019-05-10|September 13, 2018|Anticipated|2018-09-13||Interventional|||A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Subjects With Acute Myelogenous Leukemia (AML)|A Phase 1/2 Study of Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Subjects With Acute Myelogenous Leukemia Who Are ≥ 60 Years of Age and Who Are Not Eligible for Standard Anthracycline-Based Induction Therapy|Active, not recruiting||Phase 1|91|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-10 23:50:12.607545|2017-10-10 23:50:12.607545
NCT02287220|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-11-11|||November 2014||2014-11-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Non Contact Measurement of Vital Signs|Non Contact Measurement of Vital Signs|Recruiting||N/A|120|Anticipated|University of Virginia|||1||f||||f||||||||No||2017-10-10 23:50:12.711156|2017-10-10 23:50:12.711156
NCT02287207|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-06-06|||October 2015||2015-10-01|November 2015|2015-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Transcranial Direct Current Stimulation on Fine Motor Skills in Parkinson's Disease: a Pilot Study||Completed||N/A|20|Actual|Katholieke Universiteit Leuven||2|||f||||||||||||||2017-10-10 23:50:12.810523|2017-10-10 23:50:12.810523
NCT02287194|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-09-04|||November 28, 2014|Actual|2014-11-28|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|April 30, 2016|Actual|2016-04-30|6 Months|Observational [Patient Registry]|SpyChina||SpyGlass Direct Visualization System Clinical Registry in China|Clinical Registry of Cholangioscopy Using the SpyGlass™ Direct Visualization System Throughout China|Active, not recruiting||N/A|197|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-10 23:50:12.887367|2017-10-10 23:50:12.887367
NCT02287181|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-03-10|||February 2015||2015-02-01|March 2015|2015-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase IV Study Investigating the Effects of Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes|A Phase IV Study to Investigate the Effects of Varied Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes|Completed||Phase 4|100|Actual|The University of Hong Kong||2|||f||||||||||||||2017-10-10 23:50:12.958669|2017-10-10 23:50:12.958669
NCT02287168|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-03-26|||October 2014||2014-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients|Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients|Completed||Early Phase 1|34|Actual|Bezmialem Vakif University||2|||f||||f||||||||||2017-10-10 23:50:13.049832|2017-10-10 23:50:13.049832
NCT02287155|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-11-05|||January 2015||2015-01-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|bg60||"Occupation Based Health-Promotion Program for People Aged Over 60: Bliib Gsund"|"Occupation Based Health-Promotion Program for People Aged Over 60: Bliib Gsund"|Unknown status|Not yet recruiting|N/A|16|Anticipated|Zurich University of Applied Sciences||1|||f||||f||||||||||2017-10-10 23:50:13.131855|2017-10-10 23:50:13.131855
NCT02287142|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-01-31|||October 2014|Actual|2014-10-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Evaluation of Supraclavicular, Suprascapular, and Interscalene Nerve Blocks for Outpatient Shoulder Surgery|Evaluation of Supraclavicular, Suprascapular, and Interscalene Nerve Blocks for Outpatient Shoulder Surgery|Completed||N/A|189|Actual|Benaroya Research Institute||3|||f||||t||||||||||2017-10-10 23:50:13.348849|2017-10-10 23:50:13.348849
NCT02287129|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-09-19|||November 2014||2014-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|MEMORI||Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction|Metabolic and Molecular Response Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction|Recruiting||Phase 2|75|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-10 23:50:13.424767|2017-10-10 23:50:13.424767
NCT02287116|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-05|||May 2014||2014-05-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|MASK||Continuous Positive Airway Pressure Via Binasal Prong vs Nasal Mask: a Randomised Controlled Trial|Continuous Positive Airway Pressure Via Binasal Prong vs Nasal Mask: a Randomised Controlled Trial|Completed||N/A|150|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||1|||f||||f||||||||||2017-10-10 23:50:13.544435|2017-10-10 23:50:13.544435
NCT02287103|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2015-06-02|||April 2015||2015-04-01|June 2015|2015-06-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|SkippB-T2D||Eating vs Skipping Breakfast on Postprandial Hyperglycemia After Lunch and Dinner in T2D|Effect of Eating vs Skipping Breakfast on Postprandial Hyperglycemia After Subsequent Isocaloric Lunch and Dinner in Type 2 Diabetic Patients|Unknown status|Recruiting|N/A|30|Anticipated|Tel Aviv University||2|||f||||f||||||||||2017-10-10 23:50:13.61135|2017-10-10 23:50:13.61135
NCT02287090|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-05-08|||March 2011||2011-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|ROW||Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears|Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears|Active, not recruiting||N/A|400|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||||Undecided||2017-10-10 23:50:13.705034|2017-10-10 23:50:13.705034
NCT02287077|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-04-19|||December 2014||2014-12-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Umbilical Cord Milking for Neonates With Hypoxic Ischemic Encephalopathy|A Randomized Controlled Trial of Umbilical Cord Milking for Neonates With Hypoxic Ischemic Encephalopathy|Recruiting||N/A|100|Anticipated|Thomas Jefferson University||2|||f||||f||||||||||2017-10-10 23:50:13.787657|2017-10-10 23:50:13.787657
NCT02287064|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-06-06|||April 2015||2015-04-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias|An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias|Recruiting||Phase 1|10|Anticipated|University of South Florida||1|||f||||||||||||||2017-10-10 23:50:13.867737|2017-10-10 23:50:13.867737
NCT02287051|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2014-11-05|||March 2014||2014-03-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Observational|||Bowel Prep Acceptance in Clinical Practice|Acceptance and Compliance of Split-dose Bowel Preparation for Colonoscopy in Clinical Practice|Completed||N/A|1500|Actual|Valduce Hospital|||1||f||||f||||||||||2017-10-10 23:50:13.961853|2017-10-10 23:50:13.961853
NCT02287038|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-06-07|||October 15, 2014|Actual|2014-10-15|June 2017|2017-06-01|April 14, 2017|Actual|2017-04-14|March 2, 2017|Actual|2017-03-02||Observational|||Atomoxetine in Comorbid ADHD/PTSD|Atomoxetine in Comorbid ADHD/PTSD: A Pilot, Placebo-Controlled Feasibility Study|Completed||N/A|44|Actual|VA Office of Research and Development|||2||f||||f|f|f|||f|None Retained|"     Urine and blood samples will be obtained and handled by the Ralph H. Johnson VA Medical     Center. All laboratory procedures will be completed by hospital personnel who are trained in     to use all appropriate forms of PPE.   "|No||2017-10-10 23:50:14.01829|2017-10-10 23:50:14.01829
NCT02287012|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-10-06|||October 2013||2013-10-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Observational|||Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection -The European Perspective|Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection - The European Perspective|Completed||N/A|248|Actual|Association for Training, Education, and Research in Hematology, Immunology, and Transplantation|||2||f||||f||||||||||2017-10-10 23:50:14.231355|2017-10-10 23:50:14.231355
NCT02286999|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-06-14|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Probiotic Supplementation in Breastfed Newborn Infants|A Parallel-group, Randomized, Placebo-controlled Ascending Dose Phase I Study Protocol for Dietary Supplementation With Bifidobacterium Longum Subsp. Infantis (B. Infantis) in Healthy Breastfed Infants|Not yet recruiting||Phase 1|90|Anticipated|University of California, Davis||2|||f||||f|t|f||||||Undecided||2017-10-10 23:50:14.304832|2017-10-10 23:50:14.304832
NCT02012725|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-02-02|||January 2014||2014-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Molecular MRI of the Fibrotic Heart|Molecular MRI of the Fibrotic Heart|Terminated||N/A|125|Actual|University of Kentucky|||2|PI left institution|f||||f||||||||||2017-10-11 00:57:22.173146|2017-10-11 00:57:22.173146
NCT02286986|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-04-10|||September 2014||2014-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy|A 2-part Study to Investigate the Dose-ranging Pharmacokinetics and Tolerability, Followed by the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With|Active, not recruiting||Phase 1|25|Anticipated|University of Utah||1|||f||||t||||||||No||2017-10-10 23:50:14.389453|2017-10-10 23:50:14.389453
NCT02286973|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-11-07|||November 2014||2014-11-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Combined Administration of Intravenous and Topical Tranexamic Acid in Total Knee Arthroplasty|Combined Administration of Intravenous and Topical Tranexamic Acid in Total Knee Arthroplasty: Is it the Most Effective Regime? A Randomized Controlled Trial.|Unknown status|Not yet recruiting|Phase 1|264|Anticipated|Seoul National University Hospital||4|||f||||||||||||||2017-10-10 23:50:14.469429|2017-10-10 23:50:14.469429
NCT02286947|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-10-03|||November 2014||2014-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy|An Open-Label, Multi-Center Study to Evaluate the Safety and Tolerability of Eteplirsen in Patients With Advanced Stage Duchenne Muscular Dystrophy|Active, not recruiting||Phase 2|20|Anticipated|Sarepta Therapeutics||1|||f||||f||||||||||2017-10-10 23:50:14.640756|2017-10-10 23:50:14.640756
NCT02286934|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-06-02|||September 2014||2014-09-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Cytochrome P450 2D6 Genotype on the Clinical Effect of Carvedilol|A Clinical Trial to Investigate the Influence of Cytochrome P450 2D6 Polymorphism on the Pharmacokinetic/Pharmacodynamics Characteristics of Carvedilol in Healthy Korean Volunteers|Completed||Phase 1|24|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-10 23:50:14.749558|2017-10-10 23:50:14.749558
NCT02286921|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-09-06|||January 2015||2015-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Transformer||Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance|A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer|Recruiting||Phase 2|180|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:50:14.848843|2017-10-10 23:50:14.848843
NCT02286908|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-10-05|||June 2014||2014-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Global Strain and Mechanical Dispersion May Predict Death and Ventricular Arrhythmias Better Than Ejection Fraction|Improved Prediction of Clinical Outcome With the Use of Global Strain and Mechanical Dispersion in Patients With Myocardial Infarction and Heart Failure|Recruiting||N/A|3100|Anticipated|Oslo University Hospital|||1||f||||f||||||||Undecided||2017-10-10 23:50:14.958782|2017-10-10 23:50:14.958782
NCT02286895|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-08-18|||October 2014||2014-10-01|September 2014|2014-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali|An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali|Completed||Phase 4|605|Actual|PATH||2|||f||||f||||||||||2017-10-10 23:50:15.074778|2017-10-10 23:50:15.074778
NCT02286882|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2015-07-16|||November 2014||2014-11-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Single Ascending Oral Doses Of Pf-06409577 In Healthy Adult Subjects|Terminated||Phase 1|39|Actual|Pfizer||9||"The trial was terminated prematurely on June 19, 2015 for business reasons. There were no   safety concerns in the study which led to the decision."|f||||f||||||||||2017-10-10 23:50:15.17444|2017-10-10 23:50:15.17444
NCT02286869|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-07-28|||September 2016|Actual|2016-09-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Cardioventilatory Coupling in Critically Ill Patients||Completed||N/A|22|Actual|ASST Fatebenefratelli Sacco||3|||f||||f||||||||||2017-10-10 23:50:15.282815|2017-10-10 23:50:15.282815
NCT02286856|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-04-13|||March 2014|Actual|2014-03-01|April 2016|2016-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|DINAMITE||DINAMITE Study Nutritional State and Effect Diet in Mitochondrial Disease|DINAMITE Study: An Explorative Study of the Effect of Dietary Intervention on Body Function and Quality of Life in Adults With Mitochondrial Disease Caused by the m.3243A>G Mutation.|Completed||N/A|40|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 23:50:15.390436|2017-10-10 23:50:15.390436
NCT02286843|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-06|2017-10-02|||November 2014||2014-11-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?|Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?|Recruiting||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:50:15.483016|2017-10-10 23:50:15.483016
NCT02286635|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-15|||November 2014||2014-11-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort|A Phase 1, Open-Label, 2-Arm, Fixed-Sequence Study to Evaluate the Potential Effects of Multiple Doses of Rifampin (CYP3A4 Inducer) and Clarithromycin (CYP3A4 Inhibitor) on the Single Dose Pharmacokinetics of Deflazacort in Healthy Subjects|Completed||Phase 1|58|Actual|PTC Therapeutics||2|||f||||f||||||||||2017-10-10 23:50:17.30947|2017-10-10 23:50:17.30947
NCT02286817|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-12-22|||January 2015||2015-01-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|May 2015|Actual|2015-05-01||Interventional|NFC1-GREAT||Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder|Phase I Single Dose, Open-label, Pharmacokinetic Study Followed by Single-blind, Placebo-controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Plasma Concentration Profiles, and Targeted Efficacy of NFC-1 in Adolescents (12-17 Years of Age) With Attention-Deficit Hyperactivity Disorder and Genetic Disruption Impacting Metabotropic Glutamate Receptor Genes (NFC1-GREAT)|Completed||Phase 1|30|Actual|Aevi Genomic Medicine||1|||f||||t||||||||No||2017-10-10 23:50:15.739357|2017-10-10 23:50:15.739357
NCT02286804|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-05-06|||October 2014||2014-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Ultherapy for the Treatment of Spider Veins on the Legs|Evaluation of the Ulthera® System for Efficacious and Safe Treatment of Leg Telangiectasia|Completed||N/A|9|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-10 23:50:15.852525|2017-10-10 23:50:15.852525
NCT02286791|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-08-16|||September 2014||2014-09-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MAPRCT||Mindful Awareness Program for the Prevention of Dementia: A Randomized Controlled Trial|Mindful Awareness Program for the Prevention of Dementia: A Randomized Controlled Trial|Completed||N/A|55|Actual|National University, Singapore||2|||f||||f||||||||||2017-10-10 23:50:15.975258|2017-10-10 23:50:15.975258
NCT02286778|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-08-02|||February 2016||2016-02-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|January 2017|Actual|2017-01-01||Interventional|||Eradication of Malignant Carcinoma in the Breast Tissue|The Eradication of Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor|Completed||Phase 2/Phase 3|60|Actual|Optimal Health Research||3|||f||||t||||||||||2017-10-10 23:50:16.082767|2017-10-10 23:50:16.082767
NCT02286765|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-06-01|||October 2014||2014-10-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Ulthera® System for Treating Axillary Hyperhidrosis|Optimization of the Ulthera® System for Treating Axillary Hyperhidrosis|Completed||N/A|40|Actual|Ulthera, Inc||2|||f||||f||||||||No||2017-10-10 23:50:16.145862|2017-10-10 23:50:16.145862
NCT02286752|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-01-11|||June 2014||2014-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting.||Completed||Phase 4|98|Actual|T.C. ORDU ÜNİVERSİTESİ||2|||f||||||||||||||2017-10-10 23:50:16.233333|2017-10-10 23:50:16.233333
NCT02286739|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-04-04|||April 2015||2015-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During TKA|Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty|Recruiting||N/A|500|Anticipated|Orthosensor, Inc.||2|||f||||f||||||||||2017-10-10 23:50:16.301168|2017-10-10 23:50:16.301168
NCT02286726|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-08-23|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Study of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) at High Risk for Induction Mortality|Phase II Study of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) at High Risk for Induction Mortality|Recruiting||Phase 2|55|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-10 23:50:16.420536|2017-10-10 23:50:16.420536
NCT02286700|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-10|||November 2014||2014-11-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Interventional|||Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis|A Randomized, Double-Blind, Active Control, 5 Week Study to Evaluate the Safety and Skin Effects of A New, Twice-daily, Topically Applied Amino Acid Moisturizing Cream vs. Desonide Cream in Adult Atopic Dermatitis|Unknown status|Recruiting|Phase 3|42|Anticipated|NeoStrata Company, Inc.||2|||f||||f||||||||||2017-10-10 23:50:16.595734|2017-10-10 23:50:16.595734
NCT02286687|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-06-07|||December 22, 2014|Actual|2014-12-22|June 2017|2017-06-01|December 22, 2019|Anticipated|2019-12-22|December 22, 2019|Anticipated|2019-12-22||Interventional|||Phase II Study of BMN 673|Phase II Study of the PARP Inhibitor BMN 673 (Talazoparib Tosylate) in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA1/2 (Not Breast or Ovarian Cancer)|Active, not recruiting||Phase 2|37|Actual|M.D. Anderson Cancer Center||6|||f||||f|t|f||||||||2017-10-10 23:50:16.685207|2017-10-10 23:50:16.685207
NCT02286674|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-09-27|||November 2014||2014-11-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Use of Handheld Audiovisual Devices to Treat Pediatric Preoperative Anxiety|Use of Handheld Audiovisual Devices to Treat Pediatric Preoperative Anxiety: A Randomized Control Trial.|Recruiting||Phase 3|200|Anticipated|McLaren Health Care||2|||f||||f||||||||Undecided||2017-10-10 23:50:16.783413|2017-10-10 23:50:16.783413
NCT02286661|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-07|||September 2010||2010-09-01|November 2014|2014-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Short-Arm Casting Effective in Type A2 Fractures in the Distal Radius|Outcome Assessment in the Treatment of Type A2 Fractures of the Distal Radius by Short Arm Cast Versus Long Arm Cast|Completed||N/A|100|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:50:17.060059|2017-10-10 23:50:17.060059
NCT02286648|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-11-07|||February 2014||2014-02-01|November 2014|2014-11-01||||July 2015|Anticipated|2015-07-01||Interventional|||Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars||Unknown status|Recruiting|Phase 4|50|Anticipated|Mashhad University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:50:17.167929|2017-10-10 23:50:17.167929
NCT02286622|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-15|||December 2014||2014-12-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Single Dose Evaluation of the Effects of Renal Impairment on Deflazacort Pharmacokinetics|A Single Dose Evaluation of the Effects of Renal Impairment on Deflazacort Pharmacokinetics|Completed||Phase 1|16|Actual|PTC Therapeutics||2|||f||||f||||||||||2017-10-10 23:50:17.449484|2017-10-10 23:50:17.449484
NCT02286609|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-15|||December 2014||2014-12-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort Pharmacokinetics|A Single Dose Evaluation of the Effects of Moderate (Child-Pugh Grade B) Hepatic Impairment on Deflazacort Pharmacokinetics|Completed||Phase 1|16|Actual|PTC Therapeutics||2|||f||||f||||||||||2017-10-10 23:50:17.574198|2017-10-10 23:50:17.574198
NCT02286596|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-03-07|||April 2013||2013-04-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|June 2013|Actual|2013-06-01||Observational|APHERESE||Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia|Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia|Completed||N/A|9|Actual|Laval University|||2||f||||f||||||||||2017-10-10 23:50:17.681172|2017-10-10 23:50:17.681172
NCT02286583|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2015-03-31|||February 2015||2015-02-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|May 2015|Anticipated|2015-05-01||Interventional|RTM||Medical Radiometer - RTM - 01 - RES and Its Use in Detecting Hotspots in Female Breast|Early Detection of Breast Disease Using Medical Radiometer - RTM - 01 - RES|Unknown status|Recruiting|N/A|2000|Anticipated|Labdom Suisse||1|||f||||t||||||||||2017-10-10 23:50:17.778261|2017-10-10 23:50:17.778261
NCT02286557|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-11-07|||October 2014||2014-10-01|November 2014|2014-11-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Testing the Effects of Methylphenidate on Multiple Sclerosis|Testing the Effects of Methylphenidate on Cognitive Fatigue in Multiple Sclerosis: a Double-blind, Placebo-controlled, Randomized Clinical Trial|Unknown status|Not yet recruiting|Phase 2|36|Anticipated|Kessler Foundation||2|||f||||t||||||||||2017-10-10 23:50:17.967132|2017-10-10 23:50:17.967132
NCT02286544|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-03-02|||October 2014|Actual|2014-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers|Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Single Center, Randomized, Controlled Pilot Study in Healthy Volunteers|Active, not recruiting||Phase 1|36|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-10 23:50:18.059681|2017-10-10 23:50:18.059681
NCT02286531|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-08-18|||June 2010||2010-06-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PET-FETII||Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma|Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine (or FET), a New Tracer PET (Positron Emission Tomography) , in the Diagnosis of Low Grade Glioma|Completed||N/A|93|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-10 23:50:18.179852|2017-10-10 23:50:18.179852
NCT02286518|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-06-13|2016-04-27||November 2014||2014-11-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||The safety analysis set was defined as all participants who were enrolled and completed the study.|TAK-114 Single- and Multiple-Dose Phase 1 Study|A Single-center, Single- and Multiple-Dose Phase 1 Study to Evaluate the Safety and Pharmacokinetics of TAK-114 in Healthy Adult Japanese and Caucasian Male Subjects|Completed||Phase 1|82|Actual|Takeda||15|||f||||f||||||||||2017-10-10 23:50:18.313944|2017-10-10 23:50:18.313944
NCT02286505|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-05|||November 2014||2014-11-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|BrainMeasure||Automated Brain Morphometry for Dementia Diagnosis|Automated Brain Morphometry for Dementia Diagnosis|Unknown status|Not yet recruiting|N/A|80|Anticipated|King's College London||2|||f||||f||||||||||2017-10-10 23:50:20.967556|2017-10-10 23:50:20.967556
NCT02286492|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-06-09||||||June 2016|2016-06-01||||||||Expanded Access|||Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer|An Open-Label Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to or Failing Standard Chemotherapy|Approved for marketing||N/A|||Taiho Oncology, Inc.|||||||||||||||||||2017-10-10 23:50:21.086958|2017-10-10 23:50:21.086958
NCT02286479|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-08-12|||October 2014||2014-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of Loop and Primary Incision&Drainage Techniques in the Emergency Department|Comparison of Loop Drainage and Primary Incision and Drainage Techniques in Patients With Cutaneous Abscess in the Emergency Department|Completed||N/A|50|Actual|Kocaeli University||2|||f||||f||||||||Yes||2017-10-10 23:50:21.297975|2017-10-10 23:50:21.297975
NCT02286466|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-02-27|||February 11, 2013|Actual|2013-02-11|February 2017|2017-02-01|October 25, 2016|Actual|2016-10-25|October 25, 2016|Actual|2016-10-25||Interventional|||Mobile App of CBT for Anxiety and Cancer|Mobile Application of Cognitive-Behavioral Therapy (CBT) for Anxiety and Cancer|Completed||N/A|153|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:50:21.399282|2017-10-10 23:50:21.399282
NCT02286453|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-09-26|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Clinical Efficacy and Safety of Benjakul Recipe in Treating Primary Osteoarthritis of Knee Compared With Diclofenac|Clinical Efficacy and Safety of Benjakul Recipe in Treating Primary Osteoarthritis of Knee Compared With Diclofenac (Clinical Trial Phase II)|Completed||Phase 2|84|Actual|Thammasat University||2|||f||||t||||||||||2017-10-10 23:50:21.503733|2017-10-10 23:50:21.503733
NCT02286440|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-08-14|||February 2015||2015-02-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|AMOD||A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression|A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression (Abbreviation Assurex AMOD)|Recruiting||N/A|276|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:50:21.582414|2017-10-10 23:50:21.582414
NCT02286427|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-11-03|||January 2015||2015-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|MABUL||A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic Membrane|A Comparative Study of the Healing of Chronic Skin Ulcers of Recessive Dystrophic Epidermolysis Bullosa : Standard Dressing Versus Amniotic Membrane.|Recruiting||Phase 3|22|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:50:21.689687|2017-10-10 23:50:21.689687
NCT02286414|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-02-15|||February 2015||2015-02-01|October 2014|2014-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|PRESAGE-ACO||Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over|Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in the Treatment of Non Valvular Atrial Fibrillation in Patients Aged 80 Years and Over, Living at Home or in Nursing Home. A Prospective Cohort Study|Not yet recruiting||N/A|2193|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-10 23:50:21.756764|2017-10-10 23:50:21.756764
NCT02286401|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-02-16|||October 2014||2014-10-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Observational|||Functional Assessment of Coronary Artery Disease by CTA Flow Encoding|Functional Assessment of Coronary Artery Disease by CTA Flow Encoding|Recruiting||N/A|30|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-10-10 23:50:21.840755|2017-10-10 23:50:21.840755
NCT02286388|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-09-28|||February 2015||2015-02-01|September 2016|2016-09-01|August 2020|Anticipated|2020-08-01|August 2017|Anticipated|2017-08-01||Interventional|DECAT||Multicenter Trial Comparing One-step Partial Caries Removal to Complete Caries Removal for the Treatment of Deep Carious Lesions in Permanent Teeth. (DECAT : DEep CAries Treatment).|Multicenter Randomized Controlled Trial Comparing One-step Partial Caries Removal to Complete Caries Removal for the Treatment of Deep Carious Lesions in Permanent Teeth DECAT DEep CAries Treatment|Recruiting||Phase 3|464|Anticipated|Hospices Civils de Lyon||4|||f||||f||||||||||2017-10-10 23:50:21.910036|2017-10-10 23:50:21.910036
NCT02286375|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-02-23|||April 2016||2016-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Health-social Partnership Programme|Health-social Partnership Intervention Programme for Community-dwelling Older Adults: a Randomized Controlled Trial|Recruiting||N/A|480|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||||2017-10-10 23:50:23.72389|2017-10-10 23:50:23.72389
NCT02286362|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-09-26|||January 14, 2015|Actual|2015-01-14|September 2017|2017-09-01|November 10, 2016|Actual|2016-11-10|November 10, 2016|Actual|2016-11-10||Observational|||An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer||Completed||N/A|510|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:50:23.829831|2017-10-10 23:50:23.829831
NCT02286349|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-04-10|||September 2014||2014-09-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Non Invasive Brain Stimulation Effects on Attentional Performance in ADHD Adults|Effects of Noninvasive Brain Stimulation on Attentional Performance of Adults With Symptomatology of Attention Deficit Hyperactivity Disorder (ADHD)|Unknown status|Active, not recruiting|Phase 1/Phase 2|12|Anticipated|Universidade Federal de Pernambuco||4|||f||||t||||||||||2017-10-10 23:50:24.173452|2017-10-10 23:50:24.173452
NCT02286336|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2015-07-25|||October 2014||2014-10-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||The Minimum Effective Concentration of Ropivacaine in Ultrasound-guided Supraclavicular Block|The Minimum Effective Concentration of Ropivacaine in Ultrasound-guided Supraclavicular Block|Completed||N/A|102|Actual|Huazhong University of Science and Technology||2|||f||||f||||||||||2017-10-10 23:50:24.264324|2017-10-10 23:50:24.264324
NCT02286323|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-07|||November 2014||2014-11-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|EIDR||Endotracheal Intubation During Resuscitation|Can the Bonfils Intubation Fiberscope Rival the Macintosh Laryngoscope During Resuscitation With Uninterrupted Chest Compression?|Unknown status|Enrolling by invitation|N/A|130|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:50:24.343255|2017-10-10 23:50:24.343255
NCT02286310|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-06|||February 2014||2014-02-01|November 2014|2014-11-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Effect of Exercise Programs on 3-dimensional Scapular Kinematics, Disability and Pain|Effect of Exercise Programs on 3-dimensional Scapular Kinematics, Disability and Pain in Subjects With Shoulder Impingement|Unknown status|Recruiting|N/A|36|Anticipated|Hacettepe University||2|||f||||f||||||||||2017-10-10 23:50:24.426105|2017-10-10 23:50:24.426105
NCT02286297|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-06|||November 2014||2014-11-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|PETI||Pediatric Endotracheal Intubation During Resuscitation|Comparison of Intubation Through the McGrath® MAC, GlideScope®, AirTraq® and Miller Laryngoscope by Paramedics During Pediatric Cardiopulmonary Resuscitation: a Randomized Crossover Manikin Trial.|Unknown status|Recruiting|N/A|100|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:50:24.514064|2017-10-10 23:50:24.514064
NCT02286284|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-12-21|||March 2015||2015-03-01|June 2015|2015-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ADENA||Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia|Usefulness of Extracorporeal Removal of sFlt-1 in Women With Severe Preeclampsia at Less Than 26 Weeks' Gestation|Terminated||Phase 2|2|Actual|Assistance Publique - Hôpitaux de Paris||1||Safety of patients : CSI recommandation and promotor decision|f||||t||||||||||2017-10-10 23:50:24.622353|2017-10-10 23:50:24.622353
NCT02286271|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-05-05|||January 20, 2015|Actual|2015-01-20|August 2016|2016-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|PTEpD||Preliminary Testing of a Novel Device to Detect Epileptic Seizures|Preliminary Testing of a Novel Device to Detect Epileptic Seizures|Completed||N/A|117|Actual|University of Edinburgh|||1||f||||f||||||||||2017-10-10 23:50:24.74052|2017-10-10 23:50:24.74052
NCT02286258|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-08-28|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|MultiGFR||Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)|MultiGFR: Equivalency Study of Different Methods of Measuring Glomerular Filtration Rate|Suspended||Phase 1/Phase 2|350|Anticipated|Assistance Publique - Hôpitaux de Paris||2||The study was suspended after a suspected unexpected serious adverse event.|f||||f||||||||||2017-10-10 23:50:24.812249|2017-10-10 23:50:24.812249
NCT02286245|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-01-10|||March 2015||2015-03-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|CMTp||The Effectiveness and Cost-effectiveness of Medical Advice Given by Telephone for Patients Calling for Primary Care|Effectiveness and Cost-effectiveness of Medical Advice Given by Telephone for Primary Care: the Formalised Telephone Medical Advice Study, a Cluster Randomised Control Trial.|Completed||N/A|2498|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:50:24.911392|2017-10-10 23:50:24.911392
NCT02286232|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-12-06|||November 2014||2014-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Chronic Low Back Pain Randomized Controlled Trial|A Randomized Trial Comparing a Stretching/Exercise Program and Learning About Self-care Practices From a Self-care Book for Chronic Low Back Pain|Recruiting||Phase 3|60|Anticipated|Stamford Hospital||2|||f||||f||||||||No||2017-10-10 23:50:24.995727|2017-10-10 23:50:24.995727
NCT02286219|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-09-15|||November 4, 2014|Actual|2014-11-04|September 2017|2017-09-01|June 8, 2017|Actual|2017-06-08|June 8, 2017|Actual|2017-06-08||Interventional|||Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)|Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors|Completed||Phase 1|30|Actual|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 23:50:25.105525|2017-10-10 23:50:25.105525
NCT02286206|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-11-15|||January 2015||2015-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PK-CLZ||Study of the Effect of Dosing on Clozapine Levels|A Pilot Study to Determine How Frequency of Administration Modifies Steady-State Plasma Concentrations of Orally Administered Clozapine|Active, not recruiting||Phase 4|50|Anticipated|University of British Columbia||1|||f||||f||||||||No||2017-10-10 23:50:25.197303|2017-10-10 23:50:25.197303
NCT02286193|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-09-14|2016-07-26||March 2013||2013-03-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|LINCC||Creating a Clinic-Community Liaison Role in Primary Care: Engaging Patients and Community in Health Care Innovation|Creating a Clinic-Community Liaison Role in Primary Care: Engaging Patients and Community in Health Care Innovation|Completed||N/A|418|Actual|Kaiser Permanente|This was not a clinical trial. It is was a single-group observational evaluation of a delivery system innovation.||1||f||||f||||||||No||2017-10-10 23:50:25.288044|2017-10-10 23:50:25.288044
NCT02286180|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-10|||April 2014||2014-04-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01|1 Day|Observational [Patient Registry]|||Subjective Feelings of Job Stress and Frontal Activity During Verbal Fluency Test: A Near-infrared Spectroscopy Study|Job Stress and Frontal Activity During Verbal Fluency Test: A Near-infrared Spectroscopy Study|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Taichung Veterans General Hospital|||1||f||||f||||||||||2017-10-10 23:50:25.466668|2017-10-10 23:50:25.466668
NCT02286167|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-10-26|||November 2014||2014-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|GLAD||Glioma Modified Atkins-based Diet in Patients With Glioblastoma|The Feasibility and Biologic Effect of a Modified Atkins-based Intermittent Fasting Diet in Patients With Glioblastoma (GBM)|Recruiting||N/A|25|Anticipated|Wake Forest University Health Sciences||1|||f||||t||||||||||2017-10-10 23:50:25.522671|2017-10-10 23:50:25.522671
NCT02286154|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-02-28|||October 2014||2014-10-01|February 2017|2017-02-01|October 2024|Anticipated|2024-10-01|October 2024|Anticipated|2024-10-01||Interventional|TREAT||Therapeutic Response Evaluation and Adherence Trial (TREAT)|Therapeutic Response Evaluation and Adherence Trial (TREAT): A Prospective Study of Hydroxyurea for Children With Sickle Cell Anemia|Recruiting||N/A|150|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 23:50:25.735327|2017-10-10 23:50:25.735327
NCT02286128|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-04-07|||November 2014||2014-11-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Effect of NF-кB Dependent Proinflammation on Osteogenic Differentiation of the Mesenchymal Stem Cells in Type 2 Diabetes|The Effect of NF-кB Dependent Proinflammation on the Overexpression of Receptor of Advanced Glycation End Products (RAGE) and the Osteogenic Differentiation Defect in the Mesenchymal Stem Cell-isolated From Patients With Type 2 Diabetes|Recruiting||N/A|75|Anticipated|Chiang Mai University|||2||f||||f||||||Samples Without DNA|"     Serum and RNA (from peripheral blood-derived mesenchymal stem cells)   "|No||2017-10-10 23:50:25.925114|2017-10-10 23:50:25.925114
NCT02286115|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-12-13|||September 2014||2014-09-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Life-Stress Interview for Women With Chronic Urogenital Pain Conditions|Life-Stress Interview for Women With Chronic Urogenital Pain Conditions|Completed||N/A|70|Actual|William Beaumont Hospitals||2|||f||||f||||||||No||2017-10-10 23:50:26.012135|2017-10-10 23:50:26.012135
NCT02286102|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-06-26|2017-03-21||January 2011|Actual|2011-01-01|June 2017|2017-06-01|October 17, 2016|Actual|2016-10-17|August 2015|Actual|2015-08-01||Interventional|||A Prospective Randomized Study on the Clinical Benefits of OrthoPAT Drains|A Prospective Randomized Study on the Clinical Benefits of OrthoPAT Drains for Adults Undergoing Multilevel Spine Surgery for Deformity|Completed||N/A|70|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||No||2017-10-10 23:50:26.111977|2017-10-10 23:50:26.111977
NCT02286089|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2017-08-28|||April 2015||2015-04-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration|Phase I/IIa Dose Escalation Safety and Efficacy Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Cells Transplanted Subretinally in Patients With Advanced Dry-Form Age-Related Macular Degeneration (Geographic Atrophy)|Recruiting||Phase 1/Phase 2|15|Anticipated|Cell Cure Neurosciences Ltd.||1|||f||||t||||||||||2017-10-10 23:50:26.404042|2017-10-10 23:50:26.404042
NCT02286076|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-01|2014-11-06|||May 2014||2014-05-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Observational|||Influence of Laparoscopic Endometrioma Stripping Surgery on Serum Anti-mullerian Hormone Levels|Impact of Laparoscopic Endometrioma Stripping Surgery on Fertility: Pre- Operative and Post- Operative Changes of Serum Anti-mullerian Hormone Levels|Unknown status|Recruiting|N/A|100|Anticipated|Clinical Centre of Serbia|||1||f||||t||||||Samples Without DNA|"     The endometrioma specimens that will be obtained from operation will be submitted for     pathology examination   "|||2017-10-10 23:50:26.590799|2017-10-10 23:50:26.590799
NCT02286063|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-11-06|||August 2014||2014-08-01|November 2014|2014-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|AmbOx||Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)|Randomized, Controlled Crossover Trial to Evaluate the Effects of Ambulatory Oxygen on Health Status in Patients With Fibrotic Lung Disease (FLD).|Unknown status|Recruiting|Phase 4|80|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:50:26.696503|2017-10-10 23:50:26.696503
NCT02286050|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-05-09|||November 2014||2014-11-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||Effect of a Nursing Program for Patients With Cystic Fibrosis on Disease Management|Auswirkung Eines CF Nursing-Programms Auf Das Krankheitsmanagement Und Die Erfahrungen Der Behandlung Von Patientinnen Und Patienten|Completed||N/A|35|Actual|University of Zurich||1|||f||||||||||||||2017-10-10 23:50:26.794459|2017-10-10 23:50:26.794459
NCT02286037|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-11-06|||August 2013||2013-08-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Delineating Areas of Secondary Hyperalgesia: Influence of the Assessment Method|Delineating Areas of Secondary Hyperalgesia: Influence of the Assessment Method|Completed||N/A|23|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-10 23:50:26.875914|2017-10-10 23:50:26.875914
NCT02286024|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-01-16|||November 2014||2014-11-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Observational|LONGIDEP||Study of Morphological and Perfusion Imaging Predictors of Pejorative Outcome in Major Depressive Disorder|Study of Morphological and Perfusion Imaging Predictors of Pejorative Outcome in Major Depressive Disorder.|Recruiting||N/A|300|Anticipated|Rennes University Hospital|||1||f||||f||||||||||2017-10-10 23:50:26.945632|2017-10-10 23:50:26.945632
NCT02286011|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-03-29|||November 2014||2014-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TCIM/ELA||Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis|Phase I Clinical Trial on Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis.|Active, not recruiting||Phase 1|20|Anticipated|Red de Terapia Celular||2|||f||||t||||||||||2017-10-10 23:50:27.037053|2017-10-10 23:50:27.037053
NCT02285998|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-10-03|2016-08-03||October 2014||2014-10-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||The safety population included all randomized subjects who received known study vaccine and for whom some safety data were available after administration of vaccine.|Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age|Comparison of the Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine (IIV4) in Healthy, Medically Stable Adults ≥50 Years of Age|Completed||Phase 3|9003|Actual|Protein Sciences Corporation||2|||f||||f||||||||||2017-10-10 23:50:27.167153|2017-10-10 23:50:27.167153
NCT02285985|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-01-31|||February 2013||2013-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Effects of Saxagliptin on Adipose Tissue Inflammation in Humans|Effects of Saxagliptin on Adipose Tissue Inflammation in Humans|Active, not recruiting||Phase 4|50|Anticipated|Phoenix VA Health Care System||2|||f||||f||||||||No|Subject to VA regulation.|2017-10-10 23:50:28.679172|2017-10-10 23:50:28.679172
NCT02285972|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-01|2015-04-18|||November 2014||2014-11-01|November 2014|2014-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy of Intravenous Dexketoprofen and Tenoxicam on Propofol Associated Injection Pain||Completed||Phase 4|118|Actual|T.C. ORDU ÜNİVERSİTESİ||3|||f||||||||||||||2017-10-10 23:50:28.778836|2017-10-10 23:50:28.778836
NCT02285959|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-06-20|||June 2014||2014-06-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme|Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme|Recruiting||Phase 1|30|Anticipated|Global Neurosciences Institute||1|||f||||f||||||||||2017-10-10 23:50:28.860576|2017-10-10 23:50:28.860576
NCT02285946|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-05-18|||November 2014|Actual|2014-11-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|MRA-RACHIS||Comparison of Supine to Prone Position During Major Spinal Surgery|Alveolar Recruitment Maneuvers: Comparison of Supine to Prone Position During Major Spinal Surgery|Recruiting||N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:50:28.940407|2017-10-10 23:50:28.940407
NCT02285933|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-04-11|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|March 1, 2017|Actual|2017-03-01||Interventional|||Virtual Reality Exercise for Stroke Rehabilitation in Inpatients Who Are Unable to Stand|Does the Addition of Virtual Reality Training to a Standard Program of Inpatient Rehabilitation Improve Sitting Balance Ability and Function After Stroke? A Blinded Randomized Controlled Trial.|Completed||N/A|76|Actual|Bruyere Research Institute||2|||f||||f||||||||No|As this is not part of a larger, multi-centre trial, we do not plan to share our data.|2017-10-10 23:50:29.028702|2017-10-10 23:50:29.028702
NCT02285920|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-07-06|||November 2014||2014-11-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2017|Actual|2017-06-01||Interventional|SPin-D||Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial|Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent End-Stage Renal Disease (ESRD) (SPin-D) Trial|Active, not recruiting||Phase 2|129|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-10 23:50:29.137544|2017-10-10 23:50:29.137544
NCT02285894|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-21|||November 2014||2014-11-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|April 2015|Anticipated|2015-04-01||Interventional|||Can 10 Seconds Inspiratory Hold Open Atelectasis in Mechanically Ventilated Patients?|Can 10 Seconds Inspiratory Hold Open Atelectasis in Mechanically Ventilated Patients? A Pilot Study.|Unknown status|Recruiting|N/A|12|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-10-10 23:50:29.354239|2017-10-10 23:50:29.354239
NCT02285881|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-05-12|||March 2012||2012-03-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|March 2015|Actual|2015-03-01||Interventional|||Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.|Shared Decision Making in Type 2 Diabetes With a Support Decision Tool That Takes Into Account Patient Preferences, Clinical Factors and the Intensity of Treatment: Design of a Cluster Randomised Trial|Completed||N/A|153|Actual|UMC Utrecht||2|||f||||f||||||||Undecided|no plan yet, but for data request the authors can be contacted|2017-10-10 23:50:29.440133|2017-10-10 23:50:29.440133
NCT02285868|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-07-11|||November 2014||2014-11-01|July 2016|2016-07-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01|2 Months|Observational [Patient Registry]|AEGIS||ATI Evidence-based Guide Investigating Clinical Services|ATI Evidence-based Guide Investigating Clinical Services: Rehabilitation and Physical Therapy Patient Outcomes Registry|Recruiting||N/A|100000|Anticipated|ATI Holdings, LLC|||6||f||||t||||||||||2017-10-10 23:50:29.532319|2017-10-10 23:50:29.532319
NCT02285855|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-01-30|||February 2015||2015-02-01|January 2017|2017-01-01||||February 2020|Anticipated|2020-02-01||Interventional|||Metformin in Non Small Cell Lung Cancer (NSCLC)|Tumor Mutation Status Will Predict Metabolic Response to Metformin in Non Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 2|70|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:50:29.665558|2017-10-10 23:50:29.665558
NCT02285842|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-06-19|||December 2014||2014-12-01|June 2017|2017-06-01|December 2028|Anticipated|2028-12-01|December 2027|Anticipated|2027-12-01||Observational|||Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components|Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components|Enrolling by invitation||N/A|143|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||||2017-10-10 23:50:29.811553|2017-10-10 23:50:29.811553
NCT02285829|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-05-19|||January 2015||2015-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Determination of TOF Test Threshold for Obtaining Reliable Pedicle Screw Stimulation Test During Lumbar Spine Surgery|Determination of TOF Test Threshold for Obtaining Reliable Pedicle Screw Stimulation Test During Lumbar Spine Surgery|Recruiting||N/A|300|Anticipated|New York University School of Medicine|||4||f||||f|f|f||||||||2017-10-10 23:50:30.60657|2017-10-10 23:50:30.60657
NCT02285803|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-04-14|||November 2014||2014-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Transcranial Direct Current Stimulation (tDCS) in Addition to Tinnitus Retraining Therapy (TRT) for Treatment of Chronic Tinnitus Patients|The Effect of Transcranial Direct Current Stimulation (tDCS) in Addition to Tinnitus Retraining Therapy (TRT) for Treatment of Chronic Tinnitus Patients|Completed||N/A|||University Hospital, Antwerp||2|||f||||f||||||||||2017-10-10 23:50:30.828008|2017-10-10 23:50:30.828008
NCT02285790|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-01|2016-04-12|||January 2015||2015-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|B-OSS||One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy|Treatment of Basal Cell Carcinoma Using a One-stop-shop With Reflectance Confocal Microscopy: a Randomized Controlled Multicenter Trial|Completed||N/A|100|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-10 23:50:30.921078|2017-10-10 23:50:30.921078
NCT02285764|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-03-29|||November 2014||2014-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Nutritional Intervention During Gestation and Offspring Health|NIGO Health- Nutritional Intervention During Gestation and Offspring Health|Recruiting||N/A|363|Anticipated|Abbott Nutrition||2|||f||||t||||||||Undecided||2017-10-10 23:50:31.166939|2017-10-10 23:50:31.166939
NCT02285751|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-03-22|||November 2012||2012-11-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||"High on Treatment Platelet Reactivity in the Intensive Care Unit"|"High on Treatment Platelet Reactivity in the Intensive Care Unit"|Recruiting||Phase 2|200|Anticipated|Medical University of Vienna||8|||f||||t||||||||||2017-10-10 23:50:31.269689|2017-10-10 23:50:31.269689
NCT02285738|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-03-27|||December 30, 2014|Actual|2014-12-30|March 2017|2017-03-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis|Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis: A Pilot Study|Recruiting||Early Phase 1|42|Anticipated|Case Comprehensive Cancer Center||6|||f||||t|t|f|||f|||||2017-10-10 23:50:31.382364|2017-10-10 23:50:31.382364
NCT02285725|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-03-15|||March 2011||2011-03-01|March 2016|2016-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid||Active, not recruiting||N/A|21|Actual|Bone and Joint Clinic of Baton Rouge||1|||f||||f||||||||||2017-10-10 23:50:31.513828|2017-10-10 23:50:31.513828
NCT02285712|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-02-28|||March 2015||2015-03-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|IDECHO||Ultrasound-Guided Peripheral Intravenous Access by Critical Nurses.|Contribution of Ultrasound for Peripheral Intravenous Catheter Placement by Intensive Care Nurses|Completed||N/A|114|Actual|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 23:50:31.579206|2017-10-10 23:50:31.579206
NCT02285699|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-12-12|||November 2014||2014-11-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||The Gut Microbiota in Obsessive-Compulsive Disorder|A Pilot Study Examining the Gut Microbiota in Patients With Obsessive-Compulsive Disorder vs. Healthy Controls and Following 12-weeks of Open-label Selective Serotonin Reuptake Inhibitors Treatment|Recruiting||N/A|25|Anticipated|McMaster University||1|||f||||f||||||||||2017-10-10 23:50:31.646941|2017-10-10 23:50:31.646941
NCT02285686|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-06|||November 2014||2014-11-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|PRO-TROPICS||Prognostic Value of Elevated Troponins in Critical Illness Study: A Pilot Study|Prognostic Value of Elevated Troponins in Critical Illness Study: A Pilot Study|Unknown status|Not yet recruiting|N/A|220|Anticipated|McMaster University|||1||f||||f||||||Samples Without DNA|"     2 cryovials   "|||2017-10-10 23:50:31.752966|2017-10-10 23:50:31.752966
NCT02285673|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2014-11-06|||November 2013||2013-11-01|November 2014|2014-11-01|November 2015|Anticipated|2015-11-01|February 2015|Anticipated|2015-02-01||Interventional|||Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy|Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy: Phase 1/2 Study|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Acibadem University||1|||f||||f||||||||||2017-10-10 23:50:31.819059|2017-10-10 23:50:31.819059
NCT02285660|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-11-06|||June 2011||2011-06-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition|Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition for Patients With Lung, Lower Oesophageal and Pancreatic Carcinomas.|Unknown status|Recruiting|N/A|||The Leeds Teaching Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 23:50:32.020641|2017-10-10 23:50:32.020641
NCT02285647|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-08-21|||September 2014||2014-09-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant|An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant|Completed||Phase 1|138|Actual|Tesaro, Inc.||2|||f||||f||||||||||2017-10-10 23:50:32.09778|2017-10-10 23:50:32.09778
NCT02285634|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-08-02|||November 2014||2014-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.|The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.|Recruiting||N/A|100|Anticipated|Mayo Clinic||4|||f||||f||||||||||2017-10-10 23:50:32.182242|2017-10-10 23:50:32.182242
NCT02285621|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-11-17|||September 2013||2013-09-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Validation of a New Generation of Optimized Orthoses for Personalized Treatment of Adolescent Idiopathic Scoliosis||Recruiting||Phase 3|90|Anticipated|St. Justine's Hospital||2|||f||||t||||||||||2017-10-10 23:50:32.314186|2017-10-10 23:50:32.314186
NCT02285608|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-11-17|||January 2015||2015-01-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|PIMM||Partnership in Medication Management (PIMM) in Patients With Mood Disorders|Partnership in Medication Management (PIMM): The Effects of One-on-one Medication Training on Medication Adherence in Patients With Mood Disorders|Recruiting||N/A|166|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-10 23:50:32.402135|2017-10-10 23:50:32.402135
NCT02285595|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-11-17|||July 2014||2014-07-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Interventional|SUPREME||Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy|A Prospective, Multicenter Study Comparing Healing After Treatment With the Sonendo GentleWave™ System as Compared to a Traditional Root Canal Therapy Literature Control|Active, not recruiting||Phase 4|68|Actual|Sonendo, Inc.||1|||f||||f||||||||||2017-10-10 23:50:32.490756|2017-10-10 23:50:32.490756
NCT02285582|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-04-25|||October 2014||2014-10-01|April 2016|2016-04-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01|10 Years|Observational [Patient Registry]|IRHDR||International Rare Histiocytic Disorders Registry (IRHDR)|International Rare Histiocytic Disorders Registry (IRHDR)|Recruiting||N/A|80|Anticipated|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-10 23:50:32.551793|2017-10-10 23:50:32.551793
NCT02285569|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-05-26|||June 2014||2014-06-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||The Pleth Variability Index and Hypotension at Caesarean Under Spinal.|Can Changes in the Pleth Variability Index be Used to Predict Significant Hypotension During Spinal Anaesthesia for Caesarean Section?|Completed||N/A|17|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:50:32.619112|2017-10-10 23:50:32.619112
NCT02285556|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-11-16|||March 2012||2012-03-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus|The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus|Completed||N/A|560|Actual|Shanghai Mental Health Center||7|||f||||f||||||||||2017-10-10 23:50:32.685768|2017-10-10 23:50:32.685768
NCT02285543|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-08-16|||December 2016|Actual|2016-12-01|November 2015|2015-11-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients|A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell Carcinoma|Active, not recruiting||Phase 2|101|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 23:50:32.79074|2017-10-10 23:50:32.79074
NCT02285530|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-08-16|||December 2016||2016-12-01|November 2015|2015-11-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||GDF15 Based TPF Induction Chemotherapy for OSCC Patients|GDF15 (Growth Differentiation Factor 15) Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at T3/T4cN0M0 Stage: a Phase II Randomized Controlled Trial|Recruiting||Phase 2|72|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 23:50:32.903523|2017-10-10 23:50:32.903523
NCT02285517|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-11-07|||April 2013||2013-04-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Comparing Modified Meek and Mesh Techniques|Comparing Mesh and Modified Meek Skin Grafting Techniques in Third Degree Burned Patients Referred to Burn Ward of Khatam-al-anbia Hospital, Irtan|Completed||N/A|20|Actual|Shahraki, Babak N., M.D.||2|||f||||t||||||||||2017-10-10 23:50:33.004349|2017-10-10 23:50:33.004349
NCT02285504|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-04-25||2017-04-25|September 2014||2014-09-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Evaluate SAGE-547 in Female Patients With Severe Postpartum Depression|An Open-Label Proof-of-Concept Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-547 Injection in the Treatment of Adult Female Patients With Severe Postpartum Depression|Completed||Phase 2|4|Actual|Sage Therapeutics||1|||f||||f||||||||||2017-10-10 23:50:33.101083|2017-10-10 23:50:33.101083
NCT02285491|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2016-02-07|||November 2014||2014-11-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Local Anesthetic Injection Into Both Angles of the Rectus Sheath Incision|Efficacy of Local Anesthetic Injection Into Both Angles of the Rectus Sheath Incision for Postoperative Cesarean Delivery Analgesia.|Completed||Early Phase 1|225|Actual|Ain Shams Maternity Hospital||3|||f||||||||||||||2017-10-10 23:50:33.187225|2017-10-10 23:50:33.187225
NCT02285478|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-09-15|||March 2015||2015-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|DAPHNE||Pharmacokinetics of Once Daily Darunavir/Ritonavir in HIV-infected Children|Once Daily Darunavir/Ritonavir in HIV-infected Children 6-12 Years Old: a Pharmacokinetic Validation of Model Based Dosing Recommendations|Completed||N/A|12|Actual|Radboud University|||1||f||||f||||||Samples Without DNA|"     Plasma samples   "|||2017-10-10 23:50:33.273204|2017-10-10 23:50:33.273204
NCT02285465|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2015-01-09|||November 2014||2014-11-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects|A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of ASP3700 in Healthy Subjects|Withdrawn||Phase 1|0|Actual|Astellas Pharma Inc||2||Study terminated due to sponsor decision|f||||f||||||||||2017-10-10 23:50:33.349176|2017-10-10 23:50:33.349176
NCT02285452|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-05|2017-07-05|||November 2014||2014-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2015|Actual|2015-11-01||Interventional|SWI_02||Psychophysiological Effects of Thorax Wraps With Ginger and Mustard Flour|Psychophysiological Efficacy of Thorax Wraps With Ginger or Mustard Flour in Comparison to Wraps With Warm Water in Healthy Subjects - a Randomized, Placebo-controlled, Three-armed Study With Cross-over Design|Enrolling by invitation||N/A|18|Anticipated|ARCIM Institute Academic Research in Complementary and Integrative Medicine||3|||f||||||||||||||2017-10-10 23:50:33.448629|2017-10-10 23:50:33.448629
NCT02285439|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-01-23|||April 2016||2016-04-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase I/II Study of MEK162 for Children With Ras/Raf Pathway Activated Tumors|Phase I Study of MEK162 for Children With Progressive or Recurrent Cancer and a Phase II Study for Children With Low-Grade Gliomas and Other Ras/Raf/MAP Pathway Activated Tumors|Recruiting||Phase 1/Phase 2|80|Anticipated|Children's Hospital Los Angeles||3|||f||||t||||||||No||2017-10-10 23:50:33.559419|2017-10-10 23:50:33.559419
NCT02285426|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-08-24|||October 20, 2014|Actual|2014-10-20|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|June 5, 2017|Actual|2017-06-05||Observational|i-scan||HD+ I-scan Bronchoscopy Vascular Abnormalities Detection Multicenter Study|A Multicenter Study Evaluating the Diagnostic Value for Vascular Abnormalities of High Definition Bronchoscopy When Combined With I-scan Imaging Technology Compared to High Defintion Bronchoscopy Alone|Active, not recruiting||N/A|150|Anticipated|Radboud University|||1||f||||f||||||Samples Without DNA|"     biopsy of sites with abnormal or suspicious vascular patterns   "|||2017-10-10 23:50:33.670551|2017-10-10 23:50:33.670551
NCT02285413|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-11|2016-05-03|||February 2011||2011-02-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|||Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients|Immunochemotherapy: Do Platin-based Chemotherapeutics Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients?|Completed||Phase 2|54|Actual|Radboud University||2|||f||||f||||||||||2017-10-10 23:50:33.769593|2017-10-10 23:50:33.769593
NCT02285400|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2015-12-29|||November 2014||2014-11-01|July 2015|2015-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD|Effects of Continuous Positive Airway Pressure (CPAP) Level on Respiratory Mechanics and Central Drive in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|30|Actual|Zhujiang Hospital||2|||f||||t||||||||||2017-10-10 23:50:33.880288|2017-10-10 23:50:33.880288
NCT02285387|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-03|||November 2014||2014-11-01|November 2014|2014-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Rhythm Control of AF in Patients With Acute Stroke||Not yet recruiting||N/A|300|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:50:34.011473|2017-10-10 23:50:34.011473
NCT02285374|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-11-06|||November 2014||2014-11-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01||Interventional|||Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity|A Phase IV Open-label, Multi-centre, Randomised, Dual-arm, Pilot Study to Assess the Feasibility of Switching Individuals Receiving Efavirenz With Continuing Central Nervous System (CNS) Toxicity, to Dolutegravir|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|St Stephens Aids Trust||2|||f||||f||||||||||2017-10-10 23:50:34.103265|2017-10-10 23:50:34.103265
NCT02285361|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-09-15|||October 31, 2014|Actual|2014-10-31|September 2017|2017-09-01|January 28, 2020|Anticipated|2020-01-28|January 1, 2020|Anticipated|2020-01-01||Observational|||GIOTRIF rPMS in Korean Patients With NSCLC|A Regulatory Requirement Post-marketing Surveillance Study to Monitor the Safety and Efficacy of GIOTRIF®(Afatinib Dimaleate, 20mg, 30mg, 40mg, q.d) in Korean Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations or Patients With Locally Advanced or Metastatic NSCLC of Squamous Histology Progressing on or After Platinum-based Chemotherapy|Recruiting||N/A|3000|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:50:34.228892|2017-10-10 23:50:34.228892
NCT02285348|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-11-06|||April 2013||2013-04-01|November 2014|2014-11-01||||May 2015|Anticipated|2015-05-01||Interventional|||Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T|Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of Patients With Ataxia Telangiectasia|Unknown status|Recruiting|N/A|40|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-10 23:50:34.327097|2017-10-10 23:50:34.327097
NCT02285335|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-06|||November 2014||2014-11-01|November 2014|2014-11-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Effects of GINST on Human Semen||Unknown status|Not yet recruiting|N/A|60|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:50:34.46385|2017-10-10 23:50:34.46385
NCT02285322|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-04|||January 2014||2014-01-01|November 2014|2014-11-01|April 2015|Anticipated|2015-04-01|June 2014|Actual|2014-06-01||Observational|||Predictors of Blood Pressure Control and Associations With Cardiovascular Diseases in Individuals With High Blood Pressure: a CALIBER Study|Predictors of Blood Pressure Control and Associations With Cardiovascular Diseases in Individuals With High Blood Pressure: a CALIBER Study|Unknown status|Active, not recruiting|N/A|200000|Anticipated|University College, London|||2||f||||t||||||||||2017-10-10 23:50:34.563536|2017-10-10 23:50:34.563536
NCT02285309|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-04|||November 2014||2014-11-01|November 2014|2014-11-01||||July 2015|Anticipated|2015-07-01||Observational|||Perioperative Measurements of Diastolic Function in Cardiac Surgery|The Utility of Novel Measurements of Diastolic Function Involving Transoesophageal and Transthoracic Echocardiography in the Peri-operative Period in Patients Undergoing Cardiac Surgery -an Exploratory Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|University College, London|||1||f||||t||||||||||2017-10-10 23:50:34.663941|2017-10-10 23:50:34.663941
NCT02285296|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-05-18|||December 11, 2014|Actual|2014-12-11|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||The Needs and Burden of Family Caregivers of Older Adults With Cancer|The Needs and Burden of Family Caregivers of Older Adults With Cancer and Their Social Determinants|Recruiting||N/A|236|Anticipated|University Hospital, Lille||2|||f||||f||||||||Undecided||2017-10-10 23:50:34.745985|2017-10-10 23:50:34.745985
NCT02285283|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||RCT of Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps|Randomized Double-Blinded Controlled Trial of Oral Antifungal for the Treatment of Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps|Recruiting||Phase 2/Phase 3|340|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-10 23:50:34.86586|2017-10-10 23:50:34.86586
NCT02285270|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-10-25|2016-05-11||March 2014||2014-03-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Circadian Brown Adipose Tissue Metabolism|A Pilot Study to Investigate Circadian Variations in Brown Adipose Tissue Metabolism in Healthy Volunteers.|Completed||N/A|10|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 23:50:34.95603|2017-10-10 23:50:34.95603
NCT02285257|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-05|||July 2013||2013-07-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01|1 Year|Observational [Patient Registry]|||Epidemiology of Sepsis at Yuetan Subdistrict in Beijing|Epidemiology of Sepsis at Yuetan Subdistrict in Beijing|Unknown status|Recruiting|N/A|1000|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||||||2017-10-10 23:50:35.157176|2017-10-10 23:50:35.157176
NCT02285244|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-04-03|||March 12, 2015|Actual|2015-03-12|April 2017|2017-04-01|March 12, 2015|Actual|2015-03-12|March 12, 2015|Actual|2015-03-12||Interventional|||Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation|A Phase 2 Feasibility Study of Sotrastaurin for Relapsed and Refractory CLL/SLL/PLL/RT|Withdrawn||Phase 2|0|Actual|Ohio State University Comprehensive Cancer Center||1||Decision made by the Principal Investigator|f||||t||||||||||2017-10-10 23:50:35.224031|2017-10-10 23:50:35.224031
NCT02285231|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-05|||November 2013||2013-11-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Anti-hyperglycemic Effect of Short-term Arginyl-fructose Supplementation in Subjects With Pre-diabetes and Newly Diagnosed Type 2 Diabetes: Randomized, Double-blinded, Placebo-controlled Trial.||Completed||N/A|60|Actual|Yonsei University||2|||f||||t||||||||||2017-10-10 23:50:35.313112|2017-10-10 23:50:35.313112
NCT02285218|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-12|||April 2014||2014-04-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD||Unknown status|Recruiting|N/A|200|Anticipated|Yonsei University|||4||f||||f||||||Samples Without DNA|"     plasma (blood)   "|||2017-10-10 23:50:35.371195|2017-10-10 23:50:35.371195
NCT02285205|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-01-31|||November 2014||2014-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD||Completed||Phase 4|38|Actual|Yonsei University||1|||f||||f||||||||||2017-10-10 23:50:35.444012|2017-10-10 23:50:35.444012
NCT02285192|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-09-05|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer|Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer|Recruiting||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:50:35.502215|2017-10-10 23:50:35.502215
NCT02285179|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-13|||November 2014||2014-11-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|Poseidon||Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen|Phase I/Prospective Randomized Phase II Trial Of the Safety and Efficacy of Tamoxifen in Combination With GDC-0032 Compared With Tamoxifen alONe.|Recruiting||Phase 1|32|Anticipated|The Netherlands Cancer Institute||1|||f||||t||||||||||2017-10-10 23:50:35.593923|2017-10-10 23:50:35.593923
NCT02285166|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-03-30|||October 21, 2014|Actual|2014-10-21|March 2017|2017-03-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|||Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3|Specified Drug-use Survey of Lotriga Granular Capsules: OCEAN3 (Outcome Prevention on Cardiovascular Events by Antihyperlipidemic Therapy With N3-fatty Acid in Japan)|Recruiting||N/A|14000|Anticipated|Takeda|||2||f||||f||||||||||2017-10-10 23:50:35.694375|2017-10-10 23:50:35.694375
NCT02285153|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-03-22|||November 2012||2012-11-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Interventional|||Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit|Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit|Recruiting||Phase 3|460|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-10 23:50:35.940244|2017-10-10 23:50:35.940244
NCT02285140|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-08|||April 2015||2015-04-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PICS||Prevention of Infections in Cardiac Surgery|Prevention of Infections in Cardiac Surgery: a Cluster-randomized Factorial Cross-over Trial|Recruiting||N/A|3000|Anticipated|Hamilton Health Sciences Corporation||4|||f||||f||||||||||2017-10-10 23:50:36.068488|2017-10-10 23:50:36.068488
NCT02285127|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-09-11|||November 2014||2014-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study|Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study|Enrolling by invitation||N/A|260|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:50:36.178743|2017-10-10 23:50:36.178743
NCT02284932|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-09-07|||September 2011||2011-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01|6 Weeks|Observational [Patient Registry]|||Muscle Atrophy In Patients With Chronic Obstructive Pulmonary Disease|Muscle Atrophy In Patients With Chronic Obstructive Pulmonary Disease|Active, not recruiting||N/A|36|Anticipated|Laval University|||2||f||||t||||||Samples With DNA|"     Blood sample and muscle biopsy of vastus lateralis (quadriceps)   "|||2017-10-10 23:50:38.412891|2017-10-10 23:50:38.412891
NCT02285114|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-09-20|||January 20, 2015|Actual|2015-01-20|September 2017|2017-09-01|December 2024|Anticipated|2024-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected Children and Adolescents Virologically Suppressed on a 2-NRTI-Containing Regimen|A Phase 2/3, Open-Label, Multi-Cohort Switch Study to Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected Children and Adolescents Virologically Suppressed on a 2-NRTI-Containing Regimen|Recruiting||Phase 2/Phase 3|100|Anticipated|Gilead Sciences||9|||f||||t|t|f||||||||2017-10-10 23:50:36.260383|2017-10-10 23:50:36.260383
NCT02285101|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-07-27|||November 2014||2014-11-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|||Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors|Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors: Dose Escalation, Safety and PK/PD|Recruiting||Phase 1|36|Anticipated|Bio-Cancer Treatment International Limited||6|||f||||f||||||||||2017-10-10 23:50:36.434695|2017-10-10 23:50:36.434695
NCT02285088|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-03-13|||December 2014|Actual|2014-12-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease|A Phase I Randomised, Placebo-controlled, Double-blind, Single and Multiple Ascending Dose Study of the Tolerability and Pharmacokinetics of GBT440 in Healthy Subjects and Patients With Sickle Cell Disease|Active, not recruiting||Phase 1|128|Anticipated|Global Blood Therapeutics||2|||f||||||||||||||2017-10-10 23:50:36.561766|2017-10-10 23:50:36.561766
NCT02285075|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2016-01-03|||June 2011||2011-06-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Temocillin Pharmacokinetic in Hemodialysis|A Clinical Pharmacokinetic Study: Is Three Times Weekly Temocillin Appropriate for the Treatment of Severe Gram-negative Infections in Patients With ESRD Treated With Intermittent Hemodialysis?|Completed||Phase 4|16|Actual|AZ Sint-Jan AV||1|||f||||t||||||||||2017-10-10 23:50:36.658721|2017-10-10 23:50:36.658721
NCT02285062|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-09-27|||January 21, 2015|Actual|2015-01-21|September 2017|2017-09-01|September 30, 2022|Anticipated|2022-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|ROBUST||Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma|Phase 3 Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Compare the Efficacy and Safety of Lenalidomide (CC-5013) Plus R-CHOP Chemotherapy (R2-CHOP) Versus Placebo Plus R-CHOP Chemotherapy in Subjects With Previously Untreated Activated B-cell Type Diffuse Large B-cell Lymphoma|Active, not recruiting||Phase 3|570|Actual|Celgene||2|||f||||t||||||||||2017-10-10 23:50:36.81044|2017-10-10 23:50:36.81044
NCT02285049|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-02-28|||November 2014||2014-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|February 2015|Actual|2015-02-01||Observational|||Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Urticaria Control Test|Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Urticaria Control Test (UCT)|Completed||N/A|169|Actual|Mahidol University|||1||f||||f||||||||||2017-10-10 23:50:37.606797|2017-10-10 23:50:37.606797
NCT02285036|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-11-05|||September 2012||2012-09-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children|A Phase III Clinical Trial for a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children|Completed||Phase 3|1660|Actual|Walvax Biotechnology Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:50:37.724402|2017-10-10 23:50:37.724402
NCT02284997|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-05-28|||November 2014||2014-11-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Hummingbird||The Effect of an Eyelid Warming Device for the Management of Meibomian Gland Dysfunction||Completed||N/A|29|Actual|University of Waterloo||2|||f||||f||||||||||2017-10-10 23:50:38.019183|2017-10-10 23:50:38.019183
NCT02284984|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-08-22|||March 2014||2014-03-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|SYNBIoSe||Synergetic B-cell Immodulation in SLE|Synergetic B-cell Immodulation in SLE|Recruiting||Phase 2|15|Anticipated|Leiden University Medical Center||1|||f||||f||||||||||2017-10-10 23:50:38.088093|2017-10-10 23:50:38.088093
NCT02284971|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-05-01|||November 2014||2014-11-01|November 2016|2016-11-01||||March 2017|Actual|2017-03-01||Interventional|Prostate-04||Pilot Study of SBRT and CDX-1127 in Prostate Cancer|A Pilot Study to Assess the Combination of Stereotactic Body Radiation Therapy and CDX-1127 in Modulating Local and Systemic T-cell Responses Against Prostate Cancer|Terminated||Phase 1|2|Actual|University of Virginia||3||Low accruals|f||||t||||||||||2017-10-10 23:50:38.183428|2017-10-10 23:50:38.183428
NCT02284958|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-06-01|||April 2015||2015-04-01|June 2015|2015-06-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Walking Away From Back Pain, One Step at a Time|A Single-centre, Randomized Controlled Trial Investigating Clinical Utility and Cost-effectiveness of an Individualized Pedometer Driven Walking Programme for People With Chronic Low Back Pain|Unknown status|Recruiting|N/A|200|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-10-10 23:50:38.265438|2017-10-10 23:50:38.265438
NCT02284945|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-11-04|||August 2011||2011-08-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Randomized Controlled Trial of Open Stabilisation Versus TPS|A Randomized Controlled Trial Comparing Open Spinal Stabilisation and Percutaneous Solution (TPS) Surgery in Patients With Metastatic Spinal Disease.|Completed||N/A|||The Leeds Teaching Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 23:50:38.34671|2017-10-10 23:50:38.34671
NCT02284919|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-10-03|||November 2014||2014-11-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||[18F]ISO-1 PET/CT in Breast Cancer|Imaging of In Vivo Sigma-2 Receptor Expression With [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer|Recruiting||Phase 1|30|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:50:38.516867|2017-10-10 23:50:38.516867
NCT02284906|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-09-21|||November 17, 2014|Actual|2014-11-17|September 2017|2017-09-01|April 1, 2021|Anticipated|2021-04-01|April 1, 2021|Anticipated|2021-04-01||Interventional|||AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease|A Blinded Long-term Extension Study to Evaluate the Safety and Efficacy of Pioglitazone (AD-4833 Sustained Release 0.8 mg Daily) to Slow the Progression of Cognitive Decline in Subjects Who Have Completed the AD-4833/TOMM40_301 Study With Diagnosis of Mild Cognitive Impairment Due to Alzheimer Disease|Recruiting||Phase 3|149|Anticipated|Takeda||2|||f||||t||||||||||2017-10-10 23:50:38.624913|2017-10-10 23:50:38.624913
NCT02284880|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-01-07|2014-12-10||October 2010||2010-10-01|January 2015|2015-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate|Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate in Healthy Subjects|Completed||Phase 1|40|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 23:50:40.918085|2017-10-10 23:50:40.918085
NCT02284867|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2016-01-05|2014-12-23||August 2012||2012-08-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|4 Weeks|Observational [Patient Registry]|||Are Uterine Natural Killer Cells Involved in the Initiation of Preterm Labor ?|Comparison Between Uterine Natural Killer Cells In Preterm Labor And Term Labor|Completed||N/A|60|Actual|Ain Shams University|||2||f||||f||||||Samples With DNA|"     a placental sample will be taken either the patient delivered preterm or at term (term     patients will be either control term group or patients with successful treatment of preterm     labor). The placental sample taken should have part of the decidua and then the sample will     be fixed in 10% neutral-buffered formalin for 24-48 h, routinely processed, embedded in     paraffin wax, sectioned at 3 μm thickness, and mounted on 3-aminopropyl-triethoxysilane     -coated slides. Serial sections will be immunostained for CD 16 and CD56 .     Immunohisto-chemistery study will be done at Ain Shams Maternity Hospital Histopathology     department.   "|||2017-10-10 23:50:41.316989|2017-10-10 23:50:41.316989
NCT02284854|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-01-06|2014-12-09||July 2009||2009-07-01|January 2015|2015-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine|Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine in Healthy Subject|Completed||Phase 1|43|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 23:50:41.590576|2017-10-10 23:50:41.590576
NCT02284841|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-09-02|||August 2015||2015-08-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of Hilotherm Therapy on Post-operative Pain and Swelling Following Surgical Wisdom Tooth Removal|Effect of Hilotherm Therapy on Post-operative Pain and Swelling Following Surgical Lower Third Molar Removal|Unknown status|Recruiting|N/A|30|Anticipated|King's College Hospital NHS Trust||2|||f||||f||||||||||2017-10-10 23:50:42.743062|2017-10-10 23:50:42.743062
NCT02284828|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-12-02|2014-12-02||September 2007||2007-09-01|December 2014|2014-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function|Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function: Single-blind, Single-centre, Single and Multiple Dose, Fixed-order, Placebocontrolled Trial in Healthy Volunteers|Completed||Phase 1|26|Actual|Bial - Portela C S.A.||1|||f||||f||||||||||2017-10-10 23:50:42.853454|2017-10-10 23:50:42.853454
NCT02284815|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-11-04|||March 2012||2012-03-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Can Gluten-free Diet Prevent the Destruction of Beta-cells During Remission?|Diet Intervention in Newly Diagnosed Children With Type 1 Diabetes. How to Prolong Remission Using a Non-medical Approach?|Unknown status|Active, not recruiting|Early Phase 1|20|Anticipated|Herlev Hospital||2|||f||||t||||||||||2017-10-10 23:50:43.249528|2017-10-10 23:50:43.249528
NCT02284802|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2015-11-26|||September 2014||2014-09-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|||Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy|Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy|Unknown status|Recruiting|N/A|150|Anticipated|Instituto do Cancer do Estado de São Paulo||1|||f||||f||||||||||2017-10-10 23:50:43.32189|2017-10-10 23:50:43.32189
NCT02284789|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-12-02|||February 2015||2015-02-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CAJAS||Colorado Adult Joint Assessment Scale (CAJAS) Validation|Content and Psychometric Validation Study of the Colorado Adult Joint Assessment Scale (CAJAS) in Subjects With Moderate to Severe Hemophilia A Treated on Prophylaxis|Completed||N/A|30|Actual|Bayer||1|||f||||f||||||||||2017-10-10 23:50:43.412921|2017-10-10 23:50:43.412921
NCT02284776|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-12-15|||July 2013||2013-07-01|December 2015|2015-12-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|Educatherm||Preliminary Evaluation Study of Therapeutic Education on Overweight People in Addition to a Hydrotherapeutic Cure|Preliminary Evaluation Study of Therapeutic Education on Overweight People in Addition to a Hydrotherapeutic Cure at the Thermal Baths of Brides-les-Bains|Active, not recruiting||N/A|400|Anticipated|Institut Pasteur de Lille||2|||f||||t||||||||||2017-10-10 23:50:43.502163|2017-10-10 23:50:43.502163
NCT02284763|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-02-10|||October 2014||2014-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Modeling the Effect of EtCO2 on Cerebral Oxygenation|Pharmacodynamic Modeling of the Effect of End-tidal Carbon Dioxide on Cerebral Oxygen Saturation in Beach Chair Position Under General Anesthesia|Completed||N/A|55|Actual|Severance Hospital||1|||f||||f||||||||||2017-10-10 23:50:43.581009|2017-10-10 23:50:43.581009
NCT02284750|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-06-03|||December 2015||2015-12-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|DEFINITION-II||Two-stent vs Provisional Stenting Techniques for Patients With Complex Coronary Bifurcation Lesions|A Prospective, Multi-center, Randomized Trial Comparing Two-stent With Provisional Stenting Techniques for Patients With Complex Coronary Bifurcation Lesions|Recruiting||N/A|660|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t||||||||No||2017-10-10 23:50:43.658447|2017-10-10 23:50:43.658447
NCT02284737|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-09-12|||December 1, 2017|Anticipated|2017-12-01|September 2017|2017-09-01|July 30, 2021|Anticipated|2021-07-30|July 30, 2021|Anticipated|2021-07-30||Interventional|PADN-PAH||A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH|A Prospective, Multi-center, Randomized Control Trial to Investigate the Efficacy of Pulmonary Artery Denervation to Improved Functional Capacity and Hemodynamics in Patients With Pulmonary Artery Hypertension|Not yet recruiting||Phase 4|270|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t|t|f|||t|||||2017-10-10 23:50:43.854962|2017-10-10 23:50:43.854962
NCT02284724|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-03-09|||November 2014||2014-11-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Dry Needling to the Multifidus Muscle in Subjects With Low Back Pain|The Effect of Trigger Point Dry Needling to the Multifidus Muscle on Resting and Contracted Thickness of Transversus Abdominis in Subjects With Low Back Pain|Recruiting||N/A|60|Anticipated|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-10 23:50:43.984455|2017-10-10 23:50:43.984455
NCT02284711|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-10-31|||March 2015||2015-03-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|SALPOVA||Impact of Salpingectomy on Ovarian Reserve|Impact of Salpingectomy on Ovarian Reserve, With Comparison Between Two Coagulation Techniques|Recruiting||N/A|80|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:50:44.096491|2017-10-10 23:50:44.096491
NCT02284698|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2014-11-05|||December 2014||2014-12-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|CUP||Corneal Ulcer Prevention Through Health Education|Corneal Ulcer Prevention Through Health Education|Not yet recruiting||N/A|98207|Anticipated|Aravind Eye Care System|||2||f||||f||||||||||2017-10-10 23:50:44.198108|2017-10-10 23:50:44.198108
NCT02284685|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-05-27|||January 2015||2015-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Novel Intervention Promoting Eating Disorder Treatment Among College Students|A Novel Intervention Promoting Eating Disorder Treatment Among College Students|Completed||Phase 1|1149|Actual|University of Michigan||8|||f||||t||||||||||2017-10-10 23:50:44.271264|2017-10-10 23:50:44.271264
NCT02284672|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2016-02-26|||November 2014||2014-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Effect of Dexmedetomidine on Propofol Requirement for Insertion of Laryngeal Mask Airway|The Effect of Dexmedetomidine on Propofol Requirement for Insertion of Laryngeal Mask Airway|Completed||Phase 4|39|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-10 23:50:44.368715|2017-10-10 23:50:44.368715
NCT02284646|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-02-21|||November 2014||2014-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|PEPS||Physical Training Program in Ankylosing Spondylitis|Assessment of the Efficacy of a Physical Training Program in Patients With Ankylosing Spondylitis|Recruiting||N/A|56|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-10 23:50:44.530275|2017-10-10 23:50:44.530275
NCT02284633|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-03-20|||September 2014||2014-09-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer|Use of a New Blood Test to Identify Response to Targeted Treatment in Patients With EGFR Mutated Lung Cancer. Evaluation in a Multicenter Study|Recruiting||N/A|200|Anticipated|Aarhus University Hospital|||1||f||||t||||||Samples With DNA|"     Liquid biopsies: Bloodsamples investigating circulating tumor DNA   "|No||2017-10-10 23:50:44.616861|2017-10-10 23:50:44.616861
NCT02284620|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2015-07-25|||January 2015||2015-01-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|July 2015|Actual|2015-07-01||Interventional|||Continuous Femoral Nerve Block Versus Local-wound Infiltration Analgesia For Patients Receiving Total Knee Arthroplasty --- A Randomized Controlled Trial|Continuous Femoral Nerve Block Versus Local-wound Infiltration Analgesia For Patients Receiving Unilateral Total Knee Arthroplasty --- A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|320|Anticipated|First Affiliated Hospital of Chongqing Medical University||2|||f||||f||||||||||2017-10-10 23:50:44.700146|2017-10-10 23:50:44.700146
NCT02284607|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-03-07|||November 3, 2014|Actual|2014-11-03|March 2017|2017-03-01|March 13, 2015|Actual|2015-03-13|March 13, 2015|Actual|2015-03-13||Interventional|||A Study of High Dose MHAA4549A in Healthy Volunteers|A PHASE I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-ASCENDING DOSE STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF HIGH DOSE MHAA4549A IN HEALTHY VOLUNTEERS|Completed||Phase 1|14|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-10 23:50:44.804504|2017-10-10 23:50:44.804504
NCT02284594|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-05-17|||November 2014||2014-11-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts|Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts|Completed||N/A|4026|Actual|Columbia University||2|||f||||f||||||||||2017-10-10 23:50:44.888737|2017-10-10 23:50:44.888737
NCT02284412|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-04-20|||December 2014||2014-12-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|FRINeoS||Functional Respiratory Imaging After Neostigmine or Sugammadex|Visualization of Regional Lung Ventilation During Neostigmine or Sugammadex Enhanced Recovery From Moderate Residual Neuromuscular Blockade in the Anaesthetized Rat Using Functional Respiratory Imaging|Completed||Phase 4|13|Actual|Onze Lieve Vrouw Hospital||3|||f||||t||||||||||2017-10-10 23:50:47.584918|2017-10-10 23:50:47.584918
NCT02284581|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-05-05|||June 2015||2015-06-01|May 2015|2015-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|BIO-META||Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments|Evaluation of Medical Treatments (Chemotherapy, Hormonal Therapy and Biological Therapies) in Metastatic Breast Cancer Patients According to Biologic Subtype and Line of Treatment|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Consorzio Oncotech|||2||f||||t||||||Samples With DNA|"     Evaluation of duration of metastatic breast cancer treatments and numer of lines according to     biological subtype (Luminal A, Luminal B, HER2 positive, triple-negative)   "|||2017-10-10 23:50:44.982383|2017-10-10 23:50:44.982383
NCT02284568|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-12-01|||January 2015||2015-01-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo|A Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Once Daily Oral Administration of Laquinimod (0.6 or 1.5 mg) in Patients With Primary Progressive Multiple Sclerosis (PPMS) Phase 2|Active, not recruiting||Phase 2|374|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-10-10 23:50:45.16198|2017-10-10 23:50:45.16198
NCT02284555|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-02-02|2016-02-02||August 2014||2014-08-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)|A Single Centre, Open, Non-controlled Study in Healthy Subjects to Assess the Eradication of Nasal Carriage of Staphylococcus Aureus (SA) Following a Five Day Course of Mupirocin (Bactroban 2% Nasal Ointment) Using a Broth Enriched Culture Microbiological Assessment.|Completed||Phase 4|12|Actual|Destiny Pharma Ltd||1|||f||||f||||||||||2017-10-10 23:50:45.572586|2017-10-10 23:50:45.572586
NCT02284529|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-11-03|||October 2012||2012-10-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|Oxaliplatin||Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer|Evaluate the Safety of Combination of Orectalip® (Oxaliplatin), Fluorouracil and Leucovorin as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer|Completed||Phase 4|20|Actual|Sinphar Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-10 23:50:46.002538|2017-10-10 23:50:46.002538
NCT02284516|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-05-17|2016-09-30||November 2014||2014-11-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|OPUS-3|Randomized population included all participants screened for whom a randomization number was assigned.|A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye|A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use|Completed||Phase 3|711|Actual|Shire||2|||f||||||||||||||2017-10-10 23:50:46.141896|2017-10-10 23:50:46.141896
NCT02284503|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-03|||November 2014||2014-11-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)|A 30-day, Randomized, Open-Label, Multicenter Study Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With NSTE-ACS|Unknown status|Not yet recruiting|Phase 4|1350|Anticipated|Shanghai Zhongshan Hospital||3|||f||||f||||||||||2017-10-10 23:50:46.73077|2017-10-10 23:50:46.73077
NCT02284490|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-11-03|||November 2014||2014-11-01|November 2014|2014-11-01|November 2017|Anticipated|2017-11-01|October 2016|Anticipated|2016-10-01||Interventional|||High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases|High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases|Not yet recruiting||Phase 2|25|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||t||||||||||2017-10-10 23:50:46.849433|2017-10-10 23:50:46.849433
NCT02284477|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-01-27|||January 2015||2015-01-01|October 2014|2014-10-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Associations of Exposure to Phthalates With Insulin Resistance and Epigenetic Change|Associations of Exposure to Phthalates With Insulin Resistance and Epigenetic Change|Unknown status|Recruiting|N/A|60|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-10 23:50:46.981307|2017-10-10 23:50:46.981307
NCT02284464|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-09-02|||February 2015||2015-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients|Steroid Withdrawal and Novo Donor-specific Anti-HLA Antibodies in Renal Transplant Patients: a Prospective, Randomized and Controlled Study in Parallel Groups|Recruiting||Phase 4|230|Anticipated|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||2|||f||||t||||||||||2017-10-10 23:50:47.11318|2017-10-10 23:50:47.11318
NCT02284451|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-05-01|||February 2015||2015-02-01|October 2014|2014-10-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Facilitating HIV/AIDS and HIV Testing Literacy for Emergency Department Patients|Facilitating HIV/AIDS and HIV Testing Literacy for Emergency Department Patients|Enrolling by invitation||N/A|1200|Anticipated|Rhode Island Hospital||4|||f||||t||||||||||2017-10-10 23:50:47.255442|2017-10-10 23:50:47.255442
NCT02284438|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-10-02|||April 2014||2014-04-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Biofilm Formation on Different Endotracheal Tube Materials|Innovation Against Infection - Device Related Infections - Part ETT|Active, not recruiting||N/A|102|Actual|Region Skane||1|||f||||f||||||||||2017-10-10 23:50:47.350342|2017-10-10 23:50:47.350342
NCT02284425|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-05-10|||October 2014||2014-10-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study of REGN1193 in Patients With Type 2 Diabetes Mellitus||Terminated||Phase 1|72|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:50:47.457877|2017-10-10 23:50:47.457877
NCT02284399|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-25|||January 2014||2014-01-01|September 2017|2017-09-01|December 1, 2016|Actual|2016-12-01|June 28, 2016|Actual|2016-06-28||Observational|||National Prevalence and Impact of Noninvasive Prenatal Testing|National Prevalence and Impact of Noninvasive Prenatal Testing|Completed||N/A|4382|Actual|Mednax Center for Research, Education and Quality|||2||f||||f||||||||||2017-10-10 23:50:47.703766|2017-10-10 23:50:47.703766
NCT02284386|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-05-20|2016-05-20||December 2014||2014-12-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Patients undergoing total knee arthroplasty|Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty|Evaluation of the Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Subjects Undergoing for Unilateral Total Knee Arthroplasty|Completed||Phase 4|15|Actual|Pacira Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-10 23:50:47.809161|2017-10-10 23:50:47.809161
NCT02284360|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-09-25|||October 2014||2014-10-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds|A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds|Completed||Phase 1|10|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-10 23:50:48.186212|2017-10-10 23:50:48.186212
NCT02284347|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-07-12|2016-03-08||December 2014||2014-12-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Revision patients treated with NuVent|NuVent™ Revision Study||Completed||N/A|51|Actual|Medtronic Surgical Technologies||1|||f||||t||||||||||2017-10-10 23:50:48.26869|2017-10-10 23:50:48.26869
NCT02284334|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-11-04|||October 2014||2014-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Glycemic Index in Mitochondrial Disease|Acute Effects of Dietary Glycemic Index on Lactate and Glucose Homeostasis in Individuals With Primary Mitochondrial Disease|Completed||N/A|18|Actual|University of Pennsylvania|||2||f||||f||||||Samples Without DNA|"     Blood samples obtained during MMTT.   "|||2017-10-10 23:50:48.460269|2017-10-10 23:50:48.460269
NCT02284321|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-11-03|||November 2014||2014-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:50:48.673127|2017-10-10 23:50:48.673127
NCT02284308|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-08-30|||July 2016||2016-07-01|August 2017|2017-08-01|July 2023|Anticipated|2023-07-01|July 2022|Anticipated|2022-07-01||Interventional|ELDAPT||Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy|ELDAPT: Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the oPtimal Treatment Strategy|Recruiting||N/A|300|Anticipated|Maastricht Radiation Oncology||2|||f||||t||||||||||2017-10-10 23:50:48.727871|2017-10-10 23:50:48.727871
NCT02284295|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-04-13|||November 2014||2014-11-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Molecular, Cytological Features and Genetic Susceptibility of COPD Attributable to Different Environmental Exposures 2|Molecular, Cytological Features and Genetic Susceptibility of Occupational Chronic Obstructive Pulmonary Disease Attributable to Different Environmental Exposures 2.|Completed||N/A|352|Actual|Novosibirsk City Hospital #2|||2||f||||f||||||Samples With DNA|"     whole blood, serum,bronchoalveolar lavage fluid   "|||2017-10-10 23:50:48.871153|2017-10-10 23:50:48.871153
NCT02284282|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-12-02|||August 2014||2014-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|Salmon||Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery|Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery|Completed||N/A|56|Actual|Maasstad Hospital||2|||f||||t||||||||||2017-10-10 23:50:48.976399|2017-10-10 23:50:48.976399
NCT02284269|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-03-31|||October 2014||2014-10-01|March 2016|2016-03-01||||May 2020|Anticipated|2020-05-01||Observational|||Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus|Meta-analysis in Post-Marketing Surveillances for Long-Term Drug Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||N/A|18000|Anticipated|Pharmaceuticals and Medical Devices Agency, Japan|||1||f||||f||||||||||2017-10-10 23:50:49.06796|2017-10-10 23:50:49.06796
NCT02284256|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-08-14|||November 2014||2014-11-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery|A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical FibrocapsTM (RaplixaTM) and Tachosil® in Surgical Hemostasis During Hepatic Resection|Completed||Phase 3|150|Actual|Mallinckrodt||2|||f||||f||||||||||2017-10-10 23:50:49.19643|2017-10-10 23:50:49.19643
NCT02284243|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-03-21|2017-01-16||October 2014||2014-10-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Safety analysis set - All subjects receiving at least one study dose|Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy|Completed||Phase 2|168|Actual|Recro Pharma, Inc.||2|||f||||f||||||||||2017-10-10 23:50:49.328198|2017-10-10 23:50:49.328198
NCT02284230|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-08-21|||December 2014||2014-12-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|LiRA2||The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure|Glycaemic and Cardiovascular Efficacy of Liraglutide in Prediabetic Patients With End-stage Renal Disease|Withdrawn||Phase 2|0|Actual|Rigshospitalet, Denmark||2||Inability to recruit participants|f||||t||||||||||2017-10-10 23:50:49.998032|2017-10-10 23:50:49.998032
NCT02283138|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-07-16|||November 2014||2014-11-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Observational|||Prediction of Neonatal Respiratory Distress Syndrome in Preterm Fetuses by Assessment of Fetal Lung Volume by Vocal and Pulmonary Artery Resistance Index a Pilot Study||Completed||N/A|60|Actual|Ain Shams University|||1||f||||||||||||||2017-10-10 23:51:05.768603|2017-10-10 23:51:05.768603
NCT02284217|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-04-27|||December 2014||2014-12-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an External Ventricular Drainage (EVD) Device|A Prospective, Open-Label, Non-Randomized, Comparative Study Designed to Evaluate the Accuracy and Safety of HS-1000 Device, a Non-Invasive Intracranial Pressure (ICP) Monitor, in Patients Undergoing Invasive ICP Monitoring Procedure for Various Clinical Conditions|Recruiting||N/A|100|Anticipated|HeadSense Medical||1|||f||||t||||||||No||2017-10-10 23:50:50.11272|2017-10-10 23:50:50.11272
NCT02284204|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2017-01-10|||January 2012||2012-01-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Sevoflurane Associated With Oral Midazolam and Ketamine for Dental Sedation|Use of Sevoflurane, Midazolam and Ketamine in Children for Dental Sedation Treatment: Occurrence of Adverse Events|Completed||Phase 2|27|Actual|Universidade Federal de Goias||2|||f||||f||||||||Undecided|The research data can be shared with other researchers at a reasonable request.|2017-10-10 23:50:50.231512|2017-10-10 23:50:50.231512
NCT02284191|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-09-07|||January 2015||2015-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|RAPID-CTCA||Rapid Assessment of Potential Ischaemic Heart Disease With CTCA|The Role of Early CT Coronary Angiography in the Evaluation, Intervention and Outcome of Patients Presenting to the Emergency Department With Suspected or Confirmed Acute Coronary Syndrome.|Recruiting||N/A|2500|Anticipated|University of Edinburgh||2|||f||||t||||||||||2017-10-10 23:50:50.33428|2017-10-10 23:50:50.33428
NCT02284178|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-11-03|||August 2014||2014-08-01|November 2016|2016-11-01||||August 2017|Anticipated|2017-08-01||Interventional|NO-ASPIRATE||Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE|Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE|Recruiting||N/A|560|Anticipated|University of Central Florida||2|||f||||t||||||||||2017-10-10 23:50:50.620458|2017-10-10 23:50:50.620458
NCT02284165|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-05-25|2016-07-07||May 2013|Actual|2013-05-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2016|Actual|2016-05-01||Observational||Acute ischemic stroke patients in the Get With the Guidelines registry with Medicare fee-for-service health insurance. Differentiation into study arms by discharge location meets the first primary aim of the study, to describe rehab service use through 90 days.|Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke|Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke|Active, not recruiting||N/A|164246|Actual|Duke University|||1||f||||f||||||||No||2017-10-10 23:50:50.71531|2017-10-10 23:50:50.71531
NCT02284152|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-03|||January 2010||2010-01-01|November 2014|2014-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|RFS||Responsive Feeding Study|Responsive Feeding Study|Completed||N/A|32|Actual|Drexel University||1|||f||||f||||||||||2017-10-10 23:50:51.172435|2017-10-10 23:50:51.172435
NCT02284139|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-08-04|||April 2015||2015-04-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects|Pilot Trial of Epidermal Growth Factor (EGF) Ointment for the Patients With Epidermal Growth Factor Receptor (EGFR) Inhibitor Related Skin Side Effects|Recruiting||Phase 2/Phase 3|90|Anticipated|Dong-A University Hospital||3|||f||||t||||||||||2017-10-10 23:50:51.247119|2017-10-10 23:50:51.247119
NCT02284126|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-02-15|||October 2014||2014-10-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|Vanguard||Topical Vancomycin for Neurosurgery Wound Prophylaxis|Topical Vancomycin for the Reduction of Surgical Site Infections in Neurosurgery|Recruiting||Phase 3|3600|Anticipated|Columbia University||2|||f||||t||||||||Undecided||2017-10-10 23:50:51.330072|2017-10-10 23:50:51.330072
NCT02284113|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-04-14|||December 2014||2014-12-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty|A Post-Market, Multi-Center, Prospective, Double-Blind, Randomized, Controlled Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty|Active, not recruiting||N/A|150|Actual|MyoScience, Inc||2|||f||||f||||||||||2017-10-10 23:50:51.424576|2017-10-10 23:50:51.424576
NCT02284100|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-11-05|||September 2013||2013-09-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|||Animal-assisted Therapy in Pediatric Surgery: Post-operative Benefits|Animal-assisted Therapy in Pediatric Surgery: Cardiovascular, Neurological and Endocrinological Responses to Stress and Pain in the Immediate Post-operative Period|Completed||N/A|40|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-10 23:50:51.517996|2017-10-10 23:50:51.517996
NCT02284087|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-29|||September 17, 2014|Actual|2014-09-17|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|PAS-stroke||Paired Associative Stimulation in Post-stroke Hand Motor Deficits|Assessment of Paired Associative Stimulation Protocols Using Cerebellar or Visual Afferences in Post-stroke Hand Motor Deficits|Recruiting||N/A|60|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||4||f||||f||||||||||2017-10-10 23:50:51.578576|2017-10-10 23:50:51.578576
NCT02284074|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2014-11-03|||October 2010||2010-10-01|October 2014|2014-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Nasal LPS Challenge in Healthy Volunteers|Nasal Lipopolysaccharide (LPS) Challenge in Healthy Volunteers (HVs): Investigation of Tolerability, Dose Response and the Expression Profile of Intercellular Adhesion Molecule-1 (ICAM-1)|Completed||N/A|15|Actual|Imperial College London||1|||f||||f||||||||||2017-10-10 23:50:51.665208|2017-10-10 23:50:51.665208
NCT02284061|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-11-16|||November 2014||2014-11-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Physical Activity Program in Children and Adolescents With Cancer : Assessment of Benefits on Physical, Psychological and Social Health.||Recruiting||N/A|90|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||||||||||||2017-10-10 23:50:51.763929|2017-10-10 23:50:51.763929
NCT02284048|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-05|||November 2014||2014-11-01|November 2014|2014-11-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina|Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina|Not yet recruiting||Phase 4|140|Anticipated|Second Xiangya Hospital of Central South University||2|||f||||t||||||||||2017-10-10 23:50:51.82778|2017-10-10 23:50:51.82778
NCT02283125|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-04-03|||October 2014||2014-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:51:05.821689|2017-10-10 23:51:05.821689
NCT02284022|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-04-19|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|PVCAFM||Clinical Validation Protocol for BCI for the Communication of Patients Suffering From Neuromuscular Disorders.|Protocole de Validation Clinique du Logiciel d'Interface Cerveau-Ordinateur RoBIK Pour la Communication Des Patients Atteints de Maladie Neuromusculaires (MNM)|Completed||N/A|15|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||Undecided||2017-10-10 23:50:51.999121|2017-10-10 23:50:51.999121
NCT02284009|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-10-02|||October 10, 2014|Actual|2014-10-10|October 2017|2017-10-01|October 9, 2017|Anticipated|2017-10-09|October 9, 2017|Anticipated|2017-10-09||Interventional|||Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus|Study 110933: Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus|Active, not recruiting||Phase 2|68|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:50:52.200589|2017-10-10 23:50:52.200589
NCT02283996|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-01-31|||November 2014||2014-11-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment|Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment|Recruiting||Phase 4|260|Anticipated|Massachusetts General Hospital||2|||f||||||||||||||2017-10-10 23:50:52.359206|2017-10-10 23:50:52.359206
NCT02283983|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-03-21|||December 2014||2014-12-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|BANQUISE||Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose|Evaluation of Cryoprotection of Nail Toxicity Induced by Docetaxel Low Cumulative Dose. Controlled, Randomized, Open, Multicentre Prospective.|Recruiting||N/A|302|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-10 23:50:52.46274|2017-10-10 23:50:52.46274
NCT02283970|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-07-27|||December 2012||2012-12-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2014|Actual|2014-07-01||Observational|VAR||Investigation of Patients With BAV Requiring Valve and/or Aortic Repair (GISSI Outliers VAR)|Investigation of Patients With BAV Requiring Valve and/or Aortic Repair. Correlation of Surgical and ECO Distinctive Features With Histologic and Genetic Findings in Phenotypically Homogeneous Outlier Cases (GISSI VAR)|Active, not recruiting||N/A|62|Actual|Gruppo di Ricerca GISSI|||4||f||||f||||||Samples With DNA|"     Serum samples and tissue samples   "|||2017-10-10 23:50:52.631268|2017-10-10 23:50:52.631268
NCT02283957|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-12-02||2016-10-04|October 2014||2014-10-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)|Completed||Phase 2|119|Actual|Centrexion Therapeutics||4|||f||||||||||||||2017-10-10 23:50:52.731222|2017-10-10 23:50:52.731222
NCT02283944|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-08-22|||January 2015||2015-01-01|October 2014|2014-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||TMS Electrochemotherapy for Glioblastoma Multiforme|TMS Electrochemotherapy for Glioblastoma Multiforme|Suspended||Phase 2|20|Anticipated|University of Aarhus||1||Device for multi coil TMS no longer supported|f||||t||||||||||2017-10-10 23:50:52.83926|2017-10-10 23:50:52.83926
NCT02283931|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-01-21|||January 1, 2015|Actual|2015-01-01|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|LUDCO||Assessement of Hemodynamic Changes Associated With Uterine Displacement Using Noninvasive Cardiac Output Monitoring and Transthoracic Echocardiography:|Assessement of Hemodynamic Changes Associated With Uterine Displacement Using Noninvasive Cardiac Output Monitoring and Transthoracic Echocardiography:|Recruiting||N/A|25|Anticipated|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-10 23:50:52.906418|2017-10-10 23:50:52.906418
NCT02283918|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-10-01|||November 2014||2014-11-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment Battery|Study to Establish Patient-Matched Population Norms for the MS-COG|Completed||N/A|467|Actual|Biogen|||2||f||||f||||||||||2017-10-10 23:50:52.986791|2017-10-10 23:50:52.986791
NCT02283905|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-08-31|||June 2015||2015-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|BLASTO||Amphotericin-B and Voriconazole for Pulmonary Blastomycosis|Case Series of Continuously-infused Amphotericin-B and Follow-up Voriconazole Therapy for Severe Blastomycosis Pulmonary Infections|Recruiting||Phase 4|6|Anticipated|University of Manitoba||1|||f||||f||||||||Undecided||2017-10-10 23:50:53.056588|2017-10-10 23:50:53.056588
NCT02283892|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-02-22|||January 2014||2014-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|RCC||Respiratory Complaints Checklist Trial|Randomized Clinical Trial of the Impact of a Respiratory Complaints Assessment Checklist on Resources Utilization and Clinical Outcomes in an Acute Evaluation Outpatient Clinic|Completed||N/A|39|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:50:53.165817|2017-10-10 23:50:53.165817
NCT02283879|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-05-23|||March 2015||2015-03-01|July 2015|2015-07-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela|Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Cerebral Hemorrhage|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||1|||f||||t||||||||Undecided||2017-10-10 23:50:53.270888|2017-10-10 23:50:53.270888
NCT02283866|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-07-13|||June 2014||2014-06-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Bispectral Index-Guided Versus Fixed Dose Administration of Desflurane During Balanced Anesthesia With Remifentanil|Bispectral Index-Guided Versus Fixed Dose Administration of Desflurane During Balanced Anesthesia With Remifentanil|Completed||N/A|48|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-10 23:50:53.368736|2017-10-10 23:50:53.368736
NCT02283853|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-09-13|||August 31, 2014|Actual|2014-08-31|September 2017|2017-09-01|January 2, 2025|Anticipated|2025-01-02|May 21, 2020|Anticipated|2020-05-21||Interventional|CONNECT||Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)|Open-Label, Randomized, Multicenter, Multiple-Dose,Active-Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension|Recruiting||Phase 3|142|Anticipated|Biogen||2|||f||||t||||||||||2017-10-10 23:50:53.467078|2017-10-10 23:50:53.467078
NCT02283840|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-12-02|2014-12-02||May 2007||2007-05-01|December 2014|2014-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed Formulation|Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate 400mg, 600mg and 800mg Tablets Clinical Trial Formulation (CTF) Versus the To-be-marketed Formulation (TBM) in Healthy Male and Female|Completed||Phase 1|60|Actual|Bial - Portela C S.A.||6|||f||||f||||||||||2017-10-10 23:50:53.736538|2017-10-10 23:50:53.736538
NCT02283827|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-12-17|2014-12-01||January 2007||2007-01-01|December 2014|2014-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.|Phase I, Open-label Drug Interaction Study Between Eslicarbazepine Acetate 1200mg and Phenytoin 300 mg Following Multiple Dose Administrations in Healthy Male Volunteers|Completed||Phase 1|32|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 23:50:54.333136|2017-10-10 23:50:54.333136
NCT02283814|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-12-19|2014-11-28||January 2007||2007-01-01|December 2014|2014-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate|A Phase-1, Open-label, Drug Interaction Study Between Eslicarbazepine Acetate 1200 mg and Topiramate 200 mg Following Multiple Dose Administrations in Healthy Male|Completed||Phase 1|32|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 23:50:55.409242|2017-10-10 23:50:55.409242
NCT02283788|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-12-19|2014-11-28||March 2007||2007-03-01|December 2014|2014-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization|A Randomized, Double-blind, Placebo-controlled and Open Label Active-controlled, 4-period Crossover Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization in Healthy Adult Men and Women|Completed||Phase 1|67|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-10 23:50:55.891779|2017-10-10 23:50:55.891779
NCT02283775|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-04-27|||May 2015||2015-05-01|April 2017|2017-04-01|February 12, 2018|Anticipated|2018-02-12|February 12, 2018|Anticipated|2018-02-12||Interventional|PomdeSAR||SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients|A Phase 1b Study of SAR650984 (Isatuximab) in Combination With Pomalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1|45|Actual|Sanofi||1|||f||||f||||||||||2017-10-10 23:50:56.557789|2017-10-10 23:50:56.557789
NCT02283762|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-07-31|||January 15, 2015|Actual|2015-01-15|July 2017|2017-07-01|June 30, 2022|Anticipated|2022-06-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis|A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)|Active, not recruiting||Phase 2|121|Actual|Bayer||2|||f||||t|t|f||||||||2017-10-10 23:50:56.762317|2017-10-10 23:50:56.762317
NCT02283749|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||BrUOG L301 With Non-Small Cell Lung Cancer and Bone Metastases|BrUOG L301: Xofigo Following Frontline-Line Chemotherapy For Patients With Non-Small Cell Lung Cancer and Bone Metastases|Recruiting||Phase 2|36|Anticipated|Brown University||1|||f||||t|t|||||||No||2017-10-10 23:50:56.97411|2017-10-10 23:50:56.97411
NCT02283736|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-01|2016-06-13|||June 2014||2014-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|probiotic||Efficacy of Oral Probiotic Administration in Patients With Chronic Periodontitis|Efficacy of Oral Probiotic Administration in Clinical, Immunological and Microbiological Parameters of Patients With Chronic Periodontitis Treated With Non Surgical Periodontal Treatment.|Active, not recruiting||Phase 2|36|Actual|University of Chile||2|||f||||t||||||||||2017-10-10 23:50:57.169985|2017-10-10 23:50:57.169985
NCT02283723|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-01-31|||December 2014||2014-12-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|November 2016|Actual|2016-11-01||Interventional|TAPESTRY||A Randomized Controlled Trial Using the TAPESTRY Approach to Care for Older Adults|Teams Advancing Patient Experience: Strengthening Quality (TAPESTRY): A Randomized Controlled Trial Using the TAPESTRY Approach to Care for Older Adults|Active, not recruiting||N/A|316|Actual|McMaster University||2|||f||||f||||||||No||2017-10-10 23:50:57.262409|2017-10-10 23:50:57.262409
NCT02283710|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-01|2014-11-05|||May 2013||2013-05-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease|The Effect of Pentoxifylline on Liver Function Tests in Non-alcoholic Fatty Liver Disease Patients Refereed to Sina Hospital Gastroenterology Clinic|Completed||Phase 2|120|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:50:57.364003|2017-10-10 23:50:57.364003
NCT02283697|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2017-09-20|||September 2015||2015-09-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Dietary Counseling to Reduce Salt Intake in Patients With High Blood Pressure|Assessment of Effectiveness of Counseling by a Registered Dietician on Low Salt Diet in Patients With Hypertension: A Pragmatic Clinical Trial.|Recruiting||N/A|120|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 23:50:57.488312|2017-10-10 23:50:57.488312
NCT02283112|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-10-24|||October 2014||2014-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Validation of Drug Assays in Various Biological Matrices|Validation of Drug Assays in Various Biological Matrices|Recruiting||N/A|100|Anticipated|University of Liverpool|||1||f||||f||||||||||2017-10-10 23:51:05.856589|2017-10-10 23:51:05.856589
NCT02283684|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2017-02-01|||September 2014||2014-09-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2015|Actual|2015-11-01||Interventional|||GreenLight Laser Photoselective Vaporization of the Prostate vs Plasma Kinetic Vaporization of the Prostate; RCT|Green Light Laser (XPS) Photoselective Vaporization of the Prostate (PVP) Versus Bipolar Plasma Kinetic Vaporization (PKVP) of the Prostate for Treatment of Small to Moderate Sized Benign Prostate Hyperplasia: A Randomized Controlled Study|Active, not recruiting||Phase 4|120|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:50:57.600711|2017-10-10 23:50:57.600711
NCT02283671|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-04-26|||September 2015||2015-09-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B||Active, not recruiting||Phase 1|12|Actual|Fundacion Clinic per a la Recerca Biomédica||1|||f||||f||||||||||2017-10-10 23:50:57.709327|2017-10-10 23:50:57.709327
NCT02283658|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-03-21|||November 2014||2014-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer|A Phase 2 Trial of Letrozole and Everolimus in Relapsed Hormone Receptor Positive Ovarian, Fallopian Tube or Primary Peritoneal Carcinomas|Active, not recruiting||Phase 2|20|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 23:50:57.795328|2017-10-10 23:50:57.795328
NCT02283645|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-29|||January 2015||2015-01-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement|Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement : A Randomized, Double-blind, Placebo-controlled Study|Unknown status|Not yet recruiting|Phase 4|64|Anticipated|Mae Fah Luang University Hospital||2|||f||||f||||||||||2017-10-10 23:50:57.914035|2017-10-10 23:50:57.914035
NCT02283632|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-06-28|||October 2014||2014-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Trial of the Jejunal Diversion Procedure|A Trial of the Jejunal Diversion Procedure (Side-to-side Jejuno-jejunostomy) (Europe)|Completed||N/A|15|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-10-10 23:50:58.006461|2017-10-10 23:50:58.006461
NCT02283619|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-09-24|||November 2014||2014-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Left Bundle Branch Block ECG Characteristics in the Evaluation of Acute Coronary Syndrome|Correlation of Clinical Outcomes With ECG Findings in Patients With Left Bundle Branch Block Being Evaluated for Acute Coronary Syndrome - a Prospective Cohort Study|Terminated||N/A|8|Actual|Duke University|||1|"Study was found to be non-feasible. Not enough patients to perform an adequate study in the   allocated time period."|f||||||||||||||2017-10-10 23:50:58.077735|2017-10-10 23:50:58.077735
NCT02283606|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2015-09-22|||November 2015||2015-11-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|SUCI||Sonoelastography of the Uterine Cervix Before Induction of Labor|Sonoelastography of the Uterine Cervix Before Induction of Labor|Unknown status|Not yet recruiting|N/A|40|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-10 23:50:58.163653|2017-10-10 23:50:58.163653
NCT02283593|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2015-08-31|||March 2013||2013-03-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|eChangeNAT||Self-help Internet-based Relapse Prevention for Problematic Alcohol Use|Self-help Internet-based Relapse Prevention for Problematic Alcohol Use: A Naturalistic Study Among Internet Help-seekers|Completed||N/A|4165|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 23:50:58.227529|2017-10-10 23:50:58.227529
NCT02283580|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-03-03|||November 2014||2014-11-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Low Load, High-repetitive Elastic Band Resistance Training in COPD|Intramuscular and Functional Effects and Mechanism of Partitioning the Exercising Muscle Mass in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||N/A|43|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 23:50:58.307105|2017-10-10 23:50:58.307105
NCT02283567|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-09-22|||November 2015||2015-11-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|DEU||The Difference Between Elasticity of the Uterine Cervix in Singleton and Twin Pregnancies|The Difference Between Elasticity of the Uterine Cervix in Singleton and Twin Pregnancies|Unknown status|Not yet recruiting|N/A|40|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-10 23:50:58.422297|2017-10-10 23:50:58.422297
NCT02283554|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2014-11-04|||November 2013||2013-11-01|November 2014|2014-11-01||||July 2014|Actual|2014-07-01||Interventional|||Platelet Rich Fibrin With 1% Metformin Gel for Treatment of Intrabony Defects|Platelet Rich Fibrin With 1% Metformin for the Treatment of Intrabony Defects in Chronic Periodontitis : A Randomized Controlled Clinical Trial|Completed||Phase 2|120|Actual|Government Dental College and Research Institute, Bangalore||4|||f||||||||||||||2017-10-10 23:50:58.481074|2017-10-10 23:50:58.481074
NCT02283541|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-08-22|||June 2015||2015-06-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Gait, Depression, and Mind-body Therapy in Seniors|Investigating the Relationship Between Gait, Depression, and Mind-body Therapy in Seniors|Completed||N/A|27|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:50:58.563549|2017-10-10 23:50:58.563549
NCT02283528|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2017-01-21|||May 2015||2015-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Hybrid||A Comparison of Stryker Hybrid Arch Bars|A Comparison of Stryker Hybrid Arch Bars Versus Erich Arch Bars for Maxillomandibular Fixation of Mandibular Fractures: A Prospective Randomized Study|Recruiting||Phase 4|100|Anticipated|Emory University||2|||f||||t||||||||||2017-10-10 23:50:58.663812|2017-10-10 23:50:58.663812
NCT02283515|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2014-11-03|||January 2014||2014-01-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of Locally Delivred 1.2% Rosuvastatin Gel in Chronic Periodontitis|Efficacy of Locally Delivered 1.2% Rosuvastatin Gel in Non Surgical Treatment of Chronic Periodontitis Patients: A Randomised Clinical Control Trial.|Completed||Phase 2/Phase 3|65|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||t||||||||||2017-10-10 23:50:58.741042|2017-10-10 23:50:58.741042
NCT02283502|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-11-02|||September 2014||2014-09-01|October 2014|2014-10-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|MRgHIFU||Clinical Test of the MRgHIFU System on Uterine Fibroids|For Research Purpose the Clinical Test of the Magnetic Resonance Imaging Guided Focused Ultrasound Ablation System on Uterine Fibroids|Unknown status|Recruiting|Phase 1|20|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-10 23:50:58.823893|2017-10-10 23:50:58.823893
NCT02283489|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-11-03|||October 2014||2014-10-01|November 2014|2014-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors|Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors: Phase II, Multicenter, Randomized, Controlled Clinical Trial|Unknown status|Recruiting|Phase 2|180|Anticipated|Chengdu Shi Endor Biological Engineering Technology Co., Ltd||3|||f||||t||||||||||2017-10-10 23:50:58.908323|2017-10-10 23:50:58.908323
NCT02283476|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-05|||November 2014||2014-11-01|October 2014|2014-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.|The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.|Not yet recruiting||Phase 3|200|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:50:59.047759|2017-10-10 23:50:59.047759
NCT02283463|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-07-18|||September 2014||2014-09-01|July 2017|2017-07-01||||February 2018|Anticipated|2018-02-01||Interventional|||Novel Cervical Retraction Device|Patient Discomfort With a Novel Suction Based Cervical Retractor Compared to the Traditional Cervical Tenaculum|Active, not recruiting||N/A|24|Anticipated|Bioceptive||2|||f||||||||||||||2017-10-10 23:50:59.147851|2017-10-10 23:50:59.147851
NCT02283450|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-04|||May 2012||2012-05-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients|Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy patients--a Randomized Double Blind Clinical Trial|Completed||N/A|30|Actual|Harbin Medical University|||2||f||||||||||||||2017-10-10 23:50:59.216958|2017-10-10 23:50:59.216958
NCT02283437|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2017-07-02|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|PSBBP||A Problem-solving Based Bibliotherapy Program for Family Caregivers in Schizophrenia|A Randomized Controlled Trial of Problem-solving Based Bibliotherapy Program for Family Caregivers of People With Schizophrenia Spectrum Disorders|Recruiting||N/A|140|Anticipated|The Hong Kong Polytechnic University||3|||f||||f||||||||||2017-10-10 23:50:59.276968|2017-10-10 23:50:59.276968
NCT02283424|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-04|||October 2014||2014-10-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation|A Randomized ,Opened, Prospective Controlled Trial of Clinical Effectiveness for Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With Epidermal Growth Factor Receptor Gene Mutation|Active, not recruiting||Phase 4|10|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:50:59.379328|2017-10-10 23:50:59.379328
NCT02283411|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-07-13||2016-07-12|November 2014||2014-11-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems|Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring System - Personal and Abbott Sensor Based Glucose Monitoring System - Professional|Completed||N/A|156|Actual|Abbott Diabetes Care||1|||f||||f||||||||Undecided|Undecided to whether to make individual participant data available.|2017-10-10 23:50:59.456925|2017-10-10 23:50:59.456925
NCT02283398|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2015-09-24|||November 2014||2014-11-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|CARE-TAVI||Cardioprotective Effect of RIPC in Patients Undergoing TAVI|The CARE-TAVI Study: Cardioprotective Effect of Remote Ischemic Preconditioning in Patients Undergoing Transcatheter Aortic Valve Implantation|Withdrawn||N/A|0|Actual|Institut für Pharmakologie und Präventive Medizin||2||administrative issues|f||||f||||||||||2017-10-10 23:50:59.553223|2017-10-10 23:50:59.553223
NCT02283385|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-07-06|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 30, 2017|Actual|2017-06-30||Interventional|PROTECT||Mental Health Intervention for Elderly Abuse Victims|Mental Health Intervention for Elderly Abuse Victims: Providing Options to Elderly Clients Together (PROTECT)|Recruiting||N/A|350|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-10-10 23:50:59.628912|2017-10-10 23:50:59.628912
NCT02283372|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-07-17|||January 21, 2015|Actual|2015-01-21|July 2017|2017-07-01|July 30, 2018|Anticipated|2018-07-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer|Prospective Phase I Study of Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer|Recruiting||Phase 1|24|Anticipated|Washington University School of Medicine||1|||f||||t|t|t|f|f|f|||||2017-10-10 23:50:59.710286|2017-10-10 23:50:59.710286
NCT02283359|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-01-14|||December 2014||2014-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus|An Investigator Sponsored Phase 1a/1b Trial of Selinexor in Combination With Irinotecan in Patients With Adenocarcinoma of Stomach and Distal Esophagus|Terminated||Phase 1|3|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||Principal Investigator left the institution|f||||f||||||||||2017-10-10 23:50:59.812208|2017-10-10 23:50:59.812208
NCT02283346|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2014-11-04|||November 2014||2014-11-01|November 2014|2014-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|AC-P01||Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial|Single Fraction High Dose Rate (HDR) Brachytherapy Plus Hypofractionated External Beam Radiotherapy (EBRT) for Low-risk Prostate Cancer: Phase II Trial|Not yet recruiting||Phase 2|60|Anticipated|AC Camargo Cancer Center||1|||f||||t||||||||||2017-10-10 23:50:59.900611|2017-10-10 23:50:59.900611
NCT02283333|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-09-20|||December 1, 2014|Actual|2014-12-01|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|August 31, 2019|Anticipated|2019-08-31||Interventional|PGD||Treatment of Prolonged Grief Disorder in Combat Veterans|Treatment of Prolonged Grief Disorder in Combat Veterans|Recruiting||N/A|140|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:50:59.98282|2017-10-10 23:50:59.98282
NCT02282748|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-08-16|||October 2014||2014-10-01|August 2016|2016-08-01||||September 2024|Anticipated|2024-09-01||Observational|||Swiss Longitudinal Cohort|Swiss Longitudinal Cohort|Recruiting||N/A|1000|Anticipated|Hypertension Excellence Centre Lucerne|||1||f||||f||||||||||2017-10-10 23:51:09.973038|2017-10-10 23:51:09.973038
NCT02283320|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-04-14|||September 2014||2014-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer|An Open Label, Multicenter, Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as a Second-Line Therapy for Patients With KRAS Mutation Positive or Squamous Cell Non-Small Cell Lung Cancer|Completed||Phase 2|69|Actual|BIND Therapeutics||1|||f||||t||||||||||2017-10-10 23:51:00.120725|2017-10-10 23:51:00.120725
NCT02283307|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-04-14|||September 2014||2014-09-01|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Dual Energy CT Urography With Reduced Iodinated Contrast|Dual Energy CT Urography Using 50% Reduction in Iodinated Contrast: Feasibility, Image Quality, and Radiation Dose Reduction With Virtual Unenhanced Images.|Recruiting||N/A|50|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 23:51:00.375703|2017-10-10 23:51:00.375703
NCT02283294|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-09-16|||April 2015||2015-04-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|AREST||Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation|Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation|Recruiting||Phase 3|120|Anticipated|University of South Florida||2|||f||||t||||||||||2017-10-10 23:51:00.466324|2017-10-10 23:51:00.466324
NCT02283281|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2016-03-23|||May 2015||2015-05-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|Cannapremed||Anesthetic Premedication With a Cannabis Extract (Cannapremed)|Effects of a Cannabis Extract as Anaesthetic Premedication on Postoperative Pain, Nausea-vomiting and Perioperative Anxiety|Recruiting||Phase 2/Phase 3|200|Anticipated|Hadassah Medical Organization||4|||f||||t||||||||No||2017-10-10 23:51:00.569804|2017-10-10 23:51:00.569804
NCT02283268|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-08-30|2017-07-03||April 1, 2015|Actual|2015-04-01|July 2017|2017-07-01|July 6, 2016|Actual|2016-07-06|July 6, 2016|Actual|2016-07-06||Interventional|||Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery|A Phase 3, Prospective, Multicenter Study to Evaluate Efficacy and Safety of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Elective Surgical Procedures in Subjects With Severe Von Willebrand Disease|Completed||Phase 3|24|Actual|Baxalta US Inc.||1|||f||||t||||||||||2017-10-10 23:51:00.702347|2017-10-10 23:51:00.702347
NCT02283255|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-10-31|||January 2013||2013-01-01|October 2014|2014-10-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Cardiovascular, Pulmonary and Skeletal Muscle Evaluation in Late Postoperative Period of the Fontan Surgery|Cardiovascular, Pulmonary and Skeletal Muscle Evaluation in Patients With Univentricular Physiology in the Late Postoperative Period of the Fontan Surgery: Effects of Exercise Training|Unknown status|Recruiting|N/A|60|Anticipated|University of Sao Paulo||4|||f||||f||||||||||2017-10-10 23:51:03.334922|2017-10-10 23:51:03.334922
NCT02283242|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-02-13|||March 2014||2014-03-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|March 2015|Actual|2015-03-01||Interventional|GALANTA-MS||Galantamine Effects in Patients With Metabolic Syndrome|Effects of Cholinergic Stimulation on Visceral Fat, Oxidative Stress and Inflammatory Markers in Patients With Metabolic Syndrome: a Randomized Clinical Trial|Completed||Phase 4|60|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:51:03.489183|2017-10-10 23:51:03.489183
NCT02283229|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-05-01|||February 2012||2012-02-01|May 2017|2017-05-01|February 2024|Anticipated|2024-02-01|December 2016|Actual|2016-12-01||Interventional|||Newborn Head Molding and Later Asymmetries|Newborn Head Molding and Later Asymmetries in Follow up (3D Head Shape Modelling)|Active, not recruiting||N/A|135|Actual|University of Oulu||2|||f||||t||||||||No||2017-10-10 23:51:03.583039|2017-10-10 23:51:03.583039
NCT02283216|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-09-13|||June 2015||2015-06-01|September 2017|2017-09-01|September 13, 2017|Actual|2017-09-13|September 13, 2017|Actual|2017-09-13||Interventional|||Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus|Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus|Completed||N/A|5|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-10 23:51:03.700273|2017-10-10 23:51:03.700273
NCT02283203|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2016-03-21|||February 2015||2015-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A New Formulation of Intravenous Paracetamol for Fever Management|A Double-blind, Randomized, Placebo-controlled Phase IV Clinical Study of the Efficacy and Safety of a New Formulation of Paracetamol for the Management of Fever of Infectious Origin|Completed||Phase 4|80|Actual|Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.||2|||f||||f||||||||||2017-10-10 23:51:03.78092|2017-10-10 23:51:03.78092
NCT02283190|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-01-24|||April 2014||2014-04-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)|1336GCC: Open-Label, Single-Arm PK Study of IV Erwinaze (Asparaginase Erwinia Chrysanthemi) to Find the Dose With Acceptable Therapeutic and Safety Profile in Adults With Acute Myeloid Leukemia With or Without Isocitrate Dehydrogenase Mutations|Active, not recruiting||Phase 1|5|Actual|University of Maryland||1|||f||||t||||||||||2017-10-10 23:51:03.905187|2017-10-10 23:51:03.905187
NCT02283177|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-10-10|||January 2015||2015-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations|A Safety and Tolerability Trial of Crenolanib and Chemotherapy With Cytarabine and Anthracyclines in Patients With Newly Diagnosed Acute Myeloid Leukemia With FLT3 Activating Mutations|Recruiting||Phase 2|48|Anticipated|Arog Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-10 23:51:04.006551|2017-10-10 23:51:04.006551
NCT02283164|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-05-30|||March 2015||2015-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|April 2017|Actual|2017-04-01||Interventional|DEFENS||Drug Exposure Feedback and Education for Nurses' Safety|Randomized Controlled Trial to Improve Oncology Nurses' Protective Equipment Use|Active, not recruiting||N/A|380|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-10 23:51:04.134998|2017-10-10 23:51:04.134998
NCT02283151|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2014-11-02|||June 2013||2013-06-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of a Very Low Carbohydrate Diet Intervention on Weight Control in Overweight/Obese Patients in China|The Effects of a Very Low Carbohydrate Diet Intervention on Weight Control in Overweight/Obese Patients in China|Completed||Phase 2|98|Actual|Southern Medical University, China||2|||f||||f||||||||||2017-10-10 23:51:05.700507|2017-10-10 23:51:05.700507
NCT02283099|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-05-24|||November 2014||2014-11-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)|An Open Label, Single Center, Dose Escalation Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Single Ascending Dose of the Ebola Virus Vaccine rVSVΔG-ZEBOV-GP (BPSC1001)|Completed||Phase 1|30|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||t||||||||No||2017-10-10 23:51:05.924476|2017-10-10 23:51:05.924476
NCT02283086|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-02|2014-11-04|||January 2012||2012-01-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Performance Feedback on Imaging Use in the Emergency Department||Completed||N/A|43|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:51:06.006805|2017-10-10 23:51:06.006805
NCT02283073|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-02-21|||November 2014||2014-11-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Study for the Early Diagnosis of Parkinson's Disease|PDx Biomarker Assay Study for the Diagnosis of Parkinson's Disease|Active, not recruiting||N/A|410|Actual|Bio Shai Ltd.|||2||f||||f||||||Samples Without DNA|"     The mRNA in blood samples will be transcribed to cDNA.   "|||2017-10-10 23:51:06.072868|2017-10-10 23:51:06.072868
NCT02283060|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-03-10|||September 2014||2014-09-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Sleep and Cognition After Atripla to Stribild Switch|Change in Sleep Architecture and Neuropsychological Performance Following Switch From Atripla to Stribild.|Recruiting||Phase 4|30|Anticipated|University of Hawaii||2|||f||||f||||||||||2017-10-10 23:51:06.15312|2017-10-10 23:51:06.15312
NCT02283047|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-06-22|||January 2015||2015-01-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Interventional|EXERDIET-HTA||Effects of Different Aerobic Exercise Programs With Nutritional Interventions in Hypertensive and Overweight People|Effects on Blood Pressure, Cardiorespiratory Condition and Cardiovascular Risk of Different Aerobic Exercise Programs With Nutritional Interventions in Hypertensive and Overweight People.|Completed||N/A|176|Actual|Basque Country University||4|||f||||t||||||||||2017-10-10 23:51:06.253356|2017-10-10 23:51:06.253356
NCT02283034|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-02|||October 2014||2014-10-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|EPR||Effectiveness of Pediatric Resuscitation|Quality of Chest Compressions During 8 Min of Single-rescuer Pediatric Cardiopulmonary Resuscitation With Five Different CPR Feedback Devices. Randomised Crossover Manikin Trial|Unknown status|Recruiting|N/A|120|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:51:06.36243|2017-10-10 23:51:06.36243
NCT02283021|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2015-08-19|||January 2015||2015-01-01|August 2015|2015-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|||Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)|Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)|Enrolling by invitation||N/A|200|Anticipated|Hadassah Medical Organization|||2||f||||t||||||Samples Without DNA|"     Lung specimen biospsies are routinely taken from NSCLC patients and sent to pathological     evaluation. We will obtain small samples from these biopsies from the pathologist, which are     normally discarded. mRNA will be extracted from these samples.   "|||2017-10-10 23:51:06.565845|2017-10-10 23:51:06.565845
NCT02283008|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-04|||December 2014||2014-12-01|October 2014|2014-10-01||||August 2015|Anticipated|2015-08-01||Interventional|||Inhaler Technique Training|Evaluating the Efficacy of 2 Different Educational Strategies for Improving and Maintaining Inhaler Technique|Unknown status|Not yet recruiting|N/A|100|Anticipated|Northampton General Hospital NHS Trust||2|||f||||f||||||||||2017-10-10 23:51:06.646246|2017-10-10 23:51:06.646246
NCT02282995|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-04-23|||August 2012||2012-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FDFDR||Effect of Genetic Association With Functional Dyspepsia and Mood Disorders|Effect of Genetic Association With Functional Dyspepsia and Mood Disorders|Recruiting||N/A|1200|Anticipated|Chinese University of Hong Kong|||4||f||||||||||Samples With DNA|"     Nine ml of blood will be used for the detection of biomarkers for functional dyspepsia     through single nucleotide polymorphism (SNPs). The genotyping DNA will be isolated from whole     blood samples by (FlexGene DNA kit, Qiagen). High-throughput genotyping will be performed on     the serotonin 3A receptor polymorphism (rs1062613) and ghrelin CLOCK 3111C polymorphism     (rs1801260). It will be analyzed by Applied Biosystems (ABI) 3730xl DNA Analyzer.      Six ml of blood will be used for detection of plasma ghrelin and serotonin expression by     ELISA.      The remaining blood samples will be stored in the Laboratory of Institute of Digestive     Diseases for tests stated in the Aim section, also for future studies for emerging diseases     related to FGID.   "|No||2017-10-10 23:51:06.73006|2017-10-10 23:51:06.73006
NCT02282982|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-03|2016-06-29|2016-05-20||October 2014||2014-10-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|SUNRISE|Infants who received immunoprophylaxis during the RSV season|Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis|Prospective, Multi-Center, Observational Program to Assess RSV Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis in Routine Clinical Setting in the Russian Federation|Completed||N/A|359|Actual|AbbVie|||1||f||||f||||||||||2017-10-10 23:51:06.898101|2017-10-10 23:51:06.898101
NCT02282969|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-11-02|||July 2014||2014-07-01|November 2016|2016-11-01||||September 2018|Anticipated|2018-09-01||Observational|||PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing|Promoting Informed Decisions About Lung Cancer Screening: Decision Aid Update and Measures Development|Recruiting||N/A|150|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-10 23:51:07.314293|2017-10-10 23:51:07.314293
NCT02282956|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-04-29|||October 2014||2014-10-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|Hallux||Ultrasound Guided Single Shot Block of Posterior Tibial Nerve for Postoperative Pain Relief After Hallux Valgus Surgery|Monocentric, Non-blinded, Prospective Randomized Parallel Group Phase IV Clinical Study to Evaluate the Efficacy of Ultrasound Guided Single Shot Block of Nervus Tibialis Posterior for Postoperative Pain Relief After Hallux Valgus Surgery.|Recruiting||Phase 4|60|Anticipated|Spitalregion Rheintal, Werdenberg, Sarganserland||2|||f||||f||||||||||2017-10-10 23:51:07.414264|2017-10-10 23:51:07.414264
NCT02282943|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-04-04|||October 2002||2002-10-01|April 2016|2016-04-01||||December 2011|Actual|2011-12-01||Interventional|||Carbon Dioxide-laser Versus Harmonic Scalpel in the Treatment of Pelvic Pain Due to Endometriosis|Carbon Dioxide-laser Versus Harmonic Scalpel in the Treatment of Pelvic Pain Due to Endometriosis|Completed||N/A|112|Actual|Royal Surrey County Hospital||2|||f||||t||||||||||2017-10-10 23:51:07.537454|2017-10-10 23:51:07.537454
NCT02282917|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-05-02|||September 2015||2015-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma|Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma|Recruiting||Early Phase 1|20|Anticipated|Massachusetts Eye and Ear Infirmary||1|||f||||t||||||||No||2017-10-10 23:51:07.730661|2017-10-10 23:51:07.730661
NCT02282904|ClinicalTrials.gov processed this data on October 10, 2017|2014-11-04|2017-08-22|||October 22, 2014||2014-10-22|August 11, 2017|2017-08-11|January 1, 2034|Anticipated|2034-01-01|January 1, 2024|Anticipated|2024-01-01||Interventional|||Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide|Haploidentical Transplant for Patients With Chronic Granulomatous Disease (CGD) Using Post-Transplant Cyclophosphamide|Active, not recruiting||Early Phase 1|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:51:07.844847|2017-10-10 23:51:07.844847
NCT02282891|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-12-14|||January 2015||2015-01-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|January 2016|Anticipated|2016-01-01||Interventional|||"Compare the Effect of Propofol vs. Ketofol on Hemodynamic Stability During Induction of General Anesthesia"|"A Randomized-Controlled Trial to Compare the Effect of Propofol vs. Ketofol on Hemodynamic Stability During Induction of General Anesthesia"|Withdrawn||Phase 2|0|Actual|Yale University||2||No subjects were ever recruited and enrolled.|f||||f||||||||||2017-10-10 23:51:07.939984|2017-10-10 23:51:07.939984
NCT02282878|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-08-23|||September 2014||2014-09-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple Sclerosis|The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple Sclerosis|Recruiting||N/A|25|Anticipated|Yale University||2|||f||||f||||||||||2017-10-10 23:51:08.034962|2017-10-10 23:51:08.034962
NCT02282865|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-07-06|||September 2014||2014-09-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||The Relationship Between the Surgery-related Anxiety and HRV: Prediction for Aggressive Emergence Behavior||Unknown status|Recruiting|N/A|140|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-10 23:51:08.158075|2017-10-10 23:51:08.158075
NCT02282852|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-03-20|||January 2014||2014-01-01|October 2014|2014-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Can Steerable Capsule Endoscopy Enhance Gastric Emptying?|Randomised Comparison of a Standard Protocol Using Metoclopramide Versus a Hand Held Magnet to Enhance Gastric Emptying of the Small Bowel Capsule.|Completed||N/A|24|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:51:08.234581|2017-10-10 23:51:08.234581
NCT02282839|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-11-02|||January 2015||2015-01-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation|The Influence of Glutamine on the Side Effects of Chemo-radiation in Head and Neck Cancer Patients - A Randomized Controlled Trial|Recruiting||Phase 3|60|Anticipated|Taichung Veterans General Hospital||2|||f||||f||||||||||2017-10-10 23:51:08.317146|2017-10-10 23:51:08.317146
NCT02282826|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-04-12|||October 2014||2014-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis|A Randomized, Double-blind, Placebo-controlled Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Single Intravenous and Subcutaneous Doses of GZ402668 in Men and Women With Progressive Multiple Sclerosis|Completed||Phase 1|48|Actual|Sanofi||8|||f||||f||||||||||2017-10-10 23:51:08.454303|2017-10-10 23:51:08.454303
NCT02282813|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-08-22|2016-07-08|2016-06-21|April 2013||2013-04-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Intent to treat population: includes subjects receiving CTAP101 capsules only in the extension trial (up to 6 months total active therapy, subjects receiving up to 12 months receiving CTAP101 capsules (6 months in the previous trials and up to 6 months in the extension) with or without being randomized to CTAP101 capsules plus adjunctive therapy.|Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002|A Long-term Safety and Efficacy Study of CTAP101 Capsules in Subjects With Stages 3 or 4 Chronic Kidney Disease, Secondary Hyperparathyroidism and Vitamin D Insufficiency (Extension of Study CTAP101-CL-3001 or CTAP101-CL-3002)|Completed||Phase 3|298|Actual|OPKO Health, Inc.||4|||f||||f||||||||||2017-10-10 23:51:08.661987|2017-10-10 23:51:08.661987
NCT02282800|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-10-31|||November 2010||2010-11-01|October 2014|2014-10-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Observational|IVDAP||Immunolocalization of 1,25,Dihydroxyvitamin D3 in Aggressive Periodontitis Patients|Immunolocalization of 1,25,Dihydroxyvitamin D3 in Aggressive Periodontitis Patients|Completed||N/A|61|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||2||f||||f||||||||||2017-10-10 23:51:09.627029|2017-10-10 23:51:09.627029
NCT02282787|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-03-30|||January 2014||2014-01-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Dexmedetomidine Adjuvant in Retinal Surgery|DEXMEDETOMIDINE ADJUVANT TO LOCAL ANAESTHESIA FOR PERIBULBAR BLOCKS IN RETINAL SURGERY|Unknown status|Active, not recruiting|Phase 3|90|Anticipated|King Saud University||2|||f||||f||||||||||2017-10-10 23:51:09.709252|2017-10-10 23:51:09.709252
NCT02282774|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-03|||December 2013||2013-12-01|October 2014|2014-10-01||||June 2014|Actual|2014-06-01||Interventional|||Subtenon Block Combined With General Anesthesia for Vitreoretinal Surgery||Completed||Phase 3|80|Actual|King Saud University||2|||f||||f||||||||||2017-10-10 23:51:09.806863|2017-10-10 23:51:09.806863
NCT02282761|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-03-09||2017-03-09|November 2014||2014-11-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||A Trial to Assess the Antipsychotic Efficacy of ITI-007|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Antipsychotic Efficacy of ITI-007 in Patients With Schizophrenia|Completed||Phase 3|450|Actual|Intra-Cellular Therapies, Inc.||3|||f||||f||||||||||2017-10-10 23:51:09.895432|2017-10-10 23:51:09.895432
NCT02282709|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-10-16|||February 2014||2014-02-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|ImmunoDual||Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients|Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients|Completed||Phase 3|12|Actual|Foundation for Liver Research||1|||f||||t||||||||||2017-10-10 23:51:10.279219|2017-10-10 23:51:10.279219
NCT02282696|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-08-30|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|OPSA-PK||Validation Study CARES|Research on Psychosocial Aspects in the Care for Patients With Cancer: Validation Study CARES.|Completed||N/A|197|Actual|Hasselt University||1|||f||||f||||||||||2017-10-10 23:51:10.346126|2017-10-10 23:51:10.346126
NCT02282683|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-01-11|||December 2013||2013-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Long-term Prednisone Use for End-stage Heart Failure|Long-term Prednisone Use in Patients With Advanced Heart Failure (ACCF/AHA Stage D) and Hyperuricemia|Recruiting||Phase 2/Phase 3|90|Anticipated|Hebei Medical University||2|||f||||f||||||||||2017-10-10 23:51:10.413602|2017-10-10 23:51:10.413602
NCT02282657|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-03|||November 2015||2015-11-01|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|July 2017|Actual|2017-07-01||Interventional|SUPERNOVA||Strategy of UltraProtective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to seVere ARDS|Pilot Feasibility and Safety Study on Low-flow Extracorporeal CO2 Removal in Patients With Moderate ARDS to Enhance Lung Protective Ventilation|Completed||Phase 1/Phase 2|95|Actual|European Society of Intensive Care Medicine||1|||f||||f||||||||||2017-10-10 23:51:10.565166|2017-10-10 23:51:10.565166
NCT02282644|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2016-08-26|||September 2014||2014-09-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PROMET II||Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry|Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry|Active, not recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:51:10.661821|2017-10-10 23:51:10.661821
NCT02282631|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-03-29|2016-10-24||June 2014||2014-06-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|RIGHT_TRACKS||Development and Feasibility of an Incentive Scheme to Promote Walking/Cycling to School|The RIGHT TRACKS Study - Development and Feasibility of an Incentive Scheme to Promote Active School Travel in Year 5 Children|Completed||N/A|29|Actual|Newcastle University|"Few resources available to recruit schools and families
Small sample size
Small number of non-ATS trips with MVPA data
The same person delivered the intervention, collected and analysed the data"|2|||f||||t||||||||No||2017-10-10 23:51:10.732137|2017-10-10 23:51:10.732137
NCT02282618|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2014-11-03|||May 2013||2013-05-01|October 2014|2014-10-01||||May 2015|Anticipated|2015-05-01||Observational|||Effects of Cardiac Sympathetic Blockade in Patients With Chronic Heart Failure|Effects of Cardiac Sympathetic Blockade in Patients With Chronic Heart Failure, a 2-year, Prospective, Randomized Cohort Study|Unknown status|Recruiting|N/A|180|Anticipated|Harbin Medical University|||2||f||||f||||||||||2017-10-10 23:51:11.422432|2017-10-10 23:51:11.422432
NCT02282605|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-09-12|2016-02-29||September 2014||2014-09-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects|A Phase I/II Randomised, Double-blind, Placebo-controlled, Single Centre Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of Two Concentrations of XF-73 Nasal Gel in Healthy Subjects.|Completed||Phase 1/Phase 2|60|Actual|Destiny Pharma Ltd||3|||f||||f||||||||||2017-10-10 23:51:11.509703|2017-10-10 23:51:11.509703
NCT02282592|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-31|||November 2013||2013-11-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Observational|||Metabolic Syndrome and Female Breast Cancer|Metabolic Syndrome and Female Breast Cancer: a Case-control Study in Southern Brazil|Completed||N/A|164|Actual|Catholic University of Pelotas|||2||f||||||||||||||2017-10-10 23:51:12.006217|2017-10-10 23:51:12.006217
NCT02282579|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-05-07|||October 2014||2014-10-01|February 2015|2015-02-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Observational|SPAZO||Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy|Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy, in Patients With Metastatic Renal Cell Carcinoma in Daily Clinical Practice|Completed||N/A|300|Actual|Spanish Oncology Genito-Urinary Group|||1||f||||t||||||||||2017-10-10 23:51:12.083493|2017-10-10 23:51:12.083493
NCT02282566|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-10-31|||October 2014||2014-10-01|October 2014|2014-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effect of Protein-nutrition Beverages on Muscle Protein Synthesis in Women|A Pilot Trial to Assess the Effect of a Protein-Nutrition Beverage on Skeletal Muscle Protein Synthesis in Women|Unknown status|Recruiting|N/A|48|Anticipated|PepsiCo Global R&D||4|||f||||f||||||||||2017-10-10 23:51:12.227424|2017-10-10 23:51:12.227424
NCT02282553|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-04-25|||October 2014||2014-10-01|April 2017|2017-04-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Gastric Capsule Examination for Iron Deficiency Anaemia|Diagnosis of Upper Gastrointestinal Pathology in Patients With Recurrent/Refractory Iron Deficiency Anaemia: Magnetically Steerable Gastric Capsule Endoscopy Versus Conventional Gastroscopy.|Recruiting||N/A|20|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:51:12.316878|2017-10-10 23:51:12.316878
NCT02282540|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-10-28|||May 2015||2015-05-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|CT-ET||Novel Imaging of the Eustachian Tube; Patient Study|Novel Imaging of the Eustachian Tube; Patient Study|Unknown status|Recruiting|N/A|65|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-10-10 23:51:12.413054|2017-10-10 23:51:12.413054
NCT02282527|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-01-23|2016-11-11||October 2014||2014-10-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency|A Multi-center, Randomized, Double-blind, Crossover Study to Assess the Safety and Pharmacokinetics of Liquid Alpha₁-Proteinase Inhibitor (Human) Compared to Prolastin®-C in Subjects With Alpha₁-Antitrypsin Deficiency|Completed||Phase 2/Phase 3|32|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-10-10 23:51:12.519753|2017-10-10 23:51:12.519753
NCT02282514|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-07-17|||October 2014||2014-10-01|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|SPS||Stem Cell Transplantation for Stiff Person Syndrome (SPS)|Non-myeloablative Hematopoietic Stem Cell Transplantation for Stiff Person Syndrome (SPS) and Anti-GAD Antibody Variants: Progressive Encephalomyelitis With Rigidity and Myoclonus (PERM), and Adult Onset Autoimmune Anti-GAD Positive Cerebellar Ataxia|Recruiting||Phase 1/Phase 2|40|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-10 23:51:12.867086|2017-10-10 23:51:12.867086
NCT02282501|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-03-28|||August 2014||2014-08-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Leptin and Ghrelin in ICU||Completed||Phase 4|40|Actual|T.C. ORDU ÜNİVERSİTESİ||2|||f||||||||||||||2017-10-10 23:51:12.970163|2017-10-10 23:51:12.970163
NCT02282488|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2014-10-31|||April 2006||2006-04-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|June 2009|Actual|2009-06-01||Interventional|||Effect of the Level of Dietary Protein on the Infant Hormonal Profile and Body Composition|Effect of the Level of Dietary Protein on the Infant Hormonal Profile and Body Composition|Completed||N/A|238|Actual|Nestlé||3|||f||||f||||||||||2017-10-10 23:51:13.037602|2017-10-10 23:51:13.037602
NCT02282475|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-02-22|||November 2014||2014-11-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|August 2017|Anticipated|2017-08-01||Observational|||Role of Liver and Visceral Fat in Glucose and Lipid Metabolism During Pregnancy|Role of Liver and Visceral Fat in Glucose and Lipid Metabolism During Pregnancy|Enrolling by invitation||N/A|75|Anticipated|Kaiser Permanente|||2||f||||t||||||||No||2017-10-10 23:51:13.114431|2017-10-10 23:51:13.114431
NCT02282462|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-08-29|||December 2014||2014-12-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Postoperative Chest Tube Management|A Randomized Comparison of Active Suction vs. Passive Chest Tube Drainage and Regulated and Unregulated Pleural Pressure After Anatomic Lung Resection|Recruiting||Phase 4|600|Anticipated|Yale University||4|||f||||f||||||||||2017-10-10 23:51:13.177567|2017-10-10 23:51:13.177567
NCT02282449|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-10-24|||September 2013||2013-09-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Power Injectable Versus a Non-Power Injectable, Upper Arm, TIVAD for Chemotherapy|Assessment of a Power Injectable vs. a Non-Power Injectable, Upper Arm, Totally Implanted Venous Access Devices for Chemotherapy|Completed||N/A|209|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-10 23:51:13.282272|2017-10-10 23:51:13.282272
NCT02282436|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-09-07|||May 2012||2012-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01|1 Day|Observational [Patient Registry]|EXA||Substudy : Patients With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Muscle Atrophy in Patients With Chronic Obstructive Pulmonary DIsease : Substudy With Patients Who Experienced an Acute Exacerbation|Recruiting||N/A|20|Anticipated|Laval University|||1||f||||t||||||Samples With DNA|"     Blood sample and muscle biopsy of vastus lateralis (quadriceps)   "|||2017-10-10 23:51:13.375286|2017-10-10 23:51:13.375286
NCT02282423|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-05-10|||May 2014||2014-05-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PGC-1||PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes|PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes|Terminated||N/A|26|Actual|Mayo Clinic||4||PI job change|f||||t||||||||||2017-10-10 23:51:13.451073|2017-10-10 23:51:13.451073
NCT02282410|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-31|||December 2014||2014-12-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A|Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A|Unknown status|Not yet recruiting|N/A|15|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||t||||||||||2017-10-10 23:51:13.540803|2017-10-10 23:51:13.540803
NCT02282397|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-05-11|||September 2014||2014-09-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|DIaMonD||Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes|Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes|Completed||N/A|316|Actual|DexCom, Inc.||4|||f||||f||||||||No||2017-10-10 23:51:13.625993|2017-10-10 23:51:13.625993
NCT02282384|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-10-31|||October 2014||2014-10-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Interventional|AVT||An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study.|A Randomized Controlled Trial of Oseltamivir in Outpatients With Chronic Pulmonary Disease: a Pilot Study|Unknown status|Not yet recruiting|Phase 1|100|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 23:51:13.941743|2017-10-10 23:51:13.941743
NCT02282371|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-12-22|||October 2014||2014-10-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Interventional|||Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)|A Phase Ib Study of Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)|Recruiting||Phase 1|18|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:51:14.069043|2017-10-10 23:51:14.069043
NCT02282358|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-04-05|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma|An Open-Label Phase II Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma|Active, not recruiting||Phase 1/Phase 2|7|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:51:14.184095|2017-10-10 23:51:14.184095
NCT02282345|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-09-11|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Neoadjuvant Talazoparib for Patients With a BRCA Deleterious Mutation|A Pilot Study of Talazoparib as a Neoadjuvant Study in Patients With a Diagnosis of Invasive Breast Cancer and a Deleterious BRCA Mutation|Recruiting||Phase 2|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:51:14.265325|2017-10-10 23:51:14.265325
NCT02282332|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-06-30|||June 2014||2014-06-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||NIRS Ticagrelor Evaluation|The Impact of Ticagrelor on Coronary Atherosclerotic Lipid Pool and Inflammation Assessed by Near-Infrared Spectroscopy|Completed||Phase 4|30|Actual|Medstar Health Research Institute||1|||f||||f||||||||||2017-10-10 23:51:14.356681|2017-10-10 23:51:14.356681
NCT02282319|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-11-22|||October 2014||2014-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Spinal or Intravenous Dexmedetomidine in Ambulatory Surgery|Influence of Spinal or Intravenous Dexmedetomidine on Spinal Anesthesia With Chloroprocaine and Bladder Function in Day-case Surgery. A Double Blind Randomized Study.|Recruiting||Phase 4|150|Anticipated|University Hospital, Antwerp||3|||f||||f||||||||||2017-10-10 23:51:14.451557|2017-10-10 23:51:14.451557
NCT02282306|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-05-27|||September 2014||2014-09-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TTIP-PRO||Phone Interview to Prevent Recurring Opioid Overdoses|"Pilot Evaluation of the Tailored Telephone Intervention Delivered by Peers to Prevent Recurring Opioid-Overdoses"|Completed||N/A|30|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-10 23:51:14.594247|2017-10-10 23:51:14.594247
NCT02282293|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-10-26|||December 2014||2014-12-01|October 2015|2015-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)|Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE Birth Cohort 2)|Active, not recruiting||Phase 3|200|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-10 23:51:14.695281|2017-10-10 23:51:14.695281
NCT02282280|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-12-29|||October 2014||2014-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Clinical Use of Prilocaine Chlorhydrate Among a General Surgical Population|Clinical Use of Prilocaine Chlorhydrate Among a General Surgical Population|Completed||N/A|380|Actual|Astes|||1||f||||f||||||||||2017-10-10 23:51:14.830448|2017-10-10 23:51:14.830448
NCT02282267|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-02-22|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|Benefit||Blood Detection of EGFR Mutation For Iressa Treatment|Blood Detection of EGFR Mutation For Iressa Treatment|Active, not recruiting||N/A|188|Actual|Beijing Cancer Hospital||1|||f||||f|f|f||||||Undecided||2017-10-10 23:51:14.901183|2017-10-10 23:51:14.901183
NCT02282254|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2016-11-08|||October 2014||2014-10-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia|An Open-label, Randomized, Cross-over Study to Assess the Efficacy of Single-hormone and Dual-hormone Closed-loop Strategy in Regulating Overnight Glucose Levels in Type 1 diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia|Completed||Phase 2|35|Actual|Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||||2017-10-10 23:51:14.979983|2017-10-10 23:51:14.979983
NCT02282241|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-07-30|||February 2016||2016-02-01|July 2015|2015-07-01|February 2017|Anticipated|2017-02-01|June 2016|Anticipated|2016-06-01||Interventional|||Melatonin for Delirium Prophylaxis|A Randomized Double-Blind Placebo-Controlled Study on the Use of Melatonin for the Prevention of Delirium|Unknown status|Not yet recruiting|Phase 4|160|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-10 23:51:15.094852|2017-10-10 23:51:15.094852
NCT02282228|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-02-03|||November 2014||2014-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Detecting Chronic Subdural Hematoma With Microwave Technology|Detecting Chronic Subdural Hematoma With Microwave Technology - An Open Study Evaluating the Sensitivity and Specificity of a Microwave-based Device, Medfield Strokefinder MD100, to Detect Chronic Subdural Hematoma|Completed||N/A|41|Actual|Sahlgrenska University Hospital, Sweden||1|||f||||f||||||||||2017-10-10 23:51:15.212558|2017-10-10 23:51:15.212558
NCT02282215|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-03-23|||December 2014|Actual|2014-12-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia|An Open-Label Phase 2 Prospective, Randomized, Controlled Study of CLT-008 Myeloid Progenitor Cells as a Supportive Care Measure During Induction Chemotherapy for Acute Myeloid Leukemia|Recruiting||Phase 2|160|Anticipated|Cellerant Therapeutics||4|||f||||t||||||||Undecided||2017-10-10 23:51:15.295263|2017-10-10 23:51:15.295263
NCT02282202|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2014-12-09|||September 2013||2013-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of Oscillatory Positive Expiratory Pressure (oPEP) in Bronchiectasis and COPD|Evaluation of Oscillatory Positive Expiratory Pressure (oPEP) in Bronchiectasis and COPD|Completed||N/A|32|Actual|Western University, Canada||1|||f||||f||||||||||2017-10-10 23:51:15.498026|2017-10-10 23:51:15.498026
NCT02282189|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2014-12-09|||July 2012||2012-07-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Longitudinal Study of Oscillatory Positive Expiratory Pressure (oPEP) in Stable COPD|Longitudinal Study of Oscillatory Positive Expiratory Pressure (oPEP) in Stable COPD|Completed||N/A|17|Actual|Western University, Canada||1|||f||||f||||||||||2017-10-10 23:51:15.58795|2017-10-10 23:51:15.58795
NCT02282176|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-02-24|||January 2015||2015-01-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|TINN2||TINN2: Treat Infection in NeoNates 2|A Randomised, Placebo Controlled Trial of Azithromycin for the Prevention of Chronic Lung Disease of Prematurity in Preterm Infants|Withdrawn||Phase 3|0|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-10 23:51:15.692322|2017-10-10 23:51:15.692322
NCT02282163|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-02-22|||June 2015||2015-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography|A Multicenter Clinical Evaluation of Safety and Efficacy of Lumason as a Contrast Agent in Pediatric Echocardiography|Recruiting||Phase 3|92|Anticipated|Bracco Diagnostics, Inc||1|||f||||t||||||||No||2017-10-10 23:51:15.847463|2017-10-10 23:51:15.847463
NCT02282150|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-02-21|||October 2016||2016-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|PlenadrEMA||Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism|Effect of Modified-release Compared to Conventional Hydrocortisone on Fatigue, Measured by Ecological Momentary Assessments; a Pilot Study.|Enrolling by invitation||Phase 4|30|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||Undecided||2017-10-10 23:51:15.92987|2017-10-10 23:51:15.92987
NCT02282137|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-04-13|||April 2015||2015-04-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PSMA||68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer|68Ga-PSMA (ProstaMedix™) PET-CT Scan for Diagnosis and Management of Prostate Cancer|Unknown status|Recruiting|Phase 2|208|Anticipated|Radio Isotope Therapy of America||1|||f||||t||||||||||2017-10-10 23:51:16.018107|2017-10-10 23:51:16.018107
NCT02282124|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-05-31|||May 2012||2012-05-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|SMP-NEP||Effectiveness of an APN-led Self-management Program in Patients in the First Year After Renal Transplantation|Effectiveness of an Advanced Practice Nurse-led Self-management Program on Prevention of Weight Gain, Physical Activity and Medication Adherence in Patients in the First Year After Renal Transplantation|Recruiting||N/A|122|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 23:51:16.124558|2017-10-10 23:51:16.124558
NCT02282111|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-08-16|||July 2014||2014-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors|EUS-guided Core Needle Biopsy (EUS-CNB) Versus EUS-guided Single-incision With Needle Knife (SINK) for the Diagnosis of Upper Gastrointestinal Subepithelial Lesions - a Multicenter Randomized Controlled Trial|Recruiting||Phase 3|90|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:51:16.230993|2017-10-10 23:51:16.230993
NCT02282098|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-10-28|||November 2014||2014-11-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CIAFS-1||Colchicine in Atrial Fibrillation to Prevent Stroke|Targeting Inflammation in Atrial Fibrillation to Prevent Ischemic Stroke: A Feasibility Study Evaluating the Effect of Colchicine on D-dimer and Hs-CRP in Anticoagulated Patients With Atrial Fibrillation|Recruiting||Phase 3|60|Anticipated|Population Health Research Institute||2|||f||||t||||||||||2017-10-10 23:51:16.329806|2017-10-10 23:51:16.329806
NCT02282085|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-06-03|||December 2014||2014-12-01|June 2015|2015-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia|A Randomized, Multi-site, Parallel-group, Rater-blind Study Comparing Response With Aripiprazole Once Monthly and Standard of Care Oral Antipsychotics in Non-adherent Outpatients With Schizophrenia Identified Using the Brief Adherence Rating Scale|Recruiting||Phase 4|200|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-10 23:51:16.436901|2017-10-10 23:51:16.436901
NCT02282072|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-10-13|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction|PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction|Not yet recruiting||Early Phase 1|20|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:51:16.530133|2017-10-10 23:51:16.530133
NCT02282059|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-09-28|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Observational|||The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors|A Multi-center, Prospective, Non-interventional (ni) Study Of The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-differentiated Unresectable Pancreatic Neuroendocrine Tumors|Recruiting||N/A|100|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-10 23:51:16.609125|2017-10-10 23:51:16.609125
NCT02282046|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-08-14|||May 2014||2014-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Diabetes Effects on Long-Term Implant Survival and Success|Diabetes Effects on Long-Term Implant Survival and Success|Recruiting||N/A|200|Anticipated|The University of Texas Health Science Center at San Antonio|||2||f||||f||||||||||2017-10-10 23:51:16.719919|2017-10-10 23:51:16.719919
NCT02282033|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-08-28|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Performance Study of the Moderato System|Clinical Evaluation of Safety and Performance of the BackBeat Moderato System|Completed||N/A|57|Actual|BackBeat Medical Inc||1|||f||||t||||||||||2017-10-10 23:51:16.791345|2017-10-10 23:51:16.791345
NCT02282020|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-08-29|||February 6, 2015|Actual|2015-02-06|August 2017|2017-08-01|September 25, 2020|Anticipated|2020-09-25|September 28, 2018|Anticipated|2018-09-28||Interventional|SOLO3||Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments.|A Phase III, Open Label, Randomised, Controlled, Multi-centre Study to Assess the Efficacy and Safety of Olaparib Monotherapy Versus Physician's Choice Single Agent Chemotherapy in the Treatment of Platinum Sensitive Relapsed Ovarian Cancer in Patients Carrying Germline BRCA1/2 Mutations.|Recruiting||Phase 3|411|Anticipated|AstraZeneca||2|||t||||t||||||||||2017-10-10 23:51:16.907111|2017-10-10 23:51:16.907111
NCT02282007|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-06-23|||February 2014||2014-02-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life|Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life, The Feeling of Pain, Coping, Physical, Psychological and Social Functioning After the Treatment|Recruiting||N/A|170|Anticipated|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-10 23:51:17.385512|2017-10-10 23:51:17.385512
NCT02281994|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2016-07-27|||September 2014||2014-09-01|November 2014|2014-11-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Odontoid Fracture Study Treated With Pulsed Electromagnetic Fields|Safety and Efficacy of Pulsed Electromagnetic Fields (Cervical-Stim®) as an Adjunct to Enhance Union in Conservatively Treated Type II Fractures of the Odontoid Process|Enrolling by invitation||N/A|360|Anticipated|Orthofix Inc.||2|||f||||f||||||||||2017-10-10 23:51:17.518761|2017-10-10 23:51:17.518761
NCT02281981|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-09-16|||November 2014||2014-11-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Interventional|Cur||The Effects of Repeated Bouts of Downhill Running and Curcumin Supplementation on Arterial Stiffness During Recovery|The Effects of Repeated Bouts of Downhill Running and Curcumin Supplementation on Arterial Stiffness During Recovery|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|University of Prince Edward Island||2|||f||||f||||||||||2017-10-10 23:51:17.612329|2017-10-10 23:51:17.612329
NCT02281968|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2015-12-17|||December 2014||2014-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||NSAIDs for Pain After Ankle Fracture Surgery|An NSAID Pain Protocol Provides Adequate Pain Relief in Ankle Fractures Treated Operatively|Withdrawn||Phase 4|0|Actual|Northwell Health||2|||f||||t||||||||||2017-10-10 23:51:17.726783|2017-10-10 23:51:17.726783
NCT02281955|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-09-19|||August 2014||2014-08-01|September 2017|2017-09-01|November 2022|Anticipated|2022-11-01|November 2019|Anticipated|2019-11-01||Interventional|||De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study|De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal Squamous Cell Carcinoma|Recruiting||Phase 2|60|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:51:17.822184|2017-10-10 23:51:17.822184
NCT02281942|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-22|||May 2014||2014-05-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Behavioral Interventions to Target Self-Control|Behavioral Interventions to Target Self-Control in Abstinent Nicotine Dependent Smokers|Completed||N/A|39|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-10 23:51:17.950027|2017-10-10 23:51:17.950027
NCT02281929|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-05-18|||June 13, 2015|Actual|2015-06-13|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|AntibioCor||Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone|Evaluation of the Efficacy of an Antibiotic Combined With Standard Treatment in Severe Alcoholic Hepatitis|Recruiting||Phase 3|280|Anticipated|University Hospital, Lille||2|||f||||t||||||||No||2017-10-10 23:51:18.041516|2017-10-10 23:51:18.041516
NCT02281916|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-06-06|||March 2014||2014-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ACROHNEM||Safety Study of P28GST Treatment in Crohn's Disease Patients|Safety Study of P28GST Treatment in Crohn's Disease Patients, a Multicenter Phase 2 Clinical Trial|Recruiting||Phase 2|24|Anticipated|University Hospital, Lille||1|||f||||t||||||||Undecided||2017-10-10 23:51:18.287212|2017-10-10 23:51:18.287212
NCT02281903|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-15|||October 2014||2014-10-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|PRFD||Pediatric Resuscitation With Feedback CPR Devices|Is Chest Compressions Using the TrueCPRTM Feedback Device More Effective Than Manual Compressions During Pediatric Resuscitation? A Manikin Study|Completed||N/A|132|Actual|International Institute of Rescue Research and Education||1|||f||||t||||||||||2017-10-10 23:51:18.413268|2017-10-10 23:51:18.413268
NCT02281890|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-30|||October 2001||2001-10-01|October 2014|2014-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database|Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database|Completed||N/A|3493|Actual|University of Edinburgh|||2||f||||f||||||||||2017-10-10 23:51:18.519423|2017-10-10 23:51:18.519423
NCT02281877|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-12-05|||October 2014||2014-10-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Alterations in Muscle After Total Knee Arthroplasty|Alterations in Skeletal Muscle Gene Expression Following Total Knee Arthroplasty|Recruiting||N/A|20|Anticipated|University of Colorado, Denver||2|||f||||||||||||||2017-10-10 23:51:18.650791|2017-10-10 23:51:18.650791
NCT02281864|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-09-21|||December 2014||2014-12-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|May 2018|Anticipated|2018-05-01||Interventional|INSPIRE||Interventions to Help Smoking Parents of Inpatients Reduce Exposure (INSPIRE)|Interventions to Help Smoking Parents of Inpatients Reduce Exposure (INSPIRE)|Recruiting||N/A|600|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-10 23:51:18.774108|2017-10-10 23:51:18.774108
NCT02281851|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-30|||July 2013||2013-07-01|October 2014|2014-10-01||||May 2015|Anticipated|2015-05-01||Observational|||Examining Endogenous Antioxidant Levels in Well Trained Cyclists|The Effects of Habitual Antioxidant Supplementation on Endogenous Antioxidants and Oxidative Damage in Well Trained Cyclists|Unknown status|Recruiting|N/A|50|Anticipated|University of Birmingham|||2||f||||f||||||||||2017-10-10 23:51:18.879498|2017-10-10 23:51:18.879498
NCT02281838|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-11-22|||November 2012||2012-11-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Interventional|ICH-ADAPT II||The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II|The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II|Recruiting||Phase 2|270|Anticipated|University of Alberta||2|||f||||t||||||||||2017-10-10 23:51:18.984772|2017-10-10 23:51:18.984772
NCT02281825|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-04-13|||November 2014||2014-11-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||Correlating Real and Virtual World Behavioral Fluctuations in Adolescence|Correlating Real and Virtual World Behavioral Fluctuations in Adolescence|Completed||N/A|20|Actual|Shalvata Mental Health Center|||2||f||||f||||||||||2017-10-10 23:51:19.114679|2017-10-10 23:51:19.114679
NCT02281812|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-08-09|||September 2013||2013-09-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Radiofrequency Ablation in Breast Cancer|Impact of Radiofrequency Ablation on Surgical Margins in Early Stage of Malignant Breast Tumors|Terminated||N/A|40|Actual|Hospital Universitari de Bellvitge||2||Increased infection rate in study group|f||||f||||||||||2017-10-10 23:51:19.189923|2017-10-10 23:51:19.189923
NCT02281786|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-11-01|||January 2015||2015-01-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of RO6926496 in Healthy Volunteers|A SINGLE-CENTER, RANDOMIZED, INVESTIGATOR/SUBJECT BLIND, SINGLE ASCENDING DOSE, PLACEBO CONTROLLED, PARALLEL STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF RO6926496 FOLLOWING INTRAVENOUS INFUSION IN HEALTHY SUBJECTS|Completed||Phase 1|48|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-10 23:51:19.376379|2017-10-10 23:51:19.376379
NCT02281747|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-31|2017-09-20|||October 23, 2014||2014-10-23|September 14, 2017|2017-09-14|May 31, 2018|Anticipated|2018-05-31|September 23, 2015|Actual|2015-09-23||Observational|||Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries|Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries|Enrolling by invitation||N/A|530000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:51:19.792192|2017-10-10 23:51:19.792192
NCT02281721|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-09-17|||March 2015||2015-03-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|||Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection|Prospective, Observational, Multi-Center, Single-Arm, Consecutive Enrollment, Post-Marketing, International Registry of the Surpass™ Flow Diverter in Intracranial Arteries|Recruiting||N/A|150|Anticipated|Stryker Neurovascular|||1||f||||t||||||||||2017-10-10 23:51:19.884048|2017-10-10 23:51:19.884048
NCT02281708|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-10-31|||October 2014||2014-10-01|October 2014|2014-10-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma|A Multi-center Phase III Randomized Controlled Trial Comparing Between Adjuvant Chemotherapy and Observation in High Risk Patients With Completely Resected Stage Ib Lung Adenocarcinoma|Recruiting||Phase 3|1012|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-10 23:51:20.074549|2017-10-10 23:51:20.074549
NCT02281695|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-03-15|||October 2014||2014-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|MHOPEEP||PEEP Influence on Gas Exchange During Early Weaning|The Influence of Different PEEP Values on Gas Exchange in Spontaneously Breathing Patients During Early Weaning|Recruiting||N/A|150|Anticipated|Marienhospital Osnabrück||2|||f||||f||||||||||2017-10-10 23:51:20.175161|2017-10-10 23:51:20.175161
NCT02281682|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-09-22|||January 2015||2015-01-01|September 2015|2015-09-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|Akti||IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis|Topical Ingenol Mebutate Versus 5% 5-fluorouracil Versus 5% Imiquimod Versus Photodynamic Therapy in Treatment of Actinic Keratosis: a Multi-centre Randomized Efficacy and Cost-effectiveness Study|Recruiting||Phase 4|624|Anticipated|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-10 23:51:20.252983|2017-10-10 23:51:20.252983
NCT02281669|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-10-30|||November 2014||2014-11-01|October 2014|2014-10-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Observational|||Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients|Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients|Unknown status|Not yet recruiting|N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-10 23:51:20.367252|2017-10-10 23:51:20.367252
NCT02281656|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-01-08|||January 2015||2015-01-01|January 2015|2015-01-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Prospective Evaluation of Reverse End to Side Anterior Interosseous Nerve to Ulnar Nerve Transfer for Severe Compressive Ulnar Neuropathy at the Elbow|Prospective Evaluation of Reverse End to Side Anterior Interosseous Nerve to Ulnar Nerve Transfer for Severe Compressive Ulnar Neuropathy at the Elbow|Unknown status|Not yet recruiting|Phase 3|40|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:51:20.463084|2017-10-10 23:51:20.463084
NCT02281643|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-03-22|||October 2014||2014-10-01|March 2017|2017-03-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|Map2Co||Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana|Comparison of Early and Late Administration of Doxycycline in Their Efficacy Against Mansonella Perstans and in Development of Immunity Against Mycobacterial Infections|Completed||Phase 2|200|Actual|Kwame Nkrumah University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:51:20.532959|2017-10-10 23:51:20.532959
NCT02281630|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-05-18|||October 15, 2014|Actual|2014-10-15|May 2017|2017-05-01||||April 28, 2015|Actual|2015-04-28||Interventional|||Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)|Phase II, Randomized, Placebo-controlled, Double-blind, Parallel-group Study of KWA-0711 Administered Orally for 4 Weeks to Evaluate Its Efficacy and Safety, and to Determine Its Optimal Dose in Patients With Chronic Constipation (CC)|Completed||Phase 2|388|Actual|Kissei Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-10 23:51:20.607354|2017-10-10 23:51:20.607354
NCT02281617|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-30|||December 2014||2014-12-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Smart-device Apps as Memory Aids|Smart-device Apps as Memory Aids|Not yet recruiting||N/A|30|Anticipated|King's College London|||1||f||||f||||||||||2017-10-10 23:51:22.332731|2017-10-10 23:51:22.332731
NCT02281604|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-03-01|||January 2013||2013-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Observational|||In-line Filters on ICU||Enrolling by invitation||N/A|3500|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||||||2017-10-10 23:51:22.434489|2017-10-10 23:51:22.434489
NCT02281591|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-28|2014-11-28||June 2006||2006-06-01|November 2014|2014-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine|Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine Following Oral Administration in Healthy Volunteers|Completed||Phase 1|32|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-10 23:51:22.515098|2017-10-10 23:51:22.515098
NCT02281578|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-03-06|||January 2015||2015-01-01|March 2017|2017-03-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Community-based Combination HIV Prevention in Tanzanian Women|Community-based Combination HIV Prevention in Tanzanian Women at Heightened Risk|Active, not recruiting||N/A|500|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-10 23:51:23.06574|2017-10-10 23:51:23.06574
NCT02281565|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-30|||October 2014||2014-10-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|KAPsurvey||Attitudes About Blood Donation|Knowledge, Attitude and Practice About Blood Donation Among Medical Students and Medical Staff|Unknown status|Recruiting|N/A|300|Anticipated|International Institute of Rescue Research and Education|||1||f||||t||||||||||2017-10-10 23:51:23.159969|2017-10-10 23:51:23.159969
NCT02281552|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-04-16|||November 18, 2014|Actual|2014-11-18|April 2017|2017-04-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis|A Multicenter, Randomized, Double-blind, Parallel-group, Phase 3 Study To Demonstrate Non-inferiority For The Efficacy Of A Once Daily Dose Of Tofacitinib Modified Release Tablet To A Twice Daily Dose Of The Immediate Release Tablet In Adult Patients With Rheumatoid Arthritis On Background Methotrexate|Completed||Phase 3|209|Actual|Pfizer||2|||f||||t||||||||Yes|"Information relating to our policy on data sharing and the process for requesting data can be found at the following link:
http://www.pfizer.com/research/clinical_trials/trial_data_and_results/data_requests"|2017-10-10 23:51:23.242793|2017-10-10 23:51:23.242793
NCT02281539|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2016-05-25|||September 2014||2014-09-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain|Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain|Completed||N/A|14|Actual|Integrum||1|||f||||f||||||||||2017-10-10 23:51:23.595111|2017-10-10 23:51:23.595111
NCT02281526|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-01-07|2014-11-28||May 2005||2005-05-01|January 2015|2015-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093|An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 in Subjects With Moderate Hepatic Impairment.|Completed||Phase 1|17|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 23:51:23.700812|2017-10-10 23:51:23.700812
NCT02281513|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-03-28|||October 2014||2014-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|April 2015|Actual|2015-04-01||Interventional|ANTLER||Activity and Nutrition Trial in Lupus to Energize and Renew|Activity and Nutrition Trial in Lupus to Energize and Renew|Active, not recruiting||N/A|12|Actual|Northwestern University||1|||f||||f|f|f||||||Yes|Plans for Resource Sharing. The final data sets from this project will include lupus disease and damage measurements, raw and processed nutrient intake, raw and processed patient-reported outcomes, raw and processed accelerometer data, and motivational interviewing data. The final data from this project will be de-identified in accordance with HIPAA guidelines. Prior to any type of sharing, all disease activity, nutrient intake, patient-reported outcomes and accelerometer records will be made anonymous by the assignment of a new, unique subject identifier that is not linked to any clinical medical record. Requests for resource sharing will all meet the necessary IRB requirements from Northwestern University and the institution of the individual who requests the data.|2017-10-10 23:51:24.048273|2017-10-10 23:51:24.048273
NCT02281500|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-08-01|||May 2016||2016-05-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|IG0902||Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Patients With Congenital Afibrinogenaemia|Multicenter, Prospective, Open-Label, Single-Arm Trial to Evaluate the Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Patients With Congenital Afibrinogenaemia|Recruiting||Phase 1/Phase 2|22|Anticipated|Grifols Biologicals Inc.||1|||f||||t||||||||||2017-10-10 23:51:24.165186|2017-10-10 23:51:24.165186
NCT02281487|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-05-25|||July 2014||2014-07-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|HYSTUB||Hysterectomy for Benign Gynaecological Conditions With or Without Tubectomy|Hysterectomy for Benign Gynaecological Conditions With or Without Tubectomy|Completed||N/A|105|Actual|Gynaecologisch Oncologisch Centrum Zuid||2|||f||||f||||||||||2017-10-10 23:51:24.304184|2017-10-10 23:51:24.304184
NCT02281461|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-10-31|||March 2014||2014-03-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|RMC-06||Feasibility Study of PrePex Device When Performed on Early Infants & Children Male Population by Physicians|A Feasibility Study of PrePex Device for Infants and for Children, When Performed on Early Infants and Children Male Population by Physicians|Completed||N/A|60|Actual|Ministry of Health, Rwanda||2|||f||||f||||||||||2017-10-10 23:51:24.532369|2017-10-10 23:51:24.532369
NCT02281448|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-11-28|2014-11-28||March 2005||2005-03-01|November 2014|2014-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive.|Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive in Healthy Female Volunteers|Completed||Phase 1|20|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-10 23:51:24.662246|2017-10-10 23:51:24.662246
NCT02281435|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-10-31|||November 2012||2012-11-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|RMC-05||Follow Up Study to Evaluate a Non-Surgical Device for Adult Male Circumcision for Screen Failure Subjects|One-arm, Open Label, Phase I (Out of 3 Phases), Pilot Study to Verify the Safety of PrePex™ Device for Screen Failure Subjects (Men With Narrow Foreskin and Phimosis) for Adult Male Circumcision, Performed by Physicians, in a Male Population That is Scheduled to Undergo Circumcision in an Effort to Prevent the Spread of HIV.|Completed||N/A|36|Actual|Ministry of Health, Rwanda||1|||f||||f||||||||||2017-10-10 23:51:25.151911|2017-10-10 23:51:25.151911
NCT02281097|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-01|||June 2013|Actual|2013-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||Transdermal Vagal Stimulation for POTS|Transdermal Vagal Stimulation for the Treatment of Postural Tachycardia Syndrome|Active, not recruiting||N/A|18|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 23:51:31.281568|2017-10-10 23:51:31.281568
NCT02281422|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-12-18|2014-11-28||March 2005||2005-03-01|December 2014|2014-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093|An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 in Subjects With Various Degrees of Renal Impairment|Completed||Phase 1|40|Actual|Bial - Portela C S.A.||5|||f||||f||||||||||2017-10-10 23:51:25.275048|2017-10-10 23:51:25.275048
NCT02281409|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-05|||October 2014||2014-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors|A Phase I/II Study of the Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|72|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:51:26.09892|2017-10-10 23:51:26.09892
NCT02281396|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-01-19|||November 2014||2014-11-01|October 2014|2014-10-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans|A Safety Study of Freeze-dried Rabies Vaccine(MRC-5 Cell)in Chinese Humans From 10-60 Years Old|Completed||Phase 1|40|Actual|Beijing Center for Disease Control and Prevention||4|||f||||f||||||||||2017-10-10 23:51:26.224119|2017-10-10 23:51:26.224119
NCT02281383|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-02-21|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer|Phase II Study to Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer|Recruiting||Phase 2|75|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:51:26.312936|2017-10-10 23:51:26.312936
NCT02281370|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-03-19|||November 2014||2014-11-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects|A Phase I, Open-label, Randomized, Three-period Cross-over Study Evaluating the Effect of Cyclosporine on the Pharmacokinetics of Eltrombopag in Healthy Adult Subjects|Completed||Phase 1|39|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:51:26.444965|2017-10-10 23:51:26.444965
NCT02281357|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-09-26|||February 19, 2015|Actual|2015-02-19|September 2017|2017-09-01|September 7, 2017|Actual|2017-09-07|September 7, 2017|Actual|2017-09-07||Interventional|TROPOS||Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma|A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid Use in Adults and Adolescents With Oral Corticosteroid Dependent Asthma (TROPOS)|Completed||Phase 3|140|Actual|AstraZeneca||2|||f||||t|t|f||||||||2017-10-10 23:51:26.575241|2017-10-10 23:51:26.575241
NCT02281344|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-05-19|||October 2014||2014-10-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants|A Proof-of-concept Study to Assess the Effect of MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants.|Completed||Phase 1|6|Actual|Medicines for Malaria Venture||3|||f||||t||||||||||2017-10-10 23:51:26.818154|2017-10-10 23:51:26.818154
NCT02281331|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-03-15|||October 2014||2014-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Optimal Exercise Training and Nutrition Supplementation in Older Men|Evaluation of the Effects of a Combined Resistance and High-intensity Interval Exercise Training Program, Along With Nutritional Supplementation, on Strength and Physical Function in Older Men|Active, not recruiting||N/A|50|Actual|McMaster University||2|||f||||f||||||||||2017-10-10 23:51:26.922577|2017-10-10 23:51:26.922577
NCT02281318|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-05-09|2016-12-05||December 1, 2014||2014-12-01|March 2017|2017-03-01|June 10, 2016|Actual|2016-06-10|June 1, 2016|Actual|2016-06-01||Interventional|||Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control|A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre 24-week Study to Evaluate the Efficacy and Safety of Mepolizumab Adjunctive Therapy in Subjects With Severe Eosinophilic Asthma on Markers of Asthma Control|Completed||Phase 3|556|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:51:27.040636|2017-10-10 23:51:27.040636
NCT02281305|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-10-31|||October 2014||2014-10-01|October 2014|2014-10-01||||April 2015|Anticipated|2015-04-01||Interventional|||Post-MI PET Scan Imaging of Inflammation|Imaging of Inflammation in the Postischemic Myocardium: Effect of Anti-inflammatory Treatment With Colchicine|Unknown status|Recruiting|Phase 4|20|Anticipated|G.Gennimatas General Hospital||2|||f||||t||||||||||2017-10-10 23:51:28.023396|2017-10-10 23:51:28.023396
NCT02281292|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-12-09|||December 2015||2015-12-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema|A Randomized, Sham Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Diabetic Macular Edema|Withdrawn||Phase 1|0|Actual|Alcon Research||4||Management Decision|f||||t||||||||||2017-10-10 23:51:28.105562|2017-10-10 23:51:28.105562
NCT02281279|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-08-09|||October 2016||2016-10-01|August 2016|2016-08-01||||October 2020|Anticipated|2020-10-01||Interventional|||Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma|A Phase I/II Trial of Romidepsin, Rituximab and Lenalidomide (R3) in Relapsed/Refractory B Cell Lymphomas Including Transformed Follicular Lymphoma|Withdrawn||Phase 1/Phase 2|0|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-10 23:51:28.199946|2017-10-10 23:51:28.199946
NCT02281266|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-11-20|||January 2015||2015-01-01|November 2014|2014-11-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection|Investigator Initiated Study of Thymosin in HBV-related HCC|Not yet recruiting||Phase 4|360|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-10 23:51:28.454993|2017-10-10 23:51:28.454993
NCT02280369|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-01-16|||September 2014||2014-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Posture Detection for Automated Abdominal Binder|Posture Detection for Automated Abdominal Binder|Completed||N/A|21|Actual|Vanderbilt University Medical Center|||1||f||||t||||||||||2017-10-10 23:51:39.030117|2017-10-10 23:51:39.030117
NCT02281253|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-30|||April 2010||2010-04-01|October 2014|2014-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effects of a Bakery Product Enriched With Fibre and L-carnitine on Insulin Resistance in Patients With Metabolic Syndrome|Evaluation of a Bakery Product Enriched With Fibre and L-carnitine on Cardiovascular Risk Parameters in Patients With Metabolic Syndrome: a Randomized, Double-blind, Placebo-controlled Study|Completed||N/A|54|Actual|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||f||||||||||2017-10-10 23:51:28.552319|2017-10-10 23:51:28.552319
NCT02281240|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-10-07|||December 2014||2014-12-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|HCIHSCT||Hemostatic Complications in Hematopoietic Stem Cell Transplantation|Pathogenesis, Diagnosis, Management and Outcome of Hemostatic Complications in Hematopoietic Stem Cell Transplantation: A Prospective Study|Recruiting||N/A|200|Anticipated|The First Affiliated Hospital of Soochow University|||1||f||||f||||||||||2017-10-10 23:51:28.64827|2017-10-10 23:51:28.64827
NCT02281227|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-29|||October 2014||2014-10-01|October 2014|2014-10-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Determination of a Proper Needle Entry Point; Effects of Skin Compression With an Indicator on Radiation Exposure Time of Fluoroscopically Guided Transforaminal Epidural Block in Obese Patients||Unknown status|Recruiting|N/A|64|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-10 23:51:28.74381|2017-10-10 23:51:28.74381
NCT02281214|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-06-19|||November 2014||2014-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|ALCAPONE||NGS Genome Analysis in Personalisation of Lung Cancer Treatment|Genome Analysis by Next Generation Sequencing in Personalisation of Lung Cancer Treatment|Recruiting||N/A|180|Anticipated|Centre Georges Francois Leclerc||1|||f||||t||||||||||2017-10-10 23:51:28.83303|2017-10-10 23:51:28.83303
NCT02281201|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-05-02|||October 2014||2014-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects|An Open-label, Uncontrolled, Single-arm, Multicenter Phase IIIb Study to Assess the Efficacy and Safety of BE1116 in Japanese Subjects Receiving Vitamin K Antagonist Therapy With an Elevated INR and Either Acute Major Bleeding or a Requirement for Urgent Reversal of Vitamin K Antagonist Therapy for a Surgical or Invasive Medical Procedure|Completed||Phase 3|11|Actual|CSL Behring||1|||f||||||||||||||2017-10-10 23:51:28.923822|2017-10-10 23:51:28.923822
NCT02281188|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-07-25|||November 2014||2014-11-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01|10 Years|Observational [Patient Registry]|||Registry for Treatment of Upper Urinary Tract Tumours|Registry for Treatment of Upper Urinary Tract Tumours; A Multi-Center, International Registry to Evaluate the Treatment of Upper Tract Urothelial Cancer: Incidence, Indications, Treatment Types and Outcomes.|Recruiting||N/A|3000|Anticipated|Clinical Research Office of the Endourological Society|||1||f||||f||||||||||2017-10-10 23:51:29.051876|2017-10-10 23:51:29.051876
NCT02281175|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-08-03|||August 2014||2014-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||How to Ease the Withdrawal of Tranquilizers Among Older Consumers?|"The Effectiveness of a Novel Psychosocial Intervention Programme d'Aide au Succès du Sevrage  (PASSE-65+) Designed to Help Older Benzodiazepine Users to Gradually Wean Their Medication"|Recruiting||N/A|75|Anticipated|Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal||3|||f||||t||||||||||2017-10-10 23:51:29.135287|2017-10-10 23:51:29.135287
NCT02281162|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-01-07|||November 2014||2014-11-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain|The Role of Vitamin D and Quetiapine-induced Weight Gain|Completed||N/A|20|Actual|Creighton University|||2||f||||f||||||Samples Without DNA|"     40 ml venous blood will be collected in three separate tubes. One tube of 10 ml will be sent     to the Clinical Pathology Labs for the measurement of complete blood count, complete     metabolic panel, fasting lipid profile for the measurement of triglycerides, high density     lipoproteins, low density lipoproteins, very low-density lipoproteins. The complete blood     count and complete metabolic panel will be done to rule out infection or any other     co-morbidity. Another 10 ml tube will be sent to Clinical Pathology lab for the measurement     of serum 25-hydroxy D levels. The third tube with 20 ml blood will be used to measure protein     and mRNA expression of vitamin D receptor (VDR), CYP24A1 and CYP27B1, and to measure leptin     and adiponectin levels.   "|||2017-10-10 23:51:29.25103|2017-10-10 23:51:29.25103
NCT02281149|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-01-16|||November 2014||2014-11-01|December 2014|2014-12-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01|36 Months|Observational [Patient Registry]|TOMO||Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:|Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: Evaluation of the Toxicity and Quality of Life|Recruiting||N/A|300|Anticipated|Centre Oscar Lambret|||1||f||||f||||||||||2017-10-10 23:51:29.330888|2017-10-10 23:51:29.330888
NCT02281136|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2016-11-16|2016-09-26||December 2014||2014-12-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick|A Pharmacokinetic Study of Levulan Kerastick (Aminolevulinic Acid HCl) for Topical Solution, 20% Under Maximal Use Conditions|Completed||Phase 2|29|Actual|DUSA Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-10 23:51:29.450073|2017-10-10 23:51:29.450073
NCT02281123|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-07-27|||July 2014||2014-07-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|January 2015|Actual|2015-01-01||Observational|EchoCHIK||Study of the Prognostic Value of Musculoskeletal Ultrasound in Adults With Chikungunya|Study of the Prognostic Value of Musculoskeletal Ultrasound in Adults With Chikungunya|Unknown status|Active, not recruiting|N/A|200|Anticipated|University Hospital Center of Martinique|||1||f||||f||||||||||2017-10-10 23:51:31.052479|2017-10-10 23:51:31.052479
NCT02281110|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-05-09|||July 2014||2014-07-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|1 Day|Observational [Patient Registry]|DEFINE REAL||The REAL Registry for Utilization of iFR in Assessing Coronary Stenoses|A Prospective, Observational, Non-randomized European, Multi-center Registry Collecting Real Life Information for the Utilization of Instantaneous Wave Free Ratio in Assessing Coronary Stenosis Relevance in the Multi-vessel Disease Patients Population.|Completed||N/A|500|Actual|Volcano Corporation|||1||f||||f||||||||||2017-10-10 23:51:31.163164|2017-10-10 23:51:31.163164
NCT02281084|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-31|||July 6, 2015|Actual|2015-07-06|August 2017|2017-08-01|October 11, 2019|Anticipated|2019-10-11|April 15, 2019|Anticipated|2019-04-15||Interventional|||Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes|A Phase 2, International, Multicenter, Randomized, Open-label, Parallel Group to Evaluate the Efficacy and Safety of Cc-486 (Oral Azacitidine) Alone in Combination With Durvalumab (MEDI4736) in Subjects With Myelodysplastic Syndromes Who Fail to Achieve an Objective Response to Treatment With Azacitidine for Injection or Decitabine|Recruiting||Phase 2|194|Anticipated|Celgene||2|||f||||t||||||||||2017-10-10 23:51:31.416697|2017-10-10 23:51:31.416697
NCT02281071|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-10-31|||January 2012||2012-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|March 2013|Actual|2013-03-01||Interventional|||Microsurgical Instruments and Magnification May Enhance Treatment Outcomes Of Laterally Moved, Coronally Advanced Flap in Miller Class III Isolated Recession Defects|Microsurgical Instruments and Magnification May Enhance Treatment Outcomes Of Laterally Moved, Coronally Advanced Flap in Miller Class III Isolated Recession Defects|Completed||N/A|50|Actual|Cukurova University||2|||f||||||||||||||2017-10-10 23:51:31.667457|2017-10-10 23:51:31.667457
NCT02281058|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-08-08|||January 2015||2015-01-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Open-label Pilot Study of Abatacept for the Treatment of Vitiligo|Open-label Pilot Study of Abatacept for the Treatment of Vitiligo|Active, not recruiting||Phase 1|10|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-10 23:51:31.750954|2017-10-10 23:51:31.750954
NCT02281045|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-05-12|||October 2014||2014-10-01|October 2014|2014-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CITED||CITrate and Evodial for Effective Dialysis (CITED) Study|CITrate and Evodial for Effective Dialysis (CITED) Study|Completed||N/A|25|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-10 23:51:31.864113|2017-10-10 23:51:31.864113
NCT02281032|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2014-10-31|||November 2013||2013-11-01|October 2014|2014-10-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|interRAI PC||Informed Palliative Care in Nursing Homes Through the interRAI Palliative Care Instrument|Informed Palliative Care in Nursing Homes Through the interRAI Palliative Care Instrument: A Study Protocol Based on the Medical Research Council Framework|Unknown status|Enrolling by invitation|N/A|172|Anticipated|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-10 23:51:31.963725|2017-10-10 23:51:31.963725
NCT02281019|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-05-26|||November 2014||2014-11-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|6 Months|Observational [Patient Registry]|||SpyGlass AMEA Registry|Clinical Registry of Cholangioscopy Using the SpyGlass™ Direct Visualization System (DVS) Throughout the AMEA (Asia, Middle-East, Africa) Region|Active, not recruiting||N/A|526|Actual|Boston Scientific Corporation|||3||f||||f||||||Samples Without DNA|"     Tissue acquisition in the bile ducts   "|||2017-10-10 23:51:32.055043|2017-10-10 23:51:32.055043
NCT02281006|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-01-26|||January 1, 2015|Actual|2015-01-01|January 2017|2017-01-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|STS001||Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity|Randomized Controlled Trial to Test the Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer|Terminated||Phase 2|13|Actual|CHU de Quebec-Universite Laval||2||poor accrual|f||||t||||||||||2017-10-10 23:51:32.335379|2017-10-10 23:51:32.335379
NCT02280993|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-10-30|||May 2014||2014-05-01|October 2014|2014-10-01|May 2020|Anticipated|2020-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients|Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse Who Are Eligible for High Dose Treatment Followed by Autologous Peripheral Blood Stem Cell Transplantation (ASCT)|Recruiting||Phase 1|72|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-10 23:51:32.419963|2017-10-10 23:51:32.419963
NCT02280980|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-07-11|||July 2014||2014-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Oculomotor and Gaze Stability Exercises on the Improvement of Balance After Stroke|Effectiveness of Oculomotor and Gaze Stability Exercises on the Improvement of Balance After Brain Stroke in Patients Older Than 60 Years Old|Enrolling by invitation||N/A|66|Anticipated|Centro Hospitalar de Lisboa Central||2|||f||||f||||||||||2017-10-10 23:51:32.580889|2017-10-10 23:51:32.580889
NCT02280967|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-01|||January 2014||2014-01-01|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Prevention of HPV in the School Health Service|Prevention of Human Papillomavirus (HPV) Associated Cancer by Intervention Studies in Teenagers Attending School Health|Completed||N/A|832|Actual|Uppsala University||2|||f||||f||||||||||2017-10-10 23:51:32.671109|2017-10-10 23:51:32.671109
NCT02280954|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-06-11|||November 2013||2013-11-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|818012||Indocyanine Green for Solid Tumors|A Pilot and Feasibility Study of Intraoperative Imagery of Solid Tumors With Indocyanine Green|Active, not recruiting||Phase 1|48|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:51:32.791097|2017-10-10 23:51:32.791097
NCT02280941|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-04-21|||October 2014||2014-10-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|SPECT MBF||Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)|Comparison of Myocardial Blood Flow Measurements With Dedicated Solid State SPECT Camera Imaging and 99mTc-Tetrofosmin Versus PET Imaging and Rubidium-82|Recruiting||N/A|90|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-10 23:51:32.896537|2017-10-10 23:51:32.896537
NCT02280928|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2015-07-21|||October 2014||2014-10-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Development and Evaluation of a Home-Based Dual-Task Training Program to Improve Balance Performance for Older Adults|Development and Evaluation of a Home-Based Dual-Task Training Program to Improve Balance Performance for Older Adults|Completed||N/A|60|Actual|Chiang Mai University||4|||f||||f||||||||||2017-10-10 23:51:33.003012|2017-10-10 23:51:33.003012
NCT02280915|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-04-30|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Bioavailability of Iron From Savoury Food Product|Assessment of the Bioavailability of Iron in Iron Fortified Savoury Food Product in Healthy Women|Completed||N/A|24|Actual|Unilever R&D||4|||f||||f||||||||||2017-10-10 23:51:33.135984|2017-10-10 23:51:33.135984
NCT02280902|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-06-14|||February 2016|Actual|2016-02-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|INFIM||Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases|Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases|Recruiting||N/A|217|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||Samples With DNA|"     - Blood sampling   "|||2017-10-10 23:51:33.234888|2017-10-10 23:51:33.234888
NCT02280889|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-10-28|||October 2013||2013-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision|Quality of Life and Experience of Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision: a Prospective Study|Recruiting||N/A|80|Anticipated|University Children's Hospital, Zurich|||1||f||||f||||||||||2017-10-10 23:51:33.396365|2017-10-10 23:51:33.396365
NCT02280876|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-06-21|||January 2012||2012-01-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|PCNS-EM||Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)|Randomized, Comparative, Double Blind Controlled Phase II Clinical Trial, to Evaluate the Efficacy of ApE in Patients With Multiple Sclerosis (MS).|Completed||Phase 1/Phase 2|30|Actual|Universidad Austral de Chile||2|||f||||t||||||||Yes|All these trial results, will be submitted to publication in a major journal of the specialty, upon conclusion of data processing and evaluation.|2017-10-10 23:51:33.50387|2017-10-10 23:51:33.50387
NCT02280863|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-03-31|||July 2014||2014-07-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Hybrid Closed-Loop Hotel Studies With Medtronic PID Controller|Hybrid Closed-Loop Studies With Medtronic PID Controller- Hotel HCL Study|Unknown status|Recruiting|N/A|54|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-10 23:51:33.620312|2017-10-10 23:51:33.620312
NCT02280850|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-29|||October 2014||2014-10-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina|Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina: A Randomised, Double-blind, Placebo-controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Shaanxi Buchang Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-10 23:51:33.730429|2017-10-10 23:51:33.730429
NCT02280837|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2016-05-08|||March 2015||2015-03-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?|An Observational Study to Examine the Relationship Between GLP-1 Insufficiency and Severity of Coronary Artery Disease in Patients Enrolled in BOREAS Registry, a Prospective Registry of Cardiovascular and Renal Diseases. : Is GLP-1 Insufficiency a Residual Risk in Coronary Artery Disease?|Recruiting||N/A|220|Anticipated|Sapporo Medical University|||1||f||||f||||||||||2017-10-10 23:51:33.848469|2017-10-10 23:51:33.848469
NCT02280824|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-07-28|||October 23, 2014||2014-10-23|July 27, 2017|2017-07-27|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Interventional|||Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic Access|Transcaval Access for Transcatheter Aortic Valve Replacement in Patients With No Good Options for Aortic Access|Completed||Phase 1|300|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:51:33.958818|2017-10-10 23:51:33.958818
NCT02280811|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-30|2017-08-07|2017-06-08||October 14, 2014|Actual|2014-10-14|August 2017|2017-08-01|June 28, 2016|Actual|2016-06-28|June 28, 2016|Actual|2016-06-28||Interventional|||T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers|A Phase I/II Study of T Cell Receptor Gene Therapy Targeting HPV-16 E6 for HPV-Associated Cancers|Completed||Phase 1/Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t|t|f||||||||2017-10-10 23:51:34.094428|2017-10-10 23:51:34.094428
NCT02280785|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2017-04-08|||November 2014||2014-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|BRAN||Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas|A Phase II Study of Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas Other Than Anaplastic Large Cell Lymphoma|Recruiting||Phase 2|33|Anticipated|Samsung Medical Center||1|||f||||t||||||||Yes||2017-10-10 23:51:35.360033|2017-10-10 23:51:35.360033
NCT02280772|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-04-07|||April 2015||2015-04-01|April 2015|2015-04-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children|Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children: A Randomized Controlled Trial|Unknown status|Recruiting|Early Phase 1|96|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-10 23:51:35.484988|2017-10-10 23:51:35.484988
NCT02280759|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-07-05|||November 2014||2014-11-01|July 2017|2017-07-01|June 10, 2017|Actual|2017-06-10|June 10, 2017|Actual|2017-06-10||Interventional|||Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children.|Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children: A Double Blind Randomized, Placebo- Controlled Trial .|Completed||Phase 1|72|Anticipated|Medical University of Warsaw||2|||f||||t||||||||||2017-10-10 23:51:35.599594|2017-10-10 23:51:35.599594
NCT02280746|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-29|||September 2014||2014-09-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Gluten for Autism Spectrum Disorders|Gluten Dietary Intervention for Autistic Symptoms in Children With Autism Spectrum Disorders - Randomized Open Trial|Unknown status|Recruiting|N/A|70|Anticipated|Medical University of Warsaw||2|||f||||t||||||||||2017-10-10 23:51:35.694501|2017-10-10 23:51:35.694501
NCT02280733|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-05-18|||January 2005||2005-01-01|May 2016|2016-05-01|January 2026|Anticipated|2026-01-01|January 2025|Anticipated|2025-01-01|3 Months|Observational [Patient Registry]|USWR||A Real World, Observational Registry of Chronic Wounds and Ulcers|A Real World, Observational Registry of Chronic Wounds and Ulcers to Assess Quality of Care, Evidence Based Practice and Outcomes Using Linked Electronic Health Record Data|Recruiting||N/A|175000|Anticipated|U.S. Wound Registry|||1||f||||t||||||||||2017-10-10 23:51:35.816191|2017-10-10 23:51:35.816191
NCT02280720|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-30|||January 2013||2013-01-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|TIDES-OCT||Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent|A Randomized Prospective Multicenter Trial to Compare Vascular Healing and Vasodilation at 2 Months After Deployment of TItanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Drug-Eluting Stent in Patients With Acute Coronary Syndromes by Means of Optical Coherence Tomography and Coronary Flow Reserve|Completed||Phase 4|40|Actual|The Hospital District of Satakunta||2|||f||||t||||||||||2017-10-10 23:51:35.91913|2017-10-10 23:51:35.91913
NCT02280707|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-30|||March 2013||2013-03-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Intervention to Promote Water Consumption in School Lunchrooms|Grab a Cup, Fill it up! An Intervention to Promote Convenience of Drinking Water and Increase Student Water Consumption During School Lunch.|Completed||N/A|10|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-10 23:51:36.0076|2017-10-10 23:51:36.0076
NCT02280694|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-03-30|||January 2015||2015-01-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|LDMchemoCRC||Low Dose Metronomic Poly-chemotherapy for Metastatic CRC|Metronomic Poly-chemotherapy for Metastatic Colorectal Cancer at Progression Following Established Treatments: Clinical and Laboratory Research|Recruiting||Phase 2|100|Anticipated|HaEmek Medical Center, Israel||1|||f||||t||||||||No||2017-10-10 23:51:36.059959|2017-10-10 23:51:36.059959
NCT02280681|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-29|||October 2014||2014-10-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01|1 Day|Observational [Patient Registry]|||MAR With Artificial Gametes: Treatment Characteristics and Their Trade-offs Determining Treatment Preference|Medical Assisted Reproduction With Artificial Gametes in Women With Ovarian Failure: Treatment Characteristics and Their Trade-offs Determining Treatment Preference of Patients and Clinicians|Unknown status|Not yet recruiting|N/A|400|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-10 23:51:36.137566|2017-10-10 23:51:36.137566
NCT02280655|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-04-07|2014-11-04||April 2009||2009-04-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Interventional|INOBA||Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis (Aim 3)|Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis|Completed||Phase 2|43|Actual|Emory University|Only patients receiving routine transfusions were included in the study, thus excluding critically ill/actively bleeding patients requiring emergent transfusions.|2|||f||||t||||||||||2017-10-10 23:51:36.453183|2017-10-10 23:51:36.453183
NCT02280642|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-29|||March 2009||2009-03-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|ADS||Alternate Dosing Schedules Study for HPV Vaccine (ADS)|Alternate Dosing Schedules Study for HPV Vaccine|Completed||Phase 4|331|Actual|Duke University|||4||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:51:36.690524|2017-10-10 23:51:36.690524
NCT02280629|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-08-02|||October 2014||2014-10-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|PROTECT-2||Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)|Randomized, Double-blind, Double-dummy, Placebo-controlled, Phase III Clinical Trial on the Efficacy and Safety of a 48-weeks Treatment With Gastro-resistant Phosphatidylcholine (LT-02) Versus Placebo Versus Mesalamine for Maintenance of Remission in Patients With Ulcerative Colitis|Recruiting||Phase 3|400|Anticipated|Dr. Falk Pharma GmbH||3|||f||||t||||||||||2017-10-10 23:51:36.803669|2017-10-10 23:51:36.803669
NCT02280616|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-01-20|||June 2011||2011-06-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|April 2013|Actual|2013-04-01||Interventional|||Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis|Double-blind, Double-dummy, Randomized, Placebo-controlled, Phase IIa Study on the Efficacy and Tolerability of a 14-day Treatment With Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Patients With Eosinophilic Esophagitis|Completed||Phase 2|76|Actual|Dr. Falk Pharma GmbH||4|||f||||t||||||||||2017-10-10 23:51:36.929537|2017-10-10 23:51:36.929537
NCT02280603|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-06-22|||January 2014||2014-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application|A Single-center, Active-controlled, Randomized, Double-blind, Proof of Concept Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application in Male Patients With Androgenetic Alopecia|Completed||Phase 1/Phase 2|60|Actual|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-10 23:51:37.036125|2017-10-10 23:51:37.036125
NCT02280590|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-07-02|||September 2014||2014-09-01|July 2015|2015-07-01||||June 2015|Actual|2015-06-01||Interventional|||Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia||Completed||Phase 4|223|Actual|Dong-A ST Co., Ltd.||2|||f||||||||||||||2017-10-10 23:51:37.134538|2017-10-10 23:51:37.134538
NCT02280577|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-06-22|||May 2014||2014-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:51:37.203367|2017-10-10 23:51:37.203367
NCT02280564|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-29|||March 2011||2011-03-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|FL3X||Study of A Cell-Phone System to Improve Health of Youth With Diabetes|Pilot Study of A Cell-Phone System to Improve Health of Youth With Diabetes|Completed||N/A|74|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:51:37.242415|2017-10-10 23:51:37.242415
NCT02280551|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-30|||March 2010||2010-03-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|APSALS||The Australian Parental Supply of Alcohol Longitudinal Study (APSALS)|The Australian Parental Supply of Alcohol Longitudinal Study (APSALS)|Unknown status|Active, not recruiting|N/A|1927|Actual|The University of New South Wales|||2||f||||f||||||||||2017-10-10 23:51:37.327608|2017-10-10 23:51:37.327608
NCT02279979|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-04-13|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial|Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial|Terminated||N/A|9|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-10 23:51:43.010317|2017-10-10 23:51:43.010317
NCT02280538|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-31|||April 2014||2014-04-01|October 2014|2014-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ViscOA||Trial to Assess the Structural Effect and Long-term Symptomatic Relief of Intra-articular Injections of Hyaluronic Acid in Primary Knee OA|A Randomized Placebo Controlled Trial to Assess the Structural Effect and Long-term Symptomatic Relief of Repeated Intra-articular Injections of Hyaluronic Acid in Primary Knee Osteoarthritis|Recruiting||N/A|300|Anticipated|Universidade Nova de Lisboa||2|||f||||f||||||||||2017-10-10 23:51:37.415798|2017-10-10 23:51:37.415798
NCT02280525|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-08|||March 2015|Actual|2015-03-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma|A Study of Umbilical Cord Blood-Derived Natural Killer Cells in Conjunction With Lymphodepleting Chemotherapy and Lenalidomide as Immunotherapy in Patients With Hematologic Malignancies|Recruiting||Phase 1|44|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-10 23:51:37.544819|2017-10-10 23:51:37.544819
NCT02280512|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-05-12|||December 2014||2014-12-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Intra-op Monitoring With NIRS and NICOM, and Surgical Outcome in Elderly Patients With Fractures of Lower Limbs|Intraoperative Monitoring With Noninvasive Near-infrared Spectroscopy and Noninvasive Cardiac Output Measurement, and Postoperative Outcome in Elderly Patients With Fractures of Lower Extremities|Unknown status|Active, not recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-10 23:51:37.669719|2017-10-10 23:51:37.669719
NCT02280499|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-02-23|2016-01-25||November 2003||2003-11-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Multicenter Clinical Observation PROMOS®|Multicenter Clinical Observation PROMOS®|Completed||N/A|87|Actual|Smith & Nephew, Inc.|One limitation of the study relates to the small number of subjects available at the 10 year interval for final analysis due to the early termination of 2 sites.||1||f||||||||||||||2017-10-10 23:51:37.7537|2017-10-10 23:51:37.7537
NCT02280486|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-10-31|||January 2015||2015-01-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Efficacy of Saxagliptin vs.Glimepiride as Add-on Therapy in T2DM Patients With Metformin Monotherapytients|A 48-week, Multi-center, Randomized, Open Label, Parallel Group Comparison of the Comprehensive Glycemic Control of Saxagliptin and Glimepiride in Patients Inadequately Controlled With Metformin Monotherapytients With Type 2 Diabetes|Active, not recruiting||Phase 4|380|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||Undecided||2017-10-10 23:51:37.990263|2017-10-10 23:51:37.990263
NCT02280473|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-05-12|2017-05-12||November 13, 2014|Actual|2014-11-13|May 2017|2017-05-01|March 16, 2015|Actual|2015-03-16|March 16, 2015|Actual|2015-03-16||Interventional||All 188 randomized patients were included in the Intent-to Treat (ITT) and safety populations.|A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease||Completed||Phase 3|188|Actual|Allergan||2|||f||||f|t|f||||||No||2017-10-10 23:51:38.096149|2017-10-10 23:51:38.096149
NCT02280460|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-05-10|||September 2014||2014-09-01|May 2017|2017-05-01|September 2025|Anticipated|2025-09-01|September 2024|Anticipated|2024-09-01|1 Year|Observational [Patient Registry]|||ECMO: Optimization of Its Use|Extracorporeal Membrane Oxygenation(ECMO): Optimization of Its Use|Recruiting||N/A|750|Anticipated|Spectrum Health Hospitals|||2||f||||f||||||||||2017-10-10 23:51:38.430885|2017-10-10 23:51:38.430885
NCT02280447|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-01-05|||November 2014||2014-11-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents|Safety and Immunogenicity of 3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, Given as a Booster Vaccination to Adolescents With a History of IPV Vaccination at 3, 5, 12 Months and 5 Years of Age|Completed||Phase 1/Phase 2|240|Actual|Statens Serum Institut||4|||f||||f||||||||No||2017-10-10 23:51:38.502268|2017-10-10 23:51:38.502268
NCT02280434|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-11-01|||November 2014||2014-11-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Phase 1 Study Accessing the Safety and Tolerability of CBP-307|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose Escalation Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CBP-307 Following Oral Single and Multiple Escalating Dose Administration|Completed||Phase 1|64|Anticipated|Suzhou Connect Biopharmaceuticals, Ltd.||2|||f||||f||||||||||2017-10-10 23:51:38.592913|2017-10-10 23:51:38.592913
NCT02280421|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-02-16|||October 2014||2014-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Drug-Drug Interaction Study: ASP2151 and Ciclosporin|A Single-centre, Open-label, Randomised, Cross-over, Drug-drug Interaction Study to Investigate the Effect of Repeated Oral Doses of Ciclosporin on the Single-dose Pharmacokinetics of nASP2151 in Healthy Mean|Completed||Phase 1|24|Actual|Maruho Europe Limited||2|||f||||f||||||||||2017-10-10 23:51:38.673095|2017-10-10 23:51:38.673095
NCT02280408|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-01-16|||October 2014||2014-10-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)|A Phase 1 Randomized, Double-Blind, Placebo Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of Prime-Boost VSV Ebola Vaccine in Healthy Adults|Completed||Phase 1|39|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-10 23:51:38.76114|2017-10-10 23:51:38.76114
NCT02280395|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2015-08-05|||October 2014||2014-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60|A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics|Terminated||Phase 1/Phase 2|9|Actual|Pulmatrix Inc.||2||Company merger resulted in business decision to terminate the study.|f||||t||||||||||2017-10-10 23:51:38.849155|2017-10-10 23:51:38.849155
NCT02280382|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-10-16|||October 2015||2015-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Femmeze®||An Intervention to Improve Prolapse Using Femmeze® (v1)|An Intervention to Improve the Management of Posterior Vaginal Compartment Prolapse Using Femmeze®: a Feasibility Study|Recruiting||N/A|30|Anticipated|Royal Cornwall Hospitals Trust||1|||f||||f||||||||Yes||2017-10-10 23:51:38.937635|2017-10-10 23:51:38.937635
NCT02280356|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-03-17|||October 2014||2014-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer|Ultra-hypofractionated, Image-guided, Intensity-modulated Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer|Active, not recruiting||Phase 2|45|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:51:39.102216|2017-10-10 23:51:39.102216
NCT02280343|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-06-30|||March 2013||2013-03-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Oscillation Mechanics of the Respiratory System Asbestos Exposed: Early Diagnosis|OSCILLATION MECHANICS OF THE RESPIRATORY SYSTEM ASBESTOS EXPOSED : Early Diagnosis|Unknown status|Recruiting|N/A|2|Anticipated|Rio de Janeiro State University|||1||f||||f||||||||||2017-10-10 23:51:39.187244|2017-10-10 23:51:39.187244
NCT02280330|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-12-22|||November 2014||2014-11-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|MNP-CAR||Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months|Iodine Intake & Status of Preschoolers Given Micronutrient Powder for 6 Months|Completed||Phase 4|396|Actual|Nutrition Center of the Philippines||2|||f||||t||||||||||2017-10-10 23:51:39.385726|2017-10-10 23:51:39.385726
NCT02280317|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-01-04|||October 2014||2014-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VAL201-001||Dose Finding Safety Study of VAL201 in Cancer Patients|A Phase I/II, Dose Escalation Study To Assess The Safety and Tolerability of VAL201 In Patients With Advanced or Metastatic Prostate Cancer and Other Advanced Solid Tumours|Enrolling by invitation||Phase 1/Phase 2|50|Anticipated|ValiRx Plc||1|||f||||t||||||||||2017-10-10 23:51:39.479066|2017-10-10 23:51:39.479066
NCT02280304|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-06-05|||November 3, 2014|Actual|2014-11-03|June 2017|2017-06-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Meditation in Veterans With PTSD and Mild TBI|Neuroimaging Meditation Therapy in Veterans With Co-Morbid TBI and PTSD|Active, not recruiting||N/A|60|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 23:51:39.543933|2017-10-10 23:51:39.543933
NCT02280278|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-11-03|||October 2014||2014-10-01|November 2014|2014-11-01||||October 2019|Anticipated|2019-10-01||Interventional|||Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy|The Effectiveness and Safety of Adjuvant Cytokine-induced Killer Cell Immunotherapy for Stage III Colorectal Cancer Patients After Chemotherapy|Recruiting||Phase 3|550|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:51:39.716411|2017-10-10 23:51:39.716411
NCT02280265|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-29|||November 2014||2014-11-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A|Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A.|Unknown status|Not yet recruiting|N/A|15|Anticipated|Nanjing Medical University||1|||f||||t||||||||||2017-10-10 23:51:39.831395|2017-10-10 23:51:39.831395
NCT02280252|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-08-17|||March 2005||2005-03-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|October 2015|Actual|2015-10-01||Interventional|||Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response|Response, Resistance and Metastasis of Locally Advanced Breast Cancer (LABC, Stage 2B-3C) in a Multiethnic Cohort: A Phase II International Multicentric Study of Concurrent Paclitaxel and Radiation|Active, not recruiting||Phase 2|85|Actual|New York University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-10 23:51:39.908511|2017-10-10 23:51:39.908511
NCT02280226|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-07-22|||April 2014||2014-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluating the Influence of Apnea on Cardiac Function Using Cardiac Magnetic Resonance Imaging.|Evaluating the Influence of Apnea on Heart Function With Strain Analysis and Measurement of Fibrosis Derived From T1-mapping Using Cardiac Magnetic Resonance Imaging (MRI).|Completed||N/A|18|Actual|University Hospital, Bonn||1|||f||||||||||||||2017-10-10 23:51:40.091968|2017-10-10 23:51:40.091968
NCT02280213|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-01-31|||November 2014||2014-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison Four Intubation Devices|Comparison of Tracheal Intubation Using the Miller, Macintosh, Phillips and Wis-Hipple Blades During Infant Resuscitation: A Randomized Crossover Simulation Trial|Completed||N/A|145|Actual|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:51:40.153502|2017-10-10 23:51:40.153502
NCT02280200|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-09-14|||November 2014||2014-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ankle-foot Orthoses for Peripheral Artery Disease|Efficacy of Ankle-Foot Orthoses on Walking Ability in Peripheral Artery Disease: The AFO for PAD Trial I|Active, not recruiting||N/A|15|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-10 23:51:40.339527|2017-10-10 23:51:40.339527
NCT02280187|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-12-14|2016-10-14||October 2014||2014-10-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|InductOR||InductOs® in Real World Spine Surgery; A Retrospective, French, Multi-centric, Study|InductOs® in Real World Spine Surgery; A Retrospective, French, Multi-centric, Study|Completed||N/A|400|Actual|Medtronic Spinal and Biologics|||1||f||||f||||||||||2017-10-10 23:51:40.482645|2017-10-10 23:51:40.482645
NCT02280174|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-11-03|||September 2014||2014-09-01|November 2014|2014-11-01|October 2016|Anticipated|2016-10-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Linagliptin on TRL Metabolism|Effect of Linagliptin on Intestinal Triglyceride-rich-lipoprotein Metabolism in Type 2 Diabetic Patients|Unknown status|Recruiting|Phase 4|20|Anticipated|Ministry of Public Health, Argentina||2|||f||||t||||||||||2017-10-10 23:51:41.180049|2017-10-10 23:51:41.180049
NCT02280161|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-12|||September 16, 2014|Actual|2014-09-16|September 2017|2017-09-01|September 16, 2025|Anticipated|2025-09-16|September 16, 2024|Anticipated|2024-09-16||Observational|||Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer|An Investigation of the Role of Germ-Line Mutations in Cancer Predisposition, Tumor Biology, and Response to Treatment|Recruiting||N/A|2000|Anticipated|Jonsson Comprehensive Cancer Center|||1||f||||f||||||Samples With DNA|"     A blood sample of 30mL or a saliva collection (obtained by spitting into a special collection     cup) will be obtained from each patient.   "|||2017-10-10 23:51:41.29801|2017-10-10 23:51:41.29801
NCT02280148|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2014-10-30|||November 2013||2013-11-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Accessing the Driving Skills After the Endoscopy of Intravenous Anesthesia by Driving Simulator|Accessing the Driving Skills After the Endoscopy of Intravenous Anesthesia by Driving Simulator|Completed||N/A|22|Actual|Beijing Friendship Hospital||1|||f||||f||||||||||2017-10-10 23:51:41.412682|2017-10-10 23:51:41.412682
NCT02280135|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-03-29|||November 2014||2014-11-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|TC/RP||Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa|Phase I Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa|Completed||Phase 1|8|Actual|Red de Terapia Celular||2|||f||||t||||||||||2017-10-10 23:51:41.532074|2017-10-10 23:51:41.532074
NCT02280122|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-07-08|2015-05-19||September 2012||2012-09-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|MMP-8||Activated MMP-8 as Diagnostic Test for Periodontitis|Activated Matrix Metalloproteinase 8 (aMMP-8) in Saliva as Diagnostic Test for Periodontal Disease? A Case-control Study|Completed||N/A|60|Actual|Goethe University|The aMMP-8 test is sensitive to distinguish untreated periodontally diseased from healthy individuals. However, this study does not provide information how clearly the test may distinguish between gingivitis and untreated chronic periodontitis.||2||f||||f||||||||||2017-10-10 23:51:41.67198|2017-10-10 23:51:41.67198
NCT02280109|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-01-27|||November 2014||2014-11-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Interventional|FAME-05||Comparison of Tenofovir Vaginal Gel and Film Formulations|Comparison of the Pharmacokinetics and Pharmacodynamics of Single Dose Tenofovir Vaginal Gel and Film Formulation|Completed||Early Phase 1|10|Actual|CONRAD||2|||f||||f||||||||||2017-10-10 23:51:41.90567|2017-10-10 23:51:41.90567
NCT02280083|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-09-22|||July 2014||2014-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb Spasticity|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection in Chinese Subjects With Post-stroke Upper Limb Spasticity|Completed||Phase 3|180|Actual|Lanzhou Institute of Biological Products Co., Ltd||2|||f||||t||||||||No||2017-10-10 23:51:42.104092|2017-10-10 23:51:42.104092
NCT02280070|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-29|||September 2013||2013-09-01|October 2014|2014-10-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).|Randomized Phase II Study of SOX vs mFOLFOX6 as Neoadjuvant Chemotherapy in Patients With Resectable Rectal Cancer (KSCC1301).|Recruiting||Phase 2|110|Anticipated|Clinical Research Support Center Kyush||2|||f||||t||||||||||2017-10-10 23:51:42.182695|2017-10-10 23:51:42.182695
NCT02280057|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-02-22|||September 2001||2001-09-01|February 2017|2017-02-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Trial With Metformin in Women With Polycystic Ovary Syndrome|Randomized, Cross-over Trial With Metformin in Women With Polycystic Ovary Syndrome|Completed||Phase 4|56|Actual|Herning Hospital||2|||f||||t||||||||No||2017-10-10 23:51:42.32095|2017-10-10 23:51:42.32095
NCT02280031|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-12-13|||November 2014||2014-11-01|April 2016|2016-04-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|GAP||Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.|Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial|Completed||Phase 2|50|Actual|CHU de Quebec-Universite Laval||2|||f||||t||||||||||2017-10-10 23:51:42.509244|2017-10-10 23:51:42.509244
NCT02280018|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2015-01-29|||November 2014||2014-11-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Safety, Tolerability and Pharmacokinetics Study of a Single Intravenous Dose of JNJ-49122944 in Healthy Male Participants|A Double Blind, Placebo-Controlled, Randomized Study to Investigate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of JNJ-49122944 in Healthy Male Subjects|Completed||Phase 1|12|Actual|Janssen Research & Development, LLC||2|||f||||||||||||||2017-10-10 23:51:42.612294|2017-10-10 23:51:42.612294
NCT02280005|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-07-14|||October 2014|Actual|2014-10-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|WAK US 1||24 Hour Use of the Wearable Artificial Kidney|First 24 Hour Human Trial of the Wearable Artificial Kidney|Completed||N/A|8|Actual|Blood Purification Technologies, Inc.||1|||f||||t||||||||||2017-10-10 23:51:42.690863|2017-10-10 23:51:42.690863
NCT02279992|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-08|||March 27, 2012|Actual|2012-03-27|September 2017|2017-09-01|February 11, 2016|Actual|2016-02-11|October 13, 2013|Actual|2013-10-13||Interventional|LevitraCarbo||Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases|CSMC IIT: Pilot Study of Phosphodiesterase-V Inhibition to Increase Intratumoral Concentration of Carboplatin in Patients With Recurrent High Grade Gliomas and Brain Metastases|Terminated||Early Phase 1|7|Actual|Cedars-Sinai Medical Center||2||Unable to accrue to the study. Original PI no longer with the institute.|f||||f||||||||||2017-10-10 23:51:42.774199|2017-10-10 23:51:42.774199
NCT02279966|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-02-27|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder|An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-referenced (Paroxetine), Fixed-dose Study on the Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder|Completed||Phase 3|152|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-10-10 23:51:43.138063|2017-10-10 23:51:43.138063
NCT02279953|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-05-23|||October 2014||2014-10-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder|An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study on the Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder|Completed||Phase 3|151|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-10-10 23:51:43.31499|2017-10-10 23:51:43.31499
NCT02279940|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-04-04|||March 2014||2014-03-01|April 2016|2016-04-01||||January 2016|Actual|2016-01-01|90 Days|Observational [Patient Registry]|RASS||Rivaroxaban Acute Stroke Safety Study|Rivaroxaban Acute Stroke Safety Study|Completed||N/A|50|Actual|University of Alberta|||1||f||||f||||||||||2017-10-10 23:51:43.488327|2017-10-10 23:51:43.488327
NCT02279927|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-29|||October 2014||2014-10-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy|Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During|Unknown status|Recruiting|N/A|100|Anticipated|Carmel Medical Center||2|||f||||f||||||||||2017-10-10 23:51:43.578219|2017-10-10 23:51:43.578219
NCT02279914|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-09-27|||November 2014||2014-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial|Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial|Completed||N/A|118|Actual|Planned Parenthood of New York City, Inc.||2|||f||||f||||||||||2017-10-10 23:51:43.686078|2017-10-10 23:51:43.686078
NCT02279901|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-03-02|||November 2014||2014-11-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|EmmiUSleep||Impact of Automated Education and Follow-up Mechanisms on Patient Engagement|Impact of Interactive Web-Based Education and Interactive Voice Response (Automated Follow-up) Programs on CPAP Adherence for the Treatment of Obstructive Sleep Apnea|Completed||N/A|1873|Actual|Kaiser Permanente||4|||f||||f||||||||No|This study has been conducted solely within Kaiser Permanente, and it is unnecessary to release IPD to external sources or organizations.|2017-10-10 23:51:43.77622|2017-10-10 23:51:43.77622
NCT02279888|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-09-06|||January 2015||2015-01-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|||CardioMEMS HF System Post Approval Study|CardioMEMS HF System Post Approval Study|Recruiting||N/A|1200|Anticipated|St. Jude Medical|||1||f||||t||||||||Undecided||2017-10-10 23:51:43.908838|2017-10-10 23:51:43.908838
NCT02279875|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-08-18|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|July 2017|Actual|2017-07-01|November 28, 2016|Actual|2016-11-28||Interventional|||A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)|A Phase 2 Dose-ranging Trial to Evaluate the Bactericidal Activity, Safety, Tolerability and Pharmacokinetics of Linezolid in Adult Subjects With Newly Diagnosed Drug-Sensitive, Smear-Positive Pulmonary Tuberculosis.|Completed||Phase 2|113|Anticipated|Global Alliance for TB Drug Development||8|||f||||t||||||||||2017-10-10 23:51:44.016184|2017-10-10 23:51:44.016184
NCT02279862|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-05-31|||December 2, 2014|Actual|2014-12-02|May 2017|2017-05-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive|A Phase 2, Randomized, Double-Blind Study of Ipilimumab Administered at 3 mg/kg vs 10 mg/kg in Adult Subjects With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer Who Are Asymptomatic or Minimally Symptomatic|Completed||Phase 2|51|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:51:44.136473|2017-10-10 23:51:44.136473
NCT02279849|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-10-30|||March 2012||2012-03-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|BHRR||Multi-level Communications and Access Strategies to Improve the Food Environment|Multi-level Communications and Access Strategies to Improve the Food Environment:B'More Healthy: Retailer Rewards (BHRR)|Completed||N/A|444|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||t||||||||||2017-10-10 23:51:44.28679|2017-10-10 23:51:44.28679
NCT02279836|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-02-03|||October 2014||2014-10-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01||Interventional|SC20 Scope||Single Arm Post-marketing Study of SC20 Colonoscope|Open Label, Multi-center, Single Arm Post-marketing Study of SC20 Colonoscope and Colonoscopy System for Colonoscopy in Male and Female Patients >18 Years Old|Terminated||Phase 4|2|Actual|Invendo Medical GmbH||1||Study was stopped due to the expected introduction of a next product generation.|f||||t||||||||||2017-10-10 23:51:44.377157|2017-10-10 23:51:44.377157
NCT02279823|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-03-09||2017-03-09|October 2014||2014-10-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia|A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA)|Completed||Phase 2|95|Actual|Intrepid Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 23:51:44.446931|2017-10-10 23:51:44.446931
NCT02279810|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2014-10-29|||October 2014||2014-10-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|KAPsurvey||Attitudes About Organ Transplantation|Knowledge, Attitude and Practice About Organ Transplantation Among Medical Students and Medical Staff|Unknown status|Recruiting|N/A|300|Anticipated|International Institute of Rescue Research and Education|||1||f||||t||||||||||2017-10-10 23:51:44.534541|2017-10-10 23:51:44.534541
NCT02279797|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2014-10-29|||October 2014||2014-10-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|KAPsurvey||Bone Marrow Donation|Knowledge, Attitudes and Practices About Bone Marrow Donation Among Medical Students and Medical Staff|Unknown status|Recruiting|N/A|300|Anticipated|International Institute of Rescue Research and Education|||1||f||||t||||||||||2017-10-10 23:51:46.35349|2017-10-10 23:51:46.35349
NCT02279784|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-31|||October 2014||2014-10-01|October 2014|2014-10-01|October 2016|Anticipated|2016-10-01|December 2015|Anticipated|2015-12-01||Interventional|||Drug Eluting Balloon in peripherAl inTErvention for Below-The-Knee Arteries With Freeway and Lutonix||Unknown status|Recruiting|Phase 4|160|Anticipated|Ospedale San Donato||2|||f||||f||||||||||2017-10-10 23:51:46.438775|2017-10-10 23:51:46.438775
NCT02279771|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-10-30|||January 2015||2015-01-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|LessStoReS||Transanal Reinforcement of Low Rectal Anastomosis in Rectal Cancer Surgery|Multicenter Randomized Controlled Trial of Transanal Reinforcement of Low Rectal Anastomosis Versus Protective Ileostomy in the Prevention of Anastomotic Leak After Rectal Cancer Surgery|Unknown status|Not yet recruiting|N/A|140|Anticipated|Societa Italiana di Chirurgia ColoRettale||2|||f||||f||||||||||2017-10-10 23:51:46.534815|2017-10-10 23:51:46.534815
NCT02279758|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-10-30|||March 2014||2014-03-01|October 2014|2014-10-01||||December 2017|Anticipated|2017-12-01||Interventional|MetNet||A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors|A PHASE II PILOT STUDY OF METFORMIN TREATMENT IN PATIENTS WITH WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS|Recruiting||Phase 2|30|Anticipated|Instituto do Cancer do Estado de São Paulo||1|||f||||||||||||||2017-10-10 23:51:46.61698|2017-10-10 23:51:46.61698
NCT02279745|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2017-02-04|||July 2015||2015-07-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Long Term Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension|An Open-Label Extension Study of APD811-003 in Patients With Pulmonary Arterial Hypertension|Recruiting||Phase 2|60|Anticipated|Arena Pharmaceuticals||1|||f||||t||||||||||2017-10-10 23:51:46.694012|2017-10-10 23:51:46.694012
NCT02279732|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-09-07|||October 13, 2014|Actual|2014-10-13|September 2017|2017-09-01|September 24, 2018|Anticipated|2018-09-24|September 23, 2018|Anticipated|2018-09-23||Interventional|||Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin|A Randomized, Multicenter, Double-Blind, Multinational, Phase 3 Trial Comparing the Efficacy of Ipilimumab in Addition to Paclitaxel and Carboplatin Versus Placebo in Addition to Paclitaxel and Carboplatin in Subjects With Stage IV/Recurrent Non-Small Cell Lung Cancer (NSCLC) With Squamous Histology|Active, not recruiting||Phase 3|867|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-10 23:51:46.816515|2017-10-10 23:51:46.816515
NCT02279719|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-08-21|||December 2014||2014-12-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma|A Phase Ib/II Clinical Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma|Recruiting||Phase 1/Phase 2|114|Anticipated|Boston Biomedical, Inc||3|||f||||f||||||||||2017-10-10 23:51:47.126865|2017-10-10 23:51:47.126865
NCT02279706|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-04-28|||October 2014||2014-10-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|R-CAT||Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test|Linguistic Adaptation of Rhinitis Control Assessment Test (RCAT) in Korean and Responsiveness to Disease Severity, Quality of Life, and Treatment in Adult Rhinitis Patients: A Multicenter Prospective Study|Completed||N/A|130|Actual|Ajou University School of Medicine|||1||f||||t||||||||||2017-10-10 23:51:47.364282|2017-10-10 23:51:47.364282
NCT02279693|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-06-19|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|PROSTRACK||Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer||Recruiting||N/A|20|Anticipated|Centre Georges Francois Leclerc||2|||f||||f||||||||||2017-10-10 23:51:47.441985|2017-10-10 23:51:47.441985
NCT02279680|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-10-28|||June 2014||2014-06-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|MEM-T2A||Associative Memory in Adults With an Autism Spectrum Disorder|The Associative Memory in Autism Spectrum Disorders Without Intellectual Disability|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Caen||2|||f||||t||||||||||2017-10-10 23:51:47.53306|2017-10-10 23:51:47.53306
NCT02279667|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2014-12-31|2014-11-28||February 2004||2004-02-01|December 2014|2014-12-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093|Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093 in Healthy Volunteers|Completed||Phase 1|18|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-10 23:51:47.635027|2017-10-10 23:51:47.635027
NCT02279654|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-05-17|||December 17, 2014|Actual|2014-12-17|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31|3 Years|Observational [Patient Registry]|PASS MDS del5q||Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)|A Post-authorization, Non-interventional, Safety Study Study of Patients With Myelodysplastic Syndromes (MDS) Treated With Lenalidomide.|Recruiting||N/A|1800|Anticipated|Celgene|||2||f||||f||||||||||2017-10-10 23:51:48.029415|2017-10-10 23:51:48.029415
NCT02279628|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-28|||July 2014||2014-07-01|October 2014|2014-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section|Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section. Controlled Comparative Study.|Unknown status|Recruiting|Phase 4|150|Anticipated|Central Hospital, Nancy, France||3|||f||||f||||||||||2017-10-10 23:51:48.64777|2017-10-10 23:51:48.64777
NCT02279459|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-05-18|||January 2015||2015-01-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas|Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas: Assessing Tumor Perfusion and Prediction of Treatment Outcomes|Recruiting||N/A|70|Anticipated|Ottawa Hospital Research Institute|||1||f||||f|f|f||||||||2017-10-10 23:51:50.137438|2017-10-10 23:51:50.137438
NCT02279615|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-10-03|||June 2018|Anticipated|2018-06-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.|EFFICACY AND SAFETY OF COMBINATION THERAPY WITH β3-ADRENOCEPTOR AGONIST (MIRABEGRON) AND α-ADRENOCEPTOR ANTAGONIST (TAMSULOSIN) FOR TREATMENT OF OVERACTIVE BLADDER IN MALE PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA.|Not yet recruiting||Phase 4|200|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f|f|f||||||||2017-10-10 23:51:48.754637|2017-10-10 23:51:48.754637
NCT02279602|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2016-11-15|||December 2014||2014-12-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study|Rollover for Study OX4218s, A P2 Study to Investigate Safety and Activity of Fosbretabulin Tromethamine in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET With Elevated Biomarkers|Completed||Phase 2|7|Actual|Mateon Therapeutics||1|||f||||t||||||||||2017-10-10 23:51:48.857256|2017-10-10 23:51:48.857256
NCT02279589|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-03-24|||December 2014||2014-12-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|June 2016|Actual|2016-06-01||Interventional|HYPOPNEUMO||Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers|Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers|Active, not recruiting||Phase 2|60|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||||2017-10-10 23:51:48.944089|2017-10-10 23:51:48.944089
NCT02279576|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-10-13|||January 2015||2015-01-01|November 2015|2015-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|PAZOPEN-SOGUG||Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)|Phase II Study With Pazopanib and Weekly Paclitaxel in Metastatic or Locally Advanced Squamous Penile Carcinoma Patients Previously Treated With Cisplatin Based Chemotherapy|Terminated||Phase 2|4|Actual|Spanish Oncology Genito-Urinary Group||1||"The low recruitment of patients will not allow to complete the study with the required number   of patients within reasonable time."|f||||f||||||||||2017-10-10 23:51:49.055937|2017-10-10 23:51:49.055937
NCT02279563|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-30|||December 2013||2013-12-01|October 2014|2014-10-01||||February 2014|Actual|2014-02-01||Interventional|||A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis|A Randomized, Double-blind, Placebo-controlled,Parallel-group Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc. )in the Treatment of Seasonal Allergic Rhinitis|Unknown status|Enrolling by invitation|Phase 2|595|Actual|Apotex Inc.||3|||f||||t||||||||||2017-10-10 23:51:49.161748|2017-10-10 23:51:49.161748
NCT02279550|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-02-23|||November 2016||2016-11-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01|20 Years|Observational [Patient Registry]|||Institutional Registry of Hip Fracture in the Elderly|Institutional Registry of Hip Fracture in the Elderly|Recruiting||N/A|2000|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f|f|f||||||No||2017-10-10 23:51:49.235877|2017-10-10 23:51:49.235877
NCT02279537|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-09-14|||October 1, 2014|Actual|2014-10-01|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|RAINBOW||Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD|A Retrospective and Prospective Non-interventional Open Label Study to Assess the Real Life of Treatment-naive Patients With Wet Age-related Macular Degeneration in Routine Clinical Practice in France and Starting an Anti VEGF Therapy With Aflibercept|Active, not recruiting||N/A|593|Actual|Bayer|||1||f||||f|f|f||||||||2017-10-10 23:51:49.319069|2017-10-10 23:51:49.319069
NCT02279524|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-02-08|||January 2015||2015-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|Aramchol_005||A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH|A Phase IIb, Double Blind Randomized, Controlled Clinical Trial, to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH) - Aramchol 005 Study|Active, not recruiting||Phase 2/Phase 3|240|Anticipated|Galmed Pharmaceuticals Ltd||3|||f||||t||||||||||2017-10-10 23:51:49.420281|2017-10-10 23:51:49.420281
NCT02279511|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-03-28|||December 2014|Actual|2014-12-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||ATP in Alzheimer Disease|Evaluating the Effectiveness of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in Patients With Moderate Alzheimer's Disease and Severe: Double-blind Dose Finding Clinical Trial.|Completed||Phase 2|20|Actual|Fundacion Clinic per a la Recerca Biomédica||4|||f||||f||||||||||2017-10-10 23:51:49.702293|2017-10-10 23:51:49.702293
NCT02279498|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-05-19|||June 2015|Actual|2015-06-01|May 2017|2017-05-01|January 20, 2017|Actual|2017-01-20|October 2016|Actual|2016-10-01||Interventional|||SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis|A Phase 3, Randomized, Open-Label, Assessor-Blind, Noninferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency|Completed||Phase 3|128|Actual|Anthera Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:51:49.795557|2017-10-10 23:51:49.795557
NCT02279485|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-11-02|||September 2014||2014-09-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects|A Randomized, Open-Label, Crossover Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects|Completed||Phase 1|100|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-10 23:51:49.971597|2017-10-10 23:51:49.971597
NCT02279472|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-10-28|||October 2014||2014-10-01|October 2014|2014-10-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Interventional|||Optical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral Lridotomy||Unknown status|Recruiting|N/A|40|Anticipated|Second Xiangya Hospital of Central South University||1|||f||||f||||||||||2017-10-10 23:51:50.060384|2017-10-10 23:51:50.060384
NCT02279446|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-29|||October 2014||2014-10-01|October 2014|2014-10-01|April 2015|Anticipated|2015-04-01|October 2014|Actual|2014-10-01||Observational|||Development of a Validated Chart for Intermediate Vision Assessment|Development of a Validated Chart for Intermediate Vision Assessment|Unknown status|Recruiting|N/A|400|Anticipated|Democritus University of Thrace|||4||f||||f||||||||||2017-10-10 23:51:50.33797|2017-10-10 23:51:50.33797
NCT02279433|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-09-08|||September 2014||2014-09-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b|A Phase 1, Two-Part, Multi-Center, Non Randomized, Open-Label, Multiple Dose First-In-Human Study Of DS-6051b, An Oral ROS1 And NTRK Inhibitor, In Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|70|Anticipated|Daiichi Sankyo, Inc.||1|||f||||f|t|f||||||||2017-10-10 23:51:50.453064|2017-10-10 23:51:50.453064
NCT02279420|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-03-31|2017-03-31||January 5, 2015|Actual|2015-01-05|March 2017|2017-03-01|September 30, 2016|Actual|2016-09-30|August 31, 2016|Actual|2016-08-31||Interventional|||ESSENTIAL Trial™ Sham Cross-over|A Supplemental Open Label Multicenter Sham Cross-over Clinical Trial Using an Endoscopic Suturing Device (g-Cath EZ™ Suture Anchor Delivery Catheter) For Primary Weight Loss Essential Study (IDE G130163) Crossover Study|Completed||N/A|73|Actual|USGI Medical||1|||f||||f||||||||||2017-10-10 23:51:50.559875|2017-10-10 23:51:50.559875
NCT02279407|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-29|2017-02-09|2016-12-02||January 2015||2015-01-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EFFECTII||A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients|A Double-blind Randomized Placebo-controlled, Parallel-group 12 Week Study to Investigate the Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Type 2 Diabetic Patients; EFFECT II|Completed||Phase 2|223|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-10 23:51:50.758246|2017-10-10 23:51:50.758246
NCT02279394|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-08-25|||December 2014||2014-12-01|August 2017|2017-08-01|October 2023|Anticipated|2023-10-01|January 2020|Anticipated|2020-01-01||Interventional|||Trial of Combination of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma|Phase II Trial of Combination of Elotuzumab, Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma|Active, not recruiting||Phase 2|51|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:51:51.334065|2017-10-10 23:51:51.334065
NCT02279381|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-06-08|||November 2014||2014-11-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Neonatal Package Study in Rural District of Pakistan|A Randomized Controlled Trial to Evaluate the Acceptability, Feasibility and Efficacy of the Use of a Neonatal Package to Reduce Neonatal Infection in a Rural District of Pakistan|Completed||Phase 4|1450|Actual|Aga Khan University||3|||f||||t||||||||||2017-10-10 23:51:51.45775|2017-10-10 23:51:51.45775
NCT02279368|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-30|||September 2013||2013-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|||Nursing Led Interdisciplinary Intervention in Prevention of Girl Child Mortality and Maltreatment|Nursing Led Interdisciplinary Intervention in Prevention of Girl Child Mortality and Maltreatment: Randomized Controlled Trial|Completed||N/A|134|Actual|Adwin Life Care||2|||f||||t||||||||||2017-10-10 23:51:51.575515|2017-10-10 23:51:51.575515
NCT02279355|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-27|||October 2014||2014-10-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Observational|||Peri-operative Risk Factors for Postoperative Pressure Ulcer in Surgical Patients||Unknown status|Not yet recruiting|N/A|126|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-10 23:51:51.666988|2017-10-10 23:51:51.666988
NCT02279342|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-08-02|||October 2014||2014-10-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia|the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia|Terminated||Phase 4|1|Actual|Yokohama City University Medical Center||2||Entry were insufficient as expected.|f||||f||||||||||2017-10-10 23:51:51.745811|2017-10-10 23:51:51.745811
NCT02279329|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-05-08|||May 2009||2009-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging|Longitudinal Study of 3He and 129Xe Magnetic Resonance Imaging in Chronic Obstructive Pulmonary Disease|Recruiting||N/A|200|Anticipated|Western University, Canada||1|||f||||f||||||||||2017-10-10 23:51:51.851567|2017-10-10 23:51:51.851567
NCT02279316|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2016-11-16|||October 2014||2014-10-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MFYM - P||Move for Your Mind - Pilot Trial|Home Exercise, Vitamin D and Dalcroze Eurhythmics for Seniors With Mild Cognitive Impairment (MCI) or Mild Dementia|Completed||N/A|19|Actual|University of Zurich||3|||f||||t||||||||||2017-10-10 23:51:51.93948|2017-10-10 23:51:51.93948
NCT02279303|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-01-10|||April 2013||2013-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Rx for Better Breast Health|Prescription for Better Breast Health|Active, not recruiting||N/A|160|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 23:51:52.046793|2017-10-10 23:51:52.046793
NCT02279290|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-10-03|||July 2015||2015-07-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology|Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology|Recruiting||N/A|90|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-10 23:51:52.143141|2017-10-10 23:51:52.143141
NCT02279277|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-28|||October 2014||2014-10-01|October 2014|2014-10-01||||October 2016|Anticipated|2016-10-01||Interventional|||Physical Therapy Prior to Total Knee Replacement|Effect of Physical Therapy on Grade 3 or 4 Knee Osteoarthritis|Unknown status|Not yet recruiting|N/A|148|Anticipated|Rothman Institute Orthopaedics||2|||f||||f||||||||||2017-10-10 23:51:52.231324|2017-10-10 23:51:52.231324
NCT02279264|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-28|||September 2014||2014-09-01|October 2014|2014-10-01||||November 2014|Anticipated|2014-11-01||Observational|||Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients|Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients|Unknown status|Recruiting|N/A|40|Anticipated|RightBio Metrics|||1||f||||t||||||||||2017-10-10 23:51:52.298869|2017-10-10 23:51:52.298869
NCT02279251|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-10-21|||October 2013||2013-10-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|March 2018|Anticipated|2018-03-01||Interventional|LIST||School Based Low-intensity Cognitive Behavioral Intervention for Anxious Youth|School Based Low-intensity Cognitive Behavioral Intervention for Anxious Youth. A Randomized Controlled Trial|Recruiting||N/A|323|Anticipated|Uni Research||3|||f||||f||||||||||2017-10-10 23:51:52.387784|2017-10-10 23:51:52.387784
NCT02279225|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-12-13|||March 2013||2013-03-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|FM and DTM||Protocol Phototherapy Treatment for Fibromyalgia and Temporomandibular Joint Dysfunction|RANDOMIZED DOUBLE-BLIND CONTROLLED THE USE OF PHOTOTHERAPY IN FIBROMIÁLGICOS WITH TEMPOROMANDIBULAR JOINT DYSFUNCTION|Unknown status|Recruiting|N/A|61|Anticipated|University of Nove de Julho||4|||f||||f||||||||||2017-10-10 23:51:52.566572|2017-10-10 23:51:52.566572
NCT02279212|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-06|2016-05-19|||May 2010||2010-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Observational|NEUPAQ||Neuropathic Pain and Quality of Life in ICU Survivors|Neuropathic Pain and Quality of Life in ICU Survivors|Active, not recruiting||N/A|120|Anticipated|Oslo University Hospital|||1||f||||f||||||||||2017-10-10 23:51:52.653477|2017-10-10 23:51:52.653477
NCT02279199|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-04-03|||January 2014||2014-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|5 Years|Observational [Patient Registry]|||Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)|Assessment of Motor Proficiency in People With Bleeding Disorders Using the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2™)|Active, not recruiting||N/A|100|Anticipated|Oregon Health and Science University|||2||f||||f||||||||||2017-10-10 23:51:52.718699|2017-10-10 23:51:52.718699
NCT02279186|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2014-11-01|||September 2014||2014-09-01|November 2014|2014-11-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|||Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section|Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section ,A Randomized Clinical Trial .|Unknown status|Recruiting|Phase 4|200|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 23:51:52.784421|2017-10-10 23:51:52.784421
NCT02279173|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-10-02||2017-10-02|December 10, 2014|Actual|2014-12-10|August 2017|2017-08-01|September 23, 2019|Anticipated|2019-09-23|March 9, 2017|Actual|2017-03-09||Interventional|||Single Arm, Open-label, Long-term Study of Romiplostim in Thrombocytopenic Pediatric Subjects With ITP.|A Single Arm, Open-label, Long-term Efficacy and Safety Study of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)|Active, not recruiting||Phase 3|204|Actual|Amgen||1|||f||||f||||||||||2017-10-10 23:51:52.889696|2017-10-10 23:51:52.889696
NCT02279160|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2017-07-25|||December 2014||2014-12-01|February 2017|2017-02-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension|A Randomized, Double-blind, Parallel-group, Placebo-controlled Phase 2 Trial of APD811, an Oral IP Receptor Agonist, in Patients With Pulmonary Arterial Hypertension|Completed||Phase 2|60|Anticipated|Arena Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:51:53.254109|2017-10-10 23:51:53.254109
NCT02279147|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-10-28|||August 2014||2014-08-01|October 2014|2014-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.|The Prevention and Treatment of SIRS in Patients With Cholestatic Jaundice After Operation.|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:51:53.400878|2017-10-10 23:51:53.400878
NCT02279134|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-01-16|||October 2014||2014-10-01|January 2017|2017-01-01|October 2022|Anticipated|2022-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma|A Phase II/III Study of Adjuvant Chemoradiotherapy, Radiotherapy After Surgery Versus Surgery Alone in Patients With Stage ⅡB-Ⅲ Esophageal Carcinoma|Recruiting||Phase 2/Phase 3|360|Anticipated|Chinese Academy of Medical Sciences||3|||f||||t||||||||||2017-10-10 23:51:53.525039|2017-10-10 23:51:53.525039
NCT02279121|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-08-25|||November 2014||2014-11-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ATAPAC||ATAPAC Study (TauroLock Activity in Adult Cancer Patients)|Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non-hematological Cancer Treated With Intravenous Anti-tumor Therapy|Completed||N/A|162|Actual|Centre Hospitalier Régional Metz-Thionville||2|||f||||f||||||||||2017-10-10 23:51:53.634963|2017-10-10 23:51:53.634963
NCT02279069|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-28|||October 2014||2014-10-01|October 2014|2014-10-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|4roll||4-point vs 4-roll Canne as Walking Aids After Stroke|Comparison Between Classical 4-point Canne and 4-roll Canne on Gait Parameters (Gait Speed and Energy Cost) as Walking Aids After Stroke. A Multicentric Randomized Controled Cross-over Study|Unknown status|Recruiting|Phase 4|50|Anticipated|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-10-10 23:51:54.196586|2017-10-10 23:51:54.196586
NCT02279056|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-05-12|||October 2014||2014-10-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Randomized Controlled Trial of a Self-help Book for Insomnia in Patients With Co-morbid OSA and Insomnia|A Randomized Controlled Trial (RCT) of a Self-help Book for Insomnia in Patients With Co-morbid Obstructive Sleep Apnea (OSA) and Insomnia|Recruiting||N/A|180|Anticipated|University of Bergen||2|||f||||f||||||||||2017-10-10 23:51:54.290472|2017-10-10 23:51:54.290472
NCT02279043|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-07-27|||October 2015||2015-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Online Peer Influence on IUD Behaviors and Attitudes|Peer Influence on Intrauterine Contraceptive Behavior and Attitudes in an Online Social Community|Completed||N/A|630|Actual|University of California, San Francisco||2|||f||||f||||||||Yes|Deidentified data will be shared with UCSF researchers through secure email.|2017-10-10 23:51:54.384251|2017-10-10 23:51:54.384251
NCT02279017|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-01-25|||October 2014|Actual|2014-10-01|March 2016|2016-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||mHealth Messages to Sustain Recent Weight Loss - Phase 2|Mobile Health Messages to Sustain Recent Weight Loss - Phase 2|Completed||N/A|100|Actual|Duke University||1|||f||||f||||||||||2017-10-10 23:51:54.609183|2017-10-10 23:51:54.609183
NCT02279004|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-10-11|||July 2014||2014-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care|A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care|Recruiting||N/A|680|Anticipated|Dana-Farber Cancer Institute|||4||f||||t||||||Samples With DNA|"     Cell-free plasma DNA (cfDNA) derived from tumor cells   "|||2017-10-10 23:51:54.69529|2017-10-10 23:51:54.69529
NCT02278978|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-05-10|||October 2014||2014-10-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma|A Phase II Trial of BIBF1120 in Patients With Advanced FGFR3 Mutated, FGFR3 Overexpressed, or FGFR3 Wild Type Urothelial Carcinoma of Urinary Bladder, Urethra, Ureter, and Renal Pelvis and Who Have Failed Platinum-based Chemotherapy|Unknown status|Active, not recruiting|Phase 2|129|Anticipated|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-10 23:51:54.919335|2017-10-10 23:51:54.919335
NCT02278965|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-08-29|||January 22, 2015|Actual|2015-01-22|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer|Pilot Biomarker Modulation Study of Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer|Active, not recruiting||Phase 1|19|Actual|Columbia University||1|||f||||t|t|f||||||||2017-10-10 23:51:55.038882|2017-10-10 23:51:55.038882
NCT02278952|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-10-26|||December 2014||2014-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|TANGELA||Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.|Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.|Active, not recruiting||N/A|50|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-10-10 23:51:55.180838|2017-10-10 23:51:55.180838
NCT02278939|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-12-08|||November 2014||2014-11-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Fit and Trim for Diabetes Prevention|Filipinos Fit and Trim Weight Loss for Diabetes Prevention Program|Active, not recruiting||N/A|65|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:51:55.246074|2017-10-10 23:51:55.246074
NCT02278926|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-31|||January 2012||2012-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Lypo-hypertrofia Characterization in Diabetes|Ultrasound Characterization of Lipo-hypertrophy in Type 1 Diabetes Mellitus|Completed||N/A|60|Actual|Niguarda Hospital|||2||f||||f||||||||||2017-10-10 23:51:55.340882|2017-10-10 23:51:55.340882
NCT02278913|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2014-10-29|||April 2009||2009-04-01|October 2014|2014-10-01|March 2011|Actual|2011-03-01|April 2010|Actual|2010-04-01||Interventional|||Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay|Basal Bolus Regimen With Insulin Analogs Versus Human Insulin in Medical Patients With Type 2 Diabetes: A Randomized Controlled Trial in Paraguay|Completed||Phase 4|134|Actual|Universidad Nacional de Asunción||2|||f||||f||||||||||2017-10-10 23:51:55.425217|2017-10-10 23:51:55.425217
NCT02278900|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-12-17|||April 2014||2014-04-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Supporting Doctor-patient Communication in Oncology|Supporting Doctor-patient Communication in Oncology. A Randomized Controlled Trial (RCT) of Question Prompt List and Audio Recording as Communication Aids in Oncology Consultation|Active, not recruiting||N/A|180|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-10-10 23:51:55.523966|2017-10-10 23:51:55.523966
NCT02278705|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-07-02|||January 2009||2009-01-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Primary Care Clinical Practice Elements and Improving Overweight Children's Weight Status|Primary Care Clinical Practice Elements and Improving Overweight Children's Weight Status|Completed||N/A|4000|Actual|University of Texas Southwestern Medical Center|||2||f||||f||||||||||2017-10-10 23:51:57.411075|2017-10-10 23:51:57.411075
NCT02278887|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-07-17|||September 2014||2014-09-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|TIL||Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma|Randomized Phase III Study Comparing a Non-myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Tumor Infiltrating Lymphocytes and Interleukin-2 to Standard Ipilimumab Treatment in Metastatic Melanoma|Recruiting||Phase 3|168|Anticipated|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-10-10 23:51:55.609277|2017-10-10 23:51:55.609277
NCT02278874|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-04-12|||August 2014||2014-08-01|April 2017|2017-04-01||||December 2018|Anticipated|2018-12-01||Observational|||High Risk Multiple Gestation Study|Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated From Maternal Blood|Recruiting||N/A|400|Anticipated|Natera, Inc.|||1||f||||f||||||Samples With DNA|"     Maternal and Paternal blood samples      CVS or Amniocentesis sample (optional)      Child saliva sample (optional)      *Biospecimen retention is optional portion of consent form   "|||2017-10-10 23:51:55.732254|2017-10-10 23:51:55.732254
NCT02278861|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-29|||November 2011||2011-11-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|ARISOAK||Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis|Low Dose Oral Isotretinoin Versus Topical Tretinoin for Prevention of Actinic Keratosis in Immunocompetent Patients: a Randomized, Comparative Trial|Completed||Phase 2|60|Actual|Universidade Federal de Goias||2|||f||||t||||||||||2017-10-10 23:51:55.84496|2017-10-10 23:51:55.84496
NCT02278848|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-10-27|||July 2014||2014-07-01|October 2014|2014-10-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|Multimod'HCA||Multimodal Investigation in the Diagnosis and Treatment of Chronic Adult Hydrocephalus|Multimodal Investigation in the Diagnosis and Treatment of Chronic Adult Hydrocephalus|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-10-10 23:51:55.950264|2017-10-10 23:51:55.950264
NCT02278835|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-29|||March 2009||2009-03-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|January 2014|Actual|2014-01-01||Interventional|||The Effectiveness of Respiratory Physiotherapy in Mitral Valve Surgery|To Analyze the Effectiveness of Respiratory Physiotherapy Techniques in the Post Operative Mitral Valve|Completed||N/A|110|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-10 23:51:56.044485|2017-10-10 23:51:56.044485
NCT02278822|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2016-07-07|||November 2014||2014-11-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|April 2015|Actual|2015-04-01||Interventional|||Oral Liposomal Glutathione Supplementation in Healthy Subjects|Pilot Study of Oral Liposomal Glutathione Supplementation on Levels of Glutathione in Blood and Biomarkers of Oxidative Stress and Immune Function in Healthy Adults|Completed||N/A|12|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-10 23:51:56.123475|2017-10-10 23:51:56.123475
NCT02278809|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-29|||December 2013||2013-12-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|Movie Models||Promoting Healthy Lifestyle Behaviors in Schoolchildren: an Online Video Intervention for Parents|Promoting Healthy Lifestyle Behaviors in Primary Schoolchildren: Evaluation and Implementation of an Online Video Intervention for Parents|Completed||N/A|207|Actual|University Ghent||2|||f||||f||||||||||2017-10-10 23:51:56.187029|2017-10-10 23:51:56.187029
NCT02278796|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-08-18|||April 2015||2015-04-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|BEB||A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)|A Randomized Phase II Trial Comparing BeEAM With BEAM as Conditioning Regimen for Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)|Recruiting||Phase 2|98|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-10 23:51:56.258991|2017-10-10 23:51:56.258991
NCT02278783|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-09-07|2016-10-07||March 2015||2015-03-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer|Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer|Terminated||Phase 2|1|Actual|University of Utah||1||Slow Accrual|f||||t||||||||||2017-10-10 23:51:56.368739|2017-10-10 23:51:56.368739
NCT02278770|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-05-02|||December 2011||2011-12-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Observational|DDOMRI||DD Obesity MRI Study|Pilot Study: MRI Study of Diverticular Disease Symptoms and Its Relationship to Visceral Adipose Tissue|Completed||N/A|58|Actual|University of Nottingham|||1||f||||f||||||Samples With DNA|"     Serum and stool   "|||2017-10-10 23:51:56.567722|2017-10-10 23:51:56.567722
NCT02278757|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-03-14|||January 2014||2014-01-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|DPMS||Effect of Two Diets With Different Content of Protein on Weight Loss in Adults With Metabolic Syndrome|Effect of Enriched Meal Replacements Protein on Weight Loss in Adults With Metabolic Syndrome|Completed||N/A|118|Actual|Mexican National Institute of Public Health||2|||f||||t||||||||||2017-10-10 23:51:56.822302|2017-10-10 23:51:56.822302
NCT02278744|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-10-03|||October 2014||2014-10-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery|A Phase I Dose Escalation Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery|Recruiting||Phase 1|18|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:51:56.925561|2017-10-10 23:51:56.925561
NCT02278731|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-27|||May 2014||2014-05-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Exercise Protocols in Postural Balance Of Elderly Women|EFFECTS OF TWO EXERCISE PROTOCOLS IN POSTURAL BALANCE OF ELDERLY WOMEN|Completed||N/A|58|Actual|Universidade Estadual do PiauÍ||3|||f||||t||||||||||2017-10-10 23:51:57.046048|2017-10-10 23:51:57.046048
NCT02278718|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-08-02|||November 2014||2014-11-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care|A Multicenter, Multinational, Randomized, Controlled, Open Label Study, Performed in Children With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid as Compared to Standard of Care (SOC) Treatment|Recruiting||Phase 3|160|Anticipated|MediWound Ltd||2|||f||||t||||||||||2017-10-10 23:51:57.143514|2017-10-10 23:51:57.143514
NCT02278692|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-01-25|||March 2015||2015-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VitK-CUA||Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy|Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy|Recruiting||N/A|20|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-10 23:51:57.524901|2017-10-10 23:51:57.524901
NCT02278679|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-05-17|||October 2014||2014-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|DiRECT||Digital Rectal Exam Proficiency Tool|Validation of the DiRECT Proficiency Tool|Recruiting||N/A|410|Anticipated|University of Virginia|||3||f||||t||||||||||2017-10-10 23:51:57.671777|2017-10-10 23:51:57.671777
NCT02278666|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-11-03|||October 2014||2014-10-01|November 2014|2014-11-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|SATURNO||Minimally Invasive Versus Conventional Aortic Valve Replacement: a Long Term Registry|Minimally Invasive Aortic Valve Replacement Versus Conventional Aortic Valve Replacement: a Long Term Registry on Potential Benefits of the Different Surgical Techniques|Recruiting||N/A|1000|Anticipated|Maria Cecilia Hospital|||3||f||||f||||||||||2017-10-10 23:51:57.78028|2017-10-10 23:51:57.78028
NCT02278653|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-03-15|||September 2014||2014-09-01|March 2016|2016-03-01|September 2022|Anticipated|2022-09-01|September 2017|Anticipated|2017-09-01|5 Years|Observational [Patient Registry]|||Functional Outcome of Organ Preservation After Neo-adjuvant Chemo Radiation for Rectal Cancer|Follow up and Functional Outcome of Organ Saving Treatment in Patients With Good Response to Neo-adjuvant (Chemo)Radiation for Rectal Cancer|Recruiting||N/A|100|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-10 23:51:57.89258|2017-10-10 23:51:57.89258
NCT02278640|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-07-07|2016-07-07||October 2014||2014-10-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional||Safety Set - all subjects in whom the procedure was started.|Harmonic ACE®+7 Shears in Laparoscopic Hysterectomy|Prospective, Multicenter, Study Evaluating Vessel Sealing Utilizing the Harmonic ACE®+7 Shears During Total Laparoscopic Hysterectomy|Completed||Phase 4|40|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-10-10 23:51:58.027708|2017-10-10 23:51:58.027708
NCT02278627|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-08-19|||September 2014||2014-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|PTGMass||Impact of a Technique of Massage During the First Week of Hospitalization on the Recycling of the Mobility of the Knee Further to the Installation of Knee Replacement|Impact of a Technique of Massage During the First Week of Hospitalization on the Recycling of the Mobility of the Knee Further to the Installation of Knee Replacement|Recruiting||N/A|98|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-10 23:51:58.30731|2017-10-10 23:51:58.30731
NCT02278614|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-03-28|2016-11-24||December 2014||2014-12-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients|Efficacy and Safety Assessment of Fixed Combination Unpreserved Latanoprost Eye Drops and Timolol 0.5% (T2347) Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients.|Completed||Phase 3|242|Actual|Laboratoires Thea||2|||f||||f||||||||||2017-10-10 23:51:58.3852|2017-10-10 23:51:58.3852
NCT02278601|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-08-18|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|COLEUS||Comparison of Regimens VAMB, CIPCEA, PCEA|Comparison of Variable-frequency Automated Mandatory Bolus (VAMB), Computer-integrated Patient Controlled Epidural Analgesia (CIPCEA) and Conventional Patient Controlled Epidural Analgesia (PCEA) During Labour|Recruiting||Phase 3|3412|Anticipated|KK Women's and Children's Hospital||3|||f||||f||||||||||2017-10-10 23:51:58.67318|2017-10-10 23:51:58.67318
NCT02278588|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-10-29|||November 2014||2014-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|October 2016|Actual|2016-10-01||Observational|||Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.|Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.|Active, not recruiting||N/A|45|Actual|University at Buffalo|||3||f||||f||||||||||2017-10-10 23:51:58.789049|2017-10-10 23:51:58.789049
NCT02278575|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-09-22|||January 2016||2016-01-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Atenativ Effect on Uterine Blood Flow and Preeclampsia|Clinical Effect of Atenativ Treatment on Uterine Blood Flow and the Amount of Atenativ Needed to Maintain a Normal Antithrombin Lvels During Two Weeks in Early and Severe Preeclampsia|Withdrawn||Phase 4|0|Actual|Vastra Gotaland Region||1||impossible to recruit participants due to organization changes|f||||t||||||||||2017-10-10 23:51:58.863096|2017-10-10 23:51:58.863096
NCT02278562|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-03-09|||October 22, 2014|Actual|2014-10-22|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|INSPIRED||Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2|Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease|Completed||Phase 2|24|Actual|VA Office of Research and Development||3|||f||||t||||||||Undecided||2017-10-10 23:51:58.959636|2017-10-10 23:51:58.959636
NCT02278549|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-10-26|||November 2014||2014-11-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Comparison of Spinal Kinematics Between Asymptomatic Subjects and Patients With Low Back Pain|Comparison of Spinal Kinematics Between Asymptomatic Subjects and Patients With Low Back Pain Using a Multi-segment Model|Completed||N/A|22|Actual|Haute Ecole Cantonale Vaudoise de Santé|||2||f||||f||||||||||2017-10-10 23:51:59.049712|2017-10-10 23:51:59.049712
NCT02278536|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-04-12|||March 2013||2013-03-01|April 2017|2017-04-01||||December 2018|Anticipated|2018-12-01||Observational|||Multiple Gestation Study|Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated From Maternal Blood|Recruiting||N/A|200|Anticipated|Natera, Inc.|||2||f||||f||||||Samples With DNA|"     Maternal and Paternal blood samples      CVS or Amniocentesis sample (optional)      Child saliva sample (optional)      *Biospecimen retention is optional portion of consent form   "|||2017-10-10 23:51:59.144533|2017-10-10 23:51:59.144533
NCT02278523|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-28|||June 2014||2014-06-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Respiratory Physiology Variation of COPD Patients in Inspiratory Muscle Training|The Respiratory Physiology Variation of COPD Patients in Inspiratory Muscle Training|Completed||Phase 2/Phase 3|12|Actual|Guangzhou Institute of Respiratory Disease||2|||f||||t||||||||||2017-10-10 23:51:59.269326|2017-10-10 23:51:59.269326
NCT02278510|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-03-29|||December 9, 2014|Actual|2014-12-09|March 2017|2017-03-01|November 10, 2015|Actual|2015-11-10|November 10, 2015|Actual|2015-11-10||Interventional|||Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma|A Pilot Trial of Intraparenchymally-Administered Topotecan Using Convection-Enhanced Delivery (CED) in Patients With Suspected Recurrent/Progressive WHO Grade III or IV (High Grade) Glioma Requiring Stereotactic Biopsy|Completed||Early Phase 1|3|Actual|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-10 23:51:59.349028|2017-10-10 23:51:59.349028
NCT02278497|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-07-30|||November 2014||2014-11-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|WATERDAY||Assessment of Coronary Flow Reserve by PET-H215O and FFR. Comparison With Dynamic Acquisition Using CZT Camera|Assessment of Coronary Flow Reserve by PET-H215O and FFR in Patients Suspected of Coroanry Artery Disease. a Comparative Study With Dynamic Acquisition Using CZT Camera and 99mcTc-mibi.|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-10 23:51:59.444636|2017-10-10 23:51:59.444636
NCT02278484|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-03-13|2016-10-13||September 2014||2014-09-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||Sinus Balloon Dilation in Pediatric Patients|XprESS Device and PathAssist Confirmation Tools in Pediatric Patients-Expanded Indication Study|Completed||N/A|50|Actual|Entellus Medical, Inc.||1|||f||||f||||||||No||2017-10-10 23:51:59.534147|2017-10-10 23:51:59.534147
NCT02278471|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-08-02|||December 2015||2015-12-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The SCCS Polypill Pilot Trial|The SCCS Polypill Pilot Trial|Recruiting||Phase 2|300|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-10-10 23:51:59.772935|2017-10-10 23:51:59.772935
NCT02278458|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-05-21|||October 2014||2014-10-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|January 2016|Anticipated|2016-01-01||Interventional|||Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer|Phase I, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Icotinib Combined With Gemcitabine as First-line Treatment in Locally Advanced, Unresectable or Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-10 23:51:59.866845|2017-10-10 23:51:59.866845
NCT02278445|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-11-29|||November 2014||2014-11-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)|Evaluation of Lung Doppler Signals (LDS) in Detecting Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis (SSc)|Withdrawn||N/A|0|Actual|Echosense Ltd.||1||No patients|f||||f||||||||||2017-10-10 23:51:59.95839|2017-10-10 23:51:59.95839
NCT02278432|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2015-10-18|||June 2014||2014-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Observational|||Evaluation of the Prophylactic Use of Omeprazole in Patients Admitted to the State Hospital of Américo Brasiliense|Evaluation of the Prophylactic Use of Omeprazole in Patients Admitted to the State Hospital of Américo Brasiliense|Completed||N/A|427|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho|||1||f||||f||||||||||2017-10-10 23:52:00.074491|2017-10-10 23:52:00.074491
NCT02278419|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2016-10-13|||December 2014||2014-12-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection|A Phase 2a, Partly Randomized, Open-label Trial to Investigate the Efficacy and Safety of an 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Subjects With Chronic Genotype 4 Hepatitis C Infection|Completed||Phase 2|63|Actual|Janssen-Cilag International NV||3|||f||||f||||||||||2017-10-10 23:52:00.141334|2017-10-10 23:52:00.141334
NCT02278406|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-05-03|||October 2014||2014-10-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain Stimulators|Employing Near Infrared Spectroscopy to Non-invasively Assess Changes in Cerebral Perfusion in Response to Subthalamic Deep Brain Stimulation|Completed||N/A|8|Actual|Beth Israel Deaconess Medical Center||1|||f||||t||||||||||2017-10-10 23:52:00.232866|2017-10-10 23:52:00.232866
NCT02278393|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-29|||February 2014||2014-02-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Clinical Study for Evaluating the Safety of a Plant Sterol-enriched Fermented Dairy Product in Japanese Healthy Adults|A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO EVALUATE THE SAFETY OF EXCESSIVE CONSUMPTION OF PLANT STEROL-ENRICHED FERMENTED DAIRY PRODUCT OVER A 4-WEEK PERIOD IN JAPANESE HEALTHY ADULTS|Completed||N/A|84|Actual|Danone Research||2|||f||||f||||||||||2017-10-10 23:52:00.305374|2017-10-10 23:52:00.305374
NCT02278380|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-04-09|||June 2014||2014-06-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Different Glycemic Index (GI) Values in 7 Food Products|In-Vivo Glycemic Index (GI) and Insulinemic Index (II) Testing of 7 Test Foods in Total (5 Milk-based Beverage and 2 Standard Breakfast Items)|Completed||N/A|15|Actual|Danone Asia Pacific Holdings Pte, Ltd.||1|||f||||f||||||||||2017-10-10 23:52:00.381157|2017-10-10 23:52:00.381157
NCT02278367|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-07-19|||December 2014||2014-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Evaluation of 18F-AV-1451|Clinical Evaluation of 18F-AV-1451|Recruiting||Phase 2|250|Anticipated|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-10 23:52:00.452029|2017-10-10 23:52:00.452029
NCT02278354|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2017-04-13|||December 2014||2014-12-01|April 2017|2017-04-01|February 3, 2017|Actual|2017-02-03|February 3, 2017|Actual|2017-02-03||Interventional|||Tau Imaging in Professional Fighters|18F-AV-1451 PET Imaging in Professional Fighters|Completed||Phase 1|30|Actual|Avid Radiopharmaceuticals||2|||f||||f||||||||||2017-10-10 23:52:02.336194|2017-10-10 23:52:02.336194
NCT02278328|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-08-14|||February 2016||2016-02-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||MEG Study of STX209|Magnetoencephalography / Magnetic Resonance Spectroscopy Dose Response Study of Arbaclofen in Autism Spectrum Disorder|Recruiting||Early Phase 1|40|Anticipated|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-10 23:52:03.035264|2017-10-10 23:52:03.035264
NCT02278315|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-01-23|||February 2015||2015-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma|Phase 1, Open-Label, Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1|33|Anticipated|Cellectar Biosciences, Inc.||1|||f||||t||||||||||2017-10-10 23:52:03.14994|2017-10-10 23:52:03.14994
NCT02278302|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-28|2014-10-28|||August 1999||1999-08-01|October 2014|2014-10-01||||March 2000|Actual|2000-03-01||Interventional|||Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers|Placebo-controlled, Randomized, Double-blind Study Comparing the Effect of a Combination of 200 mg Dipyridamole With Sustained Release and 25 mg Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Volunteers and 10 Days of Treatment Alone and in Combination With Alcohol (Study no. 591002)|Completed||Phase 1|56|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:52:03.271766|2017-10-10 23:52:03.271766
NCT02278276|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-11-25|||April 2016||2016-04-01|November 2015|2015-11-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Assessing the Safety and Bioactivity of SG1002 in Heart Failure Patients|A Randomised, Double-blinded, Placebo-controlled Study to Assess the Safety and Bioactivity of Sodium Polysulthionate (SG1002) in Heart Failure Patients|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Sulfagenix Australia Pty Ltd.||2|||f||||f||||||||||2017-10-10 23:52:03.415406|2017-10-10 23:52:03.415406
NCT02278250|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-06-01|||January 2015||2015-01-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||An Open-Label Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-803 as a Single Agent and in Combination With Cytotoxic Chemotherapy in Subjects With Advanced Solid Tumors|An Open-Label Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-803 as a Single Agent and in Combination With Cytotoxic Chemotherapy in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|120|Anticipated|Vertex Pharmaceuticals Incorporated||5|||f||||f||||||||||2017-10-10 23:52:03.617356|2017-10-10 23:52:03.617356
NCT02278237|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-05-05|||November 2014||2014-11-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Pilot VME||Pre/Post Pilot Test of Video Module Education|Pre/Post Pilot Test of VME for the Video vs. TTG Respiratory Inhaler Technique Assessment and InstructioN Study|Completed||N/A|90|Actual|University of Chicago||1|||f||||f||||||||||2017-10-10 23:52:03.722369|2017-10-10 23:52:03.722369
NCT02278224|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2016-02-24|||November 2013||2013-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|RuCoD||Rumination Focused Cognitive Behavioral Therapy for Major Depression and Recurrent Depression|Rumination Focused Cognitive Behavioral Therapy for Major Depression and Recurrent Depression and Relapse Prevention -a Pragmatic RCT Study in a Danish Psychiatric Outpatient Service|Completed||N/A|131|Actual|University of Copenhagen||2|||f||||t||||||||Yes||2017-10-10 23:52:03.793223|2017-10-10 23:52:03.793223
NCT02278211|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-12-01|||October 2015||2015-10-01|December 2015|2015-12-01|June 2024|Anticipated|2024-06-01|June 2019|Anticipated|2019-06-01||Observational|PREFFIR||Prediction of Recurrent Events With 18F-Fluoride|Prediction of Recurrent Events With 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients With Myocardial Infarction|Recruiting||N/A|700|Anticipated|University of Edinburgh|||1||f||||f||||||||||2017-10-10 23:52:03.880927|2017-10-10 23:52:03.880927
NCT02278198|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-04-12|||November 2014||2014-11-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123|Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123|Recruiting||Phase 1|10|Anticipated|University of Colorado, Denver||1|||f||||f||||||||||2017-10-10 23:52:03.971099|2017-10-10 23:52:03.971099
NCT02278185|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-07-21|||November 11, 2015|Actual|2015-11-11|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer|An Open Label, Randomized, Phase II Trial of Metabolic Complications in Patients Treated With Enzalutamide vs Standard ADT for the Treatment of Hormone Sensitive Prostate Cancer|Recruiting||Phase 2|56|Anticipated|University of Colorado, Denver||2|||f||||t||f||||||||2017-10-10 23:52:04.060849|2017-10-10 23:52:04.060849
NCT02278172|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-05-24|||October 2014||2014-10-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|VDAF||The Effects of Vitamin D Supplementation on Aerobic Fitness in Athletes|The Effects of Vitamin D Supplementation on VO2max in Athletes: a Randomised, Double-blind, Placebo-controlled Trial|Completed||Phase 4|44|Actual|University of Ulster||2|||f||||||||||||||2017-10-10 23:52:04.343481|2017-10-10 23:52:04.343481
NCT02278159|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-10-27|||January 2000||2000-01-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Evaluation of the Integrated Home Dialysis Model||Completed||N/A|11600|Actual|Princess Alexandra Hospital, Brisbane, Australia|||4||f||||f||||||||||2017-10-10 23:52:04.450489|2017-10-10 23:52:04.450489
NCT02278146|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-11-28|2016-05-23||November 2014||2014-11-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional||Females diagnosed with either stress urinary incontinence or overactive bladder that met the inclusion criteria|Feasibility Study Evaluating the ParaPatch System|A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder|Completed||N/A|16|Actual|ParaPatch, Inc||2|||f||||f||||||||Undecided||2017-10-10 23:52:04.533529|2017-10-10 23:52:04.533529
NCT02278120|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-07-06|||November 21, 2014|Actual|2014-11-21|July 2017|2017-07-01|February 27, 2018|Anticipated|2018-02-27|February 27, 2018|Anticipated|2018-02-27||Interventional|MONALEESA-7||Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer|A Phase III Randomized, Double-blind, Placebo-controlled Study of LEE011 or Placebo in Combination With Tamoxifen and Goserelin or a Non-steroidal Aromatase Inhibitor (NSAI) and Goserelin for the Treatment of Premenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer|Active, not recruiting||Phase 3|672|Actual|Novartis||2|||f||||t|t|f||||||||2017-10-10 23:52:04.957101|2017-10-10 23:52:04.957101
NCT02278107|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-02-26|||July 2014||2014-07-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease|Evaluation of a Lightweight Nasal Interface and Ventilator for Use by Patients With Respiratory Disease|Enrolling by invitation||N/A|20|Anticipated|New Aera, Inc||2|||f||||f||||||||||2017-10-10 23:52:05.534014|2017-10-10 23:52:05.534014
NCT02278094|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2014-10-27|||September 2014||2014-09-01|October 2014|2014-10-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|OSAS||The Influences of Intervention With Home-based Recovery Activity in Obstructive Sleep Apnea Syndrome|A Randomized Controlled Study to Examine the Effect of Home-based Recovery Activity in Moderate to Severe Obstructive Sleep Apnea Syndrome Patients|Unknown status|Recruiting|N/A|120|Anticipated|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-10 23:52:05.610104|2017-10-10 23:52:05.610104
NCT02278081|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-10-27|||January 2015||2015-01-01|October 2014|2014-10-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|Pale Turbinate||The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate|The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate. A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 4|98|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-10 23:52:05.828962|2017-10-10 23:52:05.828962
NCT02278068|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-03-21|||October 2014||2014-10-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy|A First in Human (FIH) Clinical Study to Assess Safety and Performance of Hepatic Sympathetic Denervation for Treatment of Inadequately Controlled Type 2 Diabetic Subjects on Oral Antihyperglycemic Agents.|Active, not recruiting||N/A|30|Anticipated|Metavention||1|||f||||t||||||||||2017-10-10 23:52:05.923627|2017-10-10 23:52:05.923627
NCT02278055|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2017-02-02|||October 8, 2014|Actual|2014-10-08|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer|Phase II Open, Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 2|63|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:52:06.020804|2017-10-10 23:52:06.020804
NCT02278042|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-04-09|||June 2013||2013-06-01|April 2015|2015-04-01||||March 2015|Actual|2015-03-01||Interventional|||A Comparison of the Neurocognitive and Metabolic Effects of Fructose, Glucose, High Fructose Corn Syrup and Sucrose at Normal Population Consumed Levels in Adults Ages 20-60 Years Old||Completed||N/A|225|Anticipated|Rippe Lifestyle Institute||5|||f||||f||||||||||2017-10-10 23:52:06.13501|2017-10-10 23:52:06.13501
NCT02278029|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-09-27|||October 2014||2014-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Driving Performance of Teenage Patients With mTBI: a Longitudinal Assessment|Driving Performance of Teenage Patients With mTBI: a Longitudinal Assessment|Completed||N/A|60|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||t||||||||No||2017-10-10 23:52:06.215662|2017-10-10 23:52:06.215662
NCT02278016|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-12-31|||August 2014||2014-08-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01|1 Year|Observational [Patient Registry]|||Biological Markers for the Diagnosis of Central Nervous System Infective Diseases|Diagnosis Value of Procalcitonin, Interleukin-6, AgiotensininⅡin the Cerebrospinal Fluid of Patients With Central Nervous System Infective Diseases|Recruiting||N/A|150|Anticipated|Xijing Hospital|||1||f||||t||||||Samples Without DNA|"     procalcitonin,interleukin-6,agiotensininⅡ   "|||2017-10-10 23:52:06.28375|2017-10-10 23:52:06.28375
NCT02278003|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-06-09|||February 2012|Actual|2012-02-01|June 2017|2017-06-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|||A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients|A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients|Completed||N/A|69|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:52:06.355543|2017-10-10 23:52:06.355543
NCT02277990|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-08-31|||January 2015||2015-01-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|WRAP-IT||World-wide Randomized Antibiotic Envelope Infection Prevention Trial|Cardiovascular Implantable Electronic Device (CIED) Antibiotic Envelope Infection Prevention Trial|Active, not recruiting||Phase 4|7764|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||t||||||||||2017-10-10 23:52:06.481365|2017-10-10 23:52:06.481365
NCT02277626|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-12-07|2015-08-13||April 2012||2012-04-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|EF/Vest||Electro Flo 5000 and Vest Therapy|Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and Vest Therapy in|Completed||Phase 4|15|Actual|Stanford University||2|||f||||f||||||||||2017-10-10 23:52:10.713365|2017-10-10 23:52:10.713365
NCT02277977|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-27|||November 2014||2014-11-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Evaluation of Impaired Microcirculation During Septic Shock With Contrast Enhanced Ultrasound|Messung Von Mikrozirkulationsstörungen im Septischen Schock Mit Kontrastmittel- verstärkter Sonographie Evaluation of Impaired Microcirculation During Septic Shock With Contrast Enhanced Ultrasound|Unknown status|Not yet recruiting|N/A|24|Anticipated|University Hospital Freiburg||1|||f||||f||||||||||2017-10-10 23:52:07.035981|2017-10-10 23:52:07.035981
NCT02277964|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-09-13|||March 2012||2012-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Disease Control in RRMS Transferring Treatment From Natalizumab to Fingolimod|An Observational Study to Evaluate Disease Control, Safety and Immunological Changes in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Transferred From Previous Treatment With Natalizumab to Fingolimod.|Completed||N/A|25|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     -  assess alterations of the composition of myeloid cells and lymphocyte subpopulations          (i.e. naïve, central memory and effector memory and regulatory T cells, B cells) and          adhesion molecule expression in peripheral blood        -  measure autoantigen specific T cell proliferation and IFNγ production        -  characterize transcriptomic alterations (including mRNA and small non-coding RNA          expression) in lymphocytes of MS-patients        -  assess changes in plasma cytokine, chemokine, and Matrix metallo-proteinase levels        -  assess the migratory capacity of PBMCs   "|||2017-10-10 23:52:07.131113|2017-10-10 23:52:07.131113
NCT02277951|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-27|||May 2014||2014-05-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|IDR||Intubation During Resuscitation|Comparison of Four Types of Laryngoscope for Tracheal Intubation During Chest Compressions|Completed||N/A|141|Actual|International Institute of Rescue Research and Education|||1||f||||f||||||||||2017-10-10 23:52:07.220781|2017-10-10 23:52:07.220781
NCT02277938|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-05-09|||August 2013||2013-08-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Acetylamantadine Excretion by Cancer Patients|Urinary Excretion of Acetylamantadine by Cancer Patients|Recruiting||Phase 2|120|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-10-10 23:52:07.302666|2017-10-10 23:52:07.302666
NCT02277925|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-06-26|||December 2014||2014-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|PACT||Permanent Versus Absorbable Colpopexy Trial|Permanent Versus Delayed-absorbable Monofilament Suture for Vaginal Graft Attachment During Minimally-invasive Total Hysterectomy and Sacrocolpopexy: A Randomized Clinical Trial|Recruiting||Phase 4|200|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 23:52:07.451066|2017-10-10 23:52:07.451066
NCT02277912|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-27|||June 2013||2013-06-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|||Efficacy of Transcranial Magnetic Stimulation (TMS) in Central Post Stroke Pain ( CPSP)|Efficacy of Navigated Repetitive Transcranial Magnetic Stimulation in Treatment of Central Post Stroke Pain|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Helsinki University Central Hospital||3|||f||||f||||||||||2017-10-10 23:52:07.572492|2017-10-10 23:52:07.572492
NCT02277899|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2015-07-02|||September 2014||2014-09-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Primary Care, Communication, and Improving Children's Health|Primary Care, Communication, and Improving Children's Health|Unknown status|Recruiting|N/A|85|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-10 23:52:07.664125|2017-10-10 23:52:07.664125
NCT02277886|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-11-18|||November 2014||2014-11-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances|Clinical Trial: Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and GERD-related Sleep Disturbances in Patients With Erosive GERD|Unknown status|Recruiting|Phase 4|340|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-10 23:52:07.756147|2017-10-10 23:52:07.756147
NCT02277873|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-10-28|||January 2009||2009-01-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|June 2013|Actual|2013-06-01||Observational|||Models for Evaluate the Proximity of the Moon on the Frequency of Births|Two Models for Evaluate the Effect of the Proximity of the Moon on the Frequency of Births. Study on Mexican Population|Completed||N/A|25152|Actual|Hospital General de Mexico|||1||f||||f||||||||||2017-10-10 23:52:07.861985|2017-10-10 23:52:07.861985
NCT02277860|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-08-31|||May 2015||2015-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gaming Console Home-Based Exercise for Adults With Cystic Fibrosis|Gaming Console Home-Based Exercise for Adults With Cystic Fibrosis|Recruiting||N/A|6|Anticipated|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-10 23:52:07.935364|2017-10-10 23:52:07.935364
NCT02277847|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-10-27|||March 2010||2010-03-01|October 2014|2014-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia|A Phase IV, Randomized Study to Evaluate the Safety and Efficacy of Idarubicin at Different Dosages Combined With Cytarabine as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia|Unknown status|Enrolling by invitation|Phase 4|400|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-10-10 23:52:08.014972|2017-10-10 23:52:08.014972
NCT02277834|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-05-11|||August 2014||2014-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice|Characterizing the Pancreatic Adenocarcinoma Proteome From Pancreatic Juice|Completed||N/A|9|Actual|University of Alabama at Birmingham|||3||f||||f||||||Samples Without DNA|"     samples will be in 3 differant cohorts;        1. Subject with biopsy-proven Pancreatic Adenocarcinoma of the pancreas        2. Subjects witha diagnosis of Pancreatitis        3. Subject with NO pancreatic abnormality   "|No||2017-10-10 23:52:08.098787|2017-10-10 23:52:08.098787
NCT02277821|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-05-21|||October 2014||2014-10-01|October 2014|2014-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Evaluation of Stendo Pulsating Suit on Microcirculation and Central Blood Pressure in Essential Hypertension Patients|Evaluation of the Action of the Stendo Pulsating Suit on Peripheral Microcirculation and on Central Blood Pressure in Essential Hypertension Patients Treated But Not Stabilized|Unknown status|Recruiting|N/A|24|Anticipated|Stendo||1|||f||||t||||||||||2017-10-10 23:52:08.285444|2017-10-10 23:52:08.285444
NCT02277808|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-28|||December 2013||2013-12-01|October 2014|2014-10-01||||October 2014|Actual|2014-10-01||Interventional|||Which Apparatus for Inhaled Pentamidine?|Which Apparatus for Inhaled Pentamidine? A Comparison of Drug Delivery to the Lung Between Two Nebulizers: The Respirgard II and the Isoneb.|Unknown status|Recruiting|Early Phase 1|10|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-10 23:52:08.384856|2017-10-10 23:52:08.384856
NCT02277795|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-07-20|||February 2015||2015-02-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of the AccuCirc for Early Infant Male Circumcision in Nyanza, Kenya|Evaluation of the AccuCirc for Early Infant Male Circumcision in Nyanza, Kenya|Unknown status|Recruiting|N/A|600|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-10 23:52:08.47974|2017-10-10 23:52:08.47974
NCT02277782|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-12-23|||September 2015||2015-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|LITH||Intrathecal Hydromorphone for Labor Analgesia|Intrathecal Hydromorphone for Labor Analgesia|Recruiting||N/A|130|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-10 23:52:08.588011|2017-10-10 23:52:08.588011
NCT02277730|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-08-10|||May 2013||2013-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DIVA||A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability|A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability to Improve Perioperative Outcome During Spinal Anaesthesia for Caesarean Section|Active, not recruiting||Phase 2/Phase 3|252|Actual|KK Women's and Children's Hospital||2|||f||||f||||||||||2017-10-10 23:52:09.374244|2017-10-10 23:52:09.374244
NCT02277717|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-22|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients|A Two Part First-in-human Phase I Study (With Expanded Cohorts) With the Antibody-drug Conjugate SYD985 to Evaluate the Safety, Pharmacokinetics and Efficacy in Patients With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|160|Anticipated|Synthon Biopharmaceuticals BV||1|||f||||t||||||||||2017-10-10 23:52:09.465711|2017-10-10 23:52:09.465711
NCT02277704|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-03-24|||October 2014||2014-10-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|June 2016|Anticipated|2016-06-01||Interventional|AtEase||Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions|"A Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken at Bedtime in Subjects With Military-Related PTSD and Related Conditions (Protocol No. TNX-CY-P201) -AtEase STUDY"|Active, not recruiting||Phase 2|247|Actual|Tonix Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-10 23:52:09.607749|2017-10-10 23:52:09.607749
NCT02277691|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-06-26|2017-04-06||November 7, 2014|Actual|2014-11-07|June 2017|2017-06-01|April 25, 2016|Actual|2016-04-25|April 25, 2016|Actual|2016-04-25||Interventional||Randomized set included all randomized participants.|A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension|A Phase 3, Open-label, Multicenter, Long-term Study to Evaluate the Safety and Efficacy of TAK-536, Amlodipine and Hydrochlorothiazide in Subjects With Essential Hypertension|Completed||Phase 3|341|Actual|Takeda||1|||f||||f|f|f||||||||2017-10-10 23:52:09.766792|2017-10-10 23:52:09.766792
NCT02277678|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2015-09-03|||August 2013||2013-08-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Epidural Oxycodone and Epidural Morphine|Comparison of Epidural Oxycodone and Epidural Morphine for Post Caesarean Section Analgesia: a Randomised Controlled Trial|Completed||Phase 3|100|Actual|KK Women's and Children's Hospital||2|||f||||f||||||||||2017-10-10 23:52:10.38905|2017-10-10 23:52:10.38905
NCT02277665|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-12-12|||December 2014||2014-12-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|January 2017|Anticipated|2017-01-01||Interventional|RCTTM||Clinical Trial Tobacco Marijuana|Randomized Trial Evaluating Treatment for Cannabis Use Disorders Among Those Who Use Tobacco|Active, not recruiting||Phase 1|67|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 23:52:10.471794|2017-10-10 23:52:10.471794
NCT02277652|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2014-11-11|||October 2014||2014-10-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|ETID||Endotracheal Intubation Devices|Comparison of Four Different Endotracheal Intubation Devices Performed by Emergency Medical Professionals: a Manikin Study With 6 Airway Scenarios|Unknown status|Recruiting|N/A|120|Anticipated|International Institute of Rescue Research and Education||6|||f||||t||||||||||2017-10-10 23:52:10.55926|2017-10-10 23:52:10.55926
NCT02277613|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-11-03|||June 2015||2015-06-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|MI-NSTEMI||A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction|A Phase 2 Prospective, Randomized, Double-blind, Sham-controlled, Parallel-group, Multi-center Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction|Recruiting||Phase 2|90|Anticipated|Athersys, Inc||2|||f||||t||||||||||2017-10-10 23:52:11.033138|2017-10-10 23:52:11.033138
NCT02277600|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-07-25|||November 5, 2014|Actual|2014-11-05|July 2017|2017-07-01|January 12, 2015|Actual|2015-01-12|January 12, 2015|Actual|2015-01-12||Interventional|||A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)|Open-Label, Single-Sequence, Two-Cohort Study to Evaluate the Effect of Darunavir/Cobicistat and Cobicistat on BMS-626529 in Healthy Subjects|Completed||Phase 1|32|Actual|ViiV Healthcare||2|||f||||f|t|f||||||||2017-10-10 23:52:11.151477|2017-10-10 23:52:11.151477
NCT02277587|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-06-26|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|DREAM||Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)|A Randomized, Controlled, Multi-Centre Trial on the Effects of Dual-release Hydrocortisone Preparations Versus Conventional Glucocorticoid Replacement Therapy in Patients Affected by Primary and Secondary Adrenal Insufficiency. DREAM Trial.|Completed||Phase 4|89|Actual|University of Roma La Sapienza||3|||f||||f||||||||||2017-10-10 23:52:11.249355|2017-10-10 23:52:11.249355
NCT02277574|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-11-17|||June 2014||2014-06-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Interventional|||Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis|A Randomized, Multi-Dose, Placebo-Controlled, Study of the Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis|Completed||Phase 1|29|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-10 23:52:11.35524|2017-10-10 23:52:11.35524
NCT02277561|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-27|||April 2013||2013-04-01|October 2014|2014-10-01||||April 2016|Anticipated|2016-04-01||Interventional|||Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery|Prediction of Response of Brain Metastases to Brain Irradiation Using Voxel Based Diffusion Tensor Imaging|Unknown status|Recruiting|N/A|44|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-10 23:52:11.46453|2017-10-10 23:52:11.46453
NCT02277548|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-07-31|||May 2014||2014-05-01|July 2017|2017-07-01||||April 2018|Anticipated|2018-04-01||Interventional|||A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.|A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.|Recruiting||N/A|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:52:11.591821|2017-10-10 23:52:11.591821
NCT02277535|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-01-31|||December 2014||2014-12-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||An Email Intervention to Prevent Iatrogenic Malnutrition in the ICU|An Email Intervention to Prevent Iatrogenic Malnutrition in the ICU|Completed||N/A|197|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:52:11.687347|2017-10-10 23:52:11.687347
NCT02277522|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-07-11|||October 2014||2014-10-01|July 2017|2017-07-01|June 27, 2017|Actual|2017-06-27|November 2016|Actual|2016-11-01||Interventional|||CD19 Redirected Autologous T Cells for Hodgkin Lymphoma|Pilot Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Linked to TCRζ and 4-1BB Signaling Domains in Patients With Chemotherapy Relapsed or Refractory Hodgkin Lymphoma|Terminated||Early Phase 1|4|Actual|University of Pennsylvania||1||unable to meet enrollment goal|f||||t||||||||||2017-10-10 23:52:11.768473|2017-10-10 23:52:11.768473
NCT02277509|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-27|||April 2012||2012-04-01|October 2014|2014-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Chinese Diabetes Prevention Program (Chinese DPP)|Chinese Diabetes Prevention Program: An Implementation and Dissemination Study|Suspended||N/A|435|Anticipated|Albert Einstein College of Medicine, Inc.||2||Completed pilot and larger scale trial requires additional funding.|f||||t||||||||||2017-10-10 23:52:11.848604|2017-10-10 23:52:11.848604
NCT02277496|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-06-27|||July 2013|Actual|2013-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Wellness Program Implementation: School & Student Toolkits|Wellness Program Implementation: School & Student Toolkits|Active, not recruiting||N/A|14520|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-10 23:52:11.94981|2017-10-10 23:52:11.94981
NCT02277483|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-06-21|||October 2014||2014-10-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|korLAIS||Efficacy and Safety of LAIS® Mites Sublingual Tablets|Efficacy and Safety of LAIS® Mites Sublingual Tablets in Patients Aged Over 60 Years Suffering From House Dust Mite-induced Allergic Rhino-conjunctivitis With/Without Asthma|Unknown status|Recruiting|Phase 4|45|Anticipated|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-10 23:52:12.06694|2017-10-10 23:52:12.06694
NCT02277470|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-07-02|||August 2014||2014-08-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|GO-KINETIC||Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis|Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis|Unknown status|Recruiting|N/A|20|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     Stool samples and blood samples.   "|||2017-10-10 23:52:12.189035|2017-10-10 23:52:12.189035
NCT02277457|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-06-23|||September 2015||2015-09-01|June 2016|2016-06-01||||June 2021|Anticipated|2021-06-01||Interventional|||Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations|Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations|Withdrawn||Early Phase 1|0|Actual|University of Michigan Cancer Center||2|||f||||f||||||||||2017-10-10 23:52:12.329411|2017-10-10 23:52:12.329411
NCT02277262|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-25|||October 2014||2014-10-01|October 2014|2014-10-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Interventional|PROPHYBIOM||PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM)||Recruiting||Phase 4|90|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||||||||||||2017-10-10 23:52:13.712962|2017-10-10 23:52:13.712962
NCT02277444|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2017-10-03|||December 17, 2014|Actual|2014-12-17|October 2017|2017-10-01|February 21, 2023|Anticipated|2023-02-21|June 28, 2018|Anticipated|2018-06-28||Interventional|GO-VIVA||A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy|A Multicenter, Open-Label Trial of Intravenous Golimumab, a Human Anti-TNFα Antibody, in Pediatric Subjects With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy|Recruiting||Phase 3|120|Anticipated|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-10 23:52:12.4769|2017-10-10 23:52:12.4769
NCT02277431|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-10-28|||December 2014||2014-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms|A Randomized Controlled Trial of a Commercially-Available Probiotic Supplement (Trenev Trio®/Healthy Trinity®) and the Promotion of Normal Gastrointestinal Function Among Adults With Recurrent Gastrointestinal Symptoms|Completed||Phase 2/Phase 3|80|Actual|University of Maryland||2|||f||||f||||||||||2017-10-10 23:52:12.701388|2017-10-10 23:52:12.701388
NCT02277418|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-11-13|||October 2014||2014-10-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|VAVL||Venner a.p. Advance Video Laryngoscope|Intubation of Child and Infant Manikins During Resuscitation. Does the Venner™ A.P. Advance™ Video Laryngoscope Improve Nurses' Performance?|Completed||N/A|112|Actual|International Institute of Rescue Research and Education||4|||f||||t||||||||||2017-10-10 23:52:12.781121|2017-10-10 23:52:12.781121
NCT02277405|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-27|||October 2014||2014-10-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|PIDR||Pediatric Intubation During Resuscitation|A Comparison of Endotracheal Intubation Using the Shikani Optical Stylet or the Endoeye Flexible Intubation During Pediatric Resuscitation|Unknown status|Recruiting|N/A|150|Anticipated|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:52:12.864772|2017-10-10 23:52:12.864772
NCT02277392|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2016-12-06|||September 2014||2014-09-01|December 2016|2016-12-01||||June 2015|Actual|2015-06-01||Interventional|||A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer|A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Withdrawn||Phase 1|0|Actual|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 23:52:12.938975|2017-10-10 23:52:12.938975
NCT02277379|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2015-01-08|||September 2014||2014-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery|Prediction of Bleeding Outcomes / Transfusion Requirements and Assessment of Perioperative Changes in Platelet Reactivity Using Point-of-care Platelet Function Testing in Patients Undergoing Cardiac Surgery|Completed||N/A|113|Actual|University of Zagreb|||1||f||||f||||||||||2017-10-10 23:52:12.99579|2017-10-10 23:52:12.99579
NCT02277366|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-11-13|||May 2015||2015-05-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population|A Multi-center Randomized Control Study of Bronchoscopy in Early Lung Cancer Screening of High Risk Population|Terminated||N/A|400|Actual|Tang-Du Hospital|||2|"We have recruited some patients, but we haven't found any significant result by bronchoscopy in   the high risk population."|f||||t||||||||||2017-10-10 23:52:13.05244|2017-10-10 23:52:13.05244
NCT02277353|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-07-20|||October 2014||2014-10-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Evaluation of SVV From NICOM as a Predictor of Fluid Responsiveness in Prone Position During Spine Surgery|Evaluation of Stroke Volume Variation Derived From NICOM as a Predictor of Fluid Responsiveness in Prone Position During Spine Surgery|Completed||N/A|40|Actual|Samsung Medical Center|||1||f||||t||||||||||2017-10-10 23:52:13.122315|2017-10-10 23:52:13.122315
NCT02277340|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-26|||February 2014||2014-02-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|EPSITCRYSP||Endoscopic Pilonidal Sinus Treatment With Additional Crystalized Phenol|Endoscopic Treatment of Pilonidal Sinus May Decrease the Recurrence After Crystallized Phenol Application|Completed||Phase 1|23|Actual|Ankara University||1|||f||||f||||||||||2017-10-10 23:52:13.184966|2017-10-10 23:52:13.184966
NCT02277327|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-02-08|||November 2014||2014-11-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Trial to Reduce Hospitalizations in Children With Medical Complexity|Randomized Controlled Trial to Decrease Admission Rates in Medically Complex Children in a Medical Home Program|Active, not recruiting||Phase 2|200|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-10 23:52:13.257405|2017-10-10 23:52:13.257405
NCT02277314|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-01-11|||April 2014||2014-04-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|MSICS||Manual Small Incision Cataract Surgery Outcomes in an Educational Setting|Manual Small Incision Cataract Surgery Outcomes in an Educational Setting|Recruiting||N/A|100|Anticipated|University of Arizona||1|||f||||f||||||||||2017-10-10 23:52:13.329899|2017-10-10 23:52:13.329899
NCT02277301|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-10-24|||August 2014||2014-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Mellow Babies - a Pilot Waiting List Trial|Mellow Babies - a Pilot Waiting List Trial|Completed||Phase 1/Phase 2|45|Actual|University of Aberdeen||2|||f||||t||||||||No||2017-10-10 23:52:13.403312|2017-10-10 23:52:13.403312
NCT02277288|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-07-28|||December 2011||2011-12-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Does Bladder Instillation Reduce Time to Discharge After Sling Surgery|Does Intraoperative Bladder Instillation Decrease Outpatient Recovery Time After Mid-Urethral Sling|Unknown status|Recruiting|N/A|250|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-10 23:52:13.530331|2017-10-10 23:52:13.530331
NCT02277275|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2017-09-16|||August 2014||2014-08-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Different Weight Loss Diets With Different Protein Content|Effects of a BCAA-supplemented Hypocaloric Diet Versus a Standard Hypocaloric Diet on Weight Loss, Lean Mass Preservation and Improvement of Insulin Sensitivityand Its Benefits Over a High-protein Hypo-caloric Diet.|Recruiting||N/A|132|Anticipated|National University, Singapore||3|||f||||f||||||||||2017-10-10 23:52:13.61879|2017-10-10 23:52:13.61879
NCT02277249|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-11-28|2016-02-08||October 2012||2012-10-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion|Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion: a Pilot Study of Patient Preference|Completed||N/A|60|Actual|University of California, Los Angeles|There was crossover between treatment arms (4 subjects in the transvaginal group received transabdominal digoxin). This study is limited by its small sample size and attendant statistical power.|2|||f||||f||||||||||2017-10-10 23:52:13.811418|2017-10-10 23:52:13.811418
NCT02277236|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2017-05-10|||October 2014||2014-10-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|ARMS||Screening for Age-Related Skeletal Muscle Dysfunction|Creating a Model of Proactive Geriatric Care Within VISN 5: Screening for Age-Related Skeletal Muscle Dysfunction at the Washington DC VA Medical Center|Active, not recruiting||N/A|30|Actual|Washington D.C. Veterans Affairs Medical Center|||2||f||||f||||||Samples Without DNA|"     Blood samples will be collected for determination of lipid profiles, fasting insulin and     glucose levels, the oral glucose tolerance test, and selected cytokines (IL-6 and TNF-α).   "|||2017-10-10 23:52:14.034378|2017-10-10 23:52:14.034378
NCT02277223|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2017-10-03|||December 1, 2017|Anticipated|2017-12-01|October 2017|2017-10-01|December 1, 2019|Anticipated|2019-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Curcumin in Pediatric Ulcerative Colitis|Curcumin for Induction and Maintenance Therapy in Pediatric Ulcerative Colitis|Not yet recruiting||Phase 3|60|Anticipated|Schneider Children's Medical Center, Israel||2|||f||||t|f|f||||||||2017-10-10 23:52:14.120677|2017-10-10 23:52:14.120677
NCT02277210|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2017-05-02|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|October 2019|Anticipated|2019-10-01||Interventional|||Follicular Flushing in Patients With Suboptimal Responses|Effect of Follicular Flushing on the Ongoing Pregnancy Rate in Patients Who Developed Four or Fewer Follicles of 14mm Following Standard Ovarian Stimulation for In-vitro Fertilization Treatment - A Randomized Controlled Trial.|Active, not recruiting||N/A|170|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:52:14.199948|2017-10-10 23:52:14.199948
NCT02277197|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2016-09-08|||August 2015||2015-08-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)|A Phase 1b Study of Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Biomarker Correlatives|Active, not recruiting||Phase 1|14|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:52:14.263338|2017-10-10 23:52:14.263338
NCT02277184|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2016-09-12|||September 2015||2015-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma|A Phase 1b Study of Ficlatuzumab, Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Intermediate or High Risk, Previously Untreated, Locally Advanced Head and Neck Squamous Cell Carcinoma With Biomarker Correlatives|Terminated||Phase 1|1|Actual|University of Pittsburgh||1||the investigator left the institution|f||||t||||||||||2017-10-10 23:52:14.357|2017-10-10 23:52:14.357
NCT02277171|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2015-12-23|||December 2014||2014-12-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Evaluation of Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters|Prospective, Phase I, Single-Center, Evaluation of the Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters in Patients Undergoing Radical Prostatectomy|Completed||Phase 1|15|Actual|Enox Israel Ltd||1|||f||||f||||||||||2017-10-10 23:52:16.247238|2017-10-10 23:52:16.247238
NCT02277158|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-11-30|||November 2014||2014-11-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.|A Phase I Study of Concurrent Radiotherapy and Tegafur, Gimeracil and Oteracil Potassium Capsule(S-1) as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.|Unknown status|Recruiting|Phase 1|18|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||1|||f||||f||||||||||2017-10-10 23:52:16.317553|2017-10-10 23:52:16.317553
NCT02277145|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-02-07|||October 2014||2014-10-01|October 2016|2016-10-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells|Phase I Study of Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells|Active, not recruiting||Phase 1|14|Anticipated|Chinese Academy of Sciences||1|||f||||f||||||||||2017-10-10 23:52:16.390687|2017-10-10 23:52:16.390687
NCT02277132|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-07-13|||January 2015||2015-01-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|STRIDER||The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)|The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)|Recruiting||Phase 2/Phase 3|354|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-10 23:52:16.487254|2017-10-10 23:52:16.487254
NCT02277119|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-09-14|2016-05-31||October 2014||2014-10-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Clinical Study of the Optic Disc Parameters|Topcon 3D OCT-1 Maestro Optic Disc and RNFL Study: Agreement and Repeatability Comparison With the iVue|Completed||N/A|109|Actual|Topcon Medical Systems, Inc.||3|||f||||f||||||||No||2017-10-10 23:52:16.621846|2017-10-10 23:52:16.621846
NCT02277106|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-04-25||2017-04-25|September 2014||2014-09-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Evaluate SAGE-547 in Patients With Essential Tremor|A Double-blind, Placebo-controlled, Two-Period Crossover Proof-of-Concept Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-547 Injection in the Treatment of Patients With Essential Tremor|Completed||Phase 2|24|Actual|Sage Therapeutics||2|||f||||f||||||||||2017-10-10 23:52:16.996658|2017-10-10 23:52:16.996658
NCT02277093|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-04-27|2017-03-16||September 22, 2015|Actual|2015-09-22|April 2017|2017-04-01|October 27, 2016|Actual|2016-10-27|March 31, 2016|Actual|2016-03-31||Interventional|||Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer|Phase II Study With Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer|Terminated||Phase 2|11|Actual|Washington University School of Medicine|Please note that the study ended early due to the FDA issuing a clinical hold as pacritinib had increased side effects.|1||FDA issued a clinical hold as pacritinib had increased side effects|f||||t|t|f||||||No||2017-10-10 23:52:17.200102|2017-10-10 23:52:17.200102
NCT02277080|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-09-27|||October 2014|Actual|2014-10-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|January 2018|Anticipated|2018-01-01||Observational|||The Immune and Endocrine Systems in Chronic Non-cancer Patients Treated With Opioids|The Immune and Endocrine Systems in Chronic Non-cancer Patients Treated With Opioids: Effects on Cognition, Pain and Quality of Life|Enrolling by invitation||N/A|80|Anticipated|Rigshospitalet, Denmark|||2||f||||f||||||Samples With DNA|"     whole blood/serum   "|||2017-10-10 23:52:17.551197|2017-10-10 23:52:17.551197
NCT02277067|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PPH||Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.|Carbetocin Versus Misoprostol for Prevention of Postpartum Hemorrhage in Pregnant Women at High Risk Following C.S.|Recruiting||Phase 4|200|Anticipated|Beni-Suef University||2|||f||||t||||||||||2017-10-10 23:52:17.63292|2017-10-10 23:52:17.63292
NCT02277054|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-05-05|||March 2013||2013-03-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Effectiveness of Collagen-phosphorylcholine Bioengineered Cornea in Patients Requiring Lamellar Keratoplasty|A Clinical Trial to Evaluate the Safety and Effectiveness of the Collagen-phosphorylcholine Corneal Substitutes in Patients Requiring Lamellar Keratoplasty|Completed||N/A|5|Actual|The Filatov Institute of Eye Diseases and Tissue Therapy||1|||f||||f|f|f||||||No||2017-10-10 23:52:17.752599|2017-10-10 23:52:17.752599
NCT02277041|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PPH||Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.|Carbetocin Versus Misoprostol for Prevention of Postpartum Hemorrhage in Cases With Placenta Previa After C.S.|Recruiting||Phase 4|200|Anticipated|Beni-Suef University||2|||f||||t||||||||||2017-10-10 23:52:17.829278|2017-10-10 23:52:17.829278
NCT02277028|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-05-23|||April 2014||2014-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Bilateral Priming for Upper Extremity Hemiparesis in Older Adults|A Comparison of Two Types of Priming for Upper Extremity Hemiparesis|Completed||N/A|18|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-10 23:52:17.927947|2017-10-10 23:52:17.927947
NCT02277015|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-26|2014-11-11|||October 2014||2014-10-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Intubation During Pediatric Resuscitation|Pediatric Tracheal Intubation Using Four Video-laryngoscopes and the Miller Laryngoscope With and Without Chest Compressions|Unknown status|Enrolling by invitation|N/A|94|Actual|International Institute of Rescue Research and Education||2|||f||||t||||||||||2017-10-10 23:52:18.003549|2017-10-10 23:52:18.003549
NCT02277002|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-02-26|||October 2014||2014-10-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|CAPI||Commuter Air Pollution Intervention Study|Reducing Commuter Air Pollutant Exposure by Cabin Air Filtration|Completed||N/A|48|Actual|Health Canada||2|||f||||||||||||||2017-10-10 23:52:18.10917|2017-10-10 23:52:18.10917
NCT02276989|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-02-08|||December 2014||2014-12-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain|Evaluation of a Compliance Marker A Supplement to: U01DA029580-02 Opioid-Induced Hyperalgesia In Prescription Opioid Abusers: Effects of Pregabalin|Withdrawn||Phase 2|0|Actual|Georgetown University||1||poor recruitment|f||||t||||||||||2017-10-10 23:52:18.196205|2017-10-10 23:52:18.196205
NCT02276976|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2015-12-11|||March 2014||2014-03-01|December 2015|2015-12-01|September 2019|Anticipated|2019-09-01|February 2016|Anticipated|2016-02-01||Observational|||MRI,Gene And Cognitive Performance Study of Patients With Cerebral White Matter Lesions(WMLs)|MRI,Gene And Cognitive Performance Study of Patients With Cerebral White Matter Lesions|Recruiting||N/A|200|Anticipated|Huazhong University of Science and Technology|||2||f||||t||||||Samples With DNA|"     DNA extracted from whole blood sample   "|||2017-10-10 23:52:18.280572|2017-10-10 23:52:18.280572
NCT02276963|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-15|||September 2015||2015-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|||Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses|Phase I, Single-Center, Open Label Trial of Ublituximab + Glucocorticoids for the Treatment of Acute Optic Neuritis and/or Transverse Myelitis in Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)|Active, not recruiting||Phase 1|5|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 23:52:18.365399|2017-10-10 23:52:18.365399
NCT02276950|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-25|2017-09-26|||January 2011||2011-01-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Observational|HARTROCS||HeAlth-data Register sTudies of Risk and Outcomes in Cardiac Surgery|HeAlth-data Register sTudies of Risk and Outcomes in Cardiac Surgery (HARTROCS)|Active, not recruiting||N/A|150000|Anticipated|Karolinska University Hospital|||1||f||||f||||||||||2017-10-10 23:52:18.45729|2017-10-10 23:52:18.45729
NCT02276937|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-09-01|||October 2014||2014-10-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Randomized Phase IIb Trial of DVC1-0101|DVC1-0101 for Intermittent Claudication Secondary to Peripheral Artery Disease: a Randomized Phase IIb Trial|Unknown status|Recruiting|Phase 2|60|Anticipated|Kyushu University||3|||f||||t||||||||||2017-10-10 23:52:18.533489|2017-10-10 23:52:18.533489
NCT02276924|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-09-19|||October 2013||2013-10-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|UROVISIO||Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors|Diagnostic Relevance of Laser Confocal Microscopy During Reno-ureteroscopy in the Context of the Screening and Follow-up of Upper Urinary Tract Tumors|Active, not recruiting||N/A|29|Actual|Lille Catholic University||1|||f||||f||||||||||2017-10-10 23:52:18.63255|2017-10-10 23:52:18.63255
NCT02276911|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-08-25|||March 2015||2015-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy of Pre-incisional Intravenous Ibuprofen to Reduce Postoperative Pain and Opioid Dependence After Posterior Cervical or Lumbar Instrumented Spine Surgery|Safety and Efficacy of Pre-incisional Intravenous Ibuprofen to Reduce Postoperative Pain and Opioid Dependence After Posterior Cervical or Lumbar Instrumented Spine Surgery|Recruiting||Phase 2|50|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||f||||||||||2017-10-10 23:52:18.728482|2017-10-10 23:52:18.728482
NCT02276716|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-02-24|||November 2011||2011-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia|The Nutritional Supplement Phosphatidylserine in Patients With Familial|Recruiting||Phase 2|15|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 23:52:20.331113|2017-10-10 23:52:20.331113
NCT02276898|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-05-20|||November 2011||2011-11-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index|A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index as a Short-term Pharmacodynamic Biomarker in Patients With Cystic Fibrosis.|Completed||Phase 2|24|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-10 23:52:18.820875|2017-10-10 23:52:18.820875
NCT02276885|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2016-12-30|||August 2014||2014-08-01|December 2016|2016-12-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial|Prone Partial Breast Irradiation (PBI): A Prospective Randomized Trial Comparing Five Versus Three Fractions|Recruiting||N/A|284|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 23:52:19.049414|2017-10-10 23:52:19.049414
NCT02276872|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-01|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|||Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years|A Multicenter, Open-Label, 24-Week, Uncontrolled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil Extended Release Tablets Following Transition From Remodulin or Inhaled Prostacyclin Therapy or as Add-on to Current PAH Therapy in De Novo Prostacyclin Pediatric Subjects Aged 7 to 17 Years With Pulmonary Arterial Hypertension|Completed||Phase 2|40|Anticipated|United Therapeutics||3|||f||||t||||||||||2017-10-10 23:52:19.150934|2017-10-10 23:52:19.150934
NCT02276859|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-09-29|||October 2014||2014-10-01|September 2014|2014-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Normal Versus Dual Wave Insulin Bolus for High-protein Food|The Optimal Type of Bolus Following a High-protein Meal in Type 1 Diabetic Children Treated With Insulin Pumps|Completed||Phase 4|70|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-10 23:52:19.259739|2017-10-10 23:52:19.259739
NCT02276846|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2014-10-27|||October 2014||2014-10-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|January 2015|Anticipated|2015-01-01|9 Months|Observational [Patient Registry]|PEBCBLO||Palpitate-Eluting Balloon Angioplasty in the Treatment of Coronary Bifurcation Lesion Evaluated by OCT|Palpitate-Eluting Balloon Angioplasty in the Treatment of Coronary Bifurcation Lesion Evaluated by OCT|Unknown status|Recruiting|N/A|30|Anticipated|Second Hospital of Jilin University|||1||f||||t||||||||||2017-10-10 23:52:19.357735|2017-10-10 23:52:19.357735
NCT02276833|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-27|||April 2013||2013-04-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Use of Autologous Adipose-Derived Stromal Vascular Fraction to Treat Osteoarthritis of the Knee|Use of Autologous Adipose-Derived Stromal Vascular Fraction to Treat Osteoarthritis of the Knee|Completed||Phase 1|6|Actual|Renew Center, San Antonio, Texas||1|||f||||f||||||||||2017-10-10 23:52:19.429696|2017-10-10 23:52:19.429696
NCT02276820|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-09-08|||October 1, 2017|Anticipated|2017-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)|A Phase I Study Using Most Closely HLA-matched Adenovirus-specific T Lymphocytes for the Treatment of Adenovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-A)|Not yet recruiting||Phase 1|10|Anticipated|ViraCyte||1|||f||||t|t|f||||||||2017-10-10 23:52:19.497964|2017-10-10 23:52:19.497964
NCT02276807|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-07-07|||March 23, 2015|Actual|2015-03-23|July 2017|2017-07-01|October 31, 2018|Anticipated|2018-10-31|June 1, 2018|Anticipated|2018-06-01||Interventional|||Improving Mood in Veterans in Primary Care|RCT of Behavioral Activation for Depression and Suicidality in Primary Care|Recruiting||N/A|144|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 23:52:19.603102|2017-10-10 23:52:19.603102
NCT02276794|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-02-14|||October 2014||2014-10-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Thrust Versus Non-thrust Manipulation in Chronic Low Back Pain|The Effects of Thrust Versus Non-thrust Manipulation on Pain, Trunk Proprioception and Postural Stability in Subjects With Chronic Low Back Pain|Terminated||N/A|23|Actual|Federal University of Health Science of Porto Alegre||2||Time and funding constraints|f||||f||||||||||2017-10-10 23:52:19.713033|2017-10-10 23:52:19.713033
NCT02276781|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-05-04|||September 2009||2009-09-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|BRAVO||BRAVO: Biomarker Risk Assessment in Vulnerable Outpatients|BRAVO: Biomarker Risk Assessment in Vulnerable Outpatients|Completed||N/A|595|Actual|Northwestern University|||1||f||||f||||||Samples With DNA|"     Blood: EDTA plasma, Citrate plasma, serum, whole blood (DNA)* and RNA*. Lower extremity     muscle biopsies*      *genetic factors and muscle biopsies are optional study elements   "|||2017-10-10 23:52:19.821774|2017-10-10 23:52:19.821774
NCT02276768|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-08-08|||October 2014||2014-10-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method|A Phase 1b Clinical Study on the Analgesic Effect of GIC-1001 and GIC-1002 on Visceral Pain Under Rectal Distension and Rectal Sensory Threshold Using the Barostat Method in Male and Female Healthy Volunteers.|Completed||Phase 1|90|Actual|gicare Pharma Inc.||5|||f||||f||||||||Undecided||2017-10-10 23:52:19.902584|2017-10-10 23:52:19.902584
NCT02276755|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-02-22|||September 2015||2015-09-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Vitamin D Suplementation in TB Prevention|Vitamin D in TB Prevention in School Age Children|Active, not recruiting||Phase 3|8020|Anticipated|Harvard School of Public Health||2|||f||||t||||||||Undecided||2017-10-10 23:52:20.03464|2017-10-10 23:52:20.03464
NCT02276742|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-12-16|||October 2014||2014-10-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|||Lifestyle Management of CKD in Obese Diabetic Patients|Lifestyle Management of CKD in Obese Diabetic Patients|Recruiting||N/A|300|Anticipated|New York University School of Medicine||4|||f||||t||||||||||2017-10-10 23:52:20.105971|2017-10-10 23:52:20.105971
NCT02276729|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-10-27|||April 2015||2015-04-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Mirror Box Therapy for Upper Limb Function With Stroke|A Pilot Randomized Controlled Trial (RCT) of Mirror Box Therapy in Upper Limb Rehabilitation With Sub-acute Stroke Patients|Recruiting||N/A|50|Anticipated|University of Ulster||2|||f||||f||||||||No||2017-10-10 23:52:20.221812|2017-10-10 23:52:20.221812
NCT02276703|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-09-14|||October 2014|Actual|2014-10-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Comparison of the Skin Conductance Values and Patient Pain Scores During Minor Procedures in the ICU|Comparison of the Skin Conductance Values and Patient Pain Scores During Minor Procedures in the ICU|Completed||N/A|30|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-10-10 23:52:20.478193|2017-10-10 23:52:20.478193
NCT02276690|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-10-05|||August 2014|Actual|2014-08-01|November 2015|2015-11-01|September 2017|Actual|2017-09-01|October 26, 2016|Actual|2016-10-26||Interventional|HEPCIDANE||Hepcidine and Iron Deficiency in Critically Ill Patients|Medical Economic Analysis of the Interest of Hepcidin Quantitation by Quantitative Mass Spectrometry for the Diagnosis of Iron Deficiency in Anemic Critically Ill Patients|Completed||N/A|408|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:52:20.553517|2017-10-10 23:52:20.553517
NCT02276677|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-07-20|||October 2014||2014-10-01|July 2017|2017-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Oxytocin Effects on Food Motivation Pathways|Oxytocin Effects on Food Motivation Pathways|Completed||Early Phase 1|10|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:52:20.654458|2017-10-10 23:52:20.654458
NCT02276664|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-05-25|||October 20, 2014|Actual|2014-10-20|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Capitalizing on a Teachable Moment to Promote Smoking Cessation|Capitalizing on a Teachable Moment to Promote Smoking Cessation|Active, not recruiting||N/A|35|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f|f|f||||||||2017-10-10 23:52:20.734262|2017-10-10 23:52:20.734262
NCT02276651|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-06-07|||November 2014||2014-11-01|June 2017|2017-06-01|June 6, 2017|Actual|2017-06-06|June 6, 2017|Actual|2017-06-06||Observational|||Observational Trial of a Therapeutic Platelet Transfusion Regimen|A Prospective Multicenter Observational Trial of a Therapeutic Platelet Transfusion Regimen for Patients With Acute Myeloid Leukemia in Consolidation Chemotherapy|Terminated||N/A|25|Actual|Klinikum Nürnberg|||1|Insufficient recruitment|f||||t||||||||||2017-10-10 23:52:20.825337|2017-10-10 23:52:20.825337
NCT02276625|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2014-10-27|||October 2014||2014-10-01|October 2014|2014-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||One-visit Multi-site Intradermal Rabies Vaccination - Dose Finding|One-visit Multi-site Pre-exposure Intradermal Rabies Vaccination: Dose Finding in Healthy Adults.|Unknown status|Recruiting|Phase 2|30|Anticipated|Leiden University Medical Center||4|||f||||f||||||||||2017-10-10 23:52:21.011009|2017-10-10 23:52:21.011009
NCT02276612|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-06-15|||December 2014||2014-12-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents|A Phase 2/3 Open-Label Study to Evaluate the Safety and Efficacy of E/C/F/TAF in HIV-1 Infected Virologically Suppressed Adolescents|Active, not recruiting||Phase 2/Phase 3|60|Actual|Gilead Sciences||1|||f||||t||||||||||2017-10-10 23:52:21.127965|2017-10-10 23:52:21.127965
NCT02276599|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-10-10|||February 2015||2015-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Prospective Investigation of Pleth Variability Index (PVI) as a Dynamic Parameter of Fluid Responsiveness in Children|A Prospective Investigation of Pleth Variability Index (PVI) as a Dynamic Parameter of Fluid Responsiveness in Children|Recruiting||N/A|20|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-10 23:52:21.253271|2017-10-10 23:52:21.253271
NCT02276586|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-23|||January 2013||2013-01-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Prospective Clinical Evaluation of Periodontal Response to Different Prosthetic Margin Design|Prospective Clinical Evaluation of Periodontal Response to Different Prosthetic Margin Design|Completed||N/A|58|Actual|University of Padova, School of Dental Medicine||2|||f||||t||||||||||2017-10-10 23:52:21.357802|2017-10-10 23:52:21.357802
NCT02276573|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2015-10-23|||March 2015||2015-03-01|July 2015|2015-07-01||||March 2016|Anticipated|2016-03-01||Interventional|LICHENVIR||Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus|Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus|Unknown status|Recruiting|N/A|15|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-10 23:52:21.452273|2017-10-10 23:52:21.452273
NCT02276560|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-03-29|2017-03-29||January 2015||2015-01-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|LCCC1407||Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC|Phase II Multicenter Trial of Neoadjuvant Cisplatin and Nab-paclitaxel for (N2) Defined Stage IIIA Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|1|Actual|UNC Lineberger Comprehensive Cancer Center||3||This study was terminated due to lack of funding.|f||||t||||||||No||2017-10-10 23:52:21.555246|2017-10-10 23:52:21.555246
NCT02276547|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-09-12|||December 2014||2014-12-01|September 2016|2016-09-01|August 2022|Anticipated|2022-08-01|August 2017|Anticipated|2017-08-01||Interventional|TIARA-I||Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System|Early Feasibility Study of the Neovasc Tiara™ Mitral Transcatheter Heart Valve With the Tiara™ Transapical Delivery System|Recruiting||N/A|30|Anticipated|Neovasc Inc.||1|||f||||t||||||||No||2017-10-10 23:52:22.128218|2017-10-10 23:52:22.128218
NCT02276534|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-06-12|||August 2014||2014-08-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)|SENSE Theatre Research Program|Completed||N/A|136|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-10 23:52:22.276742|2017-10-10 23:52:22.276742
NCT02276521|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-09-22|||February 2015||2015-02-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Evaluation of Long Term Immunity Following HPV Vaccination|Evaluation of Long-term Immunological Responses Following Reduced Dose Quadrivalent Human Papillomavirus (HPV) Vaccine Schedules: A Phase II/III Clinical Trial|Completed||Phase 2/Phase 3|200|Actual|Murdoch Childrens Research Institute|||4||f||||t||||||Samples With DNA|"     We will be collecting blood from the participants, which include the plasma and peripheral     blood mononuclear cells.   "|||2017-10-10 23:52:22.371397|2017-10-10 23:52:22.371397
NCT02276508|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-02-16|||October 2014||2014-10-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Open Label Trial of Nissle 1917|Phase 1 Open Label Trial of Nissle 1917 to Assess Safety and Tolerance in Healthy Adult Volunteers|Completed||Phase 1|20|Actual|Nationwide Children's Hospital||1|||f||||t||||||||||2017-10-10 23:52:22.501203|2017-10-10 23:52:22.501203
NCT02276495|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-02-10|||October 2014||2014-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Does Single Injection Adductor Canal Block Improve Postoperative Analgesia in Patients Receiving Periarticular Local Anesthesia Injections for Total Knee Arthroplasty?|Does Single Injection Adductor Canal Block Improve Postoperative Analgesia in Patients Receiving Periarticular Local Anesthesia Injections for Total Knee Arthroplasty?|Recruiting||N/A|90|Anticipated|University of California, Irvine||3|||f||||t||||||||||2017-10-10 23:52:22.594759|2017-10-10 23:52:22.594759
NCT02276469|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-01-01|||July 2011||2011-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|PEER||Peer Support for Severe Mental Disorders|Randomized Controlled Trial of Peer to Peer Support for People With Severe Mental Disorders: Schizophrenia, Affective Disorders and Personality Disorders in Comparison to Standard Care|Completed||N/A|200|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-10 23:52:22.926032|2017-10-10 23:52:22.926032
NCT02276456|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-12-28|||March 2014||2014-03-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Impact of Early Follow-up on Readmission Rates in AMI Patients|The Impact of Early Versus Standard Post-Discharge Follow-up on Readmission Rates in Patients Admitted With Myocardial Infarction|Recruiting||N/A|2000|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:52:23.036638|2017-10-10 23:52:23.036638
NCT02276443|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-11-21|||November 2015||2015-11-01|November 2016|2016-11-01||||November 2020|Anticipated|2020-11-01||Interventional|||Molecular Triaging and Diagnostic Imaging to Guide Neoadjuvant Therapy|Improving Outcomes in Triple-Negative Breast Cancer Using Molecular Triaging and Diagnostic Imaging to Guide Neoadjuvant Therapy|Recruiting||N/A|360|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-10 23:52:23.115979|2017-10-10 23:52:23.115979
NCT02276430|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-06-01|||July 2014||2014-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|TACkLE||TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects|A Case-cohort Study to Identify Risk Factors for Cardiovascular Disease in Testicular Cancer Survivors|Recruiting||N/A|900|Anticipated|University Medical Center Groningen|||2||f||||f||||||Samples With DNA|"     Blood samples: analysis of cardiovascular risk factors (lipid profile, glucose metabolism,     hormonal status), platinum levels and several biomarkers.      Urine samples: microalbuminuria, platinum levels. DNA: polymorphisms in candidate genes for     development of cardiovascular damage, leukocyte telomere length   "|No||2017-10-10 23:52:23.21726|2017-10-10 23:52:23.21726
NCT02276417|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-09-21|||January 2015||2015-01-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|PICS||Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care|Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care Subtitle: : Dysfunctional HDL as a Predictor of Chronic Critical Illness and Long-term Outcomes After Sepsis|Recruiting||N/A|600|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 23:52:23.333393|2017-10-10 23:52:23.333393
NCT02276404|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-11-03|||November 2014||2014-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Preoperative Relaxation Training and Acupuncture to Minimize Perioperative Symptoms in Breast Cancer Patients|Entspannung Und Akupunktur Zur Reduktion Perioperativer Symptome Bei Brustkrebspatientinnen- Eine Randomisiert-kontrollierte Interventionsstudie im Kontext Einer Integrativ Onkologischen Versorgung (EARpeS)|Recruiting||N/A|120|Anticipated|Universität Duisburg-Essen||4|||f||||f||||||||||2017-10-10 23:52:23.456054|2017-10-10 23:52:23.456054
NCT02276391|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-27|||July 2008||2008-07-01|October 2014|2014-10-01||||October 2008|Actual|2008-10-01||Interventional|||Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers|Bioequivalence of Telmisartan Administrated in Two Different Ways: Either in Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets (an Open-label, Randomised, Single-dose, Four-period Replicated Crossover Study)|Completed||Phase 1|64|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:52:23.570484|2017-10-10 23:52:23.570484
NCT02276378|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-27|||July 2008||2008-07-01|October 2014|2014-10-01||||August 2008|Actual|2008-08-01||Interventional|||Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers|Influence of Food on the Bioavailability of Telmisartan 40 mg/HCTZ 12.5 mg Fixed-dose Combination and of Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination in Japanese Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Two-way Crossover Study)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:52:23.658861|2017-10-10 23:52:23.658861
NCT02276365|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-27|||June 2009||2009-06-01|May 2014|2014-05-01||||July 2009|Actual|2009-07-01||Interventional|||Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers|Relative Bioavailability of Both BI 10773 50 mg and Pioglitazone 45 mg After Co-administration Compared to BI 10773 and Pioglitazone Alone in Healthy Male Volunteers (an Open-label, Randomised, Crossover, Clinical Phase I Study)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:52:23.761901|2017-10-10 23:52:23.761901
NCT02276352|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-27|2014-10-27|||June 1999||1999-06-01|May 2014|2014-05-01||||August 1999|Actual|1999-08-01||Interventional|||Relative Bioavailability of Meloxicam 2 x 7.5 mg Tablets Compared to 15 mg Tablet and Dose Proportionality Over a Dose Range of 7.5 mg and 15 mg in Healthy Volunteers|An Open, Randomized, Three-way Cross-over Study in Healthy Volunteers to Evaluate the Relative Bioavailability of Meloxicam After Single p.o. Administration of 2 x 7.5 mg Meloxicam Tablets Compared to 15 mg Meloxicam Tablet, and Dose-proportionality Over a Dosage Range of 7.5 mg and 15 mg.|Completed||Phase 1|18|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:52:23.847722|2017-10-10 23:52:23.847722
NCT02276339|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2015-12-02|||October 2014||2014-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Muscle Activation in Chronic Ankle Instability and the Effect of an Exercise Programme|The Role of the Peroneus Brevis and Peroneus Longus in Patients With Chronic Ankle Instability and the Effect of an Exercise Intervention|Completed||N/A|24|Actual|University College Dublin||1|||f||||f||||||||||2017-10-10 23:52:23.949962|2017-10-10 23:52:23.949962
NCT02276326|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-12-02|||July 2014||2014-07-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2016|Actual|2016-12-01||Interventional|||Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients|Title Effect of Microbial Translocation and Supplementation With the Probiotic VSL#3 on Neuro-cognitive Functions of HIV Positive Patients Receiving HAART|Recruiting||N/A|20|Anticipated|Azienda Policlinico Umberto I||1|||f||||f||||||||||2017-10-10 23:52:24.042249|2017-10-10 23:52:24.042249
NCT02276313|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-04-18|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Observational|||BIOLUX P-III All-Comers Passeo-18 Lux Registry|BIOTRONIK - A Prospective, International, Mulit-centre, Post-market All-comers Registry to Assess the Clinical Performance of the Passeo-18 Lux Paclitaxel Releasing Balloon Catheter in Infrainguinal Arteries - III|Active, not recruiting||N/A|880|Actual|Biotronik AG|||1||f||||f||||||||||2017-10-10 23:52:24.145499|2017-10-10 23:52:24.145499
NCT02276300|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-03-16|||December 2014||2014-12-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|September 2016|Anticipated|2016-09-01||Interventional|HER2||HER2-Peptide Vaccination of Patients With Solid Tumors|A Phase 1 Study of Peptide Vaccination for the Treatment of Patients With Solid Tumors Moderately Expressing HER2/Neu|Recruiting||Phase 1|12|Anticipated|Technische Universität München||1|||f||||f||||||||||2017-10-10 23:52:24.333141|2017-10-10 23:52:24.333141
NCT02276287|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-27|||March 2013||2013-03-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||HIV Patients Illness Perception and Adherence|HIV Positive Patient's Cognitive and Emotional Illness Perception: a Possible Tool for Understanding Adherence?|Completed||N/A|187|Actual|University of Milan|||1||f||||f||||||||||2017-10-10 23:52:24.42355|2017-10-10 23:52:24.42355
NCT02276274|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-06-04|2015-06-04||June 2014||2014-06-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Pharmacokinetic analysis set: subset of participants who received the investigational product, satisfied the minimum requirements of the protocol with no significant deviations, and were assessable for pharmacokinetics.|Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects|A Randomized, Open-label, Crossover Study to Determine the Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects|Completed||Phase 3|12|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:52:24.517108|2017-10-10 23:52:24.517108
NCT02276261|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-07-18|||November 2014||2014-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Vertical Versus Horizontal Vaginal Cuff Closure on Vaginal Length After Laparoscopic Hysterectomy||Completed||N/A|43|Actual|Bridgeport Hospital||2|||f||||f||||||||||2017-10-10 23:52:26.112504|2017-10-10 23:52:26.112504
NCT02276248|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-08-13|||June 2010||2010-06-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma|Radiotherapy Combined With GDP (Gemcitabine, Cisplatin, Dexamethasone) Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma Patients With Unfavorable Prognostic Factors: an Open-label, Single-arm, Phase II Clinical Trial|Completed||Phase 2|40|Actual|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-10 23:52:26.183833|2017-10-10 23:52:26.183833
NCT02276235|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-23|||January 2014||2014-01-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Therapeutic Effect of Catgut Embedding in Obesity|The Therapeutic Effect of Catgut Embedding in Obesity-A Randomized, Double-blind, Placebo-controlled Clinical Trial|Unknown status|Enrolling by invitation|Phase 4|90|Anticipated|Taipei City Hospital||2|||f||||t||||||||||2017-10-10 23:52:26.26636|2017-10-10 23:52:26.26636
NCT02276222|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-06-02||2016-03-18|October 2014||2014-10-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|GOLDEN-5||A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD|A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)|Completed||Phase 3|1087|Actual|Sunovion Respiratory Development Inc.||2|||f||||f||||||||||2017-10-10 23:52:26.382627|2017-10-10 23:52:26.382627
NCT02276209|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-24||2017-08-24|December 2014||2014-12-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Dasotraline Adult ADHD Study|A Randomized, Double Blind, Multicenter, Placebo Controlled, Parallel Group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|636|Actual|Sunovion||3|||f||||t||||||||||2017-10-10 23:52:26.76227|2017-10-10 23:52:26.76227
NCT02276196|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-04-28|||September 2014||2014-09-01|February 2016|2016-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ELIXIRS||Effect of LIXIsenatide on the Renal System|A Phase 4, Mono-center, Randomized, Open Label, Comparator-controlled, Parallel-group, Mechanistic Intervention Trial to Assess the Effect of 8-week Treatment With the Glucagon-like Peptide-1 Receptor Agonist Lixisenatide Versus Insulin Glulisine on Renal Physiology and Biomarkers in Insulin Glargine-treated Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|40|Actual|VU University Medical Center||2|||f||||f||||||||||2017-10-10 23:52:27.020463|2017-10-10 23:52:27.020463
NCT02276183|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-11-24|||April 2015||2015-04-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Move Study in Healthy Aging People|Effects of a Test Formula Milk Powder Combined With a Physical Activity Program on Mobility in Healthy Aging Subjects With Joint Discomfort|Completed||N/A|55|Anticipated|Nestlé||1|||f||||f||||||||||2017-10-10 23:52:27.1115|2017-10-10 23:52:27.1115
NCT02276170|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-05-16|||October 2014||2014-10-01|May 2016|2016-05-01||||September 2017|Anticipated|2017-09-01||Observational|PAANS||Pharmacology of Aminophylline for Acute Kidney Injury in Neonates||Enrolling by invitation||N/A|20|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-10 23:52:27.189292|2017-10-10 23:52:27.189292
NCT02276157|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-04-19|||August 2006||2006-08-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Observational|||Direct Peroral Cholangioscopy by Using an Ultra-slim Upper Endoscope|Direct Peroral Cholangioscopy by Using an Ultra-slim Upper Endoscope|Enrolling by invitation||N/A|300|Anticipated|Soonchunhyang University Hospital|||1||f||||t||||||||||2017-10-10 23:52:27.279371|2017-10-10 23:52:27.279371
NCT02276144|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-11-20|||November 2014||2014-11-01|October 2014|2014-10-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Observational|||Metabolic Syndrome and Non-alcoholic Fatty Liver During Pregnancy|Investigation on the Frequency and Obstetric Significance of Metabolic Syndrome and Non-alcoholic Fatty Liver During Pregnancy|Recruiting||N/A|2400|Anticipated|Seoul National University Hospital|||1||f||||f||||||Samples With DNA|"     serum for lab tests   "|||2017-10-10 23:52:27.359499|2017-10-10 23:52:27.359499
NCT02276131|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-02-23|||January 2015||2015-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Human Factors and Home Use Study of the Vigilant Diabetes Management Application|Human Factors and Home Use Study of the Vigilant Diabetes Management Application|Completed||N/A|61|Actual|InSpark Technologies, Inc.||1|||f||||f||||||||||2017-10-10 23:52:27.469722|2017-10-10 23:52:27.469722
NCT02276118|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2014-10-23|||July 2014||2014-07-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Outcome Comparison of Two Total Knee Arthroplasty Systems: e.Motion-Pro Versus Genesis II|Comparisons of Prosthesis Fitness, Early Recovery Patterns, Functional Outcomes and Patient Satisfaction Between E.Motion-Pro, a New Mobile Bearing System and Genesis II, an Established Successful System|Unknown status|Recruiting|N/A|300|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:52:27.545453|2017-10-10 23:52:27.545453
NCT02276105|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-05-20|||October 2014||2014-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Investigation of Psychometric Properties of the EuroQoL EQ-5D-5L in Patients With Carpal Tunnel Syndrome|Investigation of Psychometric Properties of the EuroQoL EQ-5D-5L in Patients With Carpal Tunnel Syndrome|Completed||N/A|60|Actual|Schulthess Klinik|||1||f||||f||||||||||2017-10-10 23:52:27.638125|2017-10-10 23:52:27.638125
NCT02276092|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-10-14|||April 2015||2015-04-01|October 2015|2015-10-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01|60 Days|Observational [Patient Registry]|RASPCAP||Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With Pneumonia|Effectiveness of a Regional Antimicrobial Stewardship Program to Reduce the Length of Stay of Patients Admitted to Hospital With Community-acquired Pneumonia: a Pragmatic Multi-centre Clinical Study|Unknown status|Enrolling by invitation|N/A|2000|Anticipated|Royal Victoria Hospital, Canada|||2||f||||t||||||||||2017-10-10 23:52:27.724861|2017-10-10 23:52:27.724861
NCT02276079|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-06-30|||February 17, 2015|Actual|2015-02-17|June 2017|2017-06-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Interventional|||The Effect of Exercise on Neurorecovery Following Mild Traumatic Brain Injury|The Effect of Exercise on Neurorecovery Following Mild Traumatic Brain Injury|Completed||N/A|37|Actual|University of Florida||3|||f||||t||||||||||2017-10-10 23:52:27.819131|2017-10-10 23:52:27.819131
NCT02276066|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-09-29|||February 2015||2015-02-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS|Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care Subtitle. Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS|Recruiting||Phase 4|340|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-10 23:52:27.934792|2017-10-10 23:52:27.934792
NCT02276053|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-10-05|||November 2014||2014-11-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|VIBES||Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors|A Noninterventional Study of Vimpat® (Lacosamide) as Adjunctive Antiepileptic Drug Therapy in Patients With Brain Tumor-related Epilepsy|Active, not recruiting||N/A|93|Actual|UCB Pharma|||1||f||||f||||||||||2017-10-10 23:52:28.054204|2017-10-10 23:52:28.054204
NCT02276027|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-09-13|||January 20, 2015|Actual|2015-01-20|September 2017|2017-09-01|April 28, 2018|Anticipated|2018-04-28|April 28, 2018|Anticipated|2018-04-28||Interventional|||A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer|A Phase II, Open Label, Multiple Arm Study of Single Agent AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|66|Actual|Novartis||4|||f||||f|f|f||||||||2017-10-10 23:52:28.264689|2017-10-10 23:52:28.264689
NCT02276014|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-10-05|||April 2012||2012-04-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|BETASNP2||Effect of SNPs in the BCMO1 Enzyme|Effect of SNPs in the Beta-carotene 15, 15'-Monooxygenase (BCMO1) Enzyme on Retinol Formation and Beta-carotene Plasma Responses|Completed||N/A|85|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||3|||f||||t||||||||||2017-10-10 23:52:28.365165|2017-10-10 23:52:28.365165
NCT02276001|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-24|||June 2014||2014-06-01|October 2014|2014-10-01||||July 2014|Actual|2014-07-01||Interventional|||Drug-Drug Interaction Study in Healthy Adult Volunteers||Completed||Phase 1|20|Actual|Kowa Research Institute, Inc.||2|||f||||||||||||||2017-10-10 23:52:28.451482|2017-10-10 23:52:28.451482
NCT02275988|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-24|||June 2014||2014-06-01|October 2014|2014-10-01||||August 2014|Actual|2014-08-01||Interventional|||Drug-Drug Interaction Study in Healthy Adult Volunteers||Completed||Phase 1|20|Actual|Kowa Research Institute, Inc.||2|||f||||||||||||||2017-10-10 23:52:28.540681|2017-10-10 23:52:28.540681
NCT02275975|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-24|||July 2014||2014-07-01|October 2014|2014-10-01||||August 2014|Actual|2014-08-01||Interventional|||Drug-Drug Interaction Study in Healthy Adult Volunteers||Completed||Phase 1|20|Actual|Kowa Research Institute, Inc.||2|||f||||||||||||||2017-10-10 23:52:28.644892|2017-10-10 23:52:28.644892
NCT02275962|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-01-29|||September 2014||2014-09-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||Drug-Drug Interaction Study in Healthy Adult Volunteers||Completed||Phase 1|20|Actual|Kowa Research Institute, Inc.||2|||f||||||||||||||2017-10-10 23:52:28.957152|2017-10-10 23:52:28.957152
NCT02275949|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-08-18|||September 2014||2014-09-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage|The Efficacy and Safety of Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage|Completed||N/A|50|Actual|Kyung Hee University Hospital at Gangdong||2|||f||||t||||||||||2017-10-10 23:52:29.062451|2017-10-10 23:52:29.062451
NCT02275936|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-11-03|||February 2015||2015-02-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|SNO4||Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation|Completed||Phase 1|51|Actual|Nivalis Therapeutics, Inc.||4|||f||||t||||||||||2017-10-10 23:52:29.173653|2017-10-10 23:52:29.173653
NCT02275910|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-06-26|||November 10, 2014|Actual|2014-11-10|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Phase 1 Study of E7090 in Subjects With Solid Tumor|A Phase 1 Study of E7090 in Subjects With Solid Tumor|Recruiting||Phase 1|20|Anticipated|Eisai Inc.||1|||f||||t||||||||||2017-10-10 23:52:29.436074|2017-10-10 23:52:29.436074
NCT02275897|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-12-11|||March 2013||2013-03-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Different Injection Speeds for Spinal Anaesthesia in Caesarean Section|Injection Speed of Spinal Anaesthesia for Asian Women Undergoing Lower Segmental Caesarean Section and the Incidence of Hypotension and/or Use of Vasopressors|Completed||N/A|77|Actual|Ministry of Health, Malaysia||2|||f||||f||||||||||2017-10-10 23:52:29.552993|2017-10-10 23:52:29.552993
NCT02275884|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-23|||June 2013||2013-06-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|Choc-PD||Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease|Evaluation of Plasma Concentrations of Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease|Unknown status|Recruiting|N/A|30|Anticipated|Technische Universität Dresden||2|||f||||f||||||||||2017-10-10 23:52:29.66025|2017-10-10 23:52:29.66025
NCT02275871|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-07-10|||November 2014||2014-11-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer|Dual-energy Contrast-enhanced Digital Subtraction Mammography (CESM) as a Tool to Screen High Risk Women for Breast Cancer: a Comparison to Screening Breast MRI|Active, not recruiting||N/A|220|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:52:29.79919|2017-10-10 23:52:29.79919
NCT02275858|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-03-17|||March 2015||2015-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Enteroscopy Stiffening Device for Retrograde Balloon Assisted Enteroscopy|A Double Blind, Placebo Controlled, Randomized Cross Over Study of an Enteroscope Stiffening Device to Increase Terminal Ileum Intubation Rate During Retrograde Balloon Assisted Enteroscopy|Terminated||N/A|7|Actual|Lawson Health Research Institute||2||The study was stopped due to carry over effect in the cross over study design.|f||||f||||||||||2017-10-10 23:52:29.889511|2017-10-10 23:52:29.889511
NCT02275845|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-12-24|||September 2014||2014-09-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|Medico-GDM||Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus|Metformin vs Control to Prevent Gestational Diabetes Mellitus (GDM) in Women With a High Risk for GDM, an Open Label Randomized Controlled Trial, The Medico-GDM Trial|Recruiting||Phase 3|400|Anticipated|Maasstad Hospital||2|||f||||t||||||||||2017-10-10 23:52:30.011172|2017-10-10 23:52:30.011172
NCT02275832|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-04-21|||November 2014||2014-11-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement|Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement : A Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 4|48|Actual|Mae Fah Luang University Hospital||2|||f||||f||||||||||2017-10-10 23:52:30.134676|2017-10-10 23:52:30.134676
NCT02275819|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-07-13|||September 22, 2014|Actual|2014-09-22|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Exercise Training in Heart Failure: Changes in Cardiac Structure and Function|Exercise Training in Heart Failure: Structural and Functional Cardiac Remodeling|Recruiting||N/A|75|Anticipated|VA Office of Research and Development|||2||f||||f|f|f|||f|None Retained|"     none retained   "|||2017-10-10 23:52:30.246987|2017-10-10 23:52:30.246987
NCT02275806|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-07-18|||October 2014||2014-10-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC|A Phase II Study of Definitive Concurrent Radiation Therapy With Cisplatin and Irinotecan Chemotherapy in Locally Advanced In-operable Non-Small Cell Lung Cancer|Recruiting||Phase 2|60|Anticipated|Leo W. Jenkins Cancer Center||1|||f||||t||||||||||2017-10-10 23:52:30.374217|2017-10-10 23:52:30.374217
NCT02275793|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-03-24|||September 2011||2011-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|PVR||The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure|The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure|Recruiting||N/A|200|Anticipated|University of Toledo Health Science Campus|||3||f||||f||||||Samples With DNA|"     DNA storage for future exploratory research into genes/genetic variations which may indicate     the presence or absence of pulmonary hypertension and congestive heart failure either as an     extension of this research protocol or future protocols developed in the study of pulmonary     hypertension/chf   "|||2017-10-10 23:52:30.982398|2017-10-10 23:52:30.982398
NCT02275585|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-08|||October 2013||2013-10-01|August 2017|2017-08-01|October 2014|Anticipated|2014-10-01|January 2014|Anticipated|2014-01-01||Observational|||Portal Vein Thrombosis in Cirrhosis|Portal Vein Thrombosis in Cirrhosis: A Cohort Sudy|Withdrawn||N/A|0|Actual|Corporacion Parc Tauli|||1|other studies with more patients already publicated|f||||f||||||||||2017-10-10 23:52:33.149114|2017-10-10 23:52:33.149114
NCT02275780|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-09-19|||December 1, 2014|Actual|2014-12-01|September 2017|2017-09-01|August 18, 2019|Anticipated|2019-08-18|September 29, 2016|Actual|2016-09-29||Interventional|||Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)|A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg Once Daily Plus Ritonavir 100 mg Once Daily, Each in Combination With TRUVADA™ or EPZICOM™/KIVEXA™, in Treatment-Naïve HIV-1 Infected Subjects|Active, not recruiting||Phase 3|680|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 23:52:31.10413|2017-10-10 23:52:31.10413
NCT02275767|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-04-06|2016-04-06||October 2014||2014-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Histological Evaluation of Healing Following Ridge Preservation Using a Combined Cortical/Cancellous Mineralized Freeze-Dried Bone Allograft|Histological Evaluation of Healing Following Ridge Preservation Using a Combined Cortical/Cancellous Mineralized Freeze-Dried Bone Allograft|Completed||N/A|66|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||f||||||||No||2017-10-10 23:52:31.225512|2017-10-10 23:52:31.225512
NCT02275754|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-09-26|||November 2010||2010-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2015|Actual|2015-09-01||Interventional|||Redes III Patient Navigator Qol Study|Improving Quality of Life Among Hispanic/Latino Breast, Colorectal & Prostate Cancer Survivors: A Randomized Control Trial of Patient Navigators Using the LIVESTRONG Cancer Navigation Services Program|Active, not recruiting||N/A|300|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 23:52:31.512306|2017-10-10 23:52:31.512306
NCT02275741|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-11-14|||October 2009||2009-10-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2015|Actual|2015-09-01||Observational|||Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis|Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis|Completed||N/A|226|Actual|University of Rostock|||1||f||||f||||||Samples Without DNA|"     Serum sample   "|||2017-10-10 23:52:31.605068|2017-10-10 23:52:31.605068
NCT02275728|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-10-24|||May 2014||2014-05-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence|Evaluating the Effectiveness of Pelvic Floor Muscle Training With and Without EMG Biofeedback and Quality of Life in Peri and Postmenopausal Women With Stress Urinary Incontinence.|Unknown status|Active, not recruiting|N/A|45|Actual|Federal University of Rio Grande do Sul||3|||f||||f||||||||||2017-10-10 23:52:31.677929|2017-10-10 23:52:31.677929
NCT02275715|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-08-31|||February 2015||2015-02-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PT-F||Treatment of Feeding Problems in Children With Autism|Treatment of Feeding Problems in Children With Autism|Active, not recruiting||N/A|78|Actual|University of Florida||2|||f||||t||||||||||2017-10-10 23:52:31.762221|2017-10-10 23:52:31.762221
NCT02275702|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-03-08|||October 2014||2014-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|APV||Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients|Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients|Recruiting||Phase 4|100|Anticipated|Laval University||2|||f||||f||||||||||2017-10-10 23:52:31.854685|2017-10-10 23:52:31.854685
NCT02275689|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-09-04|||March 2015||2015-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Radiofrequency Microtenotomy for Treatment of Rotator Cuff Tendinopathy|Alternative Treatment of Rotator Cuff Tendinopathy|Completed||N/A|34|Actual|University Hospital of North Norway||3|||f||||f||||||||||2017-10-10 23:52:31.964783|2017-10-10 23:52:31.964783
NCT02275676|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-22|||September 2014||2014-09-01|October 2014|2014-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|CEDERN-1||Resting Energy Expenditure and Nutritional Status in IBD|Influence of Disease Activity of Inflammatory Bowel Disease on Resting Energy Expenditure and Nutritional Status|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital Muenster|||1||f||||f||||||||||2017-10-10 23:52:32.06202|2017-10-10 23:52:32.06202
NCT02275663|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-01-04|||December 2014||2014-12-01|January 2015|2015-01-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Azacytidine Plus FLAG for Relapsed or Refractory AML|Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor (G-CSF) Combination for Patients With Relapsed or Refractory AML|Recruiting||Phase 2|37|Anticipated|King Fahad Medical City||1|||f||||t||||||||||2017-10-10 23:52:32.16955|2017-10-10 23:52:32.16955
NCT02275650|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2014-10-23|||September 2013||2013-09-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter|The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter|Completed||N/A|37|Actual|Joint Authority for Päijät-Häme Social and Health Care||2|||f||||t||||||||||2017-10-10 23:52:32.26211|2017-10-10 23:52:32.26211
NCT02275637|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-23|||September 2014||2014-09-01|October 2014|2014-10-01|September 2022|Anticipated|2022-09-01|September 2016|Anticipated|2016-09-01||Observational|RHYTHM DETECT||Arrhythmias Detection in a Real World Population|Arrhythmias Detection in a Real World Population: the RHYTHM DETECT Registry|Recruiting||N/A|4800|Anticipated|IRCCS Policlinico S. Matteo|||1||f||||f||||||||||2017-10-10 23:52:32.335453|2017-10-10 23:52:32.335453
NCT02275624|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-05-11|||January 2015||2015-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:52:32.394945|2017-10-10 23:52:32.394945
NCT02275611|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2017-03-27|2015-01-15||January 2013||2013-01-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|OT-ETOH2||Oxytocin Treatment of Alcohol Dependence|Oxytocin Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial|Completed||Phase 2|13|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-10 23:52:32.441313|2017-10-10 23:52:32.441313
NCT02275598|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-22|||April 2013||2013-04-01|October 2014|2014-10-01|March 2015|Anticipated|2015-03-01|November 2013|Actual|2013-11-01||Interventional|||Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma|A Pilot Phase II Study To Assess The Efficacy Of Brentuximab Vedotin Administered Sequentially With ABVD Chemotherapy In Patients With Untreated Hodgkin Lymphoma.|Unknown status|Active, not recruiting|Phase 2|12|Actual|University of Modena and Reggio Emilia||1|||f||||f||||||||||2017-10-10 23:52:33.062958|2017-10-10 23:52:33.062958
NCT02275572|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-10-23|||March 2012||2012-03-01|October 2014|2014-10-01||||May 2012|Actual|2012-05-01||Interventional|REMEI||Clinical and Economical Assessment of an Intervention to Reduce Potentially Inappropriate Medication in Polymedicated Elderly Patients|Clinical and Economical Assessment of an Intervention to Reduce Potentially Inappropriate Medication in Polymedicated Elderly Patients|Completed||N/A|503|Actual|Consorci Sanitari del Maresme||2|||f||||||||||||||2017-10-10 23:52:33.214165|2017-10-10 23:52:33.214165
NCT02275559|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-11-21|||August 2015||2015-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Asthma Symptom Management Through Mindfulness Training|Asthma Symptom Management Through Mindfulness Training|Recruiting||N/A|254|Anticipated|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-10 23:52:33.27125|2017-10-10 23:52:33.27125
NCT02275546|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-06-14|2016-03-28||December 11, 2014|Actual|2014-12-11|June 2017|2017-06-01|April 10, 2015|Actual|2015-04-10|April 10, 2015|Actual|2015-04-10||Interventional|||Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)|A Multicenter, Open Label, Randomized, Two-period Crossover Study on the Insertion of MK-8342A (NuvaRing®) Placebo With and Without the Use of NuvaRing Applicator in Healthy Female Subjects|Completed||Phase 3|164|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:52:33.355241|2017-10-10 23:52:33.355241
NCT02275533|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-24|2017-09-14|||May 27, 2015|Actual|2015-05-27|May 2017|2017-05-01||||June 28, 2019|Anticipated|2019-06-28||Interventional|||Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy|Randomized Phase II Study to Assess the Role of Nivolumab as Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Acute Myelogenous Leukemia (AML) Patients After Chemotherapy (Remain Trial)|Recruiting||Phase 2|80|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-10 23:52:33.539045|2017-10-10 23:52:33.539045
NCT02275520|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-05-11|||December 2014||2014-12-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|NIO||Intraosseous Access|Comparison of NIO, BIG, EZ-IO, Jamshidi and Cook Intraosseous Devices in Adult Patients Under Resuscitation by Paramedics: a Randomized Crossover Manikin Trial.|Completed||N/A|137|Actual|International Institute of Rescue Research and Education||1|||f||||t||||||||||2017-10-10 23:52:35.740077|2017-10-10 23:52:35.740077
NCT02275507|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-04-28|||October 2014||2014-10-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery|Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery|Recruiting||N/A|100|Anticipated|Stony Brook University|||1||f||||f||||||||Undecided||2017-10-10 23:52:35.834299|2017-10-10 23:52:35.834299
NCT02275494|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-10-28|||September 2010||2010-09-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|BioHipLLD||The Influence of Leg Length Discrepancy After Total Hip Arthroplasty on Function and Quality of Life|The Influence of Leg Length Discrepancy After Total Hip Arthroplasty on Function and Quality of Life|Completed||N/A|174|Actual|Sundsvall Hospital|||3||f||||f||||||||||2017-10-10 23:52:35.913378|2017-10-10 23:52:35.913378
NCT02275481|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-09-28|2017-09-05||November 2014|Actual|2014-11-01|September 2017|2017-09-01|September 14, 2016|Actual|2016-09-14|September 14, 2016|Actual|2016-09-14||Interventional||full analysis set|A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects|A Comparative Effectiveness and Safety Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects|Terminated||Phase 4|66|Actual|Sunovion|study was terminated early due to lack of enrollment|2||lack of enrollment|f||||f||||||||||2017-10-10 23:52:36.01991|2017-10-10 23:52:36.01991
NCT02275468|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||June 2010||2010-06-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|May 2013|Actual|2013-05-01||Interventional|||Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4|Fu-zheng-qu-zhuo Oral Liquid Combined With Integrated Therapy Improves Renal Function in Patients of Chronic Kidney Disease Stage 3 and 4，a Randomized Placebo-Control Clinical Trial|Completed||Phase 2|124|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-10 23:52:37.739371|2017-10-10 23:52:37.739371
NCT02275455|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-07-25|||October 2014||2014-10-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|Do Well B||Design Of WELL Being Monitoring Systems, Application in Autism|Design Of WELL Being Monitoring Systems, Application in Autism|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||t||||||||||2017-10-10 23:52:37.822458|2017-10-10 23:52:37.822458
NCT02275442|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-10-23|||September 2014||2014-09-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|PRUGNANCY||Effect of Precariousness in RUral Areas During preGNANCY||Unknown status|Active, not recruiting|N/A|190|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:52:37.90072|2017-10-10 23:52:37.90072
NCT02275429|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-07-28|||October 2014||2014-10-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|METARUN||Metabolic Disorders in Ultramarathon Runners During and After the Reunion Island Madmen's Diagonal|"Etude Des Troubles métaboliques Induits Par Une Course à Pied très Longue Distance,  La Diagonale Des Fous  de La Réunion / Metabolic Disorders in Ultramarathon Runners of the Madmen's Diagonal Race on Reunion Island"|Completed||N/A|106|Actual|Centre Hospitalier Universitaire de la Réunion||1|||f||||f||||||||||2017-10-10 23:52:37.98226|2017-10-10 23:52:37.98226
NCT02275416|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-03-31|||November 2014||2014-11-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma|Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma|Active, not recruiting||Phase 1/Phase 2|12|Actual|Ultimovacs AS||1|||f||||t||||||||||2017-10-10 23:52:38.098799|2017-10-10 23:52:38.098799
NCT02275403|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-07-25|||March 2015||2015-03-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ACUFOCIN||Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma|Randomised Clinical Trial of Acupuncture Plus Standard Care Versus Standard Care for Chemotherapy Induced Peripheral Neuropathy (CIPN)|Recruiting||Phase 2|120|Anticipated|The Christie NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:52:38.203584|2017-10-10 23:52:38.203584
NCT02275390|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-08-15|||May 2012||2012-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|APN-PEP||Nurse-led Psycho-education Program for People With First-onset Mental Illness|Effects of a Nurse-led Psycho-education Program for People With First-onset Mental Illness in Psychiatric Outpatient Clinic: A Randomized Controlled Trial|Completed||Phase 1/Phase 2|180|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-10 23:52:38.322671|2017-10-10 23:52:38.322671
NCT02275377|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-05-18|||October 2014||2014-10-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Effects of Inspiratory Muscle Training on Blood Pressure Levels in Hypertensive Individuals|Effects of Inspiratory Muscle Training on Blood Pressure Levels in Hypertensive Individuals: a Randomized Clinical Trial.|Unknown status|Recruiting|N/A|60|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||||2017-10-10 23:52:38.426286|2017-10-10 23:52:38.426286
NCT02275364|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-06-28|2014-11-03||August 5, 2013|Actual|2013-08-05|June 2017|2017-06-01|October 30, 2013|Actual|2013-10-30|October 30, 2013|Actual|2013-10-30||Interventional|||Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion|A Magnetic Resonance Imaging Study of Nasal Strips in Subjects With Nasal Congestion|Completed||Phase 4|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:52:38.529836|2017-10-10 23:52:38.529836
NCT02275351|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-11-24|||November 2014||2014-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)|A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle- Controlled Study of the Safety, Tolerability, and Efficacy of 0.15% and 0.25% Concentrations of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)|Completed||Phase 2|310|Actual|Samumed LLC||3|||f||||f||||||||||2017-10-10 23:52:38.925951|2017-10-10 23:52:38.925951
NCT02275338|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-07-25|||October 2014||2014-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|IMIO||Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction|An International, Multicentric, Prospective, Open Label Study to Assess the Efficacy and Safety of Lanreotide Autogel 120 MG Associated to Standard of Care in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction|Recruiting||Phase 2|50|Anticipated|Ipsen||1|||f||||f||||||||||2017-10-10 23:52:39.222542|2017-10-10 23:52:39.222542
NCT02275325|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-06-20|||January 2015||2015-01-01|June 2016|2016-06-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|ReveSTAN||Preoperative Vestibular Rehabilitation Effectiveness After Vestibular Schwannoma Surgery|Assessment of the Preoperative Vestibular Rehabilitation Effectiveness on Balance Control Compensation After Vestibular Schwannoma Surgery|Recruiting||N/A|50|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 23:52:39.35369|2017-10-10 23:52:39.35369
NCT02275312|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-07-13|||July 2014||2014-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|ETREAT||ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity|ETREAT Study: A Prospective Observational Study to Evaluate the Effectiveness of Botulinum Toxin Type A (BoNT-A) Injections in Patients With Post-stroke Upper and/or Lower Limb Spasticity in the Early Stage of Spasticity Development.|Active, not recruiting||N/A|110|Actual|Ipsen|||1||f||||f||||||||||2017-10-10 23:52:39.462873|2017-10-10 23:52:39.462873
NCT02275299|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||September 2013||2013-09-01|October 2014|2014-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis|A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Iguratimod or Leflunomide in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis|Unknown status|Recruiting|Phase 4|240|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-10 23:52:39.569068|2017-10-10 23:52:39.569068
NCT02275286|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-02-22|||November 2014||2014-11-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TRASTS||Phase I-II Trial, Multicenter, Open, Exploring Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients|Phase I-II Prospective Trial, Multicenter, Open Label, Exploring the Combination of Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients|Recruiting||Phase 1/Phase 2|96|Anticipated|Grupo Espanol de Investigacion en Sarcomas||1|||f||||f||||||||No||2017-10-10 23:52:39.670867|2017-10-10 23:52:39.670867
NCT02275273|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-05-15|||April 2014||2014-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Adnexal Masses : Correlation Between MRI (Magnetic Resonance Imagery) and Anatomopathology|Adnexal Masses : Correlation Between MRI (Magnetic Resonance Imagery) and Anatomopathology|Completed||N/A|13|Actual|Brugmann University Hospital|||1||f||||t||||||||||2017-10-10 23:52:39.843794|2017-10-10 23:52:39.843794
NCT02275260|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-03-13|||December 2014||2014-12-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study|Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study (REDUCE-TE Pilot)|Terminated||N/A|110|Actual|Biotronik SE & Co. KG||1||Required number of endpoints will be obtained with sample size lower as initially planned|f||||f||||||||||2017-10-10 23:52:39.92843|2017-10-10 23:52:39.92843
NCT02275247|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-05-19|||August 2014||2014-08-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2015|Actual|2015-10-01||Interventional|||Perioperative Neuroprotection of Stellate Ganglion Block|Preventive Effect of Stellate Ganglion Block on Cerebral Vasospasm in Patients Undergoing Aneurysm Surgery|Enrolling by invitation||N/A|40|Anticipated|General Hospital of Ningxia Medical University||2|||f||||t||||||||||2017-10-10 23:52:40.051201|2017-10-10 23:52:40.051201
NCT02275234|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-08-08|||September 2014||2014-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CARE||Care After Resuscitation|A Feasibility Study of Implementing a Simple Psychological Intervention in Survivors of Cardiac Arrest and Their Family Members/Friend to Assess the Impact on Their Quality of Life and Cognitive Function|Recruiting||N/A|80|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust|||2||f||||f||||||||||2017-10-10 23:52:40.139882|2017-10-10 23:52:40.139882
NCT02275221|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-08-08|||August 2013||2013-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Immune Response in Patients With Hepatitis B and C Infection|Investigation and Elucidation of Host Immune Responses in Patients With Hepatitic B and C Virus Infection|Recruiting||N/A|150|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:52:40.249247|2017-10-10 23:52:40.249247
NCT02275208|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-05-04|||December 11, 2014|Actual|2014-12-11|May 2017|2017-05-01|January 18, 2017|Actual|2017-01-18|January 18, 2017|Actual|2017-01-18||Observational|||A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure|A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure|Completed||N/A|120|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-10 23:52:40.34113|2017-10-10 23:52:40.34113
NCT02275195|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-08-08|||November 2013||2013-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Immune Cell Dysfunction in Severe Alcoholic Hepatitis|Immune Cell Dysfunction in Severe Alcoholic Hepatitis|Recruiting||N/A|50|Anticipated|Basildon and Thurrock University Hospitals NHS Foundation Trust|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 23:52:40.421771|2017-10-10 23:52:40.421771
NCT02275182|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-02-21|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|February 20, 2017|Actual|2017-02-20|January 2017|Actual|2017-01-01||Interventional|||Impact of Dexmedetomidine on the Post-Operative Cognition Dysfunction(POCD) in Geriatric Patients|Impact of Dexmedetomidine Sedation on the Post-Operative Cognition Dysfunction——a Multiple Center,Randomized, Controlled,Double Blinded Clinical Trial.|Completed||Phase 4|864|Actual|The First Affiliated Hospital of Anhui Medical University||2|||f||||t||||||||||2017-10-10 23:52:40.506456|2017-10-10 23:52:40.506456
NCT02275169|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-01-30|||February 2015||2015-02-01|January 2015|2015-01-01|November 2016|Anticipated|2016-11-01|February 2016|Anticipated|2016-02-01||Interventional|||FSH Treatment for Non-obstructive Azoospermic Patients|Follicle-stimulating Hormone Treatment for Infertile Male Patients With Non-obstructive Azoospermia: a Multicenter Randomized Clinical Trial|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Azienda Sanitaria Locale Bari||2|||f||||t||||||||||2017-10-10 23:52:40.623827|2017-10-10 23:52:40.623827
NCT02275156|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-01-14|2015-12-08||August 2014||2014-08-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab|Phase 1, Open-label, Single-dose Study of Evolocumab (AMG 145) Administered Subcutaneously to Subjects With Normal Renal Function or Severe Renal Impairment or End Stage Renal Disease Receiving Hemodialysis|Completed||Phase 1|18|Actual|Amgen||1|||f||||f||||||||||2017-10-10 23:52:40.721672|2017-10-10 23:52:40.721672
NCT02275143|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-05-23|||October 2015||2015-10-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Computed Tomography (CT) Coronary Angiogram Evaluation in Cancer Patients Having CT Thorax, Abdomen and Pelvis|Feasibility of Computed Tomography (CT) Coronary Angiogram Evaluation in Cancer Patients Having CT Thorax, Abdomen and Pelvis (CT TAP)|Completed||N/A|80|Actual|Plymouth Hospitals NHS Trust|||1||f||||f||||||||||2017-10-10 23:52:41.316629|2017-10-10 23:52:41.316629
NCT02275130|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-02-08|||April 2014|Actual|2014-04-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Functional Effect of Treatment of Glottic Insufficiency With Calcium Hydroxyapatite|Assessment of the Functional Effect of Treatment of Glottic Insufficiency With Injection Technique With the Use of Calcium Hydroxyapatite|Recruiting||N/A|30|Anticipated|University Hospital Ostrava||1|||f||||f||||||||||2017-10-10 23:52:41.511342|2017-10-10 23:52:41.511342
NCT02275117|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-02-17|||October 2014||2014-10-01|May 2016|2016-05-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|||A Multicenter Assessment of ALD403 in Chronic Migraine|A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Dose-Ranging Phase 2 Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of ALD403 Administered Intravenously in Patients With Chronic Migraine|Completed||Phase 2|617|Actual|Alder Biopharmaceuticals, Inc.||5|||f||||f||||||||||2017-10-10 23:52:41.621211|2017-10-10 23:52:41.621211
NCT02275104|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-02-16|||September 1, 2014|Actual|2014-09-01|February 2017|2017-02-01|July 21, 2016|Actual|2016-07-21|July 21, 2016|Actual|2016-07-21||Observational|MIGAT||Multimodal Image Processing Software to Guide Cardiac Ablation Therapy||Completed||N/A|100|Actual|University Hospital, Bordeaux|||2||f||||f||||||||||2017-10-10 23:52:41.917478|2017-10-10 23:52:41.917478
NCT02275091|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-02-01|||October 2014||2014-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|||Children With Diabetes at Risk for Heart Disease.|Identifying Children With Diabetes Type 1 at High Risk for Cardiovascular Disease.|Recruiting||N/A|120|Anticipated|Georgetown University|||2||f||||f||||||||||2017-10-10 23:52:42.020205|2017-10-10 23:52:42.020205
NCT02275078|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-04-07|||October 2013||2013-10-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Innovations in Treating COPD Exacerbations: Pilot Project on Action Plans Using New Technology.|Pilot Study Evaluating the Feasibility and Potential Benefits of a Novel Approach of COPD Self-management That Includes a Phone Assessment/Reporting System (Tele-system)|Unknown status|Recruiting|N/A|40|Anticipated|McGill University Health Center||1|||f||||t||||||||||2017-10-10 23:52:42.110124|2017-10-10 23:52:42.110124
NCT02275065|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2015-02-06|||October 2014||2014-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety, Pharmacokinetics, and Antiviral Activity of GS-9883 in HIV-1 Infected Subjects|A Phase 1b Randomized, Double-Blinded, Sequential Cohort Placebo-Controlled Study of the Safety, Pharmacokinetics, and Antiviral Activity of GS-9883 in HIV-1 Infected Subjects|Completed||Phase 1|23|Actual|Gilead Sciences||4|||f||||f||||||||||2017-10-10 23:52:42.217019|2017-10-10 23:52:42.217019
NCT02275039|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-08-18|||January 2015||2015-01-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer|A Phase I Study of a p53MVA Vaccine in Combination With Gemcitabine in Ovarian Cancer|Active, not recruiting||Phase 1|9|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-10 23:52:42.807137|2017-10-10 23:52:42.807137
NCT02274129|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-08-31|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|April 19, 2016|Actual|2016-04-19|October 2015|Actual|2015-10-01||Interventional|||Clinical Survey of Oticon Medical Healing Cap|C51 - Clinical Survey of Oticon Medical Healing Cap|Completed||N/A|32|Actual|Oticon Medical||1|||f||||f||||||||||2017-10-10 23:52:53.609866|2017-10-10 23:52:53.609866
NCT02275026|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2016-12-06|||July 2015||2015-07-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|TORIE||Trajectory of Recovery in the Elderly|Trajectory of Recovery in the Elderly|Recruiting||Early Phase 1|76|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||Undecided||2017-10-10 23:52:42.915608|2017-10-10 23:52:42.915608
NCT02275013|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||January 2006||2006-01-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Levosimendan Administration and Outcome in Cardiac Surgery||Completed||N/A|159|Actual|Charite University, Berlin, Germany|||2||f||||||||||||||2017-10-10 23:52:43.017479|2017-10-10 23:52:43.017479
NCT02275000|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-05-13|||September 2014||2014-09-01|May 2015|2015-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Feasibility Study of Physiotherapy for Functional Motor Symptoms|Randomised Feasibility Study of a Physiotherapy Programme for Patients With Functional Motor Symptoms (FMS).|Completed||N/A|60|Actual|University College, London||2|||f||||f||||||||||2017-10-10 23:52:43.095671|2017-10-10 23:52:43.095671
NCT02274987|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-03-10|||September 2014||2014-09-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Molecular Profiling for Individualized Treatment Plan for DIPG|A Pilot Trial Testing the Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan in Children With Newly Diagnosed DIPG|Recruiting||N/A|27|Anticipated|University of California, San Francisco||1|||f||||t||||||||No||2017-10-10 23:52:43.184543|2017-10-10 23:52:43.184543
NCT02274974|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-06-24|||August 2014||2014-08-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine|Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine;Randomized Controlled Trial.|Completed||Phase 4|160|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 23:52:43.289856|2017-10-10 23:52:43.289856
NCT02274961|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-24|||October 2014||2014-10-01|October 2014|2014-10-01||||July 2015|Anticipated|2015-07-01||Interventional|||S-pantoprazole 10mg Phase III Clinical Study||Unknown status|Recruiting|Phase 3|174|Anticipated|Ahn-Gook Pharmaceuticals Co.,Ltd||2|||f||||f||||||||||2017-10-10 23:52:43.381858|2017-10-10 23:52:43.381858
NCT02274948|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2016-11-03|2016-07-03||July 2014||2014-07-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|September 2015|Actual|2015-09-01||Interventional|||Use of Metformin in Treatment of Childhood Obesity|Effects of Metformin on Body Weight, Composition and Metabolic Derangements in Obese Children. A Randomized Clinical Trial|Completed||Phase 4|339|Actual|University of Colombo||2|||f||||f||||||||No||2017-10-10 23:52:43.491858|2017-10-10 23:52:43.491858
NCT02274935|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-10-25|||October 2014||2014-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|DUETS||Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis|Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis|Completed||N/A|20|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-10 23:52:43.8241|2017-10-10 23:52:43.8241
NCT02274922|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-08-25|||April 2014||2014-04-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|CAMPYTEST||Evaluation of Immunochromatographic Tests for Campylobacter Detection in Stools|Evaluation of Immunochromatographic Tests for Campylobacter Detection in Stools|Completed||N/A|308|Actual|University Hospital, Bordeaux|||1||f||||f||||||Samples Without DNA|"     Serology control   "|||2017-10-10 23:52:43.89111|2017-10-10 23:52:43.89111
NCT02274909|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-23|||May 2014||2014-05-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Pilates and PNF Methods Induces Similar Strength Gains|PILATES AND PNF METHODS INDUCES SIMILAR STRENGTH GAINS, BUT DIFFERENT NEUROMUSCULAR ADAPTATIONS IN ELDERLY WOMEN|Completed||N/A|60|Actual|Universidade Estadual do PiauÍ||3|||f||||t||||||||||2017-10-10 23:52:43.949581|2017-10-10 23:52:43.949581
NCT02274896|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-22|||November 2014||2014-11-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|Bayston||Bayston Multicenter Antimicrobial PD Catheter Safety Study|A Prospective Multicenter Investigation to Evaluate the Safety of the Bayston Antimicrobial Peritoneal Dialysis Catheter in ESRD Patients|Unknown status|Not yet recruiting|Phase 1|43|Anticipated|Medical Components, Inc dba MedComp||1|||f||||t||||||||||2017-10-10 23:52:44.008329|2017-10-10 23:52:44.008329
NCT02274883|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-08-31|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of Feeding Infant Formula With Enriched Protein Fractions|The Effect of Feeding Infant Formula With Enriched Protein Fractions|Completed||N/A|451|Actual|Mead Johnson Nutrition||2|||f||||f||||||||||2017-10-10 23:52:44.07793|2017-10-10 23:52:44.07793
NCT02274870|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-01-05|||November 2014||2014-11-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery|Liposomal Bupivacaine for Total Knee Arthroplasty Postoperative Analgesia|Completed||Phase 4|65|Actual|Northwell Health||2|||f||||f||||||||Undecided||2017-10-10 23:52:44.153882|2017-10-10 23:52:44.153882
NCT02274857|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-06-02|||October 2014||2014-10-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|REAFFIRM||Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures|Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures (REAFFIRM)|Recruiting||N/A|350|Anticipated|Abbott Electrophysiology||2|||f||||t||||||||Undecided||2017-10-10 23:52:44.342226|2017-10-10 23:52:44.342226
NCT02274844|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-01-17|||April 2016||2016-04-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Improving Medication Adherence in the Alabama Black Belt|Improving Medication Adherence in the Alabama Black Belt|Recruiting||N/A|500|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||No|Data will stay at UAB|2017-10-10 23:52:44.513673|2017-10-10 23:52:44.513673
NCT02274831|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||August 2011||2011-08-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||EMail Reminder to Follow up With Primary Physician|You Have Got Got Mail....and Need Follow Up|Completed||N/A|577|Actual|Saint Joseph Mercy Health System||2|||f||||f||||||||||2017-10-10 23:52:44.594159|2017-10-10 23:52:44.594159
NCT02274818|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-05-01|||July 2015||2015-07-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|December 2016|Actual|2016-12-01||Interventional|iCOMPARE||Individualized Comparative Effectiveness of Models Optimizing Patient Safety and Resident Education.|Individualized Comparative Effectiveness of Models Optimizing Patient Safety and Resident Education (iCOMPARE).|Active, not recruiting||N/A|3500|Anticipated|University of Pennsylvania||2|||f||||t||||||||No||2017-10-10 23:52:44.656636|2017-10-10 23:52:44.656636
NCT02274805|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-01-12|||November 2014||2014-11-01|January 2017|2017-01-01||||September 2019|Anticipated|2019-09-01||Observational|Human BAT||Collection of Human Tissue Samples From the Neck Region for Characterization of Its Molecular and Biochemical Signatures|Collection of Human Tissue Samples From the Neck Region for Characterization of Its Molecular and Biochemical Signatures|Recruiting||N/A|40|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida|||1||f||||t||||||Samples With DNA|"     Muscle and adipose tissue from the neck region, and blood samples   "|||2017-10-10 23:52:44.719261|2017-10-10 23:52:44.719261
NCT02274792|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-11-02|2016-11-02||January 2015||2015-01-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Safety analysis set (all enrolled participants who received ≥ 1 dose of investigational product during the study)|Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis|A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis|Completed||Phase 4|132|Actual|Amgen||1|||f||||f||||||||||2017-10-10 23:52:44.820245|2017-10-10 23:52:44.820245
NCT02274779|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-08-30|||September 2014||2014-09-01|August 2016|2016-08-01|July 2026|Anticipated|2026-07-01|July 2015|Actual|2015-07-01||Interventional|OLIGOPELVIS||Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer|Multicentric Phase II Trial of Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS / GETUG P07)|Active, not recruiting||Phase 2|70|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||t||||||||No||2017-10-10 23:52:45.159823|2017-10-10 23:52:45.159823
NCT02274753|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-10-17|||March 2015||2015-03-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|ImmuCol2||Personalizing Colorectal Cancer Medicine (ImmuCol2)|Personalizing Colorectal Cancer Medicine: an Integrative Approach for the Identification of Prognostic Parameter Combinations at the Time of Surgery and During the Follow-up|Recruiting||N/A|220|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     The pathologist of each center will choose a tumor block containing the core of the tumor and     the invasive margin. Seven tissues sections (five of 4 microns and two of 20 microns) of this     tumor bmock will be cut and deposited on glass slides for the immunohistochemical and tumor     genetic analysis. If biopsies for diagnostic purpose are available in the laboratory of     pathology for the same patient, two tissue sections of 4 microns of each biopsy will be cut     and deposited on a glass slide. Two tubes of blood (5 ml tube without anticoagulant) and a 10     ml tube with EDTA will be taken in consultation or hospitalization before the first     chemotherapy and at 1 year, 2 years and 3 years. These samples will be used for gene     expression analysis and in the search for biological signs of autoimmunity.   "|||2017-10-10 23:52:45.447439|2017-10-10 23:52:45.447439
NCT02274740|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-01-27|||April 2015||2015-04-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients|Effect of GLP-1 Receptors Agonist Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients|Terminated||Phase 2|2|Actual|Sanofi||2||Sponsor decision not related to safety reasons|f||||f||||||||||2017-10-10 23:52:45.564806|2017-10-10 23:52:45.564806
NCT02274727|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-05-17|||September 2014||2014-09-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study|Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study|Recruiting||N/A|3000|Anticipated|University of Zurich|||1||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-10 23:52:45.659914|2017-10-10 23:52:45.659914
NCT02274714|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-01-20|||May 2010||2010-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis|Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis|Completed||N/A|203|Actual|University of Wisconsin, Madison|||2||f||||f||||||||||2017-10-10 23:52:45.80009|2017-10-10 23:52:45.80009
NCT02274701|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-24|||October 2014||2014-10-01|October 2014|2014-10-01|February 2016|Anticipated|2016-02-01|October 2015|Anticipated|2015-10-01||Interventional|||Holistic Needs Assessment in Outpatient Cancer Care|Evaluating the Impact of Holistic Needs Assessment in Outpatient Cancer Care|Unknown status|Not yet recruiting|N/A|156|Anticipated|University of the West of Scotland||2|||f||||f||||||||||2017-10-10 23:52:45.887639|2017-10-10 23:52:45.887639
NCT02274688|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-04-21|2017-02-17||March 2014||2014-03-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 2016|Actual|2016-12-01||Interventional|TSOS 5||A Comparative Effectiveness Trial of Optimal Patient-Centered Care|A Comparative Effectiveness Trial of Optimal Patient-Centered Care for US Trauma Care Systems|Completed||N/A|171|Actual|University of Washington|Because this was a multifaceted intervention, the investigation did not yield information regarding which components of the treatment were effective in targeting specific outcomes. The intervention extended up until the 6-month injury time point.|2|||f||||t||||||||||2017-10-10 23:52:45.983885|2017-10-10 23:52:45.983885
NCT02274675|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-07-03|2015-05-02||October 2014||2014-10-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Pilot Study of Robot-assisted Therapy for Post-stroke Forearm and Wrist Rehabilitation Training|A Pilot Study of Robot-assisted Therapy for Post-stroke Forearm and Wrist Rehabilitation Training|Completed||Phase 1|7|Actual|Universiti Teknologi Malaysia|The limitations of this study include the relatively small number of subjects in each group, the variation in severity level across subjects and also the lack of comparison groups to differentiate the improvement benefit from robot therapy.|1|||f||||f||||||||||2017-10-10 23:52:46.676967|2017-10-10 23:52:46.676967
NCT02274662|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-07-25||||||July 2017|2017-07-01||||||||Expanded Access|||Expanded Access Protocol Thymus Transplantation|Expanded Access Protocol Thymus Transplantation for Immunodeficiency, Hematologic Malignancies, and Autoimmune Disease Related to Poor Thymic Function|Available||N/A|||Duke University|||||||||||||||||||2017-10-10 23:52:46.937605|2017-10-10 23:52:46.937605
NCT02274636|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-05-27|||October 2014||2014-10-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|SXDSFRS||Study of a Dietary Supplement for Reflux During Sleep|Study of a Dietary Supplement for Reflux During Sleep|Unknown status|Not yet recruiting|N/A|50|Anticipated|Oral Care Research Associates, Seattle||2|||f||||f||||||||||2017-10-10 23:52:47.080378|2017-10-10 23:52:47.080378
NCT02274623|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-09-20|||December 2014||2014-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid|Effect of CTAP101 Capsules on Serum Calcium, Plasma Intact Parathyroid Hormone and Vitamin D Metabolites in Patients With Advanced Breast or Prostate Carcinomas With Metastases to Bone and Receiving Ongoing Therapy With Denosumab or Zoledronic Acid|Active, not recruiting||Phase 1|24|Anticipated|OPKO Health, Inc.||1|||f||||f||||||||||2017-10-10 23:52:47.160303|2017-10-10 23:52:47.160303
NCT02274610|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-04-27|||November 2014|Actual|2014-11-01|October 2014|2014-10-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|DOPNP201||Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer|Phase I Trial to Compare Pharmacokinetics and Safety of Docetaxel PNP With Taxotere in Subjects With Advanced Solid Tumor|Completed||Phase 1|18|Actual|Samyang Biopharmaceuticals Corporation||2|||f||||f||||||||||2017-10-10 23:52:47.234132|2017-10-10 23:52:47.234132
NCT02274597|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2015-04-24|||March 2014||2014-03-01|October 2014|2014-10-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|||Does Environmental Factors Affect Accuracy in Pre-hospital Non-invasive Temperature Measurement?|Does Environmental Factors Affect Accuracy in Pre-hospital Non-invasive Temperature Measurement?|Completed||N/A|13|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-10 23:52:47.296135|2017-10-10 23:52:47.296135
NCT02274584|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-22|||March 2014||2014-03-01|October 2014|2014-10-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)|Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Relapsed and Refractory CD30 Positive Lymphomas|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Peking University||1|||f||||t||||||||||2017-10-10 23:52:47.350405|2017-10-10 23:52:47.350405
NCT02274571|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-09-26|||September 2015||2015-09-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|RISE||Raising Insulin Sensitivity in Post Menopause|Tissue Selective Estrogen Complex to Prevent Metabolic Dysfunction in Women|Recruiting||Early Phase 1|8|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-10 23:52:47.426197|2017-10-10 23:52:47.426197
NCT02274558|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-06-09|2017-05-11|2016-10-12|October 2014||2014-10-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Interventional|KINECT 3|Safety analysis set: Included all subjects who were randomized to a treatment group and dispensed study drug, with the following 2 exclusions: (a) subjects who withdrew from the study and returned all previously dispensed study drug with all doses present, and (b) subjects who had no postbaseline safety data collected.|A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel, Fixed-Dose Study to Assess the Efficacy, Safety, and Tolerability of NBI-98854 for the Treatment of Tardive Dyskinesia|Completed||Phase 3|234|Actual|Neurocrine Biosciences||3|||f||||f||||||||||2017-10-10 23:52:47.660129|2017-10-10 23:52:47.660129
NCT02274545|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-04-18|||October 2014||2014-10-01|April 2017|2017-04-01||||May 2016|Actual|2016-05-01||Interventional|||Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old|Phase 1 Evaluation of the Safety and Immunogenicity of Live Influenza A Vaccine H7N9 (6-2) AA ca Recombinant (A/Anhui/1/2013 (H7N9) x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H7N9 Disease in 50 to 70 Year Olds in the Event of a Pandemic|Completed||Phase 1|24|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-10 23:52:48.636975|2017-10-10 23:52:48.636975
NCT02274532|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-05-13|||March 2014||2014-03-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|SoftHand||Myoelectric SoftHand Pro to Improve Prosthetic Function for People With Below-elbow Amputations: A Feasibility Study|Myoelectric SoftHand Pro to Improve Prosthetic Function for People With Below-elbow Amputations: A Feasibility Study|Enrolling by invitation||N/A|54|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-10 23:52:48.724033|2017-10-10 23:52:48.724033
NCT02274506|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-22|||July 2014||2014-07-01|October 2014|2014-10-01||||July 2018|Anticipated|2018-07-01||Interventional|||Infusion of Allogeneic, 3rd Party CD19-specific T Cells|Infusion of Allogeneic, 3rd Party CD19-specific T Cells for Patients With Refractory CD19+ B-Lineage Lymphoid Malignancies|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:52:48.909636|2017-10-10 23:52:48.909636
NCT02274493|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-09-18|||July 8, 2015|Actual|2015-07-08|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Robotic Harvest of the Latissimus Dorsi (LD) Muscles|Pilot Study of Robotic-Assisted Harvest of the Latissimus Dorsi Muscles|Active, not recruiting||N/A|15|Actual|M.D. Anderson Cancer Center||1|||f||||f|f|t|f|||||||2017-10-10 23:52:49.013134|2017-10-10 23:52:49.013134
NCT02274480|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-05-09|||October 22, 2014||2014-10-22|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity|Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-10 23:52:49.122716|2017-10-10 23:52:49.122716
NCT02274467|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-02-18|||November 2014||2014-11-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Response Patterns to the Electric Stimulation of Epidural Catheters in Term Pregnant Women|Response Patterns to the Electric Stimulation of Epidural Catheters in Term Pregnant Women: A Randomized Controlled Trial of Uniport Versus Multiport Catheters.|Completed||N/A|48|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-10 23:52:49.228007|2017-10-10 23:52:49.228007
NCT02274454|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-05-22|||November 2014||2014-11-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Investigating the Effect of Extracellular Calcium on Oxytocin-induced Human Myometrial Contractility In-vitro|Investigating the Effect of Extracellular Calcium on Oxytocin-induced Human Myometrial Contractility In-vitro|Completed||N/A|41|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||6|||f||||f||||||||||2017-10-10 23:52:49.333793|2017-10-10 23:52:49.333793
NCT02274441|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-08-12|||January 2015||2015-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|URGO||Activity and Quality of Care Indicators' for a Sentinel Network Creation|Gynaecological Emergencies: Validation of Indicators of Activity and Quality of Care for Creation of a Network Sentinel|Recruiting||N/A|2000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:52:49.459133|2017-10-10 23:52:49.459133
NCT02274428|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-04-18|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional|||Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage|Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage|Completed||Phase 1|9|Actual|Samsung Medical Center||1|||f||||t||||||||Undecided||2017-10-10 23:52:49.526036|2017-10-10 23:52:49.526036
NCT02274415|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-10-18|||September 2013||2013-09-01|October 2015|2015-10-01|March 2018|Anticipated|2018-03-01|May 2016|Anticipated|2016-05-01||Interventional|DREVAC||Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease|Study of the Immunogenicity of a Prime Boost Vaccination Strategy Combining Conjugated Anti-pneumococcal and Polysaccharide Anti-pneumococcal Vaccine Compared to Polysaccharide Anti -Pneumococcal Vaccine Alone in Patients With Sickle Cells Disease|Recruiting||Phase 2|180|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:52:49.625939|2017-10-10 23:52:49.625939
NCT02274402|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-07-31|||November 2014||2014-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Observational|Glucomad||Pharmacokinetics of Prednisone in Adults|Study of Pharmacokinetic and Pharmacodynamic Variability of Prednisone, in Adults|Completed||N/A|114|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Biospecimen Description :        -  Standard blood test as planned in the routine care follow up of corticotherapy.          Especially, numeration blood formula, renal function estimated by MDRD formula, liver          function (transminases, γGT, alkaline phosphatase, bilirubinemia, prothrombin).        -  Albuminemia, transcortin, HbA1c, 8am cortisol.        -  4 ml of blood in an dry tube for pharmacokinetic studies at each blood sample, precising          the delay between the last dose of treatment and th sampling.        -  Buccal cell collection swab   "|No||2017-10-10 23:52:49.720868|2017-10-10 23:52:49.720868
NCT02274389|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-07-18|||December 24, 2013|Actual|2013-12-24|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||A Prospective Patient Registry of Patients Exposed to Bedaquiline|Bedaquiline Patient Registry: Prospective Patient Registry of Patients Exposed to Bedaquiline In the United States|Active, not recruiting||N/A|300|Anticipated|Janssen Research & Development, LLC|||1||f||||f|t|||||||||2017-10-10 23:52:49.806763|2017-10-10 23:52:49.806763
NCT02274376|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-11-01|||August 2008||2008-08-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer|NIS Xeloda in Gastric Cancer|Completed||N/A|223|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:52:49.907744|2017-10-10 23:52:49.907744
NCT02274363|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-03-23|||April 10, 2012|Actual|2012-04-10|March 2017|2017-03-01|May 31, 2013|Actual|2013-05-31|May 31, 2013|Actual|2013-05-31||Observational|||A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis|Assessment of Psoriasis Severity in Brazilians Patients With Chronic Plaque-type Psoriasis Attending Outpatient Clinics: a Multicenter, Observational, and Cross-sectional Study (APPISOT)|Completed||N/A|1131|Actual|Janssen Pharmaceutica|||1||f||||f|t|||||||||2017-10-10 23:52:49.981857|2017-10-10 23:52:49.981857
NCT02274350|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-02-17|||May 2015||2015-05-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|||The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects|The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects|Completed||N/A|515|Actual|Herlev Hospital|||1||f||||t||||||||||2017-10-10 23:52:50.096002|2017-10-10 23:52:50.096002
NCT02274337|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2016-11-21|||September 2014||2014-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer|Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Patients With Advanced Non Small Cell Lung Cancer Who Progressed on Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Agent|Recruiting||Phase 1/Phase 2|100|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-10 23:52:50.183868|2017-10-10 23:52:50.183868
NCT02274324|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-23|||October 2014||2014-10-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease|Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson's Disease|Not yet recruiting||N/A|20|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:52:50.264772|2017-10-10 23:52:50.264772
NCT02273921|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-22|||March 2005||2005-03-01|October 2014|2014-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||EEG Classification System for Dementia|EEG Classification System for Dementia|Enrolling by invitation||N/A|2000|Anticipated|Mentis Cura||1|||f||||f||||||||||2017-10-10 23:52:55.580044|2017-10-10 23:52:55.580044
NCT02274298|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-10-13|||October 2014||2014-10-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Improving Care for Patients With Chronic Kidney Disease Using EMRALD|Improving Care for Patients With Chronic Kidney Disease Using Electronic Medical Record Interventions: A Pragmatic Cluster Randomized Trial|Active, not recruiting||N/A|221|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||No|No, final results will be aggregate although as part of the trial individual participants do receive individual level feedback|2017-10-10 23:52:50.478979|2017-10-10 23:52:50.478979
NCT02274285|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-06-28|||October 2014|Actual|2014-10-01|June 2017|2017-06-01|May 28, 2016|Actual|2016-05-28|May 28, 2016|Actual|2016-05-28||Interventional|||DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants|Immunogenicity and Safety of the DTaP-IPV/Hib Vaccine SP0204) Given as Three-dose Primary and One-dose Booster Vaccinations Versus Co-administration of DTaP-IPV Vaccine (DD-687) and Hib Vaccine (DF-098) in Infants in Japan|Completed||Phase 3|424|Actual|Sanofi||3|||f||||f||||||||Yes|"Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available the company continue to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi."|2017-10-10 23:52:50.545171|2017-10-10 23:52:50.545171
NCT02274259|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-11-23|||October 2014||2014-10-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen|Randomized Trial Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With Central Retinal Vein Occlusion With a Treat and Extend Algorithm|Active, not recruiting||Phase 4|40|Anticipated|St. Erik Eye Hospital||2|||f||||f||||||||||2017-10-10 23:52:50.731015|2017-10-10 23:52:50.731015
NCT02274246|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-08-17|||November 2014||2014-11-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|RESTORE-HV||Validation of the Efficacy of the Tool GIMIAS® for the Assessment of Left Atrial Fibrosis in a Group of Healthy Volunteers (RESTORE-HV)|GIMIAS® Tool Validation for the Detection of Left Atrium Fibrosis Through Late Enhancement Magnetic Resonance Image Processing. Pattern Determination in a Cohort of Healthy Volunteers|Completed||Phase 1|9|Actual|Fundacion Clinic per a la Recerca Biomédica||1|||f||||f||||||||||2017-10-10 23:52:50.807843|2017-10-10 23:52:50.807843
NCT02274233|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-09-28|||October 2014||2014-10-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia|Multicenter, Open-label, Dose-escalation Study of SP-420 in Subjects With Transfusion-dependent β-Thalassemia|Terminated||Phase 1|24|Actual|Sideris Pharmaceuticals||6||Changes in renal function parameters.|f||||f||||||||||2017-10-10 23:52:50.871404|2017-10-10 23:52:50.871404
NCT02274220|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-04-13|||October 2014||2014-10-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Feeding Study - Effects Post-cardiac Surgery|Randomized Study of Early Nutritional Delivery on Glucose Control, Insulin Resistance and Systemic Inflammation Following Pediatric Cardiac Surgery|Recruiting||N/A|50|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||No||2017-10-10 23:52:50.957376|2017-10-10 23:52:50.957376
NCT02274207|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-11-22|||December 2014||2014-12-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|NPWT-silver||Comparative Study of Antibacterial Effect on Silver Dressing of Negative Pressure Wound|Phase IV Study of Antibacterial Effect on Silver Dressing of NPWT|Recruiting||Phase 4|74|Anticipated|Severance Hospital||2|||f||||f||||||||||2017-10-10 23:52:51.032851|2017-10-10 23:52:51.032851
NCT02274194|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-12-07|||April 2013||2013-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Type of Breathing and CPAP on Patients With Obstructive Sleep Apnea|Nasal, Oral, Oronasal Breathing and CPAP on Nasal Mucociliary Clearance, Mucus Properties, Cytokines in Nasal Lavage and Exhaled Breath Condensate pH of Patients With Obstructive Sleep Apnea|Recruiting||N/A|30|Anticipated|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 23:52:51.118632|2017-10-10 23:52:51.118632
NCT02274181|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-03-11|||December 2014||2014-12-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration|An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration|Completed||Phase 1|6|Actual|Repros Therapeutics Inc.||1|||f||||f||||||||||2017-10-10 23:52:53.182587|2017-10-10 23:52:53.182587
NCT02274168|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2015-09-24|||April 2011||2011-04-01|September 2015|2015-09-01||||January 2018|Anticipated|2018-01-01||Interventional|||Utility of ICD Electrograms During Ventricular Tachycardia Ablation|Aid of Recording ICD Electrograms During Monomorphic Ventricular Tachycardia Ablation Procedures|Recruiting||N/A|260|Anticipated|Fundación Hospital de Madrid||2|||f||||t||||||||||2017-10-10 23:52:53.260469|2017-10-10 23:52:53.260469
NCT02274155|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-08-08|||October 2014||2014-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Anti-OX40 Antibody in Head and Neck Cancer Patients|Phase Ib Study of a Monoclonal Antibody to OX40 (MEDI6469) Administered Prior to Definitive Surgical Resection Patients With Locoregionally Advanced, Oral Head and Neck Squamous Cell Carcinoma|Active, not recruiting||Phase 1|17|Actual|Providence Health & Services||3|||f||||f||||||||||2017-10-10 23:52:53.417836|2017-10-10 23:52:53.417836
NCT02274142|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-07-13|||October 2014||2014-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Cost-effectiveness of ART Using Encapsulated or Powder-liquid Glass Ionomer Cement: Clinical Trial|Randomized Clinical Trial, Double-blinded on ART Restorations|Active, not recruiting||N/A|122|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:52:53.520712|2017-10-10 23:52:53.520712
NCT02274116|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-07-25|||October 2014||2014-10-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|May 2019|Anticipated|2019-05-01||Interventional|||Acute Intermittent Hypoxia on Leg Function Following Spinal Cord Injury|Repetitive Exposure of Intermittent Hypoxia to Enhance Walking Recovery in Persons With Chronic Spinal Cord Injury|Recruiting||Phase 1/Phase 2|20|Anticipated|Emory University||2|||f||||f||||||||||2017-10-10 23:52:53.691395|2017-10-10 23:52:53.691395
NCT02274103|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-10-23|||March 2010||2010-03-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SKYPE||Skype for Youth With Poorly Controlled Diabetes|Improving Health Through SkypeTM: Family-Based Intervention for Teens With Poorly Controlled Diabetes|Completed||Phase 4|92|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 23:52:53.786045|2017-10-10 23:52:53.786045
NCT02274090|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-22|||November 2013||2013-11-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||1% Metformin in Moderate and Severe Periodontitis|Local Drug Delivery of 1% Metformin Gel in Moderate and Severe Periodontitis Subjects: a Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|70|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||t||||||||||2017-10-10 23:52:53.845779|2017-10-10 23:52:53.845779
NCT02274077|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-07-06|||January 2016||2016-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction|Abdominal Wall Reconstruction: Postoperative Outcomes Using Transverse Abdominal Plane Anesthesia|Withdrawn||Phase 4|0|Actual|University of Rochester||2||funding for the study was terminated|f||||t||||||||||2017-10-10 23:52:53.922781|2017-10-10 23:52:53.922781
NCT02274064|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-09-26|||November 2014||2014-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Motivating Type O- Blood Donors to Return|Motivating Type O- Blood Donors to Return|Completed||N/A|598|Actual|Ohio University||2|||f||||f||||||||||2017-10-10 23:52:54.152565|2017-10-10 23:52:54.152565
NCT02274051|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-11-10|||November 2009||2009-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia|The Safety and Tolerability of Kinetin, a Nutritional Supplement That Corrects the Splicing Defect, in Patients With Familial Dysautonomia|Recruiting||Phase 2|25|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-10 23:52:54.239951|2017-10-10 23:52:54.239951
NCT02274038|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2017-06-19|||March 2015|Actual|2015-03-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer|Serial [18F]Fluorothymidine (FLT)PET/CT as a Biomarker of Therapeutic Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer|Recruiting||N/A|30|Anticipated|University of Pennsylvania||1|||f||||||||||||||2017-10-10 23:52:54.337141|2017-10-10 23:52:54.337141
NCT02274025|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-10-06|||October 2014||2014-10-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01|2 Years|Observational [Patient Registry]|||NovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer Patients|Collection of Lung Malignant Tissue for the Validation of a Novel Technology to Identify Oncogenic Mutations and Personalized Medicine|Unknown status|Recruiting|N/A|100|Anticipated|NovellusDx|||1||f||||f||||||Samples With DNA|"     Biopsy material of patient or pleural fluids.   "|||2017-10-10 23:52:54.427449|2017-10-10 23:52:54.427449
NCT02274012|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-03-10|||May 29, 2014|Anticipated|2014-05-29|March 2017|2017-03-01|August 12, 2015|Actual|2015-08-12|August 12, 2015|Actual|2015-08-12||Interventional|||Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment|Phase II Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment of HER2 Amplified Advanced Gastric, Gastroesophageal Junction and Esophageal Cancer|Withdrawn||Phase 2|0|Actual|Columbia University||1||Former PI left institution and had plans to continue at another institution.|f||||t|t|f||||||No||2017-10-10 23:52:54.500443|2017-10-10 23:52:54.500443
NCT02273999|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-23|||September 2012||2012-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Pulsed Electromagnetic Fields for Postoperative Pain: a Linical Trial in Humans|Pulsed Electromagnetic Fields for Postoperative Pain: a Randomized Controlled Clinical Trial in Patients Undergoing Mandibular Third Molar Extraction|Completed||N/A|120|Actual|University of Padova, School of Dental Medicine||3|||f||||t||||||||||2017-10-10 23:52:54.595565|2017-10-10 23:52:54.595565
NCT02273986|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-23|||August 2014||2014-08-01|October 2014|2014-10-01||||September 2014|Actual|2014-09-01||Interventional|||Drug-Drug Interaction Study in Health Adult Volunteers||Completed||Phase 1|20|Actual|Kowa Research Institute, Inc.||2|||f||||||||||||||2017-10-10 23:52:54.678049|2017-10-10 23:52:54.678049
NCT02273973|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-09-22|||November 12, 2014|Actual|2014-11-12|September 2017|2017-09-01|September 8, 2017|Actual|2017-09-08|September 8, 2017|Actual|2017-09-08||Interventional|||A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)|A Phase II Randomized, Double-Blind Study of Neoadjuvant Letrozole Plus GDC-0032 Versus Letrozole Plus Placebo in Postmenopausal Women With ER-positive/HER2-negative, Early Stage Breast Cancer|Completed||Phase 2|334|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-10 23:52:54.769226|2017-10-10 23:52:54.769226
NCT02273960|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-09-26|||November 17, 2014|Actual|2014-11-17|September 2017|2017-09-01|February 16, 2018|Anticipated|2018-02-16|April 28, 2017|Actual|2017-04-28||Interventional|ITP||Study to Evaluate Safety and Efficacy in Adult Subjects With ITP|Open Label, Adaptive Design, Ascending, Multiple-Dose Study to Evaluate Safety and Efficacy of BMS-986004 in Adult Subjects With Primary Immune Thrombocytopenia (ITP)|Active, not recruiting||Phase 1/Phase 2|52|Actual|Bristol-Myers Squibb||4|||f||||t|t|f||||||||2017-10-10 23:52:55.114441|2017-10-10 23:52:55.114441
NCT02273947|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-04-13|||October 23, 2014|Actual|2014-10-23|April 2017|2017-04-01|August 15, 2016|Actual|2016-08-15|August 15, 2016|Actual|2016-08-15||Interventional|||Food Effect Study With BMS-955176|An Open-Label, Randomized, Crossover Adaptive Design Study to Assess the Effect of Food on the Pharmacokinetics of BMS-955176 Administered as a Micronized Crystalline Tablet in Healthy Subjects|Completed||Phase 1|12|Actual|ViiV Healthcare||21|||f||||f|f|f||||||||2017-10-10 23:52:55.243995|2017-10-10 23:52:55.243995
NCT02273934|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-11-17|||April 2014||2014-04-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effectiveness of Reablement in Home Dwelling Adults|The Effectiveness of Reablement in Home Dwelling Adults. A Quasi Experimental Trial|Unknown status|Active, not recruiting|N/A|500|Anticipated|Bergen University College||2|||f||||f||||||||||2017-10-10 23:52:55.484238|2017-10-10 23:52:55.484238
NCT02273908|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-11-17|2016-08-03||July 2014||2014-07-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|PRO||PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin|Patient-reported-outcomes(PROs) in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin in Primary Care Settings|Completed||Phase 4|331|Actual|Pfizer|||2||f||||f||||||||No||2017-10-10 23:52:55.669996|2017-10-10 23:52:55.669996
NCT02273895|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-22|||April 2004||2004-04-01|October 2014|2014-10-01|January 2010|Actual|2010-01-01|October 2004|Actual|2004-10-01||Interventional|||The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study|Development of a Diagnostic Tool for Alzheimer's Disease|Completed||N/A|29|Actual|Mentis Cura||3|||f||||f||||||||||2017-10-10 23:52:56.395524|2017-10-10 23:52:56.395524
NCT02273882|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-05-22|||November 17, 2014|Actual|2014-11-17|May 2017|2017-05-01|August 19, 2016|Actual|2016-08-19|August 19, 2016|Actual|2016-08-19||Observational|SENTINEL1||An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants|The SENTINEL 1 Study: An Observational, Non-Interventional Study in the United States to Characterize Respiratory Syncytial Virus Hospitalizations Among Infants Born at 29 to 35 Weeks Gestational Age Not Receiving Immunoprophylaxis|Completed||N/A|497|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:52:56.479281|2017-10-10 23:52:56.479281
NCT02273869|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-22|||December 2014||2014-12-01|September 2014|2014-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Assessment of Ovarian Reserve in Women With Rheumatologic Diseases|The Influence of Rheumatologic Diseases on Fertility and Ovarian Reserve|Not yet recruiting||N/A|300|Anticipated|Meir Medical Center|||1||f||||t||||||Samples Without DNA|"     serum blood test   "|||2017-10-10 23:52:56.655718|2017-10-10 23:52:56.655718
NCT02273856|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-06-17|||January 2015||2015-01-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|NADIR||Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)|Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic Lymphocytic Leukaemia Or Indolent Non Hodgkin's Lymphoma|Terminated||N/A|25|Actual|Astellas Pharma Inc|||4|The study was terminated due to insufficient subject enrollment and very slow enrollment.|f||||f||||||||||2017-10-10 23:52:56.720333|2017-10-10 23:52:56.720333
NCT02273843|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-09-29|||September 2013||2013-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis|Effect of Different Dosages Oral Vitamin D on Serum Interleukin-6 in Preterm Infants With Late-onset Sepsis|Completed||Phase 1|50|Actual|Mansoura University Children Hospital||2|||f||||t||||||||||2017-10-10 23:52:56.821384|2017-10-10 23:52:56.821384
NCT02273830|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-02-28|||September 2015||2015-09-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Benefits of Liquid Oxygen in COPD Patients Presenting Desaturation During Exercise.|Benefits of Liquid Oxygen in COPD Patients Presenting Desaturation on Exercise But Without Conventional Criteria for Domiciliary Oxygen Therapy.|Recruiting||Phase 4|112|Anticipated|Hospital de Granollers||2|||f||||f||||||||||2017-10-10 23:52:56.920349|2017-10-10 23:52:56.920349
NCT02273817|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-23|||March 2011||2011-03-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Comparing the Bioquivalence of Ciclesonide Nasal Spray(Apotex Inc.) to That of Omnaris ™Nasal Spray (Sepracor, Inc.) in the Treatment of Seasonal Allergic Rhinitis|Completed||Phase 3|580|Actual|Apotex Inc.||3|||f||||t||||||||||2017-10-10 23:52:57.036278|2017-10-10 23:52:57.036278
NCT02273804|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-07-24|||June 1, 2016|Actual|2016-06-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|January 2018|Anticipated|2018-01-01||Interventional|TOBI||Topiramate and Severe Obesity|Topiramate and Severe Obesity in Children and Adolescents|Active, not recruiting||Phase 3|18|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:52:57.111192|2017-10-10 23:52:57.111192
NCT02273791|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2017-05-08|||October 2014||2014-10-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients|Hormone Replacement Therapy Versus Minimal Ovarian Stimulation for Endometrial Preparation Prior to Frozen-thawed Embryo Transfer in Polycystic Ovarian Syndrome Patients|Recruiting||Phase 4|150|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-10 23:52:57.204712|2017-10-10 23:52:57.204712
NCT02273778|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-21|||June 2011||2011-06-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||MRI and PET-CT for Radiotherapy Planning for Head and Neck Cancer|A Pilot Study Investigating the Use of Co-registered 18FDG-PET-CT and MRI for Radiotherapy Planning in Locally Advanced Head and Neck Squamous Cell Carcinoma|Completed||N/A|||The Leeds Teaching Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 23:52:57.295285|2017-10-10 23:52:57.295285
NCT02273765|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-10-04|||September 2015||2015-09-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|REFLATE TB2||Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis|Phase III Open-label Randomized Multicenter Trial to Assess the Non-inferiority of Raltegravir Compared With EFavirenz, Both in Combination With LAmivudine and TEnofovir, in ART-naïve HIV-1-infected Patients Receiving Rifampin for Active TuBerculosis|Recruiting||Phase 3|460|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-10 23:52:57.353762|2017-10-10 23:52:57.353762
NCT02273752|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-12-09|2016-12-09||November 2014||2014-11-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer|Phase II Evaluation of Real-Time, Pharmacokinetically Guided Everolimus in Patients With Hormone Receptor Positive Breast Cancer, Pancreatic Neuroendocrine Tumors (PNET), and Renal Cell Carcinoma|Terminated||Phase 2|2|Actual|Emory University|Trial closed early due to lack of timely accrual.|1||Slow accrual|f||||t||||||||No||2017-10-10 23:52:57.590536|2017-10-10 23:52:57.590536
NCT02273245|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-11-04|||January 2015||2015-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome?|Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome?|Completed||N/A|160|Anticipated|Plymouth Hospitals NHS Trust|||1||f||||f||||||||||2017-10-10 23:53:03.648801|2017-10-10 23:53:03.648801
NCT02273739|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-05-10|||October 24, 2014|Actual|2014-10-24|May 2017|2017-05-01|June 3, 2016|Actual|2016-06-03|June 3, 2016|Actual|2016-06-03||Interventional|||Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation|A Phase 1/2, Multicenter, Open-Label, Dose-Escalation Study of AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, That Harbor an IDH2 Mutation|Completed||Phase 1/Phase 2|21|Actual|Celgene||1|||f||||f||||||||||2017-10-10 23:52:57.898206|2017-10-10 23:52:57.898206
NCT02273726|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-05-04|||December 2014||2014-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of Efficacy and Safety of Roxadustat in the Treatment of Anemia in Stable Dialysis Subjects|A Phase 3, Open-Label, Randomized, Active-Controlled Study of the Efficacy and Safety of Roxadustat (FG-4592) in the Maintenance Treatment of Anemia in Subjects With End Stage Renal Disease (ESRD) on Stable Dialysis|Recruiting||Phase 3|820|Anticipated|FibroGen||2|||f||||t||||||||||2017-10-10 23:52:58.042732|2017-10-10 23:52:58.042732
NCT02273713|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-05-30|||October 2014||2014-10-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|ACTION||The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)|The ACTION Trial: a Phase Ib/II Study on the Addition of Nab-paclitaxel (Abraxane) to Capecitabine and Oxaliplatin in the First-line Treatment of Metastasized Oesophagogastric Carcinoma.|Completed||Phase 1/Phase 2|154|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-10 23:52:58.343138|2017-10-10 23:52:58.343138
NCT02273700|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-08-23|||November 2015||2015-11-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|Naco_Nîmes||Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention|Evaluation of Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention in Patients With Atrial Fibrillation|Completed||N/A|5|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-10 23:52:58.446169|2017-10-10 23:52:58.446169
NCT02273687|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2016-04-05|||October 2014||2014-10-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|EDDRAPro||Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department|Analysis of Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department: Predicting Respiratory Prognosis|Recruiting||N/A|104|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 23:52:58.531639|2017-10-10 23:52:58.531639
NCT02273674|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-02-22|||January 2014||2014-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||TMS in Borderline Personality Disorder Patients|Repetitive Transcranial Magnetic Stimulation in Borderline Personality Disorder Patients. Effects in Clinical Measurements, Inhibition, Cognitive Flexibility, and Social Cognition Process|Completed||N/A|40|Actual|Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente||2|||f||||t||||||||||2017-10-10 23:52:58.667933|2017-10-10 23:52:58.667933
NCT02273648|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2014-10-22|||November 2014||2014-11-01|October 2014|2014-10-01|August 2020|Anticipated|2020-08-01|August 2016|Anticipated|2016-08-01||Observational|||BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III French Satellite||Not yet recruiting||N/A|1000|Anticipated|Biotronik France|||1||f||||f||||||||||2017-10-10 23:52:58.919331|2017-10-10 23:52:58.919331
NCT02273635|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-10-24|||September 2014||2014-09-01|October 2014|2014-10-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|||Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS|Controlled, Randomized, Double-blind Clinical Trial, 24 Months Duration, to Compare the Efficacy, Safety and Tolerability of Andrographolide Versus Placebo in Patients With Progressive Forms of Multiple Sclerosis|Unknown status|Recruiting|Phase 1/Phase 2|68|Anticipated|Innobioscience SpA||2|||f||||t||||||||||2017-10-10 23:52:59.024669|2017-10-10 23:52:59.024669
NCT02273622|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-03-23|||October 2014||2014-10-01|October 2014|2014-10-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Human Study of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects|Nutritional Intervention Study to Evaluate the Effect of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects|Completed||N/A|20|Actual|IMDEA Food||3|||f||||f||||||||||2017-10-10 23:52:59.176751|2017-10-10 23:52:59.176751
NCT02273609|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2014-10-28|||February 2014||2014-02-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Observational|PAULA||INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)|English: Current Perspective of the Status of Anticoagulation in Clinical Practice in Primare Care. Spanish: Perspectiva Actual de la sitUación de la anticoaguLación en la práctica clínica de Atención Primaria.|Completed||N/A|1524|Actual|Hospital Universitario Ramon y Cajal|||1||f||||t||||||||||2017-10-10 23:52:59.290546|2017-10-10 23:52:59.290546
NCT02273596|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-11-22|||November 2014||2014-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Safety Study of WTX101 in Adult Wilson Disease Patients|A Phase 2, Multi-centre, Open-label, Study to Evaluate the Efficacy and Safety of WTX101 Administered for 24 Weeks in Newly Diagnosed Wilson Disease Patients Aged 18 and Older With an Extension Phase of 12 Months|Active, not recruiting||Phase 2|30|Anticipated|Wilson Therapeutics AB||1|||f||||t||||||||||2017-10-10 23:52:59.371069|2017-10-10 23:52:59.371069
NCT02273583|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-02-10|||May 2006||2006-05-01|February 2016|2016-02-01||||June 2013|Actual|2013-06-01||Interventional|||Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the Extremity||Recruiting||Phase 2|738|Anticipated|Grupo de Apoio ao Adolescente e a Crianca com Cancer||2|||f||||t||||||||||2017-10-10 23:52:59.472869|2017-10-10 23:52:59.472869
NCT02273063|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-05-10|||October 2014||2014-10-01|May 2017|2017-05-01|April 22, 2016|Actual|2016-04-22|April 22, 2016|Actual|2016-04-22||Interventional|||rTMS for PTSD Comorbid With Major Depressive Disorder|5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder|Completed||N/A|40|Actual|Butler Hospital||1|||f||||f||||||||||2017-10-10 23:53:07.217042|2017-10-10 23:53:07.217042
NCT02273570|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-09-12|||March 2015||2015-03-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|OPTIMAL||Optimal Anemia Treatment in End Stage Renal Disease (ERSD)|Single-center, Open-label, Randomized Study of Anemia Management Improvement in End Stage Renal Disease (ESRD) Patients With Secondary Hyperparathyroidism|Unknown status|Recruiting|N/A|50|Anticipated|Azienda Ospedaliera Sant'Anna||2|||f||||f||||||||||2017-10-10 23:52:59.559423|2017-10-10 23:52:59.559423
NCT02273557|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||January 2003||2003-01-01|October 2014|2014-10-01||||February 2003|Actual|2003-02-01||Interventional|||Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects|Bioavailability of Dipyridamole of Asasantin p.o. (Extended Release 200 mg Dipyridamole/25 mg ASA) in Three Experimental Formulations (Given BID Over 3 Days Each) Relative to the Standard Formulation After a run-in Phase (Persantine ER BID for 2 Days Each: 25 mg, 50 mg, 100 mg; 150 mg [Persantine®]; 200 mg Persantine/25 mg ASA [Asasantin ER] in Healthy Male Subjects. Four-way, Change-over, Randomised, Open|Completed||Phase 1|19|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:52:59.66253|2017-10-10 23:52:59.66253
NCT02273544|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||September 2002||2002-09-01|October 2014|2014-10-01||||October 2002|Actual|2002-10-01||Interventional|||Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects|Bioavailability of Dipyridamole After Asasantin (Extended Release 200mg Dipyridamole/25mg ASA) in 3 Experimental Formulations (Given b.i.d. Over 3 or 5 Days, Respectively) Relative to the Standard Formulation in 16 Healthy Female and Male Subjects. Intraindividual Comparison, Randomised, Open|Terminated||Phase 1|16|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:52:59.741816|2017-10-10 23:52:59.741816
NCT02273531|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||January 2004||2004-01-01|October 2014|2014-10-01||||March 2004|Actual|2004-03-01||Interventional|||Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers|Bioequivalence of a New Asasantin Capsule Formulation (Extended Release Combination 200 mg Dipyridamole/25 mg ASA) Compared to the Commercially Available Asasantin Capsule Formulation (Aggrenox®; Extended Release Combination 200 mg Dipyridamole/25 mg ASA) Following Multiple Oral Administration at Steady State After a run-in Phase (Persantine ER BID for 2 Days Each: 25 mg, 50 mg, 100 mg, 150 mg [Persantine®]; 200 mg Dipyridamole/25 mg ASA [Asasantin ER])- an Open Label, Randomized, Multiple-dose, Two-way Crossover, Change-over Study in Healthy Male and Female Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:52:59.81047|2017-10-10 23:52:59.81047
NCT02273518|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||April 2001||2001-04-01|October 2014|2014-10-01||||May 2001|Actual|2001-05-01||Interventional|||Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers|A Double-blind, Randomised, 3-way Cross-over Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin ER Extended Release (ER) 200 mg Dipyridamole/25 mg ASA Formulations in Healthy Male and Female Volunteers|Completed||Phase 1|18|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:52:59.883896|2017-10-10 23:52:59.883896
NCT02273505|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||April 2000||2000-04-01|October 2014|2014-10-01||||May 2000|Actual|2000-05-01||Interventional|||Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects|Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) 200/25 mg Capsules Bid and in a Combination of Persantin Immediate Release Tablets (100 mg Qid) and ASA Tablets (25 mg Bid) in an Open, Randomized, 2-way Crossover Study in Healthy Subjects|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:52:59.955159|2017-10-10 23:52:59.955159
NCT02273492|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||August 1999||1999-08-01|October 2014|2014-10-01||||October 1999|Actual|1999-10-01||Interventional|||Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects|Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin Extended Release (ER) 200/25 mg Capsules b.i.d. in a Randomized, Open, 2-way Cross-over Study in Healthy Subjects|Completed||Phase 1|28|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:00.046252|2017-10-10 23:53:00.046252
NCT02273479|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||July 1999||1999-07-01|October 2014|2014-10-01||||September 1999|Actual|1999-09-01||Interventional|||Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers|Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) 200/25 mg Capsules b.i.d. in Randomised, Double-blind, Placebo-controlled Study in Japanese Healthy Male Volunteers|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:00.138461|2017-10-10 23:53:00.138461
NCT02273466|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||February 2002||2002-02-01|October 2014|2014-10-01||||April 2002|Actual|2002-04-01||Interventional|||Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects|Pharmacokinetics of 50 mg Desipramine Daily, Given Orally Over 7 Days With and Without Concomitant Administration of 175 mg Crobenetine, Given as a 6 Hrs i.v. Infusion (One Hour Loading Dose Directly Followed by a Five Hours Maintenance Dose). A Randomized, Placebo Controlled, Single Blind (for Crobenetine), Two-way Cross Over Trial in Healthy Male Subjects|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:00.232084|2017-10-10 23:53:00.232084
NCT02273453|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||February 2003||2003-02-01|October 2014|2014-10-01||||June 2003|Actual|2003-06-01||Interventional|||Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets|A Randomised, Double-blind, Double-dummy, Placebo-controlled Cross-over Trial to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets (120 mg Valerian / 80 mg Lemon Balm)|Completed||Phase 1|54|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:53:00.741075|2017-10-10 23:53:00.741075
NCT02273440|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||May 2000||2000-05-01|October 2014|2014-10-01||||July 2000|Actual|2000-07-01||Interventional|||Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers|The Effects of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of a Single Dose of Theophylline in Healthy Male Volunteers (a Randomized, Double-blind, Placebo-controlled, Two-period, Two-way Crossover Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:00.974347|2017-10-10 23:53:00.974347
NCT02271191|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-21|||May 2012||2012-05-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Nicardipine on Renal Function in Deliberate Hypotension|Effect of Nicardipine on Renal Function in Deliberate Hypotension|Completed||Phase 4|64|Actual|Yonsei University||2|||f||||t||||||||||2017-10-10 23:53:27.653132|2017-10-10 23:53:27.653132
NCT02273427|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||February 2000||2000-02-01|October 2014|2014-10-01||||March 2000|Actual|2000-03-01||Interventional|||Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers|Randomised 3-way Cross-over Phase I Study to Investigate the Effect of Different Food Compositions (Low Fat and High Fat Meal) on Bioavailability of BIIL 284 BS 75 mg Tablet in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:53:01.080528|2017-10-10 23:53:01.080528
NCT02273414|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||July 1999||1999-07-01|October 2014|2014-10-01||||September 1999|Actual|1999-09-01||Interventional|||Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Doses of BIIL 284 BS in Healthy Male Volunteers|A Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Repeated Oral Doses (9 Days Dosing) of BIIL 284 BS (Doses: 25 mg, 150 mg, 250 mg as WIF Tablets) in Healthy Male Volunteers|Completed||Phase 1|35|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:01.158164|2017-10-10 23:53:01.158164
NCT02273401|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2014-10-23|||January 2008||2008-01-01|October 2014|2014-10-01||||August 2008|Actual|2008-08-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male Volunteers|A Randomised, Double-blind, Placebo-controlled (Within Dose Groups) Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses (0.5 μg to 70 μg Administered With the Respimat®) of BI 11054 CL in Healthy Male Volunteers|Completed||Phase 1|96|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:01.255965|2017-10-10 23:53:01.255965
NCT02273388|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-23|2017-08-25|||November 4, 2005|Actual|2005-11-04|August 2017|2017-08-01|August 26, 2022|Anticipated|2022-08-26|January 19, 2009|Actual|2009-01-19||Interventional|||BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours|An Open Phase I Single Dose Escalation Study of BI 6727 Administered Intravenously in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit|Active, not recruiting||Phase 1|65|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:53:01.35291|2017-10-10 23:53:01.35291
NCT02273362|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-22|2017-09-12|||November 24, 2014|Actual|2014-11-24|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery|Pilot Study of EGFR Inhibition With Erlotinib in Cirrhosis to Inhibit Fibrogenesis and Prevent Hepatocellular Carcinoma|Recruiting||N/A|45|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-10 23:53:02.415678|2017-10-10 23:53:02.415678
NCT02273349|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-05-01|||October 2014||2014-10-01|May 2017|2017-05-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|LuReCAA||Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency|Evaluation of the PneumRx, Inc. Lung Volume Reduction Coil for the Treatment of Emphysema in Alpha-1 Antitrypsin Deficient Patients|Withdrawn||N/A|0|Actual|University Hospital, Saarland||1|||f||||f||||||||||2017-10-10 23:53:02.541869|2017-10-10 23:53:02.541869
NCT02273336|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-04-11|||July 22, 2014|Actual|2014-07-22|April 2017|2017-04-01|July 22, 2019|Anticipated|2019-07-22|July 22, 2018|Anticipated|2018-07-22||Observational|||Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer|Genomics of Young Lung Cancer Study|Recruiting||N/A|60|Anticipated|University of Southern California|||1||f||||f|f|f||||Samples With DNA|"     Blood and tissue   "|||2017-10-10 23:53:02.616796|2017-10-10 23:53:02.616796
NCT02273323|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-12-21|2016-10-11||October 2014||2014-10-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|T||Flow Mediated Dilation in Response to Black Tea|Flow Mediated Dilation in Response to Consumption of Black Tea Versus Artificial Tea, in Non-tea Drinking Hypertensive Subjects.|Completed||N/A|30|Actual|Unilever R&D||2|||f||||f||||||||No||2017-10-10 23:53:02.720139|2017-10-10 23:53:02.720139
NCT02273310|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-12-01|2014-10-29||July 2009||2009-07-01|December 2015|2015-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|FTC||Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease|Families Taking Control (FTC): Family-based Problem-solving Intervention for School-age Children With Sickle Cell Disease|Completed||N/A|83|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-10 23:53:03.058354|2017-10-10 23:53:03.058354
NCT02273297|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-05-15|||July 2009||2009-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth|Exploring the Fuel-mediated Programming of Neonatal Growth|Active, not recruiting||N/A|2821|Actual|University of Colorado, Denver|||1||f||||||||||||||2017-10-10 23:53:03.305744|2017-10-10 23:53:03.305744
NCT02273284|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2015-08-17|||December 2014||2014-12-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Pain Perception of Children and Youth Receiving Non-sedated Botulinum Toxin-A Injections Using the Buzzy®|Pain Perception of Children and Youth Receiving Non-sedated Botulinum Toxin-A Injections Using the Buzzy®|Unknown status|Recruiting|N/A|50|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f||||||||||2017-10-10 23:53:03.389287|2017-10-10 23:53:03.389287
NCT02273271|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-10-29|||October 2015||2015-10-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|EVIDENCE||Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo|Evaluation of 3'-Deoxy-3'-[18F]Fluorothymidine -PET and Diffusion Weighted Imaging -MRI in Patients With Early Stage Non-small Cell Lung Cancer Treated With a Platinum-based Doublet as Preoperative Chemotherapy|Unknown status|Recruiting|N/A|31|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||t||||||||||2017-10-10 23:53:03.482539|2017-10-10 23:53:03.482539
NCT02273258|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-10-21|||March 2013||2013-03-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes|A Randomized, Double-Blind, Controlled, Single-Dose, 3-Treatment, 3-Period, 6-Sequence Crossover Study to Compare Exposure and Activity of SAR342434 to Humalog® Using the Euglycemic Clamp Technique, in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|30|Actual|Sanofi||3|||f||||f||||||||||2017-10-10 23:53:03.572917|2017-10-10 23:53:03.572917
NCT02273232|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2017-09-22|||January 2015||2015-01-01|September 2017|2017-09-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|RIPC-PVD||Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial|Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial|Completed||Phase 1|40|Actual|National University of Ireland, Galway, Ireland||4|||f||||t||||||||||2017-10-10 23:53:03.714302|2017-10-10 23:53:03.714302
NCT02273219|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-12-15|||November 2014||2014-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Trial of AEB071 in Combination With BYL719 in Patients With Melanoma|Phase Ib Trial of AEB071, a PKC Inhibitor, in Combination With BYL719, a PI3Kα Inhibitor, in Patients With Metastatic Uveal Melanoma|Recruiting||Phase 1|50|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-10 23:53:03.811188|2017-10-10 23:53:03.811188
NCT02273206|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-07-25|||January 2014||2014-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PCM3||Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)|Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project|Active, not recruiting||N/A|802|Actual|Clinical Directors Network||2|||f||||f||||||||||2017-10-10 23:53:04.040563|2017-10-10 23:53:04.040563
NCT02273193|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-08-09|||April 2013|Actual|2013-04-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|A1cGDM||Utility Of Hemoglobin A1C For The Diagnosis Of Gestational Diabetes|Utility Of Hemoglobin A1C (HbA1C) For The Diagnosis Of Gestational Diabetes Mellitus (GDM).|Suspended||N/A|750|Anticipated|Mike O'Callaghan Federal Hospital|||1|pending interim data analysis|f||||f||||||||||2017-10-10 23:53:04.168041|2017-10-10 23:53:04.168041
NCT02273180|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-12-21||2016-12-20|October 2014||2014-10-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|SORELLA 1||Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine|Six-Month, Randomized, Open-Label, Parallel-group Comparison of SAR342434 to Humalog® in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine, With a 6-month Safety Extension Period|Completed||Phase 3|507|Actual|Sanofi||2|||f||||f||||||||||2017-10-10 23:53:04.254139|2017-10-10 23:53:04.254139
NCT02273167|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-03-07|2016-08-19||October 2014||2014-10-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.|A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) Versus MOVIPREP Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.|Completed||Phase 3|849|Actual|Norgine||3|||f||||f||||||||||2017-10-10 23:53:04.600763|2017-10-10 23:53:04.600763
NCT02273154|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2014-10-22|||August 2014||2014-08-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder||Unknown status|Recruiting|Phase 4|240|Anticipated|Peking University||2|||f||||f||||||||||2017-10-10 23:53:05.333434|2017-10-10 23:53:05.333434
NCT02273141|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-03-07|2016-08-19||November 2014||2014-11-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.|A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) Versus Sodium Picosulfate and Magnesium Salt (SP+MS) Solution Using Day Before-Only Dosing Regimen in Adults.|Completed||Phase 3|515|Actual|Norgine||2|||f||||f||||||||||2017-10-10 23:53:05.487923|2017-10-10 23:53:05.487923
NCT02273128|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2015-04-18|||June 2014||2014-06-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|CTROP||A Study to Assess the Disturbances in Calcitonin Gene in Patients With Gum Disease and Osteoporosis|Calcitonin Receptor Gene Polymorphisms in Patients With Osteoporosis and Chronic Periodontitis-An Observational Study|Completed||N/A|50|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre|||1||f||||t||||||Samples With DNA|"     2ml of blood sample from each subject was collected in EDTA containing vials and kept at -20     degrees until DNA extraction. The genomic DNA was isolated and C/T polymorphism in CTR gene     was identified by PCR followed by restriction digestion pattern by Alu 1 restriction enzyme.   "|||2017-10-10 23:53:05.999291|2017-10-10 23:53:05.999291
NCT02273115|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-06-02|2017-03-17||October 2014||2014-10-01|June 2017|2017-06-01|September 11, 2016|Actual|2016-09-11|September 11, 2016|Actual|2016-09-11||Interventional|NOFOX||Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor|Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor (NOFOX): a Randomized Control Trial|Completed||Phase 4|323|Actual|Christiana Care Health Services||4|||f||||f||||||||No||2017-10-10 23:53:06.145359|2017-10-10 23:53:06.145359
NCT02273102|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-08-21|||March 2, 2015|Actual|2015-03-02|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|TCP-ATRA||Phase 1 Study of TCP-ATRA for Adult Patients With AML and MDS|An Open-Label, Dose Escalation, Phase 1 Study of Tranylcypromine (TCP) in Combination With ATRA (Tretinoin) for Adult Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS)|Recruiting||Phase 1|25|Anticipated|University of Miami||3|||f||||t|t|f|||f|||||2017-10-10 23:53:06.918197|2017-10-10 23:53:06.918197
NCT02273089|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-07-11|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Observational|STIFFSLEEP||CPAP to Reduce Arterial Stiffness in Non Sleepy, Moderate to Severe Obstructive Sleep Apnea (STIFFSLEEP)|Use of CPAP to Reduce Arterial Stiffness in Moderate to Severe Obstructive Sleep Apnea, Without Excessive Daytime Sleepiness (STIFFSLEEP)|Terminated||N/A|45|Actual|Centro Hospitalar de Lisboa Central|||2|Recruitment stopped due to time restrains|f||||f||||||||||2017-10-10 23:53:07.024283|2017-10-10 23:53:07.024283
NCT02273076|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-29|||October 2014||2014-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Predicting Breast Flap Necrosis by Spatial Frequency Domain Imaging|Predicting Breast Flap Necrosis by Spatial Frequency Domain Imaging|Withdrawn||N/A|0|Actual|University of California, Irvine|||1||f||||f||||||||||2017-10-10 23:53:07.105163|2017-10-10 23:53:07.105163
NCT02273024|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-03-04|||October 2014||2014-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Exercise Prior to Allogeneic Hematologic Stem Cell Transplantation|Exercise Therapy for Patients Awaiting Allogeneic Hematological Stem Cell Transplantation|Recruiting||N/A|80|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:53:07.504974|2017-10-10 23:53:07.504974
NCT02273011|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-10-21|||March 2007||2007-03-01|October 2014|2014-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Combined Spinal-epidural Versus Spinal Analgesia for Elective Caesarean Section in the Postoperative Period|Combined Spinal-epidural Versus Spinal Analgesia for Elective Caesarean Section in the Postoperative Period|Completed||N/A|60|Actual|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f||||||||||2017-10-10 23:53:07.589889|2017-10-10 23:53:07.589889
NCT02272998|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-08-02|||February 24, 2015|Actual|2015-02-24|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.|Phase II Study of Ponatinib for Advanced Cancers With Genomic Alterations in Fibroblastic Growth Factor Receptor (FGFR) and Other Genomic Targets (KIT, PDGFRá, RET FLT3, ABL1)|Recruiting||Phase 2|45|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:53:07.653326|2017-10-10 23:53:07.653326
NCT02272985|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2015-11-30|||April 2015||2015-04-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Cerebral Blood Flow During Hemodialysis|A [15O]H2O PET-CT Pilot Study Comparing Cerebral Blood Flow Before, During and After Hemodialysis|Completed||N/A|15|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-10 23:53:07.740531|2017-10-10 23:53:07.740531
NCT02272972|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-03-16|||October 2014||2014-10-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||Performance Improvement Program on Imaging II|Performance Improvement Program on Imaging II|Recruiting||N/A|250|Anticipated|AO Clinical Investigation and Documentation|||2||f||||f||||||||||2017-10-10 23:53:07.814826|2017-10-10 23:53:07.814826
NCT02272959|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-10-25|||January 2015||2015-01-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth Who do Not Respond to CBT|Attention Bias Modification Treatment for Children With Anxiety Disorders Who do Not Respond to Cognitive Behavioral Therapy: A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Tel Aviv University||2|||f||||f||||||||||2017-10-10 23:53:09.862841|2017-10-10 23:53:09.862841
NCT02272946|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-07-31|||September 2015||2015-09-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk|Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk|Recruiting||Phase 2|110|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-10 23:53:09.961951|2017-10-10 23:53:09.961951
NCT02272933|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-05|||August 2014||2014-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|GFD1||Operability and Implementation of a Patient Motion Monitoring System Using Wireless Body Worn Sensors|Operability and Implementation of a Patient Motion Monitoring System Using Wireless Body Worn Sensors|Recruiting||N/A|10|Anticipated|Texas Tech University Health Sciences Center||1|||f||||f||||||||||2017-10-10 23:53:10.063761|2017-10-10 23:53:10.063761
NCT02272920|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-10-23|||October 2014||2014-10-01|October 2014|2014-10-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|COMBI-RDN||PCI and Renal Denervation in Hypertensive Patients With Acute Coronary Syndromes|Combined Treatment With Percutaneous Coronary Intervention and Renal Denervation in Hypertensive Patients With Acute Coronary Syndromes.|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-10 23:53:10.152017|2017-10-10 23:53:10.152017
NCT02272907|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-05-18|||November 2014||2014-11-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Interventional|||Leak Pressure After Reinforcement in Gastric Specimens|Comparison of Leak Pressure in the Resected Gastric Specimen From Sleeve Gastrectomy With Different Reinforcement Techniques|Unknown status|Enrolling by invitation|N/A|48|Anticipated|Santa Barbara Cottage Hospital||4|||f||||f||||||||||2017-10-10 23:53:10.232748|2017-10-10 23:53:10.232748
NCT02272894|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-12-08|||July 2014||2014-07-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01|3 Years|Observational [Patient Registry]|||A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer|Randomized Controlled Trial to Evaluate Mesenteric Vein (14V) Lymphadenectomy for Gastric Cancer|Unknown status|Recruiting|N/A|510|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||2||f||||t||||||||||2017-10-10 23:53:10.302206|2017-10-10 23:53:10.302206
NCT02272881|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-21|||November 2014||2014-11-01|October 2014|2014-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Randomized, Prospective Clinical Trial of Immediate Flap Closure Versus Wound Care for Management of Late-stage Pressure Ulcers|The Santa Barbara Pressure Ulcer Study Comparison of Immediate Flap Closure Versus Wound Care for Management of Late-stage Pressure Ulcers: a Randomized, Prospective Clinical Trial|Unknown status|Not yet recruiting|N/A|50|Anticipated|Santa Barbara Cottage Hospital||2|||f||||f||||||||||2017-10-10 23:53:10.390696|2017-10-10 23:53:10.390696
NCT02272868|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-11-16|||January 2015||2015-01-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|FMTCD||Fecal Microbial Transplant in Pediatric Crohn's Disease|Fecal Microbial Transplant in Pediatric Crohn's Disease: A Double Blind Placebo Control Study|Recruiting||Phase 1/Phase 2|32|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-10 23:53:10.453392|2017-10-10 23:53:10.453392
NCT02272855|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-09-28|||April 30, 2014|Actual|2014-04-30|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Interventional|||A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma|A Phase II Study of Combination Treatment With HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab in Patients With Stage IIIB, Stage IIIC, or Stage IV Unresectable or Metastatic Malignant Melanoma|Active, not recruiting||Phase 2|46|Actual|Takara Bio Inc.||1|||f||||f|t|f||||||||2017-10-10 23:53:10.546253|2017-10-10 23:53:10.546253
NCT02272842|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-04-20|||April 20, 2015|Actual|2015-04-20|April 2017|2017-04-01|December 31, 2018|Anticipated|2018-12-31|February 28, 2018|Anticipated|2018-02-28||Interventional|BeLive||Vitamin B12, Neurodevelopment and Growth in Nepal|The Effect of Vitamin B12 Supplementation in Nepali Infants on Growth and Development|Active, not recruiting||Phase 2/Phase 3|600|Anticipated|Centre For International Health||2|||f||||t||||||||Undecided||2017-10-10 23:53:10.652482|2017-10-10 23:53:10.652482
NCT02272829|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-15|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|CHOACOT||Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic Pain|Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic Pain|Completed||N/A|8|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-10 23:53:10.913931|2017-10-10 23:53:10.913931
NCT02272816|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-08-30|||February 2012||2012-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Car-PET||Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT|A Multi-Centre Phase II Study Using Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT|Active, not recruiting||Phase 2|48|Actual|Barts & The London NHS Trust||1|||f||||f||||||||||2017-10-10 23:53:10.998307|2017-10-10 23:53:10.998307
NCT02272803|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-10-03|||January 22, 2015|Actual|2015-01-22|October 2017|2017-10-01|December 31, 2020|Anticipated|2020-12-31|February 9, 2017|Actual|2017-02-09||Interventional|||Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan|A Phase 2, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Subjects With Previously Untreated Multiple Myeloma in Japan|Active, not recruiting||Phase 2|90|Actual|Bristol-Myers Squibb||2|||f||||f|t|f|||t|||||2017-10-10 23:53:11.109522|2017-10-10 23:53:11.109522
NCT02272790|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-05-22|||January 30, 2015|Actual|2015-01-30|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||AZD1775 Plus Chemotherapy in Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Multicentre Phase II Study of AZD1775 Plus Chemotherapy in Patients With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 2|97|Anticipated|AstraZeneca||2|||f||||f|t|f||||||||2017-10-10 23:53:11.26857|2017-10-10 23:53:11.26857
NCT02272777|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-03-29|||July 17, 2014|Actual|2014-07-17|March 2017|2017-03-01|February 8, 2017|Actual|2017-02-08|February 8, 2017|Actual|2017-02-08||Interventional|||A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase|An Open-label Multi-center Study of Imatinib and Nilotinib in CAMN107ECN02 On-treatment Patients With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase After the End of CAMN107ECN02 Core Study|Completed||Phase 3|225|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:53:11.435346|2017-10-10 23:53:11.435346
NCT02272764|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-12-11|||October 2014||2014-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Drug-Drug Interaction Study of ALKS 5461 in Healthy Volunteers|A Phase 1 Study of the Effects of Itraconazole on the Pharmacokinetics of ALKS 5461 in Healthy Volunteers|Completed||Phase 1|24|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-10-10 23:53:11.555125|2017-10-10 23:53:11.555125
NCT02272751|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-05-18|||September 2014||2014-09-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|REIL||Relaxation and Exercise In Lymphoma Patients|A Comparison of Exercise Training With Relaxation Intervention in Lymphoma Patients Post-chemotherapy.|Unknown status|Recruiting|N/A|40|Anticipated|St George's, University of London||2|||f||||t||||||||||2017-10-10 23:53:11.640599|2017-10-10 23:53:11.640599
NCT02272738|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2015-04-20|||August 2013||2013-08-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|November 2015|Anticipated|2015-11-01||Interventional|||A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer|A Phase I Study of Chemoradiotherapy Using Gemcitabine Plus Nab-paclitaxel for Unresectable Locally Advanced Pancreatic Adenocarcinoma|Unknown status|Recruiting|Phase 1|54|Anticipated|Osaka Medical Center for Cancer and Cardiovascular Diseases||1|||f||||t||||||||||2017-10-10 23:53:11.743638|2017-10-10 23:53:11.743638
NCT02272725|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-04-07|2017-01-24||March 2015||2015-03-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|March 2016|Actual|2016-03-01||Interventional|NAKED||Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances|Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances|Completed||Phase 3|91|Actual|Stanford University||2|||f||||t|t|f|||f|||No||2017-10-10 23:53:11.830107|2017-10-10 23:53:11.830107
NCT02272712|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-01-10|||January 2017||2017-01-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||The Effectiveness of Online Treatment for Insomnia in Cancer Survivors|The Effectiveness of Online Treatment for Insomnia in Cancer Survivors: A Randomized Controlled Trial|Not yet recruiting||N/A|148|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 23:53:12.119933|2017-10-10 23:53:12.119933
NCT02272699|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2017-04-05|||November 2014||2014-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma|Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy Versus Surgery Alone in Resectable Esophageal Squamous Cell Carcinoma|Suspended||Phase 2/Phase 3|195|Anticipated|Peking University||3||"Because there are questions about adjuvant radiotherapy in this study, the clinical trial is   under re-design."|f||||t||||||||||2017-10-10 23:53:12.212533|2017-10-10 23:53:12.212533
NCT02272686|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-03-03|||June 3, 2016|Actual|2016-06-03|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma|"Targeting Bruton's Tyrosine Kinase (BTK) With Ibrutinib After Autologous Stem Cell Transplantation in Double-Hit B-Cell Lymphoma"|Active, not recruiting||Phase 2|1|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:53:12.3025|2017-10-10 23:53:12.3025
NCT02272673|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2014-10-23|||March 2011||2011-03-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|August 2013|Actual|2013-08-01||Observational|||The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia|The Effect of Honey on Episodes of Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia: A Randomized Crossover Open- Labeled Pilot Study|Completed||Phase 3|40|Actual|Ain Shams University|||1||f||||t||||||||||2017-10-10 23:53:12.377116|2017-10-10 23:53:12.377116
NCT02272660|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-08-27|||October 2014||2014-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty|Perioperative Parecoxib Administration for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty-A Randomized, Placebo-controlled Trial|Completed||Phase 4|74|Actual|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-10 23:53:12.43941|2017-10-10 23:53:12.43941
NCT02272647|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-03-21|||December 2014||2014-12-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|December 2016|Actual|2016-12-01||Interventional|||Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women|Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women|Active, not recruiting||Phase 1|47|Actual|Mayo Clinic||4|||f||||t||||||||||2017-10-10 23:53:12.707251|2017-10-10 23:53:12.707251
NCT02272634|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2017-08-17|||June 4, 2015|Actual|2015-06-04|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||A Phase 2a Study to Assess Safety, Daily Symptoms, Pharmacokinetics (PK), and Biomarkers of YPL-001 in Chronic Obstructive Pulmonary Disease (COPD) Patients|A Randomized, Double-Blind, Placebo Controlled, Multicenter Phase 2a Study to Assess Safety, Daily Respiratory Symptoms, Pharmacokinetics, and Biomarker Variations After Administration of Either YPL-001, or Placebo in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease|Recruiting||Phase 2|61|Anticipated|Yungjin Pharm. Co., Ltd.||3|||f||||||||||||||2017-10-10 23:53:12.814297|2017-10-10 23:53:12.814297
NCT02272621|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-07-17|||April 2015||2015-04-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Surgical Trauma After Partial Upper Hemisternotomy Versus Full Sternotomy Aortic Valve Replacement||Recruiting||N/A|40|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-10 23:53:12.940069|2017-10-10 23:53:12.940069
NCT02272608|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2014-10-21|||November 2012||2012-11-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Observational|||Evaluation of Sleep Apnea Related Inflammation With CRP, ESR and Neutrophil toLymphocyte Ratio||Completed||N/A|279|Actual|T.C. ORDU ÜNİVERSİTESİ|||4||f||||||||||||||2017-10-10 23:53:13.026364|2017-10-10 23:53:13.026364
NCT02272595|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-11-07|||November 2014||2014-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Observational|||Rational Therapeutics Based on Matched Tumor and Normal Tissue|A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies|Recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||Samples With DNA|"     Blood (about 2 teaspoons) drawn initially and again about 2-3 weeks after chosen treatment     begins.   "|||2017-10-10 23:53:13.091818|2017-10-10 23:53:13.091818
NCT02272582|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-05-29|||September 2014||2014-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2017|Actual|2017-01-01||Interventional|GALA||A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing CABG (STEPS)|A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing Coronary Artery Bypass Grafting (CABG)|Recruiting||N/A|100|Anticipated|Montreal Heart Institute||2|||f||||f||||||||||2017-10-10 23:53:13.187477|2017-10-10 23:53:13.187477
NCT02272569|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-08-25|||September 2014||2014-09-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Interventional|||STARflo European Safety and Efficacy Study|A Prospective, Non-comparative, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the STARflo Glaucoma Implant in Patients With Open Angle Glaucoma|Recruiting||N/A|50|Anticipated|iSTAR Medical||1|||f||||||||||||||2017-10-10 23:53:13.279775|2017-10-10 23:53:13.279775
NCT02272556|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-08-17|||February 2015||2015-02-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Investigating the Role of the Polyol Pathway in the Central Nervous System|Investigating the Role of Polyol Pathway in the Central Nervous System|Recruiting||Early Phase 1|45|Anticipated|Yale University||3|||f||||f||||||||||2017-10-10 23:53:13.401093|2017-10-10 23:53:13.401093
NCT02272543|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-09-21|||October 2014||2014-10-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Acceptability and Efficacy of 'Fish Surimi Peptide' in Under Five Children Suffering From Moderate Acute Malnutrition||Completed||Phase 1|100|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-10 23:53:13.488682|2017-10-10 23:53:13.488682
NCT02272530|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2016-10-19|||July 2012||2012-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells|Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells|Recruiting||N/A|200|Anticipated|Heinrich-Heine University, Duesseldorf|||2||f||||f||||||Samples Without DNA|"     Blood sample   "|||2017-10-10 23:53:13.567208|2017-10-10 23:53:13.567208
NCT02272517|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-21|2017-02-27|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder|An Interventional, Randomised, Double-blind, Parallel-group, Active-comparator, Flexible-dose Study on the Efficacy of Vortioxetine Versus Escitalopram on Cognitive Dysfunction in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder|Completed||Phase 3|101|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-10 23:53:13.653947|2017-10-10 23:53:13.653947
NCT02272504|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-04-26|||August 2014||2014-08-01|April 2016|2016-04-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Observational|||A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers|A Randomized Controlled Trial to Determine the Role of Biomarkers in Surveillance for Hepatocellular Carcinoma (HCC)|Recruiting||N/A|2500|Anticipated|Wako Life Sciences|||2||f||||f||||||Samples Without DNA|"     Frozen Serum samples will be retained   "|||2017-10-10 23:53:13.775518|2017-10-10 23:53:13.775518
NCT02272491|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-08-23|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|MonoZrO2crown||Monolithic Zirconia Crowns for Single Implants in the Molar Region: a Multicenter Clinical Trial|Monolithic Zirconia Crowns for Single Implants in the Molar Region: a Multicenter Randomized Controlled Clinical Trial|Recruiting||N/A|80|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-10 23:53:13.861888|2017-10-10 23:53:13.861888
NCT02272478|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-10-24|||October 2014||2014-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|AML18||Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations|A Trial for Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome|Recruiting||Phase 3|1600|Anticipated|Cardiff University||5|||f||||t||||||||||2017-10-10 23:53:13.956331|2017-10-10 23:53:13.956331
NCT02272465|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-12-07|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PROHS||Prehospital Resuscitation On Helicopter Study|Prehospital Resuscitation On Helicopter Study|Completed||N/A|1049|Actual|The University of Texas Health Science Center, Houston|||2||f||||f||||||||||2017-10-10 23:53:14.080789|2017-10-10 23:53:14.080789
NCT02272452|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-22|||October 2014||2014-10-01|October 2014|2014-10-01||||October 2017|Anticipated|2017-10-01||Observational|ExtempoRMN||Assistance in Neurosurgery (ExtempoRMN)|Assistance in Neurosurgery by Extemporaneous Analysis of Magnetic Resonance of the Metabolic Content in Excised Tissues (ExtempoRMN)|Unknown status|Not yet recruiting|N/A|1000|Anticipated|University Hospital, Strasbourg, France|||1||f||||||||||||||2017-10-10 23:53:14.190377|2017-10-10 23:53:14.190377
NCT02272439|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-12-18|||March 2012||2012-03-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01|3 Weeks|Observational [Patient Registry]|||Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan|Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan.|Completed||N/A|118|Actual|University of Saskatchewan|||8||f||||f||||||Samples With DNA|"     Blood, Follicular Fluid and Seminal Plasma Samples   "|||2017-10-10 23:53:14.271955|2017-10-10 23:53:14.271955
NCT02272426|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-06-29|||November 2014||2014-11-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||The Safety and Tolerability of an Aerobic and Resistance Exercise Program With Cognitive Training Post-stroke|The Safety and Tolerability of an Aerobic and Resistance Exercise Program With Cognitive Training Post-stroke|Recruiting||N/A|120|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 23:53:14.34741|2017-10-10 23:53:14.34741
NCT02272400|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-09-07|||August 7, 2007|Actual|2007-08-07|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PBI||Image Guided Radiotherapy (IGRT) for Prone Partial Breast Irradiation|Image Guided Radiotherapy (IGRT) for Prone Partial Breast Irradiation (PBI)|Active, not recruiting||N/A|310|Actual|New York University School of Medicine||1|||f||||t|f|f||||||||2017-10-10 23:53:15.056144|2017-10-10 23:53:15.056144
NCT02272387|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-08-23|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|April 14, 2016|Actual|2016-04-14|April 14, 2016|Actual|2016-04-14||Interventional|||Is Vitamin D Insufficiency and Deficiency Associated With Antepartum and Postpartum Depression?|Is Vitamin D Insufficiency and Deficiency Associated With Antepartum and Postpartum Depression?|Terminated||N/A|151|Actual|St. Luke's-Roosevelt Hospital Center||2||Low enrollment and limited research staffing|f||||f|f|f||||||||2017-10-10 23:53:15.135472|2017-10-10 23:53:15.135472
NCT02272374|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-20|||October 2014||2014-10-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ACCESS-China||Vascular Access Choice and Outcomes in the Elderly and Very Elderly With End Stage Renal Disease in China|Vascular Access Choice and Outcomes in the Elderly and Very Elderly With End Stage Renal Disease in China :a Multicenter Prospective Cohort Study|Not yet recruiting||N/A|500|Anticipated|Shanghai Changzheng Hospital||6|||f||||t||||||||||2017-10-10 23:53:15.222677|2017-10-10 23:53:15.222677
NCT02272361|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-10-13|||October 2014||2014-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|PROSPERE4||Trial Comparing Laparoscopic Sacropexy and Vaginal Mesh Surgery for Women Cystocele Repair.|Randomized Controlled Trial Comparing Laparoscopic Sacropexy and Vaginal Mesh Surgery for Women Cystocele Repair: Functional and Anatomical Results at Four Years Follow-up|Recruiting||N/A|262|Anticipated|University Hospital, Lille||2|||f||||t||||||||||2017-10-10 23:53:15.337028|2017-10-10 23:53:15.337028
NCT02272348|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-10-20|||December 2014||2014-12-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|EVAUTODIAB||Self-management of Type 1 Diabetes Under Functional Insulin Therapy|Evaluation of Self-management of Patients With Type 1 Diabetes After Education to Functional Insulin Therapy|Unknown status|Not yet recruiting|N/A|170|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-10 23:53:15.520344|2017-10-10 23:53:15.520344
NCT02272335|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-10-26|||December 2008||2008-12-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Facilitating Adjustment in Low Income Black Women With Breast Cancer|Facilitating Adjustment in Low Income Black Women With Breast Cancer|Completed||N/A|114|Actual|University of Miami||2|||f||||f||||||||||2017-10-10 23:53:15.616201|2017-10-10 23:53:15.616201
NCT02266654|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-04-13|||October 2014||2014-10-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Early Goal Directed Therapy in Sepsis by Emergency Medical Services|Early Goal Directed Therapy in Sepsis by EMS|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||2||Unable to enroll participants|f||||f||||||||||2017-10-10 23:54:14.484314|2017-10-10 23:54:14.484314
NCT02272322|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-01-31|||June 2014||2014-06-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|BCR||Transvaginal Treatment of Symptomatic Cystocele Grade II-III|Transvaginal Treatment of Symptomatic Cystocele Grade II-III Using Cousin Biomesh Soft Prolaps or Allium Medical Endofast Reliant|Active, not recruiting||N/A|100|Anticipated|Regionaal Ziekenhuis Heilig Hart Tienen|||1||f||||f||||||||||2017-10-10 23:53:15.718365|2017-10-10 23:53:15.718365
NCT02272309|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-11-01|||May 2014||2014-05-01|November 2016|2016-11-01||||April 2018|Anticipated|2018-04-01||Interventional|||Neurophysiological Assessment of Healthy and Impaired Human Lower Urinary Tract Function||Recruiting||N/A|150|Anticipated|University of Zurich||3|||f||||f||||||||||2017-10-10 23:53:15.793338|2017-10-10 23:53:15.793338
NCT02272296|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-10-27|||February 2015||2015-02-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Reliability of Insulin by Jet Injection|Reproducibility of Insulin Action When Administered by Needle-free Jet Injection|Completed||Phase 4|30|Actual|Radboud University||3|||f||||t||||||||||2017-10-10 23:53:15.880966|2017-10-10 23:53:15.880966
NCT02272283|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-20|||August 2011||2011-08-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|OCTACS||Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Stent Implantation|Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Nobori Stent Implantation in Patients With Non ST Segment Elevation Myocardial Infarction|Completed||N/A|100|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:53:15.989757|2017-10-10 23:53:15.989757
NCT02272270|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-06-13|||October 2014||2014-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|March 9, 2017|Actual|2017-03-09||Interventional|D-TERMINED||Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)|Phase 1 Trial in Newly Diagnosed High Grade Glioma With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide. (D-TERMINED)|Active, not recruiting||Phase 1|25|Actual|University of Utah||1|||f||||t||||||||||2017-10-10 23:53:16.069792|2017-10-10 23:53:16.069792
NCT02272244|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-04-24|||April 2014||2014-04-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients||Completed||N/A|400|Actual|Thomas Jefferson University||2|||f||||f|f|f||||||No||2017-10-10 23:53:16.28171|2017-10-10 23:53:16.28171
NCT02272231|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-02-06|||September 2014||2014-09-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Observational|||Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women|Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women|Enrolling by invitation||N/A|200|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"     Self-collected vaginal swabs from women participating in this study will be stored for future     research purposes related to the study of the vaginal microbiome.   "|Yes|De-identified data will be shared with statisticians at the University of Mississippi Medical center for statistical analysis.|2017-10-10 23:53:16.38636|2017-10-10 23:53:16.38636
NCT02272205|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-10-20|||November 2014||2014-11-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Evaluation of Conventional Antibiotic Prophylaxis During a Change of Hip or Knee Infected at a Time|Evaluation of the Effect of a Conventional Antibiotic Prophylaxis on the Positivity of Intraoperative Bacteriological Samples During a Change of Hip or Knee Infected at a Time|Unknown status|Not yet recruiting|N/A|80|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-10 23:53:16.561952|2017-10-10 23:53:16.561952
NCT02272192|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-03-06|||March 2013||2013-03-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|TADPOLE||Intervention Effects of Intensity and Delivery Style for Toddlers With Autism|Intervention Effects of Intensity and Delivery Style for Toddlers With Autism|Active, not recruiting||N/A|100|Anticipated|University of California, Davis||4|||f||||t||||||||||2017-10-10 23:53:16.63584|2017-10-10 23:53:16.63584
NCT02272179|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-10-26|||February 2014||2014-02-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ASAP||Brief Intervention for Suicide Risk Reduction in High Risk Adolescents|Brief Intervention for Suicide Risk Reduction in High Risk Adolescents|Recruiting||Phase 1|110|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-10 23:53:16.765659|2017-10-10 23:53:16.765659
NCT02272166|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-08-16|||November 2014||2014-11-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Propo-Faim||Effects of Propofol on Early Recovery of Hunger After Surgery|Effects of Propofol on Early Recovery of Hunger After Ambulatory Surgery Compared With Sevoflurane|Completed||Phase 4|116|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-10 23:53:16.869062|2017-10-10 23:53:16.869062
NCT02272153|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-01-14|||February 2014||2014-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Satiety Effects of the Combination of Egg and Whole Grains|The Effects of the Combination of Egg and Whole Grains on Appetite, Blood Glucose Response and Food Intake|Completed||N/A|48|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-10 23:53:16.947164|2017-10-10 23:53:16.947164
NCT02272140|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-03-22|||October 2014||2014-10-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Advanced XLIF Monitoring Multicenter Study|A Prospective, Non-randomized, Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF® and Its Relationship to Postoperative Nerve Health|Enrolling by invitation||N/A|316|Anticipated|NuVasive|||1||f||||f||||||||No||2017-10-10 23:53:17.023576|2017-10-10 23:53:17.023576
NCT02272127|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2014-10-20|||July 2014||2014-07-01|October 2014|2014-10-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer|Intercalated Combination of Chemotherapy Plus Icotinib for Patients Undergoing Resection of EGRF Mutation-positive Non-small-cell Lung Cancer|Recruiting||Phase 2|100|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||f||||||||||2017-10-10 23:53:17.098674|2017-10-10 23:53:17.098674
NCT02272114|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-02-02|||October 2014||2014-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:53:17.164831|2017-10-10 23:53:17.164831
NCT02272101|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2014-10-21|||November 2013||2013-11-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Rhinitis in the Elderly: The Role of Vitamin D|"Rhinitis in the Elderly: A Randomized, Double-Blind, Placebo Controlled, Cross-Over Study of the Effect of Vitamin D Supplementation on Nasal Symptoms and Rhinitis Related Quality of Life"|Completed||Phase 3|15|Actual|Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.||2|||f||||f||||||||||2017-10-10 23:53:17.198336|2017-10-10 23:53:17.198336
NCT02272088|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-10-20|||November 2014||2014-11-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|PAPPAS2||Effect of Different Intensities of Exercise on Daily Energy Expenditure With Physical Activity in Overweight Boys||Unknown status|Not yet recruiting|N/A|24|Anticipated|Rio de Janeiro State University||2|||f||||t||||||||||2017-10-10 23:53:17.268202|2017-10-10 23:53:17.268202
NCT02272075|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-10-21|||November 2014||2014-11-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia|Image Comparison of a Mobile Colposcope (SmartScope) vs. a Standard Colposcope for Directing Cervical Biopsies in Women With Abnormal Pap Smears: A Non-inferiority Trial.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Scripps Health||1|||f||||f||||||||||2017-10-10 23:53:17.34311|2017-10-10 23:53:17.34311
NCT02272062|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-08-02|||November 2014||2014-11-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PREPARED||Patient-Reported Preferences Affecting Revascularization Decisions|Patient-Reported Preferences Affecting Revascularization Decisions|Completed||N/A|203|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:53:17.401656|2017-10-10 23:53:17.401656
NCT02272049|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-11-10|||November 2014||2014-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|HPXeMR||Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults|Use of Hyperpolarized 129 Xe MR Lung Imaging in Children and Adults|Recruiting||Phase 1/Phase 2|300|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||No||2017-10-10 23:53:17.479728|2017-10-10 23:53:17.479728
NCT02272036|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-04-19|||December 2015||2015-12-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|PERICLES-II||Short Message Service in Colonoscopy Preparation (PERICLES-II-SMS)|Improvement of Colonoscopy Preparation by New Media (SMS) (PERICLES-II-Study)|Completed||N/A|500|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-10 23:53:17.778192|2017-10-10 23:53:17.778192
NCT02272023|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-09-22|||February 2015||2015-02-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Randomized Trial of Intensive Motivational Interviewing (IMI) to Improve Drinking Outcomes Among Women|Randomized Trial of Intensive Motivational Interviewing (IMI) to Improve Drinking Outcomes Among Women|Recruiting||Phase 2|220|Anticipated|Public Health Institute, California||2|||f||||f||||||||||2017-10-10 23:53:17.883692|2017-10-10 23:53:17.883692
NCT02272010|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-03-01|||October 2014||2014-10-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Dietary Intervention for Bipolar Disorder|Targeted Alterations in n-3 and n‐6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder|Recruiting||Phase 1/Phase 2|84|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 23:53:18.023936|2017-10-10 23:53:18.023936
NCT02271997|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-06-30|||October 2014||2014-10-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|Ironsuppletion||Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass||Enrolling by invitation||Phase 4|120|Anticipated|Rijnstate Hospital||3|||f||||f||||||||Undecided||2017-10-10 23:53:18.194567|2017-10-10 23:53:18.194567
NCT02271971|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2015-11-03|||October 2014||2014-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis|Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Moderate to Severe Psoriasis|Completed||N/A|39|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-10 23:53:18.440358|2017-10-10 23:53:18.440358
NCT02271958|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-10-20|||November 2010||2010-11-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis|Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis|Completed||Phase 2/Phase 3|360|Actual|Mediterranea Medica S. L.||4|||f||||t||||||||||2017-10-10 23:53:18.554196|2017-10-10 23:53:18.554196
NCT02271945|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-05-23||2017-05-23|December 1, 2014|Actual|2014-12-01|May 2017|2017-05-01|May 24, 2016|Actual|2016-05-24|May 24, 2016|Actual|2016-05-24||Interventional|||Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas|A Phase 1b/2 Open-label Study to Evaluate the Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapy in Subjects With Relapsed or Refractory Aggressive B-cell Lymphomas|Completed||Phase 1/Phase 2|10|Actual|MedImmune LLC||1|||f||||f|t|f||||||||2017-10-10 23:53:18.663406|2017-10-10 23:53:18.663406
NCT02271932|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-08-21|||October 2014||2014-10-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|September 2019|Anticipated|2019-09-01||Observational|||Multi-institutional Trial of Non-operative Management of Appendicitis|Multi-institutional Trial of Non-operative Management of Uncomplicated Pediatric Appendicitis|Recruiting||N/A|910|Anticipated|Nationwide Children's Hospital|||2||f||||t||||||||||2017-10-10 23:53:18.783527|2017-10-10 23:53:18.783527
NCT02271919|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-09-14|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Varenicline and Combined Nicotine Replacement Therapy (NRT) for Smoking Cessation|Varenicline and Combined Nicotine Replacement Therapy (NRT) for Initial Smoking Cessation and Rescue Treatment in Smokers: A Randomized Pilot Trial|Recruiting||Phase 4|500|Anticipated|M.D. Anderson Cancer Center||5|||f||||t|t|f||||||||2017-10-10 23:53:18.905855|2017-10-10 23:53:18.905855
NCT02271906|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-08-18|||July 1, 2015|Actual|2015-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting|The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Poor Accrual|f||||f|t|f||||||||2017-10-10 23:53:19.077949|2017-10-10 23:53:19.077949
NCT02271893|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-07-25|||November 2014||2014-11-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|CHEMODEX||Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management|Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management|Recruiting||Phase 2|40|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:53:19.172191|2017-10-10 23:53:19.172191
NCT02271867|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-20|||July 2009||2009-07-01|October 2014|2014-10-01||||August 2010|Actual|2010-08-01||Interventional|||Thermal QST for Interscale Block Evaluation|Thermal Quantitative Sensory Testing as a Method to Semi-quantitatively Assess the Neurosensory Effects of 3 Local Anesthetic Solutions in an Interscalene Block|Completed||Phase 4|45|Actual|University Hospital, Antwerp||3|||f||||f||||||||||2017-10-10 23:53:19.362166|2017-10-10 23:53:19.362166
NCT02271854|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-03-07|2015-12-15||October 2014||2014-10-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||ITT population: All randomized subjects who received at least one dose of the study drug on both legs = 102 Modified ITT population: Excludes the first 16 subjects who were systematically underdosed =86 Safety population: All randomized subjects who received at least one dose of study drug on either leg =102|A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness|A Randomized, Double-blind, Placebo-controlled, Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness (DOMS) of the Lower Limbs|Completed||Phase 3|102|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:53:19.445699|2017-10-10 23:53:19.445699
NCT02271841|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-03-23|||October 2014||2014-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||How Are Changing the Practices After the Introduction of the Pleth Variability Index? A Before/After Survey.|How Are Changing the Practices After the Introduction of the Pleth Variability Index? A Before/After Survey.|Recruiting||N/A|50|Anticipated|Université Catholique de Louvain|||2||f||||f||||||||||2017-10-10 23:53:19.636912|2017-10-10 23:53:19.636912
NCT02271828|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-04-20|||April 2015||2015-04-01|March 2017|2017-03-01|April 2027|Anticipated|2027-04-01|April 2027|Anticipated|2027-04-01||Interventional|||Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy|Clinically Node Negative Breast Cancer Patients Undergoing Breast Conserving Therapy: Sentinel Lymph Node Procedure Versus Follow-Up.|Recruiting||N/A|1644|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:53:19.728733|2017-10-10 23:53:19.728733
NCT02271815|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-05-05|||October 2014||2014-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Clinical and Imaging Study to Evaluate a Novel Dentifrice|A Clinical and Imaging Study to Evaluate a Novel Dentifrice|Recruiting||N/A|30|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-10 23:53:19.869025|2017-10-10 23:53:19.869025
NCT02271802|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-10-21|||June 2009||2009-06-01|October 2014|2014-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effect of a Butyrate Enema on the Systemic Concentration of Short Chain Fatty Acids|Effect of a Butyrate Enema on the Systemic Concentration of Short Chain Fatty Acids|Completed||N/A|12|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-10 23:53:19.966364|2017-10-10 23:53:19.966364
NCT02271789|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-08-25|||November 2014||2014-11-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Low-cost, Noninvasive Method to Assess Pulpal Vitality|Low-cost, Noninvasive Method to Assess Pulpal Vitality|Withdrawn||N/A|0|Actual|University of California, Irvine|||1|Not a clinical trial study|f||||f||||||||||2017-10-10 23:53:20.068873|2017-10-10 23:53:20.068873
NCT02271776|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-10-13|||October 2014||2014-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||GOS and Insulin Sensitivity|The Effects of Galactooligosaccharide (GOS) on Peripheral Insulin Sensitivity and Body Weight Control in Obese Adults With Impaired Glucose Homeostasis|Completed||N/A|46|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:53:20.131672|2017-10-10 23:53:20.131672
NCT02271763|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-03-31|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CTM||Comparing a Horizontal Ultrasound Technique With a Palpation Technique for Localising the Cricothyroid Membrane|A Descriptive Study Comparing a Horizontal Ultrasound Technique With a Palpation Technique for Localising the Cricothyroid Membrane in an Obstetric Population.|Completed||N/A|37|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:53:20.207637|2017-10-10 23:53:20.207637
NCT02271750|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-12-07|||October 2014||2014-10-01|October 2014|2014-10-01||||November 2015|Actual|2015-11-01||Observational|||IGF and Other Neurotrophic Factors in Patients With Dementia|A Study of Insulin-like Growth Factors and Other Neurotrophic Factors in the Cerebrospinal Fluid From Patients With Dementia|Completed||N/A|120|Actual|University of Aarhus|||2||f||||t||||||Samples Without DNA|"     spinal fluid and blood sample for identification of different factors   "|||2017-10-10 23:53:20.283528|2017-10-10 23:53:20.283528
NCT02265900|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2015-11-14|||November 2014||2014-11-01|November 2015|2015-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Parkinson's Disease Exercise TMS PET Study|Exercise and Parkinson's Disease: The Basis for Motor and Cognitive Benefits|Recruiting||N/A|30|Anticipated|Pacific Parkinson's Research Centre||2|||f||||f||||||||||2017-10-10 23:54:23.365737|2017-10-10 23:54:23.365737
NCT02271737|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2015-06-10|||February 2015||2015-02-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|NICCI||Newborn Infection Control and Care Initiative for Health Facilities to Accelerate Reduction of Newborn Mortality|Newborn Infection Control and Care Initiative for Health Facilities to Accelerate Reduction of Newborn Mortality|Unknown status|Enrolling by invitation|N/A|1938|Anticipated|National Institute of Public Health, Cambodia||2|||f||||f||||||||||2017-10-10 23:53:20.372591|2017-10-10 23:53:20.372591
NCT02271724|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-05-13|||September 2015||2015-09-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN|sCD163 & CD19 as Candidate Biomarkers in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - A Study of sCD163 in the Cerebrospinal Fluid|Unknown status|Recruiting|N/A|85|Anticipated|University of Aarhus|||4||f||||t||||||Samples Without DNA|"     Spinal fluid and blood sample for identification of different factors   "|||2017-10-10 23:53:20.466152|2017-10-10 23:53:20.466152
NCT02271711|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-04-04|||March 2015|Actual|2015-03-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Fourth Ventricle Infusions of Autologous Ex Vivo Expanded NK Cells in Children With Recurrent Posterior Fossa Tumors|Phase I Study of Fourth Ventricle Infusions of Autologous Ex Vivo-Expanded NK Cells in Children With Recurrent/Refractory Malignant Posterior Fossa Tumors of the Central Nervous System NOAH's (New Opportunity, Advancing Hope) Protocol|Recruiting||Phase 1|24|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-10 23:53:20.568898|2017-10-10 23:53:20.568898
NCT02271698|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-01-12|2017-01-12||December 2014||2014-12-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Dexamethasone and Pain Following Total Knee Arthroplasty|Perioperative Dexamethasone to Promote Systemic Pro-Resolution Phenotype for Prevention of Acute and Chronic Pain Post-Total Knee Arthroplasty.|Completed||Phase 4|45|Actual|Duke University||4|||f||||f||||||||||2017-10-10 23:53:20.660791|2017-10-10 23:53:20.660791
NCT02271685|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-05-19|||February 2015||2015-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Sound Estimation and Accuracy Task|Estimation and Accuracy in Sound Task Perceived to be Medically Diagnostic|Completed||N/A|600|Anticipated|Carnegie Mellon University||4|||f||||f||||||||||2017-10-10 23:53:21.161832|2017-10-10 23:53:21.161832
NCT02271672|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-06-17|||August 2014||2014-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||XP1000 RF Therapy on Waist Circumference Reduction|Effect of the XP1000 RF Therapy on Waist Circumference Reduction|Completed||N/A|60|Actual|BTL Industries Ltd.||2|||f||||f||||||||||2017-10-10 23:53:21.237318|2017-10-10 23:53:21.237318
NCT02271659|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-09-12|||June 2013||2013-06-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|GETUGP05||Medical and Economic Evaluation for Intermediate-risk Prostate Cancer|Medical and Economic Evaluation of an External Beam Radiotherapy Combined With a Brachytherapy Boost Compared With an Exclusive External Beam Radiotherapy for Intermediate-risk Prostate Cancer|Recruiting||N/A|298|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-10 23:53:21.305794|2017-10-10 23:53:21.305794
NCT02271646|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-05-17|||August 2014||2014-08-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation|Ultrasound Guided Thoracic Paravertebral Blocks: An Effective Pain Control in Percutaneous Radiofrequency Ablation of Hepatic Tumors|Completed||N/A|35|Anticipated|Mahidol University||1|||f||||f||||||||||2017-10-10 23:53:21.469328|2017-10-10 23:53:21.469328
NCT02271633|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-03-15|||September 2014||2014-09-01|May 2015|2015-05-01|March 2016|Actual|2016-03-01|December 2014|Actual|2014-12-01||Interventional|NO-what||Nitrate Supplementation; Source|The Effect of Nitrate Supplementation: Source of Supplementation|Completed||Phase 4|30|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-10 23:53:21.73058|2017-10-10 23:53:21.73058
NCT02271620|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-04-15|||January 2014||2014-01-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis|The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis|Unknown status|Recruiting|N/A|53|Anticipated|Mahidol University||1|||f||||t||||||||||2017-10-10 23:53:21.85344|2017-10-10 23:53:21.85344
NCT02271607|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2016-03-11|||October 2014||2014-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients|A Pilot Study About The Effects of Indirect-Moxibustion on Bladder- Functional Improvement and Symptoms Management in Patients With Overactive Bladder: A Randomized Controlled Trial|Completed||N/A|24|Actual|Korean Medicine Hospital of Pusan National University||2|||f||||t||||||||||2017-10-10 23:53:21.960793|2017-10-10 23:53:21.960793
NCT02271581|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-07-18|||October 2014||2014-10-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Observational|||Effect of Symptom Management on Inflammation and Survival in Metastatic Lung Cancer|INSYNC: Leo Jenkins Cancer Center (LJCC) - Symptom Management Service (SMS) Protocol -Phase II Trial Regarding The Effect Of Comprehensive Symptom Management On Inflammation And Survival In Metastatic Lung Cancer|Recruiting||N/A|100|Anticipated|Leo W. Jenkins Cancer Center|||1||f||||f||||||Samples Without DNA|"     Retain serum samples draw at baseline, 4 months, 10 months for storage and analysis by     Biodesix Laboratories.   "|||2017-10-10 23:53:22.177924|2017-10-10 23:53:22.177924
NCT02271568|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-02-18|||March 2015||2015-03-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Prospective Cohort Study of the Effect of Bariatric/Metabolic Surgery on Morbid Obesity Patients With Metabolic Syndrome|Change in Glomerular Filtration Rate and 24 Hours Ambulatory Blood Pressure After Gastric Bypass Surgery Versus Conventional Weight Loss in Morbid Obesity.|Enrolling by invitation||N/A|30|Anticipated|Hanyang University|||2||f||||t||||||||Undecided||2017-10-10 23:53:22.271573|2017-10-10 23:53:22.271573
NCT02012712|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-03-10|||July 2010||2010-07-01|March 2017|2017-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Personal Health Records and Elder Medication Use Quality|Personal Health Records and Elder Medication Use Quality|Completed||N/A|1163|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 00:57:22.258886|2017-10-11 00:57:22.258886
NCT02271555|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-20|||October 2014||2014-10-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy|Inonu University, Turgut Ozal Medical Center, Department of Anesthesiology and Reanimation Malatya|Unknown status|Not yet recruiting|Phase 4|58|Anticipated|Inonu University||2|||f||||f||||||||||2017-10-10 23:53:22.377968|2017-10-10 23:53:22.377968
NCT02271542|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2014-11-19|||November 2014||2014-11-01|November 2014|2014-11-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|||Identification of Polymorphisms Involved in the Metabolism of Propofol|Identification of Polymorphisms Involved in the Metabolism of Propofol|Unknown status|Recruiting|Phase 4|300|Anticipated|TC Erciyes University||3|||f||||f||||||||||2017-10-10 23:53:22.491178|2017-10-10 23:53:22.491178
NCT02271529|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-01-29|2016-01-29||September 2014||2014-09-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Zilver PTX Delivery System|Zilver Paclitaxel(PTX) Thumbwheel Delivery System|Completed||N/A|40|Actual|Cook Group Incorporated||1|||f||||f||||||||||2017-10-10 23:53:22.621547|2017-10-10 23:53:22.621547
NCT02271516|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-20|||October 2014||2014-10-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|October 2015|Anticipated|2015-10-01||Interventional|||to evaluate188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage|A Phase I, Open-label, Dose-escalation Study to Determine the Maximum Tolerance Dose (MTD) and to Evaluate the Safety of 188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage.|Unknown status|Not yet recruiting|Phase 1|36|Anticipated|Institute of Nuclear Energy Research, Taiwan||1|||f||||f||||||||||2017-10-10 23:53:22.89109|2017-10-10 23:53:22.89109
NCT02271503|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-09-14||2017-09-07|November 2015||2015-11-01|September 2017|2017-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease|A Study to Assess the Pharmacokinetics and Pharmacodynamics of a Single Dose of IPX203 in Patients With Advanced Parkinson's Disease|Completed||Phase 2|26|Actual|IMPAX Laboratories, Inc.||3|||f||||f|t|f||||||||2017-10-10 23:53:23.005725|2017-10-10 23:53:23.005725
NCT02271490|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-10-15|||June 2014||2014-06-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|January 2016|Anticipated|2016-01-01||Interventional|RA-ICSI||Acrosome Reaction Induction Prior to ICSI|Improvement of the Post ICSI Pregnancy Outcome by Induction of the Acrosome Reaction Prior to ICSI|Unknown status|Active, not recruiting|N/A|620|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:53:23.164736|2017-10-10 23:53:23.164736
NCT02271477|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-08-01|2014-12-01||May 2014||2014-05-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Can Vena Cava Ultrasound Guided Volume Repletion Prevent Spinal Induced Significant Hypotension in Elective Patients?|Can Vena Cava Ultrasound Guided Volume Repletion Prevent Spinal Induced Significant Hypotension in Elective Surgical Patients? A Randomized, Case Control, Prospective Trial.|Completed||N/A|160|Actual|Ente Ospedaliero Cantonale, Bellinzona|It cannot be performed blindly. Ultrasound is an operator-dependent technique.|2|||f||||t||||||||||2017-10-10 23:53:23.268507|2017-10-10 23:53:23.268507
NCT02271464|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-03-10|||March 2012||2012-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|June 2015|Anticipated|2015-06-01||Interventional|MOMA||Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer|Phase II Randomized Study of Maintenance Treatment With Bevacizumab or Bevacizumab Plus Metronomic Chemotherapy After First-line Induction FOLFOXIRI Plus Bevacizumab for Metastatic Colorectal Cancer Patients|Unknown status|Recruiting|Phase 2|222|Anticipated|Azienda Ospedaliero, Universitaria Pisana||2|||f||||t||||||||||2017-10-10 23:53:23.755582|2017-10-10 23:53:23.755582
NCT02271438|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-06-03|||October 2014||2014-10-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants|A Randomized, Double-Blind, Placebo- and Positive-Controlled, Single-Dose, Four-Way Crossover Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Subjects|Completed||Phase 1|28|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-10 23:53:24.067193|2017-10-10 23:53:24.067193
NCT02271425|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-12-17|||October 2014||2014-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants|An Absolute Bioavailability Study of Evacetrapib in Healthy Subjects Using the Intravenous Tracer Method|Completed||Phase 1|8|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:53:24.216283|2017-10-10 23:53:24.216283
NCT02271412|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-10-20|||October 2014||2014-10-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005|Completed||Phase 1|58|Actual|Luye Pharma Group Ltd.||2|||f||||t||||||||||2017-10-10 23:53:24.321818|2017-10-10 23:53:24.321818
NCT02271399|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-02-17|||October 2014||2014-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty|Randomized Controlled Study on the Prophylaxis of Venous Thromboembolic Events in Patients Undergoing Total Knee Arthroplasty: Comparison of Aspirin and Rivaroxaban|Completed||Phase 2|156|Actual|Hanyang University Seoul Hospital||2|||f||||t||||||||||2017-10-10 23:53:24.407853|2017-10-10 23:53:24.407853
NCT02271386|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-10-26|||November 2014||2014-11-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD|Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD|Recruiting||N/A|7750|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-10 23:53:24.486385|2017-10-10 23:53:24.486385
NCT02271373|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2014-10-22|||November 2012||2012-11-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Increasing Time Spent Outdoors on Myopia Prevention in School-Aged Children in Northeast China|Development and Application of Appropriate Technology for Myopia Prevention and Control|Completed||N/A|3521|Actual|Anhui Medical University||2|||f||||t||||||||||2017-10-10 23:53:24.582558|2017-10-10 23:53:24.582558
NCT02271360|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2017-02-14|||April 2014|Actual|2014-04-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome|Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome|Completed||Phase 2/Phase 3|200|Actual|Benha University||2|||f||||t||||||||||2017-10-10 23:53:24.645599|2017-10-10 23:53:24.645599
NCT02271347|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-01-30|||October 2014||2014-10-01|October 2014|2014-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|CMX||An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease|An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease|Withdrawn||Phase 2|0|Actual|Chimerix||1||Suspended Development Program|f||||f||||||||||2017-10-10 23:53:24.720967|2017-10-10 23:53:24.720967
NCT02271334|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-04-17||2017-04-17|August 2014||2014-08-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|A006-D||Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers|Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers (A Randomized, Double- or Evaluator-blinded, Single-dose, Four-arm, Crossover Pharmacokinetics (PK) Study in Healthy Adults)|Completed||Phase 2|22|Actual|Amphastar Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-10 23:53:24.786559|2017-10-10 23:53:24.786559
NCT02271321|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-21|||November 2013||2013-11-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||The Effects of White Noise on Agitated Behaviors and Cortisol Level in Saliva Among the Patients With Dementia|The Effects of White Noise on Agitated Behaviors and Cortisol in Saliva Among the Patients With Dementia|Unknown status|Recruiting|N/A|84|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:53:24.889474|2017-10-10 23:53:24.889474
NCT02271308|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-21|||March 2014||2014-03-01|October 2014|2014-10-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||The Effects of Low Resistance Training on the Residents in Nursing Homes|The Effects of Low Resistance Training Using Elastic Band on Muscle Strength, Flexibility, Quality of Life and Ease of Care in Nursing Home Residents: A Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:53:25.023676|2017-10-10 23:53:25.023676
NCT02271295|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2016-06-16|||July 2015||2015-07-01|June 2016|2016-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|Childbenox||Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Weight Heparin in Child-Pugh B Cirrhotic Patients: a Randomized Controlled Study|Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Weight Heparin in Child-Pugh B Cirrhotic Patients: a Randomized Controlled Study|Recruiting||Phase 3|138|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:53:25.115063|2017-10-10 23:53:25.115063
NCT02271282|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-09-12|||December 2014||2014-12-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Estradiol-Receptor Blockade in Older Men and Women|Pilot Study of Estradiol-Receptor Blockade in Older Men and Women|Completed||Phase 1|40|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-10 23:53:25.196369|2017-10-10 23:53:25.196369
NCT02271269|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-19|2017-04-28|||November 2014||2014-11-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|SIGMA||Study on Incentives for Glaucoma Medications Adherence|A Randomized Controlled Trial to Increase Glaucoma Medication Adherence Using Value Pricing|Completed||N/A|100|Actual|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-10 23:53:25.265773|2017-10-10 23:53:25.265773
NCT02271256|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2017-08-09|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Functional Intimate Apparel for Adolescents With Early Scoliosis|Safety and Efficacy of Functional Intimate Apparel for Adolescents With Early Scoliosis|Enrolling by invitation||N/A|20|Anticipated|The Hong Kong Polytechnic University||1|||f||||t|f|f||||||||2017-10-10 23:53:25.345838|2017-10-10 23:53:25.345838
NCT02271243|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-06-30|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections|Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections|Recruiting||N/A|20|Anticipated|Boston Children’s Hospital|||2||f||||f||||||Samples Without DNA|"     Bacteria growing from swab of oral cavity, sputum, skin, stool, and blood; stool and plasma     samples.   "|||2017-10-10 23:53:25.441806|2017-10-10 23:53:25.441806
NCT02271230|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-04-12|||August 2014||2014-08-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure||Active, not recruiting||Phase 3|25875|Actual|Brigham and Women's Hospital||4|||f||||||||||||||2017-10-10 23:53:25.520092|2017-10-10 23:53:25.520092
NCT02271204|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-20|||March 2009||2009-03-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Observational|||Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis|Post Authorization Safety Study of iv Ibandronate (Bonviva) in Postmenopausal Osteoporosis, Observational, Non-interventional Open Label Trial|Completed||N/A|700|Actual|Clinic of Endocrinology and Metabolic Disorders, Macedonia|||1||f||||f||||||||||2017-10-10 23:53:27.597452|2017-10-10 23:53:27.597452
NCT02271178|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-01-10|||April 2014||2014-04-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Multi-cap for Increase Adherence After Acute Myocardial Infarction|Multi-cap for Increase Adherence After Acute Myocardial Infarction|Terminated||Phase 3|100|Actual|Hospital El Cruce||2||The study was stopped after interim analysis due to futility.|f||||f||||||||||2017-10-10 23:53:27.719322|2017-10-10 23:53:27.719322
NCT02271165|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-11-09|||November 2014||2014-11-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|||Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study||Recruiting||Early Phase 1|10|Anticipated|Thomas Jefferson University||2|||f||||||||||||||2017-10-10 23:53:27.798181|2017-10-10 23:53:27.798181
NCT02271152|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2017-05-06|||February 2015||2015-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||FAST Mapping During Atrial Fibrillation|Focal Electrical Source and Trigger Mapping During Atrial Fibrillation|Recruiting||N/A|80|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:53:27.870636|2017-10-10 23:53:27.870636
NCT02271139|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-03-07||||||March 2017|2017-03-01||||||||Expanded Access|||Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy|An Open Label, Multicenter, Single-Arm, Expanded Access Study of Alectinib for Patients With ALK-Rearranged Non-Small Cell Lung Cancer After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy|No longer available||N/A|||Genentech, Inc.|||||||||||||||||||2017-10-10 23:53:27.944765|2017-10-10 23:53:27.944765
NCT02271126|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2017-07-01|||September 2, 2014|Actual|2014-09-02|July 2017|2017-07-01|November 30, 2016|Actual|2016-11-30|September 2016|Actual|2016-09-01||Interventional|||TEG Anticoagulation Monitoring During ECMO|Prospective Randomized Study Of Anticoagulation Monitoring With Thromboelastography Versus aPTT During Extracorporeal Membrane Oxygenation In Adults|Completed||Phase 1|42|Actual|Policlinico Hospital||2|||f||||f||||||||||2017-10-10 23:53:28.20322|2017-10-10 23:53:28.20322
NCT02271113|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-04-24|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects|A Randomized, Placebo Controlled, Phase1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects|Completed||Phase 1|32|Actual|GlycoMimetics Incorporated||3|||f||||f||||||||||2017-10-10 23:53:28.281967|2017-10-10 23:53:28.281967
NCT02271100|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-03-14|||October 2014||2014-10-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique|Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique|Recruiting||N/A|210|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-10 23:53:28.364207|2017-10-10 23:53:28.364207
NCT02271087|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-11-06|||June 2017||2017-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:53:28.442413|2017-10-10 23:53:28.442413
NCT02271074|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-07-19|||June 2012||2012-06-01|January 2016|2016-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Thol'Impilo: Bringing People Into Care|An Evaluation of Strategies to Accelerate Entry-into-care Following HIV Diagnosis Among Adults in Gauteng and Limpopo Provinces, South Africa|Completed||N/A|2398|Actual|The Aurum Institute NPC||4|||f||||t||||||||Yes|Data will be shared through identified USAID -PEPFAR Platforms.|2017-10-10 23:53:28.479736|2017-10-10 23:53:28.479736
NCT02271048|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2015-04-16|||November 2014||2014-11-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Feasibility and Effectiveness Study for Tele-ultrasonography|The Feasibility and Effectiveness Study for Clinical Application of Realtime Tele-ultrasonography Using the Smartphone|Completed||N/A|12|Actual|Hanyang University||2|||f||||t||||||||||2017-10-10 23:53:28.636969|2017-10-10 23:53:28.636969
NCT02271035|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-10-21|||October 2014||2014-10-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children|A Prospective Study Comparing the Success Rate of Injection of Dextranomer /Hyaluronic Acid (DefluxR) Versus Polyacrylate Polyalcohol (VantrisR) for Treatment of Bilateral Similar Grade Vesicoureteral Reflux in Children|Unknown status|Recruiting|Phase 4|100|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-10 23:53:28.734693|2017-10-10 23:53:28.734693
NCT02271022|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-09-22|||February 17, 2015|Actual|2015-02-17|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30|40 Days|Observational [Patient Registry]|||Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry|Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry|Recruiting||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:53:28.825365|2017-10-10 23:53:28.825365
NCT02271009|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-12-02|||October 2014||2014-10-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC|A Double-Blind, Placebo-Controlled, Randomized Trial to Compare the Efficacy and Tolerability of Three Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in Environmental Exposure Chamber|Completed||Phase 2|213|Actual|Anergis||4|||f||||t||||||||||2017-10-10 23:53:28.983836|2017-10-10 23:53:28.983836
NCT02270996|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-21|||January 2015||2015-01-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|AbxPS||Antimicrobial Stewardship in Pediatric Surgery|An Antimicrobial Stewardship Intervention Program in Pediatric Surgery|Unknown status|Not yet recruiting|N/A|100|Anticipated|Alberta Children's Hospital|||2||f||||f||||||||||2017-10-10 23:53:29.08574|2017-10-10 23:53:29.08574
NCT02270983|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-08-04||2016-08-04|October 2014||2014-10-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain|A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain|Completed||Phase 2|254|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-10 23:53:29.181284|2017-10-10 23:53:29.181284
NCT02270970|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-10-03|||October 2014||2014-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|BLAST||Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy|Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy|Recruiting||Phase 4|20|Anticipated|Oklahoma Medical Research Foundation||2|||f||||t||||||||Undecided||2017-10-10 23:53:29.540844|2017-10-10 23:53:29.540844
NCT02270957|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-09-26|||January 2014||2014-01-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ABC||Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches|Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (The ABC Study)|Recruiting||Phase 2|60|Anticipated|Oklahoma Medical Research Foundation||2|||f||||t||||||||Undecided||2017-10-10 23:53:29.652861|2017-10-10 23:53:29.652861
NCT02270944|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-06-30|2016-09-19|2015-04-29|November 1, 2014||2014-11-01|May 2017|2017-05-01|September 22, 2015|Actual|2015-09-22|April 23, 2015|Actual|2015-04-23||Interventional|||Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine|A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years|Completed||Phase 2|1053|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:53:29.776159|2017-10-10 23:53:29.776159
NCT02270931|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-08-07|||May 2014||2014-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||A Prospective Longitudinal Breast Cancer Study|A Prospective Longitudinal Study of CA 15-3 as an Aid in Monitoring Recurrence or Progressive Disease in Patients With Breast Cancer|Active, not recruiting||N/A|130|Anticipated|Fujirebio Diagnostics, Inc.|||1||f||||f||||||Samples Without DNA|"     Serum and Plasma   "|||2017-10-10 23:53:30.361247|2017-10-10 23:53:30.361247
NCT02270918|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-06-06|||November 2014||2014-11-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|4PAR||Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra|A Phase I Placebo-Controlled, Open-Label, Crossover Study to Assess the Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra in Healthy Volunteers|Completed||Phase 1|12|Actual|Thomas Jefferson University||2|||f||||f||||||||Yes||2017-10-10 23:53:30.880107|2017-10-10 23:53:30.880107
NCT02270892|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-05-01|||August 28, 2014|Actual|2014-08-28|May 2017|2017-05-01|April 3, 2017|Actual|2017-04-03|July 22, 2016|Actual|2016-07-22||Interventional|||Ultherapy for Buttock Lift|Evaluation of the Ulthera® System for Lifting of the Buttock|Completed||N/A|38|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-10 23:53:31.105711|2017-10-10 23:53:31.105711
NCT02270879|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-18|2014-10-18|||June 2014||2014-06-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Multi-formula Optimization of Second Eye Refinement According to Direction of the Prediction Error of the First Eye|Multi-formula Optimization of Second Eye Refinement According to Direction of the Prediction Error of the First Eye|Completed||N/A|156|Actual|Centro Hospitalar do Baixo Vouga|||1||f||||f||||||||||2017-10-10 23:53:31.213681|2017-10-10 23:53:31.213681
NCT02270866|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-10-15|||October 2014||2014-10-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia|Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia|Completed||N/A|12|Actual|Scion NeuroStim||1|||f||||f||||||||||2017-10-10 23:53:31.298875|2017-10-10 23:53:31.298875
NCT02270853|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-02-17|||April 2014||2014-04-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SAS CA||SAS in Patients With Bronchial Carcinoma|Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma|Recruiting||N/A|100|Anticipated|RWTH Aachen University||1|||f||||f||||||||||2017-10-10 23:53:31.403706|2017-10-10 23:53:31.403706
NCT02270840|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-01-16|||November 2014||2014-11-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Budapest Upgrade CRT Study (Version 009-4.1)|Effect of Biventricular Upgrade on Left Ventricular Reverse Remodeling and Clinical Outcomes in Patient With Left Ventricular Dysfunction and Intermittent or Permanent Apical/Septal Right Ventricular Pacing (Budapest CRT Upgrade Study)|Enrolling by invitation||N/A|360|Anticipated|Semmelweis University Heart and Vascular Center|||2||f||||t||||||||||2017-10-10 23:53:31.531897|2017-10-10 23:53:31.531897
NCT02270827|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-10-26|||June 2014||2014-06-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|SARAH||A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics|A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics|Terminated||Phase 4|5|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1|Study was set up by an MSc student who left her post.|f||||f||||||||||2017-10-10 23:53:31.642809|2017-10-10 23:53:31.642809
NCT02270814|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-05-18|||February 2, 2015|Actual|2015-02-02|May 2017|2017-05-01|May 31, 2020|Anticipated|2020-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|CACTUX||Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma|Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)|Recruiting||Phase 2|70|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||No||2017-10-10 23:53:31.730317|2017-10-10 23:53:31.730317
NCT02270801|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-04-18|||October 2014||2014-10-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy|Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP)in Pregnancy: a Single-center Clinical Trial|Recruiting||Phase 3|30|Anticipated|Shandong University||1|||f||||t||||||||||2017-10-10 23:53:31.887715|2017-10-10 23:53:31.887715
NCT02270788|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-10-02|||April 2, 2015|Actual|2015-04-02|October 2017|2017-10-01|October 17, 2016|Actual|2016-10-17|October 17, 2016|Actual|2016-10-17||Interventional|||Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies|A Phase I Pharmacokinetic, Pharmacodynamic and Feasibility Study of Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies (ARO-008)|Completed||Phase 1|10|Actual|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-10 23:53:31.977747|2017-10-10 23:53:31.977747
NCT02270775|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-17|||October 2014||2014-10-01|October 2014|2014-10-01||||June 2015|Anticipated|2015-06-01||Observational|||Traduction and Validation of the Central Sentitization Inventory Into French||Unknown status|Not yet recruiting|N/A|150|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||3||f||||||||||||||2017-10-10 23:53:32.200743|2017-10-10 23:53:32.200743
NCT02270762|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-11-17|||August 2014||2014-08-01|November 2015|2015-11-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|TILT||Early Passive Verticalization in Critically Ill Patients|Effect of Early Passive Verticalization in Pulmonary Recruitment Evaluated With Electric Impedance Tomography|Active, not recruiting||N/A|10|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f||||t||||||||||2017-10-10 23:53:32.284751|2017-10-10 23:53:32.284751
NCT02270749|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-05-06|||October 2014||2014-10-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Vitamin Deficiencies and Suppletion in Morbid Obesity|Vitamin Deficiencies and Suppletion in Morbid Obesity|Unknown status|Recruiting|Phase 4|50|Anticipated|Rijnstate Hospital||2|||f||||f||||||||||2017-10-10 23:53:32.37867|2017-10-10 23:53:32.37867
NCT02270736|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-09-21|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|May 2018|Anticipated|2018-05-01||Interventional|SIPEXI||Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability|Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Children and Adolescents (2-17 Years) With Chronic Troublesome Sialorrhea Associated With Neurological Disorders, and/or Intellectual Disability|Recruiting||Phase 3|249|Anticipated|Merz Pharmaceuticals GmbH||2|||f||||t||||||||||2017-10-10 23:53:32.504373|2017-10-10 23:53:32.504373
NCT02270723|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2014-10-17|||August 2014||2014-08-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||The Effect of Human Albumin on Coagulation Competence and Hemorrhage|Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery|Unknown status|Enrolling by invitation|Phase 4|40|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:53:32.678266|2017-10-10 23:53:32.678266
NCT02270710|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-05-23|||April 2013||2013-04-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|SLE||Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease|Immune Deregulation in Patients With SLE|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University|||2|Research direction changed|f||||f||||||Samples With DNA|"     Blood   "|Undecided||2017-10-10 23:53:32.776725|2017-10-10 23:53:32.776725
NCT02270697|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-17|||March 2012||2012-03-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Observational|||Evaluation of an Oligonucleotide Array for Rapid Identification of Dermatophytes in Clinical Specimens|Evaluation of an Oligonucleotide Array for Rapid Identification of Dermatophytes in Clinical Specimens|Completed||N/A|32|Actual|National Cheng-Kung University Hospital|||1||f||||f||||||Samples With DNA|"     -  Nail Samples        -  Scrap Samples   "|||2017-10-10 23:53:32.85014|2017-10-10 23:53:32.85014
NCT02270684|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-04-01|2016-05-10||May 2015||2015-05-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||StepRite Evaluation|Comparative Effectiveness of an Activity-Specific Monitoring Device (StepRite) on Short Term Outcomes in Adults After Total Knee Arthroplasty|Terminated||N/A|4|Actual|University of Southern California|Early termination lead to no final outcome measures being collected.|2||Recruitment and retention difficulties|f||||f||||||||||2017-10-10 23:53:32.920922|2017-10-10 23:53:32.920922
NCT02270658|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-02-22|||July 2014||2014-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|MORPHEOS||Morbidity in Patients With Hypertension and Obstructive Sleep Apnea|Morbidity in Patients With Hypertension and Obstructive Sleep Apnea|Recruiting||N/A|200|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-10 23:53:33.290674|2017-10-10 23:53:33.290674
NCT02270645|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-12-16|||October 2014||2014-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BCC||Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser|Randomized Pilot Study of Treatment for Basal Cell Carcinoma Using the Multiplex 595/1064 nm Laser|Recruiting||N/A|28|Anticipated|University of Miami||2|||f||||t||||||||||2017-10-10 23:53:33.436939|2017-10-10 23:53:33.436939
NCT02270632|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-11-23|||October 2014||2014-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX|A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.|Recruiting||Phase 2|87|Anticipated|Philogen S.p.A.||3|||f||||f||||||||||2017-10-10 23:53:33.529834|2017-10-10 23:53:33.529834
NCT02270619|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-07-07|||October 2014||2014-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|SHINE||Sleep Health, Inflammation, and Emotion Study|Sleep Loss as a Vulnerability Factor for Inflammation Induced Depressive Symptoms in Older Women|Recruiting||Early Phase 1|80|Anticipated|University of California, Los Angeles||4|||f||||||||||||||2017-10-10 23:53:33.685979|2017-10-10 23:53:33.685979
NCT02270606|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-09-14|||December 4, 2014|Actual|2014-12-04|September 2017|2017-09-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer|Phase I Study of Neoadjuvant Short Course Radiotherapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer|Active, not recruiting||Phase 1|14|Actual|Virginia Commonwealth University||1|||f||||t|t|f|||t|||||2017-10-10 23:53:33.798288|2017-10-10 23:53:33.798288
NCT02270593|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-10-16|||August 2013||2013-08-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|December 2014|Anticipated|2014-12-01|2 Years|Observational [Patient Registry]|||ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis (Accreta, Increta, Percreta).|ADAMTS, Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis(Accreta, Increta, Percreta)|Unknown status|Recruiting|N/A|30|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||1||f||||t||||||None Retained|"     serum and fetal membranes (placenta) and maternal myometrial sample   "|||2017-10-10 23:53:33.908012|2017-10-10 23:53:33.908012
NCT02270580|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||June 2012||2012-06-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Komen Breast Cancer Survivor Health Screening Promotion Project: Staying Healthy|Patient Navigation to Improve Quality of Life and Screening Practices Among Latino Breast Cancer Survivors|Completed||N/A|150|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 23:53:34.025381|2017-10-10 23:53:34.025381
NCT02270567|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-11-01|||February 2015||2015-02-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|September 2019|Anticipated|2019-09-01|5 Years|Observational [Patient Registry]|RegisterNET||RegisterNET - A Registry for Neuroendocrine Tumors in the USA|A Registry for Neuroendocrine Tumors in the USA|Recruiting||N/A|500|Anticipated|Wren Laboratories LLC|||1||f||||t||||||Samples With DNA|"     Blood collection (EDTA tube) used for neuroendocrine tumor biomarker measurements   "|||2017-10-10 23:53:34.11015|2017-10-10 23:53:34.11015
NCT02270554|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-07-20|||October 2014||2014-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy|A Prospective, Multi-center Investigation of Impact of the Endo GIA Reinforced Reload With Tri-Staple Technology During Distal Pancreatectomy|Completed||Phase 2|120|Actual|Wakayama Medical University||1|||f||||t||||||||||2017-10-10 23:53:34.2084|2017-10-10 23:53:34.2084
NCT02270541|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-03-01|||November 2014||2014-11-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2016|Actual|2016-02-01||Interventional|PreSSUB II||Prehospital Study at the Universitair Ziekenhuis Brussel II|Single-center Clinical Trial Evaluating the Efficacy, Safety, Feasibility, Reliability, and Cost-effectiveness of In-ambulance Telemedicine for Patients With Suspicion of Acute Stroke|Active, not recruiting||N/A|140|Actual|Universitair Ziekenhuis Brussel||2|||f||||t||||||||||2017-10-10 23:53:34.32992|2017-10-10 23:53:34.32992
NCT02270528|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-08-01|||October 2014||2014-10-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Acute Effects of High Intensity Interval Exercise on Executive Function|Acute Effects of High Intensity Interval Exercise on Executive Function|Recruiting||N/A|60|Anticipated|Virginia Commonwealth University||3|||f||||f||||||||||2017-10-10 23:53:34.423751|2017-10-10 23:53:34.423751
NCT02270515|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-03-24|2016-12-15||November 2013||2013-11-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|PCMH-KD||Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease|Bringing Care to Patients: A Patient-Centered Medical Home for Kidney Disease|Completed||N/A|175|Actual|University of Illinois at Chicago|Subjects were not randomized to the intervention, although their experience prior to the intervention (baseline measures) served as the historical control. Only two sites were included in the study.|1|||f||||t||||||||||2017-10-10 23:53:34.536294|2017-10-10 23:53:34.536294
NCT02270489|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-06-02|||December 11, 2014|Actual|2014-12-11|June 2017|2017-06-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|AFF009||Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA|A Randomized, Placebo-controlled, Parallel Group, Patient-blind, Phase I Study Assessing the Safety and Exploring the Immunogenicity/Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early Multiple System Atrophy|Completed||Phase 1|30|Actual|Affiris AG||3|||f||||t||||||||||2017-10-10 23:53:35.57468|2017-10-10 23:53:35.57468
NCT02270476|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-10-26|||December 2011||2011-12-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Observational|TRACK-CF||Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening|Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening|Recruiting||N/A|200|Anticipated|Heidelberg University|||2||f||||f||||||||||2017-10-10 23:53:35.674545|2017-10-10 23:53:35.674545
NCT02270463|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-01-30|||February 2015||2015-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission|A Phase 1/2 Study of SL-401 as Consolidation Therapy for Adult Patients With Adverse Risk Acute Myeloid Leukemia in First CR, and/or Evidence of Minimal Residual Disease (MRD) in First CR|Recruiting||Phase 1/Phase 2|35|Anticipated|Stemline Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:53:35.797682|2017-10-10 23:53:35.797682
NCT02270450|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-07-12|||March 2015||2015-03-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|August 2019|Anticipated|2019-08-01||Interventional|||S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction|S1316, Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction|Recruiting||Phase 3|200|Anticipated|Southwest Oncology Group||4|||f||||t||||||||||2017-10-10 23:53:35.95237|2017-10-10 23:53:35.95237
NCT02270437|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-02|2015-08-27|||June 2014||2014-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy of Cocktail Periarticular Injection in Simultaneous Total Knee Arthroplasty|Safety and Efficacy of Cocktail Periarticular Injection for Pain Management in Simultaneous Bilateral Total Knee Arthroplasty- A Prospective, Randomized Trial|Completed||Phase 4|55|Actual|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-10 23:53:36.182387|2017-10-10 23:53:36.182387
NCT02270424|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-17|||October 2014||2014-10-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe / Very Severe COPD|A Multi-center, Randomized, Double-blind, Controlled Study to Evaluate the Effectiveness of on Severe / Very Severe COPD Patients|Unknown status|Not yet recruiting|Phase 3|564|Anticipated|Henan University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-10 23:53:36.263933|2017-10-10 23:53:36.263933
NCT02270411|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-08-15|||May 2014||2014-05-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Inflammatory Cells From Various Pathologies|Development of a Method to Isolate Inflammatory Cells From Skin Biopsies of Patients With Various Pathologies for Quantitative Flow Cytometry Analysis|Recruiting||N/A|60|Anticipated|Innovaderm Research Inc.|||4||f||||f||||||||||2017-10-10 23:53:36.361047|2017-10-10 23:53:36.361047
NCT02270398|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-11-09|||October 2014||2014-10-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Dual-task Training in Chronic Stroke|Training Dual-task Balance and Walking in Community-dwelling Older Adults With Chronic Stroke: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|84|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-10 23:53:36.443966|2017-10-10 23:53:36.443966
NCT02270385|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-05-23|||November 2, 2015|Actual|2015-11-02|May 2017|2017-05-01|September 10, 2016|Actual|2016-09-10|September 10, 2016|Actual|2016-09-10||Interventional|||The Effectiveness of a Pressure Ulcer Prevention Programme for Older People in For-profit Private Nursing Homes|The Effectiveness of a Pressure Ulcer (PU) Prevention Programme for Older People in For-profit Private Nursing Homes (NHs): a Cluster Randomized Controlled Trial|Completed||N/A|1013|Actual|The Hong Kong Polytechnic University||2|||f||||t|f|f||||||No||2017-10-10 23:53:36.592289|2017-10-10 23:53:36.592289
NCT02270372|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-08-02|||November 2014||2014-11-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer|A Phase 1b Study of ONT 10 and Varlilumab in Patients With Advanced Ovarian Cancer or Breast Cancer|Completed||Phase 1|22|Actual|Cascadian Therapeutics Inc.||1|||f||||t||||||||||2017-10-10 23:53:36.67504|2017-10-10 23:53:36.67504
NCT02270359|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-01-05|||April 2014||2014-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIO||Research on Infarction With Open Arteries Using OCT and CMR|Research on Infarction With Open Arteries Using OCT and CMR (RIO)|Recruiting||N/A|200|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 23:53:36.757885|2017-10-10 23:53:36.757885
NCT02270346|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-18|||March 2012||2012-03-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Inspiratory Muscle Training in Allogeneic Hematopoietic Stem Cell Transplantation Recipients|Effects of Inspiratory Muscle Training in Allogeneic Hematopoietic Stem Cell Transplantation Recipients|Completed||N/A|40|Actual|Gazi University||2|||f||||f||||||||||2017-10-10 23:53:36.849535|2017-10-10 23:53:36.849535
NCT02270333|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-18|||April 2012||2012-04-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|||Inspiratory Muscle Training in Sarcoidosis|Effects of Inspiratory Muscle Training in Patients With Sarcoidosis|Completed||N/A|30|Actual|Gazi University||2|||f||||f||||||||||2017-10-10 23:53:36.941566|2017-10-10 23:53:36.941566
NCT02270320|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-11-09|||January 2014||2014-01-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Cognitive Effects of Tai Chi Chuan in Healthy Older Adults and Older Adults|Study of School and Graduate Institute of Physical Therapy College of Medicine in Taiwan|Completed||N/A|65|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-10 23:53:37.029571|2017-10-10 23:53:37.029571
NCT02270307|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-10-17|||January 2014||2014-01-01|October 2014|2014-10-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|MSC-CY||MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis|Allogeneic Bone Marrow Transplantation (Allo-BMT) From Human Leukocyte Antigen (HLA) - Identical Related and Unrelated Donors in Patients With Hematological Malignancies With High Risk of Relapse Using Cyclophosphamide (CY) and Mesenchymal Stromal Cells (MSC) as aGVHD Prophylaxis|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|National Research Center for Hematology, Russia||1|||f||||f||||||||||2017-10-10 23:53:37.120776|2017-10-10 23:53:37.120776
NCT02270294|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-08-01|||October 2014||2014-10-01|August 2015|2015-08-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Acute Effects of Thai Traditional Massage on Cerebrovascular Reactivity in Ischemic Stroke Patients|Acute Effects of Thai Traditional Massage on Cerebrovascular Reactivity in Ischemic Stroke Patients|Unknown status|Recruiting|N/A|18|Anticipated|Chulalongkorn University||2|||f||||||||||||||2017-10-10 23:53:37.208421|2017-10-10 23:53:37.208421
NCT02270281|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-05-15|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||The Effect of Dexmedetomidine on Microcirculation in Septic Shock|The Effect of Dexmedetomidine on Microcirculation in Septic Shock|Completed||Phase 4|30|Actual|Southeast University, China||1|||f||||t||||||||||2017-10-10 23:53:37.3031|2017-10-10 23:53:37.3031
NCT02270268|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-03-23|||November 2011||2011-11-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome|Therapeutic Effects of Pectin Supplementation in Patients With Diarrhea-predominant Irritable Bowel Syndrome|Completed||Phase 3|114|Actual|Nanjing PLA General Hospital||2|||f||||f||||||||||2017-10-10 23:53:37.382139|2017-10-10 23:53:37.382139
NCT02270255|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-03-22|||October 2014||2014-10-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Superior Hypogastric Nerve Block for Pain Control Post-UFE|Prospective Blinded Study Looking at PO/IV Analgesia Alone Versus PO/IV Analgesia With Superior Hypogastric Nerve Block for Uterine Artery Embolization Pain Management|Recruiting||Phase 2|50|Anticipated|McGill University Health Center||2|||f||||f||||||||No||2017-10-10 23:53:37.457795|2017-10-10 23:53:37.457795
NCT02270242|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-01-27|||July 2015||2015-07-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|TWILIGHT||Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention|Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention|Recruiting||Phase 4|9000|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t|t|f||||||No||2017-10-10 23:53:37.577931|2017-10-10 23:53:37.577931
NCT02270229|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-17|||November 2014||2014-11-01|October 2014|2014-10-01||||May 2015|Anticipated|2015-05-01||Observational|||Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nicaragua.|Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nicaragua.|Unknown status|Not yet recruiting|N/A|60|Anticipated|La Isla Foundation|||4||f||||||||||||||2017-10-10 23:53:37.73448|2017-10-10 23:53:37.73448
NCT02270216|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-17|||May 2014||2014-05-01|October 2014|2014-10-01||||October 2014|Anticipated|2014-10-01||Interventional|||Cardiovascular Responses to Static and Dynamic Exercise in Elderly With Isolated Systolic Hypertension|Study of Cardiovascular Responses to Static and Dynamic Exercise in Isolated Systolic Hypertension|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Khon Kaen University||2|||f||||||||||||||2017-10-10 23:53:37.822699|2017-10-10 23:53:37.822699
NCT02270203|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-06-01|||October 2014||2014-10-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|LOIS||LOIS: Long-Term Follow-Up in INSITE/SIFI|LOIS: Long-Term Follow-Up in INSITE/SIFI|Active, not recruiting||N/A|103|Actual|SI-BONE, Inc.|||1||f||||f||||||||Undecided||2017-10-10 23:53:37.932524|2017-10-10 23:53:37.932524
NCT02270190|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||August 2014||2014-08-01|October 2014|2014-10-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||PTNS as a Treatment for Tenesmus|Evaluating the Effectivenemss of Percutaneous Tibial Nerve Stimulation as a Treatment for Tenesmus in Patients With Pelvic Floor Disorders|Unknown status|Recruiting|N/A|10|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:53:38.025204|2017-10-10 23:53:38.025204
NCT02270177|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-06-13|||September 2012||2012-09-01|May 2016|2016-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|VHS||Telemedicine Versus Traditional Specialist Consultation for Headache: a Non-inferiority Trial|Patients` Satisfaction With Telemedicine Versus Traditional Specialist Consultation for Headache. An Open-labeled Randomized Non-inferiority Study Among Patients With Headache Referred to a Neurologic Outpatient Clinic|Completed||N/A|402|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-10-10 23:53:38.097589|2017-10-10 23:53:38.097589
NCT02270164|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-05-18|||October 2014||2014-10-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study|The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study|Withdrawn||N/A|0|Actual|University of Mississippi Medical Center||2||Sponsor discontinued funding due to higher than anticipated manufacturer costs|f||||f||||||||||2017-10-10 23:53:38.203759|2017-10-10 23:53:38.203759
NCT02270151|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-05-11|||November 2014||2014-11-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|IDEAL-MD||Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick|Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick|Completed||Phase 3|16000|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-10 23:53:38.288321|2017-10-10 23:53:38.288321
NCT02270138|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-04-26|||November 2014||2014-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MovingSound||An Experimental Study on Music and Sedentariness Among Mothers and Children|Movement-to-music Video Program in Decreasing Sedentary Time in Mothers and Children: a Randomized Controlled Trial|Completed||N/A|150|Actual|UKK Institute||2|||f||||f||||||||||2017-10-10 23:53:38.368547|2017-10-10 23:53:38.368547
NCT02270125|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-02-13|||September 2013||2013-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Nanoparticles in Nasal Mucosa|The Role of Nanoparticles in Inflammatory Changes of the Nasal Mucosa|Recruiting||N/A|35|Anticipated|University Hospital Ostrava|||2||f||||f||||||Samples Without DNA|"     nasal mucosa of the inferior nasal turbinate obtained by mucotomy in adult pacients nasal     mucosa of the inferior nasal turbinate obtained by mucotomy in stillborn children   "|||2017-10-10 23:53:38.443114|2017-10-10 23:53:38.443114
NCT02270112|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-10-16|||June 2014||2014-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|1 Day|Observational [Patient Registry]|DETECT-AF||Enhanced Diagnostics for Early Detection of Atrial Fibrillation|Enhanced Diagnostics for Early Detection of Atrial Fibrillation - DETECT AF Trial|Completed||N/A|287|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-10 23:53:38.534607|2017-10-10 23:53:38.534607
NCT02270099|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-08-10|||December 2014||2014-12-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|August 2016|Actual|2016-08-01||Observational|||Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects|Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)|Completed||N/A|839|Actual|Hologic, Inc.|||1||f||||f||||||Samples With DNA|"     lesion swab   "|||2017-10-10 23:53:38.600509|2017-10-10 23:53:38.600509
NCT02270086|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-09-06|||August 2011||2011-08-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Evaluating Bacterial Response in Sarcoma Management Using Fluorescence Imaging|Evaluating Bacterial Response Throughout Sarcoma Management Using An Optically Tracked, Hand-Held Fluorescent Imaging Device|Completed||N/A|20|Actual|University Health Network, Toronto|||1||f||||f||||||||Yes|Data will be presented in a peer-reviewed journal at completion of study|2017-10-10 23:53:38.685421|2017-10-10 23:53:38.685421
NCT02270073|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-10-26|||October 2014||2014-10-01|October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|PrOMET||The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study|Mindfulness Interventions in Outpatient Cognitive Behavior Therapy in Trainee Therapists: The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study|Recruiting||N/A|150|Anticipated|Heidelberg University||3|||f||||t||||||||||2017-10-10 23:53:38.745699|2017-10-10 23:53:38.745699
NCT02270060|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-09-06|||September 2014||2014-09-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Music Therapy in Sickle Cell Pain Mixed Methods Study|The Effects of a Single Music Therapy Session on the Pain of Adult Patients With Sickle Cell Disease: A Mixed Methods Study|Completed||N/A|60|Actual|University Hospitals Cleveland Medical Center||3|||f||||t||||||||Undecided||2017-10-10 23:53:38.832826|2017-10-10 23:53:38.832826
NCT02270047|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2015-03-16|||December 2014||2014-12-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SATIN||SATIN The Acute Effect of Orange Nectar With NAXUS Fibre Made by Novel Processing on Satiety and Satiation|SATIN The Acute Effect of Orange Nectar With NAXUS Fibre Made by Novel Processing on Satiety and Satiation|Completed||N/A|50|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:53:39.036346|2017-10-10 23:53:39.036346
NCT02270034|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-08-10|||November 2014||2014-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma|Phase Ib, Open-label, Multicenter, Dose-escalation Study Followed by an Extension Phase to Evaluate the Safety and Activity of the Combination of Crizotinib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 1|24|Anticipated|Grupo Español de Investigación en Neurooncología||1|||f||||f||||||||||2017-10-10 23:53:39.135333|2017-10-10 23:53:39.135333
NCT02270021|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-07-11|||July 24, 2014|Actual|2014-07-24|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Decreasing Over Screening and Treatment of Cervical Precancers in Young Women|Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women|Active, not recruiting||N/A|10500|Anticipated|University of California, San Francisco||3|||f||||f||||||||||2017-10-10 23:53:39.275836|2017-10-10 23:53:39.275836
NCT02270008|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-01-27|||October 2014||2014-10-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Reducing Perinatal Anal Incontinence Through Early Pelvic Floor Muscle Training: a Prospective Pilot Study|Reducing Perinatal Anal Incontinence Through Early Pelvic Floor Muscle Training: a Prospective Pilot Study|Completed||N/A|15|Actual|Emory University||2|||f||||t||||||||||2017-10-10 23:53:39.385968|2017-10-10 23:53:39.385968
NCT02269995|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-02-23|||March 6, 2014||2014-03-06|January 2017|2017-01-01|December 25, 2015|Actual|2015-12-25|May 14, 2015|Actual|2015-05-14||Observational|||Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma||Completed||N/A|300|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-10 23:53:39.504204|2017-10-10 23:53:39.504204
NCT02269982|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-08-14|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Observational|PROPHECY||Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY|Development of Circulating Molecular Predictors of Chemotherapy and Novel Hormonal Therapy Benefit in Men With Metastatic Castration Resistant Prostate Cancer (mCRPC)|Active, not recruiting||N/A|120|Actual|Duke University|||1||f||||f||||||Samples With DNA|"     All 120 subjects will have blood collected at 3 time points for CTC-based AR-v7 analysis.     Biopsy samples will be collected from up to 20 consenting subjects who are already undergoing     a standard of care metastatic biopsy or from a research only biopsy.   "|||2017-10-10 23:53:39.593311|2017-10-10 23:53:39.593311
NCT02269969|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-12-10|||March 2015||2015-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study|Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study|Completed||Phase 1/Phase 2|10|Actual|Sunnybrook Health Sciences Centre||1|||f||||||||||||||2017-10-10 23:53:39.695658|2017-10-10 23:53:39.695658
NCT02269956|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-04-03|||October 2014||2014-10-01|March 2017|2017-03-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Interventional|||Mealtime Symptoms in Dementia|Mealtime Symptoms in Dementia: Adaptive Leadership Approaches|Completed||N/A|132|Anticipated|Duke University||2|||f||||t||||||||||2017-10-10 23:53:39.778673|2017-10-10 23:53:39.778673
NCT02269943|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-05-09|||February 13, 2015|Actual|2015-02-13|May 2017|2017-05-01|June 15, 2017|Anticipated|2017-06-15|April 20, 2017|Actual|2017-04-20||Interventional|||Safety and Efficacy of Oral Azacitidine in Previously Treated Subjects With Locally Advanced or Metastatic Nasopharyngeal Carcinoma|A Phase 2, Multicenter, International, Single Arm Study to Assess the Safety and Efficacy of Single Agent Cc-486 (Oral Azacitidine) in Previously Treated Subjects With Locally Advanced or Metastatic Nasopharyngeal Carcinoma|Active, not recruiting||Phase 2|36|Actual|Celgene||1|||f||||f||||||||||2017-10-10 23:53:39.864841|2017-10-10 23:53:39.864841
NCT02269930|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2015-01-29|||October 2014||2014-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers|An Open-label Crossover Phase 1 Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers|Completed||Phase 1|30|Actual|Biogen||2|||f||||f||||||||||2017-10-10 23:53:40.091564|2017-10-10 23:53:40.091564
NCT02269904|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-17|||April 2014||2014-04-01|October 2014|2014-10-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Fluorouracil Implants Used for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastric Cancer.|Fluorouracil Implants（SinoFuan®）Used for Intraperitoneal Chemotherapy During Operation for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastric Cancer, Randomized, Controlled, Multicentres Open Study.|Recruiting||Phase 2|120|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:53:40.484983|2017-10-10 23:53:40.484983
NCT02269722|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2016-10-04|||July 2014||2014-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PRACTICAL||Postcath Radial Arterial Clamp Time In the CAth Lab|A Comparison of Radial Artery Clamp Times in Patients Undergoing Cardiac Catheterization Via a Percutaneous Transradial Approach|Completed||Phase 3|564|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:53:41.722459|2017-10-10 23:53:41.722459
NCT02269891|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-01-06|||October 2014||2014-10-01|January 2017|2017-01-01||||September 2017|Anticipated|2017-09-01||Interventional|14NMHB||A Clinical Trial on the Efficacy of a Combination Herbal Product, Biotropics' Nu Femme, on Menopausal Symptoms and Quality of Life in Women|A Randomized Double-Blind, Placebo-Controlled, Parallel Clinical Trial on the Efficacy of a Combination Herbal Product, Biotropics' Nu Femme, on Menopausal Symptoms and Quality of Life in Women|Recruiting||Phase 2|100|Anticipated|KGK Synergize Inc.||2|||f||||||||||||||2017-10-10 23:53:40.581973|2017-10-10 23:53:40.581973
NCT02269878|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2016-06-08|||April 2014||2014-04-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma|The Effect of FAS and FAS Ligand Genetic Polymorphisms on the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Platinum-Based Regimens|Active, not recruiting||N/A|60|Anticipated|Ain Shams University|||2||f||||f||||||||||2017-10-10 23:53:40.711795|2017-10-10 23:53:40.711795
NCT02269865|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-10-16|||December 2013||2013-12-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|CHRI||Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy|Defining and Managing the Neuropsychological Abnormalities of Myotonic Dystrophy|Unknown status|Recruiting|N/A|40|Anticipated|Stanford University|||1||f||||f||||||Samples With DNA|"     Blood Samples and Cerebrospinal Fluid (CSF) samples   "|||2017-10-10 23:53:40.797801|2017-10-10 23:53:40.797801
NCT02269852|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-09-18|||December 2013||2013-12-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine|A Single-centered, Open-labeled, Phase 4 Study of a Northern Hemisphere 2013-2014 Seasonal Trivalent Influenza Inactivated Vaccine, Anflu®|Completed||Phase 4|182|Actual|Sinovac Biotech Co., Ltd||1|||f||||f||||||||||2017-10-10 23:53:40.876007|2017-10-10 23:53:40.876007
NCT02269839|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-11-01|||September 2014||2014-09-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus|A Feasibility Study to Assess the Effectiveness of Different Modalities of Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus|Completed||N/A|40|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:53:40.94722|2017-10-10 23:53:40.94722
NCT02269826|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-17|||February 2008||2008-02-01|February 2008|2008-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Non-hormonal Vaginal Preparations in Treating Vaginal Dryness|Medical Device Study to Investigate the Efficacy and Tolerability of Vagisan® Moisturising Cream vs. Gynomunal® Vaginal Gel in a 2-period Changeover Design in n=120 Patients With Vaginal Dryness Who Cannot or do Not Wish to Use Oestrogens|Completed||N/A|117|Actual|Dr. August Wolff GmbH & Co. KG Arzneimittel||2|||f||||f||||||||||2017-10-10 23:53:41.02642|2017-10-10 23:53:41.02642
NCT02269813|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-06-18|||April 2015||2015-04-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Observational|PRIMe||PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)|PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)|Unknown status|Recruiting|N/A|450|Anticipated|West German Study Group|||2||f||||f||||||||||2017-10-10 23:53:41.11692|2017-10-10 23:53:41.11692
NCT02269800|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-17|||October 2014||2014-10-01|October 2014|2014-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD|An Efficacy Study of Benzalkonium Chloride Solution Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Lustre Pharmaceutical Lab Co., Ltd||2|||f||||f||||||||||2017-10-10 23:53:41.208498|2017-10-10 23:53:41.208498
NCT02269787|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-07-11|||October 1, 2014|Actual|2014-10-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Actual|2017-06-30||Interventional|||TeleMonitoring to Improve Substance Use Disorder Treatment After Detoxification|TeleMonitoring to Improve Substance Use Disorder Treatment After Detoxification|Active, not recruiting||N/A|256|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-10 23:53:41.284249|2017-10-10 23:53:41.284249
NCT02269774|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea|Electroanatomic Origin of Premature Atrial Beats in Patients With Paroxysmal Atrial Fibrillation Induced by Intra-thoracic Pressure Swings Simulating Obstructive Sleep Apnea|Terminated||N/A|2|Actual|University of Zurich||2||"Due to the strict in- and exclusion criteria only few patients could be enrolled into the   study."|f||||f||||||||||2017-10-10 23:53:41.352473|2017-10-10 23:53:41.352473
NCT02269761|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-10-17|||September 2014||2014-09-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Chest Ultrasound of ER Patients With Cough or SOB|Prospective Evaluation With Ultrasound of Emergency Department Patients Presenting With Cough or Dyspnea|Unknown status|Recruiting|N/A|200|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-10 23:53:41.418787|2017-10-10 23:53:41.418787
NCT02269748|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-17|||April 2012||2012-04-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Morbidity and Coverage Outcome With Connective Tissue Graft Used With Coronally Advanced Flap and Tunneling Technique|Patient Morbidity and Root Coverage Outcome After Subepithelial Connective Tissue Graft Used in Combination With Coronally Advanced Flap and Tunneling Technique: a Comparative Randomized Controlled Clinical Trial.|Completed||N/A|50|Actual|University of Padova, School of Dental Medicine||2|||f||||t||||||||||2017-10-10 23:53:41.490905|2017-10-10 23:53:41.490905
NCT02269735|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-08-18|||November 2014||2014-11-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)|A Three-part Study Parts I, II and III: Rising Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Subjects (Part I) and Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Subjects With Type 1 Diabetes Mellitus (Part II and Part III).|Completed||Phase 1|74|Actual|Merck Sharp & Dohme Corp.||11|||f||||f||||||||||2017-10-10 23:53:41.565781|2017-10-10 23:53:41.565781
NCT02269709|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-07-17|2017-06-07||November 2014||2014-11-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Stage 3 Fontan Operation Liver Ultrasound Study|Noninvasive Detection of Liver Injury Immediately Following the Fontan Operation: the Role of Ultrasound-Based Elastography|Completed||N/A|21|Actual|University of Michigan|The study is limited by the small sample size and the limited capture of follow-up Ultrasound Shear Wave Elastography data at the 6 month time point. Most patients who underwent Fontan operations received follow-up care closer to home.|1|||f||||t||||||||||2017-10-10 23:53:41.809358|2017-10-10 23:53:41.809358
NCT02269696|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-11-01|||October 2017||2017-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients|The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients|Not yet recruiting||Phase 3|70|Anticipated|Kuopio University Hospital||2|||f||||f||||||||||2017-10-10 23:53:41.993078|2017-10-10 23:53:41.993078
NCT02269683|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-05-31||||||May 2016|2016-05-01||||November 2015|Anticipated|2015-11-01||Interventional|DAVID||Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer|Randomized Controlled Trial of Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer - The DAVID-study|Withdrawn||N/A|0|Actual|Technische Universität Dresden||2||lack of funding|f||||f||||||||||2017-10-10 23:53:42.064068|2017-10-10 23:53:42.064068
NCT02269670|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-09-29|||November 2014||2014-11-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase II Study of Everolimus Beyond Progression|Phase II Study of Everolimus Beyond Progression in Postmenopausal Women With Advanced, Hormone Receptor Positive Breast Cancer|Active, not recruiting||Phase 2|4|Actual|Emory University||1|||f||||t||||||||||2017-10-10 23:53:42.128875|2017-10-10 23:53:42.128875
NCT02269657|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-12-21|2016-12-21||November 2014||2014-11-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Observational||40 subjects consented to participate; however 3 were subsequently deemed ineligible. The analysis population only includes the 37 eligible subjects.|Adolescent Idiopathic Scoliosis (AIS) Patient Positioning in EOS System®|Patients' Arm Positioning in the EOS® Stereoradiography System: Study the Sagittal Spinal Parameters and Postural Balance in EOS® Full Spine X-rays in Scoliosis|Completed||N/A|37|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||Yes|Identifiable pressure mat data from select subjects that is recorded during this study will be shared with investigators at this institution working on another approved study which requires pre-surgical pressure mat data. Many subjects in the companion study will have already undergone surgery, yet none in the current study will have at the time pressure mat data is recorded. Thus this data will be shared. Data will be stored in a password protected file on a secure shared drive and is only accessible by IRB-approved members of the current and companion study teams.|2017-10-10 23:53:42.236477|2017-10-10 23:53:42.236477
NCT02269644|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-01-21|||November 2015||2015-11-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||A P3 Comparator Trial in Community Acquired Bacterial Pneumonia|A Phase 3, Double-blinded, Randomized, Comparator Trial of the Safety and Efficacy of a Single Dose of Dalbavancin to Twice Daily Linezolid for the Treatment of Community Acquired Bacterial Pneumonia|Withdrawn||Phase 3|0|Actual|Durata Therapeutics Inc., an affiliate of Allergan plc||4|||f||||t||||||||||2017-10-10 23:53:44.312297|2017-10-10 23:53:44.312297
NCT02269631|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2017-01-15|||December 2014||2014-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Legume Diet Satiety Pilot Study|Legume Diet Satiety and Weight Loss Pilot Study|Active, not recruiting||N/A|13|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:53:44.407472|2017-10-10 23:53:44.407472
NCT02269618|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-02-05|||June 2013||2013-06-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Telehealth Program in Chronic Patients|Innovative Multidisciplinary Telehealth Program in COPD and CHF Patients: a Randomized Control Trial.|Completed||N/A|113|Actual|Fondazione Salvatore Maugeri||2|||f||||f||||||||||2017-10-10 23:53:44.496127|2017-10-10 23:53:44.496127
NCT02269605|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-12-17|||September 2014||2014-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|BRYOLAT||Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment|Bryostatin-1 Effect on HIV-1 Latency and Reservoir HIV-1 Infected Patients Receiving Antiretroviral Treatment: Pilot, Controlled, Double Blinded, Dose Searching Trial|Completed||Phase 1|12|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||3|||f||||t||||||||||2017-10-10 23:53:44.611999|2017-10-10 23:53:44.611999
NCT02269592|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-08-25|||August 2014||2014-08-01|August 2017|2017-08-01|September 2043|Anticipated|2043-09-01|December 2039|Anticipated|2039-12-01||Observational|||Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome|Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome|Recruiting||N/A|1000|Anticipated|Dana-Farber Cancer Institute|||1||f||||t||||||Samples With DNA|"     Blood, buccal swabs or mouthwashes, and urine   "|||2017-10-10 23:53:44.725686|2017-10-10 23:53:44.725686
NCT02269579|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-04-26|||April 2015||2015-04-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment|An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment|Recruiting||Phase 2|6|Anticipated|Jazz Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:53:44.841979|2017-10-10 23:53:44.841979
NCT02269566|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2016-08-10|||August 2014||2014-08-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|ILIT||Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients|A Double-blinded Placebo-controlled Randomized Clinical Trial Evaluating the Efficacy and Adverse Effect of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients|Terminated||Phase 1|24|Actual|Gachon University Gil Medical Center||2||The number of enrolled subjects did not meet the goal during the study|f||||t||||||||No||2017-10-10 23:53:44.95356|2017-10-10 23:53:44.95356
NCT02269553|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-05-12|||April 2015||2015-04-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||TMJ-1001 Bruxism Run-In/Pivotal Trial|A Pivotal Study of the TMJ NextGeneration(TradeMark) Compared to Occlusal Splint Treatment for Reduction in Nocturnal Bruxism Episodes and Monthly Migraine Episodes in Subjects Diagnosed With Sleep Bruxism|Withdrawn||N/A|0|Actual|Cardiox Corporation||2||Study redesigned into three separate trials.|f||||f||||||||||2017-10-10 23:53:45.093543|2017-10-10 23:53:45.093543
NCT02269540|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-07-20|||October 2014||2014-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)|A New Biomarker-Based Approach Towards Developing Improved Treatment for Major Depressive Disorder (MDD) Based Upon Targeting Monoamine Oxidase A (MAO-A)|Recruiting||Early Phase 1|18|Anticipated|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-10-10 23:53:45.192714|2017-10-10 23:53:45.192714
NCT02269527|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-09-12|||June 2010||2010-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of an Live Music on the Perception of Noise in the SICU: A Patient, Caregiver, and Medical Staff Environmental Study|Effects of an Integrative Music Therapy Program on the Perception of Noise in the SICU: A Patient, Caregiver, and Physician/Nursing Environmental Study|Recruiting||N/A|318|Anticipated|Beth Israel Medical Center||1|||f||||f||||||||||2017-10-10 23:53:45.425398|2017-10-10 23:53:45.425398
NCT02269514|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-01-19|||May 2014||2014-05-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Electronic Cigarettes vs Combustible Cigarettes and Nicotine Gum|A Single-Center, Randomized, Open-Label, Crossover Study to Assess Elements of Abuse Liability for Three Electronic Cigarettes|Completed||N/A|45|Actual|R.J. Reynolds Vapor Company||5|||f||||f||||||||No||2017-10-10 23:53:45.511776|2017-10-10 23:53:45.511776
NCT02269501|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-10-20|||November 2012||2012-11-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|July 2015|Anticipated|2015-07-01||Interventional|||Exercise in Migraine and Co-existing Tension-type Headache and Neck Pain|The Effect of a Specific Exercise Program on Patients Suffering From Migraine and Co-existing Tension-type Headache and Neck Pain|Unknown status|Recruiting|N/A|21|Anticipated|Danish Headache Center||2|||f||||t||||||||||2017-10-10 23:53:45.625381|2017-10-10 23:53:45.625381
NCT02269488|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2015-08-31|2015-07-30||November 2014||2014-11-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Safety analysis set|A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years|A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years|Completed||Phase 3|100|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:53:45.716111|2017-10-10 23:53:45.716111
NCT02269475|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-03-06|2015-10-29||October 2014||2014-10-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years|A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of MEDI3250 Compared to Placebo in Healthy Japanese Children Age 7 Years Through 18 Years|Completed||Phase 3|1369|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-10 23:53:45.952446|2017-10-10 23:53:45.952446
NCT02269462|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-01|||December 2012||2012-12-01|September 2017|2017-09-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|||A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation|Role of Pharmacogenetics in Efavirenz and Nevirapine Pharmacokinetics, Efficacy and Safety in Mother-infant Pairs During Pregnancy and Lactation|Completed||N/A|460|Actual|Obafemi Awolowo University|||4||f||||f||||||||||2017-10-10 23:53:46.50854|2017-10-10 23:53:46.50854
NCT02269449|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-16|||October 2014||2014-10-01|October 2014|2014-10-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|RAPandBEAT||Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial|RAP and BEAT Clinical Trial (Radial Artery Patency and Bleeding, Effectiveness, Adverse evenT Trial)|Unknown status|Not yet recruiting|N/A|1900|Anticipated|NPO International TRI Network||4|||f||||t||||||||||2017-10-10 23:53:46.625681|2017-10-10 23:53:46.625681
NCT02269436|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-01-26|||January 2015||2015-01-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS|A Multi-centre, Open-label, follow-on Study to Assess Long-term Safety and Tolerability of Intracerebroventricular Administration of sNN0029 in Patients With Amyotrophic Lateral Sclerosis|Terminated||Phase 1|11|Actual|Newron Sweden AB||1||"Issues with development and supply of infusion system for delivery of IMP. Lack of favorable   benefit risk ratio in sNN0029-003 study (review of interim data)."|f||||t||||||||||2017-10-10 23:53:46.714095|2017-10-10 23:53:46.714095
NCT02269423|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-01-16|||October 2014||2014-10-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)|A Phase 1 Randomized, Single-Center, Double-Blind, Placebo Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the BPSC-1001 (VSVΔG-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Subjects|Completed||Phase 1|39|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-10-10 23:53:46.790532|2017-10-10 23:53:46.790532
NCT02269410|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-07-18|||November 2014|Actual|2014-11-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|MIPS||Metabolic Impact of Dietary Protein Supplementation in Surgical Weight Loss|Metabolic Impact of Dietary Protein Supplementation in Surgical Weight Loss II (MIPS II)|Completed||N/A|6|Actual|Columbia University||4|||f||||f||||||||||2017-10-10 23:53:46.875659|2017-10-10 23:53:46.875659
NCT02269397|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-08-27|||July 2013||2013-07-01|August 2015|2015-08-01||||July 2016|Anticipated|2016-07-01||Observational|||Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures|Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures|Unknown status|Active, not recruiting|N/A|240|Anticipated|Cognizance Biomarkers, LLC|||1||f||||f||||||Samples Without DNA|"     Subjects will be asked to give blood for evaluation of a diagnostic blood test for epilepsy   "|||2017-10-10 23:53:46.981365|2017-10-10 23:53:46.981365
NCT02269384|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2015-02-17|||May 2014||2014-05-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||The Effects of Pain and the Memory of Pain on Autonomic and Neuromuscular Function|The Effects of Pain and the Memory of Pain on Autonomic and Neuromuscular Function|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Mount St. Mary's College, Los Angeles, CA||2|||f||||f||||||||||2017-10-10 23:53:47.091074|2017-10-10 23:53:47.091074
NCT02269358|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-25|||July 2015||2015-07-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation|Phase 4, Open Lable Non Randomized un Controlled Study. Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation|Recruiting||Phase 4|15|Anticipated|Wolfson Medical Center||1|||f||||t||||||||||2017-10-10 23:53:47.375873|2017-10-10 23:53:47.375873
NCT02269345|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-08-07|||February 2015||2015-02-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|AAstent||Auricular Acupuncture in Ureteral Stent Pain|Auricular Acupuncture: A Novel Application in Ureteral Stent Pain.|Recruiting||N/A|72|Anticipated|Mike O'Callaghan Federal Hospital||2|||f||||f||||||||||2017-10-10 23:53:47.466518|2017-10-10 23:53:47.466518
NCT02269332|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-02-01|||August 2014||2014-08-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|VitDColon||Vitamin D and Screening Colonoscopy or Polyp Surveillance|Association of 25-OH Vitamin D Status With Findings on Screening Colonoscopy.|Completed||N/A|298|Actual|Mike O'Callaghan Federal Hospital|||1||f||||f||||||||No||2017-10-10 23:53:47.553906|2017-10-10 23:53:47.553906
NCT02269319|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2017-01-16|||February 2015||2015-02-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|ABSSSI||MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection|A Phase 2, Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of MRX-I Versus Linezolid in Adult Subjects With Acute Bacterial Skin and Skin Structure Infection|Completed||Phase 2|120|Actual|MicuRx||2|||f||||f||||||||||2017-10-10 23:53:47.632121|2017-10-10 23:53:47.632121
NCT02269306|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-16|||January 2011||2011-01-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Predictors of Ovarian Response During Clomiphene Citrate Ovulation Induction in Patients With Polycystic Ovary Syndrome|Visceral Fat Area and Other Predictors of Ovarian Response During Clomiphene Citrate Ovulation Induction in Patients With Polycystic Ovary Syndrome|Completed||N/A|150|Actual|Menoufia Obstetrics and Gynecology Group||1|||f||||t||||||||||2017-10-10 23:53:47.71097|2017-10-10 23:53:47.71097
NCT02269293|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-08-03|||October 13, 2014|Actual|2014-10-13|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers|A Phase 1 Open-label Study of the Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers|Recruiting||Phase 1|48|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-10 23:53:47.799053|2017-10-10 23:53:47.799053
NCT02269280|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-02-13|||October 2014||2014-10-01|February 2017|2017-02-01|October 2026|Anticipated|2026-10-01|October 2026|Anticipated|2026-10-01||Interventional|||Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)|Phase II Randomized Study of Lower Doses of Decitabine (DAC; 20 mg/m2 IV Daily for 3 Days Every Month) Versus Azacitidine (AZA; 75 mg/m2 SC/IV Daily for 3 Days Every Month) Versus Azacitidine (AZA; 75 mg/m2 SC/IV Daily for 5 Days Every Month) in MDS Patients With Low and Intermediate-1 Risk Disease Transfusion-Dependent Versus Best Supportive Care (BSC) in MDS Patients With Low and Intermediate-1 Risk Disease Transfusion-Independent|Recruiting||Phase 2|240|Anticipated|M.D. Anderson Cancer Center||4|||f||||t|t|||||||||2017-10-10 23:53:47.909393|2017-10-10 23:53:47.909393
NCT02269267|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-09-14|||December 2014||2014-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|September 2019|Anticipated|2019-09-01||Interventional|||The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)|The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)|Active, not recruiting||Phase 2|173|Actual|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-10 23:53:48.057818|2017-10-10 23:53:48.057818
NCT02269254|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-03-04|||September 2014||2014-09-01|March 2016|2016-03-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Persona Versus NexGen||Enrolling by invitation||N/A|60|Anticipated|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 23:53:48.179724|2017-10-10 23:53:48.179724
NCT02269241|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-10-04|||October 2014||2014-10-01|October 2017|2017-10-01|October 15, 2017|Anticipated|2017-10-15|August 2016|Actual|2016-08-01||Interventional|||Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles|A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles|Active, not recruiting||Phase 3|1045|Actual|Chemo||1|||f||||f||||||||||2017-10-10 23:53:48.275339|2017-10-10 23:53:48.275339
NCT02269228|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-10-20|||February 2000||2000-02-01|October 2014|2014-10-01||||April 2000|Actual|2000-04-01||Interventional|||Tolerability of Asasantin in Healthy Female and Male Subjects|Tolerability of a Two Week Treatment With Asasantin Extended Release 200/25 mg Capsules b.i.d., Compared to Reduced Dose During the First Week of Treatment in a Double-blind, Randomised, Placebo Controlled Parallel Group Comparison Trial in Healthy Female and Male Subjects|Completed||Phase 1|100|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:53:48.442156|2017-10-10 23:53:48.442156
NCT02269215|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-10-20|||January 2000||2000-01-01|October 2014|2014-10-01||||September 2000|Actual|2000-09-01||Interventional|||Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers|A Single Blind, Placebo-controlled, Parallel-group, Single Increasing Dose Tolerance Study in Healthy Young Male Volunteers After Intravenous Administration of BIII 890 CL as Loading Dose (Dosage: 12.5, 25, 50 mg/h, Infusion Time 1 hr; 50 mg/h, Infusion Time 2 Hrs) Followed by Maintenance Dose (Dosage: 6.25, 12.5, 25 mg/h, Infusion Time 5 Hrs; 30 mg/h, Infusion Time 4 Hrs) and in Healthy Elderly Male and Female Volunteers After Intravenous Administration of BIII 890 CL as Loading Dose (Dosage: 50 mg/h, Infusion Time 1 hr) Followed by Maintenance Dose (Dosage: 25 mg/h, Infusion Time 5 Hrs)|Completed||Phase 1|73|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:48.515788|2017-10-10 23:53:48.515788
NCT02269202|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-20|||February 2002||2002-02-01|October 2014|2014-10-01||||April 2002|Actual|2002-04-01||Interventional|||Pharmacokinetics of Midazolam, With and Without Concomitant Administration of Crobenetine in Healthy Male Subjects|Pharmacokinetics of 7.5 mg Midazolam, Given Orally With and Without Concomitant Administration of 175 mg Crobenetine, Given as a 6 Hrs i.v. Infusion (One Hour Loading Dose Directly Followed by a Five Hours Maintenance Dose). A Randomised, Single Blind, Two-way Crossover Trial in Healthy Male Subjects|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:48.597255|2017-10-10 23:53:48.597255
NCT02269189|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-20|||April 2002||2002-04-01|October 2014|2014-10-01||||November 2002|Actual|2002-11-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients|A Randomized, Double-blind Within Dose, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeated Oral Doses (15-day Dosing) of BIIL 284 BS in Adult (300 mg) and Pediatric (150 mg) Cystic Fibrosis Patients|Completed||Phase 1|36|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:53:48.692126|2017-10-10 23:53:48.692126
NCT02269176|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-20|2014-10-20|||July 2000||2000-07-01|October 2014|2014-10-01||||January 2001|Actual|2001-01-01||Interventional|||Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension|12 Week, Multi-center, Randomized, Double-blind, Double Dummy, Parallel Group Trial Comparing the Efficacy and Safety of 40 & 80 mg Telmisartan and 50 & 100 mg Losartan in the Treatment of 150 Pairs of Primary Hypertension Patients|Completed||Phase 3|330|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:48.779165|2017-10-10 23:53:48.779165
NCT02269163|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-08-28|||January 26, 2016|Actual|2016-01-26|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|IGIV||A Phase 3, Multinational, Multicenter, Open-Label Study of ProMetic BioTherapeutics IVIG|A Phase 3, Multinational, Multicenter, Open-Label Study of the Safety, Tolerability, Efficacy, and PK of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10% in Adults and Children With PID|Recruiting||Phase 3|75|Anticipated|ProMetic BioTherapeutics, Inc||3|||f||||t||||||||||2017-10-10 23:53:48.857337|2017-10-10 23:53:48.857337
NCT02269150|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-04-04|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation|A Randomized Controlled Trial of Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|96|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-10 23:53:49.027424|2017-10-10 23:53:49.027424
NCT02269137|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-12-31|||March 2008||2008-03-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01|3 Months|Observational [Patient Registry]|||Assessment of Severity and Prognosis for Patients With Status Epileptics(SE)|Assessment of Severity and Prognosis for Patients With Status Epileptics|Recruiting||N/A|200|Anticipated|Xijing Hospital|||1||f||||t||||||||||2017-10-10 23:53:49.122344|2017-10-10 23:53:49.122344
NCT02269124|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-09-28|||October 2014||2014-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Use of Amplification in Children With Unilateral Hearing Loss|Use of Amplification in Children With Unilateral Hearing Loss|Recruiting||N/A|100|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||f||||||||||2017-10-10 23:53:49.193791|2017-10-10 23:53:49.193791
NCT02269111|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-10-25|||April 2015||2015-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Quantitative MRI in Assessing Disease in Patients With Brain Tumors|Quantitative High-Field Magnetic Resonance Imaging (MRI) for Assessing Brain Metastases|Suspended||N/A|10|Actual|Vanderbilt-Ingram Cancer Center||1||Change in PI and funding|f||||t||||||||||2017-10-10 23:53:49.271686|2017-10-10 23:53:49.271686
NCT02269098|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-11-10|2016-01-15||February 2012||2012-02-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|STEP-DM||The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes|The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes: STEP-Diabetes.|Completed||N/A|101|Actual|Medstar Health Research Institute|Not all subjects completed the study, yet dropout rates by arm were similar. Medication adherence was self-reported - concurrent improvement in glycemic control was concordant with its improvement. Impact on ED return visits could not be determined.|2|||f||||f||||||||No|There is currently no plan to share IPD. Study results data have been published and shared at national meetings. The PI is open to discussions about the data as requested.|2017-10-10 23:53:49.363059|2017-10-10 23:53:49.363059
NCT02269085|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-10-05|||April 2015|Actual|2015-04-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma|A Phase I/II Trial of Ibrutinib (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|8|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:53:49.804577|2017-10-10 23:53:49.804577
NCT02269072|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-03-01|||February 2015||2015-02-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Testosterone Regulation of the Natriuretic Peptide System|Testosterone Regulation of the Natriuretic Peptide System|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||2||Lack of funding|f||||t||||||||||2017-10-10 23:53:49.895664|2017-10-10 23:53:49.895664
NCT02269059|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-07-24|||December 2014||2014-12-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003)|A Multiple Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MK-7680 in Patients With Hepatitis C Infection|Completed||Phase 1|13|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-10 23:53:49.979184|2017-10-10 23:53:49.979184
NCT02269046|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-16|||December 2014||2014-12-01|August 2014|2014-08-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Interventional|AMH-RCT||Acupuncture and Moxibustion for Hyperlipemia|A Multi-center, Randomized, Stratified, Active-controlled Trial to Evaluate the Effects of Acupuncture and Moxibustion for Hyperlipidemias|Unknown status|Not yet recruiting|N/A|210|Anticipated|The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-10 23:53:50.059751|2017-10-10 23:53:50.059751
NCT02269033|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-20|||September 2008||2008-09-01|October 2014|2014-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Redes II National Patient Navigator Intervention Study|Redes en Acción: National Patient Navigator Intervention Study|Completed||N/A|480|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-10 23:53:50.187223|2017-10-10 23:53:50.187223
NCT02268500|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-12-16|||September 2014||2014-09-01|December 2015|2015-12-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Interventional|VACC-HeFT||VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)|VAccination to Improve Clinical outComes in Heart Failure Trial (VACC-HeFT): a Feasibility Study|Recruiting||Phase 4|40|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-10 23:53:55.123208|2017-10-10 23:53:55.123208
NCT02269020|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-10-24|||February 2015||2015-02-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|RoboCurage ORL||Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx|Unilateral Selective Neck Dissection at Lymph Node Levels IIa, III and IV Using a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx: the First Three Patients|Recruiting||Phase 1|3|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||t||||||||||2017-10-10 23:53:50.277784|2017-10-10 23:53:50.277784
NCT02269007|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-10-11|||May 2015||2015-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China|A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China|Completed||Phase 1|110|Actual|Jiangsu Province Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-10-10 23:53:50.415471|2017-10-10 23:53:50.415471
NCT02268994|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2017-03-09||2017-03-09|September 2014||2014-09-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD|A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia in Adult Subjects With Non-Dialysis Dependent Chronic Kidney Disease|Completed||Phase 3|234|Actual|Keryx Biopharmaceuticals||2|||f||||f||||||||||2017-10-10 23:53:50.495992|2017-10-10 23:53:50.495992
NCT02268981|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-09-02|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)|Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)|Completed||N/A|18|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||1|||f||||f||||||||||2017-10-10 23:53:50.678251|2017-10-10 23:53:50.678251
NCT02268968|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-04-12|||October 2013||2013-10-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure|Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal Contiuous Positive Airway Pressure|Completed||Phase 1|60|Actual|Mansoura University Children Hospital||2|||f||||t||||||||||2017-10-10 23:53:50.773689|2017-10-10 23:53:50.773689
NCT02268955|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-11-04|||September 2014||2014-09-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic|Assessment of the Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic|Recruiting||N/A|36|Anticipated|Maricopa Integrated Health System||2|||f||||f||||||||||2017-10-10 23:53:50.893217|2017-10-10 23:53:50.893217
NCT02268942|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-02-20|||November 2014||2014-11-01|February 2017|2017-02-01|April 2021|Anticipated|2021-04-01|October 2016|Actual|2016-10-01||Interventional|HVAD LATERAL||A Prospective, Single Arm, Multi-Center Clinical Study in Collaboration With the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS®) to Evaluate the Thoracotomy Implant Technique of the HeartWare HVAD® System in Patients With Advanced Heart Failure|A Prospective, Single Arm, Multi-Center Clinical Study in Collaboration With the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS®) to Evaluate the Thoracotomy Implant Technique of the HeartWare HVAD® System in Patients With Advanced Heart Failure (HVAD LATERAL)|Active, not recruiting||N/A|145|Actual|HeartWare, Inc.||1|||f||||t||||||||||2017-10-10 23:53:51.026369|2017-10-10 23:53:51.026369
NCT02268929|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-04-03|||October 15, 2014|Actual|2014-10-15|April 2017|2017-04-01|February 9, 2017|Actual|2017-02-09|January 11, 2017|Actual|2017-01-11||Interventional|PDM-ProValueGP||A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.|Integrated Personalized Diabetes Management (Integrated PDM):Prospective, Randomized, Controlled Intervention Study for the Evaluation of the Effectiveness and the Benefit of Integrated PDM in the Care of People With Type 2 Diabetes in General Medical Practices in Germany (GP).|Completed||N/A|414|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-10 23:53:51.166713|2017-10-10 23:53:51.166713
NCT02268916|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-07-14|||June 1, 2015|Actual|2015-06-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Physical Activity and Participation|Veterans With Diabetes Mellitus: Improving Physical Activity and Participation|Recruiting||N/A|70|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:53:51.349687|2017-10-10 23:53:51.349687
NCT02268903|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2015-10-05|||November 2014||2014-11-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|DiPER||Diuretic Versus Placebo in Pulmonary Embolism|Diuretic Versus Placebo in Pulmonary Embolism With Right Ventricular Enlargement: a Double-blind Randomized Controlled Study|Recruiting||Phase 3|270|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-10 23:53:51.465326|2017-10-10 23:53:51.465326
NCT02268890|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-07-08|||December 2014||2014-12-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma|Pharmacokinetic Study of Bortezomib (VELCADE) Administered Intravenously in Taiwanese Patients With Multiple Myeloma - A Post Approval Commitment Study|Completed||Phase 4|18|Actual|Johnson & Johnson Taiwan Ltd||1|||f||||f||||||||||2017-10-10 23:53:51.577274|2017-10-10 23:53:51.577274
NCT02268877|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-06-01|2017-05-01||March 2013||2013-03-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Randomized Prospective Analysis of Time to Diagnosis and Length of Stay of Emergency Department Pelvic Ultrasonography|A Randomized Prospective Analysis of Time to Diagnosis and Length of Stay of Emergency Department Pelvic Ultrasonography|Completed||N/A|224|Actual|Denver Health and Hospital Authority|This is not a blinded study. As such the performers may have been biased to complete these procedures more quickly than they would be if the study were not taking place.|2|||f||||f||||||||No||2017-10-10 23:53:51.67672|2017-10-10 23:53:51.67672
NCT02268864|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-02-07|2016-11-23||January 2015||2015-01-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|COMMIT|The intent-to-treat (ITT) analysis set is defined as all participants who received at least one dose of simeprevir or daclatasvir.|A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants|A Phase 2, Open-label Study to Investigate the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Subjects|Completed||Phase 2|106|Actual|Janssen-Cilag International NV||1|||f||||f||||||||||2017-10-10 23:53:51.911987|2017-10-10 23:53:51.911987
NCT02268851|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-07-05|||November 2014||2014-11-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|February 2018|Anticipated|2018-02-01||Interventional|||A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL|A Multi-center Phase I/Ib Study Evaluating the Efficacy and Safety of the Novel PI3k Delta Inhibitor TGR-1202 in Combination With Ibrutinib in Patients With Select B-Cell Malignancies|Recruiting||Phase 1|60|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:53:52.37561|2017-10-10 23:53:52.37561
NCT02268838|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-01-19|||October 2014||2014-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects|A Phase 1 Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects|Completed||Phase 1|24|Actual|Eisai Inc.||5|||f||||f||||||||||2017-10-10 23:53:52.49368|2017-10-10 23:53:52.49368
NCT02268825|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-06-27|||January 23, 2015|Actual|2015-01-23|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|MK-3475 GI||Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers|A Phase I Study of MK-3475 in Combination With Chemotherapy and Supplemental Celecoxib in Patients With Advanced GI Cancers (Colorectal/Appendiceal Adenocarcinoma, Gastroesophageal, Pancreatic and Biliary)|Active, not recruiting||Phase 1|39|Actual|University of Utah||1|||f||||t|t|f||||||||2017-10-10 23:53:52.568372|2017-10-10 23:53:52.568372
NCT02268799|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-08-12|||October 2014||2014-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation / Atrial Flutter|High Sensitivity Troponin T Levels Following Elective External Direct Current Cardioversion for Atrial Fibrillation / Atrial Flutter|Completed||N/A|101|Actual|University of Limerick|||1||f||||f||||||||||2017-10-10 23:53:52.810812|2017-10-10 23:53:52.810812
NCT02268786|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-02-28|||September 2014||2014-09-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|STAR||Single Embryo TrAnsfeR of Euploid Embryo|Prospective, Multi-center, Randomized Controlled Trial Comparing Pregnancy Outcomes Following Selection and Single Embryo Transfer (SET) Based on Preimplantation Genetic Screening (PGS) by Next Generation Sequencing (NGS) Versus Standard Morphological Assessment|Active, not recruiting||Phase 3|600|Anticipated|Illumina, Inc.||2|||f||||f||||||||||2017-10-10 23:53:52.896272|2017-10-10 23:53:52.896272
NCT02268773|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-17|||January 2000||2000-01-01|October 2014|2014-10-01||||May 2000|Actual|2000-05-01||Interventional|||Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers|A Randomised, Two-period, Cross-over Trial to Compare the Effects of Acetylsalicylic Acid (75 mg/Day) With the Combination of Acetylsalicylic Acid (25 mg) + Modified-release Dipyridamole (200 mg) (bd) on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers|Completed||Phase 1|27|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:53.072173|2017-10-10 23:53:53.072173
NCT02268760|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-17|2014-10-17|||June 2001||2001-06-01|October 2014|2014-10-01||||September 2001|Actual|2001-09-01||Interventional|||Safety, Tolerance, and Pharmacokinetics of BILN 2061 ZW in Healthy Male Subjects, Combined With Preliminary Evaluation of Food Effect|Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of 5 mg, 20 mg, 60 mg, 100 mg, 200 mg, 400 mg, 600 mg, 800 mg, 1000 mg, 1200 mg, 1500 mg, 2000 mg and 2400 mg BILN 2061 ZW (PEG 400: Ethanol Solution) in Healthy Male Subjects, Combined With Preliminary Evaluation of Food Effect of the Dose of 200 mg (Two-Stage Trial Design With Randomised Double Blind Placebo Controlled Rising Dose Part and Subsequent Open Intraindividual Comparison Part)|Completed||Phase 1|103|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:53:53.165353|2017-10-10 23:53:53.165353
NCT02268747|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-09|2016-07-01|||November 2014||2014-11-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer|Efficacy and Safety of Single Agent Pan-HER Inhibitor Dacomitinib in the Treatment of Locally Advanced Unresectable or Metastatic Squamous Cell Cancer of the Skin or With Clinical Contraindication to Surgery|Active, not recruiting||Phase 2|43|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-10 23:53:53.252073|2017-10-10 23:53:53.252073
NCT02268734|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-10-16|||April 2014||2014-04-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib|Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer (sMTC) Patients and Possible Correlation With Vandetanib Therapy|Unknown status|Recruiting|N/A|25|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||1||f||||f||||||Samples With DNA|"     primary tumor and metastases tissue samples and other biological materials, including blood     are collected   "|||2017-10-10 23:53:53.336284|2017-10-10 23:53:53.336284
NCT02268721|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-03-03|||March 2014||2014-03-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Food'to'Go - a Feasibility Study of Post-discharge Meals for Older Patients by the Use of ICT-technology|Food'to'Go - a Feasibility Study of Post-discharge Delivery of Protein- and Energy-enforced Meals for Older Patients by the Use of ICT-technology|Completed||N/A|36|Actual|Herlev Hospital||2|||f||||f||||||||||2017-10-10 23:53:53.432247|2017-10-10 23:53:53.432247
NCT02268708|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-02-17|||July 2014||2014-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|June 2015|Actual|2015-06-01||Observational|||Evaluation of Post-operative Respiratory Complications After Thoracic Surgery in Patients With COPD|Evaluation of Post-operative Respiratory Complications After Thoracic Surgery in Patients With COPD|Completed||N/A|100|Actual|Hôpital Cochin|||1||f||||f||||||||||2017-10-10 23:53:53.518114|2017-10-10 23:53:53.518114
NCT02268487|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-12-10|||January 2014||2014-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|AIUNI||Integral Assessment in Unipolar Depression|THE AIUNI - Integral Assessment in Unipolar Depression|Recruiting||Phase 4|100|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-10 23:53:55.19163|2017-10-10 23:53:55.19163
NCT02268695|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-02-23|||October 2014||2014-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TPExtreme||Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC|TPExtreme: Randomized, Controlled Trial of Platinum-Cetuximab Combined Either With Docetaxel (TPEx) or With 5FU (Extreme) in Patients With Recurrent/Metastatic Squamous Cell Cancer of the Head and Neck|Recruiting||Phase 2|416|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||2|||f||||t||||||||||2017-10-10 23:53:53.614218|2017-10-10 23:53:53.614218
NCT02268682|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-01-09|||July 2014||2014-07-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge|Improving Low-Income End Stage Renal Disease Patients' Transplant Knowledge: A Case Management Trial|Completed||N/A|558|Actual|University of California, Los Angeles||3|||f||||t||||||||No||2017-10-10 23:53:53.822207|2017-10-10 23:53:53.822207
NCT02268669|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-16|||May 2010||2010-05-01|October 2014|2014-10-01|March 2016|Anticipated|2016-03-01|October 2014|Actual|2014-10-01||Interventional|GRACIA4||Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI|A Randomized Clinical Trial Comparing Primary PCI and Post-thrombolysis PCI as Reperfusion Strategies in Patients With ST Segment Elevation Acute Myocardial Infarction|Unknown status|Active, not recruiting|Phase 4|1444|Actual|GRACIA Group||2|||f||||t||||||||||2017-10-10 23:53:53.913631|2017-10-10 23:53:53.913631
NCT02268656|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-04-20|||October 2014||2014-10-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|D-pofol||Effect-site Concentration of Propofol for I-gel Insertion During Anesthesia Induction With a Single-dose Dexmedetomidine|Preducted Effect-site Concentration of Propofol for I-gel Insertion During Anesthesia Induction|Completed||N/A|40|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-10 23:53:54.017684|2017-10-10 23:53:54.017684
NCT02268643|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-15|||January 2014||2014-01-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Ultrasound-based Breast Cancer Screening in Chinese Women|Ultrasound-based Breast Cancer Screening in Chinese Women|Recruiting||N/A|20000|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||||||2017-10-10 23:53:54.10507|2017-10-10 23:53:54.10507
NCT02268630|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-02-15|||January 2014||2014-01-01|February 2017|2017-02-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Observational|LOVE||Long Term Outcomes of Venous Thromboembolism|Long Term Outcomes of Venous Thromboembolism -the LOVE Study-|Recruiting||N/A|460|Anticipated|Ostfold Hospital Trust|||2||f||||t||||||||||2017-10-10 23:53:54.265247|2017-10-10 23:53:54.265247
NCT02268617|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-09-26|||February 2013||2013-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease|Immediate Effects of Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease|Completed||N/A|28|Actual|Ohio State University||1|||f||||f||||||||No||2017-10-10 23:53:54.360853|2017-10-10 23:53:54.360853
NCT02268604|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-10-16|||October 2010||2010-10-01|October 2014|2014-10-01||||October 2010|Actual|2010-10-01||Interventional|||Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers|Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Oral Doses of 200 and 300 mg BIIB 722 CL Tablet Tid and 300 and 450 mg BIIB 722 CL Tablet Bid Over 7 Days to Healthy Volunteer Subjects. An Open Study, Placebo-controlled Randomised Double Blind at Each Dose Level.|Terminated||Phase 1|10|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:54.463507|2017-10-10 23:53:54.463507
NCT02268591|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-03-30|||October 1, 2014|Actual|2014-10-01|March 2017|2017-03-01||||October 1, 2015|Actual|2015-10-01||Interventional|||Transcranial Stimulation During Sleep to Improve Cognition in Epilepsy|Transcranial Stimulation During Sleep to Improve Cognition in Epilepsy|Suspended||Phase 1|20|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 23:53:54.543779|2017-10-10 23:53:54.543779
NCT02268578|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-04-13|||November 2012||2012-11-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy|Efficacy of Transcranial Direct Current Stimulation for Treating Working Memory Dysfunction and Depression For Patients With Temporal Lobe Epilepsy|Withdrawn||Phase 1|0|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 23:53:54.617077|2017-10-10 23:53:54.617077
NCT02268565|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-03-13|||October 2014||2014-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms|Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms|Completed||Early Phase 1|8|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-10 23:53:54.69836|2017-10-10 23:53:54.69836
NCT02268552|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-01-24|||April 2015||2015-04-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||An Open Label Study of LMI070 in Type 1 Spinal Muscular Atrophy (SMA)|An Open Label Multi-part First-in-human Study of Oral LMI070 in Infants With Type 1 Spinal Muscular Atrophy|Active, not recruiting||Phase 1/Phase 2|42|Anticipated|Novartis||1|||f||||t||||||||||2017-10-10 23:53:54.786244|2017-10-10 23:53:54.786244
NCT02268539|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-08|||February 2014||2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in Paroxysmal Atrial Fibrillation|Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in the Treatment of Paroxysmal Atrial Fibrillation - A Pilot Study|Active, not recruiting||N/A|11|Actual|Basildon and Thurrock University Hospitals NHS Foundation Trust||4|||f||||f||||||||||2017-10-10 23:53:54.875837|2017-10-10 23:53:54.875837
NCT02268526|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-09-06|||June 2, 2015|Actual|2015-06-02|September 2017|2017-09-01|December 7, 2016|Actual|2016-12-07|December 7, 2016|Actual|2016-12-07||Interventional|||Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients|A Multi-center, Randomized, Double-blind, Placebo Controlled, Study to Evaluate the Efficacy and Safety of CSJ148 Compared to Placebo to Prevent Human Cytomegalovirus (HCMV) Replication in Stem Cell Transplant Patients|Completed||Phase 1/Phase 2|86|Actual|Novartis||2|||f||||f|t|f||||||||2017-10-10 23:53:54.953855|2017-10-10 23:53:54.953855
NCT02268513|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-01-13|||September 2014||2014-09-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study|Social and Cultural Influences on Cardiovascular Disease Risk in South Asians|Recruiting||N/A|900|Anticipated|Northwestern University|||1||f||||f||||||||||2017-10-10 23:53:55.053441|2017-10-10 23:53:55.053441
NCT02268474|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-09-09|||September 2014||2014-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea|Prospective, Randomized, Controlled Split-Face Study of the Excel V 532nm KTP Laser for the Treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea|Completed||N/A|22|Actual|Cutera Inc.||2|||f||||f||||||||||2017-10-10 23:53:55.278129|2017-10-10 23:53:55.278129
NCT02268461|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-06-26|||December 2014||2014-12-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity|Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity|Completed||N/A|4|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 23:53:55.356334|2017-10-10 23:53:55.356334
NCT02268448|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-08-30|||July 2015||2015-07-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Atopic Dermatitis Itch|Treatment of Chronic Itch in Atopic Dermatitis With Oral Clonidine and Oral Naltrexone|Recruiting||Phase 1|8|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-10 23:53:55.450864|2017-10-10 23:53:55.450864
NCT02268435|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-08-01|||March 2015||2015-03-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors|A Trial of Dovitinib in Combination With Imatinib in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors After Failure to Imatinib and Sunitinib|Withdrawn||Phase 1|0|Actual|Asan Medical Center||1||Dovitinib Production stopped|f||||f||||||||||2017-10-10 23:53:55.536813|2017-10-10 23:53:55.536813
NCT02268422|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-02-08|||October 2014||2014-10-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||Bioequivalence and Adhesion Comparison of Buprenorphine Patches|A Two-period, Randomised, Open-label, Crossover, Pharmacokinetic Study to Assess the Bioequivalence and Adhesion of Buprenorphine Transdermal System Second Generation Patch Compared With First Generation Patch, in Healthy Volunteers|Completed||Phase 1|104|Actual|Mundipharma Research Limited||2|||f||||f||||||||||2017-10-10 23:53:55.602208|2017-10-10 23:53:55.602208
NCT02268409|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-12-14|||November 2014||2014-11-01|December 2016|2016-12-01|April 2021|Anticipated|2021-04-01|February 2021|Anticipated|2021-02-01||Interventional|||ACE-536 Extension Study - Beta Thalassemia|An Open-Label Extension Study to Evaluate the Long-Term Effects of ACE-536 in Patients With β-Thalassemia Previously Enrolled in Study A536-04|Active, not recruiting||Phase 2|64|Anticipated|Acceleron Pharma, Inc.||1|||f||||f||||||||||2017-10-10 23:53:55.681095|2017-10-10 23:53:55.681095
NCT02268396|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-10-31|2016-05-23|2015-07-07|November 2014||2014-11-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional||126 received treatment on Day 1 and 29, 10 prematurely discontinued, 2 with no assessment on Day 29.|Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD|An Open-Label, Multi-Center, Dose Indicator Study of Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) in Adult Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|138|Actual|Pearl Therapeutics, Inc.||1|||f||||f||||||||||2017-10-10 23:53:55.783039|2017-10-10 23:53:55.783039
NCT02268383|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-08-26|||October 2014||2014-10-01|August 2016|2016-08-01|August 2022|Anticipated|2022-08-01|April 2022|Anticipated|2022-04-01||Interventional|||ACE-536 Extension Study - Myelodysplastic Syndromes|An Open-Label Extension Study to Evaluate the Long-Term Effects of ACE-536 for the Treatment of Anemia in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Previously Enrolled in Study A536-03|Recruiting||Phase 2|128|Anticipated|Acceleron Pharma, Inc.||1|||f||||f||||||||||2017-10-10 23:53:55.9892|2017-10-10 23:53:55.9892
NCT02268370|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-09-19|||October 2014||2014-10-01|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|TRAD||Treatment-free Remission Accomplished With Dasatinib in Patients With CML|Treatment-free Remission Accomplished With Dasatinib in Patients With CML|Recruiting||Phase 2|135|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-10 23:53:56.061498|2017-10-10 23:53:56.061498
NCT02268357|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-08-10|||October 2014||2014-10-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Effects of Propranolol on Fear of Tooth or Molar Extraction|Effects of Propranolol on Fear of Dental Extraction: Study Protocol for a Randomized Placebo-controlled Trial.|Recruiting||Phase 2/Phase 3|34|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||Undecided||2017-10-10 23:53:56.16591|2017-10-10 23:53:56.16591
NCT02268344|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2015-06-17|||July 2014||2014-07-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|ESSAN||Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection|Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection (ESSAN): a Double-blinded, Randomized Control Trial|Unknown status|Recruiting|Phase 3|60|Anticipated|University of Alberta||2|||f||||t||||||||||2017-10-10 23:53:56.24474|2017-10-10 23:53:56.24474
NCT02268331|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-09-16|||October 2014||2014-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Active vs. Passive Surveillance to Collect Adverse Events|Comparison of Active vs. Passive Surveillance to Collect Adverse Events After Chiropractic Manual Therapy in the Children|Recruiting||N/A|160|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:53:56.459115|2017-10-10 23:53:56.459115
NCT02268318|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2016-10-26|||January 2014||2014-01-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||"A Clinical Study for Evaluating the Effect of a Plant Sterol-enriched Fermented Dairy Product on Blood Lipoprotein Profile in Japanese Adults"|A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO EVALUATE THE EFFECT OF A 12-WEEK CONSUMPTION PERIOD OF SINGLE DOSE A DAY OF A PLANT STEROL-ENRICHED FERMENTED DAIRY PRODUCT ON BLOOD LIPOPROTEIN PROFILE IN JAPANESE ADULTS WITH HIGH LDL-C|Completed||N/A|154|Actual|Danone Research||2|||f||||f||||||||||2017-10-10 23:53:56.549194|2017-10-10 23:53:56.549194
NCT02268305|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-08-09|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain|The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain.|Recruiting||Phase 3|100|Anticipated|Mike O'Callaghan Federal Hospital||2|||f||||f||||||||||2017-10-10 23:53:56.643055|2017-10-10 23:53:56.643055
NCT02268292|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2014-10-15|||August 2012||2012-08-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Home Bicycle Exercise and Aerobic Capacity|The Effects of Home Bicycle Exercise Program on Hyperlipidemia, Hypertension, Blood Sugar Control, Muscle Strength and Aerobic Capacity|Completed||Phase 4|37|Actual|Taichung Veterans General Hospital||1|||f||||f||||||||||2017-10-10 23:53:56.767446|2017-10-10 23:53:56.767446
NCT02268279|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-06-07|||January 2015||2015-01-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Pharmacokinetics and Safety of Solithromycin in Adolescents and Children|A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents and Children With Suspected or Confirmed Bacterial Infection|Completed||Phase 1|84|Actual|Cempra Inc||1|||f||||t|t|f||||||||2017-10-10 23:53:56.868452|2017-10-10 23:53:56.868452
NCT02268266|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-11-17|||April 2010||2010-04-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ERIGO®LIFE||ERIGO® Life- Control of Cardiovascular Parameters Via Verticalization and Simultaneous Mobilization|ERIGO® Life - Study of Cardiovascular Parameters and Other Physiologic Parameters Under Verticalization and Simultaneous Mobilization of the Leg on Neurological Patients and Healthy Subjects|Completed||N/A|30|Actual|Swiss Federal Institute of Technology||1|||f||||f||||||||||2017-10-10 23:53:57.532522|2017-10-10 23:53:57.532522
NCT02268253|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-07-17|||December 2014||2014-12-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)|SL-401 in Patients With Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)|Recruiting||Phase 1/Phase 2|100|Anticipated|Stemline Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:53:57.654218|2017-10-10 23:53:57.654218
NCT02268240|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-01-13|||October 2014||2014-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CARE4PCS||Care for Post-Concussive Symptoms|Care for Post-Concussive Symptoms|Completed||N/A|50|Anticipated|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-10 23:53:57.824526|2017-10-10 23:53:57.824526
NCT02268227|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2014-10-17|||July 2014||2014-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:53:57.941346|2017-10-10 23:53:57.941346
NCT02268214|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-09-28|||November 11, 2014|Actual|2014-11-11|September 2017|2017-09-01|August 25, 2017|Actual|2017-08-25|January 4, 2017|Actual|2017-01-04||Interventional|DEPICT 1||Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 3|833|Actual|AstraZeneca||3|||f||||t||||||||||2017-10-10 23:53:58.049698|2017-10-10 23:53:58.049698
NCT02268201|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-11-25|||March 2012||2012-03-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule|Efficacy and Safety of Switch From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule in Maintenance Kidney Transplant Recipients: a Randomized, Controlled, Open-label, Multi-centers Clinical Trial|Terminated||Phase 4|17|Actual|Astellas Pharma Inc||2||Due to difficulty enrolling patients|f||||f||||||||||2017-10-10 23:53:58.486908|2017-10-10 23:53:58.486908
NCT02268188|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-04-04|||April 2014||2014-04-01|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Harvesting Health Program in Improving Diet and Physical Activity Level in Cancer Survivors|Harvesting Health for Cancer Survivors: A Pilot Project|Active, not recruiting||N/A|50|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:53:58.599884|2017-10-10 23:53:58.599884
NCT02268175|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-10-04|||October 2014||2014-10-01|October 2017|2017-10-01|February 2022|Anticipated|2022-02-01|June 2018|Anticipated|2018-06-01||Interventional|||Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate|A Phase II Randomized Study of Enzalutamide+Leuprolide Versus Enzalutamide+Leuprolide+Abiraterone Acetate+Prednisone as Neoadjuvant Therapy for HIgh-Risk Prostate Cancer Undergoing Prostatectomy|Active, not recruiting||Phase 2|75|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-10 23:53:58.726131|2017-10-10 23:53:58.726131
NCT02268162|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2015-11-13|||April 2015||2015-04-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination|Prospective Multicenter Randomized Control Study on Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination|Recruiting||N/A|3228|Anticipated|Tang-Du Hospital||3|||f||||t||||||||||2017-10-10 23:53:58.846477|2017-10-10 23:53:58.846477
NCT02268149|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||April 2000||2000-04-01|October 2014|2014-10-01||||July 2000|Actual|2000-07-01||Interventional|||Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects|The Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Male Subjects (A Randomized, Double-blind, Placebo-controlled, Two Period, Two-way Cross-over Study)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:58.951498|2017-10-10 23:53:58.951498
NCT02268136|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||April 1999||1999-04-01|October 2014|2014-10-01||||December 1999|Actual|1999-12-01||Interventional|||Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL|A Single-blind, Placebo-controlled, Parallel Group, Single Increasing Dose Tolerance Study in Healthy Male Volunteers After Intravenous Administration of BIII 890 CL (Dosage: 0.5 mg/h - 80 mg/h), Infusion Time 1 Hour.|Terminated||Phase 1|76|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:53:59.032112|2017-10-10 23:53:59.032112
NCT02268123|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-06-30|||October 2014||2014-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation|Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation|Active, not recruiting||N/A|600|Anticipated|Reproductive Medicine Associates of New Jersey|||1||f||||f||||||Samples With DNA|"     An aliquot semen (0.5 - 1mL) will be collected and cryopreserved for analysis for DNA     Fragmentation. Two tubes of serum (approximately 20 mL) will be collected from male partner     via venipuncture.   "|||2017-10-10 23:53:59.100863|2017-10-10 23:53:59.100863
NCT02268097|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2017-06-15|||October 29, 2014|Actual|2014-10-29|October 2014|2014-10-01|July 15, 2017|Anticipated|2017-07-15|July 15, 2017|Anticipated|2017-07-15||Interventional|||Comparison of Two Methods of Patellar Resurfacing in Total Knee Arthroplasty|Comparison of Two Methods of Patellar Resurfacing in Total Knee Arthroplasty.A Prospective, Randomized, Double-blind Study|Unknown status|Active, not recruiting|N/A|101|Actual|Peking University Third Hospital||2|||f||||t||||||||||2017-10-10 23:53:59.23988|2017-10-10 23:53:59.23988
NCT02268084|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2016-10-03|||October 2014||2014-10-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD|A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Treatment Efficacy of EEG/ECD-Guided Magnetic Resonant Therapy in Combat Veterans With Post-Traumatic Stress Disorder (PTSD).|Active, not recruiting||N/A|86|Actual|Newport Brain Research Laboratory||2|||f||||t||||||||||2017-10-10 23:53:59.330244|2017-10-10 23:53:59.330244
NCT02268071|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||November 2014||2014-11-01|October 2014|2014-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)|Arrêt du Traitement Antihypertenseur Chez Les Patients Hypertendus Suivis en Médecine Générale / Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care: The STOP-Trial|Not yet recruiting||N/A|330|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-10-10 23:53:59.400933|2017-10-10 23:53:59.400933
NCT02268058|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-10-19|2016-10-18||October 2013||2013-10-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Use of Ibuprofen and Acetaminophen for Treatment of Acute Headache Post Concussion in Children|The Use of Ibuprofen and Acetaminophen for Acute Headache in the Post Concussive Youth: A Pilot Study.|Completed||N/A|80|Actual|McMaster Children's Hospital|open label study, not blinded pilot study, no sample size calculation|4|||f||||f||||||||||2017-10-10 23:53:59.48602|2017-10-10 23:53:59.48602
NCT02268045|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-09-20|||May 2013||2013-05-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|May 2016|Actual|2016-05-01||Interventional|||Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma|A Randomized, Double-blind, Phase III Study Comparing Biosimilar Rituximab (RTXM83) Plus CHOP Chemotherapy Versus a Reference Rituximab Plus CHOP (R-CHOP) in Patients With Diffuse Large B-cell Lymphoma (DLBCL) Given as First Line|Completed||Phase 3|256|Actual|mAbxience S.A||2|||f||||t||||||||||2017-10-10 23:54:00.063721|2017-10-10 23:54:00.063721
NCT02268032|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-09-14|||May 2014||2014-05-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve|Assess the Effect of DHEA or Other Androgenic Agents on Ovarian Reserve Markers in Women With Diminished Ovarian Reserve.|Unknown status|Recruiting|Phase 1|60|Anticipated|Laboratorios Andromaco S.A.||3|||f||||f||||||||||2017-10-10 23:54:00.310817|2017-10-10 23:54:00.310817
NCT02268019|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-10-15|||January 2013||2013-01-01|October 2014|2014-10-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|||Hemostasis During Hypospadias Surgery|A Comparison Between Tourniquet Application and Epinephrine Injection for Hemostasis During Hypospadias Surgery: the Effect on Bleeding and Post-operative Outcome|Unknown status|Recruiting|N/A|70|Anticipated|Isfahan University of Medical Sciences||1|||f||||t||||||||||2017-10-10 23:54:00.40044|2017-10-10 23:54:00.40044
NCT02268006|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2014-10-15|||January 2014||2014-01-01|September 2014|2014-09-01|December 2020|Anticipated|2020-12-01|December 2015|Anticipated|2015-12-01||Interventional|BISER||IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment|Preoperative Radiochemotherapy With IMRT - Simultaneous Integrated Boost in Locally Advanced Rectal Cancer - BISER|Recruiting||Phase 2|50|Anticipated|Institute of Oncology Ljubljana||1|||f||||||||||||||2017-10-10 23:54:00.476518|2017-10-10 23:54:00.476518
NCT02267993|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-01-01|||October 2014||2014-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients|A Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Thrombopoietin in the Treatment of Thrombocytopenia After Chemotherapy in Acute Myeloid Leukemia|Recruiting||Phase 4|120|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||f||||||||No||2017-10-10 23:54:02.311514|2017-10-10 23:54:02.311514
NCT02267980|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-15|||July 2014||2014-07-01|October 2014|2014-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy|Turgut Ozal Medical Center Department of Anesthesiology and Reanimation|Unknown status|Recruiting|Phase 4|60|Anticipated|Inonu University||2|||f||||t||||||||||2017-10-10 23:54:02.423936|2017-10-10 23:54:02.423936
NCT02267967|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-06-19|||October 31, 2014|Actual|2014-10-31|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors|A Multi-Center, Open-Label, Phase Ib/II Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Sufatinib in Treating Advanced Neuroendocrine Tumors|Active, not recruiting||Phase 1|81|Actual|Hutchison Medipharma Limited||1|||f||||t||||||||Undecided||2017-10-10 23:54:02.523665|2017-10-10 23:54:02.523665
NCT02267954|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-01-26|||November 2014||2014-11-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Fast Food Photo Study|What's Wrong With This Photo? Fast Food Literacy Study|Completed||N/A|309|Actual|Carnegie Mellon University||1|||f||||f||||||||||2017-10-10 23:54:02.612818|2017-10-10 23:54:02.612818
NCT02267941|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2014-10-15|||January 2011||2011-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|January 2011|Actual|2011-01-01||Observational|||Risk Factors for Aortic Dissection in the Chinese Patients|Food and Drug Administration in China|Completed||N/A|3045|Actual|General Hospital of Beijing PLA Military Region|||2||f||||t||||||||||2017-10-10 23:54:02.696386|2017-10-10 23:54:02.696386
NCT02267915|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-02-22|||March 2015||2015-03-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|MAN2||Phase II of Efficacy and Toxicity of Maintenance Sub. Rituximab After Induction in Relapsed MCL and Non-eligible HSCT|An Open Multicenter Phase II Study of Efficacy and Toxicity of Maintenance Subcut. Rituximab After Induction With Rituximab in Patients With Relapsed or Refractory Mantle-cell Lymphoma Non-eligible for HSCT|Recruiting||Phase 2|36|Anticipated|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||f||||||||||2017-10-10 23:54:02.851787|2017-10-10 23:54:02.851787
NCT02267902|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-15|||September 2014||2014-09-01|October 2014|2014-10-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229|A Phase I, Open-Label, 2-Part Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism and Excretion of DA-1229 in Healthy Male Subjects|Unknown status|Enrolling by invitation|Phase 1|12|Anticipated|Dong-A ST Co., Ltd.||2|||f||||||||||||||2017-10-10 23:54:02.959966|2017-10-10 23:54:02.959966
NCT02267889|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-11-03|||February 2015||2015-02-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|||Ganglionated Plexus Ablation For Treatment of Atrial Fibrillation|A Pilot Study on the Role pf Ganglionated Plexus Ablation for Catheter Ablation of Atrial Fibrillation.|Active, not recruiting||N/A|20|Actual|Spectrum Dynamics||1|||f||||f||||||||||2017-10-10 23:54:03.027798|2017-10-10 23:54:03.027798
NCT02267876|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-05-11|||October 2014||2014-10-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens|Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens|Enrolling by invitation||N/A|8000|Anticipated|Becton, Dickinson and Company||1|||f||||f||||||||||2017-10-10 23:54:03.282076|2017-10-10 23:54:03.282076
NCT02267863|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-11-23|||October 2014||2014-10-01|November 2015|2015-11-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of APTO-253 HCl in Patients With Relapsed or Refractory Hematologic Malignancies|A Phase I Dose Escalation With Two Disease Specific Expansions, Multicenter, Open-label, Safety, Pharmacokinetic and Pharmacodynamic Study of LOR-253 in Patients With Relapsed or Refractory Hematologic Malignancies|Suspended||Phase 1|60|Anticipated|Aptose Biosciences Inc.||1||Drug manufacturing process and procedure review|f||||f||||||||||2017-10-10 23:54:03.447772|2017-10-10 23:54:03.447772
NCT02267850|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-11-01|||May 2013||2013-05-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Intra-Oral Photobiomodulation on Orthodontic Treatment Time|Effect of Intra-Oral Photobiomodulation on Orthodontic Treatment Time: A Randomized Control Trial|Completed||N/A|29|Actual|Biolux Research Ltd.||2|||f||||f||||||||||2017-10-10 23:54:03.553152|2017-10-10 23:54:03.553152
NCT02267837|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2015-08-12|2015-08-12||December 2012||2012-12-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||OrthoPulse™ and Its Effect on the Rate of Orthodontic Tooth Alignment: A Pilot Feasibility Study|OrthoPulse™ and Its Effect on the Rate of Orthodontic Tooth Alignment: A Pilot Feasibility Study.|Completed||N/A|20|Actual|Biolux Research Ltd.||2|||f||||f||||||||||2017-10-10 23:54:03.654129|2017-10-10 23:54:03.654129
NCT02267824|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-10-31|2016-02-15||December 2010||2010-12-01|October 2016|2016-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effects of Extraoral Photobiomodulation on the Rate of Orthodontic Alignment|The Effects of Extraoral Photobiomodulation on the Rate of Orthodontic Alignment|Completed||N/A|101|Actual|Biolux Research Ltd.||2|||f||||f||||||||||2017-10-10 23:54:03.901398|2017-10-10 23:54:03.901398
NCT02267811|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-11-01|||October 2013||2013-10-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||OrthoPulse™ Product Evaluation and Assessing Clinical Effectiveness|OrthoPulse™ Product Evaluation and Assessing Clinical Effectiveness|Completed||N/A|200|Actual|Biolux Research Ltd.||2|||f||||f||||||||||2017-10-10 23:54:04.175245|2017-10-10 23:54:04.175245
NCT02267798|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-02-02|||September 2013||2013-09-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Repetitive Arm Training + FES on Upper Extremity Motor Recovery in Sub-acute Stroke Survivors|The Effects of Repetitive Arm Training Combined With Functional Electrical Stimulation on Upper Extremity Motor Recovery in Sub-acute Stroke Survivors|Completed||N/A|64|Actual|University Hospital of Ferrara||2|||f||||t||||||||No||2017-10-10 23:54:04.262373|2017-10-10 23:54:04.262373
NCT02267785|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-03-29|||October 2014||2014-10-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Exercise Targeting Cognitive Impairment in Parkinson's Disease|Exercise Targeting Cognitive Impairment in Parkinson's Disease|Recruiting||N/A|150|Anticipated|University of Southern California||3|||f||||f||||||||||2017-10-10 23:54:04.34348|2017-10-10 23:54:04.34348
NCT02267772|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-05-01|||January 2014||2014-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women|A Randomized, Controlled Trial of IV Acetaminophen Versus IV Morphine to Manage Pain in Pregnancy: Can Opioid Use be Reduced in Pregnant Women?|Recruiting||N/A|330|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:54:04.452423|2017-10-10 23:54:04.452423
NCT02267759|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-06-17|||November 2014||2014-11-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||McGrath Videolaryngoscopy for Nasotracheal Intubation|A Comparison of McGrath Videolaryngoscopy and Macintosh Laryngoscopy for Routine Nasotracheal Intubation|Completed||N/A|70|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-10 23:54:04.538871|2017-10-10 23:54:04.538871
NCT02267746|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-16|||June 2014||2014-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris|A Multicenter, Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled Study to Evaluate the Safety and Therapeutic Equivalence of a Generic Tazarotene Foam 0.1%(Actavis) and the Reference Listed Fabior™(Tazarotene Foam, 0.1%) (Stiefel Laboratories, Inc.) in Treatment of Subjects With Acne Vulgaris|Completed||Phase 3|894|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-10 23:54:04.605463|2017-10-10 23:54:04.605463
NCT02267733|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-08-24|||October 2014||2014-10-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SHIVERING||Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients|Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients (SHIVERING Trial)|Completed||Phase 1|51|Actual|Yale University||2|||f||||f||||||||||2017-10-10 23:54:04.707383|2017-10-10 23:54:04.707383
NCT02267720|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2015-09-22|||November 2014||2014-11-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|March 2015|Actual|2015-03-01||Interventional|||Occlusal-proximal ART Restorations in Primary Molars Using 2 Different Kinds of GIC|Survival Rate and Cost Effectiveness From Two Different Materials of GIC Using in Occlusol-proximal ART Restorations in Primary Molars|Unknown status|Active, not recruiting|N/A|70|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:54:04.893888|2017-10-10 23:54:04.893888
NCT02267707|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-03-10|||May 2015||2015-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia|A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction|Terminated||Phase 1|1|Actual|Celgene||2||"Study population more infrequent than estimated. No study-related safety issues and no safety   concerns were identified for the study."|f||||t||||||||||2017-10-10 23:54:04.985607|2017-10-10 23:54:04.985607
NCT02267694|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-04-10|||August 2013||2013-08-01|April 2017|2017-04-01|November 13, 2015|Actual|2015-11-13|October 5, 2015|Actual|2015-10-05||Interventional|BRB||Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis|A Trial of Freeze-dried Black Raspberry in Maintenance of Remission of Ulcerative Colitis|Completed||Phase 1|7|Actual|UConn Health||1|||f||||t||||||||||2017-10-10 23:54:05.121018|2017-10-10 23:54:05.121018
NCT02267681|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-06-28|||October 2014||2014-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Opioid Effects on Cognitive Function Following Colonoscopy|The Effects of Fentanyl and Alfentanil as an Adjunct to Propofol on Cognitive Functions for Sedation in Colonoscopy|Completed||Phase 4|150|Actual|Ufuk University||3|||f||||f||||||||||2017-10-10 23:54:05.191119|2017-10-10 23:54:05.191119
NCT02267668|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-03-13|||July 2014||2014-07-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|STEP||Subsymptom Threshold Exercise Protocol Following Mild TBI|Subsymptom Threshold Exercise Protocol (STEP) to Recovery Following Mild Traumatic Brain Injury: A Pilot Randomized Controlled Clinical Trial|Recruiting||N/A|40|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-10 23:54:05.283727|2017-10-10 23:54:05.283727
NCT02267655|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-08-03|||May 2015||2015-05-01|August 2017|2017-08-01|June 28, 2017|Actual|2017-06-28|June 2017|Actual|2017-06-01||Interventional|||3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF|An Exploratory, 3-Part, Clinical Study to Assess the Effect of Pulsed, Inhaled Nitric Oxide (iNO) on Functional Pulmonary Imaging Parameters in Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) on Long-Term Oxygen Therapy (LTOT) (Part 1) and in Subjects With WHO Group 3 PH Associated With Idiopathic Pulmonary Fibrosis (IPF) on LTOT (Part 2 and Part 3)|Completed||Phase 1|8|Actual|Bellerophon||4|||f||||f||||||||||2017-10-10 23:54:05.377904|2017-10-10 23:54:05.377904
NCT02267642|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-01-23||2017-01-23|January 2015||2015-01-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis|Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.|Completed||Phase 2|20|Actual|AbGenomics B.V Taiwan Branch||1|||f||||f||||||||No||2017-10-10 23:54:05.481129|2017-10-10 23:54:05.481129
NCT02267629|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-06-20|2017-03-30||October 2014||2014-10-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder|Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder|Completed||Phase 2|7|Actual|New York State Psychiatric Institute||1|||f||||t||||||||No||2017-10-10 23:54:05.580943|2017-10-10 23:54:05.580943
NCT02267616|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-09-29|||December 2011||2011-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|EPIC||Effectiveness of Prolonged Use of IUD/Implant for Contraception|Effectiveness of Prolonged Use of IUD/Implant for Contraception|Recruiting||Phase 4|1350|Anticipated|Indiana University||3|||f||||t||||||||||2017-10-10 23:54:05.784566|2017-10-10 23:54:05.784566
NCT02267590|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-14|||October 2014||2014-10-01|October 2014|2014-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|CLARITY||Tissue Collection for Biomarkers Determining Resistance to Ibrutinib|Clinical Validation of Biomarkers Determining Resistance to BTK Inhibition With Ibrutinib in Mantle Cell Lymphoma & Chronic Lymphocytic Leukaemia - Stage 1|Unknown status|Recruiting|N/A|120|Anticipated|Royal Marsden NHS Foundation Trust|||2||f||||f||||||Samples With DNA|"     20mls of PB in EDTA; 5ml of BM in EDTA and/or tissue biopsy (fresh/frozen/FFPE) and/or     pleural/ascitic fluid containing tumour cells.   "|||2017-10-10 23:54:06.04296|2017-10-10 23:54:06.04296
NCT02267564|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2014-10-16|||September 2014||2014-09-01|October 2014|2014-10-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||MPFL Reconstruction With or Without Tibial Tubercle Transfer|Medial Patellofemoral Ligament (MPFL) Reconstruction With or Without Tibial Tubercle Transfer for Recurrent Patellar Instability|Recruiting||N/A|70|Anticipated|Peking University Third Hospital||2|||f||||t||||||||||2017-10-10 23:54:06.196508|2017-10-10 23:54:06.196508
NCT02267551|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-05-05|||April 2014||2014-04-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Non-inferiority Study Comparing daVinci Skills Simulator to Mimic dV-Trainer for Preparing Residents to Perform Live Human Surgery|Non-inferiority Study Comparing daVinci Skills Simulator to Mimic dV-Trainer for Preparing Residents to Perform Live Human Surgery|Terminated||N/A|||Atlantic Health System||2||low enrollment|f||||f||||||||||2017-10-10 23:54:06.297731|2017-10-10 23:54:06.297731
NCT02267525|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-08-18|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|DIGEST||The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis|Completed||Phase 2|233|Actual|Theravance Biopharma R & D, Inc.||4|||f||||f||||||||||2017-10-10 23:54:06.52469|2017-10-10 23:54:06.52469
NCT02267512|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-03-07|||July 2012||2012-07-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients|Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in de Novo Kidney Transplant Patients - a Multicenter, Randomized, Parallel Group Study|Completed||Phase 4|280|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-10 23:54:06.598817|2017-10-10 23:54:06.598817
NCT02267499|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-17|||November 2010||2010-11-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Interventional|LLM||Combined Cognitive and Physical Exercises Through Computer Games in Elderly: The LLM Project|The Effects of Combined Cognitive and Physical Exercises Through Computer Games in Elderly: The Long Lasting Memories Project (LLM)|Completed||N/A|322|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-10 23:54:06.737066|2017-10-10 23:54:06.737066
NCT02267486|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-07-14|||October 2014||2014-10-01|July 2016|2016-07-01||||March 2016|Actual|2016-03-01||Observational|QuQu||Exploratory Study for the Validity of QuQu Scale|Exploratory Study for the Validity of a Novel Dementia Rating Scale (QUick QUestion Scale) for Alzheimer's Disease Dementia|Completed||N/A|972|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan|||2||f||||||||||||||2017-10-10 23:54:06.828409|2017-10-10 23:54:06.828409
NCT02267473|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||October 2014||2014-10-01|October 2014|2014-10-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Observational|BONIKA||Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function|A Multicenter, Prospective, Observational Study of Patients With Chronic Hepatitis B Under Various Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function|Recruiting||N/A|400|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||Samples Without DNA|"     spontaneous urine sample to test for proximal tubular function   "|||2017-10-10 23:54:06.909356|2017-10-10 23:54:06.909356
NCT02267460|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-09-07|||October 2014||2014-10-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|||An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease|A Phase 3b, Open-label Pilot Study to Evaluate the Safety and Effectiveness of up to Four Treatment Cycles of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Men With Peyronie's Disease|Completed||Phase 3|30|Anticipated|Endo Pharmaceuticals||2|||f||||f||||||||||2017-10-10 23:54:06.983423|2017-10-10 23:54:06.983423
NCT02267447|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-04-26|2016-09-27||September 2000||2000-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Observational|CVDPoRT|Ontario respondents of CCHS survey cycles 1.1, 2.1, 3.1 and 4.1 (conducted in 2001, 2003, 2005 and 2007, respectively). Respondents were excluded if they were not eligible for Ontario’s universal health insurance program, were pregnant, self-reported a prior history of heart disease or stroke, or were age <20 at the time of survey administration.|Cardiovascular Disease Population Risk Tool|Risk of Cardiovascular Disease in Canada and Burden of Health Behaviours: Development of Population-based Risk Algorithms|Completed||N/A|104219|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||||Yes|The final model parameters will be provided in Predictive Modelling Markup Language (PMML) and Lime questionnaire files; as well, we will provide a mock dataset. These files can be used to generate risk estimates in computer applications.|2017-10-10 23:54:07.073211|2017-10-10 23:54:07.073211
NCT02267434|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-10-28|||December 2014||2014-12-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|AFF011||Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease|A Randomized, Placebo-controlled, Parallel Group, Patient-blinded, Multi-center, Phase I Pilot Study to Assess Tolerability and Safety of Two Doses of AFFITOPE® PD03A Formulated With Adjuvant to Patients With Early Parkinson's Disease|Completed||Phase 1|36|Actual|Affiris AG||3|||f||||t||||||||||2017-10-10 23:54:07.278156|2017-10-10 23:54:07.278156
NCT02267421|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||October 2014||2014-10-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Effects of Home Based Exercise Therapy in Early Cirrhosis|An 8 Week Randomized Controlled Trial Assessing Home Exercise Therapy in Early Cirrhosis|Unknown status|Recruiting|N/A|40|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-10 23:54:07.519099|2017-10-10 23:54:07.519099
NCT02267408|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2016-03-18|||November 2014||2014-11-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|||Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin|A Single-site, Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Patients With Unstable Warfarin Effect.|Recruiting||Phase 1/Phase 2|40|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-10 23:54:07.611571|2017-10-10 23:54:07.611571
NCT02267395|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-03-31|||November 2014||2014-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Scapular and Cervical Neuromuscular Control Deficits in Musicians With and Without Playing Injuries.|Scapular and Cervical Neuromuscular Deficits in Musicians With and Without Playing Related Musculoskeletal Disorders: A Case Control Study.|Completed||N/A|101|Actual|Vanderbilt University|||2||f||||f||||||||||2017-10-10 23:54:07.719246|2017-10-10 23:54:07.719246
NCT02266290|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-16|||January 2013||2013-01-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Kinesio® Taping in Chronic Ankle Instability|Effect of Kinesio® Taping on Measurements of Balance in Subjects With Chronic Ankle Instability: a Randomized Clinical Trial|Completed||N/A|30|Actual|Universidad Rey Juan Carlos||2|||f||||f||||||||||2017-10-10 23:54:18.266473|2017-10-10 23:54:18.266473
NCT02267382|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-12-02|||February 2015||2015-02-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets in the Treatment of Patients With Recurrent Vulvovaginal Candidiasis|Active, not recruiting||Phase 2|200|Anticipated|Viamet||5|||f||||f||||||||||2017-10-10 23:54:07.835095|2017-10-10 23:54:07.835095
NCT02267369|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-13|||January 2014||2014-01-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Causal Impact of Online Social Media on Physical Activity: A Randomized Controlled Trial|The Causal Impact of Online Social Media on Physical Activity: A Randomized Controlled Trial|Completed||N/A|217|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-10 23:54:08.065241|2017-10-10 23:54:08.065241
NCT02267356|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-08-03|||December 2014||2014-12-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets in the Treatment of Patients With Distal Lateral Subungual Onychomycosis of the Toenail|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|Viamet||5|||f||||f||||||||||2017-10-10 23:54:08.209937|2017-10-10 23:54:08.209937
NCT02267343|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-11-13|||October 2014||2014-10-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer|ONO-4538 Phase III Study A Multicenter, Double-Blind, Randomized Study in Patients With Unresectable Advanced or Recurrent Gastric Cancer|Active, not recruiting||Phase 3|480|Anticipated|Ono Pharmaceutical Co. Ltd||2|||f||||t||||||||||2017-10-10 23:54:08.425967|2017-10-10 23:54:08.425967
NCT02267330|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-05-28|||February 2012||2012-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Gonadal Radiation Exposure and Risk Secondary to Fluoroscopic Imaging During Trauma Surgery|A Descriptive Cohort Analysis of Gonadal Radiation Exposure and Risk Secondary to Fluoroscopic Imaging During Trauma Surgery About the Pelvis and Femur|Completed||N/A|135|Actual|University of Utah|||1||f||||f||||||||||2017-10-10 23:54:08.698953|2017-10-10 23:54:08.698953
NCT02267317|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-09-06|||January 2015||2015-01-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|Eritoran2||The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects|Phase 2 Study of The Role of Pharmacologic Inhibition of TLR4 With E5564 on Glucose Metabolism in Insulin Resistant Subjects.|Suspended||Phase 2|60|Anticipated|The University of Texas Health Science Center at San Antonio||3||Study drug expired, pending receipt of drug availability from supplier.|f||||f||||||||||2017-10-10 23:54:08.806917|2017-10-10 23:54:08.806917
NCT02267304|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-02-24|||October 2014||2014-10-01|February 2016|2016-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|MBBAnalgesic||Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)|Etude Comparative Monocentrique, randomisée, en Cross Over, en Double Aveugle, Contre Placebo, de l'Action de la Morphine et de la Naloxone Dans un modèle Cognitif de Gestion Des Efforts Physiques|Recruiting||Phase 2|24|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-10 23:54:08.939513|2017-10-10 23:54:08.939513
NCT02267291|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-10-02|||June 2015|Actual|2015-06-01|October 2017|2017-10-01|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Impact of Non-invasive Positive Pressure Ventilation on Cardiac Function and Echocardiographic Parameters|Impact of Non-invasive Positive Pressure Ventilation on Cardiac Function and Echocardiographic Parameters|Recruiting||N/A|30|Anticipated|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-10-10 23:54:09.029523|2017-10-10 23:54:09.029523
NCT02267278|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2017-04-27|||January 12, 2015|Actual|2015-01-12|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)|Evaluation of Ruxolitinib and Pracinostat Combination as a Therapy for Patients With Myelofibrosis|Active, not recruiting||Phase 2|25|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:54:09.134342|2017-10-10 23:54:09.134342
NCT02267265|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-06-23|||September 2015||2015-09-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TMW-NI||Pilot Study of Novel Postpartum Educational Video Intervention|A Randomized Controlled Trial Pilot Study of the Thirty Million Words® Newborn Initiative Intervention, a Novel Postpartum Educational Video|Completed||N/A|1000|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-10 23:54:09.235133|2017-10-10 23:54:09.235133
NCT02267252|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-10-03|||September 2014||2014-09-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Effects of Male-specific Antibodies on Sex Ratio||Recruiting||N/A|30|Anticipated|Odense University Hospital|||1||f||||f||||||Samples With DNA|"     Blood and ejaculates   "|||2017-10-10 23:54:09.320515|2017-10-10 23:54:09.320515
NCT02267239|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-22|||October 2014||2014-10-01|October 2014|2014-10-01||||November 2014|Anticipated|2014-11-01||Interventional|||Methodology Antiseptic Application, Influence on Oral Biofilm.|Methodology of Application and Immediate Effect of the Essential Oils and 0.2% Chlorhexidine on Oral Biofilm: Immersion Versus Mouthwash.|Unknown status|Recruiting|Phase 4|15|Anticipated|University of Santiago de Compostela||5|||f||||f||||||||||2017-10-10 23:54:09.389218|2017-10-10 23:54:09.389218
NCT02267213|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-10-13|||March 2014||2014-03-01|September 2014|2014-09-01||||July 2017|Anticipated|2017-07-01||Interventional|||Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma|An Open-Label, Single-Arm, Two-Stage, Multi-Centre Phase II Study to Evaluate the Efficacy and Safety of TLC388 as Second-line Treatment in Subjects With Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|62|Anticipated|Taiwan Liposome Company||1|||f||||t||||||||||2017-10-10 23:54:09.59935|2017-10-10 23:54:09.59935
NCT02267200|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-11-20|||October 2014||2014-10-01|June 2016|2016-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD|The Screening and Analysis of Plasma Biomarkers in Irreversible Pulmonary Arterial Hypertension Associated With Congenital Heart Disease|Completed||N/A|30|Actual|Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||||||2017-10-10 23:54:09.722779|2017-10-10 23:54:09.722779
NCT02267187|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-07-13|||October 22, 2014|Actual|2014-10-22|July 2017|2017-07-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|BTI++||Structural Fat Grafting for Craniofacial Trauma Using Manual Technique for Processing Fat Graft Material|Structural Fat Grafting for Craniofacial Trauma Using Manual Technique for Processing Fat Graft Material|Completed||N/A|15|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:54:09.783721|2017-10-10 23:54:09.783721
NCT02267174|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-07-26|||July 2014||2014-07-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|HATRICC||Handoffs and Transitions in Critical Care|Handoffs and Transitions in Critical Care (HATRICC): Optimizing Operating Room to Intensive Care Unit Handoffs|Completed||N/A|1000|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-10 23:54:09.859849|2017-10-10 23:54:09.859849
NCT02267161|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-07-19|||July 2015||2015-07-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|July 2021|Anticipated|2021-07-01||Interventional|Dacci||Infants With Agenesis of the Corpus Callosum|Outcome of Infants With Prenatal Corpus Callosum Agenesis|Recruiting||N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:54:09.933865|2017-10-10 23:54:09.933865
NCT02267148|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-01-15|||October 2014||2014-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression|Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression|Completed||N/A|53|Actual|UNC Nutrition Research Institute|||1||f||||f||||||Samples With DNA|"     Whole blood will be collected and used for DNA extraction. Plasma and serum will also be     collected and banked.   "|||2017-10-10 23:54:10.023147|2017-10-10 23:54:10.023147
NCT02267122|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-16|||January 2012||2012-01-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Total Occlusive Ionic Silver-containing Dressing vs Mupirocin Ointment Application vs Conventional Dressing in Elective Colorectal Surgery: Effect on Incisional Surgical Site Infection|Total Occlusive Ionic Silver-containing Dressing vs Mupirocin Ointment Application vs Conventional Dressing in Elective Colorectal Surgery: Effect on Incisional Surgical Site Infection|Completed||Phase 3|147|Actual|Hospital General Universitario Elche||3|||f||||||||||||||2017-10-10 23:54:10.185379|2017-10-10 23:54:10.185379
NCT02267109|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-08-17|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2016|Actual|2016-04-01||Interventional|||Phase 1 Trial of Ebola Vaccine in Mali|A Phase 1b, Dose-escalating Safety and Immunogenicity Trial of the Novel Monovalent Ebola Zaire Candidate Vaccine, cAd3-EBO Z and the Heterologous Prime-boost Candidate Vaccine Regimen of cAD3-EBO Z Followed by MVA-BN® Filo in Malian Adults Aged 18-50 Years.|Active, not recruiting||Phase 1|91|Actual|University of Maryland||5|||f||||t||||||||||2017-10-10 23:54:10.243997|2017-10-10 23:54:10.243997
NCT02267096|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-10-18|||January 2014||2014-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening|Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening|Completed||Phase 3|95|Actual|Georgetown University||2|||f||||f||||||||||2017-10-10 23:54:10.325474|2017-10-10 23:54:10.325474
NCT02267070|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-01-30|||November 2013||2013-11-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CT&E||Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode|Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode|Active, not recruiting||N/A|60|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-10 23:54:10.61567|2017-10-10 23:54:10.61567
NCT02267057|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-03-31|||August 2014||2014-08-01|March 2017|2017-03-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|DEP-PAIN-DEM||Efficacy of Pain Treatment on Depression in Patients With Dementia|Efficacy of Pain Treatment on Depression in Patients With Dementia. A Randomized Clinical Trial.|Completed||Phase 4|163|Actual|University of Bergen||2|||f||||t||||||||||2017-10-10 23:54:10.722142|2017-10-10 23:54:10.722142
NCT02267044|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-03-14|||August 2014||2014-08-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|October 2016|Actual|2016-10-01||Interventional|||Effective Pain Management of Interscalene Blocks During Shoulder Surgery|Effective Pain Management of Continuous Versus Single Shot Injection Interscalene Block During Shoulder Replacement Surgery|Active, not recruiting||N/A|76|Anticipated|TriHealth Inc.||2|||f||||f||||||||Undecided||2017-10-10 23:54:10.819065|2017-10-10 23:54:10.819065
NCT02267031|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-09-21|||October 2012||2012-10-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ACDYS||The Role of Perioperative Ventilation (Gas Exchange) During Intrabdominal Surgery on Cognitive Function|The Role of Perioperative Ventilation (Gas Exchange) During Intrabdominal Surgery on Cognitive Function: a Randomized Clinical Study|Completed||N/A|109|Actual|Northern State Medical University||4|||f||||f||||||||||2017-10-10 23:54:10.899675|2017-10-10 23:54:10.899675
NCT02267018|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-12-16|||August 2016||2016-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Diaphragm Electrical Activity of Preterm Infants on nCPAP Versus NIHFV|Effect of Nasal Continuous Positive Airway Pressure (nCPAP) Versus Non-Invasive High Frequency Ventilation (NIHFV) on the Diaphragm Electrical Activity in Very Low Birth Weight Preterm Infants|Recruiting||N/A|20|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 23:54:10.996984|2017-10-10 23:54:10.996984
NCT02267005|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-10-20|||March 2015||2015-03-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis|The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis|Unknown status|Recruiting|N/A|12|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-10 23:54:11.110768|2017-10-10 23:54:11.110768
NCT02266992|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-03-18|||September 2014||2014-09-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LAIV||Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study|Exploring Novel Mechanisms of Vaccine Failure and Induction of Pulmonary Immunity Following Live Attenuated Influenza Vaccination in HIV-infected Individuals: a Pilot Study.|Completed||Phase 2|28|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:54:11.21527|2017-10-10 23:54:11.21527
NCT02266979|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2016-11-13|||June 2014||2014-06-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Study to Determine Appropriate Nurse: Patient Ratios in Peritoneal Dialysis Programs|Study to Determine Appropriate Nurse: Patient Ratios in Peritoneal Dialysis Programs|Completed||N/A|10|Actual|Pontificia Universidade Católica do Rio Grande do Sul|||1||f||||f||||||||||2017-10-10 23:54:11.291552|2017-10-10 23:54:11.291552
NCT02266966|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-10-12|||April 2014||2014-04-01|December 2013|2013-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging||Completed||Phase 1|17|Actual|Pierre Fabre Medicament||2|||f||||f||||||||||2017-10-10 23:54:11.364076|2017-10-10 23:54:11.364076
NCT02266953|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-02-16|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||The Use of a Communication Tool About Diet|The Use of a Communication Tool About Diet in Public Health Nurse Consultations at the Child Health Centre When the Child is Aged 10 Months to 2 Years|Active, not recruiting||N/A|686|Actual|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||No||2017-10-10 23:54:11.430699|2017-10-10 23:54:11.430699
NCT02266940|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-01-21|||November 2014||2014-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets|A Phase 1, Open Label, Randomised, Single Dose, Three Way Crossover Study to Explore the Relative Bioavailability of DS 1971a Given as a 200 mg Tablet Formulation and a 200 mg Oral Suspension, and to Explore the Effects of Administration With a High Fat Meal on the Relative Bioavailability of the Tablet Formulation|Completed||Phase 1|18|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||||2017-10-10 23:54:11.528449|2017-10-10 23:54:11.528449
NCT02266927|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-02-02|||September 2014||2014-09-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2)|An Open-Label, 2-Part, Randomized, Crossover Study to Compare the Bioavailability of Intranasal Administration of 200 and 400 µg of OPTINOSE™ FLUTICASONE With 400 µg of Flonase® (Fluticasone Propionate) Nasal Spray (Part 1), and Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2) (Current Investigation is Part 2 Only)|Completed||Phase 1|28|Actual|Optinose US Inc.||2|||f||||||||||||||2017-10-10 23:54:11.605755|2017-10-10 23:54:11.605755
NCT02266914|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-04-03|||June 2014||2014-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Magnetic Resonance Elastography of Cardiac Transplant Rejection|Magnetic Resonance Elastography of Cardiac Transplant Rejection|Active, not recruiting||N/A|10|Anticipated|Ohio State University||1|||f||||f||||||||No||2017-10-10 23:54:11.680283|2017-10-10 23:54:11.680283
NCT02266901|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-16|||October 2007||2007-10-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Transluminal or Percutaneous Endoscopic Drainage and Debridement of Abcesses After Bariatric Surgery|Transluminal or Percutaneous Endoscopic Drainage and Debridement of Abcesses After Bariatric Surgery|Completed||N/A|9|Actual|Erasme University Hospital|||1||f||||f||||||||||2017-10-10 23:54:11.779879|2017-10-10 23:54:11.779879
NCT02266888|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-09-21|||October 2014||2014-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||B Cell Induction in Pediatric Lung Transplantation|B Cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation (CTOTC-08)|Recruiting||Phase 2|50|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-10 23:54:11.866479|2017-10-10 23:54:11.866479
NCT02266862|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-06-01|||August 2015|Actual|2015-08-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Changes in Renal Artery Movement Due to Respiration Before and After Fenestrated Endovascular Repair|Changes in Renal Artery Movement Due to Respiration Before and After Fenestrated Endovascular Repair|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill|||1|No funding|f||||f||||||||||2017-10-10 23:54:12.152649|2017-10-10 23:54:12.152649
NCT02266849|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-10-09|||October 2014||2014-10-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study|Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study|Terminated||Phase 3|12|Actual|Odense University Hospital||2||Insuficcient recruiting|f||||t||||||||||2017-10-10 23:54:12.236065|2017-10-10 23:54:12.236065
NCT02265913|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-06-27||2016-06-27|October 2014||2014-10-01|June 2016|2016-06-01||||January 2016|Actual|2016-01-01||Interventional|||Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis||Completed||Phase 3|4076|Actual|Perrigo Company||3|||f||||f||||||||||2017-10-10 23:54:23.161326|2017-10-10 23:54:23.161326
NCT02266836|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-10-19|||October 2014||2014-10-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||MyndMove Therapy for Severe Hemiparesis of the Upper Limb Following Stroke|Clinical Feasibility and Usability of MyndMove Therapy for FES Facilitated Treatment of Subacute and Chronic Severe Hemiparesis of the Upper Limb Following Stroke|Unknown status|Recruiting|N/A|75|Anticipated|MyndTec Inc.||1|||f||||f||||||||||2017-10-10 23:54:12.358174|2017-10-10 23:54:12.358174
NCT02266823|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-06-14|||October 2015||2015-10-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Diabetes CKD Lifestyle Technology Study|Program to Improve Care in Complex Chronic Disease|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 23:54:12.502985|2017-10-10 23:54:12.502985
NCT02266810|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-10-04|2016-06-10||September 2014||2014-09-01|October 2017|2017-10-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|PROGRESS|This is an intra-patient design where one sinus side of the patient is randomized to receive the treatment while the contralateral sinus side acts as the control.|Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus|The PROGRESS Study: Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implants Following Surgical Opening of the Frontal Sinus for Chronic Sinusitis: A Randomized Blinded Controlled Study|Completed||Phase 3|160|Actual|Intersect ENT||4|||f||||f||t|f||f|||||2017-10-10 23:54:12.658343|2017-10-10 23:54:12.658343
NCT02266797|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-02-16|2015-10-30||November 2013||2013-11-01|February 2016|2016-02-01||||September 2015|Actual|2015-09-01||Interventional|||Effect of Intravenous Corticosteroid Injections on Dysphagia After Cervical Spine Surgery|Effect of Intravenous Corticosteroid Injections on Dysphagia After Anterior Cervical Spine Surgery: a Randomized, Double-blind, Placebo-controlled Study|Terminated||Phase 3|4|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-10 23:54:13.288279|2017-10-10 23:54:13.288279
NCT02266784|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-03-06|||October 2014||2014-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|ADQUIT||Contingency Management, Quitting Smoking, and ADHD|Smoking/Nicotine Dependence in Attention Deficit Hyperactivity Disorder (ADHD)|Recruiting||Phase 1|60|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 23:54:13.580702|2017-10-10 23:54:13.580702
NCT02266771|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-03-02|||September 2014||2014-09-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|||Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice|Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice|Recruiting||N/A|40|Anticipated|LifeBridge Health||2|||f||||f||||||||No||2017-10-10 23:54:13.682067|2017-10-10 23:54:13.682067
NCT02266758|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-06-26|||May 2014||2014-05-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Randomizing Two Gestational Diabetes Screening Methods in a Diverse HMO|Comparing Two Gestational Diabetes Screening Methods: A Pragmatic Outpatient RCT|Enrolling by invitation||N/A|17626|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-10 23:54:13.771|2017-10-10 23:54:13.771
NCT02266745|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-09-11|||July 2014||2014-07-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors|A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|80|Anticipated|Phosplatin Therapeutics||1|||f||||t||||||||||2017-10-10 23:54:13.848111|2017-10-10 23:54:13.848111
NCT02266732|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-02-19|||May 2011||2011-05-01|February 2015|2015-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Ultrasound Vs Nerve Stimulation - Why is a PNS so Effective?|Ultrasound Vs Nerve Stimulation - Why is a PNS so Effective?|Completed||N/A|20|Actual|The Leeds Teaching Hospitals NHS Trust||2|||f||||||||||||||2017-10-10 23:54:13.946334|2017-10-10 23:54:13.946334
NCT02266719|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-11-25|||December 2014||2014-12-01|November 2015|2015-11-01|July 2025|Anticipated|2025-07-01|August 2018|Anticipated|2018-08-01||Interventional|||Clinical Outcomes and Radiation Safety After Endovascular Repair of Complex Abdominal Aortic Aneurysms Using CMDs|Clinical Outcomes and Radiation Safety After Endovascular Repair of Complex Abdominal Aortic Aneurysms Using Custom-Made Devices (CMD)|Recruiting||Phase 2|150|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-10 23:54:14.011733|2017-10-10 23:54:14.011733
NCT02266706|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-07-28|||September 17, 2014|Actual|2014-09-17|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|June 8, 2017|Actual|2017-06-08||Interventional|||Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)|A Phase 1, Non-comparative, Open-label Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of Ceftolozane/Tazobactam in Pediatric Patients Receiving Standard of Care Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis|Completed||Phase 1|37|Actual|Cubist Pharmaceuticals LLC||6|||f||||f||||||||||2017-10-10 23:54:14.101941|2017-10-10 23:54:14.101941
NCT02266693|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-09-12|||August 2014||2014-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Transdiagnostic iCBT for Depression and Anxiety|Efficacy of Transdiagnostic Internet-based CBT for Early Illness Unipolar Depression and Anxiety|Recruiting||N/A|60|Anticipated|Centre for Addiction and Mental Health||2|||f||||t||||||||||2017-10-10 23:54:14.20144|2017-10-10 23:54:14.20144
NCT02266680|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-07-18|||January 2012||2012-01-01|September 2016|2016-09-01|January 30, 2017|Actual|2017-01-30|January 2017|Actual|2017-01-01||Interventional|||Breathing Focused Yoga in Social Anxiety Disorder|A Randomized Controlled Trial of the Effectiveness of Breathing Focused Yoga (BFY) in Improving Symptoms of Social Anxiety Disorder|Completed||N/A|60|Actual|Centre for Addiction and Mental Health||2|||f||||t||||||||||2017-10-10 23:54:14.293425|2017-10-10 23:54:14.293425
NCT02266667|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-06-13|||April 11, 2016|Actual|2016-04-11|June 2017|2017-06-01|April 11, 2019|Anticipated|2019-04-11|October 11, 2018|Anticipated|2018-10-11||Interventional|NEMOST||"Surgical Treatment of Progressive Scoliosis With NEMOST Growing Rod"|Evaluation of the Efficiency of Nemost Growing Spine Device Associated With Physiotherapy in the Surgical Treatment of Progressive Scoliosis of the Child|Recruiting||N/A|20|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:54:14.37346|2017-10-10 23:54:14.37346
NCT02266641|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||October 2014||2014-10-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Parental One-carbon Folate and Choline Nutrition Modulates Risk of Off-spring Cancer Development: Human Cohort Study|Parental One-carbon Folate and Choline Nutrition Modulates Risk of Off-spring Cancer Development: Human Cohort Study|Unknown status|Not yet recruiting|N/A|500|Anticipated|National Taiwan University Hospital||4|||f||||f||||||||||2017-10-10 23:54:14.730373|2017-10-10 23:54:14.730373
NCT02266628|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-05-30||2017-05-30|October 2014||2014-10-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults|A Phase II Randomized, Observer-Blind, Placebo- Controlled Study to Evaluate the Immunogenicity and Safety of Respiratory Syncytial Virus (RSV) F Vaccine in Healthy Elderly Subjects and to Estimate the Incidence Rate of Medically-attended RSV Disease in Vaccine and Placebo Recipients|Completed||Phase 2|1599|Actual|Novavax||2|||f||||f|t|f||||||||2017-10-10 23:54:14.859946|2017-10-10 23:54:14.859946
NCT02266615|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-01-25|||September 2014||2014-09-01|September 2016|2016-09-01|September 2034|Anticipated|2034-09-01|September 2016|Actual|2016-09-01||Observational|KG01||Biobank Clinical Genetics Maastricht (KG01)|Biobank Clinical Genetics Maastricht|Recruiting||N/A|3600|Anticipated|Maastricht University Medical Center|||1||f||||t||||||Samples With DNA|"     DNA retrieved out of blood or tissue   "|||2017-10-10 23:54:14.988135|2017-10-10 23:54:14.988135
NCT02266602|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-07-13|||February 2012||2012-02-01|July 2017|2017-07-01|February 2022|Anticipated|2022-02-01|February 2019|Anticipated|2019-02-01||Interventional|IORTBreast||Intraoperative Radiation Therapy in Early Stage Breast Cancer|Intra-Operative Radiotherapy After Breast Conserving Therapy in the Treatment of in Situ and Early Stage Breast Cancer|Recruiting||N/A|500|Anticipated|Benaroya Research Institute||1|||f||||t||||||||||2017-10-10 23:54:15.13901|2017-10-10 23:54:15.13901
NCT02266589|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2014-10-16|||November 2011||2011-11-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock|Research of Little Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock|Completed||Phase 3|84|Actual|Nanjing PLA General Hospital||2|||f||||f||||||||||2017-10-10 23:54:15.248261|2017-10-10 23:54:15.248261
NCT02266576|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-08-03|||June 2015||2015-06-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians|A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians|Active, not recruiting||N/A|207|Actual|Stanford University||2|||f||||t|f|f||||||||2017-10-10 23:54:15.343926|2017-10-10 23:54:15.343926
NCT02266563|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-01-09|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury|Imaging [18F]AV-1451 and [18F]AV-45 in Acute and Chronic Traumatic Brain Injury|Recruiting||N/A|50|Anticipated|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||||||2017-10-10 23:54:15.483818|2017-10-10 23:54:15.483818
NCT02266550|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||October 1999||1999-10-01|October 2014|2014-10-01||||October 1999|Actual|1999-10-01||Interventional|||Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers|Investigation of Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS After Administration of a Single Oral Dose of 25 mg [14C]-BIIL 284 BS in 6 Healthy Volunteers|Completed||Phase 1|6|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:54:15.623414|2017-10-10 23:54:15.623414
NCT02266537|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||November 2005||2005-11-01|October 2014|2014-10-01||||February 2006|Actual|2006-02-01||Interventional|||Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers|A Parallel Group Study With Three Different α-antagonists and Placebo Once Daily Over Three Weeks to Assess Their Influence on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers|Completed||Phase 1|97|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:54:15.727133|2017-10-10 23:54:15.727133
NCT02266524|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||January 2005||2005-01-01|October 2014|2014-10-01||||April 2005|Actual|2005-04-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders|Pharmacokinetics, Safety and Tolerability of Single Oral Doses (0.1, 0.2, 0.4 and 0.8 mg) of Tamsulosin Hydrochloride in Children With Voiding Disorders|Completed||Phase 1|48|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:54:15.894643|2017-10-10 23:54:15.894643
NCT02266511|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||August 1999||1999-08-01|October 2014|2014-10-01||||September 1999|Actual|1999-09-01||Interventional|||Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects|A Single-dose, Randomized, Two-treatment, Two-period, Open-label, Crossover Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride 0.4-mg Capsules in Healthy Male Subjects|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:16.015092|2017-10-10 23:54:16.015092
NCT02266498|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||June 1998||1998-06-01|October 2014|2014-10-01||||July 1998|Actual|1998-07-01||Interventional|||Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy Subjects|Single-dose Pharmacokinetics of 2.5 mg BIBB 515 BS and Effect of Food After Oral Administration of Capsules to Healthy Subjects (Randomized, 2-way-cross-over, Open Study)|Completed||Phase 1|8|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:16.114922|2017-10-10 23:54:16.114922
NCT02266485|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2014-10-16|||July 1998||1998-07-01|October 2014|2014-10-01||||September 1998|Actual|1998-09-01||Interventional|||Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 515 BS or Pravastatin in Hyperlipemic Healthy Male Subjects|Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability After Multiple Oral Doses of 2.5 mg o.d. BIBB 515 BS (Capsule) or Pravastatin 20 mg Over 2 Weeks in Hyperlipemic Healthy Male Subjects (Parallel Group Comparison, Randomized, Placebo Controlled, Partly Double Blind [Pravastatin Open])|Completed||Phase 1|60|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:54:16.224551|2017-10-10 23:54:16.224551
NCT02266303|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-16|||July 2014||2014-07-01|October 2014|2014-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||The Effect of a Checklist on the Education of Simulated Patients During Insulin Initiation|The Effect of a Checklist on the Education of Simulated Patients During Insulin Initiation: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|100|Anticipated|The University of The West Indies||2|||f||||f||||||||||2017-10-10 23:54:18.187974|2017-10-10 23:54:18.187974
NCT02266472|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-16|2017-01-19|2017-01-19||November 2014||2014-11-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Treated set (TS): The TS was made up of all randomised subjects who were documented to have received the trial medication.|Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Male and Female|Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release (10 mg/1000 mg) Compared With the Free Combination of Empagliflozin and Metformin Extended Release Tablets in Healthy Subjects Following a High-fat, High-caloric Meal (an Open-label, Randomised, Single Dose, Crossover Trial)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:16.339865|2017-10-10 23:54:16.339865
NCT02266459|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2015-08-10|||October 2014||2014-10-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study to Evaluate Performance, Usability, Safety of Microwave Technology When Collecting Data From Patients With Stroke|A Prospective, Open, Multicenter Study to Evaluate the Performance, Safety and Usability of the Microwave Technology Developed by Medfield Diagnostics When Collecting Measurement Data From Patients With Clinical Signs of Stroke.|Completed||N/A|165|Actual|Medfield Diagnostics||1|||f||||f||||||||||2017-10-10 23:54:16.719852|2017-10-10 23:54:16.719852
NCT02266446|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-01-11|||June 2014||2014-06-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AIM-PC||Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders|Phase 1 Open Trial of Attention and Interpretation Modification (AIM) for Anxiety Disorders in Primary Care|Active, not recruiting||N/A|18|Anticipated|Brown University||1|||f||||t||||||||||2017-10-10 23:54:16.828434|2017-10-10 23:54:16.828434
NCT02266433|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-03-21|||August 2012||2012-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders|A Double-blinded, Prospective, Randomized, Controlled Trial Comparing Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders|Recruiting||Phase 3|780|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-10 23:54:16.940908|2017-10-10 23:54:16.940908
NCT02266420|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2015-05-26|||October 2014||2014-10-01|November 2014|2014-11-01|October 2022|Anticipated|2022-10-01|October 2021|Anticipated|2021-10-01||Interventional|COCABIO000||Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm|Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm.|Recruiting||N/A|200|Anticipated|Institut Claudius Regaud||2|||f||||f||||||||||2017-10-10 23:54:17.07701|2017-10-10 23:54:17.07701
NCT02266407|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-03-13|||September 2012||2012-09-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Surgical / Economic Effect of the Aquamantys System in Blood Management for Aseptic and Septic Revision TKA|The Surgical and Economic Effect of the Aquamantys System in Blood Management During and Following Aseptic and Septic Revision TKA|Unknown status|Recruiting|N/A|80|Anticipated|Medtronic Surgical Technologies||2|||f||||t||||||||||2017-10-10 23:54:17.20225|2017-10-10 23:54:17.20225
NCT02266394|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-08-04|||October 2014||2014-10-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Hypoxia and Inflammatory Injury in Human Renovascular Hypertension|Hypoxia and Inflammatory Injury in Human Renovascular Hypertension : Phase 1 Trial of Mesenchymal Stem Cell Therapy|Recruiting||Phase 1|42|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-10 23:54:17.293818|2017-10-10 23:54:17.293818
NCT02266381|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-09-22|2016-08-04||July 2014||2014-07-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||450 patients were then randomized into three groups.12 patients had purulent fluid in the kidney at initial punctures. A nephrostomy tube was placed and MPCNL postponed to avoid septic complications. These 12 patients were excluded from the analysis. Finally, 438 patients were accrued in the analysis.|A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy|A Prospective and Randomized Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy|Completed||N/A|450|Actual|The First Affiliated Hospital of Guangzhou Medical University||3|||f||||f||||||||||2017-10-10 23:54:17.396366|2017-10-10 23:54:17.396366
NCT02266368|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2016-09-12|||October 2014||2014-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of Antimicrobial Coated Ureteral Stents With Non-coated Stents|A Randomized Controlled Trial Comparing Antimicrobial Coated (Silver Sulfadiazine) Ureteral Stents With Non-coated Stents|Completed||Phase 4|110|Actual|Mansoura University||2|||f||||f||||||||||2017-10-10 23:54:17.711945|2017-10-10 23:54:17.711945
NCT02266355|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-02-22|||November 2014||2014-11-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction|A Pilot Study of the Role of Omalizumab (Xolair) in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction (HSR)|Recruiting||Phase 1|12|Anticipated|Yale University||1|||f||||t||||||||||2017-10-10 23:54:17.784324|2017-10-10 23:54:17.784324
NCT02266342|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-09-26|||October 2014||2014-10-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|November 2021|Anticipated|2021-11-01|5 Years|Observational [Patient Registry]|||GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry|Evaluation on the Treatment of Diseases of the Thoracic Aorta With the Thoracic Endoprosthesis GORE® TAG®|Active, not recruiting||N/A|160|Actual|W.L.Gore & Associates|||1||f||||f||||||||||2017-10-10 23:54:17.868645|2017-10-10 23:54:17.868645
NCT02266329|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-06-07|||January 4, 2016|Actual|2016-01-04|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|September 30, 2019|Anticipated|2019-09-30||Interventional|||Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin|Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin|Recruiting||Phase 1/Phase 2|228|Anticipated|VA Office of Research and Development||2|||f||||f|t|f||||||No||2017-10-10 23:54:18.008734|2017-10-10 23:54:18.008734
NCT02266316|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-10|||March 2012||2012-03-01|October 2014|2014-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Use of an Air Warming Mask for Exercise in Patients With COPD V1.0|A Randomised Controlled Trial of an Air Warming Mask to Increase Exercise Tolerance in Patients With Stable and Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD).|Unknown status|Recruiting|N/A|24|Anticipated|University of Worcester||2|||f||||f||||||||||2017-10-10 23:54:18.113535|2017-10-10 23:54:18.113535
NCT02266277|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-05-02|2017-02-08||November 2014|Actual|2014-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts|System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts.|Completed||N/A|30000|Actual|University of Massachusetts, Worcester|It is possible that our findings are not generalizable to patients in other parts of the country or to those without regular access to primary care.|6|||f||||f||||||||No||2017-10-10 23:54:18.343591|2017-10-10 23:54:18.343591
NCT02266264|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-10-04|||October 2014||2014-10-01|October 2017|2017-10-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Hyperglycemia and Effects of Daily 100 mg Versus 200 mg of Hydrocortisone Therapy in Patients With Septic Shock|Hyperglycemia and Effects of Daily 100 Milligrams Versus 200 Milligrams of Hydrocortisone Therapy in Patients With Septic Shock: A Double-Blind Randomized Controlled Trial|Completed||Phase 4|80|Actual|Srinakharinwirot University||2|||f||||t||||||||||2017-10-10 23:54:18.932313|2017-10-10 23:54:18.932313
NCT02266238|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-10-12|||January 2015||2015-01-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SAVEIT||Stenosis of Arteria-Venous Fistula in Maintenance Hemodialysis Patients: Early Intervention Trial|Randomized Controlled Trial to Compare Therapeutic Effect of Digital Subtraction Angiography(DSA)，Ultrasound Guided Balloon Dilatation and Surgical Reconstruction in Arteria-venous Fistula(AVF) Stenosis in Maintenance Hemodialysis Patients|Not yet recruiting||N/A|450|Anticipated|Shanghai Changzheng Hospital||3|||f||||t||||||||||2017-10-10 23:54:20.898531|2017-10-10 23:54:20.898531
NCT02266225|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-05-10|||June 2014||2014-06-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|Mi-LIFE||Measuring the Implementation of the LiFE Program in Primary Care for Older Adults Aged 75 Years or Older|Measuring the Implementation of a Group-based Lifestyle-integrated Functional Exercise (Mi-LiFE) Intervention Delivered in Primary Care for Older Adults Aged 75 Years or Older: A Pilot Feasibility Study|Completed||N/A|48|Actual|University of Waterloo||1|||f||||t||||||||||2017-10-10 23:54:20.982977|2017-10-10 23:54:20.982977
NCT02266212|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-10-12|||September 2011||2011-09-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study on Analgesia and Related Outcomes for Patients With Tabacco Smoking||Completed||N/A|300|Actual|Kaohsiung Veterans General Hospital.||3|||f||||||||||||||2017-10-10 23:54:21.072166|2017-10-10 23:54:21.072166
NCT02266199|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2014-10-12|||November 2012||2012-11-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Validation of a New Questionnaire Regarding Pain Management|Validation of a New Questionnaire Regarding Pain Management in Hospitals Using a Qualitative Verification|Completed||N/A|350|Actual|Ruhr University of Bochum|||2||f||||f||||||||||2017-10-10 23:54:21.138327|2017-10-10 23:54:21.138327
NCT02266186|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-03-09|||October 2013||2013-10-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|December 2016|Actual|2016-12-01||Interventional|(Victoria)||Treatment of Severe Fear of Childbirth With CBT, Comparison of ICBT With Traditional Live Therapy|Treatment of Severe Fear of Childbirth With CBT, Comparison of ICBT With Traditional Live Therapy (Victoria)|Active, not recruiting||N/A|60|Actual|Linkoeping University||3|||f||||f||||||||||2017-10-10 23:54:21.207335|2017-10-10 23:54:21.207335
NCT02266160|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-08-30|||November 2014||2014-11-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Treating Tinnitus Using Eutectic Mixture of Local Anesthetics (EMLA) 5% Cream|EMLA 5% as a Treatment for Tinnitus and Its Accompanied Symptoms|Completed||Phase 4|142|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||No||2017-10-10 23:54:21.400736|2017-10-10 23:54:21.400736
NCT02266147|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2017-08-29|||October 2014||2014-10-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma|A Phase 1/2, Non-randomized, Open-label, Multicenter, Dose Escalation and Expansion Study of Intratumoral Injections of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma|Completed||Phase 1/Phase 2|29|Actual|Dynavax Technologies Corporation||1|||f||||f||||||||||2017-10-10 23:54:21.47672|2017-10-10 23:54:21.47672
NCT02266134|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-12|2017-02-03|||June 2015||2015-06-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|iMBC||Standardized Versus Tailored Implementation of Measurement Based Care for Depression|Standardized Versus Tailored Implementation of Measurement Based Care for Depression|Enrolling by invitation||N/A|812|Anticipated|Indiana University||2|||f||||t||||||||No||2017-10-10 23:54:21.667909|2017-10-10 23:54:21.667909
NCT02266121|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-05-12|||October 2014||2014-10-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|MScog-tDCS||Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis|Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis / Améliorer Les capacités Cognitives Par tDCS Chez Les Patients Souffrants de sclérose en Plaques|Recruiting||N/A|100|Anticipated|University Hospital of Mont-Godinne||2|||f||||||||||||||2017-10-10 23:54:21.784499|2017-10-10 23:54:21.784499
NCT02266108|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-05-02|||August 2014||2014-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|ESTIMA||Economic and Social Empowerment To Increase Upwards Mobility Among Women|ESTIMA: Economic and Social Empowerment To Increase Upwards Mobility Among Women|Recruiting||N/A|120|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:54:21.892249|2017-10-10 23:54:21.892249
NCT02266095|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2016-11-02|||January 2016||2016-01-01|December 2015|2015-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|Oval-8||Oval-8 Splinting Versus Standardized Treatment With Tee Pee or Forearm Based Thumb Spica Splinting|Pilot Study of a Novel Splint Treatment for Thumb CMC Joint Arthritis: a Comparison of Oval-8 Splinting Versus Standardized Treatment With Tee Pee or Forearm Based Thumb Spica Splinting|Withdrawn||N/A|0|Actual|University of Florida||3||Study closed prior to enrolling patients|f||||f||||||||No|No plans to share participant data as no patients were enrolled in the study.|2017-10-10 23:54:21.981942|2017-10-10 23:54:21.981942
NCT02266082|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-02-16|||May 2015||2015-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Persistent Post-Surgical Pain in Women With BrCA|Biobehavioral Predictors of Persistent Post-Surgical Pain in Women Undergoing Breast Cancer Treatment|Completed||N/A|5|Actual|University of Florida|||1||f||||t||||||Samples With DNA|"     A stool sample for microbiota analysis will be collected by participants at home using a     standard test kit, and returned via mail. Fecal microbial DNA will be extracted from between     50-200 mg of fecal material. The 16S ribosomal gene (V4 region) of each sample will be     amplified using a barcoding system to allow multiplexing with the Illumina MiSeq system.      Blood samples will be collected to measure C-reactive protein (CRP) (at each visit) and     telomerase/telomere and 25(OH)D level at baseline and the 6-month visit. Venous blood samples     will be collected by trained staff.   "|||2017-10-10 23:54:22.073743|2017-10-10 23:54:22.073743
NCT02266069|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2015-02-03|||October 2014||2014-10-01|February 2015|2015-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|pro-Spinoza||PROject - Supportive and Palliative Care and INnOvation - Antwerp (Pro-Spinoza)|Implementation of the Care Pathway for Primary Palliative Care in Five Research Clusters in Belgium|Recruiting||N/A|200|Anticipated|Universiteit Antwerpen||5|||f||||f||||||||||2017-10-10 23:54:22.16284|2017-10-10 23:54:22.16284
NCT02266056|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-10-16|||August 2014||2014-08-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Benefits of Deep Neuromuscular Block and Sugammadex in Laparoscopic Colorectal Surgery||Completed||N/A|72|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:54:22.267905|2017-10-10 23:54:22.267905
NCT02266043|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-05-11|||January 2013||2013-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||Early Treatment Outcomes in Pierre-Robin-Like Phenotype|Cohort Study on Prevalence and Early Treatment Outcomes in Pierre-Robin-Like Phenotype|Active, not recruiting||N/A|50|Anticipated|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-10 23:54:22.342829|2017-10-10 23:54:22.342829
NCT02266017|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-08-02|||October 2014||2014-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mobile Pain Coping Skills Training for Cancer Pain|An Accessible Mobile Health Behavioral Intervention For Cancer Pain|Recruiting||N/A|180|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 23:54:22.519519|2017-10-10 23:54:22.519519
NCT02266004|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-03-07|||October 2014||2014-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|TDCS-FOG||Transcranial Direct Current Stimulation for Freezing of Gait|Transcranial Direct Current Stimulation for Freezing of Gait in Patients With Parkinson's Disease|Recruiting||N/A|40|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 23:54:22.592459|2017-10-10 23:54:22.592459
NCT02265991|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-10|||September 2011||2011-09-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Prospective Biomechanical Analysis of Donor-site Morbidity Following Microvascular Fibula Transplantation|Prospective Biomechanical Analysis of Donor-site Morbidity Following Microvascular Fibula Transplantation in 27 Consecutive Cases: a Clinical Cohort Study.|Completed||N/A|27|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-10 23:54:22.688946|2017-10-10 23:54:22.688946
NCT02265978|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-07-08|||October 2014||2014-10-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||CopeSmart: Using Mobile Technology to Promote Positive Mental Health in Young People|CopeSmart: Using Mobile Technology to Promote Positive Mental Health in Young People|Completed||N/A|387|Actual|University College Dublin||2|||f||||f||||||||||2017-10-10 23:54:22.749101|2017-10-10 23:54:22.749101
NCT02265965|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-11-18|||October 2015||2015-10-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|NITRO||Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension|Randomized Controlled Trial of IV Nitroglycerin in Cesarean Deliveries After Second Stage Arrest for the Prevention of Uterine Extension|Recruiting||Phase 4|100|Anticipated|University of California, San Francisco||2|||f||||t||||||||Undecided||2017-10-10 23:54:22.818989|2017-10-10 23:54:22.818989
NCT02265952|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-01-26|||October 2014||2014-10-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2016|Actual|2016-12-01||Interventional|||Study of REGN1500 in Patients With Homozygous Familial Hypercholesterolemia (HoFH)|An Open-Label, Single-Arm, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Single and Multiple Doses of REGN1500 in Patients With Homozygous Familial Hypercholesterolemia|Active, not recruiting||Phase 2|9|Actual|Regeneron Pharmaceuticals||1|||f||||f||||||||||2017-10-10 23:54:22.906913|2017-10-10 23:54:22.906913
NCT02265939|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-11|2015-04-13|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy||Completed||Phase 2|132|Actual|Nihon Pharmaceutical Co., Ltd||4|||f||||f||||||||||2017-10-10 23:54:23.009271|2017-10-10 23:54:23.009271
NCT02265926|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2014-10-15|||September 2009||2009-09-01|October 2014|2014-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Respiratory Consequences of N95-type Mask Usage in Pregnant Healthcare Workers - A Controlled Clinical Study|Respiratory Consequences of N95-type Mask Usage in Pregnant Healthcare Workers - A Controlled Clinical Study|Completed||N/A|20|Actual|National University Health System, Singapore||1|||f||||f||||||||||2017-10-10 23:54:23.088221|2017-10-10 23:54:23.088221
NCT02265887|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2015-08-06|||June 2012||2012-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01|6 Months|Observational [Patient Registry]|PAPUCO||The Pan African Pulmonary Hypertension Cohort Study|The Pan African Pulmonary Hypertension Cohort Study|Completed||N/A|254|Actual|University of Cape Town|||1||f||||f||||||||||2017-10-10 23:54:23.470032|2017-10-10 23:54:23.470032
NCT02265874|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-01-09|||October 2014||2014-10-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study|Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study|Recruiting||Phase 1/Phase 2|60|Anticipated|Ohio State University||2|||f||||t||||||||||2017-10-10 23:54:23.55942|2017-10-10 23:54:23.55942
NCT02265861|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-10-10|||January 2010||2010-01-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Response of VEGF and AT-II to HCG in PCOS|The Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women With Polycystic Ovary Syndrome|Completed||Early Phase 1|60|Actual|Nanjing University School of Medicine||4|||f||||f||||||||||2017-10-10 23:54:23.647497|2017-10-10 23:54:23.647497
NCT02265848|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-09-01|2015-10-12||October 2014||2014-10-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|HFSCS||High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System|Single Blinded, Randomized Control Trial of High Frequency Stimulation in Subjects With Precision® Spinal Cord Stimulator System to Assess Efficacy and Preferability in Back and Extremity Pain Relief|Completed||Phase 4|22|Actual|The Center for Clinical Research, Winston-Salem, NC|This study was limited by the sampling size, and by device type. Study was open to subjects who were implanted with Boston Scientific's Precision Plus device only|2|||f||||t||||||||No|No individual participants data will be shared with anyone other than study staff for analysis purposes.|2017-10-10 23:54:23.749473|2017-10-10 23:54:23.749473
NCT02265835|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-13|||January 2014||2014-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Anastomotic Airway Complications After Lung Transplantation|Anastomotic Airway Complications After Lung Transplantation : Risk Factors, Treatment Modalities and Outcome : a Single Center Experience.|Completed||N/A|432|Actual|Katholieke Universiteit Leuven|||2||f||||||||||||||2017-10-10 23:54:24.275812|2017-10-10 23:54:24.275812
NCT02265809|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-06-16|||October 2014||2014-10-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|May 2016|Actual|2016-05-01||Interventional|DILfrequency||Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes|Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes (DILfrequency)|Active, not recruiting||Phase 1/Phase 2|41|Actual|Cambridge University Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-10 23:54:24.436216|2017-10-10 23:54:24.436216
NCT02265783|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-21|2017-03-21||September 2014||2014-09-01|March 2017|2017-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable|Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable|Completed||N/A|20|Actual|Medtronic - MITG||1|||f||||f||||||||No|The data will not be shared.|2017-10-10 23:54:24.643189|2017-10-10 23:54:24.643189
NCT02265770|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-08-18|||April 2015||2015-04-01|August 2016|2016-08-01|August 2026|Anticipated|2026-08-01|June 2023|Anticipated|2023-06-01||Interventional|SIOP-EP-II||An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma|An International Clinical Program for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Ependymoma|Recruiting||Phase 2/Phase 3|480|Anticipated|Centre Leon Berard||6|||f||||t||||||||||2017-10-10 23:54:24.835966|2017-10-10 23:54:24.835966
NCT02265757|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-05-18|||June 2014||2014-06-01|May 2017|2017-05-01|March 16, 2018|Anticipated|2018-03-16|March 16, 2018|Anticipated|2018-03-16||Interventional|||Behavioral Interventions to Prevent or Delay Dementia|Comparative Effectiveness of Behavioral Interventions to Prevent or Delay Dementia (CEBIPODD)|Active, not recruiting||N/A|600|Anticipated|Mayo Clinic||5|||f||||f||||||||||2017-10-10 23:54:25.160956|2017-10-10 23:54:25.160956
NCT02265744|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-09-26|||November 13, 2014|Actual|2014-11-13|September 2017|2017-09-01|April 13, 2018|Anticipated|2018-04-13|October 1, 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lulizumab Pegol vs. Placebo on a Background of Limited Standard of Care in the Treatment of Subjects With Active Systemic Lupus Erythematosus|Active, not recruiting||Phase 2|350|Anticipated|Bristol-Myers Squibb||5|||f||||t|t|f||||||||2017-10-10 23:54:25.273005|2017-10-10 23:54:25.273005
NCT02265731|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2017-09-18|||October 21, 2014||2014-10-21|September 2017|2017-09-01|February 6, 2020|Anticipated|2020-02-06|February 6, 2020|Anticipated|2020-02-06||Interventional|||Study Evaluating Venetoclax in Subjects With Hematological Malignancies|A Phase 1/2 Study Evaluating the Safety, Pharmacokinetics and Efficacy of Venetoclax in Japanese Subjects With Hematological Malignancies|Recruiting||Phase 1|36|Anticipated|AbbVie||3|||f||||t||||||||||2017-10-10 23:54:25.704275|2017-10-10 23:54:25.704275
NCT02265718|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-07-25|||September 2014||2014-09-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers|A Randomized, Double Blind, Placebo Controlled Trial To Study Difference In Cognitive Learning Associated With Repeated Self-administration Of Remote Computer Tablet-based Application Assessing Dual-task Performance Based On Amyloid Status In Healthy Elderly Volunteers|Completed||N/A|97|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 23:54:25.833205|2017-10-10 23:54:25.833205
NCT02265705|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2016-07-01|||October 2014||2014-10-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|||A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy|Active, not recruiting||Phase 3|288|Anticipated|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 23:54:25.925353|2017-10-10 23:54:25.925353
NCT02265679|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-15|||October 2001||2001-10-01|October 2014|2014-10-01||||July 2002|Actual|2002-07-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients|A Randomized, Double-blind Within Dose, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Increasing Single Oral Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis Patients|Completed||Phase 1|45|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-10 23:54:26.073457|2017-10-10 23:54:26.073457
NCT02265666|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-15|||October 2001||2001-10-01|October 2014|2014-10-01||||November 2001|Actual|2001-11-01||Interventional|||Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS|Randomised, Open-label, Two-way Crossover Study in Male Healthy Volunteers to Investigate the Relative Bioavailability of BIIL 284 BS 5 mg Tablet FF in Comparison to Tablet C After Ingestion of a Standardised Meal|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:26.167277|2017-10-10 23:54:26.167277
NCT02265653|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-15|||November 1999||1999-11-01|October 2014|2014-10-01||||December 1999|Actual|1999-12-01||Interventional|||Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers|Randomised 3-way Cross-over Phase I Study to Investigate the Relative Bioavailability of BIIL 284 BS 75 mg Tablet C and Tablet D in Comparison to WIF Tablet in Healthy Volunteers|Completed||Phase 1|12|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:54:26.244573|2017-10-10 23:54:26.244573
NCT02265640|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-15|||October 2000||2000-10-01|October 2014|2014-10-01||||December 2000|Actual|2000-12-01||Interventional|||Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers|Randomised 4-way Cross-over Phase I Study to Investigate the Relative Bioavailability of BIIL 284 BS 75 mg Boli in Comparison to Tablet C in Fasted Condition and After Ingestion of a Standardised Meal in Healthy Volunteers|Completed||Phase 1|16|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:54:26.320068|2017-10-10 23:54:26.320068
NCT02265627|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-15|2014-10-15|||March 2000||2000-03-01|October 2014|2014-10-01||||September 2000|Actual|2000-09-01||Interventional|||Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers|Pharmacokinetics, Safety and Tolerability of Single Dose BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Subjects (An Open Label, Matched Pair, Two Center Study)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:54:26.399724|2017-10-10 23:54:26.399724
NCT02265614|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-17|||August 2014||2014-08-01|October 2014|2014-10-01||||June 2016|Anticipated|2016-06-01||Interventional|||PGS Using Microarray in IVF Patients With Repeated Implantation Failure|Preimplantation Genetic Screening (PGS) Using Microarray Technique: Method to Select the Embryo With the Greatest Chance for Successful Implantation During in Vitro Fertilization in Couples With a History of Unsuccessful IVF Attempts|Unknown status|Recruiting|N/A|130|Anticipated|IVF Research Sweden||2|||f||||t||||||||||2017-10-10 23:54:26.482533|2017-10-10 23:54:26.482533
NCT02265601|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-03-17|||March 2008||2008-03-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||End-of-Life Health Care Decisions by Patients With Advanced Cancer|End-of-Life Health Care Decisions by Patients With Advanced Cancer|Active, not recruiting||N/A|200|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-10 23:54:26.568761|2017-10-10 23:54:26.568761
NCT02265588|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-03-03|||September 2014||2014-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|October 1, 2016|Actual|2016-10-01||Interventional|HAPPY-IBD||Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).|Reducing Symptoms of Depression and Anxiety in Adolescents With Inflammatory Bowel Disease in Order to Improve Quality of Life and the Clinical Course of Disease.|Active, not recruiting||N/A|70|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-10 23:54:26.654701|2017-10-10 23:54:26.654701
NCT02265575|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-09-21|||October 2014||2014-10-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|HARK||Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of Dehydration|Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of Dehydration|Unknown status|Enrolling by invitation|Phase 2|400|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-10 23:54:26.766981|2017-10-10 23:54:26.766981
NCT02265562|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-15|||October 2014||2014-10-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy|Evaluation of the Effect of Rectal Misoprostol on Blood Loss During Abdominal Hysterectomy: A Double Blind Randomized Controlled Trial.|Unknown status|Recruiting|Phase 3|220|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:54:26.840117|2017-10-10 23:54:26.840117
NCT02265549|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-05-16|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Observational|||Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases|Value of Radiomics for the Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy (SRT) for Brain Metastases|Active, not recruiting||N/A|40|Anticipated|Maastricht Radiation Oncology|||1||f||||t||||||||||2017-10-10 23:54:26.929598|2017-10-10 23:54:26.929598
NCT02265536|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-03-22|||May 2015||2015-05-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study of LY3022855 In Participants With Breast or Prostate Cancer|Phase 1 Study to Identify the Immunomodulatory Activity of LY3022855 (IMC-CS4) in Patients With Advanced, Refractory Breast or Prostate Cancer|Recruiting||Phase 1|36|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-10 23:54:27.008893|2017-10-10 23:54:27.008893
NCT02265523|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-03-03|||January 2016||2016-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Exercise and Cycle Ergometry Post TKA - A Randomized Controlled Trial|The Effects of Exercise and Cycle Ergometry in Post-Operative Total Knee Patients-A Randomized Controlled Trial|Recruiting||N/A|100|Anticipated|Lakehead University||2|||f||||f||||||||||2017-10-10 23:54:27.103658|2017-10-10 23:54:27.103658
NCT02265510|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-04-18|||August 2014||2014-08-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies|A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies|Recruiting||Phase 1/Phase 2|141|Anticipated|Incyte Corporation||3|||f||||f||||||||||2017-10-10 23:54:27.20559|2017-10-10 23:54:27.20559
NCT02265497|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-08-15|||March 2014||2014-03-01|August 2016|2016-08-01|December 2025|Anticipated|2025-12-01|December 2018|Anticipated|2018-12-01|24 Months|Observational [Patient Registry]|Relinfo||Brazilian Network for Lymphoma Registry|Brazilian Network for Lymphoma Registry|Recruiting||N/A|550|Anticipated|Instituto Nacional de Cancer, Brazil|||1||f||||f||||||||||2017-10-10 23:54:27.361521|2017-10-10 23:54:27.361521
NCT02265484|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-11-21|||November 2013||2013-11-01|April 2013|2013-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism|A Randomized Open Labelled Placebo Controlled Trial to Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism|Completed||N/A|50|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:54:27.474552|2017-10-10 23:54:27.474552
NCT02265471|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-10-10|||June 2014||2014-06-01|April 2014|2014-04-01|July 2015|Anticipated|2015-07-01|February 2015|Anticipated|2015-02-01||Observational|PerceptR||Knowledge and Perception of Resistance to Antimicrobials Among Healthcare Workers in France|Knowledge and Perception of Resistance to Antimicrobials in French Healthcare Facilities|Unknown status|Recruiting|N/A|10000|Anticipated|Assistance Publique - Hôpitaux de Paris|||6||f||||f||||||||||2017-10-10 23:54:27.545515|2017-10-10 23:54:27.545515
NCT02265458|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-06-13|||May 2015||2015-05-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|October 2016|Actual|2016-10-01||Interventional|Mus-IRA||Musical Intervention in Non-invasive Ventilation|Musical Intervention in the ICU: Effect on Tolerance and Acceptance of Non-invasive Ventilation|Completed||N/A|114|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||Undecided||2017-10-10 23:54:27.624814|2017-10-10 23:54:27.624814
NCT02265445|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-02-20|||June 2015||2015-06-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CARBEPARGNE||Deescalating Carbapenems in Hospital Setting|Deescalating Carbapenems in Hospital Setting: a Multicentre Randomized Controlled Study Comparing Carbapenem Continuation and Switch to Another Beta-lactam for the Treatment of Infections Due to ESBL-producing Enterobacteriaceae|Terminated||Phase 4|6|Actual|Assistance Publique - Hôpitaux de Paris||2||The study was stopped for recruitment defect|f||||f||||||||Undecided||2017-10-10 23:54:27.712935|2017-10-10 23:54:27.712935
NCT02265432|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-11-12|||October 2014||2014-10-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Interventional|||Using Mobile Technology to Promote Physical Activity|iFit-Study: Using Mobile Technology to Promote Physical Activity|Recruiting||N/A|74|Anticipated|National University, Singapore||2|||f||||||||||||||2017-10-10 23:54:27.786337|2017-10-10 23:54:27.786337
NCT02265419|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-04-19|||October 2014||2014-10-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CASHSP||Use of Extracorporeal Treatment With the Cytosorb-Adsorber for the Reduction of SIRS in Heart Surgery Patients|Case-observation and Compassionate Use: Use of Extracorporeal Treatment With the Cytosorb-Adsorber for the Reduction of Postoperative Hyperinflammation and SIRS After Heart-surgery With the Use of a Heart-lung-machine|Recruiting||N/A|10|Anticipated|University of Rostock||1|||f||||t||||||||||2017-10-10 23:54:27.867203|2017-10-10 23:54:27.867203
NCT02265406|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-05-19|||October 2015||2015-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PROPHY-VAP||PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone|PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone|Recruiting||Phase 3|320|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-10 23:54:27.943348|2017-10-10 23:54:27.943348
NCT02265393|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-08-16||2017-08-16|October 2014||2014-10-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom|A 6-Month, Prospective, Randomized, Multicenter, Placebo-Controlled Safety Study of OTO-104 Given at 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease Followed by a 6-Month Open-Label Extension|Completed||Phase 2|128|Actual|Otonomy, Inc.||2|||f||||t||||||||||2017-10-10 23:54:28.052634|2017-10-10 23:54:28.052634
NCT02265380|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-02-28|||October 2014||2014-10-01|February 2017|2017-02-01|August 25, 2016|Actual|2016-08-25|August 25, 2016|Actual|2016-08-25||Interventional|||A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population|A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population|Terminated||N/A|188|Anticipated|Optomeditech Oy||2||Inability to recruit patients sufficiently|f||||f||||||||||2017-10-10 23:54:28.262513|2017-10-10 23:54:28.262513
NCT02265367|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-05-30|||January 2015||2015-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Novel Medication as a Potential Smoking Cessation Aid|Novel Medication as a Potential Smoking Cessation Aid|Completed||N/A|56|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||Undecided||2017-10-10 23:54:28.345148|2017-10-10 23:54:28.345148
NCT02265354|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-07-18|||January 11, 2017|Actual|2017-01-11|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|S4S||Developing Smokers for Smoker (S4S): A Collective Intelligence Tailoring System|Developing Smokers for Smoker (S4S): A Collective Intelligence Tailoring System|Recruiting||N/A|260|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-10 23:54:28.421425|2017-10-10 23:54:28.421425
NCT02265341|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-09-29|||December 2014||2014-12-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions|Pilot Study of Ponatinib in Biliary Cancer Patients With FGFR2 Fusions|Active, not recruiting||Phase 2|12|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-10 23:54:28.513704|2017-10-10 23:54:28.513704
NCT02265328|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-09-14|||September 2014||2014-09-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|COBS||Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis.|Efficacy of Combination Therapy of Glucocorticoids, and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis: A Pilot Study.|Completed||Phase 2|25|Actual|Dayanand Medical College and Hospital||1|||f||||t||||||||||2017-10-10 23:54:28.619001|2017-10-10 23:54:28.619001
NCT02265315|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-08-17|||October 2014||2014-10-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Voice Therapy in Parkinson Disease|Augmenting Treatment Effects of Voice Therapy in Parkinson Disease|Recruiting||Phase 2|70|Anticipated|Le Bonheur Children's Hospital||3|||f||||t||||||||Yes||2017-10-10 23:54:28.736239|2017-10-10 23:54:28.736239
NCT02265302|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||June 1998||1998-06-01|October 2014|2014-10-01||||December 1998|Actual|1998-12-01||Interventional|||Safety, Tolerability, Biological Effects and Pharmacokinetics of BIIL 284 BS in Healthy Males|A Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Single Oral Doses of BIIL 284 BS (Dose Range: 0.025 mg - 75 mg PSE Solution, 25 mg, 75 mg, 250 mg and 750 mg WIF Tablets) in Healthy Male Volunteers as Well as Food Effects at 75 mg (WIF Tablet)|Completed||Phase 1|95|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:54:28.839652|2017-10-10 23:54:28.839652
NCT02265289|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||January 1999||1999-01-01|October 2014|2014-10-01||||February 1999|Actual|1999-02-01||Interventional|||Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects|Influence of Oral Doses of 75 mg Clopidogrel on the Pharmacodynamics and Safety of Fradafiban After Oral Doses of 30 mg Lefradafiban Tid Over 8 Days in Healthy Male Subjects. An Intra-individual, Open Trial.|Completed||Phase 1|14|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:54:28.92068|2017-10-10 23:54:28.92068
NCT02265276|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-14|||October 2014||2014-10-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|GLAZED||A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease|A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease (GLAZED Trial)|Unknown status|Recruiting|Phase 3|100|Anticipated|Command Hospital, India||2|||f||||f||||||||||2017-10-10 23:54:28.993685|2017-10-10 23:54:28.993685
NCT02265250|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-08-21|||September 2014||2014-09-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment|Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment Pilot Study|Unknown status|Recruiting|N/A|20|Anticipated|Cedars-Sinai Medical Center|||4||f||||t||||||Samples Without DNA|"     We will obtain fasting lipid and inflammatory biomarkers (LDL-C, HDL-C, lipoprotein(a),     ApoB/ApoA-1 ratio, hemoglobin A1c, plasma adiponectin, hsCRP).   "|||2017-10-10 23:54:29.246965|2017-10-10 23:54:29.246965
NCT02265237|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-08-01|2017-04-26||October 28, 2014||2014-10-28|August 2017|2017-08-01|April 7, 2017|Actual|2017-04-07|July 28, 2016|Actual|2016-07-28||Interventional|AGATE-1|Safety analysis population: all participants who received at least 1 dose of study drug. One participant randomized to arm B (16 weeks arm) was erroneously administered study drug for 12 weeks (as in arm A). Therefore this participant is included in arm A for the safety population.|A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)|A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)|Completed||Phase 3|184|Actual|AbbVie||4|||f||||t|t|f||||||||2017-10-10 23:54:29.389566|2017-10-10 23:54:29.389566
NCT02265224|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-10-09|||September 2014||2014-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)|Comparative Bioavailability Study of N-acetyl-cysteine (NAC) 600 mg Uncoated Tablets vs. NAC 600 mg Film-coated Tablets in Healthy Male and Female Volunteers|Completed||Phase 1|48|Actual|Zambon SpA||2|||f||||f||||||||||2017-10-10 23:54:30.230044|2017-10-10 23:54:30.230044
NCT02265211|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-06-15|||October 2014||2014-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Mindfulness and Acceptance-Based Treatments for Social Anxiety: Defusion App|Mindfulness and Acceptance-Based Treatments for Social Anxiety: Defusion App|Completed||N/A|15|Actual|Wilfrid Laurier University||1|||f||||||||||||||2017-10-10 23:54:30.308833|2017-10-10 23:54:30.308833
NCT02265198|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-10-31|||September 2014||2014-09-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome|Relationship of Pulmonary Contusion Morphology to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome|Completed||N/A|10|Actual|Wake Forest University Health Sciences|||4||f||||f||||||Samples With DNA|"     Bronchial Alveolar Lavage - Supernatant Blood-Serum   "|No||2017-10-10 23:54:30.384848|2017-10-10 23:54:30.384848
NCT02265185|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-11-17|||October 2014||2014-10-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Measuring the Weight Status, Primary Care Usage and Dietary Intake in the Pediatric Emergency Department|Measuring the Weight Status, Primary Care Usage and Dietary Intake in the Pediatric Emergency Department|Completed||N/A|484|Actual|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||||2017-10-10 23:54:30.470752|2017-10-10 23:54:30.470752
NCT02264782|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-10-30|||July 2013||2013-07-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|PreView||PreView: The Preventive Video Education in Waiting Rooms Program|PreView: The Preventive Video Education in Waiting Rooms Program|Unknown status|Recruiting|N/A|572|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:54:34.97375|2017-10-10 23:54:34.97375
NCT02265172|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-24|||August 2009||2009-08-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||Physiotherapy Assessment of Patients Referred to Orthopaedic Surgeon|Does Orthopaedic Manual Therapy Assessment of Patients Referred to Orthopaedic Surgeon Bring Any Changes to Referral Routines, Patient Satisfaction and Health-related Variables?|Completed||N/A|208|Actual|Vastra Gotaland Region||2|||f||||f||||||||||2017-10-10 23:54:30.550997|2017-10-10 23:54:30.550997
NCT02265159|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-10-26|||May 2014||2014-05-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer|Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer|Recruiting||Phase 2/Phase 3|100|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-10 23:54:30.646904|2017-10-10 23:54:30.646904
NCT02265146|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-04-24|||September 2014||2014-09-01|April 2015|2015-04-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|15 Years|Observational [Patient Registry]|ORACLE-NIRS||ORACLE-NIRS: Lipid cORe Plaque Association With CLinical Events: a Near-InfraRed Spectroscopy Study|Association of Lipid Core Plaque With Subsequent Clinical Outcomes: a Collaborative Near-infrared Spectroscopy Study|Enrolling by invitation||N/A|10000|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-10 23:54:31.419916|2017-10-10 23:54:31.419916
NCT02265133|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-06-21|||December 2011||2011-12-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Corneal Sensitivity in Patients With Sleep Apnea Syndrome|Corneal Sensitivity and Nerve Fiber Morphology in Patients With Sleep Apnea Syndrome|Recruiting||N/A|70|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||No||2017-10-10 23:54:31.490378|2017-10-10 23:54:31.490378
NCT02265120|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-11-30|||October 2014||2014-10-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Primary Care Providers' Views and Understanding of Current Recommended Guidelines for Cervical Cancer Screening|Primary Care Providers' Views and Understanding of Current Recommended Guidelines for Cervical Cancer Screening|Completed||N/A|1000|Anticipated|University of Southern California||1|||f||||f||||||||||2017-10-10 23:54:31.585218|2017-10-10 23:54:31.585218
NCT02265107|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-16|||March 2013||2013-03-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Exercise Training on Vascular Endothelial Function of Patients Submitted to Coronary Artery Bypass Graft|Effects of Exercise Training on Vascular Endothelial Function of Patients Submitted to Coronary Artery Bypass Graft|Completed||N/A|9|Actual|Universidade Federal do Rio Grande (FURG)||1|||f||||f||||||||||2017-10-10 23:54:31.671243|2017-10-10 23:54:31.671243
NCT02265094|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-28|||December 2014||2014-12-01|October 2014|2014-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MEM-TA||Associative Memory in Autism Spectrum Disorder|Associative Memory in ASD Without Mental Retardation : Study in EEG and Neuropsychology|Not yet recruiting||N/A|80|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-10 23:54:31.768292|2017-10-10 23:54:31.768292
NCT02265081|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-07-26|||November 2014||2014-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PLUSSMODEL||A Prospective Study on USS Assessment of Pelvic Structures in 3rd Trimester of Pregnancy Versus Delivery Outcome|A Prospective Study on USS Assessment of Pelvic Structures in 3rd Trimester of Pregnancy Versus Delivery Outcome.|Completed||N/A|135|Actual|Birmingham Women's NHS Foundation Trust||3|||f||||f||||||||||2017-10-10 23:54:31.832393|2017-10-10 23:54:31.832393
NCT02265068|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-02-17|||August 2014||2014-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|Real-TICA||Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes|Real-TICA Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes. Evaluation of Antiplatelet Therapy After 12 Months in Patients Undergoing PCI and Treated With Ticagrelor During the Acute Phase of an ACS.|Completed||N/A|700|Actual|IHF GmbH - Institut für Herzinfarktforschung|||1||f||||f||||||||||2017-10-10 23:54:31.903365|2017-10-10 23:54:31.903365
NCT02265055|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||December 2010||2010-12-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Early Embryo Cleavage And Multiple Pregnancies After ICSI|Early Embryo Cleavage And Multiple Pregnancies After ICSI|Completed||Phase 1/Phase 2|193|Actual|Al-Azhar University||2|||f||||||||||||||2017-10-10 23:54:31.98774|2017-10-10 23:54:31.98774
NCT02265042|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-02-07|||January 2012||2012-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Electrostimulation on Denervated Muscles in Individuals With Spinal Cord Injury||Recruiting||N/A|10|Anticipated|Swiss Paraplegic Centre Nottwil||1|||f||||f||||||||||2017-10-10 23:54:32.05696|2017-10-10 23:54:32.05696
NCT02265029|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-09-21|||September 2014||2014-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 11, 2017|Actual|2017-09-11||Interventional|THERMALGI||Evaluation of Spa Therapy in the Treatment of Fibromyalgia|Evaluation of Spa Therapy in the Treatment of Fibromyalgia : a Randomized, Controlled, Open Multicenter Study|Active, not recruiting||N/A|220|Actual|Association Francaise pour la Recherche Thermale||2|||f||||t||||||||||2017-10-10 23:54:32.125158|2017-10-10 23:54:32.125158
NCT02265016|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-10-19|||January 2014||2014-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Regulation and Signaling of Red Blood Cell (RBC) Endothelial Nitric Oxide Synthase (eNOS) in Patients With Stable and Unstable Coronary Artery Disease|Regulation and Signaling of RBC-eNOS in Patients With Stable and Unstable Coronary Artery Disease|Recruiting||N/A|300|Anticipated|Heinrich-Heine University, Duesseldorf|||3||f||||f||||||Samples Without DNA|"     blood samples   "|||2017-10-10 23:54:32.248312|2017-10-10 23:54:32.248312
NCT02265003|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-10-19|||July 2012||2012-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Red Blood Cells as a Reflection of Endothelial Function in Old Age|Red Blood Cells as a Reflection of Endothelial Function in Old Age|Recruiting||N/A|140|Anticipated|Heinrich-Heine University, Duesseldorf|||4||f||||f||||||Samples Without DNA|"     blood samples   "|||2017-10-10 23:54:32.447821|2017-10-10 23:54:32.447821
NCT02264795|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-05-02|||November 2014||2014-11-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Does Intraperitoneal Instillation of Lidocaine at Cesarean Delivery Improve Postoperative Analgesia?|Does Intraperitoneal Instillation of Lidocaine at Cesarean Delivery Improve Postoperative Analgesia? A Randomized, Double-blind, Placebo-controlled Trial|Completed||N/A|204|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-10 23:54:34.865742|2017-10-10 23:54:34.865742
NCT02264990|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-07-06|||September 30, 2014||2014-09-30|July 2017|2017-07-01|May 14, 2018|Anticipated|2018-05-14|May 14, 2018|Anticipated|2018-05-14||Interventional|||Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer Who Are Current or Former Smokers|A Randomized, Open-Label, Multicenter, Phase 3 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers|Active, not recruiting||Phase 3|525|Anticipated|AbbVie||2|||f||||f||||||||||2017-10-10 23:54:32.547924|2017-10-10 23:54:32.547924
NCT02264977|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-08-29|2017-07-07||April 2015|Actual|2015-04-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2016|Actual|2016-07-01||Interventional|||Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms|Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (Branched TAG® Device) in the Treatment of Aortic Arch Aneurysms|Active, not recruiting||N/A|9|Actual|W.L.Gore & Associates||1|||f||||t||||||||||2017-10-10 23:54:32.918774|2017-10-10 23:54:32.918774
NCT02264964|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-09|||January 2015||2015-01-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DACAPO||Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis|Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis : a Multicenter Prospective Cohort Study|Not yet recruiting||N/A|1400|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||||2017-10-10 23:54:33.341559|2017-10-10 23:54:33.341559
NCT02264951|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||October 2013||2013-10-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Fat-induced Release of GLP-1 in Humans|Short Fatty Acids-induced Release of GLP-1 in Humans|Completed||N/A|12|Actual|Glostrup University Hospital, Copenhagen||4|||f||||f||||||||||2017-10-10 23:54:33.456498|2017-10-10 23:54:33.456498
NCT02264938|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||January 2013||2013-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation|Drusen Morphology Changes in Nonexudative Age-related Degeneration Using Spectral Domain Optical Coherence Tomography After Oral Antioxidants Supplementation: One-year Results.|Completed||N/A|35|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-10-10 23:54:33.547876|2017-10-10 23:54:33.547876
NCT02264925|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-08-22|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|VIM-CLT||Thalamic LFPs and VIM DBS in Essential Tremor: Correlation, Evolution, and Therapeutic Perspectives|Thalamic LFPs and VIM DBS in Essential Tremor: Correlation, Evolution, and Therapeutic Perspectives|Active, not recruiting||N/A|10|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 23:54:33.614085|2017-10-10 23:54:33.614085
NCT02264912|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-08-10|||July 2008||2008-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|August 2017|Actual|2017-08-01|12 Months|Observational [Patient Registry]|LAPCOR||The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry|The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry|Recruiting||N/A|2000|Anticipated|Faculty Hospital Kralovske Vinohrady|||1||f||||f||||||||||2017-10-10 23:54:33.7116|2017-10-10 23:54:33.7116
NCT02264899|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-03-10|||November 2014||2014-11-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|VASCOD||MEMENTO-VAScular COmponents of Dementia|MEMENTO-VAScular COmponents of Dementia|Recruiting||N/A|800|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 23:54:33.80772|2017-10-10 23:54:33.80772
NCT02264886|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-12-07|||January 2015||2015-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies|Pilot Study of Online, Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies|Completed||Phase 1|30|Actual|Washington University School of Medicine||1|||f||||t||||||||No||2017-10-10 23:54:33.965194|2017-10-10 23:54:33.965194
NCT02264873|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-09-27|||October 2014||2014-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2016|Actual|2016-10-01||Interventional|||Phase I, Dose Escalation Study of Decitabine|Minimizing Leukemia Relapse: A Phase I, Dose Escalation Study of Decitabine in High Risk Pediatric Leukemia Post Allogeneic Transplant|Active, not recruiting||Phase 1|3|Actual|University of Florida||1|||f||||t|t|f||||||||2017-10-10 23:54:34.079778|2017-10-10 23:54:34.079778
NCT02264860|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-10-14|||October 2014||2014-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RAISe||Researching Alveolar Macrophage Improvements With Supplements in HIV|Cohort 2: Researching Alveolar Macrophage Improvements With Supplements in HIV|Recruiting||N/A|60|Anticipated|Emory University||1|||f||||t||||||||||2017-10-10 23:54:34.163908|2017-10-10 23:54:34.163908
NCT02264847|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2017-02-07|||October 2014||2014-10-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Human Chorionic Gonadotrophin & Trigger|Trigger or Not to Trigger? : An Answer for an Old Question|Recruiting||Phase 3|200|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-10 23:54:34.251596|2017-10-10 23:54:34.251596
NCT02264834|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-02-01|||July 2014||2014-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Deambulatory Epidural During the Labour|Comparison of Two Different Peridural During the Labor and Effect of Deambulation|Recruiting||Phase 3|340|Anticipated|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 23:54:34.342447|2017-10-10 23:54:34.342447
NCT02264821|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-05-21|2015-04-22||February 2012||2012-02-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|Apcisaal||Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia|Is Continuous Wound Infusion With Ropivacaine Better Than Intrathecal Morphine for Post-caesarean Analgesia? A Prospective, Randomized, Controlled, Double Blinded Study|Completed||Phase 3|192|Actual|Brugmann University Hospital||3|||f||||f||||||||||2017-10-10 23:54:34.437194|2017-10-10 23:54:34.437194
NCT02264808|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-09-01|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Developmental Outcomes|Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (HIE).|Enrolling by invitation||N/A|40|Anticipated|University of Florida|||1||f||||f|f|f||||Samples Without DNA|"     Biomarkers will be compared to developmental outcomes, however these blood samples were     already obtained through IRB#504-2011   "|||2017-10-10 23:54:34.766999|2017-10-10 23:54:34.766999
NCT02264769|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-05-22|||October 2014||2014-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Carbetocin at Elective Cesarean Delivery Part 4|Carbetocin at Elective Cesarean Deliveries: A Non-inferiority Study Between 20 and 100 Micrograms - Part 4|Completed||N/A|110|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-10 23:54:35.085068|2017-10-10 23:54:35.085068
NCT02264756|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-08-17|||April 2013||2013-04-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01|4 Weeks|Observational [Patient Registry]|CAPASP||Improving Antibiotic Use in Hospitalized Patients With Pneumonia|Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Length of Stay of Immune-competent Adult Patients Admitted to a Hospital Ward With a Diagnosis of Community-acquired Pneumonia|Completed||N/A|763|Actual|Royal Victoria Hospital, Canada|||1||f||||f||||||||||2017-10-10 23:54:35.186864|2017-10-10 23:54:35.186864
NCT02264743|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-10-14|||November 2013||2013-11-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|November 2014|Anticipated|2014-11-01||Interventional|OPTIMISE||Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy|Comparison of Ultra-low-dose Oral Versus Trans-dermal Hormone Therapy on Coagulation Activation and Metabolic Risk Factors for Cardiovascular Disease|Unknown status|Recruiting|Phase 4|60|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:54:35.288965|2017-10-10 23:54:35.288965
NCT02264730|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-14|||July 2014||2014-07-01|October 2014|2014-10-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery - Liver Bleeding is Encountered|Phase 1 Single-Arm Study Evaluating ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery in Which Liver Bleeding is Encountered|Unknown status|Recruiting|Phase 1|20|Anticipated|Biomedica Management Corporation||1|||f||||t||||||||||2017-10-10 23:54:35.418208|2017-10-10 23:54:35.418208
NCT02264717|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-05-12|||September 2014||2014-09-01|May 2015|2015-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease|Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease|Completed||N/A|1676|Actual|University of Aarhus||2|||f||||t||||||||No||2017-10-10 23:54:35.514994|2017-10-10 23:54:35.514994
NCT02264704|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-08|||November 2014||2014-11-01|October 2014|2014-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Exercise Intensity and Immune Function in Multiple Sclerosis|Exercise Intensity and Immune Function in Multiple Sclerosis|Unknown status|Not yet recruiting|N/A|63|Anticipated|University of the West of Scotland||3|||f||||t||||||||||2017-10-10 23:54:35.599715|2017-10-10 23:54:35.599715
NCT02264691|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-10-25|||March 2009||2009-03-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|UROSA||UTMB Research on Severe Asthma (UROSA) Study|UTMB Research on Severe Asthma (UROSA) Study|Completed||N/A|131|Actual|The University of Texas Medical Branch, Galveston|||4||f||||f||||||||||2017-10-10 23:54:35.7125|2017-10-10 23:54:35.7125
NCT02264678|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-09-14|||October 21, 2014|Actual|2014-10-21|September 2017|2017-09-01|November 29, 2019|Anticipated|2019-11-29|October 30, 2018|Anticipated|2018-10-30||Interventional|||Ascending Doses of AZD6738 in Combination With Chemotherapy and/or Novel Anti Cancer Agents|A Modular Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of AZD6738 in Combination With Cytotoxic Chemotherapy and/or DNA Damage Repair/Novel Anti-cancer Agents in Patients With Advanced Solid Malignancies.|Recruiting||Phase 1/Phase 2|200|Anticipated|AstraZeneca||10|||t||||f|t|f||||||||2017-10-10 23:54:35.783121|2017-10-10 23:54:35.783121
NCT02264665|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-07-24|||May 12, 2015|Actual|2015-05-12|July 2017|2017-07-01|June 5, 2019|Anticipated|2019-06-05|June 5, 2019|Anticipated|2019-06-05||Observational|OPALINE||Observational Study In Real Life Settings Of The Systemic Treatment Of Well Differentiated, Unresectable Or Metastatic, Progressive Pancreatic Neuroendocrine Tumors (pNET): A Study Of Morbidity And Mortality At 2 Years|Observational Study In Real Life Settings Of The Systemic Treatment Of Well Differentiated, Unresectable Or Metastatic, Progressive Pancreatic Neuroendocrine Tumors (Pnet): A Study Of Morbidity And Mortality At 2 Years|Recruiting||N/A|150|Anticipated|Pfizer|||3||f||||f||||||||||2017-10-10 23:54:35.956932|2017-10-10 23:54:35.956932
NCT02264652|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-09-28|||August 2014||2014-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|HD-TDCS||High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy|High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy|Recruiting||Phase 1|20|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 23:54:36.341267|2017-10-10 23:54:36.341267
NCT02264639|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-07-06|||November 2014||2014-11-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase I Study to Assess the Safety APL-2 as an Add-On to Standard of Care in Subjects With PNH|An Open Label, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL-2 as an Add-On to Standard of Care in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH).|Active, not recruiting||Phase 1|15|Anticipated|Apellis Pharmaceuticals, Inc.||5|||f||||t||||||||||2017-10-10 23:54:36.472998|2017-10-10 23:54:36.472998
NCT02264626|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2016-10-08|||October 2014||2014-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|REMI||Sedation During Noninvasive Ventilation (NIV)|Effects of Remifentanil Based Sedation on Patient-ventilator Interaction, in Patients Undergoing Noninvasive Ventilation (NIV)|Recruiting||N/A|15|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||f||||||||||2017-10-10 23:54:36.582434|2017-10-10 23:54:36.582434
NCT02264613|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-06-26|||October 2014|Actual|2014-10-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas|A Phase 1/2a Open-Label Study to Determine the Safety and Tolerability of ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas Expressing Wild-Type p53 Protein|Recruiting||Phase 1/Phase 2|130|Anticipated|Aileron Therapeutics||2|||f||||f||||||||||2017-10-10 23:54:36.705633|2017-10-10 23:54:36.705633
NCT02264600|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-10-10|||November 2014||2014-11-01|October 2014|2014-10-01|April 2015|Anticipated|2015-04-01|February 2015|Anticipated|2015-02-01|2 Days|Observational [Patient Registry]|||Apelin in Willis Ekbom Disease|Oxidative Stress and Apelin Level in Willis Ekbom Disease|Unknown status|Not yet recruiting|N/A|30|Anticipated|Acibadem University|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-10 23:54:36.859126|2017-10-10 23:54:36.859126
NCT02264587|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-10-14|||October 2014||2014-10-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|MDGP||Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis|Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Qingdao University||2|||f||||f||||||||||2017-10-10 23:54:36.949189|2017-10-10 23:54:36.949189
NCT02264574|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-01-04|||October 2014||2014-10-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|October 2017|Anticipated|2017-10-01||Interventional|||A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve CLL or SLL|A Randomized, Multi-center, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Subjects With Treatment-naïve Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Active, not recruiting||Phase 3|212|Anticipated|Pharmacyclics LLC.||2|||f||||t||||||||||2017-10-10 23:54:37.042696|2017-10-10 23:54:37.042696
NCT02264561|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-04-07|||September 2014||2014-09-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Caffeine's Effect on Attention|The Effect of Caffeine on Attention|Completed||N/A|71|Actual|Nestlé||2|||f||||f||||||||||2017-10-10 23:54:37.332237|2017-10-10 23:54:37.332237
NCT02264548|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-05-10|||July 2009||2009-07-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy|A Phase I Study Evaluating the Integration of Hypofractionated Renal Ablative Radiotherapy in the Setting of Metastatic Renal Cell Carcinoma|Recruiting||Phase 1|30|Anticipated|Lawson Health Research Institute||1|||f||||t||||||||||2017-10-10 23:54:37.42843|2017-10-10 23:54:37.42843
NCT02264535|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-11-26|||June 2014||2014-06-01|April 2014|2014-04-01||||November 2014|Actual|2014-11-01||Interventional|||A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.|A Pilot Study for Ginkgolides Meglumine Injection Skin Testing|Completed||Phase 4|149|Actual|Jiangsu Kanion Pharmaceutical Co., Ltd||3|||f||||f||||||||||2017-10-10 23:54:37.526837|2017-10-10 23:54:37.526837
NCT02264522|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-08-28|||September 2014||2014-09-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Pilot Study Using a Pulse Oximeter Derived Photo-plethysmographic Waveform to Guide Hemodialysis Ultrafiltration|Use of Pulse Oximeter Derived Photo-plethysmographic Waveform to Guide Ultrafiltration in Hemodialysis Patients to Achieve Euvolemia While Minimizing Intra-dialytic Hypotension|Completed||N/A|10|Actual|Intelomed, Inc.||1|||f||||f||||||||No||2017-10-10 23:54:37.633567|2017-10-10 23:54:37.633567
NCT02264509|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-01-28|||September 2014||2014-09-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01|1 Day|Observational [Patient Registry]|AIHIV||Peripheral Arterial Insufficiency Associated With HIV/AIDS|Prevalence and Risk Factors of Arterial Insufficiency in Patients With HIV / AIDS|Completed||N/A|206|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||f||||||||||2017-10-10 23:54:37.721518|2017-10-10 23:54:37.721518
NCT02264496|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-02-18|||March 2014||2014-03-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|PEACOCS||Prospective Randomised Trial of Exercise and / or Antioxidants in COlorectal Cancer Patients Undergoing Surgery.|The Effects of Exercise on Outcomes in Patients Undergoing Surgery for Colorectal Cancer: a Pilot Prospective Randomised Trial.|Completed||N/A|24|Actual|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 23:54:37.84325|2017-10-10 23:54:37.84325
NCT02264483|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-08-28|||September 2014||2014-09-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Observational|||Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile.|Assessment of the Degree of Pneumonia Underdiagnosis in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations Using Chest Low-dose Computed Tomography (CT) and Comparison of Inflammatory Profile Between the Two Entities|Unknown status|Recruiting|N/A|150|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||f||||||Samples Without DNA|"     Blood samples and sputum (supernatant)   "|||2017-10-10 23:54:37.947074|2017-10-10 23:54:37.947074
NCT02264470|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-09-03|||October 2014||2014-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|FallsGOT||Fall Study in Gothenburg (FallsGOT)|Identification of Fall Risk in Patients With Stroke During Inpatient Rehabilitation on a Stroke Unit|Active, not recruiting||N/A|505|Actual|Göteborg University|||1||f||||t||||||||||2017-10-10 23:54:38.03433|2017-10-10 23:54:38.03433
NCT02264457|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-14|||November 2014||2014-11-01|October 2014|2014-10-01|October 2016|Anticipated|2016-10-01|January 2016|Anticipated|2016-01-01||Interventional|||A Intra-patient Comparison of Closed Loop and Plate Haptic Toric Intraocular Lenses|A Randomised Intra-patient Comparison of Closed Loop and Plate Haptic Toric, Aspheric, Aberration Neutral, Hydrophilic Acrylic Intraocular Lenses in Patients With Bilateral Astigmatism|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|University of Plymouth||2|||f||||||||||||||2017-10-10 23:54:38.126577|2017-10-10 23:54:38.126577
NCT02264444|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-07-26|||September 2013||2013-09-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Establishing Visualization Grading Scale on LESS Cholecystectomy|A Grading System for Laparoscopic Visualization and Predicting Factors That Affect Visualization Level During Laparoscopic Cholecystectomies: A Prospective, Single Group, Open Label Study|Completed||N/A|30|Actual|Florida Hospital Tampa Bay Division||1|||f||||f||||||||||2017-10-10 23:54:38.218295|2017-10-10 23:54:38.218295
NCT02264431|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-02-02|||January 2014||2014-01-01|February 2017|2017-02-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01|5 Years|Observational [Patient Registry]|SOON||Severe Obesity Outcome Network Cohort (SOON)|Determinants of Nocturnal Respiratory Disorders of Obese Patients Referred to in a Specialized Center.|Recruiting||N/A|500|Anticipated|University Hospital, Grenoble|||1||f||||f|f|f||||Samples With DNA|"     Serum bank, gene bank, tissue bank (subcutaneous fat, visceral fat)   "|No||2017-10-10 23:54:38.330204|2017-10-10 23:54:38.330204
NCT02264418|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-08-01|||September 2014||2014-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|KIDES-203||Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours|Safety and Tolerability of Single and Repeated Doses of ODM-203: An Open-label, Non-randomised, Uncontrolled, Dose Escalation, Multicentre, First-in-Human Study in Subjects With Advanced Solid Tumours|Recruiting||Phase 1|117|Anticipated|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-10-10 23:54:38.419561|2017-10-10 23:54:38.419561
NCT02264405|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-17|||December 2012||2012-12-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Observational|NISSC||Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study|Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis: a Prospective Non-Interventional Approach Across Europe (NISSC) for the Autoimmune Diseases Working Party of the EBMT|Recruiting||N/A|50|Anticipated|European Group for Blood and Marrow Transplantation|||1||f||||f||||||||||2017-10-10 23:54:38.519158|2017-10-10 23:54:38.519158
NCT02264392|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-01-12|||October 2014||2014-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||US Guided Versus BlindI&D for Treatment of Soft Tissue Abscesses in the ED|Ultrasound Guided Versus Blind Incision and Drainage for the Treatment of Soft Tissue Abscesses in the Emergency Department|Recruiting||N/A|274|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-10 23:54:38.608794|2017-10-10 23:54:38.608794
NCT02264379|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-04-03|||December 2014||2014-12-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|Oli-P||Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma|Effectiveness and Toxicity of a Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma|Recruiting||N/A|71|Anticipated|Technische Universität Dresden|||2||f||||f||||||Samples With DNA|"     Blood before therapy, at the end of radiotherapy, three months after the end of radiotherapy     and at progress before starting further treatment   "|No||2017-10-10 23:54:38.688826|2017-10-10 23:54:38.688826
NCT02264366|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-11-30|||October 2014||2014-10-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Activity ,Smoking Cessation, Healthy Eating and Alcohol Intervention Program:(ACCELERATION)|ACCELERATION: An Activity,Smoking Cessation, Healthy Eating and Alcohol Intervention Program With Motivational Supports Aimed at Chronic Disease Prevention|Recruiting||N/A|3000|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-10 23:54:38.799838|2017-10-10 23:54:38.799838
NCT02264340|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-14|||September 2010||2010-09-01|October 2014|2014-10-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|ERTTHU||Effects of Exercise and Relaxation Techniques on Tension Headache Pain Parameters of University Students|EFFECTS OF EXERCISE AND RELAXATION TECHNIQUES ON TENSION-TYPE HEADACHE PAIN PARAMETERS OF UNIVERSITY STUDENTS; A RANDOMIZED AND CONTROLLED CLINICAL TRIAL|Completed||N/A|152|Actual|Universidad Complutense de Madrid||2|||f||||f||||||||||2017-10-10 23:54:38.988585|2017-10-10 23:54:38.988585
NCT02264314|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-01-11|||July 2012||2012-07-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Tele-educative Program to Improve Adherence to the Use of Hearing Aids in Patients With Hearing Loss|Tele-educative Program to Improve Adherence to the Use of Hearing Aids in Patients With Hearing Loss: a Randomized Clinical Trial|Completed||N/A|200|Actual|University of Chile||2|||f||||f||||||||||2017-10-10 23:54:39.208987|2017-10-10 23:54:39.208987
NCT02264301|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-31|||August 2014||2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis|The Effect of Qingkailing Injection on Corticosteroids Withdrawal Rate in Patients With Active Rheumatoid Arthritis|Enrolling by invitation||N/A|150|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:54:39.280903|2017-10-10 23:54:39.280903
NCT02264288|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-08-29|||October 23, 2014|Actual|2014-10-23|August 2017|2017-08-01|November 14, 2018|Anticipated|2018-11-14|November 14, 2018|Anticipated|2018-11-14||Interventional|||Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease|A Phase 2 Multicenter, Randomized, Doubleblind, Placebo-Controlled, Dose Range Finding Study to Evaluate the Efficacy and Safety of Intramuscular Injection of Human Placenta-derived Cells (Pda-002) in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease|Active, not recruiting||Phase 2|182|Actual|Celgene||4|||f||||t||||||||||2017-10-10 23:54:39.352804|2017-10-10 23:54:39.352804
NCT02264275|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-20|||October 2014||2014-10-01|October 2014|2014-10-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Interventional|Ex-CED||Influence of Aerobic Exercise Training (AET) on Inflammatory Bowel Disease (IBD) in Children and Adolescents|The Influence of Aerobic Exercise Training on Disease Symptoms, Cardiovascular Fitness, Depression, Sleep and Quality of Life in Children and Adolescents Suffering From Inflammatory Bowel Disease in Switzerland|Unknown status|Recruiting|N/A|60|Anticipated|University of Basel||1|||f||||t||||||||||2017-10-10 23:54:39.550365|2017-10-10 23:54:39.550365
NCT02264262|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-08-23|||October 2014||2014-10-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Noninvasive Measurement of Sympathetic Nerve Activity in Healthy Volunteers|Noninvasive Measurement of Sympathetic Nerve Activity in Healthy Volunteers|Active, not recruiting||N/A|30|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-10 23:54:39.669544|2017-10-10 23:54:39.669544
NCT02264249|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-04-17|2016-07-25||September 2014||2014-09-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Observational|||Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation|Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation: A Prospective Observational Study|Completed||N/A|449|Actual|The Cleveland Clinic|The patients were not randomized to the two groups. Endoscopists were not blinded to the fact that patients were in the study but were unaware of the preparation type.||3||f||||f||||||||No||2017-10-10 23:54:39.73323|2017-10-10 23:54:39.73323
NCT02264067|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||July 1998||1998-07-01|October 2014|2014-10-01||||November 1998|Actual|1998-11-01||Interventional|||Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers|Phase I Clinical Study of WAL2014 (Talsaclidine) Capsule: A Single Oral Dose Study|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:43.05826|2017-10-10 23:54:43.05826
NCT02264236|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-06-12|||October 2015||2015-10-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|October 2019|Anticipated|2019-10-01||Interventional|||Vaccination of Stage IV NSCLC Patients With a Carbohydrate Mimotope Vaccine|Vaccination of Stage IV NSCLC Patients With a Carbohydrate Mimotope Vaccine|Recruiting||Phase 2|99|Anticipated|University of Arkansas||2|||f||||t||||||||||2017-10-10 23:54:41.868803|2017-10-10 23:54:41.868803
NCT02264223|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-12-14|||October 2014||2014-10-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|KLBIO||The Bioavailability of Red Clover Isoflavones|The Effects of Processing and Matrices on Bioavailability of Red Clover Isoflavones in Healthy Women|Active, not recruiting||N/A|16|Anticipated|University of Aarhus||5|||f||||t||||||||||2017-10-10 23:54:41.951715|2017-10-10 23:54:41.951715
NCT02264197|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||May 1998||1998-05-01|October 2014|2014-10-01||||June 1998|Actual|1998-06-01||Interventional|||Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects|Single-dose Pharmacokinetics of 160 mg BIBX 245 CL and Effect of Food After Oral Administration of Tablets to Healthy Subjects (Randomized, 2-way-cross-over, Open Study)|Completed||Phase 1|8|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:42.130861|2017-10-10 23:54:42.130861
NCT02264184|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||September 2008||2008-09-01|October 2014|2014-10-01||||December 2008|Actual|2008-12-01||Interventional|||Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers|An Open Label Randomized Two-way Crossover Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Single Oral Dose Pharmacokinetics of Tamsulosin in Healthy Male Volunteers (CYP2D6 Extensive Metabolizers)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:42.19688|2017-10-10 23:54:42.19688
NCT02264171|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||April 2008||2008-04-01|October 2014|2014-10-01||||June 2008|Actual|2008-06-01||Interventional|||Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers|An Open Label Randomized Two-way Crossover Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on the Single Oral Dose Pharmacokinetics of Tamsulosin in Healthy Male Volunteers (CYP2D6 Extensive Metabolizers)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:42.270525|2017-10-10 23:54:42.270525
NCT02264158|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||September 2001||2001-09-01|October 2014|2014-10-01||||March 2002|Actual|2002-03-01||Interventional|||Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers|A Double-blind, Randomised, Placebo Controlled, 6 Parallel Groups Study to Assess the Influence of Telmisartan (40 mg or 160 mg), Lacidipine (4 mg or 6 mg) and Their Combination (Telmisartan 40 mg and Lacidipine 4 mg) p.o. Once Daily for Seven Days on the QT Interval of the ECG in Healthy Male and Female Volunteers|Completed||Phase 1|149|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 23:54:42.349436|2017-10-10 23:54:42.349436
NCT02264145|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||November 1998||1998-11-01|October 2014|2014-10-01||||December 1998|Actual|1998-12-01||Interventional|||The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers|The Effect of Alcoholic-carrier Solutions Within-devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers|Completed||Phase 1|20|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:54:42.437774|2017-10-10 23:54:42.437774
NCT02264132|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-14|2014-10-14|||September 2006||2006-09-01|October 2014|2014-10-01||||November 2006|Actual|2006-11-01||Interventional|||Increasing Dose Study of Pramipexole in Two-way Cross-over Comparison of ER Tablet Versus IR Tablet in Japanese Healthy Male Volunteers|A Multiple Dose Study of Pramipexole With Increasing Doses (0.375 mg to 1.5 mg q.d.) of Oral Extended Release (ER) Tablet in Two-way Cross-over Comparison of 0.375 mg ER Tablet q.d. Versus 0.125 mg Immediate Release (IR) Tablet t.i.d. and 1.5 mg ER Tablet q.d. Versus 0.5 mg IR Tablet t.i.d. in Japanese Healthy Male Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:42.513475|2017-10-10 23:54:42.513475
NCT02264119|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||April 1998||1998-04-01|October 2014|2014-10-01||||July 1998|Actual|1998-07-01||Interventional|||Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban in Healthy Subjects|Influence of 40 mg Pantoprazole Per Day on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of 20 mg Lefradafiban Tid as Acid Free Tablet and Sachet Over 5 Days in Healthy Subjects. A 4-way Crossover Randomized Open Trial.|Completed||Phase 1|12|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:54:42.731081|2017-10-10 23:54:42.731081
NCT02264106|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||April 1998||1998-04-01|October 2014|2014-10-01||||June 1998|Actual|1998-06-01||Interventional|||Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban Over 5 Days in Healthy Subjects|Influence of 40 mg Pantoprazole Per Day on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of 30 mg Lefradafiban Tid as Acid Free Tablet and Sachet Over 5 Days in Healthy Subjects. A 4-way Crossover Randomized Open Trial|Completed||Phase 1|12|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:54:42.809598|2017-10-10 23:54:42.809598
NCT02264093|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||November 1999||1999-11-01|October 2014|2014-10-01||||February 2000|Actual|2000-02-01||Interventional|||Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers|Effects on the Airway Lumen of Single Oral Doses of Talsaclidine (12, 24, 48 and 60 mg) in Combination With a Single Oral Doses of 160 mg Propranolol in Comparison to the Effects of the Monosubstances (60 mg Talsaclidine and 160 mg Propranolol) in Healthy Elderly Male Volunteers (Partially Randomised, Open Label, Intraindividual Comparison)|Completed||Phase 1|12|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:54:42.892775|2017-10-10 23:54:42.892775
NCT02264080|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||March 1999||1999-03-01|October 2014|2014-10-01||||March 1999|Actual|1999-03-01||Interventional|||Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers|Phase I Clinical Study of WAL2014 (Talsaclidine) Capsule: A Multiple Oral Dose Study|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:42.966324|2017-10-10 23:54:42.966324
NCT02264054|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||February 1999||1999-02-01|October 2014|2014-10-01||||March 1999|Actual|1999-03-01||Interventional|||Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects|Investigation of Metabolism and Pharmacokinetics of Talsaclidine After Administration of Single Oral and Single Intravenous Dose of 20 mg of [14C]-Labelled Talsaclidine to 6 Healthy Subjects|Completed||Phase 1|6|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:43.151599|2017-10-10 23:54:43.151599
NCT02264041|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||January 2004||2004-01-01|October 2014|2014-10-01||||April 2004|Actual|2004-04-01||Interventional|||Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine|The Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine (an Open-label, Randomised, Single-dose, Two-way Crossover Study)|Completed||Phase 1|25|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:54:43.240395|2017-10-10 23:54:43.240395
NCT02264028|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||March 2004||2004-03-01|October 2014|2014-10-01||||April 2004|Actual|2004-04-01||Interventional|||Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL in 12 Healthy Male Volunteers|Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL After Administration of Single Doses of 5 mg [14C]-DK-AH 269 CL Intravenously and 10 mg [14C]-DK-AH 269 CL as Oral Solution in a Parallel-group Design in 12 Healthy Male Volunteers|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:43.347372|2017-10-10 23:54:43.347372
NCT02264015|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||January 2004||2004-01-01|October 2014|2014-10-01||||May 2004|Actual|2004-05-01||Interventional|||Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, to Healthy Male and Female Volunteers, With an Intra-individual Comparison to Moxifloxacin in a Subset of Volunteers|Pharmacodynamic Effects, Safety and Tolerability of 2 mg and 5 mg Cilobradine, Administered p.o. Once Daily Over 14 Days to Healthy Male and Female Volunteers in a Randomised, Placebo-controlled, Double Blind Study, With an Open-label Uncontrolled Intra-individual Comparison to 400 mg Moxifloxacin Single Dose in a Subset of Volunteers.|Completed||Phase 1|125|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:54:43.445098|2017-10-10 23:54:43.445098
NCT02264002|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||February 2003||2003-02-01|October 2014|2014-10-01||||November 2003|Actual|2003-11-01||Interventional|||Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy Volunteers|Pharmacodynamic Effects, Safety and Tolerability of 0.25 mg, 0.5 mg, 1 mg and 2 mg Cilobradine, Compared to 190 mg Metoprolol Succinate and Placebo, Administered p.o. Once Daily Over 14 Days to Healthy Volunteers in a Randomised, Placebo-controlled, Partly Double Blind Study, With a 4 mg/14 mg and 10 mg/20 mg Cilobradine Single Dose Versus Placebo Substudy (Double Blind, Three-fold Cross-over)|Completed||Phase 1|119|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-10 23:54:43.532542|2017-10-10 23:54:43.532542
NCT02263989|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||January 2007||2007-01-01|October 2014|2014-10-01||||April 2007|Actual|2007-04-01||Interventional|||Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers|Bioequivalence of the 40 mg Telmisartan Film-coated Tablet Compared With the Conventional 40 mg Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Two-sequence, Four-period Replicated Crossover Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:54:43.623265|2017-10-10 23:54:43.623265
NCT02263976|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-13|2014-10-13|||August 2003||2003-08-01|October 2014|2014-10-01||||June 2004|Actual|2004-06-01||Interventional|||Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male Subjects|Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Rising Inhaled BEA 2180 BR Doses (2.5 μg to 1600 μg Cation Administered With the Respimat®) in Healthy Male Subjects, Alone and Followed by Methacholine Challenge. A Randomised, Double-blind Within Dose Group, Placebo-controlled Study, With a 36 μg Tiotropium Bromide Single Dose Sub-study (Open, Two-fold Crossover).|Completed||Phase 1|101|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:54:43.700512|2017-10-10 23:54:43.700512
NCT02263950|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-09-04|||October 2014||2014-10-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|LON002-002||A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours|A Phase 1/2a Study of LON002 (Sublingual Artemether Spray) in Subjects With Advanced Solid Tumours.|Unknown status|Recruiting|Phase 1/Phase 2|87|Anticipated|LondonPharma Ltd.||1|||f||||t||||||||||2017-10-10 23:54:43.868171|2017-10-10 23:54:43.868171
NCT02263937|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-10-28|||January 2014||2014-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Deep Brain Stimulation for Patients With Dementia With Lewy Bodies|Double Blind, Randomised, Dual Centre, Crossover, Pilot Trial of Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation to Improve Cognitive Deficits in Patients With Dementia With Lewy Bodies.|Completed||N/A|6|Actual|University College, London||2|||f||||t||||||||||2017-10-10 23:54:43.953999|2017-10-10 23:54:43.953999
NCT02263924|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-12-09|||July 2015||2015-07-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SATURN||Stroke and Tocotrienol: Unique Role in Neuroprotection|Phase III, Single Centre, Double Blind, Randomised, Placebo Controlled, Parallel Group Trial to Evaluate the Efficacy and Safety of Oral Vitamin E (Mixed Tocotrienol) for 6 Months in Patients With Moderate Acute Ischemic Stroke|Recruiting||Phase 3|150|Anticipated|Seberang Jaya Clinical Research Centre||2|||f||||f||||||||||2017-10-10 23:54:44.052823|2017-10-10 23:54:44.052823
NCT02263911|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-05-15|2017-03-10||November 2014||2014-11-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of Baricitinib in Healthy Japanese Participants|Relative Bioavailability of the Baricitinib (LY3009104) Commercial Tablet Compared to the Phase 2 Tablets and the Effect of Food on the Bioavailability of the Commercial Tablet in Healthy Japanese Subjects|Completed||Phase 1|16|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-10 23:54:44.154906|2017-10-10 23:54:44.154906
NCT02262949|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-12-06|||September 2014||2014-09-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|REALITY2||A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System|A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System (REALITY2)|Completed||N/A|31|Actual|C. R. Bard||1|||f||||f||||||||||2017-10-10 23:56:14.542859|2017-10-10 23:56:14.542859
NCT02263898|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-12-20|||January 2015||2015-01-01|December 2016|2016-12-01||||December 2019|Anticipated|2019-12-01||Interventional|||Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations|Biomarkers of Durable Response With Intermittent Therapy With LGX818 and MEK162 Combined Therapy in Patients With BRAF Mutant Metastatic Melanoma|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||1||closed without enrollment|f||||t||||||||||2017-10-10 23:54:44.676232|2017-10-10 23:54:44.676232
NCT02263885|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-04-25|||April 2015||2015-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease|A Feasibility Clinical Trial of the Management of the Medically-Refractory Dyskinesia Symptoms of Advanced Idiopathic Parkinson's Disease With Unilateral Lesioning of the Globus Pallidum Using the ExAblate Transcranial System|Active, not recruiting||N/A|20|Actual|InSightec||1|||f||||t||||||||||2017-10-10 23:54:44.764198|2017-10-10 23:54:44.764198
NCT02263872|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-09-02|||October 2014||2014-10-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial|Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial|Completed||Phase 4|41|Actual|Pakistan Institute of Learning and Living||2|||f||||t||||||||||2017-10-10 23:54:44.848286|2017-10-10 23:54:44.848286
NCT02263859|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-08-23|||February 2015||2015-02-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|March 2019|Anticipated|2019-03-01||Interventional|THN3||Targeted Hypoglossal Neurostimulation Study #3|ImThera Medical Targeted Hypoglossal Neurostimulation Study #3|Recruiting||N/A|141|Anticipated|ImThera Medical, Inc.||2|||f||||f||||||||||2017-10-10 23:54:44.958682|2017-10-10 23:54:44.958682
NCT02263846|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-04-09|||November 2011||2011-11-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer|Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer|Completed||N/A|1183|Actual|Affiliated Hospital to Academy of Military Medical Sciences|||2||f||||f||||||||||2017-10-10 23:54:45.208349|2017-10-10 23:54:45.208349
NCT02263833|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-07-29|2016-06-17||September 2009||2009-09-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice|Post Marketing Surveillance of Mircera®|Completed||N/A|748|Actual|Hoffmann-La Roche|||1||f||||f||||||||No||2017-10-10 23:54:45.290758|2017-10-10 23:54:45.290758
NCT02263820|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-08-24|||January 2015||2015-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Observational|NORDICA||Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography|Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography (NORDICA Study)|Recruiting||N/A|200|Anticipated|HealthSpan Dx|||1||f||||f||||||Samples With DNA|"     Urine, plasma, buffy coat   "|||2017-10-10 23:54:45.499826|2017-10-10 23:54:45.499826
NCT02263807|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-10-14|||February 2011||2011-02-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|January 2016|Anticipated|2016-01-01||Interventional|MPFL||Knee Function in Patients With Two or More Episodes of Patella Dislocations|RCT Study:Knee Function in Patients With Two or More Episodes of Patella Dislocations|Recruiting||N/A|100|Anticipated|University Hospital, Akershus||2|||f||||t||||||||||2017-10-10 23:54:45.585939|2017-10-10 23:54:45.585939
NCT02263794|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-05-08|||October 2014||2014-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Hyperpolarized Magnetic Resonance Imaging in Asthma Pre- and Post-Bronchial Thermoplasty|Hyperpolarized Magnetic Resonance Imaging in Asthma Pre- and Post-Bronchial Thermoplasty|Enrolling by invitation||N/A|14|Anticipated|Western University, Canada||2|||f||||f||||||||||2017-10-10 23:54:45.753339|2017-10-10 23:54:45.753339
NCT02263781|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-13|||October 2014||2014-10-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|PHD||PREPL in Health and Disease|PREPL in Health and Disease|Unknown status|Not yet recruiting|N/A|125|Anticipated|Universitaire Ziekenhuizen Leuven||6|||f||||f||||||||||2017-10-10 23:54:45.882928|2017-10-10 23:54:45.882928
NCT02263768|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-06-28|||September 2014||2014-09-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Impact of Two Recall Intervals on Dental Caries Incidence, Anxiety and Quality of Life of Preschool Children|Impact of Two Recall Intervals Associated to Oral Health Counseling on Dental Caries Incidence, Anxiety and Quality of Life of Preschool Children With Low and Moderate Caries Risk: Randomized Clinical Trial|Active, not recruiting||N/A|224|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:54:46.026254|2017-10-10 23:54:46.026254
NCT02263755|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-01-23|||September 2, 2014|Actual|2014-09-02|January 2017|2017-01-01|June 25, 2015|Actual|2015-06-25|June 25, 2015|Actual|2015-06-25|10 Years|Observational [Patient Registry]|||Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis B||Completed||N/A|476|Actual|Yonsei University|||1||f||||f||||||||||2017-10-10 23:54:46.104466|2017-10-10 23:54:46.104466
NCT02263742|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-01-26|||April 2014||2014-04-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|WE||Project Wellness Enhancement: Increasing Health Care Choice and Outcomes for People With Mental Illness|Increasing Health Care Choices and Improving Health Outcomes Among Persons With Serious Mental Illness|Completed||N/A|204|Actual|Yale University||2|||f||||f||||||||||2017-10-10 23:54:46.174919|2017-10-10 23:54:46.174919
NCT02263729|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-08-13|||July 2016||2016-07-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Phase 1/2 Prospective Double-blind, Placebo-controlled Randomized Clinical Trial Using Losartan to Treat Grade II and III Hamstring Strains|Phase 1/2 Prospective Double-blind, Placebo-controlled Randomized Clinical Trial Using Losartan to Treat Grade II and III Hamstring Strains|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-10 23:54:46.251816|2017-10-10 23:54:46.251816
NCT02263716|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-01-04|||July 2015||2015-07-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|AMERICA||Actigraphy to MEasuRe Intensive Care Unit Activity|Actigraphy to MEasuRe Intensive Care Unit Activity (AMERICA)|Completed||N/A|25|Actual|Vanderbilt University Medical Center|||1||f||||f||||||||||2017-10-10 23:54:46.332752|2017-10-10 23:54:46.332752
NCT02262611|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-10|||January 2003||2003-01-01|October 2014|2014-10-01||||December 2005|Actual|2005-12-01||Observational|||Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)|Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)|Completed||N/A|266|Actual|Boehringer Ingelheim|||4||f||||||||||||||2017-10-10 23:56:19.931231|2017-10-10 23:56:19.931231
NCT02263703|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-05-01|||May 2007|Actual|2007-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional|||Immunogenicity of HPV Vaccine in Immunosuppressed Children|Immunogenicity and Duration of Immunity in Immunosuppressed Children Vaccinated With Quadrivalent HPV Vaccine|Completed||Phase 3|55|Actual|The University of New South Wales||1|||f||||f||||||||No|We would like to share publication(s) that may arise from the study when applicable.|2017-10-10 23:54:46.403086|2017-10-10 23:54:46.403086
NCT02263690|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-10-10|||June 2014||2014-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Comparison of Three Different Anesthetic Approaches for Intravitreal Injections|Comparison of Three Different Anesthetic Approaches for Intravitreal Injections: A Prospective Randomized Trial|Completed||Phase 4|92|Actual|Retina Clinic, Sao Paulo, Brazil||3|||f||||t||||||||||2017-10-10 23:54:46.521838|2017-10-10 23:54:46.521838
NCT02263677|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-10-03|||March 2014||2014-03-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI|Pilot Project Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI|Withdrawn||Phase 4|0|Actual|University of Missouri-Columbia||1||Technical difficulties have caused this study to be terminated|f||||f||||||||No||2017-10-10 23:54:46.662851|2017-10-10 23:54:46.662851
NCT02263664|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-06-21|||September 2014||2014-09-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Observational Study of Sublingual Microcirculatory Blood Flow Characteristics in Patients Undergoing Transthoracic Esophagectomy|Observational Study of Sublingual Microcirculatory Blood Flow Characteristics in Patients Undergoing Transthoracic Esophagectomy|Recruiting||N/A|250|Anticipated|University of Virginia|||1||f||||f||||||||||2017-10-10 23:54:46.784312|2017-10-10 23:54:46.784312
NCT02263651|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-05-03|||October 2014||2014-10-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|October 2018|Anticipated|2018-10-01||Interventional|QUISERMAS||Dead Space Closure With Quilting Suture Versus Conventional Closure With Drainage|Dead Space Closure With Quilting Suture Versus Conventional Closure With Drainage in Prevention of Seroma Formation After Mastectomy for Breast Cancer : a Randomized Controlled Trial|Recruiting||N/A|320|Anticipated|University Hospital, Tours||2|||f||||f||||||||Undecided||2017-10-10 23:54:46.908218|2017-10-10 23:54:46.908218
NCT02263638|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-07-03|||February 4, 2015|Actual|2015-02-04|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|February 2019|Anticipated|2019-02-01||Interventional|THERA||Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study|Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study|Recruiting||Phase 2|56|Anticipated|Rennes University Hospital||1|||f||||f||||||||||2017-10-10 23:54:47.259832|2017-10-10 23:54:47.259832
NCT02263625|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2015-08-13|||September 2014||2014-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Regional Differences In Indication for Ventral Hernia Repair|Regional Differences In Indication for Ventral Hernia Repair|Completed||N/A|30|Actual|University Hospital Koge|||1||f||||f||||||||||2017-10-10 23:54:47.377465|2017-10-10 23:54:47.377465
NCT02263612|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2016-10-24|||January 2007||2007-01-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Late Mesh Complications After 3258 Incisional Hernia Operations|Late Mesh Complications After 3258 Incisional Hernia Operations|Completed||N/A|3258|Actual|University Hospital Koge|||1||f||||f||||||||||2017-10-10 23:54:47.442515|2017-10-10 23:54:47.442515
NCT02263599|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Observational|||Conservative Treatment For Ventral Hernia|Conservative Treatment For Ventral Hernia|Completed||N/A|2089|Actual|University Hospital Koge|||2||f||||f||||||||||2017-10-10 23:54:47.522179|2017-10-10 23:54:47.522179
NCT02263586|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2015-05-02|||August 2014||2014-08-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|Ironman||Influence of Triathlon on the Electrolyte Balance|Acid-base and Electrolyte Balance Among Triathletes in the Ironman European Championship|Completed||N/A|1089|Actual|University Hospital of Cologne|||1||f||||f||||||||||2017-10-10 23:54:47.585556|2017-10-10 23:54:47.585556
NCT02263573|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-11-24|||December 2014||2014-12-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|PEP'C-R||Effect of PEP'C-R on Endurance Parameters and Maximal Cardio-respiratory Function Among Sedentary Older Seniors Over 70|Effect of a New Training Protocol: the PEP'C With Constant Load and Intermittent Recovery (PEP'C-R), on Endurance Parameters and Maximal Cardio-respiratory Function Among Sedentary Older Seniors Over 70.|Recruiting||N/A|130|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:54:47.662071|2017-10-10 23:54:47.662071
NCT02263560|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-05-11|||March 2014||2014-03-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|January 2015|Actual|2015-01-01|1 Year|Observational [Patient Registry]|SUPLOCO||Supraspinal Contributions to the Control of Human Locomotion: Clinical and Fundamental Aspects|Supraspinal Contributions to the Control of Human Locomotion: Clinical and Fundamental Aspects|Suspended||N/A|20|Actual|University of Fribourg|||2|"A first group of patients (N=10) has been tested. Additional patients may be tested but this is   not fixed yet."|f||||||||||||||2017-10-10 23:54:47.745821|2017-10-10 23:54:47.745821
NCT02263547|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-09-15|||January 2015||2015-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TERCOL||Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride|Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride|Terminated||Phase 1|14|Actual|University of South Florida||1||PK time points were not being met as expected. Determination that risks outweighed benefit.|f||||f||||||||||2017-10-10 23:54:47.824187|2017-10-10 23:54:47.824187
NCT02263534|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-07-23|||November 2014||2014-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Retropubic Single Incision Minisling Versus Tension Free Vaginal Tape for Management of Stress Urinary Incontinence|Retropubic Single Incision Minisling Versus Tension Free Vaginal Tape for Management of Stress Urinary Incontinence|Completed||Phase 4|48|Actual|Ain Shams University||2|||f||||f||||||||Undecided||2017-10-10 23:56:05.44071|2017-10-10 23:56:05.44071
NCT02263521|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2015-01-12|||October 2014||2014-10-01|January 2015|2015-01-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Observational|||Understanding Physician Work Motivation|Physician Work Motivation: A Measure Validation Study|Unknown status|Enrolling by invitation|N/A|4500|Anticipated|American Medical Association|||3||f||||f||||||||||2017-10-10 23:56:05.57578|2017-10-10 23:56:05.57578
NCT02263469|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-10-09|||August 2005||2005-08-01|August 2014|2014-08-01||||July 2006|Actual|2006-07-01||Interventional|||A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years|An Open Multi-centre Phase III Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients Under the Age of 6 Years|Completed||Phase 3|||Bio Products Laboratory||1|||f||||||||||||||2017-10-10 23:56:06.273395|2017-10-10 23:56:06.273395
NCT02263456|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-10-09|||July 1997||1997-07-01|August 2014|2014-08-01||||September 2001|Actual|2001-09-01||Interventional|||A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B|An Open Study to Compare the Pharmacokinetics and Safety of Replenine®-VF and Replenine® or Any Other High Purity Factor IX Concentrate, in Severe Haemophilia B Patients.|Completed||Phase 3|||Bio Products Laboratory||2|||f||||||||||||||2017-10-10 23:56:06.349952|2017-10-10 23:56:06.349952
NCT02263443|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-11-19|||October 2014||2014-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Appropriated Bowel Preparation Before Exploratory Laparotomy in Gynecologic Surgery|Appropriated Bowel Preparation Before Exploratory Laparotomy in Gynecologic Surgery|Completed||N/A|330|Anticipated|Chiang Mai University||3|||f||||f||||||||||2017-10-10 23:56:06.423449|2017-10-10 23:56:06.423449
NCT02263430|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2016-10-13|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease|PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease|Not yet recruiting||N/A|8|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:56:06.492717|2017-10-10 23:56:06.492717
NCT02263417|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2016-10-08|||July 2015||2015-07-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Randomized Controlled Trail Comparing Subthalamic and Pallidal Deep Brain Stimulation for Dystonia|The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Dystonia|Recruiting||Early Phase 1|40|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:56:06.552381|2017-10-10 23:56:06.552381
NCT02263404|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2016-10-13|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PINS Stimulator System to Treat Severe Anorexia Nervosa|PINS Stimulator System to Treat Severe Anorexia Nervosa|Not yet recruiting||Early Phase 1|16|Anticipated|Beijing Pins Medical Co., Ltd||1|||f||||t||||||||||2017-10-10 23:56:06.641754|2017-10-10 23:56:06.641754
NCT02263391|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-02-20|||March 2014|Actual|2014-03-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||HIV Risk and Prevention in Women|Collaborative Biosocial Research on HIV Risk and Prevention in Women|Completed||N/A|200|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-10 23:56:06.705359|2017-10-10 23:56:06.705359
NCT02263378|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-05-23|||September 2014||2014-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A New Supplement for the Immune Response to HPV Infection|Ellagic Acid and Annona Muricata May Modulate the Immune Response to High Risk HPV Infection. A Randomized, Controlled Trial.|Completed||N/A|60|Actual|University of Messina||2|||f||||||||||||||2017-10-10 23:56:06.792821|2017-10-10 23:56:06.792821
NCT02263352|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-08|||January 2013||2013-01-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01||Interventional|"SLSRPD"||A Clinical Trial to Study the Effect of Lycopene in Patients With Gum Disease and type2 Diabetes Mellitus|Systemic Lycopene as an Adjunct to Scaling and Rootplaning in Chronic Periodontitis Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|40|Actual|Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre||2|||f||||t||||||||||2017-10-10 23:56:09.544251|2017-10-10 23:56:09.544251
NCT02263339|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-18|||September 2014||2014-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|April 2016|Actual|2016-04-01||Interventional|||Exercise & Brain Health in MS|Aerobic Exercise to Improve Brain Metabolism in MS|Active, not recruiting||N/A|24|Actual|Oregon Health and Science University||3|||f||||t||||||||||2017-10-10 23:56:09.662943|2017-10-10 23:56:09.662943
NCT02263326|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-09-12|||December 2014||2014-12-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|July 2017|Actual|2017-07-01||Interventional|ASPIRE||Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure|Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure (ASPIRE) Study|Completed||Phase 3|90|Actual|Northwestern University||2|||f||||t||||||||||2017-10-10 23:56:09.752852|2017-10-10 23:56:09.752852
NCT02263313|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-07|||September 2014||2014-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||EGO-COMBO Clinical End-point Extension Study Beyond 36 Months|Evaluation of Endothelial ProGenitor Cell Capture Sirolimus-Eluting Stent by Optical Coherence Tomography: the COMBO Stent 36-months Clinical End-point Extension Study (EGO-COMBO Clinical End-point Extension Study Beyond 36 Months)|Completed||N/A|59|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-10 23:56:09.852554|2017-10-10 23:56:09.852554
NCT02263300|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-10-29|||October 2014||2014-10-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Spatial Orientation and Fiberoptic Intubation Skills in the Novice: A Randomized Controlled Trial|Does Spatial Orientation Affect the Rate of Learning Fiberoptic Intubation Skills in the Novice: A Randomized Controlled Trial|Completed||N/A|51|Actual|Northwestern University|||4||f||||f||||||||||2017-10-10 23:56:09.943712|2017-10-10 23:56:09.943712
NCT02263287|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-12-23|||October 2014||2014-10-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|LESCOD||"LESCOD: Lewy Body Screening in Cognitive Disorders"|"LESCOD: A Single Center, Prospective Study Aimed at Validating a Clinical Scale, Screening for Symptoms of Lewy Body Disease in Patients Incipient Dementia of the Alzheimer's and/or Lewy Body Type"|Recruiting||N/A|180|Anticipated|Nantes University Hospital||3|||f||||f||||||||||2017-10-10 23:56:10.034936|2017-10-10 23:56:10.034936
NCT02263274|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-06-09|||November 2013|Actual|2013-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS|Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS|Active, not recruiting||N/A|10|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-10 23:56:10.11838|2017-10-10 23:56:10.11838
NCT02263261|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-04-14|||March 2015||2015-03-01|March 2015|2015-03-01|November 2016|Anticipated|2016-11-01|June 2016|Anticipated|2016-06-01||Interventional|||Evaluation of a Human Acellular Dermal Matrix in Post Mastectomy Reconstruction|Reconstructive, Aesthetic and Patient Reported Outcomes Associated With the Use of Flex HD Pliable, Perforated Human Acellular Dermal Matrix in Implant-Based Breast Reconstruction: A Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Musculoskeletal Transplant Foundation||1|||f||||f||||||||||2017-10-10 23:56:10.184801|2017-10-10 23:56:10.184801
NCT02263248|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-05-27|||December 2014||2014-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|(IRLGREY-B)||Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine|Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine|Active, not recruiting||Phase 1/Phase 2|72|Anticipated|Centre for Addiction and Mental Health||2|||f||||t||||||||Undecided||2017-10-10 23:56:10.254581|2017-10-10 23:56:10.254581
NCT02263235|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-05-02|||June 2013||2013-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PROMARA||In Vivo Alzheimer Proteomics|Use of Targeted Quantitative Proteomics and Metabolic Labelling With Stable Isotopes for the Diagnosis and the Investigation of Neurological Disorders and in Particular Alzheimer Disease|Recruiting||N/A|110|Anticipated|University Hospital, Montpellier||3|||f||||f||||||||||2017-10-10 23:56:11.505102|2017-10-10 23:56:11.505102
NCT02263222|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-06-06|||February 2016||2016-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Feasibility Dose-escalating Study of MDT-10013 for Acute Postoperative Pain Following Total Knee Arthroplasty|A Feasibility Dose-escalating Study to Evaluate the Tolerability and Systemic Exposure of MDT-10013 Plus Routine Care in the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty|Withdrawn||Phase 2|0|Actual|Medtronic Spinal and Biologics||1|||f||||t||||||||||2017-10-10 23:56:11.604687|2017-10-10 23:56:11.604687
NCT02263209|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2017-02-21|||October 2013||2013-10-01|April 2016|2016-04-01|May 2025|Anticipated|2025-05-01|November 2015|Actual|2015-11-01||Interventional|||Investigation to Determine Safety of Taperloc Stems With BioGuard Coating When Used in Cementless Total Hip Arthroplasty|Prospective Clinical Investigation to Determine the Safety of Taperloc Stems With BioGuard Coating and Exceed ABT Taperfit Acetabular Cups With BioGuard Coating When Used in Cementless Total Hip Arthroplasty|Active, not recruiting||N/A|50|Actual|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-10-10 23:56:11.685507|2017-10-10 23:56:11.685507
NCT02263196|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-04-07|||September 2014||2014-09-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Efficacy of Alcohol After Betadine and Combination of Alcohol and Betadine on Inflammation Vascular Access|Mashhad University of Medical Sciences|Unknown status|Recruiting|Phase 1/Phase 2|96|Anticipated|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:56:11.766405|2017-10-10 23:56:11.766405
NCT02263183|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-09-13|||January 2013||2013-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||Red Palm Olein and Cardiovascular Health|Red Palm Olein and Cardiovascular Health|Active, not recruiting||N/A|53|Actual|Malaysia Palm Oil Board||2|||f||||f||||||||||2017-10-10 23:56:11.855534|2017-10-10 23:56:11.855534
NCT02263170|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-11-23|||March 2015||2015-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor. An Observational Pilot Study|Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor. An Observational Pilot Study|Completed||N/A|20|Actual|University Hospital Inselspital, Berne|||1||f||||t||||||||||2017-10-10 23:56:11.961981|2017-10-10 23:56:11.961981
NCT02263157|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-10-08|||January 2013||2013-01-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Evaluate the Association Between Infection and Thrombocytopenia|Evaluate the Association Between Blood Stream Infection (BSI) and Thrombocytopenia (Surgical Intensive Care Unit)SICU Patients|Completed||N/A|390|Actual|Jinling Hospital, China|||4||f||||||||||||||2017-10-10 23:56:12.048951|2017-10-10 23:56:12.048951
NCT02263144|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-10-08|||May 2014||2014-05-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|FICE;NICE||Resect and Discard Extension to FICE of NIcE Classification|Resect and Discard Extension to Fuji Intelligent Color Enhancement (FICE) of Narrow Band Imaging International Colorectal Endoscopic (NicE) Classification|Unknown status|Recruiting|N/A|110|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples Without DNA|"     colonic polyps   "|||2017-10-10 23:56:12.108874|2017-10-10 23:56:12.108874
NCT02263131|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-04-05|2015-03-26||October 2013||2013-10-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children|Randomized, Double Blind, Active-controlled, Phase Ⅲ Study to Evaluate the Immunogenicity and Safety of 'Ilyang Flu Vaccine Pre-filled Syringe Inj.(Influenza Split Vaccine)' in Healthy Children Aged From 6 Months to < 18 Years.|Completed||Phase 3|416|Actual|Il-Yang Pharm. Co., Ltd.||2|||f||||f||||||||No||2017-10-10 23:56:12.232252|2017-10-10 23:56:12.232252
NCT02263118|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-06-29|2015-05-31||November 2013||2013-11-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Indigenous women from San Juan Sacatepequez|A Mobile-health Pilot Experiment Targeting Mothers With Newborns in Rural Areas of San Juan Sacatepequez, Guatemala|A Mobile-health Pilot Experiment Targeting Mothers With Newborns in Rural Areas of San Juan Sacatepequez, Guatemala, in the Context of Exclusive Breastfeeding Practices|Completed||N/A|100|Actual|Universidad Francisco Marroquín|Future work could consider a wider time span and inspect complementary instruments to ensure consistency between answers to interviews and behaviour. SMSs in virtual communities could be further analyzed to locate longitudinal changes in knowledge.|4|||f||||||||||||||2017-10-10 23:56:12.647574|2017-10-10 23:56:12.647574
NCT02263105|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2017-05-12|||October 2014||2014-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas|Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas: A Single-arm Prospective Phase II Clinical Study|Recruiting||Phase 2|60|Anticipated|Huashan Hospital||1|||f||||||||||||||2017-10-10 23:56:13.252324|2017-10-10 23:56:13.252324
NCT02263079|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-10-02|||June 16, 2014|Actual|2014-06-16|October 2017|2017-10-01|October 31, 2024|Anticipated|2024-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase|A Phase IIIb, Randomized, Open-Label Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Patients in Children With HBeAg Positive Chronic Hepatitis B in the Immune-Tolerant Phase|Recruiting||Phase 3|114|Anticipated|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-10 23:56:13.454522|2017-10-10 23:56:13.454522
NCT02263066|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-07-16|||October 2014||2014-10-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|ReCARE||Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis|Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis|Completed||N/A|181|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:56:13.671416|2017-10-10 23:56:13.671416
NCT02263053|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-09-05|||January 2014||2014-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|TMD||Immediate Effects of Posterior Mobilization Versus Caudal Mobilization in Patients With Temporomandibular Disorders|Immediate Effects of Posterior Mobilization Versus Caudal Mobilization in Patients With Temporomandibular Disorders: A Randomized Clinical Trial|Completed||N/A|58|Actual|Universidade Federal do Ceara||2|||f||||t||||||||||2017-10-10 23:56:13.74364|2017-10-10 23:56:13.74364
NCT02263027|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-01-13|||October 2014||2014-10-01|September 2015|2015-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?|Do Some Healthy Adults Consistently Have Systemic Reactions to Trivalent Inactivated Split Virus Influenza Vaccines?|Completed||Phase 4|11|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-10 23:56:14.017185|2017-10-10 23:56:14.017185
NCT02263001|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-05-02|||April 2013||2013-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Acupuncture Therapy for Treatment of Musculoskeletal Pain|Auricular Acupuncture Therapy for Treatment of Musculoskeletal Pain in the Setting of Military Personnel: A Randomized Trial|Completed||N/A|8|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:56:14.179163|2017-10-10 23:56:14.179163
NCT02262988|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-08-08|||September 2014||2014-09-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Adipose-Derived Regenerative Cells in Total Knee Arthroplasty|Intra-articular Injection of Autologous Adipose-Derived Regenerative Cells (ADRCs) as Adjuvant Therapy for Total Knee Arthroplasty|Active, not recruiting||N/A|60|Actual|Fondren Orthopedic Group L.L.P.||2|||f||||f||||||||||2017-10-10 23:56:14.265035|2017-10-10 23:56:14.265035
NCT02262975|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-12-23|||July 2014||2014-07-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|ADOS||A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)||Completed||N/A|532|Actual|Eisai Inc.|||1||f||||||||||||||2017-10-10 23:56:14.351264|2017-10-10 23:56:14.351264
NCT02262962|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-06-20|||June 2005||2005-06-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Well-Child Care Redesign: A New Model of Care for Children in Low-Income Families|Well-Child Care Redesign: A New Model of Care for Children in Low-Income Families|Completed||N/A|251|Actual|University of California, Los Angeles||2|||f||||f||||||||No||2017-10-10 23:56:14.462554|2017-10-10 23:56:14.462554
NCT02262936|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-11-11|||July 2015||2015-07-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|DEFEND||Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older|A Randomized Double-blinded Trial Comparing DEsmopressin to FEsoterodine in the Treatment of Severe Nocturia in Women Aged 65 and olDer: The DEFEND Trial|Terminated||Phase 2/Phase 3|4|Actual|Mount Sinai Hospital, Canada||2||Poor recruitment|f||||f||||||||||2017-10-10 23:56:14.639968|2017-10-10 23:56:14.639968
NCT02262923|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2016-03-21|||March 2016||2016-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial|Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial|Not yet recruiting||N/A|80|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-10 23:56:14.725199|2017-10-10 23:56:14.725199
NCT02262910|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-06-22|||January 2015||2015-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of MOR209/ES414 in Metastatic Castration-Resistant Prostate Cancer|A Phase 1 Study of MOR209/ES414 in Patients Wtih Metastatic Castration-Resistant Prostate Cancer|Recruiting||Phase 1|130|Anticipated|Aptevo Therapeutics||1|||f||||f||||||||||2017-10-10 23:56:14.825935|2017-10-10 23:56:14.825935
NCT02262897|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-07|||September 2013||2013-09-01|October 2014|2014-10-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer|Single Arm Phase II Clinical Trial to Investigate the Efficacy and Safety of Nab-paclitaxel as a Single Agent in the Small Cell Lung Cancer Patients With Extensive Disease and Failed to First Line/ Second Line Chemotherapy|Unknown status|Recruiting|Phase 2|40|Anticipated|Tongji University||1|||f||||t||||||||||2017-10-10 23:56:14.924727|2017-10-10 23:56:14.924727
NCT02262884|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-06-02|||October 2014||2014-10-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|TARPAN||SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)|A Physician Preference Study of the Use of SurgiQuest AirSeal vs. Conventional Insufflation Systems for the Management of Pneumoperitoneum in Robotic Partial Nephrectomy .|Recruiting||N/A|189|Anticipated|SurgiQuest, Inc.||3|||f||||f||||||||||2017-10-10 23:56:15.059287|2017-10-10 23:56:15.059287
NCT02262871|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-04-18|||December 2014||2014-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||HFN Versus NIV in Cystic Fibrosis. The HIFEN Study|Randomized Cross-over Physiologic Study of High Flow Nasal Oxygen Cannula Versus Non-invasive Ventilation in Cystic Fibrosis. The HIFEN Study|Recruiting||N/A|15|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-10 23:56:15.177629|2017-10-10 23:56:15.177629
NCT02262858|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-10|||August 2005||2005-08-01|October 2014|2014-10-01||||October 2005|Actual|2005-10-01||Interventional|||Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II|Bioequivalence of 80 mg Telmisartan/12.5 mg HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II (an Open-label, Randomised, Single-dose, Two-sequence, Four-period Replicated Crossover Study)|Completed||Phase 1|68|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:15.286432|2017-10-10 23:56:15.286432
NCT02262845|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-03-20|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01|6 Weeks|Observational [Patient Registry]|||Short Term Pancreatic Stenting Registry|A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct|Completed||N/A|246|Actual|Boston Scientific Corporation|||5||f||||f|f|f||||||No||2017-10-10 23:56:15.367523|2017-10-10 23:56:15.367523
NCT02262832|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-08-04|||October 7, 2014||2014-10-07|July 26, 2017|2017-07-26|July 31, 2025|Anticipated|2025-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy|Compassionate Use of Metreleptin in Previously-Treated Patients With Generalized Lipodystrophy|Enrolling by invitation||Phase 3|20|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:56:15.484381|2017-10-10 23:56:15.484381
NCT02262819|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2017-08-04|||September 24, 2014||2014-09-24|July 21, 2017|2017-07-21|January 1, 2025|Anticipated|2025-01-01|January 1, 2025|Anticipated|2025-01-01||Interventional|||Human Immunity Against Staphylococcus Aureus Skin Infection|Human Immunity Against Staphylococcus Aureus Skin Infection|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:56:15.556511|2017-10-10 23:56:15.556511
NCT02262806|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-06-30|||October 6, 2014||2014-10-06|May 19, 2017|2017-05-19|July 31, 2025|Anticipated|2025-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy|Compassionate Use of Metreleptin in Previously-Treated Patients With Partial Lipodystrophy|Enrolling by invitation||Phase 3|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:56:15.635445|2017-10-10 23:56:15.635445
NCT02262793|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-10|||May 2004||2004-05-01|October 2014|2014-10-01||||July 2004|Actual|2004-07-01||Interventional|||Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects|Relative Bioavailability of Telmisartan in Micardis® and of Dipyridamole in Aggrenox® After Co-administration Compared to the Bioavailability of Telmisartan Respectively of Dipyridamole After Oral Administration of 80 mg Telmisartan Respectively of 25 mg ASA/200 mg Extended-release Dipyridamole Alone. An Open-label, Randomised, Single-dose, Four-way Crossover Study in 24 Healthy Female and Male Subjects|Completed||Phase 1|24|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:56:15.708402|2017-10-10 23:56:15.708402
NCT02262780|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-10|||December 2003||2003-12-01|October 2014|2014-10-01||||February 2004|Actual|2004-02-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses (40 mg Telmisartan / 12.5 mg HCTZ to 80 mg Telmisartan / 12.5 mg HCTZ) and Multiple Oral Doses (80 mg Telmisartan / 12.5 mg HCTZ) of Drug in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:15.789672|2017-10-10 23:56:15.789672
NCT02262234|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-09-17|||September 2014||2014-09-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study|Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Kessler Foundation||2|||f||||f||||||||||2017-10-10 23:56:23.249974|2017-10-10 23:56:23.249974
NCT02262767|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-01-13|||November 2014||2014-11-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy Subjects|A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Single Ascending Dose Study To Investigate The Safety, Tolerability, And Pharmacokinetics Of Pf 06649751 Co-administered With Trimethobenzamide Hydrochloride In Healthy Volunteers|Completed||Phase 1|9|Actual|Pfizer||2|||f||||f||||||||||2017-10-10 23:56:15.880288|2017-10-10 23:56:15.880288
NCT02262754|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-11-04|2016-07-22||October 2014||2014-10-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Full Analysis Set (FAS) included all participants randomized and who had received at least 1 dose of randomized treatment.|PF-06372865 In Subjects With Chronic Low Back Pain|A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control|Completed||Phase 2|302|Actual|Pfizer||3|||f||||f||||||||||2017-10-10 23:56:16.116041|2017-10-10 23:56:16.116041
NCT02262741|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-01|||October 15, 2014|Actual|2014-10-15|August 2017|2017-08-01|September 20, 2017|Anticipated|2017-09-20|September 20, 2017|Anticipated|2017-09-20||Interventional|||A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer|A Phase I Study to Evaluate the Safety, Tolerability, and Efficacy of MEDI4736 in Combination With Tremelimumab in Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 1|71|Actual|MedImmune LLC||1|||f||||f||||||||||2017-10-10 23:56:18.143004|2017-10-10 23:56:18.143004
NCT02262728|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-03-01|2016-08-16||September 2014||2014-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|August 2015|Actual|2015-08-01||Interventional|||An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease|A Phase 2 Open-label Study to Investigate the Efficacy, Safety and Pharmacokinetics of 12 Weeks of Treatment With Simeprevir, Daclatasvir and Sofosbuvir, Followed by a 5-Year Post-treatment Long-term Follow-up, in Treatment-naïve and Treatment-experienced Subjects With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease|Active, not recruiting||Phase 2|40|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-10 23:56:18.291879|2017-10-10 23:56:18.291879
NCT02262715|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-11-03|||July 2014||2014-07-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study to Assess the Drug-Drug Interaction Between VX-787 and Oseltamivir|A Phase 1, Randomized, 3-way Crossover, Open-label Study to Assess the Drug-drug Interaction Between VX-787 and Tamiflu®, Followed by a Double-blind, Randomized, Placebo-controlled Study to Collect Safety, Tolerability and Pharmacokinetics of VX-787, in Healthy Subjects|Completed||Phase 1|38|Actual|Janssen Infectious Diseases BVBA||3|||f||||f||||||||||2017-10-10 23:56:19.254403|2017-10-10 23:56:19.254403
NCT02262702|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-01-21|||January 2013||2013-01-01|January 2016|2016-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study|Panadol Osteo PBS Claims Cohort Study|Withdrawn||N/A|0|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-10 23:56:19.338679|2017-10-10 23:56:19.338679
NCT02262689|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-05-05|||January 8, 2015|Actual|2015-01-08|May 2017|2017-05-01|April 24, 2015|Actual|2015-04-24|April 24, 2015|Actual|2015-04-24||Interventional|||To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions|A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-10 23:56:19.414877|2017-10-10 23:56:19.414877
NCT02262676|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2017-01-20|||October 2014||2014-10-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Observational|HEROIC||Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain|Observational and Cross-sectional Study to Assess the Sociodemographic and Clinical Characteristics of Patients Treated With RIVAROXABAN in the Context of Routine Clinical Practice of Spanish Haematologists, Cardiologists and Internists (HEROIC Study)|Completed||N/A|2251|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:56:19.5008|2017-10-10 23:56:19.5008
NCT02262663|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2016-03-14|||October 2014||2014-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan|A Randomized, Double-blind, Parallel-group, Multi-center Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety After Daily Oral Administration of 4 Different Doses of Vilaprisan (BAY1002670) in Healthy Women of Reproductive Age|Completed||Phase 1|70|Actual|Bayer||4|||f||||f||||||||||2017-10-10 23:56:19.596863|2017-10-10 23:56:19.596863
NCT02262650|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-10|||April 2004||2004-04-01|October 2014|2014-10-01||||May 2004|Actual|2004-05-01||Interventional|||Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects|Relative Bioavailability of Telmisartan and SR26334, the Main Metabolite of Clopidogrel, After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After p.o. Administration of 80 mg Telmisartan and 75 mg Clopidogrel Alone. A Four-way, Single Dose, Open, Randomised Crossover Study in 24 Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:56:19.691373|2017-10-10 23:56:19.691373
NCT02262637|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-10|||September 2003||2003-09-01|October 2014|2014-10-01||||March 2006|Actual|2006-03-01||Observational|||Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)|Micardis® / MicardisPlus® PROTEKT (Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases)|Completed||N/A|4814|Actual|Boehringer Ingelheim|||3||f||||||||||||||2017-10-10 23:56:19.778351|2017-10-10 23:56:19.778351
NCT02262624|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-10|2014-10-10|||February 2005||2005-02-01|October 2014|2014-10-01||||February 2005|Actual|2005-02-01||Interventional|||Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers|Bioequivalence of 80 mg Telmisartan/12.5 mg HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Two-way Crossover Study)|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:19.853387|2017-10-10 23:56:19.853387
NCT02262598|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||September 2004||2004-09-01|October 2014|2014-10-01||||October 2004|Actual|2004-10-01||Interventional|||Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers|Bioequivalence of 40 mg Telmisartan / 12.5 mg HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Two-way Crossover Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:20.013451|2017-10-10 23:56:20.013451
NCT02262585|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||July 2002||2002-07-01|October 2014|2014-10-01||||August 2002|Actual|2002-08-01||Interventional|||Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male Volunteers|Bioequivalence Study of BIBR 277 Tablet (Mannitol Based) Compared With Its Capsule Formation in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:20.109142|2017-10-10 23:56:20.109142
NCT02262572|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||April 2003||2003-04-01|October 2014|2014-10-01||||August 2003|Actual|2003-08-01||Interventional|||Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects|Relative Bioavailability of Telmisartan and HCTZ p.o. (80 mg Telmisartan/12.5 mg HCTZ) in Two Experimental Formulations (Given t.i.d. for One Day Each) Compared to the Standard Formulation 80 mg Telmisartan/12.5 mg HCTZ (MicardisPlus®), Given t.i.d. for One Day in Healthy Female and Male Subjects. A Three-way Crossover, Open, Randomised Study|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:20.18953|2017-10-10 23:56:20.18953
NCT02262559|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||July 2002||2002-07-01|October 2014|2014-10-01||||August 2002|Actual|2002-08-01||Interventional|||Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers|Bioequivalence Study of BIBR 277 Tablet (Erythritol Based) Compared With Its Capsule Formation in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:20.268054|2017-10-10 23:56:20.268054
NCT02262546|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||May 2007||2007-05-01|October 2014|2014-10-01||||October 2007|Actual|2007-10-01||Interventional|||Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers|A Double-blind, Randomised, Placebo Controlled Study With Two Sequential Two-way Cross-over Parts to Demonstrate That the Influence of Pramipexole up to 4.5 mg Daily on the QT Interval of the ECG in Healthy Male and Female Volunteers is Comparable With Placebo, With a Positive Control (Two-way Cross-over Moxifloxacin Versus Placebo)|Completed||Phase 1|60|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:56:20.341845|2017-10-10 23:56:20.341845
NCT02262533|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-08-06|||June 2007||2007-06-01|August 2015|2015-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects|Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects|Completed||Phase 1|15|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-10 23:56:20.414157|2017-10-10 23:56:20.414157
NCT02262520|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2015-08-06|||January 2006||2006-01-01|August 2015|2015-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects|Effect of Apixaban on the Pharmacokinetics of Digoxin in Healthy Subjects|Completed||Phase 1|24|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:56:20.492302|2017-10-10 23:56:20.492302
NCT02262494|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-03-30|||April 2015||2015-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|EchoComp TVP||Location of Lower Extremity Deep Vein Thrombosis by Emergency Physicians Using Portable Compression Ultrasonography|Location of Lower Extremity Deep Vein Thrombosis by Emergency Physicians Using Portable Compression Ultrasonography: a Diagnostic Study|Recruiting||N/A|236|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-10 23:56:20.631144|2017-10-10 23:56:20.631144
NCT02262481|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-01-26|||August 2014||2014-08-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor|A Randomized, Double Blinded, Placebo Controlled Trial of Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor|Completed||N/A|48|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-10 23:56:20.717592|2017-10-10 23:56:20.717592
NCT02262468|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-10|||April 2012||2012-04-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Warwick Metal On Metal Study|Review of 750 36mm MOM Hip Replacements ( Pinnacle/Corail) With up to 6 Year Follow up|Completed||N/A|750|Actual|South Warwickshire NHS Foundation Trust|||1||f||||f||||||||||2017-10-10 23:56:20.812439|2017-10-10 23:56:20.812439
NCT02262455|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-02-10|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|January 13, 2017|Actual|2017-01-13|January 13, 2017|Actual|2017-01-13||Interventional|||Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors|An Open-Label Multiple Ascending Dose Phase 1/1B Pharmacokinetic and Pharmacodynamic Study of STM 434, an Activin Type 2B Receptor Fc Fusion, Alone and in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors|Completed||Phase 1|32|Actual|Santa Maria Biotherapeutics||2|||f||||f||||||||||2017-10-10 23:56:20.877141|2017-10-10 23:56:20.877141
NCT02262442|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-02-17|||October 2014||2014-10-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|EnkAtomizerII||Effect of the Topical Application of Anaesthetics With EnkFiberoptic Atomizer During the Bronchoscopy|Effect of the Topical Application of Anaesthetics With EnkFiberoptic Atomizer on Usage of Anaesthetics and Sedatives During the Bronchoscopy|Recruiting||Phase 4|60|Anticipated|RWTH Aachen University||2|||f||||f||||||||||2017-10-10 23:56:20.981373|2017-10-10 23:56:20.981373
NCT02262429|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2015-10-05|||October 2014||2014-10-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Quality Improvement Program (QIP) to Reduce 30-Day Readmission in Malnourished Hospitalized Patients|Does a Rapid, Comprehensive Oral Nutritional Supplementation Quality Improvement Program (QIP) Reduce 30-Day Readmission in Malnourished Hospitalized Patients?|Terminated||N/A|2386|Actual|Abbott Nutrition|||2||f||||f||||||||||2017-10-10 23:56:21.072664|2017-10-10 23:56:21.072664
NCT02262416|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-10|||January 2015||2015-01-01|October 2014|2014-10-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|GALA||GnRH Agonist and Progesterone Versus Progesterone Only for Luteal Phase Support in Antagonist Cycles|A Prospective Randomised Controlled Trial of GnRH Agonist and Progesterone Versus Progesterone Only for Luteal Phase Support in Antagonist Cycles|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Queensland Fertility Group||2|||f||||t||||||||||2017-10-10 23:56:21.152256|2017-10-10 23:56:21.152256
NCT02262403|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-07-25|||August 2014||2014-08-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2016|Actual|2016-03-01||Interventional|HIRP-01||Hookworm Immune Regulation Project|Study of Immuno-regulatory Mechanisms Induced by Hookworm Infection|Active, not recruiting||N/A|40|Actual|Brugmann University Hospital||2|||f||||f||||||||||2017-10-10 23:56:21.334768|2017-10-10 23:56:21.334768
NCT02262390|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-10|||November 2014||2014-11-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|STOP||Syphilis Treatment of Partners Trial|Comparison of Different Partner Notification Strategies After Antenatal Syphilis Screening|Unknown status|Not yet recruiting|N/A|1752|Anticipated|Makerere University||3|||f||||f||||||||||2017-10-10 23:56:21.418337|2017-10-10 23:56:21.418337
NCT02262377|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2017-01-31|||April 2015||2015-04-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|IMGV||Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression|Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression in a Disparate Urban Population|Completed||N/A|159|Actual|Boston Medical Center||2|||f||||t||||||||||2017-10-10 23:56:21.517778|2017-10-10 23:56:21.517778
NCT02262364|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-01-17|||November 2014||2014-11-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)|A Pilot Study of a Single Intra-articular Injection of Autologous Protein Solution in Patients With Knee Osteoarthritis|Completed||Phase 1|11|Actual|Zimmer Biomet||1|||f||||t||||||||||2017-10-10 23:56:21.60683|2017-10-10 23:56:21.60683
NCT02262351|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-18|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|December 2, 2016|Actual|2016-12-02|October 15, 2016|Actual|2016-10-15||Interventional|PIAAF-FP||"Program for the Identification of Actionable Atrial Fibrillation in the Family Practice Setting"|"Program for the Identification of Actionable Atrial Fibrillation in the Family Practice Setting"|Completed||N/A|2174|Actual|Population Health Research Institute||1|||f||||f||||||||||2017-10-10 23:56:21.70025|2017-10-10 23:56:21.70025
NCT02262338|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-02-28|||April 2015|Actual|2015-04-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome|A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human Iduronate 2-Sulfatase (IDS) Fusion Protein, AGT-182 in Adult Patients With Mucopolysaccharidosis II (MPS II, Hunter Syndrome)|Recruiting||Phase 1|8|Anticipated|ArmaGen, Inc||1|||f||||t||||||||||2017-10-10 23:56:21.898133|2017-10-10 23:56:21.898133
NCT02262325|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-08-02|||December 2014||2014-12-01|August 2017|2017-08-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery|A Phase II Trial Combining Hypofractionated Radiation Boost With Conventionally-Fractionated Chemoradiation in Locally Advanced Non-small Cell Lung Cancer Not Suitable for Surgery|Recruiting||Phase 2|34|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-10 23:56:22.045606|2017-10-10 23:56:22.045606
NCT02262312|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-06-08|||September 2014||2014-09-01|June 2015|2015-06-01||||June 2015|Actual|2015-06-01||Observational|||Iron Overload and Transient Elastography in Patients With Myelodysplastic Syndrome|Iron Overload and Transient Elastography in Patients With Myelodysplastic Syndrome|Completed||Early Phase 1|60|Actual|Zealand University Hospital|||1||f||||||||||||||2017-10-10 23:56:22.222385|2017-10-10 23:56:22.222385
NCT02262299|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-21|2016-12-08|||May 2015||2015-05-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|EPOS||European Trial of Pirfenidone in BOS, A European Multi-center Study|A European Multi-center, Randomised, Double-blind Trial of Pirfenidone in Bronchiolitis-obliterans-syndrome Grade 1-2 in Lung Transplant Recipients|Recruiting||Phase 2/Phase 3|80|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:56:22.311102|2017-10-10 23:56:22.311102
NCT02262286|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-02-08|||September 2014||2014-09-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|MIND||MIND (Management of Traumatic Brain Injury Diagnosis)|Study to Procure Human Specimens for Use in the Diagnosis and Management of Traumatic Brain Injury and Other Related Conditions|Completed||N/A|239|Actual|Abbott Diagnostics Division|||2||f||||f||||||Samples Without DNA|"     Plasma and serum samples stored at -70C or colder   "|||2017-10-10 23:56:22.47114|2017-10-10 23:56:22.47114
NCT02262273|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-02-28|||October 2014||2014-10-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|OSCA||OSCA - Olaparib Standard of CAre Study|Real-World Treatment Patterns, BRCA Testing Practices, Outcomes, and Health Care Utilization in Platinum-Sensitive Recurrent Serous Ovarian Cancer: A Multi-Country Retrospective Study|Completed||N/A|2123|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:56:22.551356|2017-10-10 23:56:22.551356
NCT02262260|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-02-28|||December 2014||2014-12-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SALUTE-D||Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME|A Randomized, Open-label Non-inferiority Study to Compare Safety and Efficacy of Labeled Versus Wait and Extend Regimen of Lucentis (Ranibizumab) in Turkish Patients With Visual Impairment Due to Diabetic Macular Edema.|Recruiting||Phase 3|104|Anticipated|Novartis||2|||f||||f||||||||||2017-10-10 23:56:23.051692|2017-10-10 23:56:23.051692
NCT02262247|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-03-14|||July 2014||2014-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures|A Multicenter OUS Post-Market Clinical Follow-Up of the Medrobotics Flex® Robotic System Used for Accessing and Visualizing the Oropharynx, Hypopharynx, and Larynx During Transoral Procedures|Completed||N/A|80|Actual|Medrobotics Corporation|||1||f||||f||||||||No||2017-10-10 23:56:23.173543|2017-10-10 23:56:23.173543
NCT02262221|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-06-29|||June 2014||2014-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HETeCo||Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer|Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer|Recruiting||Phase 2|330|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||Yes|Study results will be shared trough pubblications, abstracts and posters|2017-10-10 23:56:23.346422|2017-10-10 23:56:23.346422
NCT02262208|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-13|||January 2014||2014-01-01|October 2014|2014-10-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|ETSMAGV||Exercise as a Tool for Studying the Mechanisms and Applicability of Glycemic Variability|Exercise as a Tool for Studying the Mechanisms and Applicability of Glycemic Variability in Individuals With and Without Type 2 Diabetes Mellitus|Unknown status|Recruiting|N/A|69|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-10 23:56:23.512693|2017-10-10 23:56:23.512693
NCT02262195|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-04-20|||October 2014||2014-10-01|October 2014|2014-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Dysfunctional Hemoglobin|Dysfunctional Hemoglobin Pulse Co-ox|Completed||N/A|62|Actual|Nonin Medical, Inc|||2||f||||f||||||||||2017-10-10 23:56:23.632824|2017-10-10 23:56:23.632824
NCT02262182|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-09-28|||November 2014||2014-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|PEPKIN||Interest of Positive Expiratory Pressure (PEP) Delivery by EzPAP® After Cardiac Surgery in the Management of Postoperative Atelectasis|Evaluation of the Interest of Positive Expiratory Pressure (PEP) Delivery by EzPAP® Device Associated With Respiratory Physiotherapy in the Treatment of Postoperative Pulmonary Atelectasis in Patients After Cardiac Surgery|Completed||N/A|80|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-10 23:56:23.730467|2017-10-10 23:56:23.730467
NCT02262169|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-05-02|||October 2014||2014-10-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers|DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers|Recruiting||Phase 3|140|Anticipated|Dexa Medica Group||2|||f||||f||||||||||2017-10-10 23:56:23.828818|2017-10-10 23:56:23.828818
NCT02262156|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-03-27|||August 2014||2014-08-01|October 2014|2014-10-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|CBTvsSSRI||CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients|Treatment Of Depression In Patients With Temporal Lobe Epilepsy: Comparative Study Of Cognitive Behavioral Therapy Vs. Selective Serotonin Reuptake Inhibitors|Completed||N/A|15|Actual|El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez||2|||f||||f||||||||||2017-10-10 23:56:23.945212|2017-10-10 23:56:23.945212
NCT02262143|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||November 2014||2014-11-01|October 2014|2014-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia|Efficacy and Safety of Combination Therapy of Rosuvastatin and Fenofibrate Versus Rosuvastatin Monotherapy in Mixed Dyslipidemia Patients|Unknown status|Not yet recruiting|Phase 3|360|Anticipated|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||||2017-10-10 23:56:24.063735|2017-10-10 23:56:24.063735
NCT02262117|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-08-18|||February 2015||2015-02-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PRECONCEPTIO||Evaluate the Interest of the Pre-conceptional Endometrial Immune Profiling to Increase Birth Rates|A Prospective, Randomized, Controlled, Two-arm Study to Evaluate the Interest of the Pre-conceptional Endometrial Immune Profiling to Increase Birth Rates Through a Care Personalization in Reproductive Medicine Before IVF|Recruiting||N/A|400|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:56:24.265469|2017-10-10 23:56:24.265469
NCT02262104|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-23|2014-12-02|||September 2012||2012-09-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|EXDEM||Effects of an Exercise Program for Nursing Home Patients With Dementia|Effects of an Exercise Program for Nursing Home Patients With Dementia - a Six Months Assessor Blind Randomized Controlled Trial|Completed||N/A|170|Actual|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-10 23:56:24.350168|2017-10-10 23:56:24.350168
NCT02262091|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-04-09|||August 2014||2014-08-01|September 2014|2014-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Immune Benefits of WGP in Elderly|Strengthening Immunity of Prefrail and Frail Elderly by WGP|Completed||N/A|150|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-10 23:56:24.422682|2017-10-10 23:56:24.422682
NCT02262078|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-07-31|2016-11-21||October 2014||2014-10-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction|Acute Effects of Inhaled Sodium Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction|Completed||Phase 2|26|Actual|Mayo Clinic|Patients with symptoms that might independently cause symptoms were excluded, including severe valvular or coronary heart disease and advanced lung, liver or kidney disease. Cannot determine if results would apply to these co-morbidities.|2|||f||||f||||||||||2017-10-10 23:56:24.612478|2017-10-10 23:56:24.612478
NCT02262065|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-09-01|||July 2012||2012-07-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Observational|||Risk Factors for Enhanced Inflammation to Arthroplasty Wear Particles: Analysis of Cytokine Production and Polymorphisms|Individual Risk Factors for Enhanced Inflammation to Arthroplasty Wear Particles: Analysis of Cytokine Polymorphisms and in Vitro Cytokine Production to Wear Particles (Ceramic, Metal, XPE)|Active, not recruiting||N/A|195|Actual|Ludwig-Maximilians - University of Munich|||2||f||||f||||||Samples With DNA|"     blood samples of 20 patients (subgroup analysis)   "|||2017-10-10 23:56:24.912388|2017-10-10 23:56:24.912388
NCT02262052|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-02-21|||March 2015||2015-03-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Theia||Advanced Diagnostic Management of Suspected Recurrent Ipsilateral DVT With MRDTI|Advanced Diagnostic Management of Suspected Recurrent Ipsilateral Deep Vein Thrombosis of the Leg With Magnetic Resonance Direct Thrombus Imaging|Recruiting||Phase 4|305|Anticipated|Leiden University Medical Center||1|||f||||f||||||||||2017-10-10 23:56:24.995076|2017-10-10 23:56:24.995076
NCT02262039|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-01-26|2016-09-08||August 2014||2014-08-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional||All participants who agreed to participate completed the study and are included in the analysis.|Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System|Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System: A Randomized Control Trial|Completed||N/A|41|Actual|Yale University||2|||f||||f||||||||||2017-10-10 23:56:25.126912|2017-10-10 23:56:25.126912
NCT02262026|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-11-18|||November 2014||2014-11-01|November 2016|2016-11-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism|A Phase One Study Investigating the Tolerability and Effects of AZD0530 on Functional Neuroimaging Responses in Individuals With or Without a Family History of Alcoholism|Recruiting||Phase 1|90|Anticipated|Yale University||12|||f||||t||||||||||2017-10-10 23:56:25.696756|2017-10-10 23:56:25.696756
NCT02262013|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-02-08|||January 2015||2015-01-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluation of a Family-based Pediatric Obesity Program: TEENS+|Evaluation of a Family-based Pediatric Obesity Program: TEENS+|Completed||N/A|25|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-10 23:56:25.877799|2017-10-10 23:56:25.877799
NCT02262000|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-02-09|||September 2013||2013-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SABR||Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer|A Phase II Clinical Trial of Image Guided Stereotactic Ablative Radiotherapy (SABR) for T2 and Microscopic T3 (PL3), N0,M0 Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||N/A|40|Anticipated|West Virginia University||2|||f||||t||||||||No||2017-10-10 23:56:26.008559|2017-10-10 23:56:26.008559
NCT02261987|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-11-11|||November 2014||2014-11-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Resistive Inspiratory Manoeuvre as Airway Clearance Technique in Cystic Fibrosis|Role of Resistive Inspiratory Manoeuvres During Bronchial Drainage Session in Cystic Fibrosis: a Randomized Crossover Trial|Completed||N/A|32|Actual|Universidad San Jorge||3|||f||||t||||||||||2017-10-10 23:56:26.118633|2017-10-10 23:56:26.118633
NCT02261961|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-06-13|||July 23, 2014|Actual|2014-07-23|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|TDAP2||Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults|Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults|Enrolling by invitation||N/A|50|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-10 23:56:26.389381|2017-10-10 23:56:26.389381
NCT02261948|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-10-07|2015-08-04||September 2012||2012-09-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)|Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)|Completed||Phase 4|42|Actual|Centro Cardiologico Monzino||2|||f||||f||||||||||2017-10-10 23:56:26.571056|2017-10-10 23:56:26.571056
NCT02261935|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-07-04|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|December 31, 2017|Anticipated|2017-12-31||Interventional|CSNAT||Supporting Family Caregivers of Palliative Patients at Home: the Carer Support Needs Assessment Intervention|Clustered, Randomized, Controlled Trial of the Home Care Nurse Carer Support Needs Assessment Practice Tool With Family Caregivers of Palliative Patients at Home|Active, not recruiting||N/A|130|Actual|University of Victoria||2|||f||||t||||||||||2017-10-10 23:56:26.951494|2017-10-10 23:56:26.951494
NCT02261922|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-09|||October 2014||2014-10-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Ticagrelor and Endothelial Function|A Prospective Randomized Double Blind Study to Evaluate the Effect of Ticagrelor on Endothelial Function|Unknown status|Recruiting|Phase 4|20|Anticipated|Hotel Dieu de France Hospital||2|||f||||f||||||||||2017-10-10 23:56:27.106949|2017-10-10 23:56:27.106949
NCT02261909|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-08-14|||May 2015||2015-05-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Observational|||New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients|New Prognostic Kidney Function Markers in Emergency Patients|Unknown status|Recruiting|N/A|60|Anticipated|Krankenhaus Barmherzige Brüder, Regensburg|||2||f||||f||||||Samples Without DNA|"     Serum, urine   "|||2017-10-10 23:56:27.198276|2017-10-10 23:56:27.198276
NCT02261896|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-02-23|||October 2014||2014-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions|Multicenter, Randomized and Double-blinded Clinical Trial on the Use of Antibiotic Prophylaxis for EUS Guided FNA of Pancreatic Cystic Lesions|Recruiting||Phase 4|218|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||No||2017-10-10 23:56:27.304024|2017-10-10 23:56:27.304024
NCT02261883|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-07-06|||May 2015||2015-05-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn|Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study|Recruiting||Phase 2|70|Anticipated|United Therapeutics||2|||f||||t||||||||||2017-10-10 23:56:27.413508|2017-10-10 23:56:27.413508
NCT02261870|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-07-27|||December 2014||2014-12-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|DRAGET||Detection of Acute Graft Rejection in Heart Transplant Patients by Estimation of T2|"Detection of Acute Rejection in Heart Transplant Patients by Mean of T2 Quantification With MRI Open Transversal Clinical Trial With Repeated Measures"|Recruiting||N/A|190|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-10-10 23:56:27.59887|2017-10-10 23:56:27.59887
NCT02261857|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-06-22|||September 2013||2013-09-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea|Personalized Three-Dimensionally Printed CPAP Masks for Obstructive Sleep Apnea Therapy in Children With Craniofacial Anomalies|Recruiting||Early Phase 1|5|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-10 23:56:27.717055|2017-10-10 23:56:27.717055
NCT02261844|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-03-28|||December 2015||2015-12-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Resveratrol and Human Hepatocyte Function in Cancer|Resveratrol and Human Hepatocyte Function in Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|University of Louisville||2||No funding|f||||f||||||||||2017-10-10 23:56:27.841457|2017-10-10 23:56:27.841457
NCT02261831|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-02-21|||February 2014||2014-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MICIMAB||Identify Bacteria Associated With Metabolic Diseases That Reside Both in Intestinal Crypts and in Blood|Identify Bacteria Associated With Metabolic Diseases That Reside Both in Intestinal Crypts and in Blood.|Recruiting||N/A|120|Anticipated|University Hospital, Toulouse||4|||f||||f||||||||||2017-10-10 23:56:28.027727|2017-10-10 23:56:28.027727
NCT02261818|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-08-24|2017-03-07||April 2014||2014-04-01|August 2017|2017-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||30 participants|Using Peer Mentors to Deliver Depression Care|Phase 1 Study of Using Peers to Deliver Depression Care to Older Adults|Completed||N/A|30|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-10 23:56:28.122759|2017-10-10 23:56:28.122759
NCT02261805|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-07-10|||October 2014|Actual|2014-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Phase I/II Study of Ganetespib in Combination With Doxorubicin|A Phase I/II Study of Ganetespib in Combination With Doxorubicin in Solid Tumors (Phase I) and Refractory Small Cell Lung Cancer (Safety Dose Expansion, Phase II)|Terminated||Phase 1/Phase 2|10|Actual|Georgetown University||1||Company terminated drug support|f||||t||||||||||2017-10-10 23:56:28.278553|2017-10-10 23:56:28.278553
NCT02261792|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-01-03|||December 2014||2014-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SIHT||"Spontaneous Intracranial Hypotension Treatment SIHT"|Parallel Randomised Open Blind Evaluation Study of the Efficacy of 20° Trendelenburg Position During 24 Hours After Epidural Blood Patch in the Treatment of Spontaneous Intracranial Hypotension|Recruiting||N/A|66|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:56:28.351797|2017-10-10 23:56:28.351797
NCT02261779|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-07-06|||September 2014||2014-09-01|July 2015|2015-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TCP-AML||Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible|Phase I/II Pilot Trial of ATRA (Tretinoin) and TCP (Tranylcypromine) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) and no Intensive Treatment is Possible|Unknown status|Recruiting|Phase 1/Phase 2|16|Anticipated|Martin-Luther-Universität Halle-Wittenberg||1|||f||||t||||||||||2017-10-10 23:56:28.45665|2017-10-10 23:56:28.45665
NCT02261766|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-06-23|||August 2012||2012-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|EHOT||Evaluation of 5 Days Holter and 30 Days Thumb-ECG for Detection of Atrial Fibrillation in Stroke Patients|Detection of Atrial Fibrillation, -Evaluation of 5 Days Holter and 30 Days Thumb-ECG for Detection of Atrial Fibrillation in Stroke Patients|Completed||N/A|100|Actual|Herlev Hospital||1|||f||||t||||||||||2017-10-10 23:56:28.547537|2017-10-10 23:56:28.547537
NCT02261753|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-09-21|||October 2014||2014-10-01|October 2014|2014-10-01|July 26, 2017|Actual|2017-07-26|July 26, 2017|Actual|2017-07-26||Interventional|EDIBLE||Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy|A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II|Terminated||N/A|3|Actual|University College, London||2||"The study oversight committees unanimously decided to stop the study early on 26/07/2017 due to   poor recruitment."|f||||t|f|f||||||||2017-10-10 23:56:28.621767|2017-10-10 23:56:28.621767
NCT02261740|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-09-30|||October 2014||2014-10-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|POPPY||Program to Overcome Pelvic Pain With Yoga|Program to Overcome Pelvic Pain With Yoga (POPPY) (a.k.a., Development of a Therapeutic Yoga Program for Female Genito-Pelvic Pain)|Completed||N/A|16|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:56:28.750907|2017-10-10 23:56:28.750907
NCT02261727|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-02-07|||May 2014||2014-05-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TASCS||Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) Study|Low Dose Corticosteroids and Theophylline in the Treatment of Chronic Obstructive Pulmonary Disease - the TASCS Study|Recruiting||Phase 4|2400|Anticipated|The George Institute||3|||f||||t||||||||No||2017-10-10 23:56:28.81816|2017-10-10 23:56:28.81816
NCT02261701|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-05-26|||September 2014||2014-09-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Rehabilitation After Rotator Cuff Repair|Rehabilitation After Rotator Cuff Repair a Randomised Controlled Study|Recruiting||N/A|80|Anticipated|Uppsala University||2|||f||||f||||||||No||2017-10-10 23:56:29.006568|2017-10-10 23:56:29.006568
NCT02261688|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-05-17|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Salt and TH-17 in Healthy Human Subjects|Evaluation of the Influence of Salt Intake on TH17 Interleukin(IL)-17 Producing CD4+ Helper T Cells in Human Subjects|Active, not recruiting||N/A|20|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-10 23:56:29.10379|2017-10-10 23:56:29.10379
NCT02261675|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-07|||January 2013||2013-01-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Reduction in MACbar of Sevoflurane by Dexmedetomidine in Children|Dexmedetomidine Augments Block of Sympathetic Responses to Skin Incision During Sevoflurane Anesthesia in Children|Completed||N/A|63|Actual|First Affiliated Hospital, Sun Yat-Sen University||3|||f||||t||||||||||2017-10-10 23:56:29.176301|2017-10-10 23:56:29.176301
NCT02261662|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-06|||June 2014||2014-06-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection|Randomized Controlled Study of Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection|Unknown status|Recruiting|N/A|30|Anticipated|Tanta University||2|||f||||t||||||||||2017-10-10 23:56:29.255405|2017-10-10 23:56:29.255405
NCT02261649|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-08-29|||October 2014||2014-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Observational|||Impact of Cerebellar Mass Resection on Pain Processing|The Impact of Cerebellar Mass Resection on Pain Processing|Active, not recruiting||N/A|24|Actual|Dana-Farber Cancer Institute|||2||f||||t||||||||||2017-10-10 23:56:31.011849|2017-10-10 23:56:31.011849
NCT02261623|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-06-29|||March 19, 2015|Actual|2015-03-19|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31|2 Years|Observational [Patient Registry]|||Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry|Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry|Active, not recruiting||N/A|415|Actual|Boston Scientific Corporation|||4||f||||f||||||||||2017-10-10 23:56:31.698426|2017-10-10 23:56:31.698426
NCT02261610|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-09-18|||November 2014||2014-11-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Pulmonary Embolism and PCT. PE-PCT Study|Interest of PCT in the Management of Antibiotic for the Patient With a Febrile Pulmonary Embolism.|Unknown status|Recruiting|N/A|62|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:56:31.823587|2017-10-10 23:56:31.823587
NCT02261597|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-09-22|||January 2015||2015-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Challenging the Inflammatory Response System in Insomnia Disorder|Challenging the Inflammatory Response System: Are Individuals With Insomnia More Reactive?|Active, not recruiting||N/A|40|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-10-10 23:56:31.934452|2017-10-10 23:56:31.934452
NCT02261584|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-09|||August 2014||2014-08-01|October 2014|2014-10-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism|Comparative Study of Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism|Unknown status|Recruiting|N/A|40|Anticipated|Tanta University||2|||f||||t||||||||||2017-10-10 23:56:32.031352|2017-10-10 23:56:32.031352
NCT02261571|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-09|||October 2014||2014-10-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer|A Pilot Study to Estimate the Efficacy of Moxibustion Stimulation at Abdominal Acupoints on Quality of Life in Cancer Patients Under Chemotherapy|Unknown status|Not yet recruiting|N/A|20|Anticipated|The Comprehensive and Integrative Medicine Institute of South Korea||2|||f||||f||||||||||2017-10-10 23:56:32.16293|2017-10-10 23:56:32.16293
NCT02261558|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-09-12|||June 2011||2011-06-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of Clinical Music Improvisation on Resiliency in Adults Undergoing Infusion Therapy|Effects of Clinical Music Improvisation on Resiliency in Adults Undergoing Infusion Therapy|Recruiting||N/A|100|Anticipated|Beth Israel Medical Center||3|||f||||f||||||||||2017-10-10 23:56:32.274035|2017-10-10 23:56:32.274035
NCT02261545|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2015-11-17|||September 2014||2014-09-01|November 2015|2015-11-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient|The Effect of n-3 Fatty Acid Supplementation on the Expression of Sirt-1, Adiponectin Receptor 1 (AdipoR1) & Adiponectin Receptor 2 (AdipoR2) Genes of PBMC and Circulatory Levels of Resistin,Monocyte Chemotactic Protein (MCP-1) and Adiponectin of type2 Diabetes Patient|Enrolling by invitation||Phase 4|88|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:56:32.392183|2017-10-10 23:56:32.392183
NCT02261532|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-08-02|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|October 2015|Actual|2015-10-01||Interventional|||A Phase I Study of TAS-102 in Solid Tumors|A Phase 1, OPEN-Label, Non-randomized, Pharmacokinetic Study of TAS-102 in Chinese Patients With Solid Tumors|Completed||Phase 1|12|Anticipated|Taiho Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:56:32.608981|2017-10-10 23:56:32.608981
NCT02261519|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-04-06|||March 29, 2017|Actual|2017-03-29|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults|An Adaptive, Phase IIb/III, Multi-center, Prospective, Randomized, Double-Blind Placebo-controlled Study of the Safety and Efficacy of NaBen® (DAAO Inhibitor), as an Add-on Treatment for Schizophrenia in Adults|Recruiting||Phase 2/Phase 3|348|Anticipated|SyneuRx International (Taiwan) Corp||2|||f||||t|t|f||||||||2017-10-10 23:56:32.745858|2017-10-10 23:56:32.745858
NCT02261506|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-04-04|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|BALANCE||Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT|Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT|Recruiting||N/A|115|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 23:56:32.919287|2017-10-10 23:56:32.919287
NCT02261493|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-06-26|2017-06-26|2016-06-03|October 27, 2014|Actual|2014-10-27|June 2017|2017-06-01|April 20, 2016|Actual|2016-04-20|June 3, 2015|Actual|2015-06-03||Interventional|||A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides|Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)|Completed||Phase 3|787|Actual|Allergan||3|||f||||f|t|f||||||No||2017-10-10 23:56:33.202307|2017-10-10 23:56:33.202307
NCT02261480|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-09-16|||October 2014||2014-10-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Observational|||A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease|Investigation in Sickle Cell Disease of a New Reagent Assay Examining Natural Parvovirus B19 Infection|Completed||N/A|24|Actual|St. Jude Children's Research Hospital|||3||f||||f||||||Samples Without DNA|"     Blood and/or nasopharyngeal wash samples will be taken and retained. If participants agree,     leftover samples will be saved for potential health research in the future.   "|||2017-10-10 23:56:33.983369|2017-10-10 23:56:33.983369
NCT02261285|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-05-10|||October 2014||2014-10-01|September 2014|2014-09-01||||February 2015|Actual|2015-02-01||Interventional|||ONO-4538 Phase I Study in Patients With Solid Tumor|ONO-4538 Multicenter, Open-label, Uncontrolled, Phase I Study in Solid Tumor|Completed||Phase 1|18|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||f||||||||||2017-10-10 23:56:36.391861|2017-10-10 23:56:36.391861
NCT02261467|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-05-30|2017-05-30|2016-06-03|October 21, 2014|Actual|2014-10-21|May 2017|2017-05-01|April 26, 2016|Actual|2016-04-26|June 4, 2015|Actual|2015-06-04||Interventional|||A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides|Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Forehead and Glabellar Facial Rhytides|Completed||Phase 3|421|Actual|Allergan||2|||f||||f|t|f||||||No||2017-10-10 23:56:34.106453|2017-10-10 23:56:34.106453
NCT02261454|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-10-07|||November 2014||2014-11-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|GUM_RCT||RCT Gum Chewing on Bowel Function After Abdominal Surgery in Children|The Effect of Gum Chewing on Return of Bowel Function After Abdominal Surgery in Children Over the Age of 4 Years|Unknown status|Not yet recruiting|N/A|150|Anticipated|Alberta Children's Hospital||2|||f||||t||||||||||2017-10-10 23:56:34.526772|2017-10-10 23:56:34.526772
NCT02261441|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2017-04-30|||February 2014||2014-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|IBERICAN||Cardiovascular and Renal Risk in Spain|Identificación de la poBlación Española de RIesgo CArdiovascular y reNal|Recruiting||N/A|15000|Anticipated|La Sociedad Española de Médicos de Atención Primaria|||1||f|||||f|f||||||No||2017-10-10 23:56:34.639038|2017-10-10 23:56:34.639038
NCT02261428|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-03-15|2014-10-13||May 2014||2014-05-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||The participants were non intubated ICU patients who had inadequate cough leading to the inability to mobilize their secretions. The inadequate cough is result of neuromuscular disorders, ICU neuromyopathy, abdominal pain due to surgery and low consiousness due to head injuries.|Nasotracheal Suction With Tiemann Catheter Compared to the Classic Technique With the Suction Catheter|Randomized Controlled Study of Nasotracheal Suction With Tiemann Catheter Compared to the Classic Technique With the Standard One.|Completed||N/A|20|Actual|Attikon Hospital||2|||f||||t||||||||||2017-10-10 23:56:34.880957|2017-10-10 23:56:34.880957
NCT02261415|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2017-08-01|||November 2014||2014-11-01|August 2017|2017-08-01|January 2027|Anticipated|2027-01-01|January 2022|Anticipated|2022-01-01||Interventional|HeLiX||The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial|The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial: Tranexamic Acid (TXA) Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection: A Randomized Controlled Trial|Recruiting||Phase 2|300|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-10 23:56:35.367178|2017-10-10 23:56:35.367178
NCT02261402|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2016-12-13|||October 2014||2014-10-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||"Effectiveness of Medisinstart"|"Effectiveness of Medisinstart - an Open Randomized Controlled Trial of a Newly Developed Pharmacy Service"|Active, not recruiting||N/A|1480|Actual|Apokus AS||2|||f||||f||||||||No||2017-10-10 23:56:35.506533|2017-10-10 23:56:35.506533
NCT02261389|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-06-28|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET|Three-monthly Dynamic Evaluation of CEA and CA 15.3 vs Usual Practice in the Follow-up of Early Breast Cancer Patients: a Randomized Study|Recruiting||N/A|800|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||||2017-10-10 23:56:35.733211|2017-10-10 23:56:35.733211
NCT02261376|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-01-21|||September 2014||2014-09-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a||Completed||Phase 1|48|Actual|Daiichi Sankyo, Inc.||4|||f||||f||||||||||2017-10-10 23:56:35.847325|2017-10-10 23:56:35.847325
NCT02261363|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-08-18|||August 2014||2014-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|Moment||The Moment Study: Mixed Method Ecigarette Study|A Mixed Method EMA Assessment of Cognition and Behavior Among New ENDS Users: An Observational Cohort Study|Completed||N/A|117|Actual|Truth Initiative|||2||f||||t||||||||||2017-10-10 23:56:35.917561|2017-10-10 23:56:35.917561
NCT02261350|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2015-10-30|||January 2014||2014-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Post-hospitalisation Nutritional Support and Gait Speed in COPD|The Effect of Nutritional Support on Gait Speed Following Hospitalisation for Acute Exacerbation of COPD|Terminated||Phase 3|22|Actual|Royal Brompton & Harefield NHS Foundation Trust||3|||f||||f||||||||||2017-10-10 23:56:35.97917|2017-10-10 23:56:35.97917
NCT02261337|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-05-11|||December 2013|Actual|2013-12-01|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|April 2018|Anticipated|2018-04-01||Observational|||Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?|Do Gait Speed and Markers of Sarcopenia Predict Prognosis in Patients With Chronic Respiratory Disease?|Active, not recruiting||N/A|565|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||||||||||||2017-10-10 23:56:36.080722|2017-10-10 23:56:36.080722
NCT02261324|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-07-11|||December 2013||2013-12-01|July 2016|2016-07-01|January 2021|Anticipated|2021-01-01|January 2017|Anticipated|2017-01-01||Observational|||Is the 4MGS a Useful Outcome Measure Post-PPCI|Is the Four Metre Gait Speed a Useful Outcome Measure in Patients With Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention?|Active, not recruiting||N/A|560|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||||||||||||2017-10-10 23:56:36.145839|2017-10-10 23:56:36.145839
NCT02261311|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-09-15|||March 2017||2017-03-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|RADSII||An Innovation During the Surgical Wait; Evaluation of the Opportunity for Intervention|An Innovation During the Surgical Wait; Evaluation of the Opportunity for Intervention|Not yet recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||Samples Without DNA|"     Additional tissue samples will be collected at the time of initial biopsy. The samples will     be stored for neoadjuvant studies that the patient may choose to participate in during the     wait time between diaganosis and surgery.   "|||2017-10-10 23:56:36.22469|2017-10-10 23:56:36.22469
NCT02261298|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-01-16|||October 2014||2014-10-01|September 2014|2014-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||ONO-4538 Phase I Study in Patients With Solid Tumor|ONO-4538 Multicenter, Open-label, Uncontrolled, Phase I Multiple Dose Study in Solid Tumor|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|Ono Pharmaceutical Co. Ltd||3|||f||||f||||||||||2017-10-10 23:56:36.30281|2017-10-10 23:56:36.30281
NCT02261259|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-09-12|||June 2014||2014-06-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Effects of Osteopathic Manipulative Treatment on Neuromuscular Control of the Head-neck System|Effects of Osteopathic Manipulative Treatment on Neuromuscular Control of the Head-neck System|Recruiting||N/A|108|Anticipated|Michigan State University||3|||f||||t||||||||||2017-10-10 23:56:36.551246|2017-10-10 23:56:36.551246
NCT02261246|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-08-28|||June 2014||2014-06-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|TMCSMT||Trunk Motor Control Performance Before and After Spinal Manipulation Treatment|Trunk Motor Control Performance Before and After Spinal Manipulation Treatment|Recruiting||N/A|108|Anticipated|Michigan State University||3|||f||||t||||||||||2017-10-10 23:56:36.651243|2017-10-10 23:56:36.651243
NCT02261233|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-09-12|||April 2014||2014-04-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Osteopathic Manipulative Treatment and Postural Control: Systems Engineering Approach|Osteopathic Manipulative Treatment and Postural Control: Systems Engineering Approach|Recruiting||N/A|72|Anticipated|Michigan State University||2|||f||||t||||||||||2017-10-10 23:56:36.780686|2017-10-10 23:56:36.780686
NCT02261220|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-18|||October 13, 2014|Actual|2014-10-13|September 2017|2017-09-01|January 19, 2018|Anticipated|2018-01-19|January 19, 2018|Anticipated|2018-01-19||Interventional|||A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors|A Phase I Study of MEDI4736 (Anti-PD-L1 Antibody) in Combination With Tremelimumab (Anti-CTLA-4 Antibody) in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|380|Actual|MedImmune LLC||1|||f||||f|t|f||||||||2017-10-10 23:56:36.89851|2017-10-10 23:56:36.89851
NCT02261207|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-10-06|||November 2014||2014-11-01|October 2014|2014-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor|Phase II Study on Axitinib in Advanced VEGFR and/or PDGFR Solitary Fibrous Tumor|Not yet recruiting||Phase 2|16|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-10 23:56:37.238425|2017-10-10 23:56:37.238425
NCT02261194|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-11-14|||October 2014||2014-10-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy|Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy|Completed||N/A|80|Actual|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-10 23:56:37.331688|2017-10-10 23:56:37.331688
NCT02261181|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-01-21|||January 2015||2015-01-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer Patients|Preemptive Treatment With XONRID a Medical Device to Reduce Radiation Induced Dermatitis in Head and Neck Cancer Patients Receiving Curative Treatment|Unknown status|Recruiting|Phase 2|50|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-10 23:56:37.413837|2017-10-10 23:56:37.413837
NCT02261168|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-09-04|||November 2014||2014-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Day-Night Rhythm in Human Skeletal Muscle|Day-night Rhythm in Human Skeletal Muscle Metabolism|Completed||N/A|12|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-10 23:56:37.508779|2017-10-10 23:56:37.508779
NCT02261155|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-10-06|||September 2006||2006-09-01|October 2014|2014-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Changes in Sensory Perception During Hypnotic Relaxation|Veränderungen Der Sensibilität Durch Medizinische Hypnose|Completed||N/A|23|Actual|Ludwig-Maximilians - University of Munich||1|||f||||f||||||||||2017-10-10 23:56:37.594541|2017-10-10 23:56:37.594541
NCT02261142|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-07-10|||September 2013||2013-09-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy and Cost-effectiveness of Spasticity Treatment With Multifocal TENS|Evaluation of Efficacy and Cost-effectiveness of Spasticity Treatment With Multifocal Transcutaneous Electrical Stimulation, Through a Garment With built-in Electrodes in Combination With Training.|Completed||N/A|31|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-10 23:56:37.685907|2017-10-10 23:56:37.685907
NCT02261129|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||September 2008||2008-09-01|October 2014|2014-10-01||||December 2008|Actual|2008-12-01||Interventional|||Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male Volunteers|Bioequivalence of the 80 mg Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional 40 mg Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Two-sequence, Four-period Replicated Crossover Study)|Completed||Phase 1|64|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:37.780367|2017-10-10 23:56:37.780367
NCT02261116|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||April 2002||2002-04-01|October 2014|2014-10-01||||August 2002|Actual|2002-08-01||Interventional|||Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers|Does Telmisartan Compared to Candesartan Due to a Distinctly Larger Volume of Distribution Exert Stronger Effects in Relevant Peripheral Tissues, e.g. Renal and Adrenal Tissues|Completed||Phase 4|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:37.855804|2017-10-10 23:56:37.855804
NCT02261103|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||April 2006||2006-04-01|October 2014|2014-10-01||||July 2006|Actual|2006-07-01||Interventional|||Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers|A Multiple Dose Study With Increasing Pramipexole Doses (0.375 mg to 4.5 mg q.d.) of Oral Extended Release (ER) Tablets With a Three-way Cross Comparison of 4.5 mg Pramipexole ER q.d. Fasted Versus 4.5 mg Pramipexole ER q.d. Fed Versus 1.5 mg Pramipexole Immediate Release Tablets t.i.d. Fasted in Healthy Male Volunteers|Completed||Phase 1|39|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:37.939111|2017-10-10 23:56:37.939111
NCT02261090|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||June 2004||2004-06-01|October 2014|2014-10-01||||September 2004|Actual|2004-09-01||Interventional|||Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers|A Multiple Dose Seven-way Cross-over Formulation-finding Study Comparing the Oral Bioavailability of Seven Prototype Slow-release Formulations With 0.75 mg Pramipexole (Four Days Each) to Immediate-release Tablets at Steady State in Healthy Male Volunteers|Completed||Phase 1|14|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-10 23:56:38.053964|2017-10-10 23:56:38.053964
NCT02261077|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||May 2007||2007-05-01|October 2014|2014-10-01||||July 2007|Actual|2007-07-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Rising Doses of Buscopan® in Healthy Male Volunteers|A Randomised, Double-blind, Placebo-controlled Study to Assess Pharmacokinetics, Safety and Tolerability of Single Rising Oral Doses (20 mg, 60 mg, 100 mg, 200 mg and 400 mg) and Multiple Rising Oral Doses (3 x 20 mg, 3 x 60 mg and 3 x 100 mg Per Day) of Buscopan® in Healthy Male Volunteers|Completed||Phase 1|60|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:38.155301|2017-10-10 23:56:38.155301
NCT02261064|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-09|2014-10-09|||December 2008||2008-12-01|October 2014|2014-10-01||||February 2009|Actual|2009-02-01||Interventional|||Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers|Influence of Food on the Bioavailability of Telmisartan 40 mg/Amlodipine 5 mg Fixed-dose Combination and of Telmisartan 80 mg/Amlodipine 5 mg Fixed-dose Combination in Healthy Japanese Male Volunteers (a Phase I, Open-label, Randomised, Single-dose, Two-way Crossover Trial)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:56:38.243168|2017-10-10 23:56:38.243168
NCT02261051|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-04-21|||October 2014||2014-10-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|LCCM-Control||Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm|Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm|Withdrawn||N/A|0|Actual|Lancaster General Hospital|||1|Difficulty in recruitment and change in study site protocols.|f||||f||||||||||2017-10-10 23:56:38.338516|2017-10-10 23:56:38.338516
NCT02261038|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-03-05|||November 2014||2014-11-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison of the Femoral Prothesis-rotation in Conventional X-ray, in Axial CT Slices and 3D-reconstructed CT|Comparative Study pf the Femoral Prothesis-rotation in Conventional X-Ray, in Axial CT Slices and 3D-reconstructed CT|Recruiting||N/A|50|Anticipated|Kantonsspital Baselland Bruderholz||1|||f||||t||||||||||2017-10-10 23:56:38.47282|2017-10-10 23:56:38.47282
NCT02261025|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-22|||January 2008||2008-01-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis|The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis|Completed||N/A|410|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-10 23:56:38.565743|2017-10-10 23:56:38.565743
NCT02261012|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-02-07|||April 2014||2014-04-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Observational|||Examination of the Pathophysiologic Mechanisms of CRPS by Using QST, CPM, RIC, and Heart Rate Variability QST|Examination of the Pathological Mechanism of the Complex Regional Pain Syndrome of the Upper Limb in Comparison to Patients With Painful Carpal Tunnel Syndrome and Healthy Subjects - an Explorative Clinical Study|Completed||N/A|62|Actual|Ruhr University of Bochum|||3||f||||f||||||||||2017-10-10 23:56:38.643973|2017-10-10 23:56:38.643973
NCT02260999|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||May 2012||2012-05-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Observational|||Experimental Study of Detection an Intentional Performance Degradation in Grip Strength||Completed||N/A|136|Actual|Ruhr University of Bochum|||3||f||||f||||||||||2017-10-10 23:56:38.717396|2017-10-10 23:56:38.717396
NCT02260973|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-08-02|||November 2014||2014-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity|The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity Outcomes In Cases Undergoing Cataract Surgery: A Pilot Study.|Recruiting||Phase 2/Phase 3|150|Anticipated|Physician Recommended Nutriceuticals||2|||f||||||||||||||2017-10-10 23:56:39.147713|2017-10-10 23:56:39.147713
NCT02260960|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-08-02|||March 2014||2014-03-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease|The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease.|Completed||Phase 2/Phase 3|122|Actual|Physician Recommended Nutriceuticals||2|||f||||||||||||||2017-10-10 23:56:39.223607|2017-10-10 23:56:39.223607
NCT02260947|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-02-02|||October 2014||2014-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints|A Double Blind, Double Dummy, Randomized, Placebocontrolled, 5 Period Cross-over Study To Examine The Effect of Pf-06273340 On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin And Ibuprofen As Positive Controls|Completed||Phase 1|20|Actual|Pfizer||5|||f||||f||||||||||2017-10-10 23:56:39.294|2017-10-10 23:56:39.294
NCT02260934|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-06-06|||October 2014||2014-10-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|CALIBRATE||Rituximab and Belimumab for Lupus Nephritis|Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis (ITN055AI)|Active, not recruiting||Phase 2|43|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Participant level data access will be made available to the public at some point in the future via the mechanisms of : 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal.|2017-10-10 23:56:39.511506|2017-10-10 23:56:39.511506
NCT02260921|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-04-14|||October 2014||2014-10-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain|A Muti-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis|Active, not recruiting||N/A|180|Actual|MyoScience, Inc||2|||f||||f||||||||||2017-10-10 23:56:39.692061|2017-10-10 23:56:39.692061
NCT02260908|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-04-08|||October 2014||2014-10-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|OPTTICH||OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot Study|OPTTICH Pilot Study - OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage|Unknown status|Recruiting|N/A|300|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-10 23:56:39.808179|2017-10-10 23:56:39.808179
NCT02260895|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-03-15|||December 2014||2014-12-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|AEGIS||Almond Effects on Glucose Intolerance Study|Almond Effects on Glucose Intolerance Study (AEGIS)|Enrolling by invitation||N/A|20|Anticipated|Memorial Hermann Health System||2|||f||||f||||||||||2017-10-10 23:56:39.90319|2017-10-10 23:56:39.90319
NCT02260882|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-03-13|2016-01-19||October 2014||2014-10-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||One participant in the Primary Vaccination Group was withdrawn from the study before vaccination because of a protocol violation. Baseline Characteristics are based on the Full Analysis Set: participants who received at least one vaccination.|Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)|A Study Evaluating the Safety and Immunogenicity of Revaccination With 23-Valent Pneumococcal Polysaccharide Vaccine in Older Japanese Adults|Completed||Phase 4|243|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:56:39.989879|2017-10-10 23:56:39.989879
NCT02260869|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-08-28|||January 2015||2015-01-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy of Cooled and Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain|A Prospective Double Blind, Randomized Control Trial to Compare the Efficacy of Cool Radiofrequency Ablation vs. Conventional Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain|Recruiting||N/A|102|Anticipated|Millennium Pain Center||2|||f||||f||||||||||2017-10-10 23:56:40.50791|2017-10-10 23:56:40.50791
NCT02260856|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-07-12|||June 2015||2015-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Randomized Controlled Trial of Leg Length Discrepancy Techniques|PEDS Trial: Percutaneous Epiphysiodesis, Drill Versus Screws for Leg Length Discrepancy A Randomized Clinical Trial|Recruiting||Early Phase 1|170|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-10 23:56:40.637664|2017-10-10 23:56:40.637664
NCT02260843|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-04-05|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy of Tai Chi Training on Insomnia in Older Adults|Efficacy of Tai Chi Training to Alleviate Insomnia in Older Adults: A Randomized Controlled Trial|Completed||N/A|320|Actual|The Hong Kong Polytechnic University||3|||f||||f||||||||||2017-10-10 23:56:40.804802|2017-10-10 23:56:40.804802
NCT02260830|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-03-04|||August 2014||2014-08-01|March 2015|2015-03-01||||March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167|Interventional, Open-label, Part Fixed Sequence, Part-randomised Study Investigating the Pharmacokinetic Properties of up to 6 Prototype Modified Release Tablet Formulations of Lu AF11167 in Healthy Young Subjects|Completed||Phase 1|28|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-10 23:56:40.910596|2017-10-10 23:56:40.910596
NCT02260817|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-03-06|||October 2014||2014-10-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|June 2016|Actual|2016-06-01||Interventional|||Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer|Expanded Access to 11C Choline PET/CT and 11C Choline PET/MR for Staging of Recurrent Prostate Cancer With Comparison Study of CT and MR Modalities|Active, not recruiting||Phase 3|100|Anticipated|Global Isotopes, LLC d/b/a Zevacor Molecular||1|||f||||t||||||||Undecided||2017-10-10 23:56:40.987843|2017-10-10 23:56:40.987843
NCT02260804|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2017-06-05|||July 2015||2015-07-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|August 2018|Anticipated|2018-08-01||Interventional|||To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma|A Phase 3, Randomised, Parallel-group, Active-controlled, Double-blind Study to Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma|Recruiting||Phase 3|174|Anticipated|Celltrion||2|||f||||t||||||||No||2017-10-10 23:56:41.064639|2017-10-10 23:56:41.064639
NCT02260791|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-08-23|2017-07-05||December 2014||2014-12-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|ARABESC|The Safety Analysis Set was defined as the set of patients who received at least 1 dose of randomised treatment.|A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients|A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate|Completed||Phase 3|728|Actual|Fujifilm Kyowa Kirin Biologics Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:56:41.201943|2017-10-10 23:56:41.201943
NCT02260778|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-07-11|||September 2014||2014-09-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|TRACTION||Treat-to-target in RA: Collaboration To Improve adOption and adhereNce|Treat-to-target in RA: Collaboration To Improve adOption and adhereNce (TRACTION)|Active, not recruiting||N/A|11|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:56:42.495956|2017-10-10 23:56:42.495956
NCT02260765|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-08|||October 2014||2014-10-01|October 2014|2014-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual|Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual|Unknown status|Recruiting|N/A|80|Anticipated|Brainsway||2|||f||||f||||||||||2017-10-10 23:56:42.575999|2017-10-10 23:56:42.575999
NCT02260752|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-02-17|||November 2015||2015-11-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01|3 Years|Observational [Patient Registry]|COMPARE-UF||Patient Centered Results for Uterine Fibroids|Comparing Options for Management: Patient Centered Results for Uterine Fibroids|Enrolling by invitation||N/A|10000|Anticipated|Duke University|||2||f||||f||||||Samples Without DNA|"     blood assay   "|Yes||2017-10-10 23:56:42.663995|2017-10-10 23:56:42.663995
NCT02260739|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-08-07|||January 2014||2014-01-01|August 2017|2017-08-01|January 2026|Anticipated|2026-01-01|January 2019|Anticipated|2019-01-01||Interventional|S-HEMO||Sequential Analysis in Patients With an Hemopathy|Sequential Analysis in Patients With an Hemopathy|Recruiting||N/A|246|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||3|||f||||f||||||||||2017-10-10 23:56:42.765314|2017-10-10 23:56:42.765314
NCT02260726|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-05-21|||October 2014||2014-10-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Evaluation of Ultrasound for Detecting Hip Impingement|Diagnosing Deformities of the Hip Associated With Arthritis: MRI vs Ultrasound|Unknown status|Active, not recruiting|N/A|30|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-10 23:56:42.839028|2017-10-10 23:56:42.839028
NCT02260713|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-02-23|||February 2011||2011-02-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study.|Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study|Active, not recruiting||Phase 1/Phase 2|21|Actual|Indian Spinal Injuries Centre||3|||f||||t||||||||Undecided||2017-10-10 23:56:42.907569|2017-10-10 23:56:42.907569
NCT02260700|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||September 2013||2013-09-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male Participants|A Randomized, Open-Label, 3-Way Crossover Study in Healthy Older Male Subjects to Evaluate the Bioavailability, Food Effect, Safety and Tolerability of A Solid Dosage Formulation of JNJ-54861911|Completed||Phase 1|12|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-10 23:56:43.121698|2017-10-10 23:56:43.121698
NCT02260687|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-09-29|||December 5, 2014|Actual|2014-12-05|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization|Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization|Recruiting||N/A|300|Anticipated|Bayer|||1||f||||f||||||||||2017-10-10 23:56:43.247974|2017-10-10 23:56:43.247974
NCT02260674|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-03-01||2017-03-01|November 2014||2014-11-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease|A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Safety and Tolerability of JNJ-54861911 in Subjects With Early Alzheimer's Disease|Completed||Phase 2|114|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-10 23:56:43.357707|2017-10-10 23:56:43.357707
NCT02260661|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-10-07|||November 2014||2014-11-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours|A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours|Completed||Phase 1|20|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-10 23:56:43.525266|2017-10-10 23:56:43.525266
NCT02260648|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-08-24||2016-08-13|January 2015||2015-01-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia|A Double-Blind Efficacy and Safety Study of Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia|Terminated||Phase 3|68|Actual|Eli Lilly and Company||3||Study termination due to insufficient efficacy.|f||||f||||||||||2017-10-10 23:56:43.675357|2017-10-10 23:56:43.675357
NCT02260635|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-08-24||2015-09-03|November 2014||2014-11-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia|A Double-Blind Efficacy and Safety Study of Evacetrapib Followed by an Open-Label Extension in Japanese Patients With Primary Hypercholesterolemia|Terminated||Phase 3|54|Actual|Eli Lilly and Company||2||Study termination due to insufficient efficacy.|f||||f||||||||||2017-10-10 23:56:43.854639|2017-10-10 23:56:43.854639
NCT02260622|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-11-17|||October 2014||2014-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|RIFLE||Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia|A Phase 2, Open Label, Pilot Study to Examine the Use of Rivaroxaban Plus Aspirin vs. Clopidogrel Plus Aspirin for the Prevention of Restenosis After Infrainguinal Percutaneous Transluminal Angioplasty for Critical Limb Ischemia|Active, not recruiting||Phase 2|20|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-10 23:56:44.000395|2017-10-10 23:56:44.000395
NCT02260609|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-02-01|||October 2014||2014-10-01|February 2016|2016-02-01||||October 2015|Actual|2015-10-01||Interventional|||GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds|A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety and Efficacy of GrafixCORE® for the Treatment of Complex Diabetic Foot Wounds With Exposed Tendon and/or Bone|Completed||Phase 4|31|Actual|Osiris Therapeutics||1|||f||||f||||||||||2017-10-10 23:56:44.209448|2017-10-10 23:56:44.209448
NCT02260596|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-12-14|||September 2014||2014-09-01|July 2015|2015-07-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|||Respiratory Viral Infections in Pediatric Transplantation|A Multicenter Consortium to Define the Epidemiology and Outcomes of Respiratory Viral Infections in Pediatric Transplant Recipients|Completed||N/A|2669|Actual|Duke University|||1||f||||t||||||||||2017-10-10 23:56:44.308459|2017-10-10 23:56:44.308459
NCT02260583|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-10-08|||October 2014||2014-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Extracorporeal CO2 Removal in Stable Hypercapnic COPD Patients|EFFECT OF EXTRACORPOREAL CO2 REMOVAL IN STABLE COPD PATIENTS WITH CHRONIC HYPERCAPNIC RESPIRATORY FAILURE:A PILOT STUDY|Recruiting||N/A|15|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||f||||||||||2017-10-10 23:56:44.401161|2017-10-10 23:56:44.401161
NCT02260570|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-08-30|||August 1, 2015|Actual|2015-08-01|August 2017|2017-08-01|June 29, 2018|Anticipated|2018-06-29|June 29, 2018|Anticipated|2018-06-29||Interventional|||Remediation of Impaired Self-Regulation in Patients With Mild TBI|Remediation of Impaired Self-Regulation in Patients With Mild TBI|Recruiting||N/A|80|Anticipated|VA Office of Research and Development||1|||f||||t|f|f|||f|||||2017-10-10 23:56:44.521|2017-10-10 23:56:44.521
NCT02260557|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-05-09|||October 2014||2014-10-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis|A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel Group, Exploratory Phase 2 Study to Assess Efficacy and Safety of Selexipag in Adult Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis|Completed||Phase 2|74|Actual|Actelion||2|||f||||f||||||||||2017-10-10 23:56:44.642538|2017-10-10 23:56:44.642538
NCT02260544|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-09-22|||July 2014||2014-07-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|||Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection|A Multicenter, Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Cross-over Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection 20mg/10mL of Dr. Reddy's Laboratories Ltd, India, With That of Doxorubicin Hydrochloride Liposome Injection 20 mg/10mL , Manufactured by: Sun Pharmaceutical Ind. Ltd, India; in Ovarian Cancer Patients Whose Disease Has Progressed or Recurred After Platinum Based Chemotherapy and Who Are Already Receiving or Scheduled to Start Therapy With the Reference Listed Drug Under Fasting Condition.|Completed||Phase 1|49|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-10 23:56:44.768268|2017-10-10 23:56:44.768268
NCT02260531|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-01-23|||October 2014||2014-10-01|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|June 2018|Anticipated|2018-06-01||Interventional|||Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases|A Phase II Study of Cabozantinib Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases|Recruiting||Phase 2|40|Anticipated|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-10 23:56:44.872161|2017-10-10 23:56:44.872161
NCT02260518|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2016-12-16|||January 2015||2015-01-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|October 2017|Anticipated|2017-10-01||Interventional|HIPP||Promoting Health in Pregnancy and Postpartum|Promoting Health in Pregnancy and Postpartum Among Overweight/Obese Women|Recruiting||N/A|400|Anticipated|University of South Carolina||2|||f||||f||||||||||2017-10-10 23:56:44.992251|2017-10-10 23:56:44.992251
NCT02260505|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-08-04|||December 24, 2014|Actual|2014-12-24|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|ImadGist||Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)|A Randomized Multicenter Phase III Trial Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)|Recruiting||Phase 3|256|Anticipated|Centre Leon Berard||2|||f||||t||||||||||2017-10-10 23:56:45.181642|2017-10-10 23:56:45.181642
NCT02260492|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-03-28|2017-02-10||September 2014||2014-09-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional||Intent-to-Treat (ITT)|Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma|Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma|Completed||Phase 1|879|Actual|Oriel Therapeutics|One patient was randomized to OT329 SOLIS treatment but was given a Placebo kit in error. They are included in the SOLIS group for the efficacy analysis and in the Placebo group for the safety analysis as dictated by the Statistical Analysis Plan.|3|||f||||f||||||||Yes|Results delayed pending FDA review/approval of drug.|2017-10-10 23:56:45.44464|2017-10-10 23:56:45.44464
NCT02260479|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-01-27|||January 2013||2013-01-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Preheated Skin Disinfection vs Room-temperature on Bacterial Colonization During Pace Device Implantation|The Effect of Preheated Skin Disinfection in Relation to Room-temperature Skin Disinfection on Bacterial Colonization During Pace Device Implantation: a Randomized Controlled Non-inferiority Trial.|Completed||Phase 2/Phase 3|220|Actual|Örebro University, Sweden||2|||f||||f||||||||||2017-10-10 23:56:46.116533|2017-10-10 23:56:46.116533
NCT02260466|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-08-21|||October 2014||2014-10-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|AMYLOCARTESIAN||Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.|AMYLO-CARTESIAN Study :Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.|Recruiting||N/A|180|Anticipated|French Cardiology Society||1|||f||||||||||||||2017-10-10 23:56:46.188092|2017-10-10 23:56:46.188092
NCT02260453|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-08|||January 2005||2005-01-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|July 2009|Actual|2009-07-01||Interventional|CACEA||Coronary Angiography Before Elective Carotid Endarterectomy in Patients With Asymptomatic Coronary Artery Disease|Randomized Controlled Trial Analyzing the Role of Systematic Preoperative Coronary Angiography Before Elective Carotid Endarterectomy in Patients With Asymptomatic Coronary Artery Disease|Completed||Phase 3|426|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-10 23:56:46.320108|2017-10-10 23:56:46.320108
NCT02260440|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-07-26|2017-04-10||January 2015||2015-01-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|March 2016|Actual|2016-03-01||Interventional|||A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer|A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|31|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-10 23:56:46.388307|2017-10-10 23:56:46.388307
NCT02260427|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2016-09-05|||September 2014||2014-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Comparison of the I-gel and Self-pressurised Air-Q Intubating Laryngeal Airway (Air-Q sp) in the Elderly Patients||Completed||N/A|100|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:56:46.643214|2017-10-10 23:56:46.643214
NCT02260414|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-05-10|||April 14, 2015|Actual|2015-04-14|May 2017|2017-05-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|METRO B||Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer|Effects of Injection Tinzaparin Prophylactic Dose (4,500 IU Anti-Xa) on Thrombin Generation in Patients With Multiple Myeloma, Lymphoma Patients and Patients Hospitalized for an Acute Medical Condition.|Completed||Phase 2|19|Actual|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||||2017-10-10 23:56:46.716861|2017-10-10 23:56:46.716861
NCT02260401|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2017-03-31|2017-03-31||October 2013||2013-10-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|LESSER||Long Term Outcomes of Lumbar Epidural Steroid Injections for Spinal Stenosis|Long Term Outcomes of Lumbar Epidural Steroid Injections for Spinal Stenosis|Completed||N/A|165|Actual|University of Washington||2|||f||||f||||||||||2017-10-10 23:56:46.802523|2017-10-10 23:56:46.802523
NCT02260388|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-08-07|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|PAIN-CONTRoLS||Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations|Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)|Active, not recruiting||Phase 4|402|Actual|University of Kansas Medical Center||4|||f||||t||||||||||2017-10-10 23:56:47.027789|2017-10-10 23:56:47.027789
NCT02260375|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|October 2025|Anticipated|2025-10-01|October 2024|Anticipated|2024-10-01||Interventional|||MSC Therapy in Liver Transplantation|THIRD-PARTY BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS TO INDUCE TOLERANCE IN LIVER TRANSPLANT RECIPIENTS|Recruiting||Phase 1|20|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||f||||||||||2017-10-10 23:56:48.833656|2017-10-10 23:56:48.833656
NCT02260362|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2015-02-12|||October 2014||2014-10-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ItinerAir||Observatory of Pulmonary Arterial Hypertension of Congenital Heart Disease|Observatory of Pulmonary Arterial Hypertension of Congenital Heart Disease|Recruiting||N/A|400|Anticipated|French Cardiology Society|||1||f||||f||||||||||2017-10-10 23:56:48.937308|2017-10-10 23:56:48.937308
NCT02260349|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-03-09|||April 2014||2014-04-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Interest of Indocyanine Green in Neoplastic Prostatic Tissue|Interest of Indocyanine Green in the Neoplastic Prostatic Tissue Characterization and the Peroperative Surgical Margins Detection During a Radical Prostatectomy.|Withdrawn||Phase 3|0|Actual|Centre Hospitalier Universitaire de Saint Etienne||1||Scientific coordinator left the hospital|f||||f||||||||||2017-10-10 23:56:49.000789|2017-10-10 23:56:49.000789
NCT02260336|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-31|||October 2014||2014-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Panax Notoginseng Powders on Rheumatic Pain||Enrolling by invitation||N/A|80|Anticipated|Chengdu PLA General Hospital||5|||f||||t||||||||||2017-10-10 23:56:49.066056|2017-10-10 23:56:49.066056
NCT02260323|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-03-31|||October 2014||2014-10-01|March 2017|2017-03-01|February 2022|Anticipated|2022-02-01|January 2022|Anticipated|2022-01-01||Interventional|||Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases||Enrolling by invitation||N/A|300|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:56:49.142201|2017-10-10 23:56:49.142201
NCT02260310|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-31|||October 2014||2014-10-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis||Enrolling by invitation||N/A|100|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:56:49.211643|2017-10-10 23:56:49.211643
NCT02260297|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-12-02|||January 2014||2014-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||A Study of Wrist Actigraphy in Overweight and Obese Adults With Sleep Disorders|A Study of Wrist Actigraphy in Overweight and Obese Adults With Sleep Disorders|Completed||N/A|69|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||||||2017-10-10 23:56:49.279281|2017-10-10 23:56:49.279281
NCT02260284|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-03-31|||October 2014||2014-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||The Effect of Acupotome in Treating Ankylosing Spondylitis||Enrolling by invitation||N/A|100|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:56:49.387644|2017-10-10 23:56:49.387644
NCT02260271|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2017-04-17|||September 2011||2011-09-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|FN3||Florida Neonatal Neurologic Network|Florida Neonatal Neurologic Network|Enrolling by invitation||N/A|100|Anticipated|University of Florida|||1||f||||f||||||Samples Without DNA|"     blood, urine and buccal samples   "|Undecided||2017-10-10 23:56:49.527504|2017-10-10 23:56:49.527504
NCT02260258|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-03-03|||October 2014||2014-10-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|NMB_in_CA||Neuromuscular Blockade for Post-Cardiac Arrest Care|Neuromuscular Blockade for Post-Cardiac Arrest Care|Recruiting||Phase 2|80|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||Undecided||2017-10-10 23:56:49.610832|2017-10-10 23:56:49.610832
NCT02260245|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-03-01|||February 2014||2014-02-01|March 2017|2017-03-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Stepping Up for Safety: Improving Teamwork at the Planned Parenthood Affiliates Through the TeamSTEPPS Model|Stepping Up for Safety: Improving Teamwork at the Planned Parenthood Affiliates Through the TeamSTEPPS Model|Enrolling by invitation||N/A|60|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-10-10 23:56:49.733288|2017-10-10 23:56:49.733288
NCT02260232|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||June 2010||2010-06-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Worksite Exercise Intervention Effects on Cardiovascular Disease Risk Factors and Physical Activity Levels Among Healthy Employees||Completed||N/A|295|Actual|Universidad Europea de Madrid||2|||f||||f||||||||||2017-10-10 23:56:49.81268|2017-10-10 23:56:49.81268
NCT02260219|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-10-06|||January 2012||2012-01-01|September 2014|2014-09-01||||February 2013|Actual|2013-02-01||Interventional|||Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma|Comparative Study of the Safety and Efficacy of the Ahmed Glaucoma Valve Drainage Device, Model M4 (High Density Porous Polyethylene) and the Model S2 (Polypropylene) in Patients With Neovascular Glaucoma|Unknown status|Active, not recruiting|N/A|42|Actual|Asociación para Evitar la Ceguera en México||2|||f||||f||||||||||2017-10-10 23:56:49.870994|2017-10-10 23:56:49.870994
NCT02260206|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2017-04-24|||July 2014||2014-07-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|||Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion|Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion Following Catheter Ablation of Atrial Fibrillation|Recruiting||Phase 4|170|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||No||2017-10-10 23:56:49.945658|2017-10-10 23:56:49.945658
NCT02260193|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-11-17||2015-10-23|September 2014||2014-09-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Subjects With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis|Phase 2 Open-Label Study to Assess the Efficacy, Safety, and Tolerability of AKB-6548 in Subjects With Anemia Secondary to End Stage Renal Disease (ESRD), Undergoing Chronic Hemodialysis.|Completed||Phase 2|94|Actual|Akebia Therapeutics||3|||f||||f||||||||||2017-10-10 23:56:50.065262|2017-10-10 23:56:50.065262
NCT02260180|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-03-12|||October 2014||2014-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study of A-101 for the Treatment of Seborrheic Keratosis|A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Dose-Response Profile of A-101 Topical Solution in Subjects With Seborrheic Keratosis of the Face|Completed||Phase 2|116|Actual|Aclaris Therapeutics, Inc.||3|||f||||f||||||||||2017-10-10 23:56:50.209696|2017-10-10 23:56:50.209696
NCT02260167|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-10-10|||September 2014||2014-09-01|October 2014|2014-10-01||||December 2015|Anticipated|2015-12-01||Interventional|MIND||Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol|Effective Treatment of Alzheimer's and Dementia With the MIND Protocol|Unknown status|Recruiting|Phase 2|46|Anticipated|Practitioners Alliance Network||1|||f||||t||||||||||2017-10-10 23:56:50.29664|2017-10-10 23:56:50.29664
NCT02260154|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-01-10|||July 2015||2015-07-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|ODYSSEY||Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointestinal Spasm|Effectiveness of Duspatalin® (Mebeverine Hydrochloride) 200 mg b.i.d. in Patients With Post-cholecystectomy Gastrointestinal Spasm: a Post Marketing Observational Program in the Russian Federation|Completed||N/A|220|Actual|Abbott|||1||f||||f||||||||||2017-10-10 23:56:50.3957|2017-10-10 23:56:50.3957
NCT02260141|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-10-10|||September 2014||2014-09-01|October 2014|2014-10-01||||September 2015|Anticipated|2015-09-01||Interventional|||Treating Alzheimer's and Dementia With D-ribose||Unknown status|Recruiting|Phase 2|30|Anticipated|Practitioners Alliance Network||1|||f||||t||||||||||2017-10-10 23:56:50.515317|2017-10-10 23:56:50.515317
NCT02260128|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2014-10-08|||November 2014||2014-11-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery|Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery|Unknown status|Not yet recruiting|N/A|72|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-10 23:56:50.583376|2017-10-10 23:56:50.583376
NCT02260115|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-08|||November 2013||2013-11-01|August 2014|2014-08-01|July 2015|Anticipated|2015-07-01|June 2014|Actual|2014-06-01||Interventional|LABS-1||A Randomized Multi-centre Study to Assess the Safety and Manageability of a Laparoscopic Adhesion Barrier in Women Undergoing Gynecologic Laparoscopic Surgery Followed by Second Look Laparoscopy|A Randomized, Controlled, Subject and Reviewer-Blinded, Multi-Centre Study To Assess The Safety and Manageability Of LABS™ In Women Undergoing Gynaecologic Laparoscopic Surgery Followed By Second Look Laparoscopy|Unknown status|Active, not recruiting|Phase 1|78|Actual|Actamax Surgical Materials LLC||2|||f||||t||||||||||2017-10-10 23:56:50.651359|2017-10-10 23:56:50.651359
NCT02260102|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-10-24|||October 2016||2016-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|TEMOPEDI||Temocillin Pharmacokinetics in Paediatrics|Temocillin Pharmacokinetics in Paediatrics|Not yet recruiting||Phase 4|45|Anticipated|Université Catholique de Louvain||3|||f||||f||||||||||2017-10-10 23:56:50.736923|2017-10-10 23:56:50.736923
NCT02260089|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-08|||March 2000||2000-03-01|October 2014|2014-10-01||||July 2002|Actual|2002-07-01||Interventional|||Telmisartan in Mild to Moderate Hypertensive Patients|A Multicenter Open-label Study of the Efficacy and Safety of Telmisartan in Mild to Moderate Hypertensive Patients|Completed||Phase 4|134|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:50.817293|2017-10-10 23:56:50.817293
NCT02260076|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-08|||September 2001||2001-09-01|October 2014|2014-10-01||||March 2002|Actual|2002-03-01||Interventional|||Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects|Safety of Total Daily Doses of 5, 10, 15 and 20 mL PEG 400 Administered Orally to Healthy Male Human Subjects Once (QD) or Twice (BID) for 14 Days. A Single Center, Multiple Rising Dose Study, Placebo Controlled, Double-blinded at Each Dose Level|Completed||Phase 1|64|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:50.896306|2017-10-10 23:56:50.896306
NCT02260063|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-08|2014-10-08|||November 1998||1998-11-01|October 2014|2014-10-01||||January 1999|Actual|1999-01-01||Interventional|||Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy Volunteers|A Trial in Healthy Volunteers of the Relative Bioavailability of Epinastine Syrup, a New Galenic Form, Compared to the Reference Product Tablets|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:51.054109|2017-10-10 23:56:51.054109
NCT02260050|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||June 2004||2004-06-01|October 2014|2014-10-01||||July 2004|Actual|2004-07-01||Interventional|||Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers|Bioequivalence of 20 mg of the New Formulation of WAL 801 CL Dry Syrup Compared to 20 mg of the Conventional Formulation of WAL 801 CL Dry Syrup Following Oral Administration in Healthy Male Volunteers (an Open-label, Randomised, Single-dose, 2x2 Crossover Study)|Completed||Phase 1|34|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:51.164945|2017-10-10 23:56:51.164945
NCT02260037|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||August 2001||2001-08-01|October 2014|2014-10-01||||September 2001|Actual|2001-09-01||Interventional|||Dose Tolerance Study in Healthy Male Volunteers After Intranasal Application of Epinastine Nasal|A Double-blind, Randomised, Placebo-controlled Single Increasing Dose Tolerance Study in Healthy Male Volunteers After Intranasal Application of Epinastine Nasal (Dosage: 0.035 mg (0.025 % Solution) - 0.42 mg (0.3 % Solution))|Completed||Phase 1|39|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:51.279363|2017-10-10 23:56:51.279363
NCT02260024|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||October 2005||2005-10-01|October 2014|2014-10-01||||December 2005|Actual|2005-12-01||Interventional|||In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male Volunteers|A Single Dose Five-way Cross-over Study to Establish an in Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets With 0.375 mg Pramipexole in Healthy Male Volunteers|Completed||Phase 1|15|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 23:56:51.391378|2017-10-10 23:56:51.391378
NCT02260011|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-10-07|||October 2000||2000-10-01|October 2014|2014-10-01||||February 2001|Actual|2001-02-01||Interventional|||Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease|A Single-Dose, Double Blind, Crossover Trial to Determinate the Comparability of Ipratropium Bromide HFA-134a Inhalation Aerosol to the Market Standard, Atrovent® CFC Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|41|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-10 23:56:51.520543|2017-10-10 23:56:51.520543
NCT02259998|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||October 2001||2001-10-01|October 2014|2014-10-01||||December 2001|Actual|2001-12-01||Interventional|||Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers|An Open-labelled, Randomised, 2-way Crossover Study to Compare the Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets 75 mg p.o. (Present and Proposed Formulation in France) q.i.d. for Three Days in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:51.614077|2017-10-10 23:56:51.614077
NCT02259985|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||March 1998||1998-03-01|October 2014|2014-10-01||||May 1998|Actual|1998-05-01||Interventional|||Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects|Investigation of the Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose of 1 mg in Healthy Male Subjects (3-way Cross-over)|Completed||Phase 1|15|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:51.70093|2017-10-10 23:56:51.70093
NCT02259972|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||January 2010||2010-01-01|October 2014|2014-10-01||||June 2010|Actual|2010-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers|Investigation of Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of 5 to 800 mg BI 113823 Powder in Bottle (PiB) and Tablet Administered to Healthy Male Volunteers in a Partially Randomised and Double Blinded, Placebo Controlled Phase I Trial. Including Intra-individual Open Comparisons of PiB and Tablet (Fasted and Fed).|Completed||Phase 1|63|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:51.803194|2017-10-10 23:56:51.803194
NCT02259959|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||April 2007||2007-04-01|October 2014|2014-10-01||||September 2007|Actual|2007-09-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses (2 μg/5 μg, 10 μg/5 μg, and 40 μg/10 μg) of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide for 14 Days in Healthy Male Volunteers (Double-blind, Randomised, Placebo Controlled [at Each Dose Level] Study)|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:51.918015|2017-10-10 23:56:51.918015
NCT02259946|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||April 2006||2006-04-01|October 2014|2014-10-01||||July 2006|Actual|2006-07-01||Interventional|||Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers|A Randomised, Double-blind, Placebo-controlled (Within Dose Groups) Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses (2.5 μg, 5 μg, 10 μg, 20 μg and 40 μg) of BI 1744 CL (Administered With the Respimat®) in Free Dose Combination With Tiotropium Bromide 5 μg ( for Doses up to and Including 20 μg BI 1744 CL), 10 μg (for Doses of 20 μg and 40 μg BI 1744 CL) (Administered With the Respimat®) in Healthy Male Volunteers|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:52.027288|2017-10-10 23:56:52.027288
NCT02259933|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||February 2004||2004-02-01|October 2014|2014-10-01||||May 2004|Actual|2004-05-01||Interventional|||Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers|A Double-blind (at Each Dose Level), Randomised, Placebo Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Increasing Repeated Oral Doses of KUC 7483 CL Tablets (Dosage: 40, 120, 180 mg b.i.d.) Over 7 Days in Healthy Male Volunteers|Completed||Phase 1|35|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:52.126329|2017-10-10 23:56:52.126329
NCT02259920|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||December 2003||2003-12-01|October 2014|2014-10-01||||May 2004|Actual|2004-05-01||Interventional|||Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers|Open Label, Randomized, Single-dose, Five-way Crossover Study to Investigate the Regional Drug Absorption of 80 mg KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers.|Completed||Phase 1|13|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-10 23:56:52.22909|2017-10-10 23:56:52.22909
NCT02259907|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||May 2003||2003-05-01|October 2014|2014-10-01||||February 2004|Actual|2004-02-01||Interventional|||Safety, Tolerability and Pharmacokinetics of KUC 7483 Tablets in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses (40 to 400 mg) of KUC-7483 Tablets in Healthy Male Volunteers (Double-blind at Each Dose Level, Randomised, Placebo Controlled Study) as Well as Food Effects at 80 mg (Intraindividual Testing in the Same Volunteers)|Completed||Phase 1|50|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:52.333068|2017-10-10 23:56:52.333068
NCT02259894|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||March 2004||2004-03-01|October 2014|2014-10-01||||June 2004|Actual|2004-06-01||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers|Safety, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses of BIRT 2584 XX (5, 30, 100, 200, 350, 500, and 700 mg) as a Solution in PEG 400 Administered to Healthy Male Volunteers. Placebo Controlled and Blinded at Each Dose Level.|Completed||Phase 1|55|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:52.415752|2017-10-10 23:56:52.415752
NCT02259881|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||December 2002||2002-12-01|October 2014|2014-10-01||||May 2003|Actual|2003-05-01||Interventional|||Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male Volunteers|Investigation of the Effect of 0.9, 2.25 or 4.5 mg of BIBT 986 Over 1 Hour, Followed by 0.2, 0.5 or 1.0 mg/Hour of BIBT 986 for 7 Hours Given as IV Infusion on Tissue Factor Triggered Coagulation in a Randomised, Placebo Controlled, Dose Escalation Design in Healthy Male Volunteers|Completed||Phase 1|64|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:56:52.520722|2017-10-10 23:56:52.520722
NCT02259868|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-07|2014-10-07|||June 2005||2005-06-01|September 2014|2014-09-01||||September 2005|Actual|2005-09-01||Interventional|||Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects|Randomized Single Dose Multiple Crossover Relative Bioavailability Trial of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects|Completed||Phase 1|88|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:56:52.638535|2017-10-10 23:56:52.638535
NCT02259855|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-10-07|||January 2006||2006-01-01|October 2014|2014-10-01||||October 2008|Actual|2008-10-01||Interventional|||Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment|Open Label, Study to Determine the Pharmacokinetic Interactions of Steady State Tipranavir/Ritonavir (500/200 mg) and Steady State Ribavirin and Pegylated Interferon Alfa 2a in HIV Negative, HCV Infected Subjects With Mild Hepatic Impairment and the Pharmacokinetic Properties of Tipranavir/Ritonavir in HIV Negative, HCV, HBV, Hepatitis Delta Infected Subjects or Alcoholic Cirrhosis Subjects With Moderate Hepatic Impairment|Completed||Phase 1|36|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:52.737692|2017-10-10 23:56:52.737692
NCT02259842|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||March 2008||2008-03-01|October 2014|2014-10-01||||June 2008|Actual|2008-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers (Dose Range: 5 - 500 mg). A Double-blind (Within Dose Groups), Randomised, Placebo-controlled Within Dose Groups, Single Rising Dose Study, Including Re-dosing at 50 mg and 150 mg (Food Effect) and at 100 mg (Two 50 mg Tablets)|Completed||Phase 1|63|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:56:52.834422|2017-10-10 23:56:52.834422
NCT02259829|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||September 2007||2007-09-01|October 2014|2014-10-01||||November 2007|Actual|2007-11-01||Interventional|||Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers|Bioequivalence of 40 mg Telmisartan/5 mg Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers. An Open-label, Randomised, Single-dose, Two-period Crossover Study|Completed||Phase 1|84|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:52.931069|2017-10-10 23:56:52.931069
NCT02259816|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||May 2006||2006-05-01|October 2014|2014-10-01||||August 2006|Actual|2006-08-01||Interventional|||Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers|Pharmacokinetics of Repeated Oral Doses of 80 mg Telmisartan (Micardis®) at Steady State Alone and in Combination With Repeated Oral Doses of Amlodipine 10 mg (Norvasc®) at Steady State. A Two-way Crossover, Open, Randomised Design Study|Completed||Phase 1|38|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:53.020762|2017-10-10 23:56:53.020762
NCT02259803|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||October 2007||2007-10-01|October 2014|2014-10-01||||November 2007|Actual|2007-11-01||Interventional|||Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers|Relative Bioavailability of Telmisartan 80 mg/Amlodipine 5 mg Fixed-dose Combination Tablet Compared to Concomitant Use of Its Mono-components (i.e., Two Telmisartan 40 mg Tablets and Amlodipine 5 mg Tablet in Concomitant Use) Following Oral Administration in Healthy Male Volunteers (an Open-label, Randomised, Single Dose, Two-way Crossover Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:53.096952|2017-10-10 23:56:53.096952
NCT02259790|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||July 2007||2007-07-01|October 2014|2014-10-01||||August 2007|Actual|2007-08-01||Interventional|||Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers|Relative Bioavailability of Telmisartan 40 mg/Amlodipine 5 mg Fixed-dose Combination Tablet Compared to Concomitant Use of Its Mono-components (i.e., Telmisartan 40 mg Tablet and Amlodipine 5 mg Tablet in Concomitant Use) Following Oral Administration in Healthy Male Volunteers (an Open-label, Randomised, Single Dose, Two-way Crossover Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:53.177797|2017-10-10 23:56:53.177797
NCT02259777|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||September 2007||2007-09-01|October 2014|2014-10-01||||November 2007|Actual|2007-11-01||Interventional|||Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers|Influence of Food on the Bioavailability of 80 mg Telmisartan/10 mg Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers. An Open-label, Randomised, Single-dose, Two Period, Crossover Study|Completed||Phase 1|40|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:53.260373|2017-10-10 23:56:53.260373
NCT02259764|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||August 2004||2004-08-01|October 2014|2014-10-01||||September 2004|Actual|2004-09-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of KUC 7483 CL Tablets in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses (400, 440 and 480 mg) of KUC 7483 CL Tablets in Healthy Male Volunteers. A Double-blind at Each Dose Level, Randomised, Placebo Controlled Study|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:53.344787|2017-10-10 23:56:53.344787
NCT02259751|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-06|2014-10-06|||February 2004||2004-02-01|October 2014|2014-10-01||||February 2005|Actual|2005-02-01||Interventional|||Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity|A Phase I, Randomised, Double-blind, Placebo-controlled Study to Determine Pharmacodynamic Effects and Pharmacokinetics of a Single Oral Dose of 320 mg KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity|Completed||Phase 1|26|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:56:53.421222|2017-10-10 23:56:53.421222
NCT02259738|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-10-04|||January 2013||2013-01-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase||Completed||Phase 2|120|Actual|Xuanwu Hospital, Beijing||1|||f||||t||||||||||2017-10-10 23:56:53.618777|2017-10-10 23:56:53.618777
NCT02259725|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-04-18|||August 16, 2016|Actual|2016-08-16|April 2017|2017-04-01|August 16, 2020|Anticipated|2020-08-16|August 16, 2019|Anticipated|2019-08-16||Interventional|||Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors|Phase II Study of Single Agent Regorafenib in Patients With Advanced/Metastatic Neuroendocrine Tumors|Recruiting||Phase 2|48|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-10 23:56:53.701403|2017-10-10 23:56:53.701403
NCT02259712|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-10-07|||October 2013||2013-10-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|HEPFD||Effectiveness of Hipopressive Exercises Versus Classical Perineal Physiotherapy|Randomized Clinical Trial on the Effectiveness of Hipopressive Exercises Versus Classical Perineal Physiotherapy in Women With Pelvic Floor Dysfunction|Unknown status|Recruiting|N/A|78|Anticipated|University of Alcala||3|||f||||t||||||||||2017-10-10 23:56:53.820426|2017-10-10 23:56:53.820426
NCT02259673|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-04-07|||September 2014||2014-09-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Effects of Fun Physical Activity on the Interest to Daily Physical Activity and Sarcopenia of Elderly People|Mashhad University Medical of Sciences|Unknown status|Recruiting|Phase 1/Phase 2|63|Anticipated|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:56:54.13635|2017-10-10 23:56:54.13635
NCT02259660|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-10-04|||April 2015|Actual|2015-04-01|October 2017|2017-10-01|September 28, 2017|Actual|2017-09-28|September 2017|Actual|2017-09-01||Interventional|OSA||Airway Muscle Training for Obstructive Sleep Apnea|Upper Airway Muscle Training for Obstructive Sleep Apnea|Completed||N/A|47|Actual|University of Florida||2|||f||||f|f|f||||||||2017-10-10 23:56:54.226707|2017-10-10 23:56:54.226707
NCT02259647|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-09-29|||June 2014||2014-06-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma|Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma - a Randomized Controlled Trial|Unknown status|Recruiting|N/A|60|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-10 23:56:54.319676|2017-10-10 23:56:54.319676
NCT02259634|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-08-18|||June 2014||2014-06-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients|Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients|Terminated||N/A|144|Actual|St. Luke's-Roosevelt Hospital Center||2||Target sample size not reached for enrollment.|f||||t||||||||||2017-10-10 23:56:54.411257|2017-10-10 23:56:54.411257
NCT02259621|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-03-06|||September 2014||2014-09-01|March 2017|2017-03-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|NA_00092076||Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC|Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.|Recruiting||Phase 2|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t|t|f||||||No||2017-10-10 23:56:54.504107|2017-10-10 23:56:54.504107
NCT02259608|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-05-21|2016-01-25||November 2013||2013-11-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||γ-irradiated BCG to Train Innate Immunity|Training of Innate Immunity by Vaccination With γ-irradiated BCG|Completed||N/A|15|Actual|Radboud University||1|||f||||f||||||||||2017-10-10 23:56:54.700108|2017-10-10 23:56:54.700108
NCT02259595|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-04-29|||October 2014||2014-10-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC|Randomized, Placebo-controlled, Double-blind, Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC in Single Doses in Male and Female Subjects|Completed||Phase 1|32|Actual|Otologic Pharmaceutics, Inc.||4|||f||||t||||||||||2017-10-10 23:56:54.889007|2017-10-10 23:56:54.889007
NCT02259582|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-08-14|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|May 2017|Actual|2017-05-01||Interventional|DENALI||A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer|A 2-Arm Phase 2 Double-Blind Randomized Study of Carboplatin, Pemetrexed Plus Placebo Versus Carboplatin, Pemetrexed Plus Truncated Demcizumab as First-Line Treatment in Subjects With Stage IV Non-Squamous Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|81|Actual|OncoMed Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-10 23:56:55.027733|2017-10-10 23:56:55.027733
NCT02259569|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-04-23|||October 2014||2014-10-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Comparison of Peak Airway Pressure and Gastric Insufflation in Pressure-Controlled Ventilation or Volume-Controlled Ventilation With I-Gel in Pediatric Patient||Completed||N/A|34|Actual|Yonsei University||2|||f||||f||||||||||2017-10-10 23:56:55.229703|2017-10-10 23:56:55.229703
NCT02259556|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-05|2016-01-26|||October 2014||2014-10-01|January 2016|2016-01-01|October 2029|Anticipated|2029-10-01|October 2018|Anticipated|2018-10-01||Interventional|CART30||CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas|CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas|Recruiting||Phase 1/Phase 2|30|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 23:56:55.300347|2017-10-10 23:56:55.300347
NCT02259543|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2014-10-05|||August 2011||2011-08-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Root Biomodification With Citric Acid and Tetracycline Improves the Outcomes of Root Coverage|Conditioning of Root Surfaces With Citric Acid and Tetracycline for Different Application Times Improves the Outcomes of Root Coverage by Subepithelial Connective Tissue Graft: a Randomized Clinical Trial.|Completed||N/A|36|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-10 23:56:55.381039|2017-10-10 23:56:55.381039
NCT02259530|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-05-10|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Case Series for Traumatized Refugees With Khat Dependence|Sustainable and Adapted Treatment Strategies to Restore Psychological Functioning and Mental Health Among Displaced Somalis: Preparation of a Multicenter Treatment Study (P114/02/2014): Pilot Study 3.|Completed||N/A|20|Anticipated|University of Konstanz||1|||f||||f||||||||||2017-10-10 23:56:55.475148|2017-10-10 23:56:55.475148
NCT02259517|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-14|||September 2014||2014-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD|Imaging Stimulant vs. Non-Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD)|Recruiting||N/A|30|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-10 23:56:55.548606|2017-10-10 23:56:55.548606
NCT02259504|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-12-14|||July 2014||2014-07-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|COAST||COAST: Coiling of Aneurysms Smaller Than 5mm With Hypersoft®|COAST: Coiling of Aneurysms Smaller Than 5mm With Hypersoft®|Recruiting||N/A|300|Anticipated|Medical University of South Carolina||1|||f||||f||||||||||2017-10-10 23:56:55.6415|2017-10-10 23:56:55.6415
NCT02259491|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-01-17|||December 2013||2013-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Manuka Honey for Wound Care|Honey Dressings for Local Wound Care of Split Thickness Skin Graft and Free Tissue Transfer Donor Sites: A Prospective, Randomized, Controlled Trial.|Recruiting||Phase 4|60|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-10 23:56:55.733902|2017-10-10 23:56:55.733902
NCT02259478|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-03-10|||October 2014||2014-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|||Isoagglutinins in the Development of IVIG-associated Hemolysis|Elucidation of the Mechanism of IVIG-Associated Hemolysis|Completed||N/A|144|Actual|Toronto Transfusion Medicine Collaborative|||1||f||||f||||||Samples With DNA|"     Whole blood samples will be collected immediately prior and following a course of IVIG     therapy, and then again 5-10 days later   "|Yes||2017-10-10 23:56:55.817183|2017-10-10 23:56:55.817183
NCT02259465|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-03-17|||September 2014||2014-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|FOG||The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and Microbiota|A Randomised Controlled Trial of the Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and Microbiota in Healthy Volunteers|Completed||N/A|45|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-10 23:56:55.903037|2017-10-10 23:56:55.903037
NCT02259452|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-07-10|||June 2008||2008-06-01|July 2017|2017-07-01||||May 2018|Anticipated|2018-05-01||Observational|||Radiation Induced Cardiopulmonary Injury in Humans|Radiation Induced Cardiopulmonary Injury in Humans|Recruiting||N/A|80|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-10 23:56:55.996468|2017-10-10 23:56:55.996468
NCT02259439|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-03-30|||September 2012||2012-09-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|||Assessment of Updated Evaluation Scores in Critically ILL COPD Patients Admitted to Assiut University Hospital||Unknown status|Recruiting|N/A|150|Anticipated|Assiut University|||1||f||||f||||||||||2017-10-10 23:56:56.06651|2017-10-10 23:56:56.06651
NCT02259426|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-01-13|||October 2014||2014-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|DAPPI||Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission|A Double Blind Randomized Controlled Trial of Dihydroartemisinin-piperaquine Alone and in Combination With Single Dose Primaquine to Reduce Post-treatment Malaria Transmission.|Completed||Phase 3|120|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-10 23:56:56.123359|2017-10-10 23:56:56.123359
NCT02259413|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-04-03|||May 2015||2015-05-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Effect of an Exercise Rehabilitation Program in Patients on Hemodialysis|Effect of an Exercise Rehabilitation Program on Symptom Burden and Quality of Life in Hemodialysis: A Randomized Controlled Study|Recruiting||N/A|150|Anticipated|University of Manitoba||2|||f||||t||||||||Undecided||2017-10-10 23:56:56.198838|2017-10-10 23:56:56.198838
NCT02259400|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-01-30|2015-01-13||January 2010||2010-01-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|NIV||NIV Strategies for RDS in Preterm Infants. NIV (Non Invasive Ventilation), RDS (Respiratory Distress Syndrome)|Noninvasive Ventilation Strategies for Early Treatment of RDS in Preterm Infants: An RCT|Completed||Phase 2/Phase 3|280|Actual|"Azienda Ospedaliera Universitaria Policlinico G. Martino"||2|||f||||||||||||||2017-10-10 23:56:56.301118|2017-10-10 23:56:56.301118
NCT02259387|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-12-05|||October 2014||2014-10-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|Adostress||Adolescents With Migraine: What's Stress Got To Do With It?|Adolescents With Migraine: What's Stress Got To Do With It?|Recruiting||N/A|100|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples With DNA|"     Hair samples for cortisol.   "|||2017-10-10 23:56:56.916373|2017-10-10 23:56:56.916373
NCT02259374|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-10-05|||October 2014||2014-10-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Use of Tap Block in Patients After Hysterectomy|Use of Tap Block in Patients After Hysterectomy|Unknown status|Not yet recruiting|N/A|54|Anticipated|Singapore General Hospital||2|||f||||t||||||||||2017-10-10 23:56:57.014872|2017-10-10 23:56:57.014872
NCT02259361|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-05|||November 2014||2014-11-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS|Efficacy of Sustained-release Oral Dalfampridine on Upper Extremity Function in Patients With Multiple Sclerosis: a Pilot Study|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:56:57.089058|2017-10-10 23:56:57.089058
NCT02259348|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-04-24|2016-03-10||October 2014||2014-10-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|April 2015|Actual|2015-04-01||Interventional|||Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation|CD45A-Depleted Haploidentical Hematopoietic Progenitor Cell and Natural Killer Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation|Terminated||Phase 2|12|Actual|St. Jude Children's Research Hospital|The trial was terminated early due to investigator's decision.|1||Investigator's decision.|f||||f||||||||||2017-10-10 23:56:57.216823|2017-10-10 23:56:57.216823
NCT02259335|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2016-10-08|||October 2014||2014-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|WeanPRO||Weaning Form Mechanical Ventilation Using Extracorporeal CO2 Removal|A Pilot Study on the Use of Extracorporeal CO2 Removal During the Weaning Process From Mechanical Ventilation|Recruiting||N/A|15|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||f||||||||||2017-10-10 23:56:57.67716|2017-10-10 23:56:57.67716
NCT02259322|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-06-01|||September 2014||2014-09-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Loss of Control Eating Following Weight Loss Surgery|Treatment of Loss of Control Eating Following Bariatric Surgery|Recruiting||N/A|144|Anticipated|Yale University||3|||f||||||||||||||2017-10-10 23:56:57.773481|2017-10-10 23:56:57.773481
NCT02259309|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-01-12|||November 2014||2014-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Immune Modulation by Misoprostol|Immune Modulation by Misoprostol|Completed||Early Phase 1|15|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-10 23:56:57.88438|2017-10-10 23:56:57.88438
NCT02259296|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-07|||January 2015||2015-01-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TACTIC||Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure|Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure|Not yet recruiting||N/A|2200|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||||2017-10-10 23:56:58.019885|2017-10-10 23:56:58.019885
NCT02259283|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-03|||December 2012||2012-12-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|POEM||Prospective Study on the Feasibility and Results of POEM in Idiopathic Achalasia|Prospective Study on the Feasibility and Results of the Treatment of Idiopathic Achalasia With the POEM (Per Oral Endoscopic Myotomy) Technique|Completed||Phase 2|10|Actual|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-10 23:56:58.125988|2017-10-10 23:56:58.125988
NCT02259270|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-05-02|||August 2014||2014-08-01|August 2014|2014-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|ASTRA||Acid Suppressive Therapy - Review of Appropriateness|Acid Suppressive Therapy - Review of Appropriateness|Completed||N/A|600|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||t||||||||||2017-10-10 23:56:58.21345|2017-10-10 23:56:58.21345
NCT02259257|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-05|||November 2014||2014-11-01|October 2014|2014-10-01|November 2017|Anticipated|2017-11-01|November 2015|Anticipated|2015-11-01||Observational|CEUS carotid||3D/4D Ultrasound Contrast Enhanced Imaging (CEUS) for Carotid Plaque Vulnerability|3D/4D Ultrasound Contrast Enhanced Imaging (CEUS) for Carotid Plaque Vulnerability|Not yet recruiting||N/A|50|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples With DNA|"     Tissue: Carotid plaque histological specimen   "|||2017-10-10 23:56:58.301738|2017-10-10 23:56:58.301738
NCT02259244|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-03|||October 2008||2008-10-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Mediterranean and Hypolipemic Reduction Diet in Obese Patients|Effect of the Mediterranean Diet and Hypolipemic Reduction Diet in Combination With Exercise in Obese Croatian Population- 1-year Randomized Controlled Trial|Completed||N/A|124|Actual|University of Zagreb||2|||f||||f||||||||||2017-10-10 23:56:58.408181|2017-10-10 23:56:58.408181
NCT02259231|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-31|||October 2014||2014-10-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||RTA 408 Capsules in Patients With Melanoma - REVEAL|An Open-label, Multicenter, Dose-escalation, Phase 1b/2 Study of the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RTA 408 in Combination With Ipilimumab or Nivolumab in the Treatment of Patients With Unresectable or Metastatic Melanoma|Recruiting||Phase 1/Phase 2|102|Anticipated|Reata Pharmaceuticals, Inc.||8|||f||||f|t|f||||||||2017-10-10 23:56:58.483981|2017-10-10 23:56:58.483981
NCT02259218|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-04-12|||October 4, 2012|Actual|2012-10-04|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Longitudinal Metabolomic and Epigenetic Profiling of Bodyfluids From Patients With Lung and Brain Cancer Receiving Radiation Therapy|Biomarker Discovery for Toxicity and Survival in Radiation Oncology: An Integrative Molecular-Clinical Approach|Recruiting||N/A|360|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"     Blood, urine, tissue   "|||2017-10-10 23:56:58.65457|2017-10-10 23:56:58.65457
NCT02259205|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-04-07|||September 2014||2014-09-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|||Cardio Protective Properties of a Yogurt Enriched With Bioactive Lipids of Olive Oil Products|Cardio Protective Properties of a Yogurt Enriched With Bioactive Lipids of Olive Oil Products|Unknown status|Recruiting|N/A|100|Anticipated|Harokopio University||3|||f||||f||||||||||2017-10-10 23:56:58.752999|2017-10-10 23:56:58.752999
NCT02259192|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-04-18|||September 2014||2014-09-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|June 2019|Anticipated|2019-06-01||Interventional|SSD||Cochlear Implants for Adults With Single-sided Deafness|Cochlear Implantation for Single-Sided Deafness|Active, not recruiting||N/A|10|Actual|University of Southern California||1|||f||||f||||||||||2017-10-10 23:56:58.862491|2017-10-10 23:56:58.862491
NCT02259179|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-12-10|||September 2014||2014-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers|A Phase 1 Bioequivalence Study of Naltrexone SR/Bupropion SR Combination Trilayer Tablets From Two Manufacturers in Healthy Subjects|Completed||Phase 1|80|Actual|Orexigen Therapeutics, Inc||2|||f||||f||||||||||2017-10-10 23:56:58.97621|2017-10-10 23:56:58.97621
NCT02259166|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-09-16|||June 2014||2014-06-01|September 2015|2015-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Enhanced Homestead Food Production Plus+ Program in the Lake Zone, Tanzania|Impact of the Evaluation of the Enhanced Homestead Food Production Program in Sengerema, and Ukerewe in the Lake Zone,Tanzania|Completed||N/A|2325|Actual|International Food Policy Research Institute||2|||f||||f||||||||No||2017-10-10 23:56:59.089973|2017-10-10 23:56:59.089973
NCT02259153|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-03|||March 2014||2014-03-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis|A Randomized Study to Assess the Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis|Completed||N/A|20|Actual|Instituto Aragones de Ciencias de la Salud||2|||f||||||||||||||2017-10-10 23:56:59.181289|2017-10-10 23:56:59.181289
NCT02259140|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-07-11|||October 2015||2015-10-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Randomized Control Trial of Hip Dislocation Techniques for Pediatric Patients With Cerebral Palsy|ORCHID: Osteotomy vs Resection in CP Hip for Irreducible Dislocations: A Randomized Controlled Trial Comparing McHale to Castle Techniques|Recruiting||N/A|74|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-10 23:56:59.269263|2017-10-10 23:56:59.269263
NCT02259127|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-01-26|||May 2016||2016-05-01|January 2016|2016-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Randomised Trial of Dolutegravir (DTG)-Based Antiretroviral Therapy vs. Standard of Care (SOC) in Children With HIV Infection Starting First-line or Switching to Second-line ART||Not yet recruiting||Phase 2/Phase 3|700|Anticipated|PENTA Foundation||2|||f||||t||||||||||2017-10-10 23:56:59.426453|2017-10-10 23:56:59.426453
NCT02259114|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-24|||October 23, 2014|Actual|2014-10-23|March 2017|2017-03-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||A Dose-Finding Study of OTX105/MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)|A Phase IB Trial With OTX015/MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Patients With Selected Advanced Solid Tumors|Completed||Phase 1|47|Actual|Oncoethix GmbH||2|||f||||f||||||||||2017-10-10 23:56:59.499944|2017-10-10 23:56:59.499944
NCT02259101|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-05-05|||November 2013||2013-11-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||RCT of CBT for Insomnia With PLWHA|A Randomized Controlled Trial of Cognitive Behavior Therapy for Insomnia With Persons Living With HIV/AIDS|Completed||N/A|34|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:56:59.576877|2017-10-10 23:56:59.576877
NCT02259088|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-29|||November 5, 2014|Actual|2014-11-05|March 2017|2017-03-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|||A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese DME Patients|A 12-month, Randomized, Double-masked, Multicenter, Laser-controlled Phase III Study Assessing the Efficacy and Safety of 0.5 mg Ranibizumab Dosed PRN in Subjects With Visual Impairment Due to Diabetic Macular Edema in Chinese Patients|Completed||Phase 3|381|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:56:59.690985|2017-10-10 23:56:59.690985
NCT02259075|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-05-20|||February 2015||2015-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Botox Injection in Treatment of Chronic Migraine|Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Migraine. Safety Issues.|Completed||Phase 1/Phase 2|10|Actual|Norwegian University of Science and Technology||1|||f||||t||||||||||2017-10-10 23:56:59.85699|2017-10-10 23:56:59.85699
NCT02259062|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-07-05|||October 2014||2014-10-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|MELLO||Listening for Leisure After Stroke|Measuring the Effects of Listening for Leisure on Outcome After Stroke (MELLO)|Active, not recruiting||N/A|100|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f||||||||||2017-10-10 23:56:59.958089|2017-10-10 23:56:59.958089
NCT02259049|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-01-19|||October 2014||2014-10-01|September 2014|2014-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease|The Effects of L-Tyrosine on Non-invasive Ambulatory Blood Pressure and Heart Rate Monitoring in Parkinson's Disease|Completed||Early Phase 1|6|Actual|New York Institute of Technology||2|||f||||f||||||||||2017-10-10 23:57:00.108481|2017-10-10 23:57:00.108481
NCT02259036|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-06-05|||August 2014||2014-08-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|Smart-CAT||Using Smartphones to Enhance the Treatment of Childhood Anxiety|Using Smartphones to Enhance the Treatment of Childhood Anxiety|Completed||N/A|40|Actual|University of Pittsburgh||1|||f||||f||||||||No||2017-10-10 23:57:00.193996|2017-10-10 23:57:00.193996
NCT02259023|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-02-19|||February 2014||2014-02-01|February 2015|2015-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Discretionary Food Sources and Stress Perception|Discretionary Food Sources and Stress Perception|Unknown status|Active, not recruiting|N/A|24|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:57:00.304691|2017-10-10 23:57:00.304691
NCT02259010|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-01-06|||October 2014||2014-10-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma|A Phase 1 Study to Evaluate the Effect of Itraconazole, a Strong CYP3A Inhibitor, on the Pharmacokinetics of Alisertib (MLN8237) in Adult Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma|Active, not recruiting||Phase 1|24|Anticipated|Millennium Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:57:00.392886|2017-10-10 23:57:00.392886
NCT02258997|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2015-10-07|||March 2014||2014-03-01|October 2014|2014-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Hepcidin Levels in Sickle Cell Disease (SCD)|Hepcidin Levels in Sickle Cell Disease (SCD)|Completed||N/A|42|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-10 23:57:00.500888|2017-10-10 23:57:00.500888
NCT02258984|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-09-25|||October 2014||2014-10-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial|Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial|Unknown status|Enrolling by invitation|N/A|80|Anticipated|Mespere Lifesciences Inc.||2|||f||||f||||||||||2017-10-10 23:57:00.581094|2017-10-10 23:57:00.581094
NCT02258971|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-01|||March 2007||2007-03-01|September 2014|2014-09-01||||May 2007|Actual|2007-05-01||Interventional|||Metabolism and Pharmacokinetics of [14C] BEA 2180 BR Administered Orally Compared to [14C] BEA 2180 BR Administered Intravenously in Healthy Male Volunteers|Investigation of the Metabolism and Pharmacokinetics of 1200 μg (Free Cation) [14C] BEA 2180 BR Administered Orally Compared to 500 μg (Free Cation) [14C] BEA 2180 BR Administered Intravenously in Healthy Male Volunteers in an Open Label, Single-dose and Parallel Study Design|Completed||Phase 1|14|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:57:00.674112|2017-10-10 23:57:00.674112
NCT02258958|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-12-16|||January 2014||2014-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection|Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against Deep Venous Thrombosis and Pulmonary Embolus in Patients Undergoing Major Lung Resection: A Pilot Study to Evaluate the Incidence of DVT and PE After Major Lung Resection|Completed||N/A|150|Actual|McMaster University|||1||f||||f||||||||||2017-10-10 23:57:00.762446|2017-10-10 23:57:00.762446
NCT02258945|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-02-18|||April 2014||2014-04-01|April 2015|2015-04-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01|1 Year|Observational [Patient Registry]|||CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Cross-Sectional Study|Eating Behaviours, Quality of Life and Cardiometabolic Risks in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Therapy - A Cross-Sectional Study|Completed||N/A|60|Actual|Liverpool John Moores University|||2||f||||f||||||Samples Without DNA|"     Plasma will be retained for use by the research team during the study. After the study     remaining samples will be destroyed in accordance with the Human Tissue Authority Code of     Practice.   "|||2017-10-10 23:57:00.865283|2017-10-10 23:57:00.865283
NCT02258932|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-02-18|||December 2013||2013-12-01|July 2015|2015-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|12 Months|Observational [Patient Registry]|||CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Longitudinal Study|Eating Behaviours, Quality of Life and Cardiometabolic Risks in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Therapy - A Longitudinal Study|Completed||N/A|5|Actual|Liverpool John Moores University|||1||f||||f||||||Samples Without DNA|"     Plasma will be retained for use by the research team during the study. After the study     remaining samples will be destroyed in accordance with the Human Tissue Authority Code of     Practice.   "|||2017-10-10 23:57:01.147724|2017-10-10 23:57:01.147724
NCT02258919|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|SWITCH||Decompressive Hemicraniectomy in Intracerebral Hemorrhage|Swiss Trial of Decompressive Craniectomy Versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage (SWITCH): a Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:57:01.302562|2017-10-10 23:57:01.302562
NCT02258906|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-08-23|||October 2014||2014-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy|Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy|Completed||N/A|66|Actual|Yonsei University||2|||f||||t||||||||||2017-10-10 23:57:01.651571|2017-10-10 23:57:01.651571
NCT02258893|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-08-28|||January 2016||2016-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|CAPS||Indoor Air Pollution and Children With Asthma: An Intervention Trial|Indoor Nitrogen Dioxide Exposure and Children With Asthma: An Intervention Trial|Recruiting||N/A|300|Anticipated|Yale University||6|||f||||t||||||||||2017-10-10 23:57:01.788497|2017-10-10 23:57:01.788497
NCT02258880|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-10-19|||September 2014||2014-09-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke|A Phase 2, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SUN13837 Administered 28 Doses (27/28 Days) to Adult Subjects With an Acute Ischemic Stroke|Withdrawn||Phase 2|0|Actual|Daiichi Sankyo, Inc.||2||study was stopped for business/administrative reasons and not for patient safety concerns|f||||t||||||||||2017-10-10 23:57:01.981858|2017-10-10 23:57:01.981858
NCT02258867|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-12-28|||November 2014||2014-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|EYEGUARD™-US||Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis|A Randomized-Withdrawal, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Subjects With Behcet's Disease Uveitis|Terminated||Phase 3|4|Actual|XOMA (US) LLC||2|||f||||f||||||||||2017-10-10 23:57:02.228858|2017-10-10 23:57:02.228858
NCT02258854|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-10-14|||March 2014||2014-03-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|EYEGUARD™-E||An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data|An Open-Label, Non-Randomized, Single-Arm, Rollover Study to Continue Dosing of Gevokizumab in Subjects With Non Infectious Intermediate-, Posterior-, or Pan-Uveitis Patients Who Each Successfully Completed Either the X052130/CL3-78989-005 (EYEGUARD™-A) or the X052131/CL3-78989-006 (EYEGUARD™-C) Study or Who Have Controlled Ocular Inflammation After Receiving Study Drug in Study X052133 (EYEGUARD™-US)|Terminated||Phase 3|69|Actual|XOMA (US) LLC||1|||f||||f||||||||||2017-10-10 23:57:02.360467|2017-10-10 23:57:02.360467
NCT02258841|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-12-07|||October 2014||2014-10-01|December 2015|2015-12-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|||Effectiveness of an Online Safety Tool for Canadian Women Experiencing Intimate Partner Violence|Testing an Internet-based Safety Decision Aid for Women Experiencing Intimate Partner Violence|Active, not recruiting||N/A|462|Actual|Western University, Canada||2|||f||||t||||||||||2017-10-10 23:57:02.537342|2017-10-10 23:57:02.537342
NCT02258828|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-11-01|||July 2005||2005-07-01|November 2016|2016-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder|An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder|Completed||Phase 4|26|Actual|VA Nebraska Western Iowa Health Care System||2|||f||||f||||||||Yes||2017-10-10 23:57:02.656748|2017-10-10 23:57:02.656748
NCT02258815|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-10-02|||August 2010||2010-08-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma|Phase II Feasability Study Using ch14.18/CHO Antibody and Subcutaneous Interleukin 2 After Haploidentical Stem Cell Transplantation in Children With Relapsed Neuroblastoma|Unknown status|Recruiting|Phase 2|35|Anticipated|University Children’s Hospital Tuebingen||1|||f||||t||||||||||2017-10-10 23:57:02.775733|2017-10-10 23:57:02.775733
NCT02258802|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-05-11|||June 2014||2014-06-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Pilot Psychoeducational Intervention Model to Improve Nutritional Status in Low Resource Settings|A Psychoeducational Intervention Model in Nutrition to Improve Nutritional Status in a Pilot Low Resource Population in the City of Saltillo, Coahuila Mexico.|Completed||N/A|65|Actual|Universidad de Monterrey||2|||f||||t||||||||No||2017-10-10 23:57:02.926952|2017-10-10 23:57:02.926952
NCT02258789|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-10-02|||September 2010||2010-09-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|RehAtt||Assessment and Training Visio Spatial Neglect in a Virtual Reality Environment|Assessment and Training Visio Spatial Neglect in a Virtual Reality Environment|Completed||N/A|15|Actual|Umeå University||1|||f||||t||||||||||2017-10-10 23:57:03.02268|2017-10-10 23:57:03.02268
NCT02258776|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-02-27|||October 2015||2015-10-01|February 2017|2017-02-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|PomSkin||The Effect of Pomegranate on Aging and Inflammation of the Skin|Clinical Trial to Determine the Efficacy of Pomegranate for Skin Inflammation and Aging|Completed||N/A|75|Actual|University of California, Los Angeles||3|||f||||f||||||||No||2017-10-10 23:57:03.103998|2017-10-10 23:57:03.103998
NCT02258763|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-12-28|||November 2014||2014-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia|Pneumonia in Children: Aetiology, Ideal Antibiotic Duration, Quality of Life|Active, not recruiting||Phase 4|19|Actual|University of Malaya||2|||f||||f||||||||||2017-10-10 23:57:03.189405|2017-10-10 23:57:03.189405
NCT02258750|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-01-06|||November 2014||2014-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Assessing a Polydextrose Containing Soup on Food Intake, Appetite and Biomarkers of Satiation and Satiety|Experimental Study to Investigate the Effect of a High Fibre, Polydextrose-enriched Tomato Soup on Food Intake, the Experience of Appetite and Biomarkers of Satiation and Satiety|Terminated||N/A|42|Actual|University of Liverpool||2||End of EU funding for the work package under investigation|f||||f||||||||||2017-10-10 23:57:03.306984|2017-10-10 23:57:03.306984
NCT02258737|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-02|||October 2007||2007-10-01|October 2014|2014-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy of Transitional Case Management Following Psychiatric Hospital Discharge|Efficacy of Transitional Case Management Following Psychiatric Hospital Discharge: a Randomized Trial|Completed||N/A|110|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-10 23:57:03.417343|2017-10-10 23:57:03.417343
NCT02258711|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-02-18|||October 2014||2014-10-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|March 2016|Anticipated|2016-03-01||Interventional|SIMPLE||Self-Monitoring and Psychoeducation in Bipolar Patients With a Smart-phone Application|SIgns and Symptoms Self-Monitoring and Psychoeducation in bipoLar Patients With a Smart-phonE Application (SIMPLE)|Active, not recruiting||N/A|148|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-10 23:57:03.632992|2017-10-10 23:57:03.632992
NCT02258698|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-01-31|||May 2013||2013-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|May 2015|Actual|2015-05-01||Observational|||Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac Surgery|Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac Surgery|Completed||N/A|348|Actual|University Hospital, Basel, Switzerland|||1||f||||t||||||Samples Without DNA|"     blood samples (Serum)   "|||2017-10-10 23:57:03.722845|2017-10-10 23:57:03.722845
NCT02258685|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-12-09|||November 2014||2014-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.|Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.|Recruiting||N/A|93|Anticipated|University of Colorado, Denver|||6||f||||f||||||Samples Without DNA|"     Blood and rectosigmoid biopsy tissue will be collected.   "|||2017-10-10 23:57:03.82634|2017-10-10 23:57:03.82634
NCT02258672|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-05-25|||October 2014||2014-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Preoperative Rehabilitation for Patients Undergoing Surgery for Lumbar Spinal Stenosis|Effects of a Preoperative Rehabilitation Program on the Recovery of Patients Undergoing Surgery for Lumbar Spinal Stenosis: a Feasibility Study.|Recruiting||N/A|40|Anticipated|Université du Québec à Trois-Rivières||2|||f||||f||||||||||2017-10-10 23:57:03.941922|2017-10-10 23:57:03.941922
NCT02258659|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-09-08|||September 22, 2014|Actual|2014-09-22|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|OPTIMA||Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer|An Exploratory Pilot Study of Nab-paclitaxel Based Induction Chemotherapy Followed by Response-Stratified Locoregional Therapy for Patients With Stage III and IV HPV-Related Oropharyngeal Cancer - the OPTIMA HPV Trial|Active, not recruiting||Phase 2|62|Actual|University of Chicago||3|||f||||t||||||||||2017-10-10 23:57:04.068162|2017-10-10 23:57:04.068162
NCT02258646|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-02-15|||October 2014|Actual|2014-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|iTrain||Long-Term Integrated Telerehabilitation of COPD Patients. A Multi-Center Trial|Long-Term Integrated Telerehabilitation of COPD Patients. A Multi-Center Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|University Hospital of North Norway||3|||f||||||||||||||2017-10-10 23:57:04.273049|2017-10-10 23:57:04.273049
NCT02258633|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-06|||March 2009||2009-03-01|October 2014|2014-10-01||||February 2010|Actual|2010-02-01||Interventional|||The Seatbelt Intervention Study|A Brief Tailored Family-centered Seatbelt Intervention for Hospitalized Trauma|Completed||N/A|200|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:57:04.417748|2017-10-10 23:57:04.417748
NCT02258620|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-03|||June 2013||2013-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Prevention and Comparison of Different Forms of Administration of Nitrates in the Risk of Radial Spasm During Coronary Angiography.|Prevention and Comparison of Different Forms of Administration of Nitrates in the Risk of Radial Spasm During Coronary Angiography.|Completed||N/A|442|Actual|Brugmann University Hospital||3|||f||||t||||||||||2017-10-10 23:57:04.548595|2017-10-10 23:57:04.548595
NCT02258607|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-24|||March 11, 2015|Actual|2015-03-11|March 2017|2017-03-01|February 27, 2017|Actual|2017-02-27|July 19, 2016|Actual|2016-07-19||Interventional|||Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase|A Phase 1b With Expansion Study Evaluating the Efficacy and Safety of Momelotinib Combined With Trametinib in Subjects With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase|Terminated||Phase 1|21|Actual|Gilead Sciences||3|||f||||f|t|f||||||||2017-10-10 23:57:04.629168|2017-10-10 23:57:04.629168
NCT02258594|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-03|||March 2013||2013-03-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|PROSPECT||Promoting Respect and Ongoing Safety Through Patient-centeredness, Engagement, Communication and Technology|Transforming the Acute Care Environment: BWH PROSPECT Framework|Unknown status|Recruiting|N/A|4368|Anticipated|Brigham and Women's Hospital||3|||f||||f||||||||||2017-10-10 23:57:04.72911|2017-10-10 23:57:04.72911
NCT02258581|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-09-29|||December 9, 2014|Actual|2014-12-09|September 2017|2017-09-01|August 14, 2017|Actual|2017-08-14|August 14, 2017|Actual|2017-08-14||Observational|||Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection|A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection|Terminated||N/A|241|Actual|Gilead Sciences|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-10 23:57:04.836387|2017-10-10 23:57:04.836387
NCT02258568|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-02-01|||December 2013||2013-12-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|PRISM||Postnatal Smoking Relapse, Its Associated Risk Factors, and a Proactive Sustainable Preventive Intervention|Postnatal Smoking Relapse, Its Associated Risk Factors, and a Proactive Sustainable Preventive Intervention|Completed||N/A|397|Actual|Babes-Bolyai University||2|||f||||f||||||||||2017-10-10 23:57:04.992189|2017-10-10 23:57:04.992189
NCT02258555|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2015-10-15|||January 2015||2015-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma|A Phase 1b Dose-escalation Study Evaluating the Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Subjects With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma|Terminated||Phase 1|7|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-10 23:57:05.086458|2017-10-10 23:57:05.086458
NCT02258542|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2017-07-25|||November 19, 2014|Actual|2014-11-19|April 2017|2017-04-01|July 9, 2018|Anticipated|2018-07-09|October 25, 2017|Anticipated|2017-10-25||Interventional|BORA||A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA|A Multicentre, Double-blind, Randomized, Parallel Group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus Long-acting β2 Agonist (BORA)|Active, not recruiting||Phase 3|2133|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-10 23:57:05.219364|2017-10-10 23:57:05.219364
NCT02258529|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-04-11|2017-04-11||September 14, 2015|Actual|2015-09-14|April 2017|2017-04-01|May 3, 2016|Actual|2016-05-03|April 12, 2016|Actual|2016-04-12||Interventional||Intent-to-Treat (ITT) Analysis Set: all participants who received at least 1 dose of study drug.|Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma|A Phase 2, Single Arm Study Evaluating the Safety and Efficacy of Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma|Terminated||Phase 2|10|Actual|Gilead Sciences|Due to the early termination of the study, efficacy data were not available for all participants, and therefore the prespecified analyses were not conducted.|1|||f||||t|t|f||||||||2017-10-10 23:57:07.665175|2017-10-10 23:57:07.665175
NCT02258516|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-08-19|||September 2009||2009-09-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Randomized Study of the Efficacy of a New Intervention for Medication Adherence in Chronic Illness: Medications, Meaning and Me (The 3-M Study)|A Randomized Study of the Efficacy of a New Intervention for Medication Adherence in Chronic Illness: Medications, Meaning and Me (The 3-M Study)|Completed||N/A|87|Actual|Duke University||2|||f||||f||||||||||2017-10-10 23:57:08.076726|2017-10-10 23:57:08.076726
NCT02258503|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2014-10-06|||January 2013||2013-01-01|October 2014|2014-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|DOLEVA75||Impact of the Use of the Scale ALGOPLUS® on the Prescriptions of Analgesics in Emergency Department on Patients of 75 Years Old or More|Impact of the Use of the Scale ALGOPLUS® on the Prescriptions of Analgesics in Emergency Department on Patients of 75 Years Old or More|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-10 23:57:08.249599|2017-10-10 23:57:08.249599
NCT02258490|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-11-28||||||November 2016|2016-11-01||||||||Expanded Access|||Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation|Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation to Recipients With Limited Donor Engraftment|Available||N/A|||Emory University|||||||||||||||||||2017-10-10 23:57:08.355151|2017-10-10 23:57:08.355151
NCT02258477|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-02-04|2015-10-07||October 2014||2014-10-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|SWG|37 subjects were screened and enrolled into the study. Each subject was randomized to a different sequence of consumption of the weekly study beverage. 33 subjects completed the 4 week study.|A Pilot Study: Snacking, Willpower and Glucose Availability|A Pilot Study: Snacking, Willpower and Glucose Availability|Completed||N/A|37|Actual|University of Colorado, Denver|The study questionnaire involved limitations as questions were subjective in terms of how subjects defined cravings and snacking behavior. Also, food diaries may not be fully accurate accounts of subjects' actual caloric intake and food consumption.|4|||f||||f||||||||||2017-10-10 23:57:08.463786|2017-10-10 23:57:08.463786
NCT02258464|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-21|||February 17, 2015|Actual|2015-02-17|September 2017|2017-09-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|||Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer|A Phase II Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride Versus Placebo When Administered to Metastatic HER2 Negative Hormone Receptor Positive Breast Cancer Subjects With Bone Metastases Treated With Hormonal Treatment Background Therapy|Recruiting||Phase 2|227|Anticipated|Bayer||2|||f||||t||||||||||2017-10-10 23:57:08.968185|2017-10-10 23:57:08.968185
NCT02258451|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-18|||June 4, 2015|Actual|2015-06-04|September 2017|2017-09-01|March 15, 2019|Anticipated|2019-03-15|August 31, 2018|Anticipated|2018-08-31||Interventional|||Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer|A Phase II Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus When Administered to Metastatic HER2 Negative Hormone Receptor Positive Breast Cancer Subjects With Bone Metastases|Recruiting||Phase 2|311|Anticipated|Bayer||2|||f||||t|t|f||||||||2017-10-10 23:57:09.444658|2017-10-10 23:57:09.444658
NCT02258438|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-12-05|||October 2014||2014-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of Breaking up Prolonged Sitting on Metabolic Flexibility|Effect of Breaking up Prolonged Sitting on Metabolic Flexibility|Recruiting||N/A|30|Anticipated|University of Colorado, Denver||3|||f||||f||||||||||2017-10-10 23:57:09.925986|2017-10-10 23:57:09.925986
NCT02258425|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-06-16|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|FEM-CARE||Homeless Female Offenders Returning to the Community|Homeless Female Offenders Returning to the Community: Improving Hopeful Futures|Completed||N/A|130|Actual|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-10 23:57:10.01219|2017-10-10 23:57:10.01219
NCT02258412|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-05-15|2017-01-31||October 2014||2014-10-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation of Two Hand Hygiene Products in ICUs|Evaluation of Antimicrobial Efficacy of Two Hand Hygiene Products in ICUs Using Hand Prints|Completed||Phase 4|51|Actual|3M||2|||f||||f|t|f||||||No||2017-10-10 23:57:10.090065|2017-10-10 23:57:10.090065
NCT02258386|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||October 2014||2014-10-01|October 2014|2014-10-01|September 2017|Anticipated|2017-09-01|September 2015|Anticipated|2015-09-01||Observational|||Assessment of Delirium in Hospitalized Patients|Objective Assessment of Delirium in Hospitalized Patients|Unknown status|Not yet recruiting|N/A|200|Anticipated|University of Arizona|||1||f||||f||||||||||2017-10-10 23:57:10.422112|2017-10-10 23:57:10.422112
NCT02258373|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-10-17|||March 2015||2015-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|REPLACE-BG||A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes|A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes|Completed||N/A|226|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-10 23:57:10.491883|2017-10-10 23:57:10.491883
NCT02258360|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-03-28|||February 2013||2013-02-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2015|Actual|2015-06-01||Interventional|||Hypothermia and Hemostasis After Cardiac Arrest|The Effect of Therapeutic Hypothermia After Cardiac Arrest on the Haemostasis.|Active, not recruiting||N/A|82|Actual|University of Aarhus||2|||f||||||||||||||2017-10-10 23:57:10.608828|2017-10-10 23:57:10.608828
NCT02258347|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-04-20|||July 2014||2014-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||HIFU in Patients With Non-malignant Thyroid Nodules|Use of a High Intensity Focused Ultrasound (HIFU) in Patients With Non-malignant Thyroid Nodules.|Terminated||N/A|4|Actual|Theraclion||1||End of recruitment period - study recruitment objectives not reached|f||||f||||||||||2017-10-10 23:57:10.696226|2017-10-10 23:57:10.696226
NCT02258334|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-09-16|2015-09-16||October 2014||2014-10-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults|Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations|Completed||Phase 4|208|Actual|Sanofi||4|||f||||f||||||||||2017-10-10 23:57:10.786684|2017-10-10 23:57:10.786684
NCT02258321|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-01-20|||October 2014||2014-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations|A Phase 1, Open-Label, Crossover Study to Evaluate the Relative Bioavailability of a New Tablet Formulation Versus the Current Capsule Formulation of PPI-668 in Healthy Adult Volunteers|Completed||Phase 1|12|Actual|Presidio Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:57:11.57671|2017-10-10 23:57:11.57671
NCT02258308|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-04-12|||May 2010||2010-05-01|April 2017|2017-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||CDC Medicaid Asthma Home Visit Project|Medicaid Asthma Home Visit Project: Improving Health and Reducing Costs of Health Care for Children With Asthma|Completed||N/A|373|Actual|Public Health - Seattle and King County||2|||f||||f||||||||||2017-10-10 23:57:11.647926|2017-10-10 23:57:11.647926
NCT02258295|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2017-08-15|||January 18, 2017|Actual|2017-01-18|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hyaluronate Injection for Lateral Epicondylitis|Hyaluronate Injection for Lateral Epicondylitis: A Double-blind Randomized Controlled Trial|Recruiting||Phase 3|72|Anticipated|Shaare Zedek Medical Center||2|||f||||f|f|f||||||||2017-10-10 23:57:11.734322|2017-10-10 23:57:11.734322
NCT02258282|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-31|||May 2014||2014-05-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Safety and Efficacy of Etanercept in Patients With Psoriasis||Active, not recruiting||N/A|80|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:57:11.820003|2017-10-10 23:57:11.820003
NCT02258269|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-03-31|||August 2014||2014-08-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effect of Square Dance on Rheumatoid Arthritis||Enrolling by invitation||N/A|150|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:57:11.887369|2017-10-10 23:57:11.887369
NCT02258243|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-11-04|||December 2015||2015-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Interventional|||Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome|Pilot Trial Comparing Two Different Wavelengths of Light (Blue Versus Red) During LevulanTM-Based Photodynamic Therapy of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome|Active, not recruiting||Phase 2|3|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:57:12.157775|2017-10-10 23:57:12.157775
NCT02258230|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-04-27|||December 2014|Actual|2014-12-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair|Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications|Recruiting||N/A|194|Anticipated|Olympus Corporation of the Americas||4|||f||||f||||||||||2017-10-10 23:57:12.285718|2017-10-10 23:57:12.285718
NCT02258217|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-11|||June 2014||2014-06-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|June 24, 2016|Actual|2016-06-24||Interventional|||Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)|Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TAMS)|Completed||N/A|30|Actual|OhioHealth||1|||f||||f||||||||||2017-10-10 23:57:12.400223|2017-10-10 23:57:12.400223
NCT02258204|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2016-02-23|||March 2015||2015-03-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|KETA||Ketamine for Thrombolysis in Acute Ischemic Stroke|Effets de la kétamine en Association Avec le Rt-PA au Cours de l'Infarctus cérébral Aigu: étude Pilote contrôlée randomisée en Double Aveugle Avec critère de Jugement Radiologique|Recruiting||Phase 1/Phase 2|50|Anticipated|University Hospital, Caen||2|||f||||t||||||||||2017-10-10 23:57:12.480235|2017-10-10 23:57:12.480235
NCT02258191|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-04-11|||July 2014||2014-07-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|eCOPD||Pilot Study Evaluating Feasibility and Benefits of Telemonitored NIV Treatment on COPD Patients|Pilot Study Evaluating Feasibility and Benefits of Telemonitored NIV Treatment on COPD Patients|Active, not recruiting||N/A|80|Anticipated|ResMed||2|||f||||f||||||||||2017-10-10 23:57:12.602853|2017-10-10 23:57:12.602853
NCT02258178|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-10-03|||September 2014||2014-09-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Flucelvax Pregnancy Registry|Flucelvax Pregnancy Registry: an Observational Study on the Safety of Flucelvax Exposure in Pregnant Women and Their Offspring|Withdrawn||N/A|0|Actual|Seqirus|||1||f||||||||||||||2017-10-10 23:57:12.763933|2017-10-10 23:57:12.763933
NCT02258165|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-03-28|||February 2015||2015-02-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|IMAGE||Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer|Impact of Gated PET/CT on the Diagnosis of Distant Metastases of Advanced Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Recruiting||Phase 2|84|Anticipated|Queensland Centre for Gynaecological Cancer|||1||f||||f||||||||No||2017-10-10 23:57:12.862453|2017-10-10 23:57:12.862453
NCT02258152|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-08-01|||December 22, 2014|Actual|2014-12-22|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SYNAPSE||SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)|SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)|Active, not recruiting||Phase 2|80|Anticipated|Biotie Therapies Inc.||2|||f||||t||||||||||2017-10-10 23:57:13.000297|2017-10-10 23:57:13.000297
NCT02258139|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-05-31|||November 3, 2014||2014-11-03||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:57:13.128137|2017-10-10 23:57:13.128137
NCT02258126|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-01-30|||November 2014||2014-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|EFIGRO||Effect of Exercise on Hepatic Fat in Overweight Children|The Effect of Exercise on Hepatic Fat in Overweight Children; the EFIGRO Study|Recruiting||N/A|160|Anticipated|Basque Country University||2|||f||||f||||||||||2017-10-10 23:57:13.173039|2017-10-10 23:57:13.173039
NCT02258113|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-04-27|||November 2014||2014-11-01|April 2016|2016-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Measuring of Neuro-visual Functionality With Ocusweep|Measuring of Neuro-visual Functionality With New Human Visual System Device Ocusweep|Recruiting||N/A|600|Anticipated|Ocuspecto Oy||1|||f||||||||||||||2017-10-10 23:57:13.295732|2017-10-10 23:57:13.295732
NCT02258100|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-04-22|||September 2014||2014-09-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Anesthesia Information System vs Paper Anesthesia Records for Care Congruency|Retrospective Review of an Anesthesia Information System and Paper Anesthesia Records for Care Congruency in a Single Surgical Population.|Completed||N/A|189|Actual|NorthShore University HealthSystem|||2||f||||f||||||||||2017-10-10 23:57:13.387728|2017-10-10 23:57:13.387728
NCT02258087|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-10-02|||September 2014||2014-09-01|October 2014|2014-10-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|PROMOBRA||HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.|Comparison of High-dose- Versus Low-dose-rate Brachytherapy as Monotherapy in the Treatment of Early, Organ Confined Prostate Cancer.|Recruiting||Phase 2/Phase 3|50|Anticipated|National Institute of Oncology, Hungary||2|||f||||f||||||||||2017-10-10 23:57:13.475018|2017-10-10 23:57:13.475018
NCT02258074|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-12-27|||March 2015||2015-03-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|COMBINE||The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE|The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE|Active, not recruiting||Phase 3|205|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||t||||||||||2017-10-10 23:57:13.592267|2017-10-10 23:57:13.592267
NCT02258061|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-06|||August 2011||2011-08-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Optimal Cardiac Resynchronization Therapy Pacing Rate|Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-ischemic Heart Failure Patients: a Randomized Crossover Pilot Trial.|Completed||Early Phase 1|15|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:57:13.731558|2017-10-10 23:57:13.731558
NCT02258048|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-03-09|||October 2014||2014-10-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis|The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis|Withdrawn||N/A|0|Actual|New York University School of Medicine|||1|Samuel Sigal no longer with NYU|f||||f||||||||||2017-10-10 23:57:13.829756|2017-10-10 23:57:13.829756
NCT02258035|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-01-23|||November 2014||2014-11-01|November 2016|2016-11-01||||December 2016|Actual|2016-12-01||Observational|||Isolation of Vitamin D Binding Protein Isoforms From Human Volunteers|Isolation of Genotype-specific Isoforms of Human Vitamin D-binding Protein (DBP/Gc)|Active, not recruiting||N/A|24|Anticipated|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||Samples Without DNA|"     Serum will be derived from 100-150 ml of blood and used for protein purification   "|||2017-10-10 23:57:13.909881|2017-10-10 23:57:13.909881
NCT02258022|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-10-26|||October 2014||2014-10-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Changes in 13CO2/12CO2 Delta Value in Exhaled Breath as an Early Indicator of Infection in Adult Trauma Subjects|Changes in 13CO2/12CO2 Delta Value in Exhaled Breath as an Early Indicator of Infection in Adult Trauma Subjects|Terminated||N/A|11|Actual|University of Wisconsin, Madison||1||Low enrollment|f||||t||||||||||2017-10-10 23:57:14.01322|2017-10-10 23:57:14.01322
NCT02258009|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-10-26|||October 2015||2015-10-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|TIDE DME||Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema|A Randomized, Single-blinded, Multicenter, Phase IV Study to Compare Systemic VEGF Protein Dynamics Following Monthly Intravitreal Injections of 0.5 mg Ranibizumab Versus 2 mg Aflibercept Until Study Week 12 in Patients With Visual Impairment Due to Diabetic Macular Edema|Withdrawn||Phase 4|0|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:57:14.096373|2017-10-10 23:57:14.096373
NCT02257996|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-01-14|||August 2015||2015-08-01|January 2015|2015-01-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Effectiveness of Online Systematic Brief Psychodynamic Psychotherapy for Neurotic Disorders: Randomized Controlled Trial|The Effectiveness of Online Systematic Brief Psychodynamic Psychotherapy Via HIPAA Complaint Web Conferencing on Adults With Neurotic Disorders: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|32|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:57:14.19669|2017-10-10 23:57:14.19669
NCT02257983|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-03-18|||October 2014||2014-10-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Protective Effects of EPI-743 on Noise-Induced Hearing Loss|A Phase 2A Randomized, Placebo Controlled, Double Blind Study of the Protective Effects of EPI-743 (VincerinoneTM) on Noise-Induced Hearing Loss|Completed||Phase 2|77|Actual|Edison Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-10 23:57:14.296703|2017-10-10 23:57:14.296703
NCT02257970|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-03-09|||March 2009||2009-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|PB||Placebo-controlled Lymphedema Study for Arm or Leg Lymphedema|Case-controlled, Open Label Therapeutic Trial for Unilateral or Bilateral Lymphedema of Arm or Leg.|Suspended||Phase 1|150|Anticipated|Stanford University||2||study endpoints met|f||||f||||||||Undecided|grouped data may be shared|2017-10-10 23:57:14.38788|2017-10-10 23:57:14.38788
NCT02257957|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-10-02|||November 2014||2014-11-01|October 2014|2014-10-01||||September 2015|Anticipated|2015-09-01||Interventional|||Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye|Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye|Unknown status|Not yet recruiting|Phase 3|30|Anticipated|Universidad Nacional de Colombia||2|||f||||t||||||||||2017-10-10 23:57:14.487818|2017-10-10 23:57:14.487818
NCT02257944|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-06|||October 2014||2014-10-01|October 2014|2014-10-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|VOV-RCT||Assessing and Reducing Risk of Violent Re-Injury Among Victims of Urban Violence|Assessing and Reducing Risk of Violent Re-Injury Among Victims of Urban Violence: A Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|Conrad, Erich J., M.D.||2|||f||||f||||||||||2017-10-10 23:57:14.585146|2017-10-10 23:57:14.585146
NCT02257931|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-04-28|||February 2014||2014-02-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01|6 Months|Observational [Patient Registry]|GNB||Gram-negative Bacteremia in HSCT Recipients|Resistance Pattern of Gram-negative Bacteria Isolated From Blood From HSCT Recipients.|Completed||N/A|591|Actual|European Group for Blood and Marrow Transplantation|||1||f||||f||||||||||2017-10-10 23:57:14.659534|2017-10-10 23:57:14.659534
NCT02257918|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-02-16|2016-12-15||November 25, 2014||2014-11-25|January 5, 2016|2016-01-05|December 30, 2015|Actual|2015-12-30|December 30, 2015|Actual|2015-12-30||Interventional||All participants enrolled and randomized are included in the baseline analysis population.|Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea|A Randomized, Open-label Phase 2 Study to Evaluate the Efficacy and Safety of a Single Dose of Oral AZD0914 Compared to Intramuscular Ceftriaxone in the Treatment of Male and Female Subjects With Uncomplicated Gonorrhea|Completed||Phase 2|180|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f|||||t|f|||f|||||2017-10-10 23:57:14.770816|2017-10-10 23:57:14.770816
NCT02257905|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-07-23|||December 2009||2009-12-01|July 2015|2015-07-01||||July 2015|Actual|2015-07-01|5 Years|Observational [Patient Registry]|||Allo SCT in Amyloidosis Non-interventional Study|A Non-interventional Prospective Study on Allogeneic Stem Cell Transplantation in Patients With AL Amyloidosis|Completed||N/A|14|Actual|European Group for Blood and Marrow Transplantation|||1||f||||f||||||||||2017-10-10 23:57:15.6425|2017-10-10 23:57:15.6425
NCT02257892|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2017-10-05|||September 30, 2014||2014-09-30|August 8, 2017|2017-08-08|August 30, 2025|Anticipated|2025-08-30|August 30, 2024|Anticipated|2024-08-30||Observational|||Novel Genetic Disorders of the Immune System|Novel Genetic Disorders of the Immune System|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:57:15.822982|2017-10-10 23:57:15.822982
NCT02257879|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-10-05|||September 25, 2014||2014-09-25|June 6, 2017|2017-06-06|October 31, 2018|Anticipated|2018-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|||DHB Supplement Interaction Study|A Pharmacokinetic Study to Assess and Compare the Drug Interaction Risk of the Grapefruit Juice and Dietary Supplements Known to Inhibit CYP3A Enzyme Activity|Not yet recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:57:15.917846|2017-10-10 23:57:15.917846
NCT02257866|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-04|2017-06-30|||September 23, 2014||2014-09-23|May 31, 2017|2017-05-31|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis|Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:57:15.994973|2017-10-10 23:57:15.994973
NCT02257853|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-03|2017-09-09|||September 23, 2014||2014-09-23|September 6, 2017|2017-09-06|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients|A Randomized Controlled Trial to Determine the Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients|Recruiting||Phase 2|90|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-10 23:57:16.087976|2017-10-10 23:57:16.087976
NCT02257827|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-03|||January 2009||2009-01-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule|Randomized Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule.|Completed||Phase 3|220|Actual|Marilia Medicine School||2|||f||||t||||||||||2017-10-10 23:57:16.176628|2017-10-10 23:57:16.176628
NCT02257814|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-10-03|||April 2009||2009-04-01|October 2014|2014-10-01||||June 2012|Actual|2012-06-01||Interventional|||Head Start Classroom-based Approaches and Resources for Emotion and Social Skill Promotion (Head Start CARES)|Head Start Classroom-based Approaches and Resources for Emotion and Social Skill Promotion (Head Start CARES)|Completed||N/A|2670|Actual|MDRC||4|||f||||t||||||||||2017-10-10 23:57:16.252919|2017-10-10 23:57:16.252919
NCT02005965|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-03-11|||September 2007||2007-09-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2016|Actual|2016-03-01||Observational|MERCURY II||Low Rectal Cancer Study (MERCURY II)|The Low Rectal Cancer Study.|Active, not recruiting||N/A|542|Actual|Royal Marsden NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 00:59:17.154675|2017-10-11 00:59:17.154675
NCT02257801|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-01-21|||January 2013||2013-01-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MemLearn||Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and in an Acute Stressful Situation (TSST - Trier Social Stress Test): A Randomized, Double-blind, Placebo-controlled Trial)|Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and in an Acute Stressful Situation (TSST - Trier Social Stress Test): A Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 2|150|Actual|DSM Nutritional Products, Inc.||3|||f||||f||||||||||2017-10-10 23:57:16.344135|2017-10-10 23:57:16.344135
NCT02257788|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-03-07|||September 2014||2014-09-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||PRO 140 for Human Immunodeficiency Virus Infection|PRO 140 2103: A Phase 2a, Randomized Study of PRO 140 by Subcutaneous Injection in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection|Withdrawn||Phase 2|0|Actual|Drexel University||4||Unlikely to achieve targeted accrual|f||||t||||||||||2017-10-10 23:57:16.448935|2017-10-10 23:57:16.448935
NCT02257775|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-03-01|||May 2015||2015-05-01|August 2016|2016-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Observational|EVOLUTION||Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer|Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer|Recruiting||N/A|10|Anticipated|Institute of Cancer Research, United Kingdom|||1||f||||f||||||||||2017-10-10 23:57:16.553155|2017-10-10 23:57:16.553155
NCT02257762|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-09-13|||February 2016||2016-02-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia|Efficacy of a Locally-Produced Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement (LNS) for Children Under Two Years in Cambodia|Active, not recruiting||N/A|487|Actual|Institut de Recherche pour le Developpement, Cambodia||4|||f||||f||||||||||2017-10-10 23:57:16.633308|2017-10-10 23:57:16.633308
NCT02257749|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-11-30|||January 2016||2016-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial Study of an Exercise Program for Youth With Persistent Symptoms After Concussion|Comparing Active Rehabilitation to a Comprehensive Education Intervention for Youth With Persistent Post-concussion Symptoms Following Concussion.|Terminated||N/A|100|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||2||feasibility; challenges with recruitment|f||||f||||||||||2017-10-10 23:57:16.748724|2017-10-10 23:57:16.748724
NCT02257736|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-07-27|||November 26, 2014|Actual|2014-11-26|July 2017|2017-07-01|August 24, 2021|Anticipated|2021-08-24|December 20, 2018|Anticipated|2018-12-20||Interventional|||An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)|A Phase 3 Randomized, Placebo-controlled Double-blind Study of JNJ-56021927 in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)|Active, not recruiting||Phase 3|983|Actual|Aragon Pharmaceuticals, Inc.||2|||f||||f|t|||||||||2017-10-10 23:57:16.873148|2017-10-10 23:57:16.873148
NCT02257723|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-01-08|||January 2012||2012-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|||The Effect of Integrated CAM Treatment in Hospitalized Patients|The Effect of Integrated CAM Treatment in Patients Hospitalized at a Korean Medicine Hospital|Completed||N/A|2946|Actual|Jaseng Hospital of Korean Medicine|||1||f||||t||||||||||2017-10-10 23:57:17.328167|2017-10-10 23:57:17.328167
NCT02257710|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-28|||November 2015|Actual|2015-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||BIOFLOW-III UK Satellite Registry Orsiro Stent System|BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III United Kingdom Satellite|Recruiting||N/A|500|Anticipated|Biotronik UK Ltd.|||1||f||||f||||||||||2017-10-10 23:57:17.41918|2017-10-10 23:57:17.41918
NCT02257697|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-07-21|||November 2014||2014-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome|A Multi-center, Randomized, Controlled, Open-label Clinical Study to Evaluate the Efficacy and Safety of Mizoribine in Comparison With Cyclophosphamide in the Treatment of Refractory Nephrotic Syndrome|Recruiting||Phase 3|238|Anticipated|Asahi Kasei Pharma Corporation||2|||f||||f||||||||||2017-10-10 23:57:17.537495|2017-10-10 23:57:17.537495
NCT02257684|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-03-06|2017-01-05||September 2014||2014-09-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|February 2015|Actual|2015-02-01||Interventional|||A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)|A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)|Terminated||Phase 2|4|Actual|Jazz Pharmaceuticals|Only 1 patient achieved the predefined SAA level above the 0.1 IU/mL therapeutic threshold 14 days following IV pegcrisantaspase dose in Course 1. Therefore, the corresponding PK parameters for repeated administration were not calculated.|1||Sponsor decision|f||||t||||||||No||2017-10-10 23:57:17.704972|2017-10-10 23:57:17.704972
NCT02257671|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2014-10-02|||February 2012||2012-02-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|P-piller101||Oral Contraceptives and Economic Behaviour|The Influence of Oral Contraceptives on Mood, Sexuality and Economic Behavior|Unknown status|Recruiting|N/A|400|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-10 23:57:18.085017|2017-10-10 23:57:18.085017
NCT02257658|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-03|||September 2011||2011-09-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|DPMSM||Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM|Doxycycline Prophylaxis or Incentive Payments to Reduce Incident Syphilis Among HIV- Infected Men Who Have Sex With Men Who Continue to Engage in High Risk Sex: A Randomized, Controlled Pilot Study|Completed||N/A|30|Actual|Los Angeles LGBT Center||2|||f||||f||||||||||2017-10-10 23:57:18.164609|2017-10-10 23:57:18.164609
NCT02003755|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2013-12-03|||April 2011||2011-04-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effects of Continuous Passive Motion on Hypertonia of Soleus in Individuals With Cerebral Palsy||Completed||N/A|8|Actual|Chang Gung University||1|||f||||t||||||||||2017-10-11 00:59:51.635316|2017-10-11 00:59:51.635316
NCT02257645|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-05|||March 2015||2015-03-01|October 2014|2014-10-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Observational|||Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks|A Multicenter, Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization Against Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus Influenza Type B in Infants|Unknown status|Not yet recruiting|N/A|3000|Anticipated|LG Life Sciences|||1||f||||f||||||||||2017-10-10 23:57:18.283877|2017-10-10 23:57:18.283877
NCT02257632|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-28|||April 8, 2015|Actual|2015-04-08|September 2017|2017-09-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|TIDE AMD||Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration|A Randomized, Single-blinded, Multicenter, Phase IV Study to Compare Systemic VEGF Protein Dynamics Following Monthly Intravitreal Injections of 0.5 mg Ranibizumab Versus 2 mg Aflibercept Until Study Week 12 in Patients With Neovascular (Wet) Age-related Macular Degeneration|Recruiting||Phase 4|40|Anticipated|Novartis||2|||f||||f|f|f||||||||2017-10-10 23:57:18.36038|2017-10-10 23:57:18.36038
NCT02257619|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-07-03||2016-12-05|June 2014||2014-06-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|||Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer|A Randomized, Phase 2 Study of INCB039110 or Placebo in Combination With Docetaxel in Subjects With Previously Treated Stage IIIb, IV, or Recurrent Non-Small Cell Lung Cancer|Terminated||Phase 2|9|Actual|Incyte Corporation||2||Sponsor decision to not initiate part 2 due to slow enrollment and competing trials.|f||||f||||||||||2017-10-10 23:57:18.46498|2017-10-10 23:57:18.46498
NCT02257606|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-07-02|||July 2011||2011-07-01|July 2015|2015-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Robot-assisted Training of the Upper Limb in Persons With Multiple Sclerosis: an Randomized Controlled Trial|Robot-assisted Training on the Upper Limb in Persons With MS: an RCT|Completed||N/A|17|Actual|Hasselt University||2|||f||||f||||||||||2017-10-10 23:57:18.585431|2017-10-10 23:57:18.585431
NCT02257593|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-03|||May 2009||2009-05-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Developmental Adaptation to an Obesogenic Environment|Developmental Contribution to Macronutrient Selection and Appetite Control in Adult Survivors of Kwashiorkor and Marasmus|Completed||N/A|63|Actual|The University of The West Indies||3|||f||||f||||||||||2017-10-10 23:57:18.747557|2017-10-10 23:57:18.747557
NCT02257580|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-03-09|||January 2015||2015-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||The Effect of Intravenous EACA on Blood Loss and Transfusion Requirements After Bilateral VRO|The Effect of Intravenous E-Aminocaproic Acid (EACA) on Blood Loss and Transfusion Requirements After Bilateral Varus Rotational Osteotomy (VRO)|Recruiting||Phase 4|30|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||No||2017-10-10 23:57:18.822169|2017-10-10 23:57:18.822169
NCT02257567|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-10-05|||October 14, 2014|Actual|2014-10-14|October 2017|2017-10-01|March 28, 2019|Anticipated|2019-03-28|March 28, 2019|Anticipated|2019-03-28||Interventional|||A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma|A PHASE IB/II STUDY EVALUATING THE SAFETY, TOLERABILITY AND ANTI-TUMOR ACTIVITY OF POLATUZUMAB VEDOTIN (DCDS4501A) IN COMBINATION WITH RITUXIMAB (R) OR OBINUTUZUMAB (G) PLUS BENDAMUSTINE (B) IN RELAPSED OR REFRACTORY FOLLICULAR OR DIFFUSE LARGE B-CELL LYMPHOMA|Active, not recruiting||Phase 1/Phase 2|225|Actual|Hoffmann-La Roche||10|||f||||||||||||||2017-10-10 23:57:19.03046|2017-10-10 23:57:19.03046
NCT02257554|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-03-03|||September 2014||2014-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Comparing Patients' and Surgeons' Expectations of Lumbar Spine Surgery|Comparing Patients' and Surgeons' Expectations of Lumbar Spine Surgery|Recruiting||N/A|400|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-10 23:57:19.41977|2017-10-10 23:57:19.41977
NCT02257541|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-04-12|||October 2, 2014|Actual|2014-10-02|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)|A Phase Ib/II Study of BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)|Active, not recruiting||Phase 1/Phase 2|62|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:57:19.517335|2017-10-10 23:57:19.517335
NCT02257502|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-07-04|||July 2015||2015-07-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|INTUITION||Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients|Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Iodiopathic Choroidal Neovascularization in Young Patients|Recruiting||Phase 2|20|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:57:20.572826|2017-10-10 23:57:20.572826
NCT02257489|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-05-10|||September 2014||2014-09-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Phase 1 Study of ACE-083 in Healthy Subjects|A Phase 1, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Local Muscle Injections of ACE-083 in Healthy Postmenopausal Women|Completed||Phase 1|58|Actual|Acceleron Pharma, Inc.||7|||f||||f||||||||||2017-10-10 23:57:20.651884|2017-10-10 23:57:20.651884
NCT02257476|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-02-03|||August 2014|Actual|2014-08-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors|A Phase I Study of Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Malignancies|Completed||Phase 1|22|Actual|Emory University||1|||f||||t||||||||||2017-10-10 23:57:20.731128|2017-10-10 23:57:20.731128
NCT02243774|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-09|||September 2014||2014-09-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|MOTIVATE||Mail Outreach To Increase Vaccination Acceptance Through Engagement|Mail Outreach To Increase Vaccination Acceptance Through Engagement|Completed||N/A|228000|Actual|Brigham and Women's Hospital||5|||f||||||||||||||2017-10-11 00:00:11.781979|2017-10-11 00:00:11.781979
NCT02257463|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-04-07|||October 2011||2011-10-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Inspiratory Muscle Training on Exercise Performance and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease|Effect of Inspiratory Muscle Training on Exercise Performance and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|60|Actual|Mansoura University||3|||f||||t||||||||||2017-10-10 23:57:20.819291|2017-10-10 23:57:20.819291
NCT02257450|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-10-17|||October 2014||2014-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|MyEndo-PA||Primary Aldosteronism in Malaysia: A Nationwide Multicentre Study|Primary Aldosteronism in Malaysia: A Nationwide Multicentre Study|Enrolling by invitation||N/A|2500|Anticipated|International Islamic University Malaysia|||1||f||||t||||||Samples Without DNA|"     Serum, plasma   "|||2017-10-10 23:57:20.900089|2017-10-10 23:57:20.900089
NCT02257437|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-09-13|||June 2015||2015-06-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Acceptability of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia|Acceptability of a Locally-Produced Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement (LNS) for Children Under Two Years in Cambodia|Completed||N/A|92|Actual|Institut de Recherche pour le Developpement, Cambodia||4|||f||||f||||||||||2017-10-10 23:57:20.958756|2017-10-10 23:57:20.958756
NCT02257424|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-06-20|||October 2014||2014-10-01|June 2016|2016-06-01||||October 2017|Anticipated|2017-10-01||Interventional|||The BAMM Trial: BRAF, Autophagy and MEK Inhibition in Metastatic Melanoma: A Phase I/2 Trial of Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma||Recruiting||Phase 1/Phase 2|53|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-10 23:57:21.054656|2017-10-10 23:57:21.054656
NCT02257411|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-10-01|||June 2013||2013-06-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Method to Determine the Size of Laryngeal Mask Airway (LMA)|A Simple Method to Determine the Size of the ProSeal LMA (PLMA) in Children|Completed||N/A|197|Actual|Yeditepe University Hospital||1|||f||||f||||||||||2017-10-10 23:57:21.129134|2017-10-10 23:57:21.129134
NCT02257398|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-07-10|||October 6, 2014|Actual|2014-10-06|July 2017|2017-07-01|March 2, 2015|Actual|2015-03-02|March 2, 2015|Actual|2015-03-02||Interventional|||Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers|A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, 4-Period Crossover Study to Evaluate the Effect of GSK2140944 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers|Completed||Phase 1|55|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-10 23:57:21.191061|2017-10-10 23:57:21.191061
NCT02257385|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2016-02-04|2015-12-10||October 2014||2014-10-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium|Study DB2116961, A Multicentre, Randomised, Blinded, Parallel Group Study to Compare UMEC/VI (Umeclidinium/Vilanterol) in a Fixed Dose Combination With Indacaterol Plus Tiotropium in Symptomatic Subjects With Moderate to Very Severe COPD|Completed||Phase 3|967|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:57:21.343922|2017-10-10 23:57:21.343922
NCT02257372|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-07-10|2015-10-22||September 30, 2014|Actual|2014-09-30|July 2017|2017-07-01|March 24, 2015|Actual|2015-03-24|March 24, 2015|Actual|2015-03-24||Interventional|||A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Parallel Group Study to Evaluate the Effect of Umeclidinium (UMEC) Added to Inhaled Corticosteroid/ Long-acting Beta-agonist Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease COPD|Completed||Phase 4|236|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-10 23:57:21.970847|2017-10-10 23:57:21.970847
NCT02257359|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-05-12|||December 18, 2014|Actual|2014-12-18|May 2017|2017-05-01|January 29, 2015|Actual|2015-01-29|January 29, 2015|Actual|2015-01-29||Interventional|||Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers|A Phase 1, Open Label, Ascending Cohort, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban and Its Metabolite in Healthy Female Volunteers Following Administration of Epelsiban|Completed||Phase 1|12|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-10 23:57:23.869578|2017-10-10 23:57:23.869578
NCT02257346|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-10-01|||November 2014||2014-11-01|October 2014|2014-10-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Intravenous Lidocaine and Quality of Recovery After Cesarean Delivery|The Effect of Perioperative Systemic Lidocaine on Quality of Recovery After Cesarean Delivery|Unknown status|Not yet recruiting|N/A|90|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-10 23:57:23.964829|2017-10-10 23:57:23.964829
NCT02257333|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-10-07|||September 2015||2015-09-01|October 2015|2015-10-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01|2 Years|Observational [Patient Registry]|HEART-VISION||Retinal Thrombosis and Atherosclerosis|High Focused Evaluation of Atherosclerotic Risk Profile in Retinal Thrombosis: Vascular Events Incidence, Sex Involvement and Interventional Outcomes Assessed by Ophthalmologists and Internists Network|Recruiting||N/A|1000|Anticipated|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-10 23:57:24.082144|2017-10-10 23:57:24.082144
NCT02257320|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-06-08|||November 2014||2014-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|Bruxoff||TMJ NextGeneration(TM) Feasibility Study|A Feasibility Study of the Bruxoff™ Device to Assess EMG Activity in Subjects Diagnosed With Sleep Bruxism Using TMJ NextGeneration(TM)|Completed||N/A|10|Actual|Cardiox Corporation||1|||f||||f||||||||||2017-10-10 23:57:24.1688|2017-10-10 23:57:24.1688
NCT02257307|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-04-11|||July 2014||2014-07-01|April 2017|2017-04-01|March 16, 2016|Actual|2016-03-16|April 2015|Actual|2015-04-01||Observational|||Telemedicine Approaches to Evaluating Acute-Phase ROP eROP Implementation Project|Telemedicine Approaches to Evaluating Acute-Phase ROP eROP Ancillary Study - Implementation Project|Terminated||N/A|244|Actual|Children's Hospital of Philadelphia|||1|expired study|f||||t||||||||||2017-10-10 23:57:24.238142|2017-10-10 23:57:24.238142
NCT02257281|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-12-13|||October 2014||2014-10-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Effect of Therapeutic Ultrasound on Soft Tissue: An Experimentally-induced Skin Model|Chung Shan Medical University Hospital Institutional Review Board|Completed||N/A|15|Actual|Chung Shan Medical University||2|||f||||f||||||||||2017-10-10 23:57:25.528264|2017-10-10 23:57:25.528264
NCT02257268|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2015-08-18|||October 2014||2014-10-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Effectiveness of a Program for Physical Activity and Healthy Eating Promotion in Hypertensives|Effectiveness of VAMOS - a Change Behavior Program for Physical Activity and Healthy Eating Promotion - in Hypertensives|Completed||N/A|90|Actual|Universidade Federal de Santa Catarina||2|||f||||f||||||||||2017-10-10 23:57:25.6217|2017-10-10 23:57:25.6217
NCT02257255|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-05-27|||May 2014||2014-05-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Classic Cesarean Section Versus Minimally Invasive Cesarean Section: Pain Assessment|Classic Cesarean Section Versus Minimally Invasive Cesarean Section: Pain Assessment|Completed||N/A|30|Actual|Universidade do Vale do Sapucai||2|||f||||f||||||||||2017-10-10 23:57:25.701311|2017-10-10 23:57:25.701311
NCT02257242|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-05-10|||May 10, 2017|Actual|2017-05-10|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|BRiM||Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab—Phase I Trial in Indolent B-cell Lymphoma|BrUOG 326: A Phase I Dose-Escalation Study of Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With Bendamustine and Rituximab (BRiM) in Indolent Non-Hodgkin Lymphoma|Recruiting||Phase 1|10|Anticipated|Brown University||1|||f||||t|t|f||||||No||2017-10-10 23:57:25.773364|2017-10-10 23:57:25.773364
NCT02257229|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-10-01|||August 2005||2005-08-01|October 2014|2014-10-01|September 2029|Anticipated|2029-09-01|September 2029|Anticipated|2029-09-01||Observational|||Prospective Evaluation of Treatment for Clubfoot|Prospective Evaluation of Treatment for Clubfoot|Recruiting||N/A|1000|Anticipated|Texas Scottish Rite Hospital for Children|||3||f||||t||||||||||2017-10-10 23:57:25.87448|2017-10-10 23:57:25.87448
NCT02257216|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-07-16|||October 2014||2014-10-01|January 2017|2017-01-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)|A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|171|Anticipated|Enzymotec||3|||f||||f||||||||||2017-10-10 23:57:25.961241|2017-10-10 23:57:25.961241
NCT02257203|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-09-16|||October 2014||2014-10-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Primary Care Beverage Study|Evaluation of a Primary Care-Based Intervention to Reduce Consumption of Sugar-sweetened Beverages and 100% Fruit Juice Among Latino Children|Completed||N/A|82|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-10 23:57:26.045254|2017-10-10 23:57:26.045254
NCT02257190|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-10-28|||October 2014||2014-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|aIWS2||The Features Behind the Beneficial Effects of Interval-walking|The Features Behind the Beneficial Effects of Interval-walking|Completed||N/A|12|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-10 23:57:26.126671|2017-10-10 23:57:26.126671
NCT02257177|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-01-04|||September 2014||2014-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients|A Placebo-controlled RCT in HV's Investigating the Safety, Tolerability and PK (Pharmacokinetic) of TD139, a Galectin-3 Inhibitor, Followed by an Expansion Cohort Treating Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 1/Phase 2|60|Actual|Galecto Biotech AB||4|||f||||t||||||||Yes|Interim data from the patient trial will be presented at ICLAF, Dublin 2016|2017-10-10 23:57:26.211363|2017-10-10 23:57:26.211363
NCT02257164|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-06-30|||November 2014||2014-11-01|January 2015|2015-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CLICA||Anesthesic Techniques for Surgery of the Anterior Cruciate Ligament of the Knee in Ambulatory Surgery. Randomized Pilot Monocentric Trial|Anesthesic Techniques for Surgery of the Anterior Cruciate Ligament of the Knee in Ambulatory Surgery. Randomized Pilot Monocentric Trial|Completed||Phase 4|48|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 23:57:26.379326|2017-10-10 23:57:26.379326
NCT02257151|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2015-09-22|||September 2014||2014-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects|Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, and Pharmacokinetics of BMS-986142 in Healthy Subjects|Completed||Phase 1|118|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-10 23:57:26.505311|2017-10-10 23:57:26.505311
NCT02257138|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-05-17|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Ruxolitinib Plus Decitabine in Patients With Acute Myeloid Leukemia (AML)|Phase I/II Study of Ruxolitinib Plus Decitabine in Patients With Post Myeloproliferative Neoplasm - Acute Myeloid Leukemia (AML)|Recruiting||Phase 1/Phase 2|42|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-10 23:57:26.596083|2017-10-10 23:57:26.596083
NCT02257125|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-10-26|||December 2014||2014-12-01|October 2016|2016-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||ArmeoSenso - Reward|ArmeoSenso - Rewarding vs. Non-rewarding Therapy of Patients With Arm Impairments Based on Wearable Movement Sensors|Recruiting||N/A|74|Anticipated|Cereneo AG||2|||f||||f||||||||||2017-10-10 23:57:26.701329|2017-10-10 23:57:26.701329
NCT02257112|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-03-13|||April 2014||2014-04-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Measurement of Low-energy Stimulation in Patients With Atrial Fibrillation|Measurement of Low-energy Stimulation in Patients With Atrial Fibrillation|Recruiting||N/A|15|Anticipated|Cardialen, Inc.||1|||f||||f||||||||||2017-10-10 23:57:26.814031|2017-10-10 23:57:26.814031
NCT02257060|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-06-24|||September 2014||2014-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||LINEAR II - LME-159 Evaluation of a Multi-Electrode Linear Type Ablation Catheter|Evaluation of a Multi-Electrode Linear Type Ablation Catheter for Endocardial Ablation of Patients With Right Atrial Flutter|Completed||Phase 1|12|Actual|Biosense Webster, Inc.||1|||f||||||||||||||2017-10-10 23:57:27.038901|2017-10-10 23:57:27.038901
NCT02257047|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-09-30|||October 2014||2014-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Red Yeast Rice and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis||Enrolling by invitation||N/A|120|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:57:27.132009|2017-10-10 23:57:27.132009
NCT02257034|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2017-03-31|||August 2014||2014-08-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||The Effect of Tai Chi in Treating Fibromyalgia||Enrolling by invitation||N/A|120|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:57:27.207862|2017-10-10 23:57:27.207862
NCT02257021|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||February 2005||2005-02-01|October 2014|2014-10-01||||May 2005|Actual|2005-05-01||Interventional|||Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male Volunteers|Study of Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir|Completed||Phase 1|34|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:57:27.282899|2017-10-10 23:57:27.282899
NCT02257008|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||March 2003||2003-03-01|October 2014|2014-10-01||||December 2003|Actual|2003-12-01||Interventional|||Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers|An Open Study to Investigate the Effect of Different Boosting Agents on Pharmacokinetics of Single Doses of BILR 355 BS (Dose Steps: 5 and 12.5 mg) Dissolved in 5 mL PEG 400 After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|44|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:57:27.371998|2017-10-10 23:57:27.371998
NCT02256982|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-04-11|2016-04-11||October 2014||2014-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma|A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma|Terminated||N/A|3|Actual|Massachusetts General Hospital||2||Slow accrual.|f||||t||||||||||2017-10-10 23:57:27.54954|2017-10-10 23:57:27.54954
NCT02256969|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-05-25|2017-04-14||October 2014||2014-10-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MGP||Intraductal Meibomian Gland Probing Trial|Prospective, Randomized Clinical Trial of Meibomian Gland Probing Versus Sham Procedure for Refractory Meibomian Gland Dysfunction|Completed||Phase 4|45|Actual|Massachusetts Eye and Ear Infirmary||3|||f||||f|t|f||||||No||2017-10-10 23:57:27.799148|2017-10-10 23:57:27.799148
NCT02256956|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II|Effects of Amitriptyline on Central Pain Processing in Healthy Volunteers Depending on CYP Pharmacogenetics|Recruiting||Phase 4|48|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:57:28.210212|2017-10-10 23:57:28.210212
NCT02256943|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Genetic Determinants of Amitriptyline Efficiency for Pain Treatment|Effects of Amitriptyline on Central Pain Processing in Healthy Volunteers Depending on CYP Pharmacogenetics|Recruiting||Phase 4|48|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-10 23:57:28.328105|2017-10-10 23:57:28.328105
NCT02256930|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-08-07|||September 2014||2014-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|November 2014|Actual|2014-11-01||Interventional|||Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers|A Phase 1, Randomized, Evaluator Blinded, Controlled Study to Evaluate the Sensitizing Potential of M518101 in Healthy Volunteers Using a Repeat Insult Patch Test Design|Completed||Phase 1|240|Actual|Maruho North America Inc.||4|||f||||f||||||||||2017-10-10 23:57:28.572854|2017-10-10 23:57:28.572854
NCT02256917|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-08-10|||May 2015|Actual|2015-05-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A|Prospective, Open-label, Multi-centre Phase 3b Study to Assess the Efficacy and Safety of Personalized Prophylaxis With Human-cl rhFVIII in Previously Treated Adult Patients With Severe Haemophilia A|Recruiting||Phase 3|55|Anticipated|Octapharma||1|||f||||f||||||||||2017-10-10 23:57:28.668468|2017-10-10 23:57:28.668468
NCT02256904|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-09-23|||January 2015||2015-01-01|September 2015|2015-09-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|||RSA and Clinical Comparison of Anatomical and Mechanical Alignment in Total Knee Replacement|Biomechanical and Radiostereometric Analysis of the GMK Sphere Primary Total Knee Replacement. A Randomized, Double Blind Comparison of Anatomical Versus Mechanical Alignment in Total Knee Replacement.|Recruiting||N/A|134|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-10 23:57:28.82734|2017-10-10 23:57:28.82734
NCT02256891|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-07-11|2017-01-24||July 2011||2011-07-01|October 2015|2015-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|RCRPRFM||Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique|Arthroscopic Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique: A Randomized Blinded Outcomes Study|Completed||Phase 4|97|Actual|HealthPartners Institute|A disadvantage is the majority of the tears are small or medium sized. These have a higher intrinsic healing and as such may not require platelet augmentation to afford a successful outcome.|2|||f||||t||||||||||2017-10-10 23:57:28.936677|2017-10-10 23:57:28.936677
NCT01993849|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-03-07|||October 2013||2013-10-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Use of NAC in Fingernail Biting|A Randomized Placebo-controlled Trial of N-Acetylcysteine in Onychophagia|Completed||Phase 3|40|Actual|Medical University of South Carolina||2|||f||||||||||||||2017-10-11 01:03:39.941817|2017-10-11 01:03:39.941817
NCT02256878|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||August 2004||2004-08-01|October 2014|2014-10-01||||November 2006|Actual|2006-11-01||Interventional|||Study to Evaluate the Effect Single and Multiple Oral Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Amitriptyline and Nortriptyline in Healthy Male and Female Subjects|A Study to Evaluate the Effect of a Single Oral Dose and Multiple Oral Doses of 500 mg of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Amitriptyline and Nortriptyline in Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:57:29.36735|2017-10-10 23:57:29.36735
NCT02256865|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-05-03|||October 2014||2014-10-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Hormonal Mechanisms of Sleep Restriction|Hormonal Mechanisms of Sleep Restriction|Active, not recruiting||Early Phase 1|40|Actual|Los Angeles Biomedical Research Institute||2|||f||||t|t|f||||||Undecided||2017-10-10 23:57:29.470056|2017-10-10 23:57:29.470056
NCT02256852|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-02-18|||December 2014||2014-12-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer|Open Label,Single Arm,Exploratory Study to Evaluate the Safety,Tolerability,Compliance and MOA,of QBKPN SSI in Subjects With 2 or More Second Primary Pre-invasive/Invasive Adenocarcinoma Following Surgical Resection of Stage I NSCLC|Completed||Phase 2|6|Actual|Qu Biologics Inc.||1|||f||||f||||||||||2017-10-10 23:57:29.59942|2017-10-10 23:57:29.59942
NCT02256839|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-04-03|||October 2014||2014-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of the QuantiFERON-TB Test.||Active, not recruiting||N/A|260|Actual|QIAGEN Gaithersburg, Inc|||2||f||||f||||||||||2017-10-10 23:57:29.668982|2017-10-10 23:57:29.668982
NCT02256826|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||April 2005||2005-04-01|October 2014|2014-10-01||||June 2005|Actual|2005-06-01||Interventional|||Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects|Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir|Completed||Phase 1|34|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:57:29.743212|2017-10-10 23:57:29.743212
NCT02256813|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||September 2005||2005-09-01|October 2014|2014-10-01||||December 2005|Actual|2005-12-01||Interventional|||Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers|A Study to Evaluate the Effect of Multiple Doses of 500 mg of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan Dosed Orally and Midazolam Dosed IV, in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:57:29.832019|2017-10-10 23:57:29.832019
NCT02256800|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-01-20|||August 13, 2013|Actual|2013-08-13|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Analysis of UGT1A1 Promoter Polymorphism for Irinotecan Dose Escalation in Metastatic Colorectal Cancer Patients Treated With Bevacizumab Combined With FOLFIRI as the First-line Setting||Recruiting||N/A|320|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||4|||f||||f||||||||||2017-10-10 23:57:29.948336|2017-10-10 23:57:29.948336
NCT02256787|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||January 2004||2004-01-01|October 2014|2014-10-01||||September 2004|Actual|2004-09-01||Interventional|||Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food|Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of 5 mg, 20 mg, 60 mg, 120 mg, 200 mg, 300 mg, 600 mg, 1000 mg, 1500 mg, 2000 mg, 2400 mg, and 3000 mg BILB 1941 ZW (PEG 400/TRIS Solution) in Healthy Male Subjects, in a Randomised Double Blind, Placebo Controlled Rising Dose Study, Followed With an Open-label Intra-subject Three-Way Crossover Bioavailability Comparison of 600 mg BILB 1941 ZW in a PEG 400/TRIS Solution and 600 mg BILB 1941 ZW Tablet and 600 mg BILB 1941 ZW Tablet Administered With Food|Completed||Phase 1|56|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-10 23:57:30.093633|2017-10-10 23:57:30.093633
NCT02256774|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||October 2004||2004-10-01|October 2014|2014-10-01||||May 2005|Actual|2005-05-01||Interventional|||Study of Pharmacokinetic Interaction Between Combivir® (ZDV+3TC) and BILR 355 BS Plus Ritonavir in Healthy Subjects|Study of Pharmacokinetic Interaction Between Combivir® (ZDV+3TC) and BILR 355 BS Plus Ritonavir|Completed||Phase 1|51|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:57:30.172311|2017-10-10 23:57:30.172311
NCT02256761|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||January 2005||2005-01-01|October 2014|2014-10-01||||July 2005|Actual|2005-07-01||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX Administered as Multiple Doses and Safety and Pharmacokinetics of BIRT 2584 XX Administered With and Without Food as Single Dose to Healthy Male Volunteers|Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX Administered as Multiple Doses of 100 mg to 750 mg qd for 14 or 28 Days (Randomised, Double-blind Placebo Controlled Design), and Safety and Pharmacokinetics of 500 mg of BIRT 2584 XX Administered With and Without Food as Single Dose (Open, Intra-individual Comparison) to Healthy Male Volunteers|Completed||Phase 1|74|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:57:30.252214|2017-10-10 23:57:30.252214
NCT02256748|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||June 2005||2005-06-01|October 2014|2014-10-01||||August 2005|Actual|2005-08-01||Interventional|||Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers|A Study to Evaluate the Effect of Multiple Doses of 500 mg of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:57:30.33626|2017-10-10 23:57:30.33626
NCT02256735|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||August 2005||2005-08-01|October 2014|2014-10-01||||December 2005|Actual|2005-12-01||Interventional|||Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers|A Double-blinded, Randomised, Placebo Controlled, Five-way Crossover Study With One Positive Control (Open-label) (Moxifloxacin) to Assess the Influence of Oral Single Dose KUC 7483 BS (40 mg, 80 mg, 160 mg, 320 mg) on the QT/QTc Interval of the ECG in Healthy Male and Female Volunteers|Completed||Phase 1|39|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 23:57:30.40986|2017-10-10 23:57:30.40986
NCT02256371|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-06-27|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PSYCNEP||Randomized Controlled Study of the Efficacy of Hypnosis Versus Relaxation and Control in Neuropathic Pain|Efficacy of 2 Psycho-physical Methods in the Treatment of Neuropathic Pain: a Randomized Controlled Monocentric Study|Recruiting||N/A|105|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 23:57:37.256281|2017-10-10 23:57:37.256281
NCT02256722|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||October 2005||2005-10-01|October 2014|2014-10-01||||November 2005|Actual|2005-11-01||Interventional|||In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male Subjects|A Randomised, Open Label, Four-way Crossover Phase I Trial to Investigate the in Vivo Specificity of a Single Oral Dose of 320 mg KUC 7483 CL Co-administered With Bisoprolol (10 mg Daily), Propranolol (160 mg Daily), and Acipimox (500 mg Daily) Over 5 Days and a Single Inhalative Dose of 100 μg Salmeterol in Healthy Male Subjects|Completed||Phase 1|12|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-10 23:57:30.508718|2017-10-10 23:57:30.508718
NCT02256709|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-02|2014-10-02|||April 2004||2004-04-01|October 2014|2014-10-01||||August 2004|Actual|2004-08-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Oral BIBP 5371 CL in Healthy Male and Female Volunteers|Safety, Tolerability and Pharmacokinetics of BIBP 5371 CL Following Oral Administration to Healthy Male and Female Volunteers (Dose Range: 10 - 350 mg). A Double-blind (Within Treatment Groups), Randomised, Placebo-controlled, Single Rising Dose Study, Including Comparisons of 50 mg vs. 100 mg Tablet and Tablet vs. Drinking Solution, and Investigation of Food Effect|Completed||Phase 1|70|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-10 23:57:30.598009|2017-10-10 23:57:30.598009
NCT02256696|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-08-25|||April 29, 2015|Actual|2015-04-29|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Assessing PA-824 for Tuberculosis (the APT Trial)|A Phase 2 Randomized, Open-Label Trial of PA-824-Containing Regimens Versus Standard Treatment for Drug-Sensitive Sputum Smear-Positive Pulmonary Tuberculosis|Recruiting||Phase 2|183|Anticipated|Johns Hopkins University||3|||f||||t|t|f||||||||2017-10-10 23:57:30.690094|2017-10-10 23:57:30.690094
NCT02256683|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-02-26|||July 2014||2014-07-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|RE-LATED_AF||Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF|Effects of Dabigatran in Patients With AF - A Prospective, Randomized, Open-label, Explorative, Blinded-endpoint Trial to Compare the Efficacy of Dabigatran With Phenprocoumon for the Resolution of LAA Thrombus in Patients With AF|Recruiting||Phase 4|110|Anticipated|Johannes Gutenberg University Mainz||2|||f||||t||||||||||2017-10-10 23:57:30.787274|2017-10-10 23:57:30.787274
NCT02256670|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-02-03|||October 2014||2014-10-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial|Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial: Efficacy of a Text-messaging Application in Increasing Adherence With Adjuvant Endocrine Therapy for Stage I-III Hormone Receptor Positive Breast Cancer|Completed||N/A|100|Actual|Yale University||1|||f||||f||||||||||2017-10-10 23:57:31.000474|2017-10-10 23:57:31.000474
NCT02256657|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-01-18|||November 2014|Actual|2014-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|ACS QUIK||Study of a Quality Improvement Toolkit in Kerala, India, Among Hospitals Treating Acute Coronary Syndrome Patients|Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK) Cluster Randomized, Stepped Wedge Multi-center Implementation of a Locally-Developed Quality Improvement Toolkit|Active, not recruiting||N/A|21000|Anticipated|Northwestern University||5|||f||||t||||||||||2017-10-10 23:57:31.099973|2017-10-10 23:57:31.099973
NCT02256644|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-08-04|||December 1, 2013|Actual|2013-12-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|August 1, 2014|Actual|2014-08-01||Observational|||Genomics of Posttraumatic Stress Disorder in Veterans|CSP #575B - Genomics of Posttraumatic Stress Disorder Among Veterans|Active, not recruiting||N/A|20000|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|Samples With DNA|"     Affymetrix Axiom Biobank chip, with technical specifications including 295K tag SNPs, 260K     exomic content, 65K loss-of-function SNPs & INDELs, 25K psych content, and 23K eQTL     markers.   "|||2017-10-10 23:57:31.936569|2017-10-10 23:57:31.936569
NCT02256631|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-10-04|||April 2015||2015-04-01|October 2017|2017-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Evaluating the Safety and Pharmacokinetics of VRC01 and VRC01LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants|Open-Label, Dose-Escalating, Phase I Study to Determine Safety and Pharmacokinetic Parameters of Subcutaneous (SC) VRC01 and VRC01LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants|Recruiting||Phase 1|118|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-10 23:57:32.035643|2017-10-10 23:57:32.035643
NCT02256618|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-01|||August 2014||2014-08-01|October 2014|2014-10-01|February 2018|Anticipated|2018-02-01|September 2016|Anticipated|2016-09-01||Interventional|||Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy|A Pilot Feasibility and Safety Study of Autologous Umbilical Cord Blood Cell Therapy in Infants With Neonatal Encephalopathy|Recruiting||Phase 1|6|Anticipated|Neonatal Encephalopathy Consortium, Japan||1|||f||||t||||||||||2017-10-10 23:57:32.221497|2017-10-10 23:57:32.221497
NCT02256605|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-05-28|||November 2013||2013-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Vitamin D3 Supplementation in Pediatric IBD: Weely vs Daily Dosing Regimens||Completed||N/A|40|Anticipated|Nemours Children's Clinic|||2||f||||||||||||||2017-10-10 23:57:32.363763|2017-10-10 23:57:32.363763
NCT02256592|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-05-02|||October 2014||2014-10-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|FMT-HIV||Fecal Microbiota Transplantation in HIV|Reconstitution of the Gut Microbiome to Reduce HIV-Associated Inflammation|Completed||Phase 1|18|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-10 23:57:32.457087|2017-10-10 23:57:32.457087
NCT02256579|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-01|||October 2014||2014-10-01|April 2014|2014-04-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Observational|||Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients|Vietnam-Japan Cooperative Research on Prognosis of HIV-1-infection -Clinical Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction Caused by Use of Tenofovir in Vietnamese HIV-Infected Patients-|Unknown status|Enrolling by invitation|N/A|1800|Anticipated|National Center for Global Health and Medicine, Japan|||1||f||||f||||||Samples Without DNA|"     Complete blood cell count, CD4+ cell count, AST, ALT, Serum-creatinine, HIV-1 plasma viral     loads, HBs antigen, anti-HBc antibody, anti-HBs antibody, anti-HCV antibody, Urine-protein,     Urine-creatinine and urine beta2microglobulin.   "|||2017-10-10 23:57:32.570441|2017-10-10 23:57:32.570441
NCT02256566|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-07-19|||September 2014||2014-09-01|July 2017|2017-07-01|April 20, 2016|Actual|2016-04-20|April 20, 2016|Actual|2016-04-20||Interventional|||Cognitive Training for Mood and Anxiety Disorders|Cognitive Training for Mood and Anxiety Disorders|Completed||N/A|28|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-10 23:57:32.647787|2017-10-10 23:57:32.647787
NCT02256553|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-01-18|2015-12-07||October 2014||2014-10-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)|A Phase IV, Open-label, Safety and Tolerability Trial of MK-3641 and MK-7243 Coadministered in Subjects At Least 18 Years of Age With Ragweed and Grass Pollen Induced Allergic Rhinitis With or Without Conjunctivitis|Completed||Phase 4|102|Actual|ALK-Abelló A/S||1|||f||||f||||||||||2017-10-10 23:57:32.756826|2017-10-10 23:57:32.756826
NCT02256540|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-04-12|||August 2014||2014-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women|The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women|Active, not recruiting||N/A|15|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-10-10 23:57:33.117991|2017-10-10 23:57:33.117991
NCT02256527|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-07-13|||September 2014||2014-09-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||REWARDS Premier Taxus-Liberte vs Xience V|REWARDS-Premier TLX (Registry Experience at the WAshington Hospital CenteR, DeS - Premier Taxus-Liberte vs Xience V)|Completed||N/A|917|Actual|Medstar Health Research Institute|||1||f||||f||||||||||2017-10-10 23:57:33.227496|2017-10-10 23:57:33.227496
NCT02256514|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-04-08|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|HCC||Open Label Trial of Immunotherapy for Advanced Liver Cancer|Open Label Trial of Hepcortespenlisimut-L (V5) Immunotherapy for HCC|Enrolling by invitation||Phase 2|120|Anticipated|Immunitor LLC||1|||f||||t||||||||Yes|Data will be shared at study completion|2017-10-10 23:57:33.295|2017-10-10 23:57:33.295
NCT02256501|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-04-26|||June 2013|Actual|2013-06-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy|Intracoronary Transplantation of Autologous Bone Marrow Derived Mononuclear Cells (MNC) in Idiopathic Dilated Cardiomyopathy in Pediatric Patients: Clinical Trial Phase I/II|Completed||Phase 1/Phase 2|30|Actual|Royan Institute||2|||f||||t||||||||||2017-10-10 23:57:33.382157|2017-10-10 23:57:33.382157
NCT02256488|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-07-10|2015-07-10||September 2014||2014-09-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects|A Phase III, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects|Completed||Phase 3|1561|Actual|Novartis||4|||f||||||||||||||2017-10-10 23:57:33.487028|2017-10-10 23:57:33.487028
NCT02256475|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-01-05|||September 2014||2014-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|T-FORCE||Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome|A Phase 1b, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome|Completed||Phase 1|36|Actual|Neurocrine Biosciences||6|||f||||f||||||||||2017-10-10 23:57:34.094657|2017-10-10 23:57:34.094657
NCT02256462|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-10-03|||May 2015||2015-05-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial|Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial|Active, not recruiting||Phase 4|82|Actual|Schneider Children's Medical Center, Israel||2|||f||||f||||||||||2017-10-10 23:57:34.772227|2017-10-10 23:57:34.772227
NCT02256449|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-07-15|||January 2014||2014-01-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|September 2015|Actual|2015-09-01|1 Year|Observational [Patient Registry]|REPARA||REPARA Study: REgistry of PAtients With bioResorbable Device in Daily Clinical prActice|Registry of Patients With Bioresorbable Device in Daily Clinical Practice. REPARA Study|Active, not recruiting||N/A|2440|Actual|Sección Hemodinamica y Cardiologia Intervencionista|||1||f||||t||||||||||2017-10-10 23:57:34.863834|2017-10-10 23:57:34.863834
NCT02256423|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-30|||July 2014||2014-07-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects|A Single-dose, Randomised, Crossover Study to Compare the Pharmacokinetics of Three Formulations of Ibuprofen in Healthy Fasting Male and Female Subjects|Completed||Phase 1|24|Actual|Simbec Research||3|||f||||f||||||||||2017-10-10 23:57:36.86455|2017-10-10 23:57:36.86455
NCT02256410|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-01-08|||December 2013||2013-12-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Pain Detecting and Analgesic Stimulating Device on Low Back Pain|The Effects of a Pain Detecting and Analgesic Stimulating Device on Low Back Pain Patients' Clinical Outcomes|Completed||N/A|39|Actual|Vrije Universiteit Brussel||2|||f||||f||||||||||2017-10-10 23:57:36.955829|2017-10-10 23:57:36.955829
NCT02256397|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-05-03|||October 2014||2014-10-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|HCCC||Home Centered Comprehensive Care (HCCC) for Children With Asthma|Home-Centered Comprehensive Care (HCCC) for Children With Severe Asthma: A Pilot Trial|Completed||N/A|63|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:57:37.068488|2017-10-10 23:57:37.068488
NCT02256384|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-08-26|||March 2015||2015-03-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of Respiratory Acoustic Monitor in Children After Surgery|Evaluation of Respiratory Acoustic Monitor in Children After Surgery|Completed||N/A|60|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-10 23:57:37.159527|2017-10-10 23:57:37.159527
NCT02255604|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-12-01|||August 2013||2013-08-01|January 2015|2015-01-01|August 2016|Anticipated|2016-08-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Intralymphatic Immunotherapy|Effect of Intralymphatic Immunotherapy at Basophil Response and Plasmacell Kinetic in Patients With Allergic Rhinitis.|Unknown status|Active, not recruiting|Phase 2|36|Actual|University of Aarhus||3|||f||||t||||||||||2017-10-10 23:57:45.165852|2017-10-10 23:57:45.165852
NCT02256358|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-09|2014-10-06||January 2013||2013-01-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation|Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation : a Randomized Controlled Trial|Completed||N/A|68|Actual|Inje University|We did not include a placebo group.|2|||f||||f||||||||||2017-10-10 23:57:37.368361|2017-10-10 23:57:37.368361
NCT02256345|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-08-30|2017-06-14||January 2015||2015-01-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF|Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF|Completed||Phase 2|12|Actual|University of Pennsylvania|"Small sample size
Serial blood draws, which caused a decrease in hemoglobin concentration, which may have constrained the increase in VO2,peak and reduced the magnitude of the improvement in exercise capacity and quality of life."|2|||f||||f||||||||||2017-10-10 23:57:37.626398|2017-10-10 23:57:37.626398
NCT02256332|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-09-21|||January 2015||2015-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Plant-based Ingredient on Post Prandial Glucose in Type II Diabetes|Effect of Plant-based Ingredient on Post Prandial Glucose in Untreated Type II Diabetes Patients|Completed||N/A|24|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-10 23:57:38.424027|2017-10-10 23:57:38.424027
NCT02256319|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-12-17|||September 2014||2014-09-01|February 2015|2015-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|DEXPROPAR||Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity Measured Through Implanted Stimulators|Effects of Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity (Local Field Potentials) Measured Through Implanted Stimulators|Completed||Phase 4|12|Actual|Clinica Universidad de Navarra, Universidad de Navarra||3|||f||||t||||||||||2017-10-10 23:57:38.51745|2017-10-10 23:57:38.51745
NCT02256293|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-06-11|||January 2015||2015-01-01|September 2014|2014-09-01||||January 2016|Anticipated|2016-01-01||Interventional|||Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-Management|Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-Management|Withdrawn||Phase 1/Phase 2|0|Actual|Duke University||1|||f||||f||||||||||2017-10-10 23:57:38.710934|2017-10-10 23:57:38.710934
NCT02256280|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-09-10|||January 2015||2015-01-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|DATA||A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic Anesthesia|Decurarization After Thoracic Anesthesia - A Prospective Multicenter Double-blind Randomized Trial Comparing Sugammadex vs Neostigmine Reversal After Thoracic Anesthesia|Recruiting||Phase 4|266|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-10 23:57:38.782266|2017-10-10 23:57:38.782266
NCT02256267|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-12-17|||October 2014||2014-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study of LY2835219 in Healthy Participants|Effects of CYP3A Induction by Rifampin on the Pharmacokinetics of LY2835219 and Its Metabolites in Healthy Subjects|Completed||Phase 1|24|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-10 23:57:38.884182|2017-10-10 23:57:38.884182
NCT02256254|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-03-09|||September 2014||2014-09-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|SIMOX||SIMOX - Induction of Oxidative Stress|SIMOX - A Randomized, Double-blinded, Placebo Controlled Study of Simvastatins Possible Effect on Oxidative Stress on Healthy Volunteers|Completed||Phase 2|40|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:57:38.960017|2017-10-10 23:57:38.960017
NCT02256241|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-02-22|||October 2014||2014-10-01|February 2015|2015-02-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|RING UB LIGASE||The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin|The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin|Recruiting||N/A|90|Anticipated|Rambam Health Care Campus|||2||f||||f||||||Samples Without DNA|"     1. Bone marrow will be collected from othewise healthy patients undergoing orthopedic          surgery - arthroplasty for the treatment of degenerative joint disease or traumatised          patients. The bone marrow will be collected from disposable tissue that is removed          during the normal sequence of the surgery.        2. Collection of connective tissue from patients with malignancies of musculoskeletal          origin. The tissue that will be used is part of the resected tumor specimens. The tissue          will be used for:   "|||2017-10-10 23:57:39.042212|2017-10-10 23:57:39.042212
NCT02256228|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-11-10|||October 2014||2014-10-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|IPLA||Intra-Peritoneal Local Anaesthesia After Cytoreductive Surgery|Peroperative Analgesia Following Cytoreductive Surgery. A Randomized, Double-blind, Comparison Between Intra-peritoneal Local Anesthesia and Placebo - Multicenter Study|Recruiting||Phase 3|60|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-10 23:57:39.110907|2017-10-10 23:57:39.110907
NCT02256215|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2015-04-03|||December 2015||2015-12-01|April 2015|2015-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Vitamin D in the Treatment of Primary Restless Legs Syndrome|Vitamin D in the Treatment of Primary Restless Legs Syndrome: 12 Weeks, Triple-blinded, Randomized, Placebo-controlled Trial|Not yet recruiting||Phase 2/Phase 3|106|Anticipated|King Abdulaziz University||2|||f||||||||||||||2017-10-10 23:57:39.213866|2017-10-10 23:57:39.213866
NCT02256202|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-10-22|||August 2014||2014-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Observational|||Quality Assurance of Electronic Data Capturing (EDC) in Pain Treatment|Pilot Study of Quality Assurance in Interventional Pain Therapy in the Lumbal Spinal Column. Non-randomised, Evaluative, Multicentral Study Concerning the Applicability of a Tablet-PC.|Completed||N/A|64|Actual|Qualitouch-HC Foundation|||1||f||||f||||||||||2017-10-10 23:57:39.274934|2017-10-10 23:57:39.274934
NCT02256189|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-07-19|||April 2015|Actual|2015-04-01|September 2016|2016-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|SITACLAMP||Sitagliptin and Glucagon Counterregulation|The Effect of Sitagliptin on Glucagon Counterregulation and Incretin Hormones During Mild Hypoglycemia in Elderly Patients With Metformin-treated Type 2 Diabetes|Completed||Phase 4|28|Actual|Lund University||2|||f||||f||||||||||2017-10-10 23:57:39.340733|2017-10-10 23:57:39.340733
NCT02256163|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-11-03|||June 2011||2011-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Observational|TAA||Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm|Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm (TAA)|Recruiting||N/A|275|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Blood sample.   "|||2017-10-10 23:57:39.426014|2017-10-10 23:57:39.426014
NCT02256150|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-09-05|||November 2014||2014-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis|A Multi-center, Randomized, Controlled, Open-label Clinical Study to Evaluate the Efficacy and Safety of Mizoribine in Comparison With Cyclophosphamide in the Treatment of Lupus Nephritis|Recruiting||Phase 3|250|Anticipated|Asahi Kasei Pharma Corporation||2|||f||||f||||||||||2017-10-10 23:57:39.518592|2017-10-10 23:57:39.518592
NCT02256137|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-03-31|||October 8, 2014|Actual|2014-10-08|November 2016|2016-11-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Observational|||A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer|A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer|Recruiting||N/A|1493|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-10 23:57:39.657916|2017-10-10 23:57:39.657916
NCT02256124|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-06-22|||October 2014||2014-10-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|NF1-EXCEL||Effect of Lamotrigine on Cognition in NF1|The Effect of Lamotrigine on Cognitive Deficits Associated With Neurofibromatosis Type 1: a Phase II Randomized Controlled Multi-centre Trial (NF1-EXCEL)|Recruiting||Phase 2/Phase 3|60|Anticipated|Erasmus Medical Center||2|||f||||t||||||||||2017-10-10 23:57:39.765046|2017-10-10 23:57:39.765046
NCT02256111|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-08-09|||May 13, 2015|Actual|2015-05-13|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||EXTEND Exercise Trial|EXTEND: Safety and Efficacy of EXercise Training in Men Receiving ENzalutamide in Combination With Conventional Androgen Deprivation Therapy for Hormone Naïve Prostate Cancer|Recruiting||Phase 2|40|Anticipated|Duke University||2|||f||||f||||||||||2017-10-10 23:57:40.069984|2017-10-10 23:57:40.069984
NCT02256098|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-03-04|||September 2014||2014-09-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|APKnee||RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA|A Clinical Randomized Controlled RSA Trial Comparing the Cemented ATTUNE™ Fixed Bearing Cruciate Retaining Knee System With the Cemented PFC Sigma Fixed Bearing Cruciate Retaining Knee System|Active, not recruiting||N/A|64|Anticipated|Leiden University Medical Center||2|||f||||f||||||||||2017-10-10 23:57:40.188718|2017-10-10 23:57:40.188718
NCT02256085|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-01-12|||October 2013||2013-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)|Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)|Withdrawn||Phase 2|0|Actual|New York State Psychiatric Institute||3|||f||||f||||||||||2017-10-10 23:57:40.292095|2017-10-10 23:57:40.292095
NCT02256072|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-03-17|2016-08-05||September 2014||2014-09-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|APHS||Advance Planning for Home Services for Seniors|Advance Planning for Home Services for Seniors|Completed||N/A|385|Actual|Northwestern University||2|||f||||f||||||||||2017-10-10 23:57:40.425371|2017-10-10 23:57:40.425371
NCT02256059|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2014-09-30|||June 2011||2011-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Observational|LatClav||Treatment of Displaced Lateral Clavicle Fractures Using a Locking Compression Plate With Lateral Extension|Treatment of Displaced Lateral Clavicle Fractures Using a Locking Compression Plate With Lateral Extension - Clinical Observational Study|Completed||N/A|20|Actual|Technische Universität München|||1||f||||f||||||||||2017-10-10 23:57:41.252264|2017-10-10 23:57:41.252264
NCT02256046|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-02|||August 2014||2014-08-01|October 2014|2014-10-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Predictive Factors and Outcome of Esophageal Ulcers After Endoscopic Treatment of Esophageal Varices|Predictive Factors and Outcome of Esophageal Ulcers After Endoscopic Treatment of Esophageal Varices; Multicenter Study|Unknown status|Recruiting|N/A|224|Anticipated|Tanta University||1|||f||||t||||||||||2017-10-10 23:57:41.331044|2017-10-10 23:57:41.331044
NCT02256033|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-05-19|||August 2014||2014-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline|Effect of Mild Hepatic Impairment (Child-Pugh Class A) on the Single-dose Pharmacokinetics of Istradefylline|Completed||Phase 1|20|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||f||||||||||2017-10-10 23:57:41.470248|2017-10-10 23:57:41.470248
NCT02256020|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-10-01|||February 2014||2014-02-01|October 2014|2014-10-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Improvement and Mechanism of Wheel-chair Music Aerobic Exercise on Depression and Insomnia Among the Elderly in Long-term Care Facilities|Improvement and Mechanism of Wheel-chair Music Aerobic Exercise on Depression and Insomnia Among the Elderly in Long-term Care Facilities|Unknown status|Recruiting|N/A|170|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:57:41.579553|2017-10-10 23:57:41.579553
NCT02255994|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-02-05|||October 2014||2014-10-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|PRO-CURE II||UGYTEX® Mesh Versus Subvesical Plication in the Surgical Treatment of Bladder Prolapse|Comparison of Long-term Results of UGYTEX® Sub-bladder Mesh Placed Via a Transvaginal Transobturator Approach Versus Subvesical Plication Without Reinforcement in the Surgical Treatment of Bladder Prolapse|Completed||N/A|75|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-10 23:57:41.778311|2017-10-10 23:57:41.778311
NCT02255591|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-04-30|||February 2015||2015-02-01|September 2014|2014-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Shamrock Versus Lumbar Ultrasound Trident - Ultrasound Guided Block of the Lumbar Plexus|Shamrock Versus Lumbar Ultrasound Trident - Ultrasound Guided Block of the Lumbar Plexus: A Randomized Controlled Trial|Completed||Phase 4|20|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-10 23:57:45.267902|2017-10-10 23:57:45.267902
NCT02255981|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-08-01|||March 2013||2013-03-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy of Acupuncture in Macular Diseases|¿Es Util la Acupuntura en la Degeneracion Macular? Prospective Study of Efficacy of Acupuncture in Macular Diseases|Active, not recruiting||N/A|33|Actual|Escuela Neijing||2|||f||||t||||||||Yes|sex, age, ophthalmologic diagnostic data (medical examination, images) diagnostic signs on Traditional Chinese Medicine (TCM), number of sessions, visual outcome, hazards, previous treatment|2017-10-10 23:57:41.88804|2017-10-10 23:57:41.88804
NCT02255968|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-05-08|||August 2014||2014-08-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788|A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Safety, Tolerability, and Pharmacokinetic Study of EDP-788 in Healthy Adult Volunteers|Terminated||Phase 1|16|Actual|Enanta Pharmaceuticals||2|||f||||t||||||||||2017-10-10 23:57:41.981553|2017-10-10 23:57:41.981553
NCT02255955|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2014-12-25|||October 2014||2014-10-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|(PAL)||Postoperative Analgesia in Laminectomy|The Effect of Naproxen Sodium + Codeine, and Paracetamol+ Codeine on Postoperative Laminectomy Pain|Unknown status|Not yet recruiting|Phase 4|75|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||3|||f||||t||||||||||2017-10-10 23:57:42.067512|2017-10-10 23:57:42.067512
NCT02255942|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-04-13|||April 2015||2015-04-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|Rice_FeZn||The Effect of Zinc on Iron Bioavailability From Fortified Extruded Rice Fortified With Ferric Pyrophosphate|The Effect of Zinc on Iron Bioavailability From Fortified Extruded Rice Fortified With Ferric Pyrophosphate|Completed||N/A|20|Actual|Swiss Federal Institute of Technology||1|||f||||f||||||||||2017-10-10 23:57:42.161465|2017-10-10 23:57:42.161465
NCT02255929|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-04-25|||September 2014||2014-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Gamma Knife Radiosurgery for Treatment of Essential Tremor|Gamma Knife Thalamotomy for Treatment of Essential Tremor|Recruiting||N/A|183|Anticipated|Swedish Medical Center||1|||f||||f||||||||||2017-10-10 23:57:42.251595|2017-10-10 23:57:42.251595
NCT02255916|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-01-12|||September 2014||2014-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MTO_03||Short-term Effects of Sound-bed Music Therapy in Healthy Caregivers of a Hospital Oncology Ward (MTO_03)|Short-term Effects of Live Sound-bed Music on Physiological and Psychological Parameters in Healthy Oncology Staff - A Randomized Controlled Trial With Crossover Design|Completed||N/A|30|Anticipated|ARCIM Institute Academic Research in Complementary and Integrative Medicine||2|||f||||||||||||||2017-10-10 23:57:42.336733|2017-10-10 23:57:42.336733
NCT02255903|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-05-13|||February 2016|Actual|2016-02-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Middle Cerebral To Umbilical Artery Doppler Ratio And Amniotic Fluid Volume Measurement In Post-date Pregnancies in King Khalid Military Central City|Middle Cerebral To Umbilical Artery Doppler Ratio And Amniotic Fluid Volume Measurement In Post-date Pregnancies in King Khalid Military Central City|Recruiting||N/A|200|Anticipated|Benha University|||2||f||||f||||||||||2017-10-10 23:57:42.428551|2017-10-10 23:57:42.428551
NCT02255890|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-07-25|||November 2014||2014-11-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01|5 Years|Observational [Patient Registry]|||Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device|Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device; A Multi-Center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety.|Recruiting||N/A|2000|Anticipated|Clinical Research Office of the Endourological Society|||1||f||||f||||||||||2017-10-10 23:57:42.512745|2017-10-10 23:57:42.512745
NCT02255877|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-10-21|||September 2014||2014-09-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ZIPS||ZIPS Study - Zip Incision Approximation vs. STAPLE|A Prospective, Non Blinded, Randomized Controlled Post Market Study Designed to Compare the Use of the Zip Surgical Skin Closure Device vs. Conventional Steel Staples for Skin Closure in Subjects Who Undergo a bi Lateral Knee Arthroplasty|Withdrawn||Phase 4|0|Actual|ZipLine Medical Inc.||2||Change in research plan|f||||f||||||||||2017-10-10 23:57:42.582038|2017-10-10 23:57:42.582038
NCT02255864|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2016-06-06|||February 2015||2015-02-01|June 2016|2016-06-01|November 2020|Anticipated|2020-11-01|July 2016|Anticipated|2016-07-01||Interventional|RENASCENT||Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent|Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - European Trial|Active, not recruiting||Phase 2|21|Actual|Amaranth Medical Inc.||1|||f||||t||||||||Undecided||2017-10-10 23:57:42.681795|2017-10-10 23:57:42.681795
NCT02255851|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-10-02|||March 2014||2014-03-01|September 2014|2014-09-01||||December 2014|Anticipated|2014-12-01|1 Day|Observational [Patient Registry]|||Sentinel(TM) Post-Market Registry|Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement|Unknown status|Enrolling by invitation|N/A|300|Actual|Claret Medical|||1||f||||f||||||Samples With DNA|"     Capture and histopathology analysis of embolic debris. (Thrombus, valve tissue, amorphous     calcium, etc.)   "|||2017-10-10 23:57:42.794874|2017-10-10 23:57:42.794874
NCT02255838|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-06-27|||April 2015||2015-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|EVAL||Evaluation of a Disposable Flexible Bronchoscope, aScope III|Evaluation of a Disposable Flexible Bronchoscope, (aScope III) a Randomized, Controlled, Cross-over Trial|Recruiting||N/A|40|Anticipated|University of Louisville||2|||f||||f||||||||No||2017-10-10 23:57:42.871959|2017-10-10 23:57:42.871959
NCT02255825|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-05-29|||October 2014||2014-10-01|May 2015|2015-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Development of an Optimal Approach to Return of Results for Families Undergoing Next-generation Sequencing for Prenatal Diagnosis|Development of an Optimal Approach to Return of Results for Families Undergoing Next-generation Sequencing for Prenatal Diagnosis.|Unknown status|Recruiting|N/A|30|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:57:42.999384|2017-10-10 23:57:42.999384
NCT02255812|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-09-30|||March 2013||2013-03-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Taste Physiology in Healthy, Normal-weight Volunteers|Taste Physiology in Healthy, Normal-weight Volunteers|Completed||N/A|12|Actual|University Hospital, Basel, Switzerland||6|||f||||f||||||||||2017-10-10 23:57:43.109541|2017-10-10 23:57:43.109541
NCT02255799|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-09-15|||September 2014||2014-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|MEMRI-TBI-D||Multicenter Evaluation of Memory Remediation After TBI With Donepezil|Four-site, Randomized, Parallel Design, Double-blind, Placebo-controlled, 10-week Trial of Donepezil 10 mg Daily for Verbal Memory Problems Among Adults With TBI in the Subacute or Chronic Recovery Period|Recruiting||Phase 3|160|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-10 23:57:43.211141|2017-10-10 23:57:43.211141
NCT02255786|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-04-06|||October 2014||2014-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||"ACT for Parents of Children With Autism Spectrum Disorder"|Taking ACTion: Acceptance and Commitment Therapy for Parents of Children With Autism Spectrum Disorder|Unknown status|Enrolling by invitation|N/A|16|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-10 23:57:43.372041|2017-10-10 23:57:43.372041
NCT02255773|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-12-05|||November 2014||2014-11-01|December 2016|2016-12-01||||November 2018|Anticipated|2018-11-01||Interventional|||Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral Measures|Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral Measures|Active, not recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:57:43.469764|2017-10-10 23:57:43.469764
NCT02255747|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2014-09-30|||September 2014||2014-09-01|September 2014|2014-09-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Anal Dilatation for Infants and Children With Constipation|Anal Dilatation for Infants and Children With Constipation|Unknown status|Recruiting|N/A|100|Anticipated|Tongji Hospital||2|||f||||||||||||||2017-10-10 23:57:43.662283|2017-10-10 23:57:43.662283
NCT02255734|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-09-29|||April 2014||2014-04-01|September 2014|2014-09-01||||April 2014|Actual|2014-04-01||Interventional|||Bioequivalence of Two Formulations of Acyclovir|Bioequivalence of Two Formulations of Acyclovir|Completed||Phase 4|14|Actual|Yung Shin Pharm. Ind. Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:57:43.743577|2017-10-10 23:57:43.743577
NCT02255721|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-10-04|||November 2013||2013-11-01|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|SHIP||Sleep Health in Preschoolers: a Randomized Controlled Trial|Healthy Sleep Intervention For Preschool Children: A Randomized Controlled Trial of the SHIP Intervention|Active, not recruiting||N/A|500|Anticipated|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-10 23:57:43.819884|2017-10-10 23:57:43.819884
NCT02255708|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-29|||July 2014||2014-07-01|September 2014|2014-09-01||||August 2015|Anticipated|2015-08-01||Interventional|||Effects of an Intervention Program by Proprioceptive Neuromuscular Facilitation, in Muscle Force Irradiation.|Electromyography Evaluation of the Stabilizing Muscles of the Scapula and Tibial Anterior Muscle, After an Intervention Program by Proprioceptive Neuromuscular Facilitation in Muscle Force Irradiation.|Unknown status|Recruiting|Phase 1|120|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-10 23:57:43.916003|2017-10-10 23:57:43.916003
NCT02255695|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-09-29|||December 2008||2008-12-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of a School-based Exercise Program on Posture, Trunk Range of Motion, and Musculoskeletal Pain|Effects of a School-based Exercise Program on Posture, Trunk Range of Motion, and Musculoskeletal Pain - A Randomized, Controlled Trial|Completed||N/A|300|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-10-10 23:57:43.991506|2017-10-10 23:57:43.991506
NCT02255682|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-01-03|||January 2015||2015-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|LIFESTAT||Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being|Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being|Completed||Phase 4|35|Actual|University of Copenhagen||2|||f||||f||||||||No||2017-10-10 23:57:44.098404|2017-10-10 23:57:44.098404
NCT02255669|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-02-10|||October 2014||2014-10-01|September 2014|2014-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction|Comparison Between Fully Covered and Partially Covered Self-expandable Metal Stents With Anti-migration System for Malignant Distal Biliary Obstruction|Unknown status|Recruiting|N/A|106|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-10 23:57:44.198519|2017-10-10 23:57:44.198519
NCT02255656|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-27|||January 2015||2015-01-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|TOPAZ||Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409|A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)|Active, not recruiting||Phase 4|812|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-10 23:57:44.309566|2017-10-10 23:57:44.309566
NCT02255643|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-12-16|||October 2014||2014-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Motor Threshold and Motor Cortex Stimulation|The Relationship Between Motor Threshold and Effective Stimulation Threshold During Motor Cortex Stimulation|Completed||N/A|7|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-10 23:57:44.818862|2017-10-10 23:57:44.818862
NCT02255630|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-11-09|||January 2015||2015-01-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|November 2015|Actual|2015-11-01||Interventional|||Anaerobic Power and Salbutamol|The Effects of High-dose Salbutamol on Anaerobic Cycling Power|Completed||N/A|20|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-10 23:57:44.927553|2017-10-10 23:57:44.927553
NCT02255617|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-01-12|||July 2014||2014-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study|A Prospective, Single Center, Open Label Trial of Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Alberta||1|||f||||t||||||||||2017-10-10 23:57:45.068496|2017-10-10 23:57:45.068496
NCT02255578|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-09-29|||September 2014||2014-09-01|September 2014|2014-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|EPCOS||Endobarrier Treatment in Women With PCOS|Phase 3 Study Investigating the Effect of Endobarrier Treatment on Fertility in Women With Polycystic Ovary Syndrome|Not yet recruiting||Phase 3|50|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-10 23:57:45.425089|2017-10-10 23:57:45.425089
NCT02255565|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-07-03|2017-03-07||September 2014||2014-09-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional||Of the 36 participants enrolled, 27 were randomized to receive treatment. 3 participants withdrew, 2 due to time commitment issues and 1 due to stress over screening. 6 participants were deemed ineligible for the study due to no Autism Spectrum Disorder (ASD) diagnosis based on screening assessments.|Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study|Quillivant XR in Children With Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study|Completed||Phase 4|36|Actual|Seattle Children's Hospital|No placebo was available for comparison to Quillivant XR. Small sample size.|3|||f||||f||||||||||2017-10-10 23:57:45.569681|2017-10-10 23:57:45.569681
NCT02255552|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-10-02|||September 2014||2014-09-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|PROMOVI||Confirmatory Study of Eteplirsen in DMD Patients|An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy|Active, not recruiting||Phase 3|160|Anticipated|Sarepta Therapeutics||2|||f||||f||||||||||2017-10-10 23:57:46.608443|2017-10-10 23:57:46.608443
NCT02254434|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-02|||August 2014||2014-08-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions|An Open-label Single-dose Pharmacokinetic Study of an Oral Formulation in Tablets Containing Eltrombopag 50 mg (Revolade, Glaxosmithkline Mexico, S.A. De C.V.) in Healthy Volunteers Under Fasting Conditions|Completed||Phase 1|26|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-10 23:57:46.796098|2017-10-10 23:57:46.796098
NCT02254421|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-04-28|||January 31, 2015|Actual|2015-01-31|April 2017|2017-04-01|April 17, 2017|Actual|2017-04-17|April 17, 2017|Actual|2017-04-17||Interventional|||Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT) Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract|Completed||Phase 2|60|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-10 23:57:46.870966|2017-10-10 23:57:46.870966
NCT02254408|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-10-03|||January 23, 2015|Actual|2015-01-23|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|July 14, 2017|Actual|2017-07-14||Interventional|||Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT) Recipients With Respiratory Syncytial Virus (RSV) Infection of the Upper Respiratory Tract|Active, not recruiting||Phase 2|190|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-10 23:57:47.007124|2017-10-10 23:57:47.007124
NCT02254395|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-10-13|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PINS Stimulator System for Deep Brain Stimulation to Treat Obesity|PINS Stimulator System for Deep Brain Stimulation to Treat Obesity|Not yet recruiting||Early Phase 1|8|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:57:47.20525|2017-10-10 23:57:47.20525
NCT02254382|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-04-13|||March 2016||2016-03-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|ParadiseHF||Positive Airway Pressure Therapy Study in Sleep Apnea and Diastolic Heart Failure|Positive Airway Pressure Therapy Study in Sleep Apnea and Diastolic Heart Failure|Terminated||N/A|2|Actual|ResMed||1||Recruitment rates too low|f||||f||||||||||2017-10-10 23:57:47.272704|2017-10-10 23:57:47.272704
NCT02254369|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-02-17|||September 2014||2014-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects|A Randomized, Phase 1, Double-Blind, Placebo-Controlled, First-in-Human, Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects|Completed||Phase 1|44|Anticipated|GliaCure, Inc.||10|||f||||||||||||||2017-10-10 23:57:47.399445|2017-10-10 23:57:47.399445
NCT02254356|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-08-01|||May 2012||2012-05-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Zilver Flex Post-Market Study in Japan|Zilver PTX Post-Market Surveillance Study of Bare Metal Stents for Treating Femoropopliteal Artery Disease in Japan|Active, not recruiting||N/A|239|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-10 23:57:47.478497|2017-10-10 23:57:47.478497
NCT02254343|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-09-14|||September 2014||2014-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effects of Proximal and Distal Robot-assisted Therapy Combined With Functional Training|Effects of Proximal and Distal Robot-assisted Therapy Combined With Functional Training on Stroke Rehabilitation|Completed||N/A|45|Actual|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-10 23:57:47.543631|2017-10-10 23:57:47.543631
NCT02254317|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-02-06|||September 2014||2014-09-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|GSE3||Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance|Dose-dependent Effect of Grape Seed Extract (GSE) on Glucose Control in People With Impaired Glucose Tolerance|Active, not recruiting||N/A|20|Anticipated|Institute for Food Safety and Health, United States||4|||f||||f||||||||Undecided||2017-10-10 23:57:47.747878|2017-10-10 23:57:47.747878
NCT01982721|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-03-30|||November 2014||2014-11-01|March 2016|2016-03-01||||October 2016|Anticipated|2016-10-01||Interventional|||Evaluation of an Acceleration-Based Prosthetic Knee Locking Mechanism for Reducing the Risk of Falling in Transfemoral Amputees||Not yet recruiting||N/A|||Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 01:06:37.646672|2017-10-11 01:06:37.646672
NCT02254291|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-08-16||2016-12-06|October 2, 2014|Actual|2014-10-02|August 2017|2017-08-01|November 11, 2015|Actual|2015-11-11|November 11, 2015|Actual|2015-11-11||Interventional|SUSTAIN™||A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes|Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily, Both as Monotherapy in Japanese Subjects With Type 2 Diabetes|Completed||Phase 3|308|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-10 23:57:47.928766|2017-10-10 23:57:47.928766
NCT02254278|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-03-02|||October 2014||2014-10-01|March 2017|2017-03-01||||May 31, 2019|Anticipated|2019-05-31||Interventional|||Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer|A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer|Active, not recruiting||Phase 2|295|Actual|NRG Oncology||2|||f||||t||||||||||2017-10-10 23:57:49.772309|2017-10-10 23:57:49.772309
NCT02255539|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-04-01|||January 2015||2015-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:57:50.360371|2017-10-10 23:57:50.360371
NCT02255526|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-04-07|||September 2014||2014-09-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Observational|||BodyGuardian Respiration and Activity Validation Testing|BodyGuardian Respiration and Activity Validation Testing|Completed||N/A|24|Actual|Preventice|||2||f||||f||||||||No|Not an applicable study under section 801|2017-10-10 23:57:50.409432|2017-10-10 23:57:50.409432
NCT02255513|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-20||2017-09-07|May 2014||2014-05-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CEES||A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD|A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.|Completed||Phase 3|48|Actual|Ironshore Pharmaceuticals and Development, Inc||2|||f||||f||||||||||2017-10-10 23:57:50.491264|2017-10-10 23:57:50.491264
NCT02255487|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-07-07|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||IrrSept vs. Standard of Care in Prevention of Surgical Site Infections|A Phase IV, Multicenter, Prospective, Randomized, Controlled Clinical Study to Compare the IrriSept System Versus Standard of Care on the Prevalence of Surgical Site Infection in Patients With Abdominal Trauma or Acute Surgical Abdomen|Completed||Phase 4|625|Actual|Irrimax Corporation||2|||f||||t||||||||||2017-10-10 23:57:50.670083|2017-10-10 23:57:50.670083
NCT02255474|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-09-24|||September 2014||2014-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|BLINK||Bifocal Lenses In Nearsighted Kids|Soft Bifocal Contact Lens Myopia Control|Active, not recruiting||N/A|294|Actual|Ohio State University||3|||f||||t||||||||||2017-10-10 23:57:50.797859|2017-10-10 23:57:50.797859
NCT02255461|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-27|||October 2014||2014-10-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors|Phase I Study of CDK 4-6 Inhibitor PD-0332991 (Palbociclib; IBRANCE) in Children With Recurrent, Progressive or Refractory Central Nervous System Tumors|Recruiting||Phase 1|55|Anticipated|Pediatric Brain Tumor Consortium||1|||f||||t|t|||||||||2017-10-10 23:57:50.903405|2017-10-10 23:57:50.903405
NCT02255448|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-10-02|||November 2014||2014-11-01|September 2014|2014-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|esCCO||Evaluation of the esCCO Non-invasive Cardiac Output Measurement Device in Pregnancy|Evaluation of the esCCO Non-invasive Cardiac Output Measurement Device in Pregnancy|Unknown status|Not yet recruiting|N/A|100|Anticipated|King's College Hospital NHS Trust||1|||f||||f||||||||||2017-10-10 23:57:51.068075|2017-10-10 23:57:51.068075
NCT02255435|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-09-25|||January 2015||2015-01-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|January 2020|Anticipated|2020-01-01||Interventional|||RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe|A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia (MOXIe)|Recruiting||Phase 2|172|Anticipated|Reata Pharmaceuticals, Inc.||9|||f||||t||||||||||2017-10-10 23:57:51.129331|2017-10-10 23:57:51.129331
NCT02255422|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-11-14|||April 2015||2015-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR|A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Mitochondrial Myopathy (MOTOR)|Recruiting||Phase 2|100|Anticipated|Reata Pharmaceuticals, Inc.||8|||f||||t||||||||||2017-10-10 23:57:51.39647|2017-10-10 23:57:51.39647
NCT02255409|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-10-26||2016-10-26|October 2014||2014-10-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05|A Phase III, Randomized, Observer Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV), Administered to Subjects Previously Vaccinated in Trial V118_0|Completed||Phase 3|607|Actual|Seqirus||2|||f||||||||||||||2017-10-10 23:57:51.54565|2017-10-10 23:57:51.54565
NCT02255396|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-09-30|||January 2009||2009-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|||Estradiol and Testosterone Levels in Seminal Plasma of Men With Non-obstructive Azoospermia|Are Estradiol and Testosterone Levels in Seminal Plasma Predictive for Efficient Spermatogenesis in Men With Non- Obstructive Azoospermia|Completed||N/A|50|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:57:51.670886|2017-10-10 23:57:51.670886
NCT02255383|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-10-12|||July 2014||2014-07-01|August 2016|2016-08-01|December 2027|Anticipated|2027-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Persona Total Knee Arthroplasty Outcomes Study|Persona The Personalized Knee System TKA Outcomes Study: Prospective Multicenter Study of the Persona Knee System|Recruiting||N/A|1000|Anticipated|Zimmer Biomet||1|||f||||f||||||||Undecided||2017-10-10 23:57:51.744318|2017-10-10 23:57:51.744318
NCT02255370|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-07-25|||December 2014||2014-12-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|POPCUR||Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease|Controlled, Randomized, Double Blind Study, Comparing Curcumin to Thiopurines in the Prevention of Post-op Recurrence in Crohn Disease|Recruiting||Phase 3|122|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-10 23:57:51.871037|2017-10-10 23:57:51.871037
NCT02255357|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-10-25|||March 2015||2015-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.|Investigation of the Effect of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients|Active, not recruiting||Phase 2/Phase 3|43|Actual|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-10 23:57:51.980304|2017-10-10 23:57:51.980304
NCT02255344|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-06-17|||August 2014||2014-08-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01|2 Years|Observational [Patient Registry]|RENASCA-IMSS||Multicenter Study to Develop a Risk Model for Early Major Cardiovascular Events|Multicenter Study to Develop a Risk Model for Early Major Cardiovascular Events Based on the IMSS National Registry of Acute Coronary Syndromes (RENASCA IMSS). Stage 1|Recruiting||N/A|15000|Anticipated|Instituto Mexicano del Seguro Social|||2||f||||f||||||||||2017-10-10 23:57:52.090605|2017-10-10 23:57:52.090605
NCT02255331|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-03-15|||August 2014||2014-08-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Magnetic Resonance Imaging as a Biomarker For Adverse Local Tissue Reaction In Individuals With Hip Arthroplasty|Magnetic Resonance Imaging as a Biomarker For Adverse Local Tissue Reaction In Individuals With Hip Arthroplasty|Recruiting||N/A|240|Anticipated|Hospital for Special Surgery, New York|||2||f||||f||||||Samples Without DNA|"     1. A small sample of soft tissues surrounding a total hip replacement will be retained for     histological evaluation   "|Yes|We will encourage the sharing of our final research data to enable further exploration of the data not presented in the application and for encouraging other individuals to develop new methods of data analysis. The data will be organized by subject number and by date of procedure (e.g. radiographs, MRI, serum metal ion levels, histology, wear analysis, etc.) for ease of identifying a specific dataset. The data will be stored on our servers and back-up drives. Individuals requesting electronic data will be given a link to a private web server to download the requested information, or will be requested to pay a nominal fee to burn the data to CD or DVD or to download to an individual's blank external hard drive, and for mailing charges depending on the type of data requested. Our goal is to make the data as easily accessible to the public as possible.|2017-10-10 23:57:52.193027|2017-10-10 23:57:52.193027
NCT02255318|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-10-27|||January 2015||2015-01-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition|Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition|Recruiting||N/A|70|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-10 23:57:52.298568|2017-10-10 23:57:52.298568
NCT02255305|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-03-22|||January 2015||2015-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI|Fecal Microbiota Transplantation Versus Standard Medical Therapy for Initial Treatment of Recurrent Clostridium Difficile Infection|Recruiting||Phase 2|60|Anticipated|NorthShore University HealthSystem||2|||f||||t||||||||||2017-10-10 23:57:52.409761|2017-10-10 23:57:52.409761
NCT02255292|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-10-01|||November 2014||2014-11-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||A Study: Pure CBD as Single-agent for Solid Tumor.||Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-10 23:57:52.524916|2017-10-10 23:57:52.524916
NCT02255279|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-11-30|2016-01-04||October 2014||2014-10-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.|A Phase 3, Observed-Blind, Randomized, Multi-center Study to Evaluate Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.|Completed||Phase 3|287|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:57:52.646981|2017-10-10 23:57:52.646981
NCT02255266|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-11-18|||March 2015||2015-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice|Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice|Completed||N/A|1788|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-10 23:57:53.885266|2017-10-10 23:57:53.885266
NCT02255253|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-03-09|||October 2014||2014-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population|Efficacy of Telmisartan 40mg and Hydrochlorothiazide 25mg Monotherapy in High Sodium Intake Patients With Mild to Moderate Hypertension: a Multicenter Randomized Double-blinded Parallel Controlled Trial|Completed||N/A|1410|Actual|The George Institute for Global Health, China||2|||f||||t||||||||||2017-10-10 23:57:53.97883|2017-10-10 23:57:53.97883
NCT02255240|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-05-26|||September 2014||2014-09-01|September 2014|2014-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|LEVEL UP||LEVEL UP: Video Games for Activity in Breast Cancer Survivors|LEVEL UP: Leveraging Electronic Videogames for Exercise and Leisure: Understanding Preferences of Breast Cancer Survivors|Withdrawn||N/A|0|Actual|The University of Texas Medical Branch, Galveston||1||Relinquished grant funding due to receipt of another incompatible grant|f||||f||||||||||2017-10-10 23:57:54.10001|2017-10-10 23:57:54.10001
NCT02255045|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-09-14|||July 2014||2014-07-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|October 2015|Anticipated|2015-10-01||Interventional|||Assess of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea|Evaluation of the Effect of a Vaginal Ring With Meloxicam on Primary Dysmenorrhea in Women of Childbearing Age|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Laboratorios Andromaco S.A.||4|||f||||f||||||||||2017-10-10 23:57:56.332001|2017-10-10 23:57:56.332001
NCT02255227|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-05-29|||April 2015||2015-04-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PneumoMICI||Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD|Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease|Recruiting||Phase 2|150|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-10 23:57:54.194354|2017-10-10 23:57:54.194354
NCT02255201|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-04-06|||October 2014||2014-10-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pre-Workout on Exercise Performance and Cognition|A Randomized, Double-Blind, Crossover Clinical Trial Comparing the Effects of Four Pre-Workout Beverages on Muscular Strength and Endurance and Cognitive Performance in Healthy Adult Males|Completed||N/A|24|Actual|Miami Research Associates||5|||f||||||||||||||2017-10-10 23:57:54.417895|2017-10-10 23:57:54.417895
NCT02255188|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-09-07|||October 2014||2014-10-01|July 2015|2015-07-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|||Experimental Study of the Vascular Prosthesis Manufactured by Electrospinning|Evaluate Hemocompatibility Vascular Prosthesis to Prevent Its Thrombosis|Completed||N/A|120|Actual|Meshalkin Research Institute of Pathology of Circulation|||4||f||||t||||||||||2017-10-10 23:57:54.512223|2017-10-10 23:57:54.512223
NCT02255175|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-09-12|||October 1, 2015||2015-10-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|PEERS||Perimenopausal Effects of Estradiol on Reward Responsiveness|Effects of Estradiol on Neural Reward System and Depression in the Perimenopause|Recruiting||Phase 4|50|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:57:54.612251|2017-10-10 23:57:54.612251
NCT02255162|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-08-15|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML|Safety and Feasibility of Lenalidomide in Combination With HLA-mismatched Stem-cell Microtransplantation as Post-remission Therapy in Patients With Acute Myeloid Leukemia (AML)|Terminated||Phase 1|8|Actual|Massachusetts General Hospital||1||Slow Accrual|f||||t||||||||||2017-10-10 23:57:54.742531|2017-10-10 23:57:54.742531
NCT02255149|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-01-27|2016-03-17||September 2011||2011-09-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Feasibility Study for Growth Bone Vertically With Titanium Mesh and Allograft in Lower Posterior Jaw|Vertical Ridge Augmentation Using Titanium Mesh and Allograft in Posterior Mandible: A Feasibility Study|Completed||N/A|10|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-10 23:57:54.852821|2017-10-10 23:57:54.852821
NCT02255136|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-05-27|||March 2012|Actual|2012-03-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|SBRCTHILARBA||Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial Asthma|An Evidence-based Single-blind Randomized Controlled Trial Searching for the Efficacy of Homoeopathic Medicines in Reducing Serum Levels of Cytokines (IL - 10, 13) and Immunoglobulin E in Allergic Rhinitis and/or Induced Bronchial Asthma|Active, not recruiting||N/A|100|Actual|Mahesh Bhattacharyya Homoeopathic Medical College and Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:57:55.035001|2017-10-10 23:57:55.035001
NCT02255123|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-03-22|||October 2014||2014-10-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study|A Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study (CTOT-18)|Completed||N/A|178|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||f||||||||||2017-10-10 23:57:55.120579|2017-10-10 23:57:55.120579
NCT02255097|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-06-07|2017-04-20||October 24, 2014|Actual|2014-10-24|June 2017|2017-06-01|October 16, 2017|Anticipated|2017-10-16|April 22, 2016|Actual|2016-04-22||Interventional|||Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)|A Phase II Clinical Trial of Single Agent Pembrolizumab (MK-3475) in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Who Have Failed Platinum and Cetuximab|Active, not recruiting||Phase 2|172|Actual|Merck Sharp & Dohme Corp.||1|||f||||f|t|f||||||No||2017-10-10 23:57:55.326641|2017-10-10 23:57:55.326641
NCT02255084|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-10-25|||February 2015||2015-02-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|APACHE-3||Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women|Attitude of Unscreened Women Face to Different Strategies to Participate in Cervical Cancer Screening by Vaginal Self-sampling : Home-mailed or Invitation to Remove to Their General Practitioner|Completed||N/A|3612|Actual|University Hospital, Tours||2|||f||||f||||||||||2017-10-10 23:57:56.100852|2017-10-10 23:57:56.100852
NCT02255071|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-06-08|||June 2014||2014-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||The Efficacy of Neiguan (P6 Point) Acupressure in Patients With Gastroesophageal Reflux Disease (GERD)|The Efficacy of Neiguan (P6 Point) Acupressure in Patients With Gastroesophageal Reflux Disease (GERD)|Unknown status|Active, not recruiting|N/A|64|Anticipated|China Medical University Hospital||2|||f||||f||||||||||2017-10-10 23:57:56.171507|2017-10-10 23:57:56.171507
NCT02255058|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-02-27|||August 2014||2014-08-01|October 2014|2014-10-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|MIND||MIND Score for Prolonged Mechanical Ventilation|Psychometric Validation of the Multi-INdependency Dimensions (MIND) Score for Patients Under Prolonged Mechanical Ventilation|Completed||N/A|129|Actual|Linde AG|||1||f||||f||||||||||2017-10-10 23:57:56.259511|2017-10-10 23:57:56.259511
NCT02255032|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-06-28||2017-06-28|October 2014||2014-10-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|DOGWOOD||Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis|A Randomized, Masked, Multicenter Study to Assess the Safety and Efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the Treatment of Subjects With Macular Edema Following Uveitis|Completed||Phase 2|22|Actual|Clearside Biomedical, Inc.||2|||f||||f||||||||No||2017-10-10 23:57:56.41858|2017-10-10 23:57:56.41858
NCT02255019|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-10-01|||May 2011||2011-05-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||MRI in Patients With Inflammatory Bowel Disease|MRI in Patients With Inflammatory Bowel Disease|Completed||N/A|125|Actual|Copenhagen University Hospital at Herlev|||1||f||||f||||||Samples Without DNA|"     Patients will receive a faeces sample kit the first day they meet to MRI. The sample should     be taken two days after the MRI scan and sent through the mail. The sample should contain     about 5-10 g of faeces and it will be analyzed by ELISA method for calprotectin. Calprotectin     is a good marker for the degree of inflammation in the intestines.   "|||2017-10-10 23:57:56.530502|2017-10-10 23:57:56.530502
NCT02255006|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-09-29|||May 2014||2014-05-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|AURORAS||Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury|Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury Via Adenosine Triphosphate-sensitive Potassium Channels or Prostaglandin Pathway|Unknown status|Recruiting|N/A|36|Anticipated|Kyunghee University Medical Center||4|||f||||t||||||||||2017-10-10 23:57:56.601288|2017-10-10 23:57:56.601288
NCT02254993|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-12-16||2016-12-15|October 2014||2014-10-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses|A Phase 2, Open-Label Study to Evaluate the Safety, Microbiology and Pharmacokinetics of C16G2 Administered in Single or Multiple Oral Gel Doses to Healthy Adult Subjects|Completed||Phase 2|52|Actual|C3 Jian, LLC||11|||f||||f||||||||||2017-10-10 23:57:56.710677|2017-10-10 23:57:56.710677
NCT02254980|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-08-29|||February 2013||2013-02-01|August 2016|2016-08-01|October 2026|Anticipated|2026-10-01|October 2016|Anticipated|2016-10-01||Interventional|E1-hip||Migration and Head Penetration of Vitamin-E Diffused Cemented Polyethylene Cup in Total Hip Arthroplasty|Migration and Head Penetration of Vitamin-E Diffused Cemented Polyethylene Cup Compared to Standard Cemented Cup in Total Hip Arthroplasty. A Randomized, Single-blinded, Clinical Trial|Recruiting||N/A|50|Anticipated|Danderyd Hospital||2|||f||||f||||||||||2017-10-10 23:57:56.83123|2017-10-10 23:57:56.83123
NCT02254967|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-06-07|||November 6, 2014|Actual|2014-11-06|June 2017|2017-06-01|May 5, 2016|Actual|2016-05-05|March 27, 2016|Actual|2016-03-27||Interventional|EXTEND||A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population|A Phase IIIB/IV Randomized, Controlled, Open-label, Parallel Group Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration Fidaxomicin Therapy in the Sustained Clinical Cure of Clostridium Difficile Infection in an Older Population|Completed||Phase 4|364|Actual|Astellas Pharma Inc||2|||f||||t|f|f||||||Undecided||2017-10-10 23:57:56.948643|2017-10-10 23:57:56.948643
NCT02254954|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-11-01|||October 2014||2014-10-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma|A Single-center, Open-label, Phase 1 Study of Macitentan, Radiotherapy and Temozolomide Concurrent Therapy Followed by Maintenance Therapy With Macitentan and Temozolomide in Subjects With Newly Diagnosed Glioblastoma|Completed||Phase 1|30|Actual|Actelion||1|||f||||f||||||||||2017-10-10 23:57:57.295461|2017-10-10 23:57:57.295461
NCT02254941|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-08-10|||August 2014||2014-08-01|August 2016|2016-08-01||||September 2017|Anticipated|2017-09-01||Observational|||Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer|Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer|Recruiting||N/A|1950|Anticipated|Grupo Espanol Multidisciplinario del Cancer Digestivo|||2||f||||f||||||Samples With DNA|"     Colon biopsy   "|||2017-10-10 23:57:57.383448|2017-10-10 23:57:57.383448
NCT02254928|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-01-15|||September 2014||2014-09-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|MANCOR||Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders|Comparative Study Between the Use of Corifollitropin Alfa and Daily Recombinant FSH in the Controlled Ovarian Stimulation of Poor Responders|Terminated||Phase 4|26|Actual|IVI Sevilla||2||Lack of funding|f||||||||||||||2017-10-10 23:57:57.487506|2017-10-10 23:57:57.487506
NCT02254915|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-03-31||||||March 2015|2015-03-01||||January 2020|Anticipated|2020-01-01||Interventional|SHTC-EUROPE-1||SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I|A Multi-Centre, Randomised, Open-Label Active-Controlled Study Comparing Safety and Efficacy of Synergo Radiofrequency (RF)-Induced Hyperthermia-Chemotherapy With Mitomycin C (RITE) Versus Bacillus Calmette-Guérin (BCG) as First-Line Treatment of Non-Muscle Invasive Papillary Bladder Cancer (NMIBC)|Withdrawn||Phase 3|0|Actual|Medical Enterprises Europe B.V.||2||"Shortages of the active comparator drug (BCG) on the market worldwide and a growing uncertainty   as to its future supply."|f||||t||||||||||2017-10-10 23:57:57.591898|2017-10-10 23:57:57.591898
NCT02254902|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-05-11|||September 2014||2014-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Physical Activity and Education Program for Somali Women|Physical Activity and Education to Reduce Cancer Risk Among Somali Women (Ladnaan Project)|Terminated||N/A|27|Actual|University of California, San Diego||2||Changes in funding status|f||||f||||||||||2017-10-10 23:57:57.704684|2017-10-10 23:57:57.704684
NCT02254889|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-02-11|||April 2011||2011-04-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pain After Endoscopic Submucosal Dissection|Pain After Endoscopic Submucosal Dissection|Completed||N/A|156|Actual|Gangnam Severance Hospital||2|||f||||t||||||||||2017-10-10 23:57:57.802077|2017-10-10 23:57:57.802077
NCT02254876|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-05-28|||September 2013||2013-09-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Effectiveness of NeuroMuscular Taping on Painful Hemiplegic Shoulder|Effectiveness of NeuroMuscular Taping in a Population of Post Stroke Hemiplegic Patients Suffering From Painful Shoulder Syndrome - Randomized Controlled Trial (RCT)|Completed||N/A|40|Actual|University of Bologna||2|||f||||f||||||||||2017-10-10 23:57:57.877715|2017-10-10 23:57:57.877715
NCT02254863|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-06-27|||September 2014||2014-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|DUOC-01||UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells|Augmentation of Umbilical Cord Blood Transplantation for Inherited Metabolic Diseases With Intrathecal Administration of Human Umbilical Cord Blood-Derived Oligodendrocyte-Like Cells|Recruiting||Phase 1|12|Anticipated|Duke University||1|||f||||t||||||||||2017-10-10 23:57:57.967032|2017-10-10 23:57:57.967032
NCT02254850|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-09-30|||May 2013||2013-05-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|August 2013|Actual|2013-08-01||Interventional|||Mesoglycan, Vascular Reactivity and Metabolic Syndrome|The Mesoglycan and Vascular Reactivity in the Metabolic Syndrome|Completed||Phase 4|30|Actual|Federico II University||2|||f||||f||||||||||2017-10-10 23:57:58.076028|2017-10-10 23:57:58.076028
NCT02254837|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-10-20|||May 2012||2012-05-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Zilver PTX Post-Market Study in Japan|Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan|Active, not recruiting||N/A|909|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-10 23:57:58.197882|2017-10-10 23:57:58.197882
NCT02254824|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-09-29|||October 2013||2013-10-01|September 2014|2014-09-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients|Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients (EMINENT Study)|Unknown status|Recruiting|Phase 4|300|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital||3|||f||||t||||||||||2017-10-10 23:57:58.267952|2017-10-10 23:57:58.267952
NCT02254811|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-01-12|||September 2014||2014-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff|A Prospective, Multi-center, Randomized Trial of Fecal Microbiota Transplantation (FMT) Delivered by Capsule vs Colonoscopy in the Management of Recurrent Clostridium Difficile Infection (CDI)|Active, not recruiting||Phase 2/Phase 3|116|Actual|University of Alberta||2|||f||||t||||||||No||2017-10-10 23:57:58.36848|2017-10-10 23:57:58.36848
NCT02254798|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-29|||January 2014||2014-01-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|PLASMA-INCA||Biomarkers for Acute Graft-versus-host Disease|Diagnostic and Prognostic Biomarkers for Acute Graft-versus-host Disease: a Prospective Single Centre Biological Study|Recruiting||N/A|315|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     blood sample on day 7, 14, 21, 28 and at GVHD onset   "|||2017-10-10 23:57:58.442794|2017-10-10 23:57:58.442794
NCT02254785|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2017-03-01|||October 2014||2014-10-01|September 2016|2016-09-01||||May 2020|Anticipated|2020-05-01||Interventional|||Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer|A Phase II, Randomized, Multi-center Study of Cabazitaxel Versus Abiraterone or Enzalutamide in Poor Prognosis-metastatic Castration-resistant Prostate Cancer|Recruiting||Phase 2|120|Anticipated|British Columbia Cancer Agency||2|||f||||f||||||||||2017-10-10 23:57:58.539336|2017-10-10 23:57:58.539336
NCT02254772|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-09-04|2017-09-04||September 2014||2014-09-01|February 2017|2017-02-01|January 26, 2017|Actual|2017-01-26|November 10, 2016|Actual|2016-11-10||Interventional|||A Phase I/II Study of Intratumoral Injection of SD-101|A Phase I/II Study of Intratumoral Injection of SD-101, an Immunostimulatory CpG, and Intratumoral Injection of Ipilimumab, an Anti-CTLA4 Monoclonal Antibody, in Combination With Local Radiation in Low-Grade B-Cell Lymphomas|Completed||Phase 1/Phase 2|9|Actual|Stanford University||1|||f||||t|t|f||||||||2017-10-10 23:57:58.872913|2017-10-10 23:57:58.872913
NCT02254759|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-11-01|||October 2014||2014-10-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy Participants||Completed||Phase 1|12|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-10-10 23:57:59.263967|2017-10-10 23:57:59.263967
NCT02254746|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-06-06|||September 2014||2014-09-01|June 2017|2017-06-01|March 2025|Anticipated|2025-03-01|September 2020|Anticipated|2020-09-01||Interventional|||A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer|A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer|Recruiting||N/A|27|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||t||||||||||2017-10-10 23:57:59.362912|2017-10-10 23:57:59.362912
NCT02254733|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-11-16|||February 2012||2012-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Assertive Community Treatment With CBT and SST for Schizophrenia|Enhancing Assertive Community Treatment With Cognitive Behavioral Therapy and Social Skills Training for Schizophrenia.|Completed||N/A|178|Actual|Veterans Medical Research Foundation||2|||f||||t||||||||No||2017-10-10 23:57:59.481161|2017-10-10 23:57:59.481161
NCT02254720|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-01|||September 2006||2006-09-01|September 2014|2014-09-01||||December 2006|Actual|2006-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BEA 2180 BR in Healthy Male Volunteers|A Randomised, Single-blind, Placebo-controlled (Within Dose Groups) Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses (2.5 μg, 7.5 μg, 25 μg, 50 μg, 100 μg, 200 μg, 350 μg, 500 μg Free Cation) BEA 2180 BR in Healthy Male Volunteers With an Additional Arm by Inhalation in One Dose Group (1600 μg)|Completed||Phase 1|71|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:57:59.615697|2017-10-10 23:57:59.615697
NCT02254707|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2014-10-01|||July 2004||2004-07-01|September 2014|2014-09-01||||April 2006|Actual|2006-04-01||Interventional|||Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection|A Multinational Randomised, Double-blind, Placebo Controlled Study to Evaluate the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW Oral Solution Administered Q8H for Five Days to Patients With Chronic Hepatitis C Genotype 1 Virus Infection|Completed||Phase 1/Phase 2|96|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:57:59.72034|2017-10-10 23:57:59.72034
NCT02254694|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-05-27|||September 2014||2014-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||The Influence of High Heeled Shoes on the Sagittal Balance of the Spine and Whole Body|The Influence of High Heeled Shoes on the Sagittal Balance of the Spine and Whole Body|Completed||N/A|23|Actual|University of Zurich||1|||f||||f||||||||||2017-10-10 23:57:59.807286|2017-10-10 23:57:59.807286
NCT02254681|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2016-10-12|||September 2014||2014-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study of Low-Dose Radiation Therapy to the Whole Liver in Combination With Gemcitabine and Cisplatin in Intrahepatic Cholangiocarcinoma|A Phase 2 Study of Low-Dose Fractionated Radiation Therapy to the Whole Liver in Combination With Gemcitabine and Cisplatin in Locally Advanced Mass-Forming Intrahepatic Cholangiocarcinoma|Terminated||Phase 2|6|Actual|Allina Health System||1||lack of funding|f||||t||||||||||2017-10-10 23:57:59.890368|2017-10-10 23:57:59.890368
NCT02254668|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2014-09-29|||December 2013||2013-12-01|September 2014|2014-09-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Interventional|OCTandCAV||Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography|Intracoronary Analysis of Cardiac Allograft Vasculopathy in Comparison to Coronary Artery Disease by Means of Optical Coherence Tomography|Recruiting||Phase 4|278|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-10 23:58:00.02948|2017-10-10 23:58:00.02948
NCT02254655|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-08-16|||November 2013||2013-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|November 2014|Actual|2014-11-01||Interventional|||The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis|The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis, a Controlled and Randomized Trial|Completed||Phase 2|119|Actual|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-10 23:58:00.207806|2017-10-10 23:58:00.207806
NCT02254642|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-10-19|||November 2016||2016-11-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Effects of Ischemic Preconditioning After Aortic Clamping|Protective Effects of Ischemic Preconditioning on Cardiac, Renal, Pulmonary and Muscular Functions After Aortic Clamping|Not yet recruiting||Early Phase 1|200|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:58:00.973257|2017-10-10 23:58:00.973257
NCT02254629|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-08-30|||July 2014||2014-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|August 2015|Actual|2015-08-01||Interventional|||The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients|The Effects of Laxative-probiotic Sequential Treatment on the Symptoms and Fecal Microbiota in the IBS Patients.|Completed||Phase 1|56|Actual|Shandong University||3|||f||||t||||||||||2017-10-10 23:58:01.117715|2017-10-10 23:58:01.117715
NCT02254616|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-07-06|||August 2014||2014-08-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Hybrid Approach to Mirror Therapy and Transcranial Direct Current Stimulation for Stroke Recovery|Hybrid Approach to Mirror Therapy and Transcranial Direct Current Stimulation for Stroke Recovery: A Follow up Study on Brain Reorganization, Motor Performance of Upper Extremity, Daily Function, and Activity Participation|Recruiting||N/A|80|Anticipated|Chang Gung Memorial Hospital||4|||f||||f||||||||||2017-10-10 23:58:01.220632|2017-10-10 23:58:01.220632
NCT02254603|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-29|||May 2013||2013-05-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Effects of the Combined Therapy of Acupuncture and Yoga Exercise on Weight Loss|To Evaluate the Effects of Weight-loss by the Combined Therapy of Acupuncture and Yoga Exercise|Unknown status|Recruiting|N/A|74|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:58:01.345941|2017-10-10 23:58:01.345941
NCT02254590|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-01|||September 2009||2009-09-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Irrigation Endoscopic Decompression|Irrigation Endoscopic Decompressive Laminotomy. A New Endoscopic Approach for Spinal Stenosis Decompression|Completed||N/A|104|Actual|Cairo University||1|||f||||f||||||||||2017-10-10 23:58:01.508323|2017-10-10 23:58:01.508323
NCT02254577|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-06-27|||October 2014||2014-10-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer|A Randomized, Three-armed, Non-Inferiority Study of Vaginal Progesterone (Endometrin®) Compared to Intramuscular Progesterone in Oil (PIO) in Infertile Subjects Undergoing Frozen Embryo Transfer (FET)|Active, not recruiting||Phase 4|1170|Anticipated|Shady Grove Fertility Reproductive Science Center||2|||f||||t||||||||||2017-10-10 23:58:01.631585|2017-10-10 23:58:01.631585
NCT02254551|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-12-23|2016-10-28||January 2015||2015-01-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma|Phase II Trial of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma With a Dose-Finding Lead-In|Terminated||Phase 2|7|Actual|SCRI Development Innovations, LLC|Early termination of study during dose-escalation did not support continuation of study.|1||Safety lead-in data did not support continuation of study.|f||||f||||||||||2017-10-10 23:58:01.901075|2017-10-10 23:58:01.901075
NCT02254538|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-09-29|||May 2002||2002-05-01|September 2014|2014-09-01||||February 2003|Actual|2003-02-01||Interventional|||A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers|A Double-blind (at Each Dose Level), Randomised, Placebo-controlled Single Increasing Dose Safety, Tolerability and Preliminary Pharmacokinetics Study in Healthy Male Volunteers After Oral Administration of BILR 355 BS Solved in PEG 400 (Dosage: 1 - 200 mg)|Completed||Phase 1|54|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:02.366593|2017-10-10 23:58:02.366593
NCT02254525|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-10-01|||May 2012||2012-05-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||A Multicenter Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain|A Multicenter, Randomized, Double-blind, and Parallel Groups, Placebo-controlled Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain.|Terminated||Phase 3|231|Actual|Biomendi S.A.U.||2||Sample not reached in traumathology arm|f||||f||||||||||2017-10-10 23:58:02.452262|2017-10-10 23:58:02.452262
NCT02254499|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-09-22|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Prediction of Pain After Total Knee Arthroplasty|Prospective Descriptive Study of Nociceptive and Psychological Prediction of Pain After Total Knee Arthroplasty (TKA)|Completed||N/A|60|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-10 23:58:02.579064|2017-10-10 23:58:02.579064
NCT02254486|ClinicalTrials.gov processed this data on October 10, 2017|2014-10-01|2017-04-19|2016-08-19||August 2014||2014-08-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Either trisulfate solution or NER1006 administered as a split dose, the evening before and on the day of colonoscopy|Phase III Study Comparing Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 With Trisulfate Bowel Cleansing Solution Using 2-Day Split-Dosing Regimen in Adults|A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) Versus a Trisulfate Bowel Cleansing Solution Using 2-Day Split-Dosing Regimen in Adults|Completed||Phase 3|621|Actual|Norgine||2|||f||||f||||||||||2017-10-10 23:58:02.650032|2017-10-10 23:58:02.650032
NCT02254473|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-07-10|||August 2014||2014-08-01|February 2017|2017-02-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Evaluating the Efficacy of Lateral Heel Wedges of Osteoarthritis of the Knee|Evaluating the Efficacy of Lateral Heel Wedges of Osteoarthritis of the Knee|Completed||N/A|80|Anticipated|HealthPartners Institute||2|||f||||f||||||||||2017-10-10 23:58:03.067552|2017-10-10 23:58:03.067552
NCT02254460|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-06-08|2017-01-02||February 6, 2013||2013-02-06|June 2017|2017-06-01|March 8, 2013|Actual|2013-03-08|March 1, 2013|Actual|2013-03-01||Interventional|||Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk|A Double Blind, Randomized, Two-way Cross-over Study to Investigate the Uptake of Iron From Micronutrient Fortified Powder vs. From Tailored Control in Milk.|Completed||N/A|25|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:58:03.147435|2017-10-10 23:58:03.147435
NCT02254447|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-05-12|||December 2, 2014|Actual|2014-12-02|May 2017|2017-05-01|January 8, 2015|Actual|2015-01-08|January 8, 2015|Actual|2015-01-08||Interventional|||Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions|An Open-label, Randomized, Single Dose, Three-way Crossover, Six Sequence Pilot Study to Determine the Relative Bioavailability of Candesartan Cilexetil 16mg From Two Candidate Tablet Formulations of GW615775 Relative to One 16mg Tablet of Reference Candesartan Cilexetil in Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|18|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-10 23:58:03.365485|2017-10-10 23:58:03.365485
NCT02254265|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-11-18||2016-02-13|September 2014||2014-09-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca|A Randomized, Multicenter, Double-Masked, Vehicle-Controlled, Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca|Completed||Phase 2/Phase 3|455|Actual|Ocular Technologies SARL||3|||f||||f||||||||Undecided||2017-10-10 23:58:03.461082|2017-10-10 23:58:03.461082
NCT02254252|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-03-28|2014-10-03||March 2012||2012-03-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Nicorandil on Angina Symptoms in Patients With Coronary Slow Flow|Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon Visited in Imam Reza Hospital, Mashhad, Iran|Completed||Phase 4|54|Actual|Mashhad University of Medical Sciences||2|||f||||f||||||||||2017-10-10 23:58:03.553362|2017-10-10 23:58:03.553362
NCT02254239|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-08-18|||February 4, 2016|Actual|2016-02-04|March 2017|2017-03-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma|Phase 1 Study of Everolimus in Combination With Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin Lymphoma|Active, not recruiting||Phase 1|26|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-10 23:58:03.791871|2017-10-10 23:58:03.791871
NCT02254226|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-09-29|||November 2004||2004-11-01|September 2014|2014-09-01||||January 2005|Actual|2005-01-01||Interventional|||Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers|A Randomised, Open-label Four-way Crossover Study to Evaluate Pharmacokinetics of Salmeterol (Serevent®) After Inhalation of a 25 μg and 50 μg Single Dose (Metered Dose Inhaler) and a 50 μg and 100 μg Single Dose (Diskus®) in Healthy Male Volunteers|Completed||Phase 1|26|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:58:04.001739|2017-10-10 23:58:04.001739
NCT02254213|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-09-29|||June 2005||2005-06-01|September 2014|2014-09-01|August 2007|Actual|2007-08-01|August 2005|Actual|2005-08-01||Observational|||Intra-individual Stability in Electroencephalography (EEG) Parameters|Intra-individual Stability in EEG Parameters|Completed||N/A|15|Actual|Mentis Cura|||1||f||||f||||||||||2017-10-10 23:58:04.104352|2017-10-10 23:58:04.104352
NCT02254200|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-07-20|||January 2013||2013-01-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|INTFMOBE||Exercise Training and Fitness in Severe Obesity|Effect of Short-term High-intensity Interval and Fatmax Training on Aerobic and Metabolic Fitness in Obese Subjects|Completed||N/A|19|Actual|Istituto Auxologico Italiano||2|||f||||t||||||||||2017-10-10 23:58:04.18552|2017-10-10 23:58:04.18552
NCT02254187|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-09-29|||September 2005||2005-09-01|September 2014|2014-09-01||||October 2005|Actual|2005-10-01||Interventional|||Pharmacokinetics of Salmeterol Via HandiHaler® in Healthy Male Volunteers|A Randomised, Open-label Three-way Crossover Study to Evaluate the Pharmacokinetics of Salmeterol After Inhalation of a 25 μg and 50 μg Single Dose (Inhalation Powder, Hard PE Capsule for HandiHaler®2) and a 50 μg Single Dose (Serevent® Diskus®) in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:58:04.287869|2017-10-10 23:58:04.287869
NCT02254174|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-09-30|||March 2006||2006-03-01|September 2014|2014-09-01||||July 2006|Actual|2006-07-01||Interventional|||Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers|A Randomised, Open-label Four-way Crossover Study to Evaluate Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Single Dose (7.5 μg Tiotropium, 25 μg Salmeterol, Inhalation Powder, Hard Capsule, HandiHaler®2), a Free Combined Single Dose of 18 μg Tiotropium [Spiriva® HandiHaler®] and 50 μg Salmeterol [Serevent® Diskus®], a Single Dose of 50μg Salmeterol (Serevent® Diskus®) and a Single Dose of 18 μg Tiotropium (Spiriva® HandiHaler®) in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:58:04.382455|2017-10-10 23:58:04.382455
NCT02254161|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2015-05-10|||November 2014||2014-11-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Multiple Rising Dose of BI 1181181 Given Orally in Young Healthy Male and Elderly Healthy Male/Female Volunteers|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 1181181 Given Orally q.d. for 10 Days in Young Healthy Male and Elderly Healthy Male/Female Volunteers (Randomized, Double-blind, Placebo Controlled Within Dose Groups Phase I Study)|Terminated||Phase 1|36|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:58:04.508473|2017-10-10 23:58:04.508473
NCT02254148|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-12-19|||October 2014||2014-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)|The Effect of Multiple Doses of BI 187004 on the Single Dose Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P-glycoprotein Substrate (Digoxin) Administered Orally in an Open-label, One-sequence Trial in Healthy Subjects|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:04.611574|2017-10-10 23:58:04.611574
NCT02254135|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||December 2006||2006-12-01|September 2014|2014-09-01||||January 2007|Actual|2007-01-01||Interventional|||Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BEA 2180 BR in Healthy Male Volunteers|A Randomised, Single-blind, Placebo-controlled (Within Dose Groups) Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Peroral Doses (400, 800, 1200 μg Free Cation) BEA 2180 BR in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:04.716123|2017-10-10 23:58:04.716123
NCT02254122|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||May 2004||2004-05-01|September 2014|2014-09-01||||February 2005|Actual|2005-02-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BEA 2180 BR in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses (20 µg, 50 µg, 100 µg, 200 µg and 400 µg) of BEA 2180 BR for 21 Days in Healthy Male Volunteers (Double-blind, Randomised, Placebo Controlled [at Each Dose Level] Study)|Completed||Phase 1|59|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:04.80589|2017-10-10 23:58:04.80589
NCT02254109|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||April 2008||2008-04-01|September 2014|2014-09-01||||October 2008|Actual|2008-10-01||Interventional|||Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising of BEA 2180 BR in Japanese Healthy Male Volunteers|A Randomised, Double-blind, Placebo-controlled (Within Dose Groups) Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising Inhalative Doses (50 μg, 100 μg and 200 μg q.d. for 14 Days) of BEA 2180 BR in Japanese Healthy Male Volunteers|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:04.923331|2017-10-10 23:58:04.923331
NCT02254096|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||May 2002||2002-05-01|September 2014|2014-09-01||||July 2002|Actual|2002-07-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects|Safety, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BIRT 1696 BS as a Solution (10, 100, 400, 1000, 2000, 3000 mg) in 15 ml PEG 400 to Healthy Human Subjects. A Three Part Study: Part 1 Placebo-controlled, Randomised, Dose Escalating Double Blinded Within Each Dose Level; Part 2 Open Label Grapefruit Juice Effect in 100 mg Dose Level Group; Part 3 Open Label Food Effect in 400 mg Dose Level Group|Completed||Phase 1|46|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:58:05.023875|2017-10-10 23:58:05.023875
NCT02254083|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||February 2003||2003-02-01|September 2014|2014-09-01||||May 2003|Actual|2003-05-01||Interventional|||Tolerability and Pharmacokinetics/-Dynamics of BIBT 986 BS in Healthy Male Subjects|Tolerability and Pharmacokinetics/-Dynamics of 0.5 mg and 1.0 mg (Actual 0.8 mg) of BIBT 986 BS Per Hour Given as IV Infusion Over 32 Hours in Healthy Male Subjects. Placebo Controlled, Double Blind Randomised at Each Dose Level|Completed||Phase 1|16|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:58:05.12485|2017-10-10 23:58:05.12485
NCT02254070|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||June 2003||2003-06-01|September 2014|2014-09-01||||August 2004|Actual|2004-08-01||Interventional|||Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment|Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of 1.0 mg of BIBT 986 BS Given as a Single Dose Infusion Over 30 Minutes in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment in an Open, Group Comparison Design|Completed||Phase 1|23|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:05.22794|2017-10-10 23:58:05.22794
NCT02254057|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||July 2002||2002-07-01|September 2014|2014-09-01||||October 2002|Actual|2002-10-01||Interventional|||Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects|Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses of 0.1 mg, 0.3 mg, 1.0 mg, 2.5 mg, 5.0 mg, and 10.0 mg BIBT 986 BS (IV Infusion Over 30 Minutes) in Healthy Male Subjects. Placebo Controlled, Double Blind Randomised at Each Dose Level|Completed||Phase 1|47|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:05.330906|2017-10-10 23:58:05.330906
NCT02254044|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||October 2003||2003-10-01|September 2014|2014-09-01||||November 2004|Actual|2004-11-01||Interventional|||Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus|An Open Phase I Dose Escalation Study of Bivatuzumab Mertansine Administered Intravenously Once Per Week for Three Weeks in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus With Repeated Administration Courses in Patients With Clinical Benefit|Terminated||Phase 1|7|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:05.425399|2017-10-10 23:58:05.425399
NCT02254031|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||July 2003||2003-07-01|September 2014|2014-09-01||||January 2005|Actual|2005-01-01||Interventional|||Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer|An Open Phase I Dose Escalation Study of Bivatuzumab Mertansine Administered Intravenously Once Per Week for Three Weeks in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer With Repeated Administration Courses in Patients With Clinical Benefit|Terminated||Phase 1|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:05.513248|2017-10-10 23:58:05.513248
NCT02253329|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-05-20|||January 2015||2015-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ESPRO2||NMES During the Day and Prior to Sleep|The Effect of Neuromuscular Electrical Stimulation on Post-prandial Protein Accretion During the Day and Prior to Sleep|Completed||N/A|16|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:58:14.481212|2017-10-10 23:58:14.481212
NCT02254018|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||September 2002||2002-09-01|September 2014|2014-09-01||||February 2005|Actual|2005-02-01||Interventional|||Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck|An Open Phase I Single Dose Escalation Study of Bivatuzumab Mertansine Administered Intravenously in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck With Repeated Administration in Patients With Clinical Benefit|Completed||Phase 1|31|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:05.600099|2017-10-10 23:58:05.600099
NCT02254005|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||October 2002||2002-10-01|September 2014|2014-09-01||||December 2004|Actual|2004-12-01||Interventional|||Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast Cancer|An Open Phase I Single Dose Escalation Study of Bivatuzumab Mertansine Administered Intravenously in Female Patients With CD44v6 Positive Metastatic Breast Cancer With Repeated Administration in Patients With Clinical Benefit|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:05.688502|2017-10-10 23:58:05.688502
NCT02253992|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-09-15|||September 29, 2014|Actual|2014-09-29|September 2017|2017-09-01|September 27, 2019|Anticipated|2019-09-27|December 26, 2018|Anticipated|2018-12-26||Interventional|||An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma|A Phase 1/2 Dose Escalation and Cohort Expansion Study of the Safety and Tolerability of Urelumab Administered in Combination With Nivolumab in Advanced/Metastatic Solid Tumors and B-cell Non-Hodgkins Lymphoma|Recruiting||Phase 1/Phase 2|200|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-10 23:58:05.778266|2017-10-10 23:58:05.778266
NCT02253979|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2014-09-30|||January 2013||2013-01-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Comparison of VivaSightTM Double Lumen Tube With a Conventional Double Lumen Tube|Comparison of VivaSightTM Double Lumen Tube With a Conventional Double Lumen Tube in Adult Patients Undergoing Video Assisted Thoracoscopic Surgery|Completed||Phase 4|71|Actual|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-10 23:58:05.968291|2017-10-10 23:58:05.968291
NCT02253966|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-06-03|||October 2014||2014-10-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty||Completed||Phase 2|48|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-10 23:58:06.052055|2017-10-10 23:58:06.052055
NCT02253953|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||November 2002||2002-11-01|September 2014|2014-09-01||||December 2003|Actual|2003-12-01||Interventional|||Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers|An Open Study to Investigate the Effect of Two Times Oral 100 mg Ritonavir Capsules on Pharmacokinetics of Single Doses of BILR 355 BS (Dose Steps: 5 and 12.5 mg) Dissolved in 5 mL PEG 400 After Oral Administration in Healthy Male Volunteers, and a Double Blind, Placebo Controlled Study for Doses From 25 mg to 100 mg BILR 355 BS|Completed||Phase 1|62|Actual|Boehringer Ingelheim||10|||f||||||||||||||2017-10-10 23:58:06.199863|2017-10-10 23:58:06.199863
NCT02253940|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||October 2006||2006-10-01|September 2014|2014-09-01||||December 2006|Actual|2006-12-01||Interventional|||Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers|An Open-label, Randomized, Crossover Relative BA Study of Pharmacokinetics and Safety of New SDS-containing Tablet and Capsule Formulations of BILR 355 Compared to the Current Formulation (50 mg Tablet), After Single Dose Oral Administration of BILR 355 Plus Low Dose Ritonavir in Healthy Male Volunteers|Completed||Phase 1|40|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:06.391358|2017-10-10 23:58:06.391358
NCT02253927|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||May 2006||2006-05-01|September 2014|2014-09-01||||August 2006|Actual|2006-08-01||Interventional|||Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers|Phase I Sequential Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose (225 Mg-450 mg) Oral Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers|Completed||Phase 1|48|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:06.499476|2017-10-10 23:58:06.499476
NCT02253914|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||February 2004||2004-02-01|September 2014|2014-09-01||||December 2004|Actual|2004-12-01||Interventional|||Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers|An Investigator Blinded, Randomized, Placebo-controlled Multiple Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers|Completed||Phase 1|100|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:58:06.579707|2017-10-10 23:58:06.579707
NCT02253901|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||March 2005||2005-03-01|September 2014|2014-09-01||||May 2005|Actual|2005-05-01||Interventional|||Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers|Study of Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir|Completed||Phase 1|33|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:06.666778|2017-10-10 23:58:06.666778
NCT02253888|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||May 2005||2005-05-01|September 2014|2014-09-01||||June 2005|Actual|2005-06-01||Interventional|||Bioequivalence Study of Tipranavir Stored at Controlled Temperature Compared With Tipranavir Stored at Controlled Refrigerated Conditions, Orally Co-administered With Ritonavir in Healthy Male and Female Volunteers|An Open-label, Randomized, Single-dose, Two-way Crossover Bioequivalence Study Assessing Subjects Receiving Tipranavir 500 mg Stored at Controlled Temperature (Testproduct 30°C/70% RH) Compared With Tipranavir 500 mg Stored at Controlled Refrigerated Conditions (Reference Product 2-8°C), Orally Co-administered With Ritonavir 200 mg Under Fasting Conditions to Healthy Male and Female Volunteers|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:06.753569|2017-10-10 23:58:06.753569
NCT02253875|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||November 2005||2005-11-01|September 2014|2014-09-01||||February 2006|Actual|2006-02-01||Interventional|||Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers|A Single-centre, Open-label Study in Healthy Adult Volunteers to Determine the Effects of Multiple-dose Omeprazole (ANTRA® 40 mg qd) on the Single-dose Pharmacokinetics of Tipranavir 500 mg Coadministered With Ritonavir 200 mg|Completed||Phase 1|15|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:06.838167|2017-10-10 23:58:06.838167
NCT02251509|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-06-15|||December 2016||2016-12-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Rate Control in Atrial Fibrillation|Rate Control in Atrial Fibrillation: A Randomized, Double-Blind, Crossover Comparison of Carvedilol and Metoprolol Tartrate|Not yet recruiting||Phase 4|20|Anticipated|Creighton University||2|||f||||f||||||||||2017-10-10 23:58:42.336631|2017-10-10 23:58:42.336631
NCT02253862|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||December 2005||2005-12-01|September 2014|2014-09-01||||March 2006|Actual|2006-03-01||Interventional|||Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers|Assessment of Single-dose Oral Tadalafil Pharmacokinetic Characteristics When Simultaneously Co-administered With Single-dose and Steady-state Tipranavir/Ritonavir 500 mg/200 mg to Healthy Male Volunteers|Completed||Phase 1|17|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:06.935819|2017-10-10 23:58:06.935819
NCT02253849|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||November 2005||2005-11-01|September 2014|2014-09-01||||June 2006|Actual|2006-06-01||Interventional|||Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers|A Single Centre, Open-label Study With Healthy Adult Volunteers to Determine the Effects of Single-dose and Steady-state TPV/r 500/200 mg on the Steady-state Pharmacokinetics of Carbamazepine (200 mg Twice Daily)|Completed||Phase 1|28|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:07.047668|2017-10-10 23:58:07.047668
NCT02253836|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-30|2014-09-30|||January 2005||2005-01-01|September 2014|2014-09-01||||July 2005|Actual|2005-07-01||Interventional|||Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir|A Single-Centre Open-Label Study in Healthy Adult Volunteers to Assess the Pharmacokinetic Interactions Between Steady-State TPV (500 mg) and Single-Dose and Steady-State Atazanavir (300 mg QD) in the Presence of Ritonavir (100 mg)|Completed||Phase 1|21|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:07.17816|2017-10-10 23:58:07.17816
NCT02253823|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-29|||December 2001||2001-12-01|September 2014|2014-09-01||||March 2002|Actual|2002-03-01||Interventional|||Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers|A Single Center, Open-Label, Randomised, Parallel, Multiple Dose Comparison of the Effect of Tipranavir 500 mg and Ritonavir 100 mg or Tipranavir 750 mg and Ritonavir 200 mg, Administered Daily on 3 Non-Consecutive Days and Twice Daily for 7 Days, on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) 600 mg a Day in Healthy Adult Volunteers|Completed||Phase 1|68|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:07.253424|2017-10-10 23:58:07.253424
NCT02253810|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-02-27|||October 2014||2014-10-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy|The Effect of Intravenous Tranexamic Acid on Blood Loss and Transfusion After Periacetabular Osteotomy: a Prospective, Double-blinded, Randomized Controlled Trial|Enrolling by invitation||N/A|80|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-10 23:58:07.333639|2017-10-10 23:58:07.333639
NCT02253797|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-29|||July 2003||2003-07-01|September 2014|2014-09-01||||July 2003|Actual|2003-07-01||Interventional|||Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects|A Phase I Multiple Oral Dose Trial of Tipranavir 500 mg/Ritonavir 200 mg Dosed to Steady State Followed by Single-dose 14C-radiolabeled Tipranavir Co-administered With Tipranavir 500 mg/Ritonavir 200 mg to Characterize the Excretion Balance and Metabolite Profile of 14C-radiolabeled Tipranavir in Healthy Male Subjects|Completed||Phase 1|||Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:07.424651|2017-10-10 23:58:07.424651
NCT02253784|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-10-01|||October 2014||2014-10-01|October 2014|2014-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Comparison Between Perineural and Systemic Effect of Dexamethasone as an Adjuvant for Prolongation of Four Nerve Blocks With Bupivacaine in Total Knee Arthroplasty||Unknown status|Not yet recruiting|N/A|90|Anticipated|Hillel Yaffe Medical Center||3|||f||||t||||||||||2017-10-10 23:58:07.508313|2017-10-10 23:58:07.508313
NCT02253771|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2015-06-04|||August 2014||2014-08-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Shockwave Therapy for Acute Low Back Pain|Shockwave Therapy for Acute Low Back Pain: a Randomized Placebo-controlled Clinical Trial|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital Muenster||2|||f||||f||||||||||2017-10-10 23:58:07.588179|2017-10-10 23:58:07.588179
NCT02253758|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2014-09-28|||October 2014||2014-10-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Arousal Pathways and Emergence From Sedation|Arousal Pathways and Emergence From Sedation|Unknown status|Not yet recruiting|N/A|20|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-10 23:58:07.685724|2017-10-10 23:58:07.685724
NCT02253745|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-05-04||2015-06-01|July 2013||2013-07-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)|A Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Repeat Oral Doses of V81444 in Volunteers With Attention Deficit / Hyperactivity Disorder (ADHD)|Completed||Phase 1/Phase 2|31|Actual|Vernalis (R&D) Ltd||2|||f||||f||||||||||2017-10-10 23:58:07.804777|2017-10-10 23:58:07.804777
NCT02253732|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-28|||September 2014||2014-09-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|Brain-Muscle||Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs|Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs|Unknown status|Recruiting|N/A|35|Anticipated|Slovak Academy of Sciences||1|||f||||f||||||||||2017-10-10 23:58:07.895346|2017-10-10 23:58:07.895346
NCT02253719|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-10-06|||October 2014||2014-10-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia|Screening for Prevention of Cervical Cancer in HIV-positive and HIV-negative Cambodian Women Using Direct Visualization With Acetic Acid|Completed||N/A|1000|Actual|Sihanouk Hospital Center of HOPE|||2||f||||t||||||||||2017-10-10 23:58:08.012474|2017-10-10 23:58:08.012474
NCT02253706|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-28|||October 2014||2014-10-01|July 2014|2014-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Oxygen Supplementation During Bronchoscopy: High Flow Versus Low Flow Oxygen|Oxygen Supplementation During Bronchoscopy: High-Flow Nasal Cannula or Low-Flow Nasal Cannula|Unknown status|Not yet recruiting|N/A|100|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-10 23:58:09.868428|2017-10-10 23:58:09.868428
NCT02252757|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2014-10-14|||September 2014||2014-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|Remote-CO-1||Assess Measurements of Wireless Cardiac Output Device|Validation of Measurements From CoVa Sensor (VALIDATION-CO-1) Study to Assess Measurements of Wireless Cardiac Output Device|Completed||N/A|25|Anticipated|Aventyn, Inc.|||1||f||||f||||||||||2017-10-10 23:58:25.704708|2017-10-10 23:58:25.704708
NCT02253693|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-05-03|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01|2 Years|Observational [Patient Registry]|||Exploratory Pilot Study of Physical Activity Monitoring in Adult Patients With Haemophilia A by Means of Accelerometry|"Descriptive Pilot Study of Monitoring of Physical Activity in Adult Patients With Haemophilia A Arthropathy by Means of Accelerometry, Image Tests and Physical Condition Parameters. Benefits Associated With That Monitoring"|Completed||N/A|28|Actual|University of Valencia|||1||f||||t||||||||No||2017-10-10 23:58:09.958691|2017-10-10 23:58:09.958691
NCT02253680|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2014-09-30|||November 2013||2013-11-01|September 2014|2014-09-01|August 2015|Anticipated|2015-08-01|November 2014|Anticipated|2014-11-01||Interventional|||The Use of Compression Bandages in Total Knee Replacement Surgery|A Prospective, Randomised Control Trial Investigating the Use of a Two-layer, Short-stretch Compression Bandage in Elective Total Knee Replacement - Feasibility|Unknown status|Active, not recruiting|N/A|50|Anticipated|Northumbria Healthcare NHS Foundation Trust||2|||f||||t||||||||||2017-10-10 23:58:10.068193|2017-10-10 23:58:10.068193
NCT02253667|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-28|2017-01-24|||September 2014||2014-09-01|January 2017|2017-01-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients|Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Patients: a Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Hospital Sao Joao||2||"One of the investigators left the department, Master Degree in which this study was part of her   thesis. No patients were enrolled."|f||||f||||||||||2017-10-10 23:58:10.137365|2017-10-10 23:58:10.137365
NCT02253654|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-05-18|2017-04-03||April 1, 2015|Actual|2015-04-01|May 2017|2017-05-01|May 25, 2016|Actual|2016-05-25|April 27, 2016|Actual|2016-04-27||Interventional||All randomized participants|Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis|A Randomized, Multicenter, Double-blind Study Evaluating Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis|Completed||Phase 4|216|Actual|Amgen||2|||f||||f||||||||||2017-10-10 23:58:10.256358|2017-10-10 23:58:10.256358
NCT02253641|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-09-20|||April 2015||2015-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The STRENGTH Study: Shapely Sisters Targeting Realistic Exercise and Nutrition Goals Through Healthy Habits|The STRENGTH Study: Shapely Sisters Targeting Realistic Exercise and Nutrition Goals Through Healthy Habits|Completed||N/A|40|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:58:12.295661|2017-10-10 23:58:12.295661
NCT02253628|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2014-09-29|||February 2014||2014-02-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Acute Effect of Coffee Consumption on Stomach, Self-reported Gastrointestinal Symptoms and Stress.|The Acute Effect of Coffee Consumption on Salivary Gastrin, Alpha-amylase and Cortisol Concentrations, on Self-reported Gastrointestinal Symptoms, on Self-reported Psychometric Assessments and on Blood Pressure.|Completed||N/A|40|Actual|Agricultural University of Athens||4|||f||||f||||||||||2017-10-10 23:58:12.373688|2017-10-10 23:58:12.373688
NCT02253615|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-05-11|||June 2014||2014-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Resistance Training in Untrained Older Adults|Effects of 16 Weeks of Resistance Training Using Elastic Resistance or Machines on Muscle Mass, Strength and Postural Control in Untrained Older Adults.|Completed||N/A|68|Actual|University of Brasilia||2|||f||||t||||||||||2017-10-10 23:58:12.469477|2017-10-10 23:58:12.469477
NCT02253602|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-07-26|||September 2014||2014-09-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|IMPROVE||Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer|Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer: an Optimization and Pilot Study|Recruiting||N/A|41|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||f||||||||||2017-10-10 23:58:12.547575|2017-10-10 23:58:12.547575
NCT02253589|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-05-10|||October 2014||2014-10-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|MIkhat||Motivational Interviewing (MI) to Reduce Khat Use|Evaluation of Motivational Interviewing (MI) to Reduce Khat Use Among Somali Refugees in Kenya|Completed||N/A|200|Anticipated|University of Konstanz||2|||f||||f||||||||||2017-10-10 23:58:12.644651|2017-10-10 23:58:12.644651
NCT02253576|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2015-11-12|||June 2014||2014-06-01|November 2015|2015-11-01||||June 2014|Actual|2014-06-01||Interventional|7HSinED||Inhaled Hypertonic Saline for Bronchiolitis|7% Hypertonic Saline to Treat Bronchiolitis in the Emergency Department|Withdrawn||N/A|0|Actual|Queen's University||2||Study not funded - never initiated|f||||f||||||||||2017-10-10 23:58:12.808425|2017-10-10 23:58:12.808425
NCT02253563|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-05-10|||June 2011||2011-06-01|May 2016|2016-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Resistance Versus Balance Training in Parkinson's Disease|Resistance Training Versus Balance Training to Improve Postural Control in Patients With Parkinson's Disease - a Randomized Controlled Rater Blinded Trial|Completed||N/A|40|Actual|University of Kiel||2|||f||||f||||||||||2017-10-10 23:58:12.901586|2017-10-10 23:58:12.901586
NCT02253550|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-02-22|||October 2014||2014-10-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection|A Phase 2, Open-Label Study to Investigate the Efficacy and Safety of an 8-Week and 12-Week Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Subjects With Chronic Genotype 4 Hepatitis C Virus Infection With and Without Cirrhosis|Completed||Phase 2|30|Anticipated|Peter J. Ruane, M.D., Inc.||2|||f||||f||||||||||2017-10-10 23:58:12.968837|2017-10-10 23:58:12.968837
NCT02253537|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-04-03|||October 2014||2014-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of the QuantiFERON-TB Test.||Recruiting||N/A|60|Anticipated|QIAGEN Gaithersburg, Inc|||1||f||||f||||||||||2017-10-10 23:58:13.05664|2017-10-10 23:58:13.05664
NCT02253524|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-27|||November 2012||2012-11-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo|Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo|Completed||Phase 4|200|Actual|Pamukkale University||2|||f||||t||||||||||2017-10-10 23:58:13.139261|2017-10-10 23:58:13.139261
NCT01970631|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-04-07|||November 2013||2013-11-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|SPARKS||The Study of Physical Activity Rewards After Knee Surgery||Recruiting||Phase 1/Phase 2|200|Anticipated|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 01:09:57.865922|2017-10-11 01:09:57.865922
NCT02253511|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-09-29|||July 2014||2014-07-01|September 2014|2014-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma|A Prospective Randomized Control Study of Cidan Capsule Combined With Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|400|Anticipated|Beijing Weida Cancer Hospital of Chinese Traditional Medical Sciences||2|||f||||t||||||||||2017-10-10 23:58:13.231138|2017-10-10 23:58:13.231138
NCT02253498|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-10-13|||December 2016||2016-12-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome|The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome|Not yet recruiting||Early Phase 1|20|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:58:13.32544|2017-10-10 23:58:13.32544
NCT02253485|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2014-09-29|||August 2012||2012-08-01|August 2012|2012-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Efficacy of Antiviral Therapy in Pregnancy in Preventing Vertical Transmission of HBV in Mothers With a High Viral Load|Case-control Study of Antiviral Therapy During Entire and the Third Trimester of Pregnancy in Preventing MTCT of HBV in Mothers With High Serum HBV DNA Load|Unknown status|Enrolling by invitation|N/A|600|Anticipated|Beijing Ditan Hospital|||4||f||||t||||||||||2017-10-10 23:58:13.395585|2017-10-10 23:58:13.395585
NCT02253472|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-10-13|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Obsessive-Compulsive Disorder|The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Obsessive-Compulsive Disorder|Not yet recruiting||Early Phase 1|30|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:58:13.471996|2017-10-10 23:58:13.471996
NCT02253459|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-03-06|||August 2014|Actual|2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer|Phase III Clinical Trials of UTD1 Injection Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced and Metastatic Breast Cancer|Active, not recruiting||Phase 3|405|Actual|Beijing Biostar Technologies, Ltd||2|||f||||t||||||||||2017-10-10 23:58:13.557563|2017-10-10 23:58:13.557563
NCT02253446|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-09-27|||May 2013||2013-05-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Comparison of Analgesic İmpacts of Piroxicam and Diclofenac Sodium in the Treatment of Primary Dysmenorrhea|A Comparison of Analgesic İmpacts of Piroxicam and Diclofenac Sodium in the Treatment of Primary Dysmenorrhea:A Double-Blind, Randomized Trial|Completed||Phase 4|400|Actual|Pamukkale University||2|||f||||t||||||||||2017-10-10 23:58:13.651204|2017-10-10 23:58:13.651204
NCT02253433|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-01-30|||January 8, 2015|Actual|2015-01-08|January 2017|2017-01-01|January 15, 2018|Anticipated|2018-01-15|January 15, 2018|Anticipated|2018-01-15||Interventional|HIIT-BAC||The Houston HIIT-BAC for African Americans|The Houston Home-Based Integrated Intervention Targeting Better Asthma Control (HIIT-BAC) for African Americans|Active, not recruiting||N/A|264|Actual|Baylor College of Medicine||2|||f||||t||||||||Yes|Participants receive laboratory, exposure and other data to help them manage their asthma through our providers and community health workers. Aggregate and/or de-identified data will be made available as described in our protocol.|2017-10-10 23:58:13.735075|2017-10-10 23:58:13.735075
NCT02253420|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-09-21|||October 8, 2014|Actual|2014-10-08|September 2017|2017-09-01|December 19, 2018|Anticipated|2018-12-19|June 28, 2018|Anticipated|2018-06-28||Interventional|||COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients|An Open-label Non-randomized, Phase 1 Study to Evaluate the Effect of (a) Itraconazole or Rifampin on the Pharmacokinetics of a Single Intravenous Dose of Copanlisib and (b) Copanlisib on Cardiovascular Safety in Subjects With Advanced Solid Tumors and Non-Hodgkin's Lymphoma|Recruiting||Phase 1|46|Anticipated|Bayer||2|||f||||f|t|f||||||||2017-10-10 23:58:13.82168|2017-10-10 23:58:13.82168
NCT02253407|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2016-04-13|||September 2014||2014-09-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children|A Phase IV, Non-Inferiority, Observer Blind Randomized Clinical Study Comparing Safety And Immunogenicity Of MMR Subcutaneous Vaccination By Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe For The Administration In Healthy Children In India Aged 15 To 18 Months|Completed||Phase 4|341|Actual|Serum Institute of India Pvt. Ltd.||2|||f||||f||||||||||2017-10-10 23:58:13.930983|2017-10-10 23:58:13.930983
NCT02253394|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-03-01|||September 2015||2015-09-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study|The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study (The CAPS-PAH Study)|Recruiting||Phase 4|30|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-10 23:58:14.034428|2017-10-10 23:58:14.034428
NCT02253381|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2015-04-27|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Position During Spinal Anesthesia on Hemodynamic Change in Cesarean Section|Effect of Position During Spinal Anesthesia on Hemodynamic Change in Pregnant Women Undergoing Cesarean Section: Randomized Trial|Completed||N/A|140|Actual|Prince of Songkla University||2|||f||||t||||||||||2017-10-10 23:58:14.15857|2017-10-10 23:58:14.15857
NCT02253368|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-03-02|||November 2014||2014-11-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Home Sleep and Metabolism|Home Sleep and Metabolism|Recruiting||N/A|210|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-10 23:58:14.241024|2017-10-10 23:58:14.241024
NCT02253355|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-27|2016-10-13|||December 2016||2016-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PINS Stimulator System for Patients With Treatment Resistant Depression|PINS Stimulator System for Patients With Treatment Resistant Depression|Not yet recruiting||Early Phase 1|20|Anticipated|Beijing Pins Medical Co., Ltd||2|||f||||t||||||||||2017-10-10 23:58:14.328232|2017-10-10 23:58:14.328232
NCT02253342|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-10-28|||September 2014||2014-09-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects|A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects|Completed||Phase 1|30|Actual|Wockhardt||1|||f||||f||||||||||2017-10-10 23:58:14.400541|2017-10-10 23:58:14.400541
NCT02253316|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-09-21|||January 20, 2015|Actual|2015-01-20|September 2017|2017-09-01|October 31, 2022|Anticipated|2022-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma|A Phase II Study of IRD (Ixazomib, Lenalidomide, & Dexamethasone) for Consolidation Therapy Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma|Recruiting||Phase 2|240|Anticipated|Washington University School of Medicine||3|||f||||t|t|f|||f|||||2017-10-10 23:58:14.588826|2017-10-10 23:58:14.588826
NCT02253303|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-09-26|||October 2014||2014-10-01|September 2014|2014-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of the Extraction-site, - Midline Incision vs Off-midline Incision-|Evaluation of the Extraction-site Location in Laparoscopic Colorectal Surgery - Midline Incision vs Off-midline Incision-|Unknown status|Not yet recruiting|N/A|100|Anticipated|Wakayama Medical University||2|||f||||t||||||||||2017-10-10 23:58:14.821097|2017-10-10 23:58:14.821097
NCT02253290|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-08-20|||December 2014||2014-12-01|August 2015|2015-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01|18 Years|Observational [Patient Registry]|||Neuropsychological and Psychosocial Follow up of Children and Adolescents With Neuromuscular Disease|Neuropsychological and Psychosocial Follow up of Children and Adolescents With Neuromuscular Disease|Recruiting||N/A|300|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-10 23:58:14.908967|2017-10-10 23:58:14.908967
NCT02253277|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-06-03|||February 18, 2015|Actual|2015-02-18|June 2017|2017-06-01|August 18, 2019|Anticipated|2019-08-18|August 18, 2019|Anticipated|2019-08-18||Interventional|CoRNea||Safety and Tolerability of Combined Treatment With Nilotinib and Ruxolitinib in CML and Ph+ ALL Patients|A Phase Ib Single-arm, Open-label, Multicenter Study to Assess the Safety and Tolerability of Combined Treatment With Nilotinib 300mg BID and Ruxolitinib Increasing Dose in CML and Ph+ ALL Patients|Active, not recruiting||Phase 1/Phase 2|5|Actual|Novartis||1|||f||||f|f|f||||||No||2017-10-10 23:58:14.999405|2017-10-10 23:58:14.999405
NCT02253264|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-08-29|||November 2014||2014-11-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients|A Phase 1 Open-label Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients With Magnetic Resonance Imaging Evidence of Leptomeningeal Enhancement|Completed||Phase 1|8|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-10 23:58:15.099004|2017-10-10 23:58:15.099004
NCT02253251|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-09-27|||September 2014||2014-09-01|September 2017|2017-09-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01|10 Years|Observational [Patient Registry]|||Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment|Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment|Recruiting||N/A|15000|Anticipated|MiraKind|||4||f||||t||||||Samples Without DNA|"     DNA will be isolated from the submitted sample and kept with permission for additional     studies.   "|||2017-10-10 23:58:15.298339|2017-10-10 23:58:15.298339
NCT02253238|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-02-15|||January 2014|Actual|2014-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients|Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients|Recruiting||N/A|282|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-10 23:58:15.419645|2017-10-10 23:58:15.419645
NCT02253225|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-08-28|||January 2013||2013-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Observational|||Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study|An fMRI Study of Self Processing and Self Focus in Major Depression and Bipolar Disorder|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital|||3||f||||f||||||||||2017-10-10 23:58:15.533569|2017-10-10 23:58:15.533569
NCT02253212|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2017-08-28|||July 2014||2014-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|SONOCLOUD||Safety of BBB Opening With the SonoCloud|A Study to Evaluate the Safety of Transient Opening of the Blood-Brain Barrier by Low Intensity Pulsed Ultrasound With the SonoCloud Implantable Device in Patients With Recurrent Glioblastoma Before Chemotherapy Administration|Recruiting||Phase 1/Phase 2|31|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-10 23:58:15.626382|2017-10-10 23:58:15.626382
NCT02253199|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-29|2016-03-26|||October 2014||2014-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of Age on the Median Effective Dose (ED50) of Intranasal Dexmedetomidine for Rescue Sedation Following Failed Sedation With Oral Chloral Hydrate During Magnetic Resonance Imaging||Completed||Phase 4|120|Actual|Guangzhou Women and Children's Medical Center||4|||f||||t||||||||||2017-10-10 23:58:15.725714|2017-10-10 23:58:15.725714
NCT02253186|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-12-04|||September 2014||2014-09-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MARILYN||Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphoedema|Monocentre, Controlled, Randomized, Open Label, Clinical Study to Assess Safety and Efficacy of Auto-Adjustable MOBIDERM(R) Arm Sleeve in the Management of Upper Limb Lymphoedema During Night-time of Maintenance Phase|Completed||N/A|40|Actual|Thuasne||2|||f||||f||||||||||2017-10-10 23:58:15.810119|2017-10-10 23:58:15.810119
NCT02253173|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-04-20|2016-08-08||September 2014||2014-09-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|REJOICE|The modified intent to treat (MITT) population was the primary efficacy population, defined as all ITT subjects who received the treatment to which they were randomized, had baseline values for all co-primary variables, and had at least one post-baseline value for any of the four co-primary variables at any visit.|Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women|A Phase 3, Randomized, Double-blind, Placebo-controlled, Multi-center Trial to Evaluate the Safety and Efficacy of TX-004HR in Postmenopausal Women With Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy|Completed||Phase 3|764|Actual|TherapeuticsMD||4|||f||||f||||||||||2017-10-10 23:58:16.006498|2017-10-10 23:58:16.006498
NCT02253160|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-08-24|2015-05-05||September 2014||2014-09-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|CMNC|Healthy adult specialized blood donors|An Evaluation of the Spectra Optia CMNC Collection Procedure|A Randomized, Crossover Trial to Characterize the Performance of the Spectra Optia Apheresis System Versus the COBE Spectra Apheresis System for Collection of Mononuclear Cells in Healthy Adult Donors|Completed||N/A|23|Actual|Terumo BCT||2|||f||||f||||||||||2017-10-10 23:58:19.411742|2017-10-10 23:58:19.411742
NCT02252055|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-06-01|||March 2015||2015-03-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|ONEatDC||The ONE Study ATDC Trial|A Phase I/II Monocentric Trial of Cellular Immunotherapy Based on Autologous Tolerogenic Dendritic Cells (ATDCs) Administration in Patients With Renal Insufficiency Receiving as First Transplantation a Kidney Transplant From a Living-donor.|Recruiting||Phase 1/Phase 2|16|Anticipated|Nantes University Hospital||1|||f||||t||||||||||2017-10-10 23:58:20.307142|2017-10-10 23:58:20.307142
NCT02252042|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-09-18|||November 17, 2014|Actual|2014-11-17|September 2017|2017-09-01|June 12, 2018|Anticipated|2018-06-12|May 15, 2017|Actual|2017-05-15||Interventional|||Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)|A Phase III Randomized Trial of MK-3475 (Pembrolizumab) Versus Standard Treatment in Subjects With Recurrent or Metastatic Head and Neck Cancer|Active, not recruiting||Phase 3|495|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-10 23:58:20.408528|2017-10-10 23:58:20.408528
NCT02252029|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-05-08|||December 2014||2014-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Observational|RotaNeo||Rotavirus Vaccine in Premature Babies|RotaNeo: Evaluation of Rotavirus Vaccine Administration in Premature Babies in the Neonatal Unit|Completed||N/A|20|Actual|University of Oxford|||1||f||||f||||||Samples With DNA|"     Stool, serum   "|||2017-10-10 23:58:20.497106|2017-10-10 23:58:20.497106
NCT02252016|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-05-25|2016-11-22||October 22, 2014|Actual|2014-10-22|May 2017|2017-05-01|June 14, 2016|Actual|2016-06-14|December 7, 2015|Actual|2015-12-07||Interventional|||Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)|A Phase III Double Blind Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic HCV GT1, GT4 and GT6 Infection With Inherited Blood Disorders With and Without HIV Co-Infection|Completed||Phase 3|159|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-10 23:58:20.574416|2017-10-10 23:58:20.574416
NCT02252003|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-08-08|||May 21, 2015|Actual|2015-05-21|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|NOUNOURS||Development and Validation of a New Pain Scale for Children|Development of a New Pain Rating Scale for Children and Validation Against Criteria by Comparison With Faces Pain Scale - Revised (FPS-R) and Visual Analogue Scale (VAS)|Recruiting||N/A|248|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:58:20.921098|2017-10-10 23:58:20.921098
NCT02251977|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-21|2016-11-08|||September 2014||2014-09-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer|The Effect of Monosialotetrahexosylganglioside (GM1) in Prevention of Oxaliplatin Induced Neurotoxicity in Colorectal Cancer Patients Who Received Oxaliplatin-based Adjuvant Chemotherapy: A Multi-center, Randomized, Placebo-controlled Trial|Recruiting||Phase 3|188|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:58:21.057019|2017-10-10 23:58:21.057019
NCT02251964|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-04-25|||September 2014||2014-09-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|RITUX-IP||Rituximab in Interstitial Pneumonitis|Rituximab in Life Threatening Therapy Resistant Progressive Interstitial Pneumonitis|Active, not recruiting||Phase 2/Phase 3|20|Anticipated|St. Antonius Hospital||1|||f||||f||||||||||2017-10-10 23:58:21.256725|2017-10-10 23:58:21.256725
NCT02251951|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-05|2015-10-07|||September 2012||2012-09-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer|A Multicenter, Phase II, Single-Arm Clinical Trial of Nab-Paclitaxel as Salvage Treatment for Patients With Locally Advanced or Metastatic Adenocarcinomas of the Stomach and Gastro-esophageal Junction.|Completed||Phase 2|39|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-10-10 23:58:21.34346|2017-10-10 23:58:21.34346
NCT02251938|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-12-25|||September 2014||2014-09-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|32-009||A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program|A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program|Active, not recruiting||Phase 3|60|Actual|Santen Inc.||1|||f||||f||||||||||2017-10-10 23:58:21.443223|2017-10-10 23:58:21.443223
NCT02251925|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-05-05|||September 2012||2012-09-01|April 2012|2012-04-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles|Comparison of Pregnancy Outcomes in Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|460|Anticipated|Royan Institute||4|||f||||t||||||||||2017-10-10 23:58:21.571272|2017-10-10 23:58:21.571272
NCT02253147|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-06-09|||September 2014||2014-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-10 23:58:21.693902|2017-10-10 23:58:21.693902
NCT02253134|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-09-30|||August 2010||2010-08-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|ITHO04||Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Origin With External Loop-Recorder (SpiderFLASH)|Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Origin With External Loop-Recorder (SpiderFLASH)|Completed||N/A|395|Actual|LivaNova|||1||f||||f||||||||||2017-10-10 23:58:21.745923|2017-10-10 23:58:21.745923
NCT02253121|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-03-09|||February 2015||2015-02-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|March 2016|Actual|2016-03-01||Interventional|GluCon-COPD||Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Randomized, Double-blind, Placebo-controlled Trial on the Effectiveness and Safety of Dapagliflozin for Blood Glucose Control During Glucocorticoid Treatment for Acute Exacerbation COPD|Active, not recruiting||Phase 4|46|Actual|Slotervaart Hospital||2|||f||||f||||||||||2017-10-10 23:58:21.83455|2017-10-10 23:58:21.83455
NCT02253108|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-09-12|||May 2014||2014-05-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|April 2015|Actual|2015-04-01||Interventional|OCT SORT-OUT||The OCT SORT-OUT VIII Study|Randomized Comparison of the Biolimus-eluting Biomatrix Neoflex™ og Everolimus-eluting SYNERGY™ Stents in All-comer Patients With Ischemic Heart Disease - The OCT SORT-OUT VIII|Active, not recruiting||N/A|160|Anticipated|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-10 23:58:21.941908|2017-10-10 23:58:21.941908
NCT02253095|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-06-02|||October 2014||2014-10-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Combined Package of Interventions for Environmental Enteropathy|Randomized, Double Blind, Placebo Controlled Trial Comparing the Impact of a Combined Package of Interventions vs Placebo in the Treatment of Sub-clinical Environmental Enteropathy in Rural Malawian Children|Completed||N/A|253|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-10 23:58:22.069779|2017-10-10 23:58:22.069779
NCT02253082|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-12-19|||November 2014||2014-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|VIPER-OCTA||Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28)|Effects of OctaplasLG® on Endothelial Integrity in Patients Undergoing Emergency Surgery for Thoracic Aortic Dissections - a Randomized, Controlled, Single-blinded Investigator-initiated Pilot Trial|Completed||Phase 4|44|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||No||2017-10-10 23:58:22.155216|2017-10-10 23:58:22.155216
NCT02253069|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-12-08|||September 2014||2014-09-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||PHMB-based Antiseptic Use in Full-thickness Surgical Wounds|A Study of Polyhexanide-based Antiseptic in Full-thickness Surgical Wounds in Dermatologic Surgery|Completed||N/A|40|Actual|Region Skane||2|||f||||t||||||||||2017-10-10 23:58:22.259215|2017-10-10 23:58:22.259215
NCT02253056|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2015-03-30|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|MIFT||Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting|Montag Ist Fasten-Tag (German) - MIFT [Monday is Fasting Day]|Completed||N/A|36|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-10 23:58:22.340307|2017-10-10 23:58:22.340307
NCT02253043|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-10-13|||May 2014||2014-05-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease|The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease|Recruiting||N/A|10|Anticipated|Beijing Pins Medical Co., Ltd||1|||f||||t||||||||||2017-10-10 23:58:22.422803|2017-10-10 23:58:22.422803
NCT02253030|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-04-21|||September 2014||2014-09-01|April 2015|2015-04-01||||September 2017|Anticipated|2017-09-01||Observational|||OCT Angiography in Wet AMD|Optical Coherence Tomography Angiography in Neovascular Age-related Macular Degeneration|Unknown status|Recruiting|N/A|145|Anticipated|Oregon Health and Science University|||3||f||||||||||||||2017-10-10 23:58:22.524292|2017-10-10 23:58:22.524292
NCT02253017|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-07-27|||September 2014||2014-09-01|July 2015|2015-07-01||||September 2022|Anticipated|2022-09-01||Observational|EP3C||Evaluation of Therapeutic Strategies in Pediatric Cataract Surgery|Assessment Practices Registry in Congenital Cataract Surgery and Infantile|Recruiting||N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-10 23:58:22.888588|2017-10-10 23:58:22.888588
NCT02253004|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-08-20|||September 2014||2014-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Induction of Migraine Aura With Cilostazol|The Effect of the Selective PDE3 Inhibitor on Migraine With Aura Induction and Vascular Endothelial Function.|Completed||Early Phase 1|16|Actual|Herlev Hospital||2|||f||||f||||||||||2017-10-10 23:58:23.000546|2017-10-10 23:58:23.000546
NCT02252991|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-12-23|||September 2014||2014-09-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|APACAN||Adaptated Physical Activity in Cancerology|APACAN study_Adaptated Physical Activity in Cancerology|Terminated||N/A|3|Actual|Centre Jean Perrin||2||Difficulty to include patients|f||||f||||||||||2017-10-10 23:58:23.071121|2017-10-10 23:58:23.071121
NCT02252978|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-07-28|||July 2016|Actual|2016-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy|A Phase II, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial Evaluating the Role of an Empiric 2-Week Course of Ciprofloxacin on Rates of Detection of Cancer by Prostate Biopsy in Men With Abnormal Serum Prostate Specific Antigen Found at Screening (PREP Trial)|Withdrawn||Phase 2|0|Actual|Wake Forest University Health Sciences||2||No funding support|f||||f|t|f||||||||2017-10-10 23:58:23.134374|2017-10-10 23:58:23.134374
NCT02252965|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-11-28|2016-11-28||December 2014||2014-12-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|November 2015|Actual|2015-11-01||Interventional|CONSENT|Intent to Treat (ITT) population included all subjects who were randomly allocated to a treatment based on the intention to treat|Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes|CONSENT - Comparison of metfOrmin XR to IR as moNotherapy in the Newly diagnoSed Type 2 diabEtes Patients for the gastroiNtestinal Tolerability and Efficacy: a Randomized, Parallel Control, Open-label and Multicenter Study|Completed||Phase 4|532|Actual|Merck KGaA||2|||f||||t||||||||||2017-10-10 23:58:23.271867|2017-10-10 23:58:23.271867
NCT02252952|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-12-15|||February 2013||2013-02-01|December 2014|2014-12-01||||March 2015|Anticipated|2015-03-01||Interventional|||The Effect of Sugar Sweetened and Diet Beverages Consumed as Part of a Weight-Maintenance Diet on Fat Storage|A Comparison of the Effects of Sugar Sweetened Beverages (SSBs), Diet Beverages and Water on Weight, Body Composition, Liver and Muscle Fat Infiltration, Visceral Fat, Neurocognitive Function, Blood Lipids, Insulin Resistance and Hydration Status in Healthy Weight and Overweight, Premenopausal Females Aged 20-50|Unknown status|Active, not recruiting|N/A|99|Anticipated|Rippe Lifestyle Institute||3|||f||||f||||||||||2017-10-10 23:58:24.337976|2017-10-10 23:58:24.337976
NCT02252926|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-08-15|||September 2014||2014-09-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Local Anesthetic Treatment of Oral Pain in Patients With Mucositis|Clinical Trial With Lozenges as Local Anesthetic Treatment for Head/Neck Cancer Patients With Oral Mucositis|Completed||Phase 2|70|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-10 23:58:24.514986|2017-10-10 23:58:24.514986
NCT02252913|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-04-07|||September 2014||2014-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer|A Phase Ib, Open-label Study of Safety and Pharmacokinetics of Volitinib in Combination With Docetaxel in Patients With Advanced Gastric Cancer|Completed||Phase 1|25|Actual|Hutchison Medipharma Limited||1|||f||||f||||||||Undecided||2017-10-10 23:58:24.605005|2017-10-10 23:58:24.605005
NCT02252900|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-05-09|||December 2013||2013-12-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|POST-IMAGE||Long-term Clinico-radiological Evolution of Patients With Brain Lesions During Infectious Endocarditis|Long-term Clinico-radiological Evolution of Patients With Symptomatic and Asymptomatic Brain Lesions During Infectious Endocarditis|Recruiting||N/A|130|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-10 23:58:24.688154|2017-10-10 23:58:24.688154
NCT02252887|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-05-03|||January 12, 2015|Actual|2015-01-12|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy|Phase II Study of Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab- or Pertuzumab-Based Therapy|Active, not recruiting||Phase 2|45|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:58:24.781774|2017-10-10 23:58:24.781774
NCT02252874|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-02-17|||September 2014||2014-09-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||Can Entertaining Action-video Games Enhance Dynamic Visual Function and Improve Balance? A Randomized Controlled Trial.|Can Entertaining Action-video Games Enhance Dynamic Visual Functions and Improve Balance? A Randomized Controlled Trial.|Recruiting||N/A|198|Anticipated|The Hong Kong Polytechnic University||3|||f||||f||||||||||2017-10-10 23:58:24.889285|2017-10-10 23:58:24.889285
NCT02252861|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-02-22|||October 2013||2013-10-01|February 2016|2016-02-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01|5 Years|Observational [Patient Registry]|FLAAC||French Database of Left Atrial Appendage Closure|French Database of Left Atrial Appendage Closure|Active, not recruiting||N/A|840|Actual|Henri Mondor University Hospital|||1||f||||t||||||||||2017-10-10 23:58:24.98143|2017-10-10 23:58:24.98143
NCT02252848|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-05-04|||March 2014||2014-03-01|May 2016|2016-05-01|August 2019|Anticipated|2019-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase I Clinical Trial to Determine the Safety of Clonidine in Infants With HIE During Therapeutic Hypothermia.|Phase I Clinical Trial to Determine the Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia.|Recruiting||Phase 1|55|Anticipated|Gauda, Estelle B., M.D.||2|||f||||f||||||||||2017-10-10 23:58:25.077463|2017-10-10 23:58:25.077463
NCT02252835|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2015-03-30||2015-02-16|August 2014||2014-08-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout|A Phase 2, Open-label, Drug-Drug Interaction Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination With Febuxostat for the Treatment of Hyperuricemia in Patients With Gout|Completed||Phase 2|32|Actual|CymaBay Therapeutics, Inc.||2|||f||||||||||||||2017-10-10 23:58:25.181462|2017-10-10 23:58:25.181462
NCT02252822|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-11-17|||September 2014||2014-09-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Improving Treatment Engagement for Adolescents With Bulimia Nervosa|Does Offering Adolescents Anonymous Access to Online CBT Self-Help for Bulimia Nervosa Improve Engagement in Treatment-Pilot Study|Completed||N/A|1|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-10 23:58:25.280699|2017-10-10 23:58:25.280699
NCT02252809|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-29|||November 2008||2008-11-01|September 2014|2014-09-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects|An Open-Label, Parallel Group, Controlled Study in Healthy Subjects to Characterize Biological Responses to Immunological Challenges and to Measure the Effect of Marketed Anti-Inflammatory Agents on Those Responses|Completed||Early Phase 1|51|Actual|Brugmann University Hospital||3|||f||||t||||||||||2017-10-10 23:58:25.359027|2017-10-10 23:58:25.359027
NCT02252796|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-02-09|||July 2014||2014-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|HySBst||Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer|Phase I Dose Escalation Study of a Hypofractionated Stereotactic Boost (HySBst) to the Primary Site in Patients With Stage II-III Non-small Cell Lung Cancer|Active, not recruiting||Phase 1|18|Anticipated|West Virginia University||2|||f||||t||||||||No||2017-10-10 23:58:25.440028|2017-10-10 23:58:25.440028
NCT02252783|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-07-31|||September 2017|Anticipated|2017-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||BFPET for Regional Myocardial Perfusion Imaging|A Phase II Open-Labeled Study to Evaluate BFPET as a Myocardial Perfusion Imaging Agent for the Evaluation of Coronary Artery Disease|Not yet recruiting||Phase 2|40|Anticipated|Fluoropharma, Inc.||1|||f||||f|t|f||||||||2017-10-10 23:58:25.533395|2017-10-10 23:58:25.533395
NCT02252770|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-11-01|||September 2014||2014-09-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Nitric Oxide Supplementation in Argininosuccinic Aciduria|Nitric Oxide Supplementation as a Therapeutic Intervention in Argininosuccinic Aciduria|Recruiting||N/A|12|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-10 23:58:25.60892|2017-10-10 23:58:25.60892
NCT02252744|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-02-02|2015-09-22||November 2012||2012-11-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis|Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis|Completed||N/A|286|Actual|Western University of Health Sciences|||1||f||||f||||||||Undecided||2017-10-10 23:58:25.781857|2017-10-10 23:58:25.781857
NCT02252731|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-09-26|||September 2013||2013-09-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects|A Phase 1, Open-label, One-sequence Crossover Study to Evaluate the Effect of Multiple Doses of FG 4592 on the Pharmacokinetics of Warfarin in Healthy Subjects|Completed||Phase 1|22|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-10 23:58:26.101353|2017-10-10 23:58:26.101353
NCT02252718|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-01-04|2016-11-05||September 2014||2014-09-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational||Children between 2 and 18 months of age who were not toilet trained were eligible for the study. Exclusion criteria included parental inability to understand the study procedure and lack of parental consent to participate.|Amsterdam Stool Scale: Usefulness in Clinical Setting|Amsterdam Stool Scale: Usefulness in Clinical Setting|Completed||N/A|100|Actual|Medical University of Warsaw|Limitations of our study included the lack of external validity. Children were recruited in only one paediatric department. Only one physician conducted stool assessment in vivo and only one physician evaluated photographs.||1||f||||f||||||||||2017-10-10 23:58:26.200164|2017-10-10 23:58:26.200164
NCT02252705|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-04-10|||July 2014||2014-07-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01|4 Years|Observational [Patient Registry]|REMEHIP||Mexican Registry of Pulmonary Hypertension|Mexican Registry of Pulmonary Hypertension|Enrolling by invitation||N/A|1000|Anticipated|Remehip|||2||f||||f||||||||||2017-10-10 23:58:26.334906|2017-10-10 23:58:26.334906
NCT02252692|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2014-09-26|||August 2014||2014-08-01|September 2014|2014-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Relative Bioavailability Study With Enalapril in Healthy Volunteers|Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|Ethicare GmbH||3|||f||||f||||||||||2017-10-10 23:58:26.402877|2017-10-10 23:58:26.402877
NCT02252679|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-11-23|||October 2014||2014-10-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Observational|eCaSIS||Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium Disorders|Endogenous Calcium Stable Isotope Study (eCaSIS): Evaluation of MC-ICP-MS as a Diagnostic Tool for Metabolic Bone Diseases and Disorders of Calcium Metabolism|Recruiting||N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven|||4||f||||f||||||Samples Without DNA|"     Plasma, serum, spot urine and/or 24h urine collection samples   "|||2017-10-10 23:58:26.488268|2017-10-10 23:58:26.488268
NCT02252666|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-04-04|||March 2014||2014-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|January 2017|Actual|2017-01-01||Interventional|||Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS)|Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS)|Active, not recruiting||N/A|6|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-10 23:58:26.593603|2017-10-10 23:58:26.593603
NCT02252653|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-07-19|||June 2014||2014-06-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Observational|||DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis|DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis|Completed||N/A|1010|Actual|Alnylam Pharmaceuticals|||1||f||||f||||||Samples Without DNA|"     Blood samples for TTR sequencing and cardiac function biomarkers; abdominal fat-pad aspirate     for amyloid presence (optional for TTR positive patients only)   "|Undecided||2017-10-10 23:58:26.692104|2017-10-10 23:58:26.692104
NCT02252640|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-12-02|||January 2015||2015-01-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S|A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of Concomitant Administration of the Combination Malaria Vaccine Candidate Regimen of RTS,S/AS01¬B + ChAd63 and MVA Encoding ME-TRAP and Also RTS,S/AS01B Alone|Completed||Phase 1/Phase 2|48|Actual|University of Oxford||6|||f||||t||||||||||2017-10-10 23:58:26.9592|2017-10-10 23:58:26.9592
NCT02252627|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-01-26|||August 2014||2014-08-01|January 2015|2015-01-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||The Effect of Phenylephrine and Ephedrine on Microvascular Blood Flow|An Observational Study to Test the Effect of the Vasoactive Drugs Phenylephrine and Ephedrine on the Stroke Volume and Microvascular Blood Flow of Healthy Volunteers|Unknown status|Recruiting|N/A|8|Anticipated|University of Nottingham|||1||f||||f||||||||||2017-10-10 23:58:27.066868|2017-10-10 23:58:27.066868
NCT02252614|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-09-29|||September 2014||2014-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of Intravenous Naproksen Sodium+Codein and Paracetamol+Codein on Postoperative Pain on Postoperative Pain|Efficacy of Intravenous Naproksen Sodium+Codein and Paracetamol+Codein on Postoperative Pain and Contramal Consumption After a Lumbar Disk Surgery|Unknown status|Not yet recruiting|Phase 4|75|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||3|||f||||t||||||||||2017-10-10 23:58:27.154698|2017-10-10 23:58:27.154698
NCT02252601|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-04-11|||January 2015||2015-01-01|April 2016|2016-04-01||||July 2018|Anticipated|2018-07-01||Interventional|3D-CF||Evaluation of the High Frequency Digit Triplet Test in Cystic Fibrosis|An Evaluation of the High Frequency Digit Triplet Test as a Screening Tool for Early Detection of Hearing Loss in Individuals With Cystic Fibrosis|Recruiting||N/A|388|Anticipated|University of Nottingham||4|||f||||f||||||||||2017-10-10 23:58:27.231104|2017-10-10 23:58:27.231104
NCT02252588|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-06-28|||September 2014||2014-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CLIMB||The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease|The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive|Recruiting||Phase 2|40|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:58:27.347775|2017-10-10 23:58:27.347775
NCT02252575|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-04-07|||September 2014||2014-09-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|April 2015|Actual|2015-04-01||Interventional|||Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices|Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices|Active, not recruiting||N/A|100|Anticipated|Deutsches Herzzentrum Muenchen||1|||f||||f||||||||||2017-10-10 23:58:27.440207|2017-10-10 23:58:27.440207
NCT02252562|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-01-21|||September 2013||2013-09-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Interventional|||Hand Hygiene and Hospital Acquired Infections|Reduction in 30-Day Postoperative Healthcare-Associated Infections Through Use of a Novel Hand Hygiene System|Completed||N/A|3256|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-10 23:58:27.510227|2017-10-10 23:58:27.510227
NCT02252549|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-07-25|||April 2015||2015-04-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||An International Randomized Study to Compare SPIES Versus WLI|The SPIES Non-Muscle-Invasive Bladder Cancer Study - A Multicenter Randomized Controlled Study; A Multicenter International Randomized Controlled Study to Compare the Outcome Using the Storz Professional Image Enhancement System (SPIES) Versus White Light Imaging (WLI) During TURB of Non-Muscle-Invasive Bladder Cancer (NMIBC).|Enrolling by invitation||N/A|1928|Anticipated|Clinical Research Office of the Endourological Society||2|||f||||t||||||||||2017-10-10 23:58:27.606586|2017-10-10 23:58:27.606586
NCT02252536|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-09-13|||June 2015||2015-06-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder|Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of HORIZANT (Gabapentin Enacarbil) Extended-Release Tablets for the Treatment of Alcohol Use Disorder|Completed||Phase 2|346|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||2|||f||||t||||||||||2017-10-10 23:58:27.696692|2017-10-10 23:58:27.696692
NCT02252523|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-09-26|||April 2014||2014-04-01|September 2014|2014-09-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Dexmedetomidine-based Sedation in Neurocritical Care Patients|Feasibility of Dexmedetomidine-based Sedation in Neurocritical Care Patients : a Pilot Study|Unknown status|Recruiting|Phase 2|66|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-10 23:58:27.804138|2017-10-10 23:58:27.804138
NCT02252510|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-09-26|||January 2013||2013-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Observational|||Reliability for the Detection of Sperm DNA Damage by a Sperm Chromatin Dispersion Test (Halosperm)|Evaluation of the Reliability for the Measurement of Sperm DNA Damage by a Sperm Chromatin Dispersion Test (Halosperm)|Completed||N/A|40|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-10 23:58:27.897106|2017-10-10 23:58:27.897106
NCT02252497|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-03-11|||April 2014||2014-04-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PORTO||Tranexamic Acid in Total Hip Arthroplasty.|Tranexamic Acid in Total Hip Arthroplasty: Single Preoperative Administration vs Perioperative Administration. A Randomized Control Trial.|Completed||Phase 4|168|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t||||||||||2017-10-10 23:58:27.964272|2017-10-10 23:58:27.964272
NCT02252484|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-09-06|||October 2014||2014-10-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Energy Balance for Prostate Cancer Survivorship|Energy Balance for Prostate Cancer Survivorship|Completed||N/A|20|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 23:58:28.061539|2017-10-10 23:58:28.061539
NCT02252471|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2014-09-25|||July 2012||2012-07-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice Females|Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice Females|Completed||N/A|28|Actual|University of Houston||1|||f||||t||||||||||2017-10-10 23:58:28.17631|2017-10-10 23:58:28.17631
NCT02252458|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-01-08|||August 2014||2014-08-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|FentaOIH-V||Can Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?|Can Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers? A Prospective, Randomized, Double-blinded Crossover Study|Completed||N/A|21|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-10 23:58:28.265073|2017-10-10 23:58:28.265073
NCT02252445|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-07-20|2016-05-02||November 2014||2014-11-01|September 2014|2014-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Propofol and Sevoflurane for Catheter-Related Bladder Discomfort|Effect of Propofol and Sevoflurane on Postoperative Catheter-Related Bladder Discomfort|Completed||N/A|82|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:58:28.361119|2017-10-10 23:58:28.361119
NCT02252432|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-11-02|||February 2013||2013-02-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effects of Ketamine and Methadone on Postoperative Pain for Laminectomy|Intraoperative Ketamine and Methadone for Laminectomy: Effect on Recovery, Postoperative Pain, and Opioid Requirements|Recruiting||Phase 4|114|Anticipated|Cedars-Sinai Medical Center||3|||f||||f||||||||||2017-10-10 23:58:28.782833|2017-10-10 23:58:28.782833
NCT02252419|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2014-10-16|||October 2014||2014-10-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Interventional|||Combined Effect of Dexamethasone and Paracetamol for Postoperative Sore Throat|Combined Effect of Preoperative Dexamethasone and Intraoperative Paracetamol on Postoperative Sore Throat for Patients Undergoing Urologic Surgery|Unknown status|Not yet recruiting|N/A|242|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-10 23:58:28.903555|2017-10-10 23:58:28.903555
NCT02252406|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-02-02|||September 2015||2015-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|IRMA||Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome|Impact of Ranolazine on Inflammatory, Thrombogenic, Lipogenic, Biomarkers in Women With Angina and Metabolic Syndrome.|Recruiting||Phase 4|40|Anticipated|University of Florida||2|||f||||t||||||||No||2017-10-10 23:58:29.004117|2017-10-10 23:58:29.004117
NCT02252393|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-11-08|||October 2015||2015-10-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer|Prospective Randomized Comparison of Intracorporeal Versus Extracorporeal Urinary Diversion During Robotic Radical Cystectomy|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center||2||waiting on surgeon training|f||||f||||||||||2017-10-10 23:58:29.099211|2017-10-10 23:58:29.099211
NCT02252380|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-05-17|||May 2015||2015-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders|A Feasibility Clinical Trial of the Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for the Management of Treatment-Refractory Movement Disorders|Recruiting||N/A|10|Anticipated|InSightec||1|||f||||t||||||||||2017-10-10 23:58:29.192416|2017-10-10 23:58:29.192416
NCT02252367|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-10-24|||November 2015||2015-11-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms Secondary to Prostatic Hyperplasia|Double-blind, Placebo-controlled Study on Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia to Assess Changes in Pressure Flow Study and in Molecular Profile of Prostatic Tissue After 12 Weeks Treatment With Tadalafil.|Recruiting||Phase 4|86|Anticipated|University of Florence||2|||f||||f||||||||||2017-10-10 23:58:29.283699|2017-10-10 23:58:29.283699
NCT02252354|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-09-22|2015-10-27||September 2014||2014-09-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Safety analysis set (SAS) included all participants who were enrolled and received at least 1 dose of study drug.|TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability Study|An Open-Label, Single-Centre,Two Part Phase I Mass Balance Study to Assess the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of Orally Administered [14C]-TAK-385 in Healthy Male Subjects|Completed||Phase 1|12|Actual|Takeda||2|||f||||f||||||||||2017-10-10 23:58:29.457205|2017-10-10 23:58:29.457205
NCT02252341|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2015-04-16|||September 2014||2014-09-01|April 2015|2015-04-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|NACBD||Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder|Effects of N-Acetyl-Cysteine on Oxidative Stress Biomarkers in Bipolar Patients With and Without Tobacco Use Disorder|Unknown status|Enrolling by invitation|Phase 4|130|Anticipated|Universidade Estadual de Maringá||2|||f||||t||||||||||2017-10-10 23:58:30.639682|2017-10-10 23:58:30.639682
NCT02252328|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-05-11|||September 2015||2015-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients|Can Simvastatin Significantly Reduce the Amount of Immunosuppressive Medication Required by Patients With Sight Threatening Uveitis? A Phase 2b, Single Site, Randomized, Placebo Controlled, Double Blinded Trial.|Recruiting||Phase 2/Phase 3|50|Anticipated|University College, London||2|||f||||t||||||||No||2017-10-10 23:58:30.724155|2017-10-10 23:58:30.724155
NCT02252315|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-03-31|||January 2015||2015-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Written Versus Verbal Education for Mild Traumatic Brain Injury|Written Versus Verbal Education for Mild Traumatic Brain Injury|Unknown status|Recruiting|N/A|80|Anticipated|University of British Columbia||2|||f||||||||||||||2017-10-10 23:58:30.919652|2017-10-10 23:58:30.919652
NCT02252302|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-10-31|||May 2015||2015-05-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Exercise in Air Pollution and Lung Health in Asthmatics|The Effects of Inhaled Beta-2-Agonists and Air Pollution on Lung Function and Athletic Capacity|Active, not recruiting||N/A|20|Anticipated|University of British Columbia||8|||f||||f||||||||||2017-10-10 23:58:31.030606|2017-10-10 23:58:31.030606
NCT02252289|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-02-19|||September 2014||2014-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Fluctuation of Airway Function in Children With Asthma|Fluctuation of Airway Function in Children With Asthma Phenotype as a Predictor of Outcome|Completed||N/A|120|Actual|Imperial College London|||2||f||||f||||||||No||2017-10-10 23:58:31.161081|2017-10-10 23:58:31.161081
NCT02252276|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-29|||January 2014||2014-01-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Effects of Manual Therapy and Exercise in the Treatment of Ankle Sprains|Effects of Manual Therapy and Exercise in the Treatment of Recurrent Ankle Sprains: Randomised Trial|Completed||N/A|54|Actual|University of Alcala||2|||f||||t||||||||||2017-10-10 23:58:31.26835|2017-10-10 23:58:31.26835
NCT02252263|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2017-09-15|||December 9, 2014|Actual|2014-12-09|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 27, 2018|Anticipated|2018-02-27||Interventional|||A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma|A Phase I Open Label Dose Escalation and Randomized Cohort Expansion Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma|Active, not recruiting||Phase 1|136|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-10 23:58:31.393083|2017-10-10 23:58:31.393083
NCT02252250|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-02-22|||October 2014||2014-10-01|February 2016|2016-02-01|October 2021|Anticipated|2021-10-01|November 2018|Anticipated|2018-11-01||Interventional|||Transanal Minimal Invasive Surgery Versus Conventional Laparoscopic Surgery for Rectal Cancer|A Prospective Cohort Study of Transanal Laparoscopic Total Mesentery Excision Versus Conventional Laparoscopic Surgery for Rectal Cancer|Recruiting||Phase 2|100|Anticipated|Third Military Medical University||2|||f||||t||||||||||2017-10-10 23:58:31.989212|2017-10-10 23:58:31.989212
NCT02252237|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-12-15|||December 2014||2014-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|GLUCOPED||Pharmacokinetics of Prednisone, Prednisolone, Methylprednisolone in Children|Study of Pharmacokinetic Variability of Corticoids (Prednisone, Prednisolone, Methylprednisolone) in Children|Active, not recruiting||N/A|146|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Buccal cell collection swab   "|No||2017-10-10 23:58:32.118917|2017-10-10 23:58:32.118917
NCT02252224|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2016-12-02|||September 2014||2014-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance|Post-Marketing Surveillance to Evaluate the Safety and Efficacy of Forxiga in Patients With Type 2 Diabetes in Korea|Completed||N/A|3371|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-10 23:58:32.241575|2017-10-10 23:58:32.241575
NCT02252211|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-10-04|||September 2014||2014-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|LUD2014-002||Safety and Bio-Imaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers|A Phase I Safety and Bioimaging Trial of DS-8895a in Patients With Advanced or Metastatic EphA2 Positive Cancers|Active, not recruiting||Phase 1|9|Actual|Ludwig Institute for Cancer Research||1|||f||||f||||||||||2017-10-10 23:58:32.343405|2017-10-10 23:58:32.343405
NCT02252198|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||February 2014||2014-02-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|FIND||Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests|Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests for the Diagnosis of Pulmonary Tuberculosis in Comparison to Geneexpert MTB/RIF|Unknown status|Enrolling by invitation|N/A|900|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-10-10 23:58:32.436841|2017-10-10 23:58:32.436841
NCT02252185|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-12-02|||July 2014||2014-07-01|March 2015|2015-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||A Clinical Study of a Spine Fusion System in Vertebral Body Fusion Surgery|A Prospective, Multicenter, Randomized, Open-label, Controlled Study to Evaluate the Safety and Efficacy of a Spine Fusion System in Vertebral Body Fusion Surgery|Completed||N/A|106|Actual|Johnson & Johnson Medical (Suzhou) Ltd.||2|||f||||f||||||||||2017-10-10 23:58:32.531301|2017-10-10 23:58:32.531301
NCT02252172|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-08-24|||February 16, 2015|Actual|2015-02-16|August 2017|2017-08-01|November 22, 2024|Anticipated|2024-11-22|December 22, 2019|Anticipated|2019-12-22||Interventional|||Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma|A Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy|Active, not recruiting||Phase 3|744|Actual|Janssen Research & Development, LLC||2|||f||||t|t|f||||||||2017-10-10 23:58:32.689746|2017-10-10 23:58:32.689746
NCT02252159|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-09-26|||July 2014||2014-07-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Observational|||Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)|Prospective, Non-interventional Study of Disease Progression and Treatment of Patients With Polycythemia Vera in United States Academic or Community Clinical Practices|Active, not recruiting||N/A|2544|Actual|Incyte Corporation|||2||f||||f||||||Samples With DNA|"     Blood sample(s), two vials, one with heparin, another with ethylenediaminetetraacetic acid     (EDTA) will be collected at enrollment and then annually thereafter until the end of study     for serum analysis of proteins and assessment of allele burden and mutations.   "|||2017-10-10 23:58:33.279917|2017-10-10 23:58:33.279917
NCT02252146|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-02-06|||June 2014||2014-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation|Phase I/II Open-label, Multiple-dose, Dose-escalation Study to Evaluate the Safety and Tolerability of IMO-8400 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Presence of the MyD88 L265P Mutation|Completed||Phase 1/Phase 2|6|Actual|Idera Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-10 23:58:34.05986|2017-10-10 23:58:34.05986
NCT02252133|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-26|2015-12-24|2015-11-19||October 2014||2014-10-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||This analysis group includes all randomized subjects.|DAILIES TOTAL1® Lens Centration in a Japanese Population|Pilot Evaluation of DAILIES TOTAL1® Lens Centration in a Japanese Population|Completed||N/A|53|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:58:34.157008|2017-10-10 23:58:34.157008
NCT02252120|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-26|||January 2014||2014-01-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Laryngeal Mask Airway Supreme Versus Laryngeal Tube|Laryngeal Mask Airway Supreme Versus Laryngeal Tube in Non-paralysed, Anesthetized Children. A Randomized, Crossover Study Assessing Oropharyngeal Leak Pressure and Fiberoptic Position Using the Size 2|Completed||N/A|60|Actual|Schulthess Klinik||2|||f||||f||||||||||2017-10-10 23:58:35.984409|2017-10-10 23:58:35.984409
NCT02252107|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-05-18|||October 2014||2014-10-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1|10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1|Recruiting||Phase 2|45|Anticipated|Radboud University||1|||f||||t||||||||||2017-10-10 23:58:36.051972|2017-10-10 23:58:36.051972
NCT02252094|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-05-21|||May 22, 2017|Actual|2017-05-22|May 2017|2017-05-01|January 30, 2020|Anticipated|2020-01-30|December 31, 2019|Anticipated|2019-12-31||Interventional|U-Protect||Ultra-protective Pulmonary Ventilation Supported by Low Flow ECCO2R for Severe ARDS|Ultra-protective Pulmonary Ventilation Supported by Low Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) and Prone Positioning for ARDS; a Pilot Study.|Recruiting||N/A|50|Anticipated|National University Health System, Singapore||2|||f||||f|f|f||||||||2017-10-10 23:58:36.145097|2017-10-10 23:58:36.145097
NCT02252081|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-03-13|||October 1, 2014|Actual|2014-10-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Metformin in Kidney Disease|Dysmetabolism of Chronic Kidney Disease and Vascular Health|Recruiting||Phase 2|120|Anticipated|VA Office of Research and Development||2|||f||||t||||||||Undecided||2017-10-10 23:58:36.247095|2017-10-10 23:58:36.247095
NCT02252068|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-06-26|||January 2015||2015-01-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Treatment for Opioid Dependence and Anxiety Disorders|Behavioral Treatment Development for Co-occurring Opioid Dependence and Anxiety Disorders|Recruiting||N/A|60|Anticipated|Mclean Hospital||2|||f||||f||||||||No||2017-10-10 23:58:36.340524|2017-10-10 23:58:36.340524
NCT02251912|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-07-14|2017-05-23||July 2015|Actual|2015-07-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|OTETOH-3||Oxytocin Treatment of Alcohol Dependence|Oxytocin Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial|Completed||Phase 2|22|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:58:36.433805|2017-10-10 23:58:36.433805
NCT02251899|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-03-26|||January 2010||2010-01-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||A Disease Management Study Targeted to Reduce Health Care Utilization for Patients With Congestive Heart Failure|A Disease Management Study Targeted to Reduce Health Care Utilization for Patients With Congestive Heart Failure|Unknown status|Recruiting|Phase 3|10000|Anticipated|Health Navigator||2|||f||||f||||||||||2017-10-10 23:58:36.791884|2017-10-10 23:58:36.791884
NCT02251886|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-01-18|2016-08-15||January 2003||2003-01-01|January 2017|2017-01-01|September 2014|Actual|2014-09-01|January 2011|Actual|2011-01-01||Interventional|||Moxibustion in a Randomized Trial for Version of Breech Position From Week 32|Moxibustion for Version of Singleton Breech Position Before Term|Completed||N/A|200|Actual|Herning Hospital||4|||f||||f||||||||||2017-10-10 23:58:36.884705|2017-10-10 23:58:36.884705
NCT02251873|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||September 2001||2001-09-01|September 2014|2014-09-01||||March 2002|Actual|2002-03-01||Interventional|||Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers|An Open Label, Randomised, Parallel Group Study of the Drug-drug Pharmacokinetic Interaction of Steady State Tipranavir (SEDDS SEC) 500 mg and Ritonavir (Soft Gelatin Capsules) 100 mg or Tipranavir 750 mg and Ritonavir 200 mg, Both Bid for 13.5 Days With Single Dose Didanosine 400 mg (Delayed Release Capsule EC Beadlets) in Healthy Volunteers|Completed||Phase 1|50|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:38.505334|2017-10-10 23:58:38.505334
NCT02251860|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-09-26|||May 31, 2014|Actual|2014-05-31|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2019|Anticipated|2019-05-31||Observational|ARATA||Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice|A Prospective, Non-Interventional Study in Germany to Evaluate the Long-Term Effectiveness and Tolerability of Subcutaneously Administered RoActemra® (Tocilizumab; TCZ) in Patients With Rheumatoid Arthritis in Daily Clinical Practice (as Recommended in Label)|Recruiting||N/A|1500|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-10 23:58:38.591712|2017-10-10 23:58:38.591712
NCT02251847|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||July 2014||2014-07-01|September 2014|2014-09-01||||July 2015|Anticipated|2015-07-01||Interventional|||The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients||Unknown status|Recruiting|Phase 3|400|Anticipated|IlDong Pharmaceutical Co Ltd||6|||f||||||||||||||2017-10-10 23:58:38.69131|2017-10-10 23:58:38.69131
NCT02251834|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-04-27|||January 2015||2015-01-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|HISSPI||Hispanic Secondary Stroke Prevention Initiative|Hispanic Secondary Stroke Prevention Initiative|Recruiting||N/A|300|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-10 23:58:38.812111|2017-10-10 23:58:38.812111
NCT02251821|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-09-12|||October 20, 2014|Actual|2014-10-20|September 2017|2017-09-01||||March 1, 2018|Anticipated|2018-03-01||Interventional|||JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis|JAK Inhibitor Prior to Allogeneic Stem Cell Transplant for Patients With Primary and Secondary Myelofibrosis: A Prospective Study|Recruiting||Phase 2|33|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f||||||||2017-10-10 23:58:38.929791|2017-10-10 23:58:38.929791
NCT02251808|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-10-12|||September 2014||2014-09-01|May 2016|2016-05-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01||Observational|||Satisfaction Survey on PINS Stimulator System for Patients With Parkinson's Disease|Satisfaction Survey on PINS Stimulator System for Patients With Parkinson's Disease|Recruiting||N/A|612|Anticipated|Beijing Pins Medical Co., Ltd|||1||f||||t||||||||||2017-10-10 23:58:39.160892|2017-10-10 23:58:39.160892
NCT02251795|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||August 2007||2007-08-01|September 2014|2014-09-01||||June 2008|Actual|2008-06-01||Interventional|||Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects|Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects|Completed||Phase 1|52|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:58:39.369789|2017-10-10 23:58:39.369789
NCT02251782|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-06-29|||October 2014||2014-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|ADMIT||Adherence to Minimally Invasive Testing|Adherence to Minimally Invasive CRC Screening In Non-Adherent Patients Who Have Not Completed Colorectal Cancer Screening|Completed||N/A|490|Actual|Epigenomics, Inc|||3||f||||f||||||||||2017-10-10 23:58:39.495464|2017-10-10 23:58:39.495464
NCT02251769|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||August 2003||2003-08-01|September 2014|2014-09-01||||September 2003|Actual|2003-09-01||Interventional|||Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir|A Single-centre Open-label Study in Healthy Adult Volunteers to Determine the Effects of Single-dose and Steady-state TPV/r (500 mg/200 mg) on the Steady-state Pharmacokinetics of Clarithromycin (BIAXIN®) 500 mg Bid and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:39.591744|2017-10-10 23:58:39.591744
NCT02251756|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||July 2014||2014-07-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.|Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.|Completed||N/A|20|Actual|Galderma||4|||f||||f||||||||||2017-10-10 23:58:39.675311|2017-10-10 23:58:39.675311
NCT02251743|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-11-10|||June 2014||2014-06-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD|Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD|Recruiting||N/A|140|Anticipated|Ohio State University||2|||f||||f||||||||No||2017-10-10 23:58:39.770509|2017-10-10 23:58:39.770509
NCT02251730|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-05-11|||August 2014||2014-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Smoking Cessation in Head and Neck Cancer Patients Receiving Curative Radiation Therapy|A Feasibility and Efficacy Study of Smoking Cessation Program in Head and Neck Cancer Patients Receiving Curative Radiation Therapy|Completed||Phase 2|64|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-10 23:58:39.881248|2017-10-10 23:58:39.881248
NCT02251691|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2015-04-06|||April 2014||2014-04-01|April 2015|2015-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant|The Influence of Once-daily Versus Twice-daily Immunosuppressive Regimen on Drug Compliance in Patients After Renal Transplantation|Unknown status|Recruiting|Phase 4|90|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:58:40.246951|2017-10-10 23:58:40.246951
NCT02251678|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-12-07|||September 2014||2014-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluate the Effect of Elimune Capsules|Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis|Completed||Phase 1|21|Actual|Elorac, Inc.||1|||f||||f||||||||||2017-10-10 23:58:40.366824|2017-10-10 23:58:40.366824
NCT02251665|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-03-31|||January 2011||2011-01-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||National Cerebral and Cardiovascular Center (NCVC) Stroke Registry|National Cerebral and Cardiovascular Center (NCVC) Stroke Registry|Recruiting||N/A|6000|Anticipated|National Cerebral and Cardiovascular Center|||1||f||||f||||||||||2017-10-10 23:58:40.461669|2017-10-10 23:58:40.461669
NCT02251652|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-03-15|2017-03-15||April 2013||2013-04-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses|An Investigator-Initiated Study to Assess the Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands|Completed||Phase 4|16|Actual|Icahn School of Medicine at Mount Sinai|Study limitations include small sample size and the fact that LSRs may unblind the investigator.|2|||f||||t||||||||||2017-10-10 23:58:40.58463|2017-10-10 23:58:40.58463
NCT02251639|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-04-25|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Diagnostic Aids for Detection and Diagnosis of Oral Cancer|Evaluation of Diagnostic Aids for Detection and Diagnosis of Oral Cancer|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1||Study design improvements.|f||||f|f|t|f|||||||2017-10-10 23:58:40.84868|2017-10-10 23:58:40.84868
NCT02251626|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2016-09-13|||April 2014||2014-04-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|CoQ10||Assessing Bioavailability of CoQ10 Supplementation in Burn Patients|Assessing Bioavailability and Effects of Ubiquinol Supplementation on Biomarkers of Mitochondrial Function/Integrity, Metabolic Dysfunction, and Circulating Alarmins in Burn Patients|Recruiting||Early Phase 1|50|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-10 23:58:40.936548|2017-10-10 23:58:40.936548
NCT02251613|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-10-05|2015-01-26||December 2013||2013-12-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||This reporting group includes all randomized participants.|Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan|Effectiveness of Olopatadine HCl Ophthalmic Solution, 0.1% Compared to Epinastine HCl Ophthalmic Solution, 0.05% in the Treatment of Allergic Conjunctivitis to Japanese Cedar Pollen|Completed||Phase 4|50|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:58:41.041506|2017-10-10 23:58:41.041506
NCT02251600|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-08-15|||December 2014||2014-12-01|August 2017|2017-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy|A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy|Completed||Phase 1|24|Actual|PTC Therapeutics||1|||f||||f||||||||||2017-10-10 23:58:41.215957|2017-10-10 23:58:41.215957
NCT02251587|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-02-02|||September 2014||2014-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The $Ensible Weight Program: An Intervention Tailored for Low Income Women|The $Ensible Weight Program: An Intervention Tailored for Low Income Women|Completed||N/A|28|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 23:58:41.434929|2017-10-10 23:58:41.434929
NCT02251574|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-01-04|||September 2014||2014-09-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults|Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults|Completed||N/A|37|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-10-10 23:58:41.531821|2017-10-10 23:58:41.531821
NCT02251561|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-06-03|2015-05-20||November 2013||2013-11-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||This analysis population includes all subjects who used the study products.|Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan|Clinical Evaluation of Opti-Free III Compared to Opti-Free Plus®|Completed||N/A|36|Actual|Alcon Research||2|||f||||f||||||||||2017-10-10 23:58:41.644512|2017-10-10 23:58:41.644512
NCT02251548|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-09-15|||October 2014||2014-10-01|September 2017|2017-09-01|April 2021|Anticipated|2021-04-01|April 2018|Anticipated|2018-04-01||Interventional|iFCR||A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia|A Phase II Study of Ibrutinib in Combination With Fludarabine, Cyclophosphamide, and Rituximab (iFCR) in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia|Recruiting||Phase 2|85|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-10 23:58:41.862518|2017-10-10 23:58:41.862518
NCT02251535|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||July 2014||2014-07-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|April 2015|Anticipated|2015-04-01||Interventional|DePuyAttune||In-vivo Comparison of Different Levels of Femoral Rollback in a Primary Total Knee Arthroplasty|Retrospective Non-randomized In-vivo Comparison of Different Levels of Femoral Rollback in the ATTUNE Total Knee Arthroplasiy System on the Basis of Fluoroscopic and Marker-based Motion Capture Evaluation.|Unknown status|Recruiting|N/A|30|Anticipated|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-10 23:58:42.06245|2017-10-10 23:58:42.06245
NCT02251522|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-05-11|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Observational|STEPS||A Single Time-Point Study to Evaluate the ConforMIS iTotal® (CR) Knee Versus Off-the-Shelf|A Single Time-Point Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System Versus Off-the-Shelf Replacement|Completed||N/A|873|Actual|ConforMIS, Inc.|||2||f||||f|f|t|f|f|t|||No||2017-10-10 23:58:42.183228|2017-10-10 23:58:42.183228
NCT02251496|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-05-02|||September 2014||2014-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|COPD||COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.|Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks, Weight Changes and Functional Capacity in Chronic Obstructive Pulmonary Disease; Randomized Controlled Dietary Intervention|Active, not recruiting||N/A|32|Actual|University of Iceland||2|||f||||f||||||||||2017-10-10 23:58:42.468915|2017-10-10 23:58:42.468915
NCT02251483|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-07-27|||September 2014||2014-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth|Use of Serum-derived Immunoglobulin/Protein Isolate (SBI) for the Maintenance of Health in Subjects With Irritable Bowel Syndrome (IBS) Following Successful Treatment of Small Intestinal Bacterial Overgrowth (SIBO)|Completed||N/A|2|Actual|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-10 23:58:42.595172|2017-10-10 23:58:42.595172
NCT02251470|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-12-01|||October 2014||2014-10-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|WiiMobil||Home-based Balance Training Using Wii Fit After Stroke: A Feasibility Study|The Application of a Video-game System (Nintendo Wii®) as an Independent Exercise Program to Improve Mobility After Stroke - a Randomized Phase II Trial|Completed||Phase 1/Phase 2|14|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-10-10 23:58:42.72015|2017-10-10 23:58:42.72015
NCT02251457|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-03-18|||August 2014||2014-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1|Open Label Trial of Ranolazine in Myotonia Congenita, Paramyotonia Congenita, & Myotonic Dystrophy Type 1|Recruiting||Phase 2|24|Anticipated|Ohio State University||1|||f||||f||||||||Undecided||2017-10-10 23:58:42.839696|2017-10-10 23:58:42.839696
NCT02251444|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-08-03|||May 2014||2014-05-01|August 2016|2016-08-01||||August 2016|Actual|2016-08-01||Interventional|||Regulation of Emotions and Coping Behaviour in Patients With Chronic Recurrent Low Back Pain|Emotionsregulation Und Bewältigungsverhalten in Zusammenhang Mit Ambulanter Rehabilitation Oder Physikalischer Therapie Bei Chronischem Rückenschmerz|Terminated||N/A|42|Actual|Karl Landsteiner Institute of Remobilization and Functional Health||2||recruitment problems in the controle group|f||||||||||||||2017-10-10 23:58:42.951415|2017-10-10 23:58:42.951415
NCT02251431|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-07-13|||September 2014||2014-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome|A PROSPECTIVE, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, RANDOMIZED TRIAL OF EXTENDED RELEASE EXENATIDE VERSUS PLACEBO IN DIABETIC PATIENTS WITH TYPE 4 CARDIORENAL SYNDROME (EXTEND-CRS Trial)|Recruiting||Phase 3|104|Anticipated|Baylor Research Institute||2|||f||||t||||||||||2017-10-10 23:58:43.039376|2017-10-10 23:58:43.039376
NCT02251418|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-03-29|||February 2015||2015-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Shockwave Therapy of Chronic Diabetic Foot Ulcers|Extracorporeal Shockwave Therapy (ESWT) of Chronic Diabetic Foot Ulcers|Completed||N/A|23|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-10 23:58:43.176778|2017-10-10 23:58:43.176778
NCT02251405|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-10-20|||October 2014||2014-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Bidme||Behaviour Intervention to Decrease Melamine Exposure||Completed||N/A|16|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-10 23:58:43.318153|2017-10-10 23:58:43.318153
NCT02251392|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-11-30|||August 2015||2015-08-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|ChamomillaTH||Evaluation of Therapeutic Efficacy in Use of Chamomilla Gel, Chamomilla Infuse and Urea in Radiodermatitis|Evaluation of Therapeutic Efficacy in Use of Chamomila Gel, Chamomila Infuse and Urea in Patients With Breast or Head and Neck Cancer That Developed Radiodermatitis|Enrolling by invitation||Phase 3|100|Anticipated|University of Brasilia||3|||f||||f||||||||||2017-10-10 23:58:43.393025|2017-10-10 23:58:43.393025
NCT02251379|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-09-05|||October 2014||2014-10-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|ECATCh||Environmental Control as Add-on Therapy in Childhood Asthma|Environmental Control as Add-on Therapy in Childhood Asthma|Recruiting||Phase 2|200|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:58:43.482207|2017-10-10 23:58:43.482207
NCT02251366|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-09-07|||October 2014||2014-10-01|May 2015|2015-05-01||||June 2016|Anticipated|2016-06-01||Interventional|||NVAMD Satellite Study|A Multi-Satellite Comparison of Standard-of-Care, Physician-Based Retinal Evaluation Versus Physician-Guided Diagnostic Evaluation in the Management of Neovascular Age-Related Macular Degeneration With Anti-Vascular Endothelial Growth Factor Therapy|Unknown status|Recruiting|N/A|200|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-10 23:58:43.586328|2017-10-10 23:58:43.586328
NCT02251353|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2015-03-05|||June 2014||2014-06-01|September 2014|2014-09-01|June 2022|Anticipated|2022-06-01|June 2019|Anticipated|2019-06-01|5 Years|Observational [Patient Registry]|IMET||Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients|Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients: Prospective, Observational, Multi-institutional Registration Study - IMET|Recruiting||N/A|300|Anticipated|Federation of Breast Diseases Societies|||1||f||||t||||||||||2017-10-10 23:58:43.696438|2017-10-10 23:58:43.696438
NCT02251340|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2016-11-30|||June 2015||2015-06-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Randomized Controlled Trial of an Eczema Care Plan|Randomized Controlled Trial of an Eczema Care Plan|Completed||N/A|211|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-10 23:58:43.785542|2017-10-10 23:58:43.785542
NCT02251327|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||February 2014||2014-02-01|September 2014|2014-09-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Observational|(XpertDST)||Feasibility and Accuracy of a Novel Xpert Cartridge|Feasibility and Accuracy of a Novel Xpert Cartridge for Rapid Moledular Detection of Drug Resistant Mycobacterium Tuberculosis in Sputum|Unknown status|Enrolling by invitation|N/A|550|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-10-10 23:58:43.855259|2017-10-10 23:58:43.855259
NCT02251002|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-08-21|||July 2015||2015-07-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Frontoparietal Priority Maps as Biomarkers for MTBI|Frontoparietal Priority Maps as Biomarkers for MTBI|Enrolling by invitation||N/A|88|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-10 23:58:46.777453|2017-10-10 23:58:46.777453
NCT02251314|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-03-07|||September 2014||2014-09-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01|3 Years|Observational [Patient Registry]|||Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma|The Utility and Relevance of Exome Sequence Analysis and Circulating Tumour DNA in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma|Recruiting||N/A|6|Anticipated|University Health Network, Toronto|||1||f||||t||||||Samples With DNA|"     -  Pre-mortem bloods taken to obtain ctDNA        -  Post-mortem bloods and tissue To understand to what extent circulating DNA (found in          Blood) represents the genetic content of underlying tumour metastases in BRAF mutant          melanoma, and        -  To correlate the appearance of metastasis-specific mutations in the ctDNA with          histological features in the tumours such as degree of necrosis, inflammation,          microvascular density, and location or size of primary tumour and metastases   "|||2017-10-10 23:58:43.924788|2017-10-10 23:58:43.924788
NCT02251301|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-05-01|||January 2015||2015-01-01|August 2016|2016-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Milk Plus Exercise: A Novel Strategy to Treat Diabetes.|The Effect of Adding Milk in Proximity to Exercise During an Interval Training Intervention in Type 2 Diabetes (T2D) on Metabolic and Cardiovascular Health.|Completed||N/A|52|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-10 23:58:44.004707|2017-10-10 23:58:44.004707
NCT02251288|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-09-14|||July 14, 2015|Actual|2015-07-14|February 9, 2017|2017-02-09|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine|A Phase I Randomized Study in Healthy Adults to Assess the Safety, Reactogenicity and Immunogenicity of Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine|Recruiting||Phase 1|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f|||||t|f|||f|||||2017-10-10 23:58:44.093043|2017-10-10 23:58:44.093043
NCT02251275|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2017-06-20|||September 2014||2014-09-01|June 2017|2017-06-01||||May 2018|Anticipated|2018-05-01||Interventional|||Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease|A Phase 3b, Multi-center, Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan (OPC 41061, 30 mg to 120 mg/Day, Split Dose) in Subjects With Autosomal Dominant Polycystic Kidney Disease|Active, not recruiting||Phase 3|2500|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t||||||||||2017-10-10 23:58:44.35635|2017-10-10 23:58:44.35635
NCT02251262|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-01-24|||June 22, 2015|Actual|2015-06-22|January 2017|2017-01-01|June 22, 2017|Anticipated|2017-06-22|June 22, 2017|Anticipated|2017-06-22||Interventional|ENDOTEP||Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection|Assessment of Diagnostic Accuracy of 18FDG-PET-CT in Patients With Suspicion of Pacing or Defibrillation Lead Infection: a Prospective Multi-center Study|Recruiting||N/A|250|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 23:58:44.833829|2017-10-10 23:58:44.833829
NCT02251249|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-01-24|||September 8, 2014|Actual|2014-09-08|January 2017|2017-01-01|June 8, 2017|Anticipated|2017-06-08|June 8, 2017|Anticipated|2017-06-08||Interventional|GASTRIM||Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study.||Recruiting||Phase 4|40|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-10 23:58:44.95417|2017-10-10 23:58:44.95417
NCT02251236|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-05-22|||January 2016||2016-01-01|May 2017|2017-05-01|January 18, 2017|Actual|2017-01-18|January 18, 2017|Actual|2017-01-18||Interventional|||Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals|Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals|Completed||N/A|14|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:58:45.079815|2017-10-10 23:58:45.079815
NCT02251223|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||February 2001||2001-02-01|September 2014|2014-09-01||||February 2002|Actual|2002-02-01||Interventional|||Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects|An Open Label Multinational Study of the Effects of Three Dose Pairs of Tipranavir/Ritonavir (b.i.d.) on the Pharmacokinetic Characteristics of Protocol -Defined, Baseline, Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects.|Completed||Phase 1/Phase 2|208|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:58:45.174192|2017-10-10 23:58:45.174192
NCT02251210|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||May 2001||2001-05-01|September 2014|2014-09-01||||November 2002|Actual|2002-11-01||Interventional|||Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid Arthritis|Three Month, Randomised, Double-blind, Double-dummy, Placebo-controlled, Multiple Dose-range Study of the Efficacy and Safety of BIIL 284 BS (5, 25 and 75 mg p.o. Once Daily) in Adult Patients With Active Rheumatoid Arthritis|Completed||Phase 2|404|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:58:45.263308|2017-10-10 23:58:45.263308
NCT02251197|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||July 2001||2001-07-01|September 2014|2014-09-01||||October 2002|Actual|2002-10-01||Interventional|||Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke|A Randomised, Double-blind, Placebo-controlled, Clinical Trial to Evaluate the Safety and Tolerability in 108 Patients (18 Per Dose Group) With Acute Ischemic Stroke After Intravenous Administration From 6 to 72 Hours of BIII 890, as Loading Dose Followed by Maintenance Dose, in Escalating Dose Panels From 87.5 mg up to 1495 mg (Total Dose)|Completed||Phase 2|97|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:45.355956|2017-10-10 23:58:45.355956
NCT02251184|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||October 2000||2000-10-01|September 2014|2014-09-01||||November 2000|Actual|2000-11-01||Interventional|||Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH|Comparison of Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH by the Prior Administration of a Proton-pump Inhibitor: An Open-label 2-way Randomized Cross-over Study in Healthy Male and Female Subjects Age 40-65.|Completed||Phase 4|31|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:45.460281|2017-10-10 23:58:45.460281
NCT02250625|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-05-21|||May 2014||2014-05-01|May 2014|2014-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Study Vitamin D in Healthy Individuals|A Prospective Collection of Peripheral Blood Specimens to Study Vitamin D in Healthy Individuals|Completed||N/A|482|Actual|Fujirebio Diagnostics, Inc.|||1||f||||f||||||Samples With DNA|"     Serum and plasma   "|||2017-10-10 23:58:51.124522|2017-10-10 23:58:51.124522
NCT02251171|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||August 2003||2003-08-01|September 2014|2014-09-01||||October 2003|Actual|2003-10-01||Interventional|||Effects of Steady-state TPV/RTV on the Single-dose Pharmacokinetics of Rifabutin and the Effects of Single-dose Rifabutin on the Steady-state Pharmacokinetics of TPV in Healthy Adult Volunteers|A Single-centre Open-label Study in Healthy Adult Volunteers to Determine the Effects of Steady-state TPV/RTV (500 mg/200 mg) on the Single-dose Pharmacokinetics of Rifabutin (MYCOBUTIN®) 150 mg, and the Effects of Single-dose Rifabutin (150 mg) on the Steady-state Pharmacokinetics of TPV 500 mg (Co-administered With RTV 200 mg)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:58:45.549301|2017-10-10 23:58:45.549301
NCT02251158|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||October 2003||2003-10-01|September 2014|2014-09-01||||December 2003|Actual|2003-12-01||Interventional|||Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects|Relative Bioavailability of 500/200 mg of Tipranavir/Ritonavir Paediatric Solution Compared to 500/200 mg of Tipranavir/Ritonavir Capsules Following Oral Administration and Bioavailability of 500/200 mg Tipranavir/Ritonavir Paediatric Solution Under the Influence of Food in Healthy Female and Male Subjects. An Open-label, Randomised, Single-dose, Three-way Crossover Trial.|Completed||Phase 1|30|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:58:45.640956|2017-10-10 23:58:45.640956
NCT02251145|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||May 2002||2002-05-01|September 2014|2014-09-01||||June 2002|Actual|2002-06-01||Interventional|||Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers|A Single Centre, Open-Label, Randomised, Parallel, Multiple Dose Comparison of the Effects of Tipranavir 500 mg and Ritonavir 100 mg or Tipranavir 750 mg and Ritonavir 200 mg Twice a Day for 11.5 Days on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate 300 mg in Healthy Volunteers|Completed||Phase 1|49|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:45.722565|2017-10-10 23:58:45.722565
NCT02251132|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||October 2000||2000-10-01|September 2014|2014-09-01||||December 2000|Actual|2000-12-01||Interventional|||Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers|An Open-label, Parallel Group, Multiple-dose Investigation of the Pharmacokinetics of Tipranavir Soft Elastic Capsules SEDDS and Ritonavir Soft Gel Capsules and Their Effects on Cytochrome P-450 (3A4) Activity in Normal Healthy Volunteers|Completed||Phase 1|113|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-10 23:58:45.824403|2017-10-10 23:58:45.824403
NCT02251119|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-25|2014-09-25|||July 2002||2002-07-01|September 2014|2014-09-01||||January 2003|Actual|2003-01-01||Interventional|||The Pharmacodynamic/Pharmacokinetic Interaction of Tipranavir and Ritonavir With Loperamide in Healthy Volunteers|The Pharmacodynamic/Pharmacokinetic Interaction of Tipranavir and Ritonavir With Loperamide in Healthy Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:58:45.945363|2017-10-10 23:58:45.945363
NCT02251093|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-03-24|||May 2014||2014-05-01|March 2016|2016-03-01||||February 2016|Actual|2016-02-01||Interventional|GYNOCANS||Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis|Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis. International Phase III, Randomised, Multi-centre, Parallel-group, Two Arm, Double-blind Superiority Trial Versus Placebo.|Completed||Phase 3|350|Actual|Probionov||2|||f||||t||||||||||2017-10-10 23:58:46.13042|2017-10-10 23:58:46.13042
NCT02251080|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-04-18|||September 2014||2014-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Attention Deficit/Hyperactivity Disorder Internet Survey Study in a College Student Population|Attention Deficit/Hyperactivity Disorder (ADHD) Internet Survey Study in a College Student Population|Completed||N/A|10|Actual|Wake Forest University Health Sciences|||2||f||||f||||||||||2017-10-10 23:58:46.226784|2017-10-10 23:58:46.226784
NCT02251067|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-03-27|||September 2014||2014-09-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes|Completed||Phase 2|165|Actual|Vascular Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-10 23:58:46.298234|2017-10-10 23:58:46.298234
NCT02251054|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-09-24|||October 2012||2012-10-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|OAB||Virtual Avatar Coaches for Behavioral Therapy of Patients With Overactive Bladder|Virtual Avatar Coaches for Behavioral Therapy of Patients With Overactive Bladder|Completed||N/A|47|Actual|Miami VA Healthcare System||2|||f||||t||||||||||2017-10-10 23:58:46.439664|2017-10-10 23:58:46.439664
NCT02251041|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-12-16|||September 2014||2014-09-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|CAPITL||Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)|Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL): a First-in-men Study|Recruiting||Phase 2|72|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-10 23:58:46.518456|2017-10-10 23:58:46.518456
NCT02251028|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-11-14|||January 2014||2014-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Value-based Cognitive Behavioral Therapy for Prevention of Chronic Whiplash-associated Disorders|Value-based Cognitive Behavioural Therapy for the Prevention of Chronic Whiplash Associated Disorders: A Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|University of Southern Denmark||2|||f||||f||||||||No||2017-10-10 23:58:46.626555|2017-10-10 23:58:46.626555
NCT02251015|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-09-09|||July 2011||2011-07-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of the Use of Occlusal Splint on the Postural Balance of Individuals With Temporomandibular Disorder|Evaluation of Postural Balance in Individuals With Temporomandibular Disorder by Means of Force Platform After Using Occlusal Stabilizer Splint Disorder|Completed||Phase 3|49|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-10 23:58:46.706208|2017-10-10 23:58:46.706208
NCT02250989|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-24|||July 2014||2014-07-01|September 2014|2014-09-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|INGLIVEF||The Influence of Glycaemia and Insulinemia on Vasomotor Endothelial Function After Myocardial Infarction|Influence of Glycaemia and Insulinemia on Vasomotor Endothelial Function After Ischemia/Reperfusion Lesion on Patients in Acute Phase of ST Segment Elevation Myocardial Infarction (STEMI)|Unknown status|Recruiting|N/A|75|Anticipated|University of Campinas, Brazil|||3||f||||t||||||Samples Without DNA|"     Plasma, whole blood.   "|||2017-10-10 23:58:46.841009|2017-10-10 23:58:46.841009
NCT02250976|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-24|||September 2014||2014-09-01|September 2014|2014-09-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca|A Clinical Trial to Evaluate the Pharmacokinetics of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca Under Fed Condition in Healthy Male Volunteers|Unknown status|Recruiting|Phase 1|40|Anticipated|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-10 23:58:47.029576|2017-10-10 23:58:47.029576
NCT02250963|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-24|||July 2014||2014-07-01|September 2014|2014-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Prognostic Accuracy of Coronary CT and Dobutamine Stress Echocardiography in Patient Undergoing Non-cardiac Surgery||Unknown status|Recruiting|N/A|317|Anticipated|Gyeongsang National University Hospital|||2||f||||t||||||||||2017-10-10 23:58:47.131952|2017-10-10 23:58:47.131952
NCT02250950|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-05-18|||June 2014||2014-06-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||An Examination of the Efficacy of a Self-Determination Theory and Motivational Interviewing Exercise Intervention|Decreasing Disparities in Physical Activity: An Intervention Based on Self-Determination Theory and Motivational Interviewing|Completed||Phase 2/Phase 3|57|Actual|Syracuse University||2|||f||||t||||||||||2017-10-10 23:58:47.251804|2017-10-10 23:58:47.251804
NCT02250937|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-03-20|||October 27, 2014|Actual|2014-10-27|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Recruiting||Phase 2|116|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-10 23:58:47.351079|2017-10-10 23:58:47.351079
NCT02250924|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-11-28|||June 2015||2015-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Caffeinated Gum to Prevent Post-Operative Ileus: A Prospective, Randomized, Placebo-controlled Trial|Caffeinated Gum to Prevent Post-Operative Ileus: A Prospective, Randomized, Placebo-controlled Trial|Recruiting||Phase 3|435|Anticipated|The Guthrie Clinic||3|||f||||f||||||||||2017-10-10 23:58:47.504232|2017-10-10 23:58:47.504232
NCT02250911|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-09-08|||September 2014||2014-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden|Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden|Active, not recruiting||N/A|88|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||f||||||||||2017-10-10 23:58:47.604502|2017-10-10 23:58:47.604502
NCT02250898|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2015-09-22|||September 2014||2014-09-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Massage for Post Breast Surgery|Massage for Pain and Mobility in Post-Breast Surgery Patients|Completed||N/A|21|Actual|MetroHealth Medical Center||2|||f||||f||||||||||2017-10-10 23:58:47.719415|2017-10-10 23:58:47.719415
NCT02250885|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-11-03|||August 2014||2014-08-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors|Investigator Initiated, Phase 2 Clinical Trial of Selinexor (KPT-330) for the Treatment of Poorly Differentiated Lung and Gastroenteropancreatic Tumors|Completed||Phase 2|14|Actual|Gabrail Cancer Center Research||1|||f||||f||||||||Undecided||2017-10-10 23:58:47.834866|2017-10-10 23:58:47.834866
NCT02250872|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-04-18|||December 2014||2014-12-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury|Effect of DPP4 Inhibitors on Cisplatin-induced Acute Kidney Injury|Recruiting||Phase 2/Phase 3|182|Anticipated|Seoul National University Bundang Hospital||2|||f||||f||||||||Undecided||2017-10-10 23:58:47.943368|2017-10-10 23:58:47.943368
NCT02250859|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-21|2015-08-25|||September 2014||2014-09-01|September 2014|2014-09-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||A Pharmacokinetic Study of Minocycline in Male and Female Volunteers|An Open-label, Multiple Dose Study to Assess the Pharmacokinetic Profile of Minocycline From FMX-101 Foam (4%) in Male and Female Volunteers|Completed||Phase 1|12|Actual|Foamix Ltd.||1|||f||||f||||||||||2017-10-10 23:58:48.08415|2017-10-10 23:58:48.08415
NCT02250846|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-25|||January 2015||2015-01-01|September 2014|2014-09-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|EABM||Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC|Phase II Study of EGFR-TKI in Patients With EGFR Mutation Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis|Unknown status|Not yet recruiting|Phase 2|70|Anticipated|Wuhan Union Hospital, China||2|||f||||f||||||||||2017-10-10 23:58:48.192415|2017-10-10 23:58:48.192415
NCT02250833|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-04-08|||September 2014||2014-09-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||CKD-828 (80/5mg) Pharmacokinetic Study|To Compare the Pharmacokinetics and Safety of CKD-828 80/5mg to Coadministration of Telmisartan 80mg and S-amlodipine 5mg in Healthy Male Volunteers|Completed||Phase 1|69|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:58:48.278338|2017-10-10 23:58:48.278338
NCT02250820|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-08-31|||November 2014||2014-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)|A Qualitative Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography|Recruiting||Phase 1|280|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-10 23:58:48.406775|2017-10-10 23:58:48.406775
NCT02250807|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-09-28|2016-09-28||January 2015||2015-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection|A Phase 3, Multicenter, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of a 12-Week Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive or -Experienced Subjects With Chronic Genotype 4 Hepatitis C Virus Infection|Completed||Phase 3|40|Actual|Janssen R&D Ireland||1|||f||||f||||||||||2017-10-10 23:58:48.577156|2017-10-10 23:58:48.577156
NCT02250794|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-23|||October 2014||2014-10-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit|Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-10 23:58:48.902195|2017-10-10 23:58:48.902195
NCT02250781|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-21|||January 2015||2015-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Oral ONC201 in Treating Patients With Advanced Solid Tumors|A First-in-Human Phase I Single-Agent Open-Label Dose-Escalation Study of Every Three-Week Dosing of Oral ONC201 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|30|Anticipated|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-10 23:58:49.008945|2017-10-10 23:58:49.008945
NCT02250768|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-23|||July 2013||2013-07-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|RIF||Effects of Embryogen in RIF Patients|Effects of Granulocyte - Macrophage Colony - Stimulating Factor (GM-CSF) Supplementation in Embryo Culture in Patients With Repeated Implantation Failure|Completed||Phase 4|60|Actual|Vietnam National University||1|||f||||f||||||||||2017-10-10 23:58:49.110284|2017-10-10 23:58:49.110284
NCT02250755|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-11-03|||June 2013||2013-06-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|METAPERF||MRI Perfusion on T1 and T2 Brain Lesion(s)|Comparison of MRI Sequences T1 and T2 * Cerebral Perfusion to Aid in the Diagnosis and Evaluation of Brain Therapeutic Response With Chemotherapy or Targeted Therapy(s) Lesion(s) in Patients Treated and Followed for a Pulmonary Neoplasia|Completed||N/A|30|Actual|University Hospital, Lille||1|||f||||f||||||||||2017-10-10 23:58:49.192297|2017-10-10 23:58:49.192297
NCT02250742|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2016-05-21|||September 2014||2014-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Dry Needling on Trunk Muscle Function in Low Back Pain Patients|The Effect of Dry Needling on Trunk Muscle Function in Low Back Pain Patients|Completed||N/A|40|Actual|University of Haifa||2|||f||||||||||||||2017-10-10 23:58:49.274299|2017-10-10 23:58:49.274299
NCT02250729|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-03-07|||July 2014||2014-07-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ALPHO||Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure|Anaphylaxis to Neuromuscular Blocking Agents and Pholcodine Exposure. Case-control Study|Recruiting||N/A|780|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-10 23:58:49.360408|2017-10-10 23:58:49.360408
NCT02250716|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-12-01|||October 2012||2012-10-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|August 2015|Actual|2015-08-01||Interventional|||A Comparison of Immediate Treatment of CIN1 With Cryotherapy and 12 Month Cytology Follow up in HIV Seropositive Women|A Comparison of Immediate Treatment of CIN1 With Cryotherapy and Regular 12 Month Cytology Follow up in HIV Seropositive Women|Active, not recruiting||N/A|480|Anticipated|University of Witwatersrand, South Africa||2|||f||||f||||||||||2017-10-10 23:58:49.529315|2017-10-10 23:58:49.529315
NCT02250703|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-06-29|2017-01-09||September 2014||2014-09-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Intranasal Dexmedetomidine Premedication in Children|Comparing Intranasal Dexmedetomidine With Oral Midazolam as Premedication for Older Children Undergoing General Anesthesia for Dental Rehabilitation|Completed||Phase 3|75|Actual|University of Mississippi Medical Center|All the consecutive patients were screened for eligibility. Patients were not selected on the basis of need for premedication.|2|||f||||f||||||||||2017-10-10 23:58:49.623107|2017-10-10 23:58:49.623107
NCT02250690|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-09-24|||September 2013||2013-09-01|July 2014|2014-07-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|||Neuromodulation on Motor Function in Parkinson's Disease|Transcranial Direct Current Stimulation (tDCS) Associated With Gait Training in Improving Motor Function in Parkinson's Disease|Unknown status|Enrolling by invitation|N/A|24|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 23:58:50.004635|2017-10-10 23:58:50.004635
NCT02250677|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-23|||April 2014||2014-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||LIFESTAT - Living With Statins, a Cross Sectional Study|LIFESTAT - Living With Statins, a Cross Sectional Study on the Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being|Completed||N/A|75|Actual|University of Copenhagen|||3||f||||f||||||Samples With DNA|"     Samples with plasma, muscle and fat biopsies are retained for analysis after enrolment of the     last subject.   "|No||2017-10-10 23:58:50.110122|2017-10-10 23:58:50.110122
NCT02250664|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|P2S2||Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers|Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers|Recruiting||Phase 1/Phase 2|282|Anticipated|University of Vermont||3|||f||||t||||||||||2017-10-10 23:58:50.21126|2017-10-10 23:58:50.21126
NCT02250651|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-07-03|||December 16, 2014|Actual|2014-12-16|July 2017|2017-07-01|August 20, 2020|Anticipated|2020-08-20|April 4, 2019|Anticipated|2019-04-04||Interventional|||Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension|The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension|Recruiting||Phase 3|600|Anticipated|Allergan||3|||f||||f|t|f||||||||2017-10-10 23:58:50.332726|2017-10-10 23:58:50.332726
NCT02250638|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-08-07|||May 2014||2014-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Longitudinal Pancreatic Cancer Study|A Prospective Longitudinal Study of CA 19-9 as an Aid in Monitoring Disease in Patients With Pancreatic Cancer|Recruiting||N/A|140|Anticipated|Fujirebio Diagnostics, Inc.|||1||f||||f||||||Samples With DNA|"     Serum and Plasma   "|||2017-10-10 23:58:51.012183|2017-10-10 23:58:51.012183
NCT02250612|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-01-27|||October 2014||2014-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|SYLTAG||SYL040012, Treatment for Open Angle Glaucoma|A Phase II, Observer Masked, Active Controlled Study of SYL040012 for the Treatment of Elevated Intraocular Pressure in Patients With Open-angle Glaucoma or Ocular Hypertension|Completed||Phase 2|184|Actual|Sylentis, S.A.||5|||f||||||||||||||2017-10-10 23:58:51.197423|2017-10-10 23:58:51.197423
NCT02250599|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-12-28|||August 2014||2014-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma|Multi-center, Randomized, Controlled, Open-label Study of Bevacizumab With Carboplatin and Paclitaxel Versus Carboplatin and Paclitaxel in Patients With Metastatic Nasopharyngeal Carcinoma|Recruiting||Phase 2|80|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-10 23:58:51.348132|2017-10-10 23:58:51.348132
NCT02250586|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-05-02|||March 1, 2015|Actual|2015-03-01|May 2017|2017-05-01|December 24, 2018|Anticipated|2018-12-24|August 1, 2018|Anticipated|2018-08-01||Interventional|||Internet Based Cognitive Behavior Therapy for Concerned Significant Others of Problem Gamblers|Internet Based Cognitive-behavioral Therapy for Concerned Significant Others of Problem Gamblers: a Randomized Wait-list Controlled Trial|Active, not recruiting||N/A|150|Anticipated|Stockholm University||2|||f||||f||||||||||2017-10-10 23:58:51.514149|2017-10-10 23:58:51.514149
NCT02250573|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-24|||December 2005||2005-12-01|August 2014|2014-08-01||||April 2006|Actual|2006-04-01||Interventional|||An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery|An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery.|Completed||Phase 3|||Bio Products Laboratory||1|||f||||||||||||||2017-10-10 23:58:51.600434|2017-10-10 23:58:51.600434
NCT02250560|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-24|||April 2000||2000-04-01|August 2014|2014-08-01||||November 2003|Actual|2003-11-01||Interventional|||A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.|An Open Study to Investigate the Safety and Efficacy of Replenine®-VF by Continuous Infusion in Haemophilia B Patients Undergoing Major Surgery.|Completed||Phase 3|||Bio Products Laboratory||1|||f||||||||||||||2017-10-10 23:58:51.729678|2017-10-10 23:58:51.729678
NCT02250547|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-07-15|||July 2012||2012-07-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Observational|OSCAR||Optimization With SonR Method in the ClinicAl pRactice|Optimization With SonR Method in the ClinicAl pRactice|Active, not recruiting||N/A|278|Anticipated|LivaNova|||1||f||||f||||||||||2017-10-10 23:58:51.865108|2017-10-10 23:58:51.865108
NCT02250534|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-10-05|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women|Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women|Recruiting||Phase 1/Phase 2|282|Anticipated|University of Vermont||3|||f||||t||||||||||2017-10-10 23:58:52.043036|2017-10-10 23:58:52.043036
NCT02250521|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-08-15|||August 2014||2014-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||McGrath MAC ISR-McGRATH MAC Video Laryngoscope Study|McGRATH MAC Video Laryngoscope - To View or Not To View?|Completed||N/A|100|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||Undecided||2017-10-10 23:58:52.202393|2017-10-10 23:58:52.202393
NCT02250508|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-24|||December 2004||2004-12-01|August 2014|2014-08-01||||June 2005|Actual|2005-06-01||Interventional|||A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.|A Randomised, Comparative, Single Dose, Open Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Different Types of Von Willebrand Disease.|Completed||Phase 2|||Bio Products Laboratory||2|||f||||||||||||||2017-10-10 23:58:52.30287|2017-10-10 23:58:52.30287
NCT02250495|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2015-09-11|||October 2014||2014-10-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|VIBE||The Sympara VIBE Study for Hypertension|VIBE: A Clinical Study to Evaluate the Sympara Therapeutic System for the Treatment of Hypertension|Terminated||Phase 1/Phase 2|8|Actual|Sympara Medical, Inc.||1||Company closed|f||||t||||||||||2017-10-10 23:58:52.387773|2017-10-10 23:58:52.387773
NCT02250482|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-24|||November 2001||2001-11-01|August 2014|2014-08-01||||August 2003|Actual|2003-08-01||Interventional|||An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.|An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.|Completed||Phase 3|||Bio Products Laboratory||1|||f||||||||||||||2017-10-10 23:58:52.476006|2017-10-10 23:58:52.476006
NCT02250469|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-01-16|||September 2014||2014-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CHARACTER SCS||A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthesia Between 2 Spinal Cord Stimulation Systems|A Randomised Pilot Study to Assess differenCes in tHe Subjects' Experience of stimulAtion-Induced paRaesthesiA Between Two Different Spinal Cord sTimulation dEvices: the Axium® DoRsal Root Ganglion Stimulation System Versus the Prime Advanced Dorsal Column Stimulation System|Terminated||N/A|5|Actual|St. Jude Medical||2|||f||||f||||||||||2017-10-10 23:58:52.576148|2017-10-10 23:58:52.576148
NCT02250456|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-10-04|||July 2013|Actual|2013-07-01|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01||Observational|AVAST||AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)|Detect, Monitor and Prevent Vascular Abnormalities Associated With Turner Syndrome|Recruiting||N/A|125|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-10 23:58:52.650645|2017-10-10 23:58:52.650645
NCT02250430|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-24|||September 2014||2014-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Phase 1 Study Assessing Local Cutaneous Effects of SB204|A Phase 1, Single-Center, Split-Face Study Assessing Local Cutaneous Effects After Application of SB204 2% and SB204 4% in Healthy Volunteers|Completed||Phase 1|8|Actual|Novan, Inc.||1|||f||||f||||||||||2017-10-10 23:58:52.838816|2017-10-10 23:58:52.838816
NCT02250404|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-04-11|||August 22, 2014|Actual|2014-08-22|April 2017|2017-04-01|August 22, 2019|Anticipated|2019-08-22|August 22, 2018|Anticipated|2018-08-22||Observational|||Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide|Pilot Study of the Identification of the Molecular Signatures of Relapse in Small Cell Lung Cancer|Recruiting||N/A|3|Anticipated|University of Southern California|||1||f||||f|f|f||||Samples With DNA|"     Tissue   "|||2017-10-10 23:58:52.999637|2017-10-10 23:58:52.999637
NCT02250391|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2016-09-07|||September 2014||2014-09-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis|Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis|Completed||Phase 3|72|Actual|Nihon Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-10 23:58:53.090847|2017-10-10 23:58:53.090847
NCT02250378|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-09-14|||October 2014||2014-10-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer|Feasibility Study of Stereotactic Body Radiation Therapy Followed by Wedge Resection for Peripherally Located Early Stage Non-small Cell Lung Cancer|Withdrawn||N/A|0|Actual|University of Southern California||1||No accrual|f||||t||||||||||2017-10-10 23:58:53.162123|2017-10-10 23:58:53.162123
NCT02250365|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-08-15|||October 13, 2014|Actual|2014-10-13|August 2017|2017-08-01|August 10, 2017|Actual|2017-08-10|August 10, 2017|Actual|2017-08-10||Interventional|||Electrical Stimulation of the Paretic Upper Limb in the Early Stroke Phase|Electrical Somatosensory Stimulation of the Paretic Upper Limb in Acute Stroke Patients - a Randomized Controlled Study|Completed||N/A|102|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-10 23:58:53.249338|2017-10-10 23:58:53.249338
NCT02250352|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-04-11|||November 14, 2013|Actual|2013-11-14|April 2017|2017-04-01|November 14, 2024|Anticipated|2024-11-14|November 14, 2023|Anticipated|2023-11-14||Observational|||Core Biopsies for Establishing a Breast Tumor Tissue Repository|Core Biopsies of Breast Tumor Tissue Repository|Recruiting||N/A|1450|Anticipated|University of Southern California|||4||f||||t|f|f||||Samples With DNA|"     Tumor Tissue Blood   "|||2017-10-10 23:58:53.38538|2017-10-10 23:58:53.38538
NCT02250339|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-01-25|||December 2013||2013-12-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric Disorders|Phase 2: A Prospective Observational Study of Feasibility and Tentative Effectiveness of Multi-Systemic and Multicomponent Family-Based Intervention for Families of Children With Neuropsychiatric and/or Psychiatric Disorder(s).|Active, not recruiting||N/A|230|Anticipated|Social Insurance Institution, Finland|||3||f||||f||||||||||2017-10-10 23:58:53.483283|2017-10-10 23:58:53.483283
NCT02250326|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-07-25|||January 7, 2015|Actual|2015-01-07|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|July 17, 2017|Actual|2017-07-17||Interventional|abound2L+||Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer|A Phase 2, Open-Label, Multi-Center Study to Assess Safety and Efficacy of Second/Third-Line Treatment With NAB®-Paclitaxel (ABI-007) In Combination With Epigenetic Modifying Therapy Of CC-486, Or Immunotherapy of Durvalumab (MEDI4736), Or As Monotherapy In Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC): Abound.2L+|Active, not recruiting||Phase 2|240|Actual|Celgene||3|||f||||t||||||||||2017-10-10 23:58:53.593772|2017-10-10 23:58:53.593772
NCT02250313|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-20|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|PASCUAL||PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study|PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study|Active, not recruiting||N/A|600|Actual|MDx Health|||2||f||||f||||||Samples Without DNA|"     Archived FFPE prostate biopsy core tissue to be analyzed for this study must have been     collected from a previous, histologically confirmed cancer-negative biopsy. Patients were     considered at risk for prostate cancer due to elevated serum PSA levels, abnormal digital     rectal exam or other risk factor.      Only archived tissues will be used in this study: no new procedures to obtain new samples     from the patient will be done.   "|||2017-10-10 23:58:53.806042|2017-10-10 23:58:53.806042
NCT02250300|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-06-12|||November 2014||2014-11-01|June 2017|2017-06-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01||Interventional|||MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation|MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation|Recruiting||Phase 1/Phase 2|57|Anticipated|Medical College of Wisconsin||3|||f||||t|t|f||||||Undecided||2017-10-10 23:58:53.906215|2017-10-10 23:58:53.906215
NCT02250287|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-06-16|||December 2014||2014-12-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|MRI Pilot||New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease|Pilot and Feasibility Study: Evaluation of New Quantitative Magnetic Resonance Imaging Parameters in Assessing the Kidneys of Autosomal Dominant Polycystic Kidney Disease|Completed||N/A|20|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-10 23:58:53.996586|2017-10-10 23:58:53.996586
NCT02250274|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-08-29|2015-09-22||September 2014||2014-09-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents|Prospective Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents|Completed||Phase 4|131|Actual|Marshfield Clinic Research Foundation||2|||f||||f||||||||||2017-10-10 23:58:55.710183|2017-10-10 23:58:55.710183
NCT02250261|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-12-07|||August 2014||2014-08-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|KÄPY||Social Ecological Intervention to Promote Active Commuting to Work||Recruiting||N/A|2000|Anticipated|UKK Institute||2|||f||||f||||||||||2017-10-10 23:58:55.959248|2017-10-10 23:58:55.959248
NCT02250248|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-03-22|||December 2014|Actual|2014-12-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||AttraX® Putty vs. Autograft in XLIF®|AttraX® Putty vs. Autograft in eXtreme Lateral Interbody Fusion (XLIF®): A Prospective Randomized Single-Center Evaluation of Radiographic and Clinical Outcomes|Enrolling by invitation||N/A|70|Anticipated|NuVasive||2|||f||||f||||||||No||2017-10-10 23:58:56.037606|2017-10-10 23:58:56.037606
NCT02250235|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-23|||November 2012||2012-11-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|March 2013|Actual|2013-03-01||Interventional|||Piloting an Intervention for Improving Treatment Adherence|Piloting a Novel Behaviour Change Intervention for Improving Treatment Adherence in Haemodialysis Patients|Completed||N/A|89|Actual|University of Hertfordshire||2|||f||||t||||||||||2017-10-10 23:58:56.117586|2017-10-10 23:58:56.117586
NCT02250222|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2015-06-10|||October 2014||2014-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|L6972-02||Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus|Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LGD-6972 in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|48|Actual|Ligand Pharmaceuticals||6|||f||||t||||||||||2017-10-10 23:58:56.186381|2017-10-10 23:58:56.186381
NCT02250209|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-09-24|||July 2014||2014-07-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy|Trastuzumab Plus XELOX for HER2-positive Stage III Gastric Cancer After D2 Gastrectomy：Prospective Observational Study.|Recruiting||Phase 2|40|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-10 23:58:56.290376|2017-10-10 23:58:56.290376
NCT02250196|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-24|||March 2013||2013-03-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||A Randomized Prospective Trial Comparing Low-volume Bowel Preparation Methods|A Randomized, Prospective Tiral on Efficacy and Tolerability of Low-volume Bowel Preparation Methods for Colonoscopy|Completed||Phase 3|200|Actual|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-10 23:58:56.405375|2017-10-10 23:58:56.405375
NCT02250170|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-05-07|||October 23, 2014|Actual|2014-10-23|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor|A Phase 1, Open-label, Non-Randomized, Dose Escalation Trial to Evaluate Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor|Recruiting||Phase 1|54|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-10 23:58:56.693567|2017-10-10 23:58:56.693567
NCT02250157|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-05-17|||September 2014||2014-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies|A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies|Recruiting||Phase 1|70|Anticipated|Kinex Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-10 23:58:56.789131|2017-10-10 23:58:56.789131
NCT02250144|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-08-06|||June 2015||2015-06-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Foot Orthoses in Patellofemoral Pain Syndrome: a Prospective Randomized Study of Morpho-specific Versus Placebo Orthoses|Foot Orthoses in Patellofemoral Pain Syndrome: a Prospective Randomized Study of Morpho-specific Versus Placebo Orthoses|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:58:56.880793|2017-10-10 23:58:56.880793
NCT02250131|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-02-09|||October 2014||2014-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|GIFT||The Goal dIrected perFusion Trial in Cardiac Surgery|A Multi-center, Randomized Controlled Trial of Goal-directed Perfusion in Cardiac Surgery|Recruiting||N/A|700|Anticipated|IRCCS Policlinico S. Donato||2|||f||||f||||||||No||2017-10-10 23:58:56.984722|2017-10-10 23:58:56.984722
NCT02250118|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-05-09|||December 9, 2014|Actual|2014-12-09|May 2017|2017-05-01|December 15, 2017|Anticipated|2017-12-15|April 12, 2017|Actual|2017-04-12||Interventional|BEVAP||Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer|Phase I Study to Determine the Maximum Tolerated Dose and Evaluate the Pharmacokinetics of Intrapleural Bevacizumab After Pleural Drainage in Patients With Symptomatic Malignant Pleural Effusion in the Context of Breast Cancer|Terminated||Phase 1|1|Actual|Institut Curie||1||Insufficient Recruitment|f||||t||||||||||2017-10-10 23:58:57.101432|2017-10-10 23:58:57.101432
NCT02250105|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2016-08-05|||September 2014||2014-09-01|August 2015|2015-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia||Completed||Phase 2|80|Actual|Arisaph Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-10 23:58:57.192836|2017-10-10 23:58:57.192836
NCT02250092|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-09-29|||December 2014||2014-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Brain Stimulation and Hand Training in Children With Hemiparesis|Synergistic Effect of Combined Transcranial Direct Current Stimulation/Constraint Induced Movement Therapy in Children With Hemiparesis|Active, not recruiting||Phase 1/Phase 2|20|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-10 23:58:57.281476|2017-10-10 23:58:57.281476
NCT02250079|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-23|||June 2013||2013-06-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Polyethylene Body Bags as an Alternative to Radiant Heat Lamp During the Neonatal Adaptation in Infants Older Than 29 Weeks|Features and Differences Between Neonates Undergoing Body Bag With Polyethylene and Conventional Drying During Neonatal Adaptation in Maternal and Child Headquarters Hospital and the Victoria Hospital Engativá, Bogotá, 2013|Completed||Phase 3|100|Actual|Universidad Nacional de Colombia||2|||f||||t||||||||||2017-10-10 23:58:57.396221|2017-10-10 23:58:57.396221
NCT02250066|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-07-16|||January 2012||2012-01-01|July 2017|2017-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Prevention of Type 2 Diabetes Mellitus by Changes in Diet|Effect of Diet Therapy on Prevention of Type 2 Diabetes Mellitus Among 322 Adults Over 20 Years With Abnormal Glucose Metabolism|Completed||N/A|322|Actual|Ilam University of Medical Sciences||3|||f||||t||||||||||2017-10-10 23:58:57.493952|2017-10-10 23:58:57.493952
NCT02250053|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-08-31|||December 2015||2015-12-01|August 2016|2016-08-01||||January 2016|Actual|2016-01-01||Interventional|||Exercise and Colon Cancer|The COURAGE Trial: Colon Recurrence and Aerobic Exercise: A Feasibility Study.|Active, not recruiting||Early Phase 1|39|Actual|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-10 23:58:58.124794|2017-10-10 23:58:58.124794
NCT02250040|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-09-25|||March 2011||2011-03-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Effect of a Physiotherapy Protocol for Gait and Functional Recovery After Stroke|Development and Assessment of a New Physiotherapy Protocol for Gait Recovery After Stroke Based on Clinical and Functional Criteria|Completed||N/A|20|Actual|University of Valencia||2|||f||||f||||||||||2017-10-10 23:58:58.210322|2017-10-10 23:58:58.210322
NCT02250027|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-25|||March 2014||2014-03-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|HL301||A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on)||Completed||Phase 2|156|Actual|Hanlim Pharm. Co., Ltd.||4|||f||||f||||||||||2017-10-10 23:58:58.292657|2017-10-10 23:58:58.292657
NCT02250014|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-06-08|||October 5, 2015|Actual|2015-10-05|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer|The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer|Recruiting||Phase 1|19|Anticipated|University of Colorado, Denver||2|||f||||t||||||||No||2017-10-10 23:58:58.397729|2017-10-10 23:58:58.397729
NCT02250001|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-05-01|||September 30, 2014|Actual|2014-09-30|May 2017|2017-05-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20|48 Weeks|Observational [Patient Registry]|||Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C|Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C|Completed||N/A|2974|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-10 23:58:58.517479|2017-10-10 23:58:58.517479
NCT02249988|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-01-23|||December 2014||2014-12-01|September 2015|2015-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B|Phase IIB-III Efficacy Study of ABX203 Vaccine as an Adjunct Therapy to Nucleos(t)Ide Analogs to Maintain Control of HBV Replication After Cessation of Treatment in HBeAg Negative Patients With Chronic Hepatitis B|Completed||Phase 2/Phase 3|261|Actual|Abivax S.A.||2|||f||||t||||||||||2017-10-10 23:58:58.629285|2017-10-10 23:58:58.629285
NCT02249975|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-02-06|||January 2015||2015-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium|Efficacy of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium|Recruiting||Phase 1/Phase 2|50|Anticipated|C2 Therapeutics, Inc.||1|||f||||f||||||||No||2017-10-10 23:58:58.75406|2017-10-10 23:58:58.75406
NCT02249962|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-09-06|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|S4||Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART|Option B+: ART Safety and Durability During First and Subsequent Pregnancies|Recruiting||N/A|8600|Anticipated|University of North Carolina, Chapel Hill|||4||f||||t||||||Samples With DNA|"     Blood serum samples for:        -  HIV genotyping        -  micronutrient status        -  pharmacokinetics: efavirenz and progesterone levels for women using the contraceptive          implant only   "|||2017-10-10 23:58:58.882411|2017-10-10 23:58:58.882411
NCT02249949|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2017-09-29|||October 2014||2014-10-01|September 2017|2017-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery|A Phase II Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone in Patients With Previously Treated, Unresectable Myxoid Liposarcoma|Recruiting||Phase 2|30|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-10 23:58:59.029631|2017-10-10 23:58:59.029631
NCT02249936|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-09-25|||February 2013||2013-02-01|September 2014|2014-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations|A Phase 1, Single-Center, Randomized, 3-Way Cross-Over, Open Label Study to Evaluate the Pharmacodynamics of Different Formulations of AZD1722 in Healthy Volunteers Taking Omeprazole|Completed||Phase 1|18|Actual|Ardelyx||3|||f||||f||||||||||2017-10-10 23:58:59.773587|2017-10-10 23:58:59.773587
NCT02249923|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-12-05|||October 2014||2014-10-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01|5 Years|Observational [Patient Registry]|PPHNet||Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry|Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry|Recruiting||N/A|1000|Anticipated|University of Colorado, Denver|||1||f||||t||||||||||2017-10-10 23:58:59.890913|2017-10-10 23:58:59.890913
NCT02249910|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-03-18|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects|An Open-label, Single Arm, Sequential, Single Centre Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects|Completed||Phase 1|32|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-10 23:59:00.030087|2017-10-10 23:59:00.030087
NCT02249897|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-10-24|||January 2015||2015-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|PREL-AGES||PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs|PRELIMINARY EVALUATION OF RETINAL EFFECTS OF PHARMACOLOLOGICAL LOWERING OF SERUM LEVES OF ADVANCED GLYCATION END-PRODUCTS (AGEs) IN TYPE 2 DIABETIC PATIENTS|Recruiting||Phase 4|6|Anticipated|University of Chile||2|||f||||t||||||||||2017-10-10 23:59:00.170806|2017-10-10 23:59:00.170806
NCT02249884|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2015-11-30|||February 2014||2014-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|DRCPTR||Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis|Use of Chamomilla Recutita Gel and Urea Cream to Prevent and Treat Radiodermatitis: Phase 2 Study|Completed||Phase 2|30|Actual|University of Brasilia||6|||f||||f||||||||||2017-10-10 23:59:00.300259|2017-10-10 23:59:00.300259
NCT02249871|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-04-08|||September 2014||2014-09-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects|A Trial Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects|Completed||Phase 1|54|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-10 23:59:00.413271|2017-10-10 23:59:00.413271
NCT02249845|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-01-15|||September 2014||2014-09-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Observational|||Comparing the Diagnostic Accuracy of Clinical Dehydration Scales Among Small Children|Comparing the Diagnostic Accuracy of Clinical Dehydration Scales Among Small Children|Recruiting||N/A|108|Anticipated|Medical University of Warsaw|||1||f||||f||||||||||2017-10-10 23:59:00.600508|2017-10-10 23:59:00.600508
NCT02249832|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-07-11|||June 2013||2013-06-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||The General Use of Robots in Stroke Recovery: the Anklebot|The General Use of Robots in Stroke Recovery: the Anklebot|Recruiting||N/A|55|Anticipated|Northwell Health||1|||f||||f||||||||||2017-10-10 23:59:00.68296|2017-10-10 23:59:00.68296
NCT02249819|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-08-23|||September 2014||2014-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluating Anodal tDCS Preceding Aphasia Therapy|Evaluating Anodal tDCS Preceding Aphasia Therapy|Recruiting||Phase 1/Phase 2|24|Anticipated|Northwell Health||2|||f||||f||||||||||2017-10-10 23:59:00.761203|2017-10-10 23:59:00.761203
NCT02249806|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-05-04|||September 2014||2014-09-01|May 2017|2017-05-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01|10 Years|Observational [Patient Registry]|ZHPHCohort||Zürich Pulmonary Hypertension Outcome Assessment Cohort|Zürich Pulmonary Hypertension Outcome Assessment Cohort|Recruiting||N/A|100|Anticipated|University of Zurich|||1||f||||f||||||Samples Without DNA|"     Venous blood will be collected for serum markers and micro-RNA   "|||2017-10-10 23:59:00.845726|2017-10-10 23:59:00.845726
NCT02249793|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-05-01|||September 2014||2014-09-01|May 2017|2017-05-01||||December 2017|Anticipated|2017-12-01||Observational|||Exploratory Study of Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics|Exploratory Study in Healthy Volunteers to Define Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics|Active, not recruiting||N/A|6|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, urine, stool, and mucosal swabs from nose, mouth and rectum   "|||2017-10-10 23:59:00.937443|2017-10-10 23:59:00.937443
NCT02249780|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-04-15|||September 2014||2014-09-01|September 2014|2014-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy|The Use of Indocyanine Green Fluorescence to Assses the Vascularisation of the Parathyroid Glands During Thyroid Surgery|Completed||N/A|146|Actual|University Hospital, Geneva||2|||f||||t||||||||||2017-10-10 23:59:01.012218|2017-10-10 23:59:01.012218
NCT02249767|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-10-05|||November 2013||2013-11-01|October 2017|2017-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel|Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel|Completed||Phase 3|574|Actual|Spear Pharmaceuticals||3|||f||||t||||||||||2017-10-10 23:59:01.101849|2017-10-10 23:59:01.101849
NCT02249754|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-11-17|||September 2014||2014-09-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|NECTAc||Nutrition Education Package for Infants and Young Child Feeding and Health in Rural Tanzania|Effectiveness of a Nutrition Education Package in Improving Feeding Practices, Dietary Adequacy and Growth of Infants and Young Children in Rural Tanzania|Unknown status|Recruiting|N/A|600|Anticipated|Sokoine University of Agriculture||2|||f||||f||||||||||2017-10-10 23:59:01.167353|2017-10-10 23:59:01.167353
NCT02249741|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||August 2012||2012-08-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation|PROSPECTIVE STUDY OF PROFILE OF HEPATIC OSTEODYSTROPHY IN PATIENTS WITH NON-CHOLEASTATIC LIVER CIRRHOSIS AND IMPACT OF BISPHOSPHONATE SUPPLEMENTATION|Completed||Phase 4|47|Actual|Sir Ganga Ram Hospital||1|||f||||||||||||||2017-10-10 23:59:01.258578|2017-10-10 23:59:01.258578
NCT02249728|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-02-28|2015-11-17||June 2014||2014-06-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Absorption, Metabolism and Excretion Study of [14C]PBT2 and Absolute Bioavailability of PBT2|A Phase I , Open-Label Study to Evaluate the Absorption, Metabolism and Excretion of [14C]-PBT2 and to Estimate the Absolute Bioavailability of PBT2 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Prana Biotechnology Limited||2|||f||||f||||||||||2017-10-10 23:59:01.350105|2017-10-10 23:59:01.350105
NCT02249715|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-23|||November 2014||2014-11-01|September 2014|2014-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease|Pilot Study for Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease|Unknown status|Not yet recruiting|N/A|20|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-10 23:59:01.752091|2017-10-10 23:59:01.752091
NCT02249702|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-03-21|||April 2010||2010-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|TAUL||Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma|A Phase II Randomized - Non Comparative - Study on the Activity of Trabectedin or Gemcitabine + Docetaxel in Metastatic or Locally Relapsed Uterine Leiomyosarcoma Pretreated With Conventional Chemotherapy|Active, not recruiting||Phase 2|168|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-10 23:59:01.854013|2017-10-10 23:59:01.854013
NCT02249689|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-09-24|||January 2014||2014-01-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Three-month Clinical Evaluation of Silicone Hydrogel Definitive 65 Contact Lenses||Completed||N/A|||Contamac Ltd||2|||f||||||||||||||2017-10-10 23:59:02.030851|2017-10-10 23:59:02.030851
NCT02249312|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||July 1999||1999-07-01|September 2014|2014-09-01||||April 2000|Actual|2000-04-01||Interventional|||The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma|The Effect of BIIL 284 BS (14 Day Treatment) on Induced-sputum Variables in Patients With Bronchial Asthma (a Double-blind, Randomized, Placebo-controlled Parallel Study)|Completed||Phase 2|38|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:04.871741|2017-10-10 23:59:04.871741
NCT02249676|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-22|||January 2013||2013-01-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders|Autologous Mesenchymal Stem Cells for the Treatment of Progressive and Refractory Neuromyelitis Optica Spectrum Disorders: an Open-label Phase 2a Proof-of-concept Study|Unknown status|Recruiting|Phase 2|15|Anticipated|Tianjin Medical University General Hospital||2|||f||||t||||||||||2017-10-10 23:59:02.112219|2017-10-10 23:59:02.112219
NCT02249663|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-22|||August 2014||2014-08-01|September 2014|2014-09-01||||February 2015|Anticipated|2015-02-01||Interventional|||Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Site Study to Evaluate the Therapeutic Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray, to Dymista™ Nasal Spray|Unknown status|Recruiting|Phase 3|1535|Anticipated|Teva Pharmaceuticals USA||3|||f||||||||||||||2017-10-10 23:59:02.200288|2017-10-10 23:59:02.200288
NCT02249650|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-04-22|||May 2016||2016-05-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TSB-9-W1||To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC.|A Phase I Study to Determine the Maximum Tolerated Dose (MTD) and to Evaluate the Safety, Efficacy and Pharmacokinetics Profiles of TSB-9-W1 in Pre-treated Patients With Metastatic Colorectal Cancer (mCRC).|Not yet recruiting||Phase 1|30|Anticipated|Taiwan Sunpan Biotechnology Development Co., Ltd.||1|||f||||t||||||||Undecided||2017-10-10 23:59:02.298135|2017-10-10 23:59:02.298135
NCT02249637|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-04-05|||September 2013||2013-09-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||A Novel Technique of Circumcision Incision Orchidopexy|A Novel Technique of Circumcision Incision Orchidopexy for Palpable Low Inguinal Cryptorchidism: A Preliminary Report|Completed||N/A|14|Actual|St. Luke's Medical Center, Philippines|||2||f||||t||||||||||2017-10-10 23:59:02.400784|2017-10-10 23:59:02.400784
NCT02249624|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-01-06|||September 2014||2014-09-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors of Twin-to-Twin Transfusion Syndrome|The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors|Recruiting||N/A|60|Anticipated|St. Louis University|||1||f||||f||||||||||2017-10-10 23:59:02.48376|2017-10-10 23:59:02.48376
NCT02249611|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-10-07|||July 2014||2014-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Application of MT in Subjects With Overweight/Metabolic Abnormality---RCT|Application of Mobile Physical Activity Promotion Tool in Subjects With Overweight/Metabolic Abnormality---randomised Control Trial of Efficacy|Completed||N/A|53|Actual|National Cheng-Kung University Hospital||2|||f||||t||||||||||2017-10-10 23:59:02.586858|2017-10-10 23:59:02.586858
NCT02249598|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-09-22|||July 2013||2013-07-01|September 2014|2014-09-01||||November 2013|Actual|2013-11-01||Interventional|Lactamica 2||Competitive Carriage of Neisseria Spp(Lactamica 2)|Competitive Carriage of Neisseria Spp.; Discovering New Methods of Inhibiting Carriage of Neisseria Meningitidis (Lactamica 2)|Completed||N/A|300|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-10 23:59:02.677925|2017-10-10 23:59:02.677925
NCT02249572|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-02-29|||October 2014||2014-10-01|February 2016|2016-02-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|V-REX||Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.|Vestibular Schwannoma - Radiosurgery or Expectation|Recruiting||Phase 2/Phase 3|100|Anticipated|Haukeland University Hospital||2|||f||||t||||||||||2017-10-10 23:59:02.842156|2017-10-10 23:59:02.842156
NCT02249559|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-01-23|||July 2014||2014-07-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Observational|GKSTN||Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease|Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease|Terminated||N/A|4|Actual|New York University School of Medicine|||1||f||||t||||||||||2017-10-10 23:59:02.946775|2017-10-10 23:59:02.946775
NCT02249546|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-23|||September 2014||2014-09-01|September 2014|2014-09-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection|Comparison of the Efficacy of Triple Therapy With or Without Acetylcysteine in the First Line of Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial|Unknown status|Recruiting|Phase 4|654|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-10 23:59:03.014313|2017-10-10 23:59:03.014313
NCT02249533|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-01-31|||December 2013||2013-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|SpotLight||Evaluation of Spot Light: A Concussion Injury Management App for Youth Sports|Evaluation of Spot Light: A Concussion Injury Management App for Youth Sports|Completed||N/A|175|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-10 23:59:03.118099|2017-10-10 23:59:03.118099
NCT02249520|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-02-23|||September 2014||2014-09-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Calibration of PET-MR Imaging Protocols on Biograph mMR|Calibration of PET-MR Imaging Protocols at the Cedars-Sinai Medical Center (CSMC) Biomedical Imaging Research Institute (BIRI) Research Imaging Core|Recruiting||N/A|40|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-10 23:59:03.202277|2017-10-10 23:59:03.202277
NCT02249507|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-08-19|||September 2013||2013-09-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Aerobic Exercise in Postexercise Cardiovascular Responses in Resistant Hypertension: a Cross-over Trial|Aerobic Exercise in Postexercise Cardiovascular Responses in Resistant Hypertension: a Cross-over Randomized Controlled Trial|Completed||N/A|22|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||t||||||||||2017-10-10 23:59:03.311422|2017-10-10 23:59:03.311422
NCT02246751|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-05-10|||September 2014||2014-09-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CP_TT_UHart||Case Series_Targeted Training for Trunk Control Cerebral Palsy|Effect of Targeted Training on Sensorimotor Control of Trunk Posture|Recruiting||N/A|10|Anticipated|University of Hartford||1|||f||||f||||||||Undecided||2017-10-10 23:59:36.590032|2017-10-10 23:59:36.590032
NCT02249494|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-03-18|||October 2014||2014-10-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Mobile Application to Improve Nutritional Counseling Provided by Primary Care Physicians for Hypertension.|Nutritional Recommendations for Hypertension: Development of Mobile Application for Improve Knowledge in Lifestyle Modification for Primary Care Physicians|Completed||N/A|110|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-10 23:59:03.398153|2017-10-10 23:59:03.398153
NCT02249481|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-06-02|||April 2015||2015-04-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Comparison of Anaesthetic Methods for Total Knee Replacement Surgery|A Comparison of Continuous Adductor Canal Catheter Infusion vs Continuous Femoral Nerve Catheter Infusion for Total Knee Replacement Surgery|Recruiting||N/A|52|Anticipated|Plymouth Hospitals NHS Trust||2|||f||||f||||||||||2017-10-10 23:59:03.505133|2017-10-10 23:59:03.505133
NCT02249468|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-03-02|||October 2014|Actual|2014-10-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population|An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population|Terminated||N/A|191|Actual|PTSH Holding Singapore Pte Ltd|||2|Stop the study for futility based on recommendation from Independent Data Committee.|f||||f||||||Samples With DNA|"     Plasma samples   "|||2017-10-10 23:59:03.608551|2017-10-10 23:59:03.608551
NCT02249455|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-23|||July 2014||2014-07-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Interventional|||Effectiveness of Acapella and ELTGOL Technique to Promote Airway Clearance in COPD:a Comparative Study|Effectiveness of Acapella and ELTGOL (Expiration in Lateral Position With Open Glottis)Technique to Promote Airway Clearance in COPD Patients:a Comparative Study|Unknown status|Recruiting|N/A|30|Anticipated|PSG College of Physiotherapy||3|||f||||t||||||||||2017-10-10 23:59:03.703828|2017-10-10 23:59:03.703828
NCT02249442|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||October 2003||2003-10-01|September 2014|2014-09-01||||June 2004|Actual|2004-06-01||Interventional|||Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency|An Open-label Study to Determine the Pharmacokinetics of Single-dose and/or Steady-state TPV/r 500/200 mg in Subjects With Mild and Moderate Hepatic Insufficiency|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:03.820519|2017-10-10 23:59:03.820519
NCT02249429|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-04-19|||May 2015|Actual|2015-05-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Open-Label, Non Randomized Phase 2 Study With Safety Run-In|Open-Label, Non Randomized Phase 2 Study With Safety Run-In Evaluating Efficacy and Safety of PQR309 in Patients With Relapsed or Refractory Lymphoma|Recruiting||Phase 1/Phase 2|72|Anticipated|PIQUR Therapeutics AG||1|||f||||f|t|f||||||Undecided||2017-10-10 23:59:03.903151|2017-10-10 23:59:03.903151
NCT02249416|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-23|||November 2001||2001-11-01|September 2014|2014-09-01||||February 2002|Actual|2002-02-01||Interventional|||Comparison of the Effect of Tipranavir and Ritonavir or Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Zidovudine in Healthy Volunteers|A Single Center, Open-Label, Randomised, Parallel, Multiple Dose Comparison of the Effect of Tipranavir 500 mg and Ritonavir 100 mg or Tipranavir 750 mg and Ritonavir 200 mg Twice a Day for 11.5 Days on the Pharmacokinetic Characteristics of Zidovudine 300 mg in Healthy Volunteers|Completed||Phase 1|60|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:04.064307|2017-10-10 23:59:04.064307
NCT02249403|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||January 1999||1999-01-01|September 2014|2014-09-01||||January 2000|Actual|2000-01-01||Interventional|||Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type|Efficacy and Safety of 6, 12, 24, and 36 mg Tid po and 36 mg Bid po Talsaclidine (Free Base) for 12 Weeks in a Double-blind, Randomised, Placebo-controlled Parallel Group Comparison in Patients With Mild to Moderate Dementia of Alzheimer Type|Completed||Phase 2|362|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-10 23:59:04.157326|2017-10-10 23:59:04.157326
NCT02249390|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-08-16|||September 2014||2014-09-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|ART||Assisted Reproductive Technology Survey (ART Survey)|ART Survey: Assisted Reproductive Technology Survey|Completed||N/A|336|Actual|Pennington Biomedical Research Center|||1||f||||f||||||||||2017-10-10 23:59:04.235967|2017-10-10 23:59:04.235967
NCT02249377|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-04-26|||February 2014||2014-02-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|||PRP vs Corticosteroid in Baker's Cyst|Clinical Outcomes of Platelet Rich Plasma Injection Versus Corticosteroid Injection for Baker's Cyst|Terminated||Phase 3|50|Actual|New York University School of Medicine||2||Lack of funding|f||||f|t|f|||f|||||2017-10-10 23:59:04.303194|2017-10-10 23:59:04.303194
NCT02249364|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-10-28|||April 2014||2014-04-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Hypnose2||Hypnosis Before the Induction of Anesthesia|Interest of Hypnosis Before the Induction of Anesthesia. Study in Women Submitted to One Day Gynecological Surgical Procedures|Completed||N/A|80|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-10 23:59:04.398561|2017-10-10 23:59:04.398561
NCT02249351|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||December 1999||1999-12-01|September 2014|2014-09-01||||May 2000|Actual|2000-05-01||Interventional|||Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type|Efficacy and Safety of 48 mg Talsaclidine (Free Base) Tid po (Panel 1) and 60 mg Talsaclidine (Free Base) Tid po (Panel 2) for 12 Weeks in a Double-blind, Randomised, Placebo-controlled Within Escalating Dose Panels in 150 Patients With Mild to Moderate Dementia of Alzheimer Type|Terminated||Phase 2|54|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:04.487067|2017-10-10 23:59:04.487067
NCT02249338|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||October 1999||1999-10-01|September 2014|2014-09-01||||April 2000|Actual|2000-04-01||Interventional|||Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)|Effect of 14-Day Treatment With BIIL 284 BS on Patients With COPD (Double-Blind, Placebo-Controlled, Randomised, Parallel Group Study)|Completed||Phase 2|53|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:04.563314|2017-10-10 23:59:04.563314
NCT02249325|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-10-03|||January 2011||2011-01-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|October 2011|Actual|2011-10-01||Interventional|||Quasi Experiment of Prenatal Probiotics Against Group B Streptococcus Colonization|Effects of Probiotic Use During Pregnancy on Lactobacillus and Group B Streptococcus Vaginal Colonization: A Pilot Study|Completed||N/A|20|Actual|Marquette University||2|||f||||f||||||||||2017-10-10 23:59:04.648283|2017-10-10 23:59:04.648283
NCT02249299|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-09-23|||August 2014||2014-08-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|EMA-C||Experimental Medicine in ADHD - Cannabinoids|The Effects of Sativex on Neurocognitive and Behavioural Function in Adults With Attention-deficit/Hyperactivity Disorder; The EMA-C Study (Experimental Medicine in ADHD - Cannabinoids)|Unknown status|Recruiting|N/A|30|Anticipated|King's College London||2|||f||||f||||||||||2017-10-10 23:59:04.965012|2017-10-10 23:59:04.965012
NCT02249286|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-03-04|||January 2014||2014-01-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Integrating Nutrition Education & Household Food Production for Child Nutrition|Child-Centred Counselling and Home-Based Food Production to Improve Dietary Adequacy and Growth of Young Children in Southwest Ethiopia|Completed||N/A|404|Actual|Jimma University||2|||f||||f||||||||||2017-10-10 23:59:05.087319|2017-10-10 23:59:05.087319
NCT02249260|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-09-22|||March 2011||2011-03-01|September 2014|2014-09-01|December 2020|Anticipated|2020-12-01|August 2015|Anticipated|2015-08-01||Interventional|OsloHeartEx||A Prospective Cohort Study of Heart Patients Included in Exercise Based Rehabilitation in Oslo|Long-term Follow up of Exercise Based Cardiac Rehabilitation in Oslo|Recruiting||N/A|160|Anticipated|Oslo University Hospital||1|||f||||t||||||||||2017-10-10 23:59:05.258079|2017-10-10 23:59:05.258079
NCT02249247|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-25|||April 2001||2001-04-01|September 2014|2014-09-01||||August 2002|Actual|2002-08-01||Interventional|||Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease|Effect of 12-week Treatment of 5, 25 or 75 mg BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (Double-blind, Double Dummy, Placebo-controlled, Randomized, Parallel Group, Dose Ranging Study)|Completed||Phase 2|577|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-10 23:59:05.357775|2017-10-10 23:59:05.357775
NCT02249234|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-09-12|||August 2014||2014-08-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|ROBOT||Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain|Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain|Enrolling by invitation||Phase 2|64|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-10 23:59:05.463638|2017-10-10 23:59:05.463638
NCT02249221|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-12-04|||October 2014||2014-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)|A Randomized (Part B), Open-label (Part A) or Double-blind (Part B), Active-controlled (Part B) Phase I/IIa Study to Investigate the Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)|Completed||Phase 1/Phase 2|84|Anticipated|Green Cross Corporation||2|||f||||t||||||||||2017-10-10 23:59:05.548756|2017-10-10 23:59:05.548756
NCT02249208|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-29|||April 2014||2014-04-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|SENTINAC-01||Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.|Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide vs. Standard Technique After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer. A Randomized Controlled Trial.|Unknown status|Recruiting|Phase 3|150|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||t||||||||||2017-10-10 23:59:05.637306|2017-10-10 23:59:05.637306
NCT02249195|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||June 2014||2014-06-01|September 2014|2014-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01|2 Years|Observational [Patient Registry]|REVEAL||Sub-project: Use of Small Implantable ECG Recorder in Pregnant Women With Arrhythmia|Sub-project: Use of Small Implantable ECG Recorder in Pregnant Women With Arrhythmia|Unknown status|Recruiting|N/A|20|Anticipated|University of Cape Town|||1||f||||t||||||||||2017-10-10 23:59:05.726429|2017-10-10 23:59:05.726429
NCT02249169|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-10-26|||May 2014||2014-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome|Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome|Recruiting||N/A|240|Anticipated|Mayo Clinic|||5||f||||f||||||Samples With DNA|"     Plasma, serum, whole blood, stool, colonic mucosal tissue   "|No||2017-10-10 23:59:05.99836|2017-10-10 23:59:05.99836
NCT02249156|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-03-05|||August 2014||2014-08-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||The Effect of Financial Incentives on Utilization of Low-cost Providers|The Effect of Financial Incentives on Utilization of Low-cost Providers|Active, not recruiting||N/A|884000|Anticipated|Harvard Medical School|||2||f||||f||||||||||2017-10-10 23:59:06.086416|2017-10-10 23:59:06.086416
NCT02249143|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-22|||September 2014||2014-09-01|August 2014|2014-08-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants|Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants|Unknown status|Recruiting|N/A|60|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-10 23:59:06.167242|2017-10-10 23:59:06.167242
NCT02248805|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-02-08|||September 2014||2014-09-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma|A Phase 1, First-in-Human, Open Label, Dose Escalation Study of MGD007, A Humanized gpA33 x CD3 Dual-Affinity Re-Targeting (DART®) Protein in Patients With Relapsed/Refractory Metastatic Colorectal Carcinoma|Recruiting||Phase 1|158|Anticipated|MacroGenics||4|||f||||f||||||||||2017-10-10 23:59:11.224008|2017-10-10 23:59:11.224008
NCT02249130|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-23|||March 1999||1999-03-01|September 2014|2014-09-01||||April 2000|Actual|2000-04-01||Interventional|||Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir|Tipranavir (PNU-140690): A Fourteen Day Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients. Report on the Post-study Option, a 46-week Treatment Period of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir|Completed||Phase 2|18|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:59:06.2634|2017-10-10 23:59:06.2634
NCT02249117|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-09-23|||June 2003||2003-06-01|August 2014|2014-08-01||||August 2003|Actual|2003-08-01||Interventional|||Pharmacokinetics and Pharmacodynamics of BIWH 3 in Healthy Duffy Positive vs. Duffy Negative Male Volunteers|Pharmacokinetics and Pharmacodynamics of BIWH 3: a Randomised, Placebo-controlled, Double Blind Dose Escalation Study (0.02, 0.06, 0.2, 0.6, and 2.0 μg/kg Intravenous Over One Hour) in Healthy Duffy Positive vs. Duffy Negative Male Volunteers|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:06.373114|2017-10-10 23:59:06.373114
NCT02249104|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-04-20|2016-03-18||August 2014||2014-08-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris|Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris|Completed||Phase 4|28|Actual|Galderma Laboratories, L.P.|"Open label study with small sample size
Short duration"|1|||f||||f||||||||No||2017-10-10 23:59:06.458082|2017-10-10 23:59:06.458082
NCT02249091|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-03-01|||September 2014||2014-09-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study To Evaluate Ara-C and Idarubicin in Combination With the Selective Inhibitor Of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Relapsed Or Refractory AML|An Investigator-Initiated Study To Evaluate Ara-C and Idarubicin in Combination With the Selective Inhibitor Of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Relapsed Or Refractory AML|Active, not recruiting||Phase 2|25|Anticipated|GSO Global Clinical Research BV||1|||f||||f||||||||||2017-10-10 23:59:06.72895|2017-10-10 23:59:06.72895
NCT02249078|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2015-11-04|||December 2014||2014-12-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease|A Multicenter, Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Sequential-Cohort, Multiple-Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease|Withdrawn||Phase 1|0|Actual|Eisai Inc.||5|||f||||f||||||||||2017-10-10 23:59:06.842609|2017-10-10 23:59:06.842609
NCT02249052|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-01-06|2016-10-19||August 2014||2014-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma|A Double Blind Study to Evaluate the Safety and Efficacy of Collagenase Clostridium Histolyticum (AA4500) in the Treatment of Lipoma|Completed||Phase 2|19|Actual|Gerut, Zachary, M.D.||2|||f||||f||||||||Undecided||2017-10-10 23:59:07.04843|2017-10-10 23:59:07.04843
NCT02249039|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-05-04|||September 2015||2015-09-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravenous Clonidine for Sedation in Infants and Children Who Are Mechanically Ventilated - Dosing Finding Study|Intravenous Clonidine for Sedation in Infants and Children Who Are Mechanically Ventilated - Dosing Finding Study|Recruiting||Phase 1/Phase 2|30|Anticipated|Gauda, Estelle B., M.D.||1|||f||||t||||||||||2017-10-10 23:59:07.398382|2017-10-10 23:59:07.398382
NCT02249026|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-05-04|||October 2014||2014-10-01|May 2016|2016-05-01||||June 2016|Anticipated|2016-06-01||Interventional|||Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study|Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study|Recruiting||Phase 1/Phase 2|40|Anticipated|Gauda, Estelle B., M.D.||2|||f||||t||||||||||2017-10-10 23:59:07.497186|2017-10-10 23:59:07.497186
NCT02249013|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-08-22|||February 2015||2015-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Front-line Therapy of Epithelial Ovarian Cancers: a Therapeutic Pilot Study for the Instituto de Medicina Integral Prof. Fernando Figueira|Enrolling by invitation||Phase 2|20|Anticipated|Professor Fernando Figueira Integral Medicine Institute||1|||f||||t||||||||||2017-10-10 23:59:07.592206|2017-10-10 23:59:07.592206
NCT02249000|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-02-15|||September 2014||2014-09-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|BIOVALVE||BIOVALVE - I / II Clincial Investigation|Safety and Clinical Performance of the Self-expanding Transcatheter BIOVALVE Prosthesis in Subjects With Severe Symptomatic Aortic Stenosis Suitable for Transfemoral Transcatheter Aortic Valve Implantation|Recruiting||N/A|86|Anticipated|Biotronik AG||1|||f||||t||||||||No||2017-10-10 23:59:07.710414|2017-10-10 23:59:07.710414
NCT02248987|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||May 2014||2014-05-01|September 2014|2014-09-01||||October 2014|Anticipated|2014-10-01||Observational|||Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia||Unknown status|Recruiting|N/A|36|Anticipated|Seoul National University Hospital|||3||f||||||||||||||2017-10-10 23:59:07.878454|2017-10-10 23:59:07.878454
NCT02245087|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01||||December 2023|Anticipated|2023-12-01||Interventional|ECAD||Eliminate Coronary Artery Disease|Eliminate Coronary Artery Disease|Recruiting||Phase 2|10000|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-10 23:59:57.72159|2017-10-10 23:59:57.72159
NCT02248961|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-02-09|||May 2014||2014-05-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension|Open-label, Randomized, Multicenter, Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan), Manufactured by Boryung Pharmaceutical Co., Ltd, Republic of Korea, Tablets 60/120 mg and Cozaar® (Losartan), Manufactured by MERCK SHARP & DOHME B.V., Netherlands, Tablet 50/100 mg in Adult Patients With Grade I-II Arterial Hypertension|Completed||Phase 3|179|Actual|R-Pharm||2|||f||||f||||||||||2017-10-10 23:59:08.071604|2017-10-10 23:59:08.071604
NCT02248948|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-08-05|||September 2014||2014-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|ECOMEGA||Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children|Multicenter Randomized Controlled Trial for the Evaluation of Superiority of a Supplement With Omega-3 Fatty Acids Versus Placebo for the Improvement of Attention Deficit and Hyperactivity Disorder (ADHD) in Children|Completed||Phase 4|231|Actual|Laboratorios Ordesa||2|||f||||t||||||||||2017-10-10 23:59:08.170521|2017-10-10 23:59:08.170521
NCT02248935|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-06-08|||July 2014||2014-07-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Comparison of 2 Lightweight Y-meshes After Laparoscopic Sacrocolpopexy|Prospective Cohort Study Comparing Two Lightweight Y Meshes After Robotic-Assisted Laparoscopic Sacrocolpopexy Longterm Outcomes|Completed||N/A|316|Actual|Atlantic Health System|||1||f||||f||||||||||2017-10-10 23:59:08.260522|2017-10-10 23:59:08.260522
NCT02248909|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-03-31|||November 2014||2014-11-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|SUPPORT||Non-interventional Study of Spirometry Use to Diagnose COPD (Chronic Obstructive Pulmonary Disease) and to Prescribe Treatment to COPD Patients in the Outpatient Institutions|Non-interventional Multicenter Study of Spirometry Use to Diagnose COPD and to Prescribe Treatment to COPD Patients in the Outpatient Institutions of the healthcaRe System of the Russian FederaTion|Completed||N/A|4232|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-10 23:59:08.410757|2017-10-10 23:59:08.410757
NCT02248896|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-09-24|||January 2010||2010-01-01|September 2014|2014-09-01||||March 2011|Actual|2011-03-01||Observational|||Antihypertensive Medications and the Risk of Sepsis|Antihypertensive Medications and the Risk of Sepsis|Completed||N/A|1129062|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:08.64146|2017-10-10 23:59:08.64146
NCT02248883|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-24|2014-09-24|||December 2005||2005-12-01|September 2014|2014-09-01||||March 2006|Actual|2006-03-01||Interventional|||Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects|Assessment of Electrophysiological Effects of Tipranavir Co-administered With Ritonavir Given b.i.d. for 2.5 Days on the QT Interval in Healthy Female and Male Subjects. A Double-blind, Randomised, Placebo Controlled, Two-way Crossover Study With a Positive Control (Moxifloxacin) and Parallel Dose Groups|Completed||Phase 1|81|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:59:08.733068|2017-10-10 23:59:08.733068
NCT02248870|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-09-11|||March 2015||2015-03-01|March 2015|2015-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Femoral Nerve Block With Bupivacaine and Adjuvant Dexamethasone in Patients With Hip Fracture|Analgesic Duration af a Preoperative Single-shot Femoral Nerve Block With Bupivacaine and Adjuvant Dexamethasone in Patients With Hip Fracture|Terminated||Phase 4|7|Actual|University of Aarhus||2||Less inclusions than expected with the given criteria|f||||t||||||||||2017-10-10 23:59:08.840127|2017-10-10 23:59:08.840127
NCT02248857|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-09-12|||December 2014||2014-12-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Promoting the Universal Medication Schedule Via Mobile and EHR Technologies|Promoting the Universal Medication Schedule Via Mobile and EHR Technologies: A Physician-randomized Control Trial|Completed||N/A|452|Actual|Northwestern University||3|||f||||f||||||||||2017-10-10 23:59:08.969577|2017-10-10 23:59:08.969577
NCT02248844|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-10-12|||September 2014||2014-09-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea||Recruiting||Phase 4|600|Anticipated|Allergan|||1||f||||f||||||||||2017-10-10 23:59:09.068211|2017-10-10 23:59:09.068211
NCT02248831|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-03-19|||September 2014||2014-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Cardiopulmonary Diseases by Ultrasound|Non-invasive Evaluation of Cardiopulmonary Diseases Using Transthoracic Parametric Doppler Based Assessment of Lung Doppler Signals|Recruiting||N/A|600|Anticipated|Echosense Ltd.||1|||f||||f||||||||||2017-10-10 23:59:09.169505|2017-10-10 23:59:09.169505
NCT02248818|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-03-09|2016-08-17||November 2014||2014-11-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|AZD8108||AZD8108 SAD/MAD in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of AZD8108 in Healthy Volunteers|Completed||Phase 1|258|Actual|AstraZeneca|Conversion of AZD8108 to active moiety AZD6567 was rapid, concentrations of AZD8108 were almost all below the level of quantification, no PK parameters were calculable for AZD8108 concentrations.|2|||f||||t||||||||||2017-10-10 23:59:09.31208|2017-10-10 23:59:09.31208
NCT02248610|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-09-03|||November 2014||2014-11-01|August 2015|2015-08-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01|5 Years|Observational [Patient Registry]|FIRST||Follow-up in Rivaroxaban Patients in Setting of Thromboembolism|Follow-up in Rivaroxaban Patients in Setting of Thromboembolism|Recruiting||N/A|1500|Anticipated|King's College Hospital NHS Trust|||1||f||||t||||||||||2017-10-10 23:59:15.139646|2017-10-10 23:59:15.139646
NCT02248792|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||November 2013||2013-11-01|September 2014|2014-09-01||||January 2015|Anticipated|2015-01-01||Interventional|||Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study.|Improvement in the Quality of Life of Patients With Severe Plaque Psoriasis Treated With Systemic Methotrexate in Fixed Doses of 10mg or 25mg Orally Once Weekly: a Prospective, Randomized, Double-blind, Parallel Group Study.|Unknown status|Recruiting|Phase 4|50|Anticipated|Narayana Medical College & Hospital||2|||f||||f||||||||||2017-10-10 23:59:11.352697|2017-10-10 23:59:11.352697
NCT02248779|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-10-03|||September 2014||2014-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation|Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation: A Pilot Study|Active, not recruiting||N/A|42|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples Without DNA|"     Blood   "|||2017-10-10 23:59:11.431368|2017-10-10 23:59:11.431368
NCT02248766|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-05-25|2016-02-23||September 2014||2014-09-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||This study had a total of 30 participants. The 30 participants were evaluated with the habitual lenses (enfilcon A) and then evaluated with the (somofilcon A) lenses.|Clinical Performance of Habitual Wearers of Avaira Toric When Refitted With Clariti Toric Lenses|Clinical Performance of Habitual Wearers of Avaira Toric (Enfilcon A) When Refitted With Clariti Toric (Somofilcon A) Lenses for 1 Month.|Completed||N/A|30|Actual|Coopervision, Inc.||1|||f||||f||||||||||2017-10-10 23:59:11.502964|2017-10-10 23:59:11.502964
NCT02248753|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-08-14|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|ACWAS||Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department|Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department (ACWAS-trial)|Recruiting||N/A|437|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:59:11.791701|2017-10-10 23:59:11.791701
NCT02248740|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-12-06|||September 2008||2008-09-01|December 2016|2016-12-01|September 2028|Anticipated|2028-09-01|September 2028|Anticipated|2028-09-01||Interventional|||Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein|Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein: A Prospective Randomized Trial|Recruiting||Phase 4|125|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-10 23:59:11.964824|2017-10-10 23:59:11.964824
NCT02248727|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2016-04-15|2016-02-23||September 2014||2014-09-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Clinical Performance of Existing Wearers of Avaira Sphere Following a Refit With Clariti Elite Sphere|Clinical Performance of Existing Wearers of Avaira Sphere (Enfilcon A) Following a Refit With Clariti Elite Sphere (Somofilcon A) Lenses for 4 Weeks|Completed||N/A|30|Actual|Coopervision, Inc.||1|||f||||f||||||||||2017-10-10 23:59:12.075125|2017-10-10 23:59:12.075125
NCT02248714|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2014-09-23|||March 2014||2014-03-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|March 2015|Anticipated|2015-03-01||Interventional|||The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 Diabetes|A 4-week, Single-center, Randomized, Open-label, Parallel Group Study to Evaluate the Efficacy of Glucerna SR Using Continuous Glucose Monitoring System(CGMS) in Chinese Drug-naïve Subjects With Type 2 Diabetes|Unknown status|Recruiting|Phase 4|40|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||2|||f||||t||||||||||2017-10-10 23:59:12.348852|2017-10-10 23:59:12.348852
NCT02248701|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-07-07|||January 16, 2017|Actual|2017-01-16|July 2017|2017-07-01|June 1, 2019|Anticipated|2019-06-01|May 31, 2019|Anticipated|2019-05-31||Interventional|||Testosterone Plus Finasteride Treatment After Spinal Cord Injury|Higher-Than-Replacement Testosterone Plus Finasteride Treatment After SCI|Recruiting||Phase 2|30|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-10 23:59:12.43691|2017-10-10 23:59:12.43691
NCT02248688|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-02-15|||September 2014||2014-09-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|GETLEAN||Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically|Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically (GET LEAN)|Active, not recruiting||N/A|5|Actual|Dayton Interventional Radiology||1|||f||||t||||||||||2017-10-10 23:59:12.564311|2017-10-10 23:59:12.564311
NCT02248675|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-03-17|2017-01-24||February 2015||2015-02-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for Sleep Intervention (SI)|An Adjunctive Behavioral Sleep Intervention to Prevent Veteran Suicides|Completed||N/A|54|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-10 23:59:14.361909|2017-10-10 23:59:14.361909
NCT02248649|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-05-24|||December 1, 2014|Actual|2014-12-01|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|May 15, 2018|Anticipated|2018-05-15||Interventional|||Telemedicine Intervention to Improve Cognitive Function|A Telemedicine Intervention to Improve Cognitive Function in Patients With PD|Active, not recruiting||N/A|128|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||Undecided||2017-10-10 23:59:14.833919|2017-10-10 23:59:14.833919
NCT02248636|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-07-12|||January 22, 2015|Actual|2015-01-22|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|May 1, 2019|Anticipated|2019-05-01||Interventional|CID||Cholinesterase Inhibitor Discontinuation|Cholinesterase Inhibitor Discontinuation|Recruiting||Phase 2/Phase 3|100|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||t|||||2017-10-10 23:59:14.90947|2017-10-10 23:59:14.90947
NCT02248623|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-04-04|||March 2015||2015-03-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|ConsCIOUS||Intraoperative Anaesthesia Awareness Following Induction of Anaesthesia|An International Multi-Centre Cohort Study of the Incidence of Anaesthesia Awareness Following Laryngoscopy and Intubation: The CONSciousness, Connectedness and IntraOperative Unresponsiveness Study (ConsCIOUS)|Completed||N/A|260|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-10-10 23:59:15.03459|2017-10-10 23:59:15.03459
NCT01957358|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-05-29|||October 2013||2013-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Resolving Grief After Spinal Cord Injury|Resolving Grief and Moving On After Spinal Cord Injury|Recruiting||N/A|8|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-10-11 01:13:57.651114|2017-10-11 01:13:57.651114
NCT02248597|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-23|2017-05-25|||January 2015||2015-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases|Haploidentical Stem Cell Transplant Using Post Transplant Cyclophosphamide for GvHD Prophylaxis: A Pilot Study|Recruiting||Phase 2|24|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-10 23:59:15.296411|2017-10-10 23:59:15.296411
NCT02248584|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-24|||January 2011||2011-01-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||VITAMIN E, C and ZINC IN PATIENTS WITH SKIN CANCER: INFLUENCE ON OXIDATIVE STRESS AND INFLAMMATORY STATE|SUPPLEMENTATION OF VITAMIN E, C and ZINC IN PATIENTS WITH NON-MELANOMA SKIN CANCER: INFLUENCE ON OXIDATIVE STRESS AND INFLAMMATORY STATE|Completed||N/A|60|Actual|University of Campinas, Brazil||2|||f||||||||||||||2017-10-10 23:59:15.664707|2017-10-10 23:59:15.664707
NCT02248571|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-08-22|||August 2014||2014-08-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|IMPROVE||Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab|An Open Label, randomIzed Controlled Prospective Multicenter Two Arm Phase IV Trial to Determine Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab for Advanced (Inoperable or Metastatic) HER2-negative Hormone Receptor Positive Breast Cancer|Active, not recruiting||Phase 4|77|Actual|iOMEDICO AG||2|||f||||f||||||||||2017-10-10 23:59:15.740363|2017-10-10 23:59:15.740363
NCT02248558|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-12-20|2016-10-26||September 2014||2014-09-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Spurring Innovation to Promote HIV Testing: An RCT Evaluating Crowdsourcing|Crowdsourcing Versus Conventional HIV Testing Promotion: A Noninferiority Randomized Controlled Trial to Evaluate Promoting First-Time HIV Testing Among MSM and Transgender Individuals in China|Completed||N/A|721|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-10 23:59:15.86907|2017-10-10 23:59:15.86907
NCT02248545|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2014-09-24|||July 2011||2011-07-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|July 2013|Actual|2013-07-01||Observational|||Autoimmune Diseases And Serum Anti-Nuclear Antibodies Positivity In Non-Celiac Wheat Sensitivity Patients|Autoimmune Diseases And Serum Anti-Nuclear Antibodies Positivity In Non-Celiac Wheat Sensitivity Patients|Completed||N/A|90|Actual|University of Palermo|||3||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-10 23:59:16.393831|2017-10-10 23:59:16.393831
NCT02248532|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-05-02|||January 2014||2014-01-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|REMEDIUM||Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy (REMEDIUM)|Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy|Recruiting||Phase 2/Phase 3|80|Anticipated|University Medical Centre Ljubljana||2|||f||||t||||||||||2017-10-10 23:59:16.481794|2017-10-10 23:59:16.481794
NCT02248519|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|January 2023|Anticipated|2023-01-01|January 2018|Anticipated|2018-01-01||Interventional|LOGICA||Laparoscopic Versus Open Gastrectomy for Gastric Cancer|Laparoscopic Versus Open Gastrectomy for Gastric Cancer, a Multicenter Prospectively Randomized Controlled Trial (LOGICA-trial)|Recruiting||N/A|210|Anticipated|UMC Utrecht||2|||f||||t||||||||Undecided||2017-10-10 23:59:16.597173|2017-10-10 23:59:16.597173
NCT02248506|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-03-24|||June 2013||2013-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis|Epidemiological Study About the Clinical and Microbiological Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis.|Completed||Phase 4|56|Actual|Instituto Palacios||1|||f||||t||||||||||2017-10-10 23:59:16.748528|2017-10-10 23:59:16.748528
NCT02248493|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-03-03|||November 2012||2012-11-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|IVPARACET||Intravenous Paracetamol for Postoperative Pain|The Effect of Intravenous Paracetamol in Combination With NSAIDs for Postoperative Pain in Children|Completed||Phase 4|54|Actual|Lithuanian University of Health Sciences||2|||f||||f||||||||||2017-10-10 23:59:16.825771|2017-10-10 23:59:16.825771
NCT02248480|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-11-22|2016-06-15||October 2014||2014-10-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Al randomized participants who received at least 1 dose of study drug and had 1 post-dose efficacy assessment.|A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan|Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan|Completed||Phase 3|354|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-10 23:59:16.957767|2017-10-10 23:59:16.957767
NCT02248467|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-02-05|||May 2013||2013-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients|Study of the Effect of Testosterone Replacement Therapy on Metabolic Parameters, Prostatic Inflammation Symptoms and Lower Urinary Tract Symptoms (LUTS) in Hypogonadal Obese Subjects Eligible for Bariatric Surgery.|Recruiting||N/A|100|Anticipated|University of Florence|||3||f||||f||||||||||2017-10-10 23:59:18.156385|2017-10-10 23:59:18.156385
NCT02248454|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-04-25|||September 2014||2014-09-01|April 2017|2017-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Insulin Bolus Required for High Fat Foods in Type 1 Diabetes|Evaluation of Insulin Bolus for High Fat Meals|Completed||N/A|10|Actual|Joslin Diabetes Center||1|||f||||f|f|f||||||No||2017-10-10 23:59:18.263466|2017-10-10 23:59:18.263466
NCT02248441|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-08-23|||September 2014||2014-09-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|CONDI-HF||Effect of Remote Ischemic Conditioning in Patients With Chronic Ischemic Heart Failure|Effect of Remote Ischemic Conditioning in Patients With Chronic Ischemic Heart Failure (CONDI-HF)|Completed||N/A|47|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-10 23:59:18.349701|2017-10-10 23:59:18.349701
NCT01935453|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-08-31|||May 2012||2012-05-01|December 2011|2011-12-01||||May 2014|Actual|2014-05-01||Interventional|||A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer|A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus|Completed||Phase 1|18|Actual|OrienGene Biotechnology Ltd.||1|||f||||f||||||||||2017-10-11 01:20:15.044593|2017-10-11 01:20:15.044593
NCT02248428|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-09-04|||April 2012||2012-04-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|CTd||Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma|Clarithromycin Plus CTd (Cyclophosphamide,Thalidomide and Dexamethasone)Regimen for Patients With Newly Diagnosed Multiple Myeloma:a Phase 3 , Multicenter,Randomized, Open-Label Trial.|Recruiting||Phase 3|130|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-10 23:59:18.45174|2017-10-10 23:59:18.45174
NCT02248415|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-09-25|||September 2012||2012-09-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Administration of Warm Blood Cardioplegia With or Without Roller Pump|Administration of Warm Blood Cardioplegia With or Without Roller Pump; a Randomized Controlled Trial.|Completed||N/A|68|Actual|St. Antonius Hospital||2|||f||||t||||||||||2017-10-10 23:59:18.598704|2017-10-10 23:59:18.598704
NCT02248402|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-24|||October 2013||2013-10-01|September 2014|2014-09-01||||October 2015|Anticipated|2015-10-01||Interventional|Vax-DC/MM||Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma|A Phase 1/2a Study to Evaluate Safety and Efficacy of Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Chonnam National University Hospital||1|||f||||t||||||||||2017-10-10 23:59:18.720016|2017-10-10 23:59:18.720016
NCT02248389|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-05-25|||September 2014||2014-09-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|HIFU-KIDNEY||Evaluation of a Laparoscopic High Intensity Focused Ultrasound Probe for the Ablation of Small Renal Masses|Evaluation of a Laparoscopic High Intensity Focused Ultrasound Probe for the Ablation of Small Renal Masses|Recruiting||Phase 1|10|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-10 23:59:18.809362|2017-10-10 23:59:18.809362
NCT02248376|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-03-24|||November 2014||2014-11-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|July 2016|Actual|2016-07-01||Interventional|HYFACO||Hyaluronic Acid and Uterine Synechiae|Non-stick Gel Applicated After Scraping Surgery for Natural Miscarriage and Uterine Synechiae Prevention|Active, not recruiting||Phase 3|364|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-10 23:59:18.918776|2017-10-10 23:59:18.918776
NCT02248363|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-21|2017-08-09|||September 2014||2014-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01|12 Months|Observational [Patient Registry]|||Nationwide Evaluation of Multimodal Rehabilitation in Patients With Chronic Musculoskeletal Pain|Nationwide Evaluation of Multimodal Rehabilitation in Patients With Chronic Musculoskeletal Pain: Treatment Effectiveness and Prediction|Active, not recruiting||N/A|6500|Anticipated|Karolinska Institutet|||1||f||||f||||||||||2017-10-10 23:59:19.015857|2017-10-10 23:59:19.015857
NCT02248350|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-10-20|||September 2014||2014-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|MIGHTY||An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation Therapy|An Exercise Intervention to Mitigate Side-Effects Related to Androgen Deprivation Therapy Among Prostate Cancer Survivors.|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Georgetown University||2|||f||||t||||||||||2017-10-10 23:59:19.094513|2017-10-10 23:59:19.094513
NCT02248337|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2014-09-23|||March 2013||2013-03-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Low Volume Colon Preparation for IBD|Colon Cleasing for Colonoscopy in Patients With IBD Colitis: Efficacy and Acceptability of 4 Liter PEG vs 2 Liter PEG Plus Bisacodil|Completed||Phase 4|216|Actual|Luigi Sacco University Hospital||2|||f||||f||||||||||2017-10-10 23:59:19.193658|2017-10-10 23:59:19.193658
NCT02248324|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2016-08-29|||November 2012||2012-11-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|December 2016|Anticipated|2016-12-01||Observational|AMD-SNP||Association of Previously Verified Gene Polymorphisms With AMD in Turkish Population|A Multicenter Study on the Investigation of Previously Verified Leading Gene Polymorphisms Related to Age-related Macular Degeneration in Turkish Population|Recruiting||N/A|5000|Anticipated|Kocatepe University|||1||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-10 23:59:19.283085|2017-10-10 23:59:19.283085
NCT02248311|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-07-19|||September 2014||2014-09-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|September 2017|Anticipated|2017-09-01||Observational|PRECISED||"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population"|"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population: a Multidisciplinary Clinical and Experimental Approach (PRECISED)"|Active, not recruiting||N/A|260|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||2||f||||f||||||Samples Without DNA|"     Patients: 200 Control group: 60   "|||2017-10-10 23:59:19.387186|2017-10-10 23:59:19.387186
NCT02248298|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2014-09-20|||January 2012||2012-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis|Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy With Short Incubation Time for the Treatment of Facial and Scalp Actinic Keratosis: 12-month Follow-up Results of a Randomized, Prospective, Comparative Trial|Completed||Phase 1|93|Actual|Dong-A University||3|||f||||f||||||||||2017-10-10 23:59:19.480351|2017-10-10 23:59:19.480351
NCT02248285|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-12-19|||April 2015||2015-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|IMPACT||Implementation of a Molecular Diagnostic for Pediatric Acute Gastroenteritis: The FilmArray GI Panel IMPACT Study|Implementation of a Molecular Diagnostic for Pediatric Acute Gastroenteritis: The FilmArray GI Panel IMPACT Study|Completed||N/A|1536|Actual|BioFire Diagnostics, LLC||2|||f||||f||||||||||2017-10-10 23:59:19.570349|2017-10-10 23:59:19.570349
NCT02248272|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-10-02|||October 2011||2011-10-01|October 2017|2017-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes|The Effects of Meal Frequency on Glucose, Insulin, and Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS), People at High Risk for Developing Type 2 Diabetes and People With Type 2 Diabetes|Completed||N/A|110|Actual|Harokopio University||3|||f||||f||||||||||2017-10-10 23:59:19.657889|2017-10-10 23:59:19.657889
NCT02248259|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2015-01-22|||October 2014||2014-10-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Drug Drug Interaction Trial With Strong CYP3A4 Inhibitor (Itraconazole) in CYP2C19 Extensive Metabolizers and Poor Metabolizers|Open-label, Randomised, Two-way Crossover Study to Assess the Effect of Once Daily Itraconazole on the Pharmacokinetics of BI 409306 After a Single Oral Dose in Healthy Male Volunteers Genotyped as Poor and Extensive Metabolizers of CYP2C19|Completed||Phase 1|25|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:19.738445|2017-10-10 23:59:19.738445
NCT02248246|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-06-16|2016-03-02||August 2014||2014-08-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional||Safety Set - all subjects in whom the procedure was started.|Harmonic ACE®+7 Shears in Laparoscopic Colectomy|Prospective, Multicenter, Observational Study Evaluating Vessel Sealing Utilizing the Harmonic ACE®+7 Shears During Laparoscopic Colectomy|Completed||Phase 4|40|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-10-10 23:59:19.822593|2017-10-10 23:59:19.822593
NCT02248233|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-10-14|||October 2014||2014-10-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Nimodipine for Treating Acute Massive Cerebral Infarction|Nimodipine for Treating Acute Massive Cerebral Infarction: a Randomized, Double-blind, Controlled Clinical Study|Unknown status|Recruiting|Phase 4|72|Anticipated|Fengtian Hospital||2|||f||||f||||||||||2017-10-10 23:59:20.059749|2017-10-10 23:59:20.059749
NCT02248220|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||October 1998||1998-10-01|September 2014|2014-09-01||||October 1999|Actual|1999-10-01||Observational|||Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease|Observation of the Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease|Completed||N/A|657|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:20.164738|2017-10-10 23:59:20.164738
NCT02248207|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||January 2003||2003-01-01|September 2014|2014-09-01||||November 2003|Actual|2003-11-01||Observational|||Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease|Management of Parkinson's Disease Patients at Their First Visits in a Neurological Practice|Completed||N/A|1293|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:20.338878|2017-10-10 23:59:20.338878
NCT02248194|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-12-30|||April 2010||2010-04-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TEA||Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding|Tactile Versus Hysteroscopic Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding|Completed||Phase 2|108|Actual|Assiut University||2|||f||||t||||||||||2017-10-10 23:59:20.5079|2017-10-10 23:59:20.5079
NCT02248181|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||February 2004||2004-02-01|September 2014|2014-09-01||||December 2005|Actual|2005-12-01||Observational|||Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease|Post Marketing Surveillance Study of Sifrol® - Monotherapy in Patients With Idiopathic Parkinson's Disease|Completed||N/A|442|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:20.605833|2017-10-10 23:59:20.605833
NCT02248168|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||March 2002||2002-03-01|September 2014|2014-09-01||||January 2007|Actual|2007-01-01||Observational|||Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease|Mirapex PMS Study Final Report|Completed||N/A|1449|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:20.69599|2017-10-10 23:59:20.69599
NCT02248155|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||April 2006||2006-04-01|September 2014|2014-09-01||||November 2006|Actual|2006-11-01||Observational|||Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)|Sifrol® Onset of Action and Impact on RLS: A 12-week Observational Study in Patients With Primary RLS|Completed||N/A|2644|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:20.788307|2017-10-10 23:59:20.788307
NCT02248142|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||February 2006||2006-02-01|September 2014|2014-09-01||||January 2007|Actual|2007-01-01||Observational|||Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)|Sifrol® (Pramipexole) Impact on RLS: A 12-weeks Observational Study in Patients With Primary RLS|Completed||N/A|1029|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:20.862413|2017-10-10 23:59:20.862413
NCT02248129|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||April 2006||2006-04-01|September 2014|2014-09-01||||December 2006|Actual|2006-12-01||Observational|||Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide|Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated in General Practice With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide, the Level of Blood Pressure Control and the Modalities of Arterial Hypertension Management|Completed||N/A|4255|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:20.936525|2017-10-10 23:59:20.936525
NCT02248116|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2014-09-22|||May 1999||1999-05-01|September 2014|2014-09-01||||September 2000|Actual|2000-09-01||Interventional|||Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type|An Open-label Multicentre, Follow-up Trial to Assess the Long-term Safety and Tolerability of Oral Administration of Talsaclidine 24 mg Tid in Patients With Mild to Moderate Dementia of the Alzheimer Type|Terminated||Phase 2/Phase 3|198|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:59:20.996932|2017-10-10 23:59:20.996932
NCT02248103|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2017-04-21|2015-08-10||March 2013||2013-03-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Comparison of Autogenous Periosteal Pedicle Graft and Collagen Membrane in Management of Periodontal Intrabony Defects|Comparison of Autogenous Periosteal Pedicle Graft and Collagen Membrane in Management of Periodontal Intrabony Defects: A Randomized Controlled Clinical Trial.|Completed||N/A|20|Actual|Cairo University||2|||f||||f||||||||||2017-10-10 23:59:21.072799|2017-10-10 23:59:21.072799
NCT02248090|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-08-24|||October 22, 2014|Actual|2014-10-22|August 2017|2017-08-01|March 21, 2018|Anticipated|2018-03-21|January 31, 2017|Actual|2017-01-31||Interventional|||AZD9496 First Time in Patients Ascending Dose Study|Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD9496 in Women With Estrogen Receptor Positive HER-2 Negative Advanced Breast Cancer|Active, not recruiting||Phase 1|45|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-10 23:59:21.431385|2017-10-10 23:59:21.431385
NCT02248077|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-10-19|||October 2014||2014-10-01|October 2016|2016-10-01||||October 2016|Anticipated|2016-10-01||Interventional|||A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers|A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers|Withdrawn||Phase 4|0|Actual|Cytomedix||2||Study was redesigned in collaboration with CMS before it started.|f||||f||||||||||2017-10-10 23:59:21.563743|2017-10-10 23:59:21.563743
NCT02248064|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-02-15|||July 2014||2014-07-01|September 2014|2014-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ASI1||Auto-titrating Oxygen in Chronic Respiratory Failure|The Assessment of Intelligent Oxygen Therapy (iO2t) in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF)|Completed||N/A|26|Actual|Imperial College London||2|||f||||f||||||||No||2017-10-10 23:59:21.654933|2017-10-10 23:59:21.654933
NCT02248051|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2016-05-02|||September 2014||2014-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury|An Open-Label, Non-Randomized Study of Safety, Tolerability and Pharmacokinetics of Intravenous CXA-10 Emulsion in Subjects With Stage 3 and 4 Chronic Kidney Injury|Completed||Phase 1|12|Actual|Complexa, Inc.||1|||f||||f||||||||No||2017-10-10 23:59:21.766977|2017-10-10 23:59:21.766977
NCT02248038|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-23|||June 2014||2014-06-01|September 2014|2014-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Multicenter Clinical Trial on Laparoscopic Colorectal Cancer Surgery Compared With Open Surgery|A Multicenter Randomized Clinical Trial on Laparoscopic Colorectal Cancer Surgery Compared With Open Surgery in China|Active, not recruiting||Phase 3|1300|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-10 23:59:21.852312|2017-10-10 23:59:21.852312
NCT02248025|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2017-05-04|||September 2014||2014-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Can Capillary Refill Time Variation During Passive Leg Raising Predict Fluid Responsiveness|Can Capillary Refill Time Variation Induced by Passive Leg Raising Predict Capillary Refill Time Variation After a Fluid Load in Patients With Circulatory Failure.|Completed||N/A|34|Actual|Hopital Louis Pradel|||1||f||||f||||||||||2017-10-10 23:59:21.950044|2017-10-10 23:59:21.950044
NCT02248012|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-08-16|||December 2014||2014-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)|Everolimus and Temozolomide as 1-line Treatment in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3) With a Ki67 of 20-55%|Recruiting||Phase 2|40|Anticipated|Haukeland University Hospital||1|||f||||t||||||||||2017-10-10 23:59:22.026489|2017-10-10 23:59:22.026489
NCT02247999|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2017-06-30|||November 28, 2012||2012-11-28|April 19, 2017|2017-04-19|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Improving Cervical Cancer Screening Among HIV-Infected Women in India|Improving Cervical Cancer Prevention Among HIV-Infected Women Using Novel HPV Based Biomarker Assays|Active, not recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-10 23:59:22.134982|2017-10-10 23:59:22.134982
NCT02247986|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2017-06-30|||September 4, 2014||2014-09-04|May 18, 2015|2015-05-18|May 18, 2015|Actual|2015-05-18|May 18, 2015|Actual|2015-05-18||Interventional|||Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder|Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder|Withdrawn||Phase 1/Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-10 23:59:22.210912|2017-10-10 23:59:22.210912
NCT02247973|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-19|||February 2013||2013-02-01|September 2014|2014-09-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.|PhaseⅡTrial of Co-transplantation With Bone Marrow Derived Mesenchymal Stem Cells From Related Donors in Alternative Donor Transplantation of Severe Aplastic Anemia.|Enrolling by invitation||Phase 2|100|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||1|||f||||t||||||||||2017-10-10 23:59:22.305397|2017-10-10 23:59:22.305397
NCT02247960|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-03-17|2017-01-25||July 2014||2014-07-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|Abx|Baseline characteristics were only collected on patients who had their catheter removed (ie. started period 2).|Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy|Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy|Terminated||N/A|175|Actual|University of Rochester||2||Interim analysis determined that the study should be concluded for futility.|f||||t||||||||||2017-10-10 23:59:22.431008|2017-10-10 23:59:22.431008
NCT02247947|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2016-01-25|||September 2014||2014-09-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome|Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome|Recruiting||N/A|80|Anticipated|Universitätsklinikum Köln|||2||f||||f||||||Samples Without DNA|"     Serum and urine   "|||2017-10-10 23:59:22.770498|2017-10-10 23:59:22.770498
NCT02247934|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-02-08|||October 2014||2014-10-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)|Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)|Completed||N/A|26|Actual|Gilead Sciences|||2||f||||f||||||||||2017-10-10 23:59:22.8657|2017-10-10 23:59:22.8657
NCT02247921|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2016-02-15|||August 2014||2014-08-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RECOVER||Rehabilitation for Disabled Stroke Patients in Rural China|A Randomized Controlled Trial on Rehabilitation Through Caregiver-delivered Nurse-organized Service Programs for Disabled Stroke Patients in Rural China|Recruiting||N/A|320|Anticipated|The George Institute for Global Health, China||2|||f||||t||||||||||2017-10-10 23:59:22.969479|2017-10-10 23:59:22.969479
NCT02247908|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-09-12|||October 2014||2014-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Impact of Graphic Cigarette Warnings|A Randomized Controlled Trial Evaluating the Impact of Graphic Cigarette Warnings on Smoking Behavior|Completed||N/A|2149|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||No|No patient level data will be shared with the general public or other researchers.|2017-10-10 23:59:23.090608|2017-10-10 23:59:23.090608
NCT02247895|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-04-25|||December 2016||2016-12-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Muscle Weakness in Critically Ill Patients|Effect of Treatment With the Niveus Medical Muscle Stimulation System 110 on Quadriceps Strength In Mechanically Ventilated Patients|Terminated||N/A|2|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-10 23:59:23.232425|2017-10-10 23:59:23.232425
NCT02247882|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-21|2017-05-23|||February 2015|Actual|2015-02-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|RCT-OA||Effectiveness of Aquatic Physical Therapy for Knee Osteoarthritis Patients|Effectiveness of Health Education Compared to Aquatic Physical Therapy for Patients With Knee Osteoarthritis: a Randomized Clinical Trial|Completed||N/A|60|Actual|Universidade Estadual de Londrina||2|||f||||t|f|f||||||Yes||2017-10-10 23:59:23.347806|2017-10-10 23:59:23.347806
NCT02247869|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-09-21|||February 2012||2012-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Interventional|||Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma|Dose-dense ABVD as First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma: a Phase II, Prospective, Multi-center Study|Active, not recruiting||Phase 2|100|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-10 23:59:23.486126|2017-10-10 23:59:23.486126
NCT02247856|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-21|2014-09-23|||January 2013||2013-01-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||COPD AND ASSESSMENT OF RADIOLABELED AEROSOL DURING NONINVASIVE VENTILATION|IN VIVO ASSESSMENT OF RADIOLABELED AEROSOL DURING NONINVASIVE VENTILATION IN STABLE COPD: A RANDOMIZED CROSSOVER CLINICAL TRIAL|Completed||N/A|9|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-10 23:59:23.637561|2017-10-10 23:59:23.637561
NCT02247843|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2017-01-05|||July 2014||2014-07-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Stem Cell Gene Therapy for Sickle Cell Disease|Clinical Research Study of Autologous Bone Marrow Transplantation for Sickle Cell Disease (SCD) Using Bone Marrow CD34+ Cells Modified With the Lenti/βAS3-FB Lentiviral Vector|Recruiting||Phase 1|6|Anticipated|University of California, Los Angeles||1|||f||||t||||||||||2017-10-10 23:59:23.735667|2017-10-10 23:59:23.735667
NCT02247830|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-05-07|||July 2016||2016-07-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|PRBHNC||Management Radiodermatitis in Patients With Breast or Head and Neck Cancer|Prophylactic Interventions in the Management of Radiodermatitis in Patients With Breast or Head and Neck Cancer: a Randomized Clinical Trial|Enrolling by invitation||Phase 3|100|Anticipated|University of Brasilia||3|||f||||f||||||||||2017-10-10 23:59:23.854307|2017-10-10 23:59:23.854307
NCT02247817|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2014-09-20|||October 2014||2014-10-01|September 2014|2014-09-01||||December 2014|Anticipated|2014-12-01||Interventional|||A Combined Transvenous and Epicardial Lead Placement Procedure for Implantation of Cardiac Resynchronization Devices: a Feasibility Study.||Unknown status|Not yet recruiting|N/A|10|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-10-10 23:59:23.9517|2017-10-10 23:59:23.9517
NCT02247804|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-22|2017-06-15|||October 23, 2014|Actual|2014-10-23|June 2017|2017-06-01|May 3, 2019|Anticipated|2019-05-03|November 29, 2017|Anticipated|2017-11-29||Interventional|||Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension|The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension|Recruiting||Phase 3|600|Anticipated|Allergan||3|||f||||f|t|f||||||||2017-10-10 23:59:24.044158|2017-10-10 23:59:24.044158
NCT02247791|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-01-27|||September 2009||2009-09-01|January 2016|2016-01-01|September 2024|Anticipated|2024-09-01|September 2016|Anticipated|2016-09-01||Interventional|CHANCE||Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty|Study of Prosthesis Choice in Older Patients With a Dislocated Femoral Neck Fracture of the Hip|Active, not recruiting||N/A|140|Anticipated|Danderyd Hospital||2|||f||||f||||||||||2017-10-10 23:59:24.709537|2017-10-10 23:59:24.709537
NCT02247778|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-21|2014-09-28|||April 2014||2014-04-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2014|Actual|2014-09-01||Interventional|ClavFrac||Surgical Innovations in Treatment of Clavicle Fractures|Outcome of Mini-incision-technique for Treatment of Midshaft Fractures of the Clavicle|Unknown status|Recruiting|N/A|40|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-10 23:59:24.815579|2017-10-10 23:59:24.815579
NCT02247765|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-03-21|2016-02-15||November 2014||2014-11-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion|Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion in Healthy, Well Perfused Subjects With the USB Pulse Oximetry Monitor Interface Cable|Completed||Phase 3|18|Actual|Medtronic - MITG||2|||f||||f||||||||||2017-10-10 23:59:24.91208|2017-10-10 23:59:24.91208
NCT02247752|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-01-17|||September 2014||2014-09-01|September 2014|2014-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|PIBAC||Follow-up of HBsAg Inactive Carriers Study|Follow-up of HBsAg Inactive Carriers Study|Recruiting||N/A|1000|Anticipated|Centre Hospitalier Régional d'Orléans||1|||f||||f||||||||||2017-10-10 23:59:25.186805|2017-10-10 23:59:25.186805
NCT02247726|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-05-30||2017-05-30|September 2014||2014-09-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.|A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life|Completed||Phase 2|50|Actual|Novavax||2|||f||||t||||||||||2017-10-10 23:59:25.52115|2017-10-10 23:59:25.52115
NCT02247713|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-09-19|||September 2014||2014-09-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Observational|PERTAIN||An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries|An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries|Not yet recruiting||N/A|520|Anticipated|The Netherlands Cancer Institute|||2||f||||f||||||||||2017-10-10 23:59:25.665981|2017-10-10 23:59:25.665981
NCT02247700|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-08-01|||October 2014||2014-10-01|August 2016|2016-08-01||||November 2017|Anticipated|2017-11-01||Observational|EIT||An Observational Cohort Study of Distribution of Ventilation in Infants and Children Requiring Mechanical Ventilation by Electrical Impedance Tomography|An Observational Cohort Study of Distribution of Ventilation in Infants and Children Requiring Mechanical Ventilation by Electrical Impedance Tomography|Recruiting||N/A|50|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-10 23:59:25.73967|2017-10-10 23:59:25.73967
NCT02246959|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-06-19|||February 2015||2015-02-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Process Versus Outcomes Incentives for Lipid Management|Comparative Effectiveness of Process and Outcomes Incentives for Lipid Management|Active, not recruiting||Phase 3|764|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-10 23:59:34.989853|2017-10-10 23:59:34.989853
NCT02247687|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-10-09|||December 2014||2014-12-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)|Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)|Terminated||Phase 3|4|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||3||Low recruitment of participants for the study|f||||t||||||||||2017-10-10 23:59:25.831575|2017-10-10 23:59:25.831575
NCT02247674|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2014-09-19|||November 2012||2012-11-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|||Bilateral Movement Training for People With Stroke|Effects of Computer-aided Interlimb Force Coupling Training on Paretic Hand and Arm Motor Control Following Chronic Stroke|Completed||N/A|33|Actual|National Yang Ming University||2|||f||||t||||||||||2017-10-10 23:59:25.988592|2017-10-10 23:59:25.988592
NCT02247661|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-20|2015-10-13|||February 2012||2012-02-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Observational|HASAP||Hip Abductor Strengths, Limping and Trochanteric Tenderness After Hip Arthroplasty Due to Femoral Neck Fracture|Hip Abductor Strengths, Limping and Trochanteric Tenderness After Hip Arthroplasty Due to Femoral Neck Fracture: A Comparison Between the Lateral and Posterolateral Approaches|Completed||N/A|48|Anticipated|Sundsvall Hospital|||2||f||||f||||||||||2017-10-10 23:59:26.076565|2017-10-10 23:59:26.076565
NCT02247648|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-23|||June 2013||2013-06-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy|Efficacy of Extended-release, Once Daily Tramadol for Post Operative in Ambulatory Shoulder Arthroscopy|Unknown status|Active, not recruiting|Phase 2|100|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-10 23:59:26.14887|2017-10-10 23:59:26.14887
NCT02247635|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-10-30|||November 2008||2008-11-01|October 2014|2014-10-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Interventional|MPATPCDNC||Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women|Development of a Methodology for Diagnosis and Promoting Adherence to Treatment of Patients With Chronic Diseases and Evaluation of Their Impact on Cardiovascular Risk Factors|Completed||N/A|180|Actual|Mexican National Institute of Public Health||2|||f||||t||||||||||2017-10-10 23:59:26.235308|2017-10-10 23:59:26.235308
NCT02247622|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-09-19|||February 2012||2012-02-01|September 2014|2014-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis|Primary Sclerosing Cholangitis Telomere Length|Unknown status|Recruiting|N/A|60|Anticipated|Meir Medical Center|||3||f||||t||||||||||2017-10-10 23:59:26.315587|2017-10-10 23:59:26.315587
NCT02247609|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-10-16|||January 2014||2014-01-01|January 2014|2014-01-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|4SCAR19273||Evaluation of 4th Generation Safety-designed CAR T Cells Targeting High-risk and Refractory B Cell Lymphomas|Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting High-risk and Refractory B Cell Lymphomas|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Peking University||1|||f||||t||||||||||2017-10-10 23:59:26.414291|2017-10-10 23:59:26.414291
NCT02247596|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-19|||July 2009||2009-07-01|September 2014|2014-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effects of High-Dose Resveratrol in Non-Diabetic Obese Males|Effects of High-Dose Resveratrol on Resting Energy Expenditure and HOMA in Non-Diabetic Obese Males|Completed||Phase 2|36|Actual|Khoo Teck Puat Hospital||2|||f||||t||||||||||2017-10-10 23:59:26.505465|2017-10-10 23:59:26.505465
NCT02247583|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-09-19|||February 2011||2011-02-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|IPSOC||Investigating Patient Satisfaction With Oral Anti-Cancer Treatment|Investigating Patient Satisfaction With Oral Anti-Cancer Treatment. Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate Aspects of Pharmaceutical Care in Patients With Advanced Renal Cell Carcinoma Treated With an Oral Anti-cancer Drug.|Completed||N/A|90|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-10 23:59:26.592841|2017-10-10 23:59:26.592841
NCT02247570|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-01-26|||September 2014||2014-09-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Vestibular Rehabilitation Strategies in PTSD Effectiveness of Carrick Brain Centers Strategies Vestibular Rehabilitation Treatment in PTSD Patients Who Have Suffered Combat Related Traumatic Brain Injuries|A Randomized Controlled Trial Comparison of the Effectiveness of Carrick Brain Centers Strategies Vestibular Rehabilitation Treatment in PTSD Patients Who Have Suffered Combat Related Traumatic Brain Injuries.|Completed||N/A|75|Actual|Carrick Institute for Graduate Studies||1|||f||||f||||||||No||2017-10-10 23:59:26.669259|2017-10-10 23:59:26.669259
NCT02247557|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-03-07|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis|Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis — a Randomized, Double-blind, Placebo-controlled, Prospective Study|Completed||Phase 2|90|Actual|Buddhist Tzu Chi General Hospital||3|||f||||t|t|f|||f|||No|IPD cannot be released unless researchers obtain the approval from the Ethics Committee of the Buddhist Tzu Chi General Hospital, Hualien, Taiwan|2017-10-10 23:59:26.764734|2017-10-10 23:59:26.764734
NCT02247544|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-08-03|||March 2014||2014-03-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|TRAVELL||Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma|A Phase II Study on Trabectedin in Advanced Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma|Recruiting||Phase 2|95|Anticipated|Italian Sarcoma Group||1|||f||||f||||||||||2017-10-10 23:59:26.875175|2017-10-10 23:59:26.875175
NCT02247531|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-10-04|||October 6, 2014|Actual|2014-10-06|October 2017|2017-10-01|November 11, 2017|Anticipated|2017-11-11|June 30, 2017|Actual|2017-06-30||Interventional|SPECTRI||A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration|A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration|Active, not recruiting||Phase 3|975|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-10 23:59:27.081879|2017-10-10 23:59:27.081879
NCT02247518|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-08-19|||September 2014||2014-09-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|CKD-397DDI(A)||CKD-397 Drug-drug Interaction Study (A)|A Randomized, Open-label, Multiple Dosing, 2-way Crossover Study to Evaluate the Pharmacokinetic Effect of Tamsulosin on Tadalafil in Healthy Male Volunteers|Completed||Phase 1|16|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:59:27.634786|2017-10-10 23:59:27.634786
NCT02247505|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-08-19|||September 2014||2014-09-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|CKD-397DDI(B)||CKD-397 Drug-drug Interaction Study (B)|A Randomized, Open-label, Multiple Dosing, 2-way Crossover Study to Evaluate the Pharmacokinetic Effect of Tadalafil on Tamsulosin in Healthy Male Volunteers|Completed||Phase 1|29|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-10 23:59:27.740206|2017-10-10 23:59:27.740206
NCT02247492|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-09-09|||November 2015||2015-11-01|December 2014|2014-12-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01|36 Months|Observational [Patient Registry]|||BIOFLOW-III VIP Registry|Safety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Russia|Not yet recruiting||N/A|200|Anticipated|Biotronik Russia|||1||f||||f||||||||||2017-10-10 23:59:27.853247|2017-10-10 23:59:27.853247
NCT02247479|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-09-11|||September 17, 2014|Actual|2014-09-17|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|CHROMA||A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration|A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration|Active, not recruiting||Phase 3|905|Actual|Hoffmann-La Roche||3|||f|||||t|f||||||||2017-10-10 23:59:27.976718|2017-10-10 23:59:27.976718
NCT02247466|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-03-12|||February 2015||2015-02-01|March 2017|2017-03-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||Optimizing Surgical Conditions During Laparoscopic Umbilical, Incisional -and Linea Alba Herniotomy With Deep Neuromuscular Blockade|Optimizing Surgical Conditions During Laparoscopic Umbilical, Incisional -and Linea Alba Herniotomy With Deep Neuromuscular Blockade|Completed||Phase 4|41|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-10 23:59:28.42049|2017-10-10 23:59:28.42049
NCT02247453|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-09-01|||January 2013||2013-01-01|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|BIOMILD||Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study|Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study|Active, not recruiting||N/A|4119|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t||||||||||2017-10-10 23:59:28.514988|2017-10-10 23:59:28.514988
NCT02247440|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-08-29|||August 2014||2014-08-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|||HCV-HIV Co-infected Patient Cohort in Thailand|Response to Peg-interferon and Ribavirin for the Treatment of HCV Infection in HIV Co-infected Patients, Implemented in Public Hospitals in Thailand|Active, not recruiting||Phase 4|60|Anticipated|Institut de Recherche pour le Developpement|||1||f||||f||||||Samples With DNA|"     blood   "|||2017-10-10 23:59:28.61543|2017-10-10 23:59:28.61543
NCT02247401|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-07-28|2017-06-28||November 4, 2014||2014-11-04|July 2017|2017-07-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt|An Open-Label Study to Evaluate the Safety and Efficacy of the Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Chronic Hepatitis C Virus Genotype 4 Infection in Egypt|Completed||Phase 3|160|Actual|AbbVie||3|||f||||f||||||||||2017-10-10 23:59:28.940716|2017-10-10 23:59:28.940716
NCT02247388|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-03-09|||October 2014||2014-10-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|AB-CASI||Automated Bilingual Computerized Alcohol Screening and Intervention in Latinos (AB-CASI)|Automated Bilingual Computerized Alcohol Screen and Intervention in Latinos|Recruiting||N/A|820|Anticipated|Yale University||2|||f||||t||||||||||2017-10-10 23:59:29.453378|2017-10-10 23:59:29.453378
NCT02247375|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2014-09-23|||January 2000||2000-01-01|September 2014|2014-09-01||||May 2000|Actual|2000-05-01||Interventional|||Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)|A Double-blind, Randomized, Three Parallel Group Placebo-controlled Study to Investigate Pharmacokinetics, Effect on Expression of CD11b/CD18 (Mac-1), as Well as Safety and Efficacy of Two Oral Doses of BIIL 284 BS (Dosage: 25 mg Daily, 150 mg Daily) in Patients With Rheumatoid Arthritis Over Two Weeks|Completed||Phase 1|26|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-10 23:59:29.542043|2017-10-10 23:59:29.542043
NCT02247362|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-04-16|||November 2014||2014-11-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|April 2015|Actual|2015-04-01||Interventional|||Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years|Phase 1b/2 Double Blind, Randomized, Placebo Controlled Study of Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years|Unknown status|Active, not recruiting|Phase 1/Phase 2|200|Anticipated|VaxInnate Corporation||4|||f||||t||||||||||2017-10-10 23:59:29.639147|2017-10-10 23:59:29.639147
NCT02243072|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-05-31|||December 2014||2014-12-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|R34||Home-Based Interventions for Adolescents With Type 1 Diabetes|Translating Home-Based Interventions for Adolescents With Poorly Controlled TID|Completed||N/A|49|Actual|Wayne State University||2|||f||||t||||||||No||2017-10-11 00:00:24.924216|2017-10-11 00:00:24.924216
NCT02247349|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-09-15|||October 30, 2014|Actual|2014-10-30|September 2017|2017-09-01|September 16, 2018|Anticipated|2018-09-16|September 16, 2018|Anticipated|2018-09-16||Interventional|||BMS-986012 in Relapsed/Refractory SCLC|A Phase 1/2 Multicenter Study of BMS-986012 in Subjects With Relapsed/Refractory Small Cell Lung Cancer|Active, not recruiting||Phase 1/Phase 2|172|Anticipated|Bristol-Myers Squibb||12|||f||||f||||||||||2017-10-10 23:59:29.753704|2017-10-10 23:59:29.753704
NCT02247336|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-09-27|||August 1, 2017|Actual|2017-08-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|May 1, 2018|Anticipated|2018-05-01||Interventional|||Impact of Family History and Decision Support on High-risk Cancer Screening|Impact of Family History and Decision Support on High-risk Cancer Screening|Enrolling by invitation||N/A|650|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-10 23:59:29.93755|2017-10-10 23:59:29.93755
NCT02247323|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-04-07|||January 2016||2016-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CA125||Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125|Ovarian Malignancy Incidence in Premenopausal Women Who Were at Moderate Risk for Malignancy by Risk of Malignancy Index With Low CA 125.(Retrospective Study)|Recruiting||N/A|200|Anticipated|Beni-Suef University|||1||f||||t||||||||||2017-10-10 23:59:30.017176|2017-10-10 23:59:30.017176
NCT02247310|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-12-21|||October 2014||2014-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Observational|||BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon|BETAEVAL_Global- The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated With Betaferon®|Completed||N/A|479|Actual|Bayer|||1||f||||f||||||||||2017-10-10 23:59:30.111151|2017-10-10 23:59:30.111151
NCT02247297|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-06-22|||September 2014||2014-09-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Pancreatic Stone Protein (PSP) in Pregnant Women|Analysis of Serum Pancreatic Stone Protein (PSP) in Healthy Pregnant Women and Its Value in Predicting Inflammatory Complications During Pregnancy|Recruiting||N/A|486|Anticipated|University of Zurich|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-10 23:59:30.220415|2017-10-10 23:59:30.220415
NCT02247284|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-06-19|||March 2015||2015-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reproducibility of RNFL and ONH Measurements in OAG With Heidelberg Spectralis SD-OCT Glaucoma Module Premium Edition|Study to Investigate Reproducibility of the New Heidelberg Spectralis SD-OCT Glaucoma Module Premium Edition (Software Version 6.0) in Comparison to Reproducibility of RNFL Scans.|Recruiting||N/A|50|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-10 23:59:30.326046|2017-10-10 23:59:30.326046
NCT02247271|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-23|||September 2014||2014-09-01|September 2014|2014-09-01|August 2016|Anticipated|2016-08-01|April 2016|Anticipated|2016-04-01||Interventional|||The Role and Effectiveness of Diabetes Coaches in British Columbia|The Role and Effectiveness of Diabetes Coaches in British Columbia|Unknown status|Not yet recruiting|N/A|300|Anticipated|University of Victoria||2|||f||||f||||||||||2017-10-10 23:59:30.414077|2017-10-10 23:59:30.414077
NCT02247258|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2015-05-28|||October 2005||2005-10-01|September 2014|2014-09-01|May 2015|Actual|2015-05-01|April 2014|Actual|2014-04-01||Interventional|||Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.|Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence: Systematic Versus Endoscopic-directed Treatment. A Multi-center, Randomized, Clinical Practice Evaluation Study.|Terminated||Phase 2|63|Actual|Universitaire Ziekenhuizen Leuven||2||Slow recruitment|f||||f||||||||||2017-10-10 23:59:30.498129|2017-10-10 23:59:30.498129
NCT02247245|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2014-09-29|||September 2014||2014-09-01|September 2014|2014-09-01|July 2016|Anticipated|2016-07-01|September 2015|Anticipated|2015-09-01||Interventional|TREPPE||The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.|The Influence of Iatrogenic Chronotropic Incompetence on Exercise Tolerance in Pacemaker Patients With Chronic Heart Failure.|Unknown status|Recruiting|N/A|50|Anticipated|University of Leeds||3|||f||||f||||||||||2017-10-10 23:59:30.590752|2017-10-10 23:59:30.590752
NCT02247232|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-07-11|||December 2014||2014-12-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|October 2021|Anticipated|2021-10-01||Interventional|||Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer|Randomized, Double-blind, Placebo-controlled Trial of Z-100 Plus Radiation Therapy in Patients With Locally Advanced Cervical Cancer — A Phase III Trial|Recruiting||Phase 3|600|Anticipated|Zeria Pharmaceutical||2|||f||||t||||||||||2017-10-10 23:59:32.396418|2017-10-10 23:59:32.396418
NCT02247219|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-05-20|||June 2014||2014-06-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Promoting Health in Healthy Living Centres - a Clinical Study Among Adults|Promoting Health in Healthy Living Centres - Does it Work, How Does it Work and Why?|Active, not recruiting||N/A|118|Actual|University of Bergen||2|||f||||f||||||||Undecided|We will share data with faculty members at UoB and UoA based on agreements of analysing and Publishing.|2017-10-10 23:59:32.498334|2017-10-10 23:59:32.498334
NCT02247206|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-18|||December 2012||2012-12-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||VoIP Delivered Behavior Therapy for Tourette Syndrome|Voice Over Internet Protocol Delivered Behavior Therapy for Tourette Syndrome|Completed||Phase 2|20|Actual|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-10-10 23:59:32.602954|2017-10-10 23:59:32.602954
NCT02247193|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Interventional|||Improvement of the Appearance of Cleft Lip Scars Using Botox|Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair|Recruiting||Phase 1/Phase 2|40|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-10 23:59:32.707306|2017-10-10 23:59:32.707306
NCT02247180|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-18|||September 2014||2014-09-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Cognitive Rehabilitation in Alzheimer`s Disease|Cognitive Rehabilitation in Alzheimer`s Disease (AD)|Unknown status|Recruiting|N/A|14|Anticipated|University of Rostock||2|||f||||f||||||||||2017-10-10 23:59:32.813684|2017-10-10 23:59:32.813684
NCT02247167|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-09-18|||February 2012||2012-02-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Endothelial Dysfunction and Oxidative Stress in Children With Sleep Disordered Breathing.|Endothelial Dysfunction and Oxidative Stress in Children With Sleep Disordered Breathing.|Completed||Phase 1/Phase 2|15|Actual|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-10 23:59:32.920091|2017-10-10 23:59:32.920091
NCT02247154|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-19|||April 1999||1999-04-01|August 2014|2014-08-01||||July 2001|Actual|2001-07-01||Interventional|||A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency|A Study of the Safety and Efficacy of an Intravenous Immunoglobulin (Vigam® Liquid) in Patients With Primary or Secondary Antibody Deficiency.|Completed||Phase 4|||Bio Products Laboratory||1|||f||||||||||||||2017-10-10 23:59:33.004328|2017-10-10 23:59:33.004328
NCT02247141|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-19|||June 2000||2000-06-01|August 2014|2014-08-01||||January 2005|Actual|2005-01-01||Interventional|||A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam®|A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam® Given Via the Subcutaneous Route in Primary Antibody Deficient Patients.|Completed||Phase 3|||Bio Products Laboratory||1|||f||||||||||||||2017-10-10 23:59:33.11815|2017-10-10 23:59:33.11815
NCT02247128|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-04-21|||January 2014||2014-01-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|August 2018|Anticipated|2018-08-01||Interventional|POPular-TAVI||Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation|Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation|Recruiting||Phase 4|1000|Anticipated|St. Antonius Hospital||4|||f||||t||||||||||2017-10-10 23:59:33.393288|2017-10-10 23:59:33.393288
NCT02247115|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-03-17|||July 2014||2014-07-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01||Observational|RATES||Rapid Assessment of Trainee Endoscopy Skills (RATES) Study|Rapid Assessment of Trainee Endoscopy Skills (RATES) Study: A Prospective Multicenter Study Evaluating Competence in Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatogram Among Advanced Endoscopy Trainees|Completed||N/A|36|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-10 23:59:33.567167|2017-10-10 23:59:33.567167
NCT02247102|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2014-12-24|||September 2014||2014-09-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01||Interventional|||Investigate the Breath Hydrogen Exhalation After a Test Meal Containing Isomaltulose or Sucrose in Infants|Placebo-controlled Randomized Trial to Investigate the Breath Hydrogen Exhalation After a Test Meal Containing Isomaltulose (Palatinose™) or Sucrose in Infants Aged 6-12 Months|Unknown status|Recruiting|Phase 3|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:59:33.652743|2017-10-10 23:59:33.652743
NCT02247089|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-11-15|||February 2014||2014-02-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Massage Therapy to Control Night Shift Related Stress|The Effect of Massage Therapy to Control Night Shift Related Stress: A Pilot Prospective Randomized Crossover Trial|Completed||N/A|12|Actual|University of British Columbia|||||f||||f||||||||||2017-10-10 23:59:33.745154|2017-10-10 23:59:33.745154
NCT02247076|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-12-16|||October 2014||2014-10-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|GRAZING||Does Meal Timing Affect Energy Expenditure|Does Meal Timing Affect Energy Expenditure|Completed||N/A|11|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-10 23:59:33.827593|2017-10-10 23:59:33.827593
NCT02247063|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-12-01|||September 2013||2013-09-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Motor Cortex as a Research & Therapeutic Target in TMD|Motor Cortex as a Research and Therapeutic Target in TMD|Completed||N/A|24|Actual|University of Michigan||2|||f||||f||||||||||2017-10-10 23:59:33.90567|2017-10-10 23:59:33.90567
NCT02247050|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-05-05|||September 2014||2014-09-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Primary Care Clinician Commitments to Choosing Wisely®|Primary Care Clinician Commitments to Choosing Wisely®|Completed||N/A|45|Actual|University of Michigan||6|||f||||f||||||||||2017-10-10 23:59:33.971246|2017-10-10 23:59:33.971246
NCT02247037|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-07-19|||July 2014||2014-07-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer|Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer|Recruiting||N/A|140|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||Samples With DNA|"     Core Biopsy Specimen, Surgical Specimen   "|||2017-10-10 23:59:34.099757|2017-10-10 23:59:34.099757
NCT02247024|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2014-09-19|||December 2014||2014-12-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|Pupillometry||Pupil Response in Patients on Opioids.|Dynamic Assessment of Pupillary Reflex in Patients on High-dose Opioids|Unknown status|Not yet recruiting|N/A|100|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-10 23:59:34.199256|2017-10-10 23:59:34.199256
NCT02247011|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-08-08|2016-05-19||March 2013||2013-03-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|September 2014|Actual|2014-09-01||Interventional|PK-VF||A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal Women|A 5-Year Long-term Follow-up Study of a Cross-Sectional Cohort Study (PK-VF) For the Examination of the Association of Vitamin D/Bone Turnover/Bone Mineral Density With an Incident Fracture in Chinese Postmenopausal Women|Completed||N/A|1100|Actual|Peking Union Medical College Hospital||2|||f||||t||||||||Undecided||2017-10-10 23:59:34.270769|2017-10-10 23:59:34.270769
NCT02246985|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-02-24|||July 2014||2014-07-01|March 2016|2016-03-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|CAROTFoods||Bioavailability of Carotenoids Added Into Processed Foods|Bioavailability of Carotenoids Incorporated Into Processed Foods: Bread and Mayonnaise|Completed||N/A|20|Anticipated|University of Aberdeen||4|||f||||f||||||||No||2017-10-10 23:59:34.805441|2017-10-10 23:59:34.805441
NCT02246972|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-08-08|||May 2015||2015-05-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||BraveMind: Advancing the Virtual Iraq/Afghanistan PTSD Exposure Therapy|BRAVEMIND: Advancing the Virtual Iraq/Afghanistan PTSD Exposure Therapy System for MST|Completed||Phase 2|15|Actual|Emory University||2|||f||||f||||||||||2017-10-10 23:59:34.907518|2017-10-10 23:59:34.907518
NCT02246946|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-01-17|||December 2014||2014-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Positive Airway Pressure on Pleural Effusion After Drainage|Efficacy of the Addition of Positive Airway Pressure to Conventional Chest Physiotherapy in the Time to Resolution of Pleural Effusion After Drainage|Completed||N/A|156|Actual|Universidade Cidade de Sao Paulo||3|||f||||f||||||||||2017-10-10 23:59:35.204085|2017-10-10 23:59:35.204085
NCT02246933|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-10-06|||September 2013||2013-09-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effects of a PUFA-rich Diet on Acute Metabolic and Inflammatory High-Fat Meal Responses|Effects of a PUFA-rich Diet on Acute Metabolic and Inflammatory High-Fat Meal Responses|Completed||N/A|26|Actual|University of Georgia||2|||f||||f||||||||||2017-10-10 23:59:35.300026|2017-10-10 23:59:35.300026
NCT02246920|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||March 2014||2014-03-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients|A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Fluticasone Propionate Nasal Spray, 50 mcg With Flonase® Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis|Completed||Phase 3|1110|Actual|Teva Pharmaceuticals USA||3|||f||||f||||||||||2017-10-10 23:59:35.392571|2017-10-10 23:59:35.392571
NCT02246907|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-11-22|||January 2014||2014-01-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|EQUAL||Exercise and Quality of Life in Leukemia Patients|Effects of Exercise on Patient Reported Outcomes in Newly Diagnosed Adults With Acute Leukemia During Induction Treatment: Exercise and Quality of Life in Leukemia Patients (EQUAL)|Completed||N/A|18|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:59:35.483489|2017-10-10 23:59:35.483489
NCT02246894|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-19|||November 2003||2003-11-01|August 2014|2014-08-01||||January 2005|Actual|2005-01-01||Interventional|||A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.|An Open Multicentre Phase III Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Severe Haemophilia A.|Completed||Phase 3|||Bio Products Laboratory||1|||f||||||||||||||2017-10-10 23:59:35.578016|2017-10-10 23:59:35.578016
NCT02246881|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-19|||October 2001||2001-10-01|August 2014|2014-08-01||||January 2004|Actual|2004-01-01||Interventional|||A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.|An Open Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Severe Haemophilia A Patients.|Completed||Phase 3|||Bio Products Laboratory||2|||f||||||||||||||2017-10-10 23:59:35.662323|2017-10-10 23:59:35.662323
NCT02246868|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-19|||September 2001||2001-09-01|August 2014|2014-08-01||||August 2004|Actual|2004-08-01||Interventional|||An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.|An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.|Completed||Phase 3|||Bio Products Laboratory||1|||f||||||||||||||2017-10-10 23:59:35.75392|2017-10-10 23:59:35.75392
NCT02246855|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-22|||August 2004||2004-08-01|August 2014|2014-08-01||||December 2004|Actual|2004-12-01||Interventional|||A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy Volunteers|A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg (Vigam® Liquid and Gammaplex®) Using Standard and Accelerated Infusion Rates in Healthy Adult Volunteers (Three Treatment Arms)|Completed||Phase 1|||Bio Products Laboratory||3|||f||||||||||||||2017-10-10 23:59:35.856645|2017-10-10 23:59:35.856645
NCT02246842|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-19|||May 2004||2004-05-01|August 2014|2014-08-01||||December 2004|Actual|2004-12-01||Interventional|||A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers.|A Randomised Study Comparing the Pharmacokinetics and Tolerance of D-Gam® 1500IU to Rhophylac® 1500IUin Rh-D-negative Healthy Volunteers.|Completed||Phase 1|||Bio Products Laboratory||2|||f||||||||||||||2017-10-10 23:59:35.935511|2017-10-10 23:59:35.935511
NCT02246829|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-11-18|||September 2014||2014-09-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|START||Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START|Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®) (2mg) Over a 12-week Period for Patients Suffering From Neovascular Age-related Macular Degeneration (AMD) French SD OCT in wAMD|Completed||Phase 4|50|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-10 23:59:36.026316|2017-10-10 23:59:36.026316
NCT02246816|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2015-02-16|||February 2015||2015-02-01|November 2014|2014-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001|A Phase 3, Open Label Extension Study for Subjects That Complete Study MP-101-CL-001|Withdrawn||Phase 3|0|Actual|Marathon Pharmaceuticals, LLC||1||Transfer of IND to different marketing authorization representative.|f||||||||||||||2017-10-10 23:59:36.139688|2017-10-10 23:59:36.139688
NCT02246803|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2015-09-21|||January 2014||2014-01-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Assessment of Progression of Paroxysmal AF After CABG|The Assessment of Progression of Paroxysmal Atrial Fibrillation in Patients After Coronary Artery Bypass Grafting Through Continuous Subcutaneous Monitoring|Recruiting||Phase 3|72|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 23:59:36.230109|2017-10-10 23:59:36.230109
NCT02246790|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2015-11-12|||December 2014||2014-12-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|LABARFA||Surgical Ablation of Long-standing Persistent AF During CABG|Surgical Ablation of Long-standing Persistent Atrial Fibrillation During CABG Through Continuous Subcutaneous Monitoring|Recruiting||Phase 3|116|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-10 23:59:36.318286|2017-10-10 23:59:36.318286
NCT02246764|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-25|||September 2014||2014-09-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|93|Actual|Aerie Pharmaceuticals||3|||f||||f||||||||||2017-10-10 23:59:36.492418|2017-10-10 23:59:36.492418
NCT02246738|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-09-23|||August 2014||2014-08-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Observational|||Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts|Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts|Recruiting||N/A|66|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||9||f||||t||||||Samples With DNA|"     Blood Collection   "|||2017-10-10 23:59:36.689499|2017-10-10 23:59:36.689499
NCT02246725|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-03-06|||October 2014||2014-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|ALLAN||Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.|Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.|Recruiting||N/A|108|Anticipated|Lund University Hospital|||1||f||||f||||||||||2017-10-10 23:59:36.781303|2017-10-10 23:59:36.781303
NCT02246712|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-18|||June 2008||2008-06-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|May 2010|Actual|2010-05-01||Interventional|||Influence of Diabetes on Tramadol Pharmacokinetics|Influence of Uncontrolled Diabetes on the Kinetic Disposition, Metabolism and Pharmacokinetics-pharmacodynamics of Tramadol Enantiomers in Patients With Neuropathic Pain|Completed||Phase 4|30|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||3|||f||||f||||||||||2017-10-10 23:59:36.876127|2017-10-10 23:59:36.876127
NCT02246699|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2015-03-30|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety of a Fungal Chitosan on the Body Weight Reduction in Overweight and Obesity Volunteers|A Study to Evaluate the Efficacy and the Safety of a Fungal Chitosan on the Body Weight Reduction in Overweight and Obesity Volunteers: a Randomized, Double-blind, Parallel Groups and Placebo Controlled Clinical Trial.|Completed||N/A|114|Actual|Kitozyme||2|||f||||f||||||||||2017-10-10 23:59:36.983117|2017-10-10 23:59:36.983117
NCT02246686|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2016-10-17|||November 2014||2014-11-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients|A Randomised, Double-blind, Placebo-controlled Multi-centre Study to Investigate the Effectiveness and Safety of STW5-II as add-on Treatment for Induction of Remission in Patients With Mild to Moderate Ulcerative Colitis|Terminated||Phase 2|3|Actual|Bayer||2|||f||||f||||||||||2017-10-10 23:59:37.070572|2017-10-10 23:59:37.070572
NCT02246673|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-19|2017-06-27|2017-06-27||October 2014||2014-10-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|July 2015|Actual|2015-07-01||Interventional|||RDEA3170 and Febuxostat Combination Study in Gout Subjects|A Phase 2a, Randomized, Open-Label Study to Evaluate the Pharmacodynamic Effects and Safety of RDEA3170 Administered in Combination With Febuxostat Compared to Febuxostat Administered Alone in Adult Subjects With Gout|Completed||Phase 2|64|Actual|Ardea Biosciences, Inc.||4|||f||||f||||||||||2017-10-10 23:59:37.206096|2017-10-10 23:59:37.206096
NCT02246660|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-09-21|||January 2015||2015-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|RESTORE||RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)|RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)|Completed||N/A|66|Actual|Northwestern University||3|||f||||t||||||||Undecided||2017-10-10 23:59:38.663168|2017-10-10 23:59:38.663168
NCT02246621|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-06-14|||November 2014||2014-11-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|January 2017|Actual|2017-01-01||Interventional|MONARCH 3||A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) Plus LY2835219, a CDK4/6 Inhibitor, or Placebo in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer With No Prior Systemic Therapy in This Disease Setting|Active, not recruiting||Phase 3|450|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-10 23:59:39.046571|2017-10-10 23:59:39.046571
NCT02246608|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-09-08|||August 2014||2014-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy|Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy (NPWT)|Recruiting||N/A|24|Anticipated|Kettering Health Network||2|||f||||f||||||||||2017-10-10 23:59:39.496583|2017-10-10 23:59:39.496583
NCT02246595|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-04-22|||April 2014||2014-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SCIENS||Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction|A Phase II Randomized, Placebo-controlled, Double-blind, Dose Controlled Trial in Patients Suffering From Early, Newly Developing Abdominal or Pulmonary Derived Septic Organ Dysfunction to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and to Estimate Efficacy of the New Humanized Monoclonal i.v. Administered Antibody CaCP29|Completed||Phase 2|72|Actual|InflaRx GmbH||2|||f||||t||||||||||2017-10-10 23:59:39.587248|2017-10-10 23:59:39.587248
NCT02246582|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-10-31|2016-08-24||September 2014||2014-09-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|E3|Even though participants were randomized to two groups, data was collected as a whole and there was no intention to analyze the two groups seperately.|Adult Accuracy Study of the Enlite 3 Glucose Sensor|A Performance Evaluation of the Enlite® 3 Sensor to Support a Full 168 Hours (7 Days) of Use|Completed||N/A|118|Actual|Medtronic Diabetes||2|||f||||t||||||||||2017-10-10 23:59:39.702216|2017-10-10 23:59:39.702216
NCT02246569|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-11-18|||October 2015||2015-10-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Lung Volume Reduction Via Coils in Patients With COPD|Impact of Endoscopic Lung Volume Reduction Via Coils on Inspiratory Muscle Strength in Patients With COPD|Recruiting||N/A|20|Anticipated|RWTH Aachen University|||1||f||||f||||||||||2017-10-10 23:59:39.94741|2017-10-10 23:59:39.94741
NCT02246556|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-05-01|||October 2014||2014-10-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dichoptic Virtual Reality Therapy for Amblyopia in Adults|Dichoptic Virtual Reality Therapy for Amblyopia in Adults|Terminated||Phase 1|17|Actual|University of California, San Francisco||3||Recruitment inadequate and investigators leaving the study institution for new positions.|f||||f||||||||||2017-10-10 23:59:40.101291|2017-10-10 23:59:40.101291
NCT02246543|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-03-23|||August 2013||2013-08-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Whey Protein Study - Identification of Sustainable Satiety|Whey Protein Study - Identification of Sustainable Satiety|Completed||N/A|13|Actual|University of Aberdeen||5|||f||||t||||||||||2017-10-10 23:59:40.189259|2017-10-10 23:59:40.189259
NCT02246530|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-04-18|||July 2014||2014-07-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Non-Surgical Treatment for Rotator-Cuff Tears Using Platelet-Rich-Plasma|Non-Surgical Treatment for Rotator-Cuff Tears Using Platelet-Rich-Plasma|Recruiting||N/A|20|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-10 23:59:40.309093|2017-10-10 23:59:40.309093
NCT02246517|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-09-18|||September 2014||2014-09-01|September 2014|2014-09-01||||December 2015|Anticipated|2015-12-01||Interventional|N2O||The Effect of N2O on Chronic Neuropathic Pain Patients|The Effect of N2O on Chronic Neuropathic Pain|Unknown status|Not yet recruiting|Early Phase 1|20|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-10 23:59:40.401982|2017-10-10 23:59:40.401982
NCT02246504|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-04-20|||December 2012||2012-12-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Registry - Use of a High Intensity Focused Ultrasound (HIFU) in Patients With Non-malignant Thyroid Nodules.|Registry - Use of a High Intensity Focused Ultrasound (HIFU) in Patients With Non-malignant Thyroid Nodules.|Active, not recruiting||N/A|10|Anticipated|Theraclion||1|||f||||f||||||||||2017-10-10 23:59:40.475129|2017-10-10 23:59:40.475129
NCT02246491|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-03-23|||September 2014||2014-09-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia|Induced Pluripotent Stem (iPS) Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia|Recruiting||N/A|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-10 23:59:40.54429|2017-10-10 23:59:40.54429
NCT02246478|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-09-24|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||A Study of TAS-205 for Duchenne Muscular Dystrophy|A Phase I Study of Single and Multiple Doses of TAS-205 in Patients With Duchenne Muscular Dystrophy|Completed||Phase 1|21|Actual|Taiho Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-10 23:59:40.764092|2017-10-10 23:59:40.764092
NCT02246465|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-02-06|||July 2014||2014-07-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Revised Hypertrophic Scars|An Open-Label, Multi-Center, Prospective, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery for Hypertrophic Scars in Healthy Adults|Active, not recruiting||Phase 2|40|Anticipated|RXi Pharmaceuticals, Corp.||1|||f||||t||||||||||2017-10-10 23:59:40.868282|2017-10-10 23:59:40.868282
NCT02246452|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-19|||June 2013||2013-06-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Assessment of the Nutritional Status of Children and Adolescents With Malignancies|Assessment of the Nutritional Status of Children and Adolescents With Malignancies Aged Between 0-18, Based on BMI Percentiles and Standard Deviation Scores, at Diagnosis, During Treatment, and During Two Years Follow-up|Completed||N/A|135|Actual|University of Hohenheim|||1||f||||f||||||||||2017-10-10 23:59:40.962242|2017-10-10 23:59:40.962242
NCT02246439|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-10-05|||September 2014||2014-09-01|November 2016|2016-11-01|February 17, 2017|Actual|2017-02-17|February 17, 2017|Actual|2017-02-17||Interventional|GUARD||Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)|Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis|Completed||Phase 3|330|Actual|RedHill Biopharma Limited||2|||f||||f||||||||||2017-10-10 23:59:41.040986|2017-10-10 23:59:41.040986
NCT02246426|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-01-24|||March 2015||2015-03-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|TRuSST||Treatment of Social Cognition in Schizophrenia Trial|TRuSST: Treatment of Social Cognition in Schizophrenia Trial|Recruiting||N/A|154|Anticipated|Posit Science Corporation||2|||f||||t||||||||||2017-10-10 23:59:41.202302|2017-10-10 23:59:41.202302
NCT02246413|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-02-15|||September 2014||2014-09-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|RAINBOW-ENGAGE||Research Aimed at Improving Both Mood and Weight|RCT on Co-management of Obesity, Depression, and Elevated CVD Risk in Primary Care-- Engaging Self-regulation Targets to Understand the Mechanisms of Behavior Change and Improve Mood and Weight Outcomes|Active, not recruiting||N/A|404|Anticipated|Palo Alto Medical Foundation||2|||f||||t||||||||||2017-10-10 23:59:41.318021|2017-10-10 23:59:41.318021
NCT02246400|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-05-29|||January 2014||2014-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|eCMP||CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact|CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact|Completed||N/A|74|Actual|Palo Alto Medical Foundation||2|||f||||f||||||||||2017-10-10 23:59:41.431051|2017-10-10 23:59:41.431051
NCT02246387|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-06-07|||October 2014||2014-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MAP-POP||Follow-up Study After Manchester Operation for Pelvic Organ Prolapse|Does the Manchester Operation for Pelvic Organ Prolapse Give Sufficient Apical Fixation?|Active, not recruiting||N/A|209|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-10 23:59:41.541484|2017-10-10 23:59:41.541484
NCT02246374|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-05-17|||September 2014||2014-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease|A Feasibility Clinical Trial of the Management of the Medically-Refractory Motor Symptoms of Advanced Idiopathic Parkinson's Disease With Staged, Unilateral Lesioning of the Subthalamic Nucleus Using the ExAblate Transcranial System|Recruiting||N/A|10|Anticipated|InSightec||1|||f||||t||||||||||2017-10-10 23:59:41.618094|2017-10-10 23:59:41.618094
NCT02246361|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2015-08-26|||September 2014||2014-09-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|EDIFIP||Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication|Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication and Adherence in Emergency Ward|Completed||Phase 4|211|Actual|Floralis||2|||f||||f||||||||||2017-10-10 23:59:41.716954|2017-10-10 23:59:41.716954
NCT02246348|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-01-20|||September 2014||2014-09-01|August 2014|2014-08-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)|Evaluation of Lung Doppler Signals (LDS) in Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc)|Terminated||N/A|5|Actual|Echosense Ltd.||1||Low recruitment rate|f||||f||||||||||2017-10-10 23:59:41.84689|2017-10-10 23:59:41.84689
NCT02246335|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-08-29|||October 2009||2009-10-01|August 2016|2016-08-01|October 2020|Anticipated|2020-10-01|October 2016|Anticipated|2016-10-01||Interventional|HOPE||Hemiarthroplasty Compared to Total Hip Arthroplasty for Displaced Femoral Neck Fractures in the Elderly-elderly|Hemiarthroplasty Compared to Total Hip Arthroplasty for Displaced Femoral Neck Fractures in the Elderly-elderly. A Randomized Controlled Trial.|Active, not recruiting||N/A|120|Actual|Danderyd Hospital||2|||f||||f||||||||||2017-10-10 23:59:41.924347|2017-10-10 23:59:41.924347
NCT02246322|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-18|||August 2013||2013-08-01|September 2014|2014-09-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|EUS-FNA||A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.|A Randomized Clinical Trial With a New Needle Device Comparing 25G and 22G Needle in Endoscopic Ultrasound Fine-needle Aspiration of Solid Lesions.|Unknown status|Recruiting|N/A|144|Anticipated|Istituto Clinico Humanitas||2|||f||||t||||||||||2017-10-10 23:59:42.019556|2017-10-10 23:59:42.019556
NCT02246296|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-04-13|||December 2014||2014-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|F75||Reformulated F75 Milk to Treat Severe Acute Malnutrition|Randomized Controlled Trial of a Reduced Carbohydrate Formulation of F75 Therapeutic Milk Among Children With Severe Acute Malnutrition|Completed||Phase 2/Phase 3|842|Actual|University of Oxford||2|||f||||t||||||||||2017-10-10 23:59:42.261953|2017-10-10 23:59:42.261953
NCT02246283|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-10-31|||September 2013||2013-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|September 2015|Actual|2015-09-01||Observational|||"Schizophrenia for Life - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia"|"Schizophrenia for Life - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia"|Recruiting||N/A|10404|Anticipated|University of Southern Denmark|||1||f||||f||||||||||2017-10-10 23:59:42.387338|2017-10-10 23:59:42.387338
NCT02246270|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-08-17|||November 2014||2014-11-01|August 2017|2017-08-01|November 6, 2015|Actual|2015-11-06|November 6, 2015|Actual|2015-11-06||Interventional|||Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)|Recurrent Urinary Tract Infections and Heparin: a Double-blind Randomized Clinical Trial (RUTIH Trial)|Withdrawn||Phase 1/Phase 2|0|Actual|Oregon Health and Science University||2||Limited Funding|f||||t||||||||||2017-10-10 23:59:42.466557|2017-10-10 23:59:42.466557
NCT02246257|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-10-01|||September 2014||2014-09-01|October 2017|2017-10-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|ERACORI||Early Rheumatoid Arthritis COR Intervention|Multifactorial Intervention to Prevent Cardiovascular Disease in Patients With Early Rheumatoid Arthritis|Recruiting||N/A|300|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-10 23:59:42.559705|2017-10-10 23:59:42.559705
NCT02246244|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-06-09|||April 2009||2009-04-01|June 2016|2016-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|TADDOR||Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress|Randomized, Double Blind, Efficacy Study of Escitalopram Versus Placebo in ENT Cancer Patients Suffering From Emotional Distress|Completed||Phase 3|38|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-10 23:59:42.686001|2017-10-10 23:59:42.686001
NCT02246231|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||November 2011||2011-11-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Effect of Implant Position on Magnetic Resonance Image Distortion|The Effect of Changes in Head Position on Magnetic Resonance Image Distortion in Patients With Auditory Implants|Unknown status|Recruiting|N/A|12|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-10 23:59:42.763368|2017-10-10 23:59:42.763368
NCT02246218|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-08-15|||December 2014||2014-12-01|August 2017|2017-08-01|July 17, 2017|Actual|2017-07-17|October 11, 2016|Actual|2016-10-11||Interventional|||A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders|An Open Label Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate (GPB; RAVICTI®) in Pediatric Subjects Under Two Years of Age With Urea Cycle Disorders (UCDs)|Completed||Phase 4|27|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||1|||f||||t|t|f||||||||2017-10-10 23:59:42.86136|2017-10-10 23:59:42.86136
NCT02246192|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2015-03-18|||November 2008||2008-11-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Use of Plasma Rich in Growth Factors (PRGF) in Pilonidal Sinus Excision|Application of PRGF (Plasma Rich in Growth Factors) to Reduce the Healing Time After Pilonidal Sinus Excision. A Randomized 5-years Prospective Controlled Trial.|Completed||N/A|51|Actual|Hospital Quiron Sagrado Corazon||2|||f||||t||||||||||2017-10-10 23:59:43.082653|2017-10-10 23:59:43.082653
NCT02246179|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-11-07|||September 2014||2014-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Fractional Laser Assisted Delivery of Anesthetics|Fractional Carbon Dioxide Laser Assisted Delivery of Topical Anesthetics: a Randomized Controlled Pilot Study|Completed||Phase 4|10|Actual|Netherlands Institute for Pigment Disorders||4|||f||||f||||||||||2017-10-10 23:59:43.158725|2017-10-10 23:59:43.158725
NCT02246166|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-08-02|2015-10-08||January 2015||2015-01-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Overall participants in the test arm were 25 as 1 participant data was not included in the baseline measure as he did not completed the study (Due to protocol deviation).|The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.|A Double-Blind, Randomised, Placebo-Controlled, Parallelgroup, Single-Dose Study to Evaluate Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza Over a 4 Hour Period|Completed||Phase 4|53|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-10 23:59:43.303144|2017-10-10 23:59:43.303144
NCT02246153|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-01-07|||September 2014||2014-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients|Morbidity and Mortality of Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients: A Randomized Controlled Trial|Recruiting||Phase 3|202|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-10 23:59:44.031158|2017-10-10 23:59:44.031158
NCT02246140|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-09-07|||July 2014||2014-07-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Intracranial Arterial Stenosis and Resin of Cannabis Use|Prevalence of Intracranial Arterial Stenosis in Regular Resin of Cannabis Users Compared to Control Subjects: a Preliminary Study of Feasibility|Recruiting||N/A|60|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-10 23:59:44.124409|2017-10-10 23:59:44.124409
NCT02246127|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-05-30|||October 27, 2014|Actual|2014-10-27|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|SEQTOR||Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced pNET|Randomized Open Label Study to Compare the Efficacy and Safety of Everolimus Followed by Chemotherapy With Streptozotocin- Fluorouracilo (STZ-5FU) Upon Progression or the Reverse Sequence, in Advanced Progressive Pancreatic NETs (pNETs)|Recruiting||Phase 3|180|Anticipated|Grupo Espanol de Tumores Neuroendocrinos||2|||f||||f|f|f||||||Undecided|As per GETNE guidelines and local laws|2017-10-10 23:59:44.213115|2017-10-10 23:59:44.213115
NCT02246114|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-11-21|2016-09-29||September 2014||2014-09-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women|Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women|Terminated||N/A|1|Actual|Milton S. Hershey Medical Center|The study closed early due to lack of recruitment. Only 1 subject enrolled in the study and she terminated after the baseline visit due to a miscarriage at 9 weeks. Therefore no analysis has been performed.|2||Lack of Recruitment|f||||f||||||||||2017-10-10 23:59:44.587424|2017-10-10 23:59:44.587424
NCT02246101|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-25|||July 2014||2014-07-01|July 2017|2017-07-01|September 16, 2016|Actual|2016-09-16|September 16, 2016|Actual|2016-09-16||Observational|||World Trade Center (WTC) RENAL|Renal and Cardiovascular Impairment in WTC Responders: Implications for Diagnosis and Treatment|Completed||N/A|406|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||||||2017-10-10 23:59:44.83623|2017-10-10 23:59:44.83623
NCT02246088|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-19|||December 2013||2013-12-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Neuroscience Education on Osteoarthritis|Effect of Neuroscience Education on Subjects With Chronic Knee Pain Related to Osteoarthritis : a Randomized Controlled Trial|Unknown status|Recruiting|N/A|53|Anticipated|University of Valencia||2|||f||||t||||||||||2017-10-10 23:59:44.994103|2017-10-10 23:59:44.994103
NCT02246075|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-10-13|||July 2015||2015-07-01|October 2015|2015-10-01||||October 2016|Anticipated|2016-10-01||Interventional|||Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 24-Week, Phase 2 Study of Two Doses of EVP-6124 Hydrochloride or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently Receiving Memantine Medication With or Without Additional Acetylcholinesterase Inhibitor Co-Medication|Withdrawn||Phase 2|0|Actual|FORUM Pharmaceuticals Inc||3||Forum has decided not to proceed with this study at this time.|f||||t||||||||||2017-10-10 23:59:45.151045|2017-10-10 23:59:45.151045
NCT02246062|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-12-04|2015-06-11||June 2013||2013-06-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Impact of Preanesthetic Information and Behavioral Intervention Using Smartphone on Anxiety of Children|Impact of Preanesthetic Information and Behavioral Intervention Using Smartphone Application on Anxiety of Children|Completed||N/A|84|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||4|||f||||t||||||||||2017-10-10 23:59:45.281995|2017-10-10 23:59:45.281995
NCT02246049|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-06-15|||May 2014|Actual|2014-05-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|QUATTRO||A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC|A Multicenter, Clinical Phase II Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|69|Actual|EPS Corporation||1|||f||||t||||||||||2017-10-10 23:59:45.735186|2017-10-10 23:59:45.735186
NCT02246036|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-10-12|||December 2014||2014-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MC Monitor||Tolerance and Safety of a Duodenal Probe Monitoring the Microcirculation|Clinical Trial to Assess the Tolerance and the Safety of a Duodenal Tube Monitoring the Microcirculation in 10 Critically Ill Patients.|Completed||N/A|10|Actual|Advanced Perfusion Diagnostics||1|||f||||f||||||||||2017-10-10 23:59:45.871227|2017-10-10 23:59:45.871227
NCT02246023|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-04-13|||January 2015||2015-01-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy|Target-controlled Versus Manually-controlled Propofol Sedation in Flexible Bronchoscopy. A Randomized Non-inferiority Trial.|Completed||Phase 4|78|Actual|University of Zurich||2|||f||||t||||||||||2017-10-10 23:59:45.978813|2017-10-10 23:59:45.978813
NCT02246010|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-07-15|||July 2015||2015-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Lactose-free Milk in Infants With Acute Diarrhea in a Developing Country|Does Intake of Lactose-free Milk in Infants With Acute Gastroenteritis in a Developing Country Shorten the Duration of Diarrhea? A Randomized Clinical Trial.|Recruiting||N/A|40|Anticipated|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-10 23:59:46.1014|2017-10-10 23:59:46.1014
NCT02245997|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-12-16|||September 2014||2014-09-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma|Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma|Recruiting||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-10 23:59:46.192389|2017-10-10 23:59:46.192389
NCT02245984|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-09-20|||July 2014||2014-07-01|September 2014|2014-09-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|NP||Effect of Applying Paper- Based Versus Electronic Nursing Process on Clinical Competence of Nursing Student|Comparison Effect of Applying Paper- Based Versus Electronic Nursing Process on Clinical Competence of Undergraduate Nursing Students' of Mashhad Nursing and Midwifery School|Unknown status|Recruiting|Phase 2|60|Anticipated|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-10 23:59:46.297638|2017-10-10 23:59:46.297638
NCT02245971|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-09-05|||September 2014||2014-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study on Precutting Methods of Endoscopic Submucosal Dissection for Gastric Neoplasms Located at Lesser Curvature Side of Antrum||Recruiting||N/A|86|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-10 23:59:46.4111|2017-10-10 23:59:46.4111
NCT02245958|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2016-01-06|||August 2015||2015-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm||Completed||Phase 4|44|Actual|Allergan|||2||f||||f||||||||||2017-10-10 23:59:46.499853|2017-10-10 23:59:46.499853
NCT02245945|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-04-30||||||April 2015|2015-04-01||||April 2015|Actual|2015-04-01||Interventional|||Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females|Phase I Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females|Withdrawn||Phase 1|0|Actual|CONRAD||2|||f||||f||||||||||2017-10-10 23:59:46.594753|2017-10-10 23:59:46.594753
NCT02245932|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-09-12|||January 2015||2015-01-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CARMENS||Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)|The Effect of Resveratrol on Metabolism and Cardiovascular Risk Profile in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 3|52|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-10 23:59:46.697664|2017-10-10 23:59:46.697664
NCT02245919|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-08-28|||November 2014||2014-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Chronic Low Back Pain Rehabilitation in Primary Care: a Pilot Study|A Primary Care Biopsychosocial Intervention (Back on Track) for Patients With Chronic Low Back Pain in Which Psychosocial Factors Moderately Influence Daily Life Functioning: a Pilot Study|Active, not recruiting||N/A|18|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-10 23:59:46.835997|2017-10-10 23:59:46.835997
NCT02245906|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-09-06|||September 2014||2014-09-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|BRASIL-MET||Effect of Brazilian Fruits Peel on Metabolic Regulation and Appetite in Healthy Subjects|Investigation on Effect of Brazilian Fruits on Glucose and Insulin Responses, Anti-inflammatory Properties, Antioxidative Capacity and Satiety in Healthy Subjects|Completed||Phase 1/Phase 2|17|Actual|Lund University||3|||f||||f||||||||No||2017-10-10 23:59:46.945186|2017-10-10 23:59:46.945186
NCT02245893|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-08-22|||August 2013||2013-08-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|September 2016|Actual|2016-09-01||Interventional|ART||A Prospective Randomized Pilot Study to Compare Open Versus Percutaneous Syndesmosis Repair of Unstable Ankle Fractures|A Prospective Randomized Pilot Study to Compare Open Versus Percutaneous Syndesmosis Repair of Unstable Ankle Fractures|Active, not recruiting||N/A|50|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-10 23:59:47.050339|2017-10-10 23:59:47.050339
NCT02245880|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2015-03-31|||April 2014||2014-04-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Tracheal Intubation With Collar Immobilisation : a Comparison of Glidescope and Fastrach|A Comparison of Glidescope and ILMA in Simulated Sercial Spine Injury|Completed||Phase 4|94|Actual|Kocaeli University||2|||f||||f||||||||||2017-10-10 23:59:47.147862|2017-10-10 23:59:47.147862
NCT02245867|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-07-11|||September 2014||2014-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis|Phase Ia/Ib Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis|Active, not recruiting||Phase 1|42|Anticipated|Columbia University||2|||f||||t|t|f||||||||2017-10-10 23:59:47.226983|2017-10-10 23:59:47.226983
NCT02245854|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-19|||September 2013||2013-09-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of a New Polypectomy Snare for Cold-polypectomy for Small Colorectal Polyps|Efficacy and Safety of a New Polypectomy Snare for Cold-polypectomy for Subcentimetric Colorectal Polyps: the E-scope (Efficacy and Safety of COld PolypEctomy) Trial|Completed||N/A|250|Actual|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-10 23:59:47.328419|2017-10-10 23:59:47.328419
NCT02245841|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-12-30|||June 2015||2015-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|Acthar Gel||Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis|Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis|Recruiting||Phase 4|15|Anticipated|The Cleveland Clinic||1|||f||||f||||||||Undecided||2017-10-10 23:59:47.426511|2017-10-10 23:59:47.426511
NCT02245828|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-03-20|||July 2014||2014-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374|A Randomized, Double-blind, Placebo-controlled First-in-human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374 in Healthy Subjects|Completed||Phase 1|66|Actual|Novartis||2|||f||||f||||||||||2017-10-10 23:59:47.548566|2017-10-10 23:59:47.548566
NCT02245802|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-19|||August 2010||2010-08-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers|Multicenter Prospective Validation Study on the Prediction of In-hospital Mortality Using CU Prediction Model for Patients With Bleeding Peptic Ulcers|Completed||N/A|785|Actual|Chinese University of Hong Kong|||2||f||||f||||||||||2017-10-10 23:59:47.813565|2017-10-10 23:59:47.813565
NCT02245789|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-10-28|||September 2014||2014-09-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|MGM-PicRemi||Does the Use of a Videolaryngoscope Modifies Anesthetic Induction ?|Does the Use of a Videolaryngoscope Modifies Anesthetic Induction ?|Completed||N/A|50|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-10 23:59:47.935271|2017-10-10 23:59:47.935271
NCT02245776|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-09-13|||December 2008||2008-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Stem Cell Therapy in Incurable Neurological Disorders|Autologous Bone Marrow Mononuclear Cell Therapy for Incurable Neurological Disorders|Recruiting||Phase 1|1000|Anticipated|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-10 23:59:48.076225|2017-10-10 23:59:48.076225
NCT02245763|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-19|||November 2013||2013-11-01|September 2014|2014-09-01||||December 2018|Anticipated|2018-12-01||Observational|TMVR||STS/ACC TVT Registry Mitral Module|The Society of Thoracic Surgeons/ American College of Cardiology Transcatheter Valve Therapies Registry Mitral Module|Recruiting||N/A|4000|Anticipated|American College of Cardiology|||1||f||||t||||||||||2017-10-10 23:59:48.160729|2017-10-10 23:59:48.160729
NCT02245750|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-09-19|||August 2014||2014-08-01|September 2014|2014-09-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Value of Routine Hysteroscopy Prior to IVF/ICSI Cycles||Unknown status|Recruiting|N/A|300|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-10 23:59:48.258159|2017-10-10 23:59:48.258159
NCT02245737|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2017-10-03|||September 2014||2014-09-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|AMARANTH||An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease|A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)|Recruiting||Phase 2/Phase 3|2202|Anticipated|Eli Lilly and Company||3|||f||||t||||||||||2017-10-10 23:59:48.451286|2017-10-10 23:59:48.451286
NCT02245724|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-23|||September 2011||2011-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Stem Cell Therapy in Mental Retardation||Completed||Phase 1|51|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||No||2017-10-10 23:59:50.984247|2017-10-10 23:59:50.984247
NCT02245711|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-23|||December 2010||2010-12-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Cell Therapy in Limb Girdle Muscular Dystrophy|Intrathecal Autologous Mononuclear Cell Therapy for Limb Girdle Muscular Dystrophy|Completed||Phase 1|65|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-10 23:59:51.053648|2017-10-10 23:59:51.053648
NCT02245698|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-09-13|||December 2008||2008-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Autologous Stem Cell Therapy in Stroke|Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Stroke|Recruiting||Phase 1|200|Anticipated|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-10 23:59:51.121128|2017-10-10 23:59:51.121128
NCT02245685|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-07-18|||January 2008||2008-01-01|July 2017|2017-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center|Longitudinal Followup of Patients Under Substitution Therapy From the Moment They Enter a Specialized Care Center for Addicts to the Period They Are Monitored by a General Practitioner Outside the Specialized Care Center|Completed||N/A|113|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-10 23:59:51.201578|2017-10-10 23:59:51.201578
NCT02245672|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-05-25||2016-05-25|October 2014||2014-10-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||MGR001 / Advair Diskus Local Equivalence Study in Asthma|A Randomized, Double-blind, Double Dummy, Parallel Group Study to Determine the Local Equivalence of Multiple Doses of MGR001 to Advair Diskus Administered Via Oral Inhalation in Adult Asthma Patients|Completed||Phase 3|2725|Actual|Mylan Inc.||3|||f||||f||||||||||2017-10-10 23:59:51.27669|2017-10-10 23:59:51.27669
NCT02245659|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-03-24|||March 2015||2015-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: A Pilot Randomized-Controlled Trial|The Effect of Continuous Positive Airway Pressure (CPAP) Treatment on Glycemic Control in Gestational Diabetes: A Pilot Randomized-Controlled Trial|Recruiting||N/A|60|Anticipated|McGill University Health Center||2|||f||||f||||||||No||2017-10-10 23:59:51.679879|2017-10-10 23:59:51.679879
NCT02245646|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-10-28|||September 2014||2014-09-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Distortion Product After Stapedotomy Surgery|Subjektiv Verzerrter Höreindruck Nach Stapedotomie|Completed||N/A|60|Actual|University of Zurich|||3||f||||f||||||||||2017-10-10 23:59:51.778236|2017-10-10 23:59:51.778236
NCT02245633|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-18|||September 2014||2014-09-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|February 2015|Anticipated|2015-02-01|5 Years|Observational [Patient Registry]|||Correlation Between Vitamin D Levels to ADAMTS13 , VWF and Micro RNA Expression in Diabetic Hemodialysis Patients||Unknown status|Recruiting|N/A|70|Anticipated|Meir Medical Center|||2||f||||||||||Samples With DNA|"     miRNA will be extract from patient'w plasma   "|||2017-10-10 23:59:51.840441|2017-10-10 23:59:51.840441
NCT02245620|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-02-01|||February 2015||2015-02-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|MOTION||A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Impact of a Single Intravenous Dose of MTP-131 (Bendavia™) on Skeletal Muscle Function in the Elderly|Completed||Phase 2|41|Actual|Stealth BioTherapeutics Inc.||2|||f||||f||||||||||2017-10-10 23:59:51.93383|2017-10-10 23:59:51.93383
NCT02245607|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-11-30|||October 2014||2014-10-01|November 2015|2015-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Compensatory Cognitive Training in Clinical High Risk Latino Youth|Compensatory Cognitive Training in Clinical High Risk Latino Youth|Recruiting||N/A|120|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-10 23:59:52.010753|2017-10-10 23:59:52.010753
NCT02245594|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-17|||October 2014||2014-10-01|September 2014|2014-09-01|October 2015|Anticipated|2015-10-01|May 2015|Anticipated|2015-05-01||Observational|||GI Symptoms and Sleep Disturbances in Patients With Quiescent Crohns Disease|Gastrointestinal Motility and Sleep Disturbances in Patients With Quiescent Crohn's Disease|Unknown status|Not yet recruiting|Early Phase 1|20|Anticipated|University of Aarhus|||1||f||||t||||||Samples Without DNA|"     A single blood sample (TNF-α, IL-1, IL-6) will be taken at the laboratory.   "|||2017-10-10 23:59:52.106397|2017-10-10 23:59:52.106397
NCT02245581|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-18|||April 2013||2013-04-01|September 2014|2014-09-01||||April 2014|Actual|2014-04-01||Interventional|||Evaluations of Optimizing Perioperative Fluid Management on Postoperative Pain Outcomes||Completed||N/A|72|Actual|Kaohsiung Veterans General Hospital.||2|||f||||||||||||||2017-10-10 23:59:52.218747|2017-10-10 23:59:52.218747
NCT02245568|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-06-20|||August 2014||2014-08-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)|An Open-Label, Extension Study of the Effects of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)|Enrolling by invitation||Phase 3|1000|Anticipated|TauRx Therapeutics Ltd||1|||f||||t||||||||||2017-10-10 23:59:52.321908|2017-10-10 23:59:52.321908
NCT02245555|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||April 2006||2006-04-01|September 2014|2014-09-01||||December 2007|Actual|2007-12-01||Observational|||Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia|Observational Study About the Use of Tamsulosin in Patients With Benign Prostatic Hyperplasia|Completed||N/A|1060|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:52.710085|2017-10-10 23:59:52.710085
NCT02245542|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||April 2005||2005-04-01|September 2014|2014-09-01||||February 2006|Actual|2006-02-01||Observational|||The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)|The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)|Completed||N/A|5775|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:52.781966|2017-10-10 23:59:52.781966
NCT02245529|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||March 2005||2005-03-01|September 2014|2014-09-01||||September 2005|Actual|2005-09-01||Observational|||Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia|Secotex ®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)|Completed||N/A|982|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:52.850889|2017-10-10 23:59:52.850889
NCT02245516|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-07-08||2016-07-08|July 2014||2014-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Molokini||Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema|An Exploratory, Multi-Center, Randomized, Single-Masked Study Evaluating the Effect of KPI-121 on Intraretinal or Subretinal Fluid Secondary to Retinal Vein Occlusion or Diabetic Macular Edema|Completed||N/A|16|Actual|Kala Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-10 23:59:52.917202|2017-10-10 23:59:52.917202
NCT02245503|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||May 2003||2003-05-01|September 2014|2014-09-01||||October 2003|Actual|2003-10-01||Observational|||Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)|Comorbidity and Comedication During Prescription of ALNA® (Tamsulosin) for Patients With BPH (Benign Prostatic Hyperplasia)|Completed||N/A|7391|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:53.00603|2017-10-10 23:59:53.00603
NCT02245490|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||January 2003||2003-01-01|September 2014|2014-09-01||||April 2004|Actual|2004-04-01||Interventional|||Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms|BLADDER (BPH, LUTS And Detrusor: Dual Effect Research) Study: A Multicentre, Double-blind, Randomised, Parallel Group, Placebo-controlled Study, Aimed at Characterising the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms|Completed||Phase 4|153|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:53.169833|2017-10-10 23:59:53.169833
NCT02245477|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-05-13|||September 2014||2014-09-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|VEGF in FGR||Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth Restriction|Evaluation of Maternal Serum VEGF in Pregnant Women With Foetal Growth Restriction|Recruiting||N/A|100|Anticipated|Beni-Suef University|||2||f||||t||||||||||2017-10-10 23:59:53.254322|2017-10-10 23:59:53.254322
NCT02245464|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||November 2000||2000-11-01|September 2014|2014-09-01||||November 2006|Actual|2006-11-01||Observational|||Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension|The Post Marketing Surveillance Study Conducted With a Continuous Enrollment Method to Assess Serious Adverse Events, Adverse Events, Safety, Efficacy of Micardis Tablet (Telmisartan 20, 40, 80mg p.o. Once Daily Over 2 Weeks)|Completed||N/A|13066|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-10 23:59:53.345977|2017-10-10 23:59:53.345977
NCT01934491|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-07-19|||August 2013||2013-08-01|July 2017|2017-07-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|||Cognitive Training for Depression II|A Novel Cognitive Training Intervention for Major Depressive Disorder|Completed||N/A|51|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 01:20:27.820071|2017-10-11 01:20:27.820071
NCT02245451|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||January 2005||2005-01-01|September 2014|2014-09-01||||February 2005|Actual|2005-02-01||Interventional|||Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy Volunteers|A Single-centre, Open-label Study of Multiple Doses of Tipranavir 500 mg and Ritonavir 200 mg (Twice Daily) on the Pharmacokinetic Characteristics of Methadone Administered as a Single Dose in Healthy Volunteers|Completed||Phase 1|15|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:59:53.422271|2017-10-10 23:59:53.422271
NCT02245438|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||May 2002||2002-05-01|September 2014|2014-09-01||||June 2002|Actual|2002-06-01||Interventional|||Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers|A Single Centre, Open-label, Randomized, Parallel Group, Multiple Dose Comparison of the Effect of TPV 750 mg and RTV 200 mg or TPV 500 mg and RTV 100 mg, Administered Twice Daily, on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol (Ortho®-1/35 ) Administered as a Single Dose, in Healthy Female Adult Volunteers.|Terminated||Phase 1|52|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-10 23:59:53.506093|2017-10-10 23:59:53.506093
NCT02245425|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-17|||September 2014||2014-09-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain|A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|50|Anticipated|A.T. Still University of Health Sciences||2|||f||||f||||||||||2017-10-10 23:59:53.605521|2017-10-10 23:59:53.605521
NCT02245412|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-09-08|2017-09-08||September 2014||2014-09-01|September 2017|2017-09-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|GIGVHD||A Phase 2a Study of ALXN1007 in Subjects With Newly Diagnosed Acute GI GVHD|A Phase 2a Study of ALXN1007 in Subjects With Newly Diagnosed Acute Graft-versus-Host Disease Involving the Lower Gastrointestinal Tract|Terminated||Phase 2|25|Actual|Alexion Pharmaceuticals||3|||f||||t|t|f||||||||2017-10-10 23:59:53.754652|2017-10-10 23:59:53.754652
NCT02245399|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-10-19|||October 2014||2014-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Canola-Mediterranean Diet Study in T2DM|Canola Enriched Mediterranean Type Weight Loss Diet in Type 2 Diabetes|Active, not recruiting||N/A|164|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-10 23:59:55.067908|2017-10-10 23:59:55.067908
NCT02245386|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-17|||May 2013||2013-05-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Observational|||Effects of Pregnancy and Childbirth on Pelvic Floor Morphology and Sexual Function in Egyptian Women|Effects of Pregnancy and Parturition on Pelvic Floor Morphology and Sexual Function in Egyptian Women.|Completed||N/A|120|Actual|Al-Azhar University|||3||f||||t||||||||||2017-10-10 23:59:55.189302|2017-10-10 23:59:55.189302
NCT02245373|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-17|||June 2013||2013-06-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|July 2014|Actual|2014-07-01|12 Months|Observational [Patient Registry]|||Cost-effectiveness of a Non-Pharmacological Treatment (Active Monitoring) vs. a Pharmacological Treatment for Major Depression in Primary Care.|Cost-effectiveness of a Non-Pharmacological Treatment (Active Monitoring) vs. a Pharmacological Treatment for Major Depression in Primary Care. INFAP Study.|Unknown status|Active, not recruiting|N/A|263|Actual|Fundació Sant Joan de Déu|||2||f||||||||||||||2017-10-10 23:59:55.259609|2017-10-10 23:59:55.259609
NCT02245360|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-12-09|2015-11-03||October 2014||2014-10-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis|A Randomized, Double-blind, Placebo-controlled Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the SQ Grass SLIT-tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis|Completed||Phase 3|107|Actual|Abbott||2|||f||||f||||||||||2017-10-10 23:59:55.342251|2017-10-10 23:59:55.342251
NCT02245347|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-17|||April 2013||2013-04-01|September 2014|2014-09-01||||April 2016|Anticipated|2016-04-01||Observational|MDRTB01||Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum|Genome Sequencing of MDR TB in Sputum|Unknown status|Recruiting|N/A|50|Anticipated|St George's Healthcare NHS Trust|||1||f||||f||||||Samples Without DNA|"     Sputum samples   "|||2017-10-10 23:59:55.649352|2017-10-10 23:59:55.649352
NCT02245334|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-18|||October 2014||2014-10-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy|A Prospective Randomized Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy|Unknown status|Not yet recruiting|Phase 4|1578|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:59:55.718418|2017-10-10 23:59:55.718418
NCT02245321|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-05-22|||June 2011||2011-06-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|STRIDE||Strategies to Reduce Iron Deficiency|Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors|Completed||N/A|702|Actual|Westat||5|||f||||t||||||||||2017-10-10 23:59:55.90236|2017-10-10 23:59:55.90236
NCT02245295|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-11-14|||January 2014||2014-01-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Observational|||The Role of Sedation Technique in EBUS-TBNA|Impact of Sedation Technique on the Diagnostic Accuracy of Endobronchial Ultrasound-guided Needle Aspiration (EBUS-TBNA)|Completed||N/A|232|Actual|University of Zurich|||1||f||||t||||||||No||2017-10-10 23:59:56.160181|2017-10-10 23:59:56.160181
NCT02245282|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-05-10|||November 2014||2014-11-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Contrast Enhanced MRI of the Prostate|Contrast Enhanced MRI of the Prostate|Recruiting||N/A|20|Anticipated|OHSU Knight Cancer Institute|||1||f||||t||||||||Yes|Data will be shared to Imbio LLC|2017-10-10 23:59:56.242469|2017-10-10 23:59:56.242469
NCT02244879|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-03-06|||October 2013||2013-10-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients|Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients. A Double-blind Randomized Controlled Trial|Completed||Phase 3|192|Actual|University of Turin, Italy||3|||f||||f||||||||||2017-10-10 23:59:59.355488|2017-10-10 23:59:59.355488
NCT02245269|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||July 2003||2003-07-01|September 2014|2014-09-01||||October 2003|Actual|2003-10-01||Interventional|||Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers|A Two-way Pharmacokinetic Interaction Study of Single-Dose Atorvastatin (LIPITOR®) With Tipranavir/Ritonavir (500mg/200mg) at Steady-State and the Effect of Antacid (MAALOX®) on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir (500mg/200mg) in Healthy Volunteers|Completed||Phase 1|23|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-10 23:59:56.32822|2017-10-10 23:59:56.32822
NCT02245256|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-11-20|||September 2014||2014-09-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy of Low-dose Dexmedetomidine to Prevent Delirium in Liver Transplant Patients|Perioperative Low-dose Dexmedetomidine Decreases Incidence of Delirium in Liver Transplant Patients|Recruiting||Phase 4|210|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-10 23:59:56.41619|2017-10-10 23:59:56.41619
NCT02245243|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2015-04-29|||September 2014||2014-09-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pharmacokinetics of Delafloxacin in Subjects With and Without Hepatic Impairment|An Open Label Evaluation of the Single Dose Pharmacokinetics of Delafloxacin in Subjects With and Without Hepatic Impairment|Completed||Phase 1|40|Actual|Melinta Therapeutics, Inc.||1|||f||||t||||||||||2017-10-10 23:59:56.542202|2017-10-10 23:59:56.542202
NCT02245230|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-08-01|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension|Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension|Recruiting||Phase 1|34|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-10 23:59:56.635389|2017-10-10 23:59:56.635389
NCT02245217|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-01-04|||September 2014||2014-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|January 2017|Actual|2017-01-01||Interventional|||Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients|Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients|Terminated||N/A|9|Actual|University of Utah||1||Slow Accrual|f||||t||||||||||2017-10-10 23:59:56.749072|2017-10-10 23:59:56.749072
NCT02245204|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-10-19|||September 2014||2014-09-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Cancer|Phase 1 Trial of Tolerance and Pharmacokinetic of Chlorogenic Acid for Injection in the Advanced Malignant Tumor Subjects|Unknown status|Recruiting|Phase 1|50|Anticipated|Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd||1|||f||||f||||||||||2017-10-10 23:59:56.822019|2017-10-10 23:59:56.822019
NCT02245191|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-09-16|||July 2014||2014-07-01|May 2014|2014-05-01||||July 2014|Actual|2014-07-01||Interventional|||Ephedrine, Phenylephrine and Metaraminol Effects on Maternal Cardiac Output, Uterine Blood Flow and Fetal Circulation|Ephedrine, Phenylephrine and Metaraminol Effects on Maternal Cardiac Output, Uterine Blood Flow and Fetal Circulation in Patients With Preeclampsia Under Spinal Anesthesia for Cesarean|Unknown status|Active, not recruiting|N/A|60|Actual|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-10 23:59:56.925645|2017-10-10 23:59:56.925645
NCT02245178|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-03-27|||June 2015|Actual|2015-06-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2016|Actual|2016-08-01||Observational|CARDIA Lung||Lung Function Decline and Disease Risk From Young Adulthood to Middle Age|Lung Function Decline and Disease Risk From Young Adulthood to Middle Age|Active, not recruiting||N/A|3193|Actual|Northwestern University|||1||f||||t||||||||||2017-10-10 23:59:57.028284|2017-10-10 23:59:57.028284
NCT02245165|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-09-16|||June 2013||2013-06-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|LNMMA||Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades|Nitric Oxide Control of the Migrating Motor Complex in Man: L-NMMA Effects in Relation to Muscarinic and Serotonergic Receptor Blockade|Completed||Phase 1|29|Actual|Uppsala University||2|||f||||f||||||||||2017-10-10 23:59:57.120201|2017-10-10 23:59:57.120201
NCT02245152|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-08-16|||October 2014||2014-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|PROMIS-BF||The Effect of Integrated Prevention and Treatment on Child Malnutrition and Health in Burkina Faso: a Cluster Randomized Intervention Study|The Effect of Integrated Prevention and Treatment on Child Malnutrition and Health in Burkina Faso: a Cluster Randomized Intervention Study|Active, not recruiting||Phase 4|2400|Anticipated|International Food Policy Research Institute||2|||f||||f||||||||||2017-10-10 23:59:57.207186|2017-10-10 23:59:57.207186
NCT02245139|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-04-26|||July 1, 2014|Actual|2014-07-01|April 2017|2017-04-01|December 15, 2014|Actual|2014-12-15|September 15, 2014|Actual|2014-09-15|7 Days|Observational [Patient Registry]|SAGE||Surveillance Study of Acute Gastroenteritis in Hospitalized Children|Surveillance Study of Acute Gastroenteritis Etiologies in Hospitalized Children|Completed||N/A|198|Actual|Shaikh Ragheb Harb Hospital|||1||f||||f||||||||||2017-10-10 23:59:57.321097|2017-10-10 23:59:57.321097
NCT02245126|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-02|2014-09-17|||January 2013||2013-01-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Use of Lignocaine and Bupivacaine Mix in Adult Safe Male Circumcision|The Use of Lignocaine and Bupivacaine Mix in Adult Safe Male Circumcision; Less is More|Completed||N/A|217|Actual|International Hospital Kampala||2|||f||||f||||||||||2017-10-10 23:59:57.384779|2017-10-10 23:59:57.384779
NCT02245113|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-18|||December 2013||2013-12-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Effects of High Oleic Palm Olein, Virgin Olive Oil and Coconut Oil Diets on Markers Selected in Malaysian|Effects of High Oleic Palm Olein (HOPO), Virgin Olive Oil (OO) and Refined Bleached and Deodorized (RBD) Coconut Oil (CO) Diets on Lipid Profile, Markers of Insulin Resistance, Inflammatory and Obesity in Overweight Subject.|Completed||N/A|32|Actual|Malaysia Palm Oil Board||3|||f||||t||||||||||2017-10-10 23:59:57.495353|2017-10-10 23:59:57.495353
NCT02245100|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-08-18|||July 22, 2014|Actual|2014-07-22|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|July 2019|Anticipated|2019-07-01||Observational|||Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer|A Pilot Study to Evaluate the Predictive Value of Circulating Tumor DNA for Clinical Outcome in Patients With Advanced Head and Neck and Lung Cancers|Recruiting||N/A|50|Anticipated|Thomas Jefferson University|||1||f||||t||||||Samples With DNA|"     Blood, saliva, and tissue   "|||2017-10-10 23:59:57.596444|2017-10-10 23:59:57.596444
NCT02245074|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-15|2014-09-17|||June 2010||2010-06-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|CYTOASTHME||Non Invasive Evaluation of Bronchial Inflammation in Infants : a Study of the Sputum Cellularity After Hypertonic Saline Induction|Non Invasive Evaluation of Bronchial Inflammation in Infants : a Study of the Sputum Cellularity After Hypertonic Saline Induction|Terminated||N/A|34|Actual|University Hospital, Rouen||3||lack of recruitment|f||||f||||||||||2017-10-10 23:59:57.819046|2017-10-10 23:59:57.819046
NCT02245061|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-11-13|||September 2014||2014-09-01|November 2015|2015-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|PP||Cortical Excitability Assessment Using Paired Pulses|Cortical Excitability Assessment of Pharmacoresistant Focal Epilepsy Using Direct Electrical Stimulation During Stereo-electroencephalography|Recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-10 23:59:57.892284|2017-10-10 23:59:57.892284
NCT02245048|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-08-28|||September 2014||2014-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Observational|||CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk Stratification|Carotid Intima-Media Thickness and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk Stratification|Active, not recruiting||N/A|75|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-10 23:59:57.962777|2017-10-10 23:59:57.962777
NCT02245035|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-03-19|||October 2011||2011-10-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Observational|||Dairy Intake and Brain Health in Aging|Dairy Intake and Brain Health in Aging|Completed||N/A|60|Anticipated|University of Kansas Medical Center|||3||f||||t||||||||||2017-10-10 23:59:58.035182|2017-10-10 23:59:58.035182
NCT02245022|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-03-14|||March 14, 2017|Actual|2017-03-14|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|DolPHIN1||Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study|Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study|Recruiting||Phase 2/Phase 3|60|Anticipated|University of Liverpool||2|||f||||t|f|f||||||No||2017-10-10 23:59:58.112765|2017-10-10 23:59:58.112765
NCT02245009|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-07-30|||September 2014||2014-09-01|July 2015|2015-07-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01|2 Weeks|Observational [Patient Registry]|SEED||Safety of External Electrocardioversion in Device Patients|Safety of External Electrocardioversion in Device Patients - the SEED Registry|Unknown status|Recruiting|N/A|300|Anticipated|Universitätsklinikum Köln|||3||f||||t||||||||||2017-10-10 23:59:58.36991|2017-10-10 23:59:58.36991
NCT02244996|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-02-22|||November 2014||2014-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|April 2016|Actual|2016-04-01||Interventional|||Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum|Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum|Recruiting||Phase 2|60|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||||2017-10-10 23:59:58.46581|2017-10-10 23:59:58.46581
NCT02244970|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|MBIp||Mindfulness RCT for Early Psychosis|Brief Mindfulness-Based Intervention for Early Psychosis: A Randomized Controlled Study|Unknown status|Not yet recruiting|N/A|60|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-10 23:59:58.627456|2017-10-10 23:59:58.627456
NCT02244957|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-02-03|||September 2014||2014-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|February 2017|Actual|2017-02-01||Interventional|||Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSA|Right Ventricular Hemodynamics Using Cardiac Magnetic Resonance Imaging in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA)|Active, not recruiting||N/A|150|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-10 23:59:58.729397|2017-10-10 23:59:58.729397
NCT02244931|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-17|||September 2011||2011-09-01|September 2013|2013-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PAPAW||Comparison of Three Different Assisting Devices to Power Manual Wheelchairs in Patients With Spinal Cord Injury|Comparison of Three Assisting Devices to Power Manual Wheelchairs in Patients With Spinal Cord Injury : Assessment of Biomechanical, Physiological and Functional Properties.|Completed||N/A|106|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-10 23:59:58.909695|2017-10-10 23:59:58.909695
NCT02244918|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-09-27|||May 2015||2015-05-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|May 31, 2017|Actual|2017-05-31||Interventional|||Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers|Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers|Active, not recruiting||Phase 4|278|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-10 23:59:58.996923|2017-10-10 23:59:58.996923
NCT02244905|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-18|||August 2011||2011-08-01|May 2014|2014-05-01|August 2014|Actual|2014-08-01|March 2013|Actual|2013-03-01||Interventional|||Trial of Positive Deviance in Inpatient Wards to Reduce Hospital Infections|Trial of Positive Deviance in Inpatient Wards to Reduce Hospital Infections|Completed||N/A|16876|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-10 23:59:59.161101|2017-10-10 23:59:59.161101
NCT02244892|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-17|||September 2014||2014-09-01|September 2014|2014-09-01||||September 2015|Anticipated|2015-09-01||Observational|||Correlation of Scheimpflug Densitometry Measurements of Corneal Haze With Disability Glare||Unknown status|Recruiting|N/A|80|Anticipated|University Hospitals Cleveland Medical Center|||1||f||||||||||||||2017-10-10 23:59:59.242462|2017-10-10 23:59:59.242462
NCT02244866|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-12-23|||October 2012||2012-10-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy of Pergoveris in Aged IVF Patients|A Randomized Controlled Trial to Compare the Efficacy Between Pergoveris and Follitropin Alfa in Ovarian Stimulation in Patients Aged ≥ 35 Years|Completed||N/A|240|Actual|Vietnam National University||2|||f||||f||||||||||2017-10-10 23:59:59.456138|2017-10-10 23:59:59.456138
NCT02244853|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-18|||September 2013||2013-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease|Association of Heart Rate With Cardiovascular Disease Prognosis of Patients With Stable Coronary Artery Disease: A CALIBER Study|Unknown status|Active, not recruiting|N/A|51703|Actual|University College, London|||1||f||||f||||||||||2017-10-10 23:59:59.56332|2017-10-10 23:59:59.56332
NCT02244840|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-26|2014-09-20||December 2011||2011-12-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|Bidet(2)||Anal Resting Pressure After Bidet, Compared to Sitz Bath|The Effects of Electronic Bidet on Anal Resting Pressure, Compared to Conventional Sitz Bath in Normal Healthy Volunteers|Completed||Early Phase 1|40|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-10 23:59:59.669098|2017-10-10 23:59:59.669098
NCT02244827|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-10-28|||September 2014||2014-09-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment|A Phase I, Open Label, Single Dose Study to Evaluate The Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment|Completed||Phase 1|48|Actual|Wockhardt||1|||f||||f||||||||||2017-10-10 23:59:59.844885|2017-10-10 23:59:59.844885
NCT02244814|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-12-05|||April 2015||2015-04-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|CHOICE||Trial of Diet in Gestational Diabetes Mellitus: Metabolic Consequences to Mother and Offspring|Randomized Trial of Diet in Gestational Diabetes Mellitus: Metabolic Consequences to Mother and Offspring|Recruiting||N/A|148|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-10 23:59:59.921404|2017-10-10 23:59:59.921404
NCT02244801|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|DART||Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )|Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation: A ONE Study Clinical Trial|Recruiting||Phase 1|16|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:00:00.034639|2017-10-11 00:00:00.034639
NCT02244788|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-03-29||||||March 2017|2017-03-01||||||||Expanded Access|||Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint|Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint|Available||N/A|||Hospital for Special Surgery, New York|||||f||||||||||||||2017-10-11 00:00:00.157138|2017-10-11 00:00:00.157138
NCT02244775|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-18||||||September 2014|2014-09-01||||||||Expanded Access|||Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device|Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device|Approved for marketing||N/A|||Hospital for Special Surgery, New York|||||f||||||||||||||2017-10-11 00:00:00.243125|2017-10-11 00:00:00.243125
NCT02244762|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-17|||February 2011||2011-02-01|September 2014|2014-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment|Evaluation of the Effect of Renal Impairment on the Pharmacokinetics and Metabolism of Hydrocodone and Its Metabolites Following Administration of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg Capsules|Completed||Phase 1|37|Actual|Zogenix, Inc.||3|||f||||f||||||||||2017-10-11 00:00:00.308964|2017-10-11 00:00:00.308964
NCT02244749|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-02-08|||March 2011||2011-03-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Role of Metabolic Enzymes in Non-Melanoma Skin Cancer|Role of Metabolic Enzymes in Non-Melanoma Skin Cancer: Potential for Informative Biomarkers and Therapeutic Targets|Completed||N/A|26|Actual|University of California, Irvine|||1||f||||f||||||||||2017-10-11 00:00:00.399809|2017-10-11 00:00:00.399809
NCT02244736|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-16|||February 2013||2013-02-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01|2 Years|Observational [Patient Registry]|||Vascular Markers During OGTT in Diabetics and First-degree Relatives|Changes of the Endothelial Glycocalyx, the Elastic Properties of the Arteries and the Coronary Flow Reserve (CFR) During Oral Glucose Tolerance Test in Patients With New Onset Diabetes Mellitus and First-degree Relatives|Unknown status|Recruiting|N/A|90|Anticipated|University of Athens|||3||f||||t||||||Samples Without DNA|"     Plasma in serum for fibrosis and inflammatory markers   "|||2017-10-11 00:00:00.490187|2017-10-11 00:00:00.490187
NCT02244723|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-09-04|||June 1, 2013|Actual|2013-06-01|September 2017|2017-09-01|September 1, 2015|Actual|2015-09-01|January 1, 2015|Actual|2015-01-01||Observational|VPLUS||Diagnostic Value of Lung Ultrasound for Ventilator-Associated Pneumonia|Prospective, Observational Study of Diagnostic Value of Lung Ultrasound for Ventilator-Associated Pneumonia|Completed||N/A|98|Actual|Groupe Hospitalier Paris Saint Joseph|||1||f||||f|f|f||||Samples Without DNA|"     -  Biochemical data (WBC count with differential, arterial blood gas)        -  Microbiological data (UTA and BAL) - UTA data must have been collected within 24 hours          of enrollment and BAL data within 12 hours of enrollment (unprotected tracheal aspirate          (UTA)- fibrobronchoscopy with protected distal sampling)   "|||2017-10-11 00:00:00.604228|2017-10-11 00:00:00.604228
NCT02244710|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-11-22|||March 2015||2015-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||EndoTic - Endothelium and Ticagrelor|EndoTic - Endothelium and Ticagrelor: Pharmacological Effects Beyond Antiplatelet Therapy|Completed||N/A|109|Actual|Fundación Investigación Sanitaria en León||2|||f||||f||||||||||2017-10-11 00:00:00.719482|2017-10-11 00:00:00.719482
NCT02244697|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||The Yield of Laryngeal Ultrasound in the Evaluation of Stridor and Dysphonia in Children|The Yield of Laryngeal Ultrasound in the Evaluation of Stridor and Dysphonia in Children|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||||||||||||2017-10-11 00:00:00.825443|2017-10-11 00:00:00.825443
NCT02244684|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-16|||September 2010||2010-09-01|September 2014|2014-09-01||||February 2013|Actual|2013-02-01||Observational|||Effects of Maternal Folate and Folic Acid Supplementation on DNA Methylation in the Newborn Infant||Completed||N/A|368|Actual|St. Michael's Hospital, Toronto|||1||f||||||||||||||2017-10-11 00:00:00.906288|2017-10-11 00:00:00.906288
NCT02244671|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-03-08|||January 2014||2014-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)|Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)|Recruiting||N/A|5|Anticipated|Fox, Donald Munro, M.D., P.C.||1|||f||||f||||||||||2017-10-11 00:00:00.970601|2017-10-11 00:00:00.970601
NCT02244658|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2016-04-18|||September 2014||2014-09-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia|Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia: a Multicenter Clinical Trial|Recruiting||Phase 3|80|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-11 00:00:01.069282|2017-10-11 00:00:01.069282
NCT02244645|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-18|||December 2013||2013-12-01|September 2014|2014-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Effects of Yoga Versus Passive Modality on Pain, Disability, Salivary Cortisol Concentrations, Brain- Derived Neurotropic Factor, Heart Rate Variability and Immune Functions Among Patients With Chronic Low Back Pain: A Randomized Controlled Trial|Effects of Yoga Versus Passive Modality on Pain, Disability, Salivary Cortisol Concentrations, Brain- Derived Neurotropic Factor, Heart Rate Variability and Immune Functions Among Patients With Chronic Low Back Pain: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|86|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:00:01.167775|2017-10-11 00:00:01.167775
NCT02244632|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-09-20|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Modufolin® in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer|An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of [6R] 5,10-Methylene Tetrahydrofolate (Modufolin®) in Combination With a Fixed Dose of 5-Fluorouracil (5-FU) Alone or Together With a Fixed Dose of Oxaliplatin or Irinotecan in Patients With Stage IV Colorectal Cancer|Recruiting||Phase 1/Phase 2|50|Anticipated|Isofol Medical AB||5|||f||||f||||||||||2017-10-11 00:00:01.279293|2017-10-11 00:00:01.279293
NCT02244619|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-21|2017-05-17||September 2014|Actual|2014-09-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|KHEA||PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement|Randomized, Double-Blind, Study Comparing Oral Acetaminophen Plus Intravenous (IV) Placebo to Oral Placebo Plus IV Acetaminophen Given Perioperatively for Controlling Pain in the 24hr Post-op Period After Total Hip or Knee Joint Replacement|Completed||Phase 4|515|Actual|Kettering Health Network|Single hospital, limited to two types of surgical patient. No standard protocol for assessing pain. Oral acetaminophen administered earlier than IV per hospital protocol.|2|||f||||f||||||||||2017-10-11 00:00:01.454055|2017-10-11 00:00:01.454055
NCT02244606|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-15|||September 2014||2014-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Oral SCY-078 vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis|Open-Label, Randomized Study to Estimate Safety, PK, and Efficacy of Oral SCY-078 vs. Standard-of-Care Following IV Echinocandin Therapy in the Treatment of Invasive Candidiasis in Hospitalized Nonneutropenic Adults|Completed||Phase 2|27|Actual|Scynexis, Inc.||3|||f||||f||||||||||2017-10-11 00:00:02.17387|2017-10-11 00:00:02.17387
NCT02244593|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-04-03|||October 2014||2014-10-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||FAST MRI Study in Breast Cancer Survivors|FAST MRI Study in Breast Cancer Survivors|Recruiting||N/A|300|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||Yes|Planning on submitting preliminary results to RSNA 2017 and full publication by Oct 2018.|2017-10-11 00:00:02.364824|2017-10-11 00:00:02.364824
NCT02244580|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-09-16|2016-09-16||August 2014||2014-08-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Clinical data and breast tumour tissue samples were collected within the FinHer trial (identifier ISRCTN76560285).|"Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit MammaTyperTM"|Evaluation of the MammaTyperTM Kit, Ref 90020/90021 Performed on Clinical Material Obtained From Patients With Breast Cancer: Re-Examination of Tumor Material and Re-Evaluation of Patient Data of the FinHer-Study|Completed||N/A|1010|Actual|Biontech Diagnostics GmbH||1|||f||||f||||||||||2017-10-11 00:00:02.467407|2017-10-11 00:00:02.467407
NCT02244567|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2017-05-13|||September 2014||2014-09-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|U-C OC IN PCOS||Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women|Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin in Hyperandrogenic Lean PCOS Women|Recruiting||Phase 1|100|Anticipated|Beni-Suef University||3|||f||||t||||||||||2017-10-11 00:00:02.897953|2017-10-11 00:00:02.897953
NCT02244554|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-05-18|||July 2014||2014-07-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal|Prospective, Open-Label Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal|Completed||N/A|20|Actual|Cutera Inc.||2|||f||||f||||||||||2017-10-11 00:00:03.022381|2017-10-11 00:00:03.022381
NCT02244541|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2016-08-10|||December 2014||2014-12-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2015|Actual|2015-10-01||Interventional|ANAVEX||Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease|Phase 2a Study of ANAVEX2-73 Adaptive-Trial-Design With Repeated Doses, MTD Finding, Pharmacodynamic and Bioavailability Evaluation in Patients With Mild to Moderate Alzheimer's Disease With a 12-Month Open Label Follow-Up Period|Active, not recruiting||Phase 2|32|Anticipated|Anavex Life Sciences Corp.||4|||f||||t||||||||||2017-10-11 00:00:03.129379|2017-10-11 00:00:03.129379
NCT02244515|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-18|||June 2014||2014-06-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Consequence of Dexmedetomidine on Emergence Deliruim After Sevoflurane Anesthesia in Children With Cerebral Palsy|Consequence of Dexmedetomidine on Emergence Deliruim After Sevoflurane Anesthesia in Children With Cerebral Palsy|Unknown status|Enrolling by invitation|Phase 4|80|Anticipated|Guangzhou Women and Children's Medical Center||2|||f||||||||||||||2017-10-11 00:00:03.350374|2017-10-11 00:00:03.350374
NCT02244502|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-09-20|||September 2014||2014-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)|An Open Label Pilot Study of the NovoTTF-100L(O) System (NovoTTF Therapy) (200 kHz) Concomitant With Weekly Paclitaxel for Recurrent Ovarian Carcinoma|Active, not recruiting||Phase 1/Phase 2|31|Actual|NovoCure Ltd.||1|||f||||f||||||||||2017-10-11 00:00:03.42609|2017-10-11 00:00:03.42609
NCT02244489|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-04-17|||November 5, 2014|Actual|2014-11-05|April 2017|2017-04-01|April 5, 2017|Actual|2017-04-05|March 8, 2017|Actual|2017-03-08||Interventional|||Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma|A Phase 1b Study Evaluating Momelotinib Combined With Capecitabine and Oxaliplatin in Subjects With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma|Terminated||Phase 1|16|Actual|Gilead Sciences||2|||f||||f|t|f||||||||2017-10-11 00:00:03.539655|2017-10-11 00:00:03.539655
NCT02244463|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-05-19|||July 2015||2015-07-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer|A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer|Recruiting||Phase 2|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No|There are no plans to share individual participant data. Cumulative results will be posted here and published.|2017-10-11 00:00:03.816168|2017-10-11 00:00:03.816168
NCT02244450|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-08-28|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|DEPISTREC||Generalized Neonatal Screening of Severe Combined Immunodeficiencies|Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards|Active, not recruiting||N/A|190539|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 00:00:03.941896|2017-10-11 00:00:03.941896
NCT02244437|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2016-03-16|||October 2014||2014-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Ibuprofen vs Acetaminophen for AMS Prevention|Ibuprofen vs Acetaminophen in the Prevention of Acute Mountain Sickness: A Double Blind, Randomized Controlled Trial|Completed||Phase 4|288|Actual|Mountain Medicine Society of Nepal||2|||f||||t||||||||||2017-10-11 00:00:04.226293|2017-10-11 00:00:04.226293
NCT02244411|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-04-19|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Exercise and QUality Diet After Leukemia: The EQUAL Study|Exercise and QUality Diet After Leukemia: The EQUAL Study|Active, not recruiting||N/A|358|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:00:04.448885|2017-10-11 00:00:04.448885
NCT02244398|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-17|||February 2012||2012-02-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Community-based Delivery of Integrated Family Planning/HIV Testing and Counseling Services in Uganda|Community-based Delivery of Integrated Family Planning/HIV Testing and Counseling Services in Uganda|Completed||N/A|292|Actual|FHI 360||2|||f||||f||||||||||2017-10-11 00:00:04.566312|2017-10-11 00:00:04.566312
NCT02244385|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2017-07-18|||July 2011||2011-07-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|MAViS||Manchester Antenatal Vascular Service|Manchester Antenatal Vascular Service|Recruiting||N/A|450|Anticipated|Central Manchester University Hospitals NHS Foundation Trust|||1||f||||f||||||Samples Without DNA|"     Whole blood sample Urine sample   "|||2017-10-11 00:00:04.682692|2017-10-11 00:00:04.682692
NCT02244372|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2014-09-17|||September 2014||2014-09-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity||Unknown status|Recruiting|Phase 2/Phase 3|90|Anticipated|Chonbuk National University Hospital||3|||f||||t||||||||||2017-10-11 00:00:04.792489|2017-10-11 00:00:04.792489
NCT02244359|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-17|2016-08-24|||September 2014||2014-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|DOLCE||Improving Decision Making On Location of Care With the Frail Elderly and Their Caregivers|Improving the Decision Making Process About Location of Care With the Frail Elderly and Their Caregivers|Completed||N/A|455|Actual|CHU de Quebec-Universite Laval||2|||f||||||||||||||2017-10-11 00:00:04.926173|2017-10-11 00:00:04.926173
NCT02244346|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||May 2004||2004-05-01|September 2014|2014-09-01||||November 2004|Actual|2004-11-01||Observational|||Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)|Secotex®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)|Completed||N/A|811|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:05.062236|2017-10-11 00:00:05.062236
NCT02244333|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||February 2004||2004-02-01|September 2014|2014-09-01||||July 2004|Actual|2004-07-01||Observational|||Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)|ALNA® - AWB in Pre-treated Patients With BPS|Completed||N/A|4575|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:05.15112|2017-10-11 00:00:05.15112
NCT02244320|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||September 2002||2002-09-01|September 2014|2014-09-01||||May 2003|Actual|2003-05-01||Observational|||Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)|Observational Study in Patients With Functional BPH (Benign Prostatic Hyperplasia) Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)|Completed||N/A|4150|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:05.232305|2017-10-11 00:00:05.232305
NCT02244307|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||January 2000||2000-01-01|September 2014|2014-09-01||||June 2003|Actual|2003-06-01||Observational|||Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade|Evolution of Patients Suffering From Benign Prostatic Hyperplasia (BPH) Treated With Alpha-adrenergic Blockade (JOSEPHINE)|Completed||N/A|4561|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:05.317916|2017-10-11 00:00:05.317916
NCT02244294|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||March 2001||2001-03-01|September 2014|2014-09-01||||June 2005|Actual|2005-06-01||Interventional|||FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)|A Two Phase, Double-blinded, Randomized, Parallel Group Design, Multicenter Study of FLOMAX® Capsules, 0.4 mg Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia|Completed||Phase 2|176|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:05.419071|2017-10-11 00:00:05.419071
NCT02244281|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||May 2001||2001-05-01|September 2014|2014-09-01||||November 2003|Actual|2003-11-01||Interventional|||Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms|An Eight-week, Double-blind, Randomized, Parallel Group Design, Multicenter Study of FLOMAX® Capsules, 0.4 mg Daily Versus Placebo, in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms|Completed||Phase 2|74|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:05.524172|2017-10-11 00:00:05.524172
NCT02244268|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||October 2000||2000-10-01|September 2014|2014-09-01||||December 2001|Actual|2001-12-01||Observational|||Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia|Effect of ALNA® (Tamsulosin) on the Primary Symptoms of BPH (Benign Prostatic Hyperplasia) Syndrome|Completed||N/A|3629|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:05.630595|2017-10-11 00:00:05.630595
NCT02244255|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||August 1998||1998-08-01|September 2014|2014-09-01||||June 2000|Actual|2000-06-01||Interventional|||FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia|An Eleven-Week, Open-Label, Randomized, Multicenter, Parallel-Design, Placebo Lead-in Study of FLOMAX® Capsules, 0.4 mg Daily Versus HYTRIN® Capsules, 5 mg (With Titration) Daily in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 4|1993|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:05.745095|2017-10-11 00:00:05.745095
NCT02244242|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||July 1998||1998-07-01|September 2014|2014-09-01||||August 1999|Actual|1999-08-01||Interventional|||Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia|A Forty-Five Day, Open-label Study of the Symptomatic Relief Effects of FLOMAX® Capsules 0.4 mg Daily in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 4|493|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:00:05.869159|2017-10-11 00:00:05.869159
NCT02244229|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||April 1998||1998-04-01|September 2014|2014-09-01||||November 2000|Actual|2000-11-01||Interventional|||Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients|MICTUS (Multicentre Investigation to Characterise the Effect of Tamsulosin on Urinary Symptoms): A Multicentre, Double-blind, Randomised, Parallel Group Study, Aimed at Characterising the Effect of Tamsulosin, an Uroselective α1- Receptor Blocking Agent, on the Urological Symptoms and Their Impact on General Health Status and Quality of Life in Outpatients Affected by Symptomatic Benign Prostatic Hyperplasia: Comparison With Finasteride.|Completed||Phase 4|403|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:05.95244|2017-10-11 00:00:05.95244
NCT02244216|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||April 2000||2000-04-01|September 2014|2014-09-01||||June 2000|Actual|2000-06-01||Observational|||Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease|Postmarketing Surveillance Study (as Per § 67 (6) AMG [German Drug Law]) of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease|Completed||N/A|2914|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:06.045037|2017-10-11 00:00:06.045037
NCT02244203|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||February 2009||2009-02-01|September 2014|2014-09-01||||July 2009|Actual|2009-07-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers|Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of 0.25, 0.5, 1, 2, 4, 20, 50, 100, 150 and 200 mg BI 60732 Powder in Bottle (PIB) Administered to Healthy Male Volunteers in a Randomised, Double Blind, Placebo Controlled Phase I Trial|Completed||Phase 1|56|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:06.137859|2017-10-11 00:00:06.137859
NCT02244190|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-18|2014-09-18|||April 2008||2008-04-01|September 2014|2014-09-01||||May 2008|Actual|2008-05-01||Interventional|||Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers|Bioequivalence of Two Different Oral Solutions of 500 mg of Tipranavir (New Formulation vs. Current Formulation) Administered in Combination With 200 mg of Ritonavir (Oral Solution) to Healthy Volunteers (an Open-label, Randomised, Single Dose, Two-way Crossover Study)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:06.258115|2017-10-11 00:00:06.258115
NCT02244177|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-03-30|||November 2013||2013-11-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Observational|||Relationship of Essential Hypertension and Its Treatments on the Postoperative Pain Management: a Prospective, Observational, Cross-sectional Study||Unknown status|Recruiting|N/A|300|Anticipated|Kaohsiung Veterans General Hospital.|||3||f||||||||||||||2017-10-11 00:00:06.357267|2017-10-11 00:00:06.357267
NCT02244164|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-08-01|||October 2014||2014-10-01|July 2017|2017-07-01||||July 2019|Anticipated|2019-07-01||Interventional|||Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.|Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.|Recruiting||N/A|50|Anticipated|Erasme University Hospital||3|||f||||f||||||||||2017-10-11 00:00:06.437398|2017-10-11 00:00:06.437398
NCT02244151|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-08-11|||September 2014||2014-09-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|TIMING||Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval|Evaluation of the Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval in IVF Cycles: A Simple Blind, Randomized Controlled Trial.|Recruiting||Phase 2|176|Anticipated|Instituto de Investigacion Sanitaria La Fe||4|||f||||f||||||||||2017-10-11 00:00:06.554868|2017-10-11 00:00:06.554868
NCT02244138|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-03-06|||September 2014||2014-09-01|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|AdolCHICA||Improving Adolescent Health Outcomes Through Preventive Care Transformation|Improving Adolescent Health Outcomes Through Preventive Care Transformation|Recruiting||N/A|2831|Anticipated|Indiana University|||1||f||||f||||||||||2017-10-11 00:00:06.660879|2017-10-11 00:00:06.660879
NCT02244125|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-05-09|||April 2014||2014-04-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|January 2017|Actual|2017-01-01||Interventional|PCD||A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial|A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial|Active, not recruiting||Phase 2|100|Actual|Institut Curie||2|||f||||t||||||||No||2017-10-11 00:00:06.733325|2017-10-11 00:00:06.733325
NCT02244112|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-14|||August 2014||2014-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|May 2015|Actual|2015-05-01||Interventional|||A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies|A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies|Active, not recruiting||Phase 1|45|Actual|Amgen||3|||f||||t||||||||||2017-10-11 00:00:07.051742|2017-10-11 00:00:07.051742
NCT02244099|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-09-22|||September 2014||2014-09-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic|Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic|Completed||N/A|96|Actual|Ohio State University||1|||f||||f||||||||||2017-10-11 00:00:07.140722|2017-10-11 00:00:07.140722
NCT02244086|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-05-25|||June 2013||2013-06-01|May 2016|2016-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|EBWL||Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in Labor|Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in Labor.|Completed||Phase 4|114|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||Undecided||2017-10-11 00:00:07.232284|2017-10-11 00:00:07.232284
NCT02244073|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-02-27|||May 2015||2015-05-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|CONTROLING||Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.|Individualized Blood Glucose Control in ICU.|Terminated||N/A|2069|Actual|Hospices Civils de Lyon||2||Data safety monitoring board decision|f||||f||||||||||2017-10-11 00:00:07.333996|2017-10-11 00:00:07.333996
NCT02244060|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2015-04-05|||September 2014||2014-09-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Eye Examinations as a Gold Standard to Evaluating Survey Instruments|Eye Examinations as a Gold Standard to Evaluating Survey Instruments|Completed||N/A|4320|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 00:00:07.442379|2017-10-11 00:00:07.442379
NCT02244034|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-03-21|||May 2014||2014-05-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Observational|||Incidence and Risk Factors of Postoperative Hypothermia in Cardiac Surgery|Incidence and Risk Factors of Postoperative Hypothermia in Patients With Cardiopulmonary Bypass.|Recruiting||N/A|780|Anticipated|Mahidol University|||1||f||||f||||||||||2017-10-11 00:00:07.618077|2017-10-11 00:00:07.618077
NCT02244021|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-09-21|||December 2014||2014-12-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|July 2016|Actual|2016-07-01||Interventional|||A Pilot Phase II Study With BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients Non Responding to IGEV Salvage Treatment|A Pilot Phase II Study With BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients Non Responding to IGEV Salvage Treatment|Active, not recruiting||Phase 2|13|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-11 00:00:07.687728|2017-10-11 00:00:07.687728
NCT02244008|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-16|||July 2012||2012-07-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Accumulative Effects of Talus Mobilization|Effects of Anteroposterior Talus Mobilization on Range of Motion, Pain, and Functional Capacity in Participants With Sub-acute and Chronic Ankle Injuries: A Randomized Controlled Trial|Completed||N/A|38|Actual|Federal University of Minas Gerais||2|||f||||t||||||||||2017-10-11 00:00:07.80801|2017-10-11 00:00:07.80801
NCT02243995|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-09-16|||January 2013||2013-01-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|April 2014|Actual|2014-04-01||Interventional|||Physical Training in Sarcoidosis Patients|Physical Training in Sarcoidosis Patients With Fatigue Complaints|Unknown status|Enrolling by invitation|N/A|40|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-11 00:00:07.940647|2017-10-11 00:00:07.940647
NCT02243982|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-09-16|||March 2010||2010-03-01|December 2009|2009-12-01|December 2012|Actual|2012-12-01|June 2011|Actual|2011-06-01||Interventional|||Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease|Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in Cerebrospinal Fluid and Positron Emission Tomography in the Dementia of Parkinson's Disease|Completed||Early Phase 1|28|Actual|Fundacion Clinic per a la Recerca Biomédica||1|||f||||f||||||||||2017-10-11 00:00:08.035036|2017-10-11 00:00:08.035036
NCT02243969|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-03-21|||May 2014||2014-05-01|September 2015|2015-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|VASALA||Alpha-linolenic Acid and Blood Pressure|Effects of Alpha-linolenic Acid on 24h-ambulatory Mean Arterial Pressure in Untreated High-normal and Stage I Hypertensive Subjects|Completed||N/A|62|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:00:08.141575|2017-10-11 00:00:08.141575
NCT02243956|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-09-06|||January 2014||2014-01-01|September 2017|2017-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects on Cognitive Functions and Mood of Food Products Rich in Polyphenols|Food Design for Improved Cognitive Performance/Effects on Cognitive Functions and Mood of Food Products Rich in Polyphenols|Completed||N/A|38|Actual|Lund University||2|||f||||f||||||||||2017-10-11 00:00:08.232912|2017-10-11 00:00:08.232912
NCT02243943|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-12-11|2016-07-14||September 2014||2014-09-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Neuropa||Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile|Effect of Neuromuscular Blockade Reversal With Sugammadex on Oxygenation, Pain and Arousal States in the Post Anesthesia Care Unit|Completed||Phase 4|100|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-11 00:00:08.323792|2017-10-11 00:00:08.323792
NCT02243930|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-17|||March 2014||2014-03-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Cap-assisted Sigmoidoscopy - Influence on Pain, Duration and Rate of Success|Cap-assisted Sigmoidoscopy - Reduction in Pain, Reduction in Investigation Time and Increased Rate of Success, When Examined by the Less-experienced Endoscopist. A Prospective Randomized Clinical Trial|Completed||N/A|193|Actual|Zealand University Hospital||2|||f||||t||||||||||2017-10-11 00:00:10.466476|2017-10-11 00:00:10.466476
NCT02243917|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-06-15|||October 2014||2014-10-01|June 2017|2017-06-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors|A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered CB-5083 in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|150|Anticipated|Cleave Biosciences, Inc.||3|||f||||t||||||||No||2017-10-11 00:00:10.549025|2017-10-11 00:00:10.549025
NCT02243904|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-05-10|||August 2015||2015-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Observational|SPHERL||Study for Promotion of Health in Recycling Lead|Study for Promotion of Health in Recycling Lead|Recruiting||N/A|500|Anticipated|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-11 00:00:10.659518|2017-10-11 00:00:10.659518
NCT02243891|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-03-08|||May 2015||2015-05-01|March 2015|2015-03-01|October 2017|Anticipated|2017-10-01|December 2016|Anticipated|2016-12-01||Interventional|LAAPITUP3||AF Ablation With or Without ROX Coupler Study|Left Atrial Ablation for Paroxysmal Atrial Fibrillation and Hypertension With Implantable Loop Recorder With or Without ROX Coupler Follow Up Study: The LAAPITUP 3 Study|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Eastbourne General Hospital||2|||f||||f||||||||||2017-10-11 00:00:10.745691|2017-10-11 00:00:10.745691
NCT02243878|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-12-21|||December 2014||2014-12-01|December 2016|2016-12-01|October 2022|Anticipated|2022-10-01|May 2019|Anticipated|2019-05-01||Interventional|STAR||Stereotactic Radiotherapy for Wet AMD (STAR)|StereoTactic Radiotherapy for Wet Age-Related Macular Degeneration (STAR): A Randomised, Double-masked, Sham-controlled, Clinical Trial Comparing Low-voltage X-ray Irradiation With as Needed Ranibizumab, to as Needed Ranibizumab Monotherapy.|Recruiting||Phase 3|411|Anticipated|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-11 00:00:10.836052|2017-10-11 00:00:10.836052
NCT02243852|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-18|||September 2014||2014-09-01|September 2014|2014-09-01||||August 2015|Anticipated|2015-08-01||Observational|||Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)|Evaluation of the Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21) Concentration in Patients With Growth Hormone Deficiency (GHD)|Unknown status|Recruiting|N/A|48|Anticipated|University of Liverpool|||3||f||||f||||||Samples Without DNA|"     All patients will have a 15 ml blood sample taken for glucose, insulin, lipid profile and     liver function tests (LFTs). Insulin sensitivity will be measured by HOMA-IR. Plasma     concentrations of FGF-21 will be measured using a commercial ELISA kit (Human FGF-21;     Biovendor, Germany).      16 GHD patients, who are eligible for GH replacement therapy as part of their routine     clinical care, according to the National Institute for Clinical Excellence (NICE)     recommendations, based on the biochemical deficiency and the appropriate AGHDA questionnaire     score (AGHDA score>11) will also be re-tested following 6-months of growth hormone     replacement therapy   "|||2017-10-11 00:00:11.092495|2017-10-11 00:00:11.092495
NCT02243839|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-16|||January 2014||2014-01-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Thrombolytic Therapy Versus Surgery for Obstructive Prosthetic Valve Thrombosis|Thrombolytic Therapy Versus Surgery for Obstructive Prosthetic Valve Thrombosis: A Randomized Multicenter Study|Unknown status|Recruiting|N/A|100|Anticipated|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital||2|||f||||f||||||||||2017-10-11 00:00:11.195953|2017-10-11 00:00:11.195953
NCT02243826|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-09-18|||July 2014||2014-07-01|September 2015|2015-09-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Impact of 50% Nitrous Oxide Inhalation on Pain and Anxiety Induced by Lumbar Puncture: a Double-blind Randomized Controlled Trial|Impact of 50% Nitrous Oxide Inhalation on Pain and Anxiety Induced by Lumbar Puncture: a Double-blind Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|66|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:00:11.394057|2017-10-11 00:00:11.394057
NCT02243800|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-07-28|||November 2011||2011-11-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|SCORPION||Study of the Efficacy and Safety of Cholecalciferol Supplementation on the Activity of Rheumatoid Arthritis in Patients With Vitamin D Deficiency|Study of the Efficacy and Safety of Cholecalciferol Supplementation on the Activity of Rheumatoid Arthritis in Patients With Vitamin D Deficiency|Recruiting||Phase 3|164|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:00:11.590562|2017-10-11 00:00:11.590562
NCT02243787|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-02-29|||April 2014||2014-04-01|February 2016|2016-02-01||||September 2015|Actual|2015-09-01||Interventional|||Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis|A Randomised, Double-blind, Sequential, Ascending Single-dose Study to Evaluate Safety, Tolerability, Biological Activity, and Systemic Exposure of COVA322, a Bispecific TNF-α / IL-17A Antibody Fusion Protein, in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis|Terminated||Phase 1/Phase 2|24|Actual|Covagen||2||"Based on the observed safety profile of COVA322, the sponsor decided to stop the clinical   study."|f||||t||||||||||2017-10-11 00:00:11.700263|2017-10-11 00:00:11.700263
NCT02243761|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-04-02|||August 2012||2012-08-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Evaluating a Peer-Facilitated Skills-Based Intervention for Caregivers of Concurrent Disordered Youth|Canadian Institutes of Health Research (CIHR) Team in Innovations in Child and Youth Concurrent Disorders: Service Delivery and Treatment Subproject|Completed||N/A|100|Actual|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-10-11 00:00:11.878787|2017-10-11 00:00:11.878787
NCT02243748|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-10-13|||February 2015||2015-02-01|October 2016|2016-10-01||||February 2019|Anticipated|2019-02-01||Interventional|||Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers|Translation of a Lung Cancer Palliative Care Intervention for Clinical Practice|Recruiting||N/A|385|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 00:00:11.963836|2017-10-11 00:00:11.963836
NCT02243735|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-06-17|||November 2014||2014-11-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|FIT||Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia|Multicenter Randomized Controlled Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion in the Treatment of Preoperative Anaemia in Colorectal Cancer Patients|Unknown status|Recruiting|Phase 4|198|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:00:12.0967|2017-10-11 00:00:12.0967
NCT02243722|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||July 2014||2014-07-01|February 2014|2014-02-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01|3 Months|Observational [Patient Registry]|||Establish Quantitative Measurements of Laryngeal Sensorimotor Functions and Evaluating the Grade of Phonation and Swallowing Impairment|Establish Comprehensive Quantitative Measurements of Laryngeal Sensorimotor Functions and Evaluating the Grade of Phonation and Swallowing Impairment|Unknown status|Recruiting|N/A|70|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||||||2017-10-11 00:00:12.292218|2017-10-11 00:00:12.292218
NCT02243709|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-02-06|||September 2014||2014-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mifepristone for the Prevention of Relapses of Alcohol Drinking|A Pilot Study on the Safety and Efficacy of Mifepristone for the Prevention of Relapses of Alcohol Drinking|Recruiting||Phase 1/Phase 2|20|Anticipated|Brown University||2|||f||||f||||||||||2017-10-11 00:00:12.386548|2017-10-11 00:00:12.386548
NCT02243696|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-07-17|||September 2014||2014-09-01|July 2017|2017-07-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01|5 Years|Observational [Patient Registry]|||Protego DF4 Post Approval Registry|Protego DF4 Post Approval Registry|Active, not recruiting||N/A|1694|Actual|Biotronik, Inc.|||1||f||||f||||||||||2017-10-11 00:00:12.502842|2017-10-11 00:00:12.502842
NCT02243683|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-10-13|||September 2014||2014-09-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Safety Study of Immune System Modulator for Autoimmune Diseases|A Randomized, Placebo Controlled, Double Blind, Dose Escalating, Crossover, Safety and Pharmacokinetic Study of AX-024.HCl in Healthy Male Subjects|Completed||Phase 1|18|Actual|Artax Biopharma Inc||2|||f||||||||||||||2017-10-11 00:00:12.691339|2017-10-11 00:00:12.691339
NCT02243670|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-09-08|||August 2016|Actual|2016-08-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy|Feasibility and Validity of Using a Novel Artificial Intelligence Platform to Monitor and Optimize Medication Adherence in Patients Receiving Opioid Replacement Therapy|Completed||N/A|9|Actual|AiCure||1|||f||||f||||||||||2017-10-11 00:00:12.768802|2017-10-11 00:00:12.768802
NCT02243657|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-09-16|||May 2009||2009-05-01|September 2014|2014-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652|A Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of ASP3652 in Healthy Young and Elderly Male and Female Subjects|Completed||Phase 1|101|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-10-11 00:00:12.979495|2017-10-11 00:00:12.979495
NCT02243644|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-12-31|||March 2014||2014-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT|A Clinical Trial to Study the Effects of Two Different Duration of Same Drug Albendazole in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Scan Head at the End of 6 Months|Completed||Phase 3|97|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 00:00:13.113553|2017-10-11 00:00:13.113553
NCT02243631|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-06-13|||October 15, 2014|Actual|2014-10-15|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Effect of Probenecid on Synovial Fluid ATP Levels in CPPD|ANK-dependent ATP Efflux Causes Calcium Pyrophosphate Deposition in Cartilage|Recruiting||Early Phase 1|40|Anticipated|VA Office of Research and Development||2|||f||||f|t|f|||f|||Undecided||2017-10-11 00:00:13.243329|2017-10-11 00:00:13.243329
NCT02243618|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-15|||September 2014||2014-09-01|July 2014|2014-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer||Unknown status|Recruiting|N/A|218|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:00:13.342956|2017-10-11 00:00:13.342956
NCT02243605|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-09-04|||December 19, 2014|Actual|2014-12-19|August 2017|2017-08-01||||June 30, 2019|Anticipated|2019-06-30||Interventional|||Cabozantinib-s-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma|A Phase 2 Study of XL184 (Cabozantinib) in Treating Patients With Relapsed Osteosarcomas and Ewing Sarcomas|Recruiting||Phase 2|90|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:00:13.440993|2017-10-11 00:00:13.440993
NCT02243592|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-09-28|||September 24, 2014|Actual|2014-09-24|September 2017|2017-09-01||||January 31, 2100|Anticipated|2100-01-31||Observational|||Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment|Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders|Recruiting||N/A|300|Anticipated|National Cancer Institute (NCI)|||1||f||||f||||||||||2017-10-11 00:00:13.620293|2017-10-11 00:00:13.620293
NCT01932268|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2013-08-26|||January 2011||2011-01-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking Rifampin||Completed||Phase 2|2|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:21:00.099939|2017-10-11 01:21:00.099939
NCT02243579|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-09-12|||October 15, 2014|Actual|2014-10-15|September 2017|2017-09-01||||January 31, 2018|Anticipated|2018-01-31||Interventional|||Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome|A Phase 2 Study of MK-3475 for the Treatment of Relapsed/Refractory Mycosis Fungoides / Sezary Syndrome|Active, not recruiting||Phase 2|24|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:00:14.095163|2017-10-11 00:00:14.095163
NCT02243566|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||April 2006||2006-04-01|September 2014|2014-09-01||||January 2007|Actual|2007-01-01||Observational|||Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)|Morning Hypertension and Patient Self-monitoring|Completed||N/A|2707|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:14.20495|2017-10-11 00:00:14.20495
NCT02243553|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-16|||January 2006||2006-01-01|August 2014|2014-08-01||||July 2006|Actual|2006-07-01||Interventional|||Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers|Evaluating the Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity Using a Biomarker Cocktail in Healthy Human Volunteers|Completed||Phase 1|34|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:00:14.279345|2017-10-11 00:00:14.279345
NCT02243540|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2014-09-15|||April 2014||2014-04-01|September 2014|2014-09-01||||September 2014|Anticipated|2014-09-01||Observational|||Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy|Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy: Comparison Between Potassium-titanyl-phosphate Photoselective Vaporization of the Prostate (PVP) and Holmium Laser Enucleation of the Prostate (HoLEP)|Unknown status|Recruiting|N/A|1828|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 00:00:14.39154|2017-10-11 00:00:14.39154
NCT02243527|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-07-13|||September 2014||2014-09-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|IMT||Respiratory Muscles and Inspiratory Muscle Training|Effects of Inspiratory Muscle Training on Respiratory Muscle Mechanics and Haemodynamics in Healthy Adults|Unknown status|Recruiting|N/A|22|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:00:14.46045|2017-10-11 00:00:14.46045
NCT02243514|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-10-22|||October 2014||2014-10-01|October 2014|2014-10-01|May 2015|Anticipated|2015-05-01|February 2015|Anticipated|2015-02-01||Observational|||Intravascular Ultrasound Evaluation of Renal Nerves in Different Diseases|Intravascular Ultrasound Evaluation of the Renal Nerves Remodeling in Different Diseases|Unknown status|Recruiting|N/A|60|Anticipated|The Second Affiliated Hospital of Chongqing Medical University|||4||f||||t||||||Samples With DNA|"     whole blood, urine, stool   "|||2017-10-11 00:00:14.571521|2017-10-11 00:00:14.571521
NCT02243501|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-03-07|||September 2016||2016-09-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|BNBD||Better Nights, Better Days for Typically Developing Children|Better Nights, Better Days: Improving Psychosocial Health Outcomes in Children With Behavioural Insomnia|Recruiting||N/A|500|Anticipated|IWK Health Centre||2|||f||||t||||||||No||2017-10-11 00:00:14.681123|2017-10-11 00:00:14.681123
NCT02243488|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-03-15|||September 2014||2014-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Does Menstrual Hygiene Matter? Investigating the Impact of a Menstrual Hygiene Program on Ugandan Girls' School Absenteeism|Does Menstrual Hygiene Matter? Randomised Control Step-Wedge Trial Investigating the Impact of a Menstrual Hygiene Program (Reusable Sanitary Pad and Menstrual Health Education) on Rural Ugandan Girls' School Absenteeism|Completed||N/A|40|Actual|Irise International||2|||f||||t||||||||||2017-10-11 00:00:14.784578|2017-10-11 00:00:14.784578
NCT02243462|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2015-04-14|||August 2014||2014-08-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|PWPS||Preoperative Warming and Perioperative Shivering|Effectiveness of Pre-operative Warming in Prevention of Peri-operative Shivering|Unknown status|Recruiting|N/A|180|Anticipated|Indus Hospital||2|||f||||f||||||||||2017-10-11 00:00:14.922768|2017-10-11 00:00:14.922768
NCT02243449|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-03-09|||January 2015||2015-01-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Screening Elderly Patients for Weaning|Screening Elderly PatieNts For InclusiOn in a Weaning Trial: The SENIOR Trial|Active, not recruiting||Phase 2|100|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:00:15.029284|2017-10-11 00:00:15.029284
NCT02243436|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-06-08|||November 2014||2014-11-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma|Phase I-II Clinical Trial for the Evaluation of Brentuximab Vedotin Plus Etoposide, Solumoderin (Methylprednisolone), High Dose ARA-C (Cytarabine) and Cisplatin in the Transplant and Post-transplant Management for Relapsed or Refractory Classical Hodgkin Lymphoma Patients|Active, not recruiting||Phase 1/Phase 2|67|Actual|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||f||||||||No||2017-10-11 00:00:15.144283|2017-10-11 00:00:15.144283
NCT02243423|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2016-01-22|||October 2014||2014-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Neonatal Acid-Base Status After C Section With Maternal Tilt vs. Supine|Neonatal Acid-base Status After Elective Cesarean Delivery Under Spinal Anesthesia - a Comparison of Maternal Supine Horizontal Position Versus Left Lateral Table Tilt|Completed||N/A|100|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 00:00:15.386996|2017-10-11 00:00:15.386996
NCT02243410|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-15|||March 2014||2014-03-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Visual Analogue Scale - a Quality Assurance Study|Visual Analogue Scale (VAS) - a Quality Assurance Research Study to Assess the Quality of the VAS as a Means for Measuring Postoperative Pain.|Completed||N/A|62|Actual|Herlev Hospital|||1||f||||f||||||||||2017-10-11 00:00:15.474109|2017-10-11 00:00:15.474109
NCT01924481|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-11-05|||September 2013||2013-09-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effects of a Cocoa Shot on the Human Brain|Effects of a Cocoa Shot on the Human Brain|Completed||Early Phase 1|6|Anticipated|Wake Forest University Health Sciences||4|||f||||f||||||||||2017-10-11 01:23:24.288457|2017-10-11 01:23:24.288457
NCT02243397|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-10-20|||September 2014||2014-09-01|October 2016|2016-10-01||||September 2024|Anticipated|2024-09-01||Observational|||Molecular and Cellular Analysis of Breast Cancer|Molecular and Cellular Analysis of Breast Cancer|Recruiting||N/A|500|Anticipated|Stanford University|||1||f||||f||||||Samples With DNA|"     blood, cerebrospinal fluid, abdominal fluid, chest fluid   "|||2017-10-11 00:00:15.559541|2017-10-11 00:00:15.559541
NCT02243384|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-05-21|||September 2014||2014-09-01|May 2015|2015-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma|A Randomized Controlled Trial of Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma|Recruiting||N/A|110|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 00:00:15.663098|2017-10-11 00:00:15.663098
NCT02243371|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-07-12|||December 2014||2014-12-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab|A Randomized Phase 2 Study of the Safety, Efficacy, and Immune Response of GVAX Pancreas Vaccine (With Cyclophosphamide) and CRS-207 With or Without Nivolumab in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|96|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:00:15.779445|2017-10-11 00:00:15.779445
NCT02243358|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-10-13|||February 2014||2014-02-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|||Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer|A Neoadjuvant Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer|Recruiting||Phase 2|20|Anticipated|Henry Ford Health System||1|||f||||f||||||||Yes|Through publication in peer reviewed journal|2017-10-11 00:00:15.888649|2017-10-11 00:00:15.888649
NCT02243345|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-15|||September 2013||2013-09-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Delayed Recompression for Decompression Sickness|Delayed Recompression for Decompression Sickness|Completed||N/A|204|Actual|Assaf-Harofeh Medical Center|||2||f||||f||||||||||2017-10-11 00:00:16.030852|2017-10-11 00:00:16.030852
NCT02243332|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-06-26|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Dynamic Quadriceps Muscle Stimulation for Treatment of Patellofemoral Pain|Dynamic Quadriceps Muscle Stimulation for Treatment of Patellofemoral Pain|Completed||N/A|20|Actual|Articulate Labs||1|||f||||f||||||||||2017-10-11 00:00:16.138404|2017-10-11 00:00:16.138404
NCT02243319|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2016-10-19|||September 2014||2014-09-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904|A Randomized, Open Label, Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904 in Healthy Male Subjects|Completed||Phase 1|24|Actual|Hanmi Pharmaceutical Company Limited||6|||f||||f||||||||No||2017-10-11 00:00:16.269444|2017-10-11 00:00:16.269444
NCT02243306|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-06-08|||October 24, 2014||2014-10-24|June 2017|2017-06-01|August 16, 2017|Anticipated|2017-08-16|August 16, 2017|Anticipated|2017-08-16||Interventional|||Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis|A Repeat-Dose, Open-Label, Parallel-Group Study to Assess the Pharmacokinetics of GSK1278863 and Metabolites in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis|Recruiting||Phase 1|30|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:00:16.416744|2017-10-11 00:00:16.416744
NCT02243293|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-08-31|2017-08-31|2017-02-08|September 19, 2014||2014-09-19|August 2017|2017-08-01|February 23, 2017|Actual|2017-02-23|October 25, 2016|Actual|2016-10-25||Interventional||All participants who received atleast 1 dose of study drug (ITT population)|A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection|A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection (SURVEYOR-II)|Completed||Phase 2/Phase 3|694|Actual|AbbVie||22|||f||||f|t|f||||||||2017-10-11 00:00:16.644388|2017-10-11 00:00:16.644388
NCT02243280|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-02-18|2017-02-18||August 2014||2014-08-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||Safety population: all participants who received at least 1 dose of study drug. Two participants assigned to Arm I received the incorrect dose of study drug throughout their participation in the study (ABT-493 200 mg QD instead of 300 mg) and are therefore included in Arm A instead of Arm I in the safety population.|A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection|An Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 1, 4, 5, and 6 Infection (SURVEYOR-I)|Completed||Phase 2|174|Actual|AbbVie||11|||f||||f||||||||No||2017-10-11 00:00:20.438|2017-10-11 00:00:20.438
NCT02243267|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-11-07|||September 2014||2014-09-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Observational|||GI SPORE Colon Biosample Protocol|Biospecimens for the Diagnosis, Treatment and Prevention of Colorectal Cancer|Recruiting||N/A|1500|Anticipated|University of Michigan|||1||f||||f||||||Samples Without DNA|"     Serum Plasma Buffy Coat Tissue Stool Urine   "|||2017-10-11 00:00:21.656173|2017-10-11 00:00:21.656173
NCT02243254|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-11-16|||July 2014||2014-07-01|November 2015|2015-11-01||||April 2015|Actual|2015-04-01||Interventional|||Prevention of Remifentanil-induced Postoperative Hyperalgesia With Intravenous Ibuprofen||Completed||N/A|120|Actual|Seoul National University Hospital||4|||f||||||||||||||2017-10-11 00:00:21.733471|2017-10-11 00:00:21.733471
NCT02243241|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-15|||November 2012||2012-11-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects|A Randomized, Double-blind, Placebo- and Positive-Controlled, Parallel Group, Dose Escalating Study of the Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets at Doses up to 160 mg on QT/QTc in Healthy Adult Subjects|Completed||Phase 1|208|Actual|Purdue Pharma LP||3|||f||||f||||||||||2017-10-11 00:00:21.821593|2017-10-11 00:00:21.821593
NCT01900054|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-03-10|2015-09-17||June 2013||2013-06-01|September 2015|2015-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis||Completed||Phase 3|58|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 01:29:42.486976|2017-10-11 01:29:42.486976
NCT02243228|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2014-09-16|||August 2014||2014-08-01|September 2014|2014-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)|A Prospective Study of Inhaling Granulocyte-macrophage Colony Stimulating Factor in Adult Patients With Mild-to-moderate Autoimmune Pulmonary Alveolar Proteinosis in China: a Randomized Open-label Study|Unknown status|Recruiting|Phase 2|42|Anticipated|Peking Union Medical College Hospital||1|||f||||f||||||||||2017-10-11 00:00:21.925246|2017-10-11 00:00:21.925246
NCT02243202|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-08-10|2016-06-16||September 2014||2014-09-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||The modified intent-to-treat (mITT) analysis set included all randomized participants who received at least 1 dose of double-blind study agent.|Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects|Completed||Phase 2|335|Actual|Janssen Research & Development, LLC||4|||f||||t||||||||||2017-10-11 00:00:22.147753|2017-10-11 00:00:22.147753
NCT02243189|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-03-22|||October 2014||2014-10-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma|A Phase 1 Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in a Double-Blind, Randomized, Placebo-Controlled Setting in Healthy Subjects, and by an Open-Label Assessment in Atopic Subjects With Mild to Mild-Persistent Asthma With and Without Nasal Allergen Challenge Prior to Dosing|Terminated||Phase 1|17|Actual|Janssen Research & Development, LLC||3||Under enrollment and IP supply expiring.|f||||f||||||||||2017-10-11 00:00:23.169394|2017-10-11 00:00:23.169394
NCT02243176|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-03-03|2016-09-27||September 2014||2014-09-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SMART|The Full analysis set included all randomized subjects who took at least 1 randomized IP dose, and had at least 1 non-missing baseline and 1 post-baseline efficacy data assessments|24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy|SMART Study - A 24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With Type 2 Diabetes Mellitus (T2D) Inadequately Controlled With Metformin Monotherapy|Completed||Phase 4|689|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:00:23.283133|2017-10-11 00:00:23.283133
NCT02243163|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||May 2014||2014-05-01|September 2014|2014-09-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Effect of Yoga on Life Quality and Immunity in Breast Cancer Patients After Operation and or Chemotherapy|Effect of Yoga on Life Quality and Immunity in Breast Cancer Patients After Operation and or Chemotherapy|Unknown status|Recruiting|N/A|40|Anticipated|Chang Bing Show Chwan Memorial Hospital||1|||f||||f||||||||||2017-10-11 00:00:24.326484|2017-10-11 00:00:24.326484
NCT02243150|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-06-29|||September 2014||2014-09-01|June 2015|2015-06-01||||February 2015|Actual|2015-02-01||Interventional|||Safety, Pharmacokinetic and Pharmacodynamic Study of the CDK 4/6 Inhibitor G1T28-1|First-In-Human Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of G1T28-1 in Healthy Male and Female Subjects|Completed||Phase 1|53|Actual|G1 Therapeutics, Inc.||7|||f||||f||||||||||2017-10-11 00:00:24.409889|2017-10-11 00:00:24.409889
NCT02243137|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2014-09-15|||May 2013||2013-05-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|ECCLIPSE||Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate|Effects of Combinated Administration of Lysine Acetylsalicylate Versus Prasugrel and Aspirin on Platelet Aggregation in Healthy Volunteers|Completed||Phase 1|30|Actual|Fundacion Investigacion Interhospitalaria Cardiovascular||2|||f||||f||||||||||2017-10-11 00:00:24.498325|2017-10-11 00:00:24.498325
NCT02243124|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-08-03|||September 2014||2014-09-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)|A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome|Unknown status|Enrolling by invitation|Phase 1|18|Anticipated|Eleos, Inc.||3|||f||||f||||||||||2017-10-11 00:00:24.597368|2017-10-11 00:00:24.597368
NCT02243111|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-01-20|||September 2014||2014-09-01|June 2014|2014-06-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound|Evaluation of Lung Doppler Signals (LDS) in Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc)|Terminated||N/A|1|Actual|Echosense Ltd.||1||Low recruitment rate|f||||f||||||||||2017-10-11 00:00:24.696863|2017-10-11 00:00:24.696863
NCT02243098|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-03-31|||September 16, 2014|Actual|2014-09-16|March 2017|2017-03-01|April 7, 2015|Actual|2015-04-07|April 7, 2015|Actual|2015-04-07||Interventional|||Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects|An Open-label, One-sequence Cross Over, Single Centre Trial, Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects|Completed||Phase 1|31|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 00:00:24.767893|2017-10-11 00:00:24.767893
NCT02243085|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2014-09-15|||August 2014||2014-08-01|September 2014|2014-09-01||||October 2014|Anticipated|2014-10-01||Observational|||Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the Prostate||Unknown status|Recruiting|N/A|126|Anticipated|DongGuk University|||1||f||||f||||||||||2017-10-11 00:00:24.850178|2017-10-11 00:00:24.850178
NCT01895608|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-04-05|2017-01-27||July 2013||2013-07-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Cognitive Training and Dual-task Ability|Cognitive Training and Dual-task Ability in Older Adults|Completed||N/A|34|Actual|VA Office of Research and Development||4|||f||||f||||||||No||2017-10-11 01:30:49.19396|2017-10-11 01:30:49.19396
NCT02243059|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2015-09-24|||September 2014||2014-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MILO||Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer|Contrast Enhanced Diffusion-weighted Magnetic Resonance Imaging for Detection of Pathologic Lymph Nodes in Ovarian Cancer - a Feasibility Study.|Withdrawn||Phase 4|0|Actual|Maastricht University Medical Center||1||Problems with availability of study medicine in clinical center|f||||t||||||||||2017-10-11 00:00:25.019868|2017-10-11 00:00:25.019868
NCT02243046|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2016-03-30|2016-01-28||December 2014||2014-12-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Clinical Investigation of a Zinc Based Toothpaste in Reducing Plaque and Gingivitis|The Clinical Investigation of a Zinc Based Toothpaste as Compared to a Triclosan Based Toothpaste and Colgate Fluoride Toothpaste in Reducing Established Plaque and Gingivitis - a Six-month Study.|Completed||Phase 2|162|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-10-11 00:00:25.172657|2017-10-11 00:00:25.172657
NCT02243033|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-08-24|||May 2016||2016-05-01|September 2016|2016-09-01|November 2036|Anticipated|2036-11-01|May 2036|Anticipated|2036-05-01||Observational|LITT or FLA||Phase II Laser Focal Therapy of Prostate Cancer|A Phase II Study to Evaluate Outpatient Magnetic Resonance Image-guided Laser Focal Therapy for Prostate Cancer, a 20-year Survival Study|Recruiting||N/A|1000|Anticipated|Desert Medical Imaging|||1||f||||f||||||||||2017-10-11 00:00:25.704898|2017-10-11 00:00:25.704898
NCT02243020|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-02-16|||October 2014||2014-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Interventional|||VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke|Study MT-St-02 - Stroke - A Randomized Pilot Study Assessing Vagus Nerve Stimulation (VNS) During Rehabilitation for Improved Upper Limb Motor Function After Stroke (MicroTransponder's Vivistim System)|Active, not recruiting||N/A|17|Actual|MicroTransponder Inc.||2|||f||||f||||||||||2017-10-11 00:00:25.83106|2017-10-11 00:00:25.83106
NCT02243007|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-04-10|2016-11-16||September 2014|Actual|2014-09-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer|Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer|Terminated||Phase 2|7|Actual|Massachusetts General Hospital||2||Slow Accrual|f||||t||||||||No||2017-10-11 00:00:25.971231|2017-10-11 00:00:25.971231
NCT02242994|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-10-24|2016-10-24||March 2014||2014-03-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional||Age 7-21|Data Acquisition Study for a Communication Device for Pediatric Patients With Cerebral Palsy||Completed||N/A|5|Actual|Children's Research Institute||1|||f||||||||||||||2017-10-11 00:00:26.592745|2017-10-11 00:00:26.592745
NCT02242981|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-11-19|||September 2014||2014-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study of How the Body Breaks Down and Eliminates LY2623091|Disposition of [14C]-LY2623091 Following Oral Administration in Healthy Subjects|Completed||Phase 1|6|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 00:00:26.766967|2017-10-11 00:00:26.766967
NCT02242968|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-26|||September 10, 2014||2014-09-10|July 18, 2017|2017-07-18|September 30, 2024|Anticipated|2024-09-30|September 30, 2024|Anticipated|2024-09-30||Observational|||Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products|Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:00:26.851698|2017-10-11 00:00:26.851698
NCT02242955|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-09-14|||July 2014||2014-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|DIAMA||Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse|Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse|Completed||N/A|26|Actual|University Hospital, Lille||2|||f||||t||||||||||2017-10-11 00:00:26.956198|2017-10-11 00:00:26.956198
NCT02242942|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-28|||December 31, 2014|Actual|2014-12-31|July 2017|2017-07-01|September 1, 2021|Anticipated|2021-09-01|November 30, 2018|Anticipated|2018-11-30||Interventional|||A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax (GDC-0199) Versus Obinutuzumab + Chlorambucil in Participants With Chronic Lymphocytic Leukemia|A Prospective, Open-Label, Multicenter Randomized Phase III Trial to Compare The Efficacy and Safety of A Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and Chlorambucil in Previously Untreated Patients With CLL and Coexisting Medical Conditions|Active, not recruiting||Phase 3|445|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-11 00:00:27.10705|2017-10-11 00:00:27.10705
NCT02242929|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-03-21|||January 2016||2016-01-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|December 2017|Anticipated|2017-12-01||Interventional|SCIN||Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma|Surgical Excision Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma: an Open, Non-inferiority, Randomized Controlled Trial|Recruiting||Phase 3|144|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:00:27.810176|2017-10-11 00:00:27.810176
NCT02242916|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-01-21|||May 2014||2014-05-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|ROCOCO||State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study|In Silico Clinical Trial, Comparing State of the Art Photon Modalities With Proton and C-ion Therapy for Recurrent Head & Neck Tumors: A Multicentric Planning Study From the ROCOCO (Radiation Oncology COllaborative COmparison) Group|Completed||N/A|25|Actual|Maastricht Radiation Oncology|||1||f||||t||||||||||2017-10-11 00:00:27.971386|2017-10-11 00:00:27.971386
NCT02242903|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-07-15|||October 2014||2014-10-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study of LY3079514 in Healthy Participants|A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3079514 in Healthy Subjects|Completed||Phase 1|72|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:00:28.057763|2017-10-11 00:00:28.057763
NCT02242890|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-09-15|||February 2015||2015-02-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pilot #2 of Social Network Intrauterine Contraceptive (IUC) Intervention|Pilot #2: The Woman-to-Woman Dissemination Project: Harnessing the Power of Social Networks to Increase IUC Use|Completed||N/A|40|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 00:00:28.14379|2017-10-11 00:00:28.14379
NCT02242877|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||February 2006||2006-02-01|September 2014|2014-09-01||||October 2006|Actual|2006-10-01||Observational|TELSYS||TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older|Observational Study in Everyday Medical Practice of the Effectiveness of Telmisartan for Treatment of Isolated Systolic Hypertension in Comparison With Systolic/Diastolic Hypertension in Patients Aged 55 or Older|Completed||N/A|3320|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 00:00:28.225237|2017-10-11 00:00:28.225237
NCT02242864|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||January 2006||2006-01-01|September 2014|2014-09-01||||October 2006|Actual|2006-10-01||Observational|||Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure|Micardis® / MicardisPlus® Monitoring of Morning Hypertension and Metabolism II|Completed||N/A|1527|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:28.293561|2017-10-11 00:00:28.293561
NCT02242851|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||September 2004||2004-09-01|September 2014|2014-09-01||||May 2005|Actual|2005-05-01||Observational|||Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients|Pharmaco-epidemiological Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients|Completed||N/A|5018|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:28.372188|2017-10-11 00:00:28.372188
NCT02242838|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||September 2003||2003-09-01|September 2014|2014-09-01||||September 2006|Actual|2006-09-01||Observational|||Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension|Post-Marketing Surveillance of Micardis® (Telmisartan) Special Drug Use-results Survey on Long-term Treatment|Completed||N/A|6336|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:28.433132|2017-10-11 00:00:28.433132
NCT02242825|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||January 2006||2006-01-01|September 2014|2014-09-01||||October 2006|Actual|2006-10-01||Observational|||Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus|Micardis® / MicardisPlus® Monitoring of Morning Hypertension and Metabolism II|Completed||N/A|8148|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:28.501772|2017-10-11 00:00:28.501772
NCT02242812|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||September 2003||2003-09-01|September 2014|2014-09-01||||October 2004|Actual|2004-10-01||Interventional|||Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension|Telmisartan Effectiveness on Left Ventricular MAss Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension - a Prospective, Randomised, Double-blind Comparison of Telmisartan 80 mg Oral, Once Daily, to Metoprolol Succinate 95 mg Oral, Once Daily, Over a Period of 6 Months|Terminated||Phase 4|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:28.569487|2017-10-11 00:00:28.569487
NCT02242799|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2016-10-04|||June 2015||2015-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|DolACT||Dolutegravir Interactions With Artemisinin-based Combination Therapies|Evaluation of Dolutegravir Interactions With Artemether-Lumefantrine and Amodiaquine-Artesunate|Completed||Phase 1|46|Actual|University of Liverpool||4|||f||||t||||||||||2017-10-11 00:00:28.647758|2017-10-11 00:00:28.647758
NCT02242786|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-11-06|||August 2014||2014-08-01|November 2014|2014-11-01||||July 2015|Anticipated|2015-07-01||Interventional|||Diffusion-Weighted Magnetic Resonance Imaging|Response Assessment for External Beam Radiation Therapy in Spinal Metastasis of Hepatocellular Carcinoma (HCC): Usefulness of Diffusion-Weighted Magnetic Resonance (MR) Imaging as A Functional Imaging|Unknown status|Recruiting|Phase 2|17|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 00:00:28.77133|2017-10-11 00:00:28.77133
NCT02242773|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2017-09-20|||November 12, 2014|Actual|2014-11-12|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|MAST||The Miami MAST Trial|MRI-Guided Active Selection for Treatment of Prostate Cancer: The Miami MAST Trial|Recruiting||N/A|165|Anticipated|University of Miami||1|||f||||t|f|t|f||f|||||2017-10-11 00:00:28.8629|2017-10-11 00:00:28.8629
NCT02242760|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-01-03|||November 2014||2014-11-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris|A Phase 2, Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled Study Comparing the Efficacy, Tolerability, and Safety of SB204 Gel and Vehicle Gel Once or Twice Daily in the Treatment of Acne Vulgaris|Completed||Phase 2|213|Actual|Novan, Inc.||5|||f||||f||||||||||2017-10-11 00:00:28.984016|2017-10-11 00:00:28.984016
NCT02242747|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-15|||May 2014||2014-05-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis|Evaluation of the Tolerability and Safety of 0.015% Ingenol Mebutate Gel Compared to 5% 5-fluorouracil Cream for the Treatment of Facial Actinic Keratosis: a Prospective Randomized Trial|Completed||N/A|100|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:00:29.124803|2017-10-11 00:00:29.124803
NCT02242734|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-09-15|||February 2011||2011-02-01|September 2014|2014-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment|Evaluation of the Effect of Hepatic Impairment on the Pharmacokinetics and Metabolism of Hydrocodone and Its Metabolites Following Administration of Hydrocodone Bitartrate Extended-Release (HC-ER) 20mg Capsules|Completed||Phase 1|30|Actual|Zogenix, Inc.||3|||f||||f||||||||||2017-10-11 00:00:29.226041|2017-10-11 00:00:29.226041
NCT02242721|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-07-30|||October 2014||2014-10-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01||Observational|||Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)|Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration|Withdrawn||N/A|0|Actual|Charite University, Berlin, Germany|||1||f||||f||||||Samples Without DNA|"     Blood samples and Dialysate   "|||2017-10-11 00:00:29.305634|2017-10-11 00:00:29.305634
NCT02242708|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2014-09-15|||October 2013||2013-10-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Effectiveness of Autonomic Nervous System, Sleep Quality, and Immune Regulation for Shift Nurses Practicing Alternative Nostril Breathing|The Effectiveness of Autonomic Nervous System, Sleep Quality, and Immune Regulation for Shift Nurses Practicing Alternative Nostril Breathing|Unknown status|Recruiting|N/A|40|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||f||||||||||2017-10-11 00:00:29.386184|2017-10-11 00:00:29.386184
NCT02242695|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-09-14|||November 2014||2014-11-01|July 2015|2015-07-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis|Comparative Study of the Efficacy of 10.0 mg Dequalinium Chloride (Fluomizin®) and 100 mg Clotrimazole (Canesten®) for the Treatment of Vulvovaginal Candidiasis|Completed||Phase 4|150|Actual|Medinova AG||2|||f||||f||||||||||2017-10-11 00:00:29.520158|2017-10-11 00:00:29.520158
NCT02242682|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-06-16|||May 2014||2014-05-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Video Education: Capitalizing on Caregiver Time Spent in the Pediatric Emergency Department Waiting Room||Completed||N/A|220|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 00:00:29.651432|2017-10-11 00:00:29.651432
NCT02242669|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-08-28|||November 2014||2014-11-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders|Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders|Completed||N/A|371|Actual|Massachusetts General Hospital|||3||f||||t||||||||||2017-10-11 00:00:29.743554|2017-10-11 00:00:29.743554
NCT02242656|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-02-16|||December 2014||2014-12-01|October 2014|2014-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals|A Phase 3, Open Label Responder Treatment Period With a Randomized, Blinded, Three-Period Crossover, Followed by an Open Label Safety Period to Evaluate the Clinical Efficacy, Safety, and Pharmacokinetics of Investigational Drug MP-101 (Opium Tincture and Opium Tincture With Reduced Uncharacterized Material) to Treat Chronic Diarrhea in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals|Withdrawn||Phase 3|0|Actual|Marathon Pharmaceuticals, LLC||2||Transfer of IND to new marketing authorization holder|f||||f||||||||||2017-10-11 00:00:29.83145|2017-10-11 00:00:29.83145
NCT02242643|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-04-18|2016-03-14||October 2014||2014-10-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age|Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age|Completed||Phase 3|2432|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 00:00:30.154245|2017-10-11 00:00:30.154245
NCT02242630|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2016-10-22|2016-08-29||September 2014||2014-09-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||Fifteen subjects were enrolled in each arm except for the TAC40 arm which had 16. The average age of the cohort was 67.1 ± 10.8 years old.|Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis|Improvement in Function and Pain Due to Subacromial Bursitis in Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone|Completed||N/A|61|Actual|Keesler Air Force Base Medical Center||4|||f||||f||||||||No|No plan to release IPD to other researchers|2017-10-11 00:00:33.885637|2017-10-11 00:00:33.885637
NCT02242617|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-06-12|||November 2015|Actual|2015-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CHOICE||Adherence and Preference of Continuous Positive Airway Pressure Versus Mandibular Advancement Splints in Obstructive Sleep Apnea Patients: A Randomized Trial (CHOICE)|Adherence and Preference of Continuous Positive Airway Pressure Versus Mandibular Advancement Splints in Obstructive Sleep Apnea Patients: A Randomized Trial|Recruiting||Phase 1|60|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 00:00:34.259369|2017-10-11 00:00:34.259369
NCT02242604|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-10-24|||April 2014||2014-04-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Observational|||Characterization of Neuropsychologic and Physical Performance in Geriatric Patients With Hyponatremia.|Phenotypic Characterization of Neuropsychologic and Physical Performance in Geriatric Patients Suffering From Hyponatremia.|Recruiting||N/A|100|Anticipated|University of Cologne|||1||f||||f||||||||||2017-10-11 00:00:34.426411|2017-10-11 00:00:34.426411
NCT02242591|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-11-26|||August 2014||2014-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Adductor Canal Block vs. Placebo on Muscle Strength, Mobilisation and Pain After Total Knee Arthroplasty|Effect of Adductor Canal Block vs. Placebo on Muscle Strength, Mobilisation and Pain on the First Post-operative Day After Total Knee Arthroplasty|Completed||Phase 4|64|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-11 00:00:34.618969|2017-10-11 00:00:34.618969
NCT02242578|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-03-15|||August 2014||2014-08-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Treating Refractory Schizophrenia With rTMS|Effect of rTMS Over the Medial Cerebellum on Negative Symptoms and Cognitive Dysmetria in Subjects With Treatment Refractory Schizophrenia|Recruiting||N/A|21|Anticipated|Seton Healthcare Family||2|||f||||f||||||||||2017-10-11 00:00:34.721339|2017-10-11 00:00:34.721339
NCT02242565|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-09-28|||October 2014||2014-10-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia|Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia|Completed||N/A|500|Actual|FHI 360||2|||f||||f||||||||||2017-10-11 00:00:34.837466|2017-10-11 00:00:34.837466
NCT02242552|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-09-15|||June 2014||2014-06-01|August 2014|2014-08-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Observational|||Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood|Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood(TRICEPS Study)|Unknown status|Recruiting|N/A|30|Anticipated|St. Justine's Hospital|||1||f||||t||||||Samples With DNA|"     Blood, saliva, tumor sample (bone marrow or solid tumors)   "|||2017-10-11 00:00:34.945552|2017-10-11 00:00:34.945552
NCT02242539|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-01-11|||September 2014||2014-09-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Tools to Improve Parental Recognition of Developmental Deficits in Children|Tools to Improve Parental Recognition of Developmental Deficits in Children|Completed||N/A|547|Actual|Boston University||3|||f||||f||||||||||2017-10-11 00:00:35.046657|2017-10-11 00:00:35.046657
NCT02242526|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-10-13|||September 2014||2014-09-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|September 2017|Anticipated|2017-09-01||Interventional|||Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia|Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia|Recruiting||Phase 4|312|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-10-11 00:00:35.166205|2017-10-11 00:00:35.166205
NCT02242513|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-11-30|||April 2014||2014-04-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Ultrasound-guided Pulsed Radiofrequency for Plantar Fasciitis|Ultrasound-guided Pulsed Radiofrequency Stimulation of the Tibial Nerve for Plantar Fasciitis|Completed||N/A|36|Actual|Tri-Service General Hospital||2|||f||||t||||||||||2017-10-11 00:00:35.28326|2017-10-11 00:00:35.28326
NCT02242500|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2015-12-26|||December 2010||2010-12-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Coronally Advanced Flap With or Without Porcine Collagen Matrix for Root Coverage|Phase IV Study of Coronally Advanced Flap With or Without Porcine Collagen Matrix for Treatment of Gingival Recession: a Randomized Controlled Clinical Trial|Completed||Phase 4|40|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 00:00:35.377075|2017-10-11 00:00:35.377075
NCT02242487|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-06-30|||March 2015||2015-03-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes|A 12 Month, Dose-Level Blinded Study Investigating the Safety and Efficacy of CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)|Active, not recruiting||Phase 3|325|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-10-11 00:00:35.484503|2017-10-11 00:00:35.484503
NCT02242474|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-02-27|||July 2015||2015-07-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis|Prospective Randomized Multicentric Trial on Anti-TNFα Treatment and Infection Risk in the Perioperative Period During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis.|Recruiting||Phase 4|660|Anticipated|CHU de Quebec-Universite Laval||2|||f||||t||||||||||2017-10-11 00:00:35.748838|2017-10-11 00:00:35.748838
NCT02242461|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-16|||May 2012||2012-05-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|COPD||Rhodiola Crenulata as an Adjunctive Therapy in COPD|Rhodiola Crenulata as an Adjunctive Therapy in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|57|Actual|Chung Shan Medical University||2|||f||||f||||||||||2017-10-11 00:00:35.885014|2017-10-11 00:00:35.885014
NCT02242448|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-06-30|||July 23, 2014||2014-07-23|March 15, 2016|2016-03-15|January 15, 2021|Anticipated|2021-01-15|July 28, 2020|Anticipated|2020-07-28||Observational|||Imaging Techniques in CT: Technical Development|Imaging Techniques in CT: Technical Development|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:00:35.969132|2017-10-11 00:00:35.969132
NCT02242435|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-07-27|||September 2014||2014-09-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||AP-008 Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis|A Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Three Intra-articular Injections of Ampion™ (4 mL) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee|Completed||Phase 3|342|Actual|Ampio Pharmaceuticals. Inc.||2|||f||||t||||||||||2017-10-11 00:00:36.042479|2017-10-11 00:00:36.042479
NCT02242422|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2014-09-15|||August 2014||2014-08-01|September 2014|2014-09-01||||November 2014|Anticipated|2014-11-01||Observational|||Serial Changes in Micturition Symptoms, Urine Flow and Bladder Voiding Efficiency Following Transobturator Tape Surgery|Serial Changes in Lower Urinary Tract Symptoms, Urine Flow and Bladder Voiding Efficiency Following Transobturator Tape Surgery for Treatment of Female Stress Urinary Incontinence|Unknown status|Recruiting|N/A|200|Anticipated|DongGuk University|||1||f||||f||||||||||2017-10-11 00:00:36.113829|2017-10-11 00:00:36.113829
NCT02242409|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-02-13|||September 2014||2014-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Study of Gemcitabine and Abraxane for Pancreas Cancer|A Phase II Study of Gemcitabine and Nanoparticle-Bound Paclitaxel as Second Line Therapy in Patients With Metastatic Pancreatic Cancer|Terminated||Phase 2|4|Actual|Georgetown University||1||Testing of combination no longer relevant|f||||t||||||||||2017-10-11 00:00:36.175663|2017-10-11 00:00:36.175663
NCT02242396|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||August 2005||2005-08-01|September 2014|2014-09-01||||November 2007|Actual|2007-11-01||Observational|||A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)|A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® Under Real Clinical Conditions With the Goal to Control the Early Morning BP Rise (SURGE II)|Completed||N/A|5248|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:38.01593|2017-10-11 00:00:38.01593
NCT02242383|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||January 2005||2005-01-01|September 2014|2014-09-01||||October 2005|Actual|2005-10-01||Observational|||Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension|Morning Hypertension and Monitoring of Metabolism (AWB Morgenhochdruck & Stoffwechselmonitoring)|Completed||N/A|13248|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:38.090073|2017-10-11 00:00:38.090073
NCT02242370|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||September 1999||1999-09-01|September 2014|2014-09-01||||November 2000|Actual|2000-11-01||Interventional|MicCAT||Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension|An Open-label Evaluation of the Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Life in Patients With Essential Hypertension The MICARDIS COMMUNITY ACCESS TRIAL (MicCAT)|Completed||Phase 4|3045|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:38.164456|2017-10-11 00:00:38.164456
NCT02242357|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||January 2003||2003-01-01|September 2014|2014-09-01||||July 2003|Actual|2003-07-01||Observational|||Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension|Post-Marketing Surveillance Study Micardis® Plus|Completed||N/A|14553|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:38.237598|2017-10-11 00:00:38.237598
NCT02242344|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||April 2006||2006-04-01|September 2014|2014-09-01||||September 2007|Actual|2007-09-01||Interventional|||Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension|A Prospective, Randomized, Double-blind, Placebo-controlled, Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension After Four Weeks of Treatment|Completed||Phase 2|77|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:00:38.310305|2017-10-11 00:00:38.310305
NCT02242331|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||June 2001||2001-06-01|September 2014|2014-09-01||||May 2002|Actual|2002-05-01||Observational|||Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure|Risk of Morning Hypertension|Completed||N/A|19805|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:38.387745|2017-10-11 00:00:38.387745
NCT02242318|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||September 2001||2001-09-01|September 2014|2014-09-01||||September 2002|Actual|2002-09-01||Interventional|||Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring|A Prospective, Randomised, Double-blind, Double-dummy Trial to Compare the Efficacy of Micardis® (Telmisartan) (80 mg p.o. Once Daily) and Valsartan (160 mg p.o. Once Daily) in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring|Completed||Phase 4|440|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:00:38.459749|2017-10-11 00:00:38.459749
NCT02242305|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2017-07-26|2017-03-29||November 1, 2008|Actual|2008-11-01|July 2017|2017-07-01|July 20, 2009|Actual|2009-07-20|July 20, 2009|Actual|2009-07-20||Interventional||"Full Analysis Set (FAS): According to the Intent-to-Treat (ITT) principle, all randomized subjects who took at least one dose of study medication and who provided any data for the primary efficacy endpoint were used in FAS.
Baseline participants less than participant flow as no abdominal pain within 3 weeks following randomization were withdrawn."|Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort|A Randomized, Double-blind, Double-dummy, Active-controlled, Parallel-group, Multi-center Trial, in Contrast With Hyoscine Butylbromide Capsule 10mg, to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets 10 mg (20mg, 3 Times Daily, Orally) Over a Period of 3 Days for the Treatment of Occasional or Recurrent Episodes of Self-reported Gastric or Intestinal Spasm-like Pain|Completed||Phase 3|302|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:38.577192|2017-10-11 00:00:38.577192
NCT02242292|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||April 2006||2006-04-01|September 2014|2014-09-01||||January 2007|Actual|2007-01-01||Interventional|||Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort|A Double-blind, Placebo-controlled, Randomized, Parallel Group Study of the Efficacy and Safety of Oral Doses of 20 mg Hyoscine Butylbromide When Used On-demand up to 7 Episodes Over a Period of 6 Weeks for the Treatment of Occasional Episodes of Self-reported Abdominal Pain, Cramping, and Discomfort Associated With Cramping in an OTC-like Study Population|Completed||Phase 2|527|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:39.149999|2017-10-11 00:00:39.149999
NCT02242279|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||June 2004||2004-06-01|September 2014|2014-09-01||||December 2004|Actual|2004-12-01||Interventional|||Study to Evaluate Efficacy and Safety of Inhaled BEA 2180 BR in COPD Patients|Randomised, Double-Blind, Placebo-Controlled, 4-Way Cross-Over Study to Assess the Efficacy and Safety of a Single Dose of Orally Inhaled BEA 2180 BR (Doses 80, 200 and 800 μg) in COPD Patients Followed by an Open-Label, Active-Control (Tiotropium 72 μg)|Completed||Phase 2|37|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:00:39.239643|2017-10-11 00:00:39.239643
NCT02242266|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||July 2005||2005-07-01|September 2014|2014-09-01||||June 2006|Actual|2006-06-01||Interventional|||Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Single Dose, Placebo-controlled, Randomized, Double-blind, Double-dummy, Crossover Efficacy, Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder (5 μg and 10 μg), Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® (18 μg Tiotropium) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|121|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:00:39.333883|2017-10-11 00:00:39.333883
NCT02242253|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||September 2003||2003-09-01|September 2014|2014-09-01||||July 2004|Actual|2004-07-01||Interventional|||Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Double-dummy, Crossover Efficacy and Safety Comparison of 6-week Treatment Periods of the Free Combinations of Tiotropium Inhalation Powder Capsule (18 μg) QD + Salmeterol Metered Dose Inhaler (2 Puffs of 25 μg) QD or BID, Tiotropium Inhalation Powder Capsule (18 μg) QD and Salmeterol Metered Dose Inhaler (2 Puffs of 25 μg) BID in Patients With (COPD)|Completed||Phase 2|97|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:00:39.436279|2017-10-11 00:00:39.436279
NCT02242240|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||March 2001||2001-03-01|September 2014|2014-09-01||||December 2001|Actual|2001-12-01||Interventional|||Lung Function Changes Following the Addition of Formoterol to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Lung Function Changes Following the Addition of Formoterol Inhalation Capsules (12 µ Once or Twice Daily) to Pharmacodynamic Steady State of Once Daily Tiotropium (18 µg) Inhalation Capsule in Patients With COPD|Completed||Phase 2|95|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:00:39.544828|2017-10-11 00:00:39.544828
NCT02242227|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-16|2014-09-16|||September 2005||2005-09-01|September 2014|2014-09-01||||February 2006|Actual|2006-02-01||Interventional|||Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Single Dose, Placebo-controlled, Randomized, Double-blind, Double-dummy, Crossover Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder (25 μg Salmeterol), Administered as the Xinafoate Salt From a Hard Polyethylene Capsule Via the HandiHaler® 2, and Serevent® Diskus® (50 μg Salmeterol) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|111|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:00:39.635674|2017-10-11 00:00:39.635674
NCT02242214|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-09-15|||September 2014||2014-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01|3 Days|Observational [Patient Registry]|REMOVE||REgistry of MisOprostol 200 µg Vaginal dElivery System||Completed||N/A|106|Actual|Ferring Pharmaceuticals|||1||f||||||||||||||2017-10-11 00:00:39.7386|2017-10-11 00:00:39.7386
NCT02242201|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2016-09-12|||September 2014||2014-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||THA Lumbar Plexus Verses Periarticular|Prospective, Randomized Controlled Trial Comparing Continuous Posterior Lumbar Plexus Nerve Block vs Periarticular Injection With Ropivacaine or Liposomal Bupivacaine (Exparel&#174;) on Patients Undergoing Total Hip Arthroplasty|Completed||Phase 4|165|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 00:00:39.80993|2017-10-11 00:00:39.80993
NCT02241603|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-07-05|||November 17, 2014|Actual|2014-11-17|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|IRRSO||Insulin Resistance and Reward|Insulin Resistance and Reward Signaling in Obesity|Recruiting||Phase 2|80|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 00:00:45.597199|2017-10-11 00:00:45.597199
NCT02242188|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2017-02-21|||September 2015||2015-09-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|SIDBI||Supplementing Iron and Development in Breastfed Infants (SIDBI Study)|Effect of Iron Supplementation on Psychomotor Development of Non-anemic Exclusively or Predominantly Breastfed Infants: Randomized, Double-blind, Placebo-controlled Trial.|Recruiting||Phase 4|220|Anticipated|Medical University of Warsaw||2|||f||||f||||||||Undecided|This has not been discussed in the study team.|2017-10-11 00:00:39.893306|2017-10-11 00:00:39.893306
NCT02242175|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2014-09-14|||September 2014||2014-09-01|July 2014|2014-07-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome||Unknown status|Not yet recruiting|N/A|147|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:00:39.988643|2017-10-11 00:00:39.988643
NCT02242162|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2016-03-01|||May 2009||2009-05-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|PI MAX STIM||Establishment of a Non-invasive and Indirect Measure of Volitional Pimax|Establishment of a Non-invasive and Indirect Measure of Volitional Pimax|Completed||N/A|75|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||t||||||||||2017-10-11 00:00:40.080036|2017-10-11 00:00:40.080036
NCT02242149|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2017-05-05|||October 14, 2014|Actual|2014-10-14|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 31, 2017|Actual|2017-01-31||Interventional|DGCLFT2DM||Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects|Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects|Active, not recruiting||Phase 3|84|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 00:00:40.1621|2017-10-11 00:00:40.1621
NCT02242136|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2014-09-15|||September 2014||2014-09-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Treatment of Posttraumatic Stress Disorder and Aggressive Behavior in Soldiers and Ex-combatants|Formation, Orientation and Rehabilitation by Means of Narrative Exposure Therapy (FORNET) for Returning Soldiers of the African Union Mission to Somalia, Male and Female Ex-combatants in Burundi|Unknown status|Enrolling by invitation|N/A|64|Anticipated|University of Konstanz||2|||f||||t||||||||||2017-10-11 00:00:40.266414|2017-10-11 00:00:40.266414
NCT02242123|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2017-03-30|||January 2012|Actual|2012-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Observational|||Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.|Antiendomysium Antibodies Assay in the Culture Medium of Intestinal Mucosa: an Accurate Method for Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-transglutaminase Antibodies.|Recruiting||N/A|50|Anticipated|University of Palermo|||2||f||||f||||||Samples Without DNA|"     Duodenal biopsy specimens   "|No||2017-10-11 00:00:40.349435|2017-10-11 00:00:40.349435
NCT02242110|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-08-22|||June 2014||2014-06-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|BERRT||Brief Treatment for Trauma Nightmares in Trauma-exposed Adults With Bipolar Disorder|Efficacy of a Brief Treatment for Chronic Nightmares Among Trauma-Exposed Persons With Bipolar Disorder|Recruiting||N/A|20|Anticipated|University of Tulsa||1|||f||||f||||||||||2017-10-11 00:00:40.463726|2017-10-11 00:00:40.463726
NCT02242097|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-10-10|||January 2015||2015-01-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Interventional|||Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma|A Phase II Clinical Trial Evaluating Ibrutinib Maintenance Following Intensive Induction for Patients With Previously Untreated Mantle Cell Lymphoma (MCL)|Recruiting||Phase 2|36|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 00:00:40.562232|2017-10-11 00:00:40.562232
NCT02242084|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-14|2017-04-12|||April 2016|Actual|2016-04-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Thrombolysis in Ischemic Spinal Cord Stroke|Thrombolysis in Ischemic Spinal Cord Stroke|Active, not recruiting||Phase 2|12|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 00:00:40.836524|2017-10-11 00:00:40.836524
NCT02242071|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-23|||December 2008||2008-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|March 2015|Actual|2015-03-01||Interventional|||Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis|The Effect of Autologous Bone Marrow Mononuclear Cell Transplantation on Motor Neuron Disease/Amyotrophic Lateral Sclerosis|Completed||Phase 1|40|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||No||2017-10-11 00:00:40.941664|2017-10-11 00:00:40.941664
NCT02242058|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-10-19|||August 2013||2013-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|QST||QST-Pupillometry in Sickle Cell Disease Patients|Quantitative Sensory Testing and Pupillometry in Sickle Cell Disease Patients.|Recruiting||Early Phase 1|160|Anticipated|Children's Research Institute|||5||f||||t||||||Samples With DNA|"     Collection of blood samples at baseline to be stored in the Pain Neurobiology laboratory for     future biochemical studies.   "|||2017-10-11 00:00:41.049639|2017-10-11 00:00:41.049639
NCT02242045|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2017-10-04|||October 1, 2014|Actual|2014-10-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|December 25, 2014|Actual|2014-12-25||Interventional|||Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Adults With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas or Chronic Lymphocytic Leukemia|A Phase 1b Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Subjects With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas or Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|6|Actual|Gilead Sciences||1|||f||||f||f||||||||2017-10-11 00:00:41.16831|2017-10-11 00:00:41.16831
NCT02242032|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-05-01|||July 2014||2014-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease|A Double-Masked, Randomized, Placebo-Controlled Dose Escalation Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease|Completed||Phase 1|53|Actual|Parion Sciences||2|||f||||f||||||||||2017-10-11 00:00:41.289418|2017-10-11 00:00:41.289418
NCT02242019|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-04-16|2015-07-08||February 2013||2013-02-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Study of Erchonia Low Level Laser Light Therapy to Treat Toenail Fungus|An Evaluation of the Effect of the Erchonia LUNULA on Treating Toenail Onychomycosis|Completed||N/A|109|Actual|Erchonia Corporation||1|||f||||f||||||||No||2017-10-11 00:00:41.449189|2017-10-11 00:00:41.449189
NCT02242006|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-15|||October 2014||2014-10-01|September 2014|2014-09-01||||March 2016|Anticipated|2016-03-01||Observational|||Antimicrobial Pharmacokinetics in Critically Ill Adults During Sustained Low Efficiency Dialysis (SLED)|Antimicrobial Pharmacokinetics in Critically Ill Adults During Sustained Low Efficiency Dialysis (SLED)|Unknown status|Not yet recruiting|N/A|90|Anticipated|Ottawa Hospital Research Institute|||3||f||||||||||||||2017-10-11 00:00:41.748139|2017-10-11 00:00:41.748139
NCT02241993|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-09-15|||July 2010||2010-07-01|September 2014|2014-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||The Multi-Sensor Distance Accuracy Study|The Accuracy Benefit of Dual vs Single Amperometric Glucose Sensors in Persons With Type 1 Diabetes: Effect of Inter-sensor Distance|Completed||N/A|20|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 00:00:41.870573|2017-10-11 00:00:41.870573
NCT02241980|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-15|||August 2014||2014-08-01|September 2014|2014-09-01||||October 2014|Anticipated|2014-10-01||Observational|||Survey of Patient and Physician Knowledge and Perception Regarding Medicare Part D Plan Selection|Survey of Patient and Physician Knowledge and Perception Regarding Medicare Part D Plan Selection|Unknown status|Recruiting|N/A|2000|Anticipated|Ohio State University|||2||f||||f||||||||||2017-10-11 00:00:41.986911|2017-10-11 00:00:41.986911
NCT02241954|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-02-07|||January 2010||2010-01-01|February 2017|2017-02-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|VEPTR||Vertical Expandable Prosthetic Titanium Rib (VEPTR) for Thoracic Insufficiency Syndrome|Ertical Expandable Prosthetic Titanium Rib (VEPTR) for Thoracic Insufficiency Syndrome|Enrolling by invitation||N/A|20|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||||No||2017-10-11 00:00:42.203145|2017-10-11 00:00:42.203145
NCT02241941|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2016-10-27|||September 2014||2014-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury|Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury|Withdrawn||Phase 4|0|Actual|University of Zurich||1||Assessment of daptomycin concentrations with microdialysis technically not feasible|f||||t||||||||||2017-10-11 00:00:42.287822|2017-10-11 00:00:42.287822
NCT02241928|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-23|||January 2009||2009-01-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Stem Cell Therapy in Muscular Dystrophy|Role of Autologous Mononuclear Cell Therapy in Muscular Dystrophy|Recruiting||Phase 1|1000|Anticipated|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-11 00:00:42.374646|2017-10-11 00:00:42.374646
NCT02241915|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2014-09-13|||January 2011||2011-01-01|September 2014|2014-09-01||||May 2012|Actual|2012-05-01||Interventional|Integuseal||Use of a Microbial Sealant to Reduce Surgical Site Infections.|Microbial Sealants Do Not Decrease Surgical Site Infection for Clean Contaminated Colorectal Procedures.|Completed||Phase 4|100|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 00:00:42.461745|2017-10-11 00:00:42.461745
NCT02241902|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2014-09-15|||August 2014||2014-08-01|September 2014|2014-09-01||||March 2015|Anticipated|2015-03-01||Observational|||Impact of Postoperative Pyuria on Treatment Outcomes After PVP|Does Postoperative Pyuria Influence Treatment Outcomes After Photoselective Vaporization of the Prostate (PVP)?: A Short-term Serial Follow-up Study|Unknown status|Recruiting|N/A|120|Anticipated|DongGuk University|||2||f||||f||||||||||2017-10-11 00:00:42.541546|2017-10-11 00:00:42.541546
NCT02241889|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-04-13|2016-09-07||January 2015||2015-01-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Type 1 diabetics using an insulin pump|Three-way, Cross-over Closed-loop Exercise Study|A Randomized, Three-way, Cross-over Study to Assess the Efficacy of a Bi-hormonal Closed-loop System With vs Without Exercise Announcement vs Open-loop Therapy in Reducing Exercise-related Hypoglycemia|Completed||N/A|23|Actual|Oregon Health and Science University||3|||f||||f||||||||||2017-10-11 00:00:42.638603|2017-10-11 00:00:42.638603
NCT02241876|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-09-13|||October 2014||2014-10-01|September 2014|2014-09-01||||December 2016|Anticipated|2016-12-01||Interventional|||THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS|EVALUATION OF THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS IN HEAD AND NECK CANCER PATIENTS|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|University of Campinas, Brazil||2|||f||||||||||||||2017-10-11 00:00:43.131478|2017-10-11 00:00:43.131478
NCT02241863|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-01-04|||September 2014||2014-09-01|October 2015|2015-10-01||||September 2015|Actual|2015-09-01||Interventional|||The Effect of a Theory Based Educational Intervention on Medication Adherence to and Removes of Related Barriers in Patients With Bipolar Disorder||Completed||N/A|270|Actual|Qazvin University Of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:00:43.234715|2017-10-11 00:00:43.234715
NCT02241850|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-14|||August 2013||2013-08-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Genetic Polymorphisms Affecting Effect of High Intensity Training|Assessment of Genetic Polymorphisms Affecting Effect of High Intensity Training in Korean Healthy Volunteers|Completed||N/A|110|Actual|Kyunghee University Medical Center||1|||f||||t||||||||||2017-10-11 00:00:43.316969|2017-10-11 00:00:43.316969
NCT02241837|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-06-21|||November 2013||2013-11-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|January 2016|Actual|2016-01-01||Observational|PIII PV Loop||PARACHUTE III Pressure Volume Loop Sub-Study|PARACHUTE III: A Multinational Trial to Evaluate the Longterm Safety of the Parachute System|Terminated||N/A|11|Actual|CardioKinetix, Inc|||1||f||||f||||||||||2017-10-11 00:00:43.389173|2017-10-11 00:00:43.389173
NCT02241824|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-07-07|||January 2015||2015-01-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Chronic Opioid Use in Low Back Pain and Lumbar Orthosis Intervention|Chronic Opioid Use in Low Back Pain and Lumbar Orthosis Intervention|Unknown status|Recruiting|N/A|36|Anticipated|Aspen Medical Products||3|||f||||t||||||||||2017-10-11 00:00:43.489506|2017-10-11 00:00:43.489506
NCT02241811|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2014-09-13|||September 2014||2014-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Wound Treatment With 3% Sodium Pentaborate Pentahydrate|Deep Diabetic Foot Wound Treatment With Hydrogel Including 3% Sodium Pentaborate Pentahydrate|Unknown status|Recruiting|Phase 1|20|Anticipated|SB Istanbul Education and Research Hospital||2|||f||||f||||||||||2017-10-11 00:00:43.576548|2017-10-11 00:00:43.576548
NCT02241798|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-03-10|||August 2013||2013-08-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|August 2014|Actual|2014-08-01||Interventional|||Pre-oxygenation and Measures of Gas Exchanges During Seizures in the Epilepsy Monitoring Unit|Effects of Pre-oxygenation on Indicators of Gas Exchange and Autonomic Function During Seizures in the Epilepsy Unit|Terminated||N/A|5|Actual|New York University School of Medicine||2||Investigator is leaving the institution and has terminated the study.|f||||f||||||||||2017-10-11 00:00:43.673842|2017-10-11 00:00:43.673842
NCT02241785|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-04-24|2017-04-24||September 30, 2014|Actual|2014-09-30|April 2017|2017-04-01|May 2, 2016|Actual|2016-05-02|May 2, 2016|Actual|2016-05-02||Interventional|ESCALATE||Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies|A Phase 4 Multicenter, Open-Label, Single Arm Study to Evaluate Switching From BRACET/Gilenya® to Natalizumab in Subjects With Relapsing Forms of Multiple Sclerosis (MS)|Terminated||Phase 4|47|Actual|Biogen|As a result of early study termination and limited available data, no meaningful conclusions can be drawn.|1||Business Decision|f||||||||||||||2017-10-11 00:00:43.761236|2017-10-11 00:00:43.761236
NCT02241772|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2015-02-12|||September 2014||2014-09-01|October 2014|2014-10-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)||Completed||Phase 1/Phase 2|42|Actual|Xention Ltd||3|||f||||||||||||||2017-10-11 00:00:44.151692|2017-10-11 00:00:44.151692
NCT02241759|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2015-02-12|||August 2014||2014-08-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Study of the Electrocardiographic Effects of TA-8995|A Phase I, Single-Centre, Randomised, Placebo and Positive- Controlled, Parallel-Group Study of the Electrocardiographic Effects of TA-8995 in Healthy Male and Female Subjects|Completed||Phase 1|136|Actual|Xention Ltd||3|||f||||f||||||||||2017-10-11 00:00:44.236651|2017-10-11 00:00:44.236651
NCT02241746|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-16|||August 2012||2012-08-01|September 2014|2014-09-01||||September 2012|Actual|2012-09-01||Observational|||Malnutrition in Chinese Hospitalized Patients and Optimizing the Usage of Nutritional Screening Tools||Completed||N/A|856|Actual|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||||||||||||2017-10-11 00:00:44.328499|2017-10-11 00:00:44.328499
NCT02241733|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-09-20|||October 1, 2014|Actual|2014-10-01|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|July 31, 2018|Anticipated|2018-07-31||Interventional|||Sustainability of Pulmonary Rehab Gains|Sustainability of Rehabilitation Gains in COPD|Recruiting||Phase 3|250|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 00:00:44.419034|2017-10-11 00:00:44.419034
NCT02241707|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-04-27|||August 2014||2014-08-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01|12 Months|Observational [Patient Registry]|||Does Minimal Post-operative Compression Affect the Outcome for Endovenous Ablation in Treating Varicose Vein Patients?|Does Minimal Post-operative Compression Affect the Outcome for Endovenous Ablation in Treating Varicose Vein Patients?|Withdrawn||N/A|0|Actual|NYC Surgical Associates|||1|Since reorganization of the institute, this study is aborted. No patient was recruited.|f||||f||||||||||2017-10-11 00:00:44.645121|2017-10-11 00:00:44.645121
NCT02241694|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-07-09|||November 2014||2014-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|HERO||To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives|Haemophilia, Experiences, Results and Opportunities (HERO) in Brazil: Assessment of Psychological Effects of Haemophilia on Patients and Caregivers|Completed||N/A|200|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 00:00:44.734566|2017-10-11 00:00:44.734566
NCT02241681|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-03-25|||October 2014||2014-10-01|November 2014|2014-11-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Medium Chain Triglycerides Plasma Profile and Their Metabolites After Oral Peptamen Intake|Medium Chain Triglycerides Plasma Profile and Their Metabolites After Oral Peptamen Intake|Completed||N/A|20|Actual|Nestlé||1|||f||||f||||||||||2017-10-11 00:00:44.841464|2017-10-11 00:00:44.841464
NCT02241668|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-02-25|||June 2015||2015-06-01|February 2016|2016-02-01||||June 2015|Actual|2015-06-01||Interventional|||Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma|Pilot Study to Assess Accuracy of Time-resolved FLT PET and MR Techniques in Determining Treatment-related Necrosis From Recurrent Glioma|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||1||Withdrawn due to other initiatives|f||||f||||||||||2017-10-11 00:00:44.944104|2017-10-11 00:00:44.944104
NCT02241655|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-06-01|||January 2015||2015-01-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|ENGAGES||Electroencephalography Guidance of Anesthesia|Electroencephalography Guidance of Anesthesia to Alleviate Geriatric Syndromes (ENGAGES) Study|Recruiting||N/A|1232|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:00:45.061795|2017-10-11 00:00:45.061795
NCT02241642|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-05-25|||October 2013||2013-10-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|FRONTIER II||Safety and Performance Study of Large Hole Vascular Closure Device|Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER II Study|Recruiting||N/A|100|Anticipated|Vivasure Medical Limited||1|||f||||t||||||||||2017-10-11 00:00:45.224037|2017-10-11 00:00:45.224037
NCT02241629|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-05-06|||August 2014||2014-08-01|September 2014|2014-09-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Levo Phencynonate Hydrochloride for the Prevention of Seasickness|Levo Phencynonate Hydrochloridefor the Prevention of Motion Sickness (Seasickness): a Randomized, Double-blind, Placebo Controlled, Multicenter,PhaseⅡClinical Study|Completed||Phase 2|180|Actual|Sihuan Pharmaceutical Holdings Group Ltd.||3|||f||||f||||||||||2017-10-11 00:00:45.35108|2017-10-11 00:00:45.35108
NCT02241616|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-11-30|||September 2014||2014-09-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV|A Multi-Center Study to Assess the Efficacy and Safety of Traditional Chinese Medicine Combined With Entecavir for Patients With Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV|Recruiting||Phase 4|350|Anticipated|ShuGuang Hospital||1|||f||||f||||||||||2017-10-11 00:00:45.443705|2017-10-11 00:00:45.443705
NCT02241590|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-11-29|||September 2014||2014-09-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir|A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Assess the Efficacy and Safety of Fuzheng Huayu Combined With Entecavir in Liver Cirrhosis Patients Due to Hepatitis B Virus|Recruiting||Phase 4|700|Anticipated|ShuGuang Hospital||2|||f||||f||||||||||2017-10-11 00:00:45.714258|2017-10-11 00:00:45.714258
NCT02241577|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-15|||June 2014||2014-06-01|September 2014|2014-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|Perio-implants||Surgical and Non-surgical Treatment of Peri-implantitis|Surgical and Non-surgical Treatment of Peri-implantitis: Randomised Controlled Trial of 12-months Follow-up|Recruiting||N/A|106|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 00:00:45.865698|2017-10-11 00:00:45.865698
NCT02241564|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-12-01|||November 2007||2007-11-01|September 2014|2014-09-01||||December 2016|Anticipated|2016-12-01||Observational|MALTX||Malignancies in Transplanted Patients|Follow-up of Malignancies in Transplanted Patients|Unknown status|Recruiting|N/A|150|Anticipated|Uppsala University|||1||f||||f||||||||||2017-10-11 00:00:45.981736|2017-10-11 00:00:45.981736
NCT02241551|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer|Phase II Study of Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer|Recruiting||Phase 2|40|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:00:46.107143|2017-10-11 00:00:46.107143
NCT02241538|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-09-05|||September 2014||2014-09-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Effectiveness of Different Weekly Frequency of Modified Pilates Method Exercises in the Treatment of Chronic Nonspecific Low Back Pain|Cost Effectiveness and Effectiveness of the Addition of Different Weekly Frequency of Modified Pilates Method Exercises to a Minimal Intervention in the Treatment of Chronic Nonspecific Low Back Pain: A Randomized Controlled Trial|Completed||N/A|296|Actual|Universidade Cidade de Sao Paulo||4|||f||||t||||||||||2017-10-11 00:00:46.246693|2017-10-11 00:00:46.246693
NCT02241525|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-06-07|||February 2016||2016-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|CT for PE||CT for Pulmonary Thromboembolic Disease|Individually Optimized Uniform Contrast Enhancement in CT Angiography for the Diagnosis of Pulmonary Thromboembolic Disease|Terminated||N/A|2|Actual|University of Maryland|||2|The PI left the university|f||||t||||||||No||2017-10-11 00:00:46.368634|2017-10-11 00:00:46.368634
NCT02241512|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-05-27|||September 2014||2014-09-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis|IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis|Recruiting||Phase 2|120|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:00:46.47371|2017-10-11 00:00:46.47371
NCT02241499|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-03-06|||October 2014||2014-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|PALAESTRA||Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.|Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.|Recruiting||Phase 2|27|Anticipated|Lund University Hospital||1|||f||||f||||||||||2017-10-11 00:00:46.567693|2017-10-11 00:00:46.567693
NCT02241486|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-06-30|2017-05-05||September 2013||2013-09-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional||Only two patients were initially enrolled in this trial, which was terminated prematurely.|Sublingual Fentanyl and Procedural Burn Pain|A Randomized, Double-blind, Placebo-controlled, Cross-over Trial of Sublingual Fentanyl Spray (Subsys) and Oral Morphine for Procedural Wound Care in Adult Patients With Burn Injury Pain|Terminated||Phase 3|2|Actual|Loyola University|This trial was terminated prematurely due to a lack of study funding.|1||No funding source.|f||||f||||||||||2017-10-11 00:00:46.685235|2017-10-11 00:00:46.685235
NCT02241473|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-15|||September 2014||2014-09-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|HYPOBESE||Hypoxic Training in Obese Patients|Changes in Body Composition, Metabolic and Mechanical Responses to Hypoxic Walking Training in Obese Patients|Unknown status|Recruiting|N/A|30|Anticipated|University of Lausanne||2|||f||||t||||||||||2017-10-11 00:00:46.89451|2017-10-11 00:00:46.89451
NCT02241460|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-09-12|||March 2014||2014-03-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|Promescent||Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation|A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation|Unknown status|Enrolling by invitation|Phase 3|120|Anticipated|Kaiser Permanente||2|||f||||t||||||||||2017-10-11 00:00:47.021058|2017-10-11 00:00:47.021058
NCT02241447|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-06-13|||August 2014||2014-08-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|IMPULSE||Quality of Care in AS IMPULSE Study|Study to Improve Outcomes in Aortic Stenosis. International, Multi-center, Prospective, Observation and Interventional Cohort Study|Recruiting||N/A|800|Anticipated|Institut für Pharmakologie und Präventive Medizin||2|||f||||f||||||||Undecided||2017-10-11 00:00:47.124174|2017-10-11 00:00:47.124174
NCT02241434|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-09-23|||January 2009||2009-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Stem Cell Therapy in Duchenne Muscular Dystrophy|The Role of Autologous Bone Marrow Mononuclear Cell Therapy in Duchenne Muscular Dystrophy|Completed||Phase 1|245|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-11 00:00:47.329697|2017-10-11 00:00:47.329697
NCT02241421|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2014-09-15|||April 2012||2012-04-01|September 2014|2014-09-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|ANTIBIOTICS||The Importance of the Gut Microbiota in Body Weight Control and Insulin Sensitivity|The Effect of the Knock Down of Gut Microbiota by Antibiotics on Parameters of Body Weight Control and Insulin Sensitivity|Unknown status|Active, not recruiting|N/A|57|Anticipated|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 00:00:47.405344|2017-10-11 00:00:47.405344
NCT02241395|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-09-13|||August 2013||2013-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Cell Therapy as Treatment for Cerebral Palsy|Autologous Bone Marrow Mononuclear Cell Therapy in Cerebral Palsy|Recruiting||Phase 1|500|Anticipated|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-11 00:00:47.592293|2017-10-11 00:00:47.592293
NCT02241382|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-10-05|||September 2014||2014-09-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Cologne Cardioversion Study|Randomized Controlled Trial Comparing Internal vs External Cardioversion in ICD Patients|Recruiting||N/A|230|Anticipated|Universitätsklinikum Köln||2|||f||||t||||||||||2017-10-11 00:00:47.787677|2017-10-11 00:00:47.787677
NCT02241369|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-09-11|||May 2014||2014-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies|A Study of HPV Specific Immunotherapy in Subjects With HPV6 Associated Aerodigestive Precancerous Lesions and Malignancies|Recruiting||Phase 1|6|Anticipated|Inovio Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:00:47.994171|2017-10-11 00:00:47.994171
NCT02241343|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-11-13|||May 2014||2014-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Venous Occlusion and Limb Swelling|Venous Occlusion and Limb Swelling|Completed||N/A|10|Actual|Imperial College London||1|||f||||f||||||||||2017-10-11 00:00:48.215212|2017-10-11 00:00:48.215212
NCT02241330|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-04-13|||October 2014||2014-10-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy of Zn Biofortified Wheat in Improving Zn Status in Indian School Children With Low Zn Status|Efficacy of Zn Biofortified Wheat in Improving Zn Status in Indian School Children With Low Zn Status: a Randomized Controlled Trial|Completed||N/A|284|Actual|Swiss Federal Institute of Technology||3|||f||||f||||||||||2017-10-11 00:00:48.308013|2017-10-11 00:00:48.308013
NCT02241317|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-15|||June 2014||2014-06-01|September 2014|2014-09-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01|1 Year|Observational [Patient Registry]|DmUMM||Diabetes Mellitus at the University Medical Center of Mannheim|Effects of Training of Medical Staff on the Outcome of In-Patients With Diabetes Mellitus on Regular Wards|Unknown status|Active, not recruiting|N/A|5000|Anticipated|Universitätsmedizin Mannheim|||1||f||||f||||||Samples Without DNA|"     blood samples   "|||2017-10-11 00:00:48.4332|2017-10-11 00:00:48.4332
NCT02241304|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-01-27|||July 2014||2014-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|NEAT-3||Neurostimulation and Electromyographic Assessment of the TetraGraph (NEAT) In Patients (NEAT-3)|Neurostimulation and Electromyographic Assessment of the TetraGraph (NEAT) In Patients (NEAT-3)|Completed||N/A|50|Actual|University of Debrecen|||1||f||||t||||||||||2017-10-11 00:00:48.519513|2017-10-11 00:00:48.519513
NCT02241291|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-04-12|||March 2009||2009-03-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||CARDIOBASE Bern PCI Registry|CARDIOBASE Bern PCI Registry|Recruiting||N/A|10000|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-11 00:00:48.633109|2017-10-11 00:00:48.633109
NCT02241278|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-15|||September 2001||2001-09-01|September 2014|2014-09-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Preoperative Ketamine Has no Preemptive Analgesic Effect in Patients Undergoing Colon Surgery.|Preoperative Low-dose Ketamine Has no Preemptive Analgesic Effect in Opioid-naïve Patients Undergoing Colon Surgery When Nitrous Oxide is Used|Completed||Phase 4|48|Actual|Hospital Arquitecto Marcide||2|||f||||f||||||||||2017-10-11 00:00:48.763501|2017-10-11 00:00:48.763501
NCT02241265|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-08-25|||February 2014||2014-02-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma|Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma|Recruiting||N/A|20|Anticipated|University of Oklahoma||1|||f||||f||||||||||2017-10-11 00:00:48.875014|2017-10-11 00:00:48.875014
NCT02241252|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-05-28|||September 2013||2013-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients|Clinical Validation of an iPhone ECG System, QT Substudy|Completed||N/A|29|Actual|University of Oklahoma||1|||f||||t||||||||||2017-10-11 00:00:48.995896|2017-10-11 00:00:48.995896
NCT02241239|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2014-11-05|||August 2014||2014-08-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||A Comparison of the Estimates of Fuwai and Reynolds Risk Model|A Comparison of the Estimates of Fuwai and Reynolds Risk Model|Unknown status|Recruiting|N/A|500|Anticipated|Wuhan Asia Heart Hospital|||1||f||||t||||||||||2017-10-11 00:00:49.094768|2017-10-11 00:00:49.094768
NCT02241226|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-12-14|||September 2014||2014-09-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|SBTI||Self-Directed Biological Transformation Initiative|Self-Directed Biological Transformation Initiative|Completed||N/A|115|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:00:49.178373|2017-10-11 00:00:49.178373
NCT02241213|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-09-12|||August 2014||2014-08-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|Aphasia-ACV||Effects of MTS-r on Speech Production in Non-fluent Aphasia Post-ischemic Stroke Patients|Effects of Repetitive Magnetic Transcranial Stimulation of Low Frequency on Speech Production in Patients With Non-fluent Aphasia Post-ischemic Stroke|Recruiting||Phase 3|100|Anticipated|Fundación Cardiovascular de Colombia||2|||f||||t||||||||||2017-10-11 00:00:49.292176|2017-10-11 00:00:49.292176
NCT02241200|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-12|||July 2014||2014-07-01|September 2014|2014-09-01||||October 2014|Anticipated|2014-10-01||Interventional|||A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)|A Randomized, 2 Part, 4-treatment, 2-way Cross-over Study in Healthy Volunteers to Compare the Pharmacokinetic and Pharmacodynamic Profiles of 1ug/kg of DA-3880 and EU Sourced ARANESP® (Amgen) After Single Intravenous or Subcutaneous Administration|Unknown status|Recruiting|Phase 1|60|Anticipated|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:00:49.392854|2017-10-11 00:00:49.392854
NCT01888588|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-07-14|||September 2012||2012-09-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Risk of Uncomplicated Peptic Ulcer in the General Population|Risk of Uncomplicated Peptic Ulcer in the General Population|Completed||N/A|4000|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 01:32:43.068468|2017-10-11 01:32:43.068468
NCT02241187|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-09-25|2017-07-21||September 12, 2014|Actual|2014-09-12|February 2017|2017-02-01|September 13, 2016|Actual|2016-09-13|September 13, 2016|Actual|2016-09-13||Interventional|||Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection|Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection|Completed||N/A|2|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:00:49.495939|2017-10-11 00:00:49.495939
NCT02241174|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-10-19|||July 2014||2014-07-01|October 2015|2015-10-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis|Efficacy of 0.005% Sodium Hypochlorite Final Rinse Solution on the Reduction of Staphylococcus Aureus Colonization in Atopic Dermatitis: A Randomized Controlled Trial|Withdrawn||Phase 1|0|Actual|Makati Medical Center||2||study materials have expired, no patients were enrolled|f||||f||||||||||2017-10-11 00:00:49.74424|2017-10-11 00:00:49.74424
NCT02241161|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-09-12|||December 2013||2013-12-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Short Term Evaluation of the Soothing and Re-epithelizing Activity of Three Topical Products and Relative Combinations|Short Term Evaluation of the Soothing and Re-epithelizing Activity of Three Topical Products and Relative Combinations|Completed||Phase 3|20|Actual|Derming SRL||5|||f||||t||||||||||2017-10-11 00:00:49.852848|2017-10-11 00:00:49.852848
NCT02241148|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-09-12|||February 2014||2014-02-01|September 2014|2014-09-01||||December 2014|Anticipated|2014-12-01||Interventional|||Close Kinect Chain Exercise With Kinesio Taping in the Management of Patellofemoral Pain Syndrome||Unknown status|Recruiting|Phase 4|32|Anticipated|Universidad Autonoma de Nuevo Leon||2|||f||||||||||||||2017-10-11 00:00:50.002762|2017-10-11 00:00:50.002762
NCT02241135|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-05-30|||October 2013||2013-10-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|July 2018|Anticipated|2018-07-01||Interventional|||RNActive® Rabies Vaccine (CV7201) in Healthy Adults|Phase I Safety and Immunogenicity Trial of an Investigational RNActive® Rabies Vaccine (CV7201) in Healthy Adults|Active, not recruiting||Phase 1|134|Actual|CureVac AG||8|||f||||t||||||||||2017-10-11 00:00:50.188909|2017-10-11 00:00:50.188909
NCT02241122|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2016-01-20|||April 2015||2015-04-01|January 2016|2016-01-01||||November 2017|Anticipated|2017-11-01||Interventional|Multi-IMPROD||MRI and Biomarkers in Prostate Cancer|Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging Targeted Biopsies and Biomarkers (Multi-institutional Study)|Recruiting||N/A|400|Anticipated|Turku University Hospital||1|||f||||f||||||||||2017-10-11 00:00:50.301267|2017-10-11 00:00:50.301267
NCT02241109|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-12-09|||September 2014||2014-09-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|January 2016|Anticipated|2016-01-01||Interventional|PASP||Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity|Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity|Recruiting||Early Phase 1|200|Anticipated|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-10-11 00:00:50.429144|2017-10-11 00:00:50.429144
NCT02241096|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-07-28|||January 2015||2015-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||PK Intravenous Lidocaine Infusion|Pharmacokinetics of Intravenous Lidocaine Infusion in Children|Active, not recruiting||Phase 1|20|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 00:00:50.554158|2017-10-11 00:00:50.554158
NCT02241083|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-15|||June 2006||2006-06-01|September 2014|2014-09-01||||May 2014|Actual|2014-05-01||Interventional|||The Effect of Norepinephrine and Dopamine on Radial Forearm Free Flap Tissue Oxygen Pressure and Microdialysate Metabolite Measurements||Completed||Phase 4|25|Actual|Tampere University Hospital||3|||f||||||||||||||2017-10-11 00:00:50.666762|2017-10-11 00:00:50.666762
NCT02241070|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2014-09-12|||June 2011||2011-06-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Potential for Mindfulness-Based Intervention in Workplace Mental Health Promotion|The Potential for Mindfulness-Based Intervention in Workplace Mental Health Promotion: Results of a Randomized Controlled Trial|Completed||N/A|144|Actual|Chung Shan Medical University||2|||f||||t||||||||||2017-10-11 00:00:50.763482|2017-10-11 00:00:50.763482
NCT02241057|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-03-15|||September 2014||2014-09-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)|A Randomized, Open-Label Study to Evaluate the Temperature Profile and Adhesion of an Air-Activated Adhesive-Backed Heat Patch in Healthy Volunteers|Completed||N/A|60|Actual|Chattem, Inc.||2|||f||||t||||||||No||2017-10-11 00:00:50.841066|2017-10-11 00:00:50.841066
NCT02241044|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-13|||October 2010||2010-10-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Argon Plasma Coagulation for Bleeding Peptic Ulcers|Ivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Completed||Phase 4|116|Actual|Kaohsiung Veterans General Hospital.||2|||f||||f||||||||||2017-10-11 00:00:50.920084|2017-10-11 00:00:50.920084
NCT02241031|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2014-09-15|||September 2014||2014-09-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia|Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia in Patients With Acute Leukemia Receiving Chemotherapy|Unknown status|Recruiting|Phase 2/Phase 3|250|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 00:00:51.007557|2017-10-11 00:00:51.007557
NCT02241018|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2014-09-13|||September 2014||2014-09-01|September 2014|2014-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD|Mesenchymal Stem Cells Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation|Recruiting||Phase 2/Phase 3|200|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 00:00:51.099873|2017-10-11 00:00:51.099873
NCT02241005|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-10-05|||October 30, 2014|Actual|2014-10-30|October 2017|2017-10-01|September 19, 2017|Actual|2017-09-19|September 19, 2017|Actual|2017-09-19||Interventional|||Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci|A Randomized Controlled Trial of the Safety and Efficacy of Theraworx Bath Wipes in the Reduction of Skin Colonization With Vancomycin-Resistant Enterococci Compared to Standard Bath Wipes in Children Undergoing Hematopoietic Stem Cell Transplantation|Completed||N/A|159|Actual|St. Jude Children's Research Hospital||2|||f||||f|f|f||||||||2017-10-11 00:00:51.213513|2017-10-11 00:00:51.213513
NCT02240992|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-13|2014-09-13|||September 2014||2014-09-01|September 2014|2014-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment|Mesenchymal Stem Cells With or Without G-CSF Mobilized Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplant|Recruiting||Phase 2/Phase 3|120|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 00:00:51.322238|2017-10-11 00:00:51.322238
NCT02240979|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-08-17|||August 2014||2014-08-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||Establishing a Non-invasive Method to Measure Your Heart's Performance|Establishing a Non-invasive Method to Measure Heart Performance|Unknown status|Recruiting|N/A|100|Anticipated|Huntington Medical Research Institutes|||1||f||||f||||||||||2017-10-11 00:00:51.435848|2017-10-11 00:00:51.435848
NCT02240966|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-07-13|||August 2014||2014-08-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors|Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors|Completed||N/A|200|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 00:00:51.526021|2017-10-11 00:00:51.526021
NCT02240953|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-15|||January 2009||2009-01-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis|Comparison of Different Anticoagulation Regiments in Patients With Prosthetic Heart Valve Non-ObstructiveThrombosis|Unknown status|Recruiting|N/A|180|Anticipated|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital||4|||f||||f||||||||||2017-10-11 00:00:51.613167|2017-10-11 00:00:51.613167
NCT02240940|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-06-21|||September 2014||2014-09-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|May 2015|Actual|2015-05-01||Interventional|||PARACHUTE China Approval Trial|PARACHUTE China: Multi-center, Prospective, Single-arm Clinical Evaluation of the Safety and Efficacy of the Parachute Percutaneous Left Ventricle Partitioning System|Terminated||N/A|30|Actual|CardioKinetix, Inc||1||Company closed|f||||t||||||||||2017-10-11 00:00:51.747062|2017-10-11 00:00:51.747062
NCT02240927|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2014-09-15|||January 2010||2010-01-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves|Comparison of Different Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves: A Randomized Clinical Trial|Unknown status|Recruiting|N/A|40|Anticipated|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital||4|||f||||f||||||||||2017-10-11 00:00:51.876892|2017-10-11 00:00:51.876892
NCT02240914|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-09-13|||February 2013||2013-02-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01|6 Months|Observational [Patient Registry]|USG-DIVO||Vascular Ultrasound Versus Intravascular Ultrasound for Diagnosing Iliac Vein Obstruction|Prospective, Single-arm, Single Center, Pilot Study of Vascular Ultrasound Imaging Used as an Adjunct to Intravascular Ultrasound for Diagnosing Iliac Vein Obstruction|Unknown status|Recruiting|N/A|50|Anticipated|Instituto Dante Pazzanese de Cardiologia|||1||f||||t||||||||||2017-10-11 00:00:52.044826|2017-10-11 00:00:52.044826
NCT02240901|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2014-09-15|||April 2014||2014-04-01|September 2014|2014-09-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|LMA;ETI||An Multi-center Randomized Clinical Trial About Using LMA or ETI in Elderly Patients|Effectiveness and Pulmonary Complications of Peri-Operative Laryngeal Mask Airway Used in Elderly Patients(POLMA-EP Trial): a Multi-center Randomized Controlled Clinical Trial|Unknown status|Recruiting|N/A|6000|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 00:00:52.17558|2017-10-11 00:00:52.17558
NCT02240888|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-09-29|||October 2011||2011-10-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|Vaccimil||Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response and Protection of Infections||Active, not recruiting||N/A|300|Actual|Region Skane||4|||f||||f||||||||||2017-10-11 00:00:52.314604|2017-10-11 00:00:52.314604
NCT02240875|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-06-19|||September 17, 2014|Actual|2014-09-17|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo|A Phase Ia, Dose-Escalating, Safety and Immunogenicity Trial of the Monovalent Zaire Ebola Viral Vector Candidate Vaccine cAd3-EBO Z and the Heterologous Prime-boost Candidate Vaccine Regimen cAd3-EBO Z and MVA-BN® Filo in Healthy UK Adults|Active, not recruiting||Phase 1|92|Anticipated|University of Oxford||13|||f||||t||||||||||2017-10-11 00:00:52.433839|2017-10-11 00:00:52.433839
NCT02240862|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-09-07|||February 2015||2015-02-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|February 2022|Anticipated|2022-02-01|12 Months|Observational [Patient Registry]|C2R||The CREST-2 Registry|The CREST-2 Registry|Recruiting||N/A|4000|Anticipated|University of Maryland|||1||f||||f||||||||||2017-10-11 00:00:52.65848|2017-10-11 00:00:52.65848
NCT02240849|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-24|||June 2014||2014-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|EPNS||Effectiveness of Functional Pillow on Neck Pain, Disability, Quality of Sleep and Life|Effectiveness of Functionally Customized Pillow on Neck Pain, Disability, Quality of Sleep and Life: Randomized Controlled Trial|Completed||N/A|50|Actual|Jaseng Hospital of Korean Medicine||2|||f||||f||||||||||2017-10-11 00:00:52.808878|2017-10-11 00:00:52.808878
NCT02240836|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-09-23|||September 2014||2014-09-01|September 2014|2014-09-01|June 2026|Anticipated|2026-06-01|May 2016|Anticipated|2016-05-01||Interventional|EBBA-II||Energy Balance and Breast Cancer Aspects-II|Energy Balance and Breast Cancer Aspects-II Study|Recruiting||N/A|600|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 00:00:52.983874|2017-10-11 00:00:52.983874
NCT02240797|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-08-15|||September 2014||2014-09-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Kappa Opioid Receptor Imaging in Anorexia|Kappa Opioid Receptor Imaging in Anorexia|Terminated||N/A|7|Actual|New York University School of Medicine|||2|The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.|f||||t||||||||||2017-10-11 00:00:53.562249|2017-10-11 00:00:53.562249
NCT02240784|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-06-02|||August 2014||2014-08-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)|A Natural History Study of Acute Hepatic Porphyria (AHP) Patients With Recurrent Attacks|Recruiting||N/A|300|Anticipated|Alnylam Pharmaceuticals|||1||f||||f||||||Samples Without DNA|"     Urine and plasma samples for known proteins associated with porphyria attacks.   "|||2017-10-11 00:00:53.680419|2017-10-11 00:00:53.680419
NCT02240771|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2014-09-12|||January 2006||2006-01-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma|Randomized Control Trial of Transarterial Chemotherapy (TAC) Versus Oral Thalidomide and Capecitabine in the Treatment of Unresectable Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2/Phase 3|124|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 00:00:53.864182|2017-10-11 00:00:53.864182
NCT02240758|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2015-11-25|||September 2014||2014-09-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|GLIOFOCAL||Confocal Laser Endomicroscopy for Brain Tumors|INTRA-OPERATIVE CONFOCAL LASER ENDOMICROSCOPY FOR BRAIN TUMORS: A FEASIBILITY STUDY IN HUMAN|Terminated||Phase 1|10|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:00:54.027131|2017-10-11 00:00:54.027131
NCT02240745|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-04-14|||November 2014||2014-11-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|3-DSE||New Three-dimensional Methods of Analysis for the Detection of Coronary Artery Disease by Dobutamine Stress Echocardiography|New Three-dimensional Methods of Analysis for the Detection of Coronary Artery Disease by Dobutamine Stress Echocardiography|Recruiting||N/A|100|Anticipated|University Hospital Inselspital, Berne|||1||f||||t||||||||||2017-10-11 00:00:54.143299|2017-10-11 00:00:54.143299
NCT02240732|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2015-06-28|||September 2014||2014-09-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Surgical Tourniquets and Cerebral Emboli|Surgical Tourniquets and Cerebral Emboli Pilot Study|Completed||N/A|12|Actual|University Hospitals Coventry and Warwickshire NHS Trust|||1||f||||t||||||||||2017-10-11 00:00:54.289524|2017-10-11 00:00:54.289524
NCT02240719|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-12|2017-01-19|||October 2014||2014-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer|Phase I Study of Everolimus + Bendamustine in Patients With Relapsed/Refractory Hematological Malignancies|Recruiting||Phase 1|18|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-11 00:00:54.400694|2017-10-11 00:00:54.400694
NCT02240706|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-10-02|||January 22, 2015|Actual|2015-01-22|October 2017|2017-10-01|July 15, 2020|Anticipated|2020-07-15|November 9, 2018|Anticipated|2018-11-09||Interventional|||Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes|A Phase I/II, Multicentre, Open-label, Dose Escalation and Randomized Trial of BI 836858 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes|Recruiting||Phase 2|200|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:54.539853|2017-10-11 00:00:54.539853
NCT02240693|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-07-25|||January 15, 2015|Actual|2015-01-15|July 2017|2017-07-01|October 9, 2017|Anticipated|2017-10-09|September 11, 2017|Anticipated|2017-09-11||Interventional|||Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo|A Multi-centre, Double-blind, Parallel-group, Randomized Controlled Study to Investigate the Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Alzheimer Disease|Active, not recruiting||Phase 2|105|Anticipated|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:00:54.735146|2017-10-11 00:00:54.735146
NCT02240680|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-15|2017-05-24|||September 23, 2014|Actual|2014-09-23|May 2017|2017-05-01|April 25, 2017|Actual|2017-04-25|April 18, 2017|Actual|2017-04-18||Interventional|||Linagliptin as Add on to Basal Insulin in the Elderly|A 24 Week Randomized, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Trial of Once Daily Linagliptin, 5 Milligrams Orally, as Add on to Basal Insulin in Elderly Type 2 Diabetes Mellitus Patients With Insufficient Glycaemic Control|Completed||Phase 4|302|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:00:55.074183|2017-10-11 00:00:55.074183
NCT02240641|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-15|||May 1998||1998-05-01|September 2014|2014-09-01||||September 2000|Actual|2000-09-01||Observational|||Effect of Caldine® on Renal Function in Balanced Hypertension|Study on Protective Effect of Caldine® on Renal Function in Patients With a Balanced Hypertension|Terminated||N/A|5417|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:00:55.782901|2017-10-11 00:00:55.782901
NCT02240628|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-05-13|2016-05-13||August 2014||2014-08-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection|In Children, Placing a Synera Patch for Intravenous Access Combined With Administration of a Propofol-Lidocaine Mixture Decreases Pain Associated With Propofol Intravenous Injection.|Completed||Phase 4|76|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 00:00:55.894097|2017-10-11 00:00:55.894097
NCT02232126|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-12-19|2014-12-04||February 2011||2011-02-01|December 2016|2016-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|SWIFT||Social Work Intervention Focused on Transitions|Social Work Intervention Focused on Transitions Among At-Risk Older Adults|Completed||N/A|181|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 00:02:46.03112|2017-10-11 00:02:46.03112
NCT02240615|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-02-11|||October 2014||2014-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora|The Sinopsys Lacrimal Stent Used During the Repair of the Lacrimal System in Patients With Epiphora|Completed||Early Phase 1|10|Actual|Sinopsys Surgical||1|||f||||f||||||||||2017-10-11 00:00:56.223188|2017-10-11 00:00:56.223188
NCT02240602|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-06-14|||July 2015||2015-07-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Optimal Dose of i.v Oxycodone for Postoperative Pain After Laparoscopic Colorectal Surgery|Optimal Dose of i.v Oxycodone for Postoperative Pain After Laparoscopic Colorectal Surgery|Withdrawn||Phase 3|0|Actual|Seoul National University Hospital||3||Lack of internal resources|f||||t||||||||||2017-10-11 00:00:56.383422|2017-10-11 00:00:56.383422
NCT02240589|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-08-28|2017-05-04||December 2014||2014-12-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury|Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury|Completed||N/A|11|Actual|Indiana University|Small sample size.|2|||f||||f||||||||||2017-10-11 00:00:56.509661|2017-10-11 00:00:56.509661
NCT02240576|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-12-02|||December 2014||2014-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Possible Manifestation of Rhinitis After Nasal Fracture|Possible Manifestation of Rhinitis After Nasal Fracture|Recruiting||N/A|310|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 00:00:57.044563|2017-10-11 00:00:57.044563
NCT02240563|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-05-02|||September 2014||2014-09-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Low Level Laser Therapy for Autoimmune Thyroiditis|Long-term Follow-up After Treatment of Chronic Autoimmune Thyroiditis With Low Level Laser|Completed||N/A|43|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 00:00:57.131141|2017-10-11 00:00:57.131141
NCT02240550|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-01-15|||September 2014||2014-09-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Comparative Clinical Study to Evaluate the Effectiveness of ProFlor vs. Lichtenstein for Inguinal Hernia Repair|A Prospective, Randomized, Double-armed, Single-blinded, Comparative Clinical Study to Evaluate the Effectiveness of ProFlor vs. Lichtenstein for Inguinal Hernia Repair|Completed||N/A|50|Actual|Insightra Medical, Inc.||2|||f||||f||||||||||2017-10-11 00:00:57.223711|2017-10-11 00:00:57.223711
NCT02240537|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-04-18|||January 2015||2015-01-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|BBMPI03||Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer|"Phase I Study of an Oncofetal Antigen (OFA) Multi-Peptide Immunotherapy (BBMPI03) in Subjects With Hematologic Cancer"|Active, not recruiting||Phase 1|4|Actual|Benovus Bio, Inc.||1|||f||||f||||||||||2017-10-11 00:00:57.318569|2017-10-11 00:00:57.318569
NCT02240524|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-09-12|||July 2014||2014-07-01|September 2014|2014-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|HIPEC||Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer|A Phase III Study of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2 Lymphadenectomy|Recruiting||Phase 3|582|Anticipated|Affiliated Tumor Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 00:00:57.416788|2017-10-11 00:00:57.416788
NCT02240511|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-12|||August 2011||2011-08-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Resistance Exercise Program and Branched Chain Amino Acid Supplementation in Heart Failure Patients|Changes in Body Composition in Heart Failure Patients After a Resistance Exercise Program and Branched Chain Amino Acid Supplementation|Completed||N/A|66|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-11 00:00:59.119994|2017-10-11 00:00:59.119994
NCT02240498|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-09-08|||September 2014||2014-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities|A Phase 1 Study to Assess Safety and Feasibility of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities|Recruiting||Phase 1|21|Anticipated|University of Rochester||6|||f||||f||||||||||2017-10-11 00:00:59.212961|2017-10-11 00:00:59.212961
NCT02240485|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-09-14|||April 2011||2011-04-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|June 2016|Actual|2016-06-01||Interventional|ICT-PG||Integrative Couple Therapy for Pathological Gambling|Integrative Couple Therapy for Pathological Gambling or Individual Treatment: A Comparison of Efficacy|Active, not recruiting||N/A|80|Actual|Université du Québec à Trois-Rivières||2|||f||||t||||||||||2017-10-11 00:00:59.350115|2017-10-11 00:00:59.350115
NCT02240472|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-08-30|||January 2015||2015-01-01|August 2017|2017-08-01|December 2029|Anticipated|2029-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.|Survival and Axillary Recurrence Following Sentinel Node-positive Breast Cancer Without Completion Axillary Lymph Node Dissection - a Randomized Study of Patients With Macrometastases in the Sentinel Node|Recruiting||N/A|3500|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 00:00:59.44885|2017-10-11 00:00:59.44885
NCT02240459|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-10-12|||August 2016||2016-08-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment|A Double Blind, Randomized Four Way Cross Over Study to Compare the Effect of Fesoterodine 4mg and 8mg Once Daily and Oxybutynin 5mg Twice Daily After Steady State Dosing Versus Placebo on Cognitive Function in Subjects With Overactive Bladder, Over the Age of 75 Years With Mild Cognitive Impairment|Recruiting||Phase 2|50|Anticipated|University of Alberta||4|||f||||f||||||||||2017-10-11 00:00:59.689421|2017-10-11 00:00:59.689421
NCT02240446|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-07-18|||June 2013||2013-06-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients|Non-Invasive Brain Stimulation for Clinical Intervention for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Will no longer be conducted. We have started a different project.|f||||t||||||||||2017-10-11 00:00:59.856929|2017-10-11 00:00:59.856929
NCT02240433|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-08-31|||November 2014||2014-11-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|July 19, 2017|Actual|2017-07-19||Interventional|||A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)|A Phase 1b Study of LY2157299 in Combination With Sorafenib in Patients With Unresectable Hepatocellular Carcinoma|Active, not recruiting||Phase 1|9|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-10-11 00:01:00.094353|2017-10-11 00:01:00.094353
NCT02240420|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-01-04|||December 2014||2014-12-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|Star-Mama||Diabetes Prevention Among Post-partum Women With History of Gestational Diabetes|Reaching High Risk Post-partum Women for Nutritional Assessment and Counseling Via a Telephone-based Coaching Program|Recruiting||N/A|180|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:01:00.215358|2017-10-11 00:01:00.215358
NCT02240407|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-09-19|||October 2017|Anticipated|2017-10-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|AAV9-GAA_IM||Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease|Evaluation of Re-administration of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV9-DES-hGAA) in Patients With Late-Onset Pompe Disease (LOPD)|Recruiting||Phase 1|9|Anticipated|University of Florida||2|||f||||t|t|f||||||||2017-10-11 00:01:00.323072|2017-10-11 00:01:00.323072
NCT02240394|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-02-10|||March 2014||2014-03-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||TCD Detection of Ophthalmic Artery Blood Flow Velocity Prediction Feasibility Study of Intracranial Pressure|TCD Detection of Ophthalmic Artery Blood Flow Velocity Prediction Feasibility Study of Intracranial Pressure|Unknown status|Active, not recruiting|N/A|400|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital|||1||f||||t||||||||||2017-10-11 00:01:00.528332|2017-10-11 00:01:00.528332
NCT02240381|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-01-13|||March 2015||2015-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant|Metabolic and CD4+ T Cell Dysregulation in Post-Transplant Diabetes Mellitus|Recruiting||N/A|55|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-11 00:01:00.625105|2017-10-11 00:01:00.625105
NCT02240368|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2016-09-13|2015-05-24||September 2014||2014-09-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Performance Evaluation of the Depth of Anesthesia Monitors in Pediatric Surgery|Performance Evaluation of the Depth of Anesthesia Monitors in Pediatric Surgery. Bispectral VISTA and ENTROPY Monitor for Pediatric Anesthesia.|Completed||N/A|50|Actual|University of Foggia|||3||f||||t||||||||||2017-10-11 00:01:00.77058|2017-10-11 00:01:00.77058
NCT02240355|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-12-20|||November 2014||2014-11-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)|A Multicenter, Randomized, Double Blind, Placebo Controlled, Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6885247 Following 12 Weeks of Treatment in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH).|Terminated||Phase 1|9|Actual|Hoffmann-La Roche||3||"There was an unexpected toxicology finding observed in the 39 week monkey study. Dosing was   suspended, the study was put on hold and eventually terminated."|f||||||||||||||2017-10-11 00:01:01.301015|2017-10-11 00:01:01.301015
NCT02240342|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-12|||September 2014||2014-09-01|September 2014|2014-09-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve|Ovarian Rejuvenation: Regeneration of Ovarian Follicles in Women With Poor Ovarian Reserve by Autologous Transplantation of Bone Marrow Derived Progenitors Cells in Peripheral Blood. Pilot Study.|Unknown status|Recruiting|N/A|20|Anticipated|Hospital Universitario La Fe||1|||f||||f||||||||||2017-10-11 00:01:01.516317|2017-10-11 00:01:01.516317
NCT02240329|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-09-29|2015-08-10||March 2013||2013-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Assessment of Dystussia in Traumatic Brain Injury|Assessment of Dystussia in Traumatic Brain Injury|Completed||Early Phase 1|4|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 00:01:01.61534|2017-10-11 00:01:01.61534
NCT02240316|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-08-03|||July 8, 2014|Actual|2014-07-08|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Observational|||An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical Practice||Active, not recruiting||N/A|1076|Anticipated|Hoffmann-La Roche|||2||f||||||||||||||2017-10-11 00:01:01.831865|2017-10-11 00:01:01.831865
NCT02240303|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-02-16|||April 2015||2015-04-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|PBAM||Pain, Brain and Mobility Study|Central and Peripheral Mechanisms Predicting Clinical Pain and Physical Performance in Older Adults|Withdrawn||N/A|0|Actual|University of Florida|||2|Consolidated study with another protocol|f||||f||||||Samples Without DNA|"     Plasma samples will be stored.   "|||2017-10-11 00:01:01.920097|2017-10-11 00:01:01.920097
NCT02240290|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-08-03|||September 2013||2013-09-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant|A Single-Center, Open-Label Study of Excretion Balance, Pharmacokinetics, and Metabolism of 14C-Labeled Tozadenant After 240 mg Single Oral Dose Administration in Healthy Male Subjects|Completed||Phase 1|6|Actual|Biotie Therapies Inc.||1|||f||||f||||||||||2017-10-11 00:01:02.019673|2017-10-11 00:01:02.019673
NCT02240277|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-09-11|||November 2014||2014-11-01|September 2014|2014-09-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Observational|||Meropenem and Ciprofloxacin Dosing in Septic Shock|Meropenem and Ciprofloxacin Dosing in the Critically Ill Patient With Septic Shock - a Single Center Pharmacokinetic Study|Unknown status|Not yet recruiting|N/A|50|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 00:01:02.148402|2017-10-11 00:01:02.148402
NCT02240264|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-04-05|||January 2014||2014-01-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Omega-3 LCPUFA Intervention on Learning, Cognition, Behaviour and Visual Processing.|Food2Learn: Effect of Omega-3 LCPUFA Intervention on Learning, Cognition, Behaviour and Visual Processing.|Completed||N/A|266|Actual|Open University||2|||f||||t||||||||||2017-10-11 00:01:02.400445|2017-10-11 00:01:02.400445
NCT01885975|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-02-13|||July 2013||2013-07-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Personality Profile of Patients With Apical Ballooning Syndrome|Personality Profile of Patients With Apical Ballooning Syndrome (ABS)|Completed||N/A|53|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 01:33:17.332953|2017-10-11 01:33:17.332953
NCT02240251|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-06-01|||January 2012||2012-01-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|2 Weeks|Observational [Patient Registry]|||Excimer Laser Assisted IVC Filter Retrieval|A Prospective Review of Excimer Laser Assisted Inferior Vena Cava (IVC) Filter Retrieval|Recruiting||N/A|500|Anticipated|Northwestern University|||1||f||||t||||||||||2017-10-11 00:01:02.531753|2017-10-11 00:01:02.531753
NCT02240238|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-08-18|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer|A Phase 1b/2 Dose Escalation and Expansion Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients With Advanced Solid Tumors or Non-Small Cell Lung, Biliary Tract, and Bladder Cancer|Recruiting||Phase 1/Phase 2|182|Anticipated|NanoCarrier Co., Ltd.||1|||f||||f|t|f||||||||2017-10-11 00:01:02.646921|2017-10-11 00:01:02.646921
NCT02240225|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||January 2014||2014-01-01|September 2014|2014-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01|2 Weeks|Observational [Patient Registry]|VCSRI||Validation of Chinese SRI Questionnaire|Validation of Chinese Severe Respiratory Insufficiency （SRI）Questionnaire for COPD Patients With Chronic Hypercapnic Respiratory Failure|Unknown status|Recruiting|N/A|150|Anticipated|Guangzhou Institute of Respiratory Disease|||1||f||||f||||||||||2017-10-11 00:01:02.807489|2017-10-11 00:01:02.807489
NCT02240212|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-04-07|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|February 7, 2017|Actual|2017-02-07|February 7, 2017|Actual|2017-02-07||Interventional|||Study of Afuresertib Combined With Paclitaxel in Gastric Cancer|Phase Ib Study of Afuresertib Combined With Paclitaxel in Pre-treated HER2-negative Advanced Gastric Cancer|Completed||Phase 1|29|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:01:02.902872|2017-10-11 00:01:02.902872
NCT02240199|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-12-14|||November 2014||2014-11-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|January 2016|Actual|2016-01-01||Interventional|PLAN||Perioperative Pregabalin and Lidocaine to Reduce Chronic Breast Cancer Pain|Pregabalin and Lidocaine in Breast Cancer Surgery to Alter Neuropathic Pain (PLAN): A Pilot Trial|Active, not recruiting||Phase 3|100|Actual|McMaster University||4|||f||||f||||||||No||2017-10-11 00:01:03.028982|2017-10-11 00:01:03.028982
NCT02240173|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-02-14|||June 2017|Anticipated|2017-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia|Phase 2 Study of the Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia.|Not yet recruiting||Phase 1/Phase 2|100|Anticipated|Federal Neuro-Psychiatric Hospital, Yaba||2|||f||||f|f|f||||||||2017-10-11 00:01:03.246845|2017-10-11 00:01:03.246845
NCT02240160|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-08-10|||August 2014||2014-08-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|August 2014|Actual|2014-08-01||Interventional|||A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects|A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects|Terminated||Phase 1|6|Actual|GW Pharmaceuticals Ltd.||3|||f||||f||||||||||2017-10-11 00:01:03.378182|2017-10-11 00:01:03.378182
NCT02240147|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-07-18|||January 2015||2015-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|S2S-ACHD||Start-to-Sport - Home-based Exercise for Adolescents and Adults With Congenital Heart Disease|Start-to-Sport - Feasibility and Efficacy of Individualized, Telemonitored, Home-based Exercise for Adolescents and Adults With Congenital Heart Disease|Active, not recruiting||N/A|100|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 00:01:03.502077|2017-10-11 00:01:03.502077
NCT02240134|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-10-26|||November 2014||2014-11-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|KidsAIR||Wood Stove Interventions and Child Respiratory Health|Wood Stove Interventions and Child Respiratory Infections in Rural Communities|Recruiting||N/A|486|Anticipated|University of Montana||3|||f||||f||||||||||2017-10-11 00:01:03.609556|2017-10-11 00:01:03.609556
NCT02240121|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-04-26|||July 2014|Actual|2014-07-01|April 2017|2017-04-01|June 1, 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease|A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Multiregional, One Year Study to Assess the Efficacy and Safety of Twice Daily Oral Rifaximin Delayed Release Tablets for Induction of Clinical Remission With Endoscopic Response at 16 Weeks Followed by Clinical and Endoscopic Remission at 52 Weeks in Subjects With Active Moderate Crohn's Disease|Recruiting||Phase 3|660|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 00:01:03.738532|2017-10-11 00:01:03.738532
NCT02240108|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-04-26|||September 30, 2014|Actual|2014-09-30|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|May 2020|Anticipated|2020-05-01||Interventional|||One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease|A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Multiregional, One Year Study to Assess the Efficacy and Safety of Twice Daily Oral Rifaximin Delayed Release Tablets for Induction of Clinical Remission With Endoscopic Response at 16 Weeks Followed by Clinical and Endoscopic Remission at 52 Weeks in Subjects With Active Moderate Crohn's Disease|Recruiting||Phase 3|660|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 00:01:04.025813|2017-10-11 00:01:04.025813
NCT02240095|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-04-07|||September 2014||2014-09-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|MPFS-2||Increasing Medical and Nursing Students Searching of Current Best Evidence to Answer Clinical Questions|Multifaceted Online Interventions to Increase Medical and Nursing Students Searching of Current Best Evidence to Answer Clinical Questions (MPFS-2)|Unknown status|Active, not recruiting|N/A|800|Anticipated|McMaster University||8|||f||||f||||||||||2017-10-11 00:01:04.417452|2017-10-11 00:01:04.417452
NCT02240082|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-10-26|||March 2015||2015-03-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||COPing With Shift Work - Web Based Program for Police Officers|COPing With Shift Work|Unknown status|Enrolling by invitation|N/A|300|Anticipated|ISA Associates, Inc.||2|||f||||f||||||||||2017-10-11 00:01:04.570158|2017-10-11 00:01:04.570158
NCT02240069|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-10-26|||November 2014||2014-11-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|EldersAIR||Wood Smoke Interventions in Native American Populations|Residential Wood Smoke Interventions Improving Health in Native American Populations|Recruiting||N/A|188|Anticipated|University of Montana||3|||f||||f||||||||||2017-10-11 00:01:04.84549|2017-10-11 00:01:04.84549
NCT02240056|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-09-29|||October 2014||2014-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|TAKINSULA||Brain fMRT In Takotsubo Cardiomyopathy|Pilot Study: Central Nervous System and Hormonal Changes In Takotsubo Cardiomyopathy|Recruiting||N/A|50|Anticipated|Medical University Innsbruck|||2||f||||f||||||||||2017-10-11 00:01:04.966653|2017-10-11 00:01:04.966653
NCT02240043|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2014-09-11|||September 2011||2011-09-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Growth Hormone Evaluation in the Elderly People|Growth Hormone Evaluation in the Elderly People|Completed||N/A|48|Actual|Universidade Federal do Rio de Janeiro||1|||f||||f||||||||||2017-10-11 00:01:05.076452|2017-10-11 00:01:05.076452
NCT02240030|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-01-24|||November 2014||2014-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SPAN-PD™||Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena) (SPAN-PD™)|Completed||Phase 3|351|Actual|Acorda Therapeutics||3|||f||||t||||||||||2017-10-11 00:01:05.188553|2017-10-11 00:01:05.188553
NCT02240017|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-05-26|||September 2014||2014-09-01|September 2014|2014-09-01|September 2023|Anticipated|2023-09-01|December 2017|Anticipated|2017-12-01||Interventional|VEFORA||A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.|Randomized, Multicenter, Phase II/III Study, Evaluating Fractionated Cisplatin Chemotherapy/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.|Recruiting||Phase 2/Phase 3|420|Anticipated|Institut Claudius Regaud||2|||f||||f||||||||||2017-10-11 00:01:05.464782|2017-10-11 00:01:05.464782
NCT02240004|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-03-27|||May 2014||2014-05-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|SUPREMO||Hemo Filtration Reinfusion (HFR) Clearance Efficiency Towards P-bound Toxins and Effects on Inflammatory and Endothelial Damage Markers|"Removal of Uremic Toxins and Improvement of Chronic Inflammation With HFR in Comparison With On-Line Hemodiafiltration and High Flux Hemodialysis."|Completed||N/A|9|Actual|Hospital Universitario Reina Sofia|||1||f||||f||||||||||2017-10-11 00:01:05.652817|2017-10-11 00:01:05.652817
NCT02239991|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-09-15|||September 2014||2014-09-01|September 2014|2014-09-01|February 2016|Anticipated|2016-02-01|August 2015|Anticipated|2015-08-01||Interventional|||Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant|Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant|Unknown status|Recruiting|N/A|100|Anticipated|Hospital Israelita Albert Einstein||2|||f||||f||||||||||2017-10-11 00:01:05.728643|2017-10-11 00:01:05.728643
NCT02239978|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-01-04|2016-10-05||August 2014||2014-08-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|January 2016|Actual|2016-01-01||Observational|||Effect of Levodopa on Postural Motor Learning in Parkinson Disease|Effect of Levodopa on Postural Motor Learning in Parkinson Disease|Completed||N/A|42|Actual|VA Office of Research and Development|||2||f||||f||||||None Retained|"     No Biospecimens will be collected or retained   "|No||2017-10-11 00:01:05.872762|2017-10-11 00:01:05.872762
NCT02239965|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-02-02|||June 2014||2014-06-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Qualitative Analysis of Barriers to Consistent Use of Neuromuscular Monitoring in General Anaesthesia|Qualitative Analysis of Barriers to Consistent Use of Neuromuscular Monitoring in General Anaesthesia|Completed||N/A|40|Actual|Herlev Hospital|||1||f||||||||||||||2017-10-11 00:01:06.298871|2017-10-11 00:01:06.298871
NCT02239952|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-07-31|||November 2014||2014-11-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)|Pilot Study on the Determination of Tumor Concentrations of Protein Kinase Inhibitors in Patients With Newly Diagnosed High-grade Glioma|Recruiting||N/A|15|Anticipated|VU University Medical Center||3|||f||||t||||||||||2017-10-11 00:01:06.389029|2017-10-11 00:01:06.389029
NCT02239926|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-02-16|2016-01-05||September 2014||2014-09-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Ranolazine||Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D|Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)|Terminated||Phase 2/Phase 3|5|Actual|Mayo Clinic|The study was terminated early due to enrollment issues.|2||Difficulty in enrolling subjects|f||||f||||||||||2017-10-11 00:01:06.610287|2017-10-11 00:01:06.610287
NCT02239913|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-10-02|||September 2014||2014-09-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Topiramate-Phentermine Combinations for Cocaine Dependence|Topiramate-Phentermine Combinations for Cocaine Dependence|Recruiting||Phase 1|36|Anticipated|University of Kentucky||3|||f||||t||||||||||2017-10-11 00:01:06.862421|2017-10-11 00:01:06.862421
NCT02239900|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-06-20|||August 2014|Actual|2014-08-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors|Phase I/II Trial of Ipilimumab (Immunotherapy) and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid Malignancies|Recruiting||Phase 1/Phase 2|120|Anticipated|M.D. Anderson Cancer Center||6|||f||||t|t|f||||||||2017-10-11 00:01:06.971129|2017-10-11 00:01:06.971129
NCT02239887|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-01-13|||October 2010||2010-10-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Coherex WAVECREST I Left Atrial Appendage Occlusion Study|Coherex WAVECREST I Left Atrial Appendage Occlusion Study|Completed||N/A|155|Actual|Coherex Medical|||1||f||||f||||||||||2017-10-11 00:01:07.09506|2017-10-11 00:01:07.09506
NCT02239874|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-07-29|||July 2012||2012-07-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|October 2017|Anticipated|2017-10-01||Interventional|VITAL||VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue|THE EFFECTS OF VITAMIN D ON MAMMOGRAPHIC DENSITY AND BREAST TISSUE|Enrolling by invitation||N/A|25875|Actual|Brigham and Women's Hospital||4|||f||||f||||||||||2017-10-11 00:01:07.176645|2017-10-11 00:01:07.176645
NCT02239861|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-08-21|||April 2015|Actual|2015-04-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|||TAA-Specific CTLS for Solid Tumors (TACTASOM)|Tumor Associated Antigen (TAA)-Specific Cytotoxic T-Lymphocytes Administered to Patients With Solid Tumors|Recruiting||Phase 1|18|Anticipated|Baylor College of Medicine||1|||f||||t|t|f||||||||2017-10-11 00:01:07.295735|2017-10-11 00:01:07.295735
NCT02239835|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||December 1999||1999-12-01|September 2014|2014-09-01||||November 2001|Actual|2001-11-01||Interventional|||Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients|Tipranavir: An Open-label, Randomized Study Comparing Combination Therapy (Tipranavir and Ritonavir vs. Saquinavir and Ritonavir) Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients|Terminated||Phase 2|79|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:01:07.388372|2017-10-11 00:01:07.388372
NCT02239822|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-09-28|||December 2013||2013-12-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|TREND2||Electrical Stimulation in Patients With Unipolar Major Depression|Double Blinded Randomized Trial of eTNS as Adjuvant Treatment for Major Unipolar Depressive Disorder.|Completed||Phase 2|50|Actual|Hospital do Coracao||2|||f||||t||||||||||2017-10-11 00:01:07.481082|2017-10-11 00:01:07.481082
NCT02239809|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-09-28|||May 2014||2014-05-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|TREND1||Electrical Stimulation in Patients With Unipolar Major Depression|Double Blinded Randomized Trial of sTNS as Adjuvant Treatment for Major Unipolar Depressive Disorder.|Completed||Phase 2|20|Actual|Hospital do Coracao||2|||f||||t||||||||||2017-10-11 00:01:07.575263|2017-10-11 00:01:07.575263
NCT02239796|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-05-25|||September 2014||2014-09-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|TREAT-UI||Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence|A Feasibility Study for a Randomised Controlled Trial of Transcutaneous Posterior Tibial Nerve Stimulation to Alleviate Stroke-related Urinary Incontinence.|Completed||N/A|54|Actual|Glasgow Caledonian University||2|||f||||f||||||||||2017-10-11 00:01:07.658668|2017-10-11 00:01:07.658668
NCT02239783|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-06-19|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|November 2028|Anticipated|2028-11-01|November 2027|Anticipated|2027-11-01||Observational|||Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems|Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems|Enrolling by invitation||N/A|143|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||||2017-10-11 00:01:07.751701|2017-10-11 00:01:07.751701
NCT02239770|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2016-09-13|||September 2015||2015-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pharmacokinetics of Nicotine Film in Smokers|Pharmacokinetics of Nicotine Film in Smokers|Recruiting||N/A|24|Anticipated|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-10-11 00:01:07.841389|2017-10-11 00:01:07.841389
NCT02239757|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2015-07-30|||January 2013||2013-01-01|September 2014|2014-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Left vs Right Radial Approach in the Setting of Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction||Completed||N/A|200|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 00:01:08.103335|2017-10-11 00:01:08.103335
NCT02239744|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2016-01-12|2014-11-19||September 2014||2014-09-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||All 35 participants recivered palecbo and real intervention, and the order was random. This crossover study autonomically allows each subject to serve as his or her own control over time.|Intervention Study on the Health Impact of Air Filters in Chinese Adults|Cardiopulmonary Benefits of Reducing Indoor Particles of Outdoor Origin: a Randomized Double-blind Crossover Trial of Air Purifiers|Completed||N/A|35|Actual|Fudan University|The study only included 35 participants in 10 rooms, we might therefore have missed some potentially important but modest differences due to the relatively small sample size.|2|||f||||t||||||||||2017-10-11 00:01:08.257547|2017-10-11 00:01:08.257547
NCT02239731|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-02-21|||October 2014||2014-10-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients|A Safety, Tolerability and Efficacy Study of Doxycycline Topical Foam Administered Topically for Prevention of Epidermal Growth Factor Receptor Inhibition Skin Toxicity, to Subjects With Cancer Receiving Cetuximab or Panitumumab|Completed||Phase 2|24|Actual|Foamix Ltd.||2|||f||||f||||||||||2017-10-11 00:01:08.726689|2017-10-11 00:01:08.726689
NCT02239718|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-10-25|||October 2014||2014-10-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Novel Use of 2-unit Cantilever Resin-bonded Bridges for Replacing Missing Molar Teeth - a Randomized Clinical Trial|Novel Use of 2-unit Cantilever Resin-bonded Bridges for Replacing Missing Molar Teeth - a Randomized Clinical Trial|Recruiting||N/A|150|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:01:08.980574|2017-10-11 00:01:08.980574
NCT02239705|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-11|||September 2014||2014-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|||Mathematical Coupling of Data in Transpulmonary Thermodilution|Mathematical Coupling of Data Between Global-End Diastolic Volume Index and Cardiac Index Calculated by Edwards EV1000|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of Foggia|||2||f||||t||||||||||2017-10-11 00:01:09.126797|2017-10-11 00:01:09.126797
NCT02239692|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-05-17|2016-05-17||November 2014||2014-11-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|OPTIMA|The intention-to-treat (ITT) analysis set consisted of all randomized subjects.|A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy|A Randomised, Assessor-blinded, Multi-centre Trial Comparing the Efficacy, Safety and Tolerability of the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy|Completed||Phase 3|204|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:01:09.232734|2017-10-11 00:01:09.232734
NCT02239679|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-09-19|2017-08-16||September 2014||2014-09-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy|A Phase 2 Study Comparing the Occurrence of Actinic Keratoses on the Face in High-Risk Individuals After Cryotherapy + Photodynamic Therapy With Levulan Topical Solution + Blue Light Versus Cryotherapy + Vehicle Topical Solution + Blue Light|Completed||Phase 2|166|Actual|DUSA Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 00:01:09.955767|2017-10-11 00:01:09.955767
NCT02239666|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2017-08-02|||March 1, 2014|Actual|2014-03-01|August 2017|2017-08-01|January 5, 2017|Actual|2017-01-05|January 5, 2017|Actual|2017-01-05||Observational|||Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis|A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics|Completed||N/A|899|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:01:13.865028|2017-10-11 00:01:13.865028
NCT02239653|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-10|||June 2014||2014-06-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|MWP||Reduction of Excessive Calories From Beverages in Children|Randomized Controlled Trial to Reduce Calorie Intake From Sugar-sweetened Beverages by Children 1 - 12 Years of Age|Unknown status|Enrolling by invitation|N/A|400|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 00:01:14.214874|2017-10-11 00:01:14.214874
NCT02239640|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-04-14|||August 2014||2014-08-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|90 Days|Observational [Patient Registry]|||Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry|Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry|Active, not recruiting||N/A|1000|Anticipated|Medtronic Neurovascular Clinical Affairs|||1||f||||f||||||||No|Only multi center data will be available|2017-10-11 00:01:14.3026|2017-10-11 00:01:14.3026
NCT02239627|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-06-01|||September 2014||2014-09-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Epidural Clonidine Versus Corticosteroid for Low Back Pain|Prospective, Randomized, Double Blinded Comparison of the Analgesic Efficacy of Epidural Clonidine Versus Corticosteroid for Low Back Pain|Terminated||N/A|16|Actual|West Virginia University||2||based on interim anaylsis|f||||f||||||||||2017-10-11 00:01:14.493994|2017-10-11 00:01:14.493994
NCT02239601|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-05-18|||December 1, 2014|Actual|2014-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Chemotherapy Induced Peripheral Neuropathy. Could Physical Therapy Help Treat Symptoms?|Pre-existing Nerve Entrapment as a Risk Factor for Chemotherapy - Induced Peripheral Neuropathy (CIPN). Could There be a Role for Physical Therapy Treatment?|Active, not recruiting||N/A|56|Actual|CancerCare Manitoba||1|||f||||f||||||||Yes||2017-10-11 00:01:14.678338|2017-10-11 00:01:14.678338
NCT02239588|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-09-11|||April 2014||2014-04-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of the Effect of Pure Canterbury Stage 1 Infant Formula Milk Powder on the Growth of Infant 0-6 Months of Age|Evaluation of the Effect of Pure Canterbury Stage 1 Infant Formula Milk Powder on the Growth of Infant 0-6 Months of Age|Completed||Phase 4|120|Actual|Bright Dairy & Food Co., Ltd||3|||f||||t||||||||||2017-10-11 00:01:14.772849|2017-10-11 00:01:14.772849
NCT02239575|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-09-12|||March 2014||2014-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|GBCPRT0009||Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples|Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples|Enrolling by invitation||N/A|800|Anticipated|Global BioClinical|||1||f||||f||||||Samples With DNA|"     pre-surgical blood samples and/or surplus surgical oncology tissues   "|||2017-10-11 00:01:14.869218|2017-10-11 00:01:14.869218
NCT02239562|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-04-25|||August 2014||2014-08-01|April 2017|2017-04-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|||sPIF CLINICAL STUDY PROTOCOL FOR AUTOIMMUNE HEPATITIS|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Synthetic PreImplantation Factor (sPIF) in Autoimmune Hepatitis|Completed||Phase 1|18|Actual|University of Miami||12|||f||||t||||||||||2017-10-11 00:01:14.93267|2017-10-11 00:01:14.93267
NCT02239549|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-11|||April 2009||2009-04-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|May 2012|Actual|2012-05-01||Interventional|||Biopsy Forceps Versus Cold Snare for the Resection of Small Colonic Polyps|A Prospective Randomized Study Comparing Jumbo Cold Biopsy Forceps Versus Cold Snare for the Resection of Small Colonic Polyps|Completed||N/A|419|Actual|San Diego Veterans Healthcare System||2|||f||||t||||||||||2017-10-11 00:01:15.172551|2017-10-11 00:01:15.172551
NCT02239536|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-10-14|||June 2014||2014-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|HSP vs HSPASI||Hot Snare Versus Hot Snare Polypectomy With Saline Injection for Colorectal Polyps|Hot Snare Polypectomy Vs. Hot Snare Polypectomy After Saline Injection for the Complete Resection of Neoplastic Colorectal Polyps: Prospective, Randomized Controlled Trial|Enrolling by invitation||Phase 4|310|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-11 00:01:15.274912|2017-10-11 00:01:15.274912
NCT01883934|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-02-03|||September 2011||2011-09-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|FREDS||Frozen Embryo Donation Study|Increasing the Use of Donated Embryos: A Demonstration|Completed||N/A|3568|Actual|Boston IVF||2|||f||||f||||||||||2017-10-11 01:33:42.403719|2017-10-11 01:33:42.403719
NCT02239523|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-08-15|||February 21, 2017|Actual|2017-02-21|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit Analysis|Management Strategies by an Orthopedic Department to Improve the Evaluation and Treatment of Osteoporosis.|Recruiting||N/A|236|Anticipated|Shaare Zedek Medical Center||2|||f||||t|f|f||||||||2017-10-11 00:01:15.366984|2017-10-11 00:01:15.366984
NCT02239510|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-10-28|||September 2014||2014-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy of Linaclotide to Senna for CIC|A Randomized, Double-Blind, Trial Comparing the Efficacy of Linaclotide to Senna in Relieving Symptoms in Patients With Chronic Idiopathic Constipation (CIC)|Completed||N/A|6|Actual|TriHealth Inc.||2|||f||||f||||||||No|Recruitment was low and therefore results are insufficient to share.|2017-10-11 00:01:15.485815|2017-10-11 00:01:15.485815
NCT02239497|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2014-09-10|||March 2013||2013-03-01|September 2014|2014-09-01||||September 2013|Actual|2013-09-01||Interventional|||Femoral Preincisional Block in Acute Postoperative Pain Management of Surgery Orthopaedic Lower Limb||Completed||Phase 4|30|Actual|Hospital Central Dr. Luis Ortega||2|||f||||||||||||||2017-10-11 00:01:15.569144|2017-10-11 00:01:15.569144
NCT02239484|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-10|||March 2014||2014-03-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin|An Open-label, Randomized, Multiple-dose Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 00:01:15.640271|2017-10-11 00:01:15.640271
NCT02239458|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-04-15|||June 2015||2015-06-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis||Unknown status|Not yet recruiting|N/A|60|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 00:01:15.719865|2017-10-11 00:01:15.719865
NCT02239445|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2015-05-09|||September 2014||2014-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging||Completed||Phase 4|158|Actual|Guangzhou Women and Children's Medical Center||3|||f||||t||||||||||2017-10-11 00:01:15.898785|2017-10-11 00:01:15.898785
NCT02239432|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-10|||September 2014||2014-09-01|September 2014|2014-09-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Observational|||Telomere Biology in Early Adenocarcinoma of the Lung|Prospective Cohort Study of Telomere Biology Among Patients With Early Adenocarcinoma of the Lung|Unknown status|Recruiting|N/A|100|Anticipated|Meir Medical Center|||3||f||||f||||||Samples Without DNA|"     One peripheral blood sample is taken for lymphocyte culture and subsequently telomere length     and activity analysis (previously described, Laish I, Gene 2013;529:245-9)   "|||2017-10-11 00:01:15.995677|2017-10-11 00:01:15.995677
NCT02239419|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-10-29|||September 2014||2014-09-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||Evaluation of Carbothera in the Treatment of Foot Ulcers|Evaluation of the Clinical Utility, Efficacy and Safety of a Novel Medical Device (Carbothera) in the Treatment of Foot Ulcers|Unknown status|Recruiting|N/A|40|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:01:16.084398|2017-10-11 00:01:16.084398
NCT02239406|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-07-21|||November 2014||2014-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Acetabular Bone Vascularity in Metal-on-Metal Revisions|Acetabular Bone Vascularity in Metal-on-Metal Revisions|Terminated||N/A|7|Actual|OrthoCarolina Research Institute, Inc.|||1|Lack of enrollment interest.|f||||t||||||||No||2017-10-11 00:01:16.205553|2017-10-11 00:01:16.205553
NCT02239393|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-05-09|||June 2015||2015-06-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|MESCAMS||Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study|MEsenchymal Stem Cell Therapy for CAnadian MS Patients|Recruiting||Phase 2|40|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-11 00:01:16.276627|2017-10-11 00:01:16.276627
NCT02239380|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-01-23|||November 2014||2014-11-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan|A Multi-center, Open-label, Non-controlled Study To Evaluate The Efficacy And Safety Of Lorazepam Intravenously Administered In Subjects With Status Epilepticus Or Repetitive Status Epilepticus|Completed||Phase 3|26|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:01:16.390503|2017-10-11 00:01:16.390503
NCT02239367|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-01-23|||May 30, 2014|Actual|2014-05-30|January 2017|2017-01-01|April 13, 2015|Actual|2015-04-13|April 13, 2015|Actual|2015-04-13||Interventional|||Depression Decision Aid: Feasibility Pilot|Electronic Depression Decision Aid for Nurses in Primary Care: Development and Implementation in a Diverse Low-Income Population|Completed||N/A|18|Actual|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-11 00:01:16.522428|2017-10-11 00:01:16.522428
NCT02239354|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-05-18|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus|A Prospective, Multicenter, Open-Label, First-in-Human Phase 1/2 Study With Two Cohorts to Evaluate the Safety, Tolerability, and Efficacy of Various Doses of VC-01™ Combination Product in Subjects With Type 1 Diabetes Mellitus|Active, not recruiting||Phase 1/Phase 2|65|Anticipated|ViaCyte||2|||f||||||||||||||2017-10-11 00:01:16.601566|2017-10-11 00:01:16.601566
NCT02239341|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-11-30|||October 2014||2014-10-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Effects of Two In-hospital Antepartum Interventions on Functional Ability and Quality of Life in Early Postpartum Women.|Effects of Two In-hospital Antepartum Interventions on Functional Ability and Quality of Life in Early Postpartum Women.|Active, not recruiting||N/A|30|Anticipated|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 00:01:16.682992|2017-10-11 00:01:16.682992
NCT02239315|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-05-01|||December 2015||2015-12-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2017|Anticipated|2017-06-01||Interventional|RnaDx||Study of Tumor RNA Disruption Assay™ (RDA)|Study of Tumor RNA Disruption Assay™ (RDA) and Its Association With a Response to Neoadjuvant Chemotherapy in Breast Cancer - A Prospective Mixed-Methods Study|Terminated||N/A|1|Actual|University of Toronto||1||Lack of funding|f||||t||||||||||2017-10-11 00:01:16.86897|2017-10-11 00:01:16.86897
NCT02239302|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-07-30|||January 2014||2014-01-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|OPUS||Obstructed Defaecation: Proctography Versus Ultrasound in Symptomatic Patients|Obstructed Defaecation: Proctography Versus Ultrasound (TPUS and EVUS) in Symptomatic Patients|Completed||N/A|131|Actual|Croydon University Hospital|||1||f||||t||||||||||2017-10-11 00:01:17.000649|2017-10-11 00:01:17.000649
NCT02239289|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2015-07-10|2015-05-26||March 2014||2014-03-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Use of Biofeedback Training to Correct Abnormal Neuromechanical Pattern in Chronic Low Back Pain Patients|Correction of Abnormal Flexion-relaxation Phenomenon in Chronic Low Back Pain: the Benefit Associated With Biofeedback Training|Completed||N/A|21|Actual|Université du Québec à Trois-Rivières||1|||f||||f||||||||||2017-10-11 00:01:17.430183|2017-10-11 00:01:17.430183
NCT02239276|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-08-08||||||August 2016|2016-08-01||||||||Expanded Access|||Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies|Expanded Access Use of Stiripentol in Participants With Dravet Syndrome or Epileptic Encephalopathies Associated With Sodium Channel Mutations|Available||N/A|||Cook Children's Health Care System|||||||||||||||||||2017-10-11 00:01:17.834803|2017-10-11 00:01:17.834803
NCT02239263|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-05-15|||May 2014||2014-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:01:17.923824|2017-10-11 00:01:17.923824
NCT02239250|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-09-09|||August 2014||2014-08-01|February 2015|2015-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Water Filters and Improved Cookstoves in Western Rwanda|Assessing the Health Impact of Advance Water Filters and Improved Cookstoves in Western Province, Rwanda: A Cluster-randomised Controlled Trial|Completed||N/A|1582|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 00:01:17.968458|2017-10-11 00:01:17.968458
NCT02239237|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-12-28|||September 2014||2014-09-01|December 2016|2016-12-01||||June 2017|Anticipated|2017-06-01||Observational|||Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study|Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study|Recruiting||N/A|30000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t||||||Samples Without DNA|"     Serum will be retained from the patients who have the anaphylaxis after given the Compound     Kuh-seng Injection and the other 4 matched patients who do not has the anaphylaxis.   "|||2017-10-11 00:01:18.084551|2017-10-11 00:01:18.084551
NCT02239211|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-06-12|||September 8, 2015|Actual|2015-09-08|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|BUTEO||A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis|A Single Arm, Two-stage, Multi-centre, Phase II Clinical Trial Investigating the Safety and Activity of the Use of BTT1023 Targeting Vascular Adhesion Protein (VAP-1), in the Treatment of Patients With Primary Sclerosing Cholangitis (PSC).|Recruiting||Phase 2|41|Anticipated|University of Birmingham||1|||f||||t||||||||No||2017-10-11 00:01:18.504951|2017-10-11 00:01:18.504951
NCT02239198|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-04-17|||April 5, 2016|Actual|2016-04-05|February 2017|2017-02-01|April 13, 2017|Actual|2017-04-13|April 5, 2017|Actual|2017-04-05||Interventional|CHORIBar||Impact of a Nutritional Supplement on Metabolic Health|Attenuating the Micronutrient Malnutrition of Overnutrition (AMMO)|Completed||N/A|16|Actual|Children's Hospital & Research Center Oakland||3|||f||||f||||||||No||2017-10-11 00:01:18.617957|2017-10-11 00:01:18.617957
NCT02239185|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-09-11|||May 2012||2012-05-01|September 2014|2014-09-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|LIHR-2014||Laparoscopic Inguinal Hernia Repair in Infancy and Childhood|Laparoscopic Inguinal Hernia Repair in Infancy and Childhood; a Prospective Controlled Randomized Study of Two Different Technique|Unknown status|Recruiting|Phase 3|90|Anticipated|Al-Azhar University||2|||f||||f||||||||||2017-10-11 00:01:18.711537|2017-10-11 00:01:18.711537
NCT02239172|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine|A Phase 1 Study of the Safety and Immunogenicity of Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine in Healthy Adults|Completed||Phase 1|30|Actual|Fraunhofer, Center for Molecular Biotechnology||4|||f||||f||||||||Undecided||2017-10-11 00:01:18.818554|2017-10-11 00:01:18.818554
NCT02239159|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2017-07-06|||April 2014||2014-04-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|AID||Acupuncture-assisted-anesthesia to Improve Postoperative Outcome After Digestive Surgery in Elderly Patients|Acupuncture-assisted-anesthesia to Improve Complications After Digestive Surgery in Elderly Patients:Multi-center Double-blinded Randomized Controlled Trial|Completed||N/A|748|Actual|Fourth Military Medical University||3|||f||||t||||||||||2017-10-11 00:01:18.894946|2017-10-11 00:01:18.894946
NCT02239146|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-01-10|||October 2005||2005-10-01|January 2017|2017-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass|A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Dose Escalation Trial on Safety and Pharmacokinetics of Recombinant Factor XIII (rFXIII) in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass|Completed||Phase 1|43|Actual|Novo Nordisk A/S||2|||f||||t||||||||||2017-10-11 00:01:18.987354|2017-10-11 00:01:18.987354
NCT02228759|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-03-07|||April 2015||2015-04-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Ambulatory Continuous Adductor Canal Block to Facilitate Same Day Discharge Following Total Knee Arthroplasty: A Pilot Study||Completed||N/A|25|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 00:03:37.058186|2017-10-11 00:03:37.058186
NCT02239133|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-12-30|||August 2014||2014-08-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||R&D Supporting Pilot Study for the Assessment of the Safety and Effectiveness of the ProVATE (ProTIPI) Vaginal Pessary|Pilot Study for the Evaluation of the ProVATE (ProTIPI) Pessary Designs in the Temporary Management of Pelvic Organ Prolapse (POP) in Women|Active, not recruiting||N/A|44|Actual|ConTIPI Medical||1|||f||||f||||||||||2017-10-11 00:01:19.133022|2017-10-11 00:01:19.133022
NCT02239120|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-10-03|||November 27, 2014|Actual|2014-11-27|October 2017|2017-10-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)|Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the EfficaCy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, Oral b.i.d.) Versus Acetylsalicylic Acid (100 mg Oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT ESUS)|Recruiting||Phase 3|6000|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:01:19.31112|2017-10-11 00:01:19.31112
NCT02239107|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-11|||January 2012||2012-01-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome|N-acetyl Cysteine as an Adjuvant Therapy to Laparoscopic Ovarian Drilling in Clomiphene Citrate Resistant Polycystic Ovary Syndrome|Completed||Phase 4|70|Actual|Assiut University||2|||f||||t||||||||||2017-10-11 00:01:21.04864|2017-10-11 00:01:21.04864
NCT02239081|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-05-28|||September 2014||2014-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||A Safety and Tolerability Study of CTP-730 in Healthy Volunteers|A Randomized, Double-blind, Single Ascending Dose, Safety, Tolerability, Pharmacokinetics Study of CTP-730 in Healthy Volunteers|Completed||Phase 1|55|Actual|Concert Pharmaceuticals||7|||f||||t||||||||||2017-10-11 00:01:21.244798|2017-10-11 00:01:21.244798
NCT02239068|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-07-05|||March 2011||2011-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||CT Residual Gastric Fluid Volume|Residual Gastric Fluid With Administering Clear Liquids Within Two Hours of Anesthesia in Children|Enrolling by invitation||N/A|100|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 00:01:21.379003|2017-10-11 00:01:21.379003
NCT02239055|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-05-01|||May 2014||2014-05-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Staff Nurse Perceptions of MBT Skills Training for Working With BPD in AMH|Staff Nurse Perceptions of the Impact of Mentalization Based Treatment (MBT) Skills Training on Clinical Practice When Working With Borderline Personality Disorder (BPD) in Acute Mental Health Admission Wards: A Qualitative Analysis.|Completed||N/A|9|Actual|University of Aberdeen|||2||f||||f||||||||Undecided||2017-10-11 00:01:21.450858|2017-10-11 00:01:21.450858
NCT02239042|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-10|||October 2011||2011-10-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|LLLT||Effect of Low-level Laser Therapy on Palatal Wound Healing|Effect of Gallium-Aluminum-Arsenide Laser - AsGaAl Low-level Laser Therapy on the Healing of Human Palate Mucosa After Connective Tissue Graft Harvesting: Randomized Clinical Trial|Completed||Phase 4|32|Actual|UPECLIN HC FM Botucatu Unesp||2|||f||||f||||||||||2017-10-11 00:01:21.534135|2017-10-11 00:01:21.534135
NCT02239029|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-12-04|||August 2014||2014-08-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Platelet Rich Plasma on Osteoarthritis of Knee|The Effect of Platelet Rich Plasma on Osteoarthritis of Knee|Completed||N/A|20|Actual|Tri-Service General Hospital||2|||f||||t||||||||||2017-10-11 00:01:21.615196|2017-10-11 00:01:21.615196
NCT02239016|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-01-31|||April 2009||2009-04-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Screening Patients With Sickle Cell Disease for Kidney Damage|Screening Patients With Sickle Cell Disease for Kidney Damage|Recruiting||N/A|400|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     Urine, whole blood and serum   "|||2017-10-11 00:01:21.707188|2017-10-11 00:01:21.707188
NCT02239003|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-08-02|||January 2012||2012-01-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment||Recruiting||Phase 2|50|Anticipated|Chang Gung Memorial Hospital||2|||f||||||||||||||2017-10-11 00:01:21.817071|2017-10-11 00:01:21.817071
NCT02238990|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-03-12|||September 2014||2014-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions|Biomarkerscreening Via Transcriptome and Methylosome Analysis in Cervical Cancer and Its Preinvasive Lesions|Recruiting||N/A|100|Anticipated|University of Luebeck|||1||f||||f||||||Samples With DNA|"     tissue samples of the cervix uteri   "|||2017-10-11 00:01:21.904545|2017-10-11 00:01:21.904545
NCT02238977|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-09-13|||January 2015||2015-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Bupropion for Depression in ESRD Patients on Hemodialysis|Bupropion for Depression in ESRD Patients on Hemodialysis|Recruiting||Phase 4|40|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-10-11 00:01:21.98257|2017-10-11 00:01:21.98257
NCT02238964|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-05-01|||November 2012||2012-11-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|ROCSS||Reinforcement of Closure of Stoma Site|A Randomised Controlled Trial of Reinforcement of Closure of Stoma Site Using a Biological Mesh.|Active, not recruiting||Phase 2/Phase 3|790|Actual|University of Birmingham||2|||f||||t||||||||||2017-10-11 00:01:22.205146|2017-10-11 00:01:22.205146
NCT02238951|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-10-03|||December 2013|Actual|2013-12-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|4CP||Cancer Care Coordination for Chemotherapy Patients|Use of mHealth to Support Nurse-directed Care Coordination for Chemotherapy Patients: Improving Health, Healthcare Delivery, and Healthcare Utilization.|Active, not recruiting||N/A|60|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-11 00:01:22.343487|2017-10-11 00:01:22.343487
NCT02238938|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-05-05|||April 2014||2014-04-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|PERLA||Piecemeal Versus En Bloc Resection of Large Rectal Adenomas|Piecemeal Versus En Bloc Resection of Large Rectal Adenomas -A Prospective, Randomized Multicenter Study|Recruiting||N/A|300|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||Undecided||2017-10-11 00:01:22.42946|2017-10-11 00:01:22.42946
NCT02238912|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-10|||June 2012||2012-06-01|September 2014|2014-09-01||||April 2014|Actual|2014-04-01||Interventional|KR||Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai|Evaluation of Preclinical Toxicity of a Siddha Formulation Kandhaga Rasayanam ( KR ) and Its Therapeutic Efficacy in Padarthamarai ( Dermatophytoses ) by an Open Clinical Trial|Completed||Phase 2|50|Actual|National institute of Siddha||1|||f||||t||||||||||2017-10-11 00:01:22.663561|2017-10-11 00:01:22.663561
NCT02238899|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-05-28|||January 2011||2011-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma|Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, Central Nervous System (CNS)- Primitive Neuroectodermal Tumour (PNET), or Ependymoma|Completed||N/A|354|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||Samples With DNA|"     Tumor material, CSF, and blood   "|||2017-10-11 00:01:22.733024|2017-10-11 00:01:22.733024
NCT02238886|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-09-10|||May 2012||2012-05-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Radical Cystectomy, Nutrition and Convalescence|RADICAL CYSTECTOMY, NUTRITION AND CONVALESCENCE: CAN GOAL-DIRECTED POSTOPERATIVE NUTRITIONAL THERAPY REDUCE THE CONVALESCENCE PERIOD FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY (RC)?|Completed||N/A|36|Actual|Rigshospitalet, Denmark||2|||f||||||||||||||2017-10-11 00:01:22.793877|2017-10-11 00:01:22.793877
NCT02238873|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-10-01|||October 2014||2014-10-01|October 2014|2014-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma|Pegfilgrastim on Day +3 Compared to Day +1 for Patients With Refractory or Relapsed Aggressive Lymphoma Receiving Salvage Chemotherapy - a Randomized Controlled Trial|Not yet recruiting||Phase 3|300|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 00:01:22.949384|2017-10-11 00:01:22.949384
NCT02238860|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-11|||September 2014||2014-09-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis|A Randomised Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis|Unknown status|Recruiting|Phase 4|100|Anticipated|Asian Institute Of Medical Sciences||2|||f||||f||||||||||2017-10-11 00:01:23.08667|2017-10-11 00:01:23.08667
NCT02238847|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-06-29|||March 2015||2015-03-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|March 2017|Actual|2017-03-01||Interventional|||Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy|Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer|Active, not recruiting||Phase 4|120|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 00:01:23.214978|2017-10-11 00:01:23.214978
NCT02238834|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-09-26|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers|A Randomized, Double-blind, Placebo Controlled, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of FP-025, an MMP-12 Inhibitor, in Healthy Male Subjects|Active, not recruiting||Phase 1|80|Anticipated|Foresee Pharmaceuticals Co., Ltd.||4|||f||||t|t|f||||||||2017-10-11 00:01:23.347474|2017-10-11 00:01:23.347474
NCT02238821|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2017-03-02|||October 2007||2007-10-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Observational|COMET||Role of the MET Oncogene in Human Colorectal Cancer - A Translational Study|Role of the MET Oncogene in Human Colorectal Cancer. Possible Implications in the Activation of an Acquired Pro-thrombotic Condition - A Translational Study|Completed||N/A|60|Actual|Fondazione del Piemonte per l'Oncologia|||1||f||||f||||||||||2017-10-11 00:01:23.449065|2017-10-11 00:01:23.449065
NCT02238808|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-01-04|||August 2015||2015-08-01|January 2017|2017-01-01|January 2027|Anticipated|2027-01-01|July 2017|Anticipated|2017-07-01||Interventional|PRESTO||A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers|PRe-operative ESTradiOl Window of Opportunity Study in Post-Menopausal Women With Newly Diagnosed ER Positive Breast Cancer|Recruiting||Phase 2|20|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||No||2017-10-11 00:01:23.51723|2017-10-11 00:01:23.51723
NCT02238795|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-08-30|||April 2016||2016-04-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01|3 Months|Observational [Patient Registry]|SAPFIRE||Sepsis-Associated Purpura Fulminans International Registry - Europe|Sepsis-Associated Purpura Fulminans International Registry - Europe|Recruiting||N/A|150|Anticipated|Jena University Hospital|||1||f||||t||||||Samples Without DNA|"     Blood plasma   "|No||2017-10-11 00:01:23.608393|2017-10-11 00:01:23.608393
NCT02238782|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-03-04|2015-10-06||October 2014||2014-10-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.|A Study to Assess the Absolute Bioavailability of a Single Oral Dose of Selumetinib With Respect to an Intravenous Microdose of [14C] Selumetinib in Healthy Male Volunteers|Completed||Phase 1|21|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 00:01:23.713663|2017-10-11 00:01:23.713663
NCT02237469|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2017-05-12|||September 2010||2010-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|April 2013|Actual|2013-04-01||Observational|HUGProne||Prone Breast Radiotherapy Treatment Planning Observational Study|Retrospective Dosimetric Study of Prone Radiotherapy for Breast Cancer|Active, not recruiting||N/A|280|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 00:01:41.101014|2017-10-11 00:01:41.101014
NCT02238769|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-09-10|||July 2014||2014-07-01|September 2014|2014-09-01|October 2017|Anticipated|2017-10-01|October 2015|Anticipated|2015-10-01||Observational|||18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma|Diagnostic Accuracy of 18F-FluoroethylCholine Positron Emission Tomography for Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|80|Anticipated|Peking Union Medical College Hospital|||1||f||||f||||||||||2017-10-11 00:01:23.879812|2017-10-11 00:01:23.879812
NCT02238756|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-07-28|||September 2014||2014-09-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults|Phase I Safety and Tolerability Trial of Single and Repeat Doses of the RNA-based Adjuvant CV8102 Alone and in Combination With a Licensed Rabies Virus Vaccine in Healthy Adults|Active, not recruiting||Phase 1|72|Anticipated|CureVac AG||3|||f||||t||||||||||2017-10-11 00:01:23.995938|2017-10-11 00:01:23.995938
NCT02238743|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-07-25|||July 2014||2014-07-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|ADOPT||Assuring and Defining Outcomes Through Procedural Training Using a Proctorship Model That Collects Patient Outcomes A Single-Arm, Case-Series to Determine the Feasibility of Safe Skills Transfer for Laparoscopic Ventral Hernia Repair Utilizing a Hands-On Proctorship Model.|A Single-Arm, Case-Series to Determine the Feasibility of Safe Skills Transfer for Laparoscopic Ventral Hernia Repair Utilizing a Hands-On Proctorship Model.|Completed||N/A|10|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 00:01:24.08063|2017-10-11 00:01:24.08063
NCT02238730|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-02-15|||September 2014||2014-09-01|February 2017|2017-02-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy|Comparative Efficacy and Cognitive Side-Effects of Ultrabrief Right Unilateral Electroconvulsive Therapy and Brief Pulse Bitemporal Electroconvulsive Therapy|Withdrawn||N/A|0|Actual|Kaiser Permanente||2||Resources not available for the study|f||||t||||||||||2017-10-11 00:01:24.142879|2017-10-11 00:01:24.142879
NCT02238717|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-12-15|||September 2014||2014-09-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints|A Double Blind, Double Dummy, Randomized, Placebo-controlled, 4 Period Cross-over Study To Examine The Effect Of Pf-06372865 On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin As A Positive Control|Completed||Phase 1|20|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 00:01:24.230802|2017-10-11 00:01:24.230802
NCT02238704|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-07-26|||September 2014||2014-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MICA||Cornell University-Micronutrient Initiative Calcium Supplementation Study|A Cluster-randomized, Non-inferiority Open-label Trial of the Impact of Supplementation Regimen on Consumption of Prenatal Calcium and Iron/Folic Acid Supplements and Adherence to Related Recommendations|Completed||N/A|1032|Actual|Cornell University||2|||f||||f||||||||||2017-10-11 00:01:24.340583|2017-10-11 00:01:24.340583
NCT02238691|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-04-04|||February 2015||2015-02-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Risk of Gastric Insufflation Related to Facemask Ventilation Technique During Anaesthetic Induction, With or Without PEEP|Risk of Gastric Insufflation Related to Facemask Ventilation Technique During Anaesthetic Induction|Completed||N/A|30|Actual|Örebro University, Sweden||2|||f||||f||||||||||2017-10-11 00:01:24.463945|2017-10-11 00:01:24.463945
NCT02238678|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-10|||June 2014||2014-06-01|August 2014|2014-08-01||||June 2014|Actual|2014-06-01||Observational|||Impact of Deep Endometriosis Surgery on Bladder Function|Impact of Deep Endometriosis Surgery on Bladder Function|Unknown status|Active, not recruiting|N/A|50|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 00:01:24.542827|2017-10-11 00:01:24.542827
NCT02238665|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-11|||October 2009||2009-10-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|April 2013|Actual|2013-04-01|1 Day|Observational [Patient Registry]|||CLE for Differential Diagnosis of IBD||Completed||N/A|105|Actual|University of Erlangen-Nürnberg Medical School|||2||f||||||||||||||2017-10-11 00:01:24.593988|2017-10-11 00:01:24.593988
NCT02238652|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-04-14|||August 2014||2014-08-01|September 2014|2014-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|KOSMOS||Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy|Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy (The KOSMOS Study)|Completed||N/A|560|Actual|University of Bergen||2|||f||||f||||||||||2017-10-11 00:01:24.665074|2017-10-11 00:01:24.665074
NCT02238639|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-09-05|||October 2014||2014-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|SLICE||Pulmonary Embolism as a Cause of COPD Exacerbations|Efficacy and Safety of an Active Strategy for the Diagnosis and Treatment of Acute Pulmonary Embolism (PE) in Patients With Unexplained Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): a Randomized Clinical Trial|Recruiting||Phase 3|900|Anticipated|Ministry of Health, Spain||2|||f||||t||||||||||2017-10-11 00:01:24.962665|2017-10-11 00:01:24.962665
NCT02238626|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-08-10|||September 2014||2014-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|IBU-ALS-1201||Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)|A Single-center, Randomized, Double-blind, Placebo-controlled, 6 Month Clinical Trial Followed by an Open-label Extension to Evaluate the Safety, Tolerability and Clinical Endpoint Responsiveness of Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)|Active, not recruiting||Phase 2|120|Anticipated|MediciNova||2|||f||||t||||||||||2017-10-11 00:01:25.199675|2017-10-11 00:01:25.199675
NCT02238613|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-09-10|||August 2014||2014-08-01|September 2014|2014-09-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer|Intraluminal Implantation of Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer|Unknown status|Recruiting|N/A|140|Anticipated|307 Hospital of PLA||2|||f||||t||||||||||2017-10-11 00:01:25.287793|2017-10-11 00:01:25.287793
NCT02238587|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-09|||June 2014||2014-06-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Effect of Ganoderma on Patients With Head-and-neck Cancer|The Effect of Gandoerma Spores Powder Capsules on the Post-treatment Life Quality and Immune Modulation of the Patients With Head-and-neck Cancer|Unknown status|Recruiting|N/A|100|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||f||||||||||2017-10-11 00:01:25.379591|2017-10-11 00:01:25.379591
NCT02238574|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-10||||||September 2014|2014-09-01|December 2024|Anticipated|2024-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Diagnostics for the Treatment of Progressive Mucosal Lesions of the Oral Cavity: a Prospective Study|Chromosomal Instability as an Indicator for the Treatment of Progressive Mucosal Lesions of the Oral Cavity.|Not yet recruiting||N/A|374|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:01:25.474381|2017-10-11 00:01:25.474381
NCT02238561|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-10-29|||November 2014||2014-11-01|February 2015|2015-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||The Cost in Oxygen of Surgical Trauma|The Cost in Oxygen of Surgical Trauma (CO2ST) - a Feasibility Study of the Non-invasive Measurement of Oxygen Delivery and Consumption After Major Abdominal Surgery|Completed||N/A|40|Anticipated|Plymouth Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 00:01:25.565826|2017-10-11 00:01:25.565826
NCT02238548|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-03-28|||July 2014||2014-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|November 2014|Actual|2014-11-01||Interventional|MOSAIC||Effect of Raw Milk on the Immune Response Upon Cholera Vaccination|Effect of Raw Milk on the Immune Response Upon Cholera Vaccination|Completed||N/A|42|Actual|NIZO Food Research||3|||f||||f||||||||||2017-10-11 00:01:25.671841|2017-10-11 00:01:25.671841
NCT02238535|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-09-21|||September 2014||2014-09-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|March 2016|Anticipated|2016-03-01||Interventional|||Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension|Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension|Unknown status|Recruiting|Phase 2|60|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 00:01:25.769346|2017-10-11 00:01:25.769346
NCT02238522|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-11-12|||October 2014||2014-10-01|November 2014|2014-11-01|January 2017|Anticipated|2017-01-01|June 2016|Anticipated|2016-06-01||Interventional|||Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML|Phase 1 Open-label Dose Escalation and Expansion Study of ZEN003365 in Subjects With Relapsed or Refractory Lymphoproliferative Malignancies or Acute Myeloid Leukemia|Withdrawn||Phase 1|0|Actual|Zenith Epigenetics||2|||f||||f||||||||||2017-10-11 00:01:25.868909|2017-10-11 00:01:25.868909
NCT02238509|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-06-14|||November 2014||2014-11-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies|A Randomised, Multicentre, Open-label Phase II Trial Investigating Activity of Chemotherapy and Lapatinib and Trastuzumab in Patients With HER2-positive Metastatic Breast Cancer (MBC) Refractory to Anti HER2 Therapies|Recruiting||Phase 2|154|Anticipated|Consorzio Oncotech||2|||f||||t||||||||No||2017-10-11 00:01:26.021711|2017-10-11 00:01:26.021711
NCT02238496|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-09-07|||July 2014||2014-07-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas|Pilot Trial of Temsirolimus and Perifosine in Recurrent/Progressive Malignant Gliomas|Active, not recruiting||Phase 2|10|Actual|Columbia University||2|||f||||t||||||||Undecided||2017-10-11 00:01:26.507016|2017-10-11 00:01:26.507016
NCT02238470|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-09-21|||April 2012||2012-04-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|2 Years|Observational [Patient Registry]|HERO||Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance|Intracerebral Hemorrhage Due to Oral Anticoagulants in the Secondary Prevention of Ischemic Stroke: Prediction of the Risk by the Detection of Leukoaraiosis and Microbleeding With Magnetic Resonance|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||||2017-10-11 00:01:28.729929|2017-10-11 00:01:28.729929
NCT02238457|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-09-11||||||September 2014|2014-09-01||||||||Interventional|||Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients|Effects of Low-Dose vs High-dose Losartan on Sympathetic Hyperactivity in Patients With Congestive Heart Failure|Withdrawn||Phase 4|0|Actual|Baker IDI Heart and Diabetes Institute||2||Difficulty recruiting patients|f||||f||||||||||2017-10-11 00:01:28.893354|2017-10-11 00:01:28.893354
NCT02238444|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-10-01|||September 2014||2014-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ESWA||Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy|Efficacy and Safety of Warfarin Anticoagulation for Prevention of Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy|Recruiting||Phase 4|60|Anticipated|Yangzhou University||2|||f||||t||||||||||2017-10-11 00:01:28.994306|2017-10-11 00:01:28.994306
NCT02238431|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-05-25|||December 2014||2014-12-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Down-regulated Hormonally Controlled Cycles for Vitrification-warmed Blastocyst Transfers|Down-regulated Hormonally Controlled Cycles for Vitrification-warmed Blastocyst Transfers: Reduces Time to Transfer and Cycle Cancellation|Withdrawn||N/A|0|Actual|Antalya IVF||3||no patient uptake|f||||f||||||||||2017-10-11 00:01:29.174896|2017-10-11 00:01:29.174896
NCT02238418|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2016-03-15|||September 2014||2014-09-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|VITATOL||Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.|Vitamin D Supplementation in Children and Adolescents Seen in the Paediatric Nephrology Service: Study of the Efficacy of Service Usual Care (Cholecalciferol) and Its Impact on Calciuria.|Recruiting||Phase 4|100|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||No||2017-10-11 00:01:29.257046|2017-10-11 00:01:29.257046
NCT02238405|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-01-30|||June 2015|Actual|2015-06-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|||A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes|A Randomized Controlled Smoking Cessation Trial and Prospective Cohort Study of TB Treatment Outcomes|Recruiting||N/A|450|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 00:01:29.339086|2017-10-11 00:01:29.339086
NCT02238392|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-10|||January 2012||2012-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Adenosine vs AF Termination for Paroxysmal AF Ablation|Arrhythmia Inducibility Versus Elimination of Dormant PV Conduction as a Procedural Endpoint of Catheter Ablation for Paroxysmal Atrial Fibrillation: a Prospective Randomized Trial|Completed||N/A|150|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-11 00:01:29.418325|2017-10-11 00:01:29.418325
NCT02238379|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-05-19|2016-11-28||September 2014||2014-09-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||1 participant was lost to follow up for their placebo visit (determined after blind was broken).|Intranasal Oxytocin Administration and the Neural Correlates of Social and Non-Social Visual Perception|Oxytocin Pilot: Oxytocin and Face Perception|Completed||Early Phase 1|26|Actual|Yale University|Small sample size limiting the interpretations of ERP differences between oxytocin and placebo conditions and individual difference measures.|2|||f||||||||||||||2017-10-11 00:01:29.545041|2017-10-11 00:01:29.545041
NCT02238366|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-07-25|||November 2013||2013-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CHRONOS3||Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer|A Non-interventional, Multi-centric, Observational, Prospective Study to Collect the Criteria on Which Renewal of GnRH Analogue Treatment With Triptorelin (Diphereline 3.75mg or Diphereline pr 11.25mg) is Made in Patients Recently Diagnosed With Prostate Cancer Requiring Androgen Deprivation Therapy|Recruiting||N/A|369|Anticipated|Ipsen|||1||f||||f||||||||||2017-10-11 00:01:30.46385|2017-10-11 00:01:30.46385
NCT02238353|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-12-02|||October 2014||2014-10-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)|AZE/FLU Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)|Recruiting||Phase 4|45|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:01:30.601844|2017-10-11 00:01:30.601844
NCT02238340|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-11|||March 2012||2012-03-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Oxycodone Extended-release in the Treatment of Perioperative Pain in Patients Undergoing Orthopaedic Surgery|Oxycodone Extended-release in the Treatment of Perioperative Pain in Patients Undergoing Orthopaedic Surgery|Completed||Phase 4|40|Actual|Hospital Central Dr. Luis Ortega||2|||f||||||||||||||2017-10-11 00:01:30.722975|2017-10-11 00:01:30.722975
NCT02238327|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-10-02|||September 2014||2014-09-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|LEAP||Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes|The Study is a Multicenter, Prospective Observational Study of Pathogenesis of HIV Pulmonary Disease.|Recruiting||N/A|200|Anticipated|University of Pittsburgh|||2||f||||f||||||Samples With DNA|"     Whole blood, serum, bronchial wash and cells   "|||2017-10-11 00:01:30.854319|2017-10-11 00:01:30.854319
NCT02238314|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||January 1999||1999-01-01|September 2014|2014-09-01||||August 2001|Actual|2001-08-01||Interventional|||Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients|Tipranavir Disodium: An Open-Label ExploratorySstudy of Tipranavir and Ritonavir in Combination With One Nucleoside Reverse Transcriptase Inhibitor and One Non-Nucleoside Reverse Transcriptase Inhibitor in Multiple Protease Inhibitor-Experienced HIV Patients|Completed||Phase 2|41|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:01:31.040295|2017-10-11 00:01:31.040295
NCT02238301|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-05-31|||February 18, 2015|Actual|2015-02-18|June 2016|2016-06-01|November 17, 2017|Anticipated|2017-11-17|November 17, 2017|Anticipated|2017-11-17||Interventional|BOLD-FP||Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant Women|Study of the Fetoplacental BOLD Effect in Pregnant Women Using Functional MRI|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 00:01:31.194258|2017-10-11 00:01:31.194258
NCT02238288|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-11|||December 2013||2013-12-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|||Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients|Randomized Clinical Trial to Verify the Effectiveness of Topical Aminocaproic Acid in the Prevention of Post-exodontic Bleeding in Patients on Anticoagulants|Unknown status|Enrolling by invitation|Phase 4|154|Anticipated|Grupo de Estudos Multicentricos em Onco-Hematologia||2|||f||||f||||||||||2017-10-11 00:01:31.330735|2017-10-11 00:01:31.330735
NCT02238275|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||June 2002||2002-06-01|September 2014|2014-09-01||||December 2002|Actual|2002-12-01||Observational|||Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension|Post-Marketing Surveillance Study Micardis® Plus|Completed||N/A|8135|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:31.432729|2017-10-11 00:01:31.432729
NCT02238262|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||May 2000||2000-05-01|September 2014|2014-09-01||||December 2000|Actual|2000-12-01||Observational|||Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals|Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals|Completed||N/A|2318|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:31.517083|2017-10-11 00:01:31.517083
NCT02238249|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||October 2005||2005-10-01|September 2014|2014-09-01||||September 2007|Actual|2007-09-01||Observational|||Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria|Post Marketing Surveillance of Alesion® (Epinastine Hydrochloride) Dry Syrup -Special Drug Use-Results Survey of Alesion® Dry Syrup-|Completed||N/A|122|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:31.595877|2017-10-11 00:01:31.595877
NCT02238236|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||May 2005||2005-05-01|September 2014|2014-09-01||||April 2008|Actual|2008-04-01||Observational|||Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus|Post Marketing Surveillance of Alesion® (Epinastine Hydrochloride) Dry Syrup -Drug Use-Results Survey of Alesion® Dry Syrup-|Completed||N/A|3793|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:31.660589|2017-10-11 00:01:31.660589
NCT02238223|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||April 2004||2004-04-01|September 2014|2014-09-01||||May 2006|Actual|2006-05-01||Observational|||Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet|Post Marketing Surveillance of Alesion® (Epinastine Hydrochloride) Tablet|Completed||N/A|2001|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:31.834658|2017-10-11 00:01:31.834658
NCT02238210|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||December 2002||2002-12-01|September 2014|2014-09-01||||May 2003|Actual|2003-05-01||Interventional|||Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy|A Phase IV Safety Trial in Pediatric Patients (Ages 2-5) With Rhinorrhea Associated With a Common Cold or Allergy|Completed||Phase 4|230|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:01:31.905031|2017-10-11 00:01:31.905031
NCT02238197|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||February 2001||2001-02-01|September 2014|2014-09-01||||October 2001|Actual|2001-10-01||Observational|||Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease|Postmarketing Surveillance Study (as Per §67 (6) AMG [German Drug Law]) of Atrovent® 500µg/2ml Inhalation Solution in Chronic Obstructive Pulmonary Disease|Completed||N/A|477|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:31.980219|2017-10-11 00:01:31.980219
NCT02238184|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||January 2001||2001-01-01|September 2014|2014-09-01||||September 2001|Actual|2001-09-01||Observational|||Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)|Postmarketing Surveillance Study (as Per §67(6 )AMG [German Drug Law]) of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease|Completed||N/A|105|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 00:01:32.055586|2017-10-11 00:01:32.055586
NCT02238171|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||April 2000||2000-04-01|September 2014|2014-09-01||||December 2000|Actual|2000-12-01||Observational|||Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease|Postmarketing Surveillance Study (as Per §67(6)AMG [German Drug Law]) of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease|Completed||N/A|346|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:32.165904|2017-10-11 00:01:32.165904
NCT02238158|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||September 1999||1999-09-01|September 2014|2014-09-01||||April 2001|Actual|2001-04-01||Observational|||Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease|Postmarketing Surveillance (as Per §67(6)AMG [German Drug Law]) of Atrovent® in Chronic Obstructive Pulmonary Disease|Completed||N/A|595|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:32.244479|2017-10-11 00:01:32.244479
NCT02238145|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||January 1999||1999-01-01|September 2014|2014-09-01||||November 1999|Actual|1999-11-01||Observational|||Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease|Postmarketing Surveillance Study (as Per § 67 (6) AMG [German Drug Law] of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease|Completed||N/A|660|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:32.332304|2017-10-11 00:01:32.332304
NCT02238132|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||December 1998||1998-12-01|September 2014|2014-09-01||||November 1999|Actual|1999-11-01||Observational|||Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease|Postmarketing Surveillance Study (as Per §67(6)AMG[German Drug Law]) of Atrovent® Inhalets in Chronic Obstructive Airways Disease|Completed||N/A|374|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:32.423241|2017-10-11 00:01:32.423241
NCT02238119|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||February 2002||2002-02-01|September 2014|2014-09-01||||August 2002|Actual|2002-08-01||Interventional|||Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Double-dummy, Crossover Efficacy and Safety Comparison of 6-week Treatment Periods of the Free Combination of Tiotropium Inhalation Powder Capsule (18 μg) + Formoterol Inhalation Powder Capsule (12 μg) QD, Tiotropium Inhalation Powder Capsule (18 μg) QD and Formoterol Inhalation Powder Capsule (12 μg) BID in Patients With COPD|Completed||Phase 2|74|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:01:32.550978|2017-10-11 00:01:32.550978
NCT02238106|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-11|2014-09-11|||September 2005||2005-09-01|September 2014|2014-09-01||||February 2006|Actual|2006-02-01||Interventional|||Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Single Dose, Placebo-controlled, Randomized, Double-blind, Double-dummy, Crossover Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder (12.5 μg, 25 μg and 50 Salmeterol), Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® (50 μg Salmeterol) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|136|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:01:33.158738|2017-10-11 00:01:33.158738
NCT02238093|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-10|||October 2014||2014-10-01|September 2014|2014-09-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||Cardiorenal Syndrome in End-Stage Kidney Disease||Unknown status|Not yet recruiting|N/A|270|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 00:01:33.285661|2017-10-11 00:01:33.285661
NCT02238080|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-04-10|2017-02-20||December 2009||2009-12-01|April 2017|2017-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|IMPACT|Intention-to-Treat (ITT) population included all participants who received at least one dose of methoxy polyethylene glycol-epoetin beta after enrollment in the study.|An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Chronic Kidney Disease Participants on Dialysis|Inflammatory Markers and Mircera® Prospective Assessment of Correlation (IMPACT): A Multi-Center Observational Study Investigating the Correlation Between Inflammatory Marker Levels and ESA Dosage in CKD Patients on Dialysis Treated With Mircera®|Completed||N/A|197|Actual|Hoffmann-La Roche|The study was completed as defined in the protocol. Only 197 participants (out of planned 400) were enrolled due to slow recruitment during the study period.||1||f||||f||||||||||2017-10-11 00:01:33.408889|2017-10-11 00:01:33.408889
NCT02238067|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2017-02-21|2016-09-16||September 2011||2011-09-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational||All enrolled participants|Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis|Survey on Anemia Therapy With ESAs Medication in Chronic Kidney Disease Patients Not on Dialysis|Completed||N/A|196|Actual|Hoffmann-La Roche|The study was completed as defined in the protocol. Only 196 participants (out of planned 400) were enrolled due to slow recruitment during the study period.||1||f||||||||||||||2017-10-11 00:01:34.292335|2017-10-11 00:01:34.292335
NCT02238054|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2015-10-01|||September 2014||2014-09-01|October 2015|2015-10-01|September 2022|Anticipated|2022-09-01|September 2021|Anticipated|2021-09-01|5 Years|Observational [Patient Registry]|FRANCE-ABSORB||French Observatory Evaluating the Use of Intracoronary Prosthesis ABSORB BVS|French Observatory Evaluating the Use of Intracoronary Prosthesis ABSORB BVS|Recruiting||N/A|2000|Anticipated|French Cardiology Society|||1||f||||t||||||||||2017-10-11 00:01:36.071604|2017-10-11 00:01:36.071604
NCT02238028|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2016-04-06|2015-10-20||March 2014||2014-03-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators|Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators: a Randomized Controlled Crossover Trial Among Healthy Young Adults|Completed||N/A|28|Actual|Fudan University||2|||f||||t||||||||||2017-10-11 00:01:36.336189|2017-10-11 00:01:36.336189
NCT02238015|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-11|||October 2013||2013-10-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|May 2014|Actual|2014-05-01||Observational|TFAP||Tear Film Evaluation After Phacoemulsification|To Investigate Tear Film Change After Phacoemulsification With SS-OCT|Unknown status|Recruiting|Phase 4|60|Anticipated|Wenzhou Medical University|||2||f||||t||||||||||2017-10-11 00:01:36.850658|2017-10-11 00:01:36.850658
NCT02238002|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-11|||December 2013||2013-12-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|May 2014|Actual|2014-05-01||Observational|AOACCCAP||Assessment Of Anterior Chamber Configuration Changes After Phacoemulsification|To Investigate Changes in Anterior Chamber Angle Configuration After Phacoemulsification|Unknown status|Recruiting|N/A|64|Anticipated|Wenzhou Medical University|||2||f||||f||||||||||2017-10-11 00:01:36.935542|2017-10-11 00:01:36.935542
NCT02237989|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-10|||January 2013||2013-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects Of Native Collagen Type 2 Treatment|Effects Of Native Collagen Type 2 Treatment In Knee Osteoarthritis : A Randomized Controlled Trial|Completed||N/A|39|Actual|Eskisehir Osmangazi University||2|||f||||f||||||||||2017-10-11 00:01:37.025673|2017-10-11 00:01:37.025673
NCT02237976|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-09-19|||August 2014||2014-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SelfHypTp||Self-hypnosis in Patients Awaiting Lung Transplantation|Interest of Learning Self-hypnosis in Patients Awaiting Lung Transplantation|Active, not recruiting||N/A|78|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 00:01:37.110879|2017-10-11 00:01:37.110879
NCT02237963|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-10-28|||July 2014||2014-07-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|4 Months|Observational [Patient Registry]|IncisionPain||Influence of the Surgical Approach on the Development of a Chronic Pain After Thoracic Surgery|Influence of the Surgical Approach on the Development of a Chronic Pain After Thoracic Surgery|Completed||N/A|209|Actual|Hopital Foch|||2||f||||f||||||||||2017-10-11 00:01:37.187786|2017-10-11 00:01:37.187786
NCT02237950|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-10-13|||September 2014||2014-09-01|October 2016|2016-10-01||||January 2017|Anticipated|2017-01-01||Interventional|||Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)|A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis|Active, not recruiting||Phase 3|620|Anticipated|Starpharma Pty Ltd||2|||f||||f||||||||||2017-10-11 00:01:37.297426|2017-10-11 00:01:37.297426
NCT02237937|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2014-09-09|||September 2011||2011-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene|Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene|Unknown status|Recruiting|Phase 4|80|Anticipated|HolsboerMaschmeyer NeuroChemie GmbH||2|||f||||f||||||||||2017-10-11 00:01:37.537039|2017-10-11 00:01:37.537039
NCT02237924|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-14|||September 2014||2014-09-01|September 2014|2014-09-01|October 2020|Anticipated|2020-10-01|September 2020|Anticipated|2020-09-01||Interventional|||Effect of Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Locoregionally Advanced,Low-risk Nasopharyngeal Carcinoma|Effect of Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Locoregionally Advanced,Low-risk Nasopharyngeal Carcinoma.|Not yet recruiting||Phase 2|120|Anticipated|First Affiliated Hospital of Guangxi Medical University||2|||f||||t||||||||||2017-10-11 00:01:37.642596|2017-10-11 00:01:37.642596
NCT02237911|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-10-02|||December 2014||2014-12-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|September 7, 2017|Actual|2017-09-07||Interventional|||Comparison of Treatments Following Total Knee Replacement|A Comparison of Treatment Methods for Patients Following Total Knee Replacement.|Active, not recruiting||N/A|240|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 00:01:37.760766|2017-10-11 00:01:37.760766
NCT02237898|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-06-02|||June 2016||2016-06-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Harnessing the Power of Technology: MOMBA for Postpartum Smoking|SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking|Recruiting||Phase 1|40|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-11 00:01:37.851954|2017-10-11 00:01:37.851954
NCT02237885|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-06-02|||August 2015||2015-08-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Pain Management Using Mobile Technology in Veterans With PTSD and TBI|Pain Management Using Mobile Technology in Veterans With PTSD and TBI|Recruiting||N/A|100|Anticipated|Duke University||1|||f||||t||||||||No||2017-10-11 00:01:38.042508|2017-10-11 00:01:38.042508
NCT02237872|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-04-17|||September 2014||2014-09-01|June 2016|2016-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|BAT_PET/MRI||Detection of Brown Adipose Tissue by Magnetic Resonance Imaging|Assessment of MRI Accuracy for the Detection of Brown Adipose Tissue Using FDG-PET as a Gold Standard|Recruiting||N/A|24|Anticipated|University of North Carolina, Chapel Hill|||1||f||||t||||||||||2017-10-11 00:01:38.139024|2017-10-11 00:01:38.139024
NCT02237859|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-09-10|||August 2014||2014-08-01|September 2014|2014-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection|Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection|Unknown status|Recruiting|Phase 4|140|Anticipated|Spectrum Health Hospitals||1|||f||||f||||||||||2017-10-11 00:01:38.220463|2017-10-11 00:01:38.220463
NCT02237846|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-08-08|||September 2014||2014-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|November 2018|Anticipated|2018-11-01||Interventional|||Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis|Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis|Withdrawn||Phase 1/Phase 2|0|Actual|Translational Biosciences||2||No enrollment|f||||f||||||||||2017-10-11 00:01:38.319402|2017-10-11 00:01:38.319402
NCT02237833|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-04-26|||February 2015||2015-02-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|CONSCIOUS||Cerebral Oxygenation in Septic Patients Using Vasopressors - the Conscious Study|Cerebral Oxygenation in Septic Patients Using Vasopressors - The Conscious Study|Terminated||N/A|15|Actual|Sykehuset i Vestfold HF|||1|Too slow recruitment.|f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 00:01:38.403126|2017-10-11 00:01:38.403126
NCT02237820|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-11-18|||November 2014||2014-11-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Dexamethasone Versus Prednisone in Heart Failure Patients, Hospitalized With Exacerbation of Chronic Obstructive Pulmonary Disease.|Dexamethasone Versus Prednisone in Heart Failure Patients, Hospitalized With Exacerbation of Chronic Obstructive Pulmonary Disease.|Recruiting||Phase 4|80|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 00:01:38.488944|2017-10-11 00:01:38.488944
NCT02237807|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-10|||September 2014||2014-09-01|September 2014|2014-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions|Comparative, Randomized, Three -Period, Two-treatment, Three -Sequence, Open Label, Semi-replicate Crossover Bioequivalence Study of Dirithromycin 500 mg Enteric Coated Tablet (One Tablet) of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) Versus Dynabac 250 mg Enteric Coated Tablet (Two Tablets) of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fed Conditions|Unknown status|Not yet recruiting|Phase 1|48||Pharmaceutical Research Unit, Jordan||2|||f||||||||||||||2017-10-11 00:01:38.609773|2017-10-11 00:01:38.609773
NCT02237794|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-09|||October 2014||2014-10-01|September 2014|2014-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Effect of Medical Treatment on Longitudinal Function of the Heart||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 00:01:38.696415|2017-10-11 00:01:38.696415
NCT02237781|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-10|||October 2014||2014-10-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins|Prospective Randomized Trial on the Level of Anti-Mullerian Hormone (AMH) in Women Undergoing Controlled Ovarian Stimulation for IVFwith Gonadotropins.|Unknown status|Not yet recruiting|Phase 2/Phase 3|50|Anticipated|University of Athens||1|||f||||t||||||||||2017-10-11 00:01:38.757545|2017-10-11 00:01:38.757545
NCT02237768|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-10|||December 2014||2014-12-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions|Comparative, Randomized, Three -Period, Two-treatment, Three -Sequence, Open Label, Semi-replicate Crossover Bioequivalence Study of Dirithromycin 500 mg Enteric Coated Tablet (One Tablet) of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) Versus Dynabac 250 mg Enteric Coated Tablet (Two Tablets) of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions.|Unknown status|Not yet recruiting|Phase 1|48||Pharmaceutical Research Unit, Jordan||2|||f||||||||||||||2017-10-11 00:01:38.844376|2017-10-11 00:01:38.844376
NCT02237755|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-09|||October 2014||2014-10-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.|Prospective Randomized Trial on the Effect of Clomiphene Citrate Administration in Women With Poor Ovarian Reserve Undergoing Controlled Ovarian Stimulation for IVF. Impact on Stimulation Characteristics and Pregnancy Outcome.|Unknown status|Not yet recruiting|Phase 2/Phase 3|50|Anticipated|University of Athens||2|||f||||t||||||||||2017-10-11 00:01:38.925367|2017-10-11 00:01:38.925367
NCT02237742|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-12-16|||November 2014||2014-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Study To Understand How The Body Reacts To A Low Dose Of PF‑06427878 When Given In A Vein To Healthy, Adult, Males|A Phase 1, Non‑Randomized, Open‑Label, Single‑Dose, Single Period Study With Non‑Pharmacologically Active Dose Of Pf‑06427878 To Characterize Pharmacokinetics Following Intravenous Administration In Healthy, Adult, Male Subjects|Completed||Phase 1|6|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:01:39.016405|2017-10-11 00:01:39.016405
NCT02237729|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-04-10|||September 2014||2014-09-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|B538-07||A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))|Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects|Completed||Phase 1|362|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:01:39.088359|2017-10-11 00:01:39.088359
NCT02237716|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-09-10|||June 2014||2014-06-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Observational|||Rapid Intravenous Infusion of Mannitol Results in a Dipper-type Change in Stroke Volume Variation in Patients Undergoing Major Neurosurgery||Unknown status|Active, not recruiting|N/A|90|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||||||||||||2017-10-11 00:01:39.21171|2017-10-11 00:01:39.21171
NCT02237703|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-01-19|||March 2012||2012-03-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|March 2015|Actual|2015-03-01||Observational|||Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)|Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)|Terminated||N/A|17|Actual|New York University School of Medicine|||3|The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.|f||||t||||||||||2017-10-11 00:01:39.276753|2017-10-11 00:01:39.276753
NCT02237690|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2017-06-01|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|||Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer|A Randomized, Open Label, Single-Dose, Two-Cycle Crossover Study to Assess Bioequivalence of Test and Reference Formulations of Doxorubicin Hydrochloride Liposome Injection in Female Patients With Ovarian Cancer|Completed||Phase 1|30|Actual|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||2|||f||||f||||||||||2017-10-11 00:01:39.376512|2017-10-11 00:01:39.376512
NCT02237677|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-08-15|||June 2012||2012-06-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||CB1 Receptor PET Imaging Reveals Gender Differences in PTSD|Cannabinoid-1 (CB1) Receptor Positron Emission Tomography (PET) Imaging Reveals Gender Differences in Posttraumatic Stress Disorder (PTSD)|Terminated||N/A|36|Actual|New York University School of Medicine|||2|The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.|f||||t||||||||||2017-10-11 00:01:39.478281|2017-10-11 00:01:39.478281
NCT02237105|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-08|2016-03-14|||September 2014||2014-09-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Interventional|||The Effect of Cognitive Behavioral Therapy on the Outcome of Spinal Surgery|The Effect of Cognitive Behavioral Therapy on the Outcome of Spinal Surgery|Recruiting||N/A|20|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 00:01:44.905876|2017-10-11 00:01:44.905876
NCT02237664|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-04-03|||January 2015||2015-01-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Interventional|||Patient-Controlled Thoracic Paravertebral Block After Video-Assisted Thoracoscopic Surgery|Patient-Controlled Thoracic Paravertebral Block for Postoperative Analgesia After Video-Assisted Thoracoscopic Surgery|Unknown status|Recruiting|Phase 1/Phase 2|62|Anticipated|Dammam University||2|||f||||t||||||||||2017-10-11 00:01:39.568097|2017-10-11 00:01:39.568097
NCT02237651|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-08-19|||September 2014||2014-09-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|TNA||Topical Anesthesia / Bronchoscopy|Topical Nasopharyngeal Anesthesia in Outpatient Bronchoscopy|Completed||N/A|252|Actual|Hannover Medical School|||2||f||||t||||||||||2017-10-11 00:01:39.678905|2017-10-11 00:01:39.678905
NCT02237638|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-03-17|||April 2014||2014-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I Study on VEGF Vaccination in Metastatic Solid Tumors|A Phase I Open-label Clinical Trial, Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients With Advanced Solid Tumors|Recruiting||Phase 1|15|Anticipated|VU University Medical Center||1|||f||||t||||||||||2017-10-11 00:01:39.760236|2017-10-11 00:01:39.760236
NCT02237625|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-01-05|||September 2014||2014-09-01|January 2017|2017-01-01|September 2026|Anticipated|2026-09-01|September 2024|Anticipated|2024-09-01|100 Years|Observational [Patient Registry]|NatHisHPP||Natural History Study of Patients With Hypophosphatasia (HPP)|Natural History Study of Adult and Pediatric Patients With Hypophosphatasia|Recruiting||N/A|200|Anticipated|Duke University|||1||f||||t||||||||||2017-10-11 00:01:39.868234|2017-10-11 00:01:39.868234
NCT02237612|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-09|||January 2009||2009-01-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer|Diffusion-Weighted MRI for Staging in Localized Prostate Cancer: A Pilot Study|Completed||N/A|9|Actual|University of Southern California||1|||f||||f||||||||||2017-10-11 00:01:39.941984|2017-10-11 00:01:39.941984
NCT02237599|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-09-19|||September 2014||2014-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|EPAD||Somatosensory Evoked Potential Algorithm for Detection of Intraoperative Positional Neuropraxia|A Feasibility Study of Integrated SSEP and Detection Algorithm for Detection of Intraoperative Positional Neuropraxia|Recruiting||N/A|150|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||No||2017-10-11 00:01:40.035377|2017-10-11 00:01:40.035377
NCT02237586|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-04-21|||July 2014||2014-07-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge|Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge|Completed||Phase 1|25|Actual|Sanaria Inc.||3|||f||||t||||||||||2017-10-11 00:01:40.113524|2017-10-11 00:01:40.113524
NCT02237573|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-06-19|||December 2014||2014-12-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Impact of Handing to Patients a Copy of the Consultation Report on Their Medicine Consumption|Impact of Handing to Patients With Viral Gastroenteritis or Upper Respiratory Tract Infections a Copy of the Consultation Report on Their Medicine Consumption: a Randomized Controlled Trial|Completed||N/A|75|Actual|University Paris 7 - Denis Diderot||2|||f||||f||||||||||2017-10-11 00:01:40.214004|2017-10-11 00:01:40.214004
NCT02237560|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-04-01|||September 2014||2014-09-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|ACES||The Aerobic & Cognitive Exercise Study|The Cognitive Benefits of Interactive Mental and Physical Exercise for Older Adults at Risk for or With Mild Cognitive Impairment (MCI)|Active, not recruiting||N/A|111|Actual|Union College, New York||3|||f||||t||||||||No||2017-10-11 00:01:40.335502|2017-10-11 00:01:40.335502
NCT02237547|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-08-08|||September 2014||2014-09-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|January 2019|Anticipated|2019-01-01||Interventional|||Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury|Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury|Withdrawn||Phase 1/Phase 2|0|Actual|Translational Biosciences||1||No enrollment.|f||||t||||||||||2017-10-11 00:01:40.520291|2017-10-11 00:01:40.520291
NCT02237534|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-09-26|||September 2014||2014-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|LAVALIER||Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia|Lanthanum Carbonate Versus Calcium Carbonate for Vascular Abnormalities in Patients With Chronic Kidney Disease and Hyperphosphatemia|Enrolling by invitation||Phase 4|60|Anticipated|Osaka University||2|||f||||f||||||||||2017-10-11 00:01:40.629433|2017-10-11 00:01:40.629433
NCT02237521|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-05-19|||September 2014||2014-09-01|May 2017|2017-05-01|April 28, 2016|Actual|2016-04-28|April 28, 2016|Actual|2016-04-28||Observational|||The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease||Completed||N/A|24|Actual|Rigshospitalet, Denmark|||2||f||||f||||||Samples With DNA|"     Serum, plasma and urine   "|||2017-10-11 00:01:40.740887|2017-10-11 00:01:40.740887
NCT02237508|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-03-04|||September 2014||2014-09-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers|An Open-Label, Single-dose, Randomized, Five-Period Cross-over to Compare Pharmacokinetics Profiles of Z7200 and Symbicort Turbohaler, With and Without Charcoal Blockade in Healthy Volunteers.|Completed||Phase 1|90|Actual|Zambon SpA||5|||f||||f||||||||||2017-10-11 00:01:40.84175|2017-10-11 00:01:40.84175
NCT02237495|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-09-11|||April 9, 2014|Actual|2014-04-09|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 1, 2017|Actual|2017-03-01||Interventional|DOCS||Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)|Perioperative Infusion of Dexmedetomidine Improves Outcomes of Cardiovascular Surgery|Recruiting||Phase 2/Phase 3|1000|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 00:01:40.933906|2017-10-11 00:01:40.933906
NCT02237482|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-10|||July 2006||2006-07-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Investigating Proximal Migration in Trabecular Metal Cups Used In Acetabular Revision Surgery|Is the Trabecular Metal Cup Associated With Lower Risk of Aseptic Loosening in Acetabular Revision Surgery?|Completed||N/A|100|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-11 00:01:41.023343|2017-10-11 00:01:41.023343
NCT01879267|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-07-18|||January 2012||2012-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Exercise Effects in Huntington's Disease|Exercise Effects in Huntington's Disease|Recruiting||N/A|40|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 01:34:47.572761|2017-10-11 01:34:47.572761
NCT02237456|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-03-12|||July 2014||2014-07-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01|1 Day|Observational [Patient Registry]|||"DOCTOR Compare - A Study in the DOCTOR Series (Does Optical Coherence Tomography Optimize Revascularization?"|Comparison of Intra Vascular Optical Coherence Tomography Systems for Assessment of Coronary Tissue, Metallic Stents and Bioresorbable Vascular Scaffolds - DOCTOR Compare|Completed||N/A|11|Actual|Aarhus University Hospital Skejby|||1||f||||t||||||||||2017-10-11 00:01:41.170944|2017-10-11 00:01:41.170944
NCT02237443|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-04-07|||August 2014||2014-08-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Mask Ventilation Before and After Neuromuscular Blockade|Ventilation by Mask Before and After the Administration of Neuromuscular Blockade: a Non-inferiority Trial|Completed||Phase 4|210|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 00:01:41.263763|2017-10-11 00:01:41.263763
NCT02237430|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-03-13|||June 2014||2014-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CLOSE-UP III||Randomized Comparison of MynxGrip Vascular Closure Device and Manual Compression for Closure After Femoral Access Angiography. The Closure Devices Used in Every Day Practice Study, CLOSE-UP III Trial|Randomized Comparison of MynxGrip Vascular Closure Device and Manual Compression for Closure After Femoral Access Angiography. The Closure Devices Used in Every Day Practice Study, CLOSE-UP III Trial|Recruiting||N/A|2000|Anticipated|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 00:01:41.459182|2017-10-11 00:01:41.459182
NCT02237417|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-06-27|||September 2014||2014-09-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism|A Randomized, Open Label, Parallel Group, Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism|Recruiting||Phase 4|80|Anticipated|University of Utah||3|||f||||t||||||||||2017-10-11 00:01:41.588248|2017-10-11 00:01:41.588248
NCT02237404|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-12-01|||August 2014||2014-08-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Economic Evaluation and Communication in Remote Monitoring of People With Pacemakers|Sustainability of Cardiology Services: Economic Evaluation and Communication in Remote Monitoring of People With Pacemakers.|Active, not recruiting||Early Phase 1|90|Anticipated|University of Tromso||2|||f||||f||||||||||2017-10-11 00:01:41.69179|2017-10-11 00:01:41.69179
NCT02237391|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-09-18|||December 2014||2014-12-01|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|CIPAP||Evaluation of a Interdisciplinary Pain Program Among Patients With Chronic Pain and Frequent Emergency Department Visits|Evaluation of a Complex Interdisciplinary Pain Assessment Program Linked to Primary Care to Improve Clinical Outcomes and Reduce Health Care Utilization Among Patients With Chronic Pain and Frequent Emergency Department Visits|Active, not recruiting||N/A|46|Actual|Ottawa Hospital Research Institute||2|||f||||f|f|f||||||||2017-10-11 00:01:41.784309|2017-10-11 00:01:41.784309
NCT02237378|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-05-04|||December 2014||2014-12-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease|Evaluation of Cardiopulmonary Metabolism and Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Left Heart Disease|Recruiting||N/A|10|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||Yes|Manuscript preparation in progress|2017-10-11 00:01:41.91452|2017-10-11 00:01:41.91452
NCT02237365|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-03-05|||October 17, 2014|Actual|2014-10-17|March 2017|2017-03-01|December 22, 2016|Actual|2016-12-22|June 24, 2016|Actual|2016-06-24||Interventional|AspirinTBM||A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis|A Pilot Phase II Randomized Controlled Double Blind Trial of 81mg Aspirin Daily vs. 1000 mg Aspirin Daily vs. Placebo as Adjunctive Therapy in HIV Negative Adults With Tuberculous Meningitis|Completed||Phase 2|120|Actual|Oxford University Clinical Research Unit, Vietnam||3|||f||||t||||||||||2017-10-11 00:01:42.060407|2017-10-11 00:01:42.060407
NCT02237352|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-05-02|||September 2014||2014-09-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01|1 Day|Observational [Patient Registry]|||Mechanisms of Diabetic Nephropathy in Ecuador|Physiopathogenic Mechanisms Involved in Diabetic Nephropathy, Looking for Prevention and Treatment Solutions|Enrolling by invitation||N/A|10064|Actual|Universidad Estatal de Milagro|||2||f||||t||||||Samples Without DNA|"     Plasma and urine.   "|Undecided||2017-10-11 00:01:42.214635|2017-10-11 00:01:42.214635
NCT02237339|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-06-08|||September 2014||2014-09-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ALLAY||Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?|Does Allopurinol Regress Left Ventricular Hypertrophy in Patients With Treated Essential Hypertension?|Active, not recruiting||Phase 4|72|Actual|University of Dundee||2|||f||||t||||||||||2017-10-11 00:01:42.349454|2017-10-11 00:01:42.349454
NCT02237326|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-09-09|||October 2011||2011-10-01|September 2014|2014-09-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|SAVE||Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women|Safety and Validity Evaluation for Cervical Cancer Screening and Treatment Techniques Among HIV-infected Women|Completed||N/A|654|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:01:42.484143|2017-10-11 00:01:42.484143
NCT02237313|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2017-08-29|||July 2015||2015-07-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|SHS-Pemphigus||Identification of Vulnerability Factors in the Course of Pemphigus Patients|Identification of Vulnerability Factors in the Course of Pemphigus Patients - SHS Pemphigus Clinical Trial|Recruiting||N/A|48|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 00:01:42.58799|2017-10-11 00:01:42.58799
NCT02237300|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-02-08|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa|Tratamiento de la Bulimia Nerviosa Mediante exposición a señales Con Realidad Virtual|Completed||N/A|60|Actual|University of Barcelona||2|||f||||t|f|f||||||No||2017-10-11 00:01:42.717362|2017-10-11 00:01:42.717362
NCT02236715|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-10|||September 1999||1999-09-01|September 2014|2014-09-01||||February 2000|Actual|2000-02-01||Observational|||Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease|Postmarketing Surveillance Study (as Per §67(6)AMG[German Drug Law]) of Atrovent® Unit Dose Vial 500 µg in Chronic Obstructive Airways Disease|Completed||N/A|1039|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:48.35889|2017-10-11 00:01:48.35889
NCT02237287|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-09-28|||February 2011||2011-02-01|September 2015|2015-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers|Combination of Taliderm® and VAC for Treatment of Pressure Ulcers - a Pilot Study|Terminated||Early Phase 1|24|Actual|University Hospital, Basel, Switzerland||3||"Open label study part reduced from n=10 to n=6 because of insufficient number of patients under   antiaggregation."|f||||t||||||||||2017-10-11 00:01:42.832513|2017-10-11 00:01:42.832513
NCT02237274|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-02-20|||July 2014||2014-07-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|FALCON||Cardiopulmonary Adaptation of Short Term Exposure to High Altitude in Fontan Patients: Swiss Fontan & ALtitude COllaboratioN (FALCON) Study|Cardiopulmonary Adaptation of Short Term Exposure to High Altitude in Fontan Patients: Swiss Fontan & ALtitude COllaboratioN (FALCON) Study|Completed||N/A|34|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 00:01:42.940089|2017-10-11 00:01:42.940089
NCT02237261|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-05-15|||November 2014||2014-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|August 2017|Anticipated|2017-08-01||Interventional|BPV||Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma|Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma Not Eligible for High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation (BPV).|Active, not recruiting||Phase 2|46|Actual|University Hospital Heidelberg||1|||f||||t||||||||||2017-10-11 00:01:43.05654|2017-10-11 00:01:43.05654
NCT02237248|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-06-27|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Observational|||Function and Scoliosis Surgery|Functional Testing, and Biomechanics Before and After Scoliosis Surgery|Completed||N/A|15|Actual|Duke University|||1||f||||f||||||||||2017-10-11 00:01:43.213642|2017-10-11 00:01:43.213642
NCT02237235|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-08-31|||August 2014||2014-08-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia|Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia|Completed||Phase 2|60|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 00:01:43.311872|2017-10-11 00:01:43.311872
NCT02237222|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2016-09-16|||April 2014||2014-04-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Evaluation of Gait Performance in Children With Neuromuscular Diagnoses|Evaluation of the Gait Performance Measures 'Functional Mobility Scale' and 'Gillette Functional Assessment Questionnaire' in Children With Neuromuscular Diagnoses|Completed||N/A|72|Actual|University Children's Hospital, Zurich|||1||f||||f||||||||||2017-10-11 00:01:43.428037|2017-10-11 00:01:43.428037
NCT02237209|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-10-07|||September 2014||2014-09-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children|A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children|Completed||Phase 1|29|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 00:01:43.522749|2017-10-11 00:01:43.522749
NCT02237196|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-03-17|||October 2014||2014-10-01|March 2017|2017-03-01|February 26, 2019|Anticipated|2019-02-26|February 26, 2019|Anticipated|2019-02-26||Interventional|||Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy|Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy (ITN057AD)|Active, not recruiting||Phase 1/Phase 2|120|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t|t|f||||||Yes|The plan is to share data in upon completion of the study in: 1.)ImmPort, a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts; and 2.)TrialShare, a clinical trials research portal developed by the Immune Tolerance Network that makes data from the consortium's clinical trials publicly available.|2017-10-11 00:01:43.639433|2017-10-11 00:01:43.639433
NCT02237170|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-01-03|||June 2012||2012-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PROVENGE||Immune Monitoring on Sipuleucel-T|A Systems Biology Approach to Immune Monitoring in Patients With Castration-resistant Prostate Cancer Receiving SiPuleucel-T|Completed||N/A|36|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 00:01:43.899454|2017-10-11 00:01:43.899454
NCT02237157|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-11-04|||March 2015||2015-03-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|September 2016|Actual|2016-09-01||Interventional|||A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer|A Dose Escalation Safety Study of Locally-Delivered (Intra-Arterial) Gemcitabine in Unresectable Adenocarcinoma of the Pancreas|Active, not recruiting||Phase 4|20|Actual|RenovoRx||1|||f||||t||||||||No||2017-10-11 00:01:43.990268|2017-10-11 00:01:43.990268
NCT02237144|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-02-26|||April 2012||2012-04-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|January 2015|Actual|2015-01-01||Interventional|TMRI||Transfer Modality Research Initiative - Bangladesh|Transfer Modality Research Initiative - Bangladesh|Active, not recruiting||N/A|5000|Anticipated|International Food Policy Research Institute||5|||f||||f||||||||||2017-10-11 00:01:44.165862|2017-10-11 00:01:44.165862
NCT02237131|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2014-09-09|||April 2014||2014-04-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Interventional|||Continuous Versus Cyclic Oral Contraceptives for Endometriosis|Continuous Versus Cyclic Use of Oral Contraceptives Following Surgery for Symptomatic Endometriosis|Unknown status|Recruiting|Phase 4|50|Anticipated|University of Athens||2|||f||||t||||||||||2017-10-11 00:01:44.274568|2017-10-11 00:01:44.274568
NCT02237118|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-02-24|2016-05-03||September 2014||2014-09-01|September 2014|2014-09-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|Only||"Prospective, Randomized, Non-inferiority Investigation to Compare Effects of Mepitel® One and UrgoTul® Dressings in Acute Wound Management (Only)"|"Prospective, Randomized, Non-inferiority Investigation to Compare Effects of Mepitel® One and UrgoTul® Dressings in Acute Wound Management (Only)"|Completed||N/A|123|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-11 00:01:44.453428|2017-10-11 00:01:44.453428
NCT02237092|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-04-18|2014-09-10||June 2011||2011-06-01|April 2017|2017-04-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|IAPSB|Pregnant planned for cesarean section|Effect of Intra-abdominal Pressure to the Level of the Sensory Block at Caesarean Section Under Spinal Anesthesia|Effect of Intra-abdominal Pressure to the Level of the Sensory Block at Caesarean Section Under Spinal Anesthesia|Completed||N/A|196|Actual|Tver Regional Perinatal Center||1|||f||||t||||||||No||2017-10-11 00:01:45.00216|2017-10-11 00:01:45.00216
NCT02237079|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-09-28|||December 2014||2014-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01||Interventional|BIM||Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)|Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)|Recruiting||Phase 4|20|Anticipated|Tulane University||2|||f||||f||||||||||2017-10-11 00:01:45.282233|2017-10-11 00:01:45.282233
NCT02237066|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-03-17|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Understanding Angioplasty by the Chocolate PTA Balloon Catheter Compared to Conventional PTA Balloons Via OCT Imaging|Understanding the Mechanism of Peripheral Arterial Balloon Angioplasty by the Chocolate PTA Balloon Catheter Compared to Conventional PTA Balloons Via OCT Imaging|Withdrawn||N/A|0|Actual|TriReme Medical, LLC||2||Enrollment goals were not able to be met|f||||t||||||||||2017-10-11 00:01:45.370476|2017-10-11 00:01:45.370476
NCT02237053|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-01-12|||September 2014||2014-09-01|January 2017|2017-01-01||||June 2015|Actual|2015-06-01||Interventional|GLEE||Effects of Glucagon Administration on Energy Expenditure|A Prospective Randomized, Placebo (Saline)-Controlled, Balanced, 3-treatment Regimen Crossover Study Comparing the Effects of Prolonged (13 h) Hyperglucagonemia With Those of Acute (3 hr) Hyperglucagonemia on Energy Expenditure and Endogenous Glucose Protection (EGP).|Completed||Phase 1|6|Actual|Translational Research Institute for Metabolism and Diabetes, Florida||3|||f||||t||||||||||2017-10-11 00:01:45.449948|2017-10-11 00:01:45.449948
NCT02237040|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-05-19|||March 2010||2010-03-01|May 2015|2015-05-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A New Treatment Protocol for Paediatric Mandibular Condylar Fractures|Management of Paediatric Mandibular Condylar Fractures Simply With a Mandibular Manipulation Technique and Mouth Opening Training|Recruiting||N/A|80|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:01:45.556893|2017-10-11 00:01:45.556893
NCT02237027|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-07-18|||October 2014||2014-10-01|January 2016|2016-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TasP/PrEP||Early Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention Among Female Sex Workers in Cotonou, Benin|Demonstration Project of Early Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention Among Female Sex Workers in Cotonou, Benin|Completed||Phase 4|361|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 00:01:45.644772|2017-10-11 00:01:45.644772
NCT02237014|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-03-07|||November 2012||2012-11-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Accuracy of Peripheral Pulse Oximetry Versus Arterial Co-oximeter in Children With Cyanotic Heart Disease|Accuracy of Peripheral Pulse Oximetry Versus Arterial Co-oximeter in Children With Cyanotic Heart Disease|Completed||N/A|53|Actual|Stanford University|||1||f||||f||||||Samples Without DNA|"     whole blood   "|Yes||2017-10-11 00:01:45.745984|2017-10-11 00:01:45.745984
NCT02237001|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2017-08-21|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|STITCH||Study of Suture Repair of Torn Meniscus in the Knee|A Prospective, Non-randomized, Multi-Center Investigation of All-suture-based Repair of Horizontal Meniscal Tears (STITCH Study)|Recruiting||N/A|30|Anticipated|Ceterix Orthopaedics, Inc.||1|||f||||f||||||||||2017-10-11 00:01:45.81047|2017-10-11 00:01:45.81047
NCT02236988|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2016-03-24|||January 2014||2014-01-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study to Evaluate Pharmacokinetics of Apremilast in Heatlhy Male Subjects|A Phase 1, Open-Label, Single Center Study to Evaluate the Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast (CC-10004) in Healthy Male Subjects|Completed||Phase 1|79|Actual|Celgene Corporation||4|||f||||f||||||||||2017-10-11 00:01:46.052596|2017-10-11 00:01:46.052596
NCT02236975|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-08-18|||April 2015||2015-04-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01||Interventional|||First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis|Prospective, Multi-center, Randomized First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme eG (Electro Grafting) Based Biodegradable Polymer Sirolimus-eluting Stent and Resolute Integrity Zotarolimus-eluting Durable Polymer Stent in Patients With de Novo Coronary Artery Stenosis.|Active, not recruiting||Phase 2/Phase 3|168|Actual|Sino Medical Sciences Technology Inc.||2|||f||||t||||||||||2017-10-11 00:01:46.170999|2017-10-11 00:01:46.170999
NCT02236962|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-09-09|||April 2012||2012-04-01|September 2014|2014-09-01||||December 2014|Anticipated|2014-12-01||Interventional|||Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment|Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment|Unknown status|Recruiting|N/A|42|Anticipated|Bayside Health||2|||f||||t||||||||||2017-10-11 00:01:46.273103|2017-10-11 00:01:46.273103
NCT02236949|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-05-21|||September 2011||2011-09-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Sustainability of a Knowledge Translation Intervention to Improve Paediatric Pain|Sustainability of a Multidimensional Knowledge Translation Intervention to Improve Paediatric Pain Practices and Outcomes|Completed||N/A|3907|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 00:01:46.370813|2017-10-11 00:01:46.370813
NCT02236936|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-09-08|||February 3, 2017|Actual|2017-02-03|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|AGMT_HNO_PN||Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck|Randomized Phase III Study: Supplemental Parenteral Nutrition for Patients With Locally Advanced Inoperable Tumors of the Head and Neck, Receiving Definitive Radiotherapy With Cetuximab or Cisplatin|Recruiting||Phase 3|154|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||2|||f||||f|f|f||||||||2017-10-11 00:01:46.503174|2017-10-11 00:01:46.503174
NCT02236923|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-09|||January 1998||1998-01-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|ACS-MOON-1||Study of the Influence of the Moon and Seasons On Outcomes Following Surgery To Repair Ascending Aortic Dissection|The Influence of Lunar Cycle On Hospital Outcomes Following Ascending Aortic Dissection Repair|Completed||N/A|2684|Actual|22EON|||2||f||||f||||||||||2017-10-11 00:01:46.671938|2017-10-11 00:01:46.671938
NCT02236910|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-08-24|||July 2014||2014-07-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours|An Open Label Phase II, Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours|Recruiting||Phase 2|200|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:01:46.769671|2017-10-11 00:01:46.769671
NCT02236897|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-03-06|||August 2013||2013-08-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||PET Imaging in ALS Patients|Metabotropic Glutamate Receptor 5 (mGluR5) Imaging in Amyotrophic Lateral Sclerosis (ALS) Patients and Healthy Volunteers|Completed||N/A|36|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 00:01:46.882923|2017-10-11 00:01:46.882923
NCT02236884|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-12-16|||September 2014||2014-09-01|September 2014|2014-09-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||The Feasibility and Safety of No-scar Transanal Total Mesorectal Excision for Rectal Cancer|A Pilot Study of the Feasibility and Safety of No-scar Transanal Total Mesorectal Excision for Rectal Cancer Without Conventional Laparoscopic Assistance|Completed||Phase 1/Phase 2|20|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:01:46.982396|2017-10-11 00:01:46.982396
NCT02236871|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-09-18|||May 2014||2014-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FAMILY||Family Milk Product Two-year Dose-response Study to Enhance Bone Health|FAMILY (FAmily MILk Product Two-Year) Dose-response Study to Enhance Bone Health|Active, not recruiting||N/A|210|Anticipated|McGill University||3|||f||||f||||||||||2017-10-11 00:01:47.084028|2017-10-11 00:01:47.084028
NCT02236858|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-09-29|||March 2014|Actual|2014-03-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health|Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health|Recruiting||N/A|120|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:01:47.173689|2017-10-11 00:01:47.173689
NCT02236845|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2016-08-14|||October 2014||2014-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients|Pilot, Randomized, Cross-over Study to Evaluate Safety and Clinical Effect of Lacrima Medical Device in Patients With Chronic Insomnia|Completed||N/A|40|Actual|Lacrima Medical LTD||2|||f||||f||||||||||2017-10-11 00:01:47.267592|2017-10-11 00:01:47.267592
NCT02236832|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-03-10|||February 2015||2015-02-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|ANALOG||Study of the Neural Basis of Analogical Reasoning|Organisation du Cortex préfrontal ventrolatéral Pour l'Analogie: Approche Bimodale Chez le Sujet Sain et Chez le Patient Ayant un Syndrome Frontal.|Recruiting||N/A|225|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||5|||f||||f||||||||||2017-10-11 00:01:47.356633|2017-10-11 00:01:47.356633
NCT02236819|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-10-06|||October 2014||2014-10-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|30 Days|Observational [Patient Registry]|EuReCaONE||A Multi-centre Survey of Epidemiology, Treatment and Outcome of Patients Suffering an Out-of-hospital Cardiac Arrest|EuReCa ONE : An International, Prospective, Multi-centre, One Month Survey of Epidemiology, Treatment and Outcome of Patients Suffering an Out-of-hospital Cardiac Arrest in Europe|Completed||N/A|4000|Anticipated|German Resuscitation Registry|||1||f||||f||||||||||2017-10-11 00:01:47.474594|2017-10-11 00:01:47.474594
NCT02236806|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2015-07-17|||July 2015||2015-07-01|July 2015|2015-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SAFE||Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab|Role of ACE Inhibitors and Beta Blockers as Cardiotoxicity Prevention in Breast Cancer Patients Treated With (Neo)Adjuvant Anthracyclines and/or Trastuzumab: a Four Arm, Placebo Control, Randomized Trial|Recruiting||Phase 3|480|Anticipated|Azienda Ospedaliero-Universitaria Careggi||4|||f||||f||||||||||2017-10-11 00:01:47.54911|2017-10-11 00:01:47.54911
NCT02236793|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2017-06-28|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer|Phase III, Multicentre, Randomized, Parallel Group, Double Blinded and Control Group Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer|Completed||Phase 3|252|Actual|Adocia||2|||f||||f||||||||||2017-10-11 00:01:47.664225|2017-10-11 00:01:47.664225
NCT02236780|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-11-03|||January 2015||2015-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|MeteoFIV||Influence of Environmental Conditions on In Vitro Fertilization (IVF) Attempts and Induced Pregnancies|Influence of Environmental Conditions on In Vitro Fertilization (IVF) Attempts and Induced Pregnancies|Recruiting||N/A|24000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 00:01:47.817172|2017-10-11 00:01:47.817172
NCT02236767|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-08-15|2016-03-25||July 2014||2014-07-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Transcranial Magnetic Stimulation Treatment of Hoarding Disorder|Transcranial Magnetic Stimulation Treatment of Hoarding Disorder|Completed||N/A|1|Actual|Hartford Hospital||1|||f||||f||||||||No||2017-10-11 00:01:47.924516|2017-10-11 00:01:47.924516
NCT02236754|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-01-30|||July 2013|Actual|2013-07-01|October 2015|2015-10-01|March 1, 2017|Anticipated|2017-03-01|January 30, 2017|Actual|2017-01-30||Interventional|||Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass|Scan Re-Scan Pancreatic Beta Cell Imaging Using PET Imaging and 18F-FP-DTBZ|Withdrawn||Early Phase 1|0|Actual|Columbia University||2||Could not recruit participants|f||||t||||||||||2017-10-11 00:01:48.123842|2017-10-11 00:01:48.123842
NCT02236741|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-10|||November 2009||2009-11-01|September 2014|2014-09-01||||December 2010|Actual|2010-12-01||Observational|||The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia|The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia|Completed||N/A|26814|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:48.217822|2017-10-11 00:01:48.217822
NCT02236728|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-10|2014-09-10|||February 2008||2008-02-01|September 2014|2014-09-01||||November 2008|Actual|2008-11-01||Observational|||Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole|Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole by Neurologists in France (ETAP)|Completed||N/A|497|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:01:48.284683|2017-10-11 00:01:48.284683
NCT02236702|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-08-15|||August 2014||2014-08-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|March 2015|Actual|2015-03-01||Observational|||Kappa Opioid Receptor Imaging in Depression (KOR Depression)|Kappa Opioid Receptor Imaging in Depression (KOR Depression)|Terminated||N/A|15|Actual|New York University School of Medicine|||4|The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.|f||||t||||||||||2017-10-11 00:01:48.441987|2017-10-11 00:01:48.441987
NCT02236689|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-05-17|||April 2016||2016-04-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparing Arthroscopic Tennis Elbow Release With Arthroscopic Debridement|A Randomized, Double-blind Controlled Trial Comparing Arthroscopic Tennis Elbow Release With Arthroscopic Debridement for the Management of Chronic Lateral Epicondylitis|Recruiting||N/A|70|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-11 00:01:48.544168|2017-10-11 00:01:48.544168
NCT02236676|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-08|||June 2014||2014-06-01|September 2014|2014-09-01||||May 2016|Anticipated|2016-05-01||Interventional|||Sleep Study Among Inpatients With TBI in an Acute Rehabilitation Hospital|Sleep, Procedural Learning & Therapeutic Engagement Among Inpatients With|Unknown status|Recruiting|N/A|40|Anticipated|Kessler Foundation||1|||f||||||||||||||2017-10-11 00:01:48.635982|2017-10-11 00:01:48.635982
NCT02236663|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-03-01|||July 2015||2015-07-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness of a Safety App to Respond to Dating Violence for College Women and Their Friends|Effectiveness of a Safety App to Respond to Dating Violence for College Women and Their Friends|Active, not recruiting||N/A|649|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:01:48.712832|2017-10-11 00:01:48.712832
NCT02236650|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-12-16|||July 2014||2014-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Primary Care Stepping Stones Triple P for Children With Autism|A Pilot Study of Primary Care Stepping Stones Triple P for Children With Autism|Completed||N/A|26|Actual|St. Louis University||2|||f||||f||||||||||2017-10-11 00:01:48.82193|2017-10-11 00:01:48.82193
NCT02236637|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-09-21|||June 14, 2013|Actual|2013-06-14|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|March 14, 2018|Anticipated|2018-03-14||Observational|||A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care|A Prospective Registry of Patients With a Confirmed Diagnosis of Adenocarcinoma of the Prostate Presenting With Metastatic Castrate-Resistant Prostate Cancer|Active, not recruiting||N/A|3052|Actual|Janssen Pharmaceutica N.V., Belgium|||1||f||||f|f|f||||||||2017-10-11 00:01:48.962079|2017-10-11 00:01:48.962079
NCT02236624|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-04-18|||March 2014||2014-03-01|July 2014|2014-07-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis?|Can Aerobic Exercise Reduce Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis?|Completed||N/A|20|Anticipated|University of Aarhus||1|||f||||||||||||||2017-10-11 00:01:49.303879|2017-10-11 00:01:49.303879
NCT02236598|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-04-19|2017-02-14||January 2015||2015-01-01|April 2017|2017-04-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29||Interventional||14 participants started in the placebo arm, but only 12 completed and included in the Baseline characteristics.|The Effects of Potassium on Glucose Metabolism in African Americans|The Effects of Potassium on Glucose Metabolism in African Americans|Completed||Phase 2|61|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:01:51.539357|2017-10-11 00:01:51.539357
NCT02236585|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-01-20|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Patient-Controlled Epidural Analgesia After Uterine Artery Embolization|Does Patient-Controlled Epidural Bupivacaine-Fentanyl Offer Advantages Over Continuous Epidural Infusion After Uterine Arteries Embolization? A Controlled Prospective Study|Recruiting||N/A|60|Anticipated|Dammam University||2|||f||||t||||||||||2017-10-11 00:01:52.056778|2017-10-11 00:01:52.056778
NCT02236572|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-03-06|||November 2014||2014-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score|A Neoadjuvant Phase II Trial of Aromatase Inhibitors in Combination With Everolimus in Postmenopausal Women With Hormone Receptor Positive/HER2 Negative Breast Cancers With Low and Intermediate Risk (< 25) Oncotype Dx Recurrence Scores|Active, not recruiting||Phase 2|66|Anticipated|Yale University||1|||f||||t||||||||||2017-10-11 00:01:52.168165|2017-10-11 00:01:52.168165
NCT02236559|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-05-09|||September 2014||2014-09-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|September 2016|Actual|2016-09-01||Interventional|||High Flow Therapy for the Treatment of Respiratory Failure in the ED|Vapotherm High Flow Therapy for the Treatment of Respiratory Failure in the ED: A Randomized Controlled Trial|Completed||N/A|204|Actual|Vapotherm, Inc.||2|||f||||t||||||||||2017-10-11 00:01:52.248175|2017-10-11 00:01:52.248175
NCT02236546|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-04-12|2017-03-01||May 2012||2012-05-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|October 2014|Actual|2014-10-01||Interventional|||FDG-PET in Advanced Melanoma|FDG-PET/CT as a Biomarker for Treatment Response in Advanced Melanoma|Terminated||N/A|3|Actual|Vanderbilt-Ingram Cancer Center||1||loss of funding|f||||t||||||||||2017-10-11 00:01:52.35715|2017-10-11 00:01:52.35715
NCT02236533|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2015-05-27|||March 2014||2014-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|SFLABPASTA||Healthy Effects of an Innovative Probiotic Pasta|Healthy Effects of an Innovative Probiotic Pasta|Completed||N/A|40|Actual|University of Parma||2|||f||||t||||||||||2017-10-11 00:01:52.562273|2017-10-11 00:01:52.562273
NCT02236520|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-08-02|||September 2014||2014-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Tissue Sodium in Pre-hypertensive Patients|Tissue Sodium in Pre-hypertensive Patients|Recruiting||Phase 2|200|Anticipated|Vanderbilt University Medical Center||4|||f||||t||||||||||2017-10-11 00:01:52.666113|2017-10-11 00:01:52.666113
NCT02236507|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2015-12-22|||April 2013||2013-04-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Normal Values for 3D High Resolution Anorectal Manometry in Children|Evaluation of Anorectal Area in Children Using 3D High Resolution Anorectal Manometry.|Completed||N/A|61|Actual|Medical University of Warsaw||1|||f||||||||||||||2017-10-11 00:01:52.758221|2017-10-11 00:01:52.758221
NCT02236494|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-07-10|||October 2014|Actual|2014-10-01|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|||Study of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older Adults|Pilot Trial of Emergency Department Intervention and Referral for Alcohol Misuse in Older Adults|Completed||N/A|222|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:01:52.829823|2017-10-11 00:01:52.829823
NCT02236481|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-09|||July 2013||2013-07-01|September 2014|2014-09-01||||July 2015|Anticipated|2015-07-01||Interventional|TRACK||Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes|"No-profit Study to Ensure Normal Clinical Practice, to Evaluate the Efficacy of Anakinra in Reducing the Glycated Haemoglobin in Patients Affected by Rheumatoid Arthritis and Diabetes; Randomized, Open Label, Parallel Group,Controlled Clinical Study"|Unknown status|Recruiting|Phase 4|200|Anticipated|University of L'Aquila||2|||f||||f||||||||||2017-10-11 00:01:52.931494|2017-10-11 00:01:52.931494
NCT02236468|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-09-16|||March 2014||2014-03-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CHANGE||Creating Homestead Agriculture for Nutrition and Gender Equity (CHANGE) in Burkina Faso|Creating Homestead Agriculture for Nutrition and Gender Equity in Burkina Faso|Completed||N/A|2747|Actual|International Food Policy Research Institute||4|||f||||f||||||||||2017-10-11 00:01:53.041183|2017-10-11 00:01:53.041183
NCT02236455|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-08|||March 2012||2012-03-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Complementary Therapies Delivered Via Mobile Technologies|Effects of Complementary Therapies Delivered Via Mobile Technologies on Surgical Patients' Reports of Anxiety, Pain, and Self-Efficacy in Healing: A Pilot Randomized Controlled Trial in Iceland|Completed||N/A|105|Actual|University of San Francisco||4|||f||||f||||||||||2017-10-11 00:01:53.251924|2017-10-11 00:01:53.251924
NCT02236442|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-10-11|||October 2014||2014-10-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|PEACE||Protocol to Ease Acute Cephalalgia in Emergency-department|Therapeutic Management of Acute Cephalalgia Before and After Use of a Therapeutic Protocol in Emergency Department|Completed||N/A|200|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 00:01:53.36385|2017-10-11 00:01:53.36385
NCT02236429|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2017-02-28|||June 2015||2015-06-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|VFT||Vaginal Flora for Treatment of Bacterial Vaginosis|Vaginal Flora Transplantation for Recurrent Bacterial Vaginosis|Recruiting||N/A|10|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||Undecided||2017-10-11 00:01:53.455557|2017-10-11 00:01:53.455557
NCT02236416|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-12-03|||May 2011||2011-05-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|EPD||Physical Exercise for Prevention of Dementia|Physical Exercise and Prevention of Cognitive Decline in Subjects at Risk of Dementia: a Randomized Controlled Trial|Recruiting||Phase 3|600|Anticipated|University of Molise||2|||f||||f||||||||||2017-10-11 00:01:53.566473|2017-10-11 00:01:53.566473
NCT02236403|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-02-18|||October 2014||2014-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%|Diagnosis of Demodex Blapharitis and Treatment With Ivermectin Gel 0.1%/ Metronidazole 1%|Completed||Phase 3|60|Actual|Universidad Nacional de Colombia||2|||f||||t||||||||||2017-10-11 00:01:53.669985|2017-10-11 00:01:53.669985
NCT02236390|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-08-22|||August 2014||2014-08-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|CPTERRT||Integrating Sleep, Nightmare and PTSD Treatments|Integrating Sleep and PTSD Treatment: Examining the Role of Emotion Regulation|Recruiting||N/A|90|Anticipated|University of Tulsa||3|||f||||f||||||||||2017-10-11 00:01:53.756042|2017-10-11 00:01:53.756042
NCT02236377|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-08-22|||August 2014||2014-08-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|July 2020|Anticipated|2020-07-01||Interventional|ERRT||Dismantling Exposure, Relaxation, and Rescripting Therapy|Exposure, Relaxation, Rescripting Therapy (ERRT) Dismantling|Recruiting||N/A|30|Anticipated|University of Tulsa||4|||f||||f||||||||||2017-10-11 00:01:53.872763|2017-10-11 00:01:53.872763
NCT02236364|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-10-25|||August 2014||2014-08-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Noninvasive Blood Glucose Monitoring Method Based on Imaging of the Eye|Blood Glucose Monitoring Based on Imaging of the Eye|Terminated||N/A|25|Actual|University of Toledo Health Science Campus||1||No positive results were detected|f||||f||||||||||2017-10-11 00:01:53.98723|2017-10-11 00:01:53.98723
NCT02236351|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-09|||June 2014||2014-06-01|September 2014|2014-09-01||||February 2015|Anticipated|2015-02-01||Interventional|||New Pediatric Patching Method to Improve Compliance||Unknown status|Recruiting|N/A|156|Anticipated|Texas Children's Hospital||2|||f||||||||||||||2017-10-11 00:01:54.082823|2017-10-11 00:01:54.082823
NCT02236338|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-12-06|||September 2008||2008-09-01|December 2016|2016-12-01|September 2028|Anticipated|2028-09-01|September 2028|Anticipated|2028-09-01||Interventional|||Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein|Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein: A Prospective Randomized Trial|Recruiting||Phase 4|400|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 00:01:54.186214|2017-10-11 00:01:54.186214
NCT02236325|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-05|||January 2012||2012-01-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Brief Skills Training Intervention for Suicidal Individuals|Brief Skills Training Intervention for Suicidal Individuals|Completed||Phase 1/Phase 2|93|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 00:01:54.293976|2017-10-11 00:01:54.293976
NCT02236312|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2016-05-13||2016-05-13|September 2014||2014-09-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines|A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Three Doses of Botulinum Toxin in the Treatment of Moderate to Very Severe Glabellar Frown Lines|Completed||Phase 2|359|Actual|Q-Med AB||4|||f||||t||||||||||2017-10-11 00:01:54.370222|2017-10-11 00:01:54.370222
NCT02236299|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-04-08|||September 2014||2014-09-01|April 2016|2016-04-01||||March 2017|Anticipated|2017-03-01||Interventional|DREAM GLP-1||Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting|Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting - DREAM GLP-1|Recruiting||N/A|30|Anticipated|Papworth Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:01:54.467606|2017-10-11 00:01:54.467606
NCT02236286|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-04-07|||September 2014||2014-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact|Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact|Recruiting||N/A|20|Anticipated|Oregon Health and Science University||2|||f||||f||||||||No||2017-10-11 00:01:54.581841|2017-10-11 00:01:54.581841
NCT02236273|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2017-06-15|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents|Comparative Effectiveness of Interactive, Health Literacy Promoting Text Messages on HPV Vaccine Completion In Minority Adolescents|Active, not recruiting||N/A|956|Actual|Columbia University||2|||f||||||||||||Undecided||2017-10-11 00:01:54.68683|2017-10-11 00:01:54.68683
NCT02236260|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-09-04|||September 3, 2014|Actual|2014-09-03|September 2017|2017-09-01|June 14, 2017|Actual|2017-06-14|June 12, 2017|Actual|2017-06-12||Interventional|ACUplus||Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation|Evaluation of the Benefit Provided by the Addition of Acupunctural Analgesia With Electrostimulation to Conventional Local Anesthesia Compared to Conventional Local Anesthesia Alone in Surgery of Deep Brain Stimulation for Movement Disorders.|Completed||N/A|20|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 00:01:54.769744|2017-10-11 00:01:54.769744
NCT02236247|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-12-30|||May 2013||2013-05-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Interventional|CONSTATHE||Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure|Heart Rate Control as an Additional Therapeutic Strategy in Patients With Decompensated Heart Failure: a Prospective, Randomized, Double-blinded, Placebo-controlled Study.|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Sao Paulo||2|||f||||t||||||||No||2017-10-11 00:01:54.858111|2017-10-11 00:01:54.858111
NCT02236234|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-09-09|||January 2012||2012-01-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|HPV||Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil|Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil|Completed||Phase 4|30|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 00:01:54.953231|2017-10-11 00:01:54.953231
NCT02236208|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-09|||May 2013||2013-05-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Effect of Folate Acid on Offspring Obesity|Mechanism of Folate Acid in Influencing Offspring Obesity During Pregnancy|Unknown status|Enrolling by invitation|N/A|20000|Anticipated|Nanjing Medical University|||1||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:01:55.104468|2017-10-11 00:01:55.104468
NCT02236195|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-08-30||2017-08-29|October 2014||2014-10-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes|An Open-Label, Single-Arm, Phase 2 Study of Mocetinostat in Selected Patients With Inactivating Alterations of Acetyltransferase Genes in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma|Completed||Phase 2|17|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 00:01:55.174066|2017-10-11 00:01:55.174066
NCT02236182|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-11|||July 1998||1998-07-01|September 2014|2014-09-01||||February 1999|Actual|1999-02-01||Interventional|||Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Double-blind, Placebo Controlled Trial to Assess the Safety of Two-week Administration of 80 mcg q.i.d. and 160 mcg q.i.d. of Ipratropium Bromide, as Delivered by the RESPIMAT® Device, in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|57|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:01:55.276322|2017-10-11 00:01:55.276322
NCT02236169|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-09|||October 2000||2000-10-01|September 2014|2014-09-01||||April 2001|Actual|2001-04-01||Interventional|||Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|An Open-Label, Crossover, Pharmacokinetic Trial to Determine the Comparability of 84 µg Ipratropium Bromide HFA-134a Inhalation Aerosol to 84 µg ATROVENT® CFC Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:01:55.362054|2017-10-11 00:01:55.362054
NCT02236156|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-10-13|||September 2014||2014-09-01|October 2016|2016-10-01||||January 2017|Anticipated|2017-01-01||Interventional|||Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)|A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.|Active, not recruiting||Phase 3|620|Anticipated|Starpharma Pty Ltd||2|||f||||f||||||||||2017-10-11 00:01:55.455982|2017-10-11 00:01:55.455982
NCT02236143|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-06-17|||February 2013||2013-02-01|June 2015|2015-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Ultrahigh Field Body MR Imaging|Ultrahigh Field Body MR Imaging|Enrolling by invitation||N/A|500|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:01:55.721238|2017-10-11 00:01:55.721238
NCT02236130|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-12-22|2015-12-30||June 2014||2014-06-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Peripheral Nerve Blocks in Pediatric Orthopedic Patients|Peripheral Nerve Blocks in Pediatric Orthopedic Patients: Are There Any Post Recovery Benefits?|Terminated||N/A|49|Actual|University of Mississippi Medical Center||2||Poor response rate on follow up of patients|f||||t||||||||||2017-10-11 00:01:55.799651|2017-10-11 00:01:55.799651
NCT02236117|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-05-17|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Aerobic Training on the Autonomic Modulation in Children|The Effects of 10 Weeks of Aerobic Training on the Autonomic Modulation in Prepubertal Children: a Randomized Control Trial|Completed||N/A|160|Actual|Universidade Estadual de Londrina||2|||f||||f|f|f||||||No||2017-10-11 00:01:56.119818|2017-10-11 00:01:56.119818
NCT02236104|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-03-23|||November 2010||2010-11-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|May 2011|Actual|2011-05-01||Interventional|coughassistAFM||Effect of Mechanical Insufflation-exsufflation on Respiratory Parameters in Two Neuromuscular Populations.|Effect of Mechanical Insufflation-exsufflation on Respiratory Parameters in Two Neuromuscular Populations.|Completed||N/A|16|Actual|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||||2017-10-11 00:01:56.195114|2017-10-11 00:01:56.195114
NCT02236091|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2017-05-02|||October 2014||2014-10-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|MELMAC||Monitoring Everyday Life Motor Activity in Children|Monitoring Everyday Life Motor Activity in Children|Recruiting||N/A|40|Anticipated|University Children's Hospital, Zurich|||1||f||||t||||||||||2017-10-11 00:01:56.284597|2017-10-11 00:01:56.284597
NCT02236078|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-07-25|||November 2015||2015-11-01|July 2016|2016-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|BBA||Brief Bactericidal Activity of Anti-Tuberculosis Drugs|Brief Bactericidal Activity of Anti-Tuberculosis Drugs in Drug-Resistant Tuberculosis|Recruiting||N/A|150|Anticipated|Centers for Disease Control and Prevention||5|||f||||f||||||||||2017-10-11 00:01:56.36244|2017-10-11 00:01:56.36244
NCT02236052|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-05-09|||August 2014||2014-08-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|January 2015|Actual|2015-01-01||Interventional|||Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population|Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like Particles (VLP) Quadrivalent Influenza Vaccine in the Elderly Population|Active, not recruiting||Phase 2|450|Actual|Medicago||6|||f||||t||||||||||2017-10-11 00:01:56.580377|2017-10-11 00:01:56.580377
NCT02236039|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-09-27|||September 2014||2014-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|COPA||COPD Originates in Polluted Air|The Effects of Traffic-Related Air Pollution on Smokers at Risk for Developing COPD|Recruiting||N/A|50|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:01:56.699081|2017-10-11 00:01:56.699081
NCT02236026|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-08-11|||September 2014||2014-09-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers|A Double-Blind, Placebo-Controlled, Randomized, Crossover Design Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers: A Thorough QT/QTc Study|Completed||Phase 1|44|Actual|Population Council||3|||f||||||||||||||2017-10-11 00:01:56.798777|2017-10-11 00:01:56.798777
NCT02236013|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-09-26|||January 7, 2015|Actual|2015-01-07|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase 1 Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia|Recruiting||Phase 1|44|Anticipated|Astellas Pharma Inc||2|||t||||f||||||||||2017-10-11 00:01:56.882542|2017-10-11 00:01:56.882542
NCT02236000|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-04-11|||August 2014||2014-08-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer|A Phase Ib/II Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer|Recruiting||Phase 1/Phase 2|63|Anticipated|NSABP Foundation Inc||1|||f||||f||||||||||2017-10-11 00:01:57.024494|2017-10-11 00:01:57.024494
NCT02235974|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-05-19|||July 2014||2014-07-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|CPASS||Critical Periods After Stroke Study (CPASS)|Critical Periods After Stroke Study (CPASS); Sensitive Periods and Consumer Preferences: Optimizing Upper Extremity Stroke Rehabilitation|Recruiting||N/A|64|Anticipated|MedStar National Rehabilitation Network||4|||f||||f||||||||No|There is no plan at this time to make individual participant data available.|2017-10-11 00:01:57.23441|2017-10-11 00:01:57.23441
NCT02235961|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-07-25|||September 4, 2014|Actual|2014-09-04|July 2017|2017-07-01|July 6, 2016|Actual|2016-07-06|July 6, 2016|Actual|2016-07-06||Interventional|||Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects|A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects.|Completed||Phase 1|163|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:01:57.36188|2017-10-11 00:01:57.36188
NCT02235948|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-09|||July 2014||2014-07-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of Folic Acid Supplementation on Arsenic Lowering|Efficacy and Safety of Folic Acid Supplementation Lowering Arsenic in a Chronic, Low-level Exposed Arsenic Population: a Randomized, Double-blind, Placebo Controlled Clinical Trial.|Unknown status|Active, not recruiting|Phase 2|450|Anticipated|Wenzhou Medical University||1|||f||||t||||||||||2017-10-11 00:01:57.454999|2017-10-11 00:01:57.454999
NCT02235935|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-08|||September 2014||2014-09-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Observational|||The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy|The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy|Unknown status|Recruiting|N/A|40|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-10-11 00:01:57.534512|2017-10-11 00:01:57.534512
NCT02235922|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2014-09-06|||March 2014||2014-03-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||Effects of a Dual Task Protocol on Cognition and Functionality in Non-sedentary Older Adults||Completed||N/A|78|Actual|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-11 00:01:57.59997|2017-10-11 00:01:57.59997
NCT02235909|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-02-09|||December 2014||2014-12-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension|A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension|Recruiting||Phase 3|260|Anticipated|Arbor Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-11 00:01:57.698274|2017-10-11 00:01:57.698274
NCT02235896|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-12-30|||September 2014||2014-09-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|FAITH!||Reducing CVD Risk in African Americans Faith Communities|Cardiovascular Disease Prevention Among African-Americans by FAITH! (Fostering African-American Improvement in Total Health)|Completed||N/A|37|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:01:58.074029|2017-10-11 00:01:58.074029
NCT02235883|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-11-13|||August 2014||2014-08-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|HEART||High Performance Computing of Personalized Cardio Component Models|High Performance Computing of Personalized Cardio Component Models|Recruiting||N/A|45|Anticipated|Transilvania University of Brasov|||1||f||||||||||||||2017-10-11 00:01:58.148658|2017-10-11 00:01:58.148658
NCT02235857|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2016-10-03|||March 2015||2015-03-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children|Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 System|Recruiting||N/A|35|Anticipated|Kaneka Pharma America LLC||1|||f||||f||||||||||2017-10-11 00:01:58.356864|2017-10-11 00:01:58.356864
NCT02235844|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2017-01-23|||September 2014||2014-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)|Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)|Active, not recruiting||Phase 1|1|Actual|Allergy and Asthma Consultants, Wichita, Kansas||1|||f||||f||||||||||2017-10-11 00:01:58.631707|2017-10-11 00:01:58.631707
NCT02235831|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2016-06-08|2015-10-30||September 2014||2014-09-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||This analysis population includes all subjects/eyes exposed to any investigational product evaluated in this study.|DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance|DAILIES® AquaComfort Plus® MF - Comparative Assessment of Visual Performance Using Objective Measurements|Completed||N/A|24|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 00:01:58.741264|2017-10-11 00:01:58.741264
NCT02235818|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2014-09-08|||January 2013||2013-01-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|LE||Determining the Immediate Effects of Counterforce Bracing Versus Kinesiotaping in Patients With Tennis Elbow|Immediate Effectiveness of Counterforce Bracing Versus Kinesiotaping During Activity: A Randomized Crossover Trial in Patients With Lateral Epicondylosis|Completed||N/A|30|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:01:58.983988|2017-10-11 00:01:58.983988
NCT02235805|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2015-09-14|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Magnesium and Vascular Stiffness|The Effects of Magnesium on Vascular Stiffness: A Long-term Study in Healthy Overweight and Slightly Obese Men and Women|Completed||N/A|52|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 00:01:59.077205|2017-10-11 00:01:59.077205
NCT02235792|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-01-07|||July 2014||2014-07-01|January 2016|2016-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||High Frequency Oscillations in Neurologic Disease|Chronically-recorded Deep Brain Nuclei/Hippocampal High Frequency Oscillations (HFOs) as Biomarkers of Neurologic Disease.|Recruiting||Phase 1|15|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:01:59.188295|2017-10-11 00:01:59.188295
NCT02235779|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-09-08|||August 2014||2014-08-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Diagnostic Yield of Transbronchial Cryobiopsy in Diagnosis of Interstitial Lung Diseases|DIagnostic Yield of Transbronchial Cryobiopsies in Subjects With Interstitial Lung Disease|Unknown status|Recruiting|N/A|50|Anticipated|Laval University||1|||f||||f||||||||||2017-10-11 00:01:59.292993|2017-10-11 00:01:59.292993
NCT02235766|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-03-03|||March 2015||2015-03-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|CORELAB-CRT||Corelab Remotely Echocardiographic Imaging Acquisition in Cardiac Resynchronization Therapy Candidates|Corelab Remotely Echocardiographic Imaging Acquisition in Cardiac Resynchronization Therapy Candidates|Recruiting||N/A|50|Anticipated|Kell s.r.l.|||1||f||||f||||||||||2017-10-11 00:01:59.426659|2017-10-11 00:01:59.426659
NCT02235753|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-01-23|||December 2014||2014-12-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|November 14, 2016|Actual|2016-11-14||Interventional|HITCARE||High-intensity Exercise After Acute Cardiac Event (HITCARE)|High-Intensity Exercise Training in Cardiac Rehabilitation After Acute Coronary Event - Randomized Controlled Trial|Terminated||N/A|27|Actual|Kuopio Research Institute of Exercise Medicine||3||Recruitment was stopped due to lack of funding.|f||||t||||||||||2017-10-11 00:01:59.572346|2017-10-11 00:01:59.572346
NCT02235740|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-05-03|||November 2014||2014-11-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)|An Open Label, Two-part, Phase I/Randomized Phase II Study in Subjects With Relapsed/Refractory Multiple Myeloma to Determine a Dose of Afuresertib for Administration in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetics, and Clinical Activity of the Combination of Afuresertib With Carfilzomib Compared With Carfilzomib Alone (Part 2)|Terminated||Phase 1|1|Actual|Novartis||5|||f||||f||||||||||2017-10-11 00:01:59.706332|2017-10-11 00:01:59.706332
NCT02235727|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-01-23|||July 2014||2014-07-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Safety and Tolerability of GBR 900 in a Single Ascending Dose Study in Healthy Subjects|A Phase 1, Double-Blind, Randomised, Placebo-Controlled, Study to Evaluate the Safety and Pharmacokinetics of GBR 900 in Adult Healthy Volunteers|Completed||Phase 1|37|Actual|Glenmark Pharmaceuticals Ltd. India||2|||f||||f||||||||||2017-10-11 00:01:59.839716|2017-10-11 00:01:59.839716
NCT02235714|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-09-08|||July 2009||2009-07-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|April 2011|Actual|2011-04-01||Observational|||Exhaled Breath Condensate Biomarkers of Inflammation in Individuals With Chronic Cervical Spinal Cord Injury|Exhaled Breath Condensate Biomarkers of Inflammation in Individuals With Chronic Cervical Spinal Cord Injury|Completed||N/A|36|Actual|James J. Peters Veterans Affairs Medical Center|||3||f||||f||||||Samples Without DNA|"     Exhaled Breath Condensate Blood Serum   "|||2017-10-11 00:01:59.945469|2017-10-11 00:01:59.945469
NCT02235701|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2016-10-18|||August 2014||2014-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma|An Open-Label Phase 1/2 Study to Investigate the Preliminary Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma|Recruiting||Phase 1/Phase 2|80|Anticipated|CytRx||1|||f||||f||||||||||2017-10-11 00:02:00.059092|2017-10-11 00:02:00.059092
NCT02235688|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-06-05|||August 2014||2014-08-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors|An Open-Label Phase 1b Study to Investigate the Preliminary Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors|Completed||Phase 1|30|Anticipated|CytRx||1|||f||||f||||||||||2017-10-11 00:02:00.199122|2017-10-11 00:02:00.199122
NCT02235675|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-03-07|||December 2013||2013-12-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2016|Actual|2016-02-01||Interventional|TOBABTK||Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) Study|Prospective, Multicenter Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) Study for Infrapopliteal Arteries Using the Tack-It Endovascular System™|Completed||N/A|35|Actual|Intact Vascular||1|||f||||t||||||||||2017-10-11 00:02:00.331473|2017-10-11 00:02:00.331473
NCT02235662|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-01-08|||October 2014||2014-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone|Phase I One-Month Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Intravaginal Rings Releasing Tenofovir and Levonorgestrel or Tenofovir Alone|Completed||Phase 1|86|Actual|CONRAD||3|||f||||f||||||||||2017-10-11 00:02:00.438015|2017-10-11 00:02:00.438015
NCT02235649|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-04-08|||March 2014||2014-03-01|April 2015|2015-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||Exploring the Feasibility of Social Skills Training in People With Psychosis||Unknown status|Recruiting|N/A|50|Anticipated|Institute of Psychiatry, London||2|||f||||t||||||||||2017-10-11 00:02:00.597768|2017-10-11 00:02:00.597768
NCT02235636|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-08|||July 2012||2012-07-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|August 2012|Actual|2012-08-01||Observational|||A Randomized Cross-over Trial of Comparison Between Robotic and Laparoscopic Suturing for Gastric Defect by Novices|Da Vinci Robot Compared to Laparoscopic Suturing for Closure of Gastric Incision Among Novice: a Randomized Cross Over Trial|Completed||N/A|20|Actual|Chinese University of Hong Kong|||2||f||||f||||||||||2017-10-11 00:02:00.688222|2017-10-11 00:02:00.688222
NCT02235623|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-01-30|||August 2014||2014-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ORCA||Orchidopexy Randomized Clinical Assessment|Randomized Trial of One Stage vs Two Stage Orchidopexy for Abdominal Undescended Testis|Recruiting||N/A|66|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 00:02:00.774006|2017-10-11 00:02:00.774006
NCT02235610|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-08-14|||October 2014||2014-10-01|August 2017|2017-08-01|September 11, 2018|Anticipated|2018-09-11|December 2017|Anticipated|2017-12-01||Interventional|EVLP-CHUM||Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation|Clinical Trial of Ex Vivo Lung Perfusion (EVLP) for the Reconditioning of Marginal Donor Lungs for Transplantation.|Recruiting||N/A|50|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 00:02:00.907828|2017-10-11 00:02:00.907828
NCT02235584|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2014-09-07|||July 2009||2009-07-01|September 2014|2014-09-01||||June 2014|Actual|2014-06-01||Interventional|||Insulinotropic Effect of GLP-1 and GIP After Dexamethasone|Loss of Insulinotropic Properties of Glucagon-like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Peptide (GIP) After Glucocorticoid Induced Insulin Resistance|Completed||N/A|19|Actual|Hvidovre University Hospital||1|||f||||f||||||||||2017-10-11 00:02:01.187817|2017-10-11 00:02:01.187817
NCT02235571|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2017-10-05|||September 2014||2014-09-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||iChoose Decision Kidney Aid for End-Stage Renal Disease Patients|iChoose Kidney Decision Aid for Treatment Options Among End-Stage Renal Disease (ESRD) Patients|Completed||N/A|470|Actual|Emory University||2|||f||||t||||||||||2017-10-11 00:02:01.300897|2017-10-11 00:02:01.300897
NCT02235558|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2017-01-19|||February 1, 2013|Actual|2013-02-01|January 2017|2017-01-01|March 21, 2016|Actual|2016-03-21|March 21, 2016|Actual|2016-03-21||Interventional|SAVER-I||Superselective Administration of VErapamil During Recanalization in Acute Ischemic Stroke|Super-Selective Intra-Arterial Administration of Verapamil for Neuroprotection After Intra-Arterial Thrombolysis for Acute Ischemic Stroke Phase I Study|Completed||Phase 1|11|Actual|University of Kentucky||1|||f||||f|t|f|||f|||No||2017-10-11 00:02:01.418069|2017-10-11 00:02:01.418069
NCT02235545|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-07|2016-07-22|||August 2014||2014-08-01|July 2016|2016-07-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|||Optisure Lead Post Approval Study|Optisure Lead Post Approval Study|Active, not recruiting||N/A|1725|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-11 00:02:01.599174|2017-10-11 00:02:01.599174
NCT02235532|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-30|2015-01-13|||September 2013||2013-09-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Aloe Vera Toothpaste on Periodontal Parameters|Effects of Aloe Vera Toothpaste on Periodontal Parameters of Patients With Gingivitis|Completed||N/A|20|Actual|Islamic Azad University, Tehran||2|||f||||f||||||||||2017-10-11 00:02:01.893029|2017-10-11 00:02:01.893029
NCT02235519|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-03-27|||January 2014||2014-01-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients|A Randomized, Open Label Study to Evaluate the Pleiotropic Effects of Azilsartan Medoxomil 40 and 80 mg for 12 Weeks Over Metabolic Markers in Patients With Hypertension, Obesity or Type 2 Diabetes Mellitus|Unknown status|Recruiting|Phase 2/Phase 3|300|Anticipated|Hospital General de México Dr. Eduardo Liceaga||2|||f||||t||||||||||2017-10-11 00:02:02.030939|2017-10-11 00:02:02.030939
NCT02235506|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-07-14|||September 2014||2014-09-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A Comparison of Epidural Block With Adding Sciatic Block to Continuous Femoral Block in Total Knee Arthroplasty|A Comparison of Epidural Analgesia With Adding Sciatic Nerve Block to Continuous Femoral Nerve Block for Post-operative Pain Management Following Total Knee Arthroplasty|Unknown status|Recruiting|N/A|80|Anticipated|Yeungnam University College of Medicine||2|||f||||t||||||||||2017-10-11 00:02:02.143848|2017-10-11 00:02:02.143848
NCT02235493|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-10-22|2015-08-25||August 2014||2014-08-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational||All patients who met all of the inclusion and none of the exclusion criteria were defined as the enrolled population, which was also the analysis population.|Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09|A Single-Center, Non-interventional Substudy of ALX-HPP-502 to Assess Functional Natural History Data of Patients With Juvenile Historical Controls in ENB-006-09|Completed||N/A|6|Actual|Alexion Pharma GmbH|||1||f||||f||||||||||2017-10-11 00:02:02.254605|2017-10-11 00:02:02.254605
NCT02235480|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-06-09|||February 2014||2014-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Tazarotene Gel in Nail Psoriasis|A Phase II Trial to Evaluate the Anti-psoriatic Efficacy and Tolerability of Tazarotene in a Gel Formulation in Patients With Mild to Moderate Nail Psoriasis - Parallel Group Comparison|Completed||Phase 2|66|Actual|Almirall, S.A.||2|||f||||f||||||||||2017-10-11 00:02:02.460362|2017-10-11 00:02:02.460362
NCT02235467|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-03-31|||February 2014||2014-02-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Multisite Study: Parental Training Using Video Modelling to Develop Social Skills in Children With Autism|Multisite Study: Acquisition of Social Skills in Children With Autism Using Video Modeling in Parental Training|Completed||Phase 4|67|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 00:02:02.561418|2017-10-11 00:02:02.561418
NCT02235454|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-06-26|2017-06-26||November 2014||2014-11-01|June 2017|2017-06-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||SDOCT-GMPE Software|A Prospective Evaluation of the Novel Glaucoma Premium Edition Software for Spectral Domain Optical Coherence Tomography|Completed||N/A|57|Actual|Duke University||1|||f||||t||||||||||2017-10-11 00:02:02.676452|2017-10-11 00:02:02.676452
NCT02235441|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-07-07|||November 2014||2014-11-01|July 2017|2017-07-01|April 5, 2016|Actual|2016-04-05|April 5, 2016|Actual|2016-04-05||Interventional|||Effects of Chemoradiation and Surgery on Cardiopulmonary Fitness and Tumor Neoplastic Phenotype in Gastrointestinal Malignancies|Effects of Chemoradiation and Surgery on Cardiopulmonary Fitness and Tumor Neoplastic Phenotype in Gastrointestinal Malignancies: A Pilot Study|Terminated||N/A|8|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:02:02.874172|2017-10-11 00:02:02.874172
NCT02235428|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-09|||September 1998||1998-09-01|September 2014|2014-09-01||||September 1998|Actual|1998-09-01||Interventional|||Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children|Double-blind, Controlled Trial to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, for 120 Minutes, in Acute Asthmatic Attacks in Young Children|Terminated||Phase 4|3|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:02:02.964185|2017-10-11 00:02:02.964185
NCT02235415|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-09|||June 1998||1998-06-01|September 2014|2014-09-01||||September 1999|Actual|1999-09-01||Observational|||Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension|Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension, Under Normal Conditions Compared With an Open Clinical Trial|Completed||N/A|24526|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:03.233707|2017-10-11 00:02:03.233707
NCT02235402|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-09|||December 1997||1997-12-01|September 2014|2014-09-01||||March 2000|Actual|2000-03-01||Interventional|||A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients|A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients|Completed||Phase 4|26|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:02:03.31452|2017-10-11 00:02:03.31452
NCT02235012|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-02-11|||September 2014||2014-09-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|KETABI||Cognitive Biases Under Ketamine|Cognitive Biases in Decision Making in a Pharmacological Model of Psychosis : a Study in Healthy Humans Recieving Low Dose Anesthetic, Ketamine Versus Placebo|Recruiting||N/A|48|Anticipated|Centre Hospitalier St Anne||2|||f||||t||||||||||2017-10-11 00:02:10.08659|2017-10-11 00:02:10.08659
NCT02235389|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-09|2014-09-09|||February 1998||1998-02-01|September 2014|2014-09-01||||December 1998|Actual|1998-12-01||Observational|PHARAOH||A Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®)|A Multicentre, Feasibility Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®). Pre-Hospital Alteplase Remote Advice of Hospital (PHARAOH)|Terminated||N/A|59|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 00:02:03.399728|2017-10-11 00:02:03.399728
NCT02235376|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-10-13|||June 2013||2013-06-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|GODWEAN||Criteria of Extubation Failure of Brain Injured Patients. Elaboration of a Prognostic Score.|Criteria of Extubation Failure of Brain Injured Patients. Elaboration of a Prognostic Score.|Completed||N/A|140|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:02:03.521714|2017-10-11 00:02:03.521714
NCT02235363|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-05-08|||January 2012||2012-01-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|September 2014|Actual|2014-09-01||Interventional|TL||Thread Lift by Use of Retaining Ligaments|Thread Lift by Use of Retaining Ligaments With V-lock Barbed Sutures|Completed||N/A|97|Actual|Winners Clinic||1|||f||||f||||||||||2017-10-11 00:02:03.642504|2017-10-11 00:02:03.642504
NCT02235350|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-09-09|||June 2014||2014-06-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|September 2014|Actual|2014-09-01||Interventional|AOT||Action Observation Treatment (AOT) as a Rehabilitation Tool|Study on the Effectiveness of Action Observation Treatment (AOT) as a Rehabilitation Tool in Acute Stroke Patients and in Chronic Stroke Patients With Apraxia: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|80|Anticipated|Neuromed IRCCS||2|||f||||t||||||||||2017-10-11 00:02:03.755113|2017-10-11 00:02:03.755113
NCT02235337|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-08-09|||September 2014||2014-09-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion|The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion|Completed||N/A|248|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 00:02:03.918504|2017-10-11 00:02:03.918504
NCT02235324|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2015-05-04|||March 2015||2015-03-01|May 2015|2015-05-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer|Phase II Study of Ziv-Aflibercept Followed by the Addition of 5-FU in the Third Line Setting of Metastatic Colorectal Cancer|Withdrawn||Phase 2|0|Actual|University of Southern California||1||Lack of funding|f||||t||||||||||2017-10-11 00:02:04.026471|2017-10-11 00:02:04.026471
NCT02235311|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-06-29|2017-04-26||October 2014||2014-10-01|June 2017|2017-06-01|August 17, 2015|Actual|2015-08-17|August 17, 2015|Actual|2015-08-17||Interventional|||Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed|Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed|Terminated||N/A|3|Actual|University of Missouri-Columbia|trial eliminated due to very low enrollment Poorly adopted by GI department due to fears of using once daily PPI despite available evidence Need for expansion to more sites for better enrollment|2||Difficulty recruiting and consenting participants|f||||t||||||||||2017-10-11 00:02:04.236012|2017-10-11 00:02:04.236012
NCT02235298|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-08-03|||September 2015||2015-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 Diabetes||Recruiting||Phase 4|100|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-11 00:02:04.992971|2017-10-11 00:02:04.992971
NCT02235285|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-10-06|2015-06-19||January 2010||2010-01-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|April 2014|Actual|2014-04-01||Interventional|BA||Asian Outcomes of Primary Breast Augmentation|Asian Outcomes of Primary Breast Augmentation in 162 Consecutive Cases Using Single Antibiotic Breast Irrigation by A Single Surgeon Under Sedative Anesthesia (Propofol Infusion)|Completed||N/A|162|Actual|Winners Clinic||1|||f||||f||||||||||2017-10-11 00:02:05.119539|2017-10-11 00:02:05.119539
NCT02235272|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-01-23||2017-01-23|September 2014||2014-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation|A Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Phase III Study of the Efficacy and Safety of a Single Sub-conjunctival Injection of XG-102 for the Reduction of Post-cataract Surgery Intraocular Inflammation|Completed||Phase 3|339|Actual|Xigen SA||2|||f||||f||||||||||2017-10-11 00:02:05.338005|2017-10-11 00:02:05.338005
NCT02235259|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-07-15||2016-07-15|September 2014||2014-09-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy and Safety of XG-104 for the Treatment of Dry Eye|A Phase II, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of XG-104 Ophthalmic Solutions in the Environment, and During Challenge in the Controlled Adverse Environmental (CAESM ) Model for the Treatment of Dry Eye|Completed||Phase 2|260|Actual|Xigen SA||4|||f||||f||||||||||2017-10-11 00:02:05.448659|2017-10-11 00:02:05.448659
NCT02235246|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2015-05-08|||October 2014||2014-10-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study||Completed||Phase 4|60|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:02:05.567004|2017-10-11 00:02:05.567004
NCT02235233|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-05-02|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin|Clinical Study to Investigate the Effect of NASH (Non-alcoholic Steatohepatitis) on the Disposition of 99mTechnetium(Tc)-Mebrofenin in Healthy Subjects Compared to Patients With NASH.|Completed||Phase 1|21|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:02:05.644425|2017-10-11 00:02:05.644425
NCT02235220|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-25|||September 2014||2014-09-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Reduction of Masticatory Muscle Activity by Restoring Canine Guidance|Reduction of Masticatory Muscle Activity by Restoring Canine Guidance With Composite Resin Fillings in Patients With Bruxism.|Unknown status|Enrolling by invitation|N/A|30|Anticipated|University of Kiel||1|||f||||f||||||||||2017-10-11 00:02:05.7373|2017-10-11 00:02:05.7373
NCT02235207|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-03-10|||September 2014||2014-09-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|FUSTRA||Effectiveness of Fustra—Exercise Program in Neck and Low Back Pain|Effectiveness of Fustra—Exercise Program on Pain, Physical Fitness and Quality of Life in Female and Male Office Workers Suffering From Recurrent Neck and Low Back Pain — a Randomized Controlled Trial|Completed||N/A|175|Actual|UKK Institute||2|||f||||f||||||||No||2017-10-11 00:02:05.813812|2017-10-11 00:02:05.813812
NCT02235194|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-11-16|||August 2014||2014-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism|Influence of an Amino Acid and Chromium Containing Table Water on Glucose Response to a Test Meal in Type 2 Diabetes Patients in a Double Blind Cross - Over Design|Completed||N/A|20|Actual|Stoffwechselzentrum Rhein - Pfalz||2|||f||||f||||||||||2017-10-11 00:02:05.90113|2017-10-11 00:02:05.90113
NCT02235181|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-05-02|||April 2015||2015-04-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|STOPPIT-2||An Open Randomised Trial of the Arabin Pessary to Prevent Pre-term Birth in Twin Pregnancy|An Open Randomised Trial of the Arabin Pessary to Prevent Pre-term Birth in Twin Pregnancy in Woman With a Short Cervix (STOPPIT-2)|Recruiting||N/A|1850|Anticipated|University of Edinburgh||2|||f||||t||||||||Yes|to be confirmed|2017-10-11 00:02:06.005051|2017-10-11 00:02:06.005051
NCT02235168|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-11-25|||September 2014||2014-09-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Rollator on Walking Distance in Elderly Patients||Completed||N/A|50|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-11 00:02:06.318189|2017-10-11 00:02:06.318189
NCT02235155|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-01-13|||September 2014||2014-09-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan|Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Uzbekistan|Completed||N/A|135|Actual|Gynuity Health Projects|||1||f||||f||||||||||2017-10-11 00:02:06.384443|2017-10-11 00:02:06.384443
NCT02235142|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-10-28|||June 2014||2014-06-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|AndroCan||Prostatic Cancer Versus Androgen Deficiency|Localised Cancer of Prostate and Androgen Deficiency.|Recruiting||N/A|1500|Anticipated|Hopital Foch||1|||f||||||||||||||2017-10-11 00:02:06.45753|2017-10-11 00:02:06.45753
NCT02235129|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-09-08|||September 2014||2014-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Six Minute Walking Test and Breath-holding||Unknown status|Recruiting|N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||||||||||||2017-10-11 00:02:06.531607|2017-10-11 00:02:06.531607
NCT02235116|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-07-28|||June 2011||2011-06-01|September 2014|2014-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Predictors of Patient Attitudes and Barriers to Skin Cancer Screening|Predictors of Patient Attitudes and Barriers to Skin Cancer Screening|Completed||N/A|1040|Actual|Jonsson Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-11 00:02:06.595959|2017-10-11 00:02:06.595959
NCT02235103|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-03-11|||April 2014||2014-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|DNAFRAG||The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate.|The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate.|Completed||N/A|21|Actual|University Hospital, Ghent|||2||f||||||||||Samples With DNA|"     Sperm samples   "|||2017-10-11 00:02:06.669776|2017-10-11 00:02:06.669776
NCT02235090|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-09-18|||August 2016||2016-08-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Feasibility to Reliably Measure Functional Abilities' Changes in Nonambulant Neuromuscular Patients Without Trial Site Visiting|Assessment of Feasibility and Statistical Reliability of Functional Outcomes Measurement in Neuromuscular Patients Without Trial Site Visiting by Standard Functional Scales and by Special Autonomic Device in Double-blind, Placebo Controlled Study of Cervical Spinal Cord Transdermal Direct Current Stimulation in Patients With Spinal Muscular Atrophy|Enrolling by invitation||N/A|30|Anticipated|Charitable Foundation Children with Spinal Muscular Atrophy||3|||f||||t||||||||||2017-10-11 00:02:06.743174|2017-10-11 00:02:06.743174
NCT02235077|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-05-22|2017-04-07||December 30, 2014|Actual|2014-12-30|May 2017|2017-05-01|June 6, 2016|Actual|2016-06-06|April 12, 2016|Actual|2016-04-12||Interventional|ATHENA-HF||Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure|Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)|Completed||Phase 2|360|Actual|Duke University||2|||f||||t||||||||No||2017-10-11 00:02:06.844281|2017-10-11 00:02:06.844281
NCT02235064|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-06-23|2017-02-24||July 2014||2014-07-01|June 2017|2017-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression|Prophylactic Use of Immediate Postpartum Sertraline to Prevent Postpartum Depression: A Double Blind Randomized Placebo Controlled Trial|Terminated||N/A|2|Actual|The Cooper Health System||2||Low recruitment, completion of funding cycle|f||||f||||||||No|Only aggregate data to be reported|2017-10-11 00:02:09.213347|2017-10-11 00:02:09.213347
NCT02235051|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-08-18|||May 2015||2015-05-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors|Deciphering the Breast Cancer Exercise Paradox: The Role of DNA Repair and Inflammation|Active, not recruiting||N/A|50|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 00:02:09.723267|2017-10-11 00:02:09.723267
NCT02235038|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||Metabolic Fuels Study|A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability|Completed||N/A|30|Actual|Boston Children’s Hospital||3|||f||||f||||||||||2017-10-11 00:02:09.844052|2017-10-11 00:02:09.844052
NCT02235025|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-05|||September 2012||2012-09-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional|||Asymptomatic Versus Symptomatic Mild COPD: Comparisons at Rest and at Exercise|Ventilatory Constraints During Exercise in Asymptomatic Versus Symptomatic Patients With Mild COPD|Completed||N/A|111|Actual|Centre Hospitalier Universitaire de Besancon||3|||f||||t||||||||||2017-10-11 00:02:09.95867|2017-10-11 00:02:09.95867
NCT02234999|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-03-25|||September 2014||2014-09-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Radiolabeled Study of CC-122 in Healthy Subjects|A Phase 1, Single-center, Open-label Study to Evaluate the Metabolism and Excretion of [14C]-CC-122 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Celgene Corporation||1|||f||||t||||||||||2017-10-11 00:02:10.193461|2017-10-11 00:02:10.193461
NCT02234986|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-06-23|||October 2015||2015-10-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma|A Phase 2, Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma (FLC)|Active, not recruiting||Phase 2|29|Anticipated|CASI Pharmaceuticals, Inc.||1|||f||||f||||||||Undecided||2017-10-11 00:02:10.282203|2017-10-11 00:02:10.282203
NCT02234973|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-08-31|||September 2014||2014-09-01|August 2015|2015-08-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01|3 Years|Observational [Patient Registry]|FORGE AHEAD||Transformation of Indigenous Primary Healthcare Delivery|Transformation of Indigenous Primary Healthcare Delivery (FORGE AHEAD): Community-driven Innovations and Strategic Scale-up Toolkits|Recruiting||N/A|434|Anticipated|Lawson Health Research Institute|||1||f||||||||||||||2017-10-11 00:02:10.367732|2017-10-11 00:02:10.367732
NCT02234960|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-11-01|||August 2014||2014-08-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)|TOCILIZUMAB IN FIRST LINE BIOLOGIC TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ROUTINE CLINICAL PRACTICE IN POLAND - MULTICENTER, NON-INTERVENTIONAL, PROSPECTIVE, OBSERVATIONAL STUDY (ACT-POL)|Completed||N/A|102|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:02:10.466057|2017-10-11 00:02:10.466057
NCT02234947|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-05-26|||November 2013||2013-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|||Pancreas Volume in Preclinical Type 1 Diabetes|Pancreas Volume in Preclinical Type 1 Diabetes|Recruiting||N/A|385|Anticipated|University of Florida|||4||f||||f||||||Samples Without DNA|"     serum, whole blood   "|||2017-10-11 00:02:10.581831|2017-10-11 00:02:10.581831
NCT02234934|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-09-25|||January 2015||2015-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease|A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease|Suspended||Phase 1/Phase 2|10|Anticipated|University of California, Los Angeles||1||Serious Adverse Event, under review|f||||t||||||||||2017-10-11 00:02:10.703329|2017-10-11 00:02:10.703329
NCT02234921|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-07-03|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|DRibble||Pilot Study of DRibble Vaccine for Prostate Cancer Patients|A Pilot Study of DPV-001 DRibble Vaccine With Imiquimod in Advanced Prostate Cancer|Recruiting||Phase 1|6|Anticipated|UbiVac||1|||f||||f||||||||||2017-10-11 00:02:10.802422|2017-10-11 00:02:10.802422
NCT02234895|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-06-06|||August 2014||2014-08-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Shoe Orthotics for Improvement of Biomechanics and Symptoms of Knee Osteoarthritis|Combined Medial and Lateral Orthotics for the Treatment of Knee Osteoarthritis|Completed||N/A|26|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:02:11.002388|2017-10-11 00:02:11.002388
NCT02234882|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-06-13|||September 2014||2014-09-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study on Pharmacokinetics|Effect of BMS-663068 on the Pharmacokinetics of Rosuvastatin|Completed||Phase 1|18|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:02:11.079771|2017-10-11 00:02:11.079771
NCT02234869|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2014-11-14|||October 2014||2014-10-01|November 2014|2014-11-01|March 2018|Anticipated|2018-03-01|February 2017|Anticipated|2017-02-01||Interventional|Frequency||Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy|Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Patients With Relapsing Multiple Sclerosis Transitioning From Standard-of-care Subcutaneous Interferon Therapy to Peginterferon Beta-1a (BIIB017)|Withdrawn||Phase 4|0|Actual|Biogen||2||Due to a change in Biogen Idec's medical research plans.|f||||||||||||||2017-10-11 00:02:11.143673|2017-10-11 00:02:11.143673
NCT02234856|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-09-29|||July 2014||2014-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Laparoscopic Hysterectomy Simulator|Evaluation of Laparoscopic Hysterectomy Simulator to Improve Cognitive Surgical Knowledge of Obstetrics and Gynecology Trainees|Enrolling by invitation||N/A|200|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:02:11.227442|2017-10-11 00:02:11.227442
NCT02234843|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-09-27|||November 13, 2014|Actual|2014-11-13|September 2017|2017-09-01|July 4, 2019|Anticipated|2019-07-04|July 4, 2019|Anticipated|2019-07-04||Interventional|EINSTEIN Jr||EINSTEIN Junior Phase III: Oral Rivaroxaban in Children With Venous Thrombosis|Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of an age-and Body Weight-adjusted Rivaroxaban Regimen Compared to Standard of Care in Children With Acute Venous Thromboembolism|Recruiting||Phase 3|270|Anticipated|Bayer||2|||f||||t|t|f||||||||2017-10-11 00:02:11.324306|2017-10-11 00:02:11.324306
NCT02234830|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-05-31|||December 21, 2012|Actual|2012-12-21|May 2017|2017-05-01|May 14, 2017|Actual|2017-05-14|May 14, 2016|Actual|2016-05-14||Interventional|CLOSE-UP II||Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial|Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial|Completed||N/A|818|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 00:02:11.844019|2017-10-11 00:02:11.844019
NCT02234804|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-10-05|||July 2013||2013-07-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|DOCTOR Recross||The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study|The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study|Unknown status|Recruiting|N/A|60|Anticipated|Aarhus University Hospital Skejby||4|||f||||t||||||||||2017-10-11 00:02:11.953825|2017-10-11 00:02:11.953825
NCT02234791|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-04|||September 2014||2014-09-01|September 2014|2014-09-01||||December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|||Mutation of the BTK Gene and Genotype-phenotype Correlation of Chinese Patients With X-Linked Agammaglobulinemia||Unknown status|Not yet recruiting|N/A|100|Anticipated|Shanghai Children's Medical Center|||1||f||||||||||||||2017-10-11 00:02:12.131245|2017-10-11 00:02:12.131245
NCT02234765|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-02-13|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|GESAP||Management of Patients With Suspected of Sleep Apnea-hypopnea Syndrome From Primary Care|Management of Patients With Suspected Sleep Apnea Syndrome From Primary Care: Territorial Assistance Network.|Completed||N/A|280|Anticipated|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||||||||||||2017-10-11 00:02:12.33902|2017-10-11 00:02:12.33902
NCT02234739|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-08|||October 2014||2014-10-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|VIA-COPD||Voriconazole for IPA in Chinese Patients With COPD|Efficacy and Safety of Voriconazole for Treatment of Invasive Pulmonary Aspergillosis Secondary to COPD: a Multi-center Prospective，Open Cohort Study (VIA-COPD)|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Red Cross Hospital, Hangzhou, China||1|||f||||f||||||||||2017-10-11 00:02:12.584504|2017-10-11 00:02:12.584504
NCT02234726|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-06-16|||August 2014|Actual|2014-08-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|IECDZ||Improving Early Childhood Development in Zambia|Improving Early Childhood Development in Zambia|Completed||N/A|526|Actual|Zambia Center for Applied Health Research and Development||2|||f||||f|f|f||||||||2017-10-11 00:02:12.719502|2017-10-11 00:02:12.719502
NCT02234713|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-09-19|||January 2013||2013-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Adherence in Pediatric Multiple Sclerosis|Treatment Adherence in Pediatric Multiple Sclerosis|Completed||N/A|71|Actual|The Hospital for Sick Children||2|||f||||||||||||||2017-10-11 00:02:12.82985|2017-10-11 00:02:12.82985
NCT02234700|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-09-08|||August 2014||2014-08-01|September 2014|2014-09-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01|6 Months|Observational [Patient Registry]|ANLDO||Are Corneal Epithelial Defects Related to Changes in Ocular Bacterial Flora in Patients With ANLDO|To Estimate Whether Corneal Epithelial Defects Occur in Patients With Acquired Nasolacrimal Duct Obstructions is Linked to Changes Occurring Within Ocular Bacterial Flora in These Patients, and What Are the Specific Changes in Their Flora.|Unknown status|Recruiting|N/A|60|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||t||||||None Retained|"     Bacterial flora from the eye   "|||2017-10-11 00:02:12.951096|2017-10-11 00:02:12.951096
NCT02234674|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2015-05-21|||September 2014||2014-09-01|September 2014|2014-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pilot Efficacy Study of the Stendo Pulsating Suit in Patient With Leg Lymphoedema|Pilot Efficacy Study of the Stendo Pulsating Suit in Patient With Leg Lymphoedema|Completed||N/A|25|Actual|Stendo||2|||f||||t||||||||||2017-10-11 00:02:13.104702|2017-10-11 00:02:13.104702
NCT02234661|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-05-22|||June 2014||2014-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|CAPFAST||Expanding the Cycle of Opportunity: Simultaneously Educating Parents and Children in Head Start|Expanding the Cycle of Opportunity: Simultaneously Educating Parents and Children in Head Start|Recruiting||N/A|390|Anticipated|Northwestern University||2|||f||||f||||||||Undecided||2017-10-11 00:02:13.175895|2017-10-11 00:02:13.175895
NCT02234648|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-04-13|||August 2014||2014-08-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||To Investigate the Effect of Tart Montmorency Cherry Juice (Prunus Cerasus) on Vascular Function.|Investigate the Effect of Tart Montmorency Cherry Juice (Prunus Cerasus) on Vascular Function.|Completed||N/A|14|Actual|Northumbria University||2|||f||||t||||||||||2017-10-11 00:02:13.259325|2017-10-11 00:02:13.259325
NCT02234635|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-09-08|||August 2012||2012-08-01|September 2014|2014-09-01|February 2015|Anticipated|2015-02-01|September 2014|Anticipated|2014-09-01||Interventional|||Visual Quality Change of Eyes Implanted With Diffractive Multifocal Intraocular Lens After Cataract Surgery|Phase 1 Evaluate the Visual Quality Change of Eyes Implanted With Multifocal Intraocular Lens and Monofocal Lenses; Phase 2 Evaluate the Tear Film Quality Dynamics of Eyes Implanted With Multifocal Intraocular Lens and Monofocal Lenses.|Unknown status|Recruiting|N/A|50|Anticipated|Wenzhou Medical University||2|||f||||t||||||||||2017-10-11 00:02:13.332147|2017-10-11 00:02:13.332147
NCT02234622|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-07-07|||August 3, 2015|Actual|2015-08-03|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|July 30, 2019|Anticipated|2019-07-30||Interventional|RELIEVE||Comparing Effects of a Holistic Yoga Program and a Wellness Program on PTSD Symptoms|Outcomes of a Holistic Yoga Program Designed to Relieve PTSD (RELIEVE Trial)|Recruiting||N/A|232|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:02:13.416296|2017-10-11 00:02:13.416296
NCT02234609|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-09-09|||September 2012||2012-09-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|modARTIV||Effectiveness of Modified Class IV Atraumatic Restorative Treatment|Effectiveness of Modified Class IV Atraumatic Restorative Treatment - Results After 12 Months|Completed||N/A|69|Actual|University of Witten/Herdecke||1|||f||||f||||||||||2017-10-11 00:02:13.519412|2017-10-11 00:02:13.519412
NCT02234596|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-05-17|||September 2014||2014-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Nintedanib in Patients With Advanced Esophagogastric Cancer|Phase II Trial of Nintedanib in Patients With Advanced Esophagogastric Cancer|Active, not recruiting||Phase 2|34|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:02:13.622585|2017-10-11 00:02:13.622585
NCT02234583|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-09-29|||January 2015||2015-01-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia|An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia|Completed||Phase 3|2091|Actual|Daiichi Sankyo, Inc.||2|||f||||t||||||||||2017-10-11 00:02:13.899377|2017-10-11 00:02:13.899377
NCT02234570|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-01-19|||November 2014||2014-11-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole|A Randomized, Double-Blind Placebo-Controlled Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole|Completed||Phase 1|70|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f|||||t|f|||f|||||2017-10-11 00:02:14.712794|2017-10-11 00:02:14.712794
NCT02234557|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-08-29|||September 2014||2014-09-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Tai Chi Training for Children With ADHD|Movement-Based Training for Children With ADHD: A Feasibility Study|Recruiting||Phase 1|40|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||t||||||||Yes||2017-10-11 00:02:14.855655|2017-10-11 00:02:14.855655
NCT02234544|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2015-04-07|||October 2014||2014-10-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effect of an Inhibitor of Cholesterol Absorption on Vitamin D Levels|Estudo clínico Randomizado, Controlado e Duplo-cego do Impacto da inibição de um Transportador de Membrana do Colesterol na absorção da Vitamina D|Completed||Phase 4|52|Actual|Federal University of Rio Grande do Sul||2|||f||||t||||||||||2017-10-11 00:02:14.996309|2017-10-11 00:02:14.996309
NCT02234531|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-06-30|||April 2013||2013-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MAVASI||Comparison Study of 'Virtual Teacher' Support for Rehabilitation After Stroke.|Assessment of a Virtual Teacher Feedback for the Recovery of Upper Limb After Stroke.|Recruiting||N/A|122|Anticipated|IRCCS San Camillo, Venezia, Italy||2|||f||||t||||||||||2017-10-11 00:02:15.130799|2017-10-11 00:02:15.130799
NCT02234518|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-11-09|||October 2014||2014-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Fibers and Gut Health|Evaluation of Changes in Gut Transit Time and Gastrointestinal Symptoms Following the Consumption of a Fiber Containing Product in Adults With Constipation|Completed||N/A|120|Anticipated|Nestlé||3|||f||||f||||||||||2017-10-11 00:02:15.285372|2017-10-11 00:02:15.285372
NCT02234505|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-12-03|||September 2014||2014-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||Physiologic Range of Step-by-step Variations in Lower Limb Prosthesis Forces During Walking|Physiologic Range of Step-by-step Variations in Lower Limb Prosthesis Forces|Completed||N/A|12|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 00:02:15.39071|2017-10-11 00:02:15.39071
NCT02234492|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-08-04|||September 2014||2014-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients|The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients|Recruiting||Phase 4|82|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-11 00:02:15.477306|2017-10-11 00:02:15.477306
NCT02234479|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-08-08|2016-02-23||June 2014||2014-06-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||MediHoney for Radiation Dermatitis|A Pilot Study: Topical Application of Medihoney for Management of Radiation Dermatitis|Completed||N/A|34|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 00:02:15.633555|2017-10-11 00:02:15.633555
NCT02234466|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2014-09-08|||August 2014||2014-08-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Preoperative Oral Dexamethasone to Improve Recovery After Surgery|The Use of Preoperative Oral Dexamethasone to Improve Quality of Recovery After Breast Surgery|Unknown status|Enrolling by invitation|Phase 2|80|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:02:16.048882|2017-10-11 00:02:16.048882
NCT02234453|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-06-16|||October 2016||2016-10-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Home Testing of Blood Counts in Chemotherapy Patients|A Phase 1 Trial Assessing the Safety and Performance of the Minicare H-2000 in Home Testing of Blood Counts in Chemotherapy Patients.|Not yet recruiting||N/A|80|Anticipated|University of Leeds||1|||f||||f||||||||||2017-10-11 00:02:16.161672|2017-10-11 00:02:16.161672
NCT02234440|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2016-02-16|||September 2014||2014-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance|"Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance: a Prospective Randomized, Open Labeled, Clinical Trial"|Completed||N/A|86|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 00:02:16.260509|2017-10-11 00:02:16.260509
NCT02234427|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-11-10|2016-08-01||June 2014||2014-06-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|PARes-III||Pharmacogenomics of Antiplatelet Response|Pharmacogenomics of Antiplatelet Response|Completed||Phase 4|34|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 00:02:16.350966|2017-10-11 00:02:16.350966
NCT02234414|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-09-08|||February 2009||2009-02-01|September 2014|2014-09-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Observational|SwOF||Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in Switzerland|Pilot Study on the Epidemiology, Identification Rate and Treatment Penetration of Vertebral Fractures Due to Osteoporosis in Switzerland (SwOF)|Completed||N/A|303|Actual|Interessengemeinschaft Osteoporose|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 00:02:16.52751|2017-10-11 00:02:16.52751
NCT02233465|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-03-19|||January 2008||2008-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Treating Parastomal Hernia With a Mesh|Mesh-repair With Inraperitoneal On-lay Mesh (IPOM) for Parastomal Hernia|Completed||Phase 1/Phase 2|50|Actual|Norrbottens Lans Landsting||2|||f||||f||||||||||2017-10-11 00:02:30.478027|2017-10-11 00:02:30.478027
NCT02234401|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-03-21|||August 2014||2014-08-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NIVinCF||Non Invasive Ventilation for Acute Exacerbations in Adult CF|A Mixed Methods Study Comparing the Clinical Efficacy With the Patient Experience of Non-invasive Ventilation During an Acute Exacerbation Complicated by Respiratory Failure in Adult Cystic Fibrosis|Recruiting||N/A|16|Anticipated|Manchester Metropolitan University||2|||f||||f||||||||||2017-10-11 00:02:16.620327|2017-10-11 00:02:16.620327
NCT02234388|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-03-13|||March 2012||2012-03-01|March 2017|2017-03-01||||January 2020|Anticipated|2020-01-01|3 Years|Observational [Patient Registry]|UCTD Registry||Undifferentiated Connective Tissue Disease Registry|Undifferentiated Connective Tissue Disease Registry|Recruiting||N/A|100|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-11 00:02:16.727026|2017-10-11 00:02:16.727026
NCT02234375|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2016-09-27|||July 2017||2017-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Use of Gadolinium in CT Pulmonary Angiography|Efficacy of Gadolinium Contrast in CT Pulmonary Angiography in Patients With Allergy to Iodine|Not yet recruiting||Phase 4|100|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:02:16.813839|2017-10-11 00:02:16.813839
NCT02234362|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-06-26|2017-01-27||June 12, 2015|Actual|2015-06-12|June 2017|2017-06-01|September 29, 2016|Actual|2016-09-29|September 29, 2016|Actual|2016-09-29||Interventional|||Vortioxetine for Menopausal Depression|Vortioxetine for Menopausal Depression and Associated Symptoms|Completed||Phase 4|47|Actual|Massachusetts General Hospital|"lack of control group (important given that previous VMS medication trials have indicated modest placebo response rates, and it is difficult to determine whether the side effects are associated with the medication)
small sample size"|1|||f||||f||||||||No||2017-10-11 00:02:17.018687|2017-10-11 00:02:17.018687
NCT02234349|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-08-08|||September 2013||2013-09-01|August 2016|2016-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|ITABI||Bile Acids and Incretins in Pancreas Kidney Transplant Patients|Impact of Duodena-pancreatic Transplantation on Bile Acids and Incretins Metabolism.|Completed||N/A|50|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-11 00:02:17.802631|2017-10-11 00:02:17.802631
NCT02234336|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-05|2017-05-23|||October 2014||2014-10-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Assessment of Wall Thickness in Hypertrophic Cardiomyopathy|Assessment of Wall Thickness in Hypertrophic Cardiomyopathy|Recruiting||N/A|110|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-11 00:02:17.903214|2017-10-11 00:02:17.903214
NCT02234297|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-04-04|||October 2014||2014-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery|A Phase 1 Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Glioma Undergoing Surgery|Completed||Phase 1|17|Actual|Blaze Bioscience Inc.||1|||f||||t||||||||||2017-10-11 00:02:18.464185|2017-10-11 00:02:18.464185
NCT02234284|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-06-23|||November 12, 2014|Actual|2014-11-12|June 2017|2017-06-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|AIR||Aides in Respiration Health Coaching for COPD|Health Coaching to Reduce Disparities for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|192|Actual|University of California, San Francisco||2|||f||||t||||||||No||2017-10-11 00:02:18.563754|2017-10-11 00:02:18.563754
NCT02234271|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-09-04|||September 2012||2012-09-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Plan A Birth Control: Randomized Controlled Trial of a Mobile Health Application for Contraception Information||Completed||N/A|120|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-10-11 00:02:18.654958|2017-10-11 00:02:18.654958
NCT02234258|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-08-29|||January 2015||2015-01-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Cognitive Behavioral Social Skills Training for Youth at Risk of Psychosis|Cognitive Behavioral Social Skills Training for Youth at Risk of Psychosis|Recruiting||N/A|225|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 00:02:18.735086|2017-10-11 00:02:18.735086
NCT02234245|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-05-30|||October 2012||2012-10-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2013|Actual|2013-11-01||Interventional|||Economic Evaluation in Cardiology: Remote Monitoring of Pacemakers|Economic Evaluation in Cardiology: Remote Monitoring of Pacemakers|Active, not recruiting||N/A|83|Actual|Universidad de Almeria||2|||f||||t||||||||||2017-10-11 00:02:18.839149|2017-10-11 00:02:18.839149
NCT02234232|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-04-20|||July 2014||2014-07-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Feasibility and Safety of an Intradialytic Exercise Program: DIALY-SIZE|Exercise in the Dialysis Unit: a Randomized Factorial Pilot Study on the Feasibility and Safety of Intradialytic Exercise|Completed||Phase 4|31|Actual|University of Alberta||4|||f||||f||||||||||2017-10-11 00:02:18.926663|2017-10-11 00:02:18.926663
NCT02234219|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-28|||January 2014||2014-01-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease: A Prospective Multicenter Randomized Controlled Trial|Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease: A Prospective Multicenter Randomized Controlled Trial|Unknown status|Recruiting|N/A|50|Anticipated|Tongji Hospital||2|||f||||t||||||||||2017-10-11 00:02:19.049305|2017-10-11 00:02:19.049305
NCT02234206|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-04|||December 2012||2012-12-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||A Clinical Trial to Study the Safety and Efficacy of Chandrakanthi Choornam in Patients With Low Sperm Count|Safety and Efficacy of Chandrakanthi Choornam in Oligospermia - A Preclinical and Clinical Study|Completed||Phase 2|40|Actual|Tamil Nadu Dr.M.G.R.Medical University||1|||f||||f||||||||||2017-10-11 00:02:19.126539|2017-10-11 00:02:19.126539
NCT02234193|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-06-13|||June 2016||2016-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Reducing Side-effects of Autologous Skin Tissue Harvesting|A Pilot Clinical Trial to Reduce Side-effects of Autologous Skin Tissue Harvesting|Recruiting||Early Phase 1|28|Anticipated|Massachusetts General Hospital||7|||f||||t||||||||Yes||2017-10-11 00:02:19.207184|2017-10-11 00:02:19.207184
NCT02234180|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-03-17|||September 2014||2014-09-01|March 2017|2017-03-01|June 3, 2016|Actual|2016-06-03|June 3, 2016|Actual|2016-06-03||Interventional|||Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery|Randomized Phase II Double Blind Study of Adjuvant Regorafenib vs Placebo in Patients With Node Positive Esophageal Cancer That Completed Pre-operative Therapy|Completed||Phase 2|3|Actual|Academic and Community Cancer Research United||2|||f||||t||||||||||2017-10-11 00:02:19.326262|2017-10-11 00:02:19.326262
NCT02234167|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-09-08|||April 2002||2002-04-01|April 2014|2014-04-01||||December 2013|Actual|2013-12-01||Interventional|SHP||The Swedish Prison Program is an Intervention Prevention Program Targeting Injecting Drug Users Risk Behaviours and Infectious Diseases|Svenska Häktesprogrammet, Prevention, Risk Behaviour and Infectious Diseases Among IDU.|Suspended||N/A|||Karolinska Institutet||1||Termination of data collection|f||||t||||||||||2017-10-11 00:02:19.432474|2017-10-11 00:02:19.432474
NCT02234154|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-04-14|||December 2014||2014-12-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Post-market Study of the TOPS™ System|A Study to Evaluate the Safety and Effectiveness of the TOPS System|Recruiting||N/A|10|Anticipated|Premia Spine||1|||f||||f||||||||||2017-10-11 00:02:19.509895|2017-10-11 00:02:19.509895
NCT02234141|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-12-21||2016-12-21|November 2014||2014-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|ARROW||Selonsertib in Adults With Pulmonary Arterial Hypertension|A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 2|151|Actual|Gilead Sciences||4|||f||||t||||||||||2017-10-11 00:02:19.604805|2017-10-11 00:02:19.604805
NCT02234128|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-08-31|||July 2015||2015-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility|A Phase 2, Multicenter, Open-label Study to Measure the Safety of Extending Preservation and Assessment Time of Donor Lungs Using Normothermic Ex Vivo Lung Perfusion and Ventilation (EVLP) as Administered by the SPONSOR Using the Toronto EVLP System™|Recruiting||N/A|132|Anticipated|Lung Bioengineering Inc.||3|||f||||f||||||||||2017-10-11 00:02:19.773333|2017-10-11 00:02:19.773333
NCT02234115|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2017-07-03|||August 2014||2014-08-01|July 2017|2017-07-01|December 23, 2016|Actual|2016-12-23|August 30, 2016|Actual|2016-08-30||Interventional|||Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma|An Open-Labeled, Singled-Arm Study of the Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate for Injectable Suspension (LMIS 50 mg) in Subjects With Advanced Prostate Carcinoma|Completed||Phase 3|137|Actual|Foresee Pharmaceuticals Co., Ltd.||1|||f||||t||||||||||2017-10-11 00:02:19.893897|2017-10-11 00:02:19.893897
NCT02234102|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2015-08-20|||August 2014||2014-08-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation|Eagle AF - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation|Unknown status|Recruiting|N/A|160|Anticipated|Märkische Kliniken GmbH||2|||f||||f||||||||||2017-10-11 00:02:20.159948|2017-10-11 00:02:20.159948
NCT02234089|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-04-21|||September 2014||2014-09-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|ProComD||Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormon-Releasing-Hormon (LHRH) Agonists.||Active, not recruiting||N/A|430|Actual|Ferring Pharmaceuticals|||2||f||||||||||||||2017-10-11 00:02:20.241405|2017-10-11 00:02:20.241405
NCT02234076|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-08-16|||October 2014||2014-10-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Study on the Efficacy of Virtual Reality Exposure Therapy (VRET) for Survivors of Childhood Sexual Abuse and War Related Trauma|A Study on the Efficacy of Virtual Reality Exposure Therapy (VRET) for Survivors of Childhood Sexual Abuse and War Related Trauma|Recruiting||N/A|144|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-11 00:02:20.321909|2017-10-11 00:02:20.321909
NCT02234063|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-03-06|||November 2014||2014-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GUARDD||Genetic Testing to Understand and Address Renal Disease Disparities|Genomic Medicine Pilot for Hypertension and Kidney Disease in Primary Care|Recruiting||N/A|2050|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 00:02:20.440598|2017-10-11 00:02:20.440598
NCT02234050|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-08-31|||July 2015||2015-07-01|August 2017|2017-08-01||||July 2017|Actual|2017-07-01||Interventional|||Trabectedin for Recurrent Grade II/III Meningioma|Trabectedin for Recurrent Grade II or III Meningioma: a Randomized Phase II Study of the EORTC Brain Tumor Group|Active, not recruiting||Phase 2|86|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 00:02:20.55752|2017-10-11 00:02:20.55752
NCT02234037|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-01-26|||November 2013||2013-11-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60|A Pilot Study of Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60 Who Are Not Candidates for Standard Induction Chemotherapy|Terminated||Phase 1|3|Actual|Emory University||1||Slow accrual|f||||t|t|f||||||||2017-10-11 00:02:20.763054|2017-10-11 00:02:20.763054
NCT02234024|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-08-09|||January 2014||2014-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Oral Supplementation of Gangliosides to Treat a Rare Metabolic Disorder|Oral Supplementation of Gangliosides - A Potential Treatment for GM3 Synthase Deficiency|Enrolling by invitation||N/A|20|Anticipated|DDC Clinic - Center for Special Needs Children||1|||f||||f||||||||||2017-10-11 00:02:20.875577|2017-10-11 00:02:20.875577
NCT02234011|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-04-05|2017-01-20||September 2014|Actual|2014-09-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder|A Placebo-Controlled Crossover Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder|Terminated||Phase 2|1|Actual|Mclean Hospital||2||Terminated due to difficulty in recruiting participants.|f||||t||||||||||2017-10-11 00:02:20.977012|2017-10-11 00:02:20.977012
NCT02233998|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2015-07-31|2015-06-29||August 2014||2014-08-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Clinical Trial to Test the Effect of Marketed Mouth Rinses on Decreasing Plaque and Gum Inflammation|21 Day Clinical Efficacy of Essential Oil Containing Mouth Rinses: Effect on Reducing Existing Gingivitis and Plaque|Completed||N/A|158|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-10-11 00:02:21.138065|2017-10-11 00:02:21.138065
NCT02233985|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-05-29|2016-04-18||August 2013||2013-08-01|December 2012|2012-12-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional||In the follow-up period it was possible to obtain more patients from the baseline estimate of the sample number.|Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants|A Randomized Trial of Nebulized 3% Hypertonic Saline With Salbutamol in the Treatment of Acute Bronchiolitis in Pediatric Hospital|Completed||Phase 4|64|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||Yes|We have your membership number social security and personal data such as address and telephone number of the parents.|2017-10-11 00:02:21.747531|2017-10-11 00:02:21.747531
NCT02233972|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-10-16|||August 2014||2014-08-01|August 2014|2014-08-01||||October 2014|Actual|2014-10-01||Interventional|||A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam|A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam.|Completed||Phase 4|15|Actual|Jiangsu Kanion Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-11 00:02:22.160092|2017-10-11 00:02:22.160092
NCT02233959|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-02-16|||December 2015||2015-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Palatability of a Novel Oral Formulation of Prednsione|Palatability of a Novel Oral Formulation of Prednsione|Completed||N/A|24|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||Samples With DNA|"     Whole Blood   "|Undecided||2017-10-11 00:02:22.253655|2017-10-11 00:02:22.253655
NCT02233946|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-04-18|||January 2015||2015-01-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|cASCA||Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care|Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care|Active, not recruiting||N/A|1457|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 00:02:22.337461|2017-10-11 00:02:22.337461
NCT02233933|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-08|||September 2014||2014-09-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis|Randomized Trial of Argon Plasma Coagulation Versus Argon Plasma Coagulation and Hemospray in the Therapy of Radiation Proctitis|Unknown status|Not yet recruiting|N/A|20|Anticipated|British Columbia Cancer Agency||2|||f||||t||||||||||2017-10-11 00:02:22.469719|2017-10-11 00:02:22.469719
NCT02233920|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-08|||January 2000||2000-01-01|September 2014|2014-09-01||||December 2000|Actual|2000-12-01||Observational|||Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis|Postmarketing Surveillance Study (as Per § 67(6) AMG [German Drug Law]) of Ventilat® Metered-dose Inhaler in Chronic Obstructive Bronchitis|Completed||N/A|716|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:22.580458|2017-10-11 00:02:22.580458
NCT02233907|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-08|||October 1999||1999-10-01|September 2014|2014-09-01||||August 2001|Actual|2001-08-01||Observational|||Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease|Post-marketing Surveillance (as Per § 67(6) AMG [German Drug Law]) of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease|Completed||N/A|595|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:22.68741|2017-10-11 00:02:22.68741
NCT02233894|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-08|||February 2001||2001-02-01|September 2014|2014-09-01||||May 2002|Actual|2002-05-01||Observational|||Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease|Post-marketing Surveillance (as Per § 67(6) AMG [German Drug Law]) of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease|Completed||N/A|526|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:22.775685|2017-10-11 00:02:22.775685
NCT02233881|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-08|2014-09-08|||January 2001||2001-01-01|September 2014|2014-09-01||||November 2001|Actual|2001-11-01||Observational|||Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease|Post-marketing Surveillance (as Per § 67(6) AMG [German Drug Law]) of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease|Completed||N/A|4222|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:22.861728|2017-10-11 00:02:22.861728
NCT02233868|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2017-08-22|||September 3, 2014||2014-09-03|August 17, 2017|2017-08-17|March 1, 2020|Anticipated|2020-03-01|March 1, 2020|Anticipated|2020-03-01||Interventional|||Brain Inflammation and Function in Alcoholism|Brain Inflammation and Function in Alcoholism|Recruiting||Early Phase 1|144|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:02:22.94359|2017-10-11 00:02:22.94359
NCT02233855|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2017-06-30|||September 3, 2014||2014-09-03|June 13, 2017|2017-06-13|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Observational|||People Presenting With Neurocysticercosis in North America|NACC 002: A Multicenter Prospective Natural History Study of Patients Presenting With Neurocysticercosis in North America|Terminated||N/A|9|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:02:23.049336|2017-10-11 00:02:23.049336
NCT02233842|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2016-08-01|2016-06-16||September 2014||2014-09-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors|Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||f||||||||No||2017-10-11 00:02:23.164899|2017-10-11 00:02:23.164899
NCT02233829|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-06|2017-09-12|||September 3, 2014||2014-09-03|September 8, 2017|2017-09-08|March 2, 2020|Anticipated|2020-03-02|March 2, 2020|Anticipated|2020-03-02||Interventional|||Dopamine Rhythms in Health and Addiction|Dopamine Rhythms in Health and Addiction|Suspended||Early Phase 1|112|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:02:23.512842|2017-10-11 00:02:23.512842
NCT02233816|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-03-16|||August 2014||2014-08-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults|Immunogenicity, Safety, and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults|Active, not recruiting||Phase 2|300|Anticipated|Medicago||4|||f||||t||||||||||2017-10-11 00:02:23.623482|2017-10-11 00:02:23.623482
NCT02233803|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-08-18|2017-03-03||November 14, 2014|Actual|2014-11-14|August 2017|2017-08-01|December 11, 2015|Actual|2015-12-11|December 11, 2015|Actual|2015-12-11||Interventional|||A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma|A Randomised, Multi-centre, Open Label, Cross-over Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of Neumoterol 400 and Symbicort Forte in Adults With Asthma|Completed||Phase 4|239|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:02:23.778915|2017-10-11 00:02:23.778915
NCT02233790|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-05|||December 2014||2014-12-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI|Comparison of Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Undergoing PPCI Evaluated by SPECT|Unknown status|Not yet recruiting|Phase 4|600|Anticipated|First Hospital of China Medical University||2|||f||||t||||||||||2017-10-11 00:02:24.101907|2017-10-11 00:02:24.101907
NCT02233777|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-05|||June 2014||2014-06-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg|Bioequivalence Study of 150 mg Pregabalin Capsules Produced by PT Dexa Medica in Comparison With the Comparator Product (Lyrica® Capsule 150 mg, Pfizer Manufacturing Deutschland GmbH, Germany)|Completed||N/A|20|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 00:02:24.384463|2017-10-11 00:02:24.384463
NCT02233764|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-10-03|||October 2016|Actual|2016-10-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Iron/Zinc-Biofortified Pearl Millet on Growth and Immunity in Children Aged 12-18 Months in India|Effect of Iron- and Zinc-Biofortified Pearl Millet (ICTP8203-Fe) Consumption on Growth and Immunity in Children Aged 12-18 Months in India|Recruiting||N/A|250|Anticipated|Cornell University||2|||f||||t||||||||||2017-10-11 00:02:24.513512|2017-10-11 00:02:24.513512
NCT02233751|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-07-20|||September 2014||2014-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetic Study of Testosterone|An Open-Label Study to Evaluate the Pharmacokinetics of Testosterone After Single-Dose Injection Via QuickShot® Testosterone in Healthy Male Subjects|Completed||Phase 1|12|Actual|Antares Pharma Inc.||2|||f||||f||||||||||2017-10-11 00:02:24.680147|2017-10-11 00:02:24.680147
NCT02233738|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-05-16|||September 22, 2015|Actual|2015-09-22|May 2017|2017-05-01|January 7, 2019|Anticipated|2019-01-07|March 1, 2018|Anticipated|2018-03-01||Interventional|GMI in Vets||Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services|Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services|Recruiting||N/A|186|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 00:02:24.785279|2017-10-11 00:02:24.785279
NCT02233725|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-02|||July 2014||2014-07-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance|Pilot-Study - Incorporating Contrast-Enhanced Ultrasound (CEUS) to Real-Tim MRI / Ultrasound Fusion Imaging for Prostate Biopsies|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 00:02:24.904945|2017-10-11 00:02:24.904945
NCT02233712|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-05|||August 1999||1999-08-01|September 2014|2014-09-01||||March 2000|Actual|2000-03-01||Interventional|GC3||Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.|An Open-label, Dose-finding, Schedule-changing, Multi-center Study to Determine the Antibody Response to G17DT Treatment of Patients With Gastric Cancer.|Completed||Phase 2|33|Actual|Cancer Advances Inc.||4|||||||t||||||||||2017-10-11 00:02:25.003964|2017-10-11 00:02:25.003964
NCT02233699|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-07-14|||July 2014||2014-07-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough|A Double-blind, Randomised, Placebo-controlled, Crossover Study to Assess the Efficacy of XEN-D0501, a Transient Receptor Potential Vanilloid Receptor 1 (TRPV1) Antagonist, in Reducing the Frequency of Cough in Patients With Chronic Idiopathic Cough.|Completed||Phase 2|18|Actual|Xention Ltd||2|||f||||f||||||||||2017-10-11 00:02:25.122651|2017-10-11 00:02:25.122651
NCT02233686|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-07-14|||February 2014||2014-02-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD|A Double-blind, Randomised, Placebo-controlled, Crossover Study to Assess the Efficacy of XEN-D0501, a Transient Receptor Potential Vanilloid Receptor 1 (TRPV1) Antagonist, in Reducing the Frequency of Cough in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|27|Actual|Xention Ltd||2|||f||||f||||||||||2017-10-11 00:02:25.23284|2017-10-11 00:02:25.23284
NCT02233673|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-04-24|||March 2014||2014-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women|Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women|Active, not recruiting||N/A|250|Anticipated|University of Vermont||2|||f||||f||||||||||2017-10-11 00:02:25.316979|2017-10-11 00:02:25.316979
NCT02233660|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-03-14|||September 2014||2014-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Role of the Cervical Spine in Carpal Tunnel Syndrome|Changes in Function, Cervical Range of Motion and Pinch Grip Force After Physical Therapy in Carpal Tunnel Syndrome: A Randomized Clinical Trial|Completed||N/A|100|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 00:02:25.402115|2017-10-11 00:02:25.402115
NCT02233647|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-09-26|2016-07-26||September 2014||2014-09-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||These are data for completing subjects only. Eleven subjects were enrolled (i.e., signed consent), but only data from completing subjects were included here and in the outcomes listed throughout this report.|Phendimetrazine and Cocaine|Safety and Tolerability of Cocaine During Phendimetrazine Maintenance|Completed||Early Phase 1|11|Actual|University of Kentucky||4|||f||||f||||||||||2017-10-11 00:02:25.574414|2017-10-11 00:02:25.574414
NCT02233634|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-04-18|||October 2014||2014-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CADOS-CMR||Impact of Breathing Maneuvers on the Oxygenation Supply of the Heart Assessed With MRI in Patients With Coronary Artery Disease|Impact of Breathing Maneuvers and Oxygen Administration on Myocardial Oxygenation in Patients With Coronary Artery Disease Compared With Healthy Controls - Non-invasive Assessment With Oxygenation-sensitive Cardiovascular Magnetic Resonance Imaging (OS-CMR)|Recruiting||N/A|36|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 00:02:27.373411|2017-10-11 00:02:27.373411
NCT02233621|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-03|||June 2012||2012-06-01|September 2014|2014-09-01||||October 2016|Anticipated|2016-10-01||Interventional|ENDOTEP||Assessment of Performance of [18F]-FES for Endometriosis Diagnosis|Evaluation Des Performances de la Tomographie Par Emission de Positons Avec la 16α-[18F]Fluoro-17β-estradiol ([18F]-FES) Pour le Diagnostic de l'Endometriose|Unknown status|Recruiting|Phase 2|100|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-11 00:02:27.498316|2017-10-11 00:02:27.498316
NCT02233608|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-08-22|||January 2015||2015-01-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|AFPX||Advanced Pelvic Floor Training Program for Prostate Cancer Surgery|A Randomized Pilot Study of Conventional Versus Advanced Pelvic Floor Exercises to Treat Urinary Incontinence After Radical Prostatectomy|Active, not recruiting||Phase 1/Phase 2|88|Anticipated|University of Guelph-Humber||2|||f||||f||||||||||2017-10-11 00:02:27.597994|2017-10-11 00:02:27.597994
NCT02233595|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-05-12|||October 2014||2014-10-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Observational|Rectal PET/MRI||Evaluation of Rectal Cancer Treatment Response Using PET/MRI|Evaluation of Rectal Cancer Treatment Response Using PET/MRI|Recruiting||N/A|20|Anticipated|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 00:02:27.679368|2017-10-11 00:02:27.679368
NCT02233582|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-09-09|||September 2014||2014-09-01|September 2014|2014-09-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude|Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude|Unknown status|Not yet recruiting|Phase 1|24|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:02:27.759968|2017-10-11 00:02:27.759968
NCT02233569|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-05|||November 2012||2012-11-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of Two Mesh/Fixation Concepts for Laparoscopic Ventral and Incisional Hernia Repair|COMPARISON OF TWO DIFFERENT CONCEPTS OF MESH AND FIXATION TECHNIQUE IN THE LAPAROSCOPIC OPERATIONS FOR VENTRAL AND INCISIONAL HERNIA - A RANDOMIZED CONTROLLED MONOCENTER TRIAL.|Terminated||N/A|50|Actual|Polish Hernia Study Group||2||"The high recurrence rate and the findings during the reoperations were considered as serious   adverse events and were the reason for study termination."|f||||t||||||||||2017-10-11 00:02:27.860747|2017-10-11 00:02:27.860747
NCT02233556|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-12-10|||February 2014||2014-02-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects|Effects of Memantine on Event-related Potential in the Comparison of Patients With Early Schizophrenia and Healthy Subjects|Recruiting||N/A|20|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:02:27.975118|2017-10-11 00:02:27.975118
NCT02233530|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-30|2014-09-03|||September 2014||2014-09-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|April 2015|Anticipated|2015-04-01||Interventional|IDEA||IDEA Study Cognitive Stimulation Therapy (CST) Trial in Nigeria|Identification and Intervention for Dementia in Elderly Africans (IDEA) Study: CST Trial|Unknown status|Enrolling by invitation|N/A|8|Anticipated|Northumbria Healthcare NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:02:28.140943|2017-10-11 00:02:28.140943
NCT02233504|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2016-09-23|||August 2014||2014-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox)|Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox)|Recruiting||N/A|25|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 00:02:30.141304|2017-10-11 00:02:30.141304
NCT02233491|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-11-30|||February 2015||2015-02-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|CAVIAR||Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients|A Prospective, Randomised Controlled Trial Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients|Recruiting||N/A|130|Anticipated|University Hospital Birmingham NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:02:30.231323|2017-10-11 00:02:30.231323
NCT02233478|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-03-13|||August 2014||2014-08-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparing the Effect of Whey and Soy Protein on the Absorption of Pomegranate Polyphenols in the Human Body|Dietary Protein in Pomegranate Ellagitannin Bioavailability|Completed||Phase 3|18|Actual|University of California, Los Angeles||3|||f||||f||||||||||2017-10-11 00:02:30.353143|2017-10-11 00:02:30.353143
NCT02233452|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-09-05|||January 2012||2012-01-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Methadone and Ketamine for Neuropathic Pain Treatment|Management of Neuropathic Chronic Pain With Methadone Combined With Ketamine: Randomized, Double Blind, Active-controlled Clinical Trial|Completed||Phase 4|37|Actual|Universidade Federal de Santa Maria||3|||f||||t||||||||||2017-10-11 00:02:30.570693|2017-10-11 00:02:30.570693
NCT02233439|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-05|||September 2014||2014-09-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|||Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues|Efficacy of Herbal Galactogogues: a Double-blinded, Placebo-controlled Randomized Trial.|Unknown status|Not yet recruiting|N/A|210|Anticipated|Università degli Studi dell'Insubria||3|||f||||f||||||||||2017-10-11 00:02:30.68729|2017-10-11 00:02:30.68729
NCT02233426|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-03|||September 2014||2014-09-01|September 2014|2014-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|hypertonic||Effect of Hypertonic Solutions on Allergic Rhinitis Patients|Do Hypertonic Solutions Have an Impact on Nasal Eosinophilia in Allergic Rhinitis Patients?|Unknown status|Not yet recruiting|N/A|1000|Anticipated|Namik Kemal University|||1||f||||f||||||||||2017-10-11 00:02:30.799827|2017-10-11 00:02:30.799827
NCT02233413|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-07-19|||June 2014||2014-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|LLLT for TBI||Light Therapy for Moderate Traumatic Brain Injury|Low Level Light Therapy (LLLT) With Near Infrared Light Emitting Diodes in Patients With Moderate Traumatic Brain Injury (TBI)|Recruiting||N/A|90|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:02:30.895088|2017-10-11 00:02:30.895088
NCT02233400|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2014-09-05|||February 2013||2013-02-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||A Trial of the Cost Effectiveness of IV Acetaminophen in Bariatric Surgery|IV Acetaminophen Results in Lower Hospital Costs and Emergency Room Visits Following Bariatric Surgery: A Double-Blind Prospective Randomized Trial in A Single Accredited Bariatric Center|Completed||Phase 4|113|Actual|St. Luke's Hospital and Health Network, Pennsylvania||2|||f||||f||||||||||2017-10-11 00:02:31.003377|2017-10-11 00:02:31.003377
NCT02233387|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-01-27|||November 2014||2014-11-01|January 2016|2016-01-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|HX4-cervix||PET CT With HX4 in Cervix Cancer|Non Invasive Imaging of [18F]HX4 With Positron-Emission-Tomography (PET) in Cervix Cancer.|Recruiting||Phase 2|20|Anticipated|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-10-11 00:02:31.252554|2017-10-11 00:02:31.252554
NCT02233374|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-02-11|||September 2014||2014-09-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRISM||Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET|Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET|Recruiting||N/A|44|Anticipated|Royal North Shore Hospital||1|||f||||t||||||||No||2017-10-11 00:02:31.380526|2017-10-11 00:02:31.380526
NCT02233361|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-09-03|||January 2014||2014-01-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Use of Hearing Aids. Development and Implementation of a Counselling Program for Hearing Aid Users|Use of Hearing Aids. Development and Implementation of a Counselling Program for Hearing Aid Users.|Unknown status|Recruiting|N/A|280|Anticipated|Lovisenberg Diakonale Hospital||2|||f||||f||||||||||2017-10-11 00:02:31.49912|2017-10-11 00:02:31.49912
NCT02233348|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-03-13|||January 2015||2015-01-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Neurocognitive and Psychosocial Outcome of Youths With Autism Spectrum Disorder|Neurocognitive and Psychosocial Outcome of Youths With Autism Spectrum Disorder: a Follow-up Study|Recruiting||N/A|523|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples With DNA|"     The subjects will receive blood withdrawal. The blood sample will be used for establishing     lymphoblastoid cell lines, which will be used for molecular genetic experiments   "|||2017-10-11 00:02:31.614227|2017-10-11 00:02:31.614227
NCT02233335|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-02|||June 2013||2013-06-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||The Factors Associated With the Recurrence in Patients With Cushing Disease|The Factors Associated With the Recurrence in Patients With Cushing Disease|Completed||N/A|42|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:02:31.71536|2017-10-11 00:02:31.71536
NCT02233322|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-08-09|||August 2014||2014-08-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.|Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot|Recruiting||N/A|8|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-11 00:02:31.789803|2017-10-11 00:02:31.789803
NCT02233309|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-05-13|2015-05-13||April 2014||2014-04-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||A Prospective Observational Study of Epidural Pressures During Caudal Epidural in the Pediatric Population|Epidural Pressure Changes Following Caudal Blockade: A Prospective Observational Study|Completed||N/A|36|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:02:31.944083|2017-10-11 00:02:31.944083
NCT02233296|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-08-19|2016-02-02||January 2015||2015-01-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional||healthy male and female volunteers aged 18-|Food-Effect Study in Healthy Subjects|A Randomized Open Label Study to Compare the Bioavailability of Lasmiditan 200 mg Under Fed and Fasted Conditions in Healthy Male and Female Subjects|Completed||Phase 1|30|Actual|CoLucid Pharmaceuticals||2|||f||||f||||||||No||2017-10-11 00:02:32.223695|2017-10-11 00:02:32.223695
NCT02233283|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-08-20|||January 2014||2014-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|Polynut||Effect of Modifications of Nutritional Intake Upon Reproductive Hormones in Normal Women|Effect of Metabolic Variations Upon the Activity of the Neuroendocrine Reproductive Axis in Normal Female Volunteers|Completed||N/A|9|Actual|Centre Hospitalier Universitaire Vaudois||4|||f||||f||||||||||2017-10-11 00:02:32.685562|2017-10-11 00:02:32.685562
NCT02233270|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-07-26|||July 2013||2013-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|AEGIS||Pilot of AbStats /AEGIS System for Detecting Motility Abnormalities|Validation of the AbStats Belt and Acoustic Esophago-Gastro-Intestinal Surveillance (AEGIS) System for Analyzing Motility Abnormalities|Active, not recruiting||N/A|10|Actual|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-11 00:02:33.220294|2017-10-11 00:02:33.220294
NCT02233244|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-10-09|||September 2014||2014-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam|A Phase 1, Open-Label, Two-Period, Fixed-Sequence, Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam in Healthy Adult Subjects|Completed||Phase 1|20|Actual|Celtaxsys, Inc.||1|||f||||f||||||||||2017-10-11 00:02:33.403032|2017-10-11 00:02:33.403032
NCT02233231|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-09-04|||August 2011||2011-08-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment|Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment|Completed||Phase 4|52|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 00:02:33.511925|2017-10-11 00:02:33.511925
NCT02233218|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-02-16|||July 2014||2014-07-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers|A Phase 1, Open Label, Non-randomized, Two-cohort, Single-sequence, Crossover Study to Investigate the Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers|Completed||Phase 1|60|Actual|Yuhan Corporation||2|||f||||f||||||||||2017-10-11 00:02:33.602202|2017-10-11 00:02:33.602202
NCT02233205|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2015-07-23|||October 2014||2014-10-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System|Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Liver Metastases From Gastrointestinal Tumors and Pancreatic Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|18|Anticipated|Beijing Cancer Hospital||1|||f||||t||||||||||2017-10-11 00:02:33.716691|2017-10-11 00:02:33.716691
NCT02233192|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-07-05|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Observational|||PrEPception: Expanding Assisted Reproductive Options for Serodiscordant Couples|PrEPception: Expanding Assisted Reproductive Options for Serodiscordant Couples|Completed||N/A|50|Actual|Boston Medical Center|||1||f||||f|f|f||||Samples Without DNA|"     To measure levels of PrEP to assess medication adherence, approximately 4ml of blood will be     drawn on female participants (2 tests total for the study period). One dried blood spot will     be collected after steady state tenofovir (approximately one month after beginning PrEP) is     reached and one at the time a pregnancy is confirmed.   "|||2017-10-11 00:02:33.875308|2017-10-11 00:02:33.875308
NCT02233179|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-09-03|||June 2009||2009-06-01|September 2014|2014-09-01|November 2012|Actual|2012-11-01|August 2011|Actual|2011-08-01||Interventional|||The Association Between Unprotected Standing, Walking and Wound Healing in Diabetes|Body-worn Sensor Technology for Improving Diabetic Care During Activities of Daily Living|Completed||N/A|49|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 00:02:34.061845|2017-10-11 00:02:34.061845
NCT02233166|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-08-22|||August 2014||2014-08-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||OSA in Children Referred for Adenotonsillectomy|Obstructive Sleep Apnea in Children Referred for Adenotonsillectomy|Recruiting||N/A|115|Anticipated|Lovisenberg Diakonale Hospital|||1||f||||f||||||Samples Without DNA|"     Blood sample   "|||2017-10-11 00:02:34.206188|2017-10-11 00:02:34.206188
NCT02233153|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-04-21|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|EASE||Elder-friendly Approaches to the Surgical Environment (EASE) Study|Elder-friendly Approaches to the Surgical Environment - Implementation of an Elder Friendly Surgical Unit|Active, not recruiting||N/A|723|Actual|University of Alberta|||4||f||||f|f|f||||||No||2017-10-11 00:02:34.3145|2017-10-11 00:02:34.3145
NCT02233140|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-08-26|||October 2014||2014-10-01|August 2015|2015-08-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Effectiveness of Manual Manipulation With EPAT on Ankle Dorsiflexion and Dynamic Plantar Pressure|Do Physical Manipulation Exercises With EPAT Improve Ankle Dorsiflexion and Reduce Dynamic Plantar Forefoot Pressure in Diabetic Subjects With Equinus?: A Pilot RCT|Unknown status|Recruiting|N/A|48|Anticipated|Temple University||2|||f||||f||||||||||2017-10-11 00:02:34.994994|2017-10-11 00:02:34.994994
NCT02233127|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-04-24|||October 2014||2014-10-01|April 2017|2017-04-01|July 22, 2016|Actual|2016-07-22|July 22, 2016|Actual|2016-07-22||Observational|||Birth Cohort in Rahimyar Khan, Pakistan|A Longitudinal Birth Cohort Study in Rahimyar Khan, Pakistan|Completed||N/A|2271|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 00:02:35.186288|2017-10-11 00:02:35.186288
NCT02233114|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-01-27|||January 2015||2015-01-01|September 2015|2015-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Is Patients With Pulmonary Disease Benefit a Program With Yogic Exercises?|Subjective and Objective Effects After Yogic Exercises|Completed||N/A|40|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:02:35.313082|2017-10-11 00:02:35.313082
NCT02233101|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-03-20|2017-03-20||June 2014||2014-06-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Oral vs. Intravenous TXA Study Proposal: TJA|Oral vs. Intravenous TXA Study Proposal: TJA|Completed||N/A|178|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 00:02:35.424526|2017-10-11 00:02:35.424526
NCT02233088|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-11-18|||July 2014||2014-07-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|3ELM||A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome (3ELM Study)|A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome|Unknown status|Active, not recruiting|Phase 1/Phase 2|48|Anticipated|Rush University Medical Center||3|||f||||t||||||||||2017-10-11 00:02:35.861309|2017-10-11 00:02:35.861309
NCT02233075|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2017-09-26|||September 2014||2014-09-01|February 2017|2017-02-01|May 2017|Actual|2017-05-01|November 2016|Actual|2016-11-01||Interventional|||REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection|A Study of the Safety and Efficacy of Combination Treatment With REP 2139-Ca and Pegasys™ in Patients With Hepatitis B / Hepatitis D Co-infection|Completed||Phase 2|12|Actual|Replicor Inc.||1|||f||||f||||||||||2017-10-11 00:02:36.040719|2017-10-11 00:02:36.040719
NCT02233062|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-05|||May 2013||2013-05-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Impact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Patients With Crohn's Disease|Impact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Male Patients With Crohn's Disease|Completed||N/A|12|Actual|Jinling Hospital, China||1|||f||||f||||||||||2017-10-11 00:02:36.175662|2017-10-11 00:02:36.175662
NCT02233049|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-06-08|||October 2014||2014-10-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|BIOMEDE||Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication|Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication|Recruiting||Phase 2|250|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||4|||f||||t||||||||||2017-10-11 00:02:36.25926|2017-10-11 00:02:36.25926
NCT02233036|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2017-06-30|||March 26, 2014||2014-03-26|January 10, 2017|2017-01-10|January 10, 2017|Actual|2017-01-10|January 11, 2016|Actual|2016-01-11||Observational|||Evaluating the Transition From Pediatric to Adult Care Among Adolescents With Chronic Granulomatous Disease|Evaluating the Transition From Pediatric to Adult Care Among Adolescents With Chronic Granulomatous Disease|Completed||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:02:36.423716|2017-10-11 00:02:36.423716
NCT02233023|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-04|||June 1998||1998-06-01|September 2014|2014-09-01||||June 2000|Actual|2000-06-01||Interventional|||Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease|Matched Pair, Assessor Blinded, Open Label Clinical Trial to Assess the Ophthalmologic Safety of Long Term Oral Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease|Completed||Phase 4|705|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:02:36.51228|2017-10-11 00:02:36.51228
NCT02233010|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-05|||February 2014||2014-02-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Observational|||Usefulness of Neutrophil Gelatinase-associated Lipocalin(NGAL) to Confirm Acute Kidney Function Decrease of the Patients Who Had Non-cardiac Surgery||Completed||N/A|43|Actual|Inje University|||2||f||||||||||||||2017-10-11 00:02:36.62444|2017-10-11 00:02:36.62444
NCT02232997|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-08-20|||April 2015||2015-04-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|TIME||The optImal Hydration With sodiuM chloridE in High Risk Patients Undergoing Coronary Angiography|The optImal Hydration With sodiuM chloridE in High Risk Patients Undergoing Coronary Angiography, REduction of riSk of Contrast-Induced Nephropathy After carDiac Catheterization 2 (TIME RESCIND 2) Study|Unknown status|Recruiting|N/A|1400|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-10-11 00:02:37.574831|2017-10-11 00:02:37.574831
NCT02232971|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-03-24|||September 2014||2014-09-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|January 2015|Actual|2015-01-01||Interventional|GluST1||Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes|Treatment of Hypoglycemia With Glucagon Among Patients With Type 1 Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 4|8|Anticipated|Hvidovre University Hospital||4|||f||||t||||||||||2017-10-11 00:02:37.917391|2017-10-11 00:02:37.917391
NCT02232958|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-07-09|||September 2014||2014-09-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|HBO||Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease|The Effect of Hyperbaric Oxygen on the Functional Connectivity of Resting State Neural Networks in Patients With Cerebral Small Vessel Disease|Recruiting||N/A|20|Anticipated|St. Luke's Hospital, Chesterfield, Missouri||1|||f||||f||||||||No||2017-10-11 00:02:38.036795|2017-10-11 00:02:38.036795
NCT02232945|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2016-03-02|||April 2012||2012-04-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|BLG||Banlangen Granules Anti-seasonal Influenza Study|Banlangen Granules Anti-seasonal Influenza Study: a Randomized, Double Blind, Positive and Placebo Controlled，Clinical Study.|Recruiting||Phase 4|177|Anticipated|Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited||3|||f||||t||||||||||2017-10-11 00:02:38.134527|2017-10-11 00:02:38.134527
NCT02232932|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-09-07|||March 2014||2014-03-01|December 2016|2016-12-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|TRANSPHIL||Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma|Randomized Prospective Multicentric Study: Radio-chemotherapy and Liver Transplantation Versus Liver Resection to Treat Respectable Hilar Cholangiocarcinoma|Recruiting||N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:02:38.242916|2017-10-11 00:02:38.242916
NCT02232919|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-09-28|||April 2014||2014-04-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|BLESS||Deep Brain Stimulation for Human Morbid Obesity|Hypothalamus Deep Brain Stimulation for Human Morbid Obesity: Feasibility Trial|Completed||Phase 1|6|Actual|Hospital do Coracao||1|||f||||t||||||||||2017-10-11 00:02:38.361109|2017-10-11 00:02:38.361109
NCT02232906|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2014-09-03|||March 2011||2011-03-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)|Pilot Open Label Study to Evaluate Intravenous Ferric Carboxymaltose (Ferinject ®) in Patients With CKD (Pre-dialysis) With Anemia Treated With Epo and Oral Iron in Buenos Aires, Argentina|Completed||Phase 4|30|Actual|Hospital Aleman||1|||f||||f||||||||||2017-10-11 00:02:38.437128|2017-10-11 00:02:38.437128
NCT02232893|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-06-21|||October 2014||2014-10-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|TU100P2T3||Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy|A Randomized, Double-Blinded, Placebo-Controlled Trial of TU-100 in Patients Undergoing Laparoscopic Colectomy|Completed||Phase 2|69|Actual|Tsumura USA||2|||f||||t||||||||||2017-10-11 00:02:38.514187|2017-10-11 00:02:38.514187
NCT02232880|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-12-14|2016-07-14||August 2014||2014-08-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation|Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation|Terminated||Phase 2|1|Actual|Vanderbilt University Medical Center|No patients received treatment prior to study termination.|2||failure to recruit|f||||t||||||||Undecided||2017-10-11 00:02:38.752493|2017-10-11 00:02:38.752493
NCT02232867|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-02|||July 2011||2011-07-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Arm and Leg Cycling Exercise After Stroke|Adjunct Locomotor Training to Improve Walking Ability After Stroke|Unknown status|Recruiting|N/A|20|Anticipated|University of Victoria||1|||f||||f||||||||||2017-10-11 00:02:38.979939|2017-10-11 00:02:38.979939
NCT02232854|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-05-11|||April 2014||2014-04-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Training and Supervision Program for Depression Management|Comprehensive Technology-Assisted Training and Supervision Program to Enhance Depression Management in Primary Care|Active, not recruiting||N/A|434|Anticipated|University of Chile||2|||f||||f||||||||||2017-10-11 00:02:39.103122|2017-10-11 00:02:39.103122
NCT02232841|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-01-30|||September 2014||2014-09-01|July 2016|2016-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Electrical Impedance Imaging of Patients on Mechanical Ventilation|Pilot Study: Electrical Impedance Imaging of Patients on Mechanical Ventilation With Lung Pathology|Completed||N/A|2|Actual|Colorado State University|||1||f||||t||||||||||2017-10-11 00:02:39.190255|2017-10-11 00:02:39.190255
NCT02232828|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-07-27|||October 2014||2014-10-01|July 2015|2015-07-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Selective or Stepwise Removal of Deep Caries|Selective or Stepwise Removal of Deep Caries in Deciduous Molars: A Multi-center Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:02:39.281112|2017-10-11 00:02:39.281112
NCT02232815|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-09-06|||December 2014||2014-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Observational|||CELTIC Bifurcation Study|A Randomized Multicentre Trial to Compare Outcomes for Patients With Ischaemic Heart Disease and Bifurcation Coronary Artery Lesions Who Are Treated With Xience or Synergy Stents|Recruiting||N/A|170|Anticipated|European Cardiovascular Research Center|||1||f||||||||||||||2017-10-11 00:02:39.405397|2017-10-11 00:02:39.405397
NCT02232802|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-01-14|||August 2014||2014-08-01|September 2014|2014-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.|Comparative, Randomized, Single-dose, 2-way Cross Over Bioavailability Study of Enoxaparin Sodium Chemi (80 mg/0.8mL) and Clexane® (80 mg/0.8mL) s.c. in Healthy Adult Subjects Under Fasting Conditions.|Completed||Phase 1|46|Actual|Chemi S.p.A.||2|||f||||f||||||||||2017-10-11 00:02:39.514524|2017-10-11 00:02:39.514524
NCT02232789|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-12-03|||September 2014||2014-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Abuse Liability and Human Pharmacology of Mephedrone|Abuse Liability and Human Pharmacology of Mephedrone (4-methylmethcathinone,4-MMC)|Completed||Phase 1|12|Actual|Parc de Salut Mar||3|||f||||t||||||||||2017-10-11 00:02:39.595895|2017-10-11 00:02:39.595895
NCT02232776|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-07-12|||October 2014||2014-10-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy and Safety of Losartan in Children With Ig A Nephropathy|A Prospective Study Evaluating the Efficacy and Safety of Losartan in Children With Immunoglobulin A Nephropathy|Active, not recruiting||Phase 3|37|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 00:02:39.704568|2017-10-11 00:02:39.704568
NCT02232763|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-07-12|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria|A Prospective, Randomized, Cross-over Study Evaluating the Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria|Active, not recruiting||Phase 3|58|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:02:39.796971|2017-10-11 00:02:39.796971
NCT02232750|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-09-02|||August 2014||2014-08-01|September 2014|2014-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|Beckman||Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)|Evaluation of CPD (Cell Population Data) MNV (Mean Neutrophil Volume) as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)|Recruiting||N/A|1500|Anticipated|Ohio State University|||1||f||||t||||||||||2017-10-11 00:02:39.884059|2017-10-11 00:02:39.884059
NCT02232737|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-10-04|||October 2016||2016-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders|Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders|Recruiting||Phase 1/Phase 2|282|Anticipated|Brown University||3|||f||||t||||||||||2017-10-11 00:02:39.95631|2017-10-11 00:02:39.95631
NCT02232711|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-07-23|||November 2014||2014-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting|Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting|Completed||N/A|1082|Actual|BioFire Diagnostics, LLC|||1||f||||f||||||Samples With DNA|"     Nasopharyngeal swab (NPS) specimens   "|||2017-10-11 00:02:40.176579|2017-10-11 00:02:40.176579
NCT02232698|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-02-27|2017-01-06||September 2014||2014-09-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|IMPACT|2 pregnant subjects (1 in each group) were excluded from all efficacy analysis (as stated in the protocol).|An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT)|Randomised Controlled Study to Evaluate the Impact of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes|Completed||N/A|328|Actual|Abbott Diabetes Care||2|||f||||f||||||||||2017-10-11 00:02:40.285345|2017-10-11 00:02:40.285345
NCT02232685|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-10-10|||September 2014||2014-09-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer|Whole Body Bone Scan vs 18F-Choline PET/CT, Better Detection of Bone Metastases in Prostate Cancer Patients, PROSTAGE I|Completed||N/A|143|Actual|Odense University Hospital||1|||f||||t||||||||||2017-10-11 00:02:41.028083|2017-10-11 00:02:41.028083
NCT02232659|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-01-23|||February 2016|Actual|2016-02-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|RA-540||SynCardia 70cc TAH-t for Destination Therapy (DT)|SynCardia 70cc Temporary Total Artificial Heart (TAH-t) for Destination Therapy (DT)|Recruiting||N/A|38|Anticipated|SynCardia Systems. LLC||2|||f||||t||||||||||2017-10-11 00:02:41.22918|2017-10-11 00:02:41.22918
NCT02232646|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-07-07|||January 2017||2017-01-01|July 2017|2017-07-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies|A Phase II Clinical Study of BBI503 in Adult Patients With Advanced Urologic Malignancies|Withdrawn||Phase 2|0|Actual|Boston Biomedical, Inc||1||Low feasibility|f||||f||||||||||2017-10-11 00:02:41.34312|2017-10-11 00:02:41.34312
NCT02232633|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-07-11|||February 2015||2015-02-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer|A Phase II Clinical Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer|Recruiting||Phase 2|60|Anticipated|Boston Biomedical, Inc||1|||f||||f||||||||||2017-10-11 00:02:41.416693|2017-10-11 00:02:41.416693
NCT02232620|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-07-07|||March 13, 2017|Actual|2017-03-13|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors|A Phase II Clinical Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors|Recruiting||Phase 2|30|Anticipated|Boston Biomedical, Inc||1|||f||||f|t|f|||t|||||2017-10-11 00:02:41.504383|2017-10-11 00:02:41.504383
NCT02232607|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-04|||April 1998||1998-04-01|September 2014|2014-09-01||||June 1999|Actual|1999-06-01||Interventional|||Efficacy and Safety of Lacidipine in Chronic Stable Angina|A Randomised, Double-blind, Placebo-controlled, Multi-centre, Parallel Group, Dose Ranging Study to Investigate the Efficacy and Safety of Lacidipine in Chronic Stable Angina.|Completed||Phase 2|283|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:02:41.594606|2017-10-11 00:02:41.594606
NCT02232594|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-04|||January 2000||2000-01-01|September 2014|2014-09-01||||December 2000|Actual|2000-12-01||Observational|||Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease|Postmarketing Surveillance Study (as Per § 67 (6) AMG [German Drug Law]) of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease|Completed||N/A|834|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:41.679554|2017-10-11 00:02:41.679554
NCT02232581|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-04|||April 2004||2004-04-01|August 2014|2014-08-01||||December 2004|Actual|2004-12-01||Interventional|||Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure|Randomised, Double Blind, Placebo-controlled Dose Ranging Trial to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure|Completed||Phase 2|72|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:02:41.752978|2017-10-11 00:02:41.752978
NCT02232568|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-07-20|||September 2014||2014-09-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|April 2016|Anticipated|2016-04-01||Interventional|TOFU||Trial of Feedback on Blood Use|Trial of Feedback on Blood Use|Unknown status|Recruiting|N/A|40|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 00:02:41.848679|2017-10-11 00:02:41.848679
NCT02232555|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-04|||May 2005||2005-05-01|August 2014|2014-08-01||||May 2006|Actual|2006-05-01||Interventional|||Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain|A Ten-week, Randomized, Double-blind Study Evaluating the Efficacy of Duloxetine 60 mg Once Daily Versus Placebo in Outpatients With Major Depressive Disorder and Pain (EU-Pain Enriched Study)|Completed||Phase 3|327||Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:02:41.964282|2017-10-11 00:02:41.964282
NCT02232542|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-04|2014-09-04|||June 2003||2003-06-01|August 2014|2014-08-01||||August 2003|Actual|2003-08-01||Interventional|||Tolerability and Safety of Duloxetine BID in Healthy Female Subjects|Tolerability and Safety of 40 mg and 100 mg Duloxetine BID Given Over 7 Days in Healthy Female Subjects. A Randomised, Placebo-controlled Double-blind Trial.|Completed||Phase 1|32|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:02:42.053011|2017-10-11 00:02:42.053011
NCT02232529|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-02-23|||September 2014||2014-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pharmacokinetic Study of MIN-101 in Healthy Subjects|A Two-Part Study Designed to Evaluate the Pharmacokinetic Profile of MIN-101 and Its Main Metabolites Following Single and Multiple Dose Modified Release Prototype Formulation Administration in Healthy Cytochrome P450 2D6 Extensive Metabolizer Male and Female Subjects, and to Evaluate the Relationship Between the Pharmacokinetic Profile of MIN-101 and Its Main Metabolites and Cardiovascular Parameters.|Completed||Phase 1|32|Actual|Minerva Neurosciences||4|||f||||f||||||||||2017-10-11 00:02:42.254562|2017-10-11 00:02:42.254562
NCT02232516|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-01-03|||June 2015||2015-06-01|January 2017|2017-01-01||||July 2018|Anticipated|2018-07-01||Interventional|||Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma|Phase II Study of Romidepsin Plus Lenalidomide for Patients With Previously Untreated PTCL|Recruiting||Phase 2|35|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 00:02:42.365146|2017-10-11 00:02:42.365146
NCT02232503|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-09-21|||February 2015||2015-02-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|DIARET SK||Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia|DIARET SK - Prevalence of Diabetic Retinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in Slovakia|Completed||N/A|4011|Actual|Novartis|||1||f||||f||||||Samples With DNA|"     For the purpose of DNA isolation prior to genetic analysis two samples of peripheral blood     will be taken. Tubes with sampled material will be stored under temperature of 2 - 8°C and in     the least possible time delivered to the laboratory where DNA will be isolated. Of all the     samples delivered to the laboratory, DNA will be extracted using the automated isolation     method. From the second sample related to the genetic analysis also the plasma will be     obtained and stored at -20°C. The DNA sample is then divided into two aliquot parts which     will be stored separately for future analysis in order to decrease the risk of their     impairment. DNA isolated from cells of biological material will be properly stored prior to     further analysis. DNA will be archived by its freezing to -80°C, a temperature in which the     characteristics are maintained for several decades.   "|||2017-10-11 00:02:42.532686|2017-10-11 00:02:42.532686
NCT02232490|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-04-10|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|Hepko-V5||Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L|Phase III Randomized, Placebo-controlled Clinical Trial of Hepcortespenlisimut-L (Hepko-V5) Versus Placebo in Patients With Advanced Hepatocellular Carcinoma (HCC)|Recruiting||Phase 3|120|Anticipated|Immunitor LLC||2|||f||||t|f|f||||||Yes|DATA TO BE SHARED WITH COLLABORATORS|2017-10-11 00:02:42.628735|2017-10-11 00:02:42.628735
NCT02232477|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-05-05|||May 2014||2014-05-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS I|An Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in Mucopolysaccharidosis I|Enrolling by invitation||N/A|16|Anticipated|Los Angeles Biomedical Research Institute||1|||f||||t||||||||||2017-10-11 00:02:42.775939|2017-10-11 00:02:42.775939
NCT02232464|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-03-16|||January 2014||2014-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Disturbed Structural Connectivity of Frontostriatal and Frontoparietal Networks in Adults With ADHD|Disturbed Structural Connectivity of Frontostriatal and Frontoparietal Networks in Adults With Attention-deficit Hyperactivity Disorder|Completed||N/A|90|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 00:02:42.872725|2017-10-11 00:02:42.872725
NCT02232451|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-09-23|||November 2010||2010-11-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|June 2012|Actual|2012-06-01||Interventional|loop||Comparison of Loop-tip Cook Medical® Wire Versus Traditional Endoscopic Technique|Comparison of Loop-tip Cook Medical® Wire vs Traditional Endoscopic Technique Cannulation in the Prevention of Post-ercp Pancreatitis and Biliary Tree Access in High-risk Patients|Completed||N/A|320|Actual|Azienda Ospedaliera San Paolo||2|||f||||f||||||||||2017-10-11 00:02:42.963069|2017-10-11 00:02:42.963069
NCT02232438|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-10-05|||January 2015||2015-01-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Psychotherapy for Depressed or Anxious Adolescents With Cancer|Open Trial of Behavioral Activation Therapy for Depressed or Anxious Adolescents With Cancer|Withdrawn||N/A|0|Actual|New York State Psychiatric Institute||1||No participants enrolled.|f||||t||||||||||2017-10-11 00:02:43.056484|2017-10-11 00:02:43.056484
NCT02232425|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2016-09-22||2016-09-21|September 2014||2014-09-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)|An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation|Completed||Phase 2|88|Actual|Ixchelsis Limited||2|||f||||f||||||||||2017-10-11 00:02:43.162236|2017-10-11 00:02:43.162236
NCT02232412|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-03-30|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Monitoring the Effect of Red Blood Cell Transfusion on Cerebral Oxygen Saturation With Near Infrared Spectroscopy (NIRS) in Critically Ill Patients|Monitoring the Effect of Red Blood Cell Transfusion on Cerebral Oxygen Saturation With Near Infrared Spectroscopy (NIRS) in Critically Ill Patients|Completed||N/A|25|Actual|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-10-11 00:02:43.326779|2017-10-11 00:02:43.326779
NCT02232399|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-04-25|||October 2014||2014-10-01|April 2017|2017-04-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|MiLe-1||Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?|The Prophylactic Effect of Levosimendan in Reducting Acute Kidney Injury Postoperatively in Pediatric Patients Undergoing Corrective Heart Surgery|Completed||Phase 2|72|Actual|Göteborg University||2|||f||||t||||||||||2017-10-11 00:02:43.4193|2017-10-11 00:02:43.4193
NCT02232386|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-08-31|||February 2015||2015-02-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia|A Phase 2 Multicenter Study to Assess the Activity and the Safety of Front-line Ibrutinib Plus Rituximab (IR) in Unfit Patients With Chronic Lymphocytic Leukemia (CLL).|Active, not recruiting||Phase 2|156|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-11 00:02:43.539755|2017-10-11 00:02:43.539755
NCT02232373|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-05-12|||August 2014||2014-08-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|CEDRIC||Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates|A Pilot Double Blind, Randomised, Placebo Controlled Trial of the Effect of a Diet Low in Poorly Digested Carbohydrates on Symptoms of Post-infective Bowel Dysfunction|Terminated||N/A|9|Actual|University of Nottingham||2||Failure to recruit|f||||f||||||||No||2017-10-11 00:02:43.732758|2017-10-11 00:02:43.732758
NCT02232360|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-08-22|||January 2014||2014-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone|The Comparative Analysis of the Effects on Plaque Volume and Tissue Characteristics Between Combined Therapy With STAatin Plus FENOfibrate and Statin Alone in Mild to Moderate, Non- Intervened Coronary Artery Stenosis (STAFENO Trial)|Recruiting||Phase 3|160|Anticipated|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 00:02:43.863191|2017-10-11 00:02:43.863191
NCT02232347|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-02|||October 2014||2014-10-01|September 2014|2014-09-01|May 2017|Anticipated|2017-05-01|October 2016|Anticipated|2016-10-01||Interventional|KETABRAIN||Ketamine and Glutamate After Brain Injury : a Microdialysis Study|Effect of Ketamine Versus Sufentanil on Cerebral Glutamate After Traumatic Brain Injury : a Randomized, Double-blinded, Microdialysis Study|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Direction Centrale du Service de Santé des Armées||2|||f||||t||||||||||2017-10-11 00:02:44.012828|2017-10-11 00:02:44.012828
NCT02232334|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-03-30|||September 2014||2014-09-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of Global Osteopathic Manual Treatments in Patients With Idiopathic Gastroparesis|Effects of Global Osteopathic Manual Treatments on Patients With Idiopathic Gastroparesis|Unknown status|Recruiting|N/A|12|Anticipated|Kathleen Brannan Brown, Inc.||2|||f||||f||||||||||2017-10-11 00:02:44.144448|2017-10-11 00:02:44.144448
NCT02231567|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-01-03|||September 2014||2014-09-01|January 2016|2016-01-01||||December 2014|Actual|2014-12-01||Interventional|||Neurocognitive Rehabilitation After Hip Replacement|Effectiveness of Neurocognitive Rehabilitation in Pain Management and Functional Recovery After Hip Replacement: Randomized Controlled Trial|Suspended||N/A|54|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 00:02:54.916164|2017-10-11 00:02:54.916164
NCT02232321|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-07-26|||March 2014||2014-03-01|July 2016|2016-07-01||||October 2017|Anticipated|2017-10-01||Interventional|||Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort Study|Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort Study|Active, not recruiting||N/A|100|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 00:02:44.24908|2017-10-11 00:02:44.24908
NCT02232308|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-04-28|||July 2014||2014-07-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects|Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects|Completed||Phase 1|24|Actual|Mayo Clinic||4|||f||||f||||||||||2017-10-11 00:02:44.346014|2017-10-11 00:02:44.346014
NCT02232295|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-04|||April 2013||2013-04-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||A Clinical Trial to Study the Effect of Imagined Progressive Movements in Patients With Paralysis of One Side of the Body.|To Study the Effect of Graded Motor Imagery on Upper Limb Motor Functions and Quality of Life in Patients With Stroke|Completed||N/A|26|Actual|Maharishi Markendeswar University||2|||f||||t||||||||||2017-10-11 00:02:44.478513|2017-10-11 00:02:44.478513
NCT02232282|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-08-29|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial|Acupuncture for Female Interstitial Cystitis/Painful Bladder Syndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|Loyola University||2|||f||||f||||||||||2017-10-11 00:02:44.610206|2017-10-11 00:02:44.610206
NCT02232256|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-04-24|||December 2015|Actual|2015-12-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|CALPXT96||The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain|A Phase 3 Double Blind, Randomized, Placebo Controlled, Cross-Over Trial to Asses the Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain|Withdrawn||Phase 3|0|Actual|9305-9954 Quebec Inc||2||Site unable to enrol recruited subjects|f||||f||||||||||2017-10-11 00:02:44.866469|2017-10-11 00:02:44.866469
NCT02232243|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-03-09|||July 2015||2015-07-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors|A Pilot Study to Determine the Biological Effects of Hydroxychloroquine on PAR-4 Levels in Patients With Resectable Solid Tumors|Recruiting||Phase 1|18|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-10-11 00:02:44.985409|2017-10-11 00:02:44.985409
NCT02232230|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-07-13|||June 2014||2014-06-01|July 2016|2016-07-01||||June 2017|Anticipated|2017-06-01||Observational|||A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T|A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T|Active, not recruiting||Phase 2|20|Actual|21st Century Oncology|||1||f||||t||||||||||2017-10-11 00:02:45.094162|2017-10-11 00:02:45.094162
NCT02232217|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-04-04|||September 2014|Actual|2014-09-01|November 2016|2016-11-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Cognitive Behavioral Treatment for Improving Sleep in Overweight and Obese Youth|Cognitive Behavioral Treatment for Improving Sleep in Overweight and Obese Youth|Recruiting||N/A|60|Anticipated|University of Florida||2|||f||||t||||||||||2017-10-11 00:02:45.171603|2017-10-11 00:02:45.171603
NCT02232204|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-02|||October 2009||2009-10-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|SAVE||Sleep and Ventricular Arrhythmias Study|Sleep in Cardiac Patients With Implantable Cardioverter Defibrillators (ICD)|Completed||Phase 2|3|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 00:02:45.303009|2017-10-11 00:02:45.303009
NCT02232191|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-05-24|||December 2014||2014-12-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients|Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients|Recruiting||N/A|90|Anticipated|University of California, Davis||3|||f||||f|t|f|||f|||No||2017-10-11 00:02:45.421206|2017-10-11 00:02:45.421206
NCT02232165|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2016-08-18|||February 2013||2013-02-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MAPS||Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury|Mean Arterial Pressure in Spinal Cord Injury (MAPS): Determination of Non-inferiority of a Mean Arterial Pressure Goal of 65 mmHg Compared to a Mean Arterial Pressure Goal of 85 mmHg in Acute Human Traumatic Spinal Cord Injury.|Recruiting||Phase 3|100|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 00:02:45.637629|2017-10-11 00:02:45.637629
NCT02232152|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-05-25|||December 2014||2014-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery|A Phase I Clinical Trial of Fluorouracil (5-FU) + CPI-613 Combination in Previously Treated Metastatic Colorectal Cancer Patients|Recruiting||Phase 1|40|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 00:02:45.754091|2017-10-11 00:02:45.754091
NCT02232139|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-04-03|||March 2016||2016-03-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|4CRT||Measurement of Psychomotor Recovery After Anesthesia Using 4CRT|Measurement of Psychomotor Function Recovery in Patients After General Anesthesia Using 4-Choice Reaction Time Test|Recruiting||Phase 2|100|Anticipated|University Medicine Greifswald||2|||f||||f||||||||Undecided||2017-10-11 00:02:45.894488|2017-10-11 00:02:45.894488
NCT02232100|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-01|||January 2015||2015-01-01|September 2014|2014-09-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|ABMT-P||Attentional Bias Modification Training for People With Chronic Musculoskeletal Pain|Attentional Bias Modification Training in People With Chronic Musculoskeletal Pain: A Double-Blind Randomised Control Trial and a Qualitative Investigation of Participants' Experience.|Unknown status|Not yet recruiting|N/A|160|Anticipated|University of Southampton||4|||f||||f||||||||||2017-10-11 00:02:47.099305|2017-10-11 00:02:47.099305
NCT02232074|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-09-15|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Project SUPPORT (Socio-legal Services for Underserved Populations Thru Patient Navigation to Optimize Resources During Treatment)|Project SUPPORT (Socio-legal Services for Underserved Populations Thru Patient Navigation to Optimize Resources During Treatment)|Active, not recruiting||N/A|374|Anticipated|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-11 00:02:47.278174|2017-10-11 00:02:47.278174
NCT02232061|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-05-24|||September 29, 2014|Actual|2014-09-29|May 2017|2017-05-01|July 6, 2020|Anticipated|2020-07-06|July 6, 2020|Anticipated|2020-07-06||Interventional|||Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks in Patients Treated With Fingolimod|Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks in Patients Treated With Fingolimod|Recruiting||Phase 4|40|Anticipated|Novartis||1|||f||||f|f|f||||||No||2017-10-11 00:02:47.361899|2017-10-11 00:02:47.361899
NCT02232048|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-09-08|||September 2014||2014-09-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||The Influence of Corticosteroid Treatment on Heart Function||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 00:02:47.597718|2017-10-11 00:02:47.597718
NCT02232035|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-30|2014-09-03|||September 2014||2014-09-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Diazepam at the Active Phase of Labor|Intravenous Injection of Diazepam at the Beginning of Active Phase of Labor|Unknown status|Not yet recruiting|Phase 2|400|Anticipated|Navy General Hospital, Beijing||2|||f||||t||||||||||2017-10-11 00:02:47.685504|2017-10-11 00:02:47.685504
NCT02232022|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-06-20|||September 2014||2014-09-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke|Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke|Active, not recruiting||N/A|75|Anticipated|Northwell Health||1|||f||||t||||||||||2017-10-11 00:02:47.821466|2017-10-11 00:02:47.821466
NCT02232009|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-07-31|||May 7, 2015|Actual|2015-05-07|July 2017|2017-07-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|Firefly||Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit|Development of MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit|Terminated||N/A|9|Actual|GE Healthcare||1||"small bore size of the neonatal scanner & rapid turn-around of the NICU population having made   it difficult for successful recruitment."|f||||f||||||||||2017-10-11 00:02:47.934529|2017-10-11 00:02:47.934529
NCT02231996|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-03|||September 2014||2014-09-01|September 2014|2014-09-01||||August 2016|Anticipated|2016-08-01|2 Years|Observational [Patient Registry]|||Chronic Granulomatous Disease Study in China||Unknown status|Not yet recruiting|N/A|50|Anticipated|Shanghai Children's Medical Center|||1||f||||||||||||||2017-10-11 00:02:48.036972|2017-10-11 00:02:48.036972
NCT02231983|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-01|||September 2014||2014-09-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|50 Months|Observational [Patient Registry]|||Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China|Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China|Unknown status|Not yet recruiting|N/A|50|Anticipated|Shanghai Children's Medical Center|||1||f||||f||||||||||2017-10-11 00:02:48.118518|2017-10-11 00:02:48.118518
NCT02231970|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-04|||September 2014||2014-09-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Endoscopic Sleeve Gastroplasty for Treatment of Obesity|Endoscopic Sleeve Gastroplasty for Treatment of Obesity|Unknown status|Recruiting|N/A|100|Anticipated|Grupo Hospital de Madrid||1|||f||||f||||||||||2017-10-11 00:02:48.211887|2017-10-11 00:02:48.211887
NCT02231957|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-01-27|||July 2014|Actual|2014-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|June 2015|Actual|2015-06-01||Interventional|||Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions|Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions|Completed||N/A|416|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 00:02:48.317715|2017-10-11 00:02:48.317715
NCT02231944|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-03|||July 1997||1997-07-01|August 2014|2014-08-01||||October 2003|Actual|2003-10-01||Interventional|||An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients|An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients.|Completed||Phase 3|||Bio Products Laboratory||1|||f||||||||||||||2017-10-11 00:02:48.411351|2017-10-11 00:02:48.411351
NCT02231931|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-01-22|||September 2014||2014-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin|Relative Bioavailability of a Single Oral Dose of Digoxin, Furosemide, Metformin, and Rosuvastatin Given Alone and All Together as a Cocktail, and Investigation of the Effect of Increased Doses of Metformin or Furosemide on Relative Bioavailability of the Other Cocktail Compounds in Healthy Male Subjects|Completed||Phase 1|24|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-11 00:02:48.503042|2017-10-11 00:02:48.503042
NCT02231918|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2015-09-02|2015-07-17||May 2006||2006-05-01|September 2015|2015-09-01||||July 2007|Actual|2007-07-01||Interventional||Safety analysis set: The safety population comprised all patients who provided informed consent and received at least one dose of study drug.|Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)|An Open-label Clinical Study to Investigate Pharmacokinetics (PK) of Different Doses (0.125 mg, 0.25 mg, 0.5 mg) of Pramipexole Administered Once Daily Orally in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)|Completed||Phase 2|26|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:02:48.650123|2017-10-11 00:02:48.650123
NCT02231905|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2014-09-03|||January 2004||2004-01-01|September 2014|2014-09-01||||November 2004|Actual|2004-11-01||Interventional|||Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease|Open Label, Exploratory Clinical Trial to Assess the Safety, Tolerability and Effectiveness of a Switching From Talipexole to Pramipexole|Completed||Phase 4|29|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:02:49.856989|2017-10-11 00:02:49.856989
NCT02231892|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-06-30|||August 29, 2014||2014-08-29|April 3, 2017|2017-04-03|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study|Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study|Recruiting||Phase 4|140|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:02:49.926775|2017-10-11 00:02:49.926775
NCT02231879|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-07-13|||August 27, 2014||2014-08-27|July 12, 2017|2017-07-12|March 31, 2021|Anticipated|2021-03-31|September 30, 2020|Anticipated|2020-09-30||Interventional|||Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome|A Phase III Double-Blind Randomized Crossover Study of Plerixafor Versus G-CSF in the Treatment of Patients With WHIM Syndrome.|Recruiting||Phase 3|30|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:02:50.005808|2017-10-11 00:02:50.005808
NCT02231866|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-07-06|||August 27, 2014||2014-08-27|April 5, 2017|2017-04-05|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|||Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults|VRC 207: A Phase I/1b, Open-Label, Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccines, VRC-EBOADC069-00-VP (cAd3-EBO) and VRC-EBOADC076-00-VP (cAd3-EBOZ), in Healthy Adults|Completed||Phase 1|50|Actual|National Institutes of Health Clinical Center (CC)||6|||f||||||||||||||2017-10-11 00:02:50.108296|2017-10-11 00:02:50.108296
NCT02231853|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-08-04|||August 22, 2014||2014-08-22|August 1, 2017|2017-08-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections|Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections|Recruiting||Phase 1|15|Anticipated|National Institutes of Health Clinical Center (CC)||6|||f||||||||||||||2017-10-11 00:02:50.202781|2017-10-11 00:02:50.202781
NCT02231840|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-03|2017-07-26|||August 21, 2014||2014-08-21|July 18, 2017|2017-07-18|March 31, 2034|Anticipated|2034-03-31|April 29, 2024|Anticipated|2024-04-29||Observational|||Unit and Clinic Evaluation, Screening, Assessment, and Management|Unit and Clinic Evaluation, Screening, Assessment, and Management|Recruiting||N/A|7500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:02:50.307201|2017-10-11 00:02:50.307201
NCT02231827|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-09-14|||October 2014||2014-10-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|FREINAGE3D||Balance Control During Gait|A Study of the Balance Control During Gait : Comparison of Data Acquisition Between Force Plate and 3D Optoelectronic Gait Analysis System|Completed||N/A|50|Actual|University Hospital, Rouen||1|||f||||||||||||||2017-10-11 00:02:50.379603|2017-10-11 00:02:50.379603
NCT02231814|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-12-12|||December 2016||2016-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CDED-ADULTS||Pilot Study of Partial Enteral Nutrition With a Unique Diet for the Treatment of Adult Patients With Crohn's Disease|Dietary Therapy Using Partial Enteral Nutrition and the Crohn's Disease Exclusion Diet (CDED) for Induction and Maintenance of Remission in Mild to Moderate Crohn's Disease in Adults- A Pilot Study|Recruiting||N/A|40|Anticipated|Wolfson Medical Center||2|||f||||f||||||||||2017-10-11 00:02:50.448905|2017-10-11 00:02:50.448905
NCT02231801|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-12-29|||September 2014||2014-09-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Monitoring of Vital Signs During Skin-to-skin Holding by Mothers of Their Preterm Babies|Vital Sign Monitoring of Mother-Infant Dyads During Kangaroo Care in Preterm Infants|Completed||N/A|40|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||||||2017-10-11 00:02:50.539047|2017-10-11 00:02:50.539047
NCT02231788|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-08-19|||June 2014||2014-06-01|August 2015|2015-08-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|TENUVA-BP||The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy|A Multicenter, Prospective, Randomized, Open-label, Phase 4 Trial to Evaluate the Efficacy of Telmisartan/S-Amlodipine(Telminuvo® Tab. 40/2.5mg) on 24-hour Ambulatory BP Control Compared With Telmisartan Monotherapy in Hypertensive Patients Inadequately Controlled by Telmisartan Monotherapy|Unknown status|Recruiting|Phase 4|216|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 00:02:50.630842|2017-10-11 00:02:50.630842
NCT02231775|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-02-10|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Neoadjuvant and Adjuvant Dabrafenib and Trametinib in Patients With Clinical Stage III Melanoma (Combi-Neo)|Neoadjuvant and Adjuvant Dabrafenib and Trametinib in Patients With Clinical Stage III Melanoma (Combi-Neo)|Recruiting||Phase 2|78|Anticipated|M.D. Anderson Cancer Center||1|||f||||t|t|f||||||||2017-10-11 00:02:50.814814|2017-10-11 00:02:50.814814
NCT02231762|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-07-25|||October 2014|Actual|2014-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|SONNET||Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET|Phase II, Multicentre, Open Label Study to Evaluate the Efficacy of the Combination of Lanreotide Autogel 120mg and Temozolomide in Patients With Progressive Gastro-entero-pancreatic Neuroendocrine Tumours (GEP-NET) G1/G2 - A Pilot-Study|Completed||Phase 2|57|Actual|Ipsen||1|||f||||f||||||||||2017-10-11 00:02:50.932387|2017-10-11 00:02:50.932387
NCT02231736|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-09-01|||May 2014||2014-05-01|September 2014|2014-09-01||||February 2015|Anticipated|2015-02-01||Observational|MIKRODIAB||Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB)|Incidence of Chromosomal Damage in Type 2 Diabetes Patients|Unknown status|Recruiting|N/A|130|Anticipated|University of Vienna|||2||f||||f||||||||||2017-10-11 00:02:53.240091|2017-10-11 00:02:53.240091
NCT02231710|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-03-31|||February 2015||2015-02-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases|A Study Evaluating BPX-501 T Cells and AP1903 for Prevention of Graft Versus Host Disease (GVHD) After Haploidentical, Related, T Cell-Depleted Hematopoietic Cell Transplantation for Non-Malignant Diseases|Recruiting||Phase 1|20|Anticipated|Bellicum Pharmaceuticals||1|||f||||f||||||||Undecided||2017-10-11 00:02:53.499436|2017-10-11 00:02:53.499436
NCT02231697|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-01-31|||September 2014||2014-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)|The RECENSUS Study: A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)|Recruiting||N/A|100|Anticipated|Audentes Therapeutics|||2||f||||f||||||||||2017-10-11 00:02:53.702169|2017-10-11 00:02:53.702169
NCT02231684|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-01-23|||September 2014||2014-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide|A Randomised, Single Centre, Two Period, Incomplete Cross Over Trial in Healthy Subjects Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide|Completed||Phase 1|42|Actual|Novo Nordisk A/S||8|||f||||f||||||||||2017-10-11 00:02:53.847334|2017-10-11 00:02:53.847334
NCT02231671|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-12-22|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176|A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of 14C-ALS-008176 in Healthy Male Subjects|Completed||Phase 1|12|Actual|Alios Biopharma Inc.||2|||f||||f||||||||||2017-10-11 00:02:53.963206|2017-10-11 00:02:53.963206
NCT02231658|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2017-08-18|||July 16, 2015|Actual|2015-07-16|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Victoza® (Liraglutide) Versus Lyxumia® (Lixisenatide) on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion|Effects of Victoza® (Liraglutide) Versus Lyxumia® (Lixisenatide) on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion|Active, not recruiting||Phase 1|72|Anticipated|Profil Institut für Stoffwechselforschung GmbH||2|||f||||f||||||||||2017-10-11 00:02:54.058518|2017-10-11 00:02:54.058518
NCT02231645|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-01|||May 2013||2013-05-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|||Subthalamic Deep Brain Stimulation Effects on Decision-making Processing in Patients With Parkinson's Disease|Subthalamic Deep Brain Stimulation Effects on Moral and Economics Decision-making Processing in Patients With Parkinson's Disease|Completed||N/A|22|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||||2017-10-11 00:02:54.172429|2017-10-11 00:02:54.172429
NCT02231632|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2014-09-01|||January 2011||2011-01-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)|Phase 2/3 Clinical Trial to Assess the Safety and Immunogenicity of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)|Completed||Phase 2/Phase 3|1200|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:02:54.293581|2017-10-11 00:02:54.293581
NCT02231619|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2015-11-06|||August 2014||2014-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|m-Assist+||Use of Low Sensitivity Pregnancy Test for Self-assessment of Medical Abortion|The Feasibility of Replacing In-person Follow-up for Early Medical Abortion With a Low Sensitivity Pregnancy Test, Symptom Checklist and Text Messages in the South African Public Sector Setting.|Completed||N/A|525|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-11 00:02:54.425804|2017-10-11 00:02:54.425804
NCT02231606|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-31|2016-03-07|||September 2014||2014-09-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|PRICE||Potentiating Rural Investment in Children's Eyecare (PRICE)|Potentiating Rural Investment in Children's Eyecare (PRICE)|Completed||N/A|10234|Actual|Sun Yat-sen University||4|||f||||f||||||||||2017-10-11 00:02:54.553638|2017-10-11 00:02:54.553638
NCT02231593|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-30|||February 2013||2013-02-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|SAGIT Pilot||SAGIT for Classification of Patients With Acromegaly in Clinical Practice|Testing the Use of SAGIT for Classification of Patients With Acromegaly in Clinical Practice|Completed||N/A|71|Actual|Ipsen|||1||f||||f||||||||||2017-10-11 00:02:54.678599|2017-10-11 00:02:54.678599
NCT02231554|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2015-04-30|||September 2014||2014-09-01|September 2014|2014-09-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial|Effectiveness of Feldenkrais Method Versus a Back School Program in Patients With Chronic Low Back Pain: A Randomized Controlled Trial|Completed||N/A|53|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 00:02:55.262002|2017-10-11 00:02:55.262002
NCT02231541|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2015-06-04|||September 2014||2014-09-01|September 2014|2014-09-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Very Low Frequency Magnetic Fields in the Treatment of Fibromyalgia|Effectiveness of Very Low Frequency Magnetic Fields in the Treatment of Fibromyalgia|Completed||N/A|37|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 00:02:55.405437|2017-10-11 00:02:55.405437
NCT02231528|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-06-01|||October 2013||2013-10-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|VVC and GPS||Interest of Ultrasound Coupled to a Guidance System (GPS) for Central Venous Catheters (CVC) Insertion.|Interest of Ultrasound Coupled to a Guidance System (GPS) for Central Venous Catheters (CVC) Insertion.|Completed||Phase 3|100|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 00:02:55.528263|2017-10-11 00:02:55.528263
NCT02231515|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-09-01|||April 2014||2014-04-01|September 2014|2014-09-01||||April 2016|Anticipated|2016-04-01||Interventional|||Prospective, Randomized, Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients With POAG|A Prospective, Randomized, Controlled Study to Assess Efficacy,Safety, and Tolerability of Selective Laser Trabeculoplasty vs. Pattern Laser Trabeculoplasty in Patients With Open-angle Glaucoma|Unknown status|Recruiting|Phase 4|30|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 00:02:55.616186|2017-10-11 00:02:55.616186
NCT02231502|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-11-10|||July 2014||2014-07-01|November 2014|2014-11-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Interventional|ENRICH||Innovation in Food Production Techniques to Improve Bioactive Content|Optimising Vegetable Based Convenience Food Production to Retain Compounds Found in Vegetables|Unknown status|Active, not recruiting|N/A|20|Anticipated|University of East Anglia||2|||f||||||||||||||2017-10-11 00:02:55.829165|2017-10-11 00:02:55.829165
NCT02231489|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-12-02|||September 2014||2014-09-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Tablet Versus JNJ-42756493 Capsule in Healthy Participants|A Single-Dose, Open Label, Randomized, Two-Way Crossover Pharmacokinetic Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Following Intake of Tablet Versus Capsule in Healthy Subjects|Completed||Phase 1|12|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:02:55.934961|2017-10-11 00:02:55.934961
NCT02231463|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-01-25|||June 2014||2014-06-01|January 2016|2016-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|1 Day|Observational [Patient Registry]|||Influence of Two Different PEEP Niveaus and a Trendelenburg Positioning Manoeuvre on Subclavian Vein Diameter|Influence of Two Different PEEP Niveaus and a Trendelenburg Positioning Manoeuvre on Subclavian Vein Diameter as a Surrogate Parameter in Punctures of Central Veins|Withdrawn||N/A|0|Actual|Universitätsklinikum Köln|||1||f||||f||||||||||2017-10-11 00:02:56.055665|2017-10-11 00:02:56.055665
NCT02231450|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2015-03-17|||July 2014||2014-07-01|March 2015|2015-03-01||||March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetics Properties of Single Oral Dosing of Lu AE58054 in Subjects With Hepatic Impairment (Mild and Moderate) and in Healthy Subjects|Interventional, Open-label, Three-group Study to Determine the Pharmacokinetic Properties of Single Oral Dosing of Lu AE58054 in Patients With Hepatic Impairment (Mild and Moderate) and in Healthy Subjects|Completed||Phase 1|24|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-10-11 00:02:56.166751|2017-10-11 00:02:56.166751
NCT02231437|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-01|||January 1999||1999-01-01|September 2014|2014-09-01||||November 1999|Actual|1999-11-01||Observational|||Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease|Post-marketing Surveillance (in Accordance With § 67,6 AMG) of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease|Completed||Phase 4|3488|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:56.270275|2017-10-11 00:02:56.270275
NCT02231424|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-01|||January 1999||1999-01-01|September 2014|2014-09-01||||November 1999|Actual|1999-11-01||Observational|||Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease|Postmarketing Surveillance Study (as Per § 67 (6) AMG [German Drug Law]) of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease|Completed||N/A|713|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:56.402036|2017-10-11 00:02:56.402036
NCT02231411|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-05-24|||August 2014||2014-08-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|NRIC||Neonatal Resuscitation With Intact Cord|Neonatal Resuscitation With Intact Cord|Completed||N/A|150|Actual|Sharp HealthCare||2|||f||||t||||||||||2017-10-11 00:02:56.525944|2017-10-11 00:02:56.525944
NCT02231398|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-06-09|||September 2014||2014-09-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|nuMoM2b-HHS||nuMoM2b Heart Health Study|Pregnancy as a Window to Future Cardiovascular Health: Adverse Pregnancy Outcomes as Predictors of Increased Risk Factors for Cardiovascular Disease|Enrolling by invitation||N/A|5000|Anticipated|RTI International|||1||f||||t||||||Samples With DNA|"     Blood Samples: A research or clinical staff member collects a fasting blood draw from the     participant: 2 SST (tiger top) 10 mL tubes for serum; 2 EDTA (purple top) 10 mL tubes for     plasma, and 1 (light blue top) 2.7 mL tube for citrated plasma. Less than 3 tablespoons of     blood are collected. A 0.5 mL aliquot of whole blood from the EDTA tube is reserved. The rest     of the blood is processed and as many 0.5 mL aliquots of serum, EDTA plasma, and citrated     plasma as possible are collected. In addition, a 1.5 mL aliquot of buffy coat is collected     from one of the EDTA tubes.      Urine Sample: A research or clinical staff member collects about 20 mL of clean catch urine     from the participant and 2 urine aliquots (1.8 mL each).   "|Yes|De-identified data will be made available through an NIH data repository.|2017-10-11 00:02:56.679365|2017-10-11 00:02:56.679365
NCT02231385|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-01|2014-09-01|||September 2014||2014-09-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|||Acetic Acid Colonoscopy Enhancement Study|Acetic Acid Colonoscopy Enhancement Study|Unknown status|Not yet recruiting|N/A|500|Anticipated|Istituto Clinico Humanitas||2|||f||||f||||||||||2017-10-11 00:02:56.840947|2017-10-11 00:02:56.840947
NCT02231372|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-02|||March 2004||2004-03-01|September 2014|2014-09-01||||December 2004|Actual|2004-12-01||Observational|||Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease|Berodual® Respimat® 20/50µg/Dose Solution for Inhalation in Patients With Chronic Obstructive Airways Disease|Completed||N/A|4602|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:56.9612|2017-10-11 00:02:56.9612
NCT02231359|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-02|||January 2004||2004-01-01|September 2014|2014-09-01||||September 2004|Actual|2004-09-01||Observational|||Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease|Berodual® Respimat® 20/50µg/Dose Solution for Inhalation in Patients With Chronic Obstructive Airways Disease|Completed||N/A|2006|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:57.04052|2017-10-11 00:02:57.04052
NCT02231346|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-02|||October 2005||2005-10-01|September 2014|2014-09-01||||April 2006|Actual|2006-04-01||Observational|||Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease|Berodual® Respimat® 20/50 Microgram/Dose Solution for Inhalation: Assessment of Handling and Patient Satisfaction in Comparison to a Powder Inhaler|Completed||N/A|150|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:57.131701|2017-10-11 00:02:57.131701
NCT02231333|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-30|2015-03-20|||June 2014||2014-06-01|August 2014|2014-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis|A Randomized Controlled Trial to Study the Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis.|Unknown status|Recruiting|N/A|100|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 00:02:57.208593|2017-10-11 00:02:57.208593
NCT02231320|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-02|||December 2005||2005-12-01|September 2014|2014-09-01||||June 2006|Actual|2006-06-01||Observational|||Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease|Berodual® Respimat® 20/50 Microgram/Dose Solution for Inhalation: Assessment of Handling and Patient Satisfaction|Completed||N/A|236|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:57.300024|2017-10-11 00:02:57.300024
NCT02231307|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-09-22|||September 2014||2014-09-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||SUBLIVAC FIX Birch Phase III Short-term Efficacy|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Clinical Efficacy and Safety of SUBLIVAC FIX Birch Immunotherapy in Patients Suffering From Allergic Rhinitis/Rhinoconjunctivitis Caused by Birch Pollen.|Completed||Phase 3|406|Actual|HAL Allergy||2|||f||||f||||||||No||2017-10-11 00:02:57.375719|2017-10-11 00:02:57.375719
NCT02231294|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-02|||July 2000||2000-07-01|September 2014|2014-09-01||||January 2002|Actual|2002-01-01||Observational|||The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease|The Effect of SIFROL® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease Patients.|Completed||N/A|1464|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:57.557088|2017-10-11 00:02:57.557088
NCT02231281|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-09-01|||August 2014||2014-08-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults|A Randomized, Open-label Trial to Compare the Efficacy and Safety of Early Initiation of cART With or Without Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in Treatment-Naïve Acute HIV-1 Infected Adults|Unknown status|Recruiting|Phase 3|65|Anticipated|Tang-Du Hospital||2|||f||||t||||||||||2017-10-11 00:02:57.645589|2017-10-11 00:02:57.645589
NCT02231268|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-02|||September 2000||2000-09-01|August 2014|2014-08-01||||January 2003|Actual|2003-01-01||Observational|||Observational Study to Assess a 6-months Treatment With Gladem|Observational Study Via Internet to Assess a 6-months Treatment With GLADEM|Completed||N/A|546|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:57.787938|2017-10-11 00:02:57.787938
NCT02231255|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2014-09-16|||February 2002||2002-02-01|September 2014|2014-09-01||||December 2002|Actual|2002-12-01||Observational|||Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease|Switch Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease|Completed||N/A|1216|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:02:57.86624|2017-10-11 00:02:57.86624
NCT02231242|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-09-03|||September 2013||2013-09-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|ISCII||Intrathecal Stem Cells for Cerebral Palsy Phase II|Intrathecal Autologous Stem Cells for Children With Cerebral Palsy Phase II|Unknown status|Recruiting|Phase 2|60|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||t||||||||||2017-10-11 00:02:57.933797|2017-10-11 00:02:57.933797
NCT02231229|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-06-01|||July 2014||2014-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|FAST-TB||Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation|Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation: a National Multicenter Randomized Clinical Trial|Recruiting||Phase 4|400|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-11 00:02:58.068001|2017-10-11 00:02:58.068001
NCT02231216|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-08-21|||March 2014||2014-03-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|March 2015|Actual|2015-03-01||Interventional|WHOQOL-BREF||Quality of Life Study About the Role of Turbinectomy in Rhinoseptoplasty|The Role of Turbinectomy in Rhinoseptoplasty: a Randomized Clinical Trial With Evaluation of Quality of Life|Unknown status|Active, not recruiting|N/A|50|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 00:02:58.210983|2017-10-11 00:02:58.210983
NCT02231203|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-04-25|||October 2014||2014-10-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|EMPIRE||Effect of Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function|Effect of Intravenous Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function in Patients With Colon Cancer|Active, not recruiting||Phase 4|44|Actual|Medical Center Alkmaar||2|||f||||t||||||||||2017-10-11 00:02:58.316073|2017-10-11 00:02:58.316073
NCT02230826|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-07-31|||May 2014||2014-05-01|July 2017|2017-07-01|December 2027|Anticipated|2027-12-01|May 2027|Anticipated|2027-05-01||Observational|||Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty|Multicentric Observational Study to Evaluate Long-Term Outcome, Performance, and Safety of Tornier's Implantable Devices in Hip Arthroplasty|Recruiting||N/A|2500|Anticipated|Corin|||1||f||||f||||||||||2017-10-11 00:03:06.46084|2017-10-11 00:03:06.46084
NCT02231190|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-05-05|||January 15, 2015|Actual|2015-01-15|May 2017|2017-05-01|June 12, 2015|Actual|2015-06-12|June 12, 2015|Actual|2015-06-12||Interventional|||GSK1278863 Effects on Eccentric Exercise-Induced Muscle Damage|A Randomized, Placebo-Controlled, Double-Blind (Sponsor Unblinded) Study to Investigate Protective Effects of GSK1278863 on Eccentric Exercise Induced Muscle Damage in Healthy Male Volunteers|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:02:58.57276|2017-10-11 00:02:58.57276
NCT02231177|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2015-12-02|2015-06-19||June 2008||2008-06-01|December 2015|2015-12-01||||November 2008|Actual|2008-11-01||Interventional||Treated Set. All randomised patients who received at least one dose of trial medication were included in the treated set.|Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, 3-way Crossover Study to Compare Pharmacokinetics and Safety of 10 μg BI 1744 CL Plus 5 μg Tiotropium Bromide Given as Fixed Dose Combination Via the Respimat® Inhaler With the Pharmacokinetics and the Safety of the Single Agents, i.e. 10 μg BI 1744 CL and 5 μg Tiotropium Bromide, Delivered Via the Respimat® Inhaler Following 21 Day-treatment Periods in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|47|Actual|Boehringer Ingelheim|Additional secondary endpoints were listed in the original protocol, but according to internal rules, descriptive statistics would not be calculated unless data from at least 2/3rds of all subjects were available.|3|||f||||||||||||||2017-10-11 00:02:58.724273|2017-10-11 00:02:58.724273
NCT02231164|ClinicalTrials.gov processed this data on October 10, 2017|2014-09-02|2017-02-14|2016-12-20||October 2014||2014-10-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Randomised Set: The randomised set included all randomised patients.|LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research|Multicentre, Randomised, Double-blind, Phase III Trial to Investigate the Efficacy and Safety of Oral Nintedanib Plus Docetaxel Therapy Compared to Placebo Plus Docetaxel Therapy in Patients With Stage IIIB/IV or Recurrent, Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy|Terminated||Phase 3|12|Actual|Boehringer Ingelheim|The sponsor cancelled this trial prematurely. Thus, enrollment for 1199.128 was significantly less than what was planned (800 planned vs. 12 entered). Therefore, the objectives of this study could not be fully assessed.|2|||f||||||||||||||2017-10-11 00:02:59.725104|2017-10-11 00:02:59.725104
NCT02231151|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2015-08-04|||October 2014||2014-10-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Visual Feedback of CPR: Does Point of View Matter?|Providing Visual Feedback of Quality of CPR During Pediatric Cardiac Arrest: Does Point of View Matter?|Completed||N/A|125|Actual|Express Collaborative||1|||f||||f||||||||||2017-10-11 00:03:00.765908|2017-10-11 00:03:00.765908
NCT02231138|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-30|2016-05-31|||September 2014||2014-09-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease|Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease：a Multicentre Open Study|Active, not recruiting||Phase 4|1600|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||No|The test has not been completed.|2017-10-11 00:03:00.868224|2017-10-11 00:03:00.868224
NCT02231125|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-30|2016-07-04|||September 2014||2014-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy|Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy: a Multicentre, Double-blind, Double-dummy, Randomized Controlled Trial|Recruiting||Phase 4|1600|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||No||2017-10-11 00:03:01.15929|2017-10-11 00:03:01.15929
NCT02231112|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-11-06|||November 2014||2014-11-01|November 2014|2014-11-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Whole Breast RT on Prone Position in Korean Women|Feasibility of Prone Position in Postoperative Whole Breast Radiation Therapy in Korean Breast Cancer Patient|Unknown status|Recruiting|Phase 2|50|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 00:03:01.519882|2017-10-11 00:03:01.519882
NCT02231099|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2015-02-05|||January 2011||2011-01-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|VROUW2||Effectiveness Prolift+M Versus Conventional Vaginal Prolapse Surgery|A Prospective and Comparative Study of the (Cost)Effectiveness Preformance of Tension Free Vaginal Mesh Plus Monocryl (Prolift+M) Versus Conventional Vaginal Prolaps Surgery in Primary Pelvic Organ Prolapse|Unknown status|Active, not recruiting|N/A|176|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 00:03:01.639472|2017-10-11 00:03:01.639472
NCT02231086|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-09-15|||March 2015||2015-03-01|September 2016|2016-09-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01||Interventional|COLOPEC||Adjuvant HIPEC in High Risk Colon Cancer|Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Colon Cancer at High Risk of Peritoneal Carcinomatosis|Recruiting||Phase 3|176|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:03:01.933354|2017-10-11 00:03:01.933354
NCT02231073|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-04-07|||August 2014||2014-08-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|EEforPD||Exercise, Brain Imaging, Cognition, and Gait in Parkinsonism|Peripheral and Central Postural Disorders in the Elderly|Recruiting||N/A|120|Anticipated|Oregon Health and Science University||2|||f||||t||||||||No||2017-10-11 00:03:02.224471|2017-10-11 00:03:02.224471
NCT02231060|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-10-05|||October 2014||2014-10-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01|12 Months|Observational [Patient Registry]|HOPE||Study for the Improvement of Long-Term Outcome Prediction in Patients in Coma After Cardiac Arrest|Hypoxia and Outcome Prediction in Early Stage Coma: Towards an Improvement of Clinical and Electrophysiological Predictors|Recruiting||N/A|172|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||t||||||||||2017-10-11 00:03:02.332734|2017-10-11 00:03:02.332734
NCT02231047|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-11-15|||January 2015||2015-01-01|November 2014|2014-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||64N Nutraceutical for the Prevention of Childhood Diarrhea and Pneumonia in Low Resource Settings|64N Nutraceutical for the Prevention of Childhood Diarrhea and Pneumonia in Low Resource Settings|Not yet recruiting||N/A|50|Anticipated|H2O Health and Agriculture LLC||2|||f||||t||||||||||2017-10-11 00:03:02.539075|2017-10-11 00:03:02.539075
NCT02231034|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-03-10|||August 2014||2014-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:03:02.669077|2017-10-11 00:03:02.669077
NCT02231021|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-07-12|||September 2014||2014-09-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|PEAK||The Practical Evidence of Antidiabetic Combination Therapy in Korea|Multicenter, Randomized, Double Blind, Three-arm Parallel Group Study to Evaluate Efficacy and Safety of Alogliptin and Pioglitazone Combination Therapy on Glucose Control in Type 2 Diabetes Subjects Who Have Inadequate Control With Metformin Monotherapy in Korea|Recruiting||Phase 4|300|Anticipated|The Catholic University of Korea||3|||f||||f||||||||||2017-10-11 00:03:02.721733|2017-10-11 00:03:02.721733
NCT02231008|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-05-12|||September 2015||2015-09-01|May 2016|2016-05-01||||July 2017|Anticipated|2017-07-01||Interventional|||Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS||Recruiting||Phase 2/Phase 3|48|Anticipated|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:03:02.89297|2017-10-11 00:03:02.89297
NCT02230995|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-01-19|2017-01-19||September 2014||2014-09-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects|Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release (25 mg/1000 mg) Compared With the Free Combination of Empagliflozin and Metformin Extended Release Tablets in Healthy Subjects Following a High-fat, High-caloric Meal (an Open-label, Randomised, Single Dose, Crossover Trial)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:03:03.033704|2017-10-11 00:03:03.033704
NCT02230982|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-11-09|||February 2015||2015-02-01|November 2016|2016-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Expanded Access|||Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis|Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis|No longer available||N/A|||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 00:03:03.432363|2017-10-11 00:03:03.432363
NCT02230969|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-08-14|||November 12, 2014|Actual|2014-11-12|August 2017|2017-08-01|January 24, 2022|Anticipated|2022-01-24|January 24, 2022|Anticipated|2022-01-24||Observational|POP||Plegridy Observational Program|Plegridy™ (Peginterferon β-1a) Real World Effectiveness and Safety Observational Program|Active, not recruiting||N/A|1210|Actual|Biogen|||1||f||||f||||||||||2017-10-11 00:03:03.58563|2017-10-11 00:03:03.58563
NCT02230956|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-05-05|2017-03-08||October 2014||2014-10-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis|BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis|Completed||Phase 2|176|Actual|Allergan||3|||f||||f||||||||||2017-10-11 00:03:04.265594|2017-10-11 00:03:04.265594
NCT02230943|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-08-29|||April 2014||2014-04-01|August 2014|2014-08-01||||December 2015|Anticipated|2015-12-01|1 Year|Observational [Patient Registry]|RISE||Rheumatology Informatics System for Effectiveness|American College of Rheumatology's Rheumatology Informatics System for Effectiveness|Unknown status|Recruiting|N/A|100000|Anticipated|American College of Rheumatology|||1||f||||f||||||||||2017-10-11 00:03:04.866696|2017-10-11 00:03:04.866696
NCT02230930|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-05-01|||June 2015||2015-06-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Treatment of Apomorphine-induced Skin Reactions: a Pilot Study|Open-label Crossover Trial to Investigate the Efficacy of Treatments in Apomorphine-induced Skin Reactions|Recruiting||Phase 2|20|Anticipated|University Medical Center Groningen||4|||f||||f||||||||||2017-10-11 00:03:04.941168|2017-10-11 00:03:04.941168
NCT02230917|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-08-30|||October 2014||2014-10-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma|A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma|Withdrawn||Phase 2|0|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 00:03:05.120309|2017-10-11 00:03:05.120309
NCT02230904|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-10-01|2015-08-11||September 2014||2014-09-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional||Baseline characteristics refer to the Safety Set, consisting of all randomized subjects who entered the study and received at least 1 dose of study medication.|A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease|A Multicenter, Randomized, Double-blind, 2-way Cross-over Study to Compare the Adhesiveness of 2 Different Rotigotine Patch Formulations in Subjects With Parkinson's Disease|Completed||Phase 1|57|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 00:03:05.241367|2017-10-11 00:03:05.241367
NCT02230891|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-07-24|||October 1, 2014|Actual|2014-10-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Biomarker Guided Therapies in Stage A/B Heart Failure|Biomarker Guided Therapies in Stage A/B Heart Failure|Recruiting||Phase 2|210|Anticipated|VA Office of Research and Development||3|||f||||t|f|f|||f|||||2017-10-11 00:03:05.873775|2017-10-11 00:03:05.873775
NCT02230878|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-01-21|||May 2014||2014-05-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42847922 in Healthy Participants|A Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-42847922 in Healthy Male and Female Subjects|Completed||Phase 1|40|Actual|Janssen-Cilag International NV||4|||f||||f||||||||||2017-10-11 00:03:05.998482|2017-10-11 00:03:05.998482
NCT02230865|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-05-29|||August 2014||2014-08-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|MIRPEX-3||Prediction of Acute Postoperative Pain and Analgesic Consumption|Prediction of Acute Postoperative Pain and Analgesic Consumption by Preoperative Responses to Experimental Pain in Patients Undergoing Chest Wall Surgery|Unknown status|Recruiting|N/A|40|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-11 00:03:06.11966|2017-10-11 00:03:06.11966
NCT02230852|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-11-03|||September 2014||2014-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|PreSSUB I||Prehospital Stroke Study at the Universitair Ziekenhuis Brussel I (PreSSUB I)|Study of the Safety, Feasibility and Reliability of In-ambulance Telemedicine During Paramedic Intervention Team Transportation of Patients With Suspicion of Acute Stroke.|Completed||N/A|40|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||f||||||||||2017-10-11 00:03:06.221155|2017-10-11 00:03:06.221155
NCT02230813|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-01-25|||March 2015||2015-03-01|January 2017|2017-01-01|September 27, 2016|Actual|2016-09-27|September 27, 2016|Actual|2016-09-27||Observational|||Predictors of Oral Antibiotic Treatment Failure in Emergency Department Patients With Cellulitis|Prevalence and Predictors of Initial Oral Antibiotic Treatment Failure in Adult Emergency Department Patients With Cellulitis: a Pilot Study|Completed||N/A|152|Actual|Royal College of Surgeons, Ireland|||1||f||||f||||||||Undecided||2017-10-11 00:03:06.581975|2017-10-11 00:03:06.581975
NCT02230800|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-08-15|||January 2015||2015-01-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PPALM||PPALM-Palm Oil and Pentoxifylline Against Late Morbidity|Randomised Double-blind Placebo Controlled Phase II Trial of Tocovid SupraBio in Combination With Pentoxifylline (PTX) in Patients Suffering Long-term Adverse Effects of Radiotherapy for Pelvic Cancer|Recruiting||Phase 2|117|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:03:06.674461|2017-10-11 00:03:06.674461
NCT02230787|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-04-19|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|February 14, 2017|Actual|2017-02-14|April 22, 2016|Actual|2016-04-22||Interventional|||Gingival Recession Coverage With and Without Emdogain|Effect of Emdogain on Wound Healing After Gingival Recession Coverage Using Connective Tissue Graft: A Pilot Study|Completed||Phase 4|40|Actual|University of Bern||2|||f||||f||||||||||2017-10-11 00:03:06.788579|2017-10-11 00:03:06.788579
NCT02230774|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-09-02|||March 2013||2013-03-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|HANDsOn||Hydration Amongst Nurses and Doctors Oncall|Hydration Amongst Nurses and Doctors Oncall|Completed||N/A|88|Actual|University of Nottingham|||1||f||||f||||||Samples With DNA|"     Serum and urine sampling   "|||2017-10-11 00:03:06.916191|2017-10-11 00:03:06.916191
NCT02230761|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-01-09|2015-11-19||September 2014||2014-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)|A Phase 2, Randomized, Double-masked, Placebo-controlled Study of XOPH5 Ointment for Reduction of Lower Lid Steatoblepharon|Completed||Phase 2|90|Actual|Topokine Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 00:03:07.022564|2017-10-11 00:03:07.022564
NCT02230748|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-05-16|||July 2014||2014-07-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|January 2016|Actual|2016-01-01||Observational|LAARGE||Left-Atrium-Appendage Occluder Register - GErmany|Left-Atrium-Appendage Occluder Register - GErmany|Active, not recruiting||N/A|643|Actual|Stiftung Institut fuer Herzinfarktforschung|||1||f||||f||||||||No||2017-10-11 00:03:07.32447|2017-10-11 00:03:07.32447
NCT02230735|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-05-04|||August 2014||2014-08-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Bupivacaine Injections Into Uterosacral Ligaments During Robotic Assisted Total Hysterectomies|Effectiveness of Bupivacaine With Epinephrine Injections Into the Uterosacral Ligaments for Post-operative Pain Control and the Use of Narcotic Pain Medication Following Robotic Assisted Total Hysterectomies|Withdrawn||N/A|0|Actual|Souza, Amanda, M.D.||2||Study was never started.|f||||f||||||||||2017-10-11 00:03:07.413592|2017-10-11 00:03:07.413592
NCT02230722|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-06-29|||November 2014||2014-11-01|June 2017|2017-06-01|June 12, 2017|Actual|2017-06-12|June 12, 2017|Actual|2017-06-12||Interventional|OPTI||Improving Opioid Safety in Veterans Using Collaborative Care and Decision Support|Improving Opioid Safety in Veterans Using Collaborative Care and Decision Support|Completed||Phase 1|100|Actual|San Francisco Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-11 00:03:07.512052|2017-10-11 00:03:07.512052
NCT02230709|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-09-20|||November 2012||2012-11-01|September 2016|2016-09-01||||November 2012|Actual|2012-11-01||Interventional|||Immediate Effects of Dry Needling and Tens in Chronic Neck Pain|IMMEDIATE EFFECTS OF DRY NEEDLING VERSUS DRY NEEDLING AND TENS ON PAIN IN PATIENTS WITH CHRONIC MIOFASCIAL NECK PAIN|Completed||Phase 2|60|Actual|Universidad Rey Juan Carlos||2|||f||||f||||||||||2017-10-11 00:03:07.634422|2017-10-11 00:03:07.634422
NCT02230696|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-07-01||2015-07-01|August 2014||2014-08-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis||Completed||Phase 3|1218|Actual|Perrigo Company||3|||f||||f||||||||||2017-10-11 00:03:07.728658|2017-10-11 00:03:07.728658
NCT02230683|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-10-28|2016-06-28||August 2014||2014-08-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|PH||A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension|An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension|Completed||Phase 2|23|Actual|Conatus Pharmaceuticals Inc.||3|||f||||t||||||||||2017-10-11 00:03:07.888111|2017-10-11 00:03:07.888111
NCT02230670|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-06-06|2017-01-27||August 2014||2014-08-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|LC||A Study of IDN-6556 in Subjects With Liver Cirrhosis|A Multicenter, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Subjects With Liver Cirrhosis|Completed||Phase 2|87|Actual|Conatus Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 00:03:08.578777|2017-10-11 00:03:08.578777
NCT02230657|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-10-20||||||October 2015|2015-10-01||||August 2015|Actual|2015-08-01||Interventional|||A Prospective, Randomized Trial Comparing Same Day Discharge and Overnight Hospital Stay Among Total Hip Arthroplasties Done by the Direct Anterior Approach|A Prospective, Randomized Trial Comparing Same Day Discharge and Overnight Hospital Stay Among Total Hip Arthroplasties Done by the Direct Anterior Approach|Completed||N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-11 00:03:09.268469|2017-10-11 00:03:09.268469
NCT02230644|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-10-26|||November 2014||2014-11-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||RELAX Surgical: Effects of Environmental Design on Pre-surgical Relaxation|RELAX Surgical: Effects of Environmental Design on Pre-surgical Relaxation|Completed||N/A|40|Actual|Royal College of Music||3|||f||||t||||||||||2017-10-11 00:03:09.352981|2017-10-11 00:03:09.352981
NCT02230631|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-04-08|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes|A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes|Completed||N/A|704|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-10-11 00:03:09.433025|2017-10-11 00:03:09.433025
NCT02230436|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2017-02-20|||July 2014||2014-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Early Versus Late Drain Removal After Pancreatectomy: A Randomized Prospective Trial|The Impact of Early Versus Late Drain Removal on Postoperative Morbidity After Pancreatectomy: A Randomized Prospective Trial|Recruiting||N/A|144|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 00:03:11.164433|2017-10-11 00:03:11.164433
NCT02230618|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-08-25|||November 24, 2015|Actual|2015-11-24|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|||Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India|A Multi-centre, Prospective, Open-label, Single-arm, Non-interventional, Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India|Completed||N/A|1029|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 00:03:09.529919|2017-10-11 00:03:09.529919
NCT02230605|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-12-22|||July 2014||2014-07-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Perioperative Cognitive Protection - Cognitive Exercise and Cognitive Reserve (The Neurobics Trial)|Perioperative Cognitive Protection - Cognitive Exercise and Cognitive Reserve (The Neurobics Trial)|Recruiting||N/A|268|Anticipated|Ohio State University||2|||f||||f||||||||No||2017-10-11 00:03:09.694331|2017-10-11 00:03:09.694331
NCT02230592|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-06-30|||November 8, 2013||2013-11-08|July 18, 2016|2016-07-18|June 16, 2016|Actual|2016-06-16|June 16, 2016|Actual|2016-06-16||Observational|||PET Imaging of Brain mGluR1 Receptors Using [18F]FIMX|PET Imaging of Brain mGluR1 Receptors Using [18F]FIMX|Completed||N/A|19|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:03:09.826136|2017-10-11 00:03:09.826136
NCT02230566|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-05-12||2017-05-08|November 2014||2014-11-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 3 Study of UX003 rhGUS Enzyme Replacement Therapy in Patients With MPS 7|A Randomized, Placebo-Controlled, Blind-Start, Single-Crossover Phase 3 Study to Assess the Efficacy and Safety of UX003 rhGUS Enzyme Replacement Therapy in Patients With MPS 7|Completed||Phase 3|12|Actual|Ultragenyx Pharmaceutical Inc||4|||f||||t||||||||||2017-10-11 00:03:10.046369|2017-10-11 00:03:10.046369
NCT02230553|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-07-14|||October 2014||2014-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|M14LTK||Lapatinib Plus Trametinib in KRAS Mutant Malignancies|Phase I/II Study With Lapatinib Plus Trametinib in Patients With Metastatic KRAS Mutant Non-small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|30|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-11 00:03:10.190447|2017-10-11 00:03:10.190447
NCT02230540|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-02-17|2016-01-18||September 2014||2014-09-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Intermittent Catheterization in Spinal Cord Injured Men||Terminated||N/A|8|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 00:03:10.291468|2017-10-11 00:03:10.291468
NCT02230527|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-03-07|||October 2014|Actual|2014-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia|Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia|Recruiting||Phase 2/Phase 3|60|Anticipated|The Cleveland Clinic||2|||f||||t|t|f|||t|||No||2017-10-11 00:03:10.526768|2017-10-11 00:03:10.526768
NCT02230514|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-07-07|||November 20, 2014|Actual|2014-11-20|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones|A Phase IIa, Single Center, Prospective, Randomized, Parallel, Two-arms, Single-dose, Open-label With Blinded Assessor Pilot Clinical Trial to Assess ex Vivo Expanded Adult Autologous Mesenchymal Stromal Cells Fixed in Allogeneic Bone Tissue (XCEL-MT-OSTEO-ALPHA) in Non Hypertrophic Pseudoarthrosis of Long Bones|Recruiting||Phase 1/Phase 2|20|Anticipated|Banc de Sang i Teixits||2|||f||||f||||||||||2017-10-11 00:03:10.630602|2017-10-11 00:03:10.630602
NCT02230501|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-05-10|||February 2011||2011-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|AVS||Metabolic Activation With Protein-rich Formula Diet|Metabolic Activation With Protein-rich Formula Diet - a Randomized-controlled Trial|Recruiting||N/A|300|Anticipated|West German Center of Diabetes and Health||2|||f||||f||||||||||2017-10-11 00:03:10.752554|2017-10-11 00:03:10.752554
NCT02230488|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-06-01|||September 2014||2014-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Intensive Case Diabetes Management (ICDM) to Prevent Readmission|Intensive Case Diabetes Management to Prevent Readmission of Previously Identified High Risk Patients|Terminated||N/A|1|Actual|Washington University School of Medicine||2||Unable to enroll due to protocol exclusion criteria and participant population pool|f||||f||||||||||2017-10-11 00:03:10.862121|2017-10-11 00:03:10.862121
NCT02230475|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-04-20|||August 2014||2014-08-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|NMR||Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.|Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes Using the Environmental Exposure Unit (EEU). Part 2.|Completed||N/A|15|Actual|Queen's University|||1||f||||f||||||Samples With DNA|"     Urine samples will be retained for analysis via nuclear magnetic resonance. Blood samples     will be retained after separating the mononuclear layer. These samples will be tested for     epigenetic changes. Blood samples will also be retained for IgE testing.   "|||2017-10-11 00:03:10.934821|2017-10-11 00:03:10.934821
NCT02230462|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-10-02|||October 2014||2014-10-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Patient Satisfaction After Facial Reconstruction|Effects of Visualization of Pre-operative Defects on Patient Satisfaction After Facial Reconstruction for Skin Cancer Resection.|Unknown status|Not yet recruiting|N/A|80|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:03:10.996806|2017-10-11 00:03:10.996806
NCT02230449|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-09-01|||August 2014||2014-08-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|||Identifying Expression Markers of Cumulus Cells to Identify Oocyte Developmental Potential Through a Maturation Analysis|Identifying Markers of Oocyte Competence Through a Maturation Analysis|Completed||N/A|200|Actual|Memorial Sisli Hospital, Istanbul|||1||f||||f||||||Samples With DNA|"     Cumulus cells from each oocyte of every enrolled patient will be collected and mRNA & miRNA     extraction will be performed.   "|||2017-10-11 00:03:11.09548|2017-10-11 00:03:11.09548
NCT02230423|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-05-03|||May 2015||2015-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trigeminal Endonasal Perception: A Predictor for Septoplasty Outcome|Trigeminale Endonasale Perzeption, Ein Prädiktor für Das Outcome Einer Septumplastik - Eine Prospektive Kohortenstudie Mit Klinischen Und Biologischen Untersuchungen|Active, not recruiting||N/A|140|Actual|University of Zurich||1|||f||||f||||||||No||2017-10-11 00:03:11.255767|2017-10-11 00:03:11.255767
NCT02230410|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-01-24|||August 2014||2014-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|Cryoballoon||Cryo Balloon for Residual Barrett's Esophagus|CryoBalloon Focal Ablation System for Residual Barretts Esophagus Post Ablation; a Pilot Study.|Enrolling by invitation||Phase 4|10|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:03:11.331353|2017-10-11 00:03:11.331353
NCT02230384|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-07-07|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|March 9, 2017|Actual|2017-03-09|December 16, 2016|Actual|2016-12-16||Interventional|TRENDS||Novel Smoking Cessation Drug for Schizophrenia|The Development of of A Novel Therapeutic to Aid Tobacco Smoking Cessation in Persons With Schizophrenia or Schizoaffective Disorder|Completed||Phase 2|62|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:03:11.524447|2017-10-11 00:03:11.524447
NCT02230371|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-09-03|||March 2007||2007-03-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles|The Serotonin Receptor Type 3 Antagonist Granisetron as a New Treatment Approach for Patients With Chronic Myofascial Pain in the Orofacial Muscles|Completed||Phase 4|40|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:03:11.630003|2017-10-11 00:03:11.630003
NCT02230358|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-04-01|||July 2014||2014-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Cardiac Output and Duplex Sonography in Carotid Endarterectomy|Cardiac Output and Cerebral Blood-flow During Carotid Endarterectomy in Regional vs. General Anesthesia. A Prospective Randomized Controlled Single Center Study|Recruiting||N/A|90|Anticipated|Medical University Innsbruck||2|||f||||f||||||||||2017-10-11 00:03:11.738648|2017-10-11 00:03:11.738648
NCT02230345|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-08-20|||March 2014||2014-03-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|FFF||Effects of a Probiotics on the Health of Normal Young Males|Study of the Effects of a Probiotic Yoghourt on the Metabolic Health of Normal Male Volunteers|Completed||N/A|14|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 00:03:11.863995|2017-10-11 00:03:11.863995
NCT02230319|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-09-30|||October 2014||2014-10-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|September 2015|Actual|2015-09-01||Interventional|||Prevention of Paclitaxel Neuropathy With Cryotherapy|Prevention of Paclitaxel Neuropathy With Cryotherapy|Unknown status|Active, not recruiting|Phase 2|39|Anticipated|Medical Oncology & Hematology Associates of Northern Virginia||1|||f||||f||||||||||2017-10-11 00:03:12.056312|2017-10-11 00:03:12.056312
NCT02230293|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-09-02|||March 2008||2008-03-01|September 2014|2014-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|MULTIHAS||Assistance Multidisciplinary in Hypertensive Patient: Randomized Clinical Trial|Assistance Multidisciplinary in Hypertensive Patient: Randomized Clinical Trial|Completed||N/A|124|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 00:03:12.23856|2017-10-11 00:03:12.23856
NCT02230280|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-05-17|||May 8, 2017|Actual|2017-05-08|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||My Stroke Team (MYST): Stroke App Pilot Study|Strengthening Community-Based Stroke Care: A Pilot Study of a Community Navigation and Rehabilitation Intervention That Includes a Mobile Health Solution|Recruiting||N/A|30|Anticipated|McMaster University||1|||f||||f|f|f||||||||2017-10-11 00:03:12.32171|2017-10-11 00:03:12.32171
NCT02230267|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's Disease|High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's Disease|Completed||Phase 2|27|Actual|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-11 00:03:12.628049|2017-10-11 00:03:12.628049
NCT02230254|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-09-04|||April 9, 2014|Actual|2014-04-09|September 2017|2017-09-01|July 31, 2015|Actual|2015-07-31|June 22, 2014|Actual|2014-06-22||Interventional|||PE PREMIER CHINA CLINICAL TRIAL|PE PREMIER China: A Prospective, Multicenter Trial to Assess the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)|Completed||Phase 3|||Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 00:03:12.735882|2017-10-11 00:03:12.735882
NCT02230241|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-05-04|||September 2014||2014-09-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|CEPHEUSII||CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)|CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II|Completed||N/A|2700|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:03:12.815647|2017-10-11 00:03:12.815647
NCT02230228|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-03-21|||April 2014||2014-04-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Phase 1 Safety Study of ALK-001 in Healthy Volunteers|A Phase 1, Open Label, Repeat Dose Study to Investigate the Safety and Pharmacokinetics of 4-week Daily Dosing of ALK-001 in Healthy Volunteers|Completed||Phase 1|40|Actual|Alkeus Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:03:12.921878|2017-10-11 00:03:12.921878
NCT02230215|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-09-06|||June 2015||2015-06-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Assessment of Conventional and Patient-specific Instrumentation in Total Knee Arthroplasty|Assessment of Conventional and Patient-specific Instrumentation in Total Knee Arthroplasty|Active, not recruiting||N/A|50|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:03:13.000084|2017-10-11 00:03:13.000084
NCT02230202|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-03-10|||September 2014||2014-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|1 Day|Observational [Patient Registry]|||Endothelial Microparticles: A Novel Marker of Vascular Dysfunction|Endothelial Microparticles: A Novel Marker of Vascular Dysfunction|Completed||N/A|90|Actual|University of Colorado, Denver|||3||f||||f||||||Samples Without DNA|"     plasma and urine biospecimens to be retained.   "|||2017-10-11 00:03:13.080481|2017-10-11 00:03:13.080481
NCT02230189|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-07-17|||March 2015||2015-03-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|ACE||Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics|Mechanistic Study of Epithelial miRNAs and T-cell Recruitment Dynamics That Occur After Allergen Challenge in Patients With Asthma.|Recruiting||N/A|38|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 00:03:13.15896|2017-10-11 00:03:13.15896
NCT02230176|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-07-11|||February 2015||2015-02-01|July 2016|2016-07-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|OCCLURANDOM||Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II|Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II.|Recruiting||Phase 2|80|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 00:03:13.232687|2017-10-11 00:03:13.232687
NCT02230163|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-10-31|||September 2014||2014-09-01|August 2014|2014-08-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|CHIKIVIG-01||Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins|Prevention of Chikungunya Infection in Neonates: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Centre Hospitalier Universitaire de Pointe-a-Pitre||1|||f||||t||||||||||2017-10-11 00:03:13.38833|2017-10-11 00:03:13.38833
NCT02230150|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-29|||December 2012||2012-12-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ADhesion-HF||ADHESION TO THERAPEUTIC STRATEGIES FOR OUTPATIENTS WITH HEART FAILURE - ADhesion-HF|ADHESION TO THERAPEUTIC STRATEGIES FOR OUTPATIENTS WITH HEART FAILURE - ADhesion-HF|Completed||N/A|25|Actual|Federal University of Bahia||1|||f||||f||||||||||2017-10-11 00:03:13.495422|2017-10-11 00:03:13.495422
NCT02230137|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-07-19|||February 2015||2015-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Diabeto-SMS||Text Message for Adolescents With Poorly Controlled Type 1 Diabetes|Impact of Mobile Phone Short Text Messages on the Glycaemic Control of Adolescents With Poorly Controlled Type 1 Diabetes.|Completed||N/A|92|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-11 00:03:13.579299|2017-10-11 00:03:13.579299
NCT02230124|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-09-02|||December 2004||2004-12-01|August 2014|2014-08-01||||July 2015|Anticipated|2015-07-01||Interventional|||Magnetic Resonance Elastography in Hydrocephalus|Magnetic Resonance Elastography in Hydrocephalus|Unknown status|Recruiting|N/A|40|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-10-11 00:03:13.688152|2017-10-11 00:03:13.688152
NCT02230111|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2015-08-31|||November 2013||2013-11-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Impact of Cognitive Dietary Restraint on Perceived Stress, Appetite Sensations, Food Cravings During Energy Restriction|Impact of Cognitive Dietary Restraint on Perceived Stress, Appetite Sensations and Food Cravings During Energy Restriction in Women With Obesity|Completed||N/A|58|Actual|Laval University||2|||f||||f||||||||||2017-10-11 00:03:13.787853|2017-10-11 00:03:13.787853
NCT02230098|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-01-15|||August 2013||2013-08-01|November 2013|2013-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CONDI-PET||Effects of Remote Ischemic Conditioning on Myocardial Perfusion in Humans|Effects of Remote Ischemic Conditioning on Myocardial Perfusion in Humans|Completed||Phase 3|50|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:03:13.909624|2017-10-11 00:03:13.909624
NCT02230085|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-01-18|2016-10-11||September 2014||2014-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Observational|ARI||Adherence Risk Indicator Validation Study|A Validation Study of an Adherence Risk Indicator Statistical Prediction Model.|Completed||N/A|110|Actual|Fisher and Paykel Healthcare|||1||f||||f||||||||||2017-10-11 00:03:14.008676|2017-10-11 00:03:14.008676
NCT02230072|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-06-22|||July 2014||2014-07-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|December 2018|Anticipated|2018-12-01||Interventional|fMMC||Fetoscopic Meningomyelocele Repair Study|Minimally Invasive Fetal Neural Tube Defect Repair Study|Recruiting||Phase 1|45|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 00:03:14.196703|2017-10-11 00:03:14.196703
NCT02230059|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-24|||July 2013||2013-07-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|REALIST-PRO||Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)|Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC): Real Life Analysis In Brazilian Oncology Centers (REALIST-PRO)|Completed||Early Phase 1|382|Actual|Janssen Research & Development, LLC|||1||f||||f||||||||||2017-10-11 00:03:14.331402|2017-10-11 00:03:14.331402
NCT02230046|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-01-18|||October 2014||2014-10-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants|A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of 2 Abiraterone Acetate Coated Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Uncoated Tablet Formulation Under Fasted Conditions in Healthy Male Subjects|Completed||Phase 1|102|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-11 00:03:14.466194|2017-10-11 00:03:14.466194
NCT02230033|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-10-19|||September 2014||2014-09-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927|An Open-Label, Randomized, Parallel-Group Drug-Drug Interaction Study to Assess the Effect of Multiple Doses of Itraconazole or Gemfibrozil on the Pharmacokinetics of a Single Dose of JNJ-56021927 in Healthy Male Subjects|Completed||Phase 1|45|Actual|Aragon Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 00:03:14.597369|2017-10-11 00:03:14.597369
NCT02230020|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-08-07|||August 15, 2013|Actual|2013-08-15|August 2017|2017-08-01|December 13, 2015|Actual|2015-12-13|December 13, 2015|Actual|2015-12-13||Observational|EHFT||Efficacy of High Flow Therapy in COPD At Home|Efficacy of High Flow Therapy in COPD At Home|Terminated||N/A|8|Actual|Johns Hopkins University|||1|Sponsor funding|f||||f||||||None Retained|"     CRP Fibrinogen   "|||2017-10-11 00:03:14.735108|2017-10-11 00:03:14.735108
NCT02230007|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-09-02|||June 2013||2013-06-01|December 2013|2013-12-01|July 2015|Anticipated|2015-07-01|May 2015|Anticipated|2015-05-01||Interventional|||Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly|Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly|Unknown status|Recruiting|Phase 4|64|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 00:03:14.819262|2017-10-11 00:03:14.819262
NCT02229994|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-07-31|||March 16, 2010|Actual|2010-03-16|July 2017|2017-07-01|December 30, 2015|Actual|2015-12-30|March 27, 2014|Actual|2014-03-27||Observational|DYSLIM||Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases|Development of a New Tool for Dyspnea Measurement (DYSLIM for Dyspnea Limitation) in Chronic Respiratory Diseases|Completed||N/A|199|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 00:03:14.916715|2017-10-11 00:03:14.916715
NCT02229981|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-04-25|||July 2014||2014-07-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|ABC-102||Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma|An Early-Phase Clinical Trial Evaluating ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma|Recruiting||Phase 1/Phase 2|33|Anticipated|RedHill Biopharma Limited||1|||f||||f|t|f||||||||2017-10-11 00:03:15.021735|2017-10-11 00:03:15.021735
NCT02229968|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-08-07|||October 2014||2014-10-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Efficacy of Amicar for Children Having Craniofacial Surgery|Efficacy of ε-Aminocaproic Acid (EACA) in Children Undergoing Craniofacial Reconstruction Surgery|Recruiting||Phase 2|44|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-11 00:03:15.131736|2017-10-11 00:03:15.131736
NCT02229955|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2014-09-02|||December 2013||2013-12-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|HL_TSPR_302||Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease|A Multicenter, Randomized, Double-blind Phase Ⅲ Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group 12 Weeks After Treatment in Moderate to Severe Dry Eye Disease|Completed||Phase 3|86|Actual|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:03:15.232018|2017-10-11 00:03:15.232018
NCT02229942|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2016-04-11|||September 2014||2014-09-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|RituxME||B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.|B-lymphocyte Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Multicentre, Randomized, Double-blind and Placebo Controlled Phase-III Study With Rituximab Induction and Maintenance Treatment.|Active, not recruiting||Phase 3|152|Anticipated|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 00:03:15.322319|2017-10-11 00:03:15.322319
NCT02229929|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-08-08||2016-08-08|July 2014||2014-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Pharmacokinetics of Intravenous CR845 in Hemodialysis Patients, and Its Safety and Efficacy in Hemodialysis Patients With Uremic Pruritus|Completed||Phase 2|89|Actual|Cara Therapeutics, Inc.||6|||f||||f||||||||||2017-10-11 00:03:15.429678|2017-10-11 00:03:15.429678
NCT02229916|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-07-18|||December 2013||2013-12-01|July 2017|2017-07-01|September 2029|Anticipated|2029-09-01|September 2019|Anticipated|2019-09-01|8 Years|Observational [Patient Registry]|SAG TCCS||Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS|Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS|Recruiting||N/A|6900|Anticipated|Cantonal Hospital of St. Gallen|||1||f||||t||||||||||2017-10-11 00:03:15.568692|2017-10-11 00:03:15.568692
NCT02229903|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-02-08|||September 2014||2014-09-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD|A Prospective Double Blind Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (dTMS) in Obsessive-Compulsive Subjects|Recruiting||Phase 3|98|Anticipated|Brainsway||2|||f||||t||||||||||2017-10-11 00:03:15.648523|2017-10-11 00:03:15.648523
NCT02229890|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||June 2006||2006-06-01|August 2014|2014-08-01||||March 2009|Actual|2009-03-01||Observational|||An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke|SITS-NEW Safe Implementation of Thrombolysis in Stroke in the Non EU-World: An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke|Completed||N/A|593|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:03:15.804797|2017-10-11 00:03:15.804797
NCT02229877|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-04-17|||October 31, 2014|Actual|2014-10-31|April 2017|2017-04-01|May 31, 2015|Actual|2015-05-31|May 31, 2015|Actual|2015-05-31||Interventional|||A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264)|A Study in Healthy Subjects to Assess the Effect of Intragastric pH and Fasting on the Multiple-Dose Pharmacokinetics of AF-219|Completed||Phase 1|18|Actual|Afferent Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:03:15.869713|2017-10-11 00:03:15.869713
NCT02229864|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-08-02|2016-05-23||May 2014||2014-05-01|August 2017|2017-08-01|September 2021|Anticipated|2021-09-01|October 2014|Actual|2014-10-01||Interventional||The PK sub-study had slightly more male subjects, and slightly more subjects with dyslipidemia and hypertension requiring medication and subjects with stable angina as compared to ABSORB III Primary Analysis Group. The PK sub-study had fewer subjects who had undergone prior coronary intervention.|Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions|ABSORB III RCT Pharmacokinetics (PK) Sub-study|Active, not recruiting||N/A|12|Actual|Abbott Vascular||1|||f||||t||||||||||2017-10-11 00:03:15.989077|2017-10-11 00:03:15.989077
NCT02229851|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-10-02|||October 31, 2014|Actual|2014-10-31|October 2017|2017-10-01|May 7, 2018|Anticipated|2018-05-07|April 20, 2017|Actual|2017-04-20||Interventional|REAL 1||Trial to Compare the Efficacy and Safety of NNC0195-0092 With Placebo and Norditropin® FlexPro® in Adults With Growth Hormone Deficiency.|A Multicentre, Multinational, Randomised, Parallel-group, Placebo-controlled (Double Blind) and Active-controlled (Open) Trial to Compare the Efficacy and Safety of Once Weekly Dosing of NNC0195-0092 With Once Weekly Dosing of Placebo and Daily Norditropin® FlexPro® in Adults With Growth Hormone Deficiency for 35 Weeks, Followed by a 53-week Open-label Extension Period|Active, not recruiting||Phase 3|280|Anticipated|Novo Nordisk A/S||3|||f||||f|t|f||||||||2017-10-11 00:03:17.148773|2017-10-11 00:03:17.148773
NCT02229838|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||July 1999||1999-07-01|August 2014|2014-08-01||||September 1999|Actual|1999-09-01||Interventional|||Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of BIBB 1464 MS in Healthy Male Subjects, Combined With Preliminary Evaluation of Relative Bioavailability and Effect of Food|Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of 0.25 mg, 0.75 mg, 2 mg, 6 mg, and 10 mg BIBB 1464 MS (Tablet) in Healthy Male Subjects, Combined With Preliminary Evaluation of Relative Bioavailability and Effect of Food of the Dose of 0.75 mg or 2 mg or 6 mg (Two-stage Trial Design With Randomised Double Blind Placebo Controlled Rising Dose Phase and Subsequent Randomised, Open Parallel Group Phase)|Completed||Phase 1|73|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:03:17.486901|2017-10-11 00:03:17.486901
NCT02229825|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||February 2007||2007-02-01|August 2014|2014-08-01||||August 2008|Actual|2008-08-01||Interventional|||Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression|An Eight-week, Randomized, Double-blind, Two Parallel Groups, Study to Assess Clinical Response of Duloxetine 60 mg and 120 mg Per Day in Patients Hospitalized for Severe Depression.|Completed||Phase 4|339|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:03:19.508922|2017-10-11 00:03:19.508922
NCT02229812|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||December 2002||2002-12-01|August 2014|2014-08-01||||July 2006|Actual|2006-07-01||Observational|||Safe Implementation of Thrombolysis in Stroke - Monitoring Study|Safe Implementation of Thrombolysis in Stroke - Monitoring Study (SITS-MOST)|Completed||N/A|6475|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:03:19.589244|2017-10-11 00:03:19.589244
NCT02229799|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||February 2003||2003-02-01|August 2014|2014-08-01||||December 2004|Actual|2004-12-01||Observational|||Protocol for Post Marketing Surveillance of Actilyse Vial|Protocol for Post Marketing Surveillance of Actilyse Vial|Terminated||N/A|265|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:03:19.65947|2017-10-11 00:03:19.65947
NCT02229786|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||February 1998||1998-02-01|August 2014|2014-08-01||||October 1999|Actual|1999-10-01||Interventional|||Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms|Buscopan® Plus, Buscopan®, Paracetamol and Placebo: Double-blind Randomized Group Comparison to Investigate the Efficacy and Tolerability of the Film-coated Tablets in Patients With Painful Gastric or Intestinal Spasms|Completed||Phase 2|1637|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:03:19.72303|2017-10-11 00:03:19.72303
NCT02229773|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||January 2000||2000-01-01|August 2014|2014-08-01||||May 2000|Actual|2000-05-01||Interventional|||Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 1464 (Tablet) in Hyperlipemic Healthy Male Subjects|Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability After Multiple Oral Doses of 0.25 mg, 0.5 mg and 1 mg o.d. BIBB 1464 (Tablet) or Pravastatin 20 mg Over 2 Weeks in Hyperlipemic Healthy Male Subjects (Parallel Group Comparison, Randomized, Placebo Controlled, Partly Double Blind [Pravastatin Open])|Completed||Phase 1|100|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:03:19.799002|2017-10-11 00:03:19.799002
NCT02229760|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||August 2006||2006-08-01|August 2014|2014-08-01||||September 2007|Actual|2007-09-01||Interventional|||Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV|Effect of Steady State TPV/r 500 mg/200 mg on Intracellular Concentrations of Zidovudine Triphosphate and Carbovir Triphosphate|Terminated||Phase 1/Phase 2|3|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:03:19.898428|2017-10-11 00:03:19.898428
NCT02229747|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-29|||August 2001||2001-08-01|July 2014|2014-07-01||||February 2002|Actual|2002-02-01||Interventional|||Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis|Randomized, Open-label, Controlled Trial to Assess the Clinical Efficacy and Safety of Meloxicam Suspension 0.25 mg/kg/Day Once a Day, Versus Diclofenac 1 mg/kg/Day Twice a Day or Nimesulide 4 mg/kg/Day Twice a Day, for Five Days in the Treatment of Patients With Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis|Completed||Phase 4|128|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:03:19.97838|2017-10-11 00:03:19.97838
NCT02229734|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-09-13|||December 2014||2014-12-01|September 2016|2016-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|FASTR-2||Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2|Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2|Recruiting||Phase 2|60|Anticipated|Lawson Health Research Institute||1|||f||||t||||||||||2017-10-11 00:03:20.056554|2017-10-11 00:03:20.056554
NCT02229721|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-08-28|||June 2012||2012-06-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women|Female Sexual Dysfunction in the Menopause: Effect of Intranasal Oxytocin Administration on Sexual Function and Activity|Completed||Phase 2|30|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 00:03:20.145806|2017-10-11 00:03:20.145806
NCT02229708|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-12-19|||September 2014||2014-09-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|||Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity|Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity: a Randomized Controlled Trial|Active, not recruiting||Phase 3|262|Actual|Temple University||2|||f||||f||||||||||2017-10-11 00:03:20.230715|2017-10-11 00:03:20.230715
NCT02229695|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||October 2014||2014-10-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|TACACS||The Effect of Different Types of Temporary Abdominal Closure on Intra Abdominal Hypertension.|The Effect of Different Types of Temporary Abdominal Closure on Intra Abdominal Hypertension and Abdominal Compartment Syndrome.|Unknown status|Not yet recruiting|N/A|42|Anticipated|Soroka University Medical Center|||1||f||||f||||||||||2017-10-11 00:03:20.439093|2017-10-11 00:03:20.439093
NCT02229682|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-28|||October 2014||2014-10-01|September 2014|2014-09-01|October 2019|Anticipated|2019-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy|Mild-dose Intensity-modulated Radiation Treatment for Stage IE/IIE Extranodal Nasal-type NK/T-cell Lymphoma With Complete Remission Tumor After Combination of Gemcitabine, Oxaliplatin, and Asparaginase (GELOX) Chemotherapy:a Phase II Study|Not yet recruiting||Phase 2|40|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:03:20.516782|2017-10-11 00:03:20.516782
NCT02229669|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-28|||March 2011||2011-03-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|August 2012|Actual|2012-08-01||Interventional|||Coronally Advanced Flap With Two Different Techniques for the Treatment of Multiple Gingival Recessions|Coronally Advanced Flap With Two Different Techniques for the Treatment of Multiple Gingival Recessions: A Split-mouth RCT|Completed||N/A|10|Actual|Paulista University||2|||f||||t||||||||||2017-10-11 00:03:20.629114|2017-10-11 00:03:20.629114
NCT02229656|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-09-26|||February 2014||2014-02-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Olaparib and Radiotherapy in Head and Neck Cancer|Olaparib Dose Escalation Trial in Patients Treated With Radiotherapy for Stage II-III Laryngeal and Stage II-III HPV-negative Oropharyngeal Squamous Cell Carcinoma|Recruiting||Phase 1|36|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-11 00:03:20.719529|2017-10-11 00:03:20.719529
NCT02229643|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-08-13|||May 2012||2012-05-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01|6 Months|Observational [Patient Registry]|||Serum Neuroglobin and Nogo-A Concentrations in Acute Traumatic Brain Injury|Neuroglobin and Nogo-A as Biomarkers for the Prognosis of Closed Traumatic Brain Injury|Completed||N/A|34|Actual|Shanghai 6th People's Hospital|||1||f||||f||||||Samples Without DNA|"     Serum samples   "|||2017-10-11 00:03:20.827237|2017-10-11 00:03:20.827237
NCT02229630|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-05-31|||March 11, 2015|Actual|2015-03-11|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|REDIFF||Diffusion-weighted Cerebral MRI and Intra Uterine Growth Restriction.|Prognostic Value of Diffusion-weighted Cerebral MRI in Prenatal Evaluation of Foetuses With Intra Uterine Growth Restriction.|Recruiting||N/A|56|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:03:20.898502|2017-10-11 00:03:20.898502
NCT02229617|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-06-02|||July 2015||2015-07-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|STP||Subcutaneous Testosterone Project|A Pilot Study of Subcutaneous vs. Intramuscular Testosterone for Gender Affirming Therapy|Completed||Phase 1/Phase 2|14|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 00:03:20.99928|2017-10-11 00:03:20.99928
NCT02229604|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-10-06|||January 2014||2014-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Electroacupuncture for Diminished Ovarian Reserve|Electroacupuncture for Diminished Ovarian Reserve—a Cohort Study|Completed||Phase 1|57|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||Undecided||2017-10-11 00:03:21.092667|2017-10-11 00:03:21.092667
NCT02229591|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-10-25|||January 2013||2013-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|||Expiratory Flow Limitation and Postoperative Complications||Completed||N/A|330|Actual|Università degli Studi di Ferrara|||2||f||||t||||||||||2017-10-11 00:03:21.17765|2017-10-11 00:03:21.17765
NCT02229578|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-09-21|||September 2014||2014-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|LidocaineBurn||Lidocaine For Treatment of Post-operative Pain From Donor Sites Following Burn Injury.|Lidocaine In The Treatment of Post-operative Pain Management From a Donor Site After Split Thickness Skin Graft Harvesting Following Thermal Injury|Recruiting||N/A|50|Anticipated|University of Florida|||2||f||||f||||||||||2017-10-11 00:03:21.240511|2017-10-11 00:03:21.240511
NCT02229565|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-01-04|||November 2014||2014-11-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Molecular Mechanisms Underlying Prostate Cancer Disparities|Molecular Mechanisms Underlying Prostate Cancer Disparities.|Recruiting||N/A|198|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 00:03:21.355558|2017-10-11 00:03:21.355558
NCT02229552|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-02-05|||November 2012||2012-11-01|November 2015|2015-11-01||||June 2016|Anticipated|2016-06-01||Observational|||Habituation to Food as a Risk Factor for Pediatric Obesity|Habituation to Food as a Risk Factor for Pediatric Obesity|Active, not recruiting||N/A|231|Actual|State University of New York at Buffalo|||1||f||||||||||||||2017-10-11 00:03:21.441015|2017-10-11 00:03:21.441015
NCT02229539|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-29|2017-02-27|2016-12-07||November 2014||2014-11-01|February 2017|2017-02-01||||May 2016|Actual|2016-05-01||Interventional||All participants who met eligibility criteria, had mouth pain score of at least 4 on 0 to 10 scale with higher scores indicated worst pain and started the treatment.|Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy|A Phase III Placebo-Controlled, Randomized Three-Arm Study of Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy|Completed||Phase 3|275|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 00:03:21.571537|2017-10-11 00:03:21.571537
NCT02229526|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-08-29|||January 1990||1990-01-01|August 2014|2014-08-01|December 1999|Actual|1999-12-01|January 1996|Actual|1996-01-01||Interventional|FOTIP||Fish Oil Trials in Pregnancy for the Prevention of Pregnancy Complications ('FOTIP')|Randomised Clinical Trials of Fish Oil Supplementation in High Risk Pregnancies|Completed||N/A|1619|Actual|Centre for Fetal Programming, Denmark||4|||f||||t||||||||||2017-10-11 00:03:23.453972|2017-10-11 00:03:23.453972
NCT02229513|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-12-10|2015-10-28||July 2013||2013-07-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage|Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage: A Randomized Controlled Trial|Completed||N/A|200|Actual|Baylor Research Institute||2|||f||||f||||||||||2017-10-11 00:03:23.56878|2017-10-11 00:03:23.56878
NCT02229500|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-04-27|||August 2014||2014-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Investigating Optimal Propionate Delivery to the Colon Using Stable Isotope Labeling|Regulating Appetite by Targeting Nutrient Delivery in the Gut|Completed||N/A|10|Actual|Scottish Universities Environmental Research Centre||3|||f||||f||||||||||2017-10-11 00:03:24.284378|2017-10-11 00:03:24.284378
NCT02229461|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-06-16|2016-05-04||February 2015||2015-02-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Kontakt||Naproxen Sodium/ASA Platelet Study|A Randomized, Open Label, Parallel Group Study to Investigate the Effects on Serum Thromboxane by the Addition of Naproxen Sodium to Aspirin Therapy Versus Aspirin Therapy Alone|Completed||Phase 1|117|Actual|Bayer||6|||f||||f||||||||||2017-10-11 00:03:24.878683|2017-10-11 00:03:24.878683
NCT02229448|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-29|||October 2014||2014-10-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|||Retrospective Study for Diagnosis of Undetected IgG4 Related Diseases in Patients With High Serum IgG4 Levels.|A Survey of Patients With Elevated Serum IGG4 With Unknown IGG4-related Disease to Whom Biopsy Was Performed for Other Reasons and Performance of Subsequent Specific Staining for Clinical, Laboratory and Pathologic Correlation, Taken From All Patients Admitted at Meir Hospital Since January 2000 Until June 2014 .|Unknown status|Not yet recruiting|N/A|300|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 00:03:26.343386|2017-10-11 00:03:26.343386
NCT02229435|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-28|||December 2004||2004-12-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01|1 Year|Observational [Patient Registry]|UroCKDisS||Urologic-nephrological Care of Chronic Kidney Disease in Saxony-Anhalt/Magdeburg.|Laboratory Database-based Analysis of the Interdisciplinary Urologic-nephrological Care of the Chronic Kidney Disease (CKD) With Estimated Glomerular Filtration Rate (eGFR) Under 60 ml/Min of the Population in Saxony-Anhalt / Metropolitan Area Magdeburg.|Completed||N/A|1031336|Actual|University of Magdeburg|||1||f||||f||||||||||2017-10-11 00:03:26.422446|2017-10-11 00:03:26.422446
NCT02229422|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-05-23|||September 2014||2014-09-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|GA101 & HDMP||A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)|A Study of Obinutuzumab in Combination With High-Dose Methylprednisolone in Chronic Lymphocytic Leukemia Patients|Recruiting||Phase 1/Phase 2|40|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:03:26.513725|2017-10-11 00:03:26.513725
NCT02229409|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-02-03|||September 2014||2014-09-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population|Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population|Completed||N/A|265|Actual|MeYou Health, LLC||2|||f||||f||||||||No||2017-10-11 00:03:26.604902|2017-10-11 00:03:26.604902
NCT02229396|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-08-09|2017-08-09||September 4, 2014|Actual|2014-09-04|August 2017|2017-08-01|December 22, 2017|Anticipated|2017-12-22|April 26, 2016|Actual|2016-04-26||Interventional|||Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo|A 28-week, Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study With a 24-week Extension Phase Followed by a 52-week Extension Phase to Evaluate the Efficacy and Safety of Simultaneous Administration of Exenatide Once Weekly 2 mg and Dapagliflozin Once Daily 10 mg Compared to Exenatide Once Weekly 2 mg Alone and Dapagliflozin Once Daily 10 mg Alone in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin|Active, not recruiting||Phase 3|695|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:03:26.714087|2017-10-11 00:03:26.714087
NCT02229383|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-08-18|2017-08-18||September 6, 2014|Actual|2014-09-06|July 2017|2017-07-01|August 29, 2016|Actual|2016-08-29|August 29, 2016|Actual|2016-08-29||Interventional|||Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Once Weekly Exenatide Therapy Added to Titrated Basal Insulin Glargine Compared to Placebo Added to Titrated Basal Insulin Glargine in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Basal Insulin Glargine With or Without Metformin|Completed||Phase 3|464|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:03:27.855247|2017-10-11 00:03:27.855247
NCT02229370|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-12-10|||June 2014||2014-06-01|December 2015|2015-12-01|December 2025|Anticipated|2025-12-01|June 2019|Anticipated|2019-06-01|5 Years|Observational [Patient Registry]|CAR||Carotid Aneurysm Registry|Extracranial Carotid Artery Aneurysm Registry|Recruiting||N/A|500|Anticipated|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     blood withdrawel   "|||2017-10-11 00:03:28.6441|2017-10-11 00:03:28.6441
NCT02229357|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2015-04-08|||June 2014||2014-06-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine|Evaluation of Priming Effects by Pandemic Live Attenuated Influenza Vaccine (LAIV Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2)) on the Subsequent Response to Inactivated H5N1 Vaccine in Healthy Thai Volunteers: A Non-Randomized, Open Label Study|Completed||Phase 2|60|Actual|Mahidol University||1|||f||||t||||||||||2017-10-11 00:03:28.729141|2017-10-11 00:03:28.729141
NCT02229344|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-07-11|||July 1, 2014|Actual|2014-07-01|July 2017|2017-07-01|February 28, 2022|Anticipated|2022-02-28|July 30, 2021|Anticipated|2021-07-30||Observational|MOSAIK||Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea|Cohort Study of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Tertiary Referral Hospital Setting in Korea|Active, not recruiting||N/A|368|Actual|Janssen Korea, Ltd., Korea|||1||f||||f|f|f||||Samples With DNA|"     Blood sample will be collected and stored for genetic and biomarker research from     participants who agree to give additional informed consent form.   "|||2017-10-11 00:03:28.937847|2017-10-11 00:03:28.937847
NCT02229331|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-28|||September 2014||2014-09-01|August 2014|2014-08-01|September 2016|Anticipated|2016-09-01|September 2014|Anticipated|2014-09-01||Observational|3DMKFM||Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.|Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.|Unknown status|Not yet recruiting|N/A|70|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 00:03:29.040584|2017-10-11 00:03:29.040584
NCT02229318|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-08-15|2015-09-07||September 2014||2014-09-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|FruitiVits||A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.|A Taste and Acceptance Study of FruitiVits, for Use in the Dietary Management of Young Children Requiring Very Restrictive Diets Such as the Ketogenic Diet.|Completed||Phase 4|11|Actual|Vitaflo International, Ltd||1|||f||||f||||||||Undecided||2017-10-11 00:03:29.107007|2017-10-11 00:03:29.107007
NCT02229305|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2014-08-28|||December 2008||2008-12-01|August 2014|2014-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Maine Implementation Study - Phase III|Child System and Treatment Enhancement Projects (Child STEPs); The Clinic Treatment Project in Maine - Phase III|Completed||N/A|235|Actual|Harvard University||2|||f||||t||||||||||2017-10-11 00:03:29.267963|2017-10-11 00:03:29.267963
NCT02229292|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-03-09|||August 19, 2014||2014-08-19|March 2017|2017-03-01|September 26, 2016|Actual|2016-09-26|September 26, 2016|Actual|2016-09-26||Interventional|TXA2014-15||Prevention of Intraoperative Bleeding and Postoperative Swelling in Orthognathic Surgery Through the Use of Tranexamic Acid|Prevention of Bleeding and Edema in Bimaxillary Orthognathic Surgery; the Effectiveness of Tranexamic Acid on Intraoperative Bleeding and Postoperative Swelling in Orthognathic Surgery.|Completed||Phase 4|104|Actual|Hospital of South West Denmark||2|||f||||t||||||||||2017-10-11 00:03:29.366991|2017-10-11 00:03:29.366991
NCT02229279|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-01-10|||September 2015||2015-09-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|October 2016|Actual|2016-10-01||Interventional|SSRHAD||Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures|Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures|Active, not recruiting||N/A|430|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:03:29.451989|2017-10-11 00:03:29.451989
NCT02229266|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-01-15|||September 2015||2015-09-01|January 2016|2016-01-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|HINKL||Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML|Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With Haploidentical Natural Killer Cells in High-risk Acute Myeloid Leukemia|Recruiting||Phase 2|56|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 00:03:29.533818|2017-10-11 00:03:29.533818
NCT02229240|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2016-01-07|||August 2015||2015-08-01|January 2016|2016-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus|Study GLP111892: Albiglutide Versus Placebo as Add-on to Intensified Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||2||Study was cancelled prior to enrolling any patients|f||||f||||||||||2017-10-11 00:03:29.787578|2017-10-11 00:03:29.787578
NCT02229227|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-28|2017-08-11|||November 21, 2014|Actual|2014-11-21|August 2017|2017-08-01|July 24, 2017|Actual|2017-07-24|July 24, 2017|Actual|2017-07-24||Interventional|||Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus|Study 200977: Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the Treatment of Subjects With Type 2 Diabetes Mellitus: The Switch Study|Completed||Phase 3|814|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:03:29.90244|2017-10-11 00:03:29.90244
NCT02229214|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-03-08|2015-11-17||August 2014||2014-08-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects|A Phase IV, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of VI-0521 on the Glomerular Filtration Rate of Healthy Overweight or Obese Subjects|Completed||Phase 4|51|Actual|VIVUS, Inc.||2|||f||||f||||||||||2017-10-11 00:03:30.425447|2017-10-11 00:03:30.425447
NCT02229201|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-27|||May 2010||2010-05-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of Two Anaesthetics on Brain During Brain Tumour Surgery|Phase 1 Study of the Impact of Propofol vs. Sevoflurane on Brain Damage and Inflammatory Response During Brain Tumour Surgery|Completed||Phase 1|40|Actual|University Medical Centre Ljubljana||2|||f||||t||||||||||2017-10-11 00:03:31.056422|2017-10-11 00:03:31.056422
NCT02229188|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-05-15|||December 2013|Actual|2013-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|GOLD||Games to Overcome Late Life Depression|Games to Overcome Late Life Depression|Recruiting||N/A|40|Anticipated|University of Washington||3|||f||||f||||||||||2017-10-11 00:03:31.180402|2017-10-11 00:03:31.180402
NCT02229175|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-10-27|||December 2016||2016-12-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema|Comparison of Subvisible Retinal Laser Therapy With Intravitreal Bevacizumab in Treatment of Diabetic Macular Edema|Not yet recruiting||Phase 2/Phase 3|60|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:03:31.301643|2017-10-11 00:03:31.301643
NCT02229162|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-05-24|||October 2013||2013-10-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|||Delayed Umbilical Cord Clamping - C-section Pilot|Delayed Umbilical Cord Clamping For Term Infants: A Pilot Safety Trial During Cesarean Deliveries|Completed||N/A|41|Actual|University of California, Davis|||2||f||||t||||||||No||2017-10-11 00:03:31.443411|2017-10-11 00:03:31.443411
NCT02229149|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-05-18|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer|Randomized Phase II Trial of Chemotherapy of Physician's Choice Plus Trastuzumab Versus Chemotherapy of Physician's Choice Plus Trastuzumab Plus Pertuzumab In Women With Pretreated, HER2-Overexpressing Metastatic Breast Cancer (MBC)|Active, not recruiting||Phase 2|33|Actual|US Oncology Research||2|||f||||t||||||||||2017-10-11 00:03:31.539959|2017-10-11 00:03:31.539959
NCT02228941|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-28|||September 2014||2014-09-01|August 2014|2014-08-01||||September 2014|Anticipated|2014-09-01|3 Months|Observational [Patient Registry]|||NFIL3-induced Pathological Enhancement of IgE Class Switch Recombination in Hyper-IgE Syndrome||Unknown status|Not yet recruiting|N/A|40|Anticipated|Shanghai Children's Medical Center|||1||f||||||||||||||2017-10-11 00:03:35.091348|2017-10-11 00:03:35.091348
NCT02229136|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-05-18|||September 4, 2014|Actual|2014-09-04|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus|Evaluation of Miracle Mouthwash (MMW) Plus Hydrocortisone and Prednisolone Mouth Rinse as Prophylaxis for Everolimus-Associated Stomatitis|Active, not recruiting||Phase 2|104|Actual|US Oncology Research||2|||f||||t||||||||||2017-10-11 00:03:31.670474|2017-10-11 00:03:31.670474
NCT02229123|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-18|||December 2014||2014-12-01|September 2014|2014-09-01||||December 2016|Anticipated|2016-12-01||Interventional|LEVNEONAT1||Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study|Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|University Hospital, Tours||1|||f||||t||||||||||2017-10-11 00:03:31.792038|2017-10-11 00:03:31.792038
NCT02229110|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-06-15|||October 2013||2013-10-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Effectiveness of a Computerised Prompt for Primary and Secondary Care Physicians to Refer or Refer Back Type 2 Diabetes Patients|Effectiveness of a Computerised Prompt for Primary and Secondary Care Physicians to Refer or Refer Back Type 2 Diabetes Patients|Completed||N/A|2779|Actual|UMC Utrecht||2|||f||||f||||||||||2017-10-11 00:03:31.916354|2017-10-11 00:03:31.916354
NCT02229097|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-02-21|||October 2014|Actual|2014-10-01|July 2016|2016-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|COBOL||Efficacy of Coordinated Insulin Boluses in Type 1 Diabetic Patients|Clinical Efficacy of Coordinated Boluses in Type 1 Diabetic Patients Treated With Insulin Pumps: a Multicentric, Randomised, Cross Over Study|Completed||Phase 4|17|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-11 00:03:31.999077|2017-10-11 00:03:31.999077
NCT02229084|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-02-27|||January 2015||2015-01-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Vaccination of High Risk Breast Cancer Patients|A Combined Phase I/II Feasibility-and-Efficacy Study of a Carbohydrate Mimotope-based Vaccine With MONTANIDE™ ISA 51 VG Combined With Neoadjuvant Chemotherapy|Enrolling by invitation||Phase 1/Phase 2|61|Anticipated|University of Arkansas||5|||f||||t||||||||||2017-10-11 00:03:32.115136|2017-10-11 00:03:32.115136
NCT02229071|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-01-23|||April 2014||2014-04-01|March 2015|2015-03-01|October 30, 2016|Actual|2016-10-30|December 2015|Actual|2015-12-01||Interventional|||Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma|Donafenib in Advanced Hepatocellular Carcinoma: A Randomized Phase 1B Study of Safety, Efficacy, and Pharmacokinetics|Completed||Phase 1/Phase 2|106|Actual|Suzhou Zelgen Biopharmaceuticals Co.,Ltd||2|||f||||f||||||||||2017-10-11 00:03:32.195448|2017-10-11 00:03:32.195448
NCT02229058|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2017-07-25|||February 2012|Actual|2012-02-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer|Phase II Study of Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer|Completed||Phase 2|73|Actual|Sun Yat-sen University||1|||f||||f||||||||||2017-10-11 00:03:32.474306|2017-10-11 00:03:32.474306
NCT02229045|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2014-08-27|||November 2010||2010-11-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer|Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|37|Anticipated|Sun Yat-sen University||1|||f||||f||||||||||2017-10-11 00:03:32.583116|2017-10-11 00:03:32.583116
NCT02229032|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-12-05|||August 2014||2014-08-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Observational|||Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population|Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population|Recruiting||N/A|150|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     saliva for DNA analysis   "|||2017-10-11 00:03:32.671921|2017-10-11 00:03:32.671921
NCT02229019|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-10-12|||August 2014||2014-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|SMART||The Southampton Mealtime Assistance Roll-out Trial|The Southampton Mealtime Assistance Roll-out Trial|Completed||N/A|258|Actual|University Hospital Southampton NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 00:03:32.775902|2017-10-11 00:03:32.775902
NCT02229006|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-05-15|||September 2014||2014-09-01|October 2016|2016-10-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Observational|SoFIA3||Sodium Fluoride Imaging of Abdominal Aortic Aneurysms|SoFIA3: Sodium Fluoride Imaging (18F-NaF PET-CT) in Abdominal Aortic Aneurysms|Completed||N/A|96|Actual|University of Edinburgh|||2||f||||f||||||||||2017-10-11 00:03:32.856051|2017-10-11 00:03:32.856051
NCT02228993|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-09-20|||August 2014||2014-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Quality of Recovery Awake Versus Asleep Craniotomy|Quality of Recovery Following Awake Craniotomy Versus Craniotomy Performed Under General Anesthesia|Enrolling by invitation||N/A|100|Anticipated|Northwestern University|||2||f||||f||||||||||2017-10-11 00:03:33.394987|2017-10-11 00:03:33.394987
NCT02228980|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-12-22|2015-11-18||September 2014||2014-09-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China|Immunogenicity and Safety of a Single Dose (Subjects From 3 Years of Age) or Two Doses Given 28 Days Apart (Children From 6 to 35 Months of Age) of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China|Completed||Phase 4|602|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 00:03:33.514168|2017-10-11 00:03:33.514168
NCT02228967|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-04-12|||May 2015||2015-05-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|March 2016|Actual|2016-03-01||Interventional|||Alcohol Screening, Brief Intervention, and Referral to Treatment in a Military Treatment Facility|Feasibility and Pilot Testing of SBI to Reduce Alcohol Misuse Among Active Duty Members in a Military ER Setting|Active, not recruiting||N/A|795|Actual|San Diego State University||2|||f||||f||||||||||2017-10-11 00:03:34.826653|2017-10-11 00:03:34.826653
NCT02228954|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-12-02|||December 2014||2014-12-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Observational|IMPACT-RCC||IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)|Watchful Waiting in Patients With Good and Intermediate Risk Metastatic Renal Cell Carcinoma; an Imaging Guided Observational Approach. Part of: Towards Patient Tailored Cancer Treatment Supported by Molecular Imaging. IMPACT Study: Imaging Patients for Cancer Drug Selection|Recruiting||N/A|80|Anticipated|Radboud University|||1||f||||||||||||||2017-10-11 00:03:34.942024|2017-10-11 00:03:34.942024
NCT02228928|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-04-27|||February 2009||2009-02-01|September 2014|2014-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain|Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in the Management of Peripheral Neuropathic Pain ; Early Phase II, Multi-center, Randomized, and Semi-double Blind Controlled Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Samyang Biopharmaceuticals Corporation||4|||f||||f||||||||||2017-10-11 00:03:35.171691|2017-10-11 00:03:35.171691
NCT02228915|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-04-12|||August 2014||2014-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|SOD1||Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis|Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis|Recruiting||N/A|30|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     A portion of this sample will be stored for future use in study of ALS and how the critical     protien affects the disease progression long term. This sample will be stored de-identified;     therefore will not be linked to any identifying informaton about the subject. Sample will be     stored at the UNC biophysics and Biochemistry lab indefinitely   "|||2017-10-11 00:03:35.324684|2017-10-11 00:03:35.324684
NCT02228902|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2015-05-06|||August 2014||2014-08-01|May 2015|2015-05-01||||June 2015|Anticipated|2015-06-01||Interventional|||Iron Absorption Trial||Unknown status|Enrolling by invitation|Phase 4|24|Anticipated|Rijnstate Hospital||2|||f||||||||||||||2017-10-11 00:03:35.426267|2017-10-11 00:03:35.426267
NCT02228889|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-01-14|||January 2015||2015-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction||Recruiting||Phase 4|70|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-11 00:03:35.527762|2017-10-11 00:03:35.527762
NCT02228876|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-27|||August 2014||2014-08-01|August 2014|2014-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||A Family Study of Copy Number Variations in Patients With Autism Spectrum Disorder|A Family Study of Copy Number Variations in Patients With Autism Spectrum Disorder|Unknown status|Active, not recruiting|N/A|360|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     The subjects will receive blood withdrawal. The blood sample will be used for establishing     lymphoblastoid cell lines, which will be used for molecular genetic experiments.   "|||2017-10-11 00:03:35.771403|2017-10-11 00:03:35.771403
NCT02228863|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2014-08-27|||March 2014||2014-03-01|August 2014|2014-08-01||||February 2017|Anticipated|2017-02-01||Interventional|||Upper Extremity Rehabilitation Using Robot and Botulinum Toxin||Unknown status|Recruiting|Phase 4|348|Anticipated|National Rehabilitation Center, Seoul, Korea||4|||f||||f||||||||||2017-10-11 00:03:35.862095|2017-10-11 00:03:35.862095
NCT02228850|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-03-21|||November 2014||2014-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis|A Phase 2a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of the Acute Peripheral Vascular Effects, Safety and Tolerability of Alprostadil Topical Cream in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis (SSc, Scleroderma)|Completed||Phase 2|35|Actual|NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)||3|||f||||f||||||||||2017-10-11 00:03:35.991631|2017-10-11 00:03:35.991631
NCT02228837|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-12-06|||August 2014||2014-08-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome|The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome|Completed||Phase 2|50|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 00:03:36.122399|2017-10-11 00:03:36.122399
NCT02228824|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-08-11|||September 2014||2014-09-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Very-Low Nicotine Cigarettes and Non-Daily Smokers|The Effect of Very-Low Nicotine Cigarettes on Smoking in Non-Daily Smokers|Completed||N/A|312|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:03:36.21902|2017-10-11 00:03:36.21902
NCT02228811|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-12-13|||June 2014||2014-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of DCC-2701 in Participants With Advanced Solid Tumors|A Multicenter Phase 1 Ascending Dose Study of DCC-2701 To Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|105|Anticipated|Deciphera Pharmaceuticals LLC||1|||f||||f||||||||||2017-10-11 00:03:36.311035|2017-10-11 00:03:36.311035
NCT02228798|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-12-22|||July 2014||2014-07-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|PAUSE||Perioperative Anticoagulant Use for Surgery Evaluation Study|Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).|Recruiting||N/A|3291|Anticipated|McMaster University|||3||f||||t||||||Samples Without DNA|"     Blood (platelet deprived plasma) will be collected on day of surgery/procedure and measured     by 'everyday' coagulation tests that are not DOAC-specific (e.g., activated partial     thromboplastin time [aPTT]) and 'specialized' coagulation tests that are DOAC-specific     (dilute thrombin time [TT] - HemoclotTM, and anti-factor Xa assays) to determine the effect     of the pre-operative DOAC interruption protocol on the level of residual anticoagulation.   "|||2017-10-11 00:03:36.419671|2017-10-11 00:03:36.419671
NCT02228785|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-08-28|||May 1994||1994-05-01|August 2014|2014-08-01||||October 1994|Actual|1994-10-01||Interventional|CC1C||A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer|Study of the Safety and Tolerance of Three Doses of G17DT in Patients With Metastatic Colorectal Cancer.|Terminated||Phase 2|5|Actual|Cancer Advances Inc.||3||Poor local tolerance to injection.|f||||t||||||||||2017-10-11 00:03:36.668655|2017-10-11 00:03:36.668655
NCT02228772|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-02-28|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults|Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults|Recruiting||Phase 1|28|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 00:03:36.755863|2017-10-11 00:03:36.755863
NCT02228746|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-08-28|||September 2013||2013-09-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo|Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo|Completed||N/A|100|Actual|Olygose||2|||f||||t||||||||||2017-10-11 00:03:37.170868|2017-10-11 00:03:37.170868
NCT02228733|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-08-11|||June 2014||2014-06-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074|An Open-Label, Parallel-Group, Single Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-5074 Following Oral Administration and With a Food Effect Panel|Completed||Phase 1|46|Actual|KBP Biosciences||6|||f||||t||||||||||2017-10-11 00:03:37.282553|2017-10-11 00:03:37.282553
NCT02228720|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-04-25|2016-08-23||June 2014||2014-06-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|EXCEED|All patients and sinuses in whom placement of a Propel Nova Sinus Implant was attempted.|Clinical Evaluation of Propel Nova Sinus Implant in Peripheral Sinus Ostia|The EXCEED Study: A Clinical Evaluation of the Drug-Eluting Propel Nova Sinus Implant When Placed in Peripheral Sinus Ostia to Maintain Patency|Completed||N/A|15|Actual|Intersect ENT||1|||f||||f|f|t|f||f|||No||2017-10-11 00:03:37.380511|2017-10-11 00:03:37.380511
NCT02228707|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-06-14|||August 2014||2014-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers|Completed||Phase 1|56|Actual|Biogen||2|||f||||f||||||||||2017-10-11 00:03:37.793955|2017-10-11 00:03:37.793955
NCT02228694|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2015-03-16|||September 2014||2014-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|IMPROVE||The IMPROVE Study-IMPact of a Regulated ADC System|IMPact of a Regulated ADC System On Medication Distribution and Administration VariablEs|Completed||N/A|120|Actual|Hackensack University Medical Center|||1||f||||f||||||||||2017-10-11 00:03:37.889288|2017-10-11 00:03:37.889288
NCT02228681|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-08-08|||February 2015||2015-02-01|August 2017|2017-08-01||||June 28, 2017|Actual|2017-06-28||Interventional|||Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer|A Randomized Phase II Trial of Everolimus and Letrozole or Hormonal Therapy (Tamoxifen/Medroxyprogesterone Acetate) in Women With Advanced, Recurrent, or Persistent Endometria Carcinoma|Active, not recruiting||Phase 2|74|Actual|Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 00:03:37.983082|2017-10-11 00:03:37.983082
NCT02228668|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-10-13|||March 2015||2015-03-01|November 2015|2015-11-01|January 2019|Anticipated|2019-01-01|March 2018|Anticipated|2018-03-01||Observational|||Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon Carcinoma|Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon Carcinoma|Enrolling by invitation||N/A|3451|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|||1||f||||f||||||||||2017-10-11 00:03:38.222567|2017-10-11 00:03:38.222567
NCT02228655|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-02-01|||October 2014||2014-10-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD|An Exploratory, Uncontrolled, Open-labeled Trial to Evaluate the Effect of FMX-8 Treatment for Anemia in Patients With Chronic Kidney Disease (CKD), Stage 4 or 5|Terminated||Early Phase 1|2|Actual|FerruMax Pharmaceuticals, Inc.||1||Inability to recruit patients meeting eligibilty criteria.|f||||f||||||||||2017-10-11 00:03:38.33423|2017-10-11 00:03:38.33423
NCT02228642|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-10-26|||August 2014||2014-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Hypoglycemia in Hospitalized Patients|A Prospective Investigation Into the Causes, Symptoms, and Outcomes in Patients With Diabetes Who Experience Hypoglycemia During Their Hospitalization|Active, not recruiting||N/A|100|Anticipated|University of Pittsburgh|||1||f||||f||||||||Undecided||2017-10-11 00:03:38.429251|2017-10-11 00:03:38.429251
NCT02228629|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-05-12|||October 2014||2014-10-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Utility of CrocsRx Clog as a Diabetic House Shoe: a Pilot Study|Do CrocsRx Clogs Reduce Dynamic Plantar Pressure as Compared to Conventional House Shoes in Subjects With Diabetes?|Unknown status|Recruiting|N/A|45|Anticipated|Temple University||1|||f||||f||||||||||2017-10-11 00:03:38.492495|2017-10-11 00:03:38.492495
NCT02228616|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-09-14|||October 14, 2014|Actual|2014-10-14|September 2017|2017-09-01|September 28, 2016|Actual|2016-09-28|September 28, 2016|Actual|2016-09-28||Interventional|||Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation|A Multicenter, Single-Arm, Interventional, Phase 4 Study to Evaluate the Efficacy and Safety of Prucalopride in Combination With PEG or Lactulose in Women With Chronic Constipation (CC)|Completed||Phase 4|280|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||f||||||||2017-10-11 00:03:38.5909|2017-10-11 00:03:38.5909
NCT02228603|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-08-12|||August 2014|Actual|2014-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Exercise as a Life-long Medicine in Patients With Coronary Artery Disease|How to Enhance Physical Activity After Cardiac Rehabilitation? A Randomised Controlled Study Comparing Two Follow-up Training Exercise Programs|Recruiting||N/A|165|Anticipated|Norwegian University of Science and Technology||3|||f||||f|f|f||||||||2017-10-11 00:03:38.730044|2017-10-11 00:03:38.730044
NCT02228590|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-02-02||2015-06-24|August 2014||2014-08-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Examine APL-130277 in Patients With Parkinson's Disease|A Phase 2 Study to Examine the Safety, Tolerability and Efficacy of APL-130277 in Patients With Parkinson's Disease|Completed||Phase 2|19|Actual|Sunovion||1|||f||||f||||||||||2017-10-11 00:03:38.842067|2017-10-11 00:03:38.842067
NCT02228577|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-05-12|||August 2014||2014-08-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|RePASS||Safety and Performance Study of the CyPass System Applier Model 241|A Study Assessing the Safety and Performance of the Transcend CyPass System Applier Model 241 for Implantation of the CyPass Micro-Stent in Subjects With Open Angle Glaucoma Who Underwent Cataract Surgery|Completed||N/A|172|Actual|Alcon Research|||1||f||||f||||||||No||2017-10-11 00:03:38.964458|2017-10-11 00:03:38.964458
NCT02228564|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-08-07||2017-08-02|September 2014||2014-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Interventional|BOLSTER||BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease|A Prospective, Multi-Center, Non-Randomized, Single-Arm Study of the BARD® LIFESTREAM™ Balloon Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease (BOLSTER)|Active, not recruiting||N/A|155|Actual|C. R. Bard||1|||f||||f||t|f|||||||2017-10-11 00:03:40.57189|2017-10-11 00:03:40.57189
NCT02228551|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-08-26|||November 2013||2013-11-01|November 2013|2013-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|ARCPPS||Augmented Renal Clearance in the Adult Non-critically Ill Surgery Patient: a Prospective Point Prevalance Study|Augmented Renal Clearance in the Adult Non-critically Ill Surgery Patient: a Prospective Point Prevalance Study and Identification of Risk Factors|Completed||N/A|279|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 00:03:40.794026|2017-10-11 00:03:40.794026
NCT02228538|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-09-20|||October 2013||2013-10-01|May 2016|2016-05-01|September 2016|Actual|2016-09-01|May 2015|Actual|2015-05-01||Observational|||Total Knee Arthroplasty Functional Outcomes Study Research Design|Total Knee Arthroplasty Functional Outcomes Study Research Design|Terminated||Phase 4|7|Actual|ConforMIS, Inc.|||1|Not enough subject participation|f||||t||||||||||2017-10-11 00:03:40.866314|2017-10-11 00:03:40.866314
NCT02228525|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-05-09|||August 27, 2014|Actual|2014-08-27|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes|A Phase II Study of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes|Recruiting||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:03:40.947301|2017-10-11 00:03:40.947301
NCT02228512|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-06-30|||August 15, 2014||2014-08-15|May 5, 2015|2015-05-05|May 5, 2015|Actual|2015-05-05|May 5, 2015|Actual|2015-05-05||Interventional|||Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas|Phase I/II Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas (Primary Effusion Lymphoma and Large Cell Lymphoma Arising in KSHV-Associated Multicentric Castleman Disease)|Withdrawn||Phase 1/Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 00:03:41.046296|2017-10-11 00:03:41.046296
NCT02228499|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-04-15|||August 2014||2014-08-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01|3 Weeks|Observational [Patient Registry]|||Academic Achievement in Children With Asthma|Academic Achievement in Children With Asthma|Unknown status|Active, not recruiting|N/A|400|Anticipated|Children's Research Institute|||2||f||||f||||||||||2017-10-11 00:03:41.165589|2017-10-11 00:03:41.165589
NCT02228486|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-08-26|||August 2014||2014-08-01|August 2014|2014-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Relapse Prevention in Alcohol Dependency by Transcranial Direct Current Stimulation Supported Cue Exposure Therapy|Alcohol Cue-Reactivity in Patients With Alcohol Dependency and Effects of Transcranial Direct Current Stimulation (tDCS) on Cue-exposure Therapy|Unknown status|Recruiting|N/A|48|Anticipated|University Hospital Tuebingen||3|||f||||f||||||||||2017-10-11 00:03:41.239632|2017-10-11 00:03:41.239632
NCT02228473|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-10-27|||September 2014||2014-09-01|August 2014|2014-08-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Interventional|||Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort|Effect of Glycopyrrolate and Atropine as Adjuncts to Reversal of Non-Depolarizing Neuromuscular Blocking Agents on Postoperative Catheter-Related Bladder Discomfort|Unknown status|Recruiting|N/A|76|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:03:41.340609|2017-10-11 00:03:41.340609
NCT02228460|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-09-05||2017-09-05|November 2014||2014-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease|A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Enzyme Replacement Therapy (ERT) Treatment-naïve Adult Male Patients Diagnosed With Fabry Disease|Completed||Phase 2|11|Actual|Sanofi||1|||f||||t||||||||||2017-10-11 00:03:41.44205|2017-10-11 00:03:41.44205
NCT02228447|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-08-29|||February 2014||2014-02-01|August 2014|2014-08-01|February 2015|Anticipated|2015-02-01|August 2014|Actual|2014-08-01||Interventional|||Healthy Habits, Healthy Girls Preventing Unhealthy Weight Gain|Healthy Habits, Healthy Girls: a Intervention Program for Adolescent Girls From Disadvantaged Backgrounds|Unknown status|Recruiting|N/A|244|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:03:41.710926|2017-10-11 00:03:41.710926
NCT02228434|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-08-27|||May 2009||2009-05-01|August 2014|2014-08-01||||December 2011|Actual|2011-12-01||Interventional|||Study on the Tailored Intervention Strategy of Childhood Obesity Based on Monitoring Physical Activities and Dietary Behaviors|Study on the Tailored Intervention Strategy of Childhood Obesity Based on Monitoring Physical Activities and Dietary Behaviors|Completed||N/A|450|Actual|Peking University||4|||f||||||||||||||2017-10-11 00:03:41.821575|2017-10-11 00:03:41.821575
NCT02228421|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-10-05|||February 2015||2015-02-01|October 2016|2016-10-01||||June 2019|Anticipated|2019-06-01||Observational|||Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients|A Phase IV Multicenter Trial to Evaluate Real-world Pharmacoeconomics of Crizotinib and Its Companion Diagnostic Test in Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) Patients|Active, not recruiting||N/A|29|Actual|PeriPharm|||1||f||||f||||||||||2017-10-11 00:03:41.91855|2017-10-11 00:03:41.91855
NCT02228408|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-10-03|||August 28, 2017|Actual|2017-08-28|October 2017|2017-10-01|December 15, 2020|Anticipated|2020-12-15|April 15, 2019|Anticipated|2019-04-15||Interventional|HIDE||Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD|A Phase IV Randomized, Double-blind, Active-controlled, Single-center Study of the Safety and Effects on Cardiac Structure and Function of Hydralazine and Isosorbide Dinitrate in Patients With Hemodialysis Dependent ESRD|Recruiting||Phase 4|16|Anticipated|Brigham and Women's Hospital||2|||f||||t|t|f|||f|||||2017-10-11 00:03:41.991767|2017-10-11 00:03:41.991767
NCT02228226|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2015-04-15|||August 2014||2014-08-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Observational|||Follow-up Study After Bankart Repair Using MG-1|Follow-up Study After Arthroscopic Bankart Repair Using MG-1 for Dislocation of Shoulder|Completed||N/A|11|Actual|Johnson & Johnson K.K. Medical Company|||1||f||||f||||||||||2017-10-11 00:03:44.592789|2017-10-11 00:03:44.592789
NCT02228395|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-11-12|2015-11-12||September 2014||2014-09-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers|A Phase 1, Randomized, Subject- And Investigator-blind, Sponsor Open, Placebo Controlled, Single Ascending Dose Escalation Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Pf-04958242 Following Oral Dose Capsules in Healthy Subjects|Completed||Phase 1|12|Actual|Pfizer|The participants received PF-04958242 0.35 milligrams (mg), 0.6 mg and 0.8 mg instead of the proposed doses of 0.35 mg, 0.55 mg and 0.75 mg based on the review conducted after each dosing period prior to proceeding to next dosing level.|1|||f||||f||||||||||2017-10-11 00:03:42.148202|2017-10-11 00:03:42.148202
NCT02228382|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-09-29|||November 7, 2014|Actual|2014-11-07|September 2017|2017-09-01|June 1, 2021|Anticipated|2021-06-01|June 1, 2021|Anticipated|2021-06-01||Interventional|||Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors|A Phase 4 Safety And Efficacy Study Of Bosutinib (Bosulif (Registered)) In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors|Active, not recruiting||Phase 4|163|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:03:43.089749|2017-10-11 00:03:43.089749
NCT02228369|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-09-12|||November 5, 2014|Actual|2014-11-05|September 2017|2017-09-01|August 3, 2018|Anticipated|2018-08-03|August 19, 2017|Actual|2017-08-19||Interventional|BLOOM||Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer|A Phase I, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumour Activity of AZD3759 or AZD9291 in Patients With EGFR Mutation Positive Advanced Stage Non Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1|108|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:03:43.269049|2017-10-11 00:03:43.269049
NCT02228356|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-05-10|||June 2012||2012-06-01|May 2016|2016-05-01||||June 2017|Anticipated|2017-06-01||Observational|||Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer|Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer|Recruiting||N/A|50|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||||||||||||2017-10-11 00:03:43.495162|2017-10-11 00:03:43.495162
NCT02228343|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-26|||January 2013||2013-01-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||A Prospective Trial of Ayurveda for Coronary Artery Disease|A Prospective Trial of Ayurveda for Coronary Artery Disease|Completed||N/A|19|Actual|University of New Mexico||1|||f||||f||||||||||2017-10-11 00:03:43.59334|2017-10-11 00:03:43.59334
NCT02228330|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-07-31|||July 2014||2014-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Prospective Clinical Trial - Obturator Reflex Predictors and Blockage|Prospective Clinical Trial - Obturator Reflex Predictors and Blockage|Enrolling by invitation||N/A|50|Anticipated|Rabin Medical Center||1|||f||||t||||||||Undecided||2017-10-11 00:03:43.679976|2017-10-11 00:03:43.679976
NCT02228317|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-12-08|||September 2014||2014-09-01|July 2014|2014-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Emergency Medical Technician Treat-and-leave Patients Receiving Telemedicine Consultation With Emergency Medical Dispatch Physician - a Controlled Before and After Pilot-study|Emergency Medical Technician Treat-and-leave Patients Receiving Telemedicine Consultation With Emergency Medical Dispatch Physician - a Controlled Before and After Pilot-study|Completed||N/A|774|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 00:03:43.759921|2017-10-11 00:03:43.759921
NCT02228304|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2016-11-15||2016-11-15|September 2014||2014-09-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)|A Multi-Center, Two-Stage, Open-Label Phase I and Randomized, Active Controlled, Masked Phase II Study to Evaluate the Safety and Efficacy of Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology Compared With Eylea for the Treatment of Recurrent CNV Secondary to AMD|Terminated||Phase 1/Phase 2|42|Actual|Neurotech Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:03:43.854398|2017-10-11 00:03:43.854398
NCT02228291|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-07-06|||March 2014||2014-03-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Citric Flavonoid on Endothelial Function|The Effect of Citric Flavonoid Administration on Endothelial Function and Gut Barrier Function|Completed||N/A|68|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:03:44.013248|2017-10-11 00:03:44.013248
NCT02228278|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-09-14|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Text4Fit||Healthcare Text Messaging to Improve Diet, Physical Activity and Weight Loss in a Pediatric Lipid Clinic|Text 4 Fit Project: Healthcare Text Messaging to Improve Health Outcomes and Medication Compliance in Overweight and Obese Adolescents.|Recruiting||N/A|300|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-11 00:03:44.110763|2017-10-11 00:03:44.110763
NCT02228265|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-06-19|||March 12, 2013|Actual|2013-03-12|June 2017|2017-06-01||||October 1, 2018|Anticipated|2018-10-01||Observational|||Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide|Identifying Mechanisms of Resistance to Enzalutamide (MDV3100) Treatment in Men With Castration-Resistant Prostate Cancer|Recruiting||N/A|65|Anticipated|OHSU Knight Cancer Institute|||1||f||||t||||||Samples With DNA|"     Tissue and blood   "|||2017-10-11 00:03:44.210894|2017-10-11 00:03:44.210894
NCT02228252|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2015-05-04|||August 2014||2014-08-01|August 2014|2014-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of Protein Quality and Time-factor by Consumption of a Pre-meal on Postprandial Lipemia in Subjects With the Metabolic Syndrome.|Whey Protein, Postprandial Lipemia and Cardiovascular Disease: Evaluation of the Effect of a Pre-meal of Whey Protein on Postprandial Lipiemia in Subjects With the Metabolic Syndrome and Type 2 Diabetes|Completed||N/A|16|Actual|Aarhus University Hospital||4|||f||||t||||||||||2017-10-11 00:03:44.341164|2017-10-11 00:03:44.341164
NCT02228239|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-12-29|||September 2014||2014-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|DRiVESaFe||Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants|A Double-blind, Randomized, Placebo-Controlled, 3-way Crossover Study to Evaluate the Single Dose Effects of Intranasal Esketamine on Safety of On-Road Driving in Healthy Subjects|Completed||Phase 1|26|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-11 00:03:44.479059|2017-10-11 00:03:44.479059
NCT02228213|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-07-12|||October 2014||2014-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis|A Phase 2B Randomised, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of MIS416 in the Treatment of Subjects With Secondary Progressive Multiple Sclerosis|Completed||Phase 2|93|Actual|Innate Immunotherapeutics||2|||f||||t||||||||||2017-10-11 00:03:44.682377|2017-10-11 00:03:44.682377
NCT02228200|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-26|||June 2012||2012-06-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Nurse-led Care Program for Cancer Patients in Chemotherapy Day Center|A Nurse-led Care Program on Quality of Life and Health Care Utilization for Cancer Patients in a Chemotherapy Day Center: A Randomized Controlled Trial|Completed||N/A|150|Actual|The Hong Kong Polytechnic University||2|||f||||f||||||||||2017-10-11 00:03:44.79961|2017-10-11 00:03:44.79961
NCT02228187|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-07-31|||July 2015||2015-07-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Brain-Computer Interface System for Training Memory and Attention in Elderly|Brain-computer Interface System for Training Memory and Attention in Elderly With Subjective Memory Deficits and Age Related Cognitive Decline (ARCD)|Completed||Phase 2|240|Actual|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-11 00:03:44.919834|2017-10-11 00:03:44.919834
NCT02228174|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-10-14|||October 2014||2014-10-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|SONATA||Sonography Guided Transcervical Ablation of Uterine Fibroids|Evaluation of the Gynesonics System for Transcervical Treatment of Symptomatic Uterine Fibroids With Radiofrequency Ablation Under Integrated Intrauterine Sonography Guidance|Active, not recruiting||N/A|147|Anticipated|Gynesonics||1|||f||||t||||||||||2017-10-11 00:03:45.026868|2017-10-11 00:03:45.026868
NCT02228161|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2014-09-02|||March 2013||2013-03-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Effects of Yoga in Mental Health Professional Helpers|The Effects of Yoga on Work-related Stress and Stress Adaption Among the Professional Helpers of Psychiatry|Unknown status|Recruiting|N/A|60|Anticipated|Chang Bing Show Chwan Memorial Hospital||2|||f||||f||||||||||2017-10-11 00:03:45.194603|2017-10-11 00:03:45.194603
NCT02228135|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-27|2017-07-24|||September 2014||2014-09-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage||Completed||N/A|9843|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 00:03:45.467645|2017-10-11 00:03:45.467645
NCT02228122|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-12-01|||October 2014||2014-10-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of Aquacel® Ag+ Extra Dressing on Wound Biofilms||Completed||N/A|10|Anticipated|University of Manchester||1|||f||||f||||||||||2017-10-11 00:03:45.556122|2017-10-11 00:03:45.556122
NCT02228109|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-05-28|||December 2014||2014-12-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|BUICK||Multifocal Lens Centration and Its Effect on Visual Performance in a Presbyopic Population||Completed||N/A|35|Actual|University of Waterloo||3|||f||||f||||||||||2017-10-11 00:03:45.643218|2017-10-11 00:03:45.643218
NCT02228096|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-09-28|||August 14, 2014|Actual|2014-08-14|September 2017|2017-09-01|October 17, 2024|Anticipated|2024-10-17|October 17, 2024|Anticipated|2024-10-17||Interventional|||Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients|A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Pediatric Patients With Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia|Recruiting||Phase 2|67|Anticipated|Novartis||1|||f||||t|t|f||||||||2017-10-11 00:03:45.72842|2017-10-11 00:03:45.72842
NCT02228083|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-10-15|||September 2014||2014-09-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|DAHFP||Dental Anesthesia in Heart Failure Patients|Occurrence of Heart Arrhythmia During Restorative Dental Procedure Under Local Anesthesia , in Heart Failure Pacients. A Double-blind Study|Unknown status|Recruiting|N/A|70|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:03:45.870855|2017-10-11 00:03:45.870855
NCT02228070|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-05-12|||July 2015||2015-07-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Strabismus Measurements Using Automated 3D Video Oculography|Strabismus Measurements Using Automated 3D Video Oculography|Recruiting||N/A|200|Anticipated|University of Zurich||1|||f||||||||||||||2017-10-11 00:03:46.089816|2017-10-11 00:03:46.089816
NCT02228057|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-02-11|||August 2014||2014-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Long Term Patency Following Arterial Repair|Long Term Patency Following Arterial Repair|Completed||N/A|13|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-10-11 00:03:46.166541|2017-10-11 00:03:46.166541
NCT02228044|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-08-26|||September 2008||2008-09-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment|Alcohol, Suicide, and HIV Prevention for Teens in Mental Health Treatment|Completed||N/A|81|Actual|George Mason University||2|||f||||t||||||||||2017-10-11 00:03:46.25961|2017-10-11 00:03:46.25961
NCT02228031|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-08-11|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Oxytocin, Emotions and Mirror Neurons|The Influence of Oxytocin on the Mirror Neuron System: Developing Brain Imaging Paradigms for Future Therapeutic Interventions|Completed||Early Phase 1|44|Actual|University of Maryland||2|||f||||t|t|f||||||||2017-10-11 00:03:46.380304|2017-10-11 00:03:46.380304
NCT02228018|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-02-02|||March 2015||2015-03-01|January 2016|2016-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers|The Comparison of Electronic Auscultation Coupled With Computer Aided Lung Sound Analysis (CALSA) and Functional Respiratory Imaging (FRI) and Repeatability of FRI Biomarkers in Healthy Subjects and Asthma Patients|Withdrawn||N/A|0|Actual|FLUIDDA nv||1||Other strategies followed|f||||t||||||||No||2017-10-11 00:03:46.475158|2017-10-11 00:03:46.475158
NCT02228005|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-05-03|||July 2014||2014-07-01|December 2015|2015-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults|The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults|Completed||Phase 4|25|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 00:03:46.562535|2017-10-11 00:03:46.562535
NCT02227992|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-06-27|||July 2014||2014-07-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study|A Prospective, Randomized, Controlled, Study Evaluating the Safety and Effectiveness of EVARREST® Sealant Matrix in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic and Thoracic (Non-cardiac) Surgery in Paediatric Patients|Recruiting||Phase 4|40|Anticipated|Ethicon, Inc.||2|||f||||f||||||||Yes||2017-10-11 00:03:46.654314|2017-10-11 00:03:46.654314
NCT02227979|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-04-07|||September 2013||2013-09-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of PURPLE Cry Intervention|Biological Bases of Individual Variation in Paternal Nurturance|Completed||N/A|42|Actual|Emory University||2|||f||||t||||||||||2017-10-11 00:03:46.777802|2017-10-11 00:03:46.777802
NCT02227966|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-31|||September 2014||2014-09-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Pilot Study of tDCS for Mild Cognitive Impairment|A Pilot Study for the Improvement of Cognitive Function (ADAS-Cog 13) After Transcranial Direct Current Stimulation in Mild Cognitive Impairment|Unknown status|Not yet recruiting|N/A|20|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:03:46.865155|2017-10-11 00:03:46.865155
NCT02227953|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-31|||August 2014||2014-08-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease|A Pilot Study for the Improvement of Cognitive Function (ADAS-Cog 11) After Transcranial Direct Current Stimulation in Mild to Moderate Alzheimer's Disease|Unknown status|Recruiting|N/A|20|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:03:46.958903|2017-10-11 00:03:46.958903
NCT02227940|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-10-05|||January 8, 2015|Actual|2015-01-08|October 2017|2017-10-01|June 11, 2018|Anticipated|2018-06-11|December 11, 2017|Anticipated|2017-12-11||Interventional|||Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer|A Phase I Study of Ceritinib (LDK378), a Novel ALK Inhibitor, in Combination With Gemcitabine-Based Chemotherapy in Patients With Advanced Solid Tumors|Recruiting||Phase 1|96|Anticipated|Roswell Park Cancer Institute||3|||f||||t||||||||||2017-10-11 00:03:47.058806|2017-10-11 00:03:47.058806
NCT02227927|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-11-17||||||November 2016|2016-11-01||||||||Expanded Access|||Treatment Use of Domperidone for Gastroparesis|Treatment Use of Domperidone for Gastroparesis|Available||N/A|||The Cleveland Clinic|||||||||||||||||||2017-10-11 00:03:47.220144|2017-10-11 00:03:47.220144
NCT02227914|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-04-28|||December 2014||2014-12-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma|Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma|Withdrawn||Phase 1/Phase 2|0|Actual|Amgen||2||Study stopped due to administrative reasons|f||||t||||||||||2017-10-11 00:03:47.303749|2017-10-11 00:03:47.303749
NCT02227901|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-12-19|||September 2002||2002-09-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|June 2007|Actual|2007-06-01||Interventional|||Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I Trial of R115777 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 00:03:47.400959|2017-10-11 00:03:47.400959
NCT02227888|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-11-03|||October 2014||2014-10-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SNO3||PK Study of N91115 in Cystic Fibrosis Patients|A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients|Completed||Phase 1|6|Actual|Nivalis Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 00:03:47.494831|2017-10-11 00:03:47.494831
NCT02227875|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-03-03||2017-03-03|August 2014||2014-08-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|INSTRIDE 2||Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)|AN OPEN-LABEL, RANDOMIZED, MULTI-CENTER, PARALLEL GROUP CLINICAL TRIAL COMPARING THE EFFICACY AND SAFETY OF MYLAN'S INSULIN GLARGINE WITH LANTUS® IN TYPE 2 DIABETES MELLITUS PATIENTS|Completed||Phase 3|560|Actual|Mylan Inc.||2|||f||||f||||||||||2017-10-11 00:03:47.599466|2017-10-11 00:03:47.599466
NCT02227862|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-03-02|||August 2014||2014-08-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|INSTRIDE 1||Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)|AN OPEN-LABEL, RANDOMIZED, MULTI-CENTER, PARALLEL-GROUP CLINICAL TRIAL COMPARING THE EFFICACY AND SAFETY OF MYLAN'S INSULIN GLARGINE WITH LANTUS® IN TYPE 1 DIABETES MELLITUS PATIENTS|Completed||Phase 3|558|Actual|Mylan Inc.||2|||f||||f||||||||||2017-10-11 00:03:47.934407|2017-10-11 00:03:47.934407
NCT02227849|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-07-03|||August 2014||2014-08-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus|An Open-Label, Multicenter Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Canagliflozin (TA-7284) as add-on to GLP-1 Analogue in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|71|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 00:03:48.402717|2017-10-11 00:03:48.402717
NCT02227836|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-07-10|||August 2014||2014-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|EoE||Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis|Efficacy of Allergy Patch Testing in Directed Dietary Therapy of Eosinophilic Esophagitis: A Pilot Study|Active, not recruiting||N/A|8|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:03:48.501599|2017-10-11 00:03:48.501599
NCT02227264|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2016-10-16|||June 2014||2014-06-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?|Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?|Recruiting||N/A|118|Anticipated|Karolinska University Hospital||1|||f||||t||||||||No||2017-10-11 00:03:55.097088|2017-10-11 00:03:55.097088
NCT02227823|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-26|||July 2014||2014-07-01|August 2014|2014-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|EMOTAS||Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3|Safety and Efficacy Study of Anti-cholinesterase Therapy on the Motor Functions in Patients With Spinal Muscular Atrophy Type 3.|Unknown status|Recruiting|Phase 2|20|Anticipated|Centre Hospitalier Régional de la Citadelle||2|||f||||f||||||||||2017-10-11 00:03:48.585562|2017-10-11 00:03:48.585562
NCT02227810|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-02-07|2016-08-15||August 2012||2012-08-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Electrical Stimulation in Patients With Prolonged Mechanical Ventilation|Effects of Muscular Electrical Stimulation on Skeletal and Lung Mechanics in Patients With Prolonged Mechanical Ventilation|Completed||N/A|53|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||No||2017-10-11 00:03:48.698198|2017-10-11 00:03:48.698198
NCT02227797|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-09-11|||January 19, 2015|Actual|2015-01-19|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|September 8, 2017|Actual|2017-09-08||Interventional|||MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients|MT2013-37R: Voriconazole Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Patients|Active, not recruiting||Phase 1|66|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-10-11 00:03:49.146553|2017-10-11 00:03:49.146553
NCT02227784|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-09-02||2015-12-23|October 2014||2014-10-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ACCENTUATE||A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol|The Addition of Evacetrapib to Atorvastatin Compared to Placebo, High Intensity Atorvastatin, and Atorvastatin With Ezetimibe to Evaluate LDL-C Lowering in Patients With Primary Hyperlipidemia - The ACCENTUATE Study|Terminated||Phase 3|366|Actual|Eli Lilly and Company||4||Study termination due to program termination.|f||||f||||||||||2017-10-11 00:03:49.272048|2017-10-11 00:03:49.272048
NCT02227771|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-05-17|||December 2014||2014-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 31, 2016|Actual|2016-12-31||Observational|||Consistent CTO Trial|CONventional Antegrade vs Sub-Intimal Synergy sTENTing in Chronic Total Occlusions|Active, not recruiting||N/A|215|Anticipated|European Cardiovascular Research Center|||1||f||||||||||||||2017-10-11 00:03:49.556172|2017-10-11 00:03:49.556172
NCT02227745|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-03-18|||January 2014||2014-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|March 2015|Actual|2015-03-01||Observational|||Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema|Efficacy of Dorzolamide as an Adjuvant to Improve Visual Function After Focal Photocoagulation Treatment in Diabetic Patients With Clinically Significant Macular Edema|Unknown status|Recruiting|N/A|60|Anticipated|Hospital Juarez de Mexico|||2||f||||f||||||||||2017-10-11 00:03:49.801204|2017-10-11 00:03:49.801204
NCT02227732|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-08-04|||April 2014||2014-04-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural Effusions||Completed||N/A|10|Actual|CareFusion||1|||f||||||||||||||2017-10-11 00:03:49.930993|2017-10-11 00:03:49.930993
NCT02227719|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-01-22|||September 2015||2015-09-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Customized Titanium Membrane for Growing Jaw Bone Horizontally|The Use of Customized Titanium Membrane for Horizontal Ridge Augmentation With Simultaneous Implant Placement|Withdrawn||Phase 4|0|Actual|University of Michigan||2||Funding|f||||f||||||||||2017-10-11 00:03:50.040336|2017-10-11 00:03:50.040336
NCT02227706|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-06-27|||August 2014||2014-08-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study|A Prospective, Randomized, Controlled Study Evaluating EVICEL® Fibrin Sealant as an Adjunct to Haemostasis During Abdominal, Retroperitoneal, Pelvic or Thoracic (Non-Cardiac) Surgery in Paediatric Patients|Recruiting||Phase 4|40|Anticipated|Ethicon, Inc.||2|||f||||f||||||||Yes||2017-10-11 00:03:50.161473|2017-10-11 00:03:50.161473
NCT02227693|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-06-19|||July 2014||2014-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia|Completed||Phase 2|39|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-11 00:03:50.318765|2017-10-11 00:03:50.318765
NCT02227680|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-01-27|||July 2014||2014-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Massage Therapy Versus Music Therapy Pilot Study|Massage Therapy vs. Music Therapy vs. Usual Care in an Inpatient Setting: A Pilot Study|Completed||N/A|90|Actual|Boston Medical Center||3|||f||||f||||||||||2017-10-11 00:03:50.45005|2017-10-11 00:03:50.45005
NCT02227667|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-05-23|||December 2, 2014|Actual|2014-12-02|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer|Phase II Study to Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer|Recruiting||Phase 2|48|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:03:50.557819|2017-10-11 00:03:50.557819
NCT02227654|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-11-09|||September 2016||2016-09-01|November 2016|2016-11-01|August 2022|Anticipated|2022-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors|Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors|Recruiting||N/A|3290|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-10-11 00:03:50.721558|2017-10-11 00:03:50.721558
NCT02227641|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-06-23|||October 2014||2014-10-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation|Prospective, Open, Randomized, Two-arm, Controlled, Multicenter Clinical Phase I/IIa Trial to Evaluate the Safety and Efficacy of Adoptive Immunotherapy With Allogeneic CMV/EBV Specific, Peptide Stimulated T-cells (CD3+) for Prevention or Preemptive Therapy of Reactivation of CMV and/or EBV in Patients After Allogeneic, HLA Identical Stem Cell Transplantation|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 00:03:50.824517|2017-10-11 00:03:50.824517
NCT02227628|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-10-14|||April 2013||2013-04-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Absorption and Antioxidant Effects of Polyphenolics From Acai|Absorption and Antioxidant Effects of Polyphenolics From Acai|Completed||N/A|50|Actual|Texas A&M University||2|||f||||t||||||||||2017-10-11 00:03:50.975603|2017-10-11 00:03:50.975603
NCT02227615|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-10-14|||March 2013||2013-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Absorption of Mango in Healthy Individuals|Profile of Metabolites After the Intake of Mango (Mangifera Indica, l.) Var. Keitt in Humans|Active, not recruiting||N/A|30|Anticipated|Texas A&M University||2|||f||||t||||||||||2017-10-11 00:03:51.067716|2017-10-11 00:03:51.067716
NCT02227602|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-10-14|||January 2014||2014-01-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Anti- Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease|The Consumption of Mango Beverage Improves Biomarkers for Inflammation in Inflammatory Bowel Disease Patients|Active, not recruiting||N/A|90|Anticipated|Texas A&M University||2|||f||||t||||||||||2017-10-11 00:03:51.156323|2017-10-11 00:03:51.156323
NCT02227589|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-08-01|||January 2015||2015-01-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|T-TAAD||Treatment for Teens With Alcohol Abuse and Depression|Treatment for Teens With Alcohol Abuse and Depression|Recruiting||N/A|170|Anticipated|Duke University||3|||f||||t||||||||||2017-10-11 00:03:51.241563|2017-10-11 00:03:51.241563
NCT02227576|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-05-17|||July 10, 2014|Actual|2014-07-10|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PLATUM||Prevention of Thrombocytopenia in Glioblastoma Patients|Secondary Prophylaxis Use of Romiplostim for the Prevention of Thrombocytopenia Induced by Temozolomide in Newly Diagnosed Glioblastoma Patients|Recruiting||Phase 2|35|Anticipated|University Hospital, Lille||1|||f||||t||||||||No||2017-10-11 00:03:51.359386|2017-10-11 00:03:51.359386
NCT02227563|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-11-01|||March 2014||2014-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||tDCS & Auditory Hallucinations in Schizophrenia|tDCS & Auditory Hallucinations in Schizophrenia (AVH-SZ)|Terminated||N/A|3|Actual|Herzog Hospital||2||Lack of participants that fit inclusion criteria|f||||t||||||||||2017-10-11 00:03:51.468025|2017-10-11 00:03:51.468025
NCT02227550|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-04-12|||December 2014||2014-12-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|April 2017|Actual|2017-04-01||Interventional|AXAFA||Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy|An Investigator-driven, Prospective, Parallel-group, Randomised, Open, Blinded Outcome Assessment (PROBE), Multi-centre Trial to Determine the Optimal Anticoagulation Therapy for Patients Untergoing Catheter Ablation of Atrial Fibrillation|Active, not recruiting||Phase 4|663|Actual|German Atrial Fibrillation Network||2|||f||||t||||||||||2017-10-11 00:03:51.552862|2017-10-11 00:03:51.552862
NCT02227537|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2015-04-20|||October 2014||2014-10-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Evaluation of the Providence Nighttime Brace for the Treatment of Adolescence Idiopathic Scoliosis|Evaluation of the Providence Nighttime Brace for the Treatment of Adolescence Idiopathic Scoliosis|Unknown status|Recruiting|N/A|100|Anticipated|OrthoGeorgia|||1||f||||f||||||||||2017-10-11 00:03:51.695738|2017-10-11 00:03:51.695738
NCT02227524|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-07-20|||April 2014||2014-04-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|TRAMS||Trekking Poles to Aid Multiple Sclerosis Gait Impairment|Trekking Poles to Aid Multiple Sclerosis Gait Impairment|Recruiting||N/A|30|Anticipated|Rowan University||4|||f||||f||||||||No||2017-10-11 00:03:51.794695|2017-10-11 00:03:51.794695
NCT02227511|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-05-13|||August 2014||2014-08-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Prospective Randomized Trial of Fruits or Nuts Eaten Between Regular Meals in Healthy Subjects|Prospective Randomized Trial of Fruits or Nuts Eaten Between Regular Meals in Healthy Subjects|Completed||N/A|27|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-11 00:03:51.887917|2017-10-11 00:03:51.887917
NCT02227485|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-07-13|2014-12-26||July 2014||2014-07-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|Golnaar||Iranian Traditional Mouth Rinse Punica Granatum Pleniflora (Golnaar) in Treatment of Gingivitis in Diabetic Patients|Evaluation of the Effects of an Iranian Traditional Mouth Rinse Punica Granatum Pleniflora (Golnaar) in Treatment of Gingivitis in Patients With Diabetes Mellitus|Completed||N/A|80|Actual|Shiraz University of Medical Sciences|Small sample size|2|||f||||t||||||||Yes|All the records have been collected and archived, and can be reused if is necessary.|2017-10-11 00:03:52.266146|2017-10-11 00:03:52.266146
NCT02227472|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-06-07|||September 8, 2014|Actual|2014-09-08|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease|Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease: Family and Environmental Factors|Recruiting||N/A|99|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-11 00:03:52.855911|2017-10-11 00:03:52.855911
NCT02227290|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-10-27||2016-10-06|August 2014||2014-08-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Pediatric Subjects With Tinea Corporis|A Phase 4, Double-Blind, Randomized, Vehicle-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of Naftin (Naftifine Hydrochloride) Cream, 2% in Pediatric Subjects With Tinea Corporis|Completed||Phase 4|230|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-11 00:03:54.841554|2017-10-11 00:03:54.841554
NCT02227459|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-05-09|||October 2014||2014-10-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)|A Phase 1b/2, Open Label, Randomized, Repeat Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Biological Activity, and Pharmacokinetics of ND-L02-s0201 Injection, A Vitamin A-coupled Lipid Nanoparticle Containing siRNA Against HSP47, in Subjects With Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)|Completed||Phase 1|25|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-11 00:03:52.97709|2017-10-11 00:03:52.97709
NCT02227446|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-12-22|||October 2014||2014-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|VANCO||Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)|Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (Vancomycin Study)|Recruiting||Phase 3|1000|Anticipated|Major Extremity Trauma Research Consortium||2|||f||||t||||||||||2017-10-11 00:03:53.100526|2017-10-11 00:03:53.100526
NCT02227433|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-08-08|||September 2014||2014-09-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|December 2016|Anticipated|2016-12-01||Interventional|FIL BVHD01||A Phase II Study of Brentuximab Vedotin (BV) in the Treatment of Elderly Hodgkin Lymphoma (HL) Patients at First Relapse or With Primary Refractory Disease.|A Phase II Study of Brentuximab Vedotin (BV) in the Treatment of Elderly Hodgkin Lymphoma (HL) Patients at First Relapse or With Primary Refractory Disease.|Recruiting||Phase 2|20|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-11 00:03:53.222208|2017-10-11 00:03:53.222208
NCT02227420|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-08-22|||October 2014||2014-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|CortIL||Effects of IL-1 Beta on the HPA-axis in Obese Persons|Effects of IL-1 Beta on the Hypothalamic-pituitary-adrenal (HPA) Axis in Obese Persons - the CortIL-Study|Completed||Phase 3|76|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 00:03:53.347226|2017-10-11 00:03:53.347226
NCT02227407|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-08-26|||August 2013||2013-08-01|August 2014|2014-08-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|UPGO||Reciprocating Gait Orthoses for Paraplegia Patients|NSC Assistive Technology Research: Reciprocating Gait Orthoses for Paraplegia Patients|Unknown status|Recruiting|N/A|8|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:03:53.463192|2017-10-11 00:03:53.463192
NCT02227394|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-12-16|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients|A Double Blind, Double Dummy, Randomized, Two Way Cross-over Study to Compare the Effects of Z7200 and Symbicort® Turbohaler on Functional Respiratory Imaging Parameters in Asthmatic Patients.|Completed||Phase 2|20|Actual|Zambon SpA||2|||f||||f||||||||||2017-10-11 00:03:53.583992|2017-10-11 00:03:53.583992
NCT02227381|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-07-31|||February 2011||2011-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01||Observational|||Action Medical Research|Using New Genetic Technology to Diagnose Neurodevelopmental Disorders|Completed||N/A|119|Actual|Central Manchester University Hospitals NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     DNA extracted from whole blood, saliva or skin biopsy   "|||2017-10-11 00:03:53.716747|2017-10-11 00:03:53.716747
NCT02227368|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-06-21|2017-05-19||October 20, 2014|Actual|2014-10-20|June 2017|2017-06-01|May 23, 2016|Actual|2016-05-23|May 23, 2016|Actual|2016-05-23||Interventional|TI-PAD EVR|All randomised subjects with the exception of one subject who did not undergo EVR.|Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR|A Phase II Multicentre, Randomised, Double-Blind, Controlled, Parallel-Group Study to Evaluate the Walking Time Effect of Long-Term Ticagrelor in Comparison to Long-Term Aspirin Administration in Ambulatory Patients With Peripheral Artery Disease Undergoing Endovascular Revascularization - The Ticagrelor in Peripheral Artery Disease Endovascular Revascularization Study TI-PAD I EVR|Terminated||Phase 2|40|Actual|AstraZeneca|This study was terminated early for low enrolment. Less than 25% of anticipated number of subjects were enroled and there was an imbanlance between groups. Therefore, the results should be interpreted with caution.|2|||f||||f||||||||||2017-10-11 00:03:53.80288|2017-10-11 00:03:53.80288
NCT02227355|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-07-01|||September 2014||2014-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|NEUPART||Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease|A Multi-center Noninterventional Study to Evaluate the Effectiveness of Neupro® (Rotigotine Transdermal Patch) and Levodopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)|Completed||N/A|195|Actual|UCB Pharma|||2||f||||f||||||||||2017-10-11 00:03:54.343162|2017-10-11 00:03:54.343162
NCT02227342|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-12-13|||July 2014||2014-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis|A Prospective, Single Center, Open Label Trial of Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis|Completed||Phase 1/Phase 2|3|Actual|University of Alberta||1|||f||||t||||||||||2017-10-11 00:03:54.504928|2017-10-11 00:03:54.504928
NCT02227316|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-05-18|||August 2014||2014-08-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure|A Prospective, Double Blind, Randomized, Placebo Controlled Study to Compare the Effectiveness of Intravenous Acetaminophen and Intravenous Ibuprofen in Reducing Post Procedural Pain in the Uterine Fibroid Embolization Procedure|Completed||Phase 4|40|Actual|University of California, Los Angeles||4|||f||||f||||||||||2017-10-11 00:03:54.66819|2017-10-11 00:03:54.66819
NCT02227277|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-09-08|||January 2015||2015-01-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|BEAT-HIV||Reducing Proviral HIV DNA With Interferon-a|Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy|Active, not recruiting||Phase 2|54|Anticipated|The Wistar Institute||3|||f||||t||||||||||2017-10-11 00:03:54.984652|2017-10-11 00:03:54.984652
NCT02227251|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-08-02|||November 2014||2014-11-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Recruiting||Phase 2|130|Anticipated|Karyopharm Therapeutics Inc||1|||f||||t|t|||||||||2017-10-11 00:03:55.224688|2017-10-11 00:03:55.224688
NCT02227225|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-01-13|||September 2014||2014-09-01|January 2015|2015-01-01||||August 2015|Anticipated|2015-08-01||Observational|||Factors Affecting the Incidence of Postoperative Delirium in Frail Elderly|Factors Affecting the Incidence of Postoperative Delirium in Frail Elderly Undergoing Non-cardiac Surgery: An Observational Study|Unknown status|Recruiting|N/A|50|Anticipated|Singapore General Hospital|||1||f||||f||||||||||2017-10-11 00:03:58.145984|2017-10-11 00:03:58.145984
NCT02227212|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-12-02|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM|A Multi-Center,Open-Label, Single-Arm, Multiple Dose Study With HOE901-U300 to Assess The Ease of Use And Safety of a New U300 Pen Injector in Insulin-Naïve Patients With T2DM|Completed||Phase 3|40|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:03:58.244166|2017-10-11 00:03:58.244166
NCT02227199|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-09-14|||October 10, 2014|Actual|2014-10-10|September 2017|2017-09-01||||September 15, 2018|Anticipated|2018-09-15||Interventional|BV-ICE||Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma|A Phase I/II Trial of Brentuximab Vedotin (BV), Ifosfamide (I), Carboplatin (C), and Etoposide (E) for Patients With Relapsed or Refractory Hodgkin Lymphoma (BV-ICE)|Recruiting||Phase 1/Phase 2|42|Anticipated|University of Washington||1|||f||||t|t|f||||||||2017-10-11 00:03:58.373303|2017-10-11 00:03:58.373303
NCT02227186|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-04-28|||August 1, 2014|Actual|2014-08-01|April 2017|2017-04-01|July 31, 2015|Actual|2015-07-31|July 31, 2015|Actual|2015-07-31||Interventional|SKIPP RCT||Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York|Study of Effectiveness of a School-located Influenza Vaccination Program in Raising Influenza Vaccination Rates|Completed||N/A|20461|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:03:58.546295|2017-10-11 00:03:58.546295
NCT02227173|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-11-17|||September 2014||2014-09-01|October 2014|2014-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|DDI||A Phase 1 Drug-drug Interaction Study in Healthy Volunteers|Effect of BMS-986020 on the Pharmacokinetics of Montelukast, Flurbiprofen, and Digoxin as Probe Substrates for CYP2C8, CYP2C9, and P-gp|Completed||Phase 1|20|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-10-11 00:03:58.634868|2017-10-11 00:03:58.634868
NCT02227160|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2016-12-05|||May 2016||2016-05-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Group Interventions for Suicidal African Americans|Group Interventions for Suicidal African Americans|Recruiting||N/A|190|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 00:03:58.737282|2017-10-11 00:03:58.737282
NCT02227147|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-08-13|||February 2015||2015-02-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 Neurotrophic Keratitis|An 8-week Phase II, Multicenter, Randomized, Double-masked, Vehicle Controlled Parallel Group Study With a 24 or 32 Week Follow-up Period to Evaluate the Efficacy of a Formulation Containing Anti-oxidant of Recombinant Human Nerve Growth Factor (rhNGF) 20 µg/ml, Eye Drops Solution Versus Vehicle Containing Anti-oxidant in Patients With Stage 2 and 3 Neurotrophic Keratitis|Unknown status|Recruiting|Phase 2|48|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||f||||||||||2017-10-11 00:03:58.915754|2017-10-11 00:03:58.915754
NCT02227134|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-07-17|||February 2015||2015-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ultrasound to Predict a Pediatric Difficult Airway and Obstructive Sleep Apnea Syndrome in Children||Recruiting||N/A|100|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 00:03:59.088257|2017-10-11 00:03:59.088257
NCT02227121|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-12-20|2016-12-20||February 2015||2015-02-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Acute Defibrillation Study||Terminated||N/A|16|Actual|Medtronic Cardiac Rhythm and Heart Failure||1||Sufficient enrollments under current protocol for further development & studies|f||||f||||||||No||2017-10-11 00:03:59.18325|2017-10-11 00:03:59.18325
NCT02227108|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-03-09|2016-08-04||August 2014||2014-08-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||The intent-to-treat (ITT) population included all participants who entered the study.|Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma|A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin|Terminated||Phase 2|37|Actual|MedImmune LLC|The study was terminated prior to a planned interim analysis based on lack of required efficacy in the first 32 participants enrolled.|1||"The study was terminated prior to a planned interim analysis based on lack of required efficacy   in the first 32 participants enrolled."|f||||t||||||||||2017-10-11 00:03:59.562274|2017-10-11 00:03:59.562274
NCT02227095|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-03-04|||May 2008||2008-05-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Interventional|SMART||Exercise & Overweight Children's Cognition|Exercise & Overweight Children's Cognition|Completed||N/A|175|Actual|Augusta University||2|||f||||f||||||||||2017-10-11 00:04:00.57135|2017-10-11 00:04:00.57135
NCT02227082|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-09-26|||October 2013||2013-10-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|January 2019|Anticipated|2019-01-01||Interventional|||Olaparib and Radiotherapy in Inoperable Breast Cancer|Olaparib Dose Escalation in Combination With High Dose Radiotherapy to the Breast Andregional Lymph Nodes in Patients With Breast Cancer|Recruiting||Phase 1|36|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-11 00:04:00.696034|2017-10-11 00:04:00.696034
NCT02227069|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-03-27|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers|A Phase 1, 21-Day, Randomized, Evaluator Blinded, Controlled Study to Evaluate the Irritation Potential of M518101 in Healthy Volunteers, Using a Cumulative Irritant Patch Test Design|Completed||Phase 1|30|Actual|Maruho North America Inc.||4|||f||||f||||||||||2017-10-11 00:04:00.797461|2017-10-11 00:04:00.797461
NCT02227056|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-08-25|||January 2014||2014-01-01|July 2014|2014-07-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Effect of Methylphenidate on Ecologic Function in Paediatric Acquired Brain Injury Population|Effect of Methylphenidate on Ecologic Function in Paediatric Acquired Brain Injury Population|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Loewenstein Hospital||1|||f||||t||||||||||2017-10-11 00:04:00.912287|2017-10-11 00:04:00.912287
NCT02227043|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-03-01|||September 2014||2014-09-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|SOWOT||Study Of Weight Development Over Time|Study Of Adipose Tissue Function and Weight Development Over Time|Completed||N/A|105|Actual|Karolinska Institutet|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, adipose tissue, adipocytes   "|||2017-10-11 00:04:01.031376|2017-10-11 00:04:01.031376
NCT02227030|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-26|||April 2000||2000-04-01|August 2014|2014-08-01||||September 2000|Actual|2000-09-01||Interventional|||Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects|Tolerability and Pharmacokinetics of Single Oral Administration of 10, 20, 50, 100, 200 and 300 mg BIIB 722 CL (Calculated as Free Base) as Drinking Solution and of 200, 450, 600 and 750 mg BIIB 722 CL as Filmcoated Tablet in Healthy Subjects. An Open Study With Rising Doses, Partly Uncontrolled Intra-individual Comparison, Placebo Randomised Double Blind at Each Dose Level.|Completed||Phase 1|71|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:04:01.109602|2017-10-11 00:04:01.109602
NCT02227017|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-26|||February 2006||2006-02-01|August 2014|2014-08-01||||April 2006|Actual|2006-04-01||Interventional|||Relative Bioavailability of Tipranavir (TPV)/Ritonavir (RTV) at Steady State Administered as Oral Solutions vs. Capsules in the Fed and Fasted State in Healthy Volunteers|An Open-label, Single-site, One-sequence Cross-over Study to Assess the Relative Bioavailability of TPV/r 500 mg/200 mg at Steady State When TPV and RTV Are Administered as Oral Solutions vs. Capsules in the Fed and Fasted State.|Completed||Phase 1|35|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:04:01.222272|2017-10-11 00:04:01.222272
NCT02227004|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-03-22|||December 30, 2011||2011-12-30|March 2017|2017-03-01|December 30, 2017|Anticipated|2017-12-30|December 2017|Anticipated|2017-12-01||Interventional|||Safety of Magnetic Resonance Imaging in Patients With Pacemakers and Defibrillators|Safety of Clinically Indicated Magnetic Resonance Imaging in Patients With Permanent Pacemakers (PPM) and Implanted Cardioverter Defibrillators|Active, not recruiting||N/A|1700|Actual|Johns Hopkins University||1|||f||||f||||||||No||2017-10-11 00:04:01.372959|2017-10-11 00:04:01.372959
NCT02226991|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-26|||April 2006||2006-04-01|August 2014|2014-08-01||||July 2006|Actual|2006-07-01||Interventional|||Effects of Steady-state Efavirenz 600 mg QD (Sustiva®) on Tipranavir Concentration at Steady-state in Healthy Adult Volunteers|A Single-centre, Open-label Study to Assess the Effects of Steady-state Efavirenz 600 mg QD (Sustiva®) on Tipranavir Concentration When Tipranavir/Ritonavir Are Administered at Doses 500 mg/200 mg BID to Steady-state in Healthy Adult Volunteers|Completed||Phase 1|34|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:04:01.520039|2017-10-11 00:04:01.520039
NCT02226978|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-26|||February 2007||2007-02-01|August 2014|2014-08-01||||May 2007|Actual|2007-05-01||Interventional|||Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers|An Open-label One-sequence Cross-over Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir 500/200 mg With Single-dose Valaciclovir (500 mg) in Healthy Volunteers|Completed||Phase 1|29|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:04:01.633498|2017-10-11 00:04:01.633498
NCT02226965|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-03-13|||December 2014||2014-12-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|September 2016|Actual|2016-09-01||Interventional|||PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)|A Phase II Study of PNT2258 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Active, not recruiting||Phase 2|61|Anticipated|Sierra Oncology, Inc.||1|||f||||t||||||||Undecided||2017-10-11 00:04:01.734109|2017-10-11 00:04:01.734109
NCT02226952|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-26|||November 2001||2001-11-01|August 2014|2014-08-01||||April 2002|Actual|2002-04-01||Interventional|||Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection|A Randomised, Double-blind, Placebo Controlled Trial With 25 mg, 200 mg and 500 mg BILN 2061 ZW Given p.o. at Two Consecutive Days Bid to Investigate the Antiviral Efficacy, Pharmacokinetics, Safety in Patients With Chronic Hepatitis C Virus Infection|Completed||Phase 1/Phase 2|51|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:04:01.874791|2017-10-11 00:04:01.874791
NCT02226939|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-26|||September 2002||2002-09-01|August 2014|2014-08-01||||November 2002|Actual|2002-11-01||Interventional|||Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C|A Randomised, Double-blind, Placebo Controlled Trial With 200 mg BILN 2061 ZW Given p.o. at Two Consecutive Days Bid to Investigate the Antiviral Efficacy, Pharmacokinetics, Safety in Patients With Cirrhosis and Chronic Hepatitis C|Completed||Phase 2|10|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:04:01.976373|2017-10-11 00:04:01.976373
NCT02226926|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2014-08-26|||July 2000||2000-07-01|August 2014|2014-08-01||||September 2000|Actual|2000-09-01||Interventional|||Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers|Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers|Completed||Phase 1|15|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:04:02.066687|2017-10-11 00:04:02.066687
NCT02226913|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-08-29|||February 2013||2013-02-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Sodium Bicarbonate Buffered Lidocaine on the Success of IAN Block of Teeth With Irreversible Pulpitis|Effect of Sodium Bicarbonate Buffered Lidocaine on the Success of Inferior Alveolar Nerve Block for Teeth With Symptomatic Irreversible Pulpitis: A Prospective, Randomized Double-blind Study|Completed||Phase 3|80|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||No||2017-10-11 00:04:02.151987|2017-10-11 00:04:02.151987
NCT01868152|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-03-19|||April 2013||2013-04-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||The Realtime Detection for Prediction of Opioid Analgesic|Study of Prediction of Opioid Analgesic|Completed||N/A|131|Actual|Huazhong University of Science and Technology|||1||f||||t||||||||||2017-10-11 01:38:49.158691|2017-10-11 01:38:49.158691
NCT02226900|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-25|||August 2014||2014-08-01|August 2014|2014-08-01||||October 2016|Anticipated|2016-10-01||Interventional|MERGING||Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel Disease|Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel Disease|Unknown status|Recruiting|N/A|60|Anticipated|InCor Heart Institute||2|||f||||f||||||||||2017-10-11 00:04:02.247799|2017-10-11 00:04:02.247799
NCT02226887|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-04-11|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|May 2018|Anticipated|2018-05-01||Interventional|ILEOCLOSE||Prophylaxis of Ileostomy Closure Site Hernia by Placing Mesh|"Prospective Randomized Clinical Trial of Ileostomy Closure Site Hernia and it´s Prophylaxis by Placing an Absorbable Mesh "|Recruiting||Phase 4|120|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||No||2017-10-11 00:04:02.360707|2017-10-11 00:04:02.360707
NCT02226874|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-06-30|||August 9, 2014||2014-08-09|May 23, 2017|2017-05-23|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Observational|||Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation|A Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation|Completed||N/A|38|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:04:02.478801|2017-10-11 00:04:02.478801
NCT02226861|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-06-30|||August 21, 2014||2014-08-21|June 2, 2017|2017-06-02|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation|Ultra Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation|Recruiting||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:04:02.695821|2017-10-11 00:04:02.695821
NCT02226848|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-06-30|||August 15, 2014||2014-08-15|May 31, 2017|2017-05-31|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in People With Persistent Symptoms During the Subacute Period After Traumatic Brain Injury|Effect of Administration of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Patients With Persistent Symptoms During the Subacute Period After TBI|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:04:02.802965|2017-10-11 00:04:02.802965
NCT02226835|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-06-30|||August 13, 2014||2014-08-13|January 24, 2017|2017-01-24|January 24, 2017|Actual|2017-01-24|January 24, 2017|Actual|2017-01-24||Observational|||Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198|An Investigation of Retinal Findings in Patients With Signs and Symptoms of Alzheimer's Disease Enrolled in 09-M-0198|Terminated||N/A|33|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:04:02.880779|2017-10-11 00:04:02.880779
NCT02226822|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2017-07-18|||September 20, 2014|Actual|2014-09-20|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|J-DISCOVER||DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan|J-DISCOVER: DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan|Active, not recruiting||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:04:02.968056|2017-10-11 00:04:02.968056
NCT02226809|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-26|||June 2014||2014-06-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|ReCuSS||Multi-center Study of Residual Neuromuscular Block Incidence in the Post-anesthesia Care Unit|Incidence of Residual Neuromuscular Block in Adult Patients in the Postanesthesia Care Unit. An Observational Cross-sectional Study of a Multicenter Cohort. The Residual Curarization in Spain Study (ReCuSS).|Completed||N/A|763|Actual|University of Valencia|||1||f||||f||||||||||2017-10-11 00:04:03.27083|2017-10-11 00:04:03.27083
NCT02226796|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-04-21|||September 1, 2015|Actual|2015-09-01|April 2017|2017-04-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia|Effects of a Combination of Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Non-fluent Aphasia|Recruiting||N/A|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|t|f|f||||Undecided|The protocol for sharing individual participant data with other researchers has not yet been determined as data collection is in progress.|2017-10-11 00:04:03.470092|2017-10-11 00:04:03.470092
NCT02226783|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-26|2015-09-18|||March 2013||2013-03-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||D5611C00003 - Food Interaction Study With AZD1722 Tablet in Healthy Subjects|Phase I Study in Healthy Subjects to Evaluate the Pharmacodynamics (PD) of AZD1722 Given With and Without Food (Part A) and a 2-way Crossover to Evaluate the PD of AZD1722 Given as a Free-base Tablet With and Without Omeprazole (Part B)|Completed||Phase 1|37|Actual|Ardelyx||5|||f||||f||||||||||2017-10-11 00:04:03.574505|2017-10-11 00:04:03.574505
NCT02226770|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-08-26|||July 2010||2010-07-01|August 2014|2014-08-01|October 2016|Anticipated|2016-10-01|October 2014|Anticipated|2014-10-01||Interventional|Anxiety-CHF||Heart-focused Anxiety in Patients With Heart Failure and ICD|Heart-focused Anxiety in Patients With Implantable Cardioverter Defibrillator (ICD) and/or Mechanical Cardiovascular Assist Device (AD) (Anxiety-CHF)|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Saarland||1|||f||||||||||||||2017-10-11 00:04:03.679095|2017-10-11 00:04:03.679095
NCT02226757|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-08-25|||August 2014||2014-08-01|August 2014|2014-08-01||||August 2016|Anticipated|2016-08-01||Interventional|||Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients|Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients After Progression on TKI-treatment; a Pilot-study|Unknown status|Not yet recruiting|Phase 2|16|Anticipated|VU University Medical Center||1|||f||||f||||||||||2017-10-11 00:04:03.794368|2017-10-11 00:04:03.794368
NCT02226744|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-12-30|||August 2014||2014-08-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study to Measure Relaxation From Different Types of Focused Breathing Exercises|Focused Breathing Study|Terminated||Phase 1|24|Actual|Vanderbilt University Medical Center||2||No funds to complete study as anticipated, preliminary data used for future grant|f||||f||||||||||2017-10-11 00:04:03.883794|2017-10-11 00:04:03.883794
NCT02226731|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-02-02|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|TUB||Intrauterine Tamponade With a Belfort-Dildy Balloon in the Treatment of Immediate Postpartum Hemorrhage|Assessment of the Efficacy of Early Intrauterine Tamponade With a Belfort-Dildy Balloon Obstetric Tamponade System in the Treatment of Immediate Postpartum Hemorrhage|Recruiting||N/A|650|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-11 00:04:03.966179|2017-10-11 00:04:03.966179
NCT02226718|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-25|||October 2014||2014-10-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Validation of a Questionnaire for Measuring Quality of Life in Patients With Chronic Inflammation of the Middle Ear|Validation of a Questionnaire for Measuring Health-related Quality of Life in Patients With Chronic Otitis Media|Unknown status|Not yet recruiting|N/A|160|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-11 00:04:04.084244|2017-10-11 00:04:04.084244
NCT02226705|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-08-12|||January 2015||2015-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|MICCA||Endoscopic Surgical Treatment of Rhino-Sinusal Mucormycosis|Treatment of Rhino-Sinusal Mucormycosis Through Transnasal Endoscopic Surgery Extended to the Skull Base.|Recruiting||Phase 2|23|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:04:04.165088|2017-10-11 00:04:04.165088
NCT02226692|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-05-26|||October 2011||2011-10-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Observational|||Prognostic Factors of Disabling Low Back Pain in Patients With Chronic Low Back Pain|Risk of Poor Prognosis in Patients With Chronic Low Back Pain : Can it be Predicted by Physical Tests and Screening Tools ? - An Observational Study|Completed||N/A|53|Actual|Université du Québec à Trois-Rivières|||1||f||||f||||||||||2017-10-11 00:04:04.284908|2017-10-11 00:04:04.284908
NCT02226679|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-08-25|||January 2014||2014-01-01|August 2014|2014-08-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||An Open Label Rollover Trial for Patients Randomized to the Control Group of Study LSH-10-001|An Open Label Rollover Trial for Patients Randomized to the Control Group of Study LSH-10-001 (Rollover Study for AUGMENT-HF)|Unknown status|Active, not recruiting|N/A|24|Anticipated|LoneStar Heart, Inc.||1|||f||||t||||||||||2017-10-11 00:04:04.370674|2017-10-11 00:04:04.370674
NCT02226666|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-01-12|||August 2013||2013-08-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration|Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration|Completed||N/A|107|Actual|University of Michigan|||2||f||||f||||||||No||2017-10-11 00:04:04.454562|2017-10-11 00:04:04.454562
NCT02226653|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-05-08|||September 2014||2014-09-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study of Evacetrapib in Healthy Japanese Participants|A Bioequivalence and Food Effect Study of Evacetrapib Evaluating a Single Tablet Compared to Two Tablets in Healthy Japanese Subjects|Completed||Phase 1|48|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:04:04.54364|2017-10-11 00:04:04.54364
NCT02226640|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-01-12|||November 2010||2010-11-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|ORIGINS||Uncovering the 'ORIGINS' of Diabetes|Uncovering the 'ORIGINS' of Diabetes|Completed||N/A|80|Actual|Translational Research Institute for Metabolism and Diabetes, Florida|||8||f||||t||||||Samples With DNA|"     Blood Urine Fat tissue Muscle Tissue   "|||2017-10-11 00:04:04.630925|2017-10-11 00:04:04.630925
NCT02226627|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-09-06|||March 2014||2014-03-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Observational|||Latin American Survey of Nutrition and Health / Estudio Latinoamericano de Nutrición y Salud|Latin American Survey of Nutrition and Health / Estudio Latinoamericano de Nutrición y Salud|Completed||N/A|9000|Actual|Hospital Infantil Sabará|||1||f||||t||||||||||2017-10-11 00:04:04.728904|2017-10-11 00:04:04.728904
NCT02226614|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-06-14|||August 2014||2014-08-01|December 2015|2015-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Development of a Head Cooling Device|Development of a Head-cooling Device for Brain Injury: Healthy Volunteer Study|Completed||N/A|40|Actual|University of Edinburgh||1|||f||||f||||||||||2017-10-11 00:04:04.812704|2017-10-11 00:04:04.812704
NCT02226601|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-05-29|||October 2014||2014-10-01|May 2015|2015-05-01||||October 2016|Anticipated|2016-10-01||Interventional|||Aprepitant to Mitigate Opioids' Cognitive Side Effects|Aprepitant to Mitigate Opioids' Cognitive Side Effects|Unknown status|Recruiting|N/A|50|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-11 00:04:04.884644|2017-10-11 00:04:04.884644
NCT02226588|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-02-12|||October 2014||2014-10-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Comparison of Primary and Secondary Prevention of Postpartum Hemorrhage at the Community Level in Egypt|Two Community Strategies Comparing Use of Misoprostol for Secondary Prevention to Primary Prevention for Postpartum Hemorrhage: A Randomized Cluster Non-Inferiority Study in El Beheira Governorate, Egypt|Completed||Phase 4|2827|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-11 00:04:04.964876|2017-10-11 00:04:04.964876
NCT02226575|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-03-05|||September 2011||2011-09-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|November 2014|Actual|2014-11-01||Interventional|MANCAF||Management and Coaching in Atrial Fibrillation|Study of Management and Coaching in Atrial Fibrillation|Unknown status|Active, not recruiting|N/A|150|Actual|FUTURUM, Academy of Health and Science||2|||f||||t||||||||||2017-10-11 00:04:05.085175|2017-10-11 00:04:05.085175
NCT02226562|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-07-30|2015-07-30||September 2014||2014-09-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity|Completed||Phase 2|191|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:04:05.19145|2017-10-11 00:04:05.19145
NCT02226549|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-02-05|2016-02-05||July 2014||2014-07-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Safety Analysis Set: participants who received at least 1 dose of study drug.|Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis|A Phase 2, Randomized, Open-Label Study of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Subjects With Chronic Genotype 1 HCV Infection and Cirrhosis|Completed||Phase 2|47|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||f||||||||||2017-10-11 00:04:05.836223|2017-10-11 00:04:05.836223
NCT02226536|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-26|||December 2005||2005-12-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Vestibular Dysfunction and Glucose Metabolism|Fractionated and Restrictive Glucose Diet in Patients With Vestibular Dysfunction: a Randomized Controlled Trial|Completed||N/A|51|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:04:06.442292|2017-10-11 00:04:06.442292
NCT02226523|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-08-15|||February 2014||2014-02-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|6 Months|Observational [Patient Registry]|||Magnetic Nanoparticles System in Acute Coronary Syndrome|The Development and Clinical Application of Rapid Assays Using Multi-antibody-activated Magnetic Nanoparticles System in Acute Coronary Syndrome|Recruiting||N/A|1000|Anticipated|Far Eastern Memorial Hospital|||1||f||||f||||||Samples Without DNA|"     plasma/serum   "|||2017-10-11 00:04:06.51973|2017-10-11 00:04:06.51973
NCT02226510|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|MET-REMODEL||MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease|MetfoRmin and Its Effects on Myocardial Dimension and Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease|Active, not recruiting||Phase 4|68|Actual|University of Dundee||2|||f||||f||||||||||2017-10-11 00:04:06.645224|2017-10-11 00:04:06.645224
NCT02226497|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-08-15|||January 9, 2015|Actual|2015-01-09|August 2017|2017-08-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy|Integrating a Telemonitoring Device Into the Outpatient Management of Adult Patients Following Intensive Chemotherapy for MDS and Non-APL AML: A Randomized Pilot Study|Recruiting||N/A|40|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 00:04:06.792239|2017-10-11 00:04:06.792239
NCT02226484|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-12-19|||August 2014||2014-08-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?|Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?|Completed||Phase 1|26|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||No|No plans to share data|2017-10-11 00:04:06.927122|2017-10-11 00:04:06.927122
NCT02226471|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2014-08-25|||March 2012||2012-03-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01|3 Years|Observational [Patient Registry]|||Serum CTRP3 and RBP4 Levels in Obesity and Hypertension|Serum CTRP3 and RBP4 Levels in Obesity and Hypertension|Completed||N/A|2000|Actual|Third Military Medical University|||4||f||||t||||||||||2017-10-11 00:04:07.025888|2017-10-11 00:04:07.025888
NCT02226458|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-03-09|||October 2014||2014-10-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|Autism||An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder|An Exploratory Open-Label Phase 2 Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder|Withdrawn||Phase 2|0|Actual|Edison Pharmaceuticals Inc||1||This study was halted prior to enrolling.|f||||f||||||||||2017-10-11 00:04:07.111239|2017-10-11 00:04:07.111239
NCT02226445|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-08-26|||September 2010||2010-09-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Treatment Drop-out and Missed Appointments Among Adults With ADHD|Treatment Drop-out and Missed Appointments Among Adults With Attention-Deficit/Hyperactivity Disorder: Associations With Patient- and Disorder-related Factors|Completed||N/A|153|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 00:04:07.241234|2017-10-11 00:04:07.241234
NCT02226419|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-05-04|||August 2013||2013-08-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CTD||Fat and Sugar Metabolism During Exercise, With and Without L-carnitine in Patients With Carnitine Transporter Deficiency|Fat and Carbohydrate Metabolism During Exercise, With and Without L-carnitine Supplementation in Patients With Carnitine Transporter Deficiency|Completed||N/A|14|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 00:04:07.452728|2017-10-11 00:04:07.452728
NCT02226406|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-01-13|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|EFRA||Effect of Early Physical Exercise on Pulmonary Ventilation and Recruitment|Effect of Early Physical Exercise on Pulmonary Ventilation and Recruitment Evaluated With Electric Impedance Tomography.|Completed||N/A|50|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f||||t||||||||||2017-10-11 00:04:07.530969|2017-10-11 00:04:07.530969
NCT02226393|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-08-17|||October 2014||2014-10-01|March 2015|2015-03-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluating Effectiveness of Dyadic Prolonged Exposure on 2-4 Years Old vs. Toddler-parent Focused Treatment|Evaluating Effectiveness of Dyadic Prolonged Exposure Treatment on 2-4 Years Old vs. Toddler-parent Focused Treatment|Recruiting||N/A|100|Anticipated|Association for Children at Risk||2|||f||||t||||||||||2017-10-11 00:04:07.674483|2017-10-11 00:04:07.674483
NCT02226380|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2014-08-26|||October 2013||2013-10-01|August 2014|2014-08-01||||December 2014|Anticipated|2014-12-01||Interventional|FOLFOX6||FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer|A Phase II Study of Neoadjuvant Chemotherapy With Modified FOLFOX6 Regimen and Effects of Tumor Regression in Locally Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|75|Anticipated|Peking Union Medical College Hospital||1|||f||||f||||||||||2017-10-11 00:04:07.806672|2017-10-11 00:04:07.806672
NCT02226367|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-10-05|||January 2015||2015-01-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD|Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD|Recruiting||N/A|300|Anticipated|Seattle Institute for Biomedical and Clinical Research||2|||f||||t||||||||||2017-10-11 00:04:07.901345|2017-10-11 00:04:07.901345
NCT02226354|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-09-01|||May 2014||2014-05-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of the Safety and Efficacy of Dietary Buglossoides Oil|Study of the Safety and Efficacy of Dietary Buglossoides Oil|Completed||Phase 1|40|Actual|Réseau de Santé Vitalité Health Network||2|||f||||f||||||||||2017-10-11 00:04:08.024332|2017-10-11 00:04:08.024332
NCT02226341|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-03-17|||October 2014||2014-10-01|March 2016|2016-03-01|July 2024|Anticipated|2024-07-01|January 2024|Anticipated|2024-01-01||Interventional|ACTHar||ACTHar in the Treatment of Lupus Nephritis|Open-label Prospective Randomized Study to Determine the Efficacy and Safety of Two Dosing Regimens of ACTHar in the Treatment of Proliferative Lupus Nephritis.|Recruiting||Phase 4|20|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-11 00:04:08.163433|2017-10-11 00:04:08.163433
NCT02226328|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-06-29|||November 2014||2014-11-01|June 2015|2015-06-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety.||Unknown status|Recruiting|Phase 4|128|Anticipated|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 00:04:08.309462|2017-10-11 00:04:08.309462
NCT02226315|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2015-09-15|||August 2014||2014-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies|A Retrospective Analysis of Fetal Outcome Compared to Massively Parallel Sequencing Test Results Obtained From Multiple Gestation Pregnancies at Increased Risk for Fetal Chromosomal Aneuploidy|Terminated||N/A|50|Actual|Sequenom, Inc.|||1|Slow enrollment of eligible subjects|f||||f||||||Samples With DNA|"     Some subjects will be asked to provide a buccal cell sample for sequencing.   "|||2017-10-11 00:04:08.414859|2017-10-11 00:04:08.414859
NCT02226302|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-04-20|||July 2014||2014-07-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|FETCH||Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer|Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer|Unknown status|Recruiting|N/A|16|Anticipated|Queensland Centre for Gynaecological Cancer|||3||f||||f||||||Samples With DNA|"     Omental fat samples will be stored for one year for study purposes. They will not be stored     for future research   "|||2017-10-11 00:04:08.488818|2017-10-11 00:04:08.488818
NCT02226289|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-08-27|||August 2014||2014-08-01|August 2014|2014-08-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01||Interventional|BATTLE||Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment|Phase II Study of Bevacizumab-containing Regimen in Patients With Metastatic Colorectal Cancer Who Failed to Cytotoxic Treatment|Recruiting||Phase 2|30|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:04:08.593109|2017-10-11 00:04:08.593109
NCT02226276|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-09-14|||January 7, 2015|Actual|2015-01-07|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer|A Pilot Study of 64Cu-DOTA-Trastuzumab Positron Emission Tomography in Treatment of Advanced HER2 Positive Breast Cancer With the Antibody Drug Conjugate Ado-trastuzumab Emtansine|Active, not recruiting||N/A|10|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:04:08.713355|2017-10-11 00:04:08.713355
NCT02226250|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-02-06|||August 2014||2014-08-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|SR||Absorption and Metabolic Profiles of a Sugar-based Beverage|Absorption Profile of a Sugar-based Beverage on Inflammatory Mechanism by Timing of Beverage Consumption Relative to Meal Intake.|Active, not recruiting||N/A|12|Anticipated|Institute for Food Safety and Health, United States||1|||f||||t||||||||||2017-10-11 00:04:08.928922|2017-10-11 00:04:08.928922
NCT02226237|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-01-13|||September 2010||2010-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy|URINARY INCONTINENCE AND ERECTIL DYSFUNCTION AFTER RADICAL PROSTATECTOMY: A Randomized Controlled Trial Comparing Pelvic Muscle Exercises With or Without Electrical Stimulation|Completed||N/A|237|Actual|Barretos Cancer Hospital||3|||f||||f||||||||||2017-10-11 00:04:09.002893|2017-10-11 00:04:09.002893
NCT02226224|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2017-07-17|||June 2014||2014-06-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro|Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro|Recruiting||N/A|120|Anticipated|Beijing Cancer Hospital|||4||f||||f||||||||||2017-10-11 00:04:09.092241|2017-10-11 00:04:09.092241
NCT02226211|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-08-26|||June 2014||2014-06-01|August 2014|2014-08-01||||December 2014|Anticipated|2014-12-01||Interventional|||Ambu Aura-i Laryngeal Mask Versus Air-Q Intubating Laryngeal Airway for Tracheal Intubation in Adults|Ambu® Aura-iTM Laryngeal Mask Versus Air-QTM Intubating Laryngeal Airway as Conduits for Tracheal Intubation in Adults. A Randomized Comparative Clinical Trial|Unknown status|Recruiting|Phase 3|50|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-11 00:04:09.169575|2017-10-11 00:04:09.169575
NCT02226198|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-07-01|2015-12-18||November 2014||2014-11-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|HYDRA|Number of baseline participants are not the same as started as there was a lead-in phase in between and as 6 of the 20 patients starting did not enter the cross-over phase, the beginning of which defines the baseline.|A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia|A Randomized, Double-blind, Placebo-controlled, Multi-center, Cross-over Study of Rosuvastatin in Children and Adolescents (Aged 6 to <18 Years) With Homozygous Familial Hypercholesterolemia (HoFH)|Completed||Phase 3|20|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:04:09.349205|2017-10-11 00:04:09.349205
NCT02226185|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2015-05-26|||December 2014||2014-12-01|May 2015|2015-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence|Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence:a Prospective, Double Blind, Randomized, Placebo-controlled, Multicenter Clinical Trial|Recruiting||Phase 2/Phase 3|200|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 00:04:11.81885|2017-10-11 00:04:11.81885
NCT02226172|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-09-28|||October 6, 2014|Actual|2014-10-06|September 2017|2017-09-01|December 24, 2017|Anticipated|2017-12-24|December 14, 2016|Actual|2016-12-14||Interventional|||Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib|A Phase 2, Double-blind, Randomized Safety And Efficacy Study Of Glasdegib (Pf-04449913) Versus Placebo In Patients With Myelofibrosis Previously Treated With Ruxolitinib|Recruiting||Phase 2|222|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-11 00:04:11.910179|2017-10-11 00:04:11.910179
NCT02226159|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-09-26|||August 2014|Actual|2014-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|SPIES||Surgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain|Surgery Prevention by Transforaminal Injection of Epidural Steroids for Cervical Radicular Pain (SPIES): a Randomized, Controlled Trial|Recruiting||Phase 4|60|Anticipated|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-11 00:04:12.073642|2017-10-11 00:04:12.073642
NCT02226146|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2016-11-08|||February 2016||2016-02-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid|An Open-Label, Proof of Concept Study Designed to Evaluate the Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Newly Diagnosed, Moderate to Extensive Bullous Pemphigoid|Recruiting||Phase 2|15|Anticipated|Immune Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:04:12.2271|2017-10-11 00:04:12.2271
NCT02226133|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2015-05-01|||April 2015||2015-04-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|VALET||Video-Assisted Left Atrial Appendage Exclusion Trial|"A Clinical Trial to Evaluate Safety and Effectiveness of the LAAx,Inc., TigerPaw System II LAA Exclusion Device for the Exclusion of the Left Atrial Appendage Via Video-Assisted Thoracoscopic Surgery (VATS)"|Withdrawn||N/A|0|Actual|LAAx, Inc.||1||stopped for operational reasons|f||||t||||||||||2017-10-11 00:04:12.404282|2017-10-11 00:04:12.404282
NCT02226120|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-08-18|||October 16, 2014|Actual|2014-10-16|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction|A Multicenter Study to Evaluate Safety and Tolerability in Patients With Chronic Heart Failure and Reduced Ejection Fraction From PARADIGM-HF Receiving Open Label LCZ696|Active, not recruiting||Phase 3|2009|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 00:04:12.566459|2017-10-11 00:04:12.566459
NCT02226107|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-09-29|||January 2014||2014-01-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Latino Peers as Patient Navigators for Colon Cancer Screening|Training Latinos as Peer Patient Navigators for Colon Cancer Screening|Completed||N/A|85|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 00:04:13.617538|2017-10-11 00:04:13.617538
NCT02226094|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-04-03|||November 2013||2013-11-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension|A Prospective, Randomized, Controlled Clinical Feasibility Investigation of the Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects|Terminated||Phase 1/Phase 2|35|Actual|OcuTherix, Inc.||4||Lack of funding|f||||f||||||||||2017-10-11 00:04:13.716472|2017-10-11 00:04:13.716472
NCT02226081|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-04-18|||June 2014||2014-06-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|BE3||ShearWave™ Elastography of Breast Lesions in Chinese Patients|Assessment of ShearWave™ Elastography in the Ultrasonic Diagnosis of Breast Cancer in Chinese Patients|Completed||N/A|2273|Actual|SuperSonic Imagine|||1||f||||f||||||||||2017-10-11 00:04:13.842206|2017-10-11 00:04:13.842206
NCT02226068|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-03-26|||June 2002||2002-06-01|August 2014|2014-08-01|January 2004|Actual|2004-01-01|August 2003|Actual|2003-08-01||Interventional|||Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis|Ciclosporine and Extracorporal Photopheresis (ECP) Are Equipotent in Treating Severe Atopic Dermatitis (AD): A Randomized Cross-over Study Comparing Two Efficient Treatment Modalities|Completed||N/A|20|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:04:13.961477|2017-10-11 00:04:13.961477
NCT02226055|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-08-26|||September 2014||2014-09-01|August 2014|2014-08-01|July 2017|Anticipated|2017-07-01|November 2014|Anticipated|2014-11-01||Observational|||An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka|An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka|Unknown status|Not yet recruiting|N/A|350|Anticipated|University of Edinburgh|||4||f||||f||||||Samples With DNA|"     Urine samples: up to 30ml Blood samples: up to 40ml - 2 x EDTA blood bottles + 2 x serum gel     Z bottles   "|||2017-10-11 00:04:14.044919|2017-10-11 00:04:14.044919
NCT02226042|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-05-01|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Investigating the Mechanisms of Mindfulness-based Cognitive Therapy (MBCT)|Investigating the Neuropsychological Mechanisms Underlying Mindfulness-based Cognitive Therapy|Active, not recruiting||N/A|112|Actual|University of Manchester||3|||f||||f||||||||No||2017-10-11 00:04:14.153997|2017-10-11 00:04:14.153997
NCT02226029|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-04-08|||August 2014||2014-08-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|Q-MRemulsion||Quantitative MR Methods for Lipid Emulsions|Quantitative Magnetic Resonance (MR) Methods for Non-invasive Imaging of Gastro-intestinal (GI) Processing of Lipid Emulsions in Healthy Subjects.|Completed||Early Phase 1|22|Actual|University of Zurich||2|||f||||t||||||||||2017-10-11 00:04:14.283513|2017-10-11 00:04:14.283513
NCT02226016|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-23|||September 2014||2014-09-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Levator Muscle Strength Evaluation|Quantitative Evaluation of Levator Palpebra Muscle Strength|Unknown status|Not yet recruiting|N/A|50|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 00:04:14.428264|2017-10-11 00:04:14.428264
NCT02226003|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-02-23|2017-02-23||September 2014||2014-09-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Initial Combination of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Subjects With T2DM With Inadequate Glycemic Control on Diet and Exercise|Completed||Phase 3|291|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 00:04:14.588989|2017-10-11 00:04:14.588989
NCT02225990|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-09-29|||July 2015||2015-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|QualPro||Implementation of Comprehensive Stroke Rehabilitation Therapy for Enhanced Quality of Life|Implementation of Gait Coordination, Mobility, and Fitness Training for Enhanced Quality of Life and Participation in Life Roles|Recruiting||N/A|40|Anticipated|University of Florida||4|||f||||f|f|||||||||2017-10-11 00:04:15.742245|2017-10-11 00:04:15.742245
NCT02225977|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2017-05-23|||July 31, 2013|Actual|2013-07-31|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|December 31, 2016|Actual|2016-12-31||Observational|||Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.|Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.|Completed||N/A|125|Anticipated|University of Southern California|||5||f||||f||||||||||2017-10-11 00:04:15.861174|2017-10-11 00:04:15.861174
NCT02225964|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2016-08-19|||January 2014||2014-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD||Recruiting||N/A|200|Anticipated|Xuanwu Hospital, Beijing|||1||f||||t||||||||||2017-10-11 00:04:15.939426|2017-10-11 00:04:15.939426
NCT02225951|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-09-04|||July 2014||2014-07-01|September 2017|2017-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|GDM-MTT||Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.|A Randomised, Controlled, Open-label Trial to Investigate the Effect of a New Nutritional Supplement on Postprandial Glucose Response in Women Diagnosed With Gestational Diabetes Mellitus.|Terminated||N/A|3|Actual|Danone Asia Pacific Holdings Pte, Ltd.||2||Current protocol is not optimal/feasible|f||||f||||||||||2017-10-11 00:04:16.021334|2017-10-11 00:04:16.021334
NCT02225938|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-04-05|||August 2014||2014-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ICU-RECOVERY||ICU Recovery in Australian Patients|ICU Recovery: A Multicentre Cohort Study in Critically Ill Patients to Determine Functional Recovery and Quality of Life|Completed||N/A|264|Actual|Australian and New Zealand Intensive Care Research Centre|||1||f||||f||||||||||2017-10-11 00:04:16.123395|2017-10-11 00:04:16.123395
NCT02225925|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-11-17|||August 2014||2014-08-01|November 2015|2015-11-01|March 2021|Anticipated|2021-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound|Phase II Study of Dynamic Intraoperative Dosimetry for Prostate Brachytherapy Using Registered Fluoroscopy and Ultrasound|Recruiting||Phase 2|24|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:04:16.240689|2017-10-11 00:04:16.240689
NCT02225912|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2014-08-25|||February 2005||2005-02-01|August 2014|2014-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers||Completed||Phase 4|||BioHealth Technologies Inc.||2|||f||||||||||||||2017-10-11 00:04:16.355845|2017-10-11 00:04:16.355845
NCT02225899|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-01-18|||September 2014||2014-09-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|BEAM-CF||BioEnergetics and Metabolomics in Cystic Fibrosis|Integration of Nutritional Metabolomics With Bioenergetics in Cystic Fibrosis|Recruiting||N/A|130|Anticipated|Emory University|||3||f||||f||||||Samples Without DNA|"     We will collect sputum, urine, and blood.   "|||2017-10-11 00:04:16.532601|2017-10-11 00:04:16.532601
NCT02225886|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-09-22|||January 1, 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|FeVitC||Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients|Effects of Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients With Iron Overload|Not yet recruiting||Phase 4|100|Anticipated|Anemia Working Group Romania||2|||f||||t|f|f||||||||2017-10-11 00:04:16.629898|2017-10-11 00:04:16.629898
NCT02225873|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2015-11-30|||September 2014||2014-09-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||The Effectiveness of Exercises Protocol in Management of Neck Pain|The Effectiveness of Two Training Protocols When Managing Chronic Cervical Pain: Controlled Randomized Clinical Trial.|Completed||N/A|40|Actual|University of Alcala||2|||f||||t||||||||||2017-10-11 00:04:16.768416|2017-10-11 00:04:16.768416
NCT02225860|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-02-10|2016-12-02||May 2014||2014-05-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease|Low Osmolar Diet and Adjusted Water Intake for Vasopressin Suppression in ADPKD|Completed||Phase 2/Phase 3|34|Actual|Tufts Medical Center|Small sample size and short follow up duration.|2|||f||||f||||||||||2017-10-11 00:04:16.860761|2017-10-11 00:04:16.860761
NCT02225847|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-02-02|||September 2014||2014-09-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Gardening on Brain Activity|Effect of Gardening on Brain Activity|Completed||N/A|23|Actual|University of Florida||2|||f||||f||||||||Yes|"At the completion of the study de-identified raw fMRI data from the study will be submitted to OpenfMRI, an open source fMRI database repository located at: https://openfmri.org/.
De-identified processed datasets from the brain scans will be submitted to BrainMap or Neurosynth for open source access suitable for meta-analysis of processed fMRI data from brain imaging studies. The URL for BrainMap: http://www.brainmap.org/.
The URL for Neurosynth is: http://www.neurosynth.org/."|2017-10-11 00:04:17.159765|2017-10-11 00:04:17.159765
NCT02225834|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-08-25|||November 2011||2011-11-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Atorvastatin in Acute Stroke Treatment|Effects of Early Atorvastatin Treatment During the Acute Phase of Stroke on Immunoinflammatory Markers and Outcome in Patients With Acute Ischemic Stroke Classified as LAAS According TOAST Classification|Completed||Phase 4|50|Actual|University of Palermo||2|||f||||f||||||||||2017-10-11 00:04:17.264797|2017-10-11 00:04:17.264797
NCT02225821|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-12-21|||November 2014||2014-11-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|WIFI||Wound Infections Following Implant Removal|Antibiotic Prophylaxis to Prevent Wound Infections Following Implant Removal|Completed||Phase 4|500|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||Undecided||2017-10-11 00:04:17.378092|2017-10-11 00:04:17.378092
NCT02225808|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-09-01|||August 2014||2014-08-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Neural Mechanisms of CBT for Anxiety in Autism|Neural Mechanisms of Cognitive-Behavioral Therapy for Anxiety in Children With Autism Spectrum Disorder: A Pilot Study|Recruiting||N/A|10|Anticipated|Yale University||1|||f||||t||||||||||2017-10-11 00:04:17.534325|2017-10-11 00:04:17.534325
NCT02225795|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-03-28|||August 2014||2014-08-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.|A Pilot Study of Autologous Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Children and Young Adults With Refractory Crohn's Disease.|Recruiting||N/A|15|Anticipated|TriStar Health||1|||f||||t||||||||||2017-10-11 00:04:17.638429|2017-10-11 00:04:17.638429
NCT02225782|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-05-10|||October 2014||2014-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Trial to Compare 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring Hemodialysis Catheter Function|A Randomized Double-blind Controlled Study to Compare the Effectiveness of 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring|Recruiting||N/A|150|Anticipated|University of Windsor||2|||f||||f||||||||||2017-10-11 00:04:17.750114|2017-10-11 00:04:17.750114
NCT02225769|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-10-11|||December 2014||2014-12-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|e-POCT||Electronic Algorithms Based on Host Biomarkers to Manage Febrile Children|Electronic Algorithms Based on Host Biomarkers Point of Care Tests to Decide on Admission and Antibiotic Prescription in Tanzanian Febrile Children|Completed||N/A|3192|Actual|Swiss Tropical & Public Health Institute||3|||f||||t||||||||||2017-10-11 00:04:17.876917|2017-10-11 00:04:17.876917
NCT02225756|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-06-01|||December 2013||2013-12-01|May 2015|2015-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|ACA4||Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms|Brief Administration of Cyclosporine A to Induce the Stabilisation of the Diameter of Small Diameter Abdominal Aortic Aneurysms.|Recruiting||Phase 2|360|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-10-11 00:04:17.989035|2017-10-11 00:04:17.989035
NCT02225743|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-06-25|||August 2014||2014-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Observational Examination of Thermoregulation in Total Joint Arthroplasty|Observational Examination of Thermoregulation in Total Joint Arthroplasty|Completed||N/A|110|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-10-11 00:04:18.098042|2017-10-11 00:04:18.098042
NCT02225730|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2016-12-21|||September 2013||2013-09-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|iCAS||Imaging Collaterals in Acute Stroke (iCAS)|Imaging Collaterals in Acute Stroke|Recruiting||N/A|200|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 00:04:18.20038|2017-10-11 00:04:18.20038
NCT02225717|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-12-23|||December 2014||2014-12-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|TrophY2||Identification of Spontaneous Delivery Markers|Markers of Fetal Membranes Remodelling in Cervicovaginal Fluid and Delivery|Recruiting||N/A|260|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:04:18.341524|2017-10-11 00:04:18.341524
NCT02225704|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-08-09|||June 2015||2015-06-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Radium-223 in Combination With Enzalutamide|A Phase II Study of Radium-223 in Combination With Enzalutamide in Progressive Metastatic Castrate-Resistant Prostate Cancer|Active, not recruiting||Phase 2|44|Anticipated|Cancer Trials Ireland||1|||f||||f||||||||||2017-10-11 00:04:18.477264|2017-10-11 00:04:18.477264
NCT02225678|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-05-13|||July 2014||2014-07-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Minimally Invasive Biomarker for Asthma Disease Severity|Feasibility of Using an Eosinophil-Specific Biomarker-(Eosinophil Peroxidase) in Clinical Practice|Completed||N/A|25|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"     sputum   "|||2017-10-11 00:04:18.761757|2017-10-11 00:04:18.761757
NCT02225665|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-01-06|||August 2014||2014-08-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART|A Phase 1/2, Open-Label Study to Assess the Safety and Tolerability of Repeat Doses of Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects Following Cyclophosphamide Conditioning|Active, not recruiting||Phase 1/Phase 2|12|Anticipated|Sangamo Therapeutics||2|||f||||f||||||||||2017-10-11 00:04:18.891001|2017-10-11 00:04:18.891001
NCT02225652|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2014-08-25|||September 2010||2010-09-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|September 2013|Actual|2013-09-01||Interventional|||A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.|A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.|Completed||Phase 2|11|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-11 00:04:19.034103|2017-10-11 00:04:19.034103
NCT02225639|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2015-07-07|||August 2014||2014-08-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||PRC-063 in an ADULT Workplace Environment|A Randomized, Double-blind Study of the Time Course of Response of PRC-063 in Adults With ADHD in a Simulated Adult Workplace Environment|Completed||Phase 3|60|Actual|Rhodes Pharmaceuticals, L.P.||2|||f||||f||||||||||2017-10-11 00:04:19.146867|2017-10-11 00:04:19.146867
NCT02225626|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2015-05-10|||September 2014||2014-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects|Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:04:19.325327|2017-10-11 00:04:19.325327
NCT02225613|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-08-05|||October 2014||2014-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|Thermasport||Spa Rehabilitation After Cruciate Ligament Injury in Sportsmen|Comparison Between Two Rehabilitation Programs (Conventional and Aquatic) After Cruciate Ligament Injury in Sportsmen|Recruiting||N/A|128|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-11 00:04:19.443768|2017-10-11 00:04:19.443768
NCT02225600|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-09-13|||May 2013||2013-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults|The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults: A Pilot Behavioral Study|Recruiting||N/A|40|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 00:04:19.867724|2017-10-11 00:04:19.867724
NCT02225574|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-02-03|||March 11, 2015|Actual|2015-03-11|February 2017|2017-02-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Interventional|||An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)|An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)|Completed||Phase 1/Phase 2|1|Actual|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 00:04:20.106939|2017-10-11 00:04:20.106939
NCT02225561|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2016-05-09|||January 2015||2015-01-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|SICARE||SNPeCPR In Cardiac Arrest REsuscitation|SNPeCPR Pour la prIse en Charge Des Arrêts CaRdiaques Extrahospitaliers|Recruiting||Phase 3|462|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:04:20.217225|2017-10-11 00:04:20.217225
NCT02225548|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2015-12-18|||September 2014||2014-09-01|December 2015|2015-12-01||||January 2016|Anticipated|2016-01-01||Interventional|||Sagene 2014 - Parkinson's Disease and Erectile Dysfunction|An Open-label Trial of Oral Selegiline 5 or 10 mg and Tadalafil 2.5mg Co-administration to Male Patients With Parkinson's Disease and Moderate Erectile Dysfunction.|Recruiting||Phase 4|10|Anticipated|University of South Florida||1|||f||||||||||||||2017-10-11 00:04:20.321146|2017-10-11 00:04:20.321146
NCT02225535|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-06-27|||July 2014||2014-07-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Investigation of a Physiotherapist and Nurse Practitioner Intervention for Chronic Low Back Disorders Delivered Through Telehealth|Advancing Interprofessional Primary Health Care Services in Rural Settings for People With Chronic Low Back Disorders: Investigation of a Physiotherapist and Nurse Practitioner Intervention Delivered Through Telehealth|Completed||N/A|60|Anticipated|University of Saskatchewan||3|||f||||f||||||||||2017-10-11 00:04:20.411806|2017-10-11 00:04:20.411806
NCT02225522|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-06-22|||October 2014||2014-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|NSIGHT||Genomic Sequencing in Acutely Ill Neonates|Prospective Randomized Trial of the Clinical Utility of Rapid Next Generation Sequencing in Acutely Ill Neonates|Completed||N/A|65|Actual|Children's Mercy Hospital Kansas City||2|||f||||t||||||||||2017-10-11 00:04:20.518179|2017-10-11 00:04:20.518179
NCT02225509|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-10-23|||October 2014||2014-10-01|October 2014|2014-10-01||||December 2016|Anticipated|2016-12-01||Interventional|CITHY||Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology|Clinical Validation of the Diagnostic Performance of a Molecular Signature to Determine the Malignant or Benign Profile of a Thyroid Nodule With Indeterminate Cytological Analysis|Unknown status|Recruiting|N/A|1000|Anticipated|Diaxonhit||1|||f||||f||||||||||2017-10-11 00:04:20.613429|2017-10-11 00:04:20.613429
NCT02225496|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-09-28|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma|A Phase II Study of Transoral Robotic Surgery With Adjuvant Therapy for Surgically Resectable HPV-positive Oropharyngeal Cancer|Recruiting||Phase 2|150|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:04:20.705947|2017-10-11 00:04:20.705947
NCT02225483|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-25|2017-02-02|||September 2014||2014-09-01|January 2016|2016-01-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Observational|||Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function|Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function|Completed||N/A|42|Actual|CancerCare Manitoba|||1||f||||f||||||||||2017-10-11 00:04:20.908942|2017-10-11 00:04:20.908942
NCT02225470|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-11-14|||September 2013||2013-09-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes|An Open-label Randomized Parallel Two-arm Multicenter Study of Eribulin Versus Vinorelbine in Female Subjects With Locally Recurrent or Metastatic Breast Cancer, Previously Treated With At Least Two and a Maximum of Five Prior Chemotherapy Regimens, Including an Anthracycline and a Taxane|Active, not recruiting||Phase 3|530|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 00:04:21.028706|2017-10-11 00:04:21.028706
NCT02225457|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-03-05|||December 2013||2013-12-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|May 2016|Anticipated|2016-05-01||Interventional|Polynut||Study of the Mechanisms of Metabolic Adaptations to Overfeeding|Study of the Determinants and Mechanisms of Adaptation of Metabolic Responses to Controlled Overfeeding in Female and Male Healthy Volunteers|Recruiting||N/A|52|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 00:04:21.193749|2017-10-11 00:04:21.193749
NCT02225444|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-04-13|||September 2015||2015-09-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|April 2019|Anticipated|2019-04-01||Observational|||A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®|A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF|Active, not recruiting||N/A|42|Anticipated|Bioventus LLC|||1||f||||f||||||||||2017-10-11 00:04:21.316287|2017-10-11 00:04:21.316287
NCT02225431|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-24|2015-10-15|||September 2012||2012-09-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Personalized Versus Standard Hydration for Prevention of CI-AKI: a Randomized Trial With Bioimpedance Analysis|Personalized Versus Standard Hydration for Prevention of Contrast Induced Acute Kidney Injury. A Randomized Trial With Bioimpedance Analysis.|Completed||Phase 4|296|Actual|Ospedale Misericordia e Dolce||2|||f||||t||||||||||2017-10-11 00:04:21.440185|2017-10-11 00:04:21.440185
NCT02225418|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-07-20|||November 2014||2014-11-01|July 2015|2015-07-01||||November 2015|Anticipated|2015-11-01||Interventional|TQL||Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy|Ultrasoundguided Transmuscular Quadratus Lumborum Block After Elective Laparoscopic Cholecystectomy. A Prospective, Randomized Clinical Trial.|Withdrawn||N/A|0|Actual|Bispebjerg Hospital||2||Change of jobs|f||||t||||||||||2017-10-11 00:04:21.546791|2017-10-11 00:04:21.546791
NCT02225405|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-09-11|||April 2015|Actual|2015-04-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Induction Study of Cisplatin, Docetaxel, and Nintedanib Stage IB-IIIA Non-Small Cell Lung Cancer (NCLC)|Phase I Study of Induction Cisplatin, Docetaxel and Nintedanib for Stage IB-IIIA Non-Small Cell Lung Cancers Amenable for Surgical Resection|Recruiting||Phase 1|45|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:04:21.661364|2017-10-11 00:04:21.661364
NCT02225392|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-01-23|||April 2014||2014-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|TASMA||Unravelling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma|Unravelling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma|Recruiting||N/A|40|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:04:21.782976|2017-10-11 00:04:21.782976
NCT02225379|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-01-10|||September 2014||2014-09-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Hypo-Sense||Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of Hypoglycemia|Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense Sensor as a Tool for Detection of Hypoglycemia - Exploratory Study for Prototype Rev 1|Completed||N/A|3|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 00:04:21.933518|2017-10-11 00:04:21.933518
NCT02225366|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-06-19|||July 8, 2015|Actual|2015-07-08|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Intratumoral Injections of LL37 for Melanoma|Induction of Antitumor Response in Melanoma Patients Using the Antimicrobial Peptide LL37|Active, not recruiting||Phase 1/Phase 2|4|Actual|M.D. Anderson Cancer Center||1|||f||||t|t|f||||||||2017-10-11 00:04:22.030315|2017-10-11 00:04:22.030315
NCT02225340|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-08-22|||January 2014||2014-01-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia|Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia|Completed||N/A|348|Actual|Laval University|||2||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 00:04:22.274917|2017-10-11 00:04:22.274917
NCT02225327|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-08-26|||October 2013||2013-10-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine|Immunogenicity and Safety of MF59-adjuvanted Trivalent Influenza Vaccine (Fluad) and 23-valent Pneumococcal Polysaccharide Vaccine (PPV23) in the Elderly: Single Versus Concomitant Vaccination|Completed||Phase 4|224|Actual|Korea University Guro Hospital||4|||f||||t||||||||||2017-10-11 00:04:22.358192|2017-10-11 00:04:22.358192
NCT02225314|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-01-06|||April 2012||2012-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Computer-based Cognitive Training for Individuals With Parkinson's Disease|Computer-based Cognitive Training for Individuals With Parkinson's Disease|Completed||N/A|25|Actual|Virginia Commonwealth University||3|||f||||f||||||||||2017-10-11 00:04:22.449169|2017-10-11 00:04:22.449169
NCT02225301|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-03-30|||June 2014||2014-06-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|iLookOut||iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers|Early Childhood Practitioner's Knowledge and Attitudes Regarding Reporting Child Abuse/Neglect-iLookOut|Recruiting||N/A|20000|Anticipated|Milton S. Hershey Medical Center||1|||f||||f||||||||||2017-10-11 00:04:22.562043|2017-10-11 00:04:22.562043
NCT02225288|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2015-03-31|||September 2014||2014-09-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||A Study of E2022 Tape Formulation (Overlay-integrated E2022 18 mg Tape Formulation) for Different Application Sites and Intervals in Japanese Healthy Elderly Males||Completed||Phase 1|48|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-11 00:04:22.665295|2017-10-11 00:04:22.665295
NCT02225275|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-03-31|||March 31, 2016|Actual|2016-03-31|March 2017|2017-03-01|March 1, 2023|Anticipated|2023-03-01|March 1, 2023|Anticipated|2023-03-01||Interventional|||Combination of Lenalidomide and Obinutuzumab (GA101) in Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|Combination of Lenalidomide and Obinutuzumab (GA101) in Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:04:22.757423|2017-10-11 00:04:22.757423
NCT02225262|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-08-25|||January 2008||2008-01-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors|Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Emulating Homogenous Dose Distribution|Unknown status|Active, not recruiting|N/A|100|Anticipated|Community Cancer Center, Normal, Illinois||1|||f||||f||||||||||2017-10-11 00:04:22.86754|2017-10-11 00:04:22.86754
NCT02224170|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-21|||September 2014||2014-09-01|August 2014|2014-08-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy||Unknown status|Not yet recruiting|N/A|70|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:04:41.195258|2017-10-11 00:04:41.195258
NCT02225249|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-22|||October 2014||2014-10-01|August 2014|2014-08-01|July 2017|Anticipated|2017-07-01|October 2016|Anticipated|2016-10-01||Observational|VASCULUX||VASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng Transplantation|Examination of the Pulmonary Vascular Barrier in Patients During Lung Transplantation|Unknown status|Not yet recruiting|N/A|30|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||f||||||Samples With DNA|"     Blood samples will be taken. In summary, 61.2 ml blood will be collected at 7 specific time     points.      Components of the vascular barrier are examined, in detail hyaluronan, syndecan-1, and     angiopoietin-2.   "|||2017-10-11 00:04:22.954995|2017-10-11 00:04:22.954995
NCT02225236|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-02-06|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Improving Self-regulation & School Readiness in Preschoolers|Improving Self-regulation & School Readiness in Preschoolers|Active, not recruiting||N/A|144|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 00:04:23.036387|2017-10-11 00:04:23.036387
NCT02225223|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-01-18|||December 2014||2014-12-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|STARRT||Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s)|Evaluation of Targeted Radiofrequency Ablation and Vertebral Augmentation Prior to or Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s) [The STARRT Study]|Terminated||N/A|36|Actual|Merit Medical Systems, Inc.||2||Difficulty Enrolling|f||||f||||||||||2017-10-11 00:04:23.120567|2017-10-11 00:04:23.120567
NCT02225210|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-08-24|||September 2014||2014-09-01|August 2014|2014-08-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Effects of Dexmedetomidine Sedation on Delirium and Haemodynamic in Mechanical Ventilated Elderly Patients|Effects of Dexmedetomidine Sedation on Delirium and Haemodynamic in Mechanical Ventilated Elderly Patients -a Single Center,Randomized and Controlled Trial|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Fuling Central Hospital of Chongqing City||2|||f||||f||||||||||2017-10-11 00:04:23.237595|2017-10-11 00:04:23.237595
NCT02225197|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-08-25|||December 2007||2007-12-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors|A Phase II Study of Fractionated CyberKnife Stereotactic Radiosurgery to Perioptic Tumors|Unknown status|Active, not recruiting|N/A|10|Actual|Community Cancer Center, Normal, Illinois||1|||f||||f||||||||||2017-10-11 00:04:23.317759|2017-10-11 00:04:23.317759
NCT02225184|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-06-30|||August 1, 2014||2014-08-01|May 11, 2017|2017-05-11|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans|The Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans|Enrolling by invitation||N/A|135|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:04:23.40356|2017-10-11 00:04:23.40356
NCT02225171|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-06-30|||July 29, 2014||2014-07-29|March 14, 2017|2017-03-14|March 14, 2017|Actual|2017-03-14|March 14, 2017|Actual|2017-03-14||Observational|||Physicians' Experiences With and Attitudes Toward Non-Medical Sex Selection Through Preimplantation Genetic Diagnosis|Physicians' Experiences With and Attitudes Toward Non-Medical Sex Selection Through Preimplantation Genetic Diagnosis|Completed||N/A|45|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:04:23.473281|2017-10-11 00:04:23.473281
NCT02225158|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-06-30|||August 15, 2014||2014-08-15|May 11, 2017|2017-05-11|May 11, 2017|Actual|2017-05-11|May 11, 2017|Actual|2017-05-11||Observational|||Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection|Longitudinal Study of Immune Responses to Mycobacterium Tuberculosis (Mtb) in Subjects With Latent Tuberculosis (TB) Infection(LTBI) With or Without Concomitant Helminth Infection|Terminated||N/A|1|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:04:23.532538|2017-10-11 00:04:23.532538
NCT02225145|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-09-21|||August 15, 2014||2014-08-15|September 20, 2017|2017-09-20|September 20, 2017|Actual|2017-09-20|September 9, 2016|Actual|2016-09-09||Observational|||Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease|Fertility Preservation in Females Who Will be Undergoing Gonadotoxic Therapy, Hematopoietic Stem Cell Transplantation, and in Females With Sickle Cell Disease|Completed||N/A|22|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:04:23.612704|2017-10-11 00:04:23.612704
NCT02225132|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-08-22|||August 13, 2014||2014-08-13|August 7, 2017|2017-08-07|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease|Assessment of Computerized Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in Subjects With Sickle Cell Disease|Recruiting||Early Phase 1|24|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:04:23.677781|2017-10-11 00:04:23.677781
NCT02225119|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-10-03|||August 13, 2014||2014-08-13|September 26, 2017|2017-09-26|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||The Focal Electro-Oculogram in Macular Disease|The Focal Electro-Oculogram in Macular Disease|Recruiting||N/A|130|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:04:23.759027|2017-10-11 00:04:23.759027
NCT02225106|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-23|2017-10-05|||August 6, 2014||2014-08-06|June 20, 2017|2017-06-20|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|||Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI|Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:04:23.836005|2017-10-11 00:04:23.836005
NCT02225093|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-06-26|||October 2, 2013|Actual|2013-10-02|June 2017|2017-06-01|February 3, 2014|Actual|2014-02-03|February 3, 2014|Actual|2014-02-03||Interventional|||A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer|A Phase 1 Open-label Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates for CYP1A2 and CYP2D6 in Male Subjects With Prostate Cancer|Completed||Phase 1|12|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:04:23.916242|2017-10-11 00:04:23.916242
NCT02225080|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-07-22|||October 2014||2014-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Duragen® Secure Post Marketing Clinical Follow-up (PMCF)|Duragen® Secure Post Marketing Clinical Follow-up (PMCF)|Completed||N/A|100|Actual|Integra LifeSciences Corporation|||1||f||||f||||||||||2017-10-11 00:04:24.011694|2017-10-11 00:04:24.011694
NCT02225067|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-05-01|||August 2014||2014-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring|Unblinded Comparison Study for Relationship and Reproducibility Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring, in Patients With Acid-related Diseases and Healthy Volunteers|Completed||Phase 2|40|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:04:24.07353|2017-10-11 00:04:24.07353
NCT02225054|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-04-25|||May 2013||2013-05-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|DEX||The Effect of Dexmedetomidine on Brachial Plexus Block for Shoulder Surgery|The Analgesic Effect of Dexmedetomidine as an Adjunct to Local Anesthetics in Ultrasound-guided Interscalene Approach to Brachial Plexus Block for Shoulder Surgery: A Randomized Controlled Trial|Completed||Phase 2|99|Actual|Women's College Hospital||3|||f||||f||||||||||2017-10-11 00:04:24.137434|2017-10-11 00:04:24.137434
NCT02225041|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-06-19|||August 2014||2014-08-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|RESTORE-cog||Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood|Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood|Recruiting||N/A|810|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 00:04:24.224388|2017-10-11 00:04:24.224388
NCT02225028|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-05-02|||November 2014||2014-11-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Feasibility of Telephone Counseling to Increase Physical Fitness in SCI|Feasibility of Telephone Counseling to Increase Physical Fitness in SCI (Co-Motion Study)|Completed||N/A|15|Actual|University of Washington||2|||f||||f||||||||Undecided||2017-10-11 00:04:24.557814|2017-10-11 00:04:24.557814
NCT02225015|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-06-07|||January 2015||2015-01-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Cancer Prevention in Women With a BRCA Mutation|Cancer Prevention in Women With a BRCA Mutation: A Follow-up Genetic Counselling Intervention|Recruiting||Phase 1|300|Anticipated|Women's College Hospital||2|||f||||f||||||||||2017-10-11 00:04:24.655607|2017-10-11 00:04:24.655607
NCT02225002|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2014-08-22|||January 2004||2004-01-01|August 2014|2014-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors|Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors|Completed||Phase 1|||Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 00:04:24.759978|2017-10-11 00:04:24.759978
NCT02224989|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-11-16|||April 2015||2015-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Mind-Body Intervention for Veterans With PTSD|A Pilot Feasibility Study of a Novel Mind-body Intervention Program for Veterans With PTSD|Recruiting||N/A|60|Anticipated|University of Utah||1|||f||||t||||||||No||2017-10-11 00:04:24.839357|2017-10-11 00:04:24.839357
NCT02224976|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-01-26|||January 2014||2014-01-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Intense Training on Ovarian Function and Bone Turnover|Impact of Intense Exercise Training on Energy Availability, Ovarian Function and Bone Turnover in Female Athletes|Completed||N/A|18|Actual|USDA, Western Human Nutrition Research Center||1|||f||||f||||||||Undecided||2017-10-11 00:04:24.950327|2017-10-11 00:04:24.950327
NCT02224963|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-09-29|||May 2009||2009-05-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2016|Actual|2016-06-01||Interventional|MADAS||Macular Degeneration and Aging Study|Improving Care Planning and Well-being in Older Adults With Macular Degeneration|Active, not recruiting||N/A|250|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 00:04:25.045163|2017-10-11 00:04:25.045163
NCT02224950|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-03-21|||November 2014||2014-11-01|March 2017|2017-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema|Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||3||Withdrawn from IRB before approval|f||||f||||||||||2017-10-11 00:04:25.135409|2017-10-11 00:04:25.135409
NCT02224937|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-11-13|||December 2013||2013-12-01|November 2014|2014-11-01||||February 2014|Actual|2014-02-01||Interventional|||MELATOX: Evaluation of Percutaneous Dissolvement of Melatonin When Used as Sunscreen; a Randomized, Placebo Controlled, Double-blind Crossover Study on Healthy Volunteers.|MELATOX: Evaluation of Percutaneous Dissolvement of Melatonin When Used as Sunscreen; a Randomized, Placebo Controlled, Double-blind Crossover Study on Healthy Volunteers.|Completed||Phase 1|10|Actual|University Hospital Koge||2|||f||||t||||||||||2017-10-11 00:04:25.293997|2017-10-11 00:04:25.293997
NCT02224924|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-05-11|||August 21, 2014|Actual|2014-08-21|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures|Effect of Autologous Blood Patch Injection Versus BioSentry Hydrogel Tract Plug in the Reduction of Pneumothorax Risk Following Lung Biopsy Procedures|Active, not recruiting||Phase 3|600|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:04:25.41138|2017-10-11 00:04:25.41138
NCT02224911|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-02-15|||July 2014||2014-07-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|LITT||Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer|Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer: A Pilot Feasibility Study|Active, not recruiting||N/A|8|Anticipated|Jonsson Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 00:04:25.533766|2017-10-11 00:04:25.533766
NCT02224898|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2015-11-16|||August 2014||2014-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis|Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis|Completed||N/A|18|Actual|Stanford University|||2||f||||t||||||||||2017-10-11 00:04:25.641085|2017-10-11 00:04:25.641085
NCT02224885|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-04-26|||January 2015||2015-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Needle-based Confocal Laser Endomicroscopy in Fluoroscopy-guided Procedures|Needle-based Confocal Laser Endomicroscopy in Fluoroscopy-guided Procedures for Lung Applications (Biopsies and Ablation) and Liver Procedures in Interventional Radiology: a Feasibility Study|Completed||N/A|6|Actual|Mauna Kea Technologies||1|||f||||f||||||||No||2017-10-11 00:04:25.743904|2017-10-11 00:04:25.743904
NCT02224872|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-07-12|||August 2014||2014-08-01|July 2017|2017-07-01||||August 2019|Anticipated|2019-08-01||Interventional|||Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia|A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched/Haploidentical Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes|Recruiting||Phase 2|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:04:25.847814|2017-10-11 00:04:25.847814
NCT02224859|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-03-23|||March 2014||2014-03-01|March 2015|2015-03-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|INV-CS-001||Invictus Medical, Medical Cranial Support Device (CSD) is a Device Safety Study in Infants at Risk of Head Ulcers.|Clinical Safety and Utility of the Invictus Cranial Support Device (CSD)|Withdrawn||N/A|0|Actual|Invictus Medical, Inc.||1||Organization has withdrawn their 510k submission and stopped the study|f||||t||||||||||2017-10-11 00:04:26.042419|2017-10-11 00:04:26.042419
NCT02224833|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-07-26|||January 2015||2015-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|PHARM-PC||Inappropriate Prescription in Elderly and Polypharmacy Patients in Primary Care (PHARM-PC) Trial|Pharmacist-led Intervention to Reduce Potentially Inappropriate Prescription in Elderly and Polypharmacy Patients at Primary Care Setting (PHARM-PC) Cluster Randomized Trial|Completed||N/A|549|Actual|Hospital Comarcal de Inca||2|||f||||f||||||||No||2017-10-11 00:04:26.305706|2017-10-11 00:04:26.305706
NCT02224820|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-01-18|2016-02-18||June 2014||2014-06-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||0ne patient interrupted treatment.|Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease|A Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous IdeS After Administration of Ascending Doses in Chronic Kidney Disease Patients|Completed||Phase 2|8|Actual|Hansa Medical AB||1|||f||||t||||||||No||2017-10-11 00:04:26.416186|2017-10-11 00:04:26.416186
NCT02224807|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-07-17|||July 2014||2014-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DCIS||Effects of Diet and Exercise on Ductal Carcinoma in Situ|Exploring Effects of Weight Loss on Ductal Carcinoma In Situ|Active, not recruiting||N/A|32|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 00:04:26.805849|2017-10-11 00:04:26.805849
NCT02224794|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-05-01|||September 2014||2014-09-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|1 Month|Observational [Patient Registry]|||LIFE Study: Least Invasive Fast-Track EVAR|LIFE Study: Least Invasive Fast-Track EVAR With the Ovation® Abdominal Stent Graft Platform|Completed||N/A|250|Actual|TriVascular, Inc.|||3||f||||f||||||||||2017-10-11 00:04:26.928563|2017-10-11 00:04:26.928563
NCT02224768|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-12-18|||July 2015||2015-07-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey|YERVOY Risk Minimisation Tool Evaluation Survey|Completed||N/A|158|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 00:04:32.125158|2017-10-11 00:04:32.125158
NCT02224755|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-08-15|||September 2014||2014-09-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|HM3™||MOMENTUM 3 IDE Clinical Study Protocol|Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol|Active, not recruiting||N/A|1028|Actual|St. Jude Medical||2|||f||||t||||||||||2017-10-11 00:04:32.224875|2017-10-11 00:04:32.224875
NCT02224742|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-04-18|||August 2013||2013-08-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||LeucoPatch in the Management of Hard-to-heal Diabetic Foot Ulcers|LeucoPatch in the Management of Hard-to-heal Diabetic Foot Ulcers|Recruiting||Phase 4|250|Anticipated|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 00:04:32.611913|2017-10-11 00:04:32.611913
NCT02224729|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-10-19|||August 2014||2014-08-01|October 2016|2016-10-01||||September 2019|Anticipated|2019-09-01||Interventional|||Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma|Phase II Study of Bendamustine, Bortezomib, and Dexamethasone (BBD) for Newly Diagnosed Patients With Multiple Myeloma|Active, not recruiting||Phase 2|37|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 00:04:32.809319|2017-10-11 00:04:32.809319
NCT02224716|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2015-06-11|||July 2014||2014-07-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in Hospitals|Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in Hospitals|Unknown status|Recruiting|N/A|968|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||2||f||||f||||||||||2017-10-11 00:04:32.938926|2017-10-11 00:04:32.938926
NCT02224703|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-10-11|||March 2015||2015-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome.|Recruiting||Phase 3|150|Anticipated|GW Research Ltd||3|||f||||t||||||||||2017-10-11 00:04:33.038521|2017-10-11 00:04:33.038521
NCT02224690|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-02-22||2017-02-22|March 2015||2015-03-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|GWPCARE4||A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults.|Completed||Phase 3|171|Actual|GW Research Ltd||2|||f||||t||||||||||2017-10-11 00:04:33.740774|2017-10-11 00:04:33.740774
NCT02224677|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-12-11|||November 2013||2013-11-01|December 2015|2015-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|CLOCK||Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)|Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)|Recruiting||N/A|685|Anticipated|Seattle Children's Hospital|||5||f||||f||||||Samples With DNA|"     Saliva   "|||2017-10-11 00:04:33.845854|2017-10-11 00:04:33.845854
NCT02224664|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-02-03|2017-02-03||October 2014||2014-10-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||Full analysis set (FAS) included all participants who received at least 1 dose of study medication (L-Dopa or PF-06649751) in Period 1 and/or Period 2.|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson`s Disease|A Phase 1b, 2-period, Open Label, Multicenter, Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06649751 In Subjects With Parkinson`s Disease And Motor Fluctuations|Completed||Phase 1|50|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 00:04:34.041654|2017-10-11 00:04:34.041654
NCT02224651|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-07-01|||September 2014||2014-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions|A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Substitution, Crossover, Single Dose Escalation Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Pf 06650833 Delivered In Multiple Formulations In Healthy Subjects Under Fasted And Fed Conditions|Completed||Phase 1|40|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 00:04:35.991428|2017-10-11 00:04:35.991428
NCT02224625|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-01-27|2016-02-05||August 2014||2014-08-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Participants in the Sensitization study received the following 4 products ( 2% CHG cloth, Vehicle cloth, DynaHex and Saline). Participants in the Irritation study received the same 4 products in addition to SLS.|Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth|Randomized and Observer-blinded Study to Evaluate the Cumulative Irritation and Contact Sensitizing Potential of One Finished Test Product|Completed||Phase 3|249|Actual|Medline Industries||5|||f||||f||||||||Yes|Data to be shared with FDA|2017-10-11 00:04:36.210976|2017-10-11 00:04:36.210976
NCT02224599|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-08-09|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Treatment of Patients With Progressive and/or Refractory Solid Malignancies|Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Low Dose Granulocyte-Macrophage Colony Stimulating Factor, in Patients With Progressive and/or Refractory Solid Malignancies|Recruiting||Phase 1/Phase 2|23|Anticipated|Kiromic, LLC||1|||f||||t|t|f|||f|||||2017-10-11 00:04:36.584975|2017-10-11 00:04:36.584975
NCT02224586|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-21|||August 2014||2014-08-01|August 2014|2014-08-01|July 2015|Anticipated|2015-07-01|March 2015|Anticipated|2015-03-01||Observational|||Resting State Functional Magnetic Resonance Imaging Study of Jaundice Infants Before and After Light Treatment.|Resting State Functional Magnetic Resonance Imaging Study of Jaundice Infants Before and After Light Treatment.|Unknown status|Recruiting|N/A|20|Anticipated|Hangzhou Normal University|||1||f||||t||||||||||2017-10-11 00:04:36.674834|2017-10-11 00:04:36.674834
NCT02224573|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-01-27|||June 2015||2015-06-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes|An Open Label Extension Study to Investigate the Safety of Cannabidiol (GWP42003-P; CBD) in Children and Young Adults With Inadequately Controlled Dravet or Lennox-Gastaut Syndromes.|Enrolling by invitation||Phase 3|540|Anticipated|GW Research Ltd||1|||f||||t||||||||||2017-10-11 00:04:36.762106|2017-10-11 00:04:36.762106
NCT02224560|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-09-18||2017-09-18|March 2015||2015-03-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|GWPCARE3||A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults.|Completed||Phase 3|210|Anticipated|GW Research Ltd||3|||f||||t||||||||||2017-10-11 00:04:36.837075|2017-10-11 00:04:36.837075
NCT02224547|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-09-08|||January 2013||2013-01-01|September 2014|2014-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System|Phase II Protocol for Risk-adapted Stereotactic Body Radio Therapy for Stage T1-T3N0 Non-Small Cell Lung Carcinoma|Recruiting||Phase 2|58|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||t||||||||||2017-10-11 00:04:36.931347|2017-10-11 00:04:36.931347
NCT02224534|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-11-14|||October 2014||2014-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|HEALING-AMI||Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction|High PlatElet Inhibition With TicAgrelor to Improve Left Ventricular RemodeLING in Patients With ST-segment ElevAtion Myocardial Infarction: the HEALING-AMI Trial.|Recruiting||Phase 4|326|Anticipated|Gyeongsang National University Hospital||2|||f||||t||||||||No||2017-10-11 00:04:37.016549|2017-10-11 00:04:37.016549
NCT02224521|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-06-13|||April 20, 2009|Actual|2009-04-20|June 2017|2017-06-01|June 8, 2010|Actual|2010-06-08|June 8, 2010|Actual|2010-06-08||Interventional|||GSK2190915A - Bioavailability Study|An Open-label, Randomised, Single-dose, Multi-cohort, Crossover Bioavailability Study of a Solution Formulation and Three Capsule Formulations of GSK2190915 in Healthy Adult Subjects Followed by a Repeat-dose, Randomized, Parallel Group, Double-blinded Study of One Selected Capsule Formulation and Matched Placebo in Elderly Healthy Subjects|Completed||Phase 1|67|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:04:37.160384|2017-10-11 00:04:37.160384
NCT02224508|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-03-27|2017-02-02||September 2014||2014-09-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|CARE||Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks|Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks|Completed||N/A|1588|Actual|Kaiser Permanente|This phase of the evaluation reports after-only survey data comparing prevalent chronic opioid therapy patients who had been exposed or not exposed to the health plan opioid risk reduction initiatives for at least one year.||2||f||||f||||||||Yes|"A complete, cleaned, de-identified copy of the final dataset used in conducting the final analyses will be made available to other qualified researchers within nine months of the end of the final year of funding upon approval by the Group Health Human Subject's Review Committee.
Given the complexity of the final dataset, our expectation would be that other researchers using the data would require technical assistance from our research team to understand the data and to employ appropriate methods of data analysis. Or, other researchers may prefer to have us analyze the study data to produce analyses according to their specifications. Since use of the dataset by other investigators, or analyses carried out by us for other researchers, would occur after the grant award period has ended, we will expect necessary funding of technical support, data transfers and/or data analyses to be obtained by the research team requesting access to the final dataset."|2017-10-11 00:04:37.380017|2017-10-11 00:04:37.380017
NCT02224495|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||September 2011||2011-09-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of Exercise Training on Cardiac Structure and Function|The Effect of Exercise Training on Cardiac Structure and Function|Completed||Phase 1/Phase 2|200|Actual|Gaia Hospital||2|||f||||f||||||||||2017-10-11 00:04:38.23279|2017-10-11 00:04:38.23279
NCT02224482|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-02-13|||February 2012||2012-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|PROGRESS||Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS)|Randomized Clinical Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors|Recruiting||N/A|600|Anticipated|Fox Chase Cancer Center||2|||f||||t||||||||||2017-10-11 00:04:38.312402|2017-10-11 00:04:38.312402
NCT02224469|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-11-08|||November 2013||2013-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|UNP||First Study With a Brain Implant to Help Locked-in Patients Communicate at Home|Utrecht Neural Prosthesis (UNP): A Pilot Study on Controllability of Brain Signals and Application in locked-in Patients|Recruiting||N/A|5|Anticipated|UMC Utrecht||1|||f||||t||||||||Yes|selected datasets will be available through a public repository after publication of results|2017-10-11 00:04:38.424306|2017-10-11 00:04:38.424306
NCT02224456|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-12-16|||March 2015||2015-03-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis|A Prospective, Multi-center, Cohort Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) Therapy in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis|Active, not recruiting||Phase 4|240|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:04:38.517273|2017-10-11 00:04:38.517273
NCT02224443|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||September 2014||2014-09-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Effects of Different Doses of Dexmedetomidine on Postoperative Cognitive Dysfunction in Elderly Hypertensive Patients|Effects of Different Doses of Dexmedetomidine on Postoperative Cognitive Dysfunction in Elderly Hypertensive Patients-A Single Center,Randomized, Double-blinded,Controlled Study|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|First Affiliated Hospital Xi'an Jiaotong University||3|||f||||t||||||||||2017-10-11 00:04:38.645418|2017-10-11 00:04:38.645418
NCT02224430|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-01-18|||August 2014||2014-08-01|January 2017|2017-01-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|||Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors|Remote Physiological, Behavioral and Symptom Assessment Study to Identify Predictors of Symptom Exacerbation and Relapse in Schizophrenia|Active, not recruiting||N/A|40|Actual|University of Alabama at Birmingham|||1||f||||t||||||||Undecided||2017-10-11 00:04:38.768503|2017-10-11 00:04:38.768503
NCT02224417|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-08-20|||March 2015||2015-03-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|TRIAD||Trial to Incentivise Adherence for Diabetes|A Randomized Controlled Trial to Improve Diabetes Outcomes Through Financial Incentives|Recruiting||N/A|240|Anticipated|Duke-NUS Graduate Medical School||3|||f||||f||||||||||2017-10-11 00:04:38.853017|2017-10-11 00:04:38.853017
NCT02224404|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-02-23|2016-05-18||September 2014||2014-09-01|August 2014|2014-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended|Open, Non-comparative, Multi-centre Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended|Completed||N/A|21|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 00:04:38.985505|2017-10-11 00:04:38.985505
NCT02224391|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-09-15|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01||Interventional|||Smartphone-Delivered Training for Smokers|Smartphone-Delivered Attentional Bias Modification Training for Quitting Smokers|Recruiting||N/A|750|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 00:04:39.197325|2017-10-11 00:04:39.197325
NCT02224378|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-03-31|||March 2012||2012-03-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Prediction of Fluid Responsiveness in Atrial Fibrillation Patients Who Underwent Valvular Heart Surgery: Peep-induced Increase in Central Venous Pressure vs. Passive Leg Raising||Completed||N/A|44|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:04:39.318601|2017-10-11 00:04:39.318601
NCT02224365|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-12-06|||August 2014||2014-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effects of Apple Consumption on Cardiovascular Health in Prediabetics and Type 2 Diabetics|Regular Apple Consumption Improves Cardiovascular Risk Factors and Glycemic Control in Overweight and Obese Prediabetics and Type 2 Diabetics|Completed||Phase 2|50|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 00:04:39.413208|2017-10-11 00:04:39.413208
NCT02224352|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-07-26|||July 2014||2014-07-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||VentFree: A Novel Abdominal Stimulator to Assist With Ventilator Weaning|VentFree: A Novel Abdominal Stimulator to Assist With Ventilator Weaning|Completed||N/A|15|Actual|Edward Hines Jr. VA Hospital||1|||f||||f||||||||||2017-10-11 00:04:39.528519|2017-10-11 00:04:39.528519
NCT02224339|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-01-27|||September 2014||2014-09-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|24 Months|Observational [Patient Registry]|CEUS||New Technologies to Determine Carotid Plaque Vulnerability|New Technologies to Determine Carotid Plaque Vulnerability: A Pilot Study to Assess Contrast-Enhanced Ultrasound (CEUS) and Strain Deformation Imaging in Patients of Known or Suspected Coronary Artery Disease|Recruiting||N/A|216|Anticipated|Mayo Clinic|||1||f||||t||||||||||2017-10-11 00:04:39.616441|2017-10-11 00:04:39.616441
NCT02224326|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2017-06-16|||June 2011||2011-06-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|Vogel||Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia|Prospective Study to Evaluate the Predictive Value of Vagus Somatosensory Evoked Potentials (VSEP) and Near-infrared Spectroscopy (NIRS) in the Early Diagnosis of Alzheimer´s Disease|Active, not recruiting||N/A|604|Actual|University of Wuerzburg|||1||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 00:04:39.72675|2017-10-11 00:04:39.72675
NCT02224313|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-08-03|||December 2015||2015-12-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women|Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women|Recruiting||N/A|30|Anticipated|Eastern Virginia Medical School||3|||f||||t||||||||Undecided||2017-10-11 00:04:39.821838|2017-10-11 00:04:39.821838
NCT02224287|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-04-10|||January 2013||2013-01-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Assessment of Fluoroscopy Times With Surgeon Versus Technologist Control|Assessment of Fluoroscopy Times With Surgeon Versus Technologist Control: A Prospective Randomized Trial|Completed||N/A|74|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 00:04:40.083733|2017-10-11 00:04:40.083733
NCT02224261|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-08-03|||September 2011|Actual|2011-09-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|July 2017|Actual|2017-07-01||Interventional|PTaws||Effectiveness of Physical Therapy on Axillary Web Syndrome After Breast Cancer Surgery|Effectiveness of Physical Therapy on Axillary Web Syndrome After Breast Cancer Surgery: a Randomized Controlled Trial|Active, not recruiting||N/A|80|Anticipated|University of Alcala||2|||f||||t||||||||||2017-10-11 00:04:40.298833|2017-10-11 00:04:40.298833
NCT02224248|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-11-10|||October 2014||2014-10-01|December 2015|2015-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Including Fitness Testing in Preventive Health Checks on Cardiorespiratory Fitness and Motivation|The Effect of Including Fitness Testing in Preventive Health Checks on Cardiorespiratory Fitness and Motivation to Change Physical Activity Behaviour|Completed||N/A|2201|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:04:40.386112|2017-10-11 00:04:40.386112
NCT02224222|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-05-25|||July 2014||2014-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01|2 Years|Observational [Patient Registry]|||Assessment of Frailty as a Risk Factor for Cardiac and Vascular Surgery|Assessment of Frailty as a Risk Factor for Cardiac and Vascular Surgery|Recruiting||N/A|300|Anticipated|Semmelweis University Heart and Vascular Center|||2||f||||f||||||||||2017-10-11 00:04:40.745851|2017-10-11 00:04:40.745851
NCT02224209|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-11-14|||November 2014||2014-11-01|November 2014|2014-11-01|September 2017|Anticipated|2017-09-01|October 2016|Anticipated|2016-10-01||Interventional|STEP||Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis|Comparison of Staged Angioplasty v.s. Routine Single-stage Stenting (CAS) in the Treatment of Patients With Carotid Artery Stenosis at High Risk of Hyperperfusion (STEP）: A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 4|158|Anticipated|Beijing Tiantan Hospital||2|||f||||t||||||||||2017-10-11 00:04:40.833194|2017-10-11 00:04:40.833194
NCT02224196|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-01-23|||August 13, 2014|Actual|2014-08-13|January 2017|2017-01-01|January 30, 2015|Actual|2015-01-30|January 30, 2015|Actual|2015-01-30||Interventional|||Comparison of Peak Airway Pressure and Gastric Insufflation in Manual Ventilation and Pressure-controlled Ventilation With Facemask During Anesthesia Induction in Children||Completed||N/A|48|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:04:41.020386|2017-10-11 00:04:41.020386
NCT02224183|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-07-18|||March 2015||2015-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Yoga vs. Education for Veterans With Chronic Low Back Pain|Veterans Back to Health: A Study Comparing Yoga and Education for Veterans With Chronic Low Back Pain|Completed||N/A|120|Actual|Boston Medical Center||2|||f||||t||||||||||2017-10-11 00:04:41.112284|2017-10-11 00:04:41.112284
NCT02224157|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-09-04|||November 28, 2014|Actual|2014-11-28|September 2017|2017-09-01|August 16, 2017|Actual|2017-08-16|August 16, 2017|Actual|2017-08-16||Interventional|SYGMA2||A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma|A Clinical Study Comparing Symbicort 'as Needed' With Pulmicort Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma|Completed||Phase 3|4219|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:04:41.315498|2017-10-11 00:04:41.315498
NCT02224144|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-22|2017-07-18|||August 2014||2014-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bone Mass and Strength After Kidney Transplantation|A Comparative Trial of Calcitriol Versus Placebo for the Preservation of Bone Mass and Strength After Kidney Transplantation|Active, not recruiting||Phase 2|80|Actual|Columbia University||2|||f||||t|t|f|||f|||||2017-10-11 00:04:42.483342|2017-10-11 00:04:42.483342
NCT02224131|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-22|||January 2015||2015-01-01|August 2014|2014-08-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|ATIASC||Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling|Randomized Comparison of Platelet Function Monitoring to Adjust Antiplatelet Therapy Versus a Common Antiplatelet Treatment for Intracranial Aneurysm Stent-assisted Coiling|Not yet recruiting||Phase 4|1856|Anticipated|Beijing Tiantan Hospital||2|||f||||t||||||||||2017-10-11 00:04:42.616152|2017-10-11 00:04:42.616152
NCT02224118|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-09-08|||July 2009||2009-07-01|September 2014|2014-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus|Safety, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Dose of CNTO 3649 in Healthy Adult Men and Multiple Subcutaneous Doses of CNTO 3649 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|64|Actual|Janssen Pharmaceutical K.K.||7|||f||||f||||||||||2017-10-11 00:04:42.754519|2017-10-11 00:04:42.754519
NCT02224105|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||March 2010||2010-03-01|August 2014|2014-08-01||||May 2010|Actual|2010-05-01||Interventional|||Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects|Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of a BI 653048 BS H3PO4 Capsule Formulation Administered as Multiple Doses of 25 mg to 200 mg Once Daily (qd) for 3 Days Assessing Pharmacodynamics as Endotoxin-induced Inflammatory Response of a Single Intravenous Bolus Administration of 2 ng/kg Body Weight Lipopolysaccharide (LPS). A Randomised, Double-blind Within Dose Groups, Placebo-controlled, Multiple Rising Dose Phase I Trial With Open-label Active Comparator in Healthy Male Subjects|Completed||Phase 1|56|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:04:42.868843|2017-10-11 00:04:42.868843
NCT02224092|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-08-21|||October 2010||2010-10-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|July 2011|Actual|2011-07-01||Interventional|||Effects of Supplementation in Healthy Russian Population|Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Selected Nutrients Blood Level and Heart Health Risk Factors in Russian Population|Completed||N/A|120|Actual|Access Business Group||2|||f||||f||||||||||2017-10-11 00:04:42.990264|2017-10-11 00:04:42.990264
NCT02224079|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||April 2002||2002-04-01|August 2014|2014-08-01||||June 2002|Actual|2002-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BIIB 722 CL and HPβCD in Young Healthy Male Volunteers|Safety, Tolerability and Preliminary Pharmacokinetics of Single Rising Doses of 1 mg, 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 37.5 mg, 50 mg, 75 mg, 100 mg, 125 mg and 150 mg BIIB 722 CL (Calculated as 'Free Base') and HPβCD Given as Intravenous Infusion Over 30 Minutes to Young Healthy Male Subjects. A Single-centre, Single-blind, Placebo-controlled, Randomised Study.|Completed||Phase 1|100|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:04:43.06872|2017-10-11 00:04:43.06872
NCT02224066|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-06-02|||January 2016|Actual|2016-01-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|May 2017|Actual|2017-05-01||Interventional|REAC-TAVI||Platelet Reactivity After TAVI: A Multicenter Pilot Study|Assessment of Platelet REACtivity After Transcatheter Aortic Valve Implantation|Active, not recruiting||Phase 4|60|Anticipated|Hospital de Meixoeiro||3|||f||||t||||||||Undecided||2017-10-11 00:04:43.140589|2017-10-11 00:04:43.140589
NCT02224053|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-05-23|2015-11-26||September 2014||2014-09-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers|A Phase I, Fixed Sequence, Open-label, Study to Assess the Pharmacokinetics of AZD9291 in Healthy Male Volunteers When a Single Oral Dose of AZD9291 80 mg is Administered Alone and in Combination With Omeprazole|Completed||Phase 1|136|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 00:04:43.253964|2017-10-11 00:04:43.253964
NCT02224040|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-26|||August 2013||2013-08-01|August 2014|2014-08-01|August 2015|Anticipated|2015-08-01|December 2014|Anticipated|2014-12-01||Interventional|||Typhoid Fever: Combined vs. Single Antibiotic Therapy|Typhoid Fever: Combined vs. Single Antibiotic Therapy. A Prospective Randomized Controlled Study in Nepal.|Unknown status|Recruiting|Phase 4|120|Anticipated|Sheba Medical Center||4|||f||||f||||||||||2017-10-11 00:04:43.920434|2017-10-11 00:04:43.920434
NCT02224027|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-12-28|||August 2014||2014-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Comparison of Laryngeal Mask and I-gel to Laryngoscope by Novice Operators in Simulated Difficult Airway|Comparison of Proceal Laryngeal Mask Airway and I-gel to Machintoch Laryngoscope by Novice Operators in Simulated Difficult Airway - a Manikin Study.|Recruiting||N/A|109|Anticipated|Yeungnam University College of Medicine||3|||f||||t||||||||||2017-10-11 00:04:44.007262|2017-10-11 00:04:44.007262
NCT02224014|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||June 2005||2005-06-01|August 2014|2014-08-01||||March 2006|Actual|2006-03-01||Observational|||Lendormin D® Tablet (Drug Use Result Survey)|Lendormin D® Tablet (Drug Use Result Survey)|Completed||Phase 4|485|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:04:44.101253|2017-10-11 00:04:44.101253
NCT02224001|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-09-11|||January 2008||2008-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|TP||A New Concept in the Tip Plasty of Asian Rhinoplasty|A New Concept in the Tip Plasty of Asian Rhinoplasty : The Flag Technique by Use of Only A Septal Cartilage Without Septal Extension Grafts|Completed||N/A|161|Actual|Winners Clinic||1|||f||||f||||||||||2017-10-11 00:04:44.172387|2017-10-11 00:04:44.172387
NCT02223806|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-11-23|||April 2014||2014-04-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|UTAMP||Active Management of the Third Stage of Labour: Uterine Tonus Assessment by Midwife vs. Patient Self-administration|Active Management of the Third Stage of Labour: Uterine Tonus Assessment by Midwife vs. Patient Self-administration|Completed||N/A|800|Actual|UMC Utrecht||2|||f||||f||||||||||2017-10-11 00:04:45.817767|2017-10-11 00:04:45.817767
NCT02223988|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-05-05|||July 2014|Actual|2014-07-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|VICTOR||Occurrence of Ventilator Associated Pneumonia in Italian ICU Using Cuffed Tracheostomy Tubes With Subglottic Secretion Drainage|Occurrence of Ventilator Associated Pneumonia (VAP) in Italian ICU Using Cuffed Tracheostomy Tubes With Subglottic Secretion Drainage: a Prospective Observational Study.|Completed||N/A|100|Actual|University of Turin, Italy||1|||f||||||||||||||2017-10-11 00:04:44.247742|2017-10-11 00:04:44.247742
NCT02223975|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-08-03|||August 2014||2014-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Observational|Vulval VS||Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease|Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease|Suspended||N/A|200|Anticipated|Gloucestershire Hospitals NHS Foundation Trust|||1|Study suspended pending further funding|f||||f||||||Samples With DNA|"     Histological sections of vulval and lymph node tissue.   "|||2017-10-11 00:04:44.322792|2017-10-11 00:04:44.322792
NCT02223962|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-04-30|||March 2013||2013-03-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Effects of Physical Activity Counseling After an Exacerbation in COPD|The Effects of a Physical Activity Counseling Program Immediately After an Exacerbation in Patients With COPD.|Completed||N/A|30|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 00:04:44.398647|2017-10-11 00:04:44.398647
NCT02223949|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||October 2014||2014-10-01|August 2014|2014-08-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Labor Induction and Maternal BMI, Comparison of Different Pre-induction Cervical Ripening Methods|Labor Induction and Maternal BMI: Comparison of Different Pre-induction Cervical Ripening Methods: The Cook Double Balloon Catheter vs PGE1 Tablets in Lean, Overweight, and Obese Women. A Prospective Randomized Study.|Unknown status|Not yet recruiting|Phase 2/Phase 3|624|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 00:04:44.472844|2017-10-11 00:04:44.472844
NCT02223936|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-21|||February 2009||2009-02-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|February 2011|Actual|2011-02-01||Interventional|EDEN||Follow up of Neurologic Development of Children Who Presented at the First Trimester of Pregnancy an Isolated Nuchal Anomaly With Normal Karyotype|Follow up of Neurologic Development of Children Who Presented at the First Trimester of Pregnancy an Isolated Nuchal Anomaly With Normal Karyotype|Completed||N/A|500|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 00:04:44.635185|2017-10-11 00:04:44.635185
NCT02223923|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-03-30|||July 2014||2014-07-01|March 2016|2016-03-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|Patriot||Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid Tumours|A Phase I Study to Assess the Tolerability, Safety and Biological Effects of ATR Inhibitor (AZD6738) as a Single Agent and in Combination With Palliative Radiation Therapy in Patients With Solid Tumours|Recruiting||Phase 1|100|Anticipated|Royal Marsden NHS Foundation Trust||4|||f||||t||||||||||2017-10-11 00:04:44.714441|2017-10-11 00:04:44.714441
NCT02223910|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-10-27|||February 2014||2014-02-01|October 2016|2016-10-01||||June 2016|Actual|2016-06-01||Interventional|||Neurofeedback Training of Alpha-band Coherence After Stroke|Neurofeedback Training of Alpha-band Coherence After Stroke: a Randomized Controlled Crossover Trial|Completed||N/A|13|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 00:04:44.817843|2017-10-11 00:04:44.817843
NCT02223897|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||July 2014||2014-07-01|August 2014|2014-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions|Umbilical Cord Mesenchymal Stem Cells Transplantation for Treatment of Patients With Ischemic-type Biliary Lesions After Liver Transplantation|Recruiting||Phase 2/Phase 3|66|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:04:44.914433|2017-10-11 00:04:44.914433
NCT02223884|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2014-08-27|||July 2011||2011-07-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy||Completed||Phase 2|30|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 00:04:45.004411|2017-10-11 00:04:45.004411
NCT02223871|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-11-25|2016-07-01||June 2014||2014-06-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects|A Proof-of-concept Study to Assess the Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects|Completed||Phase 1|8|Actual|Actelion||1|||f||||f||||||||||2017-10-11 00:04:45.106686|2017-10-11 00:04:45.106686
NCT02223858|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-09-08|||July 13, 2015|Actual|2015-07-13|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|SPA||Staying Positive With Arthritis Study|Staying Positive: An Intervention to Reduce Osteoarthritis Pain Disparities|Active, not recruiting||N/A|517|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:04:45.447985|2017-10-11 00:04:45.447985
NCT02223845|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-21|||February 2013||2013-02-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Randomised Controlled Trial of the Effect of Music on Women Undergoing Assisted Reproductive Technology Treatments.|Randomised Controlled Trial of the Effect of Music on Women Undergoing Assisted Reproductive Technology Treatments.|Completed||N/A|42|Actual|University of Southampton||2|||f||||t||||||||||2017-10-11 00:04:45.542184|2017-10-11 00:04:45.542184
NCT02223832|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||February 2009||2009-02-01|August 2014|2014-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study to Evaluate the Pharmacokinetics, Tolerability, and Safety of ACT-128800 in Japanese and Caucasian Healthy Male and Female Subjects|Single-center, Open-label, Parallel-group Study to Evaluate the Pharmacokinetics, Tolerability, and Safety of a Single Dose of 40 mg ACT-128800 in Japanese and Caucasian Healthy Male and Female Subjects|Completed||Phase 1|20|Actual|Actelion||1|||f||||f||||||||||2017-10-11 00:04:45.612419|2017-10-11 00:04:45.612419
NCT02223819|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-12-15|||March 2015||2015-03-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy|Phase II Trial of Adjuvant Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy|Recruiting||Phase 2|10|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-11 00:04:45.70015|2017-10-11 00:04:45.70015
NCT02223416|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-03-17||||||August 2014|2014-08-01||||January 2015|Actual|2015-01-01||Interventional|||A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo||Completed||Phase 1|||Gedeon Richter Plc.||2|||f||||||||||||||2017-10-11 00:04:51.354645|2017-10-11 00:04:51.354645
NCT02223793|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-07-01|||September 2014||2014-09-01|July 2016|2016-07-01|February 2022|Anticipated|2022-02-01|December 2015|Actual|2015-12-01||Interventional|VISA||Vascular Lifestyle-Intervention and Screening in Pharmacy|Effects of Cardiovascular Risk Screening in Pharmacies: A Randomized Study|Active, not recruiting||N/A|583|Actual|University of Oslo||3|||f||||f||||||||||2017-10-11 00:04:45.923214|2017-10-11 00:04:45.923214
NCT02223780|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-20|||September 2013||2013-09-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Early Palliative Care for Patients With Severe and Very Severe COPD: a Randomised Study|Can Early Introduction of Specialized Palliative Care Limit Intensive Care, Emergency and Hospital Admissions in Patients With Severe and Very Severe COPD? A Randomized Study|Unknown status|Recruiting|N/A|180|Anticipated|University Hospital, Geneva||2|||f||||t||||||||||2017-10-11 00:04:46.031087|2017-10-11 00:04:46.031087
NCT02223767|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-01-11|||August 2014||2014-08-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|BEAT||TMS Augmented Exposure Therapy|Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Height Phobics|Completed||N/A|47|Actual|Wuerzburg University Hospital||2|||f||||f||||||||||2017-10-11 00:04:46.156233|2017-10-11 00:04:46.156233
NCT02223754|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-07-18|2016-06-08||August 2014||2014-08-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||The analysis population consists of subjects that were dispensed a study lens.|Evaluation of an Investigational Multifocal Lens||Completed||N/A|371|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 00:04:46.26316|2017-10-11 00:04:46.26316
NCT02223741|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-03-18|||August 2014||2014-08-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01|12 Months|Observational [Patient Registry]|||Observational Study of the Conjugated Rehabilitation on Children With Cerebral Palsy|An Observational Study of the Conventional Rehabilitation and Traditional Korean Medicine Conjugated Rehabilitation on Children With Cerebral Palsy|Recruiting||N/A|300|Anticipated|Korean Medicine Hospital of Pusan National University|||2||f||||f||||||||||2017-10-11 00:04:46.71692|2017-10-11 00:04:46.71692
NCT02223728|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-11-21|||August 2014||2014-08-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|ProjectLIFT||Evaluation of a Telehealth Lifestyle Management Program to Improve Healthy Behaviors Post Head Injury|Evaluation of Telehealth Lifestyle Program for Persons With Traumatic Brain Injury: Objective 2|Recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 00:04:46.98571|2017-10-11 00:04:46.98571
NCT02223715|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-08-23|2016-06-28||March 2014||2014-03-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries|A Prospective Study to Characterize the Management and Outcome of Clostridium Difficile Infection （CDI) in Asian Pacific Countries|Completed||N/A|600|Actual|Otsuka Pharmaceutical Co., Ltd.|||1||f||||f||||||||||2017-10-11 00:04:47.07938|2017-10-11 00:04:47.07938
NCT02223676|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-08-21|||October 2013||2013-10-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Clinical Pharmacists in the Emergency Department|Is Length of Stay in the Emergency Department Reduced When Clinical Pharmacists Conduct Medication History? - a Cluster Randomized Study|Unknown status|Active, not recruiting|N/A|860|Anticipated|Randers Regional Hospital||2|||f||||f||||||||||2017-10-11 00:04:47.57127|2017-10-11 00:04:47.57127
NCT02223663|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-04-27|||January 27, 2016||2016-01-27||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:04:47.634829|2017-10-11 00:04:47.634829
NCT02223650|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-04-11|2016-08-30||December 2014||2014-12-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|IXT3||A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia|A Pilot Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia|Completed||N/A|58|Actual|Jaeb Center for Health Research|Small sample size; only 8-weeks of follow up; high test-retest variability of control; some regression to the mean may be present; do not know if treatment effect would persist after overminus lenses are replaced with usual spectacle correction.|2|||f||||t||||||||Yes|In accordance with the NIH data sharing policy, a de-identified database is placed in the public domain on the PEDIG public website after the completion of each protocol and publication of the primary manuscript.|2017-10-11 00:04:47.698234|2017-10-11 00:04:47.698234
NCT02223637|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-05-17|||September 1, 2014|Actual|2014-09-01|May 2017|2017-05-01|August 30, 2018|Anticipated|2018-08-30|August 30, 2018|Anticipated|2018-08-30|10 Months|Observational [Patient Registry]|||Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry|MENVEO® Pregnancy Registry: an Observational Study on the Safety of MENVEO Exposure in Pregnant Women and Their Offspring|Recruiting||N/A|100|Anticipated|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 00:04:48.721756|2017-10-11 00:04:48.721756
NCT02223624|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-09-20|||August 2014||2014-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of an Eccentric Exercise Program on Quality of Life and Function in People With Chronic Heart Failure.|Effect of an Eccentrically Biased Aerobic Exercise Program on Quality of Life and Functional Capacity in People With Chronic Heart Failure: A Randomized Controlled Trial.|Recruiting||N/A|75|Anticipated|La Trobe University||3|||f||||f||||||||||2017-10-11 00:04:48.831251|2017-10-11 00:04:48.831251
NCT02223403|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-21|||October 2012||2012-10-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Nitrate-rich Beetroot Juice on Exercise Performance in Heart Failure Patients|Single Dose of Nitrate-rich Beetroot Juice Does Not Improve Steady State Oxygen Consumption or Six-minute Walk Distance in Patients With Systolic Heart Failure.|Completed||N/A|12|Actual|Brooke Army Medical Center||2|||f||||t||||||||||2017-10-11 00:04:51.448089|2017-10-11 00:04:51.448089
NCT02223611|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-21|||December 2014||2014-12-01|August 2014|2014-08-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|S1VSNP||Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection|Phase ⅡTrial of S1 Capsule Plus Cisplatin Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment in Stage Ⅱ-ⅢA Non-small Cell Lung Cancer (NSCLC) After Complete Resection|Not yet recruiting||Phase 2|100|Anticipated|Hebei Medical University Fourth Hospital||2|||f||||t||||||||||2017-10-11 00:04:48.968201|2017-10-11 00:04:48.968201
NCT02223598|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-06-15|||July 2014||2014-07-01|June 2017|2017-06-01||||December 2018|Anticipated|2018-12-01||Interventional|CLC-102||A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies|A Phase 1, Dose-Escalation/Dose-Expansion Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamic Effects of Orally Administered CB-5083 in Subjects With Lymphoid Hematological Malignancies|Terminated||Phase 1|120|Anticipated|Cleave Biosciences, Inc.||3|||f||||t||||||||||2017-10-11 00:04:49.098315|2017-10-11 00:04:49.098315
NCT02223585|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2015-04-17|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Gut Microbiota and Proteins Intake|Gut Microbial Response to Well-balanced Diet With Emphasis on Animal or Vegan Protein|Completed||N/A|40|Anticipated|Nestlé||1|||f||||f||||||||||2017-10-11 00:04:49.238259|2017-10-11 00:04:49.238259
NCT02223572|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||September 2014||2014-09-01|August 2014|2014-08-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture|Secondary Fracture Prevention in Patients Hospitalized for Hip Fracture: Adding the Metabolic Treatment to the Surgical One.|Unknown status|Not yet recruiting|N/A|50|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 00:04:49.347443|2017-10-11 00:04:49.347443
NCT02223559|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-08-08|||August 2014||2014-08-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Non-invasive Assessment of Pulmonary Artery Pressure|Non-invasive Assessment of Pulmonary Artery Pressure and Right Ventricular Function in Patients With Pulmonary Hypertension|Completed||N/A|90|Actual|Medical University of Graz|||1||f||||f||||||Samples Without DNA|"     Serum and plasma samples will be retrained   "|||2017-10-11 00:04:49.441831|2017-10-11 00:04:49.441831
NCT02223546|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||October 2013||2013-10-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Observational|CVdi||Circadian Macular Volume Changes in the Choroid|Pilotstudy: Diurnal Changes in Choroidal Volume|Completed||N/A|15|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-11 00:04:49.509913|2017-10-11 00:04:49.509913
NCT02223533|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-21|||January 2012||2012-01-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|||Multimodal Analgesia With Interfascial Continuous Wound Infiltration: A Randomized Clinical Trial|Multimodal Analgesia With Interfascial Continuous Wound Infiltration of a Local Anaesthetic vs Intravenous Opioids After Laparoscopic Colon Surgery: A Randomized Clinical Trial.|Completed||Phase 4|110|Actual|Hospital Galdakao-Usansolo||2|||f||||f||||||||||2017-10-11 00:04:49.582578|2017-10-11 00:04:49.582578
NCT02223520|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2017-05-23|||November 2014||2014-11-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|TREAT PARENTS||Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial|Treating Parents to Reduce Neonatal Intensive Care Unit (NICU) Transmission of Staphylococcus Aureus|Recruiting||N/A|400|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:04:49.660302|2017-10-11 00:04:49.660302
NCT02223507|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||August 2000||2000-08-01|August 2014|2014-08-01||||September 2000|Actual|2000-09-01||Interventional|||Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers|A Single-blind, Placebo-controlled Single Dose Tolerance Study in Healthy Elderly Male and Female Volunteers After Intravenous Administration of BIIR 561 CL as Loading Dose (Dosage: 75 mg/h, Infusion Time 1 Hour) Followed by Maintenance Dose (Dosage: 40 mg/h and 75 mg/h, Infusion Time 5 Hours)|Completed||Phase 1|13||Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:04:49.770248|2017-10-11 00:04:49.770248
NCT02223494|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||October 1998||1998-10-01|August 2014|2014-08-01||||March 2000|Actual|2000-03-01||Interventional|||Safety of Terbogrel in Patients With Primary Pulmonary Hypertension|An Open-label, Long-term Safety Evaluation of Terbogrel in Patients With Primary Pulmonary Hypertension|Terminated||Phase 2|33|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:04:49.858574|2017-10-11 00:04:49.858574
NCT02223481|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||May 1998||1998-05-01|August 2014|2014-08-01||||September 1999|Actual|1999-09-01||Interventional|||Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension|A Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension|Completed||Phase 2|71|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:04:49.926597|2017-10-11 00:04:49.926597
NCT02223468|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-03-28|||January 2016||2016-01-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Human Microbiota and Liver Transplant|Prospective Study To Characterize The Human Microbiota In Liver Transplantation And Its Impact On Early Outcome|Recruiting||N/A|40|Anticipated|Hospital Vall d'Hebron|||1||f||||t||||||Samples Without DNA|"     Stool samples Portal nodes Periphereal blood   "|||2017-10-11 00:04:50.022445|2017-10-11 00:04:50.022445
NCT02223455|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-03-15|||October 2014||2014-10-01|March 2016|2016-03-01|March 2019|Anticipated|2019-03-01|August 2016|Anticipated|2016-08-01||Interventional|||Building an Optimal Hand Hygiene Bundle|Building an Optimal Hand Hygiene Bundle: A Mixed Methods Approach|Recruiting||N/A|59|Anticipated|Iowa City Veterans Affairs Medical Center||3|||f||||f||||||||||2017-10-11 00:04:50.134772|2017-10-11 00:04:50.134772
NCT02223442|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-20|||September 2014||2014-09-01|November 2012|2012-11-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Observational|||Central Analgesic Drugs for the Treatment of Chronic Pain|Cognitive Study on the Use of Central Analgesic Drugs in the Management of Chronic Pain|Unknown status|Not yet recruiting|N/A|300|Anticipated|University of Parma|||1||f||||f||||||||||2017-10-11 00:04:50.290827|2017-10-11 00:04:50.290827
NCT02223429|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-04-27|2017-02-28||August 2014||2014-08-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||Only participants who completed the study were included in the baseline analysis. Among the 32 subjects who started the study, one participant did not complete MRI scanning and was not included in any data analysis.|Neurobiological Bases of Paternal Nurturance|Biological Bases of Individual Variation in Paternal Nurturance|Completed||N/A|35|Actual|Emory University|Plasma levels of vasopressin (AVP) and peripheral levels of oxytocin (OT) were not assayed due to lack of funding.|2|||f||||t||f||||||||2017-10-11 00:04:50.415726|2017-10-11 00:04:50.415726
NCT02223377|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-09-06|||January 2015||2015-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|SAME-Day||Satisfactory Analgesia Minimal Emesis in Day Surgeries|Most Effective Opioid Analgesia in Ambulatory Surgeries: a Randomized Control, Investigator Blinded, Parallel Group With Superiority Design Study of Morphine Versus Hydromorphone|Recruiting||N/A|532|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 00:04:51.672555|2017-10-11 00:04:51.672555
NCT02223364|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-08-29|2017-06-16||July 2014||2014-07-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Peripheral Nerve Blocks vs Periarticular Local Anesthetic Injection for Total Knee Arthroplasty (TKA)|Prospective, Randomized, Controlled Trial Comparing Continuous Femoral and Single Injection Sciatic Peripheral Nerve Blocks vs Periarticular Injection With Ropivacaine or Liposomal Bupivacaine (Exparel) on Patients Undergoing Total Knee Arthroplasty|Completed||Phase 4|165|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 00:04:51.827542|2017-10-11 00:04:51.827542
NCT02223351|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-12-09|||September 2014||2014-09-01|August 2014|2014-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Drug-Drug Interaction Study: ASP2151 and Ritonovir|A Single-centre, Open-label, Randomised, Crossover, Drug-drug Interaction Study to Investigate the Effect of a Single Oral Dose of Ritonavir on the Single Dose Pharmacokinetics of ASP2151 in Healthy Men|Completed||Phase 1|48|Actual|Maruho Europe Limited||2|||f||||f||||||||||2017-10-11 00:04:53.020095|2017-10-11 00:04:53.020095
NCT02223325|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-11-19|||August 2014||2014-08-01|August 2014|2014-08-01||||August 2016|Anticipated|2016-08-01||Observational|||Evaluation of Prognosis and Prognostic Scores in Geriatric Patients With Acute Pancreatitis|Evaluation of Prognosis and Prognostic Scores in Geriatric Patients With Acute Pancreatitis: A Prospective Cohort Study|Unknown status|Active, not recruiting|N/A|150|Anticipated|Gazi University|||2||f||||f||||||||||2017-10-11 00:04:53.273949|2017-10-11 00:04:53.273949
NCT02223312|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-08-10|||July 28, 2017|Actual|2017-07-28|August 2017|2017-08-01|January 31, 2019|Anticipated|2019-01-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Therapy for Progressive and/or Refractory Hematologic Malignancies|Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Low Dose GM-CSF, in Patients With Progressive and/or Refractory Hematologic Malignancies|Recruiting||Phase 1/Phase 2|23|Anticipated|Kiromic, LLC||1|||f||||t|t|f||||||||2017-10-11 00:04:53.366477|2017-10-11 00:04:53.366477
NCT02223299|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-08-29|||November 2015||2015-11-01|August 2016|2016-08-01||||March 2016|Actual|2016-03-01||Interventional|||Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.|A Randomized Double-Blind Placebo-Controlled Pilot Study of L-tyrosine and L-tryptophan in Depressed Patients Receiving L-methylfolate and and SSRI|Terminated||N/A|10|Actual|John D. Dingell VA Medical Center||2||PI left the VA|f||||f||||||||||2017-10-11 00:04:53.497981|2017-10-11 00:04:53.497981
NCT02223273|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-09-20|||September 2016||2016-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|BRIDGE-Stroke||Brazilian Intervention to Increase Evidence Usage in Practice - Stroke ( BRIDGE-Stroke)|A Cluster Randomized Trial to Evaluate the Increase in Usage of Evidence-based Practices for Stroke Treatment Using a Multifaceted Strategy|Recruiting||Phase 4|1140|Anticipated|Hospital do Coracao||2|||f||||f||||||||||2017-10-11 00:04:53.709692|2017-10-11 00:04:53.709692
NCT02223260|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2016-07-28|2016-07-28||September 2014||2014-09-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional||Treated set (TS): the treated set included 8 patients who were dispensed study medication and were documented to have taken at least 1 dose of trial medication.|Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age|Open-label, Single Dose, Tolerability, Pharmacokinetic/Pharmacodynamics and Safety Study of Dabigatran Etexilate Given at the End of Standard Anticoagulant Therapy in Children Aged Less Than 1 Year Old|Completed||Phase 2|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:04:53.830128|2017-10-11 00:04:53.830128
NCT02223247|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-08-11|||November 2013||2013-11-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors|A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors|Completed||Phase 1|180|Anticipated|3V Biosciences, Inc.||1|||f||||t|t|f||||||||2017-10-11 00:04:54.186979|2017-10-11 00:04:54.186979
NCT02223234|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-01-03|||September 2014||2014-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||Guelph Family Health Study: Pilot Study|Guelph Family Health Study: Pilot Study|Completed||N/A|44|Actual|University of Guelph||3|||f||||f||||||||||2017-10-11 00:04:54.286647|2017-10-11 00:04:54.286647
NCT02223221|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-07-09|||August 2014||2014-08-01|July 2017|2017-07-01|April 30, 2017|Actual|2017-04-30|July 31, 2016|Actual|2016-07-31||Interventional|||Effects of PGS in Infertile Female Patients With RPL|Effects of Preimplantation Genetic Screening for Aneuploidies in Infertile Female Patients With Recurrent Spontaneous Abortion History|Completed||N/A|189|Actual|ShangHai Ji Ai Genetics & IVF Institute||2|||f||||t||||||||||2017-10-11 00:04:54.374228|2017-10-11 00:04:54.374228
NCT02222844|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-03-17|||August 2014||2014-08-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|IMPRESS||Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers|Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers|Recruiting||N/A|243|Anticipated|Royal Marsden NHS Foundation Trust||3|||f||||t||||||||||2017-10-11 00:05:00.240678|2017-10-11 00:05:00.240678
NCT02223208|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-08-01|||September 2014||2014-09-01|August 2017|2017-08-01|March 2025|Anticipated|2025-03-01|September 2019|Anticipated|2019-09-01||Interventional|FIL_PTCL13||Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas|Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study|Recruiting||Phase 1/Phase 2|110|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||||||||||||2017-10-11 00:04:54.483567|2017-10-11 00:04:54.483567
NCT02223195|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||September 2014||2014-09-01|August 2014|2014-08-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Observational|||Biomarkers in Saliva in Children With Juvenil Idiopathic Arthritis|Biomarkers in Saliva in Children With Juvenil Idiopathic Arthritis|Unknown status|Not yet recruiting|N/A|80|Anticipated|Folktandvården Stockholms län AB|||1||f||||f||||||Samples With DNA|"     Saliva sampels   "|||2017-10-11 00:04:54.779176|2017-10-11 00:04:54.779176
NCT02223182|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-12-16|||November 2014||2014-11-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Interventional|MILES||Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy|A Double-Blind, Placebo-Controlled Randomized Trial to Study the Viaskin Milk Efficacy and Safety for Treating IgE-Mediated Cow's Milk Allergy in Children|Active, not recruiting||Phase 1/Phase 2|198|Actual|DBV Technologies||4|||f||||t||||||||||2017-10-11 00:04:54.857682|2017-10-11 00:04:54.857682
NCT02223169|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-05-02|||April 2014||2014-04-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|CardiProtein||Human Intervention Study of Egg Protein Derivative on Cardiovascular Risk|Dietary Intervention Study to Assess the Effects of Albumin-Derived Peptides on Cardio-Metabolic Risk Factors in Adults|Completed||N/A|69|Actual|University College Cork||2|||f||||t||||||||||2017-10-11 00:04:55.146208|2017-10-11 00:04:55.146208
NCT02223156|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||March 2014||2014-03-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Observational|MYPAF||Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation-MYPAF|Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation-MYPAF, a Randomized Controlled Three Arms Study|Unknown status|Recruiting|N/A|132|Anticipated|Danderyd Hospital|||3||f||||t||||||Samples Without DNA|"     BNP and CRP   "|||2017-10-11 00:04:55.219868|2017-10-11 00:04:55.219868
NCT02223143|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-11-14|||January 2009||2009-01-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||A Registration Study for Dyslipidemia|A Registration Study for Primary and Secondary Prevention in Dyslipidemic Taiwanese|Recruiting||N/A|35000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||Yes||2017-10-11 00:04:55.29051|2017-10-11 00:04:55.29051
NCT02223130|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-01-26|||July 2014||2014-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Addressing Discrimination and Mistrust Among Black Men: Phase III|Addressing Discrimination and Mistrust Among Black Men: Phase III|Completed||N/A|64|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 00:04:55.360279|2017-10-11 00:04:55.360279
NCT02223117|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2016-06-10|||September 2014||2014-09-01|June 2016|2016-06-01||||July 2016|Anticipated|2016-07-01||Interventional|||Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)|Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)|Active, not recruiting||Early Phase 1|15|Anticipated|Cellphire, Inc.||2|||f||||t||||||||||2017-10-11 00:04:55.440674|2017-10-11 00:04:55.440674
NCT02223104|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-07-30|||October 2013||2013-10-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Randomized Controlled Multicenter Study to Evaluate the Performance of Flexima® Active vs. Sensura® in Patients With Colostomy||Completed||Phase 4|70|Actual|BBraun Medical SAS||2|||f||||f||||||||||2017-10-11 00:04:55.508974|2017-10-11 00:04:55.508974
NCT02223091|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-08-03|||September 2014||2014-09-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|KOKON-AS||KOKON Consultation on Complementary Medicine in Oncology - a Pilot Study|Prospective, Multi-center, Cluster-randomized, Pragmatic, Mixed-method Pilot Study Evaluating a Consultation Training Program for Physicians Within the Framework of KOKON (Competence Network Complementary Medicine in Oncology)|Completed||N/A|137|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:04:55.588003|2017-10-11 00:04:55.588003
NCT02223078|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-06-19|||July 2000||2000-07-01|August 2014|2014-08-01|November 2001|Actual|2001-11-01|August 2001|Actual|2001-08-01||Interventional|CC4||Two Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer.|Phase II, Randomised, Double-blind, Placebo-controlled, Parallel Group, Two Centre Study to Determine the Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer.|Completed||Phase 2|||Cancer Advances Inc.||2|||||||||||||||||2017-10-11 00:04:55.678771|2017-10-11 00:04:55.678771
NCT02223065|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-03-25|2016-02-17||September 2014||2014-09-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State|A Bioequivalence Study of Fixed-dose Combination Tablet of 5 Milligrams Saxagliptin/10 Milligrams Dapagliflozin Relative to Their Respective Individual Components Coadministered to Healthy Subjects in the Fasted State|Completed||Phase 1|36|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:04:55.775931|2017-10-11 00:04:55.775931
NCT02223052|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-09-28|||October 27, 2014|Actual|2014-10-27|September 2017|2017-09-01|September 5, 2018|Anticipated|2018-09-05|August 18, 2018|Anticipated|2018-08-18||Interventional|||Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies|A Phase 1, Open-label, Multicenter, Randomized, 2-Period, Crossover Study to Evaluate the Bioequivalence and Food Effect Bioavailability of CC-486 (Oral Azacitidine) Tablets in Adult Cancer Subjects|Recruiting||Phase 1|90|Anticipated|Celgene||4|||f||||f||||||||||2017-10-11 00:04:56.12127|2017-10-11 00:04:56.12127
NCT02223039|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-03-15||2016-02-17|May 2014||2014-05-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis|Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of AbGn-168H Administered by Intravenous Infusion to Patients With Moderate to Severe Chronic Plaque Psoriasis (Randomised, Double-blind, Placebo-controlled)|Completed||Phase 2|50|Actual|AbGenomics B.V Taiwan Branch||3|||f||||f||||||||||2017-10-11 00:04:56.272999|2017-10-11 00:04:56.272999
NCT02223026|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||January 2010||2010-01-01|August 2014|2014-08-01||||March 2010|Actual|2010-03-01||Interventional|||Relative Bioavailability of a Linagliptin+Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects|Relative Bioavailability of a 2.5 mg Linagliptin / 1000 mg Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects in an Open, Randomised, Single-dose, Two-way Crossover, Phase I Trial|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:04:56.379388|2017-10-11 00:04:56.379388
NCT02223013|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||April 1999||1999-04-01|August 2014|2014-08-01||||May 1999|Actual|1999-05-01||Interventional|||Relative Bioavailability and Tolerability of Two New Different Extended Release Capsules of BIBV 308 SE, Versus a Solution of BIBV 308 SE in Healthy Subjects|Relative Bioavailability and Tolerability of Two New Different Extended Release Capsules of 50 mg BIBV 308 SE Each, Versus a Solution of 50 mg BIBV 308 SE Administered Orally Twice a Day for 3.5 Days to Healthy Subjects (Cross-over, Open, Randomized)|Completed||Phase 1|9|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:04:56.454645|2017-10-11 00:04:56.454645
NCT02223000|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||March 1998||1998-03-01|August 2014|2014-08-01||||July 1998|Actual|1998-07-01||Interventional|||Relative Bioavailability and Tolerability of Various Experimental Formulations of BIBV 308 SE in Healthy Subjects|Relative Bioavailability and Tolerability of Various Experimental Formulations of 50 mg BIBV 308 SE Administered Orally Twice a Day Over 3.5 Days to Healthy Subjects (Intraindividual Comparison, Open, Partially Randomised).|Completed||Phase 1|9|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:04:58.281372|2017-10-11 00:04:58.281372
NCT02222987|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||February 1999||1999-02-01|August 2014|2014-08-01||||March 1999|Actual|1999-03-01||Interventional|||Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects|Influence of Oral Doses of 75 mg Clopidogrel on the Pharmacodynamics and Safety of Oral Doses of 100 mg Terbogrel Bid Over 8 Days in Healthy Male Subjects. An Intra-individual, Open Trial.|Completed||Phase 1|14|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:04:58.354113|2017-10-11 00:04:58.354113
NCT02222974|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||January 1999||1999-01-01|August 2014|2014-08-01||||August 1999|Actual|1999-08-01||Interventional|||Single Increasing Dose Tolerance Study in Healthy Male Volunteers of BIIR 561 CL|A Single-blind, Placebo-controlled Single Increasing Dose Tolerance Study in Healthy Male Volunteers After Intravenous Administration of BIIR 561 CL (Dosage: 1mg/h - 175 mg/h), Infusion Time 1 Hour|Completed||Phase 1|84|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:04:58.437998|2017-10-11 00:04:58.437998
NCT02222961|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-21|2014-08-21|||November 1999||1999-11-01|August 2014|2014-08-01||||June 2000|Actual|2000-06-01||Interventional|||Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers|A Single-blind, Placebo-controlled Single Increasing Dose Tolerance Study in Healthy Male Volunteers After Intravenous Administration of BIIR 561 CL as Loading Dose (Dosage: 37.5 mg/h - 150 mg/h, Infusion Time 1 Hour) Followed by Maintenance Dose (Dosage: 20 mg/h - 40 to 125 mg/h), Infusion Time 5 Hours|Completed||Phase 1|60||Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:04:58.507966|2017-10-11 00:04:58.507966
NCT02222948|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-12-20||2016-12-20|September 2014||2014-09-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|EMPIRE||Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis|A Phase 2a/2b Double-Blind, Randomized, Placebo-Controlled Study Assessing Efficacy, Safety, and Dose-Response of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)|Terminated||Phase 2|112|Actual|Sanofi||5||"Study discontinued based on planned interim analysis of the primary endpoint. Not linked to any   safety concern."|f||||t||||||||||2017-10-11 00:04:58.5901|2017-10-11 00:04:58.5901
NCT02222935|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-21|||June 2014||2014-06-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|CLB||Effectiveness of Balance Training in Chronic Low Back Pain Patients|Effectiveness of Balance Training Over Routine Back Exercise in Improving Functional Outcomes of Chronic Low Back Pain Patients|Unknown status|Active, not recruiting|Early Phase 1|48|Actual|PSG Hospitals||2|||f||||t||||||||||2017-10-11 00:04:58.72926|2017-10-11 00:04:58.72926
NCT02222922|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-09-28|||October 17, 2014|Actual|2014-10-17|September 2017|2017-09-01|July 24, 2019|Anticipated|2019-07-24|July 24, 2019|Anticipated|2019-07-24||Interventional|||A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors|A First-in-human Phase 1, Dose Escalation, Safety And Pharmacokinetic Study Of Pf-06647020 In Adult Patients With Advanced Solid Tumors|Recruiting||Phase 1|190|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 00:04:58.830555|2017-10-11 00:04:58.830555
NCT02222883|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-02-22|||March 2015||2015-03-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Observational|BRCA-Screening||Prevalence of BRCA in Patients With Ovarian Cancer|Prevalence of BRCA in Patients With Primary or Platinum Sensitive Recurrent Ovarian Cancer.|Active, not recruiting||N/A|530|Actual|AGO Research GmbH|||2||f||||f||||||||Undecided||2017-10-11 00:04:59.327321|2017-10-11 00:04:59.327321
NCT02222870|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2015-09-16|2015-09-16||August 2014||2014-08-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine|Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)|Completed||Phase 4|60|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:04:59.510628|2017-10-11 00:04:59.510628
NCT02222857|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-21|||August 2014||2014-08-01|August 2014|2014-08-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Prophylactic Laser Photocoagulation and Vitrectomy for Acute Retinal Necrosis|Prophylactic Laser Photocoagulation and Vitrectomy for Acute Retinal Necrosis|Unknown status|Not yet recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:05:00.152753|2017-10-11 00:05:00.152753
NCT02222831|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-04-27|||June 2014||2014-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2016|Actual|2016-01-01||Interventional|||Optimizing IVF Treatment - the Impact of Time-lapse Culture and Preimplantation Factor (PIF) on Embryo Development.|Optimizing IVF Treatment - the Impact of Time-lapse Culture and Preimplantation Factor (PIF) on Embryo Development.|Active, not recruiting||N/A|100|Anticipated|Regionshospitalet Viborg, Skive||2|||f||||f||||||||||2017-10-11 00:05:00.417414|2017-10-11 00:05:00.417414
NCT02222818|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-11-08|2016-11-08||October 2014||2014-10-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CRTee|All subjects randomized to either Group A (CAFR first) or Group B (CAFRPlus first).|Cardiac Resynchronization Therapy Efficacy Enhancements|Cardiac Resynchronization Therapy Efficacy Enhancements|Completed||N/A|71|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f||||||||No||2017-10-11 00:05:00.514788|2017-10-11 00:05:00.514788
NCT02222805|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-09-22|||October 2014|Actual|2014-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later Neurodevelopment|Effect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later Neurodevelopment in Late Pre-term and Term Infants; a Facility-based Randomized-controlled Trial in Nepal|Active, not recruiting||N/A|540|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-11 00:05:01.086573|2017-10-11 00:05:01.086573
NCT02222792|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-20|||June 2012||2012-06-01|August 2014|2014-08-01|July 2016|Anticipated|2016-07-01|May 2014|Actual|2014-05-01||Observational|||BJI Inoplex 2 : Test for Diagnosis of Prosthetic Infections|Evaluation of the BJI Inoplex 2 Kit for the Multiplex Serological Diagnosis of Bone and Joint Prosthetic Device Infections|Unknown status|Active, not recruiting|N/A|540|Anticipated|Diaxonhit|||3||f||||f||||||Samples Without DNA|"     Serologic assays of sera collected from septic or non-septic patients will be performed in     series and operators will be blind in terms of clinical and microbiological status in order     to avoid any interpretation bias due to information collected in advance   "|||2017-10-11 00:05:01.218917|2017-10-11 00:05:01.218917
NCT02222779|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-20|||September 2014||2014-09-01|August 2014|2014-08-01||||August 2019|Anticipated|2019-08-01||Observational|||Quantification of Transition Metals|Quantification of Transition Metals in Patients at the Cologne University Hospital|Not yet recruiting||N/A|3000|Anticipated|University of Cologne|||4||f||||||||||Samples Without DNA|"     Remaining portions of samples collected for diagnostic or therapeutic reasons (paired CSF and     blood serum samples). No lumbar puncture will be done specifically for this protocol.   "|||2017-10-11 00:05:01.301032|2017-10-11 00:05:01.301032
NCT02222766|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-20|||June 2011||2011-06-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|PTT||Parents and Tots Together: A Family-Based Obesity Prevention Intervention|Parents and Tots Together: A Family-Based Intervention to Promote Healthy Eating and Activity Behaviors Among Preschool Children|Completed||N/A|112|Actual|University of Guelph||2|||f||||f||||||||||2017-10-11 00:05:01.410517|2017-10-11 00:05:01.410517
NCT02222753|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-20|||January 2014||2014-01-01|August 2014|2014-08-01||||December 2018|Anticipated|2018-12-01||Observational|||Immunological Markers Screening for Colorectal Cancer|Therapeutic Effect and Prognosis Predication Related Immunocyte Subgroup and Immunologic Factors Screeing for Colorectal Cancer|Recruiting||N/A|5000|Anticipated|State Key Laboratory of Cancer Biology|||1||f||||t||||||Samples With DNA|"     Tissue and blood specimens   "|||2017-10-11 00:05:01.521059|2017-10-11 00:05:01.521059
NCT02222740|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-08-19|||September 2002||2002-09-01|August 2014|2014-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain|A Multiple-Dose, Safety, Tolerability, and Pharmacokinetic Dose-Escalation Study of Hydrocodone Bitartrate Extended Release (HC-ER) in Patients With Chronic, Moderate to Severe Osteoarthritis Pain|Completed||Phase 2|37|Actual|Zogenix, Inc.||2|||f||||f||||||||||2017-10-11 00:05:01.649889|2017-10-11 00:05:01.649889
NCT02222727|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-09-08|||January 2014||2014-01-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|DASH||Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage|Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage|Terminated||Phase 2|19|Actual|St George's, University of London||2||CT scanner software incompatible|f||||f||||||||||2017-10-11 00:05:01.791773|2017-10-11 00:05:01.791773
NCT02222714|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-05-23|||October 2014||2014-10-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|RHAPSODY||Safety Evaluation of 3K3A-APC in Ischemic Stroke|A Multi-center, Phase 2 Study Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, a Recombinant Variant of Human APC, in Combination With tPA, Mechanical Thrombectomy or Both in Moderate to Severe Acute Ischemic Stroke|Active, not recruiting||Phase 2|110|Actual|ZZ Biotech, LLC||5|||f||||t|t|f||||||Undecided||2017-10-11 00:05:01.958003|2017-10-11 00:05:01.958003
NCT02222701|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-20|||May 2003||2003-05-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01|10 Years|Observational [Patient Registry]|reacondcomp||Composite Resins Reconditioned, Behavior and Survival: Clinical Follow-up 10 Years|Composite Resins Reconditioned, Behavior and Survival: Clinical Follow-up 10 Years|Completed||N/A|25|Actual|University of Chile|||3||f||||t||||||||||2017-10-11 00:05:02.220458|2017-10-11 00:05:02.220458
NCT02222688|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-06-02|||August 2014||2014-08-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia|A Phase I Clinical Trial to Determine the Safety and Tolerability of UC-961 (Cirmtuzumab), an Anti-ROR1 Monoclonal Antibody, for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Who Are Ineligible for Chemotherapy|Recruiting||Phase 1|56|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:05:02.309144|2017-10-11 00:05:02.309144
NCT02222675|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-04-12|||April 2009||2009-04-01|August 2014|2014-08-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|MAC-001||Conserving Breast Surgery - Comparison of Conventional With Sonography|Comparison of Sonographically Assisted With Conventionally Breast Surgery - Prospective, Randomised, Multicenter, Parallel Group Study With Two Study Arms|Completed||N/A|46|Actual|University Women's Hospital Tübingen||2|||f||||||||||||||2017-10-11 00:05:02.397902|2017-10-11 00:05:02.397902
NCT02222662|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2016-04-27|||June 2014||2014-06-01|December 2015|2015-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Parent-delivered Massage for Children With Autism - Ages 6 to 11|Phase 1 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism Ages 6 to 11|Completed||N/A|35|Actual|Western Oregon University||2|||f||||f||||||||||2017-10-11 00:05:02.483668|2017-10-11 00:05:02.483668
NCT02222649|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-03-04|||July 2014||2014-07-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Interventional|||Evaluation of the High Dose Vitamin D3 Supplementation Effect and Influence of Polymorphism VDR Gene on Oxidative Stress and Inflammatory Process in Elderly|EVALUATION OF THE HIGH DOSE VITAMIN D3 SUPPLEMENTATION EFFECT AND INFLUENCE OF POLYMORPHISM VDR GENE ON OXIDATIVE STRESS AND INFLAMMATORY PROCESS IN ELDERLY|Unknown status|Recruiting|Phase 2|40|Anticipated|Federal University of Paraíba||2|||f||||t||||||||||2017-10-11 00:05:02.600412|2017-10-11 00:05:02.600412
NCT02222636|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-19|||September 2014||2014-09-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||The Clinical Research of Intranasal Dexmedetomidine Used in Plastic Surgery of Children|The Clinical Research of Intranasal Dexmedetomidine Used in Plastic Surgery of Children : A Single Center ,Randomized ,Double-blinded, Controlled Study.|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:05:02.730013|2017-10-11 00:05:02.730013
NCT02222623|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-08-03|||April 2015||2015-04-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|InovaDM2||The Inova Type 2 Diabetes Mellitus Study|Insulin Glargine vs NPH as Basal Insulin on Glycemic Values in Hospitalized Patients: The Inova Diabetes Study|Withdrawn||N/A|0|Actual|Inova Health Care Services||2||No participants enrolled|f||||f||||||||||2017-10-11 00:05:02.830894|2017-10-11 00:05:02.830894
NCT02222610|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2017-02-22|||August 2014||2014-08-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|RRR||Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.|A Randomized, Active-Controlled, Phase II Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation in Subjects With Radiation Retinopathy (RRR Study).|Recruiting||Phase 2|40|Anticipated|Greater Houston Retina Research||3|||f||||f||||||||No||2017-10-11 00:05:02.944169|2017-10-11 00:05:02.944169
NCT02222597|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-24|||April 2014||2014-04-01|August 2014|2014-08-01||||December 2014|Anticipated|2014-12-01||Observational|||An Evaluation of Near-Infrared Spectroscopy for Intracranial Hematoma Detection of Head Trauma Patients in the Emergency Department.|An Evaluation of Near-Infrared Spectroscopy for Intracranial Hematoma Detection of Head Trauma Patients in the Emergency Department.|Unknown status|Recruiting|N/A|400|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:05:03.106922|2017-10-11 00:05:03.106922
NCT02222584|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-20|||June 2014||2014-06-01|August 2014|2014-08-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Observational|||The Effects of Physical Activity on Patients With Inflammatory Bowel Disease||Unknown status|Recruiting|N/A|200|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:05:03.224086|2017-10-11 00:05:03.224086
NCT02222571|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-01-03|||July 2013||2013-07-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Formative Research - Developing a Family-based Obesity Prevention Intervention in the Canadian Context|Formative Research - Developing a Family-based Obesity Prevention Intervention in the Canadian Context|Completed||N/A|28|Actual|University of Guelph||2|||f||||t||||||||||2017-10-11 00:05:03.322082|2017-10-11 00:05:03.322082
NCT02222558|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-04-21|2016-03-16||September 2014||2014-09-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional||Subjects that began each defined period.|Oral Testosterone for the Treatment of Hypogonadism in Males|A Phase 2B Study to Determine the Dose Response Pharmacokinetics of TSX-002 (Testosterone) in Hypogonadal Males|Completed||Phase 2|25|Actual|TesoRx Pharma, LLC||6|||f||||f||||||||||2017-10-11 00:05:03.433547|2017-10-11 00:05:03.433547
NCT02222545|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-07-28|||August 2014||2014-08-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies|A Phase 2, Uncontrolled, Three-Stage, Dose-Escalation Cohort Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Clinical Activity of OMS721 in Adults With Thrombotic Microangiopathies|Recruiting||Phase 2|89|Anticipated|Omeros Corporation||3|||t||||t||||||||||2017-10-11 00:05:03.851845|2017-10-11 00:05:03.851845
NCT02222532|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-02-16|||June 2013||2013-06-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|I-TRICC||Oral Triiodothyronine for Infants Less Than 5 Months & Malnourished Children Undergoing Cardiopulmonary Bypass in Indonesia|Tetronine (Sodium Liothyronine) for Infants & Children Undergoing Cardiopulmonary Bypass in a Middle Income Nation (OTICC Study)|Completed||Phase 3|224|Actual|National Cardiovascular Center Harapan Kita Hospital Indonesia||2|||f||||t||||||||||2017-10-11 00:05:04.139363|2017-10-11 00:05:04.139363
NCT02222519|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-10-22|||October 2014||2014-10-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|||Interaction of Statins and Nondepolarizing Muscle Relaxants|Interaction of Statins and Nondepolarizing Muscle Relaxants|Unknown status|Recruiting|Phase 4|60|Anticipated|First Hospital of China Medical University|||2||f||||t||||||||||2017-10-11 00:05:04.24355|2017-10-11 00:05:04.24355
NCT02222506|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-09-01|||April 2013||2013-04-01|September 2016|2016-09-01||||February 2016|Actual|2016-02-01||Interventional|||Safety Evaluation of the KLOX BioPhotonic System in Diabetic Foot Ulcers|A Prospective Case Series Evaluating the Safety of the KLOX BioPhotonic System in Diabetic Foot Ulcers|Completed||N/A|10|Actual|KLOX Technologies Inc.||1|||f||||f||||||||||2017-10-11 00:05:04.355119|2017-10-11 00:05:04.355119
NCT02222493|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-08-09|2017-06-26|2017-06-26|August 26, 2014|Actual|2014-08-26|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 29, 2016|Actual|2016-06-29||Interventional||The Intent-to-Treat (ITT) Population was defined as all participants who were randomized to study treatment.|A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).|A Phase 3 Randomized, Double-blind Study Assessing The Efficacy And Safety Of Pf-06438179 And Infliximab In Combination With Methotrexate In Subjects With Moderately To Severely Active Rheumatoid Arthritis Who Have Had An Inadequate Response To Methotrexate|Completed||Phase 3|650|Actual|Pfizer|Data from the first treatment period (from baseline to Week 30 pre-dose) are presented. Results from all 3 treatment periods should be available by April 2018. The report will be updated by then.|2|||f||||t||||||||||2017-10-11 00:05:04.484762|2017-10-11 00:05:04.484762
NCT02222298|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-11-02|||April 2012||2012-04-01|November 2015|2015-11-01||||November 2015|Actual|2015-11-01||Interventional|||Video Assisted Ablation of Pilonidal Sinus Versus Conventional Treatment|Video Assisted Ablation of Pilonidal Sinus Versus Convention Off-midline Bas Com Cleft Lift Procedure|Completed||N/A|300|Anticipated|Federico II University||2|||f||||||||||||||2017-10-11 00:05:06.704863|2017-10-11 00:05:06.704863
NCT02222480|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-06-30|||October 2014||2014-10-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide|A 2-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan in Combination With Hydrochlorothiazide in Patients With Mild to Moderate Hypertension|Completed||Phase 2|103|Actual|Boryung Pharmaceutical Co., Ltd||5|||f||||f||||||||||2017-10-11 00:05:05.408588|2017-10-11 00:05:05.408588
NCT02222467|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-02-22|||November 2012||2012-11-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers|A Prospective Case Series Evaluating the Safety of the KLOX BioPhotonic System in Venous Leg Ulcers|Completed||N/A|10|Actual|KLOX Technologies Inc.||1|||f||||f||||||||||2017-10-11 00:05:05.525331|2017-10-11 00:05:05.525331
NCT02222454|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-02-22|||November 2012||2012-11-01|February 2016|2016-02-01||||August 2015|Actual|2015-08-01||Interventional|||Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers|A Prospective Case Series Evaluating the Safety of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers|Completed||N/A|3|Actual|KLOX Technologies Inc.||1|||f||||f||||||||||2017-10-11 00:05:05.615978|2017-10-11 00:05:05.615978
NCT02222441|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-02-18|||October 2014||2014-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)|A Phase 1, Open-label, Fixed-sequence, 2-cohort, 2-period Study To Investigate The Effect Of Modafinil And Pioglitazone Given As Multiple Doses On Single Dose Pharmacokinetics Of Palbociclib (Pd-0332991) In Healthy Volunteers|Completed||Phase 1|14|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:05:05.71252|2017-10-11 00:05:05.71252
NCT02222428|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||April 2009||2009-04-01|August 2014|2014-08-01||||July 2009|Actual|2009-07-01||Interventional|||Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Mono Products of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers|An Open Label, Randomised, Three-way Crossover Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Mono Products of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers|Completed||Phase 1|36||Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:05:05.815885|2017-10-11 00:05:05.815885
NCT02222415|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-21|||October 2011||2011-10-01|August 2014|2014-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Exercise Training in Healthy Young Men|The Impact of Timed Protein Supplementation to Maximize the Skeletal Muscle Adaptive Response to Resistance Type Exercise Training in Healthy Young Men|Completed||N/A|44|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:05:05.897435|2017-10-11 00:05:05.897435
NCT02222402|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-06-08|||January 2015||2015-01-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|PEDAL||PrEscription of Intra-Dialytic Exercise to Improve quAlity of Life in Patients With Chronic Kidney Disease|Evaluating the Clinical and Cost-effectiveness of Intra-dialytic Exercise for the Improvement of Health-related Quality of Life in People With Stage 5 Chronic Kidney Disease Undergoing Maintenance Haemodialysis Renal Replacement Therapy.|Recruiting||Phase 2/Phase 3|380|Anticipated|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-11 00:05:05.966537|2017-10-11 00:05:05.966537
NCT02222389|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-09-26|||September 2014||2014-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Contingency Management for the Treatment of Co-Occurring Alcohol and Drug Misuse|P20 Research Project 1 Contingency Management for the Treatment of Co-Occurring Alcohol and Drug Misuse|Recruiting||N/A|150|Anticipated|Washington State University||4|||f||||||||||||||2017-10-11 00:05:06.046909|2017-10-11 00:05:06.046909
NCT02222376|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-02-12|||October 2013||2013-10-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PirDFI||Effect of Topic Pirfenidone in Diabetic Ulcers|Effect of Treatment of Diabetic Foot Ulcers With Topic 8% 1-phenyl-5-methyl-2-[1h]-Pyridone (Pirfenidone) Combined With Modified Disulfur Diallyl Oxide (Odd-m) in Gel.|Completed||Phase 3|36|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||||2017-10-11 00:05:06.134989|2017-10-11 00:05:06.134989
NCT02222363|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-06-01|||August 2014||2014-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors|A Phase I Study of the Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors|Recruiting||Phase 1|48|Anticipated|Vivolux AB||1|||f||||f||||||||||2017-10-11 00:05:06.229185|2017-10-11 00:05:06.229185
NCT02222350|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-04-20|||July 2014||2014-07-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes|A Phase 2, Placebo-controlled, Double-blind Study of DS-8500a in Patients With Type 2 Diabetes|Completed||Phase 2|100|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||||2017-10-11 00:05:06.345546|2017-10-11 00:05:06.345546
NCT02222324|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-11-02|||August 2014||2014-08-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects|A Randomized, Double-Blind, Placebo and Active-Controlled, Single-Dose, 4-Treatment Crossover Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects|Completed||Phase 1|60|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-11 00:05:06.539858|2017-10-11 00:05:06.539858
NCT02222311|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-20|||November 2014||2014-11-01|August 2014|2014-08-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Observational|||Influence of Vitamin D Deficiency on the Development of Autism||Not yet recruiting||N/A|300|Anticipated|Hillel Yaffe Medical Center|||3||f||||t||||||||||2017-10-11 00:05:06.627672|2017-10-11 00:05:06.627672
NCT02222285|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-07-16|||August 2014|Actual|2014-08-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|May 2017|Actual|2017-05-01||Interventional|||An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)|An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)|Active, not recruiting||N/A|56|Actual|Enzymotec||3|||f||||f||||||||||2017-10-11 00:05:06.770077|2017-10-11 00:05:06.770077
NCT02222272|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-20|||January 2010||2010-01-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|||Effect of 2nd Gen TKI in CML|Effect of Prior Therapy With Nilotinib or Dasatinib on the Outcome After Allogeneic Stem Cell Transplantation for Patients With Chronic Myeloid Leukaemia|Unknown status|Active, not recruiting|N/A|432|Actual|European Group for Blood and Marrow Transplantation|||1||f||||f||||||||||2017-10-11 00:05:07.026055|2017-10-11 00:05:07.026055
NCT02222259|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-05-03|||September 2014||2014-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|||A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients|A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients (A GEM Study for Older Cancer Patients)|Active, not recruiting||N/A|60|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 00:05:07.133459|2017-10-11 00:05:07.133459
NCT02222246|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-07-31|2017-05-12||March 15, 2015|Actual|2015-03-15|June 2017|2017-06-01|June 30, 2016|Actual|2016-06-30|May 31, 2016|Actual|2016-05-31||Interventional|||Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease|Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease|Completed||Phase 4|106|Actual|Duke University||2|||f||||t||||||||||2017-10-11 00:05:07.248176|2017-10-11 00:05:07.248176
NCT02222233|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-08-20|||January 2010||2010-01-01|August 2014|2014-08-01||||March 2010|Actual|2010-03-01||Interventional|||Relative Bioavailability of BI 671800 HEA in Healthy Male Volunteers|Relative Bioavailability of Single Doses of 200 mg BI 671800 HEA Administered Orally as a Delayed Release (Enteric Coated) Tablet; or Via the EnterionTM Capsule as Solution to the Jejunum, Ascending Colon or Descending Colon; or Via the EnterionTM Capsule as Particulate to the Ascending Colon. An Open-label, Five Periods, Fixed Sequence Phase I Study in Healthy Male Volunteers|Completed||Phase 1|10|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:05:08.035289|2017-10-11 00:05:08.035289
NCT02222220|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2014-08-20|||January 2012||2012-01-01|January 2012|2012-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Metoclopramide as Treatment of Clozapine-induced Hypersalivation|Metoclopramide as Treatment of Clozapine-induced Hypersalivation|Completed||Phase 3|61|Actual|Beersheva Mental Health Center||2|||f||||f||||||||||2017-10-11 00:05:08.120866|2017-10-11 00:05:08.120866
NCT02222207|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2016-07-25|2016-06-11|2015-10-12|October 2014||2014-10-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|DREAM||Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration|A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration|Terminated||Phase 2|52|Actual|Bayer|As the study was prematurely terminated since pre-defined proof of concept (PoC) criteria were not met in Part A, hence part B was not initiated. Part B related end points and data were not reported since it is not conducted.|8|||f||||t||||||||||2017-10-11 00:05:08.230956|2017-10-11 00:05:08.230956
NCT02222194|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-07-22|||August 2014||2014-08-01|July 2017|2017-07-01|May 30, 2017|Actual|2017-05-30|March 2017|Actual|2017-03-01||Observational|ASTER3||The Value of Surgical Mediastinal Staging in Clinical N1 Lung Cancer|Assessment of Surgical Mediastinal sTaging in cN1 Lung canceR|Completed||N/A|105|Actual|University Hospital, Gasthuisberg|||1||f||||f||||||||||2017-10-11 00:05:08.78041|2017-10-11 00:05:08.78041
NCT02222181|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-04-03|2016-04-03||April 2014||2014-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease|Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease|Completed||N/A|55|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||1|||f||||f||||||||No||2017-10-11 00:05:08.891957|2017-10-11 00:05:08.891957
NCT02222168|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-20|2014-11-19|||September 2014||2014-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetics of BI 409306 After a High Fat, High Caloric Meal and After a Single Oral Dose Given at Bed Time in Healthy Volunteers|Open, Randomised, Two-way Crossover Study to Assess the Effect of a High Fat, High Caloric Meal on the Pharmacokinetics of BI 409306, Followed by a Fixed Sequence Period to Investigate the Pharmacokinetics of BI 409306 After a Single Oral Dose Given at Bed Time in Healthy Male and Female Volunteers|Completed||Phase 1|18|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:05:09.205365|2017-10-11 00:05:09.205365
NCT02222155|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-11-15|||September 2014||2014-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis|A Randomized, Double-Blind, Placebo-Controlled, Dose Assessment Phase 2 Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis|Completed||Phase 2|42|Actual|ChemoCentryx||3|||f||||t||||||||||2017-10-11 00:05:09.296033|2017-10-11 00:05:09.296033
NCT02222142|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2014-08-20|||January 2010||2010-01-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Volatile Versus Propofol Anesthesia in OPCAB|Comparison of Propofol and Isoflurane Anesthesia on Cardioprotection and Clinical Outcomes in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery : A Propensity-score Analysis|Completed||N/A|1080|Actual|Samsung Medical Center|||2||f||||t||||||||||2017-10-11 00:05:09.471509|2017-10-11 00:05:09.471509
NCT02222129|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-04-06|2015-04-06||December 2012||2012-12-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Six patients were excluded from the 0.25% bupivacaine group: one for seizures; four for NSAID and/or PCA use; and one for incomplete data. Nine patients were excluded from the liposomal bupivacaine group; one for remaining intubated overnight; four for surgical complications; three for a hospital stay >5 days due to ileus; and one for NSAID use.|Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery|A Randomized Controlled Trial for Pain Control in Laparoscopic Urologic Surgery: 0.25% Bupivacaine Versus Long-Acting Liposomal Bupivacaine|Completed||Phase 4|206|Actual|Knight, Richard, M.D.||2|||f||||f||||||||||2017-10-11 00:05:09.579241|2017-10-11 00:05:09.579241
NCT02222116|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-03-29|||October 2015||2015-10-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|MASTER-OCT||OCT Study of the MGuard Prime Stent in Patients With Heart Attacks|OCT Study of the MGuard Prime Embolic Protection Stent in Patients With Acute ST-segment Elevation Myocardial Infarction|Withdrawn||Phase 4|0|Actual|InspireMD||2||Market move to DES|f||||t||||||||||2017-10-11 00:05:09.98484|2017-10-11 00:05:09.98484
NCT02222103|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-08-03|||January 2016||2016-01-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|||Pilot Study of the MultiSense Patch to Record Cardiopulmonary Data During Sleep and Wake Cycles|Pilot Study of the MultiSense Patch to Record Cardiopulmonary Data During Sleep and Wake Cycles|Completed||N/A|10|Actual|Scripps Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:05:10.100009|2017-10-11 00:05:10.100009
NCT02222090|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-20|||July 2014||2014-07-01|August 2014|2014-08-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Observational|||Therapy With New Oral Anticoagulants|Therapy With New Oral Anticoagulants in Patients With Atrial Fibrillation and Renal Impairment|Unknown status|Recruiting|N/A|1500|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 00:05:10.368271|2017-10-11 00:05:10.368271
NCT02222077|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-09-13|||July 2014||2014-07-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Central Blood Pressure in Adolescents and Young Adults|Diurnal Variation of Central Blood Pressure in Adolescents and Young Adults and Association With Indices of Asymptomatic Target-organ Damage|Recruiting||N/A|150|Anticipated|University of Athens|||1||f||||f||||||||||2017-10-11 00:05:10.497989|2017-10-11 00:05:10.497989
NCT02222064|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-12-03|||August 2014||2014-08-01|May 2015|2015-05-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Pilot of Mindfulness Therapy for Inpatients With Gastro-intestinal Pain|Exploratory Study of Mindfulness for Inpatients With Chronic Gastrointestinal Pain: Does it Reduce Pain Related Distress and Increase Confidence in Pain Self-management?|Completed||N/A|15|Actual|University College, London||1|||f||||f||||||||||2017-10-11 00:05:10.611248|2017-10-11 00:05:10.611248
NCT02222051|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-04-09|||August 2014||2014-08-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|TaiChiNe||Tai Chi for Chronic Non-specific Neck Pain|Tai Chi for Chronic Non-specific Neck Pain: A Randomized Controlled Trial|Completed||N/A|114|Actual|Universität Duisburg-Essen||3|||f||||f||||||||||2017-10-11 00:05:10.717011|2017-10-11 00:05:10.717011
NCT02222038|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-02-04|||August 2014||2014-08-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Genetic Variants in Linear Localized Scleroderma|Investigation of the Genetic Architecture of Linear Localized Scleroderma (LLS) (Linear Morphea) by Whole Exome Sequencing. A Tailored Approach to Test the Hypothesis That LLS is a Genetic Mosaic Condition|Recruiting||N/A|50|Anticipated|University Children's Hospital, Zurich||1|||f||||f||||||||||2017-10-11 00:05:10.85806|2017-10-11 00:05:10.85806
NCT02222025|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-04-21|||August 2014||2014-08-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Injury Prevention in Children´s Football|Injury Prevention in Children´s Football (FIFA 11+ Kids): a Cluster-randomized Controlled Trial|Completed||N/A|3895|Actual|University of Basel||2|||f||||||||||||||2017-10-11 00:05:10.975286|2017-10-11 00:05:10.975286
NCT02222012|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2014-08-20|||August 2014||2014-08-01|August 2014|2014-08-01|September 2017|Anticipated|2017-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Neuromarkers Identification in Major Depressive Disorder Based on Monitoring Measures|Identification of Neuromarkers in Novel Neuromodulation Treatment in Major Depressive Disorder Based on Integration of Multiple Monitoring Measures|Unknown status|Not yet recruiting|N/A|20|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 00:05:11.072805|2017-10-11 00:05:11.072805
NCT02221999|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-07-13|||January 2014|Actual|2014-01-01|July 2017|2017-07-01|October 2022|Anticipated|2022-10-01|July 2017|Anticipated|2017-07-01||Interventional|SHPD002||Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients|A Prospective, Randomized, Open-label Comparison of Preoperative Weekly Paclitaxel and Cisplatin With or Without Endocrine Therapy in Patients With Operable Hormone Receptor Positive and Triple Negative Locally Advanced Breast Cancer|Recruiting||Phase 2/Phase 3|250|Anticipated|RenJi Hospital||3|||f||||t||||||||||2017-10-11 00:05:11.205537|2017-10-11 00:05:11.205537
NCT02221986|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-09-19|||February 1, 2015|Actual|2015-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Interdisciplinary Specialised Rehabilitation Among Glioma Patients|The Effect of a Six Weeks Interdisciplinary Rehabilitation in Terms of HRQoL, Physical Performance and Symptom Burden Among Glioma Patients - a Prospective RCT Study.|Recruiting||N/A|112|Anticipated|Odense University Hospital||2|||f||||||||||||||2017-10-11 00:05:11.372912|2017-10-11 00:05:11.372912
NCT02221973|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-11-11|||July 2013||2013-07-01|August 2014|2014-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Lipidown||Effect of a Low Fat Milk Product on Lipids Profile in Dyslipidemia Subjects|Effect of a Low Fat Milk Product on Serum Lipids Profile in Chinese Primary Dyslipidemia Subjects|Completed||N/A|75|Actual|Nestlé||3|||f||||f||||||||||2017-10-11 00:05:11.491961|2017-10-11 00:05:11.491961
NCT02221960|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-06-19|||September 15, 2014|Actual|2014-09-15|June 2017|2017-06-01|October 8, 2019|Anticipated|2019-10-08|April 10, 2018|Anticipated|2018-04-10||Interventional|||A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors|A Phase 1 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors|Active, not recruiting||Phase 1|39|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 00:05:11.587448|2017-10-11 00:05:11.587448
NCT02221947|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-03-21|2016-03-21||June 2014||2014-06-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Preliminary Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bryostatin 1 in Patients With Alzheimer's Disease|Terminated||Phase 1/Phase 2|9|Actual|Neurotrope Bioscience, Inc.||2||Part 2 of study replaced by NTRP-101-202, assessing 3 doses of bryostatin.|f||||f||||||||||2017-10-11 00:05:11.741724|2017-10-11 00:05:11.741724
NCT02221934|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-09-20|||October 9, 2014|Actual|2014-10-09|September 2017|2017-09-01|September 2023|Anticipated|2023-09-01|December 2018|Anticipated|2018-12-01||Interventional|||Electrical Nerve Block for Amputation Pain|High-Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study|Recruiting||N/A|130|Anticipated|Neuros Medical, Inc.||2|||f||||t||||||||||2017-10-11 00:05:12.168558|2017-10-11 00:05:12.168558
NCT02221921|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-20|||September 2014||2014-09-01|August 2014|2014-08-01|September 2021|Anticipated|2021-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI|Clinical Evaluation of the Safety and Performance of the MicroPort's Transcatheter Aortic Valve and Delivery System for Treatment of Severe Aortic Stenosis|Not yet recruiting||N/A|89|Anticipated|Shanghai MicroPort Medical (Group) Co., Ltd.||1|||f||||t||||||||||2017-10-11 00:05:12.301379|2017-10-11 00:05:12.301379
NCT02221908|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-09-25|||August 2014||2014-08-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Observational|||ED Decision Making Among Hypotensive Patients|ED Decision Making Among Hypotensive Patients|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Mespere Lifesciences Inc.|||1||f||||f||||||||||2017-10-11 00:05:12.415216|2017-10-11 00:05:12.415216
NCT02221895|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-11-02|||March 2014||2014-03-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 Months|The Effect of Early (2-3 Week Postpartum) Versus Traditional (6-8 Week Postpartum) Follow-Up on Breastfeeding Rates at 6 Months|Recruiting||N/A|346|Anticipated|Madigan Army Medical Center||2|||f||||t||||||||Undecided||2017-10-11 00:05:12.540989|2017-10-11 00:05:12.540989
NCT02221882|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-07-07|||August 2014||2014-08-01|July 2017|2017-07-01|March 7, 2017|Actual|2017-03-07|March 7, 2017|Actual|2017-03-07||Interventional|||A Study of LY3164530 in Participants With Cancer|A Phase 1 Study of LY3164530, a Bispecific Antibody Targeting MET and EGFR, in Patients With Advanced or Metastatic Cancer|Completed||Phase 1|45|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 00:05:12.714312|2017-10-11 00:05:12.714312
NCT02221869|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-15|||September 2014||2014-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy||Active, not recruiting||Phase 3|97|Actual|Jazz Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:05:12.811388|2017-10-11 00:05:12.811388
NCT02221856|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-02-07|||February 8, 2017|Actual|2017-02-08|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Comparison of the Alignment Achieved Using Computer-guided Indirect Bonding of Orthodontic Brackets to Conventional Appliance Placement|A Prospective Clinical Trial Comparing the Alignment Achieved Using Computer-guided Indirect Bonding of Orthodontic Brackets to Conventional Orthodontic Appliance Placement|Recruiting||N/A|30|Anticipated|Harvard School of Dental Medicine||2|||f||||t||||||||||2017-10-11 00:05:13.000845|2017-10-11 00:05:13.000845
NCT02221843|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-07-11|||August 2014||2014-08-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Sunbit UV Measuring Device to Track Sun Behavior|An Observational Single Center Pilot Study Using a Wearable UV Sensor (Sunbit) Measuring UV Exposure of Patients at High Risk for Skin Cancer - SUNBIT Study|Terminated||N/A|10|Actual|University of Zurich|||1|Company dissolved, no study devices available anymore|f||||f||||||||No|none intended|2017-10-11 00:05:13.096836|2017-10-11 00:05:13.096836
NCT02221830|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-04-27|||February 2015||2015-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|PHP3||Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)|Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)|Recruiting||Early Phase 1|124|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 00:05:13.203557|2017-10-11 00:05:13.203557
NCT02221817|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2015-06-01|||August 2014||2014-08-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Comparison of Ultrasound Guided Versus Blind Corticosteroid Injection for Trochanteric Bursitis|Prospective, Randomized Trial of Ultrasound Guided and Blind Corticosteroid Injection for Trochanteric Bursitis|Completed||N/A|80|Actual|West Virginia University||2|||f||||f||||||||||2017-10-11 00:05:13.335821|2017-10-11 00:05:13.335821
NCT02221804|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-21|||May 2014||2014-05-01|August 2014|2014-08-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)|The Effect of Two Weeks of Voluntary Reduced Physical Activity in COPD - A Novel Methodology for Anabolic Drug Development|Unknown status|Recruiting|N/A|45|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||3|||f||||t||||||||||2017-10-11 00:05:13.465363|2017-10-11 00:05:13.465363
NCT02221791|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-10-14|||June 2014||2014-06-01|August 2014|2014-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|FLAVO2||Comparison of Pure Epicatechin and Cocoa on Markers of Vascular Function|Comparison of Pure Epicatechin and Cocoa on Markers of Vascular Function|Completed||N/A|20|Actual|Wageningen University||3|||f||||f||||||||||2017-10-11 00:05:13.674598|2017-10-11 00:05:13.674598
NCT02221778|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01|July 2020|Anticipated|2020-07-01|August 2018|Anticipated|2018-08-01||Interventional|||SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE|Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Partial Response to Transarterial Chemoembolization|Recruiting||Phase 2|25|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 00:05:13.853867|2017-10-11 00:05:13.853867
NCT02221765|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-01-13|||August 2014||2014-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PP14201b1c||Safety, Tolerability and Efficacy Study of PP1420 in HV|A Double-Blind, Randomised, Placebo-Controlled Dose Escalation Study to Assess the Safety, Tolerability and Efficacy of Single and Multiple Doses of PP 1420 in Healthy Subjects.|Terminated||Phase 1/Phase 2|49|Actual|Imperial College London||2||Expected PK&no safety issues in 1B.1Cwon't proceed due to lack of 1Befficacy|f||||t||||||||||2017-10-11 00:05:14.034364|2017-10-11 00:05:14.034364
NCT02221752|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-19|||June 2009||2009-06-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health|Impact of Iron/Folic Acid Versus Folic Acid Supplements During Pregnancy on Maternal and Children's Health: A Randomized Controlled Trial in China|Completed||N/A|2367|Actual|Peking University First Hospital||2|||f||||t||||||||||2017-10-11 00:05:14.200065|2017-10-11 00:05:14.200065
NCT02221739|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-10-11|||June 2014||2014-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2015|Actual|2015-07-01||Interventional|||Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)|Phase II Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|39|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 00:05:14.335789|2017-10-11 00:05:14.335789
NCT02221726|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-09-12|||August 2014||2014-08-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study to Assess Adhesion Quality and Wear of Placebo JNJ-35685-AAA-G-023 Transdermal System in Healthy Adults|Evaluation of Scoring Methods to Assess Adhesion Quality and Wear of the Placebo JNJ-35685-AAA-G-023 5.5 cm^2 and 44 cm^2 Transdermal Systems|Completed||Early Phase 1|16|Actual|Janssen Research & Development, LLC||2|||f||||||||||||||2017-10-11 00:05:14.45878|2017-10-11 00:05:14.45878
NCT02221713|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-09-10|||December 2015||2015-12-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||The Gut Microbiome in Diverticulitis and Diverticulosis|Assessment of the Gut Microbiome in Diverticulitis and Diverticulosis|Unknown status|Not yet recruiting|N/A|100|Anticipated|King's College Hospital NHS Trust|||4||f||||f||||||Samples With DNA|"     stool samples and rectal swabs of stool   "|||2017-10-11 00:05:14.544204|2017-10-11 00:05:14.544204
NCT02221700|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-07-06|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Massage for Chemotherapy Induced Peripheral Neuropathy (CIPN)|A Pilot Study of Massage for Symptom Reduction in Chemotherapy-Induced Peripheral Neuropathy|Recruiting||N/A|90|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 00:05:14.641509|2017-10-11 00:05:14.641509
NCT02221687|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-04-18|||August 2014||2014-08-01|April 2016|2016-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|GOLFIII||The Combiotic-Study|Evaluation of the Efficacy and Safety of an Infant Formula Containing Synbiotics and Its Effects on the Incidence of Infectious Diseases in the Infant Gut : a Double-blind, Randomized, Controlled Interventional Study|Recruiting||N/A|560|Anticipated|HiPP GmbH & Co. Vertrieb KG||3|||f||||f||||||||||2017-10-11 00:05:14.7726|2017-10-11 00:05:14.7726
NCT02221661|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-21|||December 2011||2011-12-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01|12 Months|Observational [Patient Registry]|DIALOG||Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center|Non-interventional Longitudinal Study in Alzheimer Disease Diagnosis in Primary Consultants Patients With Cognitive and / or Memory Complaint Requiring Specialized Exploration Using AclarusDx® Blood Test in Memory Centers|Completed||N/A|606|Actual|Diaxonhit|||1||f||||t||||||Samples With DNA|"     Whole blood samples collected in PAXgene® blood RNA tubes   "|||2017-10-11 00:05:17.233283|2017-10-11 00:05:17.233283
NCT02221648|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-07-18|2015-09-07||December 2012||2012-12-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain|Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain|Terminated||Phase 2|43|Actual|Yale University|This study was terminated due to relocation of the PI. The initial goal was enrolling 90 patients. The number enrolled at the time of termination was 43, with 37 completed the study. Results may not provide enough statistical power.|2||PI retired and moved- funding sponsor contacted and Oked|f||||f||||||||||2017-10-11 00:05:17.317024|2017-10-11 00:05:17.317024
NCT02221635|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2014-08-18|||March 2013||2013-03-01|August 2014|2014-08-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Observational|||Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Schizoaffective|A Study to Evaluate the Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder|Unknown status|Recruiting|Phase 3|540|Anticipated|Xijing Hospital|||2||f||||t||||||||||2017-10-11 00:05:17.663866|2017-10-11 00:05:17.663866
NCT02221622|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-04-18|||August 2014||2014-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|Allo||Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD|Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase 1|Recruiting||Phase 1|24|Anticipated|University of Southern California||4|||f||||t||||||||||2017-10-11 00:05:17.75996|2017-10-11 00:05:17.75996
NCT02221609|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2016-08-23|||October 2014||2014-10-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Movement System Impairment Based Classification Versus General Exercise for Chronic Non-specific Low Back Pain: a Randomised Controlled Trial|Movement System Impairment Based Classification Versus General Exercise for Chronic Non-specific Low Back Pain: a Randomised Controlled Trial|Completed||N/A|148|Actual|Universidade Cidade de Sao Paulo||2|||f||||f||||||||||2017-10-11 00:05:17.887699|2017-10-11 00:05:17.887699
NCT02221596|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-09-12|||September 2014||2014-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vitamin D and Muscle Metabolic Function|Vitamin D Contribution to Muscle Metabolic Function in Aged Adults|Recruiting||N/A|56|Anticipated|University of Kentucky||4|||f||||f||||||||||2017-10-11 00:05:18.098728|2017-10-11 00:05:18.098728
NCT02221570|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-10-02|||June 2014||2014-06-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis|A Randomized Placebo Controlled Study of Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis|Unknown status|Recruiting|N/A|100|Anticipated|Tanta University||2|||f||||t||||||||||2017-10-11 00:05:18.369564|2017-10-11 00:05:18.369564
NCT02221557|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-08-08|2017-07-10||March 2015||2015-03-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Case Series of New Alloplastic Bone Graft Material|Clinical and Histomorphometric Evaluation of Beta-tricalcium Phosphate/Polylactide Bone Substitute for Socket Preservation|Completed||N/A|8|Actual|Sunstar Americas||1|||f||||f||||||||||2017-10-11 00:05:18.492687|2017-10-11 00:05:18.492687
NCT02221544|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||September 2014||2014-09-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effect of Low-frequency rTMS on Motor Function in PD Patients With Freezing of Gait|The Effect of Low-frequency Repetitive Transcranial Magnetic Stimulation on Motor Function in Patients With Parkinson's Disease (PD) With Freezing of Gait (FOG).|Unknown status|Not yet recruiting|N/A|20|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 00:05:18.734407|2017-10-11 00:05:18.734407
NCT02221531|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-12-07|||August 2014||2014-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|CARBETOCIN||Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN|Double-blind Randomised Non-inferiority Trial to Assess Efficacy and Safety of Carbetocin After Caesarean Section Applied as Iv-bolus as Compared to a Short-infusion|Completed||Phase 4|140|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 00:05:18.857023|2017-10-11 00:05:18.857023
NCT02221518|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-12-22|||October 2014||2014-10-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Control and Reward Circuits in Obsessive Compulsive Disorder|Control & Reward Circuits as Targets for Repetitive Thoughts and Behaviors|Recruiting||N/A|80|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 00:05:18.955536|2017-10-11 00:05:18.955536
NCT02221505|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-04-02|||December 2014||2014-12-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia|A Phase I, Multicenter, Open-label Dose Escalation and Expansion Study of LOP628, Administered Intravenously in Adult Patients With cKit-positive Tumors and Acute Myeloid Leukemia|Terminated||Phase 1|3|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:05:19.069209|2017-10-11 00:05:19.069209
NCT02221492|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-03-29|||November 2014||2014-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma|A Randomized, Open-label, Two-arm Parallel Group, Comparative Study for Assessing the Clinical Benefit of Subcutaneous Injection of Plerixafor Plus G-CSF for Mobilization and Collection of Peripheral Hematopoietic Stem Cells in Japanese Patients With Non-Hodgkin Lymphoma|Completed||Phase 2|32|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:05:19.190847|2017-10-11 00:05:19.190847
NCT02221479|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-08-03|||October 2014||2014-10-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma|A Randomized, Open-label, Two-arm Parallel Group, Comparative Study for Assessing the Clinical Benefit of Subcutaneous Injection of Plerixafor Plus G-CSF for Mobilization and Collection of Peripheral Hematopoietic Stem Cells in Japanese Patients With Multiple Myeloma|Completed||Phase 2|14|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:05:19.302482|2017-10-11 00:05:19.302482
NCT02221466|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-04-27|||February 2014||2014-02-01|April 2017|2017-04-01|January 21, 2016|Actual|2016-01-21|January 21, 2016|Actual|2016-01-21||Observational|||Measurement of Endothelial Function With Peripheral Arterial Tonometry in Patients Undergoing Hyperbaric Oxygen Therapy|Measurements of Endothelial Function by Means of Peripheral Arterial Tonometry in Diabetic Foot Ulcer Patients Undergoing Hyperbaric Oxygen Therapy.|Completed||N/A|45|Actual|Rigshospitalet, Denmark|||2||f||||f||||||Samples With DNA|"     Whole blood and serum.   "|||2017-10-11 00:05:19.399069|2017-10-11 00:05:19.399069
NCT02221440|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2015-05-25|||September 2014||2014-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Maternal Oxygen Administration for Fetal Distress|Prophylactic Maternal Low Flow Nasal Oxygen Administration During the Second Stage of Labor for Fetal Distress|Completed||N/A|443|Actual|Navy General Hospital, Beijing||2|||f||||t||||||||||2017-10-11 00:05:19.618791|2017-10-11 00:05:19.618791
NCT02221427|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-07-18|||December 2014||2014-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|March 2017|Actual|2017-03-01||Interventional|LAPS||The Labour Progression Study, a Cluster Randomised Trial on Labour Progression for First Time Mothers|The Labour Progression Study, a Cluster Randomised Trial on Labour Progression for First Time Mothers|Active, not recruiting||N/A|6582|Anticipated|Ostfold Hospital Trust||2|||f||||t||||||||||2017-10-11 00:05:19.711605|2017-10-11 00:05:19.711605
NCT02221414|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||January 2010||2010-01-01|August 2014|2014-08-01||||March 2010|Actual|2010-03-01||Interventional|||Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers|Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Two-way Crossover, Phase I Trial)|Completed||Phase 1|95|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:05:19.810657|2017-10-11 00:05:19.810657
NCT02221401|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||January 2010||2010-01-01|August 2014|2014-08-01||||April 2010|Actual|2010-04-01||Interventional|||Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers|Bioequivalence of a 2.5 mg Linagliptin / 1000 mg Metformin Fixed-dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 1000 mg Tablets Administered Together in Healthy Male and Female Volunteers (an Open-label, Randomised, Single Dose, Two-way Crossover, Phase I Trial)|Completed||Phase 1|96|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:05:19.89261|2017-10-11 00:05:19.89261
NCT02221388|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||February 2010||2010-02-01|August 2014|2014-08-01||||July 2010|Actual|2010-07-01||Interventional|||Relative Bioavailability of Different Formulations of BI 671800 in Healthy Male and Female Volunteers|Relative Bioavailability of Different Salt Forms and Formulations of Single Doses Either 50 or 200 mg BI 671800 in the Fasted or Fed State. An Open-label, Randomised, Phase I Study With a 3-period Crossover Followed by Two Treatment Periods in Fixed Sequence in Healthy Male and Female Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:05:20.114303|2017-10-11 00:05:20.114303
NCT02221375|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||June 2008||2008-06-01|August 2014|2014-08-01||||September 2008|Actual|2008-09-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Multiple Rising Inhalative Doses of Butylated Hydroxytoluene Via Respimat Soft MistTM Inhaler B (Sub-study 1) and Safety, Tolerability and Pharmacokinetics of Multiple Rising Inhalative Doses of BI 54903 XX Via Respimat Soft MistTM Inhaler B as Randomised, Double-blind, Placebo-controlled Phase I Trial in Healthy Male Volunteers (Main Study) and Comparison of Systemic Exposure Following a Single Dose of BI 54903 XX Via Respimat Soft MistTM Inhaler B and of a Single Dose of Ciclesonide Via MDI (Randomised, Open-label, Two-way Crossover Sub-study 2)|Completed||Phase 1|56|Actual|Boehringer Ingelheim||9|||f||||||||||||||2017-10-11 00:05:20.212866|2017-10-11 00:05:20.212866
NCT02221362|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-10-27|||December 2014||2014-12-01|September 2015|2015-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease|A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease|Terminated||N/A|30|Actual|BioMarin Pharmaceutical|||1||f||||f||||||Samples With DNA|"     Blood and urine samples to be collected for exploratory research, Genetic/Genomic testing is     optional requiring specific consent   "|||2017-10-11 00:05:20.345512|2017-10-11 00:05:20.345512
NCT02221349|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-01-09|||August 2014||2014-08-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Clinical Study of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene|A Randomized Clinical Study of the Safety and Effectiveness of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene|Completed||N/A|30|Actual|Procter and Gamble||2|||f||||f||||||||||2017-10-11 00:05:20.48573|2017-10-11 00:05:20.48573
NCT02221336|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-01-13|||September 2014||2014-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|MONARCAII||Daily Subjective and Objective Smartphone Measures of Illness Activity to Treat Bipolar Disorder- The MONARCA II Trial|Daily Electronic Monitoring of Subjective and Objective Measures of Illness Activity in Bipolar Disorder - The MONARCA II Trial (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes II)|Recruiting||N/A|300|Anticipated|Psychiatric Centre Rigshospitalet||2|||f||||f||||||||||2017-10-11 00:05:20.610291|2017-10-11 00:05:20.610291
NCT02221323|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-12-29|||September 2014||2014-09-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1|A Trial to Compare the Pharmacokinetics and Pharmacodynamics of Insulin Lispro Administered s.c. Into Lipohypertrophic or Normal Abdominal Adipose Tissue in Subjects With Diabetes Mellitus Type 1|Completed||Phase 2|18|Actual|Profil Institut für Stoffwechselforschung GmbH||1|||f||||f||||||||||2017-10-11 00:05:20.741441|2017-10-11 00:05:20.741441
NCT02221310|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-05-05|||November 2011||2011-11-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS|A Pilot Study of Gemtuzumab Ozogamicin in Combination With Busulfan and Cyclophosphamide (Immunochemotherapy) and Allogeneic Stem Cell Transplantation in Patients With High Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome|Recruiting||Phase 2|25|Anticipated|New York Medical College||1|||f||||f||||||||Undecided||2017-10-11 00:05:20.827741|2017-10-11 00:05:20.827741
NCT02221297|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2015-10-28|||May 2014||2014-05-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Lipid-lowering Effect of a Plant Stanol Ester Supplement Product|Lowering Serum LDL-cholesterol With a Plant Stanol Ester Supplement Product|Completed||N/A|103|Actual|Raisio Group||2|||f||||||||||||||2017-10-11 00:05:20.952252|2017-10-11 00:05:20.952252
NCT02221284|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-07-02|||June 30, 2014|Actual|2014-06-30|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||"Alogliptin Tablets Specified Drug-use Survey Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"|"Nesina Tablets Specified Drug-use Survey Type 2 Diabetes Mellitus: Combination Therapy With Hypoglycemic Drug (Insulin Preparation or Rapid-acting Insulin Secretagogues, Etc)"|Completed||N/A|965|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:05:21.069733|2017-10-11 00:05:21.069733
NCT02221271|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-04-11|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome||Completed||Phase 3|22|Actual|Nihon Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-11 00:05:21.243697|2017-10-11 00:05:21.243697
NCT02221258|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-10-05|||October 2014||2014-10-01|March 2015|2015-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|RA||Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)|Phase 1 Clinical Trial to Evaluate the Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 1|9|Actual|Kang Stem Biotech Co., Ltd.||1|||f||||t||||||||||2017-10-11 00:05:21.371588|2017-10-11 00:05:21.371588
NCT02221245|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-04-05|||April 5, 2013|Actual|2013-04-05|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 23, 2017|Actual|2017-01-23||Observational|||Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer Patients|Interrogation of Wnt, Notch, and Hedgehog Activity in Chemonaive Tumors Collected During the Staging Ultrasound Endoscopies of Patients Diagnosed With Esophageal Cancer|Active, not recruiting||N/A|24|Actual|University of Miami|||1||f|||||f|f||||Samples With DNA|"     Esophageal cancer tumor cells   "|||2017-10-11 00:05:21.46739|2017-10-11 00:05:21.46739
NCT02221232|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-07-13||2016-07-11|August 2014||2014-08-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ZX-ZP-0035||Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™|A Pilot Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZuraPrep™|Terminated||Phase 2|64|Actual|Zurex Pharma, Inc.||4||To assess product performance (test and reference products), move into further testing.|f||||f||||||||||2017-10-11 00:05:21.561706|2017-10-11 00:05:21.561706
NCT02221219|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-04-17|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury|Indomethacin and Delayed Umbilical Cord Clamp for Preterm Infant IVH|Recruiting||Phase 1/Phase 2|400|Anticipated|University of Kentucky||4|||f||||t||||||||||2017-10-11 00:05:21.671609|2017-10-11 00:05:21.671609
NCT02221206|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-09-17|||August 2014||2014-08-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Volumetric Analysis of Root Resorption With Mini-Screw Implant Anchorage-assisted Retraction of Maxillary Incisors|Clinical Observation for the Root Resorption With Mini-Screw Implant Anchorage-assisted Retraction of Maxillary Incisors|Unknown status|Active, not recruiting|N/A|60|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-10-11 00:05:21.78863|2017-10-11 00:05:21.78863
NCT02221193|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-19|||July 2013||2013-07-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Comparing Site Specific Mouth Disinfection With Commercial Oral Mouth Rinse With Traditional Oral Maouth Disinfection|Site-Specific Mouth Rinsing to Improve Oral Odor by Altering Bacterial Counts: Blind Crossover Clinical Study|Completed||Early Phase 1|20|Actual|Al-Baha University||1|||f||||f||||||||||2017-10-11 00:05:21.869385|2017-10-11 00:05:21.869385
NCT02221180|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-11-24|||August 2014||2014-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants|A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release (IR) 1 x (150 mg/500 mg) With Respect to the Metformin IR Tablet (Locally Sourced From Canada [Glucophage, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 50 mg and 1 x 100 mg) in Healthy Fed and Fasted Subjects|Completed||Phase 1|2|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-11 00:05:21.938585|2017-10-11 00:05:21.938585
NCT02221167|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-02-10|||July 2014||2014-07-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|Rx Milk||Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes|Rx Milk: Donor Milk Supplementation to Increase Breastfeeding Duration & Exclusivity, a Randomized Controlled Trial|Completed||N/A|60|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 00:05:22.041152|2017-10-11 00:05:22.041152
NCT02221154|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-06-15|||November 2014||2014-11-01|July 2016|2016-07-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Interventional|FIV-INOPK||Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)|Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)|Terminated||Phase 4|49|Actual|Centre Hospitalier Departemental Vendee||2||Difficulty recruiting|f||||t||||||||||2017-10-11 00:05:22.131994|2017-10-11 00:05:22.131994
NCT02221141|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-08-23|||December 2013||2013-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography||Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire Dinant Godinne - UCL Namur|||1||f||||||||||||||2017-10-11 00:05:22.236896|2017-10-11 00:05:22.236896
NCT02221128|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-10-02|||July 2014||2014-07-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||PerClot to Control Bleeding in Endoscopic Sinus Surgery|A Post Market Surveillance Study Evaluating the Safety and Effectiveness of PerClot to Control Mild Bleeding in Subjects Undergoing Endoscopic Sinus Surgery|Completed||N/A|12|Actual|CryoLife Europa|||1||f||||f||||||||||2017-10-11 00:05:22.314115|2017-10-11 00:05:22.314115
NCT02221115|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-03-08|||August 2014||2014-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|GoogleGlass||A Survey of Google Glass by Orthopaedic Trauma Patients and Surgeons|A Survey-driven Evaluation of Patients Response to the Introduction of Google Glass in the Orthopaedic Trauma Clinic|Active, not recruiting||N/A|127|Actual|McGill University Health Center||2|||f||||f||||||||No||2017-10-11 00:05:22.40232|2017-10-11 00:05:22.40232
NCT02221102|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||December 2013||2013-12-01|August 2014|2014-08-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Edoxaban for TIA and Acute Minor Stroke|Treatment of Edoxaban Versus Aspirin for Non-disabling Cerebrovascular Events: Rationale, Objectives, and Design|Unknown status|Not yet recruiting|Phase 2/Phase 3|3700|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:05:22.502104|2017-10-11 00:05:22.502104
NCT02221089|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2014-08-18|||January 2013||2013-01-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Retaron® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans||Completed||N/A|40|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 00:05:22.622844|2017-10-11 00:05:22.622844
NCT02221076|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-08-28|||July 2014||2014-07-01|August 2017|2017-08-01|April 18, 2016|Actual|2016-04-18|April 18, 2016|Actual|2016-04-18||Interventional|||Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.|Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Examinations or Surgical Procedures for Gynecological Cancers : a Feasibility Study|Completed||N/A|16|Actual|Mauna Kea Technologies||1|||f||||f||||||||||2017-10-11 00:05:22.716509|2017-10-11 00:05:22.716509
NCT02221063|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-05-24|||October 2014||2014-10-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Interventional|||Thiamin Fortified Fish Sauce as a Means of Combating Infantile Beriberi in Rural Cambodia|Thiamin Fortified Fish Sauce as a Means of Combating Infantile Beriberi in Rural Cambodia|Completed||Phase 1|366|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-11 00:05:22.798899|2017-10-11 00:05:22.798899
NCT02221050|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-19|||January 2014||2014-01-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01|15 Days|Observational [Patient Registry]|||Hemodialysis and Wanting for Protein-rich Foods|Influence of Chronic Renal Failure and Hemodialysis on Liking and Wanting for Foods|Completed||N/A|48|Actual|University of Burgundy|||1||f||||f||||||||||2017-10-11 00:05:22.898261|2017-10-11 00:05:22.898261
NCT02221037|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-04-20|||April 28, 2015||2015-04-28|April 2017|2017-04-01|November 1, 2018|Anticipated|2018-11-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery|A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients Undergoing Oesophagectomy Surgery|Recruiting||Phase 2|80|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:05:23.097372|2017-10-11 00:05:23.097372
NCT02219217|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-08-12|||October 2014||2014-10-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||SSAT061: PK of DTG and EVT/COBI in Healthy Volunteers|Pharmacokinetics of DOLUTEGRAVIR Once Daily and ELVITEGRAVIR/COBICISTAT Once Daily Over 10 Days Following Drug Intake Cessation in Healthy Volunteers|Completed||Phase 1|17|Actual|St Stephens Aids Trust||1|||f||||f||||||||||2017-10-11 00:05:57.61392|2017-10-11 00:05:57.61392
NCT02221024|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-19|||July 2011||2011-07-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Normal Saline Flushes at 12 vs 24 Hours Intervals for Maintaining Peripheral Intravenous Catheters Patency|Randomized Controlled Trial to Evaluate the Efficacy of Normal Saline Flushes at 12 and 24 Hours Intervals in Maintaining Peripheral Intravenous Catheters Patency|Completed||Phase 3|400|Actual|IRCCS Burlo Garofolo||2|||f||||f||||||||||2017-10-11 00:05:23.267302|2017-10-11 00:05:23.267302
NCT02221011|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-04-12|||August 2014||2014-08-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Extracorporeal Shock Wave Therapy on Spasticity|The Effect of Extracorporeal Shock Wave Therapy on Spasticity|Completed||N/A|60|Actual|Tri-Service General Hospital||3|||f||||t||||||||||2017-10-11 00:05:23.373974|2017-10-11 00:05:23.373974
NCT02220998|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-09-26|2016-07-27|2016-04-08|September 2014||2014-09-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|ASTRAL-2|Safety Analysis Set: participants who received at least 1 dose of study drug.|Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection|A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 HCV Infection|Completed||Phase 3|269|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 00:05:23.49457|2017-10-11 00:05:23.49457
NCT02220985|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-06-27|||February 3, 2015|Actual|2015-02-03|June 2017|2017-06-01||||February 3, 2019|Anticipated|2019-02-03||Interventional|||Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD|A Phase II Study Evaluating Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD|Recruiting||Phase 2|80|Anticipated|Fred Hutchinson Cancer Research Center||4|||f||||t||||||||||2017-10-11 00:05:24.485811|2017-10-11 00:05:24.485811
NCT02220972|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-02-09|||March 2015||2015-03-01|January 2015|2015-01-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures|Withdrawn||Phase 4|0|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 00:05:24.76749|2017-10-11 00:05:24.76749
NCT02220959|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-10-09|||May 2014||2014-05-01|October 2014|2014-10-01||||September 2014|Actual|2014-09-01||Interventional|||Is Preoperative Exercise Test in Morbid Obese Patients a Predictive Test for Extubation?|Is Preoperative Exercise Test in Morbid Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy a Predictive Test for Extubation?|Completed||N/A|50|Actual|Istanbul University||1|||f||||||||||||||2017-10-11 00:05:24.869583|2017-10-11 00:05:24.869583
NCT02220946|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2014-08-19|||January 2014||2014-01-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|EVESOFS||Effect of Vaginal Electrical Stimulation on Female Sexual Dysfunction||Unknown status|Active, not recruiting|N/A|54|Actual|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||f||||||||||2017-10-11 00:05:24.941523|2017-10-11 00:05:24.941523
NCT02220933|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-03-23|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|MS-SPI||Effect of MD1003 in Spinal Progressive Multiple Sclerosis|Effect of MD1003 in Spinal Progressive Multiple Sclerosis: a Pivotal Randomized Double Blind Placebo Controlled Study|Active, not recruiting||Phase 3|144|Anticipated|MedDay Pharmaceuticals SA||2|||f||||t||||||||||2017-10-11 00:05:25.036159|2017-10-11 00:05:25.036159
NCT02220920|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-10-24|2016-08-03||August 2014||2014-08-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin (TA-7284) as add-on to Insulin in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|146|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 00:05:25.17358|2017-10-11 00:05:25.17358
NCT02220907|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2016-08-05|||August 2014||2014-08-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes|Long-term Administration Study of MT-2412 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|153|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 00:05:25.621764|2017-10-11 00:05:25.621764
NCT02220894|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2017-09-28|||October 30, 2014|Actual|2014-10-30|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Study of MK-3475 (Pembrolizumab) Versus Platinum-based Chemotherapy for Participants With PD-L1-positive Advanced or Metastatic Non-small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)|A Randomized, Open Label, Phase III Study of Overall Survival Comparing Pembrolizumab (MK-3475) Versus Platinum Based Chemotherapy in Treatment Naïve Subjects With PD-L1 Positive Advanced or Metastatic Non-Small Cell Lung Cancer (Keynote 042)|Recruiting||Phase 3|1240|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t|t|f||||||||2017-10-11 00:05:25.759405|2017-10-11 00:05:25.759405
NCT02220868|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-08-03|||July 2014||2014-07-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study|Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study|Completed||Phase 4|10|Actual|Saint Michael's Medical Center||1|||f||||f||||||||||2017-10-11 00:05:25.973701|2017-10-11 00:05:25.973701
NCT02220855|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-04-13|||September 2014||2014-09-01|April 2016|2016-04-01||||November 2017|Anticipated|2017-11-01||Interventional|||A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas|A Phase II Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas|Recruiting||Phase 2|27|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-11 00:05:26.058502|2017-10-11 00:05:26.058502
NCT02220842|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-08-01|||December 18, 2014|Actual|2014-12-18|August 2017|2017-08-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2019|Anticipated|2019-05-01||Interventional|||A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma|A Phase Ib Study of the Safety and Pharmacology of Atezolizumab Administered With Obinutuzumab in Patients With Relapsed/Refractory Follicular Lymphoma or Atezolizumab Administered With Obinutuzumab or Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma|Recruiting||Phase 1|92|Anticipated|Hoffmann-La Roche||5|||f||||||||||||||2017-10-11 00:05:26.164658|2017-10-11 00:05:26.164658
NCT02220829|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-03-16|||September 2015||2015-09-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy|Prophylactic Versus Therapeutic Alpha-Blockers in Prostate Cancer Patients Undergoing Radical Course Radiation Therapy ± HDR Boost. A GROUQ Phase III Randomized Clinical Trial (PCS-VII).|Recruiting||Phase 3|188|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||f||||||||||2017-10-11 00:05:26.411895|2017-10-11 00:05:26.411895
NCT02220816|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-08-18|||October 2014||2014-10-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy of an Attentional Process Training Using Competitive Versus Non Competitive Strategies|Efficacy of an Attentional Process Training Using Competitive Versus Non Competitive Strategies|Completed||N/A|60|Actual|Hospitales Nisa||2|||f||||f||||||||||2017-10-11 00:05:26.573505|2017-10-11 00:05:26.573505
NCT02220803|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-08-15|||March 2014||2014-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction|A Short Term Open, Randomized Cross Over Trial Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension|Completed||Phase 2|13|Actual|Göteborg University||3|||f||||||||||||||2017-10-11 00:05:26.711214|2017-10-11 00:05:26.711214
NCT02220790|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-07-11|||January 2015||2015-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|30 Days|Observational [Patient Registry]|BIOPIC||BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia|Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric|Recruiting||N/A|500|Anticipated|Duke University|||1||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-11 00:05:26.971585|2017-10-11 00:05:26.971585
NCT02220777|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||November 2010||2010-11-01|August 2014|2014-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug, and the Interaction Between ASP8477 and Omeprazole in Healthy Postmenopausal Females and Healthy Young Vasectomized Males|A Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of ASP8477 in Healthy Postmenopausal Females and Healthy Young Vasectomized Males, Including a Food Effect Part and a Part to Investigate the Interaction Between ASP8477 and Omeprazole|Completed||Phase 1|72|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 00:05:27.160992|2017-10-11 00:05:27.160992
NCT02220764|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-03-23|2015-03-04||May 2008||2008-05-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Zirconia Based Fixed Dental Prostheses|Prospective Evaluation of Zirconia Based Tooth- and Implant- Supported Fixed Dental Prostheses|Completed||N/A|32|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-10-11 00:05:27.330048|2017-10-11 00:05:27.330048
NCT02220751|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||March 2009||2009-03-01|August 2014|2014-08-01|June 2012|Actual|2012-06-01|September 2011|Actual|2011-09-01||Interventional|||Diagnostic Biomarkers Related to Periodontal Disease Activity in Diabetic|Diagnostic Biomarkers Related to Periodontal Disease Activity in Diabetic|Completed||Phase 3|56|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 00:05:27.744536|2017-10-11 00:05:27.744536
NCT02220738|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-06-14|||September 2014||2014-09-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors|A Multiple-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors|Terminated||Phase 1|19|Actual|AbbVie||2||Slow subject enrollment|f||||f||||||||||2017-10-11 00:05:27.868479|2017-10-11 00:05:27.868479
NCT02220725|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-09-19||2017-09-19|May 2014||2014-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban|A Phase 3 Randomized, Double-blind, Placebo-controlled Study in Older Subjects to Assess Safety and the Reversal of Rivaroxaban Anticoagulation With Intravenously Administered Andexanet Alpha|Completed||Phase 3|80|Actual|Portola Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:05:27.957092|2017-10-11 00:05:27.957092
NCT02220712|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-10-21|||July 2014||2014-07-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia||Completed||Phase 1|17|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:05:28.084221|2017-10-11 00:05:28.084221
NCT02220699|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2016-07-18|||January 2014||2014-01-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Observational|||Screening for Osteoporosis in General Practice|Screening for Osteoporosis in General Practice. Identifying Patients With Osteoporosis in General Practice by Using the Program Data Capture|Completed||N/A|367|Actual|Aalborg University|||1||f||||f||||||||No||2017-10-11 00:05:28.171797|2017-10-11 00:05:28.171797
NCT02220686|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-07-25|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|VAPOR||Vascular Physician Offer and Report (VAPOR) Trial|Vascular Physician Offer and Report (VAPOR) Trial|Completed||N/A|156|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-11 00:05:28.269985|2017-10-11 00:05:28.269985
NCT02219204|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-08-03|||March 2015||2015-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry Eye|Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry Eye|Completed||N/A|150|Actual|Singapore National Eye Centre||3|||f||||f||||||||||2017-10-11 00:05:57.813903|2017-10-11 00:05:57.813903
NCT02220673|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||November 2009||2009-11-01|August 2014|2014-08-01||||May 2010|Actual|2010-05-01||Interventional|||Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)|Serial Lung Function Measurements in 12 Healthy and 48 Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT, 0.1% and 0.5%) Administered With the Respimat® B (RMT-B) vs. Corresponding RMT-B and HFA MDI Without BHT; Repeated Increasing Doses With 2, 4, and 6 Actuations of Low Concentration Prior to High Concentration on Separate Days, Double Blind for RMT-B Use, Randomised 4-way Cross-over Design|Completed||Phase 1|61|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:05:28.393571|2017-10-11 00:05:28.393571
NCT02220660|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||March 2009||2009-03-01|August 2014|2014-08-01||||June 2009|Actual|2009-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers|A Single-blind, Randomised, Two-way Crossover Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:05:28.533007|2017-10-11 00:05:28.533007
NCT02220647|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-19|2014-08-19|||January 2010||2010-01-01|August 2014|2014-08-01||||April 2010|Actual|2010-04-01||Interventional|||Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers|Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets Administered Together in Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Two-way Crossover, Phase I Trial)|Completed||Phase 1|96|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:05:28.676124|2017-10-11 00:05:28.676124
NCT02220634|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-13|||August 2014||2014-08-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|RHINO||Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension|Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension|Terminated||N/A|10|Anticipated|National Jewish Health||1||PI left National Jewish Health|f||||t||||||||||2017-10-11 00:05:28.816472|2017-10-11 00:05:28.816472
NCT02220621|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||October 2011||2011-10-01|August 2014|2014-08-01||||April 2012|Actual|2012-04-01||Interventional|||Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion|A Prospective, Multi-center, Randomized, Controlled Clinical Study on Self-crosslinked Sodium Hyaluronate Gel for Prevention of Intrauterine Adhesion|Completed||N/A|120|Actual|BioRegen Biomedical (CHangzhou) Co., Ltd||2|||f||||||||||||||2017-10-11 00:05:28.909083|2017-10-11 00:05:28.909083
NCT02220608|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-09-14|||February 20, 2015|Actual|2015-02-20|September 2017|2017-09-01|November 30, 2016|Actual|2016-11-30|July 31, 2016|Actual|2016-07-31||Interventional|||Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma|A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma|Completed||Phase 1|10|Actual|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-11 00:05:29.064811|2017-10-11 00:05:29.064811
NCT02220595|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-18|||April 2011||2011-04-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||A Comparison of Cognitive Function After Carotid Endarterectomy and Stenting|A Comparison of Cognitive Function After Carotid Endarterectomy and Stenting|Completed||N/A|60|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 00:05:29.23699|2017-10-11 00:05:29.23699
NCT02220582|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-09-06|||November 2013||2013-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|May 2017|Actual|2017-05-01||Observational|||Canadian Alliance for Healthy Hearts and Minds|A Pan-Canadian, Multi-ethnic Cohort Study in Healthy Participants Aimed to Better Understand the Impact of Individual, Socioeconomic and Other Environmental Factors Leading to Cardiac and Vascular Disease|Active, not recruiting||N/A|7900|Anticipated|Montreal Heart Institute|||1||f||||f||||||Samples With DNA|"     The study will precisely phenotype individuals with respect to cardiac, vascular and     cognitive dysfunction and to identify novel targets for indicators of early disease.   "|||2017-10-11 00:05:29.403272|2017-10-11 00:05:29.403272
NCT02220569|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-09-21|||October 2014||2014-10-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|PULSE-ECCho||PhysioFlow to Detect Cardiotoxicity in Chemo|PhysioFlow Use in Longterm Screening and Evaluation of Cardiotoxicity in Chemotherapy|Unknown status|Recruiting|N/A|100|Anticipated|McGill University Health Center|||1||f||||t||||||||||2017-10-11 00:05:29.535951|2017-10-11 00:05:29.535951
NCT02220556|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-07-06|||December 2010||2010-12-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CTC-CEC-ADN||Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology|Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology|Recruiting||N/A|360|Anticipated|Institut Curie|||||f||||f||||||||||2017-10-11 00:05:29.639326|2017-10-11 00:05:29.639326
NCT02220543|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-08-28|||August 2014||2014-08-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Chronic Low Back Pain Rehabilitation in Primary Care: an RCT|The Effectiveness of a Biopsychosocial Rehabilitation Program in Primary Care (Back on Track) Versus Primary Care as Usual in Patients With Chronic Low Back Pain in Which Psychosocial Factors Minimally Influence Daily Life Functioning: a Randomized Controlled Trial|Completed||N/A|25|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:05:29.735815|2017-10-11 00:05:29.735815
NCT02220530|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2014-08-18|||October 2014||2014-10-01|August 2014|2014-08-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01|30 Days|Observational [Patient Registry]|||Sedation Effect on the Global Quality Colonoscopy|Sedation Effect on the Global Quality Colonoscopy|Unknown status|Enrolling by invitation|N/A|7000|Anticipated|Hospital San Juan de Dios Tenerife|||2||f||||t||||||||||2017-10-11 00:05:29.870057|2017-10-11 00:05:29.870057
NCT02218827|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-14|||September 2014||2014-09-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Topical Steroid Treatment For Dry Eye|Evaluation of Steroidal Treatment For Dry Eye Disease|Unknown status|Not yet recruiting|N/A|30|Anticipated|Meir Medical Center||1|||f||||t||||||||||2017-10-11 00:06:01.379951|2017-10-11 00:06:01.379951
NCT02220517|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-03-23|||November 2011||2011-11-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate Biopsy|A Prospective Randomized Study Comparing the Diagnostic Efficacy of MR-guided in Bore Prostate Biopsy Versus MRI/US Fusion-guided Prostate Biopsy in Men With at Least One Negative Prostate Biopsy|Completed||N/A|480|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 00:05:29.998365|2017-10-11 00:05:29.998365
NCT02220504|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-03-13|||July 2004|Actual|2004-07-01|March 2017|2017-03-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|ADARFEP||3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals|Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-episode Non-affective Psychosis Individuals: A 3-year Follow-up|Completed||N/A|68|Actual|Fundación Marques de Valdecilla||2|||f||||f|f|f||||||No||2017-10-11 00:05:30.119077|2017-10-11 00:05:30.119077
NCT02220491|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-07-20|||October 2014||2014-10-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Amadeus||Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases|A Randomized Phase II Study of 20 Gy in 5 Fractions Whole Brain Radiotherapy Versus 15 Gy in 1 Fraction Volumetric Modulated Arc Therapy for One to Ten Brain Metastases|Recruiting||Phase 2|20|Anticipated|British Columbia Cancer Agency||2|||f||||f||||||||||2017-10-11 00:05:30.28484|2017-10-11 00:05:30.28484
NCT02220478|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-08-11|||November 2014||2014-11-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Signature Acetabular Posterior/Lateral Data Collection|A Prospective Controlled Study on Signature Anterior Posterior/Lateral Acetabular Cup Placement System in Total Hip Arthroplasty|Active, not recruiting||N/A|150|Anticipated|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-10-11 00:05:30.477039|2017-10-11 00:05:30.477039
NCT02220452|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-17|2017-07-16|||August 2014||2014-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Intraoperative Music Listening on Sevoflurane Consumption and Recovery Parameters|The Effect of Intraoperative Music Listening on Sevoflurane Consumption and Recovery Parameters|Recruiting||N/A|60|Anticipated|Aretaieion University Hospital||2|||f||||t||||||||||2017-10-11 00:05:30.70178|2017-10-11 00:05:30.70178
NCT02220439|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-08-19|||September 2013||2013-09-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Does the Fecal Microbiome Influence Rotarix Immunogenicity|Nested Case-control Analysis of the Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan|Completed||N/A|76|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f||||||Samples Without DNA|"     fecal samples   "|||2017-10-11 00:05:30.855741|2017-10-11 00:05:30.855741
NCT02220426|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-04-21|||September 2014||2014-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study|Phase 1 Study: Detection of Brown Adipose Tissue in Normal Volunteers Using a 3 Tesla (3T) Magnetic Resonance Imaging System and Hyperpolarized (HP) Xenon Gas|Recruiting||Phase 1|24|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 00:05:30.957799|2017-10-11 00:05:30.957799
NCT02220413|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2016-05-26|||August 2014||2014-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Predictors of Lactogenesis II|Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding|Active, not recruiting||N/A|186|Anticipated|University of South Florida|||1||f||||f||||||||||2017-10-11 00:05:31.092921|2017-10-11 00:05:31.092921
NCT02220400|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||September 2014||2014-09-01|August 2014|2014-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|KPPOCD||Ketamine Prevent POCD|Low Dose Ketamine Prevent the Postoperative Cognitive Dysfunction in Aged Patients Underwent Orthopaedic Surgery，a Randomized Control Double Blinded Multicenter Clinical Trail|Unknown status|Not yet recruiting|N/A|484|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-11 00:05:31.203969|2017-10-11 00:05:31.203969
NCT02220387|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-10-05|||August 2014||2014-08-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Molecular, Cytological Features and Genetic Susceptibility of COPD Attributable to Different Environmental Exposures|Molecular, Cytological Features and Genetic Susceptibility of Occupational Chronic Obstructive Pulmonary Disease Attributable to Different Environmental Exposures|Completed||N/A|352|Actual|Novosibirsk City Hospital #2|||2||f||||f||||||Samples With DNA|"     whole blood, serum,bronchoalveolar lavage fluid   "|||2017-10-11 00:05:31.36816|2017-10-11 00:05:31.36816
NCT02220374|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2017-08-30|||November 2014||2014-11-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||A RCT of Supportive Finger Tape for PIPJ Osteoarthritis|Supportive Tape for Arthritis of the Proximal Interphalangeal Joint: A Two Group Parallel Randomised Placebo Controlled Trial|Completed||N/A|44|Anticipated|Mid Yorkshire Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 00:05:31.505337|2017-10-11 00:05:31.505337
NCT02220361|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-09-28|||September 2014||2014-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Dexmedetomidine on Prevention of Side Effects of Hemabate|Phase 4 Study of Effects of Dexmedetomidine on Prevention of Side Effects of Hemabate in Cesarean Section Patients|Unknown status|Enrolling by invitation|Phase 4|120|Actual|Guangzhou Women and Children's Medical Center||3|||f||||t||||||||||2017-10-11 00:05:31.631575|2017-10-11 00:05:31.631575
NCT02220348|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-09-02|||July 2014||2014-07-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|LIN-PK-01||A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically|An Open-label, Multiple-dose, Milk-only Lactation Study in Lactating Women Receiving Linaclotide Therapeutically|Unknown status|Recruiting|Phase 1|8|Anticipated|Forest Laboratories||1|||f||||f||||||||||2017-10-11 00:05:31.765633|2017-10-11 00:05:31.765633
NCT02220335|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-06-03|||August 2014||2014-08-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|PADN-5||Pulmonary Arterial Denervation in Patients With Pulmonary Arterial Hypertension Associated With the Left Heart Failure|Pulmonary Arterial Denervation in Patients With Pulmonary Arterial Hypertension Associated With the Left Heart Failure: a Randomised Controlled Trial|Recruiting||N/A|100|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t||||||||No||2017-10-11 00:05:31.901418|2017-10-11 00:05:31.901418
NCT02220322|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-10-18|||October 2013||2013-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01|1 Year|Observational [Patient Registry]|||Age-related Cognitive Change of Femur|Age-related Cognitive Change of Femur|Recruiting||N/A|1000|Anticipated|Tomidahama Hospital|||1||f||||f||||||||||2017-10-11 00:05:32.07172|2017-10-11 00:05:32.07172
NCT02220309|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-08-03|||August 2013||2013-08-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Stanford RAD Study (Research on Anxiety and Depression)|Neural Dimensions of Threat Reactivity and Regulation for Understanding Anxiety|Recruiting||N/A|160|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"     We will collect saliva samples, and in exploratory analysis focus on consideration of genes     associated with neuroimaging-behavior constructs.   "|||2017-10-11 00:05:32.178013|2017-10-11 00:05:32.178013
NCT02220296|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-04-09|||August 2014||2014-08-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus|A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|62|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 00:05:32.304334|2017-10-11 00:05:32.304334
NCT02220283|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||June 2014||2014-06-01|August 2014|2014-08-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Comparison of the Effects of Open and Endovascular Aortic Aneurysm Repair on Long-term Renal Function|Comparison of the Effects of Open and Endovascular Aortic Aneurysm Repair on Long-term Renal Function|Unknown status|Recruiting|N/A|500|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:05:32.641142|2017-10-11 00:05:32.641142
NCT02220270|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-08-17|||May 2015||2015-05-01|August 2015|2015-08-01|August 2017|Anticipated|2017-08-01|November 2016|Anticipated|2016-11-01||Observational|COM-01||Hyperion™ International Registry Trial|A Prospective, Multi-center Study to Evaluate the Safety and Performance of the Hyperion™ ASD and PDA Closure Systems.|Unknown status|Recruiting|N/A|200|Anticipated|European Cardiovascular Research Center|||1||f||||f||||||||||2017-10-11 00:05:32.778951|2017-10-11 00:05:32.778951
NCT02220257|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-08-18|||January 2012||2012-01-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|August 2014|Anticipated|2014-08-01||Observational|POZREM||The Influence of Partial Remission Phase of Type 1 Diabetes on Patient Outcome|Influence of Occurrence of Remission and Its Duration on Development of Chronic Complications of Type 1 Diabetes and Patient Outcome|Unknown status|Active, not recruiting|N/A|140|Anticipated|Poznan University of Medical Sciences|||1||f||||||||||||||2017-10-11 00:05:32.980864|2017-10-11 00:05:32.980864
NCT02220244|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-03-23|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2015|Actual|2015-12-01||Interventional|MS-ON||Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis|Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: a Pivotal Randomized Double Masked Placebo Controlled Study|Active, not recruiting||Phase 3|105|Anticipated|MedDay Pharmaceuticals SA||2|||f||||t||||||||||2017-10-11 00:05:33.113748|2017-10-11 00:05:33.113748
NCT02220231|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-04-16|||August 2014||2014-08-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Echocardiographic Evaluation of the Change on Pulmonary Blood Flow and Cardiac Function Induced by Capnothorax During One Lung Ventilation|Echocardiographic Evaluation of the Change on Pulmonary Blood Flow and Cardiac Function Induced by Capnothorax During One Lung Ventilation|Completed||N/A|25|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 00:05:34.733593|2017-10-11 00:05:34.733593
NCT02220218|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-11-18|||August 2014||2014-08-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted Participants|A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release (IR) 1 x (50 mg/500 mg) With Respect to the Metformin IR Tablet (Locally Sourced From Canada [Glucophage, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 50 mg) in Healthy Fed and Fasted Subjects|Completed||Phase 1|2|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-11 00:05:34.849036|2017-10-11 00:05:34.849036
NCT02220205|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-04-21|2016-07-27||April 2014||2014-04-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Evaluation of the PelvicSim Simulator for Training in Intrauterine Device Insertions|Evaluation of the PelvicSim Simulator for Training in Intrauterine Device Insertions|Completed||N/A|60|Actual|Beth Israel Deaconess Medical Center|Participants directed their own practice time. An investigator answered questions but did not provide other feedback unless specifically asked.|2|||f||||f||||||||||2017-10-11 00:05:35.036937|2017-10-11 00:05:35.036937
NCT02220192|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-04-05|||December 2014||2014-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||An Alternative Treatment for Cervical Intraepithelial Neoplasia Using the Focal Loop Electrosurgical Excision Procedure|Focal Loop Electrosurgical Excision Procedure for High-Grade Cervical Intraepithelial Neoplasia: an Alternative Treatment Approach|Completed||N/A|11|Actual|University of Alabama at Birmingham||1|||f||||t||||||||No||2017-10-11 00:05:35.625764|2017-10-11 00:05:35.625764
NCT02220179|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-06-01|||August 2014||2014-08-01|June 2015|2015-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Resilience for Children and Young People in Foster Care and Residential Care in Denmark|Resilience for Children and Young People|Unknown status|Active, not recruiting|N/A|9000|Anticipated|University of Aarhus||3|||f||||f||||||||||2017-10-11 00:05:35.818115|2017-10-11 00:05:35.818115
NCT02218034|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-04-28|||August 2014||2014-08-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris||Completed||Phase 1|78|Actual|Allergan||4|||f||||f||||||||||2017-10-11 00:06:14.825475|2017-10-11 00:06:14.825475
NCT02220166|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||November 2010||2010-11-01|August 2014|2014-08-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease|Phase II Study on Safety of 60 Days Administration of Triticum Monococcum in Patients With Celiac Disease on Remission in Gluten Free Diet|Completed||Phase 2|8|Actual|Università degli Studi di Brescia||1|||f||||f||||||||||2017-10-11 00:05:35.991253|2017-10-11 00:05:35.991253
NCT02220153|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-10-02|||July 2014||2014-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A First-In-Human Study With a Single Dose UCB7665 in Healthy Volunteers|A Subject-Blind, Investigator-blind, Randomized, Placebo-controlled, First-in-human Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous and Subcutaneous Doses of UCB7665 in Healthy Subjects|Completed||Phase 1|41|Actual|UCB Pharma||9|||f||||f||||||||||2017-10-11 00:05:36.161735|2017-10-11 00:05:36.161735
NCT02220140|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-06-01|||August 2014||2014-08-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Resilience for Young People With ADHD - a Randomized Controlled Trial of a Brief Intervention Program.|Resilience for Young People With Attention Deficit Hyperactivity Disorder (ADHD) - a Randomized Controlled Trial of a Brief Intervention Program.|Unknown status|Active, not recruiting|N/A|8000|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:05:36.321371|2017-10-11 00:05:36.321371
NCT02220127|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2015-03-19|||September 2014||2014-09-01|March 2015|2015-03-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Interventional|||RCT of the 4mm vs. the 8mm Collimator for GKR of Brain Micrometastases|Optimal Radiation Method for Gamma Knife Radiosurgery of Brain Micrometastases: A Multi-centre Randomised Clinical Trial (RCT) of the 4mm vs. the 8mm Collimator.|Recruiting||N/A|298|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 00:05:36.439584|2017-10-11 00:05:36.439584
NCT02220114|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-08-25|||May 2014||2014-05-01|August 2015|2015-08-01||||December 2016|Anticipated|2016-12-01||Interventional|SoluWest||Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy|Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy. Observational, Descriptive, Open-label, Multi-centric, Non-randomized Study|Unknown status|Recruiting|N/A|50|Anticipated|Targeon SAS||1|||f||||t||||||||||2017-10-11 00:05:36.60618|2017-10-11 00:05:36.60618
NCT02220101|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-08-18|||April 2014||2014-04-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|Temp||Temperature Measurement in Surgical and Intensive Care Patients - Comparison of Four Measurement Methods|Temperature Measurement in Surgical and Intensive Care Patients - Comparison of Four Measurement Methods|Unknown status|Recruiting|N/A|120|Anticipated|Sykehuset i Vestfold HF|||1||f||||f||||||||||2017-10-11 00:05:36.800891|2017-10-11 00:05:36.800891
NCT02220088|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-18|||August 2014||2014-08-01|August 2014|2014-08-01|January 2016|Anticipated|2016-01-01|September 2015|Anticipated|2015-09-01||Interventional|||The Efficacy and Safety of Retreatment With Transarterial Chemoembolization (TACE) for Patients Who Showed TACE-resistant: a Randomized Controlled Trial|The Efficacy and Safety of Retreatment With Transarterial Chemoembolization (TACE) for Patients Who Showed TACE-resistant: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|262|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:05:36.917711|2017-10-11 00:05:36.917711
NCT02220075|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-15|||October 2013||2013-10-01|August 2014|2014-08-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Fiberoptic Evaluation of the LMA(Laryngel Mask Airway) Position During Anesthesia With Spontaneous Respiration or Controlled Ventilation in Children||Unknown status|Recruiting|N/A|100|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-11 00:05:37.074055|2017-10-11 00:05:37.074055
NCT02220062|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-08-18|||August 2014||2014-08-01|August 2014|2014-08-01||||August 2016|Anticipated|2016-08-01||Interventional|||Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain Killer||Unknown status|Not yet recruiting|N/A|166|Anticipated|Samsung Medical Center||2|||f||||||||||||||2017-10-11 00:05:37.156422|2017-10-11 00:05:37.156422
NCT02220049|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-03-24|||December 2010||2010-12-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|VELDAY||Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors|Phase I Dose Escalation of Velcade (Bortezomib) Daily Dose in Patients With Advances or Metastatic Solid Tumors|Completed||Phase 1|18|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 00:05:37.240955|2017-10-11 00:05:37.240955
NCT02220036|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||June 2014||2014-06-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||Effect of Magnesium Supplementation on Patients With Diabetic Nephropathy|Effect of Magnesium Supplementation on Kidney Function, Insulin Resistance and Metabolic Profile in Patients With Diabetic Nephropathy|Unknown status|Not yet recruiting|N/A|80|Anticipated|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:05:37.347963|2017-10-11 00:05:37.347963
NCT02220023|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-02-10|||July 2014||2014-07-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|iNO||Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI|Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI|Completed||Early Phase 1|17|Actual|Vanderbilt University Medical Center||1|||f||||f||||||||||2017-10-11 00:05:37.499173|2017-10-11 00:05:37.499173
NCT02220010|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2014-08-18|||June 2014||2014-06-01|August 2014|2014-08-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Does Post Operative Pancreatic Fistula, After Left Sided Resections, Heal Faster After the Introduction of a Pancreatic Stent?|Does a Pancreatic Stent Reduce the Healing Time of Post Operative Pancreatic Fistula (POPF) After Distal Pancreatic Resection - an Open Randomized Clinical Multicenter Trial|Unknown status|Recruiting|N/A|60|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:05:37.601652|2017-10-11 00:05:37.601652
NCT02219997|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2016-04-20|2016-02-24||October 2014||2014-10-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||This analysis population includes all subjects who were reaction tested.|Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration|Functional Benefit With ACRYSOF® Natural Chromophore|Completed||N/A|90|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:05:37.724069|2017-10-11 00:05:37.724069
NCT02219984|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-11-22|||October 2011||2011-10-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|November 2018|Anticipated|2018-11-01|1 Year|Observational [Patient Registry]|||START-Register: Survey on Anticoagulated Patients Register|Phase 4 Study on Clinical History of Patients Who Start a Chronic Anticoagulant Treatment|Active, not recruiting||N/A|10810|Actual|St. Orsola Hospital|||1||f||||t||||||Samples Without DNA|"     plasma samples for measurements of anticoagulant drug activity   "|Undecided||2017-10-11 00:05:38.003911|2017-10-11 00:05:38.003911
NCT02219971|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2017-05-02|||August 2014|Actual|2014-08-01|May 2016|2016-05-01|May 6, 2015|Actual|2015-05-06|May 6, 2015|Actual|2015-05-06||Interventional|||Phase I Study of Kukoamine B Mesilate in Healthy Volunteers|Randomized, Double-blind Placebo-controlled Phase I Study to Assess Safety, Tolerance and Pharmacokinetics of a Single Intravenous Injection Kukoamine B Mesilate in Healthy Volunteers|Completed||Phase 1|52|Actual|Tianjin Chasesun Pharmaceutical Co., LTD||7|||f||||f||||||||||2017-10-11 00:05:38.149915|2017-10-11 00:05:38.149915
NCT02219958|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-09-05|||September 2012||2012-09-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|September 2016|Actual|2016-09-01||Observational|||Evaluation of Quality of Care - Multi-disciplinary Risk Assessment and Management Programme for Patients With Hypertension, HA (QoC RAMP-HT)|Evaluation of Quality of Care - Multi-disciplinary Risk Assessment and Management Programme for Patients With Hypertension, HA (QoC RAMP-HT)|Completed||N/A|2496|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 00:05:38.275159|2017-10-11 00:05:38.275159
NCT02219945|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-05-31|||November 2013|Actual|2013-11-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|December 2014|Actual|2014-12-01||Interventional|YOGYATBNOSE||ENOSE in Pulmonary Tuberculosis in Yogyakarta|The Accuracy of the eNose in the Diagnostics and Monitoring of Treatment of Treatment-naive TB Patients|Completed||N/A|389|Actual|University Medical Center Groningen||6|||f||||f||||||||||2017-10-11 00:05:38.360391|2017-10-11 00:05:38.360391
NCT02219932|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-18|2017-02-06|2017-02-06||September 2014||2014-09-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ENHANCE|Safety population: all participants who received at least 1 dose of study drug.|Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis|A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis (ENHANCE)|Completed||Phase 3|646|Actual|Biogen||2|||f||||t||||||||||2017-10-11 00:05:38.496079|2017-10-11 00:05:38.496079
NCT02219919|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2016-05-10|||August 2014||2014-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Nociceptive Gain Processing After Physical Therapy in Carpal Tunnel Syndrome|Changes in Nociceptive Gain Processing After Physical Therapy and Surgery in Carpal Tunnel Syndrome: A Randomized Clinical Trial|Completed||N/A|100|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 00:05:41.221525|2017-10-11 00:05:41.221525
NCT02219906|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-06-07|||May 2014||2014-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation|Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation|Enrolling by invitation||Phase 3|118|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 00:05:41.326467|2017-10-11 00:05:41.326467
NCT02219893|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-05-24|||August 2014||2014-08-01|May 2017|2017-05-01|December 10, 2016|Actual|2016-12-10|December 10, 2016|Actual|2016-12-10||Interventional|ImmunoPeCa||Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial|Phase I/II Trial of MOC31PE Immunotoxin in Peritoneal Carcinomatosis From Colorectal Carcinoma|Completed||Phase 1/Phase 2|15|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 00:05:41.44281|2017-10-11 00:05:41.44281
NCT02219880|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-05-11|||October 13, 2015|Actual|2015-10-13|May 2017|2017-05-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|KGAD||Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial|Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial|Recruiting||Phase 4|210|Anticipated|University of Melbourne||2|||f||||f||||||||||2017-10-11 00:05:41.54916|2017-10-11 00:05:41.54916
NCT02219867|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-28|||August 2014||2014-08-01|August 2014|2014-08-01|August 2017|Anticipated|2017-08-01|January 2016|Anticipated|2016-01-01||Interventional|Ketamie||Ketamine Infusions for Major Depression Disorder|Evaluation of Safety and Efficacy of Sub-anesthetic Ketamine Infusions as a Treatment for Patients Diagnosed With Resistant Major Depression|Unknown status|Not yet recruiting|N/A|10|Anticipated|Sheba Medical Center||1|||f||||t||||||||||2017-10-11 00:05:41.692163|2017-10-11 00:05:41.692163
NCT02219854|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-10-18|||July 2014||2014-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Single-center Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer||Recruiting||N/A|178|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:05:41.789205|2017-10-11 00:05:41.789205
NCT02219841|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-01-27|||August 2014||2014-08-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|August 2015|Anticipated|2015-08-01||Observational|ISOLATE||Impact of Life-Style Modification On Ablation Outcome in Atrial Fibrillation|Impact of Life-Style Modification On Ablation Outcome in Atrial Fibrillation|Unknown status|Recruiting|N/A|50|Anticipated|Texas Cardiac Arrhythmia Research Foundation|||2||f||||f||||||||||2017-10-11 00:05:42.036582|2017-10-11 00:05:42.036582
NCT02219828|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-12-17|||June 2014||2014-06-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|AIR TRIP||AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP)|AnakInRa for Treatment of Recurrent Idiopathic Pericarditis|Completed||Phase 4|21|Actual|Maria Vittoria Hospital||2|||f||||t||||||||||2017-10-11 00:05:42.181331|2017-10-11 00:05:42.181331
NCT02219815|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-04-24|||April 2015||2015-04-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|PREHAB||Pre-operative Rehabilitation for Reduction of Hospitalization After Coronary Bypass and Valvular Surgery.|Pre-operative Rehabilitation for Reduction of Hospitalization After Coronary Bypass and Valvular Surgery.|Recruiting||N/A|244|Anticipated|St. Boniface General Hospital Research Centre||2|||f||||t||||||||No||2017-10-11 00:05:42.325467|2017-10-11 00:05:42.325467
NCT02219802|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-08-15|||August 2014||2014-08-01|August 2014|2014-08-01||||December 2016|Anticipated|2016-12-01||Interventional|REVELATION||Drug-coated Balloon Versus Drug-eluting Stent in Acute Myocardial Infarction|Revascularization With Paclitaxel-coated Balloon Angioplasty Versus Drug-eluting Stenting in Acute Myocardial Infarction - a Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|120|Anticipated|Onze Lieve Vrouwe Gasthuis||2|||f||||t||||||||||2017-10-11 00:05:42.495553|2017-10-11 00:05:42.495553
NCT02219789|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-05-23|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery|A Phase I Trial to Evaluate the Safety of the Addition of Alisertib to Fulvestrant in Women With Advanced Hormone Receptor Positive (HR+) Breast Cancer|Active, not recruiting||Phase 1|10|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 00:05:42.653813|2017-10-11 00:05:42.653813
NCT02219776|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2016-09-27|||September 2015||2015-09-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Decreasing Infection In Arthroscopic Shoulder Surgery|Decreasing Proprionbacterium Acne Skin Colonization Prior to Arthroscopic Shoulder Surgery|Recruiting||Phase 3|100|Anticipated|McLaren Health Care||2|||f||||f||||||||Undecided||2017-10-11 00:05:42.780095|2017-10-11 00:05:42.780095
NCT02219763|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-08-15|||June 2014||2014-06-01|June 2014|2014-06-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||The Effects of a Weight Management Program on Body Weight and Quality of Life|A Longitudinal Study to Investigate the Effects of a 14-visit Comprehensive Lifestyle Weight Management Program on Body Weight and Quality of Life|Unknown status|Recruiting|N/A|50|Anticipated|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-11 00:05:42.895912|2017-10-11 00:05:42.895912
NCT02219750|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-03-15|||August 2013||2013-08-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|August 2015|Actual|2015-08-01||Interventional|COMPAR||Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients|Comparison of Switching to Premixed Insulin With Add-on Rapid-acting Insulin in Poorly Controlled Type 2 Diabetes Treated With Basal Insulin|Recruiting||Phase 4|200|Anticipated|Mackay Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:05:42.99827|2017-10-11 00:05:42.99827
NCT02219737|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-09-12|||September 12, 2014|Actual|2014-09-12|September 2017|2017-09-01||||March 21, 2018|Anticipated|2018-03-21||Interventional|||Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma|A Phase I Study Combining Ibrutinib With Rituximab, Ifosfamide, Carboplatin, and Etoposide (R-ICE) in Patients With Relapsed or Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Active, not recruiting||Phase 1|24|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:05:43.131135|2017-10-11 00:05:43.131135
NCT02219724|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-08-22|||August 12, 2014|Actual|2014-08-12|August 2017|2017-08-01|June 23, 2018|Anticipated|2018-06-23|June 23, 2018|Anticipated|2018-06-23||Interventional|||A Study to Assess Safety and Pharmacokinetics of MOXR0916 in Participants With Locally Advanced or Metastatic Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of MOXR0916 Administered Intravenously as a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors|Active, not recruiting||Phase 1|174|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 00:05:43.348052|2017-10-11 00:05:43.348052
NCT02219711|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-07-17|||August 2014||2014-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer|A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies|Recruiting||Phase 1|260|Anticipated|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 00:05:43.558125|2017-10-11 00:05:43.558125
NCT02219698|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-07-30|||July 2014||2014-07-01|July 2015|2015-07-01||||July 2015|Actual|2015-07-01||Interventional|||Symptomatic Treatment of Acute Uncomplicated Diverticulitis|Symptomatic Treatment of Acute Uncomplicated Diverticulitis|Completed||N/A|158|Anticipated|Helsinki University Central Hospital||1|||f||||||||||||||2017-10-11 00:05:43.726907|2017-10-11 00:05:43.726907
NCT02219685|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2016-10-07|2016-08-02||August 2014||2014-08-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|August 2015|Actual|2015-08-01||Interventional||Safety Analysis Set: participants who were randomized into the study and received at least 1 dose of study drug.|Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection|A Phase 2, Single-Center, Double-Blind, Placebo-Controlled, Randomized Study to Investigate the Effect of Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 1 HCV Infection|Completed||Phase 2|40|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 00:05:43.88815|2017-10-11 00:05:43.88815
NCT02219672|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2014-08-18|||July 2014||2014-07-01|August 2014|2014-08-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection|Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir of Chinese HIV/AIDS Patients In Acute HIV-1 Infection|Unknown status|Recruiting|Phase 3|18|Anticipated|Peking Union Medical College||2|||f||||t||||||||||2017-10-11 00:05:45.372819|2017-10-11 00:05:45.372819
NCT02219659|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-09-13|||April 2014||2014-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pilot Study on Pairing Sedation Strategies and Weaning|Comparing Strategies of Pairing Sedation and Weaning Protocols on Outcomes of Mechanical Ventilation: A Pilot Study|Recruiting||N/A|90|Anticipated|MemorialCare Health System||3|||f||||t||||||||||2017-10-11 00:05:45.561222|2017-10-11 00:05:45.561222
NCT02219646|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-08-18|||March 2010||2010-03-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|DiVa||Diabetes & Vardenafil|Monitoring of Endothelial Dysfunction During Chronic Administration of Vardenafil in Patients With Type 2 Diabetes Mellitus: A Longitudinal, Randomised, Placebo-controlled, Double Blind, Phase II b, Clinical Trial|Completed||Phase 2|54|Actual|Azienda USL Modena||2|||f||||t||||||||||2017-10-11 00:05:45.741224|2017-10-11 00:05:45.741224
NCT02219633|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-06-13|||July 2014||2014-07-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)|An Explorative Trial Evaluating the Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)|Completed||Phase 1|30|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 00:05:45.912722|2017-10-11 00:05:45.912722
NCT02219620|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-06-20|||August 2014||2014-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|MiM||Examining the Effects of (MiM) Treatment on Emotional and Cognitive Functioning of Residents in Long-term Care|Examining the Effects of (MiM) Treatment on Emotional and Cognitive Functioning of Residents in Long-term Care|Completed||N/A|30|Actual|George Mason University||2|||f||||t||||||||||2017-10-11 00:05:46.029847|2017-10-11 00:05:46.029847
NCT02219607|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2014-08-16|||January 2014||2014-01-01|August 2014|2014-08-01||||March 2015|Anticipated|2015-03-01||Observational|||Liver Enzymes and Fluid Balance Following Colorectal Surgery||Unknown status|Recruiting|N/A|50|Anticipated|Attikon Hospital|||2||f||||f||||||||||2017-10-11 00:05:46.16953|2017-10-11 00:05:46.16953
NCT02219594|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2014-08-18|||June 2014||2014-06-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Comparative Study of OCT，Gemstone CT and 320-detector Row Spiral CT for Evaluating Restenosis of Coronary Artery Stent|The Comparative Study of OCT，Gemstone CT and 320-detector Row Spiral CT for Evaluating Restenosis of Coronary Artery Stent|Unknown status|Recruiting|N/A|150|Anticipated|Xuzhou Central Hospital||2|||f||||t||||||||||2017-10-11 00:05:46.290123|2017-10-11 00:05:46.290123
NCT02219581|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-07-11|||August 2014||2014-08-01|July 2017|2017-07-01|September 25, 2018|Anticipated|2018-09-25|September 25, 2018|Anticipated|2018-09-25||Interventional|||Steroids in Total Knee Arthroplasty|Evaluation of Intravenous Glucocorticoid Therapy in Total Knee Arthroplasty|Recruiting||Phase 4|150|Anticipated|Emory University||3|||f||||t||||||||||2017-10-11 00:05:46.42333|2017-10-11 00:05:46.42333
NCT02219568|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-07-27|||February 2014||2014-02-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy of Wireless Capsule Endoscopy and CT Enterography in Obscure Gastrointestinal Bleeding|Efficacy of Wireless Capsule Endoscopy and CT Enterography in Obscure Gastrointestinal Bleeding : Prospective Blinded Comparative Study|Completed||N/A|52|Actual|Mahidol University||1|||f||||||||||||||2017-10-11 00:05:46.587763|2017-10-11 00:05:46.587763
NCT02219555|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-16|2017-08-02|||September 2014||2014-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|DUCATS||DUCATS Trial: Dynamic Ultrasound to Enhance Understanding of Carpal Tunnel Syndrome|DUCATS Trial: Dynamic Ultrasound to Enhance Understanding of Carpal Tunnel Syndrome|Recruiting||N/A|300|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:05:46.69196|2017-10-11 00:05:46.69196
NCT02219542|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-06-30|||August 2014||2014-08-01|May 2014|2014-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Cytokines of Patients With Transversus Abdominis Plane Block After Laparoscopic Colonic Surgery|Cytokines of Patients After Laparoscopic Colonic Surgery|Completed||Phase 4|80|Actual|China Medical University, China||2|||f||||t||||||||||2017-10-11 00:05:46.798872|2017-10-11 00:05:46.798872
NCT02219529|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-07-19|||August 2014||2014-08-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|MCE||Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases|Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases: A Prospective Self-controlled Comparative Multicenter Trial|Completed||Phase 3|350|Actual|Changhai Hospital||2|||f||||t||||||||||2017-10-11 00:05:46.903262|2017-10-11 00:05:46.903262
NCT02219516|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-03-14|2017-03-14||August 1, 2014|Actual|2014-08-01|March 2017|2017-03-01|May 13, 2016|Actual|2016-05-13|October 30, 2015|Actual|2015-10-30||Interventional|||Mild, Moderate and Severe Renal Impairment Study|A Phase 1, Single-Dose, Open Label, Pharmacokinetic and Pharmacodynamic Study of RDEA3170 in Adult Male Subjects With Mild, Moderate, and Severe Renal Impairment|Completed||Phase 1|31|Actual|Ardea Biosciences, Inc.||4|||f||||f||||||||||2017-10-11 00:05:47.059939|2017-10-11 00:05:47.059939
NCT02219503|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2016-05-23|2016-05-23||September 2014||2014-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|TURQUOISE-III|Baseline analyses included all participants.|A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis|An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)|Completed||Phase 3|60|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 00:05:48.502566|2017-10-11 00:05:48.502566
NCT02219490|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-08-01|||November 5, 2014||2014-11-05|August 2017|2017-08-01|October 4, 2021|Anticipated|2021-10-04|October 4, 2021|Anticipated|2021-10-04||Interventional|TOPAZ-I||A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection|An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes With ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ-I)|Active, not recruiting||Phase 3|1650|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-11 00:05:48.950819|2017-10-11 00:05:48.950819
NCT02219477|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-06-09|2017-06-09||November 24, 2014|Actual|2014-11-24|June 2017|2017-06-01|March 3, 2017|Actual|2017-03-03|June 13, 2016|Actual|2016-06-13||Interventional|TURQUOISE-CPB||A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis|An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)|Completed||Phase 3|36|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 00:05:49.518775|2017-10-11 00:05:49.518775
NCT02219464|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-05-26|2017-02-03||August 2014||2014-08-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Nasopharyngeal Versus Nasal Cannula Oxygen Supplementation in Surgery Patients|Nasopharyngeal Versus Nasal Cannula Oxygen Supplementation in Surgery Patients|Completed||N/A|60|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 00:05:50.696881|2017-10-11 00:05:50.696881
NCT02219451|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-18|||August 2013||2013-08-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Exercise Improve Sympathetic Modulation in Chronic Heart Failure Patients|Exercise Training Improves Oscillatory Pattern and Arterial Baroreflex Control of Sympathetic Nerve Activity in Patients With Chronic Heart Failure|Completed||Phase 4|26|Actual|University of Sao Paulo General Hospital||1|||f||||f||||||||||2017-10-11 00:05:51.016259|2017-10-11 00:05:51.016259
NCT02219438|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-01-21|||August 2014||2014-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Continuous Adductor Canal Nerve Blocks: Relative Effects of a Basal Infusion v. Hourly Bolus Doses|Continuous Adductor Canal Nerve Blocks: Relative Effects of a Basal Infusion v. Hourly Bolus Doses|Completed||Phase 4|24|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:05:51.110569|2017-10-11 00:05:51.110569
NCT02219425|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-01-29|||June 2014||2014-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Gene Expression Analysis of the Endometrium After Endometrial Biopsy in Fertile Women|Gene Expression Analysis of the Endometrium After Endometrial Biopsy in Fertile Women|Completed||N/A|10|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 00:05:51.212285|2017-10-11 00:05:51.212285
NCT02219412|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-06-20|||August 2014||2014-08-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy|An Open Label, Two Arms, Randomized Controlled Pilot Study Comparing the Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable Coronary Artery Disease Treated With Ticagrelor Monotherapy or Ticagrelor and Asprin|Completed||Phase 4|70|Actual|Peking University First Hospital||2|||f||||f||||||||No||2017-10-11 00:05:51.328079|2017-10-11 00:05:51.328079
NCT02219399|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-08-15|||January 2001||2001-01-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2004|Actual|2004-01-01||Interventional|||DHA Supplementation and Pregnancy Outcome|Maternal DHA Supplementation and Pregnancy Outcome|Completed||N/A|871|Actual|Colorado State University||3|||f||||f||||||||||2017-10-11 00:05:51.611236|2017-10-11 00:05:51.611236
NCT02219386|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-30|||January 2011||2011-01-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Dry Needling of the Trapezius Muscle in Office Workers With Neck Pain|Dry Needling of the Trapezius Muscle in Office Workers With Neck Pain. Randomised, Single Blinded Clinical Trial|Completed||N/A|44|Actual|University of Alcala||2|||f||||t||||||||||2017-10-11 00:05:51.733841|2017-10-11 00:05:51.733841
NCT02219373|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-15|||October 2014||2014-10-01|August 2014|2014-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study|Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Double-Blind, Randomized Clinical Effectiveness Study.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Boston Children’s Hospital||3|||f||||t||||||||||2017-10-11 00:05:51.821152|2017-10-11 00:05:51.821152
NCT02219360|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-08-15|||August 2014||2014-08-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Observational|TripAE||Treatment in Patients Hospitalized With Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Treatment in Patients Hospitalized With Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Unknown status|Not yet recruiting|N/A|400|Anticipated|Beijing Chao Yang Hospital|||1||f||||f||||||Samples With DNA|"     25-(OH)-VD3 and glycated albumin will be tested   "|||2017-10-11 00:05:51.941052|2017-10-11 00:05:51.941052
NCT02219347|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2016-03-22|||August 2014||2014-08-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|BioRRA||Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)|Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)|Recruiting||N/A|110|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust||1|||f||||f||||||||No||2017-10-11 00:05:52.026572|2017-10-11 00:05:52.026572
NCT02219334|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-07-05|||September 2014||2014-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparing Nasal Suction Devices in Children With Bronchiolitis: A Pilot Study|Comparing Nasal Suction Devices in Children With Bronchiolitis: A Pilot Study|Recruiting||N/A|150|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 00:05:52.156548|2017-10-11 00:05:52.156548
NCT02219321|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-11-09|||December 2014||2014-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lidocaine Infusion for Chronic Pain in Opioid Dependent Patients|Lidocaine Infusion for Chronic Pain in Opioid Dependent Patients|Recruiting||Phase 3|40|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-11 00:05:52.314553|2017-10-11 00:05:52.314553
NCT02219308|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-11-14|||August 2014||2014-08-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Pain Control for Intrauterine Device Placement Using Paracervical Block|Pain Control for Intrauterine Device Placement: A Randomized Controlled Trial of Paracervical Block|Unknown status|Recruiting|N/A|144|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:05:52.439706|2017-10-11 00:05:52.439706
NCT02219295|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-03-18|||December 2011||2011-12-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|SEGATROM||SEGATROM: Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition|Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition|Completed||N/A|97|Anticipated|German Institute of Human Nutrition||4|||f||||f||||||||||2017-10-11 00:05:52.600206|2017-10-11 00:05:52.600206
NCT02219282|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-05-25|2015-04-26||August 2010||2010-08-01|May 2017|2017-05-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Geriatric Patients and Laryngeal Mask Unique|A Comparison of Laryngeal Mask UniqueTM in Denticulate and Edentulate Geriatric Patients|Completed||N/A|66|Actual|Dokuz Eylul University||2|||f||||f||||||||||2017-10-11 00:05:52.755011|2017-10-11 00:05:52.755011
NCT02219269|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-12-02|||March 2014||2014-03-01|December 2014|2014-12-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01|6 Months|Observational [Patient Registry]|||A Complex Contraception Registry|A Complex Contraception Registry - UC Family Planning Collaborative Study|Unknown status|Recruiting|N/A|250|Anticipated|University of California, San Diego|||1||f||||t||||||||||2017-10-11 00:05:53.277442|2017-10-11 00:05:53.277442
NCT02219256|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-03-22|2017-01-23||August 2014||2014-08-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||The safety analysis set included all participants who were enrolled, received 1 dose of study drug (after study drug dosing started) including those who did not complete all scheduled study visits.|A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single Intravenous Infusion and Subcutaneous Administration of TAK-079 in Healthy Subjects|Completed||Phase 1|74|Actual|Takeda||3|||f||||f||||||||||2017-10-11 00:05:53.522022|2017-10-11 00:05:53.522022
NCT02219243|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-10-24|||August 2014||2014-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Interpretive Biases in Children With Social Anxiety|Modification of Interpretive Biases in Children With Social Anxiety|Terminated||N/A|5|Actual|University of Wisconsin, Milwaukee||3|||f||||f||||||||||2017-10-11 00:05:57.374672|2017-10-11 00:05:57.374672
NCT02219191|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-31|||August 2014||2014-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases|The Effect of Puerarin Tablets in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases|Active, not recruiting||N/A|150|Anticipated|Chengdu PLA General Hospital||2|||f||||t||||||||||2017-10-11 00:05:57.934531|2017-10-11 00:05:57.934531
NCT02219178|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-05-30|||November 2014||2014-11-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma|A Phase II Study of the Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib, and Dexamethasone Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|42|Actual|Cancer Trials Ireland||1|||f||||f||||||||||2017-10-11 00:05:58.073669|2017-10-11 00:05:58.073669
NCT02219165|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-03-15|||January 2015||2015-01-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|IVIG||Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study|Efficacy of IntraVenous ImmunoGlobulins (IVIG) in Toxic Shock Syndromes (Staphylococcal and Streptococcal): a Paediatric Pilot Study.|Recruiting||Phase 2|20|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 00:05:58.207484|2017-10-11 00:05:58.207484
NCT02219152|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-15|||September 2014||2014-09-01|August 2014|2014-08-01|February 2017|Anticipated|2017-02-01|September 2015|Anticipated|2015-09-01||Interventional|||Topical Instillation of Tranexamic Aacid in Bronchoscopy to Decrease Bleeding During Entobronchial & Transbronchial Biopsiy: a Prospective Double Blind Placebo Controlled Study||Unknown status|Not yet recruiting|Phase 2|120|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:05:58.366743|2017-10-11 00:05:58.366743
NCT02219139|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-03-02|||December 2012||2012-12-01|March 2016|2016-03-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||A Comparative, Randomized, Prospective, Performance Evaluation of Abutments in Single Tooth Gaps|A Comparative, Randomized, Prospective, Clinical Pilot Study to Evaluate the Performance of Modified Study Abutments in Single Tooth Gaps|Withdrawn||N/A|0|Actual|Institut Straumann AG||1||No patients could be recruited|f||||f||||||||No||2017-10-11 00:05:58.465811|2017-10-11 00:05:58.465811
NCT02219126|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-08-09|||August 2014||2014-08-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Homogenization and Pasteurization of Milk on the Stomach Problems in Adults|Effect of Homogenization and Pasteurization of Milk on the Stomach Problems in Adults|Completed||N/A|11|Actual|University of Turku||2|||f||||f||||||||||2017-10-11 00:05:58.576277|2017-10-11 00:05:58.576277
NCT02219113|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-07-19|||July 2014||2014-07-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage|Effectiveness and Safety of Intraarticular Administration of Autologous Adipose-Derived Regenerative Cells for Treatment of Degenerative Damage of Knee Articular Cartilage|Completed||Phase 1/Phase 2|12|Actual|Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation||1|||f||||f||||||||||2017-10-11 00:05:58.669265|2017-10-11 00:05:58.669265
NCT02219100|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-08-18|||November 2010||2010-11-01|August 2014|2014-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus|Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus|Completed||N/A|613|Actual|Gynuity Health Projects||2|||f||||||||||||||2017-10-11 00:05:58.780978|2017-10-11 00:05:58.780978
NCT02219074|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-09-05|||June 2011|Actual|2011-06-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris|A Feasibility Study to Evaluate the Safety and Preliminary Efficacy of the Sebacia Acne Treatment System for the Treatment of Acne Vulgaris|Completed||N/A|350|Actual|Sebacia, Inc.||2|||f||||f||||||||||2017-10-11 00:05:59.015139|2017-10-11 00:05:59.015139
NCT02219061|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-09-16|||May 2014||2014-05-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Observational|EWMM||Early Waning of Maternal Measles and Meningitis C Antibodies|Observation Study on Early Waning of Maternal Measles and Meningitis C Antibodies|Unknown status|Recruiting|N/A|100|Anticipated|Guangzhou Center for Disease Control and Prevention|||1||f||||t||||||Samples Without DNA|"     Children's Serum will be collected for measles and meningitis C antibodies test by ELISA     method.   "|||2017-10-11 00:05:59.108037|2017-10-11 00:05:59.108037
NCT02219035|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-08-15|||December 2014||2014-12-01|August 2014|2014-08-01||||December 2016|Anticipated|2016-12-01||Observational|||A Prospective Investigation of the VWF-ADAMTS 13 Axis in Acute Ischaemic Brain Injury (TIAs and Stroke).|A Prospective Investigation of the VWF-ADAMTS 13 Axis in Acute Ischaemic Brain Injury (TIAs and Stroke).|Unknown status|Not yet recruiting|Phase 1|200|Anticipated|University College, London|||3||f||||t||||||||||2017-10-11 00:05:59.365682|2017-10-11 00:05:59.365682
NCT02219022|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-08-12|||July 2011||2011-07-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Progressive Resistance Exercise in Rheumatoid Arthritis|Progressive Resistance Exercise in Rheumatoid Arthritis Patients: a Randomized Controlled Trial|Completed||Phase 4|60|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 00:05:59.44641|2017-10-11 00:05:59.44641
NCT02219009|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-05-11||2016-05-11|August 2014||2014-08-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole|A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole|Completed||Phase 2|67|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-10-11 00:05:59.573095|2017-10-11 00:05:59.573095
NCT02218996|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-06-16|||August 2014|Actual|2014-08-01|June 2017|2017-06-01|December 2027|Anticipated|2027-12-01|December 31, 2017|Anticipated|2017-12-31||Observational|TADCAROC||Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics|Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics (TADCAROC)|Active, not recruiting||N/A|260|Anticipated|Helse Stavanger HF|||1||f||||f||||||||No||2017-10-11 00:05:59.724539|2017-10-11 00:05:59.724539
NCT02218983|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-04-14|||June 2014||2014-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Prognostic Value of Limited Transthoracic Echocardiogram (LTTE) During Trauma Resuscitation|The Prognostic Value of Limited Transthoracic Echocardiogram (LTTE) During Trauma Resuscitation|Recruiting||N/A|110|Anticipated|Riverside County Regional Medical Center||2|||f||||f||||||||||2017-10-11 00:05:59.83248|2017-10-11 00:05:59.83248
NCT02218970|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-08-03|||September 2012||2012-09-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||The Effect of Muscular Strength Training in Patients With Drug Addiction|The Effect of Muscular Strength Training in Patients With Drug Addiction|Completed||N/A|24|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 00:05:59.935925|2017-10-11 00:05:59.935925
NCT02218957|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-06-02|||August 2014||2014-08-01|June 2016|2016-06-01||||October 2017|Anticipated|2017-10-01||Interventional|||Extended Pouch Roux-en-Y Gastric Bypass Study|Restrictive Extended Pouch in Roux-en-Y Gastric Bypass: a Prospective Randomized Control Trial|Active, not recruiting||N/A|130|Actual|Rijnstate Hospital||2|||f||||f||||||||||2017-10-11 00:06:00.036742|2017-10-11 00:06:00.036742
NCT02218944|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-10-07|||September 2014||2014-09-01|October 2014|2014-10-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Smoking Response Inhibition Training|Response Inhibition Training in Smoking Cessation|Unknown status|Enrolling by invitation|N/A|150|Anticipated|North Dakota State University||3|||f||||f||||||||||2017-10-11 00:06:00.138318|2017-10-11 00:06:00.138318
NCT02218931|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-09-29|||July 2014||2014-07-01|January 2017|2017-01-01|April 30, 2017|Actual|2017-04-30|November 2016|Actual|2016-11-01||Interventional|ESTEEM||ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes|Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes (ESTEEM): A Randomised Trial|Completed||N/A|3442|Actual|Queen Mary University of London||3|||f||||t||||||||||2017-10-11 00:06:00.230758|2017-10-11 00:06:00.230758
NCT02218918|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-18|||July 2014||2014-07-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|GWT/TWT||Comparison of Supervised Ground Walk Training and Treadmill Walk Training in COPD Patients|Phase 0 Study of Comparison Between Ground Walk Training and Treadmill Walk Training in COPD Patients|Unknown status|Active, not recruiting|Early Phase 1|40|Anticipated|PSG Hospitals||2|||f||||t||||||||||2017-10-11 00:06:00.334878|2017-10-11 00:06:00.334878
NCT02218905|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-29|||August 2014||2014-08-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|1minSTS||Normative Values and Forming Regression Equations for One Minute Sit to Stand Test in Healthy Normal Indian Population|Phase 0 Study of Reference Values for One Minute Sit to Stand Test in Healthy Indian Population - a Cross Sectional Study|Unknown status|Enrolling by invitation|Early Phase 1|196|Actual|PSG Hospitals||1|||f||||t||||||||||2017-10-11 00:06:00.414997|2017-10-11 00:06:00.414997
NCT02218892|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-08-15|||February 2011||2011-02-01|August 2014|2014-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis|Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis|Recruiting||N/A|150|Anticipated|Folktandvården Stockholms län AB|||1||f||||f||||||Samples With DNA|"     whole blood, serum,saliva   "|||2017-10-11 00:06:00.529345|2017-10-11 00:06:00.529345
NCT02218879|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-09-02|||August 2014||2014-08-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS|Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With Relapsing-Remitting Multiple Sclerosis|Terminated||N/A|7|Actual|Yale University|||1||f||||f||||||||||2017-10-11 00:06:00.631318|2017-10-11 00:06:00.631318
NCT02218866|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-08-11|||January 2012||2012-01-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|BAR||The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration|The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration|Active, not recruiting||N/A|205|Anticipated|University of Utah|||3||f||||f||||||Samples With DNA|"     DNA, serum, tissue   "|||2017-10-11 00:06:00.730796|2017-10-11 00:06:00.730796
NCT02218853|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-05-13|||April 2014||2014-04-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|PARDIP||Psychosis and Affective Research Domains and Intermediate Phenotypes|Psychosis and Affective Research Domains and Intermediate Phenotypes|Recruiting||N/A|350|Anticipated|University of Texas Southwestern Medical Center|||3||f||||f||||||Samples With DNA|"     DNA will be extracted from blood (or buccal swab) and stored at the UT Southwestern Human     Genetic Center in a departmental freezer at -80 degrees. Part of the blood sample will be     used to create an immortalized lymphocyte culture (a lymphoblastoid cell line) for future     genetic analysis, and will be stored in a Cell Bank at the UT Southwestern Human Genetic     Center. The blood samples will be labeled by a coded identifier (number) and will not be     personally identifiable. Only specifically designated research staff from Dr. Tamminga's     group and from the UT Southwestern Human Genetic Center will have an access to stored DNA     samples. All samples will be de-identified. The genetic data will be in password-protected     computers in the Investigators' research offices.   "|||2017-10-11 00:06:01.121258|2017-10-11 00:06:01.121258
NCT02218840|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-08-14|||April 2014||2014-04-01|August 2014|2014-08-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Behavioral Pharmacology Associated With Cigar Smoking|Behavioral Pharmacology Associated With Cigar Smoking|Unknown status|Recruiting|N/A|106|Anticipated|Food and Drug Administration (FDA)|||1||f||||t||||||Samples Without DNA|"     blood, urine   "|||2017-10-11 00:06:01.25285|2017-10-11 00:06:01.25285
NCT02218814|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-01-29|||August 2014||2014-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|ACB||Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKA|Prospective, Double-blind, Randomized Study to Evaluate a Single Shot Adductor Canal Nerve Block Versus Femoral Nerve Block Combined With LIA (Local Infiltration Analgesia): Early Postoperative Period Functional Outcomes After Total Knee Replacement|Completed||N/A|106|Actual|Presence Saint Joseph Medical Center||2|||f||||t||||||||||2017-10-11 00:06:01.5303|2017-10-11 00:06:01.5303
NCT02218801|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-03-30|||May 2015||2015-05-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01|2 Years|Observational [Patient Registry]|CLIMB||A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program|A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program|Recruiting||N/A|200|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||t||||||None Retained|"     whole blood, plasma, serum and left-over tissue samples from either primary tumor or liver     metastasis   "|||2017-10-11 00:06:01.684497|2017-10-11 00:06:01.684497
NCT02218788|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-09-24|||December 2013||2013-12-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Observational|||Injectable Filler for Facial Soft Tissue Augmentation|An Open-label, Retrospective, Postmarketing Study of Safety and Performance of Hydroxytite, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation.|Enrolling by invitation||N/A|218|Actual|Panaxia Ltd|||1||f||||f||||||||||2017-10-11 00:06:01.927245|2017-10-11 00:06:01.927245
NCT02218775|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2015-05-26|||October 2014||2014-10-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|KOR1||FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study|A Phase 1 Study of Kappa and Mu Opioid Receptor Occupancy Associated With Repeated Dosing of LY24516302|Withdrawn||Phase 1|0|Actual|Duke University||1||Funding for the study ended with one subject consented, but not randomized|f||||t||||||||||2017-10-11 00:06:02.047847|2017-10-11 00:06:02.047847
NCT02218762|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-02-09|||October 2014||2014-10-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler|A Randomised, Two Treatment, Four-Way Cross-Over (Replicate Design), Two Sequence, Repeat Dose Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the Low Airflow Resistance Fluticasone Propionate/Salmeterol (100/50 mcg) ROTAHALER Inhaler Relative to Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the DISKUS Inhaler|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||2||"It was decided that data from this study are no longer required and therefore it is not   necessary to expose patients to the study medication"|f||||f||||||||||2017-10-11 00:06:02.186124|2017-10-11 00:06:02.186124
NCT02218749|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-02-01|||August 2014||2014-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Triaging Patients With Musculoskeletal Disorders Directly to Physiotherapists at Primary Health Care Clinics.|The Effects of Triaging Patients With Musculoskeletal Disorders Directly to Physiotherapists at Primary Health Care Clinics: a Pilot Study and Randomized Controlled Trial.|Recruiting||N/A|360|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-11 00:06:02.351569|2017-10-11 00:06:02.351569
NCT02218736|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2017-09-30|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FASTMAS_Kor2||Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a|A Phase 2a Study to Evaluate the Kappa Opioid Receptor As a Target for the Treatment of Mood and Anxiety Spectrum Disorders by Evaluation of Whether CERC-501 Engages Key Neural Circuitry Related to the Hedonic Response|Recruiting||Phase 2|90|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 00:06:02.635754|2017-10-11 00:06:02.635754
NCT02218723|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-05-12|||October 28, 2014|Actual|2014-10-28|May 2017|2017-05-01|December 19, 2014|Actual|2014-12-19|December 19, 2014|Actual|2014-12-19||Interventional|||Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation|An Open-label, Randomised, Cross-over, Single Dose Study in Healthy Volunteers to Evaluate the Unit Dose Dry Powder Inhaler (UD-DPI) With Four Different Formulations for the Delivery of Fluticasone Furoate and to Compare the Pharmacokinetic Profile With the Fluticasone Furorate ELLIPTA Presentation|Completed||Phase 1|30|Actual|GlaxoSmithKline||10|||f||||f||||||||||2017-10-11 00:06:02.833218|2017-10-11 00:06:02.833218
NCT02218710|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-14|||September 2014||2014-09-01|August 2014|2014-08-01||||June 2015|Anticipated|2015-06-01||Observational|||Bone Structure in Patients With Adult Onset Growth Hormone Deficiency Assessed Using High Resolution Peripheral Quantitative Computed Tomography|Bone Geometry, Volumetric Density, Microarchitecture and Estimated Bone Strength Assessed by High Resolution Peripheral Quantitative Computed Tomography in Patients With Adult Onset Growth Hormone Deficiency|Unknown status|Not yet recruiting|N/A|45|Anticipated|Odense University Hospital|||2||f||||f||||||||||2017-10-11 00:06:02.994227|2017-10-11 00:06:02.994227
NCT02218684|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-08-15|||September 1998||1998-09-01|July 2014|2014-07-01||||November 1998|Actual|1998-11-01||Interventional|||Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects|Tolerability and Pharmacokinetics of 80 mg Telmisartan in Combination With 2, 4, or 6 mg Lacidipine. An Open, Single Rising Dose Group Comparison Trial - Placebo Randomised Double Blind in Each Dose Group - in Male Healthy Subjects|Completed||Phase 1|27|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:06:05.318661|2017-10-11 00:06:05.318661
NCT02218671|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-08-15|||March 2000||2000-03-01|August 2014|2014-08-01||||March 2000|Actual|2000-03-01||Interventional|||Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers|Clinical Pharmacological Study on Absorption From Mucous Membrane of Oral Cavity of WE 941 OD Tablets|Completed||Phase 1|10||Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:05.417604|2017-10-11 00:06:05.417604
NCT02218658|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-08-15|||July 2000||2000-07-01|August 2014|2014-08-01||||August 2000|Actual|2000-08-01||Interventional|||Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) in Healthy Adult Males|The Bioequivalence Between WE 941 OD Tablets (0.25mg as the Basis) Taken Without Water and Brotizolam Conventional Tablets (Lendormin® Tablets, 0.25 mg as the Basis) Taken With Water, as a Single Administration in Healthy Adult Male Subjects (Open-labelled, 2-way Cross-over Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:05.50875|2017-10-11 00:06:05.50875
NCT02218645|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-15|2014-08-15|||August 2000||2000-08-01|August 2014|2014-08-01||||September 2000|Actual|2000-09-01||Interventional|||Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) Taken With Water in Healthy Adult Males|The Bioequivalence Between WE 941 OD Tablets (0.25mg as the Basis) and Brotizolam Conventional Tablets (Lendormin® Tablets, 0.25 mg as the Basis), Both Taken With Water, as a Single Administration in Healthy Adult Male Subjects (Open-labelled, 2-way Cross-over Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:05.58436|2017-10-11 00:06:05.58436
NCT02218632|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-14|||July 2012||2012-07-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Glycosylation in Patients With Galactosaemia|Galactosaemia, a Modifiable Multi-system Glycosylation Disorder?|Completed||N/A|26|Actual|Children's University Hospital, Ireland||2|||f||||f||||||||||2017-10-11 00:06:05.662014|2017-10-11 00:06:05.662014
NCT02218619|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-12-09|||August 2015||2015-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes|Clinical Investigation of Efficacy of Tauroursodeoxycholic Acid (TUDCA) to Enhance Pancreatic Beta Cell Survival In Type 1 Diabetes by Reducing Endoplasmic Reticulum Stress|Recruiting||Phase 2|20|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-11 00:06:05.765949|2017-10-11 00:06:05.765949
NCT02218606|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-07-11|||August 2014|Actual|2014-08-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer|An Exploratory Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer|Recruiting||Phase 2|55|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||t||||||||||2017-10-11 00:06:05.876329|2017-10-11 00:06:05.876329
NCT02218593|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-14|||July 2014||2014-07-01|August 2014|2014-08-01|July 2015|Anticipated|2015-07-01|October 2014|Anticipated|2014-10-01||Interventional|||WREX Outcome Study|WREX Outcome Study|Unknown status|Enrolling by invitation|N/A|42|Actual|Nemours Children's Clinic||1|||f||||f||||||||||2017-10-11 00:06:06.152978|2017-10-11 00:06:06.152978
NCT02218580|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-09-12|||May 2015||2015-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Massage Therapy in Juvenile Idiopathic Arthritis|Massage Therapy for Children With Juvenile Idiopathic Arthritis Experiencing Pain: a Pilot Randomized Controlled Trial|Recruiting||N/A|30|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 00:06:06.225513|2017-10-11 00:06:06.225513
NCT02218567|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-14|||June 2014||2014-06-01|June 2014|2014-06-01||||March 2016|Anticipated|2016-03-01||Interventional|HUNTEXPERT||Behavioural Problems in Huntington Disease : Analysis and Enhancement of Caregiver and Patient Experience||Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-11 00:06:06.357819|2017-10-11 00:06:06.357819
NCT02218554|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-14|||January 2012||2012-01-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|BRONJ||Performance Evaluation of the Micromedic BRONJ Risk Assessment in Vitro Diagnostic Assay|Performance Evaluation of the Micromedic BRONJ Risk Assessment in Vitro Diagnostic Assay.|Unknown status|Recruiting|N/A|150|Anticipated|Micromedic Technologies Ltd||2|||f||||f||||||||||2017-10-11 00:06:06.45049|2017-10-11 00:06:06.45049
NCT02218541|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-09-13|||October 2014|Actual|2014-10-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Fabrication of a Definitive Cad/Cam Titanium Abutment Prior to Guided Surgery: a Pilot Study.|Fabrication of a Definitive Cad/Cam Titanium Abutment Prior to Guided Surgery: a Pilot Study.|Completed||N/A|28|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:06:06.545994|2017-10-11 00:06:06.545994
NCT02218528|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-02-17|||August 2014||2014-08-01|August 2014|2014-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effect of a Plant-based Ingredient on Glucose Response|An Exploratory Study of a Plant-based Ingredient for Reducing the Post-prandial Blood Glucose Response in Healthy Indian Adults, When Administered With a Meal|Completed||N/A|48|Actual|Unilever R&D||6|||f||||f||||||||||2017-10-11 00:06:06.617878|2017-10-11 00:06:06.617878
NCT02218515|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-14|||September 2010||2010-09-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft|Evaluation of Gingival Crevicular Fluid Transforming Growth Factor-β1 Level After Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft|Completed||Phase 4|30|Actual|Marmara University||3|||f||||f||||||||||2017-10-11 00:06:06.698649|2017-10-11 00:06:06.698649
NCT02218502|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-03-24|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|October 1, 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|SUBSONiC||Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses|Regional Study Into the Performance and Cost-effectiveness of Simple Ultrasound-based Rules Compared to the Currently Used Risk of Malignancy Index in the Diagnosis of Ovarian Cancer|Terminated||N/A|50|Actual|Maastricht University Medical Center||2||interim analysis showed incorrect use of simple rules|f||||t||||||||||2017-10-11 00:06:06.795265|2017-10-11 00:06:06.795265
NCT02218489|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-10-19||2016-10-19|July 2014||2014-07-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|Maui||Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease|A Phase II, Double-Masked, Randomized, Vehicle-Controlled Study to Evaluate the Effect of KPI-121 0.25% Ophthalmic Suspension on Signs and Symptoms of Inflammatory Meibomian Gland Disease|Completed||Phase 2|206|Actual|Kala Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:06:06.911277|2017-10-11 00:06:06.911277
NCT02218476|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-14|||September 2013||2013-09-01|August 2014|2014-08-01||||September 2016|Anticipated|2016-09-01||Interventional|coenzyme Q10||Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome Patients||Unknown status|Recruiting|N/A|50||Maimónides Biomedical Research Institute of Córdoba||1|||f||||||||||||||2017-10-11 00:06:07.123008|2017-10-11 00:06:07.123008
NCT02217358|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-09-07|||February 2012||2012-02-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions|Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions|Completed||N/A|150|Actual|University Hospital Ostrava||1|||f||||f||||||||||2017-10-11 00:06:07.388029|2017-10-11 00:06:07.388029
NCT02217345|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-03-01|||September 2015||2015-09-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|NAFLD||Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease|Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:06:07.490582|2017-10-11 00:06:07.490582
NCT02217332|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-02-28|||August 2014||2014-08-01|February 2017|2017-02-01|January 20, 2017|Actual|2017-01-20|December 14, 2016|Actual|2016-12-14||Interventional|CS201||Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia|Safety and Preliminary Efficacy of Dexpramipexole in Patients With Chronic Sinusitis With Nasal Polyps and Eosinophilia (CSNP-E)|Completed||Phase 2|20|Actual|Knopp Biosciences||1|||f||||f||||||||||2017-10-11 00:06:07.596847|2017-10-11 00:06:07.596847
NCT02217319|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-08-01|||September 2012||2012-09-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Cardioprotection by Sevoflurane Preconditioning in Noncardiac Thoracic Surgery|Does a Sevoflurane Preconditioning Have Cardioprotective Properties in Noncardiac Thoracic Surgery?|Completed||N/A|100|Actual|Dr. Horst Schmidt Klinik GmbH||2|||f||||f||||||||||2017-10-11 00:06:07.721509|2017-10-11 00:06:07.721509
NCT02217306|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-13|||January 2014||2014-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational|||Contrast Sensitivity and Diabetic Macular Edema|Contrast Sensitivity and Diabetic Macular Edema|Completed||N/A|132|Actual|Hospital Juarez de Mexico|||1||f||||f||||||||||2017-10-11 00:06:07.828447|2017-10-11 00:06:07.828447
NCT02217293|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-13|||November 2012||2012-11-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy of Pulsed Radiofrequency of the Median Nerve Under Ultrasound Guidance in Patients With Carpal Tunnel Syndrome|Efficacy of Pulsed Radiofrequency of the Median Nerve Under Ultrasound Guidance in Patients With Carpal Tunnel Syndrome|Completed||N/A|44|Actual|Tri-Service General Hospital||2|||f||||t||||||||||2017-10-11 00:06:07.914687|2017-10-11 00:06:07.914687
NCT02217280|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-05-26|2017-04-18||April 2015||2015-04-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Dispersal Pattern for Spine Injections (Gadolinium Contrast)|Dispersal Pattern of Injectate After Cervical Epidural Steroid Evaluated With Magnetic Resonance Imaging|Completed||N/A|20|Actual|University of Missouri-Columbia||1|||f||||f||||||||||2017-10-11 00:06:08.055555|2017-10-11 00:06:08.055555
NCT02217267|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-14|||August 2014||2014-08-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain|Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain : A Pilot Study|Unknown status|Recruiting|Phase 3|50|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-11 00:06:08.289074|2017-10-11 00:06:08.289074
NCT02217254|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-10-30|||October 2014||2014-10-01|October 2014|2014-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|OneFreeze||The OneFreeze Study|THE ONE FREEZE STUDY: A PROSPECTIVE MULTI-CENTER RANDOMIZED CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF ONE VS. TWO CRYOABLATIONS PER PULMONARY VEIN FOR THE TREATMENT OF ATRIAL FIBRILLATION|Unknown status|Recruiting|N/A|90|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:06:08.419296|2017-10-11 00:06:08.419296
NCT02217241|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-13|||January 2012||2012-01-01|August 2014|2014-08-01||||March 2013|Actual|2013-03-01||Interventional|||Effect of Hand-off Skills Training for Students During the Medicine Clerkship|Effect of Hand-off Skills Training for Students During the Medicine Clerkship: A Randomized Study|Completed||N/A|95|Actual|George Washington University||2|||f||||f||||||||||2017-10-11 00:06:08.526039|2017-10-11 00:06:08.526039
NCT02217228|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-09-08||2017-09-05|September 2014||2014-09-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris|A Randomized, Prospective, Multicenter, Controlled Study With Blinded Assessment to Determine the Safety and Effectiveness of the Sebacia Acne Treatment System in the Treatment of Inflammatory Acne Vulgaris|Completed||N/A|394|Actual|Sebacia, Inc.||3|||f||||f||||||||||2017-10-11 00:06:08.611489|2017-10-11 00:06:08.611489
NCT02218450|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-12-09|||July 2014||2014-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:06:08.743328|2017-10-11 00:06:08.743328
NCT02218437|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-14|||October 2013||2013-10-01|August 2014|2014-08-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|MSC-SAA||Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived）|Child With Severe Aplastic Anemia (SAA) Therapy: the Injection of Umbilical Cord Derived Mesenchymal Stem Cells.|Unknown status|Recruiting|Phase 4|20|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 00:06:08.793141|2017-10-11 00:06:08.793141
NCT02218424|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-04-24|||October 2014||2014-10-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Magnesium vs Placebo for Tonsillectomy|Systemic Magnesium to Improve Postoperative Pain in Pediatric Patients Undergoing Tonsillectomy: A Randomized, Double Blinded, Placebo Controlled Trial|Completed||Phase 2/Phase 3|60|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 00:06:08.903995|2017-10-11 00:06:08.903995
NCT02218411|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-08-14|||September 2012||2012-09-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Video-supported Group-based Otago Exercise Programme on Physical Performance in Older Adults.|Effectiveness of a Video-supported Group-based Otago Exercise Programme on Physical Performance in Community-dwelling Older Adults: a Pilot Randomized Controlled Trial|Completed||Phase 1|55|Actual|Cardenal Herrera University||1|||f||||t||||||||||2017-10-11 00:06:09.008756|2017-10-11 00:06:09.008756
NCT02218398|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-08-15|||May 2013||2013-05-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients|Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients, a Randomized Controlled Trial|Unknown status|Recruiting|N/A|120|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-11 00:06:09.093485|2017-10-11 00:06:09.093485
NCT02218385|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-10-18|||August 2014||2014-08-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid|A Single-arm, Multi-laboratory Clinical Trial of the ForeCYTE Breast Aspirator for Sample Collection, Processing and Cytological Testing of Nipple Aspirate Fluid|Completed||N/A|52|Actual|Atossa Genetics, Inc.|||1||f||||f||||||||Undecided||2017-10-11 00:06:09.198209|2017-10-11 00:06:09.198209
NCT02218372|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-08-28|||October 30, 2014|Actual|2014-10-30|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|SUNSHINE||A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)|A Phase 3, Multicenter, Investigator-blind, Randomized, Parallel Group Study to Investigate the Safety and Efficacy of Fidaxomicin Oral Suspension or Tablets Taken q12h, and Vancomycin Oral Liquid or Capsules Taken q6h, for 10 Days in Pediatric Subjects With Clostridium Difficile-associated Diarrhea|Recruiting||Phase 3|144|Anticipated|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 00:06:09.292672|2017-10-11 00:06:09.292672
NCT02218359|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-11-16|||October 2014||2014-10-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization|A Randomized Double-Blind, Placebo-Controlled, Crossover to Open Label, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® AFIS Inline System in Mechanically Ventilated Patients With Gram-negative and/or Gram-positive Bacterial Colonization|Withdrawn||Phase 2|0|Actual|Cardeas Pharma||2||No Participants Enrolled|f||||f||||||||||2017-10-11 00:06:09.57039|2017-10-11 00:06:09.57039
NCT02218346|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2015-12-11|||August 2014||2014-08-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Food Effect Study of AG-221 in Healthy Male Subjects|A Phase 1, Two-Way Crossover Study to Assess the Pharmacokinetics and Safety of a Single Dose of AG-221 in Healthy Male Subjects When Administered Under Fed and Fasted Conditions|Completed||Phase 1|30|Actual|Agios Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:06:09.692707|2017-10-11 00:06:09.692707
NCT02218333|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-10-15|||August 2014||2014-08-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Health Effects of Milk Proteins in Elderly Subjects|Effect of Milk Proteins on Body Composition, Muscle Strength, Inflammation and Bone Health in Elderly Subjects|Completed||N/A|50|Actual|University of Oslo||2|||f||||f||||||||||2017-10-11 00:06:09.780092|2017-10-11 00:06:09.780092
NCT02218307|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-05-30|2016-09-28||November 2011||2011-11-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Use of Antibiotic Sinonasal Rinse After Sinus Surgery|The Use of Antibiotic Sinonasal Rinse After Sinus Surgery: A Randomized Double-Blind Control Trial|Completed||Phase 4|68|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 00:06:10.124326|2017-10-11 00:06:10.124326
NCT02218294|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-10-27|||August 2014||2014-08-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study to Determine How BCX4161 is Metabolized and Eliminated by the Body|A Phase 1 Study to Evaluate the Absorption, Metabolism and Excretion of BCX4161 Following Administration of a Single, Oral Dose of [14C]-Radiolabelled BCX4161 to Healthy Male Subjects|Completed||Phase 1|7|Actual|BioCryst Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:06:10.3678|2017-10-11 00:06:10.3678
NCT02218281|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-08-25|||September 2014||2014-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation|Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation|Completed||N/A|146|Actual|University of Massachusetts, Worcester||3|||f||||t||||||||||2017-10-11 00:06:10.455698|2017-10-11 00:06:10.455698
NCT02218268|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-12-12|2016-08-04||October 2014||2014-10-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Arterial Stiffness in Type I Diabetes Mellitus|Acute Effect of a Mixed Meal With and Without Extra Insulin on Arterial Stiffness, a Prospective Randomized Study.|Completed||N/A|60|Actual|University of Florida|||2||f||||f||||||||||2017-10-11 00:06:10.540583|2017-10-11 00:06:10.540583
NCT02218255|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-10-19|||August 2014||2014-08-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|PPS||Eeva™ Pregnancy Pilot Study (PPS)|Eeva™ Pregnancy Pilot Study (PPS)|Unknown status|Recruiting|N/A|240|Anticipated|Progyny, Inc.||3|||f||||f||||||||||2017-10-11 00:06:10.738225|2017-10-11 00:06:10.738225
NCT02218242|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-08-03|||July 2015||2015-07-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 31, 2019|Anticipated|2019-08-31||Interventional|||Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound|A Single-arm, Phase II Study of Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound at the Time of Definitive Resection|Recruiting||Phase 2|70|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-10-11 00:06:10.818528|2017-10-11 00:06:10.818528
NCT02214199|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-09|2016-04-20|||August 2014||2014-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Effectiveness of Cervicothoracic Manipulative Treatment in Unilateral Shoulder Impingement Syndrome: A Randomized Controlled Trial.||Completed||Early Phase 1|92|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-11 00:07:00.820172|2017-10-11 00:07:00.820172
NCT02218216|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-06-22|2017-04-27||September 2014||2014-09-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|||TBI MR Study 3 Houston Methodist|Advanced MRI Applications for Mild Traumatic Brain Injury - Study 3|Terminated||N/A|16|Actual|GE Healthcare|Early termination due to limited enrollment|2||Sponsor terminated study early to start a larger feasability study|f||||f||||||||No||2017-10-11 00:06:11.01969|2017-10-11 00:06:11.01969
NCT02218190|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-05-08|||August 2014||2014-08-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Alvimopan and Ileus in PSF|A Randomized Trial of Alvimopan for the Reduction of Ileus After Long Posterior Spinal Fusion|Active, not recruiting||N/A|30|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:06:11.436002|2017-10-11 00:06:11.436002
NCT02218177|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-01-04|||August 2014||2014-08-01|January 2016|2016-01-01||||August 2016|Anticipated|2016-08-01||Observational|||Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD|Neovascular Age-related Macular Degeneration: Intraocular Inflammatory Cytokines in the Non-responder to Ranibizumab Treatment|Active, not recruiting||N/A|30|Actual|University Health Network, Toronto|||3||f||||f||||||Samples Without DNA|"     Aqueous Humour from Eye   "|||2017-10-11 00:06:11.559041|2017-10-11 00:06:11.559041
NCT02218164|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-09-19|||August 12, 2014|Actual|2014-08-12|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma|A Phase 2 Study of Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma|Active, not recruiting||Phase 2|8|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 00:06:11.656685|2017-10-11 00:06:11.656685
NCT02218151|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-10-18|||October 2014||2014-10-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|February 2020|Anticipated|2020-02-01||Interventional|||Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2|Patient-Centered Medical Home Care for Hematopoietic Stem Cell Transplantation: A Randomized Phase 2 Study|Recruiting||N/A|180|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 00:06:11.774687|2017-10-11 00:06:11.774687
NCT02218138|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-02-10|||January 2013||2013-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls|Depression and Insulin Resistance in Adolescents|Completed||N/A|35|Actual|Colorado State University||2|||f||||t||||||||No||2017-10-11 00:06:11.881227|2017-10-11 00:06:11.881227
NCT02218125|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-02-03|||September 2014||2014-09-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|MENSCH||A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults|A Phase I Study of Modified Vaccinia Ankara With Mosaic HIV Inserts in Healthy, HIV-Uninfected Adults, Some of Whom Have Previously Received an Adenovirus Type 26 ENVA.01 Vaccine|Completed||Phase 1|25|Actual|Crucell Holland BV||4|||f||||t||||||||||2017-10-11 00:06:11.988347|2017-10-11 00:06:11.988347
NCT02218112|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-10-05|||June 2014||2014-06-01|October 2017|2017-10-01|July 31, 2017|Actual|2017-07-31|July 2017|Actual|2017-07-01|1 Year|Observational [Patient Registry]|OBBYSS||Impact of Weight Loss After a Bypass Surgery on Renal Hemodynamic Under Stress Conditions|Effect of Weight Loss Induced by a Bypass Surgery on Renal Salt Excretion, Renal Hemodynamic and on Neurohormonal Responses During an Induced Orthostatic Stress in Obese Patients|Completed||N/A|36|Actual|Centre Hospitalier Universitaire Vaudois|||2||f||||f||||||||||2017-10-11 00:06:12.08637|2017-10-11 00:06:12.08637
NCT02218099|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-02-20|||September 2013||2013-09-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease|A Phase 1 Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 (Part 1) and a Multiple Dose, Placebo-controlled, Exploratory Safety, Pharmacokinetic and Pharmacodynamic Study in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease (Part 2)|Completed||Phase 1/Phase 2|55|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:06:14.154747|2017-10-11 00:06:14.154747
NCT02218086|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-11-03|||August 2014||2014-08-01|November 2015|2015-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectivity of Slackline-Training in Physiotherapy|Effectivity of Slackline-Training in Physiotherapy - a Randomised Controlled Study|Recruiting||N/A|80|Anticipated|Thim van der Laan University College Physiotherapy||2|||f||||f||||||||||2017-10-11 00:06:14.264395|2017-10-11 00:06:14.264395
NCT02218073|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2015-01-07|||October 2014||2014-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetic Study of JNJ-42756493 in Healthy Participants|A Single-Dose, Open-Label, Randomized, Two-Way Crossover Pharmacokinetic Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Following Intake of a Tablet Versus a Solution and to Assess the Absolute Bioavailability of Orally Administered JNJ-42756493 Following Concomitant Administration of an Intravenous Microdose of the Stable Isotope JNJ-61818549 in Healthy Subjects|Completed||Phase 1|8|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:06:14.392848|2017-10-11 00:06:14.392848
NCT02218060|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-03-21|||January 2014||2014-01-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Coronary CT Angiography Using a Novel 3rd Generation Dual-Source CT System|Coronary CT Angiography Using a Novel 3rd Generation Dual-Source CT System: Diagnostic Performance and Potential for Reduction in Radiation Dose and Contrast Material Requirement|Suspended||N/A|50|Anticipated|Medical University of South Carolina||2||Data Analysis|f||||f||||||||||2017-10-11 00:06:14.482231|2017-10-11 00:06:14.482231
NCT02218047|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-11-22|||November 2014||2014-11-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|CONTI-PV||AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.|An Open-label, Multicenter, Phase IIIb Study Assessing the Long-term Efficacy and Safety of AOP2014 and Standard First Line Treatment (BAT) in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study|Active, not recruiting||Phase 3|170|Actual|AOP Orphan Pharmaceuticals AG||2|||f||||f||||||||||2017-10-11 00:06:14.576768|2017-10-11 00:06:14.576768
NCT02218021|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-12-01|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users|A Randomized, Double-Blind, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Abuse Potential and Safety of Orally Administered Samidorphan in Non-Dependent Recreational Opioid Users|Completed||Phase 1|59|Actual|Alkermes, Inc.||6|||f||||f||||||||||2017-10-11 00:06:16.316646|2017-10-11 00:06:16.316646
NCT02218008|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-10-31|||July 2014||2014-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|||A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study|A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder (the FORWARD-5 Study)|Completed||Phase 3|407|Actual|Alkermes, Inc.||3|||f||||f||||||||||2017-10-11 00:06:16.421428|2017-10-11 00:06:16.421428
NCT02217995|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-10-14|||September 2014||2014-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients|A Pilot Randomized Trial Testing Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients|Active, not recruiting||N/A|32|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-11 00:06:16.582017|2017-10-11 00:06:16.582017
NCT02217982|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-02-20|2016-11-08||July 2014||2014-07-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|IIT9|5 patients total qualified for the trial after monitoring of GI symptoms after initiation of DMF|Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation|A Pilot Study to Assess Dimethyl Fumarate (Tecfidera) Related GI Symptom Mitigation Via Food Bolus Alteration and Simethicone/Loperamide Administration|Terminated||Phase 4|5|Actual|Rocky Mountain MS Research Group, LLC|This trial was closed down early because the anticipated number of patients experiencing GI symptoms was not met - therefore not enough patients qualified for the treatment and control arms for analysis.|2||Study did not meet required enrollment numbers|f||||f||||||||||2017-10-11 00:06:16.667345|2017-10-11 00:06:16.667345
NCT02217969|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-12-07|||January 2017||2017-01-01|December 2016|2016-12-01|March 2022|Anticipated|2022-03-01|January 2021|Anticipated|2021-01-01||Interventional|SLUScore™||Prospective Trial of Alerting to Extended Hypotensive Exposures on Long-Term Outcome After Surgery|Prospective, Randomized Trial of Alerting to Extended Hypotensive Exposures on Long-Term Outcome Following Adult Non-Cardiac Surgical Procedures: The SLUScore™ Trial|Not yet recruiting||N/A|56248|Anticipated|St. Louis University||2|||f||||t||||||||||2017-10-11 00:06:16.927344|2017-10-11 00:06:16.927344
NCT02217956|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-01-25|||June 2011||2011-06-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CHIPASTIN||Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma|Phase I Study of Cisplatin Hyperthermic Intraperitoneal Chemotherapy Dose Escalation After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma Previously Treated by Chemotherapy and Completed by Bevacizumab for 15 Months|Completed||Phase 1|30|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 00:06:17.020039|2017-10-11 00:06:17.020039
NCT02217943|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-03-14|||July 1, 2014|Actual|2014-07-01|March 2017|2017-03-01|July 1, 2021|Anticipated|2021-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Prospective Metabolic Surgery in T2DM Chinese Subjects|A Prospective, Multi-Center Study for the Evaluation of Metabolic Surgery in Subjects With Type 2 Diabetes in China|Active, not recruiting||N/A|101|Actual|Ethicon Endo-Surgery||2|||f||||f||||||||||2017-10-11 00:06:17.19692|2017-10-11 00:06:17.19692
NCT02217930|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-10-28|||August 2014||2014-08-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers|A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive- Controlled, Crossover Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers|Completed||Phase 1|80|Actual|Wockhardt||3|||f||||f||||||||||2017-10-11 00:06:17.307486|2017-10-11 00:06:17.307486
NCT02217917|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-05-06|||October 2015||2015-10-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Rivipansel With rHuPH20 in Healthy Subjects|A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Controlled, Single And Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Rivipansel (pf 06460031) Following Subcutaneous Administration With Rhuph20 (pf 06744547) In Healthy Subjects|Completed||Phase 1|27|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:06:17.410979|2017-10-11 00:06:17.410979
NCT02217904|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-07-07|||September 17, 2015|Actual|2015-09-17|July 2017|2017-07-01|May 11, 2017|Actual|2017-05-11|May 11, 2017|Actual|2017-05-11||Interventional|||A Study of MK-8591 in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)|A Single-Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8591 Monotherapy in Anti-Retroviral Therapy (ART)-Naive, HIV-1 Infected Patients|Completed||Phase 1|30|Actual|Merck Sharp & Dohme Corp.||7|||f||||f||||||||||2017-10-11 00:06:17.516376|2017-10-11 00:06:17.516376
NCT02217891|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-04-19|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|IFACT||IFACT: Incidental Findings in Advanced Cancer Therapy|IFACT: Incidental Findings in Advanced Cancer Therapy|Active, not recruiting||N/A|60|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 00:06:17.602763|2017-10-11 00:06:17.602763
NCT02217878|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2017-08-12|2016-02-04||August 2014||2014-08-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|IMPRESSION||Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction|A Randomized, Double-blind Study Evaluating the Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor and Its Active Metabolite (AR-C124910XX) in Patients With ST-segment Elevation Myocardial Infarction and Non-ST-segment Elevation Myocardial Infarction.|Completed||Phase 4|74|Actual|Collegium Medicum w Bydgoszczy||2|||f||||f||||||||||2017-10-11 00:06:17.721194|2017-10-11 00:06:17.721194
NCT02217865|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-05-30|||July 2014|Actual|2014-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer|Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer|Recruiting||N/A|220|Anticipated|M.D. Anderson Cancer Center|||2||f||||f|f|||||||||2017-10-11 00:06:18.793169|2017-10-11 00:06:18.793169
NCT02217852|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-28|||August 2014||2014-08-01|August 2014|2014-08-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Treatment of Hypertension in Tibetan Adult Population|A Randomized, Open-label, Positive Drug Controlled Clinical Trials to Compare the Efficacy of Nitrendipine and Hydrochlorothiazide , Captopril Plus Hydrochlorothiazide and Beijing Hypotensive No.0 in Tibetan Hypertension|Unknown status|Not yet recruiting|Phase 4|800|Anticipated|West China Hospital||4|||f||||t||||||||||2017-10-11 00:06:18.910478|2017-10-11 00:06:18.910478
NCT02217839|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-14|||April 2012||2012-04-01|August 2014|2014-08-01||||January 2013|Actual|2013-01-01||Interventional|||Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173||Completed||Phase 1|42|Actual|Aspireo Pharmaceuticals Limited||2|||f||||f||||||||||2017-10-11 00:06:19.166802|2017-10-11 00:06:19.166802
NCT02217826|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-18||||||August 2014|2014-08-01||||April 2014|Actual|2014-04-01||Interventional|||Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173||Completed||Phase 1|8|Actual|Aspireo Pharmaceuticals Limited||3|||f||||||||||||||2017-10-11 00:06:19.291173|2017-10-11 00:06:19.291173
NCT02217813|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-01-06|||October 2014||2014-10-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Bioequivalence Study Comparing Two Different Tafamidis Formulations|A Phase 1, Open-label, Randomized, Crossover, Single Dose Study To Determine The Bioequivalence Of Pf-06291826 (Tafamidis) 20 Mg Capsule Manufactured By Catalent Versus Capsule Manufactured By Pii In Healthy Subjects Under Fasted Conditions|Completed||Phase 1|26|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:06:19.406286|2017-10-11 00:06:19.406286
NCT02217787|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-10-24|||September 2014||2014-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Food Effect Study for PF-06372865|A Phase 1, Cross-over, Randomized, Single-dose Open Label Study To Determine The Effect Of Food On The Pharmacokinetics Of Orally Administered Pf-06372865 In Healthy Adult Subjects|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:06:19.67287|2017-10-11 00:06:19.67287
NCT02217774|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-09-27|||November 2014||2014-11-01|September 2017|2017-09-01|August 23, 2015|Actual|2015-08-23|August 23, 2015|Actual|2015-08-23||Interventional|||MGUIDE MORE Dental Implant Planning System- Clinical Accuracy Study|MGUIDE MORE Dental Implant Planning System- Clinical Accuracy Study|Completed||N/A|10|Actual|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-11 00:06:19.831602|2017-10-11 00:06:19.831602
NCT02217761|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-13|||March 2012||2012-03-01|August 2014|2014-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Pharmacokinetic Study in Patients Receiving Posaconazole Therapy in Taiwan|Pharmacokinetic Study in Patients Receiving Posaconazole Therapy in Taiwan|Unknown status|Enrolling by invitation|N/A|400|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood, serum. white cells, saliva   "|||2017-10-11 00:06:19.997786|2017-10-11 00:06:19.997786
NCT02217748|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2015-11-29|||July 2014||2014-07-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Name Generator Order Effects in Social Networks|Understanding Name Generator Order Effects When Eliciting Social Networks in Rural Uganda: A Randomized Controlled Trial|Completed||N/A|1557|Anticipated|Massachusetts General Hospital||6|||f||||f||||||||||2017-10-11 00:06:20.095103|2017-10-11 00:06:20.095103
NCT02217735|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-17|||August 2011||2011-08-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PDEWS||Expressive Writing for Individuals With Parkinson's Disease and Their Caregivers|Randomized Controlled Expressive Writing Pilot in Individuals With Parkinson's Disease and Their Caregivers|Completed||N/A|40|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 00:06:20.198381|2017-10-11 00:06:20.198381
NCT02217722|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2016-08-10|||October 2014||2014-10-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Use of the Ulcerative Colitis Diet for Induction of Remission|An Open Label Non Randomized Pilot Study: Use of the Ulcerative Colitis Diet for Induction of Remission.|Terminated||N/A|9|Actual|Wolfson Medical Center||2||We have submitted a multi center study, with the same nutritional therapy|f||||t||||||||||2017-10-11 00:06:20.295039|2017-10-11 00:06:20.295039
NCT02217709|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-04-18|||September 8, 2014|Actual|2014-09-08|April 2017|2017-04-01|September 8, 2019|Anticipated|2019-09-08|September 8, 2018|Anticipated|2018-09-08||Interventional|||Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer|Phase 2 Trial of Phenelzine in Non-metastatic Recurrent Prostate Cancer|Recruiting||Phase 2|46|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-11 00:06:20.385737|2017-10-11 00:06:20.385737
NCT02217696|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-13|||July 2013||2013-07-01|August 2014|2014-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|LEXI||Prediction and Intervention in Developmental Dyslexia|Neuronal Markers of Grapheme-phoneme Training Response for Prediction of Successful Reading Acquisition in Children at Familial Risk for Developmental Dyslexia|Recruiting||N/A|110|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 00:06:20.514213|2017-10-11 00:06:20.514213
NCT02217683|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-03-16|||March 2016||2016-03-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion|Pulmonary Hemodynamic Effects of Stored Red Blood Cell Transfusion in Post-Operative Cardiac Surgical Patients: Influence of Breathing Nitric Oxide. A Randomized Controlled Trial in the Cardiac-Intensive Care Unit.|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||3||This trial never started due to lack of funding.|f||||t||||||||||2017-10-11 00:06:20.638486|2017-10-11 00:06:20.638486
NCT02217670|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-01-19||||||January 2016|2016-01-01||||January 2016|Anticipated|2016-01-01||Interventional|||Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated Tablet||Withdrawn||Phase 1|0|Actual|Disphar International B.V.||2||Commercial reasons|f||||||||||||||2017-10-11 00:06:20.744591|2017-10-11 00:06:20.744591
NCT02217657|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2016-05-30|||August 2013||2013-08-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||SmartTouch Catheter for Left Anterior Line - SmarT Line Study|"Bidirectional Conduction Block of Left Atrial Anterior Line in Patients With Left Atrial Ablation - Reduction of RF Applications Using the Thermocool SmartTouch Contact Force Sensing Catheter"|Recruiting||Phase 4|75|Anticipated|Klinikum der Universitaet Muenchen||2|||f||||f||||||||No||2017-10-11 00:06:20.847198|2017-10-11 00:06:20.847198
NCT02217644|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-14|||November 2008||2008-11-01|August 2014|2014-08-01||||June 2009|Actual|2009-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers (Dose Range: 0.1 mg - 1500 mg). A Singleblind (Within Dose Groups), Randomised, Placebo-controlled Within Dose Groups, Single Rising Dose Phase I Study|Completed||Phase 1|80|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:06:20.962328|2017-10-11 00:06:20.962328
NCT02217631|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-14|2014-08-14|||October 2009||2009-10-01|August 2014|2014-08-01||||March 2010|Actual|2010-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 653048 BS H3PO4 Capsule Multiple Rising Doses in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (Biomarkers) of BI 653048 BS H3PO4 Capsule Formulation Administered as Multiple Doses of 25 mg to 200 mg qd for 10 Days. A Randomised, Double-blind Within Dose Groups, Placebo-controlled, Multiple Rising Dose Trial With Open-label Active Comparator|Completed||Phase 1|140|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:06:21.070663|2017-10-11 00:06:21.070663
NCT02217618|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-09-26|||August 2014||2014-08-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of LY2409021 in Healthy Participants|A Single Dose Pharmacokinetic Study of LY2409021 Tablet Administered in Healthy Subjects|Completed||Phase 1|16|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 00:06:21.175372|2017-10-11 00:06:21.175372
NCT02217605|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-14|||March 2011||2011-03-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|31PMRS_FRU||31P Magnetic Resonance Spectroscopy Fructose Study|Investigating the Effects of an Oral Fructose Challenge on Hepatic ATP Reserves in Healthy Volunteers|Completed||N/A|10|Actual|University of Nottingham||1|||f||||t||||||||||2017-10-11 00:06:21.246927|2017-10-11 00:06:21.246927
NCT02217592|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-03-10|||March 2013||2013-03-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand|Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast (NE) Thailand|Unknown status|Recruiting|N/A|5020|Anticipated|University of Oxford|||1||f||||f||||||Samples With DNA|"     Blood. Urine, pus, sputum, throat swab, and stool (if available)   "|||2017-10-11 00:06:21.343233|2017-10-11 00:06:21.343233
NCT02217579|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-06-08|||August 2013||2013-08-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Protein and Prebiotic Fiber Intake on Adiposity in Overweight and Obese Adults|Effect of Protein and Prebiotic Fiber Intake on Adiposity in Overweight and Obese Adults|Active, not recruiting||N/A|132|Anticipated|University of Calgary||4|||f||||f||||||||No||2017-10-11 00:06:21.450056|2017-10-11 00:06:21.450056
NCT02217566|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-05-26|||September 23, 2014|Actual|2014-09-23|May 2017|2017-05-01|April 26, 2018|Anticipated|2018-04-26|October 24, 2017|Anticipated|2017-10-24||Interventional|||Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy|Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer, Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy|Active, not recruiting||Phase 2|46|Actual|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-11 00:06:21.540533|2017-10-11 00:06:21.540533
NCT02217553|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-15|||December 2013||2013-12-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||The Effect of Vitamin D Supplementation on HIV-associated Platelet Hyperreactivity|The Effect of Vitamin D Supplementation on HIV-associated Platelet Hyperreactivity|Completed||N/A|50|Actual|Universitas Padjadjaran||1|||f||||t||||||||||2017-10-11 00:06:21.642905|2017-10-11 00:06:21.642905
NCT02217540|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-18|||January 2012||2012-01-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Mulligan Concept Mobilisation With Movement for Shoulder Dysfunction in Older Adults|Mulligan Concept Mobilisation With Movement for Shoulder Dysfunction in Older Adults- A Pilot Randomised Clinical Trial|Completed||N/A|44|Actual|University of Alcala||2|||f||||f||||||||||2017-10-11 00:06:21.727938|2017-10-11 00:06:21.727938
NCT02217527|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-08-30|||November 2014||2014-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|UH3-P2||Test of Novel Drug for Smoking Cessation|Development of a Novel Therapeutic for Smoking Cessation|Active, not recruiting||Phase 2|32|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:06:21.821837|2017-10-11 00:06:21.821837
NCT02217514|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-14|||February 2008||2008-02-01|August 2014|2014-08-01||||March 2008|Actual|2008-03-01||Interventional|||Effects of BI 44370 TA Orally Applied as Tablets on the Pharmacokinetics of Orally Administered Midazolam Solution in Healthy Volunteers|Effects of 100 mg and 500 mg BI 44370 TA Orally Applied as 50 mg Tablets on the Pharmacokinetics of 2 mg Orally Administered Midazolam Solution. An Open-label, Randomised, Parallel Group, Fixed-sequence Study With Intraindividual Comparison of Midazolam Pharmacokinetics With and Without BI 44370 TA|Completed||Phase 1|48|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:06:21.905449|2017-10-11 00:06:21.905449
NCT02217501|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-10-03|||November 2015||2015-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ASPIRE||Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities|Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities|Recruiting||Phase 3|404|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||Yes|Study results will be posted on clinical.trials.gov and through publications and presentations|2017-10-11 00:06:22.011453|2017-10-11 00:06:22.011453
NCT02217488|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-13|||May 2008||2008-05-01|August 2014|2014-08-01||||September 2008|Actual|2008-09-01||Interventional|||Single Ascending Dose Tolerability Study of DG3173||Completed||Phase 1|72|Actual|Aspireo Pharmaceuticals Limited||2|||f||||||||||||||2017-10-11 00:06:22.307|2017-10-11 00:06:22.307
NCT02217475|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-06-30||2017-06-30|September 2014|Actual|2014-09-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|June 2016|Actual|2016-06-01||Interventional|CENTAUR||Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis|CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis|Active, not recruiting||Phase 2|289|Actual|Tobira Therapeutics, Inc.||3|||f||||t||||||||||2017-10-11 00:06:22.395393|2017-10-11 00:06:22.395393
NCT02217462|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-08-04|||October 2014||2014-10-01|October 2015|2015-10-01||||July 2018|Anticipated|2018-07-01||Observational|PEAS||Pregnancy Eating Attributes Study|Diet, Obesity, and Weight Change in Pregnancy|Recruiting||N/A|450|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||Samples With DNA|"     Serum Plasma White and red blood cells Urine Stool   "|||2017-10-11 00:06:22.672559|2017-10-11 00:06:22.672559
NCT02217449|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-13|||January 2011||2011-01-01|August 2014|2014-08-01||||August 2014|Anticipated|2014-08-01||Observational|||Virtual Chromoendoscopy for Distal Polyps||Unknown status|Recruiting|N/A|230|Anticipated|University of Erlangen-Nürnberg Medical School|||2||f||||||||||||||2017-10-11 00:06:22.767172|2017-10-11 00:06:22.767172
NCT02217436|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-07-07|||April 2014||2014-04-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||iPad as a Distraction Tool During Facial Laceration Repair|iPad as a Distraction Tool During Facial Laceration Repair|Completed||N/A|77|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-11 00:06:22.867406|2017-10-11 00:06:22.867406
NCT02217423|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-12-06|||September 2014||2014-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|RACCRPPT||Abdominal Circumference and Cardiorespiratory Repercussions in Patients Submitted to Physical Therapy|The Relationship Between Abdominal Circumference and Cardiorespiratory Repercussions in Hospitalized Patients Submitted to Physical Therapy|Completed||N/A|46|Actual|Universidade Federal de Sao Carlos||4|||f||||f||||||||||2017-10-11 00:06:22.955396|2017-10-11 00:06:22.955396
NCT02217410|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-08-01|||February 11, 2015|Actual|2015-02-11|August 2017|2017-08-01|October 26, 2019|Anticipated|2019-10-26|October 26, 2019|Anticipated|2019-10-26||Interventional|||CCFZ533X2201 - PoC Study in de Novo Renal Transplantation|A 12-month Randomized, Multiple Dose, Open-label, Study Evaluating Safety, Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) and Efficacy of an Anti-CD40 Monoclonal Antibody, CFZ533, in Combination With Mycophenolate Mofetil (MMF) and Corticosteroids (CS), With and Without Tacrolimus (Tac), in de Novo Renal Transplant Recipients|Recruiting||Phase 1/Phase 2|51|Anticipated|Novartis||3|||f||||t||||||||||2017-10-11 00:06:23.067353|2017-10-11 00:06:23.067353
NCT02217397|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-03-16|||August 2014||2014-08-01|August 2014|2014-08-01||||July 2015|Anticipated|2015-07-01||Interventional|||Combinations of Oral Appliance and CPAP for Patients With Severe Obstructive Sleep Apnea Untolerate High-pressure CPAP|Combinations of Oral Appliance and CPAP for Patients With Severe Obstructive Sleep Apnea Untolerate High-pressure CPAP|Unknown status|Not yet recruiting|N/A|60|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:06:23.194336|2017-10-11 00:06:23.194336
NCT02217384|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-04-08|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|September 2016|Actual|2016-09-01||Observational|||Whole Gut Microbiome Sequencing in Patients With Anorexia Nervosa|Whole Gut Microbiome Sequencing in Patients With Anorexia Nervosa|Active, not recruiting||N/A|151|Actual|Odense University Hospital|||1||f||||t||||||Samples With DNA|"     Gut microbiome Serum and plasma Cells (buffy coat) Urine   "|Undecided||2017-10-11 00:06:23.269354|2017-10-11 00:06:23.269354
NCT02217371|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-08-08|||September 2, 2014|Actual|2014-09-02|August 2017|2017-08-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|VEILLETDAH||Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity|Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity|Completed||N/A|19|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 00:06:23.34399|2017-10-11 00:06:23.34399
NCT02217215|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-13|||August 2014||2014-08-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|Spectral||Initial Study With the CNDS Advanced Cervical Scan to Recalibrate Spectral Data for Use in Future Screening Studies|Initial Study With the CNDS Advanced Cervical Scan to Recalibrate Spectral Data for Use in Future Screening Studies|Unknown status|Not yet recruiting|Phase 1|800|Anticipated|Guided Therapeutics|||1||f||||f||||||Samples With DNA|"     cells from the cervix to collect and test for HPV   "|||2017-10-11 00:06:23.423273|2017-10-11 00:06:23.423273
NCT02217202|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-13|||April 2014||2014-04-01|August 2014|2014-08-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Observational|||Study of AQUACEL™ Ag Surgical Cover Dressing Following Total Knee Replacement|Prospective Cohort Study of the AQUACEL™ Ag SURGICAL Cover Dressing in Total Knee Replacement Surgery|Withdrawn||N/A|0|Actual|Golden Jubilee National Hospital|||1|Funding withdrawn before ethical approval granted|f||||f||||||||||2017-10-11 00:06:23.535037|2017-10-11 00:06:23.535037
NCT02217189|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-02-01|||July 2011||2011-07-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Study of the Effect of Oral Zinc Supplementation on Superoxide Radical Scavengers|Study of the Effect of Oral Zinc Supplementation on Superoxide Radical Scavengers in Spermatozoa of Patients With Asthenospermia|Completed||Phase 2|120|Actual|Babylon University||2|||f||||f||||||||||2017-10-11 00:06:23.614872|2017-10-11 00:06:23.614872
NCT02217176|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2014-08-14|||May 2011||2011-05-01|August 2014|2014-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Ultrasonography of the Neck: The Influence of Airway Devices on Vascular Topography in Pediatric Patients||Completed||N/A|92|Actual|Ankara University|||2||f||||f||||||||||2017-10-11 00:06:23.726394|2017-10-11 00:06:23.726394
NCT02217163|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-10-08|||October 2014||2014-10-01|October 2014|2014-10-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Single Arm Study of Carfilzomib in Transplant Eligible High Risk Multiple Myeloma|A PHASE 2 SINGLE ARM STUDY OF CARFILZOMIB IN TRANSPLANT ELIGIBLE HIGH RISK MULTIPLE MYELOMA|Recruiting||Phase 2|30|Anticipated|Singapore General Hospital||1|||f||||f||||||||||2017-10-11 00:06:23.809149|2017-10-11 00:06:23.809149
NCT02217150|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-01-18|||June 2013||2013-06-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01|3 Months|Observational [Patient Registry]|PCS||The STAR Prospective Clinical Series|The DFINE STAR™ Tumor Ablation Prospective Clinical Series|Completed||N/A|50|Actual|Merit Medical Systems, Inc.|||1||f||||f||||||||||2017-10-11 00:06:23.913142|2017-10-11 00:06:23.913142
NCT02217137|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-11-16|||June 2014||2014-06-01|June 2014|2014-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients|Analysing Tear Protein, Conjunctival Cells, and Imaging Eyes in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus|Completed||N/A|80|Actual|Singapore National Eye Centre|||1||f||||f||||||Samples Without DNA|"     Tear samples will be collected from the schimers strips for protein analysis   "|||2017-10-11 00:06:24.007007|2017-10-11 00:06:24.007007
NCT02217124|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-08-09|||July 2014||2014-07-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Impact of High Fiber Snacks on Adiposity, Glucose Regulation and Appetite|Impact of High Fiber Snacks on Adiposity, Glucose Regulation and Appetite in Children|Completed||N/A|45|Actual|San Diego State University||2|||f||||t||||||||||2017-10-11 00:06:24.081998|2017-10-11 00:06:24.081998
NCT02217111|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-01-21|||January 2015||2015-01-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Prospective Study of Voice Therapy in Children: A Pilot Study||Completed||N/A|12|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 00:06:24.184053|2017-10-11 00:06:24.184053
NCT02217098|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-07-13|||July 2014||2014-07-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|February 2015|Actual|2015-02-01||Interventional|ARTUSP||The Survival Rate of Glass Ionomer Cement, Glass Carbomer Cement and Compomer in Occlusal and Proximal ART Restorations|The Survival Rate of Glass Ionomer Cement, Glass Carbomer Cement and Compomer in Occlusal and Proximal ART Restorations|Active, not recruiting||N/A|530|Actual|University of Sao Paulo||3|||f||||f||||||||No||2017-10-11 00:06:24.288194|2017-10-11 00:06:24.288194
NCT02217085|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-10-04|||May 2014||2014-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Colorectal Polyp Resection Adequacy|Determining True Colorectal Polyp Resection Adequacy: Correlation of Endoscopic Margins With Histopathologic Margins|Recruiting||N/A|500|Anticipated|Rush University Medical Center|||1||f||||f||||||Samples With DNA|"     Polyp margins will be biopsied and retained.   "|||2017-10-11 00:06:24.43015|2017-10-11 00:06:24.43015
NCT02217072|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-08-13|||September 2013||2013-09-01|August 2014|2014-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Educational Support Interventions for Children in Care|A Randomized Controlled Trial of Educational Support Interventions for Children in Care|Recruiting||N/A|190|Anticipated|The Danish National Centre For Social Research||3|||f||||t||||||||||2017-10-11 00:06:24.496497|2017-10-11 00:06:24.496497
NCT02217059|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-06-14|||August 2014||2014-08-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Emergency Department Home Blood Pressure Monitoring and BpTRU Study|Congruence of Emergency Department Attendings' Predictions of Hypertension With Results of Home Blood Pressure Monitoring|Recruiting||N/A|150|Anticipated|Rhode Island Hospital|||3||f||||f||||||||No||2017-10-11 00:06:24.592231|2017-10-11 00:06:24.592231
NCT02217046|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-04-24|||December 2013||2013-12-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Decrease Implantation Site INFECTION : a Randomized Controlled Trial|Phase 1 Study of Prevention of Cardiac Device Replacement Site Infection|Recruiting||N/A|352|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-11 00:06:24.679708|2017-10-11 00:06:24.679708
NCT02217033|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-04-17|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo|A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy|Terminated||N/A|16|Actual|South Sound Care Foundation||2||"After an interim analysis the Company providing the product decided not to continue with the   study"|f||||f||||||||||2017-10-11 00:06:24.781671|2017-10-11 00:06:24.781671
NCT02217020|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2016-09-28|||August 2014||2014-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|September 2016|Actual|2016-09-01||Interventional|FORTUNE||Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer|A Phase II Study of Neoadjuvant FOLFOXIRI Chemotherapy Alone in Treating Patients With Locally Advanced Rectal Cancer|Active, not recruiting||Phase 2|84|Actual|Sun Yat-sen University||1|||f||||f||||||||||2017-10-11 00:06:24.887108|2017-10-11 00:06:24.887108
NCT02217007|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-04-14|||April 2015||2015-04-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome|A Phase 2a, Open-Label Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Orally Administered SNC-102 in Subjects With Tourette Syndrome|Completed||Phase 2|16|Actual|Synchroneuron Inc.||1|||f||||f||||||||||2017-10-11 00:06:24.96338|2017-10-11 00:06:24.96338
NCT02216994|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-10-27|||January 2013||2013-01-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||A New Scoring System Improves Diagnostic Accuracy of Intestinal Dysganglionosis --a Prospective Study|Efficacy and Accuracy of a New Diagnostic Scoring System to Differentiate Hirschsprung Disease From Hirschsprung Disease Allied Disorders in the Patients With Suspected Intestinal Dysganglinosis: a Prospective Study|Unknown status|Recruiting|N/A|80|Anticipated|Tongji Hospital||1|||f||||t||||||||||2017-10-11 00:06:25.063805|2017-10-11 00:06:25.063805
NCT02216981|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-10-25|||August 2014||2014-08-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Examining the Feasibility and Acceptability of Good Quality Intensive CBT for OCD and Good Quality Weekly CBT for OCD|A Pilot Randomised Controlled Trial to Assess the Feasibility of Cognitive Behavioural Therapy (CBT) Delivered in Time-Intensive and Weekly Treatment Formats for Treatment Resistant Obsessive Compulsive Disorder (OCD).|Active, not recruiting||N/A|40|Anticipated|University of Bath||3|||f||||f||||||||||2017-10-11 00:06:25.16039|2017-10-11 00:06:25.16039
NCT02216968|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-07-11|||July 2012|Actual|2012-07-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Increasing Vegetable Intake in Children|Increasing Vegetable Intake in Children|Completed||N/A|600|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 00:06:25.255023|2017-10-11 00:06:25.255023
NCT02216955|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-10-30|||January 2009||2009-01-01|October 2014|2014-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Nutrition and Lifestyle Study Cohort of Gastric Cancer in China|Impact of Nutrition, Dietary Pattern, Obesity, Physical Activity, Depression, Diabetes, Aspirin Use and Vitamin Supplement in Colorectal Cancer in China|Unknown status|Recruiting|N/A|50000|Anticipated|State Key Laboratory of Cancer Biology|||1||f||||t||||||||||2017-10-11 00:06:25.327131|2017-10-11 00:06:25.327131
NCT02216942|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-05-18|||January 2015||2015-01-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2015|Actual|2015-07-01||Interventional|||Endodontic Treatment of Necrotic Primary Teeth With Guedes Pinto Paste: A Randomized Clinical Trial|Endodontic Treatment of Primary Teeth With Guedes Pinto Paste: A Randomized Clinical Trial|Active, not recruiting||Phase 3|98|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:06:25.540871|2017-10-11 00:06:25.540871
NCT02216929|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-13|||January 2011||2011-01-01|January 2011|2011-01-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Observational|ICU||Assessment of the Patients of Emergency Consultation|The Demographics, Mortality and Clinical Diagnosis of the Patients Who Were Evaluated, Intubated and Interned to ICU by the Anesthesiology in 2010-2011|Completed||N/A|287|Actual|Umraniye Education and Research Hospital|||1||f||||t||||||||||2017-10-11 00:06:25.663225|2017-10-11 00:06:25.663225
NCT02216916|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2015-01-07|||August 2014||2014-08-01|January 2015|2015-01-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing Therapy||Unknown status|Recruiting|Phase 2|49|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 00:06:25.749454|2017-10-11 00:06:25.749454
NCT02216903|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-13|||August 2014||2014-08-01|August 2014|2014-08-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||Respiratory Motion Related Ablation Gap and Clinical Outcome After Catheter Ablation for Atrial Fibrillation||Not yet recruiting||N/A|500|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:06:25.849238|2017-10-11 00:06:25.849238
NCT02216890|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-03-29|||August 2014|Actual|2014-08-01|March 2017|2017-03-01|February 10, 2017|Actual|2017-02-10|February 10, 2017|Actual|2017-02-10||Interventional|||Safety Study of SGN-CD70A in Cancer Patients|A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies|Completed||Phase 1|38|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-10-11 00:06:25.940026|2017-10-11 00:06:25.940026
NCT02216877|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-04-27|||August 2014||2014-08-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease|Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease - A Dose-Finding Trial|Completed||Phase 1/Phase 2|36|Actual|Zealand University Hospital||3|||f||||f||||||||||2017-10-11 00:06:26.071519|2017-10-11 00:06:26.071519
NCT02216864|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-02-07|||August 2014||2014-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Multiple Subcisions on Rolling Acne Scars|Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Multiple Subcisions on Rolling Acne Scars|Active, not recruiting||N/A|5|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 00:06:26.182264|2017-10-11 00:06:26.182264
NCT02216851|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-10-13|||September 2014||2014-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root|A Randomized, Open Label, No-treatment Controlled, Multi-center, Efficacy and Safety Study Using Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root|Completed||N/A|132|Actual|Q-Med AB||2|||f||||t||||||||||2017-10-11 00:06:26.27316|2017-10-11 00:06:26.27316
NCT02216838|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-02-07|||August 2014||2014-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Facial Flushing With Botulinum Toxin A Injections|Treatment of Facial Flushing With Botulinum Toxin A Injections: A Split-Face, Double-blinded, Randomized Control Trial|Active, not recruiting||N/A|16|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 00:06:26.354277|2017-10-11 00:06:26.354277
NCT02216825|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||November 2013||2013-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile||Completed||Phase 2|10|Actual|Micropharma Limited||2|||f||||f||||||||||2017-10-11 00:06:26.439826|2017-10-11 00:06:26.439826
NCT02216812|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-01-04|||August 2014||2014-08-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Does Vitamin C Reduce Finger Stiffness After Distal Radius Fractures?|Does Vitamin C Reduce Finger Stiffness After Distal Radius Fractures? A Placebo Randomized Controlled Trial|Enrolling by invitation||N/A|126|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:06:26.511014|2017-10-11 00:06:26.511014
NCT02216799|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-02-24|||March 2013||2013-03-01|April 2015|2015-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|GLUCOSE-in-PN||Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)|Glargine Insulin Versus Continous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)|Completed||Phase 4|61|Actual|King Faisal Specialist Hospital & Research Center||2|||f||||f||||||||||2017-10-11 00:06:26.625118|2017-10-11 00:06:26.625118
NCT02216786|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-08-25|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|MANTA||A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer|A Randomized Phase II Study of Fulvestrant in Combination With the Dual mTOR Inhibitor AZD2014 or Everolimus or Fulvestrant Alone in Estrogen Receptor-positive Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 2|333|Actual|Queen Mary University of London||4|||f||||t||||||||||2017-10-11 00:06:26.734335|2017-10-11 00:06:26.734335
NCT02216773|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-08-26|||July 2014||2014-07-01|August 2015|2015-08-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|REBIRTH||Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)|Liver Regeneration: a Single-centre, Prospective, Randomised Controlled Trial Comparing Radiofrequency Assisted Liver Partition With Portal Vein Ligation (RALPP) With Portal Vein Embolization (PVE) for Preoperative Induction of Liver Hypertrophy in Patients With Insufficient Future Liver Remnant Volume for Major Liver Resection.|Unknown status|Recruiting|N/A|26|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 00:06:26.978948|2017-10-11 00:06:26.978948
NCT02216760|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-09-07|||August 2014||2014-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Ripple-VT||Using Ripple Mapping to Guide Substrate Ablation of Scar Related Ventricular Tachycardia.|Determining the Pathophysiological Role of Slow Conduction Channels Identified by Ripple Mapping of the Ventricular Scar.|Recruiting||N/A|110|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 00:06:27.090402|2017-10-11 00:06:27.090402
NCT02216747|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-13|||September 2014||2014-09-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|NS||Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse|Treatment of Nephrotic Syndrome Relapse With Low Steroid Dose|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Rabin Medical Center||3|||f||||t||||||||||2017-10-11 00:06:27.192829|2017-10-11 00:06:27.192829
NCT01850472|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-07-08|||March 2013||2013-03-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|MIDAS||Brain Mechanisms of Emotion and Motivation: A Mind-Body Study|Brain Mechanisms of Emotion and Motivation: A Mind-Body Study|Completed||N/A|88|Actual|Mclean Hospital|||1||f||||f||||||||||2017-10-11 01:43:36.519931|2017-10-11 01:43:36.519931
NCT02216734|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-13|||July 2014||2014-07-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|EPAZ||Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe|Effects of Mother Support Groups on Prevention of Mother-To-Child Transmission (PMTCT) Outcomes in Mutare & Makoni Districts, Zimbabwe: A Cluster Randomized Controlled Trial|Unknown status|Recruiting|N/A|300|Anticipated|Family AIDS Caring Trust||2|||f||||f||||||||||2017-10-11 00:06:27.291933|2017-10-11 00:06:27.291933
NCT02216721|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-11-30|||August 2014||2014-08-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism|The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism|Completed||N/A|35|Actual|University Malaysia Sarawak|||2||f||||t||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 00:06:27.404503|2017-10-11 00:06:27.404503
NCT02216708|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2014-08-20|||May 2011||2011-05-01|March 2011|2011-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Slow Versus Rapid Rehydration of Severely Malnourished Children|Comparison of Rapid and Slow Rehydration of Severely Malnourished Children Suffering From Dehydrating Diarrhoea and Impact on Renal Function and Subsequent Growth of Children|Completed||Phase 2|208|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-11 00:06:27.476069|2017-10-11 00:06:27.476069
NCT02216695|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-12-08|2016-08-08||October 2014||2014-10-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Epidemiology of Acute Kidney Injury in England - 1998 to 2013|Epidemiology of Acute Kidney Injury in England - 1998 to 2013|Completed||N/A|64882|Actual|Derby Hospitals NHS Foundation Trust|||1||f||||f||||||||No|The data is freely available from www.hscic.gov.uk|2017-10-11 00:06:27.56713|2017-10-11 00:06:27.56713
NCT02216682|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-12|||August 2014||2014-08-01|August 2014|2014-08-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Observational|||Assessing the Efficacy of Intravenous Acetaminophen Versus the Oral Formulation for Perioperative Pain Treatment|Assessing the Efficacy of Intravenous Acetaminophen Versus the Oral Formulation for Perioperative Pain Treatment|Unknown status|Not yet recruiting|N/A|174|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 00:06:27.884368|2017-10-11 00:06:27.884368
NCT02216669|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-03-01|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer|Phase I Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer|Withdrawn||Phase 1|0|Actual|Maastricht Radiation Oncology||1||No financial agreement|f||||t|f|f||||||No||2017-10-11 00:06:27.977422|2017-10-11 00:06:27.977422
NCT02216656|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-03-03|||July 2014||2014-07-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Phase 2 Study of KHK7580|A Randomized, Double-blind, Parallel-group, Dose-finding Study of KHK7580 for Secondary Hyperparathyroidism Patients Receiving Hemodialysis|Completed||Phase 2|201|Actual|Kyowa Hakko Kirin Co., Ltd||5|||f||||f||||||||||2017-10-11 00:06:28.085918|2017-10-11 00:06:28.085918
NCT02216643|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-01-19|||January 2017|Actual|2017-01-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|RESILIENT||EndoVascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke|Randomization of Endovascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke Due to Large VEssel OcclusioN Trial|Recruiting||Phase 3|690|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||Yes||2017-10-11 00:06:28.207713|2017-10-11 00:06:28.207713
NCT02216630|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-07-22|||August 2014||2014-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease|An Open-label, Non-Randomized, Multi-center Study to Assess the Safety and Effects of Intravenous Implantation of Liposuction Derived Autologous Adipose-derived Stem Cells in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1/Phase 2|26|Actual|Kimera Society Inc||1|||f||||f||||||||||2017-10-11 00:06:28.474293|2017-10-11 00:06:28.474293
NCT02216617|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-13|||August 2014||2014-08-01|August 2014|2014-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|TAPIS||Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy|A Phase I Study Evaluating the Combination Afatinib With Docetaxel and Cisplatin (TPA) in Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Upper Aerodigestive Tract|Unknown status|Recruiting|Phase 1|22|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||1|||f||||t||||||||||2017-10-11 00:06:28.578031|2017-10-11 00:06:28.578031
NCT02216604|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2017-07-13|||May 2011||2011-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ONKOKIDS-HD||Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment|Physical Activity Intervention Program for Childhood Cancer Patients Under Chemo- and/or Radiation Therapy|Recruiting||N/A|60|Anticipated|German Cancer Research Center||2|||f||||f||||||||||2017-10-11 00:06:28.696048|2017-10-11 00:06:28.696048
NCT02216591|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-05-23|2017-04-19||August 2014||2014-08-01|May 2017|2017-05-01|June 29, 2016|Actual|2016-06-29|June 29, 2016|Actual|2016-06-29||Interventional|IMPACT||Improving Memory Performance by Applying Cognitive Training|Impact of Cognitive Training on Medication Adherence in HIV-infected Individuals|Completed||N/A|33|Actual|Duke University|The overall target sample size of 40 was not reached, and therefore we may have been underpowered to detect differences on secondary outcome measures.|2|||f||||f||||||||||2017-10-11 00:06:28.818338|2017-10-11 00:06:28.818338
NCT02216578|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-09-13|||February 2, 2017|Actual|2017-02-02|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Ph II CABOGIST in GIST|Phase II Study of Cabozantinib in Patients With Gastrointestinal Stromal Tumor (GIST) Who Progressed During Neoadjuvant, Adjuvant or Palliative Therapy With Imatinib and Sunitinib|Recruiting||Phase 2|50|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||t|f|f||||||||2017-10-11 00:06:29.285344|2017-10-11 00:06:29.285344
NCT02216565|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-10-21|||December 2014||2014-12-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|EASY||Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase|Benefits of the Endovascular Treatment in the Early Management of Proximal Sylvian Artery Thrombosis in Patients Refractory or Ineligible to Intravenous Fibrinolysis : a Multicenter Controled Randomized Trial|Recruiting||N/A|250|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||t||||||||||2017-10-11 00:06:29.429058|2017-10-11 00:06:29.429058
NCT02216552|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-05-02|||August 2015||2015-08-01|May 2017|2017-05-01|March 20, 2017|Actual|2017-03-20|January 1, 2017|Actual|2017-01-01||Interventional|||Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents|Safety and Efficacy of Resveratrol for the Treatment of Non-Alcoholic Fatty Liver Disease and Associated Insulin Resistance in Overweight and Obese Adolescents|Completed||Phase 2/Phase 3|10|Actual|University of Manitoba||2|||f||||t||||||||No||2017-10-11 00:06:29.563744|2017-10-11 00:06:29.563744
NCT02216539|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-13|2016-05-12|||July 2014||2014-07-01|May 2016|2016-05-01||||December 2014|Actual|2014-12-01||Interventional|AUTOHYPNOSE-TP||Interest of Learning Self-hypnosis for Patients Awaiting Lung Transplantation||Terminated||N/A|5|Actual|Fondation Ophtalmologique Adolphe de Rothschild||2||Change of sponsor|f||||t||||||||||2017-10-11 00:06:29.892723|2017-10-11 00:06:29.892723
NCT02216513|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-07-17|||September 2014||2014-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage|Deferoxamine: An Emerging Therapy to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage|Terminated||Early Phase 1|2|Actual|Brigham and Women's Hospital||2||"Principle Investigator is moving to another institution and plans to restart this proctocol in   the new location."|f||||f||||||||||2017-10-11 00:06:30.253427|2017-10-11 00:06:30.253427
NCT02216487|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-27|||June 2014||2014-06-01|August 2014|2014-08-01|November 2016|Anticipated|2016-11-01|June 2016|Anticipated|2016-06-01||Interventional|Chime||Trial of FOLF(HA)Iri With Cetuximab in mCRC|Phase II Single Arm Trial of FOLF(HA)Iri Plus Cetuximab in Irinotecan-naïve Second Line Patients With KRAS Wild Type Metastatic Colorectal Cancer|Unknown status|Recruiting|Phase 2|45|Anticipated|Western General Hospital, Australia||1|||f||||t||||||||||2017-10-11 00:06:30.567678|2017-10-11 00:06:30.567678
NCT02216474|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-02-13|||September 2014||2014-09-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Brain Stimulation in Movement Disorders|Brain Stimulation in Movement Disorders|Active, not recruiting||N/A|100|Anticipated|Birmingham and Solihull Mental Health NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:06:30.733081|2017-10-11 00:06:30.733081
NCT02216461|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-13|||January 2006||2006-01-01|August 2014|2014-08-01||||April 2006|Actual|2006-04-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Multiple Rising Inhaled Doses (7.5 to 60 mg Daily for 12 Days) of BIBW 2948 BS Inhalation Powder, Hard Capsule for HandiHaler® in Healthy Male Volunteers (Randomised, Double-blind Placebo-controlled Within Dose Groups)|Completed||Phase 1|36|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:06:30.896717|2017-10-11 00:06:30.896717
NCT02216448|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-08-13|||September 2014||2014-09-01|August 2014|2014-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|ASTOR||Arthroscopy Simulator Training vs OR Training Knee|The Benefit of Arthroscopic Simulator Training Versus Operating Room Training in Diagnostic Knee Arthroscopy for Residents With Basic Arthroscopic Skills|Not yet recruiting||N/A|17|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:06:31.038124|2017-10-11 00:06:31.038124
NCT02216435|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-09-27|||July 2014||2014-07-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata|Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata in Movement Initiation and Perception|Recruiting||N/A|70|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 00:06:31.170966|2017-10-11 00:06:31.170966
NCT02216422|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-05-23|2016-05-23||September 2014||2014-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Turquoise-IV|Baseline analyses included all participants.|A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection|An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered With Ribavirin (RBV) in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (Turquoise-IV)|Completed||Phase 3|36|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 00:06:31.269801|2017-10-11 00:06:31.269801
NCT02216409|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-07-17|||August 2014||2014-08-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody|A First-in-Human Phase 1 Dose Escalation Trial of Hu5F9-G4 in Patients With Advanced Solid Malignancies|Recruiting||Phase 1|96|Anticipated|Forty Seven, Inc.||1|||f||||f||||||||||2017-10-11 00:06:31.578337|2017-10-11 00:06:31.578337
NCT02216396|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-12-03|||April 2014||2014-04-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|MARQUE2||A Naturalistic Two-year Cohort Study of Agitation and Quality of Life in Care Homes|MARQUE (Managing Agitation and Quality of Life) Stream 2: A Naturalistic Two-year Cohort Study of Agitation and Quality of Life in Care Homes|Unknown status|Active, not recruiting|N/A|1734|Anticipated|University College, London|||1||f||||t||||||||||2017-10-11 00:06:31.663303|2017-10-11 00:06:31.663303
NCT02216383|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-03-22|||February 2015||2015-02-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|IMox||Intramuscular Oxytocics: A Comparison Study of Intramuscular Carbetocin, Syntocinon and Syntometrine for the Third Stage of Labour Following Vaginal Birth|Intramuscular Oxytocics: A Randomised Control Trial of Intramuscular Carbetocin, Syntocinon and Syntometrine for the Third Stage of Labour Following Vaginal Birth|Recruiting||Phase 3|6285|Anticipated|North Bristol NHS Trust||3|||f||||t||||||||||2017-10-11 00:06:31.767574|2017-10-11 00:06:31.767574
NCT02216370|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-11|||April 2014||2014-04-01|August 2014|2014-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Detection of Occult Paroxysmal AF in Cryptogenic Stroke or TIA Patients Using an Implantable Loop Recorder and Correlation With Genetic Markers.|Detection of Occult Paroxysmal Atrial Fibrillation in Cryptogenic Stroke Patients or TIA Using an Implantable Loop Recorder and Correlation With Genetic Markers.|Recruiting||N/A|125|Anticipated|University Hospital, Martin|||2||f||||f||||||||||2017-10-11 00:06:31.94074|2017-10-11 00:06:31.94074
NCT02216357|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-04-09|2017-02-02||August 2014||2014-08-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease|Completed||Phase 2|19|Actual|Cumberland Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:06:32.053893|2017-10-11 00:06:32.053893
NCT02216344|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-09-28|||August 2014||2014-08-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Controlled Acute Hypoxia Study - Abbreviated Sensor Line|Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples Using the Abbreviated Sensor Line in Healthy Subjects With the USB Pulse Oximetry Monitor Interface Cable|Completed||N/A|13|Actual|Medtronic - MITG|||1||f||||f||||||||No||2017-10-11 00:06:32.75932|2017-10-11 00:06:32.75932
NCT02216331|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-01-12|||March 2010||2010-03-01|August 2015|2015-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)|A Phase I Open-label Trial to Investigate the Pharmacokinetic Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects|Completed||Phase 1|32|Actual|Global Alliance for TB Drug Development||4|||f||||f||||||||||2017-10-11 00:06:32.845013|2017-10-11 00:06:32.845013
NCT02216318|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||October 2013||2013-10-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|light-age||Energy-efficient and Health Promoting Light for Elderly People|A Study of Two Different Light Conditions for Healthy Subjects Above 65 Years|Completed||N/A|29|Actual|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-10-11 00:06:32.956475|2017-10-11 00:06:32.956475
NCT02216305|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-11-18|||September 2014||2014-09-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||HAL-RAR Versus Hemorrhoidectomy in the Treatment of Grade III-IV Hemorrhoids. Prospective, Randomized Trial|Prospective and Randomized Trial Comparing Dopplper-Guided Transanal Hemorrhoid Artery Ligation With Recto-anal Repair (HAL-RAR) Versus Excisional Hemorrhoidectomy for the Treatment of Grade III-IV Hemorrhoids|Recruiting||Phase 4|60|Anticipated|Hospital Plató||2|||f||||f||||||||||2017-10-11 00:06:33.045118|2017-10-11 00:06:33.045118
NCT02216292|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-11|||June 2012||2012-06-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|April 2013|Actual|2013-04-01||Observational|||Impact of Preterm Single Donor Milk in Very Low Birth Weight Infants|Impact of Preterm Single Donor Milk on Enteral Feeding in Very Low Birth Weight Infants|Completed||N/A|300|Actual|Medical University of Vienna|||2||f||||t||||||||||2017-10-11 00:06:33.153142|2017-10-11 00:06:33.153142
NCT02216279|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-09-28|||September 2014||2014-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PB-02||Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension|Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension|Completed||Phase 2|45|Actual|Montreal Heart Institute||2|||f||||t||||||||||2017-10-11 00:06:33.27495|2017-10-11 00:06:33.27495
NCT02216266|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-03-09|||April 2014||2014-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation if Physostigmine Reduces Symptoms in Patients Who Has Developed a Delirium in Intensive Care After a Surgery|Monocenter, Double Blind, Randomised, Placebo Controlled Study to Evaluate Physostigmine for the Treatment of Delirium in Perioperative Intensive Care Medicine|Recruiting||Phase 3|120|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 00:06:33.3977|2017-10-11 00:06:33.3977
NCT02216253|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-09|2015-08-24|||October 2014||2014-10-01|August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Interventional|||L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.|L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection: a Double-blind Randomized Controlled Trial.|Completed||N/A|150|Actual|IRCCS San Raffaele||2|||f||||t||||||||||2017-10-11 00:06:33.527242|2017-10-11 00:06:33.527242
NCT02216240|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||December 2010||2010-12-01|February 2014|2014-02-01||||December 2014|Anticipated|2014-12-01||Interventional|Para-SVT||Safety and Efficacy of Paramedic Treatment of Regular Supraventricular Tachycardia|Safety and Efficacy of Paramedic Treatment of Regular Supraventricular Tachycardia|Unknown status|Recruiting|N/A|90|Anticipated|Barts & The London NHS Trust||2|||f||||||||||||||2017-10-11 00:06:33.607546|2017-10-11 00:06:33.607546
NCT02216227|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-15|||April 2014||2014-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Checklist to Prevent MRSA Surgical Site Infections|Checklist to Prevent MRSA Surgical Site Infections|Recruiting||N/A|10748|Anticipated|Iowa City Veterans Affairs Medical Center||1|||f||||f||||||||||2017-10-11 00:06:33.734719|2017-10-11 00:06:33.734719
NCT02216214|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-08-31|||October 14, 2014|Actual|2014-10-14|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|PILLAR||Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)|A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)|Recruiting||Phase 4|800|Anticipated|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:06:33.917246|2017-10-11 00:06:33.917246
NCT02216201|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-11-07|||December 2014||2014-12-01|November 2014|2014-11-01||||December 2015|Anticipated|2015-12-01||Observational|||Clinical Utility of SUDOSCAN in the Pediatric Population|Clinical Utility of SUDOSCAN in the Pediatric Population|Withdrawn||N/A|0|Actual|Impeto Medical|||1|Sponsor terminated study|f||||||||||||||2017-10-11 00:06:36.258661|2017-10-11 00:06:36.258661
NCT02216019|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-13|||November 2013||2013-11-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|INFLUX||Diagnostic Interest of Leukocyte Immunophenotyping Using Multiparameter 8-color Flow Cytometry in Heart Surgery|Diagnostic Interest of Leukocyte Immunophenotyping Using Multiparameter 8-color Flow Cytometry in Heart Surgery|Completed||N/A|60|Actual|University Hospital, Limoges|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 00:06:38.456043|2017-10-11 00:06:38.456043
NCT02216188|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2015-08-14|||August 2014||2014-08-01|August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Interventional|AFF008A||Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity|Phase IB Follow-up, Randomized, Controlled, Parallel Group, Patient-blinded, Single-center Study to Assess One Boost With AFFITOPE® PD01A With Regard to Safety/Tolerability, Immunological + Clinical Activity in Patients Who Have Received the Vaccine Within the Study AFF008|Completed||Phase 1|28|Actual|Affiris AG||3|||f||||t||||||||||2017-10-11 00:06:36.348763|2017-10-11 00:06:36.348763
NCT02216175|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-08-29|||January 2017||2017-01-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|SOCMA||Improving the Safety of Oral Immunotherapy in Cow's Milk Allergy|Phase 2/3 Clinical Trial to Assess the Effect of a Sublingual Treatment Phase Prior to Oral Immunotherapy in Children With Cow's Milk Allergy|Not yet recruiting||Phase 2/Phase 3|53|Anticipated|Imperial College London||3|||f||||||||||||||2017-10-11 00:06:36.458719|2017-10-11 00:06:36.458719
NCT02216162|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-12|||April 2014||2014-04-01|August 2014|2014-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|PROACTIVE||PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program|PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program Including a Regular Physical Training, a Medical and Nutritional Follow-up, on Adjuvant Hormonal Treatment Compliance in Breast Cancer Patients Over 70 Years.|Recruiting||N/A|87|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 00:06:36.592342|2017-10-11 00:06:36.592342
NCT02216149|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-03-04|||January 2015||2015-01-01|March 2016|2016-03-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|FluoHeart||Effects of S-1 and Capecitabine on Coronary Artery Blood Flow|Effects of S-1 and Capecitabine in Combination With Oxaliplatin on the Coronary Artery Blood Flow in Patients Metastatic Gastrointestinal Tract Adenocarcinoma: a Randomized Phase II Study|Recruiting||Phase 2|40|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 00:06:36.711939|2017-10-11 00:06:36.711939
NCT02216136|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-10-03|||April 2014||2014-04-01|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|T:B||Tumor: Breast Ratio Study|A Prospective Trial to AssessTumor:Breast Ratio and Patient Satisfaction in Following Lumpectomy Versus Mastectomy With Reconstruction|Active, not recruiting||N/A|186|Anticipated|Washington University School of Medicine|||3||f||||t||||||||||2017-10-11 00:06:36.835729|2017-10-11 00:06:36.835729
NCT02216123|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-04-10|||April 30, 2015||2015-04-30|April 2017|2017-04-01|November 4, 2016|Actual|2016-11-04|November 4, 2016|Actual|2016-11-04||Interventional|||Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria|A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in the Treatment of Subjects With Plasmodium Vivax Malaria|Completed||Phase 3|251|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 00:06:36.934981|2017-10-11 00:06:36.934981
NCT02216110|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-09|2015-05-19|||May 2003||2003-05-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|||Endoscopic Submucosal Dissection Versus Gastrectomy|Long-term Outcomes of Endoscopic Submucosal Dissection Versus Gastrectomy for Early Gastric Cancer|Completed||N/A|500|Actual|Soonchunhyang University Hospital|||2||f||||t||||||||||2017-10-11 00:06:37.198418|2017-10-11 00:06:37.198418
NCT02216097|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-05-26|2016-03-10||October 2014||2014-10-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder|A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd|Terminated||Phase 2|14|Actual|Pfizer|There were no efficacy evaluations done in this study because of a change in the planned analysis after the study was prematurely terminated due to GCP non-compliance that resulted in data integrity and quality issues.|2||"The study stopped based on Pfizer portfolio prioritization and not due to safety and/or   efficacy concern or change in benefit:risk assessment of PF-04457845."|f||||f||||||||||2017-10-11 00:06:37.338733|2017-10-11 00:06:37.338733
NCT02216084|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-03-01|||September 2014||2014-09-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)|BAX930 (rADAMTS13): A Phase 1 Prospective, Uncontrolled, Open-Label, Multicenter, Dose-Escalation Study Evaluating the Safety and Pharmacokinetics in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)|Completed||Phase 1|16|Actual|Baxalta US Inc.||1|||f||||t||||||||||2017-10-11 00:06:37.884966|2017-10-11 00:06:37.884966
NCT02216071|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-12|||July 2014||2014-07-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Comparative Efficacy and Safety of Two Ciprofloxacin 0.3% and Dexamethasone 0.1% Formulations in Subjects With Acute Otitis Externa|A Phase 3, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study of the Comparative Efficacy and Safety of EXL CDOS in Subjects With Acute Otitis Externa|Unknown status|Recruiting|Phase 3|500|Anticipated|Exela Pharma Sciences, LLC.||2|||f||||f||||||||||2017-10-11 00:06:38.018114|2017-10-11 00:06:38.018114
NCT02216058|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-12|||April 2013||2013-04-01|August 2014|2014-08-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease|A Prospective, Multicenter Trial of NOYA Sirolimus-Eluting Stent With Biodegradable Coating in Patients With Coronary Artery Disease|Recruiting||N/A|2000|Anticipated|Medfavour (Beijing) Medical Co., Ltd||1|||f||||t||||||||||2017-10-11 00:06:38.134093|2017-10-11 00:06:38.134093
NCT02216045|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2016-07-28|||June 2014||2014-06-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|HCV||Effect of Camel Milk on Chronic Hepatitis C|Investigating the Effects of Camel Milk Products on the Laboratory Markers in the Patients With Chronic Hepatitis C, Genotype 2 & 3|Completed||Phase 2|40|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||No|individual participant data (IPD) is confidential in researchers .|2017-10-11 00:06:38.259102|2017-10-11 00:06:38.259102
NCT02216032|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-06-22|||November 2014||2014-11-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|TMW HV RCT||Thirty Million Words Home Visiting: A Longitudinal RCT|Thirty Million Words Home Visiting: A Longitudinal RCT|Enrolling by invitation||N/A|200|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 00:06:38.361418|2017-10-11 00:06:38.361418
NCT02215993|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-05-22|||July 2013||2013-07-01|May 2017|2017-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|SAMPA||Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis|Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis After Loading Dose of Clopidogrel|Completed||Phase 4|50|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 00:06:38.623385|2017-10-11 00:06:38.623385
NCT02215980|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-05|||July 2014||2014-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS|A PHASE III, MULTICENTRE, RANDOMIZED, CONTROLLED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS|Recruiting||Phase 3|200|Anticipated|Fondazione Neoplasie Sangue Onlus||2|||f||||f||||||||||2017-10-11 00:06:38.704579|2017-10-11 00:06:38.704579
NCT02215967|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-10-03|||August 6, 2014||2014-08-06|October 2, 2017|2017-10-02|October 31, 2019|Anticipated|2019-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma|A Phase I Clinical Trial of T-Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma|Active, not recruiting||Phase 1|25|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:06:38.801972|2017-10-11 00:06:38.801972
NCT02215954|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-04-18|2016-10-24||September 2014||2014-09-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Intention-To-Treat Analysis set|A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing|A Phase III, Randomized, Assessor-Blinded, Parallel-Group, Multi-Centre, Clinical Study With FE 999169 for Oral Administration Versus Niflec® for Colon Cleansing: J-CLEAR|Completed||Phase 3|637|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-10-11 00:06:38.909864|2017-10-11 00:06:38.909864
NCT02215941|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-04-28|||August 2014||2014-08-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers|A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Dose Escalation Study to Characterize the Pharmacokinetics and Safety of 8% TV-45070 Ointment Following 7.5 Days of Twice Daily Topical Application in Healthy Subjects|Completed||Phase 1|45|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-10-11 00:06:39.473742|2017-10-11 00:06:39.473742
NCT02215928|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-04-18|||July 2014||2014-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|||Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors|Tumor Genomic Profiling: A Personalized Medicine Approach|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"     liquid biopsy   "|||2017-10-11 00:06:39.556902|2017-10-11 00:06:39.556902
NCT02215915|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-09-12|||August 1, 2014|Actual|2014-08-01|September 2017|2017-09-01|May 12, 2020|Anticipated|2020-05-12|May 12, 2018|Anticipated|2018-05-12||Interventional|ULTIMATE||"Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All-comers Coronary Lesions （ULTIMATE Trial）"|"Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All-comers Coronary Lesions （ULTIMATE Trial）"|Recruiting||N/A|1448|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t||||||||||2017-10-11 00:06:39.662301|2017-10-11 00:06:39.662301
NCT02215902|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-03-13|||December 2014||2014-12-01|March 2017|2017-03-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Interventional|AEMD-IDE-20||Safety Study of the Aethlon Hemopurifier|A Clinical Safety Study of the Aethlon Hemopurifier® in Chronic ESRD Patients With HCV Infection|Terminated||N/A|8|Actual|Aethlon Medical Inc.||1||"Adequate safety data has been accumulated and the # of patients meeting inclusion criteria has   diminished."|f||||f||||||||Undecided||2017-10-11 00:06:39.769384|2017-10-11 00:06:39.769384
NCT02215889|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-05-24|||June 2014||2014-06-01|May 2017|2017-05-01|June 2028|Anticipated|2028-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Partial Liver Segment 2/3 Transplantation Study|A Phase I/II Clinical Trial to Evaluate the Benefit and Efficacy of Liver Resection And Partial Liver Segment 2/3 Transplantation With Delayed Total Hepatectomy as Treatment for Selected Patients With Liver Metastases From ColoRectal Carcinoma|Recruiting||Phase 1/Phase 2|20|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 00:06:39.858895|2017-10-11 00:06:39.858895
NCT02215876|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-04-13|||September 2014||2014-09-01|April 2016|2016-04-01|March 2020|Anticipated|2020-03-01|August 2017|Anticipated|2017-08-01||Interventional|||Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer|A Phase II (Single Center) Study of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer|Withdrawn||Phase 2|0|Actual|Sidney Kimmel Comprehensive Cancer Center||1||No patients recruited.|f||||t||||||||||2017-10-11 00:06:39.944194|2017-10-11 00:06:39.944194
NCT02215863|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-03-31|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years|Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13) and MF59-adjuvanted Influenza Vaccine (Fluad) After Concomitant Vaccination in Adults Aged ≥60 Years|Completed||Phase 4|1195|Actual|Korea University Guro Hospital||3|||f||||t||||||||||2017-10-11 00:06:40.043272|2017-10-11 00:06:40.043272
NCT02215850|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-05-13|||October 2014||2014-10-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours|A Phase I, Multi-center, Open-label, Study to Investigate the Safety, Tolerability and Pharmacokinetic of SLC-0111 in Subjects With Advanced Solid Tumours|Completed||Phase 1|24|Actual|Welichem Biotech Inc.||1|||f||||f||||||||||2017-10-11 00:06:40.14336|2017-10-11 00:06:40.14336
NCT02215837|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2016-05-23|||August 2014||2014-08-01|November 2015|2015-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer|Randomized,Controlled,Multicenter Study of Autologous Tumor Lysate-pulsed Dendritic and Cytokine-induced Killer Cells(Ag-D-CIK) Combined With Chemotherapy for Gastric Cancer.|Active, not recruiting||Phase 2|40|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||2|||f||||t||||||||Undecided||2017-10-11 00:06:40.225977|2017-10-11 00:06:40.225977
NCT02215824|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-21|||October 2002||2002-10-01|August 2014|2014-08-01||||October 2003|Actual|2003-10-01||Interventional|COINART-1||Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia|A Randomised, Double-blind, Placebo-controlled, Dose Escalation Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics of Different Doses (0.2, 0.6, 2.0, 6.0, and 20.0 μg/hr) of BIWH 3 Administered for 6 Hours in Patients With Chronic Critical Limb Ischaemia (CLI, Fontaine Class III or IV). COINART-1 Trial (First COllateral INto ARTery Trial)|Terminated||Phase 1|7|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:40.332479|2017-10-11 00:06:40.332479
NCT02215811|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-08-12|||March 2014||2014-03-01|August 2014|2014-08-01||||December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells|Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells|Unknown status|Recruiting|Phase 1|10|Anticipated|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 00:06:40.42105|2017-10-11 00:06:40.42105
NCT02215798|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-21|||July 2006||2006-07-01|August 2014|2014-08-01||||October 2009|Actual|2009-10-01||Observational|||Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients|Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients|Completed||N/A|269|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:06:40.533052|2017-10-11 00:06:40.533052
NCT02215785|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||April 2013||2013-04-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of Consumption of Kiwifruit on Constipation in Adults|Improvement of Functional Constipation With Kiwifruit Intake in a Mediterranean Patient Population: Open Non-controlled and Non-randomized Longitudinal Study|Completed||N/A|46|Actual|Jordi Gol i Gurina Foundation||1|||f||||f||||||||||2017-10-11 00:06:40.604548|2017-10-11 00:06:40.604548
NCT02215772|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||September 2008||2008-09-01|August 2014|2014-08-01||||October 2008|Actual|2008-10-01||Interventional|||Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers|A Phase I Trial to Investigate the Metabolism and Pharmacokinetics of an Open Label Single Dose of 200 mg [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers|Completed||Phase 1|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:06:40.715035|2017-10-11 00:06:40.715035
NCT02215759|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||January 2009||2009-01-01|August 2014|2014-08-01||||June 2009|Actual|2009-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets in Healthy Male and Female Volunteers|Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets (100 mg, 200 mg and 300 mg Three Times Every Two Hours on One Day and q.d. for Another 2 to 3 Days) in Healthy Male and Female Volunteers, a Randomised, Doubleblind, Placebo-controlled Within Dose Groups Phase I Study|Completed||Phase 1|34|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:40.81675|2017-10-11 00:06:40.81675
NCT02215746|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||January 2008||2008-01-01|August 2014|2014-08-01||||April 2008|Actual|2008-04-01||Interventional|||Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female Volunteers|Relative Oral Bioavailability of BI 44370 TA Drinking Solution (100 mg and 200 mg) and BI 44370 TA Tablets (100 mg as Two 50 mg Tablets) With and Without a High Fat Meal in Healthy Male and Female Volunteers: A Single Dose, Open-label, Randomised Six-way Cross-over Trial|Completed||Phase 1|12|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:06:40.91758|2017-10-11 00:06:40.91758
NCT02215733|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||February 2011||2011-02-01|August 2014|2014-08-01||||February 2012|Actual|2012-02-01||Observational|||The Use of Angiotensin Receptor Blockers and the Risk of Cancer|The Use of Angiotensin Receptor Blockers and the Risk of Cancer|Completed||N/A|1165781|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:06:41.013857|2017-10-11 00:06:41.013857
NCT02215720|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-02-09|||April 2011||2011-04-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|TORERO||Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors|Phase I Study of Temsirolimus and Cetuximab in Adults Patients With Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|42|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 00:06:41.0997|2017-10-11 00:06:41.0997
NCT02215707|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-05-12|||June 2014||2014-06-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses|A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses|Completed||Phase 1|67|Actual|Sanaria Inc.||7|||f||||t||||||||||2017-10-11 00:06:41.190364|2017-10-11 00:06:41.190364
NCT02215694|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-02|2014-08-11|||June 2012||2012-06-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels|Supplementation of Dual Probiotic Strains, Lactobacillus Curvatus HY7601 and Lactobacillus Plantarum KY1032, Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels in Nondiabetic and Hypertriglyceridemic Subjects|Completed||Phase 3|128|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:06:41.289054|2017-10-11 00:06:41.289054
NCT02215681|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-08-12|||June 2014||2014-06-01|July 2014|2014-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Acupuncture Effect on Inflammatory Markers in Pediatric Otitis Media With Effusion: A Pilot Study|Acupuncture Effect on Inflammatory Markers in Pediatric Otitis Media With Effusion: A Pilot Study|Unknown status|Recruiting|N/A|100|Anticipated|Ziv Hospital||2|||f||||f||||||||||2017-10-11 00:06:41.385725|2017-10-11 00:06:41.385725
NCT02215655|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-04-27|||September 2014||2014-09-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence|Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence|Completed||N/A|150|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 00:06:41.552089|2017-10-11 00:06:41.552089
NCT02215642|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-10-30|||January 2009||2009-01-01|October 2014|2014-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Nutrition and Lifestyle Study Cohort of Colorectal Cancer in China|Impact of Nutrition, Dietary Pattern, Obesity, Physical Activity, Depression, Diabetes, Aspirin Use and Vitamin Supplement in Colorectal Cancer in China|Unknown status|Recruiting|N/A|50000|Anticipated|State Key Laboratory of Cancer Biology|||1||f||||t||||||||||2017-10-11 00:06:41.626216|2017-10-11 00:06:41.626216
NCT02215629|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-01-26||||||October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia|A Phase I Dose Escalation Study of VS-4718, A Focal Adhesion Kinase Inhibitor, In Subjects With Relapsed or Refractory Acute Myeloid Leukemia or B-Cell Acute Lymphoblastic Leukemia|Withdrawn||Phase 1|0|Actual|Verastem, Inc.||1|||f||||f||||||||||2017-10-11 00:06:41.709968|2017-10-11 00:06:41.709968
NCT02215616|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2017-07-15|||November 30, 2014|Actual|2014-11-30|July 2017|2017-07-01|September 6, 2018|Anticipated|2018-09-06|August 7, 2018|Anticipated|2018-08-07||Interventional|LEGATO-HD||A Clinical Study in Subjects With Huntington's Disease to Assess the Efficacy and Safety of Three Oral Doses of Laquinimod|A Multicenter, Multinational, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Laquinimod (0.5, 1.0 and 1.5 mg/Day) as Treatment in Patients With Huntington's Disease|Recruiting||Phase 2|400|Anticipated|Teva Pharmaceutical Industries||4|||f||||f|t|f||||||||2017-10-11 00:06:41.824751|2017-10-11 00:06:41.824751
NCT02215603|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-01-12|||August 2014||2014-08-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Effects of Disrupting Prolonged Sitting With Different Physical Activity Protocols on Metabolic Risk Factors in Sedentary Adults||Recruiting||N/A|10|Anticipated|Rigshospitalet, Denmark||4|||f||||||||||||||2017-10-11 00:06:42.218651|2017-10-11 00:06:42.218651
NCT02215590|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-12-30|||September 2014||2014-09-01|December 2015|2015-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Re-Step: Dynamic Balance Treatment of Gait for Acquired Brain Injury (ABI) Victims|Re-Step: a Computerized Dynamic Balance Treatment for Rehabilitation of Unassisted Gait in ABI Victims: a Prospective, Exploratory and Interventional Clinical Trial|Active, not recruiting||N/A|60|Anticipated|Reuth Medical Center||1|||f||||t||||||||||2017-10-11 00:06:42.311309|2017-10-11 00:06:42.311309
NCT02215577|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-12|||June 2014||2014-06-01|August 2014|2014-08-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|LIGRO||ALPPS Versus PVE/PL|Comparison of Two Different Models of Liver Growth Stimulation in Advanced Colorectal Liver Metastatic Disease, (LIGRO Trial) Enabling Liver Resection|Recruiting||N/A|100|Anticipated|Regionalt Cancercentrum Väst||2|||f||||t||||||||||2017-10-11 00:06:42.409021|2017-10-11 00:06:42.409021
NCT02215564|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-05-27|||October 2014||2014-10-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Observational|||Bordetella Pertussis Carriage in College-aged Students|Bordetella Pertussis Carriage in College-aged Students|Unknown status|Active, not recruiting|N/A|150|Anticipated|University of Virginia|||1||f||||f||||||||||2017-10-11 00:06:42.566376|2017-10-11 00:06:42.566376
NCT02215551|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-08|||October 1, 2014|Actual|2014-10-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|July 1, 2018|Anticipated|2018-07-01||Observational|||Predictors of Decompressive Laminectomy Outcomes|Toward Optimizing Decompressive Laminectomy Outcomes: Looking Outside the Spine|Recruiting||N/A|350|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|||||2017-10-11 00:06:42.647812|2017-10-11 00:06:42.647812
NCT02215538|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-12|||November 2004||2004-11-01|August 2014|2014-08-01|June 2006|Actual|2006-06-01|February 2006|Actual|2006-02-01||Interventional|||OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD|Concerta in the Treatment of Adult ADHD and a Comparison of Four Adult ADHD Scales and Effects on Personality|Completed||Phase 2/Phase 3|47|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 00:06:42.75813|2017-10-11 00:06:42.75813
NCT02215525|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-08-11|||April 2014||2014-04-01|July 2014|2014-07-01|May 2015|Anticipated|2015-05-01|October 2014|Anticipated|2014-10-01||Interventional|||Treatment of Chronic HCV Infected Egyptian Patients With Electromagnetic Waves and Herbal Therapy|Treatment of Chronic HCV Infected Egyptian Patients With Electromagnetic Waves and Herbal Therapy|Unknown status|Recruiting|Phase 3|160|Anticipated|Egyptian Military Medical Services||2|||f||||t||||||||||2017-10-11 00:06:42.893444|2017-10-11 00:06:42.893444
NCT02215512|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-07-02|||February 6, 2015|Actual|2015-02-06|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|BRAINSTORM||Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases|A Phase 1 Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases (BRAINSTORM)|Active, not recruiting||Phase 1|29|Actual|EpicentRx, Inc.||1|||f||||f||||||||||2017-10-11 00:06:43.024343|2017-10-11 00:06:43.024343
NCT02215499|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2015-05-28|||July 2014||2014-07-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics|A Double-Blind, Phase 1, Single-Center, Single-Ascending Dose Study of JZP-386 Compared to Xyrem® vs. Placebo to Evaluate the Safety and Pharmacokinetics|Completed||Phase 1|28|Actual|Concert Pharmaceuticals||3|||f||||f||||||||||2017-10-11 00:06:43.125731|2017-10-11 00:06:43.125731
NCT02215486|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-09|2015-05-26|||April 2014||2014-04-01|May 2015|2015-05-01||||September 2014|Actual|2014-09-01||Interventional|||The Effect of Head Massage Therapy on the Regulation of the Autonomic Nervous System|Head Massage Intervention to Decrease Physiological Signs of Stress as Assessed by Changes in the Autonomic Nervous System Functions in Healthy Volunteers: A Pilot Study|Completed||N/A|10|Actual|Children's & Women's Health Centre of British Columbia|||||f||||||||||||||2017-10-11 00:06:43.233135|2017-10-11 00:06:43.233135
NCT02215473|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-11|||August 2013||2013-08-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bacteremia in Periodontal Patients|Influence of Pre-procedural Oral Rinse in the Induced Bacteremia by Periodontal Instrumentation: a Randomized Clinical Trial|Completed||Phase 4|80|Actual|University of Taubate||4|||f||||||||||||||2017-10-11 00:06:43.311217|2017-10-11 00:06:43.311217
NCT02215460|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-11|||April 2012||2012-04-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours|Effectiveness of Two Non-surgical Periodontal Treatment Protocols: Randomized Controlled Clinical Trial|Completed||Phase 4|130|Actual|University of Taubate||10|||f||||||||||||||2017-10-11 00:06:43.41411|2017-10-11 00:06:43.41411
NCT02215447|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-06-28|||May 2015||2015-05-01|August 2016|2016-08-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|NABNEC||A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas|A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas|Active, not recruiting||Phase 2|4|Actual|Barwon Health||1|||f||||t||||||||||2017-10-11 00:06:43.554061|2017-10-11 00:06:43.554061
NCT02215434|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||September 2009||2009-09-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|April 2013|Actual|2013-04-01||Interventional|TESTOSTERONE||Safety Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women|Phase 2 Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women|Completed||Phase 2|60|Actual|University Potiguar||2|||f||||f||||||||||2017-10-11 00:06:43.655374|2017-10-11 00:06:43.655374
NCT02215421|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-10-12|||June 2015||2015-06-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Mommio: Training in Vegetable Parenting|Kiddio Food Fight: Training Parents in Effective Vegetable Parenting|Withdrawn||N/A|0|Actual|Archimage, Inc.||2||Funding did not allow for completion of game programming|f||||f||||||||||2017-10-11 00:06:43.76598|2017-10-11 00:06:43.76598
NCT02215408|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-01-20|||February 2015||2015-02-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|MEDFOCUS||MEDication Focused Outpatient Care for Underutilization of Secondary Prevention|MEDication Focused Outpatient Care for Underutilization of Secondary Prevention|Active, not recruiting||N/A|402|Actual|University of Iowa||2|||f||||t|f|f||||||Yes|IPD sets will be created without direct or indirect identifiers and reviewed to make sure that elements cannot be used to potentially identify individual subjects. We will create SAS datasets in transport format and package them along with a copy of the protocol, data dictionaries, and a manual that shows the user how to import the data into their own system. Investigators requesting access to the data will be asked to complete a data sharing agreement that provides for: 1) a commitment to using the data only for research purposes and not to identify any individual participant; 2) a commitment to securing the data using appropriate computer technology; and 3) a commitment to destroying or returning the data after analyses are completed.|2017-10-11 00:06:43.889193|2017-10-11 00:06:43.889193
NCT02215395|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-08-11|||March 2014||2014-03-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||An Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication Miconazole Nitrate on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring in Normal Ovulating Women|Phase 1, Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication (Miconazole Nitrate) on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring Releasing a Daily Dose of 150 ug of NES and 15 ug of EE|Completed||Phase 1|45|Actual|Population Council||1|||f||||f||||||||||2017-10-11 00:06:44.069541|2017-10-11 00:06:44.069541
NCT02215382|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-04-18|||August 2014||2014-08-01|August 2014|2014-08-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Intraocular Pressure Changes Associated With Tracheal Extubation: Comparison of Sugammadex With Conventional Reversal of Neuromuscular Blockade||Completed||Phase 4|36|Actual|T.C. ORDU ÜNİVERSİTESİ||2|||f||||||||||||||2017-10-11 00:06:44.205419|2017-10-11 00:06:44.205419
NCT02215369|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-09-20|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|SeCure||SeCure Endovenous Laser Treatment Study|Prospective Safety and Effectiveness Study: VenaCure Endovenous Laser Treatment (EVLT) 400 µm Fiber Procedure Kit for Treatment of Incompetent Perforator Veins|Recruiting||N/A|86|Anticipated|Angiodynamics, Inc.||1|||f||||f||||||||||2017-10-11 00:06:44.308606|2017-10-11 00:06:44.308606
NCT02215356|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-11|||August 2014||2014-08-01|August 2014|2014-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer|Icotinib With Concurrent Radiotherapy Versus Etoposide/Cisplatin With Concurrent Radiotherapy in Stage III Non-small Cell Lung Cancer With EGFR 19/21 Mutation|Active, not recruiting||Phase 2|120|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 00:06:44.454139|2017-10-11 00:06:44.454139
NCT02215343|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-02-16|||August 2014||2014-08-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MyNewGut||Effect of Prebiotic and PUFA on the Gut Microbiota and Metabolic Risk Markers|Effect of Prebiotic Fibre and Polyunsaturated Fatty Acid (PUFA) on the Gut Microbiota and Metabolic Risk Markers in a Metabolically Challenged Population|Completed||N/A|30|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 00:06:44.628757|2017-10-11 00:06:44.628757
NCT02215330|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-12|||October 2014||2014-10-01|August 2014|2014-08-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy|A Randomized, Double-masked, Placebo Controlled Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy|Unknown status|Not yet recruiting|Phase 2/Phase 3|60|Anticipated|Vienna Institute for Research in Ocular Surgery||2|||f||||f||||||||||2017-10-11 00:06:44.764877|2017-10-11 00:06:44.764877
NCT02215317|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-02-22|||December 2011||2011-12-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Sleep and Stent Study: a Multicentre, Prospective Study|Impact of Obstructive Sleep Apnea on Cardiovascular Outcomes in Patients Treated With Percutaneous Coronary Intervention|Completed||N/A|1815|Actual|National University, Singapore|||2||f||||t||||||||||2017-10-11 00:06:44.864886|2017-10-11 00:06:44.864886
NCT02215304|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-12-13|||June 2014||2014-06-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PROBINFANT||Safety and Tolerance Study of Three Probiotic Strains in Infants|A Randomized, Double-blind, Placebo-controlled Intervention Study to Assess the Safety and Tolerance Effect of Three Probiotic Strains in Infants|Completed||N/A|221|Actual|ProbiSearch SL||4|||f||||f||||||||||2017-10-11 00:06:44.948748|2017-10-11 00:06:44.948748
NCT02215291|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-08-25|||July 2014||2014-07-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|March 2016|Actual|2016-03-01|12 Months|Observational [Patient Registry]|||NvisionVLE™ Registry System Registry|High Resolution Optical Imaging of the Esophagus Using the NvisionVLE™ Imaging Registry|Active, not recruiting||N/A|1000|Actual|NinePoint Medical|||1||f||||f||||||||||2017-10-11 00:06:45.074943|2017-10-11 00:06:45.074943
NCT02215265|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-12|||December 2014||2014-12-01|August 2014|2014-08-01||||December 2019|Anticipated|2019-12-01||Interventional|PATHOS||Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)|A Phase II/III Trial of Risk-stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer|Not yet recruiting||Phase 2/Phase 3|242|Anticipated|Velindre NHS Trust||5|||f||||t||||||||||2017-10-11 00:06:45.291127|2017-10-11 00:06:45.291127
NCT02215252|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-03-26|2016-07-12||November 10, 2014|Actual|2014-11-10|March 2017|2017-03-01|September 28, 2015|Actual|2015-09-28|July 15, 2015|Actual|2015-07-15||Interventional||The safety analysis set consisted of all participants who received at least one dose of study medication.|A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)|A Randomized Double Blind Placebo And Active Controlled Parallel Group Phase 2 Study To Evaluate PF-05089771 As A Monotherapy And As An Add-on To Pregabalin For The Treatment Of Painful Diabetic Peripheral Neuropathy|Completed||Phase 2|141|Actual|Pfizer||4|||f||||f|t|f||||||Yes|"Information relating to our policy on data sharing and the process for requesting data can be found at the following link:
http://www.pfizer.com/research/clinical_trials/trial_data_and_results/data_requests"|2017-10-11 00:06:45.627484|2017-10-11 00:06:45.627484
NCT02215239|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-03-13|||January 2014||2014-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Development of Workplace Physical Activity Promotion Models in Taiwan|Development of Workplace Physical Activity Promotion Models in Taiwan|Unknown status|Recruiting|N/A|240|Anticipated|National Taiwan University Hospital||4|||f||||f||||||||||2017-10-11 00:06:47.169338|2017-10-11 00:06:47.169338
NCT02215226|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-12|||July 2014||2014-07-01|August 2014|2014-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01|3 Months|Observational [Patient Registry]|V98_28OBTP||GBS Sero-correlate of Protection|Establishing a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged <=90 Days|Unknown status|Recruiting|N/A|35000|Anticipated|University of Witwatersrand, South Africa|||1||f||||f||||||Samples Without DNA|"     Cord blood and maternal blood (serum samples) Vaginal swab samples from mothers Invasive GBS     isolates from cases   "|||2017-10-11 00:06:47.285712|2017-10-11 00:06:47.285712
NCT02215213|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-07-15|||June 2013||2013-06-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|||Assessment of Dose Effectiveness of Vitamin D Supplementation During Pregnancy- a Dose Comparison Trial|Assessment of Dose Effectiveness of Vitamin D Supplementation During Pregnancy|Completed||N/A|350|Actual|Aga Khan University||3|||f||||f||||||||||2017-10-11 00:06:47.374238|2017-10-11 00:06:47.374238
NCT02215200|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-07-08|||December 2014||2014-12-01|July 2016|2016-07-01||||October 2016|Anticipated|2016-10-01||Interventional|ATG-GCSF||ATG-GCSF in New Onset Type 1 Diabetes|Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes|Active, not recruiting||Phase 2|84|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-10-11 00:06:47.495392|2017-10-11 00:06:47.495392
NCT02215187|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-11-21|||July 2013||2013-07-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Telehealth-Education-Based Program for Military Caregivers of Injured Service Members With Head Injuries|Cognitive Behavioral Therapy (CBT) for Caregivers of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Service Members With Combat-Related Traumatic Brain Injuries (TBI)|Recruiting||N/A|130|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 00:06:47.657903|2017-10-11 00:06:47.657903
NCT02215174|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-04-24|||February 2015||2015-02-01|April 2015|2015-04-01||||December 2016|Anticipated|2016-12-01||Interventional|RST||Rosuvastatin Interethnic PK Study|Rosuvastatin Pharmacokinetic (PK) Study in Caucasian and Asian Morbid Obese Patients|Unknown status|Recruiting|Phase 1|20|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:06:47.788462|2017-10-11 00:06:47.788462
NCT02215161|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-04-28|||September 2014||2014-09-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Selinexor (KPT-330) in Patients With Metastatic Castration-Resistant Prostate Cancer and Prior Therapy With Abiraterone and/or Enzalutamide|Phase II Single Agent Study of Selinexor (KPT-330) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Prior Therapy With Abiraterone and/or Enzalutamide|Active, not recruiting||Phase 2|14|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 00:06:47.920691|2017-10-11 00:06:47.920691
NCT02215148|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-09-06|||November 2014||2014-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients|Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients|Terminated||N/A|1|Actual|University of North Carolina, Chapel Hill|||1|Slow subject enrollment and contracting issues; sponsor decided to abort study|f||||t||||||Samples Without DNA|"     Blood samples for pharmacokinetic sampling will be collected in serum separator tubes at 0,     0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 16, 20, 24, 30 and 36 hours after the dose of study drug is     administered. Serum sodium will be collected at baseline and 2, 4, 6, 8, 12, 24, and 36 hours     after study drug administration. Approximately 180 mL of blood will be collected over 36     hours. Urinary output and urine specific gravity will be collected 0-2, 2-4, 3-6, 6-8, 8-12,     and 12-24 hours after tolvaptan administration.   "|||2017-10-11 00:06:48.013354|2017-10-11 00:06:48.013354
NCT02215135|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-08-11|||January 2014||2014-01-01|August 2014|2014-08-01||||June 2015|Anticipated|2015-06-01||Interventional|||Corifollitropin Alfa Application in PCOS Patients|Corifollitropin Alfa in Combination With Elective Cryopreservation of All Embryos After GnRH Agonist Triggering of Final Oocyte Maturation in PCOS Patients- a Prospective, Observational Proof-of -Concept Study|Unknown status|Recruiting|Phase 4|30|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:06:48.11127|2017-10-11 00:06:48.11127
NCT02215122|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-11|||October 2013||2013-10-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs|A Bioequivalence Study to Assess the Systemic Exposure of Fluticasone Propionate and Salmeterol Administered as a Fixed Dose Combination From Different Dry Powder Inhalers in Healthy Subjects|Completed||Phase 1|40|Actual|Mylan Inc.||3|||f||||f||||||||||2017-10-11 00:06:48.209826|2017-10-11 00:06:48.209826
NCT02215109|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-08-29|||April 2012||2012-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Retinal Vessel Diameter in Branch Retinal Vein Occlusion|Change of Retinal Vessel Diameter in Branch Retinal Vein Occlusion After Intravitreal Bevacizumab Injection|Completed||N/A|25|Actual|Kyungpook National University|||1||f||||t||||||||No||2017-10-11 00:06:48.31275|2017-10-11 00:06:48.31275
NCT02215096|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-08-17|||November 13, 2014|Actual|2014-11-13|August 2017|2017-08-01|November 16, 2018|Anticipated|2018-11-16|November 16, 2018|Anticipated|2018-11-16||Interventional|||Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer|A Phase I, Open-label, Dose-finding Study of GSK2636771 Administered in Combination With Enzalutamide (Xtandi^TM ) in Male Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)|Recruiting||Phase 1|64|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:06:48.393431|2017-10-11 00:06:48.393431
NCT02215083|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-07-10|||August 2014||2014-08-01|July 2017|2017-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer|L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer|Withdrawn||Phase 1|0|Actual|Eastern Regional Medical Center||1||Insufficient Patient Population|f||||f||||||||||2017-10-11 00:06:48.530527|2017-10-11 00:06:48.530527
NCT02215070|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-06-30|||February 2015|Actual|2015-02-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Pasireotide in Prevention of GI Toxicity|Prevention of Gastrointestinal Toxicity From Total Body Irradiation or High Dose Chemotherapy With Pasireotide|Recruiting||Phase 2|40|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 00:06:48.616435|2017-10-11 00:06:48.616435
NCT02215057|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-08-02|||August 2014||2014-08-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of Topical Anesthesia Alone Versus Combined With Intracameral LIdocaine 1%|Evaluation of Topical Anesthesia Alone Versus Combined With Intracameral Lidocaine 1% in Patients Undergoing Implantable Collamer Lens (ICL) Procedure|Completed||N/A|45|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 00:06:48.711315|2017-10-11 00:06:48.711315
NCT02215044|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-12|||June 2007||2007-06-01|August 2014|2014-08-01||||December 2008|Actual|2008-12-01||Interventional|||Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase I Open-label Dose-finding Study of Intravenous BI 2536 Administered in Repeated 4-week Cycles as Repeated Doses on Day 1 and Day 15 in Combination With Gemcitabine Administered on Day 1, Day 8 and Day 15 in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Terminated||Phase 1|12|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:06:48.793242|2017-10-11 00:06:48.793242
NCT02215031|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||September 2008||2008-09-01|August 2014|2014-08-01||||November 2008|Actual|2008-11-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses of BI 44370 BS Solution in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses (10 to 50 mg) of BI 44370 BS Solution in Healthy Male Volunteers (Randomised, Single-blind, Placebo-controlled Within Dose Groups, Phase I)|Completed||Phase 1|23|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:48.860863|2017-10-11 00:06:48.860863
NCT02215018|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||April 2007||2007-04-01|August 2014|2014-08-01||||August 2007|Actual|2007-08-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers (Dose Range: 5 - 800 mg). A Double-blind (Within Dose Groups), Randomised, Placebo-controlled Within Dose Groups, Single Rising Dose Study, Including Re-dosing at 100 mg and 500 mg (Solution) and at 200 mg (Four 50 mg Tablets)|Completed||Phase 1|56|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:06:48.941546|2017-10-11 00:06:48.941546
NCT02215005|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||June 2007||2007-06-01|August 2014|2014-08-01||||September 2007|Actual|2007-09-01||Interventional|||Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers|Steady State Pharmacokinetics of 80 mg Telmisartan (Micardis®), 10 mg Ramipril (Delix®) or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers (an Open-label, Randomised, Multiple-dose, Three-way Crossover Study)|Completed||Phase 1|42|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:06:49.030496|2017-10-11 00:06:49.030496
NCT02214992|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||March 2007||2007-03-01|August 2014|2014-08-01||||June 2007|Actual|2007-06-01||Interventional|||Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers|Bioequivalence of 80 mg Telmisartan / 10 mg Ramipril Fixed Dose Combination Compared With the Monocomponents, Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Three-way Crossover Study)|Completed||Phase 1|84|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:06:49.118917|2017-10-11 00:06:49.118917
NCT02214979|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||March 2007||2007-03-01|August 2014|2014-08-01||||June 2007|Actual|2007-06-01||Interventional|||Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers|Bioequivalence of 40 mg Telmisartan / 2.5 mg Ramipril Fixed Dose Combination Compared With the Monocomponents, Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Three-way Crossover Study)|Completed||Phase 1|84|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:06:49.204077|2017-10-11 00:06:49.204077
NCT02214966|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||October 2007||2007-10-01|August 2014|2014-08-01||||December 2007|Actual|2007-12-01||Interventional|||Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers|Influence of Food on the Bioavailability of 80 mg Telmisartan / 10 mg Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Two-sequence, Two-period Crossover Study)|Completed||Phase 1|42|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:49.330972|2017-10-11 00:06:49.330972
NCT02214186|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-01-16|2015-07-06||January 2014||2014-01-01|July 2014|2014-07-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Restrictive Fluid Therapy in Severe Preeclampsia|Impact of Restrictive Fluid Therapy on Renal Function in Severe Preeclamptic Women Submitted to Cesarean Section Under Spinal Anesthesia|Completed||N/A|46|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:07:00.929095|2017-10-11 00:07:00.929095
NCT02214953|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||October 2007||2007-10-01|August 2014|2014-08-01||||December 2007|Actual|2007-12-01||Interventional|||Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers|An Open, Randomised, Single-dose, Four-way Cross-over Formulation Finding Study of the Oral Bioavailability of Four Prototype Extended Release Formulations With 25 mg BI 11634, and Intra-individual Comparison to Immediate-release Tablets (25 mg) in Healthy Male Volunteers|Completed||Phase 1|17|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:06:49.439451|2017-10-11 00:06:49.439451
NCT02214940|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||June 2007||2007-06-01|August 2014|2014-08-01||||September 2007|Actual|2007-09-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple, Rising Oral Doses of BI 11634 Oral Solution in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple, Rising Oral Doses of 2.5 mg, 5 mg, 7.5 mg, and 10 mg BI 11634 Oral Solution Administered t.i.d. for 5 Days to Healthy Male Volunteers; Randomised, Doubleblind, Placebo-controlled at Each Dose Level|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:49.559487|2017-10-11 00:06:49.559487
NCT02214927|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||May 2007||2007-05-01|August 2014|2014-08-01||||July 2007|Actual|2007-07-01||Interventional|||Pharmacokinetics and Relative Bioavailability of 11634 Immediate Release Tablet in Healthy Male Volunteers|Relative Bioavailability of 10 mg BI 11634 Immediate Release Tablet (IR) Compared to 10 mg of Oral Solution Following Oral Administration in Healthy Male Volunteers (Open-label, Single-dose, Intra-individual Comparison); Determination of Pharmacokinetics of 5 mg, 10 mg and 25 mg IR-tablet Formulation (Open-label, Single Dose)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:49.858779|2017-10-11 00:06:49.858779
NCT02214914|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||November 2006||2006-11-01|August 2014|2014-08-01||||March 2007|Actual|2007-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of 5, 10, 25, 50, 100, 200 and 400 mg BI 11634 Solution Administered to Healthy Male Volunteers. Randomised, Double-blind, Placebo Controlled at Each Dose Level. Intra-individual Comparison of Solution to an Immediate Release Tablet Formulation at One Dose Level (50 mg)|Completed||Phase 1|56|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:06:49.99371|2017-10-11 00:06:49.99371
NCT02214901|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||March 2005||2005-03-01|August 2014|2014-08-01||||July 2005|Actual|2005-07-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male Volunteers|A Randomised, Double-blind, Placebo-controlled (Within Dose Groups) Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses BIBW 2948 BS (0.75 to 150 mg Inhalation Powder, Hard Capsule for HandiHaler®) in Healthy Male Volunteers|Completed||Phase 1|91|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:06:50.132206|2017-10-11 00:06:50.132206
NCT02214888|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-12|2014-08-12|||May 2003||2003-05-01|August 2014|2014-08-01||||January 2004|Actual|2004-01-01||Interventional|||Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis|A 12 Week Double-blind, Randomized, Placebo-controlled Trial to Investigate Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets at Doses of 50 and 70 mg Administered Twice a Day in Patients With Active Rheumatoid Arthritis Who Have Failed at Least One DMARD|Terminated||Phase 2|170|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:06:50.258199|2017-10-11 00:06:50.258199
NCT02214875|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-08-11|||July 2014||2014-07-01|August 2014|2014-08-01|March 2017|Anticipated|2017-03-01|June 2016|Anticipated|2016-06-01||Interventional|LJM||"Lafiyan Jikin Mata Excellent Health for Mothers"|Increasing Retention-in-care of HIV Positive Women in PMTCT Services Through Continuous Quality Improvement -Break Through Series in Primary & Secondary Health Care Facilities in Nigeria: A Cluster Randomized Controlled Trial|Unknown status|Recruiting|N/A|640|Anticipated|Centre for Integrated Health Programs, Nigeria||2|||f||||t||||||||||2017-10-11 00:06:50.398541|2017-10-11 00:06:50.398541
NCT02214862|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2016-02-03|||March 2013||2013-03-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|[F18]-FDDNP||2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism|Pilot, Exploratory Study With [F18]-FDDNP-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism|Completed||Early Phase 1|40|Actual|Fundacion Clinic per a la Recerca Biomédica||1|||f||||t||||||||||2017-10-11 00:06:50.531857|2017-10-11 00:06:50.531857
NCT02214849|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-04-28|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||LATCH: Lactation Advice Thru Texting Can Help|LATCH: Lactation Advice Thru Texting Can Help|Completed||N/A|249|Actual|Yale University||1|||f||||f||||||||||2017-10-11 00:06:50.654541|2017-10-11 00:06:50.654541
NCT02214836|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-05-12|||October 2014||2014-10-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Ultrasound Imaging of Kidney Stones and Lithotripsy|Ultrasound Imaging of Kidney Stones and Lithotripsy|Recruiting||N/A|70|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-11 00:06:50.812922|2017-10-11 00:06:50.812922
NCT02214823|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-05-01|||July 2012||2012-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|eStimCycle||eStimCycle: Early Rehabilitation in Critical Care|Functional Electrical Stimulation Assisted Cycling (eStimCycle):A Novel Intervention to Improve Outcomes in the Critically Ill|Recruiting||N/A|154|Anticipated|University of Melbourne||2|||f||||t||||||||||2017-10-11 00:06:50.958537|2017-10-11 00:06:50.958537
NCT02214810|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-02-18|||January 2015||2015-01-01|February 2016|2016-02-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||A Study of Postsurgical Pain Control for Lower Extremity Fractures|A Randomized, Single-blinded, Prospective Study of Postsurgical Pain Control After Open Reduction and Internal Fixation of Lower Extremity Fractures With Liposomal Marcaine.|Withdrawn||Phase 1/Phase 2|0|Actual|Broward Health||2|||f||||t||||||||||2017-10-11 00:06:51.1462|2017-10-11 00:06:51.1462
NCT02214797|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-06-23|||September 2014||2014-09-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Dispensing Study to Assess Visual Performance of Prototype Contact Lenses|Dispensing Study to Assess Visual Performance of Prototype Contact Lenses|Completed||N/A|67|Actual|Brien Holden Vision||4|||f||||f||||||||||2017-10-11 00:06:51.270201|2017-10-11 00:06:51.270201
NCT02214173|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-07-15|||January 2015||2015-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BRM4||The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV|The Effect of an Enhanced Rice Bran Nutritional Supplement on Metabolic Syndrome Variables in HIV|Completed||N/A|47|Actual|University of Miami||2|||f||||f||||||||No||2017-10-11 00:07:01.775586|2017-10-11 00:07:01.775586
NCT02214784|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-02-02|||December 2012||2012-12-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence|A Randomised Controlled Double-Blind Clinical Study To Evaluate The Safety And Performance Of Neuromuscular Electrical Stimulation (NMES) With The Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence|Completed||Phase 2|50|Actual|Bio-Medical Research, Ltd.||2|||f||||f||||||||||2017-10-11 00:06:51.444692|2017-10-11 00:06:51.444692
NCT02214758|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-08|||November 2012||2012-11-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional|NutOrMed||Optimising Nutrition, Oral Health and Medication for Older Home Care Clients (NutOrMed)|Optimising Nutrition, Oral Health and Medication for Older Home Care Clients|Completed||N/A|300|Actual|University of Eastern Finland||4|||f||||t||||||||||2017-10-11 00:06:51.803948|2017-10-11 00:06:51.803948
NCT02214745|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2014-08-11|||October 2014||2014-10-01|August 2014|2014-08-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Observational|||Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community||Unknown status|Not yet recruiting|N/A|400|Anticipated|Hillel Yaffe Medical Center|||4||f||||t||||||||||2017-10-11 00:06:51.913013|2017-10-11 00:06:51.913013
NCT02214732|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-08-29|||August 2014||2014-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Mindfulness Based Cognitive Therapy for Psychological Distress in Pregnancy|A Randomized Controlled Trial of Mindfulness Based Cognitive Therapy for Psychological Distress in Pregnancy|Active, not recruiting||N/A|61|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 00:06:52.035142|2017-10-11 00:06:52.035142
NCT02214719|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-04-01|||August 2014||2014-08-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|EASI-IDM||Edmonton Automated Sugar Intelligence - Intelligent Diabetes Management, EASI-IDM, App Program to Assist Diabetes Care|Edmonton Automated Sugar Intelligence for Intelligent Diabetes Management, (EASI-IDM), a Computer Program to Assist People With Diabetes.|Active, not recruiting||N/A|100|Anticipated|University of Alberta||1|||f||||f||||||||||2017-10-11 00:06:52.169499|2017-10-11 00:06:52.169499
NCT02214706|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-02-07|||July 2014||2014-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|January 2016|Actual|2016-01-01||Interventional|||Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus|Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus in an Open Label Pilot Study (POLAR).|Terminated||N/A|17|Actual|Erasmus Medical Center||4||Lack of efficacy / adverse events|f||||f||||||||||2017-10-11 00:06:52.294549|2017-10-11 00:06:52.294549
NCT02214693|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-08-25|||July 2014||2014-07-01|August 2015|2015-08-01||||March 2015|Actual|2015-03-01||Interventional|||PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients|A Clinical Study to Investigate the Pharmacokinetics/Pharmacodynamics and Tolerability of DA-1229(Evogliptin) Tablet in Renal Impaired Patients|Completed||Phase 1|30|Actual|Dong-A ST Co., Ltd.||4|||f||||t||||||||||2017-10-11 00:06:52.445501|2017-10-11 00:06:52.445501
NCT02214680|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-10-13|||October 2015||2015-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter|The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter|Unknown status|Not yet recruiting|Phase 2|25|Anticipated|Carmel Medical Center||1|||f||||f||||||||||2017-10-11 00:06:52.549239|2017-10-11 00:06:52.549239
NCT02214667|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2017-07-10|||February 2015||2015-02-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates|Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates|Recruiting||N/A|72|Anticipated|RTI International||2|||f||||f||||||||||2017-10-11 00:06:52.644629|2017-10-11 00:06:52.644629
NCT02214654|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2014-08-11|||August 2014||2014-08-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01|1 Month|Observational [Patient Registry]|||A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage|A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage|Unknown status|Not yet recruiting|N/A|144|Anticipated|Tianjin Medical University|||1||f||||t||||||None Retained|"     We will collect blood samples from the vena mediana cubiti, volume of sample blood will be     5ml.Centrifuge samples at 700gfor 20 min at 4 °C with no brake.Remove gently the upper phase     (plasma) with a 5 ml pipette into a separate tube and store in 0.25 ml aliquots.Distribute     500 μl of samples into one isotype control and three sample tubes and add the special     antibodies.Then account the CECs and sCD40/40L,etc.   "|||2017-10-11 00:06:52.769457|2017-10-11 00:06:52.769457
NCT02214641|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-09-14|||October 2014||2014-10-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|June 2016|Actual|2016-06-01||Interventional|REAL||Resilient, Empowered, Active Living: REAL Diabetes Study|Diabetes Self-Management Lifestyle Intervention for Urban Minority Young Adults|Completed||N/A|81|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 00:06:52.886241|2017-10-11 00:06:52.886241
NCT02214628|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-08-23|||July 2014||2014-07-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD||Terminated||Phase 2|101|Actual|Ophthotech Corporation||1|||f||||f||||||||||2017-10-11 00:06:52.970294|2017-10-11 00:06:52.970294
NCT02214615|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2017-05-08|2016-06-15||April 2014||2014-04-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations|Pilot Study on the Response of Inherited Erythromelalgia Patients With NaV1.7 Mutations to Carbamazepine: Clinical Imaging Study|Completed||Phase 4|2|Actual|VA Connecticut Healthcare System|all subjects had to have erythromelalgia SCN9A mutation S241T|2|||f||||f||||||||||2017-10-11 00:06:53.083969|2017-10-11 00:06:53.083969
NCT02214602|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-05-18|||July 2014||2014-07-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|NMIBCIVT||Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer|The Value of Immediate Post-operative Intravesical Epirubicin Instillation in Intermediate and High Risk Non Muscle Invasive Bladder Cancer (NMIBC): A Randomized Controlled Trial|Recruiting||Phase 4|240|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 00:06:53.425186|2017-10-11 00:06:53.425186
NCT02214589|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-08-21|||August 2014||2014-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Non-pharmacological Interventions for Procedural Pain in Premature Neonates|Non-pharmacological Interventions for Procedural Pain in Premature Neonates|Recruiting||N/A|250|Anticipated|Loma Linda University||3|||f||||t||||||||||2017-10-11 00:06:53.592567|2017-10-11 00:06:53.592567
NCT02214576|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2015-08-13|||September 2011||2011-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|HIGHER||High Flow Nasal Canula Oxygen Helps Preoxygenate ARDS Patients|Observational Study of High Flow Nasal Canula Oxygen to Preoxygenate ARDS Patients That Require Intubation|Completed||N/A|50|Actual|Hôpital Louis Mourier|||1||f||||f||||||||||2017-10-11 00:06:53.692885|2017-10-11 00:06:53.692885
NCT02214563|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2017-09-24|||August 2014|Actual|2014-08-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|CHAMBER||Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients|Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients (CHAMBER): A Multicenter, Double-blind, Randomized, Placebo-controlled Trial|Completed||Phase 4|90|Anticipated|Osaka University||4|||f||||f||||||||||2017-10-11 00:06:53.783954|2017-10-11 00:06:53.783954
NCT02214550|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-07-27|||July 2014||2014-07-01|July 2016|2016-07-01|September 2025|Anticipated|2025-09-01|September 2019|Anticipated|2019-09-01||Interventional|CRAMPP||Chronic Pain Risk Associated With Menstrual Period Pain|Deciphering the Hormonal and Nociceptive Mechanisms Underlying Bladder Pain|Recruiting||Phase 4|255|Anticipated|NorthShore University HealthSystem Research Institute||5|||f||||t||||||||Undecided||2017-10-11 00:06:53.920106|2017-10-11 00:06:53.920106
NCT02214537|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-03-01|||February 2016||2016-02-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|MACs-ESD||Does DNA Sperm Fragmentation Affects Embryo Morphokinetic?|Embryo Development Measure Depending on the DNA Sperm Fragmentation|Suspended||N/A|60|Actual|IVI Madrid||1||Because we don´t have the necessary technology anymore|f||||t||||||||||2017-10-11 00:06:54.030103|2017-10-11 00:06:54.030103
NCT02214524|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-15|||August 2014||2014-08-01|August 2014|2014-08-01|January 2015|Anticipated|2015-01-01|November 2014|Anticipated|2014-11-01||Interventional|||Comparison of Active and Passive Perioperative Warming Techniques in Reducing Intraoperative Blood Loss|Comparison of Active Warming System and Conventional Passive Warming Care in Reducing Intraoperative Blood Loss for Patients Undergoing Major Surgery|Unknown status|Not yet recruiting|N/A|60|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 00:06:54.110148|2017-10-11 00:06:54.110148
NCT02214511|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-08-08|||July 2014||2014-07-01|June 2014|2014-06-01||||October 2015|Anticipated|2015-10-01||Observational|SENSO||Biomarkers of Social Sensitivity in Major Depression|Etude de la sensibilité Aux Signaux Sociaux Dans la dépression, Modulateurs Psychologiques, Comportementaux et Inflammatoires.|Unknown status|Active, not recruiting|N/A|90|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||Samples With DNA|"     Blood samples to explore inflammatory cytokines. Dosage of IL-6, IL-10, TNFa, IP-10, MCP-1,     MIP-1b, Rantes, sIL-6Ra, IL1ra, VEGF, Leptin, PECAM1, sTie2, sVEGFR1, sVEGFR2 will be     performed by luminex technique and usCRP, srIL2 ans sCD14 by ELISA technique.   "|||2017-10-11 00:06:54.209798|2017-10-11 00:06:54.209798
NCT02214498|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-13|||May 2015||2015-05-01|August 2014|2014-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|THYME||Treatment of HYpertension: Morning Versus Evening|Treatment of HYpertension: Morning Versus Evening|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Erasmus Medical Center||2|||f||||f||||||||||2017-10-11 00:06:54.291737|2017-10-11 00:06:54.291737
NCT02214485|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-08-10|||March 2011||2011-03-01|August 2014|2014-08-01|February 2012|Actual|2012-02-01|March 2011|Actual|2011-03-01||Interventional|||Integrated Care and Lower Extremity Strength Training Among Community-Dwelling Frail Older Adults in Taiwan|Integrated Care and Lower Extremity Strength Training Among Community-Dwelling Frail Older Adults in Taiwan|Completed||N/A|98|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:06:54.388758|2017-10-11 00:06:54.388758
NCT02214472|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-11-09|||January 2013||2013-01-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||Treatment of Rumination by Biofeedback - a Randomized Controlled Trial|Valoración Objetiva y Tratamiento de la rumiación.|Completed||N/A|24|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-11 00:06:54.465788|2017-10-11 00:06:54.465788
NCT02214459|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-11|2017-03-21|||July 2015|Actual|2015-07-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|DASH Mobile||Dietary Approaches to Stopping Hypertension (DASH) Mobile App Pilot|Dietary Approaches to Stopping Hypertension (DASH) Mobile App Pilot|Completed||N/A|24|Actual|Boston University||1|||f||||f||||||||||2017-10-11 00:06:56.356513|2017-10-11 00:06:56.356513
NCT02214446|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-08-21|||January 2014||2014-01-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Factors Related to Truth Telling in Primary Caregivers|Explore Factors Related to Truth Telling in Primary Caregivers of Children Newly Diagnosed With Cancer|Unknown status|Recruiting|N/A|84|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:06:56.452286|2017-10-11 00:06:56.452286
NCT02214433|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2015-02-24|||August 2014||2014-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers|A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Debio 1450 in Healthy Subjects|Completed||Phase 1|70|Actual|Debiopharm International SA||11|||f||||t||||||||||2017-10-11 00:06:56.559368|2017-10-11 00:06:56.559368
NCT02214420|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-07-05|||October 2014||2014-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||SMV + SOF With/Without RBV for IFN-II Patients With CHC|Simeprevir (SMV) + Sofosbuvir (SOF) With or Without Ribavirin (RBV) for Interferon-intolerant or Ineligible (IFN-II) Patients With Chronic Hepatitis C (CHC)|Completed||Phase 4|24|Actual|SC Liver Research Consortium, LLC||2|||f||||f||||||||||2017-10-11 00:06:56.73165|2017-10-11 00:06:56.73165
NCT02214407|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-07-11|||October 31, 2014|Actual|2014-10-31|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|GFM-DAC-CMML||Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMML|A Randomized Phase III Study of Decitabine (DAC) With or Without Hydroxyurea (HY) Versus HY in Patients With Advanced Proliferative Chronic Myelomonocytic Leukemia (CMML)|Recruiting||Phase 3|168|Anticipated|Groupe Francophone des Myelodysplasies||2|||f||||t||||||||||2017-10-11 00:06:56.847389|2017-10-11 00:06:56.847389
NCT02214394|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-08-07|||August 2014||2014-08-01|August 2014|2014-08-01||||October 2014|Anticipated|2014-10-01||Interventional|||Detection of Propofol in Exhaled Breath|Propofol in Exhaled Breath: Real-time Detection by Surface Acoustic Wave Sensors.|Unknown status|Not yet recruiting|N/A|15|Anticipated|Xhale Assurance||1|||f||||f||||||||||2017-10-11 00:06:57.137661|2017-10-11 00:06:57.137661
NCT02214381|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-06-18|||July 2014||2014-07-01|June 2015|2015-06-01|July 2021|Anticipated|2021-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response|A Prospective, Multicenter, Open-label Comparison of Pre-surgical Myocet/ Cyclophosphamide (MC) q3w Followed by Either MC or Paclitaxel - Depending on Early Response Assessment by Ultrasound or by Toxicity for Elderly Non Frail Primary Breast Cancer Patients With Increased Risk of Relapse.|Recruiting||Phase 2|300|Anticipated|West German Study Group||2|||f||||t||||||||||2017-10-11 00:06:57.342159|2017-10-11 00:06:57.342159
NCT02214368|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-08-15|||January 2013||2013-01-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Noninvasive Ventilation Bundle in Postoperative Respiratory Failure|The Efficacy and Safety of Noninvasive Ventilation Bundle in Postoperative Respiratory Failure|Completed||N/A|158|Actual|West China Hospital||2|||f||||t||||||||||2017-10-11 00:06:57.449859|2017-10-11 00:06:57.449859
NCT02214342|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-12-15|||July 2014||2014-07-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Virtual Reality Based Balance Training in People With Mild Cognitive Impairment|Virtual Reality Based Balance Training in People With Mild Cognitive Impairment: A Pilot Study|Completed||N/A|20|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 00:06:57.539676|2017-10-11 00:06:57.539676
NCT02214329|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-11|||February 2014||2014-02-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Sensor-based Balance Training in Diabetes: A Virtual Reality Paradigm|Game-Based Virtual Reality Approach for Improving Balance, Reducing Falls, and Preventing Complications In Diabetes|Unknown status|Recruiting|N/A|60|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-11 00:06:57.621216|2017-10-11 00:06:57.621216
NCT02214316|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-04-27|||October 2015||2015-10-01|April 2016|2016-04-01||||April 2016|Actual|2016-04-01||Interventional|||IVF in Pediatric Concussion||Terminated||Phase 1/Phase 2|2|Actual|Washington University School of Medicine||1|||f||||||||||||||2017-10-11 00:06:57.727862|2017-10-11 00:06:57.727862
NCT02214303|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-10|||April 2013||2013-04-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|SAIRA||The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases|The Role of Th9 Cells Expression and Eosinophils Activity in the Course of Allergic Airway Diseases|Unknown status|Recruiting|N/A|100|Anticipated|Lithuanian University of Health Sciences|||3||f||||t||||||Samples Without DNA|"     Induced sputum and peripheral blood samples   "|||2017-10-11 00:06:57.804429|2017-10-11 00:06:57.804429
NCT02214290|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-08-11|||September 2012||2012-09-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males|Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males|Completed||N/A|16|Actual|Florida State University||3|||f||||f||||||||No||2017-10-11 00:06:57.916432|2017-10-11 00:06:57.916432
NCT02214264|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-03-30|||October 2014||2014-10-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Brief Trainings to Buffer Against Acute Stress Effects|Brief Trainings to Buffer Against Acute Stress Effects|Enrolling by invitation||N/A|350|Anticipated|University of Wisconsin, Madison||4|||f||||f||||||||||2017-10-11 00:06:58.173834|2017-10-11 00:06:58.173834
NCT02214251|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-07-27|||August 2014||2014-08-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||The Electrophysiological Investigation of Higher Level Neural Manifestations of Freezing of Gait in Parkinson's Disease Patient||Completed||N/A|50|Actual|China Medical University Hospital||1|||f||||||||||||||2017-10-11 00:06:58.278321|2017-10-11 00:06:58.278321
NCT02214238|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2017-03-13|2016-10-11||August 2014||2014-08-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Evaluation of Treatment Efficacy and Comfort of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea.|Evaluation of Treatment Efficacy and Comfort of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea, in Comparison to a Market Released Device.|Completed||N/A|49|Actual|Fisher and Paykel Healthcare||2|||f||||f||||||||||2017-10-11 00:06:58.369583|2017-10-11 00:06:58.369583
NCT02214225|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-10|2017-01-31|2015-10-14||August 2014||2014-08-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional||The Full Analysis Set (FAS) was used for analysis of subject characteristics and comprised all subjects who gave informed consent and who were randomized to treatment. Screening failures were not included in the FAS.|A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.|A Phase 3, Randomized, Multicenter, Double-blinded Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (CSL QIV) in Comparison With a US Licensed 2014/2015 Trivalent Influenza Vaccine (CSL TIV-1), and a Trivalent Influenza Vaccine Containing the Alternate B Strain (CSL TIV-2), in Adults Aged 18 Years and Above.|Completed||Phase 3|3484|Actual|Seqirus||3|||f||||t||||||||||2017-10-11 00:06:58.687106|2017-10-11 00:06:58.687106
NCT02214212|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-05-13|||December 2013||2013-12-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TWILIGHT||TWILIGHT Study: Effect of Light Exposure During Acute Rehabilitation on Sleep After TBI|TWILIGHT: Effect of Light Exposure During Acute Rehabilitation on Sleep After TBI.|Recruiting||Phase 2/Phase 3|128|Anticipated|University of Washington||2|||f||||t||||||||Undecided||2017-10-11 00:07:00.708205|2017-10-11 00:07:00.708205
NCT02214160|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-05-22|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|||Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies.|An Open-label Long-Term Safety and Efficacy Extension Study in Subjects With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Previously Enrolled in UX007 or Triheptanoin Studies|Enrolling by invitation||Phase 2|100|Anticipated|Ultragenyx Pharmaceutical Inc||1|||f||||f||||||||||2017-10-11 00:07:01.871146|2017-10-11 00:07:01.871146
NCT02214147|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-08-26|||September 2014||2014-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function|Pharmacokinetics of Oral Alisertib (MLN8237) in Adult Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function|Completed||Phase 1|36|Actual|Takeda||3|||f||||f||||||||||2017-10-11 00:07:02.003384|2017-10-11 00:07:02.003384
NCT02214134|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-01-17|||May 2015||2015-05-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|5 Years|Observational [Patient Registry]|SPECTAlung||SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access|SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access|Recruiting||N/A|3500|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||3||f||||t||||||Samples With DNA|"     FFPE blocks of tumour tissue Blood samples Pleural effusion samples   "|||2017-10-11 00:07:02.155801|2017-10-11 00:07:02.155801
NCT02214121|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-03-10|||September 11, 2014|Actual|2014-09-11|March 2017|2017-03-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|HESTIA 1||A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease|Multicenter, Open-label, Randomised, Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor Followed by a Double-blind, Randomised, Parallel-group, Placebo-controlled 4 Weeks Extension Phase in Paediatric Patients With Sickle Cell Disease|Completed||Phase 2|74|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:07:02.316363|2017-10-11 00:07:02.316363
NCT02214108|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-03-03|||November 2012||2012-11-01|March 2014|2014-03-01|December 2015|Actual|2015-12-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Physical Activity Through Interactive Video Games in Overweight Children|Effect of Physical Activity Trough Interactive Video Games in Overweight, Randomized, Controlled Study.|Completed||Phase 3|60|Actual|Centro Pediatrico Albina de Patino||2|||f||||f||||||||||2017-10-11 00:07:02.485898|2017-10-11 00:07:02.485898
NCT02214095|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-08-11|||January 2012||2012-01-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Glucosamine Periodontal Adjunctive Therapy|Glucosamine Sulphate as an Adjunctive Therapy to Closed Mechanical Debridement Reduced Gingival Cervicular Fluid IL-1β in Patients With Chronic Periodontitis|Terminated||Early Phase 1|40|Actual|Ain Shams University||2||had been finished|f||||t||||||||||2017-10-11 00:07:02.618491|2017-10-11 00:07:02.618491
NCT02214082|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-09|2017-07-19|||September 2014||2014-09-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety of Same Day Discharge After Elective Percutaneous Coronary Intervention|Feasibility and Safety of Same Day Discharge After Elective Percutaneous Coronary Intervention (PCI) in a Tertiary Care Hospital in Karachi, Pakistan.|Completed||N/A|210|Actual|Indus Hospital||2|||f||||f||||||||||2017-10-11 00:07:02.732358|2017-10-11 00:07:02.732358
NCT02214069|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-01-24|||August 2014|Actual|2014-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Observational|iRead||Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation|Assessing the Accuracy of an Atrial Fibrillation Detection Algorithm Using Novel Smart Phone Technology in Detecting the Presence of Atrial Fibrillation. iRead Study|Active, not recruiting||N/A|60|Actual|The Cleveland Clinic|||1||f||||f|f|t|f|f|t|||No||2017-10-11 00:07:02.828402|2017-10-11 00:07:02.828402
NCT02214056|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-05-05|||February 2015||2015-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|DéProPAss||Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Feasibility|Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Part I Feasibility|Completed||N/A|27|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 00:07:02.923848|2017-10-11 00:07:02.923848
NCT02214043|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-07-19|||January 2012||2012-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01|5 Years|Observational [Patient Registry]|||Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population|Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population|Recruiting||N/A|600|Anticipated|Chinese Pulmonary Vascular Disease Research Group|||2||f||||t||||||Samples Without DNA|"     BNP，D-dimer   "|||2017-10-11 00:07:03.081656|2017-10-11 00:07:03.081656
NCT02214030|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-08-14|||September 2013||2013-09-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy Study of Assiut Femoral Compression Device Versus Manual Compression in the Achievement of Hemostasis|A Randomized Comparison of Assiut Femoral Compression Device Versus Manual Compression in the Achievement of Hemostasis After Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 3|400|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-11 00:07:03.205896|2017-10-11 00:07:03.205896
NCT02214004|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-05-04|||March 2015||2015-03-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|October 2017|Anticipated|2017-10-01||Interventional|HERAKLES||Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women|A Phase II Trial of Preoperative HER2 Targeting and Endocrine Therapy in Postmenopausal Women With HER2 and HR Positive Breast Cancer|Recruiting||Phase 2|132|Anticipated|Gangnam Severance Hospital||1|||f||||t||||||||Undecided||2017-10-11 00:07:03.485393|2017-10-11 00:07:03.485393
NCT02213991|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-05-04|||August 2014||2014-08-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|June 2017|Anticipated|2017-06-01||Interventional|||Intraoperative Radiotherapy for Korean Patients With Breast Cancer|A Phase II Trial Investigating Acute Local Toxicities of Intraoperative Radiotherapy as a Boost Dose in Korean Breast Cancer Patients Undergoing Breast Conserving Surgery|Active, not recruiting||Phase 2|215|Actual|Gangnam Severance Hospital||1|||f||||f||||||||Undecided||2017-10-11 00:07:03.670087|2017-10-11 00:07:03.670087
NCT02213978|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-05-26|||November 2014||2014-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|2 Weeks|Observational [Patient Registry]|VTEH||A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients|A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients|Recruiting||N/A|1000|Anticipated|Beijing Chao Yang Hospital|||1||f||||t||||||||||2017-10-11 00:07:03.781854|2017-10-11 00:07:03.781854
NCT02213965|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-07-19|||November 2014||2014-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Study Comparing the Handling of Two Peripheral IV Catheter Systems|Clinical Investigation Acc. to MPG §23b: Open-label Prospective Study Comparing the Handling of the Handling of Two Peripheral IV Catheter (PIV) Systems (Ported and Non Ported) in Randomized Order|Completed||N/A|2268|Actual|B. Braun Melsungen AG|||2||f||||f||||||||||2017-10-11 00:07:03.895692|2017-10-11 00:07:03.895692
NCT02213952|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-02-28|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|PRPULCERAS||PRP ULCERAS: Clinical Trial Phase III|Efficacy of Autologous Platelet-Rich Plasma in the Treatment of Vascular Ulcers in Primary Care: Clinical Trial Phase III|Active, not recruiting||Phase 3|150|Anticipated|Basque Health Service||2|||f||||t||||||||||2017-10-11 00:07:04.19729|2017-10-11 00:07:04.19729
NCT02213939|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-07-11|||August 2014||2014-08-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical Impact of Cytokine in Cardiac Surgery|Removal of Cytokine on Cardiopulmonary Bypass With CytoSorb® Compared to on- and Off-pump Myocardial Revascularization|Recruiting||N/A|300|Anticipated|University Hospital of Cologne|||3||f||||t||||||Samples Without DNA|"     whole blood, serum   "|||2017-10-11 00:07:04.316444|2017-10-11 00:07:04.316444
NCT02213926|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-07-28|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|February 2017|Actual|2017-02-01||Interventional|||An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma|An Open-label, Phase 2 Study of ACP-196 in Subjects With Mantle Cell Lymphoma|Active, not recruiting||Phase 2|124|Actual|Acerta Pharma BV||1|||f||||f|t|f||||||||2017-10-11 00:07:04.422367|2017-10-11 00:07:04.422367
NCT02213913|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-09-28|||July 29, 2014|Actual|2014-07-29|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas|Prospective, Multi-center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas|Recruiting||Phase 1/Phase 2|46|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-11 00:07:04.526908|2017-10-11 00:07:04.526908
NCT02213900|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-03-02|2016-12-30||September 2013||2013-09-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PE-POD||Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy|Preventing Post-Operative Delirium in Pneumonectomy, Esophagectomy and Thoracotomy Patients|Completed||Phase 4|135|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 00:07:04.741955|2017-10-11 00:07:04.741955
NCT02213887|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-11-15|||September 2014||2014-09-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|PK-PPI||Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications|A Pilot Study to Determine if Pantoprazole Modifies Steady-State Plasma Concentrations of Orally Administered Psychotropic Medications|Enrolling by invitation||Phase 4|220|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:07:05.068522|2017-10-11 00:07:05.068522
NCT02213874|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-03-15|||January 2012||2012-01-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Influence of Trust in the Health Care System on Postpartum Contraceptive Choice|The Influence of Trust in the Health Care System on Postpartum Contraceptive Choice|Completed||N/A|208|Actual|Medical University of South Carolina||1|||f||||f||||||||||2017-10-11 00:07:05.249451|2017-10-11 00:07:05.249451
NCT02213861|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-10-18|||November 2014||2014-11-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma|A Randomized Phase 2 Study to Evaluate Three Treatment Regimens of SHAPE, a Histone Deacetylase Inhibitor, in Patients With Stage IA, IB or IIA Cutaneous T-Cell Lymphoma|Active, not recruiting||Phase 2|60|Anticipated|TetraLogic Pharmaceuticals||3|||f||||f||||||||||2017-10-11 00:07:05.349888|2017-10-11 00:07:05.349888
NCT02213848|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-06-29|||August 2014||2014-08-01|August 2014|2014-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Calcium Chloride on Recovery From Neuromuscular Blockade|Effect of Calcium Chloride on Recovery From Neuromuscular Blockade in Patients Undergoing General Anesthesia|Completed||N/A|58|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:07:05.458022|2017-10-11 00:07:05.458022
NCT02213835|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-12-07|||June 2014||2014-06-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|SCD||Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative Colitis|Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative Colitis|Active, not recruiting||N/A|10|Anticipated|Seattle Children's Hospital||1|||f||||f||||||||||2017-10-11 00:07:05.553976|2017-10-11 00:07:05.553976
NCT02213822|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-08-26|||May 2013||2013-05-01|July 2014|2014-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01|5 Years|Observational [Patient Registry]|||Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis|MOLECULAR TESTING OF CANCER BY INTEGRATED GENOMIC, TRANSCRIPTOMIC, AND PROTEOMIC ANALYSIS|Unknown status|Recruiting|N/A|500|Anticipated|Rhode Island Hospital|||1||f||||f||||||Samples With DNA|"     Tissue, blood, saliva, body fluid   "|||2017-10-11 00:07:05.662676|2017-10-11 00:07:05.662676
NCT02213809|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-03-18|||October 2014||2014-10-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Case Method Education on COPD to General Practitioners|Effect of Case Method Education to General Practitioners on Their Knowledge on COPD and on the Health of Their Patients With COPD|Recruiting||N/A|180|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:07:05.846259|2017-10-11 00:07:05.846259
NCT02213432|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-02-22|||September 2014||2014-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||Influenza Vaccination in Cancer Patients|Randomized Controlled Trial to Compare Seroprotection Rate According to Timing of Influenza Vaccination in Adult Patients With Non-Hematologic Malignancies Receiving Scheduled Cytotoxic Chemotherapy|Terminated||N/A|97|Actual|Seoul National University Hospital||2||Insufficient enrollment|f||||f||||||||||2017-10-11 00:07:10.434591|2017-10-11 00:07:10.434591
NCT02213796|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-08|||January 2013||2013-01-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units|Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units|Completed||Phase 4|9|Actual|Prince of Songkla University||1|||f||||f||||||||||2017-10-11 00:07:05.978646|2017-10-11 00:07:05.978646
NCT02213783|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2014-08-08|||February 2011||2011-02-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia|Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia Following Administration by 4-hour Infusion and Bolus Injection.|Completed||Phase 4|12|Actual|Prince of Songkla University||2|||f||||f||||||||||2017-10-11 00:07:06.100628|2017-10-11 00:07:06.100628
NCT02213770|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-01-22|||August 2014||2014-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Long Term Effect of High-intensity Training After Heart Transplantation||Completed||N/A|41|Actual|Oslo University Hospital|||2||f||||f||||||Samples Without DNA|"     Blodsamples from the patients will be studied:      Standard samples: RBC, WBC, plates, CRP, kreatinin, urea, liver tests, thyorid gland tests,     lipid profile, fasting- glucose og hba1c, Pro BNP, troponin T, uric acid.      Supplement: Inflammation cytokines/chemokines such as TNF alfa, sTNFR2 og IL-6, IL-10, MCP-1     og IL-8. Growth factors and inhibitors for innervation. Markers for endothelial function;     endotelin and von- Willebrand faktor and anti- trombotic factors; fibrinogen, plasminogen     activator inhibitor-1.   "|||2017-10-11 00:07:06.220923|2017-10-11 00:07:06.220923
NCT02213757|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-03-14|||August 2014||2014-08-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|EVER||Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)|Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH): A Randomized Controlled Trial [EVER Study]|Recruiting||Phase 4|124|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||No||2017-10-11 00:07:06.354823|2017-10-11 00:07:06.354823
NCT02213744|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-01-04|||July 2014||2014-07-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|HERMIONE||MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients|A Randomized, Multicenter, Open Label Study of MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in Anthracycline Naive Patients With Locally Advanced/Metastatic HER2-Positive Breast Cancer|Terminated||Phase 2/Phase 3|113|Actual|Merrimack Pharmaceuticals||2||Felt not to show benefit over control per DMC and confirmed via futility analysis|f||||||||||||||2017-10-11 00:07:06.511177|2017-10-11 00:07:06.511177
NCT02213731|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-09-12|||December 2014||2014-12-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Cryoballoon Ablation for Early Persistent Atrial Fibrillation (Cryo4 Persistent AF)|Cryoballoon Ablation for Early Persistent Atrial Fibrillation|Active, not recruiting||N/A|130|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||f||||||||||2017-10-11 00:07:06.865173|2017-10-11 00:07:06.865173
NCT02213718|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-08-07|||July 2014||2014-07-01|August 2014|2014-08-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||The Effect of Desflurane on Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting|The Effect of Desflurane on Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting|Unknown status|Recruiting|Phase 4|60|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 00:07:07.011354|2017-10-11 00:07:07.011354
NCT02213705|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-04-15|||June 2014||2014-06-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|MSC||Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells|Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells|Recruiting||Phase 1/Phase 2|20|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||||||||||||2017-10-11 00:07:07.174398|2017-10-11 00:07:07.174398
NCT02213692|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-02-02|||May 2014||2014-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|7 Days|Observational [Patient Registry]|||Comparative Study on Liver Resection Between Harmonic Scalpel Versus Crush-clamping Method|Comparative Study on Liver Resection Between Harmonic Scalpel Versus Crush-clamping Method: A Prospective Randomized Study|Terminated||N/A|120|Actual|Fudan University|||2||f||||t||||||||||2017-10-11 00:07:07.289953|2017-10-11 00:07:07.289953
NCT02213679|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-01-30|||August 2014||2014-08-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Guanidinoacetic Acid Loading for Chronic Fatigue Syndrome|Guanidinoacetic Acid Loading for Chronic Fatigue Syndrome|Completed||N/A|20|Actual|Center for Health, Exercise and Sport Sciences, Serbia||2|||f||||t||||||||Undecided||2017-10-11 00:07:07.408842|2017-10-11 00:07:07.408842
NCT02213666|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-03-23|2016-01-14||January 2012||2012-01-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Observational|ICE-TEE|Patients enrolled into study that underwent ICE and TEE imaging.|Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography|Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography for Imaging of the Left Atrial Appendage and Right Atrial Appendage in Patients With Atrial Fibrillation|Completed||N/A|72|Actual|Beth Israel Deaconess Medical Center|This study compared TEE and ICE for visualization of the LAA and RAA in a specific patient population with nonvalvular AF treated with chronic anti-coagulation. The utility of ICE in other patient populations has not been examined.||1||f||||f||||||||No||2017-10-11 00:07:07.535412|2017-10-11 00:07:07.535412
NCT02213653|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-04-28|||April 2013||2013-04-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency|Phase IV Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency|Terminated||Phase 4|24|Actual|Centre Francois Baclesse||3|||f||||t||||||||||2017-10-11 00:07:07.736938|2017-10-11 00:07:07.736938
NCT02213640|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-02-14|||December 26, 2014|Actual|2014-12-26|February 2017|2017-02-01|December 25, 2019|Anticipated|2019-12-25|December 25, 2019|Anticipated|2019-12-25||Interventional|PRIStiM1||Potentiation of the Effects of Prismatic Adaptation by Transcranial Direct Current Stimulation (tDCS) : Evaluation of Functional Interest in Negligence Rehabilitation|Potentiation of the Effects of Prismatic Adaptation by Transcranial Direct Current Stimulation (tDCS) : Evaluation of Functional Interest in Negligence Rehabilitation|Recruiting||N/A|24|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 00:07:07.867841|2017-10-11 00:07:07.867841
NCT02213614|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-06-22|||August 2014||2014-08-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|December 2015|Anticipated|2015-12-01||Interventional|LWGVP||Lithium Water in Gun Violence Prevention|Lithium Water Use in Gun Violence Prevention|Unknown status|Active, not recruiting|N/A|400|Anticipated|American Society Of Thermalism And Climatology Inc||2|||f||||t||||||||||2017-10-11 00:07:08.099732|2017-10-11 00:07:08.099732
NCT02213601|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||June 2011||2011-06-01|August 2014|2014-08-01||||October 2012|Actual|2012-10-01||Interventional|||Efficacy of Yoga for Postpartum Depression|Efficacy of Yoga for Depressed Postpartum Women: A Randomized Controlled Trial|Completed||N/A|57|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 00:07:08.386198|2017-10-11 00:07:08.386198
NCT02213588|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||July 2013||2013-07-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Plant Concentrate Blend on Oxidative Stress in Healthy Humans|Effects of Plant Concentrate Blend on Oxidative Stress in Healthy Humans|Completed||N/A|120|Actual|Access Business Group||2|||f||||t||||||||||2017-10-11 00:07:08.502029|2017-10-11 00:07:08.502029
NCT02213575|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-08-07|||July 15, 2017|Actual|2017-07-15|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study 3: Minocycline Decreases Microglia Activation|Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients|Recruiting||Phase 1|9|Anticipated|University of Florida||1|||f||||f|f|f||||||||2017-10-11 00:07:08.589915|2017-10-11 00:07:08.589915
NCT02213562|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-08-15|||July 2014||2014-07-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia|A Randomized, Double-blind, Parallel Group Study to Evaluate the Effect of Chrysanthemum Flower Oil and Its Dose-dependency in Subjects With Hyperuricemia|Completed||N/A|21|Anticipated|Hiroshima University||3|||f||||f||||||||||2017-10-11 00:07:08.68401|2017-10-11 00:07:08.68401
NCT02213549|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2015-03-17|||July 2014||2014-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Coadministration of Ume Paste (Prunus Mume) and Ginger Powder|A Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Determine the Effect of Ume Paste and Ginger Powder in Prediabetic Subjects.|Completed||N/A|40|Anticipated|Hiroshima University||2|||f||||f||||||||||2017-10-11 00:07:08.777778|2017-10-11 00:07:08.777778
NCT02213536|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-02-18|||August 2015||2015-08-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|September 2016|Anticipated|2016-09-01||Observational|SPARE||Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain.|Investigating the Efficacy of Scalp Sparing Radiotherapy Treatment to the Whole Brain: Examining the Effect of Hair Loss and Re-growth|Recruiting||N/A|20|Anticipated|HCA International Limited|||1||f||||f||||||||||2017-10-11 00:07:08.867739|2017-10-11 00:07:08.867739
NCT02213523|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||September 2012||2012-09-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|November 2012|Actual|2012-11-01||Interventional|||ABG Oxidative Stress Study Protocol-1|Proof of Concept Study to Evaluate the Effect of Oxidative Stress Response of Plant Concentrate Blends in Healthy Men|Completed||N/A|60|Actual|Access Business Group||4|||f||||t||||||||||2017-10-11 00:07:08.98051|2017-10-11 00:07:08.98051
NCT02213510|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-05-18|2016-02-29||August 2014||2014-08-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ZIPS||ZIPS Study - Zip Incision aPproximation vs. Suture|A Prospective, Non-blinded, Randomized Controlled Post-market Study Designed to Compare the Use of the Zip Surgical Skin Closure Device Versus Conventional Sutures for Skin Closure in Subjects Who Undergo a CIED Procedure.|Completed||N/A|40|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:07:09.104471|2017-10-11 00:07:09.104471
NCT02213497|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-06-21|||April 2014||2014-04-01|June 2016|2016-06-01||||April 2017|Anticipated|2017-04-01||Interventional|||Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer|Phase I Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer|Recruiting||Phase 1|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 00:07:10.042135|2017-10-11 00:07:10.042135
NCT02213484|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-03-14|||July 1, 2014|Actual|2014-07-01|March 2017|2017-03-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Observational|||Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes|Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes|Completed||N/A|20|Actual|University of Colorado, Denver|||2||f||||f|f|f||||Samples With DNA|"     Fractionated blood samples will be retained at a part of the study including plasma,     platelets and mononuclear cells. At this time genetic testing (genotyping) of individual     biospecimens is not included in the IRB-approved protocol.   "|||2017-10-11 00:07:10.135945|2017-10-11 00:07:10.135945
NCT02213471|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-08|||July 2012||2012-07-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Patient Preference for Biopsy Notification|Patient Preference for Biopsy Notification|Completed||N/A|301|Actual|University of California, San Francisco|||1||f||||||||||||||2017-10-11 00:07:10.231702|2017-10-11 00:07:10.231702
NCT02213458|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-03-24|||February 2015||2015-02-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Care Ecosystem: Navigating Patients and Families Through Stages of Care|University of California, San Francisco (UCSF) and University of Nebraska Medical Center (UNMC) Care Ecosystem|Active, not recruiting||N/A|780|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:07:10.322358|2017-10-11 00:07:10.322358
NCT02213419|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-02-10|||October 2014||2014-10-01|July 2014|2014-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study|EUS-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study|Unknown status|Recruiting|Phase 1|40|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 00:07:10.540012|2017-10-11 00:07:10.540012
NCT02213406|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-07-04||||||July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|||Neuronal and Sensory Perception of Fat|Fat and the Brain-Neuronal and Sensory Fat Perception|Completed||N/A|||University Hospital Tuebingen||1|||f||||f||||||||||2017-10-11 00:07:10.641799|2017-10-11 00:07:10.641799
NCT02213393|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-11-11|||October 2014||2014-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CwC||Cater With Care Effect Study|Effectiveness of Cater With Care Products in Reaching Recommendations for Protein Intake During and After Hospital Stay and in Improving Functional Status After Hospital Stay in Elderly Patients.|Completed||N/A|162|Actual|Wageningen University||2|||f||||f||||||||||2017-10-11 00:07:10.748152|2017-10-11 00:07:10.748152
NCT02213380|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-09-20|||September 2014||2014-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|RAGADelirium||Effect of Anesthesia on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery|Effect of Regional Anaesthesia and General Anaesthesia on Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery: a Multicenter Randomized Controlled Trial.|Recruiting||N/A|1000|Anticipated|Wenzhou Medical University||2|||f||||t||||||||||2017-10-11 00:07:10.857167|2017-10-11 00:07:10.857167
NCT02213367|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-08-25|||July 2014||2014-07-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Bilastine Updosing in Chronic Spontaneous Urticaria|Phase 3 Study, Exploratory, Disease Activity Controlled Dose Escalating Study to Assess the Efficacy, and Safety of Treatment With Bilastine 20 mg, 40 mg and 80 mg in Chronic Spontaneous Urticaria.|Completed||Phase 3|30|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 00:07:11.03965|2017-10-11 00:07:11.03965
NCT02213354|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-07-03||2017-07-03|October 2014||2014-10-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||H7N9 Mix and Match With MF59 in Healthy Elderly Persons|A Phase II Randomized, Partially-Blinded, Controlled Trial in Healthy Adults Aged 65 Years and Older to Assess the Safety, Reactogenicity, and Immunogenicity of an MF59-Adjuvanted, Monovalent Inactivated Influenza A/H7N9 Virus Vaccine Administered Intramuscularly at Different Intervals and Dosages|Completed||Phase 2|479|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-10-11 00:07:11.138275|2017-10-11 00:07:11.138275
NCT02213341|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-11-07|||August 2014||2014-08-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Impact of Vaccination on Th2 Immunity in Infancy|Impact of Vaccination on Th2 Immunity in Infancy|Completed||N/A|77|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:07:11.26915|2017-10-11 00:07:11.26915
NCT02213328|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-03-31|||April 2015||2015-04-01|March 2017|2017-03-01|March 1, 2016|Actual|2016-03-01|March 1, 2016|Actual|2016-03-01||Interventional|||Evaluating the Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents|CHAMPS: Choices For Adolescent Prevention Methods For South Africa. Pilot Study B: 'PlusPills' A Demonstration Open Label Study to Assess the Acceptability and Use of Truvada Pre-exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents, 15-19 Years of Age|Completed||Phase 2|149|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-11 00:07:11.362962|2017-10-11 00:07:11.362962
NCT02213315|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-01-08|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Pharmacokinetics, Immunogenicity, and Safety of Mavrilimumab in Healthy Japanese Subjects|Completed||Phase 1|39|Actual|MedImmune LLC||3|||f||||f||||||||||2017-10-11 00:07:11.465346|2017-10-11 00:07:11.465346
NCT02213302|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-02-10|||July 2014||2014-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Premedication by Midazolam for Emergency Surgery|Effects of Premedication by Midazolam on Preoperative Anxiety for Emergency Surgery|Completed||Phase 4|59|Actual|University Hospital, Lille||2|||f||||t||||||||||2017-10-11 00:07:11.545525|2017-10-11 00:07:11.545525
NCT02213289|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-06-06|||January 2015||2015-01-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression|PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression|Recruiting||Phase 2|104|Anticipated|University of Chicago||6|||f||||t||||||||||2017-10-11 00:07:11.767059|2017-10-11 00:07:11.767059
NCT02213276|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-06-09|||August 2014||2014-08-01|August 2014|2014-08-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|GLUBONE||The Effect of Glucose on Bone - Direct og Indirect?|The Effect of Glucose on Bone - Direct or Indirect?|Unknown status|Active, not recruiting|N/A|12|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-10-11 00:07:11.864025|2017-10-11 00:07:11.864025
NCT02213263|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-09-28|||September 30, 2014|Actual|2014-09-30|September 2017|2017-09-01|April 25, 2018|Anticipated|2018-04-25|October 30, 2017|Anticipated|2017-10-30||Interventional|||A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)|A Phase 3, Randomized, Double-blind Study Of Pf-05280586 Versus Rituximab For The First-line Treatment Of Patients With Cd20-positive, Low Tumor Burden, Follicular Lymphoma|Recruiting||Phase 3|394|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-11 00:07:12.00574|2017-10-11 00:07:12.00574
NCT02213250|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-06-13|2016-05-04||March 2015||2015-03-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All participants were included in the baseline population.|An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B|An Open-label, Single Dose Pharmacokinetic Study Of Benefix (Nonacog Alfa, Recombinant Factor Ix) In Male Chinese Subjects With Hemophilia B|Completed||Phase 1|12|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:07:14.812026|2017-10-11 00:07:14.812026
NCT02213237|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-12-12|||July 2011||2011-07-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Application of SERS and Metabolomics in Sepsis|The Application of SERS and Metabolomics in Sepsis|Recruiting||N/A|120|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 00:07:15.209067|2017-10-11 00:07:15.209067
NCT02213224|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-08|||August 2014||2014-08-01|August 2014|2014-08-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|NF-NAFLD||Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease|Evaluation of Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|180|Anticipated|Nanfang Hospital of Southern Medical University||3|||f||||t||||||||||2017-10-11 00:07:15.295871|2017-10-11 00:07:15.295871
NCT02213211|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-01-03|||April 2014||2014-04-01|August 2014|2014-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||School-based Programme of Malaria Diagnosis and Treatment in Southern Malawi|Impact of a School-based Programme of Malaria Diagnosis and Treatment on School Attendance in Southern Malawi|Completed||N/A|3667|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||Yes|"In order to maximise the usefulness of the study results, it is intended that individual participant data (IPD) will be shared with the wider research community for scientific purposes only, as anonymized, non-personal, individual and summary information. The information will be shared in ways that do not reveal individual participant's identities or household location. The data will be available, on request, through The Data Compass: the London School of Hygiene & Tropical Medicine (LSHTM) curated digital repository of research data. This will be made available at the stage of publication of the impact results in 2017."|2017-10-11 00:07:15.407205|2017-10-11 00:07:15.407205
NCT02213198|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-01-25|2016-11-08||August 2014||2014-08-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Improving Transitional Care Experiences in Mental Health|Improving Transitional Care Experiences in Mental Health|Completed||N/A|465|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||Yes|Deidentified data provided by PI as requested velligand@uthscsa.edu|2017-10-11 00:07:15.514631|2017-10-11 00:07:15.514631
NCT02213185|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-11-19|||September 2014||2014-09-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||EMLA and Sterile Water Injections - Pain From Injections|Effect of EMLA® Patches for Reducing Pain Associated With Sterile Water Injections - a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|University of Skövde||4|||f||||f||||||||Undecided||2017-10-11 00:07:16.019432|2017-10-11 00:07:16.019432
NCT02213172|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-01-06|||September 2014||2014-09-01|January 2017|2017-01-01||||August 2017|Anticipated|2017-08-01||Interventional|14PIHL||Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome|Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome: an 8-Week, Randomized, Placebo-Controlled Study|Recruiting||Phase 2|285|Anticipated|KGK Synergize Inc.||3|||f||||||||||||||2017-10-11 00:07:16.141199|2017-10-11 00:07:16.141199
NCT02213159|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2016-07-12|||July 2014||2014-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery|Intraoperative Dexmedetomidine Versus Morphine for Postoperative Analgesia After Laparoscopic Bariatric Surgery|Completed||Phase 2/Phase 3|60|Actual|American University of Beirut Medical Center||2|||f||||f||||||||No||2017-10-11 00:07:16.264283|2017-10-11 00:07:16.264283
NCT02213146|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2017-05-31|||August 2014||2014-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes|A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes|Completed||Phase 1/Phase 2|38|Actual|Adocia||3|||f||||f||||||||||2017-10-11 00:07:16.376775|2017-10-11 00:07:16.376775
NCT02213133|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-08-03|||July 2014||2014-07-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|STARRS||Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas|A Phase 2, Open-Label Study of the Safety and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck, Lung, or Esophagus|Terminated||Phase 2|45|Actual|Karyopharm Therapeutics Inc||1||"Due to enrollment challenges and availability of other options for lung cancer patients. The   termination is not a consequence of any safety concern."|f||||f||||||||Yes||2017-10-11 00:07:16.503607|2017-10-11 00:07:16.503607
NCT02213120|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-08|2015-05-27|||August 2014||2014-08-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|VERTIGO||To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.|To Study the Characteristics of Different Types of Vertigo in Patients Attending the ENT Clinics.|Completed||N/A|400|Actual|Abbott|||1||f||||f||||||||||2017-10-11 00:07:16.658241|2017-10-11 00:07:16.658241
NCT02213107|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-08-22|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Enzalutamide & Dutasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.|A Phase II Study of Enzalutamide Plus Dutasteride as First Line Treatment for Vulnerable Patients =/> 65 Years Old With Systemic Prostate Cancer.|Active, not recruiting||Phase 2|40|Anticipated|University of Rochester||1|||f||||t||||||||||2017-10-11 00:07:16.792848|2017-10-11 00:07:16.792848
NCT02213094|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-06-30|||October 2013||2013-10-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Nicotinamide Safety Study|A Dose Escalation Safety Study of Vitamin B3 Amide Supplementation in Women With Hypertensive Complications of Pregnancy|Completed||Phase 1|10|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 00:07:16.904558|2017-10-11 00:07:16.904558
NCT02213081|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-09-27|||February 2015||2015-02-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Ulipristal for Endometriosis-related Pelvic Pain|Phase IV Pilot Study of Ulipristal Acetate for Treatment of Endometriosis-related Pelvic Pain|Active, not recruiting||Phase 4|25|Anticipated|Northwestern University||1|||f||||f||||||||No||2017-10-11 00:07:17.017707|2017-10-11 00:07:17.017707
NCT02213068|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-09-15|||July 2014||2014-07-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Belatacept 3 Month Post Transplant Conversion Study|Randomized Conversion Of Epstein-Barr Virus (EBV)+ Kidney Transplant Recipients Of Living Or Standard Criteria Donors At Three Months Post Transplantation To Belatacept With MPA Or Belatacept With Low-Dose Tacrolimus (50% Of Dose) Compared To Patients Remaining On Center Specific Standard Therapy Of Tacrolimus And MPA|Recruiting||Phase 4|51|Anticipated|Northwestern University||3|||f||||f||||||||||2017-10-11 00:07:17.138104|2017-10-11 00:07:17.138104
NCT02213055|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-06-20|2016-03-30||May 2009||2009-05-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||There were 58 evaluable subjects in the experimental (LiceMD) arm of the study.|Pediatric Head Lice Study Product Comparison|Safety and Efficacy of a 100% Dimethicone Pediculocide in School-Age Children|Completed||Phase 2|97|Actual|Hackensack University Medical Center||2|||f||||f||||||||Yes|The protocol and clinical dataset will be made available upon request to any scientist wishing to use them for non-commercial purposes.|2017-10-11 00:07:17.283305|2017-10-11 00:07:17.283305
NCT02213029|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-05-03|||August 28, 2014|Actual|2014-08-28|May 2017|2017-05-01|February 7, 2016|Actual|2016-02-07|February 7, 2016|Actual|2016-02-07||Interventional|||A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban|Study IVF116828:A Multi-Cohort Phase I Study to Investigate the Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban (GSK557296) in Healthy Female Volunteers During Control and Challenge States With and Without Oxytocin|Terminated||Phase 1|33|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:07:17.835224|2017-10-11 00:07:17.835224
NCT02213016|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-08|||September 2013||2013-09-01|August 2014|2014-08-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|||Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients|Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Cognitive, Anxiety and Depressive Symptoms in Patients Diagnosed With Major Depressive Disorder|Unknown status|Recruiting|Phase 4|80|Anticipated|Universidad Nacional Autonoma de Mexico||4|||f||||t||||||||||2017-10-11 00:07:17.95233|2017-10-11 00:07:17.95233
NCT02212990|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-04-05|||September 2014||2014-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine|Clinical Immunization Safety Assessment (CISA): A Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (IIV) Administered to Children 6 Through 47 Months of Age|Completed||Phase 4|104|Actual|Duke University||3|||f||||f||||||||||2017-10-11 00:07:18.332934|2017-10-11 00:07:18.332934
NCT02212977|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-10-14|2016-06-20||September 2014||2014-09-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Comparison of Topical Skin Adhesive to Subcuticular Suture Closure of Implantable Port Incisions|Comparison of Topical Skin Adhesive to Subcuticular Suture Closure of Implantable Port Incisions|Completed||N/A|109|Actual|Duke University|Small sample size, underpowered to demonstrate small differences in rates of dehiscence or infection.|2|||f||||f||||||||||2017-10-11 00:07:18.459303|2017-10-11 00:07:18.459303
NCT02212964|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-03-30|||July 2014||2014-07-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Differentiation of Pseudoprogression and True Progression Through High Field Susceptibility Weighted Imaging and R2*|Differentiation of Pseudoprogression and True Progression Through High Field Susceptibility Weighted Imaging and R2*|Completed||N/A|18|Actual|Centre for Functional and Metabolic Mapping|||1||f||||f||||||||||2017-10-11 00:07:18.805566|2017-10-11 00:07:18.805566
NCT02212951|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-01-15||2016-01-15|May 2014||2014-05-01|January 2016|2016-01-01||||July 2014|Actual|2014-07-01||Interventional|||Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500|A Single-blind Crossover Study of the Pharmacokinetic and Postprandial Glucose Dynamics of BIOD-531 Compared to Humulin R U-500 and Humalog Mix 75/25 in Subjects With Type 2 Diabetes Mellitus Who Are Treated With 50-200 Units of Insulin Per Day|Completed||Phase 1/Phase 2|12|Actual|Biodel||4|||f||||f||||||||||2017-10-11 00:07:18.915064|2017-10-11 00:07:18.915064
NCT02212938|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||September 2006||2006-09-01|August 2014|2014-08-01||||November 2006|Actual|2006-11-01||Interventional|||Influence of a Standardised High Fat Breakfast on the Bioavailability of BI 14332 CL in Healthy Male Volunteers|Influence of a Standardised High Fat Breakfast on the Bioavailability of 10 mg BI 14332 CL Taken as Two Tablets of 5 mg q.d. in Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Two-way Crossover Trial)|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:07:19.04742|2017-10-11 00:07:19.04742
NCT02212730|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-09-15|||December 3, 2014|Actual|2014-12-03|September 2017|2017-09-01|June 21, 2021|Anticipated|2021-06-21|June 21, 2021|Anticipated|2021-06-21||Interventional|||A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)|A Clinical Trial to Evaluate the Effect of Neoadjuvant MK-3475 (Pembrolizumab) Therapy on Intratumoral Immune Infiltrates in Renal Cell Cancer (RCC) Patients Undergoing Surgical Resection|Recruiting||Phase 1|36|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||f||||||||2017-10-11 00:07:20.956424|2017-10-11 00:07:20.956424
NCT02212925|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||November 2006||2006-11-01|August 2014|2014-08-01||||March 2007|Actual|2007-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses (0.5, 2.5, 10 and 20 mg q.d. for 10 Days) of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes (Randomised, Double-blind, Placebo-controlled Within the Dose Groups), Followed by a 4-week Treatment Part* (Randomised, Double-blind, Placebo-controlled) of Two Doses (Planned 5 and 20 mg) Selected on the Basis of Tolerability and DPP-4 Inhibition in the Multiple Rising Dose Part|Terminated||Phase 1|38|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:07:19.144711|2017-10-11 00:07:19.144711
NCT02212899|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2016-12-04|||February 2015||2015-02-01|December 2016|2016-12-01|February 2025|Anticipated|2025-02-01|December 2016|Actual|2016-12-01|10 Years|Observational [Patient Registry]|||Prospective, Observational Registry of Renaissance-guided Spine Surgeries|Prospective, Observational Registry of Renaissance-guided Spine Surgeries|Terminated||N/A|93|Actual|Mazor Robotics|||1|Sponsor Decision|f||||f||||||||||2017-10-11 00:07:19.347548|2017-10-11 00:07:19.347548
NCT02212886|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-06-01|||October 2014||2014-10-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS|A Prospective 1-year, Open-label, Two Arms, Multicentre, Phase IIa Study to Assess Safety, Tolerability and Efficacy of Once a Month Long-acting Intramuscular Injection of 80 or 40 mg Glatiramer Acetate (GA Depot) in Subjects With Relapsing Remitting Multiple Sclerosis(RRMS)|Active, not recruiting||Phase 1/Phase 2|24|Actual|Mapi Pharma Ltd.||2|||f||||f||||||||||2017-10-11 00:07:19.444554|2017-10-11 00:07:19.444554
NCT02212873|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-09-21|||February 2014||2014-02-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|MyBFF@school||My Body is Fit and Fabulous at School|School-based Intervention Program - My Body is Fit and Fabulous|Completed||N/A|332|Actual|Ministry of Health, Malaysia||2|||f||||t||||||||||2017-10-11 00:07:19.558218|2017-10-11 00:07:19.558218
NCT02212860|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-11-04|||March 2015||2015-03-01|November 2016|2016-11-01|April 2023|Anticipated|2023-04-01|April 2018|Anticipated|2018-04-01||Interventional|SIGNAL||Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy|A Phase II Trial to Evaluate Single Dose Stereotactic Radiation Therapy (SBRT) Prior to Surgery for Early Stage Breast Carcinoma|Recruiting||Phase 2|120|Anticipated|Lawson Health Research Institute||1|||f||||t||||||||Undecided||2017-10-11 00:07:19.663566|2017-10-11 00:07:19.663566
NCT02212847|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-10-25|||July 2013||2013-07-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Spatial Orientation and Vestibular Function|Spatial Orientation and Vestibular Function in Patients With Acute or Chronic Unilateral Vestibular Deficits and in Patients With Bilateral Vestibular Deficits|Recruiting||N/A|120|Anticipated|University of Zurich||1|||f||||f||||||||No||2017-10-11 00:07:19.787926|2017-10-11 00:07:19.787926
NCT02212834|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-03-15|2016-11-28||October 2013||2013-10-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|SIMBA|Characteristics at time of surveillance exam|Surveillance Imaging Modalities for Breast Cancer Assessment|Comparative Effectiveness of Surveillance Modalities in Breast Cancer Survivors|Completed||N/A|36444|Actual|Kaiser Permanente|This study was not a clinical trial. It was a cohort analysis of existing data.||2||f||||f||||||||No||2017-10-11 00:07:19.897322|2017-10-11 00:07:19.897322
NCT02212821|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-11-29|||September 2014||2014-09-01|August 2014|2014-08-01||||September 2016|Actual|2016-09-01||Interventional|||Brain Mechanisms Underlying the Effect of the Motilin Receptor Agonist Erythromycin on Hunger in Normal Weight Subjects||Completed||Phase 4|14|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:07:20.334579|2017-10-11 00:07:20.334579
NCT02212808|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-03-21|||May 2014||2014-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Antimicrobial Stewardship in Community Hospitals|A Multicenter, 3-Stage Cluster Randomized Historically-Controlled Crossover Trial to Determine the Feasibility and Outcomes From Two Antimicrobial Stewardship Interventions in Community Hospitals|Completed||N/A|3972|Actual|Duke University||2|||f||||t||||||||||2017-10-11 00:07:20.42786|2017-10-11 00:07:20.42786
NCT02212795|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-06-25|||May 2014||2014-05-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|Bacteriocide||Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin|Phase I Study of Pharmacokinetics and Bacteriocidal Activity|Completed||Phase 1|18|Actual|Dong Wha Pharmaceutical Co. Ltd.||3|||f||||t||||||||||2017-10-11 00:07:20.529357|2017-10-11 00:07:20.529357
NCT02212782|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-06-25|||September 2014||2014-09-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|PLID||the Pharmacokinetic Profiles of Linagliptin With DW1029M|A Randomized, Open-label, Multiple-dose, Crossover Phase I Clinical Study to Evaluate DW1029M Influence the Pharmacokinetic Profiles of Linagliptin After Oral Administration in Healthy Male Volunteer|Completed||Phase 1|12|Actual|Dong Wha Pharmaceutical Co. Ltd.||2|||f||||t||||||||||2017-10-11 00:07:20.658682|2017-10-11 00:07:20.658682
NCT02212769|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-06-25|||August 2014||2014-08-01|August 2014|2014-08-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|PLD||the Pharmacokinetic Profiles of Losartan With DW1029M|A Randomized, Open-label, Multiple-dose, Crossover Phase I Clinical Study to Evaluate DW1029M Influence the Pharmacokinetic Profiles of Losartan After Oral Administration in Healthy Male Volunteer|Completed||Phase 1|12|Actual|Dong Wha Pharmaceutical Co. Ltd.||2|||f||||t||||||||||2017-10-11 00:07:20.754231|2017-10-11 00:07:20.754231
NCT02212756|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-06-25|||August 2014||2014-08-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|PMD||Pharmacokinetic Profiles of Metformin With DW1029M|A Randomized, Open-label, Multiple-dose, Crossover Phase I Clinical Study to Evaluate DW1029M Influence the Pharmacokinetic Profiles of Metformin After Oral Administration in Healthy Male Volunteer|Completed||Phase 1|12|Actual|Dong Wha Pharmaceutical Co. Ltd.||2|||f||||t||||||||||2017-10-11 00:07:20.846147|2017-10-11 00:07:20.846147
NCT02212717|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-07-18|||August 2014||2014-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DRAC||A Randomized Controlled Trial on EGBD vs PC for Acute Cholecystitis.|Endosonography-guided Gallbladder Drainage (EGBD) Versus Percutaneous Cholecystostomy (PC) in Patients Suffering From Acute Cholecystitis That Are Unsuitable for Surgery. A Randomized Controlled Trial.|Recruiting||Phase 2/Phase 3|60|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:07:21.064967|2017-10-11 00:07:21.064967
NCT02212704|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-12-01|||October 2014||2014-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Verticality Perception - Multisensory Contribution|Verticality Perception - Dissociating Head and Trunk Contributors in Healthy Human Subjects|Completed||N/A|12|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 00:07:21.178968|2017-10-11 00:07:21.178968
NCT02212691|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-10-25|||January 2012||2012-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Functional Neuroimaging of Pain Using EEG and fMRI|Functional Neuroimaging of Pain in Sickle Cell Disease Patients|Recruiting||N/A|25|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||No||2017-10-11 00:07:21.255039|2017-10-11 00:07:21.255039
NCT02212678|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-02-17|||September 2014||2014-09-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease|Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease|Completed||Phase 2|9|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-11 00:07:21.336735|2017-10-11 00:07:21.336735
NCT02212665|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-05-30|||January 2014||2014-01-01|May 2017|2017-05-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Life Without Diabetes|Life Without Diabetes|Active, not recruiting||N/A|125|Anticipated|University Hospital, Gentofte, Copenhagen||5|||f||||f||||||||||2017-10-11 00:07:21.598381|2017-10-11 00:07:21.598381
NCT02212652|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-08-29|||January 2017||2017-01-01|August 2016|2016-08-01||||April 2020|Anticipated|2020-04-01||Interventional|VISTA||Vitamin D to Improve Nutrition Prior to Bariatric Surgery and Investigate the Relationship With Negative Outcomes|The Effect of VItamin D Supplementation on Nutritional STatus and Adverse Outcomes in Bariatric Surgery (VISTA)|Not yet recruiting||N/A|70|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 00:07:21.72999|2017-10-11 00:07:21.72999
NCT02212639|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-04-15|||September 2014||2014-09-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|KADIG 01||Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma|Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma|Recruiting||Phase 2|17|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:07:21.888962|2017-10-11 00:07:21.888962
NCT02212626|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-07-31|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ROBINSON||Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion||Completed||Phase 4|30|Actual|Flanders Medical Research Program||1|||f||||||||||||||2017-10-11 00:07:22.000776|2017-10-11 00:07:22.000776
NCT02212613|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-07-05|||September 2014||2014-09-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability|Protocol 331-13-004: An Exploratory, Multicenter, Single-blind, fMRI Study of Fixed-dose Brexpiprazole (OPC 34712) (2 mg/Day Tablets) as an Adjunctive Treatment|Withdrawn||Phase 3|0|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1||Low enrollment|f||||f||||||||||2017-10-11 00:07:22.104217|2017-10-11 00:07:22.104217
NCT02212600|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|2 Years|Observational [Patient Registry]|||Proximal Humerus Fracture: A Prospective Cohort|Determinants of Functional Outcome and Quality of Life in Patients With a Low Energy, Proximal Humerus Fracture: A Prospective Cohort|Not yet recruiting||N/A|500|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-11 00:07:22.208144|2017-10-11 00:07:22.208144
NCT02212587|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-06-09|||September 2014||2014-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex|Pilot Study of the in Vivo Efficacy of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex|Completed||Phase 1|10|Actual|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-11 00:07:22.322747|2017-10-11 00:07:22.322747
NCT02212574|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-10-05|||March 2015||2015-03-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma|Pilot Study Assessing the Feasibility of a Surgery and Chemotherapy-Only Approach in the Upfront Therapy of Children With Wnt Positive Standard Risk Medulloblastoma|Recruiting||N/A|13|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:07:22.422048|2017-10-11 00:07:22.422048
NCT02212561|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-03-01|||August 2014|Actual|2014-08-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome|A Phase I/II Study of the Selective Inhibitor of Nuclear Export Selinexor (KPT-330) in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Leukemia or Myelodysplastic Syndrome|Completed||Phase 1|19|Actual|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-11 00:07:22.612673|2017-10-11 00:07:22.612673
NCT02212548|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-05-01|||March 2012||2012-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2013|Actual|2013-12-01||Interventional|||Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose|Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose|Completed||N/A|30|Actual|Royal North Shore Hospital||1|||f||||t||||||||Yes|Other centres with ethics approval to use annonymised data|2017-10-11 00:07:22.763823|2017-10-11 00:07:22.763823
NCT02212535|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-09-14|||December 2015||2015-12-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|DrepaMob||Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients|Open Study of Phase I / II Evaluating Tolerance and Efficacy of Mobilization and Collection of Peripheral Hematopoietic Stem Cells Device After a Single Injection of 0.24mg/kg of Plerixafor in Sickle Cell Patients|Recruiting||Phase 1/Phase 2|5|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:07:22.884415|2017-10-11 00:07:22.884415
NCT02212522|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-06-27|||November 2004||2004-11-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|ISIS-DIAB||Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early Complications|Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early Complications. French Multicentric Cohort of Diabetic Patients.|Recruiting||N/A|20000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     whole blood   "|No||2017-10-11 00:07:23.013713|2017-10-11 00:07:23.013713
NCT02212509|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-06|||January 2013||2013-01-01|August 2014|2014-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Functional Recovery After Cardiac Surgery : Does Delirium and Calorie Intake Matter?|Functional Recovery After Cardiac Surgery : Does Delirium and Calorie Intake Matter?|Recruiting||N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:07:23.162999|2017-10-11 00:07:23.162999
NCT02212496|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-10-27|||August 2014||2014-08-01|October 2014|2014-10-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Identification the Cause of Cerebral Infarction in Patients With Cancer|Identification the Cause of Cerebral Infarction in Patients With Cancer|Unknown status|Recruiting|N/A|124|Anticipated|Samsung Medical Center|||2||f||||f||||||||||2017-10-11 00:07:23.246253|2017-10-11 00:07:23.246253
NCT02212483|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-01-16|||September 2014||2014-09-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|July 2018|Anticipated|2018-07-01||Interventional|ECENVIR||Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients|Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients (ECENVIR Study)|Recruiting||N/A|300|Anticipated|Rennes University Hospital||3|||f||||f||||||||||2017-10-11 00:07:23.337185|2017-10-11 00:07:23.337185
NCT02212470|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-10-06|||July 2014||2014-07-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Drug Eluting Ballon Versus Stenting in the Superficial Femoral Artery|Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery|Unknown status|Recruiting|Phase 4|84|Anticipated|Instituto Dante Pazzanese de Cardiologia||2|||f||||t||||||||||2017-10-11 00:07:23.524689|2017-10-11 00:07:23.524689
NCT02212457|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-06-22|2017-03-02|2015-05-29|August 21, 2014|Actual|2014-08-21|May 2017|2017-05-01|March 3, 2016|Actual|2016-03-03|May 22, 2015|Actual|2015-05-22||Interventional|||Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents|A Phase 2b, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Immunogenicity and Safety of GSK Meningococcal ABCWY Vaccine Administered at Different Schedules Compared to GSK Meningococcal Group B Vaccine, in Healthy Adolescents|Completed||Phase 2|1063|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-10-11 00:07:23.87746|2017-10-11 00:07:23.87746
NCT02212444|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-06-02|||June 2014||2014-06-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Comparing the Effects of Two Foot and Ankle Splints for Foot Pain|The Effectiveness of a Dynamic Elastomeric Fabric Orthoses (DEFO) in the Management of Plantar Fasciitis: A Feasibility Study|Completed||N/A|30|Actual|Plymouth Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 00:07:28.370651|2017-10-11 00:07:28.370651
NCT02212431|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-11-04|||August 2014||2014-08-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||First Study of Oral Cysteamine in Cystic Fibrosis|An Open Label Investigation of the Tolerability and Pharmacokinetics of Oral Cysteamine in Adults With Cystic Fibrosis.|Completed||Phase 1/Phase 2|10|Actual|University of Aberdeen||1|||f||||t||||||||||2017-10-11 00:07:28.474014|2017-10-11 00:07:28.474014
NCT02212418|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-02|2014-08-06|||March 2013||2013-03-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|UVa_1||Effect of an Abdominal Hypopressive Technique Program on Pelvic Floor Muscles and Urinary Incontinence in Women|Effect of an Abdominal Hypopressive Technique Program on Pelvic Floor Muscles and Urinary Incontinence in Women: A Randomized Cross-over Trial|Completed||N/A|42|Actual|University of Valladolid||1|||f||||f||||||||||2017-10-11 00:07:28.572443|2017-10-11 00:07:28.572443
NCT02212405|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-08-30|||July 2014||2014-07-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Does the Insula Control Smoking-Induced Dopamine Release? A TMS/[11C]-PHNO Study in Humans.|Does the Insula Control Smoking-Induced Dopamine Release? A TMS/[11C]-PHNO Study in Humans (Part II).|Completed||N/A|8|Actual|Centre for Addiction and Mental Health||3|||f||||t||||||||||2017-10-11 00:07:28.640768|2017-10-11 00:07:28.640768
NCT02212392|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-06|||January 2013||2013-01-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic Antibiotics|COMPARING THE OUTCOME IN PATIENTS OF ACUTE PANCREATITIS, WITH AND WITHOUT PROPHYLACTIC ANTIBIOTICS.|Completed||Phase 1/Phase 2|90|Actual|Benazir Bhutto Hospital, Rawalpindi||2|||f||||f||||||||||2017-10-11 00:07:28.74467|2017-10-11 00:07:28.74467
NCT02212379|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-08-17|||January 2015||2015-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL|A Non-comparative Phase II Trial Evaluating the Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age With an HIV-RNA Plasma Viremia Below 50 Copies/mL Under a Current Boosted Protease Inhibitor Containing Regimen (ANRS 163 ETRAL)|Active, not recruiting||Phase 2|160|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 00:07:28.855305|2017-10-11 00:07:28.855305
NCT02212366|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-01-30|||May 2014||2014-05-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||To Enhance Cognition in Late Life Depression Using Transcranial Direct Current Stimulation|Enhancing Cognition in Patients With Late-Life Depression: A Randomized Controlled Trial of Transcranial Direct Current Stimulation|Recruiting||N/A|36|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-11 00:07:29.00812|2017-10-11 00:07:29.00812
NCT02212353|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-08-09|||September 1, 2014|Actual|2014-09-01|August 2017|2017-08-01|December 16, 2014|Actual|2014-12-16|December 12, 2014|Actual|2014-12-12||Observational|PERFECTED||Care Delivery in Acute Hospital Settings: an Observational Study|Care Delivery in Acute Hospital Settings: an Observational Study. WP1 P3|Completed||N/A|180|Actual|University of East Anglia|||3||f||||t||||||||||2017-10-11 00:07:29.118264|2017-10-11 00:07:29.118264
NCT02212340|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-09-26|||July 2014||2014-07-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Comparison Between Propofol-remifentanil Total Intravenous Anesthesia and Desflurane-remifentanil Balanced Anesthesia With Regard to Post-anesthetic Functional Recovery Measured With QoR-40 in Vitrectomy||Completed||N/A|84|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:07:29.210212|2017-10-11 00:07:29.210212
NCT02212327|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-08-02|||August 2014||2014-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Testing Tissue Sodium Stores in CAPD Patients—Aims 1 & 2|Testing Tissue Sodium Stores in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients Receiving Icodextrin or Glucose-Based Dialysate, A Randomized Trial—Aims 1 & 2|Recruiting||N/A|60|Anticipated|Vanderbilt University Medical Center|||2||f||||f||||||Samples Without DNA|"     blood and urine samples   "|||2017-10-11 00:07:29.305516|2017-10-11 00:07:29.305516
NCT02212314|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-05-30|||May 2014||2014-05-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|WSRIT||Response Inhibition Training for Children With Williams Syndrome|Developing Treatments to Improve Psychosocial Functioning in Children With Williams Syndrome Part 1: Response Inhibition Training for Children With Williams Syndrome|Completed||N/A|25|Actual|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-10-11 00:07:29.388526|2017-10-11 00:07:29.388526
NCT02212301|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2016-09-26|2016-08-04||July 2014||2014-07-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All subjects that were dispensed at least one study lens.|Comparison of Two Marketed Lenses in a Controlled Environment||Completed||N/A|45|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 00:07:29.485376|2017-10-11 00:07:29.485376
NCT02212288|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-01-13|||September 2014||2014-09-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|StressOX-PCU||Antioxidant Signature in Adult Patients With Phenylketonuria|Antioxidant Signature in Adult Patients With Phenylketonuria (PKU) and Healthy Volunteers : Relationship With Metabolic Disturbances|Completed||Phase 4|20|Actual|University Hospital, Tours|||2||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 00:07:29.873249|2017-10-11 00:07:29.873249
NCT02212275|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-08-24|||August 2015||2015-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Cortical Metrics in Intervention Trials With Autism Spectrum Disorders|Initial Development of Cortical Metrics, an Objective, Physiologically-Based Outcome Measure, for Intervention Trials in Autism Spectrum Disorders (ASD)|Withdrawn||Phase 2/Phase 3|0|Actual|Duke University||2||lack of funding|f||||f||||||||||2017-10-11 00:07:30.007497|2017-10-11 00:07:30.007497
NCT02212262|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-09-27|||July 23, 2014|Actual|2014-07-23|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Role of Osteocytes in Myeloma Bone Disease|Role of Osteocytes in Myeloma Bone Disease|Recruiting||N/A|240|Anticipated|Indiana University|||2||f||||t||||||||||2017-10-11 00:07:30.208528|2017-10-11 00:07:30.208528
NCT02212249|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-03-23|||May 2014||2014-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Sclerocadh1||Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis|Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis|Completed||N/A|85|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 00:07:30.388442|2017-10-11 00:07:30.388442
NCT02212236|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-10-27|||September 2014||2014-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Psychological Intervention for Distress During HSCT|Development and Evaluation of a Psychological Intervention to Alleviate Distress During Haematopoietic Stem-cell Transplantation|Completed||Phase 2|45|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-11 00:07:30.57197|2017-10-11 00:07:30.57197
NCT02212223|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-07-12|||September 2014||2014-09-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ODIN||Marwo-D Research -Need for Vitamin D in Different Population Groups|Food-based Solutions for Optimal Vitamin D Nutrition and Health Through the Life Cycle (ODIN)|Completed||N/A|147|Actual|Helsinki University||6|||f||||f||||||||||2017-10-11 00:07:30.761488|2017-10-11 00:07:30.761488
NCT02212210|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-08-28|||February 2012||2012-02-01|August 2014|2014-08-01|October 2015|Actual|2015-10-01|April 2014|Actual|2014-04-01||Interventional|||Maternal Epidural Steroids and Hyperthemia|Maternal Epidural Steroids to Prevent Neonatal Exposure to Hyperthermia and Inflammation|Terminated||Early Phase 1|135|Actual|Medical University of South Carolina||2||"PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study is   closed"|f||||t||||||||||2017-10-11 00:07:30.884741|2017-10-11 00:07:30.884741
NCT02212197|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-03-15|2016-12-12||September 2014||2014-09-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer|A Phase II, Open Label, Active Control, Multi-National, Multi-Centre, Randomized, Parallel Group Study Assessing Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of CAM2032 (Leuprolide Acetate FluidCrystal® Injection Depot Once Monthly) After Repeat Doses of 3.75 mg and 7.5 mg of Leuprolide Acetate vs. Eligard® 7.5 mg in Patients With Prostate Cancer|Completed||Phase 2|51|Actual|Camurus AB||3|||f||||f||||||||||2017-10-11 00:07:31.004447|2017-10-11 00:07:31.004447
NCT02212184|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-11-30|||August 2014||2014-08-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Diaphragm Release Manual Technique Efficacy in COPD Patients|Diaphragm Release Manual Technique Efficacy on Diaphragmatic Mobility, Respiratory Muscle Strength and Exercise Performance in COPD Patients: a Randomized Controlled Trial|Completed||N/A|26|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 00:07:31.879262|2017-10-11 00:07:31.879262
NCT02212171|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-08-04|||September 2012||2012-09-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|TRIAP||TRIAP: Is Triage by Healthcare Mini-teams Effective to Improve Efficiency in Primary Health Care?|TRIAP: Is Triage by Healthcare Mini-teams Effective to Improve Efficiency in Primary Health Care?|Completed||Phase 2|10000|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 00:07:31.957737|2017-10-11 00:07:31.957737
NCT02212158|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-07|||September 2014||2014-09-01|August 2014|2014-08-01|November 2015|Anticipated|2015-11-01|April 2015|Anticipated|2015-04-01||Interventional|||Diabetes Intervention Program for Adolescents With Persistent High HA1c|Diabetes Intervention Program for Adolescents With Persistent High HA1c|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-10-11 00:07:32.373168|2017-10-11 00:07:32.373168
NCT02212145|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-01-19|||June 1988||1988-06-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|September 2015|Anticipated|2015-09-01||Observational|SoPP||Follow-up of Sollentuna Prevention Program|Long-term Follow-up of an Individual and Population-based Program Aimed at Preventing Cardiovascular Disease in Sollentuna Municipality|Unknown status|Active, not recruiting|N/A|1600000|Anticipated|Karolinska Institutet|||3||f||||f||||||||||2017-10-11 00:07:32.493564|2017-10-11 00:07:32.493564
NCT02212132|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-08-05|||April 2013||2013-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Relations Between Cognitive Complaints and Cognitive Scores Goals in Cancer: Assessment of Metamemory|Relations Between Cognitive Complaints and Cognitive Scores Goals in Cancer: Assessment of Metamemory|Completed||N/A|60|Actual|Centre Francois Baclesse|||2||f||||t||||||||||2017-10-11 00:07:32.563433|2017-10-11 00:07:32.563433
NCT02212119|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-07|||December 2010||2010-12-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|February 2013|Actual|2013-02-01||Interventional|||Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness|A Randomized, Placebo Controlled Trial of Botulinum Toxin for Paratonic Rigidity in People With Advanced Cognitive Impairment|Completed||Phase 2|10|Actual|Assistive Technology Clinic, Canada||2|||f||||t||||||||||2017-10-11 00:07:32.645247|2017-10-11 00:07:32.645247
NCT02212106|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-09-20|2015-08-20||September 2014||2014-09-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years|A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.|Completed||Phase 4|402|Actual|Seqirus||2|||f||||t||||||||||2017-10-11 00:07:32.7822|2017-10-11 00:07:32.7822
NCT02212093|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-07-22|||June 2014||2014-06-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|pneumonia||5 Years Mortality-rate in Patients Treated for Severe Pneumonia in an ICU - a Retrospective Study|Cause-specific 5 Years Mortality-rate in Patients Treated for Severe Pneumonia in an ICU - a Retrospective Study|Completed||N/A|236|Actual|University Hospital, Akershus|||1||f||||f||||||Samples Without DNA|"     Bacteriology tests   "|||2017-10-11 00:07:33.481261|2017-10-11 00:07:33.481261
NCT02212080|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2015-03-10|||September 2014||2014-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784|One-center, Randomized, Placebo-controlled, Double Blind, Parallel Group Study to Investigate the Safety, Tolerability and Pharmacokinetics of Increasing Single Oral Doses (5-1000 mg, Solution) of BAY1214784 Including the Relative Bioavailability of BAY1214784 Administered as Solution With Two Different Concentrations in 56 Healthy Postmenopausal Women|Completed||Phase 1|48|Actual|Bayer||2|||f||||f||||||||||2017-10-11 00:07:33.566002|2017-10-11 00:07:33.566002
NCT02212067|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-06-08|||August 11, 2014|Actual|2014-08-11|June 2017|2017-06-01|May 11, 2015|Actual|2015-05-11|May 11, 2015|Actual|2015-05-11||Interventional|||A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes|A Single-centre, Randomised, Double-blind, Multiple-dose, Placebo-controlled, Parallel-group Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes|Completed||Phase 1|87|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 00:07:33.649628|2017-10-11 00:07:33.649628
NCT02212054|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-06|||August 2013||2013-08-01|August 2014|2014-08-01|January 2015|Anticipated|2015-01-01|August 2014|Anticipated|2014-08-01||Interventional|||A Trial on Treatments of Hirschsprung Allied Disease|A Prospective, Randomized Controlled Trial of Conservative Versus Surgery Treatment of Children With Hirschsprung Allied Disease|Unknown status|Recruiting|Early Phase 1|50|Anticipated|Tongji Hospital||2|||f||||t||||||||||2017-10-11 00:07:33.76411|2017-10-11 00:07:33.76411
NCT02212041|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-05-15|||September 24, 2014|Actual|2014-09-24|August 2015|2015-08-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|APUS e-Cigs||Electronic Cigarettes in Smokers With Mental Illness|Acceptability, Patterns of Use and Safety of Electronic Cigarette in People With Mental Illness: a Pilot Study|Completed||N/A|50|Actual|King's College London||1|||f||||f||||||||||2017-10-11 00:07:33.871046|2017-10-11 00:07:33.871046
NCT02212028|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-11-01|2016-11-01||October 2014||2014-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Two patients in the whole tablets arm were excluded from the analysis because of missing data for the primary end point.|Pharmacological Effects of Crushing Prasugrel in STEMI Patients|Pharmacodynamic and Pharmacokinetic Profiles of Prasugrel in Patients With ST Elevation Myocardial Infarction: A Randomized Comparison of Standard Versus Crushed Formulation|Completed||Phase 4|52|Actual|University of Florida||2|||f||||t||||||||No||2017-10-11 00:07:34.001026|2017-10-11 00:07:34.001026
NCT02212015|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-10-26|||July 2014||2014-07-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|EVA||Evaluation of Votrient in Angiosarcoma|Single-arm, Multicenter, Open Label Phase II Trial to Evaluate the Efficacy of Pazopanib in Combination With Paclitaxel in Advanced and Relapsed Angiosarcoma|Recruiting||Phase 2|44|Anticipated|Heidelberg University||1|||f||||f||||||||||2017-10-11 00:07:34.988271|2017-10-11 00:07:34.988271
NCT02212002|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-07|||May 2013||2013-05-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational|MICROBIOTA-SO||Effect of Intrapartum Antibiotic Prophylaxis (IAP) on the Development of the Neonatal Gut Microbiota.|Effect of Intrapartum Antibiotic Prophylaxis (IAP) on the Development of Neonatal Gut Microbiota|Completed||N/A|84|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||2||f||||f||||||||||2017-10-11 00:07:35.905494|2017-10-11 00:07:35.905494
NCT02211989|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||February 2006||2006-02-01|August 2014|2014-08-01||||April 2006|Actual|2006-04-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 14332 CL Powder in Healthy Male Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses (0.5 mg to 200 mg) of BI 14332 CL as Powder in the Bottle Reconstituted With 0.1% Tartaric Acid Administered to Healthy Male Subjects. A Randomised and Placebo-controlled Trial, Double Blinded Within Dose Groups|Completed||Phase 1|53|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:07:36.02407|2017-10-11 00:07:36.02407
NCT02211625|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-12-04|||July 2014||2014-07-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Safety, Tolerability, PD and PK Study in Healthy Adults|A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacodynamics And Pharmacokinetics of TRV734 in Healthy Adult Male and Female Subjects|Completed||Phase 1|75|Actual|Trevena Inc.||2|||f||||t||||||||||2017-10-11 00:07:39.742676|2017-10-11 00:07:39.742676
NCT02211976|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||October 2003||2003-10-01|August 2014|2014-08-01||||November 2003|Actual|2003-11-01||Interventional|||Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and Their Combination in Constipation and Bloatedness|Comparative Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and the Combination of Both in the Treatment of Constipation and Bloatedness: an Open, Randomised, Parallel Group Trial|Completed||Phase 3|30|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:07:36.183162|2017-10-11 00:07:36.183162
NCT02211963|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-12|||February 2007||2007-02-01|August 2014|2014-08-01||||June 2007|Actual|2007-06-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Four Multiple Rising Oral Doses (50-800 mg b.i.d. or q.d. for 8 Days) of BI 44847 as Tablet in Female and Male Patients With Type 2 Diabetes|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:07:36.297493|2017-10-11 00:07:36.297493
NCT02211950|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||October 2008||2008-10-01|August 2014|2014-08-01||||December 2008|Actual|2008-12-01||Interventional|||Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers|Evaluation of Relative Bioavailability of BI 44847 in Different Ethnic Groups (Subjects of White, Asian, and African Origin), and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers. An Open-label, Single-dose, Parallel Group, Phase 1 Study (Group 1 With Additional Crossover Aspects)|Completed||Phase 1|37|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:07:36.413293|2017-10-11 00:07:36.413293
NCT02211937|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||January 2007||2007-01-01|August 2014|2014-08-01||||March 2007|Actual|2007-03-01||Interventional|||Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers|Relative Oral Bioavailability of 400 mg BI 44847 as Suspension Compared to 400 mg BI 44847 as Tablet and the Influence of Food (Standardised High Fat Breakfast) on the Tablet in a Single Dose, Open-label, Randomised Three-way Crossover Trial and Relative Oral Bioavailability of 40 mg BI 44847 as Solution Compared to 40 mg BI 44847 as Tablet in Healthy Male Volunteers in a Single Dose, Open-label, Randomised Two-way Crossover Trial|Completed||Phase 1|25|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:07:36.541564|2017-10-11 00:07:36.541564
NCT02211924|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||August 2007||2007-08-01|August 2014|2014-08-01||||September 2007|Actual|2007-09-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Administered to Healthy Male Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses (50 mg to 800 mg) of BI 44847 as Tablet(s) Administered to Healthy Male Subjects. A Randomised, Placebo-controlled (Within Dose Groups) and Double-blinded Trial|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:07:36.667968|2017-10-11 00:07:36.667968
NCT02211911|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||February 2008||2008-02-01|August 2014|2014-08-01||||May 2008|Actual|2008-05-01||Interventional|||Pharmacokinetics of Bisacodyl or Sodium Picosulfate Administered Orally in Healthy Lactating Females|Investigation of the Pharmacokinetics of 10 mg Bisacodyl (Coated Tablets) or 10 mg Sodium Picosulfate (Drops) Administered Orally in Healthy Lactating Females|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:07:36.777273|2017-10-11 00:07:36.777273
NCT02211898|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||July 2004||2004-07-01|August 2014|2014-08-01||||January 2005|Actual|2005-01-01||Interventional|||Clinical Study of BNS003 on Swelling in Legs Due to Venous Reflux|Clinical Study of BNS003 on Swelling Due to Disorder of Leg Venous Reflux|Completed||Phase 3|180|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:07:36.871259|2017-10-11 00:07:36.871259
NCT02211885|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||October 2002||2002-10-01|August 2014|2014-08-01||||November 2002|Actual|2002-11-01||Interventional|||Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects|A Phase I Single Oral Dose (100 mg) Trial to Characterize the Excretion Balance of 14c-radiolabeled BIRB 796 BS and to Determine Its Metabolites in Normal Male Subjects|Completed||Phase 1|6|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:07:36.941911|2017-10-11 00:07:36.941911
NCT02211872|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||August 2004||2004-08-01|August 2014|2014-08-01||||March 2007|Actual|2007-03-01||Interventional|||BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit|An Open Phase I Single Dose Escalation Study of BI 2536 BS Administered Intravenously in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit|Completed||Phase 1|63|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:07:37.029194|2017-10-11 00:07:37.029194
NCT02211859|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||August 2004||2004-08-01|August 2014|2014-08-01||||December 2007|Actual|2007-12-01||Interventional|||Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit|An Open Phase I Repeated Dose Escalation Study of BI 2536 BS Administered Intravenously in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit|Completed||Phase 1|70|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:07:37.683434|2017-10-11 00:07:37.683434
NCT02211846|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-10-02|||July 2014||2014-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder|A Multicentre, Open-label, Single Ascending Dose Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS Tablets in Pediatric Subjects From 5 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)|Completed||Phase 1|34|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:07:38.023464|2017-10-11 00:07:38.023464
NCT02211833|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2014-08-07|||October 2006||2006-10-01|August 2014|2014-08-01||||February 2009|Actual|2009-02-01||Interventional|||Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer|A Phase I Open-label Dose Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer|Completed||Phase 1|41|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:07:38.142202|2017-10-11 00:07:38.142202
NCT02211820|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-07|2017-08-08|||August 1, 2014||2014-08-01|October 12, 2016|2016-10-12|October 12, 2016|Actual|2016-10-12|June 20, 2016|Actual|2016-06-20||Observational|||PET Imaging in Chronic Traumatic Encephalopathy|PET Imaging in Chronic Traumatic Encephalopathy|Completed||N/A|6|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:07:38.231104|2017-10-11 00:07:38.231104
NCT02211807|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-10-14|||April 2014||2014-04-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Suicidality and Suicide Attempt Among HIV Patients on Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens|The Risk of Suicidality and Suicide Attempt Among HIV Patients Initiating Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens|Completed||N/A|11400|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 00:07:38.322681|2017-10-11 00:07:38.322681
NCT02211794|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-07-16|||January 2014||2014-01-01|July 2017|2017-07-01|June 2025|Anticipated|2025-06-01|June 2025|Anticipated|2025-06-01||Observational|||Journey II BCS EU Observational Trial|A Prospective, Non-randomized, Consecutive Series, Multicenter, Observational Trial to Evaluate the Clinical Outcome of Total Knee Arthroplasty Using Journey II BCS Total Knee System|Enrolling by invitation||N/A|177|Anticipated|Smith & Nephew, Inc.|||1||f||||t|f|f||||||||2017-10-11 00:07:38.400841|2017-10-11 00:07:38.400841
NCT02211781|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-07-11|||August 1, 2014||2014-08-01|July 5, 2017|2017-07-05|August 1, 2014|Actual|2014-08-01|August 1, 2014|Actual|2014-08-01||Observational|||Study of Diets and Way of Life of Native Americans and Hispanics in New Mexico During the Time of the Trinity Nuclear Test|A Pilot Study of Dietary and Lifestyle Patterns Among Native Americans and Hispanics/Latinos in New Mexico at the Time of the Trinity Nuclear Test|Completed||N/A|9|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:07:38.501216|2017-10-11 00:07:38.501216
NCT02211768|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-06-30|||August 1, 2014||2014-08-01|April 17, 2017|2017-04-17|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1|Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1: Clinical, Histopathologic, and Genomic Analysis|Recruiting||Early Phase 1|15|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:07:38.573648|2017-10-11 00:07:38.573648
NCT02211742|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-04-07|||August 2014||2014-08-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|DapaT1DM||Dapagliflozin in Type 1 Diabetes|Short-term Effects of Dapagliflozin on Fasting and Postprandial Glucose Homeostasis in Male Type 1 Diabetes Patients.|Unknown status|Recruiting|Phase 4|12|Anticipated|Medical University Innsbruck||2|||f||||t||||||||||2017-10-11 00:07:38.780173|2017-10-11 00:07:38.780173
NCT02211729|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-08-06|||August 2014||2014-08-01|August 2014|2014-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|SMCAZ||A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children|A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children|Unknown status|Not yet recruiting|Phase 3|19200|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 00:07:38.993732|2017-10-11 00:07:38.993732
NCT02211716|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-01-11|||June 2014||2014-06-01|February 2016|2016-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Physician-Initiated Trial Investigating the BeGraft Peripheral Stent Graft System|Physician-Initiated PMCF Trial Investigating the BeGraft Peripheral Stent Graft System for the Treatment of Iliac Lesions|Completed||Phase 4|70|Actual|Flanders Medical Research Program||1|||f||||t||||||||Undecided||2017-10-11 00:07:39.106312|2017-10-11 00:07:39.106312
NCT02211703|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2014-08-06|||September 2014||2014-09-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Observational|||National Epidemiologic Survey on the Incidence of Perioperative Hypothermia|National Epidemiologic Survey on the Incidence of Perioperative Hypothermia in Patients With Elective Surgery Under General Anesthesia in China|Unknown status|Not yet recruiting|N/A|2208|Anticipated|Peking Union Medical College Hospital|||1||f||||f||||||||||2017-10-11 00:07:39.193269|2017-10-11 00:07:39.193269
NCT02211690|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-05-25|||August 2014||2014-08-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|dPEP||The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis|The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis|Completed||Phase 4|100|Actual|St Vincent's Hospital, Sydney||1|||f||||f||||||||||2017-10-11 00:07:39.273089|2017-10-11 00:07:39.273089
NCT02211677|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-07-11|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Observational|||Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma|Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction of TNM Staging System in Nasopharyngeal Carcinoma: A Prospective Multi-institutional Observation Study|Recruiting||N/A|500|Anticipated|Sun Yat-sen University|||3||f||||f||||||||||2017-10-11 00:07:39.365671|2017-10-11 00:07:39.365671
NCT02211664|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-07-31|||June 2014||2014-06-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Interventional|BIOLUX 4EVER||Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results)||Active, not recruiting||Phase 4|120|Actual|Flanders Medical Research Program||1|||f||||||||||||||2017-10-11 00:07:39.460867|2017-10-11 00:07:39.460867
NCT02211651|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-01-12|||December 2013||2013-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PlacentA-DM||Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)|Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)|Completed||N/A|150|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida|||3||f||||t||||||Samples With DNA|"     Blood Adipose tissue Placental tissue Umbilical Cord tissue Umbilical Cord blood   "|||2017-10-11 00:07:39.569511|2017-10-11 00:07:39.569511
NCT02211612|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-10-25|||September 2014||2014-09-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LIPOGAIN-2||Overeating Different Fats and Influence on Muscle Mass and Body Fat Accumulation|Role of Fatty Acids in Skeletal Muscle Hypertrophy and Ectopic Fat Accumulation During Overfeeding (LIPOGAIN-2)|Completed||N/A|60|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 00:07:39.835171|2017-10-11 00:07:39.835171
NCT02211599|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-09-20|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Fat Burning After a Meal|Post-Prandial Substrate Utilization in Response to the Inclusion of Sweetened Beverage to Meals With Different Levels of Protein Content|Completed||N/A|29|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 00:07:39.941353|2017-10-11 00:07:39.941353
NCT02211586|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-01-12|||June 2014||2014-06-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|BIDO||Effects and Response of LY2605541 in Patients With Type 1 Diabetes Mellitus (BIDO)|Evaluation of the Effects of LY2605541 on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus (BIDO)|Completed||Phase 1|62|Actual|Translational Research Institute for Metabolism and Diabetes, Florida||2|||f||||t||||||||||2017-10-11 00:07:40.054151|2017-10-11 00:07:40.054151
NCT02211573|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||May 2013||2013-05-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|||Aquatic Aerobic Training, Cardiorespiratory and Metabolic Variables in Coronary Artery Disease|Effects of Aquatic Aerobic Training on Body Composition and Cardiorespiratory and Metabolic Variables in Patients With Coronary Artery Disease|Completed||N/A|21|Actual|Universidade Metodista de Piracicaba||2|||f||||f||||||||||2017-10-11 00:07:40.1555|2017-10-11 00:07:40.1555
NCT02211560|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-01-16|||September 2014||2014-09-01|January 2016|2016-01-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment|A, Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)|Recruiting||N/A|360|Anticipated|Enzymotec||2|||f||||f||||||||||2017-10-11 00:07:40.265419|2017-10-11 00:07:40.265419
NCT02211547|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-01-27|||August 2014||2014-08-01|January 2017|2017-01-01|October 2015|Anticipated|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Low Level Laser Therapy on Pain Induced by Placement of Orthodontic Separators in Pediatric Patients|Effect of Low Level Laser Therapy on Pain Induced by Placement of Orthodontic Separators in Pediatric Patients|Withdrawn||N/A|0|Actual|University of Colorado, Denver||3||No subjects enrolled|f||||t||||||||||2017-10-11 00:07:40.450455|2017-10-11 00:07:40.450455
NCT02211521|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-12-09|||August 2014||2014-08-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Comparison of Autologous Platelet-rich Plasma With Hyaluronic Acid for the Treatment of Osteoarthritis of the Knee Joint|Randomized, Double Blind, Comparison Clinical Trial to Test the Efficacy and Safety of Intraarticular Injection of Autologous Platelet-rich Plasma (PRP) for the Treatment of Osteoarthritis of the Knee Joint|Completed||Phase 3|110|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 00:07:40.702041|2017-10-11 00:07:40.702041
NCT02211508|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-08-05||2015-07-27|July 2014||2014-07-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|PERRFECT-301||Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301|A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia|Terminated||N/A|236|Actual|Cerephex Corporation||2||"Trial terminated Feb '15. Interim analysis results missed primary endpoint, intended signal not   delivered in Tx arm, sham results as expected. No safety issues."|f||||f||||||||||2017-10-11 00:07:40.823909|2017-10-11 00:07:40.823909
NCT02211495|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-11-18|||July 2014||2014-07-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||ULCERS - Electrical Stimulation in Diabetic Foot Ulceration|Electrical Stimulation in Diabetic Foot Ulceration|Completed||N/A|8|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 00:07:40.953311|2017-10-11 00:07:40.953311
NCT02211482|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-08-10|||October 2014||2014-10-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2016|Actual|2016-03-01||Interventional|PADDLE||Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study|Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study|Completed||Phase 4|20|Actual|The Huesped Foundation||1|||f||||f||||||||||2017-10-11 00:07:41.035988|2017-10-11 00:07:41.035988
NCT02211469|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-09-16|||August 2014||2014-08-01|April 2015|2015-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects|A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects|Completed||Phase 1|41|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 00:07:41.122551|2017-10-11 00:07:41.122551
NCT02211456|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-11-21|||December 2014||2014-12-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|DOUBLE-CRT||An Assessment of Dual Site Left Ventricular Endocardial Pacing|Dual Site Left Endocardial Pacing for Cardiac Resynchronisation Therapy|Completed||N/A|15|Actual|Oxford University Hospitals NHS Trust||1|||f||||t||||||||||2017-10-11 00:07:41.249347|2017-10-11 00:07:41.249347
NCT02211443|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-04-08|||January 2015||2015-01-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer|A Phase I Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of SCT200, a Recombinant Full Human Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody，in Patients With Metastatic Colorectal Cancer Following Fluoropyrimidine, Irinotecan and Oxaliplatine Chemotherapy Regiment|Unknown status|Enrolling by invitation|Phase 1|21|Anticipated|Sinocelltech Ltd.||1|||f||||f||||||||||2017-10-11 00:07:41.333158|2017-10-11 00:07:41.333158
NCT02211417|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-01-25|||January 2015||2015-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Oral DS107G in Moderate to Severe Atopic Dermatitis|A Randomised, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Orally Administered DS107G to Patients With Moderate to Severe Atopic Dermatitis|Completed||Phase 2|102|Actual|Dignity Sciences Ltd.||2|||f||||f||||||||||2017-10-11 00:07:41.541173|2017-10-11 00:07:41.541173
NCT02211404|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-10-19|||April 2014||2014-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Children's Sleep in the ICU||Completed||N/A|11|Actual|Nationwide Children's Hospital|||1||f||||||||||||||2017-10-11 00:07:41.669052|2017-10-11 00:07:41.669052
NCT02211391|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-08-10|||July 2014||2014-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Nighttime Protein Intake on Overnight Lipolysis and Morning Fat Oxidation in Obese Men|The Effect of Nighttime Protein Intake on Overnight Lipolysis and Morning Fat Oxidation in Obese Men.|Completed||N/A|12|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 00:07:41.727922|2017-10-11 00:07:41.727922
NCT02211378|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-06|||September 2012||2012-09-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Stress on Observers and Their Subsequent Performance During High Fidelity Simulation-based Training.|Effects of Stress on Observers and Their Subsequent Performance During High Fidelity Simulation-based Training: A Randomized Controlled Trial.|Completed||N/A|33|Actual|KK Women's and Children's Hospital||2|||f||||f||||||||||2017-10-11 00:07:41.814883|2017-10-11 00:07:41.814883
NCT02211365|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-02-14|||February 2014||2014-02-01|February 2017|2017-02-01|April 2024|Anticipated|2024-04-01|March 2017|Anticipated|2017-03-01|10 Years|Observational [Patient Registry]|RCSN||Registro Campania Salute Network on Hypertension|Registro Campania Salute Network for the Treatment of Hypertension and Correlated Diseases|Recruiting||N/A|10000|Anticipated|Federico II University|||1||f||||t||||||||||2017-10-11 00:07:41.89747|2017-10-11 00:07:41.89747
NCT02211352|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-08-06|||May 2012||2012-05-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|KRGCBP||Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension|Randomized Control Clinical Trial for Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension|Completed||Phase 2|58|Actual|Daegu Catholic University Medical Center||2|||f||||t||||||||||2017-10-11 00:07:42.206585|2017-10-11 00:07:42.206585
NCT02211339|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-05-04|||June 2014||2014-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A New Intervention for Social Skills Following Brain Injury (Version1)|An Investigation Into the Effectiveness of a Social Communication Skills Training Programme for Adults Following Severe Traumatic Brain Injury (TBI) Using a Peer-to-peer Learning Model|Active, not recruiting||N/A|24|Anticipated|University College, London||2|||f||||f||||||||Undecided||2017-10-11 00:07:42.294846|2017-10-11 00:07:42.294846
NCT02211326|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-05-07|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|January 2017|Actual|2017-01-01||Interventional|||Genotype-guided Warfarin Individualized Treatment|Pharmacogenetic Algorithm of Response to Warfarin During Initial Anticoagulation in Chinese Elderly Patients|Completed||Phase 4|660|Actual|The Third Xiangya Hospital of Central South University||2|||f||||t||||||||||2017-10-11 00:07:42.400351|2017-10-11 00:07:42.400351
NCT02211313|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-10-02|||August 2014||2014-08-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluation of Ureteral Stents in the Management of Stone Disease|Evaluation of Ureteral Stents in the Management of Stone Disease|Recruiting||N/A|100|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 00:07:42.519091|2017-10-11 00:07:42.519091
NCT02211300|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-06-25|||April 2014||2014-04-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|MANAGE IDE||MANAGE Automated Glucose Monitoring|MANUAL VS. AUTOMATED MONITORING ACCURACY OF GLUCOSE|Unknown status|Recruiting|N/A|230|Anticipated|OptiScan Biomedical Corporation||1|||f||||t||||||||||2017-10-11 00:07:42.618388|2017-10-11 00:07:42.618388
NCT02211274|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-09-11|||July 1, 2016|Actual|2016-07-01|September 2017|2017-09-01|June 1, 2019|Anticipated|2019-06-01|December 30, 2018|Anticipated|2018-12-30||Interventional|||VA Community Living Centers to Home|Improving Veteran Transitions From VA Community Living Centers to the Community|Enrolling by invitation||N/A|60|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-11 00:07:42.830548|2017-10-11 00:07:42.830548
NCT02211261|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-05-08|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus|A Phase 1 Double-blind, Placebo-controlled, Randomized, Single- And Multiple-ascending Dose Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Pf-06293620 In Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|84|Actual|Pfizer||9|||f||||f||||||||||2017-10-11 00:07:42.935291|2017-10-11 00:07:42.935291
NCT02211248|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-08-06|||December 2011||2011-12-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Cardiovascular Autonomic Control Evaluation Through Cardiac Frequency Variability in Hypertensive Patients|Cardiovascular Autonomic Control Evaluation Through Cardiac Frequency Variability in Hypertensive Patients Subjected to Distinct Interventions: Clinical Trial|Completed||N/A|36|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 00:07:43.212636|2017-10-11 00:07:43.212636
NCT02211235|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-08-22|||August 2014||2014-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Continuous Glucose Monitoring in Controls With and Without Cystic Fibrosis|Characterization of Glucose Variability by Continuous Glucose Monitoring in Non-diabetic Youth With and Without Cystic Fibrosis|Recruiting||N/A|130|Anticipated|University of Colorado, Denver|||1||f||||f|f|f||||Samples Without DNA|"     Alternative markers of glycemia, including fructosamine, glycated albumin, and     1,5-anhydroglucitol, Oral Glucose Tolerance Test (OGTT) derived markers of insulin secretion     and insulin sensitivity   "|||2017-10-11 00:07:43.322445|2017-10-11 00:07:43.322445
NCT02211222|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-03-15||||||March 2016|2016-03-01|June 2015|Anticipated|2015-06-01|August 2015|Anticipated|2015-08-01||Expanded Access|||An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer|An Open-Label, Randomized, Multicenter, Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer|Approved for marketing||N/A|||Eisai Inc.|||||||||||||||||||2017-10-11 00:07:43.439308|2017-10-11 00:07:43.439308
NCT02211209|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-05-01|||August 2014||2014-08-01|May 2017|2017-05-01|March 27, 2017|Actual|2017-03-27|December 2016|Actual|2016-12-01||Interventional|||The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ISIS 304801 Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)|Completed||Phase 3|67|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 00:07:43.586962|2017-10-11 00:07:43.586962
NCT02211196|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-08-14|||February 2013|Actual|2013-02-01|August 2017|2017-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evidence-Based Tobacco Cessation Strategies in Patients With Cancer|Implementing Evidence-Based Tobacco Cessation Strategies in Oncology Clinics|Completed||N/A|377|Actual|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 00:07:43.827733|2017-10-11 00:07:43.827733
NCT02211183|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2016-05-04|||August 2014||2014-08-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||InSpace™ System in Comparison to Best Repair of Massive Rotator Cuff Tear|A Randomized, Two-arm, Prospective, Subject Blind Study to Assess the Safety and Efficacy of InSpace™ Device in Comparison to Full Thickness Massive Rotator Cuff Repair in Subjects Scheduled for a Repair Surgery.|Terminated||N/A|4|Actual|OrthoSpace Ltd.||2||Very Low recruitment rate|f||||f||||||||||2017-10-11 00:07:43.950937|2017-10-11 00:07:43.950937
NCT02211170|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||February 2000||2000-02-01|August 2014|2014-08-01||||April 2000|Actual|2000-04-01||Interventional|||Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects|The Effect of Single Oral Dose BIRB 796 BS (50 and 600 mg) on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects. A Placebo-controlled, Randomised, Parallel, Double-blinded Study.|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:07:44.086089|2017-10-11 00:07:44.086089
NCT02211157|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-07|||March 2000||2000-03-01|August 2014|2014-08-01||||July 2000|Actual|2000-07-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects|Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets (20, 30, 150, 300, and 600 mg) Administered Orally to Healthy Human Subjects Once Daily for 7 Days. A Placebo Controlled, Randomised, Double Blinded Study|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:07:44.208554|2017-10-11 00:07:44.208554
NCT02211144|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||March 2002||2002-03-01|August 2014|2014-08-01||||November 2002|Actual|2002-11-01||Interventional|||Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects|Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally (Total Daily Dose 90, 120, 150 or 180 mg) to Healthy Human Subjects for 14 Days. A Placebo-controlled, Dose Escalation Study Double Blinded at Each Dose Level|Completed||Phase 1|120|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:07:44.338068|2017-10-11 00:07:44.338068
NCT02211131|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-06-12|||February 3, 2015|Actual|2015-02-03|June 2017|2017-06-01|April 30, 2022|Anticipated|2022-04-30|April 20, 2019|Anticipated|2019-04-20||Interventional|||Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma|A Phase 2, Multicenter, Randomized, Open-label Trial Assessing the Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Resectable, Stage IIIB to IVM1a Melanoma|Active, not recruiting||Phase 2|150|Actual|Amgen||2|||f||||f||||||||||2017-10-11 00:07:44.458315|2017-10-11 00:07:44.458315
NCT02211118|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-02-06|||October 2014||2014-10-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|||Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD|Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD|Completed||Phase 4|30|Actual|Dayton VA Medical Center||1|||f||||t||||||||||2017-10-11 00:07:44.679582|2017-10-11 00:07:44.679582
NCT02211105|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-04-18|||July 2014||2014-07-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01|3 Years|Observational [Patient Registry]|STAR Registry||Registry to Compare Two Surgical Treatments for GERD|Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF): Anti- Reflux Treatment Registry|Terminated||N/A|46|Actual|American Gastroenterological Association|||2|Unexpected low accrual|f||||t||||||||||2017-10-11 00:07:44.766765|2017-10-11 00:07:44.766765
NCT02211092|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-03-30|||November 2013||2013-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Feasibility Study of a Home-based Physical Activity Intervention for Family Caregivers of People With Advanced Cancer|Development and Pilot Testing of a Home-Based Physical Activity Intervention for Family Caregivers of People With Advanced Cancer|Completed||N/A|28|Actual|Jewish General Hospital||2|||f||||f||||||||||2017-10-11 00:07:44.881916|2017-10-11 00:07:44.881916
NCT02211079|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-11-23|||September 2014||2014-09-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates|"An Open-Label, Fixed-Sequence Study in Healthy Male Subjects to Assess the Drug Interaction Potential of Multiple-Doses of JNJ-54861911 With a Drug Cocktail Representative for CYP3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates"|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 00:07:44.988328|2017-10-11 00:07:44.988328
NCT02211066|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-03-31|||October 2014||2014-10-01|March 2015|2015-03-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|TIGER-BVS||TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization|TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization|Recruiting||Phase 4|100|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 00:07:45.110664|2017-10-11 00:07:45.110664
NCT02207049|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-07-14|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||The Effect of Snack Consumption on Energy Intake in Preschoolers|The Effect of Snack Consumption on Energy Intake in Preschoolers|Active, not recruiting||N/A|20|Anticipated|University of Tennessee||3|||f||||f||||||||||2017-10-11 00:08:46.219523|2017-10-11 00:08:46.219523
NCT02211053|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2014-08-05|||July 2014||2014-07-01|August 2014|2014-08-01||||July 2016|Anticipated|2016-07-01||Interventional|ECHOT4||Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled Trial|Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|60|Anticipated|Hopital du Sacre-Coeur de Montreal||2|||f||||f||||||||||2017-10-11 00:07:45.22443|2017-10-11 00:07:45.22443
NCT02211040|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-05-04|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||eHealth Intervention to Promote Self-regulation of Physical Activity and Fruit and Vegetable Intake Among Adults Who Visit General Practice|Effect Evaluation of an eHealth Intervention to Promote Self-regulation of Physical Activity and Fruit and Vegetable Intake Among Adults in General Practice|Completed||N/A|426|Actual|University Ghent||2|||f||||f||||||||||2017-10-11 00:07:45.35587|2017-10-11 00:07:45.35587
NCT02211027|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-09-04|||September 2016||2016-09-01|September 2017|2017-09-01|December 2028|Anticipated|2028-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA|Active Immunization of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Using Fibroblasts Transfected With DNA From Autologous Tumor|Withdrawn||Phase 1|0|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:07:45.444868|2017-10-11 00:07:45.444868
NCT02211014|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-12-01|||February 2015||2015-02-01|December 2016|2016-12-01||||June 2017|Anticipated|2017-06-01||Interventional|||An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma|An Open-Label, Phase 1b Study of ACP-196 With and Without Dexamethasone in Subjects With Multiple Myeloma|Active, not recruiting||Phase 1|28|Actual|Acerta Pharma BV||2|||f||||f||||||||||2017-10-11 00:07:45.528653|2017-10-11 00:07:45.528653
NCT02211001|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2014-08-05|||October 2010||2010-10-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|November 2010|Actual|2010-11-01||Interventional|||Pilates, Postural Global Reeducation and Ball Exercises|Comparative Study of Strenght, Endurance, Flexibility of Muscle Trunk Between the Techniques: Global Postural Reeducation , Pilates and Segmented Dynamic Exercises.|Completed||N/A|100|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 00:07:45.617427|2017-10-11 00:07:45.617427
NCT02210988|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-08-05|||May 2011||2011-05-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Evaluating the Therapeutic Effect of Acupuncture on Acute Ischemic Stroke Patients||Completed||N/A|38|Actual|Cathay General Hospital||1|||f||||t||||||||||2017-10-11 00:07:45.710026|2017-10-11 00:07:45.710026
NCT02210975|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-06|||July 2014||2014-07-01|August 2014|2014-08-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients After Sleeve Gastrectomy|An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients After Sleeve Gastrectomy|Unknown status|Recruiting|N/A|10|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-11 00:07:45.984025|2017-10-11 00:07:45.984025
NCT02210962|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-02-16|||September 2011||2011-09-01|February 2015|2015-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|OFFER||Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia|Omega-3 Fatty Acids in First-episode Schizophrenia - a Randomized Controlled Study of Efficacy and Relapse Prevention (OFFER). Rationale, Design, and Methods.|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Medical Universtity of Lodz||2|||f||||t||||||||||2017-10-11 00:07:46.107891|2017-10-11 00:07:46.107891
NCT02210949|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-04-04|||August 2014|Actual|2014-08-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery|Pre-operative Treatment With Erythropoietin and Iron Supplement for Prevention of Perioperative Blood Transfusion in Cardiac Surgery|Terminated||Phase 4|7|Actual|Catharina Ziekenhuis Eindhoven||1||Low inclusion rate|f||||f||||||||||2017-10-11 00:07:46.219066|2017-10-11 00:07:46.219066
NCT02210936|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-07-11|||July 2014||2014-07-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||SCOSI-M: Preventing Prescription Drug Problems|Preventing Prescription Drug Problems: A Pilot Military Opioid Safety Initiative|Active, not recruiting||N/A|93|Actual|Brandeis University||1|||f||||||||||||||2017-10-11 00:07:46.332345|2017-10-11 00:07:46.332345
NCT02210923|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-05|||October 2013||2013-10-01|August 2014|2014-08-01||||August 2014|Actual|2014-08-01||Observational|||Effect Baroreflex Activation Therapy on the Carotid Body|Carotid Baroreflex Activation and Its Effect on the Chemoreflex Study|Unknown status|Recruiting|N/A|20|Anticipated|Maastricht University Medical Center|||1||f||||t||||||Samples Without DNA|"     Arterial blood for analysis of PaCO2, PaO2 and pH   "|||2017-10-11 00:07:46.405171|2017-10-11 00:07:46.405171
NCT02210910|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-01-04|||June 2012||2012-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||InSpace™ System Over Rotator Cuff Repair in Comparison to Repair Alone.|A Randomized, Two-arm, Prospective, Subject Blind Study to Assess the Efficacy and Safety of InSpace™ Device Implanted Over a Rotator Cuff Repair in Comparison With Rotator Cuff Repair Only in Subjects With a Full-thickness Large to Massive Rotator Cuff Tear.|Active, not recruiting||N/A|39|Actual|OrthoSpace Ltd.||2|||f||||||||||||||2017-10-11 00:07:46.518373|2017-10-11 00:07:46.518373
NCT02210897|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-02-17|||August 2014||2014-08-01|April 2015|2015-04-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Influence of Renal Function on the Circadian Variation of Cardiac Troponin|Influence of Renal Function on the Circadian Variation of Cardiac Troponin|Completed||N/A|20|Actual|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-11 00:07:46.614962|2017-10-11 00:07:46.614962
NCT02210884|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2017-02-02|||October 2014||2014-10-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Maternal Vit D Supplements & Infant and Maternal Biomarkers & Outcomes in Southern Ethiopia|Effects of Maternal Vitamin D Supplementation on Markers of Vitamin D Status and Related Infant and Maternal Outcomes in Southern Ethiopia|Completed||N/A|240|Anticipated|Oklahoma State University||2|||f||||t||||||||||2017-10-11 00:07:46.720447|2017-10-11 00:07:46.720447
NCT02210689|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-03-18|||January 2014||2014-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women||Completed||Phase 3|604|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-11 00:07:50.395483|2017-10-11 00:07:50.395483
NCT02210871|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-06|2015-06-29|||August 2014||2014-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function|A Multi-centre, Open-label, Parallel-group Trial Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Completed||Phase 1|44|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 00:07:46.82776|2017-10-11 00:07:46.82776
NCT02210858|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-05-08|||May 2000||2000-05-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders|Phase I/II Study of Tipifarnib [ZARNESTRATM, Farnesyltransferase Inhibitor R115777 (NSC 702818)] in Patients With Myeloproliferative Disorders|Completed||Phase 1/Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 00:07:46.922858|2017-10-11 00:07:46.922858
NCT02210845|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-02-16|||July 2018|Anticipated|2018-07-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Lifestyle Strategies for Improving Diabetes Outcomes|Impact of Two Lifestyle Strategies for Improving Diabetes Related Health Outcomes in a Specialty Care Setting: A Randomized Controlled Trial|Not yet recruiting||N/A|200|Anticipated|BCDiabetes.Ca||3|||f||||t|f|f||||||No|There is no plan to share IPD to other researchers except those involved in the trial|2017-10-11 00:07:47.030923|2017-10-11 00:07:47.030923
NCT02210832|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-08-05|||January 2014||2014-01-01|August 2014|2014-08-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women|Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant|Recruiting||N/A|345|Anticipated|University of Vermont||3|||f||||f||||||||||2017-10-11 00:07:47.17527|2017-10-11 00:07:47.17527
NCT02210819|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-02-27|||June 2014||2014-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Observational|XALIA LEA||Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy|XALIA LEA- Xarelto for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE) in Latin America, EMEA and Asia|Completed||N/A|1989|Actual|Bayer|||2||f||||f||||||||||2017-10-11 00:07:47.325833|2017-10-11 00:07:47.325833
NCT02210806|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-04-17||2017-04-17|July 2014||2014-07-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|A006-B3||Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation|Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)|Completed||Phase 2|22|Actual|Amphastar Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-10-11 00:07:47.52647|2017-10-11 00:07:47.52647
NCT02210793|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-02|2014-08-05|||April 2012||2012-04-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Dry Eye Evaluation After Transepithelial PRK|Evaluation of Dry Eye Following Transepithelial Photorefractive Keratectomy in Comparison to Conventional LASIK: a Comparative Study|Completed||N/A|40|Actual|AL-Nour Eye Hospital||2|||f||||f||||||||||2017-10-11 00:07:47.693685|2017-10-11 00:07:47.693685
NCT02210780|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-02-07||2017-02-07|August 2014||2014-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Study of Dupilumab (REGN668/ SAR231893) and Immune Responses in Adults With Atopic Dermatitis (AD)|A Randomized, Double-Blind, Placebo-Controlled, Study Investigating Vaccine Responses in Adults With Moderate to Severe Atopic Dermatitis Treated With Dupilumab|Completed||Phase 2|194|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:07:47.773869|2017-10-11 00:07:47.773869
NCT02210767|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-02-13|||August 2014||2014-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Walnuts on Central Blood Pressure, Arterial Stiffness Indices, Lipoproteins, and Other CVD Risk Factors||Recruiting||N/A|50|Anticipated|Penn State University||3|||f||||f||||||||||2017-10-11 00:07:49.85434|2017-10-11 00:07:49.85434
NCT02210754|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-08-04|||March 2014||2014-03-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Characterization of Nicotine Exposure and Urge-to-Smoke Following Use of Electronic and Conventional Cigarettes|Characterization of Nicotine Exposure and Urge-to-Smoke Following a Single Controlled Administration and Short-Term Ad Lib Use of Electronic Cigarettes and Conventional Cigarettes in Adult Smokers|Completed||N/A|24|Actual|Lorillard Tobacco Company||6|||f||||f||||||||||2017-10-11 00:07:49.960319|2017-10-11 00:07:49.960319
NCT02210741|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-05|||August 2014||2014-08-01|August 2014|2014-08-01|February 2024|Anticipated|2024-02-01|February 2024|Anticipated|2024-02-01||Observational|||Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease|Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease|Not yet recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:07:50.066659|2017-10-11 00:07:50.066659
NCT02210728|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-08-29|||April 2006||2006-04-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder|Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder|Active, not recruiting||N/A|200|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-10-11 00:07:50.129417|2017-10-11 00:07:50.129417
NCT02210715|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-04-21|||March 2015||2015-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients|Randomized Study Comparing Switching to Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Monoinfected Patients Impact on Fatty Liver and Liver Fibrosis Assessed by Noninvasive Diagnostic Methods|Enrolling by invitation||Phase 4|58|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-11 00:07:50.237391|2017-10-11 00:07:50.237391
NCT02210702|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-08-04|||July 2014||2014-07-01|August 2014|2014-08-01||||January 2015|Anticipated|2015-01-01||Interventional|||Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales|Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales|Unknown status|Recruiting|Phase 4|33|Anticipated|The Jones Institute||3|||f||||||||||||||2017-10-11 00:07:50.315991|2017-10-11 00:07:50.315991
NCT02210676|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-12-20|||June 2014||2014-06-01|December 2016|2016-12-01||||January 2016|Actual|2016-01-01||Interventional|||Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger|Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||1||Due to the investigator leaving the institution, the study was terminated|f||||f||||||||||2017-10-11 00:07:51.716698|2017-10-11 00:07:51.716698
NCT02210663|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-07-19|||July 2014||2014-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors|A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors|Completed||Phase 1|16|Actual|AbbVie||1|||f||||t||||||||||2017-10-11 00:07:51.798819|2017-10-11 00:07:51.798819
NCT02210650|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-08-29|||November 2014||2014-11-01|August 2016|2016-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney|Randomized Controlled Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney|Recruiting||N/A|100|Anticipated|Indiana Kidney Stone Institute||2|||f||||t||||||||||2017-10-11 00:07:51.883854|2017-10-11 00:07:51.883854
NCT02210637|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Non Attendance at Scheduled Appointments as a Marker of Mortality and Hospital Admission|Non Attendance at Scheduled Appointments as a Marker of Visits in the Emergency Department, Hospitalization and Mortality|Recruiting||N/A|177083|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 00:07:51.993712|2017-10-11 00:07:51.993712
NCT02210624|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-08-08|||March 2013||2013-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy Assessment of Autologous Bone-marrow Derived Adult Mesenchymal Stem Cell Therapy in Patients With Anoxic(or Hypoxic) Brain Injury Pilot Trial|An Open-label, Safety and Efficacy Assessment of Autologous Bone-marrow Derived Mesenchymal Stem Cell Therapy in Anoxic (or Hypoxic) Brain Injury.|Recruiting||N/A|4|Anticipated|Hanyang University Seoul Hospital||1|||f||||t||||||||||2017-10-11 00:07:52.07448|2017-10-11 00:07:52.07448
NCT02210611|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-02-27|||January 2015||2015-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||36 Versus 42 Hour Time Interval From Ovulation to Intrauterine Insemination|36 Versus 42 Hour Time Interval From Ovulation Induction to Intrauterine Insemination in Stimulated Cycles With GnRH Antagonists|Recruiting||N/A|276|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-11 00:07:52.172199|2017-10-11 00:07:52.172199
NCT02210598|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-04-17|||March 2014||2014-03-01|April 2017|2017-04-01||||January 2018|Anticipated|2018-01-01||Interventional|||Outpatient Labor Induction With the Transcervical Foley Balloon|Outpatient Labor Induction With the Transcervical Foley Balloon: A Randomized Trial Comparing Outpatient Immediate Removal Foley Versus Standard Inpatient Foley Induction|Recruiting||N/A|64|Anticipated|University of Southern California||2|||f||||t||||||||||2017-10-11 00:07:52.26336|2017-10-11 00:07:52.26336
NCT02210585|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-01-18|||May 2014||2014-05-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|STIMOBIII||Study of Neuromuscular Electrical Stimulation to Increase Spontaneous Physical Activity in Obesity Patient|Study of Multi-site Neuromuscular Electrical Stimulation to Increase Spontaneous Physical Activity in Obesity Patient Carrying Severe Inactive: Randomized Controlled Trial vs Placebo|Recruiting||N/A|148|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 00:07:52.363866|2017-10-11 00:07:52.363866
NCT02210572|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-11-27|||August 2014||2014-08-01|August 2014|2014-08-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Prebiotics Versus Low FODMAPs Diet on Intestinal Microbiota and Symptoms|Effect of Prebiotics on Intestinal Gas Production, Microbiota and Digestive Symptoms|Completed||N/A|40|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-11 00:07:52.462198|2017-10-11 00:07:52.462198
NCT02210559|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-09-18|||July 2014||2014-07-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic Cancer|A Randomized, Open Label, Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic Cancer|Active, not recruiting||Phase 1/Phase 2|37|Actual|FibroGen||2|||f||||f||||||||||2017-10-11 00:07:52.665122|2017-10-11 00:07:52.665122
NCT02210546|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-08-04|||May 2013||2013-05-01|August 2014|2014-08-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|MRIB||Contrast-enhanced MR Imaging as a Breast Cancer Screening in Women at Intermediate Risk|A Multicenter Randomised Trial of Contrast-enhanced MR Imaging as a Breast Cancer Screening Tool Alternative to Mammography and Ultrasonography in Women at Intermediate Risk. Feasibility, and Short Term Results.|Unknown status|Recruiting|N/A|2000|Anticipated|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||2|||f||||f||||||||||2017-10-11 00:07:52.812195|2017-10-11 00:07:52.812195
NCT02210520|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-08-04|||October 2013||2013-10-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect of Ultrasound and Laser in Chronic Low Back Pain: Randomized Double-blinded Controled Trial|Effect of Laser and Ultrasound in Pain and Disability in Women With Chronic Non-specific Low Back Pain: Randomized Double-blinded Controled Trial|Unknown status|Recruiting|Phase 1|22|Anticipated|University of Sao Paulo General Hospital||4|||f||||t||||||||||2017-10-11 00:07:52.953399|2017-10-11 00:07:52.953399
NCT02210507|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-01-09|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Beta-carotene Absorption and Bioconversion to Vitamin A From Biofortified Cassava Gari|Beta-carotene Absorption and Bioconversion to Vitamin A in a Biofortified Cassava Gari Meal and a White Cassava Gari Meal With Added Red Palm Oil|Completed||N/A|10|Actual|USDA, Western Human Nutrition Research Center||3|||f||||f||||||||||2017-10-11 00:07:53.07027|2017-10-11 00:07:53.07027
NCT02210312|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-07-21|||May 2014||2014-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|DeprPOCD||Study of Depressive Symptoms Predicting Postoperative Cognitive Dysfunction|Are Preoperative Depressive Symptoms Predictive for Postoperative Dysfunction in Non-cardiac Surgery?|Completed||N/A|300|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-11 00:07:54.459203|2017-10-11 00:07:54.459203
NCT02210494|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2014-08-04|||April 2013||2013-04-01|August 2014|2014-08-01||||August 2015|Anticipated|2015-08-01||Interventional|||Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR)|Phase 1 Study of Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR)|Unknown status|Recruiting|Phase 1|5|Anticipated|Effexus Pharmaceutical||1|||f||||t||||||||||2017-10-11 00:07:53.209019|2017-10-11 00:07:53.209019
NCT02210481|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-06|||February 2014||2014-02-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|GLU-MAC||The Role of Intravitreal Glucose in Macular Thinning Following Surgery for Retinal Detachment or Epimacular Membrane|Impact of Intravitreal Glucose Rate in Macular Thinning Following Retinal Detachment or Epimacular Membrane Surgery|Unknown status|Recruiting|N/A|60|Anticipated|CHU de Reims|||1||f||||f||||||||||2017-10-11 00:07:53.306914|2017-10-11 00:07:53.306914
NCT02210468|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-08-19|||May 2015||2015-05-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee|A Phase I/II, Multicenter, Double-Blind, Placebo-controlled Safety and Efficacy Study to Evaluate APIC-CF Therapy for Mild to Moderate Primary Osteoarthritis of the Knee|Unknown status|Recruiting|Phase 1/Phase 2|300|Anticipated|Cytonics Corporation||3|||f||||||||||||||2017-10-11 00:07:53.412981|2017-10-11 00:07:53.412981
NCT02210455|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-03-08|||July 2014||2014-07-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|July 2016|Anticipated|2016-07-01||Interventional|SF-FASD||Parenting Training for Children With FASD|Strongest Families FASD: Parent Training for Challenging Behaviour in Children With Fetal Alcohol Spectrum Disorder (FASD)|Recruiting||N/A|200|Anticipated|IWK Health Centre||2|||f||||f||||||||||2017-10-11 00:07:53.514354|2017-10-11 00:07:53.514354
NCT02210442|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-03-10|||January 17, 2017|Actual|2017-01-17|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EDUCAGUIA||Effectiveness of Educational Games to Implementation Clinical Practice Guidelines to Family Medicine Residents in Spain.|Educaguia Project: Clinical Trial, Randomised by Clusters, to Assess the Effectiveness of a Strategy With Educational Games to Implementation pf Clinical Practice Guidelines to Family Medicine Residents in Spain.|Recruiting||N/A|394|Anticipated|Gerencia de Atención Primaria, Madrid||2|||f||||f||||||||||2017-10-11 00:07:53.617201|2017-10-11 00:07:53.617201
NCT02210429|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-03|2015-07-27|||January 2009||2009-01-01|June 2015|2015-06-01|November 2015|Anticipated|2015-11-01|June 2014|Actual|2014-06-01||Interventional|||Supraclavicular Blocks for Post-Operative Pain Control in Supracondylar Fracture Fixation, a Retrospective Analysis of Single Shot Catheter Techniques|Supraclavicular Blocks for Post-Operative Pain Control in Supracondylar Fracture Fixation, a Retrospective Analysis of Single Shot Catheter Techniques|Unknown status|Active, not recruiting|N/A|200|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||4|||f||||f||||||||||2017-10-11 00:07:53.711332|2017-10-11 00:07:53.711332
NCT02210416|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2015-10-11|||December 2012||2012-12-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01||Observational|||Costs of Complications in Inguinal Hernia Repair||Completed||N/A|968|Actual|North Karelia Central Hospital|||2||f||||f||||||||||2017-10-11 00:07:53.792714|2017-10-11 00:07:53.792714
NCT02210403|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-08-04|||April 2013||2013-04-01|February 2013|2013-02-01||||September 2015|Anticipated|2015-09-01||Interventional|||The Influence of tDCS on the Arm and Hand Function in Stroke Patients||Unknown status|Recruiting|N/A|26|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-11 00:07:53.864151|2017-10-11 00:07:53.864151
NCT02210390|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-12-21|||June 2012||2012-06-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Culturally Adapted Psychological Intervention for Bipolar Disorder in Pakistan|Feasibility RCT of the Efficacy of a Culturally Adapted Psychological Intervention for Bipolar Disorder in Pakistan|Completed||N/A|36|Actual|Pakistan Institute of Learning and Living||2|||f||||t||||||||||2017-10-11 00:07:53.947657|2017-10-11 00:07:53.947657
NCT02210377|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-03|2016-01-28|||March 2015||2015-03-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A Preliminary Randomized Study of Tianjiu (Auto-moxibustion) Effects in Patients With Intradialytic Hypotension|Department of Traditional Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung|Recruiting||Phase 2|45|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||Undecided|Depending on the progress to decide.|2017-10-11 00:07:54.045212|2017-10-11 00:07:54.045212
NCT02210364|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-12-13|||April 2013||2013-04-01|May 2016|2016-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).|Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Unresectable Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC)|Completed||Phase 1|81|Actual|PharmaMar||1|||f||||||||||||||2017-10-11 00:07:54.132797|2017-10-11 00:07:54.132797
NCT02210351|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||September 2014||2014-09-01|August 2014|2014-08-01||||January 2017|Anticipated|2017-01-01||Interventional|||Evaluation of Association Between Apical Dysfunction and Trans Apical Access for TAVR, in Patients With Severe Aortic Stenosis, Undergoing Trans Apical Trans Catheter Aortic Valve Replacement (TAP-TAVR).|Evaluation of Association Between Apical Dysfunction and Trans Apical Access for TAVR, in Patients With Severe Aortic Stenosis, Undergoing Trans Apical Trans Catheter Aortic Valve Replacement (TAP-TAVR).|Unknown status|Not yet recruiting|N/A|45|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 00:07:54.202323|2017-10-11 00:07:54.202323
NCT02210338|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-04-27|||August 2014||2014-08-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||A Comparison of the C-mac and Bonfils Intubation Fibrescope|A Comparison of the C-mac and Bonfils Intubation Fibrescope for Tracheal Intubation in Patients With a Simulated Difficult Airway|Recruiting||N/A|64|Anticipated|Singapore General Hospital||2|||f||||f||||||||||2017-10-11 00:07:54.274562|2017-10-11 00:07:54.274562
NCT02210325|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-09-08|||August 2014|Actual|2014-08-01|September 2017|2017-09-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Interventional|SOLITAIRE-U||Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea|An Open-Label, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of a Single Dose of Oral Solithromycin Compared to Single-Dose Intramuscular Ceftriaxone Plus Single-Dose Oral Azithromycin in the Treatment of Male and Female Patients With Uncomplicated Urogenital Gonorrhea With or Without Concomitant Chlamydia|Completed||Phase 3|264|Actual|Cempra Inc||2|||f||||f||||||||||2017-10-11 00:07:54.359312|2017-10-11 00:07:54.359312
NCT02210286|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-10-12|||July 2014||2014-07-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia|The Use of Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Mild to Moderate Dementia|Completed||N/A|20|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 00:07:54.754936|2017-10-11 00:07:54.754936
NCT02210273|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-08-18|||August 2014||2014-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2016|Actual|2016-08-01||Interventional|SUCCESS||Solace Stress Urinary inContinence Control Efficacy and Safety Study|Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects With Stress Urinary Incontinence|Active, not recruiting||N/A|220|Anticipated|Solace Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 00:07:54.868719|2017-10-11 00:07:54.868719
NCT02210260|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-09-13|||September 2013||2013-09-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PROSP||Pain Relief After Colorectal Surgery: Spinal Combined With Painbuster® vs Painbuster® Alone.|Pain Relief After Colorectal Surgery: Single-shot Spinal Combined With Painbuster® vs Painbuster® Alone. A Pilot Randomised Controlled Trial|Completed||N/A|79|Actual|York Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:07:55.02569|2017-10-11 00:07:55.02569
NCT02210234|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||May 2010||2010-05-01|August 2014|2014-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Wheat Bioactives and Immune Function|Wheat Bioactives and Immune Function|Completed||N/A|43|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 00:07:55.300269|2017-10-11 00:07:55.300269
NCT02210221|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-07-26|||October 2014||2014-10-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|December 1, 2017|Anticipated|2017-12-01|6 Months|Observational [Patient Registry]|CENTER-TBI||CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI|Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI)|Recruiting||N/A|5400|Anticipated|University Hospital, Antwerp|||1||f||||t||||||Samples With DNA|"     whole blood samples   "|||2017-10-11 00:07:55.447464|2017-10-11 00:07:55.447464
NCT02210208|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2017-07-05|2017-07-05||September 2014||2014-09-01|January 2016|2016-01-01|June 15, 2016|Actual|2016-06-15|June 2016|Actual|2016-06-01||Interventional|MpT Ag 03||An Open, Non Controlled, Multi-centre, Clinical Investigation to Verify Performance and Safety of a Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients and the Usefulness of a Marketed Donor Site Dressing.|An Open, Non Controlled, Multi-centre, Clinical Investigation to Verify Performance and Safety of a Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients and the Usefulness of a Marketed Donor Site Dressing.|Completed||N/A|28|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 00:07:55.799147|2017-10-11 00:07:55.799147
NCT02210195|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-07-05|2017-07-05||September 4, 2014|Actual|2014-09-04|July 2017|2017-07-01|December 19, 2016|Actual|2016-12-19|December 19, 2016|Actual|2016-12-19||Interventional|||Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence|Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence|Completed||Phase 2|20|Actual|The Scripps Research Institute||2|||f||||f||||||||||2017-10-11 00:07:56.105423|2017-10-11 00:07:56.105423
NCT02210182|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-03-11|||August 2014||2014-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma|A Phase I Clinical Study on the Hepatic Uptake, Pharmacokinetics, Safety and Tolerance of a New Oral Pentamidine Formulation in Hepatocellular Carcinoma Subjects Undergoing Thermal Ablation|Completed||Phase 1|29|Actual|Oncozyme Pharma Inc.||2|||f||||t||||||||||2017-10-11 00:07:56.524081|2017-10-11 00:07:56.524081
NCT02210169|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-12-04|||September 2014||2014-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates|A Randomised Controlled Trial (RCT) of Continuous and Intermittent Infusion of Vancomycin in Neonates|Recruiting||N/A|200|Anticipated|Murdoch Childrens Research Institute||2|||f||||t||||||||||2017-10-11 00:07:56.657608|2017-10-11 00:07:56.657608
NCT02210156|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-05|||January 2012||2012-01-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effects of a Supplement on Acute Respiratory Infections|Effects of a Dietary Supplement on the Incidence of Acute Respiratory Infections in Susceptible Adults|Completed||N/A|45|Actual|Omnilife Manufactura, SA de CV||2|||f||||f||||||||||2017-10-11 00:07:56.770603|2017-10-11 00:07:56.770603
NCT02210143|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||February 2011||2011-02-01|August 2014|2014-08-01||||March 2013|Actual|2013-03-01||Observational|||An Explorative Study To Develop A Predictive Model Based On Avascular Exposed Root Surface Area For Root Coverage||Completed||N/A|91|Actual|Cukurova University|||3||f||||||||||||||2017-10-11 00:07:56.923967|2017-10-11 00:07:56.923967
NCT02210130|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2016-10-20|||May 2014||2014-05-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|MICROBREAK2||The Microvascular Brain Retina And Kidney Study|Measure of Specific Determinants of the Cerebral Small Vessel Disease in HIV+ Patients|Recruiting||N/A|200|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||t||||||||||2017-10-11 00:07:57.010271|2017-10-11 00:07:57.010271
NCT02210117|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-09-19|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Nivolumab vs Nivolumab + Bevacizumab vs Nivolumab + Ipilimumab in Metastatic Renal Cell Carcinoma (mRCC)|A Pilot Randomized Tissue-Based Study Evaluating Anti-PD1 Antibody or Anti-PD1 + Bevacizumab or Anti-PD1 + Anti-CTLA-4 in Patients With Metastatic Renal Cell Carcinoma Who Are Eligible for Cytoreductive Nephrectomy, Metastasectomy or Post-Treatment Biopsy|Recruiting||Early Phase 1|105|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-11 00:07:57.119338|2017-10-11 00:07:57.119338
NCT02210104|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-07-17|||December 2016||2016-12-01|July 2017|2017-07-01||||December 2019|Anticipated|2019-12-01||Interventional|||Adoptive Therapy Using Antigen-Specific CD4 T-Cells|Phase I Study of Cellular Adoptive Immunotherapy Using Autologous CD4+ NY-ESO-1-Specific T Cells and Anti-CTLA4 For Patients With NY-ESO-1-Expressing Tumors|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1||Issues with tetramer staining|f||||f||||||||||2017-10-11 00:07:57.291953|2017-10-11 00:07:57.291953
NCT02210091|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-02-23|2016-12-02|2016-10-20|September 2014||2014-09-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||BAX 855 Pediatric Study|A Phase 3 Prospective, Uncontrolled, Multicenter Study Evaluating Pharmacokinetics, Efficacy, Safety, and Immunogenicity of BAX 855 (PEGylated Full-length Recombinant FVIII) in Previously Treated Pediatric Patients With Severe Hemophilia A|Completed||Phase 3|75|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-10-11 00:07:57.464254|2017-10-11 00:07:57.464254
NCT02210078|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-09-12|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Third-Party Cytotoxic T-Lymphocytes (CTLs) for Cytomegalovirus (CMV) Infection|Most Closely HLA Matched Allogeneic CMV Specific Cytotoxic T-Lymphocytes (CTL) to Treat CMV Infection After Hemopoietic Stem Cell Transplantation (HSCT)|Recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:07:59.171715|2017-10-11 00:07:59.171715
NCT02210065|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-05-26|||March 3, 2015|Actual|2015-03-03|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation|The Pre-Emptive Use of Recipient-Derived Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation After Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 2|6|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:07:59.305369|2017-10-11 00:07:59.305369
NCT02210052|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-06-27|2017-03-28||September 2014||2014-09-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety of Spine Radiofrequency Procedures|Safety of Lumbar Spine Radiofrequency Procedures in the Presence of Posterior Pedicle Screws: A Prospective Trial|Completed||N/A|6|Actual|Mayo Clinic||1|||f||||f||||||||No||2017-10-11 00:07:59.415649|2017-10-11 00:07:59.415649
NCT02210039|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-07-14|||June 2014||2014-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Using Spectrally Encoded Confocal Microscopy (SECM) to Visualise the Esophagus Using an SECM Probe|Pilot Study to Image the Esophagus Using a SECM Probe|Completed||N/A|12|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:07:59.644792|2017-10-11 00:07:59.644792
NCT02210013|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-08-05|||January 2012||2012-01-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01|11 Months|Observational [Patient Registry]|||Differences in Ovarian Aging Between Caucasian and Indian Women|Ethnicity as a Determinant of Ovarian Aging: Differences Between Caucasian and Indian Women|Completed||N/A|400|Actual|IVI Madrid|||2||f||||f||||||||||2017-10-11 00:07:59.878368|2017-10-11 00:07:59.878368
NCT02209987|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-10-23|||August 2014||2014-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults|A Phase 1 Study to Evaluate the Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Subjects|Completed||Phase 1|28|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 00:08:00.177569|2017-10-11 00:08:00.177569
NCT02209974|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-08-05|||February 2004||2004-02-01|August 2014|2014-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD|Inhaled Corticosteroids do Not Modify the Systemic Inflammation Induced by Exercise in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|23|Actual|Hospital Son Llatzer||2|||f||||t||||||||||2017-10-11 00:08:00.288682|2017-10-11 00:08:00.288682
NCT02209961|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-08-05|||March 2014||2014-03-01|August 2014|2014-08-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Observational|||Combined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With Cataract|To Check the Efficacy and Saftey of Combined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With Cataract|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 00:08:00.895017|2017-10-11 00:08:00.895017
NCT02209948|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-08-10|||August 2014||2014-08-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.|Clinical Trial Phase IIB Randomized, Multicenter, of Continuation or Non Continuation With 6 Cycles of Temozolomide After the First 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.|Recruiting||Phase 2|160|Anticipated|Grupo Español de Investigación en Neurooncología||2|||f||||f||||||||||2017-10-11 00:08:01.022267|2017-10-11 00:08:01.022267
NCT02209935|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-09-05|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|||RCT: Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury|RCT Early Rehabilitation Protocol vs. Usual Care in the Pediatric ICU for Children With Acute Brain Injury|Completed||Phase 2|58|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:08:01.213151|2017-10-11 00:08:01.213151
NCT02209922|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-07-22|||December 2014||2014-12-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effects of tDCS Combined With Balance Training on Postural Control in Chronic Stroke Patients|The Effects of tDCS Combined With Balance Training on Postural Control in Chronic Stroke Patients ( A Randomized Controlled Trial)|Recruiting||N/A|60|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:08:01.321824|2017-10-11 00:08:01.321824
NCT02207036|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-05-05|||October 2014||2014-10-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|TSP||Tobacco Status Project: Social Media Intervention for Young Adult Smokers|Social Media Intervention for Young Adult Smokers|Completed||N/A|501|Actual|University of California, San Francisco||2|||f||||f||||||||No||2017-10-11 00:08:46.338512|2017-10-11 00:08:46.338512
NCT02209909|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-04-20|||July 2014||2014-07-01|August 2014|2014-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery|Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery|Completed||N/A|48|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:08:01.478259|2017-10-11 00:08:01.478259
NCT02209896|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-03|2015-05-18|||December 2014||2014-12-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|October 2015|Anticipated|2015-10-01||Interventional|||BlueWind Reprieve System for the Treatment of PNP|Safety and Performance of the BlueWind Medical Reprieve System for the Treatment of Patients With Peripheral Neuropathic Pain|Unknown status|Recruiting|N/A|10|Anticipated|Rainbow Medical||1|||f||||f||||||||||2017-10-11 00:08:01.636753|2017-10-11 00:08:01.636753
NCT02209883|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-08-05|||November 2012||2012-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01|1 Day|Observational [Patient Registry]|washout||The Effect of Sevofluorane on Wash-out Time in COPD|The Effects of Chronic Obstructive Pulmonary Disease on the Washout Time of Sevofluorane Anesthesia|Completed||N/A|60|Actual|Duzce University|||2||f||||f||||||||||2017-10-11 00:08:01.758587|2017-10-11 00:08:01.758587
NCT02209870|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2015-04-01|||January 2011||2011-01-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||The Impact of Resuscitation Quality of CPR Team by Implantation of Electronic Checklist and Alarming System Through Video-recording Analyses|The Impact of Resuscitation Quality of CPR Team by Implantation of Electronic Checklist and Alarming System Through Video-recording Analyses|Unknown status|Active, not recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:08:01.863504|2017-10-11 00:08:01.863504
NCT02209857|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-02-14|||January 2013||2013-01-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|Symphony||The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy|The Symphony Triple A Study: Using Symphony as an Adjunct to Histopathologic Parameters When the Doctor is Ambivalent About the Administration and Type of Adjunctive Systemic Therapy|Completed||N/A|660|Actual|Diakonessenhuis, Utrecht|||1||f||||f||||||Samples With DNA|"     The tissue specimen for MammaPrint® analysis consists of a tumour block or 10 unstained     slides with 5µm section on each slide. The tissue can be shipped as formalin fixed paraffin     embedded (FFPE) tissue. For further information: www.agendia.com or www.symphonytripleA.nl.   "|||2017-10-11 00:08:01.982114|2017-10-11 00:08:01.982114
NCT02209844|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||August 2006||2006-08-01|August 2014|2014-08-01||||January 2007|Actual|2007-01-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Powder in Healthy Male Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses (2.5 mg to 1200 mg) of BI 44847 as Powder in the Bottle Reconstituted With 0.2% Natrosol Solution Administered to Healthy Male Subjects. A Randomised, Placebo-controlled (Within Dose Groups) and Double-blinded Trial|Completed||Phase 1|72|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:08:02.345071|2017-10-11 00:08:02.345071
NCT02209831|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||November 2001||2001-11-01|August 2014|2014-08-01||||January 2002|Actual|2002-01-01||Interventional|||Bioavailability of Oral BIRB 796 BS Tablets With and Without Administration of Oral Pantoprazole in Healthy Male Volunteers|An Open Label, Randomised, Crossover Study of the Bioavailability of Oral BIRB 796 BS Tablets (30 mg Single Dose) With and Without Administration of Oral Pantoprazole in Healthy Male Volunteers to Assess the Effect of Gastric pH on Absorption of BIRB 796 BS.|Completed||Phase 1|22|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:08:02.450901|2017-10-11 00:08:02.450901
NCT02209818|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-03-11|||August 2014||2014-08-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Laser Application in Pain Management Following the Use of Orthodontic Elastomeric Separators|Evaluation of Low Level Laser Therapy (LLLT) Effect on Pain Management Caused by Orthodontic Elastomeric Separators|Completed||N/A|72|Actual|Damascus University||2|||f||||t||||||||||2017-10-11 00:08:02.555521|2017-10-11 00:08:02.555521
NCT02209805|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||January 2001||2001-01-01|August 2014|2014-08-01||||March 2001|Actual|2001-03-01||Interventional|||Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects|Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally (Total Daily Dose 30, 60, and 120 mg) to Healthy Human Subjects for 14 Days. A Double-blind, Placebo-controlled, Parallel Group Study.|Completed||Phase 1|49|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:08:02.67903|2017-10-11 00:08:02.67903
NCT02209792|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||October 2001||2001-10-01|August 2014|2014-08-01||||January 2004|Actual|2004-01-01||Interventional|||Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease|A Randomised, Double-blind, Placebo-controlled, Five* Parallel Groups, Dose Finding Study of BIRB 796 BS (10, 20, 30, and 60 mg*) Administered Twice a Day Orally Over 8 Weeks in Patients With Moderate to Severe Crohn's Disease Followed by a 18 Weeks Treatment Extension in Patients With Clinical Remission or Clinical Response After 8 Weeks Treatment With the Respective Dose of BIRB 796 BS - Extension Phase. * Subsequent to Amendment 4 (Dated 11 Jun 2002) a 60 mg b.i.d. Group Was Included.|Terminated||Phase 2|284|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:08:02.762437|2017-10-11 00:08:02.762437
NCT02209779|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||May 2001||2001-05-01|August 2014|2014-08-01||||June 2002|Actual|2002-06-01||Interventional|||Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis|A Randomised, Parallel, Double-blind, Placebo-controlled Study to Investigate Efficacy and Safety of Different Doses (5, 10, 20 and 30 mg) of BIRB 796 BS Administered Twice a Day Orally Over 4 Weeks in Patients With Active Rheumatoid Arthritis Who Have Failed at Least One DMARD|Completed||Phase 2|167|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:08:02.872228|2017-10-11 00:08:02.872228
NCT02209766|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-04-11|2015-10-30||August 2014||2014-08-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||All randomized subjects|A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)|A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics in Healthy Male Japanese (Single-blind, Randomized, Placebo-controlled) and Caucasian (Open-label) Subjects After Single and Once Daily Multiple Oral Doses of D5884|Completed||Phase 1|86|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:08:02.981192|2017-10-11 00:08:02.981192
NCT01846884|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-15|||November 2012||2012-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Specimen Stability Study|Urine Sample Processing Study:Analysis of Fresh Versus Frozen Urine Samples From Critically Ill Subjects|Completed||N/A|124|Actual|Astute Medical, Inc.|||1||f||||f||||||||||2017-10-11 01:44:34.141555|2017-10-11 01:44:34.141555
NCT02209753|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||June 2001||2001-06-01|August 2014|2014-08-01||||September 2002|Actual|2002-09-01||Interventional|||BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis|Phase II, Randomized, Double-blind, Placebo Controlled, Multi-center, Four Week Trial of BIRB 796 BS 5, 10, 20 and 30 mg Oral Tablets Versus Placebo Administered BID in Patients With Moderate to Severe Plaque-type Psoriasis|Completed||Phase 2|182|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:08:03.681112|2017-10-11 00:08:03.681112
NCT02209740|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-02|2015-12-28|||July 2014||2014-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|TDFOUT||Renal and Bone Outcome After Switching Tenofovir to Different Antiretroviral Strategies|A Prospective, Cohort Study of Renal and Bone Outcome After Changing Tenofovir in Patients With Renal Toxicity According to Antiretroviral Strategy|Completed||N/A|245|Actual|Asociacion para el Estudio de las Enfermedades Infecciosas|||1||f||||f||||||||||2017-10-11 00:08:03.787652|2017-10-11 00:08:03.787652
NCT02209727|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||December 2000||2000-12-01|August 2014|2014-08-01||||June 2002|Actual|2002-06-01||Interventional|||Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer|A Phase I Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer|Terminated||Phase 1|9|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:08:03.881604|2017-10-11 00:08:03.881604
NCT02209714|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||November 1999||1999-11-01|August 2014|2014-08-01||||February 2000|Actual|2000-02-01||Interventional|||Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male Volunteers|A Single Increasing Dose Safety, Tolerability and Pharmacodynamics (Citric Acid Challenge) Study After Oral Administration of BIIF 1149 BS (Single Doses as Tablets: 40, 65, 100 mg) in Healthy Male Volunteers (Randomised, Double-blind Within Each Dose Group, Placebo-controlled, Parallel Groups)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:08:03.958273|2017-10-11 00:08:03.958273
NCT02209701|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||December 1999||1999-12-01|August 2014|2014-08-01||||July 2000|Actual|2000-07-01||Interventional|||Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors|A Phase I Intensive Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors Who Receive Radiation Therapy|Terminated||Phase 1|3|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:08:04.044051|2017-10-11 00:08:04.044051
NCT02209688|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||February 2000||2000-02-01|August 2014|2014-08-01||||March 2000|Actual|2000-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESR 1150 CL in Healthy Subjects|"Administration of ESR 1150 CL in Ascending Doses of 0.5, 1, 2, 4 and 8 mg in an Open, Group Comparison and Placebo-controlled Design (Placebo Randomised Double Blind in the Dose Groups) for the Assessment of Safety, Tolerability (Maximum Tolerated Dose, MTD), Pharmacokinetics and Pharmacodynamics in 5 Groups of 8 Female and 5 Male Healthy Subjects, and 4 mg Additionally in Fed State, in a Cross Over Design. Safety, Tolerability and Pharmacokinetics of MTD/4, MTD/2 and MTD in 6 Healthy Male Subjects, Identified as CYP2D6 and/or Spartein Poor Metabolizers, in a 3-fold Cross Over, Open Study."|Terminated||Phase 1|39|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:08:04.130049|2017-10-11 00:08:04.130049
NCT02209675|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-10-12|||December 2012||2012-12-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation||Completed||N/A|25|Actual|Ain Shams University||1|||f||||f||||||||||2017-10-11 00:08:04.238062|2017-10-11 00:08:04.238062
NCT02209662|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-04|||October 2014||2014-10-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Safety and Efficacy Study of APIC-PRP in Non-healing Diabetic Foot Ulcers|A Multi-Center, Randomized Trial Comparing the Effectiveness of APIC-PRP to Control, When Added to Standard of Care in the Treatment of Non-healing Diabetic Foot Ulcers|Unknown status|Not yet recruiting|N/A|274|Anticipated|Cytonics Corporation||2|||f||||f||||||||||2017-10-11 00:08:04.321254|2017-10-11 00:08:04.321254
NCT02209649|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-05|2014-08-05|||October 1999||1999-10-01|August 2014|2014-08-01||||December 1999|Actual|1999-12-01||Interventional|||Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects|Bioavailability of Lacidipine 4 mg and Telmisartan 40 mg Administered Orally as Two Experimental Fixed Dose Combination Tablets Relative to Separate Tablets. An Open Randomised Three-way Cross-over Steady State Trial in 6 Female and 6 Male Healthy Subjects|Completed||Phase 1|12|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:08:04.401213|2017-10-11 00:08:04.401213
NCT02209636|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-08-16|||September 15, 2014|Actual|2014-09-15|August 2017|2017-08-01|June 30, 2019|Anticipated|2019-06-30|March 21, 2019|Anticipated|2019-03-21||Interventional|||Phophate Lowering Trial|Phosphate Lowering to Treat Vascular Dysfunction in Chronic Kidney Disease|Recruiting||Phase 4|60|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||t|||||2017-10-11 00:08:04.484404|2017-10-11 00:08:04.484404
NCT02209623|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-07-19|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|May 2016|Actual|2016-05-01||Observational|Tdap||TDAP Safety in Pregnant Women|Clinical Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) Safety in Pregnant Women|Active, not recruiting||N/A|375|Actual|Vanderbilt University Medical Center|||1||f||||f|f|f||||Samples Without DNA|"     Serum Samples   "|||2017-10-11 00:08:04.613919|2017-10-11 00:08:04.613919
NCT02209610|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-05-09|||July 1, 2015|Actual|2015-07-01|May 2017|2017-05-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||Premature Fatigue in Veterans With Heart Failure: Neuronal Influences|Premature Fatigue in Veterans With Heart Failure: Neuronal Influences|Completed||N/A|32|Actual|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-11 00:08:04.702532|2017-10-11 00:08:04.702532
NCT02209597|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-10-31|||June 2014||2014-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Interventional|BALANCE||Bupropion in Depression|Bioequivalence and Clinical Effects of Generic and Brand Bupropion|Active, not recruiting||N/A|77|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-10-11 00:08:04.807544|2017-10-11 00:08:04.807544
NCT02209584|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-08-31|||May 2014||2014-05-01|May 2015|2015-05-01|December 8, 2015|Actual|2015-12-08|April 15, 2015|Actual|2015-04-15|3 Months|Observational [Patient Registry]|PROCEDE-2000||Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients|An Open Registry to Measure the Impact of Adding Genomic Testing (Prolaris®) on the Treatment Decision Following Biopsy in Newly Diagnosed Prostate Cancer Patients by Specialists|Completed||N/A|274|Actual|Myriad Genetic Laboratories, Inc.|||1||f||||f||||||||||2017-10-11 00:08:04.917225|2017-10-11 00:08:04.917225
NCT02209571|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-12-10|||October 2014||2014-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Breath Analysis in in Adults With Cystic Fibrosis (CF)|Exhaled Breath Analysis by Secondary Electrospray Ionisation Mass Spectrometry (SESI-MS) in Adults With Cystic Fibrosis: An Exploratory Matched Case-Control Study|Completed||N/A|60|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 00:08:04.990818|2017-10-11 00:08:04.990818
NCT02209558|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-04-13|||August 2014||2014-08-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Sternal||The Effect of Visual Sternal Precautions on Behavioral Intentions and Readmissions|The Effect of Visual Sternal Precautions on Behavioral Intentions and Readmissions|Completed||N/A|19|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 00:08:05.10342|2017-10-11 00:08:05.10342
NCT02209545|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-09-04|||October 2014||2014-10-01|September 2016|2016-09-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Misoprostol for Reduction of Blood Loss During Fibroid Surgery|Buccal Misoprostol Prior to Abdominal Myomectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial|Recruiting||Phase 4|50|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 00:08:05.191377|2017-10-11 00:08:05.191377
NCT02209532|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-06-22|||December 2015||2015-12-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|FILM||A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping|A Randomized, Prospective, Open Label, Multicenter Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping|Completed||N/A|180|Actual|Novadaq Technologies Inc.||2|||f||||t||||||||||2017-10-11 00:08:05.298876|2017-10-11 00:08:05.298876
NCT02209519|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-09-26|||February 2015||2015-02-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Randomized Controlled Trial of Treatment of Male Partners of Women With BV|Randomized Controlled Trial of Treatment of Male Partners of Women With BV|Recruiting||Phase 3|736|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:08:05.403986|2017-10-11 00:08:05.403986
NCT02209506|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-07-18|2016-06-01||July 2014||2014-07-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional||Baseline analysis set included all participants who were randomized.|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential-Cohort, Ascending Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Non-Japanese and Japanese Subjects|Terminated||Phase 1|23|Actual|Takeda||10||Long-term animal toxicology findings (see detailed description).|f||||f||||||||||2017-10-11 00:08:05.541381|2017-10-11 00:08:05.541381
NCT02209493|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-05|||January 2013||2013-01-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|August 2013|Actual|2013-08-01||Interventional|||Effects of Nopales (Opuntia Spp.) on Lipoprotein Profile and Oxidative Stress in Moderately Hypercholesterolemic Adults|The Efficacy of Nopales (Opuntia Spp.) on Lipoprotein Profile and Oxidative Stress Among Moderately Hypercholesterolemic Adults|Completed||N/A|27|Actual|Arizona State University||2|||f||||f||||||||||2017-10-11 00:08:07.119123|2017-10-11 00:08:07.119123
NCT02209480|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-04|||December 2007||2007-12-01|August 2014|2014-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|ATNeck||Alexander Technique Neck Pain|Randomized Controlled Trial on the Efficacy of F.M. Alexander Technique in Chronic Neck Pain Patients|Completed||N/A|72|Actual|Universität Duisburg-Essen||3|||f||||f||||||||||2017-10-11 00:08:07.236567|2017-10-11 00:08:07.236567
NCT02209467|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-10-28|||August 2014||2014-08-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Balance and Falls in Multiple Sclerosis|Balance and Falls in Multiple Sclerosis: Intervention and Perceptions From Patients and Next of Kins|Completed||N/A|52|Actual|Örebro County Council||2|||f||||f||||||||||2017-10-11 00:08:07.357344|2017-10-11 00:08:07.357344
NCT02209454|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-06-16|2015-05-27||April 2014||2014-04-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional||Twenty-six (26) subjects were randomized (14 male and 12 female) for 24 to complete the study. A total of 25 subjects (13 male and 12 female) completed the study. NOTE: Treatments were administered in a crossover manner, with the same population but one healthy subjects being exposed to the Reference and Test IMP.|Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations|Comparative Study of the Bioavailability of Dexketoprofen Trometamol Following Single Doses of 25mg Enantyum® Oral Solution vs. Keral® Tablets in Healthy Subjects|Completed||Phase 1|26|Actual|Menarini Group||2|||f||||f||||||||||2017-10-11 00:08:07.50975|2017-10-11 00:08:07.50975
NCT02209441|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-04||||||August 2014|2014-08-01||||||||Expanded Access|||Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer||Available||N/A|||Chinese Academy of Medical Sciences|||||f||||||||||||||2017-10-11 00:08:07.911191|2017-10-11 00:08:07.911191
NCT02209428|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-03-21|||June 2014||2014-06-01|March 2015|2015-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas|A Prospective Cohort to Study the Effect of Postoperative Upfront Temozolomide Chemotherapy on IDH Mutational Low Grade Gliomas in Eloquent Areas|Unknown status|Recruiting|Phase 2|50|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-11 00:08:08.033524|2017-10-11 00:08:08.033524
NCT02209415|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-08-04|||April 2011||2011-04-01|August 2014|2014-08-01|August 2016|Anticipated|2016-08-01|January 2016|Anticipated|2016-01-01||Interventional|EUFURO||EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer|Endoscopic Ultrasound (EUS) and PET-CT Based Follow-up of Patients Radically Resected for Cancer of the Oesophagus, Stomach or Pancreas.|Unknown status|Active, not recruiting|N/A|182|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 00:08:08.259967|2017-10-11 00:08:08.259967
NCT02209402|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-08-04|||April 2012||2012-04-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Endure||ENdothelial DysfUnction in Renal Disease and Exercise Training|Effect of a 3-month Aerobic Training Program on Endothelial Function in Mild-to-moderate CKD: a Randomized Controlled Trial|Completed||N/A|40|Actual|Universiteit Antwerpen||2|||f||||||||||||||2017-10-11 00:08:08.402164|2017-10-11 00:08:08.402164
NCT02209389|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-08-18|||August 2014||2014-08-01|August 2014|2014-08-01|August 2017|Anticipated|2017-08-01|August 2015|Anticipated|2015-08-01|2 Years|Observational [Patient Registry]|||OctavaPink for Women With Dense Breast After Negative Mammography|OctavaPink® For Dense Breast After Negative Mammography|Unknown status|Not yet recruiting|N/A|1750|Anticipated|Eventus Diagnostics Ltd|||2||f||||f||||||Samples With DNA|"     Human plasma samples   "|||2017-10-11 00:08:08.524036|2017-10-11 00:08:08.524036
NCT02209376|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-01-25|||July 2014||2014-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma|Pilot Study of Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma|Active, not recruiting||N/A|12|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:08:08.678743|2017-10-11 00:08:08.678743
NCT02209363|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-01-12|||April 2015||2015-04-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|COPE-PAP||Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure Therapy|Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure Therapy (COPE-PAP Trial)|Recruiting||N/A|90|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 00:08:08.7613|2017-10-11 00:08:08.7613
NCT02209350|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-09-11|||August 2014||2014-08-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of the AFB and Stenting of the Iliac Arteries|Prospective Randomized Clinical Study of the Aorto-femoral Bypass and the Iliac Arteries With Stenting Recanalization Effectiveness in Patients With the Iliac Segment Occlusive Disease|Recruiting||Phase 1|200|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 00:08:08.865062|2017-10-11 00:08:08.865062
NCT02209337|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-03|2017-06-19|||September 2014|Actual|2014-09-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2016|Actual|2016-03-01||Interventional|||Demonstrate the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse|Demonstrate the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse|Active, not recruiting||N/A|20|Actual|Lyra Medical Ltd.||1|||f|||||f|f||||||||2017-10-11 00:08:08.974003|2017-10-11 00:08:08.974003
NCT02209324|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-03-15|||November 2013||2013-11-01|March 2016|2016-03-01||||July 2015|Actual|2015-07-01||Interventional|||Open-label Study of ASP2151 in Herpes Simplex Patients|Open-label Study of ASP2151 in Herpes Simplex Patients|Completed||Phase 3|250|Anticipated|Maruho Co., Ltd.||1|||f||||t||||||||||2017-10-11 00:08:09.070753|2017-10-11 00:08:09.070753
NCT02209311|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-11-29|||September 2014||2014-09-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs|Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Tissue Engineered Construction Based on a Synthetic Tricalcium Phosphate and Autologous Multipotent Mesenchymal Stromal Cells Obtained From Oral Mucosa|Enrolling by invitation||Phase 1/Phase 2|12|Anticipated|Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation||1|||f||||f||||||||||2017-10-11 00:08:09.153866|2017-10-11 00:08:09.153866
NCT02209298|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-04-17|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|November 2016|Actual|2016-11-01||Observational|||CoreValve VIVA Study Evaluation of the Clinical Outcomes of CoreValve in Degenerative Surgical Aortic Bioprosthesis.|Evaluation of the Clinical Outcomes of CoreValve in Degenerative Surgical Aortic Bioprosthesis. A Prospective, Observational Post-market Study.|Active, not recruiting||N/A|200|Actual|Medtronic Cardiovascular|||1||f||||t||||||||||2017-10-11 00:08:09.247527|2017-10-11 00:08:09.247527
NCT02209285|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-06-29|||January 2016||2016-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Community Vascular and Multiple Chronic Conditions Intervention Study|(Aging, Community and Health Research Unit) ACHRU - Community Partnership Program for Older Adults With Multiple Chronic Conditions|Recruiting||N/A|160|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-11 00:08:09.371938|2017-10-11 00:08:09.371938
NCT02209272|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-03-21|||August 2014||2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Bacteriostatic Saline to Buffered Lidocaine for Ultrasound Guided Hip Joint Injection Local Anesthesia|Local Anesthesia for Ultrasound Guided Hip Joint Injections: A Double-Blinded Randomized Controlled Trial of Bacteriostatic Saline Versus Buffered Lidocaine|Recruiting||Phase 4|68|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:08:09.496653|2017-10-11 00:08:09.496653
NCT02209246|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-08-01|||July 2013||2013-07-01|August 2014|2014-08-01||||July 2014|Actual|2014-07-01||Interventional|||The Effect of Feedback Regarding Illness Behavior on Patient Satisfaction in Hand Surgery|The Effect of Feedback Regarding Illness Behavior on Patient Satisfaction in Hand Surgery|Completed||N/A|128|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:08:09.754038|2017-10-11 00:08:09.754038
NCT02209233|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-02-05|||February 2015||2015-02-01|February 2015|2015-02-01||||February 2015|Actual|2015-02-01||Interventional|||Effects of Massage on Post-operative Pain in Urologic Patients|Effects of Massage on Post-operative Pain in Urologic Patients|Withdrawn||N/A|0|Actual|Loma Linda University||2|||f||||t||||||||||2017-10-11 00:08:09.849072|2017-10-11 00:08:09.849072
NCT02209220|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-09-26|||September 2014||2014-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|APAP-CPAP||Impact of Automatic Positive Airway Pressure on Treatment Compliance in OSA Patients Awaiting Bariatric Surgery|Impact of Automatic Positive Airway Pressure on Treatment Compliance in Obstructive Sleep Apnea Patients Awaiting Bariatric Surgery|Active, not recruiting||N/A|50|Anticipated|Laval University||2|||f||||f||||||||||2017-10-11 00:08:09.943008|2017-10-11 00:08:09.943008
NCT01846871|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-12-01||2016-12-01|June 2013||2013-06-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|September 2014|Actual|2014-09-01||Interventional|||Tivozanib for Recurrent Glioblastoma|A Phase II Study of Tivozanib in Recurrent Glioblastoma|Completed||Phase 2|10|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:44:34.35454|2017-10-11 01:44:34.35454
NCT02209207|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-02-23|||July 2014||2014-07-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Continuous Versus Interval Walking Training in Patients With COPD - a Pilot Study|Continuous Versus Interval Walking Training in Patients With Severe Chronic Obstructive Pulmonary Disease - a Pilot Study|Completed||N/A|20|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 00:08:10.038934|2017-10-11 00:08:10.038934
NCT02209194|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-09-25|||June 2014||2014-06-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Post-market Registry in Patients With Iliac Aneurysm Undergoing Endovascular Stenting With the E-liac Stent Graft System|PLIANT - A Post-market Registry in Patients With Iliac Aneurysm Undergoing Endovascular Stenting With a New Generation of Low Profile E-liac Stent Graft System|Active, not recruiting||N/A|47|Actual|JOTEC GmbH|||1||f||||f||||||||||2017-10-11 00:08:10.15873|2017-10-11 00:08:10.15873
NCT02209181|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-12-10|2016-10-12|2016-02-29|August 2014||2014-08-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Dental Pain Study to Test the Effectiveness of a New Pain Reliever Medicine|A Randomized, Double-blind, Placebo- and Active-controlled Trial to Investigate the Single-dose Efficacy, Safety, and Pharmacokinetics of 250 and 1000 mg JNJ-10450232 in Postoperative Dental Pain|Completed||Phase 2|269|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||f||||||||||2017-10-11 00:08:10.504377|2017-10-11 00:08:10.504377
NCT02209168|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-04-03|||November 2015||2015-11-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population|Differences in Ovarian Reserve Markers, Vitamin D Serum Levels and Reproductive Outcomes Between Infertile Indian, Arabian and Caucasian Population|Recruiting||N/A|600|Anticipated|IVI Madrid|||3||f||||t||||||Samples Without DNA|"     Vitamine D serum levels.   "|||2017-10-11 00:08:15.177351|2017-10-11 00:08:15.177351
NCT02209155|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-04-24|||November 2013||2013-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||R-Verapamil for the Prophylaxis of Episodic Cluster Headache|A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of R-Verapamil in the Prophylaxis of Episodic Cluster Headache|Active, not recruiting||Phase 2|30|Anticipated|Center Laboratories, Inc.||2|||f||||f||||||||||2017-10-11 00:08:15.281755|2017-10-11 00:08:15.281755
NCT02209142|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-07-26|||February 2012||2012-02-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|November 2015|Actual|2015-11-01||Interventional|||Blood Biomarkers in Major Depression|Blood Biomarkers in Major Depression|Active, not recruiting||N/A|275|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 00:08:15.389692|2017-10-11 00:08:15.389692
NCT02209129|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-04|||August 2014||2014-08-01|August 2014|2014-08-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|||Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women|3D Digital Breast Tumorsynthesis Versus 2D Digital Mammography in the Clinical Evaluation of Women at High Risk for Breast Cancer|Unknown status|Recruiting|N/A|1000|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 00:08:15.49288|2017-10-11 00:08:15.49288
NCT02209116|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-06-21|||July 2014||2014-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|AQUA2||Assessing QbTest Utility in ADHD: A Randomised Controlled Trial|A RCT Comparing the Effects of Providing Clinicians and Patients With the Results of an Objective Measure of Activity and Attention (QbTest) Versus Usual Care on Diagnostic and Treatment Decision Making in Children and Young People With ADHD|Completed||N/A|267|Actual|University of Nottingham||2|||f||||t||||||||||2017-10-11 00:08:15.60608|2017-10-11 00:08:15.60608
NCT02209103|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-11-19|||March 2014||2014-03-01|August 2014|2014-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Sleep Improving Effects of Orange Phenolics|Determination of the Sleep Improving Effects of Phenolics From an Orange Peel Extract|Completed||N/A|77|Actual|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-11 00:08:15.758126|2017-10-11 00:08:15.758126
NCT02209077|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-08-01|||June 2013||2013-06-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|S-2013-1||Spectralis OCT Repeatability and Reproducibility Study|Repeatability and Reproducibility of Optic Nerve Head (ONH), Retinal Nerve Fiber Layer (RNFL), and Macula Parameters With the Heidelberg Spectralis OCT.|Completed||N/A|32|Actual|Heidelberg Engineering GmbH||2|||f||||f||||||||||2017-10-11 00:08:16.169579|2017-10-11 00:08:16.169579
NCT02209064|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-02-08|2015-11-16||December 2013||2013-12-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|EASE2||"EASE Epicardial Access With the EpiAccess System"|EASe 2- an Epicardial Access Study With the EpiAccess System- A Post-market Follow up Study.|Completed||N/A|25|Actual|EpiEP, Inc.||1|||f||||t||||||||No||2017-10-11 00:08:16.282885|2017-10-11 00:08:16.282885
NCT02209051|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-08-07|||July 2014||2014-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers|A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers|Completed||Phase 4|29|Actual|Derma Sciences, Inc.||2|||f||||f||||||||||2017-10-11 00:08:16.586385|2017-10-11 00:08:16.586385
NCT02209038|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-01-05|||July 2014||2014-07-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Choice Sets for Advance Directives|A Randomized Trial of Expanded Choice Sets to Increase Completion of Advance Directives|Completed||N/A|321|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 00:08:16.720768|2017-10-11 00:08:16.720768
NCT02209025|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-09-04|||June 2014||2014-06-01|August 2014|2014-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Theobromine, Vascular Function and Intestinal apoA-I Production|The Effects of Short-term Theobromine Supplementation on Vascular Function and Intestinal apoA-I Production in Fasting and in the Postprandial State|Completed||N/A|48|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 00:08:16.927495|2017-10-11 00:08:16.927495
NCT02209012|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-09-22|||August 2014||2014-08-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Observational|||Twelve Month Follow-Up of CP0108|Twelve Month Follow-Up Evaluation of Subjects Participating in DUSA-CP0108 (A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities)|Completed||Phase 3|206|Actual|DUSA Pharmaceuticals, Inc.|||2||f||||f||||||||||2017-10-11 00:08:17.050279|2017-10-11 00:08:17.050279
NCT02208999|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-04-19|||December 2013||2013-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PRECISION||Follow-up of Post-spinal Implantable Neurostimulator PRECISION®|Two-years Follow-up of Post-spinal Implantable Neurostimulator PRECISION®|Active, not recruiting||N/A|105|Actual|Cemka-Eval|||1||f||||t|f|||||||No|Individual participant data will not be shared; Only aggregated data will be communicated|2017-10-11 00:08:17.232605|2017-10-11 00:08:17.232605
NCT02208986|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-02-02|||August 2014||2014-08-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study|GnRHa Trigger in Asian Oocyte Donors Co-treated With a GnRH Antagonist - a Dose Finding Study|Completed||N/A|165|Actual|Vietnam National University||3|||f||||f||||||||No||2017-10-11 00:08:17.344467|2017-10-11 00:08:17.344467
NCT02208973|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-03-07|||May 2014||2014-05-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||"Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses"|"Randomized, Double Blind, Placebo Controlled, Parallel Groups Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses in Healthy Volunteers."|Completed||Phase 1|40|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||6|||f||||f||||||||||2017-10-11 00:08:17.446767|2017-10-11 00:08:17.446767
NCT02208960|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-07-13|||November 2014||2014-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Newborn Kit to Save Lives and Brains in Kenya|An Integrated Toolkit to Save Newborn Lives and Brains in Kenya|Completed||Phase 3|2294|Actual|The Hospital for Sick Children||4|||f||||t||||||||||2017-10-11 00:08:17.583828|2017-10-11 00:08:17.583828
NCT02208947|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-06-13|||April 2014||2014-04-01|June 2017|2017-06-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Consumer Engagement to Increase Advance Care Planning|Consumer Engagement to Increase Advance Care Planning|Terminated||Phase 3|77|Actual|University of Pittsburgh||2||failure to accure|f||||f||||||||||2017-10-11 00:08:17.71278|2017-10-11 00:08:17.71278
NCT02208934|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-03-07|||September 2014||2014-09-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers|Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 ( 5 mg, 10 mg, 20 mg and 40 mg ) in Healthy Young Male Volunteers|Completed||Phase 1|32|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||5|||f||||f||||||||||2017-10-11 00:08:18.034139|2017-10-11 00:08:18.034139
NCT02208921|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-03-24|||September 2014||2014-09-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|1 Day|Observational [Patient Registry]|START-INDIA||An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Patients|An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease in Type 2 Diabetes Patients in India|Completed||N/A|3000|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-11 00:08:18.17157|2017-10-11 00:08:18.17157
NCT02208908|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-08-05|||April 2014||2014-04-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Oral Care and Cancer: Assessing the Contribution of Training Healthcare Teams to Support the Oral Status of Patients Hospitalized in Palliative Situation|Oral Care and Cancer: Assessing the Contribution of Training Healthcare Teams to Support the Oral Status of Patients Hospitalized in Palliative Situation|Completed||N/A|280|Actual|Centre Francois Baclesse|||1||f||||t||||||||||2017-10-11 00:08:18.321718|2017-10-11 00:08:18.321718
NCT02208895|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-03-15|||February 2014||2014-02-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Correlation of In-lab Pleural Fluid Glucose Measurements With a Finger Stick Glucometer and Portable Point of Care Testing Device (i-STAT).|Correlation of In-lab Pleural Fluid Glucose Measurements With a Finger Stick Glucometer and Portable Point of Care Testing Device (i-STAT).|Recruiting||N/A|30|Anticipated|University of Oklahoma|||3||f||||t||||||None Retained|"     Pleural fluid   "|||2017-10-11 00:08:18.440998|2017-10-11 00:08:18.440998
NCT02208882|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2015-07-03|||August 2014||2014-08-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120|Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of BMS-986120 in Healthy Subjects and the Effect of BMS-986120 on the Pharmacokinetics of Midazolam in Healthy Subjects|Completed||Phase 1|24|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 00:08:18.561469|2017-10-11 00:08:18.561469
NCT02208869|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-02|2017-04-29|||January 2014||2014-01-01|April 2017|2017-04-01|December 2026|Anticipated|2026-12-01|December 2017|Anticipated|2017-12-01|10 Years|Observational [Patient Registry]|RuFH||Russian Familial Hypercholesterolemia Registry|Prospective Russian Study Evaluating the Extent of Underdiagnosed and Undertreated of Familial Hypercholesterolaemia in the Population|Recruiting||N/A|1000|Anticipated|Russian Cardiology Research and Production Center|||1||f||||t||||||Samples With DNA|"     whole blood, serum, white cells, urine   "|||2017-10-11 00:08:18.674913|2017-10-11 00:08:18.674913
NCT02208856|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-04|||September 1999||1999-09-01|August 2014|2014-08-01||||December 1999|Actual|1999-12-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of Single Rising Doses Oral BIRB 796 BS in Healthy Human Subjects|Safety, Pharmacokinetics and Pharmacodynamics of Single Rising Doses (1, 4, 15, 50, 100, 200, 400, and 600 mg) Oral BIRB 796 BS in Healthy Human Subjects. A Placebo Controlled, Randomised Study, Double Blinded at Each Dose Level|Completed||Phase 1|64|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:08:18.938453|2017-10-11 00:08:18.938453
NCT02208492|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-03|2014-12-08|||September 2011||2011-09-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study||Completed||Phase 4|75|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:08:22.605075|2017-10-11 00:08:22.605075
NCT02208843|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-08-07|||October 2, 2014|Actual|2014-10-02|August 2017|2017-08-01|June 13, 2017|Actual|2017-06-13|May 18, 2017|Actual|2017-05-18||Interventional|||Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation|An Open Label, Single-arm Phase IV Study to Assess the Efficacy and Safety of Afatinib as Second-line Therapy for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harbouring an EGFR Mutation (Del19 or L858R) Who Have Failed First-line Treatment With Platinum-based Chemotherapy|Completed||Phase 4|60|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:08:19.027084|2017-10-11 00:08:19.027084
NCT02208830|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-01-13|||January 2012||2012-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|PCBCQ||Physical Capacity in Patients With Bronchiectasis Before and After Rehabilitation Program|Effects of Pulmonary Rehabilitation Associated With Respiratory Therapy vs Physiotherapy in Physical Capacity, Peripheral Muscle Strength and Quality of Life in Patients With Bronchiectasis: a Randomized Controlled Trial.|Completed||Phase 1/Phase 2|50|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-11 00:08:19.156237|2017-10-11 00:08:19.156237
NCT02208817|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-05-18|||August 2014||2014-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|PRefill||The Paediatric Refill Study (PRefill)|Development of a Novel Paediatric Continuous Early Warning Monitor for the Children at Risk of Respiratory and Cardiovascular Collapse - The Paediatric Refill Study (PRefill)|Completed||N/A|75|Actual|University of Nottingham|||4||f||||f||||||||||2017-10-11 00:08:19.252826|2017-10-11 00:08:19.252826
NCT02208804|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-11-07|||November 2014||2014-11-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Interventional|SIM||Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization|Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization for the Treatment of Colorectal Liver Metastases (SIM Trial)|Recruiting||Phase 2/Phase 3|25|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-11 00:08:19.354781|2017-10-11 00:08:19.354781
NCT02208791|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-12-15|||July 2014||2014-07-01|June 2014|2014-06-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant|Evaluation of the Effects of Sirolimus Addition to the Triple Immunosuppression Protocol on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Sensitized Kidney Transplant Recipients - a Pilot Study|Unknown status|Recruiting|Phase 4|45|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:08:19.457268|2017-10-11 00:08:19.457268
NCT02208778|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-05-15|||December 2014||2014-12-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|IPRO||Imaging Pain Relief in Osteoarthritis|Functional Brain Imaging to Understand the Mechanisms of Pain Relief in Knee Osteoarthritis|Active, not recruiting||Phase 4|81|Anticipated|University of Nottingham||4|||f||||f||||||||||2017-10-11 00:08:19.556173|2017-10-11 00:08:19.556173
NCT02208765|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-01-22|||January 2015||2015-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EVAPERF||Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity|Prognostic Value of Myocardial Perfusion Heterogeneity Assessed by Stress Single Photon Emission Computed Tomography|Recruiting||N/A|1600|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 00:08:19.670755|2017-10-11 00:08:19.670755
NCT02208739|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-07-13|||December 2011||2011-12-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Nonsurgical Periodontal Therapy Verses Oral Hygiene Instructions on Patients With Chronic Periodontitis|Effect of Nonsurgical Periodontal Therapy Verses Oral Hygiene Instructions on Clinical Parameters as Well as Immunological and Microbial Profile of Patients With Chronic Periodontitis|Completed||N/A|56|Actual|University of Malaya||2|||f||||t||||||||||2017-10-11 00:08:19.91346|2017-10-11 00:08:19.91346
NCT02208726|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-05-16|||September 2013||2013-09-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|November 2013|Actual|2013-11-01||Interventional|||The Effect of Picricum Acidum and Phosphoricum Acidum Homaccord on Perceived Levels of Anxiety in University Students|The Effect of Picricum Acidum and Phosphoricum Acidum Homaccord on Perceived Levels of Anxiety in University Students|Completed||Phase 2|30|Actual|University of Johannesburg||2|||f||||t||||||||No||2017-10-11 00:08:20.067272|2017-10-11 00:08:20.067272
NCT02208713|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-04-26|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD)|Intramuscular Transplantation of Autologous Muscle Derived Stem Cell(MDSC) and Adipose Derived Mesenchymal Stem Cells (AD-MSC) in Patients With Facioscapulohumeral Dystrophy (FSHD), Phase I Clinical Trial|Recruiting||Phase 1|21|Anticipated|Royan Institute||1|||f||||t||||||||||2017-10-11 00:08:20.190207|2017-10-11 00:08:20.190207
NCT02208700|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2014-08-01|||January 2014||2014-01-01|August 2014|2014-08-01||||October 2015|Anticipated|2015-10-01||Interventional|ANUS1305||Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patients on Chronic Ventilation- a Pilot Study|Efficacy of the Use of Enteral Feeding High in EPA,GLA and Antioxidants in LTAC Patients on Chronic Ventilation- a Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Grace Hospital, Cleveland, Ohio||2|||f||||f||||||||||2017-10-11 00:08:20.305424|2017-10-11 00:08:20.305424
NCT02208687|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2014-08-08|||August 2014||2014-08-01|August 2014|2014-08-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Effectiveness and Cost-effectiveness of the Energetic Program|Energetic, a Self Management Group Program Aimed at Reconditioning and Social Participation in Persons With a Muscle Disease; a Multicentre Randomized Controlled Trial.|Unknown status|Recruiting|Phase 2|50|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 00:08:20.421115|2017-10-11 00:08:20.421115
NCT02208479|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-09-22|||June 2014||2014-06-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Cardiac Surgery and Diaphragm Function|Diaphragmatic Dysfunction in Cardiac Surgery: Observational Study|Completed||N/A|66|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-11 00:08:22.744501|2017-10-11 00:08:22.744501
NCT02208674|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-11-14|||September 2014||2014-09-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Early Identification and Action in CKD|Early Identification and Action in CKD|Completed||N/A|47|Actual|Geisinger Clinic||2|||f||||t||||||||No|Data for this study may be obtained upon request, after permission to do so is granted by the Geisinger IRB and information security office. Readers should contact the principal investigator (achang@geisinger.edu) for further information.|2017-10-11 00:08:20.583793|2017-10-11 00:08:20.583793
NCT02208661|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-03-20|||March 2014||2014-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|MAPLE||Psychological Concomitants of Morquio A Syndrome - Longitudinal Effects of Enzyme Replacement Therapy (The MAPLE Study)|Psychological Concomitants of Morquio A Syndrome - Longitudinal Effects of Enzyme Replacement Therapy|Active, not recruiting||N/A|15|Anticipated|Emory University|||1||f||||t||||||||No|There is no plan to share IPD with other researchers|2017-10-11 00:08:20.72525|2017-10-11 00:08:20.72525
NCT02208648|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2016-05-23|||September 2014||2014-09-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|CAMP||Coronary Assessment for Mortality Prediction|Coronary Assessment for Mortality Prediction|Recruiting||N/A|180|Anticipated|Plymouth Hospitals NHS Trust|||2||f||||f||||||||||2017-10-11 00:08:20.822963|2017-10-11 00:08:20.822963
NCT02208635|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-04-26|||October 2012||2012-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|HPZM||Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months|Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months|Completed||N/A|60|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-10-11 00:08:20.926305|2017-10-11 00:08:20.926305
NCT02208622|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-05-09|||August 2013||2013-08-01|May 2017|2017-05-01||||December 2013|Actual|2013-12-01||Interventional|||Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet|Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet|Active, not recruiting||N/A|50|Actual|University of Colorado, Denver||4|||f||||f||||||||||2017-10-11 00:08:21.035156|2017-10-11 00:08:21.035156
NCT02208609|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-04-27|||January 2012||2012-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Zinc Bioavailability From Amaranth-enriched Maize Tortillas|Absorption of Zinc (Zn) From Traditional Maize Tortillas and Amaranth-enriched Tortillas by Toddlers in the Indigenous Post-Mayan Population|Completed||N/A|20|Actual|University of Colorado, Denver||2|||f||||f||||||||No||2017-10-11 00:08:21.14191|2017-10-11 00:08:21.14191
NCT02208596|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2014-08-03|||September 2014||2014-09-01|August 2014|2014-08-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial||Unknown status|Not yet recruiting|Phase 4|150|Anticipated|Third Affiliated Hospital of Zhengzhou University||3|||f||||t||||||||||2017-10-11 00:08:21.274589|2017-10-11 00:08:21.274589
NCT02208583|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-08-04|||June 2014||2014-06-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Molecular Phenotype Changes and Personalized Treatment for CRPC|Exploratory Study of Molecular Phenotype Changes and Personalized Treatment for Patients With Castration Resistant Prostate Cancer|Unknown status|Recruiting|N/A|150|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 00:08:21.367829|2017-10-11 00:08:21.367829
NCT02208570|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-04-19|||July 2014||2014-07-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Predictability of the Pulse Pressure Variation (PPV) During Spontaneous Ventilation on the Incidence of Hypotension During Induction of Anesthesia|Predictability of the Pulse Pressure Variation During Spontaneous Ventilation on the Incidence of Hypotension During Induction of Anesthesia|Recruiting||N/A|172|Anticipated|Seoul National University Hospital||4|||f||||||||||||||2017-10-11 00:08:21.652598|2017-10-11 00:08:21.652598
NCT02208557|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-08-03|||July 2014||2014-07-01|August 2014|2014-08-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|PREBIOUS||Usefulness of a Prothetic Absorbable Mesh in Incisional Hernia Prevention After Midline Laparotomy|PREBIOUS Trial : A Multicenter Randomized Controlled Trial of Preventive Midline Laparotomy Closure With a Bioabsorbable Mesh for the Prevention of Incisional Hernia.|Unknown status|Recruiting|Phase 4|488|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-11 00:08:21.768756|2017-10-11 00:08:21.768756
NCT02208544|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-11-23|||June 2015||2015-06-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|EfFECTS||FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS)|Efficacy of [18F]-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography (FDG-PET) in Evaluation of Cytological Indeterminate Thyroid Nodules Prior to Surgery: a Multicentre Cost-effectiveness Study|Recruiting||N/A|132|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-11 00:08:21.944654|2017-10-11 00:08:21.944654
NCT02208531|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-03|2017-08-31|||February 2014||2014-02-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TTS Bangladesh||Transition to Scale of Nutrition and Psychosocial Stimulation Program for Malnourished Children|Transition to Scale of an Integrated Program of Nutritional Care and Psychosocial Stimulation to Improve Malnourished Children's Development in Bangladesh|Recruiting||N/A|6400|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f||||||||||2017-10-11 00:08:22.177723|2017-10-11 00:08:22.177723
NCT02208518|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-08-04|||October 2013||2013-10-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Quantitative And Qualitative Eus Elastography|Could Quantitative And Qualitative EUS-Elastography Results Be Affected By The Compression Rate And The Diameter Of The Region Of Interest (ROI)?|Completed||N/A|45|Actual|Instituto Ecuatoriano de Enfermedades Digestivas|||1||f||||t||||||||||2017-10-11 00:08:22.29998|2017-10-11 00:08:22.29998
NCT02208505|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-08-03|||February 2014||2014-02-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion|Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion During Emergence in Adults After Thyroidectomy: Comparison With High-dose Remifentanil Infusion Alone|Completed||Phase 4|168|Actual|Yonsei University||2|||f||||||||||||||2017-10-11 00:08:22.496794|2017-10-11 00:08:22.496794
NCT02208466|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-09|||September 2014||2014-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients|Effects of Contralesional Repetitive Magnetic Stimulation Combined With Fluoxetine on Motor Recovery in Acute Stroke Patients|Recruiting||Phase 2|45|Anticipated|Spaulding Rehabilitation Hospital||3|||f||||f||||||||||2017-10-11 00:08:22.843595|2017-10-11 00:08:22.843595
NCT02208453|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2017-07-27|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|June 2018|Anticipated|2018-06-01||Interventional|||InSpace™ System Implantation in a Procedure Under Local Anesthesia|A Single Arm, Open-label, Prospective, Study to Assess the Feasibility, Efficacy and Safety of InSpace™ Device Implantation in a Procedure Under Local Anesthesia for a Treatment of Subjects With Massive, Irreparable Rotator Cuff Tear|Active, not recruiting||N/A|45|Actual|OrthoSpace Ltd.||1|||f||||f||||||||||2017-10-11 00:08:22.967402|2017-10-11 00:08:22.967402
NCT02208440|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-03|2017-01-04|||July 2014||2014-07-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||InSpace™ System in Comparison to Best Repair of Massive Rotator Cuff Tear.|A Randomized, Two-arm, Prospective, Subject Blind Study to Assess the Safety and Efficacy of InSpace™ Device in Comparison to Full Thickness Massive Rotator Cuff Repair in Subjects Scheduled for a Repair Surgery.|Recruiting||N/A|40|Anticipated|OrthoSpace Ltd.||2|||f||||f||||||||||2017-10-11 00:08:23.0675|2017-10-11 00:08:23.0675
NCT02208427|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-12-14|||August 2014||2014-08-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan|Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan|Active, not recruiting||Phase 3|283|Actual|National Taiwan University Hospital||2|||f||||t||||||||Undecided||2017-10-11 00:08:23.158747|2017-10-11 00:08:23.158747
NCT02208414|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-08-03|||June 2012||2012-06-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques|A Randomized Double-Blind Placebo-Controlled Crab Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques in NTU Campus|Unknown status|Active, not recruiting|N/A|80|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:08:23.26546|2017-10-11 00:08:23.26546
NCT02208401|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-08-12|||January 2014||2014-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Randomised Comparison of 2 Cold Snare Polypectomy Techniques|A Prospective Randomised Comparison of Cold Snare Polypectomy Versus Cold Snare Pseudosuction Technique|Completed||N/A|112|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:08:23.395321|2017-10-11 00:08:23.395321
NCT02208388|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-06-18|||August 2014||2014-08-01|June 2017|2017-06-01|April 2024|Anticipated|2024-04-01|December 2019|Anticipated|2019-12-01||Interventional|PERFUSE RCT||Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial|Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve|Recruiting||N/A|1000|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 00:08:23.520827|2017-10-11 00:08:23.520827
NCT02208375|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-04|2017-08-23|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||A Phase Ib Study of the Oral PARP Inhibitor Olaparib With the Oral mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial, Triple Negative Breast, and Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Phase Ib Study of the Oral PARP Inhibitor Olaparib With the Oral mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial, Triple Negative Breast, and Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Recruiting||Phase 1/Phase 2|150|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-11 00:08:23.740838|2017-10-11 00:08:23.740838
NCT02208362|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-09-01|||May 18, 2015|Actual|2015-05-18|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma|Phase I Study of Cellular Immunotherapy Using Central Memory Enriched T Cells Lentivirally Transduced to Express an IL13Rα2-Specific, Hinge-Optimized, 41BB-Costimulatory Chimeric Receptor and a Truncated CD19 for Patients With Recurrent/Refractory Malignant Glioma|Recruiting||Phase 1|100|Anticipated|City of Hope Medical Center||4|||f||||t|t|f||||||||2017-10-11 00:08:23.898952|2017-10-11 00:08:23.898952
NCT02208349|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-10-03|||April 2014||2014-04-01|October 2017|2017-10-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||King Video Laryngoscope Versus Direct Laryngoscopy for Prehospital Intubation: A Randomized Controlled Trial|King Video Laryngoscope Versus Direct Laryngoscopy for Prehospital Intubation: A Randomized Controlled Trial|Terminated||N/A|83|Actual|Saint Vincent Hospital, Pennsylvania||2||"We ran an interim analysis and found that additional enrollment would not alter our current   findings so terminated the trial."|f||||t||||||||||2017-10-11 00:08:24.089197|2017-10-11 00:08:24.089197
NCT02208336|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-04-17|||October 2010|Actual|2010-10-01|April 2017|2017-04-01|February 23, 2015|Actual|2015-02-23|February 23, 2015|Actual|2015-02-23||Observational|||Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy|Evaluation of a Data Driven System for Insuring Timely Monitoring for Brain Tumor Patients for Management of Myelosuppression|Completed||N/A|79|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-11 00:08:24.205861|2017-10-11 00:08:24.205861
NCT02208323|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-09-30|||July 2015||2015-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Advancement of Modified Bubble CPAP|Advancement of Modified Bubble CPAP for the Use in Children in Low Resource Settings: A Study of Safety|Completed||Phase 2|87|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||No||2017-10-11 00:08:24.315673|2017-10-11 00:08:24.315673
NCT02208310|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-08-31|2017-03-19||April 2015||2015-04-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|RODIN-CD||Trial of High Dose Vitamin D in Patient's With Crohn's Disease|A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease|Terminated||Phase 4|11|Actual|University of Michigan|Very few patients with inactive disease had low vitamin D levels, so most patients screened were ineligible. This made recruitment very slow, and the project was terminated.Suggests low vitamin D could be a marker of activity, rather than a cause|2||Unable to enroll at rate anticipated, insufft low vitamin D in clin rem @ 5 sites|f||||f||||||||||2017-10-11 00:08:24.436001|2017-10-11 00:08:24.436001
NCT02208297|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-02-08|||September 2014||2014-09-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery|Study to Assess Loteprednol Etabonate Ophthalmic Gel, 0.38% Versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery|Completed||Phase 3|322|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||Yes||2017-10-11 00:08:25.098579|2017-10-11 00:08:25.098579
NCT02208284|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-03-03|||August 2014||2014-08-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Single Escalating Oral Doses Of Pf-06427878 Co-administered With Meal In Healthy Adult Subjects|Completed||Phase 1|16|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:08:25.189757|2017-10-11 00:08:25.189757
NCT02208271|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-09-26|||August 2014||2014-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty|A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty|Recruiting||N/A|100|Anticipated|OrthoCarolina Research Institute, Inc.|||3||f||||t||||||||||2017-10-11 00:08:25.285606|2017-10-11 00:08:25.285606
NCT02208258|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-01-28|||September 2014||2014-09-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.||Withdrawn||N/A|0|Actual|Consure Medical Pvt. Ltd.||1||Hospital had initiated a conflicting study, hence the study was terminated.|f||||f||||||||||2017-10-11 00:08:25.364989|2017-10-11 00:08:25.364989
NCT02208245|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-08-02|||February 2014||2014-02-01|August 2014|2014-08-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Prospective Clinical Trial Comparing Infraclavicular Versus Axillary Approach to Brachial Plexus Block|Prospective Randomized Clinical Trial Comparing Infraclavicular Versus Axillary Approach to Brachial Plexus Block.|Unknown status|Active, not recruiting|N/A|46|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 00:08:25.44056|2017-10-11 00:08:25.44056
NCT02208232|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-08-01|||June 2012||2012-06-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Observation of Rotation of an Intraocular Lens|Observation of Rotation of the MC 6125 AS Intraocular Lens|Completed||N/A|100|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-11 00:08:25.534377|2017-10-11 00:08:25.534377
NCT02208219|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-10-26|||November 2013||2013-11-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|NEUROMUSIC||Music Therapy to Restore Motor Deficits After Stroke|The Application of Music Therapy in the Neurorehabilitation of Motor Deficits After Subacute Stroke|Recruiting||N/A|120|Anticipated|University of Barcelona||3|||f||||f||||||||||2017-10-11 00:08:25.603029|2017-10-11 00:08:25.603029
NCT02208206|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-02-02|||July 2014||2014-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Analysis of Markers in the Blood Correlated With Neuropathic Pain|Neuropathic Pain: Association Between Phenotype and Biomarkers|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"     Whole blood, plasma, serum   "|||2017-10-11 00:08:25.716574|2017-10-11 00:08:25.716574
NCT02208193|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-07-29|||July 2014||2014-07-01|July 2015|2015-07-01|September 2017|Anticipated|2017-09-01|October 2016|Anticipated|2016-10-01||Interventional|JAZ ART||Alzheimer's Disease, Art and Garden|Alzheimer's Disease and Healing Gardens: Study of the Cognitive and Psycho-behavioral Effects of an Artistic Dimension|Unknown status|Recruiting|N/A|60|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-10-11 00:08:25.801564|2017-10-11 00:08:25.801564
NCT02208180|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-06-04|||September 2014||2014-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|HHL||Heart Healthy Lenoir: Return of Results Study|Heart Healthy Lenoir: Return of Results Study|Completed||N/A|135|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 00:08:25.904024|2017-10-11 00:08:25.904024
NCT02208167|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-09-14|||April 7, 2015|Actual|2015-04-07|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HXTC||Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy|IGHID 1320 - A Phase I Study to Evaluate the Safety, Immunologic, and Virologic Responses of HIV-1 Antigen Expanded Specific T Cell Therapy (HXTC) as a Therapeutic Strategy in HIV-Infected Individuals Started on Antiretroviral Therapy During Acute and Chronic Infection|Active, not recruiting||Phase 1|12|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 00:08:25.989604|2017-10-11 00:08:25.989604
NCT02208154|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-01-08|||December 2013||2013-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|RGNOSIS||Ecological Effects of Decolonisation Strategies in Intensive Care|RGNOSIS: Ecological Effects of Decolonisation Strategies in Intensive Care|Recruiting||Phase 3|10800|Anticipated|UMC Utrecht||4|||f||||t||||||||||2017-10-11 00:08:26.286773|2017-10-11 00:08:26.286773
NCT02208141|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-08-01|||October 2010||2010-10-01|July 2014|2014-07-01||||October 2020|Anticipated|2020-10-01||Observational|LeipAT Child||Leipzig Adipose Tissue Childhood Cohort|Determinants of Adipose Tissue Development and Obesity in Children and Adolescents|Recruiting||N/A|1000|Anticipated|University of Leipzig|||1||f||||f||||||Samples With DNA|"     -  adipose tissue sample        -  mRNA from adipose tissue samples, adipocytes, stromal vascular fraction        -  protein from whole adipose tissue samples        -  blood samples for DNA analysis, serum samples        -  urine samples   "|||2017-10-11 00:08:26.433846|2017-10-11 00:08:26.433846
NCT02208128|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-07-31|||May 2014||2014-05-01|July 2014|2014-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|MORE||Molecular Determinants for Therapy Response on Renal Cell Carcinoma|Molecular Determinants for Therapy Response on Renal Cell Carcinoma|Recruiting||N/A|4|Anticipated|Heidelberg University||1|||f||||t||||||||||2017-10-11 00:08:26.52184|2017-10-11 00:08:26.52184
NCT02208115|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-08-01|||November 2013||2013-11-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Post-exercise Appetite Responses in Type 1 Diabetes|A Comparison of the Appetite Responses to High and Low Glycemic Index Post-exercise Meals Under Matched Insulinemia and Fibre in Type 1 Diabetes|Completed||N/A|10|Actual|Northumbria University||2|||f||||t||||||||||2017-10-11 00:08:26.611603|2017-10-11 00:08:26.611603
NCT02208102|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-05-19|||July 2014||2014-07-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|April 2015|Actual|2015-04-01||Observational|IMPACTII||Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation|Association of Cardiac Biomarkers With AF Ablation|Unknown status|Active, not recruiting|N/A|155|Anticipated|Texas Cardiac Arrhythmia Research Foundation|||1||f||||f||||||Samples Without DNA|"     Plasma from whole blood   "|||2017-10-11 00:08:26.683365|2017-10-11 00:08:26.683365
NCT02208089|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-03-14|||August 2014||2014-08-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|TransPRKCXL||Simultaneous TransPRK and Corneal Collagen Cross-Linking|A Prospective Trial of Simultaneous Combined Transepithelial Photorefractive Keratectomy and Corneal Collagen Cross-linking for Keratoconus|Active, not recruiting||N/A|50|Anticipated|Moorfields Eye Hospital NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:08:26.749075|2017-10-11 00:08:26.749075
NCT02208076|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-04-20|||July 2014||2014-07-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS COL||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia|"Easypod Connect: A National, Multicentre, Observational Registry to Evaluate Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Columbia"|Completed||N/A|44|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 00:08:26.833828|2017-10-11 00:08:26.833828
NCT02208063|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-07-18|||December 2014||2014-12-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial|A Phase 3 Multicenter, Randomized, Open-label, Clinical Trial of Telavancin Versus Standard Intravenous Therapy in the Treatment of Subjects With Staphylococcus Aureus Bacteremia Including Infective Endocarditis|Recruiting||Phase 3|248|Anticipated|Theravance Biopharma Antibiotics, Inc.||2|||f||||t||||||||||2017-10-11 00:08:26.997723|2017-10-11 00:08:26.997723
NCT02208050|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-05-09|||March 2014||2014-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||A Double Blind, Randomized, Placebo Controlled, Crossover Study of the Effectiveness of Oral Fampridine in Improving Upper Limb Function in Progressive Multiple Sclerosis|A Phase IV Double Blind, Randomized, Placebo Controlled, Crossover Study of the Effectiveness of Oral Fampridine in Improving Upper Limb Function in Progressive Multiple Sclerosis|Active, not recruiting||Phase 4|66|Actual|University College Dublin||2|||f||||t||||||||||2017-10-11 00:08:27.137119|2017-10-11 00:08:27.137119
NCT02208037|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-11-21|||August 2014||2014-08-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)|A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN #1203; Progress I)|Active, not recruiting||Phase 2|279|Actual|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||t||||||||Yes|Findings will be published in a manuscript|2017-10-11 00:08:27.290071|2017-10-11 00:08:27.290071
NCT02208024|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-07-27|||August 2014||2014-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body|Phase I Study to Evaluate the Feasibility of Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body|Recruiting||Phase 1|20|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-11 00:08:27.526112|2017-10-11 00:08:27.526112
NCT02208011|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-07-20|||August 2014||2014-08-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes|A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes|Completed||N/A|140|Actual|Louisiana State University, Baton Rouge|||1||f||||||||||||||2017-10-11 00:08:27.631504|2017-10-11 00:08:27.631504
NCT02207998|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-05-18|||July 2013||2013-07-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy of Homoeopathy and Physiotherapy in Chronic Low Back Pain Due to Osteoarthritis|The Efficacy of the Homoeopathic Complex and Physiotherapy in the Treatment of Chronic Low Back Pain Due to Osteoarthritis|Completed||Phase 2|30|Actual|University of Johannesburg||2|||f||||t||||||||No||2017-10-11 00:08:27.701722|2017-10-11 00:08:27.701722
NCT02207985|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-08-01|||January 2007||2007-01-01|August 2014|2014-08-01||||January 2018|Anticipated|2018-01-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma|Non Myeloablative Allogeneic Stem Cell Transplantation as Adjuvant Treatment in Patients With Pancreatic Adenocarcinoma|Recruiting||Phase 1/Phase 2|10|Anticipated|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 00:08:27.800462|2017-10-11 00:08:27.800462
NCT02207959|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-04-28|||January 2015||2015-01-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Gastric In Vivo Study|Endoscopic Multispectral Imaging for the Early Detection of Gastric Neoplasia|Terminated||Phase 1|8|Actual|Icahn School of Medicine at Mount Sinai||1||PI left institution|f||||f||||||||||2017-10-11 00:08:28.007986|2017-10-11 00:08:28.007986
NCT02207946|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-04-26||2017-04-26|September 2014||2014-09-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Botulinum Toxin A to Treat Arm Tremor|Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of NT 201 in the Unilateral Treatment of Essential Tremor of the Upper Limb|Completed||Phase 2|30|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-10-11 00:08:28.109521|2017-10-11 00:08:28.109521
NCT02207933|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-08-01|||June 2013||2013-06-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Effect of Anterioposterior Weight Shifting Training With Visual Biofeedback in Patients With Step Length Asymmetry After Stroke||Unknown status|Recruiting|N/A|34|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:08:28.214391|2017-10-11 00:08:28.214391
NCT02207920|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-04-12|||July 2014||2014-07-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults|A Phase 1b Clinical Trial to Evaluate the Safety and Immunogenicity of Different Combinations of DNA-HIV-PT123 and AIDSVAX® B/E in Healthy, HIV Uninfected Adult Participants|Completed||Phase 1|104|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-11 00:08:28.317792|2017-10-11 00:08:28.317792
NCT02207907|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-03-16|2015-11-02||August 2014||2014-08-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||To Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste|A Six Month Clinical Study Based in the US to Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste|Completed||Phase 2|247|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:08:28.46976|2017-10-11 00:08:28.46976
NCT02207894|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-30|||August 2006||2006-08-01|May 2017|2017-05-01|December 2027|Anticipated|2027-12-01|December 2026|Anticipated|2026-12-01||Observational|||A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI|A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled (High Dose) Immune Tolerance Induction (ITI)|Recruiting||N/A|300|Anticipated|Haemophilia Centre Rhine Main|||1||f||||f||||||Samples With DNA|"     whole blood, serum, white cells, plasma.   "|||2017-10-11 00:08:28.897493|2017-10-11 00:08:28.897493
NCT02207881|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-04-13|||July 2014||2014-07-01|July 2014|2014-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis|A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis|Completed||Phase 2|40|Actual|Yung Shin Pharm. Ind. Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:08:28.987795|2017-10-11 00:08:28.987795
NCT02207868|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-05-29|||June 2014||2014-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|EVA3D||3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH|3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH (EVA 3D Pilot Study)|Recruiting||N/A|6|Anticipated|Elisabethinen Hospital|||1||f||||f||||||||Undecided||2017-10-11 00:08:29.092125|2017-10-11 00:08:29.092125
NCT02207855|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-11-28|||June 2014||2014-06-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants||Completed||N/A|21|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:08:29.175276|2017-10-11 00:08:29.175276
NCT02207842|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-04-28|||November 2014||2014-11-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||The Determination of the Effect of Volatile Anesthetics on Leukocyte Function ex Vivo|The Determination of the Effect of Volatile Anesthetics on Leukocyte Function ex Vivo|Completed||N/A|41|Actual|Boston Children’s Hospital|||2||f||||f||||||||||2017-10-11 00:08:29.240972|2017-10-11 00:08:29.240972
NCT02207829|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-09-07|2016-01-11||September 1, 2014||2014-09-01|September 2017|2017-09-01|June 15, 2015|Actual|2015-06-15|May 25, 2015|Actual|2015-05-25||Interventional|||A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease|A Randomized, Blinded, Double-dummy, Parallel-group Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg Compared With Tiotropium 18 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|1017|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:08:29.327564|2017-10-11 00:08:29.327564
NCT02207816|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-06-21|||September 18, 2014|Actual|2014-09-18|June 2017|2017-06-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa|Extension to Study MALARIA-055 PRI (NCT00866619) for Evaluation of Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine (SB257049) in Infants and Children in Africa|Completed||Phase 3|3084|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 00:08:30.190505|2017-10-11 00:08:30.190505
NCT02207790|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-11-02|||July 2014||2014-07-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects|Completed||Phase 1|32|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-11 00:08:30.369397|2017-10-11 00:08:30.369397
NCT02207777|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-09-19|||August 2014||2014-08-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|RBD-T2D||Weight Loss-Independent Metabolic Effects of Roux-En-Y Gastric Bypass in Diabetes|Weight Loss-Independent Metabolic Effects of Roux-En-Y Gastric Bypass in Diabetes|Recruiting||N/A|96|Anticipated|Washington University School of Medicine||5|||f||||t|f|f||||||||2017-10-11 00:08:30.464838|2017-10-11 00:08:30.464838
NCT02207764|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-12-19|||September 2014||2014-09-01|July 2014|2014-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Reiki as a Complementary Therapy: A Pilot Study|Reiki as a Complementary Therapy: A Pilot Study|Withdrawn||N/A|0|Actual|Sidney Kimmel Comprehensive Cancer Center||2||competing priorities at the organization|f||||t||||||||||2017-10-11 00:08:30.569658|2017-10-11 00:08:30.569658
NCT02207751|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-04-13|||September 2014||2014-09-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|||Improving Outcomes in Peritoneal Dialysis|Improving Outcomes in Peritoneal Dialysis: Identification and Characterization of Optimal Clinical Practice to Enhance Peritoneal Dialysis Catheter Functionality, Minimize Access-related Complications and Promote Peritoneal Dialysis as an Initiating Therapeutic Modality for Chronic Kidney Disease.|Withdrawn||N/A|0|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 00:08:30.657246|2017-10-11 00:08:30.657246
NCT02207738|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-31|||January 2012||2012-01-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Efficacy Between Fractional Microneedling Radiofrequency and Bipolar Radiofrequency for Acne Scar|Comparative Study of Efficacy and Safety Between Fractional Microneedling Radiofrequency and Bipolar Radiofrequency Treatment for Acne Scar|Completed||N/A|23|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:08:30.720531|2017-10-11 00:08:30.720531
NCT02207725|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-09-19||2017-09-19|March 2014||2014-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|||A Study in Older Subjects to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Apixaban|A Phase 3 Randomized, Double-Blind, Placebo-controlled Study in Older Subjects to Assess Safety and the Reversal of Apixaban Anticoagulation With Intravenously Administered Andexanet Alfa|Completed||Phase 3|68|Actual|Portola Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:08:30.818111|2017-10-11 00:08:30.818111
NCT02207712|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-10-05|||November 2014||2014-11-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CANDLE||Noctura400 Treatment for Diabetic Retinopathy (CANDLE)|Noctura400 Treatment for Diabetic Retinopathy: Pilot Study to Demonstrate and Evaluate the Care Pathway for National Health Service (NHS) Adoption|Recruiting||N/A|240|Anticipated|PolyPhotonix Medical||2|||f||||t||||||||No||2017-10-11 00:08:30.896836|2017-10-11 00:08:30.896836
NCT02207699|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-07-31|||May 2014||2014-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers|Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers|Completed||Phase 1|68|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 00:08:32.774479|2017-10-11 00:08:32.774479
NCT02207686|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-11-12|||September 2014||2014-09-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Observational|||Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?|Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?|Enrolling by invitation||N/A|50|Anticipated|University of Copenhagen|||1||f||||f||||||Samples With DNA|"     Whole blood Tumor tissue (Paraffin embedded and fresh frozen)   "|||2017-10-11 00:08:32.87386|2017-10-11 00:08:32.87386
NCT02207673|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-05-11|||November 2014||2014-11-01|May 2016|2016-05-01||||April 2018|Anticipated|2018-04-01||Interventional|||A New Method for Delineation of Epileptic Brian Tissue During Epilepsy Surgery (The HFO Study)|Intra-operative Detection and Localisation of High Frequency Oscillations in the ECoG to Guide Epilepsy Surgery|Recruiting||N/A|78|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-11 00:08:32.948991|2017-10-11 00:08:32.948991
NCT02207660|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-02-03|||July 2014||2014-07-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix|Cisplatin Plus One Day 24 Hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix.|Completed||N/A|30|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 00:08:33.053737|2017-10-11 00:08:33.053737
NCT02207647|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-09-20|||April 2014||2014-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Observational|||Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients||Active, not recruiting||N/A|1000|Anticipated|Olive View-UCLA Education & Research Institute|||1||f||||f||||||Samples With DNA|"     Cerebrospinal fluid and blood serum are being collected.   "|||2017-10-11 00:08:33.149532|2017-10-11 00:08:33.149532
NCT02207634|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-06-19||2017-06-19|September 10, 2014|Actual|2014-09-10|June 2017|2017-06-01|November 11, 2016|Actual|2016-11-11|November 11, 2016|Actual|2016-11-11||Interventional|EBBINGHAUS||Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects|A Double-Blind, Placebo Controlled, Multicenter Study to Assess the Effect of Evolocumab on Cognitive Function in Patients With Clinically Evident Cardiovascular Disease and Receiving Statin Background Lipid Lowering Therapy: A Study for Subjects Enrolled in the FOURIER (Study 20110118) Trial|Completed||Phase 3|1974|Actual|Amgen||2|||f||||t||||||||||2017-10-11 00:08:33.289251|2017-10-11 00:08:33.289251
NCT02207621|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-07-11||2016-07-11|July 2014||2014-07-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension||Completed||Phase 3|756|Actual|Aerie Pharmaceuticals||3|||f||||f||||||||||2017-10-11 00:08:34.498084|2017-10-11 00:08:34.498084
NCT02207608|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-05-26|2014-12-01||September 2011||2011-09-01|May 2015|2015-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side Effects|Pilot Study of Influence of Hyaluronic Acid (HA) on Bacillus Calmette-Guérin (BCG) Local Side Effects|Completed||Phase 2|30|Actual|University of Rome Tor Vergata||2|||f||||f||||||||||2017-10-11 00:08:34.604121|2017-10-11 00:08:34.604121
NCT02207595|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-03-04|||August 2014||2014-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects|A Randomized, Investigator- and Subject-blind, Placebo-controlled, Combined Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects|Completed||Phase 1|60|Actual|UCB Pharma||5|||f||||f||||||||||2017-10-11 00:08:34.901891|2017-10-11 00:08:34.901891
NCT02207582|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-10-25|||July 2014||2014-07-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|tRNS-depr||Prefrontal Transcranial Random Noise Stimulation in Patients With Depression|Prefrontal Transcranial Random Noise Stimulation in Patients With Depression|Terminated||N/A|44|Actual|University of Regensburg||2||no efficacy|f||||f||||||||No||2017-10-11 00:08:35.003896|2017-10-11 00:08:35.003896
NCT02207387|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-03-31|||October 2013||2013-10-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Ambulosono Rasagiline Musical Walking Study|A Sensorimotor Contingency-based Musical Walking Program for People Living With Parkinson's Disease|Unknown status|Recruiting|N/A|60|Anticipated|University of British Columbia||5|||f||||||||||||||2017-10-11 00:08:42.632582|2017-10-11 00:08:42.632582
NCT02207556|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-05-11|||October 2014||2014-10-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|DUAL||Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial|Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis (DUAL) Trial: A Phase II Open Label Study of Oral Doxycycline Administered as an Adjunct to Plasma Cell Directed Therapy in Light Chain (AL) Amyloidosis|Recruiting||Phase 2|31|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 00:08:35.249407|2017-10-11 00:08:35.249407
NCT02207543|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-02-09|||June 2014||2014-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Assessment of Patient Satisfaction in Palliative Cancer When They Return Home After Hospitalization in Palliative Care|Assessment of Patient Satisfaction in Palliative Cancer When They Return Home After Hospitalization in Palliative Care|Terminated||N/A|4|Actual|Centre Francois Baclesse||1||Loss of patients|f||||t||||||||||2017-10-11 00:08:35.336075|2017-10-11 00:08:35.336075
NCT02207530|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-04-28|||October 24, 2014|Actual|2014-10-24|April 2017|2017-04-01|March 30, 2018|Anticipated|2018-03-30|September 26, 2016|Actual|2016-09-26||Interventional|||Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Active, not recruiting||Phase 2|112|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 00:08:35.43612|2017-10-11 00:08:35.43612
NCT02207517|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-08-24|||May 2014||2014-05-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|July 2017|Actual|2017-07-01||Interventional|CITT-ART||Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency|Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART)|Active, not recruiting||Phase 3|311|Actual|Salus University||2|||f||||t||||||||||2017-10-11 00:08:36.36518|2017-10-11 00:08:36.36518
NCT02207491|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-02-11||2015-07-09|July 2014||2014-07-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Rocket-1||Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension|A Double-masked, Randomized, Multi-center, Active-controlled, Parallel, 3-month Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-13324 Ophthalmic Solution, 0.02% Compared to Timolol Maleate Ophthalmic Solution, 0.5% in Patients With Elevated Intraocular Pressure|Completed||Phase 3|411|Actual|Aerie Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:08:36.587982|2017-10-11 00:08:36.587982
NCT02207478|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2015-10-28|2015-09-23||July 2014||2014-07-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||ENB-GS-TBLB for the Diagnosis of PPLs|Diagnostic Value of Electromagnetic Navigation Bronchoscopy With a Guide Sheath for Peripheral Pulmonary Lesions : a Randomized Controlled Trial|Completed||N/A|80|Actual|Shanghai Chest Hospital||2|||f||||t||||||||||2017-10-11 00:08:36.693473|2017-10-11 00:08:36.693473
NCT02207465|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-07-28|||July 2014||2014-07-01|July 2017|2017-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer|A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer|Recruiting||Phase 1|42|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:08:37.116974|2017-10-11 00:08:37.116974
NCT02207452|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-06-26|||August 5, 2010|Actual|2010-08-05|June 2017|2017-06-01|July 4, 2011|Actual|2011-07-04|July 4, 2011|Actual|2011-07-04||Interventional|||Helium-3 MRI Imaging Study in COPD|A Randomized, Methodology Study to Investigate the Use of 3He-MRI Lung Ventilation and Proton MRI Perfusion Imaging to Detect Changes in Ventilation Perfusion Relationships in Chronic Obstructive Pulmonary Disease (COPD) Patients; a Proof of Concept Study.|Completed||Phase 1|11|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 00:08:37.216468|2017-10-11 00:08:37.216468
NCT02207439|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-07-31|||July 2014||2014-07-01|July 2017|2017-07-01||||July 2019|Anticipated|2019-07-01||Interventional|||A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma Larynx|A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma Larynx|Recruiting||Phase 2|28|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:08:37.327013|2017-10-11 00:08:37.327013
NCT02207426|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-04-07|||July 2014||2014-07-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™|A Phase 1 Study in Healthy Volunteers Investigating the Delivery of Tobramycin Using the TobrAir® 6.0 Device Compared With the Delivery of Marketed Tobramycin Nebuliser Solution (TOBI®) by PARI LC® PLUS and PARI TurboBoy® SX and With Delivery of Tobramycin by the TOBI® Podhaler™ Device, Using Pharmacokinetic and Pharmacoscintigraphic Methods.|Completed||Phase 1|12|Actual|Pharmaero ApS||3|||f||||f||||||||||2017-10-11 00:08:37.427127|2017-10-11 00:08:37.427127
NCT02207413|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-03-21|2015-10-15||August 2014||2014-08-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children|Safety and Immunogenicity Study of GSK Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK23211381A) Manufactured With a New Process in Adults and Children|Completed||Phase 3|1886|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-10-11 00:08:37.683112|2017-10-11 00:08:37.683112
NCT02207400|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-06-06|2015-12-21||August 25, 2014|Actual|2014-08-25|June 2017|2017-06-01|April 30, 2015|Actual|2015-04-30|February 1, 2015|Actual|2015-02-01||Interventional|||To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms|A Six Month Clinical Study Based in the US to Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms|Completed||Phase 2|246|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:08:42.016737|2017-10-11 00:08:42.016737
NCT02207374|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-03-30||2016-12-06|August 4, 2014|Actual|2014-08-04|March 2017|2017-03-01|February 27, 2016|Actual|2016-02-27|February 27, 2016|Actual|2016-02-27||Interventional|SUSTAIN™||A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes|Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes Who Are Insufficiently Controlled on Diet/Exercise Therapy or OAD Monotherapy|Completed||Phase 3|601|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 00:08:42.752341|2017-10-11 00:08:42.752341
NCT02207361|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-12-21|||December 2013||2013-12-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer|A Randomized Prospective Clinical Trial of Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin as First-Line Treatment in Metastatic Breast Cancer|Unknown status|Recruiting|Phase 4|120|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 00:08:42.936742|2017-10-11 00:08:42.936742
NCT02207348|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2016-12-08|||August 2014||2014-08-01|December 2016|2016-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors|A Randomised, Open-label, Single-centre, Two-period, Cross-over Trial Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:08:43.044028|2017-10-11 00:08:43.044028
NCT02207335|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-12-21|||December 2013||2013-12-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer|A Multicenter Randomized Phase Ⅲ Clinical Trial of Gemcitabine in Combination With Capecitabine Versus Gemcitabine Plus Carboplatin as First-line Treatment in Triple-negative Recurrent or Metastatic Breast Cancer|Unknown status|Recruiting|Phase 3|120|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 00:08:43.126483|2017-10-11 00:08:43.126483
NCT02207322|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-01-28|||August 2014|Actual|2014-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|January 2016|Actual|2016-01-01||Interventional|SHIELD||Supportive Care Intervention In Patients Hospitalized For Hematopoietic Stem Cell Transplantation (Shield)|Randomized Study of a Targeted Inpatient Supportive Care Intervention in Patients Hospitalized for Hematopoietic Stem Cell Transplantation (HSCT)|Active, not recruiting||N/A|160|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:08:43.223907|2017-10-11 00:08:43.223907
NCT02207309|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-02-09|||December 2014||2014-12-01|February 2015|2015-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||Pazopanib Maintenance Phase II|A Randomized, Double Blind, Phase II Trial of Pazopanib Versus Placebo as Maintenance Therapy in Patients With Retroperitoneal and Visceral High-risk Soft Tissue Sarcomas Following Prior Neo- and/or Adjuvant Doxorubicin / Ifosfamide Chemotherapy With Regional Hyperthermia|Unknown status|Recruiting|Phase 2|150|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||||||||||||2017-10-11 00:08:43.309705|2017-10-11 00:08:43.309705
NCT02207296|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-09-10|||February 2015||2015-02-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|February 2017|Anticipated|2017-02-01||Interventional|OPVI||Operative Hemodynamic Optimization Using the Plethysmographic Variability Index During Orthopedic Surgery|Operative Hemodynamic Optimization Using the Plethysmographic Variability Index During Orthopedic Surgery : a Multicentric Prospective Randomized Controlled Study|Recruiting||Phase 3|440|Anticipated|University Hospital, Caen||2|||f||||||||||||||2017-10-11 00:08:43.409083|2017-10-11 00:08:43.409083
NCT02207283|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-07-25|||March 2012||2012-03-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||PDE5 Inhibition to Alleviate Functional Muscle Ischemia in Becker Muscular Dystrophy|PDE5 Inhibition to Alleviate Functional Muscle Ischemia in Becker Muscular Dystrophy|Completed||Phase 4|12|Anticipated|Cedars-Sinai Medical Center||2|||f||||||||||||||2017-10-11 00:08:43.509853|2017-10-11 00:08:43.509853
NCT02207270|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-08-27|||August 2014||2014-08-01|August 2015|2015-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SOCRATES||Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day Discharge|A Randomized Cost Minimization Analysis Comparing Same Day Discharge With Overnight Hospital Stay Following Elective and Low Risk Urgent Percutaneous Coronary Intervention.|Terminated||N/A|4|Actual|Saint Joseph Mercy Health System||2||Unable to meet projected enrollment|f||||f||||||||||2017-10-11 00:08:43.604425|2017-10-11 00:08:43.604425
NCT02207257|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-25||2017-09-18|March 2014||2014-03-01|September 2017|2017-09-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban|Phase II Randomized, Sequential Group, Evaluation of Ascending Reversal Doses of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With Edoxaban Following PER977 Reversal|Completed||Phase 2|65|Actual|Perosphere, Inc.||5|||f||||t||||||||||2017-10-11 00:08:43.757462|2017-10-11 00:08:43.757462
NCT02206113|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-01-26|||May 2013||2013-05-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Sit to Stand Intervention for Allina Health Employees|A Sit-to-Stand Intervention for Allina Health Employees: A Pilot Study|Completed||N/A|39|Actual|Allina Health System||2|||f||||f||||||||||2017-10-11 00:08:57.757557|2017-10-11 00:08:57.757557
NCT02207218|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2017-06-07|||August 4, 2014|Actual|2014-08-04|June 2017|2017-06-01|August 4, 2020|Anticipated|2020-08-04|August 4, 2020|Anticipated|2020-08-04||Observational|||To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan|A Multicentre, Non-interventional Post Marketing Study of Safety and Efficacy of NovoEight® (rFVIII) During Long-Term Treatment of Haemophilia A in Japan|Recruiting||N/A|35|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 00:08:44.75695|2017-10-11 00:08:44.75695
NCT02207205|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-30|||April 2014||2014-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture|A Study to Determine Variability in the Measurement of Whole Blood Clotting Time (WBCT) Between Blood Drawn From Indwelling Catheters and Direct Venipuncture|Completed||N/A|10|Actual|Perosphere, Inc.||1|||f||||f||||||||||2017-10-11 00:08:44.840918|2017-10-11 00:08:44.840918
NCT02207192|ClinicalTrials.gov processed this data on October 10, 2017|2014-08-01|2014-08-05|||August 2005||2005-08-01|August 2014|2014-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Postural Changes in Lung Volumes in Obesity|Effect of Weight Loss on Postural Changes in Pulmonary Function : a Longitudinal Study in Morbidly Obese to Obese Subjects Following Gastroplasty|Completed||N/A|12|Actual|Association pour la Formation du Personnel à la Medecine d'Urgence|||1||f||||f||||||||||2017-10-11 00:08:44.918509|2017-10-11 00:08:44.918509
NCT02207179|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-03-30|||January 2014||2014-01-01|March 2015|2015-03-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|||Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology|Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology: An Ex-vivo Pilot Study of Real-time Breast Margin Imaging in Women Undergoing Breast Conservation Surgery for Early Stage Breast Cancer|Unknown status|Recruiting|Early Phase 1|40|Anticipated|LumaMed||1|||f||||f||||||||||2017-10-11 00:08:44.990962|2017-10-11 00:08:44.990962
NCT02207166|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2015-03-17|||August 2014||2014-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|IPEOHUBPMBUR||Identify Possible Errors on Home Use Blood Pressure Monitors by Usability Reasoning|Identify Possible Errors on Home Use Blood Pressure Monitors by Usability Reasoning (IPEOHUBPMBUR)|Completed||N/A|22|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:08:45.189854|2017-10-11 00:08:45.189854
NCT02207153|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-09-19|||December 2016||2016-12-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|1 Year|Observational [Patient Registry]|RACE||Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients|Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients|Not yet recruiting||N/A|400|Anticipated|University Hospital, Basel, Switzerland|||2||f||||f||||||Samples Without DNA|"     At the beginning and the end of the dialysis session, at the time of the monthly routine     blood tests additional venous blood samples will be collected. All draws will be performed     after a three day interdialytic interval. Until the time of en bloc analysis the aliquots     will be stored at -80°. All study data and blood samples will be stored for 10 years after     study termination, for the future assessment of novel cardiovascular biomarkers. The stored     blood samples will be anonymised and only labelled by a barcode. This barcode be     unambiguously linked to the study ID code for the individual patient. There will be no direct     link between the original participant details and the blood sample bar code.   "|||2017-10-11 00:08:45.265461|2017-10-11 00:08:45.265461
NCT02207140|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2016-06-20|||October 2014||2014-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Multi-species Probiotic HOWARU® Restore, on Gut Microbiota of Elderly|Effect of Multi-species Probiotic HOWARU® Restore, on Gut Microbiota of Elderly|Completed||Early Phase 1|90|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 00:08:45.365648|2017-10-11 00:08:45.365648
NCT02207127|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-10-24|||July 2014||2014-07-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|June 2020|Anticipated|2020-06-01||Observational|MRI in OSA||Magnetic Resonance Imaging in Obstructive Sleep Apnea|Magnetic Resonance Imaging in Obstructive Sleep Apnea|Recruiting||N/A|40|Anticipated|University of Southern California|||1||f||||f||||||||||2017-10-11 00:08:45.451866|2017-10-11 00:08:45.451866
NCT02207114|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-10-05|||January 2012||2012-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Using Biomarkers to Optimize Antibiotic Strategies in Sepsis|Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network - Randomized Control Trial|Active, not recruiting||N/A|145|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:08:45.573419|2017-10-11 00:08:45.573419
NCT02207101|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-07-09|||December 2014||2014-12-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Enduoxy||Study to Assess the Effect of OXYJUN on Ejection Fraction and Markers of Cardiovascular Injury|The Effect of Investigational Product E-OJ-01 (OXYJUN) on Left Ventricular Ejection Fraction and Markers of Cardiovascular Injury.|Completed||N/A|32|Actual|Vedic Lifesciences Pvt. Ltd.||2|||f||||f||||||||||2017-10-11 00:08:45.693009|2017-10-11 00:08:45.693009
NCT02207075|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-02-16|||July 2014||2014-07-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Measuring Active Microglia in Progressive Multiple Sclerosis|Measuring Active Microglia in Progressive Multiple Sclerosis|Recruiting||N/A|26|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||||No||2017-10-11 00:08:45.962144|2017-10-11 00:08:45.962144
NCT02207062|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-03-07|||October 2014||2014-10-01|March 2017|2017-03-01||||October 2018|Anticipated|2018-10-01||Interventional|||Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma|A Pilot Study of Single-Agent Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma|Recruiting||N/A|20|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 00:08:46.078697|2017-10-11 00:08:46.078697
NCT01846117|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2015-01-06|||April 2013||2013-04-01|August 2013|2013-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|MOD||Once-Daily Oral Dose of BeneFlax to Healthy Older Adults|Once-Daily Oral Dose of BeneFlax to Healthy Older Adults|Completed||Phase 2|32|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 01:44:50.192239|2017-10-11 01:44:50.192239
NCT02207023|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-05-08|||October 2014||2014-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|Stroke Coach||Healthy Lifestyles After Stroke|A Telehealth Intervention to Promote Chronic Disease Management After Stroke: A Pilot Randomized Controlled Study|Recruiting||N/A|124|Anticipated|University of British Columbia||2|||f||||t||||||||No||2017-10-11 00:08:46.488096|2017-10-11 00:08:46.488096
NCT02207010|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-01-04|||July 2014||2014-07-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 0 Study of AZD1775 in Recurrent GBM Patients|A Phase 0 Study of AZD1775 in Preoperative Glioblastoma Multiforme (GBM) Patients Scheduled for Resection to Evaluate for Central Nervous System (CNS) Penetration|Active, not recruiting||Early Phase 1|20|Actual|St. Joseph's Hospital and Medical Center, Phoenix||1|||f||||t||||||||||2017-10-11 00:08:46.647739|2017-10-11 00:08:46.647739
NCT02206997|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-05-01|||February 2014||2014-02-01|May 2017|2017-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Evaluation of a Patient Warming Concept Following the German S3 Guideline for Prevention of Intraoperative Hypothermia|Evaluation of a Patient Warming Concept Following the New German Speaking S3 Guideline for Prevention of Intraoperative Hypothermia With Respect to Incidence and Complications of Perioperative Hypothermia|Completed||N/A|485|Actual|University of Schleswig-Holstein|||2||f||||f||||||||||2017-10-11 00:08:46.742931|2017-10-11 00:08:46.742931
NCT02206984|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-07-19|||August 2015||2015-08-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Endocrine Response in Women With Invasive Lobular Breast Cancer|A Trial of Endocrine Response in Women With Invasive Lobular Breast Cancer|Recruiting||N/A|150|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 00:08:46.810287|2017-10-11 00:08:46.810287
NCT02206971|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-07-30|||May 2012||2012-05-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Biomarker Feedback for Smoking Cessation|Biomarker Feedback for Smoking Cessation|Unknown status|Active, not recruiting|N/A|60|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:08:46.919858|2017-10-11 00:08:46.919858
NCT02206958|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-06-11|||March 2014||2014-03-01|June 2015|2015-06-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|DUET||Defeating Urinary Incontinence With Exercise Training (DUET) Feasibility Study|Preventing Toileting Disability in Frail Older Women|Unknown status|Recruiting|N/A|53|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:08:46.993911|2017-10-11 00:08:46.993911
NCT02206945|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-06|||July 2015||2015-07-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|May 2019|Anticipated|2019-05-01||Interventional|||Neurofeedback for Obsessive-Compulsive Disorder (OCD)|Neurofeedback of Activity in the Orbitofrontal Cortex for OCD|Recruiting||N/A|54|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 00:08:47.07968|2017-10-11 00:08:47.07968
NCT02206932|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-11-21||||||November 2014|2014-11-01||||November 2014|Actual|2014-11-01||Interventional|||A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C|An Open Label, Pilot Study to Investigate the Safety and Efficacy of 12 Weeks of Simeprevir and Sofosbuvir, for HIV-infected, HCV Genotype 1 Patients With Advanced Fibrosis|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 00:08:47.180984|2017-10-11 00:08:47.180984
NCT02206919|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-07-31|||June 2014||2014-06-01|July 2014|2014-07-01||||November 2015|Anticipated|2015-11-01||Observational|||Magnetic Resonance Imaging of Vascular Function|Magnetic Resonance Imaging of Vascular Function|Unknown status|Not yet recruiting|N/A|60|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-10-11 00:08:47.274862|2017-10-11 00:08:47.274862
NCT02206906|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-06-20|||July 2014||2014-07-01|June 2015|2015-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Incentives to Promote Medication Adherence Among HIV-Infected Youth|Investigation of Incentives to Promote Medication Adherence Among HIV-Infected Youth on Antiretroviral Therapy|Completed||N/A|25|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 00:08:47.355769|2017-10-11 00:08:47.355769
NCT02206893|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-07-27|||March 2014||2014-03-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluating Consumer m‐Health Services for User Engagement and Health Promotion: An Organizational Field Experiment||Completed||N/A|425|Actual|Carnegie Mellon University||5|||f||||||||||||||2017-10-11 00:08:47.447797|2017-10-11 00:08:47.447797
NCT02206880|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-04-24|||November 2014||2014-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|January 2017|Actual|2017-01-01||Observational|DELIRIUM-CS||The Delirium-CS Canada Study|"Examining DELIRIUM in Postoperative Cardiac Surgery Patient in Canada: Providing a National Snapshot of an Increasingly Devastating Complication"|Enrolling by invitation||N/A|234|Anticipated|St. Boniface General Hospital Research Centre|||1||f||||f||||||||||2017-10-11 00:08:47.645053|2017-10-11 00:08:47.645053
NCT02206867|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-06-12|||August 2014||2014-08-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pharmacokinetics and Safety Study of LBAL in Healthy Subjects|A Randomized, Double-Blind, Parallel-Group Clinical Study to Compare Pharmacokinetics, Safety and Tolerability of LBAL 40 mg With Humira® 40 mg After a Single Subcutaneous Administration in Healthy Male Volunteers|Completed||Phase 1|116|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-11 00:08:47.742578|2017-10-11 00:08:47.742578
NCT02206854|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-09-10|||June 2014||2014-06-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects|Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects|Completed||Phase 1|16|Actual|Goethe University||1|||f||||f||||||||||2017-10-11 00:08:47.820075|2017-10-11 00:08:47.820075
NCT02206841|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-11-24|||June 2014||2014-06-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|August 2018|Anticipated|2018-08-01|3 Years|Observational [Patient Registry]|NAFLD||Establishment of NAFLD Cohort and Development of Fibrosis Markers|Establishment of Non-alcoholic Fatty Liver Disease Cohort and Development of Markers to Predict Histologic Progression of Liver Fibrosis|Recruiting||N/A|1000|Anticipated|Seoul National University Boramae Hospital|||1||f||||f||||||Samples With DNA|"     Obtained blood samples will be stored by serum and plasma for future analysis.   "|No||2017-10-11 00:08:47.904671|2017-10-11 00:08:47.904671
NCT02205892|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-09-25|||August 2014||2014-08-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Clinical Study for Topical Lupeol in Acne|Clinical Study for the Effectiveness and Safety of Topical Lupeol in Mild to Moderate Acne|Completed||N/A|16|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:08:59.641272|2017-10-11 00:08:59.641272
NCT02206828|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-08-16|||July 2014||2014-07-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|June 2017|Actual|2017-06-01|2 Years|Observational [Patient Registry]|SymCHro||The SymCHro - Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair|Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair|Active, not recruiting||N/A|100|Actual|Medtronic - MITG|||1||f||||t||||||||||2017-10-11 00:08:48.000753|2017-10-11 00:08:48.000753
NCT02206815|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-05-15|||August 2014||2014-08-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||"Safety of Ticagrelor+ Warfarinin Comparison With Clopidogrel+Aspirin+Warfarin"|Safety of Ticagrelor Plus Warfarin Versus Clopidogrel+Aspirin+Warfarin in Patients With Persistent or Permanent Atrial Fibrillation and Undergoing PCI-S: A Randomized, Open, Controlled, Parallel Group, Multi-center Trial|Recruiting||Phase 4|296|Anticipated|Southeast University, China||2|||f||||t||||||||No||2017-10-11 00:08:48.072866|2017-10-11 00:08:48.072866
NCT02206802|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-01-23|||July 2014||2014-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Minoxidil Response Testing in Females With Female Pattern Hair Loss|Minoxidil Response Testing in Females With Female Pattern Hair Loss|Active, not recruiting||N/A|300|Anticipated|Applied Biology, Inc.|||2||f||||f||||||Samples Without DNA|"     Plucked hair follicles with visible bulbs   "|||2017-10-11 00:08:48.18344|2017-10-11 00:08:48.18344
NCT02206789|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-07-31|||February 2012||2012-02-01|October 2011|2011-10-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection|Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection|Recruiting||N/A|200|Anticipated|Aravind Eye Care System||2|||f||||f||||||||||2017-10-11 00:08:48.314583|2017-10-11 00:08:48.314583
NCT02206776|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-03-30|2017-01-03||September 2014||2014-09-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD|Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With Obsessive Compulsive Disorder (OCD)|Terminated||Phase 2|2|Actual|New York State Psychiatric Institute||2||poor tolerability and low enrollment rate|f||||t||||||||No||2017-10-11 00:08:48.419491|2017-10-11 00:08:48.419491
NCT02206763|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-03-20|||October 16, 2014|Actual|2014-10-16|March 2017|2017-03-01|February 16, 2017|Actual|2017-02-16|January 12, 2017|Actual|2017-01-12||Interventional|||Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC)|A Phase 1b Study of Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naïve Metastatic Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|11|Actual|Gilead Sciences||1|||f||||f|t|f||||||||2017-10-11 00:08:48.743588|2017-10-11 00:08:48.743588
NCT02206750|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-07-25|||July 2014||2014-07-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|SOZIAL||The Interaction of Social Factors With Air Pollution|The Interaction of Social Factors With Air Pollution|Completed||N/A|40|Actual|Environmental Protection Agency (EPA)||2|||f||||f||||||||||2017-10-11 00:08:48.854726|2017-10-11 00:08:48.854726
NCT02206737|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-07-31|||July 2014||2014-07-01|July 2014|2014-07-01||||September 2014|Anticipated|2014-09-01||Interventional|||The Effects of Electronic Cigarettes on the Microcirculation of the Hand|The Effects of Electronic Cigarettes on the Microcirculation of the Hand|Unknown status|Recruiting|N/A|20|Anticipated|Chelsea and Westminster NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:08:48.954811|2017-10-11 00:08:48.954811
NCT02206724|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-11-23|||August 2016||2016-08-01|November 2015|2015-11-01|August 2024|Anticipated|2024-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer|PROSPECTIVE EVALUATION OF STEREOTACTIC BODY RADIOTHERAPY FOR METASTATIC PROSTATE CANCER|Not yet recruiting||Phase 2|35|Anticipated|Sharp HealthCare||1|||f||||f||||||||||2017-10-11 00:08:49.056046|2017-10-11 00:08:49.056046
NCT02206711|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-09-11|||August 2014||2014-08-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.|Pharmacokinetics and Metabolism of [14C] BMS-955176 in Healthy Male Subjects|Completed||Phase 1|9|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:08:49.137825|2017-10-11 00:08:49.137825
NCT02206698|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-05-14|||July 2014||2014-07-01|April 2015|2015-04-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01|30 Days|Observational [Patient Registry]|||Pediatric Blunt Abdominal Trauma Clinical Prediction Model|Multicenter, Prospective Development of a Clinical Prediction Model to Determine Which Children Can Safely Avoid Abdominal CT Scanning During the Initial Evaluation of Blunt Abdominal Trauma|Unknown status|Recruiting|N/A|3000|Anticipated|Medical University of South Carolina|||1||f||||t||||||||||2017-10-11 00:08:49.207658|2017-10-11 00:08:49.207658
NCT02206685|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-12-12|||May 2014||2014-05-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Trial Comparing Single Intra-op Dose of Methadone Versus Placebo in Patients Undergoing Spine Surgery|A Randomized Blinded Prospective Trial Comparing Single Intraoperative Dose of Methadone Versus Placebo in Pediatric Patients Undergoing Spine Surgery.|Recruiting||Phase 4|56|Anticipated|Baylor College of Medicine||2|||f||||t||||||||Undecided||2017-10-11 00:08:51.163919|2017-10-11 00:08:51.163919
NCT02206672|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-11-04|||July 2014||2014-07-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|FACE||EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS|EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS|Unknown status|Recruiting|N/A|15|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:08:51.25297|2017-10-11 00:08:51.25297
NCT02206659|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-07-31|||August 2000||2000-08-01|July 2014|2014-07-01||||February 2001|Actual|2001-02-01||Interventional|||Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension|An Open-label Evaluation of Trough and Peak Effects of 40 mg Telmisartan Tablet by Ambulatory Blood Pressure Monitoring in Chinese Patients With Mild to Moderate Essential Hypertension|Completed||Phase 3|20|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:08:51.328839|2017-10-11 00:08:51.328839
NCT01845753|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-12-21|||October 2012||2012-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|February 2015|Actual|2015-02-01||Observational|||Molecular Screening for Lynch Syndrome in Denmark|Molecular Screening for Lynch Syndrome in Denmark|Active, not recruiting||N/A|5000|Actual|Vejle Hospital|||1||f||||f||||||||||2017-10-11 01:44:54.224512|2017-10-11 01:44:54.224512
NCT02206646|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-07-31|||February 2003||2003-02-01|July 2014|2014-07-01||||February 2009|Actual|2009-02-01||Observational|||Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction|Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® (Tenecteplase) in Korean Patients With Acute Myocardial Infarction|Completed||N/A|987|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:08:51.413511|2017-10-11 00:08:51.413511
NCT02206633|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-06-22|||November 2014||2014-11-01|November 2014|2014-11-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Observational|||Hydration Monitor Validation in Elderly|The Validity of Ultrasound Velocity to Assess Hydration Status of Elderly Residing in Assisted Living Facilities|Completed||N/A|73|Actual|Artann Laboratories|||1||f||||f||||||||||2017-10-11 00:08:51.484986|2017-10-11 00:08:51.484986
NCT02206620|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-31|||July 2014||2014-07-01|July 2014|2014-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Cholinergic Augmentation on Measures of Balance and Gait|Effects of Cholinergic Augmentation on Measures of Balance and Gait|Recruiting||Phase 2|100|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 00:08:51.605776|2017-10-11 00:08:51.605776
NCT02206607|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-02-04|2015-12-14||September 2014||2014-09-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||The baseline analysis population included all participants who received at least 1 dose of study treatment (PF-04937319).|Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.|A Phase 1, Randomized, Open-label, Cross-over, Single-day Study Of Pf-04937319 To Characterize Relative Bioavailability, Tolerability, And Pharmacodynamics Of Four Oral Formulations In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin|Completed||Phase 1|39|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 00:08:51.753249|2017-10-11 00:08:51.753249
NCT02206594|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2015-08-20|||January 2014||2014-01-01|July 2014|2014-07-01||||August 2015|Actual|2015-08-01||Interventional|||Combined Cataract Surgery and Planned Descemetorhexis|Combined Cataract Surgery and Planned Descemetorhexis|Completed||N/A|2|Actual|Medical College of Wisconsin||1|||f||||f||||||||||2017-10-11 00:08:52.858396|2017-10-11 00:08:52.858396
NCT02206581|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-01-20|||October 2014||2014-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Observational|||Using Hydration Monitor to Detect Changes in the Hydration Status Athletes|The Validity of Ultrasound Velocity to Detect Changes in the Hydration Status of Male and Female Athletes During Acute Dehydration and Rehydration|Completed||N/A|82|Actual|Artann Laboratories|||1||f||||f||||||||||2017-10-11 00:08:52.93551|2017-10-11 00:08:52.93551
NCT02206568|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-05-19|||June 2014||2014-06-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus|A Randomised Trial Investigating Pharmacokinetic Properties of Ultra-Rapid-Acting Insulin Lispro (URAL) in Subjects With Type 1 Diabetes Mellitus|Withdrawn||Phase 1|0|Actual|Perosphere, Inc.||1|||f||||t||||||||||2017-10-11 00:08:53.026655|2017-10-11 00:08:53.026655
NCT02206555|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-03-30|||November 2014||2014-11-01|February 2015|2015-02-01||||November 2016|Anticipated|2016-11-01||Interventional|PRELUDE||PrEP Demonstration Project (PRELUDE Study)|Implementation of HIV Preexposure Prophylaxis With Antiretroviral Medications Among People at High Risk for HIV Infection: A Demonstration Project|Unknown status|Recruiting|Phase 4|400|Anticipated|Kirby Institute||1|||f||||t||||||||||2017-10-11 00:08:53.138284|2017-10-11 00:08:53.138284
NCT02206542|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2015-03-03|||June 2014||2014-06-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Scientifically Merged Acupuncture and Robot-assisted Technology (SMART) for Rehabilitation of Frozen Shoulder Syndrome: Second-year Project-Comparison of Robot and Conventional Physiotherapy (Including Preliminary Test on Healthy Volunteers)|Scientifically Merged Acupuncture and Robot-assisted Technology (SMART) for Rehabilitation of Frozen Shoulder Syndrome: Second-year Project-Comparison of Robot and Conventional Physiotherapy (Including Preliminary Test on Healthy Volunteers)|Unknown status|Recruiting|Phase 2|30|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:08:53.262939|2017-10-11 00:08:53.262939
NCT02206516|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-08-02|||July 2014||2014-07-01|August 2014|2014-08-01||||August 2016|Anticipated|2016-08-01||Interventional|BMST||Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD).|Using Combined Neuroimaging Techniques and Clinical Measures to Assess Feasibility of tDCS as an Intervention in Adult ADD.|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 00:08:53.459482|2017-10-11 00:08:53.459482
NCT02206503|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-09-05|||March 2013||2013-03-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2015|Actual|2015-04-01||Interventional|||Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)|A PHASE II, MULTI-CENTER, OPEN LABEL STUDY OF CYCLOPHOSPHAMIDE IN MULTIPLE MYELOMA PATIENTS WITH BIOCHEMICAL PROGRESSION DURING LENALIDOMIDE-DEXAMETHASONE TREATMENT FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA|Active, not recruiting||Phase 2|13|Actual|Fondazione Neoplasie Sangue Onlus||1|||f||||t||||||||||2017-10-11 00:08:53.569141|2017-10-11 00:08:53.569141
NCT02206490|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-03-02|||January 2012||2012-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|GWI Treatment||Trial of Naltrexone and Dextromethorphan for Gulf War Illness|Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses|Completed||Phase 2|60|Actual|East Carolina University||4|||f||||f||||||||||2017-10-11 00:08:53.676524|2017-10-11 00:08:53.676524
NCT02206477|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2014-07-31|||August 2014||2014-08-01|July 2014|2014-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||DMSO for Prevention of Capsular Contraction in Alloplastic Breast Reconstruction||Not yet recruiting||Phase 2/Phase 3|110|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 00:08:53.769638|2017-10-11 00:08:53.769638
NCT02205879|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-01-09|||January 2013||2013-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pregabalin for Alcohol Dependence|Double Blind Placebo Controlled Randomized Clinical Trial of Pregabalin for Alcohol Dependence|Active, not recruiting||Phase 4|100|Actual|St. Petersburg Bekhterev Research Psychoneurological Institute||2|||f||||f||||||||||2017-10-11 00:08:59.727871|2017-10-11 00:08:59.727871
NCT02206464|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-07-06|||July 29, 2014||2014-07-29|January 7, 2016|2016-01-07|January 7, 2016|Actual|2016-01-07|January 7, 2016|Actual|2016-01-07||Interventional|||H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...|VRC 315: A Phase I Open-Label, Randomized Study of H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boost|Completed||Phase 1|30|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 00:08:53.877556|2017-10-11 00:08:53.877556
NCT02206451|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-31|2017-06-30|||July 16, 2014||2014-07-16|June 29, 2016|2016-06-29|July 16, 2014|Actual|2014-07-16|July 16, 2014|Actual|2014-07-16||Observational|||Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali|Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Don(SqrRoot)(Copyright)gu(SqrRoot)(Copyright)Bougou Mali|Completed||N/A|110|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:08:54.002363|2017-10-11 00:08:54.002363
NCT02206438|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-30|||July 2014||2014-07-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Clinical Efficacy of Supraglottic Airway Device, Self-pressurized Air-Q Intubating Laryngeal Airway (ILA -SP) in Adult Patients: Comparison With Classic-laryngeal Airway (c-LMA)||Unknown status|Recruiting|N/A|84|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 00:08:54.085827|2017-10-11 00:08:54.085827
NCT02206425|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-02-27|||September 2014|Actual|2014-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients|A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple (MM) Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib|Recruiting||Phase 1/Phase 2|60|Anticipated|Oncotherapeutics||8|||f||||t||||||||||2017-10-11 00:08:54.181056|2017-10-11 00:08:54.181056
NCT02206412|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-31|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|May 2015|Anticipated|2015-05-01||Observational|||Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Off-pump Coronary Artery Bypass Graft||Unknown status|Recruiting|N/A|530|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:08:54.497431|2017-10-11 00:08:54.497431
NCT02206399|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-06-24|||August 2014||2014-08-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Non-Invasive Hemoglobin Study|Non-Invasive Hemoglobin Multi-Center Observational Study|Completed||N/A|237|Actual|Convergence Biometrics|||1||f||||||||||||||2017-10-11 00:08:54.585495|2017-10-11 00:08:54.585495
NCT02206386|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-07-30|||January 2013||2013-01-01|July 2014|2014-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Homecare Agency-Randomized Trial of Web Implementation Strategy for Depression|Homecare Agency-Randomized Trial of Web Implementation Strategy for Depression|Unknown status|Enrolling by invitation|N/A|7800|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 00:08:54.671162|2017-10-11 00:08:54.671162
NCT02206373|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-08-09|||January 2013||2013-01-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||How to Dose a Patient According to Renal Function? Glomerular Filtration Rate (GFR) or Creatinine Clearance (ClCr)|How to Dose a Patient According to Renal Function? Glomerular Filtration Rate (GFR) or Creatinine Clearance (ClCr)|Unknown status|Recruiting|N/A|60000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:08:54.776367|2017-10-11 00:08:54.776367
NCT02206360|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-05-12|||April 2014||2014-04-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01|5 Years|Observational [Patient Registry]|PCEDP||Pancreatic Cancer Early Detection Program|Observational Study to Analyze the Outcomes of Subjects Who - Based Upon Their Sufficiently Elevated Risk for the Development of Pancreatic Adenocarcinoma- Elect to Undergo Early Detection Testing|Recruiting||N/A|50|Anticipated|White Plains Hospital|||1||f||||t||||||||||2017-10-11 00:08:54.84831|2017-10-11 00:08:54.84831
NCT02206334|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-05-18|||August 2014|Actual|2014-08-01|May 2017|2017-05-01||||February 2018|Anticipated|2018-02-01||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer|A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases|Recruiting||Phase 1|84|Anticipated|NRG Oncology||1|||f||||t||||||||||2017-10-11 00:08:55.070098|2017-10-11 00:08:55.070098
NCT02206321|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-02-02|||March 2011||2011-03-01|February 2017|2017-02-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Effects of Computer Navigation Versus Conventional Total Knee Arthroplasty on Endothelial Damage Marker Levels|Comparison of Navigation and Conventional Total Knee Arthroplasties|Recruiting||N/A|100|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||Samples With DNA|"     Obtain the serum and hemovac drainage from the patients, and analyze the concentrations of     the markers   "|||2017-10-11 00:08:55.467596|2017-10-11 00:08:55.467596
NCT02206308|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-07-31|||May 2012||2012-05-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma.|A Phase I Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SCT400, a Recombinant Chimeric Anti-CD20 Monoclonal Antibody，in Patients With CD20+ B-cell Non Hodgkin's Lymphoma.|Completed||Phase 1|15|Actual|Sinocelltech Ltd.||1|||f||||f||||||||||2017-10-11 00:08:55.556016|2017-10-11 00:08:55.556016
NCT02206100|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-09-25||2017-09-18|April 2014||2014-04-01|September 2017|2017-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PER977||PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin|Phase I/II Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Single, Hourly-Repeating, Escalating Doses of PER977 Following a Single Subcutaneous Dose of Enoxaparin|Completed||Phase 1/Phase 2|40|Actual|Perosphere, Inc.||4|||f||||f||||||||||2017-10-11 00:08:57.880651|2017-10-11 00:08:57.880651
NCT02206295|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-07-30|||September 2012||2012-09-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg|A Single-center, Open-label, Randomized, Two-period, Two-treatment, Crossover Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg (Reference Drug) or as Single Tablet of 1600 μg (Test Drug)|Completed||Phase 1|80|Actual|Actelion||2|||f||||f||||||||||2017-10-11 00:08:55.660646|2017-10-11 00:08:55.660646
NCT02206282|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-30|||August 2006||2006-08-01|July 2014|2014-07-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Observational|||Prevalence of Asymptomatic Rupture in SILIMED Breast Implants|Prevalence of Asymptomatic Rupture in SILIMED Breast Implants|Completed||N/A|390|Actual|Silimed Industria de Implantes Ltda|||1||f||||t||||||||||2017-10-11 00:08:55.786457|2017-10-11 00:08:55.786457
NCT02206269|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-04-19|||April 2015|Actual|2015-04-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|CARE||China Alair System Registry Study-CARE Study|Registry of Bronchial Thermoplasty (BT) Procedures in China|Recruiting||N/A|225|Anticipated|BSC International Medical Trading (Shanghai) Co., Ltd.|||1||f||||f||||||||||2017-10-11 00:08:55.846077|2017-10-11 00:08:55.846077
NCT02206256|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-04-25|||November 2014||2014-11-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|OLIVIER||Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function|Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function|Active, not recruiting||Phase 4|62|Actual|Medical Center Alkmaar||2|||f||||t||||||||||2017-10-11 00:08:55.949163|2017-10-11 00:08:55.949163
NCT02206243|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-05-19|||September 2014||2014-09-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Observational|EmboProstate||Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia|An Observational Study to Evaluate the Safety and Efficacy of Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia|Active, not recruiting||N/A|7|Actual|Jena University Hospital|||1||f||||f||||||||||2017-10-11 00:08:56.067048|2017-10-11 00:08:56.067048
NCT02206230|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-12-31|||August 2014||2014-08-01|December 2015|2015-12-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Trial of Hypofractionated Radiation Therapy for Glioblastoma|A Randomized Controlled Trial of Conventional Versus Hypofractionated Radiation Therapy With Temozolomide for Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 2|132|Anticipated|AHS Cancer Control Alberta||2|||f||||t||||||||||2017-10-11 00:08:56.173949|2017-10-11 00:08:56.173949
NCT02206217|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-03-07|||August 2014||2014-08-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Myopia Control With the Multi-segment Lens|The Clinical Trial of Myopia Control in Schoolchildren Using the Multi-segment (MS) Lens|Active, not recruiting||N/A|183|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||No||2017-10-11 00:08:56.282151|2017-10-11 00:08:56.282151
NCT02206204|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-07-30|||June 2012||2012-06-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects|Single-center, Double-blind, Randomized, Placebo- and Positive-controlled, Parallel-group With Nested Cross-over, Multiple-dose, Up-titration Study of the Effects of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects|Completed||Phase 1|159|Actual|Actelion||3|||f||||f||||||||||2017-10-11 00:08:56.36737|2017-10-11 00:08:56.36737
NCT02206191|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-07-31|||July 2013||2013-07-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|PCON||The Primary Care Obesity Network (PCON): Incorporating Principles of Self-regulation of Intake|The Primary Care Obesity Network (PCON): Incorporating Principles of Self-regulation of Intake|Unknown status|Active, not recruiting|N/A|150|Anticipated|Nationwide Children's Hospital|||1||f||||t||||||||||2017-10-11 00:08:56.497699|2017-10-11 00:08:56.497699
NCT02206178|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-07-28|||September 2013||2013-09-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PANACE||Acetaminophen's Antinociceptive Effect When Associated With N-Acetylcysteneine|ACETAMINOPHEN ANTINOCICEPTIVE EFFECT WHEN ASSOCIATED WITH N-ACETYLCYSTENEINE|Completed||Phase 1|24|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:08:56.594351|2017-10-11 00:08:56.594351
NCT02206165|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-03-27|||March 2014||2014-03-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension|A Randomized, Double-blind, Multi-center, Phase 2 Trial to Evaluate the Efficacy and Safety of Candesartan/Amlodipine Combined or Alone and Select Better Dose of CKD-330 in Patients With Essential Hypertension|Unknown status|Recruiting|Phase 2|456|Anticipated|Chong Kun Dang Pharmaceutical||8|||f||||||||||||||2017-10-11 00:08:56.68455|2017-10-11 00:08:56.68455
NCT02206152|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-08-23|||February 2015||2015-02-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|NAC for HAAF||A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes|A Randomized Double Blinded Study to Examine the Use of N-Acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes|Recruiting||Phase 1/Phase 2|36|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:08:56.786477|2017-10-11 00:08:56.786477
NCT02206139|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-03-10|||July 2014||2014-07-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Level of Burn Out of Surgical Residents Working in All Hospitals of Lahore|Burn Out Among Surgical Residents Working at All Institutes in Lahore: An Area of Grave Concerns|Completed||N/A|150|Actual|Services Hospital, Lahore|||1||f||||t||||||||||2017-10-11 00:08:56.89009|2017-10-11 00:08:56.89009
NCT02206126|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-30|||March 2012||2012-03-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Weight Loss and Obstructive Sleep Apnea|Effects of Energy Restriction on Sleep Apnea, Sympathetic Activity, Oxidative Stress, Inflammatory Biomarkers, Endothelial Function, Body Adiposity, Metabolic Profile and Blood Pressure in Obese Patients With Obstructive Sleep Apnea|Completed||N/A|21|Actual|Rio de Janeiro State University||2|||f||||f||||||||||2017-10-11 00:08:56.961519|2017-10-11 00:08:56.961519
NCT02206087|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-09-25||2017-09-25|June 2014||2014-06-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin|Phase I/II Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of a Single Escalating Dose of PER977 Following Administration of Unfractionated Heparin|Completed||Phase 1/Phase 2|60|Anticipated|Perosphere, Inc.||6|||f||||f||||||||||2017-10-11 00:08:58.008707|2017-10-11 00:08:58.008707
NCT02206074|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-07-30|||May 2012||2012-05-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|Ex nit as||The Effect of Dietary Nitrate Supplementation on Ability of Individuals With Type 2 Diabetes to Perform Exercise|The Effect of Dietary Nitrate Supplementation on Ability of Individuals With Type 2 Diabetes to Perform Exercise|Completed||N/A|57|Actual|NIHR Exeter Clinical Research Facility||2|||f||||f||||||||||2017-10-11 00:08:58.115608|2017-10-11 00:08:58.115608
NCT02206061|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-10-05|||July 2014||2014-07-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|SB-ACT||School-based Asthma Care for Teens (SB-ACT)|School-based Asthma Care for Teens (SB-ACT)|Recruiting||N/A|430|Anticipated|University of Rochester||3|||f||||t||||||||||2017-10-11 00:08:58.20543|2017-10-11 00:08:58.20543
NCT02206048|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-12-01|||October 2015||2015-10-01|December 2016|2016-12-01||||October 2018|Anticipated|2018-10-01||Interventional|||Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix|Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix|Recruiting||N/A|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:08:58.297159|2017-10-11 00:08:58.297159
NCT02206035|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-06-12|||December 2014||2014-12-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase II Open-Label Trial of Tacrolimus/Methotrexate and Tocilizumab for the Prevention of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation|Phase II Open-Label Trial of Tacrolimus/Methotrexate and Tocilizumab for the Prevention of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation|Active, not recruiting||Phase 2|35|Actual|Medical College of Wisconsin||1|||f||||||||||||||2017-10-11 00:08:58.417599|2017-10-11 00:08:58.417599
NCT02206022|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-02-21|||August 2014||2014-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|REMIDOLCATH||Remifentanil And Local Anesthesia Compared With Local Anesthesia For The Insertion Of Central Venous Catheters|REMIFENTANIL AND LOCAL ANESTHESIA COMPARED WITH LOCAL ANESTHESIA FOR THE INSERTION OF CENTRAL VENOUS CATHETERS IN AWAKE PATIENTS|Recruiting||Phase 4|90|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-11 00:08:58.541086|2017-10-11 00:08:58.541086
NCT02206009|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2016-01-05|||July 2014||2014-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Use of a Collagen Membrane for Soft Tissue Grafting|PriMatrix Dermal Repair Scaffold Utilization Intraorally|Completed||Phase 1|8|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:08:58.678681|2017-10-11 00:08:58.678681
NCT02205996|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-31|||November 2011||2011-11-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Effects of Hypoglycaemia in People With Type 2 Diabetes|The Effects of Hypoglycaemia on Platelets Function and Inflammatory Markers in People With Type 2 Diabetes and Normal Controls.|Completed||N/A|18|Actual|University of Hull||2|||f||||t||||||||||2017-10-11 00:08:58.79833|2017-10-11 00:08:58.79833
NCT02205983|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-03-04|||January 2015||2015-01-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|HESS||The Effects of Hydromorphone on Responses to Verbal Tasks|The Effects of Hydromorphone on Responses to Verbal Tasks|Enrolling by invitation||N/A|72|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 00:08:58.917547|2017-10-11 00:08:58.917547
NCT02205970|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-12-15|||August 2010||2010-08-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Application of Electrical Neurostimulation Transcutaneous in Patients With Primary Dysmenorrhea.|Methodological Proposal of Application of Electrical Neurostimulation Transcutaneous (Comparative Study Between Proposed Method of Application Versus Traditional Method in Patients With Primary Dysmenorrhea).|Completed||N/A|124|Actual|Universidade Federal de Sao Carlos||1|||f||||f||||||||||2017-10-11 00:08:59.007394|2017-10-11 00:08:59.007394
NCT02205957|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2016-01-13|||July 2014||2014-07-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|||Training Quality in Anaesthesia and Intensive Care: Tunisian Residents Feed Back|Training Quality in Anesthesia and Intensive Care : Tunisians Residents' Feed Back|Completed||N/A|160|Actual|University Hospital, Mahdia|||1||f||||f||||||||||2017-10-11 00:08:59.100327|2017-10-11 00:08:59.100327
NCT02205944|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-07-04|||September 2014||2014-09-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes|The Impact of Exercise on Vascular Remodeling, Arteriovenous Fistula Creation and Use in Patients With Chronic Kidney Disease: A Randomized Controlled Trial|Recruiting||N/A|210|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 00:08:59.166722|2017-10-11 00:08:59.166722
NCT02205931|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-02|||January 2015||2015-01-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|KIWE||Ketogenic Diet in Infants With Epilepsy (KIWE)|A Randomised Controlled Trial of the Ketogenic Diet in the Treatment of Epilepsy in Children Under the Age of Two Years|Recruiting||Phase 4|160|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 00:08:59.259932|2017-10-11 00:08:59.259932
NCT02205918|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-07-27|||July 1, 2017|Actual|2017-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Brain-Behavior Interactions in Tic Suppression|Integrative Examination of Neurobehavioral Mechanisms in Tic Suppression|Recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||||||2017-10-11 00:08:59.468885|2017-10-11 00:08:59.468885
NCT02205905|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-09-26|||July 2014||2014-07-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male Subjects|An Open-label, Single-dose, Non-randomized Study of the Absorption, Metabolism, and Excretion of Intravenously Administered 14C-labeled PER977 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Perosphere, Inc.||1|||f||||t||||||||No||2017-10-11 00:08:59.565882|2017-10-11 00:08:59.565882
NCT02205866|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-05-06|||August 2014||2014-08-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|June 2017|Anticipated|2017-06-01||Interventional|||Incidence of Non Receptive Endometrium in Obese Women|Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.|Recruiting||N/A|180|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-10-11 00:08:59.824507|2017-10-11 00:08:59.824507
NCT02205853|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-09-04||||||August 2015|2015-08-01||||October 2017|Anticipated|2017-10-01||Interventional|||Implementation of Physical Cancer Rehabilitation Programmes in a European Healthcare System.|An Evaluation of a Patient-directed Strategy Compared With a Multi-faceted Strategy to Implement Physical Cancer Rehabilitation Programmes; a Controlled Before and After Study.|Unknown status|Recruiting|N/A|10|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 00:08:59.956379|2017-10-11 00:08:59.956379
NCT02205840|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-01-19||2015-01-19|July 2014||2014-07-01|January 2015|2015-01-01||||November 2014|Actual|2014-11-01||Interventional|||A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.|A Multicenter, Randomized, Double-masked and Placebo-controlled Study Evaluating the Efficacy and Safety of SI-614 Ophthalmic Solution in Patients With Dry Eye|Completed||Phase 2/Phase 3|240|Actual|Seikagaku Corporation||2|||f||||f||||||||||2017-10-11 00:09:00.09004|2017-10-11 00:09:00.09004
NCT02205827|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-09-25|||April 2014||2014-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements|A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements|Completed||N/A|12|Actual|Perosphere, Inc.||1|||f||||f||||||||||2017-10-11 00:09:00.173086|2017-10-11 00:09:00.173086
NCT02205814|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2015-10-02|2015-07-06||April 2014||2014-04-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|ALBATROSS-3|Baseline analysis was performed on the ITT-population (n=431). The ITT-population included all patients randomised via IXRS.|Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee|A Double-blind, Randomised, Placebo-controlled, Four Parallel Arm, Dose-finding Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Single Intra-articular Injections of Fasitibant in Patients With Symptomatic Osteoarthritis of the Knee.|Completed||Phase 2|436|Actual|Menarini Group||4|||f||||f||||||||||2017-10-11 00:09:00.293144|2017-10-11 00:09:00.293144
NCT02205801|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-06-28|||July 2014|Actual|2014-07-01|June 2017|2017-06-01||||June 2017|Actual|2017-06-01||Interventional|||Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy|A Randomized Control Trial Comparing Bilateral Superficial Cervical Plexus Block and Local Wound Infiltration in Thyroidectomy and Parathyroidectomy|Enrolling by invitation||N/A|40|Anticipated|University of Chicago||4|||f||||t||||||||||2017-10-11 00:09:01.240007|2017-10-11 00:09:01.240007
NCT02205788|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-09-21|||July 2014||2014-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Observational|||Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas|Feasibility of Biodynamic Imaging for Predicting Effect of Gemcitabine and Nab-paclitaxel on Metastatic Adenocarcinoma of the Pancreas|Withdrawn||N/A|0|Actual|Indiana University|||1||f||||t||||||Samples With DNA|"     core needle biopsy of tumor   "|||2017-10-11 00:09:01.353479|2017-10-11 00:09:01.353479
NCT02205775|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-07-30|||May 2010||2010-05-01|February 2011|2011-02-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|REMEDY||Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty|Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty - The REMEDY Study|Terminated||Phase 3|280|Actual|G. d'Annunzio University||4||difficult recruitment|f||||t||||||||||2017-10-11 00:09:01.47275|2017-10-11 00:09:01.47275
NCT02205762|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-11-17|||July 2014||2014-07-01|October 2016|2016-10-01|July 2023|Anticipated|2023-07-01|November 2018|Anticipated|2018-11-01||Interventional|||LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis|LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis|Recruiting||Phase 2/Phase 3|1100|Anticipated|North American Consortium for Histiocytosis||6|||f||||t||||||||||2017-10-11 00:09:01.619963|2017-10-11 00:09:01.619963
NCT02205749|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-04-21|||January 2013||2013-01-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Preferred Consent Models for Secondary Uses of Biospecimens Among Diverse Women|Preferred Consent Models for Secondary Uses of Biospecimens Among Diverse Women|Unknown status|Active, not recruiting|N/A|454|Anticipated|Washington University School of Medicine||3|||f||||f||||||||||2017-10-11 00:09:02.289551|2017-10-11 00:09:02.289551
NCT02205723|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-02-10|||December 3, 2014|Actual|2014-12-03|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|SNAPP||Smartphone-facilitated Asthma Control|Smartphone-facilitated Medication Notification for Asthma Control in Pediatric Patients (SNAPP) Pilot Study|Suspended||N/A|30|Anticipated|Vanderbilt University Medical Center||2||Terminated due to inability retain participants.|f||||f||||||||||2017-10-11 00:09:02.475931|2017-10-11 00:09:02.475931
NCT02205710|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-07-21|||August 2016||2016-08-01|July 2016|2016-07-01||||August 2017|Anticipated|2017-08-01||Interventional|||Cognitive Training in Aging||Not yet recruiting||N/A|90|Anticipated|Bruyere Research Institute||2|||f||||||||||||||2017-10-11 00:09:02.588307|2017-10-11 00:09:02.588307
NCT02205697|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-01-15|||August 2014||2014-08-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|TPBIIFV||Theory of Planned Behavior and Implementation Intentions|Theory of Planned Behavior and Implementation Intentions: Effective for Improving Fruit and Vegetable Intake in Women of Low Socioeconomic Status?|Completed||N/A|31|Actual|Boston University||1|||f||||f||||||||||2017-10-11 00:09:02.710338|2017-10-11 00:09:02.710338
NCT02205684|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-05-20|||August 2014||2014-08-01|May 2015|2015-05-01|December 2019|Anticipated|2019-12-01|April 2017|Anticipated|2017-04-01||Interventional|EPHAPS||Effects of Physical Activity in Psychosis|Effects of Aerobic High Intensity Training on Symptoms, Cognition, Cortical Structure, Substance Use and Metabolic Indices in Patients With Schizophrenia Spectrum Disorder|Enrolling by invitation||N/A|126|Anticipated|Sykehuset i Vestfold HF||2|||f||||f||||||||||2017-10-11 00:09:02.799882|2017-10-11 00:09:02.799882
NCT02205658|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-29|||January 2014||2014-01-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Observational|||Sensory Processing Difficulties in Adults and Adolescents|Standardization of the Adult/ Adolescent Sensory History|Unknown status|Recruiting|N/A|1300|Anticipated|The Spiral Foundation at OTA Watertown|||3||f||||f||||||||||2017-10-11 00:09:03.011414|2017-10-11 00:09:03.011414
NCT02205645|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-04-05|||April 2015||2015-04-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Initial Safety Evaluation of FibroFix™ Meniscus|A Prospective Open-Label Study to Evaluate the Safety of the Meniscal Repair Scaffold, FibroFix™ Meniscus, in the Treatment of Meniscal Defects|Terminated||N/A|4|Actual|Orthox Limited||1||Safety. Devices explanted. 12m post-explant safety f/u as agreed with UK MHRA|f||||f||||||||||2017-10-11 00:09:03.093989|2017-10-11 00:09:03.093989
NCT02205632|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-12-10|||February 2014||2014-02-01|December 2014|2014-12-01||||November 2014|Actual|2014-11-01||Interventional|||Relationships Between Macular Pigment Optical Density and Lacquer Cracks in High Myopic Patients.||Completed||N/A|39|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-11 00:09:03.176829|2017-10-11 00:09:03.176829
NCT02205619|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-29|||September 2013||2013-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Amount of Cementum After Scaling, Root Planing and Glycine Air Polishing|Remaining Root Substance Comparing a New Ultrasonic Scaling Device, Hand Instrumentation and Subgingival Air Polishing With Glycine. An in Vivo and in Vitro Study|Completed||Phase 2/Phase 3|48|Actual|University of Roma La Sapienza||4|||f||||t||||||||||2017-10-11 00:09:03.261792|2017-10-11 00:09:03.261792
NCT02205606|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-09-21|||June 2014||2014-06-01|July 2014|2014-07-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia|A Randomized, Double-Blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of HCP1306 Tablet in Patients With Primary Hypercholesterolemia|Completed||Phase 3|412|Actual|Hanmi Pharmaceutical Company Limited||6|||f||||f||||||||||2017-10-11 00:09:03.375119|2017-10-11 00:09:03.375119
NCT02205593|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-07-13|||July 2012||2012-07-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Haut-Tief Patient Education on Psoriasis and Eczema|A Prospective, Randomized, Controlled Study of the Impact of Education and Stress-reduction Techniques on Psoriasis and Eczema.|Recruiting||N/A|80|Anticipated|University of Zurich||2|||f||||f||||||||No||2017-10-11 00:09:03.513829|2017-10-11 00:09:03.513829
NCT02205580|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-09-28|||September 2014||2014-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Tonsillectomy or Adeno-tonsillectomy in Children|Comparison of Three Different Rates of Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Coblation Tonsillectomy or Adeno-tonsillectomy in Children|Unknown status|Enrolling by invitation|Phase 4|60|Anticipated|Guangzhou Women and Children's Medical Center||3|||f||||t||||||||||2017-10-11 00:09:03.62694|2017-10-11 00:09:03.62694
NCT02205567|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-08-05|||June 2014||2014-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Observational|||Bergamot and Cardio-Metabolic Risk Factors|The Effect of Bergamot on Plasma Lipids, Lipoproteins and Carotid Intima-media Thickness|Completed||N/A|160|Actual|University of Palermo|||2||f||||f||||||Samples Without DNA|"     Serum and plasma samples   "|||2017-10-11 00:09:03.730419|2017-10-11 00:09:03.730419
NCT02205554|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-10-13|||August 2014||2014-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Omnitram Pharmacokinetic Study In Healthy Volunteers|A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Triple Cross-Over Study Investigating The Safety, Oral Steady-State Pharmacokinetics, And Clinical Activity Of 20 Mg Omnitram And 50 Mg Tramadol In Normal Human Subjects|Completed||Phase 1|43|Actual|Syntrix Biosystems, Inc.||3|||f||||f||||||||||2017-10-11 00:09:03.82039|2017-10-11 00:09:03.82039
NCT02205541|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-05-17|||June 2015||2015-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ECULISHU||Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU|Early Treatment With the Monoclonal C5 Antibody Eculizumab in Pediatric Patients Affected by Shiga-toxin Related Hemolytic and Uremic Syndrome: A Phase III Prospective Randomized Controlled Therapeutic Trial Versus Placebo|Recruiting||Phase 3|100|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 00:09:03.948934|2017-10-11 00:09:03.948934
NCT02205528|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-08-03|||August 18, 2014|Actual|2014-08-18|August 2017|2017-08-01|December 2, 2015|Actual|2015-12-02|December 2, 2015|Actual|2015-12-02||Interventional|||A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Phase 2a Study With an Open-Label Active Group to Assess the Efficacy and Safety of Once-Daily NNC0090-2746 in Type 2 Diabetic Patients Inadequately Controlled With Metformin|Completed||Phase 2|108|Actual|Novo Nordisk A/S||3|||f||||||||||||||2017-10-11 00:09:04.201644|2017-10-11 00:09:04.201644
NCT02205515|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-07-22|||March 2016||2016-03-01|July 2016|2016-07-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|EBRT||An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis|An Open Label, Single-Centre, Pilot Study for Radiosensitization of Everolimus With External Beam Radiotherapy for the Treatment of Metastatic Neuroendocrine Liver Metastasis|Recruiting||Phase 1/Phase 2|14|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 00:09:04.382115|2017-10-11 00:09:04.382115
NCT02205502|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-07-29|||January 2014||2014-01-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Lidocaine as Local Anesthetics in Children Under Ketamine Sedation|Efficacy of Lidocaine as Local Anesthetics in Children Under Procedural Sedation and Analgesia Using Ketamine|Unknown status|Recruiting|Phase 4|58|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:09:04.477638|2017-10-11 00:09:04.477638
NCT02205489|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-06-08|||October 2014||2014-10-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|EMERALD||Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA|Single Arm Study To Assess Comprehensive Infusion Guidance For The Management Of The Infusion- Associated Reactions (IARs) In Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated With LEMTRADA|Completed||Phase 4|58|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:09:04.592437|2017-10-11 00:09:04.592437
NCT02205476|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-12-21|2015-12-21||December 2014||2014-12-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Enrolled analysis set included all participants who signed an informed consent and for whom data were collected for Part A of this trial.|A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study|A Long-term Efficacy Assessment Following Initial Scar Revision Surgery And Phase 2 Open-label Study To Evaluate Safety Of Re-treatment With Pf-06473871|Terminated||Phase 2|10|Actual|Pfizer|The study was prematurely terminated at the discretion of sponsor as study B5301001 did not meet its pre-defined efficacy endpoints for the dosing regimens evaluated.|2||"B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study   B5301012 was terminated in 1/6/2015. No safety concerns identified."|f||||f||||||||||2017-10-11 00:09:04.767291|2017-10-11 00:09:04.767291
NCT02205463|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-31|||December 2014||2014-12-01|July 2014|2014-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer|A Phase Ib Study of KD019 Plus Trastuzumab in Patients With HER2 Overexpressed or Amplified Metastatic or Unresectable Adenocarcinoma of Esophagus, Gastroesophageal Junction and Stomach|Withdrawn||Phase 1|0|Actual|New York University School of Medicine||1||IND application withdrawn|f||||t||||||||||2017-10-11 00:09:05.249554|2017-10-11 00:09:05.249554
NCT02205450|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2014-07-30|||September 2014||2014-09-01|July 2014|2014-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell|Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell|Unknown status|Not yet recruiting|N/A|15|Anticipated|Corporacion Parc Tauli|||1||f||||f||||||||||2017-10-11 00:09:05.334164|2017-10-11 00:09:05.334164
NCT02205437|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-03-13|||January 2015|Actual|2015-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|GEXANT||Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia|Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia: Evidence From Pharmacogenetics in the Light of Personalized Medicine|Recruiting||N/A|200|Anticipated|Fundación Marques de Valdecilla|||6||f||||f|f|f||||Samples With DNA|"     Whole blood, RNA   "|No||2017-10-11 00:09:05.414564|2017-10-11 00:09:05.414564
NCT02205424|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-07-25|||May 2011||2011-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CANVAS||Cognition And Neocortical Volume After Stroke|Is Stroke Neurodegenerative? A Longitudinal Study of Brain Volume and Cognitive Decline Following Stroke (CANVAS: Cognition And Neocortical Volume After Stroke).|Active, not recruiting||N/A|175|Actual|The Florey Institute of Neuroscience and Mental Health|||2||f||||t||||||||No||2017-10-11 00:09:05.49834|2017-10-11 00:09:05.49834
NCT02205411|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-09-26|||September 2014||2014-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation|A Prospective, Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the HeartAssist 5® VAD System Compared to the Thoratec HeartMate II® VAD and HeartWare® HVAD for Left Ventricular Support in Patients Awaiting Cardiac Transplantation|Recruiting||N/A|192|Anticipated|ReliantHeart Inc.||2|||f||||t||||||||||2017-10-11 00:09:05.580561|2017-10-11 00:09:05.580561
NCT02205398|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-09-13|||July 28, 2014|Actual|2014-07-28|September 2017|2017-09-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy|A Phase Ib, Open-label, Multicenter, Dose Escalation and Expansion Study, to Evaluate the Safety, Pharmacokinetics and Activity of INC280 in Combination With Cetuximab in c-MET Positive CRC and HNSCC Patients Who Have Progressed After Anti-EGFR Monoclonal Antibody Therapy.|Terminated||Phase 1|13|Actual|Novartis||1|||f|||||t|f||||||||2017-10-11 00:09:05.770716|2017-10-11 00:09:05.770716
NCT02205385|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-09-13|||October 2014||2014-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|TMR||Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation|Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation|Recruiting||N/A|200|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 00:09:05.911446|2017-10-11 00:09:05.911446
NCT02205372|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2015-09-14|||July 2014||2014-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy|A Phase II, Randomised, Double-blind, Placebo-controlled Study of MT-3995 (Low Dose) in Subjects With Diabetic Nephropathy|Completed||Phase 1/Phase 2|31|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 00:09:06.042433|2017-10-11 00:09:06.042433
NCT02205359|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-02-24|||July 2014||2014-07-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||AdaptResponse Clinical Trial|AdaptResponse Clinical Trial|Recruiting||N/A|3000|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||t||||||||||2017-10-11 00:09:06.287001|2017-10-11 00:09:06.287001
NCT02205346|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-08-20|||February 2014||2014-02-01|August 2014|2014-08-01|June 2015|Anticipated|2015-06-01|February 2015|Anticipated|2015-02-01||Observational|||Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea|Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea|Unknown status|Recruiting|N/A|25|Anticipated|Eastern Virginia Medical School|||1||f||||f||||||Samples Without DNA|"     urine sample   "|||2017-10-11 00:09:06.989253|2017-10-11 00:09:06.989253
NCT02205333|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-06-01|2017-03-27||August 13, 2014|Actual|2014-08-13|June 2017|2017-06-01|April 8, 2016|Actual|2016-04-08|April 8, 2016|Actual|2016-04-08||Interventional|MEDI6469||A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies|A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas|Terminated||Phase 1/Phase 2|48|Actual|MedImmune LLC|The study was terminated early at the Sponsor’s discretion.|9||The study was terminated early at the sponsor's discretion.|f||||f||||||||||2017-10-11 00:09:07.185533|2017-10-11 00:09:07.185533
NCT01832064|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-07-29|||June 2013||2013-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Active Living Tool Kit for Chronic Conditions|Development of a Mailed Chronic Disease Self-Management Program|Completed||N/A|255|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 01:48:35.826573|2017-10-11 01:48:35.826573
NCT02205320|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-29|||February 2014||2014-02-01|July 2014|2014-07-01|September 2014|Anticipated|2014-09-01|August 2014|Anticipated|2014-08-01||Interventional|||A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers||Unknown status|Recruiting|Phase 1|192|Anticipated|Dr. Reddy's Laboratories Limited||6|||f||||f||||||||||2017-10-11 00:09:10.969142|2017-10-11 00:09:10.969142
NCT02205307|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-06-22|||January 2015||2015-01-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|PILLAR III||A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection|A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection|Terminated||N/A|330|Actual|Novadaq Technologies Inc.||2||Slow recruitment|f||||t||||||||||2017-10-11 00:09:11.062924|2017-10-11 00:09:11.062924
NCT02205294|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-09-01|||November 2014||2014-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Osteopathic Treatment and Deep Vein Thrombosis (DVT)|The Effect of Osteopathic Treatment in Acute Proximal Leg Deep Vein Thrombosis (DVT) to Reduce Pain and Swelling|Recruiting||N/A|40|Anticipated|Nova Scotia Health Authority||2|||f||||t||||||||||2017-10-11 00:09:11.196009|2017-10-11 00:09:11.196009
NCT02205281|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-05-26|||June 2014||2014-06-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PIH||Partners in Health: A Couples-based Approach to Obesity Prevention|Partners in Health: A Couples-based Approach to Obesity Prevention.|Active, not recruiting||N/A|30|Actual|California Polytechnic State University-San Luis Obispo||2|||f||||f||||||||||2017-10-11 00:09:11.285917|2017-10-11 00:09:11.285917
NCT02205268|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-10-13|||March 2013||2013-03-01|October 2015|2015-10-01||||March 2016|Anticipated|2016-03-01||Interventional|ADHDNTx||Near Infrared Spectroscopy Neurofeedback Training for ADHD|A Pilot Study of Near Infrared Spectroscopy Neurofeedback Training of Prefrontal Cortex in Attention Deficit Hyperactivity Disorder|Unknown status|Recruiting|N/A|48|Anticipated|North Essex Partnership NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:09:11.366531|2017-10-11 00:09:11.366531
NCT02205255|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-03-28|||August 1, 2014|Actual|2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|FarmEc||BACE Trial Substudy 2 - FarmEc Substudy|BACE Trial - The Pharmaco-economic Impact of the Azithromycin Intervention|Recruiting||Phase 3|350|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||No||2017-10-11 00:09:13.571292|2017-10-11 00:09:13.571292
NCT02205242|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-03-28|||September 2014||2014-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|PROactive||BACE Trial Substudy 1 - PROactive Substudy|BACE Trial - Physical Activity as a Crucial Patient Reported Outcome in COPD|Recruiting||Phase 3|60|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||No||2017-10-11 00:09:13.780403|2017-10-11 00:09:13.780403
NCT02205229|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-05-15|||August 2014||2014-08-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01|1 Month|Observational [Patient Registry]|ComPASS||Compounded Pain Preparation Absorption Study|Compounded Pain Preparation Absorption Study (ComPPAS)|Suspended||N/A|40|Anticipated|Medimix Specialty Pharmacy, LLC|||1|Poor enrollment|f||||||||||||||2017-10-11 00:09:13.915697|2017-10-11 00:09:13.915697
NCT02205216|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2015-07-03|||September 2014||2014-09-01|July 2015|2015-07-01||||August 2017|Anticipated|2017-08-01||Interventional|||Can tDCS Enhance Efficacy of Rehabilitative Intervention for Freezing of Gait in Parkinson's Disease?|Can Transcranial Direct Stimulation Enhance the Efficacy of a Rehabilitative Intervention for the Treatment of Freezing of Gait in Parkinson's Disease? A Double Blind Randomized Controlled Study|Unknown status|Recruiting|N/A|40|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||||2017-10-11 00:09:13.990816|2017-10-11 00:09:13.990816
NCT02205190|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-10-13|||July 2014||2014-07-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin|A Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin in Healthy Male Volunteers|Completed||Phase 1|81|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-10-11 00:09:14.215229|2017-10-11 00:09:14.215229
NCT02205177|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-04-04|||January 15, 2016|Actual|2016-01-15|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Youth Mayo Clinic Anxiety Coach Pilot Study|Expanding Access to Therapy for Childhood Anxiety Disorders Via Smart Phones - PILOT|Completed||N/A|10|Actual|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-11 00:09:14.301142|2017-10-11 00:09:14.301142
NCT02205164|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-30|||October 2011||2011-10-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients|Phase II Randomized Study of Multiple Doses of Palonosetron Plus Aprepitant Versus Multiple Doses of Palonosetron Alone in Preventing CINV in Patients With Newly Diagnosed AML or High-risk MDS Receiving Multiple Days Chemotherapy|Unknown status|Recruiting|Phase 2|134|Anticipated|Associazione Salentina Angela Serra||2|||f||||f||||||||||2017-10-11 00:09:14.446337|2017-10-11 00:09:14.446337
NCT02205151|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-10-13|||July 2014||2014-07-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets|An Open-label, Randomized, Single-dose, 2×2 Crossover Study to Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets in Healthy Male Volunteers|Completed||Phase 1|86|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-10-11 00:09:14.668327|2017-10-11 00:09:14.668327
NCT02205138|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-30|2017-01-31|||October 2014||2014-10-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion|A Pilot Phase 2a, Multicentre, Open, Proof-of-concept Study on the Safety and the Efficacy of Allogeneic Osteoblastic Cells (ALLOB®) Implantation in Lumbar Spinal Fusion|Recruiting||Phase 2|38|Anticipated|Bone Therapeutics S.A||1|||f||||f||||||||||2017-10-11 00:09:14.75956|2017-10-11 00:09:14.75956
NCT02205125|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-07-29|||August 2013||2013-08-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Cold Polypectomy Site Study|Prospective Characterization of the Mucosal Defect After Cold Snare Polypectomy|Completed||N/A|88|Actual|Western Sydney Local Health District|||1||f||||t||||||Samples Without DNA|"     All polypectomy specimens were submitted for histopathological assessment as per clinical     practice. The biopsy samples from the irregular areas were also submitted in the same     fashion. All specimens are stored as per current clinical practice.   "|||2017-10-11 00:09:14.856599|2017-10-11 00:09:14.856599
NCT02205099|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-10-12||2016-10-12|July 2014||2014-07-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia|A Single-center, Randomized, Double-blind, Flexible-dosage, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia|Completed||Phase 1/Phase 2|39|Actual|SK Life Science||4|||f||||f||||||||||2017-10-11 00:09:15.01711|2017-10-11 00:09:15.01711
NCT02205086|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-07-29|||August 2014||2014-08-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|Rheumatology||Empowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology|Empowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology|Unknown status|Not yet recruiting|N/A|30|Anticipated|SimulConsult, Inc.||1|||f||||f||||||||||2017-10-11 00:09:15.115796|2017-10-11 00:09:15.115796
NCT02205073|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-07-01|||July 2014||2014-07-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Phase 1, Randomized, Double-blind, Placebo-controlled Crossover Study of RG7314 on the Potential Regulation of Higher Brain Functions in Healthy Male Participants: Proof of Mechanism|A RANDOMIZED, DOUBLE-BLIND, THREE PERIOD CROSS-OVER, PLACEBO CONTROLLED, PROOF OF MECHANISM STUDY TO INVESTIGATE THE EFFECT OF RG7314 ON VASOPRESSIN (AVP) PATHWAY ACTIVATION IN HEALTHY MALE SUBJECTS|Completed||Phase 1|32|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:09:15.227839|2017-10-11 00:09:15.227839
NCT02205060|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-07-29|||July 2014||2014-07-01|July 2014|2014-07-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Virtual Reality Cue Exposurefor the Relapse Prevention of Tobacco Consumption|Interventionnal and Randomized Study Measuring Virtual Reality Cue Exposure for the Relapse Prevention of Tobacco Consumption Versus Cognitive and Behavioral Approaches Therapy|Unknown status|Recruiting|N/A|120|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 00:09:15.353555|2017-10-11 00:09:15.353555
NCT02205047|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-10-11|||September 2015||2015-09-01|October 2016|2016-10-01|September 2024|Anticipated|2024-09-01|September 2020|Anticipated|2020-09-01||Interventional|INNOVATION||Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma|INtegratioN of Trastuzumab, With or Without Pertuzumab, Into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer: the INNOVATION-TRIAL|Recruiting||Phase 2|220|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||3|||f||||t||||||||||2017-10-11 00:09:15.560296|2017-10-11 00:09:15.560296
NCT02205034|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-05-10|||May 2013||2013-05-01|May 2017|2017-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|OTBB2||Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants|Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants|Completed||Phase 1/Phase 2|18|Actual|University Hospital, Toulouse||3|||f||||t||||||||||2017-10-11 00:09:15.876226|2017-10-11 00:09:15.876226
NCT02205021|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-30|||January 2014||2014-01-01|July 2014|2014-07-01||||March 2014|Actual|2014-03-01||Observational|||Neck Fat Accumulation and Its Relationship to Cardiovascular Risk and Metabolic Syndrome|Compartmental Neck Fat Accumulation and Its Relationship to Cardiovascular Risk and Metabolic Syndrome|Completed||N/A|303|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 00:09:15.977797|2017-10-11 00:09:15.977797
NCT02205008|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-07-29|||October 2012||2012-10-01|July 2014|2014-07-01|November 2018|Anticipated|2018-11-01|December 2015|Anticipated|2015-12-01||Interventional|EPIC-GC||Intraperitoneal Chemotherapy and Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection of Serosa-positive Gastric Cancer|Prospective Randomized Multicenter Phase III Trial of Intraperitoneal Chemotherapy and Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection of Serosa-positive Gastric Cancer|Recruiting||Phase 3|230|Anticipated|Kyungpook National University||2|||f||||f||||||||||2017-10-11 00:09:16.059222|2017-10-11 00:09:16.059222
NCT02204995|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-09-02|||September 2014||2014-09-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Surgical Treatment for Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 4|Trapeziectomy With Ligament Reconstruction and Tendon Interposition or Simple Trapeziectomy for Treating Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 4: a Randomized Clinical Trial|Recruiting||N/A|62|Anticipated|Isala||2|||f||||f||||||||||2017-10-11 00:09:16.186755|2017-10-11 00:09:16.186755
NCT02204982|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-07-28|||September 2014||2014-09-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|DYNAMO + R||Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma|Terminated||Phase 3|13|Actual|Verastem, Inc.||2||Sponsor is focusing on studies which can enable registration of duvelisib|f||||t||||||||||2017-10-11 00:09:16.290935|2017-10-11 00:09:16.290935
NCT02204969|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-01-05|||January 2015||2015-01-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|LIWA||LIWA for Treatment of Alzheimer Patients|Transcranial Magnetic Stimulation (TMS) and Lithium Water for Treatment of Alzheimer Patients|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|American Society Of Thermalism And Climatology Inc||2|||f||||t||||||||||2017-10-11 00:09:16.56271|2017-10-11 00:09:16.56271
NCT02204956|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-03-18|||April 2015||2015-04-01|March 2015|2015-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Smoking Cessation Following Psychiatric Hospitalization|Extended Care for Smoking Cessation Following Psychiatric Hospitalization|Not yet recruiting||Phase 2|422|Anticipated|University of Texas at Austin||2|||f||||t||||||||||2017-10-11 00:09:16.691422|2017-10-11 00:09:16.691422
NCT02204943|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-25|||May 6, 2015|Actual|2015-05-06|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer|Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer|Completed||N/A|20|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:09:16.828645|2017-10-11 00:09:16.828645
NCT02204930|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-10-20|||July 2014||2014-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||PeproStat Haemostat Study in Subjects Undergoing Liver Surgery|A Multi-centre, Open-label, Uncontrolled, First-in-Human Study to Evaluate the Safety and Tolerability and Explore the Efficacy of PeproStat in Gelita-Spon® Gelatin Sponge in Subjects Undergoing Open Liver Resection Surgery|Completed||Phase 1|20|Actual|Haemostatix Ltd||1|||f||||f||||||||||2017-10-11 00:09:16.934317|2017-10-11 00:09:16.934317
NCT02204904|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-18|||December 2014||2014-12-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|||Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)|A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in Males ≤17 Years of Age Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral Adrenoleukodystrophy|Recruiting||N/A|35|Anticipated|bluebird bio|||3||f||||t||||||||||2017-10-11 00:09:17.144943|2017-10-11 00:09:17.144943
NCT02204891|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-03-17|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Probiotics in Intestinal Bacterial Overgrowth|A Clinical Study of the Efficacy of a Formulation of Four Probiotics in Patients With Syndrome of Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome|Completed||N/A|26|Actual|University of Athens||2|||f||||f||||||||No||2017-10-11 00:09:17.29332|2017-10-11 00:09:17.29332
NCT02204878|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-29|||July 2014||2014-07-01|July 2014|2014-07-01||||August 2015|Anticipated|2015-08-01||Interventional|||Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy|A Randomized, Phase IV Study Exploring the Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy|Unknown status|Recruiting|Phase 4|100|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 00:09:17.427109|2017-10-11 00:09:17.427109
NCT02204865|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-11-08|||March 2014||2014-03-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Observational|ApneaScan||Validation of the ApneaScan Algorithm in Sleep Disordered Breathing|Sleep-Disordered Breathing in Patients With Implanted Cardiac Devices: Validation of the ApneaScan Algorithm and Implications for Prognosis|Recruiting||N/A|180|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 00:09:17.527699|2017-10-11 00:09:17.527699
NCT02204852|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-04-21|||September 2014||2014-09-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|CO-ILEPSS||Co-administration of Iloprost and Eptifibatide in Septic Shock Patients|Safety and Efficacy of Iloprost and Eptifibatide Co-administration Compared to Standard Therapy in Patients With Septic Shock - a Randomized, Controlled, Double-blind Investigator-initiated Trial|Completed||Phase 2|18|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 00:09:17.641115|2017-10-11 00:09:17.641115
NCT02204839|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-01-14|||January 2014||2014-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM|The Metabolic and Glycaemic Effects of a Combined Basal-Bolus Insulin Reduction And Carbohydrate Feeding Strategy For Evening Exercise in Type 1 Diabetes Mellitus|Completed||N/A|10|Actual|Northumbria University||1|||f||||t||||||||||2017-10-11 00:09:17.756209|2017-10-11 00:09:17.756209
NCT02204826|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-07-29|||April 2011||2011-04-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study|Effects of Korean Red Ginseng on Semen Parameters in Male Infertility Patients: a Randomized, Placebo-controlled, Double-blind Clinical Study|Completed||Phase 4|80|Actual|Pusan National University Hospital||4|||f||||t||||||||||2017-10-11 00:09:17.842975|2017-10-11 00:09:17.842975
NCT02204813|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-05-17|||July 2014|Actual|2014-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery|To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery|Active, not recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t||||||||No||2017-10-11 00:09:17.949852|2017-10-11 00:09:17.949852
NCT02204800|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-08-23|||August 2014||2014-08-01|August 2016|2016-08-01||||August 2017|Anticipated|2017-08-01||Observational|||Active Surveillance of the Small Renal Mass|Active Surveillance of the Small Renal Mass: An Integrated Biomarker Trial|Recruiting||N/A|48|Anticipated|Yale University|||2||f||||f||||||||||2017-10-11 00:09:18.070297|2017-10-11 00:09:18.070297
NCT02204787|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-05-31|||December 2014||2014-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|STICCS||Treatment of Negative Symptoms and Schizophrenia|A Double Blind Sham Controlled Trial of tDCS for Treatment of Negative Symptoms in Patients With Schizophrenia|Recruiting||Phase 1/Phase 2|60|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 00:09:18.17356|2017-10-11 00:09:18.17356
NCT02204774|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-06-13|||July 2014||2014-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Is Obstructive Sleep Apnoea a Risk Factor for Thoracic Aortic Aneurysm Expansion? A Prospective Cohort Study.|Is Obstructive Sleep Apnoea a Risk Factor for Thoracic Aortic Aneurysm Expansion? A Prospective Cohort Study.|Recruiting||N/A|340|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-11 00:09:18.252408|2017-10-11 00:09:18.252408
NCT02204761|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-27|||September 9, 2014|Actual|2014-09-09|September 2017|2017-09-01||||February 1, 2018|Anticipated|2018-02-01||Interventional|||Proton Beam Radiation Therapy in Treating Patients With Recurrent Thoracic Cancer Who Have Received Prior Radiation Therapy|Definitive Re-irradiation With Proton Beam Radiotherapy for Patients With Recurrent Thoracic Cancers|Active, not recruiting||N/A|6|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 00:09:18.328579|2017-10-11 00:09:18.328579
NCT02204748|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-01-05|2015-08-13||November 2014||2014-11-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System|Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty|Completed||N/A|5|Actual|The University of Tennessee, Knoxville|||1||f||||f||||||||||2017-10-11 00:09:18.421688|2017-10-11 00:09:18.421688
NCT02204735|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-07-14|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TIME||Timing of Meals for Weight Loss|Timing of Meals for Weight Loss|Active, not recruiting||N/A|30|Anticipated|University of Tennessee||2|||f||||t||||||||||2017-10-11 00:09:18.755887|2017-10-11 00:09:18.755887
NCT02204722|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-02-20|||September 2014||2014-09-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|IDEAL||A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients|A Phase IV Study to Evaluate Efficacy and Safety of Imatinib(Glinib®) 600mg/Day Depending on Early Molecular Response in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase|Active, not recruiting||Phase 4|150|Anticipated|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:09:18.842182|2017-10-11 00:09:18.842182
NCT02204709|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-28|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Disease Risk Reduction and Omega-3 Rich Rainbow Trout (Fish for Health)|Disease Risk Reduction and n-3 Rich Rainbow Trout (Fish for Health)|Recruiting||N/A|43|Anticipated|USDA Grand Forks Human Nutrition Research Center||3|||f||||f||||||||||2017-10-11 00:09:18.945774|2017-10-11 00:09:18.945774
NCT02204696|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-11-30|||December 2010||2010-12-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Tonsillectomy in Adults With Tonsillar Hypertrophy and Obstructive Sleep Apnea|The Role of Tonsillectomy in Adults With Marked Tonsillar Hypertrophy and Obstructive Sleep Apnea|Withdrawn||N/A|0|Actual|University of Southern California|||1|No participants enrolled|f||||f||||||||||2017-10-11 00:09:19.042672|2017-10-11 00:09:19.042672
NCT02204683|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-07-11|||July 2014||2014-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|DRAW||A Pharmacokinetic Study of Intravitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Wet Age-related Macular Degeneration (DRAW).|A Pharmacokinetic Study of Intravitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Wet Age-related Macular Degeneration (the DRAW Study)|Completed||Phase 1|5|Actual|University of Nebraska||2|||f||||f||||||||||2017-10-11 00:09:19.121424|2017-10-11 00:09:19.121424
NCT02204670|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-03-29|||July 2014||2014-07-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|EXIT||EXIT: Prospective Study of the Response to Exercise|Exercise and Irisin Trial (EXIT): Prospective Cohort Study of the Determinants of the Metabolic Response to Exercise in Obese Adolescents|Completed||N/A|15|Actual|University of Manitoba|||1||f||||f||||||||||2017-10-11 00:09:19.200717|2017-10-11 00:09:19.200717
NCT02204657|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-06-23|2016-06-23||April 2013||2013-04-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||The Effect of Continuous Glucose Monitoring on Glycemic Control in Insulin-requiring Gestational Diabetes Mellitus|The Effect of Professional Continuous Glucose Monitoring on Diabetes Management,Hypoglycemia and Glycemic Control in Insulin-requiring Gestational Diabetes Mellitus|Completed||N/A|50|Actual|University of Malaya|small sample size|2|||f||||t||||||||No||2017-10-11 00:09:19.317321|2017-10-11 00:09:19.317321
NCT02204644|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2015-07-27|||June 2014||2014-06-01|July 2014|2014-07-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML|Randomized, Multi-center, Open-label Phase III Study of the Efficacy and Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia.|Unknown status|Recruiting|Phase 3|480|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:09:19.691837|2017-10-11 00:09:19.691837
NCT02204631|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-05-24|||August 12, 2014|Actual|2014-08-12|May 2017|2017-05-01|December 22, 2016|Actual|2016-12-22|December 22, 2016|Actual|2016-12-22||Interventional|||2 Phase Use Of Educational Materials In Head And Neck Cancer Center|A Two-phase Study to Evaluate the Use of Educational Materials in the Head and Neck Cancer Center|Completed||N/A|60|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:09:19.795541|2017-10-11 00:09:19.795541
NCT02204618|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-08-21|||October 2014||2014-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|CISSD||Cochlear Implantation in Single Sided Deafness and Asymmetrical Hearing Loss: a Cost/Utility Study.|Cochlear Implantation in Single Sided Deafness and Asymmetrical Hearing Loss: a Cost/Utility Study.|Active, not recruiting||N/A|160|Actual|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-11 00:09:19.885229|2017-10-11 00:09:19.885229
NCT02204605|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-12-20|||May 2014||2014-05-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Video-based Consensus Opinion for Hand and Upper Extremity Problems||Withdrawn||N/A|0|Actual|Massachusetts General Hospital||2||The principal investigator left the institution.|f||||f||||||||||2017-10-11 00:09:20.011572|2017-10-11 00:09:20.011572
NCT02204592|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-01-29|||December 2014||2014-12-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Level of Burn Out of Surgical Residents Working in Government Hospitals of Lahore|Burn Out Among Surgical Residents Working at Government Institutes in Lahore: An Area of Grave Concerns|Completed||N/A|133|Actual|Services Hospital, Lahore|||1||f||||f||||||||No||2017-10-11 00:09:20.117685|2017-10-11 00:09:20.117685
NCT02204579|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-10-27|2016-10-27|2016-03-07|July 2014||2014-07-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations|Open-label Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Intravenous NPSP795 in Autosomal Dominant Hypocalcemia Due to Mutations in the Calcium-sensing Receptor Gene: A Drug Repurposing Study|Completed||Phase 2|7|Actual|Shire||1|||f||||t||||||||||2017-10-11 00:09:20.212813|2017-10-11 00:09:20.212813
NCT02204566|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-04-14|||January 2013||2013-01-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation|Pilot Study of OFDI Capsule Imaging of the Esophagus of Patients With Atrial Fibrillation Following RF Ablation|Completed||Phase 1|6|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:09:20.988387|2017-10-11 00:09:20.988387
NCT02204553|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-01-04||||||January 2016|2016-01-01||||||||Expanded Access|||Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma|An Expanded Treatment Protocol of Panobinostat (LBH589) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma Who Have Had at Least One Prior Line of Therapy|No longer available||N/A|||Novartis|||||||||||||||||||2017-10-11 00:09:21.088479|2017-10-11 00:09:21.088479
NCT02204540|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2015-10-19|||July 2014||2014-07-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|WEBCAM||Feasibility of Using Webcams in Clinical Studies|Validation of Video Monitoring to Assess Compliance in Clinical Interventions|Completed||N/A|7|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 00:09:21.25239|2017-10-11 00:09:21.25239
NCT02204527|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-01-25|||October 2015|Actual|2015-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Supplementation of Vitamin D in Patients With Type 2 Diabetes and Hypertension|Supplementation of Vitamin D in Patients With Type 2 Diabetes and Hypertension: Randomized Clinical Trial|Terminated||N/A|40|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 00:09:21.349117|2017-10-11 00:09:21.349117
NCT02204514|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-10-16|||April 2014||2014-04-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||The Effects of Surgery for Painful External Snapping Hip||Completed||N/A|62|Actual|Northern Orthopaedic Division, Denmark|||1||f||||f||||||||||2017-10-11 00:09:21.452274|2017-10-11 00:09:21.452274
NCT02204501|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-07-14|||May 2014||2014-05-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers|A Phase 1, Randomized, Open-Label Study to Evaluate the Effect of Vapendavir (BTA798) on the Pharmacokinetics of Orally Administered Midazolam, a CYP3A4 Substrate, in Healthy Male and Female Volunteers|Completed||Phase 1|24|Actual|Aviragen Therapeutics||2|||f||||f||||||||||2017-10-11 00:09:21.542787|2017-10-11 00:09:21.542787
NCT02204488|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-09-02|||September 2014||2014-09-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Surgical Treatment for Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 2-3|Total Joint Arthroplasty or Trapeziectomy for Treating Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 2 and 3: a Randomized Clinical Trial|Recruiting||N/A|62|Anticipated|Isala||2|||f||||f||||||||||2017-10-11 00:09:21.654193|2017-10-11 00:09:21.654193
NCT02204475|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-10-13|||November 2014||2014-11-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066)|A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 Versus Boceprevir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR Prior Treatment Failure Subjects With Chronic HCV GT1 Infection|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:09:21.769757|2017-10-11 00:09:21.769757
NCT02204462|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-05-20|||April 2015||2015-04-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|January 2017|Anticipated|2017-01-01||Interventional|||FBnTP Imaging of Breast Cancer|FBnTP Positron Emission Mammography Imaging of Mitochondria Function - Breast Cancer|Recruiting||Phase 1|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||Yes|via manuscripts publication|2017-10-11 00:09:21.86413|2017-10-11 00:09:21.86413
NCT02204449|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-11-30|2015-06-03||July 2014||2014-07-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Cardiac Rehabilitation Peer Mentorship|Mentorship to Promote Cardiac Rehabilitation Enrollment: A Randomized Controlled Trial|Completed||N/A|94|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 00:09:21.986382|2017-10-11 00:09:21.986382
NCT02204436|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-29|||November 2013||2013-11-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Clinical Study for the Evaluation of the Depigmenting Activity of a Cosmetic Product on Spotted Hand Skin|Clinical Study for the Evaluation of the Depigmenting Activity of a Cosmetic Product on Spotted Hand Skin|Completed||Phase 3|22|Actual|Derming SRL||1|||f||||t||||||||||2017-10-11 00:09:22.293654|2017-10-11 00:09:22.293654
NCT02204423|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-07-29|||February 2014||2014-02-01|July 2014|2014-07-01|November 2015|Anticipated|2015-11-01|May 2015|Anticipated|2015-05-01||Interventional|||Upper Extremity Dysfunction Post Radial Percutaneous Coronary Intervention|Upper Extremity Dysfunction Post Radial PCI: A Cohort Study Evaluating Upper Extremity Dysfunction After Percutaneous Coronary Intervention Using the Radial Artery as Access Route|Unknown status|Recruiting|N/A|500|Anticipated|Albert Schweitzer Hospital||1|||f||||t||||||||||2017-10-11 00:09:22.401497|2017-10-11 00:09:22.401497
NCT02204410|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-05-30|2017-04-26||July 2014||2014-07-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Omega-3 Supplementation to ADHD Medication in Children|A Pilot Study of Omega-3 Fatty Acid Supplementation to ADHD Medication in Children With ADHD and Deficits in Emotional Self-Regulation|Completed||Phase 4|21|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-11 00:09:22.523099|2017-10-11 00:09:22.523099
NCT02204397|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-05-25|||November 2015||2015-11-01|May 2017|2017-05-01|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Interventional|||Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 Melitis|A Single-center, Open-Label, Exploratory Study to Assess the Tolerability and Safety of the Addition of Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With Type 1 Diabetes Mellitus|Completed||Phase 2|5|Actual|Jewish General Hospital||1|||f||||f||||||||Undecided|IPD sharing is still under review and will be determined at a later date|2017-10-11 00:09:22.786839|2017-10-11 00:09:22.786839
NCT02204384|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-02-13|||August 2014||2014-08-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|March 2016|Actual|2016-03-01||Interventional|||Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes Mellitus|Plasma Glucose and Insulin Responses After Consumption of Breakfasts With Different Sources of Soluble Fiber in Type 2 Diabetes Patients: a Randomized Crossover Clinical Trial|Completed||N/A|19|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||t||||||||Undecided||2017-10-11 00:09:22.883595|2017-10-11 00:09:22.883595
NCT02204371|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-06-06|2017-04-20||February 25, 2015|Actual|2015-02-25|April 2017|2017-04-01|February 10, 2016|Actual|2016-02-10|February 10, 2016|Actual|2016-02-10||Interventional|||Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia|A Phase II Study to Evaluate the Effects of up to 12 Weeks of Pazopanib Dosing on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia|Terminated||Phase 2|7|Actual|GlaxoSmithKline||2||"The study was terminated as the asset was sold to another company who decided not to pursue   this indication with this drug."|f||||f||||||||||2017-10-11 00:09:23.163888|2017-10-11 00:09:23.163888
NCT02204358|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-07-28|||January 2012||2012-01-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|July 2014|Actual|2014-07-01||Interventional|||Treatment of Infertility by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells|Clinical Study of the Treatment of Infertility Caused by Severe Intrauterine Adhesions by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells|Unknown status|Recruiting|Phase 4|30|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||t||||||||||2017-10-11 00:09:25.967852|2017-10-11 00:09:25.967852
NCT02204345|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-01-24||2017-01-24|October 2014||2014-10-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology|Open Label Phase Ib/II, Multicenter Study of the Combination of RO5479599 With Carboplatin and Paclitaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) of Squamous Histology Who Have Not Received Prior Chemotherapy or Targeted Therapy for NSCLC|Terminated||Phase 1/Phase 2|12|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:09:26.07307|2017-10-11 00:09:26.07307
NCT02204332|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-07-29|||March 2013||2013-03-01|July 2014|2014-07-01||||September 2013|Actual|2013-09-01||Interventional|COMETA||Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment|Phase II-b Randomized Study of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment|Terminated||Phase 2|38|Actual|Hospital Clinico Universitario de Santiago||2||Interim analysis performed on the first 10 patients showed no efficacy of cabazitaxel|f||||f||||||||||2017-10-11 00:09:26.184329|2017-10-11 00:09:26.184329
NCT02204319|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-05-31|2016-10-04||March 2014||2014-03-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||seven completed study and three withdrew|Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief|Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief|Terminated||N/A|10|Actual|ProHealth Care, Inc|Early termination leading to small numbers of subjects analyzed were the choice of the participant to end participation. One participant became pregnant during the study. Other reasons were related to participant cost of healthcare visits.|1|||f||||f||||||||Undecided||2017-10-11 00:09:26.287133|2017-10-11 00:09:26.287133
NCT02204306|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-08-12|||April 2014||2014-04-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Genotype Guided Chemotherapy in Gastric Cancer Patients|TSER Genotype Guided Chemotherapy in Metastatic Gastric Cancer Patients: A Phase II Study in China|Unknown status|Recruiting|Phase 2|330|Anticipated|Central South University||3|||f||||t||||||||||2017-10-11 00:09:26.481929|2017-10-11 00:09:26.481929
NCT02204293|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-07-25|||June 2012||2012-06-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|CONSIDER||Canakinumab for Treatment of Adult Onset Still's Disease|Canakinumab for Treatment of Adult Onset Still's Disease to Achieve Reduction of Arthritic Manifestation|Recruiting||Phase 2|68|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 00:09:26.585158|2017-10-11 00:09:26.585158
NCT02204280|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-07-20|||August 2014||2014-08-01|July 2014|2014-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy|Urine UbA52 is a Biomarker of Early Diabetic Nephropathy|Completed||N/A|120|Actual|Hebei Medical University Third Hospital|||4||f||||t||||||Samples Without DNA|"     morning urine   "|||2017-10-11 00:09:26.669837|2017-10-11 00:09:26.669837
NCT02204254|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-07-29|||March 2014||2014-03-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|Rosac-RF||RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea|Prospective, Open Label, Randomized Study Comparing Bipolar Radiofrequency Potentiated by Infrared Light to Doxycycline in Patient With Papulopustular Rosacea|Unknown status|Recruiting|N/A|40|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 00:09:26.853291|2017-10-11 00:09:26.853291
NCT02204241|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-05-09|||June 2014||2014-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2015|Actual|2015-06-01||Interventional|CCD||Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients|A Multicenter, Open Label Phase I/II Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma (MM) Patients|Recruiting||Phase 1/Phase 2|71|Anticipated|Stichting Hemato-Oncologie voor Volwassenen Nederland||1|||f||||f||||||||||2017-10-11 00:09:26.951871|2017-10-11 00:09:26.951871
NCT02204228|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-10-13|||September 2014||2014-09-01|October 2016|2016-10-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Observational|||TITAN™ Reverse Shoulder System|A Post-market Clinical Follow-up Study of the TITAN™ Reverse Shoulder System Used in Primary or Revision Total Shoulder Arthroplasty|Recruiting||N/A|150|Anticipated|Integra LifeSciences Corporation|||1||f||||f||||||||||2017-10-11 00:09:27.061425|2017-10-11 00:09:27.061425
NCT02204215|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-07-28|||January 2014||2014-01-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|EA-ICUAW||Electric Acupuncture for ICU-acquired Weakness in Mechanical Ventilation Patients|Phase 1 Study of Electric Acupuncture for ICU-acquired Weakness in Mechanical Ventilation Patients With Sepsis/Multiple Organ Dysfunction Syndrome|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Jiangsu Province Hospital of Traditional Chinese Medicine||1|||f||||t||||||||||2017-10-11 00:09:27.161209|2017-10-11 00:09:27.161209
NCT02203279|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-09-26|||July 2014||2014-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of Three Hard Relining Materials in Complete Dentures|Evaluation of Three Hard Relining Materials in Complete Dentures: An In-vivo Study|Completed||N/A|36|Actual|Damascus University||3|||f||||t||||||||||2017-10-11 00:09:42.597922|2017-10-11 00:09:42.597922
NCT02204202|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-11-02|||February 2014||2014-02-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||PET Assessment of Acute Lung Transplant Rejection|Positron Emission Tomography Assessment of Acute Lung Transplant Rejection|Recruiting||Phase 1|60|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples Without DNA|"     cells from bronchoalveolar lavage specimen; tissues from biopsy specimens   "|||2017-10-11 00:09:27.258489|2017-10-11 00:09:27.258489
NCT02204189|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-29|||March 2014||2014-03-01|July 2014|2014-07-01|February 2017|Anticipated|2017-02-01|October 2014|Anticipated|2014-10-01||Interventional|||The Clinical Study of Acute Pancreatitis Treated by TongFuSan|The Clinical Study of Acute Pancreatitis With Gastrointestinal Dysfunction Treated by TongFuSan for External Application on ShenQue Acupoint|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Beijing Friendship Hospital||1|||f||||t||||||||||2017-10-11 00:09:27.369514|2017-10-11 00:09:27.369514
NCT02204176|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-11-01|||August 2013||2013-08-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|EBYA||Exercise Behavior Among Young Adults Study|Exercise Behavior Among Young Adults Study|Completed||N/A|221|Actual|Wayne State University||3|||f||||t||||||||||2017-10-11 00:09:27.604205|2017-10-11 00:09:27.604205
NCT02204163|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-09-11|||June 2014||2014-06-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome|A Phase III, Multi-center, Randomized, Comparative, Parallel, Open Study to Assess the Efficacy and Safety After Treatment of Eutropin® Inj. Compared to Genotropin® in Infants/Toddlers With Prader-Willi Syndrome|Unknown status|Recruiting|Phase 3|34|Anticipated|LG Life Sciences||2|||f||||||||||||||2017-10-11 00:09:27.748373|2017-10-11 00:09:27.748373
NCT02204150|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-10-26|||February 2012||2012-02-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study to Image the Esophagus Using the OFDI Capsule|Pilot Study for Imaging of the Esophagus Using an OFDI Capsule|Recruiting||Phase 1|54|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||Undecided||2017-10-11 00:09:27.867902|2017-10-11 00:09:27.867902
NCT02204137|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-04-27|||August 2014||2014-08-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Falls Risk Questionnaire in Older Adults With Cancer|Pilot Study of the Falls Risk Questionnaire in Older Adults With Cancer|Completed||N/A|21|Actual|Washington University School of Medicine|||1||f||||f||||||||No||2017-10-11 00:09:27.9864|2017-10-11 00:09:27.9864
NCT02204124|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-09-07|||January 1, 2015|Actual|2015-01-01|September 2017|2017-09-01|August 23, 2017|Actual|2017-08-23|August 23, 2017|Actual|2017-08-23||Interventional|||Whipple Procedure: Standard of Care vs. Thunderbeat|Thunderbeat™ Integrated Bipolar and Ultrasonic Forceps in the Whipple Procedure: A Prospective Registry Trial|Terminated||N/A|44|Actual|Washington University School of Medicine||2||Principal Investigator and Study Sponsor decided to terminate the study early|f||||t|f|t|f|f|f|||||2017-10-11 00:09:28.128498|2017-10-11 00:09:28.128498
NCT02204111|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-09-04|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|YonLife||Patient Directed Intervention to Improve the Quality of Life for Patients With Soft Tissue Sarcoma|Patient Directed Intervention Towards a Multidimensional Recommendation Guideline to Improve the Quality of Life for Patients With Soft Tissue Sarcoma Under Palliative Treatment With Trabectedin|Completed||N/A|77|Anticipated|GWT-TUD GmbH|||2||f||||f||||||||||2017-10-11 00:09:28.289839|2017-10-11 00:09:28.289839
NCT02204098|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-07-17|||January 7, 2015|Actual|2015-01-07|July 2017|2017-07-01|October 31, 2024|Anticipated|2024-10-31|February 28, 2019|Anticipated|2019-02-28||Interventional|||Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy|A Phase 1B Randomized Clinical Trial to Evaluate the Safety and Immune Response to a Mammaglobin-A DNA Vaccine in Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy|Recruiting||Phase 1|60|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||||2017-10-11 00:09:28.476247|2017-10-11 00:09:28.476247
NCT02204085|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-02-23|||September 2014||2014-09-01|February 2017|2017-02-01|July 2021|Anticipated|2021-07-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|53|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 00:09:28.716453|2017-10-11 00:09:28.716453
NCT02204072|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-09-19|||November 11, 2014|Actual|2014-11-11|September 2017|2017-09-01|April 27, 2018|Anticipated|2018-04-27|September 25, 2017|Anticipated|2017-09-25||Interventional|||BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)|A Phase Ib/II, Multicentre, Open Label, Randomized Study of BI 836845 in Combination With Enzalutamide, Versus Enzalutamide Alone, in Metastatic Castration-Resistant Prostate Cancer (CRPC) Following Disease Progression on Docetaxel-Based Chemotherapy and Abiraterone|Recruiting||Phase 1|121|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:09:28.88603|2017-10-11 00:09:28.88603
NCT02204059|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-29|||December 1999||1999-12-01|July 2014|2014-07-01||||February 2001|Actual|2001-02-01||Interventional|||Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer|A Phase I Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4, in Patients With Non-small Cell Lung Cancer|Completed||Phase 1|9|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:09:29.099923|2017-10-11 00:09:29.099923
NCT02204046|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-29|||January 2000||2000-01-01|July 2014|2014-07-01||||February 2001|Actual|2001-02-01||Interventional|||Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast|A Phase I Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4, in Patients With Adenocarcinoma of the Breast|Completed||Phase 1|9|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:09:29.217889|2017-10-11 00:09:29.217889
NCT02204033|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-29|||March 1999||1999-03-01|July 2014|2014-07-01||||June 2001|Actual|2001-06-01||Interventional|||Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck Cancer|A Phase I Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody BIWA 4, in Patients With Head and Neck Cancer|Completed||Phase 1|33|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:09:29.318564|2017-10-11 00:09:29.318564
NCT02204020|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-07-06|||April 2015||2015-04-01|July 2016|2016-07-01||||August 2018|Anticipated|2018-08-01||Interventional|UPCI 13-165||Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS|Phase II Study of 5-azacytidine Maintenance After Allogeneic Hematopoietic Cell Transplantation for High-risk Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)|Withdrawn||Phase 2|0|Actual|University of Pittsburgh||1||Lack of interest with investigators - no subjects enrolled|f||||t||||||||||2017-10-11 00:09:29.449295|2017-10-11 00:09:29.449295
NCT02204007|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-02-15|2016-12-20||June 2014||2014-06-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Real Time 3D Imaging and Surrogate Bone Model|Comparison of Acetabular Shell Position Using 3D Planning vs. Standard Preoperative Planning: A Randomized Clinical Trial|Terminated||N/A|36|Actual|The Cleveland Clinic|Early termination leading to small numbers of subjects analyzed|2||Small number of subjects|f||||t||||||||No||2017-10-11 00:09:29.588585|2017-10-11 00:09:29.588585
NCT02203994|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-01-25|||July 2014|Actual|2014-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|ESWT||Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Spasticity in Persons With Spinal Cord Injury|The Effect of Extracorporeal Shock Wave Therapy (ESWT) on Lower Limb Spasticity in Persons With an Incomplete Spinal Cord Injury|Completed||N/A|20|Actual|Swiss Paraplegic Centre Nottwil||1|||f||||t||||||||||2017-10-11 00:09:29.92397|2017-10-11 00:09:29.92397
NCT02203981|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-10-21|||January 2014||2014-01-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational|||TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000|TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000|Completed||N/A|12|Actual|Topcon Medical Systems, Inc.|||1||f||||f||||||||||2017-10-11 00:09:30.057593|2017-10-11 00:09:30.057593
NCT02203968|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-04-13|||October 2014||2014-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|FiiRST||Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)|Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST): a Randomized Feasibility Trial|Completed||Phase 1/Phase 2|50|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-11 00:09:30.183564|2017-10-11 00:09:30.183564
NCT02203955|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-23|||August 2014||2014-08-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Sc-FOS for Pouchitis Prevention|Prevention of Pouchitis With Short-Chain Fructooligosaccharide Therapy, A Double-Blind, Placebo-Controlled Trial|Active, not recruiting||Phase 1|15|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:09:30.317383|2017-10-11 00:09:30.317383
NCT02203942|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-01-26|||July 2014||2014-07-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|VAST||Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis|Comparing NAAT Testing to Standard Methods in Diagnosis of Vaginal Infections in the General Gynecology and Vulvovaginal Referral Offices.|Completed||N/A|300|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-10-11 00:09:30.398443|2017-10-11 00:09:30.398443
NCT02203929|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-02-10|||June 2014||2014-06-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Preoperative Progression of Macular Holes|Preoperative Progression of Macular Holes Using Optical Coherence Tomography|Completed||N/A|37|Actual|Glostrup University Hospital, Copenhagen|||2||f||||f||||||||||2017-10-11 00:09:30.491398|2017-10-11 00:09:30.491398
NCT02203916|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-10-25|2016-10-25||July 2014||2014-07-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional||Safety Analysis Set (SAS) included all participants who received at least 1 dose of double-blind study drug and were randomized only once.|Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-491 in Korean Subjects With Essential Hypertension|Completed||Phase 3|328|Actual|Takeda||3|||f||||f||||||||||2017-10-11 00:09:30.589232|2017-10-11 00:09:30.589232
NCT02203903|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-11-21|||January 2015||2015-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies|Multi-institutional Prospective Phase I Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies|Recruiting||Phase 1|36|Anticipated|Children's Research Institute||1|||f||||t||||||||||2017-10-11 00:09:31.420838|2017-10-11 00:09:31.420838
NCT02203890|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-07-28|||June 2012||2012-06-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Normative State and Variation in Growth, Hematology, Hydration, Oxidation, Infection, Inflammation, Guatemalan Children|Study on the Normative State and Inter- and Intra-individual Variation in Growth, Hematology, Hydration and Markers of Oxidation, Infection and Inflammation in Preschool Children With a Similar Dietary Intake|Completed||N/A|91|Actual|Center for Studies of Sensory Impairment, Aging and Metabolism|||1||f||||f||||||Samples Without DNA|"     Urine, feces, saliva and blood   "|||2017-10-11 00:09:31.544747|2017-10-11 00:09:31.544747
NCT02203877|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2016-08-11|||August 2013||2013-08-01|July 2014|2014-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of Lactobacillus Fermentum CECT5716 on the Incidence of Mastitis|Nutritional Intervention Study, Randomized, Double-blind, Parallel Group to Evaluate the Effect of Lactobacillus Fermentum CECT5716 Consumption on the Incidence of Mastitis|Completed||N/A|625|Actual|Biosearch S.A.||2|||f||||f||||||||No||2017-10-11 00:09:31.747769|2017-10-11 00:09:31.747769
NCT02203864|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-30|||August 1998||1998-08-01|July 2014|2014-07-01||||February 2001|Actual|2001-02-01||Interventional|||Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma|An Open-label, Multicenter, Controlled, Combined Parallel Group and Dose Escalation (0, 0.12, 1.2, 12.0 µg IL-2/10**8 Cells/24 Hours) Study, to Evaluate the Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 Containing Melanoma Cells Transfected With the Human IL-2 Gene in Patients With Advanced Malignant Melanoma|Completed||Phase 1|49|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:09:31.834923|2017-10-11 00:09:31.834923
NCT02203851|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-10-05|||November 20, 2014|Actual|2014-11-20|October 2017|2017-10-01|August 15, 2018|Anticipated|2018-08-15|August 15, 2018|Anticipated|2018-08-15||Interventional|||Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis|An Open Label Extension Trial Assessing the Safety and Efficacy of BI 655066/ ABBV-066/Risankizumab Administered Subcutaneously in Patients With Moderate to Severe Chronic Plaque Psoriasis|Active, not recruiting||Phase 2|104|Anticipated|AbbVie||1|||f||||t||||||||||2017-10-11 00:09:31.9495|2017-10-11 00:09:31.9495
NCT02203838|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-01-30||2017-01-30|June 2014||2014-06-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia|An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia|Completed||Phase 3|500|Actual|Indivior Inc.||1|||f||||f||||||||No||2017-10-11 00:09:32.13476|2017-10-11 00:09:32.13476
NCT02203825|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-12-22|||March 2015||2015-03-01|December 2016|2016-12-01||||March 2017|Anticipated|2017-03-01||Interventional|||Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands|A Phase 1 Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands in Patients With Acute Myeloid Leukemia (AML)/Advanced Myelodysplastic Syndrome (MDS-RAEB) and Multiple Myeloma.|Active, not recruiting||Phase 1|12|Actual|Celyad (formerly named Cardio3 BioSciences)||1|||f||||t||||||||||2017-10-11 00:09:32.342048|2017-10-11 00:09:32.342048
NCT02203812|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-07-26|||January 2015||2015-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Probiotic Lozenge on Gingivitis and Periodontitis|The Effect of Probiotic Lozenge Administration on Gingivitis and on Mild & Moderate Periodontitis: A Randomized Controlled Clinical Trial.|Completed||Phase 3|32|Actual|CD Pharma India Pvt. Ltd.||2|||f||||f||||||||||2017-10-11 00:09:32.448727|2017-10-11 00:09:32.448727
NCT02203799|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-07-26|||November 13, 2014|Actual|2014-11-13|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|Peanut Flour||Peanut Oral Immunotherapy in Children With Peanut Allergy|IMMUNE RESPONSES IN PEANUT ALLERGIC SUBJECTS UNDERGOING PEANUT ORAL IMMUNOTHERAPY|Enrolling by invitation||Phase 1|30|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 00:09:34.18858|2017-10-11 00:09:34.18858
NCT02203786|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-04-11|2016-01-20||September 2009||2009-09-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|HFDEX|All participants were above 18 years of age.|D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement|Comparative Effects of a D2 and Mixed D1-D2 Dopamine Antagonist on Gambling and Amphetamine Reinforcement in Pathological Gamblers and Healthy Controls|Completed||Phase 2|60|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-11 00:09:34.306864|2017-10-11 00:09:34.306864
NCT02203773|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-07-10|||November 14, 2014||2014-11-14|July 2017|2017-07-01|March 26, 2020|Anticipated|2020-03-26|March 29, 2018|Anticipated|2018-03-29||Interventional|||Phase 1b Acute Myelogenous Leukemia (AML) Study With ABT-199 + Decitabine or Azacitidine (Chemo Combo)|A Phase 1b Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine in Treatment-Naive Subjects With Acute Myelogenous Leukemia Who Are ≥ 60 Years of Age and Who Are Not Eligible for Standard Induction Therapy|Active, not recruiting||Phase 1|260|Anticipated|AbbVie||3|||f||||f||||||||||2017-10-11 00:09:35.398397|2017-10-11 00:09:35.398397
NCT02203760|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-07-28|||September 2013||2013-09-01|July 2014|2014-07-01|June 2016|Anticipated|2016-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -|Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -|Unknown status|Recruiting|Phase 2|107|Anticipated|University Medicine Greifswald||2|||f||||f||||||||||2017-10-11 00:09:35.687449|2017-10-11 00:09:35.687449
NCT02203747|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-11-18|2015-09-30||August 2014||2014-08-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Observational|||Patient Perception of Visual Distortions||Completed||N/A|79|Actual|Abbott Medical Optics|||2||f||||f||||||||||2017-10-11 00:09:35.916425|2017-10-11 00:09:35.916425
NCT02203734|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-10-08|||February 2012||2012-02-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Massage To Improve Uterine Artery Blood Flow|Massage to Reduce Intrauterine Artery Resistance, Prematurity and Low Birthweight|Completed||N/A|24|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 00:09:36.914073|2017-10-11 00:09:36.914073
NCT02203721|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-11-15|2016-09-28||September 2014||2014-09-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Clinical Investigation of a New Intraocular Lens|Clinical Investigation of the Tecnis Symfony Extended Range of Vision IOL, Model ZXR00|Completed||N/A|324|Actual|Abbott Medical Optics||2|||f||||f||||||||No||2017-10-11 00:09:37.059784|2017-10-11 00:09:37.059784
NCT02203708|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-07-28|||July 2012||2012-07-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|PAM-B||Supportive Program for Mother With BPD|"Effect on Relationship of a Brief Preventive Program: Pragmatic Pilot Randomized Controlled Trial. - Supportive Program for Mother With BPD"|Completed||N/A|10|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 00:09:37.56854|2017-10-11 00:09:37.56854
NCT02203695|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-09-01|||August 2014||2014-08-01|September 2016|2016-09-01|August 2025|Anticipated|2025-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy|Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men With High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy|Recruiting||Phase 2|122|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:09:37.705218|2017-10-11 00:09:37.705218
NCT02203682|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-28|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Doxycycline Treatment in Mild Graves' Orbitopathy|The Effect of Subantimicrobial Dose Doxycycline in Mild Graves' Orbitopathy|Unknown status|Recruiting|Phase 2|20|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:09:37.895068|2017-10-11 00:09:37.895068
NCT02203669|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-28|||July 2014||2014-07-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Occupational/Physical Therapy to Reduce Morbidity Post-Operative Bilateral Breast Reconstruction|The Use of Occupational/Physical Therapy to Reduce Upper Extremity Morbidity Post-Operative Bilateral Breast Reconstruction|Unknown status|Enrolling by invitation|N/A|75|Anticipated|University of Tennessee||3|||f||||f||||||||||2017-10-11 00:09:38.032701|2017-10-11 00:09:38.032701
NCT02203656|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-12-08|||October 2013||2013-10-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|PACE||Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults|Feasibility Study of Post-hospitalization Interventions to Improve Physical Function|Active, not recruiting||Phase 1|113|Actual|The University of Texas Medical Branch, Galveston||5|||f||||f||||||||No|No. This is a small Phase 1 pre-pilot study. Risk of loss of confidentiality|2017-10-11 00:09:38.141799|2017-10-11 00:09:38.141799
NCT02203643|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-09-05|||February 2015||2015-02-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2016|Actual|2016-10-01||Interventional|FORTE||Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.|A MULTICENTER, RANDOMIZED, OPEN LABEL PHASE II STUDY OF CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CCyd) as Pre Transplant INDUCTION and Post Transplant Consolidation or CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (CRd) as Pre Transplant INDUCTION and Post Transplant Consolidation or Continuous Treatment With CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (12 Cycles) Without Transplant, All Followed by MAINTENANCE With LENALIDOMIDE (R) Versus LENALIDOMIDE AND CARFILZOMIB (CR) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS ELEGIBLE FOR AUTOLOGOUS TRANSPLANT|Active, not recruiting||Phase 2|477|Actual|University of Turin, Italy||3|||f||||t||||||||||2017-10-11 00:09:38.279751|2017-10-11 00:09:38.279751
NCT02203630|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-08-13|||August 2014||2014-08-01|August 2014|2014-08-01||||June 2016|Anticipated|2016-06-01||Interventional|||A Pilot Trial of Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients|A Randomized Controlled Pilot Trial of Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients|Unknown status|Recruiting|Phase 4|75|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-10-11 00:09:38.403774|2017-10-11 00:09:38.403774
NCT02203617|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-04-13|||April 2005||2005-04-01|April 2017|2017-04-01|July 2010|Actual|2010-07-01|June 2009|Actual|2009-06-01||Interventional|||Using Baby Books to Promote Maternal and Child Health|Using Baby Books to Promote Maternal and Child Health|Completed||N/A|198|Actual|Vanderbilt University||3|||f||||f||||||||||2017-10-11 00:09:38.580533|2017-10-11 00:09:38.580533
NCT02203604|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-09-21|||November 2014||2014-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery|A Phase II Single Arm Study of High-Dose IL-2 and Ipilimumab in Patients With Unresectable Stage III and Stage IV Melanoma|Active, not recruiting||Phase 2|82|Anticipated|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-10-11 00:09:38.879238|2017-10-11 00:09:38.879238
NCT02203591|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2015-05-13||2015-03-25|July 2014||2014-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||In Vivo Patient Preoperative Preps Efficacy Study||Completed||Phase 3|1035|Actual|3M||4|||f||||||||||||||2017-10-11 00:09:39.055587|2017-10-11 00:09:39.055587
NCT02203578|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-02-13|2017-02-13||November 2014||2014-11-01|February 2017|2017-02-01|June 14, 2016|Actual|2016-06-14|June 14, 2016|Actual|2016-06-14||Interventional||Participants > 18 years old with steroid (or IST) refractory aGVHD or cGVHD were enrolled.|Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease|A Pilot Study of Romidepsin for Therapy of Graft-versus-Host Disease|Terminated||N/A|1|Actual|Rutgers, The State University of New Jersey||1||slow accrual|f||||f||||||||||2017-10-11 00:09:39.217323|2017-10-11 00:09:39.217323
NCT02203565|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-06-26|2017-05-22||July 2014||2014-07-01|June 2017|2017-06-01|July 7, 2016|Actual|2016-07-07|July 7, 2016|Actual|2016-07-07||Interventional|||Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy|Pilot Study to Investigate the Impact of Hypochlorite in the Prevention of Radiation Dermatitis|Completed||Phase 2|20|Actual|Stanford University||1|||f||||t|t|f||||||||2017-10-11 00:09:39.572864|2017-10-11 00:09:39.572864
NCT02203552|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-08-07|||June 23, 2015|Actual|2015-06-23|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer|Randomized Placebo Controlled Study of Minocycline for Amelioration of Chemotherapy Induced Affective Disorders|Recruiting||N/A|36|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:09:39.801602|2017-10-11 00:09:39.801602
NCT02203539|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-07-01|||July 2014||2014-07-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|EX-Light||The Influence of Light Exposure on Exercise Performance Dependent on Chronotype.|The Influence of Different Light Exposures on Endurance Performance, Handgrip Strength and Reaction Time in Consideration of the Chronotype.|Completed||N/A|74|Actual|University of Basel||3|||f||||t||||||||||2017-10-11 00:09:39.944332|2017-10-11 00:09:39.944332
NCT02203526|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-07-26|||July 24, 2014||2014-07-24|April 14, 2017|2017-04-14|June 15, 2023|Anticipated|2023-06-15|June 15, 2022|Anticipated|2022-06-15||Interventional|||Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma|Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma|Suspended||Phase 1|18|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:09:40.047049|2017-10-11 00:09:40.047049
NCT02203513|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2017-09-21|||July 24, 2014||2014-07-24|September 8, 2017|2017-09-08|June 3, 2019|Anticipated|2019-06-03|June 4, 2018|Anticipated|2018-06-04||Interventional|||A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer|A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) In BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, and High Grade Serous Ovarian Cancer|Recruiting||Phase 2|153|Anticipated|National Institutes of Health Clinical Center (CC)||5|||f||||||||||||||2017-10-11 00:09:40.204233|2017-10-11 00:09:40.204233
NCT02203500|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-08-05|||October 1998||1998-10-01|August 2014|2014-08-01||||January 1999|Actual|1999-01-01||Interventional|||Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy Subjects|Tolerability and Pharmacokinetics of 80 mg Telmisartan and 6 mg Lacidipine Alone and in Combination After 7 Days Treatment. An Open Randomised Three-way Cross-over Trial in Female and Male Healthy Subjects|Completed||Phase 1|26|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:09:40.345755|2017-10-11 00:09:40.345755
NCT02203487|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-29|2014-07-29|||November 1999||1999-11-01|July 2014|2014-07-01||||June 2000|Actual|2000-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male Volunteers|A Double-blind (Within Dose Groups), Randomised, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability and Preliminary Pharmacokinetics of Increasing Repeated Oral Doses (Nine Days Treatment of 5 mg and 10 mg and Eighteen Days Treatment of 25 mg and 40 mg) of BIIF 1149 BS in Healthy Male Volunteers|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:09:40.476657|2017-10-11 00:09:40.476657
NCT02203474|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-08-26|||August 2014||2014-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease|A Randomized, Double-Blind, Double-Dummy, Parallel Group, Dose-Ranging Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), Placebo HFA BAI, and Open-Label SPIRIVA® HandiHaler® (18 mcg) in Patients With Chronic Obstructive Pulmonary Disease|Withdrawn||Phase 2|0|Actual|Teva Pharmaceutical Industries||5|||f||||f||||||||||2017-10-11 00:09:40.571563|2017-10-11 00:09:40.571563
NCT02203461|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-11-04|||July 2014||2014-07-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication|Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication - A Controlled, Mono Center, Three-arm, Randomized Phase I Study.|Completed||Phase 1|30|Actual|Technische Universität München||3|||f||||t||||||||||2017-10-11 00:09:40.666748|2017-10-11 00:09:40.666748
NCT02203448|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-05-22|||May 1, 2014|Actual|2014-05-01|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|||Facet Wedge Post Market Study|A Multi-centre, Prospective, Single-arm Post Market Clinical Follow up Study (PMCF) of the FACET WEDGE Spinal System to Assess Outcomes in Subjects With Chronic Low Back Pain Due to Degenerative Disc Disease (DDD), Facet Joint Disease and/or Pseudo Arthrosis Post Anterior Instrumentation|Active, not recruiting||N/A|50|Actual|Synthes GmbH|||1||f||||t||||||||||2017-10-11 00:09:40.786931|2017-10-11 00:09:40.786931
NCT02203435|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-08-05|||January 2014||2014-01-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||The Patient Characteristics and Mortality of Code Blue Calls|The Characteristics of the Blue-code Calls; Five Years Survey.|Completed||N/A|1050|Actual|Umraniye Education and Research Hospital|||1||f||||t||||||||||2017-10-11 00:09:40.919162|2017-10-11 00:09:40.919162
NCT02203422|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2016-04-18|||July 2014||2014-07-01|July 2014|2014-07-01||||July 2015|Anticipated|2015-07-01||Interventional|||A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）|Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）|Withdrawn||Phase 3|0|Actual|Shandong University||2||No eligible patient was enrolled.|f||||t||||||||||2017-10-11 00:09:41.020911|2017-10-11 00:09:41.020911
NCT02203409|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-07-08|||July 2014||2014-07-01|July 2014|2014-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy|Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy|Unknown status|Recruiting|N/A|30|Anticipated|Southwest Hospital, China|||1||f||||t||||||||||2017-10-11 00:09:41.126963|2017-10-11 00:09:41.126963
NCT02203396|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2016-05-03|||August 2014||2014-08-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|OSP||A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia|A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia|Recruiting||Phase 2|40|Anticipated|Institute of Hematology & Blood Diseases Hospital||1|||f||||t||||||||||2017-10-11 00:09:41.221225|2017-10-11 00:09:41.221225
NCT02203383|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-11-08|||June 2014||2014-06-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||The Effect of CRT on the Hypercapnic Ventilatory Response|Sleep Disordered Breathing in Patients With Implanted Cardiac Devices: Assessment of the Change in Sensitivity to Carbon Dioxide With Cardiac Resynchronization Therapy.|Suspended||N/A|40|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||2|Pending further equipment and staff|f||||t||||||||||2017-10-11 00:09:41.3172|2017-10-11 00:09:41.3172
NCT02203370|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-05-19|||July 2014||2014-07-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|July 2015|Anticipated|2015-07-01||Observational|||Cerebral Oximetry for Carotid EEA||Unknown status|Recruiting|N/A|126|Anticipated|Salzburger Landeskliniken|||1||f||||f||||||Samples Without DNA|"     S100B and NSE blood samples taken twice, before and after the surgical procedure   "|||2017-10-11 00:09:41.400282|2017-10-11 00:09:41.400282
NCT02203357|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-10-27|||March 2014||2014-03-01|July 2014|2014-07-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|||A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults|A Randomized, Opened, Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Young Adults|Unknown status|Recruiting|Phase 4|354|Anticipated|Peking University||3|||f||||||||||||||2017-10-11 00:09:41.493693|2017-10-11 00:09:41.493693
NCT02203344|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-12-24|||August 2014||2014-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||BIS Monitoring to Detect Deep Sedation|Use of Bispectral Index Monitoring as an Alert to Detect Deep Sedation in Mechanical Ventilated Patients: a Prospective Observational Study|Completed||N/A|45|Actual|Capital Medical University|||2||f||||t||||||||||2017-10-11 00:09:41.58989|2017-10-11 00:09:41.58989
NCT02203331|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2017-01-05||2017-01-05|October 2014||2014-10-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Bay98-7196, Dose Finding / POC Study|A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period|Completed||Phase 2|305|Actual|Bayer||6|||f||||f||||||||||2017-10-11 00:09:41.684071|2017-10-11 00:09:41.684071
NCT02203318|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2016-10-31|||July 2014||2014-07-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Observational|||Can the Hypertrophy of Contralateral Testis Predict the Absence of the Non-palpable Testis in the Boys Aged From 6months to 18months of Age ?||Completed||N/A|60|Actual|Yonsei University|||3||f||||f||||||||||2017-10-11 00:09:42.272418|2017-10-11 00:09:42.272418
NCT02203305|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-14|||October 2014||2014-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CI in SSD||Cochlear Implantation in Cases of Single-Sided Deafness|Cochlear Implantation in Cases of Single-Sided Deafness|Active, not recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill||3|||f||||||||||||||2017-10-11 00:09:42.3533|2017-10-11 00:09:42.3533
NCT02203292|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2016-07-28|||August 2014||2014-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TRAHT||Transfusion Requirements After Head Trauma|Transfusion Requirements After Head Trauma|Completed||Phase 2|44|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:09:42.470656|2017-10-11 00:09:42.470656
NCT02203266|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-27|2017-01-31|||February 2014|Actual|2014-02-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Teaching Inhaler Use With the INCA Device in a Community Pharmacy Setting|A Randomised, Parallel-group, Multi-centre Trial Using a Novel INCA Tracker Device to Measure and Monitor Compliance and Technique of Seretide Diskus Inhaler in a Community Pharmacy Setting|Recruiting||N/A|200|Anticipated|Beaumont Hospital||3|||f||||f||||||||||2017-10-11 00:09:42.774965|2017-10-11 00:09:42.774965
NCT02203253|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-08-23|||July 2014||2014-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting|Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting From Highly Emetogenic Chemotherapy: a Randomized, Multicenter, Double-blind, Placebo-controlled Phase III Trial|Completed||Phase 3|642|Actual|China Medical University, China||2|||f||||f||||||||||2017-10-11 00:09:42.884249|2017-10-11 00:09:42.884249
NCT02203240|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2015-07-20|||June 2014||2014-06-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Cocoa and Metabolic Health in Prediabetes|Dietary Cocoa for Inhibition of Metabolic Endotoxemia and Glucose Intolerance|Unknown status|Recruiting|N/A|36|Anticipated|Virginia Polytechnic Institute and State University||2|||f||||f||||||||||2017-10-11 00:09:43.027032|2017-10-11 00:09:43.027032
NCT02203227|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-28|||August 2014||2014-08-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia|Efficacy and Safety Study of Dietary Supplements (BioTurmin, BioTurmin-WD and MaQxan) on Cotinine Level and Oxidative Stress Marker in Chronic Smokers Having Mild to Moderate Hyperlipidemia|Unknown status|Not yet recruiting|N/A|60|Anticipated|Olive Lifesciences Pvt Ltd||4|||f||||t||||||||||2017-10-11 00:09:43.140138|2017-10-11 00:09:43.140138
NCT02203214|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2016-09-12|||August 2013||2013-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|Ligamys||Induced ACL Healing With the Ligamys Technique: a Prospective, Multicenter Observational Case Series|Induced ACL Healing With the Ligamys Technique: a Prospective, Multicenter Observational Case Series|Completed||N/A|110|Actual|Mathys Ltd Bettlach|||1||f||||f||||||||Undecided||2017-10-11 00:09:43.275392|2017-10-11 00:09:43.275392
NCT02203201|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|October 2016|Actual|2016-10-01||Observational|NCWS||Diagnostic Significance of Positive EmA Antibodies in the Duodenal Culture Medium of Not-Celiac Wheat Sensitivity (NCWS)|Diagnostic Significance of Positive Anti-endomysium Antibodies in the Culture Medium of the Intestinal Biopsies in Not-Celiac Wheat Sensitivity (NCWS)|Recruiting||N/A|50|Anticipated|University of Palermo|||2||f||||f||||||||||2017-10-11 00:09:43.387395|2017-10-11 00:09:43.387395
NCT02203188|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-12-18|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|TOYOTA||Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's Syndrome||Completed||N/A|14|Anticipated|University of Waterloo||2|||f||||f||||||||||2017-10-11 00:09:43.512228|2017-10-11 00:09:43.512228
NCT02203175|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-09-23|||April 2011||2011-04-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|VRS||Prevention of Propofol Injection Pain|The Effect of Fentanyl-propofol Mixture on Propofol Injection Pain.|Completed||Phase 2/Phase 3|150|Actual|Yeditepe University Hospital||2|||f||||f||||||||||2017-10-11 00:09:43.615058|2017-10-11 00:09:43.615058
NCT02203162|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-06-24|2016-01-22||July 2014||2014-07-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||adult nonsmokers|Effect of Electronic Cigarette Use on Cough Reflex Sensitivity|Effect of Electronic Cigarette Use on Cough Reflex Sensitivity|Completed||Phase 4|30|Actual|Montefiore Medical Center||1|||f||||f||||||||Yes|data to be shared (published) after study completion.|2017-10-11 00:09:43.74833|2017-10-11 00:09:43.74833
NCT02203149|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-02-24|2016-08-18||August 2014||2014-08-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|October 2015|Actual|2015-10-01||Interventional|||Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058)|A Phase II, Randomized Clinical Trial to Study the Safety, Tolerability, and Efficacy of the Combination Regimen of MK-5172 and MK-8742 in Japanese Subjects With Chronic Hepatitis C and a Phase III, Randomized Placebo-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of the Combination Regimen of MK-5172 and MK-8742 in Japanese Subjects With Chronic Hepatitis C|Completed||Phase 2/Phase 3|399|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:09:44.058893|2017-10-11 00:09:44.058893
NCT02203136|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-07-27|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging|Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     At the time of biopsy, a portion of the fresh human tumor biopsy samples utilized for DNA and     RNA extraction.   "|||2017-10-11 00:09:45.408831|2017-10-11 00:09:45.408831
NCT02203123|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-07-28|||March 2014||2014-03-01|July 2014|2014-07-01||||April 2015|Anticipated|2015-04-01||Interventional|||Ratio of Inferior Vena Cava and Aorta Diameter in Dehydrated Children||Unknown status|Recruiting|N/A|226|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 00:09:45.553476|2017-10-11 00:09:45.553476
NCT02203110|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-07-25|||January 2014||2014-01-01|July 2014|2014-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|SCAHAVAP||The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia|The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia|Unknown status|Recruiting|N/A|150|Anticipated|University Medical Centre Ljubljana|||1||f||||f||||||Samples Without DNA|"     Whole blood, two 7 ml samples   "|||2017-10-11 00:09:45.659023|2017-10-11 00:09:45.659023
NCT02203097|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-03-08|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of Different End-tidal Carbon-dioxide Levels on Cerebral CO2 Vasoreactivity and the Stiffness of Systemic Arteries During Propofol Anesthesia|The Effect of Different End-tidal Carbon-dioxide Levels on Cerebral CO2 Vasoreactivity and the Stiffness of Systemic Arteries During Propofol Anesthesia|Completed||Phase 4|25|Actual|University of Debrecen||1|||f||||t||||||||||2017-10-11 00:09:45.759546|2017-10-11 00:09:45.759546
NCT02203084|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-09-19|||September 1, 2014||2014-09-01|September 2017|2017-09-01|August 1, 2017|Actual|2017-08-01|June 1, 2017|Actual|2017-06-01||Observational|||Social Determinants in Chronic Disease in British Columbia|The Influence of Social Determinants and Access to Health Care on the Outcome of Children With Chronic Health Problems in British Columbia|Completed||N/A|300|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 00:09:45.868267|2017-10-11 00:09:45.868267
NCT02203071|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-07-12|||June 2014||2014-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Comparison of BioCartilage Versus Marrow Stimulating Procedure for Cartilage Defects of the Knee|Comparison of BioCartilage Versus Marrow Stimulating Procedure for Cartilage Defects of the Knee|Active, not recruiting||N/A|25|Actual|University of Missouri-Columbia|||2||f||||t||||||||||2017-10-11 00:09:45.994737|2017-10-11 00:09:45.994737
NCT02203058|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-07-25|||March 2012||2012-03-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||Pursed-lips Breathing and Dynamic Hyperinflation|Pursed-lips Breathing Reduces Reduces Dynamic Hyperinflation Induced by Activities of Daily Living Test in Patients With COPD|Completed||N/A|25|Actual|University of the State of Santa Catarina||2|||f||||f||||||||||2017-10-11 00:09:46.082114|2017-10-11 00:09:46.082114
NCT02203045|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-05-13|||October 2012||2012-10-01|October 2014|2014-10-01||||August 2014|Actual|2014-08-01||Interventional|||Outcomes Following Tourniquet and Non-Tourniquet Assisted Total Knee Arthroplasty|Outcomes Following Tourniquet and Non-Tourniquet Assisted Total Knee Arthroplasty|Completed||N/A|28|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 00:09:46.32816|2017-10-11 00:09:46.32816
NCT02203032|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-08-11|2017-06-14|2016-07-12|October 7, 2014|Actual|2014-10-07|August 2017|2017-08-01|May 24, 2016|Actual|2016-05-24|December 25, 2015|Actual|2015-12-25||Interventional|NAVIGATE|Baseline analysis included all participants who were enrolled at Week 0 and received at least 1 dose of study agent administration.|A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab|A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab|Completed||Phase 3|872|Actual|Janssen Research & Development, LLC||3|||f||||t|t|f||||||||2017-10-11 00:09:46.480346|2017-10-11 00:09:46.480346
NCT02203006|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-08-25|||February 2011||2011-02-01|August 2016|2016-08-01|August 2028|Anticipated|2028-08-01|February 2028|Anticipated|2028-02-01||Interventional|OVIHD||HIV Patients Cohort|Constitution of an Open Monocentric Cohort of HIV Infected Patients|Recruiting||N/A|764|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:09:48.004447|2017-10-11 00:09:48.004447
NCT02202993|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-03-30|||August 2014||2014-08-01|March 2017|2017-03-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM|TAU-2014-1: Phase I Trial of Mibefradil Dihydrochloride With Hypofractionated Re-Irradiation Therapy in Treating Patients With Recurrent Glioblastoma Multiforme (GBM)|Completed||Phase 1|24|Anticipated|Cavion LLC||1|||f||||t||||||||||2017-10-11 00:09:48.136387|2017-10-11 00:09:48.136387
NCT02202967|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2016-01-07|||January 2016||2016-01-01|January 2016|2016-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|MASTERS||Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs|Misoprostol for the Healing of Small Bowel Ulceration in Patients With Obscure Blood Loss While Taking Low-dose Aspirin or Nonsteroidal Antiinflammatory Drugs [MASTERS Trial]|Recruiting||Phase 3|104|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||t||||||||||2017-10-11 00:09:48.447446|2017-10-11 00:09:48.447446
NCT02202954|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-06-19|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|June 2017|Actual|2017-06-01||Interventional|NEURORESTORE||Comparison of Two Rehabilitation Strategies in Patients With Hemiparesis One Year or More After Stroke|Comparison of Two Rehabilitation Strategies in Patients With Hemiparesis One Year or More After Stroke. Efficacy and Cost After One Year Treatment. A Randomized, Controlled, Multicenter, Single Blind Study|Active, not recruiting||N/A|124|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:09:48.572671|2017-10-11 00:09:48.572671
NCT02202941|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-10-16|||August 2014||2014-08-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|PRODA||Procalcitonin-guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients|Effect of Procalcitonin-guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients in Korea|Unknown status|Recruiting|N/A|50|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:09:48.687104|2017-10-11 00:09:48.687104
NCT02202928|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-12-23|||July 2014||2014-07-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer|Phase 2 Study of Autologous Tumor Lysate-pulsed DC-CIK Cell in Colorectal Cancer After Surgery|Active, not recruiting||Phase 2|60|Anticipated|Shenzhen Hornetcorn Bio-technology Company, LTD||2|||f||||f||||||||||2017-10-11 00:09:48.818124|2017-10-11 00:09:48.818124
NCT02202915|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-04-24|||September 2014||2014-09-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||CBT for Pediatric OCD: Community Training Pilot|CBT for Pediatric OCD: Community Training Pilot|Active, not recruiting||N/A|46|Actual|Rhode Island Hospital||1|||f||||t||||||||||2017-10-11 00:09:48.93057|2017-10-11 00:09:48.93057
NCT02202902|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-09-28|||June 2014||2014-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CORTICOEUR||Cardiac Steatosis in Cushing's Syndrome|Evaluation of Cardiac Steatosis in Cushing's Syndrome. A 1H-Magnetic Resonance Spectroscopy Study|Recruiting||N/A|60|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 00:09:49.004266|2017-10-11 00:09:49.004266
NCT02202889|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-25|||September 2000||2000-09-01|July 2014|2014-07-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Improving Bone Health in Adolescence Through Targeted Behavioral Intervention|Improving Bone Health in Adolescence Through Targeted Behavioral Intervention|Completed||N/A|848|Actual|Purdue University||1|||f||||f||||||||||2017-10-11 00:09:49.114228|2017-10-11 00:09:49.114228
NCT02202876|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-05-10|||November 2014||2014-11-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|Redoxy||Redox Imbalance and the Development of Cystic Fibrosis Diabetes|Redox Imbalance and the Development of Cystic Fibrosis Diabetes|Recruiting||N/A|98|Anticipated|Emory University||4|||f||||f||||||||No||2017-10-11 00:09:49.228407|2017-10-11 00:09:49.228407
NCT02202863|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-25|||April 2013||2013-04-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional|||Effects of Wine Grape Pomace Flour Used as a Dietary Supplement on Metabolic Syndrome Components|Study on the Effects of Wine Grape Pomace Flour, Used as a Dietary Supplement to Increase the Intake of Dietary Fiber and Antioxidants in Human, on Components of Metabolic Syndrome, Plasma Antioxidants, Oxidative Stress Markers and Inflammatory Markers|Completed||N/A|47|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 00:09:49.32874|2017-10-11 00:09:49.32874
NCT02202850|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-06-05|||August 12, 2014|Actual|2014-08-12|June 2017|2017-06-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Observational|REACH AS||Defining Remission With Etanercept in AS in Real Life Clinical Practice|Defining Which Remission Criterion At Month 6 Predicts Remission At Month 12 In A Real Life Clinical Practice, In A Cohort Of Ankylosing Spondylitis Patients Treated With Etanercept (Enbrel (Registered))|Completed||N/A|76|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 00:09:49.426136|2017-10-11 00:09:49.426136
NCT02202837|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-05-24|||August 12, 2014|Actual|2014-08-12|May 2017|2017-05-01|April 24, 2017|Actual|2017-04-24|April 24, 2017|Actual|2017-04-24||Observational|REACH RA||Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice|Defining Which Remission Criterion At Month 6 Predicts Remission At Month 12 In A Real Life Clinical Practice, In A Cohort Of Rheumatoid Arthritis Patients Treated With Etanercept (Enbrel (Registered))|Completed||N/A|135|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 00:09:49.590656|2017-10-11 00:09:49.590656
NCT02202824|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2015-11-29|||July 2014||2014-07-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Measuring Beliefs and Norms About Violence Against Women|Measuring Beliefs and Norms About Violence Against Women in Rural Uganda: A Randomized Controlled Trial|Completed||N/A|1557|Anticipated|Massachusetts General Hospital||3|||f||||f||||||||||2017-10-11 00:09:49.744768|2017-10-11 00:09:49.744768
NCT02202811|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-07-29|||August 2014||2014-08-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Circadian Rhythms and Cardiovascular Risk|Circadian Rhythms and Cardiovascular Risk|Recruiting||N/A|36|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 00:09:49.82667|2017-10-11 00:09:49.82667
NCT02202798|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-02-03|||November 2013||2013-11-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||New Devices to Measure the Intracuff Pressure||Completed||N/A|400|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:09:50.098787|2017-10-11 00:09:50.098787
NCT02202785|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-04-06|2017-01-13||July 2, 2014||2014-07-02|April 2017|2017-04-01|January 15, 2016|Actual|2016-01-15|January 15, 2016|Actual|2016-01-15||Interventional||Safety population included all participants who received any amount of MLN0264.|A Study of MLN0264 in Patients With Pancreatic Cancer|A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)|Terminated||Phase 2|43|Actual|Takeda||1||Business Decision, No Safety or Efficacy Concerns|f||||f||||||||||2017-10-11 00:09:50.218703|2017-10-11 00:09:50.218703
NCT02202772|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-02-17|||December 2014||2014-12-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CGC||Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder|A Phase I Trial for the Use of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment of BCG-Refractory Non-muscle Invasive Urothelial Carcinoma of the Bladder Cancer|Recruiting||Phase 1|24|Anticipated|Columbia University||5|||f||||t|t|f||||||Undecided||2017-10-11 00:09:51.579836|2017-10-11 00:09:51.579836
NCT02202759|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-04-06|2017-01-13||August 4, 2014|Actual|2014-08-04|April 2017|2017-04-01|January 15, 2016|Actual|2016-01-15|January 15, 2016|Actual|2016-01-15||Interventional||Safety population included all participants who received any amount of MLN0264.|A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction|A Phase 2 Trial of MLN0264 in Previously Treated Patients With Metastatic or Recurrent Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C (GCC)|Terminated||Phase 2|38|Actual|Takeda||1||Business Decision, No Safety or Efficacy Concerns|f||||f||||||||||2017-10-11 00:09:51.779576|2017-10-11 00:09:51.779576
NCT02202746|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-11-11|||July 2014||2014-07-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer|A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral Lucitanib in Patients With FGF Aberrant Metastatic Breast Cancer|Active, not recruiting||Phase 2|178|Actual|Clovis Oncology, Inc.||2|||f||||t||||||||||2017-10-11 00:09:53.270012|2017-10-11 00:09:53.270012
NCT02202733|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-07-13|||April 2014||2014-04-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Skill-based Cooking Intervention to Reduce Eating Out|A Caretaker Cooking Skills Intervention to Reduce Eating Out|Completed||N/A|33|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 00:09:53.436407|2017-10-11 00:09:53.436407
NCT02202720|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2014-11-25|||August 2014||2014-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|SEVORASS||Evaluation of Richmond Agitation Sedation Scale According to Alveolar Concentration of Sevoflurane During a Sedation With Sevoflurane in ICU Patients|Evaluation of Richmond Agitation Sedation Scale According to Alveolar Concentration of Sevoflurane During a Sedation With Sevoflurane in ICU Patients|Completed||Phase 2|30|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 00:09:53.614135|2017-10-11 00:09:53.614135
NCT02202707|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-08-18|||May 2014||2014-05-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Vasomotor Symptoms and Cardiovascular Control|Vasomotor Symptoms and Cardiovascular Control|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center||1||No funding obtained to conduct study|f||||||||||||||2017-10-11 00:09:53.691561|2017-10-11 00:09:53.691561
NCT02202694|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-01-13|||March 2012||2012-03-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Culturally Adapted Cognitive Behavior Therapy for Psychosis in Pakistan|Feasibility Study of Culturally Adapted Cognitive Behavior Therapy for Psychosis in Pakistan|Completed||N/A|36|Actual|Pakistan Institute of Learning and Living||2|||f||||f||||||||||2017-10-11 00:09:53.768934|2017-10-11 00:09:53.768934
NCT02202681|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-10-27|||August 2013||2013-08-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule|Pilot Study for Imaging of the Duodenum Using an OFDI Capsule|Recruiting||Phase 1|24|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-11 00:09:53.854861|2017-10-11 00:09:53.854861
NCT02202668|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-04-17|||September 2014|Actual|2014-09-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers|Transcutaneous Raman Spectroscope Analyses of Diabetic Foot Ulcers|Terminated||N/A|5|Actual|University of Michigan||1||TRS probe performance does not meet primary outcome data requirements|f||||f||||||||||2017-10-11 00:09:53.936908|2017-10-11 00:09:53.936908
NCT02202655|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-28|||May 2014||2014-05-01|July 2014|2014-07-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Observational|NSCLC||Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer|Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer|Unknown status|Recruiting|N/A|50|Anticipated|Beijing Chao Yang Hospital|||1||f||||t||||||||||2017-10-11 00:09:54.0103|2017-10-11 00:09:54.0103
NCT02202642|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2014-07-24|||January 2012||2012-01-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Improvement of Limbal Epithelial Culture Technique by Using Collagenase to Isolate Limbal Stem Cells|The Improvement of Limbal Epithelial Culture Technique for the Treatment of Unilateral Limbal Insufficiency by Using Collagenase to Isolate Limbal Stem Cells|Unknown status|Recruiting|Phase 1|10|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:09:54.093595|2017-10-11 00:09:54.093595
NCT02202629|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-28|||July 2014||2014-07-01|July 2014|2014-07-01||||December 2014|Anticipated|2014-12-01||Interventional|CEOPTB||Plant Based Extracts and Cognition|The Effects of Different Combinations of Plant Based Extracts on Cognitive Function and Cerebral Blood Flow in Humans|Unknown status|Not yet recruiting|N/A|32|Anticipated|PepsiCo Global R&D||4|||f||||f||||||||||2017-10-11 00:09:54.190129|2017-10-11 00:09:54.190129
NCT02202616|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-05-17|||August 27, 2014|Actual|2014-08-27|May 2017|2017-05-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|POWER||Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)|Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)|Completed||Phase 4|401|Actual|Novartis||1|||f||||t|f|f||||||||2017-10-11 00:09:54.276473|2017-10-11 00:09:54.276473
NCT02202603|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-10-06|||July 2011||2011-07-01|October 2015|2015-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects|A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects|Completed||Phase 1|42|Actual|Entera Bio Ltd.||13|||f||||t||||||||||2017-10-11 00:09:54.357276|2017-10-11 00:09:54.357276
NCT02202590|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-07-11|||October 2013||2013-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus|Pilot Study to Image the Esophagus Using Spectrally Encoded Confocal Microscopy (SECM)|Recruiting||Phase 1|72|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:09:54.455729|2017-10-11 00:09:54.455729
NCT02202577|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-07-26|||March 2014||2014-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CAPICA||Chlorhexidine-Alcohol Versus Povidone-Iodine for Cesarean Antisepsis|Chlorhexidine-Alcohol Versus Povidone-Iodine for Surgical Site Antisepsis Prior to Cesarean Delivery|Completed||N/A|932|Actual|Case Western Reserve University||2|||f||||f||||||||Undecided||2017-10-11 00:09:54.554481|2017-10-11 00:09:54.554481
NCT02202564|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2014-07-28|||October 2006||2006-10-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|October 2011|Actual|2011-10-01||Interventional|||Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma||Completed||Phase 2|81|Actual|Huazhong University of Science and Technology||2|||f||||||||||||||2017-10-11 00:09:54.642642|2017-10-11 00:09:54.642642
NCT02202538|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-06-26|2016-10-26||August 2014||2014-08-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Indego||Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).|Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).|Completed||N/A|53|Actual|Parker Hannifin Corporation||1|||f||||t||||||||||2017-10-11 00:09:56.710521|2017-10-11 00:09:56.710521
NCT02202525|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-07-28|||January 2001||2001-01-01|July 2014|2014-07-01||||March 2002|Actual|2002-03-01||Observational|||Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension|Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy|Completed||N/A|2148|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:09:57.077994|2017-10-11 00:09:57.077994
NCT02202512|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-28|2014-12-23|||September 2014||2014-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers|Effect of Repeated Oral Doses of BI 1060469, BI 1021958 and Active Controls, Cimetidine and Naproxen, on Measured GFR Via Renal Clearance of Iohexol in Healthy Male Subjects (a Phase I Study; Single-blind, Randomized, Placebo-controlled Within BI Groups and Open-label for the Active Controls)|Completed||Phase 1|53|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:09:57.159414|2017-10-11 00:09:57.159414
NCT02202499|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-08|||July 17, 2014||2014-07-17|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 11, 2015|Actual|2015-12-11||Interventional|||Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence|Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence: Intervention Development and Feasibility Trial|Active, not recruiting||Early Phase 1|86|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f|t|f||||||||2017-10-11 00:09:57.287326|2017-10-11 00:09:57.287326
NCT02202486|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-25|||September 2012||2012-09-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Observational|||Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI|Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI|Unknown status|Recruiting|N/A|600|Anticipated|Glostrup University Hospital, Copenhagen|||3||f||||t||||||Samples Without DNA|"     Creatinine, blood glucose, potassium, haemoglobin, erytrocyte profile   "|||2017-10-11 00:09:57.427199|2017-10-11 00:09:57.427199
NCT02202473|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24||||||July 2014|2014-07-01||||February 2014|Actual|2014-02-01||Interventional|||Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects||Completed||Phase 4|192|Actual|Southeast University, China||2|||f||||t||||||||||2017-10-11 00:09:57.674813|2017-10-11 00:09:57.674813
NCT02202460|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-07-25|||August 2014||2014-08-01|July 2014|2014-07-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01|18 Months|Observational [Patient Registry]|||The Potential Biomark of Serious Psychosis:a Prospective,Case-controled Study|The Potential Biomark of Serious Psychosis: Including the Variation of Brain MRI, BDNF and Oxidative Stress-related Immunological Factors in Different Phases.|Not yet recruiting||N/A|200|Anticipated|Central South University|||1||f||||t||||||Samples With DNA|"     blood   "|||2017-10-11 00:09:57.810159|2017-10-11 00:09:57.810159
NCT02202447|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-07-25|||May 2014||2014-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase 1 of EC1169 In Patients With Recurrent MCRPC|A Phase 1 Study of A Prostate-Specific Membrane Antigen Targeting-Tubulysin Conjugate EC1169 In Patients With Recurrent Metastatic, Castration-Resistant Prostate Cancer (MCRPC)|Recruiting||Phase 1|40|Anticipated|Endocyte||1|||f||||f||||||||||2017-10-11 00:09:57.932332|2017-10-11 00:09:57.932332
NCT02202434|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-03-23|||September 22, 2014|Actual|2014-09-22|March 2017|2017-03-01|February 2023|Anticipated|2023-02-01|March 8, 2017|Actual|2017-03-08||Interventional|REPRISE III||Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement|REPRISE III: Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Randomized Clinical Evaluation|Suspended||N/A|2092|Anticipated|Boston Scientific Corporation||7||Continued Access Study cohort enrollment voluntarily suspended due to field action|f||||t||||||||||2017-10-11 00:09:58.086217|2017-10-11 00:09:58.086217
NCT02202421|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-01-28|||January 2015||2015-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|T-ABA||T-ABA Group Based Early Intervention For Parents of Children With ASD|Targeted Applied Behavior Analysis (T-ABA) Group Based Early Intervention for Parents of Children With Autism Spectrum Disorder (ASD)|Enrolling by invitation||N/A|36|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 00:09:58.340697|2017-10-11 00:09:58.340697
NCT02202408|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-01-11|||June 2014||2014-06-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670|A Phase I, Double-blind, Randomized, Placebo-controlled, Single-Dose Escalation, First-in-human Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SKI2670 After Oral Administration in Healthy Female Subjects|Recruiting||Phase 1|16|Anticipated|SK Chemicals Co.,Ltd.||2|||f||||f||||||||||2017-10-11 00:09:58.463727|2017-10-11 00:09:58.463727
NCT02202395|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-06-02|||June 2014||2014-06-01|June 2017|2017-06-01|December 28, 2016|Actual|2016-12-28|April 30, 2015|Actual|2015-04-30||Interventional|T8||Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate|A Radomized, Double-blind, and Placebo-controlled Multicenter Clinical Trial of Hydroxytriptolide, in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate|Completed||Phase 1/Phase 2|120|Actual|Shanghai Pharmaceuticals Holding Co., Ltd||4|||f||||t||||||||||2017-10-11 00:09:58.595692|2017-10-11 00:09:58.595692
NCT02202382|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-29|||April 2011||2011-04-01|July 2014|2014-07-01||||January 2012|Actual|2012-01-01||Interventional|||Effects of Korean Red Ginseng on Male Infertility||Completed||Phase 4|80|Actual|Pusan National University Hospital||4|||f||||||||||||||2017-10-11 00:09:58.744642|2017-10-11 00:09:58.744642
NCT02202369|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-09-11|||February 2015||2015-02-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|||Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study|Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study|Recruiting||Phase 4|124|Anticipated|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-11 00:09:58.840946|2017-10-11 00:09:58.840946
NCT02202343|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-26|2015-04-09|||October 2013||2013-10-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effectiveness of School-based Health and Nutrition Education to Improve Health and Dietary Practices of Primary School Children From Jimma Zone||Completed||N/A|1000|Actual|Jimma University||1|||f||||f||||||||||2017-10-11 00:09:59.382011|2017-10-11 00:09:59.382011
NCT02202330|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-08-05|||January 2014||2014-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Using 5 Minute Videos for Numeracy and Literacy Challenged Stroke Survivors to Improve Outcomes|Translating Knowledge for Action Against Stroke - Using 5 Minute Videos for Numeracy and Literacy Challenged Stroke Survivors and Caregivers to Improve Outcomes|Completed||N/A|310|Actual|Aga Khan University||2|||f||||t||||||||||2017-10-11 00:09:59.473098|2017-10-11 00:09:59.473098
NCT02202317|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-11-04|||April 2013||2013-04-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors|Follow-up Yttrium-90 Internal Pair Production PET/CT Imaging in Patients With Primary or Metastatic Liver Tumors as Compared With Brehmsstrahlung Imaging: A Prospective Case Series|Completed||N/A|9|Actual|University of Miami||1|||f||||||||||||||2017-10-11 00:09:59.562069|2017-10-11 00:09:59.562069
NCT02202304|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-05-12|||September 10, 2017|Anticipated|2017-09-10|May 2017|2017-05-01|December 10, 2020|Anticipated|2020-12-10|September 10, 2019|Anticipated|2019-09-10||Interventional|||The Effects of Chlorhexidine/Thymol Varnish on Partial Denture Patient|The Effects of Chlorhexidine/Thymol Varnish on the Abutment Teeth in Partial Denture Wearers.|Withdrawn||Phase 4|0|Actual|University of Aberdeen||2||Researcher changed jobs. Unable to carry out the project|f||||t|f|f||||||Yes|within 6 months|2017-10-11 00:09:59.643663|2017-10-11 00:09:59.643663
NCT02202291|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-09-18|||October 13, 2014|Actual|2014-10-13|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|RAY-GENE||Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon|Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon|Recruiting||N/A|350|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 00:09:59.778878|2017-10-11 00:09:59.778878
NCT02202278|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-07-24|||June 2014||2014-06-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Observational|||Study of Serum Levels of Oxidative Stress Markers in Ovarian Hyperstimulation Patients|Serum Levels of IMA, TAC, TOS, OSI and MDA in Severe OHSS Patients Underwent Long Agonist Protocol Intracytoplasmic Sperm for Determining Oxidative Stress Status|Unknown status|Recruiting|N/A|25|Anticipated|Karadeniz Technical University|||2||f||||f||||||Samples Without DNA|"     Blood of involved patients in study was drawn for study for ischemia modified albumin (IMA),     malondialdehyde (MDA), total oxidative capacity (TOS), total antioxidative capacity (TAS) and     oxidative stress capacity (OSI) levels. After the study all blood samples will be destroyed     according to regulations.   "|||2017-10-11 00:09:59.921274|2017-10-11 00:09:59.921274
NCT02202265|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-07-27|||September 2014||2014-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2017|Actual|2017-07-01||Interventional|GENUTRI||Polymorphisms in CD36 and STAT3 Genes and Different Dietary Interventions Among Patients With Coronary Artery Disease|Effect of Polymorphisms in CD36 and STAT3 Genes on Different Dietary Interventions Among Patients With Coronary Artery Disease: a Randomized Clinical Trial With a Nutrigenetic Approach|Recruiting||N/A|204|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||3|||f||||f||||||||||2017-10-11 00:10:00.041856|2017-10-11 00:10:00.041856
NCT02202252|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-03-25|2015-03-09||July 2014||2014-07-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Single Versus Double Drains After Mastectomy|Comparison of Single Versus Double Drains After Modified Radical Mastectomy|Completed||N/A|60|Actual|Ankara Diskapi Training and Research Hospital||2|||f||||f||||||||||2017-10-11 00:10:00.188608|2017-10-11 00:10:00.188608
NCT02202239|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||September 2014||2014-09-01|July 2014|2014-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients||Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Zhujiang Hospital||2|||f||||t||||||||||2017-10-11 00:10:00.472069|2017-10-11 00:10:00.472069
NCT02202226|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-03-04|||January 2013||2013-01-01|March 2015|2015-03-01||||February 2015|Actual|2015-02-01||Interventional|||Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia|Interventional, Randomised, Double-blind, Placebo-controlled, Sequential Group, Multiple Dose Study Investigating the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of Lu AF35700 in Patients With Schizophrenia|Completed||Phase 1|96|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 00:10:00.59127|2017-10-11 00:10:00.59127
NCT02202213|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-02-17|||October 2013||2013-10-01|February 2015|2015-02-01||||February 2015|Actual|2015-02-01||Interventional|||Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia|Interventional, Randomised, Double-blind, Placebo Controlled, Multiple-dose Study Investigating the Safety, Tolerability, PK and PD Properties of Lu AF11167 in Patients With Schizophrenia|Completed||Phase 1|47|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 00:10:00.675225|2017-10-11 00:10:00.675225
NCT02202200|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2016-04-15|||May 2014||2014-05-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|November 2016|Anticipated|2016-11-01||Interventional|OPTIMUM||Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma|An Open Label Multicenter, Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma With BRAFv600 Mutated and CDKN2A Loss and Expression of Rb and Treated by Vemurafenib|Recruiting||Phase 1/Phase 2|40|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||||||||||||2017-10-11 00:10:00.749918|2017-10-11 00:10:00.749918
NCT02202187|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-06-09|||September 26, 2011|Actual|2011-09-26|June 2017|2017-06-01|February 15, 2012|Actual|2012-02-15|February 15, 2012|Actual|2012-02-15||Interventional|||A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers|A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of GSK2140944 in Healthy Adult Subjects|Completed||Phase 1|48|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 00:10:00.838409|2017-10-11 00:10:00.838409
NCT02202174|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-07-27|||June 2014||2014-06-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||The Safety and Efficacy of Supraglottic Airway Use in Children|The Safety and Efficacy of Supraglottic Airway Use in Children|Unknown status|Recruiting|N/A|10000|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||||||2017-10-11 00:10:00.93791|2017-10-11 00:10:00.93791
NCT02201992|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-08-10|||August 18, 2014|Actual|2014-08-18|August 2017|2017-08-01|May 2027|Anticipated|2027-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)|A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Placebo for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein|Recruiting||Phase 3|378|Anticipated|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 00:10:03.685827|2017-10-11 00:10:03.685827
NCT02202148|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-01-30|||July 2015||2015-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Liver Stiffness Measurement in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal||Completed||N/A|195|Actual|Centre Hospitalier Esquirol|||1||f||||f||||||||||2017-10-11 00:10:01.187976|2017-10-11 00:10:01.187976
NCT02202135|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2017-09-01|2015-12-18||June 2014||2014-06-01|September 2017|2017-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Randomized patients|Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.|A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) vs Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities.|Terminated||Phase 3|4|Actual|Pfizer|Early termination leading to small number of subjects analyzed.|2||"Overall study status is changed to Terminated due to low enrollment"|f||||||||||||||2017-10-11 00:10:01.276088|2017-10-11 00:10:01.276088
NCT02202122|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-06-22|||September 2014||2014-09-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01|1 Month|Observational [Patient Registry]|||Interest of the OSA (Obstructive Sleep Apnea) Predictive Scores in the Prognosis of Postoperative Mortality of Femoral Neck Fractures|Interest of the OSA (Obstructive Sleep Apnea) Predictive Scores in the Prognosis of Postoperative Mortality of Femoral Neck Fractures.|Withdrawn||N/A|0|Actual|Astes|||1|lack of investigators|f||||f||||||||||2017-10-11 00:10:01.708463|2017-10-11 00:10:01.708463
NCT02202109|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-06-20|||January 2015||2015-01-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida|Addressing Cervical Cancer Disparity in South Florida: CBPR in Action|Recruiting||N/A|700|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-11 00:10:01.83371|2017-10-11 00:10:01.83371
NCT02202096|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-06-13|||February 2015||2015-02-01|June 2016|2016-06-01||||February 2016|Anticipated|2016-02-01||Interventional|||A Pilot Randomized Trial of a Comprehensive Transitional Care Program for Colorectal Cancer Patients|A Pilot Randomized Trial of the Comprehensive Transitional Care Program for Medically Underserved Colorectal Cancer Surgery Patients|Withdrawn||N/A|0|Actual|The University of Texas Health Science Center, Houston||2||Resources were not readily available to begin the study.|f||||f||||||||||2017-10-11 00:10:01.959015|2017-10-11 00:10:01.959015
NCT02202083|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2015-06-04|||June 2014||2014-06-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||The Comparison of Oxytocin Induced Labor and Cook Balloon Induced Labor|The Comparison of Oxytocin Induced Labor and Cook Balloon Induced Labor|Unknown status|Recruiting|Phase 4|300|Anticipated|West China Second University Hospital||1|||f||||t||||||||||2017-10-11 00:10:02.133977|2017-10-11 00:10:02.133977
NCT02202070|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-25||||||July 2014|2014-07-01||||December 2015|Anticipated|2015-12-01||Interventional|TMJ||Botox for Treatment of TMJ Disorder With Bruxism|Phase 1 Study of Role of Botox in Myofascial Temporomandibular Disorder|Unknown status|Not yet recruiting|Phase 1|32|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:10:02.278812|2017-10-11 00:10:02.278812
NCT02202057|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-09-16|||September 2014||2014-09-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Respiratory Load Magnitude Estimation in PD|Magnitude Estimation of Respiratory Resistive Load in Parkinson's Disease|Completed||N/A|30|Actual|University of Florida|||2||f||||f||||||||||2017-10-11 00:10:02.446472|2017-10-11 00:10:02.446472
NCT02202044|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-04-27|||February 24, 2015|Actual|2015-02-24|April 2017|2017-04-01|May 11, 2016|Actual|2016-05-11|May 11, 2016|Actual|2016-05-11||Interventional|||Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection|Adjuvant Sequential Intravesical BCG (Bacillus Calmette-Guérin) and Electromotive Mitomycin-C (EMDA/MMC) After Transuretheral Resection (TUR) in Patients With Primary High Risk Non-Muscle Invasive Transitional Cell Carcinoma of the Bladder|Terminated||N/A|13|Actual|University of Colorado, Denver||1||The institution was requiring extensive changes to the protocol|f||||f||||||||No||2017-10-11 00:10:02.596917|2017-10-11 00:10:02.596917
NCT02202031|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-07-12|||September 2014||2014-09-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CURE||Controlling Urgency Through Relaxation Exercises||Active, not recruiting||N/A|161|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:10:02.739765|2017-10-11 00:10:02.739765
NCT02202018|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-06-01|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|||A Cluster Randomized Trial to Assess the Impact of Patient and Provider Education on Use of Home Dialysis|Patient and Provider Education for Patients With Severe Chronic Kidney Disease: Assessing the Impact on Barriers and Use of Home Dialysis|Active, not recruiting||N/A|55|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 00:10:02.8499|2017-10-11 00:10:02.8499
NCT02202005|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-08-21|||August 2014||2014-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Multiple Dose BE Study With Nevirapine 400mg PR Tablets|A Multiple Dose, Open Label, Pivotal, 4 Period, 2 Treatment, Sequence Full Replicative Crossover Study to Assess the Bioequivalence (BE) of TEVA's Generic Once Daily Nevirapine 400 mg Prolonged Release (PR) Formulation Compared With the Approved Reference Product Viramune® 400 mg Prolonged Release Tablets Under Fasted Conditions in HIV1 Infected Patients|Completed||Phase 1|46|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 00:10:02.979875|2017-10-11 00:10:02.979875
NCT02201979|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-11-18|||July 2014||2014-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Laser Fluorescent Imaging of Nipple and Areola During Breast Lift|Laser Fluorescent Imaging of Nipple and Areola During Breast Lift in Combination With Breast Implants|Completed||N/A|15|Actual|Swanson Center|||1||f||||f||||||||||2017-10-11 00:10:09.717405|2017-10-11 00:10:09.717405
NCT02201966|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-07-02|||August 2014||2014-08-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|||Regional Interdependence of the Shoulders and Hips in Gymnasts With Low Back Pain|Regional Interdependence of the Shoulders and Hips in Gymnasts With Low Back Pain|Withdrawn||N/A|0|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 00:10:09.809608|2017-10-11 00:10:09.809608
NCT02201953|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-09-01|2016-09-01||July 2014||2014-07-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|ASTRAL-3|Safety Analysis Set: participants who were randomized into the study and received at least 1 dose of study drug.|Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection|A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Subjects With Chronic Genotype 3 HCV Infection|Completed||Phase 3|558|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 00:10:09.914108|2017-10-11 00:10:09.914108
NCT02201940|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-07-27|2016-07-27|2016-04-08|July 2014||2014-07-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|ASTRAL-1|Safety Analysis Set: participants who received at least 1 dose of study drug.|Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects With Chronic HCV|Completed||Phase 3|741|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 00:10:12.955222|2017-10-11 00:10:12.955222
NCT02201927|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-02-02|||April 2014||2014-04-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|GVS||Stimulation Galvanique Vestibulaire|Galvanic Vestibular Stimulation : Role in the Improvement of Egocentric Frame in Patient With Right Parietal Lobe Lesions|Terminated||N/A|16|Actual|Centre d'Investigation Clinique et Technologique 805||3||lack of performance|f||||t||||||||||2017-10-11 00:10:14.201778|2017-10-11 00:10:14.201778
NCT02201914|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-24|||January 2014||2014-01-01|July 2014|2014-07-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|||Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF|Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF: a Randomized Study|Unknown status|Recruiting|Phase 4|250|Anticipated|Bioroma||3|||f||||t||||||||||2017-10-11 00:10:14.291649|2017-10-11 00:10:14.291649
NCT02201901|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-10-24|2016-08-24||July 2014||2014-07-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|ASTRAL-4|Safety Analysis Set: participants who were randomized into the study and received at least 1 dose of study drug.|Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis|A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects With Chronic HCV Infection and Child-Pugh Class B Cirrhosis|Completed||Phase 3|268|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|3|||f||||t||||||||||2017-10-11 00:10:14.429593|2017-10-11 00:10:14.429593
NCT02201888|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-25|||January 2010||2010-01-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study|Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study|Completed||N/A|130|Actual|FIDMAG Germanes Hospitalàries||3|||f||||f||||||||||2017-10-11 00:10:16.196964|2017-10-11 00:10:16.196964
NCT02201875|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-07-24|||September 2014||2014-09-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Observational|PERHYP1||Intrinsic Periodic Pattern of Breathing|Study of Periodic Breathing in Healthy Humans|Unknown status|Not yet recruiting|N/A|120|Anticipated|Association pour la Recherche en Physiologie de l'Environnement|||3||f||||f||||||||||2017-10-11 00:10:16.308436|2017-10-11 00:10:16.308436
NCT02201862|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-07-14|||April 2014||2014-04-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|NICHE||Non-Invasive Chromosomal Evaluation of Trisomy Study|Non-Invasive Chromosomal Evaluation of Trisomy Study|Recruiting||N/A|2000|Anticipated|Roche Sequencing Solutions|||2||f||||f||||||Samples With DNA|"     Plasma   "|||2017-10-11 00:10:16.411244|2017-10-11 00:10:16.411244
NCT02201849|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-01-12|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults|A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral ALKS 8700 in Healthy Adults|Completed||Phase 1|104|Actual|Alkermes, Inc.||3|||f||||f||||||||||2017-10-11 00:10:16.531532|2017-10-11 00:10:16.531532
NCT02201836|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||January 2006||2006-01-01|July 2014|2014-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||The Effects of Music Therapy as a Complementary Intervention in the Treatment of Pediatric Asthma|The Effects of Music Therapy as a Complementary Intervention in the Treatment of Pediatric Asthma|Completed||N/A|200|Actual|Beth Israel Medical Center||3|||f||||f||||||||||2017-10-11 00:10:16.668395|2017-10-11 00:10:16.668395
NCT02201823|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-07-01|||February 2014||2014-02-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients|A PHASE I/Ib, FIRST IN HUMAN, DOSE-ESCALATION STUDY OF ABTL0812 IN PATIENTS WITH ADVANCED SOLID TUMOURS|Completed||Phase 1|27|Actual|Ability Pharmaceuticals SL||1|||f||||t||||||||||2017-10-11 00:10:16.757557|2017-10-11 00:10:16.757557
NCT02201810|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-09-14|||May 2015||2015-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Freedom||Enhancing the Efficacy of Smoking Quit Line in the Military (AFIII Renewal)|Enhancing the Efficacy of Smoking Quit Line in the Military|Recruiting||Phase 3|1900|Anticipated|University of Tennessee||3|||f||||t||||||||||2017-10-11 00:10:16.85721|2017-10-11 00:10:16.85721
NCT02201797|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-06-22|||October 2014||2014-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body|Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body|Completed||N/A|13|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 00:10:16.980673|2017-10-11 00:10:16.980673
NCT01830608|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-04-07|||January 2015||2015-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Risk Factors for Drusen Progression||Withdrawn||N/A|0|Actual|Medical University of Vienna|||1|Could not find a Sponsor for the study|f||||||||||||||2017-10-11 01:49:09.337381|2017-10-11 01:49:09.337381
NCT02201784|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-01-14|2015-01-14||December 2012||2012-12-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Spinal Anaesthesia With Levobupivacaine 0.5% and Ropivacaine 0.75% for Lower Limb Orthopaedic Surgery|A Comparative Study Between Levobupivacaine 0.5% and Ropivacaine 0.75% in Patients Undergoing Spinal Anaesthesia for Lower Limb Orthopaedic Surgery.|Completed||Phase 4|60|Actual|Aligarh Muslim University|Exact baricity was not known as Specific gravity was not measured; Quality of anaesthesia was not assessed|2|||f||||t||||||||||2017-10-11 00:10:17.100907|2017-10-11 00:10:17.100907
NCT02201771|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-08-04|||July 2014||2014-07-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|DACAB||Compare the Efficacy of Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery||Completed||Phase 4|500|Actual|Ruijin Hospital||3|||f||||||||||||||2017-10-11 00:10:17.578317|2017-10-11 00:10:17.578317
NCT02201758|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-10-24|||January 2017||2017-01-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|FLC&UC||Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment|Flaxseed Lignan-enriched Complex (FLC) for the Treatment of Patients With Mild to Moderately Severe Ulcerative Colitis (UC): A Pilot Assessment.|Not yet recruiting||Phase 2|56|Anticipated|University of Saskatchewan||2|||f||||||||||||||2017-10-11 00:10:17.711539|2017-10-11 00:10:17.711539
NCT02201732|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-06-19|||November 5, 2014|Actual|2014-11-05|June 2017|2017-06-01|October 5, 2019|Anticipated|2019-10-05|April 5, 2019|Anticipated|2019-04-05||Interventional|HY-PER||Effectiveness of Hysteroscopy in the Treatment of Intrauterine Trophoblastic Retentions|Assessment of the Effectiveness of Hysteroscopy in the Treatment of Intrauterine Trophoblastic Retentions|Active, not recruiting||N/A|577|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:10:17.849583|2017-10-11 00:10:17.849583
NCT02201719|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-04-04|||July 2014||2014-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|NAPPED I||Norwegian Adenomyosis Study I|Norwegian Adenomyosis Study: Pathophysiology, Peristalsis, Expression Profiling and Diagnostics, Part I|Completed||N/A|100|Actual|Oslo University Hospital|||2||f||||t||||||||||2017-10-11 00:10:17.969488|2017-10-11 00:10:17.969488
NCT02201706|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-05-05|||October 2013||2013-10-01|May 2015|2015-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye|The Explore Study for the Efficacy and Safety of Multi-electrocoagulation Retinectomy in the Treatment of Retinal Re-detachment in Silicone Oil Filled Eye|Unknown status|Recruiting|N/A|9|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:10:18.223663|2017-10-11 00:10:18.223663
NCT02201693|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-08-25|||December 2014||2014-12-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|CD-HOPE||Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease|Randomised Trial Comparing 12 Months of Cyclic Enteral Nutrition to Supplementary Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-11 00:10:18.35419|2017-10-11 00:10:18.35419
NCT02201680|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2014-07-24|||June 2012||2012-06-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|||Anxiety Level of Child and Parents During Preoperative Anesthesia Evaluation|Anxiety Level of Child and Parents During Preoperative Anesthesia Evaluation|Completed||N/A|117|Actual|Istanbul University|||1||f||||t||||||||||2017-10-11 00:10:18.482058|2017-10-11 00:10:18.482058
NCT02201667|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-31|||August 2014||2014-08-01|July 2014|2014-07-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI|An Open-label Study Evaluating the Acute Efficacy of Treatment With Ticagrelor Versus Clopidogrel on Myocardial Tissue-level Perfusion Assessed by TMPFC and MRI in Patients With High-risk NSTE-ACS Undergoing Early PCI（EARLY-MYO II）|Unknown status|Not yet recruiting|Phase 4|444|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-11 00:10:18.582661|2017-10-11 00:10:18.582661
NCT02201654|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-12-14|||June 2014||2014-06-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Stylet vs No Stylet During EBUS TBNA|Stylet Versus no Stylet in Endobronchial Ultrasound Transbronchial Aspiration (EBUS-TBNA)|Completed||N/A|121|Actual|Johns Hopkins University||1|||f||||||||||||||2017-10-11 00:10:18.712918|2017-10-11 00:10:18.712918
NCT02201641|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-03-01|||July 2012||2012-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial|Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial|Active, not recruiting||Phase 4|53|Actual|King's College London||4|||f||||t||||||||No||2017-10-11 00:10:18.79656|2017-10-11 00:10:18.79656
NCT02201628|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-24|||July 2014||2014-07-01|July 2014|2014-07-01|April 2015|Anticipated|2015-04-01|January 2015|Anticipated|2015-01-01||Interventional|||Correlation of Nasopharyngeal (NP) and Lower Oesophageal (LO) Temperatures in Ventilated Children|Comparison of Nasopharyngeal and Lower Oesophageal Temperatures Under General Anaesthesia With an Endotracheal Tube With Leak|Unknown status|Recruiting|N/A|100|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:10:18.907319|2017-10-11 00:10:18.907319
NCT02201615|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-08-26|||January 2010||2010-01-01|August 2014|2014-08-01||||May 2011|Actual|2011-05-01||Interventional|||The Effect of Perineal Massage in Childbirth|The Effect of Perineal Massage in Childbirth: the Rate of Episiotomy Procedures, Perineal Tears and the Length of the Second Stage of Labour|Completed||N/A|284|Actual|Cumhuriyet University||1|||f||||f||||||||||2017-10-11 00:10:19.060484|2017-10-11 00:10:19.060484
NCT02201602|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-08-31|||August 2014||2014-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study|Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study|Completed||Phase 4|8|Actual|Khoo Teck Puat Hospital||2|||f||||f||||||||||2017-10-11 00:10:19.149157|2017-10-11 00:10:19.149157
NCT02201589|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-04-16|||September 2013||2013-09-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Feasibility of Endovascular Repair Of Ascending Aortic Pathologies|Proposed Single Center Investigational Device Exemption: Feasibility of Endovascular Repair Of Ascending Aortic Pathologies|Recruiting||N/A|20|Anticipated|Los Angeles Biomedical Research Institute||1|||f||||f||||||||Undecided||2017-10-11 00:10:19.247605|2017-10-11 00:10:19.247605
NCT02201576|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-08-25|||February 2015||2015-02-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|February 2018|Anticipated|2018-02-01||Interventional|TRIBUTE||Bortezomib in Rejection of Kidney Transplants|Treatment of Chronic Active Antibody-mediated Rejection With Bortezomib in Kidney Transplantation|Recruiting||Phase 2|100|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:10:19.364215|2017-10-11 00:10:19.364215
NCT02201563|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-06-20|||November 2015||2015-11-01|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Minocycline Therapy for Management of Adverse Radiation Effects|A Safety and Feasibility Study of Minocycline Therapy for Management of Adverse Radiation Effects After Brain Metastases Radiosurgery|Recruiting||Phase 1|15|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 00:10:19.489312|2017-10-11 00:10:19.489312
NCT02201550|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||February 2013||2013-02-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide|Regulation of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide (Victoza)|Completed||N/A|9|Actual|Hvidovre University Hospital|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 00:10:19.579497|2017-10-11 00:10:19.579497
NCT02201537|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-08-25|||March 2013||2013-03-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|Imag-NCT||Kidney Disease and Ultrasound Imaging|Non-invasive Diagnosis of Chronic Kidney Disease in Renal Transplants Kidney Transplanted Using Ultrasound Functional Imaging|Active, not recruiting||N/A|141|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:10:19.648009|2017-10-11 00:10:19.648009
NCT02201524|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-08-11|2016-08-11||November 2014||2014-11-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||The full analysis set (FAS) included all randomized participants who received at least 1 dose of the randomized study drug (PF-04965842 or placebo).|Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis|A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis|Terminated||Phase 2|59|Actual|Pfizer|The study was terminated early due to changes in the prioritization of the drug development portfolio and the early termination was not safety related.|4||"Study terminated 26 June 2015 due to changes in the drug development portfolio. This study was   not terminated for reasons of safety and/or efficacy"|f||||f||||||||||2017-10-11 00:10:19.816247|2017-10-11 00:10:19.816247
NCT02201511|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-11-09|||September 2014||2014-09-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions|A Phase 1, Open-label Study In Healthy Subjects To Investigate the Pharmacokinetics Of Pf-06412562 Following Single Oral Administration Of Modified Release Formulation In Fasted And Fed States|Completed||Phase 1|12|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 00:10:22.63678|2017-10-11 00:10:22.63678
NCT02201498|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||September 2014||2014-09-01|July 2014|2014-07-01||||March 2016|Anticipated|2016-03-01||Interventional|||Randomized Clinical Trial for Primary Molar Pulpotomy, Biodentine Vs Formocresol-ZOE|A New Technique for Primary Molar Pulpotomy : A Randomized Clinical Trial Comparing the Radiographic and Clinical Success of the Formocresol-zinc Oxide Eugenol Technique and the Biodentine Technique|Unknown status|Not yet recruiting|N/A|180|Anticipated|Université de Montréal||2|||f||||||||||||||2017-10-11 00:10:22.749838|2017-10-11 00:10:22.749838
NCT02201485|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-08-31|||May 2014||2014-05-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|||Budd-Chiari Syndrome in China: Balloon Angioplasty Alone or Combined With Stent Placement?|Balloon Angioplasty Alone Versus in Combination With Stent Placement for the Treatment of Budd-Chiari Syndrome in China: An Randomized Controlled Trial|Recruiting||N/A|48|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-11 00:10:22.866627|2017-10-11 00:10:22.866627
NCT02201472|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-02-13|||August 2014||2014-08-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MRE in Infants||Magnetic Resonance Elastography in Infants|Magnetic Resonance Elastography in Infants|Terminated||N/A|2|Actual|Children's Hospital Medical Center, Cincinnati||1||Change of research focus|f||||f||||||||||2017-10-11 00:10:22.992779|2017-10-11 00:10:22.992779
NCT02201459|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-08-06|||August 2014||2014-08-01|August 2014|2014-08-01|August 2019|Anticipated|2019-08-01|January 2018|Anticipated|2018-01-01||Interventional|PETALs||Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients|Randomized Multicenter Phase III Study Comparing the Rate of Molecular Response 4.5 at 12 Months in Newly Diagnosed Philadelphia Positive Chronic Phase Chronic Myelogenous Leukemia Patients Receiving Either Frontline Nilotinib 600 mg Daily or Nilotinib 600 mg Daily Combined to Pegylated Interferon-alfa 2a (Peg-IFN)|Recruiting||Phase 3|200|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 00:10:23.084087|2017-10-11 00:10:23.084087
NCT02201446|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-01-02|2015-07-28||March 2014||2014-03-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Observational|||The Role of Circulating Soluble CD74 in Acute Lung Injury|Relationship Between Elevated Soluble Cluster of Differentiation 74 (CD74) and Severity of Experimental and Clinical ALI/ARDS.|Completed||N/A|139|Actual|Changhai Hospital|||2||f||||f||||||Samples Without DNA|"     ARDS patients and healthy volunteers   "|No||2017-10-11 00:10:23.226444|2017-10-11 00:10:23.226444
NCT02201433|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-02-10|||July 2014||2014-07-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|PERAM-QUAL||Study on the Treatment of Children and Their Families in Services Related to Early Childhood|Study on the Treatment of Children and Their Families in Services Related to Early Childhood Morvan Hospital Qualitative Study|Recruiting||N/A|80|Anticipated|University Hospital, Brest|||3||f||||t||||||||||2017-10-11 00:10:23.877931|2017-10-11 00:10:23.877931
NCT02201420|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-08-03|2016-06-23||September 2014||2014-09-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT|Evaluation of Technetium Tc 99m Tilmanocept Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage From KS Lesions by SPECT/CT Imaging.|Completed||Phase 2|5|Actual|Navidea Biopharmaceuticals||1|||f||||f||||||||Undecided||2017-10-11 00:10:23.961319|2017-10-11 00:10:23.961319
NCT02201407|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-30|||December 18, 2014|Actual|2014-12-18|August 2017|2017-08-01|April 10, 2017|Actual|2017-04-10|April 10, 2017|Actual|2017-04-10||Observational|||An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study|Open, Multicenter, Local, Non-Randomized, Non-Interventional Study in Patients With Chronic Hepatitis B Receiving Therapy With PEGASYS® (Peginterferon Alfa-2a 40kD) - PRO B|Completed||N/A|50|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:10:24.170418|2017-10-11 00:10:24.170418
NCT02201381|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-06-12|||May 22, 2017|Actual|2017-05-22|June 2017|2017-06-01|October 22, 2023|Anticipated|2023-10-22|May 22, 2022|Anticipated|2022-05-22||Interventional|METRICS||Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer|A Non Randomised, Non Blinded Real World Trial of the Safety, Tolerability and Effectiveness of Metabolic Medicines for the Treatment of Cancer Compared Against Historical Controls|Recruiting||Phase 3|207|Anticipated|Health Clinics Limited||1|||f||||t|f|f|||f|||No||2017-10-11 00:10:24.592947|2017-10-11 00:10:24.592947
NCT02201368|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2014-07-25|||November 2009||2009-11-01|July 2014|2014-07-01|October 2011|Actual|2011-10-01|March 2010|Actual|2010-03-01||Interventional|||Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects|Study to Evaluate the Effectiveness of Dietary Treatment With Triheptanoin in Patients With Long-chain Fatty Acid Beta-oxidation Defects|Withdrawn||Phase 3|0|Actual|Hospital Clinico Universitario de Santiago||2||IMP management difficulties|f||||f||||||||||2017-10-11 00:10:24.795813|2017-10-11 00:10:24.795813
NCT02201355|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-12-28|||September 2014||2014-09-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck|A Phase I Study of Reduced-Volume Hypofractionated, PET-directed Intensity Modulated Radiotherapy Concurrent With Weekly Cisplatin Chemotherapy for T1/2N0-2 Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 1|8|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 00:10:24.966386|2017-10-11 00:10:24.966386
NCT02201342|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-04-24|||July 2014||2014-07-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents|A Phase I/II Dose Escalation Trial of Udenafil in Adolescents With Single Ventricle Physiology After Fontan Palliation|Completed||Phase 1/Phase 2|36|Actual|Mezzion Pharma Co. Ltd||6|||f||||t||||||||||2017-10-11 00:10:25.104971|2017-10-11 00:10:25.104971
NCT02201329|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-25|2015-09-30|||August 2014||2014-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia|An Open Label Phase I Trial of Intravenous Volasertib in Combination With Subcutaneous Azacitidine in Japanese Patients With Higher-risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia|Completed||Phase 1|5|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:10:25.220243|2017-10-11 00:10:25.220243
NCT02201316|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-12|||February 3, 2014|Actual|2014-02-03|May 2017|2017-05-01|March 18, 2014|Actual|2014-03-18|March 18, 2014|Actual|2014-03-18||Interventional|||A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions|An Open-label, Randomised, Single Dose, Three-Way Crossover, Six Sequence, Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (Gasmotin) in Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|18|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 00:10:25.333189|2017-10-11 00:10:25.333189
NCT02201303|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-05-05|||January 13, 2014|Actual|2014-01-13|May 2017|2017-05-01|July 2, 2015|Actual|2015-07-02|July 2, 2015|Actual|2015-07-02||Interventional|||Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression|A Single-Center In Vitro Study to Evaluate GSK1325756 Inhibition of CD11b Cell Surface Expression in Healthy Adults and Respiratory Syncytial Virus-Infected Children <2 Years (200591)|Completed||Phase 1|40|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:10:25.43926|2017-10-11 00:10:25.43926
NCT02201290|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-07-27|||June 18, 2013|Actual|2013-06-18|July 2017|2017-07-01|July 4, 2017|Actual|2017-07-04|July 4, 2017|Actual|2017-07-04||Interventional|||A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|An Extension Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenia Purpura (ITP)|Completed||Phase 3|9|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-11 00:10:25.552359|2017-10-11 00:10:25.552359
NCT02201277|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-05-27|||June 2014||2014-06-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|ODEN||ODEN Trial: Option vs. Denali IVC Filters|Prospective Randomized Evaluation of the Denali and Option Inferior Vena Cava Filters|Unknown status|Recruiting|N/A|150|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:10:25.643349|2017-10-11 00:10:25.643349
NCT02201264|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-04-10|||March 2007||2007-03-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01|5 Days|Observational [Patient Registry]|CPORT||Cardiovascular Patient Outcomes and Research Team Primary PCI Registry|The Atlantic CPORT Primary PCI Registry|Unknown status|Recruiting|N/A|6500|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 00:10:25.767685|2017-10-11 00:10:25.767685
NCT02201251|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-09-22|||October 6, 2014|Actual|2014-10-06|September 2017|2017-09-01|March 26, 2019|Anticipated|2019-03-26|March 27, 2018|Anticipated|2018-03-27||Interventional|||A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy|A Randomized, Active-Controlled, Open-Label, Flexible-Dose Study to Assess the Safety and Tolerability of Topiramate as Monotherapy Compared With Levetiracetam as Monotherapy in Pediatric Subjects With New or Recent-Onset Epilepsy|Recruiting||Phase 3|282|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 00:10:25.933241|2017-10-11 00:10:25.933241
NCT02200861|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-11-04|||July 2014||2014-07-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Tooth Extraction With Deep Sedation in Children: A Retrospective Study|Tooth Extraction With Deep Sedation in Children: A Retrospective Study|Completed||N/A|885|Actual|TC Erciyes University|||1||f||||f||||||||||2017-10-11 00:10:31.426355|2017-10-11 00:10:31.426355
NCT02201238|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-06-28|||October 1, 2014|Actual|2014-10-01|June 2017|2017-06-01|November 21, 2014|Actual|2014-11-21|November 21, 2014|Actual|2014-11-21||Interventional|||Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium|A Pharmacokinetics Study Comparing Systemic Exposure of Topical Diclofenac/Menthol Gels Versus Voltaren Gel and Oral Diclofenac Sodium in Healthy Volunteers at Steady State|Completed||Phase 1|18|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 00:10:26.535018|2017-10-11 00:10:26.535018
NCT02201225|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-04-16|||October 2014||2014-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children.|A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children Aged 6 to 12 Years Receiving Nutritional Supplement With or Without Micronutrient Fortification|Completed||Phase 1|109|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:10:26.651454|2017-10-11 00:10:26.651454
NCT02201212|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-02-08|||September 2014||2014-09-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|May 2018|Anticipated|2018-05-01||Interventional|||Everolimus for Cancer With TSC1 or TSC2 Mutation|A Phase II Trial of Everolimus for Cancer Patients With Inactivating Mutations in TSC1 or TSC2 or Activating MTOR Mutations|Recruiting||Phase 2|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:10:26.745462|2017-10-11 00:10:26.745462
NCT02201199|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-12-23|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus|A Single-Center, Randomized, Double-Blind, 3-Treatment, 3-Period, 6-Sequence Cross-Over Study To Compare The Pharmacokinetic And Pharmacodynamic Effects of Single Doses of Insulin Glargine Given As U200 And U500 To Lantus® In A Euglycemic Clamp Setting In Subjects With Type 1 Diabetes|Completed||Phase 1|36|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 00:10:26.865779|2017-10-11 00:10:26.865779
NCT02201186|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-19|2017-04-24|||October 2014||2014-10-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||To Determine the Effect of Honey Enema in the Treatment of Patients With Acute Pouchitis|To Determine the Effect of Honey Enema in the Treatment of Patients With Acute Pouchitis (Pilot Study)|Completed||Phase 2|10|Actual|St. Paul's Hospital, Canada||1|||f||||f||||||||||2017-10-11 00:10:26.962306|2017-10-11 00:10:26.962306
NCT02201173|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-04-25|||July 2014||2014-07-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Health Outcomes After Locomotor Training in Spinal Cord Injury||Recruiting||N/A|80|Anticipated|Stony Brook University||1|||f||||f||||||||||2017-10-11 00:10:27.076253|2017-10-11 00:10:27.076253
NCT02201160|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-23|||January 2009||2009-01-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||Potential Role of n-3 Fatty Acids in the Treatment of NAFLD in Pediatric Patients|Impact of n-3 Fatty Acid Supplementation on the Metabolic Abnormalities in Children With NAFLD|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|St. Justine's Hospital||2|||f||||t||||||||||2017-10-11 00:10:27.174324|2017-10-11 00:10:27.174324
NCT02201147|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-05-02|||July 2014||2014-07-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Cold Snare Polypectomy Vs. Cold Forceps Polypectomy Using Narrow-band Imaging Endoscopy for Removal of Diminutive Colorectal Polyps|Prospective Comparison of Cold Snare Polypectomy and Cold Forceps Polypectomy Using Narrow-band Imaging Endoscopy for Diminutive Colorectal Polyps|Completed||N/A|146|Actual|Soonchunhyang University Hospital||2|||f||||t||||||||||2017-10-11 00:10:27.268974|2017-10-11 00:10:27.268974
NCT02201134|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-07-28|||July 2014||2014-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SEVOCAR||SEVOflurane Inhalation in CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia|SEVOflurane Inhalation in CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia|Recruiting||N/A|18|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 00:10:27.443725|2017-10-11 00:10:27.443725
NCT02201121|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-24|||March 2014||2014-03-01|October 2013|2013-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Influences of Phenylephrine, Dopamine and Ephedrine on Stroke Volume Variation and Pulse Pressure Variation|Influences of Phenylephrine, Dopamine and Ephedrine on Stroke Volume Variation and Pulse Pressure Variation|Completed||N/A|94|Actual|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 00:10:27.543913|2017-10-11 00:10:27.543913
NCT02201095|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-10-12|||October 2014||2014-10-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Active Warming During Elective Caesearean Section|Active Warming for Elective Caesarean Section - a RCT|Completed||N/A|130|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||3|||f||||t||||||||||2017-10-11 00:10:27.883852|2017-10-11 00:10:27.883852
NCT02201082|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-08-24|||September 2012||2012-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2013|Actual|2013-07-01||Interventional|||Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session||Completed||N/A|15|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 00:10:27.994475|2017-10-11 00:10:27.994475
NCT02201069|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-08-18|||August 2014||2014-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||My Health Coach Study|My Health Coach Study|Completed||N/A|82|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 00:10:28.092048|2017-10-11 00:10:28.092048
NCT02201056|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-06-01|2016-06-01||July 2014||2014-07-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Analysis was performed on safety set which included all participants who were enrolled and received study drug.|Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single Doses of TAK-935 in Healthy Subjects|Completed||Phase 1|48|Actual|Takeda||7|||f||||f||||||||||2017-10-11 00:10:28.244435|2017-10-11 00:10:28.244435
NCT02201043|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-11-17|||February 2013||2013-02-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis|Completed||Phase 2|197|Actual|Shanghai Pharmaceuticals Holding Co., Ltd||3|||f||||f||||||||||2017-10-11 00:10:29.59503|2017-10-11 00:10:29.59503
NCT02201030|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-06-21|||September 2014||2014-09-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Immunogenicity and Safety Study of NBP606 in Healthy Infants|Multi-Center, Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of Primary Vaccination With NBP606 in Healthy Infants|Recruiting||Phase 3|534|Anticipated|SK Chemicals Co.,Ltd.||2|||f||||f||||||||Undecided||2017-10-11 00:10:29.701571|2017-10-11 00:10:29.701571
NCT02201017|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-23|||June 2014||2014-06-01|July 2014|2014-07-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Observational|||HeartTrends HRV Algorithm for the Detection of Myocardial Ischemia|HeartTrends HRV Algorithm for the Detection of Myocardial Ischemia|Unknown status|Recruiting|N/A|621|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:10:29.799313|2017-10-11 00:10:29.799313
NCT02200991|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-10-04|||August 2014||2014-08-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine|A Randomized, Multicenter, Open-Label, Parallel-Group, 28 Days Phase IV Study Comparing The Postprandial Plasma Glucose Profile of Lixisenatide With That of Sitagliptin Add-On to Insulin Glargine in Type 2 Diabetes Mellitus|Completed||Phase 4|136|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:10:30.287438|2017-10-11 00:10:30.287438
NCT02200978|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2016-04-28|||September 2011||2011-09-01|April 2016|2016-04-01|September 2022|Anticipated|2022-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia|A Multicenter and Randomized Prospective Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia|Enrolling by invitation||Phase 4|250|Anticipated|South China Children's Leukemia Group||2|||f||||t||||||||||2017-10-11 00:10:30.418275|2017-10-11 00:10:30.418275
NCT02200965|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-03-16|||March 2013||2013-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|WICKED||Impact of Individualized Structured Information Provision to the Patients, on Diabetes Related Outcomes|The National Health Service (NHS) Choice and Information Revolution - Exploring the Utilization of High Quality Clinical Data Governance Processes to Promote Informed Patient Driven Care in a Locally Integrated English Diabetes Health Economy.|Completed||N/A|17002|Actual|The Royal Wolverhampton Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 00:10:30.534999|2017-10-11 00:10:30.534999
NCT02200952|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-07-25|||June 2013||2013-06-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01|9 Months|Observational [Patient Registry]|||Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS|Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS|Unknown status|Recruiting|N/A|16|Anticipated|San Carlo Public Hospital, Potenza, Italy|||1||f||||f||||||||||2017-10-11 00:10:30.608677|2017-10-11 00:10:30.608677
NCT02200939|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-07-10|||July 2014||2014-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Post-Market Evaluation of the Rotation Medical Rotator Cuff System|Post-Market Evaluation of the Rotation Medical Rotator Cuff System|Recruiting||N/A|100|Anticipated|Rotation Medical, Inc.||2|||f||||f||||||||||2017-10-11 00:10:30.703272|2017-10-11 00:10:30.703272
NCT02200926|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-09-08|||July 2014||2014-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|November 2015|Actual|2015-11-01||Interventional|||Non-pharmacological Treatment for Essential Isolated Systolic Hypertension in Elderly|Effects of Slow Loaded and Unloaded Breathing Training|Completed||N/A|30|Actual|Khon Kaen University||3|||f||||t||||||||Undecided||2017-10-11 00:10:30.818251|2017-10-11 00:10:30.818251
NCT02200913|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-08-25|||August 2014||2014-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Core Stabilization Exercise on Balance|Effects of Core Stabilization Exercise on Balance in Low Back Pain Patients With Clinical Lumbar Instability|Recruiting||N/A|60|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-10-11 00:10:30.911713|2017-10-11 00:10:30.911713
NCT02200900|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||August 2014||2014-08-01|July 2014|2014-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Study of Respiratory Physiology During High Flow Nasal Cannula Treatment in Preterm Neonates.|Study of Nasopharyngeal Pressures, Tidal Breathing Indices and Inspired Gas Concentrations During High Flow Nasal Cannula (HFNC) and CPAP Treatment in Neonates|Unknown status|Not yet recruiting|N/A|45|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 00:10:31.002573|2017-10-11 00:10:31.002573
NCT02200887|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||September 2013||2013-09-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Sleep Homeostasis in Parkinson's Disease|Ruolo Della Sleep Homeostasis Nello Sviluppo Delle Discinesie Indotte Della L-Dopa Nei Pazienti Affetti da Malattia di Parkinson in Fase Avanzata. The Role of Sleep Homeostasis in the Progress of Dyskinesi, Induced by L-Dopa in Patients With Advanced Parkinsons Disease.|Unknown status|Recruiting|N/A|48|Anticipated|Ospedale Civico, Lugano|||4||f||||f||||||||||2017-10-11 00:10:31.20244|2017-10-11 00:10:31.20244
NCT02200874|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-10-25|||November 2012||2012-11-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Investigation of the Effectiveness and Efficiency of a Structural Clinical Nutrition Support|Investigation of the Effectiveness and Efficiency of a Structural Clinical Nutrition Support by an Interdisciplinary Nutrition Support Team at the University Hospital Tübingen|Recruiting||N/A|840|Anticipated|University of Hohenheim|||2||f||||f||||||||||2017-10-11 00:10:31.297174|2017-10-11 00:10:31.297174
NCT02200276|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-10-29|||March 2014||2014-03-01|October 2015|2015-10-01|June 2019|Anticipated|2019-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Influenza Immunization in Adults Over Age 75|Influenza Immunization in Adults Over Age 75|Recruiting||N/A|525|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 00:10:39.615804|2017-10-11 00:10:39.615804
NCT02200848|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-05-10|||April 2014||2014-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)|A Phase I Study of Lenalidomide in Combination With Rituximab and Ibrutinib in Relapsed and Refractory CLL and SLL|Terminated||Phase 1|5|Actual|Georgetown University||1||Recruitment difficulties|f||||t||||||||||2017-10-11 00:10:31.501456|2017-10-11 00:10:31.501456
NCT02200835|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||January 2012||2012-01-01|January 2014|2014-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Gender-related Differences in Chinese Patients With AAD||Completed||N/A|2015|Actual|General Hospital of Beijing PLA Military Region|||1||f||||t||||||||||2017-10-11 00:10:31.642858|2017-10-11 00:10:31.642858
NCT02200822|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||July 2014||2014-07-01|July 2014|2014-07-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|STOP-CRT||Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients|Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding Patients to Cardiac Resynchronization Therapy: the STOP-CRT Trial|Unknown status|Recruiting|Phase 4|80|Anticipated|Hasselt University||4|||f||||t||||||||||2017-10-11 00:10:31.721303|2017-10-11 00:10:31.721303
NCT02200809|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-11-23|||July 2014||2014-07-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||MR-guided Focal Laser Ablation of the Prostate|MR-guided Focal Laser Ablation of the Prostate|Active, not recruiting||Phase 2|20|Anticipated|Radboud University||1|||f||||f||||||||||2017-10-11 00:10:31.876282|2017-10-11 00:10:31.876282
NCT02200796|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2016-06-27|||April 2014||2014-04-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Role of Dietary Protein on Satiety, Food Intake and Thermic Effect of Food|Role of Dietary Protein in a Familiar Breakfast Meal on Subjective Satiety, Food Intake and Thermic Effect of Food in Normal Weight and Overweight/Obese Children|Completed||N/A|21|Actual|Ryerson University||4|||f||||f||||||||||2017-10-11 00:10:31.981304|2017-10-11 00:10:31.981304
NCT02200783|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-07-21|||July 2014||2014-07-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|July 2015|Actual|2015-07-01||Interventional|TRIPTABLE||Randomized Comparison of Radiological Exposure With TRIPTable® in Patients With Acute Coronary Syndromes|Randomized Comparison of Radiological Exposure Between Radial and Femoral Technique Assessing Use of Protective Device Dedicated TRIPTable® in Patients With Acute Coronary Syndromes Undergoing Cardiac Catheterization|Unknown status|Active, not recruiting|N/A|99|Anticipated|Marilia Medicine School||3|||f||||f||||||||||2017-10-11 00:10:32.090478|2017-10-11 00:10:32.090478
NCT02200770|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-09-28|||January 6, 2015|Actual|2015-01-06|September 2017|2017-09-01|May 10, 2023|Anticipated|2023-05-10|May 15, 2019|Anticipated|2019-05-15||Interventional|||A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders|A Double-masked, Placebo-controlled Study With Open-label Period to Evaluate the Efficacy and Safety of MEDI-551 in Adult Subjects With Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders|Recruiting||Phase 2/Phase 3|252|Anticipated|MedImmune LLC||2|||f||||t|t|f||||||||2017-10-11 00:10:32.235825|2017-10-11 00:10:32.235825
NCT02200757|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-08-17|||September 2014||2014-09-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|September 2016|Anticipated|2016-09-01||Interventional|||Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer|A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy|Recruiting||Phase 2|132|Anticipated|CytRx||2|||f||||t||||||||||2017-10-11 00:10:32.593822|2017-10-11 00:10:32.593822
NCT02200744|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2015-02-03|||April 2014||2014-04-01|February 2015|2015-02-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Observational|MEMOPROPO||Incidence of Recall After Procedural Sedation With Propofol in the Emergency Department|Incidence of Recall After Procedural Sedation With Propofol in the Emergency Department|Unknown status|Recruiting|N/A|250|Anticipated|Centre Hospitalier Universitaire de la Réunion|||1||f||||f||||||||||2017-10-11 00:10:33.157043|2017-10-11 00:10:33.157043
NCT02200731|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2016-12-16|||July 2014||2014-07-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||FAMOS: Psychosocial Intervention for Childhood Cancer Survivors and Their Families|FAMOS: The Effect of Psychosocial Intervention for Childhood Cancer Survivors and Their Families: A Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|Danish Cancer Society||2|||f||||f||||||||Undecided||2017-10-11 00:10:33.26948|2017-10-11 00:10:33.26948
NCT02200718|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-02-22|||November 2017||2017-11-01|February 2016|2016-02-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis|A Phase I Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis|Not yet recruiting||Phase 1|12|Anticipated|Immune Response BioPharma, Inc.||2|||f||||t||||||||||2017-10-11 00:10:33.378035|2017-10-11 00:10:33.378035
NCT02200705|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-05-09|||October 2014||2014-10-01|September 2016|2016-09-01|July 2021|Anticipated|2021-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Cryoablation of Low Risk Small Breast Cancer- Ice3 Trial|Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial)|Recruiting||N/A|150|Anticipated|IceCure Medical Ltd.||1|||f||||||||||||||2017-10-11 00:10:33.496824|2017-10-11 00:10:33.496824
NCT02200692|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-10-06|||June 2014||2014-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Observational|||Allergic Transfusion Reactions in Plasma Transfusion|Risk Factors for Allergic Transfusion Reactions in Patients Receiving Plasma Transfusion|Active, not recruiting||N/A|20|Anticipated|Haukeland University Hospital|||1||f||||f||||||Samples Without DNA|"     Samples from patients receiving plasma transfusion and samples from plasma units transfused.   "|No||2017-10-11 00:10:33.625366|2017-10-11 00:10:33.625366
NCT02200679|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-05-15|||January 2014||2014-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||National Study on Autism Spectrum Disorder in China|Study on Approach and Standards for Diagnosis, Prevention and Control of Autism Spectrum Disorder in Children in China|Completed||N/A|143755|Actual|Fudan University|||1||f||||t||||||Samples With DNA|"     whole blood 2*5ml, (isolate Plasma, Serum and white cell) Hair, Urine(biosample will be     collected only for Cases 1200 +Controls 1200)   "|||2017-10-11 00:10:33.707984|2017-10-11 00:10:33.707984
NCT02200666|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-09-18|||October 3, 2014|Actual|2014-10-03|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Observational|||Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use|Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use|Active, not recruiting||N/A|21|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:10:33.815867|2017-10-11 00:10:33.815867
NCT02200653|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||May 2000||2000-05-01|July 2014|2014-07-01||||February 2001|Actual|2001-02-01||Interventional|TOPAS||A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)|A Prospective, Randomised, Double-Blind, Double-Dummy, Titration-to-Response Trial Comparing MICARDIS® (Telmisartan) (40 or 80 mg p.o. Once Daily) and COZAAR® / LORZAAR® (Losartan) (50 or 100 mg p.o. Once Daily) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (TOPAS STUDY = Telmisartan and LOsartan ComParative ABPM Study)|Completed||Phase 4|387|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:10:34.076493|2017-10-11 00:10:34.076493
NCT02200640|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||March 2000||2000-03-01|July 2014|2014-07-01||||December 2000|Actual|2000-12-01||Interventional|||A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)|A Prospective, Randomized, Double-Blind, Double-Dummy, Titration-to-Response Trial Comparing MICARDIS® (Telmisartan) (40 & 80 mg QD) and COZAAR® (Losartan) (50 & 100 mg QD) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring|Completed||Phase 4|333|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:10:34.170204|2017-10-11 00:10:34.170204
NCT02200627|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-02-21|||September 2014||2014-09-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Forxiga Tablets Specific Clinical Experience Investigation for Elderly|Forxiga Tablets Specific Clinical Experience Investigation for Elderly|Completed||N/A|1724|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:10:34.289423|2017-10-11 00:10:34.289423
NCT02200614|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-09-26|||September 12, 2014|Actual|2014-09-12|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|April 16, 2018|Anticipated|2018-04-16||Interventional|ARAMIS||Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer (ARAMIS)|A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer|Recruiting||Phase 3|1500|Anticipated|Bayer||2|||f||||t|t|f||||||||2017-10-11 00:10:34.504809|2017-10-11 00:10:34.504809
NCT02200601|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-02-11|||July 2014||2014-07-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pre-Market Algorithm Validation Study|Pre-Market Algorithm Validation Study|Completed||N/A|30|Actual|Heart Force Medical Inc.||1|||f||||f||||||||||2017-10-11 00:10:35.870017|2017-10-11 00:10:35.870017
NCT02200588|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-03-13|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|2 Days|Observational [Patient Registry]|10PAFIP||Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP|A Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program (PAFIP)|Enrolling by invitation||N/A|277|Anticipated|Fundación Marques de Valdecilla|||2||f||||f|f|f||||Samples With DNA|"     Whole blood, plasma and serum.   "|No||2017-10-11 00:10:35.968871|2017-10-11 00:10:35.968871
NCT02200575|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||May 1999||1999-05-01|July 2014|2014-07-01||||December 2000|Actual|2000-12-01||Observational|||Pharmacovigilance and Patient Compliance in Hypertensive Patients|Pharmacovigilance and Patient Compliance in Hypertensive Patients. Observational Study|Completed||N/A|10333|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:10:36.090383|2017-10-11 00:10:36.090383
NCT02200562|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-02-27|||December 2014||2014-12-01|February 2017|2017-02-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma|A Phase I/II Study of Concurrent Ipilimumab and Dabrafenib in Unresectable Stage III or Stage IV Melanoma|Terminated||Phase 1|6|Actual|University of Utah||1||"BMS withdrew support and required this trial to stop enrolling; Phase II portion never began,   only a Phase I trial."|f||||t||||||||||2017-10-11 00:10:36.220735|2017-10-11 00:10:36.220735
NCT02200549|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2017-05-16|||December 2014||2014-12-01|March 2016|2016-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effects of Combined Cycle Training and Inspiratory Muscle Training in Patients With COPD|Effects of Combined Cycle Training and Inspiratory Muscle Training on Exercise Performance ,Health-related Quality,Dyspnoea ,Body Composition,Depressive Symptomatology in Patients With Chronic Obstructive Pulmonary Disease(COPD)|Completed||N/A|90|Actual|Zhujiang Hospital||3|||f||||t||||||||No||2017-10-11 00:10:36.983866|2017-10-11 00:10:36.983866
NCT02200536|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-03-25|2015-02-13||March 2013||2013-03-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Impact of Providing Free Preventive Dental Health Products on Infant's Tooth Brushing and Bottle-feeding Termination Practices|Effectiveness of an Oral Health Promotion Program in Infant's Tooth Brushing and Bottle-feeding Termination Practices: a Randomized Controlled Trial|Completed||N/A|92|Actual|Damascus University||3|||f||||t||||||||||2017-10-11 00:10:37.155827|2017-10-11 00:10:37.155827
NCT02200523|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-01-26|||June 2014||2014-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|SARA||Self Abrading Rapidly Applied Electrode Validation|Self Abrading Rapidly Applied (SARA) Electrode Phase II|Completed||N/A|48|Actual|Cleveland Medical Devices Inc||2|||f||||f||||||||||2017-10-11 00:10:37.508197|2017-10-11 00:10:37.508197
NCT02200510|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-08-26|||June 2011||2011-06-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|iTransition||Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease|Patient-Provider Interventions to Improve Transition to Adult Care in SCD|Completed||N/A|72|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||No||2017-10-11 00:10:37.614311|2017-10-11 00:10:37.614311
NCT02200484|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2015-04-09|||April 2013||2013-04-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Project HERA||Project HERA (Health, Education, and Relationship-building for Adolescents- Moms and Tots)|Helping Ethnically Diverse Teen Moms Prevent Obesity in Their Preschool Children|Completed||Phase 1/Phase 2|25|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 00:10:37.719816|2017-10-11 00:10:37.719816
NCT02200471|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-02-02|||October 2013||2013-10-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Cosmetic Dermatology Study|Evaluation of VeinViewer in Cosmetic Dermatology|Unknown status|Recruiting|Phase 4|100|Anticipated|Christie Medical Holdings, Inc.||1|||f||||f||||||||||2017-10-11 00:10:37.820295|2017-10-11 00:10:37.820295
NCT02200458|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-03-03|2015-02-02||November 2012||2012-11-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Near-infrared Software Performance Study|Near-Infrared Software Performance Study|Completed||N/A|62|Actual|Christie Medical Holdings, Inc.||1|||f||||f||||||||||2017-10-11 00:10:37.921108|2017-10-11 00:10:37.921108
NCT02200445|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-06-20|||February 2015||2015-02-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Low Dose IL-2 for Ulcerative Colitis|A Phase I Study of Low Dose Subcutaneous Interleukin-2 (IL-2) For The Treatment of Ulcerative Colitis.|Recruiting||Phase 1|28|Anticipated|Boston Children’s Hospital||1|||f||||t|t|f||||||Undecided||2017-10-11 00:10:38.159174|2017-10-11 00:10:38.159174
NCT02200432|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-07-07|||May 2014||2014-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|PERSPECT||Patient Experience Recommender System for Persuasive Communication Tailoring|PERSPECT: Patient Experience Recommender System for Persuasive Communication Tailoring|Completed||N/A|972|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-11 00:10:38.286421|2017-10-11 00:10:38.286421
NCT02200419|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-12-01|||October 2014||2014-10-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|TACS||POC - Transfusion Algorithm Cardiac Study|Blood Conservation in Cardiac Surgery Using a Novel Transfusion Algorithm Based on Point-of-care Testing-A Stepped-wedge Cluster Randomized Controlled Trial|Completed||N/A|7402|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 00:10:38.370923|2017-10-11 00:10:38.370923
NCT02200406|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-15|||July 2014||2014-07-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Desvenlafaxine in Opioid-Dependent Patients|An Open-Label Pilot Study of Desvenlafaxine for Opioid-Dependent Patients With Comorbid Depression|Completed||Phase 4|18|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t||||||||||2017-10-11 00:10:38.62964|2017-10-11 00:10:38.62964
NCT02200393|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-24|||February 2011||2011-02-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Abdominal Functional Electrical Stimulation (AFES) to Assist Ventilator Weaning in Tetraplegia|Feasibility Study Using Abdominal Functional Electrical Stimulation (AFES) to Assist Ventilator Weaning in Tetraplegia|Completed||N/A|10|Actual|University of Glasgow||1|||f||||t||||||||||2017-10-11 00:10:38.729832|2017-10-11 00:10:38.729832
NCT02200380|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-04-06||2017-04-06|July 2014||2014-07-01|April 2017|2017-04-01|April 13, 2016|Actual|2016-04-13|March 2016|Actual|2016-03-01||Interventional|||A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs|A Pilot Study of CDX-301 (rhuFlt3L) With or Without Plerixafor for the Mobilization and Transplantation of Allogeneic Blood Cell Grafts in HLA-Matched Donor/Recipient Sibling Pairs|Terminated||Phase 2|36|Actual|Celldex Therapeutics||2|||f||||f||||||||||2017-10-11 00:10:38.817776|2017-10-11 00:10:38.817776
NCT02200367|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-23|||January 2011||2011-01-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||E-mental Health Support for Rural Areas|AN e- MENTAL HEALTH COLLABORATIVE PROGRAMME TO DEPRESSION MANAGEMENT IN RURAL PRIMARY CARE IN CHILE:A PILOT CLINICAL STUDY.|Completed||N/A|254|Actual|University of Chile||2|||f||||f||||||||||2017-10-11 00:10:38.919922|2017-10-11 00:10:38.919922
NCT02200354|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2016-02-22|||July 2014||2014-07-01|January 2016|2016-01-01||||July 2017|Anticipated|2017-07-01||Interventional|||The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab|The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab for Patients With Advanced Non-squamous Non-small Cell Lung Cancer|Recruiting||Phase 2|25|Anticipated|Kobe City General Hospital||1|||f||||f||||||||||2017-10-11 00:10:38.990778|2017-10-11 00:10:38.990778
NCT02200341|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-03-24|||August 2015||2015-08-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effects of Mindfulness-based Cognitive Therapy on Brain Mechanisms in Depression|MBCT Effects on Brain Mechanisms of Interoceptive Awareness and Rumination in MDD|Recruiting||N/A|90|Anticipated|Massachusetts General Hospital||2|||f||||||||||||||2017-10-11 00:10:39.08728|2017-10-11 00:10:39.08728
NCT02200328|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-04-17|2016-03-29||August 2014||2014-08-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients|Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients: A Randomized Clinical Trial|Terminated||Phase 4|76|Actual|The Cleveland Clinic|"Early termination:
Many patients did not comply with the protocol instructions.
Lack of resources to conduct the study.
Many patients did not respond to follow up calls."|2||Patients noncompliant with instructions and follow ups could not be completed.|f||||t||||||||No||2017-10-11 00:10:39.176012|2017-10-11 00:10:39.176012
NCT02200315|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-02-01|||May 2014||2014-05-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|KSWEET-01||No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy|Phase II Study of the Efficacy of no Antimicrobial Prophylaxis Use for Laparoscopic Distal Gastrectomy for Gastric Carcinoma|Completed||Phase 2|98|Actual|Korean South West East Gastric Surgery Group||1|||f||||t||||||||No||2017-10-11 00:10:39.391804|2017-10-11 00:10:39.391804
NCT02200302|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2017-03-07|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01|1 Year|Observational [Patient Registry]|MID-C||Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Adolescent Idiopathic Scoliosis (AIS)|Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Adolescent Idiopathic Scoliosis (AIS)|Terminated||N/A|2|Actual|Apifix|||1|lack of cooperation and compliance|f||||f||||||||||2017-10-11 00:10:39.490807|2017-10-11 00:10:39.490807
NCT02200289|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-11-23|||October 2014||2014-10-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||In Utero Household Air Pollution Exposure and Lung Development in Ghana|In Utero Biomass Smoke Exposure, Pro-oxidant/Antioxidant Imbalance and Lung Function in Rural Ghana|Completed||N/A|400|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||Samples With DNA|"     Cord blood, placenta   "|||2017-10-11 00:10:39.555476|2017-10-11 00:10:39.555476
NCT02200263|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-12-21|||November 2014||2014-11-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|LUVIA||The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism|A Randomized Placebo-controlled Trial to Investigate the Effect of Lutein and Zeaxanthin Supplementation on Macular Pigment and Visual Function in Albinism - LUtein for VIsion in Albinism (LUVIA)|Recruiting||N/A|28|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-11 00:10:39.695331|2017-10-11 00:10:39.695331
NCT02200250|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-12-15|||October 2013||2013-10-01|December 2015|2015-12-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|CBE||Long Term Barrett's Endoscopic Mucosal Resection Study|Long Term Outcomes of Patients Undergoing Endoscopic Resection of Barrett's Oesophagus (BO) With High Grade Dysplasia (HGD) and Early Adenocarcinoma|Recruiting||N/A|200|Anticipated|Western Sydney Local Health District|||1||f||||t||||||||||2017-10-11 00:10:39.796503|2017-10-11 00:10:39.796503
NCT02200237|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-08-15|||September 2014||2014-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|EV71||A Clinical Study for Inactivated Vaccine Against EV71||Completed||Phase 2|366|Actual|Medigen Vaccine Biologics Corp.||2|||f||||t||||||||||2017-10-11 00:10:39.872605|2017-10-11 00:10:39.872605
NCT02200224|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-05-06|||April 2015||2015-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Clinical Utility of Rapid CT/NG Testing in the ED|Clinical Utility of Rapid CT/NG Testing in the ED|Completed||N/A|300|Actual|Johns Hopkins University||2|||f||||f||||||||No||2017-10-11 00:10:39.95553|2017-10-11 00:10:39.95553
NCT02200211|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-04-11|||September 11, 2014|Actual|2014-09-11|April 2017|2017-04-01|August 19, 2016|Actual|2016-08-19|August 19, 2016|Actual|2016-08-19||Interventional|ATS18||Study of Binocular Computer Activities for Treatment of Amblyopia|Study of Binocular Computer Activities for Treatment of Amblyopia|Completed||N/A|485|Actual|Jaeb Center for Health Research||2|||f||||t||||||||Yes|In accordance with the NIH data sharing policy, a de-identified database is placed in the public domain on the PEDIG public website after the completion of each protocol and publication of the primary manuscript.|2017-10-11 00:10:40.038163|2017-10-11 00:10:40.038163
NCT02200198|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-07-24|||February 2011||2011-02-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Respiratory Muscle Training in Malnourished Patients Undergoing Abdominal Surgery|Effect of Respiratory Muscle Training in Malnourished Patients Undergoing Upper Abdominal Surgery|Completed||N/A|45|Actual|University of Sao Paulo General Hospital||3|||f||||f||||||||||2017-10-11 00:10:40.132818|2017-10-11 00:10:40.132818
NCT02200185|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-11-26|||April 2012||2012-04-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TIMORNEB||Titrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings|Efficacy and Safety of Nebulized Morphine Given at Two Different Doses Compared to Intravenous Morphine in Post-traumatic Acute Pain: a Randomized Controlled Double Blind Study|Completed||N/A|300|Actual|University of Monastir||3|||f||||t||||||||||2017-10-11 00:10:40.205684|2017-10-11 00:10:40.205684
NCT02200172|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-07-18|||December 2014||2014-12-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study|The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study Prior to a Larger Randomized Controlled Trial|Completed||Phase 2|60|Actual|Bruyere Research Institute||2|||f||||t||||||||||2017-10-11 00:10:42.26713|2017-10-11 00:10:42.26713
NCT02200159|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-11-25|||June 2014||2014-06-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Predictive Factors of Failure or Success of Sedation With Dexmedetomidine in ICU|Predictive Factors of Failure or Success of Sedation With Dexmedetomidine in ICU|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:10:42.373626|2017-10-11 00:10:42.373626
NCT02200146|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-24|||March 2009||2009-03-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|HySSAS||Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).|Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). A Multicenter, Prospective, Controlled, Randomized Trial.|Completed||Phase 3|94|Actual|University of Milano Bicocca||2|||f||||t||||||||||2017-10-11 00:10:42.465577|2017-10-11 00:10:42.465577
NCT02200133|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-09-05|||April 2015||2015-04-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors|Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors|Completed||N/A|495|Anticipated|Center for International Blood and Marrow Transplant Research||2|||f||||t||||||||||2017-10-11 00:10:42.552796|2017-10-11 00:10:42.552796
NCT02200120|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-07-20|||January 2013||2013-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury|Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury- Assessment of Dialysis Adequacy and Infection Rates|Completed||N/A|150|Actual|Brigham and Women's Hospital|||1||f||||t||||||||||2017-10-11 00:10:42.687942|2017-10-11 00:10:42.687942
NCT02200107|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-04-12|||September 2014||2014-09-01|July 2014|2014-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Integrated Treatment Program for Osteoarthritis of the Knee|Implementing and Evaluating Integrated Medical and Physiotherapy Treatment Program for Osteoarthritis of the Knee by Family Doctors in Primary Care Clinics|Unknown status|Recruiting|N/A|155|Anticipated|Meir Medical Center||2|||f||||||||||||||2017-10-11 00:10:42.763947|2017-10-11 00:10:42.763947
NCT02200094|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||December 1999||1999-12-01|July 2014|2014-07-01||||October 2000|Actual|2000-10-01||Observational|||Micardis®. Observational Study in Patients With Essential Hypertension|Micardis®. Observational Study|Completed||N/A|4532|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:10:42.857176|2017-10-11 00:10:42.857176
NCT02200081|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-03-22|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|IMPULSE||Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC|Randomized Clinical Study of Maintenance Therapy With Immunomodulator MGN1703 in Patients With Extensive Disease Small Cell Lung Cancer After Platinum-Based First-Line Therapy|Active, not recruiting||Phase 2|102|Actual|Mologen AG||2|||f||||t||||||||||2017-10-11 00:10:42.941835|2017-10-11 00:10:42.941835
NCT02200068|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-06-17|||June 2014||2014-06-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CARNet||CARNet : Self-Monitoring and Co-driving in Rheumatology With Internet : Rheumatoid Arthritis Cohort (Usual Care Study)|Usual Care Randomized Study Measuring the Impact of an Online Personal Health Record (Sanoia) in Rheumatoid Arthritis Patients on Reported Outcomes|Completed||N/A|320|Actual|Association Accompagnement pour un Internet en Médecine et Santé au Service des Usagers||2|||f||||f||||||||||2017-10-11 00:10:43.043389|2017-10-11 00:10:43.043389
NCT02200055|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-09-21|||May 2012||2012-05-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need|The Use of Multifrequency Bioimpedance Assessments as an Estimate of Perioperative Total Body Volume and Postoperative Fluid Resuscitation|Completed||N/A|86|Actual|United States Naval Medical Center, Portsmouth||1|||f||||f||||||||Yes|Data analysis has been hampered by a shift in biostatisticians within the command. Funding being secured for new biostats position in our department|2017-10-11 00:10:43.315842|2017-10-11 00:10:43.315842
NCT02200042|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-09-06|||September 29, 2014|Actual|2014-09-29|September 2017|2017-09-01|July 2024|Anticipated|2024-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Gemcitabine Hydrochloride and Cisplatin With or Without Radiation Therapy in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery|Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma|Recruiting||Phase 3|182|Anticipated|NRG Oncology||2|||f||||t||||||||||2017-10-11 00:10:43.437787|2017-10-11 00:10:43.437787
NCT02200029|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-06-15|||June 2014||2014-06-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption|Open-Label Study With Ademetionine (Heptral®) in Subjects With Intrahepatic Cholestasis (IHC) Associated With Alcoholic Liver Disease (ALD)|Completed||Phase 3|75|Actual|Abbott||2|||f||||f||||||||||2017-10-11 00:10:43.737834|2017-10-11 00:10:43.737834
NCT02200016|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-06-10|||November 2014||2014-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Displacement of Popliteal Sciatic Nerve Catheters After Major Foot and Ankle Surgery||Completed||Phase 4|40|Actual|Kolding Sygehus||2|||f||||t||||||||||2017-10-11 00:10:43.855876|2017-10-11 00:10:43.855876
NCT02200003|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-08-08|||February 2015||2015-02-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|ABMT||Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers|Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers|Recruiting||Phase 3|90|Anticipated|Hunter College of City University of New York||2|||f||||t||||||||||2017-10-11 00:10:43.970042|2017-10-11 00:10:43.970042
NCT02199990|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2014-07-23|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01|3 Months|Observational [Patient Registry]|||The Effect of Propofol or Etomidate on Cognitive Function for 1-3 Years Old Children|the Study of Propofol or Etomidate Affecting to the Cognitive Function for 1-3 Years Old Children in the 7 Days and 3 Months.|Unknown status|Recruiting|N/A|150|Anticipated|Guilin Medical University, China|||1||f||||t||||||||||2017-10-11 00:10:44.088195|2017-10-11 00:10:44.088195
NCT02199977|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-12-14|||June 2014||2014-06-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector|Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector|Completed||N/A|444|Actual|Duke University||4|||f||||f||||||||||2017-10-11 00:10:44.168284|2017-10-11 00:10:44.168284
NCT02199951|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-07-24|||September 2013||2013-09-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Observational|||Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania|Observational Study to Evaluate the Clinical Safety After Introduction of the Fixed Dose Artemisinin-based Combination Therapy Eurartesim® (Dihydroartemisinin/Piperaquine [Dha/Pqp]) in Public Health Districts in Sub-Saharan Africa.|Unknown status|Recruiting|Phase 4|10000|Anticipated|INDEPTH Network|||1||f||||t||||||||||2017-10-11 00:10:44.417907|2017-10-11 00:10:44.417907
NCT02199938|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-05-16|||January 2010||2010-01-01|April 2016|2016-04-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Identification and Characterization of Molecular Markers in Musculoskeletal Tumors|Identification and Characterization of Molecular Markers in Musculoskeletal Tumors|Recruiting||N/A|1000|Anticipated|Balgrist University Hospital|||1||f||||f||||||Samples With DNA|"     blood serum blood plasma tumor tissue tumor free tissue   "|Undecided||2017-10-11 00:10:44.588492|2017-10-11 00:10:44.588492
NCT02199925|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-04-15|||June 2013||2013-06-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|April 2015|Anticipated|2015-04-01||Interventional|||An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum|A Phase IV, Single-site, Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|IMMUNOe International Research Centers||1|||f||||t||||||||||2017-10-11 00:10:44.703442|2017-10-11 00:10:44.703442
NCT02199912|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-08-18|||October 7, 2013|Actual|2013-10-07|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|ANC2||Study of the Relationship Between Clinical and Paraclinical Markers During Situations of Cachexia and Pre-cachexia in Patients Over 70 Years With Colorectal Surgery|ANC2 Pilot Study Study of the Relationship Between Clinical and Paraclinical Markers During Situations of Cachexia and Pre-cachexia in Patients Over 70 Years With Colorectal Surgery|Recruiting||N/A|60|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:10:44.800467|2017-10-11 00:10:44.800467
NCT02199899|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||March 1999||1999-03-01|July 2014|2014-07-01||||July 1999|Actual|1999-07-01||Interventional|||Safety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male Volunteers|A Single Increasing Dose Safety, Tolerability and Pharmacodynamics (Citric Acid Challenge) Study After Oral Administration of BIIF 1149 BS (Drinking Solution, Single Doses: 0.1 - 25 mg; in Addition, at 25 mg Also as a 25 mg Tablet) in Healthy Young Male Volunteers (Randomised, Double-blind, Placebo-controlled, Parallel Groups)|Completed||Phase 1|64|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:10:44.931006|2017-10-11 00:10:44.931006
NCT02199886|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||July 1998||1998-07-01|July 2014|2014-07-01||||December 2001|Actual|2001-12-01||Interventional|||Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection|A Phase I Single Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection|Terminated||Phase 1|6|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:10:45.037004|2017-10-11 00:10:45.037004
NCT02199873|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-10-28|||June 1998||1998-06-01|October 2014|2014-10-01||||September 1998|Actual|1998-09-01||Interventional|||Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers|A Single Increasing Dose Safety, Tolerability and Pharmacodynamics (Methacholine Challenge) Study After Inhalational Administration of BIIX 1 XX (Single Doses: 5 - 800 mcg) in Healthy Young Male Volunteers (Randomised, Double-blind, Placebo-controlled)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:10:45.108835|2017-10-11 00:10:45.108835
NCT02199860|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||May 2003||2003-05-01|July 2014|2014-07-01||||February 2004|Actual|2004-02-01||Interventional|||Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers|A Double-blind (at Each Dose Level), Randomised, Placebo-controlled, Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Two Spray-dried Formulations of BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers|Completed||Phase 1|63|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:10:45.427546|2017-10-11 00:10:45.427546
NCT02199847|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-24|2014-07-24|||June 2000||2000-06-01|July 2014|2014-07-01||||January 2001|Actual|2001-01-01||Interventional|||Evaluation of the Effects of Pharmaton Tablets on Mental Performance and Physical Fatigue in Nurses Working Night Shift|An Evaluation of the Effects of Pharmaton® Caplets Film-coated Tablets on Mental Performance and Physical Fatigue in Nurses Working Night Shifts: a Double-blind, Placebo Controlled Pilot Trial|Completed||Phase 2|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:10:45.516654|2017-10-11 00:10:45.516654
NCT02199834|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-12-21|||February 2013||2013-02-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Personalized Feedback Report and Peer Support on Diabetes|A Quality Improvement Project Evaluating the Effect of Regular Personalized Feedback Report and Peer Support for Patients With Diabetes in Hong Kong|Completed||N/A|1488|Actual|Chinese University of Hong Kong||4|||f||||f||||||||||2017-10-11 00:10:45.606242|2017-10-11 00:10:45.606242
NCT02199821|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-07-24|||February 2011||2011-02-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|||Inflammatory Response With Different Lipid Emulsions In Parenteral Nutrition In Children After Bone Marrow Transplantation||Completed||N/A|14|Actual|Maimónides Biomedical Research Institute of Córdoba||2|||f||||||||||||||2017-10-11 00:10:45.719479|2017-10-11 00:10:45.719479
NCT02199808|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-04-21|||April 2014||2014-04-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Fatty Acids and Executive Function Development in 7-12 Year Olds|Fatty Acids and Executive Functions: Cortical Activation and Behavioral Performance.|Completed||N/A|79|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-11 00:10:45.79255|2017-10-11 00:10:45.79255
NCT02199782|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-23|||February 2015||2015-02-01|July 2014|2014-07-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Pilot Study of Cognitive Assessment in Welsh Speakers|Pilot Study of Cognitive Assessment in Welsh Speakers|Unknown status|Not yet recruiting|N/A|100|Anticipated|National Health Service, United Kingdom||2|||f||||f||||||||||2017-10-11 00:10:46.000444|2017-10-11 00:10:46.000444
NCT02199769|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-23|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Reducing Type 2 Diabetes Diagnostic Delays Using Decision Support|Harnessing the Electronic Medical Record to Reduce Delays in the Diagnosis of Type 2 Diabetes: a Systems-based, Decision Support Approach|Unknown status|Active, not recruiting|N/A|500|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 00:10:46.13889|2017-10-11 00:10:46.13889
NCT02199756|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-05-01|||July 2014||2014-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Nanovectors to Prevent Placental Passage of Tocolytic Agents|Development of Nanovectors to Prevent Placental Passage of a Tocolytic Agent|Recruiting||N/A|24|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples Without DNA|"     Uterine biopsy   "|||2017-10-11 00:10:46.275732|2017-10-11 00:10:46.275732
NCT02199743|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-12-28|||February 2013||2013-02-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Lurasidone Effects on Tissue Glutamate in Schizophrenia|Lurasidone Effects on Tissue Glutamate in Schizophrenia|Completed||Phase 4|50|Actual|University of Texas Southwestern Medical Center||3|||f||||f||||||||||2017-10-11 00:10:46.373173|2017-10-11 00:10:46.373173
NCT02199717|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-12-08|2016-10-12||September 2013||2013-09-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|July 2014|Actual|2014-07-01|7 Days|Observational [Patient Registry]|HEPS|42 boys with severe hemophilia 24 boys with moderate/mild hemophilia|An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia|An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia|Completed||N/A|66|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 00:10:46.490226|2017-10-11 00:10:46.490226
NCT02199704|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-07-31|||June 2014||2014-06-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series|Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series|Completed||N/A|1|Actual|University of Manchester||1|||f||||f||||||||||2017-10-11 00:10:46.752706|2017-10-11 00:10:46.752706
NCT02199509|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-06-12|2017-03-28||July 2014||2014-07-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia|Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia: A Randomized, Double-Blind Placebo-Controlled Cross-Over Study|Completed||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 00:10:48.565936|2017-10-11 00:10:48.565936
NCT02199691|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-11-06||2015-09-29|July 2014||2014-07-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Interventional|||Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents|A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents|Completed||Phase 2|1692|Actual|Sanofi||4|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-11 00:10:46.857282|2017-10-11 00:10:46.857282
NCT02199678|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-11-19|||July 2014||2014-07-01|July 2014|2014-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction|A Randomized,Double Blind, Parallel Group, Placebo Controlled Dose Ranging Study to Assess the Analgesic Efficacy, Tolerability, Safety and Pharmacokinetic/Pharmacodynamic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction|Completed||Phase 2|120|Actual|Lotus Clinical Research, LLC||4|||f||||f||||||||||2017-10-11 00:10:47.066254|2017-10-11 00:10:47.066254
NCT02199665|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-11-28|||June 2014||2014-06-01|November 2016|2016-11-01||||April 2018|Anticipated|2018-04-01||Interventional|SINE||Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase I Study of the Combination of a Selective Inhibitor of Nuclear Export (SINE), Selinexor With Carfilzomib and Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1|48|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-11 00:10:47.146781|2017-10-11 00:10:47.146781
NCT02199652|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-08-10|||March 2014||2014-03-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|REST-ON PTSD||Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)|Reducing Suicidal Ideation Through Treatment of Nightmares-PTSD|Recruiting||Phase 4|10|Anticipated|Augusta University||2|||f||||t||||||||No||2017-10-11 00:10:47.254402|2017-10-11 00:10:47.254402
NCT02199639|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-04-29|||March 2014||2014-03-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|ibHEro||Transcultural Multidisciplinary Evaluation of Patients With Hemophili|Multidisciplinary Evaluation of Patients With Hemophilia of Spain, El Salvador and Bolivia. An Observational Study|Unknown status|Recruiting|N/A|100|Anticipated|Universidad Católica San Antonio de Murcia|||3||f||||f||||||||||2017-10-11 00:10:47.347735|2017-10-11 00:10:47.347735
NCT02199626|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-23|||September 2013||2013-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||SECOND GENERATION COLON CAPSULE ENDOSCOPY (CCE-2) IN PEDIATRIC CROHN'S DISEASE (CD).|SECOND GENERATION COLON CAPSULE ENDOSCOPY (CCE-2) IN PEDIATRIC CROHN'S DISEASE (CD).|Completed||Phase 4|40|Actual|Azienda Policlinico Umberto I||1|||f||||f||||||||||2017-10-11 00:10:47.435227|2017-10-11 00:10:47.435227
NCT02199613|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-06-16|||October 2014||2014-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|QuaDar||Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy|Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir in Treatment-experienced Patients: Quality Control Monitoring of a Treatment Simplification Strategy|Active, not recruiting||Phase 4|10|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 00:10:47.502736|2017-10-11 00:10:47.502736
NCT02199600|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-04-07|||October 2012||2012-10-01|April 2016|2016-04-01||||October 2022|Anticipated|2022-10-01||Interventional|||The Medacta International GMK Sphere Post-Marketing Surveillance Study||Recruiting||N/A|500|Anticipated|Medacta International SA||1|||f||||||||||||||2017-10-11 00:10:47.596478|2017-10-11 00:10:47.596478
NCT02199587|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-11-23|||December 2014||2014-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test|The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or Growth Hormone Provocation Test|Recruiting||N/A|80|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 00:10:47.698237|2017-10-11 00:10:47.698237
NCT02199574|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-05-20|2016-05-20||August 2014||2014-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional||11 participants received 133 mg/10 mL EXPAREL following protocol amendment subsequent to 1 participant receiving 266 mg/20 mL EXPAREL according to the original protocol.|Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy|Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy|Completed||Phase 4|12|Actual|Pacira Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-11 00:10:47.785807|2017-10-11 00:10:47.785807
NCT02199561|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-12-13|||July 2014||2014-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease|A Prospective, Single Center, Open Label Trial of Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease|Completed||Phase 1/Phase 2|3|Actual|University of Alberta||1|||f||||t||||||||||2017-10-11 00:10:48.163521|2017-10-11 00:10:48.163521
NCT02199548|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-06-03|||July 2014||2014-07-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||The Good Patient Study|The Good Patient Study|Completed||N/A|43|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 00:10:48.248077|2017-10-11 00:10:48.248077
NCT02199535|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-11-04|||August 2014||2014-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||The Analysis of the Risks of the Personnel Working in Anesthesiology Departments in Turkey|The Analysis of the Risks of the Personnel Working in Anesthesiology Departments in Turkey|Completed||N/A|568|Actual|TC Erciyes University|||1||f||||f||||||||||2017-10-11 00:10:48.347952|2017-10-11 00:10:48.347952
NCT02199522|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-27|||July 2014||2014-07-01|July 2014|2014-07-01|November 2014|Anticipated|2014-11-01|July 2014|Anticipated|2014-07-01||Interventional|||Clinical Observation of Titration Induction and Convention Induction of Propofol|Clinical Observation of Titration Induction and Convention Induction of Propofol|Unknown status|Recruiting|Phase 4|160|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:10:48.4369|2017-10-11 00:10:48.4369
NCT02199496|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-10-05|||July 16, 2014||2014-07-16|July 12, 2017|2017-07-12|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency|An Open-Label Phase I/II Pilot Study to Assess the Safety/Tolerability and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency|Recruiting||Phase 1/Phase 2|10|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:10:48.850297|2017-10-11 00:10:48.850297
NCT02199483|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2017-06-30|||July 21, 2014||2014-07-21|June 29, 2017|2017-06-29|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Observational|||Metabolic and Neural Adaptations to Weight Loss, Plateau, and Regain|Metabolic and Neural Adaptations to Weight Loss, Plateau, and Regain|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:10:48.961787|2017-10-11 00:10:48.961787
NCT02199470|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2016-09-02|||April 2013||2013-04-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Observational|||β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed|β-cell Function in Type Diabetes May Not Be As Low As Presumed|Completed||N/A|135|Actual|Istanbul Medeniyet University|||3||f||||f||||||Samples Without DNA|"     Serum c-peptide levels   "|||2017-10-11 00:10:49.059077|2017-10-11 00:10:49.059077
NCT02199457|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-08-22|||July 2017||2017-07-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Demonstrate the Clinical Accuracy of the Smartphone Vital Signs System (SVSS)|An Open Label, Clinical Performance Study to Demonstrate the Clinical Accuracy of the Smartphone Vital Signs System (SVSS)|Not yet recruiting||N/A|105|Anticipated|Léman Micro Devices SA||1|||f||||f||||||||||2017-10-11 00:10:49.162324|2017-10-11 00:10:49.162324
NCT02199444|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-02-17|||June 2014||2014-06-01|September 2014|2014-09-01||||May 2015|Anticipated|2015-05-01||Interventional|||Effect of Sevelamer on P-cresol Levels in CKD||Unknown status|Recruiting|Phase 3|200|Anticipated|Federico II University||2|||f||||||||||||||2017-10-11 00:10:49.259415|2017-10-11 00:10:49.259415
NCT02199431|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-09-18|||July 2014||2014-07-01|September 2015|2015-09-01||||February 2015|Actual|2015-02-01||Interventional|||Study to Evaluate the Effect of a Known and Marketed Product, Itraconazole (Mycosis Treatment) on Lu AF11167 Entering the Body and Subsequently Elimination. The Study is a Drug-drug Interaction Study in Healthy Volunteers.|Interventional, Open-label, Interaction Study Investigating the Effects of Itraconazole (Inhibitor of CYP3A4/5) on the Pharmacokinetics and Safety and Tolerability of Lu AF11167 in Healthy Young Subjects|Completed||Phase 1|20|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 00:10:49.374715|2017-10-11 00:10:49.374715
NCT02199418|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-01-23|||January 2013||2013-01-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|November 2015|Actual|2015-11-01||Interventional|SHPD001||Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer|Phase 2 Study of Weekly Paclitaxel in Combination With Cisplatin as Neoadjuvant Therapy for Locally Advanced Breast Cancer Patients|Completed||Phase 2|132|Actual|RenJi Hospital||1|||f||||t||||||||||2017-10-11 00:10:49.480865|2017-10-11 00:10:49.480865
NCT02199405|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2014-09-01|||September 2014||2014-09-01|September 2014|2014-09-01||||September 2015|Anticipated|2015-09-01||Interventional|||"Study on the Early Warning and Treatment of Cervical Spondylosis of Cervical Type on Young People Based on the  Move Generate Yang  Theory"|"Study on the Early Warning and Treatment of Cervical Spondylosis of Cervical Type on Young People Based on the  Move Generate Yang  Theory"|Unknown status|Recruiting|N/A|140|Anticipated|First Teaching Hospital of Tianjin University of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-11 00:10:49.624961|2017-10-11 00:10:49.624961
NCT02199392|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-02-12|||November 2011||2011-11-01|January 2015|2015-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy Volunteers||Completed||Phase 1|15|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-11 00:10:49.755055|2017-10-11 00:10:49.755055
NCT02199379|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-04-13|||November 2011||2011-11-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects|A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects|Completed||Phase 1|26|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-11 00:10:49.89967|2017-10-11 00:10:49.89967
NCT02199366|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-09-18|||September 2014||2014-09-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|October 2018|Anticipated|2018-10-01||Observational|||Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy|Prospective Pilot Study of Early Markers of Radiation-Induced Cardiac Injury in Patients With Left-Sided Breast Cancer Receiving Photon or Proton Therapy|Recruiting||N/A|16|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-11 00:10:50.041696|2017-10-11 00:10:50.041696
NCT02199353|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-24|||November 2012||2012-11-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|OTSALD||Occupational Therapy Programme of Patients With Dementia Performing Activities of Daily Living|Effectiveness of A Therapy Programme Based On The Reestablishment of Cognitive Functions on The Independence of Patients With Dementia Performing Activities of Daily Living - A Pilot Study|Completed||N/A|58|Actual|University of Extremadura||2|||f||||f||||||||||2017-10-11 00:10:50.204888|2017-10-11 00:10:50.204888
NCT02199340|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-04-18|||July 2011||2011-07-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The iStep Study: Development and Validation of an Incremental Exercise Step Test for Children With Cystic Fibrosis|The iStep Study: Development and Validation of an Incremental Exercise Step Test for Children With Cystic Fibrosis|Completed||N/A|24|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||t||||||||Undecided||2017-10-11 00:10:50.31845|2017-10-11 00:10:50.31845
NCT02199327|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-08-07|||May 2014||2014-05-01|August 2016|2016-08-01|July 2017|Actual|2017-07-01|December 16, 2016|Actual|2016-12-16||Interventional|||Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia|Clinical Trial to Compare Topical Interferon Alfa 2b And Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia|Completed||Phase 4|18|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||||2017-10-11 00:10:50.452418|2017-10-11 00:10:50.452418
NCT02199314|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-09-19|||March 2013||2013-03-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|April 2016|Actual|2016-04-01||Interventional|||Anesthesia and Motor Evoked Potential (MEP) Recruitment|The Effect of Anesthesia on the Recruitment of Motor Evoked Potentials Using an Increased Number of Pulses|Completed||N/A|30|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 00:10:50.568363|2017-10-11 00:10:50.568363
NCT02199301|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-07-22|||December 2011||2011-12-01|September 2012|2012-09-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Tolerance Induction in Living Donor Kidney Transplantation With Hematopoietic Stem Cell Transplantation|Tolerance Induction in Living Donor Kidney Transplantation With Hematopoietic Stem Cell Transplantation|Recruiting||N/A|6|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-11 00:10:50.669538|2017-10-11 00:10:50.669538
NCT02199288|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-11-01|||August 2014||2014-08-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Effectiveness, Safety & Nurse Management Study of MabThera SC in Patients With Non-Hodgkin's Lymphoma: Real-Life Setting|A NON-INTERVENTIONAL STUDY TO EVALUATE THE EFFECTIVENESS, SAFETY AND NURSE MANAGEMENT DURING INDUCTION TREATMENT WITH MABTHERA S.C. FOLLOWING A FIRST INITIAL MABTHERA I.V. TREATMENT, IN PATIENTS WITH NON-HODGKINS LYMPHOMA IN A REAL-LIFE SETTING|Completed||N/A|54|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:10:50.80636|2017-10-11 00:10:50.80636
NCT02199275|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-07-23|||August 2013||2013-08-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01|1 Day|Observational [Patient Registry]|GUT||Effect of General Anesthesia on Enterocyte Damage|Impact of General Anesthesia on Enterocyte Damage|Unknown status|Recruiting|N/A|50|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||t||||||Samples Without DNA|"     Blood samples on venous puncture   "|||2017-10-11 00:10:50.925762|2017-10-11 00:10:50.925762
NCT02199262|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-23|||February 2004||2004-02-01|July 2014|2014-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Quality Improving Program on Agitation in the Surgical Intensive Care Unit|Quality Improving Program on Agitation in the Surgical Intensive Care Unit|Completed||N/A|1107|Actual|University Hospital, Geneva||3|||f||||f||||||||||2017-10-11 00:10:51.002534|2017-10-11 00:10:51.002534
NCT02199249|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-06|||April 2015||2015-04-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Open Reduction Syndesmosis Tightrope Versus Screw Fixation|A Prospective Randomized Multi Center Study to Compare Open Reduction, TightRope Fixation (OT) Versus Open Reduction Screw Fixation (OS) of the Tibia - Fibular Syndesmosis.|Recruiting||N/A|72|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:10:51.123732|2017-10-11 00:10:51.123732
NCT02199236|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-22|||July 2014||2014-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management|A Phase I, Dose Escalation Trial of Endoluminal High Dose Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management|Recruiting||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:10:51.269657|2017-10-11 00:10:51.269657
NCT02199223|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-09-21|||June 2014||2014-06-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Regorafenib + Panitumumab for Colorectal Cancers|Combination Study of Panitumumab and Regorafenib in Advanced or Metastatic KRAS and NRAS Wild Type Colorectal Cancers|Terminated||Phase 1|2|Actual|University of Utah||1||Slow accrual|f||||t||||||||||2017-10-11 00:10:51.45779|2017-10-11 00:10:51.45779
NCT02199210|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-08-09|||August 2014||2014-08-01|August 2016|2016-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Exploring Self-regulatory Processes in Anesthesiologists During Massive Transfusion|Optimizing Intra-Operative Massive Transfusion: Probing for Forethought|Recruiting||N/A|40|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:10:51.574072|2017-10-11 00:10:51.574072
NCT02199197|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-04-12|||June 2014||2014-06-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer|A Phase 2 Randomized Study Comparing Radium Ra 223 Dichloride Plus Enzalutamide With Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer|Recruiting||Phase 2|50|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-11 00:10:51.729967|2017-10-11 00:10:51.729967
NCT02199184|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-08-11|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Burkitt Leukemia - Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Ofatumumab (EPOCH - O)|Phase II Study of the Dose Adjusted EPOCH Regimen in Combination With Ofatumumab/Rituximab as Therapy for Patients With Newly Diagnosed or Relapsed/Refractory Burkitt Leukemia or Relapsed/Refractory Acute Lymphoblastic Leukemia|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 00:10:51.857778|2017-10-11 00:10:51.857778
NCT02199171|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-09-17|||July 2014||2014-07-01|September 2014|2014-09-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|||Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer|A Phase I Dose-escalation and Pharmacokinetic Study of Hyperthermic Intraoperative Intraperitoneal Chemotherapy (HIPEC) Carboplatin at the Time of Cytoreductive Surgery for the Initial Treatment in Patients With Advanced Ovarian, Fallopian Tube, and Peritoneal Carcinomas.|Unknown status|Recruiting|Phase 1|30|Anticipated|University of California, Irvine||1|||f||||t||||||||||2017-10-11 00:10:52.045784|2017-10-11 00:10:52.045784
NCT02199158|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-22|||July 2012||2012-07-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|ALPIECA||Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies|Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies An Anterior Segment Optical Coherence Tomography Study|Completed||N/A|10|Actual|Instituto de Oftalmología Fundación Conde de Valenciana||1|||f||||f||||||||||2017-10-11 00:10:52.187543|2017-10-11 00:10:52.187543
NCT02199145|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-09-29|||July 2015||2015-07-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|April 2016|Anticipated|2016-04-01||Interventional|SOURIS||Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy|Indication and Response to Immunosuppressive Treatment in Membranous Nephropathy : Role of Anti-mouse PLA2R1 ELISA|Unknown status|Recruiting|N/A|50|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:10:52.311642|2017-10-11 00:10:52.311642
NCT02199132|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-07-31|||July 2014||2014-07-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli|Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli|Completed||N/A|50|Actual|Corporacion Parc Tauli|||1||f||||f||||||||||2017-10-11 00:10:52.452334|2017-10-11 00:10:52.452334
NCT02199119|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2014-07-22|||October 2013||2013-10-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Television Viewing and Exercise on Appetite, Satiety, and Food Intake in Children|Effect of Television Viewing During Exercise on Subjective Appetite, Satiation, and Food Intake in 9 to 14 Year Old Children|Completed||N/A|13|Actual|Ryerson University||4|||f||||f||||||||||2017-10-11 00:10:52.570705|2017-10-11 00:10:52.570705
NCT02199106|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-23|||January 2009||2009-01-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||Effectiveness of Neuronavigated Continuous Theta Burst Stimulation of the Left Heschl's Gyrus in Chronic Tinnitus|Effectiveness of Neuronavigated Continuous Theta Burst Stimulation of the Left Heschl's Gyrus in Chronic Tinnitus|Completed||N/A|23|Actual|University of Regensburg||2|||f||||f||||||||||2017-10-11 00:10:52.706802|2017-10-11 00:10:52.706802
NCT02199093|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-05-10|||May 2014||2014-05-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Functional Rehabilitation of Upper Limb Apraxia in Patients Poststroke|Functional Rehabilitation of Upper Limb Apraxia in Patients Poststroke: Randomized Clinical Trial|Active, not recruiting||N/A|40|Anticipated|Universidad de Granada||2|||f||||t||||||||||2017-10-11 00:10:53.000637|2017-10-11 00:10:53.000637
NCT02199080|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-05-12|||July 2014||2014-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||D-dimer Assay for the Exclusion of Intra-atrial Thrombus Risk Before Ablation of Atrial Fibrillation|Etude du Dosage Des d-dimères sériques Pour le Diagnostic d'Exclusion Des Thrombi Intra-atriaux Avant Ablation Endocavitaire de Fibrillation Atriale|Completed||N/A|2506|Actual|Groupe Hospitalier de la Rochelle Ré Aunis||1|||f||||f||||||||||2017-10-11 00:10:53.161263|2017-10-11 00:10:53.161263
NCT02199067|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-01-23|||July 2014||2014-07-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|PIAG1||Measurement of Exhaled Propofol|Measurement of Exhaled Propofol During a Total Intravenous Anesthesia With Propofol and Remifentanil|Suspended||N/A|20|Anticipated|University of Erlangen-Nürnberg Medical School|||1|technical difficulties of probe measurement|f||||f||||||Samples With DNA|"     arterial blood samples (serum)   "|||2017-10-11 00:10:53.366819|2017-10-11 00:10:53.366819
NCT02199054|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-19|2017-04-07|||July 2014||2014-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome|Evaluation of Functional Snack Foods Containing Safflower Oil and Soy on Endpoints of Energy Metabolism in Postmenopausal Women With Metabolic Syndrome|Active, not recruiting||N/A|20|Anticipated|Ohio State University||3|||f||||t||||||||||2017-10-11 00:10:53.467487|2017-10-11 00:10:53.467487
NCT02199015|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-09-11|||November 1, 2017|Anticipated|2017-11-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|Andreani1||Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy|Lateral Cord Electrical Stimulation Can Improve Spasticity in Chronic Spastic Cerebral Palsy|Not yet recruiting||N/A|40|Anticipated|Sociedad Argenttina de Neuromodulación||1|||f||||t|f|t|f|f|t|||||2017-10-11 00:10:54.02036|2017-10-11 00:10:54.02036
NCT02199002|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-07-10|||July 2014||2014-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acid Pocket: Position and Aspiration|Acid Pocket: Different Position and Chemical Content Between Healthy Volunteers and GERD Patients|Recruiting||N/A|70|Anticipated|Katholieke Universiteit Leuven||5|||f||||f||||||||||2017-10-11 00:10:54.157455|2017-10-11 00:10:54.157455
NCT02198989|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-12-02|||January 2014||2014-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effects of Peer Support and Yoga Music on T2DM With Depression and Sleep Disorders|Effects of Peer Support and Yoga Music on T2DM With Depression and Sleep Disorders|Completed||N/A|45|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||||2017-10-11 00:10:54.289694|2017-10-11 00:10:54.289694
NCT02198976|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-12-15|||April 2014||2014-04-01|December 2015|2015-12-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Observational|ABCDE||Australian Barrett's Cohort With Dysplasia and Early Cancer Study|Australian Barrett's Cohort With Dysplasia and Early Cancer Study|Recruiting||N/A|300|Anticipated|Western Sydney Local Health District|||1||f||||t||||||||||2017-10-11 00:10:54.40114|2017-10-11 00:10:54.40114
NCT02198963|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-02-02|2015-08-10||July 2014||2014-07-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||21 Day Cumulative Skin Irritation of RUT058-60|Phase 1 21-Day Evaluation of the Cumulative Irritation Potential of RUT058-60 on Abraded and Non-Abraded Skin Sites|Completed||Phase 1|43|Actual|Pulmatrix Inc.|Results from 36 subjects receiving all applications and completing all visits|3|||f||||t||||||||||2017-10-11 00:10:54.515897|2017-10-11 00:10:54.515897
NCT02198950|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-23|2014-07-23|||November 2009||2009-11-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Observational|||Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis|Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis: a Prospective, Bicentric Study|Completed||N/A|400|Actual|Central Hospital, Nancy, France|||1||f||||f||||||Samples Without DNA|"     plasmas   "|||2017-10-11 00:10:54.87666|2017-10-11 00:10:54.87666
NCT02198937|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-10-24|||June 2014||2014-06-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans||Terminated||N/A|10|Actual|University of Zurich|||2|Funding unclear|f|||||||||||"     Blood sample   "|||2017-10-11 00:10:54.983466|2017-10-11 00:10:54.983466
NCT02198924|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-04-04|||December 2013||2013-12-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients|A Study to Evaluate Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib Post Total Knee Arthroplasty in Osteoarthritis Patients|Completed||Phase 4|246|Actual|Peking Union Medical College Hospital||2|||f||||t||||||||No||2017-10-11 00:10:55.109279|2017-10-11 00:10:55.109279
NCT02198911|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-07-14|||June 2013|Actual|2013-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effects of Chewing Gum on a Computer Task and Liking Ratings of Ice Cream|The Effects of Chewing Gum on a Computer Task and Liking Ratings of Ice Cream|Active, not recruiting||N/A|20|Anticipated|University of Tennessee||3|||f||||t||||||||||2017-10-11 00:10:55.279731|2017-10-11 00:10:55.279731
NCT02198898|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2017-08-14|||July 2013||2013-07-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|January 2016|Actual|2016-01-01||Interventional|||Anti-adhesion Effect of GUARDIX-SGⓇ in Gastric Cancer Surgery|Prospective Multicenter Trial for Anti-adhesion Effect of GUARDIX-SGⓇ Following Radical Gastrectomy in Patients With Gastric Cancer.|Active, not recruiting||Phase 3|224|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-10-11 00:10:55.400827|2017-10-11 00:10:55.400827
NCT02198885|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-11-02|||August 2014||2014-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|FAST-01||Comparing Use of a Prehospital Ultrasound System and Standard Prehospital Care in Thoracoabdominal Trauma|Post-marketing, Single-center, Controlled, Open-Label, Feasibility Study Comparing Use of a Prehospital Ultrasound System and Standard Prehospital Care in Patients With Thoracoabdominal Trauma.|Enrolling by invitation||N/A|20|Anticipated|University of Saskatchewan|||2||f||||f||||||||||2017-10-11 00:10:55.52068|2017-10-11 00:10:55.52068
NCT02198872|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-23|||September 2014||2014-09-01|July 2014|2014-07-01|February 2018|Anticipated|2018-02-01|July 2015|Anticipated|2015-07-01||Interventional|||Aquatic and Land Aerobic Training, Cardiorespiratory and Metabolic Variables in Cardiorespiratory Diseases|Effects of Aquatic and Land Aerobic Training on Body Composition and Cardiorespiratory and Metabolic Variables in Patients With Cardiorespiratory Diseases|Not yet recruiting||Early Phase 1|40|Anticipated|Universidade Metodista de Piracicaba||2|||f||||f||||||||||2017-10-11 00:10:55.673169|2017-10-11 00:10:55.673169
NCT02198859|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-01-06|||April 2014||2014-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer|Phase 1 Study of Evaluation of Lithium and it's Effect on Clinically Localized Prostate Cancer.|Completed||Phase 1|11|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-11 00:10:55.84212|2017-10-11 00:10:55.84212
NCT02198846|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-23|||June 2014||2014-06-01|July 2014|2014-07-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||A Study to Compare Insulin Pump With Conventional Treatment in Type 2 Diabetes|A Study to Compare the Efficacy and Safety of Insulin Pump Treatment in Patients With Uncontrolled Type 2 Diabetes Mellitus|Unknown status|Recruiting|N/A|140|Anticipated|Konkuk University Medical Center||2|||f||||f||||||||||2017-10-11 00:10:55.97303|2017-10-11 00:10:55.97303
NCT02198833|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-04-05|2017-02-01||September 2014||2014-09-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||No analysis completed due to inability to place study catheter in all but two patients due to inability to clear urine of bacteria.|Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection|Clinical Study to Assess the Efficacy of a Novel Micro-Patterned Foley Catheter to Reduce Catheter-Associated UrinaryTract Infection Among Spinal Cord Injury Patients|Terminated||N/A|2|Actual|Baylor College of Medicine|Two major factors: 1) Production of the study catheter took much longer than expected. Only size 16 French Foley available; and 2) The inability to clear asymptomatic bacteriuria from patients’ urinary bladder prior to study catheter placement.|2||Study catheter manufacturing issues. Poor enrollment.|f||||t||||||||No|Number of patients entered in the study is too small for analysis of data.|2017-10-11 00:10:56.121833|2017-10-11 00:10:56.121833
NCT02198820|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-06-22|||October 2014||2014-10-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01|1 Month|Observational [Patient Registry]|||Practice Survey on Femoral Neck Fractures and the Incidence of Type of Anesthesia on Patient Outcome|Practice Survey on Femoral Neck Fractures and the Incidence of Type of Anesthesia on Patient Outcome in the Saint-Luc Bouge Hospital|Withdrawn||N/A|0|Actual|Astes|||2|lack of investigators|f||||f||||||||||2017-10-11 00:10:56.447776|2017-10-11 00:10:56.447776
NCT02198807|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-06-12|||March 2014||2014-03-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|July 2014|Actual|2014-07-01||Interventional|FOSPIP||Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria|A Phase IIa Proof of Concept Study to Explore the Efficacy, Tolerability and Safety of Fosmidomycin Sodium When Administered With Piperaquine Tetraphosphate to Adults and Older Children With Acute Uncomplicated Plasmodium Falciparum Malaria|Unknown status|Active, not recruiting|Phase 2|100|Actual|Jomaa Pharma GmbH||1|||f||||f||||||||||2017-10-11 00:10:56.567527|2017-10-11 00:10:56.567527
NCT02198794|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-12-01|||October 2014||2014-10-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|RIM-TD||Reducing Involuntary Movements in Tardive Dyskinesia|An Open-Label, Long-Term Safety Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia|Active, not recruiting||Phase 3|343|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-11 00:10:56.697752|2017-10-11 00:10:56.697752
NCT02198781|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-12-05|||July 2014||2014-07-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Right Ventricle (RV) Markers of Future Pacing Induced Ventricular Dysfunction - Pilot|Does a Measure Exist in the Right Ventricle Which Can Act as a Surrogate Marker for Future Ventriclar Sysfunction When Pacing - a Pilot Study|Completed||N/A|3|Actual|Basildon and Thurrock University Hospitals NHS Foundation Trust|||1||f||||f||||||||Undecided||2017-10-11 00:10:57.014377|2017-10-11 00:10:57.014377
NCT02198768|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-01-30|||September 2012||2012-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Observational|||Ankle Fracture vs Ankle Fracture-Dislocation|Functional Outcome After Ankle Fractures and Ankle Fracture-Dislocations: A Prospective Study|Completed||N/A|80|Actual|Carolinas Healthcare System|||2||f||||t||||||||Undecided|Data Sharing will need to be discussed with investigators.|2017-10-11 00:10:57.13609|2017-10-11 00:10:57.13609
NCT02198755|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-23|||December 2014||2014-12-01|July 2014|2014-07-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Detection of Osteomyelitis Using High Resolution Ultrasound|Sensitivity, Specificity and Predictive Value of High Resolution (B-Mode) Ultrasonography (HRUS) for the Detection of Osteomyelitis in Chronic Wound Patients|Unknown status|Not yet recruiting|N/A|100|Anticipated|Calvary Hospital, Bronx, NY||2|||f||||f||||||||||2017-10-11 00:10:57.249967|2017-10-11 00:10:57.249967
NCT02198742|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-02-02|||June 2013||2013-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Comparison Between Two Video Laryngoscopes,in Successfully Intubating Pediatric Mannequins w/wo Difficult Airways|A Comparison Between Two Video Laryngoscopes,the Truview PCD and the Glidescope Cobalt AVL, in Successfully Intubating Pediatric Mannequins With and Without Difficult Airways|Completed||Phase 1|30|Actual|Baylor College of Medicine||3|||f||||f||||||||||2017-10-11 00:10:57.383046|2017-10-11 00:10:57.383046
NCT02198729|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-12-15|||July 2014||2014-07-01|December 2015|2015-12-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|RESDEMR||Comparison Rectal Endoscopic Submucosal Dissection to Endoscopic Mucosal Resection|Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection for Sessile Polyps and Laterally Spreading Lesions of the Rectum - a Prospective Randomised Trial|Recruiting||N/A|300|Anticipated|Western Sydney Local Health District||2|||f||||t||||||||||2017-10-11 00:10:57.498971|2017-10-11 00:10:57.498971
NCT02198716|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-08-13|||November 2008||2008-11-01|August 2014|2014-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|XIMA||Xience or Vision Stent Management of Angina in the Elderly|Multi-centre, Randomised,Prospective Trial of Xience or Vision Stent, Management of Angina in the Elderly|Completed||N/A|800|Actual|Brighton and Sussex University Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 00:10:57.645246|2017-10-11 00:10:57.645246
NCT02198703|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-23|2015-09-14|||September 2014||2014-09-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia|RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOR EVALUATING THE EFFICACY OF AB-LIFE PROBIOTIC PRODUCT ON THE LDL-CHOLESTEROL REDUCTION IN THE MODERATE HYPERCHOLESTEROLEMIA|Completed||N/A|104|Actual|AB Biotics, SA||2|||f||||||||||||||2017-10-11 00:10:57.77303|2017-10-11 00:10:57.77303
NCT02198690|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-06-01|||September 2014||2014-09-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Trial of a Mammography Decision Aid for Women Aged 75 and Older|Randomized Trial of a Mammography Decision Aid for Women Aged 75 and Older|Active, not recruiting||N/A|541|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-10-11 00:10:57.984001|2017-10-11 00:10:57.984001
NCT02198677|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-01-05|||July 2014||2014-07-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Cardiovascular Response to Two Manual Techniques for Neck Pain|Randomized Trial of Cardiovascular Response to Two Manual Techniques Non-thrust Joint Manipulation of the Cervical Spine in Patients With Non-traumatic Mechanical Neck Pain.|Recruiting||N/A|34|Anticipated|Azusa Pacific University||2|||f||||f||||||||||2017-10-11 00:10:58.087405|2017-10-11 00:10:58.087405
NCT02198664|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-06-07|||August 2014||2014-08-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using (CPNA) Peanut OIT Safety Follow-On Study|Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen (CPNA) Peanut Oral Immunotherapy (OIT) Safety Follow-On Study|Active, not recruiting||Phase 2|53|Anticipated|Aimmune Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 00:10:58.244068|2017-10-11 00:10:58.244068
NCT02198638|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-05-12|||December 2013||2013-12-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays Units|Influenza Vaccination of HCW and Hospital Acquired Influenza in Patients|Completed||N/A|541|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:10:58.888407|2017-10-11 00:10:58.888407
NCT02198625|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2014-07-22|||March 2014||2014-03-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Influence of Moderate Inspired Oxygen Fraction (FiO2) and Protective Ventilation on Postoperative Pulmonary Complication||Unknown status|Recruiting|Phase 4|280|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||4|||f||||t||||||||||2017-10-11 00:10:58.995702|2017-10-11 00:10:58.995702
NCT02198612|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-12-22|||March 2015||2015-03-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|FREEDOM||"FREEDOM: Pilot Study of the Feasibility and Safety of Resuming Early Walking After Manual Compression in Patients Treated for Peripheral Artery Disease by Endovascular Technique Involving Retrograde Femoral Puncture"|"FREEDOM: Pilot Study of the Feasibility and Safety of Resuming Early Walking After Manual Compression in Patients Treated for Peripheral Artery Disease by Endovascular Technique Involving Retrograde Femoral Puncture"|Completed||N/A|30|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 00:10:59.116685|2017-10-11 00:10:59.116685
NCT02198599|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-23|||March 2011||2011-03-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|MFP||Mobility Enhancing Nursing Intervention|Effects of Mobility-Enhancing Nursing Intervention in Patients With MS and Stroke: Randomised Controlled Trial|Completed||N/A|140|Actual|Zurich University of Applied Sciences||2|||f||||f||||||||||2017-10-11 00:10:59.213714|2017-10-11 00:10:59.213714
NCT02198586|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-03-01|||April 2014||2014-04-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Observational|||Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old|Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old|Completed||N/A|575|Actual|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation|||1||f||||f||||||||||2017-10-11 00:10:59.316955|2017-10-11 00:10:59.316955
NCT02198573|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-22|||July 2013||2013-07-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|||Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar|Molecular Assessment of Artemisinin Resistance Markers, K13 Kelch Propeller and Multi-drug Resistant Gene Polymorphism in Eastern and Western Border Areas of Myanmar|Completed||N/A|91|Actual|Department of Medical Research, Lower Myanmar|||1||f||||t||||||Samples With DNA|"     dried blood spot   "|||2017-10-11 00:10:59.4161|2017-10-11 00:10:59.4161
NCT02198560|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-09-09|||August 2014||2014-08-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Observational|||RS-3000 Lite Agreement Study||Completed||N/A|30|Actual|Nidek Co. LTD.|||1||f||||f||||||||||2017-10-11 00:10:59.542994|2017-10-11 00:10:59.542994
NCT02198547|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-07-22|||March 2014||2014-03-01|March 2014|2014-03-01|March 2015|Anticipated|2015-03-01|March 2014|Actual|2014-03-01||Interventional|Mg||Magnesium as Adjuvant for Sciatic Block|Evaluation of Magnesium as Adjuvant to Ropivacaine for Sciatic Block at Popliteal Level.|Unknown status|Recruiting|N/A|60|Anticipated|Campus Bio-Medico University||2|||f||||f||||||||||2017-10-11 00:10:59.650442|2017-10-11 00:10:59.650442
NCT02198534|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-11-22|||June 2014||2014-06-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Observational|FEL||Comparison of the Freiburg Visual Acuity Test (FrACT) With the EDTRS- and Landoltring Charts|Comparison of the Freiburg Visual Acuity Test (FrACT) With the EDTRS- and Landoltring Charts: a) Assessment of the Inter-test Agreement and the Test-retest Reliability b) Analysis of Examinees' / Examiner's Subjective Rating and of Test Durations|Completed||N/A|25|Actual|Aalen University|||1||f||||f||||||None Retained|"     None applicable   "|||2017-10-11 00:10:59.796046|2017-10-11 00:10:59.796046
NCT02198521|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-02|||July 2014||2014-07-01|February 2017|2017-02-01|September 2016||2016-09-01|September 2016|Actual|2016-09-01|6 Months|Observational [Patient Registry]|||Staged Bilateral Carpal Tunnel Release: Which Side Hurts More?|Staged Bilateral Carpal Tunnel Release: Which Side Hurts More?|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||1|The researcher and principal investigator working on this study left the institution.|f||||f||||||||||2017-10-11 00:10:59.895321|2017-10-11 00:10:59.895321
NCT02198495|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-09-17|||September 2014||2014-09-01|September 2016|2016-09-01||||November 2018|Anticipated|2018-11-01||Interventional|COPEFER||Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients|Continuous Versus Periodic Intravenous Iron Supplementation in Maintenance Hemodialysis Patients|Recruiting||Phase 4|140|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 00:11:00.077853|2017-10-11 00:11:00.077853
NCT02198482|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-12-02|||February 2016||2016-02-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)|Dose Finding Safety Run-in Phase Followed by a Randomized Phase II Trial of Intensive Chemotherapy With or Without Volasertib (BI 6727) Administered Prior or After Chemotherapy in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)|Terminated||Phase 2|6|Actual|University of Ulm||3||"development program of study drug volasertib was stopped by Boehringer Ingelheim due to   manufacturing problems"|f||||t||||||||||2017-10-11 00:11:00.217342|2017-10-11 00:11:00.217342
NCT02198469|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-22|||January 2012||2012-01-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis|A Randomized, Prospective Study Comparing Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Ablative Fractional Laser Treatment for Actinic Cheilitis|Completed||Phase 1|33|Actual|Dong-A University||2|||f||||f||||||||||2017-10-11 00:11:00.44405|2017-10-11 00:11:00.44405
NCT02198456|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-05-29|||July 2014||2014-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PARIS||Imaging Control Study, 3D Echo, MR and RHC.|Prostanoid Therapy in Severe Pulmonary Arterial Hypertension - Imaging Control Study, 3D Echo, MR and RHC.|Recruiting||N/A|12|Anticipated|Elisabethinen Hospital|||1||f||||f||||||||Undecided||2017-10-11 00:11:00.552463|2017-10-11 00:11:00.552463
NCT02198443|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-02-20|||June 6, 2015|Actual|2015-06-06|July 2014|2014-07-01||||July 15, 2016|Actual|2016-07-15||Interventional|STRIB-PEP||Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.|Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.|Completed||Phase 4|160|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 00:11:00.642729|2017-10-11 00:11:00.642729
NCT02198430|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2016-08-26|2016-06-29||May 2014||2014-05-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Observational|HOLISTIC||Multidisciplinary Evaluation of Patients With Hemophilia|Multidisciplinary Assessment of the Physical, Functional and Psychosocial Alterations in Patients With Hemophilia. An Observational Study.|Completed||N/A|104|Actual|Universidad de Murcia|||2||f||||f||||||||||2017-10-11 00:11:00.7419|2017-10-11 00:11:00.7419
NCT02198417|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-03-21|||July 2014||2014-07-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||Metformin Treatment in Polycystic Ovary Syndrome (PCOS)|Effects of Metformin on Mitochondrial Function in Polycystic Ovary Syndrome|Active, not recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:11:00.96941|2017-10-11 00:11:00.96941
NCT02198404|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-09-29|||June 2014||2014-06-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|PROPOPAL1||Pilot Study of Sedation With Propofol in Refractory Pains Due to Care in Palliative Care Unit|Pilot Study of Sedation With Propofol in Refractory Pains Due to Care in Palliative Care Unit|Unknown status|Recruiting|Phase 4|10|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:11:01.047656|2017-10-11 00:11:01.047656
NCT02198391|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-22|||October 2014||2014-10-01|July 2014|2014-07-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Study of Echinaforce Junior Tablets in Children With Acute Colds|Multicenter Open-label, Randomized Clinical Trial to Assess the Safety and Efficacy of Echinaforce® Junior Tablets in Two Dosages for the Therapy of Common Cold Symptoms in Children (4-12 Years)|Unknown status|Not yet recruiting|N/A|200|Anticipated|Bioforce AG|||2||f||||f||||||||||2017-10-11 00:11:01.12321|2017-10-11 00:11:01.12321
NCT02198378|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2017-04-24|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SCADOLII||Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia.|Analgesia of Acute Coronary Syndromes With ST-segment Elevation in a Pre-hospital Setting. Randomized Non-inferiority Trial of the Association MEOPA + Paracetamol Versus Morphine.|Completed||Phase 4|680|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 00:11:01.218824|2017-10-11 00:11:01.218824
NCT02198365|ClinicalTrials.gov processed this data on October 10, 2017|2009-01-04|2014-07-22|||January 2007||2007-01-01|July 2014|2014-07-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Observational|||Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia|Comparison of Human Papillomavirus Integrated DNA and Messenger RNA for Detection and Prediction in Progression of Cervical Neoplasia|Completed||N/A|250|Actual|Cathay General Hospital|||1||f||||f||||||Samples With DNA|"     HPV DNA and mRNA   "|||2017-10-11 00:11:01.4161|2017-10-11 00:11:01.4161
NCT02198352|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-28|||June 1998||1998-06-01|July 2014|2014-07-01||||August 1998|Actual|1998-08-01||Interventional|||Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers|A Double-blind, Placebo-controlled Single Rising Dose Tolerability Study (Parallel Groups) in Healthy Male and Female Volunteers After Intravenous Administration of BIBN 4096 BS (Dosage: 0.1 - 10 mg)|Completed||Phase 1|55|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:11:01.480805|2017-10-11 00:11:01.480805
NCT02198339|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-22|||February 1999||1999-02-01|July 2014|2014-07-01||||December 1999|Actual|1999-12-01||Interventional|||Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment of a Single Attack of Acute Migraine Headache|A Phase II a, Double-Blind, Randomised, Group Sequential Adaptive Assignment Design Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Seven Fixed Doses of Intravenous BIBN 4096 BS Ranging From 0.1 to 10.0 mg Versus Placebo in the Treatment of a Single Attach of Acute Migraine Headache|Completed||Phase 2|126|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:11:01.586225|2017-10-11 00:11:01.586225
NCT02198326|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-22|||July 1999||1999-07-01|July 2014|2014-07-01||||August 1999|Actual|1999-08-01||Interventional|||Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female Volunteers|A Double-blind (Within Dose Groups), Placebo-controlled Single Rising Dose Tolerability Study (Parallel Groups) in Healthy Male and Female Volunteers After Intranasal Administration of BIBN 4096 BS (Dosage: 2.5 - 20 mg)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:11:01.66694|2017-10-11 00:11:01.66694
NCT02198313|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-22|||April 1999||1999-04-01|July 2014|2014-07-01||||April 1999|Actual|1999-04-01||Interventional|||A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers|A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX (100 µg, 200 µg, 400 µg b.i.d. for 14 Days ) in Healthy Male Volunteers (Randomised, Double-blind Within Each Dose Group, Placebo-controlled, Parallel-group)|Terminated||Phase 1|8|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:11:01.732608|2017-10-11 00:11:01.732608
NCT02198300|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2015-07-28|||November 2012||2012-11-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|POLBOS II||DES Versus BiOSS LIM - POLBOS II Study|Regular Drug Eluting Stent Versus Dedicated Bifurcation Sirolimus-eluting Stent BiOSS LIM in Coronary Bifurcation Treatment - Randomized POLBOS II Study.|Completed||Phase 4|202|Actual|Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland||2|||f||||f||||||||||2017-10-11 00:11:01.805842|2017-10-11 00:11:01.805842
NCT02198287|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-22|||January 1999||1999-01-01|July 2014|2014-07-01||||April 1999|Actual|1999-04-01||Interventional|||Dose Extension Study of BIIX 1 XX in Healthy Young Male Volunteers|A Single Increasing Dose Safety and Tolerability Study (Dose Extension) After Inhalational Administration of BIIX 1 XX (Single Doses: 800 - 2000 mcg) in Healthy Young Male Volunteers (Randomised, Double-blind, Placebo-controlled)|Completed||Phase 1|54|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:11:01.895373|2017-10-11 00:11:01.895373
NCT02198274|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-07-22|||February 2000||2000-02-01|July 2014|2014-07-01||||October 2000|Actual|2000-10-01||Interventional|||Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer|A Phase II Uncontrolled Sudy to Evaluate the Antitumour Activity and Safety of Intravenous BIBH 1, Administered in a Weekly Dose of 100 mg in 12 Weeks, in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|25|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:11:01.967172|2017-10-11 00:11:01.967172
NCT02198261|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-01-23|||July 2014||2014-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Minoxidil Response Testing in Males With Androgenetic Alopecia|Minoxidil Response Testing in Males With Androgenetic Alopecia|Active, not recruiting||N/A|300|Anticipated|Applied Biology, Inc.|||2||f||||f||||||Samples Without DNA|"     Plucked hair follicles with visible bulbs   "|||2017-10-11 00:11:02.037143|2017-10-11 00:11:02.037143
NCT02198248|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-07-25|||October 2014||2014-10-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|March 2018|Anticipated|2018-03-01||Interventional|LoVAS||Low-dose Glucocorticoid Vasculitis Induction Study|Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial|Recruiting||Phase 4|140|Anticipated|Chiba University||2|||f||||t||||||||||2017-10-11 00:11:02.138228|2017-10-11 00:11:02.138228
NCT02198235|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-05-22|2015-07-21||October 2012||2012-10-01|May 2017|2017-05-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop)|Prolonged Popliteal Fossa Nerve Blockade|Completed||Phase 1|90|Actual|Hospital for Special Surgery, New York||3|||f||||f||||||||No||2017-10-11 00:11:04.210683|2017-10-11 00:11:04.210683
NCT02198209|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-08-21|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation|Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation|Not yet recruiting||Phase 4|18|Anticipated|Cedars-Sinai Medical Center||1|||f||||f|t|f||||||||2017-10-11 00:11:04.577819|2017-10-11 00:11:04.577819
NCT02198196|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-02-03|||August 2014||2014-08-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Mind/Body Stress Management to Improve Outcomes in Workplace Weight Loss Programs|Mind/Body Stress Management to Improve Outcomes in Workplace Weight Loss Programs|Completed||N/A|75|Actual|Alere Wellbeing||2|||f||||t||||||||||2017-10-11 00:11:04.680153|2017-10-11 00:11:04.680153
NCT02198183|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-02-11|||July 2014||2014-07-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Observational|TSA NIRS||Total Shoulder Arthroplasty Near-infrared Spectroscopy|The Effects of Positive-pressure Ventilation on Cerebral Oxygenation and Cardiac Output in Total Shoulder Arthroplasty.|Completed||N/A|34|Actual|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-11 00:11:04.77742|2017-10-11 00:11:04.77742
NCT02198170|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-02-11|||February 2011||2011-02-01|January 2015|2015-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers||Completed||Phase 1|18|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 00:11:04.87479|2017-10-11 00:11:04.87479
NCT02198157|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-02-20|||July 2014||2014-07-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|cath2stage||Urinary Catheterization and Second Stage of Labor|Effect of Intermittent Versus Continuous Bladder Catheterization During Labor on Second Stage Duration|Completed||N/A|184|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-11 00:11:04.961496|2017-10-11 00:11:04.961496
NCT02198144|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-07-22|||August 2009||2009-08-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Cut Your Pressure Too: The Altadena Barbershop Blood Pressure Study, Phase 2 (Intervention Pilot Study)|Barber-Based Intervention for Hypertension in Black Men: Follow-Up Evaluation|Completed||N/A|14|Actual|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-11 00:11:05.182111|2017-10-11 00:11:05.182111
NCT02198131|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-05-25|||October 2009||2009-10-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia|Pulsed Dye Laser for Treatment of Post Radiation Dysphonia|Completed||N/A|9|Actual|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 00:11:05.283217|2017-10-11 00:11:05.283217
NCT02198118|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-22|||January 2010||2010-01-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Domiciliary Physiotherapy During Breast Cancer Radiation|Domiciliary Physiotherapy During Breast Cancer Radiation|Completed||N/A|36|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:11:05.389992|2017-10-11 00:11:05.389992
NCT02198105|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-07-21|||May 2014||2014-05-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01|1 Year|Observational [Patient Registry]|DEBTRAK||Registry of Cutting Balloon and DCB Intervention in Femoropopliteal Stenosis/Occlusion.|Registry of Cutting Balloon and DCB Intervention in Femoropopliteal Stenosis/Occlusion.|Active, not recruiting||N/A|20|Anticipated|Caritasklinik St. Theresia|||1||f||||f||||||||||2017-10-11 00:11:05.480071|2017-10-11 00:11:05.480071
NCT02198092|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-09-08|||July 2014||2014-07-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|Septin9||Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes|Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes|Recruiting||N/A|46|Anticipated|University of Pennsylvania|||4||f||||f||||||Samples With DNA|"     Blood samples will be used as per the study protocol. Consented subjects will provide at     least 10 ml but not more than 20 ml (for repeating testing) of blood at each time point for     Epi proColon testing. An additional volume of up to 10 ml anticoagulated blood will be drawn     for circulating colonic epithelial cell analysis at each time point. Blood samples will be     stored and will only be used in future research with the express written permission of study     subjects. Subjects may withdraw consent from the study or for future use of blood samples at     any time.   "|||2017-10-11 00:11:05.584432|2017-10-11 00:11:05.584432
NCT02198079|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-05-22|||March 2010||2010-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida|A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida|Completed||N/A|85|Actual|University of Miami|||1||f||||f||||||None Retained|"     one sputum, throat, or bronchoalveolar lavage   "|||2017-10-11 00:11:05.698475|2017-10-11 00:11:05.698475
NCT02198066|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-07-21|||July 2010||2010-07-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Comparison of Post-Sternotomy Dressings|A Comparison of Post-Sternotomy Dressings|Completed||N/A|351|Actual|Carilion Clinic||3|||f||||f||||||||||2017-10-11 00:11:05.796317|2017-10-11 00:11:05.796317
NCT02198053|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-07-20|||May 2014||2014-05-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|1 Year|Observational [Patient Registry]|||the Effect Between Platelet Reactivation and Antiplatelet Drugs|Effect of 180 mgTicagrelor Compared With 90 mg Ticagrelor on Platelet Reactivity in Patients Undergoing Elective PCI.|Unknown status|Active, not recruiting|N/A|74|Anticipated|Beijing Anzhen Hospital|||2||f||||f||||||Samples Without DNA|"     Platelet reactivity   "|||2017-10-11 00:11:05.905973|2017-10-11 00:11:05.905973
NCT02198040|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-12-30|2015-10-07||January 2012||2012-01-01|December 2016|2016-12-01|June 2014|Actual|2014-06-01|October 2012|Actual|2012-10-01||Interventional|ELBOW||Physiotherapy in the Haemophilic Arthropathy of the Elbow.|Physiotherapy in the Treatment of Elbow Hemophilic Arthropathy: Manual Therapy vs Educational Physiotherapy. A Randomized Clinical Trial|Completed||N/A|27|Actual|Universidad Católica San Antonio de Murcia|A limitation of our study is the low sample size (n = 27), although 96% of paients who met the inclusion criteria participated Due to the randomization of subjects there was no division proportionate according to the severity of haemophilia|3|||f||||f||||||||||2017-10-11 00:11:05.999907|2017-10-11 00:11:05.999907
NCT02198027|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-09-20|||July 2014||2014-07-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Peritubal Infiltration of Bupivacaine in PCNL|Role of Peritubal Infiltration of 0.25% Bupivacaine in Percutaneous Nephrolithotomy (PCNL) in Postoperative Pain Control|Unknown status|Recruiting|Phase 4|68|Anticipated|Indus Hospital||2|||f||||t||||||||||2017-10-11 00:11:06.601149|2017-10-11 00:11:06.601149
NCT02198001|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-22|||January 2014||2014-01-01|July 2014|2014-07-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|PRF||Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction|Prospective Randomized Clinical Study: Role of Platelet Rich Fibrin (PRF) in the Tooth Extraction Site in the Prevention of Jaw Osteonecrosis on Patients Under Bisphosphonates Therapy|Unknown status|Recruiting|N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 00:11:06.815518|2017-10-11 00:11:06.815518
NCT02197975|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-10-27|||August 2014||2014-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Randomized, Crossover Safety and Pharmacokinetics Study of PT010|A Phase I, Randomized, Double Blind, Placebo-Controlled, Two Period, Ascending Dose, Crossover Study to Assess the Safety and Pharmacokinetics of Two Doses of PT010 in Healthy Adult Subjects of Japanese Descent Following a Single Dose and After Chronic Dosing for 7 Days|Completed||Phase 1|20|Actual|Pearl Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 00:11:07.015469|2017-10-11 00:11:07.015469
NCT02197962|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-10-04|||May 2010||2010-05-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Radial Shockwave Therapy for Treatment of Pain in Knee Osteoarthritis|Efficacy of Radial Shockwave Therapy for Treatment of Pain in Knee Osteoarthritis|Completed||Phase 2|105|Actual|University of Sao Paulo||2|||f||||t||||||||No||2017-10-11 00:11:07.088999|2017-10-11 00:11:07.088999
NCT02197949|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-11-07|||July 2014||2014-07-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Preoperative and Intraoperative Quantification of Axillary Tumoral Load|Preoperative and Intraoperative Quantification of Axillary Tumoral Load to Reduce the Need of Axillary Lymph Node Dissection in Breast Cancer Patients With Positive Lymph-nodes at Diagnosis|Terminated||N/A|12|Actual|Parc de Salut Mar|||1|Slow recuitment|f||||f||||||||No||2017-10-11 00:11:07.165455|2017-10-11 00:11:07.165455
NCT02197936|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-04-04|||July 2014||2014-07-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|NAPPEDIII||Norwegian Adenomyosis Study III: Peristalsis|Norwegian Adenomyosis Study: Pathophysiology, Peristalsis, Expression Profiling and Diagnostics, Part III|Active, not recruiting||N/A|20|Anticipated|Oslo University Hospital|||2||f||||t||||||||||2017-10-11 00:11:07.299687|2017-10-11 00:11:07.299687
NCT02197923|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-09-14|||July 2014||2014-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|NAPPED II||Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis|Norwegian Adenomyosis Study: Pathophysiology, Peristalsis, Expression Profiling and Diagnosis, Part 2|Active, not recruiting||N/A|80|Anticipated|Oslo University Hospital|||2||f||||t||||||Samples With DNA|"     whole blood and biopsies from uterine myometria and uterine endometria   "|||2017-10-11 00:11:07.441686|2017-10-11 00:11:07.441686
NCT02197897|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-06-19|||June 2015||2015-06-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|BCTamoxifen||Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors|Phase II Trial of Estrogen Receptor Targeted Treatment of Non-Muscle Invasive Bladder Cancer With Tamoxifen.|Recruiting||Phase 2|19|Anticipated|Baylor College of Medicine||1|||f||||t||||||||No||2017-10-11 00:11:07.634256|2017-10-11 00:11:07.634256
NCT02197884|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2014-10-13|||July 2014||2014-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants|An Open-Label, Fixed-Sequence Study to Assess Effects of Clarithromycin on the Single-Dose Pharmacokinetics of JNJ-54861911 in Healthy Male Subjects|Completed||Phase 1|13|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:11:07.755516|2017-10-11 00:11:07.755516
NCT02197871|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-07-21|||July 2014||2014-07-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of Nutritional Supplementation in Malnourished Patients in Stable COPD|Effects of Nutritional Supplementation in Malnourished Patients in Stable COPD:a Randomised Controlled Trial|Unknown status|Recruiting|Phase 4|100|Anticipated|Zhujiang Hospital||2|||f||||t||||||||||2017-10-11 00:11:07.849447|2017-10-11 00:11:07.849447
NCT02197858|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-22|2015-12-03|||July 2014||2014-07-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Observational|HMPR1||Comparability of Invasive and Non-invasive Haemodynamic Monitoring|Clinical Comparison of Hemodynamic Parameters Using Invasive Versus Non-invasive Continuous Blood-pressure Technology During a Total Intravenous Anaesthesia (TIVA).|Completed||N/A|40|Actual|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-10-11 00:11:07.956004|2017-10-11 00:11:07.956004
NCT02197845|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-07-11|||October 2012||2012-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SHiP HU||Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators|Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators|Recruiting||N/A|439|Anticipated|Virginia Commonwealth University||3|||f||||t||||||||||2017-10-11 00:11:08.01906|2017-10-11 00:11:08.01906
NCT02197832|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2015-12-10|||September 2012||2012-09-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A RCT on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing FET Cycles|A Randomized Controlled Trial on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing Frozen-thawed Embryo Transfer Treatment Cycles|Terminated||N/A|20|Actual|The University of Hong Kong||2||Difficulty in recruiting participants.|f||||f||||||||||2017-10-11 00:11:08.148078|2017-10-11 00:11:08.148078
NCT02197819|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-08-23|||February 2013||2013-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|EERAADS||A Randomized Evaluation of Emergent Immobilization in External Rotation in the Management of Acute Anterior Dislocations of the Shoulder||Recruiting||N/A|75|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:11:08.23515|2017-10-11 00:11:08.23515
NCT02197806|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-10-30|2015-10-30||July 2014||2014-07-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia||Completed||Phase 2|65|Actual|Allergan||4|||f||||f||||||||||2017-10-11 00:11:08.334493|2017-10-11 00:11:08.334493
NCT02197793|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-10-26|||July 2014||2014-07-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Activating Treatment as Prevention Through Community Mobilization in South Africa|Activating Treatment as Prevention Through Community Mobilization in South Africa|Recruiting||N/A|2510|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:11:08.744357|2017-10-11 00:11:08.744357
NCT02197780|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-05-03|||September 2014||2014-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01|6 Months|Observational [Patient Registry]|CACATU||Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD|Calprotectin or Calgranulin C-test Before Undergoing Endoscopy: a Prospective Diagnostic Accuracy Study Comparing Two Fecal Biomarkers for Pediatric IBD|Completed||N/A|355|Actual|University Medical Center Groningen|||1||f||||f||||||Samples Without DNA|"     Feces   "|Undecided||2017-10-11 00:11:08.862633|2017-10-11 00:11:08.862633
NCT02197767|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-04-27|||November 2014||2014-11-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis|A Single Center Pilot Trial of Rituximab in the Treatment of Fibrillary Glomerulonephritis|Active, not recruiting||Phase 2|11|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:11:08.999302|2017-10-11 00:11:08.999302
NCT02197754|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-01-15|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Adaptation in Polyphenol Bioavailability and Bioactivity During Long Term Exposure to Polyphenol-Rich Foods||Completed||N/A|28|Actual|USDA Beltsville Human Nutrition Research Center||1|||f||||f||||||||||2017-10-11 00:11:09.100401|2017-10-11 00:11:09.100401
NCT02197741|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-11-21|||February 2012||2012-02-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|December 2012|Actual|2012-12-01||Observational|||The Effect of an Additional Bolus Application in Patients With Intrathecal Opiate Administration - a Pilot Study|The Effect of an Additional Bolus Application in Patients With Intrathecal Opiate Administration - a Pilot Study|Completed||N/A|10|Actual|Swiss Paraplegic Centre Nottwil|||2||f||||f||||||||||2017-10-11 00:11:09.187308|2017-10-11 00:11:09.187308
NCT02197728|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-03-02|||February 2014||2014-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparing Two Devices of Uterine Manipulation and Vaginal Fornix Delineation at Total Laparoscopic Hysterectomy|Comparing Two Devices of Uterine Manipulation and Vaginal Fornix Delineation at Total Laparoscopic Hysterectomy|Completed||N/A|91|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:11:09.269375|2017-10-11 00:11:09.269375
NCT02197715|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-08-08|||August 2014||2014-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|SAFE||Sex and Female Empowerment|Improving Women's Sexual Health While in Drug Addiction Treatment|Recruiting||N/A|90|Anticipated|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-11 00:11:09.354153|2017-10-11 00:11:09.354153
NCT02197702|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-11-27|||September 2014||2014-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|DIVA||Vitamin D in Preschoolers With Viral-induced Asthma|Vitamin D In the Prevention of Viral-induced Asthma of Preschoolers: a Randomised Controlled Trial (RCT)- (DIVA)|Completed||Phase 2/Phase 3|47|Actual|St. Justine's Hospital||2|||f||||t||||||||Undecided||2017-10-11 00:11:09.448575|2017-10-11 00:11:09.448575
NCT02197689|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-22|||January 2010||2010-01-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|||A Trial for a Personalized Medication Management Platform to Improve Medication Adherence|Mobile Intelligent Personal Medication Management Platform|Completed||N/A|763|Actual|Taipei Medical University||2|||f||||f||||||||||2017-10-11 00:11:09.553019|2017-10-11 00:11:09.553019
NCT02197676|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-07-11|||August 4, 2014|Actual|2014-08-04|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 6, 2016|Actual|2016-02-06||Interventional|||A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to Azacitidine or Decitabine After at Least 6 Courses or Relapsing After a Response|A Phase II Trial of SGI-110 in Patients With IPSS High and Int 2 Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20-30% Marrow Blasts or Chronic Myelomonocytic Leukemia Type 2 Not Responding to Azacitidine or Decitabine After at Least 6 Courses or Relapsing After a Response|Active, not recruiting||Phase 2|56|Actual|Groupe Francophone des Myelodysplasies||1|||f||||f||||||||||2017-10-11 00:11:09.628542|2017-10-11 00:11:09.628542
NCT02197663|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-08|2015-10-20|||April 2013||2013-04-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Clinical Evaluation of Acupuncture on the Complications of Cerebral Vascular Accident|Clinical Evaluation of Acupuncture on the Complications of Cerebral Vascular Accident|Terminated||Phase 1|60|Actual|China Medical University Hospital||2||the numbers of drop-out patients are more than we anticipate|f||||f||||||||||2017-10-11 00:11:09.751386|2017-10-11 00:11:09.751386
NCT02197650|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-07-11||||||July 2017|2017-07-01||||||||Expanded Access|EAP||Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase|Expanded Access Program for a Multicentre, Open, Non Randomized Study, Evaluating Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase|Available||N/A|||ERYtech Pharma|||||f||||||||||||||2017-10-11 00:11:09.83937|2017-10-11 00:11:09.83937
NCT02197637|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-07-19|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|August 2017|Anticipated|2017-08-01||Interventional|OVIMA-1210||Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma|Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma|Suspended||Phase 2|39|Anticipated|Centre Oscar Lambret||1||Analysis before next stage (extension cohort)|f||||t|f|f||||||||2017-10-11 00:11:09.953091|2017-10-11 00:11:09.953091
NCT02197624|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-21|||June 2012||2012-06-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|April 2013|Actual|2013-04-01||Observational|||Genetic Variants and Iron Absorption|Metabolic Adaptation to Plant-based Diets in Asian Populations|Completed||N/A|57|Actual|Cornell University|||1||f||||f||||||Samples With DNA|"     Two 10 mL blood samples and one 3 mL blood sample were collected.   "|||2017-10-11 00:11:10.30142|2017-10-11 00:11:10.30142
NCT02197611|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-10-19|||September 2015||2015-09-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01|1 Day|Observational [Patient Registry]|ADHAESIONE||Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.|Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia. The Haemo-Adhaesione Questionnaire|Unknown status|Recruiting|N/A|100|Anticipated|Universidad de Murcia|||1||f||||f||||||||||2017-10-11 00:11:10.406142|2017-10-11 00:11:10.406142
NCT02197598|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-12-13|||September 2014||2014-09-01|December 2016|2016-12-01||||December 2015|Actual|2015-12-01||Interventional|||Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use|Exploratory, Interventional, Open-label, Fixed-dose Study With Selincro® As-needed Use, in Alcohol Dependent Patients With Liver Impairment|Completed||Phase 4|45|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 00:11:10.493955|2017-10-11 00:11:10.493955
NCT02197585|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-07-21|||June 2007||2007-06-01|July 2014|2014-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|UHU||Comparison of Mesh Fixation Wit Cyanoacrylate vs Suture in Inguinal Hernia Surgery|Cyanoacrylate vs Suture for Mesh Fixation in Inguinal Hernia Surgery|Completed||N/A|150|Actual|Hospital del Mar||2|||f||||t||||||||||2017-10-11 00:11:10.604375|2017-10-11 00:11:10.604375
NCT02197572|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-01-12|||September 2014||2014-09-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of MLN0128 on the QTc Interval in Participants With Advanced Solid Tumors|A Phase 1 Study to Evaluate the Effect of MLN0128 on the QTc Interval in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|30|Anticipated|Takeda||1|||f||||f||||||||||2017-10-11 00:11:10.697404|2017-10-11 00:11:10.697404
NCT02197559|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-10-21|||January 2014||2014-01-01|July 2014|2014-07-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Observational|||Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis|A Prospectie Cohort Study of Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis|Completed||N/A|168|Actual|Xuanwu Hospital, Beijing|||1||f||||t||||||||||2017-10-11 00:11:10.813321|2017-10-11 00:11:10.813321
NCT02197546|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-07-21|||July 2010||2010-07-01|July 2014|2014-07-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|AcuDent||Acupuncture for Pain During Injection of Local Anaesthetic|Acupuncture Reduces Pain and Autonomous Distress During Injection of Local Anaesthetic in Children - a Randomised Crossover Investigation|Completed||N/A|49|Actual|University Medicine Greifswald||2|||f||||f||||||||||2017-10-11 00:11:10.924944|2017-10-11 00:11:10.924944
NCT02197533|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-09-29|||July 2014||2014-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions|Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions|Recruiting||N/A|60|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:11:11.028423|2017-10-11 00:11:11.028423
NCT02197520|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2015-06-23|||July 2014||2014-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics|The Effect of Treatment With Basal Insulin Peglispro or Insulin Glargine on Insulin Sensitivity and the Effect of Prandial Insulin Lispro in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|24|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:11:11.153477|2017-10-11 00:11:11.153477
NCT02197507|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-07-21|||September 2014||2014-09-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Digitized Grip Strength|Evaluation of Grip Strength With Digitized Sensor in Adults With Rheumatoid Arthritis|Unknown status|Not yet recruiting|N/A|150|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 00:11:11.273024|2017-10-11 00:11:11.273024
NCT02197494|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-07-21|||January 2014||2014-01-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two Period, Two-sequence, Single Oral Dose, Crossover, Bioequivalence Study of Two Formulations of Valsartan 320mg Tablet in Healthy, Adult, Human Subjects Under Fed Condition.|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 00:11:11.372023|2017-10-11 00:11:11.372023
NCT02197104|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-08-28|||January 2015||2015-01-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Citocoline for Treatment of FXTAS|Phase 2 Study of Citocoline for Treatment in Fragile X-associated Tremor/Ataxia Syndrome|Completed||Phase 2|10|Actual|Rush University Medical Center||1|||f||||t||||||||||2017-10-11 00:11:17.427985|2017-10-11 00:11:17.427985
NCT02197468|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-06-20|||March 2015||2015-03-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01|1 Year|Observational [Patient Registry]|PINGU||Preterm Infant Gut (PINGU) - a Norwegian Multi Centre Study|Gut Microbiome Study in Preterm Infants - a Norwegian Multi Centre Study|Completed||N/A|60|Actual|University Hospital of North Norway|||1||f||||f||||||Samples With DNA|"     Fecal samples for bacterial DNA analyses   "|||2017-10-11 00:11:11.59697|2017-10-11 00:11:11.59697
NCT02197455|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-03-31|2017-01-30||July 2014||2014-07-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Tofacitnib for the Treatment of Alopecia Areata and Variants|Tofacitnib for the Treatment of Alopecia Areata and Variants|Completed||Phase 2|30|Actual|Yale University||1|||f||||f||||||||No||2017-10-11 00:11:11.724908|2017-10-11 00:11:11.724908
NCT02197442|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-07-21|||January 2014||2014-01-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Four-period, Two-sequence, Single Oral Dose, Crossover, Fully Replicate Bioequivalence Study of Two Formulations of Valsartan 320 mg Tablet in Healthy, Adult, Human Subjects Under Fasting Condition|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 00:11:11.940656|2017-10-11 00:11:11.940656
NCT02197429|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-18|||February 2012||2012-02-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Acupuncture for the Treatment of Vulvodynia|Acupuncture for the Treatment of Vulvodynia|Completed||N/A|36|Actual|Schlaeger, Judith M., CNM, LAc, PhD||2|||f||||f||||||||||2017-10-11 00:11:12.061345|2017-10-11 00:11:12.061345
NCT02197416|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-10-03|||September 29, 2014|Actual|2014-09-29|October 2017|2017-10-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||Safety of Dabigatran Etexilate in Blood Clot Prevention in Children|Open Label, Single Arm Safety Prospective Cohort Study of Dabigatran Etexilate for Secondary Prevention of Venous Thromboembolism in Children From 0 to Less Than 18 Years|Recruiting||Phase 3|100|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:11:12.215566|2017-10-11 00:11:12.215566
NCT02197403|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2016-07-25|||December 2013||2013-12-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|DEX||Paradoxical Excitement Response During Sedation Between Dexmedetomidine and Propofol in Hazardous Alcohol Drinker|Comparative Study on Development of Paradoxical Excitement Response During Sedation Using Dexmedetomidine or Propofol in Hazardous Alcohol Drinkers|Active, not recruiting||Phase 4|110|Anticipated|Chonnam National University Hospital||4|||f||||t||||||||Undecided||2017-10-11 00:11:12.523728|2017-10-11 00:11:12.523728
NCT02197390|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-10-04|||May 2012||2012-05-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|February 2016|Actual|2016-02-01||Interventional|Our Choice||An Ecological Approach to Addressing Childhood Obesity Issues in Imperial County|An Ecological Approach to Addressing Childhood Obesity Issues in Imperial County|Active, not recruiting||N/A|1184|Actual|San Diego State University||4|||f||||t||||||||||2017-10-11 00:11:12.655493|2017-10-11 00:11:12.655493
NCT02197364|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-18|||December 2013||2013-12-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||The Role of KL-6 in the Clinical Diagnosis of ILD|The Role of KL-6 as a Serum Biomarker in the Clinical Diagnosis of Interstitial Lung Diseases (ILD) in China|Completed||N/A|1190|Actual|Shanghai Pulmonary Hospital, Shanghai, China|||1||f||||t||||||Samples Without DNA|"     The residual serums in the clinical laboratory.   "|||2017-10-11 00:11:12.934299|2017-10-11 00:11:12.934299
NCT02197351|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-03-30|||July 2014||2014-07-01|March 2017|2017-03-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Narrow Band Imaging for Gastric Neoplasia|Prospective Controlled Trial of Narrow Band Imaging for Detection of Gastric Cancer Precursors|Recruiting||N/A|220|Anticipated|University of Southern California||1|||f||||t||||||||Undecided||2017-10-11 00:11:13.024212|2017-10-11 00:11:13.024212
NCT02197338|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-04-13|||April 2016||2016-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Randomized Trial of Wire and Sphincterotome Systems for Biliary Cannulation|Randomized Controlled Trial of Short Versus Long Wire and Small Versus Standard Sphincterotomes for Initial Biliary Cannulation|Completed||N/A|498|Anticipated|University of Southern California||4|||f||||t||||||||||2017-10-11 00:11:13.172219|2017-10-11 00:11:13.172219
NCT02197325|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-09-19|||January 2015||2015-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Pressure Controlled Intermittent Coronary Sinus Occlusion as an Adjunct to PCI in Acute Coronary Syndrome.|Pressure Controlled Intermittent Coronary Sinus Occlusion as an Adjunct to PCI in Acute Coronary Syndrome. (An Observational Study Evaluating the Effect of PICSO Treatment Concomitant to pPCI in Patients With Anterior NSTEMI or Following pPCI in STEMI)|Recruiting||N/A|60|Anticipated|Miracor Medical Systems||2|||f||||f||||||||||2017-10-11 00:11:13.295697|2017-10-11 00:11:13.295697
NCT02197312|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-03-29|||June 18, 2010|Actual|2010-06-18|March 2017|2017-03-01|November 23, 2013|Actual|2013-11-23|November 23, 2013|Actual|2013-11-23||Interventional|||NobelProceraTM Bridge Shaded Zirconia|A Clinical Evaluation of NobelProceraTM Bridge Shaded Zirconia|Terminated||N/A|25|Actual|Nobel Biocare||1||Business reasons|f||||f||||||||||2017-10-11 00:11:13.420021|2017-10-11 00:11:13.420021
NCT02197299|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-12-01|||August 2014||2014-08-01|December 2015|2015-12-01||||July 2016|Anticipated|2016-07-01||Interventional|||Improving Glycaemic Control With L-carnitine|Increasing Skeletal Muscle Carnitine Content to Improve Glycaemic Control in Type 2 Diabetes Mellitus|Recruiting||Phase 2|24|Anticipated|University of Nottingham||2|||f||||f||||||||||2017-10-11 00:11:13.509349|2017-10-11 00:11:13.509349
NCT02197286|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-10-07|||February 2015||2015-02-01|October 2015|2015-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia|Vitamin-D Treatment Targeted to Hyperprolinemia-Associated Schizophrenia.|Withdrawn||Phase 2|0|Actual|New York University School of Medicine||2||Personnel changes at study site.|f||||f||||||||||2017-10-11 00:11:13.610794|2017-10-11 00:11:13.610794
NCT02197273|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-08-30|2016-05-10||July 2014||2014-07-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA)|Efficacy of Liposomal Bupivacaine Versus Standard Analgesia in Pain Management of Total Joint Arthroplasty|Completed||N/A|211|Actual|OhioHealth|No early termination or technical problems identified.|2|||f||||f||||||||No||2017-10-11 00:11:13.728256|2017-10-11 00:11:13.728256
NCT02197260|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-21|||September 2008||2008-09-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|GAR||Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing|Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing on Clinical, Microbiological and Systemic Response|Completed||Phase 4|80|Actual|University of Geneva, Switzerland||2|||f||||f||||||||||2017-10-11 00:11:14.067758|2017-10-11 00:11:14.067758
NCT02197234|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-09-14|2016-04-08||December 22, 2014|Actual|2014-12-22|September 2017|2017-09-01|January 4, 2018|Anticipated|2018-01-04|April 30, 2015|Actual|2015-04-30||Interventional|||Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC|A Phase I, Open-Label, Non-Randomised, Multicentre Study to Assess the Effect of AZD9291 on the Pharmacokinetics of Simvastatin (a Sensitive CYP3A4 Substrate) in Patients With EGFRm Positive NSCLC Whose Disease Has Progressed on an EGFR TKI|Active, not recruiting||Phase 1|52|Actual|AstraZeneca|At end of Part B, the CAP allowed patients to continue receiving AZD9291 if still deriving clinical benefit. No clinical data was databased during the CAP; thus AE data is presented to end of Part B only.|1|||f||||f||||||||||2017-10-11 00:11:15.355067|2017-10-11 00:11:15.355067
NCT02197221|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-08-16|||January 2015||2015-01-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|January 2020|Anticipated|2020-01-01||Interventional|IFM2014-02||Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma|IFM 2014-02 Study: A Randomized Phase III Study of Bortezomib-Melphalan 200 Conditioning Regimen Versus Melphalan 200 for Frontline Transplant Eligible Patients With Multiple Myeloma|Recruiting||Phase 3|300|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 00:11:16.141346|2017-10-11 00:11:16.141346
NCT02197208|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2015-12-10|||October 2014||2014-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET|A Randomized Controlled Comparison of Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in Frozen-thawed Embryos Transfer|Completed||N/A|300|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:11:16.420793|2017-10-11 00:11:16.420793
NCT02197195|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2014-07-20|||February 2014||2014-02-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Sugars-sweetened Beverages and Exercise on Glycaemic Response and Subjective Appetite in Children|The Role of Chocolate Milk and Fruit Drink on Subjective Appetite and Glycaemic Response With or Without Exercise in Normal Weight 9-14 Year Old Boys|Completed||N/A|8|Actual|Ryerson University||4|||f||||f||||||||||2017-10-11 00:11:16.530784|2017-10-11 00:11:16.530784
NCT02197182|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2015-03-20|||June 2014||2014-06-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study|An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study|Suspended||Early Phase 1|60|Anticipated|CDA Research Group, Inc.||2||Not for safety reasons|f||||f||||||||||2017-10-11 00:11:16.61756|2017-10-11 00:11:16.61756
NCT02197169|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2016-12-07|||August 2014||2014-08-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|TARGET-I||DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors|A Phase 1b, Randomized, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) and Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma (TARGET-I)|Active, not recruiting||Phase 1|37|Actual|DNAtrix, Inc.||2|||f||||f||||||||||2017-10-11 00:11:16.713648|2017-10-11 00:11:16.713648
NCT02197156|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2014-07-21|||August 2002||2002-08-01|July 2014|2014-07-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Active Comparator Study of Hydrocodone Bitartrate Extended Release (HC-ER) in Adults Following Bunionectomy Surgery|Completed||Phase 2|241|Actual|Zogenix, Inc.||6|||f||||f||||||||||2017-10-11 00:11:16.830022|2017-10-11 00:11:16.830022
NCT02197143|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-18|||March 2013||2013-03-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain|A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain: A Double-Blind, Randomized, Controlled Trial|Completed||Phase 4|286|Actual|Pamukkale University||3|||f||||t||||||||||2017-10-11 00:11:16.937582|2017-10-11 00:11:16.937582
NCT02197117|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-05-07|||March 2011||2011-03-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|ERIC-LYSIS||Effect of Remote Ischemic Conditioning in Heart Attack Patients|Effect of Remote Ischaemic Conditioning in STEMI Patients Treated by thromboLYSIS: A Randomised Controlled Clinical Trial (the ERIC-LYSIS Study)|Completed||N/A|519|Actual|University College, London||2|||f||||t||||||||||2017-10-11 00:11:17.318361|2017-10-11 00:11:17.318361
NCT02197091|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-08-14|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Communication Effectiveness in Cancer Treatment|A Health Services Research Study to Evaluate Communication Effectiveness in Oncology Treatment|Completed||N/A|100|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-11 00:11:17.534006|2017-10-11 00:11:17.534006
NCT02197078|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-10-03|||July 30, 2014|Actual|2014-07-30|October 2017|2017-10-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin|Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin|Recruiting||N/A|99999|Anticipated|Boehringer Ingelheim|||4||f||||||||||||||2017-10-11 00:11:17.650167|2017-10-11 00:11:17.650167
NCT02197065|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-21|2017-06-02|2017-04-20||September 2014|Actual|2014-09-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|POST-OP Pilot||Pilot Study of Atorvastatin for Orthopedic Surgery Patients|The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial|Completed||Phase 2|20|Actual|Hospital for Special Surgery, New York|Small sample size: recruitment was made difficult by comorbidities in hip fracture patients that limited participation, the reluctance of arthroplasty patients to enroll in an interventional trial, and statin use in 40% of the target population.|2|||f||||f||||||||No||2017-10-11 00:11:17.761481|2017-10-11 00:11:17.761481
NCT02197052|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-18|||June 2013||2013-06-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||iScreen Study: Best Methods for Social Screening in Pediatric Caregivers|iScreen Study: Best Methods for Social Screening in Pediatric Caregivers|Completed||N/A|552|Actual|University of California, San Francisco|||2||f||||f||||||||||2017-10-11 00:11:18.332232|2017-10-11 00:11:18.332232
NCT02197039|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2014-07-20|||August 2011||2011-08-01|July 2014|2014-07-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01|3 Days|Observational [Patient Registry]|CSE||The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers|The Selection Criteria for Deciding Who Needs the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers|Unknown status|Recruiting|N/A|350|Anticipated|National Cheng-Kung University Hospital|||2||f||||t||||||Samples With DNA|"     whole blood, serum, white cells, gastric tissue   "|||2017-10-11 00:11:18.406892|2017-10-11 00:11:18.406892
NCT02197026|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-21|||October 1998||1998-10-01|July 2014|2014-07-01||||February 2000|Actual|2000-02-01||Interventional|||Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis|A Multicentre, Open-label and Randomized Clinical Trial to Compare in Patient With Knee Osteoarthritis the Medicoeconomic Benefits as Well as Effectiveness and Safety of Synvisc® Versus Usual Treatments.|Completed||Phase 4|518|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:11:18.713412|2017-10-11 00:11:18.713412
NCT02197013|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-21|||September 2012||2012-09-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Evaluation of Introcan Safety 3 Closed IV Catheter|Evaluation of Introcan Safety 3 Closed IV Catheter|Completed||N/A|200|Actual|B. Braun Melsungen AG|||2||f||||f||||||||||2017-10-11 00:11:18.851483|2017-10-11 00:11:18.851483
NCT02197000|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-20|2016-04-21|||September 2014||2014-09-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers|A Nutritional Intervention to Decrease Breast Density Among Female BRCA Carriers -A Prospective Clinical Trial|Recruiting||N/A|36|Anticipated|Rabin Medical Center||1|||f||||t||||||||Undecided||2017-10-11 00:11:18.958043|2017-10-11 00:11:18.958043
NCT02196987|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-21|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Does the Act of Urination During Urethral Catheterisation in Males Reduce Pain?|Pain Level During Male Urethral Catheterisation - Does Patient Attempted Urination During Catheterisation Reduce Pain? A Prospective Randomized Study|Unknown status|Recruiting|N/A|96|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||||||2017-10-11 00:11:19.103097|2017-10-11 00:11:19.103097
NCT02196974|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-08-29|||January 2013||2013-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Bronchoscopic Approach to the Peripheral Lung Nodule - Endobronchial Ultrasound, Electromagnetic Navigation and Cryobiopsy|Bronchoscopic Approach to the Peripheral Lung Nodule - Endobronchial Ultrasound, Electromagnetic Navigation and Cryobiopsy|Completed||N/A|27|Actual|University of Calgary||1|||f||||f||||||||||2017-10-11 00:11:19.237309|2017-10-11 00:11:19.237309
NCT02196961|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-08-28|||June 2014||2014-06-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|ADMEC-O||Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies Versus Observation|Prospective Randomized Trial of an Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma (MCC) With Immune Checkpoint Blocking Antibodies (Nivolumab, Opdivo®; Ipilimumab (Yervoy®) Every 3 Weeks for 12 Weeks Versus Observation|Recruiting||Phase 2|177|Anticipated|University Hospital, Essen||3|||f||||f||||||||||2017-10-11 00:11:19.359819|2017-10-11 00:11:19.359819
NCT02196948|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-19|2014-12-02|||July 2014||2014-07-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy|Electrolysis Percutaneous Therapeutic (EPTE) for the Management of Supraspinatus Tendinopathy|Completed||N/A|36|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 00:11:19.598365|2017-10-11 00:11:19.598365
NCT02196935|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-19|2017-04-18|||September 2010||2010-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Los Angeles Prospective GI Biliary and EUS Series|Prospective Evaluation of Pancreatic, Biliary, and Gastrointestinal Neoplasia by Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS)|Recruiting||N/A|2500|Anticipated|University of Southern California|||1||f||||f|f|f||||||Undecided||2017-10-11 00:11:19.713663|2017-10-11 00:11:19.713663
NCT02196896|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-16|||June 2014||2014-06-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Enhancing Inpatient Psychotherapeutic Treatment With Online Self-help : Acceptance and Efficacy|Enhancing Inpatient Psychotherapeutic Treatment With Online Self Help in a Randomised Controlled Trial: Acceptance and Efficacy|Completed||N/A|229|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||No||2017-10-11 00:11:20.468131|2017-10-11 00:11:20.468131
NCT02196883|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-06-10|||May 2014||2014-05-01|July 2014|2014-07-01||||May 2015|Anticipated|2015-05-01||Interventional|||"Steroid Injections Given at the Level of MRI Pathology Versus at the Level of Clinical Symptoms to See if One is More Effective Than the Other."|A Prospective, Randomized, Single Blind Study Comparing Transforaminal Epidural Steroid Injections at the Level of MRI Pathology vs Clinical Symptoms|Withdrawn||N/A|0|Actual|State University of New York - Upstate Medical University||2||PI no longer part of practice|f||||t||||||||||2017-10-11 00:11:20.589907|2017-10-11 00:11:20.589907
NCT02196870|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2015-06-23|||July 2014||2014-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01|3 Years|Observational [Patient Registry]|||Effects of Chest Wall Elastance on Pulmonary Mechanics of Acute Respiratory Failure (ARF)|Physiological Effects of Chest Wall Elastance on Pulmonary Mechanics of Acute Respiratory Failure Patientstranspulmonary Pressure|Completed||N/A|12|Actual|Southeast University, China|||1||f||||t||||||||||2017-10-11 00:11:20.694423|2017-10-11 00:11:20.694423
NCT02196857|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-03-09|||February 2015|Actual|2015-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation|Phase II Study of Sorafenib Plus 5-Azacitidine for the Initial Therapy of Patients With Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome With FLT3-ITD Mutation|Recruiting||Phase 2|52|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:11:20.807377|2017-10-11 00:11:20.807377
NCT02196844|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-07-17|||September 29, 2014|Actual|2014-09-29|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Yoga Program for Lung Cancer Patients and Caregivers|Couple-Based Yoga Program for Patients Receiving Thoracic Radiation and Their Family Caregivers|Active, not recruiting||N/A|64|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-10-11 00:11:20.985265|2017-10-11 00:11:20.985265
NCT02196831|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-08-28|||July 2015||2015-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Tesamorelin Effects on Liver Fat and Histology in HIV|Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:11:21.168138|2017-10-11 00:11:21.168138
NCT02196818|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-04-07|||March 2013||2013-03-01|April 2016|2016-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup|A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty|Recruiting||N/A|200|Anticipated|Medacta International SA||1|||f||||||||||||||2017-10-11 00:11:21.316519|2017-10-11 00:11:21.316519
NCT02196805|ClinicalTrials.gov processed this data on October 10, 2017|2009-08-25|2014-07-20|||March 2009||2009-03-01|July 2014|2014-07-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers||Completed||N/A|120|Anticipated|Otsuka Beijing Research Institute||2|||f||||f||||||||||2017-10-11 00:11:21.465197|2017-10-11 00:11:21.465197
NCT02196792|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-07-05|||May 1, 2009||2009-05-01|July 2017|2017-07-01|May 1, 2030|Anticipated|2030-05-01|May 1, 2015|Actual|2015-05-01||Interventional|||Assessment of Polyethylene Wear, Migration and Clinical Outcome in Total Hip Replacement|Assessment of Polyethylene Wear, Migration and Clinical Outcome in Total Hip Replacement - A Prospective Randomized Control Trial|Active, not recruiting||N/A|100|Actual|Odense University Hospital||4|||f||||f||||||||||2017-10-11 00:11:21.591832|2017-10-11 00:11:21.591832
NCT02196779|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-19|2014-11-18|||July 2014||2014-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01|6 Months|Observational [Patient Registry]|||Laser Fluorescent Imaging of Abdominal Skin During Abdominoplasty|Laser Fluorescent Imaging of Abdominal Skin During Abdominoplasty|Completed||N/A|20|Actual|Swanson Center|||1||f||||f||||||||||2017-10-11 00:11:21.697538|2017-10-11 00:11:21.697538
NCT02196766|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-03-30|2015-12-15||July 2014||2014-07-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Overall participants group prior to randomization of study lens pairs and solution.|BIOCLEAN FIRST CARE EX in Combination With Biofinity Lens|BIOCLEAN FIRST CARE EX in Combination With Biofinity Lens: A Two Week Crossover Study|Completed||N/A|30|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 00:11:21.79571|2017-10-11 00:11:21.79571
NCT02196753|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-05-27|||March 2014||2014-03-01|May 2015|2015-05-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Observational|PET Guidance I||PET CT in Suspected CIED Infection, a Pilot Study - PET Guidance I|Positron Emission Tomography Combined With Computed Tomography (PET CT) in Suspected Cardiovascular Implantable Electronic Device Infection, a Pilot Study - PET Guidance I|Unknown status|Recruiting|N/A|40|Anticipated|Institute of Cardiology, Warsaw, Poland|||2||f||||f||||||||||2017-10-11 00:11:22.127142|2017-10-11 00:11:22.127142
NCT02196740|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-21|||June 2013||2013-06-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Research of the Application of Triple Antibiotic Paste in Primary Teeth With Pericpical Periodontitis|Randomized Controlled Research of the Application of Triple Antibiotic Paste in Primary Teeth With|Unknown status|Active, not recruiting|N/A|100|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:11:22.252185|2017-10-11 00:11:22.252185
NCT02196727|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-21|||May 2013||2013-05-01|May 2013|2013-05-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01|1 Month|Observational [Patient Registry]|||Evaluation of Postoperative Pain Following Bascom Cleft Lift Operation|Evaluation of Post-operative Pain in Bascom Cleft Lift Operation Receiving Multimodal Analgesia and Spinal Saddle Block in Day Case Surgery Setting.|Completed||N/A|32|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 00:11:22.344006|2017-10-11 00:11:22.344006
NCT02196714|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-03-14|2016-05-24||July 2014||2014-07-01|March 2017|2017-03-01||||September 2014|Actual|2014-09-01||Interventional||Analysis Set: All Subjects Randomized|PK Study of PT003 and PT001 in Japanese Healthy Subjects|A Phase I, Randomized, Double-Blind, Single-Dose, Four-Period, Four-Treatment, Cross-Over Study Evaluating the Safety and Pharmacokinetics of Two Doses of PT003 and Two Doses of PT001 in Japanese Healthy Subjects|Completed||Phase 1|24|Actual|Pearl Therapeutics, Inc.||4|||f||||f||||||||||2017-10-11 00:11:22.45384|2017-10-11 00:11:22.45384
NCT02196701|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-03-20|||July 2014|Actual|2014-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|CLEAR||Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study|Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study|Completed||Phase 3|46|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 00:11:24.161064|2017-10-11 00:11:24.161064
NCT02196688|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-02-18|||April 2014||2014-04-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Study of Fruquintinib in Patients With Metastatic Colorectal Cancer（CRC）|A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Trial to Compare the Efficacy and Safety of Fruquintinib Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With CRC as 3rd or Above Therapy|Completed||Phase 2|71|Actual|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-11 00:11:26.171731|2017-10-11 00:11:26.171731
NCT02196675|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-19|2016-06-16|2015-11-16||July 2014||2014-07-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational||All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure. Two enrolled subjects were converted to an open procedure and thus were not included in this summary. These subjects were followed for safety.|Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea|A Prospective, Multi-Center Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea|Completed||N/A|105|Actual|Ethicon Endo-Surgery|||1||f||||f||||||||||2017-10-11 00:11:26.307338|2017-10-11 00:11:26.307338
NCT02196662|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-04-20|||July 2014||2014-07-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|IBD98-M||Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers|Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers|Completed||Phase 1|30|Actual|Holy Stone Healthcare Co., Ltd||3|||f||||t||||||||||2017-10-11 00:11:27.041101|2017-10-11 00:11:27.041101
NCT02196649|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-08-13|||October 2014||2014-10-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|CuRB||Clip Placement Following Endoscopic Mucosal Resection - Randomised Trial|Prophylactic and Endoscopic Clip Placement to Prevent Clinically Significant Post Wide Field Endoscopic Mucosal Resection Bleeding - a Randomised Controlled Trial.|Recruiting||N/A|300|Anticipated|Western Sydney Local Health District||2|||f||||f||||||||||2017-10-11 00:11:27.162013|2017-10-11 00:11:27.162013
NCT02196636|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-11-01|||July 2014||2014-07-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Phase 1 Study of RO6806127 in Healthy Male Volunteers|A Single-center, Randomised, Double-blind, Adaptative, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including the Effect of Food), and Pharmacodynamics or RO6806127 in Healthy Male Subjects|Completed||Phase 1|37|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:11:27.26169|2017-10-11 00:11:27.26169
NCT02196623|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-08-31|||June 2015|Actual|2015-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Hypoxia and Exercise in the Elderly|Hypoxia and Aerobic Exercise Interactions in Age-related Metabolic Muscle Dysfunction|Active, not recruiting||N/A|29|Actual|Hannover Medical School||2|||f||||f||||||||||2017-10-11 00:11:27.368574|2017-10-11 00:11:27.368574
NCT02196610|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-04-28|||November 2014||2014-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Feasibility Study of Arterial Stiffness in Hemodialysis Patients|Arterial Stiffness in Healthy Subjects and Patients With End‐Stage‐ Renal Disease: A Feasibility Study|Terminated||N/A|36|Actual|Ottawa Hospital Research Institute|||2|Limited funds available to complete full recruitment. Enrolment achieved: 90%.|f||||f||||||||No||2017-10-11 00:11:27.478276|2017-10-11 00:11:27.478276
NCT02196597|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-07-18|||January 2013||2013-01-01|July 2014|2014-07-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Observational|||Value of Anorectal Manometry Before Ileo- or Sigmoidostomy Closure After Rectal Resection|Prospective Multi-center Evaluation of the Value of Anorectal Manometry Before Closure of Protective Ileostomy or Sigmoidostomy After Rectal Resection in Patients With Rectal Carcinoma|Unknown status|Recruiting|N/A|30|Anticipated|German Society for Neurogastroenterology and Motility|||2||f||||f||||||||||2017-10-11 00:11:27.732099|2017-10-11 00:11:27.732099
NCT02196584|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-19|2016-06-22|||August 2014||2014-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01||Observational|||Clinical Evaluation of the RAVI-Guide|Clinical Evaluation of the Rapid Access Vitreal Injection Guide (RAVI-Guide)|Completed||N/A|55|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-10-11 00:11:27.86348|2017-10-11 00:11:27.86348
NCT02196571|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-19|2016-07-16|||July 2014||2014-07-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|March 2015|Actual|2015-03-01||Interventional|||Structured Aerobic and Resistance Exercise and Gestational Diabetes|The Impact of Structured Aerobic and Resistance Exercise on the Course and Outcome of Gestational Diabetes Mellitus|Completed||N/A|42|Actual|Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse||2|||f||||f||||||||||2017-10-11 00:11:27.941692|2017-10-11 00:11:27.941692
NCT02196558|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-08-23|||June 9, 2014|Actual|2014-06-09|August 2017|2017-08-01|July 13, 2017|Actual|2017-07-13|August 2016|Actual|2016-08-01||Interventional|||A Phase 1/2 Study of E6011 in Japanese Subjects With Rheumatoid Arthritis|A Phase 1/2 Study of Repeated Subcutaneous E6011 Administration in Japanese Subjects With Rheumatoid Arthritis|Completed||Phase 1/Phase 2|37|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-11 00:11:28.052254|2017-10-11 00:11:28.052254
NCT02196545|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-18|||August 2011||2011-08-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|MOTODEM||Physical Activity Training Program for Patients With Alzheimer's Dementia|An Easily Accessible Physical Activity Training Program for Patients With Alzheimer's Dementia: Effect on Clinical and Neurobiological Parameters (MOTODEM)|Completed||N/A|30|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-10-11 00:11:28.190469|2017-10-11 00:11:28.190469
NCT02196532|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-21|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Retinal Nerve Fiber Layer Thickness Changes in Migraine: A Meta-Analysis of Case-control Studies|Retinal Nerve Fiber Layer Thickness Changes in Migraine: A Meta-Analysis of Case-control Studies|Unknown status|Recruiting|N/A|500|Anticipated|Wenzhou Medical University|||2||f||||f||||||||||2017-10-11 00:11:28.310776|2017-10-11 00:11:28.310776
NCT02196519|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-18|||April 2013||2013-04-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Clinical Evaluation of Cohera Sylys Surgical Sealant as an Adjunct to Standard Bowel Anastomosis Closure||Completed||N/A|16|Actual|Cohera Medical, Inc.||1|||f||||t||||||||||2017-10-11 00:11:28.415251|2017-10-11 00:11:28.415251
NCT02196493|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-02-17|||December 2013||2013-12-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|AZCC||An Open Label Trial of Azithromycin in Chronic Productive Cough|An Open Label Trial of Azithromycin in Chronic Productive Cough|Recruiting||Phase 3|50|Anticipated|University of Nottingham||1|||f||||f||||||||No||2017-10-11 00:11:28.746672|2017-10-11 00:11:28.746672
NCT02196480|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-18|||January 2008||2008-01-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy|Short and Long-term Immunogenicity and Safety Following the 23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy|Completed||Phase 4|27|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:11:28.880678|2017-10-11 00:11:28.880678
NCT02196467|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-03-01|||May 2014||2014-05-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|January 2019|Anticipated|2019-01-01||Interventional|||Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients|Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients|Recruiting||Phase 1/Phase 2|10|Anticipated|CHU de Quebec-Universite Laval||2|||f||||t||||||||Yes|The clinical trial results that have a relation to its objectives will be published as scientific papers in scientific journals or presented at scientific meetings, but without revealing the identity of the participants who will always remain anonymous.|2017-10-11 00:11:28.97565|2017-10-11 00:11:28.97565
NCT02196454|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-06-19|||July 2014||2014-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Video to Promote HPV Vaccination|Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination|Active, not recruiting||N/A|300|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 00:11:29.102488|2017-10-11 00:11:29.102488
NCT02196441|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-18|||August 2014||2014-08-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Evaluation of Deep Topical Fornix Nerve Block Versus Topical Anaesthesia Procedure|Evaluation of Deep Topical Fornix Nerve Block Versus Topical Anaesthesia in Patients Undergoing Implantable Contact Lens Procedure|Unknown status|Not yet recruiting|N/A|102|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-11 00:11:29.231137|2017-10-11 00:11:29.231137
NCT02196428|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-12-03|||September 2014||2014-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Medical Telemonitoring Plus Individual Teleconsultation in Elderly|Medical Telemonitoring Plus Individual Teleconsultation Based on an Ambient Assisted Living (AAL-) Wizard - an Interdisciplinary, Integrated Innovation.|Completed||N/A|30|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 00:11:29.370398|2017-10-11 00:11:29.370398
NCT02196415|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-11-20|||July 2014||2014-07-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|May 2017|Anticipated|2017-05-01||Observational|||Three-Dimensional Hindfoot Alignment Measurements Based On Biplanar Radiographs: Prospective Clinical Feasibility Study|Three-Dimensional Hindfoot Alignment Measurements Based On Biplanar Radiographs: Prospective Clinical Feasibility Study|Recruiting||N/A|50|Anticipated|Balgrist University Hospital|||1||f||||f||||||||||2017-10-11 00:11:29.491393|2017-10-11 00:11:29.491393
NCT02196402|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-18|||October 2013||2013-10-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Narrow Band Imaging in the Prediction of Surveillance Intervals After Polypectomy in Community Practice: Ready for (a European) Prime Time||Completed||N/A|280|Actual|Valduce Hospital|||1||f||||f||||||||||2017-10-11 00:11:29.601537|2017-10-11 00:11:29.601537
NCT02196389|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-12-02|||September 2014||2014-09-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison Between 4 Different Nasal Dilators|Comparison Between 4 Different Nasal Dilators: Objective vs Subjective Parameters|Recruiting||Phase 4|100|Anticipated|Universitaire Ziekenhuizen Leuven||4|||f||||f||||||||||2017-10-11 00:11:29.80842|2017-10-11 00:11:29.80842
NCT02196376|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-09-13|||July 2014||2014-07-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|||Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome|Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome|Active, not recruiting||N/A|212|Actual|Vanderbilt University Medical Center|||2||f||||f||||||Samples Without DNA|"     Blood will be drawn for future assay and analysis of the following tests:      Antibodies regulating cardiovascular function      The clinical significance of these antibodies is unknown. We will share the results of the     antibody panel with the subject, but with the caveat that no clinical interpretation or     comment on significance can be made.      Inflammatory markers   "|||2017-10-11 00:11:29.942416|2017-10-11 00:11:29.942416
NCT02196363|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-02-01|||July 2010||2010-07-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Observational|NUPS||New Ultrasound Parameters for Predicting Birthweight|New Ultrasound Parameters for Predicting Birthweight|Completed||N/A|253|Actual|Central Manchester University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 00:11:30.115351|2017-10-11 00:11:30.115351
NCT02196337|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-04-18|||July 2014||2014-07-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|SIMPLIFY||Salt Iodization: Meeting the Needs of Pregnancy, Lactation and Infancy|Salt Iodization and the 1st 1000 Days: Does a USI Program Cover the Iodine Requirement of Pregnant and Lactating Women and Infants?|Completed||N/A|8000|Actual|Swiss Federal Institute of Technology|||6||f||||f||||||Samples With DNA|"     Urine, dried blood spots, breast milk   "|No||2017-10-11 00:11:30.362646|2017-10-11 00:11:30.362646
NCT02196324|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-07-20|||July 2014||2014-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)|A Randomized, Double-Blind, Placebo-Controlled, Study of Neurokinin-1 Receptor Antagonist Serlopitant in Subjects With Prurigo Nodularis|Completed||Phase 2|128|Actual|Menlo Therapeutics Inc.||2|||f||||f||||||||No||2017-10-11 00:11:30.473965|2017-10-11 00:11:30.473965
NCT02196311|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-09-26|||March 2014||2014-03-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Observational|||Treatment Of Supracondylar Fractures Closed Reduction And Circular Ring External Fixation Versus Open Reduction and Internal Fixation|TREATMENT OF SUPRACONDYLAR FRACTURES IN ADOLESCENTS: CLOSED REDUCTION AND CIRCULAR RING EXTERNAL FIXATION VERSUS OPEN REDUCTION AND INTERNAL FIXATION|Recruiting||N/A|20|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-10-11 00:11:30.581755|2017-10-11 00:11:30.581755
NCT02196298|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-01-30|||October 2012|Actual|2012-10-01|January 2017|2017-01-01|January 30, 2017|Actual|2017-01-30|November 2016|Actual|2016-11-01||Interventional|||A Randomized Trial Comparing the Lokomat® With a Gait-related Physiotherapy Program in Children With Cerebral Palsy|A Randomized Cross-over Clinical Trial Comparing the Impact of the Lokomat® Gait Training System With a Gait-related Physiotherapy Program in Children With Cerebral Palsy|Completed||Phase 2|32|Actual|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||t||||||||||2017-10-11 00:11:30.693537|2017-10-11 00:11:30.693537
NCT02196285|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-06-21|||September 2015||2015-09-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|MR||Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella|A Phase I, Open, Uncontrolled Study, to Evaluate the Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella in Young Adults|Completed||Phase 1|30|Actual|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||1|||f||||t||||||||||2017-10-11 00:11:30.887663|2017-10-11 00:11:30.887663
NCT02196272|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-18|||July 2014||2014-07-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Interventional|||Nurse-led Reminder Program for Therapy Adherence, Clinical Outcomes and Trust in Nurses in Diabetic Patients|The Efficacy of a Nurse-led Reminder Program on Therapy Adherence, Clinical Outcomes and Trust in Nurses in Diabetic Patients.|Unknown status|Not yet recruiting|N/A|120|Anticipated|Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti||2|||f||||||||||||||2017-10-11 00:11:31.035945|2017-10-11 00:11:31.035945
NCT02196259|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-03-21|2016-05-31||February 2008||2008-02-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Anesthesia and Functional Connectivity: An Analysis of fMRI Changes|Anesthesia and Brain Functional Connectivity: An Analysis of fMRI Changes in Chronic Pain and Refractory Depression|Terminated||N/A|16|Actual|University of Michigan|These data should be interpreted with caution because of the small sample size due to the nature of this pilot study.|3||Funding cessation.|f||||f||||||||Undecided||2017-10-11 00:11:31.154919|2017-10-11 00:11:31.154919
NCT02196246|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-21|||August 2014||2014-08-01|July 2014|2014-07-01||||August 2014|Anticipated|2014-08-01||Observational|||Moletest Clinical Study in Scotland|A Clinical Study to Evaluate the Ability of an iPad Based Photographic Image Analysis System to Discriminate Benign Skin Lesions From Those Considered Suspect for Melanoma|Unknown status|Not yet recruiting|N/A|1000|Anticipated|Moletest Scotland Ltd|||1||f||||f||||||Samples Without DNA|"     Sample of suspect lesion taken for Biopsy, sample is only retained from initial inspection     until Biopsy, not other Biospecimen retention is required   "|||2017-10-11 00:11:31.583508|2017-10-11 00:11:31.583508
NCT02196233|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-08-11|||November 2012||2012-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Surgical Treatment of Adult Trigger Finger|A Prospective, Randomized Trial Evaluating the Type of Incision on Outcomes and Patient Satisfaction in the Surgical Treatment of Trigger Finger|Active, not recruiting||N/A|145|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 00:11:31.691513|2017-10-11 00:11:31.691513
NCT02196220|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-08-11|||July 2013||2013-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Ultrasonographic Assessment of Carpal Tunnel Syndrome|Ultrasonographic Assessment of Carpal Tunnel Syndrome in Children With Mucopolysaccharidosis and Comparison to Median Nerve Anatomy in Healthy Children.|Enrolling by invitation||N/A|150|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 00:11:31.791741|2017-10-11 00:11:31.791741
NCT02196207|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-04-27|||March 1, 2018|Anticipated|2018-03-01|April 2017|2017-04-01|March 2024|Anticipated|2024-03-01|February 2024|Anticipated|2024-02-01||Interventional|INHIBIT||Hemophilia Inhibitor Prevention (INHIBIT) Trial|Phase II Single-Arm Trial of Preemptive Prophylaxis With Long-Acting Recombinant Factor VIII Fc Fusion Protein, Eloctate, to Prevent Inhibitor Formation in Children With Severe Hemophilia A|Not yet recruiting||Phase 2|65|Anticipated|University of Pittsburgh||1|||f||||t|t|f|||f|||Yes|A biologic specimen and data repository for this trial will be available, pending NHLBI approval, at BioLINCC https://biolincc.nhlbi.nih.gov, to any research or investigator who makes formal application request and is formally approved by NHLBI.|2017-10-11 00:11:31.876345|2017-10-11 00:11:31.876345
NCT02196194|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-18|||September 2002||2002-09-01|July 2014|2014-07-01||||August 2003|Actual|2003-08-01||Observational|||A Prescription-Event Monitoring (PEM) Study of Tiotropium|A Prescription-Event Monitoring (PEM) Study of Tiotropium Based on Prescription Data Collected by the Prescription Pricing Authority (PPA) in England for Tiotropium (Spiriva®)|Completed||N/A|13891|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:11:32.016111|2017-10-11 00:11:32.016111
NCT02193269|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-01-23|||July 2013||2013-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Minocycline in Humans|Cognitive Effects of Minocycline in Humans|Recruiting||N/A|40|Anticipated|Yale University||2|||f||||t||||||||No||2017-10-11 00:12:32.267505|2017-10-11 00:12:32.267505
NCT02196168|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-03-22|2016-11-18||March 2014||2014-03-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Randomized Phase II Trial of Cisplatin With or Without Wee1 Kinase Inhibitor AZD1775 (MK-1775) for First-line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (RM-SCCHN)|Terminated||Phase 2|6|Actual|National Cancer Institute (NCI)||2||Inadequate accrual rate|f||||t||||||||||2017-10-11 00:11:36.34966|2017-10-11 00:11:36.34966
NCT02196155|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-09-21|||July 2016||2016-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis|Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis: a Randomized Controlled Study|Recruiting||N/A|54|Anticipated|University Hospital Inselspital, Berne||3|||f||||t||||||||||2017-10-11 00:11:37.823402|2017-10-11 00:11:37.823402
NCT02196142|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-06-23|||November 2014||2014-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CAR-Bern 2013||Acute Effects of Cortisol on Alcohol Craving in Alcohol Dependence|Acute Effects of Cortisol on Alcohol Craving in Alcohol Dependence|Completed||Phase 3|48|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 00:11:37.976176|2017-10-11 00:11:37.976176
NCT02196129|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-11-17|||July 2014||2014-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Immediate Pain Relieving Effects of Sinbaro-3 for Low Back Pain|Immediate Pain Relieving Effects of Sinbaro-3 Pharmaco-acupuncture in Low Back Pain Patients; A Randomized Controlled Trial|Completed||Phase 3|60|Actual|Jaseng Hospital of Korean Medicine||2|||f||||t||||||||||2017-10-11 00:11:38.099974|2017-10-11 00:11:38.099974
NCT02196116|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-02-11|||July 2014||2014-07-01|February 2015|2015-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|EDUMA||Amyloïd Load in Elderly Population: Effect of Cognitive Reserve|Amyloïd Load in Elderly Population: Effect of Cognitive Reserve|Unknown status|Recruiting|N/A|120|Anticipated|University Hospital, Bordeaux||3|||f||||f||||||||||2017-10-11 00:11:38.208599|2017-10-11 00:11:38.208599
NCT02196103|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-17|||September 2014||2014-09-01|July 2014|2014-07-01|September 2018|Anticipated|2018-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Management of Labor in Patients With Previous Cesarian Section|Management of Labor in Patients With Previous Cesarian Section and Premature Rupture of Membranes Who Desire TOLAC: Comparison Between the Use of Standard Expectant Management and the Double-balloon Catheter Device. A Prospective Randomized Study|Not yet recruiting||Phase 2/Phase 3|200|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 00:11:38.328383|2017-10-11 00:11:38.328383
NCT02196090|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-02-26|||July 2014||2014-07-01|February 2016|2016-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Application of Vagal Stimulation in Exposure and Response Prevention for Obsessive Compulsive Disorder|Application of Vagal Stimulation by Cold Face Mask in Exposure and Response Prevention for Obsessive Compulsive Disorder|Recruiting||N/A|10|Anticipated|King's College London||1|||f||||f||||||||||2017-10-11 00:11:38.437342|2017-10-11 00:11:38.437342
NCT02196077|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-05-12|2016-12-20|2016-02-16|August 1, 2014|Actual|2014-08-01|May 2017|2017-05-01|March 1, 2015|Actual|2015-03-01|March 1, 2015|Actual|2015-03-01||Interventional|PT009001|The ITT population used in participant flow, Population is defined as all subjects who were randomized to treatment and received at least one dose of BFF MDI 320/9.6 ug, BFF MDI 160/9.6 ug, BFF MDI 80/9.6 ug, BD MDI 320 ug or FF MDI 9.6 ug. Statistical tabulations and analyses will be by randomized treatment.|Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double Blind, Chronic Dosing (28 Days), Four Period, Five Treatment, Incomplete Block, Multi Center, Crossover Study to Assess the Efficacy and Safety of PT009, PT008, and PT005 in Subjects With Moderate to Severe COPD|Completed||Phase 2|180|Actual|Pearl Therapeutics, Inc.||5|||f||||f|t|f||||||Yes||2017-10-11 00:11:38.597828|2017-10-11 00:11:38.597828
NCT02196064|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-08-04|||May 2014||2014-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|hEPAtic||"Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the The HEPAVIR HEPATIC SAFETY Cohort."|"Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the The HEPAVIR HEPATIC SAFETY Cohort. hEPAtic Study."|Completed||N/A|519|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||||||2017-10-11 00:11:39.800574|2017-10-11 00:11:39.800574
NCT02196051|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-08-12|||November 2007||2007-11-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.|Lipid and Carbohydrate Metabolism: Effects of Exercise|Recruiting||N/A|80|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 00:11:39.894439|2017-10-11 00:11:39.894439
NCT02196038|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-10-31|||September 2014||2014-09-01|October 2016|2016-10-01||||November 2020|Anticipated|2020-11-01||Interventional|REHAB-HF||A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients|REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients|Recruiting||N/A|360|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 00:11:40.038259|2017-10-11 00:11:40.038259
NCT02196025|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-09-21|||May 2015||2015-05-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TMSI||Transcranial Magnetic Stimulation for Treatment of Insomnia|An Open Label Trial of Sequential Bifrontal Low Frequency Repetitive Transcranial Magnetic Stimulation (r-TMS) in the Treatment of Primary Insomnia|Recruiting||N/A|25|Anticipated|University of Florida||1|||f||||t|f|t|f|f|f|||||2017-10-11 00:11:40.180525|2017-10-11 00:11:40.180525
NCT02196012|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-07-18|||September 2013||2013-09-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||A Technology-Based Intervention for the Reduction of Overweight and Obesity Among College Students|"The UTK Health Study A Technology-Based Weight Loss Intervention for the Reduction of Overweight and Obesity Among College Students."|Completed||N/A|23|Actual|The University of Tennessee, Knoxville||2|||f||||f||||||||||2017-10-11 00:11:40.28591|2017-10-11 00:11:40.28591
NCT02195999|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-11-29|||December 2013||2013-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CPI||Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy|Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy|Recruiting||N/A|12|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-11 00:11:40.379256|2017-10-11 00:11:40.379256
NCT02195986|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-08-04|2017-08-04||June 2014||2014-06-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||The Baseline Analysis Population includes all randomized subjects.|A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis|Clinical Endpoint Therapeutic Equivalence Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%; Mylan) to Estrace® Cream (0.01%; Warner Chilcott) in Postmenopausal Females With Atrophic Vaginitis|Completed||Phase 3|366|Actual|Mylan Inc.||3|||f||||f||||||||||2017-10-11 00:11:40.525797|2017-10-11 00:11:40.525797
NCT02195973|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-09-18|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer|Phase IB Trial of LDE225 and Weekly Paclitaxel in Recurrent Platinum Resistant Ovarian Cancer|Active, not recruiting||Phase 1|15|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 00:11:41.383636|2017-10-11 00:11:41.383636
NCT02195960|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-07-12|||June 2014||2014-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|ATHENA||Supplementation With Dietary Anthocyanins and Side Effects of Radiotherapy for Breast Cancer|Supplementation With Dietary Anthocyanins and Side Effects of Radiotherapy for Breast Cancer|Recruiting||N/A|300|Anticipated|Neuromed IRCCS||2|||f||||f||||||||No||2017-10-11 00:11:41.478745|2017-10-11 00:11:41.478745
NCT02195947|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-08-08|||July 2014||2014-07-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Antagonist Protocol in Poor Responders|Does the Addition of Growth Hormone to the Invitro Fertilization/ Intracytoplasmic Sperm Injection Antagonist Protocol Improve Outcome in Poor Responders? A Randomized Controlled Trial|Completed||Phase 4|141|Actual|Cairo University||2|||f||||f||||||||||2017-10-11 00:11:41.589403|2017-10-11 00:11:41.589403
NCT02195934|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-09-02|||July 2014||2014-07-01|April 2016|2016-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|OJ & CVD||The Orange Juice and Cardiovascular Disease Study|The Orange Juice and Cardiovascular Disease Study|Completed||N/A|41|Actual|Quadram Institute||2|||f||||f||||||||||2017-10-11 00:11:41.829221|2017-10-11 00:11:41.829221
NCT02195921|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-06-14|||April 2015||2015-04-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Different Effectiveness of Single Acupoint（ST36 or CV12) vs Matching Acupoints(ST36 and CV12) in Chemotherapy-induced Nausea and Vomiting||Unknown status|Recruiting|N/A|160|Anticipated|Tianjin University of Traditional Chinese Medicine||4|||f||||t||||||||||2017-10-11 00:11:41.90798|2017-10-11 00:11:41.90798
NCT02195908|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-06-14|||August 2014||2014-08-01|July 2014|2014-07-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|||The Different Effectiveness of Single Acupoint（PC6 or CV12) vs Matching Acupoints(PC6 and CV12) in Chemotherapy-induced Nausea and Vomiting|The Comparative Study on the Effectiveness of Single Acupoint and Matching Acupoints.|Unknown status|Recruiting|N/A|160|Anticipated|Tianjin University of Traditional Chinese Medicine||4|||f||||t||||||||||2017-10-11 00:11:41.99113|2017-10-11 00:11:41.99113
NCT02195895|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-09-12|||April 2014||2014-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury Previously Treated With Teriparatide|12 Month Open-Label Extension Study of the Effect of Alendronate on Bone in People With Chronic SCI Previously Treated With Teriparatide|Active, not recruiting||Phase 2|17|Actual|Northwestern University||1|||f||||f||||||||||2017-10-11 00:11:42.092342|2017-10-11 00:11:42.092342
NCT02195882|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-07-03|||May 2014||2014-05-01|July 2014|2014-07-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Effect of an Exercise Program of the Scapular Muscle Stabilizers in Amateur Kayakers Shoulder Pain||Completed||N/A|11|Actual|CEU San Pablo University||1|||f||||||||||||||2017-10-11 00:11:42.191544|2017-10-11 00:11:42.191544
NCT02195869|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-04-13|||July 2014||2014-07-01|April 2016|2016-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease|A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease|Active, not recruiting||Phase 1/Phase 2|45|Actual|Pharmacyclics LLC.||4|||f||||||||||||||2017-10-11 00:11:42.269701|2017-10-11 00:11:42.269701
NCT02195856|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-07-20|||July 2014||2014-07-01|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|March 9, 2015|Actual|2015-03-09||Interventional|DiMPLe||Effects of Nitrate on Liver Perfusion and Sugar Control|The Effect of Dietary Nitrate on Hepatic Perfusion and Incretin Secretion|Completed||N/A|31|Actual|NIHR Exeter Clinical Research Facility||2|||f||||f||||||||||2017-10-11 00:11:42.380868|2017-10-11 00:11:42.380868
NCT02195843|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-18|||August 2014||2014-08-01|July 2014|2014-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|QUADRA-ME||Quadripolar Leads for the Management of Heart Failure Patients in the Middle East|Quadripolar Leads for the Management of Heart Failure Patients in the Middle East|Unknown status|Not yet recruiting|Phase 4|389|Anticipated|King Abdullah International Medical Research Center||2|||f||||||||||||||2017-10-11 00:11:42.483158|2017-10-11 00:11:42.483158
NCT02195830|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-21|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|||Inferior Vena Cava Collapsibility Index in Severe Sepsis|Bedside Ultrasound of Inferior Vena Cava Collapsibility in Emergency Department Patients Presenting With Severe Sepsis and Septic Shock|Unknown status|Not yet recruiting|N/A|112|Anticipated|Teesside University||1|||f||||f||||||||||2017-10-11 00:11:42.559323|2017-10-11 00:11:42.559323
NCT02195817|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-02-27|||August 2014|Actual|2014-08-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care|Interventional, Open-label Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care|Terminated||Phase 4|378|Actual|H. Lundbeck A/S||2||The study was terminated due to enrolment challenges|f||||f||||||||||2017-10-11 00:11:42.666447|2017-10-11 00:11:42.666447
NCT02193256|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-05-11|||July 2014||2014-07-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Varenicline + Prazosin for Heavy Drinking Smokers|Pilot Trial of Varenicline and Prazosin to Treat Heavy Drinking Smokers|Completed||Early Phase 1|5|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:12:32.419726|2017-10-11 00:12:32.419726
NCT02195804|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||May 2009||2009-05-01|July 2014|2014-07-01||||June 2009|Actual|2009-06-01||Interventional|||Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) in Fasting, Healthy Male Volunteers|A Phase I Open-label, Randomised, Single Dose, Three-way Crossover Relative Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) Formulations Following Oral Administration in Fasting, Healthy Male Volunteers|Completed||Phase 1|42|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:11:42.868318|2017-10-11 00:11:42.868318
NCT02195791|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-01-18|||July 2014||2014-07-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Neuroprotection of Pioglitazone in Acute Ischemic Stroke|Mechanism of Hyperglycemia and Neuroprotection Effect of Pioglitazone in Acute Ischemic Stroke|Terminated||Phase 2|4|Actual|Taipei Medical University Shuang Ho Hospital||2||Diffculty in participant enrollment|f||||f||||||||||2017-10-11 00:11:42.970726|2017-10-11 00:11:42.970726
NCT02195778|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-18|||June 2013||2013-06-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|2 Years|Observational [Patient Registry]|LIT||Assessment of Health Literacy Among Adult Patients in the United Arab Emirates to Facilitate Clinical Trials Recruitment.|Assessment of Health Literacy Among Adult Patients in the United Arab Emirates to Facilitate Clinical Trials Recruitment.|Unknown status|Active, not recruiting|N/A|1500|Anticipated|Tawam Hospital|||3||f||||f||||||||||2017-10-11 00:11:43.057438|2017-10-11 00:11:43.057438
NCT02195765|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-17|||June 2002||2002-06-01|July 2014|2014-07-01|October 2005|Actual|2005-10-01|October 2004|Actual|2004-10-01||Interventional|||Randomized Clinical Trial of Enamel Matrix Derivative: Radiographic Analysis|Two-year Randomized Clinical Trial of Enamel Matrix Derivative Treated Infrabony Defects: Radiographic Analysis|Completed||N/A|48|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:11:43.140366|2017-10-11 00:11:43.140366
NCT02195752|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-05-07|||November 2014||2014-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01|2 Years|Observational [Patient Registry]|TrackingCPC||Lexington Observational Study of Treatment With Compounded Pain Creams|Observational Study of Patient and Physician Experiences During Treatment of Pain With Compounded Pharmaceuticals|Terminated||N/A|26|Actual|Lexington Independent Studies, LLC|||1|Sponsor financial decision stemming from low recruitment|f||||f||||||||||2017-10-11 00:11:43.248745|2017-10-11 00:11:43.248745
NCT02195739|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-09-30|||September 2013||2013-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|March 2014|Actual|2014-03-01||Observational|||Nicotine Replacement Therapy and Cardiovascular Disease|A Retrospective, Real-life Evaluation of the Cardiovascular Disease Risk Associated With Exposure to Pharmacological Smoking Cessation Interventions in a Representative UK Primary Care Patient Population.|Unknown status|Active, not recruiting|N/A|61050|Actual|Research in Real-Life Ltd|||3||f||||f||||||||||2017-10-11 00:11:43.332222|2017-10-11 00:11:43.332222
NCT02195726|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2014-07-18|||January 2013||2013-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|EUROCRIPS||Efficacy of RIPC to Reduce AKI for Patients Undergoing PCI|The EUROpean and Asian Cardiac and Renal Remote Ischemic Pre-conditioning Study : A Prospective, Randomized Control Trial|Completed||Phase 4|1110|Actual|Azienda Ospedaliera Città della Salute e della Scienza di Torino||2|||f||||f||||||||||2017-10-11 00:11:45.253157|2017-10-11 00:11:45.253157
NCT02195713|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-01-20|2015-08-03||July 2014||2014-07-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Evaluation of a Novel Electronic Urine Output Monitor (eUOM)|Evaluation of a Novel Electronic Urine Output Monitor (eUOM)|Completed||N/A|20|Actual|Potrero Medical|||2||f||||t||||||||||2017-10-11 00:11:45.372235|2017-10-11 00:11:45.372235
NCT02195700|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-04-24||2017-04-24|June 2014|Actual|2014-06-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ARM-TD||Aim to Reduce Movements in Tardive Dyskinesia|A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia|Completed||Phase 2/Phase 3|117|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 00:11:45.584852|2017-10-11 00:11:45.584852
NCT02195687|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2016-02-17|2016-02-17||September 2014||2014-09-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||BOTOX® in the Treatment of Crow's Feet Lines in China||Completed||Phase 3|417|Actual|Allergan||2|||f||||f||||||||||2017-10-11 00:11:45.750924|2017-10-11 00:11:45.750924
NCT02195674|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2015-11-12|||April 2013||2013-04-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|EFP||EMBARK Follow-up Project|Exploring Massage Benefits for Arthritis of the Knee (EMBARK): Post-study Massage Questionnaire|Completed||N/A|240|Anticipated|Duke University|||1||f||||f||||||||||2017-10-11 00:11:46.149098|2017-10-11 00:11:46.149098
NCT02195661|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-05-25|||April 2014||2014-04-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children|The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children|Active, not recruiting||Phase 3|194|Actual|University of Cape Town||2|||f||||t||||||||||2017-10-11 00:11:46.216718|2017-10-11 00:11:46.216718
NCT02195648|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-17|||September 2014||2014-09-01|July 2014|2014-07-01|August 2015|Anticipated|2015-08-01|November 2014|Anticipated|2014-11-01||Interventional|TTH||Sub-occipital Muscle Inhibition in Tension Type Headache|Treatment Efficacy of Tension Type Headache After Application of Sub-occipital Muscle Inhibition Technique Associated With Interferential Electrotherapy|Unknown status|Not yet recruiting|N/A|60|Anticipated|Universidad Católica San Antonio de Murcia||2|||f||||f||||||||||2017-10-11 00:11:46.31632|2017-10-11 00:11:46.31632
NCT02195635|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-09-06|||July 2014||2014-07-01|September 2016|2016-09-01||||October 2014|Actual|2014-10-01||Interventional|||Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects|A Phase 1, Open-label, Single-center, 2-period, Single Sequence Drug-drug Interaction Study to Evaluate the Effects of Octreotide Acetate Injection (Sandostatin®) on the Pharmacokinetics of Single-dose Telotristat Etiprate in Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|Lexicon Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:11:46.428006|2017-10-11 00:11:46.428006
NCT02195622|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-02-22|||September 2013||2013-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2015|Actual|2015-01-01||Interventional|||Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures|Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures|Completed||N/A|90|Actual|Indiana Kidney Stone Institute||2|||f||||f||||||||||2017-10-11 00:11:46.541454|2017-10-11 00:11:46.541454
NCT02195609|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-09-15|||March 2014||2014-03-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|OMEGASI||Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms|Randomized Open Label Study to Evaluate the Effect of (Omega-3) EPA + Docosahexaenoic Acid (DHA) vs Soy Isoflavones in 100 Postmenopausal Women Between 45-65 Years With Moderate to Severe Vasomotor Symptoms.|Completed||Phase 4|75|Actual|Instituto Palacios||2|||f||||t||||||||||2017-10-11 00:11:46.628338|2017-10-11 00:11:46.628338
NCT02195596|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-18|||April 2013||2013-04-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|January 2015|Anticipated|2015-01-01||Interventional|EFA-P||Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.|Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.|Unknown status|Recruiting|N/A|80|Anticipated|Basque Health Service||2|||f||||t||||||||||2017-10-11 00:11:46.760993|2017-10-11 00:11:46.760993
NCT02195583|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-04-09|2015-03-26||June 2014||2014-06-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||All randomized participants were evaluated for baseline characteristics|The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ|The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ|Completed||N/A|62|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 00:11:46.935925|2017-10-11 00:11:46.935925
NCT02195570|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-02|||October 2015||2015-10-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Contingency Management for Smoking Cessation in Pregnant Minority Women|Contingency Management for Smoking Cessation in Pregnant Minority Women|Active, not recruiting||N/A|60|Anticipated|University of Miami||2|||f||||t||||||||||2017-10-11 00:11:47.631034|2017-10-11 00:11:47.631034
NCT02195557|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-21|||April 2002||2002-04-01|July 2014|2014-07-01||||March 2003|Actual|2003-03-01||Observational|||Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis|Synvisc® in Knee Osteoarthritis: Retrospective Follow-up in Treated Patients Since at Least Three Years|Completed||N/A|16|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:11:47.731958|2017-10-11 00:11:47.731958
NCT02195544|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-18|||October 1998||1998-10-01|July 2014|2014-07-01||||April 2000|Actual|2000-04-01||Observational|||Use of Synvisc® in Knee Osteoarthritis - Survey on Practice|"Use of SYNVISC in Knee Osteoarthritis. Survey on Practice. U.S.A.G.E Pratique"|Completed||N/A|70|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:11:47.809316|2017-10-11 00:11:47.809316
NCT02195531|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-16|||January 2014||2014-01-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||BIG4 CPAP Study Educational Materials and Usage Feedback to Promote CPAP Adherence|BIG4 CPAP Educational Materials and Usage Feedback to Promote CPAP Adherence|Unknown status|Recruiting|N/A|150|Anticipated|Philips Respironics||3|||f||||f||||||||||2017-10-11 00:11:47.89438|2017-10-11 00:11:47.89438
NCT02195518|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-08-03|||March 2015||2015-03-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study|A Multi-centre, Single-arm, Open-label Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate(TDF) Treatment in Chinese Chronic Hepatitis B (CHB) Subjects Following Failure of Multiple Nucleos(t)Ide Analogues(NAs)|Active, not recruiting||Phase 4|200|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:11:48.019689|2017-10-11 00:11:48.019689
NCT02195505|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-18|||September 2001||2001-09-01|July 2014|2014-07-01||||April 2002|Actual|2002-04-01||Observational|||Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study|Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study (U.S.A.G.E. Médico-Economique)|Completed||N/A|374|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 00:11:48.143648|2017-10-11 00:11:48.143648
NCT02195492|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-18|||April 2002||2002-04-01|July 2014|2014-07-01||||March 2003|Actual|2003-03-01||Observational|||Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis|Synvisc® in With Knee Osteoarthritis: Retrospective Follow-up in Active Patients|Completed||N/A|41|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:11:48.347199|2017-10-11 00:11:48.347199
NCT02195479|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2017-08-24|||December 9, 2014|Actual|2014-12-09|August 2017|2017-08-01|October 20, 2021|Anticipated|2021-10-20|November 1, 2017|Anticipated|2017-11-01||Interventional|||A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma|A Phase 3, Randomized, Controlled, Open-label Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy|Recruiting||Phase 3|700|Anticipated|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 00:11:48.475111|2017-10-11 00:11:48.475111
NCT02195466|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-18|2014-07-18|||June 2003||2003-06-01|July 2014|2014-07-01||||July 2003|Actual|2003-07-01||Interventional|||Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult Volunteers|A Single Centre, Open-label Study, in Healthy Adult Volunteers, to Determine the Effects of Single-dose and Steady-state TPV/RTV 500/200 mg on the Steady-state Pharmacokinetics of Fluconazole 100 mg qd (200 mg Loading Dose)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:11:49.11731|2017-10-11 00:11:49.11731
NCT02195453|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-17|||August 2014||2014-08-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer|A Randomized,Double-blind,Placebo-Controlled,Multicenter Clinical Trail of Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer|Unknown status|Not yet recruiting|Phase 4|520|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||f||||||||||2017-10-11 00:11:49.216683|2017-10-11 00:11:49.216683
NCT02195440|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-09-19|||August 2014||2014-08-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis|An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis|Completed||Phase 1|14|Actual|Komagome Hospital||1|||f||||f||||||||||2017-10-11 00:11:49.311181|2017-10-11 00:11:49.311181
NCT02195427|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-03-23|||June 2014||2014-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:11:49.421345|2017-10-11 00:11:49.421345
NCT02195414|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-03-11|2014-12-23||July 2014||2014-07-01|March 2016|2016-03-01|September 2019|Anticipated|2019-09-01|November 2014|Actual|2014-11-01||Interventional|||NeoVas Bioresorbable Coronary Scaffold First-in-Man Study|Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With de Novo Coronary Artery Lesion (NeoVas): a First-in-Man Study|Active, not recruiting||Phase 1|31|Actual|Lepu Medical Technology (Beijing) Co., Ltd.||1|||f||||t||||||||Undecided||2017-10-11 00:11:49.485708|2017-10-11 00:11:49.485708
NCT02195401|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-17|||May 2010||2010-05-01|July 2014|2014-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||The Effects of a Clean Room Sleeping Environment on Elemental and Chemical Concentrations in Children With Autism|The Effects of a Clean Room Sleeping Environment on Elemental and Chemical Concentrations in Children and Adolescents With Autism Spectrum Disorders|Completed||N/A|10|Actual|The Children's Institute|||1||f||||t||||||||||2017-10-11 00:11:49.904665|2017-10-11 00:11:49.904665
NCT02195388|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-21|||December 2009||2009-12-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01|5 Years|Observational [Patient Registry]|FOREVER||Focus On Stiffness Reduction, Endothelial Function and Autonomic Nervous System|Phase 1 Study - Focus On Stiffness Reduction, Endothelial Function and Autonomic Nervous System improVement in Patients After MI With or Without hypErtension After Cardiovascular Rehabilitation.|Completed||N/A|120|Actual|Medical Universtity of Lodz|||3||f||||t||||||Samples Without DNA|"     VEGF-A, ADMA, NT-proBNP, creatinine, uric acid, LDL, HDL, total cholesterol, trigliceride,     ALT,GGTP, CRP, fibrinogen,   "|||2017-10-11 00:11:50.013193|2017-10-11 00:11:50.013193
NCT02195375|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-27|||September 2014||2014-09-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Flutiform® Compared With Seretide® in the Treatment of COPD|A Randomised Double-blind, Double-dummy Parallel Group Study to Compare the Efficacy and Safety of Fluticasone Propionate / Formoterol Fumarate (Flutiform®) 500/20 µg BID and 250/10 µg BID Versus Salmeterol / Fluticasone (Seretide®) 50/500 µg BID in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2/Phase 3|923|Actual|Mundipharma Research Limited||3|||f||||||||||||||2017-10-11 00:11:50.211581|2017-10-11 00:11:50.211581
NCT02195362|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-18|||May 2010||2010-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:11:50.330298|2017-10-11 00:11:50.330298
NCT02195349|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-07-24|||July 30, 2014|Actual|2014-07-30|July 2017|2017-07-01|August 15, 2018|Anticipated|2018-08-15|August 15, 2018|Anticipated|2018-08-15||Interventional|||A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis|A Randomised, Double Blind (Sponsor Unblinded), Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a IV Dose of GSK2831781 in Healthy Subjects and Patients With Plaque Psoriasis|Recruiting||Phase 1|67|Anticipated|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:11:50.394118|2017-10-11 00:11:50.394118
NCT02195336|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-18|||August 2014||2014-08-01|July 2014|2014-07-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|BevMar||dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.|Diffusion MR (dMRT) During First Line Treatment of Non Squamous Lung Cancer With Chemotherapy Combined With Bevacizumab: Time Course and Prognostic and Predictive Impact.|Not yet recruiting||N/A|20|Anticipated|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 00:11:50.780468|2017-10-11 00:11:50.780468
NCT02195323|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-01-03|||April 2014||2014-04-01|November 2015|2015-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)|Administration of Autologous Bone Marrow Mesenchymal Stem Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)|Completed||Phase 1|7|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 00:11:50.961091|2017-10-11 00:11:50.961091
NCT02195310|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-05-23|||November 2013|Actual|2013-11-01|November 2016|2016-11-01|May 2, 2017|Actual|2017-05-02|May 2, 2017|Actual|2017-05-02||Interventional|||The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.|The Use of PrevenaTM Incision Management System on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.|Terminated||N/A|341|Actual|KCI Europe Holding B.V.||2||due to futility|f||||f||||||||No||2017-10-11 00:11:51.096471|2017-10-11 00:11:51.096471
NCT02195297|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-17|||September 2013||2013-09-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||"Evaluation of the Activity of a Pharmacological Anticellulitis Product vs. a Reference Product on the Market"|"Clinical and Instrumental Evaluation of the Activity of a Pharmacological Anticellulitis Product vs. a Reference Product on the Market: Comparison Within Subjects (Double Blind Study)"|Completed||Phase 3|22|Actual|Derming SRL||2|||f||||t||||||||||2017-10-11 00:11:51.249892|2017-10-11 00:11:51.249892
NCT02195271|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-07-18|||March 2014||2014-03-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Neuroplasticity:Melatonin and Transcranial Current Stimulation in Healthy Subjects.|Effect of Melatonin and Transcranial Direct Current Stimulation (tDCS) on Neuroplasticity and the Heat-pain Detection Threshold in Healthy Subjects:Randomized, Double-blind,Crossover Trial|Unknown status|Recruiting|Phase 2|50|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 00:11:51.510818|2017-10-11 00:11:51.510818
NCT02195258|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2014-07-17|||November 2010||2010-11-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|May 2012|Actual|2012-05-01|1 Day|Observational [Patient Registry]|Pegase||Pharmacogenetic of Salbutamol in Pediatric Asthma Crisis|Pharmacogenetic of the Salbutamol Efficacy in Asthma Crisis for Children in Emergency Department|Completed||N/A|95|Actual|Hôpital Necker-Enfants Malades|||1||f||||t||||||Samples With DNA|"     Saliva from patient were collected using Oragen®.DNA OG-500 kit, (DNA Genotek, Kanata,     Canada) or swabs (Catch-All™ sample collection swabs from Epicentre Biotechnologies, Madison,     WI), and stored at room temperature or -20°C, respectively.   "|||2017-10-11 00:11:51.629189|2017-10-11 00:11:51.629189
NCT02195245|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-10-12|||August 2014||2014-08-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate|A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate|Completed||N/A|20|Actual|DMF Medical Incorporated||2|||f||||f||||||||||2017-10-11 00:11:51.722855|2017-10-11 00:11:51.722855
NCT02195232|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-01-19|||January 2015||2015-01-01|January 2017|2017-01-01|April 2023|Anticipated|2023-04-01|August 2018|Anticipated|2018-08-01||Interventional|CAT IQ||Cancer Associated Thrombosis and Isoquercetin (CAT IQ)|Randomized, Placebo-controlled, Double-blind Phase II/III Trial of Oral Isoquercetin to Prevent Venous Thromboembolic Events in Cancer Patients.|Recruiting||Phase 2/Phase 3|618|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:11:51.829439|2017-10-11 00:11:51.829439
NCT02195219|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-03-02|||June 2014||2014-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Two Therapeutic Techniques for the Treatment of Acromioclavicular Dislocations|Clinical Trial to Compare the Efficacy of Two Therapeutic Techniques for the Treatment of Acromioclavicular Grade III Dislocations|Suspended||N/A|32|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-11 00:11:52.027505|2017-10-11 00:11:52.027505
NCT02195206|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-10-03|||July 2014||2014-07-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Hyperpolarized Xenon-129 Lung Magnetic Resonance Imaging: Healthy Adult Volunteer Pilot Study|Development of Hyperpolarized Xenon-129 Lung Magnetic Resonance Imaging Hardware and Software: Healthy Adult Volunteer Pilot Study|Recruiting||N/A|20|Anticipated|The Hospital for Sick Children|||1||f||||t||||||||||2017-10-11 00:11:52.151469|2017-10-11 00:11:52.151469
NCT02195193|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-08-17|||November 2014||2014-11-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|I-Care||Integrating Depression Care in Acute Coronary Syndromes Care in China|Integrating Depression Care in Acute Coronary Syndromes Patients in Low Resource Hospitals in China|Recruiting||N/A|4000|Anticipated|The George Institute for Global Health, China||2|||f||||t||||||||||2017-10-11 00:11:52.287305|2017-10-11 00:11:52.287305
NCT02195180|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-07-26|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma|Phase II, Randomized, Controlled, Clinical Trial Exploring Efficacy and Safety of ERY001 (L-asparaginase Encapsulated in Red Blood Cells) in Association With Gemcitabine or FOLFOX4 in Second-line Therapy for Patients With Progressive Metastatic Pancreatic Carcinoma|Active, not recruiting||Phase 2|141|Actual|ERYtech Pharma||2|||f||||t||||||||||2017-10-11 00:11:52.429418|2017-10-11 00:11:52.429418
NCT02195167|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-03-30|||July 2014||2014-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Dasotraline SEP360-105 Pediatric PK/PD Study|A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder|Completed||Phase 1|105|Actual|Sunovion||1|||f||||f||||||||||2017-10-11 00:11:52.634797|2017-10-11 00:11:52.634797
NCT02195154|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-04-27|||November 2013||2013-11-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism|18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism: Investigating the Correlation Between Cerebral Structural and Functional Changes, and Clinical Manifestation|Recruiting||Phase 2|60|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:11:52.767879|2017-10-11 00:11:52.767879
NCT02195141|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-02-02|||January 2014||2014-01-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer|Randomized Phase II Tiral of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer|Unknown status|Recruiting|Phase 2|104|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||||2017-10-11 00:11:52.891751|2017-10-11 00:11:52.891751
NCT02195128|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-09-30|||May 2014||2014-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:11:53.038047|2017-10-11 00:11:53.038047
NCT02195115|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-03-04|||February 2014||2014-02-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Trial of Laparoscopic Cholecystectomy vs. Non-operative Treatment for Gallbladder Dyskinesia|Randomized Controlled Trial of Laparoscopic Cholecystectomy vs. Non-operative Treatment for Gallbladder Dyskinesia|Unknown status|Recruiting|Phase 2|60|Anticipated|CAMC Health System||2|||f||||t||||||||||2017-10-11 00:11:53.098799|2017-10-11 00:11:53.098799
NCT02195102|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-11-17|||December 2014||2014-12-01|November 2014|2014-11-01|December 2021|Anticipated|2021-12-01|August 2021|Anticipated|2021-08-01||Observational|AP TAVR||The Asian Pacific TAVR Multicenter Registry|Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement in the Asian Population The Asian Pacific TAVI Multicenter Registry A MULTICENTER, OBSERVATIONAL STUDY|Not yet recruiting||N/A|2000|Anticipated|Queen Elizabeth Hospital, Hong Kong|||1||f||||t||||||||||2017-10-11 00:11:53.259245|2017-10-11 00:11:53.259245
NCT02195089|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-04-18|||March 2014||2014-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)|A Phase 1/2a Trial to Evaluate the Efficacy and the Safety of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)|Completed||Phase 1/Phase 2|19|Actual|BioLeaders Corporation||3|||f||||f||||||||||2017-10-11 00:11:53.538171|2017-10-11 00:11:53.538171
NCT02195076|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-17|||July 2014||2014-07-01|July 2014|2014-07-01||||July 2017|Anticipated|2017-07-01|3 Years|Observational [Patient Registry]|||Non Invasive Detection of Lung and Breast Cancer by Odor Signature|A Clinical Study Design to Evaluate the Specificity and Sensitivity of Our Novel System for Detection of Breast and Lung Cancer by Odor Signature|Unknown status|Recruiting|N/A|400|Anticipated|BioSense Medical LTD|||3||f||||||||||Samples Without DNA|"     urine samples and exhaled breath samples   "|||2017-10-11 00:11:53.684741|2017-10-11 00:11:53.684741
NCT02193243|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-12-14|||June 2013||2013-06-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Value of 6-minute Walk Test in Grown Ups With Congenital Heart Defects (GUCH)|The Diagnostic Value of Six-Minute Walk Test in Grown-Up Patients With Congenital Heart Disease (GUCH)|Completed||N/A|100|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 00:12:32.54569|2017-10-11 00:12:32.54569
NCT02195063|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-01-27|||November 2013||2013-11-01|January 2015|2015-01-01||||December 2016|Anticipated|2016-12-01||Observational|||Survey Study for Pain Management, Wound Care, Scar Care or UDT|Survey of Patients Who Have Been Prescribed a Topical Compound for Pain Management, Wound Care or Scar Care or to Patients Who Have Been Requested to do a Urinary Drug Test (UDT) by Their Provider.|Unknown status|Recruiting|Phase 4|10000|Anticipated|Rahm Foundation|||4||f||||f||||||||||2017-10-11 00:11:53.852747|2017-10-11 00:11:53.852747
NCT02195050|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-07-20|||January 2014||2014-01-01|July 2017|2017-07-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||Hypertriglyceridaemia - Cause and Effects|Hypertriglyceridaemia: Therapeutic Targets, Genetic Causes, and Associated Neuropathy|Recruiting||N/A|1396|Anticipated|Central Manchester University Hospitals NHS Foundation Trust|||3||f||||f||||||Samples With DNA|"     Serum & plasma samples will be stored for further studies.   "|||2017-10-11 00:11:53.976859|2017-10-11 00:11:53.976859
NCT02195037|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-05-18|||July 2014||2014-07-01|August 2014|2014-08-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|||Changes in Cardiac Output During Delayed Umbilical Cord Clamping|Changes in Cardiac Output During Delayed Umbilical Cord Clamping|Completed||N/A|20|Actual|Sharp HealthCare|||1||f||||f||||||||||2017-10-11 00:11:54.075413|2017-10-11 00:11:54.075413
NCT02195024|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-10-13|||July 2014||2014-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MRI-rePACE||Cardiac MRI After Pacemaker Replacement|Cardiac MRI After Replacement of Long Term Implanted PACEmakers by a MRI Conditional Pulse Generator (MRI-rePace)|Recruiting||Phase 4|50|Anticipated|Paracelsus Medical University||2|||f||||f||||||||||2017-10-11 00:11:54.147745|2017-10-11 00:11:54.147745
NCT02195011|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-05-04|||July 2014|Actual|2014-07-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases|A Two Arm Safety Study of Regorafenib Before or After SIR-Spheres Microspheres (90Y) for the Treatment of Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases|Active, not recruiting||Phase 2|25|Actual|SCRI Development Innovations, LLC||2|||f||||f|t|t|f|f||||||2017-10-11 00:11:54.5211|2017-10-11 00:11:54.5211
NCT02194998|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-10-02|||August 2015||2015-08-01|October 2017|2017-10-01||||April 2018|Anticipated|2018-04-01||Interventional|C_ASCENT||Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy|Interferon-Free Therapy for Chronic Hepatitis C Virus Genotype 1 Infection in Participants With HIV-1 Coinfection Receiving Concurrent Antiretroviral Therapy (C_ASCENT)|Recruiting||Phase 2|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-11 00:11:54.672073|2017-10-11 00:11:54.672073
NCT02194985|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-09-29|||October 2014||2014-10-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease|An Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of Migalastat Hydrochloride Monotherapy in Subjects With Fabry Disease|Active, not recruiting||Phase 3|76|Actual|Amicus Therapeutics||1|||t||||t||||||||||2017-10-11 00:11:54.944332|2017-10-11 00:11:54.944332
NCT02194972|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-18|||May 2009||2009-05-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Clinical Effects of Soluble Dietary Fiber Supplementation|Study of Soluble Dietary Fiber on Colonic Transit Time and Clinical Symptoms in Adults With Slow-transit Constipation|Completed||Phase 3|80|Actual|Nanjing PLA General Hospital||2|||f||||f||||||||||2017-10-11 00:11:55.16539|2017-10-11 00:11:55.16539
NCT02194959|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-25|||July 2011||2011-07-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Peer Patient Navigation for Colon Cancer Screening|Training African American Peers as Patient Navigators for Colon Cancer Screening|Completed||N/A|800|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 00:11:55.269522|2017-10-11 00:11:55.269522
NCT02194946|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-11-07|||July 2014||2014-07-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|C-MODDI||Chinese Medicine on Deferring Dialysis Initiation|Effectiveness of Chinese Medicine on Deferring Dialysis Initiation for Stage 5 Chronic Kidney Disease|Enrolling by invitation||Phase 1/Phase 2|875|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||2|||f||||t||||||||Undecided||2017-10-11 00:11:55.448371|2017-10-11 00:11:55.448371
NCT02194920|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-11-04|||October 2014||2014-10-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|||Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function|Arathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function|Completed||N/A|20|Actual|University of Roma La Sapienza|||1||f||||||||||||||2017-10-11 00:11:55.820374|2017-10-11 00:11:55.820374
NCT02194894|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2017-03-28|||June 2014||2014-06-01|June 2014|2014-06-01|March 19, 2015|Actual|2015-03-19|March 19, 2015|Actual|2015-03-19||Interventional|||The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients|The Effect of Daily Acetaminophen on Patients With Non-alcoholic Fatty Liver Disease (NAFLD) Compared to Healthy Controls|Withdrawn||N/A|0|Actual|University of Southern California||2||No patients enrolled|f||||t||||||||||2017-10-11 00:11:56.057983|2017-10-11 00:11:56.057983
NCT02192853|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-04|2017-09-07|||May 2013||2013-05-01|September 2017|2017-09-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Correlation Between Plasma- and Endothelial DPP-4 Activity|Plasma and Endothelial Activity of Dipeptidyl Peptidase 4 During Different Doses of Sitagliptin|Completed||Phase 4|20|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-11 00:12:44.216736|2017-10-11 00:12:44.216736
NCT02194881|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-07-31|||October 2014||2014-10-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Observational|IVACAFTOR1||Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation|Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation - Efficacy and Safety Results After the First Year of Treatment in the Real Life Setting.|Completed||N/A|57|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 00:11:56.165421|2017-10-11 00:11:56.165421
NCT02194868|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2016-05-17|||February 2016||2016-02-01|May 2016|2016-05-01|September 2020|Anticipated|2020-09-01|April 2020|Anticipated|2020-04-01||Observational|REG-Allo||Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)|Role and Interactions Between Immunoregulatory T Lymphocytes Subtypes After Allogeneic Haematopoietic Stem Cell Transplantation (HSCT): Identification of New Partners Implicated on the Development of GVT (Graft Versus Tumor) and Anti-infectious Responses Without GVHD (Graft Versus Host Disease)|Recruiting||N/A|140|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     Whole blood, hematopoietic stem cell of bone marrow   "|||2017-10-11 00:11:56.27781|2017-10-11 00:11:56.27781
NCT02194855|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-07-16|||November 2014||2014-11-01|July 2014|2014-07-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic Analysis|Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic Analysis.|Unknown status|Not yet recruiting|N/A|120|Anticipated|Fudan University||4|||f||||t||||||||||2017-10-11 00:11:56.404651|2017-10-11 00:11:56.404651
NCT02194842|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-05-24|||October 2015||2015-10-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|November 2019|Anticipated|2019-11-01||Interventional|||Phase III Radium 223 mCRPC-PEACE III|A Randomized Multicenter Phase III Trial Comparing Enzalutamide vs. a Combination of Ra223 and Enzalutamide in Asymptomatic or Mildly Symptomatic Castration Resistant Prostate Cancer Patients Metastatic to Bone.|Recruiting||Phase 3|560|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 00:11:56.509133|2017-10-11 00:11:56.509133
NCT02194829|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-09-04|||July 1, 2014|Actual|2014-07-01|August 2017|2017-08-01||||June 1, 2019|Anticipated|2019-06-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery|A Phase I and Randomized Phase II Study of Nab-Paclitaxel/Gemcitabine With or Without AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas|Active, not recruiting||Phase 1/Phase 2|133|Anticipated|National Cancer Institute (NCI)||4|||f||||f||||||||||2017-10-11 00:11:56.731084|2017-10-11 00:11:56.731084
NCT02194816|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2017-07-26|||September 2012||2012-09-01|July 2017|2017-07-01|December 2040|Anticipated|2040-12-01|December 2040|Anticipated|2040-12-01||Observational|||Complementary & Alternative Medicine in Parkinson's Disease (CAM Care in PD)|Complementary & Alternative Medicine in Parkinson's Disease|Recruiting||N/A|2000|Anticipated|Bastyr University|||1||f||||f||||||||||2017-10-11 00:11:56.916246|2017-10-11 00:11:56.916246
NCT02194803|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-02-28|||December 8, 2011|Actual|2011-12-08|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|OCEAN||Observation of Treatment Patterns With Lucentis in Approved Indications|Observation of Treatment Patterns With Lucentis and Real Life Ophthalmic Monitoring, Including Optional OCT in Approved Indications|Completed||N/A|5778|Actual|Novartis|||2||f||||f||||||||||2017-10-11 00:11:57.031909|2017-10-11 00:11:57.031909
NCT02194790|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||December 2012||2012-12-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.|Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.|Completed||N/A|238|Actual|Bhumirajanagarindra Kidney Institute, Thailand||2|||f||||t||||||||||2017-10-11 00:11:57.113054|2017-10-11 00:11:57.113054
NCT02194777|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-22|||June 2001||2001-06-01|July 2014|2014-07-01||||August 2001|Actual|2001-08-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female Volunteers|A Double-blind (at Each Dose Level), Randomised, Placebo-controlled Single Increasing Dose Safety, Tolerability and Pharmacokinetics Study in Healthy Male and Female Volunteers After Inhalative Administration of BIBN 4096 BS (Dosage: 5 - 80 mg)|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:11:57.233187|2017-10-11 00:11:57.233187
NCT02194764|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-17|||June 2014||2014-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||An Adherence Tool to Manage Narcotic -Addicted HIV Patients|A Breath-based Naltrexone Adherence Tool to Manage Narcotic-addicted HIV Patients.|Completed||N/A|8|Actual|Xhale Assurance||1|||f||||f||||||||||2017-10-11 00:11:57.326322|2017-10-11 00:11:57.326322
NCT02194751|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-06-26|||June 2018|Anticipated|2018-06-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma|Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma|Not yet recruiting||Phase 2|30|Anticipated|XEME Biopharma Inc.||1|||f||||f|t|f||||||||2017-10-11 00:11:57.430031|2017-10-11 00:11:57.430031
NCT02194738|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-09-28|||August 18, 2014|Actual|2014-08-18|September 2017|2017-09-01|September 28, 2021|Anticipated|2021-09-28|September 28, 2021|Anticipated|2021-09-28||Observational|||Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)|Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)|Recruiting||N/A|8300|Anticipated|National Cancer Institute (NCI)|||1||f||||f||||||||||2017-10-11 00:11:58.222971|2017-10-11 00:11:58.222971
NCT02194725|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-07-08|||July 6, 2014||2014-07-06|July 7, 2017|2017-07-07|July 7, 2017|Actual|2017-07-07|April 20, 2015|Actual|2015-04-20||Observational|||Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular Dystrophy|Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular Dystrophy|Completed||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:12:07.355459|2017-10-11 00:12:07.355459
NCT02194712|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-03-13|||January 2015||2015-01-01|March 2017|2017-03-01||||January 2018|Anticipated|2018-01-01||Observational|||Detection of Schistosomiasis CAA in Travellers After High-risk Water Contact|Detection of Schistosomiasis Circulating Anodic Antigen (CAA) in Travellers After High-risk Water Contact|Recruiting||N/A|155|Anticipated|Leiden University Medical Center|||1||f||||f||||||Samples With DNA|"     serum, urine and faeces   "|||2017-10-11 00:12:07.423609|2017-10-11 00:12:07.423609
NCT02194686|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-10-11|||January 2013||2013-01-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease|Cilostazol Enhances the Number and Functions of Circulating Endothelial Progenitor Cells Mediated Through Multiple Mechanisms in Patients With High Risk for Cardiovascular Disease|Completed||Phase 4|71|Actual|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-11 00:12:08.190708|2017-10-11 00:12:08.190708
NCT02194673|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-16|||January 2012||2012-01-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Acute Effects of Natural and Interesterified Fats-margarine on Lipemic and Insulinemic Response|Acute Effects of Natural and Interesterified Fats-formulated Margarine on Lipemic and Insulinemic Response|Completed||N/A|20|Actual|Malaysia Palm Oil Board||3|||f||||t||||||||||2017-10-11 00:12:08.278646|2017-10-11 00:12:08.278646
NCT02194660|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-08-26|||January 2014||2014-01-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01|24 Months|Observational [Patient Registry]|||Fragility Fracture Liaison Service Project|Fragility Fracture Liaison Service Project|Unknown status|Recruiting|N/A|600|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 00:12:08.535128|2017-10-11 00:12:08.535128
NCT02194647|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-09-02|||July 2014||2014-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Anti-osteoporosis Medication Monitoring and Management Service|Anti-osteoporosis Medication Monitoring and Management Service|Completed||N/A|500|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:12:08.609537|2017-10-11 00:12:08.609537
NCT02194634|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-01-05|||July 2014||2014-07-01|June 2015|2015-06-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)||Unknown status|Recruiting|Phase 3|248|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.||2|||f||||f||||||||||2017-10-11 00:12:08.671817|2017-10-11 00:12:08.671817
NCT02194621|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-03-30|2016-02-01||January 2014||2014-01-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Clinical Investigation to Examine Toothpaste Effect on Oral Bacteria|A Randomized, Single Center, Three Cell, Double Blind and Parallel Groups Clinical Study Conducted in Newark, NJ to Evaluate the Antibacterial Effects of Two Toothpastes Containing 0.3% Triclosan/2% Copolymer/0.243% Sodium Fluoride in a Silica Base as Compared to a Control Regular Fluoride Toothpaste on Oral Bacteria 12 Hours After 13 Days Product Use.|Completed||Phase 4|128|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-10-11 00:12:08.814022|2017-10-11 00:12:08.814022
NCT02194608|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-06-23|||December 2011||2011-12-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)|A Randomized Clinical Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Individuals With Type 2 Diabetes|Completed||N/A|500|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:12:09.176228|2017-10-11 00:12:09.176228
NCT02194595|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-22|||September 2014||2014-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PREVAIL||Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)|Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)|Recruiting||Phase 3|120|Anticipated|Mount Sinai Hospital, Canada||3|||f||||f||||||||||2017-10-11 00:12:09.253172|2017-10-11 00:12:09.253172
NCT02194582|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-03-22|||June 1996|Actual|1996-06-01|March 2017|2017-03-01|January 2035|Anticipated|2035-01-01|January 2035|Anticipated|2035-01-01||Observational|FSGS / NS||Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure|Molecular and Genetic Analysis of Inherited Kidney Dysfunction|Recruiting||N/A|2050|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||Samples With DNA|"     Usually saliva In some cases, a blood sample may be obtained In some cases, a urine sample     may be requested   "|||2017-10-11 00:12:09.438794|2017-10-11 00:12:09.438794
NCT02194569|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-07-12|||July 2014||2014-07-01|July 2016|2016-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Magnesium Balance of Citrate-based Continuous Venovenous Hemofiltration, Effect of Citrate Dose.|Magnesium Balance of Citrate-based Continuous Venovenous Hemofiltration, Effect of Citrate Dose.|Recruiting||N/A|20|Anticipated|Ziekenhuis Oost-Limburg||2|||f||||f||||||||||2017-10-11 00:12:09.532144|2017-10-11 00:12:09.532144
NCT02194556|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-17|||July 2014||2014-07-01|July 2014|2014-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC|Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Untreated Advanced Non-small-cell Lung Cancer: a Randomized, Open-label Study|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 00:12:09.629453|2017-10-11 00:12:09.629453
NCT02194543|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-16|||March 2014||2014-03-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||High-Definition 3D Visualization System for Ophthalmic Surgery||Completed||N/A|20|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 00:12:09.748405|2017-10-11 00:12:09.748405
NCT02194530|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-05-23|||January 2015||2015-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy|Pilot Study to Collect Blood From Research Subjects Allergic and Non-allergic to Peanut to Study Immune Modulation With Anti-IgE Therapy in Mice|Recruiting||N/A|80|Anticipated|Weill Medical College of Cornell University|||4||f||||f||||||Samples With DNA|"     Whole blood   "|Undecided||2017-10-11 00:12:09.829844|2017-10-11 00:12:09.829844
NCT02194517|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-03-16|||April 2013||2013-04-01|July 2014|2014-07-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Impact of ELKa, the Toolset for Food Exchanges Calculation on Metabolic Control in Pediatric Diabetic Patients.|Impact of ELKa, the Toolset for Prandial Insulin Dose Calculation on Metabolic Control in Children and Adolescent With Diabetes Type 1.|Completed||N/A|106|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 00:12:09.970407|2017-10-11 00:12:09.970407
NCT02194504|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-04-16|||September 2014||2014-09-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity|The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity|Completed||N/A|110|Actual|Wageningen University||3|||f||||f||||||||||2017-10-11 00:12:10.118854|2017-10-11 00:12:10.118854
NCT02194491|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-06-24|||April 2014||2014-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662|A Phase 1 11β-Hydroxysteroid Dehydrogenase 1 Enzyme Occupancy Study Using a Positron Emission Tomography Ligand [11C]AS2471907- ([11C]MOZAT) and Following Single Oral Dose Administration of ASP3662 in Healthy Male Adult Subjects|Completed||Phase 1|18|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 00:12:10.215526|2017-10-11 00:12:10.215526
NCT02194478|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-08-31|||October 2013||2013-10-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Stress Reduction for Busy Professionals|Pilot Study of a Brief Mind/Body Meditation Intervention for Allina Health Employees|Completed||N/A|101|Actual|Allina Health System||1|||f||||f||||||||||2017-10-11 00:12:10.32225|2017-10-11 00:12:10.32225
NCT02194465|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2015-05-08||2015-05-08|August 2014||2014-08-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study of LY2623091 in Participants With High Blood Pressure|A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension|Completed||Phase 2|306|Actual|Eli Lilly and Company||7|||f||||f||||||||||2017-10-11 00:12:10.434598|2017-10-11 00:12:10.434598
NCT02194452|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-04-27|||September 2013||2013-09-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors|Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors|Withdrawn||N/A|0|Actual|University of Iowa||1|||f||||t||||||||||2017-10-11 00:12:10.664349|2017-10-11 00:12:10.664349
NCT02194439|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-11-02|||January 2014||2014-01-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|||Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease|Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease|Enrolling by invitation||N/A|430|Anticipated|Indiana University|||1||f||||t||||||Samples With DNA|"     Whole Blood, Plasma, Peripheral Blood Mononuclear Cells (PBMC), Saliva, Bronchoalveolar     lavage (BAL)   "|||2017-10-11 00:12:10.815819|2017-10-11 00:12:10.815819
NCT02194426|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-01-25|||July 2014||2014-07-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patients|A Phase I Multi-centre, Open-label, Repeated-dose, Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MP0250 in Patients With Advanced Solid Tumours|Recruiting||Phase 1/Phase 2|37|Anticipated|Molecular Partners AG||1|||f||||f||||||||||2017-10-11 00:12:10.9398|2017-10-11 00:12:10.9398
NCT02194413|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-01-30|||March 2012|Actual|2012-03-01|January 2017|2017-01-01|January 18, 2017|Actual|2017-01-18|January 2016|Actual|2016-01-01||Interventional|||Effects of Healing Touch on Patients Undergoing Hematopoietic Stem Cell Transplant|Effects of Healing Touch on Patients Undergoing Hematopoietic Stem Cell Transplant|Completed||N/A|60|Actual|University of Iowa||2|||f||||t||||||||No||2017-10-11 00:12:11.05266|2017-10-11 00:12:11.05266
NCT02194400|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-12-08|||July 2014||2014-07-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus|A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|32|Actual|Resolve Therapeutics||2|||f||||t||||||||||2017-10-11 00:12:11.168475|2017-10-11 00:12:11.168475
NCT02194387|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-07-07|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Pilot Tests to Optimize the Delivery of Energy Balance Interventions|Pilot Tests to Optimize the Delivery of Energy Balance Interventions|Recruiting||N/A|272|Anticipated|M.D. Anderson Cancer Center||16|||f||||f|f|f||||||||2017-10-11 00:12:11.488875|2017-10-11 00:12:11.488875
NCT02194374|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-06-09|||January 2015|Actual|2015-01-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)|A Study to Infuse ROR1-Specific Autologous T Cells for Patients With Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1||Study closed with no enrollment due to unavailability of reagent.|f||||f||||||||||2017-10-11 00:12:11.699524|2017-10-11 00:12:11.699524
NCT02194361|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||December 1999||1999-12-01|July 2014|2014-07-01||||July 2000|Actual|2000-07-01||Interventional|||Efficacy of a Standardised Bilberry Extract in Improving the Night Vision of Healthy Volunteers|Efficacy of a Bilberry Extract Standardised to a Content of 25% Anthocyanosides in Improving the Night Vision of Healthy Volunteers: a Double-blind, Randomized, Placebo Controlled, Cross-over Trial Over 2 x 28 Days|Completed||Phase 2|119|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:11.856701|2017-10-11 00:12:11.856701
NCT02194348|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-22|||February 2000||2000-02-01|July 2014|2014-07-01||||March 2000|Actual|2000-03-01||Interventional|||Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers|A Double-blind (Within Dose Groups), Randomized, Placebo-controlled Single Increasing Dose Tolerability Study (Parallel Groups) in Healthy Male and Female Volunteers After Subcutaneous Administration of BIBN 4096 (Dosage: 2.5 - 30 mg)|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:11.945565|2017-10-11 00:12:11.945565
NCT02194335|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-22|||October 2000||2000-10-01|July 2014|2014-07-01||||December 2000|Actual|2000-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIBN 4096 BS in Healthy Male and Female Volunteers|A Double-blind (Within Dose Groups), Randomised, Placebo-controlled Single Increasing Dose Safety, Tolerability and Pharmacokinetics Study (Parallel Groups) in Healthy Male and Female Volunteers After Oral Administration of BIBN 4096 BS Drinking Solution (Dosage: 20 - 200 mg)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:12.040323|2017-10-11 00:12:12.040323
NCT02194322|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-22|||November 2001||2001-11-01|July 2014|2014-07-01||||January 2002|Actual|2002-01-01||Interventional|||Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers|A Double-blind (at Each Dose Level), Randomised, Placebo-controlled Single Increasing Dose Safety, Tolerability and Pharmacokinetics Study in Healthy Male and Female Volunteers After Intranasal Administration of BIBN 4096 BS (Dosage: 6.25 mg - 200mg )|Completed||Phase 1|38|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:12.126639|2017-10-11 00:12:12.126639
NCT02194309|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||September 2006||2006-09-01|July 2014|2014-07-01||||December 2006|Actual|2006-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine (Free Dose Combination) in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:12.240556|2017-10-11 00:12:12.240556
NCT02194296|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||June 1999||1999-06-01|July 2014|2014-07-01||||July 1999|Actual|1999-07-01||Interventional|||Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers|An Open Label, Randomised, Two-way Crossover Study in Healthy Female and Male Volunteers to Evaluate the Relative Bioavailability of a 20 mg Ambroxol Hydrochloride Lozenge in Comparison to 30 mg Ambroxol Hydrochloride Syrup (Mucosolvan®)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:12.327354|2017-10-11 00:12:12.327354
NCT02194283|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-22|||October 2009||2009-10-01|July 2014|2014-07-01||||November 2009|Actual|2009-11-01||Interventional|||Study to Evaluate Safety, Tolerability and Pharmacokinetics of Increasing Repeated Oral Doses of Ambroxol Lozenges in Healthy Male Volunteers|A Double-blind (at Each Dose Level), Randomised, Placebo Controlled Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of Increasing Repeated Oral Doses of Ambroxol Lozenges (Dosage: 20, 40, 80 mg Three Times Daily) Over 4 Days in Healthy Male Volunteers|Completed||Phase 1|34|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:12.51358|2017-10-11 00:12:12.51358
NCT02194270|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||September 2004||2004-09-01|July 2014|2014-07-01||||February 2005|Actual|2005-02-01||Interventional|||Relative Bioavailability of Ambroxol Hydrochloride of Soft Pastilles Compared to Ambroxol Hydrochloride Syrup in Healthy Male and Female Volunteers|Relative Bioavailability of Ambroxol Hydrochloride Following Oral Administration of Soft Pastilles 15 mg (Test) Compared to 15 mg of Syrup (15mg/5mL, Reference I) and Compared to 15 mg of Syrup (30mg/5mL) (Reference II) in Healthy Male and Female Volunteers. An Open-label, Randomised, Single-dose, 3-way Crossover Study|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:12:12.626271|2017-10-11 00:12:12.626271
NCT02194257|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||October 2008||2008-10-01|July 2014|2014-07-01||||December 2008|Actual|2008-12-01||Interventional|||Investigation of the Metabolism and Pharmacokinetics of Ambroxol in Healthy Male Volunteers|Investigation of the Metabolism and Pharmacokinetics of an Open Label Single Dose of 20 mg Ambroxol Administered as a Lozenge Together With an Oral Solution of 0.4 mg [14C]-Ambroxol in Healthy Male Volunteers|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:12.753252|2017-10-11 00:12:12.753252
NCT02194244|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-11-01|||August 2014||2014-08-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662|A Randomized, Open-Label, Four Period, Four-Treatment Crossover Study to Investigate the Comparative Bioavailability of Film-Coated Tablet and Granule Formulations of RG1662 Under Fed and Fasted Conditions in Healthy Volunteers|Completed||Phase 1|18|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 00:12:12.865552|2017-10-11 00:12:12.865552
NCT02194231|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-08-03|||July 2013||2013-07-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ATREUS||ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)|ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM)|Recruiting||Phase 2|141|Anticipated|Mario Negri Institute for Pharmacological Research||1|||f||||f||||||||||2017-10-11 00:12:12.9984|2017-10-11 00:12:12.9984
NCT02194218|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||September 2009||2009-09-01|July 2014|2014-07-01||||November 2009|Actual|2009-11-01||Interventional|||Pharmacokinetic Properties of Nevirapine Extended Release Tablets When Administered Orally in Healthy Male Volunteers|An Open-label, Randomised, Single Dose, Parallel-group Phase I Study to Investigate the Pharmacokinetic Properties of 200 mg Nevirapine Extended Release Tablets When Administered Orally as 2x100 mg Tablets or as 4x50 mg Tablets in Healthy Male Volunteers|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:13.271375|2017-10-11 00:12:13.271375
NCT02194205|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||October 2000||2000-10-01|July 2014|2014-07-01||||June 2001|Actual|2001-06-01||Interventional|||Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A One-year Randomized, Double-blind, Placebo and Active-controlled Parallel Design Safety and Efficacy Comparison of COMBIVENT HFA Inhalation Aerosol to COMBIVENT (CFC) Inhalation Aerosol in Patients With COPD|Terminated||Phase 3|360|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:12:13.384452|2017-10-11 00:12:13.384452
NCT02194192|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-03-13|||July 2014||2014-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section|Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section; a Randomized, Double Blinded, Placebo Controlled Trial|Completed||N/A|168|Actual|Mahidol University||3|||f||||t||||||||||2017-10-11 00:12:13.529578|2017-10-11 00:12:13.529578
NCT02194179|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||December 2006||2006-12-01|July 2014|2014-07-01||||May 2007|Actual|2007-05-01||Interventional|||Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects|Steady State Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Steady State 400 mg of Viramune® (200 mg BID), in HIV-1 Infected Subjects, an Open Label, Non Randomised, Multidose and Multistage Parallel Group Study. (ERVIR)|Completed||Phase 1|92|Actual|Boehringer Ingelheim||9|||f||||||||||||||2017-10-11 00:12:13.676247|2017-10-11 00:12:13.676247
NCT02194166|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-08-14|||July 18, 2014|Actual|2014-07-18|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|ESCAPE||A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration|An Open-Label, Randomized, Cross-Over, Multicenter, Phase IIIb Study, to Assess Patients' Tolerability of Trastuzumab Administrated Subcutaneously (SC) Either Via a Single Use Injection Device (SID) or Via Vial for Manual Administration (SC Vial) in Patients With HER2-Positive Early Breast Cancer (eBC)|Active, not recruiting||Phase 3|90|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:12:13.847636|2017-10-11 00:12:13.847636
NCT02194153|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-17|||May 2001||2001-05-01|July 2014|2014-07-01||||March 2003|Actual|2003-03-01||Observational|||Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With Metalyse|Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Prehospital or Early Inhospital (Emergency Department) Thrombolysis With Metalyse ®|Completed||N/A|351|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:12:14.032505|2017-10-11 00:12:14.032505
NCT02194140|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2014-07-16|||July 2014||2014-07-01|July 2014|2014-07-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|us||Improvement of Appendix Identification and Appendicitis Diagnosis in us After Administration of Oral Contrast Medium|Improvement of Appendix Identification and Appendicitis Diagnosis in Ultrasound After Administration of Iodinated Oral Contrast Medium|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center||1|||f||||f||||||||||2017-10-11 00:12:14.120609|2017-10-11 00:12:14.120609
NCT02194127|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-17|2014-07-23|||November 1998||1998-11-01|July 2014|2014-07-01||||June 1999|Actual|1999-06-01||Interventional|||Efficacy and Tolerability of a Bilberry Extract in Volunteers With Impaired Twilight and Night Vision|Efficacy and Tolerability of a Treatment Over 28 Days With a Bilberry Extract Standardised to a Content of 25% Anthocyanidines in Volunteers With Impaired Twilight and Night Vision|Completed||Phase 2|195|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:14.250151|2017-10-11 00:12:14.250151
NCT02194114|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-16|||January 2004||2004-01-01|July 2014|2014-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Dietary Protein Requirements in Hemodialysis Patients|Dietary Protein Intake and Its Effect on Nitrogen Balance in Maintenance Hemodialysis (MHD) Patients|Completed||N/A|13|Actual|Los Angeles Biomedical Research Institute||1|||f||||t||||||||||2017-10-11 00:12:14.356849|2017-10-11 00:12:14.356849
NCT02194101|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-16|||August 2014||2014-08-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Observational|||Supernormal Goal for Proximal Femur Fracture|Supernormal Oxygen Delivery May Not be a Valid Goal for Patients With Proximal Femur Fracture. An Observational Pilot Study|Unknown status|Not yet recruiting|N/A|30|Anticipated|Guangzhou First People's Hospital|||1||f||||f||||||||||2017-10-11 00:12:14.466122|2017-10-11 00:12:14.466122
NCT02194088|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-04-18|2016-11-01||April 2014||2014-04-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|November 2014|Actual|2014-11-01||Interventional|||Combined Medication for Improved Analgesia in Superficial Pain|Potential for Improved Analgesia From Combined Medication for Superficial Pain|Active, not recruiting||Phase 3|100|Actual|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-11 00:12:14.620596|2017-10-11 00:12:14.620596
NCT02194075|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-10-22|||October 2013||2013-10-01|December 2013|2013-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder||Completed||Phase 4|60|Actual|Guangdong General Hospital||2|||f||||t||||||||||2017-10-11 00:12:14.991359|2017-10-11 00:12:14.991359
NCT02194062|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-01-25|2016-10-19||January 2015||2015-01-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Nasal Steroids After FESS in CRSwNP|A Comparison of Budesonide Nasal Irrigation in Different Head Positions and Fluticasone Nasal Spray in Post-operative Functional Endoscopic Sinus Surgery Patients With Chronic Rhinosinusitis With Nasal Polyposis|Completed||N/A|32|Actual|Yale University|Small numbers recruited due to time constraints. Not all patients included in final data analysis because of loss to follow up and time constraints of collecting the data.|3|||f||||f||||||||||2017-10-11 00:12:15.112813|2017-10-11 00:12:15.112813
NCT02194049|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-06-20|||July 2014||2014-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer|Phase I Trial of Cisplatin and Etoposide Plus BKM120 in Advanced Solid Tumors, With an Emphasis on Small Cell Lung Cancer|Completed||Phase 1|3|Actual|University of California, Davis||1|||f||||t||||||||||2017-10-11 00:12:15.550713|2017-10-11 00:12:15.550713
NCT02194036|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-01-31|||August 2014|Actual|2014-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|LOF||Learning Oriented Physiotherapy - a New Approach|The Effect of Learning Oriented Physiotherapy on Health-Related Functioning and Quality of Life in Patients With Various Anxiety Disorders|Enrolling by invitation||N/A|80|Anticipated|Central Norway Regional Health Authority||2|||f||||f||||||||||2017-10-11 00:12:15.666299|2017-10-11 00:12:15.666299
NCT02194023|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2014-07-17|||September 2011||2011-09-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.|Inhibition of de Novo Plaque Formation and Side Effects of Two New Mouthrinse Formulations: 0.12% and 0.03% Chlorhexidine Digluconate, Respectively, in a 4-day Non-brushing Model. A Triple-blind, Randomized Clinical Trial.|Completed||Phase 2|200|Actual|Universitat Internacional de Catalunya||4|||f||||t||||||||||2017-10-11 00:12:15.795524|2017-10-11 00:12:15.795524
NCT02194010|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-10-04|||April 2014||2014-04-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|DSI and HMSN||Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)|Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)|Recruiting||N/A|415|Anticipated|University of Iowa|||2||f||||f||||||||||2017-10-11 00:12:15.929355|2017-10-11 00:12:15.929355
NCT02193997|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-09-26|||June 2012|Actual|2012-06-01|September 2017|2017-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Constipation Fiber Trial|Double-blind, Placebo-controlled Study to Examine the Effects of Dietary Fiber in Treating Childhood Constipation|Completed||N/A|60|Actual|University of Iowa||3|||f||||t|f|f||||||||2017-10-11 00:12:16.261494|2017-10-11 00:12:16.261494
NCT02193958|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-07-24|||July 2014||2014-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies|A Phase 1/2a, Dose Escalation Study of FF-10501-01 for the Treatment of Advanced Hematologic Malignancies|Recruiting||Phase 1/Phase 2|68|Anticipated|Fujifilm Pharmaceuticals U.S.A., Inc.||9|||f||||f||||||||||2017-10-11 00:12:16.599171|2017-10-11 00:12:16.599171
NCT02193945|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-07-08|||August 2014||2014-08-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|OZONE||A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA|OZONE: Ocriplasmin Ellipsoid Zone Retrospective Data Collection Study|Completed||N/A|134|Actual|ThromboGenics|||1||f||||f||||||||||2017-10-11 00:12:16.726753|2017-10-11 00:12:16.726753
NCT02193932|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-01-30|||January 2013||2013-01-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Electroencephalogram (EEG) Triggered Functional Magnetic Resonance Imaging (fMRI) in Epilepsy Patients|EEG-triggered fMRI in Epilepsy Patients|Recruiting||N/A|50|Anticipated|Baptist Health South Florida||1|||f||||f||||||||||2017-10-11 00:12:16.883902|2017-10-11 00:12:16.883902
NCT02193919|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2014-07-16|||March 2007||2007-03-01|July 2014|2014-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy|A Single-Center, Prospective, Single-Blind, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy|Completed||N/A|30|Actual|Bagel, Jerry, M.D.|||3||f||||f||||||||||2017-10-11 00:12:16.985099|2017-10-11 00:12:16.985099
NCT02193906|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2014-07-16|||December 2012||2012-12-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|June 2013|Actual|2013-06-01||Interventional|MS_Rehab||Neuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation Program|Neuropsychological Profile of a Portuguese Patient's Group With Multiple Sclerosis and Results of a Cognitive Rehabilitation Program|Unknown status|Active, not recruiting|N/A|75|Anticipated|Aveiro University||2|||f||||f||||||||||2017-10-11 00:12:17.187102|2017-10-11 00:12:17.187102
NCT02193893|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-17|||January 2010||2010-01-01|July 2014|2014-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|NeuStem-ALS||Biological Treatment of Amyotrophic Lateral Sclerosis|Safety/Efficacy Study for the Biological Treatment of Amyotrophic Lateral Sclerosis With Autologous Stem/Progenitor Cells|Enrolling by invitation||Phase 1|50|Anticipated|Pomeranian Medical University Szczecin||2|||f||||f||||||||||2017-10-11 00:12:17.313243|2017-10-11 00:12:17.313243
NCT02193880|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-12-27|||October 2014||2014-10-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|ABD||Safety and Efficacy Trial for Alpha-Beta Depleted T-Cell Infusions Post Haplo Transplant|Phase I/II Study of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 00:12:17.42554|2017-10-11 00:12:17.42554
NCT02193867|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-09-05|||June 2014|Actual|2014-06-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Clinical Trial in Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency|A Phase 2, Open Label, Multicenter Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Sebelipase Alfa in Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency|Active, not recruiting||Phase 2|10|Actual|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-10-11 00:12:17.573729|2017-10-11 00:12:17.573729
NCT02193854|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-07-16|||September 2013||2013-09-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Teledermatology Solution Through Mobile Phone in Rural Mongolia|Teledermatology Solution Through Mobile Phone in Rural Mongolia|Completed||N/A|441|Actual|Taipei Medical University||1|||f||||f||||||||||2017-10-11 00:12:17.684504|2017-10-11 00:12:17.684504
NCT02193841|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2017-01-24|||March 2015||2015-03-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|SBoCK||Simple Bone Cysts in Kids|Simple Bone Cysts in Kids (SBoCK)|Recruiting||Phase 3|160|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 00:12:17.785239|2017-10-11 00:12:17.785239
NCT02193828|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-09-07|2015-06-12||July 2014||2014-07-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Analysis based on Safety population; all randomized subjects who received an injection of study medication. One subject did not receive study medication.|Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules|A Phase 2a, Double-blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Effectiveness of AA4500 in the Treatment of Dupuytren's Disease Nodules|Completed||Phase 2|76|Actual|Endo Pharmaceuticals||4|||f||||f||||||||||2017-10-11 00:12:18.067386|2017-10-11 00:12:18.067386
NCT02193815|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-05-02|2016-03-04||September 2014||2014-09-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||The safety population included all enrolled participants who received at least 1 dose of investigational product.|A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis|A Phase 1, Single- Center, Randomized, Double-blind, Vehicle And Active Comparator-controlled Trial To Evaluate The Antipsoriatic Activity And Safety Of A Topically Applied Pf-06263276 Formulation In A Psoriasis Plaque Test|Completed||Phase 1|15|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:12:19.567791|2017-10-11 00:12:19.567791
NCT02193802|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2015-04-26|||May 2014||2014-05-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|CHANCE||Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease|Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease|Suspended||N/A|48|Anticipated|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||1||Lack of enrollment, amendment to colon capsule|f||||f||||||||||2017-10-11 00:12:20.315723|2017-10-11 00:12:20.315723
NCT02193789|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-02-19|||June 2014||2014-06-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Covered Self-expandable Metallic Stents Insertion Using Clips and Suture Materials for Preventing Migration|The Effect of Newly Designed Covered Self-expandable Metallic Stents Insertion Using Clips and Suture Materials for Preventing Migration in Benign Stricture of Gastroduodenal Anastomosis: a Pilot Study|Completed||N/A|13|Actual|Ajou University School of Medicine||1|||f||||t||||||||||2017-10-11 00:12:20.444578|2017-10-11 00:12:20.444578
NCT02193776|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-06-29|||November 2014||2014-11-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|February 2016|Actual|2016-02-01||Interventional|NC-005||A Phase 2 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.|A Phase 2 Open-Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide During 8 Weeks of Treatment in Adult Subjects With Newly Diagnosed Drug-Sensitive or Multi Drug-Resistant, Smear-Positive Pulmonary Tuberculosis.|Active, not recruiting||Phase 2|240|Actual|Global Alliance for TB Drug Development||4|||f||||t||||||||||2017-10-11 00:12:20.532539|2017-10-11 00:12:20.532539
NCT02193763|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2017-03-14|||August 2009||2009-08-01|March 2016|2016-03-01|December 2015||2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Bedside Ultrasound Assisted Pediatric Lumbar Puncture|Bedside Ultrasound Assisted Pediatric Lumbar Puncture--A Randomized Controlled Trial|Suspended||N/A|120|Anticipated|Advocate Health Care||4||PI has relocated to another institution, no other site PI to take over|f||||f||||||||||2017-10-11 00:12:20.682211|2017-10-11 00:12:20.682211
NCT02193750|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-10-31|||August 2015||2015-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease|Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease: A Randomized, Controlled Trial|Recruiting||N/A|48|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-10-11 00:12:20.793762|2017-10-11 00:12:20.793762
NCT02193737|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-10-10|||May 2014||2014-05-01|July 2014|2014-07-01||||September 2016|Actual|2016-09-01||Interventional|I-DRINC||Effects of Drinking at PACU Discharge After General Anaesthesia With Airway Control on Aspiration, Vomiting and Patients Comfort|Effects of Drinking at PACU Discharge After General Anaesthesia With Airway Control on Aspiration, Vomiting and Patients Comfort.|Unknown status|Recruiting|N/A|||Poitiers University Hospital||2|||f||||||||||||||2017-10-11 00:12:21.057822|2017-10-11 00:12:21.057822
NCT02193724|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-05-15|||November 4, 2014|Actual|2014-11-04|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma|Feasibility, Validation and Differentiation of Induced Pluripotent Stem Cells Produced From Patients With Heritable Retinoblastoma|Recruiting||N/A|20|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     Skin samples or peripheral blood samples to be used to generate pluripotent stem cells.   "|||2017-10-11 00:12:21.154228|2017-10-11 00:12:21.154228
NCT02193711|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-07-25|||January 2015||2015-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Delivra Joint Health Cream In The Treatment Of Pain Caused By Osteoarthritis Of The Knee|Randomized, Double Blind, Placebo Controlled Trial With Open Label Extension Of Delivra Joint Health Cream In The Treatment Of Pain Caused By Osteoarthritis Of The Knee|Active, not recruiting||Phase 3|160|Actual|Delivra, Inc.||2|||f||||||||||||||2017-10-11 00:12:21.268793|2017-10-11 00:12:21.268793
NCT02193698|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-07-27|||July 2014||2014-07-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial|Single Arm Open-label Trial to Investigate the Efficacy and Safety of Lenlidomide as a Treatment for Recurrent or Refractory Crow-Fukase (POEMS) Syndrome|Completed||Phase 2|5|Actual|Chiba University||1|||f||||t||||||||||2017-10-11 00:12:21.353122|2017-10-11 00:12:21.353122
NCT02193685|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-08-10|||February 2010||2010-02-01|August 2016|2016-08-01|December 2025|Anticipated|2025-12-01|December 2022|Anticipated|2022-12-01||Observational|HAEC||Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease|Identification of Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease|Recruiting||N/A|400|Anticipated|Cedars-Sinai Medical Center|||2||f||||f||||||Samples With DNA|"     Procedures include prospective data collection from medical records venipuncture and stool     collection. 4 cc of blood will be drawn at the screening visit for genetic and immune     testing. Additional 8.5 cc of blood will be drawn for CSMC patients for establishment of cell     lines.      1. Stool sample collected at screening or follow-up if patient unable to provide at     screening.      DNA will be prepared from blood for Genome Wide Association Study and mutational analysis 2.     Serological immune markers for inflammatory bowel disease (IBD) including ANCA, ASCA, OMPC,     I2, and CBir1 and any newly identified markers. These tests will only be performed on     patients who consent to the immune response sub-study. No additional blood sample required.     3. Collect and store fresh fecal specimens for future evaluation by molecular methodologies     to determine relative proportions of enteric microflora.   "|||2017-10-11 00:12:21.44797|2017-10-11 00:12:21.44797
NCT02193672|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-07-14|||August 2014||2014-08-01|July 2014|2014-07-01||||August 2020|Anticipated|2020-08-01||Interventional|||A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy|A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:12:21.552213|2017-10-11 00:12:21.552213
NCT02193659|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2015-08-24|||September 2013||2013-09-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|cereals||Changes Induced by Breakfast Cereals Enriched With Omega-3 in the Lipidic Profile|Changes Induced by Breakfast Cereals Enriched With Omega-3 in the Lipidic Profile: a Randomized Simple Controlled Trial|Completed||N/A|96|Actual|Universidad Miguel Hernandez de Elche||1|||f||||t||||||||||2017-10-11 00:12:21.641383|2017-10-11 00:12:21.641383
NCT02193646|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-10-04|||November 2010||2010-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Endoscopic Size Assessment of Advanced Adenomatous Polyps|Endoscopic Size Assessment of Advanced Adenomatous Polyps; Inter Observer Variations|Recruiting||N/A|1000|Anticipated|Rush University Medical Center|||1||f||||f||||||||||2017-10-11 00:12:21.75841|2017-10-11 00:12:21.75841
NCT02193633|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-03-11|||April 2013||2013-04-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|TAX-TORC||A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.|TAX-TORC: A Phase I Multi-centre Trial of the Combination of AZD2014 (Dual mTORC1 and mTORC2 Inhibitor) and Weekly Paclitaxel in Patients With Solid Tumours.|Unknown status|Recruiting|Phase 1|70|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:12:21.856702|2017-10-11 00:12:21.856702
NCT02193620|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2015-11-03|||April 2013||2013-04-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|September 2014|Actual|2014-09-01||Interventional|||Study of PHN131 in Patients After Surgery|A Randomized, Double Blind, Placebo-controlled, Multiple Dose Study to Assess the Efficacy, Safety and Pharmacokinetics of Oral Nalbuphine, an Oral Soft Capsule, for Post-hemorrhoidectomy Pain Management|Unknown status|Active, not recruiting|Phase 2/Phase 3|120|Anticipated|PhytoHealth Corporation||2|||f||||f||||||||||2017-10-11 00:12:22.011476|2017-10-11 00:12:22.011476
NCT02193607|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-07-15|||January 2014||2014-01-01|July 2014|2014-07-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|PTOS||Outcomes of Pelvic Surgery With and Without Anti-incontinence Procedure in Occult Stress Urinary Incontinence Patients|Improved Reconstruction Pelvic Surgery With and Without Tension-free Vaginal Tape-obturator in Women With Occult Stress Urinary Incontinence(PTOS): a Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|196|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 00:12:22.23109|2017-10-11 00:12:22.23109
NCT02193594|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2015-06-04|||January 2014||2014-01-01|June 2015|2015-06-01|May 2020|Anticipated|2020-05-01|September 2017|Anticipated|2017-09-01||Interventional|||Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma|Phase Ⅱ/Ⅲ Study of Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma|Recruiting||Phase 2/Phase 3|214|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 00:12:22.367357|2017-10-11 00:12:22.367357
NCT02193581|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-03-19|||August 30, 2017|Anticipated|2017-08-30|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging|Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging: the MDS (Melanoma Detecting System)|Not yet recruiting||N/A|50|Anticipated|Orlucent, Inc|||1||f||||t||||||||||2017-10-11 00:12:22.541306|2017-10-11 00:12:22.541306
NCT02193568|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-09-25|||April 2014||2014-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy|A Prospective, Single-Blinded, Randomized Study of Awake vs Intubated General Anesthesia in Patients Undergoing Elective Craniotomy for Supratentorial Glioma Resection|Recruiting||Phase 4|80|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:12:22.657932|2017-10-11 00:12:22.657932
NCT02193555|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-11-04|||July 2014||2014-07-01|July 2014|2014-07-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Visual Performance of Prototype Contact Lens Designs|Visual Performance of Prototype Contact Lens Designs|Completed||N/A|91|Actual|Brien Holden Vision||2|||f||||f||||||||||2017-10-11 00:12:22.795408|2017-10-11 00:12:22.795408
NCT02193542|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-01-23|||July 1, 2014|Actual|2014-07-01|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|DADB||Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients|Prospective Observation Study of Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients|Recruiting||N/A|400|Anticipated|Brigham and Women's Hospital|||1||f||||f|f|f||||||No||2017-10-11 00:12:22.925804|2017-10-11 00:12:22.925804
NCT02193529|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-15|||June 2014||2014-06-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Dietary Intake After Laparoscopic Sleeve Gastrectomy —a 5 Year Study|Weight Loss and Metabolic Surgery Center Min-Sheng General Hospital|Unknown status|Recruiting|N/A|40|Anticipated|Min-Sheng General Hospital|||1||f||||t||||||||||2017-10-11 00:12:23.035391|2017-10-11 00:12:23.035391
NCT02193516|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2014-07-15|||July 2014||2014-07-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Identification of Corticomedullary Differentiation Along Different Stage of Pregnancy||Unknown status|Not yet recruiting|N/A|330|Anticipated|Meir Medical Center|||1||f||||||||||||||2017-10-11 00:12:23.152999|2017-10-11 00:12:23.152999
NCT02193503|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-02-07|||March 2014||2014-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||MVX-ONCO-1 in Patients With Solid Tumor|An Open Phase I Clinical Study Assessing Safety and Tolerability of MVX-ONCO-1 in Patients With Solid Tumor Who Are Not/Not Any Longer Amenable to Standard Therapy|Recruiting||Phase 1|25|Anticipated|Maxivax SA||1|||f||||t||||||||||2017-10-11 00:12:23.260386|2017-10-11 00:12:23.260386
NCT02193490|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-04-11|||July 2014||2014-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||DNase Treatment for Dry Eyes|Safety and Efficacy Of Recombinant Human Deoxyribonuclease Eye Drops In Patients With Sjogren's and Non-Sjogren Dry Eye Disease|Recruiting||Phase 1/Phase 2|72|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 00:12:23.380525|2017-10-11 00:12:23.380525
NCT02193477|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2015-03-05|||July 2014||2014-07-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Effect of TEAS on the Incidence Rate of SIRS in Patients Undergoing Abdominal Surgery|Effect of Transcutaneous Electrical Acupoint Stimulation (TEAS)on the Incidence Rate of Systemic Inflammatory Response Syndrome (SIRS) in Patients Undergoing Radical Surgery for Gastric Cancer|Completed||N/A|105|Actual|Fourth Military Medical University||3|||f||||f||||||||||2017-10-11 00:12:23.492524|2017-10-11 00:12:23.492524
NCT02193464|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-07-23|||September 2014||2014-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01|10 Years|Observational [Patient Registry]|EPICODE||Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk|Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea|Recruiting||N/A|100|Anticipated|Kyungpook National University|||1||f||||f||||||||||2017-10-11 00:12:23.61188|2017-10-11 00:12:23.61188
NCT02193451|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2016-03-22|||October 2014||2014-10-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|UPSTREAM||Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods|A Randomised Controlled Trial to Determine the Clinical and Cost Effectiveness of Invasive Urodynamic Studies for Diagnosis and Management of Bladder Outlet Obstruction in Men in the United Kingdom National Health Service (NHS)|Recruiting||N/A|800|Anticipated|North Bristol NHS Trust||2|||f||||t||||||||Yes||2017-10-11 00:12:23.723192|2017-10-11 00:12:23.723192
NCT02193438|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-16|||May 2011||2011-05-01|July 2014|2014-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Physiologic Effect of Spices Ingestion|Physiologic Effect of Spices Ingestion|Completed||N/A|19|Actual|Nestlé||4|||f||||f||||||||||2017-10-11 00:12:23.889446|2017-10-11 00:12:23.889446
NCT02193425|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-08-04|||June 26, 2014||2014-06-26|July 27, 2017|2017-07-27|March 31, 2021|Anticipated|2021-03-31|March 22, 2021|Anticipated|2021-03-22||Interventional|||Reliability of the Human Brain Connectome|Reliability Of The Human Brain Connectome|Recruiting||Early Phase 1|180|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:12:24.019495|2017-10-11 00:12:24.019495
NCT02193412|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-08-22|||January 4, 2015|Actual|2015-01-04|August 2017|2017-08-01|October 3, 2017|Anticipated|2017-10-03|October 3, 2017|Anticipated|2017-10-03||Interventional|||Influence of Variations of Systemic Venous Return on Analgesia Nociception Index (ANI) During General Anaesthesia|Influence of Variations of Systemic Venous Return on Analgesia Nociception Index (ANI) During General Anaesthesia|Recruiting||N/A|30|Anticipated|University Hospital, Lille||1|||f||||f||||||||||2017-10-11 00:12:24.14181|2017-10-11 00:12:24.14181
NCT02193399|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-08-28|||September 2014||2014-09-01|June 2014|2014-06-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|TRAS||Physiotherapy in Hematopoietic Stem Cell Transplantation|Effectiveness of Physiotherapy in the Prevention of Physical Sequelae in Patients Treated With Hematopoietic Stem Cell Transplantation. A Pilot Study.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Universidad Católica San Antonio de Murcia||2|||f||||f||||||||||2017-10-11 00:12:24.285461|2017-10-11 00:12:24.285461
NCT02193386|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-14|||September 2010||2010-09-01|September 2010|2010-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evidence-based Physical Therapy in Children With Cerebral Palsy|Evidence-based Practice and Its Effectiveness in Physical Therapy Treatment of Children With Bilateral Spastic Cerebral Palsy.|Completed||N/A|16|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 00:12:24.397003|2017-10-11 00:12:24.397003
NCT02193360|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-08-23|||May 2015||2015-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Pilot Study of FFP104 Dose Escalation in PBC Subjects|A Phase I/II, Open Label, Multicenter, Pilot Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacodynamics of FFP104 in Subjects Previously Diagnosed With Primary Biliary Cirrhosis (PBC)|Recruiting||Phase 1/Phase 2|24|Anticipated|Fast Forward Pharmaceuticals||1|||f||||t||||||||||2017-10-11 00:12:24.630966|2017-10-11 00:12:24.630966
NCT02193347|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-06-15|||December 2015||2015-12-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|RESIST||IDH1 Peptide Vaccine for Recurrent Grade II Glioma|Patients With IDH1 Positive Recurrent Grade II Glioma Enrolled in a Safety and Immunogenicity Study of Tumor-Specific Peptide Vaccine|Recruiting||Phase 1|24|Anticipated|Duke University||1|||f||||t||||||||||2017-10-11 00:12:24.748555|2017-10-11 00:12:24.748555
NCT02193334|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-10-05|||June 2014||2014-06-01|March 2015|2015-03-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase I/II Study of KP-100IT in Acute Spinal Cord Injury|A Phase I/II Study to Evaluate the Safety and Efficacy of Intrathecal Injection of KP-100IT in Subjects With Acute Spinal Cord Injury|Recruiting||Phase 1/Phase 2|48|Anticipated|Kringle Pharma, Inc.||2|||f||||t||||||||||2017-10-11 00:12:24.873855|2017-10-11 00:12:24.873855
NCT02193321|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-11-30|||July 2014||2014-07-01|November 2015|2015-11-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Safety and Efficacy Study of Amniotic Membrane Patch to Treat Postoperative Atrial Fibrillation|Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving an Amniotic Membrane Patch Placed on the Epicardial Surface|Withdrawn||Phase 1/Phase 2|0|Actual|University of Arizona||2|||f||||t||||||||||2017-10-11 00:12:24.973534|2017-10-11 00:12:24.973534
NCT02193308|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2014-07-17|||September 2007||2007-09-01|July 2014|2014-07-01||||November 2007|Actual|2007-11-01||Interventional|||Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers|Bioequivalence of 80 mg Telmisartan / 10 mg Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers. An Open-label, Randomised, Single-dose, Two Sequence, Two-period Crossover Study|Completed||Phase 1|84|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:25.076889|2017-10-11 00:12:25.076889
NCT02193230|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-06-05|||October 2014||2014-10-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|DACE||Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence|Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence.|Unknown status|Recruiting|N/A|30|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 00:12:32.634528|2017-10-11 00:12:32.634528
NCT02193217|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-02-19||||||February 2015|2015-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303||Completed||Phase 1|81|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||||||||||||2017-10-11 00:12:32.759551|2017-10-11 00:12:32.759551
NCT02193204|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-07-14|||September 2011||2011-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Chronic Alcohol, Stress Inflammatory Response and Relapse Risk|Chronic Alcohol, Stress Inflammatory Response and Relapse Risk|Completed||N/A|116|Actual|Yale University||4|||f||||f||||||||||2017-10-11 00:12:32.871664|2017-10-11 00:12:32.871664
NCT02193191|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-08-18|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease|Safety and Efficacy Trial of Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease|Recruiting||Phase 1|39|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:12:32.997402|2017-10-11 00:12:32.997402
NCT02193178|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-12-27|2016-08-02||July 2014||2014-07-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||One participant discontinued and therefore data was not included in analysis.|Multicenter Dispensing Study of Biofinity Toric Made-To-Order Lenses in Extended Power Ranges|Multicenter Dispensing Study of Biofinity Toric Made-To-Order Lenses in Extended Power Ranges|Completed||N/A|15|Actual|Coopervision, Inc.||1|||f||||f||||||||||2017-10-11 00:12:33.182147|2017-10-11 00:12:33.182147
NCT02193165|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-07-27|2014-11-14||July 2014||2014-07-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Clinical Efficacy of Three Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste and a Mouthwash in Controlling Dental Plaque and Gingivitis|The Comparative Efficacy of Three Oral Hygiene Multi-component Regimens Encompassing the Use of a Manual Toothbrush, Toothpaste and a Mouthwash in Controlling Established Dental Plaque and Gingivitis.|Completed||Phase 3|120|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-10-11 00:12:34.051115|2017-10-11 00:12:34.051115
NCT02193152|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-07-18|||April 27, 2015|Actual|2015-04-27|July 2017|2017-07-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Pazopanib in Molecularly Selected Patients With Advanced NSCLC|A Pilot Study of Pazopanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-11 00:12:34.701861|2017-10-11 00:12:34.701861
NCT02193139|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2015-07-15||2015-07-15|December 2013||2013-12-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis|A Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of An Anticholinergic Agent for the Treatment of Primary Axillary Hyperhidrosis|Completed||Phase 2|195|Actual|Watson Pharmaceuticals||5|||f||||||||||||||2017-10-11 00:12:35.445754|2017-10-11 00:12:35.445754
NCT02193126|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-06-01|||September 2014||2014-09-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Trauma Focus Model for Reducing Long-Term Foster Care|Permanency Innovations Initiative- Trauma Focus Model for Reducing Long-Term Foster Care Project|Completed||N/A|||Westat|||||f||||f||||||||||2017-10-11 00:12:35.558501|2017-10-11 00:12:35.558501
NCT02193113|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-03-01|||July 18, 2014|Actual|2014-07-18|March 2017|2017-03-01|June 4, 2015|Actual|2015-06-04|June 4, 2015|Actual|2015-06-04||Interventional|||A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME|An Open Label, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacodynamics of a Novel Intravitreal Plasma Kallikrein Inhibitor in Subjects With Central Involved Diabetic Macular Edema and Reduced Vision|Completed||Phase 1|14|Actual|KalVista Pharmaceuticals, Ltd.||3|||f||||t||||||||No||2017-10-11 00:12:35.676396|2017-10-11 00:12:35.676396
NCT02193100|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-02-29|||August 2014||2014-08-01|January 2016|2016-01-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center|PRE AND POST TREATMENT METABOLOMIC ANALYSIS OF LEUKEMIA: A Translational Clinical Trial of the Brown Cancer Center|Withdrawn||Phase 1/Phase 2|0|Actual|James Graham Brown Cancer Center|||2||f||||t||||||||||2017-10-11 00:12:35.803362|2017-10-11 00:12:35.803362
NCT02193087|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-06-09|2016-05-19||August 6, 2014|Actual|2014-08-06|June 2017|2017-06-01|May 19, 2015|Actual|2015-05-19|May 19, 2015|Actual|2015-05-19||Interventional||All randomized participants.|Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)|A Randomized, Double Blind, Phase 2 Study to Assess the Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Adults|Completed||Phase 2|1002|Actual|Takeda||4|||f||||f||||||||||2017-10-11 00:12:36.154527|2017-10-11 00:12:36.154527
NCT02193074|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-06-29|2017-05-16||August 19, 2014|Actual|2014-08-19|June 2017|2017-06-01|November 21, 2016|Actual|2016-11-21|November 21, 2016|Actual|2016-11-21||Interventional|ENDEAR||A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy|A Phase 3, Randomized, Double-Blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Infantile-onset Spinal Muscular Atrophy|Terminated||Phase 3|122|Actual|Biogen||2||"After a positive interim analysis, the decision was made to terminate the study early to allow   for participants to enroll into an open label study"|t||||t||||||||||2017-10-11 00:12:40.472423|2017-10-11 00:12:40.472423
NCT02192866|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-06-28|||February 2014||2014-02-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies|Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies|Recruiting||N/A|270|Anticipated|University of Colorado, Denver|||3||f||||t||||||Samples With DNA|"     Blood samples.   "|||2017-10-11 00:12:44.1265|2017-10-11 00:12:44.1265
NCT02193061|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-08-15|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|June 2017|Actual|2017-06-01||Interventional|||Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs|Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between Rota Vaccine 5 and Rota Vaccine 1 Using Seven Combined Anti-rotavirus Prevention Programs: ROTA 1,ROTA 2,ROTA 3,ROTA 4,ROTA 5,ROTA 6,ROTA 7 in Infants at 2, 4 and 6 Months of Age in Mexico City.|Active, not recruiting||Phase 3|1498|Anticipated|National Institute of Pediatrics, Mexico||7|||f||||t||||||||||2017-10-11 00:12:41.93443|2017-10-11 00:12:41.93443
NCT02193048|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-16|2017-04-11|||September 2014||2014-09-01|April 2017|2017-04-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|PROGNOS||Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease||Recruiting||N/A|500|Anticipated|Ferring Pharmaceuticals|||1||f||||||||||||||2017-10-11 00:12:42.041282|2017-10-11 00:12:42.041282
NCT02193035|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-04-12|||June 2014||2014-06-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Microparticles in Severe Aortic Stenosis|Microparticles as an Inflammatory Marker in Severe Aortic Stenosis.|Completed||N/A|15|Actual|InCor Heart Institute||1|||f||||f||||||||No||2017-10-11 00:12:42.121402|2017-10-11 00:12:42.121402
NCT02193022|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-08-28|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Miltefosine for Children With PKDL|A Study for Safety and Efficacy of Miltefosine for Treatment of Children and Adolescents With Post-Kala-azar Dermal Leishmaniasis (PKDL) in Bangladesh and Association of Serum Vitamin E and Exposure to Arsenic With PKDL|Recruiting||Phase 3|80|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||1|||f||||t||||||||||2017-10-11 00:12:42.20666|2017-10-11 00:12:42.20666
NCT02193009|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-06-17|||July 2011||2011-07-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||SipSmarter: A Nutrition Literacy Approach to Reducing Sugary Beverages|SipSmarter: A Nutrition Literacy Approach to Reducing Sugary Beverages|Unknown status|Active, not recruiting|N/A|304|Actual|Virginia Polytechnic Institute and State University||2|||f||||f||||||||||2017-10-11 00:12:42.476359|2017-10-11 00:12:42.476359
NCT02192996|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-16|||December 2012||2012-12-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|February 2013|Actual|2013-02-01||Interventional|||Probiotic Supplementation to Improve the GUT Microbiota of Very Low Birth Weight Preterm, a Pilot Study|Probiotic Supplementation to Improve the GUT Microbiota of Very Low Birth Weight, a Pilot Study|Completed||Early Phase 1|5|Actual|Hospital Universitario La Paz||1|||f||||f||||||||||2017-10-11 00:12:42.585871|2017-10-11 00:12:42.585871
NCT02192983|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2015-11-30|||November 2008||2008-11-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|5 Years|Observational [Patient Registry]|||A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.|A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer|Completed||N/A|242|Actual|Shanghai Zhongshan Hospital|||1||f||||f||||||||||2017-10-11 00:12:42.682852|2017-10-11 00:12:42.682852
NCT02192970|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-16|||August 2014||2014-08-01|July 2014|2014-07-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|BEARRD||Bevacizumab Against Recurrent Retinal Detachment||Unknown status|Not yet recruiting|Phase 2|100|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 00:12:42.760389|2017-10-11 00:12:42.760389
NCT02192957|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-04-20|||August 2015||2015-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Ottawa AF Cardioversion Protocol|Developing a Standardized Atrial Fibrillation Cardioversion Protocol|Recruiting||N/A|389|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 00:12:42.876461|2017-10-11 00:12:42.876461
NCT02192944|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-11-02|||July 2014||2014-07-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparison of the ECG Effects Related to Pharmacokinetic Profile of Chloroquine and Piperaquine|Comparison of the Electrocardiographic Effects in Relation to Pharmacokinetic Profile of Chloroquine and Piperaquine in Healthy Thai Subjects|Completed||Phase 4|16|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 00:12:42.989982|2017-10-11 00:12:42.989982
NCT02192931|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-08-22|||September 2014||2014-09-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users|A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users|Recruiting||Phase 4|147|Anticipated|University of Utah||3|||f||||t||||||||||2017-10-11 00:12:43.087875|2017-10-11 00:12:43.087875
NCT02192918|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-05-05|||April 2012||2012-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Pilot Investigation of Behavioral Alternatives to Indoor Tanning|Pilot Investigation of Behavioral Alternatives to Indoor Tanning|Completed||N/A|74|Actual|University of Massachusetts, Worcester||3|||f||||t||||||||||2017-10-11 00:12:43.186078|2017-10-11 00:12:43.186078
NCT02192892|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-08-05|||June 2014||2014-06-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|AMY-01||Acceptability Among Children and Caregivers of Amylase Porridges|Acceptability of α-amylase Fortified Blended Foods Among Children 12-36 Months Old Children and Caregivers in Burkina Faso|Completed||N/A|240|Actual|DSM Food Specialties||18|||f||||t||||||||||2017-10-11 00:12:43.414553|2017-10-11 00:12:43.414553
NCT02192879|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-09-13|2016-07-25||August 2014||2014-08-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||TEA vs. PVB vs. PCA in Liver Resection Surgery|A Comparison of the Efficacy of Alternative Analgesia Modalities in Complex Hepatic Resection Surgery: Thoracic Epidural Analgesia Versus Continuous Paravertebral Block With Patient-Controlled Analgesia Versus Patient-Controlled Analgesia|Terminated||N/A|10|Actual|Duke University|Unable to recruit adequate number of participants, and decision was made to terminate the study.|3||Unable to recruit subjects|f||||t||||||||||2017-10-11 00:12:43.586312|2017-10-11 00:12:43.586312
NCT02192840|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-15|||October 2010||2010-10-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|POLBOS||POLish Bifurcation Optimal Stenting Study|Regular DES Versus BiOSS Expert® Stent in Coronary Bifurcation Treatment - Randomized, Multicenter, Open-label, Controlled POLBOS I (POLish Bifurcation Optimal Stenting) Study|Completed||Phase 4|243|Actual|Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland||2|||f||||t||||||||||2017-10-11 00:12:44.336911|2017-10-11 00:12:44.336911
NCT02192827|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-11-30|||April 2015||2015-04-01|November 2015|2015-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Use of Dexamethasone in Pediatric Asthma Exacerbations|Efficacy of Single vs. Double Dose Dexamethasone for Mild to Moderate Asthma in a Pediatric Emergency Department|Recruiting||Phase 3|254|Anticipated|University at Buffalo||2|||f||||t||||||||||2017-10-11 00:12:44.48751|2017-10-11 00:12:44.48751
NCT02192814|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-07-28|2015-10-30||June 2014||2014-06-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional||"Participant Flow refers to the Safety Set (SS), consisting of all enrolled subjects who received at least 1 infusion of iv LCM.
Subjects participating in EP0009 (NCT01832038) have been enrolled to EP0024."|Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures|A Multicenter, Open-label Study to Evaluate the Safety and Tolerability of Intravenous Lacosamide as Replacement for Oral Lacosamide in Japanese Adults With Partial-onset Seizures With or Without Secondary Generalization|Completed||Phase 3|9|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 00:12:44.617738|2017-10-11 00:12:44.617738
NCT02192801|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-07-16|||April 2014||2014-04-01|January 2014|2014-01-01||||April 2016|Anticipated|2016-04-01||Observational|||Kidney Function in Patients With Bladder Exstrophy|Evaluation of Long-term Renal Function in Patients After Surgical Repair of Classical Bladder Exstrophy|Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 00:12:45.241224|2017-10-11 00:12:45.241224
NCT02192788|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-08-03|||August 2014||2014-08-01|August 2016|2016-08-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer|Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer|Recruiting||Phase 2|68|Anticipated|Grupo de Investigación Clínica en Oncología Radioterapia||1|||f||||f||||||||||2017-10-11 00:12:45.302331|2017-10-11 00:12:45.302331
NCT02192775|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-09-05|||March 2015||2015-03-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus|A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With Cyclophosphamide, in Patients With Recurrent of Refractory Multiple Myeloma|Recruiting||Phase 2|16|Anticipated|University of Arkansas||1|||f||||t||||||||||2017-10-11 00:12:45.386125|2017-10-11 00:12:45.386125
NCT02192762|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-05-01|||July 2011||2011-07-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation|A Pilot Study of Withdrawal Regulation Training vs. Relaxation Training for Smoking Cessation (Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation)|Completed||N/A|60|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:12:45.475605|2017-10-11 00:12:45.475605
NCT02192736|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-08-08|||July 2014||2014-07-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma|Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Translational Biosciences||1|||f||||t||||||||||2017-10-11 00:12:45.635129|2017-10-11 00:12:45.635129
NCT02192723|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-07-10|||June 2012||2012-06-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia|Effectiveness of 6 Antipsychotic Drugs in the Treatment of Acute Exacerbations of Chronic Inpatients With Schizophrenia: a Randomized Double-blind Study|Completed||N/A|550|Actual|Beijing HuiLongGuan Hospital||6|||f||||t||||||||||2017-10-11 00:12:45.705379|2017-10-11 00:12:45.705379
NCT02192710|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-07-15|||May 2013||2013-05-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|IPAD||Reduction of Preoperative Anxiety in Children: Electronic Tab vs Midazolam|Reduction of Preoperative Anxiety in Children: Electronic Tab vs Midazolam|Completed||Phase 3|118|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 00:12:45.796016|2017-10-11 00:12:45.796016
NCT02192697|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-07-09|||January 23, 2014|Actual|2014-01-23|July 2017|2017-07-01|June 22, 2017|Actual|2017-06-22|January 15, 2016|Actual|2016-01-15||Interventional|||An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations|Phase I and II Study of ASP8273 — An Open-label Study of the Oral Administration of ASP8273 in Patients With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Mutations —|Terminated||Phase 1/Phase 2|124|Actual|Astellas Pharma Inc||3||Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.|f||||f||||||||||2017-10-11 00:12:45.875432|2017-10-11 00:12:45.875432
NCT02192684|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-03-14|2016-11-18||September 2010||2010-09-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Interventional|||Obesity, Sleep Apnea, and Insulin Resistance|Interfacing Adiposity, Sleep Apnea, and Insulin Resistance|Completed||N/A|45|Actual|Stanford University|Unrecognized adverse effect of pioglitazone could have obviated a beneficial effect of enhanced insulin sensitivity on OSA related sleep measures.|2|||f||||t||||||||||2017-10-11 00:12:46.108457|2017-10-11 00:12:46.108457
NCT02192671|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-01-05|||May 2015||2015-05-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|HR-HCC/PHT||HR Versus RFA for HCC in Patients With PHT|Hepatic Resection Versus Radiofrequency Ablation for Patients With Hepatocellular Carcinoma and Portal Hypertension|Recruiting||Phase 3|120|Anticipated|Guangxi Medical University||2|||f||||f||||||||||2017-10-11 00:12:46.388462|2017-10-11 00:12:46.388462
NCT02192658|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-07-11|||November 2014||2014-11-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Observational|HandiVIH||Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa|Disability and HIV: an Appraisal of the Vulnerability of People With Disabilities to HIV Infection in Two Main Cities of Sub-Saharan Africa|Completed||N/A|1610|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||2||f||||t||||||||||2017-10-11 00:12:46.525167|2017-10-11 00:12:46.525167
NCT02192645|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-07-19|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study|The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study (SPAR Study)|Active, not recruiting||Phase 3|453|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-11 00:12:46.625854|2017-10-11 00:12:46.625854
NCT02192632|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2015-03-10|||January 2014||2014-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Dermatologists' Educational Demonstration for Epiduo Application||Completed||N/A|85|Actual|Seoul National University Hospital||3|||f||||||||||||||2017-10-11 00:12:46.747061|2017-10-11 00:12:46.747061
NCT02192619|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-09-05|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup|National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup|Recruiting||N/A|300|Anticipated|Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH|||1||f||||f||||||||||2017-10-11 00:12:46.848633|2017-10-11 00:12:46.848633
NCT02192606|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-10-03|2017-07-11||November 2013||2013-11-01|October 2017|2017-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|3DRCT||Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?|Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? A Randomized Controlled Trial Comparing 3D Laparoscopy Versus Standard Laparoscopy|Completed||N/A|57|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 00:12:47.01009|2017-10-11 00:12:47.01009
NCT02192593|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-03-03|||November 2011||2011-11-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|January 2014|Actual|2014-01-01||Interventional|||Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations|Randomized Controlled Trial of Computerized Cognitive Behavioral Therapy for Auditory Hallucinations in Persons With Psychosis|Completed||N/A|45|Actual|Boston University Charles River Campus||2|||f||||f||||||||||2017-10-11 00:12:47.495763|2017-10-11 00:12:47.495763
NCT02192580|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2014-07-16|||July 2014||2014-07-01|July 2014|2014-07-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in Children||Unknown status|Recruiting|Phase 3|60|Anticipated|Shahid Beheshti University||2|||f||||t||||||||||2017-10-11 00:12:47.589518|2017-10-11 00:12:47.589518
NCT02192567|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-03-01|||September 2014||2014-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Open Label Study of DS-5573a|Phase 1, Open Label Study to Assess the Safety and Pharmacokinetics of DS-5573a in Japanese Patients With Advanced Solid Malignant Tumors|Terminated||Phase 1|19|Actual|Daiichi Sankyo, Inc.||1||Business decision|f||||t||||||||||2017-10-11 00:12:47.69555|2017-10-11 00:12:47.69555
NCT02192554|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-07-25|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo|A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial|Completed||N/A|450|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|||1||f||||t||||||||||2017-10-11 00:12:47.819477|2017-10-11 00:12:47.819477
NCT02192541|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-09-12|||July 9, 2014||2014-07-09|April 14, 2017|2017-04-14|February 25, 2016|Actual|2016-02-25|February 25, 2016|Actual|2016-02-25||Interventional|||Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas|Phase I Study of Ganetespib and Ziv-Aflibercept in Patients With Advanced Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas|Completed||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:12:48.107038|2017-10-11 00:12:48.107038
NCT02192528|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-08-10|||June 2012||2012-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|November 2013|Actual|2013-11-01||Observational|Calcitop||Vitamin D and Outcome in Cardiac Surgery|25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D and Postoperative Outcome in Cardiac Surgical Patients|Completed||N/A|3852|Actual|Heart and Diabetes Center North-Rhine Westfalia|||1||f||||f||||||||No||2017-10-11 00:12:48.240349|2017-10-11 00:12:48.240349
NCT02192515|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-02-08|||July 2014||2014-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects|A Phase 1 Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects|Completed||Phase 1|40|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-11 00:12:48.341399|2017-10-11 00:12:48.341399
NCT02192502|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-12-12|||March 2015||2015-03-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|SHARP||Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical Patients|A Randomized Controlled Investigation of the Effects of 6% Hydroxyethylstarch 130/0.4 (Voluven) on Renal Function in Patients Having Aortic Valve Replacement With or Without Coronary Artery Bypass Grafting|Recruiting||Phase 3|140|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-11 00:12:48.449225|2017-10-11 00:12:48.449225
NCT02192489|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-09-27|||November 2014||2014-11-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase 2 Study With CC-220 in Skin Sarcoidosis|A Phase 2A, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Sequential, Dose-Ascending Study Of CC-220 In Subjects With Chronic Cutaneous Sarcoidosis|Withdrawn||Phase 2|0|Actual|Celgene Corporation||3||Administrative|f||||f||||||||||2017-10-11 00:12:48.538654|2017-10-11 00:12:48.538654
NCT02191696|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2015-01-28|||June 2014||2014-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Observational Study of ICD and Pacemaker Sensing in the Presence of IMED-4 Operation|Observational Study of ICD and Pacemaker Sensing in the Presence of IMED-4 Operation|Completed||N/A|24|Actual|Intersection Medical, Inc.|||1||f||||f||||||||||2017-10-11 00:12:58.55449|2017-10-11 00:12:58.55449
NCT02192476|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-18|||June 2013||2013-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|CTPT||Efficacy of CTPT Method in the Treatment of Post Stroke Shoulder Subluxation|Efficacy of California Tri-pull Taping Method in the Treatment of Post Stroke Shoulder Subluxation- A Randomized Clinical Trial.|Completed||Phase 1|30|Actual|Maharishi Markendeswar University||2|||f||||t||||||||||2017-10-11 00:12:48.654457|2017-10-11 00:12:48.654457
NCT02192463|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||April 2006||2006-04-01|July 2014|2014-07-01||||August 2006|Actual|2006-08-01||Interventional|||Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune® Oral Suspension in Healthy Male Volunteers|Relative Bioavailability of Different Oral Viramune Extended Release Formulations Containing 300 mg or 400 mg Compared to 200 mg or 400 mg as One or Two 200 mg IR Tablets Following Administration in Healthy Male Volunteers - an Openlabel, Non-randomized, Parallel Group Study|Completed||Phase 1|204|Actual|Boehringer Ingelheim||12|||f||||||||||||||2017-10-11 00:12:48.765814|2017-10-11 00:12:48.765814
NCT02192450|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-03-15|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HypoDeg||Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia|The Effect of Insulin Degludec on Risk of Symptomatic Nocturnal Hypoglycaemia in Subjects With Type 1 Diabetes and High Risk of Nocturnal Severe Hypoglycaemia|Active, not recruiting||Phase 4|149|Actual|Nordsjaellands Hospital||2|||f||||t||||||||||2017-10-11 00:12:48.886414|2017-10-11 00:12:48.886414
NCT02192437|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-01-12|||June 2014||2014-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|||Dietary Methionine and Cysteine Restriction in Healthy Adults|Dietary Methionine and Cysteine Restriction in Healthy Adults|Active, not recruiting||N/A|20|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 00:12:49.037745|2017-10-11 00:12:49.037745
NCT02192424|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-03-22|||July 2014||2014-07-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|RESET-IT||Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)|A Randomized Controlled Trial to Evaluate Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes: REmission Studies Evaluating Type 2 DM - Intermittent Insulin Therapy (RESET-IT)|Recruiting||Phase 3|148|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||No||2017-10-11 00:12:49.448161|2017-10-11 00:12:49.448161
NCT02192411|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-15|||July 2014||2014-07-01|July 2014|2014-07-01||||December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of Variable Lidocaine Concentrations in Tumescent Anesthesia for Pain Control During and After Endovenous Laser Procedure; Non-inferiority Trial|Efficacy of Variable Lidocaine Concentrations in Tumescent Anesthesia for Pain Control During and After Endovenous Laser Procedure; a Double Blinded, Randomized, Controlled Non-inferiority Trial|Unknown status|Not yet recruiting|N/A|70|Anticipated|Midwest Vein Center||2|||f||||t||||||||||2017-10-11 00:12:49.578065|2017-10-11 00:12:49.578065
NCT02192398|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2016-09-12|||September 2014||2014-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)|Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)|Recruiting||N/A|120|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 00:12:49.697528|2017-10-11 00:12:49.697528
NCT02192372|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||February 2014||2014-02-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Metabolic Syndrome and Contrast Induced Nephropathy|Impact of Metabolic Syndrome on Development of Contrast Induced Nephropathy After Elective Percutaneous Coronary Intervention|Completed||N/A|599|Actual|Ankara University|||2||f||||f||||||||||2017-10-11 00:12:49.820169|2017-10-11 00:12:49.820169
NCT02192359|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-06-09|||March 7, 2016|Actual|2016-03-07|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas|A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination With Intravenous Irinotecan in Patients With Recurrent High-Grade Gliomas|Recruiting||Phase 1|53|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:12:49.905524|2017-10-11 00:12:49.905524
NCT02192346|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2017-08-08|||July 2014||2014-07-01|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|||α-TEA in Advanced Cancer|Phase I Study of Alpha-tocopheryloxyacetic Acid (α-TEA) in Patients With Advanced Cancer|Active, not recruiting||Phase 1|17|Actual|Providence Health & Services||9|||f||||f||||||||||2017-10-11 00:12:50.045582|2017-10-11 00:12:50.045582
NCT02192333|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-09-27|||August 3, 2015|Actual|2015-08-03|September 2017|2017-09-01||||October 7, 2017|Anticipated|2017-10-07||Interventional|||Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors|Young Adult Cancer Survivor Network Study of the Essential Elements of Care (YA-EEC-14)|Active, not recruiting||N/A|455|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 00:12:50.172729|2017-10-11 00:12:50.172729
NCT02192320|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-03-25|||July 2014||2014-07-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders|The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Oriental Neurosurgery Evidence-Based-Study Team||2|||f||||f||||||||||2017-10-11 00:12:50.308607|2017-10-11 00:12:50.308607
NCT02192307|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-09-12|||July 2014||2014-07-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effectiveness of Two Water-Based Potassium Oxalate Desensitizers||Completed||N/A|60|Actual|Procter and Gamble||2|||f||||f||||||||||2017-10-11 00:12:50.515979|2017-10-11 00:12:50.515979
NCT02192294|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-10-30|||August 2014||2014-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Absolute Bioavailability Of Bosutinib|An Open-label, Randomized, 2-period Crossover Study To Evaluate Absolute Bioavailability Of Bosutinib In Healthy Subjects|Completed||Phase 1|14|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:12:50.639606|2017-10-11 00:12:50.639606
NCT02192281|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-14|||March 2011||2011-03-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Randomized Experiment of Playworks|Randomized Experiment of Playworks|Completed||N/A|2278|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-11 00:12:50.747446|2017-10-11 00:12:50.747446
NCT02192268|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-02-22|||August 1, 2017||2017-08-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|PEP/HFOO||Assesment of the Effectiveness of High Frequency Oral Oscillation and Mask of PEP in Children With Pneumonia|ASSESSMENT OF THE EFFECTIVENESS OF HIGH FREQUENCY ORAL OSCILLATION AND MASK OF PEP IN CHILDREN WITH PNEUMONIA|Not yet recruiting||N/A|30|Anticipated|Hospital Sirio-Libanes||3|||f||||t||||||||||2017-10-11 00:12:50.876905|2017-10-11 00:12:50.876905
NCT02192255|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-07-15|||January 2012||2012-01-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||SUPREME-DM (Diabetes Mellitis) Treatment Study|An Intervention to Feedback 'Early' Non-Adherence Data to ImproveCardiovascular Disease Risk Factor Outcomes in Patients With Diabetes|Completed||N/A|2378|Actual|HealthPartners Institute||2|||f||||f||||||||||2017-10-11 00:12:50.988944|2017-10-11 00:12:50.988944
NCT02192242|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-15|||June 2007||2007-06-01|July 2014|2014-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Investigating a Model for Acute Ischemic Pain in Humans|Investigating a Model for Acute Ischemic Pain in Humans|Completed||N/A|11|Actual|Ludwig-Maximilians - University of Munich||1|||f||||f||||||||||2017-10-11 00:12:51.085335|2017-10-11 00:12:51.085335
NCT02192229|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-07-14|||August 2014||2014-08-01|July 2014|2014-07-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Efficacy of the Dose Regimen of Oral Vitamin D 50,000 IU in the Treatment of Vitamin D Deficiency|Safety and Efficacy Evaluation of the Dose Regimen of Vitamin D 50,000 IU(Biodal) Tablet Supplementation in the Treatment of Population With Vitamin D Deficiency.|Unknown status|Not yet recruiting|Phase 2|80|Anticipated|Hayat Pharmaceutical Co. PLC||2|||f||||t||||||||||2017-10-11 00:12:51.177385|2017-10-11 00:12:51.177385
NCT02192216|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2015-09-01|||February 2014||2014-02-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|September 2015|Actual|2015-09-01||Interventional|||The Effect of Resistance Training and Aerobic Training on Body Composition During Chemotherapy|The Effect of Resistance Training and Aerobic Training on Body Composition During Chemotherapy|Terminated||N/A|16|Anticipated|Department of Public Health, Denmark||1||Recruiting issues and limited personel ressources|f||||t||||||||||2017-10-11 00:12:51.307503|2017-10-11 00:12:51.307503
NCT02192203|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-27|||April 1, 2014|Actual|2014-04-01|June 2017|2017-06-01|July 15, 2014|Actual|2014-07-15|July 15, 2014|Actual|2014-07-15||Interventional|||A Safety Study to Investigate the Skin Sensitization Potential of MFC51123|Safety Study to Investigate the Skin Sensitization Potential of MFC51123|Completed||Phase 1|227|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 00:12:51.448727|2017-10-11 00:12:51.448727
NCT02192190|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2015-09-03||2015-09-03|July 2014||2014-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain|A Phase 2, Randomized, Double-Blind, Placebo and Active-Controlled Trial of LY2951742 in Patients With Mild to Moderate Osteoarthritis Pain of the Knee|Terminated||Phase 2|268|Actual|Eli Lilly and Company||6||Interim assessment: Lack of efficacy|f||||t||||||||||2017-10-11 00:12:51.584252|2017-10-11 00:12:51.584252
NCT02192177|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2014-07-14|||September 2013||2013-09-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.|Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.|Unknown status|Recruiting|N/A|50|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||2||f||||t||||||None Retained|"     Maternal venous and umbilical cord blood.   "|||2017-10-11 00:12:51.786181|2017-10-11 00:12:51.786181
NCT02192164|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-04-11|2017-04-11||November 2013||2013-11-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational||All treated participants with available post-baseline documentation.|Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis|Non-interventional Study Of The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis|Completed||N/A|126|Actual|Pfizer|Prioritization of outcome measures as primary and secondary was based on the study team’s discretion.||1||f||||f||||||||||2017-10-11 00:12:51.896414|2017-10-11 00:12:51.896414
NCT02192151|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2014-07-14|||October 2011||2011-10-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Observational|||Study of PHN131 in Healthy Volunteers|The Pharmacokinetic and Bioavailability Studies of PHN131, an Oral Formulation of Nalbuphine Hydrochloride, in Healthy Volunteers|Terminated||N/A|16|Actual|PhytoHealth Corporation|||1|Not completed its inspection.(CSR completed)|f||||f||||||||||2017-10-11 00:12:52.314773|2017-10-11 00:12:52.314773
NCT02192138|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-14|||April 2014||2014-04-01|June 2014|2014-06-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Pathophysiological Effects of Intrapleural Pressure Changes During Therapeutic Thoracentesis|Ventilation, Gas Exchange and Cardiac Function in Relation to Intrapleural Pressure Changes in Patients Undergoing Therapeutic Thoracentesis|Unknown status|Recruiting|N/A|60|Anticipated|Medical University of Warsaw||1|||f||||f||||||||||2017-10-11 00:12:52.399272|2017-10-11 00:12:52.399272
NCT02192125|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-09-14|||January 2014||2014-01-01|May 2015|2015-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|REWIRE||REWIRE - Rehabilitative Wayout In Responsive Home Environments, A Pilot Trial|Phase 1 REWIRE - Rehabilitative Wayout In Responsive Home Environments, A Pilot Trial|Completed||Early Phase 1|17|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 00:12:52.526395|2017-10-11 00:12:52.526395
NCT02192112|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-03-22|||June 2014||2014-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Advanced XLIF Monitoring Pilot Study|Evaluation of Transcutaneous Stimulation of Lumbosacral Nerve Roots: A Pilot Study|Enrolling by invitation||N/A|20|Anticipated|NuVasive|||1||f||||f||||||||||2017-10-11 00:12:52.645581|2017-10-11 00:12:52.645581
NCT02192099|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-10-03|||September 8, 2014|Actual|2014-09-08|October 2017|2017-10-01|October 15, 2019|Anticipated|2019-10-15|October 15, 2019|Anticipated|2019-10-15||Interventional|||Open Label Extension for GLYX13-C-202, NCT01684163|Phase 2, Open Label Extension for Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder Previously Treated With GLYX-13 (Extension of GLYX13-C-202, NCT01684163)|Active, not recruiting||Phase 2|61|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:12:52.735315|2017-10-11 00:12:52.735315
NCT02192086|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-14|||August 2012||2012-08-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Goal Directed Fluid Administration for Kidney Transplantation|The Effect of Non-Invasive Goal Directed Fluid Administration on Graft Function in Kidney Transplantation|Completed||Early Phase 1|21|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 00:12:52.845289|2017-10-11 00:12:52.845289
NCT02192073|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-01-11|||May 2014||2014-05-01|January 2016|2016-01-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Analysis of Suprapectoral and Subpectoral Biceps Tenodesis|Prospective Analysis of Arthroscopic Suprapectoral and Open Subpectoral Biceps Tenodesis: 1 Year Follow-Up|Recruiting||N/A|60|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 00:12:52.955886|2017-10-11 00:12:52.955886
NCT02192060|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-07-14|||May 2013||2013-05-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy of a Triclosan Formulation to Control the Initial Subgingival Biofilm Formation|Efficacy of a Triclosan Formulation to Control the Initial Subgingival Biofilm Formation|Completed||N/A|28|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 00:12:53.107555|2017-10-11 00:12:53.107555
NCT02192047|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-15|||September 2012||2012-09-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Chronic Effects of Natural and Interesterified Fats Margarine on Insulin Sensitivity and Selected Markers of Cardiovascular Diseases (CVD)|Chronic Effects of Natural Palm-based Margarine and Interesterified Palm- and Soy-based Margarine on Insulin Sensitivity and Selected Markers of Cardiovascular Diseases (CVD)|Completed||N/A|85|Actual|Malaysia Palm Oil Board||3|||f||||t||||||||||2017-10-11 00:12:53.377472|2017-10-11 00:12:53.377472
NCT02192034|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-10-26|||March 2013||2013-03-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Optimizing Navigation to Successful Colorectal Cancer Screening|Optimizing Navigation to Successful Colorectal Cancer Screening|Completed||N/A|156|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 00:12:53.489848|2017-10-11 00:12:53.489848
NCT02192021|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-03-23|||January 2016||2016-01-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|MNA-D||Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)|Phase I, Single-Arm, Open-Label, Dose Escalation Trial of MNA-Doxorubicin (MNA-D) in Patients-Subjects With Cutaneous T-cell Lymphoma (CTCL)|Recruiting||Phase 1|54|Anticipated|University of Pittsburgh||1|||f||||t||||||||No||2017-10-11 00:12:53.586765|2017-10-11 00:12:53.586765
NCT02192008|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-05-23|||December 2014||2014-12-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study|Investigating the Mechanisms and Determinants of Systemic and Mucosal Immunity to Salmonella Typhi and Salmonella Paratyphi A in naïve and Previously Exposed Individuals - A Challenge and Rechallenge Study|Recruiting||N/A|130|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-11 00:12:53.715056|2017-10-11 00:12:53.715056
NCT02191995|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-03-10|||July 2014||2014-07-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|TEP||Yoga in the Treatment of Eating Disorders: a Randomized Trial|Yoga in the Treatment of Eating Disorders: a Randomized Trial|Completed||N/A|38|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:12:53.842814|2017-10-11 00:12:53.842814
NCT02191982|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-09-11|||June 2014||2014-06-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|S-PACT||The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older|A Randomized, Wait-list Controlled Clinical Trial: the Effect of a Physical Activity Program on Fatigue After Potentially Curative Chemotherapy Among Cancer Survivors Age 65 or Older -- PACT (Physical Activity After Chemotherapy)|Completed||N/A|44|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:12:53.946264|2017-10-11 00:12:53.946264
NCT02191969|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-09-11|||June 2014||2014-06-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer|The Impact of a Physical Activity Intervention in Older Patients Undergoing Adjuvant Chemotherapy for Colorectal Cancer: a Randomized, Controlled Trial|Recruiting||N/A|40|Anticipated|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:12:54.051071|2017-10-11 00:12:54.051071
NCT02191956|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-10-02|||April 2013||2013-04-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|TE-HNC||Technology to Enhance Treatment for Early Conduct Problems in Low Income Families|Technology to Enhance Treatment for Early Conduct Problems in Low Income Families|Recruiting||N/A|102|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:12:54.168785|2017-10-11 00:12:54.168785
NCT02191943|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-01-22|||November 2014||2014-11-01|July 2014|2014-07-01|December 2019|Anticipated|2019-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Lesion Progression of Approximal Caries After Resin Infiltration|Long-term Bi-center Trial to Compare the Radiological Cavity Progression of Approximal Caries Following Infiltration or Standard Treatment|Withdrawn||N/A|0|Actual|DMG Dental Material Gesellschaft mbH||2|||f||||f||||||||||2017-10-11 00:12:54.272418|2017-10-11 00:12:54.272418
NCT02191930|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-05-10|||September 2015|Actual|2015-09-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|B-CAP||Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma|Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma - a GHSG-NLG Intergroup Phase II Trial -|Recruiting||Phase 2|70|Anticipated|University of Cologne||2|||f||||||||||||||2017-10-11 00:12:54.372377|2017-10-11 00:12:54.372377
NCT02191904|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-07-14|||January 2011||2011-01-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Laryngoscope Types and The Cervical Motion||Completed||N/A|150|Actual|Trakya University||3|||f||||||||||||||2017-10-11 00:12:54.528365|2017-10-11 00:12:54.528365
NCT02191891|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-10-03|||October 21, 2014|Actual|2014-10-21|October 2017|2017-10-01|March 2, 2018|Anticipated|2018-03-02|March 2, 2018|Anticipated|2018-03-02||Interventional|||Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)|A Phase Ib Open-label Clinical Trial of Once Daily Oral Treatment of Afatinib Plus Weekly Intravenous Infusion of Xentuzumab (BI 836845) in Patients With EGFR Mutant Non-small Cell Lung Cancer With Progression Following Prior EGFR Tyrosine Kinase Inhibitors|Recruiting||Phase 1|34|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:12:54.5866|2017-10-11 00:12:54.5866
NCT02191878|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-07-20|||June 2014||2014-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma|Open-Label, Multi-Center, Phase 1, Dose Escalation Study With Phase 2 Expansion Cohort to Determine the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|43|Actual|Arbutus Biopharma Corporation||1|||f||||f||||||||||2017-10-11 00:12:54.700138|2017-10-11 00:12:54.700138
NCT02191865|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2015-12-21|2015-12-21||July 2014||2014-07-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional||Treated set: The treated set (TS) included all subjects who were dispensed study medication and were documented to have taken atleast one dose of investigational treatment.|Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers|Pharmacokinetics, Safety and Tolerability of Nintedanib Single Oral Dose in Male and Female Patients With Different Degrees of Hepatic Impairment (Child-Pugh Classification A and B) as Compared With Nintedanib Administration to Male and Female Healthy Subjects (a Non-blinded, Parallel Group Study of Phase I)|Completed||Phase 1|33|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:12:54.834796|2017-10-11 00:12:54.834796
NCT02191852|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-16|||June 1999||1999-06-01|July 2014|2014-07-01||||October 1999|Actual|1999-10-01||Interventional|||Pharmacokinetic Study of Seresis® in the Skin in Healthy Young Female Volunteers|A Pharmacokinetic Study on the Antioxidant Activity of Seresis® in the Skin: an Open, Uncontrolled, Non-randomized Intra-individual Pilot Trial in Healthy, Young Female Volunteers|Completed||Phase 1|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:12:55.240706|2017-10-11 00:12:55.240706
NCT02191839|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-15|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery|Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury and Post Operative Bleeding in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: Double-blind, Placebo-controlled Pilot Study|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Soroka University Medical Center||2|||f||||t||||||||||2017-10-11 00:12:57.223517|2017-10-11 00:12:57.223517
NCT02191826|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-11-29|||July 2014||2014-07-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study of SOM0226 in Familial Amyloid Polyneuropathy|Study of SOM0226 in Familial Amyloid Polyneuropathy (FAP) Patients and Asymptomatic Carriers to Evaluate Protein Stabilization Activity|Completed||Phase 1/Phase 2|17|Actual|SOM Biotech SL||2|||f||||f||||||||||2017-10-11 00:12:57.38846|2017-10-11 00:12:57.38846
NCT02191813|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-16|||March 2000||2000-03-01|July 2014|2014-07-01||||July 2000|Actual|2000-07-01||Interventional|||Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers|The Ability of Seresis to Act as a Skin Protection Agent: a Double-blind, Parallel Group, Placebo-controlled Trial in Healthy, Young Female Volunteers|Completed||Phase 2|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:57.486245|2017-10-11 00:12:57.486245
NCT02191800|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-04-18|||September 2014||2014-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:12:57.577114|2017-10-11 00:12:57.577114
NCT02191787|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-16|||March 1998||1998-03-01|July 2014|2014-07-01||||May 1998|Actual|1998-05-01||Interventional|||Pharmacokinetic-pharmacodynamic Assessment of Seresis® in Healthy Volunteers|Pharmacokinetic-pharmacodynamic Assessment of Seresis® o.d.: an Open, Uncontrolled, Non-randomised Intraindividual Pilot-study|Completed||Phase 1|10|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:12:57.62401|2017-10-11 00:12:57.62401
NCT02191774|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-03-03|||September 2014||2014-09-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Medical Abortion up to 10 Weeks Gestation at Home|Medical Abortion up to 10 Weeks Gestation at Home|Recruiting||N/A|600|Anticipated|Karolinska Institutet|||2||f||||t||||||||No||2017-10-11 00:12:57.709906|2017-10-11 00:12:57.709906
NCT02191761|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-09-18|||June 2014||2014-06-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer|Phase1, Open-Label, Dose Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer|Suspended||Phase 1|25|Anticipated|Samumed LLC||1||pending results of a separate study|f||||f||||||||||2017-10-11 00:12:57.820832|2017-10-11 00:12:57.820832
NCT02191748|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-07-21|||September 2014||2014-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo|Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo|Terminated||Phase 2/Phase 3|22|Actual|Rutgers, The State University of New Jersey||3||"Principal investigator made the decision to close study and not submit a renewal. Lack of fixed   research personnel to carry out the study effectively."|f||||f||||||||||2017-10-11 00:12:57.9226|2017-10-11 00:12:57.9226
NCT02191735|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-01-07|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|C-POC||RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care|Performance Evaluation of the RAMP® Cardiac Tests / RAMP® 200 in a Point-Of-Care Setting (C-POC)|Completed||N/A|719|Actual|Response Biomedical Corp.|||4||f||||f||||||Samples With DNA|"     EDTA plamsa specimens   "|||2017-10-11 00:12:58.080375|2017-10-11 00:12:58.080375
NCT02191722|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-05-09|||August 2014||2014-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||"Medikidz Explain JIA Comic Book- Hebrew"|Evaluating the Efficacy of a Comic Book as an Educating Tool for Children With Juvenile Idiopathic Arthritis|Completed||N/A|4|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 00:12:58.214203|2017-10-11 00:12:58.214203
NCT02191709|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-14|||January 2009||2009-01-01|July 2014|2014-07-01||||February 2009|Actual|2009-02-01||Interventional|||Relative Bioavailability of Dextromethorphan Syrup in Comparison to Dextromethorphan Soft Pastilles in Healthy Male and Female Subjects|A Phase I, Single Dose, Controlled Two-way Crossover Study to Evaluate the Relative Bioavailability of Orally Administered Dextromethorphan Syrup (21 mg Dextromethorphan Hydrobromide Monohydrate) in Comparison to Dextromethorphan Soft Pastilles (21 mg Dextromethorphan Hydrobromide Monohydrate) in Healthy Male and Female Subjects Who Are Extensive Metabolisers for Cytochrom P450 (CYP) 2D6|Completed||Phase 1|18|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:12:58.453153|2017-10-11 00:12:58.453153
NCT02191683|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-05-20|||July 2014||2014-07-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01|21 Months|Observational [Patient Registry]|FOETALforNCD||Foetal Exposure and Epidemiological Transition: Role of Anaemia in Early Life for Non-communicable Diseases Later|Foetal Exposure and Epidemiological Transition: the Role of Anaemia in Early Life for Non-communicable Diseases in Later Life|Active, not recruiting||N/A|1748|Actual|University of Copenhagen|||2||f||||f||||||Samples With DNA|"     Periperal vein blood, umbilical cord blood, placentas   "|||2017-10-11 00:12:58.623494|2017-10-11 00:12:58.623494
NCT02191670|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-14|||April 2005||2005-04-01|July 2014|2014-07-01||||January 2006|Actual|2006-01-01||Observational|||Observational Study of METALYSE® in Patients With Acute Myocardial Infarction In Russian Federation|A Post-registration, Open Label Therapeutic Observational Study of METALYSE® in Patients With Acute Myocardial Infarction In Russian Federation.|Completed||N/A|60|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:12:58.732753|2017-10-11 00:12:58.732753
NCT02191657|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-14|||November 2006||2006-11-01|November 2007|2007-11-01|April 2010|Actual|2010-04-01|May 2008|Actual|2008-05-01||Interventional|||Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects|A Double Blind, Placebo-controlled, Dose-escalating, Multiple Dose Study, Investigating the Safety, Antiretroviral Activity, Tolerability and Pharmacokinetic Profile of Deferiprone When Administered in Healthy Volunteers and Asymptomatic HIV Infected Subjects|Completed||Phase 1|26|Actual|ApoPharma||3|||f||||t||||||||||2017-10-11 00:12:58.823459|2017-10-11 00:12:58.823459
NCT02191644|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-15|||January 2013||2013-01-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Dietary Intervention Replacing Carbohydrate With Protein and Fat Has Greater Effect on Peripheral Blood Mononuclear Cell Metabolites Than on Plasma Metabolites in Patients With Prediabetes or Type-2 Diabetes|Dietary Intervention Replacing Carbohydrate With Protein and Fat Has Greater Effect on Peripheral Blood Mononuclear Cell Metabolites Than on Plasma Metabolites in Patients With Prediabetes or Type-2 Diabetes|Completed||Phase 2|82|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:12:58.950965|2017-10-11 00:12:58.950965
NCT02191631|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-12-21|||August 2014||2014-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|BiPOCD||Internet-delivered CBT for Adolescents With OCD: A Randomized Controlled Study|Internet-delivered Cognitive Behavior Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Study|Completed||N/A|67|Actual|Karolinska Institutet||2|||f||||f||||||||Undecided||2017-10-11 00:12:59.066228|2017-10-11 00:12:59.066228
NCT02191618|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-09-26|||August 2014||2014-08-01|September 2016|2016-09-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|WEB-IT||The WEB-IT Clinical Study|The WEB® Intrasaccular Therapy Study (WEB-IT)|Active, not recruiting||N/A|150|Actual|Sequent Medical, Inc||1|||f||||t||||||||||2017-10-11 00:12:59.181488|2017-10-11 00:12:59.181488
NCT02191605|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-10-05|||September 2015||2015-09-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy|Computer-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Marijuana Use in Pregnancy: Planning a Stage II Trial|Active, not recruiting||Phase 1|60|Actual|Wayne State University||5|||f||||t||||||||||2017-10-11 00:12:59.369117|2017-10-11 00:12:59.369117
NCT02191592|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-03-01|||July 2014||2014-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|July 2015|Actual|2015-07-01|6 Weeks|Observational [Patient Registry]|||EMA-Defined Tinnitus Subgroups|Identification of Unique Tinnitus Subgroups Using Ecological Momentary Assessment (EMA).|Completed||N/A|40|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 00:12:59.482826|2017-10-11 00:12:59.482826
NCT02191566|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-08-29|||November 2014||2014-11-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|SOHUG||S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy|A Phase II Study of Adjuvant Chemotherapy of S-1 With Oxaliplatin in Gastric Cancer at Stage IIIB/ IV (AJCC 6th) After D2 Resection|Recruiting||Phase 2|30|Anticipated|Kangbuk Samsung Hospital||1|||f||||f||||||||||2017-10-11 00:12:59.775875|2017-10-11 00:12:59.775875
NCT02191553|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-07-31|||September 2014||2014-09-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|September 2015|Actual|2015-09-01||Interventional|||Differential Effect of Four Mindfulness Exercises|Differential Effect of Four Mindfulness Exercises on Mindfulness, Cerebral Cartography and Heart Ratio Variability|Completed||N/A|80|Actual|Grupo de Investigación en salud mental en Atención Primaria||4|||f||||f||||||||||2017-10-11 00:12:59.887485|2017-10-11 00:12:59.887485
NCT02191540|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-21|||January 2011||2011-01-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients|A Phase 3, Multi-Center, Single-Arm, Open-Label Study For The Safety And Efficacy Of Mistletoe Extract (AbnobaViscum® Injection) In Malignant Pleural Effusions|Completed||Phase 3|68|Actual|Abnoba Korea||1|||f||||f||||||||||2017-10-11 00:13:00.031306|2017-10-11 00:13:00.031306
NCT02191527|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-10-15|||September 2013||2013-09-01|October 2014|2014-10-01||||October 2014|Actual|2014-10-01||Interventional|||Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique|Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services and Their Impact on Mother and Child Health Outcomes in Cabo Delgado Province, Mozambique|Completed||N/A|600|Anticipated|Elizabeth Glaser Pediatric AIDS Foundation||2|||f||||f||||||||||2017-10-11 00:13:00.167918|2017-10-11 00:13:00.167918
NCT02191514|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-01-04|||July 2014||2014-07-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Prehospital Management of Stroke Patients by Emergency Medical Services|Prehospital Management of Stroke Patients by Emergency Medical Services - an Evaluation of Emergency Medical Dispatch and Ambulance Personnel.|Completed||N/A|2653|Actual|Emergency Medical Services, Capital Region, Denmark|||1||f||||||||||||||2017-10-11 00:13:00.273642|2017-10-11 00:13:00.273642
NCT02191501|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-09-19|||March 2014||2014-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity|Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity|Suspended||N/A|15|Anticipated|Northwell Health||1||Suspended as we are looking for more durable method/device|f||||t||||||||||2017-10-11 00:13:01.134549|2017-10-11 00:13:01.134549
NCT02191488|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-02-24|||July 2014||2014-07-01|February 2016|2016-02-01||||July 2019|Anticipated|2019-07-01||Interventional|||ALA-induced PpIX Fluorescence During Brain Tumor Resection|Quantification of ALA-induced PpIX Fluorescence During Brain Tumor Resection|Recruiting||Phase 1|540|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 00:13:01.260005|2017-10-11 00:13:01.260005
NCT02191475|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-13|||May 2014||2014-05-01|May 2014|2014-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|Tigecycline||Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock|Tigecycline (Hai Zheng Li Xing®) Combined With Piperacillin/Tazobactam (Tazocin ®) Empirical Treatment of Severe Sepsis and Septic Shock in Patients With Abdominal Infection|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 00:13:01.378452|2017-10-11 00:13:01.378452
NCT02191462|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-09-08|||July 2014||2014-07-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|14NBHC||A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects|A Randomized, Double-blind, Cross-over Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects|Completed||Phase 1|12|Actual|KGK Synergize Inc.||3|||f||||||||||||||2017-10-11 00:13:01.53047|2017-10-11 00:13:01.53047
NCT02191449|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2015-02-23|||June 2014||2014-06-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||The Influence of Preoperative Warfarin Medication on Thromboelastography and Blood Transfusion|Influence of Warfarin on Thromboelastography and Transfusion|Completed||N/A|107|Actual|Konkuk University Medical Center|||1||f||||t||||||||||2017-10-11 00:13:01.676063|2017-10-11 00:13:01.676063
NCT02191436|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2015-10-19|||May 2015||2015-05-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01|1 Day|Observational [Patient Registry]|ADHERENCE||Adherence to Treatment in Hemophilia|Psychosocial Factors and Adherence to Treatment in Patients With Hemophilia. A Multicenter Study|Unknown status|Recruiting|N/A|200|Anticipated|Universidad de Murcia|||1||f||||f||||||||||2017-10-11 00:13:01.771292|2017-10-11 00:13:01.771292
NCT02191423|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-13|||January 2015||2015-01-01|July 2014|2014-07-01||||June 2016|Anticipated|2016-06-01||Interventional|||Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression|The Effect of Oxytocin on Brain Attachment and Empathy Networks, and the Association Between the Brain Response and Treatment Outcome of Brief Dyadic Psychotherapy - in Women Suffering From Postpartum Depression|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-11 00:13:01.906084|2017-10-11 00:13:01.906084
NCT02191410|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2015-04-03|||June 2015||2015-06-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||Nondependent Lung Ventilation and Fluid Responsiveness|Comparative Study of the Non-dependent Continuous Positive Airway Pressure and High-frequency Positive-pressure Ventilation on Fluid Responsiveness During One-lung Ventilation for Thoracoscopic Surgery|Unknown status|Not yet recruiting|Phase 3|62|Anticipated|Dammam University||2|||f||||t||||||||||2017-10-11 00:13:02.057181|2017-10-11 00:13:02.057181
NCT02191384|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-03-05|||July 2014||2014-07-01|March 2015|2015-03-01||||May 2015|Anticipated|2015-05-01||Interventional|||Comparison of Orcinoside With Placebo in Treatment of MDD|Proof Of Concept Study of Orcinoside in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial|Unknown status|Recruiting|Phase 2|210|Anticipated|Shanghai Mental Health Center||7|||f||||t||||||||||2017-10-11 00:13:02.365027|2017-10-11 00:13:02.365027
NCT02191371|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-10-12|||July 2014||2014-07-01|August 2014|2014-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Anesthetics on Oxygenation and Microcirculation During One-lung Ventilation|Effect of Anesthetics on Oxygenation and Microcirculation During One-lung Ventilation|Completed||N/A|104|Actual|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-11 00:13:02.557866|2017-10-11 00:13:02.557866
NCT02191358|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-02-27|||October 2014||2014-10-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01|4 Months|Observational [Patient Registry]|IMPACT||YouScript IMPACT Registry|YouScript IMPACT (Improving Medication Protocols and Abating Cost of Treatment) Registry|Completed||N/A|800|Actual|Genelex Corporation|||2||f||||f||||||||||2017-10-11 00:13:02.683179|2017-10-11 00:13:02.683179
NCT02191345|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2017-02-18|||July 2014||2014-07-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effectiveness of Guided Imagery for a Nonprofit's Employees|A Randomized Controlled Trial Measuring the Effectiveness of Prerecorded Guided Imagery in Reducing Compassion Fatigue, Burnout, Perceived Stress, and State Anxiety of a Mental Health Nonprofit's Employees|Completed||N/A|69|Actual|FrontLine Service||2|||f||||t||||||||No||2017-10-11 00:13:02.837391|2017-10-11 00:13:02.837391
NCT02191332|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||December 1999||1999-12-01|July 2014|2014-07-01||||November 2001|Actual|2001-11-01||Observational|||Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen|Collecting Data in Patients With HIV Infection Type 1 After Switching From a Protease Inhibitor-containing Therapy Regimen and a Viral Load Below Detection Level to a Viramune®-Containing Therapy Regimen|Completed||N/A|147|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:13:02.935857|2017-10-11 00:13:02.935857
NCT02191150|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-02-05|||June 2014||2014-06-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|SHADE||Study of Haemodialysis Patients Switching From Aranesp to Biosimilar|Retrospective Study of Stable Haemodialysis Patients Switched From Darbepoetin Alfa to Epoetin Alfa Biosimilar|Completed||N/A|272|Actual|Amgen|||1||f||||f||||||||||2017-10-11 00:13:04.325408|2017-10-11 00:13:04.325408
NCT02191319|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||January 2002||2002-01-01|July 2014|2014-07-01||||August 2004|Actual|2004-08-01||Observational|||Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens|Observational Study With Antiretroviral Treated Patients Switching Therapy Because of Therapeutic Reasons From Protease Inhibitor- or NNRTI-containing Regimens to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens|Completed||N/A|55|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:13:03.004099|2017-10-11 00:13:03.004099
NCT02191306|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2014-07-14|||October 2013||2013-10-01|July 2014|2014-07-01||||March 2014|Actual|2014-03-01|1 Week|Observational [Patient Registry]|||Utilizing Computed Tomographic Angiography to Evaluate Coronary Artery Disease in Patients on Long-Term Antiretroviral Therapy||Completed||N/A|78|Actual|Florida State University|||2||f||||||||||||||2017-10-11 00:13:03.073903|2017-10-11 00:13:03.073903
NCT02191293|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||May 2002||2002-05-01|July 2014|2014-07-01||||September 2006|Actual|2006-09-01||Observational|||Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®|Long-term Observational Study in Patients Under Anti-retroviral Combination Therapy Who Were Switched From Protease Inhibitors or Other NNRTI to Viramune® Plus Two Nucleoside Reverse Transcriptase Inhibitors (NRTI) for Reasons of Therapy. (Long-Term Switch)|Completed||N/A|228|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:13:03.158395|2017-10-11 00:13:03.158395
NCT02191280|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||April 1998||1998-04-01|July 2014|2014-07-01||||September 1998|Actual|1998-09-01||Interventional|||Antistax® in Patients With Chronic Venous Insufficiency|The Ability of Antistax® to Improve Chronic Venous Insufficiency (CVI) I and II in Male and Female Patients: a Dose Response Study|Completed||Phase 2|260|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:13:03.227597|2017-10-11 00:13:03.227597
NCT02191267|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2017-02-02|||January 2015||2015-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tau Imaging of Chronic Traumatic Encephalopathy|Tau Imaging of Chronic Traumatic Encephalopathy|Enrolling by invitation||Phase 2|30|Anticipated|Brigham and Women's Hospital||3|||f||||f||||||||||2017-10-11 00:13:03.302294|2017-10-11 00:13:03.302294
NCT02191254|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||April 2004||2004-04-01|July 2014|2014-07-01||||October 2004|Actual|2004-10-01||Interventional|||Efficacy and Tolerability of Antistax® in Male and Female Patients Suffering From Chronic Venous Insufficiency|A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial to Evaluate Efficacy and Tolerability of Antistax® Film Coated Tablets, 360 mg/Day Orally, in Male and Female Patients Suffering From Chronic Venous Insufficiency|Completed||Phase 3|245|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:13:03.442117|2017-10-11 00:13:03.442117
NCT02191241|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||August 2001||2001-08-01|July 2014|2014-07-01||||September 2004|Actual|2004-09-01||Interventional|||Pharmacokinetics of a Single Oral Dose of 1,800 mg Red Vine Leaf Extract (Antistax®)|An Open, Uncontrolled Trial in Healthy Volunteers to Explore the Plasma and Urinary Pharmacokinetics of a Single Oral Dose of 1,800 mg Red Vine Leaf Extract (Antistax®)|Completed||Phase 1|12|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:13:03.537048|2017-10-11 00:13:03.537048
NCT02191228|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||April 2008||2008-04-01|June 2014|2014-06-01||||February 2010|Actual|2010-02-01||Interventional|||Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple 5 mg Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function in a Monocentric, Open, Parallel-group, Phase I Trial|Completed||Phase 1|51|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-11 00:13:03.613197|2017-10-11 00:13:03.613197
NCT02191215|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||June 2003||2003-06-01|July 2014|2014-07-01||||May 2004|Actual|2004-05-01||Observational|||Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS|Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS|Completed||N/A|442|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:13:03.732196|2017-10-11 00:13:03.732196
NCT02191202|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||June 2004||2004-06-01|July 2014|2014-07-01||||February 2006|Actual|2006-02-01||Observational|||Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression|Observational Study of the Impact on Quality-of-life of a Switch From a Virologically Effective Regimen to a Regimen Containing a Non-Nucleoside Reverse Transcriptase Inhibitor (QUALVI) Nevirapine (Viramune®) Clinical Phase IV|Completed||N/A|283|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:13:03.81356|2017-10-11 00:13:03.81356
NCT02191189|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||May 2005||2005-05-01|July 2014|2014-07-01||||January 2006|Actual|2006-01-01||Interventional|||Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract in Healthy Males|A Single-dose, 2-part, Open-label, Randomised, Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract|Completed||Phase 1|27|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:13:04.02876|2017-10-11 00:13:04.02876
NCT02191176|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||June 2009||2009-06-01|July 2014|2014-07-01||||July 2009|Actual|2009-07-01||Interventional|||Study to Investigate Safety With Special Emphasis on ECG Effects and Tolerability After Oral Doses of Dextromethorphan Hydrobromide Monohydrate in Healthy Male and Female Subjects|A Phase I Multiple Dose Trial to Investigate Safety With Special Emphasis on ECG Effects and Tolerability After Oral Doses of 30 mg q.i.d. and 90 mg q.i.d. Dextromethorphan Hydrobromide Monohydrate (2 mg/mL Syrup) in Healthy Male and Female Subjects for 2 Days Followed by a Morning Dose (Extensive Metabolisers of CYP 2D6) and for 10 Days Followed by a Morning Dose (Poor Metabolisers of CYP 2D6) (Randomised, Double-blind, Placebo-controlled Groups)|Completed||Phase 1|48|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:13:04.132843|2017-10-11 00:13:04.132843
NCT02191163|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-15|2014-07-15|||April 2002||2002-04-01|July 2014|2014-07-01||||August 2002|Actual|2002-08-01||Interventional|||Efficacy of Antistax® in Improving Microcirculation of the Skin in the Leg in Patients Suffering From Chronic Venous Insufficiency|A 17 Week, Randomised, Double-blind, Placebo Controlled Cross-over Trial to Evaluate the Efficacy of Antistax® Film Coated Tablets (Extr. Vitis Vinifera Siccum), 360 mg/Day p.o. in Improving Microcirculation of the Skin in the Leg of Male and Female Patients Suffering From Chronic Venous Insufficiency|Completed||Phase 2|71|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:13:04.222908|2017-10-11 00:13:04.222908
NCT02191124|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-15|||June 2011||2011-06-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial|Measurement-based Care vs. Standard Care for Major Depressive Disorder: a Randomized Controlled Trial With Masked Raters|Completed||Phase 4|164|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 00:13:04.687179|2017-10-11 00:13:04.687179
NCT02191098|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-04-19|||June 2015||2015-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALT-803||Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People|Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People on Optimized ART With Undetectable Plasma HIV RNA|Recruiting||Phase 1|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-11 00:13:04.87122|2017-10-11 00:13:04.87122
NCT02191085|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2017-03-21|||September 2014||2014-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||"Evaluation of a Fast Track Respiratory Therapy Clinic for Patients With Suspected Severe Sleep-Disordered Breathing"|"Evaluation of a Fast Track Respiratory Therapy Clinic for Patients With Suspected Severe Sleep-Disordered Breathing"|Active, not recruiting||N/A|164|Anticipated|University of Calgary||2|||f||||f||||||||Undecided||2017-10-11 00:13:04.969352|2017-10-11 00:13:04.969352
NCT02191072|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-14|||July 2014||2014-07-01|July 2014|2014-07-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria|Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria|Unknown status|Not yet recruiting|N/A|20|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 00:13:05.092686|2017-10-11 00:13:05.092686
NCT02191059|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2014-07-30|||July 2014||2014-07-01|July 2014|2014-07-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer|Single Arm, Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel as Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR:|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||t||||||||||2017-10-11 00:13:05.198196|2017-10-11 00:13:05.198196
NCT02191046|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2014-10-31|2014-07-15||March 2013||2013-03-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Eighty sinusitis children participated in the study. 74 participants were finally assessed. six participants were discontinue irrigated their nose during treatment due to the nasal symptoms score improve; one patient from squeezable bottle group, five patients from disposable syringe group.|Effect of Squeezable Bottle Nasal Irrigation Device in Children With Sinusitis|A Randomized- Controlled Study Comparing the Effect of Squeezable Bottle Nasal Irrigation Device With Syringe in Children With Sinusitis|Completed||N/A|80|Actual|Thammasat University||2|||f||||f||||||||||2017-10-11 00:13:05.311815|2017-10-11 00:13:05.311815
NCT02191033|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-04-27|2017-04-27||January 2015||2015-01-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Text Messaging for Smoking Cessation in College Health Clinics|Text Messaging to Augment Physician Brief Advice for Smoking Cessation in College Health Clinics|Completed||N/A|40|Actual|Yale University|This is a pilot and feasibility study.|2|||f||||f||||||||||2017-10-11 00:13:05.652758|2017-10-11 00:13:05.652758
NCT02191020|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-07-11|||February 2013||2013-02-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis|Multi-center, Randomized, Double Blind, Placebo Parallel-Controlled Study of the Efficacy and Safety of Total Glucosides of Paeony Combined With Acitretin Capsules to Treat Psoriasis Vulgaris|Completed||N/A|108|Actual|Xijing Hospital||2|||f||||||||||||||2017-10-11 00:13:05.972423|2017-10-11 00:13:05.972423
NCT02191007|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2014-07-11|||November 2013||2013-11-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis|Multi-center,Single Blind, Parallel-Controlled Study of the Efficacy and Safety of Calcipotriol Betamethasone Ointment Plus Calcipotriol Ointment in Sequential Therapy to Psoriasis Vulgaris|Completed||N/A|230|Actual|Xijing Hospital||3|||f||||||||||||||2017-10-11 00:13:06.059569|2017-10-11 00:13:06.059569
NCT02190994|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-05|2014-07-11|||August 2013||2013-08-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|||Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions|Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions|Unknown status|Recruiting|Phase 4|100|Anticipated|West China Hospital||4|||f||||f||||||||||2017-10-11 00:13:06.144374|2017-10-11 00:13:06.144374
NCT02190981|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-05-10|||July 2014||2014-07-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|February 2017|Actual|2017-02-01||Observational|||Point of Care Ultrasound for Suspected Small Bowel Obstruction in the Emergency Department|Point of Care Ultrasound for Suspected Small Bowel Obstruction in the Emergency Department|Active, not recruiting||N/A|106|Anticipated|WellSpan Health|||1||f||||f||||||||No||2017-10-11 00:13:06.261695|2017-10-11 00:13:06.261695
NCT02190968|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-09-07|||March 2015||2015-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance|Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance.|Active, not recruiting||Phase 3|460|Actual|University of Toronto||2|||f||||t||||||||||2017-10-11 00:13:06.371558|2017-10-11 00:13:06.371558
NCT02190955|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-07-11|||January 2013||2013-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01|1 Year|Observational [Patient Registry]|||Assessment of the Educational Experiences for Patients Newly Diagnosed With Nephrotic Syndrome|Assessment of the Educational Experience for Patients With Newly Diagnosed Nephrotic Syndrome|Completed||N/A|186|Actual|University of South Florida|||1||f||||f||||||||||2017-10-11 00:13:06.48239|2017-10-11 00:13:06.48239
NCT02190942|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-09-21|||September 2013||2013-09-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|1 Year|Observational [Patient Registry]|||VCRC Patient Contact Registry Patient-Reported Data Validation Study|VCRC Validation of Patient-Reported Diagnostic Data|Enrolling by invitation||N/A|140|Anticipated|University of South Florida|||1||f||||f||||||||||2017-10-11 00:13:06.546708|2017-10-11 00:13:06.546708
NCT02190929|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-07-11|||March 2012||2012-03-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01|1 Year|Observational [Patient Registry]|||Educational Needs of Patients With Systemic Vasculitis|Educational Needs of Patients With Systemic Vasculitis- an International Survey|Completed||N/A|386|Actual|University of South Florida|||1||f||||f||||||||||2017-10-11 00:13:06.646592|2017-10-11 00:13:06.646592
NCT02190916|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-07-11|||October 2011||2011-10-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01|1 Year|Observational [Patient Registry]|||Vasculitis Illness Perception (VIP) Study|Illness Perception, Fatigue, and Function in Systemic Vasculitis (The VCRC Vasculitis Perception (VIP) Study)|Completed||N/A|707|Actual|University of South Florida|||1||f||||f||||||||||2017-10-11 00:13:06.75175|2017-10-11 00:13:06.75175
NCT02190903|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-02-24|||October 2013||2013-10-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia|A Randomized Controlled Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia|Completed||Phase 4|15|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:13:06.842863|2017-10-11 00:13:06.842863
NCT02190890|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2017-07-11|||September 2013||2013-09-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|May 2014|Actual|2014-05-01||Interventional|||Dry Needling Dosage in the Treatment of Myofascial Neck Pain|Effectiveness of Different Deep Dry Needling Dosages on Pain and Postpunction Soreness in the Treatment of Patients With Cervical Myofascial Pain|Completed||Phase 2|150|Actual|Universidad Rey Juan Carlos||4|||f||||||||||||||2017-10-11 00:13:06.985727|2017-10-11 00:13:06.985727
NCT02190877|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-21|||April 2014||2014-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Monitoring Subjects With Fluid-Management Issues In the Home Environment|A Study for Monitoring Subjects With Fluid-Management Issues Using Repeated Measurements In the Home Environment|Completed||N/A|23|Actual|toSense, Inc.|||1||f||||f||||||||||2017-10-11 00:13:07.065389|2017-10-11 00:13:07.065389
NCT02190851|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-12-05|||April 2015||2015-04-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|September 2017|Anticipated|2017-09-01||Interventional|UROPARKTENS||Transcutaneous Electrical Nerve Stimulation (TENS) for Lower Urinary Tract Disorders in Parkinson's Syndrome|Evaluation of Treatment by Transcutaneous Electrical Nerve Stimulation (TENS) of the Posterior Tibial Nerve for Lower Urinary Tract Disorders in Parkinson's Syndrome|Recruiting||N/A|220|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||Undecided||2017-10-11 00:13:07.241174|2017-10-11 00:13:07.241174
NCT02190838|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2016-12-29|||April 2014||2014-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma|Phase II Multicenter Randomized Study to Compare Dacarbazine With Melatonin or Metformin Versus Dacarbazine in the First Line Therapy of Disseminated Melanoma|Recruiting||Phase 2|96|Anticipated|Petrov Research Institute of Oncology||3|||f||||t||||||||No||2017-10-11 00:13:07.507313|2017-10-11 00:13:07.507313
NCT02190825|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-10-27|||November 2014||2014-11-01|October 2015|2015-10-01||||April 2016|Anticipated|2016-04-01||Interventional|||Safety and Efficacy Study of the NeuGuide Device||Unknown status|Active, not recruiting|N/A|15|Actual|Pop Medical Solutions||1|||f||||||||||||||2017-10-11 00:13:07.628493|2017-10-11 00:13:07.628493
NCT02190812|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-13|||April 2013||2013-04-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|April 2015|Anticipated|2015-04-01||Interventional|||An Intelligent Evaluation of Wrist Strength for the Elderly People and Its Clinical Application|An Intelligent Evaluation of Wrist Strength for the Elderly People and Its Clinical Application|Unknown status|Recruiting|N/A|160|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:13:07.705351|2017-10-11 00:13:07.705351
NCT02190799|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-08-30|||May 2014||2014-05-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Anti-MERS-COV Convalescent Plasma Therapy|Anti-MERS-COV Convalescent Plasma Therapy|Active, not recruiting||Phase 2|20|Anticipated|King Abdullah International Medical Research Center||1|||f||||t||||||||||2017-10-11 00:13:07.804143|2017-10-11 00:13:07.804143
NCT02190786|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-10-16||||||October 2015|2015-10-01||||March 2015|Actual|2015-03-01||Interventional|||Phase II Exploratory Clinical Study of KUX-1151||Completed||Phase 2|||Kissei Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 00:13:07.892487|2017-10-11 00:13:07.892487
NCT02190773|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-13|||January 2010||2010-01-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Effect of Surgical Therapy on RANKL/OPG (Osteoprotegerin) System|Effect of Surgical Periodontal Therapy on the RANKL/OPG System : Do we Need Osteo-immune Modulation Targeting RANKL?|Completed||N/A|65|Actual|Hacettepe University|||3||f|||||||||||"     Gingival Crevicular fluid (GCF) is collected at baseline and 3 months after the surgical     treatment.   "|||2017-10-11 00:13:07.969165|2017-10-11 00:13:07.969165
NCT02190760|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2014-07-13|||September 2014||2014-09-01|July 2014|2014-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block.|Comparison Between Perineural and Systemic Effect of Dexamethasone as an Adjuvant for Prolongation of the Interscalene Brachial Plexus Block.|Unknown status|Not yet recruiting|N/A|90|Anticipated|Hillel Yaffe Medical Center||3|||f||||t||||||||||2017-10-11 00:13:08.060835|2017-10-11 00:13:08.060835
NCT02190747|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-13|2017-08-01|||July 2014||2014-07-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of a RARγ-Specific Agonist (Palovarotene) in the Treatment of Preosseous Flare-ups in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)|Active, not recruiting||Phase 2|40|Actual|Clementia Pharmaceuticals Inc.||4|||f||||t||||||||||2017-10-11 00:13:08.161323|2017-10-11 00:13:08.161323
NCT02190734|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-12-26|||May 2014||2014-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pushing Behaviors in Individuals Post-stroke|Inpatient Rehabilitation Treatments and Effect on Pushing Behaviors in Individuals Post-stroke|Recruiting||N/A|12|Anticipated|Shirley Ryan AbilityLab||1|||f||||f||||||||||2017-10-11 00:13:08.319098|2017-10-11 00:13:08.319098
NCT02190721|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-09-01|||May 12, 2015|Actual|2015-05-12|September 2017|2017-09-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04||Interventional|||A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement|A Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Efficacy, and Immunogenicity of Daily Subcutaneous Administration of 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement|Completed||Phase 2|50|Actual|Teva Pharmaceutical Industries||1|||f||||t|t|f||||||||2017-10-11 00:13:08.448073|2017-10-11 00:13:08.448073
NCT02190708|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2015-10-19|||June 2014||2014-06-01|July 2014|2014-07-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole|A Phase I, Open Label Study to Assess the Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole in Healthy Male Subjects|Completed||Phase 1|18|Actual|Probiodrug AG||1|||f||||f||||||||||2017-10-11 00:13:08.63943|2017-10-11 00:13:08.63943
NCT02190695|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-04-25|||April 2013||2013-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Leukemia SPORE Phase II 3-arm DAC Randomized Study for R/R and Elderly Acute AML and MDS|Leukemia SPORE Phase II Randomized Study of Decitabine Versus Decitabine and Carboplatin Versus Decitabine and Arsenic in Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Recruiting||Phase 2|130|Anticipated|Temple University||3|||f||||f||f||||||||2017-10-11 00:13:08.767375|2017-10-11 00:13:08.767375
NCT02190682|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2015-02-15|||October 2014||2014-10-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01|4 Months|Observational [Patient Registry]|||Data Collection for Prediction of Postoperative Chronic Pain for a Software|Data Collection for Prediction of Postoperative Chronic Pain for Establishing a Software by Using Data Mining Technology|Unknown status|Recruiting|N/A|2000|Anticipated|Istanbul University|||1||f||||t||||||||||2017-10-11 00:13:08.931973|2017-10-11 00:13:08.931973
NCT02190669|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-11-12|||June 2014||2014-06-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Exercise and Diabetes - an Observational Study of Exercise and Blood Glucose Control|Exercise and Diabetes - an Observational Study of Exercise and Blood Glucose Control|Completed||N/A|12|Actual|William Sansum Diabetes Center|||3||f||||f||||||||||2017-10-11 00:13:09.073367|2017-10-11 00:13:09.073367
NCT02190656|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-04-04|||May 2014||2014-05-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Observational|||Anterior Resection Syndrome Following Sphincter-preserving Surgery|Anterior Resection Syndrome Following Sphincter-preserving Surgery|Completed||N/A|1197|Actual|Queen Mary University of London|||1||f||||f||||||||||2017-10-11 00:13:09.163764|2017-10-11 00:13:09.163764
NCT02190643|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-04-05|||April 2013||2013-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Improving Nicotine Patch Adherence Among Latino HIV-Positive Smokers|Improving Nicotine Patch Adherence Among Latino HIV-Positive Smokers|Completed||N/A|40|Actual|RAND||2|||f||||f||||||||||2017-10-11 00:13:09.250635|2017-10-11 00:13:09.250635
NCT02190630|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-01-03|||December 2013||2013-12-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Study to Measure the Effect of Part Time Versus Full Time Orthodontic Appliance Wear|A Prospective Randomised Controlled Trial Investigating the Skeletal and Dental Effects of a Removable Brace That Works on the Upper and Lower Teeth at the Same Time Worn Part Time Versus Full Time|Active, not recruiting||N/A|62|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-10-11 00:13:09.344329|2017-10-11 00:13:09.344329
NCT02190617|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-05-08|||December 2014||2014-12-01|July 2014|2014-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|G2P||Guidelines to Practice: Reducing Asthma Health Disparities Through Guideline Implementation||Unknown status|Enrolling by invitation|N/A|550|Anticipated|Public Health - Seattle and King County||4|||f||||t||||||||||2017-10-11 00:13:09.444063|2017-10-11 00:13:09.444063
NCT02190604|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-07-18|2016-11-23||July 31, 2012|Actual|2012-07-31|July 2017|2017-07-01|November 30, 2015|Actual|2015-11-30|November 30, 2015|Actual|2015-11-30||Interventional|||Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients|A Randomized, Double Blind Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cystic Fibrosis Patients|Terminated||Phase 1/Phase 2|153|Actual|Novartis||20|||f||||t||||||||||2017-10-11 00:13:09.644127|2017-10-11 00:13:09.644127
NCT02190591|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-03-08|2016-10-03||May 2014||2014-05-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Use of Peanut Labor Ball Following Epidural Anesthesia|Use of Peanut Labor Ball for Pelvic Positioning for Nulliparous Patients Following Epidural|Completed||N/A|204|Actual|TriHealth Inc.||2|||f||||t||||||||Undecided||2017-10-11 00:13:15.20183|2017-10-11 00:13:15.20183
NCT02190578|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-04-23|||July 2014||2014-07-01|July 2014|2014-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test|Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test for the Detection of HIV-1 Antibodies in Fingerstick and Venous Whole Blood Samples|Completed||N/A|1649|Actual|MedMira Laboratories Inc.||1|||f||||f||||||||||2017-10-11 00:13:15.541816|2017-10-11 00:13:15.541816
NCT02190565|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-04-07|||April 7, 2017|Actual|2017-04-07|April 2017|2017-04-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|||Safety and Efficacy Study of a Food Supplement for Pregnant and Lactating Women|Supplementation With WellnessPack Mama During Pregnancy and Lactation - a Randomized Double-blind, Placebo-controlled Study|Withdrawn||N/A|0|Actual|Oriflame Cosmetics AB||2||Business decision - strategy changes and budget limitations|f||||f||||||||No||2017-10-11 00:13:15.653608|2017-10-11 00:13:15.653608
NCT02190552|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-09-12|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Observational|ARISE||Analysis of Revascularisation in Ischemic Stroke With EmboTrap|A.R.I.S.E. Analysis of Revascularisation in Ischemic Stroke With EmboTrap: Post Marketing Observational Study of CE Marked EmboTrap Mechanical Thrombectomy Device|Active, not recruiting||N/A|40|Actual|Neuravi Limited|||1||f||||t||||||||||2017-10-11 00:13:15.74705|2017-10-11 00:13:15.74705
NCT02190539|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-03-25|||August 2014||2014-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Homeopathic Protocol for Advanced Breast Cancer|The Banerji Protocol for Advanced Breast Cancer- Feasibility Study|Enrolling by invitation||N/A|30|Anticipated|Meir Medical Center||1|||f||||t|f|f||||||Yes|Publications, Presentations in international meetings|2017-10-11 00:13:15.852165|2017-10-11 00:13:15.852165
NCT02190526|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-04-14|||September 2014||2014-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome|Therapeutic Effects of Mesalamine and Amitriptyline in IBS: a Randomized Clinical Trial|Withdrawn||Phase 4|0|Actual|Tehran University of Medical Sciences||3||Study stopped due to lack of volunteer patients.|f||||t||||||||||2017-10-11 00:13:15.959739|2017-10-11 00:13:15.959739
NCT02190513|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-14|||February 2011||2011-02-01|July 2014|2014-07-01||||June 2013|Actual|2013-06-01||Observational|||Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease|Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease and Prevalence of Celiac Disease in Children With Eosinophilic Esophagitis in a Tertiary Community Hospital|Completed||N/A|56|Actual|St. John Health System, Michigan|||1||f||||f||||||||||2017-10-11 00:13:16.069286|2017-10-11 00:13:16.069286
NCT02190500|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-09-12|||August 2014||2014-08-01|September 2016|2016-09-01|August 2021|Anticipated|2021-08-01|January 2021|Anticipated|2021-01-01||Observational|BEST-MSU||BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit|BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit Compared to Standard Management by Emergency Medical Services:The BEST-MSU Study|Recruiting||Phase 2/Phase 3|1200|Anticipated|Memorial Hermann Health System|||2||f||||t||||||||||2017-10-11 00:13:16.137647|2017-10-11 00:13:16.137647
NCT02190487|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-07-14|||May 2011||2011-05-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Incidence and Risk Factors of Acute Kidney Injury After Thoracic Aortic Surgery Due to Dissection||Completed||N/A|100|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 00:13:16.287379|2017-10-11 00:13:16.287379
NCT02190474|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-03-02|||July 2014||2014-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mindfulness Interventions and Chronic Widespread Pain in Adolescents|Mindfulness Interventions and Chronic Symptoms|Completed||N/A|29|Actual|Yale University||1|||f||||t||||||||||2017-10-11 00:13:16.37734|2017-10-11 00:13:16.37734
NCT02190461|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-08-23|||April 2013||2013-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Impact of Early Respiratory Rehabilitation in the Exacerbations of Re-admitted COPD Patients|Impact of Early Respiratory Rehabilitation in the Exacerbations of Re-admitted Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 3|60|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-11 00:13:16.521528|2017-10-11 00:13:16.521528
NCT02190448|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-04-06|||March 2013||2013-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SLS||Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation|A Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation|Completed||N/A|60|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 00:13:16.637964|2017-10-11 00:13:16.637964
NCT02190435|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-04-17|2017-04-17||July 2014||2014-07-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Computer-Assisted Navigation for Intramedullary Nail Fixation of Intertrochanteric Femur Fractures|Computer-Assisted Navigation for Intramedullary Nail Fixation of Intertrochanteric Femur Fractures|Completed||N/A|65|Actual|William Beaumont Hospitals||2|||f||||t|f|t||||||No||2017-10-11 00:13:16.766127|2017-10-11 00:13:16.766127
NCT02190422|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-05-25|||June 2014||2014-06-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01|3 Months|Observational [Patient Registry]|Heart and ART||Effect of Assisted Reproductive Technology on Cardiac Development in Childhood Assessed by Echocardiography|Effect of Assisted Reproductive Technology on Cardiac Development in Childhood Assessed by Echocardiography|Completed||N/A|200|Actual|Nanjing Medical University|||1||f||||t||||||||||2017-10-11 00:13:17.094281|2017-10-11 00:13:17.094281
NCT02190409|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-14|||December 2011||2011-12-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|||An Invivo Study to Compare the Stability of Dental Implants With or Without Platelet Rich Fibrin Application|The Effect Of Platelet Rich Fibrin on Implant Stability|Completed||N/A|20|Actual|Necmettin Erbakan University||1|||f||||t||||||||||2017-10-11 00:13:17.168864|2017-10-11 00:13:17.168864
NCT02190396|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2014-07-12|||March 2014||2014-03-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Vitamin D Deficiency and Placental Calcification in Low-risk Obstetric Population - Are They Related?|Vitamin D Deficiency and Placental Calcification in Low-risk Obstetric Population - Are They Related?|Completed||N/A|60|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital|||2||f||||t||||||None Retained|"     Maternal venous and umbilical cordon blood   "|||2017-10-11 00:13:17.267665|2017-10-11 00:13:17.267665
NCT02190383|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-03-14|||November 2013||2013-11-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy of a Habit Reversal Treatment on Tic-symptoms|Within Subject Design on the Efficacy of Habit Reversal Treatment Programme in Children and Adolescents With Tics|Recruiting||N/A|50|Anticipated|University of Cologne||1|||f||||f||||||||||2017-10-11 00:13:17.354155|2017-10-11 00:13:17.354155
NCT02190370|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-03-14|||November 2013||2013-11-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy of a Resources Activation Treatment on Tic-symptoms|Within Subject Design on the Efficacy of a Resources Activation Treatment Programme in Children and Adolescents With Tics|Recruiting||N/A|50|Anticipated|University of Cologne||1|||f||||f||||||||||2017-10-11 00:13:17.461864|2017-10-11 00:13:17.461864
NCT02190357|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-09-12|||August 2014||2014-08-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial|Rifaximin Reduces the Complications of Decompensated Cirrhosis|Recruiting||Phase 4|200|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||||2017-10-11 00:13:19.38822|2017-10-11 00:13:19.38822
NCT02190344|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-02-27|||June 2014||2014-06-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Functionality of an 8-Channel Paddle Coil for Use With MRI|Study to Evaluate the Functionality of an Eight-Channel Paddle Coil System Using MRI|Completed||N/A|1|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 00:13:19.505005|2017-10-11 00:13:19.505005
NCT02190331|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-07-14|||October 2012||2012-10-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|||Effects of a Resistance and Stretching Training Program on Forward Head and Protracted Shoulder Posture Adolescents|The Effects of Training and Detraining After an 8 Month Resistance and Stretching Training Program on Forward Head and Protracted Shoulder Postures in Adolescents|Completed||N/A|275|Actual|Faculdade de Motricidade Humana||2|||f||||t||||||||||2017-10-11 00:13:19.622268|2017-10-11 00:13:19.622268
NCT02190318|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2014-07-31|||November 2013||2013-11-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Residual Renal Function Preservation in Peritoneal Dialysis Patients|The Effects of Losartan and Spironolactone on Residual Renal Function Preservation in Peritoneal Dialysis Patients|Unknown status|Recruiting|N/A|96|Anticipated|Second Xiangya Hospital of Central South University||4|||f||||||||||||||2017-10-11 00:13:19.714894|2017-10-11 00:13:19.714894
NCT02190305|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-04-23|||May 2014||2014-05-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Rapid Diagnostics for HIV and Hepatitis|Rapid Diagnostics for HIV and Hepatitis - Multiplo HBc/HIV/HCV and Reveal HBsAg|Unknown status|Recruiting|N/A|4000|Anticipated|MedMira Laboratories Inc.||1|||f||||f||||||||||2017-10-11 00:13:19.834891|2017-10-11 00:13:19.834891
NCT02190292|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-08-29|||June 2014||2014-06-01|August 2017|2017-08-01||||June 30, 2017|Actual|2017-06-30||Observational|||PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort||Completed||N/A|185|Anticipated|Karolinska Institutet|||3||f||||||||||Samples With DNA|"     blood (whole blood and serum)   "|||2017-10-11 00:13:19.952549|2017-10-11 00:13:19.952549
NCT02190279|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2017-06-30|||June 26, 2014||2014-06-26|April 19, 2017|2017-04-19|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||18F-DCFBC PET/CT in Prostate Cancer|A Pilot Study of 18F-DCFBC PET/CT in Prostate Cancer|Active, not recruiting||Early Phase 1|116|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 00:13:20.091277|2017-10-11 00:13:20.091277
NCT02190266|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2017-07-13|||July 2, 2014||2014-07-02|July 12, 2017|2017-07-12|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Observational|||Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis|The Pathogenesis and Genetics of Disseminated or Refractory Coccidiodomycosis|Recruiting||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:13:20.184403|2017-10-11 00:13:20.184403
NCT02190253|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2017-06-30|||July 6, 2014||2014-07-06|February 27, 2017|2017-02-27|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Seroprevalence of Hepatitis E in People With an Organ Transplant|Hepatitis E in the Organ Transplant Population|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:13:20.304299|2017-10-11 00:13:20.304299
NCT02190240|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-01-09|||January 2012||2012-01-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Effect of Complementary and Alternative Medicine on Pain Among Inpatients|Effect of Complementary and Alternative Medicine on Pain Among Inpatients|Completed||N/A|4422|Actual|Allina Health System|||1||f||||t||||||||||2017-10-11 00:13:20.498128|2017-10-11 00:13:20.498128
NCT02190227|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-02-02|||May 2013||2013-05-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer Treatment|Tumor RNA Disruption Assay as a Tool to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer: Optimizing Timing of Biopsy|Completed||Phase 2|30|Actual|Jewish General Hospital||1|||f||||f||||||||||2017-10-11 00:13:20.586961|2017-10-11 00:13:20.586961
NCT02190214|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-10-17|||August 2014||2014-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|MyEndo-Thyroid||Thyroid Disorders in Malaysia: A Nationwide Multicentre Study|Thyroid Disorders in Malaysian: A Nationwide Multicentre Study|Completed||N/A|2498|Actual|International Islamic University Malaysia|||1||f||||t||||||Samples With DNA|"     Whole Blood Serum   "|||2017-10-11 00:13:20.707708|2017-10-11 00:13:20.707708
NCT02190201|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-11-19|||July 2014||2014-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Comparison of McGrath and Macintosh Laryngoscope for DLT Intubation|A Randomised Controlled Trial Comparing McGrath Series 5 Videolaryngoscope and Macintosh Laryngoscope for Double Lumen Tube Intubation|Completed||Phase 4|114|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 00:13:20.802362|2017-10-11 00:13:20.802362
NCT02190188|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2016-09-12|||March 2014||2014-03-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||The Influence of Wedge Insoles After Partial Meniscectomy|Effect of Orthotic Devices in the Recovery After Partial Meniscectomy|Recruiting||N/A|60|Anticipated|Medical University Innsbruck||3|||f||||||||||||||2017-10-11 00:13:20.912961|2017-10-11 00:13:20.912961
NCT02190175|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2015-04-15|||June 2014||2014-06-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|||Management of Atrial Fibrillation With Flecainide : the AFFLEC Study|Multicentre Non Interventional Study in the Management of Atrial Fibrillation With Flecainide|Unknown status|Recruiting|N/A|144|Anticipated|Hellenic Cardiovascular Research Society|||1||f||||f||||||||||2017-10-11 00:13:21.00522|2017-10-11 00:13:21.00522
NCT02190162|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-11-14|||July 2014||2014-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Influence of Tantum Verde® on Recovery Following Tonsillectomy|A Prospective Double-blined Randomized Trial to Evaluate The Influence of Tantum Verde® on Recovery Following Tonsillectomy|Recruiting||N/A|60|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||t||||||||||2017-10-11 00:13:21.087111|2017-10-11 00:13:21.087111
NCT02190149|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-14|2016-04-13|||July 2014||2014-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|SPACE||Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS|Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS|Completed||N/A|64|Actual|Baxalta US Inc.|||2||f||||f||||||||||2017-10-11 00:13:21.210909|2017-10-11 00:13:21.210909
NCT02190136|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-11|||December 2006||2006-12-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|January 2008|Actual|2008-01-01||Interventional|PRISE||Yoga Improves Aerobic Fitness, Glycemia and Mood State and Reduces Abdominal Obesity|Yoga Improves Aerobic Fitness, Glycemia and Mood State and Reduces Abdominal Obesity in Overweight Women: The PRISE Study|Completed||N/A|39|Actual|Skidmore College||3|||f||||f||||||||||2017-10-11 00:13:21.37042|2017-10-11 00:13:21.37042
NCT02190123|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-01-07|||September 2014||2014-09-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|REWINDER||REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.|REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets in Patients With Acute Coronary Syndrome in Belgium/Luxembourg (REWINDER)|Completed||N/A|430|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:13:21.482582|2017-10-11 00:13:21.482582
NCT02190110|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-12|2016-02-06|||August 2014||2014-08-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Pulmonary Embolism Diagnosis: Ultrasound Wells Score vs Traditional Wells Score|Ultrasound Wells Score vs Traditional Wells Score in the Diagnostic Approach to Pulmonary Embolism|Completed||N/A|444|Actual|Azienda Ospedaliero-Universitaria Careggi|||1||f||||f||||||||||2017-10-11 00:13:21.606774|2017-10-11 00:13:21.606774
NCT02190097|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-07-24|||January 2015||2015-01-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Paleo Versus Healthy ADA Diets for Treatment of Polycystic Ovarian Syndrome (PCOS)|PALEOLITHIC VS Healthy ADA DIETS FOR TREATMENT OF POLYCYSTIC OVARIAN SYNDROME (PCOS)|Recruiting||N/A|40|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:13:21.702306|2017-10-11 00:13:21.702306
NCT02190084|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-02-09|||May 2014||2014-05-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia|Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia|Recruiting||Phase 4|20|Anticipated|Central Arkansas Veterans Healthcare System||2|||f||||f||||||||||2017-10-11 00:13:21.817363|2017-10-11 00:13:21.817363
NCT02190071|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2016-05-25|||June 2014||2014-06-01|July 2015|2015-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|EUS-FNA||Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer|Comparison of the Diagnostic Accuracy Between Base and Cover Slide Smear After Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer|Completed||N/A|73|Actual|Seoul National University Hospital|||1||f||||t||||||Samples Without DNA|"     One identical and skilled endoscopist's EUS-FNA sampling with multiple punctures   "|||2017-10-11 00:13:21.902894|2017-10-11 00:13:21.902894
NCT02190058|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-01-19|||July 2014||2014-07-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Multiple Dose Study of DS-1971a|A PHASE I, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO ASSESS SAFETY, TOLERABILITY AND PHARMACOKINETICS OF DS-1971A IN HEALTHY MALE SUBJECTS|Completed||Phase 1|32|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 00:13:21.973456|2017-10-11 00:13:21.973456
NCT02190045|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-08-19|||September 2013||2013-09-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|September 2015|Actual|2015-09-01||Interventional|||Wii-Fit For Balance And Gait In Elderly Veterans|Wii-Fit For Balance And Gait In Elderly Veterans|Active, not recruiting||N/A|29|Actual|Central Arkansas Veterans Healthcare System||2|||f||||f||||||||||2017-10-11 00:13:22.066918|2017-10-11 00:13:22.066918
NCT02190032|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2015-02-22|||July 2014||2014-07-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Modified Angled Tube vs. Conventional Angled Tube in Double-lumen Endotracheal Tube Intubation|Comparison of Individually Modified Angled Tube and Conventional Angled Tube in Double-lumen Endotracheal Tube Intubation: A Randomized Clinical Trial|Completed||N/A|108|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:13:22.179188|2017-10-11 00:13:22.179188
NCT02190019|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-02-09|||April 2014||2014-04-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|April 2015|Actual|2015-04-01||Interventional|||Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment:Pilot Study|Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment:Pilot Study|Active, not recruiting||Phase 4|14|Actual|Central Arkansas Veterans Healthcare System||2|||f||||f||||||||||2017-10-11 00:13:22.271378|2017-10-11 00:13:22.271378
NCT02190006|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-01-20|||July 2014||2014-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Comparison Between the Role of Follicular Output Rate and Preovulatory Count in the Prediction of Pregnancy in Women With Polycystic Ovarian Syndrome Undergoing Intra Cytoplasmic Sperm Injection (ICSI)|Comparison Between the Role of Follicular Output Rate and Preovulatory Count in the Prediction of Pregnancy in Women With Polycystic Ovarian Syndrome Undergoing Intra Cytoplasmic Sperm Injection (ICSI)|Recruiting||N/A|300|Anticipated|Cairo University|||1||f||||t||||||||||2017-10-11 00:13:22.36759|2017-10-11 00:13:22.36759
NCT02189993|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-07-15|||January 2010||2010-01-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|April 2012|Actual|2012-04-01||Observational|||Limited Long Term Survival in Patients After In-hospital Intestinal Failure Requiring Total Parenteral Nutrition|Limited Long Term Survival in Patients After In-hospital Intestinal Failure Requiring Total Parenteral Nutrition|Completed||N/A|437|Actual|VU University Medical Center|||1||f||||f||||||||||2017-10-11 00:13:22.677056|2017-10-11 00:13:22.677056
NCT02189980|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-01-14|||June 2014||2014-06-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Aromatherapy Using a Nasal Clip After Surgery|Aromatherapy Using a Nasal Clip After Surgery|Recruiting||N/A|300|Anticipated|Balanced Health plus||2|||f||||t||||||||||2017-10-11 00:13:22.768381|2017-10-11 00:13:22.768381
NCT02189967|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-09-26|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|November 2023|Anticipated|2023-11-01|November 2022|Anticipated|2022-11-01||Interventional|||Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation|Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation|Recruiting||N/A|308|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 00:13:22.893171|2017-10-11 00:13:22.893171
NCT02189590|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-10-22|||July 2014||2014-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Assessment of the I-gel and Air-Q Supraglottic Airways as Conduits for Tracheal Intubation in Children|A Randomized Comparison of the I-gel and Air-Q as Conduits for Fiberoptic-guided Tracheal Intubation in Children|Completed||N/A|96|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-11 00:13:29.239211|2017-10-11 00:13:29.239211
NCT02189954|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2015-08-05|2015-04-26||July 2011||2011-07-01|August 2015|2015-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients|Effect of Laryngeal Mask Cuff Pressure on Postoperative Pharyngolaryngeal Complications in Geriatric Patients|Completed||Phase 4|90|Actual|Dokuz Eylul University|Limitations of our study include the lack of imaging with a fiberoptic bronchoscope after LMU placement and not evaluating the position in the hypopharynx of the supraglottic airway device in the geriatric age group.|2|||f||||f||||||||||2017-10-11 00:13:23.092724|2017-10-11 00:13:23.092724
NCT02189941|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-04-14|2015-12-23||May 2014||2014-05-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers|Pilot Study of the Pharmacokinetic Profile of a Single Dose of Deferiprone Sustained-Release Formulation in Healthy Volunteers|Completed||Phase 1|11|Actual|ApoPharma||3|||f||||f||||||||||2017-10-11 00:13:23.428963|2017-10-11 00:13:23.428963
NCT02189928|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-03-05|||January 2015||2015-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|RESCUE-BRAIN||REmote iSchemic Conditioning in acUtE BRAin INfarction Study|Lower Limb Ischaemic Per-conditioning in Acute Cerebral Infarction (<H6): Multicenter Randomized Study With Stratification on IV Thrombolysis and PROBE Design (Prospective Randomized Open Trial With Blinded End-Point)|Recruiting||N/A|200|Anticipated|Versailles Hospital||2|||f||||t||||||||Undecided||2017-10-11 00:13:24.027443|2017-10-11 00:13:24.027443
NCT02189915|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-04-13|2016-02-16||January 2012||2012-01-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Open-Label Creatine Study for Female Meth Users|Open-Label Creatine Monohydrate Supplementation in Depressed Female Methamphetamine Users|Terminated||N/A|14|Actual|University of Utah||1||Received funding for the next phase of the study|f||||f||||||||||2017-10-11 00:13:24.194229|2017-10-11 00:13:24.194229
NCT02189902|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-07-14|||January 2012||2012-01-01|July 2014|2014-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Botswana Vitamin D Supplementation Study in HIV/AIDS|Botswana Vitamin D Supplementation Study in HIV/AIDS|Completed||Phase 3|60|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 00:13:24.45|2017-10-11 00:13:24.45
NCT02189889|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-02-07|||April 2013||2013-04-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|APART||Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery|Active Preoperative Anemia Management to Reduce Erythrocyte Transfusion in Patients Undergoing Cardiac Surgery (APART): A Pilot, Feasibility Study|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||Undecided|All data and information collected during this study will be considered confidential and remains the sole property of UTSW Medical Center. Data may be shared with AMAG Pharmaceuticals, Inc., prior to any publications. All data used in the analysis and summary of this study will be anonymous, and without reference to specific subject names.|2017-10-11 00:13:24.54827|2017-10-11 00:13:24.54827
NCT02189876|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-04-05|||July 2013||2013-07-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|FemAALES||Females of African American Legacy Empowering Self (FemAALES)|Reducing HIV/STD Risk in African American Women With At-Risk Male Partners|Active, not recruiting||N/A|325|Anticipated|Charles Drew University of Medicine and Science||2|||f||||f||||||||||2017-10-11 00:13:24.69048|2017-10-11 00:13:24.69048
NCT02189863|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-01-21|2015-12-14||August 2014||2014-08-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||This analysis population includes all randomized participants who successfully tried at least one study lens.|Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses|Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses|Completed||N/A|33|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:13:24.804932|2017-10-11 00:13:24.804932
NCT02189850|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-07-18||2016-07-18|June 2014||2014-06-01|July 2016|2016-07-01||||January 2015|Actual|2015-01-01||Interventional|||Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy||Completed||Phase 2|32|Actual|Braintree Laboratories||2|||f||||||||||||||2017-10-11 00:13:25.083181|2017-10-11 00:13:25.083181
NCT02189824|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-10-29|||August 2014||2014-08-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Interventional|SCRAMBLE||Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation|Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation|Unknown status|Recruiting|Phase 1|12|Anticipated|University of Sydney||1|||f||||f||||||||||2017-10-11 00:13:26.235663|2017-10-11 00:13:26.235663
NCT02189811|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-05-02|||September 2014||2014-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Polio End-game Strategies - Poliovirus Type 2 Challenge Study|Polio End-game Strategies - Poliovirus Type 2 Challenge Study|Completed||Phase 4|900|Actual|Aga Khan University||5|||f||||t||||||||||2017-10-11 00:13:26.34235|2017-10-11 00:13:26.34235
NCT02189798|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-07-05|||April 2014||2014-04-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness|Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness|Recruiting||N/A|50|Anticipated|Advanced Bionics||3|||f||||f||||||||||2017-10-11 00:13:26.486954|2017-10-11 00:13:26.486954
NCT02189785|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2016-09-29|||August 2016||2016-08-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Endogenous Opioid Mechanisms for Rejection Sensitivity|Endogenous Opioid Mechanisms for Rejection Sensitivity|Recruiting||N/A|96|Anticipated|Stony Brook University|||1||f||||f||||||Samples With DNA|"     saliva, whole blood, blood plasma   "|||2017-10-11 00:13:26.68789|2017-10-11 00:13:26.68789
NCT02189772|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-03-03|||August 2014||2014-08-01|December 2014|2014-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects|Randomized, Double-blind, Placebo-controlled, Multi-center, Fixed Dose Study Designed to Evaluate the Safety and Tolerability of a Single Administration of MG01CI (Metadoxine Extended Release, MDX) in Adolescents With Predominantly Inattentive Attention Deficit Hyperactivity Disorder|Completed||Phase 2|83|Actual|Alcobra Ltd.||2|||f||||f||||||||||2017-10-11 00:13:26.810741|2017-10-11 00:13:26.810741
NCT02189759|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-04-04|2017-02-17||August 2014|Actual|2014-08-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Kangaroo Mother Care to Prevent Hypothermia in Term Infants|A Randomized Trial of Kangaroo Mother Care to Prent Neonatal Hypothermia - Trials 2A & 2 B|Completed||N/A|375|Actual|University of Alabama at Birmingham||4|||f||||t||||||||||2017-10-11 00:13:26.968715|2017-10-11 00:13:26.968715
NCT02189746|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-02-17|||June 2014||2014-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Kangaroo Mother Care to Prevent Hypothermia in Preterm Infants|A Randomized Trial of Kangaroo Mother Care to Prevent Neonatal Hypothermia - Trials 1A & 1B|Recruiting||N/A|220|Anticipated|University of Alabama at Birmingham||4|||f||||t||||||||||2017-10-11 00:13:27.707657|2017-10-11 00:13:27.707657
NCT02189733|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-11-13|||July 2014||2014-07-01|July 2014|2014-07-01||||September 2014|Actual|2014-09-01||Interventional|||Bioequivalence of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab.|A Phase I, Single Center, Open-Label, Randomized, Single Dose Cross-Over Study in Healthy Male Subjects to Investigate the Bioequivalence and Tolerability of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab.|Completed||Phase 1|24|Actual|Ablynx||2|||f||||f||||||||||2017-10-11 00:13:27.851816|2017-10-11 00:13:27.851816
NCT02189720|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-05|2017-01-31||||||January 2017|2017-01-01||||||||Expanded Access|EAP-001||Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients|An Open-Label, Expanded Access Protocol for Amifampridine Phosphate Treatment in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS) and Downbeat Nystagmus|Available||N/A|||Catalyst Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 00:13:27.945273|2017-10-11 00:13:27.945273
NCT02189707|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2015-05-06|||August 2014||2014-08-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Probiotic Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Constipation.|Effects of 4-week Bifidobacterium-lactis HN019 Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Functional Constipation: A Double-blind, Randomized, Placebo-controlled Dose-ranging Trial|Completed||Phase 2|228|Actual|Danisco Sweeteners Oy||3|||f||||f||||||||||2017-10-11 00:13:28.081445|2017-10-11 00:13:28.081445
NCT02189694|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-09-01|||June 2014||2014-06-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp|An Open-label, Randomized, Three-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Conventional Pump Therapy in Regulating Overnight Glucose Levels in Children With Type 1 Diabetes in a Diabetes Camp|Completed||Phase 2|33|Actual|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-11 00:13:28.224697|2017-10-11 00:13:28.224697
NCT02189681|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-05|2015-08-26|||July 2014||2014-07-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Landmark Guided Midline Versus Pre-procedural Ultrasound Guided Paramedian at L5S1 for Spinal Anaesthesia|Comparison of Conventional Landmark Guided Midline (Group C) Versus Pre-procedural Ultrasound Guided Paramedian at L5S1 (Group P) Technique for Spinal Anaesthesia|Completed||N/A|120|Actual|Cork University Hospital||2|||f||||f||||||||||2017-10-11 00:13:28.361883|2017-10-11 00:13:28.361883
NCT02189668|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-08-18|||July 2014||2014-07-01|August 2016|2016-08-01|July 2025|Anticipated|2025-07-01|July 2015|Actual|2015-07-01||Interventional|||Non-operative Management of Pediatric Appendicitis With an Appendicoltih|Non-operative Management of Uncomplicated Appendicitis With an Appendicolth in Children|Terminated||N/A|14|Actual|Nationwide Children's Hospital||2||High failure rate|f||||f||||||||No||2017-10-11 00:13:28.47519|2017-10-11 00:13:28.47519
NCT02189655|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-01-31|||March 2016||2016-03-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects|Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects|Recruiting||Phase 4|100|Anticipated|China Medical University, China||2|||f||||t||||||||||2017-10-11 00:13:28.573884|2017-10-11 00:13:28.573884
NCT02189642|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-03-08|||July 13, 2013||2013-07-13|March 2017|2017-03-01|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Observational|||Boston Children's Hospital Post Anesthesia Care Unit Outcomes Study|Evaluation of Perioperative Outcomes in Children: Creation of the Boston Children's Hospital Perioperative Outcomes Registry|Completed||N/A|643|Actual|Boston Children’s Hospital|||4||f||||f||||||||||2017-10-11 00:13:28.688865|2017-10-11 00:13:28.688865
NCT02189629|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2017-09-11|||February 23, 2015|Actual|2015-02-23|September 2017|2017-09-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||CD5789 Long Term Safety Study on Acne Vulgaris|A LONG-TERM SAFETY AND EFFICACY STUDY OF CD5789 50 µg/g CREAM IN SUBJECTS WITH ACNE VULGARIS|Completed||Phase 3|455|Actual|Galderma R&D||1|||f||||f||||||||||2017-10-11 00:13:28.79564|2017-10-11 00:13:28.79564
NCT02189616|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-08-18|||July 2014||2014-07-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on Asthma Control|Evaluate the Clinical Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on the Self-management and Outcomes of Poorly-controlled Asthma: a Multicenter Randomized Controlled Trial|Unknown status|Recruiting|N/A|360|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:13:28.980786|2017-10-11 00:13:28.980786
NCT02189603|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-10|||June 2014||2014-06-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）|Evaluation of Safety and Immunogenicity of Recombinant (E. Coli) Hepatitis E Vaccine（Hecolin®） in Seniors Aged Over 65 Years|Unknown status|Recruiting|Phase 4|600|Anticipated|Xiamen University||3|||f||||t||||||||||2017-10-11 00:13:29.116015|2017-10-11 00:13:29.116015
NCT02189577|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-03-28|||June 2014||2014-06-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Trigon||Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients|A Multinational, Multicentre, Randomised, Double Blind, Placebo-Controlled, 2-way Crossover Study to Evaluate the Efficacy and Safety of Glycopyrrolate Bromide Administered Via pMDI (CHF 5259), for the Treatment of Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|100|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 00:13:29.342333|2017-10-11 00:13:29.342333
NCT02189564|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-04-29|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|July 2014|Actual|2014-07-01||Interventional|KFSP-REWARD||Rewarding Feedback in Motor Learning and Rehabilitation|"Die Auswirkung Von Dopaminergen Belohnungsreizen Auf Das Lernen Einer Motorischen Fertikgeit Bei Gesunden Probanden Effects of Dopaminergic Reward on Motor Skill Learning in Healthy Subjects"|Completed||N/A|45|Actual|Cereneo AG||3|||f||||f||||||||||2017-10-11 00:13:29.477082|2017-10-11 00:13:29.477082
NCT02189551|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-07-10|||June 2014||2014-06-01|July 2014|2014-07-01||||September 2014|Anticipated|2014-09-01||Interventional|LOKOMAT||Advanced Robotic Training With Additional Degrees of Freedom: Towards a Free-walking System||Unknown status|Recruiting|N/A|||Cereneo AG||2|||f||||||||||||||2017-10-11 00:13:29.54936|2017-10-11 00:13:29.54936
NCT02189538|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-02-14|||January 2013||2013-01-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|OmegaBurn||Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients|Effect of Omega-3 PUFA From Fish in Major Burn Patients. EFECTO DE ÁCIDOS GRASOS POLIINSATURADOS OMEGA 3 DERIVADOS DE ACEITE DE PESCADO, EN QUEMADOS GRAVES|Recruiting||N/A|100|Anticipated|Centro Nacional de Quemados, Uruguay||2|||f||||f||||||||||2017-10-11 00:13:29.651268|2017-10-11 00:13:29.651268
NCT02189525|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-07-18|||August 2014||2014-08-01|July 2016|2016-07-01||||December 2017|Anticipated|2017-12-01||Observational|AWARE||Evaluation of Mild TBI in Collegiate Athletes|AWARE: Mild Traumatic Brain Injury in Collegiate Athletes - A Prospective Study With Blood-based Biomarkers, Advanced Neuroimaging and the Head Impact Telemetry System (HITS)|Recruiting||N/A|500|Anticipated|Banyan Biomarkers, Inc|||2||f||||f||||||||||2017-10-11 00:13:29.996382|2017-10-11 00:13:29.996382
NCT02189512|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-07-10|||May 2014||2014-05-01|May 2014|2014-05-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|IMMO||Study on the Effect of Surgical Intestinal Manipulation|CD14/CD16 Activation in Brain-death Organ Donors and Effect of Surgical Intestinal Manipulation|Unknown status|Recruiting|N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:13:30.100232|2017-10-11 00:13:30.100232
NCT02189499|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-06-06|||September 2014||2014-09-01|June 2016|2016-06-01|November 2020|Anticipated|2020-11-01|June 2016|Anticipated|2016-06-01||Interventional|MEND II||Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent|Amaranth Endovascular Study of a Drug-Eluting Bioresorbable Coronary Scaffold|Active, not recruiting||Phase 2|42|Actual|Amaranth Medical Inc.||1|||f||||f||||||||Undecided||2017-10-11 00:13:30.189951|2017-10-11 00:13:30.189951
NCT02189486|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-10-12|||August 2014||2014-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Prostate Cancer Upgrading Reference Set|Biomarkers and Clinical Parameters Associated With Gleason Score Upgrading|Recruiting||N/A|600|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||t||||||Samples With DNA|"     Blood, voided urine and prostate tissue slides and blocks   "|||2017-10-11 00:13:30.313933|2017-10-11 00:13:30.313933
NCT02189473|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-08-04|||July 2010||2010-07-01|August 2017|2017-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|SCORE-2||Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression|Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression (10 x 3 Gy Versus 5 x 4 Gy)|Completed||N/A|203|Actual|University of Schleswig-Holstein||2|||f||||t||||||||||2017-10-11 00:13:30.485658|2017-10-11 00:13:30.485658
NCT02189460|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-09-27|||July 2014||2014-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|SEMVIE||Effect of Normal Aging on Language Processing|Cognitive Mechanisms and Cerebral Substrate of Naming Impairment During Aging. Behavior and Neuroimaging Approaches.|Recruiting||N/A|60|Anticipated|University Hospital, Grenoble|||1||f||||t||||||||||2017-10-11 00:13:30.65089|2017-10-11 00:13:30.65089
NCT02189447|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-05|2014-07-10|||January 2011||2011-01-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Photorefractive Keratectomy and Corneal Cross-linking in Keratoconus||Completed||N/A|44|Actual|The Eye Center and The Eye Foundation for Research in Ophthalmology||1|||f||||f||||||||||2017-10-11 00:13:30.756217|2017-10-11 00:13:30.756217
NCT02189434|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-07-10|||June 2014||2014-06-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Does Serum Procalcitonin Levels Predict Sepsis in Patients Undergoing Cytoreductive Surgery|A Pilot Study to Determine the Correlation of Serum Procalcitonin Levels and Development of Sepsis in Patients Undergoing Cytoreductive Surgery|Completed||N/A|20|Actual|Eastern Regional Medical Center|||1||f||||f||||||Samples With DNA|"     Collection of serum blood specimens   "|||2017-10-11 00:13:30.851689|2017-10-11 00:13:30.851689
NCT02189421|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-10-30|||April 2014||2014-04-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|July 2015|Actual|2015-07-01||Interventional|||Multibending vs Conventional Endoscope for Direct Peroral Cholangioscopy|Comparison of Multibending and Conventional Ultra-slim Upper Endoscope for the Direct Advance Into the Bile Duct Without Assisting Accessory in Peroral Cholangioscopy|Unknown status|Active, not recruiting|N/A|110|Anticipated|Soonchunhyang University Hospital||1|||f||||f||||||||||2017-10-11 00:13:30.937861|2017-10-11 00:13:30.937861
NCT02189408|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-07-11|||July 2010||2010-07-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PRP-Bochum||Clinical Study of Pain Reduction by Peri-arthroscopic PRP Application in Knee Degeneration|Effect of Platelet Rich Plasma ( PRP ) Applied During Knee Arthroscopy on Pain, Function and Quality of Life - A RCT With a Follow up of 12 Months|Completed||Phase 4|58|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-11 00:13:31.076403|2017-10-11 00:13:31.076403
NCT02189395|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-09-27|||April 2013||2013-04-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting|Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting|Terminated||Phase 4|52|Actual|Riverside County Regional Medical Center||2||difficulty in subject recruitment|f||||t||||||||||2017-10-11 00:13:31.200214|2017-10-11 00:13:31.200214
NCT02189369|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-03-06|||February 2015||2015-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Diagnostic Test for Endometrial Receptivity 24 Hours Before Embryo Transfer|Clinical Validation of a Diagnostic Test Which Measures the Endometrial Prostaglandins Liquid 24 Hours Before Embryo Transfer and That is Capable of Predicting a State of Endometrial Receptivity|Recruiting||N/A|120|Anticipated|Igenomix||8|||f||||f||||||||||2017-10-11 00:13:31.460509|2017-10-11 00:13:31.460509
NCT02189356|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-12|||September 2011||2011-09-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Gulhane Military Medical Academy Ethical Committee Exercise Program for Pregnant Women With Low Back and Pelvic Pain|Evaluation of the Efficacy of an Exercise Program for Pregnant Women With Low Back and Pelvic Pain: A Prospective Randomized Controlled Trial|Completed||N/A|96|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||2|||f||||f||||||||||2017-10-11 00:13:31.583333|2017-10-11 00:13:31.583333
NCT02189343|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-08-31|||September 15, 2014|Actual|2014-09-15|August 2017|2017-08-01|October 3, 2017|Anticipated|2017-10-03|October 3, 2017|Anticipated|2017-10-03||Interventional|||Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma|A Phase 1b Multi-Center, Open Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Anti-Tumor Activity of an Alternative Liquid Formulation of ACY-1215 (Ricolinostat) In Combination With Pomalidomide and Low-Dose Dexamethasone In Patients With Relapsed and Refractory Multiple Myeloma|Active, not recruiting||Phase 1|16|Actual|Celgene||1|||f||||t||||||||||2017-10-11 00:13:31.656999|2017-10-11 00:13:31.656999
NCT02189330|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-07-14|||May 2014||2014-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples|A Phase 1, Open-Label, Randomized, 2-Cohort, Crossover, Single Dose Study to Estimate the Relative Bioavailability of PF 06291826 (Tafamidis) Following Administration of Two Oral Formulations Versus Commercial Capsule in Healthy Subjects Under Fasted Conditions|Completed||Phase 1|24|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 00:13:31.773158|2017-10-11 00:13:31.773158
NCT02189317|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-06-28|2016-05-07||August 2014||2014-08-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction|Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction|Completed||Phase 4|50|Actual|Emory University|The study lacked a third comparison group of participants who received placebo which may have provided another internal control. Additionally, there was a difference in the total milligrams of bupivacaine administered in each study group.|2|||f||||f||||||||||2017-10-11 00:13:31.869091|2017-10-11 00:13:31.869091
NCT02189304|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-09-05|||June 2014||2014-06-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Pharmacokinetics and Safety Study of PT010 in Healthy Subjects|A Phase I, Randomized, Double-Blind, Single-Dose, Three-Period, Three-Treatment, Cross-Over Study Evaluating the Pharmacokinetics and Safety of a Single Dose of PT010, a Single Dose of PT009, and a Single Dose of Open-Label Symbicort® Turbohaler® in Healthy Subjects|Completed||Phase 1|60|Anticipated|Pearl Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 00:13:32.266743|2017-10-11 00:13:32.266743
NCT02189291|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-09-28|||July 2014||2014-07-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|CARESS||Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy|When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?|Recruiting||N/A|100|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 00:13:32.395589|2017-10-11 00:13:32.395589
NCT02189278|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-08-31|||October 2013||2013-10-01|January 2017|2017-01-01|June 12, 2017|Actual|2017-06-12|June 12, 2017|Actual|2017-06-12||Interventional|||Improving Adherence to Recommended Surveillance in Breast Cancer Survivors|Improving Adherence to Recommended Surveillance in Breast Cancer Survivors|Completed||N/A|100|Actual|Duke University||2|||f||||t||||||||||2017-10-11 00:13:32.528758|2017-10-11 00:13:32.528758
NCT02189265|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-11|||January 2000||2000-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|December 2011|Actual|2011-12-01||Observational|||Assessing the Impact of Smoke-free Legislation on Perinatal Health in the Netherlands|Assessing the Impact of Smoke-free Legislation on Perinatal Health in the Netherlands|Completed||N/A|2069695|Actual|University of Edinburgh|||1||f||||f|||||||"     None Retained   "|||2017-10-11 00:13:32.645429|2017-10-11 00:13:32.645429
NCT02189252|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-05-11|2016-03-29||October 2014||2014-10-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|ECLIPSEIV||An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis|A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis|Completed||Phase 1|30|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 00:13:32.819933|2017-10-11 00:13:32.819933
NCT02189239|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-06-24|||January 2015||2015-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy Study of Zeller Entspannung Film Coated Tablets on Acute Stress|A Phase IV, Randomised, Placebo Controlled Study to Investigate the Effects of Zeller Entspannung Film Coated Tablets on Cortisol Responses in Healthy Volunteers With Acute Stress|Completed||Phase 4|72|Actual|Max Zeller Soehne AG||3|||f||||f||||||||||2017-10-11 00:13:33.762413|2017-10-11 00:13:33.762413
NCT02189226|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-10|||November 2013||2013-11-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection||Unknown status|Recruiting|N/A|62|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:13:33.830953|2017-10-11 00:13:33.830953
NCT02189213|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-07-20|||July 2014||2014-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep|Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep|Active, not recruiting||N/A|60|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 00:13:33.906863|2017-10-11 00:13:33.906863
NCT02189200|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-05-10|||October 2012||2012-10-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Nutritional Counseling Associated With the Ingestion of Oat Bran in Hypercholesterolemic Subjects|Effect of Nutritional Counseling Associated With the Ingestion of Oat Bran in Hypercholesterolemic Subjects in Secondary Prevention|Completed||N/A|132|Actual|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-11 00:13:34.000152|2017-10-11 00:13:34.000152
NCT02189187|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-07-26|||December 2014||2014-12-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|June 2016|Actual|2016-06-01||Interventional|||Keeping Weight Off: Brain Changes Associated With Healthy Behaviors|Keeping Weight Off: Brain Changes Associated With Healthy Behaviors|Completed||N/A|55|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 00:13:34.122371|2017-10-11 00:13:34.122371
NCT02189174|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-06-06|||August 2014||2014-08-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies|A Phase I/II Multicenter, Open-label Study of CLR457, Administered Orally in Adult Patients With Advanced Solid Malignancies|Terminated||Phase 1/Phase 2|31|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:13:34.222478|2017-10-11 00:13:34.222478
NCT02189161|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-06-03|2016-04-26||July 2014||2014-07-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||subjects who have biopsy-proven HSIL and are HIV-negative or HIV-positive.|A Safety and Tolerability of Circumferential Anal Canal Radiofrequency Ablation For Anal Intraepithelial Neoplasia|A Safety and Tolerability Trial of Circumferential Anal Canal Radiofrequency Ablation For Anal Intraepithelial Neoplasia Using the Barrx™ Ablation System|Completed||N/A|10|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-11 00:13:34.348568|2017-10-11 00:13:34.348568
NCT02189148|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-07-20|||November 2014||2014-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|PREDICTION||First-trimester Prediction of Preeclampsia|First-trimester Prediction of Preeclampsia and Other Placenta-mediated Pregnancy Complications|Recruiting||N/A|7600|Anticipated|CHU de Quebec-Universite Laval|||1||f||||f||||||Samples Without DNA|"     Maternal serum   "|||2017-10-11 00:13:34.558431|2017-10-11 00:13:34.558431
NCT02189135|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-12-15|||July 2014||2014-07-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Making Ramadhan Fasting a Safer Experience With Technology Study|Making Ramadhan Fasting a Safer Experience With Technology Study|Completed||Phase 4|85|Actual|Monash University||2|||f||||f||||||||||2017-10-11 00:13:34.822912|2017-10-11 00:13:34.822912
NCT02189122|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-06-03|2016-03-18||July 2014||2014-07-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparative Effects of Aspirin and NHP-544C|Comparative Effects of Rapid-Release Aspirin and NHP-544C on Basal and Bradykinin Stimulated Prostacyclin Production|Completed||N/A|61|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 00:13:34.942342|2017-10-11 00:13:34.942342
NCT02189109|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-09-22|||May 2014||2014-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|GBM||The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma|A Phase 1b Dose-finding, Pharmacokinetic and Pharmacodynamic Study of NVX-108 Combined With Radiation and Temozolomide in Patients With Newly-diagnosed Glioblastoma Multiforme|Active, not recruiting||Phase 1|25|Anticipated|NuvOx Pharma Pty Ltd||1|||f||||t||||||||||2017-10-11 00:13:35.565231|2017-10-11 00:13:35.565231
NCT02189096|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-12-04|||May 2014||2014-05-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|VELPS||Validation of Early Warning Score & Lactate in Prehospital Screening|Validation of Early Warning Score & Lactate in Prehospital Screening|Completed||N/A|705|Actual|University of the West of Scotland|||3||f||||f||||||||||2017-10-11 00:13:35.697632|2017-10-11 00:13:35.697632
NCT02189083|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-07-10|||May 2014||2014-05-01|July 2014|2014-07-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids|A Double-blind, Randomized, Two-dose Trial of Tumor-shrinking Decoction (TSD), a Chinese Medicine Preparation in Patients With Symptomatic Uterine Fibroids|Unknown status|Recruiting|Phase 3|78|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 00:13:35.806358|2017-10-11 00:13:35.806358
NCT02189070|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-05-13|||July 2013||2013-07-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01|1 Year|Observational [Patient Registry]|PAPAYA||The PAtient Preference Analysis of Yearly Follow-up After PCI (PAPAYA)|What Patients Really Want - Patient Preferences Regarding Annual Follow-up After Medical Interventions: The PAPAYA Study|Completed||N/A|2566|Actual|Thorax Centrum Twente|||2||f||||f||||||||||2017-10-11 00:13:35.935391|2017-10-11 00:13:35.935391
NCT02189057|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-07-13|||November 2014||2014-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|MOD||A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression|A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management of Depression|Recruiting||N/A|276|Anticipated|Mayo Clinic||2|||f||||f|f|f||||||||2017-10-11 00:13:36.021641|2017-10-11 00:13:36.021641
NCT02189044|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2014-07-10|||August 2012||2012-08-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Pilates and Muscle Strength Respiratory|Effects of the Method Pilates Exercises in Muscle Strength Respiratory of Elderly Women: a Clinical Trial|Completed||N/A|7|Actual|Universidade Federal do Triangulo Mineiro||1|||f||||t||||||||||2017-10-11 00:13:36.14374|2017-10-11 00:13:36.14374
NCT02189031|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-03-17|||February 2013||2013-02-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Observational|||Sensory Feedback for Touch and Proprioception With Prosthetic Limbs|Sensory Feedback Tactor Systems for Implementation of Physiologically Relevant Cutaneous Touch and Proprioception With Prosthetic Limbs|Enrolling by invitation||N/A|49|Anticipated|Louis Stokes VA Medical Center|||2||f||||f||||||||||2017-10-11 00:13:36.239279|2017-10-11 00:13:36.239279
NCT02189018|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-11|||August 2014||2014-08-01|July 2014|2014-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|ACTION||Activity To Improve Outcomes in Peripheral Arterial Disease|Activity To Improve Outcomes in Peripheral Arterial Disease|Unknown status|Not yet recruiting|N/A|80|Anticipated|Baltimore VA Medical Center||4|||f||||t||||||||||2017-10-11 00:13:36.353192|2017-10-11 00:13:36.353192
NCT02189005|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2015-05-14|||November 2013||2013-11-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Precrea||Study to Evaluate Safety and Efficacy of PreCrea® on Subjects With Higher Than Normal Blood Sugar Levels|A Prospective, Double Blind, Placebo-Controlled, Randomized, Multicentric, Study to Evaluate the Efficacy and Safety of PreCrea®, a Twice-daily Dietary Supplement in People With Higher Than Normal Blood Sugar Levels.|Completed||Phase 3|210|Actual|PreEmptive Meds, Pvt. Ltd||2|||f||||t||||||||||2017-10-11 00:13:36.479679|2017-10-11 00:13:36.479679
NCT02188992|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-10-25|||January 2014||2014-01-01|July 2014|2014-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|ExPRES||Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study|Early Prediction of Severe Sepsis (ExPRESSepsis) Study|Completed||N/A|401|Actual|University of Edinburgh|||3||f||||f||||||Samples Without DNA|"     Samples of serum and plasma will be stored frozen.   "|||2017-10-11 00:13:36.606163|2017-10-11 00:13:36.606163
NCT02188979|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2014-07-10|||March 2012||2012-03-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|GLOBE||GlideScope With EGRI Assessment in Obese Patients|GlideScope Videolaryngoscopy and Pre-Operative Assessment of El-Ganzouri Risk Index for Tracheal Intubation in Morbidly Obese Patients The Prospective Observational GLOBE Study|Completed||N/A|195|Actual|Università degli Studi di Brescia|||1||f||||f||||||||||2017-10-11 00:13:36.735558|2017-10-11 00:13:36.735558
NCT02188966|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-12-08|||May 2014||2014-05-01|March 2014|2014-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Application of Geographical Information System Data in the Emergency Department, Effect on Trauma Team and Medical Emergency Team Wait|Telemedical Solutions in Medical Emergencies, Advantages and Disadvantages for Patients, Healthcare Professionals, and Healthcare System. Study 4: Application of Geographical Information System Data in the Emergency Department, Effect on Trauma Team and Medical Emergency Team Wait - a Before and After Study|Completed||N/A|599|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 00:13:36.847424|2017-10-11 00:13:36.847424
NCT02188953|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-09-15|||August 2014||2014-08-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ACCS100||Evaluation of ACCS100 to Reduce Aflatoxin Exposure in Kenya|Evaluation of the Effectiveness, Acceptability, and Palatability of Air Classified Calcium Silicate (ACCS100) Clay to Reduce Aflatoxin Exposure in a High-risk Community in Kenya|Completed||Phase 2|50|Actual|Kenya Medical Research Institute||2|||f||||f||||||||||2017-10-11 00:13:36.947726|2017-10-11 00:13:36.947726
NCT02188940|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-02-19|||July 2014||2014-07-01|July 2014|2014-07-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|||Exercise Training to Lose Weight in Obese Asthmatics|Effects of Exercise Training in a Weight-loss Lifestyle Intervention on Clinical Control and Psychosocial Morbidity in Obese Asthmatics: a Randomized and Controlled Trial|Completed||N/A|55|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||Yes||2017-10-11 00:13:37.070974|2017-10-11 00:13:37.070974
NCT02188927|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-11|2014-07-11|||August 2014||2014-08-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect of an Advanced Notification Letter on Screening Colonoscopy Participation|Participation in Screening Colonoscopy in Response to an Advanced Notification Letter Plus Standard Invitation Versus Standard Invitation Only - a Population-based Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|6800|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||f||||||||||2017-10-11 00:13:37.185544|2017-10-11 00:13:37.185544
NCT02188914|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-08-15|||November 1, 2014|Actual|2014-11-01|August 2017|2017-08-01|July 30, 2016|Actual|2016-07-30|July 30, 2016|Actual|2016-07-30||Observational|||Brain Imaging Studies of the Effect of Inhalant Use Disorder|Neurobiología Del Consumo de Substancias Psicoactivas: PET-CT- Inhalables|Completed||N/A|70|Actual|Instituto para la Atención y Prevención de las Adicciones en la Ciudad de México|||2||f||||t||||||Samples With DNA|"     cDNA obtained from reversal transcription of RNA isolated from periferical blood cells   "|||2017-10-11 00:13:37.273914|2017-10-11 00:13:37.273914
NCT02188901|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-10-17|||June 2014||2014-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study|Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study|Completed||N/A|523|Actual|Yonsei University||1|||f||||t||||||||||2017-10-11 00:13:37.370168|2017-10-11 00:13:37.370168
NCT02188888|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-08-06|||December 2013||2013-12-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Echocardiographic and Arterial Pressure Waveform Changes After Reducing Heart Rate With Esmolol in Septic Shock Patients|Heart Rate Reduction With Esmolol is Associated With Improved Arterial Elastance in Patients With Septic Shock. A Prospective Observational Study|Completed||N/A|45|Actual|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 00:13:37.44282|2017-10-11 00:13:37.44282
NCT02188862|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-14|||September 2012||2012-09-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region|Genome-wide Association Study of Susceptibility to Rheumatic Heart Disease in Fiji and New Caledonia|Completed||N/A|2372|Actual|University of Oxford|||2||f||||f||||||Samples With DNA|"     Blood collected from all participants for extraction of DNA   "|||2017-10-11 00:13:37.626258|2017-10-11 00:13:37.626258
NCT02188849|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-10-01|2015-10-01||October 2014||2014-10-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Effects of Creatine Supplementation on Muscle Mass and Function Among Older Women Subjected to Resistance Training|Effects of Creatine Supplementation on Muscle Mass and Function Among Older Women Subjected to Resistance Training|Completed||Phase 3|50|Actual|University of Chile||2|||f||||t||||||||||2017-10-11 00:13:37.729296|2017-10-11 00:13:37.729296
NCT02188836|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-11|||January 2008||2008-01-01|July 2014|2014-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Electromagnetic Stimulation as Coadjuvant in the Healing of Diaphyseal Femoral Fractures|Electromagnetic Stimulation as Coadjuvant in the Healing of Diaphyseal Femoral Fractures: a Randomized Controlled Trial|Completed||Phase 3|64|Actual|Fundacion Clinica Valle del Lili||2|||f||||t||||||||||2017-10-11 00:13:38.0076|2017-10-11 00:13:38.0076
NCT02188823|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-06-14|||July 2014|Actual|2014-07-01|June 2017|2017-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Examining the Effects of Diet on Health in Prediabetes With an Online Program|Examining the Effects of Diet on Health in Prediabetes With an Online Program|Terminated||N/A|11|Actual|University of California, San Francisco||1||low recruitment|f||||f||||||||||2017-10-11 00:13:38.086588|2017-10-11 00:13:38.086588
NCT02188810|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-02-11|||April 2014||2014-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults|A Phase I Randomized, Observer-blind, Controlled, Dose Escalation Trial of the Safety and Tolerability of a Single Intramuscular Dose of a PAL Adjuvant (FB-631) Co-administered With Seasonal TIV (2013-2014) in Healthy Adults.|Active, not recruiting||Phase 1|48|Anticipated|Folia Biotech Inc.||6|||f||||t||||||||||2017-10-11 00:13:38.190506|2017-10-11 00:13:38.190506
NCT02188797|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-04-15|||January 2014||2014-01-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Substance Use and Sexual Risk Reduction Intervention for Homeless Youth|Brief AOD Use and Sexual Risk Reduction Group MI Intervention for Homeless|Completed||N/A|200|Actual|RAND||2|||f||||t||||||||||2017-10-11 00:13:38.292214|2017-10-11 00:13:38.292214
NCT02188784|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-06-09|2016-12-30||September 3, 2014|Actual|2014-09-03|June 2017|2017-06-01|April 6, 2016|Actual|2016-04-06|April 6, 2016|Actual|2016-04-06||Interventional|IRONOUT|All randomized patients|Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure|Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure|Completed||Phase 3|225|Actual|Duke University||2|||f||||t||||||||Yes|After the study results have been published, site-specific participant data will be shared with sites upon request. Sites are expected to follow their specific institutional policies regarding sharing results with their participants.|2017-10-11 00:13:38.434321|2017-10-11 00:13:38.434321
NCT02188771|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-04-25|||February 2014||2014-02-01|July 2014|2014-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthritis||Completed||Phase 1/Phase 2|11|Actual|ProCore Ltd.||1|||f||||f||||||||||2017-10-11 00:13:39.740463|2017-10-11 00:13:39.740463
NCT02188758|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-02-07|||July 2014||2014-07-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment|Do Changes in Serum Hepcidin-25 Concentration Predict Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment Responses?|Recruiting||N/A|23|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||f||||||Samples With DNA|"     Bacterial DNA and RNA will be isolated from sputum samples and stored for future analyses.   "|||2017-10-11 00:13:39.838397|2017-10-11 00:13:39.838397
NCT02188745|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-03-25|||August 2015||2015-08-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|POLLY||ER Reactivation Therapy for Breast Cancer|Phase II Pre-emptive OsciLLation of ER activitY Levels Through Alternation of Estradiol/Anti-estrogen Therapies Prior to Disease Progression in ER+/HER2- Advanced Breast Cancer|Recruiting||Phase 2|59|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 00:13:41.837056|2017-10-11 00:13:41.837056
NCT02188732|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-11|||September 2014||2014-09-01|July 2014|2014-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes|Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes|Not yet recruiting||N/A|300|Anticipated|Dartmouth-Hitchcock Medical Center||3|||f||||t||||||||||2017-10-11 00:13:41.981589|2017-10-11 00:13:41.981589
NCT02188719|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-10-14|||December 2014||2014-12-01|October 2016|2016-10-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|deLTa||Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation|Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Liver Transplantation (RTB-002)|Recruiting||Phase 1|24|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-11 00:13:42.102224|2017-10-11 00:13:42.102224
NCT02188706|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-03-21|||July 2014|Actual|2014-07-01|March 2017|2017-03-01|July 2026|Anticipated|2026-07-01|July 2026|Anticipated|2026-07-01||Interventional|||A Leukemia SPORE Phase II Clinical Trial Comparing Decitabine Versus Decitabine/Carboplatin and Decitabine/Arsenic for the Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Leukemia SPORE Phase II Randomized Study of Decitabine Versus Decitabine and Carboplatin Versus Decitabine and Arsenic in Relapsed, Refractory and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Active, not recruiting||Phase 2|120|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-11 00:13:42.321925|2017-10-11 00:13:42.321925
NCT02188693|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-10|||July 2014||2014-07-01|July 2014|2014-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01|3 Years|Observational [Patient Registry]|||Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer|Maintenance Versus Observation With 6 Cycles of Gemcitabine Plus Taxol Sequential Gemcitabine Single Agent in Patients With Metastatic Breast Cancer|Recruiting||N/A|267|Anticipated|Xijing Hospital|||2||f||||f||||||Samples With DNA|"     2 ml blood sample is needed before enrollment.   "|||2017-10-11 00:13:42.424394|2017-10-11 00:13:42.424394
NCT02188680|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-06-13|||January 2014||2014-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|FructIBS||Irritable Bowel Syndrome and Low FODMAP Diet|Does Irritable Bowel Syndrome Improved by Low FODMAP Diet ?|Recruiting||N/A|112|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 00:13:42.509078|2017-10-11 00:13:42.509078
NCT02188667|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-03-29|||July 2014||2014-07-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|I-PRO||Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care|An Integrative and Sustainable Approach to Pain Management in Primary Care|Completed||N/A|21|Actual|University of Florida||2|||f||||f||||||||Undecided||2017-10-11 00:13:42.58767|2017-10-11 00:13:42.58767
NCT02188654|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-09|||September 2013||2013-09-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Metformin in Psoriatic Arthritis|Metformin: A Valid Add-On Drug in the Treatment of Psoriatic Arthritis-Randomized Controlled Trial|Completed||N/A|56|Actual|Faculty of Medicine, University of Alexandria||2|||f||||t||||||||||2017-10-11 00:13:42.689368|2017-10-11 00:13:42.689368
NCT02188641|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-09|||June 2013||2013-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Exercise and Diet on Psoriatic Arthritis|EFFECT OF EXERCISE AND DIETARY WEIGHT LOSS ON SYMPTOMS AND SYSTEMIC INFLAMMATION IN OBESE ADULTS WITH PSORIATIC ARTHRITIS: RANDOMIZED CONTROLLED TRIAL|Completed||N/A|55|Actual|Faculty of Medicine, University of Alexandria||4|||f||||t||||||||||2017-10-11 00:13:42.898736|2017-10-11 00:13:42.898736
NCT02188628|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-02-17|||July 2014||2014-07-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Refinement and Clinical Evaluation of the H-Man for Arm Rehabilitation After Stroke|Refinement and Clinical Evaluation of the H-Man: A Novel, Portable, Inexpensive Planar Robot for Arm Rehabilitation After Stroke|Recruiting||Phase 1/Phase 2|44|Anticipated|Tan Tock Seng Hospital||2|||f||||f||||||||No||2017-10-11 00:13:42.999483|2017-10-11 00:13:42.999483
NCT02188615|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2014-07-09|||June 2011||2011-06-01|July 2014|2014-07-01|July 2019|Anticipated|2019-07-01|June 2015|Anticipated|2015-06-01||Interventional|NACRFMIE||Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer|A Single Institution Prospective Randomized Controlled Clinical Trial of Neo-adjuvant Chemoradiotherapy Followed by Mckeown Minimally Invasive Esophagectomy (MIE) Versus Mckeown MIE for Locally Advanced Squamous Cell Esophageal Carcinoma|Recruiting||Phase 2|120|Anticipated|Taizhou Hospital||3|||f||||t||||||||||2017-10-11 00:13:43.114437|2017-10-11 00:13:43.114437
NCT02188602|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2014-07-10|||July 2013||2013-07-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Effect of Cumulative Chloride Dose on Development of Acute Kidney Injury in Critically Ill Children|Retrospective Investigation of Chloride Dosing and Its Effect on Acute Kidney Injury|Unknown status|Active, not recruiting|N/A|1500|Anticipated|Stanford University|||2||f||||t||||||||||2017-10-11 00:13:43.238206|2017-10-11 00:13:43.238206
NCT02188589|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2017-01-01|2016-06-17||May 2014||2014-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse|Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse|Active, not recruiting||N/A|30|Actual|Spirox, Inc.||1|||f||||f||||||||||2017-10-11 00:13:43.314409|2017-10-11 00:13:43.314409
NCT02188576|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-04-11|||August 2014||2014-08-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery|The Efficacy and Population Pharmacokinetics/ Pharmacogenomics of a Reduced Dose of Tranexamic Acid for Craniosynostosis Surgery|Recruiting||Phase 4|68|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||No||2017-10-11 00:13:43.518475|2017-10-11 00:13:43.518475
NCT02188563|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-05-20|||May 2014||2014-05-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|May 2015|Actual|2015-05-01||Interventional|||A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers|Efficacy and Impact of a Comprehensive Smoking Cessation Intervention During Radiation for Upper Aerodigestive Cancers|Unknown status|Active, not recruiting|N/A|30|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||||2017-10-11 00:13:43.649025|2017-10-11 00:13:43.649025
NCT02188550|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-05-18|||June 2014||2014-06-01|May 2015|2015-05-01||||June 2016|Anticipated|2016-06-01||Interventional|||Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer|Phase II Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer (CRAD001CUS242T)|Unknown status|Recruiting|Phase 2|20|Anticipated|Sinai Hospital of Baltimore||1|||f||||f||||||||||2017-10-11 00:13:43.757353|2017-10-11 00:13:43.757353
NCT02188537|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-09-28|||December 2, 2014||2014-12-02|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma|Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma. A Multicenter Phase II Trial|Active, not recruiting||Phase 2|34|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 00:13:43.862288|2017-10-11 00:13:43.862288
NCT02188524|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-12-06|||April 2014||2014-04-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of Training Older Adults in Tai Chi and Compensatory Stepping on Balance Control|The Effect of Training Older Adults in Tai Chi and Compensatory Stepping on Balance Control|Completed||N/A|22|Actual|Wilfrid Laurier University||2|||f||||f||||||||||2017-10-11 00:13:44.000014|2017-10-11 00:13:44.000014
NCT02188511|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-05-23|||January 2014||2014-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effects of Electronic Cigarettes on Lung Biology|Effects of Electronic Cigarettes on Lung Biology|Recruiting||N/A|50|Anticipated|Weill Medical College of Cornell University||5|||f||||t||||||||Undecided||2017-10-11 00:13:44.091465|2017-10-11 00:13:44.091465
NCT02188498|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-01-09|||September 2013||2013-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|Holter||Electrocardiography Data Analysis in Sleep Disorders|Electrocardiography Data Analysis in Sleep Disorders|Active, not recruiting||N/A|120|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-10-11 00:13:44.225323|2017-10-11 00:13:44.225323
NCT02188485|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-07-07|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|||Social Connections and Late Life Suicide|Social Connections and Late Life Suicide|Completed||N/A|62|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 00:13:44.309932|2017-10-11 00:13:44.309932
NCT02188472|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-01|2014-07-09|||November 2010||2010-11-01|July 2014|2014-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|PENTRIOX||Pentriox - Induction of Oxidative Stress|PENTRIOX - a Randomized, Placebo-controlled Clinical Study on the Possible Induction of Oxidative Stress by Phenoxymethylpenicillin and Trimethoprim on Healthy Volunteers|Completed||Phase 1|90|Actual|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-10-11 00:13:44.401718|2017-10-11 00:13:44.401718
NCT02188459|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-06-14|||October 2014||2014-10-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|BIBS||Placebo-controlled Trial of Bupropion for Smoking Cessation in Pregnant Women|Placebo-controlled Trial of Bupropion for Smoking Cessation in Pregnant Women|Recruiting||Phase 2|360|Anticipated|University of Pennsylvania||2|||f||||t||||||||No||2017-10-11 00:13:44.505347|2017-10-11 00:13:44.505347
NCT02188446|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-04-10|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|STOP-OP||Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients|Randomised Controlled Multicenter Study.Effect of an Intensive Smoking- and/or Alcohol Cessation Intervention Placed Shortly Before and 5 Weeks After Bladder Cancer Surgery on Postoperative Complications|Recruiting||N/A|110|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:13:44.620753|2017-10-11 00:13:44.620753
NCT02188433|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-11-16|||May 2014||2014-05-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Promoting Smoking Cessation in the Community Via QTW 2014|Building Capacity and Promoting Smoking Cessation in the Community Via Quit to Win Contest 2014: a Randomized Controlled Trial|Completed||N/A|1307|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 00:13:44.719298|2017-10-11 00:13:44.719298
NCT02188394|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-01-03|||July 2014||2014-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Anesthetic Blockades and Migraine|Effects of Anesthetic Blockades on Pain Modulation in Migraine|Completed||Phase 2|36|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 00:13:45.202257|2017-10-11 00:13:45.202257
NCT02188381|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-08-17|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Role of Gut Microbiota in Hypertension|The Role of Gut Microbiota in Hypertension|Recruiting||N/A|398|Anticipated|University of Florida|||4||f||||f|f|f||||Samples With DNA|"     Stool Samples   "|||2017-10-11 00:13:45.302564|2017-10-11 00:13:45.302564
NCT02188368|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-03-08|||August 2014||2014-08-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|||Pomalidomide for Lenalidomide for Failures|A Phase 2 Study of Pomalidomide as a Replacement for Lenalidomide for Multiple Myeloma Patients Relapsed or Refractory to a Lenalidomide-Containing Combination Regimen|Recruiting||Phase 2|45|Anticipated|Oncotherapeutics||3|||f||||t||||||||||2017-10-11 00:13:45.422464|2017-10-11 00:13:45.422464
NCT02188355|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-08-02|||October 2014||2014-10-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01|1 Year|Observational [Patient Registry]|e-Ultimaster||Prospective, Single-arm, Multi Centre Observations Ultimaster Des Registry|Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice|Recruiting||N/A|37000|Anticipated|Terumo Europe N.V.|||1||f||||f||||||||||2017-10-11 00:13:45.700704|2017-10-11 00:13:45.700704
NCT02188342|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-07-26|||January 2015|Actual|2015-01-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|HITCa||Assessing The Effectiveness of a Preoperative High Intensity Interval Training Programme In Older Colorectal Cancer Patients|Effectiveness of Short Term, High Intensity, Interval Exercise Training in Older Colorectal Cancer Patients in Improving Preoperative Fitness|Completed||N/A|18|Actual|University of Nottingham||1|||f||||f||||||||||2017-10-11 00:13:47.731849|2017-10-11 00:13:47.731849
NCT02188329|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-07-09|||November 2011||2011-11-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|NSECE||National Survey of Early Care and Education|National Survey of Early Care and Education|Completed||N/A|31436|Actual|National Opinion Research Center|||4||f||||f||||||||||2017-10-11 00:13:47.828699|2017-10-11 00:13:47.828699
NCT02188316|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-10|||March 2014||2014-03-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Jumbo and Hot Biopsy Forceps|The Histological Quality and Adequacy of Diminutive Colorectal Polyps Resected Using Jumbo Versus Hot Biopsy Forceps|Completed||N/A|179|Actual|Camlıca Erdem Hospital||2|||f||||t||||||||||2017-10-11 00:13:47.918429|2017-10-11 00:13:47.918429
NCT02188303|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-01-21|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants|A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of the Oxyntomodulin Analog, LY2944876, in Healthy Japanese Subjects and Healthy Non-Japanese Subjects|Terminated||Phase 1|48|Actual|Eli Lilly and Company||6||The termination criteria of the protocol was met during dose escalation.|f||||f||||||||||2017-10-11 00:13:47.996535|2017-10-11 00:13:47.996535
NCT02188290|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-10-05|||September 2014||2014-09-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation|An Observational Cohort Study on Transplant-Related Mortality in Patients Receiving Either a Hematopoietic Stem Cell Transplantation Without ATIR or an Umbilical Cord Blood Transplantation|Completed||N/A|178|Actual|Kiadis Pharma|||4||f||||f||||||||||2017-10-11 00:13:48.077882|2017-10-11 00:13:48.077882
NCT02188277|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-01-25|||July 2014||2014-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|XEBEC||Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy|Multi-center Open Comparative Randomized Trial of Clinical and Neurophysiological Efficacy and Safety of Xeomin (Botulinum Toxin Type A) vs. Botox (Complex of Botulinum Toxin Type A and Hemagglutinin) in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy|Completed||Phase 2|64|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-10-11 00:13:48.170504|2017-10-11 00:13:48.170504
NCT02188043|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-09-28|||November 2013||2013-11-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|Relay||Project Relay Model for Recruiting Alcohol Dependent Patients in General Hospitals|Relay Model for Recruiting Alcohol Dependent Patients in General Hospitals - A Single-blind Pragmatic Randomised Trial|Completed||N/A|1000|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 00:13:50.245366|2017-10-11 00:13:50.245366
NCT02188251|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2015-08-11|||September 2014||2014-09-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|14AWHG||A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants|A Randomized, Double-blind, Placebo Controlled, Parallel Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants|Completed||Phase 2|100|Actual|KGK Synergize Inc.||2|||f||||||||||||||2017-10-11 00:13:48.407574|2017-10-11 00:13:48.407574
NCT02188238|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-10-03|||July 2014||2014-07-01|October 2017|2017-10-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Observational|||Effect of Oral Health Ingredients on the Acquired Salivary Pellicle|Effect of Active Ingredients in Oral Health Products on the in Vitro Structure of the Acquired Salivary Pellicle.|Enrolling by invitation||N/A|10|Anticipated|Quadram Institute|||1||f||||f||||||||||2017-10-11 00:13:48.499888|2017-10-11 00:13:48.499888
NCT02188225|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2017-08-27|||July 2014||2014-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Comparison of Acupuncture and Fluoxetine on Quality of Life in Menopausal Women|Comparison of the Effects of Acupuncture and Fluoxetine on Quality of Life in Menopausal Women|Enrolling by invitation||N/A|140|Anticipated|Gonabad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:13:48.568865|2017-10-11 00:13:48.568865
NCT02188212|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-09-23|||March 2010||2010-03-01|July 2014|2014-07-01||||November 2013|Actual|2013-11-01||Interventional|||Nobel Procera Crown Shaded Zirconia and NobelProceraTM Full Contour Crown IPS e.Max CAD|A Clinical Evaluation of Hand-veneered, Porcelain-fused NobelProceraTM Crown Shaded Zirconia and NobelProceraTM Full Contour Crown IPS e.Max CAD on Molars|Terminated||N/A|53|Actual|Nobel Biocare||1|||f||||f||||||||||2017-10-11 00:13:48.667252|2017-10-11 00:13:48.667252
NCT02188199|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-10|||May 2012||2012-05-01|July 2014|2014-07-01||||December 2016|Anticipated|2016-12-01|1 Year|Observational [Patient Registry]|||C3 Total Joint Patient Registry|Clinical Care Continuum (C3) Total Joint Patient Registry|Unknown status|Recruiting|N/A|10000|Anticipated|DC2 Healthcare|||2||f||||f||||||||||2017-10-11 00:13:48.7461|2017-10-11 00:13:48.7461
NCT02188173|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2016-05-31|||July 2014||2014-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)||Completed||N/A|200|Actual|Allergan|||1||f||||f||||||||||2017-10-11 00:13:49.105701|2017-10-11 00:13:49.105701
NCT02188160|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-07-17||2016-07-08|June 2014||2014-06-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|Kauai||Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease|A Phase II, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease|Completed||Phase 2|150|Actual|Kala Pharmaceuticals, Inc.||2|||f||||f||||||||No||2017-10-11 00:13:49.259035|2017-10-11 00:13:49.259035
NCT02188147|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-08-14|||August 2014||2014-08-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ASAP||Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study|Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study Protocol|Recruiting||N/A|80|Anticipated|Zoll Medical Corporation||1|||f||||f||||||||||2017-10-11 00:13:49.408485|2017-10-11 00:13:49.408485
NCT02188134|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2015-04-06|||October 2014||2014-10-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Observational|||Quantifying the Attentive Behaviors of Older Adults During Over-the-counter Drug Selection|Quantifying the Attentive Behaviors of Older Adults During Over-the-counter Drug Selection|Completed||N/A|82|Actual|Michigan State University|||1||f||||f||||||||||2017-10-11 00:13:49.513672|2017-10-11 00:13:49.513672
NCT02188121|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-07-11|||February 2015||2015-02-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|FITNESS||Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients|Fixed Dose Intervention Trial of New England Enhancing Survival in Serious Mental Illness Patients|Recruiting||Phase 4|300|Anticipated|Mclean Hospital||2|||f||||t||||||||||2017-10-11 00:13:49.592706|2017-10-11 00:13:49.592706
NCT02188108|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-10-26|||July 2014||2014-07-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Validation of the Wisconsin Stone-QOL|Validation of the Wisconsin Stone-QOL, a Quality of Life Survey for Kidney Stone Formers|Recruiting||N/A|2000|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 00:13:49.689121|2017-10-11 00:13:49.689121
NCT02188095|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-01-25|||September 2014||2014-09-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|November 2015|Actual|2015-11-01||Observational|||Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis|Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis|Active, not recruiting||N/A|100|Actual|Aesculap AG|||1||f||||f||||||||||2017-10-11 00:13:49.794455|2017-10-11 00:13:49.794455
NCT02188082|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-10|||May 2014||2014-05-01|May 2014|2014-05-01||||August 2017|Anticipated|2017-08-01||Interventional|FIRST||Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST）|Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST）|Unknown status|Recruiting|Phase 2/Phase 3|336|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:13:49.877982|2017-10-11 00:13:49.877982
NCT02188069|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-09-24|||June 2014||2014-06-01|September 2015|2015-09-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01|3 Years|Observational [Patient Registry]|||Canadian SCAD Study|Canadian Spontaneous Coronary Artery Dissection (SCAD) Cohort Study|Recruiting||N/A|750|Anticipated|Cardiology Research UBC|||1||f||||f||||||||||2017-10-11 00:13:50.037948|2017-10-11 00:13:50.037948
NCT02188056|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-10-20|||October 2014||2014-10-01|July 2014|2014-07-01||||August 2017|Anticipated|2017-08-01|1 Year|Observational [Patient Registry]|REMOTEV||Observational Prospectif Monocentric Registry of Patients Suffering From VIE|Observational Prospectif Monocentric Registry of Patients Suffering From VIE|Unknown status|Not yet recruiting|N/A|300|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 00:13:50.178852|2017-10-11 00:13:50.178852
NCT02188030|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-07-09|||June 2014||2014-06-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|Exercise||Individual and Group Exercise Program for Industrial Workers With CANS: Randomized Controlled Trial|Individual Exercise Program for Industrial Workers With Complaints of the Arm, Neck, or Shoulder (CANS): Study Protocol for a Randomized Controlled Trial.|Unknown status|Recruiting|N/A|100|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t||||||||||2017-10-11 00:13:50.330155|2017-10-11 00:13:50.330155
NCT02188004|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-07-13|||June 2014||2014-06-01|July 2014|2014-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases|The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases In Male and Female Aged Over 18 Years In China|Completed||N/A|4691|Actual|Xiamen University|||1||f||||f||||||Samples With DNA|"     Male:Two swabs were used to collect exfoliated skin cells from the coronal sulcus     /glans/shaft and anal      Female:Three swabs were used to collect exfoliated skin cells from the vagina，vulva and anal   "|||2017-10-11 00:13:50.746806|2017-10-11 00:13:50.746806
NCT02187991|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2016-09-15|||February 2015||2015-02-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer|A Phase II, Multicenter, Randomized, Parallel Group Study to Compare Alisertib in Combination With Paclitaxel vs. Paclitaxel Alone in Patients With Metastatic or Locally Recurrent Breast Cancer|Recruiting||Phase 2|252|Anticipated|US Oncology Research||4|||f||||t||||||||||2017-10-11 00:13:50.81112|2017-10-11 00:13:50.81112
NCT02187978|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-09-26|||July 2014||2014-07-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Early Total Enteral Feeding Versus Conventional Enteral Feeding in Stable Very Low Birth Weight Infants|Comparison of Early Total Enteral Feeding (ETEF) Versus Conventional Enteral Feeding (CEF) in Stable Very Low Birth Weight (VLBW) Infants - A Randomized Controlled Trial|Completed||N/A|180|Actual|Lady Hardinge Medical College||2|||f||||t||||||||||2017-10-11 00:13:50.904007|2017-10-11 00:13:50.904007
NCT02187965|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-10|||August 2011||2011-08-01|August 2011|2011-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Impact of Muscle Fat Accumulation on the Genomic Profile of Skeletal Muscle in Older Adults||Completed||N/A|11|Actual|Purdue University|||1||f||||||||||Samples With DNA|"     muscle tissue, RNA   "|||2017-10-11 00:13:50.985966|2017-10-11 00:13:50.985966
NCT02187952|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-04-12|||July 2014||2014-07-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Impact of Behavioral Feeding Intervention on Parent-Child Attachment in Young Children|Impact of Behavioral Feeding Intervention on Parent-Child Attachment in Young Children|Completed||Phase 4|24|Actual|University of Michigan||2|||f||||||||||||||2017-10-11 00:13:51.051603|2017-10-11 00:13:51.051603
NCT02187939|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-02-20|||May 2013||2013-05-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|GROOVE||Get in the GROOVE!|Get in the GROOVE (Girls Realizing Options Through OpenSim Virtual Experiences)!|Completed||N/A|375|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 00:13:51.125233|2017-10-11 00:13:51.125233
NCT02187926|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-12-01|||May 2011||2011-05-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|ATLAS||Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece|Observational Study for the Evaluation of Clinical Effectiveness in Routine Practice of Daxas® (Roflumilast), in Approximately 2700 Patients With Severe and Very Severe COPD (Chronic Obstructive Pulmonary Disease) in Greece|Completed||N/A|2577|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:13:51.214219|2017-10-11 00:13:51.214219
NCT02187900|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2014-07-10|||June 2014||2014-06-01|July 2014|2014-07-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.|Phase 3 Study of Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f|Unknown status|Recruiting|Phase 3|300|Anticipated|Second Xiangya Hospital of Central South University||2|||f||||t||||||||||2017-10-11 00:13:51.362347|2017-10-11 00:13:51.362347
NCT02187887|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-04-12|||May 2015||2015-05-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|April 2016|Actual|2016-04-01||Interventional|||Online Program for Young Adult Veteran Drinkers|Brief Online Intervention to Reduce Heavy Alcohol Use Among Young Adult Veterans|Active, not recruiting||N/A|793|Actual|RAND||2|||f||||f||||||||||2017-10-11 00:13:51.538795|2017-10-11 00:13:51.538795
NCT02187874|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2016-04-23|||July 2014||2014-07-01|April 2016|2016-04-01||||July 2017|Anticipated|2017-07-01||Interventional|CODE-P||Timing of Umbilical Cord Occlusion in Premature Babies( <33 w). Delayed vs Early.|Timing of Umbilical Cord Occlusion in Premature Babies( <33 w). Delayed vs Early.|Recruiting||N/A|150|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||||2017-10-11 00:13:51.639152|2017-10-11 00:13:51.639152
NCT02187692|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2014-07-10|||August 2012||2012-08-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional|||The Effectiveness of the Meta-cognitive Training Among Patients With Chronic Schizophrenia|The Effectiveness of The Meta-cognitive Training Among Chronic Schizophrenia Patients Treated Within Community Support Groups in Poland.|Completed||N/A|50|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 00:13:54.26503|2017-10-11 00:13:54.26503
NCT02187848|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-05-09|||July 23, 2014|Actual|2014-07-23|May 2017|2017-05-01|April 8, 2019|Anticipated|2019-04-08|April 8, 2019|Anticipated|2019-04-08||Interventional|||Evaluation of SAR408701 in Patients With Advanced Solid Tumors|A First-in-Human Study for the Evaluation of the Safety, Pharmacokinetics and Antitumor Activity of SAR408701 in Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|152|Anticipated|Sanofi||5|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-11 00:13:52.059226|2017-10-11 00:13:52.059226
NCT02187822|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-09-28|||October 9, 2014|Actual|2014-10-09|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases|A Phase 1 Study of TPI 287 Concurrent With Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases From Advanced Breast and Non-Small Cell Lung (NSCL) Cancer|Suspended||Phase 1|36|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1||sponsor review|f||||f|t|f||||||||2017-10-11 00:13:52.284919|2017-10-11 00:13:52.284919
NCT02187809|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-02-22|2016-10-28||March 2015||2015-03-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||At the time of study termination, one patient had had been treated|Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome|Multi-site, Prospective, Open-label, Long-term, Flexible Dose, Interventional Study to Evaluate the Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome|Terminated||Phase 3|3|Actual|H. Lundbeck A/S|Early termination leading to small numbers of subjects treated and no analysis. One patient was treated for 33 days.|1||The study was terminated due to recruitment challenges|f||||t||||||||||2017-10-11 00:13:52.382722|2017-10-11 00:13:52.382722
NCT02187796|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-08-03|||May 2014||2014-05-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|HAND||Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic|PREVALENCE of HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS (HAND) in a SCHOOL of MEDICINE HIV/AIDS OUTPATIENT CLINIC|Completed||N/A|50|Actual|East Tennessee State University|||5||f||||f||||||||||2017-10-11 00:13:52.614147|2017-10-11 00:13:52.614147
NCT02187783|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-09-22|||August 25, 2014|Actual|2014-08-25|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|SIGNATURE||LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)|Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 8 - LEE011 for Patients With CDK4/6 Pathway Activated Tumors|Active, not recruiting||Phase 2|106|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 00:13:52.716351|2017-10-11 00:13:52.716351
NCT02187770|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-10-13|||July 2014||2014-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Precision of IMED-4 Lung Fluid Measurements|Precision of IMED-4 Lung Fluid Measurements|Completed||N/A|46|Actual|Intersection Medical, Inc.|||1||f||||t||||||||||2017-10-11 00:13:52.905265|2017-10-11 00:13:52.905265
NCT02187757|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-05-14|||November 2013||2013-11-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Prelip||Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels|A Prospective, Double Blind, Placebo-Controlled, Randomized, Multicentric, Study to Evaluate the Safety, Efficacy and Tolerability of PreLipid®, a Twice-daily Nutritional Supplement in Subjects With Higher Than Normal Blood Lipid Levels|Completed||Phase 3|180|Actual|PreEmptive Meds, Pvt. Ltd||2|||f||||t||||||||||2017-10-11 00:13:52.983898|2017-10-11 00:13:52.983898
NCT02187744|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-04-13|2017-02-22||September 23, 2014||2014-09-23|April 2017|2017-04-01|March 9, 2016|Actual|2016-03-09|March 9, 2016|Actual|2016-03-09||Interventional||All participants who were randomized into the study.|A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)|A Randomized, Double-blind Pharmacokinetic Study Of Pf-05280014 Plus Taxotere (Registered) And Carboplatin Versus Herceptin (Registered) Plus Taxotere (Registered) And Carboplatin For The Neoadjuvant Treatment Of Patients With Operable Her2-positive Breast Cancer|Completed||Phase 3|226|Actual|Pfizer|It was decided that the secondary study objective to explore the relationship between drug exposure and pCR for PF-05280014 versus trastuzumab-EU would not be analyzed.|2|||f||||t||||||||||2017-10-11 00:13:53.114218|2017-10-11 00:13:53.114218
NCT02187731|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-03-04|||June 2013|Actual|2013-06-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|FULIMA||Functional Imaging in Multiple Myeloma -PET/CT and Diffusion Weighted Imaging in Multiple Myeloma|FULIMA - A Prospective Study of Dual Time PET/CT and Diffusion Weighted MRI in Multiple Myeloma|Active, not recruiting||N/A|70|Actual|Odense University Hospital|||1||f||||t||||||||||2017-10-11 00:13:53.979245|2017-10-11 00:13:53.979245
NCT02187718|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-10|||January 2015||2015-01-01|July 2014|2014-07-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|AMBULANT||Ambulatory SNP Under Local Anaesthesia in a Subgroup of Breast Cancer Patients - Trial|A Prospective Single-centre Randomised Controlled Clinical Trial Comparing Sentinel Node Procedure Under Local Anaesthesia to Traditional Sentinel Node Procedure Under General Anaesthesia in Patients <60 Years With a Breast Carcinoma >20 mm.|Unknown status|Not yet recruiting|N/A|80|Anticipated|Medical Center Alkmaar||2|||f||||f||||||||||2017-10-11 00:13:54.065468|2017-10-11 00:13:54.065468
NCT02187705|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-10|||May 1999||1999-05-01|July 2014|2014-07-01||||May 2000|Actual|2000-05-01||Observational|||Micardis® in Patients With Essential Hypertension|Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals|Completed||Phase 4|1688|Actual|Boehringer Ingelheim|||3||f||||||||||||||2017-10-11 00:13:54.188958|2017-10-11 00:13:54.188958
NCT02187146|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-10-24|||September 2013||2013-09-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|VIDIO||The Effects of Serum Vitamin D and IVF Outcome|The Effects of Serum Vitamin D and IVF Outcome: a Prospective Cohort Study|Completed||N/A|504|Actual|University of Birmingham|||1||f||||t||||||||||2017-10-11 00:14:00.8132|2017-10-11 00:14:00.8132
NCT02187679|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2015-02-09|||January 2014||2014-01-01|February 2015|2015-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome|An Open Label, One Arm Pilot Study to Measure the Efficacy and Safety of Dysport in the Treatment of Vocal Tics in Patients With Tourette's Syndrome and Chronic Tic Disorders|Unknown status|Recruiting|N/A|30|Anticipated|Detroit Clinical Research Center||1|||f||||||||||||||2017-10-11 00:13:54.358415|2017-10-11 00:13:54.358415
NCT02187666|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-09|||December 2011||2011-12-01|July 2014|2014-07-01||||December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|||NOC2 Spine Registry|National Neurosurgical and Orthopedic Optimum Care Continuum Spine Registry Exposure for Various Implants/Products|Unknown status|Recruiting|N/A|10000|Anticipated|DC2 Healthcare|||2||f||||f||||||||||2017-10-11 00:13:54.460658|2017-10-11 00:13:54.460658
NCT02187653|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-09|||September 2011||2011-09-01|July 2014|2014-07-01||||December 2016|Anticipated|2016-12-01|6 Weeks|Observational [Patient Registry]|IOM||Intraoperative Monitoring (IOM) Patient Registry|Spine Registry Exposure for: Lumbar and Cervical Surgery Utilizing IOM|Unknown status|Recruiting|N/A|10000|Anticipated|DC2 Healthcare|||2||f||||f||||||||||2017-10-11 00:13:54.68532|2017-10-11 00:13:54.68532
NCT02187640|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-08-17|||June 2013||2013-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Self-administered Acupressure in Psychiatric Patients With Constipation|A Randomised Controlled Trial of Self-administered Acupressure in Adult Psychiatric Patients With Constipation|Completed||Phase 1/Phase 2|78|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 00:13:54.790503|2017-10-11 00:13:54.790503
NCT02187627|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-01-11|||August 2014||2014-08-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants|Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Tau Imaging With Positron Emission Tomography in Healthy Control Subjects and Subjects With Alzheimer's Disease|Completed||Phase 1|52|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:13:54.899955|2017-10-11 00:13:54.899955
NCT02187614|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-03-17|||August 2014||2014-08-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management|A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management|Completed||Phase 4|1645|Actual|Hamad Medical Corporation||3|||f||||f||||||||||2017-10-11 00:13:55.02732|2017-10-11 00:13:55.02732
NCT02187601|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-03-26|||August 2014||2014-08-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function|Beta Study to Evaluate Functionality and Equivalence of MPBA (Multi Purpose Breath Analyzer-new Generation Exalenz Breath Analyzer) Compared to Currently Approved BreathID System in Assessment of Liver Function|Completed||N/A|20|Actual|Exalenz Bioscience LTD.||2|||f||||f|f|f||||||No||2017-10-11 00:13:55.148984|2017-10-11 00:13:55.148984
NCT02187588|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-11|||February 1998||1998-02-01|July 2014|2014-07-01||||May 1999|Actual|1999-05-01||Interventional|||Study to Assess the Kinetic of the Analgesic Effect and Tolerability of Eschscholtzia Californica Versus Ibuprofen and Placebo in the Treatment of Pain After Surgery of the Third Molar|Short Term Double Blind Randomised Controlled Study to Assess the Kinetic of the Analgesic Effect and the Tolerability of Eschscholtzia Californica 500 mg and 1000 mg Versus Ibuprofen 200 mg and Placebo in the Treatment of Pain After Surgery of the Third Molar|Completed||Phase 2|200|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:13:55.259662|2017-10-11 00:13:55.259662
NCT02187575|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-11|||July 2002||2002-07-01|July 2014|2014-07-01||||September 2002|Actual|2002-09-01||Interventional|||Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy Volunteers|Bioequivalence Study of UHAC62XX 10 mg Tablets Compared With 10 mg Capsules Following Multiple Peroral Administration in Healthy Volunteers (An Open-label, Randomised, Two-way Crossover Study)|Completed||Phase 1|26|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:13:55.370221|2017-10-11 00:13:55.370221
NCT02187562|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-10|2014-07-11|||July 2002||2002-07-01|July 2014|2014-07-01||||August 2002|Actual|2002-08-01||Interventional|||Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females|Effect of Steady State Meloxicam 15 mg/Day on Low Dose Aspirin (100 mg/Day) Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females. An Open, Randomised, Two-way Crossover Study.|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:13:55.458383|2017-10-11 00:13:55.458383
NCT02187549|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2015-10-02|||June 2014||2014-06-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee||Unknown status|Active, not recruiting|N/A|332|Anticipated|Fidia Farmaceutici s.p.a.||2|||f||||f||||||||||2017-10-11 00:13:55.555846|2017-10-11 00:13:55.555846
NCT02187536|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-09|||April 2000||2000-04-01|July 2014|2014-07-01||||May 2000|Actual|2000-05-01||Interventional|||Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy Subjects|Pharmacokinetics of Single Oral Doses of 40 mg Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan 80 mg Daily, Given Orally Over 6 Days. A Randomised, Placebo Controlled, Double Blind (for Telmisartan), Two Way Cross Over Trial in Healthy Subjects|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:13:55.68666|2017-10-11 00:13:55.68666
NCT02187523|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-09|||October 1999||1999-10-01|July 2014|2014-07-01||||December 1999|Actual|1999-12-01||Interventional|||Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects|Relative Oral Bioavailability of 40 mg Telmisartan / 12.5 mg HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Subjects. A 4 Period Cross-over, Open, Randomized, Replicate Design Study|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:13:55.767071|2017-10-11 00:13:55.767071
NCT02187510|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-04-27|||July 2014||2014-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Umbilical Cord Milking vs Delayed Cord Clamping in Preterm Infants Born by Cesarean Section|Umbilical Cord Milking Compared With Delayed Cord Clamping to Increase Plancental Transfusion in Preterm Infants Less Than 34 Weeks' Gestation Born by Cesarean Section. Randomised Clinical Trial|Completed||N/A|40|Actual|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-11 00:13:55.871172|2017-10-11 00:13:55.871172
NCT02187497|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-09|||June 1998||1998-06-01|July 2014|2014-07-01||||September 1998|Actual|1998-09-01||Interventional|||Pharmacokinetics of BIBR 277 in Hypertensive Patients|BIBR 277 Capsules Pharmacokinetics Study of Hypertensive Patients|Completed||Phase 2|93|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:13:55.993689|2017-10-11 00:13:55.993689
NCT02187484|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2014-07-09|||August 1998||1998-08-01|July 2014|2014-07-01||||August 1999|Actual|1999-08-01||Interventional|||BIBR 277 Capsules in Hypertensive Patients With Nephropathy|BIBR 277 Capsules Clinical Study on Hypertension With Nephropathy|Completed||Phase 2|23|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:13:56.100404|2017-10-11 00:13:56.100404
NCT02187471|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-02-03|||October 2014|Actual|2014-10-01|February 2017|2017-02-01|January 12, 2017|Actual|2017-01-12|January 6, 2017|Actual|2017-01-06||Interventional|||Treatment of Pain Associated With Fibromyalgia|A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia|Completed||Phase 3|1301|Actual|Daiichi Sankyo, Inc.||4|||f||||t||||||||||2017-10-11 00:13:56.195943|2017-10-11 00:13:56.195943
NCT02187458|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-08-06|||November 2013||2013-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:13:56.576009|2017-10-11 00:13:56.576009
NCT02187445|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-02-16|||June 2014||2014-06-01|February 2017|2017-02-01|February 13, 2017|Actual|2017-02-13|December 2016|Actual|2016-12-01||Interventional|||Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial|Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial|Completed||Phase 1|36|Actual|Vanderbilt University Medical Center||1|||f||||t||||||||||2017-10-11 00:13:56.614924|2017-10-11 00:13:56.614924
NCT02187432|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-05-26|||August 2013||2013-08-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|||The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe|The Eurocyst Initiative: Building a Reference Center Network Across EUROpe to Establish a Large-scale Longitudinal Observational Cohort of Autosomal Dominant polyCYSTic Kidney Disease (ADPKD) Patients|Unknown status|Recruiting|N/A|1100|Anticipated|University of Zurich|||1||f||||f||||||Samples With DNA|"     The following samples will be collected: blood, spot urine and 24h urine   "|||2017-10-11 00:13:56.698291|2017-10-11 00:13:56.698291
NCT02187419|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-04-12|||December 1, 2014|Actual|2014-12-01|April 2017|2017-04-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Interventional|||Hypnosis to Improve Sleep In Menopause|Hypnosis to Improve Sleep in Menopause: Determination of Optimal Dose and Method|Completed||N/A|84|Actual|Baylor University||4|||f||||t||||||||No||2017-10-11 00:13:56.863582|2017-10-11 00:13:56.863582
NCT02187406|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-02-02|||June 2014||2014-06-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Ankle Athletic Taping Fatigue After a Standard Tennis Warm up||Completed||N/A|10|Actual|CEU San Pablo University||3|||f||||f||||||||||2017-10-11 00:13:57.454067|2017-10-11 00:13:57.454067
NCT02187393|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-11-25|||July 2015||2015-07-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis|Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis|Withdrawn||N/A|0|Actual|University of Colorado, Denver|||1|Technical difficulties with the wet bench side of proposed studies.|f||||f||||||Samples With DNA|"     -  (3) tubes of blood        -  sample of cells from the nose   "|||2017-10-11 00:13:57.743873|2017-10-11 00:13:57.743873
NCT02187380|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-09|||June 2010||2010-06-01|July 2014|2014-07-01||||August 2012|Actual|2012-08-01||Observational|SIMCA||Studying the Impact of Medication Counselling by Community Pharmacists in Patients Starting a Treatment With Antidepressants|Studying the Impact of Medication Counselling by Community Pharmacists in Patients Starting a Treatment With Antidepressants|Completed||N/A|223|Actual|Katholieke Universiteit Leuven|||2||f||||f||||||||||2017-10-11 00:13:57.823797|2017-10-11 00:13:57.823797
NCT02187367|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-07-17|||May 2015||2015-05-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|EGF||Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients|Phase 3 Open-label, Multicentre, Randomised Trial to Establish Safety & Efficacy of an EGF Cancer Vaccine in Inoperable, Stage IV Biomarker Positive,Wild Type EGF-R NSCLC Patients Eligible to Receive Standard Treatment and Supportive Care|Recruiting||Phase 3|418|Anticipated|Bioven Sdn. Bhd.||2|||f||||t||||||||||2017-10-11 00:13:57.939648|2017-10-11 00:13:57.939648
NCT02187354|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-07-26||||||July 2017|2017-07-01||||||||Expanded Access|RIALTO||Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL|An Open-Label, Multi-center, Expanded Access Protocol of Blinatumomab for the Treatment of Pediatric and Adolescent Subjects With Relapsed and/or Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)|Available||N/A|||Amgen||||||||t|||||||||||2017-10-11 00:13:58.187929|2017-10-11 00:13:58.187929
NCT02187341|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-10|||June 2014||2014-06-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of Exercise and 5-HTP on Cortisol Levels|Effects of Exercise and 5-HTP on Cortisol Levels|Unknown status|Recruiting|N/A|12|Anticipated|Benedictine University||2|||f||||f||||||||||2017-10-11 00:13:58.300318|2017-10-11 00:13:58.300318
NCT02187328|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-10|||June 2014||2014-06-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of Fruit Juices on Hormone Metabolism|Effect of Grapefruit Juice and Exercise on Cortisol Levels|Unknown status|Recruiting|N/A|12|Anticipated|Benedictine University||2|||f||||f||||||||||2017-10-11 00:13:58.473334|2017-10-11 00:13:58.473334
NCT02186197|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-07-14|||July 2014||2014-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||The Impact of Fellow-performed Cardiopulmonary Ultrasound Exams|The Impact of Fellow-performed Cardiopulmonary Ultrasound Exams on the Diagnosis and Management of Shock and Respiratory Failure|Completed||N/A|112|Actual|Beth Israel Medical Center|||1||f||||t||||||||||2017-10-11 00:14:17.439003|2017-10-11 00:14:17.439003
NCT02187315|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-07-10|||May 2014||2014-05-01|July 2014|2014-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study|Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With Intensity-modulated Radiotherapy In The Treatment Of Locally Advanced Nasopharyngeal Carcinoma PhaseⅡClinical Randomized Study|Recruiting||Phase 2|160|Anticipated|Guiyang Medical University||2|||f||||f||||||||||2017-10-11 00:13:58.574657|2017-10-11 00:13:58.574657
NCT02187302|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-04-18|||July 2014||2014-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||CRLX101 in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)|A Randomized, Phase 2 Study to Assess the Safety and Efficacy of CRLX101 in Combination With Bevacizumab in Patients With Metastatic Renal Cell Carcinoma (RCC) Versus Standard of Care (SOC) (Investigator's Choice)|Completed||Phase 2|115|Actual|NewLink Genetics Corporation||2|||f||||f||||||||||2017-10-11 00:13:58.71968|2017-10-11 00:13:58.71968
NCT02187289|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-09|2017-02-23|||October 2014||2014-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|LYNC||A Study to See Whether Adding Night-time Compression to the Standard Care Will Result in Improved Control of Arm Swelling (Lymphedema) in Breast Cancer Subjects|Night-time Compression for Breast Cancer Related Lymphedema (LYNC): A Randomized Controlled Efficacy Trial|Active, not recruiting||N/A|120|Anticipated|AHS Cancer Control Alberta||3|||f||||f||||||||||2017-10-11 00:13:58.96818|2017-10-11 00:13:58.96818
NCT02187276|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-05|2014-09-10|||June 2009||2009-06-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia|The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Mild and Moderate Alzheimer Disease and Mixed Dementia: a Naturalistic Study|Completed||N/A|129|Actual|Federal University of Minas Gerais|||1||f||||t||||||Samples With DNA|"     Genetic and biochemical analyzes A blood sample (5 mL) was withdrawn from all patients on the     first consultation for DNA extraction and APOE genotyping in its different allelic forms (Ɛ2,     Ɛ3, Ɛ4). An additional blood sample (10 mL) was withdrawn from patients who took donepezil     (51 patients) and was kept in a tube with heparin and frozen at - 70 ° C. In this group of     patients, we genotyped the APOE and assessed the polymorphism of CYP 2D6 (*3,*4,*5,*6     and*10). This procedure was done when they came at 3, 6 and 12 months consultation,     respectively.   "|||2017-10-11 00:13:59.121456|2017-10-11 00:13:59.121456
NCT02187263|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-03-24|||December 2014||2014-12-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|12 Months|Observational [Patient Registry]|TORCH||German Centre for Cardiovascular Research Cardiomyopathy Register|DZHK TranslatiOnal Registry for CardiomyopatHies Deutsches Zentrum für Herz- Und Kreislauf-Forschung (DZHK)|Recruiting||N/A|2300|Anticipated|Heidelberg University|||6||f||||t||||||Samples With DNA|"     EDTA, serum, urine   "|||2017-10-11 00:13:59.222408|2017-10-11 00:13:59.222408
NCT02187250|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-08|||March 2014||2014-03-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome|Short-term Treatment With PDE-4 Inhibitor Roflumilast or GLP-1 Agonist Liraglutide or Metformin in Treatment Naive Obese Women With Polycystic Ovary Syndrome|Completed||Phase 4|45|Actual|University Medical Centre Ljubljana||3|||f||||f||||||||||2017-10-11 00:13:59.332921|2017-10-11 00:13:59.332921
NCT02187224|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-11-10|||September 2016||2016-09-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Progesterone Effect on Individuals Diagnoses With AD and PTSD.|Progesterone Treatment in Reducing Trauma and Alcohol Induced Craving in Individuals Diagnoses With Alcohol Dependence (AD) and Post-tramatic Stress Disorder (PTSD).|Recruiting||Phase 2/Phase 3|34|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 00:13:59.557247|2017-10-11 00:13:59.557247
NCT02187211|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-07-07|||July 2015||2015-07-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Minocycline's Effects on Alcohol Responses in Humans|Minocycline's Effects on Alcohol Responses in Humans|Recruiting||Phase 1|60|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 00:13:59.659208|2017-10-11 00:13:59.659208
NCT02187198|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-07-07|||March 2015||2015-03-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Buprenorphine Treatment for Opioid Dependence|Buprenorphine Treatment for Prescription Opioid Dependence|Recruiting||Phase 1/Phase 2|20|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 00:13:59.790128|2017-10-11 00:13:59.790128
NCT02187185|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-01-27|||April 2009||2009-04-01|January 2017|2017-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Salivary Inflammatory Biomarkers: Predictors & Comparative Effects of Sonicare/Elite-Flexcare in Stages of Perio Disease|Studies of Salivary Inflammatory Biomarkers During Biofilm Overgrowth: Confirmation of Predictors and Comparative Effects of Sonicare/Elite-Flexcare in Various Stages of Periodontal Disease|Completed||N/A|175|Actual|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-11 00:13:59.900026|2017-10-11 00:13:59.900026
NCT02187172|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-06-14|||July 2014||2014-07-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|VIP-U||Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)|A PHASE IV, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF USTEKINUMAB ON VASCULAR INFLAMMATION IN PSORIASIS|Active, not recruiting||Phase 4|43|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 00:14:00.024539|2017-10-11 00:14:00.024539
NCT02187159|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-06-30||2017-06-30|November 2014|Actual|2014-11-01|June 2017|2017-06-01|July 4, 2016|Actual|2016-07-04|July 4, 2016|Actual|2016-07-04||Interventional|||Treatment of Pain Associated With Fibromyalgia|A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia|Completed||Phase 3|1270|Actual|Daiichi Sankyo, Inc.||4|||f||||t|t|f||||||||2017-10-11 00:14:00.155525|2017-10-11 00:14:00.155525
NCT02187133|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-06-07|||December 2014|Actual|2014-12-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma|A Phase Ib Dose Escalation Trial of Carfilzomib in Combination With Bendamustine and Rituximab In Patients With Relapsed or Refractory Non-Hodgkin Lymphoma|Recruiting||Phase 1|30|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 00:14:00.910429|2017-10-11 00:14:00.910429
NCT02187120|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-09-05|||July 2014||2014-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PATCH||Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)|A Multi-centre Randomised, Double-blinded, Placebo-controlled Trial of Pre-hospital Treatment With Tranexamic Acid for Severely Injured Patients at Risk of Acute Traumatic Coagulopathy.|Recruiting||Phase 3|1184|Anticipated|Monash University||2|||f||||t||||||||||2017-10-11 00:14:01.039574|2017-10-11 00:14:01.039574
NCT02187107|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-08-22|||January 2005||2005-01-01|August 2014|2014-08-01|March 2009|Actual|2009-03-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials|An Open Label Trial of TMC114/Rtv in HIV-1 Infected Subjects Who Were Randomized in the Trials TMC114-C201, TMC114-C207 or in Sponsor Selected Phase I Trials|Completed||Phase 2|52|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||f||||||||||2017-10-11 00:14:01.325359|2017-10-11 00:14:01.325359
NCT02187094|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-05-11|||June 2014||2014-06-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis||Completed||Phase 1/Phase 2|80|Actual|Targacept Inc.||4|||f||||f||||||||||2017-10-11 00:14:01.454907|2017-10-11 00:14:01.454907
NCT02187081|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-03-27|||March 15, 2017|Actual|2017-03-15|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC|Radiofrequency Ablation Accompanied With Spontaneous Sorafenib Administration in the Treatment of Early to Intermediate Stage Hepatocellular Carcinoma: a Prospective Multicenter Cohort Study.(REASSESS)|Recruiting||N/A|380|Anticipated|Southwest Hospital, China||2|||f||||t|f|f||||||||2017-10-11 00:14:01.560705|2017-10-11 00:14:01.560705
NCT02187068|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-07|||April 2012||2012-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|December 2012|Actual|2012-12-01||Interventional|||Dexmedetomidine Pharmacokinetics in the Obese|Dexmedetomidine Pharmacokinetics in the Obese|Completed||Phase 4|40|Actual|Pontificia Universidad Catolica de Chile||4|||f||||t||||||||||2017-10-11 00:14:01.696077|2017-10-11 00:14:01.696077
NCT02187055|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-02-14|||August 2014||2014-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ORAL STRATEGY||An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate|A Phase 3b/4 Randomized Double Blind Study Of 5 Mg Of Tofacitinib With And Without Methotrexate In Comparison To Adalimumab With Methotrexate In Subjects With Moderately To Severely Active Rheumatoid Arthritis|Completed||Phase 4|1132|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 00:14:01.837107|2017-10-11 00:14:01.837107
NCT02187042|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-09-28|||October 2015|Actual|2015-10-01|September 2017|2017-09-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Observational|RENACALL||Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line|Pragmatic Study Evaluating The Impact Of A Therapy Management Platform On The Management Of Patients Suffering From Advanced/Metastatic Renal Cell Carcinoma And Receiving First Line Treatment With Sunitinib, Versus Standard Follow-up|Recruiting||N/A|186|Anticipated|Pfizer|||2||f||||f||||||||||2017-10-11 00:14:04.329214|2017-10-11 00:14:04.329214
NCT02187029|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-09-23|2015-12-08||July 2014||2014-07-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.|A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects|Terminated||Phase 1|30|Actual|Pfizer||4||"B7911002 was prematurely discontinued due to a safety concern that led to decision to terminate   the study on 10 Nov 2014"|f||||f||||||||||2017-10-11 00:14:04.588507|2017-10-11 00:14:04.588507
NCT02187016|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-02-05|2015-11-23||June 2014||2014-06-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety Study of Interproximal Cleaning Modalities on Oral Health|A Randomized, Parallel Design Study to Assess the Effects of Three Interproximal Cleaning Modalities Versus a Manual Toothbrush Control on Gingivitis and Plaque Following a Period of Home Use|Completed||N/A|290|Actual|Philips Oral Healthcare||4|||f||||f||||||||No||2017-10-11 00:14:07.441082|2017-10-11 00:14:07.441082
NCT02187003|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-10-02|||June 8, 2015|Actual|2015-06-08|October 2017|2017-10-01|July 10, 2018|Anticipated|2018-07-10|July 10, 2018|Anticipated|2018-07-10||Interventional|||Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Evaluate The Efficacy And Safety Of Rivipansel (Gmi-1070) In The Treatment Of Vaso-occlusive Crisis In Hospitalized Subjects With Sickle Cell Disease|Recruiting||Phase 3|350|Anticipated|Pfizer||2|||f||||t|t|f||||||||2017-10-11 00:14:07.878126|2017-10-11 00:14:07.878126
NCT02186990|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2014-08-12|||May 2014||2014-05-01|August 2014|2014-08-01||||August 2014|Actual|2014-08-01||Interventional|||Comparison of Etomidate, Propofol and Etomidate-propofol Combination in Terms of Effects on Haemodynamic Response to Intubation||Completed||Phase 4|90|Actual|T.C. ORDU ÜNİVERSİTESİ||3|||f||||||||||||||2017-10-11 00:14:08.347921|2017-10-11 00:14:08.347921
NCT02186977|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-03-27|||March 2016||2016-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|POC_VAX-ID||Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID|Proof Of Concept Study: Immunogenicity and Safety of Hepatitis B Injection in the Dermis in Healthy Volunteers Using an Intradermal Injection Device (VAX-ID)|Completed||Phase 1|48|Actual|Novosanis NV||4|||f||||f||||||||No||2017-10-11 00:14:08.435425|2017-10-11 00:14:08.435425
NCT02186964|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-09|||February 2011||2011-02-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Tension Free Primary Closure, Karydaks and Limberg Flap Methods|Randomised Prospective Comparison of Tension-free Primary Closure, Karydakis and Limberg Flap Methods in Treatment of Pilonidal Sinus Disease|Completed||N/A|150|Actual|Konya Training and Research Hospital||3|||f||||f||||||||||2017-10-11 00:14:08.537987|2017-10-11 00:14:08.537987
NCT02186951|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-12-12|||July 2014||2014-07-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|ANTHARTIC||Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious Complications|Prevention of Early Ventilator-associated Pneumonia With Antibiotic Therapy in Patients Treated With Mild Therapeutic Hypothermia After Cardiac Arrest.|Active, not recruiting||Phase 3|197|Actual|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 00:14:08.648222|2017-10-11 00:14:08.648222
NCT02186925|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-04-20|||August 2014||2014-08-01|July 2014|2014-07-01|August 2025|Anticipated|2025-08-01|August 2019|Anticipated|2019-08-01||Observational|||A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.||Recruiting||N/A|1000|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-11 00:14:08.892446|2017-10-11 00:14:08.892446
NCT02186912|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-04-04|||January 2014||2014-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||All-On-4® Treatment Concept|A Clinical Evaluation of All-On-4® Treatment Concept in the Mandible or Maxilla on 4 NobelActive®Implants With a Fixed NobelProcera® Implant Bridge|Terminated||N/A|28|Actual|Nobel Biocare||2||The study stopped as the performance of the study showed insufficient patient recruitment.|f||||f||||||||||2017-10-11 00:14:08.975833|2017-10-11 00:14:08.975833
NCT02186899|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2014-07-07|||March 2014||2014-03-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Peripheral Nerve Block (Femoral - Sciatic - Obturator) Versus General Anesthesia for Arthroscopic ACL Repair|Comparison of Femoral - Sciatic - Obturator Nerve Block vs General Anesthesia in Combination With Continuous or Bolus Femoral Nerve Block for Arthroscopic ACL Repair Regarding the Time of Patient Mobilasation|Unknown status|Recruiting|N/A|150|Anticipated|Larissa University Hospital||3|||f||||f||||||||||2017-10-11 00:14:09.060801|2017-10-11 00:14:09.060801
NCT02186886|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-09|||June 2014||2014-06-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab|Personalised Medicine: a Break Through Approach for Early Determination of Anti Tumor Necrosis Factor (TNF) Responders and Non Responders Among Patients With Ulcerative Colitis in a Prospective Study With Golimumab (Simponi)|Unknown status|Recruiting|Phase 4|50|Anticipated|Kliniken im Naturpark Altmuehltal||1|||f||||f||||||||||2017-10-11 00:14:09.168907|2017-10-11 00:14:09.168907
NCT02186860|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-08-11|||July 2016||2016-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia|Treatment of Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia by Third Generation Chimeric Antigen Receptor (CAR)-Modified T Cells|Recruiting||Phase 1|5|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-11 00:14:09.539515|2017-10-11 00:14:09.539515
NCT02186847|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-12-20|||August 2014||2014-08-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|||Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer|Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC|Active, not recruiting||Phase 2|168|Actual|NRG Oncology||2|||f||||t||||||||||2017-10-11 00:14:09.683851|2017-10-11 00:14:09.683851
NCT02186834|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-10-03|||September 19, 2014|Actual|2014-09-19|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma|Investigator-Initiated Phase I/II Clinical Trial of Selinexor (KPT-330) and Liposomal Doxorubicin for Relapsed and Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|28|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-11 00:14:10.505307|2017-10-11 00:14:10.505307
NCT02186821|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-11-27|||September 2014||2014-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|SIGNATURE||Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)|Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module - 7 Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1|Completed||Phase 2|45|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:14:10.621802|2017-10-11 00:14:10.621802
NCT02186808|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-09-23|2016-03-23||May 2005||2005-05-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||T-116_Procera-Bridge Zirconia - A Clinical Study|Procera-Bridge Zirconia - A Clinical Study|Completed||N/A|80|Actual|Nobel Biocare||1|||f||||f||||||||No||2017-10-11 00:14:10.805102|2017-10-11 00:14:10.805102
NCT02186795|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-06-25|||April 2013||2013-04-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|THA||Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia|Improvement in Total Hip Arthroplasty Patient Outcomes With Regional Anesthesia and Multimodal Analgesia: A Retrospective Analysis|Completed||N/A|117|Actual|Medical University of South Carolina|||2||f||||f||||||||||2017-10-11 00:14:11.017391|2017-10-11 00:14:11.017391
NCT02186782|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2017-03-21|||June 2014||2014-06-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Concomitant CC and E2 Versus CC Alone in Ovulation Induction|Concomitant Clomiphene Citrate and Estradiol Versus Clomiphene Citrate Alone in Ovulation Induction: a Randomized Controlled Trial|Recruiting||Phase 4|600|Anticipated|Mansoura University||2|||f||||f||||||||Undecided||2017-10-11 00:14:11.104672|2017-10-11 00:14:11.104672
NCT02186769|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-06-17|||July 2014||2014-07-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder|A Randomized, Open-Label Pharmacokinetic Study of LY03004 Compared to Risperdal® Consta® Following a Single Intramuscular Injection at 25 mg or 50 mg in Stable Patients With Schizophrenia and/or Schizoaffective Disorder|Completed||Phase 1|16|Actual|Luye Pharma Group Ltd.||2|||f||||f||||||||||2017-10-11 00:14:11.229101|2017-10-11 00:14:11.229101
NCT02186756|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-08|||April 2005||2005-04-01|July 2014|2014-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Randomized Controlled Trial to Evaluate the Effectiveness of Electromyography (EMG)-Biofeedback in Patients With Fibromyalgia|Biofeedback in Patients With Fibromyalgia - a Randomized Controlled Trial|Completed||N/A|40|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 00:14:11.313177|2017-10-11 00:14:11.313177
NCT02186743|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-01-20|||July 2014||2014-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Irritable Bowel Syndrome and Food Sensitivity|Irritable Bowel Syndrome and Food Sensitivity: Assessing Clinical Outcomes and Inflammatory Cellular Pathways|Completed||N/A|58|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:14:11.401522|2017-10-11 00:14:11.401522
NCT02186730|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-09-07|||March 2014||2014-03-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|August 2016|Actual|2016-08-01||Interventional|CITADAL||Computerised Intervention/Treatment for Adolescent Depression and Low Mood:|Computerised Intervention/Treatment for Adolescent Depression and Low Mood: Feasibility Phase 2|Active, not recruiting||N/A|48|Anticipated|Leeds and York Partnership NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:14:11.500888|2017-10-11 00:14:11.500888
NCT02186717|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-03-21|||June 2014||2014-06-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Does Chewing Gum Hasten Return of Bowel Function Post-Operatively in Patients Undergoing Spinal Surgery|Does Chewing Gum Hasten Return of Bowel Function Post-operatively in Patients Following Spinal Surgery? A Prospective, Randomized, Controlled Trial|Completed||N/A|144|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||No||2017-10-11 00:14:11.601282|2017-10-11 00:14:11.601282
NCT02186704|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-01-24|||July 2014||2014-07-01|January 2017|2017-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|SENSE||Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)|Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial|Recruiting||N/A|450|Anticipated|Weill Medical College of Cornell University|||3||f||||t||||||||No||2017-10-11 00:14:11.699777|2017-10-11 00:14:11.699777
NCT02186691|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-07-08|||May 2014||2014-05-01|July 2014|2014-07-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Right and Left Ventricle Remodeling Predictors After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot|Right and Left Ventricle Remodeling Predictors After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot.|Recruiting||N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:14:11.813939|2017-10-11 00:14:11.813939
NCT02186678|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-11-16|||July 2014||2014-07-01|November 2015|2015-11-01|February 2018|Anticipated|2018-02-01|July 2017|Anticipated|2017-07-01||Interventional|DOTATATE||Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation|Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation: Monocentric Prospective Study|Active, not recruiting||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:14:11.90174|2017-10-11 00:14:11.90174
NCT02186665|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-03-31|2017-02-15||July 2014||2014-07-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Plaque Psoriasis Study in Pediatric Subjects|A Multicenter, Randomized, Double Blind, Parallel Group, Vehicle Controlled, Study of the Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 8 Weeks in Pediatric Subjects (2 to 12 Years of Age) With Mild to Moderate Plaque Psoriasis|Completed||Phase 4|19|Actual|Galderma|Study terminated early due to slow enrollment.|2|||f||||||||||||||2017-10-11 00:14:11.980604|2017-10-11 00:14:11.980604
NCT02186652|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-06-21|||June 4, 2014|Actual|2014-06-04|June 2017|2017-06-01|September 13, 2015|Actual|2015-09-13|September 13, 2015|Actual|2015-09-13||Interventional|PAN01||PK Study With Pantoprazole in Obese Children and Adolescents|The Effect of Obesity on the Pharmacokinetics of Pantoprazole in Children and Adolescents|Completed||Phase 1|40|Anticipated|Duke University||1|||f||||t||||||||||2017-10-11 00:14:12.292536|2017-10-11 00:14:12.292536
NCT02186639|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-08-09|||June 2014||2014-06-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|December 2016|Actual|2016-12-01||Observational|||Breath Analysis in Chronic Obstructive Lung Disease (COPD)|Exhaled Breath Analysis in Patients With COPD by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS)|Recruiting||N/A|40|Anticipated|University of Zurich|||2||f||||f||||||||||2017-10-11 00:14:12.377448|2017-10-11 00:14:12.377448
NCT02186626|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-01-31|||February 2014||2014-02-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age|Phase 1 Study of the Safety and Immunogenicity of a 2-Dose Regimen of West Nile/Dengue 4-3´Δ30 Chimeric Virus Vaccine (WN/DEN4Δ30), a Live Attenuated Vaccine for West Nile Encephalitis, in Flavivirus-naïve Adults 50-65 Years of Age|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 00:14:12.452163|2017-10-11 00:14:12.452163
NCT02186613|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2014-12-19|||October 2014||2014-10-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Telephone Support From Primary Care for Breastfeeding Mothers|Telephone Support From Primary Care to Breastfeeding Mothers: A Randomized and Multicenter Clinical Trial|Unknown status|Recruiting|N/A|434|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 00:14:12.537979|2017-10-11 00:14:12.537979
NCT02186600|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-06-08|||February 2015||2015-02-01|June 2015|2015-06-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|HOPE||Study Comparing Bone Loss in Women Who Take Calcium and Vitamin D With Women Who Also Take Risedronate or Exercise|Randomized Control Trial of Bone Loading Exercises Versus Risedronate on Bone Health in Post-Menopausal Women|Recruiting||Phase 3|309|Anticipated|University of Nebraska||3|||f||||t||||||||||2017-10-11 00:14:12.623553|2017-10-11 00:14:12.623553
NCT02186587|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-11-22|2016-04-14||June 2014||2014-06-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Interventional|||iTotal Pilot Study of ConforMIS Custom Total Knee Implant|CT-navigated, Patient-specific Custom Total Knee Replacement Versus Standard Total Knee Replacement: Comparison With a Marker-less Gait Analysis System and Validated Outcome Scores|Completed||N/A|28|Actual|University of Missouri-Columbia||1|||f||||t||||||||No||2017-10-11 00:14:12.899425|2017-10-11 00:14:12.899425
NCT02186574|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-05-27|||May 2015||2015-05-01|May 2015|2015-05-01||||June 2017|Anticipated|2017-06-01||Interventional|||Tenofovir to Prevent HBV Reactivation|A Multi-centre Phase III Study to Evaluate Preemptive Tenofovir for Prevention of Hepatitis B Virus Reactivation in HBsAg Negative/Anti-HBc Positive Individuals Undergoing Rituximab-based Chemotherapy for Non-Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 3|184|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 00:14:13.079793|2017-10-11 00:14:13.079793
NCT02186561|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-06-30|||July 2014||2014-07-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|March 2017|Actual|2017-03-01||Interventional|PREMIER||Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device|PREMIER PROSPECTIVE STUDY ON EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH PIPELINE™ EMBOLIZATION DEVICE|Active, not recruiting||N/A|141|Anticipated|Medtronic Neurovascular Clinical Affairs||1|||f||||f||||||||||2017-10-11 00:14:13.191473|2017-10-11 00:14:13.191473
NCT02186548|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-09-28|||November 2013||2013-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|PDC||The Impact of Surgical Technique on PDC|Closed Versus Open Surgical Exposure of Palatally Displaced Canines (PDC); Treatment and Treatment Outcome Including Aspects of Cost-benefit and Patients´Perceptions. A Multicenter Prospective Randomized Clinical Trial|Active, not recruiting||N/A|120|Anticipated|Örebro County Council||2|||f||||f||||||||||2017-10-11 00:14:13.313727|2017-10-11 00:14:13.313727
NCT02186535|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-01-07|||August 2014||2014-08-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Role of Vitamin D in Female Reproductive Tract Immunity|The Role of Vitamin D in Female Reproductive Tract Immunity|Completed||Phase 1|22|Actual|CONRAD||2|||f||||||||||||||2017-10-11 00:14:13.403911|2017-10-11 00:14:13.403911
NCT02186522|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-10-25|||July 2014||2014-07-01|November 2015|2015-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|INFECT||Immune Failure in Critical Therapy (INFECT) Study|Immune Failure in Critical Therapy(INFECT) Study: Phenotyping Immune Cell Dysfunction to Predict Outcomes in Critically Ill Adults|Completed||N/A|168|Actual|University of Edinburgh|||1||f||||f||||||Samples Without DNA|"     Samples of serum and plasma stored frozen   "|||2017-10-11 00:14:13.573124|2017-10-11 00:14:13.573124
NCT02186509|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-10-19|||January 2015||2015-01-01|October 2016|2016-10-01||||July 2019|Anticipated|2019-07-01||Interventional|||Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas|Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas|Recruiting||Phase 1|24|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 00:14:13.676793|2017-10-11 00:14:13.676793
NCT02186496|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-11-27|||July 2014||2014-07-01|June 2014|2014-06-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)|A Randomized, Open-label, Single-dosing, 2x2 Crossover Study to Compare the Safety and Pharmacokinetics of CKD-330 (Fixed-dose Combination of Candesartan 8 mg and Amlodipine 5 mg) With Coadministration of the Two Separate Drugs in Healthy Male Volunteers|Completed||Phase 1|32|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 00:14:13.796627|2017-10-11 00:14:13.796627
NCT02186483|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-06-23|||August 2014||2014-08-01|July 2014|2014-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin|An Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Drug-drug Interaction Following Coadministration of Metformin and Rosuvastatin in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Jeil Pharmaceutical Co., Ltd.||3|||f||||f||||||||No||2017-10-11 00:14:13.898187|2017-10-11 00:14:13.898187
NCT02186470|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-09-18|||June 2015|Actual|2015-06-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer|Feasibility of Assessing Radiation Response With MRI/CT Directed Preoperative Accelerated Partial Breast Irradiation in the Prone Position for Hormone Responsive Early Stage Breast Cancer|Recruiting||N/A|30|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||f||||||||2017-10-11 00:14:14.008223|2017-10-11 00:14:14.008223
NCT02186457|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-03-05|||November 2014||2014-11-01|March 2017|2017-03-01|August 2024|Anticipated|2024-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Antibiotic Irrigation for Pancreatoduodenectomy|Routine Antibiotic Irrigation in Patients Undergoing Pancreatoduodenectomy to Reduce Infection and Fistula Rates|Recruiting||N/A|164|Anticipated|Indiana University||2|||f||||t||||||||No||2017-10-11 00:14:14.150032|2017-10-11 00:14:14.150032
NCT02186444|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-08-18|||June 2, 2014|Actual|2014-06-02|August 2017|2017-08-01|August 17, 2017|Actual|2017-08-17|December 30, 2016|Actual|2016-12-30||Observational|||Navigator Guided e-Psychoeducational Intervention|Navigator Guided e-Psychoeducational Intervention for Prostate Cancer Patients and Their Caregivers|Completed||N/A|391|Actual|H. Lee Moffitt Cancer Center and Research Institute|||2||f||||f|f|f||||||||2017-10-11 00:14:14.254518|2017-10-11 00:14:14.254518
NCT02186431|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-07-08|||July 2014||2014-07-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CLIK||Contact Lenses and Infiltrative Keratitis|Contact Lenses and Infiltrative Keratitis|Completed||N/A|32|Actual|State University of New York College of Optometry||2|||f||||f||||||||||2017-10-11 00:14:14.342458|2017-10-11 00:14:14.342458
NCT02186418|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-08-29|||July 2014||2014-07-01|August 2017|2017-08-01|August 2033|Anticipated|2033-08-01|August 2032|Anticipated|2032-08-01||Interventional|||Gene Transfer for Patients With Sickle Cell Disease|Gene Transfer for Patients With Sickle Cell Disease Using a Gamma Globin Lentivirus Vector: An Open Label Phase I/II Pilot Study|Recruiting||Phase 1/Phase 2|10|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 00:14:14.428233|2017-10-11 00:14:14.428233
NCT02186184|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2016-03-09|||June 2014||2014-06-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial|Effect of Orthokeratology on Myopia Progression in Chinese Children|Recruiting||Phase 4|100|Anticipated|Beijing Tongren Hospital||2|||f||||t||||||||||2017-10-11 00:14:17.546853|2017-10-11 00:14:17.546853
NCT02186405|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2016-10-27|||October 2015||2015-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Interventional|||Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism|Effects of Levothyroxine Treatment on Hemodynamic and Isotopic Renal Functions in Subclinical Hypothyroidism|Withdrawn||Phase 4|0|Actual|Centre Hospitalier Universitaire de Nice||1||No patient corresponding to inclusion criteria couldn't be enrolled in the study|f||||f||||||||||2017-10-11 00:14:14.540754|2017-10-11 00:14:14.540754
NCT02186392|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-08-12|||May 2014||2014-05-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|June 2015|Actual|2015-06-01||Interventional|||The Impact of Ergonomic Circadian Light on Hospitalized Stroke Patients in a Rehabilitation Unit|The Impact of Ergonomic Circadian Light on Hospitalized Stroke Patients in a Rehabilitation Unit|Unknown status|Active, not recruiting|N/A|110|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-10-11 00:14:14.630813|2017-10-11 00:14:14.630813
NCT02186379|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2015-04-23|||November 2012||2012-11-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|REPACE||Eating RePace Study|Eating Pace Retraining in Childhood Obesity Prevention|Completed||N/A|28|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 00:14:14.737582|2017-10-11 00:14:14.737582
NCT02186366|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-09-01|||September 2014||2014-09-01|September 2014|2014-09-01||||October 2015|Anticipated|2015-10-01||Interventional|||Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type|"Study of Abdominal Massage Therapy for Generalized Anxiety Disorder Based on the  Essence Fosters Spirit  Theory"|Unknown status|Recruiting|N/A|140|Anticipated|First Teaching Hospital of Tianjin University of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-11 00:14:14.833473|2017-10-11 00:14:14.833473
NCT02186353|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-04-10|||September 2014||2014-09-01|April 2017|2017-04-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Processing Responses of Grains (PRO-Grains) Study|Effect of Intact vs. Highly Processed Whole Grains on Insulin Sensitivity and Other Cardiometabolic Risk Factors in Hyperinsulinemic Adults|Withdrawn||N/A|0|Actual|Boston Children’s Hospital||3||Lack of adequate funding|f||||||||||||||2017-10-11 00:14:14.947435|2017-10-11 00:14:14.947435
NCT02186340|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-08-28|||January 2013||2013-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effects of Inspiratory Muscle Training on Breathing Pattern in Patients With Chronic Obstructive Pulmonary Disease||Completed||N/A|50|Actual|Katholieke Universiteit Leuven||1|||f||||||||||||||2017-10-11 00:14:15.089545|2017-10-11 00:14:15.089545
NCT02186327|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-07-22|||August 2014||2014-08-01|January 2015|2015-01-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Integrative Health Coaching in Community Settings|Community Coaching: Integrative Health Coaching Initiative for Behavior Change and Assessment of Perceived Needs in the Community Setting|Completed||N/A|74|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:14:15.185145|2017-10-11 00:14:15.185145
NCT02186314|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-08-01|||February 2014||2014-02-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Right Bifocal Ventricular Cardiac Pacing on Serum Level Natriuretic Peptides in Patients With Heart Failure|Effect of Right Bifocal Ventricular Cardiac Pacing on Serum Level Natriuretic Peptides in Patients With Heart Failure and Pacemaker Indication|Recruiting||N/A|20|Anticipated|Instituto Dante Pazzanese de Cardiologia||2|||f||||f||||||||||2017-10-11 00:14:15.288441|2017-10-11 00:14:15.288441
NCT02186301|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-09-05|||November 2014||2014-11-01|September 2017|2017-09-01|June 28, 2017|Actual|2017-06-28|June 28, 2017|Actual|2017-06-28||Interventional|||TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy|TIGER 1: A Randomized, Open-Label, Phase 2/3 Study of CO-1686 or Erlotinib as First-Line Treatment of Patients With EGFR-Mutant Advanced/Metastatic NSCLC|Terminated||Phase 2/Phase 3|100|Actual|Clovis Oncology, Inc.||2||Sponsor discontinued development of CO-1686 for NSCLC|f||||t||||||||||2017-10-11 00:14:15.411818|2017-10-11 00:14:15.411818
NCT02186288|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-07-23|||July 2014||2014-07-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|OXIDIA||Effect of High-flow Nasal Cannula Oxygen on Lung Volumes Determined by Electrical Impedance Tomography|Effect of High-flow Nasal Cannula Oxygen on Lung Volumes Determined by Electrical Impedance Tomography|Completed||N/A|20|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:14:15.643022|2017-10-11 00:14:15.643022
NCT02186275|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-05-17|||February 2016||2016-02-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|ViDiPeC||The Vitamin D in Pediatric Crohn's Disease|Randomized Controlled Trial of High Dose Vitamin D in Children With Newly Diagnosed Crohn's Disease for the Prevention of Relapses|Recruiting||Phase 3|316|Anticipated|St. Justine's Hospital||2|||f||||t||||||||||2017-10-11 00:14:15.728881|2017-10-11 00:14:15.728881
NCT02186262|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-10-20|||March 2014||2014-03-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|RODIG||Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas|Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas|Recruiting||N/A|80|Anticipated|Turku University Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood, frozen tumor tissue   "|||2017-10-11 00:14:15.888814|2017-10-11 00:14:15.888814
NCT02186249|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2017-02-06||||||February 2017|2017-02-01||||||||Expanded Access|CheckMate218||Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma|Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Subjects With Unresectable or Metastatic Melanoma|No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 00:14:15.99559|2017-10-11 00:14:15.99559
NCT02186236|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-09-26|||July 2014||2014-07-01|September 2016|2016-09-01||||September 2016|Actual|2016-09-01||Observational|||Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients|A Pilot Study Testing the Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients|Completed||N/A|84|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     periphera blood sample and urine sample   "|||2017-10-11 00:14:16.190772|2017-10-11 00:14:16.190772
NCT02186223|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-02-17|2016-12-14||January 2015|Actual|2015-01-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Population includes all subjects that had the Angel® Catheter placed.|The Angel® Catheter Pivotal Clinical Trial|The Angel® Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects|Completed||N/A|172|Actual|BiO2 Medical||1|||f||||t||||||||No||2017-10-11 00:14:16.300383|2017-10-11 00:14:16.300383
NCT02186171|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-09-26||2016-09-26|June 2014||2014-06-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|BRIDGE||A Double-blind Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Compare the Efficacy and Safety of Romosozumab (AMG 785) With Placebo in Men With Osteoporosis|Completed||Phase 3|245|Actual|Amgen||2|||f||||f||||||||||2017-10-11 00:14:17.685852|2017-10-11 00:14:17.685852
NCT02186158|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-09-14|||February 2015||2015-02-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PNEUMO-VITA-C||Interest of Ascorbic Acid in the Management of Pneumonia in Elderly People Hospitalized.|Interest of Ascorbic Acid in the Management of Pneumonia in Elderly People Hospitalized.|Completed||Phase 2|9|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 00:14:17.894493|2017-10-11 00:14:17.894493
NCT02186145|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-04-08|||January 2016||2016-01-01|July 2014|2014-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections|Single Blind Randomized Study of Efficacy and Safety of Vaginal Cream With Association of Metronidazole, Nystatin and Dexamethasone in the Treatment of Bacterial and Fungal Vaginal Infections|Unknown status|Not yet recruiting|Phase 3|160|Anticipated|Marjan Industria e Comercio ltda||2|||f||||t||||||||||2017-10-11 00:14:18.032306|2017-10-11 00:14:18.032306
NCT02186132|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||March 2012||2012-03-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||0.6 vs. 1.2 mg Atropine Together With Neostigmine 2.5 mg on Heart Rate in Patient Receiving Muscle Relaxant|The Effect of 0.6 vs. 1.2 Milligram Atropine Together With Neostigmine 2.5 Milligram on Heart Rate in Patient Receiving Muscle Relaxant During General Anesthesia|Completed||Phase 4|40|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 00:14:18.170122|2017-10-11 00:14:18.170122
NCT02186119|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2015-07-10|||July 2014||2014-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study of Abicipar Pegol in Patients With Diabetic Macular Edema||Completed||Phase 2|151|Actual|Allergan||4|||f||||t||||||||||2017-10-11 00:14:18.276878|2017-10-11 00:14:18.276878
NCT02186106|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-07|||January 2012||2012-01-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Dosage Calculation for Vitamin D Treatment|The Effect of Oral Loading Doses of Cholecalciferol on the Serum Concentration of 25-OH-vitamin-D|Completed||Phase 4|31|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 00:14:18.41824|2017-10-11 00:14:18.41824
NCT02186093|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-09|||April 2014||2014-04-01|July 2014|2014-07-01||||November 2014|Anticipated|2014-11-01|2 Years|Observational [Patient Registry]|||Clinical, Physiological and Prognostic Implication of Microvascular Status|Clinical, Physiological and Prognostic Implication of Index of Microcirculatory Resistance|Unknown status|Recruiting|N/A|1197|Anticipated|Seoul National University Hospital|||4||f||||t||||||||||2017-10-11 00:14:18.546797|2017-10-11 00:14:18.546797
NCT02186080|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-04-20|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia|Evaluation of the Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia Induced by High Fat Diet in Patients With Type 2 Diabetes|Completed||N/A|10|Actual|Seoul National University Hospital||2|||f||||t||||||||No||2017-10-11 00:14:18.65796|2017-10-11 00:14:18.65796
NCT02186067|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2015-06-24|||February 2014||2014-02-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Developing an Integrated System Approach for the Management of Hypertension: A Pilot Study|Developing an Integrated System Approach for the Management of Hypertension: A Pilot Study|Completed||N/A|118|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-11 00:14:18.777361|2017-10-11 00:14:18.777361
NCT02186054|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2015-11-17|||June 2014||2014-06-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||T2 Weighted Imaging of the Liver With Fast Spin Echo MRI|Enhancement of T2 Weighted Imaging of the Liver With Fast Spin Echo Magnetic Resonance Imaging (MRI).|Terminated||N/A|50|Anticipated|Ottawa Hospital Research Institute||1||Trial Logistics|f||||f||||||||||2017-10-11 00:14:18.87404|2017-10-11 00:14:18.87404
NCT02186041|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2017-06-30|||August 2014||2014-08-01|June 2017|2017-06-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Observational|SOUNDS||Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational Study|Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS):an Observational Study|Active, not recruiting||N/A|321|Actual|Medtronic International Trading Sarl|||3||f||||f||||||||||2017-10-11 00:14:18.986805|2017-10-11 00:14:18.986805
NCT02186028|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-09-26|||July 2014||2014-07-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Oral Daily Supplementation With 400 IU Vs 200 IU of Vitamin D in Term Healthy Neonates|Effect Of Oral Daily Supplementation With 400 IU Vs 200 IU Of Vitamin D In Term Healthy Newborns: A Randomised Control Trial|Completed||Phase 4|200|Actual|Lady Hardinge Medical College||2|||f||||t||||||||||2017-10-11 00:14:19.144718|2017-10-11 00:14:19.144718
NCT02186015|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-07-20|||February 2015||2015-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|SAFE-D||Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)|Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)|Recruiting||Phase 1|30|Anticipated|Loyola University||1|||f||||f||||||||||2017-10-11 00:14:19.254953|2017-10-11 00:14:19.254953
NCT02186002|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-09|||December 2011||2011-12-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A)|Single-center, Double-blind, Placebo-controlled, Randomized, Single-ascending Dose, With Nested Cross-over for Food Effect, to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A)|Completed||Phase 1|40|Actual|Actelion||6|||f||||f||||||||||2017-10-11 00:14:19.430431|2017-10-11 00:14:19.430431
NCT02185989|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2017-04-12|||July 15, 2014|Actual|2014-07-15|April 2017|2017-04-01|November 24, 2016|Actual|2016-11-24|November 24, 2016|Actual|2016-11-24||Interventional|PROMOREA1||Electrical Muscle Stimulation and Bicycling Combined to Early Standard Rehabilitation in the ICU|Early Rehabilitation Combining Daily Electrical Muscle Stimulation and Early Bedside Cycling Exercise, Compared to Early Standard Rehabilitation. A Randomized, Assessor-blinded, Single-center Study in Intensive Care Patients.|Completed||N/A|314|Actual|Centre Hospitalier Régional d'Orléans||2|||f||||f||||||||||2017-10-11 00:14:19.56915|2017-10-11 00:14:19.56915
NCT02185976|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-02-09|||January 2014||2014-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Effect of Cartoons on Preoperative Anxiety in Paediatric Patients.|Preoperative Anxiety in Paediatric Patients; do Cartoons Help?|Recruiting||N/A|60|Anticipated|Balikesir University||2|||f||||f||||||||||2017-10-11 00:14:19.651244|2017-10-11 00:14:19.651244
NCT02185963|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-05-02|||October 2014||2014-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes|Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Patients With Type 2 Diabetes|Completed||Phase 4|50|Actual|Seoul National University Bundang Hospital||1|||f||||t||||||||||2017-10-11 00:14:19.748926|2017-10-11 00:14:19.748926
NCT02185950|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-07-09|||June 2012||2012-06-01|July 2014|2014-07-01|March 2016|Anticipated|2016-03-01|January 2015|Anticipated|2015-01-01||Interventional|||The Effects of Therapeutic Resources on Structure and Function of Normal and Burned Skin||Unknown status|Recruiting|N/A|60|Anticipated|University of Sao Paulo||4|||f||||t||||||||||2017-10-11 00:14:19.834499|2017-10-11 00:14:19.834499
NCT02185937|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-03-30|||August 2014||2014-08-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ABILITY||Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy|Influence of an Acidic Beverage (Coca-Cola) on the Exposure to Imatinib (GLIvec) After Major gastrecTomY in Patients With Gastrointestinal Stromal Tumors (ABILITY)|Terminated||Phase 1|5|Actual|Radboud University||2||inclusion was too slow|f||||f||||||||||2017-10-11 00:14:19.923085|2017-10-11 00:14:19.923085
NCT02185924|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-07|||January 2009||2009-01-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|September 2011|Actual|2011-09-01||Interventional|||Combination of Continuous Femoral Block and Intravenous Parecoxib For Postoperative Analgesia After Total Knee Arthroplasty|COMBINATION OF CONTINUOUS FEMORAL BLOCK AND INTRAVENOUS PARECOXIB FOR POSTOPERATIVE ANALGESIA AFTER TOTAL KNEE ARTHROPLASTY. A DOUBLE BLIND PROSPECTIVE STUDY.|Completed||Phase 2/Phase 3|90|Actual|Asklepieion Voulas General Hospital||2|||f||||f||||||||||2017-10-11 00:14:19.996674|2017-10-11 00:14:19.996674
NCT02185911|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-03-04|||June 2014||2014-06-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|ADAPTATION||Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis|Observational Study of Correction of Anaemia With Darbepoetin Alfa at Monthly Dose Frequency in EU and Australian Patients With Chronic Kidney Disease Not on Dialysis|Completed||N/A|308|Actual|Amgen|||1||f||||f||||||||||2017-10-11 00:14:20.082242|2017-10-11 00:14:20.082242
NCT02185898|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-01-21|||May 2014||2014-05-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes|A Single-Center Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes|Completed||N/A|71|Actual|R.J. Reynolds Vapor Company||6|||f||||f||||||||No||2017-10-11 00:14:20.422431|2017-10-11 00:14:20.422431
NCT02185885|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-04-08|||July 2014||2014-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|PPCI||Perfusion Pressure Cerebral Infarction Trial (PPCI)|The Importance of Mean Arterial Pressure During Cardiopulmonary Bypass to Prevent Cerebral Complications After Cardiac Surgery - a Randomised Clinical Trial.|Completed||N/A|197|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:14:20.52246|2017-10-11 00:14:20.52246
NCT02185872|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-03-30|||February 2012||2012-02-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||CrossFit Exercise to Improve Glucose Control for Overweight and Obese Adults|The Influence of a CrossFit Exercise Program on Glucose Control in Overweight and Obese Individuals|Completed||N/A|23|Actual|Kansas State University||2|||f||||f||||||||||2017-10-11 00:14:20.644545|2017-10-11 00:14:20.644545
NCT02185859|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-10-16|||July 2014||2014-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast Mastectomy||Completed||N/A|126|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 00:14:20.745974|2017-10-11 00:14:20.745974
NCT02185846|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2014-07-09|||June 2014||2014-06-01|May 2014|2014-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed Condition|Comparative, Randomized, Two -Period, Two-treatment, Two -Sequence, Open Label, Crossover Bioequivalence Pilot Study of Dirithromycin 500 mg Enteric Coated Tablet (One Tablet) of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) Versus Dynabac 250 mg Enteric Coated Tablet (Two Tablets) of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fed Conditions.|Completed||Phase 1|12|Actual|Pharmaceutical Research Unit, Jordan||2|||f||||||||||||||2017-10-11 00:14:20.818391|2017-10-11 00:14:20.818391
NCT02185833|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2014-07-09|||June 2014||2014-06-01|May 2014|2014-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition|Comparative, Randomized, Two -Period, Two-treatment, Two -Sequence, Open Label, Crossover Bioequivalence Pilot Study of Dirithromycin 500 mg Enteric Coated Tablet (One Tablet) of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) Versus Dynabac 250 mg Enteric Coated Tablet (Two Tablets) of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions.|Completed||Phase 1|12|Actual|Pharmaceutical Research Unit, Jordan||2|||f||||||||||||||2017-10-11 00:14:20.908945|2017-10-11 00:14:20.908945
NCT02185820|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-05-09|||June 2014||2014-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|July 2015|Actual|2015-07-01||Interventional|CPD||Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)|A MULTICENTER, OPEN LABEL PHASE I/II STUDY OF CARFILZOMIB, POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (MM) PATIENTS|Active, not recruiting||Phase 1/Phase 2|57|Actual|Stichting Hemato-Oncologie voor Volwassenen Nederland||1|||f||||t||||||||||2017-10-11 00:14:21.013247|2017-10-11 00:14:21.013247
NCT02185807|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-08-14|||July 2014||2014-07-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Video-assisted Informed Consent for Cataract Surgery|Does Video-assisted Informed Consent for Cataract Surgery Improve Patients' Satisfaction|Completed||N/A|80|Actual|Guangzhou First People's Hospital||2|||f||||f||||||||Undecided||2017-10-11 00:14:21.130035|2017-10-11 00:14:21.130035
NCT02185794|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2015-10-08|||June 2014||2014-06-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection|Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 1|100|Actual|Gilead Sciences||5|||f||||f||||||||||2017-10-11 00:14:21.228568|2017-10-11 00:14:21.228568
NCT02185781|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-08-31|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)|Phase I Protocol of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL) in Complete Hematologic Remission (CHR) But With Persistent/Recurrent Minimal Residual Disease (MRD) ≥60 Years or Not Eligible for Other Post-CHR Treatment Modalities|Recruiting||Phase 1|6|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-11 00:14:21.347046|2017-10-11 00:14:21.347046
NCT02185768|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-08-10|||December 2014||2014-12-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|October 2016|Anticipated|2016-10-01||Interventional|IDASPHERE II||Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II|Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II|Recruiting||Phase 2|91|Anticipated|Federation Francophone de Cancerologie Digestive||1|||f||||t||||||||||2017-10-11 00:14:21.470588|2017-10-11 00:14:21.470588
NCT02185755|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-08-17|||August 2014||2014-08-01|August 2017|2017-08-01||||August 2016|Actual|2016-08-01||Interventional|||Internet Monitoring vs Medication to Control Blood Sugar in Type 2 Diabetes|Investigating if an Internet-Based Glucose Monitoring System is as Effective as Medication at Reducing HbA1c Levels in Type 2 Diabetes Mellitus|Active, not recruiting||N/A|60|Anticipated|Endocrine Research Society||2|||f||||f||||||||||2017-10-11 00:14:21.609632|2017-10-11 00:14:21.609632
NCT02185742|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-01-19|||July 2014||2014-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SUCCESS||Planning for SUCCESS|Planning for Sustained, Unbroken Connections to Care, Entry Services, and Suppression (SUCCESS)-- A Project to Improve the Connection to Community Care for HIV Infected Persons Leaving Jail in Atlanta|Completed||N/A|113|Actual|Emory University||2|||f||||f||||||||||2017-10-11 00:14:21.686389|2017-10-11 00:14:21.686389
NCT02185729|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-12-18|2014-12-18||June 2008||2008-06-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|TPN1||Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers|Randomized Study Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion: Effects on Endothelial Function, Inflammatory Markers, Oxidative Stress, Immune Function, Autonomic Nervous System, Insulin Sensitivity and Carbohydrate Metabolism|Completed||Phase 2/Phase 3|12|Actual|Emory University|Short duration and involved healthy volunteers--not clear whether the use of olive oil-based lipid emulsions may result in improved clinical outcomes over traditional lipid emulsions in hospitalized patients with medical and surgical illness.|1|||f||||t||||||||||2017-10-11 00:14:23.583297|2017-10-11 00:14:23.583297
NCT02185716|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-01-25|||January 2014||2014-01-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|July 2015|Actual|2015-07-01||Interventional|||Transversus Abdominis Plane Block (TAP) for Laparoscopic Cholecystectomy Surgery|Comparison Of Ultrasound Guided Transversus Abdominis Plane Block (TAP) and Local Infiltration Analgesia During Laparoscopic Cholecystectomy Surgery|Active, not recruiting||Phase 4|75|Anticipated|Duzce University||3|||f||||||||||||||2017-10-11 00:14:23.85215|2017-10-11 00:14:23.85215
NCT02185703|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2015-08-03|||July 2014||2014-07-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Amici||Chordate System S020 Acute Migraine Clinical Investigation|A Randomized, Placebo-controlled, Double-blind, Multi-center Clinical Investigation to Evaluate the Performance and Safety of the Chordate System When Used in the Treatment of Acute Migraine Attacks of Moderate to Severe Intensity|Terminated||N/A|51|Actual|Chordate Medical||2||Too slow recruitment rate|f||||f||||||||||2017-10-11 00:14:23.932502|2017-10-11 00:14:23.932502
NCT02185690|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-09-20|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|MEK162||A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung|A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung|Not yet recruiting||Phase 1|30|Anticipated|University Health Network, Toronto||1|||f||||t|t|f|||t|||||2017-10-11 00:14:24.040842|2017-10-11 00:14:24.040842
NCT02185677|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-01-08|||May 2014||2014-05-01|January 2015|2015-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|CogAMS||Cognitive and Behavioral Dysexecutive Syndrome in Multiple System Atrophy|Comparison of Cognitive and Behavioral Dysexecutive Syndrome Between Parkinsonian Form and Cerebellar Form of Multiple System Atrophy and Analysis of Correlates With an Imaging Study.|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Bordeaux|||2||f||||f||||||||||2017-10-11 00:14:24.178392|2017-10-11 00:14:24.178392
NCT02185664|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-14|||April 2011||2011-04-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Use of Static Ultrasound Guidance for Internal Jugular Vein Cannulation in Adult Cardiac Surgical Patients|Comparison of the Landmark Technique and the Static Ultrasound Guided Technique for Internal Jugular Vein Cannulation in Adult Cardiac Surgical Patients.|Completed||N/A|201|Actual|Govind Ballabh Pant Hospital||2|||f||||t||||||||||2017-10-11 00:14:24.279173|2017-10-11 00:14:24.279173
NCT02185651|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-12-14|||October 2016||2016-10-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||A Pilot Study of Zavesca® in Patients With Pompe Disease and Infusion Associated Reaction|A Pilot Study of the Effects of Oral Administration of Zavesca® on Anti-rhGAA Immune Response in Subjects With Pompe Disease Receiving rhGAA Enzyme Replacement Therapy|Recruiting||Phase 1|6|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-11 00:14:24.367275|2017-10-11 00:14:24.367275
NCT02185261|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-07-06|||June 2014||2014-06-01|July 2014|2014-07-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Interferon α for the Therapy of Minimal Residual Disease|Interferon α for the Therapy of Minimal Residual Disease Following Hematopoietic Stem Cell Transplantation|Recruiting||N/A|81|Anticipated|Peking University People's Hospital||1|||f||||t||||||||||2017-10-11 00:14:28.952088|2017-10-11 00:14:28.952088
NCT02185638|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-07-03|||December 2008||2008-12-01|July 2014|2014-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|YGD||Appetite Suppression Effects of an Herbal Combination of Yerba maté, Guarana, Damiana (YGD), and 12 Other Herbal Components, Versus YGD Supplementation Alone|Appetite Suppression Effects of an Herbal Combination of Yerba maté, Guarana, Damiana (YGD), and 12 Other Herbal Components, Versus YGD Supplementation Alone|Completed||N/A|19|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 00:14:24.588566|2017-10-11 00:14:24.588566
NCT02185625|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-05-18|||July 2014||2014-07-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Reduction of Adverse Pregnancy Outcomes With a Smartphone Application in Ghana|Reduction of Adverse Pregnancy Outcomes With a Smartphone Application in Ghana: a Cluster Randomized Trial|Completed||N/A|3773|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:14:24.686859|2017-10-11 00:14:24.686859
NCT02185612|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-08-06|||October 2016||2016-10-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|EARN-Health||The EARN-Health Trial of Financial Savings and Health|EARN-Health: A Randomized Controlled Trial of the Effects of an Incentivized Savings Program on Depression, Anxiety, Substance Abuse, and Locus of Control|Active, not recruiting||N/A|700|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 00:14:24.814382|2017-10-11 00:14:24.814382
NCT02185586|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2016-02-27|||May 2014||2014-05-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||A Prospective Randomized Controlled Trial of Lower Abdominal Three-port Laparoscopic Cholecystectomy|A Prospective Randomized Controlled Trial of Traditional Three-port Laparoscopic Cholecystectomy Versus Lower Abdominal Three-port Laparoscopic Cholecystectomy|Completed||N/A|105|Actual|China-Japan Friendship Hospital||3|||f||||t||||||||Undecided||2017-10-11 00:14:25.142415|2017-10-11 00:14:25.142415
NCT02185573|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2015-10-02|||July 2014||2014-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Two Different Methods of Resin Composite Application In Class II Restorations|Evaluation of Two Different Methods of Resin Composite Application Using Bulk-fill Technique In Class II Restorations|Completed||N/A|60|Actual|Damascus University||3|||f||||t||||||||||2017-10-11 00:14:25.236276|2017-10-11 00:14:25.236276
NCT02185560|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2017-09-25|||June 27, 2014|Actual|2014-06-27|September 2017|2017-09-01|June 30, 2021|Anticipated|2021-06-30|March 31, 2020|Anticipated|2020-03-31||Observational|JPMS-DTC||Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib|Drug Use Investigation of Sorafenib/ NEXAVAR® for Unresectable Differentiated Thyroid Carcinoma (DTC)|Recruiting||N/A|443|Anticipated|Bayer|||1||f||||f||||||||||2017-10-11 00:14:25.339788|2017-10-11 00:14:25.339788
NCT02185547|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-06|2016-05-23|||May 2016||2016-05-01|May 2016|2016-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|MAGDALENA||Effects and Consequences for Mother and Child From Treatment for Depression|Effects and Consequences for Mother and Child From Treatment for Depression, A Prospective Randomized, Placebo- Controlled, Trial With Internet-based Cognitive Behavior Therapy and Sertraline or Placebo for Moderate Depression in Pregnancy|Not yet recruiting||Phase 4|200|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:14:25.434286|2017-10-11 00:14:25.434286
NCT02185534|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-05-18|2015-09-18||August 2014||2014-08-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||The overall number of baseline participants is 84, as it comprised all randomized subjects, although one subject withdrew consent prior to the first dose. Thus the safety population includes 83 subjects only.|Clopidogrel Bioequivalence Study in Healthy Subjects|An Open-label, Randomised, Three-way Crossover Study in Healthy Subjects to Assess the Bioequivalence of European Source Generic Clopidogrel Tablets and US and Japanese Source Branded Clopidogrel (Plavix®) Tablets.|Completed||Phase 1|144|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:14:25.542154|2017-10-11 00:14:25.542154
NCT02185521|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-04-27|||November 2014||2014-11-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|HII||Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator|Hemodynamic Instability Rules Based Advisor: The Impact to Care With a New Predictive Indicator (HIRBA 2.0)|Recruiting||N/A|3000|Anticipated|Philips Healthcare||2|||f||||t||||||||||2017-10-11 00:14:26.256524|2017-10-11 00:14:26.256524
NCT02185508|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||January 2011||2011-01-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|July 2014|Actual|2014-07-01||Observational|||Intra-operatory Neurophysiological Monitoring Changes as a Predictive Clinical Outcome Measure in Lumbar Radiculopathy.|Intra-operatory Neurophysiological Monitoring Changes as a Predictive Clinical Outcome Measure in Radiculopathy Associated to Lumbar Disk Disease. Two Years Follow-up|Unknown status|Active, not recruiting|N/A|200|Anticipated|American British Cowdray Medical Center|||1||f||||||||||||||2017-10-11 00:14:26.363354|2017-10-11 00:14:26.363354
NCT02185495|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-05|2014-12-16|||July 2014||2014-07-01|November 2014|2014-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Screening for Early Lung Cancer in Shanghai, China|Screening and Diagnosing for Early Lung Cancer in Shanghai Communities With Imaging Procedures|Unknown status|Recruiting|Phase 2|3000|Anticipated|Shanghai Changzheng Hospital||1|||f||||t||||||||||2017-10-11 00:14:26.592093|2017-10-11 00:14:26.592093
NCT02185482|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-02-04|||August 2014||2014-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Physician Led Counseling in Management of Depression in Type 2 Diabetes Mellitus|Physician Led Counseling for Depression in Type 2 Diabetes Mellitus: A Randomized, Controlled Trial|Completed||N/A|150|Actual|Adwin Life Care||2|||f||||t||||||||||2017-10-11 00:14:26.688253|2017-10-11 00:14:26.688253
NCT02185469|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-07-08|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment|Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment|Unknown status|Not yet recruiting|N/A|30|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 00:14:26.773283|2017-10-11 00:14:26.773283
NCT02185456|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-11-05|||September 2014||2014-09-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|BV-LbRC||Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis|Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis|Unknown status|Recruiting|Early Phase 1|200|Anticipated|Wayne State University||5|||f||||t||||||||||2017-10-11 00:14:26.885912|2017-10-11 00:14:26.885912
NCT02185443|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2016-05-10|||May 2014||2014-05-01|May 2016|2016-05-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases|Stereotactic Body Radiation Therapy for the Treatment of Unresectable Liver Metastases in Patients With Colorectal Adenocarcinoma, Carcinoma of the Anal Canal and Gastrointestinal Neuroendocrine Tumors|Recruiting||Phase 2|43|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 00:14:27.000019|2017-10-11 00:14:27.000019
NCT02185430|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-10-11|||July 2014||2014-07-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Dexmedetomidine on Respiratory Mechanics and Oxygenation During One Lung Ventilation With Chronic Obstructive Lung Disease||Completed||N/A|63|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:14:27.119504|2017-10-11 00:14:27.119504
NCT02185417|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-06-30|||June 15, 2016|Actual|2016-06-15|June 2017|2017-06-01|April 15, 2023|Anticipated|2023-04-15|October 15, 2022|Anticipated|2022-10-15||Interventional|DCP||Diuretic Comparison Project|CSP #597 - Diuretic Comparison Project|Recruiting||Phase 3|13500|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-11 00:14:27.211859|2017-10-11 00:14:27.211859
NCT02185404|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-11-08|||April 2015||2015-04-01|November 2016|2016-11-01||||January 2017|Anticipated|2017-01-01||Interventional|||Gait Enhancing Mobile Shoe for Stroke Rehabilitation||Recruiting||N/A|5|Anticipated|University of South Florida||1|||f||||f||||||||||2017-10-11 00:14:27.350538|2017-10-11 00:14:27.350538
NCT02185391|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-03-29|||May 2014||2014-05-01|April 2015|2015-04-01|November 2015|Actual|2015-11-01|November 2014|Actual|2014-11-01||Interventional|INSERT||Interactive Education of Patients With Coronary Heart Disease|Development of Sustainable Methods in Interactive Patient Education to Improve Adherence After Cardiac Rehabilitation|Completed||N/A|260|Actual|Paracelsus Harz Clinic Bad Suderode.||2|||f||||f||||||||||2017-10-11 00:14:27.447873|2017-10-11 00:14:27.447873
NCT02185378|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-04-16|||July 2014||2014-07-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of 1:1 Inspiratory to Expiratory Ratios on Oxygenation and Intrapulmonary Shunt Fraction During One Lung Ventilation in the Obese Patients|Effects of 1:1 Inspiratory to Expiratory Ratios on Oxygenation and Intrapulmonary Shunt Fraction During One Lung Ventilation in the Obese Patients|Completed||N/A|36|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:14:27.538749|2017-10-11 00:14:27.538749
NCT02185365|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-02-08|||July 2015||2015-07-01|February 2015|2015-02-01||||September 2016|Anticipated|2016-09-01||Interventional|||Evaluation of T1rho Magnetic Resonance Imaging for Diagnosis of Cartilage Lesions in Hips With Developmental Dysplasia|Evaluation of T1rho Magnetic Resonance Imaging for Diagnosis of Cartilage Lesions in Hips With Developmental Dysplasia|Unknown status|Not yet recruiting|N/A|20|Anticipated|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-10-11 00:14:27.615268|2017-10-11 00:14:27.615268
NCT02185352|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-01-17|||September 2014||2014-09-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|A-Plus||Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases|Randomized Phase II Study of Induction Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy (WBRT) Versus WBRT Alone in Breast Cancer With Untreated Brain Metastases|Recruiting||Phase 2|126|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:14:27.701064|2017-10-11 00:14:27.701064
NCT02185339|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-06-23|2016-03-30||July 2014||2014-07-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics|Effects of Deep Versus Moderate Neuromuscular Blockade on Intraoperative Respiratory Mechanics in Patients Undergoing Laparoscopic Renal Surgery: a Prospective, Randomized, Parallel Design Study|Completed||Phase 4|61|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-11 00:14:27.85306|2017-10-11 00:14:27.85306
NCT02185326|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-01-26|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Microflare Protocol in Poor Responders|Growth Hormone Co-treatment With the Microflare Stimulation Protocol in IVF/ICSI, Can it be a New Hope for Poor Responders?|Completed||Phase 4|145|Actual|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-11 00:14:28.426866|2017-10-11 00:14:28.426866
NCT02185313|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-10-26|||August 2013||2013-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Gaze Holding in Cerebellar Patients|Verticality Perception and Gaze Holding in Healthy Human Subjects and Patients With Acute and Chronic Cerebellar Disorders|Recruiting||N/A|90|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-11 00:14:28.533061|2017-10-11 00:14:28.533061
NCT02185300|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-11-26|||July 2014||2014-07-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers|A Phase 1, Single Dose, Crossover, Relative Bioavailability Study of a Dolutegravir Dispersible Tablet as Compared to a Dolutegravir Pediatric Granule Formulation and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers(200401)|Completed||Phase 1|15|Actual|ViiV Healthcare||5|||f||||f||||||||||2017-10-11 00:14:28.613986|2017-10-11 00:14:28.613986
NCT02185274|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-07-03|||October 2013||2013-10-01|July 2014|2014-07-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|||Observational Study on Metabolism and Psychopathology in Transsexual Patients|Observational Study on the Short- and Long-term Effects of Cross-sex-hormone Treatment on Metabolism and Psychopathology in Transsexuals Patients.|Recruiting||N/A|100|Anticipated|Max-Planck-Institute of Psychiatry|||1||f||||f||||||Samples With DNA|"     -  2 x 10ml serum        -  10ml urine        -  Hair sample        -  7,5ml EDTA-Blood for DNA and plasma        -  2,5ml blood for mRNA-Analysis        -  8,5ml stabilized serum        -  Stool sample (2-5ml)   "|||2017-10-11 00:14:28.823312|2017-10-11 00:14:28.823312
NCT02185248|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-03-20|||March 2013||2013-03-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Wellness Action Plan Trial Addressing Childhood Obesity|Randomized Controlled Trial of a Wellness Action Plan to Address the Childhood Obesity Epidemic|Completed||N/A|181|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 00:14:29.083063|2017-10-11 00:14:29.083063
NCT02185235|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-07-03|||June 2014||2014-06-01|July 2014|2014-07-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||A Randomized Controlled Trial of Electrical Stimulation to Treat Pelvic Floor Disorder|To Evaluate The Efficacy of Electrical Stimulation and Biofeedback Treatment for Pelvic Floor Disorder Women|Unknown status|Recruiting|N/A|200|Anticipated|Mackay Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:14:29.174272|2017-10-11 00:14:29.174272
NCT02185222|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-06-29|||July 2014||2014-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|D-COG||Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint|Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint|Recruiting||Phase 3|68|Anticipated|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 00:14:29.271797|2017-10-11 00:14:29.271797
NCT02185209|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-09-01|||March 2015||2015-03-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics|Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics A Prospective, Double Blind, Randomized, Three Armed, Parallel, Placebo Controlled Clinical Trial|Recruiting||Phase 4|66|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 00:14:29.575201|2017-10-11 00:14:29.575201
NCT02185196|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2016-09-04|||June 2014||2014-06-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|Vitamin-D||Vitamin-D Supplementation: Impact on Severe Pneumonia Among Under-five Children|Vitamin D Supplementation: Impact on Severe Pneumonia Among Under-five Children|Recruiting||Phase 1|350|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-11 00:14:29.730566|2017-10-11 00:14:29.730566
NCT02185183|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-09-21|2014-09-07||January 2008||2008-01-01|January 2008|2008-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD)|Phase 2 Clinical Trial for Oral Administration of Alequel for Patients With IBD|Completed||Phase 1/Phase 2|22|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 00:14:29.878745|2017-10-11 00:14:29.878745
NCT02185170|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-09-21|||July 2014||2014-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections|Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections.|Terminated||N/A|5|Actual|University Hospital, Grenoble||1||Results of 5 first patients show that chips' cauterization interferes the signal|f||||f||||||||||2017-10-11 00:14:30.121991|2017-10-11 00:14:30.121991
NCT02185157|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-06|||October 2011||2011-10-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effects of Dual-task Exercises on Gait Parameters and Cognitive Function in Elderly Women: A Randomized Controlled Trial|Effects of Dual-task Versus Aerobic Training on Gait Stride Variability and Cognitive Function of Independent Community-dwelling Elderly Women: A Randomized Controlled Trial|Completed||N/A|68|Actual|Federal University of Minas Gerais||2|||f||||t||||||||||2017-10-11 00:14:30.247918|2017-10-11 00:14:30.247918
NCT02185144|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-09-18|||February 2014||2014-02-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PFT||PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients|The PFT Intervention: Linking Triply Diagnosed Inpatients to Community Care|Recruiting||N/A|240|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:14:30.358515|2017-10-11 00:14:30.358515
NCT02185131|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-03-24|2016-08-17||September 2013||2013-09-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PT-MAD||Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.|Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.|Completed||Phase 2|16|Actual|University of Pittsburgh||2|||f||||f||||||||No|No individual subject data will be shared.|2017-10-11 00:14:30.50458|2017-10-11 00:14:30.50458
NCT02185118|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-07-06|||June 2014||2014-06-01|July 2014|2014-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Subanesthetic Isoflurane/Sevoflurane in 60% Oxygen on Clinical In-vitro Experimental Sepsis|In-vitro Experimental Study About Effects of Subanesthetic Isoflurane/Sevoflurane in 60% Oxygen on Clinical In-vitro Sepsis|Recruiting||N/A|50|Anticipated|Fourth Military Medical University||1|||f||||f||||||||||2017-10-11 00:14:30.809205|2017-10-11 00:14:30.809205
NCT02185105|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-01-24|2016-08-02||June 2014||2014-06-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Clinical Validation of Biofinity Toric MTO (Made To Order) Lenses|Clinical Validation of Biofinity Toric MTO (Made To Order) Lenses|Completed||N/A|30|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 00:14:30.942434|2017-10-11 00:14:30.942434
NCT02185092|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-05-19|||October 2014||2014-10-01|May 2017|2017-05-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Probiotic Use in Patients With Prior COPD Exacerbation|Probiotic Use in Patients With Prior COPD Exacerbation|Withdrawn||N/A|0|Actual|University of Oklahoma||2||Lost funding|f||||t||||||||No||2017-10-11 00:14:31.694645|2017-10-11 00:14:31.694645
NCT02185079|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-05|2016-07-25|||January 2014||2014-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Metrics Based Performance Based Progression in Provision of Labor Epidural Analgesia|The Effect of Metrics Based Performance Based Progression in Provision of Labor Epidural Analgesia on Clinical Performance and Clinical Outcome|Recruiting||N/A|16|Anticipated|Cork University Hospital||2|||f||||f||||||||||2017-10-11 00:14:31.792256|2017-10-11 00:14:31.792256
NCT02185066|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-12-28|||July 2014||2014-07-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR||Completed||Phase 1|42|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 00:14:31.904174|2017-10-11 00:14:31.904174
NCT02183987|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-09-05|||September 2014||2014-09-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Preventing Early Dialysis Starts|Knowledge Translation Interventions to Prevent the Early Initiation of Dialysis: A Cluster Randomized Trial|Completed||N/A|55|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:14:46.219098|2017-10-11 00:14:46.219098
NCT02185053|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-07-25|||July 2014||2014-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia|A Phase II, Single-Blind, Placebo-Controlled, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of CPC-201 in Patients With Alzheimer's Disease Type Dementia|Completed||Phase 2|41|Actual|Chase Pharmaceuticals Corporation||1|||f||||t||||||||||2017-10-11 00:14:31.999409|2017-10-11 00:14:31.999409
NCT02185040|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2017-08-14|||September 16, 2014|Actual|2014-09-16|June 2017|2017-06-01|April 14, 2018|Anticipated|2018-04-14|April 14, 2018|Anticipated|2018-04-14||Interventional|||A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.|A Pilot, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Study To Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of CC-220 In Subjects With Systemic Lupus Erythematosus|Active, not recruiting||Phase 2|42|Actual|Celgene||5|||f||||f||||||||||2017-10-11 00:14:32.082955|2017-10-11 00:14:32.082955
NCT02185027|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-07-28|||June 2013||2013-06-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|GIHP-NACO||Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants|Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants|Unknown status|Recruiting|N/A|842|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-11 00:14:32.270517|2017-10-11 00:14:32.270517
NCT02185001|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-03-07|||October 2014||2014-10-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Repair of Medial Patellofemoral Ligament Compared to Conservative Treatment for First Time Patella Dislocation|Repair of Medial Patellofemoral Ligament Compared to Conservative Treatment for First Time Patella Dislocation; A Randomized Prospective Trial|Terminated||N/A|2|Actual|Orthopedic Specialty Institute||2||Inadequate patient recruitment and coordinator left organization|f||||f||||||||Undecided||2017-10-11 00:14:33.07635|2017-10-11 00:14:33.07635
NCT02184988|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-03-20||2017-02-01|August 2014||2014-08-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EV-004||Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines|A Multi-center, Open Label, Multiple Dose, Phase II Trial to Demonstrate the Safety of DWP-450 in Adult Subjects for Treatment of Moderate-to-severe Glabellar Lines.|Completed||Phase 2|353|Actual|Evolus, Inc.||1|||f||||f||||||||No|Analysis will be of combined data for all subjects entered into the study|2017-10-11 00:14:33.199217|2017-10-11 00:14:33.199217
NCT02184975|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-07-05|||March 2009||2009-03-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|August 2012|Actual|2012-08-01||Interventional|||Cold Knife Conization With and Without Lateral Hemostatic Sutures|Randomized Clinical Trial Comparing Cold Knife Conization of the Cervix With and Without Lateral Hemostatic Sutures|Completed||Phase 2|100|Actual|Barretos Cancer Hospital||2|||f||||f||||||||||2017-10-11 00:14:33.3126|2017-10-11 00:14:33.3126
NCT02184962|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-08|||May 2012||2012-05-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Periodontal Disease and Post-menopausal Osteoporosis|"Levels of RANKL and OPG in Gingival Crevicular Fluid of Patients With Post-menopausal Osteoporosis / Osteopenia and Periodontal Disease."|Completed||N/A|81|Actual|Universidad Nacional de Córdoba|||1||f||||t||||||||||2017-10-11 00:14:33.416269|2017-10-11 00:14:33.416269
NCT02184949|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-04-10|||January 2014||2014-01-01|April 2017|2017-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Observational|||Exploring the Volume-Outcome Relationship for PCI Procedures Undertaken in a UK Context: A NICOR Study|Percutaneous Coronary Interventions in the UK: The Relationship Between Procedural Volumes and Patient Outcomes in a Changing Context (A NICOR Study)|Completed||N/A|427467|Actual|University College, London|||2||f||||f||||||||||2017-10-11 00:14:33.494881|2017-10-11 00:14:33.494881
NCT02184936|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-05-10|||September 2012||2012-09-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|PRove-IT||Measuring Collaterals With Multi-phase CT Angiography in Patients With Ischemic Stroke|Precise and Rapid Assessment of Collaterals Using Multi-phase CTA in the Triage of Patients With Acute Ischemic Stroke for IA Therapy|Recruiting||N/A|500|Anticipated|University of Calgary|||1||f||||f||||||||No|No individual participant date will be shared, overall data( anonymous) will be available and shared|2017-10-11 00:14:33.592895|2017-10-11 00:14:33.592895
NCT02184923|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-10-25|||August 2014||2014-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|March 2019|Anticipated|2019-03-01||Interventional|||Verticality Perception in Stroke Patients|Verticality Perception in Patients With Acute Lateralized Lesions Along the Central Graviceptive Pathways- Acute Assessment on the Ward and the Stroke Center|Recruiting||N/A|180|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-11 00:14:33.695203|2017-10-11 00:14:33.695203
NCT02184910|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-08|||December 2013||2013-12-01|July 2014|2014-07-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01|4 Years|Observational [Patient Registry]|||Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea||Recruiting||N/A|108|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:14:33.791746|2017-10-11 00:14:33.791746
NCT02184897|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2016-07-23|||July 2014||2014-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization|Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization in Patients With Multiple Myeloma|Active, not recruiting||N/A|24|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 00:14:33.884401|2017-10-11 00:14:33.884401
NCT02184884|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-01-06|||July 2014||2014-07-01|January 2015|2015-01-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Observational|||Effect of Perioperative Clopidogrel Responsiveness on Ischemic Outcome in Patients With Acute Coronary Syndrome Undergoing Off-pump Coronary Artery Bypass Surgery||Unknown status|Recruiting|N/A|195|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-11 00:14:33.982367|2017-10-11 00:14:33.982367
NCT02184871|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-08|||May 2014||2014-05-01|July 2014|2014-07-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Observational|EtherBil||Next Generation Sequencing in Intrahepatic Cholangiocarcinoma|Next Generation Sequencing in Intrahepatic Cholangiocarcinoma (ICC) According to the Stratification of the Risk Factors|Unknown status|Recruiting|N/A|45|Anticipated|University of Bologna|||1||f||||f||||||Samples With DNA|"     Tumor tissue samples will be immediately collected after surgery: one part will be suspended     in RNAlater to prevent RNA degradation and stored at -20°C, the other will be formalin-fixed     and paraffin-embedded for histopathology examination and evaluation of asbestos fibers. For     each patient enrolled, peripheral blood will be also collected and stored at -20°C. Total RNA     and genomic DNA will be extracted from tumor tissue and peripheral blood and stored at -80°C     until use.   "|||2017-10-11 00:14:34.100408|2017-10-11 00:14:34.100408
NCT02184858|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-07-10|||June 2014||2014-06-01|July 2014|2014-07-01|January 2016|Anticipated|2016-01-01|September 2015|Anticipated|2015-09-01||Interventional|Lisi-ped||Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension|Dose Titration Study to Test Efficacy and Safety of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension.|Unknown status|Recruiting|Phase 4|33|Anticipated|University Ghent||1|||f||||t||||||||||2017-10-11 00:14:34.205861|2017-10-11 00:14:34.205861
NCT02184845|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-03-29|||January 2011||2011-01-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|March 2020|Anticipated|2020-03-01||Interventional|NA 3 MM||A 5 Year Clinical Study on NobelActive 3 mm Implants|Open, Prospective, Single Cohort, Multi-centre Study Evaluating the NobelActive 3 mm Implant Immediately Restored With Single Crowns in the Maxillary Lateral Incisor Area or Mandibular Central or Lateral Incisor Area|Active, not recruiting||N/A|84|Anticipated|Nobel Biocare||1|||f||||f||||||||||2017-10-11 00:14:34.298913|2017-10-11 00:14:34.298913
NCT02184832|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-03-14|||August 2014||2014-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Dietary Intake of Tryptophan and Metformin Response||Completed||Early Phase 1|20|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:14:34.384162|2017-10-11 00:14:34.384162
NCT02184819|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-02-24|||June 2013||2013-06-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|LICORN||Preoperative Levosimendan in CABG Patients With Poor LV Function|Effects of Levosimendan Pretreatment in Patients With Low Ejection Fraction (40 % or Less) Undergoing CABG: a Randomised, Double Blind, Multicenter Trial|Completed||Phase 3|335|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:14:34.491318|2017-10-11 00:14:34.491318
NCT02184806|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-04-13|||June 2010||2010-06-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|CAROLéLISA||Autograft of Human Ovarian Tissue : Efficiency and Safety|Autograft of Human Ovarian Tissue: Efficiency and Safety Evaluation|Recruiting||N/A|40|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:14:34.612763|2017-10-11 00:14:34.612763
NCT02184793|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-06-13|||June 2014||2014-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|Inclinometre2||Impact of an Electronic Monitoring Device on Maintaining a Correct Elevation of Head of Bed for Mechanically-ventilated Patients in Intensive Care Unit|Impact of an Electronic Monitoring Device on Maintaining a Correct Elevation of Head of Bed for Mechanically-ventilated Patients in Intensive Care Unit|Terminated||N/A|105|Actual|Assistance Publique - Hôpitaux de Paris||2||not enough inclusion|f||||f||||||||||2017-10-11 00:14:34.713428|2017-10-11 00:14:34.713428
NCT02184780|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-03-09|||September 2013||2013-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|PANO||Impact of Perinatal Anaesthesia and Analgesia on Neurocognitive Outcomes in Early Childhood|Impact of Perinatal Anaesthesia and Analgesia on Neurocognitive Outcomes in Early Childhood (PANO Study)|Active, not recruiting||N/A|468|Anticipated|KK Women's and Children's Hospital|||1||f||||f||||||||||2017-10-11 00:14:34.798153|2017-10-11 00:14:34.798153
NCT02184767|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-02-26|||July 2014||2014-07-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication|A Nonrandomized, Open-Label, Multicenter, Phase 1 Study to Assess the Safety and Pharmacokinetics of ADASUVE® (STACCATO® Loxapine for Inhalation) at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication|Completed||Phase 1|30|Actual|Teva Pharmaceutical Industries||1|||f||||t||||||||||2017-10-11 00:14:34.881147|2017-10-11 00:14:34.881147
NCT02184754|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2015-01-28|||December 2013||2013-12-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|Magenta||Magnetic Endoscope Imaging in Single-balloon-enteroscopy||Completed||N/A|10|Anticipated|Technische Universität München|||1||f||||f||||||||||2017-10-11 00:14:34.975314|2017-10-11 00:14:34.975314
NCT02184741|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-03-06|||April 2014||2014-04-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|February 2019|Anticipated|2019-02-01||Interventional|||Evaluation of the Safety and Efficacy of GB-0998 in Unexplained Primary Recurrent Miscarriage|A Randomized, Placebo-controlled, Double-blinded Study With GB-0998 for Unexplained Primary Recurrent Miscarriage|Recruiting||Phase 3|80|Anticipated|Japan Blood Products Organization||2|||f||||f||||||||||2017-10-11 00:14:35.07144|2017-10-11 00:14:35.07144
NCT02184728|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-03-23|||June 2014||2014-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of End-tidal Carbon Dioxide (ETCO2) Measured by Transportable Capnometer (EMMATM) and the Arterial pCO2 in General Anesthesia||Completed||N/A|35|Actual|Inje University||1|||f||||f||||||||||2017-10-11 00:14:35.161447|2017-10-11 00:14:35.161447
NCT02184715|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-08|||January 2009||2009-01-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Interventional|||Effects of Virtual Reality System in Children With Developmental Delays|The Additional Therapeutic Effects of Virtual Reality System in Children With Developmental Delays|Completed||Phase 4|157|Actual|Taipei Medical University||2|||f||||f||||||||||2017-10-11 00:14:35.235912|2017-10-11 00:14:35.235912
NCT02184702|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-08-29|||June 2014||2014-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Effects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder Arthroscopy||Completed||N/A|40|Actual|Inje University|||1||f||||||||||||||2017-10-11 00:14:35.306463|2017-10-11 00:14:35.306463
NCT02184689|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-10-06|||May 2014||2014-05-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study|Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study|Active, not recruiting||Phase 2/Phase 3|125|Actual|Drugs for Neglected Diseases||1|||f||||t||||||||||2017-10-11 00:14:35.371303|2017-10-11 00:14:35.371303
NCT02184676|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-07-31|||May 2015||2015-05-01|July 2016|2016-07-01|February 2020|Anticipated|2020-02-01|September 2019|Anticipated|2019-09-01||Interventional|TRAKR||T1D Risk Assessment in Kids With Relatives|Early Immunological, Metagenomic, Metabolic and Environmental Factors in the Progression to Type 1 Diabetes: the TRAKR Cohort|Recruiting||N/A|1200|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-11 00:14:35.435403|2017-10-11 00:14:35.435403
NCT02184663|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-07-29|||September 2014||2014-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer|Multicenter, Randomized Study, Evaluation of Adapted Physical Activity Program in Patients With Unresectable, Locally Advanced or Metastatic Pancreatic Cancer|Recruiting||N/A|200|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2|||f||||f||||||||||2017-10-11 00:14:35.544704|2017-10-11 00:14:35.544704
NCT02184650|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-07-19|||July 2014||2014-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Observational|EPINUTRI_3||Nutrition and Neurological Development of Very Preterm Infants|Early Nutrition and Neurological Development of Very Preterm Infants|Active, not recruiting||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||None Retained|"     saliva, whole blood   "|||2017-10-11 00:14:35.733749|2017-10-11 00:14:35.733749
NCT02184637|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-07-10|||July 31, 2014|Actual|2014-07-31|July 2017|2017-07-01|April 8, 2015|Actual|2015-04-08|April 8, 2015|Actual|2015-04-08||Interventional|||A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate|A Five-cohort, Randomized, Open-label, Parallel-group Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine (SB252263) 300mg When Co-administered With the Artemisinin-based Combination Therapies (ACT) Artemether + Lumefantrine (AL) and Dihydroartemisinin + Piperaquine Tetraphosphate (DHA+PQP)|Completed||Phase 1|120|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 00:14:35.81721|2017-10-11 00:14:35.81721
NCT02184624|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-04-25|2017-01-31||August 28, 2014|Actual|2014-08-28|April 2017|2017-04-01|July 31, 2015|Actual|2015-07-31|July 31, 2015|Actual|2015-07-31||Interventional|||Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices|An Open-label Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices (ELLIPTA, TURBUHALER, HANDIHALER, BREEZHALER, MDI, and DISKUS/ACCUHALER) in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|569|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:14:35.994814|2017-10-11 00:14:35.994814
NCT02184598|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-12-21|||July 2014||2014-07-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With ADHD|Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder|Enrolling by invitation||N/A|60|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 00:14:37.557493|2017-10-11 00:14:37.557493
NCT02184585|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-05-12|||July 10, 2014|Actual|2014-07-10|May 2017|2017-05-01|February 23, 2015|Actual|2015-02-23|February 23, 2015|Actual|2015-02-23||Interventional|||Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States|An Open-label, Randomized, Single Dose, Three-way Crossover Study to Determine the Bioavailability of Two Fixed Dose Combination Capsule Formulations of Dutasteride and Tamsulosin Hydrochloride (0.5mg/0.2mg) Relative to Co-administration of Dutasteride 0.5mg Capsules and Tamsulosin Hydrochloride 0.2mg Tablets in Healthy Male Subjects in the Fed and Fasted States|Completed||Phase 1|84|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:14:37.689968|2017-10-11 00:14:37.689968
NCT02184559|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-08|||February 2012||2012-02-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|August 2014|Anticipated|2014-08-01||Interventional|||Postoperative Analgesia After Caesarean Section Under ALR: TAP Block Versus Catheter Scar Infiltration|Postoperative Analgesia After Caesarean Section Under ALR: TAP Block Versus Catheter Scar Infiltration|Unknown status|Recruiting|Phase 3|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 00:14:38.395873|2017-10-11 00:14:38.395873
NCT02184546|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-08-31|||July 2014||2014-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Outcomes Data of Adipose Stem Cells to Treat Parkinson's Disease||Active, not recruiting||N/A|75|Actual|StemGenex|||1||f||||||||||||||2017-10-11 00:14:38.519946|2017-10-11 00:14:38.519946
NCT02184533|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-01-17|||July 2014||2014-07-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer|A Phase I Study Evaluating the Efficacy and Safety of Sodium Selenite in Combination With Palliative Radiation Therapy in Patients With Metastatic Cancer|Recruiting||Phase 1|27|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 00:14:38.614445|2017-10-11 00:14:38.614445
NCT02184520|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-03-16|||May 2012||2012-05-01|March 2017|2017-03-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System|A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System|Recruiting||N/A|360|Anticipated|Globus Medical Inc||2|||f||||t||||||||||2017-10-11 00:14:38.765318|2017-10-11 00:14:38.765318
NCT02184507|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-10-23|||June 2013||2013-06-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|ECIRRA||Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress|Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress|Completed||Phase 2|92|Actual|Shiraz University of Medical Sciences||4|||f||||t||||||||||2017-10-11 00:14:39.474846|2017-10-11 00:14:39.474846
NCT02184494|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-03-07|2015-07-02||August 2014||2014-08-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|PDMSLac||Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients|Phase 1 Study of A Double-Blind Placebo-Controlled Study of the Effect of Beta-Alanine and Whole Body Vibration on Neurologic Motoric Function, Vascular Function, and Quality of Life in Parkinson's Disease|Completed||N/A|34|Actual|Florida State University||3|||f||||f||||||||Yes|If, and when requested, participants may review findings by contacting the PI. Other than participants, only investigators will have access to the data.|2017-10-11 00:14:39.639204|2017-10-11 00:14:39.639204
NCT02184481|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-08|||September 2013||2013-09-01|July 2014|2014-07-01||||June 2014|Actual|2014-06-01||Interventional|||Working Memory Training for Dysphoric Students|Working Memory Training to Decrease Depression, Anxiety and Rumination in Dysphoric Students|Completed||N/A|94|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-11 00:14:40.35231|2017-10-11 00:14:40.35231
NCT02184468|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-08|||September 2011||2011-09-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|SAMS||Survival Study After Out-of-hospital Cardiac Arrest|Dual Dispatch of EMS, Fire Fighters and/or Police in Out-of-hospital Cardiac Arrest Implemented in Nine Counties in Sweden - Can More Lives be Saved by Using This Method?|Unknown status|Recruiting|N/A|6000|Anticipated|Karolinska Institutet||1|||f||||t||||||||||2017-10-11 00:14:40.490115|2017-10-11 00:14:40.490115
NCT02184455|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-10-10|||August 2015||2015-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment|A Feasibility Study of DermGEN Dermal Regeneration Scaffold for the Treatment of Diabetic Foot Ulcers|Recruiting||Phase 1|20|Anticipated|DeCell Technologies Inc.||1|||f||||t||||||||||2017-10-11 00:14:40.62988|2017-10-11 00:14:40.62988
NCT02184442|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-02-10|||September 2013|Actual|2013-09-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2014|Actual|2014-02-01||Interventional|PAS II||The PARTNER TRIAL - Post Approval Study Part II|Assessment of Safety, Effectiveness, Adherence to Indication and Learning Curve of the SAPIEN™ THV With Retroflex for Inoperable Patients and With RetroFlex or Ascendra for High Risk Operable Patients Post Approval Period (US)|Active, not recruiting||Phase 4|5000|Actual|Edwards Lifesciences||1|||f||||t||||||||||2017-10-11 00:14:40.76904|2017-10-11 00:14:40.76904
NCT02184429|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2015-04-16|||July 2014||2014-07-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions|A Phase 1, Double Blind, Sponsor Open, Placebo Controlled Combined Single And Multiple Ascending Dose Study To Investigate The Safety, Tolerability And Food Effect On Pharmacokinetics Of Pf-06669571 Following Oral Doses In Healthy Subjects|Completed||Phase 1|56|Actual|Pfizer||7|||f||||f||||||||||2017-10-11 00:14:40.871596|2017-10-11 00:14:40.871596
NCT02184416|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-09-28|||October 31, 2014|Actual|2014-10-31|September 2017|2017-09-01|July 20, 2019|Anticipated|2019-07-20|July 20, 2019|Anticipated|2019-07-20||Observational|ADONIS||Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting|Axitinib In Advanced / Metastatic Renal Cell Carcinoma - A Non-interventional Study Of Real World Treatment Outcomes In Patients Receiving 2nd Line Axitinib After 1st Line Sunitinib (Adonis)|Recruiting||N/A|750|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-11 00:14:40.999843|2017-10-11 00:14:40.999843
NCT02184403|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-07-08|||May 2010||2010-05-01|July 2014|2014-07-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Quality of Life After Laser Cordectomy in Early Glottic Cancer|Quality of Life After Laser Cordectomy in Early Glottic Cancer|Unknown status|Recruiting|N/A|80|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||||||2017-10-11 00:14:41.298881|2017-10-11 00:14:41.298881
NCT02184390|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2016-02-01|||May 2013||2013-05-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Parenting Your Young Child With Autism: A Web-Based Tutorial|Parenting Your Young Child With Autism: A Web-Based Tutorial|Completed||N/A|104|Actual|Center for Psychological Consultation||2|||f||||f||||||||||2017-10-11 00:14:41.37159|2017-10-11 00:14:41.37159
NCT02184377|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-07-08|||August 2013||2013-08-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Observational|||The Function of Cricothyroid Muscle and Its Impaction on Mandarin Lexical Tones in Unilateral Vocal Fold Paralysis|The Function of Cricothyroid Muscle and Its Impaction on Mandarin Lexical Tones in Unilateral Vocal Fold Paralysis: a Quantified Laryngeal Electromyography Based Research|Unknown status|Enrolling by invitation|Early Phase 1|60|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||||||2017-10-11 00:14:41.49497|2017-10-11 00:14:41.49497
NCT02184364|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||November 1998||1998-11-01|July 2014|2014-07-01||||September 2000|Actual|2000-09-01||Interventional|||Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints|Double-blind Dose/Response Study Comparing Klimadynon® With Conjugated Oestrogens in Women Suffering From Menopausal Complaints|Completed||Phase 3|161|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:14:41.581717|2017-10-11 00:14:41.581717
NCT02184351|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||May 2001||2001-05-01|July 2014|2014-07-01||||November 2001|Actual|2001-11-01||Interventional|||Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis|A Prospective Randomized, Blinded Parallel Group Study of Clotrimazole Troches vs. Mycelex® Troches (10 mg Troche Five Times a Day for 14 Days) in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis|Completed||Phase 3|187|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:41.674402|2017-10-11 00:14:41.674402
NCT02184338|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||August 2004||2004-08-01|July 2014|2014-07-01||||November 2004|Actual|2004-11-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BIRB 1017 BS as a Solution in PEG 400 / 26% Ethanol Administered to Healthy Male Subjects|Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BIRB 1017 BS (5, 25, 100, 250, 500, and 800 mg) as a Solution in PEG 400 / 26% Ethanol Administered to Healthy Male Subjects. Placebo Controlled and Blinded at Each Dose Level|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:41.740346|2017-10-11 00:14:41.740346
NCT02184325|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||November 1999||1999-11-01|July 2014|2014-07-01||||February 2000|Actual|2000-02-01||Interventional|||Safety and Tolerability of Kiddi® Pharmaton Fizz Effervescent Tablets in Children|Safety and Tolerability of Kiddi® Pharmaton Fizz Effervescent Tablets, Comparing the Marketed Formula With an Improved One With a Reduced Mineral Amount, and a Comparator Product: a Double-blind, Controlled, Randomised, Three Arm Cross-over Study in Children|Completed||Phase 2|96|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:41.807678|2017-10-11 00:14:41.807678
NCT02184312|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||April 2008||2008-04-01|July 2014|2014-07-01||||July 2008|Actual|2008-07-01||Interventional|||Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers|An Open-label, Non-randomised, Single-dose, Parallel-group Study of Pharmacokinetic Properties of 200 mg (2 x 100 mg Tablets Once Daily) and 300 mg (3 x 100 mg Tablets Once Daily) Nevirapine Extended Release Formulations Compared to 200 mg VIRAMUNE® Tablet as Well as to 400 mg Nevirapine Extended Release Tablet Following Oral Administration in Healthy Male Volunteers|Completed||Phase 1|96|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:14:41.867337|2017-10-11 00:14:41.867337
NCT02184299|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||April 1999||1999-04-01|July 2014|2014-07-01||||January 2000|Actual|2000-01-01||Interventional|||Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients|A Multicenter, Randomized, Open-label, Controlled Study of Nevirapine (VIRAMUNE®) and a Short Course of Prednisone to Determine the Safety and Effectiveness of This Strategy in Preventing Nevirapine (VIRAMUNE®) Associated Rash.|Completed||Phase 4|138|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:41.938885|2017-10-11 00:14:41.938885
NCT02184286|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||May 1999||1999-05-01|July 2014|2014-07-01||||February 2000|Actual|2000-02-01||Interventional|||Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients|An Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE®) and Saquinavir-sgc (Fortovase®) in HIV-1 Infected Patients|Terminated||Phase 1|5|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:42.002574|2017-10-11 00:14:42.002574
NCT02184273|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-09|||March 2002||2002-03-01|July 2014|2014-07-01||||March 2004|Actual|2004-03-01||Interventional|||Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children Undergoing Minor Surgery|Randomized, Double Blind, Comparative Trial of the Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children of 6 and 11 Years Old Undergoing Minor Surgery|Completed||Phase 4|122|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:42.072781|2017-10-11 00:14:42.072781
NCT02184260|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-09|||December 1998||1998-12-01|July 2014|2014-07-01||||May 2002|Actual|2002-05-01||Interventional|ATIS||Efficacy and Safety of Metamizole Versus Placebo as Antithermic Therapy in the Acute Phase of Ischemic Stroke|A Randomized, Multicentre, Double-blind Clinical Trial of Metamizole 2 g /8 h, I.V. Ampoules, Versus Placebo Each 8 h, I.V. Ampoules, Administered During 3 Days Consecutively as Antithermic Therapy in the Acute Phase of Ischemic Stroke. A 30-day Study. (ATIS Study)|Terminated||Phase 4|58|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:42.142834|2017-10-11 00:14:42.142834
NCT02184247|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-08|||April 1998||1998-04-01|July 2014|2014-07-01||||May 1998|Actual|1998-05-01||Interventional|||Bioavailability of Two Sustained-release Theophylline Products in Healthy Males|A Study to Compare the Bioavailability of Two Sustained-release Theophylline Products|Completed||Phase 1|22|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:43.89535|2017-10-11 00:14:43.89535
NCT02184234|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||June 2001||2001-06-01|July 2014|2014-07-01||||October 2001|Actual|2001-10-01||Interventional|||Tolerability of Antistax® in Patients Suffering From Chronic Venous Insufficiency (CVI)|A 6-week, Open, Multicentre Safety Trial to Evaluate the Tolerability Profile of Antistax® Film Coated Tablets (Extr. Vitis Viniferae Siccum), 360 mg/Day Per os, in Male and Female Patients Suffering From Chronic Venous Insufficiency|Completed||Phase 4|65|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:43.987441|2017-10-11 00:14:43.987441
NCT02184221|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-08-30|||May 2010||2010-05-01|August 2017|2017-08-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|DTMS||Deep-brain Magnetic Stimulation (DMS) in the Treatment of Major Depressive Disorder|The Effectiveness of Deep-brain Magnetic Stimulation in the Treatment of Major Depressive Disorder：a Preliminary Study|Completed||N/A|22|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 00:14:44.055589|2017-10-11 00:14:44.055589
NCT02184195|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-09-21|||December 16, 2014|Actual|2014-12-16|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|May 31, 2018|Anticipated|2018-05-31||Interventional|POLO||Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy|A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Maintenance Olaparib Monotherapy in Patients With gBRCA Mutated Metastatic Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum Based Chemotherapy|Recruiting||Phase 3|145|Anticipated|AstraZeneca||2|||f||||t||||||||||2017-10-11 00:14:44.244247|2017-10-11 00:14:44.244247
NCT02184182|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-07-08|||June 2014||2014-06-01|July 2014|2014-07-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|LAPS||Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS)|Liver Resection After Portal Vein Ligation / Embolization and Transection Plane Devascularization With Radio Frequency / Microwave: Pilot Study on Primary and Secondary Liver Tumors|Unknown status|Recruiting|Phase 2|10|Anticipated|Azienda Ospedaliera di Padova||1|||f||||f||||||||||2017-10-11 00:14:44.761723|2017-10-11 00:14:44.761723
NCT02184169|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-01-30|||December 2012|Actual|2012-12-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|Oxy-CAHN||Oxygen Consumption-based Assessments of Hemodynamics in Neonates Following Congenital Heart Surgery (Oxy-CAHN Study)|Oxygen Consumption-based Assessments of Hemodynamics in Neonates Following Congenital Heart Surgery (Oxy-CAHN Study)|Recruiting||N/A|40|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 00:14:44.895009|2017-10-11 00:14:44.895009
NCT02184156|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-05-04|||June 2014||2014-06-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||AP-007 Study to Evaluate Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion in the Knee of Adults With Pain Due to Osteoarthritis|A Prospective Phase I/II Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion™ (4 ML) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee|Completed||Phase 1/Phase 2|47|Actual|Ampio Pharmaceuticals. Inc.||2|||f||||f||||||||||2017-10-11 00:14:44.992304|2017-10-11 00:14:44.992304
NCT02184143|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-02-28|||August 2014||2014-08-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Postoperative Management for Degenerative Spinal Conditions|Comparative Effectiveness of Postoperative Management for Degenerative Spinal Conditions|Active, not recruiting||N/A|260|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 00:14:45.106302|2017-10-11 00:14:45.106302
NCT02184130|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-10-25|||October 2011||2011-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|November 2016|Anticipated|2016-11-01||Interventional|||Altered Vestibular Perception and Transcranial Magnetic Stimulation|Altered Vestibular Perception by Virtual Lesions of Cerebral and Cerebellar Structures Using Repetitive Transcranial Magnetic Stimulation - Implications for Human Vestibular Dysfunction|Active, not recruiting||N/A|80|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-11 00:14:45.188593|2017-10-11 00:14:45.188593
NCT02184117|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-05-12|||July 2014||2014-07-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|CONTRAST||CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)|CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)|Completed||N/A|763|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-11 00:14:45.26489|2017-10-11 00:14:45.26489
NCT02184104|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-11-03|||July 2014||2014-07-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|November 2015|Actual|2015-11-01||Interventional|||Caffeine Disposition After Inhalation|Pharmacokinetics and Pharmacodynamics of a 100 mg Caffeine Dose After Oral Consumption of an Energy Drink or Inhalation Using the Aeroshot Administration Device|Active, not recruiting||N/A|18|Anticipated|University of Tennessee||2|||f||||f||||||||No||2017-10-11 00:14:45.391944|2017-10-11 00:14:45.391944
NCT02184091|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||January 1999||1999-01-01|July 2014|2014-07-01||||July 1999|Actual|1999-07-01||Interventional|||Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine|An Open-Label, Single Dose Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine (VIRAMUNE®)|Completed||Phase 1|41|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:45.464937|2017-10-11 00:14:45.464937
NCT02184078|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-08|2014-07-11|||October 1998||1998-10-01|July 2014|2014-07-01||||December 1998|Actual|1998-12-01||Interventional|||Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients|An Open-label Study in HIV+ Patients to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®)|Completed||Phase 4|19|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:45.536164|2017-10-11 00:14:45.536164
NCT02184065|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-08|||January 2004||2004-01-01|July 2014|2014-07-01||||April 2007|Actual|2007-04-01||Observational|||Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases|Clinical and Therapeutic Evaluation of Meloxicam in Mexican Patients With Rheumatic Diseases|Completed||N/A|22639|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:14:45.603265|2017-10-11 00:14:45.603265
NCT02184052|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-08|||July 2003||2003-07-01|July 2014|2014-07-01||||March 2005|Actual|2005-03-01||Observational|||Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions|Meloxicam (MOBIC®) Ampoule Post Marketing Surveillance Study|Completed||N/A|121|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:14:45.663797|2017-10-11 00:14:45.663797
NCT02184039|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-08|||May 2003||2003-05-01|July 2014|2014-07-01||||July 2004|Actual|2004-07-01||Observational|||Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases|Clinical Therapeutic Evaluation Program in Patients With Rheumatic Diseases|Completed||N/A|12687|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:14:45.731487|2017-10-11 00:14:45.731487
NCT02184026|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-06-17|||December 2012||2012-12-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ERRT-C||Exposure, Relaxation, & Rescripting Therapy-Child|Exposure, Relaxation, & Rescripting Therapy-Child|Completed||N/A|2|Actual|University of Montana||1|||f||||f||||||||||2017-10-11 00:14:45.785906|2017-10-11 00:14:45.785906
NCT02184013|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-04-21|||August 2015||2015-08-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|COAST-AF||Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study|Correlation of Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation:A Pilot Study|Recruiting||N/A|30|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||t||||||||||2017-10-11 00:14:45.995955|2017-10-11 00:14:45.995955
NCT02184000|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-02|||March 2014||2014-03-01|June 2014|2014-06-01|September 2014|Anticipated|2014-09-01|August 2014|Anticipated|2014-08-01||Observational|SELF||The Role of Strain Elastography in Staging Liver Fibrosis|Usefulness of the Strain Elastography in the Assessment of Liver Fibrosis in Chronic Hepatopathy|Unknown status|Recruiting|N/A|500|Anticipated|University of Medicine and Pharmacy Craiova|||3||f||||t||||||||||2017-10-11 00:14:46.09923|2017-10-11 00:14:46.09923
NCT02183974|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-02|||June 2012||2012-06-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Suitable Method for Routine Diagnostics of EER in Children With Otitis Media With Effusion|Suitable Method for Routine Diagnostics of EER in Children With Otitis Media With Effusion|Completed||N/A|44|Actual|University Hospital Ostrava||1|||f||||f||||||||||2017-10-11 00:14:46.315396|2017-10-11 00:14:46.315396
NCT02183961|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-02|||June 2012||2012-06-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Three Methods Used in the Diagnosis of EER in Children With OME|Comparison of Three Methods Used in the Diagnosis of Extraesophageal Reflux in Children With Chronic Otitis Media With Effusion|Completed||N/A|24|Actual|University Hospital Ostrava||1|||f||||f||||||||||2017-10-11 00:14:46.407991|2017-10-11 00:14:46.407991
NCT02183948|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-03-04|||June 2014||2014-06-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Oxytocin on Masked Facial Expressions: an fMRI Study||Completed||Early Phase 1|86|Actual|University of Electronic Science and Technology of China||2|||f||||||||||||||2017-10-11 00:14:46.501809|2017-10-11 00:14:46.501809
NCT02183935|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-07-02|||July 2014||2014-07-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Treatment of Morbidly Obese Adolescent With a Duodena-jejunal Liner|Treatment of Morbidly Obese Adolescent With a Duodena-jejunal Liner - a Study on Efficacy and Pathophysiologic Mechanisms|Unknown status|Recruiting|Phase 3|10|Anticipated|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-11 00:14:46.587021|2017-10-11 00:14:46.587021
NCT02183922|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-02|||May 2008||2008-05-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Microencapsulated Fish Oil or Conjugated Linoleic Acid in Metabolic Syndrome|Hypocaloric Diet With or Without Microencapsulated Fish Oil or Conjugated Linoleic Acid on Oxidative Stress and Cardiovascular Risk Factors in Women With Metabolic Syndrome Genotyped for Polymorphisms in the Genes PPAR Gamma 2 (Pro12Ala) and Adiponectin (G276T)|Completed||N/A|37|Actual|Universidade Federal do Rio de Janeiro||3|||f||||f||||||||||2017-10-11 00:14:46.696944|2017-10-11 00:14:46.696944
NCT02183909|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-05-12|||May 2013||2013-05-01|May 2016|2016-05-01||||March 2017|Anticipated|2017-03-01||Interventional|CRUSH||Connecting Resources for Urban Sexual Health|Connecting Resources for Urban Sexual Health|Active, not recruiting||N/A|380|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 00:14:46.782868|2017-10-11 00:14:46.782868
NCT02183896|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-08-18|||July 2014||2014-07-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy of PRP (Platelet Rich Plasma) Following Arthroscopic Microfracture of Chondral Lesions of the Hip|Efficacy of PRP (Platelet Rich Plasma) Following Arthroscopic Microfracture of Chondral Lesions of the Hip|Enrolling by invitation||N/A|30|Anticipated|University of Colorado, Denver||2|||f||||f||f||||||||2017-10-11 00:14:46.89412|2017-10-11 00:14:46.89412
NCT02183883|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-12-19|||December 2016||2016-12-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|DARWIN1||Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity|Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity|Recruiting||Phase 2|48|Anticipated|University College, London||1|||f||||t||||||||||2017-10-11 00:14:46.995208|2017-10-11 00:14:46.995208
NCT02183870|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-08-13|||May 2014||2014-05-01|August 2017|2017-08-01||||September 2017|Anticipated|2017-09-01||Interventional|EUCROSS||EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer|EUCROSS: A Phase II Trial to Evaluate Efficacy and Safety of Crizotinib Treatment in Advanced Adenocarcinoma of the Lung Harbouring ROS1 Translocations|Active, not recruiting||Phase 2|30|Anticipated|University of Cologne||1|||f||||t||||||||||2017-10-11 00:14:47.103769|2017-10-11 00:14:47.103769
NCT02183857|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-01-25|||July 2014||2014-07-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Ultrasound-Guided vs Landmark Technique for Femoral Arterial Cannulation in Pediatric Cardiac Surgery|Femoral Arterial Cannulation Performed by Residents: A Comparison Between Ultrasound-Guided and Landmark Technique in Infants and Children Undergoing Cardiac Surgery|Completed||N/A|106|Actual|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-11 00:14:47.245412|2017-10-11 00:14:47.245412
NCT02183844|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-05-01|||January 2016||2016-01-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|SPA||A System for Preference Assessment in Mental Health|Implementing Patient-Centered Decision Support for Mental Health|Recruiting||N/A|90|Anticipated|University of California, Los Angeles||1|||f||||f||||||||No||2017-10-11 00:14:47.335732|2017-10-11 00:14:47.335732
NCT02183831|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-07-02|||May 2014||2014-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Comparison of Clinical Outcomes After Cataract Surgery With and Without Capsular Tension Ring||Completed||N/A|52|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 00:14:47.451087|2017-10-11 00:14:47.451087
NCT02183818|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-05-23|||April 2013||2013-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Integrative-omics of the Disordered COPD Small Airway Epithelium|Integrative-omics of the Disordered COPD Small Airway Epithelium|Recruiting||N/A|717|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||||Undecided||2017-10-11 00:14:47.522593|2017-10-11 00:14:47.522593
NCT02183805|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-02-28|||June 2014||2014-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer|Phase II Study of Chemotherapy Followed by Peripheral Stem Cell Transplantation as First Line Therapy for Metastatic Triple-negative Breast Cancer|Recruiting||Phase 2|30|Anticipated|Sun Yat-sen University||1|||f||||t||||||||Yes||2017-10-11 00:14:47.600867|2017-10-11 00:14:47.600867
NCT02183792|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|AQUA-AHF||Aquaresis Utility for Hyponatremic Acute Heart Failure Study|Aquaresis Utility for Hyponatremic Acute Heart Failure Study|Recruiting||Phase 4|50|Anticipated|University of Southern California||2|||f||||f||||||||||2017-10-11 00:14:47.682543|2017-10-11 00:14:47.682543
NCT02183779|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-12-08|||June 2014||2014-06-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Interventional|REFRAIN||PORH and Response to Cold in Raynaud's Phenomenon.|Rôle Des Acides Epoxy-eicosatriénoïques et du Monoxyde d'Azote Dans l'hyperhémie Post-occlusive cutanée Digitale et la réponse cutanée au Froid Dans le phénomène de Raynaud Primaire|Recruiting||N/A|60|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 00:14:47.778215|2017-10-11 00:14:47.778215
NCT02183766|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-02|||April 2010||2010-04-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|March 2012|Actual|2012-03-01||Interventional|||GOS Prebiotic Effect in Children Constipation|Effect of the Prebiotic 4'Galactooligosaccharides in Children and Adolescents With Functional Constipation|Completed||Phase 1|20|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-11 00:14:47.873371|2017-10-11 00:14:47.873371
NCT02183753|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-06-09|||July 2014||2014-07-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|Woodsies||Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers|Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers|Completed||Early Phase 1|39|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 00:14:47.94932|2017-10-11 00:14:47.94932
NCT02183740|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-01-25|||April 2014||2014-04-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|EPSPFI||Effect of an Educational Program for Staff in Nursing Homes Concerning Patients Fecal Incontinence|Effect of an Educational Program for Staff in Nursing Homes Concerning Patients Fecal Incontinence: a Cluster-randomized Controlled Trial|Completed||N/A|300|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||No||2017-10-11 00:14:48.026468|2017-10-11 00:14:48.026468
NCT02183727|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-04-24|||September 2015||2015-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2016|Actual|2016-09-01||Interventional|||L-C Ligament Versus Hamstring Autograft for Primary ACL Reconstruction|L-C Ligament Versus Hamstring Autograft for Primary ACL Reconstruction: A Prospective, Randomized Controlled Trial|Terminated||Phase 2/Phase 3|60|Anticipated|Soft Tissue Regeneration, Inc.||2||new product design|f||||t||||||||||2017-10-11 00:14:48.112216|2017-10-11 00:14:48.112216
NCT02183714|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||May 1998||1998-05-01|July 2014|2014-07-01||||December 1998|Actual|1998-12-01||Interventional|||The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances|The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances|Completed||Phase 3|146|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:48.189561|2017-10-11 00:14:48.189561
NCT02183701|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||April 1998||1998-04-01|July 2014|2014-07-01||||December 1998|Actual|1998-12-01||Interventional|||Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension|A Prospective Randomised Open-Label Blinded Endpoint Trial Comparing Telmisartan 80 mg and Losartan 50 mg + Hydrochlorothiazide 12.5 mg (Fixed Dose Combination) in Patients With Mild-to-Moderate Essential Hypertension Using Ambulatory Blood Pressure Monitoring|Completed||Phase 3|715|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:48.399737|2017-10-11 00:14:48.399737
NCT02183688|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||September 1998||1998-09-01|July 2014|2014-07-01||||January 2003|Actual|2003-01-01||Interventional|||Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients|A Double-blind, Randomized, Placebo-controlled Clinical Trial to Confirm the Rationale of the ASA + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients|Completed||Phase 3|1889|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:14:48.481593|2017-10-11 00:14:48.481593
NCT02183675|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2016-10-06|2016-10-06||July 2014||2014-07-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Treated set which included all subjects that were dispensed study drug and were documented to have taken at least one dose of study drug.|Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers|Pharmacokinetics of Multiple Oral Doses of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet, Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet and Telmisartan 80 mg/Amlodipine 5 mg Fixed-dose Combination Tablet at Steady State in Healthy Male Subjects: an Open-label, Randomised, Multiple-dose, Three Treatment, Three-period, Six-sequence Crossover Study|Completed||Phase 1|36|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:48.604361|2017-10-11 00:14:48.604361
NCT02183662|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||November 2009||2009-11-01|July 2014|2014-07-01||||March 2010|Actual|2010-03-01||Interventional|||Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.|Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW at 6.2 mg, 12.5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 400 mg, 600 mg, 900 mg and 1200 mg Dose Levels in Healthy Male Volunteers (Randomized, Double-blind, Placebo-controlled Within Dose Groups)|Completed||Phase 1|105|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:49.244331|2017-10-11 00:14:49.244331
NCT02183649|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||November 2009||2009-11-01|July 2014|2014-07-01||||December 2009|Actual|2009-12-01||Interventional|||Tolerability and Potential ECG Effects After a Single Oral Dose of Pentoxyverine Citrate in Healthy Male and Female Volunteers|A Phase I, Single-dose, Two-way Crossover Study to Investigate Tolerability and Potential ECG Effects After a Single Oral Dose of 192 mg Pentoxyverine Citrate (Corresponding to 121.5 mg Pentoxyverine Base) in Healthy Male and Female Volunteers (Randomised, Single-blind, Placebo-controlled)|Completed||Phase 1|18|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:49.340333|2017-10-11 00:14:49.340333
NCT02183636|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||August 2009||2009-08-01|July 2014|2014-07-01||||December 2009|Actual|2009-12-01||Interventional|||Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin/Pioglitazone Compared With Single Linagliptin and Pioglitazone Tablets Administered Together to Healthy Male and Female Subjects|Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin 5 mg/Pioglitazone 45 mg Compared With Single Linagliptin 5 mg and Pioglitazone 45 mg Tablets Administered Together to Healthy Male and Female Subjects (Open, Randomised, Single Dose, Three-period Crossover Phase I Trial)|Completed||Phase 1|39|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:49.41177|2017-10-11 00:14:49.41177
NCT02183623|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||September 2005||2005-09-01|July 2014|2014-07-01||||October 2005|Actual|2005-10-01||Interventional|||The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers|The Effect of Multiple Oral Doses of BI 1356 BS as Tablets Once Daily for Six Days on the Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of 40 mg Simvastatin Given Once Daily for 20 Days and on the Pharmacokinetics of Its Metabolite Simvastatin Acid. An Open-label Study in Healthy Male Volunteers.|Completed||Phase 1|20|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:49.513329|2017-10-11 00:14:49.513329
NCT02183610|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||July 2006||2006-07-01|July 2014|2014-07-01||||September 2006|Actual|2006-09-01||Interventional|||Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers|Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers in an Open Label, Single-dose and Parallel Study Design|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:49.609375|2017-10-11 00:14:49.609375
NCT02183597|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-08-08|||March 2016||2016-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|WBMRI||Whole-body MRI for the Detection of Metastasis|Whole-body MRI for the Detection of Metastasis|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||Undecided||2017-10-11 00:14:49.727754|2017-10-11 00:14:49.727754
NCT02183584|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||September 2009||2009-09-01|July 2014|2014-07-01||||October 2009|Actual|2009-10-01||Interventional|||Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy Volunteers|An Open Label, Two-period, Fixed Sequence, Phase 1 Trial to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin|Completed||Phase 1|16|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:49.806252|2017-10-11 00:14:49.806252
NCT02183571|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-07|2014-07-07|||February 2009||2009-02-01|July 2014|2014-07-01||||April 2009|Actual|2009-04-01||Interventional|||Bioequivalence Study of Two Strengths of Two Different Metformin Tablets Administered to Healthy Male and Female Subjects|Bioequivalence of Two Strengths (1000 mg and 500 mg) of Two Different Metformin Tablets Administered to Healthy Male and Female Subjects in an Open, Randomised, Single-dose, Two-period Crossover, Phase I Trial|Completed||Phase 1|56|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:49.899841|2017-10-11 00:14:49.899841
NCT02183558|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-07-02|||January 2010||2010-01-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|September 2012|Actual|2012-09-01||Interventional|||Screening for GDM in Women With PCOS and Controls|Glucose Metabolism and Screening for Gestational Diabetes Mellitus According to Different Sets of Criteria in Women With Polycystic Ovary Syndrome and Controls|Completed||N/A|2500|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 00:14:49.996026|2017-10-11 00:14:49.996026
NCT02183545|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-10-14|||July 2014||2014-07-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers in a Randomized, Double-blind, Placebo-controlled Design|Completed||Phase 1|80|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:50.096985|2017-10-11 00:14:50.096985
NCT02183532|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||July 2009||2009-07-01|July 2014|2014-07-01||||July 2009|Actual|2009-07-01||Interventional|||Pharmacokinetics of Single and Multiple Oral Doses of BI 1356 in Healthy Chinese Volunteers|Pharmacokinetics of Single and Multiple Oral Doses of 5 mg BI 1356 in Healthy Chinese Volunteers|Completed||Phase 1|12|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:50.178349|2017-10-11 00:14:50.178349
NCT02183519|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-02-02|2017-02-02||October 2014||2014-10-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease|Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease|Completed||Phase 1/Phase 2|44|Actual|University of Florida||2|||f||||f|t|f||||||||2017-10-11 00:14:50.275336|2017-10-11 00:14:50.275336
NCT02183506|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||September 2005||2005-09-01|July 2014|2014-07-01||||December 2005|Actual|2005-12-01||Interventional|||Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male Volunteers|Bioavailability of Both BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of Multiple Oral Doses of BI 1356 BS 10 mg Daily Alone and Metformin 850 mg Three Times a Day Alone in Healthy Male Volunteers (an Open-label, Randomized, Crossover Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:50.550217|2017-10-11 00:14:50.550217
NCT02183493|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||October 2008||2008-10-01|July 2014|2014-07-01||||December 2008|Actual|2008-12-01||Interventional|||Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects|Relative Bioavailability of a 5 mg BI 1356 Tablet Administered With and Without Food to Healthy Male and Female Subjects in an Open, Randomised, Single Dose, Two-way Crossover, Phase I Trial|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:50.630524|2017-10-11 00:14:50.630524
NCT02183480|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||July 2009||2009-07-01|July 2014|2014-07-01||||September 2009|Actual|2009-09-01||Interventional|||Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female Volunteers|Assessment of Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female Volunteers in an Open, Randomised, Multiple-dose, Three-period Crossover, Phase I Trial|Completed||Phase 1|12|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:50.701856|2017-10-11 00:14:50.701856
NCT02183467|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||January 2008||2008-01-01|July 2014|2014-07-01||||June 2008|Actual|2008-06-01||Interventional|||Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects|Assessment of the Effect of 5 mg and 100 mg of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects. A Randomised, Placebo Controlled, Double-blind, Four-way Crossover Study With Moxifloxacin as Positive Control|Completed||Phase 1|44|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:14:50.778273|2017-10-11 00:14:50.778273
NCT02183454|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-07-31|||June 2014||2014-06-01|April 2017|2017-04-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31|12 Months|Observational [Patient Registry]|MASCOT||MASCOT - Post Marketing Registry|Multinational Abluminal Sirolimus Coated BiO-Engineered StenT - The MASCOT Post Marketing Registry|Completed||N/A|2500|Actual|OrbusNeich|||1||f||||t||||||||||2017-10-11 00:14:50.856455|2017-10-11 00:14:50.856455
NCT02183441|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||April 2008||2008-04-01|July 2014|2014-07-01||||June 2008|Actual|2008-06-01||Interventional|||Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers|Relative Bioavailability of a Single Oral Dose of BI 1356 (5 mg) After Co-administration With Multiple Oral Doses of Ritonavir (200 mg Bid for 3 Days) Compared to the Bioavailability of a Single Oral Dose of BI 1356 (5 mg) Alone in Healthy Male Volunteers (an Open-label, Randomized, Two-way Crossover, Clinical Phase I Study)|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:50.945277|2017-10-11 00:14:50.945277
NCT02183428|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||May 2008||2008-05-01|July 2014|2014-07-01||||July 2008|Actual|2008-07-01||Interventional|||Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers|Relative Bioavailability of BI 1356 and Glyburide After Concomitant Administration of Multiple Oral Doses of BI 1356 5 mg Once Daily and a Single Oral Dose of Glyburide 1.75 mg Compared With the Bioavailability of BI 1356 and Glyburide After Each Treatment Given Alone in Healthy Male and Female Volunteers (an Open Label, Randomised, Two-way Crossover Study of Phase I)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:51.028895|2017-10-11 00:14:51.028895
NCT02183415|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||August 2005||2005-08-01|July 2014|2014-07-01||||January 2006|Actual|2006-01-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses (2.5, 5, and 10 mg q.d. for 28 Days) of BI 1356 BS as Tablet in Patients With Type 2 Diabetes (Randomised, Double-blind, Placebo-controlled Within the Dose Groups)|Completed||Phase 1|77|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:14:51.107203|2017-10-11 00:14:51.107203
NCT02183402|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||June 2008||2008-06-01|July 2014|2014-07-01||||September 2008|Actual|2008-09-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy Volunteers|Relative Bioavailability of Digoxin After Co-administration of Multiple Oral Doses of Digoxin (0.25 mg qd) and Multiple Oral Doses of BI 1356 (5 mg qd) Compared to the Bioavailability of Multiple Oral Doses of Digoxin (0.25 mg qd) Alone in Healthy Male and Female Volunteers (an Open-label, Randomized, Two-way Crossover Clinical Phase I Study)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:51.203972|2017-10-11 00:14:51.203972
NCT02183389|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||May 2008||2008-05-01|July 2014|2014-07-01||||October 2008|Actual|2008-10-01||Interventional|||Bioavailability of Warfarin After Coadministration With Multiple Doses of BI 1356 Compared to the Bioavailability of Warfarin Alone in Healthy Male Volunteers|Relative Bioavailability of a Single Oral Dose of Warfarin (10 mg qd) After Coadministration With Multiple Oral Doses of BI 1356 (5 mg qd) Compared to the Bioavailability of a Single Oral Dose of Warfarin (10 mg qd) Alone in Healthy Male Volunteers (an Open Label, Two Periods, Fixed-sequence, Clinical Phase I Study)|Completed||Phase 1|18|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:51.288633|2017-10-11 00:14:51.288633
NCT02183376|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||July 2008||2008-07-01|July 2014|2014-07-01||||March 2009|Actual|2009-03-01||Interventional|||Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects|Pharmacokinetics and Pharmacodynamics of BI 1356 5 mg Once Daily in Male and Female Subjects With Different Degrees of Liver Impairment (Child Pugh Classification A-C) as Compared to Male and Female Healthy Subjects (a Non-blinded, Parallel Group Study of Phase I)|Completed||Phase 1|33|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:14:51.364305|2017-10-11 00:14:51.364305
NCT02183363|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||February 2007||2007-02-01|July 2014|2014-07-01||||May 2007|Actual|2007-05-01||Interventional|||Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers|Bioavailability of BI 1356 After Single Oral Administration of 5 mg BI 1356 Given as Tablet Formulation TF IIb Relative to Tablet Formulation TF II and Tablet Formulation iFF in Healthy Male Volunteers (an Open Label, Randomised, Single-dose, Three-way Crossover Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:51.577145|2017-10-11 00:14:51.577145
NCT02183350|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||April 2005||2005-04-01|July 2014|2014-07-01||||August 2005|Actual|2005-08-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 Diabetes|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses (1, 2.5, 5, 10 and 25 mg q.d. for 12 Days) of BI 1356 BS as Powder in the Bottle (PIB) in Patients With Type 2 Diabetes (Randomised, Double-blind, Placebo-controlled Within the Dose Groups).|Completed||Phase 1|47|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:51.6698|2017-10-11 00:14:51.6698
NCT02183337|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||February 2007||2007-02-01|July 2014|2014-07-01||||April 2007|Actual|2007-04-01||Interventional|||Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers|Relative Bioavailability of Both BI 1356 and Pioglitazone After Co-administration Compared to the Bioavailability of Multiple Oral Doses of BI 1356 10 mg qd Alone and Pioglitazone 45 mg qd Alone in Healthy Male and Female Volunteers (an Open Label, Randomised, Multiple-dose, Two-way Crossover Study)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:51.761382|2017-10-11 00:14:51.761382
NCT02183324|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||February 2007||2007-02-01|July 2014|2014-07-01||||June 2007|Actual|2007-06-01||Interventional|||BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus|A Randomised, Double-blind, Placebo-controlled, Multiple Dose Phase II Study of BI 1356 BS (0.5 mg, 2.5 mg, and 10 mg in Tablet q.d. Administered Orally for 28 Days) to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|72|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:14:51.843445|2017-10-11 00:14:51.843445
NCT02183311|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||June 2006||2006-06-01|July 2014|2014-07-01||||October 2006|Actual|2006-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses (1 to 10 mg) and Multiple Rising Oral Doses (2.5 to 10 mg Once Daily for 12 Days) of BI 1356 BS in Healthy Male Volunteers (a Randomised, Double-blind, Placebo Controlled Within Dose Groups Clinical Trial)|Completed||Phase 1|56|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:51.951838|2017-10-11 00:14:51.951838
NCT02183298|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||May 2006||2006-05-01|July 2014|2014-07-01||||July 2006|Actual|2006-07-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses (0.5 mg to 10 mg) of BI 1356 BS as Formulation for Intravenous Administration in Healthy Male Volunteers. A Randomised, Single-blind, Placebo-controlled Trial, Including a Crossover Intra-subject Bioavailability Comparison of 5 mg BI 1356 BS iv Solution and 10 mg BI 1356 BS as Tablet.|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:52.052298|2017-10-11 00:14:52.052298
NCT02183285|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||November 2003||2003-11-01|January 2014|2014-01-01||||March 2004|Actual|2004-03-01||Interventional|||Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential|A 30 Day, Randomised, Double-blind, Double-dummy, Placebo-controlled, Multicentre Safety Trial to Evaluate the Tolerability Profile of Pharmaton PHL 00747 Soft Gelatine Capsules (Multivitamin, Multimineral + Omega-3 Fatty Acids) 1/Day p.o. and Pharmaton PHL 00747 Film-coated Tablets (Multivitamin, Multimineral Without Omega-3 Fatty Acids) 1/Day p.o. in Healthy, Young Female Subjects of Child-bearing Potential|Completed||Phase 3|203|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:52.140307|2017-10-11 00:14:52.140307
NCT02183272|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-08-03|||August 2016||2016-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|||Emergency Ketamine Treatment of Suicidal Ideation|Ketamine as an Adjunctive Treatment of Acute Suicidal Ideation in the Emergency Setting.|Recruiting||Phase 2/Phase 3|60|Anticipated|University of Cincinnati||2|||f||||t||||||||No||2017-10-11 00:14:52.211489|2017-10-11 00:14:52.211489
NCT02183259|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||November 1998||1998-11-01|July 2014|2014-07-01||||December 1998|Actual|1998-12-01||Interventional|||Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers|Absolute Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL 1 mg Capsule Compared to 0.015 mg Solution i.v. as Single Administration in Healthy Male Subjects (Open-labelled, 2-way Cross-over Study)|Completed||Phase 1|18|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:52.325237|2017-10-11 00:14:52.325237
NCT02183246|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||May 2000||2000-05-01|July 2014|2014-07-01||||December 2000|Actual|2000-12-01||Interventional|||Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients|A Phase III, Double-Blind, Randomized, Placebo-Controlled Study of Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients|Terminated||Phase 3|3|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:52.412724|2017-10-11 00:14:52.412724
NCT02183233|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||January 1998||1998-01-01|July 2014|2014-07-01||||June 1998|Actual|1998-06-01||Interventional|||Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia|A Double-blind Randomized, Placebo Controlled Study to Assess the Efficacy and the Safety of Eschscholtzia Californica 1000 mg Per Day in Treating Primary Insomnia During a 28 Day Treatment Duration.|Terminated||Phase 3|49|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:52.524649|2017-10-11 00:14:52.524649
NCT02183220|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||October 1998||1998-10-01|July 2014|2014-07-01||||July 1999|Actual|1999-07-01||Interventional|||Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache|A Randomised, Double Blind, Placebo- and Active-controlled Parallel Group Study Investigating the Efficacy and Tolerability of Metamizol 0.5 g and 1.0 g in Patients With Episodic Moderate Tension Headache.|Completed||Phase 3|417|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:14:52.605853|2017-10-11 00:14:52.605853
NCT02183207|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2014-07-02|||August 2013||2013-08-01|July 2014|2014-07-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||PEG by Introducer Method Via EG Scan|Percutaneous Endoscopic Gastrostomy by Introducer Method Via Visualization Through E.G. ScanTM|Unknown status|Recruiting|N/A|24|Anticipated|The Catholic University of Korea||1|||f||||f||||||||||2017-10-11 00:14:52.711818|2017-10-11 00:14:52.711818
NCT02183194|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-02-01|||July 2014||2014-07-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ACCESS||Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts|A Prospective, MultiCenter, Single-arm, Post-market Study of Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts (ACCESS)|Withdrawn||N/A|0|Actual|C. R. Bard||1||Slow recruitment|f||||f||||||||||2017-10-11 00:14:52.818964|2017-10-11 00:14:52.818964
NCT02183181|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||November 2008||2008-11-01|July 2014|2014-07-01||||January 2009|Actual|2009-01-01||Interventional|||Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult Volunteers|A Randomized, Single-dose, Two-way Crossover Study to Assess the Bioequivalence of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) Administered to Healthy Adult Volunteers|Completed||Phase 1|6|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:52.918859|2017-10-11 00:14:52.918859
NCT02183168|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||July 2001||2001-07-01|July 2014|2014-07-01||||May 2002|Actual|2002-05-01||Interventional|||Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis|A Randomized, Open Label, 3-arm Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis|Completed||Phase 3|192|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:52.997011|2017-10-11 00:14:52.997011
NCT02183155|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||May 2000||2000-05-01|July 2014|2014-07-01||||September 2000|Actual|2000-09-01||Interventional|||Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects|A Double Blind, Randomized, Parallel Group Trial to Compare the Effect of Three Doses of Meloxicam Tablets (7.5, 15 and 30 mg) With Placebo on Bleeding Time in Healthy Subjects; With Extended-release Indomethacin Capsules 75 mg (Open-label) as an Active Control to Assess Trial Sensitivity.|Completed||Phase 4|82|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:14:53.082596|2017-10-11 00:14:53.082596
NCT02183142|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||March 2001||2001-03-01|July 2014|2014-07-01||||April 2001|Actual|2001-04-01||Interventional|||Study of Relative Bioavailability of Mobic Manufactured in China in Comparison With Mobic Manufactured in Germany in Chinese Healthy Volunteers|Relative Bioavailability of 7.5 mg Mobic Tablet Manufactured in China in Comparison With 7.5 mg Tablets Manufactured in Germany After a Single Oral Dose in Chinese Healthy Volunteers, Open, Randomized, Two Way Crossover Trial|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:53.179357|2017-10-11 00:14:53.179357
NCT02183129|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||April 1999||1999-04-01|July 2014|2014-07-01||||November 1999|Actual|1999-11-01||Interventional|||Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee|Open Label Study to Assess the Efficacy and Safety of Meloxicam 7.5mg vs. Diclofenac 100mg SR in Patients With Osteoarthritis of the Knee|Completed||Phase 4|91|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:53.26478|2017-10-11 00:14:53.26478
NCT02182557|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||June 2001||2001-06-01|July 2014|2014-07-01||||January 2002|Actual|2002-01-01||Interventional|||WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients|Phase III Double-Blind Comparative Study of WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients|Completed||Phase 3|162|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:58.086379|2017-10-11 00:14:58.086379
NCT02183116|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||October 1998||1998-10-01|July 2014|2014-07-01||||February 1999|Actual|1999-02-01||Interventional|||A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee|Open Study to Access the Efficacy and Safety of Meloxicam 7.5mg in Patients With Osteoarthritis of the Knee|Completed||Phase 4|30|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:53.347881|2017-10-11 00:14:53.347881
NCT02183103|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||April 1999||1999-04-01|July 2014|2014-07-01||||May 1999|Actual|1999-05-01||Interventional|||Influence of a High Fat Breakfast in the Pharmacokinetics of UH-AC62MU in Healthy Subjects|Influence of a High Fat Breakfast in the Pharmacokinetics of UH-AC62MU (Rapid Release Tablet) Given as an Oral Single Dose of 7.5 mg in Healthy Subjects (Two Way, Crossover, Randomized, Open)|Completed||Phase 1|8|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:53.426382|2017-10-11 00:14:53.426382
NCT02183090|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||November 1998||1998-11-01|July 2014|2014-07-01||||December 1998|Actual|1998-12-01||Interventional|||Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects|Pharmacokinetics and Tolerability of a Single 15mg Meloxicam Dose Injected Intramuscularly Compared to a Single Oral 15 mg Meloxicam Tablet in Healthy Subjects. A Two-way Cross-over, Randomized, Open Study.|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:53.504492|2017-10-11 00:14:53.504492
NCT02183077|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-07|||September 1998||1998-09-01|July 2014|2014-07-01||||November 1998|Actual|1998-11-01||Interventional|||Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects|Pharmacokinetics and Tolerability of 2 x 15 mg Meloxicam (2 x 0.3 g Topical Gel) Over 7 Days Compared to 7.5 mg Meloxicam Tablet (Single Oral Dose) in Healthy Subjects. A Two-way Cross-over, Randomized, Open Study|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:53.583382|2017-10-11 00:14:53.583382
NCT02183064|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-07|||October 1998||1998-10-01|July 2014|2014-07-01||||November 2000|Actual|2000-11-01||Interventional|||Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis|A Multi-Center, Randomized, Parallel-Group, Open-Label Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis of the Hip, Knee, Hand or Spine|Completed||Phase 3|1309|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:53.668696|2017-10-11 00:14:53.668696
NCT02183051|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||April 1998||1998-04-01|July 2014|2014-07-01||||October 1998|Actual|1998-10-01||Interventional|||Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar|A Short Term Double-blind Trial to Compare the the Analgesic Efficacy and Tolerability of Meloxicam 15 mg, 7.5 mg, 3.75 mg and 1.875 mg Oral (Quick Tablet) Versus Placebo and Ibuprofen 400 mg and 200 mg Oral in the Treatment of Pain After Surgery of the Third Molar|Completed||Phase 2|381|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-11 00:14:53.752989|2017-10-11 00:14:53.752989
NCT02183038|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-07|||July 1998||1998-07-01|July 2014|2014-07-01||||February 1999|Actual|1999-02-01||Interventional|||Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis|Double-blind Study to Compare Efficacy and Safety of Meloxicam 7.5 mg and 15 mg vs. Naproxen Sodium 1100 mg in the Symptomatic Treatment of Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis Over a Period of 5 Days|Completed||Phase 2|390|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:53.852812|2017-10-11 00:14:53.852812
NCT02183025|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||January 1998||1998-01-01|July 2014|2014-07-01||||April 1999|Actual|1999-04-01||Interventional|||Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea|Double Blind Study to Evaluate Efficacy and Safety of Meloxicam 7.5 mg and 15 mg Versus Mefenamic Acid 1500 mg in the Treatment of Dysmenorrhea|Completed||Phase 2|337|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:53.950293|2017-10-11 00:14:53.950293
NCT02183012|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||August 2002||2002-08-01|July 2014|2014-07-01||||October 2002|Actual|2002-10-01||Interventional|||Study to Investigate the Relative Bioavailability of Ibuprofen in Healthy Volunteers|Open-label, Randomised, Single Dose, Four-way Crossover Study to Investigate the Relative Bioavailability of a 400 mg Ibuprofen Extrudate Tablet Compared to a 400 mg Ibuprofen Lysinate Tablet (Dolormin Extra®) and a 400 mg Ibuprofen Tablet (Brufen® 400 mg, Denmark) in Fasted Condition and After Ingestion of a Standardised Meal in Healthy Male and Female Volunteers.|Completed||Phase 1|36|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:14:54.048021|2017-10-11 00:14:54.048021
NCT02182986|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-10-26|||July 2014||2014-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children|Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)|Recruiting||N/A|1277|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||t||||||Samples With DNA|"     Blood and tissue samples.   "|||2017-10-11 00:14:54.231206|2017-10-11 00:14:54.231206
NCT02182973|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-10-31|||June 2014||2014-06-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|DHM&NAS||Donor Human Milk in Neonatal Abstinence Syndrome|Donor Human Milk for Infants With Neonatal Abstinence Syndrome|Active, not recruiting||N/A|12|Anticipated|Neolac Inc dba Medolac Laboratories|||1||f||||f||||||||Undecided||2017-10-11 00:14:54.367893|2017-10-11 00:14:54.367893
NCT02182960|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||September 1998||1998-09-01|July 2014|2014-07-01||||October 1998|Actual|1998-10-01||Interventional|||Bioavailability of Ibuprofen Enantiomers Compared With Standard Brufen Sirup in Healthy Male Volunteers|An Open Two Way Cross Over Study to Relative Bioavailability of Ibuprofen Enantiomers After Single p.o. Administration of 200 mg Syrup (T) Compared With 200 mg Standard Brufen Sirup (R)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:54.468543|2017-10-11 00:14:54.468543
NCT02182947|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-07-02|||January 2014||2014-01-01|July 2014|2014-07-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|CE||Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children|Comparison of the Use of Wireless Capsule Endoscopy With Magnetic Resonance Enterography in Children With Inflammatory Bowel Disease|Unknown status|Recruiting|N/A|34|Anticipated|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-10-11 00:14:54.537932|2017-10-11 00:14:54.537932
NCT02182934|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-07|||November 1999||1999-11-01|July 2014|2014-07-01||||April 2000|Actual|2000-04-01||Interventional|||Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Healthy Recreational Sports People|Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Recreational Sports People: a Double-blind, Placebo Controlled Pilot Study|Completed||Phase 2|26|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:54.630464|2017-10-11 00:14:54.630464
NCT02182921|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-08-01|||August 2013||2013-08-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Evaluation of Cataract Surgery Outcome|Evaluation of Surgical Outcomes of Cataract Surgery|Recruiting||N/A|20000|Anticipated|Evidence Based Cataract Study Group|||1||f||||||||||||||2017-10-11 00:14:54.701706|2017-10-11 00:14:54.701706
NCT02182908|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-07-02|||March 2007||2007-03-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|AAA||FDG PET-Scan Analysis of Evolutivity of Non-surgical Aneurysm of Abdominal Aorta|ANALYSE EN MORPHO-TEP AU FDG DE L'EVOLUTIVITE DES ANEVRISMES ABDOMINAUX AORTIQUES NON CHIRURGICAUX UNE ETUDE MULTICENTRIQUE DE L'INTER-REGION NORD-EST|Completed||N/A|51|Actual|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-11 00:14:54.779116|2017-10-11 00:14:54.779116
NCT02182895|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-05-31|2017-03-22||July 2014||2014-07-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient|Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient|Completed||Phase 4|72|Actual|Brigham and Women's Hospital||2|||f||||f||||||||No|No plan to share data.|2017-10-11 00:14:54.861911|2017-10-11 00:14:54.861911
NCT02182882|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||March 1999||1999-03-01|July 2014|2014-07-01||||October 1999|Actual|1999-10-01||Interventional|||Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Healthy People|Efficacy of Ginsana in Improving Half -Time Hemoglobin Re-oxygenation in Recreational Sportspeople: a Double Blind, Placebo Controlled Pilot Study|Completed||Phase 2|29|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:55.471584|2017-10-11 00:14:55.471584
NCT02182869|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-07|||April 2001||2001-04-01|July 2014|2014-07-01||||August 2001|Actual|2001-08-01||Interventional|||Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease)|Safety Assessment of Cumulative Dose of Combivent® HFA-propelled Metered Dose Inhaler in Comparison to Combivent® CFC-propelled Metered Dose Inhaler. A Randomised, Double-blind, Active-controlled, Two-way Cross-over Study in COPD Patients|Terminated||Phase 2|7|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:55.546926|2017-10-11 00:14:55.546926
NCT02182856|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-04|2014-07-04|||February 1998||1998-02-01|July 2014|2014-07-01||||July 2000|Actual|2000-07-01||Interventional|||Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD|A Randomised, Double-blind, Active-controlled, Within-patient Trial Comparing the Effect of Single Doses of Nebulised Ipratropium 500µg, Salbutamol Sulphate 3mg, Salbutamol 6mg and the Combination Therapy Salbutamol Sulphate 3 mg Plus Ipratropium 500µg on Arterial Oxygen Saturation in Patients With Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 4|33|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:55.641003|2017-10-11 00:14:55.641003
NCT02182843|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-02-26|||March 2014||2014-03-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Interventional|VCBM/ACDF||Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)|Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Zimmer Biomet||1|||f||||f||||||||Undecided||2017-10-11 00:14:55.749898|2017-10-11 00:14:55.749898
NCT02182830|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2017-08-15|||July 25, 2014|Actual|2014-07-25|August 2017|2017-08-01|July 5, 2017|Actual|2017-07-05|May 18, 2017|Actual|2017-05-18||Interventional|||24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension|A Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Empagliflozin (10mg, 25mg) Administered Orally, Once Daily Over 24 Weeks in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|154|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:55.91292|2017-10-11 00:14:55.91292
NCT02182817|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-03-09|||November 2013||2013-11-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|EGAIN||Exposure to General Anaesthesia in Infancy and Neurocognitive Development|Prospective Cohort Study of Effects of Exposure to General Anaesthesia in Infancy on Neurocognitive Development|Active, not recruiting||N/A|230|Anticipated|KK Women's and Children's Hospital|||2||f||||f||||||Samples With DNA|"     Buccal swabs   "|||2017-10-11 00:14:56.214|2017-10-11 00:14:56.214
NCT02182804|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-07|||February 2013||2013-02-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer|Diagnostic Values of Probe-based Confocal Laser Endomicroscopy (pCLE) and Magnifying Narrow Band Imaging (M-NBI) for Early Neoplasms Detection in Esophageal Lugol'S-voiding Lesions.|Completed||N/A|44|Actual|King Chulalongkorn Memorial Hospital||1|||f||||f||||||||||2017-10-11 00:14:56.296496|2017-10-11 00:14:56.296496
NCT02182791|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-11|||April 1998||1998-04-01|July 2014|2014-07-01||||April 1999|Actual|1999-04-01||Interventional|||Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women|An Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE® ) and Ethinyl Estradiol/Norethindrone [ORTHO-NOVUM® 1/35 (21 Pack)] in HIV-1 Infected Women|Completed||Phase 1|14|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:56.383235|2017-10-11 00:14:56.383235
NCT02182765|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-11|||April 1999||1999-04-01|July 2014|2014-07-01||||July 2001|Actual|2001-07-01||Interventional|||Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults|An Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE®), Abacavir and Amprenavir in HIV-1 Infected NNRTI Naive Adults|Terminated||Phase 1|8|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:56.591078|2017-10-11 00:14:56.591078
NCT02182752|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-01-02|||April 2013||2013-04-01|January 2016|2016-01-01||||January 2016|Actual|2016-01-01||Interventional|||The Effect of Tramadol on Interscalene Brachial Plexus Block|The Effect of Tramadol on Interscalene Brachial Plexus Block With Ropivacaine in Shoulder Surgery.|Completed||Phase 2|80|Actual|Asklepieion Voulas General Hospital||2|||f||||||||||||||2017-10-11 00:14:56.666196|2017-10-11 00:14:56.666196
NCT02182739|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-10-28|||January 2001||2001-01-01|July 2014|2014-07-01||||December 2001|Actual|2001-12-01||Observational|||Observational Study of Meloxicam in Any Labeled Indication|Programa de Experiencia Therapéutica Personalizada (Personalized Therapeutic Experience Program)|Completed||N/A|13039|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:14:56.755453|2017-10-11 00:14:56.755453
NCT02182726|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-08|||May 2001||2001-05-01|July 2014|2014-07-01||||December 2001|Actual|2001-12-01||Observational|||Postmarketing Surveillance Study With MOBEC®|COX-2 Postmarketing Surveillance Study With MOBEC® 15 mg Tablets|Completed||N/A|4760|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:14:56.824467|2017-10-11 00:14:56.824467
NCT02182713|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-07|||May 1998||1998-05-01|July 2014|2014-07-01||||September 1998|Actual|1998-09-01||Interventional|||Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm|Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm|Completed||Phase 4|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:56.894655|2017-10-11 00:14:56.894655
NCT02182700|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-03|||July 1998||1998-07-01|July 2014|2014-07-01||||December 1999|Actual|1999-12-01||Interventional|||Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis|Open Study on the Efficacy and Safety of Combivent® Aerosol (120 mcg Salbutamol Sulfate Plus 20 mcg Ipratropium Bromide) + Spacer, 12 to 24 Puffs, in Adult Patients With Moderate to Severe Asthma Crisis|Terminated||Phase 3|47|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:56.97371|2017-10-11 00:14:56.97371
NCT02182687|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-09-08|||June 2014||2014-06-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|SBRTvsTACE||Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant|A Randomized Phase II Study of Individualized Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) With DEBDOX Beads as a Bridge to Transplant in Hepatocellular Carcinoma.|Recruiting||Phase 2|60|Anticipated|Lahey Clinic||2|||f||||t||||||||||2017-10-11 00:14:57.079187|2017-10-11 00:14:57.079187
NCT02182674|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-03|2014-07-03|||October 2000||2000-10-01|July 2014|2014-07-01||||August 2001|Actual|2001-08-01||Interventional|||A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double Blind, Crossover, Placebo- and Active Controlled Dose Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With COPD|Completed||Phase 2|66|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:57.227707|2017-10-11 00:14:57.227707
NCT02182661|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-10|||July 1998||1998-07-01|July 2014|2014-07-01||||May 2000|Actual|2000-05-01||Interventional|||A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma|A Phase III Long-term Study of Ba253BINEB in Patients With Bronchial Asthma|Completed||Phase 3|88|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:57.317513|2017-10-11 00:14:57.317513
NCT02182648|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2014-07-02|||October 2014||2014-10-01|June 2014|2014-06-01||||May 2015|Anticipated|2015-05-01||Interventional|||Bispectral Index Guiding Etomidate Used in Children Aged 3 to 10 for Clinical Anesthesia Induction||Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Henan Provincial Hospital||3|||f||||t||||||||||2017-10-11 00:14:57.400367|2017-10-11 00:14:57.400367
NCT02182635|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-10|||August 1998||1998-08-01|July 2014|2014-07-01||||March 1999|Actual|1999-03-01||Interventional|||Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Phase III Long-term Study of Ba253BINEB in Patients With COPD|Completed||Phase 3|74|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:57.490492|2017-10-11 00:14:57.490492
NCT02182622|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-07|||July 2014||2014-07-01|July 2014|2014-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel|Ib Dose Finding Study of LDE225 Plus Docetaxel/Prednisone in Patients With Advanced or Metastatic Castration Resistant Prostate Cancer Who Experience Disease Progression After Receiving Docetaxel|Unknown status|Not yet recruiting|Phase 1|34|Anticipated|Hackensack University Medical Center||4|||f||||t||||||||||2017-10-11 00:14:57.566134|2017-10-11 00:14:57.566134
NCT02182609|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-09-03|||April 2013||2013-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|October 2014|Actual|2014-10-01||Interventional|||99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers|A Phase I Study of Safety, Tolerance, Pharmacokinetics and Nuclear Medicine Imaging of 99mTc-rhAnnexin V-128 Administered Intravenously in Healthy Adult Volunteers|Completed||Phase 1|14|Actual|Advanced Accelerator Applications||1|||f||||f||||||||||2017-10-11 00:14:57.692514|2017-10-11 00:14:57.692514
NCT02182596|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-19|2014-07-02|||June 2006||2006-06-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|September 2007|Actual|2007-09-01||Interventional|MYLOFRANCE2||DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML|A Dose-finding Phase I/II Trial of Daunorubicin and Cytarabine Combined to Fractionated Mylotarg® as Re-induction Treatment in Patients With First Relapse of Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|20|Actual|Acute Leukemia French Association||1|||f||||t||||||||||2017-10-11 00:14:57.79061|2017-10-11 00:14:57.79061
NCT02182583|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-10|||October 1998||1998-10-01|July 2014|2014-07-01||||June 2000|Actual|2000-06-01||Interventional|||Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Phase III Study of Ba253BINEB in Patients With COPD - Double-blind, Randomised, Double Dummy, Multiple Dose Study in Comparison With MDI|Completed||Phase 3|163|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:57.933523|2017-10-11 00:14:57.933523
NCT02182570|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||June 2001||2001-06-01|July 2014|2014-07-01||||February 2002|Actual|2002-02-01||Interventional|||WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients|Phase III Open-labeled Study of WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients|Completed||Phase 3|62|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:14:58.014762|2017-10-11 00:14:58.014762
NCT02182544|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||June 2001||2001-06-01|July 2014|2014-07-01||||December 2001|Actual|2001-12-01||Interventional|||WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis|Phase III Double-blind Comparative Study of WAL801CL Dry Syrup in Paediatric Perennial Allergic Rhinitis|Completed||Phase 3|151|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:58.224249|2017-10-11 00:14:58.224249
NCT02182531|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||August 1999||1999-08-01|July 2014|2014-07-01||||October 1999|Actual|1999-10-01||Interventional|||Epinastine and Pseudoephedrine Fixed Combination Compared to Separate Administration in Healthy Volunteers|Study of the Pharmacokinetic Interactions and Relative Bioavailability of Epinastine and Pseudoephedrine in Healthy Volunteers, Comparing Tablets Containing the Fixed Combination of the Two Substances With Tablets Containing Each of the Two Substances Separately|Completed||Phase 1|25|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:58.313042|2017-10-11 00:14:58.313042
NCT02182518|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||May 2000||2000-05-01|July 2014|2014-07-01||||July 2001|Actual|2001-07-01||Interventional|||Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis|Double-blind, Randomized, Parallel Trial to Evaluate the Clinical Efficacy and Safety of Epinastine 10 mg + Pseudoephedrine 120 mg SR, Twice a Day, Versus Epinastine 10 mg Alone, Twice a Day, in the Treatment of Outpatients With Perennial Allergic Rhinitis|Completed||Phase 3|101|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:58.420147|2017-10-11 00:14:58.420147
NCT02182505|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||September 1998||1998-09-01|July 2014|2014-07-01||||July 1999|Actual|1999-07-01||Interventional|||Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma|A Randomized, Double-blind Study to Compare the Safety and Efficacy of Berodual® Inhaled Via the Respimat® Device in Two Dosages (50 µg Fenoterol Hydrobromide + 20 µg Ipratropium Bromide and 25 µg Fenoterol Hydrobromide + 10 µg Ipratropium Bromide, 1 Puff t.i.d.) With That of Berodual® Inhaled Via the MDI With Aerochamber® (50 µg Fenoterol Hydrobromide + 21 µg Ipratropium Bromide, 2 Puffs t.i.d.) in Pediatric Patients With Asthma Over a 4 Week Period|Completed||Phase 3|535|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:14:58.527939|2017-10-11 00:14:58.527939
NCT02182479|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||April 1998||1998-04-01|July 2014|2014-07-01||||June 1999|Actual|1999-06-01||Interventional|||Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients|Comparison of the Safety and Efficacy of Berodual® Administered Via Respimat® Device (50 µg Fenoterol Hydrobromide/20 µg Ipratropium Bromide and 25 µg Fenoterol Hydrobromide/10 µg Ipratropium Bromide, 1 Puff q.i.d.) With That Administered Via the MDI (50 µg Fenoterol Hydrobromide/21 µg Ipratropium Bromide, 2 Puffs q.i.d.) in Asthma Patients Over a 12-week Period|Completed||Phase 3|631|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:14:58.725125|2017-10-11 00:14:58.725125
NCT02182466|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-02|||June 2014||2014-06-01|July 2014|2014-07-01||||December 2016|Anticipated|2016-12-01||Observational|DEKOR||German Colon Capsule Registry|Documentation of Colon Capsule Endoscopies in a National Observational Study [Dokumentation Von Kolonkapsel-Endoskopien im Rahmen Einer Bundesweiten Studie]|Unknown status|Active, not recruiting|N/A|600|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-10-11 00:14:58.84451|2017-10-11 00:14:58.84451
NCT02182453|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||June 2008||2008-06-01|July 2014|2014-07-01||||August 2008|Actual|2008-08-01||Interventional|||Single Rising Oral Doses of BI 10773 in Healthy Male Volunteers|A Phase I, Randomised, Double-blind, Placebo-controlled (Within Dose Groups) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses (1 to 100 mg) of BI 10773 in Healthy Male Volunteers|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:14:58.930007|2017-10-11 00:14:58.930007
NCT02182440|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-06-28|||December 18, 2014|Actual|2014-12-18|June 2017|2017-06-01|August 17, 2017|Anticipated|2017-08-17|May 25, 2017|Actual|2017-05-25||Interventional|STOP-AKI||A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI|A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI|Active, not recruiting||Phase 2|301|Actual|AM-Pharma||4|||f||||t||||||||Undecided||2017-10-11 00:14:59.01998|2017-10-11 00:14:59.01998
NCT02182427|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-01-26|||April 2014||2014-04-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|30 Days|Observational [Patient Registry]|MCC||Malnutrition Clinical Characteristics Validation Study|Malnutrition Clinical Characteristics Validation Study|Completed||N/A|54|Actual|Academy of Nutrition and Dietetics|||1||f||||f||||||||||2017-10-11 00:15:01.086196|2017-10-11 00:15:01.086196
NCT02182414|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||May 2009||2009-05-01|July 2014|2014-07-01||||September 2009|Actual|2009-09-01||Interventional|||Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers|Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I Administered Orally as Tablet in Single Doses of 800 mg to Healthy Volunteers, and Evaluation of the Effect of Food on the Bioavailability of a Selected Prototype (an Open-label, Two-stage, Within Parts Randomised Six-way and Two-way Crossover Phase I Study)|Completed||Phase 1|42|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-11 00:15:01.165875|2017-10-11 00:15:01.165875
NCT02182401|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||July 2009||2009-07-01|July 2014|2014-07-01||||August 2009|Actual|2009-08-01||Interventional|||Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers|An Open-label, Fixed Sequence Phase I Study in Healthy Male Volunteers to Assess Sequentially the Effects of Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA, on the Single Dose Pharmacokinetics of Midazolam and Tolbutamide and on the Systemic Exposure of BI 207127 NA and BI 201335 NA|Terminated||Phase 1|37|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:01.33152|2017-10-11 00:15:01.33152
NCT02181504|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-03-14|2017-03-14||September 2014||2014-09-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration||Completed||Phase 2|25|Actual|Allergan||3|||f||||t||||||||||2017-10-11 00:15:10.985355|2017-10-11 00:15:10.985355
NCT02182388|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||January 2007||2007-01-01|July 2014|2014-07-01||||May 2007|Actual|2007-05-01||Interventional|||Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects|Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses (5 mg to 3000 mg) of BI 207127 NA as Powder in the Bottle Reconstituted With PEG 400/Tris/SDS in Healthy Male Subjects. A Randomised, Placebo-controlled and Within Dose Groups Double-blinded Trial. Followed by an Intra-individual, Partially Randomised, Open Comparison of Powder in the Bottle and Tablet Without and With Food.|Completed||Phase 1|82|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:01.459742|2017-10-11 00:15:01.459742
NCT02182375|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||January 2010||2010-01-01|July 2014|2014-07-01||||March 2010|Actual|2010-03-01||Interventional|||Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy Volunteers|An Open Label Fixed Sequence Phase I Study to Investigate the Effect of BI 201335 Mediated UGT1A1 Inhibition on the Multiple Oral Dose Pharmacokinetics of Raltegravir (Isentress®) in Healthy Male and Female Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:01.560167|2017-10-11 00:15:01.560167
NCT02182362|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||May 2007||2007-05-01|July 2014|2014-07-01||||February 2008|Actual|2008-02-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male Subjects|Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of 20 mg, 48 mg, 120 mg, and 240 mg Once a Day of BI 201335 NA (Oral Solution) in Healthy Male Subjects, in a Randomized Double Blind, Placebo Controlled Study|Completed||Phase 1|39|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:01.677659|2017-10-11 00:15:01.677659
NCT02182349|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||June 2009||2009-06-01|July 2014|2014-07-01||||July 2009|Actual|2009-07-01||Interventional|||Metabolism and Pharmacokinetics of Oral Solution of [14C]-BI 201335 in Healthy Male Volunteers|Metabolism and Pharmacokinetics of a Single Dose of 240 mg [14C]-BI 201335 Given as Oral Solution to Healthy Male Volunteers at Steady State of BI 201335 NA Maintained With Oral Capsules of 240 mg BI 201335, a Phase I, Single-arm, Open-label Trial|Completed||Phase 1|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:01.95351|2017-10-11 00:15:01.95351
NCT02182336|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||June 2008||2008-06-01|July 2014|2014-07-01||||September 2008|Actual|2008-09-01||Interventional|||Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers|Evaluation of the Effects of Single Oral Dose and Multiple Oral Doses of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail. An Open-label, Single-arm Phase I Study in Healthy Human Volunteers|Completed||Phase 1|23|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:02.116343|2017-10-11 00:15:02.116343
NCT02182323|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||September 2006||2006-09-01|July 2014|2014-07-01||||December 2006|Actual|2006-12-01||Interventional|||Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects|Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of 4 mg, 16 mg, 48 mg, 120 mg, 240 mg, 480 mg, 800 mg, and 1200 mg BI 201335 NA (PEG 400/TRIS/Meglumine/Water Solution) in Healthy Male Subjects, in a Randomised Single Blind, Placebo Controlled Rising Dose Study, Followed With an Open-label Intra-subject Two-stage Crossover Pilot Bioavailability Comparison of 480 mg BI 201335 NA in a PEG 400/TRIS/Meglumine/Water Solution Coadministered With Food|Completed||Phase 1|74|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:02.333582|2017-10-11 00:15:02.333582
NCT02182310|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||June 2008||2008-06-01|July 2014|2014-07-01||||October 2008|Actual|2008-10-01||Interventional|||Assessment of the Effect of BI 201335 on the QT Interval in Healthy Female and Male Subjects|Assessment of the Effect of 480 mg and 1200 mg of BI 201335 as Single Dose on the QT Interval in Healthy Female and Male Subjects. A Randomised, Placebo Controlled, Double-blind, Four-way Crossover Phase-I-study With Moxifloxacin as Positive Control|Completed||Phase 1|56|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:15:02.492935|2017-10-11 00:15:02.492935
NCT02182297|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||April 2008||2008-04-01|July 2014|2014-07-01||||December 2008|Actual|2008-12-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male Subjects|Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses (40 mg to 480 mg) of BI 201335 NA as Capsule(s) Administered to Healthy Male Subjects - a Randomised, Placebo-controlled (Within Dose Groups) and Double-blind Trial|Completed||Phase 1|50|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:02.589299|2017-10-11 00:15:02.589299
NCT02182284|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||January 2008||2008-01-01|July 2014|2014-07-01||||February 2008|Actual|2008-02-01||Interventional|||Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers|An Open-label, Randomized, Crossover Relative Bioavailability Study of a New Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Current Solution Formulation (Powder in Bottle (PIB), After Single Dose Oral Administration in Healthy Volunteers|Completed||Phase 1|34|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:02.684681|2017-10-11 00:15:02.684681
NCT02182271|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||October 2004||2004-10-01|July 2014|2014-07-01||||October 2004|Actual|2004-10-01||Interventional|||Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects|Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of 5 mg, 20 mg, 60 mg, 150 mg, 300 mg, 600 mg, 1000 mg, and 1500 mg BI 201335 ZW (PEG 400/TRIS/Water Solution) in Healthy Male Subjects, in a Randomised Double Blind, Placebo Controlled Rising Dose Study, Followed With an Open-label Intra-subject Two-stage Crossover Pilot Bioavailability Comparison of 600 mg BI 201335 ZW in a PEG 400/TRIS/Water Solution Co-administered With Food|Terminated||Phase 1|8|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:02.773247|2017-10-11 00:15:02.773247
NCT02182258|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||June 2009||2009-06-01|July 2014|2014-07-01||||August 2009|Actual|2009-08-01||Interventional|||Safety and Tolerability Study of BIBF 1120 as Intravenous Infusion and Absolute Bioavailability of BIBF 1120 as Soft Gelatine Capsule in Healthy Subjects|Safety and Tolerability of Single Rising Doses of 1 mg, 3 mg, 10 mg and 20 mg of BIBF 1120 as Intravenous Infusion (Single-blind, Placebocontrolled at Each Dose Group) and Absolute Bioavailability of 100 mg BIBF 1120 as Soft Gelatine Capsule (Intra-individual Comparison)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:02.876868|2017-10-11 00:15:02.876868
NCT02182245|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||October 2005||2005-10-01|July 2014|2014-07-01||||January 2007|Actual|2007-01-01||Interventional|||Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies|A Phase I Open Label Dose Escalation Study of Oral Treatment With BIBF 1120 in Combination With Standard Treatment of Paclitaxel and Carboplatin in Patients With Advanced Gynaecological Malignancies|Completed||Phase 1|22|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:02.992464|2017-10-11 00:15:02.992464
NCT02182232|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||June 2005||2005-06-01|July 2014|2014-07-01||||May 2007|Actual|2007-05-01||Interventional|||A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer|A Phase I Open Label Dose Escalation Study of Continuous Oral Treatment With BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer|Completed||Phase 1|33|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:03.094488|2017-10-11 00:15:03.094488
NCT02182219|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||November 2005||2005-11-01|July 2014|2014-07-01||||April 2007|Actual|2007-04-01||Interventional|||Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer|A Phase I Open Label Dose Escalation Study of Continuous (Except on the Days of Chemotherapy Infusion) Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 1|21|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:03.206002|2017-10-11 00:15:03.206002
NCT02182206|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||June 2003||2003-06-01|July 2014|2014-07-01||||June 2005|Actual|2005-06-01||Interventional|||An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours|A Phase I Open Label Dose Escalation Study of Continuous Once-daily or Twice Daily Oral Treatment With BIBF 1120 in Patients With Advanced Solid Tumours|Completed||Phase 1|50|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:03.29574|2017-10-11 00:15:03.29574
NCT02182193|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||September 2006||2006-09-01|July 2014|2014-07-01||||November 2006|Actual|2006-11-01||Interventional|||Safety and Relative Bioavailability of BIBF 1120 Soft Gelatine Capsules Charge 1, BIBF 1120 Soft Gelatine Capsules Charge 2 and BIBF 1120 Drinking Solution in Healthy Male Volunteers|Safety and Relative Bioavailability of a Single Dose of 150 mg BIBF 1120 Administered as Soft Gelatine Capsules Charge 1 Compared to BIBF 1120 Soft Gelatine Capsules Charge 2 Compared to BIBF 1120 Administered as Drinking Solution Following Oral Administration to Healthy Male Volunteers in an Open, Randomised, Intra-individual, Crossover Comparison Design|Completed||Phase 1|54|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:03.401594|2017-10-11 00:15:03.401594
NCT02182180|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-05-26|||November 2014||2014-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|SC2i||SC2i Tissue and Data Repository Protocol|Surgical Critical Care InitiativeTissue and Data Acquisition Protocol|Recruiting||N/A|5000|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine|||1||f||||f||||||||||2017-10-11 00:15:03.488556|2017-10-11 00:15:03.488556
NCT02182167|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-05|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|NAC in TB DIH||A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis|A Randomised Controlled Trial of Intravenous N-acetylcysteine in the Management of Antituberculous Drug-induced Hepatitis|Recruiting||Phase 2/Phase 3|100|Anticipated|University of Cape Town||2|||f||||t||||||||||2017-10-11 00:15:03.596838|2017-10-11 00:15:03.596838
NCT02182154|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||October 2005||2005-10-01|July 2014|2014-07-01||||November 2005|Actual|2005-11-01||Interventional|||Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers|Metabolism and Pharmacokinetics of [14C]-BIBF 1120 After Administration of Single Doses of 100 mg [14C]-BIBF 1120 Oral Solution in Healthy Male Volunteers|Completed||Phase 1|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:03.959599|2017-10-11 00:15:03.959599
NCT02182141|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||April 2003||2003-04-01|July 2014|2014-07-01||||March 2005|Actual|2005-03-01||Interventional|||An Dose Escalation Study of BIBF 1120 Administered in Patients With Relapsed or Refractory Multiple Myeloma|An Open Label Dose Escalation Study of BIBF 1120 Administered Orally for Four Weeks in Patients With Relapsed or Refractory Multiple Myeloma With Repeated Administration in Patients With Clinical Benefit|Completed||Phase 1|17|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:04.054709|2017-10-11 00:15:04.054709
NCT02182128|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||June 2006||2006-06-01|July 2014|2014-07-01||||June 2009|Actual|2009-06-01||Interventional|||A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours|A Phase I Open-label Dose-escalation Study of Continuous Twice-daily Oral Treatment With BIBF 1120 in Japanese Patients With Advanced Solid Tumours|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:04.147406|2017-10-11 00:15:04.147406
NCT02182115|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-10-25|||July 2014||2014-07-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||S. Aureus Screening and Decolonization|Effectiveness of Screening and Decolonization of S. Aureus in Surgery Outpatients|Completed||Phase 4|428|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No|Aggregate data will be reported once the study has been completed.|2017-10-11 00:15:04.239722|2017-10-11 00:15:04.239722
NCT02182102|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||September 2005||2005-09-01|July 2014|2014-07-01||||May 2010|Actual|2010-05-01||Interventional|||Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer|A Phase I Open Label Study of Continuous Oral Treatment With BIBF 1120 Together With Pemetrexed in Previously Treated Patients With Non-small Cell Lung Cancer|Completed||Phase 1|26|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:04.363324|2017-10-11 00:15:04.363324
NCT02182089|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-07-20|||April 2014||2014-04-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Measuring Cardiovascular Stress in Patients on Hemodialysis Study II|Measuring Cardiovascular Stress in Patients on Hemodialysis Study II|Unknown status|Active, not recruiting|N/A|48|Anticipated|Intelomed, Inc.|||2||f||||f||||||||||2017-10-11 00:15:04.486112|2017-10-11 00:15:04.486112
NCT02182076|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||October 2005||2005-10-01|July 2014|2014-07-01||||November 2005|Actual|2005-11-01||Interventional|||Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers|Safety and Pharmacokinetics/Bioavailability of a Single Dose of 150 mg BIBF 1120 Administered as Soft Gelatine Capsules With and Without Food to Healthy Male Volunteers in an Open, Randomised, Intra-individual Crossover Comparison Design|Completed||Phase 1|15|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:04.572372|2017-10-11 00:15:04.572372
NCT02182063|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||November 2005||2005-11-01|July 2014|2014-07-01||||January 2007|Actual|2007-01-01||Interventional|||A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer|An Open Label Randomized Phase II Study of Oral Treatment With BIBF 1120 250 mg Twice Daily Versus 150 mg Twice Daily in Patients Suffering From Hormone Refractory Prostate Cancer After Progression With Docetaxel Based Regimen|Completed||Phase 2|81|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:04.682365|2017-10-11 00:15:04.682365
NCT02182050|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||August 2005||2005-08-01|July 2014|2014-07-01||||January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer|A Double-blind, Randomised Phase II Study to Determine Efficacy and Safety of Oral Treatment With BIBF 1120 ES 250 mg Twice Daily Versus 150 mg Twice Daily in Patients Suffering From Advanced Non-small-cell Lung Cancer|Completed||Phase 2|73|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:04.782683|2017-10-11 00:15:04.782683
NCT02182037|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||August 2001||2001-08-01|July 2014|2014-07-01||||September 2001|Actual|2001-09-01||Interventional|||Safety, Pharmacodynamics, and Pharmacokinetics of BIBT 1011 BS in Healthy Subjects|Safety, Pharmacodynamics, and Pharmacokinetics After Single Oral Administration of 1, 5, 10, 30, 100, 200 and 400 mg BIBT 1011 BS as Drinking Solution in Healthy Subjects. An Open, Placebo-controlled, Randomised Study, Double Blind at Each Dose Level|Completed||Phase 1|56|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:04.882369|2017-10-11 00:15:04.882369
NCT02182024|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||April 2005||2005-04-01|July 2014|2014-07-01||||March 2006|Actual|2006-03-01||Interventional|||Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of 150 mg Dabigatran Etexilate p.o. in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function in a Monocentric, Open, Parallel-group Trial|Completed||Phase 1|35|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:15:04.993866|2017-10-11 00:15:04.993866
NCT02182011|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||May 2000||2000-05-01|July 2014|2014-07-01||||June 2001|Actual|2001-06-01||Interventional|||A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)|An Open-label, Randomised, Parallel-group Comparison to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With AMI|Completed||Phase 3|49|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:05.171682|2017-10-11 00:15:05.171682
NCT02181998|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||July 2000||2000-07-01|July 2014|2014-07-01||||August 2002|Actual|2002-08-01||Interventional|ASSENT 3 Plus||A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting|A Phase IIIb-IV, Randomised, Open Label Trial on Efficacy and Safety of 2 Parallel Groups: Full Dose Tenecteplase Combined With Unfractionated Heparin or Enoxaparin in Acute Myocardial Infarction in the Prehospital Setting (ASSENT 3 Plus) ASSENT 3 Plus Was a Satellite Study to ASSENT 3 (Main Study) ASSENT (ASsessment of the Safety and Efficacy of New Thrombolytic Regimens)|Completed||Phase 3|1606|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:05.300201|2017-10-11 00:15:05.300201
NCT02181985|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||May 2000||2000-05-01|July 2014|2014-07-01||||April 2001|Actual|2001-04-01||Interventional|ASSENT 3||Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)|A Phase IIIb, Randomised, Open Label Trial With 3 Parallel Groups: Full Dose TNK-tPA Together With Heparin Sodium, Full Dose TNK-tPA Together With Enoxaparin, and Half Dose TNK-tPA Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction: ASSENT 3 (Assessment of the Safety and Efficacy of New Thrombolytic Regimens)|Completed||Phase 3|5989|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:05.385881|2017-10-11 00:15:05.385881
NCT02181972|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||May 2002||2002-05-01|July 2014|2014-07-01||||November 2002|Actual|2002-11-01||Interventional|||Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults|Efficacy and Safety of Gingko Biloba Film-coated Tablets (2 x 60 mg Daily p.o.) in Improving Cognitive Functions and Neuropsychological Functioning of Middle-aged Cognitively Intact Adults: a Double-blind, Placebo-controlled, Parallel Group, Randomised Trial|Completed||Phase 3|120|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:05.475547|2017-10-11 00:15:05.475547
NCT02181959|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||December 1998||1998-12-01|July 2014|2014-07-01||||April 1999|Actual|1999-04-01||Interventional|||Safety and Tolerability of Pharmaton Capsules in Healthy Volunteers|Safety and Tolerability of PHARMATON Capsules vs PHARMATON Capsules With DMAE vs Placebo in Healthy Volunteers (A Double-blind, Controlled Multicentre Study)|Completed||Phase 2|138|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:05.557726|2017-10-11 00:15:05.557726
NCT02181946|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||May 2001||2001-05-01|July 2014|2014-07-01||||July 2001|Actual|2001-07-01||Interventional|||Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients|An Open-label Study in HIV+ Patients to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Fluconazole (DIFLUCAN®)|Completed||Phase 4|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:05.64244|2017-10-11 00:15:05.64244
NCT02181933|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-11|||April 1999||1999-04-01|July 2014|2014-07-01||||January 2001|Actual|2001-01-01||Interventional|||Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women|A Prospective Randomised Open Label Clinical Trial to Determine the Efficacy of Nevirapine, Compared With a Combination of ZDV + 3TC, in Decreasing the Peripartum Mother to Child Transmission of HIV. Women, Who Present After 38 Weeks Gestation or in Labour After 35 Weeks Gestation and Who Are Anti-retroviral Naive, Will be Included.|Completed||Phase 3|2648|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:05.716844|2017-10-11 00:15:05.716844
NCT02181920|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||March 2000||2000-03-01|July 2014|2014-07-01||||November 2000|Actual|2000-11-01||Interventional|||Metamizol for the Treatment of Neoplastic Chronic Pain|Analgesic Effect of a New Metamizol Oral Pharmaceutical Form for the Treatment of the Neoplastic Chronic Pain: Randomized, Double-blind Crossover Clinical Trial Between Metamizol, Diclofenac and Placebo|Terminated||Phase 4|6|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:15:05.793343|2017-10-11 00:15:05.793343
NCT02181907|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-07|||March 2003||2003-03-01|July 2014|2014-07-01||||April 2003|Actual|2003-04-01||Interventional|||Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy Volunteers|Bioequivalence Study of UH-AC 62 XX Tablets 10 mg (TF4) Compared With the 10 mg Capsule Formulations Following Single Peroral Administration in Healthy Volunteers|Completed||Phase 1|22|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:05.888527|2017-10-11 00:15:05.888527
NCT02181491|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-12-20|||July 2014||2014-07-01|December 2016|2016-12-01||||August 2018|Anticipated|2018-08-01||Interventional|||PET Imaging in Cocaine Self Administration||Active, not recruiting||N/A|30|Anticipated|Yale University||1|||f||||t||||||||||2017-10-11 00:15:11.561448|2017-10-11 00:15:11.561448
NCT02181894|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-12-05|||November 2014||2014-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Identifying the Most Accurate Method for Predicting the Safe Depth of Orally Placed Neonatal Endotracheal Tubes (ETT).|Identifying the Most Accurate Method for Predicting the Safe Depth of Orally Placed Neonatal Endotracheal Tubes.|Recruiting||N/A|372|Anticipated|University of Colorado, Denver|||1||f||||t||||||||||2017-10-11 00:15:05.962656|2017-10-11 00:15:05.962656
NCT02181881|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-10-21|||May 2014||2014-05-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||DuoPACT Pilot Intervention|Relationship Factors and HIV Treatment Adherence|Completed||N/A|60|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 00:15:06.085918|2017-10-11 00:15:06.085918
NCT02181868|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-03|||January 2008||2008-01-01|July 2014|2014-07-01||||December 2013|Actual|2013-12-01||Expanded Access|||Comparison of Biodegradable and Titanium Fixation Systems in Mandibular Symphysis or Parasymphysis Solitary Fractures||Approved for marketing||N/A|||Tianjin Medical University General Hospital|||||f||||||||||||||2017-10-11 00:15:06.171516|2017-10-11 00:15:06.171516
NCT02181855|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-01-28|||June 2014||2014-06-01|January 2015|2015-01-01||||December 2015|Anticipated|2015-12-01||Interventional|||Effect of Full-thickness Gastroplication With the GERD-X System on Atypical Gastro-esophageal-reflux-symptoms|Effect of Full-thickness Gastroplication With the GERD-X System on Atypical Gastro-esophageal-reflux-symptoms.|Unknown status|Recruiting|N/A|23|Anticipated|Technische Universität München||1|||f||||f||||||||||2017-10-11 00:15:06.243511|2017-10-11 00:15:06.243511
NCT02181842|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-02|||January 2009||2009-01-01|July 2014|2014-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>|Actos Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>|Completed||N/A|246|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:15:06.364626|2017-10-11 00:15:06.364626
NCT02181829|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-10-03|||July 2014||2014-07-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases|Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases|Recruiting||Phase 2|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:15:06.454115|2017-10-11 00:15:06.454115
NCT02181816|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-06-06|||June 26, 2014|Actual|2014-06-26|June 2017|2017-06-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Observational|||"Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey Long-term Use Survey"|"Zacras Combination Tablets LD & HD Specified Drug-use Survey Long-term Use Survey"|Completed||N/A|1000|Anticipated|Takeda|||1||f||||f||||||||||2017-10-11 00:15:06.660968|2017-10-11 00:15:06.660968
NCT02181803|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-05-05|||August 2014||2014-08-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||MK-8189 Multiple Dose Study in Healthy Volunteers and Schizophrenia Patients (MK-8189-003)|A Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8189 in Healthy Volunteers and in Schizophrenia Patients|Completed||Phase 1|55|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 00:15:06.876088|2017-10-11 00:15:06.876088
NCT02181790|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-03-21|2016-03-21||June 2014||2014-06-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles|Addition of 308-nm Excimer Laser to Acitretin Therapy in the Management of Palmoplantar Psoriasis|Terminated||Phase 4|2|Actual|Icahn School of Medicine at Mount Sinai||2||Lack of subjects|f||||f||||||||Yes||2017-10-11 00:15:06.987995|2017-10-11 00:15:06.987995
NCT02181777|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-03|||March 2014||2014-03-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|GRASP||Group Training for Social Skills in Psychosis|Exploring the Feasibility of Social Skills Training in People With Psychosis.|Unknown status|Recruiting|N/A|50|Anticipated|King's College London||2|||f||||f||||||||||2017-10-11 00:15:07.338774|2017-10-11 00:15:07.338774
NCT02181764|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-02-28|||July 2014|Actual|2014-07-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia|A Phase 1, Multicenter, Open-label, Sequential Dose-escalation, Single-dose Study to Assess the Safety and Tolerability of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia.|Completed||Phase 1|15|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||t||||||||||2017-10-11 00:15:07.475186|2017-10-11 00:15:07.475186
NCT02181751|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-04|||October 2014||2014-10-01|July 2014|2014-07-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||A 1-year Program to Treat Children Who Have Been Victims of Child Sexual Abuse|A 1-year Program to Treat Children Who Have Been Victims of Child Sexual Abuse|Unknown status|Not yet recruiting|N/A|100|Anticipated|Little Warriors||2|||f||||f||||||||||2017-10-11 00:15:07.591876|2017-10-11 00:15:07.591876
NCT02181738|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-08-02|||July 19, 2014|Actual|2014-07-19|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|August 30, 2017|Anticipated|2017-08-30||Interventional|CheckMate 205||Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)|Non-Comparative, Multi-Cohort, Single Arm, Open-Label, Phase 2 Study of Nivolumab (BMS-936558) in Classical Hodgkin Lymphoma (cHL) Subjects|Active, not recruiting||Phase 2|294|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:15:07.739719|2017-10-11 00:15:07.739719
NCT02181725|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-03-15|||July 2014||2014-07-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||2B Active: Outpatient Rehabilitation for Adolescents With Chronic Pain|Effectiveness and Cost-effectiveness of a Multimodal Rehabilitation Programme (MRP) for Adolescents With Chronic Musculoskeletal Pain (12-21 Years) Compared to Care as Usual (CAU); a Randomized Clinical Trial (2B Active)|Recruiting||N/A|124|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 00:15:07.972475|2017-10-11 00:15:07.972475
NCT02181712|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-08-09|||July 2014||2014-07-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Mesenchymal Stem Cell Therapy for Lung Rejection|A Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells to Induce Remission in Lung Transplant Patients Experiencing Treatment-refractory Moderate Lung Rejection|Completed||Phase 1|9|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:15:08.110596|2017-10-11 00:15:08.110596
NCT02180347|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-07-08|||June 2014||2014-06-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|CLAM||Contact Lenses and Myopia||Completed||N/A|17|Actual|State University of New York College of Optometry|||2||f||||||||||||||2017-10-11 00:15:27.403135|2017-10-11 00:15:27.403135
NCT02181699|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-07-14|||June 2014||2014-06-01|July 2017|2017-07-01||||June 30, 2017|Actual|2017-06-30||Interventional|||Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Phase 1 Study of KHK2823 in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.|Active, not recruiting||Phase 1|60|Anticipated|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||t||||||||||2017-10-11 00:15:08.226548|2017-10-11 00:15:08.226548
NCT02181686|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-07-14|||July 2014||2014-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Iperia/Sentus QP Study|Iperia Family / Sentus QP Master Study|Completed||N/A|152|Actual|Biotronik SE & Co. KG|||2||f||||f||||||||||2017-10-11 00:15:08.339126|2017-10-11 00:15:08.339126
NCT02181673|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-04-20||2017-01-23|September 8, 2014|Actual|2014-09-08|April 2017|2017-04-01|March 22, 2017|Actual|2017-03-22|May 5, 2016|Actual|2016-05-05||Interventional|||A Study of Golimumab in Participants With Active Psoriatic Arthritis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis|Completed||Phase 3|480|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 00:15:08.502213|2017-10-11 00:15:08.502213
NCT02181660|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-04-24|||June 16, 2014|Actual|2014-06-16|April 2017|2017-04-01|June 27, 2016|Actual|2016-06-27|June 27, 2016|Actual|2016-06-27||Interventional|||Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia|Phase I Study of ASP2215 - A Phase 1 Open-Label, Dose-Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-10-11 00:15:08.814258|2017-10-11 00:15:08.814258
NCT02181647|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-03|||April 2012||2012-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|Safe Touches||Safe Touches: A Rigorous Evaluation of a Sexual Abuse Prevention Program for Children|Safe Touches: A Rigorous Evaluation of a Sexual Abuse Prevention Program for Children|Completed||N/A|492|Actual|The New York Society for the Prevention of Cruelty to Children||2|||f||||t||||||||||2017-10-11 00:15:08.912377|2017-10-11 00:15:08.912377
NCT02181634|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-07-06|||December 9, 2014|Actual|2014-12-09|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|September 24, 2016|Actual|2016-09-24||Interventional|PrE0204||Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma|A Multi-Institutional, Single Arm, Two-Stage Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma|Active, not recruiting||Phase 2|74|Actual|PrECOG, LLC.||1|||f||||t|t|f||||||||2017-10-11 00:15:09.009139|2017-10-11 00:15:09.009139
NCT02181621|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-11-16|||August 2014||2014-08-01|July 2015|2015-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs|A Prospective, Open, Comparative, Randomized, Single-centre Study to Evaluate the Effect of Cadexomer Iodine Gel (IODOSORB) Compared to Standard Dressings (SOLOSITE) on Biofilm Disruption in Infected Diabetic Foot Ulcers (DFUs)|Terminated||N/A|19|Actual|Smith & Nephew Medical Ltd||2||Recruitment challenges|f||||f||||||||||2017-10-11 00:15:09.188436|2017-10-11 00:15:09.188436
NCT02181608|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-06-30|||June 19, 2014||2014-06-19|March 24, 2015|2015-03-24|March 24, 2015|Actual|2015-03-24|March 24, 2015|Actual|2015-03-24||Observational|||Traits Associated With Early Life Stress Among Treatment-Seeking Alcoholics|Traits Associated With Early Life Stress Among Treatment-Seeking Alcoholics|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:15:09.302979|2017-10-11 00:15:09.302979
NCT02181595|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-06-30|||June 18, 2014||2014-06-18|March 22, 2017|2017-03-22|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency|Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency: An Exporatory Pilot Study.|Enrolling by invitation||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:15:09.411554|2017-10-11 00:15:09.411554
NCT02181582|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-10-05|||June 24, 2014||2014-06-24|November 23, 2016|2016-11-23|November 23, 2016|Actual|2016-11-23|June 16, 2016|Actual|2016-06-16||Interventional|||Specific PET Radioligand Binding to Translocator Protein|Evaluation of Specific PET Radioligand Binding To Translocator Protein|Completed||Phase 1|32|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:15:09.502674|2017-10-11 00:15:09.502674
NCT02181569|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-06-30|||June 26, 2014||2014-06-26|May 5, 2017|2017-05-05|December 31, 2018|Anticipated|2018-12-31|April 30, 2018|Anticipated|2018-04-30||Observational|||Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study|Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study|Enrolling by invitation||N/A|116|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:15:09.586169|2017-10-11 00:15:09.586169
NCT02181556|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-08-10|||October 2014||2014-10-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|February 2017|Anticipated|2017-02-01||Interventional|||Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer|Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer|Recruiting||Phase 2|54|Anticipated|Federation Francophone de Cancerologie Digestive||1|||f||||t||||||||||2017-10-11 00:15:09.686341|2017-10-11 00:15:09.686341
NCT02181543|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2017-10-03|||August 2013|Actual|2013-08-01|October 2017|2017-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Use of Intraoperative Clonidine for Prevention of Postoperative Agitation in Pedriatic Anesthesia With Sevoflurane.|Use of Intraoperative Clonidine for Prevention of Postoperative Agitation in Pedriatic Anesthesia With Sevoflurane.|Completed||Phase 3|30|Actual|Professor Fernando Figueira Integral Medicine Institute||2|||f||||f||||||||||2017-10-11 00:15:09.875869|2017-10-11 00:15:09.875869
NCT02181530|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2015-05-21|2015-04-10||July 2014||2014-07-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®||Completed||N/A|43|Actual|Allergan|||1||f||||f||||||||||2017-10-11 00:15:10.163853|2017-10-11 00:15:10.163853
NCT02181517|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-04-15|2016-03-07||July 2014||2014-07-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration||Completed||Phase 2|25|Actual|Allergan||3|||f||||t||||||||||2017-10-11 00:15:10.450529|2017-10-11 00:15:10.450529
NCT02181478|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2016-09-28|||July 2015||2015-07-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||Intra-Osseous Co-Transplant of UCB and hMSC|Intra-osseous Co-transplant of Cord Blood and Mesenchymal Stromal Cells: A Feasibility Study|Recruiting||N/A|12|Anticipated|Case Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 00:15:11.655492|2017-10-11 00:15:11.655492
NCT02181465|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-03|||October 1993||1993-10-01|July 2014|2014-07-01|May 1994|Actual|1994-05-01|May 1994|Actual|1994-05-01||Interventional|CC1A&B||Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.|Phase II, Open Label, Single Center, Two Arm Study Study to Assess the Safety, Tolerance and Efficacy of a 2 mg Dose of G17DT Via Intramuscular Injection in Patients With Advanced Metastatic Colorectal Adenocarcinoma.|Completed||Phase 2|11|Actual|Cancer Advances Inc.||2|||f||||||||||||||2017-10-11 00:15:11.807979|2017-10-11 00:15:11.807979
NCT02181452|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-05-11|||November 2013||2013-11-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Liver Fibrosis Assessment With ShearWave Elastography|Evaluation of SWE Performances for the Non-Invasive Diagnosis of Liver Fibrosis in Patients With Chronic Liver Diseases|Completed||N/A|2333|Actual|SuperSonic Imagine|||1||f||||f||||||||||2017-10-11 00:15:11.881606|2017-10-11 00:15:11.881606
NCT02181439|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-05-03|||October 2014||2014-10-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|CINELASER||Study Evaluating the Laser Diode Effect on the Kinetics of Orthodontic Tooth Movement (Protocol CINELASER)|Single-center, Controlled, Randomized and Double-blind Study Evaluating the Laser Diode Effect on the Kinetics of Orthodontic Tooth Movement.|Recruiting||N/A|42|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 00:15:11.988382|2017-10-11 00:15:11.988382
NCT02181426|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-09-12|||March 2012||2012-03-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Dose Response of Ketorolac in Knee Arthroscopy|Dose Response of Ketorolac in Out-Patients Undergoing Knee Arthroscopy|Recruiting||N/A|112|Anticipated|Medical University of South Carolina||4|||f||||f||||||||||2017-10-11 00:15:12.082526|2017-10-11 00:15:12.082526
NCT02181413|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-03-30|||June 30, 2014|Actual|2014-06-30|March 2017|2017-03-01|March 14, 2018|Anticipated|2018-03-14|March 14, 2018|Anticipated|2018-03-14||Interventional|||A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant|A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant|Active, not recruiting||Phase 3|652|Anticipated|Takeda||2|||f||||t||||||||||2017-10-11 00:15:12.218519|2017-10-11 00:15:12.218519
NCT02181400|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-02|||July 2014||2014-07-01|June 2014|2014-06-01|May 2017|Anticipated|2017-05-01|February 2016|Anticipated|2016-02-01||Interventional|NIRD||Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema|Pilot Study of Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema|Unknown status|Not yet recruiting|N/A|21|Anticipated|University of Sydney||3|||f||||f||||||||||2017-10-11 00:15:12.66779|2017-10-11 00:15:12.66779
NCT02181387|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-07-20|2017-06-16||September 5, 2013|Actual|2013-09-05|July 2017|2017-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?|Does Acetaminophen Reduce Neuraxial Analgesic Requirement During Labor|Terminated||Phase 4|33|Actual|Wake Forest University Health Sciences||2||funding and compounding issues|f||||t|t|f||||||||2017-10-11 00:15:12.767605|2017-10-11 00:15:12.767605
NCT02181374|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-12-30|||January 2012||2012-01-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|5 Years|Observational [Patient Registry]|CE||The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation.|The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation|Recruiting||N/A|1000|Anticipated|Xijing Hospital|||1||f||||t||||||Samples Without DNA|"     NT-proBNP   "|||2017-10-11 00:15:13.062312|2017-10-11 00:15:13.062312
NCT02181361|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-01-21|||June 2014||2014-06-01|September 2013|2013-09-01|October 2018|Anticipated|2018-10-01|December 2016|Anticipated|2016-12-01||Interventional|CE||The Secondary Prevention of Nonvalvular Atrial Fibrillation Patients With an Initial Cardioembolic Stroke|The Effectiveness and Safety of Aspirin Plus Hirudin in the Secondary Prevention of Cardioembolic Stroke|Recruiting||Phase 3|200|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 00:15:13.150706|2017-10-11 00:15:13.150706
NCT02181348|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-02|||November 2008||2008-11-01|July 2014|2014-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Vitamin E Supplementation on Hemoglobin Levels in Healthy Adults|Role of Vitamin E in Enhancing Erythropoiesis and the Molecular Mechanism of the Action of Vitamin E on Erythropoietin-secreting Cells|Completed||Phase 1/Phase 2|357|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-11 00:15:13.249064|2017-10-11 00:15:13.249064
NCT02181335|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-17|||October 1998||1998-10-01|July 2014|2014-07-01||||June 2001|Actual|2001-06-01||Interventional|||Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy|A Twelve-week, Efficacy and Safety Study Comparing Respimat ® Budesonide (100 and 200 mcg, 2 Puffs Bid) With Turbohaler ® Budesonide (200 mcg, 2 Puffs Bid) in Symptomatic Adult Moderate to Severe Asthmatic Requiring Inhaled Corticosteroids and Bronchodilator Therapy.|Completed||Phase 3|684|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:13.371502|2017-10-11 00:15:13.371502
NCT02181322|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-04|||June 2001||2001-06-01|July 2014|2014-07-01||||September 2001|Actual|2001-09-01||Interventional|||Study to Assess the Effect of Food on the Pharmacokinetics of Meloxicam After Single Administration and to Investigate Dose-proportionality Over a Dosage Range|An Open, Randomised, Four-way Crossover Study in Healthy Volunteers to Evaluate the Effect of Food on the Pharmacokinetics of Meloxicam After a Single p.o. Administration of 22.5 mg Meloxicam Oral Suspension and Dose-proportionality Over a Dosage Range of 7.5 mg to 22.5 mg.|Completed||Phase 1|24|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:15:13.549242|2017-10-11 00:15:13.549242
NCT02181309|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-02|2014-07-04|||January 2002||2002-01-01|July 2014|2014-07-01||||April 2002|Actual|2002-04-01||Interventional|||Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers|An Open, Randomised, Four-way Crossover Study in Healthy Volunteers to Evaluate the Effect of Food on the Pharmacokinetics of Meloxicam After a Single p.o. Administration of 22.5 mg Meloxicam Oral Suspension and Dose-proportionality Over a Dosage Range of 7.5 mg to 22.5 mg|Completed||Phase 1|24|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:15:13.625869|2017-10-11 00:15:13.625869
NCT02181283|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-06-20|||April 2015||2015-04-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||MiSSION STRONG - Preventing AOS Misuse in the National Guard|Preventing Alcohol/Prescribed Drug Misuse in the National Guard: Web and Peer BI|Active, not recruiting||N/A|757|Actual|University of Michigan||3|||f||||f|f|f||||||No||2017-10-11 00:15:13.77393|2017-10-11 00:15:13.77393
NCT02181270|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-06-06|||October 2013||2013-10-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Changes in Intrahepatic Lipids With Exercise|Attenuation of Interhepatic Fat and Hepatic Biomarkers With Exercise|Recruiting||N/A|30|Anticipated|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-11 00:15:13.871231|2017-10-11 00:15:13.871231
NCT02181257|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-10-04|||January 2015||2015-01-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01|1 Year|Observational [Patient Registry]|ECP Registry||Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts|Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts|Active, not recruiting||N/A|160|Anticipated|Washington University School of Medicine|||1||f||||t||||||||||2017-10-11 00:15:13.982596|2017-10-11 00:15:13.982596
NCT02181244|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-07-01|||May 2013||2013-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects|Egg Effects on Atherogenic Dyslipidemia, Glucose Metabolism and Inflammation in Diabetic Subjects|Completed||N/A|33|Actual|University of Connecticut||2|||f||||f||||||||||2017-10-11 00:15:14.118923|2017-10-11 00:15:14.118923
NCT02181218|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-09-27|||February 4, 2015|Actual|2015-02-04|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas|A Multicenter Phase I Dose-finding and Preliminary Efficacy Study of the Histone Deacetylase Inhibitor Romidepsin (Istodax) in Combination With Gemcitabine (Gemzar), Oxaliplatin (Eloxatin), and Dexamethasone for the Treatment of Adults With Relapsed/Refractory Aggressive Lymphomas|Recruiting||Phase 1|24|Anticipated|Washington University School of Medicine||3|||f||||t|t|f|||f|||||2017-10-11 00:15:14.379568|2017-10-11 00:15:14.379568
NCT02181205|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-02-07|||November 2014||2014-11-01|February 2017|2017-02-01|December 31, 2016|Anticipated|2016-12-31|December 31, 2016|Anticipated|2016-12-31||Interventional|||Sphenopalatine Ganglion Block for Post-Dural Puncture Headache|Sphenopalatine Ganglion Block for Treatment of Postdural Puncture Headache: A Prospective Randomized Double Blind Placebo Controlled Study|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||2||no eligible participant , technical difficulty, feasiblity|f||||t||||||||||2017-10-11 00:15:14.533023|2017-10-11 00:15:14.533023
NCT02181192|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-07-29|||July 2017||2017-07-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|PROST-I||Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma|Postoperative Prostate Carcinoma Recurrence: Instant Radiotherapy Versus Radiotherapy With Additional Imaging With PSA Value >= 1|Not yet recruiting||N/A|180|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-11 00:15:14.621834|2017-10-11 00:15:14.621834
NCT02181179|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-05-01|||July 2014||2014-07-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Examining Yoga's Effects on Smoking|Examining Yoga's Effects on Aspects Related to Stress and Smoking Behavior|Active, not recruiting||N/A|50|Actual|University of Texas at Austin||2|||f||||t||||||||||2017-10-11 00:15:14.722331|2017-10-11 00:15:14.722331
NCT02181166|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-01|||August 2014||2014-08-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|January 2015|Anticipated|2015-01-01||Interventional|||Diagnosis and Management of Myofascial Pain Syndrome in Women With Mastectomies||Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Sao Paulo||3|||f||||||||||||||2017-10-11 00:15:14.838513|2017-10-11 00:15:14.838513
NCT02181153|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-05-10|||December 2013||2013-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease|GENETIC, SEROLOGICAL, FECAL AND CLINICAL MARKERS IN SIBLINGS OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE|Completed||N/A|200|Actual|University of Roma La Sapienza||2|||f||||f||||||||Yes||2017-10-11 00:15:14.955023|2017-10-11 00:15:14.955023
NCT02181140|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-08-15|2015-05-21||August 2011||2011-08-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|COS||Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle|Prospective Evaluation of the Significance of the Pro-core® Needle in Differential Diagnosis of Tumorous and Inflammatory Processes|Completed||N/A|56|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||t||||||||||2017-10-11 00:15:15.064228|2017-10-11 00:15:15.064228
NCT02181127|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-06-21|2016-10-31||November 2014||2014-11-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|June 2015|Actual|2015-06-01||Interventional|||Closed-Loop Glucagon Administration For Hypoglycemia Treatment|Closed-Loop Glucagon Administration for the Automated Prevention and Treatment of Hypoglycemia|Completed||N/A|31|Actual|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-11 00:15:15.277229|2017-10-11 00:15:15.277229
NCT02181114|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-08-18|||May 2014||2014-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant|Computer Tailored Education Program to Reduce Disparities in Living Donor Kidney Transplant|Active, not recruiting||N/A|815|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 00:15:15.62241|2017-10-11 00:15:15.62241
NCT02181101|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-07-01|||September 2005||2005-09-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial||Completed||Phase 3|3754|Actual|Ludwig-Maximilians - University of Munich||4|||f||||t||||||||||2017-10-11 00:15:15.736825|2017-10-11 00:15:15.736825
NCT02181088|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-12-02|||August 2014||2014-08-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5|A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5|Completed||Phase 1|26|Actual|University of Oxford||4|||f||||t||||||||||2017-10-11 00:15:15.876948|2017-10-11 00:15:15.876948
NCT02181075|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-08-02|||July 2014||2014-07-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|TARDOX||Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours|A Proof of Concept Study to Investigate the Feasibility of Targeted Release of Doxorubicin From Lyso-thermosensitive Liposomal (LTSL) Doxorubicin (ThermoDox®) Using Focused Ultrasound in Patients With Primary or Secondary Liver Tumours|Completed||Phase 1|10|Actual|University of Oxford||1|||f||||t||||||||||2017-10-11 00:15:16.000367|2017-10-11 00:15:16.000367
NCT02181049|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-08-22|||October 2013|Actual|2013-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|February 2016|Actual|2016-02-01||Observational|CVSS||Cardiac and Vascular Late Sequelae in Long-term Survivors of Childhood Cancer (CVSS)|Cardiac and Vascular Late Sequelae in Long-term Survivors of Childhood Cancer (CVSS): a Multidisciplinary Clinical, Epidemiological and Genetic Approach|Active, not recruiting||N/A|1000|Actual|Johannes Gutenberg University Mainz|||1||f||||f||||||Samples With DNA|"     blood, serum, plasma, DNA, RNA, urine, tear fluid   "|||2017-10-11 00:15:16.313653|2017-10-11 00:15:16.313653
NCT02181036|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-07-02|||June 2014||2014-06-01|June 2014|2014-06-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Effects of Work Shop for Children With Developmental Delays|Effects of Family Work Shop for Children With Speech Developmental Delays|Unknown status|Active, not recruiting|N/A|30|Anticipated|Taipei Medical University||1|||f||||f||||||||||2017-10-11 00:15:16.41625|2017-10-11 00:15:16.41625
NCT02181023|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-10-28|||June 2014||2014-06-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD Patients|Acute Effect of Aclidinium on Hyperinflation and Lung Volume Distribution in Severe COPD Patients|Completed||Phase 4|37|Actual|University of Milan||2|||f||||t||||||||||2017-10-11 00:15:16.502457|2017-10-11 00:15:16.502457
NCT02181010|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-07-01|||January 2012||2012-01-01|July 2014|2014-07-01|January 2018|Anticipated|2018-01-01|December 2016|Anticipated|2016-12-01||Interventional|BHCK||B'More Healthy; Communities for Kids (BHCK)|B'More Healthy: Communities for Kids (BHCK)|Recruiting||N/A|890|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 00:15:16.649603|2017-10-11 00:15:16.649603
NCT02180997|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-06-23|||July 2014||2014-07-01|July 2014|2014-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin|Pharmacokinetic Drug Interaction Between Solifenacin 10mg and Tamsulosin 0.4mg in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Jeil Pharmaceutical Co., Ltd.||6|||f||||f||||||||No||2017-10-11 00:15:16.794753|2017-10-11 00:15:16.794753
NCT02180984|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-07-19|||November 2015||2015-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED|The Effects of Repetitive Transcranial Magnetic Stimulation in Obese Females With Binge Eating Disorder: a Protocol for a Double-blinded, Randomized, Sham-controlled Trial.|Recruiting||Phase 2|90|Anticipated|Federal University of São Paulo||4|||f||||t||||||||||2017-10-11 00:15:16.929652|2017-10-11 00:15:16.929652
NCT02180971|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2016-10-25|||April 2014||2014-04-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Multidetector Coronary CT In Vasospastic Angina|Diagnostic Usefulness of Multidetector Coronary CT in Vasospastic Angina|Recruiting||N/A|150|Anticipated|Dong-A University||2|||f||||t||||||||Undecided||2017-10-11 00:15:17.052307|2017-10-11 00:15:17.052307
NCT02180958|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-10-27|||July 2014||2014-07-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01|36 Months|Observational [Patient Registry]|cAVM||ONYX Evaluation in the Endovascular Treatment of Cerebral Arteriovenous Malformations (cAVM)|Assessment of ONYX in Endovascular Cerebral AVM. Prospective, Multi-centre and Observational French Study.|Recruiting||N/A|150|Anticipated|Medtronic Neurovascular Clinical Affairs|||1||f||||t||||||||||2017-10-11 00:15:17.162477|2017-10-11 00:15:17.162477
NCT02180945|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-10-27|||July 2013||2013-07-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|January 2020|Anticipated|2020-01-01|12 Months|Observational [Patient Registry]|dAVF||ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae|ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae. A French, Observational, Prospective, Multicentric, Single Arm and Open Study|Active, not recruiting||N/A|110|Actual|Medtronic Neurovascular Clinical Affairs|||1||f||||t||||||||||2017-10-11 00:15:17.259333|2017-10-11 00:15:17.259333
NCT02180932|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-10-23|||June 2014||2014-06-01|May 2014|2014-05-01||||July 2015|Actual|2015-07-01||Interventional|||Towards a Viral Etiology of Periodontal Disease in Relation to Radiotherapy Treatment of Head and Neck Cancers||Completed||N/A|25|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:15:17.337964|2017-10-11 00:15:17.337964
NCT02180919|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-07-02|||June 2010||2010-06-01|May 2010|2010-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|TELECRAFT||Implementation of Telemonitoring in Chronic Heart or Lung Failure|Implementation of Telemonitoring in the Management of Acute Exacerbations of Chronic Heart Failure and Respiratory Failure/Chronic Obstructive Pulmonary Disease|Completed||Phase 1|85|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:15:17.415807|2017-10-11 00:15:17.415807
NCT02180906|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2016-02-14|||February 2013||2013-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|BIONEC||Biomarkers in Patients With Flesh-eating Bacterial Infections|Biomarkers in Necrotizing Soft Tissue Infections - Aspects of the Innate Immune Response|Completed||N/A|169|Actual|Rigshospitalet, Denmark|||1||f||||t||||||Samples Without DNA|"     Whole blood and plasma/serum   "|No||2017-10-11 00:15:17.513382|2017-10-11 00:15:17.513382
NCT02180893|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-02-16|2016-02-16||January 2013||2013-01-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Use of Paravertebral Block for Cardiac Surgery|Study of Paravertebral Block for Cardiac Surgery|Completed||Phase 4|60|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 00:15:17.622401|2017-10-11 00:15:17.622401
NCT02180880|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-08-18|||November 2012||2012-11-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Symptom Based Treatment of Neuropathic Pain|Symptom-Based Treatment for Neuropathic Pain in Spinal Cord Injured Patients, Randomized Clinical Trial|Completed||Phase 4|63|Actual|CHA University||1|||f||||f||||||||||2017-10-11 00:15:17.865951|2017-10-11 00:15:17.865951
NCT02180854|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-02-06|||September 2014||2014-09-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Correlation Between Monitoring Frequency and Clinical Deterioration in Hospitalized Patients|Correlation Between Monitoring Frequency and Clinical Deterioration in Hospitalized Patients|Completed||N/A|600|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 00:15:19.916559|2017-10-11 00:15:19.916559
NCT02180841|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-03-28|||March 2014||2014-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SOY||Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness|Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness|Completed||N/A|20|Actual|Penn State University||3|||f||||f||||||||||2017-10-11 00:15:19.997701|2017-10-11 00:15:19.997701
NCT02180828|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-04-28|2016-04-16||July 2014||2014-07-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis|An Case-controlled Randomized Study to the Efficacy of Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis|Completed||Phase 4|240|Actual|Peking University Shenzhen Hospital||2|||f||||f||||||||Yes|http://onlinelibrary.wiley.com/doi/10.1111/myc.12485/epdf|2017-10-11 00:15:20.112958|2017-10-11 00:15:20.112958
NCT02180815|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-03-30|||September 2014||2014-09-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||REV 002 Observational Study of the ReVENT Sleep Apnea System: Minimally Invasive Treatment for Obstructive Sleep Apnea|ReVENT Sleep Apnea System, a Minimally Invasive Approach to Treat Obstructive Sleep Apnea: a Prospective Multicenter Post-Market Observational Study|Terminated||N/A|50|Anticipated|Revent Medical International B.V.|||1|Sufficient follow-up information obtained to support study goals|f||||f||||||||||2017-10-11 00:15:20.573944|2017-10-11 00:15:20.573944
NCT02180802|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-08-30|||February 2011||2011-02-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Parental Involvement Improves the Effect of Motivational Interviewing on Weight Loss in Obese Adolescents: A Randomized Controlled Trial Study||Completed||N/A|408|Actual|Qazvin University Of Medical Sciences||3|||f||||f||||||||||2017-10-11 00:15:20.697945|2017-10-11 00:15:20.697945
NCT02180789|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-11-17|||March 2013||2013-03-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation|An Open-label, Prospective Interventional Study of the Tolerability and Efficacy of Oral Harnalidge® OCAS® (Tamsulosin) 0.4 mg in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2 mg|Completed||Phase 4|100|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:15:20.824222|2017-10-11 00:15:20.824222
NCT02180776|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-07-01|||June 2012||2012-06-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ARISE||Effectiveness of Inelastic LSO Versus Standard Medical Treatment for Back Pain Associated With Kyphosis|A Randomized Crossover Pilot Study To Determine Clinical Effectiveness and Patient Wellness of Inelastic Lumbosacral Orthoses Versus Standard Medical Treatment in Patients With Back Pain AssociatEd With Kyphosis (The ARISE Study)|Completed||N/A|16|Actual|Aspen Medical Products||2|||f||||f||||||||||2017-10-11 00:15:20.915583|2017-10-11 00:15:20.915583
NCT02180763|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-08-12|||April 2014||2014-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps|A Randomized, Cross-over Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL According to the Delivery Device: Injections Using Pump or Rapid Push.|Recruiting||Phase 4|30|Anticipated|Octapharma||1|||f||||t||||||||||2017-10-11 00:15:20.994646|2017-10-11 00:15:20.994646
NCT02180750|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-01|||June 2013||2013-06-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|MWT||Phase II Randomised Controlled Trial of Memory Work Therapy at PASADA, Tanzania|An Evaluation of a Psychosocial Intervention for Orphans With HIV Infection: a Phase II Randomised Controlled Trial of Memory Work Therapy at PASADA, Tanzania|Unknown status|Active, not recruiting|N/A|48|Anticipated|Pastoral Activities and Service for AIDS Dar-Es-Salaam Archdiocese||2|||f||||f||||||||||2017-10-11 00:15:21.104508|2017-10-11 00:15:21.104508
NCT02180737|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-04-17|||January 2014||2014-01-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|Dexmed||Dexmedetomidine for Sedation During Radiological Interventional Procedures|Evaluation of Role of Dexmedetomidine as a Sole Agent in Sedation of Cancer Patients Undergoing Radiological Interventional Procedures|Completed||Phase 4|40|Actual|National Cancer Institute, Egypt||1|||f||||t||||||||||2017-10-11 00:15:21.179657|2017-10-11 00:15:21.179657
NCT02180724|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-01-31|||July 2014||2014-07-01|January 2016|2016-01-01|January 2020|Anticipated|2020-01-01|September 2017|Anticipated|2017-09-01||Interventional|||An Open-label, Phase 2 Study of Acalabrutinib in Subjects With Waldenström Macroglobulinemia|An Open-label, Phase 2 Study of Acalabrutinib in Subjects With Waldenström Macroglobulinemia|Active, not recruiting||Phase 2|106|Actual|Acerta Pharma BV||1|||f||||f|t|f||||||||2017-10-11 00:15:21.275431|2017-10-11 00:15:21.275431
NCT02180711|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-12-01|||July 2014||2014-07-01|December 2016|2016-12-01||||August 2018|Anticipated|2018-08-01||Interventional|||An Open-label, Phase 1b Study of Acalabrutinib Alone or in Combination With Rituximab in Subjects With Follicular Lymphoma|ACP 196 Alone or in Combination With Rituximab in Follicular Lymphoma|Active, not recruiting||Phase 1|40|Actual|Acerta Pharma BV||2|||f||||f||||||||||2017-10-11 00:15:21.359071|2017-10-11 00:15:21.359071
NCT02180698|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-07-17|||November 17, 2014|Actual|2014-11-17|July 2017|2017-07-01||||March 1, 2018|Anticipated|2018-03-01||Interventional|||TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery|A Phase I Study to Determine the Safety of the Combination of Stable-Emulsion Formulation of Glucopyranosyl Lipid A (GLA-SE) With Radiation in Patients With Metastatic Sarcoma|Recruiting||Phase 1|17|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 00:15:21.450119|2017-10-11 00:15:21.450119
NCT02180685|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-07-12|||January 2009||2009-01-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Reconstruction of the Medial Patellofemoral Ligament - A Randomised Controlled Trial Comparing Two Surgery Technics|Reconstruction of the Medial Patellofemoral Ligament - A Randomised Controlled Trial Comparing Two Surgery Technics|Active, not recruiting||N/A|60|Anticipated|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 00:15:21.545434|2017-10-11 00:15:21.545434
NCT02180646|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-06-06|2016-09-30||December 2011||2011-12-01|June 2017|2017-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes|Effect of a High Protein Breakfast on Glycemic Control, Insulin Sensitivity, and Beta Cell Function in Individuals With Type 2 Diabetes (T2D)|Completed||N/A|12|Actual|University of Missouri-Columbia||2|||f||||f||||||||Undecided||2017-10-11 00:15:23.647938|2017-10-11 00:15:23.647938
NCT02180633|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-06-16|||May 2013||2013-05-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|IMH_2012||Unveiling Preclinical Idiopathic Macular Hole Formation|Unveiling Preclinical Idiopathic Macular Hole Formation|Completed||N/A|200|Actual|University of Coimbra|||2||f||||||||||||||2017-10-11 00:15:23.913565|2017-10-11 00:15:23.913565
NCT02180620|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-06-06|||September 2013||2013-09-01|June 2017|2017-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Pre-dinner vs. Post-dinner Exercise on Glycemic Control|Exercise Timing and Postprandial Glycemia in Type 2 Diabetes|Completed||N/A|13|Actual|University of Missouri-Columbia||3|||f||||f||||||||No||2017-10-11 00:15:24.026633|2017-10-11 00:15:24.026633
NCT02180607|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-05-27|||October 2013||2013-10-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Neuronal Responses to Social Feedback in Major Depressive Disorder|Neuronal Responses to Social Feedback in Major Depressive Disorder|Completed||N/A|58|Actual|University of Michigan|||2||f||||f||||||Samples With DNA|"     saliva   "|||2017-10-11 00:15:24.111027|2017-10-11 00:15:24.111027
NCT02180581|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-08-23|||August 2014||2014-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|ProbiComp||Effect of Probiotics in Reducing Infections and Allergies in Young Children Starting Daycare|Effect of Probiotics in Reducing Infections and Allergies in Young Children Starting Daycare|Completed||N/A|290|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 00:15:24.18786|2017-10-11 00:15:24.18786
NCT02180568|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-10-12|||May 2014||2014-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|LOGIS||Lipiodol Localization for Ground-glass-opacity Minimal Surgery|Validation Study to Evaluate the Safety and Efficacy of Preoperative Computed Tomography-guided Localization Technique Using Lipiodol for Patients With Ground Glass Opacity Pulmonary Lesions: A Prospective Multicenter Study|Recruiting||Phase 3|250|Anticipated|Severance Hospital||2|||f||||t||||||||||2017-10-11 00:15:24.291381|2017-10-11 00:15:24.291381
NCT02180555|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-07|||February 2012||2012-02-01|July 2014|2014-07-01||||July 2015|Anticipated|2015-07-01||Observational|DIAFIC||Diabetes Mellitus After Intensive Care Admission|Incidence and Predisposing Factors for the Development of Glucose Metabolism Disturbances and Diabetes Mellitus After Intensive Care Admission|Unknown status|Recruiting|N/A|400|Anticipated|University Hospital, Antwerp|||1||f||||||||||||||2017-10-11 00:15:25.708875|2017-10-11 00:15:25.708875
NCT02180529|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-01-10|||November 2015||2015-11-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment|The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment: a Randomized, Placebo Controlled, Double-blind Trial.|Recruiting||N/A|120|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 00:15:25.959437|2017-10-11 00:15:25.959437
NCT02180516|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-04|||October 2001||2001-10-01|July 2014|2014-07-01||||September 2004|Actual|2004-09-01||Observational|||Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome|Safety and Efficacy of Meloxicam (MOBIC) Compared to Other NSAIDs in Approved Therapeutic Dosages and Routes of Administration in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome|Completed||N/A|9984|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 00:15:26.05757|2017-10-11 00:15:26.05757
NCT02180503|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-07|||August 2005||2005-08-01|July 2014|2014-07-01||||October 2005|Actual|2005-10-01||Interventional|||Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS|Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) Reconstituted With 0.1% Tartaric Acid Compared to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers (Separately at Each Dose Level) Including the Influence of Food (Standardised High Fat Breakfast) on the Bioavailability of 10 mg BI 1356 BS as Tablet in a Single Dose, Open-label, Randomised, Two-way (1 mg) and Three-way (10 mg) Crossover Trial|Completed||Phase 1|24||Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:26.135918|2017-10-11 00:15:26.135918
NCT02180490|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-04|||May 2002||2002-05-01|July 2014|2014-07-01||||July 2002|Actual|2002-07-01||Interventional|||Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers|Bioequivalence Study of UHAC 62 XX 10 mg Tablets Compared With 10 mg Capsules Following Single Peroral Administration in Healthy Volunteers (An Open-label, Randomised, Two-way Crossover Study)|Completed||Phase 1|60|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:26.219202|2017-10-11 00:15:26.219202
NCT02180477|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-04|||November 2001||2001-11-01|July 2014|2014-07-01||||December 2001|Actual|2001-12-01||Interventional|||Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers|Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation|Completed||Phase 1|9|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:15:26.293102|2017-10-11 00:15:26.293102
NCT02180464|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-06-09|||June 2014||2014-06-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Left/Right||A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis|A Phase IIa, 28-day Treatment, Multi-center, Randomized, Comparator-controlled, Observer-blind Trial With Intra-individual Left/Right Comparison to Investigate the Anti-psoriatic Efficacy and the Safety of an LAS41004 Formulation in Comparison to an Active Reference in Patients With Mild to Moderate Plaque Psoriasis|Completed||Phase 2|40|Actual|Almirall, S.A.||2|||f||||f||||||||||2017-10-11 00:15:26.381344|2017-10-11 00:15:26.381344
NCT02180451|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-03-24|||June 2014||2014-06-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)|Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)|Active, not recruiting||N/A|8|Actual|Vanda Pharmaceuticals|||1||f||||f||||||Samples With DNA|"     Melatonin and Cortisol samples will be collected   "|||2017-10-11 00:15:26.48154|2017-10-11 00:15:26.48154
NCT02180438|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-05-25|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|Stribild HIV-2||An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal|An Open Label Trial of STRIBILD™ (Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate) for ARV-naïve HIV-2 Infected Adults in Dakar, Senegal|Completed||Phase 4|30|Actual|University of Washington||1|||f||||t||||||||||2017-10-11 00:15:26.568637|2017-10-11 00:15:26.568637
NCT02180425|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-05-25|||November 2013||2013-11-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Observational|Acne||The Lipid Profile of the Skin Surface in Acne|The Lipid Profile of the Skin Surface in Acne|Completed||N/A|30|Actual|University of California, Davis|||3||f||||f||||||Samples Without DNA|"     Sebum collections from sebutapes   "|||2017-10-11 00:15:26.834012|2017-10-11 00:15:26.834012
NCT02180412|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-08-17|||April 2014||2014-04-01|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Interventional|||Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria|A Double-blind, Randomized, Placebo-controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of Porphyria|Recruiting||Phase 2|40|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 00:15:26.937167|2017-10-11 00:15:26.937167
NCT02180399|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-05-18|||February 2014|Actual|2014-02-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|SepsisMI||Serial Measurement of Capillary Blood Lactate in the Management of Sepsis|Role of the Serial Measurement of Capillary Blood Lactate in the Management of Sepsis Outside the Intensive Care|Recruiting||N/A|60|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 00:15:27.04694|2017-10-11 00:15:27.04694
NCT02180386|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-01|||June 2014||2014-06-01|July 2014|2014-07-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Effect of PlayStation Distraction in the Dental Setting|Effect of PlayStation Distraction on Children's Behavior and Pain in the Dental Setting|Unknown status|Recruiting|N/A|34|Anticipated|Universitat Internacional de Catalunya||1|||f||||t||||||||||2017-10-11 00:15:27.144956|2017-10-11 00:15:27.144956
NCT02180373|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-07-01|||December 2012||2012-12-01|July 2014|2014-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention|Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention|Enrolling by invitation||N/A|2000|Anticipated|Vascular Cures|||2||f||||f||||||Samples With DNA|"     Whole blood from 3 timepoints plus 1 tube of plasma; for vein graft bypass arm, otherwise     discarded vein tissue   "|||2017-10-11 00:15:27.231658|2017-10-11 00:15:27.231658
NCT02180360|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-06-30|||February 2012||2012-02-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Capoeira Training and Flexibility|Eight Weeks of Basic Training in Capoeira Increases Flexibility of Beginners in the Sport|Completed||N/A|21|Actual|Universidade Federal do vale do São Francisco||2|||f||||t||||||||||2017-10-11 00:15:27.314836|2017-10-11 00:15:27.314836
NCT02180334|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-06-30|||July 2014||2014-07-01|June 2014|2014-06-01|April 2015|Anticipated|2015-04-01|November 2014|Anticipated|2014-11-01||Interventional|||The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones|The Effect of Combination of Mosapride and Dipeptidyl Peptidase-4 (DPP-4) Inhibitor on Plasma Concentration of Incretin Hormones|Unknown status|Not yet recruiting|Phase 4|12|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:15:27.518603|2017-10-11 00:15:27.518603
NCT02180321|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-04-11|||June 2013||2013-06-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Tranexamic Acid Based on Pharmacokinetics in Pediatric Patients Undergoing Craniosynostosis Surgery: Randomized Controlled Trial||Completed||N/A|50|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:15:27.642871|2017-10-11 00:15:27.642871
NCT02180308|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-07-12|||June 2014||2014-06-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Interventional|||Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI|Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI|Active, not recruiting||N/A|23|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 00:15:27.722431|2017-10-11 00:15:27.722431
NCT02180295|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-08-11|||July 2014||2014-07-01|August 2015|2015-08-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)|A Phase III, Double-Blind, Lot-To-Lot Consistency Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of V212 in Healthy Adults|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 00:15:27.815752|2017-10-11 00:15:27.815752
NCT02180282|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-01-25|||July 2014||2014-07-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Impact of the M22-IPL Acne Filter on Acne Vulgaris|Impact of the M22-IPL Acne Filter on Acne Vulgaris|Terminated||N/A|13|Actual|Lumenis Ltd.||1||Low recruiting rate|f||||f||||||||||2017-10-11 00:15:27.903765|2017-10-11 00:15:27.903765
NCT02180269|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-09-11|||June 2014||2014-06-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants|A Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Japanese Male Subjects|Completed||Phase 1|24|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-10-11 00:15:27.992513|2017-10-11 00:15:27.992513
NCT02180256|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-11-03|||September 2014||2014-09-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial||Enrolling by invitation||N/A|600|Anticipated|University of Sao Paulo||4|||f||||t||||||||||2017-10-11 00:15:28.076866|2017-10-11 00:15:28.076866
NCT02180230|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-03-22|2015-12-08||October 2007||2007-10-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Immediate Function of NobelSpeedy Shorty and Brånemark System® Mk III Shorty Implants in Daily Use|Immediate Function of NobelSpeedy Shorty and Brånemark System® Mk III Shorty Implants in Daily Use|Completed||N/A|38|Actual|Nobel Biocare||1|||f||||f||||||||No||2017-10-11 00:15:28.246832|2017-10-11 00:15:28.246832
NCT02180217|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-07-12|||October 6, 2014|Actual|2014-10-06|July 2017|2017-07-01|December 7, 2018|Anticipated|2018-12-07|December 7, 2018|Anticipated|2018-12-07||Interventional|||Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease|Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease|Active, not recruiting||Phase 3|138|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 00:15:28.447785|2017-10-11 00:15:28.447785
NCT02180204|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2015-09-22|||January 2015||2015-01-01|September 2015|2015-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|TALISMAN||Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)|Phase IIb Study Comparing Tenecteplase to Alteplase in Acute Ischemic Stroke Within 3 to 4.5 Hours From Symptom Onset|Withdrawn||Phase 2/Phase 3|0|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 00:15:28.850656|2017-10-11 00:15:28.850656
NCT02180191|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-01|||January 2013||2013-01-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Gut Microbiota in Obesity and Diabetes|Comparison of Gut Microbiota in Obese, Diabetic and Healthy Control Individuals|Completed||N/A|81|Actual|Gulhane School of Medicine|||3||f||||||||||||||2017-10-11 00:15:28.958231|2017-10-11 00:15:28.958231
NCT02180178|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-09-04|||September 2013||2013-09-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01|10 Years|Observational [Patient Registry]|MICAT||Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registery|Mainzer IntraCoronAry daTabase (MICAT). Das Coronary Slow Flow- Syndrom Und Koronare Mikrozirkulationsstörungen- Register.|Recruiting||N/A|1000|Anticipated|Johannes Gutenberg University Mainz|||1||f||||f||||||Samples Without DNA|"     serum samples from patients with slow flow   "|||2017-10-11 00:15:29.048927|2017-10-11 00:15:29.048927
NCT02180165|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-09-27|||July 29, 2014|Actual|2014-07-29|September 2017|2017-09-01|February 8, 2018|Anticipated|2018-02-08|February 8, 2018|Anticipated|2018-02-08||Interventional|||Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)|A Randomized, Comparative, Open-label Study to Assess the Safety and Efficacy of MK-5592 Compared With Voriconazole in Japanese Subjects With Deep-seated Fungal Infection|Recruiting||Phase 3|112|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:15:29.161607|2017-10-11 00:15:29.161607
NCT02180152|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-03-10|||March 2015||2015-03-01|March 2015|2015-03-01||||March 2016|Anticipated|2016-03-01||Interventional|||Postprandial Walking in Obese Pregnant Women and Perinatal Outcomes - a Multicenter Randomized Clinical Trial|Postprandial Walking in Obese Pregnant Women and Perinatal Outcomes - a Multicenter Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|132|Anticipated|Professor Fernando Figueira Integral Medicine Institute||2|||f||||||||||||||2017-10-11 00:15:29.279749|2017-10-11 00:15:29.279749
NCT02180139|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-09-29|||September 2017|Anticipated|2017-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||tDCS in Cervical Dystonia|Optimizing tDCS in Cervical Dystonia|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||4||Study was withdrawn due to lack of funding and staff availability.|f||||f|f|t|f|f|f|||||2017-10-11 00:15:29.381697|2017-10-11 00:15:29.381697
NCT02180126|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-01|||August 2014||2014-08-01|July 2014|2014-07-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation||Unknown status|Not yet recruiting|N/A|160|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 00:15:29.500857|2017-10-11 00:15:29.500857
NCT02180113|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-07-25|||March 2012||2012-03-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||Spleen Stiffness Measurement With FibroScan|Feasibility and Performances of Spleen Stiffness Measurement as Surrogate Marker for Oesophageal Varices in Cirrhotic Patients.|Completed||N/A|403|Actual|Echosens||1|||f||||f||||||||||2017-10-11 00:15:29.607947|2017-10-11 00:15:29.607947
NCT02180100|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-04-27|||August 2013||2013-08-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis|A Randomized, Parallel-group Study of Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe|Completed||Phase 4|140|Actual|Peking University Shenzhen Hospital||2|||f||||f||||||||||2017-10-11 00:15:29.725516|2017-10-11 00:15:29.725516
NCT02180087|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2014-07-01|||February 2014||2014-02-01|July 2014|2014-07-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|LoDoNSAID||Reduce Nonsteroidal Antiinflammatory Drugs Doses for Analgesia After Sternotomy|Reduce Nonsteroidal Antiinflammatory Drugs Doses for Analgesia After Sternotomy|Unknown status|Recruiting|Phase 2|100|Anticipated|University Hospital, Clermont-Ferrand||4|||f||||||||||||||2017-10-11 00:15:29.854244|2017-10-11 00:15:29.854244
NCT02180074|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-06-30|||September 2013||2013-09-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Measurement of Distinct Biological Pools of Hydrogen Sulfide in Women With Cardiovascular Disease|Measurement of Distinct Biological Pools of Hydrogen Sulfide in Women With Cardiovascular Disease|Unknown status|Recruiting|N/A|230|Anticipated|Louisiana State University Health Sciences Center Shreveport|||5||f||||||||||Samples With DNA|"     Plasma.   "|||2017-10-11 00:15:29.991496|2017-10-11 00:15:29.991496
NCT02180061|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-08-22|2016-08-10||July 15, 2014|Actual|2014-07-15|August 2017|2017-08-01|March 28, 2017|Actual|2017-03-28|September 23, 2015|Actual|2015-09-23||Interventional|||Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041)|Phase Ib Study of MK-3475 in Subjects With Advanced Melanoma|Completed||Phase 1|42|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:15:30.138889|2017-10-11 00:15:30.138889
NCT02180048|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-01-04|||July 2014||2014-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"|"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"|Recruiting||N/A|150|Anticipated|Loma Linda University||3|||f||||t||||||||||2017-10-11 00:15:30.745512|2017-10-11 00:15:30.745512
NCT02180022|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2014-07-01|||April 2013||2013-04-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Onion Peel Extract on Endothelial Function|Effect of Onion Peel Extract on Endothelial Function and Endothelial Progenitor Cells in Overweight and Obese Subjects|Completed||Phase 4|62|Actual|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-11 00:15:30.919314|2017-10-11 00:15:30.919314
NCT02180009|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2016-01-26|||December 2013||2013-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01|12 Months|Observational [Patient Registry]|||Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis|Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis|Completed||N/A|1|Actual|Chinese PLA General Hospital|||4||f||||f||||||Samples With DNA|"     peripheral blood   "|||2017-10-11 00:15:31.003839|2017-10-11 00:15:31.003839
NCT02179996|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2015-07-27|||January 2014||2014-01-01|July 2015|2015-07-01|September 2015|Anticipated|2015-09-01|June 2015|Actual|2015-06-01||Interventional|VacciPrema||Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates|Comparison of Two Vaccinal Schemes for DTP-Pertussis-Hib Primo-immunisation in Very Preterm-born Neonates: a Randomised Bicentric Controlled Study|Unknown status|Active, not recruiting|Phase 4|160|Actual|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-11 00:15:31.074872|2017-10-11 00:15:31.074872
NCT02179983|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2014-06-30|||June 2014||2014-06-01|June 2014|2014-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|TRIBE||Tayside Rehabilitation in Bronchiectasis Exacerbations (TRIBE) : a Randomized Controlled Trial|A Randomized Controlled Trial of Pulmonary Rehabilitation After Exacerbations of Bronchiectasis|Unknown status|Recruiting|N/A|40|Anticipated|NHS Tayside||2|||f||||f||||||||||2017-10-11 00:15:31.163996|2017-10-11 00:15:31.163996
NCT02179970|ClinicalTrials.gov processed this data on October 10, 2017|2014-07-01|2017-07-20|||June 2015|Actual|2015-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CAM-PLEX||To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers|To Assess the Safety of Continuous IV Administration of the CXCR4 Antagonist, Plerixafor (Mozobil), and Assess Its Impact on the Immune Microenvironment in Patients With Advanced Pancreatic, High Grade Serous Ovarian and Colorectal Adenocarcinomas.|Recruiting||Phase 1|28|Anticipated|Cambridge University Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 00:15:31.263873|2017-10-11 00:15:31.263873
NCT02179957|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-07-01|||June 2014||2014-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Visual Estimation of Coronary Fractional Flow Reserve From High-definition Computed Tomographic Coronary Angiography|Visual Estimation of Coronary Fractional Flow Reserve From High-definition Computed Tomographic Coronary Angiography|Completed||N/A|85|Actual|Plymouth Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 00:15:31.357155|2017-10-11 00:15:31.357155
NCT02179944|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-08-14|||July 2014||2014-07-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion|Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion: A Prospective Physiologic Study|Completed||N/A|66|Actual|Planned Parenthood League of Massachusetts|||1||f||||f||||||||||2017-10-11 00:15:31.437069|2017-10-11 00:15:31.437069
NCT02179931|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-09-03|||June 2014||2014-06-01|September 2014|2014-09-01||||July 2014|Actual|2014-07-01||Interventional|||Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)|Interventional, Single Dose, Open-label, Randomised, Crossover, Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)|Completed||Phase 1|30|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 00:15:31.662171|2017-10-11 00:15:31.662171
NCT02179918|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-03-16|||August 19, 2014|Actual|2014-08-19|March 2017|2017-03-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Interventional|||A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)|A Phase 1b Study Of The 4-1bb Agonist Pf-05082566 In Combination With The Pd-1 Inhibitor Mk-3475 In Patients With Advanced Solid Tumors|Completed||Phase 1|23|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:15:31.752593|2017-10-11 00:15:31.752593
NCT02179905|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-07-01|||January 2013||2013-01-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Brain Imaging, Heart Rate Variability and Serum Fatty Acid in Subjects With Irritable Bowel Syndrome|Brain Imaging, Heart Rate Variability and Serum Fatty Acid in Subjects With Irritable Bowel Syndrome|Completed||N/A|69|Actual|Shin Kong Wu Ho-Su Memorial Hospital|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 00:15:31.865693|2017-10-11 00:15:31.865693
NCT02179879|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-08-26|||November 2013||2013-11-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Development and Validation of Metrics Lumbar Labor Epidural Catheter Placement|Protocol for Development and Validation of Metrics for Conventional Lumbar Epidural Catheter Placement for Labor Analgesia in Obstetric Patients|Completed||N/A|20|Actual|Cork University Hospital|||1||f||||f||||||||||2017-10-11 00:15:32.355905|2017-10-11 00:15:32.355905
NCT02179866|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-11-01|||June 2014||2014-06-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Single-center Study to Investigate How Quickly and to What Extent a Radioactive Dose of RO5285119 is Absorbed, Metabolized and Eliminated From the Body of Healthy Male Volunteers|SINGLE-CENTER, OPEN-LABEL, NON-RANDOMIZED STUDY INVESTIGATING THE EXCRETION BALANCE, PHARMACOKINETICS AND METABOLISM OF A SINGLE ORAL DOSE OF [14C]-LABELED RO5285119 IN HEALTHY MALE SUBJECTS|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:15:32.444386|2017-10-11 00:15:32.444386
NCT02179853|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2016-05-11|||November 2014||2014-11-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease|Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease|Recruiting||Phase 1/Phase 2|10|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:15:32.524565|2017-10-11 00:15:32.524565
NCT02179840|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-01-26|||March 2015||2015-03-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|June 2015|Anticipated|2015-06-01||Interventional|CHS-Brain||Assessment of Cerebral Microvascular Circulation|Assessment of Coherent Hemodynamics Spectroscopy (CHS) as a New Tool for Monitoring Cerebral Blood Flow and Autoregulation at the Microvascular Level|Unknown status|Not yet recruiting|N/A|30|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:15:32.645604|2017-10-11 00:15:32.645604
NCT02179827|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-05-26|||October 2017|Anticipated|2017-10-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Observational|||Performance of Non-Invasive Monitors During ANH|The Evaluation of Minimally Invasive Hemodynamic Monitors for the Assessment of Volume Responsiveness to Various Standard Replacement Fluids During Acute Normovolemic Hemodilution|Recruiting||N/A|30|Anticipated|University of California, Davis|||1||f||||f||||||||||2017-10-11 00:15:32.755783|2017-10-11 00:15:32.755783
NCT02179814|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-09-27|||February 20, 2012|Actual|2012-02-20|September 2017|2017-09-01|May 2022|Anticipated|2022-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls|Neuronal Correlates of Catecholamine Depletion in Patients With Bulimia Nervosa Off Medication and Healthy Controls|Suspended||N/A|60|Anticipated|University of Bern||2||Conduct of the first analyses|f||||f||||||||||2017-10-11 00:15:32.840656|2017-10-11 00:15:32.840656
NCT02179801|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-01-05|||March 2014||2014-03-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|SCAN||Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)|Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)|Recruiting||N/A|1000|Anticipated|Technische Universität München|||1||f||||f||||||||||2017-10-11 00:15:32.970928|2017-10-11 00:15:32.970928
NCT02179788|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-09-02|||June 2014||2014-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|MALMS||Metformin to Augment Low Milk Supply (MALMS) Study|Metformin to Augment Low Milk Supply in Pre-diabetic Mothers, a Phase I/II Randomized Clinical Trial|Completed||Phase 1/Phase 2|15|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 00:15:33.099333|2017-10-11 00:15:33.099333
NCT02179775|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-09|||July 2014||2014-07-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||"Effect of Sekanjabin e Safarjali (Quince Oxymel) in the Prevention of Migraine Attacks"|"Comparison of Effectiveness of Sekanjabin e Safarjali (Quince Oxymel), Propranolol and Placebo in the Prevention of Migraine Attacks in Patients With Simultaneous Upper Gastrointestinal Dysfunction"|Unknown status|Recruiting|N/A|45|Anticipated|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-10-11 00:15:33.228567|2017-10-11 00:15:33.228567
NCT02179762|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2017-05-15|||August 2014||2014-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EASE||Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer|Enhancing Active Surveillance With Exercise (EASE): A Pilot Randomized Trial in Localized Prostate Cancer Survivors|Suspended||N/A|30|Anticipated|Case Comprehensive Cancer Center||3||Insufficient staff|f||||f|f|f||||||||2017-10-11 00:15:33.351791|2017-10-11 00:15:33.351791
NCT02179749|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-10-03|||September 2014||2014-09-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Mifepristone Treatment of Alcohol Use Disorder|Glucocorticoid Antagonist Treatment of Alcohol Use Disorder|Recruiting||Phase 2|150|Anticipated|The Scripps Research Institute||3|||f||||f||||||||||2017-10-11 00:15:33.511486|2017-10-11 00:15:33.511486
NCT02179736|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-01-12|||July 2014||2014-07-01|February 2015|2015-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Post Market Evaluation After Treatment of Nasolabial Folds||Completed||N/A|114|Actual|Q-Med AB||1|||f||||f||||||||||2017-10-11 00:15:33.638765|2017-10-11 00:15:33.638765
NCT02179723|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-06-30|||March 2012||2012-03-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||Clinical Study Into the Cosmetic Results of Leukosan Adhesive|Clinical Study Into the Cosmetic Results of Leukosan Adhesive vs. Transcutaneous Wound Suture With Laparoscopic Trocar Incision|Completed||N/A|77|Actual|BSN Medical GmbH||2|||f||||f||||||||||2017-10-11 00:15:33.721381|2017-10-11 00:15:33.721381
NCT02179710|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-09-07|||March 2015||2015-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study|Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study|Completed||N/A|18|Actual|Landon Pediatric Foundation|||1||f||||f||||||||Yes|Will be made available to other users of PARI blue tooth monitoring|2017-10-11 00:15:33.817957|2017-10-11 00:15:33.817957
NCT02179697|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-01-14|||August 2014||2014-08-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Randomized Trial With an Observational Component of Non-operative Versus Operative Treatment for AO Type A3 Fractures|Radiographic and Clinical Outcomes Following Non-operative Versus Operative Treatment of AO Type A3 Fractures: A Prospective, Randomized Clinical Trial With an Observational Component|Withdrawn||N/A|0|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 00:15:33.940026|2017-10-11 00:15:33.940026
NCT02179684|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-06-30|||November 2013||2013-11-01|June 2014|2014-06-01|November 2019|Anticipated|2019-11-01|February 2018|Anticipated|2018-02-01||Interventional|||Surgery or Clincial Follow up, in Patients With Bell' s Palsy|Surgery or Clinical Follow-up in Patients With Bell's Palsy. A Prospective, Parallell, Single Center, Randomized , Open Surgery Clinical Study.|Enrolling by invitation||N/A|150|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:15:34.052551|2017-10-11 00:15:34.052551
NCT02179658|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2016-09-27|||May 2014||2014-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)|OPT-80 Phase III Study -A Multi-center, Double Blinded, Randomized, Parallel Group Study To Compare The Safety, Pharmacokinetics And Efficacy of OPT-80 With Vancomycin In Subjects With Clostridium Difficile-Associated Diarrhea (CDAD)|Completed||Phase 3|210|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 00:15:34.289524|2017-10-11 00:15:34.289524
NCT02179645|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-12-29|||May 2014||2014-05-01|June 2014|2014-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers|A Three-Part, Phase I Study Of Orally Administered GRC 27864, A Novel, Microsomal Prostaglandin E Synthase-1 Enzyme (mPGES-1) Inhibitor, To Evaluate The Safety, Tolerability And PK Of Single Ascending Doses In Healthy, Adult Subjects (Part 1a), And Of A Single Dose In Elderly Subjects (Part 2); The Effect Of Food On PK (Part 1b) In Healthy, Adult Subjects; And To Compare The Effects On Prostanoid Metabolism With Celecoxib (Part 3) In Healthy, Adult Subjects.|Completed||Phase 1|76|Actual|Glenmark Pharmaceuticals Ltd. India||3|||f||||f||||||||||2017-10-11 00:15:34.420652|2017-10-11 00:15:34.420652
NCT02179632|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-01|||January 2014||2014-01-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Disclosure of Industry Payments to Physicians and the Patient-Doctor Relationship|Disclosure of Industry Payments to Physicians and the Patient-Doctor Relationship|Completed||N/A|278|Actual|Harvard Medical School||4|||f||||f||||||||||2017-10-11 00:15:34.509739|2017-10-11 00:15:34.509739
NCT02179619|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-06-30|||December 2012||2012-12-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Dermalax(Deep) in Correction of Nasolabial Folds|A Randomized, Multi-center, Patient & Evaluator-blind, Matched Pairs, Active-controlled Design Clinical Study to Evaluate the Efficacy and Safety of Injection With Dermalax(Deep) as Compared to Restylane® in Correction of Nasolabial Fold|Completed||Phase 3|66|Actual|Across Co.,Ltd.||2|||f||||||||||||||2017-10-11 00:15:34.608987|2017-10-11 00:15:34.608987
NCT02179606|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2014-07-04|||July 2013||2013-07-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus|A Multi-Center, Randomized, Subject and Evaluator Blind, Split-Face Comparative Medical Device Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus to Restylane® Sub-Q for Correction of Nasolabial Folds|Completed||Phase 3|60|Actual|Across Co.,Ltd.||2|||f||||||||||||||2017-10-11 00:15:34.712008|2017-10-11 00:15:34.712008
NCT02179411|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-06-27|||April 2009||2009-04-01|April 2009|2009-04-01|March 2013|Actual|2013-03-01|April 2009|Actual|2009-04-01||Interventional|ortho_rein||Study of the Renal Perfusion in Healthy Volunteers and Renal Transplant Recipients During an Orthostatic Stress|Study of the Renal Perfusion in Healthy Volunteers and Renal Transplant Recipients During an Orthostatic Stress|Completed||N/A|60|Actual|University Hospital, Angers||3|||f||||t||||||||||2017-10-11 00:15:36.593324|2017-10-11 00:15:36.593324
NCT02179593|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2016-03-14|||September 2013||2013-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|3S/2S_SARPE||Effectiveness of SARPE With 3 and 2-Segment Technique: A Randomized Clinical Trial|Effectiveness of Surgically Assisted Rapid Palatal Expansion (SARPE) With 3 and 2-Segment Technique: A Randomized Clinical Trial|Active, not recruiting||N/A|50|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 00:15:34.815398|2017-10-11 00:15:34.815398
NCT02179580|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-06-30|||June 2014||2014-06-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study of Xiang-Sha-Liu-Jun-Zi-Tang in Patients With Irritable Bowel Syndrome|A Randomized Double Blind Placebo Control Study of Xiang-Sha-Liu-Jun-Zi-Tang (XSLJZT)in Patients With Irritable Bowel Syndrome|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 00:15:34.917106|2017-10-11 00:15:34.917106
NCT02179567|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-30|2015-09-25|||March 2010||2010-03-01|September 2015|2015-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC|First Line Treatment of Elderly Patients With Advanced or Metastatic NSCLC With Docetaxel and Bevacizumab|Terminated||Phase 2|26|Actual|Hellenic Oncology Research Group||1||Terminated due to poor accrual|f||||f||||||||||2017-10-11 00:15:35.003858|2017-10-11 00:15:35.003858
NCT02179554|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-02-09|||October 2014||2014-10-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Observational|Anosmia||Does Cardiopulmonary Bypass Change Olfaction?|Does Cardiopulmonary Bypass Change Olfaction?|Unknown status|Recruiting|N/A|50|Anticipated|Central Manchester University Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 00:15:35.076561|2017-10-11 00:15:35.076561
NCT02179541|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-07-01|||January 2013||2013-01-01|January 2013|2013-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||A Novel Objective Diagnostic Test for Otitis Media With Effusion|RGB Measurements as a Novel Objective Diagnostic Test for Otitis Media With Effusion|Completed||N/A|52|Actual|Bezmialem Vakif University|||4||f||||f||||||||||2017-10-11 00:15:35.138171|2017-10-11 00:15:35.138171
NCT02179528|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-09-10|||September 2014||2014-09-01|June 2014|2014-06-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)|Phase 2 Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer|Unknown status|Not yet recruiting|Phase 2|210|Anticipated|Beijing Cancer Hospital||2|||f||||||||||||||2017-10-11 00:15:35.210061|2017-10-11 00:15:35.210061
NCT02179515|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2017-07-26|||June 24, 2014||2014-06-24|April 6, 2017|2017-04-06|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|||Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)|An Open Label Phase I Study to Evaluate the Safety and Tolerability of a Modified Vaccinia Ankara (MVA) Based Vaccine Modified to Express Brachyury and T-Cell Costimulatory Molecules (MVA Brachyury-TRICOM)|Completed||Phase 1|38|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:15:35.445442|2017-10-11 00:15:35.445442
NCT02179502|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2015-09-20|||June 2014||2014-06-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||First-in-Human Single and Multiple Dose of GLPG1690|Randomized, Double-blind, Placebo-controlled, Dose-escalation Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of GLPG1690 in Healthy Male Subjects|Completed||Phase 1|40|Actual|Galapagos NV||4|||f||||f||||||||||2017-10-11 00:15:35.547897|2017-10-11 00:15:35.547897
NCT02179489|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2017-04-04|||October 2014||2014-10-01|June 2016|2016-06-01|October 2023|Anticipated|2023-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Trial Evaluating Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis|Randomized Multicentric Phase III Trial Comparing Simple Surgery to Surgery Plus HIPEC (Hyperthermic Intraperitoneal Chemotherapy) With MMC in Colorectal Patients Who Have a High Risk of Developing Colorectal Peritoneal Carcinomatosis|Recruiting||Phase 3|300|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-10-11 00:15:35.652695|2017-10-11 00:15:35.652695
NCT02179476|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-06-05|||June 2014||2014-06-01|June 2017|2017-06-01|December 2024|Anticipated|2024-12-01|July 2017|Anticipated|2017-07-01||Interventional|DUET||A Multi-Site Study of the Zyga GlyDer Facet Restoration Device In Subjects With LUmbar FacET Pain Syndrome - DUET|A Multi-Site Study of the Zyga GlyDer Facet Restoration Device In Subjects With LUmbar FacET Pain Syndrome (DUET)|Recruiting||Phase 1|20|Anticipated|Zyga Technology, Inc.||1|||f||||t||||||||||2017-10-11 00:15:35.799661|2017-10-11 00:15:35.799661
NCT02179463|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2014-12-06|||June 2014||2014-06-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|5 Years|Observational [Patient Registry]|||Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric Cancer|A Multicenter Clinical Registry to Compare Different Patterns of Response Evaluation to Neoadjuvant Chemotherapy for Gastric Cancer|Recruiting||N/A|150|Anticipated|Peking University|||1||f||||t||||||Samples Without DNA|"     Tumor, Blood Sample   "|||2017-10-11 00:15:35.913199|2017-10-11 00:15:35.913199
NCT02179450|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2014-06-30|||August 2012||2012-08-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|||Cognitive Function and Emotional Possessing in Bilateral Facial Palsy|Pilot Study Assessing Cognitive Function and Emotional Possessing in Patients With Bilateral Facial Palsy|Completed||N/A|84|Actual|Medical University of Vienna|||4||f||||f||||||||||2017-10-11 00:15:36.004585|2017-10-11 00:15:36.004585
NCT02179437|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-06-27|||July 2014||2014-07-01|June 2014|2014-06-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Observational|||Intraoperative TIVA With Propofol on Postoperative Pain and Side Effects After Liver Resection Surgery|Retrospective Study to Investigate Intraoperative TIVA With Propofol on Postoperative Pain and Side Effects After Liver Resection Surgery|Unknown status|Not yet recruiting|N/A|1000|Anticipated|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 00:15:36.079002|2017-10-11 00:15:36.079002
NCT02179424|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-10-31|2016-03-01||December 2012||2012-12-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Promoting Tobacco Control and Smoking Cessation in Workplaces [Phase I]|Assessing the Corporate Environment in Promoting Tobacco Control and Evaluation of a Smoking Cessation Programme in Workplaces in Hong Kong|Completed||N/A|642|Actual|The University of Hong Kong|The study did not randomize subjects to the intervention groups and had no control group. The 4 groups could not be assumed to be comparable. The sample size of each group varied greatly, which undermined the predictive power of the interventions.|4|||f||||t||||||||||2017-10-11 00:15:36.180689|2017-10-11 00:15:36.180689
NCT02179398|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-10-26|2014-10-21||September 2010||2010-09-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Impact of the Lab-score on Antibiotic Prescription Rate in Children With Fever Without Source|Impact of the Lab-score on Antibiotic Prescription Rate in Children Aged 7 Days to 3 Years Old With Fever Without Source.|Completed||N/A|278|Actual|University Hospital, Geneva|"heterogeneity in the total number of participating physicians (30)
recruitment in a tertiary care center (recruitment bias)"|2|||f||||f||||||||||2017-10-11 00:15:36.682262|2017-10-11 00:15:36.682262
NCT02179385|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-08-04|||June 2014||2014-06-01|August 2015|2015-08-01||||June 2016|Anticipated|2016-06-01||Interventional|CHANGE-D||Empowerment and Support for the Diabetic Patient|Coaching for Health to Achieve New Goals in Empowerment for Diabetes|Unknown status|Active, not recruiting|N/A|300|Anticipated|Clalit Health Services||2|||f||||||||||||||2017-10-11 00:15:37.153359|2017-10-11 00:15:37.153359
NCT02179372|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2016-11-28|||June 2014||2014-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases|Modulation of Fecal Calprotectin by Eicosapentaenoic Free Fatty Acid in Inflammatory Bowel Diseases|Completed||N/A|60|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||f||||||||||2017-10-11 00:15:37.23966|2017-10-11 00:15:37.23966
NCT02179359|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-10-04|||September 2, 2014|Actual|2014-09-02|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies|MT2014-10C: Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders|Recruiting||N/A|25|Anticipated|Masonic Cancer Center, University of Minnesota||3|||f||||t|f|f|||f|||||2017-10-11 00:15:37.316008|2017-10-11 00:15:37.316008
NCT02179346|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-06-23|||December 2014||2014-12-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|HIP-ACTION||Observational Study With NOVOCART® Inject in the Reconstruction of the Hip Joint With Full Thickness Cartilage Defects|Observational Study on the Feasibility, Safety and Efficacy in the Biological Reconstruction of the Hip Joint With Full Thickness Cartilage Defects With an in Situ Polymerizable and Chondrocyte Populated Biomaterial (NOVOCART® Inject)|Active, not recruiting||N/A|21|Actual|Tetec AG|||1||f||||f||||||||No||2017-10-11 00:15:37.41632|2017-10-11 00:15:37.41632
NCT02179333|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-06-28|||October 2012||2012-10-01|June 2016|2016-06-01||||June 2016|Actual|2016-06-01||Observational|STAND||Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)|Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)|Completed||N/A|30|Actual|University of South Florida|||1||f||||f||||||||||2017-10-11 00:15:37.496851|2017-10-11 00:15:37.496851
NCT02179320|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-06-30|||February 2014||2014-02-01|January 2014|2014-01-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Evaluation of the Efficacy and Neurological Effects of Dry Needling in the Treatment of Myofascial Pain Syndrome|Evaluation of the Efficacy and Neurological Effects of Dry Needling in the Treatment of Myofascial Pain Syndrome|Unknown status|Active, not recruiting|N/A|40|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 00:15:37.581839|2017-10-11 00:15:37.581839
NCT02179307|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-11-05|||August 2014||2014-08-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Individual Response to Different Volumes of Resistance Training|Determinants of Intra-individual Variation in Adaptability to Resistance Training of Different Volumes|Completed||N/A|42|Actual|Inland Norway University of Applied Sciences||1|||f||||t||||||||||2017-10-11 00:15:37.684217|2017-10-11 00:15:37.684217
NCT02179294|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-10-06|||May 2014||2014-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|RESPITE||A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour|A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour|Completed||Phase 4|401|Actual|University of Birmingham||2|||f||||t||||||||||2017-10-11 00:15:37.779643|2017-10-11 00:15:37.779643
NCT02179281|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-28|2015-03-09|||October 2014||2014-10-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|SportGuard||Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children|Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Medtronic MiniMed™ 640G Sensor Augmented Insulin Pump in Children - The SportGuard Study|Completed||N/A|100|Actual|University of Ljubljana, Faculty of Medicine||2|||f||||f||||||||||2017-10-11 00:15:37.91135|2017-10-11 00:15:37.91135
NCT02179268|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-28|||March 2012||2012-03-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Antidepressants and Bone Mineral Density|International Committee of Medical Journal Editors|Completed||Phase 3|203|Actual|Guiyang Medical University||4|||f||||t||||||||||2017-10-11 00:15:38.013185|2017-10-11 00:15:38.013185
NCT02179255|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2017-07-11|||August 2014||2014-08-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF|An Open-Label Randomized Controlled Trial (RCT) of 6 Weeks of Human Growth Hormone (HGH) Prior to Ovulation Induction for In Vitro Fertilization (IVF)|Enrolling by invitation||Phase 1/Phase 2|30|Anticipated|Center for Human Reproduction||2|||f||||f||||||||||2017-10-11 00:15:38.129747|2017-10-11 00:15:38.129747
NCT02179242|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-11-17|||September 2014||2014-09-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study to Evaluate the Effectiveness of Cardiac Rehabilitation (Rehab) for Acute Decompensated Heart Failure Patients on 6 Minute Walk Test and Quality of Life|Randomized, Single Center Study to Determine if a Cardiac Rehabilitation Program Immediately Following Hospitalization Reduces Hospital Readmissions and Improves Quality of Life Outcomes in Heart Failure Patients.|Terminated||N/A|6|Actual|Sanford Health||2||Lower than expected accrual|f||||f||||||||||2017-10-11 00:15:38.248907|2017-10-11 00:15:38.248907
NCT02179229|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-01|||June 2014||2014-06-01|June 2014|2014-06-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Effect of Pre- and Probiotics on P-cresol Plasma Levels in Patients Bearing a Kidney Allograft|Effect of Pre- and Probiotics on P-cresol Plasma Levels in Patients Bearing a Kidney Allograft|Unknown status|Recruiting|N/A|30|Anticipated|Federico II University||2|||f||||f||||||||||2017-10-11 00:15:38.347995|2017-10-11 00:15:38.347995
NCT02179216|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-10-01|||July 2014||2014-07-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|CHHO||Evaluation of the Effect of Hydration About Orthostatic Hypotension in the Elderly. Difference With Venous Compression|Evaluation of the Effect of Hydration About Orthostatic Hypotension in the Elderly. Difference With Venous Compression. A Randomized Controlled Crossover Trial.|Unknown status|Recruiting|N/A|110|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-11 00:15:38.463273|2017-10-11 00:15:38.463273
NCT02179203|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-08-12|||July 2014||2014-07-01|June 2014|2014-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01|1 Day|Observational [Patient Registry]|||Changes in Doppler Signals From the Lung Due to Cardiac Resynchronization in Heart Failure Patients|Lung Doppler Signals Changes in Response to Cardiac Resynchronization in Heart Failure Patients|Completed||N/A|10|Anticipated|Echosense Ltd.|||1||f||||f||||||||||2017-10-11 00:15:38.568217|2017-10-11 00:15:38.568217
NCT02179190|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-10-03|||June 2014||2014-06-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of the Reverse Medical Barrel™ Vascular Reconstruction Device (VRD) for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/ Branching Aneurysms|Prospective, Multi-Center, Single-Arm Study of the Reverse Medical Barrel™ Vascular Reconstruction Device (VRD) for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/ Branching Aneurysms of Middle Cerebral and Basilar Arteries|Active, not recruiting||N/A|138|Actual|Medtronic Neurovascular Clinical Affairs||1|||f||||t||||||||No||2017-10-11 00:15:38.631948|2017-10-11 00:15:38.631948
NCT02179177|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-08-11|||January 2015||2015-01-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Apixaban in Patients With Sickle Cell Disease|Impact of Daily Prophylaxis Dose Anticoagulation With a Factor Xa Inhibitor (Apixaban) in Patients With Sickle Cell Disease|Active, not recruiting||Phase 3|60|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 00:15:38.702563|2017-10-11 00:15:38.702563
NCT02179151|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-01-24||2017-01-24|September 2014||2014-09-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Interventional|bestPWS||Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome|Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months|Terminated||Phase 3|108|Actual|Zafgen, Inc.||3||FDA Clinical Hold|f||||t||||||||No||2017-10-11 00:15:38.799798|2017-10-11 00:15:38.799798
NCT02179138|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-04-09||||||April 2015|2015-04-01||||March 2015|Actual|2015-03-01||Interventional|||Paper Applicator Acceptability Study|EVALUATION OF A USER-FILLED, PAPER APPLICATOR FOR DELIVERY OF TENOFOVIR 1% GEL AMONG WOMEN IN RURAL KWAZULU-NATAL, SOUTH AFRICA|Withdrawn||Phase 1/Phase 2|0|Actual|CONRAD||1||Study no longer relevant based on change in regulatory pathway for TFV 1% gel|f||||f||||||||||2017-10-11 00:15:38.959201|2017-10-11 00:15:38.959201
NCT02179125|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-06-26|||March 2015||2015-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|REACTION||Identifying REsponders and Exploring Mechanisms of ACTION of the Endobronchial Coil Treatment for Emphysema|Identifying REsponders and Exploring Mechanisms of ACTION of the Endobronchial Coil Treatment for Emphysema|Recruiting||N/A|48|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 00:15:39.720008|2017-10-11 00:15:39.720008
NCT02179112|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2014-07-02|||July 2014||2014-07-01|July 2014|2014-07-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01|30 Days|Observational [Patient Registry]|GlobalSurg-1||Determining Universal Processes Related to Best Outcome in Emergency Gastrointestinal Surgery: an International Evaluation||Unknown status|Recruiting|N/A|2500|Anticipated|University of Edinburgh|||1||f||||f||||||||||2017-10-11 00:15:39.84781|2017-10-11 00:15:39.84781
NCT02179099|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2016-02-28|||July 2014||2014-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients|Pilot Study Evaluating Safety and Efficacy of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in OAB Patients|Terminated||Phase 1/Phase 2|3|Actual|UroGen Pharma Ltd.||1||"Decision to open a randomized controlled trial with two groups receiving different Botulinum   Toxin in comparison to placebo group."|f||||f||||||||||2017-10-11 00:15:39.947895|2017-10-11 00:15:39.947895
NCT02179086|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-09-06|||October 27, 2014|Actual|2014-10-27|September 2017|2017-09-01|May 2024|Anticipated|2024-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma|Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma|Recruiting||Phase 2|606|Anticipated|NRG Oncology||4|||f||||t||||||||||2017-10-11 00:15:40.096287|2017-10-11 00:15:40.096287
NCT02179073|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-11-21|||December 2007||2007-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Health-related Quality of Life of Patients With Neurogenic Bladder|Effects of Bladder Management on Health-related Quality of Life in Patients With Neurogenic Bladder|Enrolling by invitation||N/A|250|Anticipated|Swiss Paraplegic Centre Nottwil|||1||f||||f||||||||||2017-10-11 00:15:41.367443|2017-10-11 00:15:41.367443
NCT02179060|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-04-28|||June 2014||2014-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|COOLCAMRI||Prehospital Resuscitation Intranasal Cooling Effects Seen in MRI of the Brain After Cardiac Arrest|Prehospital Resuscitation Intranasal Cooling Effects Seen in Magnetic Resonance Imaging of the Brain After Cardiac Arrest|Active, not recruiting||N/A|10|Anticipated|Tampere University Hospital|||2||f||||f||||||||||2017-10-11 00:15:41.431277|2017-10-11 00:15:41.431277
NCT02179047|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-04-14|||June 2014||2014-06-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Observational|||Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases||Completed||N/A|120|Actual|Taipei City Hospital|||1||f||||f||||||Samples Without DNA|"     ELISA kit for Human Galectin-3 Quantikine ELISA Kit (R&D system, Minneapolis, Mn)、Human     ST2/IL-1 R4 Quantikine ELISA Kit(R&D system, Minneapolis, Mn)、Human Cystatin C Quantikine     ELISA Kit(R&D system, Minneapolis, Mn)、 Human Lipocalin-2/NGAL Quantikine ELISA Kit(R&D     system, Minneapolis, Mn)、Human midregional pro-atrial natriuretic peptide(MR-proANP) ELISA     Kit(Cusabio, China, Cn)、Soluble ST2/IL-1R4 (HUMAN) Elisa Kit(AvisceraBioscience, Santa     Clara,Ca)   "|||2017-10-11 00:15:41.519927|2017-10-11 00:15:41.519927
NCT02179034|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-09-22|||October 23, 2014|Actual|2014-10-23|September 2017|2017-09-01|June 12, 2017|Actual|2017-06-12|July 18, 2016|Actual|2016-07-18||Interventional|||Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1|Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1|Completed||Phase 1|60|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 00:15:41.602137|2017-10-11 00:15:41.602137
NCT02179021|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-11-30|||January 2014||2014-01-01|June 2014|2014-06-01|May 2015|Actual|2015-05-01|August 2014|Actual|2014-08-01||Observational|||Haemostasis and Therapeutic Hypothermia|Is Haemostasis Impaired in Cardiac Arrest Patients During Therapeutic Hypothermia?|Completed||N/A|26|Actual|University of Aarhus|||1||f||||f||||||Samples Without DNA|"     Whole blood.   "|||2017-10-11 00:15:41.705581|2017-10-11 00:15:41.705581
NCT02179008|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-03-04|||June 2014||2014-06-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SEE-1||Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension||Completed||Phase 2|184|Actual|Santen Inc.||6|||f||||f||||||||||2017-10-11 00:15:41.794966|2017-10-11 00:15:41.794966
NCT02178995|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-04-26|2016-06-04||August 2014||2014-08-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional||Total number of individuals who signed consents = 55. 4 of these individuals with epilepsy signed their consent but did not follow through and participate in the study. The remaining 51 (35 epilepsy, 16 controls) are represented here.|Methylphenidate Treatment of Attention Deficits in Epilepsy|Methylphenidate Treatment of Attentional and Cognitive Deficits in Epilepsy|Completed||Phase 4|55|Actual|Stanford University|Relatively small sample; Control is healthy patients rather than epilepsy patients; Healthy controls improve more on re-testing than epilepsy patients; Single-dose portion does not mirror clinical practice; open-label portion is not blinded.|9|||f||||f||||||||||2017-10-11 00:15:42.005787|2017-10-11 00:15:42.005787
NCT02178982|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-06-23|||May 2014||2014-05-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|APT||Standard Treatment Compliance of Participants, Effectiveness and Prognosis in Acute Respiratory Distress Syndrome|Standard Treatment Compliance of Participants, Effectiveness and Prognosis in Acute Respiratory Distress Syndrome|Completed||Phase 4|134|Actual|Southeast University, China|||2||f||||f||||||||||2017-10-11 00:15:43.556957|2017-10-11 00:15:43.556957
NCT02178969|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-05-28|||June 2014||2014-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|||Short Term Observational Study in DEB Patients|A Prospective Short-term Study to Evaluate Methodologies for the Assessment of Disease Extent, Impact, and Wound Evolution in Patients With Dystrophic Epidermolysis Bullosa (DEB)|Completed||N/A|29|Actual|Shire|||1||f||||f||||||Samples With DNA|"     Optional genetic test for DEB diagnosis   "|||2017-10-11 00:15:43.63042|2017-10-11 00:15:43.63042
NCT02178956|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2016-12-18|||August 2014||2014-08-01|December 2016|2016-12-01||||August 2017|Anticipated|2017-08-01||Interventional|BRIGHTER||A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer|A Phase III Clinical Trial of BBI608 Plus Weekly Paclitaxel vs. Placebo Plus Weekly Paclitaxel in Adult Patients With Advanced, Previously Treated Gastric and Gastro-Esophageal Junction Adenocarcinoma|Active, not recruiting||Phase 3|700|Anticipated|Boston Biomedical, Inc||2|||f||||t||||||||||2017-10-11 00:15:43.749356|2017-10-11 00:15:43.749356
NCT02178943|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-08-10|||June 2014||2014-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|D-OAR||Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling|Utility of Donor-Derived Cell-free DNA in Association With Gene-Expression Profiling (AlloMap®) in Heart Transplant Recipients (D-OAR)|Recruiting||N/A|100|Anticipated|CareDx|||1||f||||f||||||Samples With DNA|"     donor derived cf-DNA   "|||2017-10-11 00:15:46.220455|2017-10-11 00:15:46.220455
NCT02178930|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-29|2017-08-28|||August 1, 2014|Actual|2014-08-01|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|March 31, 2017|Actual|2017-03-31||Interventional|||HealthMap: an Interactive Health Plan Randomised Trial to Prevent Cardiovascular Disease in People With HIV|HealthMap: a Cluster Randomised Trial of Interactive Health Plans and Self-management Support to Prevent Cardiovascular Disease in People With HIV|Completed||N/A|731|Actual|Monash University||2|||f||||f||||||||||2017-10-11 00:15:46.415824|2017-10-11 00:15:46.415824
NCT02178917|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-08-16|||August 27, 2014|Actual|2014-08-27|August 2017|2017-08-01||||August 2017|Anticipated|2017-08-01||Interventional|||Neurofeedback for Treatment of Central Neuropathic Pain (CNP) in Sub-acute Spinal Cord Injury (SCI)|Neurofeedback Treatment of Central Neuropathic Pain (CNP) in Sub-acute Patients With Spinal Cord Injury (SCI)|Recruiting||N/A|60|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f||||||||||2017-10-11 00:15:46.533992|2017-10-11 00:15:46.533992
NCT02178904|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-05-19|||March 2014||2014-03-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|DECIDE-Gold||"Dual Energy CT for Ischemia Determination Compared to Gold Standard Non-Invasive and Invasive Techniques"|"Dual Energy Computed Tomography for Ischemia Determination Compared to Gold Standard Non-Invasive and Invasive Techniques"|Active, not recruiting||N/A|156|Anticipated|Weill Medical College of Cornell University|||1||f||||t||||||||Undecided||2017-10-11 00:15:46.612244|2017-10-11 00:15:46.612244
NCT02178878|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-06-27|||May 2014||2014-05-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Genetic and Demographic Factors That Influence the Pain and Progress of Labor|Genetic and Demographic Factors That Influence the Pain and Progress of Labor|Unknown status|Recruiting|N/A|800|Anticipated|University of Virginia|||1||f||||f||||||Samples With DNA|"     Blood sample for DNA   "|||2017-10-11 00:15:46.795387|2017-10-11 00:15:46.795387
NCT02178865|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-03-16|||June 2014||2014-06-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|December 2015|Actual|2015-12-01||Observational|||Predicting Normal vs. Carrier Status in Euploid Embryos of Translocation Carriers|Evaluation of the Accuracy of Predicting Normal or Carrier Status in Euploid Embryos Produced by Patients With Balanced Translocations|Completed||N/A|11|Actual|Reproductive Medicine Associates of New Jersey|||1||f||||f||||||Samples With DNA|"     buccal swabs and whole blood   "|No||2017-10-11 00:15:47.046883|2017-10-11 00:15:47.046883
NCT02178852|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-06-27|||August 2014||2014-08-01|June 2014|2014-06-01||||August 2015|Anticipated|2015-08-01||Interventional|TNS-nicotine||TNS for Treating Nicotine Craving|Effect of Trigeminal Nerve Stimulation (TNS) on Nicotine Craving: Phase II, Cross-over, Randomized, Sham-controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 1/Phase 2|22|Anticipated|Santa Casa Medical School||2|||f||||f||||||||||2017-10-11 00:15:47.135427|2017-10-11 00:15:47.135427
NCT02178839|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-27|||July 2014||2014-07-01|June 2014|2014-06-01||||March 2015|Anticipated|2015-03-01||Interventional|||The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease|The Effect of Oral β- Glucan Supplement on Anthropometric Measurements, Appetite, Insulin Resistance, Liver Echogenicity and Enzymes in Non Alcoholic Fatty Liver Disease Treating With Hypocaloric Diet and Vitamin E|Unknown status|Not yet recruiting|N/A|48|Anticipated|Urmia University of Medical Sciences||2|||f||||||||||||||2017-10-11 00:15:47.252082|2017-10-11 00:15:47.252082
NCT02178826|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-05-19|||January 2014||2014-01-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|NERME||Nocturnal Enuresis and Rapid Maxillary Expansion|Nocturnal Enuresis and Rapid Maxillary Expansion - Long Term Effect, Prognostic Factors, Quality of Life and Sleep Quality|Recruiting||N/A|50|Anticipated|Uppsala University Hospital||2|||f||||f||||||||No||2017-10-11 00:15:47.374224|2017-10-11 00:15:47.374224
NCT02178813|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-06-07|||July 2014||2014-07-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Safety of High Dose Minocycline in the Patient Population Undergoing Carotid Revascularization|The Safety of High Dose Minocycline in the Patient Population Undergoing Carotid Revascularization. A Phase I Study|Terminated||Phase 1|6|Actual|University of Pittsburgh||1||Study stopped prematurely because of multiple logistic difficulties|f||||t||||||||||2017-10-11 00:15:47.479681|2017-10-11 00:15:47.479681
NCT02178800|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-05-01|||February 2015||2015-02-01|May 2017|2017-05-01||||April 2017|Actual|2017-04-01||Interventional|||Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults|A Phase IIa Study to Evaluate the Safety, Tolerability and Pharmacokinetics of the Investigational Injectable HIV Integrase Inhibitor, GSK1265744, in HIV-uninfected Men and Women|Active, not recruiting||Phase 2|194|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 00:15:47.573628|2017-10-11 00:15:47.573628
NCT02178787|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-04-04|2017-01-06||April 2014||2014-04-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|UTLight||UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation|UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation|Completed||N/A|60|Actual|Beth Israel Deaconess Medical Center|The data analysis has determined that UT_BF signal and UT_OX signals were unreliable and require further development on monitoring algorithm. No results to be reported.||2||f||||f||||||||||2017-10-11 00:15:47.732079|2017-10-11 00:15:47.732079
NCT02178774|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-30|||June 2014||2014-06-01|June 2014|2014-06-01||||January 2015|Anticipated|2015-01-01||Observational|||Evaluation the Perfusion of Uterus and Lower Extremities During Cesarean Section With NIRS and Color Doppler|Using Non-invasive Near-infrared Spectroscopy and Color Doppler to Evaluate the Relationship Between the Perfusion of Uterus and Gastrocnemius Muscles of the Parturients Receiving Cesarean Section|Unknown status|Not yet recruiting|N/A|40|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:15:48.039165|2017-10-11 00:15:48.039165
NCT02178761|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2014-06-30|||October 2012||2012-10-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|PERFECT||Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms|Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms: A Multi-modality, Multi-Specialty Collaborative Study (PERFECT Program)|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital||4|||f||||t||||||||||2017-10-11 00:15:48.114253|2017-10-11 00:15:48.114253
NCT02178748|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-01-29|||June 2014||2014-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TB036||Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents|A Phase II Open Label Trial to Investigate the Effect of Schistosoma Mansoni (Sm) Infection on the Immunogenicity of a Candidate TB Vaccine, MVA85A, in BCG-vaccinated African Adolescents|Completed||Phase 2|36|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 00:15:48.25775|2017-10-11 00:15:48.25775
NCT02178735|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-01-27|||May 2014||2014-05-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Clinical Outcomes and Urodynamic Effects After Vaginal Tailored Mesh Surgery for Pelvic Organ Prolapse|Clinical Outcomes and Urodynamic Effects After Vaginal Tailored Mesh Surgery for Pelvic Organ Prolapse|Completed||Phase 4|104|Actual|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-11 00:15:48.35361|2017-10-11 00:15:48.35361
NCT02178722|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-06-20|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|||A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037/ ECHO-202)|A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (KEYNOTE-037/ ECHO-202)|Recruiting||Phase 1/Phase 2|463|Anticipated|Incyte Corporation||2|||f||||t||||||||No||2017-10-11 00:15:48.451451|2017-10-11 00:15:48.451451
NCT02178709|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-01-26|||June 3, 2014|Actual|2014-06-03|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Phase II Study of Neoadjuvant FOLFIRINOX|A Phase II Study of Neoadjuvant FOLFIRINOX in Patients With Resectable Pancreatic Ductal Adenocarcinoma With Tissue Collection|Recruiting||Phase 2|48|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-11 00:15:48.600269|2017-10-11 00:15:48.600269
NCT02178683|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-06-27|||November 2010||2010-11-01|June 2014|2014-06-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression|Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression After Conditioning With Fludarabine and Low-Dose Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor HCT|Recruiting||Phase 3|50|Anticipated|Colorado Blood Cancer Institute||1|||f||||f||||||||||2017-10-11 00:15:48.796694|2017-10-11 00:15:48.796694
NCT02178670|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-06-01|||June 2014||2014-06-01|June 2014|2014-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine|Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic Adenocarcinoma of the Ovarian|Completed||Phase 1/Phase 2|40|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f||||t||||||||||2017-10-11 00:15:48.901576|2017-10-11 00:15:48.901576
NCT02178657|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-02-06|||April 2015||2015-04-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke|Intra-arterial Autologous Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke. A Phase II, Open-label, Multicenter, Randomized and Controlled Clinical Trial.|Recruiting||Phase 2|76|Anticipated|Andalusian Initiative for Advanced Therapies||3|||f||||f||||||||||2017-10-11 00:15:49.017856|2017-10-11 00:15:49.017856
NCT02178644|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-09-07|||July 2014||2014-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer|Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer|Recruiting||N/A|24|Anticipated|Yale University||1|||f||||t||||||||||2017-10-11 00:15:49.135295|2017-10-11 00:15:49.135295
NCT02178631|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-05-26|||February 2013||2013-02-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effectiveness of Internet-based Depression Treatment (EVIDENT) in Severe Depression||Completed||N/A|163|Actual|University of Luebeck||2|||f||||f||||||||||2017-10-11 00:15:49.238471|2017-10-11 00:15:49.238471
NCT02178618|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-06-27||||||June 2014|2014-06-01||||January 2006|Actual|2006-01-01||Interventional|||Partially Covered and Uncovered Metal Stent for Malignant Distal Biliary Stricture|A Randomized Trial of Partially Covered Versus Uncovered Self Expandable Metal Stents for the Palliation of Malignant Distal Biliary Stricture|Completed||N/A|||Ajou University School of Medicine||2|||f||||t||||||||||2017-10-11 00:15:49.54748|2017-10-11 00:15:49.54748
NCT02178605|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-10-31|||October 2008||2008-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||rhBMP-2 in Cervical Arthrodesis|A Prospective Non-Randomized Investigation Of The Use Of Infuse® (rhBMP-2) In Cervical Arthrodesis|Active, not recruiting||N/A|300|Actual|Virginia Spine Institute|||1||f||||f||||||||||2017-10-11 00:15:49.650535|2017-10-11 00:15:49.650535
NCT02178592|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-06-05|||January 1, 2015||2015-01-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 30, 2017|Anticipated|2017-12-30||Interventional|||Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection|ING117175: a Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir or Efavirenz Each Administered With Two NRTIs in HIV-1-infected Antiretroviral Therapy-naïve Adults Starting Treatment for Rifampicin-sensitive Tuberculosis|Active, not recruiting||Phase 3|115|Anticipated|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 00:15:49.766167|2017-10-11 00:15:49.766167
NCT02178579|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-09-14|||November 2014||2014-11-01|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|January 31, 2018|Anticipated|2018-01-31||Observational|PROTECT||Prospective Observation of Cardiac Safety With Proteasome Inhibition|Prospective Observation of Cardiac Safety With Proteasome Inhibition|Active, not recruiting||N/A|130|Actual|Vanderbilt University Medical Center|||2||f||||t||||||Samples With DNA|"     Blood sample banked for future research.   "|||2017-10-11 00:15:49.978931|2017-10-11 00:15:49.978931
NCT02178566|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2017-08-15|||August 2015|Actual|2015-08-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|July 2020|Anticipated|2020-07-01||Interventional|||Pulmonary Rehab in COPD: Response to Tyvaso|Pulmonary Rehabilitation in COPD: Response to Inhaled Treprostinil (Tyvaso)|Recruiting||Phase 2|34|Anticipated|Inova Health Care Services||2|||f||||t||||||||||2017-10-11 00:15:50.069358|2017-10-11 00:15:50.069358
NCT02178553|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-04-06|||August 2014||2014-08-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|||Study of Exparel Versus Epidural for Pain Control After Thoracotomy|Randomized Non-inferiority Trial of Continuous Thoracic Epidural Analgesia Versus Single Intercostal Nerve Block After Thoracotomy|Enrolling by invitation||Phase 4|140|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 00:15:50.187598|2017-10-11 00:15:50.187598
NCT02178540|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-04-14|2015-08-06||August 2014||2014-08-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients|A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules|Completed||Phase 4|45|Actual|Novartis|Participating patients were naïve to the Podhaler device, and untrained in its use. Patients accessed only the approved IFU document. Open label study using placebo only, potentially impacting perception of need to complete tasks fully.|1|||f||||f||||||||||2017-10-11 00:15:50.274325|2017-10-11 00:15:50.274325
NCT02178527|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-10-07|||January 2013||2013-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PIRFECT||Podiatry Intervention to Reduce Falls in Elderly Care Trial (PIRFECT)|A Podiatry Intervention to Reduce Falls in Care Home Residents: Development, Feasibility and Acceptability Study With Exploratory Randomised Controlled Trial|Completed||N/A|47|Actual|NHS Tayside||2|||f||||f||||||||||2017-10-11 00:15:50.525495|2017-10-11 00:15:50.525495
NCT02178514|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-01-26|||December 2014||2014-12-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|November 2016|Actual|2016-11-01||Interventional|||BabyNes Nutrition System Growth Study|Do Infants Fed With BabyNes™ System Grow in Agreement With the World Health Organization (WHO) Reference?|Active, not recruiting||N/A|120|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-11 00:15:50.6343|2017-10-11 00:15:50.6343
NCT02176980|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-05-16|||October 2014||2014-10-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|HepART-RCT||Hepatitis C Alcohol Reduction Treatment|Hepatitis C Alcohol Reduction Treatment - Randomized Controlled Trial (Hep ART-RCT)|Recruiting||N/A|279|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 00:16:14.077336|2017-10-11 00:16:14.077336
NCT02178501|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2016-11-27|||January 2013||2013-01-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.|The Effect of Omega-3 Polyunsaturated Acids Supplementation on Endothelial Function, Oxidative Stress, Platelet Aggregation, Blood Coagulation and Inflammation in Patients With Type 2 Diabetes and Cardiovascular Disease|Completed||N/A|126|Actual|Jagiellonian University||2|||f||||f||||||||||2017-10-11 00:15:50.701901|2017-10-11 00:15:50.701901
NCT02178488|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-02-28|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|D-STAPH||Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers|Vitamin D Supplementation to Persistent Carriers of MRSA - A Double Blind, Randomised Controlled Trial|Active, not recruiting||Phase 2|60|Actual|Karolinska University Hospital||2|||f||||f||||||||Undecided||2017-10-11 00:15:50.793588|2017-10-11 00:15:50.793588
NCT02178462|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-01-19|||June 2014||2014-06-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Biomarkers for Gynecologic Cancer|Evaluation of AminoIndex™ (Amino Metabolomic) As Biomarkers for Gynecologic Cancer in the U. S. Population|Recruiting||N/A|160|Anticipated|Ajinomoto Co., Inc.|||4||f||||f||||||Samples Without DNA|"     Subject blood samples (plasma and serum) will be collected for testing at a single visit   "|||2017-10-11 00:15:51.169441|2017-10-11 00:15:51.169441
NCT02178436|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-08-21|||October 2014||2014-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer|A Phase Ib/II Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330, Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer|Suspended||Phase 1/Phase 2|43|Anticipated|Barbara Ann Karmanos Cancer Institute||2||"Interim analysis to determine (Maximum Tolerated Dose) MTD reached; continued suspension by   FDA, insufficient info to assess risk to pts."|f||||t||||||||||2017-10-11 00:15:51.414313|2017-10-11 00:15:51.414313
NCT02178423|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-06-08|||June 2014||2014-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CVC||Feasibility Study of CVC Diagnosis Via Ultrasound in Children|Ultrasound Guided Diagnosis of Central Venous Catheters in Children: A Feasibility Study|Completed||N/A|20|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 00:15:51.556768|2017-10-11 00:15:51.556768
NCT02178410|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-09-29|||October 2012||2012-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||VITAL Rhythm Study|Vitamin D and Omega-3 Trial (VITAL Rhythm Study)|Active, not recruiting||Phase 3|25874|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 00:15:51.653928|2017-10-11 00:15:51.653928
NCT02178397|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-07-13|||June 2014||2014-06-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|FLARE||A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR|A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR|Terminated||Phase 3|6|Actual|Centre Francois Baclesse||2||lack of recruitment|f||||t||||||||||2017-10-11 00:15:51.771805|2017-10-11 00:15:51.771805
NCT02178384|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-10-02|||June 2014||2014-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Management of Loading Forces Distribution in Mandibular Distal-extension Prostheses|An In-vivo Study to Evaluate Three Methods of Managing the Distribution of Loading Forces in Mandibular Distal-extension Prostheses (Class I Kennedy's Classification)|Completed||N/A|30|Actual|Damascus University||3|||f||||t||||||||||2017-10-11 00:15:51.923111|2017-10-11 00:15:51.923111
NCT02178371|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-02-02|||June 2014||2014-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Modified Constraint Induced Movement Therapy on Infantile Hemiplegia||Completed||N/A|16|Actual|CEU San Pablo University||2|||f||||f||||||||||2017-10-11 00:15:52.01134|2017-10-11 00:15:52.01134
NCT02178358|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-07-12|||August 2014||2014-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Interventional|||A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma|A Randomized Phase 2 Study of LY2157299 Versus LY2157299 - Sorafenib Combination Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 2|120|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 00:15:52.235952|2017-10-11 00:15:52.235952
NCT02178345|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-04-21|||June 2014||2014-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer|Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer|Recruiting||N/A|150|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 00:15:52.36879|2017-10-11 00:15:52.36879
NCT02178332|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-03-23|||March 2013||2013-03-01|March 2017|2017-03-01|September 30, 2015|Actual|2015-09-30|September 30, 2015|Actual|2015-09-30||Interventional|||Yhteispeli - Effectiveness Study on Promoting Childrens' Socio-emotional Skills in School|Yhteispeli: Intervention Effectiveness on Elementary School Childrens' Socio-emotional Skills and Psychiatric Symptoms|Completed||N/A|4400|Actual|National Institute for Health and Welfare, Finland||2|||f||||f||||||||||2017-10-11 00:15:52.496194|2017-10-11 00:15:52.496194
NCT02178319|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-26|||June 2014||2014-06-01|June 2014|2014-06-01|September 2021|Anticipated|2021-09-01|June 2021|Anticipated|2021-06-01||Interventional|||Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial|Randomized Clinical Trial Comparing Laparoscopic and Open Esophagogastric Devascularization and Splenectomy for Portal Hypertension|Recruiting||N/A|120|Anticipated|Second Affiliated Hospital of Xi'an Jiaotong University||2|||f||||f||||||||||2017-10-11 00:15:52.598459|2017-10-11 00:15:52.598459
NCT02178306|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-06-27|||September 2000||2000-09-01|June 2014|2014-06-01||||April 2002|Actual|2002-04-01||Interventional|ESPRIT||Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis|An Open-labeled, Placebo run-in, Multicentre Study to Investigate the Efficacy and Safety of Telmisartan (40 and 80 mg QD p.o.) in 3 Strata of Mild to Moderate Hypertensive Patients (Sitting Diastolic Blood Pressure ≥ 90 mmHg and ≤ 109 mmHg From Office Cuff Measurement) With Mild/Moderate or Severe Renal Impairment or Requiring Maintenance Hemodialysis. (ESPRIT Study = Efficacy and Safety in Patients With Renal Impairment Treated With Telmisartan)|Completed||Phase 4|82|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:15:52.696221|2017-10-11 00:15:52.696221
NCT02178293|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2014-07-04|||September 1998||1998-09-01|July 2014|2014-07-01||||May 1999|Actual|1999-05-01||Interventional|MISTRAL||Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride|"MISTRAL (Mouthwash In Sore Throat Relief: Antiinflammatory vs. Local Anesthetic Therapy) Efficacy and Tolerability of Ketoprofen Lysine Salt as a Mouthwash in Acute Phlogosis of the Pharyngeal Cavity; Multicentre, Randomized, Single-blind, Parallel-group Comparison Versus Benzidamine Hydrochloride"|Completed||Phase 4|214|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:15:52.773831|2017-10-11 00:15:52.773831
NCT02178280|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2014-06-26|||May 2013||2013-05-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma|Phase 1 Study of Liver Transplantation Combined With Neoadjuvant Radiochemotherapy for Unresectable Hilar Cholangiocarcinoma|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||||2017-10-11 00:15:52.844773|2017-10-11 00:15:52.844773
NCT02178267|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-27|||January 2011||2011-01-01|June 2014|2014-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Probiotics On Resistant Bacteria Colonization In Preterm Receiving Antibiotics|Effect Of Probiotics On Resistant Bacteria Colonization Preterm Newborn Infants Receiving Antibiotics In Neonatal Intensive Care Unit|Completed||N/A|51|Actual|Baskent University||1|||f||||f||||||||||2017-10-11 00:15:52.957047|2017-10-11 00:15:52.957047
NCT02178254|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-03-31|||August 2014||2014-08-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects|A Randomized, Safety, Tolerability and Pharmacokinetics 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 00:15:53.039409|2017-10-11 00:15:53.039409
NCT02178241|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-09-28|||December 11, 2014|Actual|2014-12-11|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery|Phase II Trial of Gemcitabine-Eribulin (GE) in Cisplatin Ineligible Patients With Advanced or Unresectable Urothelial Carcinoma of the Bladder|Active, not recruiting||Phase 2|21|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 00:15:53.13802|2017-10-11 00:15:53.13802
NCT02178228|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-04-10|||October 2013||2013-10-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Observational Analysis of the Cause of Leaks When Bowel is Cut and Reconnected|Prospective Assessment of Anastomotic Leak|Recruiting||N/A|1000|Anticipated|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||||||2017-10-11 00:15:53.292289|2017-10-11 00:15:53.292289
NCT02178215|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-03-15|||July 2014||2014-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients|Effect of Holly Mangrove Shower Gel Containing Acanthus Ebracteatus Vahl. on Skin Barrier Function in Atopic Dermatitis Patients|Completed||Phase 3|30|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 00:15:53.40038|2017-10-11 00:15:53.40038
NCT02178202|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-06-27||||||June 2014|2014-06-01||||||||Expanded Access|CLBP||McKenzie Exercise Vs Harmonic Technique in Chronic Low Back Pain|Prescription of Two Exercise Therapy Protocols for Treating Chronic Low Back Pain|No longer available||N/A|||University of Tehran|||||||||||||||||||2017-10-11 00:15:53.489815|2017-10-11 00:15:53.489815
NCT02178189|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-06-26|||April 2010||2010-04-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional|||RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants|Randomized Clinical Trial of High vs. Standard-Calorie Formula for Methadone-Exposed Infants|Completed||Phase 2|85|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 00:15:53.559223|2017-10-11 00:15:53.559223
NCT02178176|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-05-13|||September 2013||2013-09-01|May 2016|2016-05-01||||February 2015|Actual|2015-02-01||Interventional|||Participatory Design of Patient-centered Depression and Diabetes Care||Completed||N/A|78|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:15:53.659925|2017-10-11 00:15:53.659925
NCT02178163|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-05-23|||June 2014||2014-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer|A Study to Assess the Ability to Initiate Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Patients Based on Genomic Analyses of Tumor Specimens.|Recruiting||N/A|96|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 00:15:53.773947|2017-10-11 00:15:53.773947
NCT02178150|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-03-08|||June 2014||2014-06-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Effect of Magnesium Supplementation on Polycystic Ovary Syndrome|Effect of Magnesium Supplementation on Metabolic Profile and Sex Hormone Levels in Overweight Women With Polycystic Ovary Syndrome.|Unknown status|Recruiting|N/A|70|Anticipated|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:15:53.946927|2017-10-11 00:15:53.946927
NCT02178137|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-03-09|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|KAPS||Effect of Interventions on the Progression of Knee Osteoarthritis|Effect of Interventions on Progression of Knee Osteoarthritis - a Comparison of Effect of Glucosamine/Chondroitin or Diacerin Vs Placebo: Measured by Clinical, Radiological and Biochemical Parameters|Active, not recruiting||Phase 4|322|Actual|Indus Hospital||3|||f||||t||||||||||2017-10-11 00:15:54.10964|2017-10-11 00:15:54.10964
NCT02178124|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-03-23|||July 2014||2014-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.||Completed||Phase 1|24|Actual|Icure Pharmaceutical Inc.||2|||f||||||||||||||2017-10-11 00:15:54.264443|2017-10-11 00:15:54.264443
NCT02178111|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-11-16|||July 2014||2014-07-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|EPISIO||Comparison of Never Performing Episiotomy to Performing it in a Selective Manor|Not Performing Episiotomy Versus Selective Episiotomy: a Randomized Clinical Trial|Completed||Phase 4|237|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||t||||||||||2017-10-11 00:15:54.388306|2017-10-11 00:15:54.388306
NCT02178098|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-08-27||2015-08-13|June 2014||2014-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension|A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension|Completed||Phase 2|143|Actual|Esperion Therapeutics||2|||f||||f||||||||||2017-10-11 00:15:54.499303|2017-10-11 00:15:54.499303
NCT02178085|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-11-10|||September 2014||2014-09-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|OBAMAg||Ocular Blood Flow Assessment in Glaucoma|Ocular Blood-flow Assessment by Magnetic Resonance Angiography in Glaucoma|Recruiting||N/A|62|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 00:15:54.687311|2017-10-11 00:15:54.687311
NCT02178072|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-07-15|||July 2014||2014-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Window Trial 5-aza in HNSCC, T-tare|A Pilot Study to Assess the Activity of Demethylation Therapy in Patients With HPV Positive Compared With HPV Negative Head and Neck Squamous Cell Carcinoma (HNSCC)|Recruiting||Phase 2|20|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 00:15:54.806352|2017-10-11 00:15:54.806352
NCT02178059|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2017-01-17|2015-11-05||August 2014||2014-08-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||All subjects|Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2|An Open-label, Single-dose, 2-period Cross Over Study in Healthy Volunteers to Assess Relative Bioavailability of Terbutaline Sulphate 1.5 mg After Inhalation Via the M3 Turbuhaler Compared With the M2 Turbuhaler|Completed||Phase 1|34|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:15:54.920816|2017-10-11 00:15:54.920816
NCT02178046|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-02-08|||June 2014||2014-06-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|1 Month|Observational [Patient Registry]|||Non-Invasive Oral Biofilm Characterization|Non-Invasive Oral Biofilm Characterization|Recruiting||N/A|40|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-11 00:15:55.281147|2017-10-11 00:15:55.281147
NCT02178033|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-06-27|||January 2014||2014-01-01|June 2014|2014-06-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Interventional|||The Impact of Split Dose of Low-volume Polyethylene Glycol on Adenoma Detection Rate|The Impact of Split Dose of Low-volume Polyethylene Glycol on Adenoma Detection Rate: a Randomized, Investigator Blind, Controlled Trial|Unknown status|Recruiting|N/A|514|Anticipated|Valduce Hospital||2|||f||||f||||||||||2017-10-11 00:15:55.365566|2017-10-11 00:15:55.365566
NCT02178020|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-01-31|||July 2009||2009-07-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|10 Years|Observational [Patient Registry]|||Outcome Study of Highly-cross Linked Polyethylene vs. Standard Polyethylene for Primary Posterior Stabilized (PS) Total Knee|Prospective, Randomized Study of Highly-cross Linked Polyethylene vs. Compression Molded Polyethylene for Primary Posterior-stabilized Total Knee Arthroplasty|Enrolling by invitation||N/A|500|Anticipated|Chapel Hill Orthopedics Surgery & Sports Medicine|||2||f||||f||||||||||2017-10-11 00:15:55.46932|2017-10-11 00:15:55.46932
NCT02177994|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-27|2015-06-24|||September 2013||2013-09-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|TOAPFECSACT||Antibiotic Prophylaxis for Elective Cesarean Section|Timing of Antibiotic Prophylaxis for Elective Cesarean Section: A Randomized Controlled Trial|Completed||Phase 3|328|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-11 00:15:55.556105|2017-10-11 00:15:55.556105
NCT02177981|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-07-04|||March 2014||2014-03-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|RIPCAGE||Impact of Remote Ischemic Preconditioning Preceding Coronary Artery Bypass Grafting on Inducing nEuroprotection|A Randomized, Double-Blind, Controlled Clinical Trial: Impact of Remote Ischemic Preconditioning Preceding Coronary Artery Bypass Grafting on Inducing Neuroprotection|Completed||N/A|70|Actual|University of Zagreb||2|||f||||f||||||||||2017-10-11 00:15:55.637791|2017-10-11 00:15:55.637791
NCT02177968|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-27|||August 2012||2012-08-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Public Health Concerns of Elderly Fallers and Non-fallers in a Community|Public Health Concerns of Elderly Fallers and Non-fallers in a Southeastern Community of Brazil|Completed||N/A|100|Actual|University of Sao Paulo|||1||f||||t||||||||||2017-10-11 00:15:55.73018|2017-10-11 00:15:55.73018
NCT02177955|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2014-06-26|||January 2011||2011-01-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Comparative Study of Hemodynamic Changes Caused by Diazepam and Midazolam During Third Molar Surgery|Comparative Study of Hemodynamic Changes Caused by Diazepam and Midazolam During Third Molar Surgery. A Prospective Randomized Study|Completed||Phase 4|120|Actual|University of Pernambuco||2|||f||||t||||||||||2017-10-11 00:15:55.803391|2017-10-11 00:15:55.803391
NCT02177929|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-26|||April 2013||2013-04-01|June 2014|2014-06-01||||June 2014|Actual|2014-06-01||Interventional|Adaptive sport||Study About Acting of Adaptive Sport in Musculoskeletal, Cardiovascular System and the Quality of Life of Individuals With Spinal Cord Injury Through Biomedical Instrumentation|Study About Acting of Adaptive Sport in Musculoskeletal, Cardiovascular System and the Quality of Life of Individuals With Spinal Cord Injury Through Biomedical Instrumentation|Unknown status|Recruiting|N/A|45|Anticipated|Universidade do Vale do Paraíba||1|||f||||||||||||||2017-10-11 00:15:55.983606|2017-10-11 00:15:55.983606
NCT02177916|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-11-07|||September 2014||2014-09-01|November 2015|2015-11-01||||September 2016|Anticipated|2016-09-01||Interventional|||Patient Education Study to Determine Knowledge Acquisition in Patients Preparing to Undergo Lung Transplantation|"A Comparison of 2 Different Methods of Patient Education to Determine Knowledge Acquisition in Patients Preparing to Undergo Lung Transplantation"|Recruiting||N/A|75|Anticipated|Tampa General Hospital||2|||f||||f||||||||||2017-10-11 00:15:56.216036|2017-10-11 00:15:56.216036
NCT02177903|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-08-30|||September 2014||2014-09-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study to Determine the Effects of Pre-warming on OR Patient Temperatures and Surgical Outcomes|Randomized, Prospective Study to Determine the Effects of Pre-warming on OR Patient Temperatures and Perioperative Surgical Outcomes|Completed||N/A|220|Actual|3M||2|||f||||t||||||||||2017-10-11 00:15:56.309548|2017-10-11 00:15:56.309548
NCT02177890|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-11-30|||November 2014||2014-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers|Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers|Completed||N/A|25|Actual|Wingate Institute of Neurogastroenterology||2|||f||||f||||||||||2017-10-11 00:15:56.398939|2017-10-11 00:15:56.398939
NCT02177877|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-05-22|||June 2014||2014-06-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary|A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary|Unknown status|Recruiting|N/A|10|Anticipated|Stanford University|||1||f||||t||||||||||2017-10-11 00:15:56.482135|2017-10-11 00:15:56.482135
NCT02177864|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-09-26|||April 2012||2012-04-01|September 2017|2017-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Fiber Health Benefits|Health Benefits and Tolerance of Dietary Fiber Supplements in Children|Completed||N/A|100|Actual|University of Iowa||2|||f||||f|f|f||||||||2017-10-11 00:15:56.569766|2017-10-11 00:15:56.569766
NCT02177851|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-01-20|||June 2015||2015-06-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||The Optimization of Bioavailability From Iron Supplements: Study 2|The Optimization of Bioavailability From Iron Supplements: Examinations of Different Supplementation Regimens Including Hepcidin Profiles|Completed||N/A|20|Actual|Swiss Federal Institute of Technology||2|||f||||||||||||||2017-10-11 00:15:56.649893|2017-10-11 00:15:56.649893
NCT02177838|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-09-21|||May 2015||2015-05-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer|Selecting for Cetuximab Responders in Advanced Head and Neck SCC|Suspended||N/A|27|Anticipated|Rutgers, The State University of New Jersey||1||MedOnc turnover at the institution|f||||t||||||||||2017-10-11 00:15:56.743646|2017-10-11 00:15:56.743646
NCT02177825|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-05-05|||June 2014||2014-06-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas|Phase II Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas|Recruiting||Phase 2|25|Anticipated|St. Justine's Hospital||1|||f||||t||||||||||2017-10-11 00:15:56.856957|2017-10-11 00:15:56.856957
NCT02177786|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-01-12||2016-08-30|June 2014||2014-06-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease|A Phase 2 Double-Blind, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GS-4997 in Subjects With Diabetic Kidney Disease|Completed||Phase 2|334|Actual|Gilead Sciences||4|||f||||t||||||||||2017-10-11 00:15:57.171239|2017-10-11 00:15:57.171239
NCT02177773|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-05-11|||June 2014||2014-06-01|May 2016|2016-05-01||||June 2017|Anticipated|2017-06-01||Interventional|DOTA-TOC||Evaluation of Gallium-68 DOTA-TOC Imaging of Somatostatin Receptor Positive Malignancies|Evaluation of Gallium-68 DOTA-TOC Imaging of Somatostatin Receptor Positive Malignancies|Recruiting||Phase 2|120|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 00:15:57.507745|2017-10-11 00:15:57.507745
NCT02177760|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-12-01|||July 2014||2014-07-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Sirolimus Prophylaxis for aGVHD in TME SCID|Sirolimus in Prevention of aGVHD in Maternally Engrafted (TME) Severe Combined Immunodeficiency (SCID) Infants Receiving Unconditioned Hematopoietic Stem Cell Transplant (HSCT)|Withdrawn||Phase 2|0|Actual|University of California, San Francisco||1||Preliminary data suggested a better approach available|f||||t||||||||||2017-10-11 00:15:57.595228|2017-10-11 00:15:57.595228
NCT02177747|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-26|||November 2013||2013-11-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Smartphone-based Ophthalmoscopy|Comparison of Smartphone-based Ophthalmoscopy Versus Dilated Ophthalmic Examination for Diabetic and Nondiabetic Eye Disease|Completed||N/A|120|Actual|Università degli Studi di Brescia||1|||f||||||||||||||2017-10-11 00:15:57.699788|2017-10-11 00:15:57.699788
NCT02177734|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-06-16|||March 2016||2016-03-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|June 2016|Anticipated|2016-06-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age|An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A Administered in Adults 18 to 60 Years of Age|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||6||"The study was cancelled for scientifically legitimate reasons not related to safety or efficacy   of the vaccine."|f||||||||||||||2017-10-11 00:15:57.768496|2017-10-11 00:15:57.768496
NCT02177721|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-23|||September 29, 2017|Anticipated|2017-09-29|June 2017|2017-06-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|||An Open Label, Phase IV Study Evaluating the Clinical Benefit, Safety and Pharmacokinetics of Raxibacumab in Subjects Exposed to Bacillus Anthracis|A Phase 4, Open-label Field Study (200137) to Evaluate the Clinical Benefit, Safety and Pharmacokinetics in Subjects Treated With Raxibacumab (GSK3068483) Following Exposure to Bacillus Anthracis|Not yet recruiting||Phase 4|100|Anticipated|GlaxoSmithKline||1|||f||||f|t|f||||||||2017-10-11 00:15:57.860347|2017-10-11 00:15:57.860347
NCT02177708|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-06-26|||January 2014||2014-01-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Observational|||Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy|Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy Measured by MR|Unknown status|Recruiting|N/A|45|Anticipated|University of Aarhus|||1||f||||t||||||||||2017-10-11 00:15:57.946937|2017-10-11 00:15:57.946937
NCT02177695|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-07-12|||July 2014||2014-07-01|July 2017|2017-07-01|October 2022|Anticipated|2022-10-01|February 2020|Anticipated|2020-02-01||Interventional|COXEN||S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer|A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer|Recruiting||Phase 2|184|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 00:15:58.30206|2017-10-11 00:15:58.30206
NCT02177682|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-05-22|||August 13, 2014|Actual|2014-08-13|May 2017|2017-05-01|December 27, 2017|Anticipated|2017-12-27|July 21, 2017|Anticipated|2017-07-21||Interventional|||Study of Afuresertib Monotherapy in Japanese Relapsed Multiple Myeloma Patients|An Open-label, Dose Escalation, Phase I Study to Evaluate the Tolerability, Safety and Pharmacokinetics of Afuresertib Monotherapy in Japanese Relapsed Multiple Myeloma Patients.|Active, not recruiting||Phase 1|18|Actual|Novartis||1|||f||||f|f|f||||||No||2017-10-11 00:16:01.127305|2017-10-11 00:16:01.127305
NCT02177669|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-04-10|||June 2014||2014-06-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Test-Retest Variability of Quick Contrast Sensitivity Function Testing||Completed||N/A|100|Actual|Nova Southeastern University|||1||f||||f||||||||||2017-10-11 00:16:01.229321|2017-10-11 00:16:01.229321
NCT02177656|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-25|||January 2012||2012-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|MITI-HF||Motivational Interviewing Tailored Intervention for Patients With Heart Failure (MITI-HF)|Motivational Interviewing Tailored Intervention for Patients With Heart Failure (MITI-HF)|Completed||N/A|100|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 00:16:01.303826|2017-10-11 00:16:01.303826
NCT02177643|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-09-15|||January 2013||2013-01-01|September 2015|2015-09-01||||August 2016|Anticipated|2016-08-01||Interventional|||Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin|Effect of Diacerein in the Metabolic Control of Patients With Diabetes Mellitus Type 2 and Secondary Failure to Metformin|Unknown status|Recruiting|Phase 2|60|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-11 00:16:01.401422|2017-10-11 00:16:01.401422
NCT02177630|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2015-11-30|||August 2012||2012-08-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|MyoRacer||Magnetic Resonance Imaging in Myocarditis|Myocarditis and the Role of Advanced Magnetic Resonance Imaging|Active, not recruiting||N/A|120|Anticipated|University of Leipzig|||1||f||||f||||||||||2017-10-11 00:16:01.605189|2017-10-11 00:16:01.605189
NCT02177617|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-06-23|||December 2014||2014-12-01|April 2017|2017-04-01|January 7, 2017|Actual|2017-01-07|January 7, 2017|Actual|2017-01-07||Interventional|||Neurotoxin and Physical Therapy|Synergistic Effects of Neurotoxin and Physical Therapy|Completed||Phase 4|17|Actual|University of Florida||2|||f||||f|f|f||||||||2017-10-11 00:16:01.704012|2017-10-11 00:16:01.704012
NCT02177604|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-25|||July 2014||2014-07-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|GAINHIT||Can Brief High-intensity Interval Training Mitigate the Adverse Consequences of High-fat Overfeeding?|Can Brief High-intensity Interval Training Mitigate the Adverse Consequences of High-fat Overfeeding?|Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Adelaide||3|||f||||f||||||||||2017-10-11 00:16:01.802863|2017-10-11 00:16:01.802863
NCT02177591|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-08-07|||June 2014||2014-06-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Observational|||Observational Study of the Association Between Periodontal Disease and Cardiovascular Disease|Observational Study of the Association Between Periodontal Disease and Cardiovascular Disease|Completed||N/A|75|Actual|Texas Tech University Health Sciences Center|||3||f||||f||||||||||2017-10-11 00:16:01.906255|2017-10-11 00:16:01.906255
NCT02177578|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-10-05|||May 2014||2014-05-01|October 2017|2017-10-01|November 2020|Anticipated|2020-11-01|June 2020|Anticipated|2020-06-01||Interventional|||Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme|A Randomized Phase II Study of Subventricular Zone (SVZ) Irradiation Plus Temozolomide in Newly Diagnosed Glioblastoma Multiforme|Recruiting||Phase 2|60|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:16:01.981364|2017-10-11 00:16:01.981364
NCT02177565|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-25|||January 2000||2000-01-01|June 2014|2014-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Autologous Stem Cell Therapy for Fracture Non-union Healing|Autologous Stem Cell Therapy for Fracture Non-union Healing|Completed||N/A|35|Actual|Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust||2|||f||||f||||||||||2017-10-11 00:16:02.117347|2017-10-11 00:16:02.117347
NCT02177552|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-03-26|||June 2014||2014-06-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Interventional|SEED||Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma|Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma - Carboplatin, Docetaxel and Capecitabine (CTX) or Epirubicin, Oxaliplatin and Capecitabine: a Randomised Phase 2 Trial.|Recruiting||Phase 2|98|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:16:02.241457|2017-10-11 00:16:02.241457
NCT02177526|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2015-11-17|||June 2014||2014-06-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Imaging of High Grade Prostate Cancer|Detection of Malignant Calcifications in High Grade Prostate Cancer With Comedo-type Necrosis Using Thin Section Computed Tomography and Susceptibility Weighted Magnetic Resonance Imaging|Terminated||N/A|30|Anticipated|Ottawa Hospital Research Institute||1||trial logistics|f||||f||||||||||2017-10-11 00:16:02.484266|2017-10-11 00:16:02.484266
NCT02177513|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-06-30|||June 14, 2014||2014-06-14|April 27, 2016|2016-04-27|April 27, 2016|Actual|2016-04-27|April 27, 2016|Actual|2016-04-27||Interventional|||Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics|Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics|Completed||Phase 1|80|Anticipated|National Institutes of Health Clinical Center (CC)||5|||f||||||||||||||2017-10-11 00:16:02.559413|2017-10-11 00:16:02.559413
NCT02177500|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||January 2000||2000-01-01|July 2014|2014-07-01||||May 2000|Actual|2000-05-01||Interventional|||Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy|An Eight Week Randomized, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 40 mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 40 mg|Completed||Phase 3|327|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:02.652793|2017-10-11 00:16:02.652793
NCT02177487|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||June 1999||1999-06-01|July 2014|2014-07-01||||January 2000|Actual|2000-01-01||Interventional|||Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension|An Open-Label, Six Month Safety Evaluation of the Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg in Patients With Mild-to-Moderate Hypertension|Completed||Phase 3|100|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:16:02.720837|2017-10-11 00:16:02.720837
NCT02177474|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-26|||October 2010||2010-10-01|June 2014|2014-06-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|||Effects of a Telephone Based Peer Support to Reduce Depressive Symptoms and Improve Social Support in Women With CHD|Randomized Controlled Trial of a Telephone Based Peer Support Intervention to Reduce Depressive Symptoms and Improve Social Support in Women With Coronary Heart Disease (CHD)|Completed||N/A|108|Actual|University of Göttingen||2|||f||||f||||||||||2017-10-11 00:16:02.780585|2017-10-11 00:16:02.780585
NCT02177461|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||April 2000||2000-04-01|July 2014|2014-07-01||||August 2002|Actual|2002-08-01||Interventional|||Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension|A PROBE (Prospective, Randomised, Open-Label, Blinded Endpoint) Trial to Investigate the Efficacy and Safety of Telmisartan 40-80mg Once Daily Compared With 10-20 mg Enalapril Once Daily Over a Period of 24 Weeks in Elderly Patients With Blood Hypertension|Completed||Phase 4|374|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:16:02.865655|2017-10-11 00:16:02.865655
NCT02177448|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||September 1998||1998-09-01|July 2014|2014-07-01||||September 1999|Actual|1999-09-01||Interventional|||BIBR 277 Capsule in Patients With Essential Hypertension|A Double-blind, Parallel-group Comparison Study of BIBR 277 Capsule in Patients With Essential Hypertension|Completed||Phase 3|225|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:02.943229|2017-10-11 00:16:02.943229
NCT02177435|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||February 1999||1999-02-01|July 2014|2014-07-01||||September 1999|Actual|1999-09-01||Interventional|||Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension|An Eight Week Randomized, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 80 mg.|Completed||Phase 3|491|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:03.032175|2017-10-11 00:16:03.032175
NCT02177422|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||June 1998||1998-06-01|July 2014|2014-07-01||||November 1999|Actual|1999-11-01||Interventional|||Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension|Open-Label Follow-up Trial on Efficacy and Safety of Chronic Administration of Telmisartan 80 mg (Micardis®) Tablets as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension|Completed||Phase 3|489|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:16:03.132689|2017-10-11 00:16:03.132689
NCT02177409|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||April 1998||1998-04-01|July 2014|2014-07-01||||December 1998|Actual|1998-12-01||Interventional|||Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension|A Prospective Randomized Open-Label, Blinded-Endpoint (PROBE) Trial Comparing MICARDIS® (Telmisartan) (80 mg QD) and Amlodipine (5 mg QD) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring.|Completed||Phase 3|431|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:05.093572|2017-10-11 00:16:05.093572
NCT02177396|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||April 1998||1998-04-01|June 2014|2014-06-01||||December 1998|Actual|1998-12-01||Interventional|||MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring|A Prospective Randomized Open-Label Blinded End Point (PROBE) Trial Comparing MICARDIS® (Telmisartan) (80 mg QD) and Valsartan (80 mg QD) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring.|Completed||Phase 3|426|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:05.269387|2017-10-11 00:16:05.269387
NCT02177383|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-26|||September 2011||2011-09-01|June 2014|2014-06-01||||December 2011|Actual|2011-12-01||Interventional|||Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance|Scientific Basis of the Action of Foods Rich in Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance|Completed||N/A|15|Actual|University of the Balearic Islands||2|||f||||||||||||||2017-10-11 00:16:05.345849|2017-10-11 00:16:05.345849
NCT02177370|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-17|||February 1990||1990-02-01|June 2014|2014-06-01||||October 1996|Actual|1996-10-01||Interventional|||Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma|Effect of Fenoterol Metered Dose Inhaler (0.1 mg) on the Beta-receptor Population on Lymphocytes and the Clinical Findings Compared With Treatment With DSCG Metered Dose Inhaler in Patients With Bronchial Asthma.|Terminated||Phase 3|19|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:05.426875|2017-10-11 00:16:05.426875
NCT02177357|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-26|||November 1998||1998-11-01|June 2014|2014-06-01||||January 2000|Actual|2000-01-01||Interventional|||Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients|Pramipexole: Efficacy, Safety and Tolerability Study in Untreated and Levodopa-Treated Parkinson's Disease Patients, a Multinational Study|Completed||Phase 3|150|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:05.493307|2017-10-11 00:16:05.493307
NCT02177344|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-16|||August 1998||1998-08-01|June 2014|2014-06-01||||October 1999|Actual|1999-10-01||Interventional|||Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease|A Six Month, Randomized, Double-blind (Within Formulation), Multiple Dose Trial to Compare the Safety and Efficacy of 20 mcg and 40 mcg of Ipratropium Bromide, as Delivered by the RESPIMAT Device, to 18 mcg ATROVENT® Inhalation Aerosol (x 2 Puffs) and Respective Placebos in Adults, With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|646|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:16:05.573695|2017-10-11 00:16:05.573695
NCT02177331|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-11|||June 1995||1995-06-01|July 2014|2014-07-01||||January 1998|Actual|1998-01-01||Interventional|||Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension|Lacidipine in Medical Practice: Incidence of Rare Adverse Drug Reactions During Long-term Treatment. 3rd Follow-up Study - Long-term Use in the 4th and 5th Year Treatment Years|Completed||Phase 3|53|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:16:05.671283|2017-10-11 00:16:05.671283
NCT02177318|ClinicalTrials.gov processed this data on October 10, 2017|2008-01-31|2014-06-26|||April 2005||2005-04-01|June 2014|2014-06-01||||September 2007|Actual|2007-09-01||Observational|COPD||Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease|Drug Use Results Survey of Tiotropium Bromide|Completed||N/A|3588|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:16:05.785975|2017-10-11 00:16:05.785975
NCT02177305|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-26|||October 1998||1998-10-01|June 2014|2014-06-01||||December 1998|Actual|1998-12-01||Interventional|||Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers|A Single Increasing Dose Tolerance Study After Ocular Administration of Tiotropium (Single Doses: 0.02 - 0.4 mcg) in Healthy Male Volunteers (Randomised, Placebo-controlled, Double-blind, Parallel Groups).|Completed||Phase 1|48|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:16:08.05009|2017-10-11 00:16:08.05009
NCT02177279|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-07-07|||December 2011||2011-12-01|July 2014|2014-07-01||||February 2013|Actual|2013-02-01||Interventional|WB2001||Bioactive Phytochemicals From Wheat Bran|Identification of Novel Bioactive Compounds in Wheat Bran|Completed||N/A|8|Actual|University of Aberdeen||3|||f||||||||||||||2017-10-11 00:16:08.214487|2017-10-11 00:16:08.214487
NCT02177266|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-24|2017-05-24||May 2015||2015-05-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation|Colchicine Versus Placebo in Post-Cardiac Surgery Patients to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation|Terminated||Phase 3|2|Actual|Mayo Clinic|The data were not analyzed because the 2 subjects enrolled withdrew before completing the study; the study was terminated early due to the difficulty in enrolling subjects.|2||Difficulty in recruiting patients|f||||t|t|f|||t|||No||2017-10-11 00:16:08.313039|2017-10-11 00:16:08.313039
NCT02177253|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-26|||October 2002||2002-10-01|June 2014|2014-06-01||||March 2004|Actual|2004-03-01||Interventional|||Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease|A Comparison of Ipratropium Bromide/Salbutamol (40 mcg / 200 mcg, One Inhalation) Delivered by the Respimat ® Inhaler to COMBIVENT Inhalation Aerosol (Two Inhalations), Ipratropium Bromide Respimat ® and Placebo of Each Formulation in a 12-week, Double-blind, Safety and Efficacy Study in Adults With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|1118|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:16:08.764708|2017-10-11 00:16:08.764708
NCT02177240|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-06-25|||May 2014||2014-05-01|June 2014|2014-06-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||A Comparison of the Flex-it® to the GlideRite® Stylet for GlideScope® in Simulated Difficult Intubations.|A Randomized Comparison of the Flex-it® Articulating Stylet to the GlideRite® Rigid Stylet for Orotracheal Intubation Using the GlideScope® in Simulated Difficult Intubations. A Double Blinded Randomized Controlled Trial.|Unknown status|Recruiting|N/A|80|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||t||||||||||2017-10-11 00:16:08.883118|2017-10-11 00:16:08.883118
NCT02177227|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-07-25|||August 2014||2014-08-01|July 2017|2017-07-01|August 2024|Anticipated|2024-08-01|August 2024|Anticipated|2024-08-01||Interventional|||Attune With TruMatch TM Personalized Solutions Instruments|Attune With TruMatch TM Personalized Solutions Instruments: A Prospective Randomized Controlled Trial Comparing Clinical and Economic Outcomes in Patients With a BMI Between 30 and 50|Recruiting||N/A|184|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:16:08.997418|2017-10-11 00:16:08.997418
NCT02177214|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-11-23|||June 2014||2014-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01|13 Months|Observational [Patient Registry]|||Magnetic Resonance Imaging of Mesh Position After Ventral Hernia Repair|Prospective Study to Visualize Dynamesh ® IPOM Visible Mesh With MRI After Laparoscopic Intraperitoneal Ventral Hernia Repair.|Completed||N/A|15|Actual|Algemeen Ziekenhuis Maria Middelares|||1||f||||f||||||||No||2017-10-11 00:16:09.103095|2017-10-11 00:16:09.103095
NCT02177201|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-12-30|2015-01-19||August 2013||2013-08-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|EICVPV||Effect of Intraoperative Crystalloid Volume on Postoperative Vomiting|Effect of Intravenous Crystalloid Volume on Postoperative Nausea and Vomiting After Tonsillectomy and/or Adenoidectomy: a Prospective, Randomized, Controlled Study|Completed||N/A|160|Actual|Adnan Menderes University||2|||f||||t||||||||||2017-10-11 00:16:09.207699|2017-10-11 00:16:09.207699
NCT02177188|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2014-06-26|||April 2012||2012-04-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|HEAvyHAT||HEAVy HAT-HEAlthy Volunteers Heart to Arm Time. Haemorrhage Simulation Protocol in Healthy Volunteers|HEAVy HAT-HEAlthy Volunteers Heart to Arm Time. Haemorrhage Simulation Protocol in Healthy Volunteers.|Completed||N/A|30|Actual|University of Milano Bicocca||1|||f||||t||||||||||2017-10-11 00:16:09.508951|2017-10-11 00:16:09.508951
NCT02176993|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-11-16|||April 2014||2014-04-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|COOL||Effects of Surface Cooling On Stroke Outcome triaL (COOL)|Effects of Surface Cooling On Stroke Outcome triaL: a Feasibility and Safety Study|Active, not recruiting||N/A|50|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||f||||||||||2017-10-11 00:16:13.990418|2017-10-11 00:16:13.990418
NCT02177175|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-05-25|||June 2014|Actual|2014-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification|Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification|Active, not recruiting||Phase 2|82|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:16:09.597482|2017-10-11 00:16:09.597482
NCT02177162|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-09-11|||September 2014||2014-09-01|June 2014|2014-06-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Knee Osteoarthritis Care: A Quality Improvement Intervention in Physiotherapists|Knee Osteoarthritis Care: A Quality Improvement Intervention in Physiotherapists|Unknown status|Active, not recruiting|N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 00:16:09.716085|2017-10-11 00:16:09.716085
NCT02177149|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-05-13|||February 2014||2014-02-01|May 2015|2015-05-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|DBS||Nurse Management of Neuromodulation Therapy|Mobile Computing Platform to Improve Outcomes From Deep Brain Stimulation Therapy|Withdrawn||N/A|0|Actual|Medical College of Wisconsin||2||PI is no longer at MCW, study has been closed|f||||f||||||||||2017-10-11 00:16:09.801833|2017-10-11 00:16:09.801833
NCT02177136|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-09-29|||December 2014||2014-12-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|AESOP||Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Clinical Trial Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Primary Sclerosing Cholangitis|Active, not recruiting||Phase 2|77|Actual|Intercept Pharmaceuticals||3|||f||||t||||||||||2017-10-11 00:16:09.942169|2017-10-11 00:16:09.942169
NCT02177123|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-01-10|||May 2014||2014-05-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Post Market Study of the InnFocus MicroShunt|Post Market Study to Evaluate Safety and Effectiveness of the InnFocus Microshunt™ (MIDI Arrow) in Patients With Primary Open Angle Glaucoma|Active, not recruiting||Phase 4|100|Actual|InnFocus Inc.||1|||f||||f||||||||||2017-10-11 00:16:10.146925|2017-10-11 00:16:10.146925
NCT02177110|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-08-09|||September 2014||2014-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|SYS-ACT||A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma|A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Responsiveness in Advanced or Metastatic Malignant Melanoma (SYS-ACT)|Recruiting||N/A|80|Anticipated|Cancer Trials Ireland|||2||f||||f||||||Samples With DNA|"     Fresh frozen and FFPE tissue samples   "|||2017-10-11 00:16:10.241739|2017-10-11 00:16:10.241739
NCT02177097|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-04-09|||January 2010||2010-01-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Chronic Pain, Inflammation and Infection After Joint Replacement|Extended Biochemical Analysis and Bacteriologic Diagnosis in Patients With Loose Joint Replacements, Chronic Pain and Infection.|Completed||N/A|180|Actual|Northern Orthopaedic Division, Denmark|||3||f||||f||||||Samples With DNA|"     4 x 10 ml blood samples for each patient.   "|||2017-10-11 00:16:10.341204|2017-10-11 00:16:10.341204
NCT02177084|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-06-26|||July 2014||2014-07-01|June 2014|2014-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||Percutaneous Tibial Nerve Stimulation in the Treatment of Anterior Resection Syndrome After Rectal Cancer Surgery||Unknown status|Not yet recruiting|Phase 2|12|Anticipated|St. Orsola Hospital||2|||f||||||||||||||2017-10-11 00:16:10.457707|2017-10-11 00:16:10.457707
NCT02177071|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-10-03|||October 2015|Actual|2015-10-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|May 2020|Anticipated|2020-05-01||Interventional|SPARE||A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy|A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy|Recruiting||Phase 4|300|Anticipated|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||3|||f||||t||||||||||2017-10-11 00:16:10.69216|2017-10-11 00:16:10.69216
NCT02177058|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-08-08|||September 2012||2012-09-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|August 2014|Actual|2014-08-01||Interventional|||Reducing Hospitalizations of Nursing Home Residents|Implementing Interventions to Reduce Hospitalizations of Nursing Home Residents|Active, not recruiting||N/A|264|Actual|Florida Atlantic University||3|||f||||t||||||||||2017-10-11 00:16:10.972426|2017-10-11 00:16:10.972426
NCT02177045|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-09-30|||October 2014||2014-10-01|September 2014|2014-09-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Breast Lesions Characterization on Contrast Enhanced Ultrasound With Histopathological Correlation|Breast Lesions Characterization on Contrast Enhanced Ultrasound With Histopathological Correlation|Unknown status|Not yet recruiting|N/A|50|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-11 00:16:11.088364|2017-10-11 00:16:11.088364
NCT02177032|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-02-21|2016-08-18||June 2014||2014-06-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age|"Phase 3, Randomized, Stratified, Open Label, Multicenter, Controlled Clinical Study to Evaluate Safety and Immunogenicity of a Rabies Vaccine Administered, With and Without Human Rabies Immunoglobulin, Using the New 4-sites, 1-week Intradermal Regimen for Postexposure Prophylaxis Compared to the Currently Recommended 2-sites, TRC Intradermal Regimen in Children and Adults Subjects."|Completed||Phase 3|885|Actual|Novartis||4|||f||||f||||||||||2017-10-11 00:16:11.237105|2017-10-11 00:16:11.237105
NCT02177019|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-07-17|||August 2014||2014-08-01|May 2015|2015-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Assessment of a Personalized Health Care Intervention for Frequent Headache|Assessment of a Personalized Health Care Intervention for Frequent Headache|Completed||N/A|31|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:16:13.715305|2017-10-11 00:16:13.715305
NCT02177006|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-06-15|||June 2014||2014-06-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Helping Children be Safe Outdoors With Sun Protection|Helping Children be Safe Outdoors With Sun Protection|Completed||N/A|840|Actual|Northwestern University|||2||f||||f||||||||||2017-10-11 00:16:13.908245|2017-10-11 00:16:13.908245
NCT02176967|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-09-27|||July 2014||2014-07-01|September 2017|2017-09-01||||June 2019|Anticipated|2019-06-01||Interventional|||Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma|Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma|Recruiting||Phase 3|621|Anticipated|Children's Oncology Group||3|||f||||t||||||||||2017-10-11 00:16:14.231996|2017-10-11 00:16:14.231996
NCT02176954|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2015-03-20|||July 2014||2014-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||The Influence of Adhesive Wafer Design on Fit to the Body||Completed||N/A|40|Actual|Coloplast A/S||6|||f||||f||||||||||2017-10-11 00:16:14.896041|2017-10-11 00:16:14.896041
NCT02176941|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-06-15|||June 2014||2014-06-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|TELARTA||Telomeres and Arterial Aging|Short Telomere in Patients at High Cardiovascular Risk: a Simple Marker or a Major Determinant of Accelerated Arterial Aging|Recruiting||N/A|340|Anticipated|Central Hospital, Nancy, France|||2||f||||f||||||Samples With DNA|"     Skeletal Muscle, skin, fat (as surgical waste) and Blood sampling DNA extractions and     telomere length measurements (Southern) in muscular cells, white blood cells and endothelial     progenitor cells.      Determination, isolation and characterization of endothelial progenitor cells Microparticle     (MP) von Willebrand Factor : vWF, CD146, CD31 Tissue plasminogen activator/plasminogen     activator inhibitor-1 complexes thrombomodulin, endothelial protein C receptor, free tissue     factor pathway inhibitor sirtuin proteins Biological phenotyping of inflammatory factors in     plasma : IL2, IL4, IL6, IL8, IL10, VEGF, IFNG, TNFA, IL1A, IL1B, MCP1, EGF, CRP, Haptoglobine   "|||2017-10-11 00:16:15.018075|2017-10-11 00:16:15.018075
NCT02176928|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-12-28|||May 2014||2014-05-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Sleep-Disordered Breathing in Chronic SCI|Sleep-Disordered Breathing in Chronic SCI: A Randomized Controlled Trial of Treatment Impact on Cognition, Quality of Life, and Cardiovascular Disease|Recruiting||N/A|200|Anticipated|University of Miami||2|||f||||f||||||||||2017-10-11 00:16:15.124421|2017-10-11 00:16:15.124421
NCT02176915|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-09-08|||July 2014||2014-07-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Fresh Start Weight Loss Intervention in WIC Participants|Fresh Start: A Randomized Clinical Trial|Active, not recruiting||N/A|139|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 00:16:15.271578|2017-10-11 00:16:15.271578
NCT02176902|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-09-12|||November 1, 2014|Actual|2014-11-01|September 2017|2017-09-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer|A Phase II Randomized, Open-Label, Two-Arm Study of a Low-Fat Diet With Fish Oil Capsules vs. a Control Group in Men on Active Surveillance for Prostate Cancer|Recruiting||N/A|100|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:16:15.379322|2017-10-11 00:16:15.379322
NCT02176889|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-09-08|||June 2014||2014-06-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|14PSHS||A Parallel Study Evaluating the Safety of Lactospore® in Healthy Individuals|A Double-blind, Placebo-controlled, Parallel Study Evaluating the Safety of Lactospore® in Healthy Individuals|Completed||Phase 1|40|Actual|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-11 00:16:15.523597|2017-10-11 00:16:15.523597
NCT02176876|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-06-25|||August 2014||2014-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis|A Phase 1b, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis|Completed||Phase 1|18|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 00:16:15.637585|2017-10-11 00:16:15.637585
NCT02176863|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-08-01|||July 2014||2014-07-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|December 2017|Anticipated|2017-12-01||Interventional|FORCE||Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome|A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel‑Group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-Polio Syndrome|Recruiting||Phase 2/Phase 3|210|Anticipated|Grifols Biologicals Inc.||3|||f||||t||||||||||2017-10-11 00:16:15.77107|2017-10-11 00:16:15.77107
NCT02176850|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-07|||January 1999||1999-01-01|July 2014|2014-07-01||||May 2000|Actual|2000-05-01||Observational|||Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension|Safety, Tolerability and Efficacy of Micardis® (Telmisartan) in Patients With Essential Hypertension|Completed||N/A|19870|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:16:16.03013|2017-10-11 00:16:16.03013
NCT02176837|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-05-09|||June 2014||2014-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage|Evaluation of Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage From a Cerebral Aneurysm|Terminated||Phase 2|6|Actual|Hope Pharmaceuticals||1|||f||||t||||||||||2017-10-11 00:16:16.124374|2017-10-11 00:16:16.124374
NCT02176824|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-08-09|||June 1, 2014||2014-06-01|August 2015|2015-08-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Chronotherapy Randomized Controlled Trial|Adjunct Total Sleep Deprivation, Sleep Phase Advance, and White Light Therapy Vs. Partial Sleep Deprivation, Sleep Phase Delay, and Amber Light Therapy as Adjunctive Treatments in Acutely Suicidal and Depressed Inpatients.|Suspended||N/A|48|Anticipated|Medical University of South Carolina||3||PI|f||||f||||||||||2017-10-11 00:16:16.236348|2017-10-11 00:16:16.236348
NCT02176811|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2014-06-25|||June 2009||2009-06-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|June 2013|Actual|2013-06-01||Observational|||Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease|The Cross Sectional Study to Investigate the Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease and Healthy Controls|Completed||N/A|80|Actual|Gulhane School of Medicine|||2||f||||f||||||||||2017-10-11 00:16:16.349545|2017-10-11 00:16:16.349545
NCT02176785|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-10-01|||June 2014||2014-06-01|June 2014|2014-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Pre-Frontal tDCS on Sleep Propensity During an Afternoon Nap: RCT|The Effect of Pre-Frontal tDCS on Sleep Propensity During an Afternoon Nap: RCT|Completed||N/A|10|Actual|Medical University of South Carolina||3|||f||||f||||||||||2017-10-11 00:16:16.54674|2017-10-11 00:16:16.54674
NCT02176772|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-06-02|||April 2015||2015-04-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Iron Absorption and Utilization During Tuberculosis and After Treatment|The Effects of Tuberculosis on Dietary Iron Absorption and Systemic Iron Utilization: a Double Stable Isotope Study in Bagamoyo, Tanzania|Completed||N/A|19|Actual|Swiss Federal Institute of Technology|||1||f||||||||||||||2017-10-11 00:16:16.629251|2017-10-11 00:16:16.629251
NCT02176759|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-12-23|||September 2014||2014-09-01|June 2014|2014-06-01||||December 2014|Actual|2014-12-01||Interventional|||Iron Absorption From Rice Fortified With Ferric Pyrophosphate||Completed||N/A|20|Actual|Swiss Federal Institute of Technology||4|||f||||||||||||||2017-10-11 00:16:16.711716|2017-10-11 00:16:16.711716
NCT02176746|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-06-01|||June 2014||2014-06-01|June 2014|2014-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CSC||A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer|Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic Adenocarcinoma of the Colorectal|Completed||Phase 1/Phase 2|40|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f||||t||||||||||2017-10-11 00:16:16.785225|2017-10-11 00:16:16.785225
NCT02176733|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-06-26|||July 2011||2011-07-01|January 2014|2014-01-01||||October 2015|Anticipated|2015-10-01||Interventional|CICLO-NOHL||Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy||Unknown status|Recruiting|Phase 2|12|Anticipated|University Hospital, Angers||1|||f||||||||||||||2017-10-11 00:16:16.859832|2017-10-11 00:16:16.859832
NCT02176720|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-03-14|||May 2014||2014-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma|Randomized Metabolic Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma FDOPA PET-CT|Terminated||Phase 1/Phase 2|31|Actual|The Methodist Hospital System||2||PI left HMRI|f||||f||||||||No|No plan to share data.|2017-10-11 00:16:17.0293|2017-10-11 00:16:17.0293
NCT02176707|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-06-10|||June 2014||2014-06-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Observational|||Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis|Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis|Active, not recruiting||N/A|250|Actual|University of East Anglia|||1||f||||t||||||||||2017-10-11 00:16:17.140109|2017-10-11 00:16:17.140109
NCT02176694|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-06-09|||June 2014||2014-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ACT Me||Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care|Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care.|Completed||N/A|29|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 00:16:17.225948|2017-10-11 00:16:17.225948
NCT02176681|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-04-08|||June 2014||2014-06-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM|A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM|Recruiting||Phase 4|70|Anticipated|University Hospital, Strasbourg, France||2|||f||||t||||||||||2017-10-11 00:16:17.353247|2017-10-11 00:16:17.353247
NCT02176668|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-02-16|||June 2014||2014-06-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects|A Randomized, Open-label, Multiple-dose, Partial Crossover Study to Explore the Pharmacokinetics and the Pharmacodynamics of YH4808 New Formulation in Healthy Subjects|Completed||Phase 1|82|Actual|Yuhan Corporation||8|||f||||t||||||||||2017-10-11 00:16:17.514675|2017-10-11 00:16:17.514675
NCT02176655|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-03-17|2016-08-18||July 2014||2014-07-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||All subjects randomized to treatment are included in the baseline analysis population, whether or not they treated a headache.|Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches|Multi-Center, Double-Blind, Placebo Controlled Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches|Completed||Phase 2|31|Actual|Cady, Roger, M.D.||2|||f||||f||||||||||2017-10-11 00:16:17.658599|2017-10-11 00:16:17.658599
NCT02176642|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-01-24|||August 2014||2014-08-01|January 2016|2016-01-01|November 21, 2016|Actual|2016-11-21|November 21, 2016|Actual|2016-11-21||Interventional|APP||Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.|Double-Blind Randomized Controlled Trial of Extended Release Oxybutynin Versus Placebo in Women Receiving Posterior Tibial Nerve Stimulation for Treatment of Urgency Urinary Incontinence|Terminated||Phase 4|36|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:16:18.151237|2017-10-11 00:16:18.151237
NCT02176629|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-08-31|||August 2014||2014-08-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|MeMO-RV2||Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease|Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease. MeMO-RV2|Completed||N/A|60|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 00:16:18.291811|2017-10-11 00:16:18.291811
NCT02176616|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-25|||June 2014||2014-06-01|June 2014|2014-06-01|February 2024|Anticipated|2024-02-01|February 2024|Anticipated|2024-02-01||Interventional|||Evaluation of Proper Radiofrequency Catheter Ablation Strategy for the Patients Who Were Changed to Paroxysmal Atrial Fibrillation From Persistent Atrial Fibrillation||Not yet recruiting||N/A|120|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 00:16:18.390941|2017-10-11 00:16:18.390941
NCT02176603|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2017-02-22|||May 2014||2014-05-01|February 2017|2017-02-01|January 1, 2017|Actual|2017-01-01|July 22, 2015|Actual|2015-07-22||Observational|||Observational Study of Endothelial Dysfunction in Phenylketonuria|Observational, Investigator Initiated, Monocentric Study of the Endothelial Dysfunction in Adolescent and Adult Patients With Phenylketonuria Due to Phenylalanine Hydroxylase Deficiency|Completed||N/A|51|Actual|Charite University, Berlin, Germany|||2||f||||f||||||Samples Without DNA|"     Plasma, serum, urine will be retained. All blood samples will be destroyed immediately after     having analyzed the above mentioned parameters.   "|No||2017-10-11 00:16:18.480512|2017-10-11 00:16:18.480512
NCT02175836|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-01-27|||October 2007||2007-10-01|January 2016|2016-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|APRET||Arrhythmia Prediction Trial|Arrhythmia Prediction Trial and Risk Stratification in Heart Failure Patients - Athens.|Recruiting||N/A|500|Anticipated|University of Athens|||1||f||||f||||||||||2017-10-11 00:16:30.232319|2017-10-11 00:16:30.232319
NCT02176590|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-11-30|||August 2014||2014-08-01|November 2015|2015-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Improving Family Well-Being and Child School Readiness: Power PATH Dual Generation Intervention|Improving Family Well-Being and Child School Readiness: Power PATH Dual Generation Intervention With Head Start Preschoolers and Their Parents|Enrolling by invitation||Phase 2|540|Anticipated|University of Alabama, Tuscaloosa||2|||f||||t||||||||||2017-10-11 00:16:18.565863|2017-10-11 00:16:18.565863
NCT02176577|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-26|||June 2012||2012-06-01|June 2014|2014-06-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Study to Determine the Pharmacokinetics of Product 0405|An Open-Label, Multi-Center Study to Determine the Pharmacokinetics of Product 0405 in the Treatment of Atopic Dermatitis in Adolescent Subjects|Withdrawn||Phase 3|0|Actual|Fougera Pharmaceuticals Inc.||1||Business Reasons|f||||f||||||||||2017-10-11 00:16:18.653334|2017-10-11 00:16:18.653334
NCT02176564|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-17|||June 1999||1999-06-01|June 2014|2014-06-01||||October 2000|Actual|2000-10-01||Observational|||Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease|COPD, Inhaled Bronchodilators Association, and Quality of Life|Completed||N/A|2639|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:16:18.72974|2017-10-11 00:16:18.72974
NCT02176551|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-26|||June 2012||2012-06-01|June 2014|2014-06-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects|A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Product 0405 To A Vehicle Control In The Treatment Of Mild To Moderate Atopic Dermatitis In Pediatric Subjects|Withdrawn||Phase 3|0|Actual|Fougera Pharmaceuticals Inc.||2||Business Reasons|f||||f||||||||||2017-10-11 00:16:18.800905|2017-10-11 00:16:18.800905
NCT02176538|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-26|||June 2012||2012-06-01|June 2014|2014-06-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects|A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Product 0405 To A Vehicle Control In The Treatment Of Mild To Moderate Atopic Dermatitis In Pediatric Subjects|Withdrawn||Phase 3|0|Actual|Fougera Pharmaceuticals Inc.||2||Business Reasons|f||||f||||||||||2017-10-11 00:16:18.88382|2017-10-11 00:16:18.88382
NCT02176525|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-04-28|2016-01-21||December 2007||2007-12-01|April 2016|2016-04-01||||December 2009|Actual|2009-12-01||Interventional||Treated set (TS) included all patients who were dispensed study medication and were documented to have taken at least one dose of study treatment, regardless of randomisation. Full analysis set (FAS) included all randomised patients who were dispensed study medication and were documented to have taken at least one dose of study medication.|Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients|Safety, Antiviral Activity, and Pharmacokinetics of Multiple Oral Doses of BI 207127 NA Administered q8H for 5 Days as Monotherapy, a Randomised, Double-blind, Placebo Controlled Study|Completed||Phase 1|75|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:16:19.025752|2017-10-11 00:16:19.025752
NCT02176512|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||September 1998||1998-09-01|July 2014|2014-07-01||||October 1998|Actual|1998-10-01||Interventional|||Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects|Relative Oral Bioavailability of 80 mg Telmisartan / 12.5 mg HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Subjects. A 4 Period Cross-over, Open, Randomized, Replicate Design Study.|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:21.735582|2017-10-11 00:16:21.735582
NCT02176499|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2014-07-07|||February 1999||1999-02-01|July 2014|2014-07-01||||July 1999|Actual|1999-07-01||Interventional|||Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension|Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension On a Controlled Sodium Diet (100 mmol/Day)|Completed||Phase 3|26|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:16:21.806553|2017-10-11 00:16:21.806553
NCT02176486|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-06-06|||July 9, 2014|Actual|2014-07-09|June 2017|2017-06-01|June 8, 2018|Anticipated|2018-06-08|June 8, 2018|Anticipated|2018-06-08||Interventional|||Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis|Recruiting||Phase 1|40|Anticipated|Takeda||5|||f||||f|t|f||||||||2017-10-11 00:16:21.895907|2017-10-11 00:16:21.895907
NCT02176473|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-01-05|||June 2014||2014-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2015|Actual|2015-08-01||Interventional|||Computerized Cognitive Behavioral Therapy and Electroconvulsive Therapy|Evaluating the Feasibility and Efficacy of Computerized Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Electroconvulsive Therapy|Completed||N/A|30|Actual|Yale University||1|||f||||f||||||||||2017-10-11 00:16:22.168281|2017-10-11 00:16:22.168281
NCT02176460|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-26|2016-04-14|||October 2013||2013-10-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Colchicine for Symptom and Inflammation in Knee Osteoarthritis|A Randomized Controlled Trial of Colchicine for Symptom and Inflammation Modification in Knee Osteoarthritis|Completed||Phase 2/Phase 3|109|Actual|Singapore General Hospital||2|||f||||f||||||||Undecided||2017-10-11 00:16:22.277091|2017-10-11 00:16:22.277091
NCT02176434|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-05-03|||September 2015||2015-09-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Pilot Feasibility Study of Combined Kidney and Hematopoietic Stem Cell Transplantation to Cure End-stage Renal Disease|Pilot Feasibility Study of Combined Kidney and Hematopoietic Stem Cell Transplantation to Cure End-stage Renal Disease|Recruiting||N/A|10|Anticipated|University of Zurich||1|||f||||t||||||||No||2017-10-11 00:16:22.403109|2017-10-11 00:16:22.403109
NCT02176421|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-03-09|2015-06-22||May 2014||2014-05-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|August 2014|Actual|2014-08-01||Interventional|||A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area||Completed||N/A|80|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:16:22.551147|2017-10-11 00:16:22.551147
NCT02176408|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-04-05|||June 2014||2014-06-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression|Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression|Active, not recruiting||N/A|38|Actual|Boston University||2|||f||||f||||||||||2017-10-11 00:16:23.102074|2017-10-11 00:16:23.102074
NCT02176395|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-09-27|||June 2014||2014-06-01|September 2014|2014-09-01||||August 2015|Anticipated|2015-08-01||Interventional|||"Multi-Omics Research of Danhong Injection to Treat Acute Ischemic Stroke"|"Multi-Omics Research of Danhong Injection to Treat Acute Ischemic Stroke"|Unknown status|Recruiting|Phase 4|46|Anticipated|China Academy of Chinese Medical Sciences||3|||f||||t||||||||||2017-10-11 00:16:23.227572|2017-10-11 00:16:23.227572
NCT02176382|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-04-20|||August 2014||2014-08-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|DATA-HD||Denosumab and Teriparatide Study (DATA-HD and DATA-EX)|Denosumab and Teriparatide Study (DATA-HD and DATA-EX)|Active, not recruiting||Phase 4|76|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:16:23.360004|2017-10-11 00:16:23.360004
NCT02176369|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-05-23|||February 2013||2013-02-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|ONC-MANILA12||Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial|Maintenance Metronomic Per OS Navelbine In Advanced NSCLC Patients After Previous Platinum Based Chemotherapy: A Multicenter Randomized Best Supportive Care Controlled Phase II Study - MA.NI.LA. Trial|Active, not recruiting||Phase 2|120|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||t||||||||||2017-10-11 00:16:23.474265|2017-10-11 00:16:23.474265
NCT02176356|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-07-25|2016-05-10||June 2014||2014-06-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Safety population included all enrolled participants who received any study treatment.|Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)||Completed||Phase 4|116|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:16:23.66919|2017-10-11 00:16:23.66919
NCT02176343|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-05-30|2017-03-29||July 21, 2014|Actual|2014-07-21|May 2017|2017-05-01|August 22, 2014|Actual|2014-08-22|August 22, 2014|Actual|2014-08-22||Interventional||As Treated|Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses|Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses|Completed||N/A|37|Actual|Alcon Research||1|||f||||f|f|t|f|f|t|||||2017-10-11 00:16:24.100273|2017-10-11 00:16:24.100273
NCT02176330|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-25|||June 2008||2008-06-01|June 2014|2014-06-01|August 2012|Actual|2012-08-01|September 2010|Actual|2010-09-01||Interventional|||Does Using a 'Virtual Clinic' in Urogynaecology Improve Patient Experience and Reduce Cost?|Assessing the Impact of Using ePAQ on Quality and Cost of Patient Care in Uro-gynaecology: a Randomised Controlled Trial|Completed||N/A|195|Actual|University of Sheffield||2|||f||||f||||||||||2017-10-11 00:16:24.354022|2017-10-11 00:16:24.354022
NCT02176317|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-06-27|||June 2014||2014-06-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)|Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)|Completed||Phase 1|25|Actual|Duke University||1|||f||||t||||||||||2017-10-11 00:16:24.449744|2017-10-11 00:16:24.449744
NCT02176304|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-05-30|||June 2014|Actual|2014-06-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Does Injection Site Matter? A Randomized Controlled Trial to Evaluate Efficacy of Knee Intraarticular Injections on Improval of Patient Reported Outcomes.|Does Injection Site Matter? A Randomized Controlled Trial to Evaluate Efficacy of Knee Intraarticular Injections on Improval of Patient Reported Outcomes.|Completed||Phase 4|60|Actual|University of Puerto Rico||2|||f||||f||||||||||2017-10-11 00:16:24.559929|2017-10-11 00:16:24.559929
NCT02176278|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-08-12|||May 2014||2014-05-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|DKD-TMT||Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)|Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT) (DKD-TMT)|Recruiting||N/A|3000|Anticipated|Asia Diabetes Foundation||3|||f||||f||||||||||2017-10-11 00:16:24.757048|2017-10-11 00:16:24.757048
NCT02176265|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-09-02|||September 2014||2014-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|||Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation|Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation|Completed||N/A|31|Actual|Qvanteq AG||1|||f||||t||||||||||2017-10-11 00:16:24.902321|2017-10-11 00:16:24.902321
NCT02176252|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-06-26|||July 2013||2013-07-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects|A Phase I, Double-blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects in Healthy Male and Female Japanese Subjects After Single and Multiple Doses (Bid) of AZD1722|Completed||Phase 1|83|Actual|Ardelyx||1|||f||||f||||||||||2017-10-11 00:16:25.033069|2017-10-11 00:16:25.033069
NCT02176239|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-03-14|||June 2014||2014-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting|Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting|Active, not recruiting||N/A|20|Anticipated|AxelaCare Health Solutions, LLC|||1||f||||f||||||||||2017-10-11 00:16:25.209511|2017-10-11 00:16:25.209511
NCT02176213|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-01-05|||June 2014||2014-06-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma|A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 2|35|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 00:16:25.421099|2017-10-11 00:16:25.421099
NCT02176200|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-11|||April 2003||2003-04-01|July 2014|2014-07-01||||December 2004|Actual|2004-12-01||Interventional|||Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised Open Label, Six Way, Cross-over Scintigraphic Evaluation of the Effect of Inspiratory Flow Rate on Lung and Oropharyngeal Deposition With the Respimat® Inhaler vs a Metered Dose Inhaler (HFA-MDI) Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Terminated||Phase 3|3|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:25.526228|2017-10-11 00:16:25.526228
NCT02176187|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-11|||April 2003||2003-04-01|July 2014|2014-07-01||||December 2004|Actual|2004-12-01||Interventional|||Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease|A Randomised Open Label, Four Way, Cross-over Scintigraphic Evaluation of the Respimat® Inhaler vs a Metered Dose Inhaler (HFA-MDI) Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Poor MDI Technique|Terminated||Phase 3|3|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:25.615359|2017-10-11 00:16:25.615359
NCT02176174|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-06-07|||December 2013|Actual|2013-12-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Observational|||Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study|Ethnicity and Incidence of Twelve Cardiovascular Diseases: A CALIBER Study|Completed||N/A|1068318|Actual|University College, London|||4||f||||t||||||||||2017-10-11 00:16:25.695396|2017-10-11 00:16:25.695396
NCT02176161|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-11-02|||June 2014||2014-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Metformin Prostate Cancer Adjuvant Trial|Phase II Clinical Study of Effect of Metformin on Prostate Specific Antigen Doubling Time|Recruiting||Phase 2|70|Anticipated|Winthrop University Hospital||2|||f||||f||||||||Undecided||2017-10-11 00:16:25.793887|2017-10-11 00:16:25.793887
NCT02176148|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-01-09|||December 2014||2014-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Cutaneous Lupus Medication Experience Study|Cutaneous Lupus Medication Experience Study|Recruiting||Early Phase 1|40|Anticipated|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-10-11 00:16:25.879255|2017-10-11 00:16:25.879255
NCT02176135|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-02-25||||||February 2015|2015-02-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|Goldrake||Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection|A Dose Escalation Phase I Study to Evaluate the Safety and Tolerability of Oral Auranofin Therapy in HIV-infected Subjects Receiving Suppressive Antiretroviral Therapy|Withdrawn||Phase 1/Phase 2|0|Actual|Vaccine and Gene Therapy Institute, Florida||1|||f||||t||||||||||2017-10-11 00:16:25.986709|2017-10-11 00:16:25.986709
NCT02176122|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-08-14|||February 2014||2014-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|MERINO||RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.|Randomized Controlled Trial of Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Due to Ceftriaxone Non-susceptible E. Coli and Klebsiella Species.|Suspended||Phase 4|454|Anticipated|The University of Queensland||2||Secondary to third interim analysis by the study DSMB.|f||||t||||||||||2017-10-11 00:16:26.073828|2017-10-11 00:16:26.073828
NCT02176109|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-25|||June 2013||2013-06-01|June 2013|2013-06-01|June 2018|Anticipated|2018-06-01|June 2015|Anticipated|2015-06-01||Observational|LAM-ROS||Metabolism Des LAM|Rôle Pronostique Des métabolismes du Stress Oxydatif et du Fer Dans Les Leucémies Aiguës Myéloblastiques|Recruiting||N/A|80|Anticipated|University Hospital, Grenoble|||1||f||||t||||||Samples Without DNA|"     leukemic cells in order to rna and proteins study medullar plasma   "|||2017-10-11 00:16:26.231523|2017-10-11 00:16:26.231523
NCT02176096|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-08-02|||July 2014||2014-07-01|August 2017|2017-08-01|August 2, 2017|Actual|2017-08-02|August 2016|Actual|2016-08-01||Interventional|Glycosade GSD||Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial|Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial|Completed||N/A|4|Actual|University of Manitoba||1|||f||||t||||||||||2017-10-11 00:16:26.313089|2017-10-11 00:16:26.313089
NCT02176083|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-12-02|||March 2014||2014-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|August 2014|Actual|2014-08-01||Interventional|||Reproductive Health Survivorship Care Plan Pilot|Intervening on Reproductive Health in Young Breast Cancer Survivors|Completed||N/A|40|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:16:26.421016|2017-10-11 00:16:26.421016
NCT02176070|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-25|||February 2011||2011-02-01|June 2014|2014-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01|1 Year|Observational [Patient Registry]|||Reproductive Health in Men and Women With Vasculitis|Reproductive Health in Men and Women With Vasculitis|Completed||N/A|467|Actual|University of South Florida|||1||f||||t||||||||||2017-10-11 00:16:26.517899|2017-10-11 00:16:26.517899
NCT02176057|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-05-19|||August 2014||2014-08-01|May 2015|2015-05-01||||August 2014|Actual|2014-08-01||Interventional|NETS||Nepal Elimination of Trachoma Study|Nepal Elimination of Trachoma Study|Withdrawn||Phase 2/Phase 3|0|Actual|University of California, San Francisco||2||Nepal Ministry of Health implemented public drug treatment prior to the proposed start date|f||||||||||||||2017-10-11 00:16:28.455423|2017-10-11 00:16:28.455423
NCT02176044|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-03-08|||August 2014||2014-08-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of Nitric Oxide on Spatial Working Memory in Patients With Schizophrenia - Pilot Study|The Effect of Nitric Oxide on Spatial Working Memory in Patients With Schizophrenia - Pilot Study|Completed||Phase 1|21|Actual|King's College London||2|||f||||f||||||||||2017-10-11 00:16:28.52553|2017-10-11 00:16:28.52553
NCT02176031|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-04-03|||January 2015||2015-01-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|April 2019|Anticipated|2019-04-01||Interventional|||Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract|Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract|Recruiting||Phase 2|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:16:28.621657|2017-10-11 00:16:28.621657
NCT02175264|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-06-23|||June 2014||2014-06-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Observational|HCD GENE||Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia|Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia|Completed||N/A|73|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 00:16:38.8377|2017-10-11 00:16:38.8377
NCT02176018|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-03-21|||August 2014|Actual|2014-08-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine|A Randomized Pilot Study of Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine|Completed||Phase 2|45|Actual|Cady, Roger, M.D.||2|||f||||f||||||||||2017-10-11 00:16:28.731963|2017-10-11 00:16:28.731963
NCT02176005|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-02-03|||March 2014||2014-03-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Efficacy Study of DAV132 in Healthy Volunteers|Influence of the Administration of DAV132 7.5g Tid for 7 Days on the Fecal Levels of Moxifloxacin During and After a 5-day Oral Treatment With Moxifloxacin 400mg Oad in Healthy Volunteers|Completed||Phase 1|44|Actual|Da Volterra||4|||f||||f||||||||||2017-10-11 00:16:28.824478|2017-10-11 00:16:28.824478
NCT02175992|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-06-25|||March 2012||2012-03-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01|24 Months|Observational [Patient Registry]|||Quality of Life After Surgery for Pancreatic Carcinoma|Quality of Life After Surgery for Pancreatic Carcinoma|Unknown status|Recruiting|N/A|300|Anticipated|UMC Utrecht|||1||f||||f||||||||||2017-10-11 00:16:28.912116|2017-10-11 00:16:28.912116
NCT02175979|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-02-24|||August 2014||2014-08-01|February 2017|2017-02-01|August 31, 2017|Anticipated|2017-08-31|March 20, 2017|Anticipated|2017-03-20||Interventional|SANICSII||SANICS II Trial: Stimulation of the Autonomic Nervous System in Colorectal Surgery by Perioperative Nutrition|SANICS II Trial: A Multicenter Prospective Double-blind Randomized Controlled Trial Investigating the Effect of Stimulation of the Autonomic Nervous System in Colorectal Surgery by Perioperative Nutrition|Active, not recruiting||Phase 3|280|Actual|Catharina Ziekenhuis Eindhoven||2|||f||||t||||||||||2017-10-11 00:16:28.982596|2017-10-11 00:16:28.982596
NCT02175966|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-03-22||2017-03-22|July 2014||2014-07-01|July 2015|2015-07-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|FOURward||Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)|Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis C (FOURward Study)|Completed||Phase 2|28|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 00:16:29.085405|2017-10-11 00:16:29.085405
NCT02175953|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-10-25|||June 2014||2014-06-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Interventional|||Short-term Caregiver Psychotherapy|Psychotherapeutical Short-term Intervention for Caregivers of Persons With Dementia|Completed||Phase 2|13|Actual|University of Rostock||2|||f||||f||||||||||2017-10-11 00:16:29.199043|2017-10-11 00:16:29.199043
NCT02175940|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-25|||July 2013||2013-07-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Observational|||VEGF and PEDF in Patients With Myopic Choroidal Neovascularization|Effect of Intravitreal Ranibizumab Injection on Aqueous Humor Concentrations of Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor in Patients With Myopic Choroidal Neovascularization.|Completed||N/A|40|Actual|Università degli Studi di Brescia|||2||f||||||||||||||2017-10-11 00:16:29.405115|2017-10-11 00:16:29.405115
NCT02175914|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-06-25|||June 2014||2014-06-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis|Erythromycin as a Novel Therapy Against Familial Adenomatous Polyposis and Sporadic Colorectal Cancer by APC Nonsense Mutation Readthrough.|Unknown status|Recruiting|Phase 4|20|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 00:16:29.62259|2017-10-11 00:16:29.62259
NCT02175901|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-02-02|||July 2014||2014-07-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication|Prospective, Randomized Controlled Trial Comparing Amoxicillin and Metronidazole Based Bismuth-containing Quadruple Therapy With Amoxicillin and Clarithromycin Based Quadruple Therapy for First-line Helicobacter Pylori Eradication|Completed||Phase 4|215|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||||2017-10-11 00:16:29.734469|2017-10-11 00:16:29.734469
NCT02175888|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-04-13|||October 2015||2015-10-01|May 2015|2015-05-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||The Optimization of Bioavailability From Iron Supplements: Study 1|The Optimization of Bioavailability From Iron Supplements: Examinations of Different Supplementation Regimens Including Hepcidin Profiles|Completed||N/A|20|Actual|Swiss Federal Institute of Technology||2|||f||||||||||||||2017-10-11 00:16:29.867297|2017-10-11 00:16:29.867297
NCT02175875|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-04-06|||September 2014||2014-09-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|TICOMA||Ticagrelor for the Comatose|The Effect of Antithrombotic Treatment Administrated Through Nasogastric Tubes to Comatose Patients Undergoing Acute Percutaneous Coronary Intervention|Completed||N/A|47|Actual|Rigshospitalet, Denmark|||1||f||||t||||||Samples Without DNA|"     plasma and urine   "|||2017-10-11 00:16:29.963839|2017-10-11 00:16:29.963839
NCT02175862|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2015-10-27|||December 2009||2009-12-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01|3 Years|Observational [Patient Registry]|||Long-term Evaluation of Patients Treated by an Emergency Medical Helicopter|Long-term Evaluation of Patients Treated by an Emergency Medical Helicopter|Completed||N/A|1791|Actual|Rigshospitalet, Denmark|||2||f||||t||||||||||2017-10-11 00:16:30.055785|2017-10-11 00:16:30.055785
NCT02175849|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2016-11-13|||December 2013||2013-12-01|July 2014|2014-07-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|SNAP||Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis|Contact Tracing by Social Network Analysis to Enhance Multi-Drug Resistant Tuberculosis Case Finding in Hanoi, Vietnam|Completed||N/A|596|Actual|Oxford University Clinical Research Unit, Vietnam|||2||f||||f||||||Samples With DNA|"     Sputum Gastric Aspirate   "|||2017-10-11 00:16:30.149943|2017-10-11 00:16:30.149943
NCT02175823|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-03|||July 2014||2014-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Health Status Evaluation for Cancer Survivors by Non-intrusive Sensing System|Health Status Evaluation for Cancer Survivors by Non-intrusive Sensing System|Unknown status|Not yet recruiting|N/A|40|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:16:30.34398|2017-10-11 00:16:30.34398
NCT02175810|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-06-30|||June 2014||2014-06-01|June 2014|2014-06-01||||June 2015|Anticipated|2015-06-01||Observational|||Impact of Bariatric Surgery on Cardiorespiratory Function|Impact of Bariatric Surgery on Cardiorespiratory Function: an Observational Study|Unknown status|Recruiting|N/A|24|Anticipated|St George's, University of London|||1||f||||f||||||||||2017-10-11 00:16:30.44386|2017-10-11 00:16:30.44386
NCT02175797|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-02-17|||February 2014||2014-02-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|IKONE||Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System|Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System|Completed||Phase 3|33|Actual|LivaNova||1|||f||||f||||||||||2017-10-11 00:16:30.531353|2017-10-11 00:16:30.531353
NCT02175784|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-02-14|||March 2014||2014-03-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus|Post-marketing Clinical Study of Ipragliflozin -Study to Assess the Efficacy, Safety and Tolerability of Ipragliflozin in Combination With Insulin Preparation in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Therapy-|Completed||Phase 4|262|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 00:16:30.631439|2017-10-11 00:16:30.631439
NCT02175771|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-03-02|2017-03-02||July 2014||2014-07-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Safety population which included all randomized participants who received at least 1 dose of randomized study drug|Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma|A 26-Week Open-Label Study to Assess the Long-Term Safety of Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients 12 Years of Age and Older With Persistent Asthma|Completed||Phase 3|758|Actual|Teva Pharmaceutical Industries||8|||f||||f|t|||||||||2017-10-11 00:16:30.815605|2017-10-11 00:16:30.815605
NCT02175758|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-06-13|||June 30, 2014|Actual|2014-06-30|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection|A Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection|Active, not recruiting||Phase 2|104|Actual|Gilead Sciences||7|||f||||t|t|f||||||||2017-10-11 00:16:33.971252|2017-10-11 00:16:33.971252
NCT02175745|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-01-30|2017-01-30||December 2014||2014-12-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas|18F-FDOPA PET/CT or PET/MRI in Patients With Gliomas|Terminated||N/A|2|Actual|Stanford University|This study was underpowered due to low enrollment|1||Re-evaluate indication with the referring physicians|f||||t||||||||No||2017-10-11 00:16:34.168038|2017-10-11 00:16:34.168038
NCT02175732|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-06-02|||September 2014||2014-09-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|T1REDEEM||Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes|Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes|Unknown status|Recruiting|N/A|290|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:16:34.565459|2017-10-11 00:16:34.565459
NCT02175719|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-02-20|||April 16, 2013|Actual|2013-04-16|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A||Recruiting||N/A|150|Anticipated|Eisai Inc.|||1||f||||||||||||||2017-10-11 00:16:34.67565|2017-10-11 00:16:34.67565
NCT02175706|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-02-02|||November 2010||2010-11-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|May 2013|Actual|2013-05-01||Interventional|DUTCHPEERS||DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity|DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity (DUTCH PEERS): Randomized Multicenter Trial in All-Comers Population Treated Within Eastern NeThErlands-2 (TWENTE-2).|Active, not recruiting||N/A|1811|Actual|Thorax Centrum Twente||2|||f||||t|f|f||||||Undecided||2017-10-11 00:16:34.748703|2017-10-11 00:16:34.748703
NCT02175693|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-02-20|||April 2, 2013|Actual|2013-04-02|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia||Recruiting||N/A|150|Anticipated|Eisai Inc.|||1||f||||||||||||||2017-10-11 00:16:34.974569|2017-10-11 00:16:34.974569
NCT02175680|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-12-14|||May 2014||2014-05-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection|A Phase 2b Study to Assess Suppression of HIV-1 Replication Following Substitution of Stable Combination Antiretroviral Therapy With a PRO 140 (Monoclonal CCR5 Antibody) Monotherapy in Adult Subjects With HIV-1 Infection|Completed||Phase 2|43|Actual|CytoDyn, Inc.||1|||f||||t||||||||||2017-10-11 00:16:35.072205|2017-10-11 00:16:35.072205
NCT02175667|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-12-15|||July 2014||2014-07-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|RPG-POSTURE||Influence of the Global Postural Reeducation and the Personality in the Posture|Influence of the Global Postural Reeducation and the Personality Traits in the Range of Motion, in the Stabilometry and in the Postural Sway.|Completed||N/A|76|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||||2017-10-11 00:16:35.176989|2017-10-11 00:16:35.176989
NCT02175459|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-08-01|||August 2010||2010-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy||Recruiting||N/A|100|Anticipated|Catholic University of the Sacred Heart|||1||f||||t||||||Samples Without DNA|"     PANCREAS SAMPLES   "|||2017-10-11 00:16:36.850378|2017-10-11 00:16:36.850378
NCT02175654|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-07-31|||June 2014||2014-06-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PREVIUM||Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab|Phase II Study of Regorafenib as Single Agent for the Treatment of Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab|Terminated||Phase 2|15|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1||The trial was prematurely closed due to lack of accrual|f||||f||||||||||2017-10-11 00:16:35.292016|2017-10-11 00:16:35.292016
NCT02175641|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-09-14|||July 2015||2015-07-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Peer-Led Healthy Lifestyle Program in Supportive Housing|Peer-Led Healthy Lifestyle Program in Supportive Housing Agencies|Recruiting||N/A|300|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:16:35.398222|2017-10-11 00:16:35.398222
NCT02175628|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-04-24|||June 2014||2014-06-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Comparison of the Sensitivity and Specificity of Acoustic Angiography to the Sensitivity and Specificity of Conventional Ultrasound|Comparison of the Sensitivity and Specificity of Acoustic Angiography (Micro-tumor Detection by Quantifying Tumor-induced Vascular Abnormalities) to the Sensitivity and Specificity of Conventional Ultrasound|Recruiting||N/A|60|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:16:35.49658|2017-10-11 00:16:35.49658
NCT02175615|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-01-19|||October 2010||2010-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Pharmacological Predictors of Successful Cyclosporine Acute GVHD Prophylaxis in Children Undergoing HSCT|PHARMACOLOGICAL PREDICTORS OF SUCCESSFUL CYCLOSPORINE ACUTE GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN CHILDREN UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANT|Completed||N/A|105|Actual|The Hospital for Sick Children|||1||f||||||||||||||2017-10-11 00:16:35.607228|2017-10-11 00:16:35.607228
NCT02175602|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-02-09|||June 2014||2014-06-01|February 2015|2015-02-01||||August 2014|Actual|2014-08-01||Interventional|||Study of Drug Combination on Pharmacokinetics in Healthy Volunteers|Effect of a Combination of Daclatasvir, Asunaprevir, and BMS-791325 on the Pharmacokinetics of Selective Serotonin Reuptake Inhibitors in Healthy Subjects|Completed||Phase 1|41|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:16:35.698181|2017-10-11 00:16:35.698181
NCT02175589|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-25|||June 2014||2014-06-01|June 2014|2014-06-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation|Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation|Unknown status|Enrolling by invitation|Phase 2|80|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 00:16:35.808426|2017-10-11 00:16:35.808426
NCT02175576|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-01-23|||October 2014|Actual|2014-10-01|January 2017|2017-01-01|October 2026|Anticipated|2026-10-01|October 2026|Anticipated|2026-10-01||Interventional|GK9B||Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System|Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System|Active, not recruiting||N/A|306|Anticipated|Zimmer Biomet||2|||f||||f||||||||No||2017-10-11 00:16:35.919281|2017-10-11 00:16:35.919281
NCT02175563|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-08-25|||August 2014||2014-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Tilt Cardiopulmonary Resuscitation With a Feedback Device||Completed||N/A|36|Actual|Hanyang University||2|||f||||||||||||||2017-10-11 00:16:36.029535|2017-10-11 00:16:36.029535
NCT02175550|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-03-27|||March 2011||2011-03-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||A 5-year Clinical Evaluation Study on NobelReplace Conical Connection Implants|An Open, Prospective, Single Cohort, Multi-centre Study Evaluating the NobelReplace Conical Connection Implants Supported Single -Unit Crowns in the Maxilla.|Active, not recruiting||N/A|99|Actual|Nobel Biocare||1|||f||||f||||||||||2017-10-11 00:16:36.122209|2017-10-11 00:16:36.122209
NCT02175537|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-12-18|||June 2014||2014-06-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar|Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar|Completed||N/A|64|Actual|Microclinic International||2|||f||||f||||||||||2017-10-11 00:16:36.204835|2017-10-11 00:16:36.204835
NCT02175524|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-24|||April 2014||2014-04-01|June 2014|2014-06-01||||December 2017|Anticipated|2017-12-01||Observational|||The Association Between Areca-nut Chewing Habit and Metabolic Syndrome||Recruiting||N/A|200|Anticipated|Taichung Veterans General Hospital|||2||f||||f||||||||||2017-10-11 00:16:36.318256|2017-10-11 00:16:36.318256
NCT02175511|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-24|||December 2012||2012-12-01|June 2012|2012-06-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||A Randomized Controlled Trial for Hypertension Control by Integrating Cloud BP System and CPOE|Cloud BP System Integrated With CPOE Improves Self-Management of the Hypertensive Patients: A Randomized Controlled Trial Study|Completed||N/A|382|Actual|Taipei Medical University||2|||f||||f||||||||||2017-10-11 00:16:36.428587|2017-10-11 00:16:36.428587
NCT02175498|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-08-05|||June 2014||2014-06-01|April 2015|2015-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Homeopathic Treatment in Female Infertility|A Clinical Study to Assess the Effectiveness of Homeopathic Treatment in Female Infertility|Recruiting||Phase 3|40|Anticipated|Fr Muller Homoeopathic Medical College||1|||f||||t||||||||||2017-10-11 00:16:36.532167|2017-10-11 00:16:36.532167
NCT02175485|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2015-12-17|||June 2014||2014-06-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Evaluation of Efficacy of Dellegra in Exposure Unit|Evaluation of Efficacy of Dellegra® Combination Tablet (Fexofenadine Hydrochloride 30mg /Pseudoephedrine Hydrochloride 60mg) in Allergic Rhinitis After Japanese Cedar Antigen Exposure in Japanese Population. Open Label Study|Completed||Phase 4|24|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:16:36.649944|2017-10-11 00:16:36.649944
NCT02175472|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-04-13|||June 2014||2014-06-01|April 2017|2017-04-01|December 23, 2016|Actual|2016-12-23|October 2016|Actual|2016-10-01||Interventional|||Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease|Sixty Minute Exposure of Specific Bandwidth Light for the Treatment of Idiopathic Parkinson's Disease|Completed||N/A|92|Actual|PhotoPharmics, Inc.||2|||f||||f||||||||||2017-10-11 00:16:36.752845|2017-10-11 00:16:36.752845
NCT02175446|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-06-14|||September 2014||2014-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|GIM11-BERGI||Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients|A Phase II Single Arm Trial Evaluating the Efficacy and Safety of Eribulin in Combination With Bevacizumab for 2-Line Treatment of HER 2-Negative Metastatic Breast Cancer Progressing After 1-Line Therapy With Bevacizumab and Paclitaxel|Recruiting||Phase 2|61|Anticipated|Consorzio Oncotech||1|||f||||t||||||||No||2017-10-11 00:16:37.221104|2017-10-11 00:16:37.221104
NCT02175433|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-05-02|||October 14, 2014|Actual|2014-10-14|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies|A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies|Recruiting||Phase 1|85|Anticipated|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:16:37.447089|2017-10-11 00:16:37.447089
NCT02175420|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-02-22|||July 2012||2012-07-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Role of BCG as Booster Vaccination|Role of BCG Vaccination as Booster on Salmonella Typhi Vaccine|Completed||N/A|30|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 00:16:37.563375|2017-10-11 00:16:37.563375
NCT02175407|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-01|||April 2014||2014-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects|A Phase 1, One Sequence, Cross-over Pharmacokinetic Study to Assess the Interaction Between ASP1707 and Itraconazole, a CYP3A and P-gp Inhibitor in Healthy Female Subjects|Completed||Phase 1|14|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:16:37.678981|2017-10-11 00:16:37.678981
NCT02175394|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-04|||July 2008||2008-07-01|July 2014|2014-07-01||||October 2008|Actual|2008-10-01||Interventional|||Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal Subjects|An Open, Two-period, Fixed-sequence, Phase I Trial to Evaluate the Effect of Multiple Doses of BI 1356 on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel|Completed||Phase 1|18|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:37.786248|2017-10-11 00:16:37.786248
NCT02175381|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2015-05-14|||February 2011||2011-02-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC|A Phase I/II Trial of the Carboplatin/Gemcitabine Combination as First Line Treatment for Elderly Patients With Stage IV NSCLC.|Completed||Phase 1/Phase 2|69|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-10-11 00:16:37.877116|2017-10-11 00:16:37.877116
NCT02175368|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-08-29|||June 2012||2012-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2015|Actual|2015-06-01||Interventional|||Adhese One F Upgrade in Direct Filling Therapy|Clinical Evaluation of AdheSE One F Upgrade in Direct Filling Therapy|Active, not recruiting||N/A|28|Actual|Ivoclar Vivadent AG||1|||f||||f||||||||||2017-10-11 00:16:37.977232|2017-10-11 00:16:37.977232
NCT02175355|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-07|||October 1999||1999-10-01|July 2014|2014-07-01||||August 2000|Actual|2000-08-01||Interventional|ARAMIS||Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)|A Randomised, Double- Blind, Placebo-controlled, 6 Week Parallel-group Trial on the Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan 20 mg, 40 mg or 80 mg, p.o. Once Daily) or Hydrochlorothiazide 12.5 mg p.o. Once Daily in the Management of Patients With Isolated Systolic Hypertension (ISH). (ARAMIS - Study = Angiotensin II Receptor Antagonist Micardis in Isolated Systolic Hypertension)|Completed||Phase 3|1039|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:16:38.042843|2017-10-11 00:16:38.042843
NCT02175342|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-25|||March 1998||1998-03-01|June 2014|2014-06-01||||April 1999|Actual|1999-04-01||Interventional|||Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized, 3-week Multiple-dose, Placebo Controlled, Intraformulation Double-blind, Parallel Group Study|Completed||Phase 2|202|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-11 00:16:38.276722|2017-10-11 00:16:38.276722
NCT02175329|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-03-01|||January 2010||2010-01-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Clinical Investigation on Zirconia-ceramic Three-unit Bridges With CAD-on Veneering|A Randomized Clinical Trial of 3-unit Posterior Zirconia-ceramic Fixed Dental Prosthesis (FDPs) Veneered With Layered and Milled (CAD-on) Veneering Ceramics|Active, not recruiting||N/A|60|Actual|Ivoclar Vivadent AG||2|||f||||||||||||||2017-10-11 00:16:38.396383|2017-10-11 00:16:38.396383
NCT02175316|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-09-06|||April 2014||2014-04-01|September 2017|2017-09-01|September 6, 2017|Actual|2017-09-06|July 25, 2017|Actual|2017-07-25||Interventional|||Enhanced External Counterpulsation on Delayed Onset Muscle Soreness|Effects of Enhanced External Counterpulsation on Delayed Onset Muscle Soreness, a Pilot Study|Completed||N/A|18|Actual|David Grant U.S. Air Force Medical Center||1|||f||||f||||||||||2017-10-11 00:16:38.477141|2017-10-11 00:16:38.477141
NCT02175303|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-25|||December 2013||2013-12-01|June 2014|2014-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting||Recruiting||Phase 1/Phase 2|25|Anticipated|Karolinska Institutet||1|||f||||||||||||||2017-10-11 00:16:38.553252|2017-10-11 00:16:38.553252
NCT02175290|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2017-03-15|||June 2014||2014-06-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01|3 Years|Observational [Patient Registry]|||Machado-Joseph Disease in Israel|Machado-Joseph Disease in Israel: Clinical Phenotype and Genotype of a Jew Yemenite Subpopulation|Recruiting||N/A|250|Anticipated|Meir Medical Center|||1||f||||f||||||||Undecided||2017-10-11 00:16:38.659602|2017-10-11 00:16:38.659602
NCT02175277|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-04-11|||June 12, 2014|Actual|2014-06-12|March 2017|2017-03-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Interventional|||Darbepoetin Alfa MDS Companion Protocol|Single Arm, Companion Study to Myelodysplastic Syndrome (MDS) 20090160 Using Darbepoetin Alfa for the Treatment of Anaemic Subjects With Myelodysplastic Syndrome|Completed||Phase 3|9|Actual|Amgen||1|||f||||f||||||||||2017-10-11 00:16:38.735166|2017-10-11 00:16:38.735166
NCT02175238|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-23|||July 2014||2014-07-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects|Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects|Withdrawn||Phase 1|0|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:39.063491|2017-10-11 00:16:39.063491
NCT02175225|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-02-27|||October 2014||2014-10-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial|Study of Deferoxamine Mesylate in Intracerebral Hemorrhage|Recruiting||Phase 2|294|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-11 00:16:39.169063|2017-10-11 00:16:39.169063
NCT02175212|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-04-10|2016-05-04||November 2005||2005-11-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|June 2014|Actual|2014-06-01||Interventional|AADLPC||Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer|Phase III Multicenter Randomized Trial of Adjuvant Androgen Deprivation in Combination With Three-dimensional Conformal Radiotherapy Doses in High and Intermediate Risk Localized Prostate Cancer.|Active, not recruiting||Phase 3|362|Actual|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa|"Relatively short follow-up and low number of events.
The lack of patient-reported outcomes.
Our decision to include vascular events other than strictly cardiac events (e.g. the presence of CVA or thromboembolic disease)."|2|||f||||f||||||||||2017-10-11 00:16:40.026854|2017-10-11 00:16:40.026854
NCT02175199|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-09-14|2015-09-14||June 2014||2014-06-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||This analysis population includes all subjects / eyes exposed to any test articles evaluated in this study.|A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers|A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers|Completed||N/A|151|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:16:40.786216|2017-10-11 00:16:40.786216
NCT02175186|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2017-09-21|||January 2015||2015-01-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|DAPTALBIS||Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention|Protective Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention|Recruiting||Phase 4|60|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 00:16:41.027379|2017-10-11 00:16:41.027379
NCT02175173|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-20|||June 13, 2013|Actual|2013-06-13|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome||Active, not recruiting||N/A|715|Actual|Eisai Inc.|||1||f||||||||||||||2017-10-11 00:16:41.130659|2017-10-11 00:16:41.130659
NCT02175160|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-02-01|||July 2014||2014-07-01|June 2014|2014-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Predictability of the Ability to Perform an Emergency Stop|Predictability of the Ability to Perform an Emergency Stop in Knee Osteoarthritis and Patients With Total Knee Arthroplasty|Completed||N/A|60|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-11 00:16:41.208834|2017-10-11 00:16:41.208834
NCT02175147|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-25|||June 2014||2014-06-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|3 Months|Observational [Patient Registry]|InSup-C||Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease|Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease|Unknown status|Recruiting|N/A|576|Anticipated|Radboud University|||1||f||||f||||||||||2017-10-11 00:16:41.283472|2017-10-11 00:16:41.283472
NCT02175134|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-25|2014-07-04|||July 2014||2014-07-01|July 2014|2014-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis|IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis|Recruiting||N/A|90|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 00:16:41.375863|2017-10-11 00:16:41.375863
NCT02175121|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-05-10|2016-02-19||August 2014||2014-08-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of Pf-06291874 Given As Monotherapy To Adults With Type 2 Diabetes Mellitus|Completed||Phase 2|172|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 00:16:41.542198|2017-10-11 00:16:41.542198
NCT02175108|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2017-07-13|||June 2014||2014-06-01|October 2016|2016-10-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Diet and Activity in Cerebral Palsy|DIET, ACTIVITY AND MEDICAL CO-MORBIDITIES IN ADOLESCENTS and ADULTS WITH CEREBRAL PALSY: WHAT ARE THE EFFECTS ON THE METABOLIC PROFILE?|Completed||N/A|47|Actual|Shirley Ryan AbilityLab|||1||f||||f||||||||||2017-10-11 00:16:43.73231|2017-10-11 00:16:43.73231
NCT02175095|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-01-12|||July 2014||2014-07-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib|3'-Deoxy-3'-18F-fluorothymidine Positron Emission Tomography ([18F] FLT-PET) for the Prediction of Response to Regorafenib in the Metastatic Colorectal Cancer Patients Who Progressed After All Standard Therapies|Recruiting||N/A|68|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-11 00:16:43.809667|2017-10-11 00:16:43.809667
NCT02175082|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2017-09-11|||June 2014||2014-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Cycling in Parkinson's Disease|A Forced Cycling Exercise Program in Individuals With Parkinson's Disease: Can it Improve Gait Parameters?|Recruiting||N/A|24|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 00:16:43.918656|2017-10-11 00:16:43.918656
NCT02175069|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-07-09|||December 2013||2013-12-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Magnetic Resonance Imaging of Interscalene Plexus Block|Magnetic Resonance Imaging of Local Anesthetic Distribution: A Comparison of 5 and 15 Milliliters of Ropivacaine 0,75% for Ultrasound Guided Interscalene Plexus Blockade|Completed||Phase 4|30|Actual|Paracelsus Medical University||2|||f||||f||||||||||2017-10-11 00:16:44.034868|2017-10-11 00:16:44.034868
NCT02175056|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-10-05|||May 2014||2014-05-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study|A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study to Investigate the Tolerability, and Pharmacokinetics/Pharmacodynamics of HL2351 After a Single Subcutaneous Administration in Healthy Male Subjects|Completed||Phase 1|58|Actual|Handok Pharmaceuticals Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:16:44.16715|2017-10-11 00:16:44.16715
NCT02175043|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-04-24|||June 3, 2014|Actual|2014-06-03|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|||Clinical Benefits of Additional Complex Fractionated Atrial Electrogram Targeted Catheter Ablation for Longstanding Persistent Atrial Fibrillation||Completed||N/A|40|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:16:44.284333|2017-10-11 00:16:44.284333
NCT02175030|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-05-01|||August 2016||2016-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC|RAPID EC - Randomized Controlled Trial Assessing Pregnancy With Intrauterine Devices for Emergency Contraception|Recruiting||Phase 4|706|Anticipated|University of Utah||2|||f||||t||||||||No||2017-10-11 00:16:44.357439|2017-10-11 00:16:44.357439
NCT02175017|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-22|||June 2014||2014-06-01|April 2017|2017-04-01||||November 2015|Actual|2015-11-01||Interventional|||ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer|ONO-4538 Multicenter, Open-label, Uncontrolled, Phase II Study in Advanced Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|93|Anticipated|Ono Pharmaceutical Co. Ltd||1|||f||||f||||||||||2017-10-11 00:16:44.487472|2017-10-11 00:16:44.487472
NCT02175004|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-03-23|||June 2014||2014-06-01|March 2016|2016-03-01|August 2020|Anticipated|2020-08-01|March 2020|Anticipated|2020-03-01||Interventional|||Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)|An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (FAP)|Enrolling by invitation||Phase 3|172|Anticipated|Ionis Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 00:16:44.585734|2017-10-11 00:16:44.585734
NCT02174991|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-04-23|||June 2014||2014-06-01|April 2015|2015-04-01||||February 2015|Actual|2015-02-01||Interventional|||A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention|A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|New York Glaucoma Research Institute||2|||f||||||||||||||2017-10-11 00:16:44.71822|2017-10-11 00:16:44.71822
NCT02174965|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2014-06-24|||September 2012||2012-09-01|June 2014|2014-06-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|MiniHip||Wear and Migration in the Corin Mini-Hip/Metafix and ECIMA Polyethylene|RSA-measured in Vivo Wear, Migration and Micromotion in the Corin Mini-Hip/Metafix and ECIMA Polyethylene.|Recruiting||N/A|50|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-11 00:16:44.909691|2017-10-11 00:16:44.909691
NCT02174952|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-24|||July 2012||2012-07-01|June 2014|2014-06-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|SHIP||Self-help in Adjunct to Pharmacotherapy|Efficacy of a Self-help Parenting Intervention for Parents of Children With ADHD in Adjunct to Pharmacotherapy|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of Nottingham||2|||f||||f||||||||||2017-10-11 00:16:45.008248|2017-10-11 00:16:45.008248
NCT02174939|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2015-10-11|||February 2014||2014-02-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease|Cilostazol Enhances the Number and Functions of Circulating Endothelial Progenitor Cells and Endothelial Function Mediated Through Modification of Vasculogenesis and Angiogenesis Factors in Patients With Stable Coronary Artery Disease|Recruiting||Phase 4|300|Anticipated|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-11 00:16:45.130535|2017-10-11 00:16:45.130535
NCT02174926|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2016-05-09|||September 2014||2014-09-01|May 2016|2016-05-01||||January 2020|Anticipated|2020-01-01||Interventional|LASER||LASER Trial. LAparoscopic Elective Sigmoid Resection Following divERticulitis - a Multicenter, Prospective, Randomized Clinical Trial|LASER Trial. LAparoscopic Elective Sigmoid Resection Following divERticulitis - a Multicenter, Prospective, Randomized Clinical Trial|Recruiting||N/A|133|Anticipated|Helsinki University Central Hospital||2|||f||||||||||||||2017-10-11 00:16:45.23193|2017-10-11 00:16:45.23193
NCT02174900|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-01-29|||October 2014||2014-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)|Evaluation of the Safety of Primaquine in Combination With Artemether-lumefantrine in Glucose-6-phosphate Dehydrogynase Deficient Males With an Asymptomatic Malaria Infection in Burkina Faso (SAFEPRIM)|Completed||Phase 2/Phase 3|70|Actual|London School of Hygiene and Tropical Medicine||5|||f||||t||||||||||2017-10-11 00:16:45.458796|2017-10-11 00:16:45.458796
NCT02174887|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-03-27|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|MOAnab1||Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer|A Unicentric, Open Label, Mechanism of Action Trial, on the Biological Effect of Nab-paclitaxel Combined to Gemcitabine, in Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 1|19|Actual|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-11 00:16:45.539776|2017-10-11 00:16:45.539776
NCT02174874|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2014-06-24|||June 2011||2011-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2012|Actual|2012-05-01||Observational|||Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)|Comparison of Ondansetron Oral Solution to Orally Disintegrating Tablets for the Management of Suspected Viral Gastroenteritis in a Pediatric Emergency Department|Completed||N/A|462|Actual|Alberta Children's Hospital|||2||f||||f||||||||||2017-10-11 00:16:45.623515|2017-10-11 00:16:45.623515
NCT02174861|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-06-07|||June 30, 2014|Actual|2014-06-30|June 2017|2017-06-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|||A Study to Assess the Long-term Safety and Efficacy of AMG 334 in Chronic Migraine Prevention.|An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334|Completed||Phase 2|612|Actual|Amgen||1|||f||||f||||||||||2017-10-11 00:16:45.850118|2017-10-11 00:16:45.850118
NCT02174848|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-03-22|||June 2014||2014-06-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|TIRCON-EXT||Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration|Long-term Safety and Efficacy Study of Deferiprone in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)|Active, not recruiting||Phase 3|90|Anticipated|ApoPharma||1|||f||||t||||||||||2017-10-11 00:16:46.049461|2017-10-11 00:16:46.049461
NCT02174835|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-24|||September 2013||2013-09-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers|A Phase 1, Single-center, Randomized, Open-label Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 (Deuterated [d6] Dextromethorphan Hydrobromide/Quinidine Sulfate) in Healthy Volunteers|Completed||Phase 1|56|Actual|Avanir Pharmaceuticals||6|||f||||f||||||||||2017-10-11 00:16:46.150378|2017-10-11 00:16:46.150378
NCT02174822|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-24|||January 2014||2014-01-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects|A Phase 1, Single-center, Open-label, Sequential Drug Interaction Study Between AVP-786 (Deuterated [d6] Dextromethorphan Hydrobromide [DM]/Quinidine Sulfate [Q]) and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects|Completed||Phase 1|56|Actual|Avanir Pharmaceuticals||4|||f||||f||||||||||2017-10-11 00:16:46.233894|2017-10-11 00:16:46.233894
NCT02174809|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-01-31|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Gestational Weight Gain in Primary Care|Curbing Gestational Weight Gain in Primary Care: Using Technology Based on Behaviour Change Theory|Recruiting||N/A|100|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 00:16:46.324045|2017-10-11 00:16:46.324045
NCT02174796|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-07-18|||May 5, 2014|Actual|2014-05-05|July 2017|2017-07-01|July 2017|Actual|2017-07-01|February 2017|Actual|2017-02-01||Interventional|PECTUS||Hemodynamic Repercussions of the Correction (Surgical and Non Surgical) of Pectus Excavatum-type Thoracic Deformities|Hemodynamic Repercussions of the Correction (Surgical and Non Surgical) of Pectus Excavatum-type Thoracic Deformities|Completed||N/A|41|Actual|Centre Jean Perrin||2|||f||||f||||||||||2017-10-11 00:16:46.483873|2017-10-11 00:16:46.483873
NCT02174783|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-03-13|||June 2014||2014-06-01|July 2014|2014-07-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients|The Safety and Efficacy of Mediterranean Diet and Protein-Sparing Modified Diet on Obesity and Metabolic Syndrome in Liver Transplant Recipients: A Randomized Clinical Trial|Terminated||N/A|25|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 00:16:46.576273|2017-10-11 00:16:46.576273
NCT02174770|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-05-02|||July 2014||2014-07-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Blood Flow Restriction Training in Rehabilitation Patients|Blood Flow Restriction Training Versus Standard Physical Therapy in Post-Operative and Post-Traumatic Rehabilitation Patients|Recruiting||N/A|160|Anticipated|Brooke Army Medical Center||5|||f||||f||||||||||2017-10-11 00:16:46.658091|2017-10-11 00:16:46.658091
NCT02174757|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-12-12|||August 2014||2014-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis|A Comparative Evaluation of the Effect of Probiotic Inersan and Doxycycline on Chronic Periodontitis - A Clinical and Microbiological Study|Completed||Phase 3|30|Actual|CD Pharma India Pvt. Ltd.||3|||f||||f||||||||||2017-10-11 00:16:46.756112|2017-10-11 00:16:46.756112
NCT02174744|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-06-23|||January 2014||2014-01-01|June 2014|2014-06-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Observational|CALDOL||Concordance of Pain Detection in Patients by Doloplus® and Algoplus® Behavioural Scales|Concordance of Pain Detection in Patients by Doloplus® and Algoplus® Behavioural Scales.|Unknown status|Recruiting|N/A|210|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:16:46.839864|2017-10-11 00:16:46.839864
NCT02174731|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-08-17|||July 1, 2014|Actual|2014-07-01|August 2017|2017-08-01|April 2, 2018|Anticipated|2018-04-02|April 2, 2018|Anticipated|2018-04-02||Interventional|||Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis|A Phase 3, Multicenter, Randomized, Open-label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients|Recruiting||Phase 3|2100|Anticipated|AstraZeneca||2|||f||||t||||||||||2017-10-11 00:16:46.968986|2017-10-11 00:16:46.968986
NCT02174718|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-03-30|||November 2015||2015-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|D3forME||Evaluation of a Transdermal Vitamin D3 Delivery System, D3forME|Evaluation of a Transdermal Vitamin D3 Delivery System, D3forME|Not yet recruiting||N/A|220|Anticipated|University of Wisconsin, Madison||5|||f||||t||||||||||2017-10-11 00:16:48.048019|2017-10-11 00:16:48.048019
NCT02174705|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2014-08-13|||June 2014||2014-06-01|August 2014|2014-08-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Rotavirus vs. Sucrose for Vaccine Injection Pain|A Randomized Controlled Trial of Rotavirus Vaccine vs. Sugar Water for Vaccine Injection Pain Management in Infants|Unknown status|Recruiting|Phase 3|120|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-11 00:16:48.183415|2017-10-11 00:16:48.183415
NCT02174692|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-05-28|||February 2013||2013-02-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|MDS||Study of Muscle Repair Following Exercise in Young and Elderly People|Exploring the Metabolic and Molecular Basis of Age-related Declines in Human Skeletal Muscle Regenerative Capacity|Completed||N/A|16|Actual|University of Nottingham||2|||f||||t||||||||||2017-10-11 00:16:48.29749|2017-10-11 00:16:48.29749
NCT02174679|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-08-24||||||August 2017|2017-08-01||||||||Expanded Access|||68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)|68Ga-DOTATATE Imaging in Neuroendocrine Tumors|Available||N/A|||Jonsson Comprehensive Cancer Center|||||||||||||||||||2017-10-11 00:16:48.373092|2017-10-11 00:16:48.373092
NCT02174666|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-12-14|||June 2014||2014-06-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Isoflavone Treatment for Postmenopausal Osteopenia.|The Effects of Red Clover Treatment on Bone Tissue Regulation in Postmenopausal Osteopenia.|Active, not recruiting||N/A|87|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:16:48.475004|2017-10-11 00:16:48.475004
NCT02174653|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-01-11|||March 2014||2014-03-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides)|Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides) A Prospective, Monocentric, Randomised, Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 3|720|Actual|Dr. Willmar Schwabe GmbH & Co. KG||3|||f||||f||||||||||2017-10-11 00:16:48.593242|2017-10-11 00:16:48.593242
NCT02174640|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-02-06|||June 2014||2014-06-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|COF1||Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study|Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study|Active, not recruiting||N/A|10|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||Undecided||2017-10-11 00:16:48.691331|2017-10-11 00:16:48.691331
NCT02174627|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-07-20|||June 26, 2014|Actual|2014-06-26|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis|Active, not recruiting||Phase 3|2700|Anticipated|AstraZeneca||2|||f||||t||||||||||2017-10-11 00:16:48.852749|2017-10-11 00:16:48.852749
NCT02174614|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-09-28|||April 2015||2015-04-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|Project 1||The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT)|The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT)|Recruiting||Phase 1|150|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 00:16:50.010242|2017-10-11 00:16:50.010242
NCT02174601|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-09-05|||April 2014||2014-04-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||A Pre-endoscopic Prediction Model for Inadequate Bowel Preparation in Patients Receiving Split Dose Polyethylene Glycol Preparation||Recruiting||N/A|500|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:16:50.121931|2017-10-11 00:16:50.121931
NCT02174588|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-01-23|||January 7, 2013|Actual|2013-01-07|January 2017|2017-01-01|February 4, 2015|Actual|2015-02-04|February 4, 2015|Actual|2015-02-04||Interventional|||Moderate Sedation for Elective Upper Endoscopy With Balanced Propofol Versus Propofol Alone: a Randomized Clinical Trial||Completed||N/A|22|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:16:50.194195|2017-10-11 00:16:50.194195
NCT02174575|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-04-20|||July 2014||2014-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery|Effects of Different Inhalational Anesthetic Agents on the Incidence of Clinical and Subclinical Acute Kidney Injury After Liver Resection Surgery: a Pilot Study|Recruiting||Phase 4|40|Anticipated|Tokyo Medical and Dental University||2|||f||||f||||||||||2017-10-11 00:16:50.296273|2017-10-11 00:16:50.296273
NCT02174549|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-04-07|||September 2014||2014-09-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer|Phase I Dose-Escalating Study of Combining Intravenous Tirapazamine and Transarterial Embolization (TAE) in Hepatocellular Carcinoma|Recruiting||Phase 1|50|Anticipated|Teclison Ltd.||1|||f||||t||||||||||2017-10-11 00:16:50.496639|2017-10-11 00:16:50.496639
NCT02174536|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-24|||March 2014||2014-03-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis||Unknown status|Recruiting|Phase 2|20|Anticipated|Karolinska Institutet||2|||f||||||||||||||2017-10-11 00:16:50.61186|2017-10-11 00:16:50.61186
NCT02174523|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-06-23|||April 2014||2014-04-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects|Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects|Completed||Phase 1|14|Actual|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:16:50.731319|2017-10-11 00:16:50.731319
NCT02174510|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-06-23|||March 2014||2014-03-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects|A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects|Completed||Phase 1|37|Actual|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:16:50.838083|2017-10-11 00:16:50.838083
NCT02174497|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-06-23|||February 2008||2008-02-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||One-Day Versus Three-Day Bowel Preparation for Colonoscopy in Children|One-Day Bowel Preparation With Polyethylene Glycol 3350 (Miralax®) is as Effective and Safe as Three-Day Preparation for Colonoscopy in Children|Completed||N/A|32|Actual|St. John Health System, Michigan|||2||f||||t||||||||||2017-10-11 00:16:50.938767|2017-10-11 00:16:50.938767
NCT02174484|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-01-06|||July 2014||2014-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PREMS||Assessment of Intracardiac Electrograms Transmitted by Home Monitoring for the Remote Follow-up of Pacemaker (PREMS)|Pacemaker Remote Electrogram Monitoring Study (PREMS)|Completed||N/A|571|Actual|Biotronik SE & Co. KG|||1||f||||t||||||||||2017-10-11 00:16:51.012116|2017-10-11 00:16:51.012116
NCT02174471|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-06-02|||October 2012||2012-10-01|May 2015|2015-05-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|RELIEF-AS||Regression of Myocardial Fibrosis After Aortic Valve Replacement|REgression in Left Ventricular Interstitial Expansion and Fibrosis After Aortic Stenosis Surgery|Completed||N/A|181|Actual|University College, London|||1||f||||f||||||Samples With DNA|"     Serum and Plasma; myocardial biopsy obtained intra-operatively.   "|||2017-10-11 00:16:51.168382|2017-10-11 00:16:51.168382
NCT02174458|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-03-17|||January 2014||2014-01-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01|10 Years|Observational [Patient Registry]|||Body Contouring Surgery After Massive Weight Loss|Outcome in Body Contouring Surgery After Major Weight Loss - a Prospective Matched Single Blind Study|Completed||N/A|23|Actual|University Hospital, Basel, Switzerland|||2||f||||f||||||||||2017-10-11 00:16:51.25319|2017-10-11 00:16:51.25319
NCT02174445|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-11-22|||March 2014||2014-03-01|November 2016|2016-11-01|December 2024|Anticipated|2024-12-01|October 2023|Anticipated|2023-10-01||Interventional|DECLINE||An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years|Imatinib Continuation Versus Nilotinib 300 mg Twice Daily in Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase and Major Molecular Re-sponse (MMR) Without Molecular Response ≥ 4.5 Log (MR4.5) Receiving Imatinib at a Dose of 400 to 800 mg Daily. An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years|Recruiting||Phase 3|132|Anticipated|University Hospital Freiburg||2|||f||||f||||||||||2017-10-11 00:16:51.359638|2017-10-11 00:16:51.359638
NCT02174432|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-09-13|||August 2015||2015-08-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis|An Open Label Extension Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Prurigo Nodularis Patients|Active, not recruiting||Phase 2/Phase 3|41|Actual|Trevi Therapeutics||3|||f||||f||||||||||2017-10-11 00:16:51.709101|2017-10-11 00:16:51.709101
NCT02174419|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-05-25||2017-05-25|March 2015||2015-03-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis|A Randomized, Double-Blind, Placebo-Controlled, Parallel, 3-Arm Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Prurigo Nodularis Patients|Completed||Phase 2/Phase 3|63|Actual|Trevi Therapeutics||3|||f||||f||||||||||2017-10-11 00:16:51.805224|2017-10-11 00:16:51.805224
NCT02174406|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-07-05|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis|Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis|Recruiting||N/A|1500|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 00:16:51.907027|2017-10-11 00:16:51.907027
NCT02174393|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-02-18|||July 2014||2014-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Microneedling Plus the Universal Peel For Acne Scarring|Efficacy of Combination Therapy With Microneedling and the Universal Peel For Acne Scarring in Skin Types III-VI|Completed||N/A|15|Actual|Englewood Hospital and Medical Center||1|||f||||f||||||||||2017-10-11 00:16:51.999346|2017-10-11 00:16:51.999346
NCT02174380|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-07-07|||October 2012||2012-10-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control Program|Cost-effectiveness of a Population-based Active TB Control Program for Tuberculosis, Lima, Peru|Unknown status|Recruiting|N/A|1900|Anticipated|McGill University||2|||f||||f||||||||||2017-10-11 00:16:52.080481|2017-10-11 00:16:52.080481
NCT02174367|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-08-03|||November 2012|Actual|2012-11-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|July 2017|Actual|2017-07-01||Observational|CORE||An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis|An Observational Cohort Study to Evaluate Factors Affecting Prevalence of Fatty Liver Disease and Fibrosis and Factors Affecting Response to Treatment in Patients With Psoriasis|Active, not recruiting||N/A|400|Actual|King's College London|||1||f||||t||||||Samples With DNA|"     Serum stored for analysis of non-invasive markers of fibrosis and DNA analysis   "|||2017-10-11 00:16:52.158001|2017-10-11 00:16:52.158001
NCT02174354|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-06-24|||January 2011||2011-01-01|June 2014|2014-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|MTXPG||Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of Psoriasis|Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of Psoriasis|Enrolling by invitation||N/A|350|Anticipated|King's College London|||1||f||||t||||||Samples With DNA|"     Longitudinal study design. Serum samples will be retained with consent.   "|||2017-10-11 00:16:52.248238|2017-10-11 00:16:52.248238
NCT02174341|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-05-07|||April 2012||2012-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Pilot Study of Chikungunya Virus Infections in Southern Taiwan|Investigate the Prevalence of Serum Chikungunya Virus Infection, and Against Those Suspected Dengue Fever, Chikungunya Disease-related Tests Conducted|Recruiting||N/A|300|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||t||||||Samples With DNA|"     blood samples   "|||2017-10-11 00:16:52.313857|2017-10-11 00:16:52.313857
NCT02174328|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-06-06|||May 21, 2014|Actual|2014-05-21|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|PROVAS||Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.|Prevention of Preeclampsia With Aspirin Administered From the Beginning of Pregnancy in Recipients of Donated Oocytes.|Recruiting||Phase 3|372|Anticipated|Instituto de Investigacion Sanitaria La Fe||2|||f||||t||||||||No||2017-10-11 00:16:52.38478|2017-10-11 00:16:52.38478
NCT02174315|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-04-19|||October 2014||2014-10-01|April 2016|2016-04-01||||August 2018|Anticipated|2018-08-01||Interventional|||Motivational Incentives for Alcohol Abstinence in American Indian and Native Alaskan Adults|Contingency Management Treatment of Alcohol Abuse American Indian People|Recruiting||N/A|400|Anticipated|Washington State University||2|||f||||||||||||||2017-10-11 00:16:52.496713|2017-10-11 00:16:52.496713
NCT02174302|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-24|||June 2014||2014-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Ì-SPIES, Comparison of Cystoscopy Images in Four Different SPIES Modalities|Ì-SPIES, Comparison of Cystoscopy Images in Four Different SPIES Modalities|Completed||N/A|88|Actual|Clinical Research Office of the Endourological Society|||1||f||||f||||||||||2017-10-11 00:16:52.644956|2017-10-11 00:16:52.644956
NCT02174289|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-26|||April 2014||2014-04-01|June 2014|2014-06-01||||April 2017|Anticipated|2017-04-01||Interventional|ENDO-CRT||LV Endocardial Cardiac Resynchronisation Therapy|A Randomised Double-blinded Cross Over Study to Evaluate the Improvement of Left Ventricular Systolic Failure Using Targeted Left Ventricular Endocardial Lead Placement in Cardiac Resynchronisation Therapy.|Unknown status|Recruiting|N/A|32|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:16:52.723921|2017-10-11 00:16:52.723921
NCT02174276|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-07-31||2017-01-27|August 21, 2014|Actual|2014-08-21|July 2017|2017-07-01|June 13, 2018|Anticipated|2018-06-13|February 17, 2016|Actual|2016-02-17||Interventional|||Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Subjects With Chronic Hepatitis B and Who Are Currently Not on Treatment|A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Subjects With Chronic Hepatitis B and Who Are Currently Not on Treatment|Active, not recruiting||Phase 2|195|Actual|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-11 00:16:52.843419|2017-10-11 00:16:52.843419
NCT02174263|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-05-05|||February 2016||2016-02-01|May 2016|2016-05-01||||August 2019|Anticipated|2019-08-01||Interventional|||Tocilizumab for Chronic Graft-versus-Host Disease Treatment|Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies|Withdrawn||Phase 2|0|Actual|Fred Hutchinson Cancer Research Center||1||Study never opened due to lack of funds.|f||||t||||||||||2017-10-11 00:16:53.018095|2017-10-11 00:16:53.018095
NCT02174250|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-09-02|||June 2014||2014-06-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.|Effect of a Strong Enzyme Inducer, Rifampin, on the Single-Dose Pharmacokinetics of Istradefylline in Healthy Subjects|Completed||Phase 1|20|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||2|||f||||f||||||||||2017-10-11 00:16:53.13814|2017-10-11 00:16:53.13814
NCT02174237|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-04-10|||May 2014||2014-05-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects|LNP1892 - A Phase I, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Healthy Male and Female Subjects|Completed||Phase 1|48|Actual|Lupin Ltd.||2|||f||||f||||||||||2017-10-11 00:16:53.225258|2017-10-11 00:16:53.225258
NCT02174224|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-12-05|||June 2014||2014-06-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|AIM||At-risk Intervention and Mentoring Evaluation|Program Evaluation of a Hospital-based Violence Intervention Program (At-risk Intervention and Mentoring)|Recruiting||N/A|1000|Anticipated|Denver Health and Hospital Authority||1|||f||||f||||||||No||2017-10-11 00:16:53.322181|2017-10-11 00:16:53.322181
NCT02174211|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2016-01-22|||June 2014||2014-06-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|VITCLEAR||Effect of Vitrectomy and Posterior Vitreous Detachment on Intravitreal Ranibizumab Pharmacokinetics|A Study of the Effect of Vitrectomy and Posterior Vitreous Detachment on Ranibizumab Pharmacokinetics.|Recruiting||N/A|120|Anticipated|King's College Hospital NHS Trust||3|||f||||f||||||||||2017-10-11 00:16:53.433847|2017-10-11 00:16:53.433847
NCT02174198|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-01-25|||January 2014||2014-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Bone Remodeling After Immediate Implant Placement With and Without Bone Grafting|The Esthetic Effect of Bio-OSS Collagen® on the Mid-facial Gingival Dimensions When Placed Into Gaps Between 3i® Implants Placed Into Fresh Extraction Sockets and the Labial Plate of Bone|Active, not recruiting||N/A|32|Actual|Columbia University||2|||f||||f|f|t|f|f|f|||Undecided||2017-10-11 00:16:53.534046|2017-10-11 00:16:53.534046
NCT02174185|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2014-08-01|||August 2014||2014-08-01|August 2014|2014-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic Neobladders|A Prospective and Comparative Study of Health-related Quality of Life (HRQoL) in Patients With Conduit Diversion or Orthotopic Neobladder|Recruiting||N/A|300|Anticipated|Huazhong University of Science and Technology|||2||f||||f||||||||||2017-10-11 00:16:53.659645|2017-10-11 00:16:53.659645
NCT02174172|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-08-01|||August 18, 2014|Actual|2014-08-18|August 2017|2017-08-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors|A Phase Ib Study of The Safety And Pharmacology of Atezolizumab (Anti−Pd-L1 Antibody) Administered With Ipilimumab, Interferon-Alpha, or Other Immune-Modulating Therapies in Patients With Locally Advanced or Metastatic Solid Tumors|Recruiting||Phase 1|200|Anticipated|Hoffmann-La Roche||5|||f||||||||||||||2017-10-11 00:16:53.784915|2017-10-11 00:16:53.784915
NCT02174159|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-08-04|||September 2014||2014-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of MK-8507 in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)|A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiretroviral Activity of MK-8507 in HIV-1 Infected Patients|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 00:16:53.964011|2017-10-11 00:16:53.964011
NCT02174146|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-23|||September 2013||2013-09-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy|Effect of Non-surgical Periodontal Therapy on Leptin and Visfatin Expression in Gingival Tissues of Chronic Periodontitis With and Without Type 2 Diabetes Mellitus: A Study Utilizing ELISA and Real Time PCR|Completed||N/A|50|Actual|Cairo University||1|||f||||t||||||||||2017-10-11 00:16:54.064217|2017-10-11 00:16:54.064217
NCT02174133|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2015-03-09|||January 2014||2014-01-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Observational|LVAD||Impact of LVAD Implantation on Micro- and Macrovascular Function|Impact of LVAD Implantation on Micro- and Macrovascular Function|Completed||N/A|60|Anticipated|Heinrich-Heine University, Duesseldorf|||4||f||||f||||||||||2017-10-11 00:16:54.179339|2017-10-11 00:16:54.179339
NCT02174120|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-24|||October 2014||2014-10-01|June 2014|2014-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||The Application of Target Controlled Infusion of Etomidate Combined With Propofol in the Maintenance of Anesthesia During Brain Surgeries||Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Henan Provincial Hospital||3|||f||||t||||||||||2017-10-11 00:16:54.265912|2017-10-11 00:16:54.265912
NCT02174107|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-01-09|||April 2015||2015-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|Radiointer||Health Economics Evaluation of Percutaneous Vertebroplasty Compared to Radiation Therapy in Patients With Painful Spine Metastases.|Health Economics Evaluation of Percutaneous Vertebroplasty Compared to Radiation Therapy in Patients With Painful Spine Metastases.|Terminated||N/A|7|Actual|Centre Leon Berard||2||recruitment issues due to feasability issues in centers|f||||f||||||||||2017-10-11 00:16:54.364678|2017-10-11 00:16:54.364678
NCT02174094|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-09-23|||March 2015||2015-03-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome|Multi-site, Prospective, Randomised, Double-blind, Placebo-controlled, Parallel-group, Interventional Study to Evaluate the Efficacy, Safety, and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome|Withdrawn||Phase 3|0|Actual|H. Lundbeck A/S||2||The study was terminated due to recruitment challenges|f||||t||||||||||2017-10-11 00:16:54.490738|2017-10-11 00:16:54.490738
NCT02174081|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-06-27|||March 2014||2014-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Observational|||ARDS Prediction Score in Critically Ill Patients in China|ARDS Prediction Score in Critically Ill Patients in China|Completed||N/A|698|Actual|Southeast University, China|||1||f||||f||||||||||2017-10-11 00:16:54.599452|2017-10-11 00:16:54.599452
NCT02174068|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-07-24|||July 2014||2014-07-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|PARA-NEF||A Pharmacokinetic Drug Interaction and Tolerance Study of Paracetamol and Nefopam|A Pharmacokinetic Drug Interaction and Tolerance Study of Paracetamol and Nefopam|Completed||Phase 1|12|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 00:16:54.683016|2017-10-11 00:16:54.683016
NCT02174055|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-07-05|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Identifying and Measuring Depression in Older Cancer Patients|Identifying and Measuring Depression in Older Cancer Patients|Recruiting||N/A|330|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 00:16:54.764653|2017-10-11 00:16:54.764653
NCT02174042|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-09-09|||March 2014||2014-03-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis|The Effect of Tang Ning Tongluo Formula, a Traditional Chinese Miao Medicine, in Type 2 Diabetics: A Retrospective Clinical Analysis|Completed||Phase 2|120|Actual|Guizhou Bailing Group Pharmaceutical Co Ltd||1|||f||||f||||||||||2017-10-11 00:16:54.863203|2017-10-11 00:16:54.863203
NCT02174029|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-03-09|||June 2014||2014-06-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|||Serial Daily Diaphragm Ultrasounds in Ventilated Patients|Serial Ultrasonographic Evaluation Of Diaphragm Thickness During Mechanical Ventilation In ICU Patients|Completed||N/A|61|Actual|Fraser Health|||3||f||||f||||||||||2017-10-11 00:16:54.939556|2017-10-11 00:16:54.939556
NCT02174016|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-11-30|||January 2015||2015-01-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||The Ketogenic Diet for Pediatric Acute Brain Injury|The Ketogenic Diet for Pediatric Acute Brain Injury|Recruiting||Phase 1|5|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 00:16:55.03825|2017-10-11 00:16:55.03825
NCT02174003|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-07-23|||June 2014||2014-06-01|July 2015|2015-07-01||||August 2016|Anticipated|2016-08-01|1 Week|Observational [Patient Registry]|||Whole Body Hyperthermia Registry Study||Terminated||N/A|2|Actual|University of Arizona|||1|Investigator transferred to the University of Wisconsin - Madison|f||||f||||||||||2017-10-11 00:16:55.11352|2017-10-11 00:16:55.11352
NCT02173990|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-02-15|||July 2014||2014-07-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PULSAR||Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).|A Phase 2 Study of Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US.|Recruiting||Phase 2|80|Anticipated|Centre Oscar Lambret||1|||f||||t||||||||No||2017-10-11 00:16:55.199878|2017-10-11 00:16:55.199878
NCT02173977|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-23|||June 2014||2014-06-01|June 2014|2014-06-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF|Ultrashort Flare GnRH Agonist Combined With Flexible Multidose GnRH Antagonist Versus Flexible Multidose GnRH Antagonist for Good-prognosis IVF Patients|Unknown status|Not yet recruiting|Phase 2|200|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:16:55.318994|2017-10-11 00:16:55.318994
NCT02173964|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-04-13|||July 2014||2014-07-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)|Clinical Trial of Pinverin (Pinaverium Bromide) to Reduce Bowel Uptake of FDG in a Variety of Cancer Patients Who Undergo FDG PET/CT|Completed||Phase 4|58|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:16:55.411638|2017-10-11 00:16:55.411638
NCT02173444|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-23|||January 2013||2013-01-01|June 2014|2014-06-01||||October 2013|Actual|2013-10-01||Interventional|AMH FSH AFC||Comparison of the Accuracy and Reliability of AMH, FSH and AFC in Predicting Ovarian Response|Comparison of the Accuracy and Reliability of AMH, FSH and AFC in Predicting Ovarian Response|Completed||N/A|820|Actual|Vietnam National University|||||f||||t||||||||||2017-10-11 00:17:05.788599|2017-10-11 00:17:05.788599
NCT02173951|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-01-13|||July 2014||2014-07-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients|A Decisional Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients Naive to Iron Chelation Therapy. A Comparative Randomized Prospective Study|Unknown status|Not yet recruiting|Phase 2/Phase 3|64|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:16:55.679372|2017-10-11 00:16:55.679372
NCT02173938|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-05-01|||August 2012||2012-08-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Novel Psychosocial Influences on Smoking Cessation|Novel Psychosocial Influences on Successful Tobacco Cessation Among Treatment Seekers|Completed||N/A|61|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-10-11 00:16:55.77726|2017-10-11 00:16:55.77726
NCT02173925|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-01-05|||February 2011||2011-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|FD||Gut Hormone, Nociceptors, Neurotrophic Factors Expression in Functional Dyspepsia|Ghrelin, Leptin, Serotonin, TRPV1, NGF and GDNF Expression in the Patients With Functional Dyspepsia|Completed||N/A|314|Actual|Seoul National University Bundang Hospital|||2||f||||||||||Samples With DNA|"     Blood sample (plasma and serum), samples with DNA and paraffin-embedded tissue. During the     endoscopic examination, one pair of biopsies was obtained from the greater curvature of high     body. Biopsies are taken using standard biopsy forceps.   "|||2017-10-11 00:16:55.848378|2017-10-11 00:16:55.848378
NCT02173912|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-24|||June 2014||2014-06-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|CCA||Bioequivalence Study of CJ-30059|Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetics and Safety Following Administration of CJ-30059 and Co-administration of Candesartan Cilexetil and Amlodipine Besylate in Healthy Volunteers.|Unknown status|Recruiting|Phase 1|32|Anticipated|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 00:16:55.934308|2017-10-11 00:16:55.934308
NCT02173886|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-09-26|||June 2014||2014-06-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery||Completed||Phase 4|20|Anticipated|North Dakota State University||1|||f||||f||||||||||2017-10-11 00:16:56.127705|2017-10-11 00:16:56.127705
NCT02173873|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2014-06-23|||June 2014||2014-06-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|ZIV||Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I|Ziv-aflibercept in Eyes With Eyes With Retinal Diseases and Poor Vision-phase I|Unknown status|Recruiting|Phase 1|100|Anticipated|Rafic Hariri University Hospital||1|||f||||t||||||||||2017-10-11 00:16:56.204945|2017-10-11 00:16:56.204945
NCT02173860|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-10-20|||July 2016||2016-07-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|January 2021|Anticipated|2021-01-01||Interventional|SAVE-IT||Strategies for Revascularization in Patients Undergoing Heart Valve Surgery With Concomitant Coronary Artery Disease|Strategies for Revascularization in Patients Undergoing Heart Valve Surgery With Concomitant Coronary Artery Disease. AngIography vs Fractional Flow Reserve|Recruiting||N/A|502|Anticipated|Portuguese Society of Cardiology||2|||f||||t||||||||||2017-10-11 00:16:56.306322|2017-10-11 00:16:56.306322
NCT02173847|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-23|||January 2011||2011-01-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|||Laser Assisted Procedures in Penetrating Keratoplasty|Laser Assisted Procedures in Penetrating Keratoplasty: Femtosecond Laser Anvil-shaped Cuts and Laser Welding of the Surgical Wounds|Completed||N/A|22|Actual|Ospedale Santo Stefano||1|||f||||f||||||||||2017-10-11 00:16:56.445842|2017-10-11 00:16:56.445842
NCT02173834|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-06-24|||March 2013||2013-03-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Brown Adipose Tissue and Body Mass Index|Activation of Brown Adipose Tissue in Lean and Obese Men|Completed||N/A|20|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 00:16:56.530276|2017-10-11 00:16:56.530276
NCT02173821|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-05-04|||October 2014||2014-10-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency|A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Randomised, Open-label, Parallel-group, Multi-centre Trial (FE 999905 CS07) in Which the Efficacy and Safety of 12 Months' Treatment With One Daily Dose of ZOMACTON Were Compared to One Daily Dose of GENOTROPIN|Completed||Phase 3|23|Actual|Ferring Pharmaceuticals|||||f||||f||||||||||2017-10-11 00:16:56.702036|2017-10-11 00:16:56.702036
NCT02173808|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-02-19|||May 2011||2011-05-01|April 2014|2014-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|CCN011||A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception|A Phase I Study to Evaluate the Pharmacokinetic and Pharmacodynamic Profile of a Single Injection of Levonorgestrel Butanoate (LB) for Female Contraception|Completed||Phase 1|16|Actual|Health Decisions||1|||f||||f||||||||||2017-10-11 00:16:56.795088|2017-10-11 00:16:56.795088
NCT02173795|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-11|||October 2002||2002-10-01|July 2014|2014-07-01||||June 2003|Actual|2003-06-01||Interventional|||Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition|Berodual® Respimat® Inhaler Versus Berodual® MA Using HFA (Hydrofluoroalkane) 134a as Propellant in Adult Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Conditions, an Open-label, Crossover Trial Over a 7-week Treatment Period With Each Formulation: ' A Study to Compare Patient Preference'|Completed||Phase 3|245|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:16:56.906932|2017-10-11 00:16:56.906932
NCT02173431|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-03-28|||June 2014||2014-06-01|March 2016|2016-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01|30 Days|Observational [Patient Registry]|BEDSORES||Recognize High Pressure Areas in Human Body to Prevent Decubitus Ulcers|Mapping Pressure of Human Body to Prevent Bedsores|Withdrawn||N/A|0|Actual|Assuta Medical Center|||7|due to technical issues|f||||f||||||None Retained|"     messure of pressure of patients resting on the buttres with pressure sensors   "|||2017-10-11 00:17:05.878009|2017-10-11 00:17:05.878009
NCT02173782|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-11|||February 1998||1998-02-01|June 2014|2014-06-01||||April 1999|Actual|1999-04-01||Interventional|||Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Placebo-controlled, Within-device, Double-blind Tri-national Study to Compare the Safety and Efficacy of Berodual® Administered Via the Respimat® Device (50 µg Fenoterol Hydrobromide/20 µg Ipratropium Bromide and 25 µg Fenoterol Hydrobromide/10 µg Ipratropium Bromide, 1 Puff q.i.d) With That Administered Via the MDI (50 µg Fenoterol Hydrobromide/21 µg Ipratropium Bromide, 2 Puffs q.i.d) in COPD Patients Over a 12-week Period|Completed||Phase 3|892|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:16:56.999441|2017-10-11 00:16:56.999441
NCT02173769|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2017-04-24|2016-03-02||June 2014||2014-06-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational||Treated set which includes all patients with baseline visit data.|Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy|AKTIV: Changes in Physical Functioning in Patients With COPD During Therapy With a Combination of Spiriva® Respimat® + Striverdi® Respimat® or Spiriva® 18 Mikrogramm + Striverdi® Respimat®|Completed||N/A|1845|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:16:57.203268|2017-10-11 00:16:57.203268
NCT02173756|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2014-06-20|||June 2014||2014-06-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|MorphinOgel||Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults||Unknown status|Not yet recruiting|Phase 3|40|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 00:16:59.070253|2017-10-11 00:16:59.070253
NCT02173743|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-06-22|||July 2014||2014-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Platelet-rich Plasma in Calcific Tendinitis|Calcific Tendinitis of the Rotator Cuff: a Randomized Controlled Trial to the Effects of the Adjuvant Application of Platelet-rich Plasma After Needle Aspiration of Calcific Deposits|Active, not recruiting||N/A|80|Actual|Orthopedisch Centrum Oost Nederland||2|||f||||t||||||||Undecided||2017-10-11 00:16:59.162412|2017-10-11 00:16:59.162412
NCT02173730|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-24|||November 2002||2002-11-01|June 2014|2014-06-01||||February 2003|Actual|2003-02-01||Interventional|||BIBR 953 ZW in Healthy Elderly Subjects|Pharmacokinetics of BIBR 953 ZW After 150 mg of BIBR 1048 (Oral Pro-drug of BIBR 953) Administered as Capsule Twice Daily Over Seven Days With or Without Pantoprazole Co-treatment to Healthy Male and Female Elderly Subjects|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:16:59.244423|2017-10-11 00:16:59.244423
NCT02173717|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-24|||June 2009||2009-06-01|June 2014|2014-06-01||||July 2009|Actual|2009-07-01||Interventional|||Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers|Relative Bioavailability of Single Doses of 150 mg Dabigatran Etexilate (Capsule)When Administered Alone, After Seven Days of Dosing With 600 mg Rifampicin(Tablet), and Seven Days and Fourteen Days After Last Administration of Rifampicin in Healthy Male and Female Volunteers (an Open Label, Fixed Sequence, Phase I Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:01.117039|2017-10-11 00:17:01.117039
NCT02173691|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-25|||February 1999||1999-02-01|June 2014|2014-06-01||||May 2000|Actual|2000-05-01||Interventional|||Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)|A Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in a Six-Month, Double-Blind, Double-Dummy, Safety and Efficacy Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|584|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:01.339348|2017-10-11 00:17:01.339348
NCT02173678|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-03|||October 1999||1999-10-01|June 2014|2014-06-01||||November 1999|Actual|1999-11-01||Interventional|||Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects|A Randomized, Placebo-controlled, Double-blind, 3 Way Cross-over Safety and Tolerability Study of Single and Repetitive Dosing of COMBIVENT® HFA Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects (Cumulative Dose: 1600 mcg (HFA) or 1648 mcg (CFC) of Salbutamol Sulfate, 288 mcg of Ipratropium Bromide)|Completed||Phase 1|12|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:01.463782|2017-10-11 00:17:01.463782
NCT02173665|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-04|||October 2004||2004-10-01|July 2014|2014-07-01||||December 2004|Actual|2004-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS as a Solution at Dose Levels 2.5 -5 mg and Tablets at Dose Levels 25 - 600 mg Administered to Healthy Male Subjects. A Randomised, Double-blind, Placebo-controlled Trial, Including an Intra-subject Bioavailability Comparison of 100 mg BI 1356 BS as Tablet and as Solution. BI 1356 BS as Tablet and as Solution|Completed||Phase 1|64|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:01.558662|2017-10-11 00:17:01.558662
NCT02173652|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-04|||March 2008||2008-03-01|July 2014|2014-07-01||||April 2008|Actual|2008-04-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers|Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers. A Monocentric, Open Label, Cross-over Trial|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:01.651224|2017-10-11 00:17:01.651224
NCT02173418|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-08-16|||November 2012||2012-11-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TOPBLOC||The Effect of Phrenic Nerve Blockade on Acute and Chronic Shoulder Pain in Patients for Lobectomy and Pneumonectomy|The Effect of Phrenic Nerve Blockade on Acute and Chronic Shoulder Pain in Patients for Lobectomy and Pneumonectomy.|Completed||Phase 4|76|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-11 00:17:05.968216|2017-10-11 00:17:05.968216
NCT02173639|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-07-04|||April 2009||2009-04-01|July 2014|2014-07-01||||June 2009|Actual|2009-06-01||Interventional|||Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects|Relative Oral Bioavailability of a Fixed Dose Combination Tablet of BI 1356 2.5 mg / Metformin 1000 mg, Compared With Single BI 1356 2.5 mg and Metformin 1000 mg Tablets Administered Together to Healthy Male and Female Subjects in an Open, Randomised, Single-dose, Two-way Crossover, Phase I Trial|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:01.759475|2017-10-11 00:17:01.759475
NCT02173626|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-23|||October 2013||2013-10-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Video-Module Based Mindfulness Training on Physician Stress and Well Being|Effect of Video-Module Based Mindfulness Training on Physician Stress and Well Being|Completed||N/A|23|Actual|MultiCare Health System Research Institute||1|||f||||f||||||||||2017-10-11 00:17:01.862134|2017-10-11 00:17:01.862134
NCT02173613|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2014-06-20|||August 2012||2012-08-01|June 2014|2014-06-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|PROPAGE||Reduction the Duration of Antibiotic Therapy in the Elderly (PROPAGE)|Reduction of the Duration of Antibiotic Guided by Procalcitonin in Infections Lungs of Hospitalized Elderly: a Randomized|Unknown status|Recruiting|N/A|340|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 00:17:01.937707|2017-10-11 00:17:01.937707
NCT02173600|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-24|2014-06-24|||May 2014||2014-05-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Cardiovascular Risk Factors And Intensive Dietary Counselling|Estimation of Cardiovascular Risk After Intensive Dietary Counselling in a Primary Care Setting|Unknown status|Enrolling by invitation|N/A|630|Anticipated|Andalusian Regional Ministry of Health||2|||f||||t||||||||||2017-10-11 00:17:03.368433|2017-10-11 00:17:03.368433
NCT02173587|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2014-06-23|||February 2014||2014-02-01|June 2014|2014-06-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Study Evaluating the Efficacy of Thick Shell Mussel Lipid Extract in Chinese Subjects With Rheumatoid Arthritis|Efficacy of Thick Shell Mussel Lipid Extract in Chinese Subjects With Rheumatoid Arthritis|Unknown status|Active, not recruiting|N/A|56|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-10-11 00:17:03.444487|2017-10-11 00:17:03.444487
NCT02173574|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-01-07|||August 2014||2014-08-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Two-way Interaction Between Alisporivir and EDP239|An Open-label, Two Part Investigation of the Pharmacokinetics, Safety, and Tolerability of Alisporivir and EDP239 When Co-administered to Healthy Adult Subjects|Completed||Phase 1|42|Actual|Enanta Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:17:03.530949|2017-10-11 00:17:03.530949
NCT02173561|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-03-22|||June 2012||2012-06-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD|Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD|Completed||N/A|300|Anticipated|VA Boston Healthcare System||2|||f||||t||||||||||2017-10-11 00:17:03.620568|2017-10-11 00:17:03.620568
NCT02173548|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-08-22|||September 2014||2014-09-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|D-HART2||Interleukin-1 Blockade in HF With Preserved EF|Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Placebo-controlled Double Blinded Study (D-HART2)|Active, not recruiting||Phase 2|60|Anticipated|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 00:17:03.713437|2017-10-11 00:17:03.713437
NCT02173535|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-06-01|2017-03-15||May 1, 2014|Actual|2014-05-01|June 2017|2017-06-01|June 1, 2014|Actual|2014-06-01|June 1, 2014|Actual|2014-06-01||Interventional||All subjects that were dispensed at least 1 study lens|Quantitative Study of New Limbal Ring Prototypes||Completed||N/A|257|Actual|Johnson & Johnson Vision Care, Inc.||5|||f||||f||||||||||2017-10-11 00:17:03.836948|2017-10-11 00:17:03.836948
NCT02173522|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-06-19|||July 2014||2014-07-01|June 2017|2017-06-01|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Interventional|||Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients|Phase II Open Label Investigation of the Safety and Efficacy of Pre-Operative Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients|Completed||N/A|4|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 00:17:05.103114|2017-10-11 00:17:05.103114
NCT02173509|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-24|||May 2013||2013-05-01|June 2014|2014-06-01||||October 2013|Actual|2013-10-01||Interventional|||An Educational Intervention to Improve the Use of Antibiotics in Portuguese Health Professional|An Educational Intervention to Improve the Use of Antibiotics in Portuguese Health Professional: Cluster-randomized Trial|Completed||N/A|2300|Actual|Aveiro University||1|||f||||f||||||||||2017-10-11 00:17:05.204026|2017-10-11 00:17:05.204026
NCT02173496|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-05-26|||October 2014||2014-10-01|January 2017|2017-01-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|CEDAR||Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR)|Evaluation of Multiple Assessment Modalities for the Detection and Characterisation of the Preclinical, Pre-symptomatic Stage of Neovascular Age-related Macular Degeneration|Completed||N/A|233|Actual|Aston University|||1||f||||f||||||None Retained|"     Blood Samples   "|No||2017-10-11 00:17:05.28624|2017-10-11 00:17:05.28624
NCT02173483|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-05-15|||May 2014||2014-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Anterior Cruciate Ligament-reconstruction: Quadriceps Tendon or Hamstrings Tendon? A Prospective Trial|Anterior Cruciate Ligament-reconstruction: Quadriceps Tendon or Hamstrings Tendon? A Prospective Randomised Controlled Trial|Active, not recruiting||N/A|100|Anticipated|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 00:17:05.385657|2017-10-11 00:17:05.385657
NCT02173470|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-10-24|||July 2014||2014-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CRICKET||Chest CT With Iterative Reconstruction as an Alternative to Conventional Chest X-ray Prior to Heart Surgery|Ultra Low-dose Chest CT With Iterative Reconstructions as an Alternative to Conventional Chest X-ray Prior to Heart Surgery|Recruiting||N/A|1724|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-11 00:17:05.491021|2017-10-11 00:17:05.491021
NCT02173457|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-07-23|||June 2014||2014-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|CMAS||Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients|Phase III Study of Chiglitazar in Patients With Type 2 Diabetes Mellitus and Insufficient Glycemic Control Despite Diet and Exercise -- A Multicenter, Randomized, Double-Blind, and Sitagliptin-Controlled Trial|Active, not recruiting||Phase 3|738|Anticipated|Chipscreen Biosciences, Ltd.||3|||f||||t||||||||||2017-10-11 00:17:05.611506|2017-10-11 00:17:05.611506
NCT02173405|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-06-10|||August 2014||2014-08-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|BotoxMPP||Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain|Pelvic Floor Trigger Point Injection With OnabotulinumtoxinA for the Treatment of Severe Myofascial Pelvic Pain (MPP) - A Randomized, Controlled Trial|Unknown status|Recruiting|Phase 1|40|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-11 00:17:06.088654|2017-10-11 00:17:06.088654
NCT02173392|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-04-06|2016-11-08||September 2014||2014-09-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab|A Bioequivalence Study Comparing a Single Subcutaneous Injection With a 1.5 mL Prefilled Syringe Versus 2 Subcutaneous Injections of 1 mL and 0.5 mL Prefilled Syringes of Brodalumab 140 mg/mL to Healthy Subjects|Completed||Phase 1|145|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 00:17:06.230427|2017-10-11 00:17:06.230427
NCT02173379|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-07-13|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|April 2024|Anticipated|2024-04-01|March 2017|Actual|2017-03-01||Interventional|||Absorb IV Randomized Controlled Trial|A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions|Active, not recruiting||N/A|2610|Actual|Abbott Vascular||2|||f||||t||||||||||2017-10-11 00:17:06.609373|2017-10-11 00:17:06.609373
NCT02173366|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-09-01|||December 2013||2013-12-01|September 2017|2017-09-01|February 1, 2017|Actual|2017-02-01|November 2015|Actual|2015-11-01||Interventional|||Change Clubs for African American Women|Preliminary Investigation of Civic Engagement as a Novel Approach to Behavior Change and Body Weight Improvement in African American Females|Completed||N/A|26|Actual|Tufts University||1|||f||||f||||||||||2017-10-11 00:17:07.310357|2017-10-11 00:17:07.310357
NCT02173353|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-06-06|||February 2014||2014-02-01|June 2017|2017-06-01|December 2024|Anticipated|2024-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Feasibility of Using Ultrasound to Track Respiration Motion|Feasibility of Using Ultrasound to Track Respiration Motion|Recruiting||N/A|25|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||Undecided||2017-10-11 00:17:07.40307|2017-10-11 00:17:07.40307
NCT02173340|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-07-27|||June 2014||2014-06-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Population Pharmacodynamic Modeling of the Sedative and Side Effects of Propofol|Population Pharmacodynamic Modeling of the Sedative and Side Effects of Propofol in Patients Undergoing Spinal Anesthesia|Completed||N/A|30|Actual|Yonsei University|||1||f||||t||||||||||2017-10-11 00:17:07.540704|2017-10-11 00:17:07.540704
NCT02173327|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-23|||November 2013||2013-11-01|June 2014|2014-06-01|April 2016|Anticipated|2016-04-01|November 2014|Anticipated|2014-11-01||Interventional|||Helm CPAP Versus Mask CPAP After Major Abdominal Surgery|Continuously Helm CPAP Versus Intermittent Mask CPAP After Major Abdominal Surgery|Unknown status|Recruiting|N/A|102|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:17:07.607508|2017-10-11 00:17:07.607508
NCT02173314|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-06-01|||September 2010||2010-09-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Nevada Initiative to Reduce Long-Term Foster Care|Permanency Innovations Initiative- Nevada Initiative to Reduce Long-Term Foster Care|Completed||N/A|||Westat||1|||f||||f||||||||||2017-10-11 00:17:07.745569|2017-10-11 00:17:07.745569
NCT02173301|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-09-16|||June 2014||2014-06-01|September 2014|2014-09-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis|A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis|Completed||Phase 2|200|Actual|XenoPort, Inc.||4|||f||||f||||||||||2017-10-11 00:17:07.874163|2017-10-11 00:17:07.874163
NCT02173288|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-09-18|||July 2013||2013-07-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites|Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites|Completed||Phase 2/Phase 3|50|Actual|Postgraduate Institute of Medical Education and Research||4|||f||||t||||||||||2017-10-11 00:17:08.042577|2017-10-11 00:17:08.042577
NCT02173275|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-01-11|||May 2014||2014-05-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|CREDENCE||Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia|Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)|Recruiting||N/A|618|Anticipated|Weill Medical College of Cornell University|||2||f||||t||||||||Undecided||2017-10-11 00:17:08.170343|2017-10-11 00:17:08.170343
NCT02173262|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-09-15|||August 2014||2014-08-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|OTT14-03||REaCT Integrated Consent Model to Compare Two Standard of Care Regimens|Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for Primary Prophylaxis of Taxotere/Cyclophosphamide-Induces Febrile Neutropenia|Recruiting||N/A|35|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 00:17:08.371099|2017-10-11 00:17:08.371099
NCT02173249|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-09-13|||June 2014||2014-06-01|September 2017|2017-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety of AC-170 0.24%||Completed||Phase 1|11|Actual|Aciex Therapeutics, Inc.||1|||f||||||||||||||2017-10-11 00:17:08.520193|2017-10-11 00:17:08.520193
NCT02173236|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-23|||June 2011||2011-06-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of Platform Switching on Single Implants in the Esthetic Zone, Following Flapless Surgery and Early-Loading Protocols||Completed||N/A|26|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 00:17:08.671479|2017-10-11 00:17:08.671479
NCT02173223|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-04-23|||June 2014||2014-06-01|April 2015|2015-04-01||||February 2015|Actual|2015-02-01||Interventional|||A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt|A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|New York Glaucoma Research Institute||2|||f||||||||||||||2017-10-11 00:17:08.812486|2017-10-11 00:17:08.812486
NCT02173197|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-05-26|||July 2014||2014-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|OT||Effectiveness of Occupational Therapy Intervention in Complex Patients|Study on the Effectiveness of Occupational Therapy Intervention in Complex Patients.|Completed||N/A|20|Actual|University of Modena and Reggio Emilia|||1||f||||f||||||||||2017-10-11 00:17:09.002433|2017-10-11 00:17:09.002433
NCT02173184|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-10-28|||June 2014||2014-06-01|October 2014|2014-10-01|July 2015|Anticipated|2015-07-01|April 2015|Anticipated|2015-04-01||Interventional|||Safety and Efficacy Study of Gynevac Lactobacillus Vaccine in the Treatment of Bacterial Vaginosis|Phase III, Randomized, Double Blind, Parallel Groups, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of the Lactobacillus Vaccine Gynevac, in the Treatment of Bacterial Vaginosis|Unknown status|Recruiting|Phase 3|240|Anticipated|Amvac Kft.||2|||f||||f||||||||||2017-10-11 00:17:09.083168|2017-10-11 00:17:09.083168
NCT02173158|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-06-17|||April 2014||2014-04-01|June 2015|2015-06-01|November 2015|Anticipated|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy|A Phase 3, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Lomitapide in Japanese Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Concurrent Lipid-Lowering Therapy|Unknown status|Active, not recruiting|Phase 3|10|Anticipated|Aegerion Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 00:17:09.351823|2017-10-11 00:17:09.351823
NCT02173145|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2016-10-25|||August 2014||2014-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Azithromycin in Idiopathic Pulmonary Fibrosis|Azithromycin for the Treatment of Cough in Idiopathic Pulmonary Fibrosis- a Clinical Trial|Recruiting||N/A|25|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 00:17:09.441769|2017-10-11 00:17:09.441769
NCT02173132|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-23|||April 2010||2010-04-01|June 2014|2014-06-01||||November 2013|Actual|2013-11-01||Interventional|||Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy||Completed||Phase 3|94|Actual|University of Catania||2|||f||||||||||||||2017-10-11 00:17:09.543978|2017-10-11 00:17:09.543978
NCT02173119|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-07-14|||August 2014||2014-08-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|||Can Quantitative MRI After cTACE Help Predict Survival ?|Can Quantitative MRI After Conventional Transarterial Chemoembolization (cTACE) Help Predict Survival ?|Active, not recruiting||N/A|20|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-10-11 00:17:09.617801|2017-10-11 00:17:09.617801
NCT02173106|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-30|||June 2014||2014-06-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy|Opportunity, Validity and Security of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy : A Prospective, Randomized, Controlled, Multi-Center Clinical Trial|Unknown status|Recruiting|Phase 2|180|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 00:17:09.697203|2017-10-11 00:17:09.697203
NCT02173093|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2017-08-17|||November 2014||2014-11-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma|Treatment of Neuroblastoma and GD2-Positive Tumors With Activated T Cells Armed With OKT3 X Humanized 3F8 Bispecific Antibodies (GD2Bi): A Phase I/II Study|Recruiting||Phase 1/Phase 2|40|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 00:17:09.826184|2017-10-11 00:17:09.826184
NCT02173080|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-04-06|||June 2014||2014-06-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).|Development and Assessment of the Psychometric Properties of a Polycystic Liver Disease-specific Patient Reported Outcomes Questionnaire (PLD-Q).|Unknown status|Recruiting|N/A|544|Anticipated|Mayo Clinic|||5||f||||f||||||||||2017-10-11 00:17:09.968022|2017-10-11 00:17:09.968022
NCT02173054|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-11-28|2015-07-29||July 2014||2014-07-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne|An Evaluator-blind, Randomized, Vehicle-controlled Efficiency of Adjunctive Usage of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel for Improvement of Local Tolerance in Thai Acne Subjects|Completed||Phase 3|120|Actual|Mahidol University||3|||f||||t||||||||||2017-10-11 00:17:10.184244|2017-10-11 00:17:10.184244
NCT02173041|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2015-05-15|||August 2014||2014-08-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User|Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User: Results of the Randomized Controlled Trial|Completed||N/A|152|Actual|Macmillan Research Group UK||2|||f||||t||||||||||2017-10-11 00:17:10.902822|2017-10-11 00:17:10.902822
NCT02173028|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-02-22|||June 2013||2013-06-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|RESTORE||RESynchronizaTiOn theRapy and bEta-blocker Titration|RESynchronizaTiOn theRapy and bEta-blocker Titration : RESTORE|Completed||N/A|254|Actual|University of Florence|||2||f||||f||||||||No||2017-10-11 00:17:11.001029|2017-10-11 00:17:11.001029
NCT02173015|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-04-02|||April 2014||2014-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Fall Recovery Training for Older Adults in Continuous Care Facilities|Compensatory Step Training for Reducing the Fall Incidence of Older Adults Residing in Continuous Care Facilities|Completed||N/A|150|Anticipated|Mayo Clinic||3|||f||||f||||||||No||2017-10-11 00:17:11.088286|2017-10-11 00:17:11.088286
NCT02173002|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-03-27|||July 2014||2014-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|myIBDcoach||Integrated Care for Inflammatory Bowel Disease Patients in the Netherlands With the Novel Telemedicine Tool myIBDcoach: a Randomized Controlled Trial|Integrated Care for Inflammatory Bowel Disease Patients in the Netherlands With the Novel Telemedicine Tool myIBDcoach: a Randomized Controlled Trial|Completed||N/A|909|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:17:11.159526|2017-10-11 00:17:11.159526
NCT02172989|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2015-06-17|||June 2014||2014-06-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01|1 Week|Observational [Patient Registry]|||Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Benign Breast Neoplasm.|Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Benign Breast Neoplasm ; Observational Pilot Study for 20 Patients.|Completed||Phase 1/Phase 2|20|Actual|National Cancer Center, Korea|||1||f||||t||||||||||2017-10-11 00:17:11.258563|2017-10-11 00:17:11.258563
NCT02172976|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-04-07|||November 2014||2014-11-01|April 2016|2016-04-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma|Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer|Recruiting||Phase 2/Phase 3|126|Anticipated|Krankenhaus Nordwest||2|||f||||t||||||||||2017-10-11 00:17:11.332712|2017-10-11 00:17:11.332712
NCT02172963|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-23|||November 2011||2011-11-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis||Completed||Phase 1/Phase 2|12|Actual|Karolinska Institutet||1|||f||||||||||||||2017-10-11 00:17:11.498856|2017-10-11 00:17:11.498856
NCT02172937|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-11-08|||January 2011||2011-01-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study|Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Karolinska Institutet||2|||f||||||||||||||2017-10-11 00:17:11.971591|2017-10-11 00:17:11.971591
NCT02172924|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-11-08|||January 2017||2017-01-01|November 2014|2014-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Phase 2 Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease|A Phase 2 Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Karolinska Institutet||2|||f||||||||||||||2017-10-11 00:17:12.093431|2017-10-11 00:17:12.093431
NCT02172911|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-08-29|||May 2014||2014-05-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of INO-3112 DNA Vaccine With Electroporation in Patients With Cervical Cancer|Phase I/IIA, Open-Label, Safety, Tolerability, and Immunogenicity Study of INO-3112 Delivered by Electroporation (EP) in Women With Cervical Cancer After Chemoradiation for Newly Diagnosed Disease or Therapy for Recurrent and/or Persistent Disease|Active, not recruiting||Phase 1/Phase 2|10|Anticipated|Inovio Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:17:12.202923|2017-10-11 00:17:12.202923
NCT02172898|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-11-04|||June 2013||2013-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium|Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium|Recruiting||N/A|1260|Anticipated|Indiana University|||2||f||||t||||||Samples With DNA|"     serum/plasma, peripheral mononuclear cells, genomic DNA, stool samples, urine, and liver     tissue (where available)   "|||2017-10-11 00:17:12.313109|2017-10-11 00:17:12.313109
NCT02172885|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-08-17|||April 2014||2014-04-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TERCELOI||Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta|Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta|Active, not recruiting||Phase 1|5|Anticipated|Hospital de Cruces||1|||f||||t||||||||||2017-10-11 00:17:12.411487|2017-10-11 00:17:12.411487
NCT02172872|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-01-17|||November 2014||2014-11-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||"InDACtion vs 3+7 Induction in AML"|"10-day Decitabine Versus Conventional Chemotherapy (3+7) Followed by Allografting in AML Patients ≥ 60 Years: a Randomized Phase III Study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study Group"|Recruiting||Phase 3|600|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 00:17:12.525966|2017-10-11 00:17:12.525966
NCT02172859|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-06-23|||November 2010||2010-11-01|June 2014|2014-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|P2B_UK||Dietary Influence on Serotonin in Cognitive and Emotional Functioning in Women|Dietary Influence on Serotonin in Cognitive and Emotional Functioning in Women Using a Tryptophan-rich Protein Over 19 Days|Completed||Phase 2|59|Actual|DSM Nutritional Products, Inc.||2|||f||||f||||||||||2017-10-11 00:17:12.854548|2017-10-11 00:17:12.854548
NCT02172846|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-02-22|||May 22, 2014|Actual|2014-05-22|February 2017|2017-02-01|September 30, 2017|Anticipated|2017-09-30|August 23, 2016|Actual|2016-08-23||Interventional|||Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer|A Phase I Study of Radiation Dose Intensification With Accelerated Hypofractionated Proton Therapy and Chemotherapy for Non-small Cell Lung Cancer|Active, not recruiting||Phase 1|23|Actual|Washington University School of Medicine||1|||f||||t|t|t|f|f|f|||No||2017-10-11 00:17:12.979891|2017-10-11 00:17:12.979891
NCT02172820|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-01-04|||April 2014||2014-04-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Increasing Cardiac Rehabilitation Participation Among Medicaid Enrollees|Increasing Cardiac Rehabilitation Participation Among Medicaid Enrollees|Recruiting||N/A|130|Anticipated|University of Vermont||2|||f||||f||||||||||2017-10-11 00:17:13.203745|2017-10-11 00:17:13.203745
NCT02172807|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||December 2000||2000-12-01|June 2014|2014-06-01||||September 2001|Actual|2001-09-01||Interventional|||Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Multiple Dose Comparison of 18 µg, 36 µg of Ba679BR (Tiotropium) Inhalation Capsules and Oxitropium Metered Dose Inhaler (2 Puffs of 100µg) in a 4-week, Double-Blind, Double-Dummy, Safety and Efficacy Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|201|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:13.304012|2017-10-11 00:17:13.304012
NCT02172794|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2002||2002-05-01|June 2014|2014-06-01||||October 2005|Actual|2005-10-01||Interventional|||Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-Blind, Double-Dummy, Placebo-Controlled, Crossover Comparison of the Effect of 6-Week Treatment Periods of Tiotropium Inhalation Capsules (18 μg) and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:13.407817|2017-10-11 00:17:13.407817
NCT02172781|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2001||2001-01-01|June 2014|2014-06-01||||April 2001|Actual|2001-04-01||Interventional|||Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment|A Double-blind, Randomised, Two-way Cross-over Study to Investigate the Pharmacokinetic and Pharmacodynamic Effects of a Single Additional Dose of 500 µg Ipratropium Bromide Unit Dose Vial Inhaled Via Nebuliser Versus Placebo After 19 Days of Treatment With Tiotropium Inhalation Capsules 18 µg q.d. in Male Healthy Volunteers.|Completed||Phase 1|36|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:17:13.525664|2017-10-11 00:17:13.525664
NCT02172768|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-03-30|||October 2014||2014-10-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|MATADOR||Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease|Pharmacokinetics of Micafungin (Mycamin ®) as Antifungal Prophylaxis Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease.|Completed||Phase 2|30|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 00:17:13.659601|2017-10-11 00:17:13.659601
NCT02172755|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2017-04-18|2014-11-28||June 2002||2002-06-01|April 2017|2017-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites|Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites in Healthy Elderly Subjects Compared With Those in Healthy Young Subjects|Completed||Phase 1|30|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 00:17:13.791457|2017-10-11 00:17:13.791457
NCT02172742|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-23|2014-12-18|2014-11-28||May 2002||2002-05-01|December 2014|2014-12-01||||July 2002|Actual|2002-07-01||Interventional|||The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin|The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin in Healthy Volunteers|Completed||Phase 1|13|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 00:17:14.233756|2017-10-11 00:17:14.233756
NCT02172729|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-11-17|||June 2014||2014-06-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effect of Different Doses (Mass) of Local Anesthetic on Duration of Adductor Canal Block in Healthy Volunteers - Part 2|The Effect of Different Doses (Mass) of Local Anesthetic on Duration of Adductor Canal Block in Healthy Volunteers - Part 2|Completed||Phase 4|14|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 00:17:14.595311|2017-10-11 00:17:14.595311
NCT02172716|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-22|||May 2014||2014-05-01|June 2014|2014-06-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Disruption of Immune Homeostasis in Type 2 Diabetics With Generalized Chronic Periodontitis|Disruption of Immune Homeostasis in Type 2 Diabetics With Generalized Chronic Periodontitis|Unknown status|Recruiting|N/A|80|Anticipated|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 00:17:14.690342|2017-10-11 00:17:14.690342
NCT02172703|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-07-07|||February 2014||2014-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Non-invasive Brain Pressure Monitoring After Trauma or Hemorrhage|Validation of Non-invasive Absolute Intracranial Pressure Monitoring in Patients After Traumatic Brain Injury and Subarachnoid Hemorrhage|Completed||N/A|11|Actual|Kantonsspital Aarau||1|||f||||f||||||||||2017-10-11 00:17:14.79609|2017-10-11 00:17:14.79609
NCT02172690|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-12-06|||June 2014||2014-06-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese Patients|Laparoscopic Staging in Patients With Locally Advanced Gastric Cancer in Chinese Patients|Recruiting||N/A|450|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 00:17:14.912933|2017-10-11 00:17:14.912933
NCT02172677|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-01-06|||October 2014||2014-10-01|November 2015|2015-11-01||||April 2016|Anticipated|2016-04-01||Interventional|MULTIBRAIN_1||The Influence of Collective Schemas on Individual Memory|ETUDE D'IMAGERIE PAR RESONANCE MAGNETIQUE FONCTIONNELLE CHEZ LE SUJET SAIN DES RELATIONS ENTRE MEMOIRE COLLECTIVE ET INDIVIDUELLE|Recruiting||N/A|24|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||||||||||||2017-10-11 00:17:15.031424|2017-10-11 00:17:15.031424
NCT02172664|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-09-05|||June 2014||2014-06-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Evaluation of a Universal Adhesive in Noncarious Cervical Lesions|Clinical Evaluation of a Universal Adhesive in Noncarious Cervical Lesions|Active, not recruiting||N/A|33|Anticipated|Indiana University||2|||f||||f||||||||||2017-10-11 00:17:15.136989|2017-10-11 00:17:15.136989
NCT02172651|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-04-17|||July 2014||2014-07-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Study to Identify Transcriptional Targets of Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases Receiving Preoperative Vitamin D Supplementation.|Study to Identify Transcriptional Targets of Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases Receiving Preoperative Vitamin D Supplementation.|Recruiting||Early Phase 1|12|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:17:15.273346|2017-10-11 00:17:15.273346
NCT02172638|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-03-21|||June 2014||2014-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|PROFAST||Postoperatory Recovery in Advanced Ovarian Cancer, Fast-Track Protocol vs. Classical Management|Ensayo clínico Comparando Recuperación Postoperatoria Tras Protocolo FAST- TRACK Vs. Manejo Clásico en Cáncer de Ovario Avanzado|Recruiting||N/A|100|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||||||||||||2017-10-11 00:17:15.410848|2017-10-11 00:17:15.410848
NCT02172625|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-01-05|2016-08-14||November 2014||2014-11-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Protandim Supplementation on Oxidative Damage and Athletic Performance|The Effect of 90 Days of Protandim Supplementation on Markers of Oxidative Stress, Athletic Performance, and Recovery|Completed||N/A|40|Actual|University of Louisville|"Serum TBARS to detect lipid peroxidation is not specific.
TBARS may have been measured too quickly post-exercise."|2|||f||||t||||||||Yes|The de-identified data is in SPSS format placed as a supplement in the published PLOS ONE article: http://dx.doi.org/10.1371/journal.pone.0160559|2017-10-11 00:17:15.558969|2017-10-11 00:17:15.558969
NCT02172612|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-03-07|||September 2014||2014-09-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 2015|Actual|2015-12-01||Interventional|||A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly|Evaluation of a Patient-Centered Medication Therapy Management Intervention to Reduce Inappropriate Anticholinergic Prescribing in the Elderly|Active, not recruiting||N/A|50|Anticipated|University of Kentucky||2|||f||||f||||||||||2017-10-11 00:17:16.427535|2017-10-11 00:17:16.427535
NCT02172599|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2015-01-27|||May 2014||2014-05-01|January 2015|2015-01-01|October 2016|Anticipated|2016-10-01|February 2016|Anticipated|2016-02-01||Interventional|||Take A Stand for Workplace Health: A Sit-stand Workstation Project Evaluation|The Influence of Sit-stand Workstations Upon Total Physical Activity: a 12 Month Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|30|Actual|Brunel University||3|||f||||t||||||||||2017-10-11 00:17:16.535173|2017-10-11 00:17:16.535173
NCT02172586|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2000||2000-01-01|June 2014|2014-06-01||||January 2002|Actual|2002-01-01||Interventional|||Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients|A PROBE (Prospective, Randomised, Open-label, Blinded Endpoint) Trial to Investigate the Efficacy and Safety of Telmisartan 40-80 mg Once Daily Compared With Losartan 50-100 mg Once Daily Over a Period of 12 Weeks, and of Telmisartan 80 mg + HCTZ 12.5 mg Once Daily Compared With Losartan 100 mg Once Daily + HCTZ 12.5 mg Once Daily Over a Period of Further 12 Weeks in Mild to Moderate Hypertensive Patients (Grade 1 and Grade 2 WHO-ISH Guidelines 1999)|Completed||Phase 4|363|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:17:16.642558|2017-10-11 00:17:16.642558
NCT02172573|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 1999||1999-04-01|June 2014|2014-06-01||||July 2000|Actual|2000-07-01||Interventional|||Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease|A Double-blind, Placebo-controlled, Randomised, Multicenter Trial to Compare the Safety and Efficacy of Oral Administration of Pramipexole up to 4.5mg and Bromocriptine up to 22.5mg Combined With L-dopa in Advanced Parkinson's Disease|Completed||Phase 3|315|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:16.740421|2017-10-11 00:17:16.740421
NCT02172560|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-11-17|||March 2007||2007-03-01|June 2014|2014-06-01||||January 2008|Actual|2008-01-01||Observational|||A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler|A Retrospective Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Either of Two One-Year Trials (205.254, 205.255) of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler|Completed||N/A|441|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:17:16.853526|2017-10-11 00:17:16.853526
NCT02172547|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2006||2006-04-01|June 2014|2014-06-01||||January 2007|Actual|2007-01-01||Observational|||Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.|Effect of Spiriva® 18 Microgram on Health-related Quality of Life in COPD Patients Who Stopped Smoking During Treatment.|Completed||N/A|10821|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:17:17.008327|2017-10-11 00:17:17.008327
NCT02172534|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||September 2006||2006-09-01|June 2014|2014-06-01||||September 2008|Actual|2008-09-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients|A Randomized, Double-blind Within Dose, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Increasing Single and Multiple Doses (28-day Dosing) of Tiotropium Bromide Administered Once Daily Via the Respimat® Device in Cystic Fibrosis Patients|Completed||Phase 1|113|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:17:17.086032|2017-10-11 00:17:17.086032
NCT02172521|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2006||2006-01-01|June 2014|2014-06-01||||October 2006|Actual|2006-10-01||Observational|||Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation|Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With COPD and Proven Hyperinflation|Completed||Phase 4|1536|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:17:17.231961|2017-10-11 00:17:17.231961
NCT02172508|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2004||2004-01-01|June 2014|2014-06-01||||March 2004|Actual|2004-03-01||Interventional|||Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation|A Randomised, Double-blind, Placebo-controlled 7-week Trial to Investigate the Effects of Tiotropium Inhalation Capsules (18 μg) Once Daily on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation.|Terminated||Phase 4|15|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:17.33601|2017-10-11 00:17:17.33601
NCT02172495|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2002||2002-06-01|June 2014|2014-06-01||||October 2003|Actual|2003-10-01||Observational|||Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice|Tolerability and Efficacy of Spiriva® 18 Micrograms in Patients With COPD in Daily Practice|Completed||N/A|4700|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:17:17.441226|2017-10-11 00:17:17.441226
NCT02172482|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2002||2002-06-01|June 2014|2014-06-01||||October 2003|Actual|2003-10-01||Observational|||Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Tolerability and Efficacy of Spiriva® 18 Micrograms in Patients With COPD in Daily Practice|Completed||N/A|63127|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:17:17.541695|2017-10-11 00:17:17.541695
NCT02172469|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2001||2001-05-01|June 2014|2014-06-01||||April 2002|Actual|2002-04-01||Interventional|||Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Comparison of 18 µg of Tiotropium Inhalation Capsules and Atrovent® Metered Dose Inhaler (2 Puffs of 20 µg, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|215|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:17.667822|2017-10-11 00:17:17.667822
NCT02172456|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2002||2002-05-01|June 2014|2014-06-01||||October 2002|Actual|2002-10-01||Interventional|||Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD)|γ-Scintigraphic Evaluation of the Lung Deposition Rate and Distribution Pattern of a 99mTc-Labelled Tiotropium Powder Formulation Following Multiple Dose Inhalation of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With COPD|Completed||Phase 3|22|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:17.815465|2017-10-11 00:17:17.815465
NCT02172443|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2001||2001-06-01|June 2014|2014-06-01||||May 2002|Actual|2002-05-01||Interventional|||Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease|Comparison of 18 mcg of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (2 Puffs of 20 mcg) in a Double Blind, Double Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|50|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:17.947562|2017-10-11 00:17:17.947562
NCT02172430|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||September 2000||2000-09-01|June 2014|2014-06-01||||May 2002|Actual|2002-05-01||Interventional|||Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Multiple Dose Comparison of Tiotropium 18 μg Inhalation Capsules and Oxitropium MDI (2 Puffs of 100 μg) in a One-year, Open-Label, Safety and Efficacy Study in Patients With COPD|Completed||Phase 3|161|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:18.091446|2017-10-11 00:17:18.091446
NCT02172417|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||July 2000||2000-07-01|June 2014|2014-06-01||||November 2000|Actual|2000-11-01||Interventional|||Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects|The Effect of Concomitant Cimetidine p.o. 400 mg t.i.d. and p.o. Ranitidine 300 mg Once Daily on Single Dose Pharmacokinetics of Tiotropium (14.4 µg) Given Intravenously Over 15 Minutes in Healthy Male and Female Subjects of 50-65 Years (Randomized, Open Label, Two Independent Two-fold Crossover)|Completed||Phase 1|18|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:18.197268|2017-10-11 00:17:18.197268
NCT02172404|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||October 2000||2000-10-01|June 2014|2014-06-01||||June 2001|Actual|2001-06-01||Interventional|||HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Single-blind Two-centre Trial to Compare Administration Technique, Learning Retention of the Administration Technique and Ease of Use of the HandiHaler® With Those of the Pressurised Metered Dose Inhaler (MDI) in Patients With COPD.|Completed||Phase 3|160|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:18.29173|2017-10-11 00:17:18.29173
NCT02172391|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||November 2000||2000-11-01|June 2014|2014-06-01||||August 2001|Actual|2001-08-01||Interventional|||Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)|The Effects of Tiotropium Therapy on Airway Diameter in Patients With COPD (a Randomized, Double-blind, Placebo-controlled, Parallel-group Study)|Completed||Phase 3|81||Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:18.385976|2017-10-11 00:17:18.385976
NCT02172378|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2000||2000-05-01|June 2014|2014-06-01||||January 2002|Actual|2002-01-01||Interventional|||12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales|Effect of a 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe COPD Patients. Correlation to Dyspnoea Scales. A Double-blind, Placebo-controlled, Randomized, Parallel Group Study|Completed||Phase 3|116|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:18.488973|2017-10-11 00:17:18.488973
NCT02172365|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-05-10|||March 2014||2014-03-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Allogeneic SCT for CML, TKI Failure After TKI Failure|Retrospective Analysis of Treatment Outcomes of Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia After TKI Failure|Recruiting||N/A|350|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 00:17:18.577345|2017-10-11 00:17:18.577345
NCT02172352|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||July 1998||1998-07-01|June 2014|2014-06-01||||May 1999|Actual|1999-05-01||Interventional|||Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients|Dose Ranging Study of Ba 679 BR Inhalation Powder Following Single Inhalation in COPD Patients - Double-blind, Placebo-controlled, 4 Treatment, 4 Period Crossover Study-|Completed||Phase 2|28|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:17:18.657955|2017-10-11 00:17:18.657955
NCT02172339|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 1998||1998-04-01|June 2014|2014-06-01||||December 1998|Actual|1998-12-01||Interventional|||The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects|The Pharmacokinetic, Safety and Tolerability of Tiotropium (4.8 mcg, Single i.v. Dose) in Outpatients With Renal Impairment in Comparison to Healthy Subjects (Open Label, Group Comparison, Two-center Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:18.738743|2017-10-11 00:17:18.738743
NCT02172326|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||February 1998||1998-02-01|June 2014|2014-06-01||||September 1998|Actual|1998-09-01||Interventional|||Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD)|The Pharmacokinetics, Safety and Tolerability of Tiotropium in Elderly COPD Patients (Open Label, Monocenter Study).|Completed||Phase 3|29||Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:18.816818|2017-10-11 00:17:18.816818
NCT02172313|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-10-20|||June 2014||2014-06-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects|Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects|Completed||Phase 1|78|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 00:17:18.903056|2017-10-11 00:17:18.903056
NCT02172300|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 1999||1999-06-01|June 2014|2014-06-01||||November 2000|Actual|2000-11-01||Interventional|||Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Effect of Tiotropium on Exercise Tolerance and Static and Dynamic Lung Volumes in COPD Patients (A Randomized Double-Blind, Placebo Controlled, Parallel Group Study)|Completed||Phase 3|198|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:19.066591|2017-10-11 00:17:19.066591
NCT02172287|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||February 1999||1999-02-01|June 2014|2014-06-01||||May 2000|Actual|2000-05-01||Interventional|COPD||Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in a Six-Month, Double-Blind, Double-Dummy, Safety and Efficacy Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|623|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:19.154118|2017-10-11 00:17:19.154118
NCT02172274|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2008||2008-06-01|June 2014|2014-06-01||||July 2008|Actual|2008-07-01||Interventional|||BI 10773 Administered as Oral Solution to Healthy Male Volunteers|A Phase I, Open-label, Single-dose Trial to Investigate the Metabolism and Pharmacokinetics of 50 mg [14C]-BI 10773 When Administered as Oral Solution to Healthy Male Volunteers|Completed||Phase 1|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:19.262863|2017-10-11 00:17:19.262863
NCT02172261|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2009||2009-04-01|June 2014|2014-06-01||||June 2009|Actual|2009-06-01||Interventional|||Relative Bioavailability of BI 10773 and Glimepiride in Healthy Male Volunteers|Relative Bioavailability of Both BI 10773 and Glimepiride After Co-administration Compared to Multiple Oral Doses of BI 10773 (50 mg q.d.) Alone and a Single Dose of Glimepiride (1 mg) Alone in Healthy Male Volunteers (an Open-label, Randomised, Crossover, Clinical Phase I Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:19.367893|2017-10-11 00:17:19.367893
NCT02172248|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2009||2009-01-01|June 2014|2014-06-01||||March 2009|Actual|2009-03-01||Interventional|||Relative Bioavailability BI 10773 and Metformin in Healthy Male Volunteers|Relative Bioavailability of Both BI 10773 and Metformin After Coadministration Compared to Multiple Oral Doses of BI 10773 (50 mg q.d.) Alone and Metformin (1000 mg b.i.d.) Alone to Healthy Male Volunteers (an Open-label, Randomised, Crossover, Clinical Phase I Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:19.451598|2017-10-11 00:17:19.451598
NCT02172235|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2010||2010-04-01|June 2014|2014-06-01||||July 2010|Actual|2010-07-01||Interventional|||Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers|Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers (an Open-label, Randomised, Crossover, Clinical Phase I Study)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:17:19.527193|2017-10-11 00:17:19.527193
NCT02172222|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||July 2009||2009-07-01|June 2014|2014-06-01||||September 2009|Actual|2009-09-01||Interventional|||Relative Bioavailability of BI 10773 and Linagliptin in Healthy Male Volunteers|Relative Bioavailability of Multiple Doses BI 10773 50 mg and Linagliptin 5 mg After Concomitant Administration Compared to Multiple Doses of BI 10773 50 mg and Linagliptin 5mg Administered Alone to Healthy Male Volunteers (an Open-label, Randomised, Crossover, Clinical Phase I Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:19.607374|2017-10-11 00:17:19.607374
NCT02172209|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2008||2008-01-01|June 2014|2014-06-01||||February 2008|Actual|2008-02-01||Interventional|||Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers|The Effect of Food on the Bioavailability and Pharmacokinetics of BI 10773 Tablet, Administered as a Single Dose of 50 mg With and Without Food to Healthy Male Volunteers in an Open-label, Randomised Intraindividual Crossover Comparison Design|Completed||Phase 1|14|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:19.676034|2017-10-11 00:17:19.676034
NCT02172196|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2009||2009-05-01|June 2014|2014-06-01||||July 2009|Actual|2009-07-01||Interventional|||Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers|Relative Bioavailability of Both BI 10773 and Sitagliptin After Co-administration Compared to Multiple Oral Doses of BI 10773 (50 mg q.d.) Alone and Sitagliptin (100 mg q.d.) Alone in Healthy Male Volunteers (an Open-label, Randomised, Crossover, Clinical Phase I Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:21.514973|2017-10-11 00:17:21.514973
NCT02172183|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-20|||April 2012||2012-04-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||CBT Group for Adolescents With ADHD: a Randomized Controlled Trial|Group Therapy for Adolescents With Attention-Deficit/Hyperactivity Disorder: a Randomized Multicenter Controlled Trial|Completed||N/A|119|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||||2017-10-11 00:17:21.607429|2017-10-11 00:17:21.607429
NCT02172170|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2007||2007-01-01|June 2014|2014-06-01||||March 2007|Actual|2007-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 10773 in Healthy Male Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses (0.5 mg to 800 mg) of BI 10773 as Tablets Administered to Healthy Male Subjects. A Randomised Placebo-controlled (Within-dose Groups) and Double-blind Trial.|Completed||Phase 1|72|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:21.693909|2017-10-11 00:17:21.693909
NCT02172157|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||February 2008||2008-02-01|June 2014|2014-06-01||||April 2008|Actual|2008-04-01||Interventional|||Investigation of the Metabolism and Pharmacokinetics of [14C]BI 1744 CL and [14C]BI 1744 CL Administered as an Oral Solution in Healthy Male Subjects|Investigation of the Metabolism and Pharmacokinetics of 20 μg (Calculated as Free Base) [14C]BI 1744 CL Administered as a 3-hour Infusion and 40 μg (Calculated as Free Base) [14C]BI 1744 CL Administered as an Oral Solution.|Completed||Phase 1|11|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:21.771704|2017-10-11 00:17:21.771704
NCT02172144|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2007||2007-06-01|June 2014|2014-06-01||||October 2007|Actual|2007-10-01||Interventional|||Via Respimat® Inhaled BI 1744 CL Compared to Moxifloxacin and Placebo in Healthy Male and Female Volunteers|A Double-blind, Randomised, Placebo Controlled, Six-way Crossover Study Including an Open-label Positive Control (Moxifloxacin) to Assess the Influence of Via Respimat® Inhaled BI 1744 CL (Single Doses of 10 μg, 20 μg, 30 μg and 50 μg) on the QT/QTc Interval of the ECG in Healthy Male and Female Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:21.864535|2017-10-11 00:17:21.864535
NCT02172131|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||October 2006||2006-10-01|May 2014|2014-05-01||||February 2007|Actual|2007-02-01||Interventional|||Safety, Tolerability and Pharmacokinetics Study of BI 1744 CL in Healthy Male Subjects|Safety, Tolerability and Pharmacokinetics of Single Rising Doses of 0.5 μg, 2.5 μg, 5 μg, 10 μg, 15 μg, 20 μg, 25 μg and 30 μg BI 1744 CL (Calculated as Free Base) Given as Intravenous Infusion Over 30 Minutes to Healthy Male Subjects. A Single-centre, Single-blind, Placebo-controlled, Randomised Study.|Terminated||Phase 1|64|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:21.941307|2017-10-11 00:17:21.941307
NCT02172118|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||August 2009||2009-08-01|June 2014|2014-06-01||||December 2009|Actual|2009-12-01||Interventional|||BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function|Pharmacokinetics, Safety and Tolerability of Single Dose of BI 1744 CL (30 μg Administered With the Respimat® Inhaler) in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function in a Monocentric, Open Label, Parallel Group Phase I Trial|Completed||Phase 1|22|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:22.018217|2017-10-11 00:17:22.018217
NCT02172105|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2008||2008-01-01|June 2014|2014-06-01||||May 2008|Actual|2008-05-01||Interventional|||Multiple Rising Inhalative Doses of BI 1744 CL in Healthy Male Volunteers|A Double-blind, Randomised, Placebo Controlled (Within a Dose Group) Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising Inhalative Doses (5 μg, 10 μg and 20 μg) of BI 1744 CL for 14 Days in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:22.088827|2017-10-11 00:17:22.088827
NCT02172092|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2016-09-27|||August 2014||2014-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FDKA||Fluid Kinetics in Patients With Diabetic Ketoacidosis|Fluid Kinetics in Patients With Diabetic Ketoacidosis|Recruiting||N/A|20|Anticipated|University Hospital, Linkoeping||1|||f||||f||||||||||2017-10-11 00:17:22.167679|2017-10-11 00:17:22.167679
NCT02172079|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-22|2014-06-23|||January 2013||2013-01-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Mobilization With Movement for Shoulder Impingement|Effects of Mobilization-with-Movement on Pain and Range of Motion in Unilateral Shoulder Impingement Syndrome: A Randomized Controlled Trial|Completed||N/A|42|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 00:17:22.376111|2017-10-11 00:17:22.376111
NCT02172066|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-07-17|||June 2014||2014-06-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Narrative Exposure Therapy (NET) for Victims of the Recent Flood Disaster in Burundi|Evaluation of the Narrative Exposure Therapy (NET) as Means to Reduce Psychological Impairment in the Aftermath of the Recent Flood Disaster in Bujumbura, Burundi|Completed||N/A|51|Actual|University of Konstanz||2|||f||||t||||||||||2017-10-11 00:17:22.459881|2017-10-11 00:17:22.459881
NCT02172053|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-03-10|||October 2015||2015-10-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|REW||Resistance Exercise to Improve Fatigue in Workplace (REW)|Effectiveness of a Resistance Training Program in the Workplace to Muscle Fatigue Control in Industrial Workers: Cluster Randomized Controlled Trial.|Active, not recruiting||N/A|352|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t||||||||||2017-10-11 00:17:22.556964|2017-10-11 00:17:22.556964
NCT02172040|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-09-29|2017-07-31||June 2014||2014-06-01|September 2017|2017-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy|A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy|Completed||Phase 3|152|Actual|Kitov Pharmaceuticals, Ltd.|No limitations|4|||f||||f||||||||||2017-10-11 00:17:22.69406|2017-10-11 00:17:22.69406
NCT02172027|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-09-14|||July 2014||2014-07-01|June 2014|2014-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic Tool|Novel Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic Tool|Withdrawn||N/A|0|Actual|Meir Medical Center|||1|Technical problems with the device|f||||t||||||||||2017-10-11 00:17:23.831536|2017-10-11 00:17:23.831536
NCT02172014|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-11-23|||June 2013||2013-06-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety and Efficacy of Fentanyl Citrate in Children|Safety and Efficacy of Fentanyl Citrate in Combination With Midazolam in Critically Ill Children With Mechanical Ventilation|Completed||Phase 2|44|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:17:23.893305|2017-10-11 00:17:23.893305
NCT02172001|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-21|2016-09-27||||||March 2016|2016-03-01||||March 2015|Actual|2015-03-01||Interventional|||A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo|A Phase III, Randomised, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo in Subjects With Iron Deficiency Anaemia and Who Are Intol-erant or Unresponsive to Oral Iron Therapy|Withdrawn||Phase 3|0|Actual|Pharmacosmos A/S||2||Study design not adequate|f||||f||||||||||2017-10-11 00:17:23.986973|2017-10-11 00:17:23.986973
NCT02171988|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-04-14|||March 2014||2014-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|February 2016|Actual|2016-02-01||Interventional|POTS||Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)|Comparison of Effect of Propranolol, Bisoprolol, Pyridosgitmine in Postural Orthostatic Tachycardia Syndrome (POTS) and Prognosis After Medical Treatment|Active, not recruiting||Phase 4|150|Actual|Seoul National University Hospital||4|||f||||f||||||||||2017-10-11 00:17:24.06515|2017-10-11 00:17:24.06515
NCT02171975|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-20|||February 2014||2014-02-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Ultrasound - Guided Paramedian Techniques in Spinal Anesthesia|A Comparison of Conventional Landmark Guided Midline Versus Pre-procedure Ultrasound - Guided Paramedian Techniques in Spinal Anesthesia|Completed||N/A|100|Actual|Cork University Hospital||2|||f||||f||||||||||2017-10-11 00:17:24.319341|2017-10-11 00:17:24.319341
NCT02171962|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-03-21|||June 2014||2014-06-01|March 2017|2017-03-01|February 9, 2017|Actual|2017-02-09|December 2015|Actual|2015-12-01||Interventional|||Zilver® PTX® in China|Evaluation of the Zilver® PTX® Drug-Eluting Peripheral Stent for Treatment of Lesions of the Above-the-Knee Femoropopliteal Artery|Completed||N/A|178|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 00:17:24.41527|2017-10-11 00:17:24.41527
NCT02171949|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-04-10|||April 2015||2015-04-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases|Randomized, Open and Controlled Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases|Unknown status|Recruiting|Phase 2|30|Anticipated|Hospital Sao Rafael||2|||f||||t||||||||||2017-10-11 00:17:24.532987|2017-10-11 00:17:24.532987
NCT02171936|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-23|||May 2014||2014-05-01|June 2014|2014-06-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|PRECAPAIN||Chronic Pain and Social Vulnerability: Prevalence and Predictive Factors of the Social Vulnerability in Evaluation and Treatment of the Pain Center (CETD)|Chronic Pain and Social Vulnerability: Prevalence and Predictive Factors of the Social Vulnerability in Evaluation and Treatment of the Pain Center (CETD)|Unknown status|Recruiting|N/A|800|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:17:24.656555|2017-10-11 00:17:24.656555
NCT02171923|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-10-05|||May 2013||2013-05-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|CORVAD||Multicenter Comparative Study of the Activity of the Medial Prefrontal Cortex in Vulnerability to Depression|Medial Prefrontal Cortex and Vulnerability for Depression|Completed||N/A|77|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-11 00:17:24.750344|2017-10-11 00:17:24.750344
NCT02171910|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2016-12-02|||October 2016||2016-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Doxapram as an Additive to Propofol Sedation in Sedation for ERCP|Doxapram as an Additive to Propofol Sedation in Sedation for Endoscopic Retrograde Cholangiopancreatography|Completed||Phase 4|50|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 00:17:24.825672|2017-10-11 00:17:24.825672
NCT02171897|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-20||||||May 2014|2014-05-01||||June 2017|Anticipated|2017-06-01||Interventional|PAVO||Pertrochanter Arthroplasty Versus Osteosynthesis|Comparison of Functional Recovery After Pertrochanter Fracture Treated With Either Total Hip Replacement or Centromedullary Nailing|Unknown status|Not yet recruiting|N/A|70|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:17:24.920594|2017-10-11 00:17:24.920594
NCT02171884|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-20||||||December 2013|2013-12-01||||March 2016|Anticipated|2016-03-01||Observational|||Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in Humans|Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in Humans|Unknown status|Recruiting|N/A|152|Anticipated|Centre Hospitalier Universitaire Dijon|||4||f||||||||||||||2017-10-11 00:17:25.021793|2017-10-11 00:17:25.021793
NCT02171871|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-06-21|||January 2010||2010-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||Effects Of Passive Smoking On The Respiratory System Mechanics Of Healthy Non-Smokers In Different Body Positions|Effects Of Passive Smoking On The Respiratory System Mechanics Of Healthy Non-Smokers In Different Body Positions|Completed||Phase 1|20|Actual|Hellenic Anticancer Society||1|||f||||t||||||||||2017-10-11 00:17:25.131067|2017-10-11 00:17:25.131067
NCT02171858|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-21|||June 2013||2013-06-01|June 2014|2014-06-01||||January 2015|Anticipated|2015-01-01||Observational|MAASP||Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke|Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke|Unknown status|Enrolling by invitation|N/A|28|Anticipated|Hospital Central Sur de Alta Especialidad|||1||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 00:17:25.246264|2017-10-11 00:17:25.246264
NCT02171845|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-23||||||November 2013|2013-11-01||||January 2017|Anticipated|2017-01-01||Observational|||Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans|Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans|Unknown status|Recruiting|N/A|30|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 00:17:25.331157|2017-10-11 00:17:25.331157
NCT02171832|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||July 2009||2009-07-01|June 2014|2014-06-01||||December 2009|Actual|2009-12-01||Interventional|||Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Pharmacokinetics, Safety and Tolerability of a Single Dose of BI 1744 CL (20 μg Administered With the Respimat® Inhaler) in Patients With Mild and Moderate Hepatic Impairment (Child Pugh Classifications A and B) in Comparison to a Single Dose of BI 1744 CL (30 μg Administered With the Respimat® Inhaler) in Subjects With Normal Hepatic Function in a Monocentric, Open Label, Parallel Group Phase I Trial|Completed||Phase 1|32|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:25.438686|2017-10-11 00:17:25.438686
NCT02171819|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-11-17|||June 2014||2014-06-01|June 2014|2014-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1|A Phase 1 Double Blinded, Randomized, Placebo-Controlled Study to Examine the Safety and Immunogenicity of an Inactivated A/H5N1 Influenza Vaccine (IVACFLU-A/H5N1) Produced by IVAC in Healthy Adult Volunteers in Vietnam|Completed||Phase 1|75|Actual|Institute of Vaccines and Medical Biologicals, Vietnam||3|||f||||t||||||||||2017-10-11 00:17:25.535768|2017-10-11 00:17:25.535768
NCT02171806|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2006||2006-01-01|June 2014|2014-06-01||||September 2006|Actual|2006-09-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BI 1744 CL in Healthy Male and Female Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses (2.5 μg, 10 μg, and 30 μg) of BI 1744 CL for 14 Days in Healthy Male and Female Volunteers (Doubleblind, Randomised, Placebo Controlled [at Each Dose Level] Study)|Completed||Phase 1|47|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:25.633415|2017-10-11 00:17:25.633415
NCT02171793|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2007||2007-06-01|June 2014|2014-06-01||||July 2007|Actual|2007-07-01||Interventional|||Single Rising Peroral Doses of BI 1744 CL in Healthy Volunteers|A Randomised, Single-blind, Placebo-controlled (Within Dose Groups) Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Peroral Doses (15, 30, 40 μg Free Cation) BI 1744 CL in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:25.725314|2017-10-11 00:17:25.725314
NCT02171286|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-04-13|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||The Oncopanel Pilot (TOP) Study|The Oncopanel Pilot (TOP) Study|Completed||N/A|432|Actual|British Columbia Cancer Agency|||1||f||||f||||||Samples With DNA|"     Whole blood, plasma and tissues   "|||2017-10-11 00:17:31.022151|2017-10-11 00:17:31.022151
NCT02171780|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||February 2005||2005-02-01|June 2014|2014-06-01||||July 2005|Actual|2005-07-01||Interventional|||A Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 1744 CL in Healthy Male and Female Volunteers|A Randomised, Double-blind, Placebo-controlled (Within Dose Groups) Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses (0.5 μg to 70 μg Administered With the Respimat®) of BI 1744 CL in Healthy Male and Female Volunteers|Completed||Phase 1|122|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:25.822073|2017-10-11 00:17:25.822073
NCT02171767|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||August 2009||2009-08-01|June 2014|2014-06-01||||October 2009|Actual|2009-10-01||Interventional|||Safety and Tolerability of 4 Different Dosage Strengths of BIBW 2992 Tablets to Healthy Male Volunteers|Pharmacokinetics, Safety and Tolerability of BIBW 2992 Administered Orally as 20 mg, 30 mg, 40 mg, and 50 mg Tablets (Final Formulation) to Healthy Male Volunteers in an Open-label, Single Rising Dose, Phase I Trial|Completed||Phase 1|48|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:25.903984|2017-10-11 00:17:25.903984
NCT02171754|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||September 2009||2009-09-01|June 2014|2014-06-01||||December 2009|Actual|2009-12-01||Interventional|||Relative Bioavailability of a Single-dose Administration of BIBW 2992 and Multiple-dose Administration of Ritonavir in Healthy Volunteers|Relative Bioavailability of a Single Oral Dose of BIBW 2992 (20 mg) After Coadministration With Multiple Oral Doses of Ritonavir (200 mg Bid for 3 Days) Compared to the Bioavailability of a Single Oral Dose of BIBW 2992 (20 mg) Alone in Healthy Male Volunteers (an Open-label, Randomised, Two-way Crossover, Clinical Phase I Study)|Completed||Phase 1|22|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:25.984413|2017-10-11 00:17:25.984413
NCT02171741|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2005||2005-04-01|June 2014|2014-06-01||||December 2007|Actual|2007-12-01||Interventional|||Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid Tumors|A Phase I Dose Escalation Trial of BIBW 2992 Administration for 20, 13 or 6 Days in Combination With Docetaxel Every 21 Days|Completed||Phase 1|31|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:26.070811|2017-10-11 00:17:26.070811
NCT02171728|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||November 2004||2004-11-01|June 2014|2014-06-01||||September 2006|Actual|2006-09-01||Interventional|||Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors|A Phase I Open Label Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors|Completed||Phase 1|30|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:26.15268|2017-10-11 00:17:26.15268
NCT02171715|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2009||2009-01-01|June 2014|2014-06-01||||April 2009|Actual|2009-04-01||Interventional|||BIBW 2992 Administered as Tablet (Final Formulation) Compared to BIBW 2992 Drinking Solution and BIBW 2992 Tablet (Trial Formulation II) in Healthy Male Volunteers|Relative Bioavailability of a Single Dose 20 mg BIBW 2992 Administered as Tablet (Final Formulation) Compared to BIBW 2992 Drinking Solution and BIBW 2992 Tablet (Trial Formulation II) Following Oral Administration to Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Three-way Crossover Phase I Study)|Completed||Phase 1|22|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:26.228481|2017-10-11 00:17:26.228481
NCT02171702|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||November 2004||2004-11-01|June 2014|2014-06-01||||March 2007|Actual|2007-03-01||Interventional|||Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours|A Phase I Open Label Dose Escalation Study of Once-daily Oral Treatment With BIBW 2992 for 28 Days in Patients With Advanced Solid Tumours|Completed||Phase 1|53|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:26.299279|2017-10-11 00:17:26.299279
NCT02171689|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||July 2006||2006-07-01|June 2014|2014-06-01||||August 2006|Actual|2006-08-01||Interventional|||Metabolism and Pharmacokinetics of [14C]- BIBW 2992 MA2 in Healthy Male Volunteers|Metabolism and Pharmacokinetics of [14C]- BIBW 2992 MA2 After Administration of Single Doses of 15 mg [14C]- BIBW 2992 MA2 Oral Solution in Healthy Male Volunteers|Completed||Phase 1|8|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:26.371218|2017-10-11 00:17:26.371218
NCT02171676|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2005||2005-05-01|June 2014|2014-06-01||||March 2008|Actual|2008-03-01||Interventional|||BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors|A Phase I Open-label Dose Escalation Study of Single Oral Daily Doses of BIBW 2992 for Three Days After Administration of Docetaxel, in Patients With Advanced Solid Tumors|Completed||Phase 1|40|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:26.444651|2017-10-11 00:17:26.444651
NCT02171663|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-01-27|||March 2004||2004-03-01|January 2015|2015-01-01||||February 2006|Actual|2006-02-01||Interventional|||Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors|A Phase I Open-label Dose Escalation Study of Once-daily Oral Treatment With BIBF 2992 for 21 Days in Patients With Advanced Solid Tumors|Completed||Phase 1|43|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:26.651339|2017-10-11 00:17:26.651339
NCT02171650|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||December 2004||2004-12-01|June 2014|2014-06-01||||May 2006|Actual|2006-05-01||Interventional|||BIBW 2992 in Patients With Advanced Solid Tumors|A Phase I Open-label Extension Study of 1200.1 and 1200.2 of Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors|Completed||Phase 1|7|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:26.721949|2017-10-11 00:17:26.721949
NCT02171637|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||November 2003||2003-11-01|June 2014|2014-06-01||||February 2006|Actual|2006-02-01||Interventional|||Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors|A Phase I Open Label Dose Escalation Study of Once-daily Oral Treatment With BIBW 2992 for 14 Days in Patients With Advanced Solid Tumors|Completed||Phase 1|38|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:26.782231|2017-10-11 00:17:26.782231
NCT02171624|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||March 2009||2009-03-01|June 2014|2014-06-01||||April 2009|Actual|2009-04-01||Interventional|||Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran Etexilate|A Two-way Crossover Study to Evaluate the Safety and Pharmacokinetics of Quinidine Sulfate Alone (200 mg Orally q2h to a Maximum of 1,000 mg), Dabigatran Etexilate Alone (150 mg BID for Three Days), and the Co-administration of Dabigatran Etexilate (150 mg BID) With Quinidine Sulfate (200 mg q2h)|Completed||Phase 1|42|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:26.863358|2017-10-11 00:17:26.863358
NCT02171299|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-23|||September 2012||2012-09-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|Pain-1||Intraoperative Local Anaesthetic and Postoperative Pain|Intraoperative Wound Infiltration With Local Anaesthetic in Surgical Patients; Is There Any Late Effect on the Postoperative Pain and the Requirements of Analgesia ? A Randomized Control Trial.|Completed||N/A|400|Actual|Hellenic Red Cross Hospital||2|||f||||t||||||||||2017-10-11 00:17:30.918584|2017-10-11 00:17:30.918584
NCT02171611|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-04-27|2017-03-15||March 2009||2009-03-01|April 2017|2017-04-01||||May 2009|Actual|2009-05-01||Interventional||Treated set (TS): This subject set included all subjects who were dispensed trial medication and were documented to have taken at least one dose of investigational treatment. This set was used for safety analysis.|Bioavailability of Different Applications of Dabigatran in Healthy Volunteers|Relative Bioavailability of Dabigatran After Administration of Different Application Forms of a Single Oral Dose of 150 mg Dabigatran Etexilate (Capsule, Powder for Reconstitution Into Solution, Pellets on Food) in Healthy Male and Female Volunteers (an Open-label, Randomised, Three-way Crossover, Clinical Phase I Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:26.976102|2017-10-11 00:17:26.976102
NCT02171598|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||February 2009||2009-02-01|June 2014|2014-06-01||||July 2009|Actual|2009-07-01||Interventional|||Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects|Randomised, Open Label, 3-way Cross Over Phase I Study to Investigate the Impact of Concomitant Use of Multiple Doses of Clopidogrel (75 mg qd After a Loading Dose of 300 mg) With Multiple Doses of Dabigatran Etexilate (150 mg Bid) on the Pharmacokinetic and Pharmacodynamic Parameters, and Additionally the Impact of Single Oral Doses of 300 mg and 600 mg of Clopidogrel Administered Under Steady State Conditions of Dabigatran of 75 mg and 150 mg in Healthy Male Subjects|Completed||Phase 1|44|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:27.906194|2017-10-11 00:17:27.906194
NCT02171585|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2008||2008-06-01|June 2014|2014-06-01||||August 2008|Actual|2008-08-01||Interventional|||Bioavailability of Dabigatran With or Without Clarithromycin in Healthy Volunteers|Relative Bioavailability of Dabigatran After Single Oral Administration of 150 mg Dabigatran Etexilate (Capsule) With or Without Multiple Oral Administration of 500 mg Clarithromycin (Tablet) Bid in Healthy Male and Female Volunteers (an Open Label, Fixed Sequence, Clinical Phase I Study)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:28.0358|2017-10-11 00:17:28.0358
NCT02171572|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||October 2009||2009-10-01|June 2014|2014-06-01||||November 2009|Actual|2009-11-01||Interventional|||Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects|Safety, Tolerability and Pharmacokinetics Study After Single and Multiple Oral Doses of Dabigatran Etexilate Capsule (110mg,150 mg b.i.d., 7 Days) in Healthy Chinese Subjects (Open Label Study)|Completed||Phase 1|28|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:28.188376|2017-10-11 00:17:28.188376
NCT02171559|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||August 2008||2008-08-01|June 2014|2014-06-01||||September 2008|Actual|2008-09-01||Interventional|||Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers|Relative Bioavailability and Pharmacodynamics of Dabigatran After a Single Dose of 220 mg Dabigatran Etexilate and After 40 mg Enoxaparin s.c. for 3 Days Followed by a Single Dose of 220 mg Dabigatran Etexilate in Healthy Male and Female Volunteers (an Open-label, Randomised, Single and Multiple Dose, Two Way Crossover Phase I Study)|Completed||Phase 1|29|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:28.302139|2017-10-11 00:17:28.302139
NCT02171546|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||November 2007||2007-11-01|June 2014|2014-06-01||||January 2008|Actual|2008-01-01||Interventional|||Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers|A Two-part Study to Determine the Relative Bioavailability of Dabigatran Etexilate 150 mg Bid (Capsules) With and Without 600 mg Quinidine Sulfate Tablets (Part 1) and to Measure the Effect of Quinidine as a Probe Inhibitor of P-glycoprotein on the Absorption of Fexofenadine, a Probe Substrate of P-glycoprotein (Part 2) in Healthy Male and Female Volunteers (an Open-label, Randomised, Two Times Two-way Crossover Study)|Terminated||Phase 1|42|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:17:28.417797|2017-10-11 00:17:28.417797
NCT02171533|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2008||2008-06-01|June 2014|2014-06-01||||August 2008|Actual|2008-08-01||Interventional|||Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female Volunteers|Relative Bioavailability of Single Oral Doses of 150 mg Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages (240 mg and 480 mg Daily) (Open-label, Fixed-sequence Design), and Relative Bioavailability of Single Oral Doses of 150 mg Dabigatran Etexilate Given With or Without Single Oral Doses of 120 mg (IR) or 240 mg (ER) of Verapamil Administered at Different Time Points Relative to Dabigatran Etexilate Dosing in Healthy Male and Female Volunteers (Open-label, Randomised, Five-way Crossover Design, Phase I Study)|Completed||Phase 1|40|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:28.56269|2017-10-11 00:17:28.56269
NCT02171520|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2008||2008-05-01|June 2014|2014-06-01||||August 2008|Actual|2008-08-01||Interventional|||Bioequivalence of Two Different Generations of Drug Product of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers|Bioequivalence of Two Different Generations of Drug Product of 150 mg Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers (Double-blind, Randomised, Single Dose, Replicate Design in a Two Treatments, Four Periods Crossover Phase I Study)|Completed||Phase 1|66|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:28.673663|2017-10-11 00:17:28.673663
NCT02171507|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2006||2006-05-01|June 2014|2014-06-01||||July 2006|Actual|2006-07-01||Interventional|||Relative Bioavailability of Dabigatran and Diclofenac After Dabigatran Etexilate and Diclofenac Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers|Relative Bioavailability of Dabigatran and Diclofenac After 150 mg b.i.d. Dabigatran Etexilate and Diclofenac at 50 mg Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers (an Open Label, Randomised, Multiple- Dose, Three-way Crossover Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:28.776537|2017-10-11 00:17:28.776537
NCT02171494|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||September 2008||2008-09-01|June 2014|2014-06-01||||October 2008|Actual|2008-10-01||Interventional|||Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers|Bioequivalence of 2x5 mg of IVAX Warfarin /Formulation Tablet Compared to 10 mg of Coumadin /Formulation Tablet Following Oral Administration in Healthy Male Volunteers (an Open-label, Randomised, Single-dose, Two-treatment, Two-sequence Crossover Study) Under Fasted Conditions|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:28.889811|2017-10-11 00:17:28.889811
NCT02171481|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2008||2008-05-01|June 2014|2014-06-01||||August 2008|Actual|2008-08-01||Interventional|||Bioequivalence of Two Different Polymorphs of Dabigatran Etexilate in Healthy Male and Female Volunteers|Bioequivalence of Two Different Polymorphs of 150 mg Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers (Double-blind, Randomised, Single Dose, Replicate Design in a Two Treatments, Four Periods Crossover Phase I Study)|Completed||Phase 1|66|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:28.984535|2017-10-11 00:17:28.984535
NCT02171468|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 2006||2006-05-01|June 2014|2014-06-01||||July 2006|Actual|2006-07-01||Interventional|||Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects|Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule (110 mg and 150 mg b.i.d., 7 Days) in Healthy Japanese and Caucasian Male Subjects (Open Label Study)|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:29.087798|2017-10-11 00:17:29.087798
NCT02171455|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2006||2006-01-01|June 2014|2014-06-01||||January 2006|Actual|2006-01-01||Interventional|||Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects|Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of 600 mg, 750 mg and 900 mg Dabigatran Etexilate as Capsule in Healthy Subjects. A Randomised, Placebo-controlled Study, Double Blind at Each Dose Level|Completed||Phase 1|10|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:29.171827|2017-10-11 00:17:29.171827
NCT02171442|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2002||2002-04-01|June 2014|2014-06-01||||May 2002|Actual|2002-05-01||Interventional|||Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers|Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of 5 mg [14C]-BIBR 953 ZW Intravenously or 200 mg [14C]-BIBR 1048 Oral Solution in a Group Comparison Design in 12 Healthy Male Volunteers.|Completed||Phase 1|10|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:29.252666|2017-10-11 00:17:29.252666
NCT02171429|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-03-09|||November 30, 2014|Actual|2014-11-30|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2)||Recruiting||Phase 3|350|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:17:29.371168|2017-10-11 00:17:29.371168
NCT02171416|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-07-19|||January 2015||2015-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|Cures||Cold Contact Urticaria Treatment With Rilonacept|A Single-center, Double-blind Placebo-controlled Parallel Group Phase II Study of the Efficacy and Safety of Rilonacept in Subjects With Cold Contact Urticaria (CCU)|Recruiting||Phase 2|20|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:17:29.935315|2017-10-11 00:17:29.935315
NCT02171403|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2015-07-28|||June 2014||2014-06-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls|Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls|Completed||N/A|34|Actual|Katholieke Universiteit Leuven|||3||f||||f||||||Samples Without DNA|"     Fecal samples   "|||2017-10-11 00:17:30.099427|2017-10-11 00:17:30.099427
NCT02171390|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||August 2008||2008-08-01|March 2014|2014-03-01||||June 2012|Actual|2012-06-01||Interventional|||Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy|Phase 4 Study That Evaluates the Presence of Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Subjects With Hypogonadotrophic Hypogonadism and Effects of Two Different Testosterone Replacement Regiments on These Parameters.|Completed||Phase 4|130|Actual|Gulhane School of Medicine||2|||f||||f||||||||||2017-10-11 00:17:30.224841|2017-10-11 00:17:30.224841
NCT02171377|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-11|2017-08-29|||August 2010||2010-08-01|August 2017|2017-08-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional|Reha-Res||Quadricipital Electrical Stimulation in COPD Patients Rehabilitation|Quadricipital Electrical Stimulation in COPD Patients Rehabilitation|Completed||N/A|73|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 00:17:30.331343|2017-10-11 00:17:30.331343
NCT02171364|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-01-06|||June 2014||2014-06-01|January 2015|2015-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Prospective Randomized Study||Recruiting||N/A|44|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:17:30.414484|2017-10-11 00:17:30.414484
NCT02171351|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-02-09|||April 2016||2016-04-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|ELECTROSYMP2||Effect of Neuromuscular Electrostimulation on Sympathetic Nerve Activity in Patients With Type 2 Diabetes (ELECTROSYMP2)|Effect of Neuromuscular Electrostimulation on Sympathetic Nerve Activity in Patients With Type 2 Diabetes (ELECTROSYMP2)|Not yet recruiting||N/A|10|Anticipated|University Hospital, Caen||3|||f||||f||||||||||2017-10-11 00:17:30.502842|2017-10-11 00:17:30.502842
NCT02171338|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-08-14|||October 2013||2013-10-01|August 2014|2014-08-01|September 2014|Anticipated|2014-09-01|August 2014|Anticipated|2014-08-01||Interventional|||Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections|Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections. Can Measurement of Procalcitonin Reduce the Use of Antibiotics?|Unknown status|Active, not recruiting|Phase 4|55|Anticipated|Holbaek Sygehus||2|||f||||f||||||||||2017-10-11 00:17:30.607768|2017-10-11 00:17:30.607768
NCT02171325|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-06-05|||June 2014||2014-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment|A Phase Ⅱ Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment|Recruiting||Phase 2|54|Anticipated|Guangdong Association of Clinical Trials||1|||f||||t||||||||No||2017-10-11 00:17:30.703181|2017-10-11 00:17:30.703181
NCT02171312|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-02-08|||April 2015||2015-04-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool|Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool|Completed||N/A|126|Actual|Emory University|||2||f||||f||||||||||2017-10-11 00:17:30.788505|2017-10-11 00:17:30.788505
NCT02171273|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-23|||June 2014||2014-06-01|June 2014|2014-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism|Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism|Enrolling by invitation||N/A|50|Anticipated|Brigham and Women's Hospital||3|||f||||f||||||||||2017-10-11 00:17:31.179345|2017-10-11 00:17:31.179345
NCT02171260|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-10-31|||July 2014||2014-07-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|November 2016|Anticipated|2016-11-01||Interventional|BOLD 113||This is a Phase 1 Study of Eribulin Mesylate in Pediatric Patients With Recurrent or Refractory Solid Tumors (Excluding CNS), Including Lymphomas.||Recruiting||Phase 1|23|Anticipated|Eisai Inc.||1|||f||||f||||||||||2017-10-11 00:17:31.296236|2017-10-11 00:17:31.296236
NCT02171247|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-07-28|2014-07-28||April 2008||2008-04-01|July 2014|2014-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)|Comparison of the Use of High Iodine Concentration Contrast Material (Isovue 370) vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)|Completed||Phase 3|35|Actual|Duke University||2|||f||||||||||||||2017-10-11 00:17:31.434236|2017-10-11 00:17:31.434236
NCT02171234|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-12-19|2014-11-28||February 2001||2001-02-01|December 2014|2014-12-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093|A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093, in Young Healthy Male Volunteers.|Completed||Phase 1|32|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 00:17:31.761238|2017-10-11 00:17:31.761238
NCT02171221|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-03-02|||June 2014||2014-06-01|March 2017|2017-03-01||||June 2017|Anticipated|2017-06-01||Interventional|||Phase I Study of Oral DFP-11207 in Solid Tumors|A Phase I Study of Once-Daily Oral DFP-11207 in Patients With Solid Tumors|Active, not recruiting||Phase 1|36|Anticipated|Delta-Fly Pharma, Inc.||1|||f||||||||||||||2017-10-11 00:17:32.397513|2017-10-11 00:17:32.397513
NCT02171208|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2015-01-08|||June 2014||2014-06-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers|A Randomized, Double-Blind, Crossover Study in Healthy Volunteers to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers (Vifor SA and Biogen Idec OSD)|Completed||Phase 1|80|Actual|Biogen||2|||f||||f||||||||||2017-10-11 00:17:32.473252|2017-10-11 00:17:32.473252
NCT02171195|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-07-19|2014-11-28||July 2000||2000-07-01|July 2016|2016-07-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|||A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093|A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093 When Given to Healthy Male Adult Volunteers.|Completed||Phase 1|64|Actual|Bial - Portela C S.A.||8|||f||||f||||||||||2017-10-11 00:17:32.597645|2017-10-11 00:17:32.597645
NCT02171182|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-02-05|||January 2014||2014-01-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain|A Non-interventional Post-registration Clinical Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain|Completed||N/A|319|Actual|Astellas Pharma Inc|||1||f||||f||||||||Undecided||2017-10-11 00:17:33.398785|2017-10-11 00:17:33.398785
NCT02171169|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-09-02|||June 2014||2014-06-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Retrospective, Multicenter Clinical Evaluation of Health Economic Drivers and Complications for Two Lumbar Fusion Procedures|Retrospective, Multicenter Clinical Evaluation of Health Economic Drivers and Complications for Two Lumbar Fusion Procedures|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Baxano Surgical, Inc.|||2||f||||f||||||||||2017-10-11 00:17:33.543953|2017-10-11 00:17:33.543953
NCT02171156|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-04||||||May 2017|2017-05-01||||||||Expanded Access|||Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)|Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis|Approved for marketing||N/A|||Boehringer Ingelheim||||||||t|||||||||||2017-10-11 00:17:33.625138|2017-10-11 00:17:33.625138
NCT02171143|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-20|||April 2012||2012-04-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate|Completed||Phase 1|58|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:17:33.826796|2017-10-11 00:17:33.826796
NCT02171130|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-03-22||2017-03-22|May 2014||2014-05-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia|A Multiple Center, Open Label, Prospective, Observational Study to Evaluate the Effectiveness and Ease-of-Use of AMG504-1 Administered in the Home or Work Environments for Treating Episodes of Hypoglycemia in Patients With Type 1 Diabetes|Completed||Phase 3|129|Actual|Eli Lilly and Company||1|||f||||f||||||||No||2017-10-11 00:17:33.973794|2017-10-11 00:17:33.973794
NCT02171117|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-07-12|||March 2014||2014-03-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|IMCG-EAML||Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia|Phase III Clinical Trial of Microtransplantation to Treat Elderly Acute Myeloid Leukemia|Recruiting||Phase 3|196|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-11 00:17:34.113843|2017-10-11 00:17:34.113843
NCT02171104|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-10-04|||July 10, 2014|Actual|2014-07-10|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis|MT2013-31: Allogeneic Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Severe Osteopetrosis Following Conditioning With Busulfan (Therapeutic Drug Monitoring), Fludarabine +/- ATG|Recruiting||Phase 2|100|Anticipated|Masonic Cancer Center, University of Minnesota||7|||f||||t|t|f|||f|||||2017-10-11 00:17:34.255672|2017-10-11 00:17:34.255672
NCT02171091|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-04-05|||June 2014||2014-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Intubated ICU Patients|Impact of the Endotracheal Tube on Airway Inflammation: Prospective Analysis in Intubated ICU Patients|Recruiting||N/A|225|Anticipated|Washington University School of Medicine|||1||f||||t||||||Samples With DNA|"     blood and tracheal sample   "|||2017-10-11 00:17:34.974154|2017-10-11 00:17:34.974154
NCT02171078|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-03-16|||June 2014||2014-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance|Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance|Active, not recruiting||N/A|50881|Anticipated|University of Wisconsin, Madison|||3||f||||f||||||||||2017-10-11 00:17:35.121445|2017-10-11 00:17:35.121445
NCT02171065|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-10-26|||June 2014||2014-06-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|P2||PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.|A Multicentre Prospective Natural History Study Using Multimodality Imaging in Patients With Acute Coronary Syndromes - PROSPECT II (Natural History Study), Combined With a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial)|Recruiting||N/A|900|Anticipated|Uppsala University||2|||f||||t||||||||||2017-10-11 00:17:35.247086|2017-10-11 00:17:35.247086
NCT02171052|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2006||2006-06-01|June 2014|2014-06-01||||August 2006|Actual|2006-08-01||Interventional|||Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers|Relative Bioavailability of Dabigatran and Digoxin After 150 mg BID Dabigatran Etexilate and Digoxin at 0.25 mg QD Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers (an Open Label, Randomised, Multiple-dose, Three-way Crossover Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:35.373103|2017-10-11 00:17:35.373103
NCT02171039|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2006||2006-06-01|June 2014|2014-06-01||||August 2006|Actual|2006-08-01||Interventional|||Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers|Relative Bioavailability of Dabigatran and Atorvastatin After 150 mg BID Dabigatran Etexilate and Atorvastatin at 80 mg QD Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers (an Open-label, Randomised, Multiple-dose, Three-way Crossover Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:35.511408|2017-10-11 00:17:35.511408
NCT02171026|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2006||2006-04-01|June 2014|2014-06-01||||June 2006|Actual|2006-06-01||Interventional|||Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female Volunteers|Relative Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of 150 mg Dabigatran Etexilate b.i.d. With or Without 600 mg Amiodarone as Single Dose in Healthy Male and Female Volunteers (an Open-Label, Multiple-Dose, Group-Comparison Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:35.637528|2017-10-11 00:17:35.637528
NCT02171013|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2006||2006-04-01|June 2014|2014-06-01||||July 2006|Actual|2006-07-01||Interventional|||Bioequivalence of Two Different Drug Product Batches of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers|Bioequivalence of Two Different Drug Product Batches of 150 mg of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers (Double Blind, Randomised, Single-dose, Replicate Design in a Two-treatments, Four Periods Crossover Study)|Completed||Phase 1|66|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:35.754452|2017-10-11 00:17:35.754452
NCT02171000|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2005||2005-04-01|June 2014|2014-06-01||||May 2005|Actual|2005-05-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects|Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule (150 mg b.i.d., 7 Days) in Healthy Japanese Male Subjects (Open Label Study)|Completed||Phase 1|7|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:35.869308|2017-10-11 00:17:35.869308
NCT02170987|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||March 2006||2006-03-01|June 2014|2014-06-01||||May 2006|Actual|2006-05-01||Interventional|||Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.|Assessment of Electrophysiological Effects of 150 mg and 600 mg of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects. A Randomised, Placebo Controlled, Double-blind Three-way Crossover Study With an Open Label Positive Control (Moxifloxacin)|Completed||Phase 1|40|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:17:35.98982|2017-10-11 00:17:35.98982
NCT02170974|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||July 2004||2004-07-01|June 2014|2014-06-01||||August 2004|Actual|2004-08-01||Interventional|||Bioavailability of BIBR 953 ZW After BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as Hydroxypropyl Methylcellulose (HPMC) Polymorph II Capsule Relative to HPMC Polymorph I Capsule in Healthy Subjects.|Bioavailability of BIBR 953 ZW After 150 mg of BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as HPMC Polymorph II Capsule Relative to 150 mg HPMC Polymorph I Capsule in Healthy Subjects. A Two-way Crossover, Randomised, Open Trial|Completed||Phase 1|28|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:36.081384|2017-10-11 00:17:36.081384
NCT02170961|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-19|||February 2013||2013-02-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|PRA-MMP||Study of Polymorphisms of RAAS and MMPs in Acute Heart Failure|Study of Polymorphisms of Renin Angiotensin Aldosteron Systemv(RAAS) and Matrice Metallo Protesase (MMPs) in Acute Heart Failure (AHF)|Unknown status|Recruiting|N/A|300|Anticipated|University of Monastir|||2||f||||f||||||Samples With DNA|"     arterial blood samples collected in EDTA tubes and stored in - 20°C envirement for DNA     extraction with salting out methods.   "|||2017-10-11 00:17:36.163139|2017-10-11 00:17:36.163139
NCT02170948|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-08-28|||April 2014||2014-04-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effectiveness of the Addition of Dexmedetomidine to Analgesia for Ankle Surgery.|The Analgesic Efficacy of Dexmedetomidine as a Local Anesthetic Adjunct in Ankle Blocks for Forefoot Surgery. A Dose Ranging Study.|Recruiting||N/A|60|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 00:17:36.281901|2017-10-11 00:17:36.281901
NCT02170402|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-07-07|||June 2014||2014-06-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||China ADVATE PTP Study|Study to Evaluate Efficacy and Safety of ADVATE in the Treatment of Previously Treated Patients With Hemophilia A|Completed||Phase 4|82|Actual|Baxalta US Inc.||1|||f||||f||||||||||2017-10-11 00:17:45.652951|2017-10-11 00:17:45.652951
NCT02170935|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2002||2002-04-01|June 2014|2014-06-01||||June 2002|Actual|2002-06-01||Interventional|||Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery|Multicenter, Open-label-study to Assess PK Profile of a Single Oral Dose of 150 mg BIBR 1048 (Capsule) in Patients Shortly After Primary Elective Total Hip Replacement Surgery.|Completed||Phase 2|62|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:38.095529|2017-10-11 00:17:38.095529
NCT02170922|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||July 1999||1999-07-01|June 2014|2014-06-01||||August 1999|Actual|1999-08-01||Interventional|||Bioavailability of BIBR 1048 MS Tablets in Healthy Subjects With or Without Food|Relative Bioavailability of 200 mg Film Coated Tablets of BIBR 1048 MS With or Without Food Compared to 200 mg Solution of BIBR 1048 MS Given as Single Oral Administrations to Healthy Subjects. A 3-way Crossover, Open, Partly Randomized Study.|Completed||Phase 1|6|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:38.22549|2017-10-11 00:17:38.22549
NCT02170909|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||December 2004||2004-12-01|June 2014|2014-06-01||||June 2005|Actual|2005-06-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin|Safety, Pharmacokinetics and Pharmacodynamics After Single (150 mg, 220 mg and 300 mg) and Multiple (150 mg and 220 mg q.d. and 150 mg b.i.d.) Rising Oral Doses of BIBR 1048 MS/Capsules in Healthy Male Subjects of Japanese and Caucasian Origin. (Open Label Study)|Completed||Phase 1|42|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:38.3321|2017-10-11 00:17:38.3321
NCT02170896|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||October 2001||2001-10-01|June 2014|2014-06-01||||December 2001|Actual|2001-12-01||Interventional|||Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy Subjects|Bioavailability of BIBR 953 ZW After 50 mg of BIBR 1048 MS (Oral Prodrug of BIBR 953) in 4 Experimental Formulations Relative to Drinking Solution of BIBR 1048 MS, Each Treatment Given Bid Over 3 Days, in Healthy Subjects. Intraindividual Comparison (5-way Crossover), Randomised, Open. For Each of the 5 Treatments, Investigation of 2 Conditions: With and Without Pantoprazole (Intraindividual, Open Comparison).|Completed||Phase 1|16|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-11 00:17:38.468653|2017-10-11 00:17:38.468653
NCT02170883|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-07-04|||May 2015||2015-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS|EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS|Recruiting||N/A|370|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:17:38.611437|2017-10-11 00:17:38.611437
NCT02170870|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-07-18|||June 2014||2014-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus|Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus|Recruiting||Phase 1|104|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:17:38.756956|2017-10-11 00:17:38.756956
NCT02170857|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-07-26|||June 2014||2014-06-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Hyaluronic Acid in the Treatment of Periodontal Pockets|A Randomized Controlled Trial to Evaluate the Effect of Hyaluronic Acid on Infra-bony Defects: A Radiographic and Clinical Study.|Completed||N/A|30|Actual|Damascus University||2|||f||||t||||||||||2017-10-11 00:17:38.870555|2017-10-11 00:17:38.870555
NCT02170844|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2004||2004-06-01|June 2014|2014-06-01||||August 2004|Actual|2004-08-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin|Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of 50, 150 and 350 mg BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin. Double-blind at Each Dose Level, Placebo-controlled, Randomised Study|Completed||Phase 1|40|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:17:39.002929|2017-10-11 00:17:39.002929
NCT02170831|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||May 1999||1999-05-01|June 2014|2014-06-01||||July 1999|Actual|1999-07-01||Interventional|||Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers|Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Oral Doses of 50, 100, 200, and 400 mg BIBR 1048 MS Solution Administered TID for 7 Days to Healthy Volunteer Subjects. An Open Study, Placebo-controlled Randomised Double Blind at Each Dose Level|Completed||Phase 1|40|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:17:39.126502|2017-10-11 00:17:39.126502
NCT02170818|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-20|||March 2008||2008-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Improving Faculty's Ability to Speak Up to Others in the Operating Room|Improving Faculty's Ability to Speak Up to Others in the Operating Room: A Simulation Based Randomized Controlled Trial of an Educational Intervention|Completed||N/A|310|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:17:39.233825|2017-10-11 00:17:39.233825
NCT02170805|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||April 2001||2001-04-01|June 2014|2014-06-01||||June 2001|Actual|2001-06-01||Interventional|||Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects|Bioavailability of BIBR 953 ZW After Single Oral Doses of Two Different 50 mg Capsules of BIBR 1048 MS With and Without Coadministration of Pantoprazole to Healthy Subjects Relative to Solution. Two Groups, 3-way Crossover, Randomised, Open Trial|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:39.357391|2017-10-11 00:17:39.357391
NCT02170792|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||February 2001||2001-02-01|June 2014|2014-06-01||||March 2001|Actual|2001-03-01||Interventional|||Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MS|Bioavailability of BIBR 953 ZW After Single Oral Doses of 12.5, 50 or 200 mg BIBR 1048 MS Film-coated Tablet Over 2 Days With and Without Coadministration of Ranitidine to Healthy Subjects. Three Groups, 2-way Crossover, Randomised, Open Trial.|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:39.460369|2017-10-11 00:17:39.460369
NCT02170779|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-02-07|2016-12-12||October 2015||2015-10-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Developing and Testing a Comprehensive MS Spasticity Management Program|Developing and Testing a Comprehensive MS Spasticity Management Program|Completed||Phase 2|40|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 00:17:40.052779|2017-10-11 00:17:40.052779
NCT02170766|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||October 2000||2000-10-01|June 2014|2014-06-01||||December 2000|Actual|2000-12-01||Interventional|||Bioavailability of BIBR 953 ZW in Healthy Subjects|Bioavailability of BIBR 953 ZW After Single Oral Doses of 12.5, 25, 50 or 100 mg BIBR 1048 MS Film-coated Tablet With and Without Pre-treatment With Pantoprazole to Healthy Subjects. Four Groups, 2-way Crossover, Randomised, Open Trial.|Completed||Phase 1|48|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:17:40.76075|2017-10-11 00:17:40.76075
NCT02170753|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-06-24|||June 2014||2014-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Regional Manual Therapy and Motor Control Exercise for Chronic Low Back Pain|Regional Manual Therapy and Motor Control Exercise for the Management of Chronic Low Back Pain With Hip and Spine Motion Loss: A Randomized Clinical Trial|Completed||N/A|46|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-11 00:17:40.851143|2017-10-11 00:17:40.851143
NCT02170740|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||November 1999||1999-11-01|June 2014|2014-06-01||||January 2000|Actual|2000-01-01||Interventional|||Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects|Bioavailability of BIBR 953 ZW After Multiple Oral Doses of 50 and 200 mg BIBR 1048 MS Film-coated Tablet Administered BIDfor 3 Days or 200 mg BIBR 1048 MS With and Without Pre-treatment With Pantoprazole to Healthy Volunteer Subjects. Two Groups, 2-way Crossover, Randomised, Open Trial|Completed||Phase 1|26|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:40.96063|2017-10-11 00:17:40.96063
NCT02170727|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-03-22||2017-03-22|June 2014||2014-06-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|UNITY 4||A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1|A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1|Completed||Phase 3|169|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:17:41.16513|2017-10-11 00:17:41.16513
NCT02170714|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-20|||May 2010||2010-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2012|Actual|2012-05-01||Observational|||Efficacy of Infliximab as a Rescue Therapy in Pediatric Acute Severe Colitis|Managing Pediatric Acute Severe Colitis According to the 2011 ECCO-ESPGHAN Guidelines: Efficacy of Infliximab as a Rescue Therapy|Completed||N/A|31|Actual|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 00:17:41.287114|2017-10-11 00:17:41.287114
NCT02170701|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||October 2000||2000-10-01|June 2014|2014-06-01||||June 2001|Actual|2001-06-01||Interventional|||BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery|Multicenter, Open-label, Ascending Dose Study of BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery. Bistro I|Completed||Phase 2|289|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:41.379422|2017-10-11 00:17:41.379422
NCT02170688|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-12-17|2014-12-05||February 2004||2004-02-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Use of Electrical Impedence to Measure Lean Body Weight as a Determinant of the Dose of Contrast Media for Abdominal CT|Use of Electrical Impedence to Measure Lean Body Weight as a Determinant of the Dose of Contrast Media for Abdominal CT|Completed||Phase 4|139|Actual|Duke University||5|||f||||||||||||||2017-10-11 00:17:41.489781|2017-10-11 00:17:41.489781
NCT02170675|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||June 2009||2009-06-01|June 2014|2014-06-01||||July 2009|Actual|2009-07-01||Interventional|||Relative Bioavailability of Single Doses of Dabigatran Etexilate When Administered Alone or in Combination With a Single Dose of Ketoconazole or in Combination With q.d. Ketoconazole at Steady State in Healthy Male and Female Volunteers|Relative Bioavailability of Single Doses of 150 mg Dabigatran Etexilate (Capsule) When Administered Alone or in Combination With a Single Dose of 400 mg Ketoconazole (Tablet) or in Combination With 400 mg q.d. Ketoconazole (Tablet) at Steady State in Healthy Male and Female Volunteers (an Open Label, Fixed Sequence, Phase I Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:42.108351|2017-10-11 00:17:42.108351
NCT02170662|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-08-27|2014-07-31||November 2009||2009-11-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Topical Bimatoprost Effect on Androgen Dependent Hair Follicles|Topical Bimatoprost Effect on Androgen Dependent Hair Follicles|Completed||Phase 2|33|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:17:42.216151|2017-10-11 00:17:42.216151
NCT02170649|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-03-31|2014-11-28||September 2001||2001-09-01|March 2017|2017-03-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093|The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093 in Healthy Male Volunteers|Completed||Phase 1|12|Actual|Bial - Portela C S.A.||1|||f||||f|f|f||||||Undecided||2017-10-11 00:17:42.627757|2017-10-11 00:17:42.627757
NCT02170636|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2002||2002-01-01|June 2014|2014-06-01||||March 2002|Actual|2002-03-01||Interventional|||Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects|Bioavailability of BIBR 953 ZW After 50 mg of BIBR 1048 MS (Oral Prodrug of BIBR 953) in 4 Experimental Formulations Relative to Drinking Solution of BIBR 1048 MS, Each Treatment Given Bid Over 3 Days, in Healthy Subjects. Intraindividual Comparison (5-way Crossover), Randomised, Open. For Each of the 5 Treatments, Investigation of 2 Conditions: With and Without Pantoprazole (Intraindividual, Open Comparison).|Completed||Phase 1|15|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:42.933445|2017-10-11 00:17:42.933445
NCT02170623|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||February 2002||2002-02-01|June 2014|2014-06-01||||April 2002|Actual|2002-04-01||Interventional|||Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects|Bioavailability of BIBR 953 ZW After 50 mg of BIBR 1048 MS (Oral Prodrug of BIBR 953) in 2 Experimental Formulations Relative to Drinking Solution of BIBR 1048 MS, Each Treatment Given Bid Over 3 Days in Healthy Subjects. Intraindividual Comparison (3-way Crossover) With and Without Pantoprazole, Randomised, Open.|Completed||Phase 1|12|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:17:43.053238|2017-10-11 00:17:43.053238
NCT02170610|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||March 2002||2002-03-01|June 2014|2014-06-01||||May 2002|Actual|2002-05-01||Interventional|||Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy Subjects|Bioavailability of BIBR 953 ZW After 150 mg of BIBR 1048 (Oral Pro-drug of BIBR 953) Administered as Capsule With and Without Coadministration of Pantoprazole as Well as Under the Influence of Food in Healthy Subjects. A Threeway Crossover, Randomised, Open Trial.|Completed||Phase 1|18|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:43.163276|2017-10-11 00:17:43.163276
NCT02170597|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||August 2003||2003-08-01|June 2014|2014-06-01||||September 2003|Actual|2003-09-01||Interventional|||Bioavailability of BIBR 953 ZW Under Influence of Food in Healthy Subjects|Bioavailability of BIBR 953 ZW After 150 mg of BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as HPMC Capsule Relative to a Gelatine Capsule, and Bioavailability of the HPMC Capsule Under the Influence of Food in Healthy Subjects. A Three-way Crossover, Randomised, Open Trial|Completed||Phase 1|12|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:17:43.263113|2017-10-11 00:17:43.263113
NCT02170584|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||January 2001||2001-01-01|June 2014|2014-06-01||||March 2001|Actual|2001-03-01||Interventional|||Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males|Tolerability of Single Rising Doses of 0.1 mg, 1 mg, and 5 mg BIBR 953 ZW IV (Placebo-controlled in Each Dose Group; Substudy 1) and Absolute and Relative Bioavailability of 100mg BIBR 1048 Tablet and of Solution and of 1 mg or 5 mg BIBR 953 ZW IV (Randomized, Three-way Crossover; Substudy 2).|Completed||Phase 1|30|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:17:43.355121|2017-10-11 00:17:43.355121
NCT02170571|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||July 2005||2005-07-01|June 2014|2014-06-01||||December 2005|Actual|2005-12-01||Interventional|||Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of 150 mg Dabigatran Etexilate p.o. in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function in a Monocentric, Open, Parallel-group Design|Completed||Phase 1|24|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:17:43.473326|2017-10-11 00:17:43.473326
NCT02170558|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-03-14|||June 2014||2014-06-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Enhanced Metal Reduction Techniques for Definitive CT Scanning to Assess Spinal Fusion With TM-Ardis|Evaluating Enhanced Metal Reduction Techniques for Definitive CT Scanning to Assess Spinal Fusion With Trabecular Metal Implants (TM-Ardis)|Recruiting||N/A|35|Anticipated|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-10-11 00:17:43.581386|2017-10-11 00:17:43.581386
NCT02170545|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-12-06|||March 2014||2014-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Observational|||CT Imaging Evaluation of Humerus Fractures|Computed Tomography Evaluation of Humeral Head Perfusion in Displaced Proximal Humerus Fractures in Predicting Rates of Avascular Necrosis|Recruiting||N/A|100|Anticipated|Virginia Commonwealth University|||1||f||||f||||||Samples Without DNA|"     For those patients who undergo shoulder replacement, the humeral head bone will be collected     and processed for any evidence of avascular necrosis. Once processing and data collection is     done, the bone will be disposed of.   "|||2017-10-11 00:17:43.710993|2017-10-11 00:17:43.710993
NCT02170532|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-08-11|2014-07-10||July 2007||2007-07-01|June 2014|2014-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||All subjects will receive all 5 treatments on 5 different treatment days. Each subject will receive all 5 treatments in the same order.|Aerosolized Beta-Agonist Isomers in Asthma|Aerosolized Beta-Agonist Isomers in Asthma|Completed||Phase 4|10|Actual|Duke University||5|||f||||||||||||||2017-10-11 00:17:43.846474|2017-10-11 00:17:43.846474
NCT02170519|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-08-25|2014-08-11||September 2006||2006-09-01|June 2014|2014-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide|Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide|Terminated||Phase 4|27|Actual|Duke University||2||Project was completed|f||||f||||||||||2017-10-11 00:17:44.314648|2017-10-11 00:17:44.314648
NCT02170506|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-01-21|||April 2014||2014-04-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TENSVIRT||Effect of Sub-mental Sensitive Transcutaneous Electrical Stimulation on Pharyngeal Muscles Control : TENSVIRT Study|Effect of Sub-mental Sensitive Transcutaneous Electrical Stimulation on Pharyngeal Muscles Control|Completed||N/A|10|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 00:17:44.819805|2017-10-11 00:17:44.819805
NCT02170493|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-02-24|||January 2013||2013-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Insole Sensor to Determine Optimal Limb Loading|Development and Clinical Trial of an Insole Sensor to Determine Optimal Limb Loading in the Rehabilitation of OTA Type 42IIIB and IIIC Lower Extremity Fractures|Enrolling by invitation||N/A|50|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 00:17:44.965136|2017-10-11 00:17:44.965136
NCT02170480|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-07-12|||April 2013||2013-04-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Pin Size Influence the Incidence of Knee Pain|Does Pin Size Influence the Incidence of Knee Pain in Patients Undergoing Temporary Skeletal Traction?|Terminated||N/A|9|Actual|University of Utah|||1|"PI is moving to another university; resident researcher does not wish to continue study with   another PI."|f||||f||||||||||2017-10-11 00:17:45.053864|2017-10-11 00:17:45.053864
NCT02170467|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-12-06|||January 2015||2015-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PIANO||Study of Intestinal Permeability in Patients With Anorexia Nervosa|Study of Intestinal Permeability in Patients With Anorexia Nervosa|Recruiting||N/A|69|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 00:17:45.119729|2017-10-11 00:17:45.119729
NCT02170454|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-17|2014-06-17|||June 2008||2008-06-01|June 2014|2014-06-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|rTMSvideoSS||Effect of Pharyngeal Inhibition by rTMS on Swallowing Function|Effect of Pharyngeal Cortical Area Inhibition Induced by rTMS on Swallowing Function in Healthy Subject: Video Fluoroscopic Study.|Completed||N/A|10|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 00:17:45.22117|2017-10-11 00:17:45.22117
NCT02170441|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-17|||April 2012||2012-04-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|GCDD||Global Consortium for Drug-resistant Tuberculosis Diagnostics|Global Consortium for Drug-resistant Tuberculosis Diagnostics|Completed||N/A|1128|Actual|University of California, San Diego|||1||f||||f||||||Samples With DNA|"     Cultured isolates, processed sputum, extracted DNA (crude lysate from sputum)   "|||2017-10-11 00:17:45.317101|2017-10-11 00:17:45.317101
NCT02170428|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-17|||May 2007||2007-05-01|June 2014|2014-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|SKOT I||Diet and Well-being of Young Danish Children|The SKOT I Cohort - a Prospective Cohort Study of Diet and Well-being in Young Danish Children|Completed||N/A|263|Actual|University of Copenhagen|||1||f||||f||||||Samples With DNA|"     Urine, faeces, white cells, plama/serum   "|||2017-10-11 00:17:45.411698|2017-10-11 00:17:45.411698
NCT02170415|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-20|||June 2014||2014-06-01|June 2014|2014-06-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery|Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery|Active, not recruiting||N/A|154|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:17:45.536519|2017-10-11 00:17:45.536519
NCT02170389|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-09-15|||October 14, 2014|Actual|2014-10-14|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|September 1, 2017|Actual|2017-09-01||Interventional|||Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer|Neoadjuvant AGS-003 Immunotherapy in Patients With Localized Kidney Cancer &lt;pT2|Withdrawn||N/A|0|Actual|Roswell Park Cancer Institute||1||sponsor having financial difficulties|f||||t||||||||||2017-10-11 00:17:45.773806|2017-10-11 00:17:45.773806
NCT02170376|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-07-29|2015-07-22||September 2011||2011-09-01|July 2016|2016-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics|The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics When Administered With Immediate-release 100/25 mg Levodopa/Carbidopa in Healthy Subjects|Completed||Phase 1|80|Actual|Bial - Portela C S.A.||5|||f||||f||||||||||2017-10-11 00:17:45.892548|2017-10-11 00:17:45.892548
NCT02170350|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-10-18|||June 2014||2014-06-01|October 2016|2016-10-01||||June 2019|Anticipated|2019-06-01||Interventional|||Brief Mindful Meditation Practice in Improving Quality of Life in Patients With Cancer Undergoing Radiation Therapy|Use of a Brief Mindful Meditation Practice in Adult Cancer Patients Receiving Radiation Therapy|Active, not recruiting||N/A|17|Actual|Thomas Jefferson University||1|||f||||f||||||||||2017-10-11 00:17:48.934186|2017-10-11 00:17:48.934186
NCT02170337|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-05-30|||July 2014||2014-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps|A Randomized, Double-blind, Placebo-controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps|Completed||Phase 1|41|Actual|Amgen||2|||f||||f||||||||||2017-10-11 00:17:49.021351|2017-10-11 00:17:49.021351
NCT02170324|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-01-14|||June 2014||2014-06-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men||Completed||Phase 4|20|Actual|Wuhan General Hospital of Guangzhou Military Command||2|||f||||t||||||||||2017-10-11 00:17:49.099183|2017-10-11 00:17:49.099183
NCT02170311|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-03-19|||June 2014||2014-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia|"Phase Ib Study of Z-213 in Subjects With Iron-deficiency Anemia - To Investigate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics -"|Completed||Phase 1|24|Anticipated|Zeria Pharmaceutical||4|||f||||f||||||||||2017-10-11 00:17:49.162601|2017-10-11 00:17:49.162601
NCT02170298|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-06-20|||February 2014|Actual|2014-02-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|LEIA||Lisdexamfetamine's Effect In ADHD in the Brain and Cognition|Effects of Lisdexamfetamine on Cognitive Control and Reward Response in Adolescents and Young Adults With ADHD: Neural and Clinical Outcomes|Completed||Phase 4|13|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 00:17:49.230388|2017-10-11 00:17:49.230388
NCT02170285|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-05-27|||May 2014||2014-05-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|tDCS||Enhancing Motor Plasticity After Perinatal Stroke Using tDCS|Enhancing Developmental Motor Plasticity After Perinatal Stroke With Transcranial Direct Current Stimulation|Completed||Phase 2|23|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 00:17:49.3003|2017-10-11 00:17:49.3003
NCT02170272|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-05-03|||June 2014||2014-06-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|March 2015|Actual|2015-03-01||Interventional|||Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer Survivors|Development and Pilot Testing of a Home-Based Program for Head and Neck Cancer Survivors With Lymphedema|Terminated||N/A|20|Actual|Vanderbilt-Ingram Cancer Center||1||Unable to obtain funding|f||||t||||||||||2017-10-11 00:17:49.385729|2017-10-11 00:17:49.385729
NCT02170259|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-05-05|||January 2012||2012-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|December 2012|Actual|2012-12-01||Interventional|||Manual Therapy for Tension Headache With Psychological Disorders|Efficacy of Manual Therapy for the Treatment of Tension-type Headache in Patients With Anxiety and Depressive Disorders. A Randomized Controlled Clinical Trial|Completed||N/A|84|Actual|University of Valencia||4|||f||||t||||||||||2017-10-11 00:17:49.454186|2017-10-11 00:17:49.454186
NCT02170246|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-01-22|||August 2014||2014-08-01|January 2015|2015-01-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|SEARCH018||Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection|Adjunctive Therapy With Telmisartan Instituted With ART During Acute HIV Infection to Reduce the Establishment of Central Nervous System Reservoirs of HIV and Lymph Node Fibrosis [Southeast Asia Research Collaboration With Hawaii (SEARCH) 018]|Recruiting||Phase 1|21|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 00:17:49.525542|2017-10-11 00:17:49.525542
NCT02170233|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-06-15|||August 2014||2014-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by Ultrasonography|SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by Ultrasonography|Completed||N/A|65|Actual|Yale University|||2||f||||f||||||||||2017-10-11 00:17:49.754479|2017-10-11 00:17:49.754479
NCT02170220|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-12-01|2015-12-01||July 2014||2014-07-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment|A Phase 1, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Single Oral Dose of 5 mg Vortioxetine in Subjects With Normal Hepatic Function or Severe Hepatic Impairment|Completed||Phase 1|12|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:17:49.852035|2017-10-11 00:17:49.852035
NCT02170207|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2016-02-08|2016-02-08||January 2007||2007-01-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational||The safety analysis set was defined as all participants who were enrolled and completed the study.|Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]|Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]|Completed||N/A|63|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:17:50.463906|2017-10-11 00:17:50.463906
NCT02170194|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-10-31|||May 2014||2014-05-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Interventional|GETSmart||GETSmart: Guided Education and Training Via Smart Phones to Promote Resilience|GETSmart: Guided Education and Training Via Smart Phones to Promote Resilience|Active, not recruiting||N/A|144|Actual|Walter Reed National Military Medical Center||2|||f||||t||||||||||2017-10-11 00:17:50.896152|2017-10-11 00:17:50.896152
NCT02170181|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-02-23|||June 2014||2014-06-01|February 2017|2017-02-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation|UTSW SBRT Prospective Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation|Recruiting||N/A|5000|Anticipated|University of Texas Southwestern Medical Center|||4||f||||t||||||Samples With DNA|"     Tissue Procurement   "|||2017-10-11 00:17:51.003931|2017-10-11 00:17:51.003931
NCT02170168|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-04-27|||November 2014|Actual|2014-11-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||The Orkdal Model. Collaboration Between Specialist and Community Care Within Palliative Cancer Care|The Orkdal Model. Development, Implementation and Evaluation of Collaboration Between Specialist and Community Care Within Palliative Cancer Care|Recruiting||N/A|1100|Anticipated|St. Olavs Hospital|||6||f||||f|f|f||||||||2017-10-11 00:17:51.107065|2017-10-11 00:17:51.107065
NCT02170155|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-05-22|||December 2012||2012-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||MRI-changes in Morphometry and Cerebro Spinale Fluid (CSF) Flow in Spinal Cord Disorders||Recruiting||N/A|200|Anticipated|University of Zurich|||3||f||||t||||||||||2017-10-11 00:17:51.279309|2017-10-11 00:17:51.279309
NCT02170142|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-20|||March 2012||2012-03-01|June 2014|2014-06-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Characterization of the Functional and Structural Development of the Human Neonatal Brain From 30 Wks to 45 Wks ga|The Major Goal of This Project is to Characterize the Structural and Functional Development of Cortical Plate and White Matter of the Human Neonatal Brain From the Equivalent 30 Gestational Weeks to 45 Gestational Weeks.|Unknown status|Recruiting|N/A|102|Anticipated|University of Texas Southwestern Medical Center|||1||f||||t||||||||||2017-10-11 00:17:51.378208|2017-10-11 00:17:51.378208
NCT02170129|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-19|||February 2013||2013-02-01|June 2014|2014-06-01||||February 2013|Actual|2013-02-01||Interventional|||SINUS LIFT 100% Anorganic Bovine Bone vs. 50% Anorganic Bovine Bone + 50% Autologous Bone|Sinus Lift Grafting With Anorganic Bovine Bone vs 50% Autologous + 50% Bovine Bone. One Year Results From a Randomized Controlled Trial.|Completed||N/A|16|Actual|Università degli Studi di Sassari||2|||f||||f||||||||||2017-10-11 00:17:51.563171|2017-10-11 00:17:51.563171
NCT02170116|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2014-06-20|||November 1998||1998-11-01|June 2014|2014-06-01||||December 1998|Actual|1998-12-01||Interventional|||Pharmacodynamics, Safety and Pharmacokinetics After Oral Administration of BIBR 1048 MS in Healthy Volunteers|Pharmacodynamics, Safety and Pharmacokinetics After Single Oral Administration of 10, 30, 100, 200 and 400 mg BIBR 1048 MS as Drinking Solution in Healthy Subjects. An Open Study, Placebo Randomized Double Blind at Each Dose Level.|Completed||Phase 1|40|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:17:51.741127|2017-10-11 00:17:51.741127
NCT02170103|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-19|||May 2014||2014-05-01|June 2014|2014-06-01||||July 2015|Anticipated|2015-07-01||Interventional|MRUSMI||Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL)|Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL)|Unknown status|Recruiting|Phase 4|250|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-10-11 00:17:51.868153|2017-10-11 00:17:51.868153
NCT02170090|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-10-02|||April 2014||2014-04-01|October 2017|2017-10-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01||Interventional|ACTICCA-1||Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer|Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)|Recruiting||Phase 3|781|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-11 00:17:52.011048|2017-10-11 00:17:52.011048
NCT02170077|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-07-11|2014-07-18||April 2002||2002-04-01|July 2017|2017-07-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093|A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093 in Controlling Refractory Partial Seizures When Added to Ongoing Therapy|Completed||Phase 2|144|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 00:17:52.338187|2017-10-11 00:17:52.338187
NCT02170064|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-08-23|2014-07-18||June 2005||2005-06-01|August 2017|2017-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Pharmacokinetics, Efficacy and Tolerability of BIA 2-093|Pharmacokinetics, Efficacy and Tolerability of BIA 2-093 in Children and Adolescents With Refractory Partial Epilepsy|Completed||Phase 2|35|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 00:17:52.745843|2017-10-11 00:17:52.745843
NCT02170051|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-01|||July 2014||2014-07-01|May 2017|2017-05-01||||September 2017|Anticipated|2017-09-01||Interventional|INSPIRE||Improving Negative Symptoms of Psychosis In Real-world Environments|Improving Negative Symptoms of Psychosis In Real-world Environments|Recruiting||N/A|64|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-11 00:17:53.32629|2017-10-11 00:17:53.32629
NCT02170038|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2016-02-17|||June 2014||2014-06-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol|Open Label, One-way Crossover Study to Assess the in Vivo Formation of Ethinylestradiol Following Single Intramuscular Administration of 200 mg Norethisterone Enantate Compared to Ethinylestradiol Pharmacokinetics After Multiple Doses of a Combined Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel in Healthy Premenopausal Women|Completed||Phase 1|16|Actual|Bayer||2|||f||||f||||||||||2017-10-11 00:17:53.442985|2017-10-11 00:17:53.442985
NCT02170025|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-20|2017-09-25|||September 30, 2014|Actual|2014-09-30|September 2017|2017-09-01|March 2, 2018|Anticipated|2018-03-02|January 17, 2018|Anticipated|2018-01-17||Interventional|||Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients|Multi-center Phase 2 Study to Assess the Safety, Tolerability and Early Signs of Efficacy of Tid Orally Administered BAY63-2521 in Adult Delta F508 Homozygous Cystic Fibrosis Patients|Terminated||Phase 2|21|Actual|Bayer||4||"Based on multiple factors, the design of part 2 is no longer appropriate. There were no safety   concerns identified"|f||||t||||||||||2017-10-11 00:17:53.545282|2017-10-11 00:17:53.545282
NCT02170012|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-03-16|||July 2014||2014-07-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649|A Phase 1 Double Blind (3rd Party Open) Randomized, Placebo Controlled, Dose Escalation Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Repeat Doses Of Pf-06743649 In Healthy Elderly Subjects|Terminated||Phase 1|24|Actual|Pfizer||5||The study was prematurely terminated on 17th December 2014 due to safety concerns.|f||||f||||||||||2017-10-11 00:17:53.700608|2017-10-11 00:17:53.700608
NCT02169999|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-02-17|||June 2011||2011-06-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Personalized Decision Support for Older Patients With Diabetes|Personalized Decision Support for Older Patients With Diabetes|Completed||N/A|100|Actual|University of Chicago||2|||f||||f||||||||No||2017-10-11 00:17:53.823676|2017-10-11 00:17:53.823676
NCT02169986|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-06-19|||August 2014||2014-08-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Atopic Dermatitis Adherence Study|Family Practice Resident Research Project: Do Electronic Reminders Increase Adherence of Moisturizer Utilization in Paediatric Atopic Dermatitis?|Unknown status|Not yet recruiting|N/A|40|Anticipated|University of British Columbia||2|||f||||||||||||||2017-10-11 00:17:53.911512|2017-10-11 00:17:53.911512
NCT02169973|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-09-25|||February 2014||2014-02-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279|An Open-Label Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279|Completed||Phase 1|15|Actual|Janssen Research & Development, LLC||3|||f||||f||||||||||2017-10-11 00:17:54.019457|2017-10-11 00:17:54.019457
NCT02169960|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-12-08|||February 2014||2014-02-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|EMPATHY||Comprehensive Program for Youth Mental Health|Comprehensive Program for Youth Mental Health|Completed||N/A|5514|Actual|University of Alberta||4|||f||||t||||||||||2017-10-11 00:17:54.107526|2017-10-11 00:17:54.107526
NCT02169947|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-08-07|||March 2012|Actual|2012-03-01|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|WORD||Weight Loss and Maintenance for Rural, African American Communities of Faith (The WORD)|Weight Loss and Maintenance for Rural, African American Communities of Faith (The WORD)|Active, not recruiting||N/A|425|Actual|University of Arkansas||2|||f||||t|f|f||||||||2017-10-11 00:17:54.205017|2017-10-11 00:17:54.205017
NCT02169934|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-11-17|||June 2014||2014-06-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects|A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 Following Single Intravenous Dose Administration in Healthy Male Subjects|Completed||Phase 1|6|Actual|Trevena Inc.||1|||f||||f||||||||||2017-10-11 00:17:54.437476|2017-10-11 00:17:54.437476
NCT02169921|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-08|2016-07-28|||June 2014||2014-06-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|September 2015|Actual|2015-09-01||Interventional|||TurboHawk™ Japan Trial in Patients With PAD|Determination of Safety and Effectiveness of the TurboHawk and the SpiderFX for the Treatment of Peripheral Arterial Disease in the Superficial Femoral and/or the Popliteal Arteries in Japan|Completed||Phase 3|51|Actual|Medtronic Endovascular||1|||f||||f||||||||Undecided||2017-10-11 00:17:54.537387|2017-10-11 00:17:54.537387
NCT02169908|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-03-09|||May 2014||2014-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Interventional|LIPIDOXA||Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin|LIPIDOXA, a Pilot Study of Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin-based Regimen|Completed||N/A|35|Actual|Groupe Hospitalier Paris Saint Joseph||1|||f||||||||||||||2017-10-11 00:17:54.635694|2017-10-11 00:17:54.635694
NCT02169895|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-01-08|2015-01-08||September 2008||2008-09-01|January 2015|2015-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide|Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Benserazide: a Doubleblind, Randomized, Four-way Crossover, Placebo-controlled Study in Healthy Male Subjects|Completed||Phase 1|16|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 00:17:54.756526|2017-10-11 00:17:54.756526
NCT02169882|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2017-05-31|||December 1, 2014|Actual|2014-12-01|December 2016|2016-12-01|May 5, 2017|Actual|2017-05-05|November 5, 2016|Actual|2016-11-05||Interventional|ReDEFINe||High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study|A Randomized Double Blinded Phase 2b Clinical Trial Comparing Standard Dose With Two Higher Doses of Rifampicin for Treatment of Adults With Tuberculous Meningitis|Completed||Phase 2/Phase 3|60|Actual|Universitas Padjadjaran||3|||f||||t||||||||No||2017-10-11 00:17:55.490916|2017-10-11 00:17:55.490916
NCT02169869|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-04-13|||September 2014||2014-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Immediate Postplacental IUD Insertion|Immediate Postplacental Intrauterine Device Insertion in High-risk Patient Populations|Active, not recruiting||N/A|40|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 00:17:55.641406|2017-10-11 00:17:55.641406
NCT02169856|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-19|||July 2013||2013-07-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|EFT||Role of Emotional Freedom Techniques in Reducing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy|A Randomized Controlled Trial: Role of EFTs (Emotional Freedom Techniques) in Reducing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy.|Completed||N/A|50|Actual|Benazir Bhutto Hospital, Rawalpindi||2|||f||||f||||||||||2017-10-11 00:17:55.739227|2017-10-11 00:17:55.739227
NCT02169843|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-06-19|||May 2014||2014-05-01|June 2014|2014-06-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Small Doses of Dexmedetomidine for Emergence Agitation|Influence of Small Doses Dexmedetomidine to the Elderly Patients' Emergence Agitation|Unknown status|Recruiting|Phase 4|80|Anticipated|Tang-Du Hospital||2|||f||||||||||||||2017-10-11 00:17:55.893827|2017-10-11 00:17:55.893827
NCT02169830|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-11-30|||June 2014||2014-06-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine|A Prospective Randomized Cross-over Trial of Nortryptyline and Topiramate in the Initial Treatment of Vestibular Migraine.|Recruiting||N/A|100|Anticipated|St. Louis University||2|||f||||t||||||||Undecided||2017-10-11 00:17:56.015871|2017-10-11 00:17:56.015871
NCT02169817|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-01-20|||July 2014||2014-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|cadiLAc||Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children|Bacillus Clausii in the Treatment of Acute Community-acquired Diarrhea Among Latin American Children (cadiLAc)|Completed||Phase 4|629|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:17:56.141382|2017-10-11 00:17:56.141382
NCT02169804|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-09-29|||August 2014||2014-08-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal|An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal|Completed||Phase 1|24|Actual|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 00:17:56.26949|2017-10-11 00:17:56.26949
NCT02169791|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-06-08|||September 2014||2014-09-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Nonmyeloablative Haploidentical Transplant Followed by MLN9708|A Phase II Trial of Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation Followed By Maintenance Therapy With the Novel Oral Proteasome Inhibitor, MLN9708, in Patients With High-risk Hematologic Malignancies|Recruiting||Phase 2|25|Anticipated|Northside Hospital, Inc.||1|||f||||f||||||||||2017-10-11 00:17:56.400857|2017-10-11 00:17:56.400857
NCT02169778|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-04-28|||August 2013|Actual|2013-08-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Intermittent Versus Continuous Energy Restriction on Compensatory Mechanisms Activated During Weight Reduction|Effect of Intermittent Versus Continuous Energy Restriction on Compensatory Mechanisms Activated During Weight Reduction|Completed||N/A|34|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 00:17:56.568975|2017-10-11 00:17:56.568975
NCT02169765|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-01-05|||March 2015||2015-03-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|ARTC-HCC||HR Versus RFA for Early Stage HCC|Hepatic Resection Versus Radiofrequency Ablation for Early-stage Hepatocellular Carcinoma: a Randomized Controlled Trial|Recruiting||Phase 3|120|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-11 00:17:56.671112|2017-10-11 00:17:56.671112
NCT02169752|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-13|||September 2012||2012-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|AMERICA-PAH||Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension|Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension|Terminated||N/A|7|Actual|National Jewish Health||2||PI left National Jewish Health|f||||t||||||||||2017-10-11 00:17:56.783725|2017-10-11 00:17:56.783725
NCT02169739|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-02-01|||November 2015||2015-11-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|REM-PROTECT||Remote Preconditioning Over Time To Empower Cerebral Tissue|Pilot, Randomized, Controlled, Staggered Start, Feasibility Trial of Ischemic Preconditioning, a Promising Novel Treatment for Stroke Prevention|Recruiting||N/A|60|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 00:17:56.87304|2017-10-11 00:17:56.87304
NCT02169726|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-02-08|||December 2013||2013-12-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||A Pilot Study Non-Invasive Guidance for Therapeutic Ultrasound Treatment of Lower Back Muscle Injuries|A Pilot Study to Investigate Non-Invasive Metabolic Guidance for Improving Therapeutic Ultrasound Treatment of Lower Back Muscle Injuries|Completed||N/A|5|Actual|University of California, Irvine|||1||f||||f||||||||||2017-10-11 00:17:57.00206|2017-10-11 00:17:57.00206
NCT02169713|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-08-27|||May 2014||2014-05-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects|A Phase 1 Study to Evaluate the Effect of Steady State Solifenacin and Mirabegron on the Steady State Pharmacokinetics of Tamsulosin HCl in Healthy Male Subjects|Completed||Phase 1|20|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:17:57.091609|2017-10-11 00:17:57.091609
NCT02169700|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-09-28|||December 2013||2013-12-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Ischemic Compression on Post-needling Soreness|Ischemic Compression After Dry Needling of a Latent Myofascial Trigger Point Reduces Post-needling Soreness Intensity and Duration.|Completed||N/A|90|Actual|Universidad Rey Juan Carlos||3|||f||||t||||||||||2017-10-11 00:17:57.218982|2017-10-11 00:17:57.218982
NCT02169687|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-06-17|||June 2006||2006-06-01|June 2014|2014-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||High Intensity Focused Ultrasound Device in Patients With Autonomous Hyperfunctioning Thyroid Nodules|Pilot, Monocentric, Non-comparative Study of the Effectiveness and Safety of High Intensity Focused Ultrasound Device in Patients With Autonomous Hyperfunctioning Thyroid Nodules|Terminated||Early Phase 1|2|Actual|Theraclion||1||Protocol's modifications requested by IRB weren't feasible to continue the study|f||||f||||||||||2017-10-11 00:17:57.324848|2017-10-11 00:17:57.324848
NCT02169674|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-05-30|||September 2014||2014-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Observational|||Hepatitis B Booster Study in Adolescence|Sustaining Protection Against Hepatitis B From Infancy to Adulthood: Assessing the Case for a Booster Dose in Adolescence|Completed||N/A|359|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 00:17:57.429663|2017-10-11 00:17:57.429663
NCT02169661|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-06-20|||July 2011||2011-07-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|BABS||Burger and Beetroot Study - Lipid Oxidation Study|Lipid Oxidation of Ready Meals: Reformulation With Antioxidant Phytochemicals|Completed||N/A|16|Actual|University of Aberdeen||1|||f||||t||||||||||2017-10-11 00:17:57.542898|2017-10-11 00:17:57.542898
NCT02169648|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-18|||December 2013||2013-12-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion|Study on the Correlation Between the Treatment Effectiveness of Ranibizumab and the Role of the Cytokines in Macular Edema With Retinal Vein Occlusion|Unknown status|Recruiting|N/A|100|Anticipated|Tokyo Medical University||1|||f||||f||||||||||2017-10-11 00:17:57.643678|2017-10-11 00:17:57.643678
NCT02169635|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-18|||May 2013||2013-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|MBTAS||Macular Buckle With Three-armed Silicone|Safety and Efficacy Study of Macular Buckle With A Three-armed Silicone Capsule to Support the Posterior Staphyloma in High Myopia.|Completed||N/A|11|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:17:57.763741|2017-10-11 00:17:57.763741
NCT02169622|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-08-10|||June 18, 2013|Actual|2013-06-18|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||CABG REVEAL: Atrial Fibrillation After Coronary Artery Bypass Graft|A Prospective Look at Incidence of Atrial Fibrillation After Coronary Artery Bypass Graft and Related Morbidity/Mortality Utilizing the Reveal XT|Active, not recruiting||N/A|50|Anticipated|Saint Thomas Health|||1||f||||f||||||||||2017-10-11 00:17:57.846813|2017-10-11 00:17:57.846813
NCT02169609|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-03-08|||November 2015|Actual|2015-11-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma|Phase II Single Arm Study to Assess Dinutuximab (Ch 14.18) Combined With the Cytokines Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) and IL-2 in Patients With High-risk Neuroblastoma Not Eligible to Other Immunotherapy Trials|Active, not recruiting||Phase 2|25|Anticipated|Fundació Sant Joan de Déu||1|||f||||f||||||||||2017-10-11 00:17:57.928252|2017-10-11 00:17:57.928252
NCT02169596|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-01-11|||June 2015||2015-06-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PLATE NOX||Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?|a Single Centre Open Pilot Study to Explore if the Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?|Completed||Phase 4|74|Actual|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 00:17:58.047882|2017-10-11 00:17:58.047882
NCT02169583|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-05-12|||June 12, 2014|Actual|2014-06-12|May 2017|2017-05-01|August 28, 2014|Actual|2014-08-28|August 28, 2014|Actual|2014-08-28||Interventional|||Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects|A Two Part, Phase I, Randomized, Placebo Controlled, Double Blind Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects Protocol 201022|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:17:58.154509|2017-10-11 00:17:58.154509
NCT02169570|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-19|||December 2014||2014-12-01|June 2014|2014-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|EVIDENT||Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis|Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis (EVIDENT Study): a Randomized, Double Blind, Controlled Trial|Not yet recruiting||Phase 4|435|Anticipated|Dow University of Health Sciences||3|||f||||t||||||||||2017-10-11 00:17:58.413962|2017-10-11 00:17:58.413962
NCT02169557|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-10-06|||May 2014||2014-05-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study|Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study|Active, not recruiting||Phase 2/Phase 3|230|Actual|Drugs for Neglected Diseases||1|||f||||t||||||||||2017-10-11 00:17:58.542978|2017-10-11 00:17:58.542978
NCT02169544|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-04-24|||January 31, 2014|Actual|2014-01-31|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|||Post-marketing Study Assessing the Long-Term Safety of Abatacept|Post-marketing Study Assessing the Long-Term Safety of Abatacept|Completed||N/A|100000|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 00:17:58.623684|2017-10-11 00:17:58.623684
NCT02169531|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-01-12|||March 2014||2014-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Interventional|DISC||Ex Vivo Immunotherapy for Hyperglycemia in Type 2 Diabetes Mellitus|Pilot Study of a Cell-Based Therapy for Treatment of Hyperglycemia in Type 2 Diabetes Mellitus|Completed||Phase 1|25|Actual|B & Y Technologies||1|||f||||f||||||||||2017-10-11 00:17:58.716539|2017-10-11 00:17:58.716539
NCT02169518|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-07-20|||December 2011||2011-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PON1||Paraoxonase and HDL Qualities in Glycaemia and Inflammation|Changes in Paraoxonase Activity, HDL Properties, Inflammatory Markers and Corneal Innervation in Post-bariatric Surgery Patients, Type 1 Diabetics With and Without Nephropathy, Type 2 Diabetics, and During an Oral Glucose Tolerance Test.|Recruiting||N/A|600|Anticipated|Central Manchester University Hospitals NHS Foundation Trust|||2||f||||t||||||||||2017-10-11 00:17:58.816847|2017-10-11 00:17:58.816847
NCT02169505|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-08-17|||May 22, 2015|Actual|2015-05-22|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)|Safety and Efficacy of Brentuximab Vedotin Maintenance After Allogeneic and Haploidentical Stem Cell Transplantation in High Risk CD30+ Lymphoma (Hodgkin Lymphoma and ALCL)|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f|t|f||||||||2017-10-11 00:17:58.923599|2017-10-11 00:17:58.923599
NCT02169492|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-08-04|||January 1, 2015|Actual|2015-01-01|August 2017|2017-08-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|Re-ACT||Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke|Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke: An Observational, Prospective and Multicenter Study|Completed||N/A|103|Anticipated|Codman & Shurtleff|||1||f||||t|f|f||||||||2017-10-11 00:17:59.05172|2017-10-11 00:17:59.05172
NCT02169310|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-06-30|||March 20, 2014||2014-03-20|June 15, 2017|2017-06-15|February 1, 2019|Anticipated|2019-02-01|August 3, 2018|Anticipated|2018-08-03||Observational|||Neural Basis of Decision-Making Deficits in Traumatic Brain Injury|Neural Basis of Decision Making Deficits in Traumatic Brain Injury|Recruiting||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:18:04.835405|2017-10-11 00:18:04.835405
NCT02169479|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-07-22|2015-01-09||September 2008||2008-09-01|July 2015|2015-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa|Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa: a Doubleblind, Randomized, Four-way Crossover, Placebo-controlled Study in Healthy Male Subjects|Completed||Phase 1|16|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 00:17:59.16049|2017-10-11 00:17:59.16049
NCT02169466|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-10-02|2015-01-09||January 2009||2009-01-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide|Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide: a Double-blind, Randomized, Four-way Crossover, Placebo-controlled Study in Healthy Male Subjects|Completed||Phase 1|22|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 00:17:59.834846|2017-10-11 00:17:59.834846
NCT02169453|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-01-14|2015-01-12||October 2008||2008-10-01|January 2015|2015-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa|Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa: a Double-blind, Randomized, Four-way Crossover, Placebo-controlled Study in Healthy Male Subjects|Completed||Phase 1|12|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 00:18:01.045222|2017-10-11 00:18:01.045222
NCT02169440|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-11-18|2015-07-22||June 2009||2009-06-01|November 2015|2015-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin|Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers|Completed||Phase 1|20|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 00:18:01.987115|2017-10-11 00:18:01.987115
NCT02169427|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-07-22|2015-07-22||March 2011||2011-03-01|July 2015|2015-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites|An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites Following a Single Dose Oral Administration|Completed||Phase 1|6|Actual|Bial - Portela C S.A.||1|||f||||f||||||||||2017-10-11 00:18:02.410124|2017-10-11 00:18:02.410124
NCT02169414|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-11-19|2015-07-22||February 2010||2010-02-01|November 2015|2015-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics|Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics of a Single-dose of Immediate Release 100/25 mg Levodopa/Carbidopa and 100/25 mg Levodopa/Benserazide in Healthy Subjects|Completed||Phase 1|74|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 00:18:02.779573|2017-10-11 00:18:02.779573
NCT02169401|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-04-24|||November 2012||2012-11-01|April 2017|2017-04-01|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Observational|PREDICT||A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment for Chronic Pain|a PRospEctive Post Market Trial of Drg stImulation With the Commercially Available Axium|Completed||N/A|135|Actual|St. Jude Medical|||1||f||||||||||||||2017-10-11 00:18:03.570098|2017-10-11 00:18:03.570098
NCT02169388|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-24|||June 2014||2014-06-01|June 2014|2014-06-01|January 2015|Anticipated|2015-01-01|October 2014|Anticipated|2014-10-01||Interventional|||Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy|Effects of Gut Microflora on the Immune and Nutritional Status of CRC Patients After Chemotherapy|Unknown status|Recruiting|Phase 1|30|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-11 00:18:03.641083|2017-10-11 00:18:03.641083
NCT02169375|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-18|||November 2010||2010-11-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Sensorimotor Based Brain Computer Interface|Effect of Normalizer Adaptation on Accuracy in a Sensorimotor Based Brain-Computer Interface|Terminated||N/A|6|Actual|University of Michigan||2||Insufficient improvement in primary measures under either condition.|f||||f||||||||||2017-10-11 00:18:03.740384|2017-10-11 00:18:03.740384
NCT02169362|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-04-12|||July 2014||2014-07-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries|Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries|Active, not recruiting||Phase 1|36|Actual|Arteriocyte, Inc.||2|||f||||t||||||||||2017-10-11 00:18:03.809769|2017-10-11 00:18:03.809769
NCT02169349|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-09-09|||June 2014||2014-06-01|October 2015|2015-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|ANTiCIPe||Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer|Advancing Monitoring of NSCLC Treated With Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor (TKI) - Molecular Diagnosis on Circulating Tumor DNA|Completed||N/A|100|Actual|Rennes University Hospital|||1||f||||||||||||||2017-10-11 00:18:04.115741|2017-10-11 00:18:04.115741
NCT02169336|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-11-06|2015-10-06||June 2014||2014-06-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy, Safety, and Pharmacokinetics of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy|Terminated||Phase 2|95|Actual|Recro Pharma, Inc.|An interim analysis was performed that focused on the primary efficacy endpoint (SPID48). Observed effect size was determined for purposes of final sample size determination. The study was terminated following the interim analysis.|3||Lack of observed efficacy|f||||f||||||||||2017-10-11 00:18:04.200279|2017-10-11 00:18:04.200279
NCT02169323|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-10|||June 2014||2014-06-01|May 2017|2017-05-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic Asthmatics|Step-down of Inhaled Corticosteroids (ICS) in Non-eosinophilic Asthmatics|Completed||Phase 4|43|Actual|University Hospital of Liege||1|||f||||f||||||||||2017-10-11 00:18:04.735206|2017-10-11 00:18:04.735206
NCT02169297|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-20|||November 2011||2011-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|||Sub-Paraspinal Block in Nuss Patients. A Pilot Project|A Novel Ultrasound-Guided Extrathoracic Sub-Paraspinal Block Utilizing Multi- Perforated Soaker Catheters for Control of Perioperative Pain: A Prospective Randomized Pilot Project in Nuss Patients|Completed||Phase 4|10|Actual|Nemours Children's Clinic||2|||f||||t||||||||||2017-10-11 00:18:04.93616|2017-10-11 00:18:04.93616
NCT02169284|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-09-12|||October 1, 2014|Actual|2014-10-01|September 2017|2017-09-01||||March 30, 2018|Anticipated|2018-03-30||Interventional|||Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery|Phase II Clinical Chemoprevention Trial of Weekly Erlotinib Before Bladder Cancer Surgery|Recruiting||Phase 2|45|Anticipated|National Cancer Institute (NCI)||2|||||||t||||||||||2017-10-11 00:18:05.05017|2017-10-11 00:18:05.05017
NCT02169271|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-09-29|||November 21, 2014|Actual|2014-11-21|July 2017|2017-07-01||||July 15, 2019|Anticipated|2019-07-15||Interventional|||Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules|A Randomized Phase II Trial of Low Dose Aspirin Versus Placebo in High-Risk Individuals With CT-Detected Subsolid Lung Nodules|Active, not recruiting||Phase 2|128|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 00:18:05.204552|2017-10-11 00:18:05.204552
NCT02169258|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-09-23|||June 2014||2014-06-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|PIROUETTEPTA||Routine Coronary Catheterization in Low Extremity Artery Disease Undergoing Percutaneous Transluminal Angioplasty|Prognostic Impact of ROUtine Coronary CathETerization in Low Extremity ArTEry Disease Undergoing Percutaneous Transluminal Angioplasty (PIROUETTE-PTA Study)|Recruiting||N/A|700|Anticipated|National Cheng-Kung University Hospital||3|||f||||f||||||||||2017-10-11 00:18:05.316907|2017-10-11 00:18:05.316907
NCT02169245|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-02-04|||March 2014||2014-03-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PFB||Effects of Protein and Fiber at Breakfast on Appetite, Blood Sugar, and Cholesterol|Relative Effects of Chronic Consumption of Egg Protein at Breakfast With and Without Fiber on Brain Neural Activation, Appetite, Glycemic and Lipemic Control and Self-selected Energy Intake|Completed||N/A|20|Actual|Purdue University||4|||f||||f||||||||||2017-10-11 00:18:05.425642|2017-10-11 00:18:05.425642
NCT02169232|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-20|||May 2014||2014-05-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Videolaryngoscope Versus Fiberoptic Bronchoscope for the Awake Intubation||Unknown status|Recruiting|N/A|40|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-11 00:18:05.519403|2017-10-11 00:18:05.519403
NCT02169219|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-02-07|||June 2014||2014-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|SCOUT||Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis|Short-Course Glucocorticoids and Rituximab in ANCA-Associated Vasculitis|Active, not recruiting||Phase 4|20|Anticipated|Massachusetts General Hospital||1|||f||||f|t|f|||f|||Yes|Individual participant data will be shared upon request - without personal health information - following completion of the analysis. Inquiries should be directed to the Principal Investigator.|2017-10-11 00:18:05.618141|2017-10-11 00:18:05.618141
NCT02169206|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-19|||October 2012||2012-10-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Clinical Trial on Frozen Shoulder Using Bilateral Shoulder Radiography in Different Position|Clinical Trial on Frozen Shoulder Using Bilateral Shoulder Radiography in Different Position|Completed||N/A|21|Actual|Mashhad University of Medical Sciences||1|||f||||t||||||||||2017-10-11 00:18:05.70949|2017-10-11 00:18:05.70949
NCT02169193|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2015-12-03|||September 2015||2015-09-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|||Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium|Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium|Withdrawn||N/A|0|Actual|University Hospital, Lille||1|||f||||f||||||||||2017-10-11 00:18:05.797413|2017-10-11 00:18:05.797413
NCT02169180|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-01-23|||August 2014||2014-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma|A Phase 2 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)|Completed||Phase 2|16|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 00:18:05.891122|2017-10-11 00:18:05.891122
NCT02169167|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2015-05-23|||June 2014||2014-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparison of Resin Salve and Octenidine in Patients With Neuropathic Diabetic Foot Ulcers|Comparison of Resin Salve and Conventional Octenidine in Patients With Neuropathic Diabetic Foot Ulcers - a Prospective, Randomized and Controlled Clinical Trial|Completed||N/A|35|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 00:18:06.007151|2017-10-11 00:18:06.007151
NCT02169154|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-06-28|||June 1, 2014|Actual|2014-06-01|June 2017|2017-06-01|July 1, 2014|Actual|2014-07-01|July 1, 2014|Actual|2014-07-01||Interventional|||A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel|A Cumulative Skin Irritation Study Investigating the Skin Irritancy Potential of MFC51123 Diclofenac-Menthol Gel|Completed||Phase 1|36|Actual|GlaxoSmithKline||7|||f||||f||||||||||2017-10-11 00:18:06.133753|2017-10-11 00:18:06.133753
NCT02169141|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-20|||November 2012||2012-11-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|February 2013|Actual|2013-02-01||Observational|||Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients|Pharmacokinetics of Levofloxacin and Capreomycin in MDR-TB Patients|Completed||N/A|20|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-11 00:18:06.252124|2017-10-11 00:18:06.252124
NCT02169128|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2017-08-11|||January 2014||2014-01-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Severe Soft Tissue Infections: Perspectives of Patients and Significant Others|Severe Soft Tissue Infections: Perspectives of Patients and Significant Others|Recruiting||N/A|30|Anticipated|Göteborg University|||1||f||||||||||||||2017-10-11 00:18:06.366372|2017-10-11 00:18:06.366372
NCT02169115|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-11-02|2015-10-28||December 2012||2012-12-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|UFO||Urticaria Facticia Treatment With Omalizumab (UFO)|Double-blind, Placebo-controlled 12-week, Parallel-group Study With a 6 Weeks Follow up Period to Demonstrate Efficacy and Safety of Subcutaneous Omalizumab in Patients With Urticaria Factitia Refractory to Standard Treatment|Completed||Phase 2|61|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 00:18:06.498979|2017-10-11 00:18:06.498979
NCT02169102|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2015-04-10|||February 2013||2013-02-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Low Power Laser in Tooth Pain Modulation Caused by Irreversible Inflammation|Effect of Low Power Laser in Pain Modulation During Irreversible Inflammation of Tooth Pulp|Completed||N/A|60|Actual|University of Sao Paulo||4|||f||||f||||||||||2017-10-11 00:18:06.898018|2017-10-11 00:18:06.898018
NCT02169089|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-08-22|||January 2016||2016-01-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial|Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial|Recruiting||Phase 4|130|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-11 00:18:07.007464|2017-10-11 00:18:07.007464
NCT02169076|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-01-03|||September 2014||2014-09-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CRT-LVAD||Impact of Cardiac Resynchronization Therapy on Right Ventricular Function in Left Ventricular Assist Device Patients|Cardiac Resynchronization Therapy in Patients With Left Ventricular Assist Devices|Withdrawn||N/A|0|Actual|University of Louisville||2||IRB Approval withdrawn|f||||t||||||||||2017-10-11 00:18:07.330292|2017-10-11 00:18:07.330292
NCT02169063|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-08-29|||December 2015||2015-12-01|August 2016|2016-08-01||||November 2018|Anticipated|2018-11-01||Interventional|||Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer|PET Imaging as a Biomarker of Systemic Treatment Response for Men With Metastatic Castration-Resistant Prostate Cancer|Withdrawn||N/A|0|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 00:18:07.435355|2017-10-11 00:18:07.435355
NCT02169050|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-18|||May 2011||2011-05-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01|2 Months|Observational [Patient Registry]|||Association Between Vitamin D and Inflammation and Diabetes Risk in Morbidly Obese Pre-Menopausal Women|Vitamin D, Inflammation, and Relations to Insulin Resistance in Morbidly Obese Pre-Menopausal Women|Completed||N/A|76|Actual|University of Illinois at Chicago|||1||f||||t||||||Samples With DNA|"     Plasma Adipose tissues   "|||2017-10-11 00:18:07.556212|2017-10-11 00:18:07.556212
NCT02169037|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-03-01|||February 2016||2016-02-01|March 2016|2016-03-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|SUBSTRATE||Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation|Substrate Ablation (Focal Impulse and Rotor Modulation) Compared to Pulmonary Vein Isolation to Eliminate Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial|Recruiting||N/A|120|Anticipated|University of California, San Diego||2|||f||||t||||||||No||2017-10-11 00:18:07.627006|2017-10-11 00:18:07.627006
NCT02169024|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-01-17|||February 2014||2014-02-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||"Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: Expect With Me"|"Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: Expect With Me"|Enrolling by invitation||Phase 4|1000|Anticipated|Yale University||1|||f||||f||||||||No||2017-10-11 00:18:07.743771|2017-10-11 00:18:07.743771
NCT02169011|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-09-21|||September 2013||2013-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Secondary Breast Reconstruction With a Flap of Skin From the Back|Delayed Breast Reconstruction With Skin Flap From the Back|Active, not recruiting||N/A|50|Actual|Vejle Hospital||2|||f||||t||||||||||2017-10-11 00:18:07.859988|2017-10-11 00:18:07.859988
NCT02168998|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-19|||August 2014||2014-08-01|June 2014|2014-06-01||||December 2015|Anticipated|2015-12-01||Interventional|||Cortisol Measurement During Intravenous Access With a Medical Clown|Level of Cortisol in Stress Response During Intravenous Access in the Pediatric Emergency Department With a Medical Clown: a Randomized Prospective Pilot Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 00:18:07.975022|2017-10-11 00:18:07.975022
NCT02168985|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-07-05|||July 2014||2014-07-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|October 2014|Anticipated|2014-10-01||Interventional|TFHEVAL||Impact Evaluation Study of The Faithful House Programme on Violence Reduction in Families|Impact Evaluation for the Faithful House Program in Reducing Violence in Families in Which Couples Are Discordant or HIV/AIDS Positive in Arusha Region, in Tanzania|Unknown status|Not yet recruiting|N/A|300|Anticipated|Savannas Forever Tanzania||2|||f||||f||||||||||2017-10-11 00:18:08.05613|2017-10-11 00:18:08.05613
NCT02168972|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-11-28|||November 2014||2014-11-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|August 2017|Anticipated|2017-08-01||Interventional|GLOBAL-AF||Safety and Performance of a GLOBAL Mapping and Ablation Device for the Treatment of Atrial Fibrillation (GLOBAL-AF)|A Prospective, Non-randomized Clinical Study to Assess Safety and Performance of a Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation|Recruiting||N/A|60|Anticipated|Kardium Inc.||1|||f||||f||||||||||2017-10-11 00:18:08.171725|2017-10-11 00:18:08.171725
NCT02168959|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-03-11|||February 2013||2013-02-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Continuous Femoral Nerve Block With a Tibial Plateau Fracture|Postoperative Pain Management With a Continuous Femoral Nerve Block in Patients With a Tibial Plateau Fracture|Completed||Early Phase 1|5|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 00:18:08.391986|2017-10-11 00:18:08.391986
NCT02168946|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-08-06|||July 2014||2014-07-01|August 2017|2017-08-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||Efficacy, Safety, Tolerability of Carbavance Compared to Best Available Therapy in Serious Infections Due to Carbapenem Resistant Enterobacteriaceae, in Adults|A Phase 3, Multi-Center, Randomized, Open-Label Study of Carbavance (Meropenem/Vaborbactam) Versus Best Available Therapy in Subjects With Selected Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae|Completed||Phase 3|77|Actual|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||2|||f||||t||||||||||2017-10-11 00:18:08.511075|2017-10-11 00:18:08.511075
NCT02168556|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-06-19|||June 2013||2013-06-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Interventions to Decrease Anxiety in Patients Undergoing Urodynamic Testing|Interventions to Decrease Anxiety in Patients Undergoing Urodynamic Testing|Completed||N/A|98|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 00:18:12.440923|2017-10-11 00:18:12.440923
NCT02168907|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-25|||December 2014||2014-12-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma|Phase I Dose-Escalation Study of CPI-613, in Combination With Bendamustine and Rituximab, in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma|Terminated||Phase 1|1|Actual|Wake Forest University Health Sciences||1||Slow Accruals|f||||f|t|f||||||||2017-10-11 00:18:09.023087|2017-10-11 00:18:09.023087
NCT02168894|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-03-07|||March 2016||2016-03-01|March 2016|2016-03-01||||March 2020|Anticipated|2020-03-01||Interventional|||SINF: Peripheral Neuropathy in Cancer Survivors|A Phase I-II Study of Acupuncture for the Treatment of Chronic, Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-10-11 00:18:09.223928|2017-10-11 00:18:09.223928
NCT02168881|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-06-19|||May 2014||2014-05-01|June 2014|2014-06-01||||January 2016|Anticipated|2016-01-01||Interventional|||Oral Misoprostol Versus Vaginal Dinoprostone For Induction Of Labour: A Randomized Controlled Clinical Trial||Unknown status|Recruiting|N/A|342|Anticipated|Ain Shams University||2|||f||||||||||||||2017-10-11 00:18:09.345007|2017-10-11 00:18:09.345007
NCT02168868|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-19|2014-12-24|||May 2014||2014-05-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01|1 Day|Observational [Patient Registry]|||Immune Tests in Blood Samples From Children With ASD|In Vitro Immune Tests in Blood Samples From Children With ASD|Unknown status|Recruiting|N/A|450|Anticipated|Cell El Ltd|||2||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 00:18:09.459304|2017-10-11 00:18:09.459304
NCT02168855|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-06-06|||July 2014||2014-07-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|August 2018|Anticipated|2018-08-01||Interventional|QUITS||Cessation in Non-Daily Smokers|Cessation in Non-Daily Smokers: A RCT of NRT With Ecological Momentary Assessment|Recruiting||N/A|600|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:18:09.573409|2017-10-11 00:18:09.573409
NCT02168842|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-03-06|||September 2014||2014-09-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|November 2018|Anticipated|2018-11-01||Interventional|||Efficacy of Isradipine in Early Parkinson Disease|Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease|Active, not recruiting||Phase 3|336|Anticipated|University of Rochester||2|||f||||t||||||||Undecided||2017-10-11 00:18:09.675056|2017-10-11 00:18:09.675056
NCT02168829|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-04-21|||January 2016||2016-01-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|September 2021|Anticipated|2021-09-01||Interventional|OCEAN||Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial|The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial|Recruiting||Phase 4|1452|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||Undecided||2017-10-11 00:18:09.942405|2017-10-11 00:18:09.942405
NCT02168816|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-01-11|||June 2014||2014-06-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|CRO-OSTEO||Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for the Treatment of Diabetic Foot Osteomyelitis|Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for the Treatment of Diabetic Foot Osteomyelitis (CRO-OSTEOMYELITIS)|Recruiting||Phase 2|228|Anticipated|Loyola University||3|||f||||f||||||||No|There is no plan to share individual participant data|2017-10-11 00:18:10.142018|2017-10-11 00:18:10.142018
NCT02168803|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-01-25|||May 2014||2014-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of Evacetrapib in Participants With Abnormal Cholesterol|A Phase 1b Study to Characterize the Pharmacokinetics of Evacetrapib and Potential for Accumulation After Dosing for 12, 24, and 52 Weeks|Completed||Phase 1|101|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 00:18:10.313348|2017-10-11 00:18:10.313348
NCT02168790|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-18|||February 2011||2011-02-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2011|Actual|2011-08-01||Interventional|AmnioClip||Safety Study of a Sutureless Amniotic Membran Transplantation to Treat Ocular Surface Disorders (Expanded Access)|Interventional Study to Investigate the Safety of a Combination of Amniotic Membrane and a Holder Device (AmnioClip) in the Therapy of Ocular Surface Disorders (Sutureless Amniotic Membrane Transplantation)|Completed||Early Phase 1|7|Actual|Klinikum Chemnitz gGmbH||1|||f||||f||||||||||2017-10-11 00:18:10.418344|2017-10-11 00:18:10.418344
NCT02168764|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-02-08|||July 2014||2014-07-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|March 2018|Anticipated|2018-03-01||Interventional|||Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache|Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache|Active, not recruiting||N/A|120|Anticipated|Autonomic Technologies, Inc.||2|||f||||t||||||||||2017-10-11 00:18:10.61174|2017-10-11 00:18:10.61174
NCT02168751|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-04-04|||September 2012||2012-09-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Inflammatory Response Secondary Using Intravenous Anesthesia Versus Inhalation Anesthesia With Halogenated Agents|STUDY OF PULMONARY AND SYSTEMIC INFLAMMATORY RESPONSE SECONDARY TO LUNG RESECTION SURGERY USING INTRAVENOUS ANESTHESIA VERSUS INHALATION ANESTHESIA WITH HALOGENATED AGENTS|Completed||Phase 4|180|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-11 00:18:10.726525|2017-10-11 00:18:10.726525
NCT01808989|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-12-15|||April 2013||2013-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|CINEYSOFT||Clinical Interest of the TcPO2 Technique|Multicentric Study of the Clinical Interest of the TcPO2 Technique|Completed||N/A|600|Actual|University Hospital, Angers|||1||f||||t||||||||||2017-10-11 01:54:38.857799|2017-10-11 01:54:38.857799
NCT02168738|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-08-26|||March 2014||2014-03-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|AceDoPC||Investigation of Docosahexaenoic Acid (DHA) Metabolic Pathway in Human by Using 13C Labeled Molecules|Bioavailability of DHA-TG (Docosahexaenoic Triglyceride), DHA-PC (Docosahexaenoic Phosphatidylcholine) and AcedoPC (1-acetyl-2-docosahexaenoic-glycerophosphocholine) in Human|Completed||N/A|4|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-11 00:18:10.80935|2017-10-11 00:18:10.80935
NCT02168725|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-30|||June 2014||2014-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors|A Phase I, Dose-escalation Study of the Safety, Pharmacokinetics and Efficacy of Weekly Intravenous Briciclib in Patients With Advanced Solid Tumors|Suspended||Phase 1|54|Anticipated|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 00:18:10.898202|2017-10-11 00:18:10.898202
NCT02168712|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-18|||November 2011||2011-11-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Interval Versus Continuous Training on Functional Capacity and Quality of Life in Patients With Coronary Artery Disease|Interval Versus Continuous Exercise Training on Functional Capacity and Quality of Life in Patients With Coronary Artery Disease: a Randomized Clinical Trial|Completed||N/A|80|Actual|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz||2|||f||||f||||||||||2017-10-11 00:18:10.992706|2017-10-11 00:18:10.992706
NCT02168699|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-18|||December 2010||2010-12-01|June 2014|2014-06-01||||March 2012|Actual|2012-03-01||Interventional|||Ultrasonographic Detection of Musculocutaneous Nerve in Children|Ultrasound Imaging of Musculocutaneous Nerve in Infants, Preschoolers and Children|Completed||N/A|||Attikon Hospital||1|||f||||f||||||||||2017-10-11 00:18:11.069352|2017-10-11 00:18:11.069352
NCT02168686|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-10-05|||December 2017|Anticipated|2017-12-01|October 2017|2017-10-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency|Phase 1/2 Study of Intravenous or Intrapleural Administration of a Serotype rh.10 Replication Deficient Adeno-associated Virus Gene Transfer Vector Expressing the Human Alpha-1 Antitrypsin cDNA to Individuals With Alpha-1 Antitrypsin Deficiency|Not yet recruiting||Phase 1/Phase 2|20|Anticipated|Adverum Biotechnologies, Inc.||4|||f||||t|t|f||||||||2017-10-11 00:18:11.14674|2017-10-11 00:18:11.14674
NCT02168673|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-04-29|||April 2011||2011-04-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke|Modulation of Genes Responsible for Cilia Length by Exposure to Cigarette Smoke|Completed||N/A|1|Actual|Weill Medical College of Cornell University|||2||f||||f||||||Samples With DNA|"     Blood and cells obtained from the study may be kept for future genetic studies.   "|Undecided||2017-10-11 00:18:11.271345|2017-10-11 00:18:11.271345
NCT02168660|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-17|||March 2011||2011-03-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|January 2014|Actual|2014-01-01||Interventional|||Correction of Vitamin D Levels and Its Effect on Insulin Resistance and Weight Gain in Obese Youth|Normalization of Vitamin D Levels and Its Effect on Glucose Homeostasis in Obese Youth|Unknown status|Active, not recruiting|Phase 2|110|Actual|University of Texas Southwestern Medical Center||3|||f||||t||||||||||2017-10-11 00:18:11.347683|2017-10-11 00:18:11.347683
NCT02168647|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-08-21|||March 2015||2015-03-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|Be-Well||"The Blossom Project: Be-Well Behavioral Wellness Study in Pregnancy"|"The Blossom Project: Be Well Behavioral Wellness Study in Pregnancy to Prevent Excessive Gestational Weight Gain"|Recruiting||N/A|57|Anticipated|Iowa State University||2|||f||||f||||||||||2017-10-11 00:18:11.446224|2017-10-11 00:18:11.446224
NCT02168634|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-10-07|||November 2013||2013-11-01|October 2015|2015-10-01||||December 2015|Anticipated|2015-12-01||Interventional|||The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial|The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial|Unknown status|Recruiting|N/A|60|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||||||||||||2017-10-11 00:18:11.567165|2017-10-11 00:18:11.567165
NCT02168621|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-02-01|||February 2014||2014-02-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Intervention Study of Two Protocols for Non-surgical Treatment of Chronic Periodontitis|Approaches to Pocket/Root Debridement for Periodontal Infection Control - a Study on Effectiveness.|Recruiting||N/A|1000|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-11 00:18:11.844907|2017-10-11 00:18:11.844907
NCT02168608|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-18|||September 2014||2014-09-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|September 2015|Anticipated|2015-09-01||Interventional|||Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy|Remote Ischemia Precondition for Hepatic Protection in Patients Undergoing Hepatectomy: A Single-center Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 00:18:11.963958|2017-10-11 00:18:11.963958
NCT02168595|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-04-21|||June 2014||2014-06-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|||Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Intravenous Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects|Completed||Phase 1|28|Actual|GlycoMimetics Incorporated||3|||f||||t||||||||||2017-10-11 00:18:12.11501|2017-10-11 00:18:12.11501
NCT02168582|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-01-17|||May 2014||2014-05-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Observational|||Improvement After Physiotherapy for Low Back Pain: The Good Responders|Improvement After Physiotherapy for Low Back Pain: The Good Responders. An Observational Study in Primary Care|Recruiting||N/A|80|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 00:18:12.227586|2017-10-11 00:18:12.227586
NCT02168569|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-19|||June 2011||2011-06-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Interventional|MEFI||In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children|In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Children: A Multisite, Open-label, Two-cohort Clinical Trial in Mozambique.|Completed||Phase 4|700|Actual|Centro de Investigacao em Saude de Manhica||2|||f||||f||||||||||2017-10-11 00:18:12.327266|2017-10-11 00:18:12.327266
NCT02168530|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-11-01|||October 2014||2014-10-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)||Withdrawn||Phase 2|0|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:18:12.650406|2017-10-11 00:18:12.650406
NCT02168517|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2015-05-27|||May 2014||2014-05-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Correlation of Pain, Obesity and Fertility Potential.|Obesity, Pain and Fertility: is There Any Association?|Unknown status|Recruiting|N/A|120|Anticipated|Northern Orthopaedic Division, Denmark|||4||f||||f||||||Samples With DNA|"     A research biobank will be established during the project period. Majority of each sperm     sample will be analyzed immediately but approximately 250 ul seminal plasma will be frozen     and later analyzed at Aalborg University Biotechnology Department.   "|||2017-10-11 00:18:12.749546|2017-10-11 00:18:12.749546
NCT02168504|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2015-10-07|||June 2014||2014-06-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Electromyography Signals as Biomarkers for Parkinson's Disease|Electromyography Signals as Biomarkers for Parkinson's Disease|Completed||N/A|20|Actual|Norconnect Inc|||2||f||||t||||||||||2017-10-11 00:18:12.880937|2017-10-11 00:18:12.880937
NCT02168491|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-03-31|2016-12-23||November 2014||2014-11-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|LixiBIT||Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin|Feasibility of Once-daily Administered GLP-1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin in Patients With Type-2 Diabetes Mellitus Not Achieving Therapeutic Targets With Premixed Insulin|Completed||Phase 3|10|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 00:18:13.096502|2017-10-11 00:18:13.096502
NCT02168478|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-11-05|2015-09-25||June 2014||2014-06-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Neo-Synalar Modified 48 Hour Patch Test|A Modified 48 Hour Patch Test of Neo-Synalar Cream, Sodium Lauryl Sulfate (Positive Control) and Saline (Negative Control)|Completed||Phase 4|206|Actual|Medimetriks Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-11 00:18:13.498566|2017-10-11 00:18:13.498566
NCT02168465|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-05-06|||June 2013||2013-06-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Internet CIC||Internet Self-Management for People With Intermittent Urinary Catheters|Web-Based Self-Management Intervention for Intermittent Urinary Catheter Use|Completed||N/A|34|Actual|University of Rochester||1|||f||||t||||||||||2017-10-11 00:18:13.720559|2017-10-11 00:18:13.720559
NCT02168452|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-02-04|||June 2014||2014-06-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01|3 Months|Observational [Patient Registry]|||Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer|Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients Who Receive Neoadjuvant Chemotherapy; Observational Pilot Study|Completed||N/A|5|Actual|National Cancer Center, Korea|||1||f||||t||||||||||2017-10-11 00:18:13.817307|2017-10-11 00:18:13.817307
NCT02168439|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-01-20|2016-09-19||June 2014||2014-06-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|April 2015|Actual|2015-04-01||Interventional||38 patients were analyzed in total.|Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair|Double Blinded Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency Department|Completed||Phase 4|40|Actual|University of Pittsburgh|2 patients not included in the midazolam group: one for equipment malfunction leading to no data collected and the second due to weight error resulting in the patient receiving over twice the dose. Both recognized around the time of enrollment.|2|||f||||t||||||||||2017-10-11 00:18:13.910994|2017-10-11 00:18:13.910994
NCT02168426|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2015-08-28|||August 2013||2013-08-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Randomized Control Trial on Seprafilm and Guardix in Preventing Ileus|Randomized Control Trial on Seprafilm and Guardix in Preventing Ileus|Completed||Phase 3|200|Actual|Gachon University Gil Medical Center||2|||f||||f||||||||||2017-10-11 00:18:14.376089|2017-10-11 00:18:14.376089
NCT02168413|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-01-19|||May 2014||2014-05-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|ROBEXCI||Cortical Excitability Using Robotised and Neuronavigated Transcranial Magnetic Stimulation|Development of New Cortical Excitability Methodologies Using Robotised and Neuronavigated Transcranial Magnetic Stimulation.|Recruiting||N/A|135|Anticipated|University Hospital, Grenoble|||1||f||||t||||||||||2017-10-11 00:18:14.486605|2017-10-11 00:18:14.486605
NCT02168400|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-09-15|||July 2016||2016-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Clinical Intervention in Alcohol Use Disorder|Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Alcohol Use Disorder|Recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:18:14.581647|2017-10-11 00:18:14.581647
NCT02168387|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2015-03-02|2015-02-12||December 2010||2010-12-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy of Percussive Ventilation Therapy (MetaNeb ®) Compared With Mucolytic Agents for Atelectasis in the Mechanically Ventilated Pediatric Patient|Efficacy of Percussive Ventilation Therapy (MetaNeb ®) Compared With Mucolytic Agents for Atelectasis in the Mechanically Ventilated Pediatric Patient|Completed||Phase 4|39|Actual|Duke University|Small sample size in a single center study. Children who were extubated prior to the end of the study were not accounted for, as this was not a primary endpoint.|2|||f||||f||||||||||2017-10-11 00:18:14.716179|2017-10-11 00:18:14.716179
NCT02168374|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-06-19|||March 2008||2008-03-01|June 2014|2014-06-01|October 2011|Actual|2011-10-01|March 2010|Actual|2010-03-01||Interventional|||Properties of Glass Ionomer Cements Associated With Chlorhexidine or Doxycycline|Biological and Physicomechanical Properties of Glass Ionomer Cements Associated With Chlorhexidine or Doxycycline|Completed||Phase 2|18|Actual|University of Campinas, Brazil||3|||f||||f||||||||||2017-10-11 00:18:15.025584|2017-10-11 00:18:15.025584
NCT02168361|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-03-11|2016-02-05||December 2013||2013-12-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional||All participants that received at least a single dose of medication|The SIM-SOF Trial for Hepatitis C|The SIM-SOF Trial: A Randomized Trial Comparing Simeprevir-Sofosbuvir Versus Peginterferon/Ribavirin/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype-1a-infected Patients With Cirrhosis|Completed||Phase 4|93|Actual|Center For Hepatitis C, Atlanta, GA||2|||f||||f||||||||||2017-10-11 00:18:15.153158|2017-10-11 00:18:15.153158
NCT02168348|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2014-06-19||||||October 2013|2013-10-01||||November 2016|Anticipated|2016-11-01||Observational|||Impact of Malnutrition on the Healing of Foot Lesions in Diabetic Patients|Impact of Malnutrition on the Healing of Foot Lesions in Diabetic Patients|Unknown status|Recruiting|N/A|210|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 00:18:15.515422|2017-10-11 00:18:15.515422
NCT02168335|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-05-16|||May 2014||2014-05-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||The Efficacy of OrasaltsTM in the Treatment of Gingivitis|The Efficacy of OrasaltsTM in the Treatment of Gingivitis|Completed||Phase 2|40|Actual|University of Johannesburg||2|||f||||t||||||||No||2017-10-11 00:18:15.597397|2017-10-11 00:18:15.597397
NCT02168322|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2015-05-06|||October 2013||2013-10-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Perforated Barrier Membranes Maintain Physiologic Gingival Crevicular Fluid Growth Factor Levels|Perforated Barrier Membranes Maintain Physiologic Gingival Crevicular Fluid Growth Factor Levels During Treatment of Intrabony Defects: An In Vivo Proof-of-Principle Study|Completed||N/A|30|Actual|Al-Azhar University||1|||f||||t||||||||||2017-10-11 00:18:15.68217|2017-10-11 00:18:15.68217
NCT02168296|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-02-17|||June 2014||2014-06-01|June 2014|2014-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetics of Plant-based Ingredient|Exploratory Study to Assess the Pharmacokinetics in Relation to Blood Glucose and Insulin Levels After Intake of a Plant-based Ingredient in Healthy Subjects|Completed||N/A|20|Actual|Unilever R&D||5|||f||||f||||||||||2017-10-11 00:18:15.866266|2017-10-11 00:18:15.866266
NCT02168283|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-07-31|||December 2015||2015-12-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis Patients|Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis Patients|Suspended||Phase 4|60|Anticipated|Chinese University of Hong Kong||2||Lack of funding|f||||f||||||||||2017-10-11 00:18:15.958437|2017-10-11 00:18:15.958437
NCT02168270|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-12-03|||June 2014||2014-06-01|December 2015|2015-12-01||||December 2019|Anticipated|2019-12-01||Interventional|||Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma|A Phase I Study of Metronomic Temozolomide and Intravenous Ascorbic Acid for Patients With Recurrent High Grade Glioma|Terminated||Phase 1|3|Actual|University of Nebraska||1|||f||||t||||||||||2017-10-11 00:18:16.176995|2017-10-11 00:18:16.176995
NCT02168257|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-07-18|||June 2014||2014-06-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Neotech RAM Cannula Versus Conventional Binasal Prong Continuous Positive Airway Pressure (CPAP) to Treat Respiratory Distress in Low Birth Weight Neonates|Neotech RAM Cannula Versus Conventional Binasal Prong Continuous Positive Airway Pressure (CPAP) to Treat Respiratory Distress in Low Birth Weight Neonates|Terminated||N/A|8|Actual|Children's Hospitals and Clinics of Minnesota||2||Lack of enrollment|f||||t||||||||||2017-10-11 00:18:16.286259|2017-10-11 00:18:16.286259
NCT02168244|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-05-11|||May 2014||2014-05-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Reduction of Pain Caused by Biologic Drugs in Psoriasis|Reduction of Injection-related Pain Caused by Subcutaneous Administration of Biologic Drugs in Psoriasis|Completed||N/A|124|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||f||||||||||2017-10-11 00:18:16.403235|2017-10-11 00:18:16.403235
NCT02168231|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-04-05|||February 1, 2017|Actual|2017-02-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|BASE cohort||Abdominal Wall Repair With Strattice in Germany: a Cohort Study|Abdominal Wall Repair With Strattice in Germany: a Cohort Study (BASE Cohort)|Enrolling by invitation||N/A|80|Anticipated|Erasmus Medical Center|||1||f||||f||||||||No||2017-10-11 00:18:16.513401|2017-10-11 00:18:16.513401
NCT02168218|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-07-26|||December 2013||2013-12-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|FruMilk||Effects of Milk Proteins on Protein Synthesis in Healthy Male Subjects Fed a Hypercaloric, High Sucrose Diet|Effects of Milk Proteins on Whole Body Protein Synthesis and Ectopic Lipid Deposition During Sucrose Overfeeding in Healthy Male Subjects|Completed||N/A|12|Actual|University of Lausanne||2|||f||||f||||||||||2017-10-11 00:18:16.634256|2017-10-11 00:18:16.634256
NCT02168205|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-03-25|||May 2014||2014-05-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Food Effect and CYP1A2 Induction Study in Healthy Subjects|Hase I Open-Label Two-Part Study To Evaluate The Effect Of Food and Of CYP1A2 Induction On Pomalidomide (CC-4047) Pharmacokinetics in Healthy Subjects|Completed||Phase 1|55|Actual|Celgene Corporation||4|||f||||f||||||||||2017-10-11 00:18:16.756509|2017-10-11 00:18:16.756509
NCT02168192|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2016-03-15|||November 2010||2010-11-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|June 2011|Actual|2011-06-01||Interventional|||Breaking Bad News in Obstetrics: A Trial of Simulation-Debrief Based Education|Breaking Bad News in Obstetrics: A Trial of Simulation-Debrief Based Education|Completed||N/A|36|Actual|Montefiore Medical Center||2|||f||||f||||||||||2017-10-11 00:18:16.872575|2017-10-11 00:18:16.872575
NCT02168179|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-25|||December 2014|Actual|2014-12-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer|Safety of Treatment With KeraStat Skin Therapy in Breast Cancer Patients Developing Radiation Dermatitis|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||1||No longer pursuing study at our site.|f||||f|f|f||||||||2017-10-11 00:18:16.956705|2017-10-11 00:18:16.956705
NCT02168166|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-10-27|||May 2014||2014-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|STExFx||Short-term Working Memory and Executive Training|Short-Term Executive Functioning Training|Recruiting||N/A|40|Anticipated|Queen's University||2|||f||||f||||||||||2017-10-11 00:18:17.047897|2017-10-11 00:18:17.047897
NCT02168153|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-06-15|||August 2014||2014-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Assessment of Chiropractic Treatment Using Reaction and Response Times in Members of the Special Operation Forces (ACT2)|Assessment of Chiropractic Treatment Using Reaction and Response Times in Members of the Special Operation Forces (ACT2)|Completed||N/A|120|Actual|RAND||2|||f||||t||||||||||2017-10-11 00:18:17.156327|2017-10-11 00:18:17.156327
NCT02168140|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-05-30|||September 2014||2014-09-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma|Phase I Dose-Escalation Study of CPI-613, in Combination With Bendamustine, in Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Classic Hodgkin Lymphoma|Recruiting||Phase 1|14|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 00:18:17.275996|2017-10-11 00:18:17.275996
NCT02168127|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2015-07-07|||May 2014||2014-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD|A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD|Completed||Phase 3|360|Actual|Rhodes Pharmaceuticals, L.P.||1|||f||||f||||||||||2017-10-11 00:18:17.430803|2017-10-11 00:18:17.430803
NCT02168114|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-07-06|||July 2014||2014-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle|Optical Imaging of Dystrophic and Damaged Muscle|Recruiting||N/A|24|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-11 00:18:17.616862|2017-10-11 00:18:17.616862
NCT02168101|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-09-15|||September 2014||2014-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma|Open-Label Study to Determine the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma, Followed by an Expansion Phase at the Maximum-Tolerated Dose (MTD) - A Phase II Study|Recruiting||Phase 2|38|Anticipated|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 00:18:17.724537|2017-10-11 00:18:17.724537
NCT02168088|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-11-21|||June 2014||2014-06-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Molecular Autopsy Study|Molecular Autopsy for Sudden Cardiovascular Death|Recruiting||N/A|100|Anticipated|Scripps Translational Science Institute|||2||f||||f||||||Samples With DNA|"     Blood and/or tissue will be collected on the deceased individual. Saliva samples will be     collected on family members who have consented to participate.   "|||2017-10-11 00:18:17.837428|2017-10-11 00:18:17.837428
NCT02168075|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-10-23|||June 2014||2014-06-01|October 2014|2014-10-01||||May 2016|Anticipated|2016-05-01||Interventional|MANNITOL||Mannitol Brain Relaxation Effect|Can Mannitol Increments Provide More Brain Relaxation in Patients Undergoing Craniotomy for Supratentorial Brain Tumor Removal?|Unknown status|Recruiting|N/A|124|Anticipated|Seoul National University Hospital||4|||f||||t||||||||||2017-10-11 00:18:17.934468|2017-10-11 00:18:17.934468
NCT02168062|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-09|||June 2014||2014-06-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|STAND||Multidisciplinary Study of Androgen Deprivation Therapy (ADT) in Prostate Cancer|A Multidisciplinary Team-Based Approach to Mitigate the Impact of Androgen Deprivation Therapy in Prostate Cancer: a Randomized Phase 2|Recruiting||Phase 2|80|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:18:18.065943|2017-10-11 00:18:18.065943
NCT02168049|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Heart and Lung Function Monitoring System|Heart and Lung Function Monitoring System Evaluation|Recruiting||N/A|50|Anticipated|University of California, Los Angeles||1|||f||||t||||||||No||2017-10-11 00:18:20.082439|2017-10-11 00:18:20.082439
NCT02168036|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-05-23|||May 2013||2013-05-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.|Evaluation of the Mediastinal Lymph Nodes With Endobronchial-Guided Transbronchial Needle Aspiration in Individuals With Lung Diseases|Recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"     Mediastinal tissue/ Lung biological samples   "|Undecided||2017-10-11 00:18:20.206454|2017-10-11 00:18:20.206454
NCT02168023|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-06-02|||June 2014||2014-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Study to Evaluate DACC Dressings for the Prevention of Surgical Site Infections in Women Undergoing Caesarean Section.|Randomised Controlled Trial Evaluating Dialkylcarbamoyl Chloride (DACC) Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Caesarean Section.|Completed||N/A|543|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 00:18:20.31551|2017-10-11 00:18:20.31551
NCT02168010|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-12-08|||October 2013||2013-10-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Analgecine for Treatment of Low Back Pain|Efficacy and Safety of Analgecine for Low Back Pain: a Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial|Completed||Phase 3|584|Actual|VanWorld Pharmaceutical (Rugao) Company Limited||3|||f||||t||||||||||2017-10-11 00:18:20.461905|2017-10-11 00:18:20.461905
NCT02167997|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-08-17|||November 2013||2013-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|24 Months|Observational [Patient Registry]|NANO||EffectiveNess and SAfety of Small ANeurysm COiling Trial|EffectiveNess and SAfety of Small ANeurysm COiling Trial|Recruiting||N/A|252|Anticipated|University of Virginia|||1||f||||t||||||||||2017-10-11 00:18:20.569823|2017-10-11 00:18:20.569823
NCT02167984|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-17|||January 2009||2009-01-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Esophageal Bolus Transit in Newborns With Gastroesophageal Reflux Disease|Esophageal Bolus Transit in GERD Newborns: a Multichannel Intraluminal Impedance Study|Completed||N/A|61|Actual|University of Turin, Italy|||2||f||||f||||||||||2017-10-11 00:18:20.72657|2017-10-11 00:18:20.72657
NCT02167971|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-08-11|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|TMS/DAI||Brain Stimulation for Traumatic Brain Injury|Evaluation of Repetitive Transcranial Magnetic Stimulation on the Cognitive Rehabilitation After Traumatic Diffuse Axonal Injury.|Completed||Phase 2|30|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:18:20.79719|2017-10-11 00:18:20.79719
NCT02167958|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-05-03|||November 2014||2014-11-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source|Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source|Recruiting||Phase 1|50|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:18:20.895586|2017-10-11 00:18:20.895586
NCT02167945|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-18|2017-07-28|||June 12, 2014||2014-06-12|July 2017|2017-07-01|May 5, 2020|Anticipated|2020-05-05|May 5, 2020|Anticipated|2020-05-05||Interventional|(TOPAZ II)||A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection|An Open-Label, Multicenter Study to Evaluate Long-term Outcomes With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ II)|Active, not recruiting||Phase 3|600|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-11 00:18:21.15108|2017-10-11 00:18:21.15108
NCT02167932|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-09-11|||March 2014||2014-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer|Impact of a Physical Activity Program on Biomarkers of Aging During Adjuvant or Neoadjuvant Chemotherapy for Breast Cancer|Recruiting||N/A|48|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"     Blood samples will be taken collect p16 levels, CBC + Differential and senescence markers.   "|||2017-10-11 00:18:21.361814|2017-10-11 00:18:21.361814
NCT02167919|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-09-13|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)|Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) As an Alternative to Open Prostatectomy|Completed||N/A|15|Actual|University of North Carolina, Chapel Hill||1|||f||||f|f|t|f|||||||2017-10-11 00:18:21.483062|2017-10-11 00:18:21.483062
NCT02167906|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-17|||September 2014||2014-09-01|June 2014|2014-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Impact of Hand Osteoarthritis on Arterial Stiffness|Impact of Hand Osteoarthritis on Arterial Stiffness|Unknown status|Not yet recruiting|N/A|80|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:18:21.578964|2017-10-11 00:18:21.578964
NCT02167893|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-02-24|2016-04-25||October 2005||2005-10-01|February 2017|2017-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational||The safety analysis set was defined as all participants who were enrolled and completed the study.|"Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"|"Leuprorelin Acetate SR 11.25 mg Injection Kit Specified Drug-use Survey Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"|Completed||N/A|11288|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:18:21.688582|2017-10-11 00:18:21.688582
NCT02167880|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-07-31|||June 2014||2014-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:18:22.436688|2017-10-11 00:18:22.436688
NCT02167867|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-05-24|2015-12-31||July 2014||2014-07-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of Over-The-Counter Use of Low Level Laser Light Therapy for Body Contouring of the Waist, Hips and Thighs|Evaluation of Efficacy, Usability and Labeling Comprehension for Over-the-Counter Use of the Erchonia Corporation ZERONA® Z6 for Body Contouring of the Waist, Hips and Thighs|Completed||N/A|44|Actual|Erchonia Corporation||2|||f||||f||||||||No||2017-10-11 00:18:22.497076|2017-10-11 00:18:22.497076
NCT02167854|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-08-10|||June 16, 2014||2014-06-16|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer|A Phase I, Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer|Recruiting||Phase 1|48|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:18:22.95214|2017-10-11 00:18:22.95214
NCT02167841|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-19|||June 2014||2014-06-01|June 2014|2014-06-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Comparison of Efficiency Between Practicing of Knee Chest Position and External Cephalic Version in Cases of Breech Presentation.||Unknown status|Not yet recruiting|N/A|100|Anticipated|Meir Medical Center||2|||f||||||||||||||2017-10-11 00:18:23.10232|2017-10-11 00:18:23.10232
NCT02167828|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-05-15|||June 2014||2014-06-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2016|Actual|2016-04-01||Interventional|||Increasing Social Support to Improve HIV Care Engagement and Adherence in St. Petersburg, Russia|Increasing Social Support to Improve HIV Care Engagement and Adherence|Active, not recruiting||N/A|174|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 00:18:23.191923|2017-10-11 00:18:23.191923
NCT02167815|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-09-06|2015-10-13||May 2014||2014-05-01|May 2014|2014-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||All subjects that have used at least one product and that have some follow-up data for the primary endpoint is included in the population presented.|A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers|A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers|Completed||N/A|30|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-11 00:18:23.292219|2017-10-11 00:18:23.292219
NCT02167802|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-11-30|||March 2015||2015-03-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|DIABACT IV||Construction and Validation of a Tool for Automatic Identification of Care Pathways at Risk of Sub-optimality in the Management of Severe Infections in Children (DIABACT IV)|Construction and Validation of a Tool for Automatic Identification of Care Pathways at Risk of Sub-optimality in the Management of Severe Infections in Children (DIABACT IV)|Unknown status|Recruiting|N/A|782|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 00:18:23.819282|2017-10-11 00:18:23.819282
NCT02167789|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-17|||September 2009||2009-09-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|CLEPSYDRA||Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device|Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT|Completed||Phase 3|520|Actual|LivaNova||1|||f||||||||||||||2017-10-11 00:18:23.968396|2017-10-11 00:18:23.968396
NCT02167776|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-01-10|||June 2014||2014-06-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||From Obstacles to Opportunities for Male Circumcision in Tanzania|Cluster-randomized Study of Church-Based Intervention to Promote Male Circumcision in Tanzania|Completed||N/A|43|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||Undecided||2017-10-11 00:18:24.18405|2017-10-11 00:18:24.18405
NCT02167763|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-01-26|||November 2013||2013-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD|Study of the VeraCept Intrauterine Device for Long Acting Reversible Contraception|Active, not recruiting||Phase 1|300|Anticipated|ContraMed LLC||2|||f||||f||||||||||2017-10-11 00:18:24.279373|2017-10-11 00:18:24.279373
NCT02167750|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-17|||April 2014||2014-04-01|June 2014|2014-06-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Effect of Phytochemicals on Aspects of Cognitive Performance|Effects of Phytochemicals on Aspects of Cognitive Performance|Unknown status|Recruiting|N/A|24|Anticipated|PepsiCo Global R&D||6|||f||||||||||||||2017-10-11 00:18:24.367979|2017-10-11 00:18:24.367979
NCT02167737|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2017-09-27|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ED-STEADI||The Emergency Department Stopping Elderly Accidents, Deaths and Injuries Program|"ED-STEADI: The Emergency Department Stopping Elderly Accidents, Deaths and Injuries Program (A Pilot Study)"|Active, not recruiting||N/A|200|Actual|Lehigh Valley Hospital||2|||f||||f||||||||||2017-10-11 00:18:24.486357|2017-10-11 00:18:24.486357
NCT02167724|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-03-16|||September 2014||2014-09-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|BUCCODOR||Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or|Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or|Completed||N/A|110|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 00:18:24.583474|2017-10-11 00:18:24.583474
NCT02167711|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-02-03|||September 2014||2014-09-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Treatment for Bile Duct Cancer in the Liver|Selective Internal Radiation Therapy With Yttrium-90 Resin Microspheres Followed by Gemcitabine Plus Cisplatin for Intra-hepatic Cholangiocarcinoma: A Phase II Study|Recruiting||Phase 2|30|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 00:18:24.6805|2017-10-11 00:18:24.6805
NCT02167698|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-05-17|||February 2014||2014-02-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|APRiCE||Trial of an Alternate Mode of Providing Artificial Breaths to Children With Very Severe Pneumonia|A Parallel-arm, Single Blind Randomised Controlled Trial Comparing 'AIRWAY PRESSURE RELEASE VENTILATION' and 'LOW-TIDAL VOLUME VENTILATION' in Children With Acute Respiratory Distress Syndrome|Terminated||N/A|52|Actual|Postgraduate Institute of Medical Education and Research||2||Increased mortality in the intervention arm at 50% enrolment|f||||t||||||||Undecided|Permission would have to be sought from institution in this regard.|2017-10-11 00:18:24.766782|2017-10-11 00:18:24.766782
NCT02167685|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-07-31|||January 2014||2014-01-01|July 2017|2017-07-01||||December 2025|Anticipated|2025-12-01|10 Years|Observational [Patient Registry]|CMX001||The Chimerix CMX001 Registry|A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.|Recruiting||N/A|550|Anticipated|Chimerix|||1||f||||f||||||||||2017-10-11 00:18:24.941412|2017-10-11 00:18:24.941412
NCT02167672|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-09-26|||April 2014||2014-04-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|April 2016|Actual|2016-04-01||Observational|LIgHT||Barriers for the Uptake of LaparoScopic Hysterectomy|What Would it Take to Reduce the Proportion of Women Who Have a Hysterectomy Via an Open Abdominal Approach in Australia?|Active, not recruiting||N/A|1200|Anticipated|Queensland Centre for Gynaecological Cancer|||2||f||||f||||||||No||2017-10-11 00:18:25.184057|2017-10-11 00:18:25.184057
NCT02167659|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-06-26|||June 2014||2014-06-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema|A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement in the Prevention of Lymphedema Following Locoregional Treatment for Breast Cancer|Recruiting||N/A|1100|Anticipated|ImpediMed Limited||2|||f||||f||||||||No||2017-10-11 00:18:25.38446|2017-10-11 00:18:25.38446
NCT02167646|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-18|||January 2008||2008-01-01|February 2012|2012-02-01|August 2013|Actual|2013-08-01|April 2011|Actual|2011-04-01||Interventional|||Bilaterally Innervated Sensory Dorsal Digital Flaps for Sensory Reconstruction of the Fingers||Completed||N/A|73|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 00:18:25.549229|2017-10-11 00:18:25.549229
NCT02167633|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-10-25|||July 2014||2014-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|Stereocord||Stereotactic Radiosurgery in Metastatic Spinal Cord Compression|A Randomized Trial of Stereotactic Radiosurgery Versus Decompressive Surgery Followed by Postoperative Radiotherapy in Metastatic Spinal Cord Compression|Terminated||N/A|10|Actual|Rigshospitalet, Denmark||2||Due to low accrual rate|f||||t||||||||||2017-10-11 00:18:25.681764|2017-10-11 00:18:25.681764
NCT02167620|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-06-12|||June 2014||2014-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness|Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness|Recruiting||Phase 4|24|Anticipated|Centre for Addiction and Mental Health||2|||f||||t||||||||No||2017-10-11 00:18:25.861193|2017-10-11 00:18:25.861193
NCT02167607|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-02-06|||June 2014||2014-06-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|PPT||A Pilot Study to Characterize the Bioavailability and Plasma Profile of Potato Polyphenols in Humans|A Pilot Study to Characterize the Bioavailability and Plasma Profile of Potato Polyphenols in Humans|Active, not recruiting||N/A|12|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||Undecided||2017-10-11 00:18:25.96569|2017-10-11 00:18:25.96569
NCT02167594|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-08-31|||July 2014||2014-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers|"18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"|Completed||Phase 1|29|Actual|Avid Radiopharmaceuticals||3|||f||||f||||||||||2017-10-11 00:18:26.056916|2017-10-11 00:18:26.056916
NCT02167581|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-04-23|||January 2011||2011-01-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|TEIOS||Confrontation Phenotypes and Genotypes of Epithelial Odontogenic Tumors of the Jaws|Confrontation Phenotypic (Clinical, Radiological, Histological) and Genotypic Epithelial Odontogenic Tumors Isolated or Syndromic Jaws|Completed||N/A|319|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     serum bank and tissue bank   "|||2017-10-11 00:18:26.153551|2017-10-11 00:18:26.153551
NCT02167568|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-18|||January 2012||2012-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|ACCREM||Corpus Callosum Agenesis and Intellectual Disability|Corpus Callosum Agenesis and Intellectual Disability: Genetic and Phenotypic Characterization|Completed||N/A|360|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     blood sample   "|||2017-10-11 00:18:26.223318|2017-10-11 00:18:26.223318
NCT02167555|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-02-06|||June 2014||2014-06-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|WBB||Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period|Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period|Active, not recruiting||N/A|12|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||Undecided||2017-10-11 00:18:26.302947|2017-10-11 00:18:26.302947
NCT02167542|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-06-18|||February 2010||2010-02-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|September 2010|Actual|2010-09-01||Interventional|||Positive Pressure During Bronchoscopy|Positive Pressure During Bronchoscopy: Noninvasive Positive Pressure Ventilation vs Continuous Positive Airway Pressure Valve|Completed||N/A|24|Actual|Hospital Sao Joao||2|||f||||f||||||||||2017-10-11 00:18:26.397008|2017-10-11 00:18:26.397008
NCT02167529|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-08-09|||March 6, 2014|Actual|2014-03-06|August 2017|2017-08-01|August 2017|Actual|2017-08-01|December 31, 2016|Actual|2016-12-31||Observational|ThyrQol||Quality of Life After Thyroidectomy (ThyrQol)|A Prospective, Multicenter and Observational Trial to Evaluate Evolution of Quality of Life (SF-36) After Total Thyroidectomy.|Completed||N/A|890|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 00:18:26.513199|2017-10-11 00:18:26.513199
NCT02167516|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2015-08-18|||October 2014||2014-10-01|August 2015|2015-08-01||||July 2015|Actual|2015-07-01||Interventional|||A Clinical Study of Xin'an Medicine in the Treatment of Knee Osteoarthritis|Efficacy and Safety of Xinfeng Capsule in the Treatment of Knee Osteoarthritis (KOA) :A Randomized, Double-blind, Double-dummy, Multi-center Trial|Completed||N/A|268|Actual|The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 00:18:26.627195|2017-10-11 00:18:26.627195
NCT02167503|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-17|||May 2014||2014-05-01|June 2014|2014-06-01||||May 2020|Anticipated|2020-05-01||Observational|||Observational Study on Patients With Chronic Hepatitis B|A Retrospective-prospective Observational Study to Evaluate the Effect of Anti-viral Treatment on the Long-term Outcome in Patients With Chronic Hepatitis B (SEARCH-B Study)|Recruiting||N/A|10000|Anticipated|Nanfang Hospital of Southern Medical University|||1||f||||t||||||||||2017-10-11 00:18:26.767608|2017-10-11 00:18:26.767608
NCT02167490|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-06-29|||January 2012||2012-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|SOUND||Sentinel Node Vs Observation After Axillary Ultra-souND|A Randomized Trial Comparing Sentinel Lymph Node Biopsy Vs no Axillary Surgical Staging in Patients With Small Breast Cancer and a Negative Preoperative Axillary Assessment (IEO S637/311)|Recruiting||N/A|1560|Anticipated|European Institute of Oncology||2|||f||||f||||||||||2017-10-11 00:18:26.94934|2017-10-11 00:18:26.94934
NCT02167477|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2016-01-04|||January 2013||2013-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|February 2016|Anticipated|2016-02-01||Interventional|||Comparison of Indirect and Direct Laryngoscopy in Obese Patients|Comparison of the C-MAC Video Laryngoscope With Conventional Direct Laryngoscopy in Morbidly Obese Patients Using a Photographic Overlay Technique|Recruiting||N/A|40|Anticipated|Aintree University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:18:27.148849|2017-10-11 00:18:27.148849
NCT02167464|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-05-04|||June 2011||2011-06-01|September 2014|2014-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TRH||Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study|Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study|Completed||N/A|70|Actual|Medical University of South Carolina||4|||f||||t||||||||Yes|De-identified data file is available. Email Suparna Qanungo at MUSC.|2017-10-11 00:18:27.271089|2017-10-11 00:18:27.271089
NCT02167451|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-04-13|||July 2014||2014-07-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Maraviroc as GVHD Prophylaxis in Transplant Recipients|Maraviroc as Graft Versus Host Disease Prophylaxis in Pediatric and Adult Stem Cell Transplant Recipients|Recruiting||Phase 1/Phase 2|65|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 00:18:27.389364|2017-10-11 00:18:27.389364
NCT02167438|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-03-20|||October 2014||2014-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Reducing Cesarean Childbirth Rates Using the Hem-Avert Perianal Stabilizer|Reducing Cesarean Childbirth Rates Using the Hem-Avert Perianal Stabilizer|Terminated||N/A|117|Actual|Plexus Biomedical, Inc.||2||Lack of enrollment|f||||f||||||||||2017-10-11 00:18:27.494692|2017-10-11 00:18:27.494692
NCT02167425|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-11-19|||February 2015||2015-02-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|IMAT||Study of Integrating Antiretroviral Therapy With Methadone Treatment for People Who Inject Drugs|Reducing Failure-to-Initiate ART Among People Who Inject Drugs: the IMAT Strategy|Enrolling by invitation||N/A|800|Anticipated|Pangaea Global AIDS Foundation|||4||f||||f||||||||||2017-10-11 00:18:27.605986|2017-10-11 00:18:27.605986
NCT02167412|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-01-28|||June 2014||2014-06-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||EEG Characteristics in Youth POTS and/or Syncope|Electroencephalographic (EEG) Characteristics of Postural Tachycardia Syndrome (POTS) and Syncope (Without POTS) During Head-upright Tilt Table Testing|Recruiting||N/A|200|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 00:18:27.740978|2017-10-11 00:18:27.740978
NCT02167399|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-12-22|||June 2014||2014-06-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Observational|||Smart Phone as a Screening and Evaluation Tool to Identify Knee Valgus During Dynamic Activities|Evaluation of the Use of the Smart Phone as a Screening and Evaluation Tool to Identify Knee Valgus During Dynamic Activities.|Completed||N/A|25|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 00:18:27.845821|2017-10-11 00:18:27.845821
NCT02167386|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-04-03|||March 30, 2015|Actual|2015-03-30|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|P&S||PrEPared and Strong: Clinic-Based PrEP for Black MSM|PrEP for Black MSM: Community-Based Ethnography and Clinic-Based Treatment|Active, not recruiting||Phase 4|204|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 00:18:27.918899|2017-10-11 00:18:27.918899
NCT02167373|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-07-27|||November 2015||2015-11-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||Dashboards for Clinician Monitoring of Patients Through a Mobile Sensing Platform|Dashboards for Clinician Monitoring of Patients Through a Mobile Sensing Platform|Active, not recruiting||N/A|171|Actual|Cogito Health Inc||2|||f||||f||||||||||2017-10-11 00:18:28.015392|2017-10-11 00:18:28.015392
NCT02167360|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2017-02-13|||June 2016||2016-06-01|September 2016|2016-09-01||||January 11, 2017|Actual|2017-01-11||Interventional|||Study of Efficacy and Safety of CTL019 in Adult ALL Patients|A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Adult Patients With Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia|Withdrawn||Phase 2|0|Actual|Abramson Cancer Center of the University of Pennsylvania||1||Did not enroll|f||||t||||||||||2017-10-11 00:18:28.099474|2017-10-11 00:18:28.099474
NCT02167347|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-08-22|||February 2012||2012-02-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Culturally Adapted Family Intervention For Psychosis|Pilot Study of Culturaly Adapted Family Intervention for Psychosis|Completed||N/A|36|Actual|Pakistan Institute of Learning and Living||2|||f||||f||||||||||2017-10-11 00:18:28.165733|2017-10-11 00:18:28.165733
NCT02167334|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-04-27|||September 2013||2013-09-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|PANNIV||Using Positive Pressure Ventilation for Preoxygenation During Panendoscopy.|Non Invasive Ventilation (NIV) Versus Spontaneous Breathing for Preoxygenation During Ear, Nose, and Throat (ENT) Panendoscopy. A Controlled, Prospective, Randomized Study.|Completed||N/A|50|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-11 00:18:28.251725|2017-10-11 00:18:28.251725
NCT02167321|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-01-10|||December 2014||2014-12-01|January 2017|2017-01-01|May 2021|Anticipated|2021-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision|Adjuvant Chemotherapy With FOLFOX After Total Mesorectal Excision for Locally Advanced Rectal Cancer; an Open-label, Multicenter, Prospective, Randomized Phase 3 Trial|Recruiting||Phase 3|580|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:18:28.330952|2017-10-11 00:18:28.330952
NCT02167308|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2014-06-17|||June 2014||2014-06-01|June 2014|2014-06-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of Laser Acupuncture on Obesity|Effect of Laser Acupuncture on Obesity: a Patient-Assessor-Blinded, Randomized, Sham-controlled Crossover Trial|Unknown status|Recruiting|N/A|104|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:18:28.41034|2017-10-11 00:18:28.41034
NCT02167269|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2015-03-30|||May 2014||2014-05-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Comparison of Minimal Fresh Gas Requirements of Baby EAR and Jackson Rees Anesthetic Circuit|Comparison of Minimal Fresh Gas Requirements of Baby EAR and Jackson Rees Anesthetic Circuit for General Anesthesia in Spontaneously Breathing Children Undergoing Surgery|Completed||N/A|20|Actual|Khon Kaen University||2|||f||||f||||||||||2017-10-11 00:18:28.54876|2017-10-11 00:18:28.54876
NCT02167256|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-06-21|||December 2014||2014-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease|A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease|Active, not recruiting||Phase 2|159|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:18:28.624182|2017-10-11 00:18:28.624182
NCT02167243|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-01-23|||July 2014||2014-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||A Reinforcement Approach to Improve Diabetes Management|A Reinforcement Approach to Improve Diabetes Management - Randomized Trial|Recruiting||N/A|60|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-11 00:18:28.881787|2017-10-11 00:18:28.881787
NCT02167230|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-17|2014-06-17|||October 2014||2014-10-01|June 2014|2014-06-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|JBTinCBL||Jailed-balloon Technique in Coronary Bifurcation Lesion PCI|Effect of Jailed-Balloon Technique in Percutaneous Coronary Intervention for Non-Left Main Coronary Bifurcation Lesions: A Prospective, Randomized Study.|Unknown status|Not yet recruiting|N/A|410|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-10-11 00:18:28.970434|2017-10-11 00:18:28.970434
NCT02167217|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-01-17|||March 2014||2014-03-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy|Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 2|24|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 00:18:29.10116|2017-10-11 00:18:29.10116
NCT02167204|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-10-31|||November 2012||2012-11-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|||18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors|Cellular Proliferation Imaging Using [18F] Fluorothymidine (FLT) Positron Emission Tomography (PET) in Brain Tumors|Suspended||N/A|40|Anticipated|University of Washington||1||Accrual is temporarily on hold until a new funding source can be obtained|f||||f||||||||||2017-10-11 00:18:29.214242|2017-10-11 00:18:29.214242
NCT02167191|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-09-30|||February 2014||2014-02-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|HIT||HIT in the Healthy Elderly Population|Determining the Effectiveness of a High Intensity Interval Training Exercise Programme in the Healthy, Elderly Population|Completed||N/A|24|Actual|University of Nottingham||1|||f||||f||||||||||2017-10-11 00:18:29.33234|2017-10-11 00:18:29.33234
NCT02167178|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-01-26|||January 2013||2013-01-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Observational|||The Relationship Between Cardiac Output and Microvascular Visceral Blood Flow|Investigation of the Relationship Between Oesophageal Doppler Assessed Increases in Cardiac Output and Microvascular Visceral Blood Flow in Healthy Volunteers|Completed||N/A|24|Actual|University of Nottingham|||2||f||||f||||||||||2017-10-11 00:18:29.406605|2017-10-11 00:18:29.406605
NCT02167165|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-16|||July 2013||2013-07-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|||Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients|Role of Genetic Factors in the Response to Digoxin in the Acute Treatment of Atrial Fibrillation|Unknown status|Recruiting|N/A|150|Anticipated|University of Monastir|||1||f||||f||||||Samples With DNA|"     arterial blood samples collected in EDTA tubes and stored in - 20°C envirement for DNA     extraction with salting out methods.   "|||2017-10-11 00:18:29.498816|2017-10-11 00:18:29.498816
NCT02167152|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-02-01|||June 2014||2014-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Ischemic Preconditioning to Prevent Acute Kidney Injury|Ischemic Preconditioning to Prevent Acute Kidney Injury|Completed||N/A|115|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 00:18:29.601664|2017-10-11 00:18:29.601664
NCT02167139|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-07-10|2016-11-22||May 2014||2014-05-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy|A Randomised, Double-blind, Parallel Group, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Immunogenicity of SB5 Compared to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|544|Actual|Samsung Bioepis Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:18:29.70481|2017-10-11 00:18:29.70481
NCT02167126|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-17|||July 2012||2012-07-01|June 2014|2014-06-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Kinesio Taping Effects on Knee Extension Force Among Soccer Players|Kinesio Taping Effects on Knee Extension Force Among Soccer Players|Completed||N/A|34|Actual|University of Franca||2|||f||||f||||||||||2017-10-11 00:18:30.194124|2017-10-11 00:18:30.194124
NCT02167113|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-03-22|||March 2014||2014-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|February 2016|Actual|2016-02-01||Observational|HBVQuant||Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay|Collection of Plasma Samples From Individuals Initiating Therapy With Entecavir or Tenofovir for Chronic Hepatitis B Virus Infection for the Clinical Evaluation of the Aptima HBV Quant Assay|Active, not recruiting||N/A|331|Actual|Hologic, Inc.|||1||f||||f||||||Samples With DNA|"     Plasma   "|||2017-10-11 00:18:30.315271|2017-10-11 00:18:30.315271
NCT02167100|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-09-17|||June 2014||2014-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|RiC||Patient Retention in HIV Medical Care in a Primary Care Practice in Australia|Patient Retention in HIV Medical Care in a Primary Care Practice in Australia|Completed||N/A|1537|Actual|Holdsworth House Medical Practice|||2||f||||f||||||||||2017-10-11 00:18:30.577109|2017-10-11 00:18:30.577109
NCT02167087|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-02-15|||March 2015||2015-03-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|SENSE||Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.|Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.|Completed||N/A|30|Actual|Herlev Hospital||1|||f||||f||||||||Undecided||2017-10-11 00:18:30.664361|2017-10-11 00:18:30.664361
NCT02167074|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-08-01|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|ASPRO||A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device|A Multicenter Randomized Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device|Completed||N/A|615|Actual|Foundation for Liver Research||2|||f||||f||||||||||2017-10-11 00:18:30.772456|2017-10-11 00:18:30.772456
NCT02167061|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-11-27|||July 2014||2014-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers|A Randomized, Open-label, Crossover, Single Dose Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 5/1000 mg) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 After Single Oral Administration in Healthy Male Volunteers|Completed||Phase 1|64|Actual|Dong-A ST Co., Ltd.||4|||f||||t||||||||||2017-10-11 00:18:30.888437|2017-10-11 00:18:30.888437
NCT02167048|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-11-01|||June 2014||2014-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Children With ADHD|Effects of Low-dose Versus Normal-dose Psychostimulants on Executive Functions in Children With Attention-Deficit Hyperactivity Disorder|Recruiting||Phase 1/Phase 2|52|Anticipated|University of British Columbia||3|||f||||f||||||||Undecided||2017-10-11 00:18:30.986298|2017-10-11 00:18:30.986298
NCT02167035|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-02-20|||August 2014|Actual|2014-08-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Combigan BID Versus Simbrinza TID|Pilot Study Comparison of Combigan BID vs Simbrinza TID in Subjects Currently Treated With Latanoprost For Open-Angle Glaucoma or Ocular Hypertension|Recruiting||Phase 4|43|Anticipated|Cornerstone Health Care, PA||2|||f||||f||||||||||2017-10-11 00:18:31.15847|2017-10-11 00:18:31.15847
NCT02167022|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-10-04|||November 2014||2014-11-01|October 2016|2016-10-01||||November 2019|Anticipated|2019-11-01||Interventional|||Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy|Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy|Recruiting||N/A|110|Anticipated|University of Arizona||2|||f||||t||||||||||2017-10-11 00:18:31.260517|2017-10-11 00:18:31.260517
NCT02167009|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-06-12|||December 2014||2014-12-01|June 2015|2015-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams|Phase II, Single Arm Prospective Study to Evaluate Safety and Efficacy of Prostate Artery Embolization in Patients With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams|Recruiting||Phase 2|30|Anticipated|Tampa General Hospital||1|||f||||t||||||||||2017-10-11 00:18:31.385277|2017-10-11 00:18:31.385277
NCT02166996|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2014-06-16|||April 2011||2011-04-01|December 2012|2012-12-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||A Prospective Comparison of Suture Removal Time for Simple Surgical Defects of the Head and Neck|A Prospective Comparison of Suture Removal Time for Simple Surgical Defects of the Head and Neck|Completed||N/A|116|Actual|Sundsvall Hospital||2|||f||||f||||||||||2017-10-11 00:18:31.479782|2017-10-11 00:18:31.479782
NCT02166983|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-11-21|||January 2014||2014-01-01|November 2014|2014-11-01||||January 2016|Anticipated|2016-01-01||Interventional|||Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors|Cognitive Enhancement Program|Withdrawn||N/A|0|Actual|Stanford University||3||PI left Stanford|f||||||||||||||2017-10-11 00:18:31.569785|2017-10-11 00:18:31.569785
NCT02166970|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-02-27|||March 1, 2014|Actual|2014-03-01|February 2017|2017-02-01|October 30, 2016|Actual|2016-10-30|February 28, 2016|Actual|2016-02-28||Interventional|||Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction|Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction: A Multicenter Prospective Randomized Study|Completed||N/A|130|Actual|Soon Chun Hyang University||2|||f||||t|f|f||||||Undecided||2017-10-11 00:18:31.666649|2017-10-11 00:18:31.666649
NCT02166957|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-11-23|||November 2012||2012-11-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||"Evaluation of the Effectiveness of Endoscopic Rendez-vous Technique Foresophageal Reconstructions for the Treatment of a Total and Extensive Disruption of the Esophagus"|"Evaluation of the Effectiveness of Endoscopic Rendez-vous Technique for Esophageal Reconstructions for the Treatment of a Total and Extensive Disruption of the Esophagus"|Completed||N/A|12|Actual|Société Française d'Endoscopie Digestive|||2||f||||t||||||||||2017-10-11 00:18:31.761226|2017-10-11 00:18:31.761226
NCT02166944|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-16|||April 2014||2014-04-01|June 2014|2014-06-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Tamoxifen Treatment in Patients With Motor Neuron Disease|The Study of Tamoxifen Treatment in Patients With Motor Neuron Disease|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Taipei Medical University Shuang Ho Hospital||2|||f||||f||||||||||2017-10-11 00:18:31.845867|2017-10-11 00:18:31.845867
NCT02166931|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-16|||March 2014||2014-03-01|June 2014|2014-06-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||BRAND'S® Essence of Chicken in the Promotion of Resilience and Resistance to Stress-associated Cognitive Inhibition|The Effectiveness of BRAND'S® Essence of Chicken in the Promotion of Resilience and Resistance to Stress-associated Cognitive Inhibition|Unknown status|Recruiting|Phase 4|100|Anticipated|Taipei Medical University Shuang Ho Hospital||2|||f||||f||||||||||2017-10-11 00:18:31.959936|2017-10-11 00:18:31.959936
NCT02166918|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-11-23|||June 2013||2013-06-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2014|Actual|2014-07-01||Observational|PRIN2014||Factors Influencing Social Functioning of People With Schizophrenia|Multicenter Study on Factors Influencing Real-life Social Functioning of People With a Diagnosis of Schizophrenia|Completed||N/A|587|Actual|"University of Campania Luigi Vanvitelli"|||3||f||||t||||||Samples With DNA|"     In all subjects a blood sample of 20 ml will be withdrawn from a peripheral vein for genetic     analyses.   "|No||2017-10-11 00:18:32.051739|2017-10-11 00:18:32.051739
NCT02166905|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-01-27|||August 1, 2014||2014-08-01|January 2017|2017-01-01|February 12, 2019|Anticipated|2019-02-12|February 12, 2018|Anticipated|2018-02-12||Interventional|||DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission|A Phase I/IIb Study of DEC205mAb-NY-ESO-1 Fusion Protein (CDX-1401) Given With Adjuvant Poly-ICLC in Combination With INCB024360 for Patients in Remission With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen|Recruiting||Phase 1/Phase 2|68|Anticipated|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-11 00:18:32.148702|2017-10-11 00:18:32.148702
NCT02166892|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-02-28|||July 2014||2014-07-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Specially Designed Eating Plates Effects on Food Intake in Normal Weight and Overweight Children|The Effect of Specially Designed Eating Plates on Self-served Portions and Caloric Intake in Normal Weight and Overweight Children|Recruiting||N/A|80|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 00:18:32.261791|2017-10-11 00:18:32.261791
NCT02166879|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-08-10|||August 2012|Actual|2012-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)|Undetected Sleep Apnea in the Postanesthesia Acute Care Unit|Recruiting||N/A|900|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 00:18:32.357054|2017-10-11 00:18:32.357054
NCT02166866|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-12-20|||September 2013||2013-09-01|December 2016|2016-12-01||||September 2017|Anticipated|2017-09-01||Observational|||Phase I/II Cancer Caregiver Interventions to Improve Quality of Life and Prevent Burnout||Suspended||N/A|36|Anticipated|Mayo Clinic|||1||f||||||||||||||2017-10-11 00:18:32.432303|2017-10-11 00:18:32.432303
NCT02166853|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-03-03|||April 2014||2014-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|SEGA||Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study)|Effect of Early 48-hour Sevoflurane Inhalation on Gas Exchange and Inflammation in Patients Presenting With Acute Respiratory Distress Syndrome (ARDS) : a Monocentric, Prospective, Randomized Study.|Completed||Phase 4|50|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:18:32.494744|2017-10-11 00:18:32.494744
NCT02166840|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-10-21|||March 2007||2007-03-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|SEMS||Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors.|Self Expanding Metal Stents (SEMS) or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors.|Completed||Phase 2|92|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:18:32.593403|2017-10-11 00:18:32.593403
NCT02166827|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2017-03-30|||November 2014||2014-11-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of a NeuroAD System, for the Treatment of Alzheimer Disease|Effects of a NeuroAD System, for the Treatment of Alzheimer Disease: a Randomized, Double-blinded, Placebo-controlled Study|Terminated||N/A|1|Actual|Neuronix Ltd||2||Administrative decision|f||||f||||||||||2017-10-11 00:18:32.665691|2017-10-11 00:18:32.665691
NCT02166814|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-02-09|||August 2014||2014-08-01|June 2014|2014-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia||Completed||Phase 3|140|Actual|Boryung Pharmaceutical Co., Ltd||3|||f||||||||||||||2017-10-11 00:18:32.951109|2017-10-11 00:18:32.951109
NCT02166801|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-01-14|||January 2014||2014-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|smallstep||Small Step Intervention for Infants With Cerebral Palsy and Other Neurodevelopmental Disorders|A Small-step Program for Development of New Treatment Principles for Children With Cerebral Palsy and Other Neurodevelopmental Disorders|Recruiting||N/A|40|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:18:33.12729|2017-10-11 00:18:33.12729
NCT02166788|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2017-06-04|||January 2015||2015-01-01|June 2017|2017-06-01|August 2030|Anticipated|2030-08-01|August 2025|Anticipated|2025-08-01||Interventional|EAGLE FM||Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma|Inguinal or Ilio-inguinal Lymphadenectomy for Patients With Metastatic Melanoma to Groin Lymph Nodes and no Evidence of Pelvic Disease on PET/CT Scan - A Randomised Phase III Trial (EAGLE FM)|Recruiting||Phase 3|634|Anticipated|Australia and New Zealand Melanoma Trials Group||2|||f||||t||||||||||2017-10-11 00:18:33.271803|2017-10-11 00:18:33.271803
NCT02166775|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2016-04-04|||January 2014||2014-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Correlation Between Sagittal Balance of the Spine and Psychopathological Profile||Terminated||N/A|205|Actual|University Hospital, Strasbourg, France|||1|"Departure of psychologist in charge of questionnaires and scales administered to patients as   part of the evaluation of primary endpoint"|f||||t||||||||||2017-10-11 00:18:33.467257|2017-10-11 00:18:33.467257
NCT02166762|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-06-17|||May 2013||2013-05-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2014|Actual|2014-09-01||Interventional|QLV||Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.|Mapping of the Coronary Venous System in Patients With Heart Failure Presenting for CRT-D (Cardiac Resynchronization Therapy) Implantation. Correlating QLV Interval to Fluoroscopic LV (Left Ventricular) Lead Position.|Unknown status|Active, not recruiting|N/A|20|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 00:18:33.553236|2017-10-11 00:18:33.553236
NCT02166749|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-27|||March 1997||1997-03-01|June 2014|2014-06-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Observational|||Clinical Follow up After Subtotal and Total Hysterectomy|Ultra Long-term Follow-up of the Outcome After Subtotal Versus Total Abdominal Hysterectomy|Completed||N/A|212|Actual|Turku University Hospital|||2||f||||f||||||||||2017-10-11 00:18:33.667136|2017-10-11 00:18:33.667136
NCT02166736|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-01-11|||May 2014||2014-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2015|Actual|2015-10-01||Interventional|iFR Swedeheart||Evaluation of iFR vs FFR in Stable Angina or Acute Coronary Syndrome|Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome. A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on the Swedish Angiography and Angioplasty Registry (SWEDEHEART) Platform|Completed||N/A|2037|Actual|Uppsala University||2|||f||||t||||||||||2017-10-11 00:18:33.793101|2017-10-11 00:18:33.793101
NCT02166723|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-16|||January 2013||2013-01-01|June 2014|2014-06-01|April 2015|Anticipated|2015-04-01|January 2014|Actual|2014-01-01|1 Year|Observational [Patient Registry]|PAFCA||Persistent Atrial Fibrillation Cryoballoon Ablation|Treatment of Long Persistent Atrial Fibrillation by Single Cryoballoon Ablation of the Pulmonary Veins, Left Atrial Roof Line and Ablation of Left Lateral Ridge From Within the Appendage|Unknown status|Active, not recruiting|N/A|62|Actual|Staten Island University Hospital|||1||f||||t||||||||||2017-10-11 00:18:33.940393|2017-10-11 00:18:33.940393
NCT02166710|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-01-30|||January 2015||2015-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Adductor Canal Nerve Block Compared to a Simulated Block on Quadriceps Strength Following Knee Arthroplasty|Effect of Adductor Canal Femoral Nerve Block Compared to a Simulated Block on Knee Extensor Muscle Strength Following Total Knee Arthroplasty|Completed||N/A|60|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 00:18:34.071463|2017-10-11 00:18:34.071463
NCT02166697|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-09-26|2016-03-31||June 2006||2006-06-01|September 2016|2016-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational||The safety analysis set included all participants who were enrolled and completed the study.|"Blopress Tablets Specified Drug-use Survey Hypertension: Survey on Patients With Metabolic Syndrome"|"Candesartan Cilexetil Tablets Specified Drug-use Survey Hypertension: Survey on Patients With Metabolic Syndrome"|Completed||N/A|14151|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:18:34.225271|2017-10-11 00:18:34.225271
NCT02166684|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-12-19|||September 2014||2014-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|P4@TNO||The Potential of Do-it-yourself Devices for Obtaining Personal Health Data|The Potential of Do-it-yourself Devices for Obtaining Personal Health Data - P4@TNO Pilot Study|Completed||N/A|33|Actual|TNO||1|||f||||f||||||||||2017-10-11 00:18:35.66828|2017-10-11 00:18:35.66828
NCT02166671|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-05-12|||April 25, 2014|Actual|2014-04-25|May 2017|2017-05-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years|Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 20-23 Years After Neonatal Immunization|Terminated||N/A|9|Actual|Seoul National University Hospital||1||Participants were not recruited promptly|f||||||||||||||2017-10-11 00:18:35.782009|2017-10-11 00:18:35.782009
NCT02166658|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-06-26|||August 2015||2015-08-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2017|Actual|2017-04-01||Interventional|CaBaMet||A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)|A Phase II Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)|Suspended||Phase 2|63|Anticipated|AIO-Studien-gGmbH||1||After a recruitment of more than 2 years, only 8 patients have been registered.|f||||t||||||||||2017-10-11 00:18:35.878399|2017-10-11 00:18:35.878399
NCT02166645|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2014-06-14|||March 2014||2014-03-01|May 2014|2014-05-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Comparison Between Preterm Infants Who Are Placed on Their Back or Stomach in the Immediate Postextubation Period|Comparison of Prone and Supine Positioning in the Immediate Postextubation Period of Preterm Infants: a Randomized Controlled Trial Protocol|Unknown status|Recruiting|N/A|94|Anticipated|Uniao Metropolitana de Educacao e Cultura||2|||f||||t||||||||||2017-10-11 00:18:35.981893|2017-10-11 00:18:35.981893
NCT02166632|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-02-08|||April 2014||2014-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Postoperative Pain Control Results Using Periarticular Versus Intra-capsular Injection of Bupivacaine Liposome Injectable Suspension in Total Knee Arthroplasty|Prospective, Randomized Comparison of Postoperative Pain Control Results of Peri-articular Local Injection and Intra-capsular Injectinon of Bupivacaine Liposome Injectable Suspension After Total Knee Arthroplasty|Completed||N/A|50|Actual|Broward Health||2|||f||||f||||||||||2017-10-11 00:18:36.132714|2017-10-11 00:18:36.132714
NCT02166606|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-02-02|||April 2014|Actual|2014-04-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|Gentle||INGEVITY™ Observational Trial|INGEVITY™ Observational Trial: Assessment of Routine Experience and Magnet Resonance Imaging (MRI) Usage With a New Lead for Bradycardia Pacing|Completed||N/A|1184|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 00:18:36.412248|2017-10-11 00:18:36.412248
NCT02166593|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-08-30|||May 2014||2014-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin|A Study to Evaluate the Efficacy and Safety of Pravastatin/Fenofibrate Complex in Patients With Combined Dyslipidemia With Adequately Controlled LDL-C But Inadequately Controlled Triglyceride Level by Atorvastatin Monotherapy|Recruiting||Phase 3|302|Anticipated|Yooyoung Pharmaceutical Co.,Ltd.||2|||f||||t||||||||||2017-10-11 00:18:36.612856|2017-10-11 00:18:36.612856
NCT02166580|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-06-03|||January 2014||2014-01-01|June 2017|2017-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Accuracy of CNAP PPV Under General Anaesthesia|Comparison of the Non-invasive CNAP Pulse Pressure Variation With the Invasive Gold Standard|Completed||N/A|54|Actual|University of Schleswig-Holstein|||1||f||||f||||||||||2017-10-11 00:18:36.727701|2017-10-11 00:18:36.727701
NCT02166567|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2017-07-25|||May 2013||2013-05-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|January 2017|Actual|2017-01-01||Interventional|Spermsorting||Effect of Sorting of Apoptotic Spermatozoa on the Outcome of Assisted Reproduction|The Effect of Sorting of Non-apoptotic and Apoptotic Spermatozoa Using Flow Cytometry on the Outcome of Intracytoplasmic Sperm Injection.|Active, not recruiting||N/A|100|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 00:18:36.810455|2017-10-11 00:18:36.810455
NCT02166554|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-16|||June 2011||2011-06-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|BAP||The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions|The Efficacy and Safety of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Adhesions After Laparoscopic Gynecological Surgery: a Randomized Controlled Trial|Completed||Phase 1/Phase 2|216|Actual|BioRegen Biomedical (CHangzhou) Co., Ltd||2|||f||||f||||||||||2017-10-11 00:18:38.811243|2017-10-11 00:18:38.811243
NCT02166541|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-02-18|||January 2014||2014-01-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|||Evaluation of INRS With BCSK in Children With Spastic Bilateral Cerebral Palsy: a Randomized Controlled Trial.|"Evaluation of Intensive Neurophysiological Rehabilitation System (INRS) With Biomechanical Correction of the Spine According to Kozyavkin (BCSK) in Children With Spastic Bilateral Cerebral Palsy: a Randomized Controlled Trial."|Unknown status|Recruiting|N/A|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:18:38.954813|2017-10-11 00:18:38.954813
NCT02166528|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-06-14|||November 2013||2013-11-01|June 2014|2014-06-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Observational|PFD POP UI||The Study of Genes Localization for Female Pelvic Floor Dysfunction|The Study of Susceptibility Genes Localization for Female Pelvic Floor Dysfunction|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Third Military Medical University|||2||f||||t||||||Samples With DNA|"     The sample of blood, urine, cervical exfoliated cells and tissue of patients with POP, UI or     genital tract injury should be used only in this research with informed consent. The     remaining part will be Safekeeping. All information is strictly confidential.   "|||2017-10-11 00:18:39.079383|2017-10-11 00:18:39.079383
NCT02166515|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-06-17|||October 2013||2013-10-01|June 2014|2014-06-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Observational|||The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor|The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Third Military Medical University|||2||f||||t||||||Samples With DNA|"     The sample of blood, urine, cervical exfoliated cells and cancer tissue of patient should be     used only in this research with informed consent. The remaining part will be Safekeeping.All     information is strictly confidential.   "|||2017-10-11 00:18:39.16648|2017-10-11 00:18:39.16648
NCT02166502|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-11-17|||February 2012||2012-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Observational|||Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection|Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection|Completed||Phase 3|27|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 00:18:39.257323|2017-10-11 00:18:39.257323
NCT02166489|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2016-01-03|||March 2014||2014-03-01|November 2015|2015-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease|Evaluation the Effect of Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 1|6|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 00:18:39.371161|2017-10-11 00:18:39.371161
NCT02166450|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-18|||October 2011||2011-10-01|June 2014|2014-06-01||||December 2015|Anticipated|2015-12-01||Observational|||Effects of Denture-Related Stomatitis on Blood Pressure in Denture Wearers|Effects of Denture-Related Stomatitis on Blood Pressure, Endothelial Function and Systemic Immune Response in Patients With Dentures|Unknown status|Recruiting|N/A|80|Anticipated|Jagiellonian University|||2||f||||f||||||||||2017-10-11 00:18:41.924592|2017-10-11 00:18:41.924592
NCT02166437|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-15|2016-10-18|||November 2013||2013-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese|Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese, Prospective Study|Recruiting||N/A|500|Anticipated|Tomidahama Hospital|||3||f||||f||||||||||2017-10-11 00:18:42.03782|2017-10-11 00:18:42.03782
NCT02166411|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-07-26|||December 2013||2013-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Laparoscopic Myomectomy Using Barbed or Conventional Sutures|Laparoscopic Myomectomy Using Barbed or Conventional Sutures . A Randomized Controlled Trial|Recruiting||Phase 2|54|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-11 00:18:42.2914|2017-10-11 00:18:42.2914
NCT02166398|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-06-10|||June 2014||2014-06-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|UI15AML055MT||A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers|Phase 1 Study of Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg|Completed||Phase 1|46|Anticipated|Korea United Pharm. Inc.||2|||f||||f||||||||||2017-10-11 00:18:42.431929|2017-10-11 00:18:42.431929
NCT02166372|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-16|||March 2014||2014-03-01|June 2014|2014-06-01|December 2034|Anticipated|2034-12-01|December 2024|Anticipated|2024-12-01||Observational|TDS||Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery|Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery|Recruiting||N/A|1000|Anticipated|Min-Sheng General Hospital|||1||f||||t||||||||||2017-10-11 00:18:42.532382|2017-10-11 00:18:42.532382
NCT02166359|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-14|2016-08-05|||June 2014||2014-06-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients||Recruiting||N/A|80|Anticipated|Dong-A University||2|||f||||f||||||||||2017-10-11 00:18:42.623288|2017-10-11 00:18:42.623288
NCT02166346|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-08-15|||February 2014||2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Interventional|||Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)|Double-Blind, Placebo-Controlled Crossover Trial on the Safety and Efficacy of Sustained-Release Dalfampridine in Transverse Myelitis (Re-Launch)|Active, not recruiting||Phase 2|25|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:18:42.716566|2017-10-11 00:18:42.716566
NCT02166333|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-04-26|||July 2015||2015-07-01|April 2017|2017-04-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|STURDY||Study To Understand Fall Reduction and Vitamin D in You|Vitamin D Supplements to Prevent Falls in Older Adults: A Dose-Response Trial|Recruiting||N/A|1200|Anticipated|Johns Hopkins University||4|||f||||t||||||||||2017-10-11 00:18:42.817527|2017-10-11 00:18:42.817527
NCT02166320|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-01-04|||October 2010||2010-10-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|StentMig||Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent.|The Importance of Stent Design|Completed||Phase 2|80|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 00:18:42.939755|2017-10-11 00:18:42.939755
NCT02166307|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-06-17|||January 2009||2009-01-01|June 2014|2014-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Clinical Verification of Peptide Biomarkers for Human Aging|Clinical Verification of Peptide Biomarkers for Human Aging by Standard-Free, Label-Free LC-MS/MS Quanification of Aldehyde-modified Peptides|Completed||N/A|253|Actual|Beijing Institute of Technology|||1||f||||t||||||||||2017-10-11 00:18:43.019475|2017-10-11 00:18:43.019475
NCT02166294|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-06-26|||June 2014||2014-06-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CONDUCT I||NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers|A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks|Terminated||N/A|18|Actual|Amniox Medical, Inc.||3||Sponsor decision|f||||f||||||||||2017-10-11 00:18:43.077322|2017-10-11 00:18:43.077322
NCT02166281|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-06-16|||May 2014||2014-05-01|June 2014|2014-06-01||||May 2016|Anticipated|2016-05-01||Observational|||Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer||Unknown status|Recruiting|N/A|200|Anticipated|Azienda Ospedaliera Spedali Civili di Brescia|||1||f||||f||||||||||2017-10-11 00:18:43.180181|2017-10-11 00:18:43.180181
NCT02166268|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-01-25|||June 2014||2014-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|AV-G-03||Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber|Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber|Completed||Phase 2|140|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-10-11 00:18:43.286674|2017-10-11 00:18:43.286674
NCT02166255|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2017-08-14|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery|A Phase 1, Open-Label, Dose-Ranging Study to Assess the Safety and Immunologic Activity of APN401|Completed||Phase 1|17|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 00:18:43.365755|2017-10-11 00:18:43.365755
NCT02166242|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2016-02-14|||June 2014||2014-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers|Phase 1c Single Arm Study of Thioredoxin Reductase Inhibitor Ethaselen, for the Treatment of Thioredoxin Reductase High Expressed Advanced Non-small Cell Lung Cancers Who Have Received More Than Two Lines Standard Treatment.|Recruiting||Phase 1|40|Anticipated|Hunan Province Tumor Hospital||1|||f||||f||||||||||2017-10-11 00:18:43.574923|2017-10-11 00:18:43.574923
NCT02166229|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-08-10|||June 2014||2014-06-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma||Withdrawn||Phase 1/Phase 2|0|Actual|Yale University||1||No subjects were enrolled.|f||||f||||||||||2017-10-11 00:18:43.677162|2017-10-11 00:18:43.677162
NCT02166216|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-04-25|||June 2013||2013-06-01|April 2016|2016-04-01|June 2034|Anticipated|2034-06-01|June 2034|Anticipated|2034-06-01||Observational|NEEDED||The North Sea Race Endurance Exercise Study|The North Sea Race Endurance Exercise Study|Active, not recruiting||N/A|1200|Anticipated|Helse Stavanger HF|||1||f||||f||||||Samples With DNA|"     Serum EDTA Whole blood   "|||2017-10-11 00:18:43.759868|2017-10-11 00:18:43.759868
NCT02166190|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-06-02|||June 2014||2014-06-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|RFA RCT||RFA RCT for Pancreatic or Bile Duct Cancer|Randomized Controlled Trial Comparing Radiofrequency Ablation and Stenting vs. Stenting Alone for Biliary Obstruction Due to Unresectable Cholangiocarcinoma and Pancreatic Cancer|Unknown status|Recruiting|Phase 3|44|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 00:18:43.853702|2017-10-11 00:18:43.853702
NCT02166177|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2014-07-01|||June 2014||2014-06-01|July 2014|2014-07-01||||June 2019|Anticipated|2019-06-01||Interventional|ThRIL||Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients|Pilot Study Evaluating the Safety and Efficacy Profile of Regulatory T Cell Therapy in Liver Transplant Recipients|Recruiting||Phase 1/Phase 2|26|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||||||||||||2017-10-11 00:18:43.948128|2017-10-11 00:18:43.948128
NCT02166164|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-01-26|||June 2014||2014-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Characterization of Secondary Hyperalgesia in Healthy Volunteers|Characterization of Secondary Hyperalgesia in Healthy Volunteers|Completed||N/A|50|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 00:18:44.042409|2017-10-11 00:18:44.042409
NCT02166151|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-06-17|||July 2014||2014-07-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria|Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria|Unknown status|Not yet recruiting|Phase 3|20|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 00:18:44.148596|2017-10-11 00:18:44.148596
NCT02166138|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2015-03-18|||November 2013||2013-11-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Non-Ablative Fractional Resurfacing of Total Knee Replacement Scars|Non-Ablative Fractional Resurfacing of Total Knee Replacement Scars|Unknown status|Recruiting|N/A|108|Anticipated|Hospital for Special Surgery, New York||2|||f||||||||||||||2017-10-11 00:18:44.262285|2017-10-11 00:18:44.262285
NCT02166125|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-16|||May 2013||2013-05-01|February 2017|2017-02-01|August 26, 2017|Anticipated|2017-08-26|May 26, 2017|Anticipated|2017-05-26|1 Year|Observational [Patient Registry]|||Endoscopic Sutures For Gastrointestinal Tract Disorders: A Prospective Multicenter Registry|Endoscopic Sutures For Gastrointestinal Tract Disorders: A Prospective Multicenter Registry.|Recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|No IPD sharing|2017-10-11 00:18:44.397876|2017-10-11 00:18:44.397876
NCT02166112|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-04-05|||April 2013||2013-04-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Observational|||The Permacol Dutch Cohort Study|The Permacol Dutch Cohort Study|Completed||N/A|77|Actual|Erasmus Medical Center|||1||f||||f||||||||No||2017-10-11 00:18:44.535571|2017-10-11 00:18:44.535571
NCT02166099|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-16|||October 2012||2012-10-01|February 2017|2017-02-01|December 30, 2018|Anticipated|2018-12-30|December 1, 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|SPY||Choledochoscopy Multicenter Registry|Choledochoscopy For Diagnosing Pancreatico-Biliary Disorders: A Multicenter Registry|Recruiting||N/A|250|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|No IPD sharing|2017-10-11 00:18:44.710089|2017-10-11 00:18:44.710089
NCT02166086|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-16|||September 2011||2011-09-01|February 2017|2017-02-01|December 30, 2018|Anticipated|2018-12-30|December 1, 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|||Advanced Imaging Registry for Diagnosing Pancreatico-biliary Disorders|Advanced Imaging for Diagnosing Pancreatico-biliary Disorders: A Multicenter Registry.|Recruiting||N/A|500|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|No IPD sharing|2017-10-11 00:18:44.795977|2017-10-11 00:18:44.795977
NCT02166073|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2015-07-01|||July 2014||2014-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:18:44.895091|2017-10-11 00:18:44.895091
NCT02166060|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-13|||August 2014||2014-08-01|June 2014|2014-06-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|IvaCRT||Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy|Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Medical University of Warsaw||1|||f||||t||||||||||2017-10-11 00:18:44.954097|2017-10-11 00:18:44.954097
NCT02166047|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-16|2016-12-16||2016-12-16|June 2014||2014-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Safety and Efficacy of GS-9620 for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Subjects|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of GS-9620 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B|Completed||Phase 2|162|Actual|Gilead Sciences||12|||f||||t||||||||||2017-10-11 00:18:45.097564|2017-10-11 00:18:45.097564
NCT02166034|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-06-15|||August 2011||2011-08-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|HGHY||Effects of School Gardens on Children's Diet, Nutritional Knowledge, Etc.|Healthy Gardens, Healthy Youth (HGHY): A People's Garden School Pilot Program|Completed||N/A|3531|Actual|Cornell University||2|||f||||f||||||||||2017-10-11 00:18:45.284244|2017-10-11 00:18:45.284244
NCT02166021|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-06-07|||January 2015||2015-01-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Optimal Administration Mode of Autologous Mesenchymal Bone Marrow Stem Cells in Active and Progressive Multiple Sclerosis|Phase IIA Trial to Investigate the Optimal Way of Administration (Based on the Immunological, Clinical and Neuroradiological Effects) of Autologous Mesenchymal Bone Marrow Stem Cells (MSC) in Active and Progressive Multiple Sclerosis (MS)|Recruiting||Phase 2|36|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||||2017-10-11 00:18:45.430607|2017-10-11 00:18:45.430607
NCT02166008|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-06-12|||September 2013||2013-09-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT|Cytoprotective Agent for Peptic Ulcer Prevention in Patients Taking Dual Antiplatelet Agents: A Randomized Double-blind Placebo Control Trial Study|Suspended||Phase 2/Phase 3|142|Anticipated|King Chulalongkorn Memorial Hospital||2||Wait for the placebo|f||||t||||||||||2017-10-11 00:18:45.559181|2017-10-11 00:18:45.559181
NCT02165995|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-12-28|||September 2014||2014-09-01|December 2016|2016-12-01||||September 2018|Anticipated|2018-09-01||Interventional|||Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery|Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery and Plasticity Following Brain Tumor Surgery in or Adjacent to Eloquent Cortex|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:18:45.674866|2017-10-11 00:18:45.674866
NCT02165982|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2016-09-12|||February 2014||2014-02-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Observational|HAP-AM||Characteristics of Intensity and Dependence to Physical Activity in Anorexia Nervosa|Intensity and Dependence to Physical Activity and Its Links With Clinical and Emotional Statuses in Comparison With Healthy Controls.|Completed||N/A|300|Actual|Institut Mutualiste Montsouris|||2||f||||f||||||||||2017-10-11 00:18:45.808974|2017-10-11 00:18:45.808974
NCT02165969|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-03-31|||June 2014||2014-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|UPSIT||Olfactory Function Following Endoscopic Endonasal Skull Base Surgery|Olfactory Function Following Endoscopic Endonasal Skull Base Surgery: Clinical and Histological Outcomes|Recruiting||N/A|160|Anticipated|Ohio State University||1|||f||||f||||||||||2017-10-11 00:18:45.915266|2017-10-11 00:18:45.915266
NCT02165956|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-03-07|||March 2011||2011-03-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Interventional|CEOBE||Effect of a New Infant Cereal on Weight Gain|Effect of a New Food Product on Weight Gain During First Infancy|Completed||Phase 4|195|Actual|Laboratorios Ordesa||2|||f||||f||||||||||2017-10-11 00:18:46.032851|2017-10-11 00:18:46.032851
NCT02165943|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-12|||January 2014||2014-01-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Evaluation of Vitoss With and Without BMA for Benign Cavitary Lesions|A Combined Retrospective and Prospective Protocol to Evaluate Vitoss With and Without Bone Marrow Aspirate for Benign Cavitary Lesions|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Orthovita d/b/a Stryker|||2||f||||f||||||||||2017-10-11 00:18:46.151752|2017-10-11 00:18:46.151752
NCT02165930|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-03-31|||July 2014||2014-07-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers|An Open Label, Single Dose, Randomized, Two Way Crossover Study to Estimate Oxycodone Relative Bioavailability in Healthy Volunteers Following Administration of PF 00345439 Formulation K 40 Mg Under Fasting Conditions With 40% Ethanol Compared With Water|Completed||Phase 1|17|Actual|Pain Therapeutics||2|||f||||f||||||||||2017-10-11 00:18:46.249772|2017-10-11 00:18:46.249772
NCT02165917|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-11-02|||May 2015||2015-05-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion Barrier|Randomised, Controlled Clinical Study With Patients With Endometriosis and the Desire to Have Children - Comparison Between Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesionbarrier|Recruiting||Phase 4|60|Anticipated|Pius-Hospital Oldenburg||2|||f||||f||||||||||2017-10-11 00:18:46.348019|2017-10-11 00:18:46.348019
NCT02165904|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-06-13|||May 2014||2014-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Subarachnoid Administration of Adult Autologous Bone Marrow Mesenchymal Cells Expanded in Incomplete (SCI)|Phase I.Subarachnoid Administration of Adult Autologous Mesenchymal Bone Marrow Cells Expanded in Incomplete Spinal Cord Injury (SCI)|Completed||Phase 1|10|Actual|Puerta de Hierro University Hospital||1|||f||||f||||||||Yes|Anonymized individual data of participants will be shared with Authorities at the end of the Clinical development plan by the CTD (Common Technical Document). Results will be published in a scientific publication|2017-10-11 00:18:46.627305|2017-10-11 00:18:46.627305
NCT02165891|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-10-20|||February 2015||2015-02-01|October 2015|2015-10-01||||September 2017|Anticipated|2017-09-01||Interventional|UROVATS||Comparison of Intrapleural Urokinase and Video-Assisted Thorascopic Surgery in the Treatment of Parapneumonic Pleural Effusion in Children|Prospective Randomized Study Comparing the Efficacy and Safety of Pleural Drainage by Video-Assisted Thoracoscopic With Pleural Drainage by Percutaneous Drain Associated With Urokinase in the Treatment of Parapneumonic Pleural Effusion in Children|Unknown status|Recruiting|Phase 3|40|Anticipated|Queen Fabiola Children's University Hospital||2|||f||||f||||||||||2017-10-11 00:18:46.737426|2017-10-11 00:18:46.737426
NCT02165280|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-07-27|||June 2014||2014-06-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional|GIMPS||Guided IMagery and Patient Satisfaction (GIMPS) Following Urogynecological Surgery|Guided IMagery and Patient Satisfaction Following Urogynecological Surgery|Completed||N/A|44|Actual|Loyola University||2|||f||||f||||||||||2017-10-11 00:18:55.232124|2017-10-11 00:18:55.232124
NCT02165878|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-07-04|||March 2011|Actual|2011-03-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2016|Actual|2016-12-01||Observational|KNOW-PedCKD||KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease|KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease : A 10-year Longitudinal Cohort Study of the Chronic Kidney Disease|Active, not recruiting||N/A|458|Actual|Seoul National University Hospital|||1||f||||t||||||Samples With DNA|"     A biobank is also established for the DNA, serum and urine taken at regular interval.   "|||2017-10-11 00:18:46.843126|2017-10-11 00:18:46.843126
NCT02165865|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-08-11|||January 2014||2014-01-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|||Vascularized Composite Allotransplantation of the Hand and Upper Extremity (Hand Transplant)|Vascularized Composite Allotransplantation of the Hand and Upper Extremity for the Restoration of Form and Function in Hand Amputees|Recruiting||Phase 2|5|Anticipated|Southern Illinois University||1|||f||||f||||||||||2017-10-11 00:18:46.939844|2017-10-11 00:18:46.939844
NCT02165852|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-10-13|||January 2014||2014-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Comparison on the Efficacy of Endoscopic Snare Papillectomy With or Without Submucosal Injection|A Prospective Comparative Study of Papillectomy|Completed||Phase 3|50|Actual|Soon Chun Hyang University||2|||f||||t||||||||||2017-10-11 00:18:47.072793|2017-10-11 00:18:47.072793
NCT02165839|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-05-15|||January 2015||2015-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Brief Behavioral Intervention for Insomnia During Chemotherapy|Brief Behavioral Intervention for Insomnia During Chemotherapy|Recruiting||N/A|180|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 00:18:47.163747|2017-10-11 00:18:47.163747
NCT02165826|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-03-23|2016-09-16||May 1, 2014|Actual|2014-05-01|March 2017|2017-03-01|September 1, 2015|Actual|2015-09-01|September 1, 2015|Actual|2015-09-01||Interventional|OPTIMIZE|Safety Analysis Set (SAS) included all randomized participants who took at least one dose of study medication. Main Treatment Period.|Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD|A Multicenter, Randomized, Double-blind Phase 3 Study to Evaluate Tolerability and Pharmacokinetics of 500 μg Roflumilast Once Daily With an Up-titration Regimen in COPD, Including an Open-label Down-titration Period Evaluating Tolerability and Pharmacokinetics of 250 μg Roflumilast Once Daily in Subjects Not Tolerating 500 μg Roflumilast Once-daily|Completed||Phase 3|1323|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:18:47.316951|2017-10-11 00:18:47.316951
NCT02165800|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-10-18|||January 2014||2014-01-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients|Multicenter Study on Outcomes and Protection of Urinary and Sexual Function of Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients|Recruiting||N/A|667|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:18:50.331471|2017-10-11 00:18:50.331471
NCT02165787|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-05-22|||April 2014||2014-04-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Investigation of Gait Parameters in Health and Neurological Disease Under Varying Locomotor Conditions||Recruiting||N/A|340|Anticipated|University of Zurich|||2||f||||t||||||||||2017-10-11 00:18:50.436051|2017-10-11 00:18:50.436051
NCT02165774|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-01-27|||April 2012||2012-04-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Sacral Neuromodulation for Neurogenic LUT Dysfunction|Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Randomized, Placebo-controlled, Double-blind Clinical Trial|Recruiting||N/A|60|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 00:18:50.532045|2017-10-11 00:18:50.532045
NCT02165761|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-10-05|||July 2014||2014-07-01|October 2017|2017-10-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients|Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients Implanted With the GORE® Hybrid Vascular Graft Versus Non-heparin Bonded Synthetic Vascular Grafts.|Terminated||N/A|42|Actual|W.L.Gore & Associates||2|||f||||f||||||||||2017-10-11 00:18:50.752527|2017-10-11 00:18:50.752527
NCT02165748|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-16|||November 2013||2013-11-01|June 2014|2014-06-01||||September 2014|Anticipated|2014-09-01||Observational|||Severe Intraoperative Hyperglycemia During Craniotomy and Postoperative Infections||Unknown status|Recruiting|N/A|28|Anticipated|University of Roma La Sapienza|||1||f||||||||||||||2017-10-11 00:18:50.855101|2017-10-11 00:18:50.855101
NCT02165709|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-04-21|||June 2014||2014-06-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|RRS||Cohort Study of Risk Reducing Salpingectomy|Cohort Study of Risk Reducing Salpingectomy (RRS) Versus Standard Tubal Sterilization Among Women Who Desire Sterilization|Completed||N/A|18|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:18:51.135566|2017-10-11 00:18:51.135566
NCT02165696|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-13|||September 2014||2014-09-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|LYMPHATIC||Compression Bandaging and Manual Lymph Drainage in Women With Lymphedema|Effectiveness of the Combination of Compression Bandaging and Manual Lymph Drainage in Women With Secondary Lymphedema After Breast Cancer.|Unknown status|Not yet recruiting|N/A|44|Anticipated|University of Malaga||2|||f||||t||||||||||2017-10-11 00:18:51.224518|2017-10-11 00:18:51.224518
NCT02165683|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-06-27|||July 2014||2014-07-01|June 2017|2017-06-01|October 24, 2016|Actual|2016-10-24|October 24, 2016|Actual|2016-10-24||Observational|||Use of Propranolol to Reduce FDG Uptake in Brown Adipose Tissue in Pediatric Cancer Patients PET Scans|Investigation of Propranolol Premedication to Reduce FDG Uptake in Brown Adipose Tissue on PET Scans of Pediatric Cancer Patients|Completed||N/A|10|Actual|University of Kentucky|||1||f||||t||||||||||2017-10-11 00:18:51.34073|2017-10-11 00:18:51.34073
NCT02165670|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-07-07|||June 2014||2014-06-01|July 2016|2016-07-01|July 2021|Anticipated|2021-07-01|June 2021|Anticipated|2021-06-01|5 Years|Observational [Patient Registry]|||BASIC VALIDATE Coronary Stent Registry|BioMatrix NeoFlex Post Marketing Surveillance in Validate (the BASIC VALIDATE) Registry)|Withdrawn||N/A|0|Actual|Region Örebro County|||1|"After critique raised by peers there was a risk that the study could be interpreted as a   marketing tool for a specific product more than a scientific study."|f||||f||||||||||2017-10-11 00:18:51.413661|2017-10-11 00:18:51.413661
NCT02165657|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-05-12|||September 2013||2013-09-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Excimer Laser, Serum Markers & Psoriasis|Effects of UVB Excimer Laser on Serum Inflammatory Markers in Patients With Psoriasis|Completed||N/A|4|Actual|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-10-11 00:18:51.498666|2017-10-11 00:18:51.498666
NCT02165644|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-09-23|||September 2015||2015-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage|Targeting Carbonic Anhydrase Mediated Coupling as a Novel Vasospasm Prophylaxis in Aneurysmal Sub Arachnoid Hemorrhage|Withdrawn||Phase 2|0|Actual|University of Florida||2||The PI is leaving the University of Florida.|f||||f||||||||||2017-10-11 00:18:51.585152|2017-10-11 00:18:51.585152
NCT02165631|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-03-10|||August 2014||2014-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure|The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure|Completed||N/A|60|Actual|University of Colorado, Denver|||2||f||||f||||||||No||2017-10-11 00:18:51.687174|2017-10-11 00:18:51.687174
NCT02165618|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-06-13|||January 2014||2014-01-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|RASP-GCT||Rationalisation of Polypharmacy by the Geriatric Consultation Team|Rationalisation of Polypharmacy by the Geriatric Consultation Team Using the RASP List: a Pilot Study|Completed||N/A|60|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:18:51.760761|2017-10-11 00:18:51.760761
NCT02165605|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-02-23|||August 2013||2013-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer|Randomized, Double-Blind, Vehicle-Controlled Pilot Study of the Efficacy and Safety of HylaCareTM in the Treatment of Acute Skin Changes in Patients Undergoing External Beam Radiotherapy for Tumors of the Breast.|Active, not recruiting||N/A|30|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:18:51.876957|2017-10-11 00:18:51.876957
NCT02165579|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-06-16|||June 2014||2014-06-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Observational|||Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis|Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis|Unknown status|Not yet recruiting|N/A|80|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-11 00:18:52.068657|2017-10-11 00:18:52.068657
NCT02165566|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-06-16|||March 2013||2013-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit||Completed||Phase 4|28|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 00:18:52.160143|2017-10-11 00:18:52.160143
NCT02165553|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2015-09-04|||January 2014||2014-01-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|PHYTOVAS||Impact of Hibiscus on Cardiovascular Disease Risk|Acute Impact of Hibiscus Sabdariffa Calyces (HSC) Extract Consumption on Blood Pressure, Vascular Function and Other Cardiovascular Risk Factors|Completed||N/A|25|Actual|University of Reading||2|||f||||t||||||||||2017-10-11 00:18:52.25105|2017-10-11 00:18:52.25105
NCT02165540|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-01-06|||May 2014||2014-05-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||The Impact of Doulas in Early Pregnancy Management|The Impact of Doulas in the Surgical Management of Early Pregnancy Failure and Abortion Care|Completed||N/A|75|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 00:18:52.357288|2017-10-11 00:18:52.357288
NCT02165527|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-13|||November 2011||2011-11-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Evaluation of Bone Length Measurement|Evaluation of Bone Length Measurement Using Lunar iDXA|Completed||N/A|20|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 00:18:52.452006|2017-10-11 00:18:52.452006
NCT02165514|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-13|||July 2010||2010-07-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Cobb Angle Measurement of Kyphosis and Scoliosis|Traditional Cobb Angle Measurement of Kyphosis and Scoliosis Using Lunar IDXA|Completed||N/A|40|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 00:18:52.539827|2017-10-11 00:18:52.539827
NCT02165501|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-11-24|||January 2011||2011-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2015|Actual|2015-12-01|60 Months|Observational [Patient Registry]|JenaSepsisReg||Jena Sepsis Registry|Jena Sepsis Registry - a Sepsis-registry for Long Term Outcomes|Active, not recruiting||N/A|1995|Actual|University of Jena|||1||f||||f||||||||||2017-10-11 00:18:52.620931|2017-10-11 00:18:52.620931
NCT02165488|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-08|2017-06-11|||June 2014||2014-06-01|June 2017|2017-06-01||||May 2019|Anticipated|2019-05-01||Observational|||Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae|Gastrointestinal, Hepatic and Biliary Sequelae of Frequent Ketamine Use: a Prospective Observational Study|Recruiting||N/A|100|Anticipated|The University of Hong Kong|||1||f||||f||||||Samples With DNA|"     Saved plasma samples Gastric antral and duodenal histology obtained by upper GI endoscopy   "|||2017-10-11 00:18:52.71449|2017-10-11 00:18:52.71449
NCT02165475|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-17|||May 2002||2002-05-01|June 2014|2014-06-01||||March 2005|Actual|2005-03-01||Interventional|||Combination Therapy With Biofeedback, Loperamide and Stool Bulking Agents|Combination Therapy With Biofeedback, Loperamide and Stool Bulking Agents is Effective for the Treatment of Fecal Incontinence in Women - a Randomized Controlled Trial|Completed||N/A|||University Hospital, Linkoeping||3|||f||||f||||||||||2017-10-11 00:18:52.861578|2017-10-11 00:18:52.861578
NCT02165462|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2016-06-29|2015-10-07||September 2015||2015-09-01|September 2015|2015-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|1 Month|Observational [Patient Registry]|PROPRIO-HE||Bilateral Deficit Phenomenon in Patients With Haemophilic Arthropathy|Assessment of Bilateral Deficit Phenomenon During Dynamic Plantar Flexion Task in Patients With Haemophilic Arthropathy|Completed||N/A|17|Actual|Universidad Católica San Antonio de Murcia|||1||f||||f||||||||||2017-10-11 00:18:52.993394|2017-10-11 00:18:52.993394
NCT02165449|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-11-05|||June 2014||2014-06-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Biomarkers of Fast Acting Therapies in Major Depression|Translational Biomarkers of Fast Acting Therapies in Major Depression|Recruiting||Phase 1|30|Anticipated|University of California, Los Angeles||1|||f||||t||||||||Yes|Research data without protected health information will be shared according to approved UCLA IRB protocols.|2017-10-11 00:18:53.361869|2017-10-11 00:18:53.361869
NCT02165436|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-13|||July 2009||2009-07-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Chewing Gum Facilitates an Earlier Return to Bowel Function in Pediatric Scoliosis Patients: A Prospective Randomized Study|The Use of Chewing Gum Reduces Post-operative Ileus and Gastrointestinal Complications in Pediatric Scoliosis Patients.|Completed||N/A|83|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:18:53.499451|2017-10-11 00:18:53.499451
NCT02165423|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-02-10|||June 2014|Actual|2014-06-01|February 2017|2017-02-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Discharge to Home and Chronic Illness Care Pilot|Discharge to Home and Chronic Illness Care Pilot|Active, not recruiting||N/A|20|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 00:18:53.801722|2017-10-11 00:18:53.801722
NCT02165410|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-02-27|||November 13, 2013|Actual|2013-11-13|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|November 12, 2018|Anticipated|2018-11-12||Interventional|IRM-Aut||MRI Study of Cerebral Blood Flow in Development Disorders in Children|MRI Study of Cerebral Blood Flow in Development Disorders in Children|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:18:53.908405|2017-10-11 00:18:53.908405
NCT02165397|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-02-13|||July 2014||2014-07-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia|iNNOVATE Study: A Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study of Ibrutinib or Placebo in Combination With Rituximab in Subjects With Waldenström's Macroglobulinemia|Active, not recruiting||Phase 3|181|Actual|Pharmacyclics LLC.||3|||f||||t||||||||||2017-10-11 00:18:54.017131|2017-10-11 00:18:54.017131
NCT02165384|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-07-27|||January 2014||2014-01-01|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Hummingbird TTS Ear Tube Delivery Study|Continued Evaluation of the Preceptis Medical, Inc. Tympanostomy Ear Tube Introducer|Active, not recruiting||N/A|202|Actual|Preceptis Medical, Inc.||1|||f||||f||||||||||2017-10-11 00:18:54.226996|2017-10-11 00:18:54.226996
NCT02165371|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-12-08|||February 2014||2014-02-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Sinovuyo Caring Families Project: a Randomized Controlled Trial of a Parenting Programme|Sinovuyo Caring Families Project|Completed||N/A|296|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-11 00:18:54.317709|2017-10-11 00:18:54.317709
NCT02165358|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-11-10|||June 2014||2014-06-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I|Muscle MRI Study of Patients With Becker Muscular Dystrophy and Limb-girdle Muscular Dystrophy Type 2I|Completed||N/A|38|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-11 00:18:54.399942|2017-10-11 00:18:54.399942
NCT02165345|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-09-27|||July 16, 2014|Actual|2014-07-16|September 2017|2017-09-01|November 6, 2020|Anticipated|2020-11-06|November 6, 2020|Anticipated|2020-11-06||Interventional|||Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis|Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular-Course and Systemic Juvenile Idiopathic Arthritis|Recruiting||Phase 1|96|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:18:54.474585|2017-10-11 00:18:54.474585
NCT02165332|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-11-01|||July 2014||2014-07-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval|A Two-part, Single-center, Single-dose, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Four-way Crossover Study to Investigate the Effect of RO7033877 on the QT/QTc Interval in Healthy Subjects|Completed||Phase 1|64|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:18:54.787771|2017-10-11 00:18:54.787771
NCT02165319|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-06-13|||July 2014||2014-07-01|June 2014|2014-06-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|LateralCuff||The Cuff Pressure of an Endotracheal Tube After Supine-to-lateral Position Change|Comparison of the Cuff Pressure of an Endotracheal Tube After Supine-to-lateral Position Change: Barrel-shaped vs. Taper-shaped Cuff|Unknown status|Not yet recruiting|N/A|58|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:18:54.924327|2017-10-11 00:18:54.924327
NCT02165306|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-02-05|||June 2014||2014-06-01|February 2015|2015-02-01||||December 2014|Actual|2014-12-01||Interventional|||Enhancing Antiepileptic Drug Adherence||Completed||N/A|280|Actual|Qazvin University Of Medical Sciences||2|||f||||f||||||||||2017-10-11 00:18:55.050591|2017-10-11 00:18:55.050591
NCT02165293|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-11-01|||June 2014||2014-06-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers||Completed||Phase 1|32|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:18:55.146335|2017-10-11 00:18:55.146335
NCT02164383|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-06-14|||October 2014||2014-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Quit Smoking Study Using Smartphones|A Quit Smoking Study Using Smartphones|Completed||N/A|30|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 00:19:17.02774|2017-10-11 00:19:17.02774
NCT02165267|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-10-24|||August 2014||2014-08-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults|A Phase 1 Clinical Trial to Evaluate the Safety and Drug Levels of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01) Administered in Multiple Doses Intravenously and Subcutaneously in Different Dosing Schedules to Healthy, HIV-Uninfected Adults|Completed||Phase 1|88|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-11 00:18:55.343595|2017-10-11 00:18:55.343595
NCT02165254|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-08-28|||October 2014|Actual|2014-10-01|March 2016|2016-03-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||The Gentle Cardiac Rehabilitation Study|Development of A Tai-Chi Program To Overcome Barriers To Cardiac Rehabilitation|Completed||N/A|33|Actual|The Miriam Hospital||2|||f||||t||||||||||2017-10-11 00:18:55.487288|2017-10-11 00:18:55.487288
NCT02165241|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-03-13|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Observational|||Immunological Profile in Relation to Cardiac Geometry in Hypertension|Characterization of the Immunological Profile in Relation to Cardiac Geometry Variations in Hypertensive Patients|Completed||N/A|100|Actual|Neuromed IRCCS|||1||f||||||||||||||2017-10-11 00:18:55.610257|2017-10-11 00:18:55.610257
NCT02165228|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-13|||January 2010||2010-01-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|SICVDP||Strategies for Inflammation and Cardiovascular Disease (CVD) Prevention|A Stress Reduction Strategy for Decreasing CVD Risk Through C-reactive Protein Reduction|Completed||N/A|108|Actual|Montana State University||3|||f||||f||||||||||2017-10-11 00:18:55.674472|2017-10-11 00:18:55.674472
NCT02165215|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-03-09|||August 31, 2014|Actual|2014-08-31|March 2017|2017-03-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naïve to TNF Inhibitors|Recruiting||Phase 3|350|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:18:55.813172|2017-10-11 00:18:55.813172
NCT02165202|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-03-31|||October 2014||2014-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|TMC278LA||Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis|HPTN 076 - Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278 LA, for Pre-Exposure Prophylaxis (PrEP)|Active, not recruiting||Phase 2|132|Anticipated|PATH||2|||f||||t||||||||||2017-10-11 00:18:56.409237|2017-10-11 00:18:56.409237
NCT02165189|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-11-10|||August 2014||2014-08-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|GALAXY||An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant|A Phase 2 Open-Label Study in Patients With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant to Explore the Safety And Efficacy of Simeprevir and Sofosbuvir With and Without Ribavirin|Completed||Phase 2|46|Actual|Janssen Scientific Affairs, LLC||3|||f||||f||||||||||2017-10-11 00:18:56.548069|2017-10-11 00:18:56.548069
NCT02165176|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-10-20|||June 2014||2014-06-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis|Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis|Completed||Phase 1|24|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-10-11 00:18:56.67473|2017-10-11 00:18:56.67473
NCT02165163|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-05-21|||September 2013||2013-09-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Virtual Reality-Based Exercise in Cancer Patients|Virtual Reality-Based Exercise in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy|Completed||N/A|20|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 00:18:56.770908|2017-10-11 00:18:56.770908
NCT02165150|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-13|||August 2010||2010-08-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|SEB||Senior Elastic Band (SEB) on Institutional Elders|Development, Application , and Evaluation of the Senior Elastic Band (SEB) Exercise Program for Elderly Residents in Long-term Care Facilities|Completed||N/A|127|Actual|Kaohsiung Medical University||2|||f||||t||||||||||2017-10-11 00:18:56.84949|2017-10-11 00:18:56.84949
NCT02165137|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-08-30|||January 2010||2010-01-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Management of Major Trauma Patients at Aarau Trauma Center - Evaluation of Processes and Patient Outcome|Quality Control in the Management of Major Trauma Patients at Aarau Cantonal Hospital - Evaluation of Processes and Patient Outcome|Recruiting||N/A|1800|Anticipated|Kantonsspital Aarau|||1||f||||f||||||||||2017-10-11 00:18:56.956734|2017-10-11 00:18:56.956734
NCT02165124|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-09-07|||June 2014||2014-06-01|September 2016|2016-09-01|September 2016|Anticipated|2016-09-01|September 2016|Actual|2016-09-01||Interventional|BEAT Obesity||Bariatric Embolization of Arteries for the Treatment of Obesity|Bariatric Embolization of Arteries for the Treatment of Obesity|Active, not recruiting||Phase 1|20|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 00:18:57.543545|2017-10-11 00:18:57.543545
NCT02165111|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-10-28|2016-09-01||January 2015||2015-01-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||This trial was designed as a within-participant study where one of the 40 participants' hands was randomized to receive Onabotulinumtoxin A and the other to receive placebo. Each participant thus contributed two hands to the total number of units analyzed.|Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome|A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial Assessing the Therapeutic Efficacy of Botulinum Toxin In Treating Scleroderma-Associated Raynaud's Syndrome|Completed||Phase 3|40|Actual|Johns Hopkins University|Multi-level data prevents conclusions from being drawn from aggregate data alone. High degree of variability of the results suggests a heterogeneous group of scleroderma patients. Screening methods and no dose escalation may explain negative findings|2|||f||||t||||||||||2017-10-11 00:18:57.701304|2017-10-11 00:18:57.701304
NCT02165098|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-03-23|||June 2014||2014-06-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Cariprazine: Comparison of Slow- and Immediate-release Forms|A Single-Dose Study to Evaluate the Pharmacokinetic, Safety, Tolerability Profile and the Effects of Food on the Pharmacokinetics of Different Formulations of Cariprazine in Healthy Male Subjects|Completed||Phase 1|160|Actual|Gedeon Richter Plc.||5|||f||||f||||||||||2017-10-11 00:18:58.456191|2017-10-11 00:18:58.456191
NCT02165085|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-03-16|||June 2013||2013-06-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|MEDIC||Biomarkers in Vascular Ehlers-Danlos Syndrome|Identification of Plasmatic Biomarkers in Vascular Ehlers-Danlos Syndrome|Completed||N/A|211|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||t||||||Samples Without DNA|"     Serum, Plasma   "|||2017-10-11 00:18:58.565444|2017-10-11 00:18:58.565444
NCT02165072|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-06-21|2015-11-02||February 2014||2014-02-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury|Inferior Vena Cava Collapsibility Index in Patients With Acute Kidney Injury|Completed||N/A|30|Actual|Texas Tech University Health Sciences Center|This study is straightforward and involves measurements of the inferior vena cava. The study population was heterogeneous. Study measurements depend on the ability to identify the inferior vena cava with precision and make accurate measurements.||1||f||||f||||||||||2017-10-11 00:18:58.677067|2017-10-11 00:18:58.677067
NCT02165046|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-06-02|||February 2012||2012-02-01|June 2015|2015-06-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.|"Randomized, Single-dose, Three-way Crossover Study to Assess the Bioavailability of Using SYN006 HFA MDI (Budesonide/Procaterol 180/10mcg) vs Pulmicort pMDI (Budesonide 200 μg) and Meptin Air (Procaterol 10mcg) in Healthy Volunteer."|Completed||Phase 1|24|Actual|Intech Biopharm Ltd.||3|||f||||t||||||||||2017-10-11 00:18:59.13505|2017-10-11 00:18:59.13505
NCT02165033|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-06-02|||November 2012||2012-11-01|June 2015|2015-06-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||"Multiple-dose Pharmacokinetics Study of SYN006 HFA MDI Administered Orally to Healthy Volunteers"|"Multiple-dose Pharmacokinetics and Tolerability of SYN006 HFA MDI (Budesonide 180ug + Procaterol Hydrochloride 10ug/Dose HFA MDI) Administered Orally to Healthy Volunteers"|Completed||Phase 1|16|Actual|Intech Biopharm Ltd.||1|||f||||t||||||||||2017-10-11 00:18:59.253327|2017-10-11 00:18:59.253327
NCT02165020|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-10-04|||November 2010||2010-11-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|RPAH1||Hyaluronic Acid for Hypofractionated Prostate Radiotherapy|Hypofractionated Radiotherapy for Prostate Cancer (62 Gy in 20 Fractions of 3.1 Gy) With Hyaluronic Acid Injection|Active, not recruiting||Phase 2|36|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 00:18:59.401192|2017-10-11 00:18:59.401192
NCT02165007|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-10-19|||January 2015||2015-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Haploidentical Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease and Thalassemia Using CD34+ Positive Selected Grafts|HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH SICKLE CELL DISEASE AND THALASSEMIA USING CD34+ POSITIVE SELECTED GRAFTS|Recruiting||Phase 1|15|Anticipated|Children's Research Institute||1|||f||||t||||||||||2017-10-11 00:18:59.493874|2017-10-11 00:18:59.493874
NCT02164994|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-04-23|||April 2014||2014-04-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Observational|||Prospective Evaluation of the Long-term Effectiveness of the Femtosecond Laser-assisted Arcuate Incisions|Prospective Evaluation of the Long-term (18 Months) Effectiveness of the Femtosecond Laser-assisted Arcuate Incisions Following Cataract Surgery|Unknown status|Recruiting|N/A|100|Anticipated|Technolas Perfect Vision GmbH|||1||f||||f||||||||||2017-10-11 00:18:59.701328|2017-10-11 00:18:59.701328
NCT02164981|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-09-21|||May 2015||2015-05-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia|A Randomized Double-Blind, Placebo-Controlled, Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia|Recruiting||Phase 2|60|Anticipated|Massachusetts General Hospital||3|||f||||f||||||||||2017-10-11 00:18:59.847534|2017-10-11 00:18:59.847534
NCT02164968|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-12-21|||May 2014||2014-05-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01|2 Months|Observational [Patient Registry]|IP-ASTMA_2||Assessment of Respiratory Symptoms After Corticosteroid Treatment Period Using Impedance Pneumography|Assessment of Respiratory Symptoms After Corticosteroid Treatment Period Using Impedance Pneumography|Enrolling by invitation||N/A|75|Anticipated|Tampere University Hospital|||1||f||||f||||||||||2017-10-11 00:19:00.021207|2017-10-11 00:19:00.021207
NCT02164955|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-05-02|||June 26, 2014|Actual|2014-06-26|May 2017|2017-05-01|November 1, 2019|Anticipated|2019-11-01|November 1, 2019|Anticipated|2019-11-01|5 Years|Observational [Patient Registry]|||A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.|A Non-interventional Post Authorisation Registry of Patients Treated With Pomalidomide for Relapsed and Refractory Multiple Myeloma Who Have Received at Least Two Prior Treatment Regimens, Including Both Lenalidomide and Bortezomib, and Have Demonstrated Disease Progression on the Last Therapy|Recruiting||N/A|700|Anticipated|Celgene|||1||f||||f||||||||||2017-10-11 00:19:00.213719|2017-10-11 00:19:00.213719
NCT02164942|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-08-04|||June 2014||2014-06-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer|LCI-GU-BLA-SPEC-001: Expression of the Aurora Kinase Family and Chemoresistance in Muscle-Invasive Bladder Cancer|Terminated||N/A|6|Actual|Carolinas Healthcare System|||1|Futility|f||||t||||||||||2017-10-11 00:19:00.675151|2017-10-11 00:19:00.675151
NCT02163824|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-07-01||2016-06-30|May 2014||2014-05-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|Hawaii-1||Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation|A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation|Completed||Phase 3|380|Actual|Kala Pharmaceuticals, Inc.||4|||f||||f||||||||No||2017-10-11 00:19:24.453938|2017-10-11 00:19:24.453938
NCT02164903|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-05-24|||September 11, 2014|Actual|2014-09-11|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|January 25, 2017|Actual|2017-01-25||Observational|||LEONIDAS: Quality of Life Study in Chronic Myeloid Leukemia Patients|Mid to Long-term Quality of Life Effects Of imatiNIb Versus DASatinib in Chronic Myeloid Leukemia Patients (LEONIDAS)|Active, not recruiting||N/A|334|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto|||2||f||||f||||||||No||2017-10-11 00:19:05.21676|2017-10-11 00:19:05.21676
NCT02164890|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-07-07|||June 2014|Actual|2014-06-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|MI-K||Pharmacokinetics of Micafungin in Patients of Intensive Care Units|Pharmacokinetics of Micafungin in Patients of Intensive Care Units|Completed||Phase 4|60|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-10-11 00:19:05.456084|2017-10-11 00:19:05.456084
NCT02164877|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-13|||June 2014||2014-06-01|June 2014|2014-06-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Effect of Soluble Dietary Fiber on Bacterial Translocation in Crohn's Disease|A Randomized, Controlled Study of Soluble Dietary Fiber on Bacterial Translocation in Adults Patients With Crohn's Disease|Unknown status|Recruiting|Phase 2|20|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 00:19:05.528577|2017-10-11 00:19:05.528577
NCT02164864|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-06-28|||July 22, 2014|Actual|2014-07-22|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Interventional|||Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)|A Prospective Randomised, Open Label, Blinded Endpoint (PROBE) Study to Evaluate DUAL Antithrombotic Therapy With Dabigatran Etexilate (110mg and 150mg b.i.d.) Plus Clopidogrel or Ticagrelor vs. Triple Therapy Strategy With Warfarin (INR 2.0 - 3.0) Plus Clopidogrel or Ticagrelor and Aspirin in Patients With Non Valvular Atrial Fibrillation (NVAF) That Have Undergone a Percutaneous Coronary Intervention (PCI) With Stenting|Completed||Phase 3|2725|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:19:06.100859|2017-10-11 00:19:06.100859
NCT02164851|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-03-14|||January 2013||2013-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|NIS||Non-Invasive Shock: Differentiating Shock in the Emergency Department|Non-Invasive Shock: Differentiating Shock in the Emergency Department|Active, not recruiting||N/A|500|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||Samples Without DNA|"     50 mLs of whole blood will be collected at enrollment for biomarker analysis   "|||2017-10-11 00:19:08.397574|2017-10-11 00:19:08.397574
NCT02164838|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-06-20|||September 2014||2014-09-01|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors|A Phase 1 Study of the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib (INLYTA, IND# TBD) in Children With Recurrent or Refractory Solid Tumors|Active, not recruiting||Phase 1|51|Anticipated|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 00:19:08.465247|2017-10-11 00:19:08.465247
NCT02164825|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-02-04|||January 2014||2014-01-01|June 2014|2014-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Total Knee Arthroplasty Analgesia: Single-shot Femoral Nerve Block or Epidural?|Comparison Between Single-shot Femoral Nerve Block and Epidural Techniques for Total Knee Arthroplasty: a Randomized Controlled Trial|Completed||N/A|60|Actual|Centro Hospitalar do Tâmega e Sousa||2|||f||||t||||||||||2017-10-11 00:19:08.670678|2017-10-11 00:19:08.670678
NCT02164812|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2015-09-03|||July 2014||2014-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects|A Study to Determine the Concentration-Electrocardiographic Effects of Efavirenz in Healthy Subjects Enriched for CYP2B6 Polymorphisms|Completed||Phase 1|58|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:19:08.756189|2017-10-11 00:19:08.756189
NCT02164799|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2014-06-13|||November 2012||2012-11-01|June 2014|2014-06-01||||September 2013|Actual|2013-09-01||Observational|||The Epidemiology and Approach to Differentiating Etiologies of Shock in the Emergency Department|Establishing a Tool to Increase the Accuracy of Emergency Physicians Diagnosing Etiologies of Shock|Completed||N/A|2500|Actual|Beth Israel Deaconess Medical Center|||2||f||||f||||||||||2017-10-11 00:19:08.861195|2017-10-11 00:19:08.861195
NCT02164786|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-04-26|||June 2014||2014-06-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|||Metabolomics Dynamics Study for Severe Patient|Modeling Metabolomic Dynamics Based on Nuclear Magnetic Resonance and High Performance Liquid Chromatography for Severe Patient: a Cohort Study|Recruiting||N/A|600|Anticipated|Sichuan Academy of Medical Sciences|||1||f||||t||||||Samples Without DNA|"     plasma,urine   "|||2017-10-11 00:19:08.959656|2017-10-11 00:19:08.959656
NCT02164773|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-06-13|||October 2013||2013-10-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|||Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation.|Addition of Magnesium Sulfate to Caudal for Prevention of Emergence Agitation in Children|Unknown status|Recruiting|Phase 4|70|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:19:09.06757|2017-10-11 00:19:09.06757
NCT02164760|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-06-25|||June 2013||2013-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||The Safety of a Novel Acellular Dermal Template as Treatment for Burns and Scars|A Phase 1, Randomized, Multicentre Multinational Study to Evaluate the Safety and Feasibility of an Acellular Dermal Template Novomaix for the Treatment of Full Thickness Skin Defects in Human Patients.|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|Association of Dutch Burn Centres||2|||f||||f||||||||||2017-10-11 00:19:09.242506|2017-10-11 00:19:09.242506
NCT02164747|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-01-10|||January 2012||2012-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Observational|TMG91||Assessment of Teleconsulting in Nursing Homes to Avoid Transportations to the Emergency Units|Assessment of Teleconsulting in Nursing Homes to Avoid Transportations to the Emergency Units|Completed||N/A|341|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||||No||2017-10-11 00:19:09.36784|2017-10-11 00:19:09.36784
NCT02164734|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2017-06-27|||June 2014||2014-06-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome|Efficacy of Rescue Surfactant Delivery Via Endotracheal Intubation (INSURE Technique) Versus Laryngeal Mask Airway (LMA) for Respiratory Distress Syndrome (RDS) in Preterm Neonates|Recruiting||Phase 4|130|Anticipated|Albany Medical College||2|||f||||t||||||||||2017-10-11 00:19:09.473548|2017-10-11 00:19:09.473548
NCT02164721|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-06-29|||November 2014||2014-11-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MADIT-CHIC||Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy|Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy|Recruiting||N/A|30|Anticipated|University of Rochester||1|||f||||t||||||||||2017-10-11 00:19:09.597953|2017-10-11 00:19:09.597953
NCT02164708|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-13|||July 2012||2012-07-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Healthy Student Initiative|Healthy Student Initiative|Completed||N/A|71|Actual|York University||1|||f||||t||||||||||2017-10-11 00:19:09.741258|2017-10-11 00:19:09.741258
NCT02164695|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-11-14|||January 2015||2015-01-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|CAPRI||Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction|Cardioprotective Effects of Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention|Active, not recruiting||Phase 3|100|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:19:09.835099|2017-10-11 00:19:09.835099
NCT02164682|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-08-25|||June 2014||2014-06-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||The Effect of Caudal Block on the Postoperative Complications in Pediatric Patients After Hypospadias Repair||Completed||N/A|404|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 00:19:09.920839|2017-10-11 00:19:09.920839
NCT02164669|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-13|||May 2013||2013-05-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01|7 Days|Observational [Patient Registry]|||Exploration of Neuroimaging and Biochemical Prognostic Indicators for POCD|Exploration of Neuroimaging and Biochemical Prognostic Indicators for Post-operative Cognitive Dysfunction After Coronary Artery Bypass Graft|Unknown status|Recruiting|N/A|20|Anticipated|Xijing Hospital|||1||f||||t||||||Samples Without DNA|"     4ml venous blood will be collected, and serum IL-6， IL-8，TNF-α，NSE，S100β will be detected.   "|||2017-10-11 00:19:10.035656|2017-10-11 00:19:10.035656
NCT02164656|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-10-09|||April 2011||2011-04-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|MTS3||Mindfulness Training for Smokers Online Feasibility Study|Mindfulness Training for Smokers Online Feasibility Study|Completed||Phase 2|26|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 00:19:10.112215|2017-10-11 00:19:10.112215
NCT02164643|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-12-22|||June 2014||2014-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MEMENTOAmyGing||Longitudinal Study of Brain Amyloid imaGing in MEMENTO|Longitudinal Study of Brain Amyloid imaGing in MEMENTO|Recruiting||Phase 3|800|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 00:19:10.191832|2017-10-11 00:19:10.191832
NCT02164630|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-08-02|||September 2014||2014-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|ORION||Optimizing Resilience In Orofacial Pain and Nociception|Assessing the Efficacy of a Hope Intervention in Temporomandibular Disorder|Completed||N/A|36|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 00:19:10.420203|2017-10-11 00:19:10.420203
NCT02164617|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-06-13|||March 2014||2014-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|WSEB||Wheelchair-bound Senior Elastic Band (WSEB) Exercise Program for the Demented Seniors|Development and Evaluation of an Evidence-based Intervention Guideline of the Wheelchair-bound Senior Elastic Band (WSEB) Exercise Program for the Demented Seniors in Long-term Care Facilities|Completed||N/A|150|Actual|Kaohsiung Medical University||2|||f||||t||||||||||2017-10-11 00:19:10.545003|2017-10-11 00:19:10.545003
NCT02164604|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-06-13|||January 2011||2011-01-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease|Intravitreal Ranibizumab to Treat Retinopathy of Prematurity Stage 3 Plus Disease|Completed||N/A|6|Actual|Kantonsspital Aarau||1|||f||||f||||||||||2017-10-11 00:19:10.630917|2017-10-11 00:19:10.630917
NCT02164578|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-09-29|||April 2015||2015-04-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|MicroVasc-DIVA||Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Cardiovascular Disease|Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Low Dose Aspirin in Typ-2 Diabetic Patients With Cardiovascular Disease and Subclinical Inflammation|Recruiting||Phase 3|188|Anticipated|GWT-TUD GmbH||2|||f||||f||||||||||2017-10-11 00:19:10.778514|2017-10-11 00:19:10.778514
NCT02164565|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-08-13|||June 2014||2014-06-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||The Use of Tranexamic Acid (TXA) Intravenously, to Reduce Blood Loss in Proximal Femur Surgery|The Use of Tranexamic Acid (TXA) Intravenously, to Reduce Blood Loss in Proximal Femur Surgery|Withdrawn||Phase 4|0|Actual|HaEmek Medical Center, Israel||2||Enrollment difficulties|f||||t||||||||||2017-10-11 00:19:10.995609|2017-10-11 00:19:10.995609
NCT02163811|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-09-12|||July 1, 2014|Actual|2014-07-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|VETPALS||Self-management to Improve Function Following Amputation|Self-management to Improve Function Following Amputation|Recruiting||N/A|600|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:19:24.612325|2017-10-11 00:19:24.612325
NCT02164552|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-12|||January 2009||2009-01-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|CEOR-04-08||Vitamin D Status in Relation to Insulin Sensitivity Among Saudi Women With Polycystic Ovary Syndrome|Vitamin D Status in Relation to Insulin Sensitivity, Resistance and Inflammatory Response Among Saudi Women With Polycystic Ovary Syndrome|Unknown status|Recruiting|Phase 2|340|Anticipated|King Abdulaziz University|||2||f||||t||||||||||2017-10-11 00:19:11.087644|2017-10-11 00:19:11.087644
NCT02164526|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-06-13|||January 2013||2013-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|3 Years|Observational [Patient Registry]|||Registry for Pulmonary Hypertension Due to Left Heart Disease in China|National, Prospective, Multicenter,Observational Registry Study on Pulmonary Hypertension Due to Left Heart Disease in China|Recruiting||N/A|520|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t||||||||||2017-10-11 00:19:12.700451|2017-10-11 00:19:12.700451
NCT02164500|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-05-02|||October 2015||2015-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|JeRiCHO||JAK-inhibition in Recurrent Classical Hodgkin Lymphoma|A Phase II, Open-label, Prospective, Non-randomized, Multicenter Clinical Trial With the JAK-inhibitor Ruxolitinib in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma|Recruiting||Phase 2|37|Anticipated|University of Cologne||1|||f||||||||||||||2017-10-11 00:19:15.866919|2017-10-11 00:19:15.866919
NCT02164487|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2014-06-13|||March 2013||2013-03-01|June 2014|2014-06-01||||September 2014|Anticipated|2014-09-01||Observational|||Thiamin (Vitamin B1) Levels in Eating Disorder Adolescent Patients|Evaluating the B1 Status in Eating Disorder Female Adolescent Patients|Unknown status|Recruiting|N/A|60|Anticipated|Assaf-Harofeh Medical Center|||1||f||||||||||||||2017-10-11 00:19:15.952665|2017-10-11 00:19:15.952665
NCT02164474|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-03-15|||September 2014||2014-09-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Small Steps for Big Changes|Time-efficient High-intensity Interval Training Versus Moderate-intensity Continuous Aerobic Training for Promoting Exercise Adherence: A Randomized-controlled Trial|Completed||N/A|100|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:19:16.033008|2017-10-11 00:19:16.033008
NCT02164461|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-13|2016-06-17|||January 2015||2015-01-01|June 2016|2016-06-01||||December 2018|Anticipated|2018-12-01||Interventional|||ADXS11-001 High Dose HPV+ Cervical Cancer|PHASE 1-2 STUDY EVALUATING HIGH DOSE ADXS11-001 (1 x 10^10 CFU) TREATMENT IN WOMEN WITH HPV+ CARCINOMA OF THE CERVIX|Active, not recruiting||Phase 1/Phase 2|25|Anticipated|Advaxis, Inc.||1|||f||||f||||||||||2017-10-11 00:19:16.130169|2017-10-11 00:19:16.130169
NCT02164448|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-05-26|||June 2014||2014-06-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effects of Intraoperative Dexmedetomidine Infusion on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy||Completed||Phase 4|92|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:19:16.235255|2017-10-11 00:19:16.235255
NCT02164435|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-12|||January 2013||2013-01-01|June 2014|2014-06-01|October 2015|Anticipated|2015-10-01|July 2014|Anticipated|2014-07-01||Interventional|RDN||Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation|Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation|Unknown status|Recruiting|N/A|20|Anticipated|University of Adelaide||1|||f||||f||||||||||2017-10-11 00:19:16.315576|2017-10-11 00:19:16.315576
NCT02164422|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-06-20|||June 2014||2014-06-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Does Guanfacine Attenuate Stress-Induced Drinking?||Recruiting||Phase 2|150|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 00:19:16.40825|2017-10-11 00:19:16.40825
NCT02164409|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-01-23|||July 2012|Actual|2012-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|IIT H pylori||Changes Associated With H. Pylori and Gastric Carcinogenesis|Next-Generation Sequencing to Evaluate Transcriptomic Changes Associated With H. Pylori Infection and Gastric Cancer Carcinogenesis|Recruiting||N/A|50|Anticipated|Weill Medical College of Cornell University|||2||f||||f|f|f||||Samples With DNA|"     To examine RNA tranome of gastric cancer mucosa, in patients with H. pylori infection &     examine spectrum of disease associated with infection. We will also examine bacterial content     of samples to pinpoint specific H. pylori strain(s) & stomach microbial profile to correlate     with gastric mucosal tranome & predisposition of gastric cancer. We plan to take 2-3     additional biopsies from an area of stomach already being sampled. The biopsies will be used     for next-generation RNA & DNA sequencing & novel bioinformatics analyses. Examination of the     genetic impact of H. pylori infection in patients may expose genetic factors that influence     gastric cancer carcinogenesis & give deeper insight into molecular pathways that serve as     candidate biomarkers for gastric cancer carcinogenesis.   "|No||2017-10-11 00:19:16.548715|2017-10-11 00:19:16.548715
NCT02164396|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-10-05|2016-08-11||April 2013||2013-04-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All subjects that were randomized to a study treatment.|Impact of Soft Contact Lenses on Lid-Parallel Conjunctival Folds|Impact of Soft Contact Lenses on Lid-Parallel Conjunctival Folds|Completed||N/A|30|Actual|Johnson & Johnson Vision Care, Inc.||3|||f||||f||||||||||2017-10-11 00:19:16.633676|2017-10-11 00:19:16.633676
NCT02164370|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-10-14|||October 2013||2013-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Observational|||Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach|Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach|Completed||N/A|120|Actual|University of Washington|||3||f||||f||||||Samples Without DNA|"     VBGs   "|||2017-10-11 00:19:17.108329|2017-10-11 00:19:17.108329
NCT02164357|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-12-17|||September 2012||2012-09-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Observational|FUN-TPA||Efficacy and Security of an Endovascular Treatment as First Choice Procedure Compared With a Standard Intravenous Thrombolytic Therapy Treatment for Patients With Acute Ischemic Stroke Within 4.5 Hours After Onset|Efficacy and Security of an Endovascular Treatment as First Choice Procedure Compared With a Standard Intravenous Thrombolytic Therapy Treatment for Patients With Acute Ischemic Stroke Within 4.5 Hours After Onset: A Prospective Cohorts Study|Completed||N/A|124|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal|||3||f||||t||||||||||2017-10-11 00:19:17.176546|2017-10-11 00:19:17.176546
NCT02164344|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-12|||January 2013||2013-01-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|March 2014|Actual|2014-03-01||Interventional|PROBIO-HIV||Effects of Probiotics on Microbial Translocation and Immune Activation Markers in HIV-positive Patients on Combined Antiretroviral Therapy|Effects of Probiotics on Microbial Translocation and Immune Activation Markers in HIV-positive Patients on Combined Antiretroviral Therapy and Non-virological Study of the Effects of Therapy|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-11 00:19:17.266078|2017-10-11 00:19:17.266078
NCT02164331|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-07-16|||October 2013||2013-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Blood Pressure (BP) Visit Intensification Study|A Multimodal Quality Improvement Intervention Using the JNC Guidelines to Promote Control of Patients' BP in Federally Qualified Health Centers|Active, not recruiting||N/A|60|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 00:19:17.335008|2017-10-11 00:19:17.335008
NCT02164305|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-09-12|||May 2014||2014-05-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||The Effects of Exercise Training on Shoulder Neuromuscular Control|The Effects of Exercise Training on Shoulder Neuromuscular Control|Completed||N/A|42|Actual|University of Oregon||3|||f||||t||||||||||2017-10-11 00:19:18.324892|2017-10-11 00:19:18.324892
NCT02164292|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-12|||June 2011||2011-06-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||ALPPS: Safety, Feasibility and Efficacy at a Single Center|Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): Safety, Feasibility and Efficacy at a Single Center|Completed||N/A|30|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 00:19:18.451737|2017-10-11 00:19:18.451737
NCT02164279|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-01-11|||June 2013||2013-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|peeDIAB2||Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children|Identification and First Validation of Early Non-invasive Biomarkers of Diabetic Nephropathy in Type I Diabetic Children|Completed||N/A|140|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 00:19:18.580469|2017-10-11 00:19:18.580469
NCT02164266|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-06-13|||June 2014||2014-06-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477||Completed||Phase 1|40|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:19:18.686821|2017-10-11 00:19:18.686821
NCT02164253|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-03-08|||September 2013||2013-09-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SAFEFAIRALS||Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients|Feasibility and Safety Pilot Therapeutic Study of the Iron Chelator Deferiprone in Amyotrophic Lateral Sclerosis|Completed||Phase 2|23|Actual|University Hospital, Lille||1|||f||||f||||||||||2017-10-11 00:19:18.791511|2017-10-11 00:19:18.791511
NCT02164240|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-03-22|||July 2014||2014-07-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|December 2016|Actual|2016-12-01||Interventional|SURE||Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST|A Non-randomized, Open-label Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) Progressing After Prior Therapy With Tyrosine Kinase Inhibitors|Active, not recruiting||Phase 1|35|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:19:18.914656|2017-10-11 00:19:18.914656
NCT02164227|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-06-12|||March 2014||2014-03-01|June 2014|2014-06-01|April 2015|Anticipated|2015-04-01|July 2014|Anticipated|2014-07-01||Interventional|||Effective Use of Respiratory Patterns in the First Period of Labor in Control of Maternal Anxiety|EFFECTIVE USE OF RESPIRATORY PATTERNS IN THE FIRST PERIOD OF LABOR IN CONTROL OF MATERNAL ANXIETY: A CLINICAL TRIAL|Unknown status|Recruiting|N/A|30|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 00:19:19.021446|2017-10-11 00:19:19.021446
NCT02164214|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-09-09|||September 2011||2011-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?|DOES ETANERCEPT INFLUENCE TWEAK MODULATION OF INFLAMMATION DURING INFLAMMATORY RHEUMATISMS (PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS)?|Completed||Phase 3|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 00:19:19.140691|2017-10-11 00:19:19.140691
NCT02163798|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-08-19|||January 2005||2005-01-01|August 2014|2014-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Evaluation of Energy Expenditure and Cardiovascular Health Effects From Tai Chi and Walking Exercise|Evaluation of Energy Expenditure and Cardiovascular Health Effects From Tai Chi and Walking Exercise|Completed||N/A|374|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-11 00:19:24.73411|2017-10-11 00:19:24.73411
NCT02164201|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-07-27|||August 2014||2014-08-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery|Post Market Surveillance Study Evaluating the Operative Management of Anastomotic Bleeding by Means of an Adjunctive Application of BioFoam Surgical Matrix in Cardiovascular Surgery|Completed||N/A|75|Actual|CryoLife Europa|||1||f||||f||||||||||2017-10-11 00:19:19.241986|2017-10-11 00:19:19.241986
NCT02164188|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-08-09|||April 3, 2014|Actual|2014-04-03|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|Flourishing||The Flourishing Project: Evaluation of the Effectiveness of a Well-being Program|The Flourishing Project: Evaluation of the Effectiveness of a Well-being Program in the Personal and Relational Dimensions|Completed||N/A|120|Anticipated|Hospital Israelita Albert Einstein||2|||f||||t||||||||||2017-10-11 00:19:19.329733|2017-10-11 00:19:19.329733
NCT02164175|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-12-23|||May 2014||2014-05-01|December 2015|2015-12-01|December 2029|Anticipated|2029-12-01|December 2024|Anticipated|2024-12-01|5 Years|Observational [Patient Registry]|||Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis|Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis|Recruiting||N/A|300|Anticipated|Hemosphere, Inc.|||1||f||||f||||||||||2017-10-11 00:19:19.449272|2017-10-11 00:19:19.449272
NCT02164162|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-20|||June 2014||2014-06-01|June 2014|2014-06-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Efficacy of a Robotic-assisted Gait Training in Addition to a Conventional Physical Therapy in Parkinson's Disease|Interventional Double Blinded Randomized and Controlled Trial on the Efficacy of a Robotic-assisted Gait Training in Addition to a Conventional Physical Therapy in Parkinson's Disease|Unknown status|Recruiting|N/A|40|Anticipated|Habilita, Ospedale di Sarnico||2|||f||||t||||||||||2017-10-11 00:19:19.588409|2017-10-11 00:19:19.588409
NCT02164149|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-12|||May 2014||2014-05-01|June 2014|2014-06-01|November 2015|Anticipated|2015-11-01|November 2014|Anticipated|2014-11-01||Observational|ColonCT||Length of Tumour Feeding Artery After Colon Cancer Surgery|Length of Tumour Feeding Artery After Colon Cancer Surgery|Unknown status|Recruiting|N/A|65|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-11 00:19:19.713122|2017-10-11 00:19:19.713122
NCT02164136|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-10-18|||June 2014||2014-06-01|October 2016|2016-10-01|June 2023|Anticipated|2023-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients|Comparisons of Urinary and Sexual Function Protection and Long-term Outcomes Between Laparoscopy-assisted and Open Pelvic Autonomic Nerve Preservation Total Mesorectum Excision for Male Mid-low Rectal Cancer Patients: a Randomized Controlled Clinical Trial|Recruiting||N/A|172|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:19:19.842307|2017-10-11 00:19:19.842307
NCT02164123|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-03-05|||July 2014||2014-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Autonomic Effects of T4 Mobilization in Asymptomatic Subjects|Autonomic Effects of T4 Mobilization in Asymptomatic Subjects: Randomized Clinical Trial|Completed||N/A|86|Actual|Federal University of Health Science of Porto Alegre||3|||f||||t||||||||||2017-10-11 00:19:19.994094|2017-10-11 00:19:19.994094
NCT02164110|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2014-12-04|||May 2014||2014-05-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children|A Randomized, Single Blind, Multicenter, Therapeutic Confirmatory Study to Assess the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children|Completed||Phase 3|3632|Actual|EuBiologics Co.,Ltd||2|||f||||f||||||||||2017-10-11 00:19:20.145456|2017-10-11 00:19:20.145456
NCT02164097|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-07-29|||January 2015||2015-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||ODSH + ICE Chemotherapy in Pediatric Solid Tumors|"A Pilot Study to Evaluate the Safety and Preliminary Evidence of an Effect of ODSH (2-O, 3-O Desulfated Heparin) in Accelerating Platelet Recovery in Pediatric Patients With a Recurrent Solid Tumor Receiving ICE Chemotherapy"|Recruiting||Phase 1|6|Anticipated|New York Medical College||1|||f||||f||||||||||2017-10-11 00:19:20.266492|2017-10-11 00:19:20.266492
NCT02164084|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-04-02|||June 2014||2014-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris|A Phase 1, Single-center, Double-blind, Randomized, Cross-over, Pharmacokinetics, Safety and Tolerability Study of SB204 8% (NVN1000 Gel) and Vehicle Gel|Completed||Phase 1|18|Actual|Novan, Inc.||2|||f||||f||||||||||2017-10-11 00:19:20.390553|2017-10-11 00:19:20.390553
NCT02164071|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-03-30|||April 2012||2012-04-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|December 2013|Actual|2013-12-01||Observational|GAH||Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies|Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies|Completed||N/A|363|Actual|Celgene Corporation|||3||f||||t||||||||||2017-10-11 00:19:20.53081|2017-10-11 00:19:20.53081
NCT02164058|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-12-03|||January 2015||2015-01-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Interventional|TRIS||TandemHeart to Reduce Infarct Size (TRIS Trial)|A Randomized Controlled Multicenter Study on the Use of the TandemHeart to Reduce Infarct Size|Withdrawn||N/A|0|Actual|CardiacAssist, Inc.||2||No participants enrolled|f||||t||||||||||2017-10-11 00:19:20.71809|2017-10-11 00:19:20.71809
NCT02164045|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-07-25|||June 24, 2014|Actual|2014-06-24|July 2017|2017-07-01|July 25, 2014|Actual|2014-07-25|July 25, 2014|Actual|2014-07-25||Interventional|||Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529|Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529 From an Extended-Release Formulation of BMS-663068 in Healthy Subjects|Completed||Phase 1|38|Actual|ViiV Healthcare||2|||f||||f|t|f||||||||2017-10-11 00:19:20.859993|2017-10-11 00:19:20.859993
NCT02163018|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-07-09|||June 2014||2014-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|HAL-MPE1/0043||HAL-MPE1 First-in-human|A First-in-human, Randomized, Double Blind, Placebo Controlled, Single-centre Study to Assess the Safety and Tolerability of HAL-MPE1 in Patients With Peanut Allergy|Completed||Phase 1|17|Actual|HAL Allergy||2|||f||||t||||||||||2017-10-11 00:19:34.721451|2017-10-11 00:19:34.721451
NCT02164019|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-09-21|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur|A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of|Recruiting||N/A|114|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:19:21.304638|2017-10-11 00:19:21.304638
NCT02164006|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-06-28|||June 2014||2014-06-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients|A Multi-center Phase I/Ib Study Evaluating the Efficacy and Safety of Brentuximab Vedotin in Combination With TGR-1202, a Novel PI3K Delta Inhibitor, in Patients With Hodgkins Lymphoma|Active, not recruiting||Phase 1|14|Anticipated|TG Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 00:19:21.432575|2017-10-11 00:19:21.432575
NCT02163993|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-03-27||2016-08-12|July 2014||2014-07-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|August 2015|Actual|2015-08-01||Interventional|||A Study of LY2951742 in Participants With Migraine Headache|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine|Active, not recruiting||Phase 2|410|Actual|Eli Lilly and Company||5|||f||||t||||||||||2017-10-11 00:19:21.52436|2017-10-11 00:19:21.52436
NCT02163980|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-13|||May 2011||2011-05-01|June 2014|2014-06-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Dexmedetomidine on the Characteristics of High Volume/Low Concentration Ropivacaine in a Caudal Block in Pediatrics||Completed||N/A|80|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:19:21.674325|2017-10-11 00:19:21.674325
NCT02163967|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-06-13|||January 2013||2013-01-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effect of CES on Parasympathetic Tone|Effect of Cranial Electrical Stimulation (CES) on Autonomic Regulation|Completed||N/A|19|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 00:19:21.7565|2017-10-11 00:19:21.7565
NCT02163954|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-12|||January 2013||2013-01-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||ONSET and OFFSET of Ticagrelor in ESRD|Platelet Reactivity in Patients With End Stage Renal Disease Receiving Clopidogrel Compared With Ticagrelor|Completed||Phase 3|16|Actual|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-11 00:19:21.827704|2017-10-11 00:19:21.827704
NCT02163941|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-07-30|||May 2014||2014-05-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Meditation for Emotional Numbing in Post-Traumatic Stress Disorder|Meditation Training for Emotional Numbing in Post-traumatic Stress Disorder|Completed||Phase 1|20|Actual|Emory University||1|||f||||f||||||||||2017-10-11 00:19:21.920391|2017-10-11 00:19:21.920391
NCT02163928|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-01-24|||June 2014||2014-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2014|Actual|2014-10-01||Observational|||Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following Dietary Interventions|Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following Dietary Interventions|Active, not recruiting||N/A|30|Anticipated|Texas Tech University Health Sciences Center|||1||f||||f||||||||||2017-10-11 00:19:22.168649|2017-10-11 00:19:22.168649
NCT02163915|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-06-01|2016-03-04||June 2014||2014-06-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||Safety analysis set was defined as all participants who received at least one dose of study drug.|Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Multiple Rising Doses of TAK-137 in Adult Subjects With Attention-Deficit/Hyperactivity Disorder|Terminated||Phase 1|47|Actual|Takeda||6||To allow evaluation of emerging non-clinical data (see detailed description below)|f||||f||||||||||2017-10-11 00:19:22.296734|2017-10-11 00:19:22.296734
NCT02163902|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-09-19|||December 2013||2013-12-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101|A Multicenter, Double-blind, Nontreatment, Long Term Follow up Study of Subjects Who Completed ATX-101 (Deoxycholic Acid Injection) Clinical Trials ATX-101-11-22 or ATX-101-11-23 for the Reduction of Localized Subcutaneous Fat in the Submental Area|Completed||Phase 3|224|Actual|Kythera Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 00:19:23.829826|2017-10-11 00:19:23.829826
NCT02163889|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2015-09-25|||September 2014||2014-09-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|STAMP||Serial Therapeutic and Antifungal Monitoring Protocol|Serial Therapeutic and Antifungal Monitoring Protocol|Unknown status|Recruiting|N/A|60|Anticipated|T2 Biosystems|||1||f||||f||||||Samples With DNA|"     At each time point, three 4 ml whole blood specimens will be collected. One sample will be     tested, and the remaining samples will be available for use in investigating discrepant     T2Candida assay and blood culture results, or may be used for research purposes   "|||2017-10-11 00:19:23.9533|2017-10-11 00:19:23.9533
NCT02163876|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2016-05-31|||October 2014||2014-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury|A Single-Blind, Randomized, Parallel Arm, Phase II Proof-of-Concept Study of the Safety and Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Transplantation in Cervical Spinal Cord Injury|Terminated||Phase 2|31|Actual|StemCells, Inc.||2||Based on a business decision unrelated to any safety concerns.|f||||t||||||||||2017-10-11 00:19:24.054914|2017-10-11 00:19:24.054914
NCT02163863|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-16|||February 2010||2010-02-01|June 2014|2014-06-01|July 2014|Anticipated|2014-07-01|October 2012|Actual|2012-10-01||Interventional|Mimics||BioMimics 3D Stent Clinical Investigation: The Mimics Study|BioMimics 3D Stent Clinical Investigation: The Mimics Study|Unknown status|Active, not recruiting|N/A|86|Actual|Veryan Medical Ltd.||2|||f||||t||||||||||2017-10-11 00:19:24.172169|2017-10-11 00:19:24.172169
NCT02163850|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-04-29|||June 2015||2015-06-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|SALUS||Transcatheter Aortic Valve Replacement System Pivotal Trial|SALUS Trial TranScatheter Aortic Valve RepLacement System Pivotal Trial The Safety and Effectiveness of the Direct Flow Medical Tanscatheter Aortic Valve System|Recruiting||N/A|878|Anticipated|Direct Flow Medical, Inc.||2|||f||||t||||||||Undecided||2017-10-11 00:19:24.260257|2017-10-11 00:19:24.260257
NCT02163785|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-02-23|||June 2014||2014-06-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|APPRO||Abdominoperineal Extra-Elevators Rectal Resection for Cancer: Prone Position vs. Supine Position|Estudio A.P.PRO: Estrategia quirúrgica en la amputación Abdominoperineal cilíndrica Del Recto Por cáncer: posición de litotomía vs. Prono-navaja|Recruiting||N/A|320|Anticipated|Hospital Universitario La Fe||2|||f||||f||||||||||2017-10-11 00:19:24.840344|2017-10-11 00:19:24.840344
NCT02163772|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-12|||August 2011||2011-08-01|July 2013|2013-07-01||||July 2013|Actual|2013-07-01||Interventional|||Early Intracordal Hyaluronic Acid Injection During Spontaneous Reinnervation for Unilateral Recurrent Laryngeal Nerve Paralysis|Early Intracordal Hyaluronic Acid Injection During Spontaneous Reinnervation for Unilateral Recurrent Laryngeal Nerve Paralysis|Completed||N/A|29|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-11 00:19:25.165162|2017-10-11 00:19:25.165162
NCT02163759|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2017-03-09|||November 30, 2014|Actual|2014-11-30|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)||Recruiting||Phase 3|350|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:19:25.275023|2017-10-11 00:19:25.275023
NCT02163746|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-12|2014-06-13|||March 2014||2014-03-01|June 2014|2014-06-01||||February 2015|Anticipated|2015-02-01||Interventional|||Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing|A Prospective, Randomized, Controlled Clinical Trial Comparing the Efficacy Carbon Dioxide (CO2) Laser Excision Versus Surgical Deroofing in the Treatment of Hidradenitis Suppurativa|Unknown status|Recruiting|N/A|20|Anticipated|Henry Ford Health System||2|||f||||t||||||||||2017-10-11 00:19:25.778946|2017-10-11 00:19:25.778946
NCT02163733|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-14|2016-03-03||November 14, 2014|Actual|2014-11-14|September 2017|2017-09-01|January 4, 2018|Anticipated|2018-01-04|March 24, 2015|Actual|2015-03-24||Interventional|||Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer|An Open-label, Randomised, Phase I, Study to Determine the Effect of Food on the Pharmacokinetics of Single Oral Doses of AZD9291 in Patients With EGFRm Positive NSCLC Whose Disease Has Progressed on an EGFR TKI|Active, not recruiting||Phase 1|38|Actual|AstraZeneca|At end of Part B, the CAP allowed patients to continue receiving AZD9291 if still deriving clinical benefit. No clinical data was databased during the CAP; thus AE data is presented to end of Part B only.|2|||f||||f||||||||||2017-10-11 00:19:25.896821|2017-10-11 00:19:25.896821
NCT02163720|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-08-23|||July 10, 2014|Actual|2014-07-10|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01|12 Months|Observational [Patient Registry]|||Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)|Non Interventional Study Dealing With the Use of Trabectedin (Yondelis®)-Pegylated Liposomal Doxorubicin (Caelyx®) in Patient With Platinum-sensitive Relapse|Active, not recruiting||N/A|101|Actual|ARCAGY/ GINECO GROUP|||1||f||||f||||||||||2017-10-11 00:19:26.9783|2017-10-11 00:19:26.9783
NCT02163707|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-04-19|||June 2014||2014-06-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||UW Psilocybin Pharmacokinetics Study|Pharmacokinetics of Psilocybin in Normal Adult Volunteers|Completed||Phase 1|12|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 00:19:27.151368|2017-10-11 00:19:27.151368
NCT02163694|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-08-31|||July 30, 2014||2014-07-30|August 2017|2017-08-01|February 28, 2019|Anticipated|2019-02-28|May 31, 2018|Anticipated|2018-05-31||Interventional|||A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer|A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2 Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer|Recruiting||Phase 3|500|Anticipated|AbbVie||2|||f||||t||||||||||2017-10-11 00:19:27.27598|2017-10-11 00:19:27.27598
NCT02163681|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-03-02|||January 2011||2011-01-01|March 2016|2016-03-01||||June 2017|Anticipated|2017-06-01||Interventional|||MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Children||Recruiting||N/A|77|Anticipated|University of Virginia||1|||f||||||||||||||2017-10-11 00:19:28.126747|2017-10-11 00:19:28.126747
NCT02163668|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-13|||September 2009||2009-09-01|June 2014|2014-06-01|April 2012|Actual|2012-04-01|June 2010|Actual|2010-06-01||Interventional|||Effects of Yoga on Bone Metabolism in Premenopausal Women|Effects of an 8-month Yoga Intervention on Bone Metabolism in Healthy Middle-aged Premenopausal Women: A Randomized Controlled Study|Completed||N/A|47|Actual|University of Oklahoma||2|||f||||f||||||||||2017-10-11 00:19:28.212189|2017-10-11 00:19:28.212189
NCT02163655|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-08-24|||March 2014||2014-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|DIUPRE||Diuretics for Postpartum High Blood Pressure in Preeclampsia|Effectiveness of Postpartum Furosemide on Recovery Blood Pressure in Puerperal Women With Severe Preeclampsia: a Randomized Clinical Trial|Completed||Phase 4|120|Anticipated|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||f||||||||||2017-10-11 00:19:28.411286|2017-10-11 00:19:28.411286
NCT02163642|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-09-07|||April 2014||2014-04-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Role of Innate Immunity in Non-Cystic Fibrosis Bronchiectasis|Bronchial Infections in Patients With Non-Cystic Fibrosis (CF) Bronchiectasis; Role of Innate Lung Defense Mechanisms and Utility of an Electronic Nose for Its Diagnosis|Recruiting||N/A|50|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||Samples With DNA|"     -  Serum samples        -  Sputum samples and cultures   "|||2017-10-11 00:19:28.534545|2017-10-11 00:19:28.534545
NCT02163629|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-09-21|||April 2015||2015-04-01|September 2015|2015-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|QUIET||Impact of Stress Management Training After Cardiac Transplantation|Impact of Stress Management Training on Quality of Life and Cardiac Post-transplantation Complications in a Controlled Multicentric Comparative Study.|Recruiting||Phase 3|60|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 00:19:28.650037|2017-10-11 00:19:28.650037
NCT02163616|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-04-20|||September 2015|Actual|2015-09-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study|Treatment of Postpartum Hemorrhage With Misoprostol: Who do we Treat? Who Will Develop Fever?|Completed||Phase 3|635|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-10-11 00:19:28.774009|2017-10-11 00:19:28.774009
NCT02163603|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-03-18|||September 2014||2014-09-01|March 2016|2016-03-01||||December 2024|Anticipated|2024-12-01||Observational|||A Trial on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip|A Multi-center Study on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip|Not yet recruiting||N/A|2|Anticipated|Guangzhou Women and Children's Medical Center|||1||f||||||||||||||2017-10-11 00:19:28.855803|2017-10-11 00:19:28.855803
NCT02163590|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-03-05|||March 2014||2014-03-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Immediate Effects of Different Rates of Thoracic Mobilization on Pressure Pain Thresholds in Asymptomatic Individuals|A Preliminary Investigation Into the Immediate Effects of Different Rates of Thoracic Mobilization on Pressure Pain Thresholds in Asymptomatic Individuals|Completed||N/A|20|Actual|Federal University of Health Science of Porto Alegre||3|||f||||t||||||||||2017-10-11 00:19:28.935797|2017-10-11 00:19:28.935797
NCT02163577|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-07-14||2017-07-14|June 30, 2014|Actual|2014-06-30|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 16, 2016|Actual|2016-06-16||Interventional|||Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)|A Randomized, Open-Label, Dose Finding, Phase 2 Study to Assess the Pharmacodynamics and Safety of the Anti-FGF23 Antibody, KRN23, in Pediatric Patients With X-linked Hypophosphatemia (XLH)|Active, not recruiting||Phase 2|50|Anticipated|Ultragenyx Pharmaceutical Inc||2|||f||||t||||||||||2017-10-11 00:19:29.063064|2017-10-11 00:19:29.063064
NCT02163564|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-01-28|||April 2012||2012-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Development of an Insomnia Treatment for Depressed Adolescents|Development of an Insomnia Treatment for Depressed Adolescents|Completed||N/A|28|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 00:19:29.196328|2017-10-11 00:19:29.196328
NCT02163551|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-12-02|||June 2014||2014-06-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Respiratory Event-Related Potentials in Patients With Spinal Cord Injury|Respiratory Event-Related Potentials in Patients With Spinal Cord Injury: An Evaluation of Somatosensory Afferents|Recruiting||N/A|40|Anticipated|University of North Carolina, Charlotte|||2||f||||t||||||||||2017-10-11 00:19:29.283209|2017-10-11 00:19:29.283209
NCT02163525|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-08-08|||June 2014||2014-06-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Post Market TRUST - U.S.A. Study|The TRUST (Treatment Results of Uterine Sparing Technologies) U.S.A. Study|Recruiting||N/A|300|Anticipated|Acessa Health, Inc.||2|||f||||t||||||||||2017-10-11 00:19:29.494538|2017-10-11 00:19:29.494538
NCT02163512|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-16|||March 12, 2014|Actual|2014-03-12|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|ALB-BET||Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites|Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites|Recruiting||N/A|46|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal|||2||f||||t||||||||||2017-10-11 00:19:29.684166|2017-10-11 00:19:29.684166
NCT02163499|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-02-27|||June 2014||2014-06-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months|Multicenter, Multi-Dose, Open-Label Maintenance of Long-Term Safety and Efficacy of Sodium Zirconium Cyclosilicate (ZS) in Hyperkalemia|Completed||Phase 3|751|Actual|ZS Pharma, Inc.||1|||f||||f||||||||No||2017-10-11 00:19:29.777938|2017-10-11 00:19:29.777938
NCT02163473|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-10-12|||January 2013||2013-01-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock|Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock|Completed||N/A|63|Actual|University of Florida|||2||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 00:19:30.087358|2017-10-11 00:19:30.087358
NCT02163460|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-11|||May 2012||2012-05-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|||Repair of Large Incisional Hernias - To Drain or Not to Drain Randomised Clinical Trial|Comparative Study Between the Use of Tubular Drains in Closed Suction System and the Use of Progressive Tension Sutures in Prevention of Infection and Seromas After Surgical Repair of Large Incisional Hernias|Completed||Phase 2|42|Actual|Universidade Estadual do Oeste do Paraná||2|||f||||t||||||||||2017-10-11 00:19:30.180037|2017-10-11 00:19:30.180037
NCT02163447|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-04-02|||June 2014||2014-06-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PROMOTE-BC1||Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants|Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants (PROMOTE Birth Cohort 1)|Active, not recruiting||Phase 3|300|Actual|University of California, San Francisco||5|||f||||f||||||||||2017-10-11 00:19:30.285342|2017-10-11 00:19:30.285342
NCT02163434|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-08-02|||June 2014||2014-06-01|August 2015|2015-08-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum|Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum|Recruiting||Phase 3|80|Anticipated|University at Buffalo||2|||f||||t||||||||||2017-10-11 00:19:30.442801|2017-10-11 00:19:30.442801
NCT02163031|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-07-24|||June 2014||2014-06-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Left vs. Right Radial Approach for Routine Catheterization of Heart Transplant Patients|RADIAL 2 Heart Transplant Study: Left vs. Right Radial Approach Randomized Comparison for Routine Catheterization of Heart Transplant Patients|Completed||N/A|50|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 00:19:34.606992|2017-10-11 00:19:34.606992
NCT02163421|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-12-07|2016-01-14||June 2014||2014-06-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional||Safety analysis set included all randomized participants who received study drug.|Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration|A Phase 1, Open Label, Randomized, Parallel Group Study to Assess the Absolute Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration|Completed||Phase 1|48|Actual|Takeda||4|||f||||f||||||||||2017-10-11 00:19:30.614287|2017-10-11 00:19:30.614287
NCT02163408|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-07-20|||June 2014||2014-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery|3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery|Recruiting||N/A|140|Anticipated|Cedars-Sinai Medical Center|||2||f||||f||||||||||2017-10-11 00:19:31.310236|2017-10-11 00:19:31.310236
NCT02163395|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-05-29|2015-05-18||October 2011||2011-10-01|May 2017|2017-05-01|September 2022|Anticipated|2022-09-01|September 2013|Actual|2013-09-01||Interventional|||Performance Evaluation of FullCeram Implants in Single Tooth Gaps|A Prospective Open Label Single Arm Study to Evaluate the Performance of Straumann Monotype FullCeram (Zirconium Dioxide) Implants in Single Tooth Gaps in the Maxilla and Mandible|Active, not recruiting||N/A|44|Actual|Institut Straumann AG||1|||f||||f||||||||No||2017-10-11 00:19:31.406963|2017-10-11 00:19:31.406963
NCT02163382|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-11-20|||November 2011||2011-11-01|November 2015|2015-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|NAVANI||Impact of NAVA (Neurally Adjusted Ventilatory Assist) on Ventilatory Demand During Pediatric Non-Invasive Ventilation|Impact of NAVA (Neurally Adjusted Ventilatory Assist) on Ventilatory Demand During Pediatric Non-Invasive Ventilation|Completed||N/A|15|Actual|St. Justine's Hospital||1|||f||||f||||||||||2017-10-11 00:19:31.680876|2017-10-11 00:19:31.680876
NCT02163369|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-02-03|||July 2014||2014-07-01|February 2015|2015-02-01||||June 2015|Anticipated|2015-06-01||Interventional|||The Use of Aromatherapy for Symptom Management|The Use of Aromatherapy for Symptom Management|Unknown status|Recruiting|N/A|40|Anticipated|Central DuPage Hospital||1|||f||||f||||||||||2017-10-11 00:19:31.930534|2017-10-11 00:19:31.930534
NCT02163356|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-05-22|||May 2014||2014-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|SPOC2013-001||Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma|Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb (LXS) Oral Powder Plus Ketoconazole Plus Vincristine in Patients With Recurrent or Resistant Neuroblastoma (IND #68,254)|Recruiting||Phase 1|42|Anticipated|South Plains Oncology Consortium||1|||f||||t||||||||Undecided||2017-10-11 00:19:32.026865|2017-10-11 00:19:32.026865
NCT02163343|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-05-08|||June 2014||2014-06-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|||Serum Metal Ion Levels in Patients Who Underwent Cathcart/Corail Hemiarthroplasty for Fractured Neck of Femur|Serum Metal Ion Levels in Patients Who Underwent Cathcart/Corail Hemiarthroplasty for Fractured Neck of Femur|Unknown status|Recruiting|N/A|100|Anticipated|Royal Berkshire NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 00:19:32.143658|2017-10-11 00:19:32.143658
NCT02163330|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2017-04-12|||June 2014||2014-06-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Normal Pressure Hydrocephalus Treatment by Acetazolamide||Terminated||Phase 3|2|Actual|Rabin Medical Center||2||difficulty in recruiting participants to the study|f||||f||||||||||2017-10-11 00:19:32.221682|2017-10-11 00:19:32.221682
NCT02163317|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-06-07|||February 3, 2016|Actual|2016-02-03|June 2017|2017-06-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Interventional|||Magnetic Resonance Guided Focal Stereotactic Radiosurgery in Treating Patients With Low- or Intermediate-Risk Localized Prostate Cancer|Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer|Recruiting||N/A|12|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f|f|||||2017-10-11 00:19:32.302426|2017-10-11 00:19:32.302426
NCT02163304|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-01-07|||August 2015||2015-08-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|Sweety||Effects of Images Following Beverage Ingestion on Brain Activation|Effects of Images Following Beverage Ingestion on Brain Activation|Withdrawn||N/A|0|Actual|Pennington Biomedical Research Center||3|||f||||f||||||||||2017-10-11 00:19:32.428539|2017-10-11 00:19:32.428539
NCT02163291|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2014-06-11|||December 2013||2013-12-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer|Phase II Study of Paclitaxel Liposome Plus S-1 as Neoadjuvant Chemotherapy for Advanced Gastric Cancer|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 00:19:32.517334|2017-10-11 00:19:32.517334
NCT02163278|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-03-25|||June 2014||2014-06-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects|A Double-blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DBPR108 in Healthy Male Subjects|Completed||Phase 1|32|Actual|National Health Research Institutes, Taiwan||2|||f||||f||||||||||2017-10-11 00:19:32.625827|2017-10-11 00:19:32.625827
NCT02163265|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-05-08|||July 2014||2014-07-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Surgical Treatments of Thoracic Deformation on Cardiopulmonary Functions|Impact of Surgical Treatments of Thoracic Deformation on Cardiopulmonary Functions|Active, not recruiting||N/A|40|Anticipated|Medical University Innsbruck||1|||f||||f||||||||No||2017-10-11 00:19:32.720161|2017-10-11 00:19:32.720161
NCT02163252|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-02-18|||February 2014||2014-02-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Using a State-wide Initiative to Disseminate Effective Behavioral Weight Loss Strategies: Study 5|Does Early Intervention Improve Weight Loss Outcomes Among Individuals Enrolled in an Internet-based Weight Loss Program?|Completed||N/A|110|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 00:19:32.798353|2017-10-11 00:19:32.798353
NCT02163239|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-09-25|||March 2015||2015-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Post Market Study for FloShield 10mm Reusable Cannula and Blunt Obturator and Robotic FloShield|Post Market Study: Use of the Reusable FloShield 10mm Endoscopic Cannula and Blunt Obturator and the Robotic FloShield System During Robot-assisted Laparoscopic Single-Site Surgery. A Multicenter Historical Control Comparison|Terminated||N/A|20|Actual|Minimally Invasive Devices, Inc.|||1|Not meeting primary objective of the study|f||||f||||||||||2017-10-11 00:19:32.999061|2017-10-11 00:19:32.999061
NCT02163226|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-09-21|||August 2014|Actual|2014-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms|A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms|Recruiting||Phase 3|300|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 00:19:33.112364|2017-10-11 00:19:33.112364
NCT02163213|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-03-17|||June 2014||2014-06-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D|An Open-Label Study Evaluating the Impact of Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Twice Daily on Nutritional Status in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|Active, not recruiting||N/A|15|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:19:33.234971|2017-10-11 00:19:33.234971
NCT02163200|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-03-28|||June 2014||2014-06-01|March 2016|2016-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01|4 Months|Observational [Patient Registry]|||Changes of Pressure on Soft Tissue Before and After Total Hip Replacement to Prevent Bedsores|Changes of Pressure on Soft Tissue Before and After Total Hip Replacement to Prevent Bedsores|Withdrawn||N/A|0|Actual|Assuta Medical Center|||1|due to technical issues|f||||t||||||||||2017-10-11 00:19:33.344812|2017-10-11 00:19:33.344812
NCT02163187|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-01-05|||June 2014||2014-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation|Randomized Crossover Study of the Efficacy of Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation|Completed||Phase 2/Phase 3|4|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:19:33.413644|2017-10-11 00:19:33.413644
NCT02163174|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2014-06-12|||May 2011||2011-05-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Pentoxifylline and Late Onset Sepsis in Preterm Infants|Pentoxifylline Therapy of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial.|Completed||Phase 3|120|Actual|Mansoura University||2|||f||||f||||||||||2017-10-11 00:19:33.547251|2017-10-11 00:19:33.547251
NCT02163161|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-08-15|||June 2014||2014-06-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects|A Phase 1, Open Label, Single Dose 3 Way Crossover Study to Evaluate the Bioavailability of a Solid Dose Formulation of PF 04965842 Relative to a Suspension Formulation Under Fasting Conditions and the Effect of Food on the Bioavailability of the Solid Dosage Formulation of Pf 04965842 in Healthy Subjects|Completed||Phase 1|12|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:19:33.688922|2017-10-11 00:19:33.688922
NCT02163148|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-05-26|||May 2014||2014-05-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Predictors of Exposure Success in Public Speaking Anxiety|Predictors of Exposure Success in Public Speaking Anxiety|Completed||N/A|24|Actual|University of California, San Diego|||1||f||||f||||||||||2017-10-11 00:19:33.807825|2017-10-11 00:19:33.807825
NCT02163122|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-09-08|||January 2015||2015-01-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)|A Pilot Study to Compare Responses to Cat Allergen Exposure Using the Environmental Exposure Chamber (EEC) and Nasal Allergen Challenge (NAC)|Completed||Early Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 00:19:33.897627|2017-10-11 00:19:33.897627
NCT02163109|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-05-12|||September 2015||2015-09-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Oxygen Consumption in Critical Illness|Measurement of Oxygen Consumption in Critical Illness Using Optical Gas Analysis|Recruiting||N/A|30|Anticipated|University of Oxford|||1||f||||f||||||||||2017-10-11 00:19:34.011571|2017-10-11 00:19:34.011571
NCT02163096|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-01-07|||June 2014||2014-06-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma||Completed||N/A|23|Actual|University of Louisville|||2||f||||f||||||||||2017-10-11 00:19:34.134308|2017-10-11 00:19:34.134308
NCT02163083|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-04-19|||July 2014||2014-07-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Detection of Lymphnodes Using ICG During RARP|Detection of Lymph Nodes by Means of Intraoperative Fluorescence Lymphography Using Indocyanine Green (ICG) During the Radical Robot-assisted Prostatectomy|Active, not recruiting||N/A|120|Anticipated|St. Antonius Hospital Gronau||2|||f||||f||||||||No||2017-10-11 00:19:34.219661|2017-10-11 00:19:34.219661
NCT02163070|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-01-08|||September 2013||2013-09-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|EVEWD||Effect of Vitamin E Fortified Whey Drink on Nutritional, Inflammatory and Oxidative Markers in Hemodialysis Patients|Effect of Vitamin E Fortified Whey Drink on Nutritional Status, Inflammatory Markers and Oxidative Stress in Hemodialysis Patients|Completed||Phase 2|92|Actual|Shiraz University of Medical Sciences||4|||f||||t||||||||||2017-10-11 00:19:34.313823|2017-10-11 00:19:34.313823
NCT02163057|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-09-11|||June 2014||2014-06-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|January 2017|Actual|2017-01-01||Interventional|||Study of HPV Specific Immunotherapy in Patients With HPV Associated Head and Neck Squamous Cell Carcinoma|Prospective Study of HPV Specific Immunotherapy in Patients With HPV Associated Head and Neck Squamous Cell Carcinoma (HNSCCa)|Active, not recruiting||Phase 1/Phase 2|22|Actual|Inovio Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:19:34.412003|2017-10-11 00:19:34.412003
NCT02163044|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-03-06|||September 2014||2014-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|HPLS||The Hellenic Postprandial Lipemia Study (HPLS)|A Study to Assess the Consequences of Postprandial Lipemia in CRP as Inflammatory Marker in High-risk Adults, to Investigate Whether Hypolipidemic, Hypoglycemic or Antihypertensive Medication May Lessen the Exaggerated Postprandial Lipemia and Evaluate the Influence of Gene Polymorphisms Involved in Lipid and Glucose Metabolism on Postprandial Lipemia and Cardiovascular Outcomes.|Recruiting||N/A|1200|Anticipated|Hellenic College of Treatment of Atherosclerosis|||1||f||||f||||||||No||2017-10-11 00:19:34.508868|2017-10-11 00:19:34.508868
NCT02163005|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-09-27|||December 2016||2016-12-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography|Gadolinium Enhanced Dual-Energy Computed Tomography: A Feasibility Study to Assess Image Quality and Diagnostic Confidence|Not yet recruiting||Phase 4|50|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:19:34.819454|2017-10-11 00:19:34.819454
NCT02162992|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-08-10|||April 2014||2014-04-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Observational|||Systemic Lupus Erythematous and Heart Conduction Disorders|Repolarization Disorders and Heart Conduction Disorders in Patients With Systemic Lupus Erythematous|Unknown status|Recruiting|N/A|86|Anticipated|Germans Trias i Pujol Hospital|||2||f||||f||||||||||2017-10-11 00:19:34.92205|2017-10-11 00:19:34.92205
NCT02162966|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-03-31|||May 2014||2014-05-01|March 2015|2015-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Safety and Efficacy Study of High Dose Colistin|Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial|Unknown status|Recruiting|Phase 4|330|Anticipated|King Saud Medical City||2|||f||||f||||||||||2017-10-11 00:19:35.279056|2017-10-11 00:19:35.279056
NCT02162953|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-03-21|||February 2014||2014-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases.|Development of Induced Pluripotent Stem Cells From Patients With Best Disease and Other Inherited Retinal Degenerative Diseases.|Recruiting||N/A|100|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Whole blood (10 ml) for DNA/RNA extraction      Dermal Tissue from Skin punch biopsy   "|Undecided|All samples will be de-identified and given a code while stored and used in research. IPD available to other researchers might include age, gender, genetic mutation and diagnosis. No other information will be shared.|2017-10-11 00:19:35.417591|2017-10-11 00:19:35.417591
NCT02162940|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-12|||April 2012||2012-04-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01|6 Months|Observational [Patient Registry]|||Statin and Epidural Steroid Injection|Effect of Statin Use on Low Back Pain Steroid Injections.|Completed||Early Phase 1|300|Actual|Adnan Menderes University|||2||f||||t||||||||||2017-10-11 00:19:35.518847|2017-10-11 00:19:35.518847
NCT02162927|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-03-02|||August 2014||2014-08-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Dietary Nitrate Supplementation and Crossfit Athletes|The Effects of Six-day Dietary Nitrate Supplementation on Strength and Endurance Measurements in Male CrossFit Athletes|Completed||N/A|12|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 00:19:35.605565|2017-10-11 00:19:35.605565
NCT02162914|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-09-22|||March 2014||2014-03-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|REACHIN||Regorafenib Versus Placebo to Treat Cholangiocarcinoma|REGORAFENIB AFTER FAILURE OF GEMCITABINE AND PLATINUM-BASED CHEMOTHERAPY FOR LOCALLY ADVANCED (NON RESECTABLE) AND METASTATIC INTRA-HEPATIC OR HILAR CHOLANGIOCARCINOMA: A Randomized Double-blinded Phase II Trial.|Unknown status|Recruiting|Phase 2|66|Anticipated|Erasme University Hospital||2|||f||||f||||||||||2017-10-11 00:19:35.695134|2017-10-11 00:19:35.695134
NCT02162901|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-10-19|||March 2014||2014-03-01|October 2015|2015-10-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Interventional|DiaBEAT-it||The Reach and Effectiveness of Technology-enhanced Diabetes Prevention Programs|The Reach and Effectiveness of Technology-enhanced Diabetes Prevention Programs|Unknown status|Active, not recruiting|N/A|600|Anticipated|Virginia Polytechnic Institute and State University||5|||f||||t||||||||||2017-10-11 00:19:35.834378|2017-10-11 00:19:35.834378
NCT02162888|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-11-05|||November 2013||2013-11-01|June 2014|2014-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients||Completed||Phase 1|81|Actual|Eagle Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 00:19:35.92008|2017-10-11 00:19:35.92008
NCT02162875|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-02-09|||March 2011||2011-03-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SCORE_PAR||Schistosoma Mansoni in Mwanza Region, Tanzania|Parasitologic Impact of Different Mass Drug Administration Strategies Against Schistosoma Mansoni in Endemic Areas of Mwanza Region, Tanzania, Where Prevalence is 25% or Above|Completed||N/A|37500|Anticipated|DBL -Institute for Health Research and Development||6|||f||||f||||||||No||2017-10-11 00:19:36.193888|2017-10-11 00:19:36.193888
NCT02162862|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-08-14|2017-06-28||July 2013|Actual|2013-07-01|June 2017|2017-06-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease|Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness|Completed||Phase 4|99|Actual|University of Pittsburgh|There were no limitations to this study.|3|||f||||t||||||||||2017-10-11 00:19:36.285777|2017-10-11 00:19:36.285777
NCT02162849|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-09-14|||December 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Reward Sensitivity and Pharmacotherapy for Smoking Cessation|The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity|Recruiting||Phase 4|170|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 00:19:36.66051|2017-10-11 00:19:36.66051
NCT02162836|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-06-23|||June 27, 2014|Actual|2014-06-27|June 2017|2017-06-01|March 14, 2019|Anticipated|2019-03-14|September 17, 2018|Anticipated|2018-09-17||Interventional|||A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer|A Phase 1 Study of Androgen Receptor (AR) Antagonist JNJ-56021927 in Subjects With Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1|6|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||f||||||||2017-10-11 00:19:36.76614|2017-10-11 00:19:36.76614
NCT02162823|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-08-30|||May 2007||2007-05-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01|5 Years|Observational [Patient Registry]|SPP||Clinical Trial of Pancreatic Cancer in Stockholm.|Prospective Populationbased Study on Pancreatic Cancer in Stockholm- Mutation Profiling Characteristics, Biobanking and Risk Factors.|Completed||N/A|600|Actual|Karolinska University Hospital|||1||f||||f||||||Samples With DNA|"     Germline DNA and tumour DNA (PDAC patients). Saliva and urine (DNA).   "|||2017-10-11 00:19:36.874416|2017-10-11 00:19:36.874416
NCT02162810|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-08-30|||May 2014||2014-05-01|August 2016|2016-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Effect of Steroids on Post-Operative Complications Following Proximal Hypospadias Repair|Effect of Steroids on Post-Operative Complications Following Proximal Hypospadias Repair|Recruiting||N/A|200|Anticipated|Children's Hospital of Pittsburgh||2|||f||||f||||||||||2017-10-11 00:19:36.973597|2017-10-11 00:19:36.973597
NCT02162797|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-06-12|||October 2013||2013-10-01|June 2014|2014-06-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Zinc Supplementation Effect on Immune Recovery in HIV Patients|EFFECT OF ZINC SUPPLEMENTATION ON IMMUNE RECOVERY PROGRAM HIV PATIENTS WITH AN IPS MEDELLIN|Unknown status|Recruiting|N/A|40|Anticipated|CES University||2|||f||||f||||||||||2017-10-11 00:19:37.064332|2017-10-11 00:19:37.064332
NCT02162784|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-06-02|||February 2013||2013-02-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy Study of SYN006 HFA MDI in Asthma Patients|An Open-Label, Randomized, Cross-Over Study to Evaluate the Dose Response of SYN006 HFA MDI in Asthma Patients|Completed||Phase 2|39|Actual|Intech Biopharm Ltd.||3|||f||||t||||||||||2017-10-11 00:19:37.159063|2017-10-11 00:19:37.159063
NCT02162771|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-08-24||2017-07-25|June 2014||2014-06-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|January 2016|Actual|2016-01-01||Interventional|rituximab||To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan|A Phase 3, Randomised, Parallel-Group, Active-Controlled, Double-Blind Study to Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan, Each Administered in Combination With Cyclophosphamide, Vincristine, and Prednisone (CVP) in Patients With Advanced Follicular Lymphoma|Active, not recruiting||Phase 3|146|Actual|Celltrion||2|||f||||f|t|||||||||2017-10-11 00:19:37.254393|2017-10-11 00:19:37.254393
NCT02162758|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-03-31|2017-03-31||July 2014||2014-07-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||The safety set included all participants who were randomized and received 1 dose of study drug.|Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation|A Randomized, Double-Blind, Phase 4 Study to Evaluate the Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation|Terminated||Phase 2|6|Actual|Takeda||2||Business Decisions; No Safety Concerns|f||||f||||||||||2017-10-11 00:19:37.346577|2017-10-11 00:19:37.346577
NCT02162745|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-12|||October 2012||2012-10-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Nasal Irrigation in Infants With Bronchiolitis.|Randomized Controlled Trial to Evaluate the Efficacy of Nasal Irrigation in Infants With Bronchiolitis|Completed||Phase 3|133|Actual|IRCCS Burlo Garofolo||3|||f||||f||||||||||2017-10-11 00:19:38.083238|2017-10-11 00:19:38.083238
NCT02162732|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-07-07|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Molecular-Guided Therapy for Childhood Cancer|Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers|Recruiting||N/A|200|Anticipated|Spectrum Health Hospitals||1|||f||||t||||||||||2017-10-11 00:19:38.168699|2017-10-11 00:19:38.168699
NCT02162719|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-11-03|||September 2014||2014-09-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors|A Randomized, Phase II, Multi-Center, Placebo-Controlled Study of Ipatasertib (GDC-0068), an Inhibitor of Akt, in Combination With Paclitaxel as Front-Line Treatment for Patients With Metastatic Triple-Negative Breast Cancer|Active, not recruiting||Phase 2|124|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 00:19:40.919754|2017-10-11 00:19:40.919754
NCT02162706|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-12|||June 2013||2013-06-01|June 2014|2014-06-01|June 2025|Anticipated|2025-06-01|December 2014|Anticipated|2014-12-01||Observational|||Salivary Cortisol Measurements by Mass Spectrometry|Pilot Study of Salivary Cortisol Measurements by Mass Spectrometry|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||t||||||Samples Without DNA|"     Saliva was collected using Salivabio children's swab (SCS).   "|||2017-10-11 00:19:41.137812|2017-10-11 00:19:41.137812
NCT02162680|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-07-29|2014-06-26||March 2010||2010-03-01|June 2014|2014-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||An Evaluation of the Effectiveness of Local Anesthetics Used During Intravenous Catheter Insertion|An Evaluation of the Effectiveness of Local Anesthetics Used During Intravenous Catheter Insertion|Completed||Phase 4|99|Actual|Duke University||3|||f||||||||||||||2017-10-11 00:19:41.298884|2017-10-11 00:19:41.298884
NCT02162667|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-12-17|||June 2014||2014-06-01|December 2015|2015-12-01|June 2019|Anticipated|2019-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer|Phase 3 Efficacy and Safety Study of CT-P6 and Herceptin as Neoadjuvant and Adjuvant Treatment in Patients With Her2-positive Early Breast Cancer|Active, not recruiting||Phase 3|562|Actual|Celltrion||2|||f||||t||||||||||2017-10-11 00:19:42.985774|2017-10-11 00:19:42.985774
NCT02162654|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-11|||November 2013||2013-11-01|June 2014|2014-06-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|RIPAT||Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment|The Role of Remote Ischemic Preconditioning in the Prevention of Ischemic Brain Damage During Intracranial Aneurysm Treatment (RIPAT) - A Prospective Randomized Exploratory Study|Unknown status|Recruiting|N/A|48|Anticipated|Medical University Innsbruck||2|||f||||f||||||||||2017-10-11 00:19:43.38931|2017-10-11 00:19:43.38931
NCT02162641|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-06-02|||September 2014||2014-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|R-SeNSAR||Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer|R-SeNSAR Feasibility Study: The Role of Sentinel Node Biopsy in Patients With Anal Cancer|Withdrawn||N/A|0|Actual|The Christie NHS Foundation Trust|||1|The study was terminated early as it failed to recruit.|f||||t||||||||||2017-10-11 00:19:43.511195|2017-10-11 00:19:43.511195
NCT02162628|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2015-12-11|||August 2014||2014-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Exair® Versus Native Tissue Repair for Prolapse|Exair® Prolapse Repair System Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Exair 522 Study|Terminated||N/A|79|Actual|Coloplast A/S|||2|Device voluntarily withdrawn from commercial use by manufacturer|f||||f||||||||||2017-10-11 00:19:43.606551|2017-10-11 00:19:43.606551
NCT02162615|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-07-18|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|November 2021|Anticipated|2021-11-01|May 2018|Anticipated|2018-05-01||Observational|||Restorelle® Mesh Versus Native Tissue Repair for Prolapse|Restorelle® Transvaginal Mesh Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study|Recruiting||N/A|892|Anticipated|Coloplast A/S|||4||f||||f||||||||||2017-10-11 00:19:43.770182|2017-10-11 00:19:43.770182
NCT02162602|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-06-19|||May 2014||2014-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Bone Mineral Accretion in Young Children|Bone Mineral Accretion in Young Children|Active, not recruiting||N/A|520|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 00:19:44.1378|2017-10-11 00:19:44.1378
NCT02162589|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-16|||February 2014||2014-02-01|February 2017|2017-02-01|January 1, 2018|Anticipated|2018-01-01|December 1, 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|POEM Registry||Peroral Endoscopic Myotomy (POEM) For The Treatment Of Achalasia: A Registry|Peroral Endoscopic Myotomy (POEM) For The Treatment Of Achalasia: A Retrospective And Prospective Multicenter Registry.|Recruiting||N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|No IPD sharing|2017-10-11 00:19:44.204502|2017-10-11 00:19:44.204502
NCT02162550|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-02-08|||June 2014||2014-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus|Effect of Bydureon on Carotid Atherosclerosis Progression in T2DM|Recruiting||Phase 4|148|Anticipated|Phoenix VA Health Care System||2|||f||||f||||||||No|Subject to VA regulation.|2017-10-11 00:19:44.978522|2017-10-11 00:19:44.978522
NCT02162537|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-07-31|||December 2013|Actual|2013-12-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|METAL2||Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases|Multicentric, Randomized, Phase III Trial Comparing 2 Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Asymptomatic Brain Metastases|Recruiting||Phase 3|210|Anticipated|Centre Hospitalier Intercommunal Creteil||2|||f||||t||||||||||2017-10-11 00:19:45.135768|2017-10-11 00:19:45.135768
NCT02162524|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-01-07|||January 2014||2014-01-01|January 2016|2016-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|E-Mech Anc II||Effects of Images Following Long-term Aerobic Exercise on Brain Activation|Effects of Images Following Long-term Aerobic Exercise on Brain Activation (E-Mechanic Ancillary II)|Withdrawn||N/A|0|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 00:19:45.517769|2017-10-11 00:19:45.517769
NCT02162511|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-05-19|||May 2014||2014-05-01|May 2015|2015-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||CD34+ Cell Enriched and T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Mismatched Related Donors or Borderline Organ Function|An Expanded Access Study Using the CliniMACS System to Offer Therapeutic Manipulated Grafts That Are CD34 Cell Enriched and T Cell Depleted for Allogeneic Stem Cell Recipients With Mismatched Related Donors or Borderline Organ Function|Recruiting||Phase 2|30|Anticipated|Stanford University||3|||f||||t||||||||||2017-10-11 00:19:45.657368|2017-10-11 00:19:45.657368
NCT02162498|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-10-19|||August 2013||2013-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Determine Impact of Feeding Buddies on Adherence to WHO PMTCT Guidelines in South Africa|Effect of Feeding Buddies on Adherence to WHO PMTCT Guidelines in South Africa|Completed||N/A|932|Anticipated|PATH||2|||f||||f||||||||||2017-10-11 00:19:45.773925|2017-10-11 00:19:45.773925
NCT02162485|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-09-28|||June 2014||2014-06-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus|Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus 50/500 µG/Inhalation; A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|129|Actual|Orion Corporation, Orion Pharma||4|||f||||t||||||||||2017-10-11 00:19:45.880566|2017-10-11 00:19:45.880566
NCT02162472|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-09-08|||July 2015||2015-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis|Videocapillaroscopy Assessment During Systemic Agent Therapy in Patients With Psoriasis|Recruiting||N/A|30|Anticipated|Northwestern University|||2||f||||t||||||||||2017-10-11 00:19:45.983328|2017-10-11 00:19:45.983328
NCT02162459|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-10|||September 2013||2013-09-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Strength-enhancing Effect of Whey Protein Supplementation Following Resistance Exercise in Adolescent Males|Strength-enhancing Effect of Whey Protein Supplementation Following Resistance Exercise in Adolescent Males|Completed||N/A|18|Actual|Olympia Eye Clinic|||2||f||||f||||||||||2017-10-11 00:19:46.102436|2017-10-11 00:19:46.102436
NCT02162446|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-03-17|||June 2014||2014-06-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||68Ga-OPS202 Study for Diagnostic Imaging of GEP NET|An Open-label, Micro-dosing Study to Evaluate Safety, Biodistribution, Dosimetry and Preliminary Efficacy of Two Single 68Ga-OPS202 Doses for the Diagnostic Imaging of Somatostatin Receptor-positive Gastro-entero-pancreatic Neuroendocrine Tumors (GEP NET) Using Positron-emission Tomography / Computed Tomography (PET/CT)|Completed||Phase 1/Phase 2|12|Actual|Ipsen||1|||f||||f||||||||||2017-10-11 00:19:46.225701|2017-10-11 00:19:46.225701
NCT02162433|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-04-06|||March 2015||2015-03-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation|Does Dexmedetomidine Decrease the Incidence of Untoward Airway Events After Deep or Awake Extubation in Patients Undergoing Adenotonsillectomy With or Without Myringotomy and Tube Placement?|Recruiting||Phase 4|336|Anticipated|Massachusetts Eye and Ear Infirmary||4|||f||||t||||||||No||2017-10-11 00:19:46.321461|2017-10-11 00:19:46.321461
NCT02162420|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-10-04|||January 2015||2015-01-01|September 2017|2017-09-01|July 2024|Anticipated|2024-07-01|July 2024|Anticipated|2024-07-01||Interventional|||Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia|Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia|Recruiting||N/A|50|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-10-11 00:19:46.443164|2017-10-11 00:19:46.443164
NCT02162407|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-06-10|||October 1999||1999-10-01|June 2014|2014-06-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin|A Randomised, Three-period Crossover Trial in Healthy Subjects Investigating the Relationship Between the Pharmacodynamic Steady State and the Pharmacokinetic Steady State in the Interstitial Fluid Following iv Infusion of Insulin Detemir and Human Insulin Using Microperfusion Technique|Completed||Phase 1|13|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 00:19:46.566053|2017-10-11 00:19:46.566053
NCT02162394|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-09-20|||June 2014||2014-06-01|September 2017|2017-09-01|January 2016|Actual|2016-01-01|April 2015|Actual|2015-04-01||Observational|||A Study to Determine the Feasibility of Wireless Electrocardiography|Study to Determine the Feasibility of Wireless Electrocardiography|Completed||N/A|14|Actual|Peerbridge Health, Inc|||1||f||||t||||||||||2017-10-11 00:19:46.656131|2017-10-11 00:19:46.656131
NCT02162381|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-04-12|||June 2014||2014-06-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Methylphenidate Effect on Humphrey Visual Fields|Methylphenidate Effect on Performing Humphrey Visual Fields|Recruiting||N/A|30|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 00:19:46.758972|2017-10-11 00:19:46.758972
NCT02162368|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2017-02-13|||January 2008||2008-01-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|October 2013|Actual|2013-10-01||Observational|||Laryngeal Mask Use in Knee-chest Position in Lumbar Surgery in Neurosurgical Patients|Laryngeal Mask Use in Knee-chest Position in Lumbar Surgery in Neurosurgical Patients|Completed||N/A|358|Actual|Fundacion Clinic per a la Recerca Biomédica|||1||f||||f||||||||No||2017-10-11 00:19:46.888662|2017-10-11 00:19:46.888662
NCT02162355|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-09-14|||June 2014||2014-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Multiple Ascending Dose Study of GLPG0634 in Japanese and Caucasian Healthy Subjects|Randomized, Double-blind, Placebo-controlled Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics, of Multiple Oral Doses of GLPG0634 in Japanese and Caucasian Healthy Subjects|Completed||Phase 1|36|Actual|Galapagos NV||4|||f||||t||||||||||2017-10-11 00:19:46.967573|2017-10-11 00:19:46.967573
NCT02162342|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-04-20|||July 2014||2014-07-01|April 2016|2016-04-01||||July 2017|Anticipated|2017-07-01||Observational|||Quantification of Kinematics and Muscle Activity Patterns of the Upper Extremities of Individuals With Motor Disabilities|Quantification of Kinematics and Muscle Activity Patterns of the Upper Extremities of Individuals With Motor Disabilities|Enrolling by invitation||N/A|||Hadassah Medical Organization|||1||f||||||||||||||2017-10-11 00:19:47.068258|2017-10-11 00:19:47.068258
NCT02162329|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-03-29|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Effects of Meditation on Cognitive Function and Quality of Life|Effects of Meditation on Cognitive Function and Quality of Life|Active, not recruiting||N/A|140|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 00:19:47.143503|2017-10-11 00:19:47.143503
NCT02162316|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2014-06-23|||July 2014||2014-07-01|June 2014|2014-06-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||A Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia|A Multicenter, Randomized, Double-blind Comparative Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia|Unknown status|Not yet recruiting|N/A|136|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||2|||f||||t||||||||||2017-10-11 00:19:47.428375|2017-10-11 00:19:47.428375
NCT02162303|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-07-13|||May 2014||2014-05-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|COLPET||Colchicine in Vascular Inflammation Assessed With PET Imaging|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Colchicine on Vascular Inflammation as Assessed With Position Emission Tomography (PET) Imaging in Patients With Atherosclerotic Vascular Disease (COLPET)|Completed||Phase 2|106|Actual|Montreal Heart Institute||2|||f||||t||||||||||2017-10-11 00:19:47.556386|2017-10-11 00:19:47.556386
NCT02162290|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-11|2016-05-15|||May 2011||2011-05-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program|Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program - Nine Months Follow up|Completed||N/A|84|Actual|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 00:19:47.667971|2017-10-11 00:19:47.667971
NCT02162264|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-23|||June 2013|Actual|2013-06-01|January 2017|2017-01-01|July 22, 2016|Actual|2016-07-22|May 30, 2015|Actual|2015-05-30||Observational|||Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice||Completed||N/A|8662|Actual|Eisai Inc.|||1||f||||||||||||||2017-10-11 00:19:47.872378|2017-10-11 00:19:47.872378
NCT02162251|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-12-30|||June 2013||2013-06-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Observational|||Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease||Completed||N/A|3482|Actual|Eisai Inc.|||1||f||||||||||||||2017-10-11 00:19:47.962832|2017-10-11 00:19:47.962832
NCT02162238|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-09-02|||February 2014||2014-02-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Assessment of Zinc Intake From Enriched Water and Other Dietary Sources in Kisumu, Kenya|Assessment of Zinc Intake From Enriched Water and Other Dietary Sources in Kisumu, Kenya|Completed||N/A|186|Actual|Wageningen University||2|||f||||f||||||||||2017-10-11 00:19:48.063603|2017-10-11 00:19:48.063603
NCT02162225|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-03-07|||September 2014||2014-09-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Beet Juice for Patients With Sickle Cell Anemia|Phase 2 Study of Effects of Plasma Nitrite in Sickle Cell Anemia|Suspended||Phase 2|24|Anticipated|Wake Forest University Health Sciences||1||Enrollment was very slow. Hope to reopen as multi-site study|f||||f||||||||||2017-10-11 00:19:48.159552|2017-10-11 00:19:48.159552
NCT02162212|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-04-27|||September 2014||2014-09-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Diabetic Shoulder Mobility|Diabetic Upper Extremity Pathophysiology, Limited Joint Mobility and Disability|Active, not recruiting||Phase 1|52|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:19:48.249258|2017-10-11 00:19:48.249258
NCT02162199|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-10-21|||June 2014||2014-06-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Single Dose Study of Debio 1450 in Healthy Subjects|A Phase 1, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Escalating Oral Doses of Debio 1450 in Healthy Subjects|Completed||Phase 1|48|Actual|Debiopharm International SA||2|||f||||f||||||||||2017-10-11 00:19:48.327863|2017-10-11 00:19:48.327863
NCT02162186|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-07-13|||October 2014||2014-10-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Observational|||Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement|Analysis of Clinical Outcome and Implant Migration of the Cementless Tri-Fit Total Hip Replacement System|Recruiting||N/A|100|Anticipated|Corin|||1||f||||t||||||||||2017-10-11 00:19:48.433171|2017-10-11 00:19:48.433171
NCT02162173|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-10|||December 2012||2012-12-01|June 2014|2014-06-01||||November 2013|Actual|2013-11-01||Interventional|PIVI||Dual Focus NBI and pCLE in FAP Related Duodenal Adenoma|Diagnostic Values of Dual Focus Narrow Band Imaging and Probe-based Confocal Laser Endomicroscopy in FAP Related Duodenal Adenoma|Completed||N/A|26|Actual|King Chulalongkorn Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:19:48.530886|2017-10-11 00:19:48.530886
NCT02162160|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-11-25|||September 2013||2013-09-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Microbiological Impact of an Intimate Cream and Its Suitability to Contribute to the Feeling of Softness and Freshness in the Intimate Area of Women|Microbiological Impact of a Cream and the Feeling of Softness and Freshness in the Intimate Area of Women|Completed||Phase 2|18|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:19:48.623156|2017-10-11 00:19:48.623156
NCT02162147|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-02-07|||November 2014||2014-11-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|November 2015|Actual|2015-11-01||Observational|||How Safe Are Our Pediatric Emergency Departments?|How Safe Are Our Pediatric Emergency Departments? A National Prospective Cohort Study|Active, not recruiting||N/A|6385|Actual|Children's Hospital of Eastern Ontario|||1||f||||f||||||||||2017-10-11 00:19:48.732806|2017-10-11 00:19:48.732806
NCT02162134|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-01-11|||January 2013||2013-01-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Does Sugared or Sugar Free Chewing Gum Reduces Postoperative Ileus After Laparoscopic Cholecystectomy|Does Sugared or Sugar Free Chewing Gum Reduces Postoperative Ileus After Laparoscopic Cholecystectomy|Completed||N/A|90|Actual|Benazir Bhutto Hospital, Rawalpindi||3|||f||||f||||||||||2017-10-11 00:19:48.84245|2017-10-11 00:19:48.84245
NCT02162121|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-08-11|||May 2014||2014-05-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia?|Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia?|Completed||Phase 4|64|Actual|ASST Gaetano Pini-CTO||2|||f||||f||||||||||2017-10-11 00:19:48.994898|2017-10-11 00:19:48.994898
NCT02162095|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-06-02|||June 2014||2014-06-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Is COPD a Risk Factor for Cardiovascular Disease?|Is Chronic Obstructive Pulmonary Disease a Risk Factor for Cardiovascular Disease?|Completed||N/A|162|Actual|University of Zurich|||2||f||||f||||||||||2017-10-11 00:19:49.112736|2017-10-11 00:19:49.112736
NCT02162082|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2017-04-03|||June 2014||2014-06-01|April 2017|2017-04-01|December 2026|Anticipated|2026-12-01|December 2019|Anticipated|2019-12-01||Interventional|CSI-Ulm-CTO||Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions|Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions|Recruiting||N/A|500|Anticipated|University of Ulm||1|||f||||f||||||||Undecided||2017-10-11 00:19:49.198426|2017-10-11 00:19:49.198426
NCT02162069|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2017-04-03|||June 2014||2014-06-01|April 2017|2017-04-01|December 2025|Anticipated|2025-12-01|December 2019|Anticipated|2019-12-01||Interventional|CSI-Ulm-TAVR||Coronary and Structural Interventions Ulm - Transcatheter Aortic Valve Replacement|Coronary and Structural Interventions Ulm - Transcatheter Aortic Valve Replacement|Recruiting||N/A|2000|Anticipated|University of Ulm||1|||f||||f||||||||||2017-10-11 00:19:49.295467|2017-10-11 00:19:49.295467
NCT02162056|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2017-04-03|||November 2013||2013-11-01|April 2017|2017-04-01|December 2028|Anticipated|2028-12-01|August 2018|Anticipated|2018-08-01||Interventional|CSI-Ulm-BVS||Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold|Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold|Recruiting||N/A|2000|Anticipated|University of Ulm||1|||f||||f||||||||Undecided||2017-10-11 00:19:49.399467|2017-10-11 00:19:49.399467
NCT02162043|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|||Development and Evaluation of a Self-administered/Assisted Visual Field Screening Tool for Glaucoma|Development and Evaluation of a Self-administered/Assisted Visual Field Screening Tool for Glaucoma|Active, not recruiting||N/A|168|Actual|University of Manchester|||3||f||||f||||||||No||2017-10-11 00:19:49.517365|2017-10-11 00:19:49.517365
NCT02162030|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-12-04|||October 2014||2014-10-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Component Analysis of Acceptance and Commitment Therapy|The Impact of Self as Context in the Treatment of Long-term Health Conditions With Acceptance and Commitment Therapy; a Feasibility Pilot Study|Recruiting||N/A|24|Anticipated|University of Sheffield||2|||f||||f||||||||||2017-10-11 00:19:49.612041|2017-10-11 00:19:49.612041
NCT02162017|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2017-02-07|||March 5, 2015|Actual|2015-03-05|February 2017|2017-02-01|January 13, 2017|Actual|2017-01-13|December 20, 2016|Actual|2016-12-20||Interventional|HeadPoST||Head Position in Stroke Trial (HeadPoST)|An Investigator Initiated, International Collaborative, Multicentre, Cluster Crossover, Randomised Controlled Trial to Establish the Effects of Head Positioning on Death or Disability in Patients With Acute Stroke|Completed||N/A|11096|Actual|The George Institute||2|||f||||t||||||||No|Participant data is de-identified and therefore individual data cannot be shared|2017-10-11 00:19:49.699641|2017-10-11 00:19:49.699641
NCT02162004|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-08-30|||June 2014||2014-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Continuous Correction|Sensor-Augmented Continuous Correction in Insulin Pump-Treated Type 1 Diabetes|Terminated||N/A|2|Actual|Hvidovre University Hospital||2||Technical problems|f||||f||||||||||2017-10-11 00:19:49.807782|2017-10-11 00:19:49.807782
NCT02161991|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-02-14|||June 2014||2014-06-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers|Randomized Phase 3 Study of Aprepitant Versus Placebo in Chinese Advanced Non-small Cell Lung Cancer Who Received Highly Emetogenic Chemotherapy|Recruiting||Phase 3|180|Anticipated|Hunan Province Tumor Hospital||2|||f||||f||||||||||2017-10-11 00:19:49.895902|2017-10-11 00:19:49.895902
NCT02161978|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-02-17|||May 2011||2011-05-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|DYVA-AAGG||Vascular Dysfunction and Antiangiogenic Therapy|Micro and Macro Vascular Dysfunction Induced by Antiangiogenic Therapy: Identification of New Vascular Biomarkers (DYVA-AAGG)|Recruiting||N/A|120|Anticipated|University Hospital, Angers|||1||f||||t||||||||||2017-10-11 00:19:49.991133|2017-10-11 00:19:49.991133
NCT02161965|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-05-20|||May 2013||2013-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|VICTORIA||Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation|The VICTORIA Study (Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation) Comparison Anti-vitamin K Versus Anti-Xa.|Recruiting||Phase 4|150|Anticipated|University Hospital, Angers||2|||f||||t||||||||Yes|Data and biological samples could be shared upon acceptance between both organizations|2017-10-11 00:19:50.148307|2017-10-11 00:19:50.148307
NCT02161952|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-07-07|||May 2005||2005-05-01|June 2014|2014-06-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||Pirfenidone, an Antifibrotic and Antiinflammatory Drug|Pirfenidone, an Antifibrotic and Antiinflammatory Drug for Treatment of Patients With Cirrhosis Due to Hepatitis C Virus. Phase II/III Study|Completed||Phase 2|150|Actual|University of Guadalajara||2|||f||||t||||||||||2017-10-11 00:19:50.276448|2017-10-11 00:19:50.276448
NCT02161939|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-01-28||||||January 2016|2016-01-01||||||||Expanded Access|||A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C|A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Subjects With Chronic Hepatitis C and Decompensated Cirrhosis or Post-Liver Transplant Subjects With Chronic Hepatitis C Recurrence|No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 00:19:50.394591|2017-10-11 00:19:50.394591
NCT02161926|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-05-06|||May 2014||2014-05-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2016|Actual|2016-02-01||Interventional|MONA||Assessments of Dietary Restrictions in Young and Elderly Obese Men : Metabolism Obesity Nutrition Age|Dietary Restrictions Implications on Metabolic Changes in Obese Men : Comparison Between Two Groups of Different Ages (60-70 Years Old Versus 30-40 Years Old)|Active, not recruiting||N/A|71|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 00:19:50.504512|2017-10-11 00:19:50.504512
NCT02161913|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-04-12|||September 2014||2014-09-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of Two Psycho-educational Family Group Interventions for Persons With SCI and Their Caregivers|Comparison of Two Psycho-educational Family Group Interventions for Persons With SCI and Their Caregivers|Recruiting||N/A|64|Anticipated|St. Luke's Rehabilitation Institute||2|||f||||f||||||||||2017-10-11 00:19:50.590009|2017-10-11 00:19:50.590009
NCT02161900|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-10-18|||November 2010||2010-11-01|October 2016|2016-10-01|April 2025|Anticipated|2025-04-01|May 2020|Anticipated|2020-05-01||Interventional|||Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer|Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer|Recruiting||Phase 2/Phase 3|850|Anticipated|Tata Memorial Hospital||2|||f||||f||||||||||2017-10-11 00:19:50.679371|2017-10-11 00:19:50.679371
NCT02161887|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-28|||June 2014||2014-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|HEAL||The Healing Context in Complementary and Alternative Medicine (CAM): Initial Validation Study|The Healing Context in CAM: Instrument Development and Initial Validation - Phase 3 Validation Study|Completed||N/A|207|Actual|University of Pittsburgh|||2||f||||f||||||||||2017-10-11 00:19:50.904845|2017-10-11 00:19:50.904845
NCT02161874|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-03-20|||April 2013||2013-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|OAK||Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System|A Prospective, Randomized-controlled Evaluation of Biomet 3i's T3 Implant System for Integration Success and the Preservation of Crestal Bone|Active, not recruiting||N/A|100|Anticipated|Zimmer Biomet||2|||f||||f||||||||No||2017-10-11 00:19:50.997829|2017-10-11 00:19:50.997829
NCT01804088|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-03-16||2016-02-05|March 2013||2013-03-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|April 2015|Actual|2015-04-01||Interventional|||FORMAT Clinical Study|Clinical Investigation of the Cook Formula™ 535 Iliac Balloon-Expandable Stent|Active, not recruiting||N/A|80|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 01:56:15.875259|2017-10-11 01:56:15.875259
NCT02161861|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-06-09|||March 2014||2014-03-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|Fertiline||Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study|Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study|Suspended||N/A|160|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:19:51.115078|2017-10-11 00:19:51.115078
NCT02161848|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-04-13|||June 2014||2014-06-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|CPEO||MRI Study - Chronic Progressive External Ophthalmoplegia|Magnetic Resonance Imaging Study of Patients With Chronic Progressive External Ophthalmoplegia|Completed||N/A|133|Actual|Rigshospitalet, Denmark|||3||f||||f||||||||||2017-10-11 00:19:51.20941|2017-10-11 00:19:51.20941
NCT02161835|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-05-13|||April 2014||2014-04-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Relations Between Myotonia and Fitness|Relations Between Fitness Status and the Severity of Myotonia in Patients With Congenital Myotonia|Completed||N/A|9|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:19:51.296465|2017-10-11 00:19:51.296465
NCT02161822|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-02-15|||October 1, 2014|Actual|2014-10-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients|A Single Arm, Phase II Study of Neoadjuvant Chemoradiotherapy With Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients|Recruiting||Phase 2|86|Anticipated|Samsung Medical Center||1|||f||||f|t|f|||t|||Undecided||2017-10-11 00:19:51.398071|2017-10-11 00:19:51.398071
NCT02161809|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-05-15|||January 2015||2015-01-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|HEPA||Turn up the HEAT - Healthy Eating and Activity Time in Summer Day Camps|Turn up the HEAT - Healthy Eating and Activity Time in Summer Day Camps|Active, not recruiting||N/A|1000|Actual|University of South Carolina||2|||f||||t||||||||||2017-10-11 00:19:51.508336|2017-10-11 00:19:51.508336
NCT02161796|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-10|||September 2013||2013-09-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects|A Phase 1, Double-blind, Randomized, Placebo-controlled, 4-way Crossover Study to Evaluate the Dose-proportionality and Pharmacokinetics of FG-4592 in Healthy Young and Elderly Male and Female Subjects|Completed||Phase 1|48|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 00:19:51.61929|2017-10-11 00:19:51.61929
NCT02161783|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-08-15|||October 2014||2014-10-01|August 2016|2016-08-01|July 2021|Anticipated|2021-07-01|October 2020|Anticipated|2020-10-01||Interventional|||Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation|Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation|Recruiting||N/A|50|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 00:19:51.735007|2017-10-11 00:19:51.735007
NCT02161770|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-25|||December 22, 2014|Actual|2014-12-22|September 2017|2017-09-01|August 22, 2017|Actual|2017-08-22|May 16, 2017|Actual|2017-05-16||Interventional|||Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment|An Open-label, Non-randomised, Multicentre, Comparative, Phase I Study to Determine the Pharmacokinetics, Safety and Tolerability of AZD9291 Following a Single Oral Dose to Patients With Advanced Solid Tumours and Normal Hepatic Function or Mild or Moderate Hepatic Impairment|Completed||Phase 1|30|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:19:51.853431|2017-10-11 00:19:51.853431
NCT02161757|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-08-01|||June 13, 2014|Actual|2014-06-13|August 2017|2017-08-01|July 17, 2017|Actual|2017-07-17|February 28, 2017|Actual|2017-02-28||Interventional|STRATOS1||A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma|A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist|Completed||Phase 3|1215|Actual|AstraZeneca||4|||f||||t|t|f||||||||2017-10-11 00:19:52.025339|2017-10-11 00:19:52.025339
NCT02161744|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-12-12|||May 2014||2014-05-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety, Tolerability and Preliminary Efficacy of Adipose Derived Stem Cells for Patients With Chronic Obstructive Pulmonary Disease|A PHASE I OPEN- LABEL STUDY TO ASSESS THE SAFETY,TOLERABILITY, AND PRELIMINARY EFFICACY OF A SINGLE INTRAVENOUS DOSE OF AUTOLOGOUS ADIPOSE STEM CELL (ADULT HUMAN) TO SUBJECTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE|Recruiting||Phase 1|60|Anticipated|Arkansas Heart Hospital||1|||f||||t||||||||||2017-10-11 00:19:52.647775|2017-10-11 00:19:52.647775
NCT02161731|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-10-09|||June 2014||2014-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants|Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:19:52.799209|2017-10-11 00:19:52.799209
NCT02161718|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-03-09|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|January 11, 2017|Actual|2017-01-11||Interventional|||A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder|A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder|Completed||Phase 2|300|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-10-11 00:19:52.950906|2017-10-11 00:19:52.950906
NCT02161705|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-03-03|||July 2014||2014-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pre-op Paravertebral Blocks to Decrease Post-op Pain Following Mastectomy With Immediate TE Reconstruction|Pre-operative Paravertebral Blocks to Decrease Post-operative Pain Following Mastectomy With Immediate Tissue Expander Reconstruction|Recruiting||Phase 3|70|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 00:19:53.308356|2017-10-11 00:19:53.308356
NCT02161692|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-11|||December 1996||1996-12-01|June 2014|2014-06-01|April 2009|Actual|2009-04-01|May 2007|Actual|2007-05-01||Interventional|||Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors|Randomized Phase 2 Study of Conventional Dose Chemotherapy Versus High Dose Sequential Chemotherapy as First-line Therapy for Metastatic Poor Prognosis Germ Cell Tumors|Completed||Phase 2|||Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-11 00:19:53.454935|2017-10-11 00:19:53.454935
NCT02160730|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-07-23|||May 2014||2014-05-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Cushing's Disease With R-roscovitine|Treatment of Pituitary Cushing Disease With a Selective CDK Inhibitor, R-roscovitine|Recruiting||Phase 2|16|Anticipated|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-10-11 00:20:06.118058|2017-10-11 00:20:06.118058
NCT02161679|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-10-09|||August 2016||2016-08-01|October 2015|2015-10-01||||August 2018|Anticipated|2018-08-01||Interventional|||Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer|Randomized Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Relapsed/Refractory Triple-Negative Breast Cancer|Not yet recruiting||Phase 2|80|Anticipated|Immunomedics, Inc.||2|||f||||||||||||||2017-10-11 00:19:53.564972|2017-10-11 00:19:53.564972
NCT02161666|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-04-03|||February 2014||2014-02-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Effect of Gastric Bypass Surgery on Pancreatic Islet and Incretin Function - Follow-up Study||Completed||N/A|7|Actual|Hvidovre University Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma and serum specimens are retained   "|||2017-10-11 00:19:53.699445|2017-10-11 00:19:53.699445
NCT02161653|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-11-08|||April 2010||2010-04-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Metadoxine as a Therapy for Severe Alcoholic Hepatitis|Impact of Metadoxine in the Oxidative Stress and Early Mortality in Patients With Severe Alcoholic Hepatitis|Completed||Phase 4|135|Actual|Hospital General de Mexico||4|||f||||t||||||||||2017-10-11 00:19:53.796793|2017-10-11 00:19:53.796793
NCT02161640|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-02-22|||September 2014||2014-09-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Observational|||Vascular Dysfunction in Paediatric IBD|Investigation of Vascular Endothelial Dysfunction, Thromboembolism and Structural Arterial Disease in Paediatric and Adolescent Inflammatory Bowel Disease (IBD)|Completed||N/A|63|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust|||2||f||||f||||||Samples Without DNA|"     Platelet poor plasma (PPP)   "|||2017-10-11 00:19:53.89353|2017-10-11 00:19:53.89353
NCT02161627|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-09-30||2016-09-26|July 2014||2014-07-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Panorama||Safety and Effectiveness of Spinal Cord Stimulation With Automatic Control to Treat Chronic Pain in an Extended Trial|Prospective, Multicenter, Randomized Double-blind Crossover Study Examining the Safety and Effectiveness of Spinal Cord Stimulation Incorporating Feedback to Treat Patients With Chronic Pain of the Trunk and/or Limbs in an Extended Trial|Completed||N/A|69|Actual|Saluda Medical Pty Ltd||2|||f||||f||||||||||2017-10-11 00:19:53.991681|2017-10-11 00:19:53.991681
NCT02161614|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-01-14|||February 2014||2014-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|VEDILA||Vascular Effect of Estradiol Valerate Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery|Flow-mediated Evaluation of the Brachial Artery of Climacteric Women Using Estradiol Valerate and Placebo. Randomized, Double Blinded, Placebo Controlled Study.|Completed||N/A|60|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-11 00:19:54.244721|2017-10-11 00:19:54.244721
NCT02161601|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-10|||February 2013||2013-02-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Incorrectly Applied Cricoid Pressure During Rapid Sequence Induction. Evaluation With High-resolution Manometry.|Effect of Incorrectly Applied Cricoid Pressure During Rapid Sequence Induction. Evaluation With High-resolution Manometry|Completed||N/A|20|Actual|Örebro University, Sweden||1|||f||||f||||||||||2017-10-11 00:19:54.353815|2017-10-11 00:19:54.353815
NCT02161588|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-12-02|||June 2014||2014-06-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects|A Multiple Dose, Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects|Completed||Phase 1|48|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:19:54.431832|2017-10-11 00:19:54.431832
NCT02161575|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-09-27|||August 28, 2014|Actual|2014-08-28|September 2017|2017-09-01|September 14, 2017|Actual|2017-09-14|September 14, 2017|Actual|2017-09-14||Interventional|SAFARI||Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD|A Phase IV, Prospective, Open-label, Uncontrolled, European Study in Patients With Neovascular Age-related Macular Degeneration (nAMD), Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to Ranibizumab 0.5mg.|Completed||Phase 4|103|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-11 00:19:54.533653|2017-10-11 00:19:54.533653
NCT02161562|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-11-27|||August 2014||2014-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|OPTIMA||OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients|OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in CSU Patients|Completed||Phase 3|295|Actual|Novartis||2|||f||||f||||||||||2017-10-11 00:19:54.714503|2017-10-11 00:19:54.714503
NCT02161549|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-08-22|2017-03-29||July 2012|Actual|2012-07-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01|2 Days|Observational [Patient Registry]|||Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy|Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy|Completed||N/A|71|Actual|Motus GI Medical Technologies Ltd|||2||f||||f|f|f||||||||2017-10-11 00:19:54.981105|2017-10-11 00:19:54.981105
NCT02161523|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-07-13|||July 2014||2014-07-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation||Unknown status|Not yet recruiting|N/A|20|Anticipated|Meir Medical Center|||1||f||||||||||Samples Without DNA|"     Biopsy from lung tissue   "|||2017-10-11 00:19:55.463801|2017-10-11 00:19:55.463801
NCT02161510|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-06-05|||July 2014||2014-07-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002)|A Multiple Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Subjects With Hepatitis C Infection|Completed||Phase 1|13|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-10-11 00:19:55.568685|2017-10-11 00:19:55.568685
NCT02161497|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-04-27|||July 2014||2014-07-01|June 2014|2014-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Clinical History Taking Versus the Addition of an Electronic File Consultation in Pediatric Pre-operative Assessments|Comparison of Clinical History Taking Versus the Addition of an Electronic Patient File Consultation in Pediatric Pre-operative Assessments|Completed||N/A|200|Actual|Meir Medical Center|||1||f||||f||||||||||2017-10-11 00:19:55.727911|2017-10-11 00:19:55.727911
NCT02161484|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-09|||January 2014||2014-01-01|June 2014|2014-06-01||||December 2015|Anticipated|2015-12-01||Interventional|||Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement|A Prospective, Randomized, Blinded, Controlled Study Evaluating the Efficacy of Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement|Unknown status|Recruiting|N/A|50|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 00:19:55.863725|2017-10-11 00:19:55.863725
NCT02161471|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-10-12|||October 2009||2009-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Haemodynamics and Function of the Atria in Congenital Heart Disease by Cardiovascular Magnetic Resonance|Haemodynamics and Function of the Atria in Patients With Congenital Heart Defects - Pilot Study by Cardiovascular Magnetic Resonance|Recruiting||N/A|50|Anticipated|University Children's Hospital, Zurich|||5||f||||f||||||||||2017-10-11 00:19:56.099555|2017-10-11 00:19:56.099555
NCT02161458|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-06-22|||June 2014||2014-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Escitalopram Effects on CSF Amyloid Beta|Escitalopram Effects on CSF Amyloid Beta Total Concentrations|Active, not recruiting||Phase 4|120|Anticipated|University of Pennsylvania||4|||f||||f||||||||No||2017-10-11 00:19:56.242896|2017-10-11 00:19:56.242896
NCT02161445|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2016-06-18|||October 2012||2012-10-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|STA/AHF||Systolic Time Intervals in the Diagnosis of Heart Failure in Emergency Departement|Systolic Time Intervals: a Diagnostic Tool of Acute Heart Failure in Emergency Departement Settings|Recruiting||Phase 1|800|Anticipated|University of Monastir|||2||f||||t||||||||Yes||2017-10-11 00:19:56.399504|2017-10-11 00:19:56.399504
NCT02161432|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2016-01-26|||June 2014||2014-06-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers|Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Bioavailability of the Tablet Formulation (a Randomised, Open-label, Single Dose, Three-way Crossover Trial in Healthy Subjects)|Completed||Phase 1|17|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:19:56.510056|2017-10-11 00:19:56.510056
NCT02161419|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-04-04||2016-03-21|July 30, 2014|Actual|2014-07-30|April 2017|2017-04-01|May 25, 2016|Actual|2016-05-25|December 31, 2015|Actual|2015-12-31||Interventional|CONCEPT-SCLC||RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer|A Randomized, Double Blind, Placebo-controlled, Multicenter Phase II Study to Evaluate Efficacy and Safety of Roniciclib in Subjects With Extensive-stage Disease Small Cell Lung Cancer (SCLC) Who Are Receiving Cisplatin + Etoposide or Carboplatin + Etoposide as First-line Therapy|Terminated||Phase 2|79|Actual|Bayer||2|||f||||t||||||||||2017-10-11 00:19:56.618401|2017-10-11 00:19:56.618401
NCT02161406|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-06-09|||September 2014||2014-09-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|ASSET||A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis|A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.|Active, not recruiting||Phase 2|86|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-11 00:19:56.826887|2017-10-11 00:19:56.826887
NCT02161393|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-08-24|||February 2014|Actual|2014-02-01|August 2017|2017-08-01|January 19, 2016|Actual|2016-01-19|January 2016|Actual|2016-01-01||Interventional|LIVELY||Physical Activity Versus Pulmonary Rehabilitation in COPD|PhysicaL actIvity interVention vErsus puLmonarY Rehabilitation in COPD: The LIVELY COPD Project.|Completed||N/A|50|Actual|University of Ulster||2|||f||||t||||||||||2017-10-11 00:19:57.002698|2017-10-11 00:19:57.002698
NCT02161380|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-01-10|||July 2014||2014-07-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|LHON||Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy|An Open-label Dose Escalation Study of an Adeno-associated Virus Vector (scAAV2-P1ND4v2) for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON) Caused by the G11778A Mutation in Mitochondrial DNA|Recruiting||Phase 1|27|Anticipated|University of Miami||3|||f||||t||||||||||2017-10-11 00:19:57.166868|2017-10-11 00:19:57.166868
NCT02161367|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-12-03|||October 2014||2014-10-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Simethicone on Postoperative Ileus in Patients Undergoing Colorectal Surgery|A Randomized Controlled Trial of the Effect of Simethicone on Postoperative Ileus in Patients Undergoing Colorectal Surgery: A Pilot Study|Completed||Phase 4|100|Actual|McMaster University||2|||f||||||||||||||2017-10-11 00:19:57.312235|2017-10-11 00:19:57.312235
NCT02161354|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-06-21|||June 2014||2014-06-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study To Determine The Efficacy and Safety of Buprenorphine (as NTC-510 and NTC-510A) in Subjects With Pain Following Surgical Extraction of 1 or 2 Third Molars.|Terminated||Phase 2|52|Actual|NanoSHIFT LLC||6||safety and efficacy after cohort 5 did not warrant further dose escalation|f||||f||||||||Undecided||2017-10-11 00:19:57.471662|2017-10-11 00:19:57.471662
NCT02161341|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-04-25|||June 2014||2014-06-01|April 2016|2016-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Ocular Surface Microbiome in Dry Eye Patients|Exploratory Study on the Ocular Surface Microbiome and Correlation to Clinical Parameters|Recruiting||N/A|90|Anticipated|Singapore National Eye Centre|||1||f||||f||||||Samples Without DNA|"     Microbiome swab will be collected from the inferior fornix of the lower eyelids to determine     composition of the bacterial microbiome of the human ocular surface in normal volunteers and     dry eye patients   "|||2017-10-11 00:19:57.583357|2017-10-11 00:19:57.583357
NCT02161328|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-05-05|||February 2014||2014-02-01|May 2017|2017-05-01|July 15, 2015|Actual|2015-07-15|December 2014|Actual|2014-12-01||Observational|||Electric Impedance Tomography Before and After Dilatative Tracheotomy|EIT: Changes of Pulmonary Ventilation Before and After Tracheotomy|Completed||N/A|29|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||t||||||||||2017-10-11 00:19:57.655587|2017-10-11 00:19:57.655587
NCT02160925|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-03-06|||May 2014||2014-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma|Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma|Recruiting||N/A|100|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 00:20:04.243881|2017-10-11 00:20:04.243881
NCT02161315|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-12-21|||April 2014||2014-04-01|February 2012|2012-02-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer|A Randomized Study of Steroid Aromatase Inhibitors Versus Progestogens for Non-Steroid Aromatase Inhibitor-resistanced Late Stage Breast Cancer|Unknown status|Recruiting|N/A|80|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||2||f||||t||||||||||2017-10-11 00:19:57.720634|2017-10-11 00:19:57.720634
NCT02161302|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-10|||June 2014||2014-06-01|June 2014|2014-06-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|tDCS||THE EFFECT OF tDCS IN THE TREATMENT OF CHRONIC PELVIC PAIN ASSOCIATED WITH ENDOMETRIOSIS|THE EFFECT OF TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) IN THE TREATMENT OF CHRONIC PELVIC PAIN ASSOCIATED WITH ENDOMETRIOSIS|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 00:19:57.790133|2017-10-11 00:19:57.790133
NCT02161289|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-05-08|||September 2010||2010-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|September 2015|Actual|2015-09-01||Observational|HIV-NAT 120||Behavioral and Biomedical HIV Prevention Interventions for Thai Men Who Have Sex With Men|Behavioral and Biomedical HIV Prevention Interventions for Thai Men Who Have Sex With Men.|Completed||N/A|300|Actual|Thai Red Cross AIDS Research Centre|||1||f||||f||||||||||2017-10-11 00:19:57.892493|2017-10-11 00:19:57.892493
NCT02161276|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-09-10|||April 2014||2014-04-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|TNTL||Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule|Phase 2 Study of The Optimal Dosage of Tang Ning Tongluo Capsule for Type II Diabetes|Completed||Phase 1/Phase 2|110|Actual|Guizhou Bailing Group Pharmaceutical Co Ltd||1|||f||||t||||||||||2017-10-11 00:19:57.977028|2017-10-11 00:19:57.977028
NCT02161263|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-05-29|||March 2014||2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Observational|||Quality of Vision and Quality of Life With LASIK|Patient Quality of Vision and Quality of Life With LASIK Surgery|Active, not recruiting||N/A|50|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 00:19:58.054074|2017-10-11 00:19:58.054074
NCT02161237|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-01-11|||June 2014||2014-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|OPTIMIZE||Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation|A Multi-center, Randomized, Open-label, Pilot and Exploratory Study Investigating Safety and Efficacy in OPTIMIZEd Dosing of Advagraf® Kidney Transplantation in Asia.|Completed||Phase 4|73|Actual|Astellas Pharma Inc||2|||f||||t||||||||Undecided||2017-10-11 00:20:00.013373|2017-10-11 00:20:00.013373
NCT02161224|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-09|||September 2013||2013-09-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function|A Phase 1, Non-randomized, Open-label, Single-dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of FG-4592 in Subjects With Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function|Completed||Phase 1|16|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:20:00.094335|2017-10-11 00:20:00.094335
NCT02161211|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-05-10|||July 2014||2014-07-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|CBT||Dismantling the Components and Dosing of CBT for Co-Occurring Disorders|Dismantling the Components and Dosing of CBT for Co-Occurring Disorders|Recruiting||N/A|300|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-11 00:20:00.189075|2017-10-11 00:20:00.189075
NCT02161198|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2014-06-09|||September 2012||2012-09-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety Study of Ginseng Polysaccharide Extract|A Single-center, Randomized, Placebo-controlled, Double-blind Clinical Trial to Evaluate the Efficacy and Safety After 14-week of Ginseng Polysaccharide Extract|Completed||Phase 2|72|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-11 00:20:00.277433|2017-10-11 00:20:00.277433
NCT02161185|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-09-19||2016-06-15|May 2014||2014-05-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters|An Open-Label Safety Study of USL261 in the Outpatient Treatment of Adolescent and Adult Subjects With Seizure Clusters|Terminated||Phase 3|7|Actual|Proximagen, LLC||1||Study terminated due to slow enrollment. There were no safety concerns.|f||||f||||||||||2017-10-11 00:20:00.36617|2017-10-11 00:20:00.36617
NCT02161172|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2014-06-10|||April 2012||2012-04-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01|6 Months|Observational [Patient Registry]|||Cognitive and Psychosocial Outcome After Mild Traumatic Brain Injury|Cognitive, Functional, and Psychosocial Outcome After Mild Traumatic Brain Injury: a Cross-sectional Study at a Tertiary Care Trauma Center.|Completed||N/A|360|Actual|Shanghai 6th People's Hospital|||1||f||||f||||||||||2017-10-11 00:20:00.482016|2017-10-11 00:20:00.482016
NCT02161159|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-04-14|||June 2014||2014-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|GRACE||An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder||Completed||N/A|515|Actual|Allergan|||1||f||||f||||||||||2017-10-11 00:20:00.554697|2017-10-11 00:20:00.554697
NCT02161146|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-02-08|2015-12-22||June 2014||2014-06-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis||Completed||Phase 3|240|Actual|Allergan||5|||f||||f||||||||||2017-10-11 00:20:00.859498|2017-10-11 00:20:00.859498
NCT02161133|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-05-17|||January 1, 2015|Actual|2015-01-01|May 2017|2017-05-01|July 2, 2018|Anticipated|2018-07-02|July 2, 2018|Anticipated|2018-07-02||Interventional|||Cognitive Rehabilitation for Gulf War Illness|Cognitive Rehabilitation for Gulf War Illness|Recruiting||Phase 3|300|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-11 00:20:01.411754|2017-10-11 00:20:01.411754
NCT02161107|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2015-03-23|||April 2014||2014-04-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma|A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Parallel-Group Study to Assess the Safety and Tolerability of Grass-SPIRE in Subjects With Asthma and Grass-Induced Rhinoconjunctivitis|Completed||Phase 2|54|Actual|Circassia Limited||3|||f||||f||||||||||2017-10-11 00:20:01.677281|2017-10-11 00:20:01.677281
NCT02161094|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2014-12-01|||April 2013||2013-04-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Diabetes Incentive Performance Study (DIPS) at Shanghai Jiading District|Diabetes Incentive Performance Study（DIPS）at Shanghai Jiading District|Unknown status|Enrolling by invitation|N/A|1300|Actual|Shanghai Jiao Tong University School of Medicine||4|||f||||t||||||||||2017-10-11 00:20:01.845302|2017-10-11 00:20:01.845302
NCT02161081|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-07-06|||January 2012||2012-01-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||A Study on Improved Dynamic Myocardial Perfusion With Less Effective Radiation Dose in CT (SIMPLE CT)|Adenosine-induced Stress Myocardial Perfusion Imaging With Dual-source 128-slice CT: a Study on the Comparison of Diagnostic Performance of Dynamic Scanning Protocols|Unknown status|Recruiting|N/A|120|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 00:20:01.9562|2017-10-11 00:20:01.9562
NCT02161068|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-09-26|||December 2013||2013-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|ADPKD||Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping|Chart Review/PKD Genotyping|Recruiting||N/A|700|Anticipated|The Rogosin Institute|||1||f||||f||||||Samples With DNA|"     After informed consent is obtained, blood samples for PKD genotyping will be obtained from     the study patient. Genotype results will be made available to the patient and they will be     referred to a genetic counselor at their request. This service would not be a part of the     study and therefore, genetic counseling would be done at the patient's expense.   "|||2017-10-11 00:20:02.084467|2017-10-11 00:20:02.084467
NCT02161042|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-10-04|||August 2011||2011-08-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|||The Effect of Blood Transfusion on Endothelial Function|The Effect of Blood Transfusion on Endothelial Function|Completed||N/A|40|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||||2017-10-11 00:20:02.371925|2017-10-11 00:20:02.371925
NCT02161029|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-01-12|||June 2014||2014-06-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Flexible Endoscopy Biopsies for Submucous Tumors With a New Drill Instrument|Flexible Endoscopy Biopsies With the New Drill Biopsy Instrument for Submucous Tumors|Unknown status|Recruiting|N/A|10|Anticipated|Region Skane||2|||f||||f||||||||||2017-10-11 00:20:02.479317|2017-10-11 00:20:02.479317
NCT02161016|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-03-31|2015-02-26||June 2014||2014-06-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft|A Radiographic and Clinical Outcomes Study Evaluating map3® Cellular Allogeneic Bone Graft in Patients Undergoing Bone Grafting in the Foot/Ankle|Terminated||Phase 4|1|Actual|RTI Surgical||1||slow recruitment|f||||f||||||||||2017-10-11 00:20:02.594131|2017-10-11 00:20:02.594131
NCT02161003|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-06-08|||October 2013||2013-10-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Stem Cells Therapy for Fecal Incontinence in Children After Posterior Sagittal Ano-rectoplasty|Therapeutic Effect of Stem Cells in Fecal Incontinence in Children After Posterior Sagittal Ano-rectoplasty|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Al-Azhar University||1|||f||||t||||||||||2017-10-11 00:20:02.942225|2017-10-11 00:20:02.942225
NCT02160990|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-06-28|2016-02-16||June 2014||2014-06-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying|Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying|Completed||Phase 4|20|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 00:20:03.063402|2017-10-11 00:20:03.063402
NCT02160977|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-07-11|2014-06-11||October 2011||2011-10-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Proprioception of the Knee Post MIS TKA and MIS-QS TKA|Prospective Randomized Comparative Study on the Proprioception of the Knee Post MIS TKA (Minimally Invasive Surgery Total Knee Arthroplasty) and MIS-QS(Quadriceps Sparing ) TKA|Completed||N/A|90|Actual|Peking University Third Hospital|Limitation was that the position reconstruction measurement mainly measures the difference of the reconstructed flex angle, while the reflex circuit and motion perception of the knee was not measured.|2|||f||||t||||||||||2017-10-11 00:20:03.455413|2017-10-11 00:20:03.455413
NCT02160964|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2015-03-18|||May 2015||2015-05-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Observational|iRetrieve||Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters (iRetrieve Study)|A Prospective Multi-center Study Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters Placed Across the US|Unknown status|Not yet recruiting|N/A|1786|Anticipated|Heart and Vascular Outcomes Research Institute|||1||f||||||||||||||2017-10-11 00:20:03.863477|2017-10-11 00:20:03.863477
NCT02160951|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-01-31|||September 2014||2014-09-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies|A Multi-center, Open-label, Dose Escalation, Phase 1 Study of Oral LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies|Completed||Phase 1|13|Actual|Novartis||1|||f||||||||||||||2017-10-11 00:20:03.948702|2017-10-11 00:20:03.948702
NCT02160938|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-10|2017-07-20|||February 2013||2013-02-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01|3 Years|Observational [Patient Registry]|||Prenatal Microarray Follow-Up Study|Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis: Follow-Up|Recruiting||N/A|390|Anticipated|Columbia University|||2||f||||f||||||||||2017-10-11 00:20:04.076745|2017-10-11 00:20:04.076745
NCT02160912|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-01-08|||February 2014||2014-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Observational|||Non Interventional Study (NIS) Regarding the Application of Ectoin Mund- & Rachenspray in Patients With Acute Laryngitis and/or Acute Pharyngitis|Non Interventional Study Regarding the Application of Ectoin Mund- & Rachenspray in Patients With Acute Laryngitis and/or Acute Pharyngitis|Completed||N/A|95|Actual|Bitop AG|||2||f||||t||||||||||2017-10-11 00:20:04.371857|2017-10-11 00:20:04.371857
NCT02160899|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-12-02|||June 2014||2014-06-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Patients With High Lipoprotein(a)|A Randomized, Double Blind, Placebo-Controlled, Dose Titration, Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 494372 Administered Subcutaneously to Patients With High Lipoprotein(a)|Completed||Phase 2|65|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:20:04.472681|2017-10-11 00:20:04.472681
NCT02160886|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-08|2014-06-09|||October 2011||2011-10-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Effects of a Task Oriented Intervention With Two Goal-setting Approaches|Effects of a Task Oriented Intervention for Children With Disabilities, Based on Children's or Parent's Goals, a Randomized Study.|Completed||N/A|34|Actual|Region Gävleborg||2|||f||||f||||||||||2017-10-11 00:20:04.592181|2017-10-11 00:20:04.592181
NCT02160873|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-01-23|2015-08-31||June 2014||2014-06-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Trained runners and triathletes|Nighttime Feeding and Morning Endurance Performance|Effect of Nighttime Feeding on Morning Performance in Female Endurance Athletes|Completed||N/A|12|Actual|Florida State University||2|||f||||t||||||||No||2017-10-11 00:20:04.682072|2017-10-11 00:20:04.682072
NCT02160860|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-08-14|||May 2014||2014-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01||Observational|||Epidemiology of Helicobacter Pylori Infection Among Shanghai Children|Epidemiology of Helicobacter Pylori Infection Among Shanghai Children|Completed||N/A|1997|Actual|Children's Hospital of Fudan University|||1||f||||f||||||Samples Without DNA|"     serum will be storage in to -80℃ fridge for further test. other biospecimen will be test at     site and disposed.   "|No||2017-10-11 00:20:04.971049|2017-10-11 00:20:04.971049
NCT02160834|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2015-03-19|||January 2014||2014-01-01|June 2014|2014-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|B-MOBILE||Reducing Sedentary Time in Obese Adults (Study 2)|A Mobile Health Approach to Reducing Sedentary Time in Bariatric Surgery Patients|Withdrawn||N/A|0|Actual|The Miriam Hospital||3||study not initiated|f||||f||||||||||2017-10-11 00:20:05.155954|2017-10-11 00:20:05.155954
NCT02160821|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-06-09|||January 2011||2011-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||TAPB vs. Caudal for Lower Abdominal Surgery in Children: A Double-Blinded Randomized Controlled Trial|Transversus Abdominis Plane Block Versus Caudal Epidural for Lower Abdominal Surgery in Children: A Double-Blinded Randomized Controlled Trial|Completed||Phase 4|45|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-10-11 00:20:05.240178|2017-10-11 00:20:05.240178
NCT02160808|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-08-08|||May 2014||2014-05-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection|Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection|Recruiting||Phase 3|176|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 00:20:05.336153|2017-10-11 00:20:05.336153
NCT02160795|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2017-10-05|||March 27, 2014||2014-03-27|March 6, 2017|2017-03-06|December 31, 2018|Anticipated|2018-12-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Feasibility of Identifying a Chinese Study Population and Eligible Pediatric Cancer Cases, and Linking the Two Groups to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer.|Feasibility of Identifying the Chinese Community Intervention Program (CIP) Population and Eligible Incident Pediatric Cancer Cases, and Linking the Cases to the Population to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer (Pilot #N3)|Not yet recruiting||N/A|39456|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:20:05.572761|2017-10-11 00:20:05.572761
NCT02160782|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-01-19|||September 2014||2014-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2015|Actual|2015-09-01||Interventional|ICONIC||A Long-Term, Open-Label Study of LUM001 With a Double-Blind, Placebo Controlled, Randomized Drug Withdrawal Period to Evaluate Safety and Efficacy in Children With Alagille Syndrome|Long-Term, Open-Label Study With a Double-Blind, Placebo-Controlled, Randomized Drug Withdrawal Period of LUM001, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi), in Patients With Alagille Syndrome|Active, not recruiting||Phase 2|30|Anticipated|Shire||2|||f||||t||||||||||2017-10-11 00:20:05.660537|2017-10-11 00:20:05.660537
NCT02160769|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2017-04-25|||November 2013||2013-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Tear Layer Lipid Thickness in Pterygium Patient Before and After Surgery|The Assessment of Tear Layer and Tear Layer Lipid Distribution Pre and 1 Month Post Pterygium Surgery Using a LipiView Ocular Surface Interferometer (LipiView)|Recruiting||N/A|80|Anticipated|Singapore National Eye Centre|||1||f||||f||||||||||2017-10-11 00:20:05.784388|2017-10-11 00:20:05.784388
NCT02160756|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-10-19|||June 2014||2014-06-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants|A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Relative Bioavailability of 3 Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 Under Fasted Conditions in Healthy Male Subjects|Completed||Phase 1|75|Actual|Aragon Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 00:20:05.873151|2017-10-11 00:20:05.873151
NCT02160743|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-12-28|||May 2014||2014-05-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects||Completed||Phase 1|28|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 00:20:06.010645|2017-10-11 00:20:06.010645
NCT02160717|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-08-21|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Risk of Diabetes in Young Turner Syndrome Patients|Beta-Cell Function in Young Turner Syndrome Patients|Completed||N/A|120|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 00:20:06.283126|2017-10-11 00:20:06.283126
NCT02160704|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-02-09|||December 2014||2014-12-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Androxal in Male Infertility|PHASE 2b RANDOMIZED, PARALLEL, DOUBLE-BLIND, PLACEBO-CONTROLLED EXPLORATORY STUDY TO EVALUATE THE EFFICACY OF ANDROXAL IN IDIOPATHIC MALE INFERTILITY (PROTOCOL #01-14-40-08)|Withdrawn||Phase 2/Phase 3|0|Actual|Baylor College of Medicine||2||Difficult eligibility and lack of funding|f||||f||||||||No||2017-10-11 00:20:06.390219|2017-10-11 00:20:06.390219
NCT02160691|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-04-18|||October 2015||2015-10-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder|Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder|Recruiting||N/A|30|Anticipated|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||f||||||||||2017-10-11 00:20:06.535301|2017-10-11 00:20:06.535301
NCT02160678|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-11-02||2016-11-02|May 2014||2014-05-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris|A Double-Blind,Randomized,Parallel-Group,Vehicle-Controlled,MulticenterStudy ComparingaGenericTazaroteneCream,0.1%toReference Listed Drug Tazorac® Cream, 0.1% and Both Active Treatments to Vehicle Control in the Treatment of Acne Vulgaris|Completed||Phase 3|1741|Actual|G & W Laboratories Inc.||3|||f||||||||||||||2017-10-11 00:20:06.687048|2017-10-11 00:20:06.687048
NCT02160665|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-11-02||2016-11-02|May 2014||2014-05-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis|A Double-Blind,Randomized,Parallel-Group,Vehicle-Controlled,Multi-Center Study Comparing a Generic Tazarotene Cream, 0.05% to RLD Tazorac® Cream, 0.05% and Both Treatments to a Vehicle in the Treatment of Plaque Psoriasis|Completed||Phase 3|866|Actual|G & W Laboratories Inc.||3|||f||||f||||||||No||2017-10-11 00:20:06.812163|2017-10-11 00:20:06.812163
NCT02160652|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-07-31|||June 2014||2014-06-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Ureteral Reimplantation for the Treatment of Extrinsic Malignant Ureteral Obstruction|Ureteral Reimplantation for the Treatment of Extrinsic Malignant Ureteral Obstruction|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Rabin Medical Center|||1||f||||t||||||||Undecided||2017-10-11 00:20:06.947583|2017-10-11 00:20:06.947583
NCT02160639|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-07-11|||January 2015||2015-01-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support|Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support|Active, not recruiting||N/A|449|Actual|American Association of Diabetes Educators||2|||f||||f||||||||||2017-10-11 00:20:07.042315|2017-10-11 00:20:07.042315
NCT02160626|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2014-10-07|||June 2014||2014-06-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis|A Randomized, Double-Blind, Vehicle Controlled, Parallel Group Study of the Dose-Response Profile of A-101 Topical Solution in Subjects With Seborrheic Keratosis.|Unknown status|Active, not recruiting|Phase 2|180|Anticipated|Aclaris Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 00:20:07.176176|2017-10-11 00:20:07.176176
NCT02160613|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2014-06-07|||April 2013||2013-04-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Osteoprotegerin Before and After Periodontal Surgery|Effect of Periodontal Surgery on Osteoprotegerin Levels in Gingival Crevicular Fluid, Saliva and Gingival Tissues.|Completed||N/A|30|Actual|Cairo University||1|||f||||t||||||||||2017-10-11 00:20:07.304721|2017-10-11 00:20:07.304721
NCT02160600|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2017-04-26|||April 2014||2014-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial|Role of Split Bolus Dual Energy Single Acquisition CT in Evaluation of Urological Diseases of the Upper Urinary Tract.|Completed||N/A|124|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 00:20:07.407227|2017-10-11 00:20:07.407227
NCT02160587|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-03-11|||July 2014||2014-07-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA|A Clinical Evaluation of the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA in Healthy Adult Volunteers|Completed||Phase 1|208|Actual|Zurex Pharma, Inc.||1|||f||||f||||||||||2017-10-11 00:20:07.493884|2017-10-11 00:20:07.493884
NCT02160574|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-10-24|||June 2014||2014-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA|A 21-Day Evaluation of the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA in Healthy Adult Volunteers|Completed||Phase 1|40|Actual|Zurex Pharma, Inc.||1|||f||||f||||||||||2017-10-11 00:20:07.612437|2017-10-11 00:20:07.612437
NCT02160561|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-05-20|||April 2013||2013-04-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Feasibility of Upright Bed Position in ARDS Patients|Feasibility of Upright Bed Position in ARDS Patients|Completed||N/A|10|Actual|Wake Forest University Health Sciences||1|||f||||t||||||||No||2017-10-11 00:20:07.71828|2017-10-11 00:20:07.71828
NCT02160548|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-07|2015-12-28|||April 2015||2015-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SalbutamolOP||Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning|Effect of Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen During Resuscitation of OP Pesticide Poisoned Patients|Completed||Phase 3|75|Actual|Sylhet M.A.G.Osmani Medical College||3|||f||||t||||||||||2017-10-11 00:20:07.804566|2017-10-11 00:20:07.804566
NCT02160535|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-02-27|||May 2014||2014-05-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA|Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA|Terminated||Phase 3|13|Actual|University of Washington||1||Study discontinued due to difficulty in enrolling eligible subjects|f||||t||||||||No||2017-10-11 00:20:07.902395|2017-10-11 00:20:07.902395
NCT02160522|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2015-06-05|||May 2014||2014-05-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Endotracheal Tube (ETT) Cuff Pressure Study in the Emergency Department (ED)|Endotracheal Tube Cuff Pressure in the Pediatric Emergency Department: A Pilot Study|Completed||N/A|104|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:20:07.99325|2017-10-11 00:20:07.99325
NCT02160509|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-04-16|||June 2014||2014-06-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01|6 Months|Observational [Patient Registry]|||Telementoring for Emergency Ultrasonography Performed by Emergency Physicians With Low Experience.|Telementoring for Emergency Ultrasonography Performed by Emergency Physicians|Completed||N/A|103|Actual|Hanyang University|||1||f||||f||||||||||2017-10-11 00:20:08.075251|2017-10-11 00:20:08.075251
NCT02160496|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-11-30|||April 2014||2014-04-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Assess the Effect of Diets With Different Protein Composition - Mainly Coming From Lean Red Meat - in Body Weight and Lipid Profile in Overweight and Obese Women|A Randomized Study to Assess the Effect of Diets With Different Protein Composition - Mainly Coming From Lean Red Meat - in Body Weight and Lipid Profile in Overweight and Obese Women|Completed||N/A|90|Actual|Instituto Aragones de Ciencias de la Salud||3|||f||||||||||||||2017-10-11 00:20:08.179293|2017-10-11 00:20:08.179293
NCT02160483|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2017-08-18|||June 2015|Anticipated|2015-06-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Functional Brain Imaging and Psychological Testing in Women With Chronic Pelvic Pain|Functional Brain Imaging and Psychological Testing in Women With Chronic Pelvic Pain|Withdrawn||N/A|0|Actual|KK Women's and Children's Hospital||1||"This study is not feasible to conduct as functional brain imaging capability is inadequate.   CIRB acknowledged in June 2016."|f||||t||||||||||2017-10-11 00:20:08.29021|2017-10-11 00:20:08.29021
NCT02160470|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-07-22|||August 2012||2012-08-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|Snake/Spider||Enhancing Exposure Therapy for Snake and Spider Phobias|Enhancing Exposure Therapy for Snake and Spider Phobias With Fear Retrieval and Compound Extinction|Active, not recruiting||Phase 1/Phase 2|120|Anticipated|University of Texas at Austin||4|||f||||f||||||||||2017-10-11 00:20:08.373719|2017-10-11 00:20:08.373719
NCT02160457|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-07-24|||August 6, 2014|Actual|2014-08-06|July 2017|2017-07-01|July 5, 2017|Actual|2017-07-05|July 5, 2017|Actual|2017-07-05||Interventional|CPinMotion||Gait Analysis and Interdisciplinary Interventions for Children With Cerebral Palsy|Instrumented Gait Analysis and Individually Tailored Interdisciplinary Interventions for Children With Cerebral Palsy: A Randomized Controlled Trial|Completed||N/A|60|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 00:20:08.465097|2017-10-11 00:20:08.465097
NCT02160444|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2016-05-10|||June 2012||2012-06-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Investigating the Effects of Parent Component to Cognitive Behavior Therapy (CBT) for Youth With Anxiety Disorders|Investigating the Effects of an Added Parent Component to Cognitive Behavior Therapy for Youth With Anxiety Disorders|Recruiting||N/A|35|Anticipated|University of Texas at Austin||1|||f||||f||||||||||2017-10-11 00:20:08.573075|2017-10-11 00:20:08.573075
NCT02160431|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-05-10|||July 2014||2014-07-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Neuropsychological Profiles of Pediatric Obsessive Compulsive Disorder (OCD)|Investigating the Neuropsychological Profile of Youth With Obsessive Compulsive Disorder (OCD)|Terminated||N/A|3|Actual|University of Texas at Austin||1||Inadequate funding|f||||f||||||||||2017-10-11 00:20:08.711921|2017-10-11 00:20:08.711921
NCT02160418|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-04-28|||June 2014||2014-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|April 14, 2017|Actual|2017-04-14||Interventional|||Incentives for Daily Tooth Brushing to Reduce Gingivitis||Enrolling by invitation||N/A|152|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 00:20:08.81599|2017-10-11 00:20:08.81599
NCT02160405|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-06-06|||February 2014||2014-02-01|June 2014|2014-06-01||||April 2014|Actual|2014-04-01||Interventional|||Effect on Iron Levels by the Inclusion of Native Potato in the Diet of Children From 2 to 5 Years, ICBF Beneficiaries. Nariño. Colombia. Cluster Randomized Controlled Trial|Effect on Iron Levels by the Inclusion of Native Potato in the Diet of Children From 2 to 5 Years, ICBF Beneficiaries in the Municipalities of Carlosama, Cumbal, Guachucal, Túquerres y Pasto. Nariño. Colombia. Cluster Randomized Controlled Trial|Completed||Phase 3|212|Actual|Universidad Nacional de Colombia||1|||f||||||||||||||2017-10-11 00:20:08.893552|2017-10-11 00:20:08.893552
NCT02160392|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-06-06|||May 2010||2010-05-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|FUGTS||Female Upper Genital Tract in HIV-infected Women|Virologic, Pharmacologic, and Immunologic Characterization of the Female Upper Genital Tract in HIV-infected Women|Completed||N/A|26|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples Without DNA|"     Endometrial and cervical lavage specimens   "|||2017-10-11 00:20:08.969564|2017-10-11 00:20:08.969564
NCT02160379|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-06|||January 2011||2011-01-01|June 2014|2014-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Effects of Roux-en-Y Gastric Bypass on Gastro-intestinal Hormone Secretion and Brain Responses Food Pictures|Dynamic Effect of Gastrointestinal Hormones on Cerebral Mechanisms Involved in Brain Perception of Food Pictures After Bariatric Surgery|Completed||N/A|31|Actual|University of Lausanne|||3||f||||f||||||||||2017-10-11 00:20:09.04337|2017-10-11 00:20:09.04337
NCT02160366|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-08-25|||September 2010|Actual|2010-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients|Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients|Recruiting||N/A|2000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     Samples collected may include blood, fresh tumor tissue, urine, saliva, bone marrow, pleural     fluid, ascites, skin or hair follicle.   "|||2017-10-11 00:20:09.158416|2017-10-11 00:20:09.158416
NCT02160353|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-05-30|||May 2015|Actual|2015-05-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Neo-adjuvant Abiraterone Prostate Study|Phase II Single-arm Study Evaluating Neo-adjuvant (Pre-radical Radiotherapy) Abiraterone Acetate (Plus Prednisolone) and Gonadotropin-Releasing Hormone (GnRH) Agonist in High Risk Localised Prostate Carcinoma|Recruiting||Phase 2|40|Anticipated|Cancer Trials Ireland||1|||f||||f||||||||||2017-10-11 00:20:09.412141|2017-10-11 00:20:09.412141
NCT02160340|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-03-29|||May 2014||2014-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Observational|VAST||Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older|Phase 1 Study of Optical Coherence Tomography Images to Identify the Prevalence of Vitreomacular Adhesion and Associated Maculopathies|Active, not recruiting||N/A|1584|Actual|Nova Southeastern University|||1||f||||f||||||||||2017-10-11 00:20:09.537821|2017-10-11 00:20:09.537821
NCT02160327|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-06-23|||March 2014||2014-03-01|June 2014|2014-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Role of Cytokines and Mast Cell in the Pathogenesis of SLK, Conjunctivochalasis, and Dry Eye|The Role of Cytokines and Mast Cell in the Pathogenesis of Ocular Surface Inflammation Diseases Including Superior Limbic Keratoconjunctivitis, Conjunctivochalasis, and Dry Eye|Active, not recruiting||N/A|105|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     -  tear        -  conjunctival tissue   "|||2017-10-11 00:20:09.66792|2017-10-11 00:20:09.66792
NCT02160314|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-01-15|2016-01-15||May 2014||2014-05-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Intent-to-Treat (ITT)|A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence|A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence|Completed||N/A|224|Actual|Procter and Gamble||2|||f||||f||||||||||2017-10-11 00:20:09.769807|2017-10-11 00:20:09.769807
NCT02160301|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-05-17|||November 2017|Anticipated|2017-11-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients|Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients|Withdrawn||Phase 4|0|Actual|University of North Carolina, Chapel Hill||2||Insufficient infrastructure/funding for enrollment|f||||f|t|f||||||||2017-10-11 00:20:10.06392|2017-10-11 00:20:10.06392
NCT02160288|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-09-16|||February 2016||2016-02-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Effects of Botox in Obstructed Defecation Syndrome|Effects of Type A Botulinum Toxin in Obstructed Defecation Syndrome: a Phase II Randomized, Parallel-Group, Triple-Blind, Placebo-Controlled Trial|Recruiting||Phase 2|46|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:20:10.223578|2017-10-11 00:20:10.223578
NCT02160275|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-10-01|||June 2014||2014-06-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|APPEL4||Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format|Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, APPEL 4|Completed||N/A|16|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 00:20:10.360122|2017-10-11 00:20:10.360122
NCT02160262|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-08|2017-05-01||2017-05-01|June 2014||2014-06-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Open-label Safety Study in Adults With ADHD|A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|724|Actual|Sunovion||1|||f||||t||||||||||2017-10-11 00:20:10.495012|2017-10-11 00:20:10.495012
NCT02160249|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-05-09|||September 2015||2015-09-01|May 2017|2017-05-01|May 8, 2017|Actual|2017-05-08|March 26, 2017|Actual|2017-03-26||Interventional|RISE||RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)|RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia): a Cluster-randomised Trial|Completed||N/A|166|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 00:20:10.742815|2017-10-11 00:20:10.742815
NCT02160236|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-08|2014-11-07|||November 2014||2014-11-01|November 2014|2014-11-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam|Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam in Lumbar Disc Surgery|Unknown status|Recruiting|Phase 4|90|Anticipated|TC Erciyes University||3|||f||||f||||||||||2017-10-11 00:20:10.882996|2017-10-11 00:20:10.882996
NCT02160223|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-08|2014-12-07|||January 2012||2012-01-01|January 2012|2012-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea|Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea|Completed||Phase 4|74|Actual|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-11 00:20:10.993832|2017-10-11 00:20:10.993832
NCT02160210|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-09|||June 2014||2014-06-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Ultrafine Endoscope for Colonoscopy in Diagnosis of Colorectal Diseases|Ultrafine Endoscope for Unsedated Colonoscopy is an Effective Method to Reduce Abdominal Pain:a Prospective Randomized Study.|Unknown status|Not yet recruiting|N/A|60|Anticipated|First Affiliated Hospital of Harbin Medical University||1|||f||||t||||||||||2017-10-11 00:20:11.121677|2017-10-11 00:20:11.121677
NCT02160197|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-09|||August 2014||2014-08-01|June 2014|2014-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Outcome of Rehabilitation Following Internally Fixed Ankle Fractures|A Randomised Controlled Trial of Outcome of Different Post Operative Rehabilitation Regime Following Internally Fixed Ankle Fractures|Unknown status|Not yet recruiting|N/A|105|Anticipated|Countess of Chester NHS Foundation Trust||3|||f||||t||||||||||2017-10-11 00:20:11.236653|2017-10-11 00:20:11.236653
NCT02160184|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2014-06-09||||||June 2014|2014-06-01||||February 2015|Anticipated|2015-02-01||Interventional|NIGHT CONTROL||Nocturnal Insulin-Glucose in Hospital: Tight Control||Unknown status|Not yet recruiting|N/A|12||Corporacion Parc Tauli||1|||f||||||||||||||2017-10-11 00:20:11.363432|2017-10-11 00:20:11.363432
NCT02160171|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-08-10|||April 2013||2013-04-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|ANSeR||ANSeR- The Algorithm for Neonatal Seizure Recognition Study|A Multicentre Clinical Evaluation of a Decision Support Algorithm for Neonatal Seizure Detection|Completed||N/A|240|Actual|University College Cork|||1||f||||f||||||||||2017-10-11 00:20:11.458517|2017-10-11 00:20:11.458517
NCT02159989|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-09-12|||June 3, 2014|Actual|2014-06-03|September 2017|2017-09-01||||December 31, 2018|Anticipated|2018-12-31||Interventional|||Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|Phase I Study of MLN0128 (TAK-228) (NSC# 768435) in Combination With Ziv-Aflibercept (NSC# 724770) in Patients With Advanced Cancers|Recruiting||Phase 1|69|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:20:14.354523|2017-10-11 00:20:14.354523
NCT02160158|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-01-14|||July 2014||2014-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers|Open-label, Single-dose, Randomized, Crossover Study To Estimate The Relative Bioavailability Compared To Commercial Extended-release Tablet Formulation And The Effects Of Food Or Sprinkling On Applesauce For Fesoterodine Sustained-release Beads-in-capsule Formulations In Healthy Adult Volunteers|Completed||Phase 1|24|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 00:20:11.591258|2017-10-11 00:20:11.591258
NCT02160145|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-09-18||2017-09-18|May 2014||2014-05-01|September 2017|2017-09-01|April 14, 2017|Actual|2017-04-14|April 14, 2017|Actual|2017-04-14||Interventional|||Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease|A Phase 3b, Multi-center, Randomized-withdrawal, Placebo-controlled, Double-blind, Parallel-group Trial to Compare the Efficacy and Safety of Tolvaptan (45 to 120 mg/Day, Split-dose) in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 3|1370|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-10-11 00:20:11.746831|2017-10-11 00:20:11.746831
NCT02160132|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-03-02|||June 2014||2014-06-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.|Effect and Security of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes : A Prospective, Randomized, Controlled, Multi-Center Clinical Trial.|Unknown status|Recruiting|Phase 2|180|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 00:20:12.295341|2017-10-11 00:20:12.295341
NCT02160119|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-02-05|||June 2014||2014-06-01|February 2015|2015-02-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|AUTATTEN||Emotional and Change-related Attention in Autism|Emotional and Change-related Attention in Autism|Recruiting||N/A|140|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||||||2017-10-11 00:20:12.457076|2017-10-11 00:20:12.457076
NCT02160106|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-08-28|||July 29, 2014|Actual|2014-07-29|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||First in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid Tumors|First-in-Human Dose-Escalation Study of TEW-7197 Monotherapy in Subjects With Advanced Stage Solid Tumors|Recruiting||Phase 1|50|Anticipated|MedPacto, Inc.||1|||f||||f||||||||||2017-10-11 00:20:12.576037|2017-10-11 00:20:12.576037
NCT02160093|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-11-08|||June 2014||2014-06-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Impact of Chronic Disease Control and Aging Psychology on Outcomes of Frailty-Sarcopenia Syndrome in Ambulatory Geriatric Patients|Impact of Chronic Disease Control and Aging Psychology on Outcomes of Frailty-Sarcopenia Syndrome in Ambulatory Geriatric Patients|Completed||N/A|151|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:20:12.704664|2017-10-11 00:20:12.704664
NCT02160080|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-06-10|||January 2014||2014-01-01|June 2014|2014-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Boceprevir Treatment in Liver Pre-transplant HCV Patients|Boceprevir Treatment in Liver Pre-transplant HCV Patients|Unknown status|Recruiting|Phase 3|20|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:20:12.789699|2017-10-11 00:20:12.789699
NCT02160067|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-09-29|||May 2014||2014-05-01|June 2014|2014-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches|A Four-period, Randomised, Open-label, Crossover, Pharmacokinetic Study to Assess the Dose Proportionality and Relative Bioavailability of Buprenorphine Transdermal Delivery System Second Generation Patches Compared to First Generation Patches, in Healthy Volunteers|Completed||Phase 1|20|Actual|Mundipharma Research Limited||4|||f||||f||||||||||2017-10-11 00:20:13.077157|2017-10-11 00:20:13.077157
NCT02160054|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-06-17|||November 2013||2013-11-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)|Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)|Completed||N/A|289|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 00:20:13.226454|2017-10-11 00:20:13.226454
NCT02160041|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-05-17|||July 24, 2014|Actual|2014-07-24|May 2017|2017-05-01|May 14, 2018|Anticipated|2018-05-14|May 14, 2018|Anticipated|2018-05-14||Interventional|CBGJ398XUS04||BGJ398 for Patients With Tumors With FGFR Genetic Alterations|Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations|Recruiting||Phase 2|90|Anticipated|Novartis||1|||f||||f|t|f||||||Undecided||2017-10-11 00:20:13.489798|2017-10-11 00:20:13.489798
NCT02160028|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-02-12|||August 2014||2014-08-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pain and Placebo Analgesia. Does Extended Information About Dental Procedures Reduce Pain Induced by Dental Treatment?|Pain and Placebo Analgesia. A Double Blinded, Randomized, Clinical Study About the Impact of Information About Anesthesia, and the Experience of Pain and Stress During Dental Treatment.|Completed||N/A|52|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 00:20:13.849879|2017-10-11 00:20:13.849879
NCT02160015|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-09-04|||May 9, 2014|Actual|2014-05-09|May 2017|2017-05-01||||December 31, 2016|Actual|2016-12-31||Interventional|||Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery|A Phase 1 Study of Lenalidomide and Ibrutinib in Combination With Rituximab in Relapsed and Refractory CLL and SLL|Active, not recruiting||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:20:13.961707|2017-10-11 00:20:13.961707
NCT02160002|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-05-09|||February 2015||2015-02-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|July 2016|Actual|2016-07-01||Interventional|||Incubator Weaning of Moderately Preterm Infants|Incubator Weaning of Moderately Preterm Infants: A Randomized Controlled Trial|Active, not recruiting||N/A|366|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-10-11 00:20:14.147221|2017-10-11 00:20:14.147221
NCT02159963|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-04-22|||June 2014||2014-06-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|HIT-FSHD||High Intensity Training in Patients With Facioscapulohumeral Muscular Dystrophy|High Intensity Interval Training in Patients With Facioscapulohumeral Muscular Dystrophy|Completed||N/A|18|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:20:14.679141|2017-10-11 00:20:14.679141
NCT02159950|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-05-19|2016-02-10||January 2015||2015-01-01|May 2016|2016-05-01||||July 2015|Actual|2015-07-01||Interventional||All treated and eligible patients|Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer|A Phase II Randomized Open Label Study of Sipuleucel-T vs. Sipuleucel-T and Tasquinimod in Patients With Metastatic Castrate-Resistant Prostate Cancer (CRPC)|Completed||Phase 2|2|Actual|Roswell Park Cancer Institute|Due to the study's early closure, as a result of lack of funding, target accrual was not reached and no statistical inference of the primary and secondary aims were carried forth.|2|||f||||t||||||||||2017-10-11 00:20:14.828509|2017-10-11 00:20:14.828509
NCT02159937|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-08-03|||May 2014||2014-05-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides|In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides|Completed||N/A|33|Actual|Recepta Biopharma|||1||f||||f||||||||||2017-10-11 00:20:15.658464|2017-10-11 00:20:15.658464
NCT02159924|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2014-09-24|||June 2014||2014-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Posture and Mobility Measurements of the Upper Quadrant in Asymptomatic Subjects by Means of a Smartphone|Posture and Mobility Measurements of the Upper Quadrant in Asymptomatic Subjects by Means of a Smartphone|Completed||N/A|41|Actual|Universidade do Porto|||1||f||||t||||||||||2017-10-11 00:20:15.740691|2017-10-11 00:20:15.740691
NCT02159911|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-07|||June 2004||2004-06-01|June 2014|2014-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Observational|||Oral Misoprostol for Cervical Priming Before Hysteroscopy|Use of Oral Misoprostol for Cervical Priming Before Hysteroscopy: a Randomized Comparison of Two Dosages|Completed||N/A|84|Actual|Saint-Joseph University|||2||f||||t||||||||||2017-10-11 00:20:15.815586|2017-10-11 00:20:15.815586
NCT02159898|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-04-10|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||EndoMAXX EVT Compared to EndoMAXX|Prospective, Multicenter, Single Blind, Randomized Study Comparing the EndoMAXX EVT Fully Covered Esophageal Stent With Valve to the EndoMAXX Fully Covered Esophageal Stent for Malignant Strictures Requiring Stent Placement Across the Gastroesophageal Junction|Completed||Phase 3|60|Actual|Merit Medical Systems, Inc.||2|||f||||f||t|f|f||||||2017-10-11 00:20:15.900331|2017-10-11 00:20:15.900331
NCT02159885|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-08-09|||April 2014||2014-04-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)|Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)|Completed||N/A|53|Actual|Corporal Michael J. Crescenz VA Medical Center||2|||f||||f||||||||||2017-10-11 00:20:15.995078|2017-10-11 00:20:15.995078
NCT02159872|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-09-21|||May 2015|Actual|2015-05-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure|A Phase II Study of Omacetaxine (OM) in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure|Recruiting||Phase 2|80|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:20:16.096849|2017-10-11 00:20:16.096849
NCT02159859|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-06-14|2017-05-08||December 2014||2014-12-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients|Pharmacokinetics and Investigation of Optimal Dose of Invanz (Ertapenem) in Hemodialysis Patients|Completed||Phase 2|7|Actual|William Beaumont Hospitals|some participants had missing lab values at the pre-determined times|1|||f||||f|t|f||||||No||2017-10-11 00:20:16.200586|2017-10-11 00:20:16.200586
NCT02159846|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-06-07|||August 2013||2013-08-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01|6 Months|Observational [Patient Registry]|T2DM||Effects of Mixed Herbs on Blood Glucose and Lipid Profile in T2DM Patients|The Effects of Mixed Herbs on Blood Glucose and Lipid Profile of Patients With Established Type II Diabetes Mellitus|Completed||N/A|20|Actual|International Islamic University Malaysia|||2||f||||t||||||||||2017-10-11 00:20:16.58378|2017-10-11 00:20:16.58378
NCT02159833|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-03-08|||October 2014||2014-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|INDY||Intranasal Diagnostics in Food Allergy: a Feasibility Study|Phase 1/2 Study to Determine the Intranasal Allergen Threshold to Food Proteins in Children With Food Allergy|Enrolling by invitation||N/A|50|Anticipated|Imperial College London||1|||f||||f||||||||||2017-10-11 00:20:16.680781|2017-10-11 00:20:16.680781
NCT02159820|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2014-06-09|||June 2014||2014-06-01|June 2014|2014-06-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Interventional|DAC and CT||Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer|Addition of Decitabine to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Phase 2-3, Open-label, Randomised Controlled Trial|Recruiting||Phase 2/Phase 3|500|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 00:20:16.772941|2017-10-11 00:20:16.772941
NCT02159807|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-01-04|||September 2015||2015-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Optimizing Dose of Bupivacaine in Combined Spinal Epidurals To Reduce Side Effects|Randomized Double-blinded Study Designed to Optimize the Dose of Bupivacaine in Combined Spinal Epidurals to Reduce the Incidence of Fetal Bradycardia and Maternal Hypotension|Recruiting||N/A|180|Anticipated|St. Luke's-Roosevelt Hospital Center||3|||f||||f||||||||No||2017-10-11 00:20:16.881321|2017-10-11 00:20:16.881321
NCT02159794|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-03-24|||August 2014||2014-08-01|March 2015|2015-03-01|March 2020|Anticipated|2020-03-01|December 2014|Anticipated|2014-12-01||Interventional|HORIZON CANADA||HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA|HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA|Withdrawn||N/A|0|Actual|HLT Inc.||1||HLT determined that design changes are necessary before reopening a study|f||||t||||||||||2017-10-11 00:20:16.990556|2017-10-11 00:20:16.990556
NCT02159781|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-06-09|||July 2014||2014-07-01|June 2014|2014-06-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Effect of Periodontal Treatment on Salivary Biomarkers|Effect of Periodontal Treatment on Salivary Biomarkers.|Unknown status|Not yet recruiting|N/A|60|Anticipated|The Baruch Padeh Medical Center, Poriya||1|||f||||t||||||||||2017-10-11 00:20:17.082146|2017-10-11 00:20:17.082146
NCT02159768|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-09|2016-01-24|2015-10-25||August 2013||2013-08-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Visualization of the Larynx With the Airtraq Laryngoscope and Image Transmission|Visualization of the Larynx With the Airtraq Laryngoscope and Image Transmission|Completed||N/A|30|Actual|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 00:20:17.163482|2017-10-11 00:20:17.163482
NCT02159742|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-09-23|||July 2011||2011-07-01|September 2016|2016-09-01||||July 2021|Anticipated|2021-07-01||Observational|||Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases|Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases|Recruiting||N/A|400|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-11 00:20:19.149434|2017-10-11 00:20:19.149434
NCT02159729|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-05-05|||February 2009||2009-02-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101|Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area|Completed||Phase 2|205|Actual|Kythera Biopharmaceuticals||4|||f||||f||||||||||2017-10-11 00:20:19.235011|2017-10-11 00:20:19.235011
NCT02159716|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-06-19|||June 2014||2014-06-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||CART-meso in Mesothelin Expressing Cancers|Phase I Study of Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers|Completed||Phase 1|19|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-10-11 00:20:19.358597|2017-10-11 00:20:19.358597
NCT02159703|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-07-31|||February 2014||2014-02-01|July 2017|2017-07-01||||February 2018|Anticipated|2018-02-01||Interventional|||A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer|A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer|Recruiting||Phase 2|60|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:20:19.430744|2017-10-11 00:20:19.430744
NCT02159690|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-01-22|||September 2014||2014-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy|A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy|Withdrawn||Phase 2|0|Actual|Johns Hopkins University||1||loss of funding|f||||||||||||||2017-10-11 00:20:19.512975|2017-10-11 00:20:19.512975
NCT02159677|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-01-20|||January 2014||2014-01-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01|1 Day|Observational [Patient Registry]|EIM||Electrical Impedance Myography of Neck and Low Back Pain|Electrical Impedance Myography for the Assessment of Neck and Low Back Pain|Completed||N/A|178|Actual|Skulpt, Inc.|||4||f||||t||||||||||2017-10-11 00:20:19.612124|2017-10-11 00:20:19.612124
NCT02159664|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-09-08|||December 2014||2014-12-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Influence of Didgeridoo Practice on UA Obstruction Levels in Moderate OSA|Influence of Didgeridoo Practice on Upper Airways Obstruction Levels in Moderate Obstructive Sleep Apnea Patients|Terminated||N/A|4|Actual|Centre Hospitalier Universitaire Saint Pierre||1||difficulty to recrut patients|f||||f||||||||||2017-10-11 00:20:19.710144|2017-10-11 00:20:19.710144
NCT02159651|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-09-12|||April 1, 2014|Actual|2014-04-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia|Specified Drug Use-results Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis|Active, not recruiting||N/A|179|Actual|Astellas Pharma Inc|||2||f||||f||||||||||2017-10-11 00:20:19.811596|2017-10-11 00:20:19.811596
NCT02159638|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-06-05|||May 2013||2013-05-01|June 2014|2014-06-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|||Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes|Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes|Unknown status|Recruiting|N/A|40|Anticipated|Vastra Gotaland Region||1|||f||||f||||||||||2017-10-11 00:20:20.09336|2017-10-11 00:20:20.09336
NCT02159625|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-08-08|||June 2014||2014-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|ACES||Abdominal Compression Elastic Support (ACES)|A Study of the Use of Abdominal Compression Elastic Support (ACES) for Hemodialysis Patients|Completed||N/A|13|Actual|Global Monitors, Inc.||1|||f||||t||||||||||2017-10-11 00:20:20.228502|2017-10-11 00:20:20.228502
NCT02159612|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-05-13|||May 2014||2014-05-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|FSHD||1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy|Disease Progression in Facioscapulohumeral Muscular Dystrophy - 1 Year MRI Follow-up|Completed||N/A|45|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 00:20:20.3587|2017-10-11 00:20:20.3587
NCT02159599|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-02-13|||July 2014||2014-07-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|DUAL||Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject|An Open Label Randomized Clinical Trial, to Evaluate the Treatment With Darunavir/Ritonavir + Lamivudine Once Daily Versus Continuing With Darunavir/Ritonavir Once Daily + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject With Suppressed Plasma Viremia|Completed||Phase 4|249|Actual|Fundacion SEIMC-GESIDA||2|||f||||f||||||||||2017-10-11 00:20:20.463658|2017-10-11 00:20:20.463658
NCT02159573|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-06-04|||July 2014||2014-07-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|STRATEGY||Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)|A Multicenter, Retrospective, Observational Study Evaluating Real-world Clinical Outcomes in Relapsing-remitting Multiple Sclerosis Patients Who Transition From Tysabri® (Natalizumab) to Tecfidera® (Dimethyl Fumarate)|Completed||N/A|530|Actual|Biogen|||1||f||||f||||||||||2017-10-11 00:20:20.719523|2017-10-11 00:20:20.719523
NCT02159560|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-03-14|||June 2014||2014-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Uniport and Multiport Epidural Catheters in Post-surgical Patients|Uniport and Multiport Epidural Catheters in Post-surgical Patients|Recruiting||N/A|240|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-10-11 00:20:20.937603|2017-10-11 00:20:20.937603
NCT02159547|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2015-06-27|2015-03-16||May 2014||2014-05-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||IV Dexketoprofen vs Placebo in Migranie Attack|Study of Comparing Dexketoprofen to Placebo in Migraine Attack|Completed||Phase 4|224|Actual|Akdeniz University||2|||f||||f||||||||||2017-10-11 00:20:21.074958|2017-10-11 00:20:21.074958
NCT02159534|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-08-21|||September 2014||2014-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Primebrain Stimulation|Multicentric Prospective Randomised Single-blind Controlled Clinical Study Assessing the Effect and the Safety of Primebrain Sensorimotor Stimulation on Neurological Development of Preterm Infants (Born Before 32 Weeks' Gestation) or Infants Born Weighing Less Than 1500 g|Recruiting||N/A|70|Anticipated|Queen Fabiola Children's University Hospital||2|||f||||f||||||||||2017-10-11 00:20:21.329782|2017-10-11 00:20:21.329782
NCT02159521|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-03-17|||July 10, 2014|Actual|2014-07-10|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 30, 2016|Actual|2016-12-30||Interventional|ACCESS PTS||Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic Endovascular System|ACCelerated ThrombolySiS for Post-Thrombotic Syndrome Using EKOS|Active, not recruiting||N/A|113|Actual|EKOS Corporation||1|||f||||f||||||||Undecided||2017-10-11 00:20:21.435092|2017-10-11 00:20:21.435092
NCT02159508|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-06-09|||November 2007||2007-11-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Intensive Nutrition Counselling in Patients With Head and Neck Cancer|An Intervention Study Comparing Intensive Nutrition Counselling With On-demand Counselling in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy|Unknown status|Active, not recruiting|N/A|65|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 00:20:21.584177|2017-10-11 00:20:21.584177
NCT02159495|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-09-14|||December 1, 2015|Actual|2015-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm|Phase I Study of Cellular Immunotherapy Using T Cells Lentivirally Transduced to Express a CD123-Specific, Hinge-Optimized, CD28-Costimulatory Chimeric Antigen Receptor and a Truncated EGFR for Patients With CD123+ Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm|Recruiting||Phase 1|60|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:20:21.701018|2017-10-11 00:20:21.701018
NCT02159482|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2014-07-21|2014-06-17||November 2005||2005-11-01|June 2014|2014-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines|Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines|Terminated||Phase 2|11|Actual|Duke University|Low accrual was due to a drug manufacturing issue.|1||Low enrollment|f||||f||||||||||2017-10-11 00:20:21.840209|2017-10-11 00:20:21.840209
NCT02159469|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-08-01||2017-08-01|July 2014||2014-07-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Interventional|STEADY||Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism|A Double-blind, Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism|Completed||Phase 3|150|Actual|Antares Pharma Inc.||1|||f||||f||||||||||2017-10-11 00:20:22.246041|2017-10-11 00:20:22.246041
NCT02159456|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-08-07|||May 2014||2014-05-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Continuous Versus Intermittent Enteral Feeding in Critically Ill Patients|Continuous Versus Intermittent Enteral Feeding in Critically Ill Patients: a Prospective, Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:20:22.407381|2017-10-11 00:20:22.407381
NCT02159443|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-09-18|||July 15, 2014|Actual|2014-07-15|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody|Characterization of Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody|Recruiting||N/A|100|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     DNA from tumor tissue. Blood serum samples.   "|||2017-10-11 00:20:22.497225|2017-10-11 00:20:22.497225
NCT02159430|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-06-05|||November 2014||2014-11-01|June 2014|2014-06-01|May 2015|Anticipated|2015-05-01|February 2015|Anticipated|2015-02-01|1 Day|Observational [Patient Registry]|HAENP||Hereditary AngioEdema, Neurobiology and Psychopathology||Unknown status|Not yet recruiting|N/A|35|Anticipated|University Hospital, Catania|||1||f||||f||||||||||2017-10-11 00:20:22.600177|2017-10-11 00:20:22.600177
NCT02159417|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-04-20|||November 2013||2013-11-01|June 2014|2014-06-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|EPRIDIA||Therapeutic Education of the Patients Diabetics Imprisoned at the Paris Jail|"Feasibility of the Therapeutic Education of the Patients Diabetics Imprisoned at the Paris Jail La Santé (Maison d'arrêt Paris La Santé)"|Completed||N/A|22|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:20:22.710508|2017-10-11 00:20:22.710508
NCT02159404|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-09-12|||April 2015||2015-04-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Observational|||Seasonal Differences in Nasal Mucus Proteome and Impact of Immunotherapy||Recruiting||N/A|88|Anticipated|Medical University of Graz|||2||f||||||||||||||2017-10-11 00:20:22.810926|2017-10-11 00:20:22.810926
NCT02159391|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-09-24|||June 2014||2014-06-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|MOTIVA||The Efficacy of Brief Motivational Interviewing for Trauma Patients Related to Alcohol or Other Abuse Drugs.|The Efficacy of Brief Motivational Interviewing for Trauma Patients Related to Alcohol or Other Abuse Drugs.|Unknown status|Active, not recruiting|N/A|86|Anticipated|Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental||2|||f||||f||||||||||2017-10-11 00:20:22.913062|2017-10-11 00:20:22.913062
NCT02159378|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-09-27|||July 2014||2014-07-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|FRUCTO||Fructosamines and Gestational Diabetes (FRUCTO)|Fructosamines and Gestational Diabetes (FRUCTO)|Completed||N/A|200|Actual|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-11 00:20:23.028196|2017-10-11 00:20:23.028196
NCT02159365|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-01-10|2016-11-15||March 2014||2014-03-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|June 2016|Actual|2016-06-01||Interventional||All Treated Participants|Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients|A Phase 2 Single Arm Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients|Active, not recruiting||Phase 2|81|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:20:23.13894|2017-10-11 00:20:23.13894
NCT02159352|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-10-29|2015-08-21||June 2014||2014-06-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants|A Phase 1 Clinical Study to Assess the Effect of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Subjects|Completed||Phase 1|49|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:20:23.698219|2017-10-11 00:20:23.698219
NCT02159326|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2015-08-13|||June 2014||2014-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women|Microgynon Riociguat Drug Interaction Study to Investigate the Effect of Riociguat 2.5 mg 3 Times Daily Multiple-dose Treatment on the Plasma Concentrations of / Exposure to Levonorgestrel and Ethinyl Estradiol in Healthy Postmenopausal Women in a 2-fold Crossover Design|Completed||Phase 1|31|Actual|Bayer||2|||f||||f||||||||||2017-10-11 00:20:24.697529|2017-10-11 00:20:24.697529
NCT02159313|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2016-02-16|||June 2014||2014-06-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|||Relative Bioavailability Study|Relative Bioavailability Study of Riociguat Given Orally as a Crushed 2.5 mg Tablet Suspended in Applesauce, Crushed 2.5 mg Tablet Suspended in Water, and Whole 2.5 mg Tablet After a Continental Breakfast in Comparison to a Whole 2.5 mg Tablet Given in the Fasted State to Characterize the Pharmacokinetic Properties in Healthy Male Adult Subjects in a 4-fold Crossover Design|Completed||Phase 1|48|Actual|Bayer||4|||f||||f||||||||||2017-10-11 00:20:24.78854|2017-10-11 00:20:24.78854
NCT02159300|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-10-05|||December 2010||2010-12-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|FMP||Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study|Brain Rhythms in Fibromyalgia: A Magnetoencephalography (MEG) Study|Completed||N/A|40|Actual|New York University School of Medicine|||2||f||||f||||||||||2017-10-11 00:20:25.048457|2017-10-11 00:20:25.048457
NCT02159274|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-11-23|||March 2014||2014-03-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01|18 Months|Observational [Patient Registry]|||Shoulder Disability and Late Symptoms Following Oncoplastic Breast Surgery|Shoulder Disability and Late Symptoms Following Oncoplastic Breast Surgery|Recruiting||N/A|495|Anticipated|University of Aarhus|||2||f||||t||||||||Undecided||2017-10-11 00:20:25.293581|2017-10-11 00:20:25.293581
NCT02159261|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-08-08|||July 15, 2014|Actual|2014-07-15|August 2017|2017-08-01|August 14, 2016|Actual|2016-08-14|August 14, 2016|Actual|2016-08-14||Observational|||Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 Cycles|A Prospective Multicenter Non-interventional Study on Patients and Physicians Satisfaction of Yaz Plus|Completed||N/A|1500|Actual|Bayer|||1||f||||f||||||||||2017-10-11 00:20:25.41396|2017-10-11 00:20:25.41396
NCT02159248|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-04-27|||March 2014||2014-03-01|April 2015|2015-04-01|December 2019|Anticipated|2019-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation|09.017 - A Phase I Study of Tolfenamic Acid With Gemcitabine and Radiation in Patients With Locally Advanced or Metastatic Pancreatic Cancer Requiring Definitive or Palliative Radiation Therapy|Withdrawn||Phase 1|0|Actual|Orlando Health, Inc.||1||The study closed prior to enrolling any participants.|f||||t||||||||||2017-10-11 00:20:25.495135|2017-10-11 00:20:25.495135
NCT02159235|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-06-06|||September 2010||2010-09-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|||Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)|Heavy Metals (Cadmium, Lead, Mercury, Zinc), Angiogenesis Factors (Endostatin, Angiostatin, VEGF) and Osteopontin in Patients With Coronary Artery Disease|Completed||N/A|200|Actual|Medical University of Vienna|||2||f||||t||||||Samples With DNA|"     Blood, Urine   "|||2017-10-11 00:20:25.624573|2017-10-11 00:20:25.624573
NCT02159222|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-06-02|||April 2014||2014-04-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|STEP TO IT||Sepsis Trial of Early Physical Therapy Outside the ICU|Sepsis Trial of Early Physical Therapy Outside the ICU: A Pilot Feasibility Study|Enrolling by invitation||N/A|30|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-11 00:20:25.741796|2017-10-11 00:20:25.741796
NCT02159209|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-04-19|||February 2013||2013-02-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|DIRECT||The Drug Induced Renal Injury Consortium|The Genetic Contribution to Drug Induced Renal Injury: The Drug Induced Renal Injury Consortium (DIRECT)|Completed||N/A|634|Actual|University of California, San Diego|||1||f||||f||||||Samples With DNA|"     -  Plasma, serum, and urine stored for further analysis of biomarkers        -  Urinary chemistry        -  Urinary microscopy        -  DNA sample   "|||2017-10-11 00:20:25.850337|2017-10-11 00:20:25.850337
NCT02159196|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-06|2017-06-15|||July 2014||2014-07-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Interventional|Nebulae||Effectiveness of Routine Nebulization of Mucolytics and Bronchodilators During Mechanical Ventilation|Effectiveness of Routine Nebulization of Mucolytics and Bronchodilators in Mechanically Ventilated Intensive Care Patients'|Completed||N/A|950|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:20:25.980381|2017-10-11 00:20:25.980381
NCT02159183|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-03-02|||January 2012||2012-01-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2013|Actual|2013-09-01||Interventional|||Controlled Pilot Study to Assess Soft Tissue Reaction at the Crestal Part of a Dental Implant With ESTA Surface|A Controlled Clinical Pilot Study to Assess Soft Tissue Reaction at the Crestal Part of a Dental Implant With ESTA Surface|Active, not recruiting||N/A|43|Actual|Institut Straumann AG||2|||f||||f||||||||No||2017-10-11 00:20:26.130808|2017-10-11 00:20:26.130808
NCT02159170|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-01-15|||March 2014||2014-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|LOGIN_NGF||Cortical Representation of Hyperalgesia Induced by Nerve Growth Factor|Cortical Representation of NGF-induced Hyperalgesia|Completed||N/A|20|Actual|Central Institute of Mental Health, Mannheim||1|||f||||f||||||||||2017-10-11 00:20:26.269909|2017-10-11 00:20:26.269909
NCT02159157|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-05-17|||June 2014||2014-06-01|May 2017|2017-05-01||||March 2017|Actual|2017-03-01||Interventional|||A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer|A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer|Active, not recruiting||N/A|120|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 00:20:26.365055|2017-10-11 00:20:26.365055
NCT02159144|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2015-08-11|||June 2014||2014-06-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Cold Stress Stimulate the Browing of Subcutaneous White Adipose in Healthy Adults|Cold Stress Stimulate the Browing of Subcutaneous White Adipose in Healthy Adults|Completed||N/A|10|Actual|Wuhan General Hospital of Guangzhou Military Command||1|||f||||t||||||||||2017-10-11 00:20:26.506858|2017-10-11 00:20:26.506858
NCT02159131|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-07-02|||August 2014||2014-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects|An Open-label Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects|Completed||Phase 1|20|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-10-11 00:20:26.612052|2017-10-11 00:20:26.612052
NCT02159118|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-08-08|2014-07-15||April 2012||2012-04-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||All participants enrolled in the study were included in the baseline analysis, as the required sample size for the study was met. No participants were excluded from analysis. Analysis was made per protocol.|A Study Comparing Use of Manual and Power Bone Marrow Aspiration and Biopsy Devices in Children|A Trial of the Vidacare Powered Bone Marrow Aspiration and Core Biopsy System (OnControl by Vidacare) Compared to Traditional Manual Devices in Children|Completed||N/A|44|Actual|Vidacare Corporation||2|||f||||t||||||||||2017-10-11 00:20:26.761255|2017-10-11 00:20:26.761255
NCT02159105|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-07-18|||June 2014||2014-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Abdominal Ultrasound Assessment in the Post-cesarean Patient|Abdominal Ultrasound Assessment in the Post-cesarean Patient|Completed||N/A|105|Actual|Northwestern University|||1||f||||f||||||||||2017-10-11 00:20:27.331682|2017-10-11 00:20:27.331682
NCT02159092|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-12-10|||July 2014||2014-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Role of Contingency Management in Waterpipe Smoking Cessation|The Role of Contingency Management in Waterpipe Smoking Cessation|Completed||N/A|39|Actual|Washington State University||2|||f||||f||||||||||2017-10-11 00:20:27.436006|2017-10-11 00:20:27.436006
NCT02159079|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-04-19|||July 2014||2014-07-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|BALANCE||A Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction (BALANCE Study)|A Phase II/III Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction|Completed||N/A|30|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 00:20:27.52141|2017-10-11 00:20:27.52141
NCT02159066|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-03-29|||July 2014||2014-07-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|December 1, 2017|Anticipated|2017-12-01||Interventional|LOGIC-2||LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma|A Phase II, Multi-center, Open-label Study of Sequential LGX818/MEK162 Combination Followed by a Rational Combination With Targeted Agents After Progression, to Overcome Resistance in Adult Patients With Locally Advanced or Metastatic BRAF V600 Melanoma|Active, not recruiting||Phase 2|140|Anticipated|Array BioPharma||5|||f||||f||||||||||2017-10-11 00:20:27.626855|2017-10-11 00:20:27.626855
NCT02159053|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-09-21|||May 2015||2015-05-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MEASURE4||16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis|A Randomized, Double-blind, Placebo-controlled, Phase III Multicenter Study of Subcutaneous Secukinumab (150 mg) With and Without a Subcutaneous Loading Regimen to Assess Efficacy, Safety, and Tolerability up to 2 Years in Patients With Active Ankylosing Spondylitis|Active, not recruiting||Phase 3|350|Actual|Novartis||3|||f||||t||||||||||2017-10-11 00:20:27.790401|2017-10-11 00:20:27.790401
NCT02159040|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-03-06|2016-06-16||September 11, 2014|Actual|2014-09-11|March 2017|2017-03-01|June 26, 2015|Actual|2015-06-26|June 26, 2015|Actual|2015-06-26||Interventional|||Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.|A 2-year, Multi-center, Phase II, Open-label, Fixed-dose, Randomized Comparative Trial of Azacitidine, With or Without Deferasirox in Patients With Higher Risk Myelodysplastic Syndromes|Terminated||Phase 2|1|Actual|Novartis|No conclusion pertaining to efficacy and/or safety was drawn, only one patient was randomized to the study and their study participation was terminated prematurely due to fatal outcome of SAE.Only one patient in trial.No analysis will ever be done.|2|||f||||t||||||||||2017-10-11 00:20:28.102386|2017-10-11 00:20:28.102386
NCT02159027|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-01-03|||May 2015||2015-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Maraviroc and NeuroAIDS Pathogenesis|Maraviroc and NeuroAIDS Pathogenesis|Recruiting||Phase 2/Phase 3|42|Anticipated|University of Hawaii||2|||f||||t||||||||||2017-10-11 00:20:28.381328|2017-10-11 00:20:28.381328
NCT02159014|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-10-13|||August 2014||2014-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|DanceFit||DanceFit Prime: A Dance Based Physical Activity and Nutritional Intervention for Primary Care - A Feasibility Study|DanceFit Prime: A Dance Based Physical Activity and Nutritional Intervention to Reduce the Risk of Heart Disease, Stroke, Diabetes, and Dementia in Inactive Adults, in Primary Care Settings - A Feasibility Study|Completed||N/A|40|Actual|North Essex Partnership NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:20:28.69581|2017-10-11 00:20:28.69581
NCT02159001|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-10-15|||June 2014||2014-06-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Electroconvulsive Therapy in Clozapine-resistant Schizophrenia|Efficacy and Cognitive Effects of Electroconvulsive Therapy in Clozapine-Resistant Schizophrenia|Recruiting||N/A|20|Anticipated|Niuvanniemi Hospital||2|||f||||f||||||||||2017-10-11 00:20:28.831964|2017-10-11 00:20:28.831964
NCT02158988|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2017-02-13|||March 2014||2014-03-01|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|GASTRIPEC||Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis|Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction|Recruiting||Phase 3|180|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||Undecided||2017-10-11 00:20:28.936696|2017-10-11 00:20:28.936696
NCT02158962|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-12-29|||August 2014||2014-08-01|December 2014|2014-12-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|ESP||Empowered Sisters Project Making Choices Reducing Risks|An Integrated Risk Reduction Intervention for Abused African Caribbean Women|Unknown status|Recruiting|N/A|200|Anticipated|University of the Virgin Islands||2|||f||||t||||||||||2017-10-11 00:20:29.149935|2017-10-11 00:20:29.149935
NCT02158949|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-06-01|||June 2014||2014-06-01|June 2015|2015-06-01||||September 2014|Actual|2014-09-01||Interventional|mROAD||Study of Mobile Phone Delivered Intervention to Reduce Alcohol Consumption|Mobilizing to Reduce Overuse of Alcohol in Emergency Department Patients|Completed||N/A|100|Anticipated|University of Southern California||2|||f||||f||||||||||2017-10-11 00:20:29.29909|2017-10-11 00:20:29.29909
NCT02158923|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-05-14|||September 2014||2014-09-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|iPROVE||Individualized Perioperative Open Lung Ventilatory Strategy|Postoperative Complication and Hospital Stay Reduction With a Individualized Perioperative Lung Protective Ventilation. A Comparative, Prospective, Multicenter, Randomized Controlled Trial.|Completed||N/A|920|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||4|||f||||t||||||||||2017-10-11 00:20:29.959379|2017-10-11 00:20:29.959379
NCT02158910|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-03-06|||March 2015|Actual|2015-03-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|AID||A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients|A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients|Completed||N/A|2231|Actual|Eisai Inc.|||2||f||||f||||||||||2017-10-11 00:20:30.102818|2017-10-11 00:20:30.102818
NCT02158897|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-04-04|||March 2013||2013-03-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Multi-cycle Prolon Diet|Effect of a Periodic Fasting-mimicking Diet on Risk Factors for Metabolic Syndrome and Age-related Diseases|Completed||Phase 1/Phase 2|102|Actual|University of Southern California||2|||f||||||||||||||2017-10-11 00:20:30.198423|2017-10-11 00:20:30.198423
NCT02158104|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-06-05|||October 2013||2013-10-01|January 2014|2014-01-01||||February 2014|Actual|2014-02-01||Observational|||Soreness After Deep Dry Needling of One Latent Myofascial Trigger Point||Completed||Phase 2/Phase 3|60|Actual|CEU San Pablo University|||1||f||||||||||||||2017-10-11 00:20:41.602099|2017-10-11 00:20:41.602099
NCT02158884|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-04-15|||June 2014||2014-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|PRIORITI-MTF||PRIORITI-MTF Study- Testing Patient Response to the IDEO|Patient Response to an Integrated Orthotic and Rehabilitation Initiative for Traumatic Injuries for the Military Treatment Facilities (PRIORITI-MTF)|Active, not recruiting||N/A|90|Anticipated|Major Extremity Trauma Research Consortium||1|||f||||t||||||||||2017-10-11 00:20:30.283726|2017-10-11 00:20:30.283726
NCT02158871|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-03-15|||May 2014||2014-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Impact Study of Workplace Mental Health Education on Early Intervention for Healthcare Workers With Mental Health Issues|Beyond Silence: Comparing the Impact of Contact-based Education With Mental Health Literacy Training on Early Intervention for Healthcare Workers With Mental Health Issues|Completed||N/A|216|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 00:20:30.379503|2017-10-11 00:20:30.379503
NCT02158858|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-11-22|||June 2014||2014-06-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase 1 Study Evaluating CPI-0610 in Patients With Acute Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasms, and Myelofibrosis|A Phase 1 Study of CPI-0610, a Small Molecule Inhibitor of BET (Bromodomain and Extra-terminal) Proteins, in Patients With Acute Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasms, and Myelofibrosis|Recruiting||Phase 1|75|Anticipated|Constellation Pharmaceuticals||1|||f||||||||||||||2017-10-11 00:20:30.493862|2017-10-11 00:20:30.493862
NCT02158845|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2015-01-17|||February 2010||2010-02-01|January 2015|2015-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|SIU-LNG||Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis|Effects of the Levonorgestrel-releasing Intrauterine System Compared With the Leuprolide Acetate in Patients With Endometriosis: a Randomized Trial|Completed||Phase 4|44|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:20:30.620584|2017-10-11 00:20:30.620584
NCT02158832|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-08-28|||April 2014|Anticipated|2014-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Acupuncture for Lymphedema Secondary to Breast Cancer Treatment|Rehabilitation of Breast Cancer Treatment Related Lymphedema Using Electro-acupuncture: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|McMaster University||2||The study Principal Investigator relocated and the grant funding the trial expired.|f||||f||||||||||2017-10-11 00:20:30.773936|2017-10-11 00:20:30.773936
NCT02158819|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-05-23|||July 9, 2014|Actual|2014-07-09|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|VISHE13||Visionaire Health Economics Study Comparing Economic Outcomes Between Visionaire and Standard Instrumentation|A Prospective, Randomised Pilot Study to Compare Health Economic Outcomes Using a Patient-matched Cutting Guide Versus Standard Instrumentation in Total Knee Arthroplasty.|Completed||N/A|52|Actual|Smith & Nephew, Inc.||2|||f||||t||||||||No||2017-10-11 00:20:30.89251|2017-10-11 00:20:30.89251
NCT02158806|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-09-02|||March 2015||2015-03-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|Aspirin4VLU||Low Dose Aspirin for Venous Leg Ulcers|Low Dose Aspirin for Venous Leg Ulcers: a Randomised Trial|Completed||Phase 3|251|Actual|University of Auckland, New Zealand||2|||f||||t||||||||||2017-10-11 00:20:31.009781|2017-10-11 00:20:31.009781
NCT02158793|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-07-20|||June 2014||2014-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Craniomaxillofacial Allotransplantation|Craniomaxillofacial Allotransplantation|Recruiting||N/A|10|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 00:20:31.111821|2017-10-11 00:20:31.111821
NCT02158780|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-08-28|||January 2015|Actual|2015-01-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|EXPRESSO||Expertise-Based Randomized Controlled Trial of Scrotal Versus Inguinal Orchidopexy on Post-operative Pain|Expertise-Based Randomized Controlled Trial of Scrotal Versus Inguinal (Standard) Orchidopexy on Postoperative Pain: EXPRESSO Trial|Recruiting||N/A|162|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-11 00:20:31.226573|2017-10-11 00:20:31.226573
NCT02158767|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-09-29|||December 2013||2013-12-01|September 2016|2016-09-01||||December 2019|Anticipated|2019-12-01||Expanded Access|||Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.|Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.|Available||N/A|||Case Comprehensive Cancer Center|||||||||||||||||||2017-10-11 00:20:31.343226|2017-10-11 00:20:31.343226
NCT02158754|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-05-05|||May 2014||2014-05-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Observational|(CU-PCP)||Clinician Utilization of CORUS® CAD in Primary Care Provider Decision Making|Clinician Utilization of CORUS® CAD in Primary Care Provider Decision Making|Withdrawn||N/A|0|Actual|CardioDx|||2|Study halted due to low investigator involvement; no patients enrolled in study.|f||||f||||||||||2017-10-11 00:20:31.429934|2017-10-11 00:20:31.429934
NCT02158741|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-05-17|||September 2014||2014-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Comparison Study of Usual Care vs. Usual Care Plus Community Intervention to Manage Type 2 Diabetes|A Client-Driven Intervention to Support Self-Management Among Community-Living Older Adults With Type 2 Diabetes and Multiple Chronic Conditions|Completed||N/A|291|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 00:20:31.523739|2017-10-11 00:20:31.523739
NCT02158728|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-01-23|2016-10-31||June 2014||2014-06-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational||ICD-indicated subjects undergoing standard ICD/CRT-D implant, ICD/CRT-D change-out, ablation, electrophysiology (EP) study or Non Invasive Programmed Stimulation (NIPS), and who provided a dataset which qualified for developing and testing the sensing and detection algorithms of the new ICD, are included in the analyses.|Supraventricular Tachycardia Collection Study||Completed||N/A|80|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||No||2017-10-11 00:20:31.628481|2017-10-11 00:20:31.628481
NCT02158715|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-08-31|||April 2014||2014-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Observational|||Assessment of Validity of Depth by PocketCPR as Sites of Smartphone on Arm|Assessment of Validity of Depth by PocketCPR as Sites of Smartphone on Arm|Completed||N/A|45|Actual|Hanyang University|||1||f||||f||||||||||2017-10-11 00:20:31.866981|2017-10-11 00:20:31.866981
NCT02157389|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-01-15|||July 2012||2012-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain|Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain|Completed||N/A|80|Actual|Central Institute of Mental Health, Mannheim||1|||f||||f||||||||||2017-10-11 00:20:51.888203|2017-10-11 00:20:51.888203
NCT02158702|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-06-20|||November 2014||2014-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib|Prospective Follow-up of Relapse Myeloma Patients After Previous Exposure to Bortezomib and Lenalidomide Treated on Pomalidomide and Dexamethasone|Active, not recruiting||Phase 2|15|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 00:20:31.951042|2017-10-11 00:20:31.951042
NCT02158689|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-01-07|||June 2014||2014-06-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Treatment Modalities in Poor Responders Undergoing IVF||Completed||N/A|80|Anticipated|Istanbul University||2|||f||||f||||||||||2017-10-11 00:20:32.078779|2017-10-11 00:20:32.078779
NCT02158676|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-04-12|||October 2013||2013-10-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Prebiotic and Synbiotic Supplementation in Individuals Undergoing Roux-en-y Gastric Bypass.|Effect of Prebiotic and Synbiotic Supplementation on Inflammatory Markers, Metabolic Parameters and Nutritional Status After Roux-en-y Gastric Bypass.|Completed||N/A|18|Actual|Universidade Federal de Santa Catarina||3|||f||||t||||||||||2017-10-11 00:20:32.196214|2017-10-11 00:20:32.196214
NCT02158663|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-08-15|||June 2014||2014-06-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study Testing if Fast or Slow rTMS is Better for the Treatment of Posttraumatic Stress Disorder (PTSD)|Randomized Trial of 1 Hz Versus 10 Hz Right Prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Posttraumatic Stress Disorder (PTSD)|Recruiting||Phase 2/Phase 3|50|Anticipated|James A. Haley Veterans Administration Hospital||2|||f||||f||||||||||2017-10-11 00:20:32.30217|2017-10-11 00:20:32.30217
NCT02158650|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-08-13|||July 2014||2014-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Video-Based Treatment Options for Basal Cell Carcinoma|The Efficiency and Effectiveness of Using Video-Based Treatment Option Education Medium for Basal Cell Carcinoma Patients|Completed||N/A|32|Actual|Emory University||2|||f||||f||||||||||2017-10-11 00:20:32.391973|2017-10-11 00:20:32.391973
NCT02158637|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-05-23|||August 2010|Actual|2010-08-01|May 2017|2017-05-01|March 13, 2017|Actual|2017-03-13|March 2012|Actual|2012-03-01||Observational|||Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)|Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)|Completed||N/A|1100|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 00:20:32.485039|2017-10-11 00:20:32.485039
NCT02158624|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-06-05|||December 2013||2013-12-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Interventional|QUATRO||Ranibizumab Treatment for Age-Related Macular Degeneretion|The Correlation for Improvement of Visual Acuity and QOL After Ranibizmab Treatment for Age-Related Macular Degeneration Patients|Unknown status|Recruiting|N/A|100|Anticipated|Kyushu University||1|||f||||f||||||||||2017-10-11 00:20:32.579692|2017-10-11 00:20:32.579692
NCT02158611|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-06-05|||January 2014||2014-01-01|June 2014|2014-06-01||||July 2014|Anticipated|2014-07-01||Interventional|||Whole Person Care Research Program of the Suicide Cases Consultative Services|Whole Person Care Research Program of the Suicide Cases Consultative Services|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Far Eastern Memorial Hospital||1|||f||||f||||||||||2017-10-11 00:20:32.669649|2017-10-11 00:20:32.669649
NCT02158598|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-02-02|||June 2014||2014-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Changes in Serum 25(OH)D Concentrations Following Vitamin D Supplementation With Chewable Tablets Versus Pills||Active, not recruiting||Phase 4|38|Anticipated|CHU de Quebec-Universite Laval||3|||f||||f||||||||||2017-10-11 00:20:32.889826|2017-10-11 00:20:32.889826
NCT02158585|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-07-26|||June 2014||2014-06-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Study of Lamotrigine to Treat Ménière's Disease|Lamotrigine for Ménière's Disease: a Double-blind, Placebo-controlled Pilot Study|Completed||Phase 3|24|Actual|Dent Neuroscience Research Center||2|||f||||t||||||||||2017-10-11 00:20:32.996762|2017-10-11 00:20:32.996762
NCT02158572|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-08-25|2017-07-25||August 2014|Actual|2014-08-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional||Safety Population|Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System|A Single-arm, Open-label, Multicenter Phase 3 Study of the Contraceptive Efficacy, Safety and Tolerability of the AG200-15 Transdermal Contraceptive Delivery System (TCDS)|Completed||Phase 3|2032|Actual|Agile Therapeutics||1|||f||||f||||||||||2017-10-11 00:20:33.144831|2017-10-11 00:20:33.144831
NCT02158559|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-06-05|||March 2014||2014-03-01|June 2014|2014-06-01||||December 2015|Anticipated|2015-12-01||Interventional|Danhong||the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.|A Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI(ST- Elevation Myocardical Infarction) After the PTCA Surgery.|Unknown status|Active, not recruiting|Phase 4|180|Anticipated|Beijing Bozhiyin T&S Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:20:33.649696|2017-10-11 00:20:33.649696
NCT02158546|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-02-03||2016-02-03|May 2014||2014-05-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study|A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder (the FORWARD-3 Study)|Completed||Phase 3|447|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-10-11 00:20:33.755515|2017-10-11 00:20:33.755515
NCT02158533|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-02-03||2016-02-03|May 2014||2014-05-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study|A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder (the FORWARD-4 Study)|Completed||Phase 3|385|Actual|Alkermes, Inc.||3|||f||||f||||||||||2017-10-11 00:20:34.042779|2017-10-11 00:20:34.042779
NCT02158507|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-09|||July 2014||2014-07-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer|An Open Label, Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative (ER, PR, and HER-2 Negative) Breast Cancer|Active, not recruiting||N/A|23|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 00:20:34.503549|2017-10-11 00:20:34.503549
NCT02158494|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-09-21|||May 2014||2014-05-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|May 2017|Actual|2017-05-01||Interventional|||Noninvasive Neuromodulation for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury|Cranial Nerve Noninvasive Neuromodulation Using the PoNS for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury|Active, not recruiting||N/A|44|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 00:20:34.642764|2017-10-11 00:20:34.642764
NCT02158481|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-06-23|||April 2014||2014-04-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Dietary Ingredients on Vascular Function|Investigating the Effects of Dietary Ingredients on Vascular Function During Acute Glucose Load|Completed||N/A|50|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-11 00:20:34.791799|2017-10-11 00:20:34.791799
NCT02158468|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-06-04|||October 2011||2011-10-01|June 2014|2014-06-01|September 2014|Anticipated|2014-09-01|August 2014|Anticipated|2014-08-01||Interventional|LIPSIA-COND||Effect of Conditioning on Myocardial Damage in STEMI|Effect of Conditioning on Myocardial Damage in ST-elevation Myocardial Infarction - Comparison of Combined Intrahospital Preconditioning Plus Postconditioning Versus Postconditioning Versus Control.|Unknown status|Recruiting|Phase 4|600|Anticipated|University of Leipzig||3|||f||||t||||||||||2017-10-11 00:20:34.900636|2017-10-11 00:20:34.900636
NCT02158455|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-06-04|||February 2004||2004-02-01|June 2014|2014-06-01||||December 2014|Anticipated|2014-12-01||Interventional|||Vein vs Arterial Grafts for Coronary Artery Bypass Grafting Surgery|No-touch Saphenous Vein Grafts vs Radial Artery Grafts; A Randomized Trial.|Unknown status|Active, not recruiting|N/A|108|Actual|Region Örebro County||2|||f||||f||||||||||2017-10-11 00:20:34.992419|2017-10-11 00:20:34.992419
NCT02158442|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-08-23|2016-06-22||October 2013||2013-10-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients|Randomized Study Comparing Clinical and Microbiological Efficacy of Timentin Delivered Via Percutaneous Isolated Limb Perfusion (PILP) or Intravenous Infusion in Diabetic Subjects With Moderate to Severe Lower Limb Infection|Completed||Phase 2|15|Actual|Osprey Medical, Inc||2|||f||||f||||||||No||2017-10-11 00:20:35.100734|2017-10-11 00:20:35.100734
NCT02158429|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-06-08|||April 2011||2011-04-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of Ultrasound To Increase Parental Bonding in Women With Substance Use Disorders|Comparison Study of Three-Dimensional vs. Two-Dimensional Ultrasound in Measures of Maternal and Paternal Bonding|Unknown status|Recruiting|N/A|120|Anticipated|University of Hawaii||2|||f||||t||||||||||2017-10-11 00:20:35.456301|2017-10-11 00:20:35.456301
NCT02158416|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-03-30|||December 2013||2013-12-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Observational|||Platelet Products Tested With the ThromboLUX® Platelet Quality Test|Blinded Study on Consecutive Transfusable Platelet Products Tested With the ThromboLUX® Platelet Quality Test|Completed||N/A|116|Actual|LightIntegra Technology|||1||f||||f||||||||||2017-10-11 00:20:35.577016|2017-10-11 00:20:35.577016
NCT02158403|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-11-04|||September 2014||2014-09-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|PREVENT||PREVENtion of HeartMate II Pump Thrombosis|PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management|Completed||N/A|300|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 00:20:35.666228|2017-10-11 00:20:35.666228
NCT02158390|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-04-10|||June 2014||2014-06-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|Merck||Phenotypic Specific Communication Intervention for Children With Down Syndrome|Phenotypic Specific Communication Intervention for Children With Down Syndrome|Recruiting||N/A|82|Anticipated|Vanderbilt University||2|||f||||f||||||||No|This project does not require a data sharing plan. Results will be reported on profession journals.|2017-10-11 00:20:35.838763|2017-10-11 00:20:35.838763
NCT02158377|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-09-02|||March 2013||2013-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|TMEL||TM vs TSV Implants Loaded Early vs Conventional in Anterior and Posterior Areas|A Randomized Controlled Multicenter Study of Trabecular Metal Dental Implants vs.Tapered Screw-Vent Dental Implants Loaded Early vs. Conventionally in the Maxilla and Mandible.|Recruiting||Phase 4|75|Anticipated|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-10-11 00:20:35.970415|2017-10-11 00:20:35.970415
NCT02158351|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-06|||November 2013||2013-11-01|June 2014|2014-06-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Observational|||Gut Microbiota and Modulation of Liver Damage in NAFLD|Role and Pathogenetic Mechanisms of Intestinal Microbiota in Non-alcoholic Fatty Liver Disease Severity in Obese and Non-obese Subjects|Unknown status|Recruiting|N/A|55|Anticipated|University of Roma La Sapienza|||2||f||||f||||||Samples With DNA|"     Stool samples, serum, plasma, liver and (only in the obese patients) adipose tissue   "|||2017-10-11 00:20:36.258177|2017-10-11 00:20:36.258177
NCT02158338|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-05-29|||June 2014||2014-06-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Do Bonding Disruptions Occur More Often in Children With Asthma Than in Non-asthmatic Populations?|Do Bonding Disruptions Occur More Often in Children With Asthma Than in Non-asthmatic Populations?|Completed||N/A|150|Actual|State University of New York - Upstate Medical University|||2||f||||f||||||||||2017-10-11 00:20:36.408861|2017-10-11 00:20:36.408861
NCT02158325|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-06|||March 2011||2011-03-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Capsulorhexis Size and Capsular Outcome|Appropriate Capsulorhexis Size Results in Better Capsular Outcome When Treating Pediatric Cataract: A Randomized Controlled Trial|Completed||N/A|38|Actual|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 00:20:36.51083|2017-10-11 00:20:36.51083
NCT02158312|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-05|||May 2014||2014-05-01|June 2014|2014-06-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Bihemispheric Modulation of the Motor Cortex by Transcranial Direct Current Stimulation in Subacute Stroke Patients|Bihemispheric Modulation of the Motor Cortex by Single-session Transcranial Direct Current Stimulation During Training in Subacute Stroke Patients|Recruiting||Phase 1|30|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-11 00:20:36.611572|2017-10-11 00:20:36.611572
NCT02158299|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-06-04|||October 2013||2013-10-01|June 2014|2014-06-01||||November 2014|Anticipated|2014-11-01||Interventional|||Contrast The Role of Avitene And OK-432 in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer|Contrast The Role of Microfibrillar Collagen Hemostat Flour（Avitene） And OK-432 （Sapylin）in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer|Unknown status|Recruiting|Phase 4|3|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||3|||f||||||||||||||2017-10-11 00:20:36.703721|2017-10-11 00:20:36.703721
NCT02158286|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-04|||January 2012||2012-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|April 2013|Actual|2013-04-01||Observational|||Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet|Validation of Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet to Golden Standard, to Scintigraphy. A Pilot Study|Completed||N/A|13|Actual|Region Skane|||1||f||||||||||||||2017-10-11 00:20:36.800242|2017-10-11 00:20:36.800242
NCT02158273|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-05-02|2016-12-20||May 2014||2014-05-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Medication Development in Alcoholism: Investigating PPAR Agonists|Medication Development in Alcoholism: Investigating PPAR Agonists|Completed||Phase 2|50|Actual|The Scripps Research Institute||2|||f||||f||||||||||2017-10-11 00:20:36.879852|2017-10-11 00:20:36.879852
NCT02158260|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2014-06-05|||September 2013||2013-09-01|June 2014|2014-06-01||||June 2015|Anticipated|2015-06-01||Interventional|||A New Method To Reduce Gastric Missing Areas in Capsule Endoscopy|A New Method To Reduce Gastric Missing Areas in Capsule Endoscopy: a Single Center, Prospective and Self-controlled Trial|Unknown status|Recruiting|N/A|71|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 00:20:37.185263|2017-10-11 00:20:37.185263
NCT02158247|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-06-23|2014-06-23||January 2012||2012-01-01|June 2014|2014-06-01||||July 2012|Actual|2012-07-01||Observational||Male : 69, Female : 107|Determining the Depth of Endotracheal Tube Insertion||Completed||N/A|176|Actual|The Catholic University of Korea|||1||f||||||||||||||2017-10-11 00:20:39.138094|2017-10-11 00:20:39.138094
NCT02158234|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-10-04|||June 3, 2014|Actual|2014-06-03|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck|A Phase I Dose Escalation Trial of Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of the Head and Neck|Recruiting||Phase 1|21|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-11 00:20:39.590958|2017-10-11 00:20:39.590958
NCT02158221|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-02-09|||June 2014||2014-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load|PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load|Completed||N/A|32|Actual|Danish Headache Center||2|||f||||||||||||||2017-10-11 00:20:39.745277|2017-10-11 00:20:39.745277
NCT02158208|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-06-05|||July 2013||2013-07-01|May 2013|2013-05-01||||July 2015|Anticipated|2015-07-01||Observational|Horton CD8||Study of the T CD8 Immune Response in Horton's Disease|Study of the T CD8 Immune Response in Horton's Disease|Unknown status|Recruiting|N/A|30|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-11 00:20:39.840138|2017-10-11 00:20:39.840138
NCT02158195|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-06-05|||July 2013||2013-07-01|March 2013|2013-03-01||||July 2017|Anticipated|2017-07-01||Observational|IAHAI||Immunopathology of Autoimmune Hemolytic Anemia|Immunopathology of Autoimmune Hemolytic Anemia. Open, Prospective, Multicentre Study.|Unknown status|Recruiting|N/A|24|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-11 00:20:39.973051|2017-10-11 00:20:39.973051
NCT02158182|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-08-15|||July 2014||2014-07-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding|Comparison of Three Different Schemes:Lactulose, L-ornithine L-aspartate, or Rifaximin, Versus Placebo, as Primary Prophylaxis of the Development of Hepatic Encephalopathy After Acute Variceal Bleeding in Cirrhotic Patients|Completed||Phase 4|87|Actual|Hospital General de Mexico||4|||f||||t||||||||||2017-10-11 00:20:40.172013|2017-10-11 00:20:40.172013
NCT02158169|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-07-27|||June 2012||2012-06-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|SYNERGY||Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology|Pharmaco-epidemiological Study on the Effect of Retacrit® on Chemotherapy Induced Anaemia in Standard Oncology and Haematology Practice: Impact of Concomitant Iron Supplementation|Completed||N/A|2167|Actual|Hospira, now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-10-11 00:20:40.34329|2017-10-11 00:20:40.34329
NCT02158156|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-05|||February 2014||2014-02-01|June 2014|2014-06-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy|Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy|Unknown status|Recruiting|N/A|8|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 00:20:41.13675|2017-10-11 00:20:41.13675
NCT02158143|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2014-06-05|||October 2013||2013-10-01|June 2014|2014-06-01||||April 2014|Actual|2014-04-01||Interventional|||A Single High-dose Oral Supplement of Vitamin D in Young Chinese||Completed||N/A|28|Actual|Chinese Academy of Sciences||1|||f||||||||||||||2017-10-11 00:20:41.28824|2017-10-11 00:20:41.28824
NCT02158130|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-03-21|||September 2014||2014-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|E-Mechanic_Fol||Effects of Aerobic Exercise Detraining|Effects of Aerobic Exercise Detraining on Energy Balance in Overweight Persons|Completed||N/A|25|Actual|Pennington Biomedical Research Center|||3||f||||f||||||Samples With DNA|"     serum, plasma   "|||2017-10-11 00:20:41.381853|2017-10-11 00:20:41.381853
NCT02158117|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-02-02|||March 2014||2014-03-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use|Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use|Completed||Phase 1|12|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-10-11 00:20:41.495306|2017-10-11 00:20:41.495306
NCT02158091|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-06-12|||July 2014||2014-07-01|June 2017|2017-06-01|July 2021|Anticipated|2021-07-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL|A Phase 1b/2 Study of IPI-145 in Combination With Fludarabine, Cyclophosphamide, and Rituximab (iFCR) in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia.|Active, not recruiting||Phase 1/Phase 2|32|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 00:20:41.688483|2017-10-11 00:20:41.688483
NCT02158078|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-07-25|||June 2014||2014-06-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus|A Prospective, Single Center, Post-Market Observational Study to Assess the Efficacy, Safety, and Patient Reported Outcomes of Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus|Terminated||N/A|8|Actual|CeQur Corporation|||1|Terminated to allow continued optimization of the product.|f||||f||||||||Yes|No plan to share individual data sets, but will publish results.|2017-10-11 00:20:41.82543|2017-10-11 00:20:41.82543
NCT02158065|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2015-04-30|||May 2014||2014-05-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|MrPAPP||"Impact of Telecoaching Program on Physical Activity in Patients With COPD"|A 3-month Multicenter Randomized Trial to Evaluate the Efficacy of a Physical Activity Promotion Program on the Experience of Physical Activity in Patients With COPD (Mr PAPP)|Completed||N/A|370|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 00:20:41.952474|2017-10-11 00:20:41.952474
NCT02158052|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-09-30|||February 2015||2015-02-01|September 2016|2016-09-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease|Combined HLA-Matched Bone Marrow and Kidney Transplantation for Multiple Myeloma or Other Hematologic Disorders With End Stage Renal Disease|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 00:20:42.101261|2017-10-11 00:20:42.101261
NCT02158039|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-04-19|2015-12-22||June 2004||2004-06-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Only subjects who received the study intervention, endoscopic ultra sound (EUS)- guided ethanol lavage were included in the baseline analysis.|Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms|Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms|Completed||Phase 1|23|Actual|Mayo Clinic|Sample size was small, and a control group was not included. Neither cyst histology not degree of epithelial ablation was assessed by surgical resection in any of the study participants.|1|||f||||t||||||||||2017-10-11 00:20:42.211815|2017-10-11 00:20:42.211815
NCT02158026|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-01-20|||June 2014||2014-06-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Observational|||Evaluation of the Role of Follicular Sensitivity Index in the Prediction of Pregnancy in Women Undergoing ICSI/IVF Without Polycystic Ovarian Syndrome|Evaluation of the Role of Follicular Sensitivity Index in the Prediction of ICSI/IVF Outcome in Women Without Polycystic Ovarian Syndrome|Recruiting||N/A|1000|Anticipated|Cairo University|||1||f||||t||||||||||2017-10-11 00:20:42.555171|2017-10-11 00:20:42.555171
NCT02158013|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-07-25|||September 2014||2014-09-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TOCA||Treatment Of Chronic Anal Fissure|Treatment Of Chronic Anal Fissure (TOCA): a Randomized Clinical Trial on Levorag® Emulgel Versus Diltiazem Gel 2%|Recruiting||N/A|88|Anticipated|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 00:20:42.697734|2017-10-11 00:20:42.697734
NCT02158000|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2016-01-31|||July 2013||2013-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Aspiration of Excessive Endometrial Fluid at the Day of Ovum Retrieval Plus Diosmin in (ICSI) Cycles|Aspiration of Excessive Endometrial Fluid at the Day of Ovum Retrieval Plus Diosmin in (ICSI) Cycles|Completed||Phase 2/Phase 3|200|Actual|Benha University||2|||f||||t||||||||Yes|on research gate|2017-10-11 00:20:42.81643|2017-10-11 00:20:42.81643
NCT02157987|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-01-26|||December 2014||2014-12-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|EROSB||Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose|Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|University Hospital, Caen||1|||f||||t||||||||||2017-10-11 00:20:42.912159|2017-10-11 00:20:42.912159
NCT02157974|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-08-29|||August 2014|Actual|2014-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|APPLE||Liver and Fat Regulation in Overweight Adolescent Girls|Assessment of Hepatic Glucose and Fat Regulation in Overweight Adolescent Girls|Recruiting||N/A|120|Anticipated|University of Colorado, Denver|||2||f||||f|t|f||||Samples Without DNA|"     Serum and urine samples.   "|||2017-10-11 00:20:43.177841|2017-10-11 00:20:43.177841
NCT02157961|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-11-21|||April 2014||2014-04-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Observational|Doc'sHealth||Doctor's Health - Health Behavior of Physicians in Germany|Doc's Health - Doctor as a Patient - An Observational Study on Health Behavior of Physicians in Germany|Completed||N/A|360|Actual|University of Jena|||2||f||||f||||||||||2017-10-11 00:20:43.333429|2017-10-11 00:20:43.333429
NCT02157948|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-07-18|2017-07-18|2015-11-10|May 2014||2014-05-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis|A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis|Completed||Phase 3|394|Actual|Amgen||2|||f||||f||||||||||2017-10-11 00:20:43.456764|2017-10-11 00:20:43.456764
NCT02157935|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-05-12|2016-12-15||June 27, 2014|Actual|2014-06-27|May 2017|2017-05-01|February 8, 2016|Actual|2016-02-08|February 8, 2016|Actual|2016-02-08||Interventional|RISE|Full analysis set including all randomized patients|Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease|A Phase IIIB, 6-Month, Double-blind, Double-dummy, Randomized, Parallel-group, Multicenter Exacerbation Study of Symbicort® Pressurized Metered-Dose Inhaler (pMDI) 160/4.5 μg x 2 Actuations Twice-daily Compared to Formoterol Turbuhaler 4.5 μg x 2 Inhalations Twice-daily in Cronic Obstructive Pulmonary Disease (COPD) Patients.|Completed||Phase 3|2026|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:20:44.371247|2017-10-11 00:20:44.371247
NCT02157922|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-01-26|||October 2014||2014-10-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|SMR-2984||A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis|A Double-blind, Randomized, Placebo-controlled Cross Over Study of Inhaled Alginate Oligosaccharide (OligoG) Administered for 28 Days in Subjects With Cystic Fibrosis|Active, not recruiting||Phase 2|76|Anticipated|AlgiPharma AS||2|||f||||t||||||||Undecided||2017-10-11 00:20:45.857869|2017-10-11 00:20:45.857869
NCT02157909|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-07-16|2015-07-16||June 2014||2014-06-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||This analysis population includes all randomized subjects.|DW Evaluation of Lotrafilcon B Lenses in a Modified Design|Daily Wear (DW) Evaluation of Lotrafilcon B in a Modified Design|Completed||N/A|134|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:20:45.997888|2017-10-11 00:20:45.997888
NCT02157896|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-08-03|||May 2013||2013-05-01|August 2016|2016-08-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||Vascular Endothelial Growth Factor and Endostatin in Angiogenesis After Acute Ischemic Stroke|Dynamic Changes of Vascular Endothelial Growth Factor and Endostatin in Association With Circulating Endothelial Progenitor Cells After Acute Ischemic Stroke|Completed||N/A|30|Actual|Shanghai 6th People's Hospital|||1||f||||f||||||Samples Without DNA|"     Peripheral blood samples   "|||2017-10-11 00:20:46.254992|2017-10-11 00:20:46.254992
NCT02157883|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-05|2017-05-30|2016-03-15||November 6, 2014|Actual|2014-11-06|May 2017|2017-05-01|January 4, 2018|Anticipated|2018-01-04|April 3, 2015|Actual|2015-04-03||Interventional|||Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)|A Phase I, Open-label, Non-randomised Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of a Single Oral Dose of AZD9291 in Patients With EGFRm Positive NSCLC Whose Disease Has Progressed on an EGFR TKI|Active, not recruiting||Phase 1|47|Actual|AstraZeneca|At end of Part B, the CAP allowed patients to continue receiving AZD9291 if still deriving clinical benefit. No clinical data was databased during the CAP; thus AE data is presented to end of Part B only.|1|||f||||f||||||||||2017-10-11 00:20:46.387944|2017-10-11 00:20:46.387944
NCT02157870|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-05|||December 2004||2004-12-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer|Phase II of Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||2||NCT00102622 Phase I/II study did not progress to Phase II.|f||||t||||||||||2017-10-11 00:20:47.32924|2017-10-11 00:20:47.32924
NCT02157844|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-04-17|||April 2014||2014-04-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Observational|||Fat Metabolism in OSA and COPD|Fat Metabolism and Digestion in Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease|Recruiting||N/A|65|Anticipated|Texas A&M University|||5||f||||f||||||Samples With DNA|"     Urine, adipose tissue, serum, plasma   "|||2017-10-11 00:20:47.534301|2017-10-11 00:20:47.534301
NCT02157831|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-05|||July 2005||2005-07-01|June 2014|2014-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors|Redosing With CP-870,893 in Patients With Clinical Benefit After a Single Infusion of CP-870,893 From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors|Completed||Early Phase 1|10|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:20:47.64321|2017-10-11 00:20:47.64321
NCT02157818|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2017-05-17|||June 2014||2014-06-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||A Comparison of Sedative Drugs for Conscious Sedation During Ultrasound Guided Transbronchial Needle Aspiration|A Comparison of Dexmedetomidine Versus Midazolam for Conscious Sedation During Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA)|Completed||N/A|110|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:20:47.720989|2017-10-11 00:20:47.720989
NCT02157805|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-06-05|||August 2013||2013-08-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|||Technological Processes on Quality of Meat|Effect of Technological Processes on Nutritional Quality of Meat Proteins|Completed||N/A|10|Actual|Institut National de la Recherche Agronomique||2|||f||||f||||||||||2017-10-11 00:20:47.808882|2017-10-11 00:20:47.808882
NCT02157792|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2017-08-14|||December 2012||2012-12-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||An Open-Label, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of VX-970 in Combination With Cytotoxic Chemotherapy|An Open-Label, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of VX-970 in Combination With Cytotoxic Chemotherapy in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|205|Anticipated|Vertex Pharmaceuticals Incorporated||5|||f||||||||||||||2017-10-11 00:20:47.901031|2017-10-11 00:20:47.901031
NCT02157779|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-08-22|||March 2, 2015|Actual|2015-03-02|August 2017|2017-08-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|TOTRA||Treatment of Trauma-Related Anger|Treatment of Trauma-Related Anger in OEF/OIF/OND Veterans|Recruiting||N/A|90|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 00:20:48.095826|2017-10-11 00:20:48.095826
NCT02157766|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-12-16|||September 2014||2014-09-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Wisconsin Center for the Neuroscience and Psychophysiology of Meditation|Wisconsin Center for the Neuroscience and Psychophysiology of Meditation|Recruiting||N/A|793|Anticipated|University of Wisconsin, Madison||6|||f||||t||||||||||2017-10-11 00:20:48.214191|2017-10-11 00:20:48.214191
NCT01802606|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-02-27|||January 2010||2010-01-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|May 2011|Actual|2011-05-01||Observational|infection||Factors Related to Infection Prevention After Tension-free Inguinal Hernia Repair|Department of Pharmacy, Xijing Hospital|Completed||N/A|1200|Actual|Xijing Hospital|||1||f||||t||||||||||2017-10-11 01:56:38.578795|2017-10-11 01:56:38.578795
NCT02157753|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-08-30|||July 2012||2012-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Quality of the Detection & Treatment of Osteoporotic Fractures in a Swiss Trauma Center|Osteoporotic Fractures in a Swiss Trauma Center - Observational Study to Improve the Diagnosis and Management of and the Persistence to Therapy.|Recruiting||N/A|200|Anticipated|Kantonsspital Aarau|||1||f||||f||||||||||2017-10-11 00:20:48.371746|2017-10-11 00:20:48.371746
NCT02157740|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-10-13|||January 2014||2014-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|EVLINE||Assessment of Teleconsulting in Nursing Homes|Assessment of Teleconsulting in Nursing Homes|Unknown status|Recruiting|N/A|600|Anticipated|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||||||2017-10-11 00:20:48.448724|2017-10-11 00:20:48.448724
NCT02157727|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-10-13|||January 2014||2014-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Observational|Dite-ROP||Cost-effectiveness of Tele-expertise for Premature Infants for Retinopathy|Effectiveness and Cost-effectiveness of Tele-expertise for the Screening Examination of Premature Infants for Retinopathy of Prematurity|Completed||N/A|843|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||||||2017-10-11 00:20:48.684216|2017-10-11 00:20:48.684216
NCT02157714|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-10-19|||June 2014||2014-06-01|October 2016|2016-10-01||||September 2016|Actual|2016-09-01||Interventional|||Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of PRX002 Administered By Intravenous Infusion in Patients With Parkinson's Disease|Completed||Phase 1|64|Anticipated|Prothena Biosciences Limited||2|||f||||||||||||||2017-10-11 00:20:48.777068|2017-10-11 00:20:48.777068
NCT02157701|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-10-12|||June 2014||2014-06-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Polyherbal Capsule Formulation for Joint Health|Polyherbal Capsule Formulation for Joint Health: a Multicenter, 2-arm, Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 4|108|Actual|NewChapter, Inc.||2|||f||||f||||||||||2017-10-11 00:20:48.894423|2017-10-11 00:20:48.894423
NCT02157688|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-06-23|||March 2014||2014-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|SAFE||Impact of Staphylococcus Aureus on Folliculitis Decalvans|Role of Staphylococcus Aureus on Folliculitis Decalvans. A Comparative Bacteriological Study.|Completed||N/A|40|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-11 00:20:49.005433|2017-10-11 00:20:49.005433
NCT02157675|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-10-12|||April 2014||2014-04-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects of a Polyherbal Supplement on the Signs and Symptoms of Delayed Onset Muscle Soreness|The Effects of a Polyherbal Supplement on the Signs and Symptoms of Delayed Onset Muscle Soreness: a 2-arm, Randomized, Double-blind, Placebo-controlled, Crossover Design Study|Completed||Phase 4|27|Actual|NewChapter, Inc.||2|||f||||f||||||||||2017-10-11 00:20:49.085664|2017-10-11 00:20:49.085664
NCT02157662|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-07-27|||January 2011||2011-01-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2013|Actual|2013-07-01||Observational|CAPIRE||GISSI Outliers CAPIRE|Coronary Atherosclerosis in Outlier Subjects: Protective and Individual Risk Factor Evaluation|Active, not recruiting||N/A|544|Actual|Gruppo di Ricerca GISSI|||4||f||||f||||||Samples With DNA|"     whole blood and serum. Lipid profile Metabolic profile (HbA1c, HOMA index) inflammatory     profile (CRP, LP-PLA, pentraxine 3, MCP-1, IL-8, IL-10, IL-5, P-selectin, ICAM, VCAM-1,     CD40L, TIMP-1, MMP Genetic profile: chromosome polymorphism 9 (9p21)   "|||2017-10-11 00:20:49.187287|2017-10-11 00:20:49.187287
NCT02157649|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-04-14|||June 2014||2014-06-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin|An Open-Label, Single-Dose, Crossover Comparative Bioavailability and Pharmacokinetic Study of Codeine Phosphate/Guaifenesin Extended-Release Tablet With Immediate-Release Tablet|Completed||Phase 1|26|Actual|Nexgen Pharma, Inc||3|||f||||f||||||||||2017-10-11 00:20:49.285049|2017-10-11 00:20:49.285049
NCT02157636|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-11-22|||July 2014||2014-07-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma|A Phase 1 Study of CPI-0610, a Small Molecule Inhibitor of BET (Bromodomain and Extra-terminal) Proteins, in Patients With Previously Treated Multiple Myeloma|Recruiting||Phase 1|36|Anticipated|Constellation Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:20:49.423489|2017-10-11 00:20:49.423489
NCT02157623|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-05-01|2017-05-01||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|December 1, 2016|Actual|2016-12-01|September 1, 2016|Actual|2016-09-01||Interventional||study was terminated, no data|Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome|Pilot Trial Comparing Two Different Wavelengths of Light (Blue Versus Red) During Levulan™-Based Photodynamic Therapy of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome|Completed||N/A|7|Actual|The Cleveland Clinic||2|||f||||t||||||||Undecided||2017-10-11 00:20:49.558146|2017-10-11 00:20:49.558146
NCT02157610|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-04-06|||January 2015||2015-01-01|April 2017|2017-04-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Smoking Cessation for Cervical Cancer Survivors|Smoking Cessation for Cervical Cancer Survivors in a Safety Net Healthcare System|Recruiting||N/A|350|Anticipated|University of Oklahoma||2|||f||||f||||||||||2017-10-11 00:20:49.832333|2017-10-11 00:20:49.832333
NCT02157597|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-05-10|||November 2011||2011-11-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|NIRS||NIRS Guidance Trail in Children's Heart Surgery|Randomized Trial of Near-infrared Spectroscopy to Guide Intraoperative and Intensive Care Management in Children's Heart Surgery Requiring Cardiopulmonary Bypass|Completed||N/A|73|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||Undecided||2017-10-11 00:20:49.967835|2017-10-11 00:20:49.967835
NCT02157584|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-09-05|||June 2014||2014-06-01|September 2014|2014-09-01||||July 2014|Actual|2014-07-01||Interventional|||An Open-Label Food Effect Study of Telotristat Etiprate|A Phase 1, Randomized, Single Center, Open Label, 2 Sequence, 2 Period, Crossover Study to Evaluate the Effect of Food on the Single Dose Pharmacokinetics of Telotristat Etiprate (LX1606 Hippurate) in Healthy Male and Female Subjects|Completed||Phase 1|22|Actual|Lexicon Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:20:50.091908|2017-10-11 00:20:50.091908
NCT02157207|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2015-06-12|||April 2014||2014-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional|RACE||Racial and Aging Effects of Acute Antioxidant Supplementation|Racial and Aging Effects of Acute Antioxidant Supplementation|Completed||N/A|93|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-11 00:20:55.051714|2017-10-11 00:20:55.051714
NCT02157571|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-05|||June 2013||2013-06-01|June 2014|2014-06-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Exacerbations of Chronic Bronchitis With Levofloxacin Hydrochloride Tablet as Active Control||Unknown status|Recruiting|Phase 3|360|Anticipated|Lee's Pharmaceutical Limited||2|||f||||f||||||||||2017-10-11 00:20:50.170527|2017-10-11 00:20:50.170527
NCT02157558|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-09-05|||July 2014||2014-07-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||An Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Fexofenadine in Healthy Subjects|A Phase 1, Open-label, Single-center, 2-period, Single Sequence Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose Telotristat Etiprate on the Pharmacokinetics of Single-dose Fexofenadine, a Sensitive P Glycoprotein Substrate, in Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|Lexicon Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:20:50.27705|2017-10-11 00:20:50.27705
NCT02157545|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-07-15|||March 2014||2014-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine|The Dose-response Relationship of Rocuronium in Patients Taking Pyridostigmine Preoperatively Compared With Age and Sex Matched Controls|Withdrawn||Phase 4|0|Actual|University of Toledo Health Science Campus|||2|No eligible subjects identified. Study closed with IRB.|f||||f||||||||No|No data collected.|2017-10-11 00:20:50.362726|2017-10-11 00:20:50.362726
NCT02157532|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-08-03|||January 2013||2013-01-01|July 2016|2016-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|EASI||Endovascular Acute Stroke Intervention Trial - the EASI Trial|Intra-arterial Thrombectomy as an Acute Treatment Intervention for Stoke: the Endovascular Acute Stoke Intervention (EASI) Trial|Recruiting||N/A|480|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 00:20:50.436086|2017-10-11 00:20:50.436086
NCT02157506|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-03-22||2017-03-22|June 2014||2014-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure|A Phase IIa Study of the Safety, Tolerability and Hemodynamic Effects of a Continuous 6 Hour Intravenous Infusion of CXL-1427 in Hospitalized Patients With Systolic Heart Failure|Completed||Phase 2|46|Actual|Bristol-Myers Squibb||7|||f||||t||||||||||2017-10-11 00:20:50.629885|2017-10-11 00:20:50.629885
NCT02157493|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2015-01-20|||April 2014||2014-04-01|May 2014|2014-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation of an Entrepreneurship Program for American-Indian Youth|Evaluation of an Entrepreneurship Program on Psychosocial, Behavioral Health, Educational and Economic Outcomes Among American-Indian Youth|Unknown status|Recruiting|N/A|450|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 00:20:50.90812|2017-10-11 00:20:50.90812
NCT02157480|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-02-09|||September 2014||2014-09-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|ELECTRODIAB2||Effect of Electrostimulation on Glucose Profile of Patients With Type 2 Diabetes|ELECTRODIAB2: Effect of an Outpatient Program of Bi-quadricipital Electrostimulation on Glucose Profile of Sedentary Patients With Type 2 Diabetes.|Recruiting||Phase 2/Phase 3|48|Anticipated|University Hospital, Caen||3|||f||||f||||||||||2017-10-11 00:20:51.057878|2017-10-11 00:20:51.057878
NCT02157467|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-05-13|||June 2014||2014-06-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Combined Oral Contraceptive Effects in Female Subjects|The Effect of Coadministration of BMS-955176 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Female Subjects|Completed||Phase 1|22|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:20:51.230526|2017-10-11 00:20:51.230526
NCT02157454|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-11-09|||June 2014||2014-06-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|DIPExRCT||Effect of a Website Offering Individual Patients' Experiences for Cancer Patients|Randomized Controlled Trial to Evaluate the Effect of a Website Offering Individual Patient's Experiences on Patient Competence of Colorectal Cancer Patients|Completed||N/A|212|Actual|Berlin School of Public Health||2|||f||||f||||||||||2017-10-11 00:20:51.344603|2017-10-11 00:20:51.344603
NCT02157441|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-10-09|||July 2012||2012-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PPH||the Treatment of Postpartum Hemorrhage Due to Placenta Previa Complete Centralis|Lower Uterine Compression Sutures for the Treatment of Postpartum Hemorrhage Due to Placenta Previa Complete Centralis; Prospective Study|Completed||Phase 2/Phase 3|50|Actual|Benha University||1|||f||||f||||||||||2017-10-11 00:20:51.46824|2017-10-11 00:20:51.46824
NCT02157428|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2014-06-05|||January 2011||2011-01-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Flumazenil on Recovery From General Anesthesia With Isoflurane|Effect of Flumazenil on Recovery From General Anesthesia With Isoflurane: a Randomized Controlled Trial|Completed||N/A|36|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:20:51.587089|2017-10-11 00:20:51.587089
NCT02157415|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-04-27|||August 2013||2013-08-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prospective Cohort Study on Tolerability & Safety of Uro-Tainer® Polihexanide 0.02%|Prospective Cohort Study on the Tolerability and Safety of Uro-Tainer® Polihexanide 0.02% in Long-term Indwelling Catheterized Patients.|Recruiting||N/A|50|Anticipated|B. Braun Ltd. Centre of Excellence Infection Control||1|||f||||f||||||||||2017-10-11 00:20:51.670393|2017-10-11 00:20:51.670393
NCT02157402|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-06-03|||May 2014||2014-05-01|June 2014|2014-06-01||||September 2015|Anticipated|2015-09-01||Interventional|EYTO-SPAIN||EYTO (European Youth Tackling Obesity): A Randomized Controlled Trial in Catalonia (Spain)|A Youth Led Social Marketing Campaign to Encourage Healthy Lifestyles. EYTO (European Youth Tackling Obesity): A Randomized Controlled Trial in Catalonia (Spain)|Unknown status|Active, not recruiting|N/A|400|Anticipated|University Rovira i Virgili||2|||f||||t||||||||||2017-10-11 00:20:51.779213|2017-10-11 00:20:51.779213
NCT02157376|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-01-30|2016-11-28||July 2014||2014-07-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|SUP|Among 311 randomised patients, 300 patients received randomised treatment: 147 patients in the esomeprazole treatment group and 153 patients in the cimetidine treatment group.|Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients|Effect of Intravenous Esomeprazole Versus Cimetidine in Prevention of Stress Ulcer Prophylaxis in Chinese Seriously Ill Patients - a Randomized, Double-blind, Parallel-group Study|Completed||Phase 3|343|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:20:52.02303|2017-10-11 00:20:52.02303
NCT02157363|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-07-19|||June 2014||2014-06-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|June 2017|Actual|2017-06-01||Interventional|POETRI||POsitioning for Esophageal Cancer Resection|POsitioning for Esophageal Cancer Resection - a Randomized Controlled TRIal (POETRI)|Terminated||N/A|47|Actual|Technische Universität Dresden||2||poor recruitment due to change of surgical technique|f||||t||||||||||2017-10-11 00:20:52.526496|2017-10-11 00:20:52.526496
NCT02157350|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-06-27|||August 2014||2014-08-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|IMPETUS-D||The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT|A Prospective Study to Identify Predictive Factors for Progression and Regression of Proliferative Diabetic Retinopathy in Patients Receiving Standard Panretinal Laser Photocoagulation.|Active, not recruiting||Phase 3|100|Anticipated|Odense University Hospital||1|||f||||t||||||||No||2017-10-11 00:20:52.60074|2017-10-11 00:20:52.60074
NCT02157337|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-01-23|||March 12, 2014|Actual|2014-03-12|January 2017|2017-01-01|May 29, 2015|Actual|2015-05-29|May 29, 2015|Actual|2015-05-29||Interventional|||The Effect of Atorvastatin on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery|The Effect of Atorvastatin on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery|Completed||Phase 4|23|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:20:52.902678|2017-10-11 00:20:52.902678
NCT02157324|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-09-12|||August 2014||2014-08-01|September 2017|2017-09-01||||September 2018|Anticipated|2018-09-01||Interventional|||Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia|A Multicenter, Open-label, Phase 1 Pilot Study of ACP-196 in Combination With ACP-319 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|12|Actual|Acerta Pharma BV||2|||f||||f||||||||||2017-10-11 00:20:52.992824|2017-10-11 00:20:52.992824
NCT02157311|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-01-26|||July 2014||2014-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|ANRS162-4D||4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients|Evaluation of the Capacity of a Weekly Strategy of 4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV-1 Infected Patients With Undetectable Viral Load for at Least 12 Months, to Maintain a Virological Success With This Intermittent Maintenance Therapy After a Successful Continuous Induction Therapy.|Completed||Phase 3|100|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 00:20:53.12979|2017-10-11 00:20:53.12979
NCT02157298|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-03-29|2016-02-18||June 2014||2014-06-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Interventional||The Full Analysis Set defined as all randomized participants (as randomized) who received at least one dose of double-blind study medication, who have a non-missing baseline value and at least one post-baseline efficacy value for at least one efficacy variable during the short-term double-blind treatment period.|Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.|A 16-week Multicenter, Randomized, Parallel-group, Double-blind, Placebo-controlled Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin|Completed||Phase 4|266|Actual|AstraZeneca|For HbA1c, FPG and TBW: excluding data after insulin up-titration and for Mean Daily Insulin Dose: including data after insulin up-titration were used. For participants who did not complete week 16 last observation carried forward (LOCF) was used.|2|||f||||f||||||||||2017-10-11 00:20:53.359322|2017-10-11 00:20:53.359322
NCT02157285|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2014-06-05|||February 2013||2013-02-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|ImPACCT||Influence of Peer Mentoring on Adolescent Contraceptive Decision Making|The Influence of Peer Mentoring on Contraceptive Decision Making Among Adolescents|Completed||N/A|110|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 00:20:54.157537|2017-10-11 00:20:54.157537
NCT02157272|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-05-02|||December 2014||2014-12-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TRAPS||Rivaroxaban in Thrombotic Antiphospholipid Syndrome|A Prospective, Randomized Clinical Trial Comparing Rivaroxaban vs Warfarin in High Risk Patients With Antiphospholipid Syndrome|Recruiting||Phase 3|536|Anticipated|University of Padova||2|||f||||t||||||||||2017-10-11 00:20:54.283653|2017-10-11 00:20:54.283653
NCT02157259|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-02-17|||December 2013||2013-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|SEA050||An Observational Study of the Causes, Management, and Outcomes of Community-acquired Sepsis and Severe Sepsis in Southeast Asia|An Observational Study of the Causes, Management, and Outcomes of Community-acquired Sepsis and Severe Sepsis in Southeast Asia|Completed||N/A|2250|Actual|University of Oxford|||1||f||||f||||||Samples With DNA|"     Whole blood   "|Yes||2017-10-11 00:20:54.446605|2017-10-11 00:20:54.446605
NCT02157246|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-03-08|||October 2013||2013-10-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|RHYTHM-I||RHYTHM-I: Investigating Hypoxia in Rectal Tumours|RHYTHM-I: Modulation of Radiotherapy According to HYpoxia: Exploiting Changes in the Tumour Microenvironment to Improve Outcome in Rectal Cancer.|Completed||N/A|14|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 00:20:54.655072|2017-10-11 00:20:54.655072
NCT02157233|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-02-12|||October 2013||2013-10-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|APPA||Post-exercise Food Intake Regulation in a Hot Environment|Post-exercise Food Intake Regulation in a Hot Environment|Completed||N/A|10|Actual|University of the French West Indies and French Guiana||2|||f||||f||||||||||2017-10-11 00:20:54.805897|2017-10-11 00:20:54.805897
NCT02157220|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-03|||May 2005||2005-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2012|Actual|2012-05-01||Interventional|||Prospective Double-blinded Randomised Comparison of Profix Mobile to Fixed Bearing Knee Replacements||Completed||N/A|77|Actual|The University of New South Wales||2|||f||||f||||||||||2017-10-11 00:20:54.921775|2017-10-11 00:20:54.921775
NCT02157181|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-06-03|||June 2004||2004-06-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab|Study on the Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia|Completed||Phase 2|89|Actual|University of Giessen||1|||f||||f||||||||||2017-10-11 00:20:55.301246|2017-10-11 00:20:55.301246
NCT02157155|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2015-12-01|||June 2014||2014-06-01|June 2014|2014-06-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis|The Role of ATGL and G0/G1 Switch Gene Complex in Lipopolysaccaride (LPS) Induced Ketosis - a Controlled, Randomised, Clinical Experimental Study|Completed||N/A|9|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:20:55.740748|2017-10-11 00:20:55.740748
NCT02157142|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-03-24|||August 2014||2014-08-01|March 2015|2015-03-01|March 2020|Anticipated|2020-03-01|December 2014|Actual|2014-12-01||Interventional|HORIZON||HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON|HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON|Terminated||N/A|4|Actual|HLT Inc.||1||HLT determined that design changes are necessary before reopening the study|f||||t||||||||||2017-10-11 00:20:55.876259|2017-10-11 00:20:55.876259
NCT02157129|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-08-16|||May 2014||2014-05-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||LipoAerosol© Inhalation After Tracheostomy|LipoAerosol© Inhalation to Maintain the Functional Integrity of the Tracheo-bronchial System in Patients After Tracheostomy|Completed||N/A|100|Actual|Technische Universität München||2|||f||||t||||||||||2017-10-11 00:20:55.992243|2017-10-11 00:20:55.992243
NCT02157116|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-06-05|2014-06-05||May 2006||2006-05-01|June 2014|2014-06-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer|Dose-Dense Induction/Neoadjuvant Chemotherapy in the Treatment of Patients With Locally Advanced Non-Small Cell Lung Cancer With Additional Genomic Analyses to Identify Signatures Predictive of Chemotherapy Response.|Terminated||Phase 2|13|Actual|Duke University||1||Insufficient accrual to meet analysis goals|f||||f||||||||||2017-10-11 00:20:56.131322|2017-10-11 00:20:56.131322
NCT02157103|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-05-17|||January 2014||2014-01-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma|A Phase II Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma|Active, not recruiting||Phase 2|3|Actual|Emory University||1|||f||||t||||||||Undecided||2017-10-11 00:20:56.509746|2017-10-11 00:20:56.509746
NCT02157090|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-28|2014-06-02|||August 2009||2009-08-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.|Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS (Hansaplast®) Based on Hydrocolloids Without Active Substances in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product (Herpes Vesicle Patch of COMPEED®)|Completed||N/A|||Technische Universität Dresden||2|||f||||||||||||||2017-10-11 00:20:56.652327|2017-10-11 00:20:56.652327
NCT02157077|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2016-06-20|||December 2013||2013-12-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ARI2||Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration|A Phase III b, Multicenter Study of the Efficacy and Safety of Aflibercept Switch in Patients With Exudative AMD With Detachment of the Retinal Pigment Epithelium and Previously Treated With Ranibizumab Intravitreal Injection. (ARI2)|Completed||Phase 3|90|Actual|Centre Hospitalier Intercommunal Creteil||1|||f||||t||||||||||2017-10-11 00:20:56.746988|2017-10-11 00:20:56.746988
NCT02157064|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2017-08-31|||May 2014||2014-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Outcomes Data of Adipose Stem Cells to Treat Multiple Sclerosis|Autologous Adipose Stromal Vascular Fraction Outcomes Research Study|Active, not recruiting||N/A|220|Actual|StemGenex|||1||f||||f||||||||||2017-10-11 00:20:56.871867|2017-10-11 00:20:56.871867
NCT02157051|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-06-20|||June 2015|Actual|2015-06-01|June 2017|2017-06-01|February 2022|Anticipated|2022-02-01|February 2022|Anticipated|2022-02-01||Interventional|||Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer|A Phase I Trial of the Safety and Immunogenicity of a Multiple Antigen Vaccine (STEMVAC) in HER2 Negative Advanced Stage Breast Cancer Patients|Recruiting||Phase 1|30|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 00:20:56.948056|2017-10-11 00:20:56.948056
NCT02157038|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-01-16|||July 2014||2014-07-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Neuromuscular Mechanisms Underlying Poor Recovery From Whiplash Injuries|Neuromuscular Mechanisms Underlying Poor Recovery From Whiplash Injuries|Recruiting||Early Phase 1|100|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-11 00:20:57.056538|2017-10-11 00:20:57.056538
NCT02157025|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-04-06|||February 2015||2015-02-01|April 2017|2017-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics||Recruiting||N/A|20|Anticipated|Nova Southeastern University||2|||f||||f||||||||||2017-10-11 00:20:57.194936|2017-10-11 00:20:57.194936
NCT02156986|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-08-04|||October 2013||2013-10-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Chewing Capability Study for Infants and Toddlers|Effect of Food Structural Properties on Infants and Toddlers Mastication Abilities|Completed||N/A|68|Actual|Nestlé|||5||f||||f||||||||||2017-10-11 00:20:57.420852|2017-10-11 00:20:57.420852
NCT02156973|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-10-29|||June 2014||2014-06-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Using Media to Reduce Anxiety for Cardiac Computed Tomography|Using Media to Reduce Anxiety for Cardiac Computed Tomography|Completed||N/A|130|Anticipated|Plymouth Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 00:20:57.478056|2017-10-11 00:20:57.478056
NCT02156947|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2014-06-03|||January 2012||2012-01-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Correlation Between Power Doppler and Intraoperative Findings of Chronic and Acute Cholecystitis|Correlation Between Preoperative Power Doppler Sonography and Intraoperative Findings - Postoperative Outcomes of Chronic and Acute Cholecystitis Patients: Prospective Clinical Study|Completed||N/A|80|Actual|Samsun Education and Research Hospital|||2||f||||f||||||Samples Without DNA|"     Resected gallbladders pathology   "|||2017-10-11 00:20:57.638237|2017-10-11 00:20:57.638237
NCT02156934|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-12-03|||January 2014||2014-01-01|October 2013|2013-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Paraurethral Transplantation of Autologous Muscle Derived Stem Cells for Treatment of Stress Incontinency|Evaluation the Effect of Autologous Muscle Derived Stem Cells Injection Into the Paraurethral Tissues for Treatment of Stress Urinary Incontinency,The Randomized Clinical Trial Phase II|Completed||Phase 2|20|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 00:20:57.715769|2017-10-11 00:20:57.715769
NCT02156921|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-10-26|||May 2014||2014-05-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|June 2014|Actual|2014-06-01||Interventional|||App-guided Training in eFAST Ultrasound|Cost-effectiveness of Mobile App-guided Training in Extended Focused Assessment With Sonography for Trauma (eFAST): A Randomized Trial|Completed||N/A|34|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||No||2017-10-11 00:20:57.788974|2017-10-11 00:20:57.788974
NCT02156895|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-28|||December 31, 2017|Anticipated|2017-12-31|September 2017|2017-09-01|August 21, 2018|Anticipated|2018-08-21|August 21, 2018|Anticipated|2018-08-21||Observational|||Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea|Post Marketing Surveillance Study To Observe Safety And Efficacy Of Inlyta|Not yet recruiting||N/A|3000|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-11 00:20:58.039723|2017-10-11 00:20:58.039723
NCT02156882|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2016-09-07|||June 2014||2014-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Observational|MaTuTU||Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique|Maputo Tuberculosis Trial Unit- Project (MaTuTU- Project)|Completed||N/A|81|Actual|Ludwig-Maximilians - University of Munich|||1||f||||f||||||Samples Without DNA|"     Sputum, Urine, Blood   "|||2017-10-11 00:20:58.137395|2017-10-11 00:20:58.137395
NCT02156869|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-06-04|||November 2012||2012-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|February 2013|Actual|2013-02-01||Interventional|PSAMG||Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer Screening|Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer Screening: a Multicenter Pragmatic Randomized Controlled Trial|Completed||N/A|1170|Actual|University Paris 7 - Denis Diderot||2|||f||||f||||||||||2017-10-11 00:20:58.240082|2017-10-11 00:20:58.240082
NCT02156856|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-08-07|||May 2014||2014-05-01|August 2014|2014-08-01||||May 2015|Anticipated|2015-05-01||Observational|standart||Stroke Volume Analysis During Aortic Valve Replacement Trial||Unknown status|Recruiting|N/A|68|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 00:20:58.353472|2017-10-11 00:20:58.353472
NCT02156843|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-03-08|||June 2014||2014-06-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PIONEER||Pyridorin in Diabetic Nephropathy|A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)|Terminated||Phase 3|328|Actual|NephroGenex, Inc.||2|||f||||t||||||||||2017-10-11 00:20:58.482981|2017-10-11 00:20:58.482981
NCT02156830|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-02-04|||August 2013||2013-08-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Multidisciplinary Approach and Counseling of the Obese Patient Before and After Bariatric Surgery|Multidisciplinary Approach and Counseling of the Obese Patient Before and After Bariatric Surgery: Qualitative Interviews|Completed||N/A|48|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-11 00:20:58.971232|2017-10-11 00:20:58.971232
NCT02156817|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2014-06-02|||March 2014||2014-03-01|June 2014|2014-06-01||||March 2016|Anticipated|2016-03-01||Observational|NEMO Project||Neurophysiologic Maturation Index for Moderate and Late Preterm Infants|Neurophysiologic Maturation Index: NEMO Project for Moderate and Late Preterm Infants|Unknown status|Recruiting|N/A|171|Anticipated|Brown University|||2||f||||||||||||||2017-10-11 00:20:59.053309|2017-10-11 00:20:59.053309
NCT02156804|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-26|||October 7, 2014|Actual|2014-10-07|September 2017|2017-09-01|March 10, 2020|Anticipated|2020-03-10|February 26, 2018|Anticipated|2018-02-26||Interventional|||A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172)|A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody|Active, not recruiting||Phase 2|800|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:20:59.198521|2017-10-11 00:20:59.198521
NCT02156791|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-06-05|||August 2013||2013-08-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM|Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM Administered Subcutaneously to Hay Fever Patients|Completed||Phase 2|61|Actual|BioTech Tools S.A.||1|||f||||t||||||||||2017-10-11 00:20:59.70692|2017-10-11 00:20:59.70692
NCT02156765|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-06-04|||October 2013||2013-10-01|June 2014|2014-06-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01|6 Days|Observational [Patient Registry]|CRIST||China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients|China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients|Unknown status|Recruiting|N/A|3000|Anticipated|Ministry of Science and Technology of the People´s Republic of China|||1||f||||t||||||||||2017-10-11 00:20:59.988446|2017-10-11 00:20:59.988446
NCT02156752|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-10-02|||January 2015||2015-01-01|May 2014|2014-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Using Novel Behavioral Approaches to Improve Long-Term Weight Loss Outcomes||Active, not recruiting||N/A|190|Anticipated|The Miriam Hospital||3|||f||||f||||||||||2017-10-11 00:21:00.111931|2017-10-11 00:21:00.111931
NCT02156739|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-08-25|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Liver Lesions in Contrast-Enhanced Magnetic Resonance Imaging (MRI)|Radiologic Detection and Characterization of Benign and Malignant Liver Lesions in Contrast-Enhanced Magnetic Resonance Imaging (MRI)|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:21:00.230782|2017-10-11 00:21:00.230782
NCT02156726|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2014-06-03|||March 2011||2011-03-01|May 2014|2014-05-01|July 2015|Anticipated|2015-07-01|October 2014|Anticipated|2014-10-01||Observational|Q-lite||Observational Study of Low Dose FCR in Elderly/Comorbid CLL/SLL: The Q-lite Project|Observational Study of Low Dose FCR in the Treatment of Elderly/Comorbid Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: The Q-lite Project|Unknown status|Active, not recruiting|N/A|200|Anticipated|Czech CLL Study Group|||1||f||||f||||||||||2017-10-11 00:21:00.345588|2017-10-11 00:21:00.345588
NCT02156713|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-02-03|||May 2014||2014-05-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Constraint Induced Movement Therapy Summer Camp|Constraint Induced Movement Therapy Summer Camp for Children With Unilateral Cerebral Palsy Ages 3-7|Completed||N/A|10|Actual|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-11 00:21:00.519984|2017-10-11 00:21:00.519984
NCT02156700|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-12-23|||September 2013||2013-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors|Quantitative Real-time Ultrasound Elastography (Shear Wave Elastography - SWE™) for Characterisation of Liver Tumors|Completed||N/A|196|Actual|University Hospital Dubrava|||1||f||||f||||||||||2017-10-11 00:21:00.614561|2017-10-11 00:21:00.614561
NCT02156687|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-10-25|||May 2014||2014-05-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Randomized Trial of Y Mesh vs Dual Mesh|A Prospective Randomized Trial Comparing Restorelle Y Mesh vs. Restorelle Dual Flat Mesh for Laparoscopic and Robotic-assisted Laparoscopic Sacrocolpopexy|Recruiting||N/A|60|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 00:21:00.701924|2017-10-11 00:21:00.701924
NCT02156674|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-10-03|||January 26, 2016|Actual|2016-01-26|September 2017|2017-09-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome|Study of Administration of Intravenous Naglazyme® Following Allogeneic Transplantation for Maroteaux-Lamy Syndrome|Active, not recruiting||N/A|1|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 00:21:00.805058|2017-10-11 00:21:00.805058
NCT02156661|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-05-05|||May 2013||2013-05-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Oxytocin and Emotion Processing||Completed||Phase 1|97|Actual|University Hospital, Bonn||2|||f||||f||||||||||2017-10-11 00:21:00.888334|2017-10-11 00:21:00.888334
NCT02156648|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-01-27|||August 2014||2014-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OTT14-01||A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma|A Feasibility Study for Women Receiving Adjuvant or Neo-adjuvant Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma|Active, not recruiting||N/A|20|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-11 00:21:00.955801|2017-10-11 00:21:00.955801
NCT02156635|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-12-04|||February 2016||2016-02-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|June 2016|Anticipated|2016-06-01||Interventional|START-tDCS||Stroke Treatment Associate to Rehabilitation Therapy and Transcranial DC Stimulation|A Double-blind, Sham-controlled, Randomized Clinical Trial on Stroke Treatment Using Transcranial Direct Current Stimulation|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Federal University of Paraíba||2|||f||||f||||||||||2017-10-11 00:21:01.024444|2017-10-11 00:21:01.024444
NCT02156622|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-06-04|||July 2009||2009-07-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01|12 Months|Observational [Patient Registry]|ADEPT||CID 0911 - Adaptation of A Depression Treatment Intervention for HIV Patients in Cameroon|CID 0911 - Adaptation of A Depression Treatment Intervention for HIV Patients in Cameroon|Completed||N/A|55|Actual|University of North Carolina, Chapel Hill|||1||f||||t||||||Samples Without DNA|"     Assessed CD4 counts and viral loads   "|||2017-10-11 00:21:01.191277|2017-10-11 00:21:01.191277
NCT02156609|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-04-08|||June 2014||2014-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|HM PHP CE Mark||HeartMate PHP™ CE Mark Clinical Investigation Plan|HeartMate PHP™ CE Mark Clinical Investigation Plan|Completed||N/A|50|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 00:21:01.284124|2017-10-11 00:21:01.284124
NCT02156596|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-04-01|||February 2013||2013-02-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|NSAIvsNM||IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic|Intravenous Treatment With Non Steroidal Anti Inflammatory Drugs (NSAID) Versus Nebulized Morphine (NM) Analgesia for First-line Renal Colic: Randomized Controlled Double-blind Single-center Study.|Recruiting||Phase 1|100|Anticipated|University of Monastir||2|||f||||t||||||||Undecided||2017-10-11 00:21:01.401521|2017-10-11 00:21:01.401521
NCT02156583|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-12-11|||May 2014||2014-05-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Observational|||Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients|Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients|Recruiting||N/A|20|Anticipated|Thomas Jefferson University|||1||f||||f||||||||||2017-10-11 00:21:01.531299|2017-10-11 00:21:01.531299
NCT02156570|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-10-19|||October 2014||2014-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|DARE-C II||DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)|An Interferon Sparing Strategy of Sofosbuvir Plus Ribavirin for the Treatment of Recently Acquired Hepatitis C Infection|Active, not recruiting||Phase 4|20|Anticipated|Kirby Institute||1|||f||||t||||||||||2017-10-11 00:21:01.621971|2017-10-11 00:21:01.621971
NCT02156557|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-04-01|||June 2014||2014-06-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|KCC 1B||Study of KCC Peptide Application in the Colon|Phase 1B Study of KCC Peptide Application in the Colon|Completed||Phase 1|45|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 00:21:01.784767|2017-10-11 00:21:01.784767
NCT02156544|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2015-09-09|||June 2014||2014-06-01|May 2014|2014-05-01|August 2015|Actual|2015-08-01|October 2014|Actual|2014-10-01||Interventional|CKD-519 FIH||Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519|A Dose-block Randomized, Double-blind, Placebo-controlled, Single Dosing, Dose-escalation Phase I Clinical Trial to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 After Oral Administration in Healthy Adult Volunteers|Completed||Phase 1|41|Actual|Chong Kun Dang Pharmaceutical||5|||f||||f||||||||||2017-10-11 00:21:01.972407|2017-10-11 00:21:01.972407
NCT02156531|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-04-27|||September 2014||2014-09-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|TeenCBM||Cognitive Bias Modification for Youth Anxiety|An Efficacy-Effectiveness Trial of Cognitive Bias Modification for Youth Anxiety|Recruiting||N/A|498|Anticipated|Kaiser Permanente||3|||f||||t||||||||||2017-10-11 00:21:02.116184|2017-10-11 00:21:02.116184
NCT02156518|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-05-01|||June 2014||2014-06-01|May 2017|2017-05-01|April 3, 2018|Anticipated|2018-04-03|April 3, 2018|Anticipated|2018-04-03||Interventional|||The Efficacy of Vocal Function Exercises for Laryngeal Cancers|Investigating the Efficacy of Vocal Function Exercises in the Treatment of Voice Problems in Adults Treated With Radiation Therapy for Laryngeal Cancers|Recruiting||N/A|20|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 00:21:02.238267|2017-10-11 00:21:02.238267
NCT02156505|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-04|||January 2013||2013-01-01|June 2014|2014-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Outcome Study of Double Bare Stent for Malignant Gastric Outlet Obstruction|Phase IV Study of Double Bare Self-expandable Metallic Stent for Malignant Gastric Outlet Obstruction|Unknown status|Recruiting|Phase 4|49|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-10-11 00:21:04.339994|2017-10-11 00:21:04.339994
NCT02156492|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-01-07|||June 2014||2014-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants|A Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Study of Evacetrapib With Selected Statins in Healthy Chinese Subjects|Completed||Phase 1|62|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 00:21:04.447578|2017-10-11 00:21:04.447578
NCT02156479|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-03-06|||July 2014||2014-07-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Observational|AlloProtectCMV||Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients|Clinical Validation of an Improved T-Track® CMV Assay to Assess the Functionality of CMV Protein-reactive Cell-mediated Immunity (CMI) and Its Suitability to Determine a Protective Cut-off Value for Recurrent CMV Reactivations in Allo-HSCT Recipients|Recruiting||N/A|150|Anticipated|Lophius Biosciences GmbH|||1||f||||f||||||||||2017-10-11 00:21:04.554252|2017-10-11 00:21:04.554252
NCT02156466|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-11-28|2016-08-24||August 2014||2014-08-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Safety analysis set included all 41 subjects who received at least 1 dose of investigational medicinal product (IMP) (MSB0010841 or placebo).|Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects|Multicenter, Phase I, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, Immunogenicity, Pharmacokinetics, Pharmacodynamics and Efficacy of Multiple Ascending Doses of Subcutaneous MSB0010841 (Anti-IL17A/F Nanobody) in Male and Female Subjects With Moderate to Severe Psoriasis|Completed||Phase 1|41|Actual|Merck KGaA|"As AUCextra was more than 20% of AUC0-inf after first dose, AUCextra and all values derived from λz were regarded as implausible and AUC0-inf, MRT0-inf, t1/2, λz, CL/f, and Vz/f were not calculated after first dose."|5|||f||||||||||||||2017-10-11 00:21:04.811542|2017-10-11 00:21:04.811542
NCT02156453|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-09-13|||May 2013||2013-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01|1 Year|Observational [Patient Registry]|||Functional Recovery After Total Knee Arthroplasty|The Evaluation of Short-term Functional Recovery of Total Knee Arthroplasty Patients|Recruiting||N/A|60|Anticipated|Mahidol University|||1||f||||f||||||||||2017-10-11 00:21:08.651609|2017-10-11 00:21:08.651609
NCT02156440|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-04|||September 2011||2011-09-01|June 2014|2014-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|11SOHS||Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee|A Double Blind, Placebo Controlled Cross Over Study to Explore the Efficacy of SierraSil® Joint Formula 14™ in Adults With Osteoarthritis of the Knee|Completed||Phase 2|150|Actual|KGK Synergize Inc.||2|||f||||||||||||||2017-10-11 00:21:08.752949|2017-10-11 00:21:08.752949
NCT02156427|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-07-08|||May 2014||2014-05-01|July 2015|2015-07-01||||September 2016|Anticipated|2016-09-01||Interventional|||A Multicenter Trial of Non-cultured Epidermal Cellular Grafting Versus Hyaluronic Acid for Repigmenting Stable Leukoderma (Vitiligo and Piebaldism)||Unknown status|Recruiting|Phase 3|60|Anticipated|Laboratoires Genévrier||2|||f||||t||||||||||2017-10-11 00:21:08.868543|2017-10-11 00:21:08.868543
NCT02156414|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-04-21|||March 2013||2013-03-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01|1 Month|Observational [Patient Registry]|LNIEPLCLPC||Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer|Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer in Bogota Colombia.|Completed||N/A|135|Actual|Javeriana University|||1||f||||t||||||||||2017-10-11 00:21:09.016891|2017-10-11 00:21:09.016891
NCT02156401|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2015-04-23|||April 2013||2013-04-01|April 2015|2015-04-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Observational|VTEval||VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE|VTEval Project - Three Observational, Prospective Cohort Studies Including Biobanking to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in Venous Thromboembolism|Recruiting||N/A|2000|Anticipated|Johannes Gutenberg University Mainz|||3||f||||f||||||Samples With DNA|"     Serum, Na-Citrated Plasma, EDTA-Plasma, Lit-Heparin, DNA, RNA, Urine   "|||2017-10-11 00:21:09.177303|2017-10-11 00:21:09.177303
NCT02156388|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-02-22|||August 2013||2013-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors|A Single-center, Uncontrolled, Open, Phase 1 Study of Recombinant(Expressed by Pichia Pastoris) Human Serum Albumin/Human Granulocyte-Colony Stimulating Factor(I)Fusion Protein For Injection(GW003)to Metastatic Tumors|Completed||Phase 1|31|Actual|Jiangsu T-Mab Biopharma Co.,Ltd||8|||f||||f||||||||||2017-10-11 00:21:09.31704|2017-10-11 00:21:09.31704
NCT02156375|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-03-21|||May 2014||2014-05-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations|A Phase 1, Randomized, Open-label, Parallel-design Study to Compare Single-dose Pharmacokinetics of Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations|Completed||Phase 1|140|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:21:09.435027|2017-10-11 00:21:09.435027
NCT02156362|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-07-04|||May 2012|Actual|2012-05-01|July 2017|2017-07-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|||Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)|Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)|Recruiting||N/A|650|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:21:09.561844|2017-10-11 00:21:09.561844
NCT02156349|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-04-13|||May 15, 2014|Actual|2014-05-15|April 2017|2017-04-01|April 11, 2017|Actual|2017-04-11|April 11, 2017|Actual|2017-04-11||Interventional|PDMProValueDSP||A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.|Integrated Personalized Diabetes Management (Integrated PDM): Prospective, Randomized, Controlled Intervention Study for the Evaluation of the Effectiveness and the Benefit of Integrated PDM in the Care of People With Type 2 Diabetes in Diabetes Specialized Medical Practices in Germany (DSP)|Completed||N/A|558|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:21:09.685107|2017-10-11 00:21:09.685107
NCT02156336|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-02-09|||May 2014||2014-05-01|February 2017|2017-02-01|February 8, 2017|Actual|2017-02-08|February 8, 2017|Actual|2017-02-08||Interventional|||Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)|A Double-Blind, Placebo-Controlled, Randomized, Parallel Assignment, U.S. Study of Ranolazine for the Treatment of Patients With Diabetic Peripheral Neuropathic Pain (DPNP)|Terminated||Phase 4|4|Actual|Horizons International Peripheral Group||2||Not enough patients met study criteria for enrollment.|f||||f||||||||||2017-10-11 00:21:09.891925|2017-10-11 00:21:09.891925
NCT02156323|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-11-01|||July 2014||2014-07-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS)|A SINGLE-CENTER, OPEN-LABEL, RANDOMIZED, TWO SEQUENCE, 3-WAY CROSSOVER STUDY TO INVESTIGATE THE INTERACTION BETWEEN MULTIPLE DOSES OF COLISTIN METHANESULFONATE SODIUM (CMS) AND MULTIPLE DOSES OF RO7033877 IN HEALTHY SUBJECTS|Completed||Phase 1|28|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:21:10.042464|2017-10-11 00:21:10.042464
NCT02156310|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-06-03|||January 2009||2009-01-01|June 2014|2014-06-01||||December 2012|Actual|2012-12-01||Observational|||Mechanisms of Anti-VEGF Induced Hypertension|Associations Between Antihypertensive Drugs and Patterns of Blood Pressure Changes: a Strategy to Reduce the Burden of Anti-VEGF Induced Hypertension|Completed||N/A|2000|Actual|Flinders University|||1||f||||f||||||||||2017-10-11 00:21:10.133065|2017-10-11 00:21:10.133065
NCT02156297|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-10-07|||June 2014||2014-06-01|October 2015|2015-10-01|August 2019|Anticipated|2019-08-01|May 2019|Anticipated|2019-05-01||Observational|||Sorafenib to Treat FLT3-ITD AML|Sorafenib to Treat AML Patients With FLT3-ITD Mutation: a Non-interventional Cohort Study|Recruiting||N/A|100|Anticipated|The First Affiliated Hospital of Soochow University|||5||f||||f||||||||||2017-10-11 00:21:10.299759|2017-10-11 00:21:10.299759
NCT02156284|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-06-04|||May 2011||2011-05-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Nurse Empathic Behaviour to Reduce the Fear in Patients of Preoperative Cardiac Surgery|Nurse Empathic Behaviour to Reduce the Fear in Patients of Preoperative Cardiac Surgery|Completed||N/A|44|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-10-11 00:21:10.484054|2017-10-11 00:21:10.484054
NCT02156271|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-07-09|2014-10-20||July 2007||2007-07-01|May 2014|2014-05-01||||June 2008|Actual|2008-06-01||Interventional|||Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance|Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance|Completed||Phase 4|75|Actual|Duke University||2|||f||||||||||||||2017-10-11 00:21:10.602827|2017-10-11 00:21:10.602827
NCT02156258|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-02-01|||June 2014||2014-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Observational|||Acquisition of Breast Mammography Images|Acquisition of Digital Mammography and Breast Images for Clinical Evaluation of FujifilmDigital Breast Tomosynthesis|Active, not recruiting||Phase 3|1232|Actual|Fujifilm Medical Systems USA, Inc.|||3||f||||f||||||||||2017-10-11 00:21:11.262278|2017-10-11 00:21:11.262278
NCT02156245|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-10-27|||September 2013||2013-09-01|October 2016|2016-10-01||||February 2018|Anticipated|2018-02-01||Interventional|||Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training|Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training|Recruiting||N/A|229|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:21:11.356856|2017-10-11 00:21:11.356856
NCT02156232|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-07-05|||June 2014||2014-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Refractory Hepatic Encephalopathy|Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Refractory Hepatic Encephalopathy: a Prospective、Open-labeled、Randomized、Controlled Trial|Recruiting||N/A|40|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-11 00:21:11.438183|2017-10-11 00:21:11.438183
NCT02156219|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-07-25|||January 1, 2014|Actual|2014-01-01|February 2017|2017-02-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Impact Evaluation of Separating Women and Men in the Metro of Mexico City|"Building Capacity of State and Local Actors to Respond to Violence Against Women: Impact Evaluation of Separating Women and Men in the Metro of Mexico City, Component of the Program Viajemos Seguras"|Suspended||N/A|2360|Anticipated|Econometría Consultores|||2|The STC has had financial limitations to start implementing the intervention.|f||||f||||||||||2017-10-11 00:21:11.549152|2017-10-11 00:21:11.549152
NCT02156206|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-02-06|||June 2014||2014-06-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01||Observational|||Impact Evaluation of the 123 Women Emergency Phone Line in Medellín, Colombia|"Building Capacity of State and Local Actors to Respond to Violence Against Women: Impact Evaluation of the 123 Women Emergency Phone Line in Medellín (Colombia), Component of the Program Seguridad Pública."|Completed||N/A|765|Actual|Econometría Consultores|||2||f||||f||||||||||2017-10-11 00:21:11.64134|2017-10-11 00:21:11.64134
NCT02156193|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2014-06-04|||July 2014||2014-07-01|June 2014|2014-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Prophylactic Clip|Effect of Prophylactic Clip Application for the Prevention of Postpolypectomy Bleeding in Large Pedunculated Colonic Polyps: a Randomized, Controlled Trial|Unknown status|Not yet recruiting|N/A|340|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-10-11 00:21:11.746698|2017-10-11 00:21:11.746698
NCT02156180|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-04-20|||April 2014||2014-04-01|April 2015|2015-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma|A Prospective Cohort Study to Determine Specific Volatile Organic Compounds Present in Breath Samples of Patients With Oral Cavity or Oropharyngeal Squamous Cell Carcinoma Using Gas Chromotography-mass Spectrometry|Suspended||N/A|13|Actual|Queensland Centre of Excellence for Head and Neck Cancer|||1|Awaiting funding to facilitate selected-ion flow-tube mass spectrometry (SIFT/MS)|f||||f||||||||||2017-10-11 00:21:11.869584|2017-10-11 00:21:11.869584
NCT02156167|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2016-06-09|2016-06-09||March 2014||2014-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Clinical Assessment of the External Sound Processor Worn by Patients Implanted With Codacs|Clinical Validation of the Nucleus® CP810 Sound Processor for the Codacs™ System|Completed||N/A|15|Actual|Cochlear||1|||f||||f||||||||||2017-10-11 00:21:12.005838|2017-10-11 00:21:12.005838
NCT02156154|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-10-04|||December 2014||2014-12-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of Intravenous Acetaminophen on Postoperative Opioid-related Complications|Effect of Intravenous Acetaminophen on Postoperative Opioid-related Complications|Recruiting||Phase 3|528|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 00:21:12.288864|2017-10-11 00:21:12.288864
NCT02156141|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2014-06-04|||June 2014||2014-06-01|June 2014|2014-06-01||||June 2016|Anticipated|2016-06-01||Interventional|HIT in Kennedy||High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy|High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy|Unknown status|Not yet recruiting|N/A|30|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:21:12.403883|2017-10-11 00:21:12.403883
NCT02156128|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-01-24|||October 2013||2013-10-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Subjective Memory Complaints, Objective Memory Performance and Cognitive Training|Study of Subjective Memory Complaints, Objective Memory Performance and Cognitive Training in Patients With Complex Symptom Disorders|Completed||N/A|54|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 00:21:12.520259|2017-10-11 00:21:12.520259
NCT02156115|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-06-30|||May 28, 2014||2014-05-28|March 13, 2017|2017-03-13|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders|Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:21:12.637768|2017-10-11 00:21:12.637768
NCT02156102|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-07-06|||May 20, 2014||2014-05-20|April 3, 2017|2017-04-03|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study)|Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:21:12.741001|2017-10-11 00:21:12.741001
NCT02156089|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-04|2017-06-30|||May 16, 2014||2014-05-16|January 24, 2017|2017-01-24|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Neuroimaging, Omega-3 and Reward in Adults With ADHD (NORAA) Trial|Neuroimaging Omega-3 and Reward in Adults With ADHD (NORAA) Trial|Active, not recruiting||Phase 2|63|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:21:12.841324|2017-10-11 00:21:12.841324
NCT02156076|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-04-17||2017-03-22|July 2014||2014-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation|A Randomized, Double-Blind, Placebo-Controlled Parallel Arm Study to Evaluate the Safety, Tolerability, and Effect on Atrial Fibrillation Burden of BMS-919373 in Patients With Paroxysmal Atrial Fibrillation|Completed||Phase 2|27|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 00:21:12.94938|2017-10-11 00:21:12.94938
NCT02156063|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2015-07-13|||June 2014||2014-06-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|RESPONSE||A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)|A Randomised, Double Blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|Nora Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 00:21:13.142018|2017-10-11 00:21:13.142018
NCT02156050|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-06-03|||December 2013||2013-12-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ICT-O2||Use of a New Phototherapy Device (BBloo®) for the Treatment of Hyperbilirubinemia in the Newborn Infant|Utilisation du Dispositif BBloo® Pour le Traitement de l'ictère néonatal : Satisfaction Des Parents et Des Personnels Soignants|Unknown status|Recruiting|Phase 4|80|Anticipated|Association Pédiatrique des Groupes d'Acuueil et de Recherche||2|||f||||f||||||||||2017-10-11 00:21:13.281109|2017-10-11 00:21:13.281109
NCT02156024|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-04|||March 2014||2014-03-01|June 2014|2014-06-01||||March 2015|Anticipated|2015-03-01||Interventional|||The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension||Unknown status|Recruiting|Phase 4|400|Anticipated|Shanghai Institute of Hypertension||2|||f||||||||||||||2017-10-11 00:21:13.544506|2017-10-11 00:21:13.544506
NCT02155998|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-02-03|||July 2014||2014-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PREVENT||Non-Interventional Study PREVENT|A Non-interventional Study of Postoperative or Post-Radiation trEatment Habits in Locally adVanced Prostate Cancer patiENTs (High Risk)- PREVENT|Completed||N/A|200|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:21:13.790645|2017-10-11 00:21:13.790645
NCT02155985|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-03|2017-05-08|2016-05-27||August 2014||2014-08-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional||121 randomized participants, all of which did initiate study treatment.|Modulation of Immune Activation by Aspirin|Modulation of Immune Activation by Aspirin|Completed||Phase 2|121|Actual|AIDS Clinical Trials Group||3|||f||||t||||||||||2017-10-11 00:21:14.212901|2017-10-11 00:21:14.212901
NCT02155972|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-05-08|||May 2013||2013-05-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|ALIGN||The Safety and Effectiveness of Probiotic Supplementation on Bipolar Depression|The Safety and Effectiveness of Probiotic Supplementation on Bipolar Depression: a Proof of Concept Randomized Controlled Trial|Recruiting||Phase 2|50|Anticipated|Women's College Hospital||2|||f||||f||||||||||2017-10-11 00:21:15.632102|2017-10-11 00:21:15.632102
NCT02155959|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-06-02|||March 2011||2011-03-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Performance of a Single-piece Toric Acrylic Intraocular Lens|Rotational Stability of a Single-piece Toric Acrylic Intraocular Lens: a Pilot Study|Completed||N/A|30|Actual|Vienna Institute for Research in Ocular Surgery|||1||f||||f||||||||||2017-10-11 00:21:15.800511|2017-10-11 00:21:15.800511
NCT02155946|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-26|||December 1, 2014|Actual|2014-12-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment|Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment|Recruiting||N/A|100|Anticipated|VA Office of Research and Development||4|||f||||f|f|t|f|f|f|||||2017-10-11 00:21:15.89792|2017-10-11 00:21:15.89792
NCT02155933|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-02-21|||February 2008||2008-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|LH||Assessment of Day-night Secretion of Progesterone and LH Across Puberty|Assessment of Day-night Secretion of Progesterone and LH Across Pubertal Maturation in Girls With and Without Hyperandrogenemia (JCM023)|Recruiting||N/A|75|Anticipated|University of Virginia|||2||f||||t|f|f||||Samples Without DNA|"     Serum Urine   "|No|We do not have current plans to share IPD|2017-10-11 00:21:16.01676|2017-10-11 00:21:16.01676
NCT02155920|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-12-02|||February 2015||2015-02-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Everolimus for Children With Recurrent or Progressive Ependymoma|Phase II Study of Everolimus (RAD001, Afinitor®) for Children With Recurrent or Progressive Ependymoma|Recruiting||Phase 2|18|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 00:21:16.127797|2017-10-11 00:21:16.127797
NCT02155907|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-06-15|||June 2013||2013-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01|2 Years|Observational [Patient Registry]|||Atrial Fibrillation Detected by ELR and Holter Recording, a Comparison in Patients With Ischemic Stroke or TIA|Detection of Atrial Fibrillation in Patients With Recent Stroke or TIA: Validity of Automated Loop-recording (R.Test) Compared to Holter Recording and Predictive Value of Short Term Runs of Atrial Fibrillation and SVE for a New Stroke|Recruiting||N/A|830|Anticipated|University of Aarhus|||1||f||||f||||||||Undecided||2017-10-11 00:21:16.313093|2017-10-11 00:21:16.313093
NCT02155894|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-07-08|||May 2014||2014-05-01|April 2014|2014-04-01|July 2015|Actual|2015-07-01|May 2014|Actual|2014-05-01||Interventional|TeRA||Tight Control of Disease Activity Among Patients With RA Based on a Systematic Telemedicine Treatment Strategy|Tight Control of Disease Activity Among Patients With Rheumatoid Arthritis Based on a Systematic Telemedicine Treatment Strategy|Completed||N/A|300|Actual|University of Aarhus||3|||f||||t||||||||||2017-10-11 00:21:16.46399|2017-10-11 00:21:16.46399
NCT02155881|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-12-07|2016-06-13||August 2014||2014-08-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional||Full Analysis Set (FAS) included all randomized participants who received at least 1 dose of double-blind study medication.|Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia|A Multi-Center, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Phase III (Registration) Study to Assess the Efficacy and Safety of Ciclesonide Nasal Spray (Omnaris®) 200 mcg Once Daily in the Treatment of the Patients With Seasonal Allergic Rhinitis (SAR) in Russia|Completed||Phase 3|80|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:21:16.629181|2017-10-11 00:21:16.629181
NCT02155868|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-01-25|||June 2014||2014-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Role of Cerebral Oximetry in Reducing Postoperative Morbidity Following Cardiac Surgery|Cerebral Near-Infrared Spectroscopy Monitoring in High-Risk Cardiac Surgery Patients: A Prospective, Randomised, Single-Blinded Study|Completed||N/A|120|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 00:21:17.397154|2017-10-11 00:21:17.397154
NCT02155842|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-03-29|||June 2014||2014-06-01|March 2016|2016-03-01|December 2015|Anticipated|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TREND-HF||Exercise Training in Treating Diastolic Heart Failure|High Versus Moderate Intensity Endurance Exercise Training in Treating Diastolic Heart Failure|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||2||Unforseen problems recruiting patients|f||||f||||||||No||2017-10-11 00:21:17.581742|2017-10-11 00:21:17.581742
NCT02155829|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-07-21|||July 2013||2013-07-01|July 2014|2014-07-01||||July 2016|Anticipated|2016-07-01||Interventional|||Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD)|Riluzole for PTSD: Efficacy of a Glutamatergic Modulator as Augmentation Treatment for Posttraumatic Stress Disorder|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Uniformed Services University of the Health Sciences||2|||f||||t||||||||||2017-10-11 00:21:17.662532|2017-10-11 00:21:17.662532
NCT02155816|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-07-15|||May 2014||2014-05-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Omega 7 + 3 Combination and Systemic Inflammation|Influence of Omega 7 + 3 Combination on Systemic Inflammation and Plasma Lipoproteins in Women: a 2-month, Double Blind, Placebo-Controlled, Randomized Community Trial|Completed||N/A|68|Actual|Appalachian State University||3|||f||||f||||||||||2017-10-11 00:21:17.760682|2017-10-11 00:21:17.760682
NCT02155803|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-01-23|||February 2015||2015-02-01|January 2015|2015-01-01|November 2015|Anticipated|2015-11-01|June 2015|Anticipated|2015-06-01||Interventional|||ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study|ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study|Unknown status|Not yet recruiting|Phase 2/Phase 3|10|Anticipated|Albany Medical College||1|||f||||f||||||||||2017-10-11 00:21:17.84389|2017-10-11 00:21:17.84389
NCT02155790|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-06-06|||July 2014||2014-07-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|January 2016|Actual|2016-01-01||Interventional|||The Peregrine Study: A Safety and Performance Study of Renal Denervation|A Safety and Performance Study of Renal Denervation by Neurolysis Using the Ablative Solutions Inc. Peregrine System™ Infusion Catheter|Active, not recruiting||N/A|10|Actual|Ablative Solutions, Inc.||1|||f||||t||||||||||2017-10-11 00:21:17.938342|2017-10-11 00:21:17.938342
NCT02155777|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-03-30|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Why do Oral Contraceptives Prevent Ovarian Cancer?|Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives|Recruiting||Early Phase 1|28|Anticipated|University of Southern California||2|||f||||f||||||||No||2017-10-11 00:21:18.026592|2017-10-11 00:21:18.026592
NCT02155764|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-03-01|||September 1, 2017|Anticipated|2017-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|RP||Ridge Preservation With New Class of Osteoplastic Materials|Comparison of Octacalcium Phosphate Synthetic Bone Graft (OctoFor) and Bovine-derived Bone (Bio-Oss) for Ridge Preservation After Tooth Extraction: Open, Prospective, Non-Randomised Clinical Trial|Not yet recruiting||Phase 2|60|Anticipated|I.M. Sechenov First Moscow State Medical University||3|||f||||f|f|f|||f|||||2017-10-11 00:21:18.192136|2017-10-11 00:21:18.192136
NCT02155751|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-05-10|||July 2012|Actual|2012-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2015|Actual|2015-09-01||Interventional|||Bringing NELIP for Obese Pregnant Women Into Clinical Practice|Bringing an Evidence-based Nutrition and Exercise Lifestyle Intervention Program (NELIP) for Obese Pregnant Women Into Clinical Practice|Recruiting||N/A|23|Anticipated|Lawson Health Research Institute||4|||f||||f||||||||||2017-10-11 00:21:18.393362|2017-10-11 00:21:18.393362
NCT02155738|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-08-25|||July 2014||2014-07-01|August 2017|2017-08-01|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Interventional|||IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair|The Impact of IV Acetaminophen on Postoperative Pain in Women Undergoing Pelvic Organ Prolapse Repair: A Double-Blind Randomized Placebo Controlled Trial|Completed||Phase 4|204|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 00:21:18.496687|2017-10-11 00:21:18.496687
NCT02155725|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-08-22|||April 2014||2014-04-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|FIDEL||Fibrinogen in Haemorrhage of Delivery|Study on the Efficacy and Safety of a Therapeutic Strategy of PPH Comparing Early Administration of Human Fibrinogen vs Placebo in Patients Treated With IV Prostaglandins Following Vaginal Delivery|Recruiting||Phase 4|434|Anticipated|Laboratoire français de Fractionnement et de Biotechnologies||2|||f||||t||||||||||2017-10-11 00:21:18.584404|2017-10-11 00:21:18.584404
NCT02155712|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-02-17|||October 2014||2014-10-01|February 2017|2017-02-01|May 2026|Anticipated|2026-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Triathlon Tritanium Knee Outcomes Study|Triathlon Tritanium Knee Outcomes Study|Active, not recruiting||N/A|518|Actual|Stryker Orthopaedics||2|||f||||f||||||||||2017-10-11 00:21:18.76571|2017-10-11 00:21:18.76571
NCT02155699|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-10-24|||July 2014||2014-07-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis|Exercise and Markers of Medial Temporal Health in Youth at Ultra High-risk for Psychosis|Recruiting||N/A|45|Anticipated|University of Colorado, Boulder||3|||f||||t||||||||||2017-10-11 00:21:18.853156|2017-10-11 00:21:18.853156
NCT02155686|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2015-03-08|||June 2014||2014-06-01|February 2015|2015-02-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|e-COBAHLT||Elderly Chronic Diseases Online Biometric Analysis Home Living Technology|Etude de l'Impact Clinique de la télésurveillance à Domicile Par télémédecine de paramètres biométriques de la Personne âgée Polypathologique|Unknown status|Recruiting|N/A|536|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 00:21:18.94887|2017-10-11 00:21:18.94887
NCT02155673|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-12-22|||January 2014||2014-01-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 2 Extension Study of Study GCS-100-CS-4002|A Phase 2 Extension Study of Study GCS-100-CS-4002|Completed||Phase 2|92|Actual|La Jolla Pharmaceutical Company||2|||f||||f||||||||||2017-10-11 00:21:19.044381|2017-10-11 00:21:19.044381
NCT02155660|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-08-31|||June 25, 2014|Actual|2014-06-25|August 2017|2017-08-01|April 9, 2018|Anticipated|2018-04-09|April 9, 2018|Anticipated|2018-04-09||Interventional|TERRANOVA||Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History|A Randomised, Double-blind, Double Dummy, 56 Week Placebo-controlled, Multicentre, Parallel Group, Phase 3 Study Evaluating Efficacy/Safety of 3 Benralizumab Doses in Patients With Moderate to Very Severe COPD With Previous Exacerbations.|Active, not recruiting||Phase 3|2255|Actual|AstraZeneca||4|||f||||t||||||||||2017-10-11 00:21:19.158876|2017-10-11 00:21:19.158876
NCT02155647|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-09-21|||July 3, 2014|Actual|2014-07-03|September 2017|2017-09-01|June 30, 2025|Anticipated|2025-06-30|September 27, 2019|Anticipated|2019-09-27||Interventional|||Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200)|A Phase II, Open-Label, Multicenter Trial to Investigate the Clinical Activity and Safety of Avelumab (MSB0010718C) in Subjects With Merkel Cell Carcinoma|Recruiting||Phase 2|200|Anticipated|EMD Serono||1|||f||||t||||||||||2017-10-11 00:21:20.255173|2017-10-11 00:21:20.255173
NCT02155634|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-01-05|||July 2014||2014-07-01|January 2015|2015-01-01|March 2021|Anticipated|2021-03-01|April 2017|Anticipated|2017-04-01||Interventional|||Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma|Phase 3b, Randomized Trial of Continuous Revlimid® (Lenalidomide) Therapy Versus Observation Following Induction Therapy That Does Not Include Revlimid, Pomalyst® or Thalomid® in Newly Diagnosed Multiple Myeloma|Withdrawn||Phase 3|0|Actual|Celgene||2||"The study was terminated due to poor feasibility and lack of interest at the participating   sites."|f||||t||||||||||2017-10-11 00:21:20.580409|2017-10-11 00:21:20.580409
NCT02155621|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-10-29|||July 2014||2014-07-01|October 2015|2015-10-01|June 2025|Anticipated|2025-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Personalized Oncogenomics (POG) Program of British Columbia|Personalized Oncogenomics (POG) Program of British Columbia: Utilization of Genomic Analysis to Better Understand Tumour Heterogeneity and Evolution|Recruiting||N/A|5000|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 00:21:20.667438|2017-10-11 00:21:20.667438
NCT02155608|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-11-03|||December 2014||2014-12-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|TNS for ADHD||Trigeminal Nerve Stimulation for ADHD|Developmental Pilot Study of External Trigeminal Nerve Stimulation for ADHD|Recruiting||N/A|90|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 00:21:20.747387|2017-10-11 00:21:20.747387
NCT02155595|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-02-23|||May 2014||2014-05-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Observational|NIH fracture||Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy|Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy|Recruiting||N/A|1000|Anticipated|Henry Ford Health System|||2||f||||t||||||Samples Without DNA|"     Bone & serum to be retained per institutional guidelines and clinical practice   "|||2017-10-11 00:21:20.836586|2017-10-11 00:21:20.836586
NCT02155582|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-06-15|||August 12, 2014|Actual|2014-08-12|June 2017|2017-06-01|March 16, 2017|Actual|2017-03-16|October 4, 2016|Actual|2016-10-04||Interventional|||Copanlisib Pharmacodynamic Study|A Phase I Pharmacodynamic Study of Copanlisib (BAY 80-6946) as Monotherapy in Patients With Non-Hodgkin's Lymphoma and Solid Tumors|Completed||Phase 1|63|Actual|Bayer||2|||f||||f|f|f||||||||2017-10-11 00:21:20.919645|2017-10-11 00:21:20.919645
NCT02155569|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-06-05|||January 2014||2014-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Extraperitoneal Versus Transperitoneal Cesarean Section|Extraperitoneal Versus Transperitoneal Cesarean Section: A Prospective Randomized Comparison|Completed||N/A|100|Actual|Ataturk University||2|||f||||f||||||||||2017-10-11 00:21:21.019308|2017-10-11 00:21:21.019308
NCT02155556|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-02|||June 2014||2014-06-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Diurnal Changes of the Cornea - a Pilot Study|Diurnal Changes of the Cornea - a Pilot Study|Unknown status|Recruiting|N/A|20|Anticipated|Vienna Institute for Research in Ocular Surgery|||1||f||||f||||||||||2017-10-11 00:21:21.095118|2017-10-11 00:21:21.095118
NCT02155543|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-03-10|2016-01-07||May 2014||2014-05-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects||Completed||Phase 1|51|Actual|Allergan||7|||f||||t||||||||||2017-10-11 00:21:21.165497|2017-10-11 00:21:21.165497
NCT02155530|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2016-07-26|||June 2014||2014-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial||Completed||N/A|30|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:21:21.68632|2017-10-11 00:21:21.68632
NCT02155517|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-09-21|||May 2014||2014-05-01|July 2013|2013-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Clinical Effect of Two Pharmacokinetics Model of Propofol|Phase 4: CLINICAL EVALUATION OF TWO PHARMACOKINETICS MODELS OF PROPOFOL IN HEALTHY PEOPLE|Completed||Phase 4|10|Actual|Tiva Group||1|||f||||t||||||||||2017-10-11 00:21:21.774975|2017-10-11 00:21:21.774975
NCT02155504|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-10-29|||May 2014||2014-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects|A Phase 1, Single Ascending Oral Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects, Including a Drug-drug Interaction Part With Itraconazole|Completed||Phase 1|44|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 00:21:21.872601|2017-10-11 00:21:21.872601
NCT02155491|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-12-10|||March 2014||2014-03-01|December 2014|2014-12-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01|3 Years|Observational [Patient Registry]|GARFIELD-VTE||Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events|Global Anticoagulant Registry in the Field Observing Treatment and Outcomes in Patients With Treated Acute Venous Thromboembolic Events in the Real World|Recruiting||N/A|10000|Anticipated|Thrombosis Research Institute|||2||f||||t||||||||||2017-10-11 00:21:22.012393|2017-10-11 00:21:22.012393
NCT02155478|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-03|||February 2013||2013-02-01|June 2014|2014-06-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study|Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study|Unknown status|Recruiting|N/A|30|Anticipated|Vienna Institute for Research in Ocular Surgery||2|||f||||f||||||||||2017-10-11 00:21:22.132047|2017-10-11 00:21:22.132047
NCT02155465|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-04-17|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib|A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib|Active, not recruiting||Phase 1/Phase 2|22|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:21:22.226935|2017-10-11 00:21:22.226935
NCT02155452|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2016-10-20|||May 2014||2014-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|ALA glioma||Fluorescence and Glioma Heterogeneity|Understanding the Mechanisms of ALA-induced Fluorescence in Malignant Gliomas - Exploring the Biological Basis of Tumoral Heterogeneity.|Recruiting||N/A|25|Anticipated|Tata Memorial Hospital|||2||f||||t||||||Samples With DNA|"     The heterogeneity of fluorescence within malignant gliomas by sampling tissues from these     variable areas within the same tumor. These tissue samples will then be subjected to     pathological and biological analysis to assess proteins related to ALA metabolism and     correlated with the fluorescence emitted as well as levels of protoporphyrin IX in the     tissues.   "|||2017-10-11 00:21:22.31733|2017-10-11 00:21:22.31733
NCT02155439|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-10-21|||May 2014||2014-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study|Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study|Recruiting||Phase 4|50|Anticipated|Tampere University Hospital||2|||f||||t||||||||||2017-10-11 00:21:22.398104|2017-10-11 00:21:22.398104
NCT02155426|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-04-22|||April 2014||2014-04-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01|2 Years|Observational [Patient Registry]|||Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy|A Multicenter, Prospective, Observational Trial on the Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With 1st or 2nd Line Line Chemotherapy and Targeted Therapy|Unknown status|Recruiting|N/A|1200|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     Subjects' blood sample will be retained to evaluate the dynamic CTC count during the     treatment   "|||2017-10-11 00:21:22.483036|2017-10-11 00:21:22.483036
NCT02155413|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-03|||June 2014||2014-06-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Audit of Tolerability and Safety of Acute Pain Service|Retrospective Study to Evaluate the Tolerability and Safety of Acute Pain Service at Queen Mary Hospital Between 2009 to 2012|Unknown status|Recruiting|N/A|7500|Anticipated|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 00:21:22.557106|2017-10-11 00:21:22.557106
NCT02155400|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-04-29|||August 2014||2014-08-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Thermal Compression Device for Maintenance of Perioperative Normothermia|Phase 0 Study of a Thermal Compression Device for Maintenance of Perioperative Normothermia|Completed||N/A|37|Actual|Stanford University||5|||f||||f|f|f||||||Yes|De-identified datasets|2017-10-11 00:21:22.747344|2017-10-11 00:21:22.747344
NCT02155387|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-06-01|||April 2014||2014-04-01|June 2014|2014-06-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Extravascular Lung Water and Pulmonary Vascular Permeability After Minimally Invasive Cardiac Surgery|Extravascular Lung Water Index and Pulmonary Vascular Permeability Index Assessed by the Transpulmonary Thermodilution Method in Patients After Minimally Invasive Cardiac Surgery With Cardiopulmonary Bypass and One Lung Ventilation|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital Freiburg|||3||f||||f||||||||||2017-10-11 00:21:22.857171|2017-10-11 00:21:22.857171
NCT02155374|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-01-06|||May 2014||2014-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|GluCon-Chemo||Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy|Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy|Completed||Phase 4|26|Actual|Slotervaart Hospital||2|||f||||f||||||||||2017-10-11 00:21:22.958856|2017-10-11 00:21:22.958856
NCT02155361|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2014-11-14|||June 2014||2014-06-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Evaluation of Topical Citrullus Colocynthis Fruit Oil Efficacy in Treatment of Painful Peripheral Diabetic Neuropathy|Evaluation of Topical Citrullus Colocynthis Fruit Oil Efficacy in Treatment of Painful Peripheral Diabetic Neuropathy|Completed||Phase 1/Phase 2|70|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:21:23.086411|2017-10-11 00:21:23.086411
NCT02155348|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-03|||June 2013||2013-06-01|June 2014|2014-06-01|May 2015|Anticipated|2015-05-01|January 2015|Anticipated|2015-01-01||Interventional|||Comparison Between Bilateral Multifocal Intraocular Lenses and Pseudophakic Monovision|Comparison Between Bilateral Multifocal Intraocular Lenses and Pseudophakic Monovision: a Randomised Controlled Trial|Unknown status|Recruiting|N/A|70|Anticipated|Vienna Institute for Research in Ocular Surgery||2|||f||||f||||||||||2017-10-11 00:21:23.179854|2017-10-11 00:21:23.179854
NCT02155335|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-03-13|2016-08-11||July 2014||2014-07-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SMART|1 enrolled participant withdrew prior to treatment.|Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)|Preference for a Prefilled Syringe or Smartject™ Device for Delivering SIMPONI (Golimumab) in Patients Suffering From Moderate to Severe Ulcerative Colitis|Completed||Phase 4|100|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:21:23.278492|2017-10-11 00:21:23.278492
NCT02155322|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-04-28|2017-02-27||August 19, 2014|Actual|2014-08-19|April 2017|2017-04-01|March 21, 2016|Actual|2016-03-21|March 21, 2016|Actual|2016-03-21||Interventional|||A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400)|A Phase II Study of Pegylated Interferon Alfa-2b in AJCC Stage III (TxN1-2M0) Melanoma Subjects After Regional Lymph Node Dissection in Russia|Completed||Phase 2|33|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:21:23.485426|2017-10-11 00:21:23.485426
NCT02155309|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-11-16|||June 2014||2014-06-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray|Pharmacokinetic and Efficacy Profile of Low-Dose Intranasal Scopolamine Spray for Motion Sickness|Terminated||Phase 2/Phase 3|63|Actual|Repurposed Therapeutics, Inc.||2||Business reason|f||||t||||||||No||2017-10-11 00:21:23.730359|2017-10-11 00:21:23.730359
NCT02155296|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-04-24|||August 2014||2014-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|RPI||RCT of the Restorative Practices Intervention|Reducing Problem Behaviors Through PYD: An RCT of Restorative School Practices|Recruiting||N/A|2680|Anticipated|RAND||2|||f||||f||||||||||2017-10-11 00:21:23.827501|2017-10-11 00:21:23.827501
NCT02155283|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-06-28|2015-06-28||October 2013||2013-10-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|LBP-2||The Efficacy of the Kyrobak for Chronic Low Back Pain (LBP-2)|The Kyrobak Continuous Passive Motion Device for the Treatment of Chronic Low Back Pain: A Pilot Study|Completed||N/A|16|Actual|Radiancy||1|||f||||f||||||||||2017-10-11 00:21:23.978262|2017-10-11 00:21:23.978262
NCT02155270|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-02-09|||June 2014||2014-06-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Impact of a Corneal Pre-cut on Wound Architecture and Astigmatism in Cataract Surgery - a Pilot Study|Impact of a Corneal Pre-cut on Wound Architecture and Astigmatism in Cataract Surgery - a Pilot Study|Completed||N/A|55|Actual|Vienna Institute for Research in Ocular Surgery||2|||f||||f||||||||||2017-10-11 00:21:24.182295|2017-10-11 00:21:24.182295
NCT02155257|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-01-29|||July 2014||2014-07-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pain Expectations in Subjects With Osteoarthritis|A Feasibility Study: Understanding and Altering Pain Expectations in Subjects With Osteoarthritis of the Knee or Hip|Recruiting||Phase 4|30|Anticipated|Wake Forest University Health Sciences||3|||f||||f||||||||||2017-10-11 00:21:24.273295|2017-10-11 00:21:24.273295
NCT02155244|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-06-03|||January 2006||2006-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Observational|CBDS||Common Bile Duct Stone Management: What Have we Learned?||Completed||N/A|101|Actual|Ospedale Regionale di Mendrisio|||2||f||||f||||||||||2017-10-11 00:21:24.364797|2017-10-11 00:21:24.364797
NCT02155231|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-10-19|||February 2013||2013-02-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand|The Thai Red Cross AIDS Research Centre|Enrolling by invitation||N/A|430|Anticipated|Thai Red Cross AIDS Research Centre|||2||f||||f||||||||||2017-10-11 00:21:24.427738|2017-10-11 00:21:24.427738
NCT02155218|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-06-03|||June 2014||2014-06-01|June 2014|2014-06-01|May 2015|Anticipated|2015-05-01|February 2015|Anticipated|2015-02-01||Interventional|||Improving the Concentration of MR Contrast in the Arteries|Contrast Dynamics of the Thoracic Vasculature and Heart|Unknown status|Enrolling by invitation|N/A|120|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 00:21:24.497068|2017-10-11 00:21:24.497068
NCT02155205|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-09-05|||May 2014||2014-05-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||A Thorough QT Study of Telotristat Etiprate|Randomized, Double-blind, Placebo-controlled, Positive Controlled, 3-period, 6-sequence, Crossover Study to Define the Electrocardiogram Effects of a Single Dose of Telotristat Etiprate (LX1606) 1500 mg Compared With Placebo and Open Label Moxifloxacin in Healthy Subjects: A Thorough QT Study|Completed||Phase 1|48|Actual|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-10-11 00:21:24.593256|2017-10-11 00:21:24.593256
NCT02155192|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-10-31|||March 2014||2014-03-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||An Exploratory Genetic Study in Participants With Psoriasis|Exploratory Genetic Study in Subjects With Moderate to Severe Psoriasis|Completed||Early Phase 1|712|Actual|Janssen Research & Development, LLC|||4||f||||f||||||Samples With DNA|"     Two buccal swab samples will be collected to extract Deoxyribonucleic acid (DNA).   "|||2017-10-11 00:21:24.673975|2017-10-11 00:21:24.673975
NCT02155179|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-03-01|||August 2014||2014-08-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Sperm Pathology Samples and Morphokinetics|Embryo Kinetics and Sperm Quality. Depends on the Sperm Quality the Embryo Cleavage Rate?|Recruiting||N/A|60|Anticipated|IVI Madrid|||2||f||||t||||||||||2017-10-11 00:21:24.793545|2017-10-11 00:21:24.793545
NCT02155166|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-01-17|||February 2012||2012-02-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Intracervical on the Pain Associated With the Insertion of the LNG-IUS|Effect of Injectable Intracervical Anesthesia on the Pain Associated With the Insertion of the Levonorgestrel-releasing Intrauterine System in Women Without Previous Vaginal Delivery: a Randomized Controlled Trial|Completed||N/A|100|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:21:24.882705|2017-10-11 00:21:24.882705
NCT02155153|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2016-01-29|||June 2014||2014-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Role of Chewing Gum in Reducing Post Operative Ileus After Reversal of Ileostomy|The Effect of Gum Chewing on the Duration of Postoperative Ileus and Total Length of Hospital Stay After Reversal of Ileostomy|Completed||N/A|100|Actual|Services Hospital, Lahore||2|||f||||f||||||||||2017-10-11 00:21:24.969262|2017-10-11 00:21:24.969262
NCT02155140|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2015-01-22|||February 2011||2011-02-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Enteral Feeding in Discharged Patients|Randomised Trial of Enteral Feeding in Patients Discharged From Hospital Following Surgical Resection of an Upper Gastrointestinal Malignancy|Terminated||N/A|45|Actual|Plymouth Hospitals NHS Trust||2||Failed to recruit full number of patients|f||||f||||||||||2017-10-11 00:21:25.064381|2017-10-11 00:21:25.064381
NCT02155127|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-11-16|||October 2014||2014-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study|Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study|Completed||N/A|80|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 00:21:25.166455|2017-10-11 00:21:25.166455
NCT02155114|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2014-11-11|||April 2014||2014-04-01|November 2014|2014-11-01||||October 2014|Actual|2014-10-01||Observational|||Iron Homoeostasis in Inflammation|Iron Homoeostasis in Inflammation: A Single Center Observational Cross-sectional Study|Completed||N/A|472|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     blood samples (serum and heparinized plasma)   "|||2017-10-11 00:21:25.240525|2017-10-11 00:21:25.240525
NCT02155101|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-06-01|||May 2014||2014-05-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|MANET||Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDS|Monotherapy in Africa: Evaluation of New Therapy|Completed||Phase 3|121|Actual|University of Liverpool||2|||f||||t||||||||Undecided||2017-10-11 00:21:25.315695|2017-10-11 00:21:25.315695
NCT02155088|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-05-23|||October 30, 2014|Actual|2014-10-30|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 1, 2016|Actual|2016-12-01||Interventional|||BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer|A Phase I Trial With Cohort Expansion of BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer|Active, not recruiting||Phase 1|15|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-11 00:21:25.419324|2017-10-11 00:21:25.419324
NCT02155075|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-01|2017-09-18|||January 2015|Actual|2015-01-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|||Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System|Evaluation of Real Imaging's 3d Functional Metabolic Imaging and Risk Assessment (Mira) System|Recruiting||N/A|300|Anticipated|Real Imaging Ltd.|||1||f||||f||||||||||2017-10-11 00:21:25.512881|2017-10-11 00:21:25.512881
NCT02155062|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-03-05|||May 2014||2014-05-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Biomarkers of Whole Grain Wheat and Rye Intake|Urinary Alkylresorcinol Metabolites as a Biomarker of Whole Grain Wheat and Rye Intake|Completed||N/A|10|Actual|King's College London||3|||f||||f||||||||||2017-10-11 00:21:25.754157|2017-10-11 00:21:25.754157
NCT02155049|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-06-14|||November 2014||2014-11-01|June 2015|2015-06-01||||December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues|Phase 3 Study of Treatment of Soft Tissue Expansion and Exophthalmos in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues.|Unknown status|Recruiting|Phase 3|20|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 00:21:25.869975|2017-10-11 00:21:25.869975
NCT02155036|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-06-03|||June 2011||2011-06-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effect of Exercise on Renal Function in Predialysis|The Effect of Exercise on Renal Function and Cardiovascular Disease in Pre-dialysis (Chronic Kidney Disease Stage 3-4) Patients With Chronic Kidney Disease; a Randomised Controlled Trial Pilot Study.|Completed||Phase 1/Phase 2|20|Actual|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-11 00:21:25.982409|2017-10-11 00:21:25.982409
NCT02155023|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-03-25|||January 2014||2014-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|REACT4SENSOR||Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors|An Open, Single-centre, Non-controlled Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors Used for Continuous Glucose Monitoring in Patients With Type 1 Diabetes|Completed||N/A|8|Actual|Medical University of Graz||1|||f||||t||||||||||2017-10-11 00:21:26.063018|2017-10-11 00:21:26.063018
NCT02155010|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-08-03|2015-12-10||March 2014||2014-03-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Dexmedetomidine in Spinal Anesthesia|Hemodynamic Effect of Dexmedetomidine on Heavy Bupivacaine Spinal Anesthesia|Completed||N/A|74|Actual|Inje University|We did not assess the differences among the groups regarding postoperative analgesic consumption and the duration of sensory or motor bloakade produced by spinal anesthesia with dexmedetomidine infusion.|2|||f||||f||||||||Yes|De-identified individual participant data for all primary and secondary outcome measures will be made available within 3 years of study completion.|2017-10-11 00:21:26.169591|2017-10-11 00:21:26.169591
NCT02154997|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2016-02-28|||November 2014||2014-11-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||The Effect of Different Food Products on Post Prandial Blood Glucose in Pregnant Woman With Diabetes||Recruiting||N/A|100|Anticipated|Hadassah Medical Organization|||3||f||||||||||||||2017-10-11 00:21:26.412061|2017-10-11 00:21:26.412061
NCT02154984|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-01-11|||July 2014||2014-07-01|January 2017|2017-01-01||||May 2018|Anticipated|2018-05-01||Interventional|||Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants|A Pilot Study of Time Restricted Diet in Obese/Overweight Pre &Amp; Postmenopausal Women|Active, not recruiting||N/A|80|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 00:21:26.494521|2017-10-11 00:21:26.494521
NCT02154971|ClinicalTrials.gov processed this data on October 10, 2017|2014-06-02|2017-02-13|||November 2013||2013-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|HELO||Assessment of Age-related Hearing Loss in HIV-1 Patients|Assessment of Age-related Hearing Loss in HIV-1 Patients|Recruiting||N/A|180|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||f||||||||||2017-10-11 00:21:26.589245|2017-10-11 00:21:26.589245
NCT02154958|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-07-28|||May 2014||2014-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility|Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection Outcome in Women With Unexplained Infertility|Completed||N/A|300|Actual|Cairo University|||1||f||||t||||||||||2017-10-11 00:21:26.668058|2017-10-11 00:21:26.668058
NCT02154945|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-01-12|||January 2016||2016-01-01|June 2014|2014-06-01|January 2016|Actual|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Retinal Nerve Fiber Layer and Macular Thickness Changes During Pregnancy|Retinal Nerve Fiber Layer and Macular Thickness Changes During Pregnancy by Optical Coherence Tomography: Prospective, Observational, Nonrandomized Controlled Study|Withdrawn||N/A|0|Actual|The Baruch Padeh Medical Center, Poriya|||1|Did not go through with the study for logistical reasons|f||||t||||||||||2017-10-11 00:21:26.920917|2017-10-11 00:21:26.920917
NCT02154932|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2014-05-31|||January 2011||2011-01-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||"Single Versus Double Dose Intra-vaginal Prostaglandin E2 Misoprostol Prior Abdominal Myomectomy"|"Single Versus Double Dose Intra-vaginal Prostaglandin E2 Misoprostol Prior Abdominal Myomectomy: A Randomized Controlled Study"|Completed||Phase 4|69|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 00:21:27.010245|2017-10-11 00:21:27.010245
NCT02154919|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2014-05-31|||April 2011||2011-04-01|May 2014|2014-05-01||||December 2013|Actual|2013-12-01||Observational|CPVsSPCI||Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction|Conservative Pharmacotherapy Versus Staged Percutaneous Coronary Intervention on Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease|Completed||N/A|306|Actual|Beijing Shijitan Hospital|||2||f||||||||||||||2017-10-11 00:21:27.131394|2017-10-11 00:21:27.131394
NCT02154906|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-06-01|2016-04-23||November 2013||2013-11-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Clinical and Radiographic Evaluation of Demineralized Freeze-Dried Bone Allograft Versus Platelet Rich Fibrin for the Treatment of Periodontal Intrabony Defects in Humans|Clinical and Radiographic Evaluation of Demineralized Freeze-Dried Bone Allograft Versus Platelet Rich Fibrin for the Treatment of Periodontal Intrabony Defects in Humans|Completed||N/A|44|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 00:21:27.24984|2017-10-11 00:21:27.24984
NCT01801839|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-01-26|||August 2012||2012-08-01|January 2016|2016-01-01||||July 2015|Actual|2015-07-01||Observational|||Detection Of Monocytes/Macrophages Function And Tim-3 Expression In Septic Patients||Completed||N/A|1|Actual|Chinese PLA General Hospital|||1||f||||||||||||||2017-10-11 01:56:49.902422|2017-10-11 01:56:49.902422
NCT02154893|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2015-12-03|||January 2014||2014-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Synergic Effects of Ultrasound and Laser on the Pain Relief and Functionality|Synergic Effects of Ultrasound and Laser on the Pain Relief and Functionality in Women With Hand or Knee Osteoarthritis.|Completed||Phase 2|90|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 00:21:27.5695|2017-10-11 00:21:27.5695
NCT02154880|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-10-02|||February 2014||2014-02-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|TEAL||Translation Evaluation of Aging, Inflammation and HIV in Lung Function (TEAL)|Translation Evaluation of Aging, Inflammation and HIV in Lung Function|Recruiting||N/A|300|Anticipated|University of Pittsburgh||4|||f||||f||||||||||2017-10-11 00:21:27.708574|2017-10-11 00:21:27.708574
NCT02154867|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-01-12|||December 2014||2014-12-01|January 2015|2015-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|REFIT||Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial.|Recalibrating Intestinal Microflora in IBS by Fecal Transplantation|Completed||Phase 2|90|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 00:21:27.857404|2017-10-11 00:21:27.857404
NCT02154854|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-30|||July 2013||2013-07-01|May 2014|2014-05-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|ADEQUATEartère||Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)|Effect of Advagraf on Arterial Stiffness and on Vascular Fibrosis Plasma Markers on de Novo Renal Transplant Patients|Unknown status|Recruiting|Phase 4|104|Anticipated|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 00:21:27.970117|2017-10-11 00:21:27.970117
NCT02154841|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-02|||February 2011||2011-02-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|TASTE||Changes in Taste Perception and Preference in the Peri-operative Patient|Changes in Taste Perception and Preference in the Peri-operative Patient|Completed||N/A|30|Actual|Plymouth Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 00:21:28.153649|2017-10-11 00:21:28.153649
NCT02154828|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-05-15|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|AUTISM||Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)|Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)|Completed||N/A|103|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 00:21:28.266783|2017-10-11 00:21:28.266783
NCT02154815|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-07-02|||September 2014||2014-09-01|July 2015|2015-07-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Observational|PreKiTQoL||Pre-emptive Kidney Transplantation Quality of Life|Evaluation of the Benefits Associated With Pre-emptive Kidney Transplantation. Prospective, Multicenter and Controlled Study of Quality of Life, Psychological Adjustment Processes and Medical Outcomes of Patients Receiving a Pre-emptive Kidney Transplant Compared to a Similar Population of Recipients After a Dialysis Period of Less Than Three Years|Recruiting||N/A|390|Anticipated|Nantes University Hospital|||2||f||||f||||||||||2017-10-11 00:21:28.393353|2017-10-11 00:21:28.393353
NCT02154802|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-05-30|||July 2014||2014-07-01|May 2014|2014-05-01||||January 2017|Anticipated|2017-01-01||Interventional|||Increasing HIV Testing in Urban Emergency Departments Via Mobile Technology||Unknown status|Not yet recruiting|N/A|300|Anticipated|National Development and Research Institutes, Inc.||4|||f||||||||||||||2017-10-11 00:21:28.525349|2017-10-11 00:21:28.525349
NCT02154789|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-30|||June 2014||2014-06-01|May 2014|2014-05-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cyst|An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cysts|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|University of Edinburgh||3|||f||||f||||||||||2017-10-11 00:21:28.62012|2017-10-11 00:21:28.62012
NCT02154776|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-07-10|||June 27, 2014|Actual|2014-06-27|July 2017|2017-07-01|October 26, 2016|Actual|2016-10-26|October 26, 2016|Actual|2016-10-26||Interventional|LeeBLet||Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.|A Phase 1 Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole for the Treatment of HR+, HER2-negative Post-menopausal Women With Locally Advanced or Metastatic Breast Cancer.|Completed||Phase 1|13|Actual|Novartis||1|||f||||t|t|f||||||||2017-10-11 00:21:28.759945|2017-10-11 00:21:28.759945
NCT02154750|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-06-05|||June 2013||2013-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|AV Delay||AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals|Evaluation of AV Delay Optimization vs. Intrinsic Conduction in Patients With Long PR Intervals Receiving Dual Chamber Pacemakers for Symptomatic Bradycardia|Recruiting||N/A|50|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-11 00:21:28.937178|2017-10-11 00:21:28.937178
NCT02154737|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-09-26|||July 2013||2013-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer|A Phase I, Open-label, Dose Escalation Study of Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer|Recruiting||Phase 1|36|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:21:29.039464|2017-10-11 00:21:29.039464
NCT02154724|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-30|||September 2013||2013-09-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|ADBS||Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's Disease|Clinical Investigation for Adaptive Deep Brain Stimulation (aDBS)Closed-loop Device Controlled by Local Field Potentials in Parkinson's Disease.|Unknown status|Recruiting|N/A|20|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||1|||f||||f||||||||||2017-10-11 00:21:29.132508|2017-10-11 00:21:29.132508
NCT02154711|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-07-05|||May 2014||2014-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease|Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease|Recruiting||N/A|120|Anticipated|University of Pennsylvania|||2||f||||f||||||Samples Without DNA|"     blood   "|||2017-10-11 00:21:29.213994|2017-10-11 00:21:29.213994
NCT02154698|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-01-19|||June 2014||2014-06-01|May 2014|2014-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||22-gauge ProCore Needle v. Standard 22-gauge (P00030500)|A Multi-center Study Comparing Standard 22-gauge and 22-gauge ProCore Needles for Endobronchial Ultrasound|Unknown status|Recruiting|N/A|200|Anticipated|Medical University of South Carolina||2|||f||||||||||||||2017-10-11 00:21:29.289763|2017-10-11 00:21:29.289763
NCT02154685|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-10-01|||December 2013||2013-12-01|April 2015|2015-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Extinction Updating in Reconsolidation|Reducing Smoking Cue Reactivity and Behavior Via Retrieval-Extinction Mechanism|Completed||N/A|77|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 00:21:29.539956|2017-10-11 00:21:29.539956
NCT02154672|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-12-02|||May 2014||2014-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Prostate Cancer Screening in Men With Germline BRCA2 Mutations|Prostate Cancer Screening in Men With Germline BRCA2 Mutations|Recruiting||N/A|100|Anticipated|Yale University|||1||f||||f||||||||No||2017-10-11 00:21:29.637288|2017-10-11 00:21:29.637288
NCT02154659|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-01-07|||June 2014||2014-06-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Interventional|||The Difference of Reflux Pattern Between the Patients Who Have Postprandial Reflux Symptoms||Unknown status|Recruiting|N/A|51|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:21:29.710125|2017-10-11 00:21:29.710125
NCT02154646|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-02-09|||May 2014||2014-05-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|September 2014|Actual|2014-09-01||Interventional|||A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body|A Phase 1b Study of LY2157299 in Combination With Gemcitabine in Patients With Advanced or Metastatic Unresectable Pancreatic Cancer|Completed||Phase 1|6|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-10-11 00:21:29.786166|2017-10-11 00:21:29.786166
NCT02154633|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-04-10|||September 30, 2010|Actual|2010-09-30|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|August 31, 2014|Actual|2014-08-31||Interventional|FGT||Lessons Learned From the Family Gene Toolkit|Development of a Family Communication and Decision-support Intervention for Women That Carry a BRCA1 or a BRCA2 Mutation and Their At-Risk Female Family Members|Completed||N/A|24|Actual|University of Michigan||2|||f||||t||||||||Yes|Request for data, explanation of research question, and time frame|2017-10-11 00:21:29.866703|2017-10-11 00:21:29.866703
NCT02154620|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-12-10|||April 2013||2013-04-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|70||Distal Radius Fractures in Patients Over 70 Years - Volar Plate or Plaster|Dorsally Displaced Distal Radius Fractures in Patients Over 70 Years - Volar Plate or Plaster - A Prospective Randomized Trial|Recruiting||N/A|120|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 00:21:29.938475|2017-10-11 00:21:29.938475
NCT02154607|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-05-30|||January 2004||2004-01-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|November 2011|Actual|2011-11-01||Interventional|||Impact of Continuous Defocused CO2 Laser Vaporisation on the Histological Malignant Transformation of Erosive Oral Lichen Planus in Patients|Clinical Trial Analyzing the Impact of Continuous Defocused CO2 Laser Vaporisation on the Histological Malignant Transformation of Erosive Oral Lichen Planus|Completed||N/A|263|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-11 00:21:30.051177|2017-10-11 00:21:30.051177
NCT02154594|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-30|||February 2014||2014-02-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||"The Efficacy of Acacia Catechu Mouthrinse as Antiplaque and Antigingivitis Agent in Fixed Orthodontic Appliance Patients."||Completed||Phase 4|60|Actual|Tatyasaheb Kore Dental College||3|||f||||t||||||||||2017-10-11 00:21:30.123852|2017-10-11 00:21:30.123852
NCT02154581|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-05-19|||January 2013||2013-01-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Case Selection and Treatment Protocol for Immediate Dental Implants in the Esthetic Zone|Case Selection and Treatment Protocol for Immediate Dental Implants in the Esthetic Zone: A Controlled Clinical Trial|Active, not recruiting||N/A|43|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 00:21:30.231485|2017-10-11 00:21:30.231485
NCT02154568|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-12-11|||November 2013||2013-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Airflow in the Lungs Using Helium MRI|Flow Quantification in the Human Airways Using Hyperpolarized Helium 3 MRI|Recruiting||N/A|10|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-11 00:21:30.319075|2017-10-11 00:21:30.319075
NCT02154555|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-01-18|||May 2014||2014-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Randomized Controlled Trial Evaluating Postoperative Debridement Following Endoscopic Sinus Surgery|A Randomized Controlled Trial Evaluating Postoperative Debridement Following Endoscopic Sinus Surgery|Recruiting||N/A|30|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-10-11 00:21:30.427982|2017-10-11 00:21:30.427982
NCT02154542|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-11-20|||October 2013||2013-10-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Edi-PTP||Study to Improve Treatments and Follow-up of Children Who Need Respiratory Support|Validation of the Measurement of Respiratory Work Using Diaphragm Electrical Activity in Infant and Children During Weaning|Completed||N/A|19|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 00:21:30.512244|2017-10-11 00:21:30.512244
NCT02154529|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-08-28|||May 2014||2014-05-01|February 2017|2017-02-01|November 9, 2015|Actual|2015-11-09|November 9, 2015|Actual|2015-11-09||Interventional|||Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer|A Phase 1b/2a Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer|Terminated||Phase 1/Phase 2|17|Actual|Kadmon Corporation, LLC||8||"Sponsor closed the study in order to review data from other ongoing tesevatinib oncology   studies, and to determine feasibility of continuing this study"|f||||t||||||||||2017-10-11 00:21:30.597016|2017-10-11 00:21:30.597016
NCT02154516|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-08-30|||November 4, 2011|Actual|2011-11-04|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2014|Actual|2014-06-01||Interventional|||Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System|A Consecutive Series Pilot Study Evaluating the Safety and Effectiveness of a New Hard-on-Hard Total Hip Replacement System in Patients With Non-inflammatory Arthritis With a Standard THA Metal Ion Control Group|Active, not recruiting||N/A|26|Actual|Smith & Nephew, Inc.||2|||f||||||||||||||2017-10-11 00:21:30.717265|2017-10-11 00:21:30.717265
NCT02154503|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-02|||April 2014||2014-04-01|May 2014|2014-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia|Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia- Pilot Study|Unknown status|Recruiting|Phase 1|20|Anticipated|Vancouver General Hospital||1|||f||||t||||||||||2017-10-11 00:21:30.795997|2017-10-11 00:21:30.795997
NCT02154490|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-07-12|||June 2014||2014-06-01|July 2017|2017-07-01|April 2025|Anticipated|2025-04-01|April 2022|Anticipated|2022-04-01||Interventional|||S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer|A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-MAP)|Recruiting||Phase 2/Phase 3|10000|Anticipated|Southwest Oncology Group||16|||f||||t||||||||||2017-10-11 00:21:31.167213|2017-10-11 00:21:31.167213
NCT02154464|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-06-02|||June 2014||2014-06-01|May 2014|2014-05-01||||June 2016|Anticipated|2016-06-01||Interventional|||Morphine-sparing Effect of Intravenous Paracetamol for Post-operative Pain Management Following Laparoscopic Gastric Banding in Morbidly Obese Patients|Morphine-sparing Effect of Intravenous Paracetamol for Post-operative Pain Management Following Laparoscopic Gastric Banding in Morbidly Obese Patients|Unknown status|Not yet recruiting|N/A|220|Anticipated|Soroka University Medical Center||2|||f||||t||||||||||2017-10-11 00:21:37.100142|2017-10-11 00:21:37.100142
NCT02154451|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-05-30|||August 2013||2013-08-01|May 2014|2014-05-01||||December 2014|Anticipated|2014-12-01||Interventional|||Transient Infrared Imaging for Early Detection of Skin Cancer|Transient Infrared Imaging for Early Detection of Skin Cancer|Unknown status|Recruiting|Phase 1/Phase 2|400|Anticipated|Skinfrared LLC||1|||f||||t||||||||||2017-10-11 00:21:37.216236|2017-10-11 00:21:37.216236
NCT02154438|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2014-05-29|||May 2014||2014-05-01|May 2014|2014-05-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||The Effect of Ketamine Infusion on Lumbar Surgery|The Effect of Ketamine Infusion for Reduction of Neuropathic Pain and Improvement of Quality of Life After Lumbar Surgery|Unknown status|Recruiting|Phase 4|56|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 00:21:37.305928|2017-10-11 00:21:37.305928
NCT02154425|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-08-30|2016-12-08||September 2014||2014-09-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|CRADLE|The Safety Set consisted of all participating mothers who had received at least 1 dose of CZP.|A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers|A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)|Completed||Phase 1|17|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 00:21:37.439012|2017-10-11 00:21:37.439012
NCT02154412|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-12-21|||June 2011||2011-06-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Mechanisms of Arterial Hypotension in Chronic Spinal Cord Injury|Mechanisms of Arterial Hypotension in Chronic Spinal Cord Injury|Recruiting||N/A|24|Anticipated|University of Louisville||2|||f||||f||||||||No||2017-10-11 00:21:38.182207|2017-10-11 00:21:38.182207
NCT02154399|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-04-10|||May 2002||2002-05-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|September 2007|Actual|2007-09-01||Interventional|||EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer|Pilot Phase II Research Study of EF5 to Measure Tumor Hypoxia in Patients With Non-small Cell Lung Cancer|Completed||Phase 2|28|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 00:21:38.314396|2017-10-11 00:21:38.314396
NCT02154386|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-11-03|2015-09-30||October 2013||2013-10-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||The number of clinical measurements and core biopsies analyzed does not equal the number of subjects enrolled in each group because some subjects did not complete the study, some did not have core biopsy taken or biopsies were lost to processing issues, or some did not have clinical measurements taken at the time of implant placement|Effect of Healing Time on New Bone Formation Following Tooth Extraction and Ridge Preservation With Demineralized Freeze-Dried Bone Allograft|Effect of Healing Time on New Bone Formation Following Tooth Extraction and Ridge Preservation With Demineralized Freeze-Dried Bone Allograft|Completed||N/A|46|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 00:21:38.431972|2017-10-11 00:21:38.431972
NCT02154360|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-08-14|||May 2014||2014-05-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|Emend-IV||Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects|A Phase IB, Open Label Study to Examine the Safety, Pharmacokinetic Characteristics and Anti-Inflammatory Effects of the NK-1R Antagonist, Aprepitant, In HIV-Infected Subjects Receiving Atazanavir/Ritonavir Or Darunavir/Ritonavir|Completed||Phase 1|12|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:21:38.714496|2017-10-11 00:21:38.714496
NCT02154347|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-05-15||||||May 2017|2017-05-01||||July 2016|Actual|2016-07-01||Interventional|||Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus||Completed||Phase 4|||Kissei Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 00:21:38.814572|2017-10-11 00:21:38.814572
NCT02154334|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-12-22|||June 2014||2014-06-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine|An Open-label Study to Assess the Effects of Allergic Rhinitis and Coadministration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine|Completed||Phase 1|47|Actual|Janssen Research & Development, LLC||3|||f||||||||||||||2017-10-11 00:21:38.895185|2017-10-11 00:21:38.895185
NCT02154321|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-04-25|||February 2014||2014-02-01|April 2017|2017-04-01||||February 2020|Anticipated|2020-02-01||Observational|||Electroencephalogram and Attention Deficit Hyperactivity Disorder Study|EEG and ADHD Study|Suspended||N/A|100|Anticipated|University of Michigan|||2|Researcher's efforts are currently held for other studies and will resume once able.|f||||f||||||||||2017-10-11 00:21:38.995604|2017-10-11 00:21:38.995604
NCT02154308|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-02|||November 2012||2012-11-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01||Interventional|||Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults|A Multicenter, Open-Label, Phase 3 Clinical Study to Evaluate the Immunogenicity and Safety of IL-YANG Inactivated Split Influenza Vaccine in Healthy Adults 18 to < 65 Years of Age and in Healthy Adults ≥ 65 Years of Age.|Completed||Phase 3|787|Actual|Il-Yang Pharm. Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:21:39.086832|2017-10-11 00:21:39.086832
NCT02154295|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-30|||May 2014||2014-05-01|May 2014|2014-05-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|SAVOIR2||In Vitro and In Vivo Comparison Between Intravascular Ultrasound (IVUS) Systems|Simultaneous Acquisition of Intravascular Ultrasound and Near Infrared Spectroscopy Data in the Coronary Artery Study|Unknown status|Recruiting|Phase 4|16|Anticipated|InfraReDx||4|||f||||f||||||||||2017-10-11 00:21:39.195535|2017-10-11 00:21:39.195535
NCT02154282|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-09-06|||January 2013||2013-01-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||iPod Games in Hepatic Encephalopathy||Completed||N/A|30|Actual|Hunter Holmes Mcguire Veteran Affairs Medical Center||1|||f||||f||||||||||2017-10-11 00:21:39.286851|2017-10-11 00:21:39.286851
NCT02154269|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-08-16|||September 2015||2015-09-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy|Prospective, Double-blind, Randomized, Placebo-controlled Phase II Clinical Trial for Evaluation of G-CSF in Patients With Chronic Chagas Cardiomyopathy|Enrolling by invitation||Phase 2|70|Anticipated|Hospital Sao Rafael||2|||f||||t||||||||||2017-10-11 00:21:39.378633|2017-10-11 00:21:39.378633
NCT02154256|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-09-26|||June 2014||2014-06-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Incentive Disbursement Pattern|Increasing, Decreasing, and Stable Incentives in a Health App Aggregator Website|Completed||N/A|3519|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 00:21:39.476734|2017-10-11 00:21:39.476734
NCT02154243|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-07-27|2017-03-23||June 2014||2014-06-01|July 2017|2017-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty|An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine in Patients With Preserved Cardiac Output (CO) and an Intravenous Fluid Bolus for Patients With Low CO Following Total Hip Arthroplasty|Terminated||N/A|13|Actual|Hospital for Special Surgery, New York||3|||f||||f||||||||||2017-10-11 00:21:39.566704|2017-10-11 00:21:39.566704
NCT02154230|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-04|||November 2013||2013-11-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Sulphate-bicarbonate-calcium Water, Body Weight and Gut Microbiota|Effect of Sulphate-bicarbonate-calcium Water Consumption on the Body Weight and Gut Microbiota Composition in Overweight and Obese Patients Under Low-calorie Diet|Unknown status|Recruiting|N/A|44|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 00:21:39.841155|2017-10-11 00:21:39.841155
NCT02154217|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-29||||||May 2014|2014-05-01||||December 2004|Actual|2004-12-01||Interventional|||Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures|Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures|Completed||Phase 3|200|Actual|University of Milan||2|||f||||f||||||||||2017-10-11 00:21:40.099169|2017-10-11 00:21:40.099169
NCT02154204|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-06-28|||May 2014||2014-05-01|May 2014|2014-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||A Validation Study of Near Infrared Fluorescence Imaging of Lymphatic Vessels in Humans.||Completed||N/A|10|Actual|University of Aarhus|||1||f||||||||||||||2017-10-11 00:21:40.196114|2017-10-11 00:21:40.196114
NCT02154191|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2015-06-03|||June 2014||2014-06-01|June 2015|2015-06-01||||June 2016|Anticipated|2016-06-01||Interventional|||Level of Activity in Lumbar Spinal Stenosis Patients Pre- and Post-surgery|Level of Activity in Lumbar Spinal Stenosis Patients Pre- and Post-surgery: a Non-randomized Controlled Before-after Trial|Unknown status|Enrolling by invitation|N/A|24|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:21:40.255182|2017-10-11 00:21:40.255182
NCT02154178|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2017-03-22|||July 2014||2014-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|STAFE||Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)|Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study|Completed||N/A|110|Actual|University Hospital, Lille||2|||f||||f||||||||No||2017-10-11 00:21:40.362063|2017-10-11 00:21:40.362063
NCT02154165|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-06-02|||January 2013||2013-01-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Comparison Between Turquoise and Blue Light in Treatment of Neonatal Jaundice Using Light Emission Diodes|Comparison Between Turquoise and Blue Light in Treatment of Neonatal Jaundice Using Light Emission Diodes|Completed||N/A|90|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:21:40.452832|2017-10-11 00:21:40.452832
NCT02154139|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-01-19|2016-01-19||December 2005||2005-12-01|January 2016|2016-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational||Safety analysis set was defined as participants who were enrolled and completed the study.|"Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"|"Leuplin SR 11.25 mg for Injection Specified Drug-use Survey Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"|Completed||N/A|651|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:21:40.629507|2017-10-11 00:21:40.629507
NCT02154126|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-01-19|||May 2014||2014-05-01|May 2015|2015-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PRECISE||PRECISE: A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor|PRECISE: A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor|Completed||N/A|81|Actual|Senseonics, Inc.||1|||f||||f||||||||||2017-10-11 00:21:41.661398|2017-10-11 00:21:41.661398
NCT02154113|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-29|||October 2012||2012-10-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Ultrashape System in Combination With VelaShape II Device for Circumferential Reduction|Baseline Controlled Two-arm Multi-Center Study to Evaluate the Safety and Efficacy of Combined Multi-Focus Treatments of UltraShape® Contour I V3 System and VelaShape II Device for Non-Invasive Circumference Reduction|Completed||N/A|21|Actual|Syneron Medical||2|||f||||f||||||||||2017-10-11 00:21:41.774827|2017-10-11 00:21:41.774827
NCT02154100|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-12-06|||April 2014||2014-04-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Tart Cherry, Metabolic Syndrome, and Cardiovascular Risk|Tart Cherry Improves Cardiovascular Risk Factors Associated With Metabolic Syndrome|Completed||Phase 2|26|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 00:21:41.906994|2017-10-11 00:21:41.906994
NCT02154087|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-09-19|2016-09-19|2015-01-05|July 2014||2014-07-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|MOA 034||A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers|A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers|Terminated||Phase 2|1|Actual|Healthpoint||1||based on outcome of previous study|f||||f||||||||||2017-10-11 00:21:42.041529|2017-10-11 00:21:42.041529
NCT02154074|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-30|||May 2014||2014-05-01|May 2014|2014-05-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Dexmedetomidine Influence on the Level of Perioperative Blood Glucose and Insulin of Elderly Diabetes Patients||Unknown status|Recruiting|Phase 4|92|Anticipated|Second Affiliated Hospital of Xi'an Jiaotong University||4|||f||||f||||||||||2017-10-11 00:21:42.25874|2017-10-11 00:21:42.25874
NCT02154061|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-08|||April 2015||2015-04-01|September 2017|2017-09-01|May 26, 2017|Actual|2017-05-26|May 26, 2017|Actual|2017-05-26||Interventional|VAX-002||Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics|Systems Biology of Inactivated Influenza Vaccine (IIV) in Healthy Adults With or Without Use of Broad Spectrum Antibiotics|Completed||N/A|33|Actual|Emory University||2|||f||||f||||||||||2017-10-11 00:21:42.370123|2017-10-11 00:21:42.370123
NCT02154048|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2014-09-09|2014-06-02||April 2012||2012-04-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Analgesic Efficacy of Perineural Dexamethasone During Supraclavicular Block for Hand Surgery|Analgesic Efficacy of Perineural Dexamethasone Added to Ropivacaine 0.5% With 1:400,000 Epinephrine During Single-injection Supraclavicular Block for Outpatient Hand Surgery|Terminated||Phase 2|5|Actual|Duke University||3|||f||||f||||||||||2017-10-11 00:21:42.472974|2017-10-11 00:21:42.472974
NCT02154035|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-06-30|||May 19, 2014||2014-05-19|March 28, 2017|2017-03-28|December 31, 2019|Anticipated|2019-12-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans|Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:21:42.981969|2017-10-11 00:21:42.981969
NCT02154022|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-09-21|||May 29, 2014||2014-05-29|September 11, 2017|2017-09-11|May 1, 2020|Anticipated|2020-05-01|May 1, 2019|Anticipated|2019-05-01||Observational|||Collection of Pharmacokinetic Samples From People With Unanticipated Response or Toxicity|Collection of Pharmacokinetic Samples From Patients With Unanticipated Response or Toxicity|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:21:43.099063|2017-10-11 00:21:43.099063
NCT02154009|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-10-05|||May 20, 2014||2014-05-20|June 13, 2017|2017-06-13|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Clinical Autonomic Disorders: A Training Protocol|Clinical Autonomic Disorders: A Training Protocol|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:21:43.187988|2017-10-11 00:21:43.187988
NCT02153996|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-07-06|||May 15, 2014||2014-05-15|March 15, 2016|2016-03-15|March 15, 2016|Actual|2016-03-15|March 15, 2016|Actual|2016-03-15||Observational|||Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United States|Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United States|Terminated||N/A|3|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:21:43.294141|2017-10-11 00:21:43.294141
NCT02153983|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-09-12|||May 14, 2014||2014-05-14|August 28, 2017|2017-08-28|December 31, 2018|Anticipated|2018-12-31|June 29, 2018|Anticipated|2018-06-29||Interventional|||Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome|Pilot Study of the Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome|Recruiting||Phase 1/Phase 2|250|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:21:43.384284|2017-10-11 00:21:43.384284
NCT02153970|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-06-30|||May 14, 2014||2014-05-14|December 1, 2016|2016-12-01|November 17, 2017|Anticipated|2017-11-17|November 17, 2017|Anticipated|2017-11-17||Observational|||Calibration and Validation of the PROMIS and Neuro-QOL Questionnaires in Cerebral Palsy and Congenital Muscular Dystrophy|The Calibration and Validation of the PROMIS and Neuro-QOL Questionnaires in Cerebral Palsy and Congenital Muscular Dystrophy|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:21:43.546783|2017-10-11 00:21:43.546783
NCT02153957|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-06-30|||May 14, 2014||2014-05-14|February 16, 2017|2017-02-16|April 1, 2019|Anticipated|2019-04-01|December 31, 2018|Anticipated|2018-12-31||Interventional|||Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated With Cranial Radiation for Brain Tumors|A Randomized Controlled Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in ChildrenTreated With Cranial Radiation for BrainTumors|Recruiting||Phase 2|156|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:21:43.693423|2017-10-11 00:21:43.693423
NCT02153944|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-09-28|||May 14, 2014||2014-05-14|September 27, 2017|2017-09-27|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Interventional|||Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety|Cognitive vs. Emotional Psycho-Pharmacological Manipulations of Fear vs. Anxiety|Completed||Phase 3|138|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:21:43.841176|2017-10-11 00:21:43.841176
NCT02153931|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-06-30|||May 14, 2014||2014-05-14|March 2, 2017|2017-03-02|April 6, 2015|Actual|2015-04-06|April 6, 2015|Actual|2015-04-06||Observational|||Internet Support Group for Parents of a Child With Neurofibromatosis Type 1|Effects of an Internet Support Group for Parents of a Child With Neurofibromatosis Type 1|Completed||N/A|33|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:21:43.981435|2017-10-11 00:21:43.981435
NCT02153918|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-08-25|||May 14, 2014||2014-05-14|May 12, 2017|2017-05-12|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy|A Phase II Study of Neoadjuvant rFowlpox-PSA (L155)-TRICOM (Prostvac-F/TRICOM) in Combination With rVaccinia-PSA (L155)-TRICOM (Prostvac-V/TRICOM) in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy|Active, not recruiting||Phase 2|27|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:21:44.1032|2017-10-11 00:21:44.1032
NCT02153905|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-31|2017-08-24|||May 13, 2014||2014-05-13|August 3, 2017|2017-08-03|December 27, 2024|Anticipated|2024-12-27|December 29, 2023|Anticipated|2023-12-29||Interventional|||T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive|Phase I-II Study of the Treatment of Metastatic Cancer That Expresses MAGE-A3 Using Lymphodepleting Conditioning Followed by Infusion of Anti-MAGE-A3 HLA-A*01 Restricted TCR-Gene Engineered Lymphocytes and Aldesleukin|Recruiting||Phase 1/Phase 2|102|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:21:44.217412|2017-10-11 00:21:44.217412
NCT02153892|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-06-07|||August 2014||2014-08-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|October 2015|Actual|2015-10-01||Interventional|LVRECOVER||Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function|Clinical Protocol - A Feasibility Study Using the AccuCinch® System in the Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function|Active, not recruiting||N/A|2|Actual|Ancora Heart, Inc.||1|||f||||t||||||||||2017-10-11 00:21:44.342679|2017-10-11 00:21:44.342679
NCT02153879|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-06-02|||February 2009||2009-02-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Interventional|LOWHDL||Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment|Qualitative and Quantitative Characterization of HDL in T2D After Fenofibrate or Niacin Treatment in Spanish Population|Completed||Phase 4|30|Actual|Institut Investigacio Sanitaria Pere Virgili||2|||f||||f||||||||||2017-10-11 00:21:44.441367|2017-10-11 00:21:44.441367
NCT02153866|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-06-02|||December 2013||2013-12-01|May 2014|2014-05-01|August 2014|Anticipated|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine|The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine|Unknown status|Enrolling by invitation|Phase 4|2800|Anticipated|Sichuan Center for Disease Control and Prevention||5|||f||||t||||||||||2017-10-11 00:21:44.554961|2017-10-11 00:21:44.554961
NCT02153853|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-01-22|||June 2014||2014-06-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Does Obesity Increase the Risk of Conversion and Short Term Complications in Laparoscopic Rectal Surgery?|Does Obesity Increase the Risk of Conversion and Short Term Complications in Laparoscopic Rectal Surgery?|Unknown status|Enrolling by invitation|N/A|335|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 00:21:44.636962|2017-10-11 00:21:44.636962
NCT02153840|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2017-07-28|||December 2013||2013-12-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Interventional|||Clinical Trial of PSORI-CM01（YXBCM01） Granule to Treat Stable Plaque Psoriasis|A Double-blind, Randomized, Placebo-controlled Trial of PSORI-CM01（YXBCM01） Granule for Stable Plaque Psoriasis|Terminated||N/A|35|Actual|Guangdong Provincial Hospital of Traditional Chinese Medicine||3||Paitents were unwilling to be randomly assigned to a placebo group.|f||||t||||||||||2017-10-11 00:21:44.717806|2017-10-11 00:21:44.717806
NCT02153827|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-08-26|2016-04-28||March 2014||2014-03-01|April 2015|2015-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Shoulder Eccentric External Rotator Training for Subacromial Pain Syndrome|Shoulder External Rotator Eccentric Training for Subacromial Impingement Syndrome|Completed||N/A|48|Actual|Nova Southeastern University||2|||f||||f||||||||No||2017-10-11 00:21:44.939685|2017-10-11 00:21:44.939685
NCT02153814|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-02-21|||August 2014||2014-08-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Endometrial Injury and in Vitro Fertilization Outcomes|Pilot Study on the Effect of Endometrial Injury in Patients Undergoing in Vitro Fertilization (IVF)|Recruiting||N/A|600|Anticipated|Northwestern University||3|||f||||f||||||||||2017-10-11 00:21:45.2672|2017-10-11 00:21:45.2672
NCT02153801|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-03-31|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Interventional|||Genito Urinary Function With High or Low Inferior Mesenteric Artery Ligation in Laparoscopic Anterior Rectal Resection|Sexual Urinary Function in Patients Undergoing Laparoscopic Low Anterior Resection With Total Mesorectal Excision With High Or Low Ligation of the Inferior Mesenteric Artery With Preservation of Left Colic Artery Multicentre Randomized Trial|Completed||N/A|212|Actual|Niguarda Hospital||2|||f||||f||||||||||2017-10-11 00:21:45.379753|2017-10-11 00:21:45.379753
NCT02153788|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-02-24|2015-01-30||September 2009||2009-09-01|January 2015|2015-01-01||||September 2010|Actual|2010-09-01||Interventional|||Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia|A Randomized, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia|Completed||Phase 4|44|Actual|Duke University||2|||f||||||||||||||2017-10-11 00:21:45.50294|2017-10-11 00:21:45.50294
NCT02153775|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-31|||August 2012||2012-08-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Progressive Muscle Relaxation and Cigarette Craving|Preliminary Study of Effects of Progressive Muscle Relaxation on Cigarette Craving and Withdrawal Symptoms of Experienced Smokers in Acute Cigarette Abstinence : A Randomised Control Trial|Completed||N/A|34|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-11 00:21:46.006079|2017-10-11 00:21:46.006079
NCT02153762|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-04-11|||April 2013||2013-04-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus Cream|Assessment of Application Order When Utilizing Locoid Lotion and Hylatopic Plus Cream in the Treatment of Atopic Dermatitis|Completed||N/A|41|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|f||||||||2017-10-11 00:21:46.081382|2017-10-11 00:21:46.081382
NCT02153749|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-12-06|||September 2015||2015-09-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Effects of Brief Training on Craving Regulation|Regulation of Craving: Brief Neurocognitive Training and Neural Mechanisms|Recruiting||N/A|126|Anticipated|Yale University||3|||f||||t||||||||Undecided||2017-10-11 00:21:46.181078|2017-10-11 00:21:46.181078
NCT02153736|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-06-09|2016-12-14||April 2014||2014-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Interventional|SPEEDI||Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention|Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention (SPEEDI) - Phase 1 Clinical Trial|Active, not recruiting||N/A|14|Actual|Virginia Commonwealth University|Sample smaller than anticipated Fewer infant with brain injury than anticipated ceiling effect notes with reaching measures longer term outcomes only possible from clinical records|2|||f||||f||||||||No|Given the small sample from a specific time range the data will not be shared do to difficulty de-identifying with demographics of individual infants attached.|2017-10-11 00:21:46.305352|2017-10-11 00:21:46.305352
NCT02153710|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-08-30|||March 11, 2014|Actual|2014-03-11|August 2017|2017-08-01|September 29, 2017|Anticipated|2017-09-29|August 21, 2017|Actual|2017-08-21||Interventional|PMvSFA||Speech Therapy for Aphasia: Comparing Two Treatments|A Prospective, Controlled Study of Rehabilitation of Anomia in Aphasia|Active, not recruiting||N/A|58|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:21:47.044838|2017-10-11 00:21:47.044838
NCT02153697|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-12-15|||March 2014||2014-03-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Comparative Study of the Therapy of Solar Lentigines With a Q-switched Rubin Laser Versus a Bleaching Cream|Comparative Study Investigating the Therapy of of Solar Lentigines With the Q-switched SINON Rubin 694nm Laser Versus Pigmanorm® Cream|Completed||N/A|15|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 00:21:47.177521|2017-10-11 00:21:47.177521
NCT02153684|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-12-13|||March 2015||2015-03-01|December 2016|2016-12-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Canadian Cohort on the Origin and Progression of Airway Disease: Physiology Platform|Canadian Cohort on the Origin and Progression of Airway Disease: Physiology Platform|Recruiting||N/A|120|Anticipated|Queen's University|||4||f||||f||||||||||2017-10-11 00:21:47.293229|2017-10-11 00:21:47.293229
NCT02153671|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2015-08-26|||May 2014||2014-05-01|May 2014|2014-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Immunogenicity of H5N1 Vaccine Following H5N2|Immunogenicity of OrniFlu® Inactivated Influenza Vaccine in Subjects Previously Immunized With Live Attenuated H5N2 Influenza Vaccine and in Non-vaccinated Subjects|Completed||Phase 2|43|Actual|PATH||2|||f||||f||||||||||2017-10-11 00:21:47.380676|2017-10-11 00:21:47.380676
NCT02153658|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-05-29|||November 2013||2013-11-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|RMC-10||An Open Label, Blinded Assessor, Trial Comparing Odor Levels Due to Different Hygiene Methods With PrePexTM|A Prospective, Randomized, Open Label, Blinded Assessor, Trial Comparing Odor Levels Due to Different Hygiene Techniques When Using the PrePexTM Device|Completed||N/A|101|Actual|Ministry of Health, Rwanda||3|||f||||f||||||||||2017-10-11 00:21:47.466412|2017-10-11 00:21:47.466412
NCT02153645|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-02-09|||June 2014||2014-06-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|ALLAY-LID I||Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.|A Multicenter, Randomized, Placebo-controlled, Double-blind, 16 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias|Recruiting||Phase 3|162|Anticipated|Osmotica Pharmaceutical US LLC||3|||f||||f||||||||||2017-10-11 00:21:47.579723|2017-10-11 00:21:47.579723
NCT02153632|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-02-09|||June 2014||2014-06-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|ALLAY-LID II||Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias|A Multicenter, Randomized, Placebo-controlled, Double-blind, 26 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias|Recruiting||Phase 3|162|Anticipated|Osmotica Pharmaceutical US LLC||3|||f||||f||||||||||2017-10-11 00:21:47.808352|2017-10-11 00:21:47.808352
NCT02153606|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-03-15|||January 2015||2015-01-01|March 2016|2016-03-01||||June 2016|Anticipated|2016-06-01||Interventional|||Glycerin Suppositories Used Prophylactically in Premature Infants (SUPP): a Pilot Randomized Placebo-controlled Trial|Glycerin Suppositories Used Prophylactically in Premature Infants (SUPP): a Pilot Randomized Placebo-controlled Trial|Recruiting||N/A|30|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-11 00:21:48.280916|2017-10-11 00:21:48.280916
NCT02153593|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-09-19|||March 2013||2013-03-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|TRANEXTUM||Postoperative Bleeding Prevention in Massive Bone Tumour Resection|Postoperative Bleeding Prevention in Massive Bone Tumour Resection: a Multicentric, Randomized, Parallel, Controlled Trial to Assess the Efficacy of Tranexamic Acid Versus Evicel® and Usual Haemostasis|Terminated||Phase 3|56|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||3||Difficulty in recruitment|f||||f||||||||||2017-10-11 00:21:48.391825|2017-10-11 00:21:48.391825
NCT02153411|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-11-07|||June 2014||2014-06-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ESMAA||Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population|Evaluation of aSthma Management in Middle EAst Adult Population|Completed||N/A|7294|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:21:50.506911|2017-10-11 00:21:50.506911
NCT02153580|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-08-02|||September 24, 2014|Actual|2014-09-24|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia or B-Cell Prolymphocytic Leukemia|Phase I Study to Evaluate Cellular Immunotherapy Using Central Memory-Enriched T Cells Lentivirally Transduced to Express a CD19-Specific, Hinge-Optimized, CD28-Costimulatory Chimeric Receptor and a Truncated EGFR Following Lymphodepleting Chemotherapy in Adult Patients With CD19+ B-Cell Lymphoproliferative Neoplasms|Active, not recruiting||Phase 1|48|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:21:48.532294|2017-10-11 00:21:48.532294
NCT02153567|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-04-23|||November 2013||2013-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||SSRI Study for Functional Dyspepsia (SS)|Effect of Selective Serotonin Reuptake Inhibitor on Satiety Function in Patients With Functional Dyspepsia|Recruiting||Phase 3|72|Anticipated|Chinese University of Hong Kong||2|||f||||||||||||No||2017-10-11 00:21:48.664582|2017-10-11 00:21:48.664582
NCT02153554|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-02-06|||May 2014||2014-05-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|||Impact Evaluation of Training Civil Servants on Violence Against Women in Medellín, Colombia|"Capacity of State and Local Actors to Respond to Violence Against Women: Impact Evaluation of Training Civil Servants on Violence Against Women in Medellín (Colombia), Component of the Program Seguridad Pública"|Completed||N/A|975|Actual|Econometría Consultores||2|||f||||||||||||||2017-10-11 00:21:48.801468|2017-10-11 00:21:48.801468
NCT02153541|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-06-02|||July 2014||2014-07-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|CREWS01||Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults|Assessing the Efficacy of Antipyrine Benzocaine Otic Solution in the Ear Canal to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults.|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|Global United Pharmaceutical Corporation||2|||f||||t||||||||||2017-10-11 00:21:48.892833|2017-10-11 00:21:48.892833
NCT02153528|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-08-01|||November 2014||2014-11-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|OneRIF||Optimization of the TB Treatment Regimen Cascade|Optimization of the TB Treatment Regimen Cascade|Completed||Phase 3|946|Actual|Damien Foundation||2|||f||||t||||||||||2017-10-11 00:21:48.992489|2017-10-11 00:21:48.992489
NCT02153515|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2016-10-12|||April 2014||2014-04-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|FAB||Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood|Fingerprick Fresh Blood for Treatment of Chronic Corneal Ulcers, Persistent Epithelial Defects and Dry Eyes|Enrolling by invitation||Phase 3|60|Anticipated|Bedford Hospital NHS Trust||1|||f||||f||||||||||2017-10-11 00:21:49.079206|2017-10-11 00:21:49.079206
NCT02153502|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-05-11||2017-05-11|July 2014|Actual|2014-07-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deuterium Modified Dextromethorphan Hydrobromide/Quinidine Sulfate) as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment|Completed||Phase 2|206|Actual|Avanir Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:21:49.162531|2017-10-11 00:21:49.162531
NCT02153489|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-09-20|2016-06-01||April 2014||2014-04-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)|A Pilot, Double-blind, Placebo-controlled, 2-period Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|30|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:21:49.308497|2017-10-11 00:21:49.308497
NCT02153476|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-06-22|||February 2014||2014-02-01|May 2014|2014-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion|A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion|Completed||Phase 2|106|Actual|Allegro Ophthalmics, LLC||2|||f||||t||||||||||2017-10-11 00:21:49.864448|2017-10-11 00:21:49.864448
NCT02153463|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2015-08-05|||May 2014||2014-05-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Activity in Tourette Syndrome|Enhancing Physical Activity in Children With Tics and Tourette Syndrome: Impact on Tic Severity and Quality of Life|Completed||N/A|14|Actual|Children's Hospital of Eastern Ontario||2|||f||||f||||||||||2017-10-11 00:21:49.957421|2017-10-11 00:21:49.957421
NCT02153450|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-04-24|||May 8, 2015|Actual|2015-05-08|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Stereotactic Radiosurgery and Metformin Hydrochloride in Treating Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer|A Pilot Trial of Stereotactic Body Radiation Therapy and Metformin for Borderline-Resectable and Locally-Advanced Pancreatic Adenocarcinomas|Recruiting||Early Phase 1|15|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|t|f|||f|||||2017-10-11 00:21:50.066897|2017-10-11 00:21:50.066897
NCT02153437|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2017-02-14|||October 2014||2014-10-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers|A Study of the Effects of BMS-919373 on Atrial Effective Refractory Period in Subjects With a Dual-Chamber Pacemaker|Terminated||Phase 1|7|Actual|Bristol-Myers Squibb||3||Insufficient enrollment|f||||f||||||||||2017-10-11 00:21:50.186225|2017-10-11 00:21:50.186225
NCT02153424|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-08-15|||April 2014||2014-04-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Early Post-marketing Study of Eliquis (Apixaban)|Early Post-marketing Study of Eliquis (Apixaban)|Withdrawn||N/A|0|Actual|Bristol-Myers Squibb|||1|Business objectives have changed.|f||||f||||||||||2017-10-11 00:21:50.383268|2017-10-11 00:21:50.383268
NCT02152852|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-04-12|||November 2011||2011-11-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|April 2015|Actual|2015-04-01||Interventional|Peer-AID||Peer Support for Achieving Independence in Diabetes|Peer Support for Achieving Independence in Diabetes (Peer AID)|Completed||N/A|287|Actual|Public Health - Seattle and King County||2|||f||||f||||||||||2017-10-11 00:22:02.983458|2017-10-11 00:22:02.983458
NCT02153398|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-30|2016-11-28|2016-09-27||June 2014||2014-06-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases|An Open-label, Parallel-group, Multi-centre, Phase I/III Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Repeated Once-daily Oral Administration of D961H 10 mg and D961H 20 mg in Japanese Paediatric Patients 1 to 14 Years Old With Gastrointestinal Acid Related Diseases|Completed||Phase 3|55|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 00:21:50.859813|2017-10-11 00:21:50.859813
NCT02153385|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-06-02|||September 2010||2010-09-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effects of Yoga on Heart Rate Variability and Mood in Women|Effects of Yoga on Heart Rate Variability and Mood in Women: A Randomized Controlled Trial|Completed||N/A|52|Actual|Kaohsiung Medical University||2|||f||||f||||||||||2017-10-11 00:21:52.655873|2017-10-11 00:21:52.655873
NCT02153372|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-05-11|||July 2013||2013-07-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|BMC2012||Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial|Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures|Completed||Phase 1|10|Actual|Goethe University||1|||f||||t||||||||||2017-10-11 00:21:52.757956|2017-10-11 00:21:52.757956
NCT02153359|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-09-14|||February 2014||2014-02-01|September 2015|2015-09-01||||February 2019|Anticipated|2019-02-01||Interventional|INHALE 2||Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response|Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response|Recruiting||N/A|40|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 00:21:52.89772|2017-10-11 00:21:52.89772
NCT02153346|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-03-13|2016-12-16||June 2014||2014-06-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec|Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec|Completed||N/A|101|Actual|GlaxoSmithKline|Important limitations regarding sample size,generalizability and results interpretation.Data not reliable due to low numbers by strata. Changes in work status,full/part-time,and treatments or other factors influencing productivity were not accounted.|1|||f||||||||||||||2017-10-11 00:21:53.041026|2017-10-11 00:21:53.041026
NCT02153333|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-04-02|||February 2014||2014-02-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™|Blinded Retrospective Laboratory Evaluations to Assess the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following the Administration of GlaxoSmithKline (GSK) Biologicals' Human Rotavirus Vaccine (444563)|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||||||||Samples With DNA|"     Serum samples   "|||2017-10-11 00:21:53.637097|2017-10-11 00:21:53.637097
NCT02153320|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-05-24|||September 5, 2005|Actual|2005-09-05|May 2017|2017-05-01|October 28, 2005|Actual|2005-10-28|October 28, 2005|Actual|2005-10-28||Interventional|||Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers|A Long-term Follow-up of a Phase I/II Study to Compare the Persistence and to Perform in Depth Characterisation of the Cellular and Humoral Immune Response Following Vaccinations With GSK Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers|Completed||Phase 1|93|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 00:21:53.719305|2017-10-11 00:21:53.719305
NCT02153307|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-05-09|||January 2014||2014-01-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MARE||"Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation. The MARE Study"|"Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation. The MARE Study"|Recruiting||N/A|80|Anticipated|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec||1|||f||||f||||||||||2017-10-11 00:21:53.822379|2017-10-11 00:21:53.822379
NCT02153294|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-08-21|||August 2014||2014-08-01|August 2017|2017-08-01|November 18, 2017|Anticipated|2017-11-18|September 20, 2017|Anticipated|2017-09-20||Interventional|PReVENT-NL||PRotective VENTilation in Patients Without ARDS|PRotective VENTilation in Patients Without ARDS at Start of Ventilation - PReVENT, a Randomized Controlled Trial|Active, not recruiting||N/A|952|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:21:53.923722|2017-10-11 00:21:53.923722
NCT02153281|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-07-20|||June 2014||2014-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|DETB||Detecting Central and Peripheral Biomarkers in MDD|Detecting Central and Peripheral Biomarkers in Major Depressive Disorder (MDD)|Recruiting||N/A|15|Anticipated|Centre for Addiction and Mental Health||1|||f||||t||||||||||2017-10-11 00:21:54.044985|2017-10-11 00:21:54.044985
NCT02153268|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2017-01-11|||February 2014||2014-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Filling Bone Defects/Voids With Autologous BonoFill For Maxillofacial Bone Regeneration|Phase I/II Open Label FIH Single Center Clinical Study Aimed to Evaluate the Safety and the Efficacy of BonoFill in Reconstructing the Bone.|Completed||Phase 1/Phase 2|11|Actual|BonusBio Group Ltd||1|||f||||f||||||||No||2017-10-11 00:21:54.140558|2017-10-11 00:21:54.140558
NCT02153255|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Dynamic Gait Analysis in Children With Mucopolysaccharidosis Type IVa||Withdrawn||N/A|0|Actual|Birmingham Women's and Children's NHS Foundation Trust|||1|"Closure of Gait Analysis Laboratory - unable to set up alternative gait laboratory in time for   funders"|f||||f||||||||||2017-10-11 00:21:54.223024|2017-10-11 00:21:54.223024
NCT02153242|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-04-08|||September 2013||2013-09-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|PacingRV||The Effects of Selective Site Right Ventricular Pacing|Does a Surrogate Marker Exist That Can be Used as A Predictor For Left Ventricular Dysfunction In Patients Undergoing Right Ventricular Pacing|Completed||N/A|14|Actual|Basildon and Thurrock University Hospitals NHS Foundation Trust|||1||f||||f||||||||No||2017-10-11 00:21:54.286962|2017-10-11 00:21:54.286962
NCT02153229|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-06-30|||May 2014||2014-05-01|December 2016|2016-12-01||||May 2018|Anticipated|2018-05-01||Interventional|||MPM PDT Phase II Trial|A Randomized Phase 2 Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium -Mediated Photodynamic Therapy for Patients With Epitheliod Malignant Pleural Mesothelioma|Recruiting||Phase 2|102|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:21:54.351187|2017-10-11 00:21:54.351187
NCT02153216|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-05-18|||May 2014||2014-05-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|F-REDART||Formative Phase of Reducing Hazardous Alcohol Use & HIV Viral Load|Formative Phase of Reducing Hazardous Alcohol Use & HIV Viral Load: An RCT in ART Clinics in Vietnam|Completed||N/A|40|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||No||2017-10-11 00:21:54.469939|2017-10-11 00:21:54.469939
NCT02153203|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-10-24|||October 2014||2014-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders|Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders|Completed||N/A|42|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-11 00:21:54.548314|2017-10-11 00:21:54.548314
NCT02153190|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-11-05|||May 2014||2014-05-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|AP Hybrid||Hybrid Artificial Pancreas in Home Setting|Assessment of Hybrid Use of an Artificial Pancreas in a Home Setting for Two Months in Patients With Type 1 Diabetes|Completed||Phase 2|36|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:21:54.638654|2017-10-11 00:21:54.638654
NCT02153177|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-10-28|||January 2015||2015-01-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||The Effect of NSAIDs After a Rotator Cuff Repair Surgery.|The Effect of NSAIDs After a Rotator Cuff Repair Surgery. A Prospective Randomized Controlled Trial|Suspended||Phase 4|60|Anticipated|University of Chicago||2|||f||||||||||||||2017-10-11 00:21:54.746106|2017-10-11 00:21:54.746106
NCT02153164|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-08-10|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|July 2015|Actual|2015-07-01||Observational|||Effect of the Steep Trendelenburg Position on Respiratory Gas Heat Content|Effect of the Steep Trendelenburg Position on Respiratory Gas Heat Content|Completed||N/A|10|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 00:21:54.842196|2017-10-11 00:21:54.842196
NCT02153151|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-05|||November 11, 2013|Actual|2013-11-11|September 2017|2017-09-01|July 14, 2016|Actual|2016-07-14|February 23, 2016|Actual|2016-02-23||Observational|||Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy|A Pilot Study to Evaluate the In-vitro Effect of AMP-514, a PD-1 Inhibitor, on Peripheral Blood T Cell Proliferation and Cytokine Production From Patients With Solid Malignancies Treated With Radiotherapy (RT)|Completed||N/A|21|Actual|Thomas Jefferson University|||1||f||||t||||||Samples With DNA|"     PBMCs   "|||2017-10-11 00:21:54.900656|2017-10-11 00:21:54.900656
NCT02153138|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-05-30|||July 2014||2014-07-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Interventional|||The Effect of Plant-based Diets (Vegetarian and Vegan) on Endothelial Function and Atherogenic Parameters||Unknown status|Not yet recruiting|N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 00:21:56.896187|2017-10-11 00:21:56.896187
NCT02153125|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-05-30|||April 2014||2014-04-01|May 2014|2014-05-01||||June 2015|Anticipated|2015-06-01||Interventional|||Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy||Unknown status|Recruiting|Phase 2|30|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 00:21:56.977322|2017-10-11 00:21:56.977322
NCT02153112|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-08|||June 23, 2015|Actual|2015-06-23|September 2017|2017-09-01|November 15, 2018|Anticipated|2018-11-15|November 15, 2018|Anticipated|2018-11-15||Interventional|||Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine in Children|A Phase II, Randomized, Double-Blind, Dosage, Safety and Immunogenicity Trial of Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine Combined With Aluminum Hydroxide Adjuvant in Children, Toddlers, and Infants|Active, not recruiting||Phase 2|840|Anticipated|Takeda||10|||f||||t|f|f||||||||2017-10-11 00:21:57.096465|2017-10-11 00:21:57.096465
NCT02153099|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-11-13|2015-11-13||June 2014||2014-06-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single Doses of ENV8058 in Healthy Subjects|Completed||Phase 1|48|Actual|Takeda||7|||f||||f||||||||||2017-10-11 00:21:57.350638|2017-10-11 00:21:57.350638
NCT02153086|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-08-17|2016-08-17||March 2011||2011-03-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational||The safety analysis set was defined as all participants who were enrolled and completed the study.|Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> − Transitional Survey From the Preceding Drug-use Survey −|Rozerem 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Associated With Sleep-onset Difficulty > − Transitional Survey From the Preceding Drug-use Survey −|Completed||N/A|236|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:21:59.216229|2017-10-11 00:21:59.216229
NCT02153073|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-07-06|||May 29, 2013|Actual|2013-05-29|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|||Evaluation of the Safety and Efficacy of Long-term Use of Lotriga|Lotriga Granular Capsules Special Drug Use Surveillance (Long-term Use Survey)|Completed||N/A|3084|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:21:59.709262|2017-10-11 00:21:59.709262
NCT02153060|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-04-18|||May 2014||2014-05-01|May 2014|2014-05-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)|A Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Different Doses of Dexamethasone for Management of Immune Thrombocytopenia (ITP)|Completed||Phase 2|58|Actual|Shandong University||2|||f||||t||||||||||2017-10-11 00:21:59.79186|2017-10-11 00:21:59.79186
NCT02152839|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-07-30|||May 2013||2013-05-01|July 2015|2015-07-01||||July 2014|Actual|2014-07-01||Interventional|||The Implementation of Novel 'Heavy' Water Techniques for Determining Modulation of Muscle Protein, DNA and Lipid Synthesis Due to Ageing||Completed||N/A|20|Actual|University of Nottingham||2|||f||||||||||||||2017-10-11 00:22:03.070775|2017-10-11 00:22:03.070775
NCT02153047|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-30|||November 2011||2011-11-01|May 2014|2014-05-01|November 2014|Anticipated|2014-11-01|November 2013|Actual|2013-11-01||Interventional|RESET-ESPITAP2||Multicentric Randomized Clinical Trial to Evaluate the Long-term Effectiveness of a Motivational Intervention Against Smoking, Based on the Information Obtained From Spirometry in Primary Care.|Multicentric Randomized Clinical Trial to Evaluate the Long-term Effectiveness of a Motivational Intervention Against Smoking, Based on the Information Obtained From Spirometry in Primary Care.|Unknown status|Active, not recruiting|N/A|1100|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 00:21:59.892202|2017-10-11 00:21:59.892202
NCT02153034|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-03-22|||May 2013||2013-05-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 15, 2016|Actual|2016-12-15||Observational|Buruli_Path||Pathogenesis and Management of M. Ulcerans Disease, Buruli Ulcer|A Study of the Pathogenesis and Management of M. Ulcerans Disease, Buruli Ulcer|Active, not recruiting||N/A|400|Actual|Kwame Nkrumah University of Science and Technology|||2||f||||f||||||||||2017-10-11 00:21:59.972183|2017-10-11 00:21:59.972183
NCT02153021|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-27|||September 2014||2014-09-01|May 2014|2014-05-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||New Therapeutic Perspectives in Obesity|New Therapeutic Perspectives in Obesity|Unknown status|Not yet recruiting|Phase 1|64|Anticipated|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-11 00:22:00.122819|2017-10-11 00:22:00.122819
NCT02153008|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-08-01|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Observational|||Strep A FIA Field Study, Sofia|Sofia Strep A FIA Field Study|Completed||N/A|1708|Actual|Quidel Corporation|||1||f||||f||||||||||2017-10-11 00:22:00.263123|2017-10-11 00:22:00.263123
NCT02152995|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-22|||August 14, 2014|Actual|2014-08-14|September 2017|2017-09-01||||January 1, 2018|Anticipated|2018-01-01||Interventional|||Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer|A Phase 2 Study of Trametinib in Combination With Radioiodine (RAI) for RAS Mutant or RAS/RAF Wild-Type, RAI-Refractory Recurrent and/or Metastatic Thyroid Cancers|Recruiting||Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:22:00.41517|2017-10-11 00:22:00.41517
NCT02152969|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-11-18|||May 2014||2014-05-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)|An Open-label, Multiple-dose, Two-arm Clinical Study to Evaluate the Drug-drug Interaction and Safety of Telmisartan, Amlodipine and/or Chlorthalidone in Healthy Adult Volunteers|Completed||Phase 1|66|Actual|Yuhan Corporation||2|||f||||f||||||||||2017-10-11 00:22:01.874564|2017-10-11 00:22:01.874564
NCT02152956|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-09-12|||May 2014||2014-05-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety Study of MGD006 in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Intermediate-2/High Risk MDS|A Phase 1, First in Human, Dose Escalation Study of MGD006, a CD123 x CD3 Dual Affinity Re-Targeting (DART®) Bi-Specific Antibody Based Molecule, in Patients With Relapsed or Refractory AML or Intermediate-2/High Risk MDS|Recruiting||Phase 1|124|Anticipated|MacroGenics||1|||f||||f||||||||||2017-10-11 00:22:02.081709|2017-10-11 00:22:02.081709
NCT02152943|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-08-04|||July 17, 2014|Actual|2014-07-17|August 2017|2017-08-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients|Combination Treatment With Everolimus, Letrozole and Trastuzumab in Hormone Receptor and HER2/Neu-positive Patients With Advanced Metastatic Breast Cancer and Other Solid Tumors: Evaluating Synergy and Overcoming Resistance|Recruiting||Phase 1|42|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-11 00:22:02.275803|2017-10-11 00:22:02.275803
NCT02152930|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-04-25|||December 2014||2014-12-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|FISHTIC||The Effects of Fish Oil Supplements During Supervised Exercise Therapy in Patients With Intermittent Claudication|The Effects of Fish Oil Supplements During Supervised Exercise Therapy in Patients With Intermittent Claudication|Terminated||Phase 3|8|Actual|Medical Center Alkmaar||2||Low recruitment rate|f||||t||||||||||2017-10-11 00:22:02.4139|2017-10-11 00:22:02.4139
NCT02152917|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-05-30|||February 2014||2014-02-01|May 2014|2014-05-01|May 2015|Anticipated|2015-05-01|February 2015|Anticipated|2015-02-01||Interventional|||Comparison of Floseal® and Tranexamic Acid on Bleeding Control After Total Knee Arthroplasty|Comparison of Floseal® and Tranexamic Acid on Bleeding Control After Total Knee Arthroplasty - Randomized Prospective Study|Unknown status|Recruiting|Phase 4|45|Anticipated|University of Sao Paulo General Hospital||3|||f||||f||||||||||2017-10-11 00:22:02.508647|2017-10-11 00:22:02.508647
NCT02152904|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-08-03|||April 2014||2014-04-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01|1 Year|Observational [Patient Registry]|KPUB||Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study|Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study|Completed||N/A|892|Actual|Incheon St.Mary's Hospital|||1||f||||t||||||||||2017-10-11 00:22:02.631069|2017-10-11 00:22:02.631069
NCT02152891|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-10-03|||October 2014|Actual|2014-10-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|November 2016|Actual|2016-11-01||Interventional|CHAP-EMS||A Community Paramedicine Initiative for Older Adults Living in Subsidized Housing (CHAP-EMS/CP@Clinic)|A Community Paramedicine Initiative for Older Adults Living in Subsidized Housing (CHAP-EMS/Renamed to CP@Clinic)|Active, not recruiting||N/A|1200|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 00:22:02.728221|2017-10-11 00:22:02.728221
NCT02152878|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-11-20|||April 2014||2014-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|TDCS-BD||Transcranial Direct Current Stimulation for the Treatment of Bipolar Depression|Transcranial Direct Current Stimulation for the Treatment of Bipolar Depression|Completed||Phase 2/Phase 3|60|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:22:02.817272|2017-10-11 00:22:02.817272
NCT02152865|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2014-05-28|||December 2009||2009-12-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Clinical Trial of Lupeol for Mild-moderate Acne||Completed||N/A|25|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 00:22:02.900005|2017-10-11 00:22:02.900005
NCT02152826|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-11-17|||March 2014||2014-03-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Dental Hypersensitivity|A Clinical Study Comparing the Safety and Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Existing Dentinal Hypersensitivity|Completed||N/A|80|Actual|Procter and Gamble||2|||f||||f||||||||||2017-10-11 00:22:03.141854|2017-10-11 00:22:03.141854
NCT02152813|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-10-13|||May 2014||2014-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|RCT||Efficacy of Bilateral Stimulation With Task-oriented Training in Improving Lower Limb Motor Functions in Patients With Stroke|Efficacy of Bilateral Stimulation With Task-oriented Training in Improving Lower Limb Motor Functions in Patients With Stroke: a Randomized, Placebo-controlled Clinical Trial|Active, not recruiting||Phase 1|80|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||Undecided||2017-10-11 00:22:03.228597|2017-10-11 00:22:03.228597
NCT02152800|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-05-28|||April 2011||2011-04-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|Vacyless®||A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster|A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster|Completed||Phase 4|25|Actual|Yung Shin Pharm. Ind. Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:22:03.316125|2017-10-11 00:22:03.316125
NCT02152787|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-07-07|||May 2014||2014-05-01|July 2014|2014-07-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Propofol 1mg/kg and Propofol 0.5mg/kg for Prevention of Emergence Agitation in Children Undergoing Strabismus Surgery During Sevoflurane Anesthesia|Comparison of Propofol 1mg/kg and Propofol 0.5mg/kg for Prevention of Emergence Agitation in Children Undergoing Strabismus Surgery During Sevoflurane Anesthesia|Unknown status|Recruiting|N/A|90|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-11 00:22:03.406303|2017-10-11 00:22:03.406303
NCT02152774|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2015-04-23|||May 2014||2014-05-01|April 2015|2015-04-01||||February 2015|Actual|2015-02-01||Interventional|ROCK - CACG||A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma|A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|New York Glaucoma Research Institute||2|||f||||||||||||||2017-10-11 00:22:03.5034|2017-10-11 00:22:03.5034
NCT02152761|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-05-10|||September 16, 2014|Actual|2014-09-16|May 2017|2017-05-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery|A 24-week Double-blind Treatment and 24-week Follow-up, Randomized, Multicenter, Placebo-controlled, Phase IIa/IIb Study to Evaluate Safety and Efficacy of i.v. Bimagrumab on Total Lean Body Mass and Physical Performance in Patients After Surgical Treatment of Hip Fracture|Recruiting||Phase 2|245|Anticipated|Novartis||4|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 00:22:03.602343|2017-10-11 00:22:03.602343
NCT02152748|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-03-21|||April 2014||2014-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Disease Progression and Treatment-induced Alterations in Glioblastoma|Analysis of Disease Progression and Treatment-Induced Alterations in Glioblastoma - an Integrative Morphological and Molecular Approach|Active, not recruiting||N/A|60|Anticipated|Medical University of Vienna|||1||f||||t||||||Samples With DNA|"     Tissue   "|||2017-10-11 00:22:04.087047|2017-10-11 00:22:04.087047
NCT02152735|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-11-23|||July 2014||2014-07-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Intrauterine Cleaning After Placental Delivery at Cesarean Section: RCT|Intrauterine Cleaning After Placental Delivery at Cesarean Section: a Randomized Controlled Trial|Completed||N/A|206|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 00:22:04.16786|2017-10-11 00:22:04.16786
NCT02152722|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2015-04-06|||September 2013||2013-09-01|April 2015|2015-04-01|November 2016|Anticipated|2016-11-01|July 2016|Anticipated|2016-07-01||Observational|||Breath Test for Biomarkers in Humans Receiving Total Body Irradiation|Breath Test for Biomarkers in Humans Receiving Total Body Irradiation|Unknown status|Recruiting|N/A|30|Anticipated|Menssana Research, Inc.|||1||f||||f||||||||||2017-10-11 00:22:04.286516|2017-10-11 00:22:04.286516
NCT02152709|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-28|||November 2008||2008-11-01|May 2014|2014-05-01|October 2010|Actual|2010-10-01|March 2010|Actual|2010-03-01||Interventional|||Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine|A Phase 3, Randomized, Controlled, and Blinded Clinical Trial to Evaluate Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine for Infants and Other Age Groups.|Completed||Phase 3|1537|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 00:22:04.385796|2017-10-11 00:22:04.385796
NCT02152696|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-05-05|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|ACTorNOT||Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location|Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location - a Randomized Clinical Trial of Women at Risk for an Ectopic Pregnancy: Active Treatment Versus No Treatment|Recruiting||Phase 3|276|Anticipated|Yale University||3|||f||||t||||||||Yes|IPD will be shared with other researchers through the NICHD DASH system. It will be available 6 months after publication of the primary results.|2017-10-11 00:22:04.477715|2017-10-11 00:22:04.477715
NCT02152683|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-09-01|||March 2014||2014-03-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Linear Focused Shockwave Treatment for Erectile Dysfunction|Linear Focused Shockwave Treatment for Erectile Dysfunction|Terminated||N/A|84|Actual|Initia||2|||f||||||||||||||2017-10-11 00:22:04.777597|2017-10-11 00:22:04.777597
NCT02152670|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-06-26|||May 2014||2014-05-01|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET||Recruiting||N/A|48|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 00:22:04.872782|2017-10-11 00:22:04.872782
NCT02152644|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-12-16|||June 2016||2016-06-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Prevalence of Amyloidosis and Carpal Tunnel|Prevalence of Amyloidosis in Carpal Tunnel Surgery|Not yet recruiting||N/A|250|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 00:22:05.096788|2017-10-11 00:22:05.096788
NCT02152631|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-09-22|||October 2014||2014-10-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|JUNIPER||A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer|JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy|Active, not recruiting||Phase 3|450|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 00:22:05.214481|2017-10-11 00:22:05.214481
NCT02152618|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-06-01|||September 2010||2010-09-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PIIKIPP||Kansas Intensive Permanency Project|Permanency Innovations Initiative- Kansas Intensive Permanency Project|Completed||N/A|720|Anticipated|Westat||1|||f||||f||||||||||2017-10-11 00:22:05.83426|2017-10-11 00:22:05.83426
NCT02152605|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-08-12|2015-10-19||September 2014||2014-09-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A 12 Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy of Umeclidinium/Vilanterol 62.5/25mcg in Subjects With COPD|Completed||Phase 3|498|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:22:05.932978|2017-10-11 00:22:05.932978
NCT02152592|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-28|||October 2007||2007-10-01|May 2014|2014-05-01||||March 2009|Actual|2009-03-01||Interventional|||Controlled-Release Oxycodone Versus Naproxen at Home After Ambulatory Surgery: A Randomized Controlled Trial|Controlled-Release Oxycodone Versus Naproxen at Home After Ambulatory Surgery: A Randomized Controlled Trial|Completed||Phase 4|105|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 00:22:06.632254|2017-10-11 00:22:06.632254
NCT02152579|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-05-30|||July 2014||2014-07-01|May 2014|2014-05-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy and Safety of Monocordil Manufactured by Laboratórios Baldacci|Open Monocentric Clinical Study for the Evaluation of Efficacy and Safety of 20 mg Monocordil Tablets Manufactured by Laboratórios Baldacci in Patients With Stable Angina|Unknown status|Not yet recruiting|Phase 3|86|Anticipated|Laboratórios Baldacci S.A||1|||f||||f||||||||||2017-10-11 00:22:06.722888|2017-10-11 00:22:06.722888
NCT02152566|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-01-13|2015-08-19||April 2014||2014-04-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||From the 6 participants, 2 withdrew consent before participating in the study. 1 was lost to follow up as the participant did not turn up to his appointment.|Nasal High Flow Therapy for the Treatment of Respiratory Insufficiencies During Sleep|Study of the Effects of Nasal High Flow Therapy as a Treatment Option for Patients With Respiratory Insufficiencies During Sleep.|Terminated||N/A|6|Actual|Fisher and Paykel Healthcare||1||Difficulty with recruitment|f||||t||||||||||2017-10-11 00:22:06.826446|2017-10-11 00:22:06.826446
NCT02152553|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-06-28|||May 2014||2014-05-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|BIOCORT||Biomarker(s) for Glucocorticoids|Protein/Metabolite Biomarker(s) for Glucocorticoid Action; an Experimental Trial in Patients With Adrenal Insufficiency|Completed||N/A|11|Actual|Vastra Gotaland Region||2|||f||||f||||||||Undecided||2017-10-11 00:22:06.98696|2017-10-11 00:22:06.98696
NCT02152540|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-07-25|||October 1, 2014|Actual|2014-10-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|rTMS TBI||rTMS to Improve Cognitive Function in TBI|Repetitive Transcranial Magnetic Stimulation to Improve Cognitive Function in TBI|Recruiting||N/A|40|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 00:22:07.081531|2017-10-11 00:22:07.081531
NCT02152527|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-05-27|||January 2014||2014-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Prospective Observational Study of Trimetazidine Influence on Mitochondrial Metabolism in Human Heart Ventricle|Myocardial Energetics as a Target for Treatment of Ischemic Heart Disease: A Translational Approach From Patient to Mitochondria|Completed||N/A|55|Actual|University of Split, School of Medicine|||2||f||||f||||||Samples With DNA|"     Parts of human left ventricular muscle   "|||2017-10-11 00:22:07.288901|2017-10-11 00:22:07.288901
NCT02152514|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-01-18|||April 2013||2013-04-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo|Randomized Controlled Trial Comparing Post-VATS Analgesia Between Patients With an Intrathecal Injection of Morphine and Sufentanil Versus Placebo.|Terminated||Phase 4|34|Actual|Université de Sherbrooke||2||Due to technical details recruitment was unreasonably slow|f||||f||||||||||2017-10-11 00:22:07.378321|2017-10-11 00:22:07.378321
NCT02152501|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-09-21|||April 2016|Actual|2016-04-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Exercise and Weight Control|Exercise and Weight Control: A Search for Biological and Neurobehavioral Compensatory Mechanisms That Defend Against Exercise-Induced Negative Energy Balance|Completed||N/A|29|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 00:22:07.468261|2017-10-11 00:22:07.468261
NCT02152488|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-28|||March 2010||2010-03-01|May 2014|2014-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|TCDPOS||Cerebral Blood Flow During Flexion and Rotation of the Cervical Spine|Cerebral Blood Flow During Flexion and Rotation of the Cervical Spine|Completed||N/A|80|Actual|University of Schleswig-Holstein|||1||f||||f||||||||||2017-10-11 00:22:07.579082|2017-10-11 00:22:07.579082
NCT02152475|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2014-05-30|||May 2013||2013-05-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Photodynamic Therapy (PDT) for Oral Disinfection|PDT With Blue Light and Curcumin for Oral Disinfection|Completed||Phase 1|30|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 00:22:07.683237|2017-10-11 00:22:07.683237
NCT02152462|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-01-12|||December 2012||2012-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|POWER||Exergaming Intervention and Breast Cancer Biomarkers in Black Women|Exergaming Intervention and Breast Cancer Biomarkers in Black Women|Active, not recruiting||Phase 2|150|Anticipated|Georgetown University||2|||f||||f||||||||||2017-10-11 00:22:07.806738|2017-10-11 00:22:07.806738
NCT02152449|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-03-08|||July 2014||2014-07-01|March 2015|2015-03-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|NUTRALS||Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients|Impact on Functional Status of Early Oral Nutritional Supplementation (ONS) in Amyotrophic Lateral Sclerosis (ALS) Patients|Unknown status|Recruiting|N/A|310|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 00:22:07.905939|2017-10-11 00:22:07.905939
NCT02152436|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-12-07|||November 2013||2013-11-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2015|Actual|2015-07-01||Observational|PROPECS||Simulation-based Curriculum to Enhance Culture of Safety in Operating Rooms||Active, not recruiting||N/A|259|Actual|University Hospital, Grenoble|||2||f||||f||||||||||2017-10-11 00:22:08.084377|2017-10-11 00:22:08.084377
NCT02152423|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-12-05|||June 2013||2013-06-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|ENOXAMED||Enoxamed Study in the Treatment of Acute Coronary Syndromes|Comparison of the Anti Xa Activity in the Enoxaparin for Acute Coronary Syndromes Admitted to the Emergency. Randomized Clinical Trial ENOXAMED Versus LOVENOX|Completed||Phase 1|50|Actual|University of Monastir||2|||f||||t||||||||||2017-10-11 00:22:08.231963|2017-10-11 00:22:08.231963
NCT02152410|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-06-17|||April 2012||2012-04-01|June 2016|2016-06-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|AcuMoPE||Acupuncture Versus IV Morphine in the Treatment of Acute Pain in ED|Comparison of Two Antalgic Strategies: Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in Emergency Departement. A Randomized Trial of Efficacy and Safety|Completed||Early Phase 1|100|Actual|University of Monastir||2|||f||||t||||||||Yes||2017-10-11 00:22:08.386709|2017-10-11 00:22:08.386709
NCT02152397|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-04-14|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SHIP||Safety and Health Intervention Project|Developing a Prescription Opioid Overdose Prevention Intervention in Addictions Treatment|Completed||N/A|139|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 00:22:08.549026|2017-10-11 00:22:08.549026
NCT02152384|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-12-09|||June 2014||2014-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Compare and Measure the Effects of Insulin Peglispro and Glargine on Meal Time Insulin Requirements|The Effect of Treatment With Basal Insulin Peglispro or Insulin Glargine on the Dose Response Effect of Prandial Insulin Lispro in Patients With Type 1 Diabetes Mellitus.|Completed||Phase 1|28|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:22:08.65659|2017-10-11 00:22:08.65659
NCT02152371|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-10-12|2016-10-12||May 2014||2014-05-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|AWARD-9|All participants who received at least 1 dose of study drug.|A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes|A Randomized, Double-Blind Trial Comparing the Effect of Dulaglutide 1.5 mg With Placebo on Glycemic Control in Patients With Type 2 Diabetes on Basal Insulin Glargine|Completed||Phase 3|300|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 00:22:08.799909|2017-10-11 00:22:08.799909
NCT02152358|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-08-20|||March 2014||2014-03-01|August 2015|2015-08-01|July 2018|Anticipated|2018-07-01|March 2017|Anticipated|2017-03-01||Interventional|PTH||PTH - Preemptive Treatment for Herpesviridae|Efficacy of a Preemptive Treatment by Ganciclovir or by Aciclovir in ICU Patients Requiring Prolonged Mechanical Ventilation and Presenting a Viral Replication (CMV and/or HSV) - Prospective, Randomized, Double-blinded Multicenter Trial|Recruiting||Phase 4|480|Anticipated|Assistance Publique Hopitaux De Marseille||4|||f||||t||||||||||2017-10-11 00:22:09.912896|2017-10-11 00:22:09.912896
NCT02152345|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-08-29|||June 2014||2014-06-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients|A Randomized Clinical Trial of Efficacy and Safety on the Use of Belatacept as Compared to Tacrolimus in the Setting of Rabbit Antithymocyte Globulin Induction and Rapid Steroid Discontinuation in Deceased Donor Renal Transplant Recipients With a Focus on Ameliorating Delayed Graft Function|Recruiting||Phase 4|100|Anticipated|Columbia University||2|||f||||t||||||||Undecided||2017-10-11 00:22:10.020509|2017-10-11 00:22:10.020509
NCT02152332|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-11-21|||July 2014||2014-07-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants|A Randomized, Double-blind, Placebo- and Positive-controlled, Multiple-dose, Four-way, Cross-over Study to Evaluate the Effects of Repeated Oral Doses of JNJ-54861911 on Electrocardiogram Intervals in Healthy Subjects|Completed||Phase 1|64|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-11 00:22:10.142666|2017-10-11 00:22:10.142666
NCT02152319|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-04-26|||May 2014||2014-05-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PDRemote||Automated Telehealth Diagnostics for Remote Parkinson Monitoring|PDRemote Phase II: Automated Telehealth Diagnostics for Remote Parkinson Monitoring|Completed||N/A|21|Actual|Great Lakes NeuroTechnologies Inc.||2|||f||||f||||||||||2017-10-11 00:22:10.250789|2017-10-11 00:22:10.250789
NCT02152306|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-07-24|||April 2014||2014-04-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||Fimasartan/Amlodipine Combination Phase III|A Randomized, Double-blind Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Amlodipine Versus Fimasartan Monotherapy in Patients With Essential Hypertension Who Fail to Respond Adequately to Fimasartan Monotherapy.|Completed||Phase 3|143|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-10-11 00:22:10.56339|2017-10-11 00:22:10.56339
NCT02152293|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2015-05-22|||May 2014||2014-05-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|CLOCK||Impact of Chloroprocaine (CLOROTEKAL®) on Eligibility for Discharge From Hospital After Outpatient Surgery|Pharmacoepidemiology Study on Real Life Impact of Chloroprocaine (CLOROTEKAL®) on the Eligibility for Discharge From Hospital of Patients Requiring Short Outpatient Surgery Under Spinal Anesthesia|Completed||N/A|620|Actual|Nordic Pharma SAS|||1||f||||f||||||||||2017-10-11 00:22:10.656922|2017-10-11 00:22:10.656922
NCT02152280|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2014-05-30|||March 2014||2014-03-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke|A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke|Unknown status|Active, not recruiting|Phase 4|320|Anticipated|Beijing Bozhiyin T&S Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:22:10.727769|2017-10-11 00:22:10.727769
NCT02152267|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2016-02-03|||July 2014||2014-07-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Analgesic Effect of Cathodal tDCS Over Right DLPFC in Subjects With Muscular TMD: a Double Blind Crossover RCT|ANALGESIC EFFECT OF CATHODAL TRANSCRANIAL CURRENT STIMULATION OVER RIGHT DORSOLATERAL PREFRONTAL CORTEX IN SUBJECTS WITH MUSCULAR TEMPOROMANDIBULAR DISORDERS: A Double Blind Crossover Randomized Clinical Trial|Completed||N/A|19|Actual|Federal University of Bahia||3|||f||||t||||||||Yes|We will send a report to each subject|2017-10-11 00:22:10.794279|2017-10-11 00:22:10.794279
NCT02152254|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-01-02|||May 2014||2014-05-01|January 2017|2017-01-01||||May 2019|Anticipated|2019-05-01||Interventional|||IMPACT 2: Randomized Study Evaluating Molecular Profiling and Targeted Agents in Metastatic Cancer|Randomized Study Evaluating Molecular Profiling and Targeted Agents in Metastatic Cancer: Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT 2)|Recruiting||N/A|1362|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 00:22:10.883004|2017-10-11 00:22:10.883004
NCT02152241|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2016-10-24|||June 2014||2014-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Long-term Functional Outcome of Children With Inflammatory Bowel Disease|Long-term Functional Outcome of Children With Inflammatory Bowel Disease|Completed||N/A|105|Anticipated|University of Manitoba|||1||f||||f||||||||||2017-10-11 00:22:10.971975|2017-10-11 00:22:10.971975
NCT02152228|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-10-06|||July 2014||2014-07-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism|A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism|Completed||Phase 2|20|Actual|Entera Bio Ltd.||1|||f||||f||||||||||2017-10-11 00:22:11.040163|2017-10-11 00:22:11.040163
NCT02152215|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-12-06|||July 2014||2014-07-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Ridge Preservation Comparing a Polylactic Acid Membrane vs. an Acellular Dermal Matrix Membrane|Ridge Preservation Comparing the Clinical and Histologic Healing of a Bioabsorbable Membrane Made of Polylactic Acid and a Citric Acid Ester vs. an Acellular Dermal Matrix Allograft GBR|Completed||Phase 4|22|Actual|University of Louisville||2|||f||||f||||||||||2017-10-11 00:22:11.133393|2017-10-11 00:22:11.133393
NCT02152202|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-05-03|||July 2011||2011-07-01|May 2016|2016-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Semi-up Right Position Study|Does a Semi-upright Position During Sleep Prevent Worsening of Severity of Obstructive Sleep Apnea (OSA) on the Second Postoperative Night in Patients Following Elective Inpatient Surgery? A Two Arm, Parallel, Randomized, Controlled, First Stage Proof of Concept Trial|Completed||N/A|164|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 00:22:11.215691|2017-10-11 00:22:11.215691
NCT02152189|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-04-14|||May 2014||2014-05-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|||Screening for Fabry Disease in a Pediatric Population at Risk||Active, not recruiting||N/A|2000|Anticipated|University Hospital Heidelberg|||1||f||||f||||||||||2017-10-11 00:22:11.304055|2017-10-11 00:22:11.304055
NCT02152176|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-06-29|||July 2014||2014-07-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|TACIDOU||Morphine Titration by Patient Self-controlled by a Mechanical Device Versus Administration by the Nurse for Patients With Severe Acute Pain in the Emergency Department|Titration Morphinique autocontrôlée Par le Patient Par un Dispositif mécanique à Usage Unique Versus Administration Par l'infirmière Chez Les Patients Ayant Une Douleur aiguë sévère Aux Urgences.|Completed||Phase 4|200|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 00:22:11.457463|2017-10-11 00:22:11.457463
NCT02152163|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-10-12|||October 2012||2012-10-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|Unknown status|Recruiting|Phase 4|134|Anticipated|Delray Medical Center||2|||f||||t||||||||||2017-10-11 00:22:11.566467|2017-10-11 00:22:11.566467
NCT02152150|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-05-28|||September 2011||2011-09-01|May 2014|2014-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Feeding Trial of Bio-fortified Pearl Millet|Efficacy of Iron Bio-fortified Pearl Millet in Improving the Iron Status of Adolescents in India|Completed||N/A|246|Actual|Cornell University||2|||f||||f||||||||||2017-10-11 00:22:11.694215|2017-10-11 00:22:11.694215
NCT02152137|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-09-29|||September 2014||2014-09-01|September 2017|2017-09-01||||October 2017|Anticipated|2017-10-01||Interventional|||Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer|A Phase 2 Study of Efatutazone, an Oral PPAR Agonist, In Combination With Paclitaxel in Patients With Advanced Anaplastic Thyroid Cancer|Suspended||Phase 2|20|Anticipated|Alliance for Clinical Trials in Oncology||1||Scheduled Interim Monitoring|f||||t||||||||||2017-10-11 00:22:11.853818|2017-10-11 00:22:11.853818
NCT02152124|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-12-07|||June 2014||2014-06-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?|Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?|Enrolling by invitation||N/A|50|Anticipated|University Hospital, Ghent|||5||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 00:22:12.506068|2017-10-11 00:22:12.506068
NCT02152111|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-06-22|||February 2013||2013-02-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Hipoenergetic Effect of Diet Associated or Not With the Consumption of Coconut Flour in Women With Overweight|Effect of Hipoernergetic Diet Combined or Not With Coconut Flour on Overweight Women|Completed||N/A|86|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 00:22:12.632658|2017-10-11 00:22:12.632658
NCT02152098|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-07-25|||April 2014||2014-04-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Skeletal Muscle Strain Injuries and the Connective Tissue: Characterization, Recovery and Optimal Treatment|Skeletal Muscle Strain Injuries and the Connective Tissue: Characterization, Recovery and Optimal Treatment|Completed||N/A|85|Actual|Bispebjerg Hospital||4|||f||||f||||||||||2017-10-11 00:22:12.723979|2017-10-11 00:22:12.723979
NCT02152085|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-01-25|||May 2014||2014-05-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|September 2016|Actual|2016-09-01||Interventional|||Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis|Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis|Active, not recruiting||N/A|25|Actual|University of Colorado, Boulder||2|||f||||f||||||||||2017-10-11 00:22:12.856368|2017-10-11 00:22:12.856368
NCT02152072|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-05-28|||July 2014||2014-07-01|May 2014|2014-05-01||||September 2014|Anticipated|2014-09-01||Observational|||Using Simulation-Based Training to Incorporate Lung Ultrasound Into Physical Examination||Unknown status|Not yet recruiting|Early Phase 1|35|Anticipated|Tulane University Health Sciences Center|||1||f||||||||||||||2017-10-11 00:22:12.998531|2017-10-11 00:22:12.998531
NCT02152059|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2016-07-04|||July 2014||2014-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy|A Phase II Study of BIBF1120 in Recurrent and Platinum-Sensitive Small Cell Lung Cancer (SCLC)|Withdrawn||Phase 2|0|Actual|AHS Cancer Control Alberta||1||contract issues|f||||f||||||||||2017-10-11 00:22:13.099027|2017-10-11 00:22:13.099027
NCT02152046|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2017-07-26|||June 2014||2014-06-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||ROP Screening: Comparison of Pain Using Two Eyelid Retractors|Retinopathy of Prematurity Screening: Comparison of Pain Using Two Eyelid Retractors|Enrolling by invitation||N/A|10|Anticipated|Advocate Health Care|||2||f||||f||||||||||2017-10-11 00:22:13.242382|2017-10-11 00:22:13.242382
NCT02152033|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-10-18|||July 2014||2014-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|HCC||Home-based Continuing Care for Young Adults Leaving Residential Substance Abuse Treatment|Feasibility and Acceptability of Home-based Continuing Care|Completed||N/A|30|Actual|Treatment Research Institute||2|||f||||f||||||||||2017-10-11 00:22:13.382263|2017-10-11 00:22:13.382263
NCT02152020|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-29|2015-01-13|||May 2014||2014-05-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Patient-Centered Acupuncture for Pain (PCAP)|Patient-Centered Integration of Acupuncture to Decrease Pain for Cancer Survivors|Completed||N/A|36|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-11 00:22:13.506491|2017-10-11 00:22:13.506491
NCT02152007|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-10-05|2016-07-29||January 2014||2014-01-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional||"This is a split-body design. After a 2-week run in phase in which both feet were treated with placebo, feet were randomized and one foot received 1% sirolimus and the other placebo (randomized phase) for 8 weeks. Following the randomized phase, patients applied 1% sirolimus to both feet (open label phase) for an additional 8 weeks."|Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)|Phase 1b Clinical Trial Using Topical Sirolimus for the Treatment of Pachyonychia Congenita|Completed||Phase 1|15|Actual|TransDerm, Inc.|This study was primarily concerned with safety endpoints. Efficacy endpoints need to be improved for follow on studies.|1|||f||||f||||||||Undecided||2017-10-11 00:22:13.592074|2017-10-11 00:22:13.592074
NCT02151994|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-11-26|2014-06-11||March 2011||2011-03-01|November 2015|2015-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058.|A Double-blind, Randomised, Placebo-controlled, Combined Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058, in Healthy Male Volunteers|Completed||Phase 1|124|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 00:22:13.984749|2017-10-11 00:22:13.984749
NCT02151981|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-23|2017-04-12||August 4, 2014|Actual|2014-08-04|June 2017|2017-06-01|August 31, 2018|Anticipated|2018-08-31|April 15, 2016|Actual|2016-04-15||Interventional|AURA3||AZD9291 Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase III, Open Label, Randomized Study of AZD9291 Versus Platinum-Based Doublet Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed With Previous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Whose Tumours Harbour a T790M Mutation Within the Epidermal Growth Factor Receptor Gene (AURA3).|Active, not recruiting||Phase 3|419|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:22:16.307569|2017-10-11 00:22:16.307569
NCT02151968|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-05-28|||July 2014||2014-07-01|May 2014|2014-05-01||||December 2014|Anticipated|2014-12-01||Interventional|||Traditional Blind Versus Ultrasound-guided Peribulbar Blockade|Traditional Blind Versus Ultrasound-guided Peribulbar Blockade|Unknown status|Not yet recruiting|N/A|80|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 00:22:17.822661|2017-10-11 00:22:17.822661
NCT02151955|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-11-09|||June 2014||2014-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SUSI||Social-emotional Under 4's Screening & Intervention S.U.S.I.|Social-emotional Under 4's Screening & Intervention; A Study of Emotional Health and Development in Babies and Young Children|Completed||N/A|139|Actual|South London and Maudsley NHS Foundation Trust||1|||f||||t||||||||No||2017-10-11 00:22:17.939167|2017-10-11 00:22:17.939167
NCT02151942|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-06-16|||June 2013||2013-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|PRS||Patient-Specific Simulation Used for EVAR Procedure Rehearsal - Evaluation of Clinical Performance With and Without Prior Rehearsal|Patient-Specific Simulation Used for Case Rehearsal Prior to EVAR Procedure - Evaluation of Clinical Performance With and Without Prior Rehearsal Using the Procedure Rehearsal Studio. Multi-center Randomized Study|Unknown status|Recruiting|N/A|150|Anticipated|Simbionix US Corporation|||2||f||||f||||||||||2017-10-11 00:22:18.028663|2017-10-11 00:22:18.028663
NCT02151929|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-05-30|||May 2013||2013-05-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|August 2013|Actual|2013-08-01||Interventional|||Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction|Bioresorbable Vascular Scaffold in Patient With ST Elevation Myocardial Infarction: a Randomized Comparison With Everolimus Eluting Stent|Completed||Phase 4|100|Actual|San Giuseppe Moscati Hospital||2|||f||||f||||||||||2017-10-11 00:22:18.165835|2017-10-11 00:22:18.165835
NCT02151916|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-29|||June 2011||2011-06-01|May 2014|2014-05-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|BTT||Preventing Early Childhood Caries in Indigenous Children: the Baby Teeth Talk Study|Reducing Disease Burden and Health Inequalities Arising From Chronic Dental Disease Among Indigenous Children: an Early Childhood Caries Intervention|Unknown status|Active, not recruiting|Phase 3|544|Actual|University of Toronto||2|||f||||t||||||||||2017-10-11 00:22:18.283268|2017-10-11 00:22:18.283268
NCT02151903|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-03-16|||November 2014||2014-11-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Patients With B-cell NHL|An Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Patients With B-cell Non-Hodgkin Lymphoma (NHL)|Completed||Phase 1/Phase 2|5|Actual|Alopexx Oncology, LLC||1|||f||||t|t|f||||||||2017-10-11 00:22:18.403255|2017-10-11 00:22:18.403255
NCT02151890|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-05-30|||March 2012||2012-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|POF||Pregnancy After Stem Cell Transplantation in Premature Ovarian Failure|Pregnancy After Stem Cell Transplantation in Premature Ovarian Failure (POF)|Completed||Phase 1/Phase 2|10|Actual|Al-Azhar University||1|||f||||t||||||||||2017-10-11 00:22:18.532669|2017-10-11 00:22:18.532669
NCT02151877|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-06-25|||July 2014||2014-07-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass|Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass.|Recruiting||N/A|24|Anticipated|Advocate Health Care||2|||f||||t||||||||No||2017-10-11 00:22:18.652155|2017-10-11 00:22:18.652155
NCT02151864|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-09-06|||July 2014||2014-07-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|December 2016|Actual|2016-12-01||Interventional|||LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis|Phase Ib Study of Single Agent LDE225, an Oral Hedgehog Inhibitor, as Second-Line Therapy in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis|Active, not recruiting||Phase 1|9|Actual|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:22:18.752418|2017-10-11 00:22:18.752418
NCT02151838|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-01-17|||September 2008||2008-09-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Observational|||The Thai Red Cross Society Prevention of Mother-To-Child Transmission of HIV (TRCS PMTCT) Program|The Thai Red Cross AIDS Research Centre|Enrolling by invitation||N/A|250|Anticipated|Thai Red Cross AIDS Research Centre|||1||f||||f||||||||||2017-10-11 00:22:18.9862|2017-10-11 00:22:18.9862
NCT02151825|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-28|||September 2011||2011-09-01|May 2014|2014-05-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects|Pilot Study on the Influence of a Synbiotic Formulation (ProSynbiotic) on Gut Microbiota Composition, Adiposity and Selected Markers of Cardiometabolic Health in Overweight or Moderately Obese Individuals|Completed||N/A|54|Actual|Texas State University, San Marcos||2|||f||||f||||||||||2017-10-11 00:22:19.048158|2017-10-11 00:22:19.048158
NCT02151812|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-05-25|||August 2014||2014-08-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|December 2016|Anticipated|2016-12-01||Interventional|AGENT-ISR||Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)|A Prospective Randomized Multicenter Non-inferiority Clinical Study to Determine the Safety and Performance of the Agent™ Paclitaxel-Coated PTCA Balloon Catheter (Hemoteq) Compared to the SeQuent® Please Paclitaxel-Releasing Coronary Balloon Catheter (B.Braun) for the Treatment of Coronary In-Stent Restenosis (AGENT-ISR)|Active, not recruiting||N/A|123|Actual|Hemoteq AG||2|||f||||t||||||||||2017-10-11 00:22:19.150098|2017-10-11 00:22:19.150098
NCT02151799|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-11-03|||January 2010||2010-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|February 2014|Actual|2014-02-01||Interventional|||The Effects of Body Contouring: Abdominoplasty and Liposuction|Body Contouring - the Analysis of Non-invasive and Invasive Methods and Their Interventional Effects on Quality of Life|Completed||Phase 4|143|Actual|Tampere University Hospital||1|||f||||||||||||||2017-10-11 00:22:19.494699|2017-10-11 00:22:19.494699
NCT02151786|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-01-24|2016-01-24||January 2007||2007-01-01|January 2016|2016-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational||The safety analysis set was defined as all participants who were enrolled and completed the study.|Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]|Takepron Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]|Completed||N/A|1120|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:22:19.570478|2017-10-11 00:22:19.570478
NCT02151773|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-12-06|2016-12-06||February 2006||2006-02-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational||Analysis set included all participants who were enrolled and completed the study.|Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination|"Freeze-dried Live Attenuated Measles and Rubella Combined Vaccine Takeda Special Drug Use Surveillance of Vaccinees After the First Vaccination"|Completed||N/A|3493|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:22:20.10552|2017-10-11 00:22:20.10552
NCT02151760|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-05-02|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Safety Study of 18F-DCFPyL, a PSMA-based PET Radiotracer, in Patients With Advanced Prostate Cancer|Phase 1 Biodistribution and Pharmacokinetic Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Advanced Prostate Cancer|Active, not recruiting||Phase 1|37|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 00:22:20.420015|2017-10-11 00:22:20.420015
NCT02151747|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-05-05|||February 2014||2014-02-01|May 2017|2017-05-01|February 2015||2015-02-01|February 2015|Actual|2015-02-01||Observational|BRCANGS||Testing BRCA 1/2 Mutation Using Next Generation Sequencing|Pilot Study of Validation of Testing BRCA 1/2 Mutation Using Next Generation Sequencing|Completed||N/A|12|Actual|Severance Hospital|||2||f||||f||||||||||2017-10-11 00:22:20.483132|2017-10-11 00:22:20.483132
NCT02151734|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-28|||August 2013||2013-08-01|May 2014|2014-05-01||||December 2013|Actual|2013-12-01||Interventional|||Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis||Completed||Phase 3|242|Actual|Korea United Pharm. Inc.||2|||f||||||||||||||2017-10-11 00:22:20.54928|2017-10-11 00:22:20.54928
NCT02151721|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-08-31|||June 2014||2014-06-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|VICTORY-J||Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer|Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer|Recruiting||Phase 1|18|Anticipated|Kanazawa University||1|||f||||t||||||||Yes|The 10th patient in stage 3 was registered.|2017-10-11 00:22:20.622103|2017-10-11 00:22:20.622103
NCT02151708|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-11-24|||June 2014||2014-06-01|November 2014|2014-11-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method|Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia:|Unknown status|Not yet recruiting|N/A|78|Anticipated|Samsung Medical Center||3|||f||||f||||||||||2017-10-11 00:22:20.720693|2017-10-11 00:22:20.720693
NCT02151682|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-10-04|||December 2014||2014-12-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Open-label Trial, Enrolling Subjects Aged 6 Years to Less Than 18 Years Suffering From Pain Requiring Prolonged Release Opioid Treatment, to Evaluate the Safety and Efficacy of Tapentadol PR Versus Morphine PR, Followed by an Open-label Extension.|An Open-label Trial, Enrolling Subjects Aged 6 Years to Less Than 18 Years Suffering From Pain Requiring Prolonged Release Opioid Treatment, to Evaluate the Safety and Efficacy of Tapentadol PR Versus Morphine PR, Followed by an Open-label Extension.|Recruiting||Phase 2/Phase 3|200|Anticipated|Grünenthal GmbH||6|||f||||t||||||||||2017-10-11 00:22:20.917563|2017-10-11 00:22:20.917563
NCT02151669|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-29|||November 2013||2013-11-01|May 2014|2014-05-01|November 2016|Anticipated|2016-11-01|May 2015|Anticipated|2015-05-01||Interventional|DIET||Diet Intervention Spirometry and Tobacco|Effect of a Mediterranean Diet Intervention Pulmonary Function in Smokers:A Multicenter Randomized Clinical Trial in Primary Care Centers|Unknown status|Active, not recruiting|N/A|80|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 00:22:22.789675|2017-10-11 00:22:22.789675
NCT02151656|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-12-15|||June 2014||2014-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|FAST||F17464 in Acute Schizophrenia Trial|Effects of F17464 in Acute Exacerbation of Schizophrenia|Completed||Phase 2|158|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 00:22:22.863877|2017-10-11 00:22:22.863877
NCT02151630|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-29|||May 2014||2014-05-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts|Comparison of 70% Pyruvic Acid Solution and Duofilm Solution in Treatment of Plantar Wart|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 00:22:23.130231|2017-10-11 00:22:23.130231
NCT02151617|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-01-16|||June 2014||2014-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649|A Phase 1 Double Blind (3rd Party Open) Randomized, Placebo Controlled, Dose Escalation Study To Investigate The Safety,Tolerability, Pharmacokinetics And Pharmacodynamics Of Repeat Doses Of Pf-06743649 With Or Without Food In Healthy Adult Subjects|Completed||Phase 1|40|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 00:22:23.336532|2017-10-11 00:22:23.336532
NCT02151604|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-06-02|||April 2014||2014-04-01|June 2016|2016-06-01||||October 2016|Anticipated|2016-10-01||Interventional|||Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy|A Study to Determine Regional Lung Function in Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Radiotherapy Using Hyperpolarized Xenon Gas MR Imaging|Recruiting||Phase 2|50|Anticipated|Oxford University Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 00:22:23.457732|2017-10-11 00:22:23.457732
NCT02151591|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-12-21|||May 2014||2014-05-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||New Approaches to Smoking Cessation in Heavy Drinkers|New Approaches to Smoking Cessation in Heavy Drinkers|Recruiting||Phase 1|50|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 00:22:23.573248|2017-10-11 00:22:23.573248
NCT02151578|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-29|||January 2009||2009-01-01|May 2014|2014-05-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|HMM/P||Home Management of Malaria and Pneumonia|Home and Community Management of Fevers/Malaria and Pneumonia in Children Under-five: a Cluster Randomised Controlled Trial of an Integrated Approach in a Rural District of Burkina Faso|Completed||Phase 4|11500|Actual|World Health Organization||3|||f||||f||||||||||2017-10-11 00:22:23.691959|2017-10-11 00:22:23.691959
NCT02151565|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-28|||November 2012||2012-11-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|HTEMS||High-tone External Muscle Stimulation for Pain Reduction|High-tone External Muscle Stimulation for Treatment of Chronic Pain|Completed||N/A|100|Actual|West German Center of Diabetes and Health||2|||f||||t||||||||||2017-10-11 00:22:23.825931|2017-10-11 00:22:23.825931
NCT02151552|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-11-02|||May 2014||2014-05-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Assessing NOS Uptake With PET Imaging in Lung Inflammation|Assessing [18F](+/-)NOS Uptake With PET Imaging in Endotoxin-induced Lung Inflammation|Active, not recruiting||Early Phase 1|8|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 00:22:23.944074|2017-10-11 00:22:23.944074
NCT02151539|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-08-11|||August 2014||2014-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|POSTAGE||Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)|Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)|Recruiting||N/A|105|Anticipated|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-10-11 00:22:24.073162|2017-10-11 00:22:24.073162
NCT02151526|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-05-19|||July 2013||2013-07-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study Evaluating the Efficacy and Safety of LentiGlobin BB305 Drug Product in Beta-Thalassemia Major and Sickle Cell Disease|A Phase 1/2 Open Label Study Evaluating the Safety and Efficacy of Gene Therapy of the Beta-Hemoglobinopathies (Sickle Cell Disease and Beta-Thalassemia Major) by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral Beta-A-T87Q Globin Vector (LentiGlobin BB305 Drug Product)|Active, not recruiting||Phase 1/Phase 2|7|Anticipated|bluebird bio||1|||f||||t||||||||||2017-10-11 00:22:24.228169|2017-10-11 00:22:24.228169
NCT02151513|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-05-10|||April 2014||2014-04-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Observational|||Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain|Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain|Enrolling by invitation||N/A|30|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 00:22:24.346805|2017-10-11 00:22:24.346805
NCT02151500|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-12-07|||May 2014||2014-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Stress and Health Interview for Primary Care Patients With Medically Unexplained Symptoms|Stress and Health Interview for Primary Care Patients With Medically Unexplained Symptoms|Completed||N/A|75|Actual|Wayne State University||2|||f||||f||||||||||2017-10-11 00:22:24.431706|2017-10-11 00:22:24.431706
NCT02151487|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-09-02|||March 2014||2014-03-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||A Comparison of Ropivacaine Alone Versus Combination of Dexamethasone and Clonidine for Block|A Comparison of Ropivacaine Alone Versus Ropivacaine With Dexamethasone or Clonidine Versus a Combination of Ropivacaine, Dexamethasone, and Clonidine for Supraclavicular Brachial Plexus Block Using Ultrasound: A Prospective, Observer-blinded, Randomized Clinical Trial to Assess the Duration of Block|Completed||Phase 3|120|Actual|University of Texas Southwestern Medical Center||4|||f||||f||||||||Yes||2017-10-11 00:22:24.532031|2017-10-11 00:22:24.532031
NCT02151474|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-02-03||2015-02-03|May 2014||2014-05-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||INCB047986 in Rheumatoid Arthritis|A Double-Blind, Placebo-Controlled Study Exploring the Safety, Tolerability, and Efficacy of a 28-Day Course of INCB047986 in Subjects With Active Rheumatoid Arthritis|Terminated||Phase 2|3|Actual|Incyte Corporation||4||Business decision.|f||||f||||||||||2017-10-11 00:22:24.644001|2017-10-11 00:22:24.644001
NCT02151448|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-02-02|||July 2014||2014-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies|A Phase 1/2 Trial Evaluating αDC1 Vaccines Combined With Tumor-Selective Chemokine Modulation as Adjuvant Therapy After Surgical Resection of Peritoneal Surface Malignancies|Recruiting||Phase 1/Phase 2|168|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:22:24.887839|2017-10-11 00:22:24.887839
NCT02151435|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-07-25|||August 2013||2013-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis|Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis|Completed||N/A|43|Actual|University of Michigan|||1||f||||f||||||Samples Without DNA|"     Peripheral blood plasma obtained from individuals at 6-month intervals for up to 2 years   "|||2017-10-11 00:22:25.001296|2017-10-11 00:22:25.001296
NCT02151422|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-06-29|||November 2013||2013-11-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Breathing Exercises for Asthma|Breathing Exercises for Asthma|Completed||N/A|75|Actual|University of Michigan||1|||f||||||||||||||2017-10-11 00:22:25.098816|2017-10-11 00:22:25.098816
NCT02151409|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-02-08|||June 2008||2008-06-01|February 2017|2017-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects|A Randomised, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Trial of Anti-C5aR Antibody (NNC 0151-0000-0000) Administered by i.v. Infusion or s.c. Injection in Healthy Subjects.|Completed||Phase 1|60|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 00:22:25.360208|2017-10-11 00:22:25.360208
NCT02151396|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-29|||July 2009||2009-07-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Working Memory Training on ADHD Brain Function|Effect of Working Memory Training on ADHD Brain Function|Completed||Phase 3|37|Actual|Hartford Hospital||1|||f||||f||||||||||2017-10-11 00:22:25.462903|2017-10-11 00:22:25.462903
NCT02151370|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-28|||March 2013||2013-03-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer|"Ascites Control Treating Ovarian Cancer With Bevacizumab: ACT-OB"|Completed||N/A|3|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:22:25.655533|2017-10-11 00:22:25.655533
NCT02151357|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-10-04|||August 19, 2014|Actual|2014-08-19|October 2017|2017-10-01|October 31, 2016|Actual|2016-10-31|June 24, 2016|Actual|2016-06-24||Interventional|||Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor|Phase I, Sequential Dose Escalation Clinical Study to Investigate the Safety, Tolerability and Pharmacokinetics of in Patients With Advanced Solid Tumor|Terminated||Phase 1|17|Actual|Standard Chem. & Pharm. Co., Ltd.||1||catheter occlusion events during the study drug infusion|f||||f||||||||||2017-10-11 00:22:25.734752|2017-10-11 00:22:25.734752
NCT02151344|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-03-26|||May 2014||2014-05-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals|Phase 1 Evaluation of the Optimal Interval Between Priming With a Live Influenza A Vaccine H7N9 (6-2) AA ca Recombinant (A/Anhui/1/2013 (H7N9) x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H7N9 Disease Followed by Boost With a Non-adjuvanted Inactivated H7N9 Influenza Vaccine|Completed||Phase 1|100|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-10-11 00:22:25.823325|2017-10-11 00:22:25.823325
NCT02151331|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-01-27|||August 2014||2014-08-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy|Improving Mental Health Outcomes: Building an Adaptive Implementation|Active, not recruiting||N/A|383|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 00:22:25.922168|2017-10-11 00:22:25.922168
NCT02151318|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-06-25|||December 2014||2014-12-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Observational|||Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies|Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies|Unknown status|Recruiting|N/A|20|Anticipated|University of South Florida|||1||f||||f||||||Samples Without DNA|"     The ophthalmologist will collect samples from the tissue that is removed during patients eye     surgery that would otherwise be discarded or thrown away. Researchers will collect the sample     and grow in the laboratory conditions. These cells will then be studied for further research     on glaucoma.   "|||2017-10-11 00:22:26.019833|2017-10-11 00:22:26.019833
NCT02151305|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-27|||August 2010||2010-08-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Different Hemostasis According to the Anesthetic Agents|The Influence of Propofol and Sevoflurane on Hemostasis During Ophthalmic Surgery: Rotational Thromboelastographic Study.|Completed||N/A|66|Actual|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-11 00:22:26.114084|2017-10-11 00:22:26.114084
NCT02151279|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-05-29|||March 2014||2014-03-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|SWAP||Safety of Chitosan as Wine Fining Agent in Shrimp Allergic Patients|Safety of Chitosan as Wine Fining Agent in Shrimp Allergic Patients|Unknown status|Recruiting|N/A|15|Anticipated|Universidade do Porto||2|||f||||t||||||||||2017-10-11 00:22:26.217824|2017-10-11 00:22:26.217824
NCT02151266|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-09-01|||July 2013||2013-07-01|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|EXCITE||Exercise and Cognitive Retraining to Improve Cognition in Heart Failure.|The Feasibility of Exercise and Cognitive Retraining to Improve Memory, Attention and Concentration in Heart Failure.|Active, not recruiting||N/A|67|Actual|Emory University||3|||f||||t||||||||||2017-10-11 00:22:26.348057|2017-10-11 00:22:26.348057
NCT02151253|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-03-22|2016-07-25||May 2011||2011-05-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia|A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia|Completed||Phase 2/Phase 3|81|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:22:26.468598|2017-10-11 00:22:26.468598
NCT02151240|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-28|||May 2014||2014-05-01|May 2014|2014-05-01||||May 2015|Anticipated|2015-05-01||Interventional|Focus-101||Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster|A Multi-centered, Randomized Study to Evaluate the Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection Compared to Intravenous Acyclovir in Patients With Herpes Zoster From China|Unknown status|Not yet recruiting|Phase 4|240|Anticipated|Cttq||2|||f||||t||||||||||2017-10-11 00:22:26.784987|2017-10-11 00:22:26.784987
NCT02151227|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-12-25|||June 2014||2014-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis|Association of Dietary Magnesium Intake and Circulating Magnesium Concentration With Metabolic Syndrome: A Dose-response Meta-analysis|Completed||N/A|12|Actual|The Catholic University of Korea|||1||f||||f||||||||||2017-10-11 00:22:26.906881|2017-10-11 00:22:26.906881
NCT02151214|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-08-03|||May 2012||2012-05-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|ALIM-K||Efficacy of Parenteral Nutrition in Patients at the Palliative Phase of Cancer.|Prospective, Multicenter, Randomized Controlled Study Evaluating the Efficacy of Parenteral Nutrition on the Quality of Life and Overall Survival in Patients in the Palliative Phase of Cancer.|Recruiting||N/A|106|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-11 00:22:27.002593|2017-10-11 00:22:27.002593
NCT02151201|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2014-05-30|||November 2013||2013-11-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Impact of Influenza Vaccination in Pregnancy Video Education|Impact of Video Education on Influenza Vaccination Rate in Pregnancy|Completed||N/A|105|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 00:22:27.176255|2017-10-11 00:22:27.176255
NCT02151188|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-02-01|||March 2014||2014-03-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Liquid Protein Preloads With Different Carbohydrate Types Effects on the Glycaemic and Insulinaemic Response|Liquid Protein Preloads With Different Carbohydrate Types Effects on the Glycaemic and Insulinaemic Response|Completed||N/A|15|Actual|Clinical Nutrition Research Centre, Singapore||5|||f||||f||||||||||2017-10-11 00:22:27.286486|2017-10-11 00:22:27.286486
NCT02151175|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-01-22|||May 2014||2014-05-01|January 2016|2016-01-01||||February 2017|Anticipated|2017-02-01||Interventional|||Low-intensity Focused Ultrasound Pulsation (LIFUP) for Treatment of Temporal Lobe Epilepsy|LIFUP for Treatment of Temporal Lobe Epilepsy|Recruiting||N/A|12|Anticipated|BrainSonix Inc.||1|||f||||||||||||||2017-10-11 00:22:27.373387|2017-10-11 00:22:27.373387
NCT02151162|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-06-18|||June 2014||2014-06-01|June 2014|2014-06-01|March 2016|Anticipated|2016-03-01|September 2015|Anticipated|2015-09-01||Interventional|HNP||Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses|Mindfulness-Based Stress Management Program and Omega-3 Fatty Acids to Maintain Healthy Mental State in Hospital Nurses: Multi-Center Factorial-Design Randomized Controlled Trial Happy Nurse Project|Unknown status|Recruiting|Phase 3|120|Anticipated|National Center of Neurology and Psychiatry, Japan||4|||f||||t||||||||||2017-10-11 00:22:27.463394|2017-10-11 00:22:27.463394
NCT02151149|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-09-06|||June 9, 2014|Actual|2014-06-09|September 2017|2017-09-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Interventional|ABOUND 70+||Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly|Safety and Efficacy of Nab-paclitaxel (Abraxane) in Combination With Carboplatin as First Line Treatment in Elderly Subjects With Advance Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Open-Label, Multicenter Study (Abound.70+)|Completed||Phase 4|143|Actual|Celgene||2|||f||||f||||||||||2017-10-11 00:22:27.595788|2017-10-11 00:22:27.595788
NCT02151136|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-08-04|||November 2015||2015-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Be Sweet to Toddlers: Does Sugar Water Reduce Pain During Blood Work?|Be Sweet to Toddlers During Needles: RCT of Sucrose Compared to Placebo|Recruiting||Phase 4|140|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||f||||||||||2017-10-11 00:22:27.946451|2017-10-11 00:22:27.946451
NCT02151123|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-10-02|||March 2018|Anticipated|2018-03-01|October 2017|2017-10-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Observational|||Metabiomics Colon Cancer Clinical Research Study|Metabiomics Colon Cancer Clinical Research Study|Not yet recruiting||N/A|100|Anticipated|Metabiomics Corp|||1||f||||f||||||Samples With DNA|"     gut microbiome samples from stool, rectal and colonic mucosa   "|||2017-10-11 00:22:28.069773|2017-10-11 00:22:28.069773
NCT02151097|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-06-22|||November 2014||2014-11-01|March 2016|2016-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|PRIME||PRIME - PRostate Imaging for Margin Evaluation|A Feasibility Study to Evaluate 18F-choline Cerenkov Luminescence Imaging for Measuring Margin Status in Radical Prostatectomy Specimens|Completed||N/A|7|Actual|Lightpoint Medical Limited|||1||f||||f||||||||||2017-10-11 00:22:28.248551|2017-10-11 00:22:28.248551
NCT02151084|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2016-06-21|||November 2014||2014-11-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|||A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer|A Randomized Phase II Trial of MEK Inhibitor Selumetinib (AZD6244) Combined Continuously or Sequentially With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Patients With Advanced Biliary Cancer|Recruiting||Phase 2|48|Anticipated|University Health Network, Toronto||3|||f||||t||||||||||2017-10-11 00:22:28.331401|2017-10-11 00:22:28.331401
NCT02151071|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-09-06|||September 2017||2017-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Breast Surgery EnLight and LightPath Imaging System Study|A Pilot Study to Evaluate Molecular Imaging Using a BetaScope and a Specimen Analyser for Determining Margin and Lymph Node Status During Breast Conserving Surgery in Women With Breast Cancer|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Lightpoint Medical Limited||1|||f||||f||||||||||2017-10-11 00:22:28.454455|2017-10-11 00:22:28.454455
NCT02151058|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-05-28|2015-05-07||June 2014||2014-06-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Clinical Trial to Test the Effect of a Marketed Mouth Rinse on Stain Removal|Whitening Action of a Hydrogen Peroxide/Sodium Fluoride Containing Mouth Rinse: A 2 Week Randomized Controlled Trial|Completed||N/A|227|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-10-11 00:22:28.595301|2017-10-11 00:22:28.595301
NCT02151045|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-08-31|||March 2012||2012-03-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|EPI-AMELIE||Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica|Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica - Controlled Randomized Trial With Double Blind Evaluation|Unknown status|Recruiting|Phase 3|112|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:22:29.320246|2017-10-11 00:22:29.320246
NCT02151032|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-06-16|||November 2012|Actual|2012-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Using Multimedia Approaches to Communicate Probabilities in Patient Decision Aids for Low-Literacy Populations: Randomized Trial|Using Multimedia Approaches to Communicate Probabilities in Patient Decision Aids for Low-Literacy Populations: Randomized Trial|Active, not recruiting||N/A|201|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-10-11 00:22:29.47887|2017-10-11 00:22:29.47887
NCT02151019|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-04-14|||August 2014||2014-08-01|April 2017|2017-04-01|July 2030|Anticipated|2030-07-01|August 2020|Anticipated|2020-08-01||Interventional|TRI-LARC||Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer|Randomised Phase II Study of Pre-operative 3-D Conformal Radiotherapy (3-DCRT) Versus Intensity Modulated Radiotherapy (IMRT) for Locally Advanced Rectal Cancer|Recruiting||Phase 1/Phase 2|268|Anticipated|Cancer Trials Ireland||2|||f||||f||||||||||2017-10-11 00:22:29.589155|2017-10-11 00:22:29.589155
NCT02151006|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-05-16|||May 2014||2014-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?|Does DHEA Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response According to the Bologna Criteria? A Randomized Controlled Study|Completed||Phase 3|140|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 00:22:29.692351|2017-10-11 00:22:29.692351
NCT02150629|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-05-22|||January 2011||2011-01-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Investigating Kinematic and Electromyographic Changes After SCI and Their Relation to Clinical and Functional Outcome||Recruiting||N/A|200|Anticipated|University of Zurich|||2||f||||t||||||||||2017-10-11 00:22:33.546398|2017-10-11 00:22:33.546398
NCT02150993|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-07-18|||January 26, 2016|Actual|2016-01-26|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Interventional|FIT-2||First-Line Treatment for HIV-2|A Randomized, Non-comparative, Phase IIb, Unblinded Trial, Evaluating the Efficacy and Safety of Tenofovir-emtricitabine or Lamivudine Plus Zidovudine, Lopinavir/Ritonavir, or Raltegravir, Among ARV-naïve HIV-2 Infected Adult Patients, in West Africa|Active, not recruiting||Phase 2/Phase 3|210|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||3|||f||||t|f|f||||||||2017-10-11 00:22:29.792561|2017-10-11 00:22:29.792561
NCT02150980|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-09-29|||April 2014||2014-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|INORMUS||INternational ORthopaedic MUlticenter Study in Fracture Care (INORMUS)|INORMUS 40,000: Large Observational Cohort Study of Orthopedic Trauma Patients|Recruiting||N/A|40000|Anticipated|McMaster University|||1||f||||t||||||||||2017-10-11 00:22:29.956112|2017-10-11 00:22:29.956112
NCT02150967|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-07-24|||July 14, 2014|Actual|2014-07-14|June 2017|2017-06-01|June 29, 2020|Anticipated|2020-06-29|June 29, 2020|Anticipated|2020-06-29||Interventional|||A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma|A Phase II Multicenter, Single Arm Study of Oral BGJ398 in Adult Patients With Advanced or Metastatic Cholangiocarcinoma With FGFR2 Gene Fusions or Other FGFR Genetic Alterations Who Failed or Are Intolerant to Platinum-based Chemotherapy|Recruiting||Phase 2|120|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-11 00:22:30.271822|2017-10-11 00:22:30.271822
NCT02150954|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-08-04|2014-06-24||December 2007||2007-12-01|June 2014|2014-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor|A Randomized Comparison of Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor|Completed||Phase 4|121|Actual|Duke University||2|||f||||||||||||||2017-10-11 00:22:30.461311|2017-10-11 00:22:30.461311
NCT02150941|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-11-14|||April 2015||2015-04-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Effectiveness Study of the BioVac Direct Suction Device in Upper Gastrointestinal Bleeding|Does the BioVac Direct Suction Device Increase Identification of the Bleeding Source in Upper Gastrointestinal Bleeding: a Randomized Clinical Trial|Terminated||N/A|10|Actual|Lawson Health Research Institute||2||Enrollment too slow to complete the trial in a reasonable amount of time.|f||||t||||||||Undecided||2017-10-11 00:22:30.92428|2017-10-11 00:22:30.92428
NCT02150928|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-05-11|||May 2014||2014-05-01|May 2015|2015-05-01||||June 2015|Anticipated|2015-06-01||Interventional|||An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)|An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) Administered Following Hypersensitivity to E. Coli Asparaginase in Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|Withdrawn||Phase 2|0|Actual|Jazz Pharmaceuticals||1|||f||||||||||||||2017-10-11 00:22:31.121886|2017-10-11 00:22:31.121886
NCT02150915|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-09-24|||May 2014||2014-05-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Acute Effects of Acupuncture in the Response of the Median Neurodynamic Test|Acute Effects of Acupuncture in the Response of the Median Neurodynamic Test: a Randomised, Double-blind, Non-inferiority Trial|Completed||N/A|32|Actual|Universidade do Porto||2|||f||||t||||||||||2017-10-11 00:22:31.204497|2017-10-11 00:22:31.204497
NCT02150902|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-04-21|||March 2015||2015-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|AWARE||Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence|AUGMENTED WIDE AREA CIRCUMFERENTIAL CATHETER ABLATION FOR REDUCTION OF ATRIAL FIBRILLATION RECURRENCE - A RANDOMIZED CLINICAL TRIAL (The AWARE Trial)|Recruiting||N/A|342|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 00:22:31.286578|2017-10-11 00:22:31.286578
NCT02150889|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-03-22|||July 2014||2014-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TrainMeUpMN||Training Effects on Fuel Metabolism|Training Effects on Fuel Metabolism|Recruiting||N/A|64|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:22:31.401158|2017-10-11 00:22:31.401158
NCT02150876|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2015-12-01|||June 2014||2014-06-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||SWiss Evaluation of Bioabsorbable Polymer-coated Everolimus-eluting Coronary sTent|SWiss Evaluation of Bioabsorbable Polymer-coated Everolimus-eluting Coronary sTent The SWEET Registry|Completed||N/A|1000|Actual|University of Freiburg|||1||f||||t||||||||||2017-10-11 00:22:31.509019|2017-10-11 00:22:31.509019
NCT02150863|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-05-29|||August 2014||2014-08-01|May 2014|2014-05-01||||June 2017|Anticipated|2017-06-01||Interventional|||Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study|Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study|Unknown status|Not yet recruiting|N/A|30|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 00:22:31.613712|2017-10-11 00:22:31.613712
NCT02150850|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-05-03|||April 2012||2012-04-01|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01|3 Years|Observational [Patient Registry]|||Quebec Registry for Atypical Femur Fractures|Quebec Registry for Atypical Femur Fractures|Recruiting||N/A|150|Anticipated|McGill University|||3||f||||f||||||Samples With DNA|"     AFF patients only will be asked to deposit 2 ml of saliva into a collection tube using a     standardized protocol. Individuals unable to produce 2ml of saliva will be asked to perform     at least two buccal swabs.   "|No||2017-10-11 00:22:31.753605|2017-10-11 00:22:31.753605
NCT02150837|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-27|||January 2014||2014-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Retrospective Chart Review of the 5 & 2 & 2 and 4 & 2 & 1 Plans|A Retrospective Chart Review to Assess Weight Loss in Overweight and Obese Adults Using Either the 5 & 2 & 2 Meal Replacement Plan or the 4 & 2 & 1 Meal Replacement Plan at Medifast Weight Control Centers|Completed||N/A|372|Actual|Medifast, Inc.|||2||f||||f||||||||||2017-10-11 00:22:31.853636|2017-10-11 00:22:31.853636
NCT02150616|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-05-23|||May 2014||2014-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep|Patients With Pulmonary Hypertension or Interstitial Lung Disease Travelling to Altitude - Effect of Nocturnal Oxygen Therapy on Breathing and Sleep|Recruiting||Phase 4|50|Anticipated|University of Zurich||4|||f||||f||||||||||2017-10-11 00:22:33.625587|2017-10-11 00:22:33.625587
NCT02150824|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2015-08-12|||July 2014||2014-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin|A Randomized, Double-blind, Placebo-controlled, Parallel Groups Study to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of Three BI 187004 Doses Given Once Daily as Mono-therapy and of the Highest BI 187004 Dose Given Once Daily as Add on Treatment to Metformin Over 28 Days in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|103|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:22:32.029068|2017-10-11 00:22:32.029068
NCT02150811|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-28|2017-07-06|||March 2014||2014-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|||Observational Study of Hunner's Ulcer in Patient With Interstitial Cystitis/Bladder Pain Syndrome|Longitudinal Change of Distribution Pattern of Hunner's Ulcer in Patient With Interstitial Cystitis/Bladder Pain Syndrome|Recruiting||N/A|30|Anticipated|Asan Medical Center|||1||f||||t||||||||||2017-10-11 00:22:32.126549|2017-10-11 00:22:32.126549
NCT02150798|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-05-27|||May 2011||2011-05-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||The Effects of a High Fat and Low Carbohydrate Diet on Clinical Status in Patients With Heart Failure|The Effects of a High Fat and Low Carbohydrate Diet on Clinical Status in Patients With Heart Failure|Completed||N/A|44|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||||2017-10-11 00:22:32.215324|2017-10-11 00:22:32.215324
NCT02150785|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-12-28|||June 2014||2014-06-01|December 2014|2014-12-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|AASIST||Asia Africa Streptokinase Trial|The Effectiveness of Administering Streptokinase as a Thrombolytic Agent in the Management of Acute Stroke|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|University of Alberta||1|||f||||t||||||||||2017-10-11 00:22:32.332092|2017-10-11 00:22:32.332092
NCT02150772|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-04-08|||April 2014||2014-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Diagnostic Value of Shear Wave Elastography|Shear Wave Elastography in the Diagnosis and Risk-stratification of Thyroid Nodules - a Prospective Study|Completed||N/A|308|Actual|University of Aarhus||1|||f||||||||||||||2017-10-11 00:22:32.419354|2017-10-11 00:22:32.419354
NCT02150759|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-08-30|||May 2014||2014-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Dexmedetomidine-ketamine in Femur Proximal Fracture Patients|Comparison Study of Analgesic Effects for Dexmedetomidine-fentanyl vs Dexmedetomidine-ketamine in Femur Proximal Fracture Patients|Recruiting||N/A|46|Anticipated|Inje University||2|||f||||t||||||||No||2017-10-11 00:22:32.501892|2017-10-11 00:22:32.501892
NCT02150746|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-02-22|||February 2015||2015-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Circulating Tumor Cells in Operative Blood|Circulating Tumor Cells Shed in Operative Blood During Pancreatectomy for Pancreatic Cancer is Responsible for Peritoneal Recurrence|Completed||N/A|3|Actual|University of Florida|||1||f||||f||||||Samples With DNA|"     Whole blood Buffy coat isolated from collected whole blood   "|No||2017-10-11 00:22:32.602594|2017-10-11 00:22:32.602594
NCT02150733|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-07-13|||April 2014||2014-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment|A Phase 1, Open-Label Study Assessing the Impact of Hepatic Impairment on the Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors|Completed||Phase 1|29|Actual|Daiichi Sankyo, Inc.||4|||f||||f||||||||||2017-10-11 00:22:32.697661|2017-10-11 00:22:32.697661
NCT02150720|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-09-19|||February 2013||2013-02-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|April 2015|Actual|2015-04-01||Interventional|TRANEXFER||Prevention of Postoperative Bleeding in Subcapital Femoral Fractures|Prevention of Postoperative Bleeding in Femoral Fractures: a Multicenter, Randomized, Controlled, Parallel Clinical Trial to Assess the Efficacy of Tranexamic Acid and Fibrin Glue|Completed||Phase 3|161|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||3|||f||||f||||||||||2017-10-11 00:22:32.804641|2017-10-11 00:22:32.804641
NCT02150707|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-05-17|||May 2014||2014-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Differential Effects of Diabetes Therapy on Inflammation|The Differential Effects of Diabetes Therapy on Inflammation|Completed||N/A|17|Actual|University College Dublin|||2||f||||f||||||||||2017-10-11 00:22:32.93305|2017-10-11 00:22:32.93305
NCT02150694|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-29|||January 2012||2012-01-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|HEAP||Local Haemodynamic Effects of Apelin Agonists and Antagonists in Man in Vivo|Local Haemodynamic Effects of Apelin Agonists and Antagonists in Man in Vivo|Completed||N/A|52|Actual|University of Cambridge||3|||f||||f||||||||||2017-10-11 00:22:33.04072|2017-10-11 00:22:33.04072
NCT02150681|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-29|||October 2012||2012-10-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|MBCT||Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders|MBCT for Perinatal Women With Mood Disorders|Completed||Phase 1|39|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 00:22:33.139403|2017-10-11 00:22:33.139403
NCT02150668|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-07-11|||September 2013||2013-09-01|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Efficacy of an Organizational Skills Intervention for Middle School Students With ADHD|Efficacy of an Organizational Skills Intervention for Middle School Students With ADHD|Completed||N/A|260|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 00:22:33.25456|2017-10-11 00:22:33.25456
NCT02150655|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2014-05-29|||September 2012||2012-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|RVMM||Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women|Pilot Study Investigating Bacteria (Microbiota), Their By-products (Metabolome) and Environmental Toxins in Relation to Reproductive Health in Rwandan Women.|Completed||Early Phase 1|30|Actual|Western University, Canada||2|||f||||f||||||||||2017-10-11 00:22:33.351337|2017-10-11 00:22:33.351337
NCT02150642|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-10-28|||May 2004||2004-05-01|October 2016|2016-10-01||||December 2020|Anticipated|2020-12-01||Observational|||Probing Neural Circuitry for the Control of Movement||Recruiting||N/A|250|Anticipated|University of Zurich|||2||f||||f||||||||||2017-10-11 00:22:33.460062|2017-10-11 00:22:33.460062
NCT02150603|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-03-11|||April 2013||2013-04-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|APPROACH-IS||Patient-Reported Outcomes in Adults With Congenital Heart Disease|Assessment of Patterns of Patient-reported Outcomes in Adults With Congenital Heart Disease - International Study|Completed||N/A|4000|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 00:22:33.793516|2017-10-11 00:22:33.793516
NCT02150590|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-05-23|||May 2014||2014-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and Sleep|Patients With Chronic Obstructive Pulmonary Disease Staying at Altitude - Effect of Nocturnal Oxygen Therapy on Breathing and Sleep in|Recruiting||Phase 4|50|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 00:22:33.970425|2017-10-11 00:22:33.970425
NCT02150577|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-08-22|||May 2014||2014-05-01|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Implementation Trial of Evidence Based Practices for Mood Disorders|Partnership for Implementation of Evidence-Based Practices in Rural Primary Care|Recruiting||N/A|240|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-10-11 00:22:34.0829|2017-10-11 00:22:34.0829
NCT02150564|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2016-10-20|||March 2014||2014-03-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|Sono RCT||3D Ultra Sound for Resection of Brain Tumors|Role of 3-D Navigable Ultrasound in Resection of Intra-axial Brain Tumors - A Randomized Controlled Study|Recruiting||Phase 3|72|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:22:34.74196|2017-10-11 00:22:34.74196
NCT02150551|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-08-17|||September 2015||2015-09-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|June 2020|Anticipated|2020-06-01||Interventional|||Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease|Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease|Recruiting||Phase 1|6|Anticipated|Children's Research Institute||1|||f||||f||||||||||2017-10-11 00:22:34.879282|2017-10-11 00:22:34.879282
NCT02150538|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-04-20|||September 2013||2013-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|REAL-CRT||BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT Study|BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT Study|Recruiting||N/A|164|Anticipated|S. Anna Hospital||2|||f||||f||||||||||2017-10-11 00:22:35.000411|2017-10-11 00:22:35.000411
NCT02150525|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-05-26|||August 2010||2010-08-01|May 2014|2014-05-01||||January 2013|Actual|2013-01-01||Interventional|||Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors|A Randomized Trial to Explore the Effect of Oral Omega 3 Fatty Acids on Atrophic Vaginitis in Postmenopausal Breast Cancer Survivors|Unknown status|Active, not recruiting|Phase 2|52|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:22:35.137781|2017-10-11 00:22:35.137781
NCT02150512|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-11-20|||November 2014||2014-11-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|ReSSeS||Resuscitation Strategies in Septic Shock|Resuscitation Strategies in Septic Shock. A Randomized Controlled Trial of Two Different Fluid Loading Strategies in ICU Patients With Early Septic Shock|Unknown status|Recruiting|N/A|170|Anticipated|Medisch Spectrum Twente||2|||f||||f||||||||||2017-10-11 00:22:35.290095|2017-10-11 00:22:35.290095
NCT02150499|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-03-10|2015-11-18||July 2014||2014-07-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Pediatric subjects birth to less than or equal to 48 months of age with reactive airways disease in an acute setting|A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects|A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting|Terminated||Phase 3|18|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 00:22:35.413261|2017-10-11 00:22:35.413261
NCT02150486|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-06-03|||June 2012||2012-06-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Observational|MICOLON||Myocardial Injury and Postoperative Complications|Postoperative Myocardial Injury and Non-cardiac Complications After Major Abdominal Surgery in Patients at Risk for Coronary Artery Disease|Completed||N/A|210|Actual|St. Antonius Hospital|||1||f||||f||||||||||2017-10-11 00:22:35.850426|2017-10-11 00:22:35.850426
NCT02150473|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-04-04|||October 2014||2014-10-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients|Delayed Gadolinium-enhanced Magnetic Resonance (MR) Imaging of Cartilage - A Pilot Study to Measure the Effect of Adalimumab Plus MTX Versus Placebo Plus MTX on Cartilage in Early RA Patients|Recruiting||Phase 3|30|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 00:22:35.929506|2017-10-11 00:22:35.929506
NCT02150460|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-03-15|2015-02-13||October 2012||2012-10-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional||Patients aged 50 years and above with age related operable cataracts that presented for elective cataract surgery during the study period|A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at Kaduna, Nigeria|A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at National Eye Centre, Kaduna. Nigeria|Completed||Phase 4|100|Actual|National Eye Centre, Kaduna||2|||f||||f||||||||||2017-10-11 00:22:36.018558|2017-10-11 00:22:36.018558
NCT02150447|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-03-29|||June 2009||2009-06-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|April 2015|Actual|2015-04-01||Interventional|||The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding|Effect of Proton Pump Inhibitor on Prevention of Tumor Bleeding in Patients Under Palliative Chemotherapy for Unresectable Gastric Cancer: a Randomized, Double Blind, and Placebo Controlled Multicenter Trial|Terminated||Phase 3|394|Anticipated|National Cancer Center, Korea||2||Low enroll rate|f||||t||||||||||2017-10-11 00:22:37.588526|2017-10-11 00:22:37.588526
NCT02150434|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-28|||November 2009||2009-11-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|May 2012|Actual|2012-05-01||Interventional|FreeO2rehab||Evaluation of Automatic Oxygen Flow Titration During Walking in Patients With COPD|Evaluation of Automatic Oxygen Flow Titration During Walking in Patients With COPD|Completed||N/A|16|Actual|Laval University||3|||f||||f||||||||||2017-10-11 00:22:37.746971|2017-10-11 00:22:37.746971
NCT01801072|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-05-17|||February 2013||2013-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SPAR||Seizure Prophylaxis in Aneurysm Repair|Seizure Prophylaxis in Aneurysm Repair|Recruiting||Phase 4|400|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 01:57:04.407397|2017-10-11 01:57:04.407397
NCT02150421|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2016-06-21|||September 2013||2013-09-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||Impact of Electronic Devices on Myopia Development and Progression|Impact of School Curriculum Engaging Electronic Devices on Myopia Development and Progression in Primary Schoolchildren|Completed||N/A|201|Actual|The Hong Kong Polytechnic University|||1||f||||t||||||||No||2017-10-11 00:22:37.896199|2017-10-11 00:22:37.896199
NCT02150408|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-09-29|||April 2014||2014-04-01|September 2015|2015-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|DOTATATENET||Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine Tumors|Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine Tumors|Unknown status|Recruiting|N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:22:37.993424|2017-10-11 00:22:37.993424
NCT02150395|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-28|||July 2011||2011-07-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Impact of Music Therapy on Anxiety in Patients With Cancer Undergoing Simulation for Radiation Therapy|The Impact of Music Therapy on Anxiety in Patients Newly Diagnosed With Cancer & Undergoing Simulation for Radiation Therapy|Completed||N/A|82|Actual|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-11 00:22:38.113838|2017-10-11 00:22:38.113838
NCT02150382|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-26|||February 2014||2014-02-01|May 2014|2014-05-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Observational|CRHC||China Rural Hypertension Control Project|Effectiveness of a Standardized Protocol-based Treatment Program on Hypertension Control in Rural China.|Unknown status|Recruiting|N/A|52800|Anticipated|First Hospital of China Medical University|||1||f||||||||||||||2017-10-11 00:22:38.226945|2017-10-11 00:22:38.226945
NCT02150369|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-05-30|||February 16, 2015|Actual|2015-02-16|March 2017|2017-03-01|March 2, 2017|Actual|2017-03-02|March 2, 2017|Actual|2017-03-02||Observational|||Interleukin-2—Induced Cognitive/Affective/Sleep Symptoms|Investigating Cognitive/Affective/Sleep Symptoms During High-dose Interleukin-2 Therapy|Completed||N/A|32|Actual|Duke University|||1||f||||f||||||||||2017-10-11 00:22:38.328685|2017-10-11 00:22:38.328685
NCT02150356|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2016-03-03|||January 2014||2014-01-01|June 2015|2015-06-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Aleurone-enriched Products on Cardiovascular Risk Factors|Effects of Aleurone-enriched Products on Fasting and Postprandial Glycemic Homeostasis and Lipid Metabolism in High Cardiovascular Risk Subjects|Completed||N/A|23|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 00:22:38.460992|2017-10-11 00:22:38.460992
NCT02150343|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-08-21|||September 2014||2014-09-01|August 2017|2017-08-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|||Phase II HDM-SPIRE Safety and Efficacy Study|A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis|Completed||Phase 2|715|Actual|Circassia Limited||4|||f||||t||||||||||2017-10-11 00:22:38.610248|2017-10-11 00:22:38.610248
NCT02150317|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2016-03-28|||January 2014||2014-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TACE||Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma|A Prospective Randomized Trial Comparing Transcatheter Arterial Chemoembolization (TACE) Followed by Sorafenib Versus TACE Alone for Advanced Hepatocellular Carcinoma|Recruiting||N/A|180|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 00:22:39.104122|2017-10-11 00:22:39.104122
NCT02150304|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2015-08-04|||January 2014||2014-01-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Aminophylline Prophylaxis For Postdural Puncture Headache|Phase IV Study of Intravenous Aminophylline During Spinal Anesthesia|Completed||N/A|100|Actual|Diskapi Yildirim Beyazit Education and Research Hospital|||2||f||||t||||||||||2017-10-11 00:22:39.248966|2017-10-11 00:22:39.248966
NCT02150291|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-27|||May 2014||2014-05-01|May 2014|2014-05-01|November 2015|Anticipated|2015-11-01|May 2015|Anticipated|2015-05-01||Interventional|||A Pilot Study to Assess the Efficacy and Safety of Folic Acid and/or Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin.|A Pilot Study to Assess the Efficacy and Safety of Folic Acid and/or Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin.|Unknown status|Recruiting|Phase 4|120|Anticipated|British University In Egypt||4|||f||||t||||||||||2017-10-11 00:22:39.330978|2017-10-11 00:22:39.330978
NCT02150278|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-28|||April 2012||2012-04-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|July 2013|Actual|2013-07-01||Interventional|PREVENCON||Effectiveness of an Intervention to Reduce Driving Under the Influence of Alcohol Among Drivers|Effectiveness of an Intervention to Reduce Driving Under the Influence of Alcohol Among Drivers|Unknown status|Enrolling by invitation|N/A|120|Anticipated|Jordi Gol i Gurina Foundation||1|||f||||t||||||||||2017-10-11 00:22:39.419179|2017-10-11 00:22:39.419179
NCT02150265|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-05-26|||January 2013||2013-01-01|December 2015|2015-12-01|January 31, 2018|Anticipated|2018-01-31|June 30, 2017|Anticipated|2017-06-30||Interventional|SMART||Effectiveness of Cognitive Behavioral Short-term Treatment for Adolescents With Emotional Symptom Problems in Community Clinics in Norway|Effectiveness of Cognitive Behavioral Short-term Treatment for Adolescents With Emotional Symptom Problems in Community Clinics in Norway. A Randomized Controlled Study|Active, not recruiting||N/A|173|Actual|University of Tromso||2|||f||||f||||||||||2017-10-11 00:22:39.517583|2017-10-11 00:22:39.517583
NCT02150252|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-27|||May 2014||2014-05-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluate the Efficacy of Bu-Yang- Huan-Wu Tang（BYHWT）on Ischemic Stroke|Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Bu-Yang-Huan-Wu Tang（BYHWT）on Ischemic Stroke|Unknown status|Recruiting|Phase 2|120|Anticipated|China Medical University Hospital||1|||f||||||||||||||2017-10-11 00:22:39.620499|2017-10-11 00:22:39.620499
NCT02150239|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-06-09|||May 2014||2014-05-01|June 2014|2014-06-01|November 2014|Anticipated|2014-11-01|September 2014|Anticipated|2014-09-01|2 Weeks|Observational [Patient Registry]|||A Survey on Postoperative Pain (POP) Experience in Asian Patients.|A Survey on Postoperative Pain (POP) Experience in Asian Patients.|Unknown status|Recruiting|N/A|250|Anticipated|University of Malaya|||1||f||||f||||||||||2017-10-11 00:22:39.695539|2017-10-11 00:22:39.695539
NCT02150226|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2016-05-13|||February 2014||2014-02-01|May 2016|2016-05-01||||April 2016|Actual|2016-04-01||Interventional|||Y-TZP and In-mouth Low Thermal Degradation: A Prospective Clinical Study|Low Thermal Degradation of Monolithic Zirconia Prostheses: an up to 5-year Original Prospective Clinical Study Using ex Vivo Analyses|Completed||N/A|101|Actual|University Hospital of Liege||1|||f||||f||||||||||2017-10-11 00:22:39.767519|2017-10-11 00:22:39.767519
NCT02150213|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-10-24|2016-06-14||August 2014||2014-08-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Includes all patients who signed the informed consent form for the study.|Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492|A Multicenter Medical Safety Follow-up Study for Patients With Partial Onset Seizures Who Received More Than 28 Days of Total Exposure to BGG492 in Studies CBGG492A2207 and/or CBGG492A2212|Completed||Phase 2|59|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:22:39.846417|2017-10-11 00:22:39.846417
NCT02150200|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-07-03|||May 2014||2014-05-01|July 2014|2014-07-01||||February 2015|Anticipated|2015-02-01||Interventional|||Randomised Study Comparing Discharge 3 Days After Surgery to Home Within 24 Hours After Laparoscopic Hysterectomy.|Randomised Study Comparing Discharge 3 Days After Surgery to Home Within 24 Hours After Laparoscopic Hysterectomy.|Unknown status|Not yet recruiting|N/A|44|Anticipated|University Hospital, Strasbourg, France||2|||f||||t||||||||||2017-10-11 00:22:40.12949|2017-10-11 00:22:40.12949
NCT02150187|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2017-07-14|||May 2014||2014-05-01|July 2017|2017-07-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss|Evaluation of the Efficacy of Hcap Formula Nutrition Supplement for Treatment of Men With Androgenic Alopecia: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 2|33|Actual|Family Marketing||2|||f||||f||||||||||2017-10-11 00:22:40.222799|2017-10-11 00:22:40.222799
NCT02150174|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-10-04|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Testing Effect and Schizophrenia|Retrieval Practice in Patients With Schizophrenia : an Exploratory Study Using Word Pairs|Completed||N/A|40|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 00:22:40.31172|2017-10-11 00:22:40.31172
NCT02150161|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-09-24|||May 2014||2014-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Opioid vs. Opioid-free Anesthesia for Hip Arthroscopy|Fentanyl vs. Lidocaine/Ketamine Infusion for Hip Arthroscopy|Terminated||Phase 3|53|Actual|Clinica Santa Maria||2||DSMB estimated futility of the trial and safety risk|f||||||||||||||2017-10-11 00:22:40.386759|2017-10-11 00:22:40.386759
NCT02150148|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2016-02-05|||April 2014||2014-04-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors|Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors|Completed||N/A|46|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:22:40.471041|2017-10-11 00:22:40.471041
NCT02150135|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2016-09-04|||June 2014||2014-06-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients||Completed||Phase 1|10|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 00:22:40.60834|2017-10-11 00:22:40.60834
NCT02150122|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-03-01|||October 2014||2014-10-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Dietary Requirement for Vitamin D in Adolescents Aged 14-18 Years|A Dose-response, Double-blind Randomised Placebo-controlled Trial to Estimate the Dietary Requirement for Vitamin D in Caucasian Male and Female Adolescents Aged 14-18 Years (The ODIN Study)|Completed||N/A|120|Actual|University of Surrey||3|||f||||||||||||||2017-10-11 00:22:40.682045|2017-10-11 00:22:40.682045
NCT02150109|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2016-01-29|2015-06-03||June 2014||2014-06-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||The 'Persons With Diabetes' Arm (329) is a subset of the 'Persons With and Without Diabetes' Arm (372).|Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study)|User Performance of the Karajishi Contour Blood Glucose Monitoring System (ISO/FDA Study)|Completed||N/A|372|Actual|Ascensia Diabetes Care||2|||f||||f||||||||||2017-10-11 00:22:40.773918|2017-10-11 00:22:40.773918
NCT02150096|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-05-25|||May 2014||2014-05-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Laser and Therapeutic Ultrasound in the Management of the Chronic Non-specific Low Back Pain|Laser and and Ultrasound Effect on Pain and Disability in Women With Chronic Non-specific Low Back Pain: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|150|Anticipated|University of Sao Paulo General Hospital||4|||f||||t||||||||||2017-10-11 00:22:41.098027|2017-10-11 00:22:41.098027
NCT02150083|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-05-28|||November 2011||2011-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Trial of Two Techniques to Assess Postoperative Voiding Function|Diagnostic Accuracy of Two Techniques for Assessing Postoperative Voiding Function - A Randomized Trial|Completed||N/A|59|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:22:41.653004|2017-10-11 00:22:41.653004
NCT02150070|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-27|||August 2011||2011-08-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Intravenous Administration of ASP2408 Manufactured From a New Production Clone and Following Single Ascending Doses of Subcutaneous Injections in Healthy Subjects|Completed||Phase 1|32|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-10-11 00:22:41.743369|2017-10-11 00:22:41.743369
NCT02150057|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-05-27|||February 2010||2010-02-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy Study of an Unloading Brace for Knee Osteoarthritis|Efficacy of Medial Compartment Unloading Brace Use for Osteoarthritis of the the Knee: A Prospective Randomized Study|Completed||N/A|72|Actual|Andrews Research & Education Foundation||2|||f||||t||||||||||2017-10-11 00:22:41.828411|2017-10-11 00:22:41.828411
NCT02150044|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-09-25|2014-06-26||February 2010||2010-02-01|September 2014|2014-09-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|inVENT2|Baseline Analysis Population includes 16 lead-in subjects and 13 study cohort subjects|Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion|A Clinical Study of the Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion for Otitis Media|Completed||N/A|29|Actual|Acclarent||1|||f||||f||||||||||2017-10-11 00:22:43.784106|2017-10-11 00:22:43.784106
NCT02150031|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-25|||December 2010||2010-12-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Bacteraemia Secondary to Tooth Extraction: Chlorhexidine Prophylaxis Protocols|Bacteraemia Secondary to Tooth Extraction: a Randomized Clinical Trial on Efficacy of Three Different Chlorhexidine Prophylaxis Protocols|Completed||Phase 4|208|Actual|University of Santiago de Compostela||4|||f||||f||||||||||2017-10-11 00:22:44.023701|2017-10-11 00:22:44.023701
NCT02150018|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-07-30|||June 2014||2014-06-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|NIVIT||Effect of Non Invasive Ventilation on Lung Volumes Determined by Electrical Impedance Tomography|Effect of Non Invasive Ventilation on Lung Volumes Determined by Electrical Impedance Tomography|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:22:44.153404|2017-10-11 00:22:44.153404
NCT02150005|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2014-05-25|||January 2009||2009-01-01|May 2014|2014-05-01||||December 2010|Actual|2010-12-01||Interventional|||Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles in Patients With Coronariopathies|Effects of Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles of Patients With an Indication for Surgical Coronary Revascularization|Completed||N/A|22|Actual|Universidade Veiga de Almeida||2|||f||||f||||||||||2017-10-11 00:22:44.263271|2017-10-11 00:22:44.263271
NCT02149992|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2016-05-17|||November 2014||2014-11-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Glycemic Impact of Myo-inositol in Pregnancy|Glycemic Impact of Myo-inositol in High Risk and Gestational Diabetic Pregnancies: a Pilot Study|Recruiting||N/A|40|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-10-11 00:22:44.339119|2017-10-11 00:22:44.339119
NCT02149979|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2014-05-28|||March 2007||2007-03-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|||Closure of Skin Incision Using CO2 Laser|Closure of Skin Incision Using CO2 Laser|Completed||Phase 1|10|Actual|Tel Aviv University||1|||f||||f||||||||||2017-10-11 00:22:44.440662|2017-10-11 00:22:44.440662
NCT02149966|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-27|2014-11-07|||May 2014||2014-05-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|AG-348MAD||A Phase I Study of AG-348 in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Pharmacokinetic, and Pharmacodynamic Study of Orally Administered AG-348 in Healthy Volunteers|Completed||Phase 1|48|Actual|Agios Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:22:44.525603|2017-10-11 00:22:44.525603
NCT02149953|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-07-13|||September 19, 2014|Actual|2014-09-19|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Determination of Glycine Requirement in Pregnancy|Determination Glycine Requirements During Healthy Pregnancy Using the Indicator Amino Acid Oxidation (IAAO) Technique|Recruiting||N/A|18|Anticipated|University of British Columbia||1|||f||||t||||||||||2017-10-11 00:22:44.60255|2017-10-11 00:22:44.60255
NCT02149940|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-26|||April 2013||2013-04-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|RASP-HF||Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients.|Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients: a Pilot Study.|Completed||N/A|29|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 00:22:44.811181|2017-10-11 00:22:44.811181
NCT02149927|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-05-23|||June 2013||2013-06-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Neural Mechanisms of Sevoflurane Induced Anesthesia: an EEG fMRI Study in Healthy Volunteers||Completed||Early Phase 1|20|Actual|Technische Universität München||1|||f||||f||||||||||2017-10-11 00:22:44.91833|2017-10-11 00:22:44.91833
NCT02149914|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2014-11-19|||May 2014||2014-05-01|November 2014|2014-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients|The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients|Unknown status|Enrolling by invitation|N/A|120|Anticipated|Taichung Tzu Chi Hospital||1|||f||||f||||||||||2017-10-11 00:22:45.005905|2017-10-11 00:22:45.005905
NCT02149901|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-07-25|||October 2014||2014-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Water and Sudafed in Autonomic Failure|Effect of Drinking Water on the Pressor Response to Pseudoephedrine in Patients With Autonomic Failure|Active, not recruiting||Early Phase 1|35|Anticipated|Vanderbilt University Medical Center||4|||f||||f||||||||||2017-10-11 00:22:45.150412|2017-10-11 00:22:45.150412
NCT02149888|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-10-14|||October 2014||2014-10-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PREP-5||PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5|A Pilot Study of Daily TDF/FTC-based PrEP Among High-risk Toronto MSM:The PREPARATORY-5 Study|Completed||Phase 4|52|Actual|St. Michael's Hospital, Toronto||1|||f||||t||||||||||2017-10-11 00:22:45.30269|2017-10-11 00:22:45.30269
NCT02149875|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-05-18|2016-04-12||January 2010||2010-01-01|May 2016|2016-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke|A Comparison of Safety and Efficacy of Dl-3-n-butylphthalide and Cerebrolysin on Neurological and Behavioral Outcomes in Acute Ischemic Stroke: a Randomized, Double-blind Study.|Completed||Phase 1/Phase 2|84|Actual|Shanghai 6th People's Hospital|Foremost is the relatively small sample size, and only patients with moderate severity of stroke were enrolled, so the efficacy results of this study should be interpreted with caution.|3|||f||||t||||||||No||2017-10-11 00:22:45.424211|2017-10-11 00:22:45.424211
NCT02149862|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-09-05|||May 2014||2014-05-01|May 2014|2014-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|FIRBladd||FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors|FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors|Completed||N/A|137|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 00:22:45.965698|2017-10-11 00:22:45.965698
NCT02149849|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-01-14|||August 2014||2014-08-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Surgical Positioning of the Arm During Thoracic Surgery -Effect on Shoulder Pain After Surgery?|Lateral Surgical Positioning for Thoracic Surgery -Effect on Ipsilateral Shoulder Pain?|Completed||N/A|30|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 00:22:46.05199|2017-10-11 00:22:46.05199
NCT02149836|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-12-20|||August 2014||2014-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Study to Treat Major Depressive Disorder (MDD) With a New Medication|A Proof-Of-Concept Clinical Trial of a Novel KCNQ Potentiator in Major Depressive Disorder|Completed||Phase 2|18|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-11 00:22:46.131418|2017-10-11 00:22:46.131418
NCT02149823|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-08-04|||September 2013||2013-09-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations|Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations|Recruiting||Phase 1|120|Anticipated|Icahn School of Medicine at Mount Sinai||5|||f||||t||||||||||2017-10-11 00:22:46.225083|2017-10-11 00:22:46.225083
NCT02149810|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-08-22|||May 2014||2014-05-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Automatic Self Transcending Meditation Versus Treatment as Usual|Automatic Self-transcending Meditation (ASTM) Therapy Versus Treatment as Usual (TAU) in Late Life Depression: Implications for Cardiovascular Health and Cross-fertilization Across Different Levels of Care.|Completed||N/A|95|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:22:46.347797|2017-10-11 00:22:46.347797
NCT02149797|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-28|||January 2014||2014-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||"Comparison of Pick'n Roll Single-incision Laparoscopic Cholecystectomy Technique, and Laparoscopic Cholecystectomy"|"Prospective Randomized Comparative Study of New Single-incision Laparoscopic Cholecystectomy Technique, Pick'n Roll, Versus Conventional Four-port Laparoscopic Cholecystectomy"|Completed||N/A|60|Actual|Samsun Education and Research Hospital||3|||f||||t||||||||||2017-10-11 00:22:46.434958|2017-10-11 00:22:46.434958
NCT02149784|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-04-25|||September 2015||2015-09-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients|Palliative Resection of Asymptomatic Primary Tumor Following Effective Induction Chemotherapy in Colorectal Cancer Patients With Unresectable Distant Metastasis: a Multi-center, Prospective, Randomized Controlled Study|Recruiting||Phase 3|480|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:22:46.521679|2017-10-11 00:22:46.521679
NCT02149771|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2016-10-12|||May 2014||2014-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Combination Treatment for Advanced Liver Cancer|Transarterial Chemoembolisation (TACE) Combined With Endovascular Implantation of Bare Stent and Iodine-125 Seed Strand for the Treatment of Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis Versus TACE Alone|Completed||Phase 3|98|Actual|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-11 00:22:46.608|2017-10-11 00:22:46.608
NCT02149758|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-26|||January 2013||2013-01-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).|EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).|Completed||Phase 4|40|Actual|Tatyasaheb Kore Dental College||2|||f||||t||||||||||2017-10-11 00:22:46.695266|2017-10-11 00:22:46.695266
NCT02149745|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-06-01|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Calling the Patient's Name on Recovery From General Anesthesia||Completed||N/A|101|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 00:22:46.775856|2017-10-11 00:22:46.775856
NCT02149732|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-04-18|||May 2014||2014-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Expanded Access|||Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation|An Investigator-initiated Trial (IIT) on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation in Corneal Limbal Deficiency Patients|Available||N/A|||Seoul National University Hospital|||||f||||||||||||||2017-10-11 00:22:46.956123|2017-10-11 00:22:46.956123
NCT02149719|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2017-06-12|||May 2015|Actual|2015-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|March 13, 2017|Actual|2017-03-13||Interventional|BOPI-1||Boiled Peanut Oral Immunotherapy for the Treatment of Peanut Allergy: a Pilot Study|Phase 2 Randomised Study of Oral Immunotherapy Using Boiled Peanut to Induce Desensitisation in Children With Challenge-proven, IgE-mediated Peanut Allergy|Active, not recruiting||Phase 2|47|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 00:22:47.052983|2017-10-11 00:22:47.052983
NCT02149706|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2016-02-22|||March 2017||2017-03-01|February 2016|2016-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis|A Phase IIb Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis Slowing Disease Progression Via Vaccination|Not yet recruiting||Phase 2|150|Anticipated|Immune Response BioPharma, Inc.||2|||f||||t||||||||||2017-10-11 00:22:47.14195|2017-10-11 00:22:47.14195
NCT02149693|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2015-07-07|||August 2014||2014-08-01|July 2015|2015-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Paradigm Shift in Medical Education: Applications of High-Fidelity Simulation, Teamwork Model Development, and Concept of Flipped Classroom in Innovation and Revolution of Resuscitation Training|Paradigm Shift in Medical Education: Applications of High-Fidelity Simulation, Teamwork Model Development, and Concept of Flipped Classroom in Innovation and Revolution of Resuscitation Training|Unknown status|Recruiting|N/A|500|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:22:47.249216|2017-10-11 00:22:47.249216
NCT02149680|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2015-09-26|||January 2014||2014-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|LEAP||Long-term Effects of Accidental Dural Puncture in Patients Having Had an Epidural Blood Patch (LEAP)|Long-term Follow-up of Patients Having Had an Epidural Blood Patch Following Accidental Dural Puncture During Labour or Caesarean Section|Completed||N/A|60|Actual|Örebro University, Sweden|||2||f||||f||||||||||2017-10-11 00:22:47.344686|2017-10-11 00:22:47.344686
NCT02149667|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-06-19|||December 2014||2014-12-01|June 2017|2017-06-01|December 2028|Anticipated|2028-12-01|December 2027|Anticipated|2027-12-01||Observational|||Post Market Clinical Follow-up Study Protocol for DYNASTY® BioFoam® Acetabular Components|Post Market Clinical Follow-up Study Protocol for DYNASTY® BioFoam® Acetabular Components|Enrolling by invitation||N/A|143|Anticipated|MicroPort Orthopedics Inc.|||1||f||||f||||||||||2017-10-11 00:22:47.441192|2017-10-11 00:22:47.441192
NCT02149654|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-08-28|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|August 2016|Actual|2016-08-01|12 Months|Observational [Patient Registry]|||Engager Align Post-market Clinical Study|The Engager ALIGN Study. To Characterize the Safety and Clinical Benefit of the Engager Transcatheter Aortic Valve Implantation System in a Real World Environment.|Completed||N/A|27|Actual|Medtronic Cardiovascular|||1||f||||t||||||||||2017-10-11 00:22:47.518456|2017-10-11 00:22:47.518456
NCT02149641|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-26|||February 2006||2006-02-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2011|Actual|2011-04-01||Observational|||Parotid-sparing IMRT for Nasopharyngeal Cancer|Phase II Study of Parotid Sparing IMRT for Nasopharyngeal Cancer|Completed||N/A|42|Actual|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 00:22:47.585467|2017-10-11 00:22:47.585467
NCT02149628|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-07-27|||May 2014||2014-05-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide|The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide in Patients Undergoing Laparoscopic Surgery|Completed||Phase 4|50|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:22:47.649805|2017-10-11 00:22:47.649805
NCT02149615|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-05-26|||April 2014||2014-04-01|May 2014|2014-05-01|December 2019|Anticipated|2019-12-01|April 2019|Anticipated|2019-04-01||Interventional|AAMPTC||Antiacne Medications Pseudotumor Cerebri|Prospective Open-label Phase IV Trial to Investigate the Frequency of Optic Disc Swelling, Idiopathic Intracranial Hypertension and Dry Eye Symptoms Under Antiacne Medication Treatment|Recruiting||Phase 4|310|Anticipated|University of Zurich||4|||f||||t||||||||||2017-10-11 00:22:47.723976|2017-10-11 00:22:47.723976
NCT02149602|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-26|||July 2005||2005-07-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|November 2011|Actual|2011-11-01||Observational|PARSPORT-II||A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck|A Phase II Study of Parotid-gland Sparing Intensity-modulated Radiotherapy in Patients With Midline Tumour of the Head and Neck|Completed||N/A|120|Actual|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 00:22:47.821813|2017-10-11 00:22:47.821813
NCT02149589|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-02-05|||June 2014||2014-06-01|February 2015|2015-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Lung Imaging for Ventilatory Setting in ARDS|Lung Imaging for Ventilatory Setting in ARDS|Unknown status|Recruiting|N/A|420|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:22:47.898867|2017-10-11 00:22:47.898867
NCT02149576|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-03-15|||August 2014||2014-08-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|Intense-CT||Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer Surgery|Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer Surgery: A Pilot Study for the Intense-CT Trial|Recruiting||Phase 2|620|Anticipated|McMaster University||2|||f||||t||||||||No||2017-10-11 00:22:47.997111|2017-10-11 00:22:47.997111
NCT02149563|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-03-15|||January 2015||2015-01-01|March 2015|2015-03-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Interventional|||Oxygen Therapy in Depression|Oxygen Therapy in Depression|Unknown status|Recruiting|N/A|200|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-11 00:22:48.107239|2017-10-11 00:22:48.107239
NCT02149550|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-11-21|||August 2014||2014-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum Strains|Controlled Human Malaria Infection After Bites From Mosquitoes Infected With NF135.C10 or NF166.C8 Plasmodium Falciparum Parasites (BMGF2a)|Completed||N/A|24|Actual|Radboud University||6|||f||||t||||||||||2017-10-11 00:22:48.193781|2017-10-11 00:22:48.193781
NCT02149537|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-03-06|||December 2014||2014-12-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment|Risk Stratification for Clinical Severity of Sickle Cell Disease in Nigeria and Assessment of Efficacy and Safety During Treatment With Hydroxyurea|Active, not recruiting||Phase 4|40|Anticipated|Loyola University||2|||f||||t||||||||Undecided||2017-10-11 00:22:48.30769|2017-10-11 00:22:48.30769
NCT02149524|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-07-10|||April 2014|Actual|2014-04-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer|A Phase III Randomised, Double-Blind, Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity Between SB3 (Proposed Trastuzumab Biosimilar) and Herceptin® in Women With Newly Diagnosed HER2 Positive Early or Locally Advanced Breast Cancer in Neoadjuvant Setting|Completed||Phase 3|806|Anticipated|Samsung Bioepis Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:22:48.411316|2017-10-11 00:22:48.411316
NCT02149511|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-10-27|||September 2010||2010-09-01|October 2016|2016-10-01||||December 2020|Anticipated|2020-12-01||Observational|||Longitudinal Morphometric Changes Following SCI||Recruiting||N/A|50|Anticipated|University of Zurich|||2||f||||t||||||||||2017-10-11 00:22:48.504532|2017-10-11 00:22:48.504532
NCT02149498|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-26|||July 2014||2014-07-01|April 2014|2014-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) Signals for Healthy Controls Evoked Response Potential (ERP) Signals for Healthy Controls and Patients With Parkinson Disease||Unknown status|Not yet recruiting|N/A|100|Anticipated|Sheba Medical Center|||2||f||||t||||||||||2017-10-11 00:22:48.577914|2017-10-11 00:22:48.577914
NCT02149485|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-01-13|||January 2014||2014-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Follow-up of 5-year Old Children Born After PGD|Long-term Safety of Preimplantation Genetic Diagnosis. Follow-up of 5-year Old Children Born After PGD.|Recruiting||N/A|300|Anticipated|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-11 00:22:48.656566|2017-10-11 00:22:48.656566
NCT02149472|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-04-20|||February 2015||2015-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|TeMpOH-2||Towards Better Prognostic and Diagnostic Strategies for Haemostatic Changes During Major Obstetric Haemorrhage|Towards Better Prognostic and Diagnostic Strategies for Haemostatic Changes During Major Obstetric Haemorrhage|Recruiting||N/A|9500|Anticipated|Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research|||1||f||||f||||||Samples With DNA|"     Blood samples will be drawn for conventional haemostatic parameters and ROTEM profiles.     Remaining plasma will be frozen and stored for further evaulation.   "|Undecided||2017-10-11 00:22:48.73124|2017-10-11 00:22:48.73124
NCT02149459|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2015-09-02|||June 2014||2014-06-01|May 2014|2014-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|SMC 0712-13||Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy|Improving the Response of Recurrent Glioma to Radiation Therapy Through Metabolic Intervention|Recruiting||Phase 1|18|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 00:22:48.838699|2017-10-11 00:22:48.838699
NCT02149446|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-03-31|||April 2014||2014-04-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Does Reinforcement of the Staple Line in Left Pancreatectomy Reduce the Rate of Pancreatic Fistula?|Pancreas Fistula After Distal Pancreatic Resection: Prevention and Treatment in a Randomized Controlled Trial|Unknown status|Recruiting|N/A|100|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:22:48.948925|2017-10-11 00:22:48.948925
NCT02149433|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-12-09|||May 2012||2012-05-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|August 2014|Actual|2014-08-01||Interventional|||Pneumocystis Jerovici Pneumonia in Infants and Steroids|Early Steroid Use in Infants With Clinical Pneumocystis Jiroveci Pneumonia (PCP) in the Queen Elizabeth Central Hospital, Blantyre, Malawi|Completed||N/A|78|Actual|University of Malawi College of Medicine||1|||f||||t||||||||||2017-10-11 00:22:49.058325|2017-10-11 00:22:49.058325
NCT02149420|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-03-14|||May 2014||2014-05-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CVAY736X2201||PD of VAY736 in Patients With Primary Sjögren's Syndrome|A Single Dose, Double-blind, Placebo-controlled, Parallel Study to Assess the Pharmacodynamics, Pharmacokinetics and Safety and Tolerability of VAY736 in Patients With Primary Sjögren's Syndrome|Active, not recruiting||Phase 2|27|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:22:49.165387|2017-10-11 00:22:49.165387
NCT02149407|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-04-02|||May 2014||2014-05-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Glycerin Suppositories for Treatment of Feeding Intolerance in Preterm Infants|Efficacy and Safety of Glycerin Suppositories for Treatment of Feeding Intolerance in Very Low Birth Weight Infants|Unknown status|Recruiting|N/A|230|Anticipated|King Saud Medical City||3|||f||||t||||||||||2017-10-11 00:22:49.274798|2017-10-11 00:22:49.274798
NCT02149394|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2014-05-26|||August 2013||2013-08-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Ice Popsicle for Thirst Relief of the Surgical Patient|Efficacy of Ice Popsicle in the Management of Thirst in the Immediate Postoperative Period: Randomized Clinical Trial|Completed||N/A|208|Actual|Universidade Estadual de Londrina||2|||f||||f||||||||||2017-10-11 00:22:49.40556|2017-10-11 00:22:49.40556
NCT02149381|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-08-27|||May 2014||2014-05-01|August 2015|2015-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|PsySysNe||Psychosocial Group Interventions for Depression|Psychosocial Group Interventions for Depression: Systemic and Neurophysiological Correlates of Treatment Effect. A Randomized, Controlled Trial|Recruiting||N/A|384|Anticipated|University of Eastern Finland||3|||f||||f||||||||||2017-10-11 00:22:49.507041|2017-10-11 00:22:49.507041
NCT02149355|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-05-23|||March 2014||2014-03-01|May 2014|2014-05-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|IVPareseZahn||Teeth and Jaw Misalignment in Patients Suffering From Congenital Fourth Cranial Nerve Palsy|Teeth and Jaw Misalignment in Patients Suffering From Congenital Fourth Cranial Nerve Palsy|Recruiting||N/A|50|Anticipated|University of Zurich|||2||f||||t||||||||||2017-10-11 00:22:49.753385|2017-10-11 00:22:49.753385
NCT02149342|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-05-29|2015-09-20||May 2014||2014-05-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL|Daylight-mediated Photodynamic Therapy of Actinic Keratoses: a Randomized, Double-blinded Pilot Study Comparing Topical 0.2% Hexylaminolaevulinate With 16% Methylaminolaevulinate|Completed||Phase 1/Phase 2|14|Actual|Joint Authority for Päijät-Häme Social and Health Care|As the study was conducted as a single center pilot study, the results should be confirmed in a larger trial also valuing the patient complete response rates. A further limitation was we did not record light-doses.|1|||f||||t||||||||Yes|International peer-reviewed publication|2017-10-11 00:22:49.890529|2017-10-11 00:22:49.890529
NCT02149329|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-12-08|||December 2014||2014-12-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|SHORT||Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO|Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With Fever of Unknown Origin: a Randomized Multicenter Non-inferiority Trial.|Recruiting||Phase 4|240|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 00:22:50.222294|2017-10-11 00:22:50.222294
NCT02149316|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2016-12-22|||February 2014||2014-02-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Remote Ischemic Preconditioning With Postconditioning in Heart Transplantation Surgery|Cardioprotective Effects of Remote Ischemic Preconditioning With Postconditioning of the Recipient on Donor Heart in Heart Transplantation Surgery|Completed||N/A|60|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-11 00:22:50.374488|2017-10-11 00:22:50.374488
NCT02149303|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-03-03|2016-03-03||June 2014||2014-06-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational||Patients who received treatment at the five study sites.|Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa|A Retrospective Cohort Study With Chart Review to Assess the Management of Major Bleeding Events in NVAF Patients Treated With Dabigatran Etexilate|Completed||N/A|191|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:22:50.480406|2017-10-11 00:22:50.480406
NCT02149290|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-08-14|||February 2014||2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|TRENDS||LifeVest Trends Validation Protocol|LifeVest Trends Validation Protocol|Recruiting||N/A|200|Anticipated|Zoll Medical Corporation|||1||f||||f||||||||||2017-10-11 00:22:50.817344|2017-10-11 00:22:50.817344
NCT02149277|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-07-24|||March 2013||2013-03-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Effects of Exogenous Recombinant GCSF (Granulocyte Colony-stimulating Factor ) in Patients With Repeated Implantation Failure|Effects of Exogenous Recombinant GCSF in Patients With Repeated Implantation Failure - A Randomized Single-blind Trial|Recruiting||Phase 3|290|Anticipated|OVO R & D||2|||f||||f||||||||||2017-10-11 00:22:50.944776|2017-10-11 00:22:50.944776
NCT02149264|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-08-23|2017-06-29|2016-05-02|July 2014||2014-07-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional||Intent-to-treat (ITT) Population consists of all subjects who received at least one dose of investigational medicinal product (IMP).|A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males|A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males|Completed||Phase 3|160|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:22:51.073129|2017-10-11 00:22:51.073129
NCT02149251|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-24|2015-01-20|||May 2014||2014-05-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Does Preimplantation Genetic Diagnosis for Sex Selection Affect the Pregnancy and Miscarriage Rates in Women With an Expected Good Ovarian Response Undergoing IVF/ICSI Cycles?|Does Preimplantation Genetic Diagnosis for Sex Selection Affect the Pregnancy and Miscarriage Rates in Women With an Expected Good Ovarian Response Undergoing IVF/ICSI Cycles?|Completed||N/A|11006|Actual|Cairo University|||2||f||||f||||||||||2017-10-11 00:22:51.961584|2017-10-11 00:22:51.961584
NCT02149238|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-12-19|||February 2011||2011-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|New Drink||Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects|Acute Study to Investigate the Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects|Completed||N/A|36|Anticipated|Heinrich-Heine University, Duesseldorf||3|||f||||f||||||||||2017-10-11 00:22:52.059038|2017-10-11 00:22:52.059038
NCT02149225|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-08-16|||October 2014||2014-10-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients|A Phase I Trial of Actively Personalized Peptide Vaccinations Plus Immunomodulators in Patients With Newly Diagnosed Glioblastoma Concurrent to First Line Temozolomide Maintenance Therapy|Active, not recruiting||Phase 1|16|Actual|immatics Biotechnologies GmbH||1|||f||||t||||||||||2017-10-11 00:22:52.158548|2017-10-11 00:22:52.158548
NCT02149212|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-25|2014-07-22|||February 2013||2013-02-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Iliac Vein Stenting in Advanced Chronic Venous Insufficiency|Randomized Double-blind Trial Between Clinical and Endovascular Treatment in Patients With Advanced Chronic Venous Insufficiency and Iliac Venous Obstruction|Completed||Phase 4|50|Actual|Instituto Dante Pazzanese de Cardiologia||2|||f||||t||||||||||2017-10-11 00:22:52.273763|2017-10-11 00:22:52.273763
NCT02149199|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-09-18|||July 7, 2014|Actual|2014-07-07|September 2017|2017-09-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Interventional|SYGMA1||A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.|A Clinical Study Comparing Symbicort® 'as Needed' With Terbutaline 'as Needed' and With Pulmicort® Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma.|Completed||Phase 3|3850|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:22:52.427002|2017-10-11 00:22:52.427002
NCT02149186|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-05-22|||October 2009||2009-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interactive Motor Imagery in Virtual Reality||Recruiting||N/A|72|Anticipated|University of Zurich||1|||f||||t||||||||||2017-10-11 00:22:53.18439|2017-10-11 00:22:53.18439
NCT02149173|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-10-02|||September 15, 2010|Actual|2010-09-15|October 2017|2017-10-01|September 15, 2021|Anticipated|2021-09-15|September 15, 2018|Anticipated|2018-09-15||Interventional|||F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy|Serial [F-18] Fluoroestradiol (FES) PET Imaging to Evaluate Endocrine-Targeted Therapy|Enrolling by invitation||N/A|50|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 00:22:53.267984|2017-10-11 00:22:53.267984
NCT02149160|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-03-22|||October 2014||2014-10-01|May 2015|2015-05-01||||August 2016|Anticipated|2016-08-01||Interventional|||Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation|A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating, Phase 2a Safety, Tolerability, and Pharmacodynamic Study of Two Doses of an Histone Deacetylase Inhibitor (FRM-0334) in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|FORUM Pharmaceuticals Inc||3|||f||||||||||||||2017-10-11 00:22:53.43139|2017-10-11 00:22:53.43139
NCT02149147|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-07-14|||May 2014||2014-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Variety of Physical Activity in Normal to Overweight Adults Who Are Regularly Active|Variety of Physical Activity in Normal to Overweight Adults Who Are Regularly Active|Active, not recruiting||N/A|50|Anticipated|University of Tennessee|||1||f||||f||||||||||2017-10-11 00:22:53.624854|2017-10-11 00:22:53.624854
NCT02149134|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-23|||October 2013||2013-10-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy|Cow's Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula (TeHF2013-01) in Infants With Confirmed Cow's Milk Protein Allergy|Unknown status|Recruiting|Phase 2|29|Anticipated|Federico II University||1|||f||||||||||||||2017-10-11 00:22:53.7458|2017-10-11 00:22:53.7458
NCT02149121|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-05-30||2017-05-30|August 2014|Actual|2014-08-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2016|Actual|2016-01-01||Interventional|rituximab||PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis|A Randomized, Controlled, Double-Blind, Parallel-Group, Phase 3 Study to Compare the Pharmacokinetics, Efficacy and Safety Between CT-P10, Rituxan and MabThera in Patients With Rheumatoid Arthritis|Completed||Phase 3|384|Actual|Celltrion||3|||f||||t|t|f||||||||2017-10-11 00:22:53.852874|2017-10-11 00:22:53.852874
NCT02148926|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-05-30|||February 2014|Actual|2014-02-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01|5 Years|Observational [Patient Registry]|||Clinical and Genetic Examinations of Dilated Cardiomyopathy|Clinical and Genetic Examinations of Dilated Cardiomyopathy|Recruiting||N/A|554|Anticipated|University of Southern Denmark|||1||f||||f|f|f||||Samples With DNA|"     DNA for genetic testing   "|Undecided||2017-10-11 00:22:57.282095|2017-10-11 00:22:57.282095
NCT02149108|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2017-06-23|2017-05-08||September 25, 2014|Actual|2014-09-25|June 2017|2017-06-01|August 25, 2016|Actual|2016-08-25|May 13, 2016|Actual|2016-05-13||Interventional||Randomised Set (RS): This patient set included all patients who were randomised to receive treatment, whether treated or not.|Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)|A Double-blind, Randomised, Placebo Controlled Phase III Study of Nintedanib Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Therapies.|Completed||Phase 3|768|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:22:54.013054|2017-10-11 00:22:54.013054
NCT02149095|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-08-06|||July 2014||2014-07-01|August 2014|2014-08-01||||November 2014|Anticipated|2014-11-01||Interventional|||Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers|A Phase I, Open-label, Dose Escalation Study to Determine the Maximum Tolerated Dose and Evaluate the Safety, Tolerability and Pharmacokinetics of Single Doses of TransCon PEG Treprostinil Administered as a Subcutaneous Injection in Healthy Adult Male Volunteers|Withdrawn||Phase 1|0|Actual|United Therapeutics||1||Study will not be conducted|f||||f||||||||||2017-10-11 00:22:55.62429|2017-10-11 00:22:55.62429
NCT02149082|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-06-08|||June 2014||2014-06-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection in Children|Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection in Children|Recruiting||N/A|328|Anticipated|Children's Hospital of Philadelphia|||1||f||||t||||||||||2017-10-11 00:22:55.732194|2017-10-11 00:22:55.732194
NCT02149056|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-26|2014-05-28|||August 2013||2013-08-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design|Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design|Completed||N/A|447|Actual|Affiliated Hospital of Hebei University|||1||f||||t||||||||||2017-10-11 00:22:55.903378|2017-10-11 00:22:55.903378
NCT02149043|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-05-31|||January 2015||2015-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Thermo||Thermography in Surveillance of Ulcerative Colitis|Prototype Study on Association Between Clinical, Laboratory and Thermographic Findings in Patients With Ulcerative Colitis|Recruiting||N/A|60|Anticipated|University Hospital Dubrava|||2||f||||f||||||Samples With DNA|"     Stool sample for calprotectin mesures   "|No||2017-10-11 00:22:56.002039|2017-10-11 00:22:56.002039
NCT02149030|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-28|||March 2014||2014-03-01|May 2014|2014-05-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Interventional|HPV-004||Effectiveness of Cervical Screening in HPV Vaccinated Women|Effectiveness of Cervical Screening in HPV Vaccinated Women - A Randomized Trial|Enrolling by invitation||Phase 4|7500|Anticipated|University of Tampere||3|||f||||f||||||||||2017-10-11 00:22:56.094689|2017-10-11 00:22:56.094689
NCT02149017|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-24|||December 2010||2010-12-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|May 2011|Actual|2011-05-01||Interventional|||Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)|Phase 1 and Phase 2 Clinical Trials for the Evaluation of Pharmacokinetics, Safety, and Efficacy of SNUBH-NM-333(18F) in Alzheimer's Disease Patients and Healthy Volunteers.|Terminated||Phase 1/Phase 2|30|Actual|Seoul National University Hospital||1||SNUH-NM-333 ligand effect was judged to be insufficient.|f||||t||||||||||2017-10-11 00:22:56.219827|2017-10-11 00:22:56.219827
NCT02149004|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-05-18|||April 2015||2015-04-01|May 2016|2016-05-01|January 2035|Anticipated|2035-01-01|January 2035|Anticipated|2035-01-01||Observational|||German Centre for Infection Research HIV Translational Platform|Translational Research Platform of the TTU HIV of the German Center for Infection Research (DZIF)|Recruiting||N/A|10000|Anticipated|University Hospital of Cologne|||6||f||||t||||||Samples With DNA|"     Liquids, tissue, and pathogens from consenting patients will be stored in a decentral     biobank.   "|||2017-10-11 00:22:56.3105|2017-10-11 00:22:56.3105
NCT02148991|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-04-28|||July 2014|Actual|2014-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction|Observational Clinical Trial to Assess Irbesartan Alone or in Combination With Amlodipine and Carvedilol Effectiveness in Patients With Hypertension and Left Ventricular Dysfunction|Completed||N/A|100|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||Undecided||2017-10-11 00:22:56.598059|2017-10-11 00:22:56.598059
NCT02148978|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-23|||March 2014||2014-03-01|May 2014|2014-05-01||||August 2015|Anticipated|2015-08-01||Interventional|||Cystic Fibrosis Related Diabetes|DPP-IV Inhibition in Patients With Cystic Fibrosis|Unknown status|Recruiting|N/A|30|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-10-11 00:22:56.722296|2017-10-11 00:22:56.722296
NCT02148965|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-08-25|||September 2014||2014-09-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|PAMELA||Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial|Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial|Completed||N/A|612|Actual|Federal University of Pelotas||2|||f||||f||||||||||2017-10-11 00:22:56.849248|2017-10-11 00:22:56.849248
NCT02148952|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-08-01|||November 2014||2014-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|January 20, 2017|Actual|2017-01-20||Interventional|BetterBirth||BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program|A Matched-pair, Cluster Randomized Trial to Measure the Efficacy of the WHO Safe Childbirth Checklist Program on Severe Maternal, Fetal and Newborn Harm|Active, not recruiting||N/A|161107|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 00:22:56.975068|2017-10-11 00:22:56.975068
NCT02148939|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-03-09|||May 2014||2014-05-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Antiplatelet Effects in Stroke-Patients|Dipyrone Nullifies Aspirin Antiplatelet Effects in Stroke-Patients|Completed||N/A|61|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 00:22:57.165082|2017-10-11 00:22:57.165082
NCT02148913|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-10-04|||June 2014|Actual|2014-06-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma|A Phase I Study of Melphalan, Bendamustine, and Carfilzomib for Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma|Recruiting||Phase 1|26|Anticipated|Spectrum Health Hospitals||4|||f||||t||||||||||2017-10-11 00:22:57.428945|2017-10-11 00:22:57.428945
NCT02148900|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-01-04|||May 2013||2013-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|||Development of a Blood Test for Marfan Syndrome|Development of a Blood Test for Marfan Syndrome|Recruiting||N/A|336|Anticipated|Shriners Hospitals for Children|||3||f||||f||||||Samples With DNA|"     Plasma Frozen Cells   "|No||2017-10-11 00:22:57.572794|2017-10-11 00:22:57.572794
NCT02148887|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-05-22|||February 2014||2014-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||Plasticity of Grey and White Matter in Response to Motor Skill Training in Healthy Individuals and Those With Spinal Cord Injury||Active, not recruiting||N/A|50|Anticipated|University of Zurich|||5||f||||t||||||||||2017-10-11 00:22:57.745955|2017-10-11 00:22:57.745955
NCT02148874|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-09-18|||September 2013||2013-09-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2017|Actual|2017-05-01||Observational|||Immune Responses to the Flu Shot During Pregnancy|Immune Responses to the Flu Shot During Pregnancy|Active, not recruiting||N/A|280|Actual|Ohio State University|||1||f||||f||||||Samples With DNA|"     serum whole blood plasma   "|||2017-10-11 00:22:57.826513|2017-10-11 00:22:57.826513
NCT02148861|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-06-05|||May 2014||2014-05-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes|A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes|Completed||Phase 1|49|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:22:57.922968|2017-10-11 00:22:57.922968
NCT02148822|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-05-27|||December 2009||2009-12-01|May 2014|2014-05-01|February 2011|Actual|2011-02-01|December 2009|Actual|2009-12-01||Observational|VL&MNEthio||Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia|Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia|Completed||N/A|520|Actual|Instituto de Salud Carlos III|||2||f||||f||||||||||2017-10-11 00:22:58.232139|2017-10-11 00:22:58.232139
NCT02148809|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-05-17|2017-04-03||May 2014|Actual|2014-05-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|November 2015|Actual|2015-11-01||Interventional|||Blood Volume Analysis of Total Hip Arthroplasty Patients Under Hypotensive Anesthesia|Blood Volume Analysis of Total Hip Arthroplasty Patients Under Hypotensive Anesthesia|Completed||N/A|14|Actual|Hospital for Special Surgery, New York||1|||f||||f||||||||||2017-10-11 00:22:58.31249|2017-10-11 00:22:58.31249
NCT02148796|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-01-18|||January 3, 2017|Actual|2017-01-03|January 2017|2017-01-01|April 30, 2022|Anticipated|2022-04-30|December 31, 2021|Anticipated|2021-12-31||Interventional|ORBEX||Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness|Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)|Recruiting||Phase 2|1076|Anticipated|University of Arizona||2|||f||||t||||||||No||2017-10-11 00:22:58.50849|2017-10-11 00:22:58.50849
NCT02148783|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-05-27|||September 2014||2014-09-01|May 2014|2014-05-01|June 2017|Anticipated|2017-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI|Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Uniformed Services University of the Health Sciences||1|||f||||f||||||||||2017-10-11 00:22:58.711043|2017-10-11 00:22:58.711043
NCT02148770|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-05-27|||November 2014||2014-11-01|June 2015|2015-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of Neurofeedback on Eating Behaviour|Modulating Functional Connectivity Between Eating-related Brain Areas by Neurofeedback|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||Yes|We will share the data inside the EU-consortium|2017-10-11 00:22:58.8445|2017-10-11 00:22:58.8445
NCT02148757|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-03-20|||June 2011||2011-06-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Doppler Ultrasound Following Unicondylar Knee Replacement to Determine the Incidence of Postoperative DVT|Doppler Ultrasound Following Unicondylar Knee Replacement to Determine the Incidence of Postoperative DVT|Completed||N/A|112|Actual|Hospital for Special Surgery, New York||1|||f||||f||||||||||2017-10-11 00:22:58.973673|2017-10-11 00:22:58.973673
NCT02148744|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-01-23|||May 2014||2014-05-01|January 2017|2017-01-01|September 21, 2015|Actual|2015-09-21|September 21, 2015|Actual|2015-09-21||Interventional|||Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis|A Randomized, Double-Blinded, Placebo-Controlled, Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of XmAb®7195|Completed||Phase 1|72|Actual|Xencor, Inc.||1|||f||||f||||||||||2017-10-11 00:22:59.061309|2017-10-11 00:22:59.061309
NCT02148731|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-05-27|||January 2010||2010-01-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|MOST||MOST: Mediterranean Oncology Senior Tests|Longitudinal Study Comparing Markers of Frailty in Geriatric Assessment to Detect Vulnerability to Chemotherapy in Patients Aged 70 Years or Older With Colon Cancer|Unknown status|Active, not recruiting|N/A|180|Actual|Association Sud pour la Recherche en Oncogériatrie|||1||f||||f||||||||||2017-10-11 00:22:59.141434|2017-10-11 00:22:59.141434
NCT02148718|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-08-31|2017-07-31||June 2014|Actual|2014-06-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|August 2016|Actual|2016-08-01||Interventional|RAPIDA||Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease|Rapidity of Onset of Response to Adalimumab in Luminal Crohn's Disease (RAPIDA Study)|Completed||Phase 4|100|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 00:22:59.264236|2017-10-11 00:22:59.264236
NCT02148705|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-01-27|||April 2015||2015-04-01|January 2016|2016-01-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns|A Multicenter, Multinational, Randomized, Controlled, Assessor Blinded Study, Performed in Subjects With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid Compared to Gel Vehicle and Compared to Standard of Care|Recruiting||Phase 3|175|Anticipated|MediWound Ltd||3|||f||||t||||||||||2017-10-11 00:22:59.537229|2017-10-11 00:22:59.537229
NCT02148692|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-06-07|||July 2014||2014-07-01|June 2016|2016-06-01||||December 2017|Anticipated|2017-12-01||Interventional|PROBESE||Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients||Recruiting||N/A|2013|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 00:22:59.700884|2017-10-11 00:22:59.700884
NCT02148679|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-07-25|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|May 21, 2017|Actual|2017-05-21||Interventional|GOURMET-HF||Geriatric Out of Hospital Randomized Meal Trial in Heart Failure|Effects of Home-delivered Low-sodium Meals in Older Adults Following Heart Failure Hospitalization.|Completed||N/A|107|Actual|University of Michigan||2|||f||||||||||||||2017-10-11 00:22:59.90103|2017-10-11 00:22:59.90103
NCT02148666|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-06-06|||August 2014||2014-08-01|June 2014|2014-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|COLT||Study of Homing of Labelled Stem Cells in Human Heart.|Labelling of Stem Cells With Technetium 99- m Hexamethylene Propylene Amine Oxide ( Tc99m HMPAO)to Monitor Homing in the Human Heart. Bench to Bedside Studies [ COLT -- COronary Labelling Trial ]|Not yet recruiting||N/A|10|Anticipated|All India Institute of Medical Sciences, New Delhi|||1||f||||t||||||||||2017-10-11 00:22:59.995627|2017-10-11 00:22:59.995627
NCT02148653|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-12-02|||February 2014||2014-02-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|January 2015|Actual|2015-01-01||Interventional|||An Antiinflammatory Diet as Modulator of Cardiometabolic Risk and Body Weight in Healthy Subjects|Efficacy of an Antiinflammatory Diet as Modulator of Cardiometabolic Risk and Body Weight in Healthy Overweight Subjects: Studies of Mechanisms Involving Metabolomics and Gut Microbiota Mapping|Completed||N/A|47|Actual|Lund University||2|||f||||f||||||||||2017-10-11 00:23:00.078935|2017-10-11 00:23:00.078935
NCT02148640|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-09-22|||October 2014||2014-10-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Interventional|NOR-SWITCH||The NOR-SWITCH Study|A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SWITCHING FROM INNOVATOR INFLIXIMAB TO BIOSIMILAR INFLIXIMAB COMPARED WITH CONTINUED TREATMENT WITH INNOVATOR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, ULCERATIVE COLITIS, CROHN'S DISEASE AND CHRONIC PLAQUE PSORIASIS THE NOR-SWITCH STUDY|Completed||Phase 4|482|Actual|Diakonhjemmet Hospital||2|||f||||f||||||||||2017-10-11 00:23:00.161229|2017-10-11 00:23:00.161229
NCT02148627|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-02-14|||June 16, 2014|Actual|2014-06-16|February 2017|2017-02-01|February 11, 2017|Actual|2017-02-11|February 11, 2017|Actual|2017-02-11||Interventional|||Safety Study of LY3041658 in Healthy Participants|A Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3041658 in Healthy Subjects|Completed||Phase 1|54|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 00:23:00.934964|2017-10-11 00:23:00.934964
NCT02148614|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-07-11|||January 2014||2014-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Intake of a Polysaccharides Mix on Metabolism, Hormones and Satiety in Obese Children.|Intake of a Polysaccharides Mix (LibraMedR) in Obese Children. 1. Postprandial Effects on Metabolism, Hormones and Satiety; 2. Effects on Body Fat, Glucide and Fat Metabolism After a 60-day Treatment.|Recruiting||Phase 1/Phase 2|120|Anticipated|Azienda Ospedaliera Universitaria Integrata Verona||2|||f||||f||||||||||2017-10-11 00:23:01.017399|2017-10-11 00:23:01.017399
NCT02148601|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-11-19|||July 2013||2013-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection|Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection: an Open-label Randomized Clinical Trial|Completed||Phase 2|39|Actual|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-11 00:23:03.168542|2017-10-11 00:23:03.168542
NCT02148588|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-04-19|||August 2014||2014-08-01|April 2017|2017-04-01|January 25, 2017|Actual|2017-01-25|December 15, 2016|Actual|2016-12-15||Interventional|||Peripheral Sensory Input in Central Post Stroke Pain (CPSP)|"How Central is Central Post-stroke Pain? Investigating the Role of Peripheral Sensory Input in Maintaining Central Pain"|Completed||N/A|10|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 00:23:03.269557|2017-10-11 00:23:03.269557
NCT02148575|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-04-25|||June 2014||2014-06-01|June 2016|2016-06-01|January 2017|Actual|2017-01-01|April 2016|Actual|2016-04-01||Interventional|||Integrating Palliative Care Into Self-Management of Breast Cancer|Integrating Palliative Care Into Self-Management of Breast Cancer|Completed||N/A|109|Actual|Yale University||2|||f||||f||||||||||2017-10-11 00:23:03.364566|2017-10-11 00:23:03.364566
NCT02148562|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-05-22|||April 2014||2014-04-01|May 2014|2014-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity|Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity With Next-generation Sequencing: From Chronic Infection to End-stage Liver Disease and Liver Cancer|Enrolling by invitation||N/A|274|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||t||||||Samples With DNA|"     serum whole blood   "|||2017-10-11 00:23:03.477336|2017-10-11 00:23:03.477336
NCT02148549|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-07-22|||April 2014||2014-04-01|July 2015|2015-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|FIRINOX||Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study|The Pilot Study of Neoadjuvant Chemotherapy of FIRINOX for Patients With Borderline Resectable Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|Wakayama Medical University||1|||f||||t||||||||||2017-10-11 00:23:03.560749|2017-10-11 00:23:03.560749
NCT02145663|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2016-03-31|||May 2013||2013-05-01|March 2016|2016-03-01||||February 2016|Actual|2016-02-01||Observational|||Helsinki Ultra-acute Stroke Biomarker Study|Helsinki Ultra-acute Stroke Biomarker Study|Completed||N/A|1046|Actual|Helsinki University Central Hospital|||1||f||||||||||Samples Without DNA|"     Human Serum and Plasma   "|||2017-10-11 00:23:40.251839|2017-10-11 00:23:40.251839
NCT02148536|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-06-02|||June 2014||2014-06-01|June 2014|2014-06-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Observational|||Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome|Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome|Unknown status|Recruiting|N/A|||West China Hospital|||1||f||||f||||||||||2017-10-11 00:23:03.667825|2017-10-11 00:23:03.667825
NCT02148523|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-07-11|2017-04-14||January 2014||2014-01-01|July 2017|2017-07-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Social Forces to Improve Statin Adherence (Study B)|Using Social Comparison To Improve Medication Adherence In Statin Users With Diabetes|Completed||N/A|201|Actual|University of Pennsylvania|The interventions lasted only 3 months; differences in adherence might emerge over a longer period of time. The primary outcome of pill-bottle-measured adherence has limitations, including bottle malfunction.|3|||f||||f||||||||||2017-10-11 00:23:03.761247|2017-10-11 00:23:03.761247
NCT02148510|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-07-26|||May 2014||2014-05-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||Oral Appliance in Obstructive Sleep Apnea. A Randomized Controlled Blinded Multicenter Study Comparing Two Devices|Oral Appliance in the Treatment of Obstructive Sleep Apnea. A Randomized Controlled Blinded Multicenter Study Comparing the Efficacy of Two Devices|Enrolling by invitation||Phase 4|316|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-11 00:23:04.310922|2017-10-11 00:23:04.310922
NCT02148497|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-10-05|||May 2014||2014-05-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Multi-Colored Placido Disk Viability|Viability Study of a Multi-Colored Videokeratoscope With Extended Timescale Data|Active, not recruiting||N/A|20|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-11 00:23:04.429769|2017-10-11 00:23:04.429769
NCT02148484|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-08-18|||February 2006||2006-02-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|||Comparing Behavioral Therapies for Treating Adolescents With Post-Traumatic Stress Disorder Related to Sexual Abuse|Comparing Behavioral Therapies for Treating Adolescents With Post-Traumatic Stress Disorder Related to Sexual Abuse|Completed||Phase 2|90|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:23:04.522104|2017-10-11 00:23:04.522104
NCT02148471|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-05-10|||October 2003||2003-10-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Fatty Acids, Genes and Microbiota in Fatty Liver|Non-alcoholic Steatohepatitis Versus Simple Hepatic Steatosis: Is There a Difference in the Nutritional Factors Influencing Lipid Perioxidation and Inflammation?|Completed||N/A|205|Actual|University Health Network, Toronto|||4||f||||f||||||Samples With DNA|"     DNA - samples retained, with potential for extraction of DNA from at least one of the types     of samples retained (e.g., frozen tissue, whole blood   "|||2017-10-11 00:23:04.608577|2017-10-11 00:23:04.608577
NCT02148458|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-05-08|||June 2014||2014-06-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Short Term Intermittent Fasting and Mediterranean Diet|Metabolic and Molecular Effects of a Mediterranean Diet and Intermittent Fasting|Active, not recruiting||N/A|53|Actual|Washington University School of Medicine||2|||f||||f||||||||No|Plan to publish|2017-10-11 00:23:04.75743|2017-10-11 00:23:04.75743
NCT02148445|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2017-09-07|2017-04-30||May 2014||2014-05-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers|Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers|Completed||Phase 3|398|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 00:23:04.909149|2017-10-11 00:23:04.909149
NCT02148432|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-01-23|||May 19, 2014|Actual|2014-05-19|January 2017|2017-01-01|April 29, 2016|Actual|2016-04-29|April 29, 2016|Actual|2016-04-29||Interventional|||Establishment of Ideal IV Sedative Regimen for Successful Fiberoptic Bronchoscopy in Assessing the Site, Severity of Sleep Apnea Syndrome||Completed||N/A|31|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:23:06.063109|2017-10-11 00:23:06.063109
NCT02148419|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-02-07|||February 2014||2014-02-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Psychosocial Development of Maltreated Children: A Prospective Study|Psychosocial Development of Maltreated Children: A Prospective Study|Terminated||N/A|17|Actual|University Children's Hospital, Zurich|||1|recruiting not successful, too few participants|f||||f||||||||||2017-10-11 00:23:06.146936|2017-10-11 00:23:06.146936
NCT02148406|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-06-19|||August 2014||2014-08-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Pro-You||Programs to Support You During Chemotherapy (Pro-You)|Programs to Support You During Chemotherapy (Pro-You): Feasibility|Completed||N/A|3|Actual|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-10-11 00:23:06.2231|2017-10-11 00:23:06.2231
NCT02148393|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-05-01|||May 2014||2014-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ICE||Implantation Enhancement by Elective Cryopreservation of All Viable Embryos|Elective Blastocyst Vitrification for Endometrial Receptivity Enhancement in High-responder Patients Undergoing in Vitro Fertilisation/Intracytoplasmatic Sperm Injection (IVF/ICSI)|Recruiting||N/A|212|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||Yes||2017-10-11 00:23:06.34626|2017-10-11 00:23:06.34626
NCT02148380|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-04-19|||May 2014||2014-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Combination of Chemotherapy and Gefitinib as First-line Treatment|Combination of Chemotherapy and Gefitinib as First-line Treatment of Patients With Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomised Controlled Trial|Completed||N/A|121|Actual|Shanghai Chest Hospital||3|||f||||f||||||||Undecided||2017-10-11 00:23:06.584789|2017-10-11 00:23:06.584789
NCT02148367|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-12-30|||September 2014||2014-09-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|TBI-EPO||Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI|Effect of Administration of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Patients With Persistent Symptoms During the Subacute Period After TBI|Withdrawn||Phase 2|0|Actual|Uniformed Services University of the Health Sciences||2||"Publication of recent trials showing no effect of EPO in TBI substantially reduced equipoise   about this study."|f||||t||||||||||2017-10-11 00:23:06.687988|2017-10-11 00:23:06.687988
NCT02145650|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-11-02|||May 2014||2014-05-01|November 2015|2015-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|STRETCh||Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs||Withdrawn||N/A|0|Actual|Allergan|||1|Study suspended due to company decision prior to enrollment.|f||||f||||||||||2017-10-11 00:23:40.328494|2017-10-11 00:23:40.328494
NCT02148354|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-05-17|||March 2012||2012-03-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Internet Delivered Intervention Program for the Prevention and Treatment of Depression|Differential Efficacy of an Internet Delivered Intervention Program for the Prevention and Treatment of Mild to Moderate Depression With or Without Support by the Therapist|Completed||N/A|90|Actual|Universitat Jaume I||3|||f||||t||||||||||2017-10-11 00:23:06.790011|2017-10-11 00:23:06.790011
NCT02148341|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2014-05-27|||January 2010||2010-01-01|February 2013|2013-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Implementation of the Hospital to Home (H2H) Heart Failure Initiative|Implementation of the Hospital to Home (H2H) Heart Failure Initiative|Completed||N/A|122|Anticipated|VA Palo Alto Health Care System||2|||f||||f||||||||||2017-10-11 00:23:06.900657|2017-10-11 00:23:06.900657
NCT02148328|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-10-23|||May 2014||2014-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults|A Phase 1, Double-blind, Active-controlled, Randomized Study in Healthy Adults to Evaluate Safety, Tolerability, and Immunogenicity of a Trivalent and Quadrivalent Cell-based Virosomal Subunit Influenza Vaccine|Completed||Phase 1|240|Actual|Crucell Holland BV||4|||f||||f||||||||||2017-10-11 00:23:06.984125|2017-10-11 00:23:06.984125
NCT02148315|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2014-05-23|||August 2011||2011-08-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||School Gardens and Physical Activity|School Gardens and Physical Activity|Completed||N/A|234|Actual|Cornell University||2|||f||||f||||||||||2017-10-11 00:23:07.132979|2017-10-11 00:23:07.132979
NCT02148302|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-05-15|||May 2014||2014-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Cellutome||Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers|A Multi-center Randomized Open-Label Controlled Clinical Trial Evaluating Suction Blister Grafting Utilizing a Novel Harvesting Device (CelluTome©) and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers|Recruiting||N/A|194|Anticipated|SerenaGroup, Inc.||2|||f||||t||||||||||2017-10-11 00:23:07.21524|2017-10-11 00:23:07.21524
NCT02148289|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-06-04|||November 2012||2012-11-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CHB-BRJ-COPD||Dietary Nitrate in COPD|Dietary Nitrate in COPD: A Double-blind, Randomized, Placebo-controlled, Crossover Trial|Completed||N/A|12|Actual|Royal College of Surgeons, Ireland||2|||f||||f||||||||||2017-10-11 00:23:07.37559|2017-10-11 00:23:07.37559
NCT02148263|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-07-25|||May 2014||2014-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|CLAN||Contact Lens Adaptation in Neophytes|Contact Lens Adaptation in Neophytes|Recruiting||N/A|30|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-11 00:23:07.581664|2017-10-11 00:23:07.581664
NCT02148250|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-03-13|||July 2015||2015-07-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||PK/PD STUDY OF U-500 REGULAR INSULIN|DURATION OF ACTION AND PEAK EFFECT OF HIGH DOSE OF U-500 REGULAR INSULIN IN SEVERELY INSULIN RESISTANT SUBJECTS WITH TYPE 2 DIABETES MELLITUS.|Recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:23:07.727404|2017-10-11 00:23:07.727404
NCT02148237|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-23|2016-05-20|||August 2014||2014-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|BFCM||Increase Breastfeeding Duration Among Puerto Rican Mothers|Intervention to Increase Breastfeeding Duration Among Puerto Rican Mothers|Completed||N/A|60|Actual|Treatment Research Institute||2|||f||||f||||||||Undecided||2017-10-11 00:23:07.845955|2017-10-11 00:23:07.845955
NCT02148224|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-05-22|||April 2014||2014-04-01|May 2014|2014-05-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||Relationship of Glycemic Index Values and Subjects' Body Composition Parameters|Correlation of Glycemic Index Values and Subjects' Body Composition Parameters|Unknown status|Active, not recruiting|N/A|30|Anticipated|Nutrifood Research Center, Jakarta, Indonesia|||1||f||||f||||||||||2017-10-11 00:23:07.95839|2017-10-11 00:23:07.95839
NCT02148211|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-04-19|||June 1, 2014|Actual|2014-06-01|April 2017|2017-04-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Observational|||Fluarix®/ FluLaval®/ Fluarix® Quadrivalent/ FluLaval® Quadrivalent Vaccine Pregnancy Registry|Fluarix®/ FluLaval®/ Fluarix® Quadrivalent/ FluLaval® Quadrivalent Pregnancy Registry: a Prospective, Exploratory, Cohort Study to Detect and Describe Abnormal Pregnancy Outcomes in Women Intentionally or Unintentionally Vaccinated With Fluarix® or Fluarix® Quadrivalent or FluLaval® or FluLaval® Quadrivalent During Pregnancy or Within 28 Days Preceding Conception.|Recruiting||N/A|1800|Anticipated|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 00:23:08.040357|2017-10-11 00:23:08.040357
NCT02148198|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-05-22|||May 2013||2013-05-01|May 2014|2014-05-01||||July 2013|Actual|2013-07-01||Interventional|||Effect of NWT-03 on Blood Pressure - Part 1|A Study of Two Parts to Determine the Effect of NWT-03 on Blood Pressure in Healthy Subjects. Part 1: A Dose Ranging, Cross-over Study to Determine the Effect of 1g, 2g & 5gs of NWT-03 Versus Placebo on Blood Pressure in Healthy Subjects.|Completed||N/A|92|Actual|Newtricious R&D BV||6|||f||||t||||||||||2017-10-11 00:23:08.12897|2017-10-11 00:23:08.12897
NCT02148185|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-09-10|||May 2014||2014-05-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease|A Phase I, Open-label Study to Evaluate PK, PD, and Safety of a Single Oral Dose of MT-1303 in Subjects With Moderate to Severe Crohn's Disease|Completed||Phase 1|1|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 00:23:08.217295|2017-10-11 00:23:08.217295
NCT02148172|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-08-26|||January 2014||2014-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Optimizing Plyometric Training for Functional Recovery Post-ACL Reconstruction|Optimizing Plyometric Training for Functional Recovery Post-ACL Reconstruction|Recruiting||N/A|80|Anticipated|University of Montana||2|||f||||f||||||||||2017-10-11 00:23:08.315802|2017-10-11 00:23:08.315802
NCT02148159|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-19|||October 2014||2014-10-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer|Impact of Mechanism Based Acupuncture Intervention to Improve Weight Loss in GI Cancer Patients With Cachexia|Completed||N/A|45|Actual|University of Florida|||2||f||||t|f|f||||||||2017-10-11 00:23:08.437783|2017-10-11 00:23:08.437783
NCT02148146|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-05-01|||March 2011|Actual|2011-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis|Clinical Trial of Omegaven™ Therapy for Parenteral Nutrition Associated Cholestasis|Recruiting||Phase 1/Phase 2|30|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:23:08.539187|2017-10-11 00:23:08.539187
NCT02148133|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-10-03|||July 2014|Actual|2014-07-01|October 2017|2017-10-01|September 5, 2017|Actual|2017-09-05|September 5, 2017|Actual|2017-09-05||Interventional|||A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia|A Non-randomized, Open-label, Phase II Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia|Completed||Phase 2|21|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:23:08.646002|2017-10-11 00:23:08.646002
NCT02148120|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-03-28|||April 2014||2014-04-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler|A Phase II, Multicentre, Double-blind, Randomised, 5-way Crossover Study to Test the Non-inferiority of the Acute Bronchodilator Effect of CHF 1535 200/6 µg NEXThaler Versus CHF 1535 100/6 µg NEXThaler in Partially Controlled and Uncontrolled Adult Asthmatic Patients.|Completed||Phase 2|60|Actual|Chiesi Farmaceutici S.p.A.||5|||f||||f||||||||||2017-10-11 00:23:08.786493|2017-10-11 00:23:08.786493
NCT02148107|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-02-01|2015-11-11||May 2014||2014-05-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional||Treated set which included all subjects who received at least one dose of study drug.|Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects|Terminated||Phase 1|18|Actual|Boehringer Ingelheim|The trial was terminated prematurely because the sponsor decided to discontinue the development of BI 691751, also no PK blood samples were analysed because of the trial termination.|7|||f||||||||||||||2017-10-11 00:23:08.909983|2017-10-11 00:23:08.909983
NCT02148094|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-10-24|||January 2016||2016-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PrEP-India||Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India|Closing a Critical HIV Prevention Gap: Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) as Part of an HIV Combination Preventive Intervention for Sex Workers in Kolkata and Mysore-Mandya, India|Recruiting||Early Phase 1|2000|Anticipated|University of Manitoba||1|||f||||f||||||||No||2017-10-11 00:23:09.255925|2017-10-11 00:23:09.255925
NCT02148081|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-03-15|||August 2014||2014-08-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Functional Recovery in Critically Ill Children, the Wee-Cover Multicentre Study|Functional Recovery in Critically Ill Children - a Longitudinal Multicentre, Mixed-Methods Study|Active, not recruiting||N/A|182|Actual|McMaster University|||1||f||||f||||||||||2017-10-11 00:23:09.509816|2017-10-11 00:23:09.509816
NCT02148068|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-05-03|||May 2014||2014-05-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01|1 Year|Observational [Patient Registry]|||Changes in Body Composition Following Bariatric Surgery|Roux-en-y Gastric Bypass Versus Sleeve Gastrectomy - Analysis of the Disparate Effects on Body Composition and Associated Comorbidity Resolution|Recruiting||N/A|136|Anticipated|University of Iowa|||2||f||||t||||||||No||2017-10-11 00:23:09.597866|2017-10-11 00:23:09.597866
NCT02148055|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-06-13|||May 2014||2014-05-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|COMPER||Comparative Evaluation of IRM and Autopsy in the Evaluation of Intra Uterine Fetal Death|Comparative Evaluation of IRM and Autopsy in the Evaluation of Intra Uterine Fetal Death.|Terminated||N/A|2|Actual|University Hospital, Rouen||1||lack of recruitment|f||||f||||||||||2017-10-11 00:23:09.719635|2017-10-11 00:23:09.719635
NCT02148042|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-11-04|||April 2014||2014-04-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa|Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa|Completed||N/A|26|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-11 00:23:09.811412|2017-10-11 00:23:09.811412
NCT02148029|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-05-18|||July 1, 2014|Actual|2014-07-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|EFFORT2||Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome|Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome|Recruiting||N/A|260|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-11 00:23:09.898252|2017-10-11 00:23:09.898252
NCT02148016|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-27|||December 2012||2012-12-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation|Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Sun Yat-sen University||4|||f||||f||||||||||2017-10-11 00:23:10.039247|2017-10-11 00:23:10.039247
NCT02148003|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-04-11|||May 2014||2014-05-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of the Temperature Used in Thermal Radiofrequency Ablation|Effect of the Temperature Used in Thermal Radiofrequency Ablation on Outcomes of Lumbar Facets Medial Branches Denervation Procedures: A Randomized Double-Blinded Trial|Recruiting||N/A|237|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 00:23:10.190749|2017-10-11 00:23:10.190749
NCT02147990|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-10-21|||April 2014||2014-04-01|October 2015|2015-10-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC)|TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 2|225|Anticipated|Clovis Oncology, Inc.||1|||f||||f||||||||||2017-10-11 00:23:10.319102|2017-10-11 00:23:10.319102
NCT02147977|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-07-26|||June 2014||2014-06-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Marine n-3 Fatty Acids on Heart Rate Variability and Arrhythmias in Patients Receiving Chronic Dialysis|Effects of Marine n-3 Fatty Acids on Heart Rate Variability and Arrhythmias in Patients Receiving Chronic Dialysis (Renal Rhythm Study II)|Completed||N/A|112|Actual|Aalborg Universitetshospital||2|||f||||t||||||||||2017-10-11 00:23:10.673503|2017-10-11 00:23:10.673503
NCT02147964|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-08-16|||January 2017||2017-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ITT-5||ITT-5 Mechanisms of Spermatogenesis|Mechanisms of Hormonal Control of Spermatogenesis in Man|Not yet recruiting||Phase 2|60|Anticipated|University of Washington||4|||f||||f||||||||Undecided||2017-10-11 00:23:10.801118|2017-10-11 00:23:10.801118
NCT02147951|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-02-26||||||February 2016|2016-02-01||||||||Expanded Access|||Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma|A Phase 3b, Multicenter, Open-label, Single-arm, Expanded Access Protocol of Talimogene Laherparepvec for the Treatment of Subjects With Unresected, Stage lllB to IVM1c Melanoma|No longer available||N/A|||Amgen|||||||||||||||||||2017-10-11 00:23:10.979349|2017-10-11 00:23:10.979349
NCT02147938|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-09-26|||July 17, 2014|Actual|2014-07-17|September 2017|2017-09-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Observational|OPALE||A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)|French Multicentre Observational Study of a Prospective Cohort of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)|Completed||N/A|578|Actual|Astellas Pharma Inc|||2||f||||f||||||||||2017-10-11 00:23:11.138574|2017-10-11 00:23:11.138574
NCT02147925|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-04-28|||August 2014||2014-08-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|LIGHT-ON||Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects|Efficacy of Liraglutide vs. Sitagliptin vs. Insulin Glargine Per Day on Liver Fat When Combined With Metformin in T2DM Subjects With Non-alcoholic Fatty-liver Disease|Recruiting||Phase 4|150|Anticipated|Sun Yat-sen University||3|||f||||f||||||||||2017-10-11 00:23:11.302609|2017-10-11 00:23:11.302609
NCT02147912|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-05-27|||November 2014||2014-11-01|May 2014|2014-05-01|November 2015|Anticipated|2015-11-01|May 2015|Anticipated|2015-05-01||Interventional|EDIC||Evaluation of Depression In Chronic Obstructive Pulmonary Disease|Evaluation of Depression In Chronic Obstructive Pulmonary Disease: a Longitudinal Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|154|Anticipated|University Hospital, Catania||2|||f||||t||||||||||2017-10-11 00:23:11.413684|2017-10-11 00:23:11.413684
NCT02147899|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-11-16||2015-11-16|May 2014||2014-05-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis|A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis|Completed||Phase 2|215|Actual|Symbiomix Therapeutics||3|||f||||f||||||||||2017-10-11 00:23:11.506844|2017-10-11 00:23:11.506844
NCT02147886|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-11-21|||July 2014||2014-07-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease|A Single-Center, Randomized, Double-Blind, Parallel-Group, Dose-Controlled Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in Patients With Machado-Joseph Disease|Completed||Phase 2|15|Actual|Bioblast Pharma Ltd.||2|||f||||f||||||||||2017-10-11 00:23:11.633791|2017-10-11 00:23:11.633791
NCT02147873|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-18|||June 2014||2014-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine With or Without Birinapant With a Single Arm Open-Label Run-In Phase in Subjects With Higher Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia|Terminated||Phase 2|118|Actual|TetraLogic Pharmaceuticals||2||Study terminated due to lack of efficacy|f||||t||||||||||2017-10-11 00:23:11.771388|2017-10-11 00:23:11.771388
NCT02147860|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-07-15|||May 2014||2014-05-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Full Day and Night Closed-Loop With DiAs Platform|Full Day and Night Closed-Loop With DiAs Platform|Completed||N/A|44|Actual|University of Virginia||2|||f||||t||||||||Yes|Paper Published in Diabetes Care|2017-10-11 00:23:12.068706|2017-10-11 00:23:12.068706
NCT02147847|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-10-17|||April 2015||2015-04-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Computer-Based Auditory Rehabilitation|Neurological Treatment to Improve the Hearing in Noise Abilities of Older Adults With Hearing Impairments.|Completed||N/A|36|Actual|Massachusetts Eye and Ear Infirmary||2|||f||||f||||||||||2017-10-11 00:23:12.191125|2017-10-11 00:23:12.191125
NCT02147834|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-03-27|||August 2015||2015-08-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|IMWELL3||Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents|Effect of Ranolazine After Deferral of Percutaneous Coronary Intervention by Fractional Flow Reserve (IMWELL3)|Terminated||Phase 2|4|Actual|North Florida Foundation for Research and Education||2||due to futility|f||||t||||||||||2017-10-11 00:23:12.342211|2017-10-11 00:23:12.342211
NCT02147821|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-09-12|||August 2014||2014-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Necessity of Using Pleural Drainage Tubes After IMA Harvesting During Cardiac Surgery|Necessity of Using Pleural Drainage Tubes After IMA Harvesting During Cardiac Surgery|Recruiting||N/A|200|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 00:23:12.451641|2017-10-11 00:23:12.451641
NCT02147808|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-09-05|||May 2014||2014-05-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects|A Phase 1, Open-Label, Single-Center, 2-Period, Single-Sequence Drug-Drug Interaction Study to Evaluate the Effects of Multiple-Dose Telotristat Etiprate on the Pharmacokinetics of Single-Dose Midazolam, a Sensitive P450-3A4 Substrate, in Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|Lexicon Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:23:12.533947|2017-10-11 00:23:12.533947
NCT02147795|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-08-29|||January 2012||2012-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The German Patient Blood Management Network|Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients|Recruiting||N/A|200000|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||t||||||||||2017-10-11 00:23:12.638374|2017-10-11 00:23:12.638374
NCT02147782|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-11-29|||October 2012||2012-10-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|||Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency|Continuous Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency in Different Stages|Recruiting||N/A|300|Anticipated|Shanghai University of Traditional Chinese Medicine|||6||f||||t||||||Samples Without DNA|"     Serum and plasma of cases and controls   "|||2017-10-11 00:23:12.92866|2017-10-11 00:23:12.92866
NCT02147769|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-05-25|||May 2014||2014-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|Early NIRS||Cerebral Oxygenation and Autoregulation in Preterm Infants|Cerebral Oxygenation and Autoregulation in Preterm Infants: Association With Morbidity and Mortality|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 00:23:13.047681|2017-10-11 00:23:13.047681
NCT02147756|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-05-26|||May 2014||2014-05-01|May 2015|2015-05-01||||December 2015|Anticipated|2015-12-01||Interventional|||Histology Evaluation of the CO2RE Device Versus the RePair Device|In Vivo Histology Evaluation of the CO2RE Device Versus the RePair Device in Pre- Abdominoplasty Patients|Unknown status|Active, not recruiting|N/A|2|Actual|Syneron Medical||2|||f||||f||||||||||2017-10-11 00:23:13.172648|2017-10-11 00:23:13.172648
NCT02147743|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-27|||May 2009||2009-05-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|CCP||Preventing Adolescents From Entering the Juvenile Justice System|Preventing Adolescents From Entering the Juvenile Justice System: Testing An Empirically-Supported, Family-Based Diversion Model|Completed||N/A|120|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 00:23:13.263493|2017-10-11 00:23:13.263493
NCT02147730|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-03-01|||January 2013|Actual|2013-01-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01|3 Years|Observational [Patient Registry]|ALICE||ALICE-Regional Anesthesia in Italy: Complications and Outcomes|ALICE-Regional Anesthesia in Italy: Complications and Outcomes|Completed||N/A|400|Actual|IRCCS Policlinico S. Matteo|||1||f||||f||||||||||2017-10-11 00:23:13.350167|2017-10-11 00:23:13.350167
NCT02147717|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-07-24|||May 2014|Actual|2014-05-01|August 2016|2016-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|ELAPPS||Laser Acupuncture and Pain Management in Preterm Infants Undergoing Patent Ductus Arteriosus Ligation|Laser Acupuncture and Pain Management in Preterm Infants Undergoing Patent Ductus Arteriosus Ligation|Completed||N/A|40|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:23:13.473368|2017-10-11 00:23:13.473368
NCT02147704|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-06-30|||May 2014||2014-05-01|June 2016|2016-06-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan|Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan|Completed||Phase 4|27|Actual|DongGuk University||2|||f||||f||||||||||2017-10-11 00:23:13.593252|2017-10-11 00:23:13.593252
NCT02147691|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-08-28|2015-05-07||May 2014||2014-05-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional||subjects between 18 years and 85 years of age with moderate to severe rosacea|Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study|Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study|Completed||Phase 4|22|Actual|Derm Research, PLLC|Pilot study. Small number of participants.|2|||f||||f||||||||||2017-10-11 00:23:13.727701|2017-10-11 00:23:13.727701
NCT02147678|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-05-27|||December 2014||2014-12-01|May 2014|2014-05-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||A Comparison Between Propofol and Etomidate in Hysteroscopy on Effect of Postoperative Sedation and Cognitive Function in Elderly Patients||Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Shaanxi Provincial People's Hospital||2|||f||||f||||||||||2017-10-11 00:23:14.542218|2017-10-11 00:23:14.542218
NCT02147665|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-11-23|||March 2013||2013-03-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Effects of Hookah Smoking on Blood Flow to the Heart, Muscle and Skin|Effects of Hookah Smoking on Blood Flow to the Heart, Muscle and Skin|Recruiting||N/A|50|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-11 00:23:14.633922|2017-10-11 00:23:14.633922
NCT02147652|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-09-23|||May 2014||2014-05-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Personalized Music Therapy and Agitation in Dementia|Assessing the Effects of a Personalized Music Therapy With Headphones on Agitation in Patients With Dementia|Enrolling by invitation||N/A|60|Anticipated|University Health Network, Toronto||1|||f||||f||||||||No||2017-10-11 00:23:14.731375|2017-10-11 00:23:14.731375
NCT02147639|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-05-22|||September 2013||2013-09-01|May 2014|2014-05-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy||Unknown status|Recruiting|Phase 2/Phase 3|20|Anticipated|Cedars-Sinai Medical Center||5|||f||||||||||||||2017-10-11 00:23:14.812015|2017-10-11 00:23:14.812015
NCT02147626|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-07-19|||September 21, 2015|Actual|2015-09-21|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|HH4M||Heart Health 4 Moms|Heart Health 4 Moms: Engaging Women With a Recent History of Preeclampsia to Reduce Their Cardiovascular Disease Risk|Completed||N/A|151|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 00:23:14.918213|2017-10-11 00:23:14.918213
NCT02147600|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-06-03|||January 2014||2014-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|1 Day|Observational [Patient Registry]|||Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients|Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients|Unknown status|Recruiting|N/A|75|Anticipated|University Hospital, Ghent|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 00:23:15.212278|2017-10-11 00:23:15.212278
NCT02147561|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-04-22|2016-03-09||July 2014||2014-07-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||The Safety Population included patients enrolled in the study who received study drug. The Safety Population was used to assess the baseline characteristics.|A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine||Completed||Phase 4|280|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:23:15.660301|2017-10-11 00:23:15.660301
NCT02147548|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-07-26|||December 2013||2013-12-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly|Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly. A Monocentric, Randomized, Cross-over, Double-blind Clinical Study Versus Placebo|Completed||Phase 3|31|Actual|Biocodex||3|||f||||f||||||||||2017-10-11 00:23:15.94612|2017-10-11 00:23:15.94612
NCT02147535|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-10-10|||March 2014||2014-03-01|October 2014|2014-10-01||||August 2014|Actual|2014-08-01||Interventional|||Impact of CES1 Genotype on Metabolism of Methylphenidate|Impact of CES1 Genotype on Metabolism of Methylphenidate|Completed||Phase 4|78|Actual|Bispebjerg Hospital||1|||f||||||||||||||2017-10-11 00:23:16.031302|2017-10-11 00:23:16.031302
NCT02147522|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-04-20|2016-11-30||October 2013||2013-10-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|AHH|From April 2014 to May 2015, 1957 were screened, 22% met criteria for major depression. Of 421 study eligible, 354 patients agreed to participate but 6 did not complete the baseline assessment. It yielded a final valid enrollment number N=348, with178 (51%) randomized to the AHH intervention group and 170 (49%) to the comparison UC group.|A Helping Hand Among Low-Income Patients|A Helping Hand (AHH) to Activate Patient-Centered Depression Care Among Low-Income Patients|Completed||N/A|348|Actual|University of Southern California|1) patients lost follow up in intervention visits, outcome interviews; 2) community health workers activated in DHS-PCMH at the same time the AHH trial started; 3) reliance on self-reported outcomes while DHS medical records system update was delayed|2|||f||||f||||||||No||2017-10-11 00:23:16.144519|2017-10-11 00:23:16.144519
NCT02147509|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-07-20|||March 2013||2013-03-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|BCL||Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome|Evaluation of the Therapeutic Effect of Bandage Contact Lenses on Dry Eye Caused by Sjogren's Syndrome|Completed||N/A|64|Actual|Wenzhou Medical University||1|||f||||t||||||||||2017-10-11 00:23:16.692931|2017-10-11 00:23:16.692931
NCT02147496|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-05-21|||September 2011||2011-09-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Fluid Dairy Products Consumed Before and Within a Pizza Meal on Glycemic Response, Food Intake and Satiety in Children|The Effect of Fluid Dairy Products Consumed Before and Within a Pizza Meal on Glycemic Regulation, Food Intake and Satiety in Normal Weight and Overweight/Obese Children|Completed||Phase 1/Phase 2|57|Actual|University of Toronto||5|||f||||f||||||||||2017-10-11 00:23:16.805193|2017-10-11 00:23:16.805193
NCT02147483|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-10-25|||August 2012||2012-08-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|MBRP||Mindfulness-Based Relapse Prevention for Alcohol Use Disorders in Remission|Mindfulness-Based Relapse Prevention and Stress Reactivity in Alcohol Dependent Individuals: A Pilot Study|Active, not recruiting||N/A|104|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 00:23:16.927502|2017-10-11 00:23:16.927502
NCT02147470|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-05-21|||February 2013||2013-02-01|May 2014|2014-05-01||||December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study|Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study|Unknown status|Recruiting|N/A|25|Anticipated|University of Virginia||1|||||||f||||||||||2017-10-11 00:23:17.033187|2017-10-11 00:23:17.033187
NCT02147457|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-05-24|||October 2014||2014-10-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PREMATCH||Prematurity as Predictor of Children's Cardiovascular-renal Health|Prematurity as Predictor of Children's Cardiovascular-renal Health (PREMATCH)|Completed||N/A|180|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||Samples With DNA|"     Urine collection Blood collection   "|||2017-10-11 00:23:17.136099|2017-10-11 00:23:17.136099
NCT02147444|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-21|||November 2012||2012-11-01|May 2014|2014-05-01||||June 2016|Anticipated|2016-06-01|2 Years|Observational [Patient Registry]|EXPAND||Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation|Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Japanese Clinical Practice|Unknown status|Recruiting|N/A|7000|Anticipated|Tohoku University|||1||f||||t||||||||||2017-10-11 00:23:17.2346|2017-10-11 00:23:17.2346
NCT02147431|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-05-22|||May 2014||2014-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes|A Randomised, Single-centre, Double-blind, Cross-over Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counter-regulation Compared to Placebo in Subjects With Type 2 Diabetes|Completed||Phase 1|38|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:23:17.356353|2017-10-11 00:23:17.356353
NCT02147210|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-03-05|||September 2013||2013-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|GARRE||Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1|Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1|Completed||N/A|60|Anticipated|University Hospital, Toulouse|||2||f||||f||||||||||2017-10-11 00:23:20.067233|2017-10-11 00:23:20.067233
NCT02144909|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-06-01|||November 2013||2013-11-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Partners in Care With Semi-Structured Support Group||Completed||N/A|65|Actual|University of Hawaii||2|||f||||f||||||||||2017-10-11 00:23:55.607737|2017-10-11 00:23:55.607737
NCT02147418|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-09-15|||February 2015||2015-02-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Observational|||Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma|An Observational, Single-Institution Pilot/Feasibility Study of Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma|Recruiting||N/A|30|Anticipated|New Mexico Cancer Care Alliance|||3||f||||t||||||Samples Without DNA|"     All oropharyngeal rinse (gargle) specimens will be processed within 24 hours of collection.     Any remaining material after testing will be stored for a period not to exceed 1 year in a     secure location.   "|||2017-10-11 00:23:17.450061|2017-10-11 00:23:17.450061
NCT02147405|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-07-13|||May 20, 2014||2014-05-20|July 12, 2017|2017-07-12|December 1, 2019|Anticipated|2019-12-01|April 1, 2019|Anticipated|2019-04-01||Observational|||PET Imaging and Lymph Node Assessment of IRIS in People With AIDS|PET Imaging and Lymph Node Assessment of IRIS in Persons With AIDS|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:23:17.70346|2017-10-11 00:23:17.70346
NCT02147392|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-06-30|||May 14, 2014||2014-05-14|January 26, 2017|2017-01-26|June 16, 2016|Actual|2016-06-16|June 16, 2016|Actual|2016-06-16||Interventional|||Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People|Assessment of [11C]ER-176 to Image Translocator Protein in Brain and Whole-Body of Healthy Subjects|Completed||Early Phase 1|16|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:23:17.863065|2017-10-11 00:23:17.863065
NCT02147379|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-02-01|||May 2014||2014-05-01|February 2017|2017-02-01|January 12, 2017|Actual|2017-01-12|October 2015|Actual|2015-10-01||Interventional|||Lurasidone and Cognition in Bipolar I Disorder|Changes in Cognitive Functioning in Euthymic Bipolar Patients Treated With Lurasidone Versus Treatment as Usual; A Randomized, Open-Label Study.|Completed||Phase 3|53|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:23:17.996916|2017-10-11 00:23:17.996916
NCT02147366|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-05-24|||May 2012||2012-05-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|MIH||Indian Instrumental Music in Hypertension|Role of Music in Non Pharmacological Management of Hypertension|Completed||N/A|100|Actual|MS Ramaiah Medical College & Hospitals||2|||f||||t||||||||||2017-10-11 00:23:18.127573|2017-10-11 00:23:18.127573
NCT02147340|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-05-23|||June 2014||2014-06-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|ESTIMATE-HF||External Sensors for remoTe MoniToring of Heart Failure Patients With Implantable Defibrillators|External Sensors for remoTe MoniToring of Heart Failure Patients With Implantable Defibrillators: the ESTIMATE-HF Study|Unknown status|Not yet recruiting|N/A|186|Anticipated|IRCCS Policlinico S. Matteo|||1||f||||f||||||||||2017-10-11 00:23:18.391771|2017-10-11 00:23:18.391771
NCT02147327|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-27|||October 2013||2013-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Observational|||Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities||Completed||N/A|120|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital|||1||f||||f||||||||||2017-10-11 00:23:18.513863|2017-10-11 00:23:18.513863
NCT02147314|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-12-16|||June 2014||2014-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Evaluation of the YOFiMeter Glucometer|Evaluation of the YOFiLife Blood Glucose Monitoring System With YOFiMeter Glucometer|Completed||N/A|150|Actual|YofiMeter, LLC|||1||f||||f||||||||||2017-10-11 00:23:18.621942|2017-10-11 00:23:18.621942
NCT02147301|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-07-28|||December 2014||2014-12-01|July 2015|2015-07-01||||December 2019|Anticipated|2019-12-01||Interventional|||TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve|Prospective Phase II Study of Chemoembolization With Doxorubicin-Eluting Microspheres for Liver Transplantation Candidates With Hepatocellular Carcinoma and Marginal Hepatic Reserve|Enrolling by invitation||Phase 2|51|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 00:23:18.707807|2017-10-11 00:23:18.707807
NCT02147288|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-12-06|2016-08-11||January 2012||2012-01-01|December 2016|2016-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Prevention of Seroma Formation and Wound Complications Using NPWT Devices|Prevention of Seroma Formation and Wound Complications Using NPWT Devices|Completed||N/A|46|Actual|Yale University||10|||f||||f||||||||||2017-10-11 00:23:18.837415|2017-10-11 00:23:18.837415
NCT02147275|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-11-10|||May 2014||2014-05-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|MHPCOS||Monitoring Hypertensive Patients's Cerebral Oxygen Saturation|Monitoring Cerebral Oxygen Saturation in Hypertensive Patients Undergoing Major Abdominal Surgery|Completed||N/A|41|Actual|Huazhong University of Science and Technology|||1||f||||t||||||||||2017-10-11 00:23:19.443571|2017-10-11 00:23:19.443571
NCT02147262|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-05-11|||July 2013||2013-07-01|May 2016|2016-05-01||||July 2016|Anticipated|2016-07-01||Interventional|||Laboratory Characteristics in Chronic Atrophic Acrodermatitis|Inflammatory Proteins,Gene Polymorphisms, and Transcriptome Profiles in Patients With Chronic Atrophic Acrodermatitis|Recruiting||N/A|50|Anticipated|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-11 00:23:19.540518|2017-10-11 00:23:19.540518
NCT02147249|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-05-04|||July 2013||2013-07-01|May 2017|2017-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Cytokines and Chemokines in Erythema Migrans|Inflammatory Proteins, Gene Polymorphisms, and Transcriptome Profiles in Patients With Erythema Migrans|Recruiting||N/A|150|Anticipated|University Medical Centre Ljubljana||1|||f||||f||||||||||2017-10-11 00:23:19.679973|2017-10-11 00:23:19.679973
NCT02147236|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-21|||July 2003||2003-07-01|May 2014|2014-05-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|SSD_ASD||Social Skills in Children With Autism Spectrum Disorders|A Randomized Trial of a Structured Social Skills Development Progam for Children With Autism Spectrum Disorders|Completed||N/A|44|Actual|Yale University|||||f||||f||||||||||2017-10-11 00:23:19.807424|2017-10-11 00:23:19.807424
NCT02147223|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-04-15|||November 2013||2013-11-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Sex-dependent Effects of Flavanols on Vascular Status|Sex-dependent Effects of Flavanol Metabolism and Absorption on Vascular Status|Completed||N/A|24|Actual|Heinrich-Heine University, Duesseldorf||4|||f||||f||||||||||2017-10-11 00:23:19.929831|2017-10-11 00:23:19.929831
NCT02147197|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-03-16||2017-03-16|April 2014||2014-04-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||A Study of the Efficacy and Safety of a Single Ulipristal Treatment Course for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas|A Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas|Completed||Phase 3|144|Actual|Watson Pharmaceuticals||3|||f||||||||||||||2017-10-11 00:23:20.172435|2017-10-11 00:23:20.172435
NCT02147171|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-05-21|||November 2011||2011-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Carotenoid Supplementation and Normal Ocular Health|The Bioavailability of Retinal Carotenoids in the Older Human Eye and Their Effects on Photoreceptor Performance|Completed||Phase 2/Phase 3|88|Actual|University of Manchester||2|||f||||t||||||||||2017-10-11 00:23:20.395884|2017-10-11 00:23:20.395884
NCT02147158|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2017-07-03|||January 29, 2014|Actual|2014-01-29|July 2017|2017-07-01|January 3, 2017|Actual|2017-01-03|November 24, 2016|Actual|2016-11-24||Interventional|||A Study of the Safety and Efficacy of Intermittent Ulipristal Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas|A Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ulipristal Acetate for the Intermittent Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas|Completed||Phase 3|432|Actual|Watson Pharmaceuticals||6|||f|||||t|f||||||||2017-10-11 00:23:20.486534|2017-10-11 00:23:20.486534
NCT02147145|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-23|||August 2008||2008-08-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|August 2012|Actual|2012-08-01|3 Years|Observational [Patient Registry]|||Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)|Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)|Completed||N/A|187|Actual|Washington University School of Medicine|||1||f||||||||||||||2017-10-11 00:23:20.68253|2017-10-11 00:23:20.68253
NCT02147132|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-05-01|||March 2016||2016-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients|A Pilot Randomized, Placebo-Controlled, Crossover Study of the Effect of the Nicotine Nasal Spray and Varenicline on Cigarette Smoking Following Methadone Dosing in Methadone-Maintained Patients|Enrolling by invitation||Phase 4|20|Anticipated|University of Cincinnati||4|||f|||||t|f||||||||2017-10-11 00:23:20.748586|2017-10-11 00:23:20.748586
NCT02147119|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-04-06|||March 2014||2014-03-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Radial Artery Function Following Trans-radial Cardiac Catheterisation|Radial Artery Function Following Trans-radial Cardiac Catheterisation|Completed||N/A|5|Actual|University of Edinburgh|||1||f||||f||||||||||2017-10-11 00:23:20.839395|2017-10-11 00:23:20.839395
NCT02147106|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-05-04|||May 2014||2014-05-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|VIDEO-NET||Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study|Use of Video Consultation in Follow-up Care for Patients With a NeuroEndocrine Tumor: a Feasibility Study (VIDEO-NET Study)|Completed||N/A|26|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-11 00:23:20.911734|2017-10-11 00:23:20.911734
NCT02147093|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-06-14|2015-09-22||May 1, 2014|Actual|2014-05-01|June 2017|2017-06-01|August 1, 2014|Actual|2014-08-01|August 1, 2014|Actual|2014-08-01||Interventional||All subjects that were randomized to one of two lens wear serquences.|CLARITI (TM) 1-Day Multifocal Contact Lenses Performance and Acceptance Evaluation||Completed||N/A|41|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 00:23:21.029937|2017-10-11 00:23:21.029937
NCT02147080|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2015-09-03|||March 2011||2011-03-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|UV4me||A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults|A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults|Completed||N/A|1234|Actual|Fox Chase Cancer Center||3|||f||||f||||||||||2017-10-11 00:23:21.283405|2017-10-11 00:23:21.283405
NCT02147067|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-08-03|||September 2014||2014-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|MARINA||Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)|Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis|Recruiting||Phase 4|50|Anticipated|Emory University||2|||f||||f||||||||||2017-10-11 00:23:21.371474|2017-10-11 00:23:21.371474
NCT02147054|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-11-16|||May 2014||2014-05-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning|Pilot Study - Assessing the Impact of Using a Neuromuscular Blocking Agent to Reduce Neuromuscular Junction Damage and Intermediate Syndrome in Organophosphorus (OP) Insecticide Poisoned Patients Requiring Ventilation|Completed||Phase 2/Phase 3|45|Actual|University of Edinburgh||3|||f||||f||||||||No||2017-10-11 00:23:21.466535|2017-10-11 00:23:21.466535
NCT02147041|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-05-21|||May 2012||2012-05-01|May 2014|2014-05-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides|The Effect of Extract of Green Tea on Obese Women Obese Related Hormone Peptides|Unknown status|Enrolling by invitation|Phase 2/Phase 3|92|Anticipated|Taipei City Hospital||2|||f||||t||||||||||2017-10-11 00:23:21.557644|2017-10-11 00:23:21.557644
NCT02147028|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-01-23|||April 2016||2016-04-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|HIPPO||Hippocampal Sparing Whole Brain Radiotherapy vs Conventional Whole Brain Radiotherapy in Patients With Brain Metastases|A Randomized Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1-4 Brain Metastases|Recruiting||Phase 2|84|Anticipated|University College, London||2|||f||||f||||||||||2017-10-11 00:23:21.659983|2017-10-11 00:23:21.659983
NCT02146638|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-05-21|||April 2012||2012-04-01|May 2014|2014-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Post Operative Pain Control: Morphine vs Fentanyl|Post Operative Pain Control: Continuous Infusion of Morphine vs Fentanyl. Clinical Outcomes|Completed||N/A|60|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 00:23:26.472216|2017-10-11 00:23:26.472216
NCT02147015|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-06-06|||May 2014||2014-05-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Personalized Variable Versus Experiential or Fixed Dose Glucocorticoid Therapy in AECOPD|Personalized Variable Versus Experiential or Fixed Dose Corticosteroids Therapy in Hospitalized Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|360|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||3|||f||||f||||||||||2017-10-11 00:23:21.800049|2017-10-11 00:23:21.800049
NCT02147002|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2014-11-04|||October 2012||2012-10-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|Omega-3 acids||Omega-3 Acids and Cardio - Vascular Complications in Patients With Chronic Kidney Disease in Stage 1-3|Omega 3 Acids and Cardio - Vascular Complications in Patients With Chronic Kidney Disease in Stage 1-3|Unknown status|Recruiting|N/A|120|Anticipated|Collegium Medicum w Bydgoszczy||4|||f||||f||||||||||2017-10-11 00:23:23.606395|2017-10-11 00:23:23.606395
NCT02146989|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-03-23|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Upper Extremity Strength in Cerebral Palsy|Upper Extremity Strength in Children and Adolescents With and Without Unilateral Cerebral Palsy|Recruiting||N/A|400|Anticipated|Maastricht University Medical Center|||2||f||||f||||||||||2017-10-11 00:23:23.750071|2017-10-11 00:23:23.750071
NCT02146976|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2016-01-28|||October 2014||2014-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Postoperative Sleep Quality of Patients Anesthesia With Propofol or Sevoflurane Undergoing Thyroidectomy|Postoperative Sleep Quality of Patients Anesthesia With Propofol or Sevoflurane Undergoing Thyroidectomy|Completed||Phase 4|124|Actual|China Medical University, China||2|||f||||t||||||||Undecided||2017-10-11 00:23:23.894875|2017-10-11 00:23:23.894875
NCT02146963|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-01-30|||May 2014||2014-05-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal|Study of the BDNF- Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal|Completed||N/A|180|Actual|Centre Hospitalier Esquirol|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 00:23:24.001542|2017-10-11 00:23:24.001542
NCT02146950|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-22|2017-05-17|||June 2014||2014-06-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Observational|EURAS_LCS12||European Active Surveillance Study of LCS12|European Active Surveillance Study of LCS12|Recruiting||N/A|38000|Anticipated|Center for Epidemiology and Health Research, Germany|||3||f||||t||||||||||2017-10-11 00:23:24.079283|2017-10-11 00:23:24.079283
NCT02146937|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-03-20|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance|A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance|Withdrawn||Phase 2|0|Actual|Sidney Kimmel Comprehensive Cancer Center||1||Due to lack of accrual for this study. PI decided to close the study.|f||||t||||||||||2017-10-11 00:23:24.180153|2017-10-11 00:23:24.180153
NCT02146924|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-03-31|||September 24, 2014|Actual|2014-09-24|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia|Phase I Study to Evaluate Cellular Immunotherapy Using Memory-Enriched T Cells Lentivirally Transduced to Express a CD19-Specific, Hinge-Optimized, CD28-Costimulatory Chimeric Receptor and a Truncated EGFR Following Lymphodepleting Chemotherapy in Adult Patients With High-Risk CD19+ Acute Lymphoblastic Leukemia|Recruiting||Phase 1|48|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 00:23:24.298298|2017-10-11 00:23:24.298298
NCT02146911|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-01-31|||May 1, 2014|Actual|2014-05-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|MATCH||The MATCH (Medication Aids for Tobacco Cessation and Health) Study|Evaluating the Real-world Effectiveness of Varenicline and Bupropion for Long-term Smoking Cessation|Completed||N/A|968|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 00:23:24.394752|2017-10-11 00:23:24.394752
NCT02146898|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-01-03|||September 2013||2013-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Severity Of Hypotension Comparing Three Positions During Spinal Anesthesia For Cesarean Delivery|The Severity Of Hypotension Comparing Three Positions During Spinal Anesthesia For Cesarean Delivery|Completed||N/A|105|Actual|Beth Israel Deaconess Medical Center||3|||f||||f||||||||No||2017-10-11 00:23:24.494388|2017-10-11 00:23:24.494388
NCT02146885|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-02-08|||March 2013||2013-03-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01|3 Months|Observational [Patient Registry]|||The Use of Diffuse Optical Spectroscopy to Characterize in Response to Weight-Loss Intervention|The Use of Diffuse Optical Spectroscopy to Characterize Adipose Tissue Oxygenation and Vascular Reactivity in Response to Weight-Loss Intervention|Enrolling by invitation||N/A|60|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-11 00:23:24.682429|2017-10-11 00:23:24.682429
NCT02146872|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-05-23|||February 2014||2014-02-01|May 2014|2014-05-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|PIHS||Premature Coronary Artery Disease - Clinical and Molecular Genetic Aspects|Premature Coronary Artery Disease - Clinical and Molecular Genetic Aspects|Unknown status|Recruiting|N/A|400|Anticipated|Aarhus University Hospital Skejby|||3||f||||f||||||Samples With DNA|"     2 samples of EDTA blood (4ml glass) and 1 sample of serum (4ml glass) will be retained in a     biobank.   "|||2017-10-11 00:23:24.770234|2017-10-11 00:23:24.770234
NCT02146859|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-03-21|||May 2014||2014-05-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Predictor of Residual Neuromuscular Blockade in Recovery Room After General Anesthesia|Predictor of Residual Neuromuscular Blockade in Recovery Room After General Anesthesia|Recruiting||N/A|222|Anticipated|Mahidol University|||1||f||||f||||||||||2017-10-11 00:23:24.891582|2017-10-11 00:23:24.891582
NCT02146846|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-09-02|||October 2012||2012-10-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|April 2014|Actual|2014-04-01||Observational|||Population Pharmacokinetics of Imatinib in CML Patients in Iran|Population Pharmacokinetics of Imatinib in CML Patients in Iran|Terminated||N/A|170|Actual|Kerman University of Medical Sciences|||1||f||||t||||||||||2017-10-11 00:23:24.980668|2017-10-11 00:23:24.980668
NCT02146833|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-03-23|||May 2014||2014-05-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|March 2016|Actual|2016-03-01||Interventional|SHIP||SHIP (Selinexor in Hormone Insensitive Prostate Cancer)|A Multi-Center, Phase-2, Open-Label Study of Oral Selinexor (KPT-330) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)|Terminated||Phase 2|20|Actual|Karyopharm Therapeutics Inc||3||Due to enrollment challenges. The termination is not a consequence of any safety concern.|f||||f||||||||Yes||2017-10-11 00:23:25.088345|2017-10-11 00:23:25.088345
NCT02146820|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-06-25|||December 2013||2013-12-01|June 2015|2015-06-01||||May 2015|Actual|2015-05-01||Interventional|||Picosecond Laser for Ttreatment of Benign Pigmented Lesions|LASER TREATMENT OF BENIGN PIGMENTED LESIONS WITH A DUAL WAVELENGTH PICOSECOND LASER|Completed||N/A|60|Actual|Syneron Medical||1|||f||||f||||||||||2017-10-11 00:23:25.180781|2017-10-11 00:23:25.180781
NCT02146807|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-06-25|||October 2013||2013-10-01|June 2015|2015-06-01||||May 2015|Actual|2015-05-01||Interventional|||Laser Treatment of Tattoos With Pico Laser|LASER TREATMENT OF TATTOOS WITH A DUAL WAVELENGTH PICOSECOND LASER|Completed||N/A|60|Anticipated|Syneron Medical||1|||f||||f||||||||||2017-10-11 00:23:25.263851|2017-10-11 00:23:25.263851
NCT02146794|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-21|||May 2011||2011-05-01|May 2014|2014-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|REACH||Renal Denervation in Chronic Heart Failure|Renal Denervation in Chronic Heart Failure|Completed||Phase 1|7|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 00:23:25.35018|2017-10-11 00:23:25.35018
NCT02146781|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-03-24|||June 2014||2014-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device|A Safety and Immunogenicity Phase IC Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device|Completed||Phase 1|22|Actual|Immunomic Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 00:23:25.467143|2017-10-11 00:23:25.467143
NCT02146768|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-06-09|||January 2014||2014-01-01|June 2017|2017-06-01||||December 2015|Actual|2015-12-01||Observational|CCTA||Low-dose-contrast Cardiac Computed Tomography|A Novel Low-dose-contrast Cardiac Computed Tomography Method for Pre-Procedural Guidance in Transcatheter Aortic Valve Replacement|Completed||N/A|142|Actual|Baylor Research Institute|||1||f||||||||||||||2017-10-11 00:23:25.558883|2017-10-11 00:23:25.558883
NCT02146755|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-06-09|||August 2013||2013-08-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Improving Echo Measurements in the Diagnosis of Aortic Stenosis|Improving The Quality Of Echocardiographic Imaging Measurements In The Diagnosis Of Severe Aortic Stenosis|Completed||N/A|396|Actual|Baylor Research Institute|||1||f||||f||||||||No||2017-10-11 00:23:25.642412|2017-10-11 00:23:25.642412
NCT02146742|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-05-21|||June 2011||2011-06-01|May 2014|2014-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects|A Double Blind, Randomized and Placebo Controlled Ascending Single Oral Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ASP1707 in Healthy Young Japanese Male Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 00:23:25.730235|2017-10-11 00:23:25.730235
NCT02146729|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-02-01|||July 2014||2014-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Treatment of Thoracolumbar Spine Fractures: Percutaneously Placed Pedicle Screws Versus Open Treatment|Treatment of Thoracolumbar Spine Fractures: Percutaneously Placed Pedicle Screws Versus Open Treatment|Withdrawn||N/A|0|Actual|Allegheny Singer Research Institute||2||Research personnel changes prevented study initiation and enrollment|f||||f||||||||||2017-10-11 00:23:25.830802|2017-10-11 00:23:25.830802
NCT02146716|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-08-22|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|RESC||Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.|Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.|Completed||N/A|43|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 00:23:25.917866|2017-10-11 00:23:25.917866
NCT02146703|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-21|||August 2005||2005-08-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|November 2010|Actual|2010-11-01||Interventional|||Gemcitabine and S-1 for Advanced Biliary Tract Cancer|Phase II Trial of Gemcitabine and S-1 for Patients With Advanced Biliary Tract Cancer|Completed||Phase 2|38|Actual|Hallym University Medical Center||1|||f||||f||||||||||2017-10-11 00:23:26.010026|2017-10-11 00:23:26.010026
NCT02146690|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-09-15|||June 2014||2014-06-01|September 2014|2014-09-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Osteopathic Manipulative Treatment on Reduction of Pain in Complicated Newborns: RCT||Unknown status|Recruiting|N/A|225|Anticipated|European Institute for Evidence Based Osteopathic Medicine||3|||f||||t||||||||||2017-10-11 00:23:26.09843|2017-10-11 00:23:26.09843
NCT02146677|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-02-12|||June 2014||2014-06-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||Effect of Osteopathic Manipulative Treatment on Pain in Preterms||Unknown status|Recruiting|N/A|120|Anticipated|European Institute for Evidence Based Osteopathic Medicine||3|||f||||t||||||||||2017-10-11 00:23:26.182477|2017-10-11 00:23:26.182477
NCT02146664|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-04-18|||November 2015||2015-11-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization|The Role of DLBS1033 in The Management of Acute Non-ST Elevation of Myocardial Infarction (NSTEMI) Without Early Coronary Revascularization|Withdrawn||Phase 2/Phase 3|0|Actual|Dexa Medica Group||2||"The investigational cases were no longer relevant considering the recent implementation of our   current national healthcare system."|f||||t||||||||||2017-10-11 00:23:26.27259|2017-10-11 00:23:26.27259
NCT02146651|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-12-09|||May 2014||2014-05-01|May 2014|2014-05-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes|A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes|Completed||Phase 2|38|Actual|Adocia||4|||f||||f||||||||||2017-10-11 00:23:26.377633|2017-10-11 00:23:26.377633
NCT02146625|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-12-28|||November 2014||2014-11-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|hGH||Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects|A Dose-block Randomized, Single-blind, Placebo-controlled, Single-dosing, Dose-escalation Phase I Clinical Trial to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CJ-40002 After Subcutaneous Injection in Healthy Adult Male Volunteers|Completed||Phase 1|40|Actual|CJ HealthCare Corporation||5|||f||||f||||||||||2017-10-11 00:23:26.695644|2017-10-11 00:23:26.695644
NCT02146612|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-05-21|||December 2012||2012-12-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Amino Acid Usage Patterns in Daily Practice|An Observational Study to Evaluate Amino Acid Usage Patterns in Daily Practice|Completed||N/A|354|Actual|Abbott Nutrition|||1||f||||f||||||||||2017-10-11 00:23:26.797178|2017-10-11 00:23:26.797178
NCT02146599|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-09-10|2015-07-07||May 2014||2014-05-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Patient Perception of Visual Quality and Function||Completed||N/A|301|Actual|Abbott Medical Optics|||1||f||||f||||||||||2017-10-11 00:23:26.932422|2017-10-11 00:23:26.932422
NCT02146586|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-02-01|||May 2014||2014-05-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Clinical Evaluator Outcomes Reliability Study|Cooperative International Neuromuscular Research Group (CINRG) Clinical Evaluator Outcomes Reliability Study|Active, not recruiting||N/A|55|Anticipated|Cooperative International Neuromuscular Research Group|||3||f||||t||||||||||2017-10-11 00:23:27.122917|2017-10-11 00:23:27.122917
NCT02146573|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-01-19|||May 2014|Actual|2014-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CCI||Pediatric Continuity Care Intensivist|Pediatric Continuity Care Intensivist: Role Implementation and Randomized Control Trial|Enrolling by invitation||N/A|333|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 00:23:27.201864|2017-10-11 00:23:27.201864
NCT02146560|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-12-02|||August 2014||2014-08-01|November 2015|2015-11-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Observational|TEAMS||TEAMS (Troponin Elevation After Major Surgery) Study|Clinical Characteristics and Functional Outcomes of Postoperative Myocardial Injury: a Prospective Cohort Study. TEAMS (Troponin Elevation After Major Surgery) Study|Completed||N/A|267|Actual|University Health Network, Toronto|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 00:23:27.346058|2017-10-11 00:23:27.346058
NCT02146547|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-09-04|||February 2015|Actual|2015-02-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|July 2018|Anticipated|2018-07-01||Interventional|EULAST||European Long-acting Antipsychotics in Schizophrenia Trial|European Long-acting Antipsychotics in Schizophrenia Trial|Recruiting||Phase 4|600|Anticipated|UMC Utrecht||4|||f||||t||||||||||2017-10-11 00:23:27.43542|2017-10-11 00:23:27.43542
NCT02146534|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-01-28|||December 2013||2013-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients|Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: a Phase IV, Double-blind, Placebo-controlled Study.|Completed||Phase 4|44|Actual|Clinique Neuro-Outaouais||2|||f||||f||||||||||2017-10-11 00:23:27.71745|2017-10-11 00:23:27.71745
NCT02146521|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-04-25|||November 2017|Anticipated|2017-11-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|LACTINEDAP||Limited Abdominal CT in ED Patients With Abdominal Pain|Prospective Study of Z-axis-limited Abdominal CT Guided by Region of Tenderness in the Diagnosis and Management of Adult Emergency Department Patients With Acute Nontraumatic Abdominal Pain and Tenderness|Not yet recruiting||N/A|1000|Anticipated|Duke University|||1||f||||f||||||||||2017-10-11 00:23:27.822514|2017-10-11 00:23:27.822514
NCT02146508|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-21|||June 2013||2013-06-01|May 2014|2014-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|EXPECT||Endoscopic Prevention of Esophageal Cancer at Tenwek Hospital|Endoscopic Prevention of Esophageal Cancer at Tenwek Hospital (The EXPECT Trial) by Removal or Ablation of Esophageal Squamous Cell Dysplasia|Recruiting||N/A|75|Anticipated|Tenwek Hospital||1|||f||||t||||||||||2017-10-11 00:23:27.9179|2017-10-11 00:23:27.9179
NCT02146495|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-21|||May 2014||2014-05-01|May 2014|2014-05-01||||October 2016|Anticipated|2016-10-01||Interventional|||Neurofeedback for Fibromyalgia|Pain and Sleep Quality Measures Before and After a Course of EEG Neurofeedback in Fibromyalgia Patients|Unknown status|Recruiting|N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center||4|||f||||f||||||||||2017-10-11 00:23:28.020058|2017-10-11 00:23:28.020058
NCT02146482|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-11-17|2015-05-18||April 2013||2013-04-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Access to a Sit-stand Computer Workstation and Back Pain|Evaluating Change in Back Pain From Access to a Sit-stand Workstation|Completed||N/A|57|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 00:23:28.124997|2017-10-11 00:23:28.124997
NCT02146469|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-21|||December 2012||2012-12-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine|Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine|Unknown status|Enrolling by invitation|Phase 4|1200|Anticipated|Shanghai Municipal Center for Disease Control and Prevention||6|||f||||t||||||||||2017-10-11 00:23:28.45145|2017-10-11 00:23:28.45145
NCT02146456|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-06-16|||May 2014||2014-05-01|May 2014|2014-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Rotational Thromboelastography Study in Tranexamic Acid and Colloid Infusion|The Effect of Tranexamic Acid on Blood Coagulation After Colloid Infusion During Surgery: Rotational Thromboelastography Measurement|Completed||N/A|60|Actual|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-11 00:23:28.551058|2017-10-11 00:23:28.551058
NCT02146443|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-09-24|||June 2014||2014-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Validation and Test-retest Study of the Star-shaped Manual Dexterity Test.||Completed||N/A|31|Actual|Herlev Hospital||4|||f||||t||||||||||2017-10-11 00:23:28.629209|2017-10-11 00:23:28.629209
NCT02146430|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-06-30||2017-06-30|October 2014||2014-10-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Treatment of Pain Associated With Fibromyalgia|A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia|Completed||Phase 3|1293|Actual|Daiichi Sankyo, Inc.||4|||f||||t||||||||||2017-10-11 00:23:28.738186|2017-10-11 00:23:28.738186
NCT02146417|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-11-09|||August 2014||2014-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|LEOPARD2||Comparison of Low Versus Normal Pressure Pneumoperitoneum - With Profound Low Versus Normal Pressure Pneumoperitoneum -With Profound Muscle Relaxation- During Laparoscopic Donor Nephrectomy|A Phase IV, Blinded, Randomized Controlled Trial to Compare the Effectiveness of Low Pressure Pneumoperitoneum - With Profound Muscle Relaxation - During Laparoscopic Donor Nephrectomy to Optimize the Quality-of-recovery During the Early Post-operative Phase|Completed||N/A|64|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 00:23:29.286382|2017-10-11 00:23:29.286382
NCT02146404|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-11-09|||August 2014||2014-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Hypoglycaemia on Brain Lactate Accumulation and Cerebral Blood Flow|The Effect of Insulin-induced Hypoglycemia on Brain Lactate Accumulation and Regional Cerebral Blood Flow in Patients With Type 1 Diabetes Mellitus With and Without Hypoglycemia Unawareness and Non-diabetic Controls|Completed||N/A|21|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 00:23:29.416675|2017-10-11 00:23:29.416675
NCT02146391|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-08-07|||June 2014||2014-06-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal|AN OPEN-LABEL, RANDOMIZED, SINGLE-DOSE, TWO-WAY CROSSOVER STUDY TO EVALUATE THE EFFECT OF FOOD UPON THE PHARMACOKINETICS OF ANDROXAL|Completed||Phase 1|12|Actual|Repros Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 00:23:29.521425|2017-10-11 00:23:29.521425
NCT02146378|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-09-14|||January 10, 2014|Actual|2014-01-10|September 2017|2017-09-01|April 29, 2022|Anticipated|2022-04-29|April 29, 2022|Anticipated|2022-04-29||Observational|||Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)|Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)|Active, not recruiting||N/A|200|Anticipated|Pfizer|||1||f|||||t|f||||||||2017-10-11 00:23:29.59161|2017-10-11 00:23:29.59161
NCT02146365|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-04-07|||July 2014||2014-07-01|January 2016|2016-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers|Prospective Study to Assess the Nasopharyngeal Carriage of SPn, Long Term Safety and Immune Persistence in Healthy Kenyan PCV-primed Toddlers Who Received PATH-wSP Compared to Controls|Completed||N/A|300|Actual|PATH|||6||f||||f||||||||||2017-10-11 00:23:29.677239|2017-10-11 00:23:29.677239
NCT02146352|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-09-02|2015-09-02||June 2014||2014-06-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||AXIOS Stent With Electrocautery Enhanced Delivery System|AXIOS Stent With Electrocautery Enhanced Delivery System|Completed||N/A|30|Actual|Xlumena, Inc.||1|||f||||t||||||||||2017-10-11 00:23:29.815843|2017-10-11 00:23:29.815843
NCT02146339|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-01-26|||April 2014||2014-04-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|VALOBAB-D||Impact of Milk Polar Lipids on Lipids Digestion, Absorption and Metabolism|Impact of Milk Polar Lipids Content in a Test Meal on Lipid Composition of Ileostomy Fluid and Consequences on Postprandial Dietary Cholesterol and Fatty Acid Metabolism.|Completed||N/A|4|Actual|Hospices Civils de Lyon||6|||f||||f||||||||||2017-10-11 00:23:30.252728|2017-10-11 00:23:30.252728
NCT02146326|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-04-11|2017-04-11||December 2013||2013-12-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||The Impact of Burnout on Patient-Centered Care: A Comparative Effectiveness Trial in Mental Health|The Impact of Burnout on Patient-Centered Care: A Comparative Effectiveness Trial in Mental Health|Completed||N/A|679|Actual|Indiana University|Absence of treatment as usual condition, high staff turnover, and difficulty linking patients with specific clinicians with whom they had meaningful contact|4|||f||||f||||||||No||2017-10-11 00:23:30.453016|2017-10-11 00:23:30.453016
NCT02146313|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-08-24|||June 22, 2014|Actual|2014-06-22|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer|A Phase I, Open-Label, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of DMUC4064A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer|Active, not recruiting||Phase 1|100|Anticipated|Genentech, Inc.||3|||f|||||t|f||||||||2017-10-11 00:23:33.423137|2017-10-11 00:23:33.423137
NCT02146300|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-22|||March 2014||2014-03-01|May 2014|2014-05-01|June 2016|Anticipated|2016-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Effect of the Nasal Provocation on the Breathing Style|Effect of the Nasal Provocation on the Breathing Style and on the Calibration of Respiratory Effort Belts|Unknown status|Not yet recruiting|N/A|30|Anticipated|Oulu University Hospital||1|||f||||f||||||||||2017-10-11 00:23:33.561755|2017-10-11 00:23:33.561755
NCT02146287|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-03-27|||June 2003||2003-06-01|March 2017|2017-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Preterm Infants: Light Effects on Health and Development|Preterm Infants: Light Effects on Health and Development|Completed||N/A|121|Actual|Duke University||2|||f||||t||||||||||2017-10-11 00:23:33.677361|2017-10-11 00:23:33.677361
NCT02146274|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-06-23|||November 2013||2013-11-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|6 Months|Observational [Patient Registry]|PROSPER||Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research|Observational Study of Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research|Active, not recruiting||N/A|1877|Actual|Duke University|||1||f||||f||||||||||2017-10-11 00:23:33.790877|2017-10-11 00:23:33.790877
NCT02146261|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-10-20|||September 2013||2013-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||A Phase 1 Study of Single-dose Subcutaneous E6011 in Japanese Healthy Adult Male Subjects||Completed||Phase 1|32|Actual|Eisai Inc.||5|||f||||f||||||||||2017-10-11 00:23:33.883654|2017-10-11 00:23:33.883654
NCT02146248|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-02-17|2016-10-28||May 2014||2014-05-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||HSG and Tubal Patency Study|Tubal Patency During the Menstrual Cycle and During Treatment With Hormonal Contraceptives: a Pilot Study in Women|Completed||N/A|11|Actual|Oregon Health and Science University|This is a descriptive pilot study.|1|||f||||f||||||||||2017-10-11 00:23:34.001047|2017-10-11 00:23:34.001047
NCT02146235|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-22|||June 2008||2008-06-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Music Therapy in the Treatment of Chronic Obstructive Pulmonary Disease|The Effects of Music Therapy in the Treatment of Chronic Obstructive Pulmonary Disease|Completed||N/A|68|Actual|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-11 00:23:34.295196|2017-10-11 00:23:34.295196
NCT02146222|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-01-30|||September 2014||2014-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors|Pharmacodynamic Study Using FLT-PET/CT in Patients With Advanced Solid Malignancies Treated With a Sequential Combination of X-82 and Docetaxel|Active, not recruiting||Phase 1|14|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 00:23:34.395322|2017-10-11 00:23:34.395322
NCT02146209|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-07-31|||June 2014||2014-06-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.|Comparative Randomized, Single Dose, Three-Period Crossover Open-Label Study to Determine the Bioequivalence Of Terix Labs Ltd Metronidazole Benzoate (400 mg Metronidazole Per Sachet Oral Granules (Formula A)) Relative to 500 mg From Sanofi-aventis Flagyl 125 mg/5 ml (125 mg Metronidazole Per 5 ml Suspension (Formula B)) and Zentiva Flagyl™ 400 mg Tablets (400 mg Metronidazole Per Film Coated Tablets (Formula C)) , After an Oral Administration to Healthy Adults Under Fasting Conditions|Completed||Phase 1|6|Actual|Verisfield UK Ltd. Greek Branch||3|||f||||||||||||||2017-10-11 00:23:34.504996|2017-10-11 00:23:34.504996
NCT02146196|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2014-10-29|||February 2014||2014-02-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Robotic Assisted Rehabilitation for Heart Failure Patients and Patients After Cardiac Surgery|Roboter-unterstützte Kardiale Rehabilitation Herzinsuffzienter Patientinnen Und Patienten|Unknown status|Recruiting|N/A|12|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 00:23:34.59824|2017-10-11 00:23:34.59824
NCT02146183|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-05-22|||September 2013||2013-09-01|May 2014|2014-05-01|July 2015|Anticipated|2015-07-01|February 2015|Anticipated|2015-02-01||Interventional|steviagly||Steviol Glycoside for Use in Restoring Muscle Glycogen by Increasing the Rate of Glycogen Re-synthesis in Muscles|Compositions Comprising a Steviol Glycoside for Use in Restoring Muscle Glycogen by Increasing the Rate of Glycogen Re-synthesis in Muscles|Unknown status|Recruiting|N/A|22|Anticipated|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 00:23:34.717427|2017-10-11 00:23:34.717427
NCT02146170|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-08-22|||April 24, 2014||2014-04-24|August 14, 2017|2017-08-14|April 30, 2025|Anticipated|2025-04-30|April 30, 2024|Anticipated|2024-04-30||Observational|||Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors|Tissue Procurement and Natural History Study of Patients With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:23:34.816998|2017-10-11 00:23:34.816998
NCT02146157|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-10-12|||February 2013||2013-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes|A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes|Completed||N/A|104|Actual|NewChapter, Inc.||2|||f||||f||||||||||2017-10-11 00:23:34.911335|2017-10-11 00:23:34.911335
NCT02146144|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-05-22|||May 2014||2014-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|Peeling||Prospective, Single-blind Study Assessing the Benefit/Risk Ratio of Internal Limiting Membrane (ILM) Peeling During Epimacular Membrane (EMM) Surgery (Peeling)|Prospective, Randomized, Controlled and Single-blind Study Assessing the Benefit/Risk Ratio of Internal Limiting Membrane (ILM) Peeling During Epimacular Membrane (EMM) Surgery|Recruiting||N/A|152|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 00:23:35.015043|2017-10-11 00:23:35.015043
NCT02146131|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-01-19|||July 2014||2014-07-01|August 2014|2014-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )|Multicenter, Prospective, Randomized Trial of Bronchoscopy With Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) With Fluoroscopy for Biopsy of Pulmonary Lesions|Unknown status|Recruiting|N/A|214|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 00:23:35.126696|2017-10-11 00:23:35.126696
NCT02146118|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-05-20|||April 2014||2014-04-01|May 2014|2014-05-01|March 2016|Anticipated|2016-03-01|September 2015|Anticipated|2015-09-01||Interventional|||A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma|A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR(Epidermal Growth Factor Receptor) Mutant Lung Adenocarcinoma|Unknown status|Recruiting|Phase 2|42|Anticipated|MedicalLogic||1|||f||||t||||||||||2017-10-11 00:23:35.248511|2017-10-11 00:23:35.248511
NCT02146105|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-08-28|2015-02-03||May 2014||2014-05-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Yoga as an Intervention for Women With Knee Osteoarthritis|A Yoga Exercise Intervention Designed for Women With Knee Osteoarthritis|Completed||N/A|45|Actual|McMaster University||1|||f||||t||||||||||2017-10-11 00:23:35.348948|2017-10-11 00:23:35.348948
NCT02146092|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-03-15|||August 2014||2014-08-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung Surgery|Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung Surgery: A Prospective Blinded Randomized Trial|Recruiting||Phase 2|450|Anticipated|McMaster University||2|||f||||f||||||||No||2017-10-11 00:23:35.603841|2017-10-11 00:23:35.603841
NCT02146079|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-10-22|||May 2014||2014-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects|A Single-centre, Parallel-group, Randomised, Double-blind, Placebocontrolled, Multiple-dose Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects|Completed||Phase 1|44|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 00:23:35.745186|2017-10-11 00:23:35.745186
NCT02145884|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-02-09|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Topical Timolol Gel for the Treatment of Infantile Hemangiomas|Topical Timolol Gel for the Treatment of Infantile Hemangiomas|Completed||Phase 2|26|Actual|Rady Children's Hospital, San Diego||1|||f||||f||||||||Yes||2017-10-11 00:23:37.990925|2017-10-11 00:23:37.990925
NCT02146066|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2016-02-25||||||February 2016|2016-02-01||||||||Expanded Access|DCVax-L EAP||Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221|An Expanded Access Protocol for the Treatment of Glioblastoma Multiforme in Patients With Already Manufactured DCVax®-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Who Have Screen-Failed Protocol 020221|Available||N/A|||Northwest Biotherapeutics|||||||||||||||||||2017-10-11 00:23:35.872871|2017-10-11 00:23:35.872871
NCT02146053|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-02-03|||March 2004||2004-03-01|February 2017|2017-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Questionnaire to Assess Gastrointestinal Symptoms of Oral Iron.|Validation of a Simple Questionnaire to Assess Gastrointestinal Symptoms After Oral Ferrous Sulphate Supplementation.|Completed||Early Phase 1|20|Actual|Medical Research Council||2|||f||||f||||||||||2017-10-11 00:23:36.311996|2017-10-11 00:23:36.311996
NCT02146040|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-05-20|||October 2013||2013-10-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|FibStroke||Atrial Fibrillation as a Cause of Stroke and Intracranial Hemorrhage Study (The FibStroke Study)|Incidence and Clinical Predictors of Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation. A Retrospective Multicenter Study|Unknown status|Active, not recruiting|N/A|6000|Anticipated|University of Turku|||1||f||||f||||||||||2017-10-11 00:23:36.445266|2017-10-11 00:23:36.445266
NCT02146027|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-05-03|||January 2015||2015-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Once a Day Use of Lactobacillus Casei Shirota on HIV-infected Patients Infected Patients|Immunological Effects of Continuous, Once a Day Use of Lactobacillus Casei Shirota on HIV-infected Patients on Suppressive Antiretroviral Treatment With Poor CD4+ T-cell Recovery|Completed||Phase 2|48|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:23:36.561451|2017-10-11 00:23:36.561451
NCT02146014|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-05-28|||May 2010||2010-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Transcranial Direct Current Stimulation on Cigarette Addiction|Effects of Transcranial Direct Current Stimulation of the Prefrontal Cortex on Cigarette Smoking|Completed||N/A|30|Actual|University of Brasilia||2|||f||||f||||||||||2017-10-11 00:23:36.718352|2017-10-11 00:23:36.718352
NCT02146001|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-07-09|2016-04-20||January 2014||2014-01-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|RISE||Reducing Sedentary Behavior vs. Increasing Physical Activity in Older Adults|Reducing Sedentary Behavior vs. Increasing Physical Activity in Older Adults|Completed||N/A|38|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 00:23:36.845821|2017-10-11 00:23:36.845821
NCT02145988|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-09-25|||June 2015||2015-06-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease|Improvement of Ankle-Brachial Index by DLBS1033 Treatment in Diabetic Patients With Peripheral Arterial Disease|Recruiting||Phase 2/Phase 3|114|Anticipated|Dexa Medica Group||2|||f||||t||||||||||2017-10-11 00:23:37.123756|2017-10-11 00:23:37.123756
NCT02145975|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2014-05-22|||January 2014||2014-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine|Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine: a Randomized Parallel-group, Double-blind Clinical Trial|Completed||Phase 3|60|Actual|Universidad de Antioquia||2|||f||||f||||||||||2017-10-11 00:23:37.227377|2017-10-11 00:23:37.227377
NCT02145962|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-20|||December 2006||2006-12-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Open Multi-center Safety & Efficacy Study of Low Frequency Magnetic Fields to Treat Unresponsive Diabetic Foot Ulcers.|Application of Extremely Low Frequency Electromagnetic Fields in the Cicatrization of Ulcers With Diabetic Origin as a Method of Preventive and Complementary Treatment|Completed||N/A|27|Actual|Autonomous University of Morelos||2|||f||||t||||||||||2017-10-11 00:23:37.323079|2017-10-11 00:23:37.323079
NCT02145949|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-03-16|||January 2015||2015-01-01|March 2015|2015-03-01|February 2019|Anticipated|2019-02-01|October 2018|Anticipated|2018-10-01||Interventional|||Mechanistic Approach to Preventing Atrophy and Restoring Function in Older Adults|Mechanistic Approach to Preventing Atrophy and Restoring Function in Older Adults|Recruiting||Phase 2|80|Anticipated|University of Oregon||2|||f||||t||||||||||2017-10-11 00:23:37.424811|2017-10-11 00:23:37.424811
NCT02145936|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-08-31|||January 2013||2013-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation|Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation.|Active, not recruiting||N/A|20|Anticipated|Tufts University||3|||f||||f|f|f||||||||2017-10-11 00:23:37.551764|2017-10-11 00:23:37.551764
NCT02145923|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-06-09|||May 2014||2014-05-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis|Effectiveness and Safety of Intravenous Infusion of Bone Marrow Derived Allogeneic Multipotent Mesenchymal Stromal Cells for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis in Hematological Patients With Aplasia After High-dose Chemotherapy.|Unknown status|Enrolling by invitation|Phase 1/Phase 2|16|Anticipated|Burnasyan Federal Medical Biophysical Center||1|||f||||f||||||||||2017-10-11 00:23:37.65424|2017-10-11 00:23:37.65424
NCT02145910|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-19||||||October 2016|2016-10-01||||June 2019|Anticipated|2019-06-01||Interventional|||Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases|Phase I Study of Vemurafenib Combined With Whole Brain Radiation Therapy (WBRT) or Radiosurgery (SRS) for Melanoma Patients With BRAF Mutation Presented With Brain Metastases|Withdrawn||Phase 1|0|Actual|Thomas Jefferson University||2||Study was never opened to accrual. There is no clinical benefit to patients.|f||||t||||||||||2017-10-11 00:23:37.76072|2017-10-11 00:23:37.76072
NCT02145897|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-20|||August 2014||2014-08-01|May 2014|2014-05-01||||August 2015|Anticipated|2015-08-01||Interventional|||To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI|A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intramuscular and Intravenous Administration of Autologous ADMSCS for Treatment of Critical Limb Ischemia (CLI).|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Kasiak Research Pvt. Ltd.||3|||f||||t||||||||||2017-10-11 00:23:37.864992|2017-10-11 00:23:37.864992
NCT02145871|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-09-05|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy|A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy|Recruiting||Phase 3|282|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:23:38.086415|2017-10-11 00:23:38.086415
NCT02145858|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-10-21|||June 2014||2014-06-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01|1 Month|Observational [Patient Registry]|||Prevention of Retained-Blood Outcomes With Active Clearance Technology|Prevention of Retained-Blood Outcomes With Active Clearance Technology. ACT Registry|Unknown status|Recruiting|N/A|500|Anticipated|ClearFlow, Inc.|||1||f||||f||||||||||2017-10-11 00:23:38.203565|2017-10-11 00:23:38.203565
NCT02145845|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-07-19|||April 2014||2014-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 5, 2017|Actual|2017-06-05||Interventional|CLIC||Pilot Safety Study of Injectable SIS for Critical Limb Ischemia|Pilot Safety Study of Injectable Small Intestine Submucosa (SIS) for Critical Limb Ischemia|Active, not recruiting||N/A|13|Actual|Cook Group Incorporated||1|||f||||f||||||||||2017-10-11 00:23:38.309164|2017-10-11 00:23:38.309164
NCT02145832|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-20|||June 2014||2014-06-01|May 2014|2014-05-01|May 2017|Anticipated|2017-05-01|May 2015|Anticipated|2015-05-01||Interventional|TINN||Fluconazole Versus Micafungin in Neonates With Candidiasis|Fluconazole Versus Micafungin in Neonates With Suspected or Culture-proven Candidiasis: a Randomized Pharmacokinetic and Safety Study (TINN Project - Treat Infections iN Neonates)|Unknown status|Not yet recruiting|Phase 2/Phase 3|100|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-11 00:23:38.391814|2017-10-11 00:23:38.391814
NCT02145819|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-05-20|||January 2014||2014-01-01|May 2014|2014-05-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|PLUS||Optimal Planning of a Day 3 Cryopreserved(Frozen)-Thawed Embryo Transfer in a Natural Cycle With hCG Administration or After Spontaneous LH Peak?|Optimal Planning of a Day 3 Cryopreserved(Frozen)-Thawed Embryo Transfer in a Natural Cycle With hCG Administration or After Spontaneous LH Peak?|Unknown status|Recruiting|Phase 4|240|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||||||||||||2017-10-11 00:23:38.492789|2017-10-11 00:23:38.492789
NCT02145806|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2015-02-12|||June 2014||2014-06-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01|1 Week|Observational [Patient Registry]|||Validation of Korean Version of ICIQ-SF||Completed||N/A|134|Actual|The Catholic University of Korea|||1||f||||f||||||||||2017-10-11 00:23:38.58585|2017-10-11 00:23:38.58585
NCT02145793|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2014-05-22|||June 2012||2012-06-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Exploring the Group Visit Model for Pediatric ADHD Management in the Medical Home|Exploring the Group Visit Model for Pediatric ADHD Management in the Medical Home|Completed||N/A|56|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 00:23:38.659085|2017-10-11 00:23:38.659085
NCT02145780|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-08-22|||February 2014|Actual|2014-02-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|Poly-Nut||Polyphenols and Overfeeding|Polyphenols: Protection From Overfeeding-induced Insulin Resistance?|Completed||N/A|42|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 00:23:38.754374|2017-10-11 00:23:38.754374
NCT02145767|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-10-13|||December 2014||2014-12-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial|Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial|Recruiting||Phase 2|850|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||t||||||||||2017-10-11 00:23:38.85584|2017-10-11 00:23:38.85584
NCT02145754|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-06-29|2015-01-14||July 2013||2013-07-01|June 2015|2015-06-01||||December 2014|Actual|2014-12-01||Interventional|||Culture Media for Borrelia Burgdorferi Sensu Lato|Comparison of Two Culture Media for Cultivation of Borrelia Burgdorferi Sensu Lato|Completed||N/A|235|Actual|University Medical Centre Ljubljana||1|||f||||f||||||||||2017-10-11 00:23:38.985914|2017-10-11 00:23:38.985914
NCT02145741|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2017-08-25|||June 11, 2014|Actual|2014-06-11|August 2017|2017-08-01|September 14, 2018|Anticipated|2018-09-14|July 1, 2015|Actual|2015-07-01||Interventional|||Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours|An Open-label Phase I Dose Escalation Trial of Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|21|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:23:39.168778|2017-10-11 00:23:39.168778
NCT02145728|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-10-25|||May 2014||2014-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Cognitive Functional Therapy on Patients With Non-specific Chronic Low Back Pain|The Effect of Cognitive Functional Therapy on Patients With Non-specific Chronic Low Back Pain: a Multi-centre Randomized Trial|Active, not recruiting||N/A|208|Actual|University of Limerick||2|||f||||t||||||||||2017-10-11 00:23:39.249295|2017-10-11 00:23:39.249295
NCT02145715|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-06-25|||January 2013||2013-01-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|July 2015|Anticipated|2015-07-01||Interventional|MUKsix||Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma|A Phase I/IIa Trial of VTD-panobinostat Treatment and Panobinostat Maintenance in Relapsed and Relapsed/Refractory Multiple Myeloma Patients|Unknown status|Active, not recruiting|Phase 1/Phase 2|54|Anticipated|University of Leeds||1|||f||||t||||||||||2017-10-11 00:23:39.369748|2017-10-11 00:23:39.369748
NCT02145702|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2016-10-31|||May 2014||2014-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease|Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease|Recruiting||N/A|15|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 00:23:39.495405|2017-10-11 00:23:39.495405
NCT02145689|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-21|2014-08-12|||August 2014||2014-08-01|August 2014|2014-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity||Withdrawn||Phase 3|0|Actual|Allergan||2||The study was withdrawn prior to enrollment due to corporate decision.|f||||t||||||||||2017-10-11 00:23:39.598407|2017-10-11 00:23:39.598407
NCT02145637|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-05-27|||July 2014||2014-07-01|April 2014|2014-04-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)||Unknown status|Not yet recruiting|Phase 1|60|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 00:23:40.434976|2017-10-11 00:23:40.434976
NCT02145624|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-08-23|||October 2014||2014-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|iMAP2||A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants|A Randomised Controlled Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants|Active, not recruiting||Phase 4|366|Actual|Public Health England||3|||f||||f||||||||||2017-10-11 00:23:40.501777|2017-10-11 00:23:40.501777
NCT02145611|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-08-15|||July 2013||2013-07-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension|12-week Randomized Study to Compare the Effect of Vildagliptin vs. Glibenclamide Associated to Metformin in Endothelial Function in Patients With Type 2 Diabetes and Hypertension|Completed||Phase 4|50|Actual|Hospital de Base||2|||f||||f||||||||Undecided|The statistic analysis is being done.|2017-10-11 00:23:40.770595|2017-10-11 00:23:40.770595
NCT02145598|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-08-21|||August 2013|Actual|2013-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|GERMAIN||Treatment Optimization in Patients With Untreated Multiple Myeloma|Phase II Study of Bortezomib, Melphalan, Prednisone (VMP) Followed by Lenalidomide Maintenance vs. VMP Without Maintenance in Myeloma Patients Not Eligible to High-dose Chemotherapy and Autologous Stem Cell Transplantation|Active, not recruiting||Phase 2/Phase 3|85|Actual|University of Jena||2|||f||||f||||||||||2017-10-11 00:23:40.920006|2017-10-11 00:23:40.920006
NCT02145585|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-12-17|||March 2014||2014-03-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Robotic Pharmacological Anesthesia System for Elective Cardiac Surgery|Completely Automated Robotic Pharmacological Anesthesia System for Patients Undergoing Elective Cardiac Surgery: a Pilot Study|Completed||N/A|20|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-11 00:23:41.08591|2017-10-11 00:23:41.08591
NCT02145572|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-10-24|||May 2014||2014-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Metabolomic Profiling in Adolescents With Obesity and Diabetes|Metabolomic Profiling in Adolescents With Obesity and Diabetes|Active, not recruiting||N/A|90|Actual|University of California, San Diego|||3||f||||f||||||Samples Without DNA|"     Plasma and urine   "|||2017-10-11 00:23:41.192475|2017-10-11 00:23:41.192475
NCT02145559|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-06-26|||April 2014||2014-04-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors|A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|64|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-11 00:23:41.304512|2017-10-11 00:23:41.304512
NCT02145546|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-05-20|||May 2014||2014-05-01|May 2014|2014-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|ADA-PAF||Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation|Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation|Unknown status|Not yet recruiting|Phase 4|600|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||4|||f||||t||||||||||2017-10-11 00:23:41.871707|2017-10-11 00:23:41.871707
NCT02145533|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-22|||January 2010||2010-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|||Matrix Metalloproteinases (MMPs),Neutrophil Gelatinase-associated Lipocalin (NGAL) Tissue and Plasma Levels and Aneurysms|Evaluation of Plasma and Tissue Levels of Metalloproteinases and Neutrophil Gelatinase-associated Lipocalin in Arterial Aneurysms.|Completed||N/A|307|Actual|University of Cantanzaro|||3||f||||t||||||||||2017-10-11 00:23:42.041382|2017-10-11 00:23:42.041382
NCT02145520|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-08-14|||October 2012||2012-10-01|March 2015|2015-03-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis|Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis.|Completed||Phase 2|200|Actual|Hamad Medical Corporation||2|||f||||t||||||||||2017-10-11 00:23:42.168784|2017-10-11 00:23:42.168784
NCT02145494|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-05-20|||June 2013||2013-06-01|May 2014|2014-05-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01||Interventional|SPARC||The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife|Stereotactic Prostate Augmented Radiotherapy With Cyberknife|Recruiting||Phase 2|20|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:23:42.454515|2017-10-11 00:23:42.454515
NCT02145481|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-12-02|||May 2014||2014-05-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|DeQCAD||Decisional Quality for Patients With Coronary Artery Disease|Decisional Quality for Patients With Stable Coronary Artery Disease|Enrolling by invitation||N/A|846|Anticipated|University of California, San Francisco||3|||f||||f||||||||No||2017-10-11 00:23:42.582427|2017-10-11 00:23:42.582427
NCT02145468|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-04-27|2017-04-27|2016-03-17|June 3, 2014|Actual|2014-06-03|March 2017|2017-03-01|December 14, 2015|Actual|2015-12-14|December 14, 2015|Actual|2015-12-14||Interventional|LATITUDE||A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)|A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (PM1116197) LosmApimod To Inhibit p38 MAP Kinase as a TherapeUtic Target and moDify Outcomes After an Acute Coronary syndromE (LATITUDE)-TIMI 60.|Completed||Phase 3|3503|Actual|GlaxoSmithKline||2|||f||||t|t|f||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:23:42.887153|2017-10-11 00:23:42.887153
NCT02145455|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-07-14|||June 2015||2015-06-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|||Unity Total Knee Replacement Using Two Different Surgical Techniques|Unity Total Knee Replacement: Prospective Single-centre Clinical Study|Recruiting||N/A|100|Anticipated|Corin||2|||f||||t||||||||||2017-10-11 00:23:49.222131|2017-10-11 00:23:49.222131
NCT02145442|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-02-04|||June 2014||2014-06-01|June 2014|2014-06-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||Effects of Obex in Overweight and Obese Patients|Effects and Safety of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose|Completed||Phase 2/Phase 3|40|Actual|Catalysis SL||1|||f||||t||||||||||2017-10-11 00:23:49.414076|2017-10-11 00:23:49.414076
NCT02145429|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-05-01|||September 2013||2013-09-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Preventing Depression in Late Life: A Model for Low and Middle Income Countries|Preventing Depression in Late Life: A Model for Low and Middle Income Countries|Active, not recruiting||N/A|120|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:23:49.507906|2017-10-11 00:23:49.507906
NCT02145416|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-07-21|||October 2014||2014-10-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|ART||ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy|Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy|Recruiting||N/A|30|Anticipated|University of Oxford|||1||f||||f||||||||||2017-10-11 00:23:49.61901|2017-10-11 00:23:49.61901
NCT02145403|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-05-03|||September 2014||2014-09-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies|Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and Graft-versus-host Disease in Allogeneic Hematopoietic Cell Transplantation for High-risk Hematologic Malignancies|Recruiting||Phase 1/Phase 2|55|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 00:23:49.706926|2017-10-11 00:23:49.706926
NCT02145377|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-04-13|||July 2014||2014-07-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||PXVX0200 (CVD103-HgR) vs Shanchol in Mali|A Phase 2 Randomized, Double-Blinded Study to Compare in Malian Adults the Immunogenicity, Clinical Acceptability and Excretion Pattern Following the Ingestion of a Single Dose of PXVX0200 (CVD 103-HgR) Live Oral Cholera Vaccine Containing Either 108 Colony Forming Units [Cfu] or 109 Cfu Using Shanchol™ Killed Whole Cell Oral Cholera Vaccine as an Immunological Comparator|Completed||Phase 2|150|Actual|University of Maryland||5|||f||||f||||||||||2017-10-11 00:23:49.955334|2017-10-11 00:23:49.955334
NCT02145364|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-10-19|||May 2014||2014-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Ultherapy® for the Treatment of Acne Scars|Evaluation of the Ulthera® System for Correction of Moderate to Severe Atrophic Acne Scars|Completed||N/A|20|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-11 00:23:50.070281|2017-10-11 00:23:50.070281
NCT02145351|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-08-07|||June 2014||2014-06-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|RAPID-HF||Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure|Rate-Adaptive Atrial Pacing In Diastolic Heart Failure (RAPID-HF)|Recruiting||N/A|30|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:23:50.212204|2017-10-11 00:23:50.212204
NCT02145338|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-03-28|||September 2013|Actual|2013-09-01|March 2017|2017-03-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Interventional|AnTIC||Antibiotic Prophylaxis for Clean Intermittent Catheterisation|Antibiotic Treatment for Intermittent Bladder Catheterisation: A Randomised Controlled Trial of Once Daily Prophylaxis|Completed||Phase 4|404|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||Yes||2017-10-11 00:23:50.325028|2017-10-11 00:23:50.325028
NCT02145325|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-04-14|||April 2014||2014-04-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|TRACT||Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients|A Phase I, Single Center Trial of Adoptive Immunotherapy With T-reg Adoptive Cell Transfer (TRACT) to Prevent Rejection in Living Donor Kidney Transplant Recipients|Active, not recruiting||Phase 1|10|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 00:23:50.42253|2017-10-11 00:23:50.42253
NCT02145312|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-10-30|||October 2016||2016-10-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.||Not yet recruiting||Phase 2|51|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 00:23:50.498022|2017-10-11 00:23:50.498022
NCT02145299|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-09-15|2016-07-11||May 2014||2014-05-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional||Only 8 subjects were recruited and enrolled overall- study was terminated.|The Lumen Study: Comparing Devices for Patients With Symptomatic Femoro-popliteal Chronic Total Occlusion (CTO)|A Prospective, Multicenter, Open Label Randomized Study to Evaluate the Safety, Performance and Intraluminal Crossing of the TruePath™ CTO Device Versus The Crosser System in Patients With Symptomatic Femoro-popliteal Chronic Total Occlusion (CTO)|Terminated||Phase 2|8|Actual|Yale University||2||The study was stopped due to insufficient numbers of subjects to meet study design objectives.|f||||f||||||||||2017-10-11 00:23:50.590051|2017-10-11 00:23:50.590051
NCT02145286|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-10-25|||October 2013||2013-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow|A Phase I/II Single Arm Prospective Single Fraction Real-time Stereotactic Body Radiation Therapy Dose Escalation Trial of Rapid Helical TomoTherapy-based Radiation Therapy for Patients With Painful Osseous Metastatic Disease|Recruiting||Phase 1/Phase 2|47|Anticipated|University of Virginia||1|||f||||t||||||||No||2017-10-11 00:23:51.117803|2017-10-11 00:23:51.117803
NCT02145273|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-04-17|||September 2014||2014-09-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Healthy Moms-Healthy Kids: Reducing Maternal Depression for Better Outcomes in Head Start Children|Healthy Moms-Healthy Kids: Reducing Maternal Depression for Better Outcomes in Head Start Children|Recruiting||N/A|180|Anticipated|University of Southern California||3|||f||||f||||||||||2017-10-11 00:23:51.22211|2017-10-11 00:23:51.22211
NCT02145260|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-01-30|||July 2014||2014-07-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients|Randomized Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients|Recruiting||N/A|200|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 00:23:51.337153|2017-10-11 00:23:51.337153
NCT02145247|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-10-25|||May 2014||2014-05-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)|Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)|Recruiting||N/A|40|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:23:51.437767|2017-10-11 00:23:51.437767
NCT02145234|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-09-05|||June 30, 2014|Actual|2014-06-30|September 2017|2017-09-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29||Interventional|||Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects|A Randomized, Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects|Completed||Phase 1|140|Actual|Hoffmann-La Roche||12|||f||||f||||||||||2017-10-11 00:23:51.546938|2017-10-11 00:23:51.546938
NCT02145221|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-21|||January 2009||2009-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Music Therapy on the Recovery of Patients Undergoing Spine Surgery|The Effects of Music Therapy in the Recovery of Patients Undergoing Spine Surgery|Completed||N/A|60|Actual|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-11 00:23:51.685941|2017-10-11 00:23:51.685941
NCT02145208|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-01-24|||October 2014|Actual|2014-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Assess the Efficacy of Medi-Tate TIND Device|One-arm, Multi-center, International Prospective Study to Assess the Efficacy of Medi-Tate Temporary Implantable Nitinol Device (TINDTM) in Subjects With Benign Prostatic Hypertrophy (BPH).|Active, not recruiting||Phase 3|75|Actual|Medi-Tate Ltd.||1|||f||||f||||||||Undecided||2017-10-11 00:23:51.761916|2017-10-11 00:23:51.761916
NCT02145195|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-03-24|||June 2014||2014-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ODIN Junior||The Effect of Vitamin D Supplements on Vitamin D Status, Cardiometabolic Health and Immune Defense in Danish Children|Food-based Solutions for Optimal Vitamin D Nutrition and Health Through the Life Cycle (ODIN) Junior|Completed||N/A|130|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 00:23:51.867184|2017-10-11 00:23:51.867184
NCT02145182|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-09-12|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)|A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multi-center Study of Eculizumab for the Prevention of Delayed Graft Function After Kidney Transplantation in Adult Subjects at Increased Risk of Delayed Graft Function.|Completed||Phase 2/Phase 3|286|Actual|Alexion Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:23:51.975878|2017-10-11 00:23:51.975878
NCT02145169|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-05-08|||October 2013||2013-10-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study|Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study|Completed||N/A|20|Actual|Albert Einstein Healthcare Network||1|||f||||t||||||||No||2017-10-11 00:23:52.232354|2017-10-11 00:23:52.232354
NCT02145156|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-05-30|2016-06-02||June 2014||2014-06-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|HPV||Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination|Educational Intervention to Minimize Disparities in HPV Vaccination|Completed||N/A|1294|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-10-11 00:23:52.360652|2017-10-11 00:23:52.360652
NCT02145143|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-02-28|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study|Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study|Active, not recruiting||N/A|12|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:23:53.45085|2017-10-11 00:23:53.45085
NCT02145130|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-07-07|||May 2014||2014-05-01|July 2017|2017-07-01|January 2023|Anticipated|2023-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects|A Phase I, Two Armed, Open, Prospective and Multicentre Study to Evaluate the Safety of Autologous Tissue-engineered Dermal Substitutes and Dermo-epidermal Skin Substitutes for the Treatment of Large Deep Partial and Full Thickness Skin Defects in Children and Adults|Recruiting||Phase 1|20|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 00:23:53.545932|2017-10-11 00:23:53.545932
NCT02145117|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-03-14|||September 2013||2013-09-01|March 2017|2017-03-01||||June 2017|Anticipated|2017-06-01||Interventional|Biomarkers PTH||Brain Biomarkers w/Mind-Body Tx in Veterans With Post Traumatic Headache (PTH)|Neuroimaging Biomarkers of Mind-Body Treatment in Veterans With Post Traumatic Headache (PTH)|Active, not recruiting||N/A|20|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 00:23:53.674896|2017-10-11 00:23:53.674896
NCT02145104|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-05-20|||May 2014||2014-05-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension|Comparison of the Efficacy and Safety of Cilnidipine 10mg/Valsartan 160mg Combination Therapy, Cilnidipine 5mg/Valsartan 160mg Combination Therapy and Valsartan 160mg Monotherapy in Hypertensive Patients Inadequately Controlled With Valsartan 160mg Monotherapy: a Multicenter, Randomized, Double Blind Phase III Study|Unknown status|Recruiting|Phase 3|279|Anticipated|IlDong Pharmaceutical Co Ltd||3|||f||||f||||||||||2017-10-11 00:23:53.786471|2017-10-11 00:23:53.786471
NCT02145091|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-04-04|||May 2014||2014-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators|Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators|Recruiting||Phase 1|100|Anticipated|Johns Hopkins University||4|||f||||t||||||||||2017-10-11 00:23:53.900083|2017-10-11 00:23:53.900083
NCT02145078|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-03-29|||June 2014||2014-06-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer|A Pilot Trial of Platinum, Gemcitabine, or Pemetrexed Single- or Multi-Agent Therapy With Serial Tumor Specimen Collection in Patients With Advanced Non-Small-Cell Lung Cancer|Terminated||N/A|4|Actual|Barbara Ann Karmanos Cancer Institute||1||Slow accrual.|f||||t||||||||||2017-10-11 00:23:54.067155|2017-10-11 00:23:54.067155
NCT02145065|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-06-14|||September 2014||2014-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|PAX||First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r)|Prospective, Pivotal, First - in Man Clinical Trial of the Safety and Efficacy of a Novel Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease|Active, not recruiting||N/A|66|Actual|Balton Sp.zo.o.||2|||f||||t||||||||||2017-10-11 00:23:54.200889|2017-10-11 00:23:54.200889
NCT02145052|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-03-27|||July 2008||2008-07-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Optimal Method of Fascial Closure in High Risk Patients Undergoing Laparotomy|Optimal Method of Fascial Closure in High Risk Patients Undergoing Laparotomy: A Prospective Randomized Study|Active, not recruiting||N/A|388|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Yes|Will share de-identified data as needed|2017-10-11 00:23:54.324002|2017-10-11 00:23:54.324002
NCT02145039|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-10-03|||October 2014||2014-10-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases|Reduced Intensity Conditioning (RIC) and Transplantation of HLA-Haploidentical Related Bone Marrow (Haplo-BM) For Patients With Hematologic Diseases|Active, not recruiting||N/A|2|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 00:23:54.436965|2017-10-11 00:23:54.436965
NCT02145026|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-09-25|||August 6, 2014|Actual|2014-08-06|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Interventional|||A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)|A Prospective Open-Label Study of the Effectiveness of Epoetin Beta for Treating Anemic Patients With Low/Intermediate-1-Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 4|120|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:23:54.587476|2017-10-11 00:23:54.587476
NCT02145013|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-02-09|||November 2013||2013-11-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|June 2016|Anticipated|2016-06-01||Observational|||Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma|Assessment and Impact of Portal Hypertension Before and During Liver Resection in Patients With Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|Henri Mondor University Hospital|||2||f||||t||||||||Undecided||2017-10-11 00:23:54.733572|2017-10-11 00:23:54.733572
NCT02145000|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-06-01|||June 2014||2014-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|ROSE||Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger|Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Assess the Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis Among Infants in Niger|Recruiting||Phase 3|7770|Anticipated|Epicentre||2|||f||||t||||||||||2017-10-11 00:23:54.873473|2017-10-11 00:23:54.873473
NCT02144987|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-04-21|||April 2013||2013-04-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|BMSCT||Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy|New Therapeutic Approaches to Treat Asherman's Syndrome and Endometrial Atrophy Based in BM Stem Cells Autologous Transplantation|Completed||Phase 4|16|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||1|||f||||f||||||||||2017-10-11 00:23:55.041419|2017-10-11 00:23:55.041419
NCT02144974|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-05-21|||February 2014||2014-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Reconstruction of the Pelvic Floor After Total Pelvic Exenteration Using the TMG Flap|Reconstruction of the Pelvic Floor and the Vagina After Total Pelvic Exenteration Using the Transverse Musculocutaneous Gracilis Flap|Completed||N/A|12|Actual|Tampere University Hospital|||1||f||||f||||||||||2017-10-11 00:23:55.153268|2017-10-11 00:23:55.153268
NCT02144961|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-03-22|||January 2014||2014-01-01|March 2016|2016-03-01|September 2020|Anticipated|2020-09-01|January 2017|Anticipated|2017-01-01||Observational|SPY||The Effects of Indocyanine Green Angiography (IGA) on Deep Inferior Epigastric Artery Perforator (DIEP) Flap Design and Post-Operative Fat Necrosis|Observational Study to Compare Research-only Breast Ultrasound to Standard of Care Physical Exam for Identifying Tissue Necrosis in Post-mastectomy Patients Undergoing Planned Breast Reconstruction.|Active, not recruiting||N/A|100|Anticipated|University of Washington|||1||f||||f||||||||||2017-10-11 00:23:55.232012|2017-10-11 00:23:55.232012
NCT02144948|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-02-13|||August 2014||2014-08-01|August 2015|2015-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PUNiDIA||Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II|Pilot Study to Investigate the Effect of E-coli-nissle as Probiotic Adjuvant to Antidiabetic Standard Care in Patients With Diabetes Mellitus Type II|Completed||Phase 3|10|Actual|GWT-TUD GmbH||1|||f||||f||||||||||2017-10-11 00:23:55.30566|2017-10-11 00:23:55.30566
NCT02144935|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-09-22|||May 2014||2014-05-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|12 Months|Observational [Patient Registry]|TMCAPTURE||Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study|Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study|Recruiting||N/A|180|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||No||2017-10-11 00:23:55.399976|2017-10-11 00:23:55.399976
NCT02144922|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-10-13|||May 2014||2014-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|EPOCH||Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients|Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk|Completed||Phase 4|85|Actual|Asan Medical Center||2|||f||||f||||||||No||2017-10-11 00:23:55.509305|2017-10-11 00:23:55.509305
NCT02144896|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-09-14|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|April 10, 2015|Actual|2015-04-10|April 10, 2015|Actual|2015-04-10||Interventional|||Effect of Ankle Splinting on Vascular Function in Aging|Ankle Dorsiflexion Splinting Enhances Endothelial Function of Aged Leg Muscles|Completed||N/A|17|Actual|University of Florida||2|||f||||f|f|f||||||||2017-10-11 00:23:55.699351|2017-10-11 00:23:55.699351
NCT02144883|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-19|||September 2000||2000-09-01|May 2014|2014-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Telephone Counseling for Pregnant Smokers|Telephone Counseling for Pregnant Smokers|Completed||Phase 3|1173|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:23:55.78312|2017-10-11 00:23:55.78312
NCT02144870|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-03-14|||November 2013||2013-11-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy of Psychotherapy Treatment of Children With Tics|Randomized Control Trial on the Efficacy of Habit Reversal Treatment Programme in Children and Adolescents - a Comparison With Resource Activation Treatment|Recruiting||N/A|100|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-11 00:23:55.872445|2017-10-11 00:23:55.872445
NCT02144857|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-12-01|||January 2013||2013-01-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis|Effects of Treatment With Biological Agents on Endothelial Glycocalyx,Arterial Elastic Properties, Coronary Flow, Myocardial Deformation and Twisting in Psoriasis. Comparative Study With Patients With CAD or Untreated Hypertension.|Unknown status|Recruiting|Phase 4|120|Anticipated|University of Athens||3|||f||||f||||||||||2017-10-11 00:23:55.980499|2017-10-11 00:23:55.980499
NCT02144844|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2014-05-21|||December 2010||2010-12-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|APD||A Public Health Program to Reduce Risk of Antepartum Depression|A Behavioral Intervention to Reduce Risk of Antepartum Depression|Completed||N/A|146|Actual|East Carolina University||2|||f||||f||||||||||2017-10-11 00:23:56.085322|2017-10-11 00:23:56.085322
NCT02144831|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-12-28|||July 2014||2014-07-01|December 2014|2014-12-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|MENA-TIA||The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack|The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack.10 vs 30 Days of Combination ASA and Clopidogrel Study|Not yet recruiting||Phase 4|2400|Anticipated|University of Alberta||2|||f||||t||||||||||2017-10-11 00:23:56.175289|2017-10-11 00:23:56.175289
NCT02144818|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-19|||January 2014||2014-01-01|April 2014|2014-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian Response|GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian|Unknown status|Recruiting|N/A|60|Anticipated|Sheba Medical Center||3|||f||||f||||||||||2017-10-11 00:23:56.266909|2017-10-11 00:23:56.266909
NCT02144805|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-05-05|||January 2008||2008-01-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Closure of Uterine Incision by Single or Double Layer Technique|Evaluation of Single Versus Double-layer Technique by Closure of Cesarean Uterine Incision. A Randomized Controlled Study|Completed||N/A|77|Actual|Zealand University Hospital||2|||f||||f||||||||||2017-10-11 00:23:56.36456|2017-10-11 00:23:56.36456
NCT02144792|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-05-19|||May 2013||2013-05-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|May 2014|Anticipated|2014-05-01||Interventional|||Development and Clinical Application of [11C]Verapamil-PET|Development and Clinical Application of [11C]Verapamil-PET, a Surrogate Marker on P-glycoprotein Expression|Unknown status|Recruiting|Phase 2|30|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 00:23:56.435928|2017-10-11 00:23:56.435928
NCT02144779|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-11-19|||September 2009||2009-09-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Family Communication and Support in the Pediatric Intensive Care Unit|Improving Family Outcomes With a Communication Intervention in the Pediatric ICU|Completed||N/A|220|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 00:23:56.535533|2017-10-11 00:23:56.535533
NCT02144766|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2014-08-24|||April 2014||2014-04-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block|Prevention of Pro-inflammatory Cytokines-associated Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block|Unknown status|Recruiting|Phase 4|40|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 00:23:56.753273|2017-10-11 00:23:56.753273
NCT02144753|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-04-28|||March 2014||2014-03-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)|Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)|Terminated||Phase 2|120|Actual|Nutrabiotix, LLC||2||"Per DSMB, study fiber had given subjects more adverse events and made their IBS symptoms worse   than the psyllium group."|f||||t||||||||||2017-10-11 00:23:56.852076|2017-10-11 00:23:56.852076
NCT02144740|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-05-22|||October 2013||2013-10-01|May 2014|2014-05-01||||April 2014|Actual|2014-04-01||Interventional|||Effect of NWT-03 on Blood Pressure|A Study of Two Parts to Determine the Effect of NWT-03 on Blood Pressure in Healthy Subjects|Completed||N/A|63|Actual|Newtricious R&D BV||2|||f||||f||||||||||2017-10-11 00:23:56.967795|2017-10-11 00:23:56.967795
NCT02144727|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-04-18|||January 2014||2014-01-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|ADDICT||A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer|A Multicenter Randomized Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer|Recruiting||Phase 3|1880|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 00:23:57.088435|2017-10-11 00:23:57.088435
NCT02144714|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-07-10|||May 2014||2014-05-01|October 2014|2014-10-01||||September 2014|Actual|2014-09-01||Interventional|||Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects|A Randomised, Single-blind, Three-arm, Parallel Group, Single-dose Study to Compare the Pharmacokinetics, Safety, Tolerability and Immunogenicity of Three Formulations of Adalimumab (SB5, EU Sourced Humira® and US Sourced Humira®) in Healthy Subjects|Completed||Phase 1|189|Actual|Samsung Bioepis Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:23:57.529545|2017-10-11 00:23:57.529545
NCT02144688|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2016-03-15|||June 2011||2011-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|COMO||COMO: Cognition Study With HIV+ Patients (CTNPT 015)|CTNPT 015 - Pilot Project to Implement a Step-wise Investigation That Includes Cerebrospinal (CSF) Analysis as a Standard of Care for HIV+ Individuals With Cognitive Symptoms|Terminated||Early Phase 1|19|Actual|McGill University Health Center||1||In 14 participants who had LP, very low level viremia was found in only 1|f||||t||||||||Undecided||2017-10-11 00:23:58.342541|2017-10-11 00:23:58.342541
NCT02144662|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2017-08-24|||March 2014||2014-03-01|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|January 31, 2017|Actual|2017-01-31||Interventional|||Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion|To Investigate Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion|Completed||N/A|50|Anticipated|St. Marianna University School of Medicine||1|||f||||t||||||||||2017-10-11 00:23:58.68596|2017-10-11 00:23:58.68596
NCT02144649|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2016-10-21|||June 2015||2015-06-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery|A Comparison of Tangerine and Red Tomato Juice in Men With Prostate Cancer: A Pilot Study|Active, not recruiting||N/A|45|Actual|Ohio State University Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 00:23:58.816182|2017-10-11 00:23:58.816182
NCT02144636|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2015-02-10|||November 2012||2012-11-01|February 2015|2015-02-01||||October 2014|Actual|2014-10-01||Interventional|||Protein Supplementation and Weight Loss|Effect of Protein Supplementation on Weight Loss and Cardio Metabolic Profile of Overweight/Obese Subjects|Completed||N/A|100|Actual|Diabetes Foundation, India||2|||f||||t||||||||||2017-10-11 00:23:58.971423|2017-10-11 00:23:58.971423
NCT02144623|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-03-01|||January 2015||2015-01-01|September 2016|2016-09-01|February 6, 2017|Actual|2017-02-06|February 2016|Actual|2016-02-01||Interventional|PREVAIL||Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia|Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia|Completed||Early Phase 1|4|Actual|Lund University Hospital||1|||f||||f||||||||||2017-10-11 00:23:59.057898|2017-10-11 00:23:59.057898
NCT02144610|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-20|2017-09-14|||October 2014|Actual|2014-10-01|September 2017|2017-09-01|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|AGILITY||Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia|A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AMG0001 in Subjects With Critical Limb Ischemia|Terminated||Phase 3|46|Actual|AnGes USA, Inc.||2|||f||||t|t|f||||||||2017-10-11 00:23:59.162485|2017-10-11 00:23:59.162485
NCT02144597|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-10-28|||August 2011||2011-08-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|LCD||Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass|The Effect of a 2-week vs. 6-week Low-calorie Diet (LCD) Followed by Roux-en-Y Gastric Bypass (RYGB) on Body Composition and Surgery Outcomes in Obese Humans: a Dietary Intervention and Magnetic Resonance Imaging Study|Completed||N/A|30|Actual|Imperial College London||3|||f||||t||||||||||2017-10-11 00:23:59.424948|2017-10-11 00:23:59.424948
NCT02144584|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-08-06|||January 2014||2014-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Memantine for Enhanced Stroke Recovery|Pilot Study of Memantine for Enhanced Stroke Recovery|Recruiting||Early Phase 1|20|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-11 00:23:59.566807|2017-10-11 00:23:59.566807
NCT02144571|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-05-10|||November 2010||2010-11-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|SISTAS||Sistas Inspiring Sistas Through Activity and Support|SCCDCN-II: Research Project (Breast Cancer)|Completed||N/A|350|Actual|University of South Carolina||2|||f||||f||||||||Yes|Data will be made available upon request using our data request form and with data committee approval. We will allow the data to be shared after publication of our two primary outcome manuscripts.|2017-10-11 00:23:59.763635|2017-10-11 00:23:59.763635
NCT02144558|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-07-05|||April 2014||2014-04-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|FertiSCI||Fertility of Spinal Cord Injured Men|Evolution of Sperm Parameters and Study of Risk Factors of Impairment of Sperm Quality in Spinal Cord Injuries. Longitudinal Prospective Study.|Recruiting||N/A|35|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:23:59.874839|2017-10-11 00:23:59.874839
NCT02144545|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-09-29|||October 2013||2013-10-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Impact of Size of Gastric Sleeve on the Weight Loss. Correlation With Gastric Function and Endocrine-metabolic Changes.|Study of Impact of the Size of Gastric Sleeve o the Weight Loss in Patients Submitted to Bariatric Surgery. Evaluation of Changes in Gastric Motility and Endocrine-metabolic Function.|Unknown status|Recruiting|N/A|100|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||4|||f||||t||||||||||2017-10-11 00:24:00.035952|2017-10-11 00:24:00.035952
NCT02144532|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-08-22|||May 2014||2014-05-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|VETCOSED||Wearing a Compression Garment for Patients With Hypermobility Type of Ehlers-Danlos Syndrome|Effectiveness of Wearing a Compression Garment (SED CICATREX® Model) for Patients With Hypermobility Type of Ehlers-Danlos Syndrome|Recruiting||N/A|40|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:24:00.238402|2017-10-11 00:24:00.238402
NCT02144493|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-19|||May 2014||2014-05-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Risk Factors for Recurrence of Primary Bile Duct Stones|Case-control Study of Risk Factors for Recurrence of Primary Bile Duct Stones|Unknown status|Recruiting|N/A|2|Anticipated|Chuncheon Sacred Heart Hospital|||2||f||||f||||||||||2017-10-11 00:24:00.549979|2017-10-11 00:24:00.549979
NCT02144480|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-11-03|||October 2013||2013-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy of Early Short-term Training on Thrombogenesis in Patients Following Coronary Bypass Surgery|Efficacy of Early Short-term Training on Thrombogenesis in Patients Following Coronary Bypass Surgery|Completed||N/A|64|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||No||2017-10-11 00:24:00.650571|2017-10-11 00:24:00.650571
NCT02144467|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-09-07|||April 2014||2014-04-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||"The Establishment of Large-sample Database of Multiple-MRI/Gene/Cognition"|"The Establishment of Large-sample Database of Multiple-MRI/Gene/Cognition"|Recruiting||N/A|5000|Anticipated|Hangzhou Normal University|||1||f||||t||||||Samples With DNA|"     Peripheral Venous Blood   "|||2017-10-11 00:24:00.781365|2017-10-11 00:24:00.781365
NCT02144454|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-12-02|||June 2014||2014-06-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|DIVAS-2||Impact of Meal Fatty Acids on Postprandial Vascular Reactivity|The Acute Effects of Meals Rich in Saturated, Monounsaturated and n-6 Polyunsaturated Fatty Acids on Vascular Function|Completed||N/A|32|Actual|University of Reading||3|||f||||t||||||||||2017-10-11 00:24:00.848475|2017-10-11 00:24:00.848475
NCT02144441|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-03-13|||June 2014||2014-06-01|May 2014|2014-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pilot Study of Clinician-supported Patient Self-management of Hospital Insulin Therapy|Proof-of-concept Trial of Clinician-supported Patient Self-management of Hospital Insulin Therapy|Withdrawn||N/A|0|Actual|University of Pennsylvania||1||Very few patients met eligibility criteria, none of whom elected to enroll.|f||||t||||||||||2017-10-11 00:24:00.938181|2017-10-11 00:24:00.938181
NCT02144428|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-19|||April 2011||2011-04-01|May 2014|2014-05-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Observational|||Hypoallergenicity To Substitutive Formulas In Children With Cow's Milk Allergy|DETERMINATION OF HYPOALLERGENICITY TO SUBSTITUTIVE FORMULAS IN CHILDREN WITH COW'S MILK ALLERGY|Unknown status|Recruiting|N/A|300|Anticipated|Federico II University|||1||f||||||||||||||2017-10-11 00:24:01.019411|2017-10-11 00:24:01.019411
NCT02144415|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-08-13|||May 2014||2014-05-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users||Completed||Phase 1|80|Actual|Euthymics BioScience, Inc.||5|||f||||f||||||||||2017-10-11 00:24:01.079003|2017-10-11 00:24:01.079003
NCT02144402|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-08-03|||May 2014||2014-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Growth of Healthy Term Infants Fed Formula Containing DHA-B||Completed||N/A|159|Actual|DSM Nutritional Products, Inc.||2|||f||||f||||||||||2017-10-11 00:24:01.166815|2017-10-11 00:24:01.166815
NCT02144389|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-19|||January 2013||2013-01-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Arachidonic Acid Treatment Against Schistosomiasis Infection in Children|Effects of Arachidonic Acid Supplementation on Schistosomiasis Mansoni Infection in Egyptian School Children|Completed||N/A|335|Actual|DSM Nutritional Products, Inc.||3|||f||||f||||||||||2017-10-11 00:24:01.36827|2017-10-11 00:24:01.36827
NCT02144376|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-01-04|||March 2014||2014-03-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|February 2015|Actual|2015-02-01||Interventional|MIMIC||MRI and Microbiota Analysis in Constipation|Validation of Magnetic Resonance Imaging to Characterise Gastrointestinal Physiology, Gut Luminal Content and Its Interaction With Colonic Microbiota in Patients With Chronic Constipation|Completed||N/A|24|Actual|University of Nottingham||2|||f||||f||||||||No||2017-10-11 00:24:01.496534|2017-10-11 00:24:01.496534
NCT02144363|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-03-10|||August 2014||2014-08-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|Edi||Electrical Activity of Diaphragm as a Means to Predict Extubation Success in Preterm Infants|A Prospective Study of Diaphragmatic Electrical Activity in Preterm Infants as a Means to Predict Extubation Success|Completed||N/A|21|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||||2017-10-11 00:24:01.6693|2017-10-11 00:24:01.6693
NCT02144350|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-11-30|||August 2013||2013-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Hyperbaric Oxygen for Ulcerative Colitis|Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial|Terminated||Phase 2/Phase 3|18|Actual|Dartmouth-Hitchcock Medical Center||2||slow recruitment|f||||t||||||||||2017-10-11 00:24:01.757336|2017-10-11 00:24:01.757336
NCT02144337|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2015-07-20|2015-05-27||May 2014||2014-05-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional||All participants were included in the analysis.|Physical Activity in Children With Type 1 Diabetes Study|The Feasibility of a Physical Activity Intervention for Children With Type 1 Diabetes Mellitus: Steps To Active Kids (STAK)|Completed||N/A|13|Actual|University of Nottingham|Analysis and interpretation of secondary outcomes ongoing.|2|||f||||f||||||||||2017-10-11 00:24:01.922518|2017-10-11 00:24:01.922518
NCT02144324|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-04-20|||May 2014||2014-05-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Changes Following the Treatment of Lower Jaw Protrusion Using Two Appliances|A Comparison of the Skeletal and Dento-alveolar Changes After Treatment of Class III Malocclusion With a Modified Tandem Appliance Versus the Face Mask|Completed||N/A|30|Actual|Damascus University||2|||f||||t||||||||||2017-10-11 00:24:02.769131|2017-10-11 00:24:02.769131
NCT02144311|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-06-01|||May 2014|Actual|2014-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics|Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics|Active, not recruiting||N/A|26|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:24:02.912806|2017-10-11 00:24:02.912806
NCT02144298|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-02-12|||March 2014||2014-03-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Observational|||The Sublingual Microcirculatory Alterations in Patients Undergoing Extracorporeal Flow Conditions|The Perioperative Course of Sublingual Microcirculatory Alterations in Patients Undergoing Extracorporeal Flow Conditions: Cold Blood Compared With Cristalloid Cardioplegia|Completed||N/A|20|Actual|Medical Centre Leeuwarden|||2||f||||f||||||||||2017-10-11 00:24:03.018813|2017-10-11 00:24:03.018813
NCT02144285|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-09-03|||June 2014||2014-06-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis|A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Healthy Subjects and Patients With Chronic Kidney Disease Treated With Hemodialysis|Completed||Phase 1|24|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 00:24:03.107067|2017-10-11 00:24:03.107067
NCT02144272|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-07-15|||June 2014||2014-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis|A Phase 1 Single-Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of LY3114062 in Subjects With Inflammatory Arthritis|Completed||Phase 1|41|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 00:24:03.229696|2017-10-11 00:24:03.229696
NCT02144259|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-12-23|2014-12-19||April 2011||2011-04-01|December 2016|2016-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|PPWL||The Impact of Contraception on Postpartum Weight Loss|The Impact of Contraception on Postpartum Weight Loss: a Prospective Study|Completed||N/A|100|Actual|University of Pennsylvania|First, we chose to exclude nursing women. Second, we had a small sample with power to detect one standard deviation difference in weight loss. Third, all data were collected prospectively,thus we did not have each participant’s pre-pregnancy weight.|3|||f||||f||||||||||2017-10-11 00:24:03.347114|2017-10-11 00:24:03.347114
NCT02144246|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-01-06|||May 2014||2014-05-01|January 2016|2016-01-01||||July 2015|Actual|2015-07-01||Interventional|||Contraceptive Hormones and Women With Cystic Fibrosis|Contraceptive Hormones and Women With Cystic Fibrosis: Satisfaction and Effects on Disease|Terminated||Phase 1|5|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:24:03.726109|2017-10-11 00:24:03.726109
NCT02144233|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-02-02|||August 2014||2014-08-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|MAP||Restoring Masticatory Function to Treat Chronic Pain|Restoring Masticatory Function as Treatment for Chronic Pain: a Randomized Placebo-controlled Trial|Recruiting||N/A|110|Anticipated|University of Santiago de Compostela||2|||f||||t||||||||Yes|A closed, certificate, database called OpenClinica allows access to members of the Data and Safety Monitoring Board|2017-10-11 00:24:03.807765|2017-10-11 00:24:03.807765
NCT02144220|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-01-06|2016-11-10||March 2014||2014-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|RACE-PD||Remote Access to Care, Everywhere, for Parkinson Disease|Remote Access to Care, Everywhere: Using Telemedicine to Deliver Patient-centered Care to Patients With Parkinson Disease|Completed||N/A|277|Actual|University of Rochester||1|||f||||f||||||||||2017-10-11 00:24:03.960137|2017-10-11 00:24:03.960137
NCT02144207|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-01-30|||September 2014||2014-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Optimal Laryngoscopic View to Enable GlideScope-assisted Tracheal Intubation||Completed||N/A|160|Actual|Nova Scotia Health Authority||2|||f||||||||||||||2017-10-11 00:24:04.227296|2017-10-11 00:24:04.227296
NCT02144194|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-02-07|||March 2012||2012-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|TNM||Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca|TNM Trial: Upfront Docetaxel [T] and Alternating iv and Oral Vinorelbine [N] Followed, by Either Maintenance Oral Vinorelbine, or Observation for Advanced Breast Cancer|Active, not recruiting||Phase 2|65|Actual|Cancer Research Group - Collaborative Group, Beirut, Lebanon.||2|||f||||f||||||||No||2017-10-11 00:24:04.320019|2017-10-11 00:24:04.320019
NCT02144181|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-10-24|||May 2014||2014-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Interventional|||Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea|Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Signs and Symptoms of Erythematotelangiectatic Rosacea|Completed||N/A|88|Actual|Ulthera, Inc||4|||f||||t||||||||||2017-10-11 00:24:04.452337|2017-10-11 00:24:04.452337
NCT02144168|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-19|||January 2014||2014-01-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|PrebioticFOS||The Effect of Enteral Nutrition Supplemented With Prebiotics on Colonic Microbiota in the Critically Ill Patients|The Effect of Enteral Nutrition Supplemented With Prebiotics on Colonic Microbiota in the Critically Ill Patients: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|40|Anticipated|University of Malaya||2|||f||||f||||||||||2017-10-11 00:24:04.562531|2017-10-11 00:24:04.562531
NCT02144155|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-01-26|||March 2012||2012-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia|Open-label Study of the Long-Term Efficacy of Intranasal Oxytocin in Patients With Schizophrenia|Suspended||N/A|20|Anticipated|University of California, San Diego||2||Break in funding|f||||f||||||||||2017-10-11 00:24:04.719838|2017-10-11 00:24:04.719838
NCT02144142|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-19|||January 2015||2015-01-01|May 2014|2014-05-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients|Phase 2 Study Evaluating the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients|Unknown status|Not yet recruiting|Phase 2|10|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-10-11 00:24:04.823133|2017-10-11 00:24:04.823133
NCT02144129|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-10-24|||March 2014||2014-03-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Effects of WB-EMS in Ulcerative Colitis Patients|Effects of Different Types of Whole Body Electromyostimulation (WB-EMS) Application on Body Composition, Muscle Strength and Quality of Life in Patients With Ulcerative Colitis|Recruiting||Phase 3|60|Anticipated|University of Erlangen-Nürnberg Medical School||3|||f||||f||||||||||2017-10-11 00:24:04.941306|2017-10-11 00:24:04.941306
NCT02144116|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-10-27|||May 2014||2014-05-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Dance-movement Therapy Programme in Fibromyalgia.|Effects of a Dance-movement Therapy Programme in Patients With Fibromyalgia.|Recruiting||N/A|48|Anticipated|Universidad de Granada||2|||f||||t||||||||Undecided||2017-10-11 00:24:05.0539|2017-10-11 00:24:05.0539
NCT02144103|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-07-19|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration|Effectiveness and Safety of Subtenon Administration of Autologous Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration|Enrolling by invitation||Phase 1/Phase 2|16|Anticipated|Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation||1|||f||||f||||||||||2017-10-11 00:24:05.162873|2017-10-11 00:24:05.162873
NCT02144090|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-07-09|||May 2014||2014-05-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|O2||Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study|Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study|Completed||N/A|60|Actual|Laval University||1|||f||||f||||||||||2017-10-11 00:24:05.260042|2017-10-11 00:24:05.260042
NCT02144077|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-09-28|||January 2014||2014-01-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy|A Randomized, Observer Blind, Multinational Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) in Comparison to Metvix® in the Treatment of Non-aggressive Basal Cell Carcinoma (BCC) With Photodynamic Therapy (PDT)|Active, not recruiting||Phase 3|281|Actual|Biofrontera Bioscience GmbH||2|||f||||f||||||||||2017-10-11 00:24:05.372392|2017-10-11 00:24:05.372392
NCT02144064|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-06-29|||June 2012||2012-06-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin|Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin|Completed||Phase 3|200|Actual|Benha University||2|||f||||f||||||||||2017-10-11 00:24:05.464184|2017-10-11 00:24:05.464184
NCT02144051|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-07-13|||May 2014||2014-05-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors|A Phase I, Open-Label, Multicentre Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD5312 in Patients With Advanced Solid Tumours Where the Androgen Receptor Pathway is a Potential Factor|Completed||Phase 1|32|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 00:24:05.540039|2017-10-11 00:24:05.540039
NCT02144038|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-04-28|||July 2014||2014-07-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma|A Phase Ib/II, Multi-center, Study of Oral LGH447 in Combination With Oral BYL719 in Patients With Relapsed and Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|20|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:24:07.593001|2017-10-11 00:24:07.593001
NCT02144025|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-02-25|||May 2014||2014-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|HSCT||Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT|Prevention of Ocular Graft-Versus Host Disease With Topical Cyclosporine in Recipients of Allogeneic Hematopoietic Stem Cell Transplants Performed With a Reduced Intensity Conditioning Regimen|Completed||Phase 2|21|Actual|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||t||||||||No||2017-10-11 00:24:07.715142|2017-10-11 00:24:07.715142
NCT02144012|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-01-18|2017-01-18||June 2014||2014-06-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||The intention-to-treat (ITT) population included all randomized participants grouped according to the treatment assigned at randomization.|A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer|A Randomized, Multicenter, Open-Label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel as First-Line Treatment of Patients With Her2-Positive Progressive Or Recurrent Locally Advanced Or Metastatic Breast Cancer.|Terminated||Phase 3|49|Actual|Hoffmann-La Roche|Due to early termination of the study only limited data from a small subset (49) of the originally planned study population size (561) are available and were too limited to perform originally planned efficacy analyses as specified in the protocol.|2|||f||||||||||||||2017-10-11 00:24:07.836925|2017-10-11 00:24:07.836925
NCT02143999|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-06-26|||June 27, 2014|Actual|2014-06-27|June 2017|2017-06-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Observational|||An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma||Completed||N/A|403|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:24:08.935808|2017-10-11 00:24:08.935808
NCT02143986|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-02-01|||May 2014||2014-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FERRITGLY01||Glycosylated Ferritin in Macrophagic Activation Syndromes|Glycosylated Ferritin in Differential Diagnosis of Still's Disease, Sepsis and Other Macrophagic Activation Syndromes.|Recruiting||N/A|60|Anticipated|Brugmann University Hospital|||4||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 00:24:09.069322|2017-10-11 00:24:09.069322
NCT02143973|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-05-25||2017-05-25|September 2014||2014-09-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus|An Open Label Extension Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus|Completed||Phase 2/Phase 3|184|Actual|Trevi Therapeutics||3|||f||||f||||||||||2017-10-11 00:24:09.165743|2017-10-11 00:24:09.165743
NCT02143960|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-11-28|||September 2013||2013-09-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||VelaShape III Device in Comparison to Cryolipolysis for Circumferential Reduction|Clinical Study to Evaluate the Performance of the VelaShape III Device in Comparison to Cryolipolysis for Reduction in Waist / Love Handles / Flanks.|Completed||N/A|10|Actual|Syneron Medical||2|||f||||f||||||||||2017-10-11 00:24:09.322789|2017-10-11 00:24:09.322789
NCT02143947|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-04-29|2014-05-21||September 2008||2008-09-01|April 2015|2015-04-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|SOLE|The number participants for analysis was based upon the number of participants who attended the first data collection.|Custom Molded Foot Orthoses Effect on Foot Kinematics and Lower Extremity Electromyography During Walking and Running.|The Effect of Two Different Custom Molded Foot Orthoses on Inter-segmental Foot Kinematics and the EMG Activity of Selected Lower Leg Muscles During Walking and Running.|Completed||N/A|80|Actual|Quinnipiac University||2|||f||||f||||||||||2017-10-11 00:24:09.433693|2017-10-11 00:24:09.433693
NCT02143934|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-19|||August 2009||2009-08-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity|Host and Parasites Factors Contributing to Risk of Plasmodium Re-infection and Morbidity in Elementary School Children in Maprik, East Sepik Province|Completed||Phase 4|524|Actual|Papua New Guinea Institute of Medical Research||2|||f||||f||||||||||2017-10-11 00:24:09.948911|2017-10-11 00:24:09.948911
NCT02143921|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2014-05-20|||January 2008||2008-01-01|May 2014|2014-05-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Impact of Training on Diarrhoea Management|Impact of an NGO Training and Support Intervention on Private Sector Provider Diarrhea Management Practices|Completed||N/A|1160|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f||||||||||2017-10-11 00:24:10.074547|2017-10-11 00:24:10.074547
NCT02143908|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2014-05-20|||December 2005||2005-12-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Lysine Trial in Adults With Diarrhoea|Efficacy of Lysine Supplementation in Reducing Attack Rates of Diarrhea in Adults: a Community-based Randomized Trial in Urban Bangladesh|Completed||N/A|440|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f||||||||||2017-10-11 00:24:10.256839|2017-10-11 00:24:10.256839
NCT02143895|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-20|||December 2013||2013-12-01|May 2014|2014-05-01||||December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in Elderly|Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly. A Monocentric, Randomized, Cross-over, Double-blind Clinical Study Versus Placebo|Unknown status|Recruiting|Phase 3|30|Anticipated|Biocodex||3|||f||||f||||||||||2017-10-11 00:24:10.337219|2017-10-11 00:24:10.337219
NCT02143882|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-08-23|||September 2014||2014-09-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|LAIV Immuno||A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).|A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).|Completed||Phase 4|300|Actual|Public Health England||1|||f||||f||||||||||2017-10-11 00:24:10.435878|2017-10-11 00:24:10.435878
NCT02143869|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-04-25|||December 2013||2013-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Observational|ECCOP||Evolution of Corporeal Composition in the PeriOperative Period|Perioperative Body Composition Changes in Patients Undergoing Gastrointestinal or Lung Cancer Surgery|Active, not recruiting||N/A|374|Actual|Hôpital Européen Marseille|||1||f||||f||||||||||2017-10-11 00:24:10.523198|2017-10-11 00:24:10.523198
NCT02143856|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2014-07-21|||May 2014||2014-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food|A Randomized, Open-label, Two-way Cross-over Study to Determine the Oral Bioavailability of GLPG1205 After Single-dose Intake in Healthy Male Subjects as a Solid Formulation, With and Without Food|Completed||Phase 1|12|Actual|Galapagos NV||2|||f||||f||||||||||2017-10-11 00:24:10.610433|2017-10-11 00:24:10.610433
NCT02143843|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-02-15||2017-02-14|May 2014||2014-05-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product|An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002|Completed||Phase 1/Phase 2|75|Actual|ForSight Vision5, Inc.||1|||f||||f||||||||No|No plan to share IPD at this time. Product is investigational and not approved.|2017-10-11 00:24:10.68143|2017-10-11 00:24:10.68143
NCT02143830|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-05-09|||April 2014||2014-04-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Interventional|RAFA||HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy|A Phase II Trial of HSCT for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Risk-Adjusted Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine|Recruiting||Phase 2|70|Anticipated|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-10-11 00:24:10.77431|2017-10-11 00:24:10.77431
NCT02143817|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2015-03-09|||March 2013||2013-03-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition|The Effect of Whole-body Vibration Training Combined With L-cit Supplementation on Cardiovascular, Autonomic Function and Body Composition in Postmenopausal Women|Completed||N/A|60|Actual|Florida State University||4|||f||||f||||||||||2017-10-11 00:24:10.935791|2017-10-11 00:24:10.935791
NCT02143804|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2015-01-27||||||January 2015|2015-01-01||||||||Expanded Access|exBOND||Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer|Phase II Safety and Efficacy Study of CG0070 Oncolytic Vector Regimen in Patients With High Grade Non-Muscle Invasive Bladder Carcinoma Disease (NMIBC) Who Have Failed BCG and Refused Cystectomy|No longer available||N/A|||Cold Genesys, Inc.|||||||||||||||||||2017-10-11 00:24:11.056493|2017-10-11 00:24:11.056493
NCT02143791|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-11-10|||June 2014||2014-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|Prodigy-I||Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of the Trunk and/or Limbs|A Post-market Study Evaluating the Prodigy Neuromodulation System for the Management of Failed Back Surgery Syndrome or Chronic Intractable Pain of the Trunk and/or Limbs.|Completed||N/A|126|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 00:24:11.174925|2017-10-11 00:24:11.174925
NCT02143778|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-08-15|||November 2014|Actual|2014-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Assessing Portal Hypertension With Methacetin Breath Test|Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis|Recruiting||N/A|200|Anticipated|Exalenz Bioscience LTD.||1|||f||||f||||||||||2017-10-11 00:24:11.345359|2017-10-11 00:24:11.345359
NCT02143765|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2016-07-13|||May 2014||2014-05-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Match-101||Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus|An Open, Multi-center, Randomized Study to Evaluate the Efficacy and Safety of Mitiglinide Versus Acarbose in Patients With Type 2 Diabetes Mellitus in China|Completed||Phase 4|248|Actual|Zhongda Hospital||2|||f||||t||||||||Undecided||2017-10-11 00:24:11.544572|2017-10-11 00:24:11.544572
NCT02143752|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-09-30|||February 2012||2012-02-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Meriter Mindfulness Training for Smokers Program and Study|Meriter Mindfulness Training for Smokers Program and Study|Completed||N/A|93|Actual|University of Wisconsin, Madison|||2||f||||f||||||||||2017-10-11 00:24:11.67532|2017-10-11 00:24:11.67532
NCT02143739|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-09-14|||June 7, 2014|Actual|2014-06-07|September 2017|2017-09-01|September 15, 2016|Actual|2016-09-15|September 15, 2016|Actual|2016-09-15|12 Weeks|Observational [Patient Registry]|INITIAL||The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China|The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China.|Completed||N/A|4817|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:24:11.783261|2017-10-11 00:24:11.783261
NCT02143726|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-08-15|||October 2014||2014-10-01|August 2017|2017-08-01||||August 2020|Anticipated|2020-08-01||Interventional|||Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer|Randomized Phase II Study of Sorafenib With or Without Everolimus in Patients With Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer|Recruiting||Phase 2|34|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 00:24:11.951133|2017-10-11 00:24:11.951133
NCT02143713|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-06-02||2017-06-02|May 27, 2014||2014-05-27|June 2017|2017-06-01|May 23, 2017|Actual|2017-05-23|June 22, 2016|Actual|2016-06-22||Interventional|||Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-associated Pain|Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain|Completed||Phase 3|498|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 00:24:12.148813|2017-10-11 00:24:12.148813
NCT02143687|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-01-03|||May 2014||2014-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance|Patients With Pulmonary Hypertension or Interstitial Lung Disease Travelling to Altitude - Effect of Nocturnal Oxygen Therapy on Exercise Performance|Recruiting||Phase 4|50|Anticipated|University of Zurich||4|||f||||f||||||||||2017-10-11 00:24:12.788909|2017-10-11 00:24:12.788909
NCT02143674|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-05-20|||September 2012||2012-09-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|November 2012|Actual|2012-11-01||Interventional|||Muscle Strengthening Exercises and Global Stretching in Elderly|MUSCLE STRENGTHENING EXERCISES AND GLOBAL STRETCHING: IMPACT ON BALANCE, FEAR OF FALLING AND FUNCTIONAL CAPACITY OF ELDERLY|Completed||N/A|59|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 00:24:12.991051|2017-10-11 00:24:12.991051
NCT02143661|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-04-28|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|April 2017|Actual|2017-04-01||Observational|||eValuatIon of The ALl New Environment for crITicallY Ill Patients (VITALITY)|eValuatIon of The ALl New Environment for crITicallY Ill Patients (VITALITY)|Active, not recruiting||N/A|74|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 00:24:13.138446|2017-10-11 00:24:13.138446
NCT02143648|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2017-05-25||2017-05-25|June 2014||2014-06-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus|A Randomized, Double-Blind, Placebo-Controlled, Parallel, 3-Arm Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus|Completed||Phase 2/Phase 3|360|Actual|Trevi Therapeutics||3|||f||||f||||||||||2017-10-11 00:24:13.322656|2017-10-11 00:24:13.322656
NCT02143635|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-09-12|||July 7, 2014|Actual|2014-07-07|September 2017|2017-09-01|July 14, 2018|Anticipated|2018-07-14|June 20, 2017|Actual|2017-06-20||Interventional|||Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt|A Phase I, Open Label, Multicenter, Dose-escalation Study of HDM201 in Adult Patients With Advanced Solid and Hematological Tumors Characterized by Wild-type TP53|Recruiting||Phase 1|225|Anticipated|Novartis||4|||f||||f|t|f||||||||2017-10-11 00:24:13.604125|2017-10-11 00:24:13.604125
NCT02143622|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2016-04-19|||March 2015||2015-03-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients|A Phase Ib/II, Multicenter Study of LJM716 in Combination With Cetuximab in Patients With Platinum-pretreated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma|Withdrawn||Phase 1/Phase 2|0|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:24:13.774875|2017-10-11 00:24:13.774875
NCT02143063|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-06-23|||September 2014||2014-09-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Extending Long-term Outcomes Through an Adaptive Aftercare Intervention|Extending Long-term Outcomes Through an Adaptive Aftercare Intervention|Recruiting||N/A|280|Anticipated|UConn Health||3|||f||||t||||||||||2017-10-11 00:24:20.448863|2017-10-11 00:24:20.448863
NCT02143609|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-01-03|||May 2014||2014-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise Performance|Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen Therapy on Exercise Performance|Recruiting||Phase 4|50|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 00:24:13.874879|2017-10-11 00:24:13.874879
NCT02143596|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2014-05-23|||November 2010||2010-11-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Neuroprotective Therapy and Therapeutic Target in Emergency Department|Neuroprotective Therapy and Therapeutic Target in Emergency Department|Completed||Phase 2|159|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-11 00:24:14.005417|2017-10-11 00:24:14.005417
NCT02143583|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-06-22|2015-03-23||February 2014||2014-02-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational||Safety set : subjects having received at least one injection of AllerT or placebo in AN004T and successfully screened in AN005T|Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment|Long-term Follow-up of a Multicentre, Randomized, Double-blind, Placebo-controlled Trial (AN004T) Assessing the Efficacy and Tolerability of 2 Dosing Regimens of AllerT in Adult Subjects Allergic to Birch Pollen|Completed||Phase 2|196|Actual|Anergis|||3||f||||f||||||||||2017-10-11 00:24:14.159872|2017-10-11 00:24:14.159872
NCT02143570|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2016-04-29|||May 2014||2014-05-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women|Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women|Completed||Phase 3|80|Actual|Universidad de Valparaiso||2|||f||||f||||||||||2017-10-11 00:24:14.619731|2017-10-11 00:24:14.619731
NCT02143557|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-17|||January 2008||2008-01-01|May 2014|2014-05-01||||February 2010|Actual|2010-02-01||Interventional|||Dietary Treatment of Infants With Chylothorax|The Effectiveness of Low Fat Breast Milk for the Treatment of Chylothorax in Infants Following Cardiothoracic Surgery: A Pilot Study|Completed||N/A|16|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 00:24:14.746191|2017-10-11 00:24:14.746191
NCT02143544|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-02-03|||April 2014||2014-04-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|IABCS||Intra-aortic Balloon Counterpulsation in Patients Undergoing Cardiac Surgery|Intra-aortic Balloon Counterpulsation in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial|Recruiting||N/A|180|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:24:14.870602|2017-10-11 00:24:14.870602
NCT02143531|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-21|||September 2008||2008-09-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting|Intravenous Haloperidol Versus Ondansetron for Treatment of Established Nausea and Vomiting in Patients Undergoing Surgery With General Anesthesia: A Randomized Clinical Trial|Completed||Phase 4|120|Actual|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-11 00:24:15.011791|2017-10-11 00:24:15.011791
NCT02143518|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-05-30|||October 2014||2014-10-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Immunogenicity Study of Na-GST-1 With or Without CpG|Phase 1 Study of the Safety and Immunogenicity of Na-GST-1/Alhydrogel, With or Without a CpG ODN Adjuvant, in Healthy Adults|Completed||Phase 1|24|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-10-11 00:24:15.135541|2017-10-11 00:24:15.135541
NCT02143505|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2014-05-17|||March 2014||2014-03-01|May 2014|2014-05-01|February 2019|Anticipated|2019-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Study of Calcium Plus Vitamin D Supplementation in Prevention of Colorectal Adenomas Recurrence|Calcium Plus Vitamin D Supplementation in Prevention of Colorectal Adenomas Recurrence:a Prospective, Randomized, Placebo-controlled, Multicenter Clinical Trial|Recruiting||Phase 2/Phase 3|900|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 00:24:15.239487|2017-10-11 00:24:15.239487
NCT02143492|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-01-23|||August 2013||2013-08-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC|Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC|Completed||N/A|11|Actual|Argos Therapeutics|||1||f||||f||||||Samples With DNA|"     Excess kidney cancer tumor specimen   "|No||2017-10-11 00:24:15.341999|2017-10-11 00:24:15.341999
NCT02143479|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-09-26|||June 18, 2014|Actual|2014-06-18|September 2017|2017-09-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Observational|COBALT||A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year|A Cohort Study in Liver Transplant Patients Converted From a Tacrolimus Twice a Day (Prograf®) to Tacrolimus Once a Day (Advagraf®). French, Multisite, Observational Study|Completed||N/A|398|Actual|Astellas Pharma Inc|||2||f||||f||||||||||2017-10-11 00:24:15.438983|2017-10-11 00:24:15.438983
NCT02143466|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-07-14|||August 5, 2014|Actual|2014-08-05|July 2017|2017-07-01|December 28, 2018|Anticipated|2018-12-28|December 28, 2018|Anticipated|2018-12-28||Interventional|||AZD9291 in Combination With Ascending Doses of Novel Therapeutics|A Multi-arm, Phase Ib, Open-Label, Multicentre Study to Assess the Safety,Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of AZD9291 in Combination With Ascending Doses of Novel Therapeutics in Patients With EGFRm+ Advanced NSCLC Who Have Progressed Following Therapy With an EGFR TKI (TATTON).|Recruiting||Phase 1|298|Anticipated|AstraZeneca||4|||f||||f||||||||||2017-10-11 00:24:15.581519|2017-10-11 00:24:15.581519
NCT02143453|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2014-05-20|||August 2010||2010-08-01|May 2014|2014-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Comparative Study of High Intensity Interval Training and Endurance Training in Juvenile Obesity|Comparative Study of High Intensity Interval Training and Endurance Training in Juvenile Obesity|Completed||N/A|39|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:24:16.015362|2017-10-11 00:24:16.015362
NCT02143440|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2014-05-17|||March 2012||2012-03-01|March 2012|2012-03-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes|The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes|Unknown status|Active, not recruiting|N/A|65|Actual|RenJi Hospital||1|||f||||t||||||||||2017-10-11 00:24:16.092518|2017-10-11 00:24:16.092518
NCT02143427|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-18|2017-03-14|||May 2014||2014-05-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Treatment of Children With Peer Related Aggressive Behavior (ScouT)|Treatment of Children With Peer Related Aggressive Behavior With the Computer Based Treatment Program ScouT - a Randomized Controlled Trial|Recruiting||N/A|140|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-11 00:24:16.17199|2017-10-11 00:24:16.17199
NCT02143414|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-09-04|||January 12, 2015|Actual|2015-01-12|May 2017|2017-05-01||||July 1, 2021|Anticipated|2021-07-01||Interventional|||Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia|A Phase II Study of Blinatumomab and POMP (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) for Patients &gt;/= 65 Years of Age With Newly Diagnosed Philadelphia-Chromosome Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) and of Dasatinib, Prednisone and Blinatumomab for Patients &gt;/= 65 Years of Age With Newly Diagnosed Philadelphia-Chromosome Positive (Ph+) ALL, Relapsed/Refractory Philadelphia-Chromosome Postive (Ph+) ALL, and Philadelphia-Chromosome-Like Signature (Ph-Like) ALL With Known or Presumed Activating Dastinib-Sensitive Mutations or Kinase Fusions (DSMKF)|Recruiting||Phase 2|44|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 00:24:16.307578|2017-10-11 00:24:16.307578
NCT02143401|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-19|2017-10-04|||November 7, 2014|Actual|2014-11-07|September 2017|2017-09-01||||November 1, 2018|Anticipated|2018-11-01||Interventional|||Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors|A Phase I Trial of ABT-263 (Navitoclax), a Bcl-2 Inhibitor, and Sorafenib (Nexavar) in Patients With Relapsed or Refractory Solid Organ Tumors|Recruiting||Phase 1|44|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:24:17.218169|2017-10-11 00:24:17.218169
NCT02143388|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-11-22|||May 2014||2014-05-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Phase II Randomized Control Clinical Trial|Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Phase II Randomized Control Clinical Trial|Recruiting||Phase 2|258|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:24:17.404278|2017-10-11 00:24:17.404278
NCT02143375|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-18|||April 2013||2013-04-01|April 2013|2013-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Gingival Depigmentation by Diode Laser|Efficacy of810 nm Diode Laser on Gingival Pigmentation|Completed||Phase 1|19|Actual|Shahid Beheshti University of Medical Sciences||1|||f||||t||||||||||2017-10-11 00:24:17.55167|2017-10-11 00:24:17.55167
NCT02143362|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-07-03|||June 2014||2014-06-01|July 2014|2014-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Dexmedetomidine Combined With the Closed Loop of Target Controlled Infusion of Propofol for Anesthesia With Intraoperative Wake up|Dexmedetomidine Combined With the Closed Loop of Target Controlled Infusion of Propofol for Anesthesia With Intraoperative Wake Up-single Center,Random,Controlled Trial|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Second Affiliated Hospital of Xi'an Jiaotong University||2|||f||||f||||||||||2017-10-11 00:24:17.648891|2017-10-11 00:24:17.648891
NCT02143349|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2014-05-17|||April 2014||2014-04-01|May 2014|2014-05-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome|Investigation of Appetite Suppressant Properties Associated With Coleus Forskohlii in Overweight and Obese Individuals|Unknown status|Recruiting|Phase 3|50|Anticipated|Olive Lifesciences Pvt Ltd||2|||f||||t||||||||||2017-10-11 00:24:17.74238|2017-10-11 00:24:17.74238
NCT02143336|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-17|2014-05-20|||September 2013||2013-09-01|May 2014|2014-05-01||||September 2015|Anticipated|2015-09-01||Interventional|||Subcuticular Continuous Suture Versus Skin Staples to Reduce Surgical Site Infections in Colorectal Surgery Patients|Prospective and Comparative Pilot Study Between Subcuticular Continuous Suture Versus Skin Staples to Reduce Surgical Site Infections in Colorectal Surgery Patients.|Unknown status|Recruiting|N/A|400|Anticipated|Instituto de Investigación Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-11 00:24:17.839481|2017-10-11 00:24:17.839481
NCT02143323|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2014-12-22|||December 2013||2013-12-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI)|A Clinical Study to Evaluate the Effect of Glutathion S-transferase Polymorphism on Pharmacokinetics/Pharmacodynamics After Multiple Administration of Amoxicillin/Clavulanate and Explore Biomarkers for Drug-induced Liver Injury (DILI)|Completed||Phase 1|32|Actual|Seoul National University Hospital||4|||f||||t||||||||||2017-10-11 00:24:17.952519|2017-10-11 00:24:17.952519
NCT02143310|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-09-06|||May 2014||2014-05-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study to Evaluate the Safety of Electronic Vapor Products for 2 Years|A Multi-Centre Study to Evaluate the Safety of Use of Electronic Vapour Products for Two Years|Active, not recruiting||N/A|420|Anticipated|Fontem Ventures BV||1|||f||||t||||||||||2017-10-11 00:24:18.043807|2017-10-11 00:24:18.043807
NCT02143297|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-20|||July 2013||2013-07-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|March 2014|Actual|2014-03-01||Observational|||Automatic Estimation of the Apnea-hypopnea Index Using Neural Networks to Detect Sleep Apnea|Automatic Estimation of Apnea-hypopnea Index (AHI) Using Neural Networks to Assist in the Diagnosis of Sleep Apnea-hypopnea Syndrome (SAHS)|Unknown status|Active, not recruiting|N/A|322|Actual|Sociedad Española de Neumología y Cirugía Torácica|||2||f||||t||||||||||2017-10-11 00:24:18.120513|2017-10-11 00:24:18.120513
NCT02143284|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-11-02|||May 2014||2014-05-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|FUSE||A Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing a Full Spectrum Optical Technology|Single-Center, Exploratory Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing EndoChoice's Full Spectrum Optical Technology|Completed||N/A|30|Actual|EndoChoice Innovation Center, Ltd.||1|||f||||f||||||||||2017-10-11 00:24:18.206174|2017-10-11 00:24:18.206174
NCT02143271|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-03-03|||May 2014||2014-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis|A Single-dose Phase 1 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis|Completed||Phase 1|13|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-11 00:24:18.292996|2017-10-11 00:24:18.292996
NCT02143258|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-05-11|||March 2014||2014-03-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension|Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension|Recruiting||N/A|33|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-11 00:24:18.373393|2017-10-11 00:24:18.373393
NCT02143245|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-09-26|||June 2014||2014-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections|Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections|Recruiting||N/A|140|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-11 00:24:18.477793|2017-10-11 00:24:18.477793
NCT02143232|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-03-13|||April 2014||2014-04-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|POHM||Post Op Home Monitoring After Joint Replacements|Postop Home Monitoring After Joint Replacements (POHM)|Active, not recruiting||N/A|54|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||Undecided||2017-10-11 00:24:18.558839|2017-10-11 00:24:18.558839
NCT02143219|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-08-30|||June 2014||2014-06-01|August 2016|2016-08-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|PAMELA70||Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer|"Phase-2 Study Evaluating Overall Response Rate (Efficacy) and Autonomy Daily Living Preservation (Tolerance) of FOLFIRINOX  Pharmacogenetic Dose Adjusted, in Elderly Patients (70 yo. or Older) With a Metastatic Pancreatic Adenocarcinoma."|Recruiting||Phase 2|72|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||t||||||||No||2017-10-11 00:24:18.641524|2017-10-11 00:24:18.641524
NCT02143206|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-08-10|||September 2012||2012-09-01|August 2016|2016-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Modifying Exercise for the COPD Patient|Modifying Exercise for the COPD Patient With Arthritic Limitations to Improve Compliance in a Pulmonary Rehab Program|Completed||N/A|33|Actual|TriHealth Inc.|||1||f||||t||||||||No||2017-10-11 00:24:18.818993|2017-10-11 00:24:18.818993
NCT02143193|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-02-14|||August 2011||2011-08-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Skin-to Skin Contact on Newborn Temperature|The Effects of Skin-to-Skin Contact on Newborn Temperature, Initial Bath and Early Breastfeefing|Completed||N/A|325|Actual|TriHealth Inc.||2|||f||||t||||||||||2017-10-11 00:24:18.89771|2017-10-11 00:24:18.89771
NCT02143180|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-16|||May 2014||2014-05-01|May 2014|2014-05-01||||December 2015|Anticipated|2015-12-01||Observational|||Accuracy of RTE for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter Study|Accuracy of Real-time Tissue Elastography for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter Study.|Unknown status|Active, not recruiting|N/A|500|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||1||f||||f||||||||||2017-10-11 00:24:18.974958|2017-10-11 00:24:18.974958
NCT02143167|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-05-16|||May 2014||2014-05-01|May 2014|2014-05-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|RETRAP||Resistance Training and Amino Pyridine in Multiple Sclerosis|RETRAP - A Double Blind, Randomized, Placebo Controlled Study of the Effect of the Combination of Resistance Training and Prolonged Release Fampridine in Patients With Multiple Sclerosis|Unknown status|Recruiting|Phase 4|50|Anticipated|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 00:24:19.168426|2017-10-11 00:24:19.168426
NCT02143154|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-03-06|||October 2014||2014-10-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Observational|||Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis|Intrapartum Vancomycin in GBS-positive Women: The Effect on Vaginal Group B Streptococcus Colony Counts|Recruiting||N/A|50|Anticipated|Women and Infants Hospital of Rhode Island|||1||f||||f||||||None Retained|"     vaginal swabs collected during labor plated for GGBS bacteria and then discarded   "|Undecided||2017-10-11 00:24:19.314003|2017-10-11 00:24:19.314003
NCT02143141|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-09-22|2017-07-20||November 2011||2011-11-01|September 2017|2017-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Low Pain Prediction in Cesarean Section Patients|Eliminating Long Acting Spinal Narcotic Use and Its Associated Side Effects for Those Who do Not Need it After Cesarean Delivery|Terminated||Phase 4|13|Actual|Wake Forest University Health Sciences|Early termination leading to small number of subjects analyzed. Extreme difficulty in recruiting participants to participate in the study.|2||feasibility of population needed to complete study|f||||t|t|f||||||||2017-10-11 00:24:19.437555|2017-10-11 00:24:19.437555
NCT02143128|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-12-18|||January 2016||2016-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|ESScore||Efficacy Side-effect Score (ESS): Development and Evaluation of a New Tool for Patients After Surgery|Safety and Quality for Inpatients After Surgery at the Ward. Development and Evaluation of a New Tool: Efficacy Side-effect Score (ESS)|Not yet recruiting||N/A|600|Anticipated|Vestre VikenHF Kongsberg Sykehus|||4||f||||t||||||||||2017-10-11 00:24:19.889588|2017-10-11 00:24:19.889588
NCT02143115|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-11-29|||August 2011||2011-08-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Comparative Effectiveness of CTC & OC|Comparative Effectiveness of Virtual and Optical Colonoscopy for Colorectal (CRC) Surveillance|Completed||N/A|244|Actual|Fox Chase Cancer Center|||1||f||||t||||||||No||2017-10-11 00:24:19.987534|2017-10-11 00:24:19.987534
NCT02143089|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-16|||August 2013||2013-08-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|August 2014|Anticipated|2014-08-01||Interventional|CDSECD||Catheterization During Second Elective Caesarean Delivery|Evaluation OF Use Versus Non Use of Urinary Catheterization During Second Elective Caesarean Delivery|Unknown status|Recruiting|N/A|220|Anticipated|Ain Shams University||2|||f||||f||||||||||2017-10-11 00:24:20.190992|2017-10-11 00:24:20.190992
NCT02143076|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-05-26|||May 2014||2014-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Medication Adherence in Youth With Sickle Cell Disease (SCD)|Use of WISE Device Technology to Measure Medication Adherence in Youth With Sickle Cell Disease (SCD): A Pilot Study|Completed||N/A|36|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 00:24:20.306764|2017-10-11 00:24:20.306764
NCT02143050|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-11-21|||September 2014||2014-09-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients|A Phase I/II Trial of Dabrafenib, Trametinib and Metformin Administered to Unresectable Stage IIIC and Stage IV BRAF V600E + Melanoma Patients|Recruiting||Phase 1/Phase 2|53|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-10-11 00:24:20.593323|2017-10-11 00:24:20.593323
NCT02143037|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-06-23|||December 2013||2013-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CM Treatment for Alcohol Dependence Using New Technology|CM Treatment for Alcohol Dependence Using New Technology|Active, not recruiting||N/A|114|Anticipated|UConn Health||2|||f||||t||||||||||2017-10-11 00:24:20.737017|2017-10-11 00:24:20.737017
NCT02143024|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-04-03|||November 1, 2015|Actual|2015-11-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||A Family-based Primary Care Intervention to Enhance Older Men's Depression Care|A Family-based Primary Care Intervention to Enhance Older Men's Depression Care|Completed||N/A|23|Actual|University of California, Davis||2|||f||||f||||||||No||2017-10-11 00:24:20.842301|2017-10-11 00:24:20.842301
NCT02143011|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-07-13|||April 2014|Actual|2014-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SSS||Stress and Sugar Synergy|Synergistic Effects of Stress and Sugar Feeding on Metabolism|Active, not recruiting||N/A|23|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-11 00:24:20.956453|2017-10-11 00:24:20.956453
NCT02142998|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-04-25|||October 2014||2014-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|GERD||A Prospective Blinded Randomized Study Comparing Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-y Gastric Bypass and Their Effect on Gastro-Esophageal Reflux Disease Using 24 Horus pH Monitoring|A Prospective Blinded Randomized Study Comparing Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-y Gastric Bypass and Their Effect on Gastro-Esophageal Reflux Disease Using 24 Horus pH Monitoring|Suspended||N/A|100|Anticipated|McMaster University||2||On hold due to poor enrollment and high drop-out rate.|f||||f||||||||||2017-10-11 00:24:21.05929|2017-10-11 00:24:21.05929
NCT02142985|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-19|||April 2014||2014-04-01|May 2014|2014-05-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Interventional|VOS-HI||ScvO2 Based Vascular Filling Test in Patients With Hemodynamic Instability|ScvO2 and Cardiac Output Variation After a Vascular Filling Test in Patients With Hemodynamic Instability|Unknown status|Recruiting|Phase 2|60|Anticipated|University of Monastir||1|||f||||t||||||||||2017-10-11 00:24:21.16489|2017-10-11 00:24:21.16489
NCT02142972|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-05-16|||October 2011||2011-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Observational|||Low Back Pain and Depression: Cohort Study|Low Back Pain Disability, Intensity and Widespread Pain and Relationship to Postpartum Depression|Completed||N/A|236|Actual|Universidad Rey Juan Carlos|||1||f||||f||||||||||2017-10-11 00:24:21.266111|2017-10-11 00:24:21.266111
NCT02142959|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-01-27||2015-06-23|June 2014||2014-06-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE|A Randomized, Double-blind, Vehicle-controlled, Parallel-group Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of RTA 408 Lotion in the Treatment of Patients at Risk for Radiation Dermatitis|Completed||Phase 2|187|Actual|Reata Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 00:24:21.357386|2017-10-11 00:24:21.357386
NCT02142946|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-05-17|||April 2014||2014-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|MS-Gait||Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical Study|Quantified Balance Measures During Stance and Gait: Clinical Relevance for Multiple Sclerosis Patients in Comparison to Patients With Inner Ear Balance Problems. A Longitudinal Clinical Study.|Recruiting||N/A|300|Anticipated|University Hospital, Basel, Switzerland|||10||f||||f||||||||||2017-10-11 00:24:21.536822|2017-10-11 00:24:21.536822
NCT02142933|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-12-12|||November 2014||2014-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Simplified GBS Screening and Prevalence of ESBL in Pregnant Women|1) Accuracy of the Vagino-perineal Versus the Standard Dual Swab for Detection of Group B Streptococcus in Pregnancy 2) Prevalence and Risk Factors of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in Pregnancy|Recruiting||N/A|480|Anticipated|University Hospital, Basel, Switzerland||1|||f||||||||||||||2017-10-11 00:24:21.630315|2017-10-11 00:24:21.630315
NCT02142920|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-09-02|||July 2014||2014-07-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Investigation Of The Metabolism, And Excretion Of [14c]-PF-05212384 In Healthy Male Volunteers|A Phase One, Open-Label Single-Radiolabeled Dose Study To Investigate The Metabolism, And Excretion Of [14c]-PF-05212384 In Healthy Male Volunteers|Completed||Phase 1|6|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:24:21.74135|2017-10-11 00:24:21.74135
NCT02142907|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-02-09|||January 2013||2013-01-01|February 2015|2015-02-01|January 2020|Anticipated|2020-01-01|January 2016|Anticipated|2016-01-01|5 Years|Observational [Patient Registry]|||Evaluation of Two Boost Radiation Schedules in Post Lumpectomy Early Stage Carcinoma Breast|Evaluation of Two Boost Radiation Schedules in Post Lumpectomy Early Stage Carcinoma Breast|Recruiting||N/A|100|Anticipated|Postgraduate Institute of Medical Education and Research|||1||f||||t||||||||||2017-10-11 00:24:21.828824|2017-10-11 00:24:21.828824
NCT02142894|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-04-03|||May 2014||2014-05-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of the QuantiFERON-TB Test.||Recruiting||N/A|60|Anticipated|QIAGEN Gaithersburg, Inc|||1||f||||f||||||||||2017-10-11 00:24:21.914929|2017-10-11 00:24:21.914929
NCT02142881|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-06-15|||June 2014||2014-06-01|June 2016|2016-06-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of Masked Hypertension|Treatment of Masked Hypertension|Recruiting||Phase 4|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:24:22.006088|2017-10-11 00:24:22.006088
NCT02142868|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-01-17||||||January 2017|2017-01-01||||||||Expanded Access|||Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate|An Expanded Access Study Of Palbociclib In Combination With Letrozole As Treatment Of Post-menopausal Women With Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate|No longer available||N/A|||Pfizer|||||||||||||||||||2017-10-11 00:24:22.100822|2017-10-11 00:24:22.100822
NCT02142855|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-01-04|||May 2014||2014-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training|Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training: a Novel Temporospatial Approach|Recruiting||N/A|60|Anticipated|University of Nottingham||6|||f||||f||||||||||2017-10-11 00:24:22.311517|2017-10-11 00:24:22.311517
NCT02142842|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-01-20|||April 2013||2013-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Autologous Adipose Stem Cells and Platelet Rich Plasma Therapy for Patients With Knee Osteoarthritis|Phase I/II Study of Transplantation of Autologous Adipose Stem Cells and Activated Platelet Rich Plasma in Knee Osteoarthritis Treatment|Completed||Phase 1/Phase 2|30|Actual|University of Science Ho Chi Minh City||1|||f||||t||||||||||2017-10-11 00:24:22.409268|2017-10-11 00:24:22.409268
NCT02142816|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-15|||January 2013||2013-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|PVIvDoppler||Fluid Requirement During Surgery PVI v Doppler|Non-invasive Assessment of Fluid Requirement During Surgery: a Comparison of Oesophageal Doppler and Pleth Variability Index|Completed||N/A|38|Actual|York Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:24:22.580756|2017-10-11 00:24:22.580756
NCT02142803|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-09-12|||May 20, 2014|Actual|2014-05-20|September 2017|2017-09-01||||October 31, 2017|Anticipated|2017-10-31||Interventional|||TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors|A Phase 1 Study of MLN0128 and Bevacizumab in Patients With Recurrent Glioblastoma and Other Solid Tumors|Recruiting||Phase 1|23|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:24:22.657154|2017-10-11 00:24:22.657154
NCT02142790|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-07-20|||May 2014||2014-05-01|July 2014|2014-07-01||||June 2016|Anticipated|2016-06-01||Interventional|||Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer||Unknown status|Recruiting|Phase 4|120|Anticipated|Nanjing Luye Sike Pharmaceutical Co.,Ltd.||2|||f||||||||||||||2017-10-11 00:24:22.800308|2017-10-11 00:24:22.800308
NCT02142777|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-08-12|||July 2014||2014-07-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SEAD||S-Equol in Alzheimer's Disease (SEAD) Trial|S-Equol in Alzheimer's Disease (SEAD) Trial|Completed||Phase 1|15|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 00:24:24.624402|2017-10-11 00:24:24.624402
NCT02142764|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-12-06|||November 2014||2014-11-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|IMMUNOSEP||Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients|Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients (MS).|Completed||N/A|30|Anticipated|University Hospital, Bordeaux||3|||f||||f||||||||||2017-10-11 00:24:24.719759|2017-10-11 00:24:24.719759
NCT02142751|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-12-15|||July 2014||2014-07-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|FOREST||Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli|Phase 3, Randomized, Controlled Multicentric, Open-label Clinical Trial to Prove Non-Inferiority of Fosfomycin vs Meropenem or Ceftriaxone in the Treatment of Bacteriemic Urinary Infection Due to Multidrug Resistance in E.Coli|Recruiting||Phase 3|198|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||3|||f||||f||||||||No||2017-10-11 00:24:24.813144|2017-10-11 00:24:24.813144
NCT02142738|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-06-08|2017-04-14||August 25, 2014|Actual|2014-08-25|May 2017|2017-05-01|May 12, 2018|Anticipated|2018-05-12|May 9, 2016|Actual|2016-05-09||Interventional|||Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)|A Randomized Open-Label Phase III Trial of MK-3475 Versus Platinum Based Chemotherapy in 1L Subjects With PD-L1 Strong Metastatic Non-Small Cell Lung Cancer|Active, not recruiting||Phase 3|305|Actual|Merck Sharp & Dohme Corp.||6|||f||||t||||||||Undecided||2017-10-11 00:24:25.036807|2017-10-11 00:24:25.036807
NCT02142725|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-02-07|||July 21, 2014|Actual|2014-07-21|February 2017|2017-02-01|December 16, 2016|Actual|2016-12-16|November 11, 2016|Actual|2016-11-11||Interventional|PROTECT-1||Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis|Randomized, Double-blind, Double-dummy, Placebo-controlled, Phase III Clinical Trial on the Efficacy and Safety of a 12-weeks add-on Treatment With LT 02 vs. Placebo in Patients With Ulcerative Colitis Refractory to Standard Treatment With Mesalamine|Terminated||Phase 3|468|Actual|Dr. Falk Pharma GmbH||3||IDMC recommendation|f||||t||||||||||2017-10-11 00:24:26.416988|2017-10-11 00:24:26.416988
NCT02142712|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-11-10|2015-09-23||December 2014||2014-12-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Histamine Glutamate Antagonism in Stroke|Glutaminergic and Histaminergic Pathway Modulation in Acute Ischemic Stroke as an Effective Neuroprotection Strategy.|Completed||Phase 2|3|Actual|University of Florida||4|||f||||f||||||||||2017-10-11 00:24:26.519187|2017-10-11 00:24:26.519187
NCT02142699|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-05-15|||July 2014||2014-07-01|May 2014|2014-05-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|HACS||Heme Arginate in Cardiac Surgery Patients|Phase II Study of Heme Arginate in Patients Planned for Cardiac Surgery|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-10-11 00:24:26.925269|2017-10-11 00:24:26.925269
NCT02142686|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-01-26|||May 2014||2014-05-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Comparison Between Different Filling Pressures in Diagnostic Outpatient Hysteroscopy|Comparison Between Different Filling Pressures in Diagnostic Outpatient Hysteroscopy: A Double Blinded Randomised Controlled Trial.|Completed||N/A|240|Actual|Cairo University||3|||f||||t||||||||||2017-10-11 00:24:27.017945|2017-10-11 00:24:27.017945
NCT02142153|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-08-10|2015-04-16||August 2014||2014-08-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Healthy volunteers|F901318 Single Ascending Dose Study in Healthy Male Volunteers|F901318 - A Phase I, Double-Blind, Placebo Controlled, Single Ascending Intravenous Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male Subjects|Completed||Phase 1|40|Actual|F2G Ltd.||10|||f||||f||||||||||2017-10-11 00:24:34.697453|2017-10-11 00:24:34.697453
NCT02142673|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-08-02|||May 2014||2014-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Impact of Different Filling Pressures in Operative Outpatient Hysteroscopy on the Procedure Success Rates and Associated Pain.|The Impact of Different Filling Pressures in Operative Outpatient Hysteroscopy on the Procedure Success Rates and Associated Pain. A Randomized Double Blind Controlled Trial|Completed||N/A|240|Actual|Cairo University||3|||f||||t||||||||||2017-10-11 00:24:27.121194|2017-10-11 00:24:27.121194
NCT02142660|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2014-12-30|||January 2012||2012-01-01|April 2014|2014-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|Sprayshield||Sprayshield as Adhesion Barrier System for Obese Patients|Prospective Study Evaluating the Usefulness of Sprayshield as Adhesion Barrier System in Two Steps Laparoscopic Bariatric Surgery for Obese Patients|Completed||N/A|20|Actual|University Hospital, Montpellier|||1||f||||f||||||||||2017-10-11 00:24:27.210892|2017-10-11 00:24:27.210892
NCT02142647|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-05-22|||March 2014||2014-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Protein From Complementary Foods on Infant Growth, Body Composition and Gut Health|Effects of Dietary Protein From Meat vs. Dairy on Infant Growth, Body Composition and Gut Health|Active, not recruiting||N/A|40|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 00:24:27.295168|2017-10-11 00:24:27.295168
NCT02142634|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-02-02|||May 2014||2014-05-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Budesonide for Induction of Remission in Incomplete Microscopic Colitis|Randomised, Double-blind, Placebo-controlled, Multi-centre Trial on the Efficacy and Safety of Budesonide for Induction of Remission in Incomplete Microscopic Colitis|Recruiting||Phase 3|106|Anticipated|Dr. Falk Pharma GmbH||2|||f||||t||||||||||2017-10-11 00:24:27.385192|2017-10-11 00:24:27.385192
NCT02142621|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-09-19|||June 2014||2014-06-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Transpyloric Feeding in Severe Bronchopulmonary Dysplasia|Pilot N-of-1 Multiple Crossover Randomized Trial of Gastric and Transpyloric Feeds in Infants With Severe Bronchopulmonary Dysplasia|Active, not recruiting||N/A|15|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 00:24:27.481858|2017-10-11 00:24:27.481858
NCT02142608|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-06-03|||August 2014||2014-08-01|March 2015|2015-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer|A Pilot Clinical Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer by Molecular Imaging of VEGFR2|Completed||Phase 1/Phase 2|19|Actual|Bracco Diagnostics, Inc||1|||f||||f||||||||||2017-10-11 00:24:27.559249|2017-10-11 00:24:27.559249
NCT02142595|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-09-22|||May 2014||2014-05-01|May 2014|2014-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Postoperative Sleep Quality of Patients Sedation With i.v. Dexmedetomidine or Midazolam Undergoing TURP|Comparison of the Postoperative Sleep Quality of Patients Sedation With i.v. Dexmedetomidine or Midazolam Undergoing Transurethral Prostatic Resection(TURP)|Completed||Phase 4|111|Actual|China Medical University, China||3|||f||||t||||||||||2017-10-11 00:24:27.760925|2017-10-11 00:24:27.760925
NCT02142582|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-05-03|||May 2014||2014-05-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ORS||Comparison of Different Oral Rehydration Solutions|Comparison of Different Oral Rehydration Solutions (ORS) in Short Bowel Syndrome (SBS) Patients on Home Parenteral Nutrition (HPN): A Prospective Double-blinded Randomized Controlled Trial.|Completed||N/A|28|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:24:27.843969|2017-10-11 00:24:27.843969
NCT02142569|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-05-03|||December 2015||2015-12-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|TOCO-CRYR||Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood|Effects of a Tocotrienol-Enriched Fraction of Palm Oil and Chinese Red Yeast Rice on Serum Lipids in Hypercholesterolemic Subjects|Suspended||Phase 2/Phase 3|80|Anticipated|University of California, Los Angeles||4||We were unable to procure the supplement for this study.|f||||f||||||||No||2017-10-11 00:24:27.93084|2017-10-11 00:24:27.93084
NCT02142556|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-15|||November 2008||2008-11-01|May 2014|2014-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics|The Efficacy and Safety of Once-daily Quetiapine Extended Release in Patients With Schizophrenia Switched From Other Antipsychotics|Completed||Phase 3|61|Actual|Tri-Service General Hospital||1|||f||||f||||||||||2017-10-11 00:24:28.041785|2017-10-11 00:24:28.041785
NCT02142543|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-06-04|||March 2012||2012-03-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer|The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer|Completed||Early Phase 1|23|Actual|Texas A&M University||2|||f||||f||||||||||2017-10-11 00:24:28.131518|2017-10-11 00:24:28.131518
NCT02142530|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-06-19|||October 2014||2014-10-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Carfilzomib Plus Belinostat in Relapsed/Refractory NHL|Carfilzomib Plus Belinostat in Relapsed/Refractory Non-Hodgkin Lymphoma Subtypes: A Phase 1 Study|Recruiting||Phase 1|30|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 00:24:28.216512|2017-10-11 00:24:28.216512
NCT02142517|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-19|||June 2011||2011-06-01|June 2011|2011-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|PJ||Comparative Study Between Duct to Mucosa and Invagination Pancreaticojejunostomy After Pancreaticoduodenectomy:|Comparative Study Between Duct to Mucosa and Invagination Pancreaticojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Study|Completed||N/A|120|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 00:24:28.324015|2017-10-11 00:24:28.324015
NCT02142504|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-08-18|2017-01-03|2016-11-29|May 15, 2014|Actual|2014-05-15|August 2017|2017-08-01|January 6, 2016|Actual|2016-01-06|January 6, 2016|Actual|2016-01-06||Interventional||Randomized Set included all randomized participants.|Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults|Phase II, Randomized, Placebo-controlled, Double-blind, Safety and Immunogenicity Trial of Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in Healthy Adults|Completed||Phase 2|454|Actual|Takeda||3|||f||||t||||||||||2017-10-11 00:24:28.490537|2017-10-11 00:24:28.490537
NCT02139488|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-09-26|||December 2013||2013-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Organ Motion and Early Tumor Response Measurement|Organ Motion and Early Tumor Response Measurement During Chemotherapy for Esophageal Cancer|Recruiting||N/A|70|Anticipated|The Netherlands Cancer Institute|||1||f||||f||||||||||2017-10-11 00:25:18.184321|2017-10-11 00:25:18.184321
NCT02142478|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-03-31|||May 2014||2014-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Evaluation of Two Different Delivery Approaches of a GP Exercise Referral Scheme|Theory-informed Evaluation of Two Delivery Approaches of a GP Exercise Referral Scheme|Completed||N/A|202|Actual|Liverpool John Moores University|||2||f||||f||||||||||2017-10-11 00:24:30.146422|2017-10-11 00:24:30.146422
NCT02141698|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-15|||October 2007||2007-10-01|May 2014|2014-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential-Panel, Ascending Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects|Completed||Phase 1|73|Actual|Takeda||15|||f||||f||||||||||2017-10-11 00:24:30.23863|2017-10-11 00:24:30.23863
NCT02141685|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-07-09|||May 2014||2014-05-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|||Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)|Correlating Time-Lapse Parameters Detected by Eeva™ With Array-Comparative Genomic Hybridization Results and Ongoing Pregnancy Rates (aCGH Study)|Unknown status|Active, not recruiting|N/A|50|Anticipated|Progyny, Inc.|||1||f||||f||||||||||2017-10-11 00:24:30.367398|2017-10-11 00:24:30.367398
NCT02142465|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-19|||January 2014||2014-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:24:30.452157|2017-10-11 00:24:30.452157
NCT02142452|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-04-18|||March 2014||2014-03-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain|Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain|Active, not recruiting||N/A|55|Actual|Stanford University||2|||f||||f||||||||Yes||2017-10-11 00:24:30.506595|2017-10-11 00:24:30.506595
NCT02142439|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-03-07|||January 2014||2014-01-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||STERK - Strength Training and Eating Disorders|Strength Training and Eating Disorders (STERK - Styrketrening og Spiseforstyrrelser)|Active, not recruiting||N/A|6|Actual|Telemark University College||4|||f||||f||||||||No|No IPD will be made available to other researchers|2017-10-11 00:24:30.624169|2017-10-11 00:24:30.624169
NCT02142426|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-11-24|||August 2011||2011-08-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||A Retrospective Analysis of Laboratory Testing on Chronic Wound Patients|A Retrospective Analysis of Laboratory Testing on Chronic Wound Patients|Completed||N/A|2000|Actual|Southwest Regional Wound Care Center|||1||f||||f||||||Samples Without DNA|"     To pursue statistical analysis on a series of molecular laboratory results obtained from     chronic wounds   "|||2017-10-11 00:24:30.858145|2017-10-11 00:24:30.858145
NCT02142413|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-05-15|||May 2014||2014-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|February 2017|Actual|2017-02-01||Observational|HEBRAS||HEart and BRain Interfaces in Acute Ischemic Stroke|HEart and BRain Interfaces in Acute Ischemic Stroke (HEBRAS) - A Prospective Oberservational Cohort Study|Active, not recruiting||N/A|368|Actual|Charite University, Berlin, Germany|||1||f||||t||||||Samples Without DNA|"     Biomarkers indicating myocardial damage (cardiac Troponin T), autonomic function     (Norepinephrine), prediction of atrial fibrillation (BNP).   "|||2017-10-11 00:24:30.958397|2017-10-11 00:24:30.958397
NCT02142400|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-04-13|||May 2014||2014-05-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Multiple Ascending Dose Study of DS-1093 in Healthy Subjects|A Double Blind, Randomised, Placebo-controlled, Multiple Ascending-dose Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of DS 1093a in Healthy Male Subjects|Completed||Phase 1|31|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 00:24:31.089979|2017-10-11 00:24:31.089979
NCT02142387|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-19|||August 2014||2014-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HEROS||Before and After Community Intervention Trial With Dispatcher Assisted CPR Program|Layperson Training of Dispatcher Assisted Basic Life Support for Improving Outcomes After Out-of-Hospital Cardiac Arrest; a Nonradomized before-and After- Community Intervention Trial|Recruiting||N/A|4000|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 00:24:31.18849|2017-10-11 00:24:31.18849
NCT02142374|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-19|||March 2014||2014-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:24:31.274132|2017-10-11 00:24:31.274132
NCT02142361|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-05-25|2016-02-23||May 2014||2014-05-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional||The subject sample consisted of 60 habitual hydrogelcontact lens wearers (omafilcon A, ocufilcon D or methafilcon B), refitted with silicone hydrogel lens (enfilcon A)|Clinical Performance of Habitual Hydrogel vs. Silicone Hydrogel Toric Contact Lenses|Clinical Performance of Habitual Wearers of Hydrogel Toric Lenses When Refitted With Avaira Toric Silicone Hydrogel Lenses|Completed||Phase 4|60|Actual|Coopervision, Inc.||3|||f||||f||||||||||2017-10-11 00:24:31.357594|2017-10-11 00:24:31.357594
NCT02142348|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-15|||June 2014||2014-06-01|May 2014|2014-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Longitudinal Study of Primary Osteoporosis in Shanghai Postmenopausal Women|Longitudinal Study of Primary Osteoporosis in Shanghai Postmenopausal Women|Not yet recruiting||N/A|3000|Anticipated|Shanghai University of Traditional Chinese Medicine|||1||f||||t||||||Samples With DNA|"     Basal whole blood is collected for serum and DNA extraction.   "|||2017-10-11 00:24:32.801577|2017-10-11 00:24:32.801577
NCT02142335|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-05-16|||March 2014||2014-03-01|May 2014|2014-05-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma|A Phase II Trial of the Combination of Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma|Unknown status|Recruiting|Phase 2|17|Anticipated|California Cancer Assocaties for Research & Excellence||1|||f||||f||||||||||2017-10-11 00:24:32.892257|2017-10-11 00:24:32.892257
NCT02142322|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2014-05-15|||June 2004||2004-06-01|May 2014|2014-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer|A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer|Completed||Phase 2|52|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 00:24:32.988639|2017-10-11 00:24:32.988639
NCT02142309|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2016-04-19|||October 2005||2005-10-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|October 2015|Actual|2015-10-01||Interventional|AMAZING||Glycemic Durability After Metformin Failure|Effect of Glimepiride, Vildagliptin, Pioglitazone and Canagliflozin on Durability of Glycemic Control After Metformin Failure in Type 2 Diabetes|Recruiting||Phase 4|450|Anticipated|"University of Campania Luigi Vanvitelli"||4|||f||||f||||||||||2017-10-11 00:24:33.068941|2017-10-11 00:24:33.068941
NCT02142296|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-02-15|||May 2014||2014-05-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)|A 12-month, Exploratory Open-label Study of Eylea (Aflibercept) in Subjects With Retinal Pigment Epithelial Detachment Secondary to Neovascular Age-related Macular Degeneration|Completed||Phase 4|37|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 00:24:33.191608|2017-10-11 00:24:33.191608
NCT02142283|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-07-24|||July 2014||2014-07-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|DAWN||Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo|Diffusion Weighted Imaging (DWI) or Computerized Tomography Perfusion (CTP) Assessment With Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention (DAWN)|Active, not recruiting||N/A|500|Anticipated|Stryker Neurovascular||2|||f||||t||||||||||2017-10-11 00:24:33.289037|2017-10-11 00:24:33.289037
NCT02142270|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2014-05-19|||January 2015||2015-01-01|May 2014|2014-05-01|January 2018|Anticipated|2018-01-01|January 2016|Anticipated|2016-01-01|3 Years|Observational [Patient Registry]|||Epidemiology of Sudden Cardiac Arrest in Sub-Saharan Africa: Rationale and Design||Not yet recruiting||N/A|250000|Anticipated|Cameroon Resuscitation Council|||2||f||||||||||||||2017-10-11 00:24:33.46057|2017-10-11 00:24:33.46057
NCT02142257|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-01-26|||May 2014||2014-05-01|January 2016|2016-01-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Comparison of Gastric Bypass and AspireAssist Aspiration Therapy for Treatment of Morbid Obesity|Gastric Bypass Procedure and AspireAssist Aspiration Therapy System for the Treatment of Morbid Obesity, Observational Study Over 5 Years|Active, not recruiting||N/A|100|Actual|Blekinge County Council Hospital|||2||f||||t||||||||No|There is no plan to share individual participant data.|2017-10-11 00:24:33.550909|2017-10-11 00:24:33.550909
NCT02142244|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-02-01|||May 2014||2014-05-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Fluorescence Surgery for Sentinel Node Identification in Melanoma|Infrared Fluorescence Guided Surgery for Sentinel Node Identification in Cutaneous Melanoma|Recruiting||N/A|318|Anticipated|Barretos Cancer Hospital||1|||f||||t||||||||||2017-10-11 00:24:33.648453|2017-10-11 00:24:33.648453
NCT02142231|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-01-06|||April 2014||2014-04-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|AcuTA||AcuTA: Acupuncture in Test Anxiety|Acupuncture Randomized Trial for Preventing Test Anxiety|Completed||N/A|25|Actual|Goethe University||2|||f||||f||||||||||2017-10-11 00:24:33.759535|2017-10-11 00:24:33.759535
NCT02142218|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-09-28|||June 2014||2014-06-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Expanded Access|Checkmate 168||Expanded Access Program With Nivolumab to Treat Melanoma|Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti CTLA-4 Monoclonal Antibody (Checkmate 168: CHECKpoint Pathway for nivoluMAb Clinical Trial Evaluation 168)|No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 00:24:33.854687|2017-10-11 00:24:33.854687
NCT02142205|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-16|||May 2012||2012-05-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Efficacy of Natalizumab (BG00002, Tysabri®) in Russian Participants With Relapsing Remitting Multiple Sclerosis (RRMS)|A Prospective, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety and Efficacy in RUSsian RRMS Patients on One Year Treatment With Natalizumab (TYSabri®).|Completed||Phase 4|100|Actual|Biogen||1|||f||||f||||||||||2017-10-11 00:24:34.226889|2017-10-11 00:24:34.226889
NCT02142192|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-09-27|||December 2014||2014-12-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|SIMPLIFY||Natalizumab Subcutaneous Immunogenicity and Safety Study|A Multicenter, Open-Label Immunogenicity and Safety Study of Subcutaneous Natalizumab 300 mg Administered to Subjects With Relapsing Multiple Sclerosis|Terminated||Phase 2|2|Actual|Biogen||1||Sponsor's decision.|f||||f||||||||||2017-10-11 00:24:34.347696|2017-10-11 00:24:34.347696
NCT02142179|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2016-07-06|||November 2012||2012-11-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|KARE||Impact of a Curriculum Intervention on Asthma Knowledge in Adolescents of a Public School in Salvador-Bahia-Brazil|Impact of a Curriculum Intervention on Asthma Knowledge in Adolescents of a Public School in Salvador-Bahia-Brazil|Completed||N/A|181|Actual|Federal University of Bahia||2|||f||||f||||||||||2017-10-11 00:24:34.464994|2017-10-11 00:24:34.464994
NCT02142166|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-09-22|||April 2014||2014-04-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|bioSAB||The Role of Biomarker in Serum, Cerebrospinal Fluid and Parenchyma in the Context of Aneurysmal Subarachnoid Hemorrhage.|Die Rolle Der Biomarker in Serum, Liquor Und Parenchym im Rahmen Der Aneurysmatischen Subarachnoidalblutung: Verlauf Und Korrelation zu Therapie Und Outcome - bioSAB -|Unknown status|Recruiting|N/A|40|Anticipated|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 00:24:34.575433|2017-10-11 00:24:34.575433
NCT02142140|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-09-18|||December 2012||2012-12-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)|Efficacy of Careful Medication and Tailored Case Management Follow up Treatment for Children With Attention Deficit Hyperactivity Disorder|Active, not recruiting||N/A|326|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 00:24:35.646568|2017-10-11 00:24:35.646568
NCT02142127|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2015-05-28|||April 2014||2014-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|June 2014|Actual|2014-06-01||Interventional|||Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers|An Open-Label, Single Oral Dose Phase I Study to Determine the Excretion Balance of Radiocarbon (i.e., the Sum of 14C-Labelled GFT505 and Its 14C-Metabolites) and to Investigate the Metabolic Profile and Pharmacokinetics of GFT505|Completed||Phase 1|6|Actual|Genfit||1|||f||||f||||||||||2017-10-11 00:24:35.80263|2017-10-11 00:24:35.80263
NCT02142114|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-12-18|||May 2014||2014-05-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Assessment of Comfort Level Following an Intravitreal Injection by 30 or 32 Gauge Needles|Assessment of Comfort Level Following an Intravitreal Injection by 30 or 32 Gauge Needles|Recruiting||Early Phase 1|200|Anticipated|Retina Health Center||2|||f||||f||||||||||2017-10-11 00:24:35.894181|2017-10-11 00:24:35.894181
NCT02142101|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-01-04|||December 2013||2013-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Evaluation of Gut Bacteria in Patients With Polycystic Kidney Disease|Gut Microbiota of Renal Patients|Completed||N/A|18|Actual|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||Samples With DNA|"     Serum and urine will be saved for metabolite analysis; stool will be used to extract     bacterial DNA for sequencing.   "|||2017-10-11 00:24:36.008831|2017-10-11 00:24:36.008831
NCT02142088|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2014-05-19|||June 2014||2014-06-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|MICU||Comparative Study of GlySure Continuous Intra-vascular Glucose Monitoring and Intermittent Monitoring in Medical ICU|A Clinical Study to Evaluate the Safety of the GlySure Continuous Intra-vascular Glucose Monitoring System, and Its Performance in Comparison to Intermittent Blood Glucose Monitoring in Adult Intensive Care Unit Patients|Unknown status|Not yet recruiting|N/A|60|Anticipated|GlySure||1|||f||||t||||||||||2017-10-11 00:24:36.096817|2017-10-11 00:24:36.096817
NCT02142075|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-10-10|||March 2014||2014-03-01|October 2016|2016-10-01||||September 2015|Actual|2015-09-01||Interventional|DAPTOREA||Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure||Completed||Phase 3|||Poitiers University Hospital||1|||f||||||||||||||2017-10-11 00:24:36.182027|2017-10-11 00:24:36.182027
NCT02142062|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-08-10|||July 2014||2014-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Observational|VIDIO||Venogram vs. Intravascular Ultrasound (IVUS) for Diagnosing Iliac Vein Obstruction|Prospective, Single-arm, Multi-center, Pilot Study of IVUS Imaging Used as an Adjunct to Multiplanar Venography During Iliac-common Femoral Vein Assessment for Possible Endovascular Intervention|Completed||N/A|100|Actual|Volcano Corporation|||1||f||||f||||||||||2017-10-11 00:24:36.297974|2017-10-11 00:24:36.297974
NCT02142049|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-08-18|||May 2014||2014-05-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma|A Multicenter Study of Ibrutinib and Lenalidomide in Combination With DA-EPOCH-R in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|56|Anticipated|Pharmacyclics LLC.||5|||f||||f||||||||||2017-10-11 00:24:36.407755|2017-10-11 00:24:36.407755
NCT02142036|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2017-09-26|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|August 2018|Anticipated|2018-08-01||Interventional|MetAction||N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy|N-of-1 Trial of Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy|Active, not recruiting||Phase 2|50|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 00:24:36.548016|2017-10-11 00:24:36.548016
NCT02142023|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-06-15|||March 1, 2014||2014-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:24:36.652057|2017-10-11 00:24:36.652057
NCT02142010|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-08-26|||August 2014||2014-08-01|August 2014|2014-08-01||||June 2015|Anticipated|2015-06-01||Interventional|||Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast Cancer||Unknown status|Recruiting|N/A|67|Anticipated|Nanjing Luye Sike Pharmaceutical Co.,Ltd.||1|||f||||t||||||||||2017-10-11 00:24:36.702031|2017-10-11 00:24:36.702031
NCT02141997|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2016-09-22|2016-09-22||July 2014||2014-07-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate|A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate|Completed||Phase 2|222|Actual|AbbVie||4|||f||||t||||||||||2017-10-11 00:24:36.811473|2017-10-11 00:24:36.811473
NCT02141984|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-04-07|2017-02-21||May 2014||2014-05-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Surveillance of Humira in Korean JIA Patients|Post-Marketing Surveillance of Humira Injection in Korean JIA Patients Under the New-Drug Re-examination|Completed||N/A|28|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 00:24:37.600015|2017-10-11 00:24:37.600015
NCT02141971|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-16|2017-05-01|||June 1, 2013|Actual|2013-06-01|May 2017|2017-05-01|April 15, 2017|Actual|2017-04-15|April 15, 2017|Actual|2017-04-15||Observational|DSBI||Down Syndrome Biomarker Initiative (DSBI)|Down Syndrome Biomarker Initiative: A Natural History Study of Alzheimer's Disease in Down Syndrome (Pilot Study)|Completed||N/A|12|Actual|University of California, San Diego|||3||f||||f||||||Samples With DNA|"     blood, urine, cerebrospinal fluid   "|No||2017-10-11 00:24:37.832937|2017-10-11 00:24:37.832937
NCT02141958|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-07-10|||April 2014||2014-04-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety Study of Fenretinide in Adult Patients With Cystic Fibrosis|An Adaptive Phase I Intra-patient Dose Escalation Study of Fenretinide in Adult Cystic Fibrosis Patients|Completed||Phase 1|15|Actual|McGill University Health Center||2|||f||||t||||||||||2017-10-11 00:24:37.963842|2017-10-11 00:24:37.963842
NCT02141945|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-03-27|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|||Microbiome Test for the Detection of Colorectal Polyps and Cancer|Metabiomics Neoplasia Clinical Research Study|Completed||N/A|260|Actual|Metabiomics Corp|||1||f||||f||||||Samples With DNA|"     gut microbiome samples from stool, rectal and colonic mucosa   "|||2017-10-11 00:24:38.047097|2017-10-11 00:24:38.047097
NCT02141932|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-01-11|||September 2014||2014-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pocket-size Cardiovascular Ultrasound in Stroke|Clinical Influence of Pocket-size Ultrasound Examinations of the Carotid Arteries and Heart in Patients Admitted With Stroke|Completed||N/A|80|Actual|Levanger Hospital||1|||f||||t||||||||||2017-10-11 00:24:38.131411|2017-10-11 00:24:38.131411
NCT02141919|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-01-06|||June 2014||2014-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer|A Phase II Trial of Stereotactic Ablative Body Radiation Therapy (SABR) for Patients With Primary Renal Cancer (RCC)|Recruiting||Phase 2|16|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 00:24:38.224061|2017-10-11 00:24:38.224061
NCT02141906|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-11-22|||December 2014||2014-12-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||"A Pilot Study of OncozeneTM Microspheres for Intra-arterial Delivery of Doxorubicin"|"A Pilot Study of OncozeneTM Microspheres for Intra-arterial Delivery of Doxorubicin for the Treatment of Patients With Unresectable Hepatocellular Cancer"|Active, not recruiting||N/A|20|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-11 00:24:38.322223|2017-10-11 00:24:38.322223
NCT02141893|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-19|||December 2009||2009-12-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|February 2012|Actual|2012-02-01||Interventional|||Effectiveness of a Multi-level Clinic and Family Asthma Intervention With a Randomized Control Trial|Effectiveness of a Multi-level Clinic and Family Asthma Intervention With a Randomized Control Trial|Completed||N/A|404|Actual|University of Puerto Rico||2|||f||||t||||||||||2017-10-11 00:24:38.409189|2017-10-11 00:24:38.409189
NCT02141867|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-01-11|2016-01-11||May 2014||2014-05-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01|1 Month|Observational [Patient Registry]|SASOS||South African Surgical Outcomes Study|South African Surgical Outcomes Study|Completed||N/A|3927|Actual|University of KwaZulu|||1||f||||f||||||||||2017-10-11 00:24:38.740174|2017-10-11 00:24:38.740174
NCT02141854|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-05-02|2017-02-28||June 2014||2014-06-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Randomized participants|Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma|A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy|Completed||Phase 3|882|Actual|Teva Pharmaceutical Industries||5|||f||||f||||||||||2017-10-11 00:24:38.97456|2017-10-11 00:24:38.97456
NCT02141841|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-10-23|||January 2013||2013-01-01|October 2015|2015-10-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01|2 Years|Observational [Patient Registry]|||Effect of Age on the Median Effective Concentration(EC50) for Motor Block With Spinal Plain Bupivacaine|Effect of Age on the Median Effective Concentration(EC50) for Motor Block With Spinal Plain Bupivacaine|Withdrawn||N/A|0|Actual|China Three Gorges University, Yichang, China|||1|because the study is very complicated and cannot be performed in the practice|f||||t||||||||||2017-10-11 00:24:41.180368|2017-10-11 00:24:41.180368
NCT02141828|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2016-08-02|||May 2014||2014-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene|A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene|Completed||Phase 1|18|Actual|Epizyme, Inc.||1|||f||||f||||||||||2017-10-11 00:24:41.313172|2017-10-11 00:24:41.313172
NCT02141815|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-05-18|||May 2014||2014-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Effect of Arabinoxylan-oligosaccharides (AXOS) on Intestinal Generation of Microbial Metabolites in Chronic Kidney Disease||Completed||Phase 2|40|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-11 00:24:41.485878|2017-10-11 00:24:41.485878
NCT02141802|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-15|||May 2014||2014-05-01|May 2014|2014-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Clinical Effectiveness of Increased Standing Time in Non-ambulant Children With Cerebral Palsy:a Pilot Study|Clinical Effectiveness of Increased Standing Time in Non-ambulant Children With Cerebral Palsy:a Pilot Study|Unknown status|Recruiting|N/A|30|Anticipated|University of Plymouth||2|||f||||t||||||||||2017-10-11 00:24:41.647387|2017-10-11 00:24:41.647387
NCT02141789|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-05-10|||November 2014|Actual|2014-11-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Outpatient Psychotherapeutic Treatment for Alcohol Dependent Individuals With Comorbid Psychiatric Disorders||Recruiting||N/A|35|Anticipated|University of Konstanz||1|||f||||f||||||||||2017-10-11 00:24:42.38799|2017-10-11 00:24:42.38799
NCT02141776|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-11-15|||May 2014||2014-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant Depression|A Randomized Blinded Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation of Left Prefrontal Cortex in Patients With Treatment-resistant Depression|Recruiting||Phase 4|24|Anticipated|University of Florida||2|||f||||t||||||||||2017-10-11 00:24:42.517643|2017-10-11 00:24:42.517643
NCT02140814|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-11-30|||May 2014||2014-05-01|November 2016|2016-11-01||||February 2016|Actual|2016-02-01||Interventional|NIAC-PKD1||Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease|Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease|Completed||Phase 2|10|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 00:24:57.925701|2017-10-11 00:24:57.925701
NCT02141763|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-08-31|||May 2014||2014-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis|A Subject-blind, Investigator-blind, Randomized, Placebo-controlled Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of UCB4940 in Subjects With Psoriatic Arthritis|Completed||Phase 1|53|Actual|UCB Pharma||5|||f||||f||||||||||2017-10-11 00:24:42.662654|2017-10-11 00:24:42.662654
NCT02141750|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-15|||November 2012||2012-11-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Observational|RENASICA_III||THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES|THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES|Completed||N/A|8296|Actual|Third National Registry of Acute Coronary Syndromes|||1||f||||t||||||||||2017-10-11 00:24:42.854414|2017-10-11 00:24:42.854414
NCT02141737|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-16|||May 2014||2014-05-01|May 2014|2014-05-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General Anesthesia|Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General Anesthesia|Unknown status|Recruiting|Phase 4|272|Anticipated|Tang-Du Hospital||4|||f||||t||||||||||2017-10-11 00:24:42.95421|2017-10-11 00:24:42.95421
NCT02141724|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-03-31|||April 2014||2014-04-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|||Wheelchair Positioning and Pain in Neuromuscular Patients|Assessment of Wheelchair Positioning and Pain in Adults Patients With Neuromuscular Disorder|Completed||N/A|120|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-11 00:24:43.093179|2017-10-11 00:24:43.093179
NCT02141711|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-05-15|||October 2008||2008-10-01|May 2014|2014-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|TAK-438_107||TAK-438 - Safety, Blood Levels & Effects of Repeated Doses|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential-Panel, Multiple Repeat Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Non-Japanese Male Subjects|Completed||Phase 1|48|Actual|Takeda||5|||f||||f||||||||||2017-10-11 00:24:43.18532|2017-10-11 00:24:43.18532
NCT02141672|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-09-21|||June 2014||2014-06-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|AURA-LV||AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)|A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg BID, or 39.5 mg BID) With Placebo in Achieving Remission in Patients With Active Lupus Nephritis|Completed||Phase 2|265|Actual|Aurinia Pharmaceuticals Inc.||3|||f||||t||||||||||2017-10-11 00:24:43.330422|2017-10-11 00:24:43.330422
NCT02141659|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-02|||May 16, 2014|Actual|2014-05-16|June 2017|2017-06-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|||This is a Phase 1, Open-label, and Multicenter Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Efficacy of TAK-385 in Japanese Patients With Androgen Deprivation Treatment-naïve Nonmetastatic Prostate Cancer.|A Phase 1, Randomized, Open-Label Study of TAK-385, an Oral Gonadotropin-Releasing Hormone (GnRH) Antagonist in Japanese Patients With Androgen Deprivation Treatment-Naïve Nonmetastatic Prostate Cancer|Completed||Phase 1|43|Actual|Takeda||1|||f||||f|f|f||||||||2017-10-11 00:24:43.678111|2017-10-11 00:24:43.678111
NCT02141646|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-12-11|||February 2012||2012-02-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|DASH||DASH - Decision Making in Adolescent Sexual Health|Adolescent Decision Making and HIV Risk Avoidance: Neurocognitive Factors|Active, not recruiting||N/A|300|Anticipated|University of New Mexico||1|||f||||f||||||||||2017-10-11 00:24:43.830188|2017-10-11 00:24:43.830188
NCT02141633|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-10-25|2016-07-07||April 2013||2013-04-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|smoker3||Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment|Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment|Completed||N/A|31|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 00:24:44.170917|2017-10-11 00:24:44.170917
NCT02141620|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-11-16|2016-08-11||May 2014||2014-05-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Completing participants.|n-Acetylcysteine and Cocaine|Motivation for Cocaine and Non-Drug Reinforcers: Targeting Glutamate Homeostasis|Completed||Early Phase 1|15|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-11 00:24:44.624578|2017-10-11 00:24:44.624578
NCT02141607|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-10-03|||October 2014||2014-10-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|June 2016|Actual|2016-06-01||Observational|Shockomics||Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock|Multiscale Approach to Describe the Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock|Completed||N/A|70|Actual|Shockomics Consortium|||4||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 00:24:45.914854|2017-10-11 00:24:45.914854
NCT02141594|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-16|||August 2013||2013-08-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|PPAA||Posterior Pole Asymmetry Analysis (PPAA) for Early Glaucoma|Diagnostic Ability of Posterior Pole Asymmetry Analysis Parameters (PPAA) of Spectralis Optical Coherence Tomography (OCT) in Detecting Early Glaucoma|Completed||N/A|156|Actual|Dr T V Patel Eye Institute|||2||f||||f||||||||||2017-10-11 00:24:46.062152|2017-10-11 00:24:46.062152
NCT02141581|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-04-03|2017-01-13||August 2011||2011-08-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)|Vaccination and Infection: Indicators of Immunological Health and Responsiveness. Project 1: Plasmablast Trafficking and Antibody Response in Influenza Vaccination;|Completed||Phase 4|86|Actual|Stanford University||3|||f||||f||||||||Yes|The NIH Human Immunology Project Consortium (HIPC) data repositories (ImmPORT) may store the results of the research assays results. Genetic data that is developed in this study may be made available to other researchers through the National Center for Biotechnology Information (NCBI) databases. Results from research assays will be labeled with a unique ID code and the volunteer identity (except for age) will not be disclosed.|2017-10-11 00:24:46.161668|2017-10-11 00:24:46.161668
NCT02141568|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-04-20|||March 2015||2015-03-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Clinic Intervention in Frequent Attenders Suffering From Unexplained Medical Symptoms|The Effect of Multidisciplinary Clinic Intervention in Frequent Attenders Suffering From Unexplained Medical Symptoms, Cost-Effectiveness Analysis. Randomized Control Trial.|Enrolling by invitation||N/A|100|Anticipated|Soroka University Medical Center||3|||f||||f||||||||||2017-10-11 00:24:46.785334|2017-10-11 00:24:46.785334
NCT02141555|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2014-05-14|||July 2014||2014-07-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss|Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss: a Pilot Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 2/Phase 3|20|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-11 00:24:46.896025|2017-10-11 00:24:46.896025
NCT02141542|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-07-20|||May 2014||2014-05-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma|Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma|Active, not recruiting||Phase 1|15|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:24:47.024963|2017-10-11 00:24:47.024963
NCT02141529|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-03-15|||May 2014||2014-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Intraarticular Pulse Radiofrequency to Treat Chronic Knee Pain|Bipolar Versus Unipolar Intraarticular Pulsed Radiofrequency Thermocoagulation in Chronic Knee Pain Treatment: A Prospective Randomized Study|Completed||N/A|100|Actual|Cukurova University||2|||f||||f||||||||||2017-10-11 00:24:47.142125|2017-10-11 00:24:47.142125
NCT02141516|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-12-22|2016-03-03||May 2014||2014-05-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.|A Phase IIIb, Open Label, Controlled, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Doses of Novartis Meningococcal Group B Vaccine When Administered to Immunocompromised Patients From 2 to 17 Years of Age Who Are at Increased Risk of Meningococcal Disease Because of Complement Deficiency or Asplenia Compared to Matched Healthy Controls.|Completed||Phase 3|239|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:24:47.283881|2017-10-11 00:24:47.283881
NCT02141503|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-30|||May 1, 2014||2014-05-01|February 17, 2017|2017-02-17|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Clinical Biomarkers in Alpha-mannosidosis|Clinical Biomarkers in Alpha-Mannosidosis|Recruiting||N/A|15|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:24:48.725063|2017-10-11 00:24:48.725063
NCT02141490|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-30|||May 2, 2014||2014-05-02|March 1, 2017|2017-03-01|December 30, 2018|Anticipated|2018-12-30|February 6, 2018|Anticipated|2018-02-06||Interventional|||Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers|Evaluation of Ferumoxytol Enhanced MRI for the Detection of Lymph Node Metastases in Genitourinary (Prostate, Bladder and Kidney)Cancers|Recruiting||Phase 2|56|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 00:24:48.816134|2017-10-11 00:24:48.816134
NCT02141477|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-06-23|||May 6, 2015|Actual|2015-05-06|June 2017|2017-06-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)|A Phase II Study of Omacetaxine (OM) and Decitabine (DAC) in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f|t|f||||||||2017-10-11 00:24:48.948735|2017-10-11 00:24:48.948735
NCT02141464|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-07-17|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|February 2016|Actual|2016-02-01||Observational|||Energy Balance and Weight Gain With Ivacaftor Treatment|Energy Balance and Weight Gain With Ivacaftor Treatment of CFTR Gating Mutations|Completed||N/A|24|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||Samples Without DNA|"     serum, urine, stool   "|||2017-10-11 00:24:49.035713|2017-10-11 00:24:49.035713
NCT02141451|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-10-04|||May 2014||2014-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL|Study of the ADAM17 Inhibitor INCB7839 Combined With Rituximab After Autologous Hematopoietic Cell Transplantation (HCT) For Patients With Diffuse Large B Cell Non-Hodgkin Lymphoma (DLBCL)|Recruiting||Phase 1/Phase 2|33|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 00:24:49.094207|2017-10-11 00:24:49.094207
NCT02141438|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-09-21|||August 20, 2014|Actual|2014-08-20|September 2017|2017-09-01|December 31, 2023|Anticipated|2023-12-31|September 30, 2023|Anticipated|2023-09-30||Observational|REASSURE||Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer|Radium-223 Alpha Emitter Agent in Non-intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation|Recruiting||N/A|1440|Anticipated|Bayer|||1||f||||f||||||||||2017-10-11 00:24:50.926206|2017-10-11 00:24:50.926206
NCT02141425|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2014-06-02|||March 2014||2014-03-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects|A Phase 1, Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP015K Following Single Doses in Healthy Subjects|Completed||Phase 1|16|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 00:24:51.173098|2017-10-11 00:24:51.173098
NCT02141412|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-04-15|||September 2009||2009-09-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia|Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia: A Dose-Finding Study|Unknown status|Recruiting|Phase 4|216|Anticipated|American University of Beirut Medical Center||4|||f||||f||||||||||2017-10-11 00:24:51.255254|2017-10-11 00:24:51.255254
NCT02141399|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-01-12|||May 2014||2014-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Long-Term Safety Study of ALKS 5461|A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)|Active, not recruiting||Phase 3|1500|Anticipated|Alkermes, Inc.||1|||f||||f||||||||||2017-10-11 00:24:51.386219|2017-10-11 00:24:51.386219
NCT02141373|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-04-02|||October 2013||2013-10-01|April 2015|2015-04-01||||October 2015|Anticipated|2015-10-01||Interventional|||Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection|Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection|Unknown status|Recruiting|N/A|136|Anticipated|King Hussein Cancer Center||2|||f||||f||||||||||2017-10-11 00:24:52.004713|2017-10-11 00:24:52.004713
NCT02141360|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-06-22|2017-04-27||July 2014||2014-07-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|TBI-2||Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF|Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF|Terminated||N/A|17|Actual|GE Healthcare|Early termination of study due to limited recruitment|2||Sponser terminated early to start a larger feasability study|f||||f||||||||No||2017-10-11 00:24:52.111113|2017-10-11 00:24:52.111113
NCT02141347|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-04-12|||May 22, 2014|Actual|2014-05-22|April 2017|2017-04-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|||Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma|A Ph1 Open-Label Multicentre Study to Assess Safety, Tolerability, PK and Anti-tumor Activity of Tremelimumab /Tremelimumab With MEDI4736 in Japanese With Advanced Solid Malignancies or Tremelimumab in Japanese With Malignant Mesothelioma|Completed||Phase 1|73|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:24:52.383131|2017-10-11 00:24:52.383131
NCT02141334|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-02-17|||June 4, 2014||2014-06-04||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:24:52.477864|2017-10-11 00:24:52.477864
NCT02141321|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-03-17|||May 2014||2014-05-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section|SUB LINGUAL MISOPROSTOL PRIOR TO IUD INSERTION IN WOMEN WITH ONLY PREVIOUS CESARIAN SECTION: A Randomized Controlled Trial|Completed||Phase 2/Phase 3|124|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:24:52.517826|2017-10-11 00:24:52.517826
NCT02141308|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-04-21|||May 2014||2014-05-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|||OCT in Rare Chorioretinal Diseases|Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Rare Retinal and Choroidal Diseases|Unknown status|Recruiting|N/A|150|Anticipated|Oregon Health and Science University|||1||f||||||||||||||2017-10-11 00:24:52.60309|2017-10-11 00:24:52.60309
NCT02141295|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-07-07|||June 30, 2014|Actual|2014-06-30|July 2017|2017-07-01|February 1, 2017|Actual|2017-02-01|July 29, 2016|Actual|2016-07-29||Interventional|McCAVE||A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer|A Phase II, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of RO5520985 (Vanucizumab) Plus FOLFOX Versus Bevacizumab Plus FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer|Completed||Phase 2|200|Actual|Hoffmann-La Roche||6|||f|||||t|f||||||||2017-10-11 00:24:52.718212|2017-10-11 00:24:52.718212
NCT02141282|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-08-01|||September 10, 2014||2014-09-10|August 2017|2017-08-01|December 6, 2018|Anticipated|2018-12-06|December 6, 2018|Anticipated|2018-12-06||Interventional|||A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy|A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy|Active, not recruiting||Phase 2|120|Anticipated|AbbVie||3|||f||||f||||||||||2017-10-11 00:24:53.063138|2017-10-11 00:24:53.063138
NCT02141269|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-05-19|||June 2012||2012-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Comparitive Effectiveness of PME Versus Transthoracic Echocardiogram (TTE)|Comparative Effectiveness of Pocket, Mobile, Hand-held Echocardiography and Conventional Transthoracic Echocardiography in an Inpatient and Outpatient Clinical Setting|Completed||N/A|200|Actual|Scripps Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:24:53.215135|2017-10-11 00:24:53.215135
NCT02141256|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2014-06-04|||October 2013||2013-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|EET-studie||Can Protein Intake be Increased by Offering Protein-enriched Foods and Drinks?|Can Protein Intake be Increased by Offering Protein-enriched Foods and Drinks? Evaluation of a Pilot in a Local Residential Care Home.|Completed||N/A|24|Actual|Wageningen University||1|||f||||f||||||||||2017-10-11 00:24:53.306221|2017-10-11 00:24:53.306221
NCT02141243|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-01-06|||May 2015||2015-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Evaluation of Lingual Frenotomy in Newborns With Simultaneous Lip Tie for the Relief of Breastfeeding Pain.|Randomized, Controlled Trial Evaluating Lingual Frenotomy in Newborns With Simultaneous Lip Tie for the Relief of Breastfeeding Pain.|Recruiting||N/A|200|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-11 00:24:53.420052|2017-10-11 00:24:53.420052
NCT02141230|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2016-06-29|||December 2015||2015-12-01|June 2016|2016-06-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.|Evaluation of the Characteristics of Alli® Purchasers in the European Union Following the Revision to the Alli® Pack Information.|Withdrawn||N/A|0|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:24:53.530115|2017-10-11 00:24:53.530115
NCT02141217|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-08-25|2014-08-14||March 21, 2013|Actual|2013-03-21|August 2017|2017-08-01|December 28, 2013|Actual|2013-12-28|December 28, 2013|Actual|2013-12-28||Interventional|AUGDENT||AUGMENTIN™ in Dental Infections|Efficacy, Safety and Tolerability of Amoxicillin + Clavulanic Acid (875mg/125mg) Two Times a Day Compared to Clindamycin (150mg) Four Times a Day for 5-7 Days in Treatment of Acute Odontogenic Infection With or Without Abscess|Completed||Phase 4|472|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:24:53.643365|2017-10-11 00:24:53.643365
NCT02141204|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2017-04-17|||October 23, 2017|Anticipated|2017-10-23|April 2017|2017-04-01|May 27, 2018|Anticipated|2018-05-27|May 27, 2018|Anticipated|2018-05-27||Interventional|||Immunogenicity and Safety Study of Two Different Formulations of Human Rotavirus Vaccine, Rotarix in Healthy Infants|Immunogenicity and Safety Study of Two Different Formulations of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine, Rotarix in Healthy Infants|Not yet recruiting||Phase 4|308|Anticipated|GlaxoSmithKline||2|||f|||||t|f|||f|||Yes||2017-10-11 00:24:54.157879|2017-10-11 00:24:54.157879
NCT02141191|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-07-24|||June 2014||2014-06-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device|A Randomized Crossover Mucociliary Clearance Study of Aerosolized 7% NaCl Solution Administered Overnight by the tPAD Device to Subjects With Cystic Fibrosis|Completed||Phase 1|12|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 00:24:54.254752|2017-10-11 00:24:54.254752
NCT02141178|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-01-04|||May 2015||2015-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of Bupivacaine and Exparel for Carpal Tunnel Release|Does Long-Acting Liposomal Bupivacaine Provide Improved Pain Relief Over Bupivicaine Alone in Carpal Tunnel Release?|Withdrawn||N/A|0|Actual|University of Pittsburgh||2||No IRB approval|f||||f||||||||||2017-10-11 00:24:54.354785|2017-10-11 00:24:54.354785
NCT02141165|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-03-14|||March 2014|Actual|2014-03-01|January 2017|2017-01-01|March 2017|Actual|2017-03-01|April 2016|Actual|2016-04-01||Interventional|Primary||Home Nasal Pressure for Sleep Apnea Management in Primary Case|Efficacy and Cost-Effectiveness of a Super Simplified System for the Management of Patients With Sleep Apneas in Primary Healthcare.|Completed||N/A|280|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||f||||||||||2017-10-11 00:24:54.446173|2017-10-11 00:24:54.446173
NCT02141152|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-12-28|||February 2015||2015-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|NEXT-1||Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model|Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model: The Master Protocol|Completed||N/A|895|Actual|Samsung Medical Center|||5||f||||f||||||Samples With DNA|"     fresh tissue or FFPE   "|||2017-10-11 00:24:54.54192|2017-10-11 00:24:54.54192
NCT02141139|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2014-05-14|||September 2014||2014-09-01|May 2014|2014-05-01||||January 2016|Anticipated|2016-01-01||Interventional|||Perioperative Inflammation and Breast Cancer Outcome|Suppression of Inflammation by Using NSAIDs During Peri-operative Period Can Affect the Prognosis of Breast Cancer.|Unknown status|Not yet recruiting|Phase 3|1568|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:24:54.613646|2017-10-11 00:24:54.613646
NCT02141126|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-04-24|||June 2013||2013-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|||Lower Limb Resistance Training in Older Inpatients|Can Lower Limb Resistance Training Improve Strength, Muscle Mass and Functional Outcomes in Older Inpatients in a Post-acute Rehabilitation Unit? A Randomised Controlled Trial|Active, not recruiting||N/A|60|Actual|Royal College of Surgeons, Ireland||2|||f||||f||||||||||2017-10-11 00:24:54.718565|2017-10-11 00:24:54.718565
NCT02141100|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-10-06|||July 2014||2014-07-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma|A Phase 1-2 Study of 6-Thioguanine in Combination With Methotrexate and 6-Mercaptopurine During Maintenance Therapy of Childhood Non-Hodgkin's Lymphoma|Withdrawn||Phase 1/Phase 2|0|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 00:24:54.952972|2017-10-11 00:24:54.952972
NCT02141087|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-15|2015-07-09||||||July 2015|2015-07-01||||||||Expanded Access|||Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone|A Treatment Protocol to Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone|Approved for marketing||N/A|||Genentech, Inc.|||||||||||||||||||2017-10-11 00:24:55.06942|2017-10-11 00:24:55.06942
NCT02141074|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-02-21|||July 2, 2014|Actual|2014-07-02|February 2017|2017-02-01|October 30, 2022|Anticipated|2022-10-30|October 30, 2022|Anticipated|2022-10-30||Interventional|paradigm™6||Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B|An Open-label Single-arm Multicentre Non-controlled Phase 3 a Trial Investigating Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Untreated Patients With Haemophilia B (FIX Activity Below or Equal to 2 Percent)|Recruiting||Phase 3|50|Anticipated|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 00:24:55.161153|2017-10-11 00:24:55.161153
NCT02141061|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-09-02|||May 2014||2014-05-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Comparison of Two Formulations of Proellex for Oral Administration|A Double-Blind Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Oral Administration|Completed||Phase 1|12|Actual|Repros Therapeutics Inc.||2|||f||||t||||||||||2017-10-11 00:24:55.433042|2017-10-11 00:24:55.433042
NCT02141048|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-03-11|||April 2014||2014-04-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of the Parent Centre's Positive Parenting Skills Training.|Evaluation of the Parent Centre's Positive Parenting Skills Training: A Randomised Controlled Trial.|Completed||N/A|140|Actual|University of Cape Town||2|||f||||f||||||||Yes|All baseline, post-test and follow-up data will be shared on request. Please contact the Principal Investigator for access.|2017-10-11 00:24:55.60704|2017-10-11 00:24:55.60704
NCT02141035|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-03-31|||September 2015||2015-09-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome|Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome; a Randomized Control Trial.|Recruiting||Phase 2/Phase 3|20|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 00:24:55.748238|2017-10-11 00:24:55.748238
NCT02141022|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-05-08|||August 2013||2013-08-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya|A Pilot Study of Plasticity-Based and Adaptive Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya|Completed||N/A|20|Actual|Stony Brook University||2|||f||||f||||||||No||2017-10-11 00:24:55.941318|2017-10-11 00:24:55.941318
NCT02139891|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-09-25|||May 2014||2014-05-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effects of Multipoint Pacing CRT-D on Neurohormonal Activation.|Randomized, Crossover Study of the Effects of MultiPoint Left Ventricular Pacing on Neurohormonal Activation.|Completed||N/A|30|Actual|University of Rome Tor Vergata||2|||f||||f||||||||||2017-10-11 00:25:11.203956|2017-10-11 00:25:11.203956
NCT02141009|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-12-19|||April 2014||2014-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CAPolista||Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status|Response to Pneumococcal Vaccination in Patients After Community Acquired Pneumonia With Streptococcus Pneumoniae Compared to Pneumonia Patients With Another Pathogen.|Completed||Phase 4|60|Actual|St. Antonius Hospital||1|||f||||f||||||||||2017-10-11 00:24:56.103545|2017-10-11 00:24:56.103545
NCT02140996|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-10-12|||September 2014||2014-09-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|MUC-1||Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers|Ad-sig-hMUC-1/ecdCD40L Vector Vaccine for Immunotherapy of Epithelial Cancers|Recruiting||Phase 1|24|Anticipated|Singapore Clinical Research Institute||1|||f||||t||||||||||2017-10-11 00:24:56.207145|2017-10-11 00:24:56.207145
NCT02140983|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-10-03|||August 2013|Actual|2013-08-01|October 2017|2017-10-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|LGT||Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes|Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes|Completed||N/A|45|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 00:24:56.325532|2017-10-11 00:24:56.325532
NCT02140970|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-06-08|||May 2014||2014-05-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal|Double-blind, Placebo-controlled Randomized Controlled Trial of NSAID Prior to Ureteral Stent Removal in a Pediatric Population|Recruiting||N/A|40|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 00:24:56.466248|2017-10-11 00:24:56.466248
NCT02140957|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-01-06|2015-11-23||January 2007||2007-01-01|January 2016|2016-01-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Office Based Intervention to Reduce Bottle Use in Toddlers: TARGet Kids! Pragmatic Randomized Trial|Office Based Intervention to Reduce Bottle Use in Toddlers: TARGet Kids! Pragmatic Randomized Trial|Completed||N/A|251|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 00:24:56.613372|2017-10-11 00:24:56.613372
NCT02140944|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-07-11|||February 2015||2015-02-01|July 2017|2017-07-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Observational|||IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence|IMPAACT P1107: Cord Blood Transplantation With CCR5Δ32 Donor Cells in HIV-1 Infected Subjects Who Require Bone Marrow Transplantation for Any Indication and Its Observed Effects on HIV-1 Persistence|Recruiting||N/A|25|Anticipated|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|||2||f||||f||||||Samples With DNA|"     For consenting participants, blood and tissue samples   "|||2017-10-11 00:24:56.946584|2017-10-11 00:24:56.946584
NCT02140931|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-09-14|||August 2014||2014-08-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Assessment of Blood-Borne Autologous Angiogenic Cell Precursors Therapy in Patients With Critical Limb Ischemia|A Randomized Double Blind Placebo Controlled Clinical Study to Assess Blood-Borne Autologous Angiogenic Cell Precursors Therapy in Patients With Critical Limb Ischemia|Unknown status|Recruiting|Phase 2|95|Anticipated|Hemostemix||2|||f||||t||||||||||2017-10-11 00:24:57.073736|2017-10-11 00:24:57.073736
NCT02140918|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-10-28|||July 2014||2014-07-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|AFLUCO4||Fludrocortisone in Healthy Volunteers (AFLUCO4)|Hemodynamic and Biological Effects of 3 Increasing Doses of Fludrocortisone in Healthy Volunteers|Unknown status|Recruiting|Phase 2|12|Anticipated|Rennes University Hospital||4|||f||||f||||||||||2017-10-11 00:24:57.194595|2017-10-11 00:24:57.194595
NCT02140905|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-19|||April 2014||2014-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis|Validation of Neck-Worn Monitoring System - A Study for Monitoring Subjects With Fluid-Management Issues Using Repeated Measurements During Hemodialysis|Completed||N/A|49|Actual|toSense, Inc.|||1||f||||f||||||||||2017-10-11 00:24:57.311526|2017-10-11 00:24:57.311526
NCT02140892|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-15|||July 2014||2014-07-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute Exacerbation||Unknown status|Not yet recruiting|N/A|75|Anticipated|Sheba Medical Center||3|||f||||f||||||||||2017-10-11 00:24:57.380476|2017-10-11 00:24:57.380476
NCT02140879|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-05-14|||April 2014||2014-04-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||LA Moms and Babies Study (LAMBS) for Nutrition and Growth|LA Moms and Babies Study (LAMBS) for Nutrition and Growth|Unknown status|Recruiting|N/A|60|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 00:24:57.454171|2017-10-11 00:24:57.454171
NCT02140866|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-09-19|||May 2014||2014-05-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|RAHExercise||Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial|Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Randomized Controlled Trial|Completed||N/A|55|Actual|Parker Research Institute||2|||f||||f||||||||||2017-10-11 00:24:57.553447|2017-10-11 00:24:57.553447
NCT02140853|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-14|||November 2011||2011-11-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|MDR||MDR Bacilli Surveillance and Clinical Feature in China|Multi-drug Resistant Gram-negative Bacilli-surveillance and Clinical Feature in China|Unknown status|Recruiting|N/A|1500|Anticipated|Sun Yat-sen University|||2||f||||t||||||Samples Without DNA|"     sputum, pleural effusion or blood   "|||2017-10-11 00:24:57.645404|2017-10-11 00:24:57.645404
NCT02140840|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-04-06|||March 2015||2015-03-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||UARK 2014-08 A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib|A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib in Patients With Relapsed of Refractory Multiple Myeloma|Withdrawn||Phase 2|0|Actual|University of Arkansas||||PI left institution|f||||t||||||||||2017-10-11 00:24:57.738428|2017-10-11 00:24:57.738428
NCT02140827|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-12-20|||May 2014||2014-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Instant Messaging Program (Wechat) Improve the Quality of Bowel Preparation|Communication Through Instant Messaging Program for the Improvement of Bowel Preparation: a Two Centers Study|Completed||N/A|770|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 00:24:57.829166|2017-10-11 00:24:57.829166
NCT02140801|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-02-09|||May 2014||2014-05-01|February 2017|2017-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel|A Randomised, Open-label, Parallel Group, Multi-center Study Using OCT to Comparing the Efficacy and Safety of Ticagrelor With Clopidogrel in the Prevention of Subclinical Thrombus in Patients After Drug-eluting Stent Implantation|Recruiting||Phase 4|352|Anticipated|Nanjing First Hospital, Nanjing Medical University||2|||f||||t|t|f|||t|||No||2017-10-11 00:24:58.025167|2017-10-11 00:24:58.025167
NCT02140788|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-11-06|2014-11-06||May 2011||2011-05-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Subjects who signed a consent form|Effects of Metformin and Fish Oil on Treatment With Clozapine|A Comparison Of The Effects Of Added Metformin (Versus No Added Metformin) On Psychopathology, Lipids, And Measures of Inflammation During The Initiation Or Re-Institution Of Treatment With Clozapine In Patients With Schizophrenia Or Schizoaffective Disorder|Terminated||Phase 4|34|Actual|Duke University|Patients were not randomized per protocol and the study was terminated. Data analysis was not performed.|4||PI left institution|f||||||||||||||2017-10-11 00:24:58.146011|2017-10-11 00:24:58.146011
NCT02140775|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-12-20|||April 2014||2014-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS|Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS|Recruiting||N/A|140|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 00:24:58.434249|2017-10-11 00:24:58.434249
NCT02140749|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-12-10|||April 2014||2014-04-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TOMCAT||Trial on Short-chain Fructooligosaccharides, Microbiota, and Constipation in Adults|Randomized, Placebo-controlled Double-blind Cross-over Study to Evaluate the Effects of Short-chain Fructooligosaccharides on Stool Frequency in Constipated Subjects|Completed||N/A|120|Actual|NIZO Food Research||3|||f||||t||||||||||2017-10-11 00:24:58.65064|2017-10-11 00:24:58.65064
NCT02140736|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-03-16|||September 2009||2009-09-01|July 2015|2015-07-01|August 1, 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|ORHEO||Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology|Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study|Completed||N/A|2333|Actual|Hospira, now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-10-11 00:24:58.814242|2017-10-11 00:24:58.814242
NCT02140723|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-03-21|||August 2011||2011-08-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|PART1||p53 and Response to Preoperative Radiotherapy for T2 and T3|PART1 - a Prospective Phase II Study to Evaluate the Impact of TP53 Gene Mutations in Patients With Preoperative Radiotherapy for T2 and T3 Rectal Cancer|Recruiting||N/A|60|Anticipated|Medical University of Vienna|||1||f||||f||||||Samples With DNA|"     whole blood diagnostic tumor biopsy   "|||2017-10-11 00:24:59.48814|2017-10-11 00:24:59.48814
NCT02140710|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2014-05-14|||December 2010||2010-12-01|May 2014|2014-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Impact of Visceral Osteopathic Treatment on Meconium Evacuation in Preterm Infants|The Impact of Visceral Osteopathic Treatment on the Meconium Evacuation in Very Low Birth Weight Infants|Completed||Phase 4|41|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 00:24:59.600071|2017-10-11 00:24:59.600071
NCT02140697|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-05-13|||May 2014||2014-05-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy and Safety of Hippophae Rhamnoides L. Leaf Extract on Body Fat||Completed||Phase 2/Phase 3|80|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 00:24:59.695536|2017-10-11 00:24:59.695536
NCT02140684|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-14|||March 2012||2012-03-01|May 2014|2014-05-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Exhaled Nitric Oxide in Asthma Management|Exhaled Nitric Oxide in Asthma Management: a Retrospective Real-life Observational Evaluation of the Use of Exhaled Nitric Oxide Measurements for Asthma Management in a UK Primary Care Population|Suspended||N/A|400|Anticipated|Research in Real-Life Ltd|||2|suspended due to lack of data.|f||||||||||||||2017-10-11 00:24:59.780715|2017-10-11 00:24:59.780715
NCT02140671|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-14|||May 2012||2012-05-01|May 2014|2014-05-01|August 2015|Anticipated|2015-08-01|August 2014|Anticipated|2014-08-01||Observational|||Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes|To Deliver a Pilot Project on Effective Interventions to Ensure: Diagnostic Accuracy, Management of Risk and Control and Self-management for Asthma Patients.|Unknown status|Active, not recruiting|N/A|33370|Anticipated|Research in Real-Life Ltd|||2||f||||||||||||||2017-10-11 00:24:59.875865|2017-10-11 00:24:59.875865
NCT02140658|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-14|||May 2014||2014-05-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Interventional|||Health Education Interventions for Statins Medication Compliance and Clinical Prognosis of Ischemic Stroke Patients|Affect of Multiple Health Education Interventions for Statins Medication Compliance and Clinical Prognosis of Ischemic Stroke Patients: a Prospective Cohort Study|Unknown status|Not yet recruiting|N/A|1500|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-10-11 00:24:59.96771|2017-10-11 00:24:59.96771
NCT02140645|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-12-15|2016-03-29||May 2014||2014-05-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational||All patients who did not violate any inclusion/exclusion criteria.|Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy|Association of Clinical Covariates With Non-insulin Diabetes Medication Initiation Using Electronic Medical Records (EMR)|Completed||N/A|166613|Actual|Boehringer Ingelheim|||6||f||||||||||||||2017-10-11 00:25:00.102582|2017-10-11 00:25:00.102582
NCT02140632|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2016-08-31|||December 2013||2013-12-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome|Local Steroid Injection vs Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Clinical Trial|Completed||Phase 4|50|Actual|Kwong Wah Hospital||2|||f||||f||||||||||2017-10-11 00:25:01.378173|2017-10-11 00:25:01.378173
NCT02140619|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-14|||May 2014||2014-05-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Interventional|||Multiple Health Education Interventions for Medication Compliance and Clinical Prognosis of Ischemic Stroke Patients|Multiple Health Education Interventions for Secondary Prevention Medication Compliance and Clinical Prognosis of Ischemic Stroke Patients: a Prospective Cohort Study|Unknown status|Not yet recruiting|N/A|1800|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-10-11 00:25:01.504044|2017-10-11 00:25:01.504044
NCT02140606|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-13|||May 2014||2014-05-01|May 2014|2014-05-01||||December 2015|Anticipated|2015-12-01||Interventional|||Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)|An Open Phase I Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics, and Efficacy of Intravenous Cafusertib Hydrochloride in Combination With Subcutaneous Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)|Unknown status|Recruiting|Phase 1|||Jiangsu Hansoh Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 00:25:01.602041|2017-10-11 00:25:01.602041
NCT02140593|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-03-09|2017-01-10||September 2014||2014-09-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||The Laparotomy Study|Muscle Relaxation During Open Upper Abdominal Surgery - Can the Surgical Conditions be Optimized?|Completed||Phase 4|128|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 00:25:01.717963|2017-10-11 00:25:01.717963
NCT02140580|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-07-05|||December 2011||2011-12-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|OPTIMIST-A||OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP|Multicentre Randomised Controlled Trial of Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on Continuous Positive Airways Pressure|Recruiting||Phase 4|606|Anticipated|Menzies Institute for Medical Research||2|||f||||t||||||||No||2017-10-11 00:25:02.139095|2017-10-11 00:25:02.139095
NCT02140567|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-03-16|||November 2014||2014-11-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Observational|SPS||Syncope Prediction Study|Syncope Prediction Study|Completed||N/A|140|Actual|Medtronic BRC|||1||f||||f||||||||||2017-10-11 00:25:02.391525|2017-10-11 00:25:02.391525
NCT02140554|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-09-06|||August 2014||2014-08-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in Severe Sickle Cell Disease|A Phase 1 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With the LentiGlobin BB305 Lentiviral Vector in Subjects With Severe Sickle Cell Disease|Recruiting||Phase 1|29|Anticipated|bluebird bio||3|||f||||t||||||||||2017-10-11 00:25:02.47986|2017-10-11 00:25:02.47986
NCT02140541|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-14|||February 2013||2013-02-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||The Clinical Profile of UK Asthma Patients With Raised Blood Eosinophils|The Clinical Profile of UK Asthma Patients With Raised Blood Eosinophils|Unknown status|Active, not recruiting|N/A|130248|Actual|Research in Real-Life Ltd|||2||f||||f||||||||||2017-10-11 00:25:02.584274|2017-10-11 00:25:02.584274
NCT02140528|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-04-26|||August 2013|Actual|2013-08-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures|Evaluation the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures|Completed||Phase 2|40|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 00:25:02.671457|2017-10-11 00:25:02.671457
NCT02140515|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-05-05|||November 2012||2012-11-01|August 2012|2012-08-01|November 2016|Anticipated|2016-11-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism|Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation by Using Recombinant Luteinizing Hormone (rLH) and Recombinant Follicle Stimulating Hormone (rFSH) in Patients With Hypogonadotropic Hypogonadism|Unknown status|Recruiting|Phase 4|90|Anticipated|Royan Institute||2|||f||||t||||||||||2017-10-11 00:25:02.769081|2017-10-11 00:25:02.769081
NCT02140502|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-05-16|||May 2015||2015-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|August 2015|Actual|2015-08-01|2 Years|Observational [Patient Registry]|||Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate Biopsy|Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate Biopsy|Completed||N/A|200|Actual|Helsinki University Central Hospital|||1||f||||f||||||Samples Without DNA|"     rectal culture swabs   "|||2017-10-11 00:25:02.906941|2017-10-11 00:25:02.906941
NCT02140489|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2014-05-15|||February 2014||2014-02-01|May 2014|2014-05-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01||Interventional|||Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin|An Open-label, Randomized, Single-dose Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin in Healthy Male Volunteers|Unknown status|Recruiting|Phase 1|30|Anticipated|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 00:25:03.010653|2017-10-11 00:25:03.010653
NCT02140463|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-01-26|||February 2014||2014-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Observational|||Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)|Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)|Recruiting||N/A|260|Anticipated|Samsung Medical Center|||1||f||||f||||||Samples With DNA|"     circulating free DNA   "|||2017-10-11 00:25:03.420454|2017-10-11 00:25:03.420454
NCT02140450|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-05-13|||February 2012||2012-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection|Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection: the Effect of Pretreatment With Antiglaucoma Agents|Completed||N/A|70|Actual|Mashhad University of Medical Sciences||5|||f||||f||||||||||2017-10-11 00:25:03.52394|2017-10-11 00:25:03.52394
NCT02140437|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-12-24|||March 2014||2014-03-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC|An Open-label, Multi-center, Randomized Phase II Study of Fulvestrant Anastrozole Combination Versus Anastrozole Alone in Patients With Luminal A-like Postmenopausal Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|Fudan University||2||The progress of enrollment is too slow.|f||||t||||||||||2017-10-11 00:25:03.638753|2017-10-11 00:25:03.638753
NCT02140424|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-09-22|||August 2013||2013-08-01|September 2015|2015-09-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Observational|||Bone Health in Youth With Type 1 Diabetes|Bone Mineral Accrual and Microarchitecture in Youth With Type 1 Diabetes|Recruiting||N/A|66|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples Without DNA|"     serum, plasma, urine   "|||2017-10-11 00:25:03.729722|2017-10-11 00:25:03.729722
NCT02140411|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-05-02|||April 25, 2015|Actual|2015-04-25|May 2017|2017-05-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|||Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.|Chilean Interventional Open Label Pilot Study, to Assess the Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema.|Completed||Phase 4|21|Actual|Novartis||1|||f|||||f|f||||||||2017-10-11 00:25:03.804722|2017-10-11 00:25:03.804722
NCT02140398|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-05-14|||April 2014||2014-04-01|May 2014|2014-05-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|ESLOD||Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS Women|Endometrial Scratching at Time of Laproscopic Ovarian Drilling in Women With Anovulatory Infertility Due to Polycystic Ovarian Syndrome (PCOS): Randomized Controlled Trial.|Unknown status|Recruiting|Phase 4|500|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 00:25:03.885191|2017-10-11 00:25:03.885191
NCT02140385|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-08-27|||July 2014||2014-07-01|August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Interventional|||Role of Preservation of Scarpa's Fascia in Abdominoplasty|Role of Preservation of Scarpa's Fascia in Abdominoplasty: a Prospective Trial|Withdrawn||N/A|0|Actual|Loma Linda University||2|||f||||t||||||||||2017-10-11 00:25:04.01813|2017-10-11 00:25:04.01813
NCT02140372|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-01-26|2016-01-26||May 2014||2014-05-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Anti-platelet Effects of Colchicine in Healthy Volunteers|Anti-platelet Effects of Colchicine in Healthy Volunteers|Completed||Phase 4|10|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-11 00:25:04.148562|2017-10-11 00:25:04.148562
NCT02140359|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-11-10|||June 2015||2015-06-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|October 2016|Actual|2016-10-01||Interventional|||Enhancing Housing First Programs With a Social Network Substance Use Intervention|Enhancing Housing First Programs With a Social Network Substance Use Intervention|Active, not recruiting||N/A|50|Actual|RAND||2|||f||||f||||||||||2017-10-11 00:25:04.473238|2017-10-11 00:25:04.473238
NCT02140346|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-07-01|||August 2014||2014-08-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPD|A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Inhaled RV1729 in Patients With COPD|Completed||Phase 1|48|Actual|Respivert Ltd||2|||f||||f||||||||||2017-10-11 00:25:04.566573|2017-10-11 00:25:04.566573
NCT02140333|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2015-02-11|||August 2013||2013-08-01|February 2015|2015-02-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC|Phase 3 Study of Erlotinib 100mg or 150mg in Treating EGFR Mutated Patients With Non-small Cell Lung Cancer|Recruiting||Phase 3|220|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 00:25:04.653415|2017-10-11 00:25:04.653415
NCT02140320|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-04-13|||July 2014||2014-07-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 Days|A Randomised, Double Blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treatment With Single and Repeat Doses of Inhaled RV1729 in Healthy Subjects for up to 28 Days and Subjects With Stable Asthma for 14 Days|Completed||Phase 1|49|Actual|Respivert Ltd||4|||f||||f||||||||||2017-10-11 00:25:04.736883|2017-10-11 00:25:04.736883
NCT02140307|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-15|||January 2013||2013-01-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|October 2013|Actual|2013-10-01||Interventional|RR-MHP OC13||Relaxation-Response-based Mental Health Promotion - Open and Calm 2013|Study of Potential Health Effects of a Relaxation-response-based Mental Health Promotion Course (RR-MHP) and the Possibilities for Its Applications in the Danish Public Health Sector|Unknown status|Active, not recruiting|N/A|72|Actual|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-10-11 00:25:04.832812|2017-10-11 00:25:04.832812
NCT02140294|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-02-09|||May 2014||2014-05-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease|Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease - A Randomized Control Trial|Completed||N/A|147|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 00:25:04.926631|2017-10-11 00:25:04.926631
NCT02140281|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-09-18|||May 2014||2014-05-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers|A Phase 1, Single-center, Randomized, 2-Way Cross-over, Open-label Study to Evaluate the Effect of Oral Repeated Doses of AZD1722 on the Pharmacokinetics of Oral Cefadroxil in Healthy Volunteers|Completed||Phase 1|71|Actual|Ardelyx||2|||f||||f||||||||||2017-10-11 00:25:05.01607|2017-10-11 00:25:05.01607
NCT02140268|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-09-18|||May 2014||2014-05-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers|A Phase 1, Single-center, Fixed-sequence, Open Label Study to Evaluate the Effect of Oral Repeated Doses of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers|Completed||Phase 1|65|Actual|Ardelyx||3|||f||||f||||||||||2017-10-11 00:25:05.108119|2017-10-11 00:25:05.108119
NCT02140255|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-07-11|||January 2015||2015-01-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission|IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study|Recruiting||Phase 1/Phase 2|472|Anticipated|International Maternal Pediatric Adolescent AIDS Clinical Trials Group||1|||f||||f||||||||||2017-10-11 00:25:05.209869|2017-10-11 00:25:05.209869
NCT02140242|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-08-10|||April 16, 2014|Actual|2014-04-16|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|DaunoDouble||Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML|Randomized Comparison Between Two Dose Levels of Daunorubicin and Between One Versus Two Cycles of Induction Therapy for Adult Patients With Acute Myeloid Leukemia ≤65 Years|Recruiting||Phase 3|600|Anticipated|Technische Universität Dresden||3|||f||||f||||||||||2017-10-11 00:25:05.400587|2017-10-11 00:25:05.400587
NCT02140229|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-05-14|||October 2014||2014-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|REVECHO||Is Ultrasound Remission a Real Remission? Does Ultrasound Permit to Achieve and Maintain the Remission in Rheumatoid Arthritis Patients More Efficiently Than Clinical Scores?|REVECHO Study (REmission Véritable en ECHOgraphie) Is Ultrasound Remission a Real Remission? Does Ultrasound Permit to Achieve and Maintain the Remission in Rheumatoid Arthritis Patients More Efficiently Than Clinical Scores?|Recruiting||N/A|450|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 00:25:05.683319|2017-10-11 00:25:05.683319
NCT02140216|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-08-28|||May 2014||2014-05-01|August 2017|2017-08-01|June 18, 2017|Actual|2017-06-18|June 18, 2017|Actual|2017-06-18||Observational|||Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients|The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients|Completed||N/A|60|Actual|Mahidol University|||3||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 00:25:05.833968|2017-10-11 00:25:05.833968
NCT02140203|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-05-14|||July 2010||2010-07-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2011|Actual|2011-08-01||Interventional|||Effects of Yoga on Metabolic Syndrome|Effect of Yoga on Metabolic Abnormalities Outcomes in Middle-Aged and Older Adults With Metabolic Syndrome|Completed||N/A|182|Actual|The Hong Kong Polytechnic University||4|||f||||t||||||||||2017-10-11 00:25:05.97184|2017-10-11 00:25:05.97184
NCT02140177|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-07-11|||May 12, 2014||2014-05-12|July 3, 2017|2017-07-03|March 6, 2018|Anticipated|2018-03-06|December 1, 2017|Anticipated|2017-12-01||Observational|||Ask Suicide-Screening Questions to Everyone in Medical Settings (asQ em): Development of a Suicide Risk Screening Instrument for Adult Medical Inpatients|Ask Suicide-Screening Questions to Everyone in Medical Settings (asQ'em): Development of a Suicide Risk Screening Instrument for Adult Medical Inpatients|Recruiting||N/A|610|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:25:06.102387|2017-10-11 00:25:06.102387
NCT02140164|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-03-17|2016-11-17||May 2014||2014-05-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|||Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa|Pilot Study to Evaluate Oral Minocycline in the Treatment of Cystoid Macular Edema Associated With Retinitis Pigmentosa|Completed||Phase 1/Phase 2|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||No||2017-10-11 00:25:06.20892|2017-10-11 00:25:06.20892
NCT02140151|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-08-01|||September 2014||2014-09-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PREVENT||Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration|Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (AMD) in Vulnerable Eyes With Nonexudative AMD Trial: A Multicenter, Prospectively Randomized, Masked and Controlled, Interventional Investigator Sponsored Phase I/II Study|Recruiting||Phase 1/Phase 2|100|Anticipated|Southern California Desert Retina Consultants, MC||2|||f||||f||||||||||2017-10-11 00:25:06.612656|2017-10-11 00:25:06.612656
NCT02140138|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-06-10|||June 2014||2014-06-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer|An Open Label Randomised Phase II Trial of RNActive® Cancer Vaccine (CV9104) in High Risk and Intermediate Risk Patients With Prostate Cancer|Terminated||Phase 2|35|Actual|CureVac AG||3||"Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for   administrative reasons."|f||||f||||||||||2017-10-11 00:25:06.77173|2017-10-11 00:25:06.77173
NCT02140125|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-06-30|||August 2012||2012-08-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects|Phase I Study of ASP2408 -Subcutaneous Single-dose, Placebo-controlled Study in Non-elderly Healthy Adult Male Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 00:25:06.893399|2017-10-11 00:25:06.893399
NCT02140099|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-08-16|||March 2014||2014-03-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of the Healthy Relationships Plus Program for Youth|Evaluation of the Healthy Relationships Plus Program for Youth|Completed||N/A|238|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 00:25:07.109192|2017-10-11 00:25:07.109192
NCT02140086|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-03-01|||January 2014||2014-01-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Buteyko Based Remedial Breathing Therapy With Children With Asthma||Completed||N/A|32|Actual|ARCIM Institute Academic Research in Complementary and Integrative Medicine||2|||f||||||||||||||2017-10-11 00:25:07.245952|2017-10-11 00:25:07.245952
NCT02139878|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2017-02-24|2016-10-24||May 2014||2014-05-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Short-term Health Effects of Wild Blueberry Juice Consumption|Short-term Health Effects of Wild Blueberry Juice Consumption|Completed||N/A|20|Actual|University of Prince Edward Island||2|||f||||t||||||||||2017-10-11 00:25:11.325213|2017-10-11 00:25:11.325213
NCT02140073|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-05-15|||December 2013||2013-12-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity|Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Belarusian Medical Academy of Post-Graduate Education||2|||f||||||||||||||2017-10-11 00:25:07.336603|2017-10-11 00:25:07.336603
NCT02140060|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-11-24|2015-11-24||June 2014||2014-06-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||This analysis population includes all subjects who were randomized, received study medication, and completed at least 1 scheduled on-therapy study visit.|6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension|A 6-Week Proof-of-Concept Study Evaluating the Safety and IOP-Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|327|Actual|Alcon Research||6|||f||||f||||||||||2017-10-11 00:25:07.448698|2017-10-11 00:25:07.448698
NCT02140047|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2015-10-15|||April 2014||2014-04-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||Exploratory Clinical Study of MT-2301|Exploratory Clinical Study of MT-2301 in Healthy Infants (Phase 2)|Completed||Phase 2|157|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||t||||||||||2017-10-11 00:25:08.173266|2017-10-11 00:25:08.173266
NCT02140034|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2014-05-15|||May 2013||2013-05-01|May 2014|2014-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|EPL||Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled Trial|Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled Trial (EPL Study)|Unknown status|Recruiting|N/A|600|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-11 00:25:08.297163|2017-10-11 00:25:08.297163
NCT02140021|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-08-14|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer|Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer|Recruiting||N/A|500|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:25:08.413964|2017-10-11 00:25:08.413964
NCT02140008|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-09-21|||May 2014||2014-05-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||A Comparison of the I-gel and the Self-pressurised Air-Q Intubating Laryngeal Airway in Children||Completed||N/A|80|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:25:08.53465|2017-10-11 00:25:08.53465
NCT02139995|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2014-05-13|||May 2014||2014-05-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||West-China Transfusion Score for Critically-ill Patients|West-China Transfusion Score for Critically-ill Patients|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|West China Hospital||2|||f||||f||||||||||2017-10-11 00:25:08.633739|2017-10-11 00:25:08.633739
NCT02139982|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-07-25|2014-05-21||January 2011||2011-01-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Study of Regional Hemodynamic Changes After Specific Brachial Plexus Block by Ultrasound Guidance|The Study of Regional Hemodynamic Changes After Specific Brachial Plexus Block by Ultrasound Guidance|Completed||Phase 1|110|Actual|Wenzhou Medical University||10|||f||||f||||||||||2017-10-11 00:25:08.763525|2017-10-11 00:25:08.763525
NCT02139956|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-15|||May 2014||2014-05-01|May 2014|2014-05-01||||May 2014|Actual|2014-05-01|2 Days|Observational [Patient Registry]|||Assessment of the Internal Urethral Sphincter and the Vagina by Three Dimensional Ultrasound|Ultrasonic Assessment of the Urethra and the Vagina in Normal Continent Women and Women Suffering From Stress Urinary Incontinence|Unknown status|Active, not recruiting|N/A|140|Actual|Ain Shams University|||2||f||||||||||||||2017-10-11 00:25:10.144028|2017-10-11 00:25:10.144028
NCT02139943|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2016-06-07|2016-06-07||May 2014||2014-05-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Modified intent-to-treat analysis set included all randomized participants who took at least 1 dose of double-blind study drug.|A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)|A Randomized Phase 2, Double-blind, Placebo-controlled, Treat-to-Target, Parallel-group, 3-arm, Multicenter Study to Assess the Efficacy and Safety of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Subjects With Type 1 Diabetes Mellitus|Completed||Phase 2|352|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 00:25:10.247009|2017-10-11 00:25:10.247009
NCT02139917|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-08-09|||August 2014||2014-08-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|ESRF||Effects of a Transitional Palliative Care Model on Patients With End-stage Renal Failure|Effects of a Transitional Palliative Care Model on Patients With ESRF|Active, not recruiting||N/A|176|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 00:25:10.949308|2017-10-11 00:25:10.949308
NCT02139904|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-04-07|||March 1, 2016|Actual|2016-03-01|April 2017|2017-04-01|December 1, 2018|Anticipated|2018-12-01|March 1, 2018|Anticipated|2018-03-01||Interventional|VIM||Vinorelbine in Mesothelioma|A Randomised Phase II Trial of Oral Vinorelbine as Second Line Therapy for Patients With Malignant Pleural Mesothelioma|Recruiting||Phase 2|200|Anticipated|Wales Cancer Trials Unit||2|||f||||t||||||||||2017-10-11 00:25:11.084714|2017-10-11 00:25:11.084714
NCT02138565|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-08-09|||March 2014||2014-03-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|August 2016|Anticipated|2016-08-01||Interventional|GAS||Effect of Bariatric Surgery on Kidney Function|Effect of Bariatric Surgery on Kidney Function|Unknown status|Active, not recruiting|N/A|20|Actual|Steno Diabetes Center||1|||f||||t||||||||||2017-10-11 00:25:35.897523|2017-10-11 00:25:35.897523
NCT02139865|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-03-14|||May 2014||2014-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||The Effects of Lifting Light or Heavy Weights on Muscle Growth and Strength in Trained Young Men|The Effects of Resistance Training Intensity on Muscular Hypertrophy and Strength in Young, Resistance Trained Men|Completed||N/A|50|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 00:25:11.552547|2017-10-11 00:25:11.552547
NCT02139852|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-09-16|||June 2014||2014-06-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|Phase 1||Capsaicinoid Ingestion, Human Metabolism and Exercise|The Physiological Effects of Capsaicinoid Ingestion on Human Metabolism and Exercise Performance|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|University of Prince Edward Island||2|||f||||f||||||||||2017-10-11 00:25:11.62386|2017-10-11 00:25:11.62386
NCT02139839|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-05-13|||September 2012||2012-09-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14|A Single-Center Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14 on Subjects With Intermediate Nugent Scores|Completed||Early Phase 1|14|Actual|Kimberly-Clark Corporation||2|||f||||f||||||||||2017-10-11 00:25:11.684788|2017-10-11 00:25:11.684788
NCT02139826|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-12-16|||May 2014||2014-05-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men|A Randomised, Single-dose, 3-way Crossover Study to Evaluate the Relative Bioavailability of the IX-01 Capsule Formulation Compared With the IX-01 Aqueous Dispersion Formulation, and the Effect of Food on the IX-01 Capsule Formulation, in Healthy Male Subjects|Completed||Phase 1|12|Actual|Ixchelsis Limited||3|||f||||f||||||||||2017-10-11 00:25:11.753545|2017-10-11 00:25:11.753545
NCT02139813|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-05-29|||May 2014||2014-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|YOMEGA||Omega Loop Versus Roux-en-Y Gastric Bypass|Prospective Multicentric Randomized Trial of Efficiency and Safety of Laparoscopic Omega Loop Bypass Versus Roux-en-Y Gastric Bypass|Active, not recruiting||N/A|256|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 00:25:11.833158|2017-10-11 00:25:11.833158
NCT02139800|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-03-23|||August 2014||2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SAIL||Sustained Aeration of Infant Lungs Trial|Sustained Aeration of Infant Lungs Trial|Recruiting||N/A|600|Anticipated|University of Pennsylvania||2|||f||||t||||||||Undecided||2017-10-11 00:25:13.858848|2017-10-11 00:25:13.858848
NCT02139787|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-13|||September 2012||2012-09-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Radio Stories About Children's Healthy Eating and Exercise|Somali, Latino & Hmong Radio Stories About Children's Healthy Eating and Exercise: A SoLaHmo Pilot Study|Completed||N/A|146|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:25:14.08769|2017-10-11 00:25:14.08769
NCT02139774|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-12-02|||October 2013||2013-10-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer|Feasibility of an Evidence-based Walking Program in a Sample of Men Age >65 Undergoing Treatment for Prostate Cancer|Terminated||N/A|15|Actual|UNC Lineberger Comprehensive Cancer Center|||4|inadequate accrual|f||||t||||||||||2017-10-11 00:25:14.184834|2017-10-11 00:25:14.184834
NCT02139761|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-08-11|||September 2014||2014-09-01|August 2017|2017-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder|L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder|Withdrawn||Phase 2|0|Actual|University of Maryland||2||Study funding has not been established|f||||t||||||||||2017-10-11 00:25:14.261663|2017-10-11 00:25:14.261663
NCT02139748|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-12-06|||July 2014||2014-07-01|May 2014|2014-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Clinical Effect of Implant Placement With a Simultaneous Soft Tissue Allograft|The Clinical Effect of Implant Placement and Simultaneous Grafting Using Acellular Dermal Matrix Allograft vs. Acellular Dermal Matrix Allograft Plus Bovine-Derived Xenograft|Completed||N/A|28|Actual|University of Louisville||2|||f||||t||||||||||2017-10-11 00:25:14.329047|2017-10-11 00:25:14.329047
NCT02139735|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-05-13|||March 2012||2012-03-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|June 2013|Actual|2013-06-01||Interventional|||Therapeutic Response of Ultrasound and Muscular Stretching in Temporomandibular Disorder Patients|Therapeutic Response of Ultrasound and Muscular Stretching in Temporomandibular Disorder Patients: Clinical Trial|Completed||N/A|18|Actual|Universidade Federal de Santa Maria||3|||f||||t||||||||||2017-10-11 00:25:14.405315|2017-10-11 00:25:14.405315
NCT02139722|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-05|||January 2, 2014|Actual|2014-01-02|May 2017|2017-05-01|July 30, 2017|Anticipated|2017-07-30|May 28, 2017|Anticipated|2017-05-28||Interventional|||Patient-Centered Care and Asian Americans|A Patient-Centered Intervention to Increase Screening of Hepatitis B and C Among Asian Americans|Active, not recruiting||N/A|431|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:25:14.481914|2017-10-11 00:25:14.481914
NCT02139709|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2015-06-02|||January 2007||2007-01-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Milk-derived Gangliosides for Inflammatory Bowel Disease|Milk-derived Gangliosides as Novel Anti-inflammatory Therapy for Inflammatory Bowel Disease|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 00:25:14.549305|2017-10-11 00:25:14.549305
NCT02139696|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-13|||May 2014||2014-05-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|May 2015|Anticipated|2015-05-01||Observational|FINGOPET||Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation|Does Targeting of Sphingosine-1 Phosphate Receptors Reduce Microglial Activation in Multiple Sclerosis? A [11C]PK11195 Brain PET Study|Unknown status|Not yet recruiting|N/A|10|Anticipated|Turku University Hospital|||1||f||||f||||||||||2017-10-11 00:25:14.739602|2017-10-11 00:25:14.739602
NCT02139683|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-04-20|||January 2014||2014-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Feasibility Study Assessing the Treatment of Fibroadenomata With a Circumferential Sonication Treatment With HIFU|High Intensity Focused Ultrasound for the Treatment of Fibroadenomata (HIFU-F)|Active, not recruiting||Phase 3|50|Anticipated|Theraclion||1|||f||||f||||||||||2017-10-11 00:25:14.841281|2017-10-11 00:25:14.841281
NCT02137824|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-13|||May 2014||2014-05-01|May 2014|2014-05-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients||Recruiting||N/A|12|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-10-11 00:25:49.02227|2017-10-11 00:25:49.02227
NCT02139670|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-10-31|||October 2013||2013-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01|9 Months|Observational [Patient Registry]|||Thrombin Generation and Gestational Outcome|Thrombin Generation and Gestational Outcome in Women With Recurrent Pregnancy Loss|Recruiting||N/A|120|Anticipated|HaEmek Medical Center, Israel|||1||f||||t||||||Samples Without DNA|"     4 cc of serum will be retain until all blood samples will be collected   "|||2017-10-11 00:25:14.935531|2017-10-11 00:25:14.935531
NCT02139657|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-07-22|||March 2014||2014-03-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||An Open-label, Single-Arm Study to Evaluate the Safety and Rabies Virus Antibody Titers of Intramuscularly Administered Rabies Immune Globulin (Human)|An Open-label, Single-arm Study to Evaluate the Safety and Antibody Titers Specific to the Rabies Virus in Healthy Subjects After Receiving a Single Dose of Intramuscularly Administered Rabies Immune Globulin (Human)|Completed||Phase 1|12|Actual|Grifols Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 00:25:15.009821|2017-10-11 00:25:15.009821
NCT02139644|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-02-28|2017-02-28||June 2014||2014-06-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Intent to treat population|Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma|A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Low-dose or or Mid-dose Inhaled Corticosteroid Therapy|Completed||Phase 3|787|Actual|Teva Pharmaceutical Industries||5|||f||||f||||||||||2017-10-11 00:25:15.139563|2017-10-11 00:25:15.139563
NCT02139631|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-09-13|||May 2014||2014-05-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Hemodynamic Repercussions of Noninvasive Ventilation|Evaluation of the Hemodynamic Repercussions of Non Invasive Ventilation in Healthy Individuals by Doppler Echocardiography|Completed||N/A|30|Actual|Federal University of Uberlandia||1|||f||||t||||||||||2017-10-11 00:25:17.107167|2017-10-11 00:25:17.107167
NCT02139618|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-03-05|||April 2014||2014-04-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage|A Double-blind Randomized-controlled Trial to Assess the Efficacy of Methyl Aminolevulinate + Daylight vs Placebo + Daylight in Patients With Facial Photodamage|Completed||Phase 2|60|Actual|Fundación Dermabase||2|||f||||f||||||||||2017-10-11 00:25:17.202014|2017-10-11 00:25:17.202014
NCT02139605|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-04-24|||August 2013||2013-08-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2017|Anticipated|2017-07-01||Interventional|||"Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant Chemotherapy"|Phase III Randomized Controlled Trial Comparing D2 Versus D3 Lymphadenectomy on Outcomes of Non-metastatic, Resectable, But Locally Advanced, Gastric Cancer Following Neoadjuvant (Perioperative) Chemotherapy (ELANCe Trial)|Recruiting||N/A|400|Anticipated|Tata Memorial Centre||2|||f||||t||||||||Undecided|data of patient kept confidential|2017-10-11 00:25:17.321723|2017-10-11 00:25:17.321723
NCT02139592|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-07-06|||April 17, 2014|Actual|2014-04-17|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|||"Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"|"ADCETRIS IV Infusion − Special Drug Use Surveillance (All-case Surveillance) Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"|Completed||N/A|140|Anticipated|Takeda|||1||f||||f||||||||||2017-10-11 00:25:17.45834|2017-10-11 00:25:17.45834
NCT02139579|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2014-05-13|||May 2014||2014-05-01|May 2014|2014-05-01||||December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer|An Open-labeled, Single Arm, Multicenter Phase II Study to Evaluate Efficacy and Safety of Bevacizumab Plus Chemotherapy for Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer With EGFR-TKI Resistance|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:25:17.566403|2017-10-11 00:25:17.566403
NCT02139566|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2016-01-13|||July 2014||2014-07-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Improving Consent and Survey Procedures for Young MSM in Web-based HIV Prevention|Improving Consent and Survey Procedures for Young MSM in Web-based HIV Prevention|Completed||N/A|2405|Actual|Emory University||4|||f||||f||||||||||2017-10-11 00:25:17.673333|2017-10-11 00:25:17.673333
NCT02139553|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-01-23|||May 2014|Actual|2014-05-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Rhythmic Upper-limb Training in Stroke Patients||Completed||N/A|14|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||Undecided||2017-10-11 00:25:17.775311|2017-10-11 00:25:17.775311
NCT02139540|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-01-13|||November 2012||2012-11-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Nitrous Oxide as Treatment for Major Depression - a Pilot Study|Nitrous Oxide as Treatment for Major Depression - a Pilot Study|Active, not recruiting||Phase 2|40|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:25:17.863767|2017-10-11 00:25:17.863767
NCT02139527|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-05-13|||May 2007||2007-05-01|May 2014|2014-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01|5 Years|Observational [Patient Registry]|||CARES Lumbar Artificial Disc Registry|The Centers for Arthroplasty Research and Education in Spine (CARES) Lumbar Artificial Disc Registry Protocol|Terminated||Phase 4|120|Actual|DePuy Spine|||1|Low enrollment and follow-up data on enrolled patients.|f||||f||||||||||2017-10-11 00:25:17.962792|2017-10-11 00:25:17.962792
NCT02139514|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-24|||January 2013||2013-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders||Completed||N/A|10|Actual|Yale University||2|||f||||||||||||||2017-10-11 00:25:18.023728|2017-10-11 00:25:18.023728
NCT02139501|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-04-18|||May 2014||2014-05-01|November 2014|2014-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||An Investigation of rhTPO With Different Frequencies in the Management of ITP|A Randomized Study to Evaluate the Efficacy and Safety of Different Doses and Frequencies of Recombinant Human Thrombopoietin (rhTPO) in the Management of Primary Immune Thrombocytopenia (ITP)|Completed||Phase 3|48|Actual|Shandong University||3|||f||||t||||||||||2017-10-11 00:25:18.104467|2017-10-11 00:25:18.104467
NCT02139475|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-05-14|||May 2014||2014-05-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Factors Influencing Quality of Bowel Cleansing for Colonoscopy in Patients With Colorectal Cancer Surgery; Prospective Observational Study||Unknown status|Recruiting|N/A|400|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:25:18.260465|2017-10-11 00:25:18.260465
NCT02139462|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-10-03|||May 2015||2015-05-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Optimizing Fidelity to Family-Based Treatment for Adolescent Anorexia Nervosa|Optimizing Fidelity to Family-Based Treatment for Adolescent Anorexia Nervosa|Completed||N/A|47|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 00:25:18.328562|2017-10-11 00:25:18.328562
NCT02139449|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-05-13|||May 2014||2014-05-01|May 2014|2014-05-01|May 2025|Anticipated|2025-05-01|May 2025|Anticipated|2025-05-01||Observational|||Prospective Study on Prognosis of Cardiac Resynchronized Therapy (CRT), Implantable Cardioverter Defibrillator (ICD) Implantation in Patients With Congestive Heart Failure (CHF)||Recruiting||N/A|1000|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:25:18.394334|2017-10-11 00:25:18.394334
NCT02139436|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-06-15|||December 2013||2013-12-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Hybrid-FES Exercise to Prevent Cardiovascular Declines in Acute SCI|Hybrid-FES Exercise to Prevent Cardiovascualr Declines in Acute SCI|Recruiting||N/A|60|Anticipated|Spaulding Rehabilitation Hospital||3|||f||||f||||||||||2017-10-11 00:25:18.459218|2017-10-11 00:25:18.459218
NCT02139423|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-08-23|||November 2014||2014-11-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|March 2018|Anticipated|2018-03-01||Interventional|CymeAudit||Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening|Feasibility to Achieve, Before One Month of Age, the Diagnosis of Congenital CMV Diagnosis and the Formal Audiologic Assessment in Newborns Who Failed Newborn Hearing Screening|Recruiting||N/A|624|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:25:18.649472|2017-10-11 00:25:18.649472
NCT02139410|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-05-13|||June 2008||2008-06-01|September 2013|2013-09-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Observational|ISAAC||IGF-1, Sarcopenia and Mortality: a Cohort Study in Patient With Cognitive Impairment|Insulin Like Growth Factor 1 and Risks of Sarcopenia and Mortality in Patients With Cognitive Impairment|Completed||N/A|589|Actual|University of Roma La Sapienza|||2||f||||t||||||||||2017-10-11 00:25:18.732923|2017-10-11 00:25:18.732923
NCT02139397|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-04-25|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of DFMO in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma|A Phase I/II Trial of DFMO in Combination With Bortezomib in Patients With Relapsed or Refractory Neuroblastoma|Recruiting||Phase 1/Phase 2|38|Anticipated|Spectrum Health Hospitals||1|||f||||t||||||||||2017-10-11 00:25:18.830446|2017-10-11 00:25:18.830446
NCT02139384|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-04-24|||August 2012||2012-08-01|April 2017|2017-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Clinical Pediatric Pneumonia Score in Critically Ill Children|Development of a Clinical Pediatric Pneumonia Score in Critically Ill Children Admitted With Acute Respiratory Failure|Withdrawn||N/A|0|Actual|Loma Linda University|||1|The study was withdrawn due to inability to enroll patients in a timely fashion.|f||||f||||||||||2017-10-11 00:25:18.958979|2017-10-11 00:25:18.958979
NCT02139371|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-12-11|||May 2014||2014-05-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography|64Cu-DOTA-AE105. Evaluation of a New Radiotracer Targeting uPAR (Urokinase Plasminogen Activator Receptor) for Positron Emission Tomography Imaging of the Invasive Cancer Phenotype. First in Man.|Completed||Early Phase 1|10|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 00:25:19.029746|2017-10-11 00:25:19.029746
NCT02139358|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-06-30|||September 5, 2014|Actual|2014-09-05|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer|Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer|Active, not recruiting||Phase 1/Phase 2|46|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 00:25:19.111032|2017-10-11 00:25:19.111032
NCT02139345|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-04-24|||September 23, 2014|Actual|2014-09-23|April 2017|2017-04-01|November 23, 2016|Actual|2016-11-23|November 23, 2016|Actual|2016-11-23||Interventional|||TC-A Registration Study|A Prospective, Randomized, Multicenter Clinical Study to Compare the Safety and Efficacy of TC-A PS Total Knee System With TC-PLUS Solution PS Total Knee System in Chinese Subjects|Completed||N/A|162|Actual|Smith & Nephew Medical (Shanghai) Ltd||2|||f||||f|f|f||||||No||2017-10-11 00:25:19.194178|2017-10-11 00:25:19.194178
NCT02139332|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-26|||June 2015||2015-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FPT PFR||A Primary Prevention Trial to Strengthen Child Attachment in a Native Community|A Primary Prevention Trial to Strengthen Child Attachment in a Native Community|Recruiting||N/A|300|Anticipated|University of Washington||2|||f||||f||||||||No||2017-10-11 00:25:19.290102|2017-10-11 00:25:19.290102
NCT02139319|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-08-04|||March 2014||2014-03-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee||Completed||Phase 1|22|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-11 00:25:19.371745|2017-10-11 00:25:19.371745
NCT02139306|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-11-25|||June 2014||2014-06-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)|A Phase 3 Efficacy and Safety Study of Ataluren (PTC124®) in Patients With Nonsense Mutation Cystic Fibrosis|Active, not recruiting||Phase 3|208|Anticipated|PTC Therapeutics||2|||f||||t||||||||||2017-10-11 00:25:19.46453|2017-10-11 00:25:19.46453
NCT02139293|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-09-01|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pilot Study - Auricular Vagus Nerve Stimulation Effects on Cardiovascular Parameters|Functional Mapping of Auricular Vagal Stimulation Points on Cardiovascular Parameters in Healthy Subjects - Pilot Study|Not yet recruiting||N/A|10|Anticipated|Medical University of Vienna||1|||f|||||f|f||||||||2017-10-11 00:25:19.762434|2017-10-11 00:25:19.762434
NCT02135913|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-04-28|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|||Roles of Vitamin D and HDL in Obese Children|Roles of Vitamin D and HDL in Obese Children|Completed||N/A|1|Actual|University of Kentucky||1|||f||||f||||||||||2017-10-11 00:26:16.407488|2017-10-11 00:26:16.407488
NCT02139280|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-07-27|||December 2013||2013-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy|A Prospective Randomized Trial Examining Low- or Intermediate-Dose Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy|Recruiting||Phase 2|56|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 00:25:19.866904|2017-10-11 00:25:19.866904
NCT02139267|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-07-11|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia|A Randomized, Open-label, Multi-center, Phase 2 Clinical Trial to Determine the Optimal Dose and Evaluate the Safety of GX-188E, a DNA-based Therapeutic Vaccine, Administered Intramuscularly by Electroporation (EP) in HPV Type 16 and/or 18 Positive Patients With Cervical Intraepithelial Neoplasia 3 (CIN 3)|Completed||Phase 2|72|Actual|Genexine, Inc.||2|||f||||f||||||||||2017-10-11 00:25:20.024255|2017-10-11 00:25:20.024255
NCT02139241|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-11-17|||June 2013||2013-06-01|May 2014|2014-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery|The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery|Completed||N/A|114|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:25:20.21542|2017-10-11 00:25:20.21542
NCT02139228|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-10-13|2015-05-19||November 2014||2014-11-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children|A Phase IIIb, Controlled, Open Label, Single-Center, Persistency, Extension Study in Chinese Children After a 2+1 Dose Series of Either CRM197-Conjugate Haemophilus Influenzae Type b Vaccine or Tetanus Toxoid-Conjugate Haemophilus Influenzae Type b Vaccine|Completed||Phase 3|426|Actual|Novartis||2|||f||||f||||||||||2017-10-11 00:25:20.312558|2017-10-11 00:25:20.312558
NCT02139215|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-05|||April 2014||2014-04-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Observational|||Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients|A Phase IV Multicenter Trial to Evaluate Real-world Health Outcomes and Economic Impact of Panitumumab Versus Standard-of-care in the Treatment of Patients With Chemotherapy-refractory Metastatic Colorectal Cancer|Active, not recruiting||N/A|72|Actual|PeriPharm|||1||f||||f||||||||||2017-10-11 00:25:20.573872|2017-10-11 00:25:20.573872
NCT02139202|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-05-01|||May 2014||2014-05-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|September 2015|Actual|2015-09-01||Interventional|||Heartstrong Pilot Program|HeartStrong Pilot Program - Automated Hovering to Improve Medication Adherence Among Myocardial Infarction Patients|Completed||N/A|17|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 00:25:20.663033|2017-10-11 00:25:20.663033
NCT02139189|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-07-18|||June 2014||2014-06-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Restore Myocardial Function With CorMatrix® ECM® Particulate (P-ECM)|RESTORE Myocardial Function With CorMatrix® ECM® Particulate (P-ECM) Implantation in Subjects With LVEF 25 to 40% Study|Completed||N/A|9|Actual|CorMatrix Cardiovascular, Inc.||1|||f||||f||||||||||2017-10-11 00:25:20.783852|2017-10-11 00:25:20.783852
NCT02139176|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-04-28|2015-09-02||March 2014||2014-03-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||HIV-infected women eligible for Option B+|Assessing Strategies for Increasing Male Involvement in Malawi's Antenatal Program|Assessing Strategies for Increasing Male Involvement in Malawi's Antenatal Program|Completed||N/A|200|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:25:20.877668|2017-10-11 00:25:20.877668
NCT02139163|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-02-23|||October 2002||2002-10-01|February 2016|2016-02-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01|6 Months|Observational [Patient Registry]|CAPNETZ||Epidemiological Study on Community Acquired Pneumonia|Epidemiological Study on Community Acquired Pneumonia|Recruiting||N/A|10150|Anticipated|Hannover Medical School|||1||f||||f||||||||||2017-10-11 00:25:21.207772|2017-10-11 00:25:21.207772
NCT02139150|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-09-08|||May 2014||2014-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy|Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy|Suspended||N/A|200|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-11 00:25:21.337732|2017-10-11 00:25:21.337732
NCT02139137|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-01-17|2016-11-08||January 2010||2010-01-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Evaluating a Novel Working Memory Training Program to Decrease Symptoms of PTSD|Evaluating a Novel Working Memory Training Program to Decrease Symptoms of PTSD|Completed||N/A|47|Actual|San Diego State University||2|||f||||f||||||||No||2017-10-11 00:25:21.483437|2017-10-11 00:25:21.483437
NCT02139111|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-07-07|||April 2014||2014-04-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||PRC-063 in Adolescent ADHD|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adolescent ADHD Patients|Completed||Phase 3|360|Actual|Rhodes Pharmaceuticals, L.P.||5|||f||||f||||||||||2017-10-11 00:25:22.184112|2017-10-11 00:25:22.184112
NCT02139098|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-05-04|||May 2014||2014-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALPHASOM||Alternative Dosing Regimens in the Pharmacotherapy of Insomnia|Phase III Study on Alternative Dosing Regimens in the Pharmacotherapy of Mild to Moderate Insomnia|Recruiting||Phase 3|150|Anticipated|Philipps University Marburg Medical Center||5|||f||||t||||||||||2017-10-11 00:25:22.455686|2017-10-11 00:25:22.455686
NCT02139085|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-08-06|||August 2014||2014-08-01|August 2014|2014-08-01|July 2016|Anticipated|2016-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Great Saphenous Vein Electrocoagulation|A Prospective Double Blind Randomized Controlled Trial Of Electrocoagulation Versus Radiofrequency Treatment Of The Great Saphenous Vein In Patients With Varicose Veins.|Unknown status|Recruiting|Phase 2|82|Anticipated|Instituto Dante Pazzanese de Cardiologia||2|||f||||f||||||||||2017-10-11 00:25:22.615706|2017-10-11 00:25:22.615706
NCT02139072|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-03|||March 2015||2015-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients|Accuracy of CoaguChek XS in Patients With Antiphospholipid Antibody Syndrome|Completed||N/A|60|Actual|University of Florida|||2||f||||f||||||||||2017-10-11 00:25:22.737679|2017-10-11 00:25:22.737679
NCT02139059|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-02-02|||June 2014||2014-06-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Delayed or Direct Ureteroscopy in the Treatment of Pediatric Calcular Anuria|Staged Ureteroscopy After Initial Urinary Drainage Versus Direct Ureteroscopy in the Treatment of Pediatric Obstructive Calcular Anuria|Unknown status|Recruiting|N/A|50|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-11 00:25:22.828926|2017-10-11 00:25:22.828926
NCT02139046|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-09-15|2016-09-15|2016-06-22|April 2014||2014-04-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Full Analysis Set (FAS) included all participants who were randomized and received at least 1 dose of double-blind study medication.|Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout|A Phase 3, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of Febuxostat 40 mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout|Completed||Phase 3|1790|Actual|Takeda||5|||f||||t||||||||||2017-10-11 00:25:23.025235|2017-10-11 00:25:23.025235
NCT02139033|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-06-10|||May 2014||2014-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome|A Single-Center Evaluation of Retaine™ Ophthalmic Emulsion in the Management of Tear Film Stability and Ocular Surface Staining in Patients Diagnosed With Dry Eye|Completed||Phase 4|42|Actual|Ocusoft, Inc.||1|||f||||||||||||||2017-10-11 00:25:25.537763|2017-10-11 00:25:25.537763
NCT02139020|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-13|||February 2013||2013-02-01|October 2016|2016-10-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Observational|||Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients|Prospective Collection of Plasma Samples From Patients Treated With Molecular Targeted Therapies for Squamous Cell Carcinoma of the Head and Neck|Recruiting||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||Samples With DNA|"     One EDTA tube is collected at the beginning of the study and there are only plasma samples at     baseline, during treatment, and at progression.   "|||2017-10-11 00:25:25.632178|2017-10-11 00:25:25.632178
NCT02139007|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-04-04|2017-02-08||June 2014|Actual|2014-06-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|EDGE||Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study|Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study|Completed||Phase 4|27|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 00:25:25.907631|2017-10-11 00:25:25.907631
NCT02138994|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-03-27|||July 2014||2014-07-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care|Clinical Assessment of the Next Science Wound Gel Efficacy in Chronic Wound Compared to Standard of Care|Completed||N/A|43|Actual|Next Science TM||2|||f||||f||||||||||2017-10-11 00:25:26.555088|2017-10-11 00:25:26.555088
NCT02138981|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-05-14|||May 2014||2014-05-01|May 2014|2014-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Hepatectomy Versus Chemoembolization as the Initial Treatment for Resectable Hepatocellular Carcinoma Beyond Milan Criteria|Hepatic Resection Versus Transarterial Chemoembolization as the Initial Treatment for Resectable Hepatocellular Carcinoma Beyond Milan Criteria|Recruiting||Phase 4|436|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:25:26.667451|2017-10-11 00:25:26.667451
NCT02138968|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-08-31|||September 2013||2013-09-01|August 2015|2015-08-01||||August 2015|Actual|2015-08-01||Interventional|||Clinical and Economic Assessment of a Pre-frail Screening Program|Clinical and Economic Assessment of an Opportunistic Screening Program for Pre-frailty State in Elderly Population.|Completed||N/A|170|Actual|Consorci Sanitari del Maresme||2|||f||||||||||||||2017-10-11 00:25:26.795017|2017-10-11 00:25:26.795017
NCT02138955|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-14|2017-05-06|||March 2014||2014-03-01|May 2017|2017-05-01|June 30, 2017|Anticipated|2017-06-30|June 2017|Anticipated|2017-06-01||Interventional|||A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer|: A PHASE Ib DOSE ESCALATION STUDY ON THE SAFETY, TOLERABILITY AND ACTIVITY OF LIPOSOMAL CURCUMIN IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC CANCER|Active, not recruiting||Phase 1/Phase 2|33|Anticipated|SignPath Pharma, Inc.||1|||f||||t||||||||||2017-10-11 00:25:26.905402|2017-10-11 00:25:26.905402
NCT02138942|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-05-30|||November 2014||2014-11-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|LIR||Automated Administration of Fluids Guided by Dynamic Parameters and Cardiac Output During General Anesthesia|Automated Administration of Intravenous Fluids Guided by Dynamic Parameters and Cardiac Output During General Anesthesia: a Pilot Feasibility Study|Recruiting||Phase 2|42|Anticipated|Centre Hospitalier Universitaire de Nīmes||1|||f||||t||||||||||2017-10-11 00:25:27.059833|2017-10-11 00:25:27.059833
NCT02138929|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-04-21|||November 10, 2014|Actual|2014-11-10|April 2017|2017-04-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma|A Phase I Study of LDE225 in Combination With Everolimus in Patients With Advanced Gastroesophageal Adenocarcinoma|Active, not recruiting||Phase 1|25|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:25:27.282653|2017-10-11 00:25:27.282653
NCT02138916|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-08-24|||June 13, 2014|Actual|2014-06-13|August 2017|2017-08-01|April 17, 2018|Anticipated|2018-04-17|April 17, 2018|Anticipated|2018-04-17||Interventional|GALATHEA||Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History|Randomised, Double-blind, 56 Week Placebo-controlled, Parallel Group, Multicentre, Phase 3 Study to Evaluate the Efficacy and Safety of 2 Doses of Benralizumab in Patients With Moderate to Very Severe COPD With a History of Exacerbations|Active, not recruiting||Phase 3|1656|Actual|AstraZeneca||3|||f||||t||||||||||2017-10-11 00:25:27.452517|2017-10-11 00:25:27.452517
NCT02138903|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-11-28|||January 2014||2014-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|CARWEAN||A Cardiac Ultrasound Evaluation of Two Types of Weaning Trials of Mechanical Ventilation for a First Weaning Trial|A Cardiac Ultrasound Evaluation of Two Types of Weaning Trials of Mechanical Ventilation for a First Weaning Trial|Completed||N/A|120|Actual|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-11 00:25:28.788131|2017-10-11 00:25:28.788131
NCT02138890|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-12-09||2016-08-22|May 2014||2014-05-01|December 2016|2016-12-01|April 2020|Anticipated|2020-04-01|October 2015|Actual|2015-10-01||Interventional|PROGRESS II||APSS-33-00: A Multicenter, Pilot Study of Autologous Protein Solution (APS) in Knee Osteoarthritis (OA)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study of a Single, Intra-Articular Injection of Autologous Protein Solution (APS) in Patients With Osteoarthritis (OA) of the Knee|Active, not recruiting||Phase 2|46|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-10-11 00:25:28.909372|2017-10-11 00:25:28.909372
NCT02138877|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2016-01-19|||January 2014||2014-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Dismembered Pyeloplasty With and Without After Coming Stent|Dismembered Pyeloplasty With and Without After Coming Stent in Neonatal Ureteropelvic Junction Obstruction|Completed||N/A|30|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 00:25:29.038563|2017-10-11 00:25:29.038563
NCT02138851|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-05-13|||June 2013||2013-06-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||The Effects of a Ficus Carica in Subjects With Functional Constipation|Randomized, Double-Blind, Placebo-Controlled, Parallel Trial in Subjects With Functional Constipation, to Evaluate the Improvement in Constipation of Ficus Carica|Completed||Phase 2/Phase 3|80|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 00:25:29.236499|2017-10-11 00:25:29.236499
NCT02138838|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-08-16|2017-07-13|2017-04-20|November 7, 2014|Actual|2014-11-07|August 2017|2017-08-01|June 23, 2016|Actual|2016-06-23|June 23, 2016|Actual|2016-06-23||Interventional|||Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis|A Randomized, Open-label, Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Dialysis|Terminated||Phase 3|55|Actual|Amgen||2||Sponsor decision|f||||f||||||||||2017-10-11 00:25:29.36359|2017-10-11 00:25:29.36359
NCT02138825|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-05-03|2017-05-03||June 4, 2014|Actual|2014-06-04|May 2017|2017-05-01|September 14, 2016|Actual|2016-09-14|May 5, 2016|Actual|2016-05-05||Interventional|RISE-IIP||Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)|A Randomized, Double-blind, Placebo-controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in Patients With Symptomatic Pulmonary Hypertension Associated With Idiopathic Interstitial Pneumonias (IIP).|Terminated||Phase 2|147|Actual|Bayer|The study was prematurely terminated following a recommendation from the independent data safety monitoring committee (DMC) and steering committee (SC).|2||"Study terminated per recommendation of iDMC. On iDMC request, protocol amended to include   4-month safety follow-up for patients after withdrawal of riociguat."|f||||t|t|||||||||2017-10-11 00:25:30.397667|2017-10-11 00:25:30.397667
NCT02138812|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-08-28|||May 9, 2014|Actual|2014-05-09|August 2017|2017-08-01|December 21, 2017|Anticipated|2017-12-21|December 7, 2017|Anticipated|2017-12-07||Interventional|||Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel|An Open-label Phase I Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of Oral BAY1161909 in Combination With Weekly Intravenous Paclitaxel Given in an Intermittent Dosing Schedule in Subjects With Advanced Malignancies|Active, not recruiting||Phase 1|69|Actual|Bayer||1|||f||||f|t|f||||||||2017-10-11 00:25:31.86694|2017-10-11 00:25:31.86694
NCT02138799|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-10-14|||July 2013||2013-07-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men|A Phase I, Randomized, Open-label, 2-arm Parallel-design Study to Determine the Effect of Multiple-dose Rifampin on the Pharmacokinetics, Safety and Tolerability of Single-dose Enzalutamide in Healthy Male Subjects|Completed||Phase 1|28|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:25:32.003329|2017-10-11 00:25:32.003329
NCT02138786|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-05-25|||November 2014||2014-11-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|SIRRT||Selinexor in Initial or Relapsed/Refractory Richter's Transformation|A Phase 2 Study of the Safety and Anti-tumor Activity of the Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Initial or Refractory and/or Relapsed Richter's Transformation (RT)|Terminated||Phase 2|26|Actual|Karyopharm Therapeutics Inc||1||"Due to enrollment challenges in this rare disease. The termination is not a consequence of any   safety concern."|f||||t||||||||Yes||2017-10-11 00:25:32.272725|2017-10-11 00:25:32.272725
NCT02138773|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-07-14|||April 2014||2014-04-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects|A Randomized, Single Dose, Open-label, Cross-over Study on Bioequivalence of Two Formulations of Tamsulosin Hydrochloride Prolonged Release Capsule (Tamsulosin Pellet From Meppel Plant and Nishine Plant) Under Fed and Fasted Conditions in Chinese Healthy Male Subjects|Completed||Phase 1|80|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 00:25:32.423685|2017-10-11 00:25:32.423685
NCT02138760|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2014-05-14|||August 2014||2014-08-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate Biopsy|Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate Biopsy|Unknown status|Not yet recruiting|N/A|400|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 00:25:32.559041|2017-10-11 00:25:32.559041
NCT02138747|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-12-21|2016-10-19||July 2014||2014-07-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|PREFER|The Randomized Analysis Set (RAS) included all participants who were randomized to the study.|A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)|A Prospective, Double-Blind, Randomized, Two-Period Crossover, Multi-Center Study to Evaluate the Tolerability and Patient Preference Between Myrbetriq® and Detrol® LA in Subjects With Overactive Bladder (OAB)|Completed||Phase 4|376|Actual|Astellas Pharma Inc||4|||f||||f||||||||Undecided||2017-10-11 00:25:32.717564|2017-10-11 00:25:32.717564
NCT02138734|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-08-14|||July 2014||2014-07-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||QUILT-2.005: A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer|A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer|Recruiting||Phase 1/Phase 2|81|Anticipated|Altor BioScience||2|||f||||t||||||||||2017-10-11 00:25:34.1848|2017-10-11 00:25:34.1848
NCT02138721|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-05-02|||May 2014||2014-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|LoMP||Local Treatment With RP for Newly-diagnosed mPCa|Local Treatment With Radical Prostatectomy (RP) for Newly-diagnosed Metastatic Prostate Cancer (mPCa).|Recruiting||N/A|80|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 00:25:34.425919|2017-10-11 00:25:34.425919
NCT02138708|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-07-20|||January 2016||2016-01-01|July 2015|2015-07-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|ReVAch||Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt|Pharmacological Test of Pulmonary Endothelium-dependent Vascular Reactivity to Acetylcholine in Pulmonary Arterial Hypertension With Congenital Cardiac Shunt Child and Adult|Suspended||N/A|50|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:25:34.582364|2017-10-11 00:25:34.582364
NCT02138695|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-01-07|||May 2014||2014-05-01|January 2015|2015-01-01|April 2024|Anticipated|2024-04-01|April 2024|Anticipated|2024-04-01||Observational|||The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study||Recruiting||N/A|3100|Anticipated|Yonsei University|||1||f||||||||||||||2017-10-11 00:25:34.681251|2017-10-11 00:25:34.681251
NCT02138682|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-07-15|||July 2014||2014-07-01|July 2014|2014-07-01||||April 2016|Anticipated|2016-04-01||Observational|||Validation of DaTscan for Detection of Parkinson Disease Related Disorders|Validation of DaTscan for Detection of Parkinsonian Disease and Related Disorders Using Neuropathologically-confirmed Parkinson Disease From Human Brain Tissue|Unknown status|Enrolling by invitation|Phase 4|20|Anticipated|Wisconsin Institute for Neurologic and Sleep Disorders S.C.|||1||f||||f||||||Samples Without DNA|"     Fixed brain tissue   "|||2017-10-11 00:25:34.761581|2017-10-11 00:25:34.761581
NCT02138669|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-15|||January 2011||2011-01-01|May 2014|2014-05-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Intacs for Keratoconus|INTACS® Prescription Inserts Used to Treat Patients With Keratoconus as a Humanitarian Use Device|Recruiting||N/A|25|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 00:25:34.876977|2017-10-11 00:25:34.876977
NCT02138656|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-05-03|||March 2014||2014-03-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CHIC||CHiropractic for Infantile Colic Study|The Effectiveness of Chiropractic in the Treatment of Infantile Colic|Terminated||N/A|160|Anticipated|University of Southampton||4||Review of recruitment methods|f||||t||||||||||2017-10-11 00:25:35.042186|2017-10-11 00:25:35.042186
NCT02138643|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-04-10|||February 2016|Actual|2016-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Laparoscopy Heller Myotomy With Fundoplication Associated Versus Peroral Endoscopic Myotomy (POEM)|Laparoscopy Heller Myotomy With Fundoplication Associated Versus Peroral Endoscopic Myotomy (POEM)|Active, not recruiting||N/A|30|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||No||2017-10-11 00:25:35.175697|2017-10-11 00:25:35.175697
NCT02138630|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2015-09-16|||June 2014||2014-06-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Capsaicinoid Ingestion, Human Metabolism and Exercise (Phase 2)|The Physiological Effects of Capsaicinoid Ingestion on Human Metabolism and Exercise Performance|Unknown status|Active, not recruiting|Early Phase 1|15|Anticipated|University of Prince Edward Island||2|||f||||f||||||||||2017-10-11 00:25:35.286314|2017-10-11 00:25:35.286314
NCT02138617|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-03-17|||May 2014||2014-05-01|March 2017|2017-03-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer|Genotype-Directed Phase II Study Of Higher Dose Of Irinotecan In First-Line Metastatic Colorectal Cancer Patients Treated With Folfiri Plus Bevacizumab|Recruiting||Phase 2|100|Anticipated|UNC Lineberger Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 00:25:35.393474|2017-10-11 00:25:35.393474
NCT02138604|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-06-18|||June 2013||2013-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01|12 Months|Observational [Patient Registry]|dP/dtAMDED||Non Invasive dP/dt to Detect an Acute Ischemic Myocardial Dysfunction in Emergency Department|Non Invasive dP/dt is Not a Good Index to Detect an Acute Ischemic Myocardial Dysfunction in Emergency Department (ED)|Active, not recruiting||N/A|500|Actual|University of Monastir|||1||f||||t||||||||Yes||2017-10-11 00:25:35.56776|2017-10-11 00:25:35.56776
NCT02138591|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-06-14|||February 2016||2016-02-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.|Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.|Withdrawn||Phase 3|0|Actual|University of Missouri, Kansas City||2|||f||||f||||||||||2017-10-11 00:25:35.659466|2017-10-11 00:25:35.659466
NCT02138552|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-05-12|||October 2013||2013-10-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|OML0113||Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to Placebo|Phase II Study to Assess Bacterial Count Reduction of Three Octenidine Mouthwash Concentrations in Comparison to a Placebo in Patients With Mild Gingivitis|Completed||Phase 2|90|Actual|Schülke & Mayr GmbH||3|||f||||f||||||||||2017-10-11 00:25:35.998285|2017-10-11 00:25:35.998285
NCT02138526|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-09-26|||June 2014|Actual|2014-06-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|DIET||Pazopanib Tolerability When Given With Food|Improving the Tolerability of the Oral Targeted Anticancer Drug Pazopanib by Food Intake (DIET)|Recruiting||Phase 1|79|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 00:25:36.215893|2017-10-11 00:25:36.215893
NCT02138513|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-18|||April 2014||2014-04-01|February 2016|2016-02-01|May 1, 2017|Actual|2017-05-01|July 20, 2016|Actual|2016-07-20||Interventional|BeMind||(Cost-)Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Cancer Patients|(Cost-) Effectiveness of Mindfulness Based Cognitive Therapy (MBCT) in Cancer Patients: a Superiority Trial of Online and Face-to-face Treatment Versus Treatment as Usual (TAU).|Completed||N/A|245|Actual|Radboud University||3|||f||||t||||||||||2017-10-11 00:25:36.502411|2017-10-11 00:25:36.502411
NCT02138500|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-09-23|||May 2014||2014-05-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865|A Phase 1, Open-label Study To Evaluate Central Occupancy Of The Benzodiazepine Binding Site Of Gabaa Receptors By Positron Emission Tomography (Pet) With Ligand [11c]Flumazenil Following Single Dose Of Pf-06372865 In Healthy Subjects|Completed||Phase 1|5|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:25:36.613356|2017-10-11 00:25:36.613356
NCT02138487|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-08-18|||August 2014||2014-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ReCOUP||Restricted Convalescence: Outcomes Following Urogynecologic Procedures|Restricted Convalescence: Outcomes Following Urogynecologic Procedures|Active, not recruiting||N/A|108|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 00:25:36.732453|2017-10-11 00:25:36.732453
NCT02138474|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-05-16|||April 2014||2014-04-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Efficacy of Lacticum Acidum Homaccord in the Treatment of Chronic Tension-type Headaches|The Efficacy of Lacticum Acidum Homaccord in the Treatment of Chronic Tension-type Headaches|Completed||Phase 2|30|Actual|University of Johannesburg||2|||f||||t||||||||No||2017-10-11 00:25:36.844739|2017-10-11 00:25:36.844739
NCT02138461|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-09-16|2014-09-16||October 2013||2013-10-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops|Subjective Patient Assessment Comparing Overall Tolerability and Satisfaction of a Prostaglandin Analogue Including Either Bimatoprost 0.01% or Latanoprost.|Completed||N/A|211|Actual|MDbackline, LLC|||2||f||||f||||||None Retained|"     Note patients will be recruited to fill out a questionnaire, describing their symptoms     related to glaucoma use drops. In this study, we are examining only patients taking either     bimatoprost or latanoprost, thus 2 cohorts. However, this is not an interventional study, and     there will be only one study visit (enrollment and questionnaire at the same time) and no     change in the patient's prescribed therapy.   "|||2017-10-11 00:25:36.949424|2017-10-11 00:25:36.949424
NCT02138448|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-06-09|||January 2017|Actual|2017-01-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Implementing Personal Health Records to Promote Evidence-Based Cancer Screening|Implementing Personal Health Records to Promote Evidence-Based Cancer Screening|Recruiting||N/A|46|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 00:25:37.217237|2017-10-11 00:25:37.217237
NCT02138435|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-09-12|||March 2014||2014-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Observational|||Longterm Outcome After Ventricular Septal Defect Closure|Cardiac Output During Exercise in Young Adults Operated for Ventricular Septal Defect as Children|Completed||N/A|40|Actual|University of Aarhus|||2||f||||f||||||||||2017-10-11 00:25:37.327668|2017-10-11 00:25:37.327668
NCT02138422|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-06-26|||July 2014||2014-07-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|November 2015|Actual|2015-11-01||Interventional|||A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer|A Double Blind, Placebo Controlled Pivotal Phase III Study Evaluating Xilonix™ in Symptomatic Colorectal Cancer Patients Refractory to Standard Therapy|Active, not recruiting||Phase 3|276|Anticipated|XBiotech, Inc.||2|||f||||t||||||||||2017-10-11 00:25:37.421912|2017-10-11 00:25:37.421912
NCT02138409|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-10-04|||November 30, 2017|Anticipated|2017-11-30|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting|A Pilot, Randomized, Double-blind, Placebo-controlled Single-center Study to Evaluate the Safety and Efficacy of SUBSYS™ (Fentanyl Sublingual Spray) for the Treatment of Acute Procedure-related Pain in a Monitored Setting|Not yet recruiting||Phase 3|60|Anticipated|INSYS Therapeutics Inc||5|||f||||f|t|f||||||||2017-10-11 00:25:37.53528|2017-10-11 00:25:37.53528
NCT02138396|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-12-11|||January 2014||2014-01-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions|Single-Dose, Open-Label, Two-Period, Two-Treatment, Two-Sequence Crossover Exploratory Bioavailability Study of Subsys® (Fentanyl Sublingual Spray), 400 mcg, and Fentanyl Citrate Injection 2 mL x 0.05 mg/mL (Total Dose 100 mcg) Under Fasted Conditions|Completed||N/A|12|Actual|INSYS Therapeutics Inc||2|||f||||f||||||||||2017-10-11 00:25:37.768032|2017-10-11 00:25:37.768032
NCT02138383|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-06-30|||May 22, 2014|Actual|2014-05-22|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 15, 2016|Actual|2016-12-15||Interventional|||Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer|A Phase I Trial With Cohort Expansion of Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer|Active, not recruiting||Phase 1|25|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 00:25:37.893015|2017-10-11 00:25:37.893015
NCT02138370|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-05-27|||April 2015||2015-04-01|May 2015|2015-05-01||||September 2016|Anticipated|2016-09-01||Observational|||Comprehensive Immune-landscape in Localized Colorectal Cancer|Tissue Und Liquid Immune Biopsies to Predict Clinical Outcome in Localized Colorectal Cancer Patients - Retrospective Clinical Observational Study.|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-11 00:25:38.077091|2017-10-11 00:25:38.077091
NCT02138357|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-01-06|||December 2014||2014-12-01|January 2015|2015-01-01||||December 2016|Anticipated|2016-12-01||Interventional|Butrans||Butrans for Treatment of Restless Legs Syndrome|Butrans for Treatment of Restless Legs Syndrome|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||2||No funding|f||||f||||||||||2017-10-11 00:25:38.144497|2017-10-11 00:25:38.144497
NCT02138344|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-05-22|||April 2006||2006-04-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Assessment of Neuropathic Pain||Recruiting||N/A|300|Anticipated|University of Zurich|||3||f||||t||||||||||2017-10-11 00:25:38.261854|2017-10-11 00:25:38.261854
NCT02138331|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-12|||April 2014||2014-04-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|||Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM)|Phase 1 Study of The Effect of Cell-Free Cord Blood Derived Microvesicles On β-cell Mass in Type 1 Diabetes Mellitus (T1DM) Patients|Unknown status|Enrolling by invitation|Phase 2/Phase 3|20|Anticipated|General Committee of Teaching Hospitals and Institutes, Egypt||1|||f||||t||||||||||2017-10-11 00:25:38.357081|2017-10-11 00:25:38.357081
NCT02138318|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-05-13|||May 2012||2012-05-01|May 2014|2014-05-01||||May 2015|Anticipated|2015-05-01||Interventional|||High Definition Versus Chromoendoscopy for Dysplasia Detection in Ulcerative Colitis (UC)|Randomized Controlled Trial of High Definition White Light Endoscopy Versus Chromoendoscopy for Dysplasia Detection in Ulcerative Colitis Surveillance|Unknown status|Recruiting|N/A|152|Anticipated|The Leeds Teaching Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 00:25:38.508236|2017-10-11 00:25:38.508236
NCT02138305|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-09-26|||December 2014||2014-12-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|PERSEUS||Correlation Study of Imaging Data Acquired During CABG With Data Acquired in the Cath Lab|Collaborative Pilot Study to Determine the Correlation Between Intra-Operative Observations Using SPY® Near Infra-Red Imaging and Cardiac Catheterization Laboratory Physiological Assessment of Lesion Severity (PERSEUS Pilot Study)|Recruiting||N/A|30|Anticipated|East Carolina University||1|||f||||f||||||||||2017-10-11 00:25:38.621786|2017-10-11 00:25:38.621786
NCT02138292|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-05-31|||July 2014||2014-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma|A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma|Active, not recruiting||Phase 1|21|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 00:25:38.7341|2017-10-11 00:25:38.7341
NCT02138279|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-04-22|||April 2014||2014-04-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Observational|||Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements|Comparative Study of the Topcon Tonometers - CT-800, CT-1, CT-1P and TRK-2P to Demonstrate Conformance to ANSI Z80.10-2009 Ophthalmic Instruments -Tonometers, to the FDA Guidance for Industry and FDA Staff, Tonometer-Premarket Notification [510(k)] Submissions, and to the Applicable Supplemental Information Sheet and Comparison of Pachymetry Values for CT-1P and TRK-2P With the Konan CellChek Plus (Predicate)|Completed||N/A|65|Actual|Topcon Medical Systems, Inc.|||1||f||||f||||||||||2017-10-11 00:25:38.851359|2017-10-11 00:25:38.851359
NCT02138266|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-04-22|||February 2014||2014-02-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Observational|||Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements|Comparative Study of the Topcon Specular Microscope SP-1P and the Konan Specular Microscope CELLCHEK XL (Predicate Device) for the Measurements of Endothelial Cell Density Measurements, Coefficient of Variation of Endothelial Cell Area, ％ Hexagonality, Central Corneal Thickness|Completed||N/A|65|Actual|Topcon Medical Systems, Inc.|||3||f||||f||||||||||2017-10-11 00:25:38.948955|2017-10-11 00:25:38.948955
NCT02138253|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-04-04|||May 2014||2014-05-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|POLT-HCV-SVR||A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV|A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy|Active, not recruiting||Phase 2|60|Anticipated|Conatus Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 00:25:39.045725|2017-10-11 00:25:39.045725
NCT02138240|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-01-31|||December 2016||2016-12-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks|Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks|Recruiting||N/A|48|Anticipated|Johns Hopkins University||1|||f||||||||||||No||2017-10-11 00:25:39.24049|2017-10-11 00:25:39.24049
NCT02138214|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-12-22|||June 2014||2014-06-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|||Thyroid Gland Removal With or Without Central Lymph Node Dissection in Treating Patients With Node Negative Thyroid Cancer|Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer|Recruiting||Phase 2|140|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 00:25:39.498844|2017-10-11 00:25:39.498844
NCT02138201|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-11-16|||January 2014||2014-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Representation of the Bladder Innervation Using Diffusion Tensor Imaging Fiber Tracking With MRI - a Pilot Study||Completed||N/A|10|Actual|Swiss Paraplegic Centre Nottwil|||2||f||||f||||||||||2017-10-11 00:25:39.66007|2017-10-11 00:25:39.66007
NCT02138188|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-13|||September 2013||2013-09-01|May 2014|2014-05-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Observational|||Psychological Aspects and Insulin Pump Therapy|Psychological Aspects and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetic Adults.|Unknown status|Recruiting|N/A|36|Anticipated|Universita di Verona|||1||f||||||||||||||2017-10-11 00:25:39.763951|2017-10-11 00:25:39.763951
NCT02138175|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-02-03|||January 2016||2016-01-01|February 2015|2015-02-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Continuous Hemoglobin Monitoring: Detection of Acute Blood Loss - Accurate, Timely and Cost-effective|Continuous Hemoglobin Monitoring: Detection of Acute Blood Loss - Accurate, Timely and Cost-effective|Withdrawn||N/A|0|Actual|Carolinas Healthcare System|||1|Sponsor (Masimo) suspended trial due to change in corporate ownership|f||||t||||||||||2017-10-11 00:25:39.876037|2017-10-11 00:25:39.876037
NCT02138162|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-12|||August 2013||2013-08-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men|A Phase 1, Non-randomized, Open-label, Single-dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Enzalutamide in Male Subjects With Severe Hepatic Impairment and Normal Hepatic Function|Completed||Phase 1|16|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:25:39.985348|2017-10-11 00:25:39.985348
NCT02138149|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-11-16|||November 2013||2013-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?||Completed||N/A|47|Actual|Swiss Paraplegic Centre Nottwil|||2||f||||f||||||||||2017-10-11 00:25:40.153096|2017-10-11 00:25:40.153096
NCT02138136|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-23|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|April 2017|Actual|2017-04-01||Interventional|||Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation|A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation|Active, not recruiting||Phase 3|420|Actual|Sucampo Pharma Americas, LLC||1|||f||||t||||||||||2017-10-11 00:25:40.271229|2017-10-11 00:25:40.271229
NCT02138123|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-06-06|||December 2011||2011-12-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Intraocular Lens-shell Technique in Phacoemulsification|Intraocular Lens-Shell Technique: An Adjustment of Surgical Procedure Makes Differences in Treating Dense Nucleus Cataract|Completed||N/A|80|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:25:40.544694|2017-10-11 00:25:40.544694
NCT02138110|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-09-20|||April 2014||2014-04-01|July 2017|2017-07-01||||September 2017|Anticipated|2017-09-01||Interventional|||The INSPIRE Study: Probable Benefit of the Neuro- Spinal Scaffold for Treatment of AIS A Thoracic Acute Spinal Cord Injury|The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM) for Safety and Neurologic Recovery in Subjects With Complete Thoracic AIS A Spinal Cord Injury|Active, not recruiting||Phase 3|20|Anticipated|InVivo Therapeutics||1|||f||||t||||||||||2017-10-11 00:25:40.826478|2017-10-11 00:25:40.826478
NCT02138097|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2015-09-02|2015-07-29||May 2014||2014-05-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational||All patients included in the study|Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns|A Description of Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns Including Initiation, Switching, and Discontinuation|Completed||N/A|615067|Actual|Boehringer Ingelheim|||8||f||||||||||||||2017-10-11 00:25:41.036359|2017-10-11 00:25:41.036359
NCT02138084|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2017-09-21|||May 14, 2014|Actual|2014-05-14|September 2017|2017-09-01|July 24, 2014|Actual|2014-07-24|July 24, 2014|Actual|2014-07-24||Interventional|||Drug-drug Interaction (DDI) Rifabutin|Pharmacokinetic Interaction Study to Evaluate the Pharmacokinetic Effect of Rifabutin on BMS-626529, the Active Moiety of BMS-663068, With and Without Ritonavir in Healthy Subjects|Completed||Phase 1|102|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 00:25:43.532693|2017-10-11 00:25:43.532693
NCT02138071|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-10-05|||April 2014||2014-04-01|June 2015|2015-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Psychological Variables in Physiotherapy Treatment of Low Back Pain: A Comparison of Group and Individual Treatment|Psychological Variables in Physiotherapy Treatment for LBP: a Comparison Between Individual and Gruop Treatment|Completed||N/A|180|Actual|Bait Balev Hospital|||2||f||||t||||||||Undecided||2017-10-11 00:25:43.636161|2017-10-11 00:25:43.636161
NCT02138058|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-05-08|||January 2015||2015-01-01|December 2015|2015-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TFO||Topiramate Trial for Compulsive Buying|Double Blind Controlled Trial of Topiramate for Compulsive Buying|Completed||Phase 2|42|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:25:43.742141|2017-10-11 00:25:43.742141
NCT02138045|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-13|2016-01-04|||May 2014||2014-05-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|TODINELI||Treatment of Diabetic Neuropathy With Liraglutide|A Randomized, Double-blinded, Single-centre, Parallel-group, Placebo-controlled, Prospective Trial of Neuroprotective Effect of Liraglutide for Treatment of Diabetic Neuropathy.|Enrolling by invitation||N/A|40|Anticipated|Aalborg Universitetshospital||2|||f||||t||||||||||2017-10-11 00:25:43.864608|2017-10-11 00:25:43.864608
NCT02138032|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-12-05|||May 2014||2014-05-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Message Content on Intention to Quit Smoking|Effects of Message Content on Intention to Quit Smoking in Smokers With Peripheral Artery Disease - a Randomised Controlled Trial|Terminated||N/A|17|Actual|University of Stirling||2||Student study which ended at the end of their course.|f||||t||||||||||2017-10-11 00:25:43.988815|2017-10-11 00:25:43.988815
NCT02138019|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2014-05-13|||December 2009||2009-12-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Application of Fibrin Glue (Tissucol Duo Quick) in External Eye Surgeries|The Application of Fibrin Glue (Tissucol Duo Quick) in External Eye Surgeries|Completed||N/A|60|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:25:44.09284|2017-10-11 00:25:44.09284
NCT02138006|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-08-31|2015-11-16||September 1982||1982-09-01|August 2016|2016-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SDIS||Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes|Stockholm Diabetes Intervention Study|Completed||N/A|102|Actual|Karolinska Institutet||2|||f||||f||||||||Yes||2017-10-11 00:25:46.098442|2017-10-11 00:25:46.098442
NCT02137993|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2014-05-11|||March 2012||2012-03-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia|A Multi-center, Randomized, Double Blind, Parallel, PhaseⅣ Trial to Evaluate the Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia, Schizophreniform Disorder and Schizoaffective Disorder|Completed||Phase 4|64|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 00:25:46.577685|2017-10-11 00:25:46.577685
NCT02137980|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-04-10|||April 2011||2011-04-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01|1 Week|Observational [Patient Registry]|CPORT||Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site|Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site|Unknown status|Recruiting|N/A|28000|Anticipated|Johns Hopkins University|||1||f||||t||||||||||2017-10-11 00:25:46.687657|2017-10-11 00:25:46.687657
NCT02137967|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-05-13|||August 2011||2011-08-01|May 2014|2014-05-01|June 2016|Anticipated|2016-06-01|September 2014|Anticipated|2014-09-01||Interventional|||Sodium Hypochlorite Pulpotomies in Primary Molars: Comparison With Conventional 20% Formocresol Pulpotomies|Clinical Evaluation of Sodium Hypochlorite Pulpotomies in Primary Molars: A Long-Term Follow-Up in Comparison With Conventional 20% Formocresol Pulpotomies|Unknown status|Recruiting|Early Phase 1|200|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:25:46.913902|2017-10-11 00:25:46.913902
NCT02137954|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-08-27|||May 2014||2014-05-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|LIDOSP||Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study.|Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study.|Unknown status|Recruiting|Phase 3|200|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 00:25:47.056488|2017-10-11 00:25:47.056488
NCT02137941|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-05-12|||September 2010||2010-09-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Stress Management Programs in Fire-fighters|Stress Management Programs in Fire-fighters of Paris: a Randomized Controlled Trial|Completed||N/A|180|Actual|French Defence Health Service||3|||f||||f||||||||||2017-10-11 00:25:47.188263|2017-10-11 00:25:47.188263
NCT02137928|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2014-12-18|||January 2006||2006-01-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Carboplatin Periocular Injection for Retinoblastoma|Carboplatin Periocular Injection in the Treatment for Retinoblastoma--A Single Center, Randomized Study to Evaluate the Efficacy of Carboplatin in Subjects With Retinoblastoma|Unknown status|Recruiting|Phase 3|50|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:25:47.295977|2017-10-11 00:25:47.295977
NCT02137915|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-05-31|||April 2014||2014-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration|Long-Term Follow-up Study of the Phase I/II Safety and Preliminary Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration|Terminated||N/A|8|Actual|StemCells, Inc.|||1|Based on a business decision unrelated to any safety concerns.|f||||t||||||||||2017-10-11 00:25:47.584313|2017-10-11 00:25:47.584313
NCT02137902|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-04-23|||June 2015||2015-06-01|April 2016|2016-04-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|HEALTHH||Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study|Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study|Recruiting||N/A|300|Anticipated|Stanford University||2|||f||||f||||||||Undecided||2017-10-11 00:25:47.675401|2017-10-11 00:25:47.675401
NCT02137889|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-05-12|||July 2012||2012-07-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|VAY736Y||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients|A Phase 1, Muticenter, Open-label, Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 When Administered Intravenously in Relapsed or Refractory Chronic Lymphocytic Leukemia Patients|Terminated||Phase 1|3|Actual|Novartis||2||"Study terminated on 04Oct2013 for business reasons after being on hold for 10 months. Early   termination was not due to safety concerns."|f||||f||||||||||2017-10-11 00:25:47.772243|2017-10-11 00:25:47.772243
NCT02137876|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-12-28|||April 2014||2014-04-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Effects of Thymoglobulin on Human B Cells|Effects of Thymoglobulin on Proliferation, Activation, and Differentiation of Human B Cells|Recruiting||N/A|15|Anticipated|Northwestern University|||1||f||||f||||||Samples With DNA|"     20ml of whole blood will be drawn from each subject each time they are asked to have blood     drawn. The total amount of blood collected from subjects will not exceed 360 ml (1.5 cups)     within any eight week period throughout the two year timespan patients may be asked to     participate in this study.   "|||2017-10-11 00:25:47.869771|2017-10-11 00:25:47.869771
NCT02137863|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-05-13|||June 2011||2011-06-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy|Phase 4 Study of Dexmedetomidine Effects on Preventing Contrast Induced Nephropathy|Completed||Phase 4|60|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 00:25:47.961899|2017-10-11 00:25:47.961899
NCT02137850|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-09-28|||June 2014||2014-06-01|September 2016|2016-09-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|pathfinder™6||Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A|An Open-label Single-arm Multicentre Non-controlled Phase 3a Trial Investigating Safety and Efficacy of N8-GP in Prophylaxis and Treatment of Bleeding Episodes in Previously Untreated Paediatric Patients With Severe Haemophilia A|Enrolling by invitation||Phase 3|125|Anticipated|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 00:25:48.062131|2017-10-11 00:25:48.062131
NCT02137837|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-11-04|||May 2014||2014-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|September 2017|Anticipated|2017-09-01||Interventional|||S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer|Fulvestrant Alone Versus Fulvestrant and Everolimus Versus Fulvestrant, Everolimus and Anastrozole: A Phase III Randomized Placebo-Controlled Trial in Postmenopausal Patients|Active, not recruiting||Phase 3|825|Anticipated|Southwest Oncology Group||3|||f||||t||||||||||2017-10-11 00:25:48.241825|2017-10-11 00:25:48.241825
NCT02137811|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-07-20|||April 2014||2014-04-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo)|Chart Review of Demographics and Clinical Outcomes and Physician Attitudes in Patients Who Have Received the Microculture Kinetic (MiCK) Apoptosis Test|Withdrawn||N/A|0|Actual|DiaTech Oncology|||1|Company decided to remove CLIA test from Market.|f||||f||||||||||2017-10-11 00:25:49.135723|2017-10-11 00:25:49.135723
NCT02137785|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-08-17|2015-07-22||May 2014||2014-05-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||ITT|Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities|A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities|Completed||Phase 3|269|Actual|DUSA Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:25:49.554042|2017-10-11 00:25:49.554042
NCT02137772|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-12-07|||June 2014||2014-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)|A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients|Completed||Phase 3|570|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 00:25:52.276556|2017-10-11 00:25:52.276556
NCT02137759|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-10-04|||May 2014||2014-05-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|May 2018|Anticipated|2018-05-01||Interventional|||MRSI to Predict Response to RT/TMZ ± Belinostat in GBM|Quantitative Magnetic Resonance Spectroscopic Imaging (MRSI) to Predict Early Response to Standard Radiation Therapy (RT)/Temozolomide (TMZ) ± Belinostat Therapy in Newly-Diagnosed Glioblastomas (GBM)|Recruiting||Phase 2|87|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 00:25:52.365867|2017-10-11 00:25:52.365867
NCT02137746|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-05-23|||December 2013|Actual|2013-12-01|June 2015|2015-06-01|March 20, 2017|Actual|2017-03-20|April 2015|Actual|2015-04-01||Interventional|||Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer|Open-label, One-arm, Multi-centre Phase II Clinical Trial Treated With Second Cycle of Active Cellular Immunotherapy With DCVAC/PCa in Patients With Localized Prostate Cancer After Primary Radical Prostatectomy Without Objective Progression|Completed||Phase 2|24|Actual|Sotio a.s.||1|||f||||f||||||||||2017-10-11 00:25:52.482448|2017-10-11 00:25:52.482448
NCT02137733|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-10|||June 2013||2013-06-01|May 2014|2014-05-01||||May 2016|Anticipated|2016-05-01||Interventional|||The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)|The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)|Unknown status|Recruiting|N/A|220|Anticipated|Mebix Inc||2|||f||||||||||||||2017-10-11 00:25:52.5962|2017-10-11 00:25:52.5962
NCT02137720|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-07-17|||June 2014||2014-06-01|July 2016|2016-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||Translating Telephonic Diabetes Self-management Support to Primary Care Practice|Translating Telephonic Diabetes Self-management Support to Primary Care Practice: The NYC Care Calls Trial|Recruiting||N/A|875|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 00:25:53.157408|2017-10-11 00:25:53.157408
NCT02137707|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-10-02|||November 2012||2012-11-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Observational|IGLOO||Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya|An Investigator-initiated, Multicenter, Phase IV, Open-label Study to Evaluate the Biological Basis for Disease Progression in Relapsing-remitting Multiple Sclerosis Patients Treated in Routine Practice With Gilenya for 2 Years|Active, not recruiting||N/A|100|Anticipated|McGill University|||1||f||||f||||||Samples With DNA|"     serum, peripheral blood mononuclear cells, DNA   "|||2017-10-11 00:25:53.281328|2017-10-11 00:25:53.281328
NCT02137694|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-01-11|||April 2014||2014-04-01|December 2015|2015-12-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Interventional|PapU-APV||Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer|Comparison of the Urinary and Vaginal Auto-takings for the Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer.|Completed||N/A|460|Actual|University Hospital, Brest||1|||f||||t||||||||||2017-10-11 00:25:53.394271|2017-10-11 00:25:53.394271
NCT02137681|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-04-18|||May 2014||2014-05-01|May 2014|2014-05-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|||A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）|2 Cycles Rituximab Compared With Standard Regimen in Management of ITP|Withdrawn||Phase 3|0|Actual|Shandong University||2||No eligible patient was enrolled.|f||||t||||||||||2017-10-11 00:25:53.482322|2017-10-11 00:25:53.482322
NCT02137668|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-11-10|||July 2010||2010-07-01|November 2016|2016-11-01|July 2028|Anticipated|2028-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin|The Human Gastrointestinal Tract Microbiota in the Setting of Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin|Recruiting||Phase 1|200|Anticipated|Sacramento Pediatric Gastroenterology||1|||f||||f||||||||Yes|Data collected throughout study and will be shared via publications when available at certain time points.|2017-10-11 00:25:53.704278|2017-10-11 00:25:53.704278
NCT02137655|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-03-08|||May 2014||2014-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|0-21||Recovery After Fast Track THA / TKA|Prospective Descripive Study of Subacute Function After Total Hip or Knee Arthroplasty|Completed||N/A|112|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 00:25:53.785497|2017-10-11 00:25:53.785497
NCT02135900|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2015-05-15|2015-03-26||December 2009||2009-12-01|May 2015|2015-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|HOSA||The Use of Heliox in Obstructive Sleep Apnea Syndrome|The Use of Heliox in Obstructive Sleep Apnea Syndrome.|Completed||Phase 2|32|Actual|Northwell Health||1|||f||||f||||||||||2017-10-11 00:26:16.507643|2017-10-11 00:26:16.507643
NCT02137642|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-09-21|||August 2014||2014-08-01|September 2016|2016-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation|A Single-center, Placebo-controlled, Double-blind, Study to Evaluate the Effects of RM-131 on Colonic Motor Functions in Patients With Chronic Constipation|Completed||Phase 1|18|Actual|Motus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 00:25:53.86132|2017-10-11 00:25:53.86132
NCT02137629|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-08-24|||December 2010||2010-12-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea|VIDAZA® Drug Use Examination|Completed||N/A|511|Actual|Celgene Corporation|||1||f||||f||||||||||2017-10-11 00:25:53.951171|2017-10-11 00:25:53.951171
NCT02137616|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-12|||June 2012||2012-06-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Antipsychotic to Treat Psychosis Syndrome|Effectiveness of Antipsychotic Drugs to Treat Psychosis Syndrome: an Open Label, Controlled Study|Unknown status|Recruiting|N/A|300|Anticipated|Central South University||4|||f||||t||||||||||2017-10-11 00:25:54.170038|2017-10-11 00:25:54.170038
NCT02137603|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-03-01|2015-07-08||April 2014||2014-04-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Fast Track Appendectomy for Suppurative Appendicitis|Fast Track Appendectomy in Pediatric Patients With Intraoperative Findings of Suppurative Appendicitis|Completed||N/A|36|Actual|Johns Hopkins All Children's Hospital|The small number of patients enrolled in each arm and the low number of 30-day patient follow up limit the interpretation of the current results.|2|||f||||f||||||||||2017-10-11 00:25:54.298745|2017-10-11 00:25:54.298745
NCT02137590|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-13|||September 2011||2011-09-01|May 2014|2014-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|11SEHS||An Open Label Pilot Study to Evaluate the Efficacy of Spanish Black Radish on the Induction of Phase I and Phase II Enzymes|An Open Label Pilot Study to Evaluate the Efficacy of Spanish Black Radish on the Induction of Phase I and Phase II Enzymes in Healthy Male Subjects|Completed||Phase 1|20|Actual|KGK Synergize Inc.||1|||f||||||||||||||2017-10-11 00:25:54.548868|2017-10-11 00:25:54.548868
NCT02137577|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-06-03|||May 2014||2014-05-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China|Prospective, Multi-center and Randomized Controlled Clinical Study to Verify Effectiveness and Safety of Drug-eluting Balloon in PTA Procedure of the Infrapopliteal Artery|Recruiting||N/A|200|Anticipated|Acotec Scientific Co., Ltd||2|||f||||t||||||||||2017-10-11 00:25:54.629925|2017-10-11 00:25:54.629925
NCT02137564|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-07-21|||July 2015||2015-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma|A Phase II Study of Gamma Secretase Inhibitor PF-03084014 in Patients With AIDS-Associated Kaposi Sarcoma|Withdrawn||Phase 2|0|Actual|AIDS Malignancy Consortium||1||Drug supply unavailable|f||||f||||||||||2017-10-11 00:25:54.741348|2017-10-11 00:25:54.741348
NCT02137551|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2016-02-09|||August 2014||2014-08-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|ABM||ABM for ACO Beneficiaries|Appointment Based Model (ABM) for Accountable Care Organization (ACO) Beneficiaries|Completed||N/A|595|Actual|American Pharmacists Association Foundation||3|||f||||f||||||||||2017-10-11 00:25:54.860445|2017-10-11 00:25:54.860445
NCT02137538|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-11-17|||November 2009||2009-11-01|November 2014|2014-11-01||||November 2019|Anticipated|2019-11-01||Interventional|||Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole|Randomization to Letrozole vs. Anastrozole in Short Pubertal Males|Recruiting||Phase 4|80|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 00:25:54.993542|2017-10-11 00:25:54.993542
NCT02137525|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-06-30||||||June 2017|2017-06-01||||June 29, 2017|Actual|2017-06-29||Interventional|||Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain|A Randomized, Multicenter, Double-Blind, Double Dummy, Active Comparator, Dose-Ranging Study to Explore the Efficacy of SUBSYS® in Emergency Department Patients With Acute Pain|Withdrawn||Phase 2|0|Actual|INSYS Therapeutics Inc||4||Study was never initiated|f|||||t|f||||||||2017-10-11 00:25:55.153749|2017-10-11 00:25:55.153749
NCT02137512|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-08-26|2016-04-27||August 2014||2014-08-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|CTR3||Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use|Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use|Completed||Phase 3|30|Actual|Jaeb Center for Health Research||1|||f||||t||||||||||2017-10-11 00:25:55.384004|2017-10-11 00:25:55.384004
NCT02137499|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-11-18|||August 2013||2013-08-01|May 2014|2014-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|VeINS||Venous Insufficiency and Neuromuscular Stimulation|Venous Insufficiency and Neuromuscular Stimulation|Completed||N/A|40|Actual|Imperial College London||4|||f||||t||||||||||2017-10-11 00:25:56.074383|2017-10-11 00:25:56.074383
NCT02137486|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2017-04-29|||April 2015||2015-04-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|June 2016|Actual|2016-06-01||Observational|MV:main branch||Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques|Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques|Recruiting||N/A|214|Anticipated|Taipei City Hospital|||1||f||||f||||||||||2017-10-11 00:25:56.1977|2017-10-11 00:25:56.1977
NCT02137473|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-10-12|||August 2014||2014-08-01|October 2016|2016-10-01||||January 2016|Actual|2016-01-01||Interventional|||Bovine vs. Human Milk-Based Fortifier Study|Optimizing Mothers' Milk for Preterm Infants (OptiMoM) Program of Research: Study 2-Bovine vs. Human Milk-Based Fortifier Study|Active, not recruiting||N/A|127|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 00:25:56.283758|2017-10-11 00:25:56.283758
NCT02137460|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-10-03|||May 2014||2014-05-01|October 2017|2017-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|KBASE||Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease|Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease|Active, not recruiting||N/A|920|Anticipated|Seoul National University Hospital|||4||f||||t||||||Samples With DNA|"     Plasma, Serum, DNA, RNA, hair, and stool   "|||2017-10-11 00:25:56.409023|2017-10-11 00:25:56.409023
NCT02137447|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-03-21|2016-12-29||May 2014||2014-05-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions|A Prospective Observational Study of the Use of Negative Pressure Wound in High Risk Surgical Closed Incisions.|Completed||Phase 4|10|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 00:25:56.547441|2017-10-11 00:25:56.547441
NCT02137434|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-05-09|||February 2014||2014-02-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Calcium Over Postprandial Effects of Fatty Meal on Metabolism, Blood Pressure, Oxidative Stress, Endothelial Function.|Influence of Dietary and Supplementary Calcium Over the Postprandial Effects of a Fatty Meal on Metabolism Profile, Blood Pressure, Oxidative Stress, and Endothelial Function of Obese Women.|Unknown status|Recruiting|N/A|15|Anticipated|Rio de Janeiro State University||3|||f||||t||||||||||2017-10-11 00:25:56.793272|2017-10-11 00:25:56.793272
NCT02137421|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-04-30|||April 2012||2012-04-01|May 2014|2014-05-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome|Effects of Resveratrol on Crosstalk Between Canonical β-catenin/Wnt and FOXO Pathways in Coronary Artery Disease Patients With Metabolic Syndrome: A Case Control Study|Completed||N/A|20|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:25:56.928962|2017-10-11 00:25:56.928962
NCT02137408|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-09-17|||December 2014||2014-12-01|August 2014|2014-08-01|April 2016|Anticipated|2016-04-01|November 2015|Anticipated|2015-11-01||Interventional|DHA-2||Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health|Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health and Reduce the Risks of Preterm Delivery|Withdrawn||N/A|0|Actual|Children's Hospital Medical Center, Cincinnati||2||PI no longer at Institution|f||||t||||||||||2017-10-11 00:25:57.026471|2017-10-11 00:25:57.026471
NCT02137395|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-08-12|||June 2014||2014-06-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of Dexamethasone on Sugammadex Reversal|The Effect of Dexamethasone on Sugammadex Reversal in Pediatric Patients Undergoing Adenotonsillectomy: a Randomized, Placebo-controlled Study|Completed||Phase 4|60|Actual|Cukurova University||2|||f||||f||||||||||2017-10-11 00:25:57.160666|2017-10-11 00:25:57.160666
NCT02137382|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-01-21|2015-09-18||January 2014||2014-01-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|Completed||Phase 3|41|Actual|Abbott||2|||f||||f||||||||||2017-10-11 00:25:57.353364|2017-10-11 00:25:57.353364
NCT02137369|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2016-11-22|||September 2014||2014-09-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ISLAND||The ISLAND Study: InSuLa Assessed Needs for Depression|Testing an Imaging Biomarker for Treatment Stratification in Major Depression|Recruiting||Phase 4|150|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 00:25:57.719888|2017-10-11 00:25:57.719888
NCT02137356|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-09-02|||December 2014||2014-12-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer|An Investigator Sponsored Phase I Trial of Selinexor Combined With Standard Capecitabine Based Chemoradiation as a Neoadjuvant Treatment in Locally Advanced Rectal Cancer|Unknown status|Recruiting|Phase 1|28|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 00:25:57.82936|2017-10-11 00:25:57.82936
NCT02137343|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-03-04||2015-10-28|July 2014||2014-07-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|RILOMET-2||A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Advanced MET-Positive Gastric or Gastroesophageal Junction Adenocarcinoma|Terminated||Phase 3|34|Actual|Amgen||2||"All Amgen sponsored AMG102 clinical studies were terminated following a pre-planned Data   Monitoring Committee safety review of study 20070622."|f||||t||||||||||2017-10-11 00:25:57.932196|2017-10-11 00:25:57.932196
NCT02137330|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-07-21|||January 2014||2014-01-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|Obalon||Obalon in Children With Severe Obesity|Tolerance and Efficacy of the Swallowable Obalon® Gastric Balloons System in Children With Severe Obesity|Completed||Phase 3|10|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||t||||||||||2017-10-11 00:25:58.078513|2017-10-11 00:25:58.078513
NCT02137317|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-02-20|||August 2014||2014-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Farming, Personal Protective Equipment, Nepal|Prevention of Farmers' Exposure to Pesticides With Relevant Personal Protective Equipment in Chitwan District of Nepal|Completed||N/A|45|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 00:25:58.173891|2017-10-11 00:25:58.173891
NCT02137304|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-03-06|||February 2015||2015-02-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|COUGHELP||A Method to Optimize Mecanical In-exsufflation in Neuromuscular Diseases|A Method to Optimize Mecanical In-exsufflation in Neuromuscular Diseases|Recruiting||N/A|40|Anticipated|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||||2017-10-11 00:25:58.30122|2017-10-11 00:25:58.30122
NCT02137291|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-10-07|||May 2014||2014-05-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Observational|IPg2||IPg2 Study: Left-sided Lung Isolation|IPg2 Study - Left-sided Lung Isolation: Comparison of Twodevices|Unknown status|Recruiting|N/A|40|Anticipated|Laval University|||2||f||||f||||||||||2017-10-11 00:25:58.392649|2017-10-11 00:25:58.392649
NCT02137278|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-12-28|||March 2014||2014-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|STOP-VD||Stop Vasodepressor Drugs in Reflex Syncope|Randomized Controlled Trial on Discontinuation of Vasoactive Drugs in Patients With Hypotensive Reflex Syncope|Completed||Phase 3|58|Actual|Gruppo Italiano Multidisciplinare per lo Studio della Sincope||2|||f||||f||||||||||2017-10-11 00:25:58.511246|2017-10-11 00:25:58.511246
NCT02137265|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-05-12|||September 2015||2015-09-01|May 2016|2016-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism|A Randomized, Double-blind, Placebo-controlled Trial of Clomiphene Citrate of Clomiphene Citrate in Hypoandrogenism and Azoospermia|Recruiting||N/A|158|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 00:25:58.64469|2017-10-11 00:25:58.64469
NCT02137252|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2016-07-29|||May 2014||2014-05-01|July 2016|2016-07-01|April 2022|Anticipated|2022-04-01|August 2018|Anticipated|2018-08-01||Interventional|||Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer|Naltrexone Randomized Controlled Trial for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer|Active, not recruiting||Phase 2|300|Anticipated|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-11 00:25:58.800066|2017-10-11 00:25:58.800066
NCT02137239|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2017-06-28|||December 31, 2015|Actual|2015-12-31|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Regimen Optimization Study|Evaluation of Acute Rejection Rates in de Novo Renal Transplant Recipients Following Thymoglobulin Induction, CNI-free, Nulojix (Belatacept)-Based Immunosuppression|Active, not recruiting||Phase 2|70|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-11 00:25:58.926696|2017-10-11 00:25:58.926696
NCT02137213|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-06-23|||August 2014||2014-08-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation|Oral Naloxone for Treatment of Opioid-induced Constipation in Patients Receiving Methadone Maintenance Treatment|Completed||Phase 2|20|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 00:25:59.497081|2017-10-11 00:25:59.497081
NCT02137200|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-10-31|||May 2014||2014-05-01|October 2016|2016-10-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|OMSS||Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial|Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial|Recruiting||N/A|3184|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:25:59.639605|2017-10-11 00:25:59.639605
NCT02137187|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2017-07-18|||October 2014||2014-10-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|APAF-CRT||Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure|A Randomized Controlled Trial of Atrioventricular (AV) Junction Ablation and Biventricular Pacing Versus Optimal Pharmacological Therapy in Patients With Permanent Atrial Fibrillation|Recruiting||Phase 3|1830|Anticipated|Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella||2|||f||||t||||||||||2017-10-11 00:25:59.808921|2017-10-11 00:25:59.808921
NCT02137174|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-10|2014-05-12|||January 2012||2012-01-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|May 2013|Actual|2013-05-01||Interventional|||Home and School Visits Intervention for Children With DM TYPE 1|The Efficacy of Constructed Intervention by Home and School Visits on Glycemic Control in Children With Type I Diabetes|Completed||Phase 2/Phase 3|92|Actual|Ben-Gurion University of the Negev||2|||f||||f||||||||||2017-10-11 00:25:59.94941|2017-10-11 00:25:59.94941
NCT02137161|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-10-28|||November 2013||2013-11-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|REPEX||Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery|The Reggio Emilia Study on Bromfenac for Patients With PseudoEXfoliation Syndrome Undergoing Cataract Surgery: the REPEX Study|Completed||Phase 4|62|Actual|Arcispedale Santa Maria Nuova-IRCCS||2|||f||||f||||||||||2017-10-11 00:26:00.063|2017-10-11 00:26:00.063
NCT02137148|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2015-03-02|||June 2014||2014-06-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Sonic Window Study Evaluation Plan|Observational Study of the Sonic Window Handheld Ultrasound System for Assistance With Vascular Access and Needle Placement|Withdrawn||N/A|0|Actual|Analogic Corporation|||1|Study was cancelled|f||||f||||||||||2017-10-11 00:26:00.186398|2017-10-11 00:26:00.186398
NCT02137135|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-12|2014-05-12|||August 2012||2012-08-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Menstrual Phase and Postoperative Pain|The Influence of the Menstrual Cycle on Acute and Persistent Pain After Laparoscopic Cholecystectomy|Completed||Early Phase 1|64|Actual|Adnan Menderes University||2|||f||||t||||||||||2017-10-11 00:26:00.276879|2017-10-11 00:26:00.276879
NCT02137122|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-06-23|||January 2015||2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Neuromodulation of Cognition in Older Adults|Neuromodulation of Cognition in Older Adults: The Stimulated Brain Study|Recruiting||N/A|120|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-11 00:26:00.39568|2017-10-11 00:26:00.39568
NCT02137109|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-10-16|||March 2014||2014-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri|Meta-Analysis of the Safety and Efficacy of Natalizumab in Pediatric Patients With Multiple Sclerosis|Completed||N/A|400|Actual|Biogen|||1||f||||f||||||||||2017-10-11 00:26:00.527847|2017-10-11 00:26:00.527847
NCT02137096|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-06-13|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Observational|||Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma|High Dose Conditioning With Ifosfamide, Carboplatin, and Etoposide With Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma|Completed||N/A|1|Actual|University of Florida|||1||f||||t||||||Samples With DNA|"     hematopoietic stem cells   "|||2017-10-11 00:26:00.606387|2017-10-11 00:26:00.606387
NCT02137083|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-04-26|||April 2014||2014-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer|A Prospective Single-center Randomized Phase 2 Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Postmenopausal, Hormone-receptor Positive and HER2-negative Metastatic Breast Cancer|Terminated||Phase 2|22|Actual|Fudan University||2||The enrollment is too slow.|f||||f||||||||||2017-10-11 00:26:00.712259|2017-10-11 00:26:00.712259
NCT02137070|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-08-28|||August 2014||2014-08-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|WISEBrain||The WISE (Weightloss Intervention Surgical Effects) Brain Study|Obesity and Type 2 Diabetes, Bariatric Surgery Effects on Brain Function|Recruiting||N/A|200|Anticipated|University of Florida|||2||f||||f|f|f||||Samples With DNA|"     Blood samples will be retained for biomarker analysis.   "|||2017-10-11 00:26:00.817264|2017-10-11 00:26:00.817264
NCT02137057|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2015-06-12|||May 2014||2014-05-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||The Effect of Spinal Anesthesia on Heart Rate Variability in Diabetic Patients||Completed||N/A|66|Actual|Yonsei University|||2||f||||t||||||||||2017-10-11 00:26:00.923489|2017-10-11 00:26:00.923489
NCT02137044|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-05-10|||July 2014||2014-07-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|MS-CARE||Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study|Improving the Quality of Care for Pain and Depression in Persons With Multiple Sclerosis|Enrolling by invitation||N/A|200|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 00:26:00.995925|2017-10-11 00:26:00.995925
NCT02137031|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-05-09|||September 2012||2012-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CHILD||Continuous Glucose Monitoring and Metabolic Control in Children With Type 1 Diabetes|Continuous Glucose Monitoring and HbA1c in Children for Longterm Diabetes Management|Completed||N/A|40|Actual|University of Toronto||1|||f||||t||||||||||2017-10-11 00:26:01.115992|2017-10-11 00:26:01.115992
NCT02137018|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-06-12|||March 2013||2013-03-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|36P||"Nanotechnologies Applied to General Surgery and Emergency Surgery: Buckypaper as a New Fixing Method for Prosthetic Materials for the Treatment of Hernia and Incisional Hernia in Laparotomy and Laparoscopic"|"Nanotechnologies Applied to General Surgery and Emergency Surgery: The Buckypaper as a New Fixing Method for Prosthetic Materials in the Treatment of Abdominal Wall Hernias, Diaphragmatic Hernias, Diaphragmatic Rupture, Incisional Hernia and Abdominal Wall Disaster in Laparotomy Procedure and Laparoscopic Procedures."|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Actual|University of Roma La Sapienza||4|||f||||t||||||||||2017-10-11 00:26:01.418511|2017-10-11 00:26:01.418511
NCT02137005|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-06-28|||May 2014||2014-05-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|CPAT||Cerebral Palsy Adult Transition Longitudinal Study|Walking and Its Effect on Health and Function in Individuals With Cerebral Palsy as They Transition to Adulthood: A Health Outcomes Study|Recruiting||N/A|72|Anticipated|University of Colorado, Denver|||1||f||||t||||||||||2017-10-11 00:26:01.607905|2017-10-11 00:26:01.607905
NCT02136992|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2014-05-12|||December 2011||2011-12-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|IPF||Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial for Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 2|160|Actual|Shanghai Pulmonary Hospital, Shanghai, China||2|||f||||t||||||||||2017-10-11 00:26:01.786566|2017-10-11 00:26:01.786566
NCT02136979|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-12-09|||March 2014||2014-03-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Observational|||Effect of Cardiopulmonary Bypass on Serum CD39 and CD73 Level|Effect of Cardiopulmonary Bypass on Serum CD39 and CD73 Level|Recruiting||N/A|1|Anticipated|Konkuk University Medical Center|||1||f||||f||||||Samples Without DNA|"     whole blood, urine   "|||2017-10-11 00:26:01.911362|2017-10-11 00:26:01.911362
NCT02136966|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-04-12|||November 2014||2014-11-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Joint Infant and Young Child Nutrition Program and Malnutrition Prevention|Joint Infant and Young Child Nutrition Program in Burkina Faso : Impact Evaluation|Completed||N/A|2212|Actual|Institut de Recherche en Sciences de la Sante, Burkina Faso||2|||f||||t||||||||||2017-10-11 00:26:02.011585|2017-10-11 00:26:02.011585
NCT02136953|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-04-25|||May 2014||2014-05-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Physical Exercise in OCD: Treatment Efficacy, Additive Benefits to CBT, and Cognitive Correlates of Change|An Examination of Structured Physical Exercise in OCD: Treatment Efficacy, Additive Benefits to CBT, and Cognitive Correlates of Change|Active, not recruiting||N/A|480|Anticipated|Sunnybrook Health Sciences Centre||4|||f||||t||||||||||2017-10-11 00:26:02.112809|2017-10-11 00:26:02.112809
NCT02136940|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-01-16|||April 2014||2014-04-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension|A Phase 2a, Multicenter, Randomized, Double-masked, Placebo-controlled, Parallel-group Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension|Completed||Phase 2|103|Actual|Amakem, NV||4|||f||||f||||||||||2017-10-11 00:26:02.251893|2017-10-11 00:26:02.251893
NCT02136927|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-10-20|||August 2014||2014-08-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer||Terminated||Phase 1|33|Actual|Sun Pharma Advanced Research Company Limited||2|||f||||f||||||||||2017-10-11 00:26:02.381141|2017-10-11 00:26:02.381141
NCT02136901|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-12-20|||June 2014||2014-06-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|VENUS||The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System)|The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System) A Multi-center, Prospective, Randomized, Interventional, Superiority Clinical Study|Active, not recruiting||N/A|37|Actual|Active Implants||2|||f||||f||||||||||2017-10-11 00:26:02.754239|2017-10-11 00:26:02.754239
NCT02134782|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-07-17|||October 2014||2014-10-01|July 2017|2017-07-01||||October 2019|Anticipated|2019-10-01||Interventional|||Yoga Fatigue Study|A Randomized Controlled Trial of Individualized Yoga to Reduce Fatigue in Hospitalized Children Receiving Intensive Chemotherapy|Recruiting||N/A|210|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 00:26:33.2334|2017-10-11 00:26:33.2334
NCT02136888|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-05-12|||August 2011||2011-08-01|May 2014|2014-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects|A Single-center, Double-blind, Randomized, Placebo- and Positive-controlled, Parallel-group, Multiple-dose, Up-titration Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects|Completed||Phase 1|116|Actual|Actelion||2|||f||||f||||||||||2017-10-11 00:26:02.88489|2017-10-11 00:26:02.88489
NCT02136875|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-05-13|||July 2008||2008-07-01|May 2014|2014-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation|Phase IV Study; Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation|Completed||Phase 4|37|Actual|McGill University Health Center||1|||f||||t||||||||||2017-10-11 00:26:03.092551|2017-10-11 00:26:03.092551
NCT02136862|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-08-22|||August 2014||2014-08-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Observational|RG012-01||ATHENA: Natural History of Disease Study in Alport Syndrome Patients|A Natural History Study to Observe Disease Progression, Standard of Care and Investigate Biomarkers in Alport Syndrome Patients|Active, not recruiting||N/A|250|Anticipated|Regulus Therapeutics Inc.|||1||f||||f||||||||||2017-10-11 00:26:03.229676|2017-10-11 00:26:03.229676
NCT02136849|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-03-24|||July 2014||2014-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|HUGODIMS||Inter-regional Project of the Great Western Exploration Approach for Exome Molecular Causes Severe Intellectual Disability Isolated or Syndromic|Inter-regional Project of the Great Western Exploration Approach for Exome Molecular Causes Severe Intellectual Disability Isolated or Syndromic|Completed||N/A|228|Actual|Nantes University Hospital|||1||f||||f||||||Samples With DNA|"     2 tubes of 5 ml EDTA blood   "|||2017-10-11 00:26:03.377067|2017-10-11 00:26:03.377067
NCT02136836|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-12|||May 2014||2014-05-01|April 2014|2014-04-01||||March 2015|Anticipated|2015-03-01||Observational|HER2||Investigation of the Proportion of Human Epidermal Growth Factor Receptor 2 Protein Overexpression of Gastric Adenocarcinoma and Prognostic Effect of HER2, and Analysis of Practice Pattern of Herceptin Use in Stage IV Gastric Cancer||Unknown status|Active, not recruiting|N/A|860|Anticipated|Yonsei University|||1||f||||||||||||||2017-10-11 00:26:03.468504|2017-10-11 00:26:03.468504
NCT02136823|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-05-09|||June 2009||2009-06-01|May 2014|2014-05-01||||May 2015|Anticipated|2015-05-01||Interventional|||Impact of Persistent Conductances on Motor Unit Firing in SCI|Impact of Persistent Conductances on Motor Unit Firing in SCI|Unknown status|Active, not recruiting|N/A|50|Anticipated|Shirley Ryan AbilityLab||5|||f||||||||||||||2017-10-11 00:26:03.5484|2017-10-11 00:26:03.5484
NCT02136810|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-08-09|||October 2015||2015-10-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Perioperative Blood Pressures and Chronic Hypertension|The Association Between Home Blood Pressures and Clinic Blood Pressures in Patients Presenting for Surgery.|Active, not recruiting||N/A|200|Actual|Yale University|||1||f||||f||||||||||2017-10-11 00:26:03.651606|2017-10-11 00:26:03.651606
NCT02136797|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2017-02-27|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation|A Phase II Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|41|Anticipated|Atara Biotherapeutics||1|||t|||||t|f||||||||2017-10-11 00:26:03.723187|2017-10-11 00:26:03.723187
NCT02136784|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-05-09|||April 2014||2014-04-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals|Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals|Unknown status|Recruiting|N/A|12|Anticipated|University of California, Los Angeles||7|||f||||f||||||||||2017-10-11 00:26:03.814202|2017-10-11 00:26:03.814202
NCT02136771|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-11-23|||June 2011||2011-06-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Styrian Vitamin D Hypertension Trial|Styrian Vitamin D Hypertension Trial: A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Effects of Vitamin D Supplementation on Systolic Ambulatory Blood Pressure in Vitamin D Deficient Hypertensive Patients|Completed||Phase 4|200|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-11 00:26:03.935164|2017-10-11 00:26:03.935164
NCT02136758|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-08|||April 2009||2009-04-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|CRC||Cardiovascular Risk Clinic|Cardiovascular Risk Clinic|Terminated||N/A|207|Actual|Windber Research Institute||2||Funding cut due to government sequestration|f||||f||||||||||2017-10-11 00:26:04.021699|2017-10-11 00:26:04.021699
NCT02136745|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-09|||May 2009||2009-05-01|May 2014|2014-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD|Genomic and Clinical Effects Associated With a Relaxation Response Mind-Body Intervention in Patients With Irritable Bowel Syndrome and Inflammatory Bowel Disease|Completed||N/A|48|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:26:04.103973|2017-10-11 00:26:04.103973
NCT02136732|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-05-16|||October 2013||2013-10-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Chronic Care Management for Adults at FQHCs|Chronic Care Management Model Translation to Multimorbid Aging Adults at FQHCs|Active, not recruiting||N/A|290|Actual|Washington State University||2|||f||||t||||||||||2017-10-11 00:26:04.185377|2017-10-11 00:26:04.185377
NCT02136719|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-11|2017-05-13|||April 2014||2014-04-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Bimanual Uterine Compression to Reduce Blood Loss and Prevent Postpartum Haemorrhage After Vaginal Delivery|Bimanual Uterine Compression to Reduce Blood Loss and Prevent Postpartum Haemorrhage After Vaginal Delivery|Completed||N/A|520|Actual|Benha University||2|||f||||f||||||||||2017-10-11 00:26:04.262452|2017-10-11 00:26:04.262452
NCT02136706|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2015-12-14|||December 2015||2015-12-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol|Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol: A Pilot Study|Withdrawn||N/A|0|Actual|VA St. Louis Health Care System||1||Sponsor and site were unable to complete a final contract to support the study|f||||f||||||||No||2017-10-11 00:26:04.37606|2017-10-11 00:26:04.37606
NCT02136667|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-01-05|||April 2014||2014-04-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Observational|||Preeclampsia and Circulating Biomarkers||Unknown status|Recruiting|N/A|64|Anticipated|University of Aarhus|||2||f||||t||||||Samples With DNA|"     Blood serum Blood plasma Urine   "|||2017-10-11 00:26:04.662717|2017-10-11 00:26:04.662717
NCT02136654|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-04-19|||July 2015||2015-07-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|Namaste||Novel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care|Novel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care|Recruiting||N/A|600|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 00:26:04.734498|2017-10-11 00:26:04.734498
NCT02136641|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2014-05-08|||June 2011||2011-06-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Study of Comparison of the Effectiveness of Three Diagrams for Sedation in Spinal Anesthesia|Study of Comparison of the Effectiveness of Three Diagrams for Sedation in Spinal Anesthesia|Completed||Phase 4|75|Actual|Universidad de Cartagena||3|||f||||t||||||||||2017-10-11 00:26:04.818685|2017-10-11 00:26:04.818685
NCT02136628|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-10-24|||July 2014||2014-07-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|Herniapreven||Hernia Prevention. Effectiveness of Reinforced Tension Line (RTL) Technique Compared With the Conventional Method|Posincisional Hernia Prevention. Effectiveness of Reinforced Tension Line (RTL) Technique Compared With the Conventional Method|Completed||Phase 4|76|Actual|Universidad de Guanajuato||2|||f||||t||||||||||2017-10-11 00:26:04.901573|2017-10-11 00:26:04.901573
NCT02136615|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-11-30|||July 2014||2014-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|HOTAIR3||Does Hyperbaric Oxygen Therapy Lead to a Sustained Increase in Insulin Sensitivity?|Does Hyperbaric Oxygen Therapy Lead to a Sustained Increase in Insulin|Completed||N/A|12|Actual|University of Adelaide|||1||f||||f||||||Samples With DNA|"     Serum, adipose tissue   "|||2017-10-11 00:26:04.984675|2017-10-11 00:26:04.984675
NCT02136602|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-05-09|||January 2012||2012-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01|2 Months|Observational [Patient Registry]|||Interventricular Cardiac Septal Thickness in Fetus of Diabetic Mother Correlated to Postnatal Outcome|Interventricular Cardiac Septal Thickness in Fetus of Diabetic Mother Correlated to Postnatal Outcome|Completed||N/A|120|Actual|Ain Shams University|||1||f||||f||||||None Retained|"     pregnant over 35 weeks. medically free.single intrauterine pregnancy   "|||2017-10-11 00:26:05.081711|2017-10-11 00:26:05.081711
NCT02136589|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-05-12|||September 2008||2008-09-01|May 2014|2014-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ENTICHIR||Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes|Effect of Non-steroid Anti-inflammatory Drug on Travoprost-induced Conjunctival Hyperemia and Intraocular Pressure Reduction in Normal Eyes|Completed||Phase 4|40|Actual|Tokyo University||1|||f||||f||||||||||2017-10-11 00:26:05.13766|2017-10-11 00:26:05.13766
NCT02136576|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-07-24|||May 2014||2014-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Caries Prevention Products & Dentinal Hypersensitivity|Comparing Three Caries Prevention Products on Dentinal Hypersensitivity - A Pilot Study|Recruiting||N/A|50|Anticipated|Tufts University School of Dental Medicine||3|||f||||f||||||||||2017-10-11 00:26:05.204405|2017-10-11 00:26:05.204405
NCT02136563|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-07-13|||April 2014||2014-04-01|July 2016|2016-07-01||||March 2018|Anticipated|2018-03-01||Observational|BRIGHTEN||Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents|oBservational Clinical Research In Chronic Kidney Disease Patients With Renal Anemia : Renal proGnosis in Patients With Hyporesponsive Anemia To Erythropoiesis Stimulating Agents, darbepoetiN Alfa|Enrolling by invitation||N/A|2000|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||f||||||||||2017-10-11 00:26:05.298369|2017-10-11 00:26:05.298369
NCT02136550|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-12-03|||February 2013||2013-02-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Smoking Cessation on the Human Airway: Mucus Secretion, Inflammatory and Proteomic Profile in Nose and miRNAs in Blood|Smoking Cessation on the Human Airway: Mucus Secretion, Inflammatory and Proteomic Profile in Nasal Lavage and miRNAs in Blood|Recruiting||N/A|36|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 00:26:07.336936|2017-10-11 00:26:07.336936
NCT02136537|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-04-14|||August 2014||2014-08-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Interventional|PAD||Electrical Stimulation in Peripheral Arterial Disease|Electrical Stimulation in Peripheral Arterial Disease|Terminated||N/A|40|Actual|Imperial College London||2||Member of staff moved on to training post. Trial halted and terminated|f||||t||||||||||2017-10-11 00:26:07.440102|2017-10-11 00:26:07.440102
NCT02136524|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-11-01|||April 2014||2014-04-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC-0973) in Tablet vs. Capsule Formulation|A PHASE 1, OPEN-LABEL, SINGLE-DOSE, RANDOMIZED, 2-PERIOD, 2-TREATMENT SEQUENCE CROSS-OVER STUDY TO ASSESS THE RELATIVE BIOAVAILABILITY OF COBIMETINIB ADMINISTERED AS A TABLET FORMULATION COMPARED TO A CAPSULE FORMULATION IN HEALTHY SUBJECTS|Completed||Phase 1|28|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 00:26:07.525317|2017-10-11 00:26:07.525317
NCT02136511|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-10-27||||||October 2014|2014-10-01||||||||Expanded Access|||Expanded Access for Idelalisib in Combination With Rituximab in Chronic Lymphocytic Leukemia|An Expanded Access Protocol for Idelalisib in Combination With Rituximab for Relapsed, Previously Treated Subjects With Chronic Lymphocytic Leukemia|Approved for marketing||N/A|||Gilead Sciences|||||||||||||||||||2017-10-11 00:26:07.615465|2017-10-11 00:26:07.615465
NCT02136498|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2016-10-25|2016-08-15||October 2014||2014-10-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|MyMAP||My Mobile Advice Program: A Randomized Pilot Feasibility Study|Internet-based Medication Adherence Program for Nicotine Dependence Treatment|Completed||N/A|66|Actual|Kaiser Permanente|The primary limitation of this pilot study is the small sample size, which prevents definitive conclusions about the efficacy of the MyMAP intervention.|2|||f||||f||||||||No||2017-10-11 00:26:07.710749|2017-10-11 00:26:07.710749
NCT02136485|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-06-25|||June 2014||2014-06-01|June 2014|2014-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Mindfulness-based Stress Reduction in Multiple Sclerosis|Mindfulness-based Stress Reduction in Multiple Sclerosis - a Randomised Controlled Trial|Unknown status|Recruiting|N/A|50|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 00:26:08.05178|2017-10-11 00:26:08.05178
NCT02136472|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-01-06|||April 2014||2014-04-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||Female Subfertility: a Metabolic and Vascular Profile|Female Subfertility: a First Sign of Metabolic and Cardiovascular Anomalies?|Recruiting||N/A|512|Anticipated|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-11 00:26:08.13808|2017-10-11 00:26:08.13808
NCT02136459|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-08|||October 2012||2012-10-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Non-neural Vocal Changes After Thyroidectomy|Assessment of Non-neural Voice Changes in Thyroidectomy Patients: A Randomized Control Trial|Completed||N/A|57|Actual|South Infirmary-Victoria University Hospital||2|||f||||f||||||||||2017-10-11 00:26:08.216028|2017-10-11 00:26:08.216028
NCT02136433|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2014-09-17|||February 2014||2014-02-01|September 2014|2014-09-01||||August 2015|Anticipated|2015-08-01||Interventional|TBL||Using Tablets for Upper Extremity Rehabilitation Post Acquired Brain Injury|Using Tablets for Upper Extremity Rehabilitation Post Acquired Brain Injury|Unknown status|Recruiting|N/A|40|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:26:08.530224|2017-10-11 00:26:08.530224
NCT02136407|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-05-12|||October 2009||2009-10-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Seasonal Variations in Serum 25-hydroxy Vitamin-D Levels in a Swedish Cohort|Seasonal Variations in Serum 25-hydroxy Vitamin-D Levels in a Swedish Cohort|Completed||N/A|615|Actual|Sahlgrenska University Hospital, Sweden|||2||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 00:26:08.724745|2017-10-11 00:26:08.724745
NCT02136394|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-04-06|||February 2014||2014-02-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|||The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis|Investigation Into the Role of Gastroesophageal Reflux in Pulmonary Fibrosis in Scleroderma|Recruiting||N/A|100|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||2||f||||t||||||||||2017-10-11 00:26:08.808581|2017-10-11 00:26:08.808581
NCT02136381|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-08|||May 2014||2014-05-01|May 2014|2014-05-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Lifestyle Interventions at Retirement|Pilot Randomised Controlled Trial of an Internet-based Lifestyle Intervention for People Around Retirement|Unknown status|Recruiting|N/A|90|Anticipated|Newcastle University||2|||f||||f||||||||||2017-10-11 00:26:08.909597|2017-10-11 00:26:08.909597
NCT02136368|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-09-06|||January 2014||2014-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Body and Brain Exercise for Older Adults With Memory Complaints|A Combined Exercise Program Plus Cognitive Training for Older Adults With Self-reported Cognitive Complaints: The Multi-modal, Mind-motor (M4) Study|Completed||N/A|127|Actual|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-11 00:26:09.030056|2017-10-11 00:26:09.030056
NCT02136355|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-03-13|||September 2014||2014-09-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|January 2019|Anticipated|2019-01-01||Interventional|||A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer|A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer|Recruiting||Phase 2|40|Anticipated|Lawson Health Research Institute||1|||f||||t||||||||||2017-10-11 00:26:09.131157|2017-10-11 00:26:09.131157
NCT02136342|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2014-10-19|||May 2014||2014-05-01|October 2014|2014-10-01||||August 2015|Anticipated|2015-08-01||Interventional|||Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer|Phase 1 Trial Evaluating Tolerability and Pharmacokinetics of Chlorogenic Acid for Injection in Patients With Advanced Cancer|Terminated||Phase 1|||Chinese Academy of Medical Sciences||1||Study site change|f||||f||||||||||2017-10-11 00:26:09.206601|2017-10-11 00:26:09.206601
NCT02136329|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-06-12|||June 2013||2013-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Revaki-001||A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery|A Phase I Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery|Completed||Phase 1|36|Actual|University of Leicester||1|||f||||t||||||||||2017-10-11 00:26:09.280206|2017-10-11 00:26:09.280206
NCT02136316|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-09|2015-12-14|||May 2014||2014-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|MAD||A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Subjects|A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of Ascending Oral Multiple Doses of ASP7962 in Healthy Male and Female Subjects|Completed||Phase 1|48|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 00:26:09.360883|2017-10-11 00:26:09.360883
NCT02136303|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-06-03|||February 2015||2015-02-01|June 2016|2016-06-01||||December 2018|Anticipated|2018-12-01||Interventional|KALESIGHT||Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients|Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of Patients With Age-related Macular Degeneration - an Alternative to Supplements With Isolated Xanthophylls|Recruiting||N/A|90|Anticipated|University of Jena||14|||f||||f||||||||||2017-10-11 00:26:09.464007|2017-10-11 00:26:09.464007
NCT02136290|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-08-19|||May 2014||2014-05-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CHOICES||Prepackaged Foods to Promote Weight Loss|Randomized Clinical Trial of Portion-Controlled Prepackaged Foods to Promote Weight Loss - CHOICES Study.|Completed||N/A|184|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:26:09.609518|2017-10-11 00:26:09.609518
NCT02136277|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2015-01-25|||January 2015||2015-01-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Observational|MaMiFlo||Vascular Changes During Colorectal Surgery|Measurement of Changes in Macro- and Microvascular Blood Flow During Major Colorectal Surgery|Unknown status|Recruiting|N/A|32|Anticipated|University of Nottingham|||1||f||||f||||||||||2017-10-11 00:26:09.724188|2017-10-11 00:26:09.724188
NCT02136264|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2015-11-10|||June 2013||2013-06-01|November 2015|2015-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|PCFADASH-HT||Study of Personalized Dietary Intervention for the Control of Essential Hypertension|Randomized Controlled Trial of a Personalized Dietary Intervention Approach for the Control of Essential Hypertension|Recruiting||N/A|50|Anticipated|University of Nigeria, Enugu Campus||2|||f||||t||||||||||2017-10-11 00:26:09.828384|2017-10-11 00:26:09.828384
NCT02136251|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-08|||September 2014||2014-09-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|Glenoid||Total Shoulder Replacement Outcomes With Autologous Bone Graft as Fixator for Glenoid Anchor Peg.|Five Year Outcome Follow-up of Glenoid Anchor Peg Component Fixation Utilizing Autologous Bone Graft in Total Shoulder Arthroplasty.|Unknown status|Not yet recruiting|N/A|48|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-10-11 00:26:09.914979|2017-10-11 00:26:09.914979
NCT02136238|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-04-10|2014-11-18||September 2013||2013-09-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Functional Performance of Voluntary Opening and Closing Body Powered Prostheses|A Clinical Trial Comparing Functional Performance of Voluntary Opening and Closing Body Powered Prosthetic Terminal Devices|Completed||N/A|18|Actual|University of South Florida||3|||f||||t||||||||||2017-10-11 00:26:09.997212|2017-10-11 00:26:09.997212
NCT02136225|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-01-20|||March 2014|Actual|2014-03-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Reducing Youth Access to Firearms Through the Health Care Setting|Reducing Youth Access to Firearms Through the Health Care Setting|Enrolling by invitation||N/A|500|Anticipated|University of Colorado, Denver||3|||f||||f|f|f||||||||2017-10-11 00:26:10.402662|2017-10-11 00:26:10.402662
NCT02136212|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-08-31|||April 2013||2013-04-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia|Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia - New Data|Completed||N/A|57|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:26:10.479907|2017-10-11 00:26:10.479907
NCT02136199|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-05-23|||September 2014||2014-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Use of Decision Aids in Clinical Encounters|Patient-centered Dissemination of Evidence-based Medicine: Share EBM|Completed||N/A|62|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:26:10.579891|2017-10-11 00:26:10.579891
NCT02136186|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-09-05|||October 2014||2014-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Home Telemonitoring in Patients at High Risk for Readmission|Home Telemonitoring in Patients at High Risk for Readmission|Recruiting||N/A|1900|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:26:10.691724|2017-10-11 00:26:10.691724
NCT02136173|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-04-07|||December 2012||2012-12-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Weight Loss Effect of the Sequential Balloons|Study of Weight Loss Effect of the Sequential Balloons|Unknown status|Recruiting|N/A|300|Anticipated|Mansoura University||1|||f||||t||||||||||2017-10-11 00:26:10.777186|2017-10-11 00:26:10.777186
NCT02136160|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-08|||March 2013||2013-03-01|May 2014|2014-05-01||||May 2013|Actual|2013-05-01||Interventional|||Population-based Intervention to Promote Health in Elementary Schools|Rakuns: Setting-based Prevention Program to Promote Positive Experiences in Health Promoting Lifestyle Choices|Completed||N/A|249|Actual|Ludwig-Maximilians - University of Munich|||||f||||f||||||||||2017-10-11 00:26:10.916572|2017-10-11 00:26:10.916572
NCT02136147|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-03-21|||June 2015||2015-06-01|March 2017|2017-03-01||||March 2019|Anticipated|2019-03-01|12 Months|Observational [Patient Registry]|ADAPT||ADHD Medication and Predictors of Treatment Outcome|Naturalistic Study of ADHD Medication and Predictors of Treatment Outcome|Enrolling by invitation||N/A|2000|Anticipated|Karolinska Institutet|||5||f||||f||||||Samples With DNA|"     Saliva   "|Undecided||2017-10-11 00:26:11.024296|2017-10-11 00:26:11.024296
NCT02136134|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-08-24|2016-12-20||August 15, 2014|Actual|2014-08-15|August 2017|2017-08-01|July 15, 2021|Anticipated|2021-07-15|January 11, 2016|Actual|2016-01-11||Interventional|||Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma|Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Subjects With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 3|499|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 00:26:11.242777|2017-10-11 00:26:11.242777
NCT02136121|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-08|||June 2010||2010-06-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Prospective Investigation of Robotic Single-port System||Completed||Phase 1/Phase 2|19|Actual|Intuitive Surgical||1|||f||||t||||||||||2017-10-11 00:26:13.097938|2017-10-11 00:26:13.097938
NCT02136108|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-08-19|||September 2015||2015-09-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|OPENtext||Optimizing Patient Engagement in a Novel Pain Management Initiative (OPEN)|Optimizing Patient Engagement in a Novel Pain Management Initiative (OPEN)|Recruiting||N/A|200|Anticipated|Inflexxion, Inc.||2|||f||||f||||||||No||2017-10-11 00:26:13.357573|2017-10-11 00:26:13.357573
NCT02136095|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-05-08|||September 2013||2013-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Promising Initial Experience With Intra-operative Fluorescent Cholangiography|Promising Initial Experience With Intra-operative Fluorescent Cholangiography|Completed||N/A|35|Actual|Hvidovre University Hospital||1|||f||||f||||||||||2017-10-11 00:26:13.544759|2017-10-11 00:26:13.544759
NCT02136082|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-09-26|||August 2013||2013-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Asha II||Asha Improving Health and Nutrition of Indian Women With AIDS and Their Children|Asha Improving Health and Nutrition of Indian Women With AIDS and Their Children|Recruiting||Phase 1/Phase 2|600|Anticipated|University of California, Los Angeles||4|||f||||t||||||||||2017-10-11 00:26:13.663492|2017-10-11 00:26:13.663492
NCT02136069|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-03-31|||April 15, 2014|Actual|2014-04-15|March 2017|2017-03-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors|PHASE III, RANDOMIZED, MULTICENTER DOUBLE-BLIND, DOUBLE DUMMY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ETROLIZUMAB COMPARED WITH INFLIXIMAB IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE NAÏVE TO TNF INHIBITORS|Recruiting||Phase 3|720|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:26:13.806986|2017-10-11 00:26:13.806986
NCT02136056|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-09-12|||September 2014||2014-09-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|jos||Effects of a Self-management Course for Adults on Sick-leave|Effects of a Self-management Course for Adults on Sick-leave; Outcomes in Registry Based Measures of Return to Work and Questionnaire Based Measures of Well-being and Quality of Life|Recruiting||N/A|1200|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:26:14.457305|2017-10-11 00:26:14.457305
NCT02136043|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-05-25|||May 2014||2014-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Kinetic Oscillation Stimulation (KOS) of Nasal Mucosa in Non-allergic Rhinitis: Investigation of Treatment Procedure|A Randomized Study (With Active Treatment in Both Treatment Groups) to Evaluate How a New Vibration Treatment in the Nose in Patients With Non-allergic Rhinitis Can be Done as Convenient as Possible to the Patient|Completed||N/A|29|Actual|Halmstad County Hospital||2|||f||||f||||||||||2017-10-11 00:26:14.626553|2017-10-11 00:26:14.626553
NCT02136030|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-08|||February 2011||2011-02-01|October 2010|2010-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis|A Randomized Study to Evaluate the Safety and Efficacy of Liposomal Amphotericin B and Amphotericin B Deoxycholate With or Without Flucytosine Followed by Fluconazole, for the Treatment of Cryptococcal Meningitis|Unknown status|Recruiting|N/A|84|Anticipated|TTY Biopharm||2|||f||||f||||||||||2017-10-11 00:26:14.711366|2017-10-11 00:26:14.711366
NCT02136017|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-08|||January 2013||2013-01-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Post-License Safety Evaluation of Influenza Virus Vaccine|Phase 4 Study of Post-License Safety Evaluation of Influenza Split Vaccine|Completed||N/A|400000|Actual|Sichuan Center for Disease Control and Prevention|||1||f||||t||||||||||2017-10-11 00:26:14.817813|2017-10-11 00:26:14.817813
NCT02136004|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-11-01|2016-11-01||May 2014||2014-05-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Closer||The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System|The Closer Trial: A Multi-center, Prospective, Single Arm Trial to Evaluate the Safety and Efficacy of the Rex Medical Closer Vascular Sealing System (VSS) for the Management of the Femoral Arteriotomy After Percutaneous Endovascular Procedures|Completed||N/A|220|Actual|Rex Medical||1|||f||||t||||||||Yes|After multi-center manuscript is published.|2017-10-11 00:26:14.905342|2017-10-11 00:26:14.905342
NCT02135991|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-26|||September 2013||2013-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|February 2018|Anticipated|2018-02-01||Interventional|PREP||Preparing to Run Effective Prevention|Preparing to Run Effective Prevention|Active, not recruiting||N/A|990|Actual|RAND||2|||f||||f||||||||||2017-10-11 00:26:15.318101|2017-10-11 00:26:15.318101
NCT02135978|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-03-20|||April 2012||2012-04-01|March 2015|2015-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Maintenance of Shoulder Health and Function After Spinal Cord Injury|Southern California Spinal Cord Injury Model System: A Randomized Clinical Trial to Evaluate Two Prevention Programs for Maintenance of Shoulder Health and Function After Spinal Cord Injury|Unknown status|Active, not recruiting|N/A|166|Anticipated|Rancho Research Institute, Inc.||3|||f||||f||||||||||2017-10-11 00:26:15.471396|2017-10-11 00:26:15.471396
NCT02135965|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-12-17|||April 2009||2009-04-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|CALM||Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate|Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate.|Completed||Early Phase 1|8|Actual|Pennington Biomedical Research Center||8|||f||||f||||||||||2017-10-11 00:26:15.601039|2017-10-11 00:26:15.601039
NCT02135952|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-06|||September 2011||2011-09-01|May 2014|2014-05-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis|Metronidazole and Amoxicillin as Adjuncts to Scaling and Root Planing for the Treatment of Type 2 Diabetic Subjects With Periodontitis: a Randomized Placebo-controlled Clinical Trial|Unknown status|Active, not recruiting|Phase 4|58|Actual|University of Guarulhos||2|||f||||t||||||||||2017-10-11 00:26:15.828962|2017-10-11 00:26:15.828962
NCT02135939|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-07-05|||March 11, 2014|Actual|2014-03-11|July 2017|2017-07-01|April 2022|Anticipated|2022-04-01|February 2, 2017|Actual|2017-02-02||Interventional|||Vegan vs AHA Diet on Inflammation and Glucometabolic Profile in Patients With CAD|Effects of a Whole-food Plant-based Vegan Diet on Markers of Inflammation and Glucometabolic Profile in Patients With Coronary Artery Disease|Active, not recruiting||N/A|100|Actual|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-11 00:26:15.965693|2017-10-11 00:26:15.965693
NCT02135926|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-02-15|||March 2014||2014-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|THRILL||Comparison of Thrombectomy and Standard Care for Ischemic Stroke in Patients Ineligibility for Tissue Plasminogen Activator Treatment|Thrombectomy in Patients Ineligible for iv tPA|Terminated||N/A|4|Actual|University Hospital Heidelberg||2||Results from MR CLEAN, ESCAPE, EXTEND-IA, and SWIFT PRIME made randomization unethical.|f||||t||||||||||2017-10-11 00:26:16.164191|2017-10-11 00:26:16.164191
NCT02135887|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-03-07|||November 2013||2013-11-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|MB-6||A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.|The Purpose of This Study is to Evaluate the Effectiveness of MB-6 as Adjuvant Therapy in Reducing Neutropenia When Given Oxaliplatin-based Chemotherapy in Patients With Stage 3 Colorectal Cancer Previously Treated With Surgery.|Recruiting||N/A|184|Anticipated|Microbio Co Ltd|||2||f||||t||||||||||2017-10-11 00:26:16.728818|2017-10-11 00:26:16.728818
NCT02135874|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-03-28|||October 2014|Actual|2014-10-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids - Mixed Phenotype Acute Leukemia (MPAL)|A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids for Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 00:26:16.843046|2017-10-11 00:26:16.843046
NCT02135861|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-05-22|||July 30, 2014|Actual|2014-07-30|May 2017|2017-05-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Interventional|||A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure|An Evaluation of DCE-MRI Measures of Pulmonary Oedema and Vascular Permeability in Healthy Subjects and in Patients With Cardiac Failure: A Methods Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure|Completed||Phase 1|29|Actual|GlaxoSmithKline||3|||f||||f|f|f||||||||2017-10-11 00:26:16.988516|2017-10-11 00:26:16.988516
NCT02135835|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-08-01|||August 2014||2014-08-01|May 2014|2014-05-01||||December 2015|Anticipated|2015-12-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure|A Multicentre, Parallel-Group, Randomised, Double-Blind Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure.|Unknown status|Recruiting|Phase 4|356|Anticipated|China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:26:17.235796|2017-10-11 00:26:17.235796
NCT02135822|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-15|||May 2014||2014-05-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|NAPGAP||Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer|Phase II Trial of Nab-paclitaxel Plus Gemcitabine in First-line Treatment of Chinese Patients With Advanced Pancreatic Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 00:26:17.402513|2017-10-11 00:26:17.402513
NCT02135809|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-06-29|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|March 30, 2017|Actual|2017-03-30|June 2015|Actual|2015-06-01||Interventional|||Pancreatic Metal Stents in Chronic Pancreatitis|Fully Covered Self Expanding Metal Stents (FCSEMS) for Refractory Pancreatic Duct Strictures in Patients With Chronic Pancreatitis|Completed||N/A|10|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 00:26:17.525136|2017-10-11 00:26:17.525136
NCT02135796|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-09-06|||October 2008||2008-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Echocardiography in Septic Shock|ICU Echocardiography in Resuscitation of Sepsis and Septic Shock|Recruiting||N/A|172|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-10-11 00:26:17.614567|2017-10-11 00:26:17.614567
NCT02135783|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-02-04|||October 2014||2014-10-01|February 2016|2016-02-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|CARICH||Decompressive Craniectomy Combined With Hematoma Removal to Treat ICH|A Randomised Trial to Establish the Efficacy and Safety of Decompressive Craniectomy Combined With Hematoma Removal in Patients With Intracerebral Hemorrhage|Recruiting||N/A|200|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 00:26:17.704889|2017-10-11 00:26:17.704889
NCT02135770|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-07-06|||January 2013||2013-01-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis|Randomized Control Trial to Assessed the Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Severe Sepsis|Completed||Phase 3|115|Actual|Indonesia University||2|||f||||f||||||||||2017-10-11 00:26:17.800008|2017-10-11 00:26:17.800008
NCT02135757|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-10-05|||August 2014||2014-08-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Observational|||Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients|A Phase IV Multicenter Trial to Evaluate Real-world Health Outcomes, Economic Impact and Resistance Mechanisms of Panitumumab in the Treatment of Patients With Chemotherapy-refractory Metastatic Colorectal Cancer|Active, not recruiting||N/A|23|Actual|PeriPharm|||1||f||||||||||||||2017-10-11 00:26:17.893043|2017-10-11 00:26:17.893043
NCT02135744|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-08|||February 2010||2010-02-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions|Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions and Emergency Department Visits: a Randomized, Controlled Trial.|Completed||N/A|172|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-10-11 00:26:17.965393|2017-10-11 00:26:17.965393
NCT02135731|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-09|||February 2009||2009-02-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||APHID- Primary Care Accuracy Study|APHID- Sensitivity and Specificity of a Medication Reconciliation Technology - A Primary Care Randomized Controlled Trial|Completed||N/A|220|Actual|Portland VA Medical Center||2|||f||||f||||||||||2017-10-11 00:26:18.057989|2017-10-11 00:26:18.057989
NCT02135718|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-06-06|||June 2014||2014-06-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma|A Preference Study of Inhaler Attributes Between Two Inhalers; ELLIPTA and MDI, in Adult Subjects With Asthma|Completed||N/A|288|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 00:26:18.161824|2017-10-11 00:26:18.161824
NCT02135705|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-05-08|||March 2014||2014-03-01|May 2014|2014-05-01|September 2028|Anticipated|2028-09-01|March 2028|Anticipated|2028-03-01|10 Years|Observational [Patient Registry]|LOWER||LOWER: Lomitapide Observational Worldwide Evaluation Registry|LOWER: Lomitapide Observational Worldwide Evaluation Registry|Enrolling by invitation||N/A|300|Anticipated|Aegerion Pharmaceuticals, Inc.|||1||f||||f||||||||||2017-10-11 00:26:18.280218|2017-10-11 00:26:18.280218
NCT02135692|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-09-28|||May 29, 2014|Actual|2014-05-29|September 2017|2017-09-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Interventional|||A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects|Study 201312: A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects With a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial|Active, not recruiting||Phase 3|375|Actual|GlaxoSmithKline||1|||t||||t|t|f||||||||2017-10-11 00:26:18.39106|2017-10-11 00:26:18.39106
NCT02135679|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-07-18|||September 2012||2012-09-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Observational|||The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy|The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy|Recruiting||N/A|160|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||6||f||||t||||||||||2017-10-11 00:26:18.714913|2017-10-11 00:26:18.714913
NCT02135666|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2015-11-16|||May 2015||2015-05-01|November 2015|2015-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)|Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)|Withdrawn||Phase 4|0|Actual|GlaxoSmithKline||2||"This study has been cancelled before initiation due to company's prioritisation decisions   linked to resources restrictions."|f||||||||||||||2017-10-11 00:26:18.816528|2017-10-11 00:26:18.816528
NCT02135653|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-07-28|||March 2013||2013-03-01|July 2017|2017-07-01||||September 2018|Anticipated|2018-09-01||Observational|||A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer|A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer|Active, not recruiting||N/A|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-11 00:26:18.902979|2017-10-11 00:26:18.902979
NCT02135640|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-05-09|||July 17, 2014|Actual|2014-07-17|May 2017|2017-05-01|February 17, 2015|Actual|2015-02-17|February 17, 2015|Actual|2015-02-17||Interventional|||China HVT Safety, PK, PD|A Randomized, Single-blind, Parallel-group, Placebo-controlled, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab Administered Subcutaneously to Healthy Adults in China|Completed||Phase 1|64|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:26:18.982403|2017-10-11 00:26:18.982403
NCT02135627|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2016-11-21|||April 2014||2014-04-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||TC-325 (HEMOSPRAY™) VS. CURRENT STANDARD OF CARE IN MANAGING MALIGNANT GASTROINTESTINAL BLEEDING: A PILOT STUDY TO INFORM A RANDOMIZED CONTROLLED TRIAL.||Completed||N/A|20|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 00:26:19.086995|2017-10-11 00:26:19.086995
NCT02135614|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-05-31|||June 9, 2014|Actual|2014-06-09|May 2017|2017-05-01|April 12, 2017|Actual|2017-04-12|March 20, 2017|Actual|2017-03-20||Interventional|||Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection|Completed||Phase 2|190|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-11 00:26:19.181592|2017-10-11 00:26:19.181592
NCT02135588|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-07-11|||October 2013||2013-10-01|July 2017|2017-07-01||||September 2017|Anticipated|2017-09-01||Interventional|||Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions||Recruiting||Phase 1|10|Anticipated|Eastern Regional Medical Center||1|||f||||f||||||||||2017-10-11 00:26:19.644177|2017-10-11 00:26:19.644177
NCT02135575|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-01-05|||May 2014||2014-05-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Exercise Training on Cardiovascular Health in Middle-aged Women|Effects of Exercise Training on Cardiovascular Health in Middle-aged Women|Active, not recruiting||N/A|40|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-11 00:26:19.746773|2017-10-11 00:26:19.746773
NCT02135562|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-09-18|||August 8, 2014|Actual|2014-08-08|September 2017|2017-09-01|April 19, 2017|Actual|2017-04-19|April 19, 2017|Actual|2017-04-19||Interventional|||Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors|A Pilot Study of a Protein-Sparing Modified Fast for Weight Loss in Obese Endometrial Cancer Survivors|Completed||N/A|11|Actual|Case Comprehensive Cancer Center||1|||f||||f|f|f||||||||2017-10-11 00:26:19.869585|2017-10-11 00:26:19.869585
NCT02135549|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2015-07-17|||May 2014||2014-05-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin|Randomized, Dose-Ranging, Cross-over, Placebo-controlled Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin|Completed||N/A|24|Actual|Boston Therapeutics||3|||f||||f||||||||||2017-10-11 00:26:20.055474|2017-10-11 00:26:20.055474
NCT02135536|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-03-27||2017-03-27|May 2014||2014-05-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis|A Phase 2, Multi-Center Study to Evaluate Three Doses of NGM282 Administered for 24 Weeks in Patients With Primary Biliary Cirrhosis (PBC) Who Have Completed Study 13-0103|Completed||Phase 2|36|Actual|NGM Biopharmaceuticals, Inc||3|||f||||f||||||||||2017-10-11 00:26:20.161754|2017-10-11 00:26:20.161754
NCT02135523|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-05-06|||April 2014||2014-04-01|April 2014|2014-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian Cancer After Definitive Treatment; Multi-institutional Clinical Trial||Recruiting||Phase 2|70|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 00:26:20.327524|2017-10-11 00:26:20.327524
NCT02135510|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-03-20|||June 2013||2013-06-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|MEDEA||MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy|MEtoclopramide, DExamethasone or Axoli (Palonoseton) for the Prevention of Delayed Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy: the MEDEA-trial|Recruiting||Phase 3|450|Anticipated|VU University Medical Center||3|||f||||t||||||||||2017-10-11 00:26:20.47056|2017-10-11 00:26:20.47056
NCT02135484|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-09-28|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases|An Observation, Open Label Study of Alpharadin (Radium 223) in Patients With Castrate Resistant Prostate Cancer Bone Metastases|Active, not recruiting||N/A|25|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:26:20.655675|2017-10-11 00:26:20.655675
NCT02135471|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-09|||June 2009||2009-06-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|November 2011|Actual|2011-11-01||Interventional|||Root Coverage in Smokers With Acellular Dermal Matrix Graft and Enamel Matrix Derivative|A 12-month Randomised Controlled Prospective Clinical Study for Root Coverage in Smokers With Acellular Dermal Matrix Graft and Enamel Matrix Derivative|Completed||Phase 2|19|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:26:20.803356|2017-10-11 00:26:20.803356
NCT02135458|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-12-08|||April 2014||2014-04-01|December 2014|2014-12-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Interventional|AUTONOM@DOM||Evaluation of the AUTONOM@DOM Telemonitoring System for People With Heart Failure|"Clinical and Medico-economic Assessment of Conventional Care Plus the Autonom@Dom Telemonitoring System Versus a Conventional Care Package Alone, for People With Heart Failure in Several French Structures."|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 00:26:20.948255|2017-10-11 00:26:20.948255
NCT02135445|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-03-01|2016-12-13|2016-05-06|June 2014||2014-06-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Safety population included all participants who received at least one dose of study medication.|Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer|A Phase 2, Randomized, Open-Label, Parallel Group Study Evaluating the Safety and Efficacy of TAK-385, an Oral Gonadotropin-Releasing Hormone (GnRH) Antagonist, for Patients With Localized Prostate Cancer Requiring Neoadjuvant and Adjuvant Androgen Deprivation Therapy With External Beam Radiation Therapy (EBRT)|Completed||Phase 2|103|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:26:21.169107|2017-10-11 00:26:21.169107
NCT02135432|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-01-05|2016-05-25||May 2015||2015-05-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||TOPIC Trial for COPD|A Randomized, Double-Blind, Placebo Controlled Pilot Study to Determine the Safety and Efficacy of Ivacaftor (VX-770) for the Treatment of Chronic Obstructive Pulmonary Disease (The TOPIC Trial)|Completed||Early Phase 1|12|Actual|University of Alabama at Birmingham|this pilot trial was under powered and potentially too brief to detect definitive changes in lung function|2|||f||||t||||||||||2017-10-11 00:26:23.696596|2017-10-11 00:26:23.696596
NCT02135419|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-09-01|||September 24, 2014||2014-09-24|September 2017|2017-09-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2022|Anticipated|2022-06-30||Interventional|ANCHOR||Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions|ANCHOR Study: Anal Cancer/HSIL Outcomes Research Study|Recruiting||Phase 3|5058|Anticipated|AIDS Malignancy Consortium||2|||f||||t||||||||||2017-10-11 00:26:24.103854|2017-10-11 00:26:24.103854
NCT02135406|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-03-16|||May 2014||2014-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2015|Actual|2015-09-01||Interventional|||CART-19 for Multiple Myeloma|Pilot Study Of Redirected Autologous T Cells Engineered To Contain Anti-CD19 Attached To TCRζ And 4-1BB Signaling Domains Coupled With Salvage Autologous Stem-Cell Transplantation (ASCT) In Multiple Myeloma Patients With Early Relapse/Progression After Initial ASCT|Active, not recruiting||Phase 1|13|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:26:24.318261|2017-10-11 00:26:24.318261
NCT02135393|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-08|||April 2009||2009-04-01|May 2014|2014-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|FOLTIPS||Where is the Initial Site of Biotransformation of Folates in Humans?|Folic Acid Handling by the Human Gut: Implications for Food Fortification and Supplementation|Completed||N/A|6|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 00:26:24.399793|2017-10-11 00:26:24.399793
NCT02135380|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2014-05-12|||August 2014||2014-08-01|May 2014|2014-05-01||||August 2015|Anticipated|2015-08-01||Interventional|||Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis|A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intravenous Autologous Adipose Derived Adult Stem Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF).|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Kasiak Research Pvt. Ltd.||3|||f||||t||||||||||2017-10-11 00:26:24.553713|2017-10-11 00:26:24.553713
NCT02135367|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-09-12|||January 2013|Actual|2013-01-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PRP-012||Platelet-rich Plasma (PRP) vs Viscosupplementation for the Treatment of Early Knee Articular Degenerative Pathology|Platelet-rich Plasma (PRP) vs Viscosupplementation for the Treatment of Early Knee Articular Degenerative Pathology: a Randomized Double-blind Controlled Trial|Active, not recruiting||N/A|185|Actual|Istituto Ortopedico Rizzoli||2|||f||||t||||||||||2017-10-11 00:26:24.669915|2017-10-11 00:26:24.669915
NCT02135354|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-03-28|||August 1, 2014|Actual|2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|BACE||Azithromycin for Acute Exacerbations Requiring Hospitalization|Belgian Trial With Azithromycin During Acute COPD Exacerbations|Recruiting||Phase 3|500|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||No||2017-10-11 00:26:24.902095|2017-10-11 00:26:24.902095
NCT02134769|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-11-11|||August 2014||2014-08-01|July 2015|2015-07-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|Bionect||Influence of Bionecteurs on Catheter-associated Infection|Incidence of Catheter-related Bloodstream Infections Using Bionecteur Device|Completed||N/A|221|Actual|University Hospital Tuebingen||2|||f||||t||||||||No||2017-10-11 00:26:33.349356|2017-10-11 00:26:33.349356
NCT02135341|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-08|2017-02-14|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired Contractility|Comparative Study of Safety and Efficacy Between 100 U Suburothelial Injection and 50 U Suburothelial Plus 50 U Urethral Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired Contractility|Completed||Phase 2|60|Actual|Buddhist Tzu Chi General Hospital||2|||f||||f||||||||No|No IPD is planned to share|2017-10-11 00:26:25.148499|2017-10-11 00:26:25.148499
NCT02135328|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-06|||September 2012||2012-09-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||SoLaHmo Radio Stories About Children's Healthy Eating and Exercise|Somali, Latino & Hmong Radio Stories About Children's Healthy Eating and Exercise: A SoLaHmo Pilot Study|Completed||N/A|123|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:26:25.301|2017-10-11 00:26:25.301
NCT02135315|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-05-16|||October 2013||2013-10-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|IAPREC||Intensive Arterial Pressure Control in Acute Coronary Syndrome|Interest of an Intensive Arterial Pressure Control in Acute Coronary Syndrome|Unknown status|Recruiting|Early Phase 1|400|Anticipated|University of Monastir||2|||f||||t||||||||||2017-10-11 00:26:25.402795|2017-10-11 00:26:25.402795
NCT02135302|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-07|||October 2013||2013-10-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects|A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects|Completed||Phase 1|24|Actual|Tetraphase Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:26:25.544008|2017-10-11 00:26:25.544008
NCT02135289|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-04-23|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|IGRA||The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID|The Role of Interferon Gamma Releasing Assays (IGRA) in Screening and Monitoring for Tuberculosis During Anti-TNF Therapy in Patients With Immune-mediated Inflammatory Disease (IMID)|Active, not recruiting||N/A|560|Anticipated|Chinese University of Hong Kong|||2||f||||t||||||||No||2017-10-11 00:26:25.637108|2017-10-11 00:26:25.637108
NCT02135276|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-09-04|||December 2013||2013-12-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects|A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects|Completed||Phase 1|12|Actual|Tetraphase Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:26:25.720101|2017-10-11 00:26:25.720101
NCT02135263|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2014-07-29|||April 2012||2012-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype|Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype|Completed||Phase 4|44|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 00:26:25.808549|2017-10-11 00:26:25.808549
NCT02135250|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-01-26|||January 2014||2014-01-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Study on Therapeutic Effect of Treating Mental Stress Induced Myocardial Ischemia|Study on Therapeutic Effect of Treating Mental Stress Induced Myocardial Ischemia With Conventional Therapy for Coronary Heart Disease Combined With Traditional Chinese Medicine :Design and Methods|Unknown status|Recruiting|N/A|120|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||||2017-10-11 00:26:25.912185|2017-10-11 00:26:25.912185
NCT02135237|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-06-23|||January 2014||2014-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Contingency Management for Alcohol Use Disorders|Contingency Management for Alcohol Use Disorders|Recruiting||N/A|120|Anticipated|UConn Health||2|||f||||t||||||||||2017-10-11 00:26:26.047665|2017-10-11 00:26:26.047665
NCT02135224|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-07|||December 2011||2011-12-01|May 2014|2014-05-01||||July 2014|Anticipated|2014-07-01||Interventional|EFVD||the Effects of Epidural Fentanyl on Vaginal Delivery|The Effects of Fentanyl Added to Ropivacaine for Labour Epidural Analgesia on the Progress, Duration or Mode of Delivery: a Randomized, Double Blind Study.|Unknown status|Recruiting|N/A|60|Anticipated|University of Athens||2|||f||||||||||||||2017-10-11 00:26:26.18157|2017-10-11 00:26:26.18157
NCT02135211|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-10-19|||September 2012||2012-09-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|October 2014|Actual|2014-10-01||Interventional|||Healthy Directions After Lung Surgery Pilot|Feasibility and Acceptability of a Lifestyle Intervention for Patients Receiving Surgical Treatment for Lung Surgery|Active, not recruiting||Early Phase 1|72|Anticipated|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-11 00:26:26.283463|2017-10-11 00:26:26.283463
NCT02135198|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-08-27|||September 2014||2014-09-01|April 2015|2015-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effects of GABA Modulator AZD7325 on Cortical Excitability|A Phase I Single Site, Single Dose, Randomised, Double-blind, Placebo Controlled 3-way Cross-over Biomarker Study Investigating the Effect of the GABA Modulator AZD7325 on Short Interval Intracortical Inhibition (SICI) in Healthy Volunteers|Completed||Phase 1|12|Actual|University College, London||3|||f||||t||||||||||2017-10-11 00:26:26.389761|2017-10-11 00:26:26.389761
NCT02135185|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-08-16|||July 2012|Actual|2012-07-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|NUTRIMOUV||Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative Intent|Phase II Study, Multicentric, Randomized Studying the Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative Intent|Completed||Phase 2|70|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||f||||||||||2017-10-11 00:26:26.517269|2017-10-11 00:26:26.517269
NCT02135172|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-12-09|||October 2013||2013-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|ACUTE||Breaks in Sedentary Time and Glucose Regulation in Women|Does Breaking Sedentary Time Improve Glucose Regulation in Women With Impaired Glucose Tolerance? A Balanced Incomplete Block Design Study|Completed||N/A|22|Actual|University of Leicester||3|||f||||t||||||||||2017-10-11 00:26:26.599358|2017-10-11 00:26:26.599358
NCT02135159|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-08-10|||February 2014||2014-02-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|BIRTH||Patients With Brain Metastases From HER2-positive Breast Cancer|A Phase I Study to Evaluate the Feasibility of Different Sequences of Combined Trastuzumab Emtansine (T-DM1) and Whole-brain Radiotherapy in Patients With Brain Metastases From HER2-positive Breast Cancer|Completed||Phase 1|36|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||4|||f||||f||||||||||2017-10-11 00:26:26.68994|2017-10-11 00:26:26.68994
NCT02135146|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-11-01|||January 2014||2014-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach|Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach|Completed||Phase 4|40|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 00:26:26.783724|2017-10-11 00:26:26.783724
NCT02135133|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-05-25|||June 2014||2014-06-01|May 2017|2017-05-01|March 2021|Anticipated|2021-03-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL|A Phase II Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Leukemia (SLL)|Suspended||Phase 2|50|Anticipated|Dana-Farber Cancer Institute||1||Due to safety of idelalisib in previously untreated CLL/SLL|f||||t||||||||||2017-10-11 00:26:26.877855|2017-10-11 00:26:26.877855
NCT02135120|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-07-11|||March 2013||2013-03-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||The Efficacy of Peripheral Nerve Blocks With Intrathecal Morphine in Improving Analgesia After Unilateral Total Knee Arthroplasty|Do Peripheral Nerve Blocks When Used as Part of a Multimodal Regimen Inclusive on Intrathecal Morphine Improve Analgesia After Unilateral Total Knee Arthroplasty? A Randomized Controlled Trial|Recruiting||N/A|45|Anticipated|American University of Beirut Medical Center||3|||f||||||||||||||2017-10-11 00:26:26.9924|2017-10-11 00:26:26.9924
NCT02135094|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-11-17|||January 2014||2014-01-01|January 2015|2015-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Low Intensity Ultrasound Therapy for Upper Back Pain Relief|Short Term Effects of Long Duration Low Intensity Continuous Ultrasound for Trapezius Muscle Pain|Completed||N/A|60|Actual|ZetrOZ, Inc.||2|||f||||f||||||||||2017-10-11 00:26:27.341713|2017-10-11 00:26:27.341713
NCT02135081|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-01-12|||December 2008||2008-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Observational|CBF||Cerebral Blood Flow in Single Ventricles Throughout Staged Surgical Reconstruction|A Magnetic Resonance Imaging Study to Determine Cerebral Blood Flow Changes in Single Ventricle Patients During Staged Reconstruction as Compared to Normal Children|Active, not recruiting||N/A|260|Actual|Children's Hospital of Philadelphia|||2||f||||t||||||||||2017-10-11 00:26:27.454418|2017-10-11 00:26:27.454418
NCT02135068|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-01-26|||January 2015||2015-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop|Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop|Completed||Early Phase 1|15|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:26:27.547781|2017-10-11 00:26:27.547781
NCT02135055|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-05-07|||May 2014||2014-05-01|May 2014|2014-05-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Effect of Midazolam on Inflammatory Response and Organ Function in Mechanically Ventilated Sepsis Patients With Different Immune Status|Effect of Midazolam on Inflammatory Response and Organ Function in Mechanically Ventilated Sepsis Patients With Different Immune Status.|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Xiangya Hospital of Central South University||4|||f||||f||||||||||2017-10-11 00:26:27.663688|2017-10-11 00:26:27.663688
NCT02135042|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-06-17|||April 2014||2014-04-01|June 2016|2016-06-01||||July 2021|Anticipated|2021-07-01||Interventional|||Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA|Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)|Recruiting||Phase 2/Phase 3|924|Anticipated|NRG Oncology||4|||f||||t||||||||||2017-10-11 00:26:27.837224|2017-10-11 00:26:27.837224
NCT02135016|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-08-28|2014-08-08||April 2014||2014-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effect of Thoracic Epidural Anesthesia With Different Block Level on Propofol Induction|The Effect of Thoracic Epidural Anesthesia With Different Block Level on Propofol Concentration During General Anesthesia Induction|Completed||Phase 4|45|Actual|First Hospital of China Medical University||3|||f||||t||||||||||2017-10-11 00:26:29.001075|2017-10-11 00:26:29.001075
NCT02135003|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-05-08|||October 2010||2010-10-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Non-enrolment and Non-adherence to HIV Care in a Community-based Program, Rakai, Uganda|Non-enrolment and Non-adherence to HIV Care in a Community-based Program, Rakai, Uganda|Completed||N/A|1209|Actual|Rakai Health Sciences Program||1|||f||||f||||||||||2017-10-11 00:26:29.649033|2017-10-11 00:26:29.649033
NCT02134990|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-04-21|||June 2014||2014-06-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer|A Phase IIa, Open-Label, Single- Center Study to Assess the Activity of Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|20|Anticipated|Oshadi Drug Administration||1|||f||||f||||||||||2017-10-11 00:26:29.800121|2017-10-11 00:26:29.800121
NCT02134977|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-08-24|2016-08-24||September 2011||2011-09-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational||Safety analysis set was defined as participants who received at least one dose of study medication.|"Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: QOL Survey in Premenopausal Breast Cancer Patients"|"Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: QOL Survey in Premenopausal Breast Cancer Patients"|Completed||N/A|2816|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:26:30.025672|2017-10-11 00:26:30.025672
NCT02134964|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-03-05|||June 2014||2014-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 1 Safety and PK Study of OLT1177 Capsules|A Phase 1, Randomized, Dose Escalation, Single Center, Safety and Pharmacokinetic Study of Single and Multi-Dose, Orally Administered OLT1177 Capsules in Healthy Subjects|Completed||Phase 1|35|Actual|Olatec Industries LLC||2|||f||||||||||||||2017-10-11 00:26:30.97707|2017-10-11 00:26:30.97707
NCT02134938|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-05-07|||July 2013||2013-07-01|April 2014|2014-04-01||||September 2014|Anticipated|2014-09-01||Interventional|||Effects of Viscous Fibre Containing Foods on Satiety (Gel Form)|Effects of High-Fibre, Low-Energy Density Viscous Gel Meals on Satiety, Appetite Regulation and Subsequent Food Intake in Healthy Individuals|Unknown status|Recruiting|Phase 1|20|Anticipated|St. Michael's Hospital, Toronto||3|||f||||f||||||||||2017-10-11 00:26:31.227121|2017-10-11 00:26:31.227121
NCT02134925|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-03-13|||June 2014||2014-06-01|March 2017|2017-03-01||||January 2017|Actual|2017-01-01||Interventional|||Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps|Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas|Active, not recruiting||Phase 2|120|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 00:26:31.324259|2017-10-11 00:26:31.324259
NCT02134912|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-10-26|||August 2014||2014-08-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib|S1300: A Randomized, Phase II Trial of Crizotinib Plus Pemetrexed Versus Pemetrexed Monotherapy in ALK-Positive Non-squamous NSCLC Patients Who Have Progressed Systemically After Previous Clinical Benefit From Crizotinib Monotherapy|Recruiting||Phase 2|114|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 00:26:31.500855|2017-10-11 00:26:31.500855
NCT02134899|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-12-08|||May 2014||2014-05-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EVERKYSTE||The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients|An Open-labelled Multicenter Randomized Study on the Efficacy of Everolimus in Reducing Total Native Kidney Volume in Kidney Transplanted Patients With Autosomal Dominant Polycystic Kidney Disease|Recruiting||Phase 3|40|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:26:32.160084|2017-10-11 00:26:32.160084
NCT02134886|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-10-05|||July 2014||2014-07-01|June 2015|2015-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection|A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection|Terminated||Phase 1|48|Actual|National Cancer Institute (NCI)||1||No Accrual|f||||||||||||||2017-10-11 00:26:32.302787|2017-10-11 00:26:32.302787
NCT02134873|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-05-26|||July 2013||2013-07-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SPiN||Sucrose Practices for Pain in Neonates|Sucrose Practices for Pain in Neonates: A Program of Research: Part A (Trial 1 and 2): Determining the Minimally Effective Dose of Sucrose for Procedural Pain in Infants|Completed||N/A|291|Actual|The Hospital for Sick Children||6|||f||||t||||||||||2017-10-11 00:26:32.462822|2017-10-11 00:26:32.462822
NCT02134860|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-09-19|||June 2014||2014-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bed Rest, Alternate Daily Fasting and Incretin Effect|A Randomized Controlled Study on the Incretin Effect, Cognitive Function and Controlled Fasting During Bed Rest in Healthy Male Volunteers|Completed||N/A|20|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:26:32.603167|2017-10-11 00:26:32.603167
NCT02134847|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2016-02-23|||July 2013||2013-07-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|ROSTERS||Multi-center Clinical Trial of Limiting Resident Work Hours on ICU Patient Safety|Multi-center Clinical Trial of Limiting Resident Work Hours on ICU Patient Safety|Recruiting||N/A|300|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 00:26:32.696665|2017-10-11 00:26:32.696665
NCT02134834|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-12-11|||May 2014||2014-05-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of OP0595 Administered Intravenously in Healthy Male Subjects.|Completed||Phase 1|40|Actual|Meiji Seika Pharma Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:26:32.828318|2017-10-11 00:26:32.828318
NCT02134821|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-07|||June 2012||2012-06-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Influence of Pain Sensitivity on Lumbar Surgery Outcomes|Influence of Pain Sensitivity on Surgical Outcomes After Lumbar Spine Surgery in Patients With Lumbar Spinal Stenosis|Completed||N/A|171|Actual|Seoul National University Hospital|||2||f||||f||||||||||2017-10-11 00:26:32.927148|2017-10-11 00:26:32.927148
NCT02134808|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-08-25|||October 2014||2014-10-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder|Placebo-Controlled Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder: a Magnetic Resonance Spectroscopy Study|Recruiting||N/A|100|Anticipated|University of Utah||2|||f||||t||f||||||||2017-10-11 00:26:33.018419|2017-10-11 00:26:33.018419
NCT02134795|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-12-20|||May 2014||2014-05-01|December 2016|2016-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease|A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease|Completed||N/A|6|Actual|Scion NeuroStim||1|||f||||f||||||||||2017-10-11 00:26:33.141699|2017-10-11 00:26:33.141699
NCT02134756|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2015-12-09|||May 2014||2014-05-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Impact of Nutritional Supplementation on Aerobic Performance and Fatigue|Impact of Nutritional Supplementation on Aerobic Performance and Fatigue|Completed||N/A|30|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 00:26:33.425208|2017-10-11 00:26:33.425208
NCT02134743|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2016-09-15|||April 2014||2014-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluation of the Stability of Implants With Two Different Surface Treatments|Evaluation of the Stability of Implants With Two Different Surface Treatments: a Randomized Clinical Trial|Completed||N/A|21|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:26:33.500665|2017-10-11 00:26:33.500665
NCT02134730|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-01-29|||September 2013||2013-09-01|January 2015|2015-01-01||||January 2015|Actual|2015-01-01||Interventional|||School-based Universal Prevention for Anxiety and Depression in Sweden: A Cluster-randomized Trial|School-based Universal Prevention for Anxiety and Depression in Sweden: A Cluster-randomized Trial Using the FRIENDS for Life Manual|Completed||N/A|695|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 00:26:35.629042|2017-10-11 00:26:35.629042
NCT02134717|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-06-20|2016-08-08||January 2014||2014-01-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|GRADS||Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes|An Interventional Study of the Effect of CCR5 Inhibition With Maraviroc on Immune Cells in the the Lung and in Peripheral Blood of Patients With Sarcoidosis|Terminated||N/A|3|Actual|University of Pittsburgh||1||Poor recruitment|f||||t||||||||||2017-10-11 00:26:35.717408|2017-10-11 00:26:35.717408
NCT02134704|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-08-29|||September 2014||2014-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MOUVSCO||MOUVSCO: Kinematic Analysis of the Trunk in Patients With Moderate Scoliosis|Kinematic Analysis of the Trunk in Patients With Moderate Scoliosis|Terminated||N/A|48|Actual|University Hospital, Grenoble||2||"All patients were recruted but it has been difficulte to recrute all volunteers (15/30) .   However data should be sufficient for analyse of data."|f||||f||||||||||2017-10-11 00:26:35.939083|2017-10-11 00:26:35.939083
NCT02134691|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-06-02|||August 2013||2013-08-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Randomized Trial of Prolonged Exposure for the Treatment of Posttraumatic Stress Disorder (PTSD)||Recruiting||Phase 1|100|Anticipated|University of Puerto Rico||2|||f||||f||||||||||2017-10-11 00:26:36.0179|2017-10-11 00:26:36.0179
NCT02134678|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-04-30|||May 2011||2011-05-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Assessing Change in Short Term Therapy for Depression|Assessing Change in Short Term Therapy for Depression Using ESM|Completed||N/A|56|Actual|University of North Carolina, Greensboro||2|||f||||t||||||||||2017-10-11 00:26:36.104487|2017-10-11 00:26:36.104487
NCT02134665|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-05-07|||May 2013||2013-05-01|May 2014|2014-05-01|May 2014|Anticipated|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Unexpected Pharmacokinetics of Vancomycin in Patients With Severe Acute Pancreatitis Compared With Pneumonia|Unexpected Pharmacokinetics of Vancomycin in Patients With Severe Acute Pancreatitis Compared With Pneumonia|Unknown status|Recruiting|N/A|200|Anticipated|Ruijin Hospital|||2||f||||f||||||||||2017-10-11 00:26:36.21298|2017-10-11 00:26:36.21298
NCT02134652|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-06-10|||January 2015||2015-01-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever|Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever|Withdrawn||N/A|0|Actual|University of Massachusetts, Worcester|||1|Unable to conduct study because of political issues in host country.|f||||t||||||||||2017-10-11 00:26:36.318315|2017-10-11 00:26:36.318315
NCT02134639|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-08-03|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|GALTEP||PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation|Development of an Innovative Gallium 68 Radiolabeling of DOTATOC (68Ga-DOTATOC) for PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation|Completed||N/A|20|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-11 00:26:36.411829|2017-10-11 00:26:36.411829
NCT02134626|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-05-07|||August 2010||2010-08-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Simvastatin Effect on Portal Hypertension|Simvastatin Effect in Portal Hypertension Measured by Portal Hemodynamic Gradient and Azygos Vein Doppler in Echoendoscopy|Completed||Phase 3|34|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 00:26:36.498608|2017-10-11 00:26:36.498608
NCT02134613|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-05-25|||January 2009||2009-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity|99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity|Recruiting||Phase 2|50|Anticipated|Universidade Federal do Rio de Janeiro||1|||f||||t||||||||||2017-10-11 00:26:36.706874|2017-10-11 00:26:36.706874
NCT02134600|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-05-22|||May 2014||2014-05-01|May 2014|2014-05-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|OmegaChild||OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer|OmegaChild - Omega-3 Supplementation to Children Now in Full Remission From a Previous Cancer; an Early Phase Dose-finding Study.|Unknown status|Recruiting|Phase 1|40|Anticipated|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 00:26:36.799978|2017-10-11 00:26:36.799978
NCT02134587|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-07-26|2015-03-29||February 2012||2012-02-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Interventional|EIPhv||Educational Intervention in Pharmacovigilance for Hospital Health Professionals|Implementation of a Hospital Pharmacovigilance Service and Comparison of Algorithms for Adverse Drug Reaction Causality Assessment|Completed||N/A|203|Actual|Universidade Estadual Paulista Júlio de Mesquita Filho||1|||f||||f||||||||||2017-10-11 00:26:36.947954|2017-10-11 00:26:36.947954
NCT02134574|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-09-04|||February 2014||2014-02-01|September 2015|2015-09-01|June 2033|Anticipated|2033-06-01|June 2033|Anticipated|2033-06-01||Observational|DataDiag2012||Prospective Cohort With Hemopathy in Languedoc-Roussillon|Prospective Cohort Study of Clinical and Laboratory Data of Patients With Hemopathy in Languedoc-Roussillon|Recruiting||Early Phase 1|500|Anticipated|University Hospital, Montpellier|||1||f||||f||||||Samples With DNA|"     Blood and marrow   "|||2017-10-11 00:26:37.337702|2017-10-11 00:26:37.337702
NCT02133300|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-02-18|||May 2014||2014-05-01|February 2015|2015-02-01||||December 2015|Anticipated|2015-12-01||Interventional|NESCI||NMES in Critically Ill Patients|Neuromuscular Electrical Stimulation in Critically Ill Patients|Unknown status|Recruiting|N/A|90|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 00:26:55.663698|2017-10-11 00:26:55.663698
NCT02134561|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-05-06|||September 2013||2013-09-01|February 2013|2013-02-01||||September 2017|Anticipated|2017-09-01||Interventional|PREHUNT||Assessment of the Psychological, Cognitive and Social Resources of Applicants for Huntington's Disease and Presymptomatic Genetic Testing||Unknown status|Recruiting|N/A|25|Anticipated|University Hospital, Angers||1|||f||||||||||||||2017-10-11 00:26:37.457675|2017-10-11 00:26:37.457675
NCT02134548|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-12-04|||June 2013||2013-06-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Sensitivity Study of Diagnostic for Detection of Chagas Infection|Determination of Estimated Sensitivity for Chagas Detect Plus Rapid Tests|Completed||N/A|1601|Actual|InBios International, Inc.|||1||f||||||||||Samples Without DNA|"     serum   "|||2017-10-11 00:26:37.565499|2017-10-11 00:26:37.565499
NCT02134535|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-01-26|||May 2014||2014-05-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Optimization of the ex Vivo Challenge|Optimization of the ex Vivo Challenge|Completed||N/A|73|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-10-11 00:26:37.639827|2017-10-11 00:26:37.639827
NCT02134522|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-04-25|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease|The Role of Obstructive Sleep Apnea in the Pathogenesis of Hepatic Steatosis in Obese Children and Adolescents|Completed||N/A|1|Actual|Yale University||1|||f||||f||||||||No||2017-10-11 00:26:37.721284|2017-10-11 00:26:37.721284
NCT02134509|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-07-11|||October 2014||2014-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Smartphone Application for Smoking Cessation|Smartphone Application for Smoking Cessation|Completed||N/A|511|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:26:37.823972|2017-10-11 00:26:37.823972
NCT02134496|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-11-24|||June 2014||2014-06-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||PACU Discharge Without Motorfunction Assessment After Spinal Anaesthesia|PACU Discharge Without Motorfunction Assessment After Spinal Anaesthesia for Total Hip or Knee Arthroplasty - a Multicenter Randomized Controlled Trial|Completed||N/A|1511|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:26:37.928664|2017-10-11 00:26:37.928664
NCT02134483|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-02-20|||September 1, 2013|Actual|2013-09-01|February 2017|2017-02-01|December 1, 2015|Actual|2015-12-01|May 1, 2015|Actual|2015-05-01||Interventional|||Parathyroid Allo-transplantation With a New Technique|Parathyroid Allo-transplantation With a New Technique|Completed||N/A|7|Actual|SB Istanbul Education and Research Hospital||1|||f||||||||||||||2017-10-11 00:26:38.056736|2017-10-11 00:26:38.056736
NCT02134470|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-04-28|||April 2014||2014-04-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Diagnostic Relevance of Salivary Testosterone Concentrations in Doping Control.|Diagnostic Relevance of Salivary Testosterone Concentrations After Exogene Low-dose Hormone Application as a Screening Method for in Doping Control.|Unknown status|Active, not recruiting|N/A|12|Anticipated|Paracelsus Medical University||1|||f||||f||||||||||2017-10-11 00:26:38.142041|2017-10-11 00:26:38.142041
NCT02134457|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2017-03-08|||August 2014||2014-08-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|CARE-ROP||Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity|Multicenter Randomized Double Masked Parallel Design Exploratory Study to Assess Safety and Efficacy of Two Different Doses of Intravitreal Anti-VEGF Treatment With Ranibizumab (0.12 mg vs. 0.20 mg) in Infants With Retinopathy of Prematurity (ROP)|Completed||Phase 2|19|Actual|University Hospital Freiburg||2|||f||||t||||||||||2017-10-11 00:26:38.236501|2017-10-11 00:26:38.236501
NCT02134444|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-01-06|||May 2014||2014-05-01|April 2014|2014-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Game Based Vestibular Exercise for Home Rehabilitation|Comparison of Clinical and Game-based Rehabilitation for Balance Impairments and Gaze Dysfunction in Clients With Vestibular Disorders|Unknown status|Recruiting|N/A|50|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:26:38.346463|2017-10-11 00:26:38.346463
NCT02134431|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-03-08|||May 2014||2014-05-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in Adolescents|Dose-response Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Model of Tissue Infectibility in Adolescents|Completed||N/A|13|Actual|University of California, Los Angeles|||2||f||||f||||||||||2017-10-11 00:26:38.442221|2017-10-11 00:26:38.442221
NCT02134418|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-02-03|||March 2015||2015-03-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Evaluation of Social Skills Intervention on Cognitive Function in Schizophrenia|Evaluation of an Intervention Program Designed to Improve Understanding of Irony on the Hemispheric Processing of Ambiguous Figurative Language in Adults With Schizophrenia|Unknown status|Not yet recruiting|N/A|35|Anticipated|Clalit Health Services||2|||f||||t||||||||||2017-10-11 00:26:38.519516|2017-10-11 00:26:38.519516
NCT02134405|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-01-04|||August 2014||2014-08-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia|Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia: a Multi-national, Randomised, Double-blind, Placebo-controlled Study|Recruiting||Phase 4|200|Anticipated|University of Malaya||2|||f||||f||||||||||2017-10-11 00:26:38.604838|2017-10-11 00:26:38.604838
NCT02134392|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-03-16|||December 2013||2013-12-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|FMT||Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection|Fecal Microbiota Transplantation (FMT) for Recurrent or Refractory C. Difficile Infection (CDI) in Pediatric and Young Adult Patients|Recruiting||Phase 1|15|Anticipated|Nationwide Children's Hospital||1|||f||||f|t|f|||f|||Yes|Deidentified data will be put into a database of FMT recipients.|2017-10-11 00:26:38.700572|2017-10-11 00:26:38.700572
NCT02134379|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-04-13|||April 2014||2014-04-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation|"Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation: A Pilot Trial of the Dynamic Thoracic Impedance Bed Rest Test"|Completed||N/A|11|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-11 00:26:38.905068|2017-10-11 00:26:38.905068
NCT02129348|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-09-20|||June 2014||2014-06-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Treatment of Psychosis and Agitation in Alzheimer's Disease|Treatment of Psychosis and Agitation in Alzheimer's Disease|Recruiting||Phase 2|80|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 00:29:23.970154|2017-10-11 00:29:23.970154
NCT02134366|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-07|||July 2014||2014-07-01|May 2014|2014-05-01||||July 2015|Anticipated|2015-07-01||Interventional|||Clobazam Use in Epilepsia Partialis Continua - Pilot Study|A Phase III, Randomized, Open Label, Single Center, Study on the Effects of Treatment of Epilepsia Partialis Continua With Clobazam Compared to Treatment With or in Addition to Lorazepam and/or Clonazepam|Unknown status|Not yet recruiting|Phase 3|18|Anticipated|The Cooper Health System||3|||f||||f||||||||||2017-10-11 00:26:39.007198|2017-10-11 00:26:39.007198
NCT02134353|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-06-14|||October 2014||2014-10-01|June 2017|2017-06-01|September 30, 2017|Anticipated|2017-09-30|June 12, 2017|Actual|2017-06-12||Interventional|||A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects|Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects|Active, not recruiting||Phase 3|440|Anticipated|Pharmaxis||2|||f||||t||||||||||2017-10-11 00:26:39.158809|2017-10-11 00:26:39.158809
NCT02134340|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-10-14|||June 2014||2014-06-01|April 2016|2016-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours|A Phase 1a, Multi-centre, Open-label, Non-randomized Study to Assess the Safety, Biodistribution and Tumour Uptake of [I-124]-CPD-1028 Injection|Completed||Phase 1|2|Actual|Centre for Probe Development and Commercialization||1|||f||||f||||||||||2017-10-11 00:26:39.482487|2017-10-11 00:26:39.482487
NCT02134327|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-07|||August 2014||2014-08-01|April 2014|2014-04-01||||April 2015|Anticipated|2015-04-01||Interventional|||Effect of Dexmedetomidine Versus Midazolam Versus a Combination of the Two as a Premedication for Children Undergoing Bilateral Myringotomy Tube Insertion|Effect of Dexmedetomidine Versus Midazolam Versus a Combination of the Two as a Premedication for Children Undergoing Bilateral Myringotomy Tube Insertion: A Randomized, Blinded Study|Unknown status|Not yet recruiting|N/A|60|Anticipated|Nemours Children's Clinic||1|||f||||t||||||||||2017-10-11 00:26:39.580297|2017-10-11 00:26:39.580297
NCT02134314|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-07-28|||September 2014||2014-09-01|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|March 13, 2017|Actual|2017-03-13||Interventional|C1INHDGF||C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI|Assessing Safety and Efficacy of Preoperative and Post-Transplant C1 Inhibitor (Berinert®) vs. Placebo in Recipients of a Renal Allograft From Deceased High Risk Donors and Its Impact on DGF and IRI|Active, not recruiting||Phase 1/Phase 2|70|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-11 00:26:39.728009|2017-10-11 00:26:39.728009
NCT02134301|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-07-12|||May 2014||2014-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections|An Open Label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of Oritavancin Single Dose Infusion in Pediatric Patients Less Than 18 Years of Age With Suspected or Confirmed Bacterial Infections (ORKIDS)|Recruiting||Phase 1|60|Anticipated|The Medicines Company||1|||f||||t||||||||||2017-10-11 00:26:39.87166|2017-10-11 00:26:39.87166
NCT02134288|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-01-23|||April 2014||2014-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Belatacept for Renal Transplant Recipients With Delayed Graft Function|Prospective, Randomized Trial of Belatacept Switch in Renal Transplant Recipients With Delayed Graft Function|Recruiting||Early Phase 1|40|Anticipated|Ohio State University||2|||f||||f||||||||No||2017-10-11 00:26:40.018389|2017-10-11 00:26:40.018389
NCT02134275|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-04-12|||July 2015||2015-07-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Whole Body Vibration Training for Healthy Body Composition in Young Adults|Whole Body Vibration Training for Healthy Body Composition in Young Adults|Active, not recruiting||N/A|176|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 00:26:40.155361|2017-10-11 00:26:40.155361
NCT02134262|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-11-04|||May 2014||2014-05-01|November 2014|2014-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes|Clinical Research of Gene Therapy for Refractory B-Cell Non-Hodgkin Lymphoma Using Autologous T Cells Expressing a Chimeric Antigen Receptor Specific to the CD19 Antigen|Unknown status|Recruiting|Phase 1/Phase 2|18|Anticipated|Jichi Medical University||4|||f||||t||||||||||2017-10-11 00:26:40.240059|2017-10-11 00:26:40.240059
NCT02134249|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2016-01-29|||April 2014||2014-04-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|infertility||Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome|Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome|Completed||Phase 2/Phase 3|200|Actual|Benha University||2|||f||||t||||||||Yes|with other researcher on research gate|2017-10-11 00:26:40.367771|2017-10-11 00:26:40.367771
NCT02134223|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-10-26|||April 2014||2014-04-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Methylation Status of BDNF Gene After Dialectical Behavior Therapy in BPD|Changes in Methylation Status of BDNF Gene After Receiving Dialectical Behavior Therapy in Patients With Borderline Personality Disorder|Recruiting||N/A|180|Anticipated|Mackay Memorial Hospital||3|||f||||t||||||||No||2017-10-11 00:26:40.539152|2017-10-11 00:26:40.539152
NCT02134210|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-09-15||2016-09-15|June 2014||2014-06-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)|A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Chronic Plaque Psoriasis (RaPsOdy)|Completed||Phase 3|521|Actual|Coherus Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 00:26:40.649162|2017-10-11 00:26:40.649162
NCT02134184|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-01-09|2016-12-16||October 2012||2012-10-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SLVP025||The Influence of Chronic CMV Infection on Influenza Vaccine Responses|The Influence of Chronic Cytomegalovirus Infection on Influenza Vaccine Responses|Completed||Phase 4|78|Actual|Stanford University||3|||f||||f||||||||Yes|The NIH Human Immunology Project Consortium (HIPC) data repositories (ImmPORT) may store the results of the research assays results. Genetic data that is developed in this study may be made available to other researchers through the National Center for Biotechnology Information (NCBI) databases. Results from research assays will be labeled with a unique ID code and the volunteer identity (except for age) will not be disclosed.|2017-10-11 00:26:41.162056|2017-10-11 00:26:41.162056
NCT02134171|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-03-24|||June 2014|Actual|2014-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MATRISK||Early Predictive Factors of Cardiac and Cerebral Involvement in TMA|Identification of Early Predictive Factors of Cardiac and Cerebral Involvement in Thrombotic Microangiopathies|Active, not recruiting||N/A|119|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:26:41.762038|2017-10-11 00:26:41.762038
NCT02134145|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-08-24|||January 2015||2015-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|November 2016|Actual|2016-11-01||Observational|SCOUT||Scanadu Consumer Health Outcomes (SCOUT) Study|Usability Study of the Scanadu Scout|Active, not recruiting||N/A|5000|Actual|Scripps Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:26:42.042869|2017-10-11 00:26:42.042869
NCT02134132|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-12-03|||January 2012||2012-01-01|November 2011|2011-11-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Utilization of Platelet Gel for Treatment of Diabetic Foot Ulcers|Utilization of Umbilical Cord Blood-derived Platelet Gel for Treatment of Diabetic Foot Ulcers,a Randomized Double Blind Clinical Trial|Completed||Phase 1/Phase 2|30|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 00:26:42.964833|2017-10-11 00:26:42.964833
NCT02134119|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2016-11-08|2016-07-12||January 2012||2012-01-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes|Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes|Completed||N/A|45|Actual|University of Georgia|A limitation is that we did not control for the menstrual cycle. Additionally, we used self-reported physical activity data which relies on accuracy of reporting.|2|||f||||t||||||||No||2017-10-11 00:26:43.131221|2017-10-11 00:26:43.131221
NCT02134106|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2014-12-12|||January 2015||2015-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|XDR-GNB||Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria|Multi-center, Open-label Randomized Controlled Trial on the Efficacy of Combination Antibiotic Therapy for Serious Infections Caused by Extensively Drug-resistant Gram-negative Bacteria (XDR-GNB)|Unknown status|Not yet recruiting|Phase 2/Phase 3|150|Anticipated|Tan Tock Seng Hospital||2|||f||||t||||||||||2017-10-11 00:26:43.916117|2017-10-11 00:26:43.916117
NCT02134093|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-07-09|||July 2014||2014-07-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients|Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients -a Single-center, Randomized ,Double-blinded and Controlled Trial|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Tang-Du Hospital||3|||f||||||||||||||2017-10-11 00:26:44.121515|2017-10-11 00:26:44.121515
NCT02134080|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-03-18|||May 2014||2014-05-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||FAAH Inhibitor Trial for Adults With Tourette Syndrome|FAAH Inhibitor Trial for Adults With Tourette Syndrome|Suspended||Phase 2|10|Anticipated|Yale University||2||Clinical hold placed on the study pending results from another study|f||||||||||||||2017-10-11 00:26:44.239773|2017-10-11 00:26:44.239773
NCT02134067|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-06-12|||August 2014||2014-08-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors|A Phase 1, Open-Label, Non-Randomized, Dose-Escalating Safety, Tolerability and Pharmacokinetic Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors|Recruiting||Phase 1|74|Anticipated|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-10-11 00:26:44.356998|2017-10-11 00:26:44.356998
NCT02134054|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-08-26|||April 2014||2014-04-01|August 2016|2016-08-01|November 2020|Anticipated|2020-11-01|November 2015|Actual|2015-11-01||Observational|SUSI-CS||Stavanger IBD Study - Cross Sectional|Stavanger University Hospital IBD Study - a Cross Sectional Longitudinal Study on Patients Treated With Biologics|Active, not recruiting||N/A|210|Actual|Helse Stavanger HF|||1||f||||f||||||Samples Without DNA|"     Standard blood sampling Serum sampling - trough/antibodies of biological agent   "|No||2017-10-11 00:26:44.49204|2017-10-11 00:26:44.49204
NCT02134041|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-05-06|||October 2012||2012-10-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Observational|TBI||Amyloid Accumulation After Mild Traumatic Brain Injury|Observational Study for Amyloid Accumulation After Mild Traumatic Brain|Unknown status|Recruiting|N/A|150|Anticipated|Taipei Medical University Shuang Ho Hospital|||2||f||||t||||||Samples With DNA|"     peripheral blood for APOE genotyping   "|||2017-10-11 00:26:44.585708|2017-10-11 00:26:44.585708
NCT02134028|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-06-15|||July 21, 2014|Actual|2014-07-21|June 2017|2017-06-01|October 2, 2019|Anticipated|2019-10-02|October 2, 2019|Anticipated|2019-10-02||Interventional|||Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)|Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study|Enrolling by invitation||Phase 2/Phase 3|2206|Anticipated|Sanofi||1|||f||||t||||||||||2017-10-11 00:26:44.791628|2017-10-11 00:26:44.791628
NCT02134002|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-12-07|||June 2014||2014-06-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|RAPID||A PET Exploration of the Mechanism of Action of Dopamine Beta-hydroxylase Inhibition in Cocaine Addicts|Dopamine Beta-hydroxylase Inhibition Induced Blunting of Dopaminergic Response to Psychostimulant Administration. A PET Exploration of the Mechanism of Action of a New Therapeutic Strategy in Cocaine Addicts|Withdrawn||Phase 4|0|Actual|Assistance Publique - Hôpitaux de Paris||2||Too selective recrutment criteria, none eligible patients|f||||f||||||||||2017-10-11 00:26:46.159205|2017-10-11 00:26:46.159205
NCT02133989|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-04-24|||June 2014||2014-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CRECAS||Clopidogrel Resistance and Embolism in Carotid Artery Stenting|Ticlopidine+Ginkgo Biloba Versus Clopidogrel in Clopidogrel Resistant Patients Undergoing Cartoid Artery Stent Placement|Recruiting||Phase 3|86|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 00:26:46.306957|2017-10-11 00:26:46.306957
NCT02133976|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-02-17|||June 2014||2014-06-01|February 2015|2015-02-01||||September 2018|Anticipated|2018-09-01||Interventional|||Mechanisms of Psychosocial Chronic Pain Treatments|Mechanisms of Psychosocial Chronic Pain Treatments|Recruiting||N/A|400|Anticipated|Rush University Medical Center||4|||f||||t||||||||||2017-10-11 00:26:46.442246|2017-10-11 00:26:46.442246
NCT02133963|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-05-15|||May 2014||2014-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|DREAMSS||Determining Relationships Among Maternity Stress & Sleep|Sleep Dysregulation and Neuroendocrine Stress Reactivity: Towards a Biopsychosocial Model of Vulnerability to Postpartum Depression|Completed||N/A|17|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples Without DNA|"     Serum, Plasma, Adrenocorticotropic hormone (ACTH), Cortisol   "|||2017-10-11 00:26:46.564765|2017-10-11 00:26:46.564765
NCT02133950|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-06|||May 2014||2014-05-01|May 2014|2014-05-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Efficacy Study of Segmentation of PGD Treatment|A Single Centre Randomised Controlled Study Into the Segmentation of Preimplantation Genetic Diagnosis (PGD) Treatment by Comparing Cumulative Pregnancy Rates Following Cryopreservation of All Genetically Transferable Embryos After PGD, Compared to Fresh Embryo Transfer Cumulative With Frozen Embryo Transfer of Genetically Transferable Embryos.|Unknown status|Not yet recruiting|N/A|252|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||t||||||||||2017-10-11 00:26:46.663117|2017-10-11 00:26:46.663117
NCT02133937|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-11-01|||April 2014||2014-04-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers|A Single-center, Randomized Open-label, Single-dose, Parallel Group Study to Investigate the Relative Bioavailability of a High Concentration Liquid Formulation (Hclf) in Prefilled Syringes Versus the Reference Lyophilized Formulation (Lyof) of Gantenerumab Following Administration by Subcutaneous Injection in Healthy Volunteers|Completed||Phase 1|31|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:26:46.771402|2017-10-11 00:26:46.771402
NCT02133924|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-01-31|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease|Phase II Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease|Recruiting||Phase 2|90|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t|t|f||||||||2017-10-11 00:26:46.859674|2017-10-11 00:26:46.859674
NCT02133911|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-06|||May 2014||2014-05-01|May 2014|2014-05-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|RAMP-DCM||A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy|Effects of Ranolazine on Myocardial Perfusion in Patients With Dilated Cardiomyopathy|Unknown status|Recruiting|Phase 2|70|Anticipated|University Medical Centre Ljubljana||2|||f||||t||||||||||2017-10-11 00:26:47.056652|2017-10-11 00:26:47.056652
NCT02133898|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-14|||February 2016||2016-02-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||The Use Of L-Methylfolate As A Treatment For Depression|The Use Of A Genetic Marker To Predict Response To L-Methylfolate As A Treatment For Depression|Recruiting||N/A|75|Anticipated|University of Florida||1|||f||||f||||||||||2017-10-11 00:26:47.188133|2017-10-11 00:26:47.188133
NCT02133885|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-18|||December 2016|Actual|2016-12-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients|Angiotensin and Neuroimmune Activation in Hypertension|Recruiting||Phase 1/Phase 2|101|Anticipated|University of Florida||2|||f||||f|f|f||||||||2017-10-11 00:26:47.295843|2017-10-11 00:26:47.295843
NCT02133872|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-08-07|||October 2014||2014-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients|Angiotensin and Neuroimmune Activation in Hypertension|Recruiting||Phase 1|175|Anticipated|University of Florida||2|||f||||f||||||||||2017-10-11 00:26:47.402806|2017-10-11 00:26:47.402806
NCT02133859|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-04-26|||May 2014||2014-05-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Observational|||Adaptive Servo-ventilation Monitoring Study|Feasibilty of Respiratory Monitoring With Adaptive Servoventilation (PaceWave™) to Predict Worsening of Heart Failure in Patients With Severe Heart Failure and Sleep-disordered Breathing|Completed||N/A|40|Actual|ResMed|||1||f||||f||||||||||2017-10-11 00:26:47.535864|2017-10-11 00:26:47.535864
NCT02133287|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-06-24|||August 2013||2013-08-01|June 2017|2017-06-01|August 2022|Anticipated|2022-08-01|June 2018|Anticipated|2018-06-01||Interventional|||To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization|A Prospective, Multi-center, Randomized Trial To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization|Recruiting||N/A|2000|Anticipated|Beijing AmsinoMed Medical Device Co., Ltd||2|||f||||t||||||||No||2017-10-11 00:26:55.752016|2017-10-11 00:26:55.752016
NCT02133846|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-12-05|||May 2014||2014-05-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|TPI-287-4RT||Safety Study of TPI-287 to Treat CBS and PSP|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI 287 in Patients With Primary Four Repeat Tauopathies: Corticobasal Syndrome or Progressive Supranuclear Palsy|Active, not recruiting||Phase 1|44|Anticipated|University of California, San Francisco||4|||f||||t||||||||||2017-10-11 00:26:47.647674|2017-10-11 00:26:47.647674
NCT02133833|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-07-03|||July 2014||2014-07-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Quantum Spectrum Radiation Emitter for Adhesive Capsulitis|Quantum Spectrum Radiation Emitter for Adhesive Capsulitis (Frozen Shoulder or Stiff Painful Shoulder): a Prospective, Self-controlled Trial|Unknown status|Recruiting|Phase 1|24|Anticipated|Nanjing Junxie Hospital||1|||f||||f||||||||||2017-10-11 00:26:47.771588|2017-10-11 00:26:47.771588
NCT02133820|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-06-26|||April 2014||2014-04-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.|A 4-part, Single-dose, Open-label, Randomised, Crossover, Exploratory Study in Healthy Subjects to Assess the Influence of an Opioid Antagonist on How the Body Processes a Strong Painkiller, When Co-administered in a Fasted and Fed State.|Completed||Phase 1|16|Actual|Mundipharma Research Limited||4|||f||||f||||||||||2017-10-11 00:26:47.885713|2017-10-11 00:26:47.885713
NCT02133807|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-09|||September 2009||2009-09-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|LaRCA||Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis|A 72-week, Prospective, Parallel-group, Partially Blinded, Controlled Phase IIIb Study Evaluating the Impact of Specific Lp(a) Apheresis on Atherosclerotic Disease Burden in Coronary Heart Disease Patients With High Lipoprotein(a) Level.|Completed||Phase 3|32|Actual|Russian Cardiology Research and Production Center||2|||f||||t||||||||||2017-10-11 00:26:48.024812|2017-10-11 00:26:48.024812
NCT02133794|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-05-06|||June 2014||2014-06-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Tomosynthesis Use in Detecting Subtle Occult Hip Fractures|Tomosynthesis Use in Detecting Subtle Occult Hip Fractures|Unknown status|Not yet recruiting|N/A|60|Anticipated|Medical Imaging Informatics Research Centre at McMaster||1|||f||||f||||||||||2017-10-11 00:26:48.176961|2017-10-11 00:26:48.176961
NCT02133781|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-04-03|2017-01-13||July 2009||2009-07-01|April 2017|2017-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||B-cell Immunity to Influenza (SLVP017)- Year 1, 2009|U19 Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire- Year 1, 2009|Completed||Phase 4|51|Actual|Stanford University||3|||f||||f||||||||No||2017-10-11 00:26:48.283142|2017-10-11 00:26:48.283142
NCT02133768|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-03-06|||May 2014||2014-05-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Routine Bladder Catheterisation Through Fast-track Hip and Knee Replacement - What Are the Consequences?|Routine Bladder Catheterisation Through Fast-track Hip and Knee Replacement - What Are the Consequences?|Completed||N/A|800|Actual|Lundbeck Foundation|||1||f||||f||||||||||2017-10-11 00:26:48.831136|2017-10-11 00:26:48.831136
NCT02133755|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-06|||July 2014||2014-07-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|PCOS-Pilot||Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study|Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|IWK Health Centre||1|||f||||f||||||||||2017-10-11 00:26:49.027714|2017-10-11 00:26:49.027714
NCT02133742|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-28|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2017|Actual|2017-03-01||Interventional|||A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer|A Phase 1b, Open Label, Dose Finding Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of Axitinib (Ag-013736) In Combination With Pembrolizumab (Mk-3475) In Patients With Advanced Renal Cell Cancer|Active, not recruiting||Phase 1|52|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:26:49.16402|2017-10-11 00:26:49.16402
NCT02133729|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-07-24|||June 2011||2011-06-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|IMAGE||Metabolic Risk Following Gestational Diabetes Mellitus|IMAGE (Metabolic Risk During Gestation) : Prospective Study of Women With Gestational Diabetes|Completed||N/A|255|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 00:26:49.36251|2017-10-11 00:26:49.36251
NCT02133716|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2015-03-17|||October 2013||2013-10-01|May 2014|2014-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|LACTEET||Efficacy of Breast Milk Expressed and Sucrose in Procedural Pain in Preterm|Efficacy of Breast Milk Expressed Versus Sucrose Relief Procedural Pain of Venipuncture in Preterm.|Completed||Phase 4|54|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-11 00:26:49.532718|2017-10-11 00:26:49.532718
NCT02133703|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-10-21|||October 2015||2015-10-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility|Decision Making Interventions for Women Receiving Uninformative BRCA1/2 Test Results or Positive BRCA1/2 Test Results|Enrolling by invitation||N/A|600|Anticipated|Georgetown University||6|||f||||t||||||||||2017-10-11 00:26:49.728592|2017-10-11 00:26:49.728592
NCT02133690|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-03-13|||May 2014||2014-05-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|||A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants|Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Live Attenuated Bovine-Human Rotavirus Reassortant Pentavalent Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants|Completed||Phase 3|7500|Actual|Serum Institute of India Pvt. Ltd.||2|||f||||t||||||||||2017-10-11 00:26:49.883949|2017-10-11 00:26:49.883949
NCT02132728|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-21|||March 2007||2007-03-01|May 2014|2014-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Impact of Flaxseed on the Syndrome Metabolic Inflammation|Flaxseed and Lignans: Effect of Consumption on Nutritional and Inflammatory Markers|Completed||N/A|52|Actual|University of Sao Paulo||4|||f||||f||||||||||2017-10-11 00:28:25.778173|2017-10-11 00:28:25.778173
NCT02133677|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-05-06|||May 2014||2014-05-01|February 2014|2014-02-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|||A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases|A Phase II, Open-label, Single-arm, Multi-center Pilot Study to Evaluate the Efficacy and Safety of Whole-brain Radiotherapy With Concomitant Temozolomide in Lung Cancer and Breast Cancer Patients With Brain Metastases|Unknown status|Not yet recruiting|Phase 2|24|Anticipated|Far Eastern Memorial Hospital||1|||f||||||||||||||2017-10-11 00:26:50.048108|2017-10-11 00:26:50.048108
NCT02133664|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-02|2017-03-22||June 2014||2014-06-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis|Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis|Completed||Phase 1/Phase 2|54|Actual|Oregon Health and Science University||2|||f||||t||||||||Undecided||2017-10-11 00:26:50.183086|2017-10-11 00:26:50.183086
NCT02133651|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-12-08|||April 2014||2014-04-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Mucosal Versus Fecal Microbiota in FMT|Characterization of the Microbial Genomics of Fecal Bacteriotherapy (FBT): Intestinal Microbiota Transplantation (IMT) for Recurring Clostridium Difficile|Completed||N/A|10|Actual|Emory University|||1||f||||t||||||Samples With DNA|"     Fecal matter from the consented donor, consented recipient at 3 time points will be stored in     a -80 freezer.   "|||2017-10-11 00:26:50.733052|2017-10-11 00:26:50.733052
NCT02133638|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-06|||May 2014||2014-05-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery|Sevoflurane-based Volatile Induction and Maintenance of Anaesthesia (VIMA) Strategy Decreases the Risk of Postoperative Delirium in Elderly Patients With Registered Cerebral Hypoxemia Episodes During General Surgery|Unknown status|Recruiting|Phase 4|130|Anticipated|Negovsky Reanimatology Research Institute||2|||f||||f||||||||||2017-10-11 00:26:50.814412|2017-10-11 00:26:50.814412
NCT02133625|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2016-05-12|||August 2011||2011-08-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors|A Phase I Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|28|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 00:26:50.967754|2017-10-11 00:26:50.967754
NCT02133612|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-04-13|||December 2007||2007-12-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2012|Actual|2012-05-01||Interventional|||Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma|Phase 2 Study of Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Patients With Advanced Esophageal Cancer|Completed||Phase 2|43|Actual|Chinese Academy of Medical Sciences||1|||f||||||||||||||2017-10-11 00:26:51.088894|2017-10-11 00:26:51.088894
NCT02133599|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-07-21|||May 2014||2014-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL|Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With Acute Lymphoblastic Leukemia and Lymphoma|Active, not recruiting||N/A|16|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||t||||||||||2017-10-11 00:26:51.178525|2017-10-11 00:26:51.178525
NCT02133586|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-07-25|||January 2014||2014-01-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|January 2016|Actual|2016-01-01||Interventional|ENDZONE||Effects of Sequential Exposure to Nitrogen Dioxide and Ozone in Healthy Adult Human Volunteers.|Effects of Sequential Exposure to Nitrogen Dioxide and Ozone in Healthy Adult Human Volunteers.|Active, not recruiting||N/A|54|Actual|Environmental Protection Agency (EPA)||4|||f||||f||||||||||2017-10-11 00:26:51.288905|2017-10-11 00:26:51.288905
NCT02133573|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-03-03|||May 2014||2014-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randomized Trial of Maternal Progesterone Therapy|Randomized Trial of Maternal Progesterone Therapy to Improve Neurodevelopmental Outcomes in Infants With Congenital Heart Disease|Recruiting||Phase 2|130|Anticipated|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 00:26:51.446306|2017-10-11 00:26:51.446306
NCT02133560|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-24|||May 2014||2014-05-01|May 2017|2017-05-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||Use of Mobile Technology for Intensive Training in Medication Management|Use of Mobile Technology for Intensive Training in Medication Management|Completed||N/A|46|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:26:51.598062|2017-10-11 00:26:51.598062
NCT02133547|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2015-07-27|||February 2014||2014-02-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Observational|||Determination of Normal Values of Nasal Nitric Oxide in Adults|Determination of Normal Values of Nasal Nitric Oxide Measured With the NIOX MINO Analyzer in Adults: a Pilot Study|Completed||N/A|200|Actual|Centre Hospitalier Universitaire Vaudois|||1||f||||f||||||||||2017-10-11 00:26:51.687436|2017-10-11 00:26:51.687436
NCT02133534|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-06-03|2014-06-03||February 2008||2008-02-01|June 2014|2014-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease|The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease|Terminated||Phase 4|1|Actual|Duke University|Early termination of trial due to lack of enrollment.|1||failure to enroll|f||||||||||||||2017-10-11 00:26:51.753795|2017-10-11 00:26:51.753795
NCT02133521|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2017-02-08|||October 2014||2014-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|ADDLIST||DLBS1033 for Acute Ischemic Stroke Patients|Addition of DLBS1033 to Standard Therapy for Acute Ischemic Stroke Patients|Recruiting||Phase 2/Phase 3|160|Anticipated|Dexa Medica Group||2|||f||||t||||||||||2017-10-11 00:26:51.896485|2017-10-11 00:26:51.896485
NCT02133495|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-07|||January 2011||2011-01-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|||An Outcomes Assessment of the Utility of Belladerm Acellular Dermal Allograft in Ocular Lower Lid Retraction Repair|Use of Non-Cadaveric Human Acellular Dermal Tissue (BellaDerm®) in Lower Eyelid Retraction Repair|Completed||N/A|12|Actual|SGM Physician Research Consortium||1|||f||||f||||||||||2017-10-11 00:26:52.222235|2017-10-11 00:26:52.222235
NCT02133482|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-07-14|||July 2014||2014-07-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667 in Healthy Male Subjects (Single-blind, Partially Randomised, Placebo-controlled Parallel Group Design)|Withdrawn||Phase 1|0|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:26:52.295786|2017-10-11 00:26:52.295786
NCT02133469|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2016-05-19|||June 2012||2012-06-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae|Effectiveness of PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae in 2 to 5 Years Old Healthy Chinese Children.|Completed||N/A|3281|Actual|Centers for Disease Control and Prevention, China||2|||f||||t||||||||||2017-10-11 00:26:52.358184|2017-10-11 00:26:52.358184
NCT02133456|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-07|2014-05-07|||January 2014||2014-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Observational|||A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older|A Post-marketing Safety Study of SIBP's Inactivated, Split-virion Influenza Vaccine Administered in Chinese Subjects Aged 3 Years and Older|Completed||N/A|166240|Actual|Centers for Disease Control and Prevention, China|||1||f||||t||||||||||2017-10-11 00:26:52.463917|2017-10-11 00:26:52.463917
NCT02133443|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-07|||April 2014||2014-04-01|May 2014|2014-05-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||NAVASET: Nava Level Titration Using Comfort Scales|Neurally Adjusted Ventilatory Assist (NAVA) Levels Titration During Weaning Using Ventilatory Comfort Scales: a Physiological Evaluation|Unknown status|Recruiting|N/A|15|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-11 00:26:52.518316|2017-10-11 00:26:52.518316
NCT02133430|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-05-08|||January 2014||2014-01-01|May 2014|2014-05-01|April 2015|Anticipated|2015-04-01|February 2015|Anticipated|2015-02-01||Interventional|||Optimized Anesthesia to Reduce Incidence of Postoperative Delirium|Optimized Anesthesia to Reduce Incidence of Postoperative Delirium in Elderly Undergoing Elective, Non-cardiac Surgery: a Randomized Controlled Trial (POD-II)|Unknown status|Recruiting|Phase 2/Phase 3|140|Anticipated|Chiang Mai University||2|||f||||f||||||||||2017-10-11 00:26:52.595114|2017-10-11 00:26:52.595114
NCT02133417|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-03-14|||July 2014||2014-07-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|QTUS||Non-Inferiority Quantitative Transmission Ultrasound Case Collection Study|A Prospective Multi-center Case Collection Study of Breast Imaging Examinations From Women With Mammographically-detected Lesion(s) to Evaluate the Non-inferiority of Digital Mammography (XRM) and Quantitative Transmission Ultrasound (QTUS) Together Compared to XRM and Hand Held Ultrasound (HHUS) Together in the Evaluation of Lesion(s) Detected With Diagnostic Mammography.|Completed||N/A|287|Actual|QT Ultrasound LLC|||1||f||||f||||||||||2017-10-11 00:26:52.672898|2017-10-11 00:26:52.672898
NCT02133404|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-11-26|||March 2014||2014-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis|Phase II Study of ASP7991 -A Double-blind, Cinacalcet Hydrochloride-controlled, Dose-ascending Study in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis -|Completed||Phase 2|62|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:26:52.736906|2017-10-11 00:26:52.736906
NCT02133391|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-09-27|||February 18, 2015|Actual|2015-02-18|September 2017|2017-09-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Interventional|ACO/PH||Accountable Care Organizations/ Public Health Collaborative|Agency for Healthcare Research and Quality R18: Accountable Care Organizations (ACO)/ Public Health Collaborative Preventive Care Delivery to Priority Populations|Completed||N/A|78354|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 00:26:52.820697|2017-10-11 00:26:52.820697
NCT02133378|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-13|||March 2014||2014-03-01|September 2017|2017-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Prospective Clinical Trial of the Hemopatch Topic Hemostatic in Cardiac Surgery|Prospective, Randomized Clinical Trial of the Hemopatch Topic Hemostatic in Cardiac Surgery.|Completed||N/A|170|Actual|Cardiochirurgia E.H.||2|||f||||f||||||||||2017-10-11 00:26:52.885424|2017-10-11 00:26:52.885424
NCT02133365|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-07-11|||September 2014||2014-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2017|Actual|2017-03-01||Interventional|||Atrial Fibrillation, Cardiac Symptoms, and Anxiety|Atrial Fibrillation, Cardiac Symptoms, and Anxiety|Suspended||N/A|130|Anticipated|Brigham and Women's Hospital||2||Changes in availability of study personnel|f||||f||||||||||2017-10-11 00:26:54.805181|2017-10-11 00:26:54.805181
NCT02133352|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-05-15|2016-02-01||July 2011||2011-07-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction|Proof of Concept Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction|Completed||Phase 4|10|Actual|Boston University|Small sample size; not all subjects completed Day 180 assessments|1|||f||||f|t|f|||f|||No||2017-10-11 00:26:54.937812|2017-10-11 00:26:54.937812
NCT02133339|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-10-29|||May 2014||2014-05-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Single Ascending Dose Study of TRN-157 in Healthy Subjects|A Phase I, Randomized, Double-blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety and Tolerability of Nebulized, TRN-157 Inhalation Solution in Healthy Subjects|Completed||Phase 1|30|Actual|Theron Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-11 00:26:55.370387|2017-10-11 00:26:55.370387
NCT02133326|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-01-19|||March 2014||2014-03-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|Caldolor||Efficacy Study of IV Ibuprofen vs IV Acetaminophen Post Surgical Extraction|Assessment of Preemptive Analgesic Effect of Caldolor® vs. Ofirmev® on Third Molar Surgery: A Prospective, Randomized, Double-blinded Clinical Trial|Active, not recruiting||Phase 2|67|Actual|Tufts University School of Dental Medicine||2|||f||||f||||||||No||2017-10-11 00:26:55.456702|2017-10-11 00:26:55.456702
NCT02133313|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-04-17|||May 2014||2014-05-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01|3 Years|Observational [Patient Registry]|||Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis|Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis|Completed||N/A|49|Actual|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"     Biospecimens will be retained. Cells harvested from spent peritoneal dialysate will have RNA     isolated and then cDNA will be preserved.      Supernatent of spent peritoneal dialysate will be kept.   "|||2017-10-11 00:26:55.578155|2017-10-11 00:26:55.578155
NCT02133274|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-02-12|||August 2014|Actual|2014-08-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2016|Actual|2016-02-01||Interventional|PREPArE||A Psychosocial Intervention Plus Early Palliative Care in the Reduction of Depression of Advanced Cancer Patients|A Phase II Randomized Controlled Trial to Evaluate a Brief Psychosocial Intervention Together With Early Palliative Care in Reducing Depressive Symptoms of Patients With Advanced Cancer Starting First Line Palliative Chemotherapy|Terminated||N/A|63|Actual|Barretos Cancer Hospital||3||"Planned interim analysis did not show the expected benefit of intervention A over B (effect   size <0.2)."|f||||f||||||||||2017-10-11 00:26:56.005431|2017-10-11 00:26:56.005431
NCT02133261|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-06-25|||June 2014||2014-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||BDx 7 Day ECG Patch: Electrode Adhesion Clinical Study|BDx 7 Day ECG Patch: Electrode Adhesion Clinical Study|Completed||N/A|10|Actual|Bardy Diagnostics, Inc.|||1||f||||f||||||||||2017-10-11 00:26:56.121558|2017-10-11 00:26:56.121558
NCT02133248|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-06-06|||May 2014||2014-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Observational|||Identification of Donor Specific B Cells and Antibody Mediated Rejection|Identification of Donor Specific B Cells Will Positively Affect Monitoring and Treatment of Donor Specific Antibodies and Antibody Mediated Rejection|Recruiting||N/A|50|Anticipated|University of Wisconsin, Madison|||3||f||||f||||||Samples With DNA|"     Frozen peripheral blood mononucleated cells and plasma   "|||2017-10-11 00:26:56.191588|2017-10-11 00:26:56.191588
NCT02133235|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-10-20|2015-06-30||May 2014||2014-05-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial Blocker|The Need and the Effectiveness of Fiberoptic Bronchoscopy for Better Lung Collapse in Vedio-assisted Thoracic Operations Using Endobronchial Blockers|Completed||N/A|112|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:26:56.309253|2017-10-11 00:26:56.309253
NCT02133222|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-10-20|||May 2014||2014-05-01|March 2016|2016-03-01|August 2016|Actual|2016-08-01|July 2014|Actual|2014-07-01||Interventional|AMMAM||Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy|Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy.|Completed||N/A|22|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:26:56.687139|2017-10-11 00:26:56.687139
NCT02133209|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-08-07|||May 2014||2014-05-01|August 2017|2017-08-01|April 2018||2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||MRI Outcomes of Mindfulness Meditation for Migraine|MRI Outcomes of Mindfulness Meditation for Migraine|Active, not recruiting||N/A|112|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:26:56.773183|2017-10-11 00:26:56.773183
NCT02133196|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-08-24|||April 17, 2014||2014-04-17|August 1, 2017|2017-08-01|February 28, 2020|Anticipated|2020-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer|A Phase II Study Using Autologous Young Tumor-Infiltrating Lymphocytes (TIL) Derived From Patients With Non-Small Cell Lung Cancer Following Non-Myeloablative Lymphocyte Depleting Preparative Regimen|Recruiting||Phase 2|85|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:26:56.891056|2017-10-11 00:26:56.891056
NCT02133183|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-12|||May 12, 2014|Actual|2014-05-12|September 2017|2017-09-01||||December 31, 2018|Anticipated|2018-12-31||Interventional|||Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma|Pilot Study of MLN0128 (TAK-228) in Preoperative Recurrent Glioblastoma (GBM) Patients|Recruiting||N/A|40|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 00:26:57.025596|2017-10-11 00:26:57.025596
NCT02133170|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-06|||September 2014||2014-09-01|May 2014|2014-05-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|BI-MIND||"Mindfulness vs Psychoeducation in Bipolar Disorder"|Comparative Efficacy of Two Adjunctive Psychosocial Interventions (Mindfulness or Psychoeducation) Versus Treatment as Usual in Bipolar Patients With Subsyndromal Deppresive Symptoms: A Pilot Randomized Trial|Unknown status|Not yet recruiting|N/A|140|Anticipated|Instituto de Investigación Hospital Universitario La Paz||3|||f||||f||||||||||2017-10-11 00:26:57.180914|2017-10-11 00:26:57.180914
NCT02133157|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2014-10-29|||April 2010||2010-04-01|May 2014|2014-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|HMPL||Phase I Study of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors|Phase I Study of Safety and Pharmacokinetics of Sulfatinib(HMPL-012) in Patients With Advanced Solid Tumors|Completed||Phase 1|71|Actual|Hutchison Medipharma Limited||1|||f||||t||||||||||2017-10-11 00:26:57.29578|2017-10-11 00:26:57.29578
NCT02133144|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-06|||February 2014||2014-02-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|February 2015|Anticipated|2015-02-01||Interventional|||Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation|Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation|Unknown status|Recruiting|N/A|40|Anticipated|Helsinki University||2|||f||||f||||||||||2017-10-11 00:26:57.383837|2017-10-11 00:26:57.383837
NCT02133131|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-03-07|2016-09-27||June 2014||2014-06-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)|A Phase II Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172, MK-8742, and Sofosbuvir in Treatment-Naïve Subjects With Chronic HCV GT1 or GT3 Infection|Completed||Phase 2|143|Actual|Merck Sharp & Dohme Corp.||7|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:26:57.551097|2017-10-11 00:26:57.551097
NCT02133118|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-03-14|||January 1998||1998-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|5 Years|Observational [Patient Registry]|ZODIAC-39||Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.|A Prospective Observational Cohort Study; The Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.|Completed||N/A|16293|Actual|Medical Research Foundation, The Netherlands|||1||f||||f||||||||||2017-10-11 00:26:58.452691|2017-10-11 00:26:58.452691
NCT02133105|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-02-01|||April 2014||2014-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ELDOR||Levosimendan Versus Dobutamine for Renal Function in Heart Failure|Efficacy of Intravenous Levosimendan Compared With Dobutamine on Renal Hemodynamics and Function in Chronic Heart Failure|Enrolling by invitation||Phase 3|30|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-11 00:26:58.560868|2017-10-11 00:26:58.560868
NCT02133092|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-10-14|||December 2013||2013-12-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections|Prospective Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections|Completed||Early Phase 1|62|Actual|Janssen Research & Development, LLC|||1||f||||f||||||||||2017-10-11 00:26:58.661984|2017-10-11 00:26:58.661984
NCT02133079|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2015-12-10|||March 2012||2012-03-01|December 2015|2015-12-01|November 2019|Anticipated|2019-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96|Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96|Active, not recruiting||Phase 1/Phase 2|20|Actual|Cure&Sure Biotech Co., LTD||1|||f||||t||||||||||2017-10-11 00:28:18.21425|2017-10-11 00:28:18.21425
NCT02133066|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-08-01|2017-02-24||May 2014||2014-05-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of Bedside Ultrasound Assistance on the Proportion of Successful Infant Spinal Taps|The Effect of Bedside Ultrasound Assistance on the Proportion of Successful Infant Lumbar Punctures in a Pediatric Emergency Department: A Randomized Controlled Trial|Completed||N/A|128|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 00:28:19.766937|2017-10-11 00:28:19.766937
NCT02133053|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-05-06|||May 2011||2011-05-01|May 2014|2014-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray|Non Interventional Study of Ectoin Allergy Nasal Spray Compared to Beclomethasone Nasal Spray|Completed||N/A|50|Actual|Bitop AG|||2||f||||f||||||||||2017-10-11 00:28:20.118134|2017-10-11 00:28:20.118134
NCT02133040|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-01-24|||May 2014||2014-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue|Identification and Regulation of Brown Adipose Tissue (BAT) in Humans. Implications for Energy Expenditure in Humans and in the Treatment of Obesity and Related Metabolic Diseases|Recruiting||N/A|10|Anticipated|Aarhus University Hospital|||1||f||||f||||||Samples With DNA|"     Serum and fat tissue   "|||2017-10-11 00:28:20.18932|2017-10-11 00:28:20.18932
NCT02133027|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-03|||April 2014||2014-04-01|May 2014|2014-05-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Role of the Right Portal Pedicle and Rouviere's Sulcus as an Anatomic Landmark in Laparoscopic Cholecystectomy|Role of the Right Portal Pedicle and Rouviere's Sulcus as an Anatomic Landmark in Laparoscopic Cholecystectomy in Chinese Population|Unknown status|Recruiting|N/A|60|Anticipated|Zhujiang Hospital||2|||f||||t||||||||||2017-10-11 00:28:20.262354|2017-10-11 00:28:20.262354
NCT02133014|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-03|||April 2014||2014-04-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||The Study of Laparoscopic-assisted Percutaneous Catheter-directed Drainage to Treat Early Severe Acute Pancreatitis|The Study of Laparoscopic-assisted Percutaneous Catheter-directed Drainage to Treat Early Severe Acute Pancreatitis in Chinese Population.|Unknown status|Recruiting|N/A|60|Anticipated|Zhujiang Hospital||2|||f||||t||||||||||2017-10-11 00:28:20.352574|2017-10-11 00:28:20.352574
NCT02133001|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-10-13||2016-10-13|May 2014||2014-05-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide|A Double-blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Subjects Who Are Assessed to be at Imminent Risk for Suicide|Completed||Phase 2|68|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:28:20.447046|2017-10-11 00:28:20.447046
NCT02132988|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-05-06|||November 2013||2013-11-01|May 2014|2014-05-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer|An Open Labeled Phase II Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 2|110|Anticipated|Mackay Memorial Hospital||1|||f||||f||||||||||2017-10-11 00:28:20.567345|2017-10-11 00:28:20.567345
NCT02132975|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-10-17|||May 2014||2014-05-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PROSBOT-Apollo||Motorised Probe Holder Assisting Prostate Biopsies|Pilot Study of a Motorised Probe Holder Assisting Prostate Biopsies|Completed||N/A|20|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 00:28:20.743414|2017-10-11 00:28:20.743414
NCT02132962|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-10-28|||May 2014||2014-05-01|September 2015|2015-09-01||||October 2015|Actual|2015-10-01||Interventional|||Sarcopenia and Cirrhosis||Completed||N/A|17|Actual|Rigshospitalet, Denmark||2|||f||||||||||||||2017-10-11 00:28:20.849428|2017-10-11 00:28:20.849428
NCT02132949|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-08-18|2017-03-01||July 14, 2014|Actual|2014-07-14|August 2017|2017-08-01|December 3, 2020|Anticipated|2020-12-03|March 3, 2016|Actual|2016-03-03||Interventional||Intent to treat (ITT) population included all participants who were enrolled regardless of whether they received any study treatment. One participant in Cohort B who was HER2 negative and was enrolled by error was excluded from the ITT population.|A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer|A Multicenter, Multinational, Phase II Study to Evaluate Perjeta in Combination With Herceptin and Standard Neoadjuvant Anthracycline-Based Chemotherapy in Patients With HER2-Positive, Locally Advanced, Inflammatory, or Early-Stage Breast Cancer|Active, not recruiting||Phase 2|401|Actual|Hoffmann-La Roche|The study is still ongoing and the results are based on the primary analysis (clinical cut-off date of 03 March 2016). Full data from the adjuvant and treatment-free follow-up periods are anticipated by December 2020.|2|||f|||||t|f||||||||2017-10-11 00:28:20.966154|2017-10-11 00:28:20.966154
NCT02132936|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-07-13|2016-02-04||June 2014||2014-06-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris|LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris|Completed||Phase 3|504|Actual|LEO Pharma|None reported|4|||f||||f||||||||||2017-10-11 00:28:22.160036|2017-10-11 00:28:22.160036
NCT02132923|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2015-10-02|||December 2013||2013-12-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Infections|Prospective Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Infections|Completed||Early Phase 1|49|Actual|Janssen R&D Ireland|||1||f||||f||||||||||2017-10-11 00:28:23.036978|2017-10-11 00:28:23.036978
NCT02132897|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2014-06-14|||May 2014||2014-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Fed Bioequivalence Study of CBZ Formulations|Fed Bioequivalence Study of Carbamazepine Controlled Release Formulations in Healthy Male Uruguayan Subjects|Completed||Phase 1|20|Actual|Center for Clinical Pharmacology Research Bdbeq S.A.||2|||f||||t||||||||||2017-10-11 00:28:23.183928|2017-10-11 00:28:23.183928
NCT02132884|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-11-22|||March 2015||2015-03-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer|CancerCodeTM Informed, Molecularly Targeted Therapies in Non-small Cell Lung Cancer|Terminated||N/A|1|Actual|Fox Chase Cancer Center||2||Feasibility|f||||t||||||||||2017-10-11 00:28:23.276488|2017-10-11 00:28:23.276488
NCT02132871|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-08-08|||May 2014||2014-05-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Preload Dependency by Impedance Cardiography After Cardiac Surgery|Noninvasive Assessment of Preload Dependency by Passive Leg Raising Test and Impedance Cardiography Compared to Echocardiographic Measurements After Cardiac Surgery|Completed||N/A|65|Actual|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 00:28:23.393521|2017-10-11 00:28:23.393521
NCT02132858|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-09-08|||July 2014||2014-07-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Observational|||Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation|Assessing Intratumoral Heterogeneity and Chemoradiation Response in Locally Advanced Rectal Cancer Utilizing Sequencing and PET/CT|Recruiting||N/A|40|Anticipated|Fox Chase Cancer Center|||1||f||||t||||||||||2017-10-11 00:28:23.480021|2017-10-11 00:28:23.480021
NCT02132845|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-01-24|||March 2016|Actual|2016-03-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer|A Prospective Randomized Trial Comparing the Effectiveness of Physician Discretion Guided Therapy Versus Physician Discretion Guided Plus Next-Generation Sequence Directed Therapy|Recruiting||N/A|100|Anticipated|Fox Chase Cancer Center||2|||f||||f||||||||||2017-10-11 00:28:23.596994|2017-10-11 00:28:23.596994
NCT02132832|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-05-03|2017-02-22||June 2013||2013-06-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Buspirone, Stress, and Attentional Bias to Marijuana Cues|Buspirone, Stress, and Attentional Bias to Marijuana Cues|Completed||Phase 2|45|Actual|The University of Texas Health Science Center, Houston|The study intends to evaluate reduction of attentional-bias in non-treatment seekers, and it is not designed or powered to address treatment effects on marijuana use.|2|||f||||t|t|f|||f|||||2017-10-11 00:28:23.766694|2017-10-11 00:28:23.766694
NCT02132819|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-05-05|||February 2014||2014-02-01|May 2014|2014-05-01|April 2015|Anticipated|2015-04-01|January 2015|Anticipated|2015-01-01||Interventional|Tx-TRAGI||Withholding Feeds During Red Blood Cell Transfusion and TRAGI|The Effect of Withholding Feeds During Red Blood Cell Transfusion on Development of TRAGI in Very Low Birth Weight Infants|Unknown status|Recruiting|Phase 4|150|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-11 00:28:24.249606|2017-10-11 00:28:24.249606
NCT02132806|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-02-09|||March 2014||2014-03-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|October 2015|Actual|2015-10-01||Interventional|||Piezosurgery in the Treatment of Class II Furcation Involvement|Piezosurgery in the Treatment of Class II Furcation Involvement|Active, not recruiting||N/A|30|Actual|University of Trieste||3|||f||||t|f|f||||||||2017-10-11 00:28:24.357437|2017-10-11 00:28:24.357437
NCT02132793|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-11-01|||March 2014||2014-03-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|RELAX||Remote Exercise for Learning Anger and Excitation Management|Remote Exercise for Learning Anger and Excitation Management (RELAX)|Completed||Phase 1/Phase 2|58|Actual|VA Pacific Islands Health Care System||2|||f||||f||||||||No||2017-10-11 00:28:24.452577|2017-10-11 00:28:24.452577
NCT02132780|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-06-09|||May 2014||2014-05-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|AD-NAFLD||Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease|The Impact of Autonomic Dysfunction on Liver-Related Symptoms in Non-Alcoholic Fatty Liver Disease and Their Relationship to Systemic Inflammation and Insulin Resistance|Completed||N/A|25|Actual|Virginia Commonwealth University|||1||f||||f||||||||Undecided|We completed this pilot with 23 participants. Sharing data is to be determined.|2017-10-11 00:28:24.549115|2017-10-11 00:28:24.549115
NCT02132767|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-11-21|2016-09-30||May 2014||2014-05-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All randomized patients|Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation|Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation|Completed||Phase 3|523|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 00:28:24.638337|2017-10-11 00:28:24.638337
NCT02132754|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-09-19|||June 27, 2014|Actual|2014-06-27|September 2017|2017-09-01|October 17, 2019|Anticipated|2019-10-17|October 17, 2019|Anticipated|2019-10-17||Interventional|||Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)|Phase 1 Trial of Single Agent MK-4166 and MK-4166 in Combination With Pembrolizumab in Subjects With Advanced Malignancies|Recruiting||Phase 1|92|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:28:25.593809|2017-10-11 00:28:25.593809
NCT02132741|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-12-07|||May 2014||2014-05-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Observational|||Optical Coherence Tomography (OCT) in Hypertension & Chronic Kidney Disease (CKD)|ASSESSMENT OF RETINAL VASCULATURE USING OPTICAL COHERENCE TOMOGRAPHY IN HEALTH, HYPERTENSION & CHRONIC KIDNEY DISEASE|Recruiting||N/A|150|Anticipated|University of Edinburgh|||5||f||||f||||||||||2017-10-11 00:28:25.69114|2017-10-11 00:28:25.69114
NCT02132715|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-08-22|||September 2014||2014-09-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|KAATSU-OA||KAATSU Training to Enhance Physical Function of Older Adults With Osteoarthritis|KAATSU Training to Enhance Physical Function of Older Adults With Osteoarthritis|Completed||N/A|35|Actual|University of Florida||2|||f||||t||||||||Undecided||2017-10-11 00:28:25.91128|2017-10-11 00:28:25.91128
NCT02132702|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-04-27|||August 2014||2014-08-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Performance Attributes and User Progression While Using Ekso|Performance Attributes and User Progression While Using Ekso Robotic Exoskeleton in an Eight Week, Over Ground, Locomotor Program in Individuals With Spinal Cord Injury|Unknown status|Enrolling by invitation|N/A|65|Actual|Ekso Bionics||1|||f||||||||||||||2017-10-11 00:28:26.039125|2017-10-11 00:28:26.039125
NCT02132689|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-01-27|||March 2011||2011-03-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|CONTACT-SPE||Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism|Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism in Context of Pulmonary Hypertension, Right Heart Failure and Patient Functional Ability|Unknown status|Recruiting|Phase 4|100|Anticipated|University Hospital Ostrava||2|||f||||f||||||||||2017-10-11 00:28:26.191075|2017-10-11 00:28:26.191075
NCT02132676|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-08-04|||April 25, 2016|Actual|2016-04-25|August 2017|2017-08-01|February 29, 2020|Anticipated|2020-02-29|March 15, 2019|Anticipated|2019-03-15||Observational|SHARES||Shared Health Appointments and Reciprocal Enhanced Support|Peer Support to Enhance Diabetes Shared Medical Appointments: Examining Comparative Effectiveness in VA Health Systems|Recruiting||N/A|896|Anticipated|VA Office of Research and Development|||3||f||||f|f|f|||f|||||2017-10-11 00:28:26.348606|2017-10-11 00:28:26.348606
NCT02132663|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-04-30|||May 2014||2014-05-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants|The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants|Completed||N/A|315|Anticipated|Mead Johnson Nutrition||2|||f||||f||||||||||2017-10-11 00:28:26.534971|2017-10-11 00:28:26.534971
NCT02132650|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-09-26|||June 2, 2014|Actual|2014-06-02|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|April 2, 2018|Anticipated|2018-04-02||Interventional|ABC of Walking||Rehabilitating Corticospinal Control of Walking|Rehabilitation of Corticospinal Control of Walking Following Stroke|Recruiting||Phase 2|60|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:28:26.698295|2017-10-11 00:28:26.698295
NCT02132637|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-09-03||2015-09-03|May 2014||2014-05-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|IMAGINE 8||A Study to Compare the Effect of Double Doses of Long-acting Insulin Therapies in Participants With Type 2 Diabetes|A Comparison of Pharmacodynamics When Receiving a Double Dose of Insulin Peglispro or Insulin Glargine in Patients With Type 2 Diabetes Mellitus: A Double-Blind, Crossover Design Study|Completed||Phase 3|68|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:28:26.804726|2017-10-11 00:28:26.804726
NCT02132624|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-10-26|||April 2014||2014-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.|CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.|Active, not recruiting||Phase 1/Phase 2|15|Anticipated|Uppsala University||1|||f||||t||||||||||2017-10-11 00:28:26.898456|2017-10-11 00:28:26.898456
NCT02132611|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2017-06-28|2016-09-06||June 2014||2014-06-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|September 2015|Actual|2015-09-01||Interventional|COAST||Coronary Orbital Atherectomy System Study|Coronary Orbital Atherectomy System Study|Completed||N/A|100|Actual|Cardiovascular Systems Inc||1|||f||||t||||||||No||2017-10-11 00:28:26.98992|2017-10-11 00:28:26.98992
NCT02132598|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-09-05|||December 2015||2015-12-01|September 2017|2017-09-01|June 2028|Anticipated|2028-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases|A Single-Arm Phase II Clinical Trial of Cabozantinib (XL184) in Patients With Previously Treated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases With and Without C Met Amplification|Recruiting||Phase 2|54|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:28:27.308934|2017-10-11 00:28:27.308934
NCT02132585|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-05|||January 2010||2010-01-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|March 2013|Actual|2013-03-01||Observational|SPEEDCARS||Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction|Cross Sectional Study of Use of Speckle Tracking Echocardiography in the Early Diagnosis of Cardiovascular Dysfunction and Performance in Sjogren Patients|Unknown status|Active, not recruiting|N/A|700|Anticipated|University of Roma La Sapienza|||2||f||||t||||||||||2017-10-11 00:28:27.424239|2017-10-11 00:28:27.424239
NCT02132572|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-06|2016-07-26|2016-07-26||May 2014||2014-05-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|RANBI||Retrospective Study of Incidence and Etiology of Reoperation After Primary Augmentation With Natrelle® Breast Implants|Retrospective Multi-centre, Post-marketing Study to Evaluate the Incidence and Aetiology of Reoperations With Allergan Natrelle® Breast Implants in Primary Augmentation (RANBI)|Completed||N/A|201|Actual|Allergan|||1||f||||f||||||||||2017-10-11 00:28:27.500645|2017-10-11 00:28:27.500645
NCT02132559|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-05|||October 2011||2011-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Effect of Dehydroepiandrosterone Administration in Patients With Poor Ovarian Response According to the Bologna Criteria||Completed||N/A|386|Actual|Chinese Medical Association|||1||f||||t||||||||||2017-10-11 00:28:27.736038|2017-10-11 00:28:27.736038
NCT02132546|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-02|||February 2011||2011-02-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Interventional|||Spectrophotometric Evaluation of Chlorhexidine Pigmentations After Oral Surgery: a Prospective Randomized Clinical Trial|Spectrophotometric Evaluation of Chlorhexidine Pigmentations After Periodontal Flap Surgery: a Prospective Randomized Clinical Trial|Completed||Phase 2|60|Actual|University of Trieste||3|||f||||||||||||||2017-10-11 00:28:27.814266|2017-10-11 00:28:27.814266
NCT02132533|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-05-10|||May 2014||2014-05-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|Nifedipine||Nifedipine for Acute Tocolysis of Preterm Labor|Nifedipine for Acute Tocolysis of Preterm Labor|Recruiting||Phase 3|150|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:28:27.885542|2017-10-11 00:28:27.885542
NCT02132520|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-09-15|||March 2014||2014-03-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Interventional|||A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training|A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined Repetitive Transcranial Magnetic Stimulation and Brain-Computer Interface Training|Completed||N/A|30|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-11 00:28:27.972469|2017-10-11 00:28:27.972469
NCT02132507|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-10-25|||January 2011||2011-01-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Multimodal Functional Neuroimaging in Epilepsy Patients|Multimodal Functional Neuroimaging in Epilepsy Patients|Recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||||2017-10-11 00:28:28.060711|2017-10-11 00:28:28.060711
NCT02132494|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-11-16|||March 2014||2014-03-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ASK||Active Smarter Kids: A Cluster-randomized Controlled Trial|Active Smarter Kids: A Cluster-randomized Controlled Trial Investigating the Effect of Daily Physical Activity on Children's Academic Performance and on Risk Factors for Lifestyle-related Non-communicable Diseases|Completed||N/A|1256|Anticipated|Sogn og Fjordane University College||2|||f||||t||||||||||2017-10-11 00:28:28.144359|2017-10-11 00:28:28.144359
NCT02132481|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-01-11|||June 2015||2015-06-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|SRSS||Using Smartphones to Provide Recovery Support Services|Using Smartphones to Provide Recovery Support Services Experiment|Recruiting||N/A|400|Anticipated|Chestnut Health Systems||4|||f||||t||||||||Yes|After the study is completed, interested researchers can contact the study PI for permission to use the individual level (but de-identified) data.|2017-10-11 00:28:28.227481|2017-10-11 00:28:28.227481
NCT02132455|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-05-10|||January 2014||2014-01-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||The Utility of Timed Segmental Withdrawal During Screening Colonoscopy|The Utility of Timed Segmental Withdrawal During Screening Colonoscopy for Increasing Adenoma Detection Rate. A Randomized Controlled Clinical Trial|Completed||N/A|326|Actual|Texas Tech University Health Sciences Center, El Paso||4|||f||||||||||||No||2017-10-11 00:28:28.550147|2017-10-11 00:28:28.550147
NCT02132442|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-01-07|||March 2014||2014-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|VDLS||Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes|Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes|Completed||Phase 3|12|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 00:28:28.648067|2017-10-11 00:28:28.648067
NCT02132429|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-03-30|||May 2014||2014-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects|Phase I, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 333 in Healthy Subjects and Migraine Subjects|Terminated||Phase 1|16|Actual|Amgen||2||The study was stopped due to an administrative decision not safety.|f||||f||||||||||2017-10-11 00:28:28.74988|2017-10-11 00:28:28.74988
NCT02132416|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-11-21|||May 2014||2014-05-01|November 2014|2014-11-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Operative Treatment of Unstable Thoracic Cage Injuries and Chest Wall Deformity in Trauma|Prospective Controlled Study of Surgical Management of Unstable Thoracic Cage Injuries and Chest Wall Deformity in Trauma|Unknown status|Recruiting|N/A|120|Anticipated|Sahlgren´s University Hospital||2|||f||||t||||||||||2017-10-11 00:28:28.84605|2017-10-11 00:28:28.84605
NCT02132403|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-04-29|||August 2014||2014-08-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PM-01||(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer|PM-01: Phase 1b Study of PGG Beta Glucan (Imprime PGG®) in Combination With Anti-MUC1 Antibody (BTH1704) and Gemcitabine (Gemzar®) for the Treatment of Advanced Pancreatic Cancer|Terminated||Phase 1|3|Actual|University of Illinois at Chicago||1||Drug Recall|f||||t||||||||||2017-10-11 00:28:28.982348|2017-10-11 00:28:28.982348
NCT02132390|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-06-02|||May 2014||2014-05-01|June 2014|2014-06-01||||May 2024|Anticipated|2024-05-01||Interventional|||Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea|Study of Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea|Not yet recruiting||Phase 3|300|Anticipated|Peking Union Medical College Hospital||4|||f||||t||||||||||2017-10-11 00:28:29.092732|2017-10-11 00:28:29.092732
NCT02132364|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-05-17|||January 30, 2014|Actual|2014-01-30|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|CEOPS||Controlled Education Of Patients After Stroke|Controlled Education Of Patients After Stroke|Recruiting||N/A|800|Anticipated|University Hospital, Lille||2|||f||||f||||||||No||2017-10-11 00:28:29.23825|2017-10-11 00:28:29.23825
NCT02132351|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-04-07|||August 2013||2013-08-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Hepatic Fibrosis Non-invasive Methods Questionnaire|Acceptability, Reliability and Applicability of Liver Biopsy and Noninvasive Methods for Assessment of Hepatic Fibrosis and Cirrhosis Among Hepatologists; a Web Based Survey|Completed||N/A|717|Actual|Al-Azhar University|||1||f||||f||||||||||2017-10-11 00:28:29.38293|2017-10-11 00:28:29.38293
NCT02132338|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-05-05|||June 2014||2014-06-01|May 2014|2014-05-01|November 2017|Anticipated|2017-11-01|June 2015|Anticipated|2015-06-01||Interventional|||Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment|Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment|Enrolling by invitation||Early Phase 1|191|Actual|Federal University of Minas Gerais||1|||f||||f||||||||||2017-10-11 00:28:29.46171|2017-10-11 00:28:29.46171
NCT02132325|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-07-18|||April 2014||2014-04-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|March 2016|Actual|2016-03-01||Interventional|||Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer|Phase I/IIA: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer|Active, not recruiting||N/A|19|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:28:29.565451|2017-10-11 00:28:29.565451
NCT02132312|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-06-30|||July 2014||2014-07-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|ILR7||A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement|A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement|Unknown status|Active, not recruiting|Phase 3|72|Actual|Omeros Corporation||2|||f||||f||||||||||2017-10-11 00:28:29.661796|2017-10-11 00:28:29.661796
NCT02132299|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-04-25|||April 2014||2014-04-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults|Phase 1, Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults|Completed||Phase 1|67|Actual|Sanaria Inc.||7|||f||||t||||||||||2017-10-11 00:28:29.783725|2017-10-11 00:28:29.783725
NCT02132286|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2014-05-05|||December 2008||2008-12-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression|Serotonin Transporter Genetic Variation and Amygdala Responses to Quetiapine and Selective Serotonin Reuptake Inhibitor Treatment in Major Depression|Completed||Phase 4|57|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 00:28:29.922696|2017-10-11 00:28:29.922696
NCT02132273|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-09-23|||April 2014||2014-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study|Use of an Educational Story to Prepare Children With Developmental Disabilities for Overnight Polysomnography|Completed||N/A|26|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||No||2017-10-11 00:28:30.023352|2017-10-11 00:28:30.023352
NCT02132260|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-05-04|||August 2013||2013-08-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis|A Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Safety and Efficacy of a Naftifine Hydrochloride Cream 2%and the Naftin® Cream 2% in Patients With Tinea Pedis|Completed||Phase 1|890|Actual|Taro Pharmaceuticals USA||3|||f||||f|f|f|||f|||No||2017-10-11 00:28:30.130753|2017-10-11 00:28:30.130753
NCT02132247|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-03-06|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|October 2016|Actual|2016-10-01||Interventional|||Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries|An Open-label, Prospective, Uncontrolled Study of the Safety and Local Tolerability of the Diclofenac Epolamine Patch (Flector Patch) in Pediatric Patients With Minor Soft Tissue Injuries|Active, not recruiting||Phase 4|104|Actual|IBSA Institut Biochimique SA||1|||f||||f||||||||||2017-10-11 00:28:30.235874|2017-10-11 00:28:30.235874
NCT02132234|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-05|||June 2013||2013-06-01|May 2014|2014-05-01||||July 2014|Anticipated|2014-07-01||Interventional|||Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis|Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis|Unknown status|Recruiting|Phase 4|100|Anticipated|Jagiellonian University||2|||f||||||||||||||2017-10-11 00:28:30.366533|2017-10-11 00:28:30.366533
NCT02132221|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-05-05|||October 2013||2013-10-01|May 2014|2014-05-01|March 2015|Anticipated|2015-03-01|November 2014|Anticipated|2014-11-01||Interventional|||Cessation of Long-term Opioid Therapy in Chronic Pain Patients|Long-term Opioid Therapy in Chronic Pain Patients: Investigation of Tapering Strategies and Impact on Hyperalgesia|Unknown status|Recruiting|N/A|50|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:28:30.482659|2017-10-11 00:28:30.482659
NCT02132208|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-05-06|||January 2012||2012-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Evaluation of the TICCS Capacity to Identify Trauma Patients With Acute Coagulopathy and Massive Bleeding|Pre-hospital Identification of Trauma Patients With Early Acute Coagulopathy and Massive Bleeding: Results of a Prospective Non-interventional Clinical Trial Evaluating the Trauma Induced Coagulopathy Clinical Score (TICCS).|Completed||N/A|82|Actual|Centre Hospitalier Régional de la Citadelle|||1||f||||f||||||Samples Without DNA|"     Whole blood sample for Thromboelastometry and standard coagulation tests.   "|||2017-10-11 00:28:30.594317|2017-10-11 00:28:30.594317
NCT02132195|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-08-17|||May 2014||2014-05-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome|Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome|Recruiting||Phase 3|60|Anticipated|Emory University||2|||f||||t|t|f||||||||2017-10-11 00:28:30.677963|2017-10-11 00:28:30.677963
NCT02132182|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-05-30|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Monocyte Phenotypic and Functional Differences|A Canine/ Human Translational Model of Phenotypic and Functional Differences Between Monocytes in Patients With and Without Sarcoma|Recruiting||N/A|90|Anticipated|Duke University|||1||f||||t||||||Samples With DNA|"     Whole blood samples (~15 to 20 mls) will be obtained from 90 humans over 3 years presenting     to Duke with osteosarcoma. Only patients who would normally have blood drawn as part of     standard care will be included. Research blood will be in addition to what is normally     collected. Samples will be de-identified and then transferred to researchers as NC State's     College of Veterinary Medicine. These researchers will use the samples to perform a CBC and     evaluate monocyte phenotype and function. These results will be compared to published     historical normal values for healthy human monocytes. This data will also be compared with     canine data already gathered.   "|||2017-10-11 00:28:30.868832|2017-10-11 00:28:30.868832
NCT02132169|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-09-05|2017-06-27|2015-04-30|May 2014||2014-05-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Multi-Center Study Evaluating the Safety of AC-170 0.24%|A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 0.24% Ophthalmic Solution Used Twice Daily in Healthy Adult Subjects and in Pediatric Subjects With a History or Family History of Atopic Disease (Including Allergic Conjunctivitis)|Completed||Phase 3|512|Actual|Aciex Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 00:28:30.968088|2017-10-11 00:28:30.968088
NCT02132143|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-05-05|||January 2014||2014-01-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2||Unknown status|Recruiting|N/A|60|Anticipated|People's Hospital of Guangxi||2|||f||||t||||||||||2017-10-11 00:28:31.46675|2017-10-11 00:28:31.46675
NCT02132130|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-04-20|||October 9, 2014|Actual|2014-10-09|April 2017|2017-04-01|June 12, 2019|Anticipated|2019-06-12|June 12, 2019|Anticipated|2019-06-12||Interventional|||Safety, Tolerability and Efficacy for CGF166 in Patients With Bilateral Severe-to-profound Hearing Loss|A Three-part, Multicenter, Open Label, Single Dose Study to Assess the Safety, Tolerability, and Efficacy of Intra Labyrinthine (IL) CGF166 in Patients With Severe-to-profound Hearing Loss|Recruiting||Phase 1/Phase 2|45|Anticipated|Novartis||6|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 00:28:31.549544|2017-10-11 00:28:31.549544
NCT02132117|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-06-22|2016-06-22||June 2014||2014-06-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea||Completed||Phase 3|445|Actual|Allergan||2|||f||||f||||||||||2017-10-11 00:28:31.645844|2017-10-11 00:28:31.645844
NCT02132104|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-10-20|||November 2014||2014-11-01|October 2014|2014-10-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficiency of Amnion Graft to Prevent Intrauterine Adhesions After Hysteroscopic Surgery|Amnion Graft for Preventing Intrauterine Adhesions Following Hysteroscopic Surgery|Unknown status|Not yet recruiting|N/A|208|Anticipated|Capital Medical University||2|||f||||t||||||||||2017-10-11 00:28:32.097275|2017-10-11 00:28:32.097275
NCT02132091|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-12-11|||March 2011||2011-03-01|December 2015|2015-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress|The Effect of Intermittent Fasting on Adaptive Oxidative Stress Response and Mitochondrial Biogenesis|Completed||N/A|37|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 00:28:32.223104|2017-10-11 00:28:32.223104
NCT02132078|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2014-05-05|||January 1992||1992-01-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Epidemiology of Diverticulitis in Lung Transplant Recipients|Long-term Follow-up of Lung Transplant Recipients With Diverticulitis|Completed||N/A|18|Actual|University of Zurich|||2||f||||t||||||||||2017-10-11 00:28:32.333385|2017-10-11 00:28:32.333385
NCT02132065|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2016-11-06|||June 2014||2014-06-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Unilateral Dual TAP (Transverses Abdominal Plane) Blok i Forbindelse Med Laparoskopisk Nyre Operation|Unilateral Dual TAP (Transverses Abdominal Plane) Blok i Forbindelse Med Laparoskopisk Nyre Operation|Recruiting||N/A|30|Anticipated|University Hospital Roskilde||2|||f||||t||||||||||2017-10-11 00:28:32.399346|2017-10-11 00:28:32.399346
NCT02132052|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-02-08|||November 2013||2013-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2014|Actual|2014-12-01||Observational|PHENO||Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.|Defining Cognitive and Motor Phenotypes of Parkinson's Disease (PD) With Magnetoencephalography|Recruiting||N/A|18|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 00:28:32.605056|2017-10-11 00:28:32.605056
NCT02132039|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-05-05|||May 2014||2014-05-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|||A Randomised Controlled Trial of Home-based Exercise Intervention for Caregivers of Persons With Dementia|A Randomised Controlled Trial of Home-based Exercise Intervention for Caregivers of Persons With Dementia|Recruiting||N/A|272|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:28:32.702228|2017-10-11 00:28:32.702228
NCT02132026|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-12-02|||November 2014||2014-11-01|December 2014|2014-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|SALTIRE II||Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.|SALTIRE II and RANKL Inhibition in Aortic Stenosis|Unknown status|Recruiting|Phase 2|150|Anticipated|University of Edinburgh||4|||f||||f||||||||||2017-10-11 00:28:32.848521|2017-10-11 00:28:32.848521
NCT02132013|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2016-05-12|||June 2014||2014-06-01|May 2016|2016-05-01||||December 2015|Actual|2015-12-01||Interventional|SUBLIME||SodiUm Burden Lowered by Lifestyle Intervention: Self-Management and E-health Technology|SodiUm Burden Lowered by Lifestyle Intervention: Self-Management and E-health Technology|Completed||N/A|99|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 00:28:33.002423|2017-10-11 00:28:33.002423
NCT02132000|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-03|||April 2014||2014-04-01|May 2014|2014-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients||Recruiting||Phase 2/Phase 3|3036|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:28:33.110025|2017-10-11 00:28:33.110025
NCT02131987|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-10-28|||January 2006||2006-01-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|RRDHHR||Radiological Riskfactors for Dislocation of Hip Hemiarthroplasty|Radiological Riskfactors for Dislocation of Hip Hemiarthroplasty Through a Posterolateral Approach as Treatment for Femoral Neck Fracture|Completed||N/A|324|Actual|Sundsvall Hospital|||2||f||||f||||||||||2017-10-11 00:28:33.213009|2017-10-11 00:28:33.213009
NCT02131974|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-02-11|||September 2013||2013-09-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|ET_Tube||Ultrasound Confirmation of Endotracheal Tube Location Using a Saline Filled Cuff|Ultrasound Confirmation of Endotracheal Tube Location Using a Saline Filled Cuff|Unknown status|Recruiting|N/A|100|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||t||||||||||2017-10-11 00:28:33.316351|2017-10-11 00:28:33.316351
NCT02131961|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-06-09|||October 2014||2014-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|EZCast-DFU||EZCast-DFU Study With Portal for Application of Topical Medications|A Study to Evaluate the Feasibility of Using a Modified Cast Walker With a Portal for Application of Topical Medications in Diabetic Foot Ulcers|Completed||Phase 1|4|Actual|University of Miami||1|||f||||f||||||||||2017-10-11 00:28:33.443126|2017-10-11 00:28:33.443126
NCT02131948|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-11-30|||November 2013||2013-11-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|Nasal insulin||Regulation of Endogenous Glucose Production by Brain Insulin Action|Regulation of Endogenous Glucose Production by Brain Insulin Action|Completed||Phase 1|8|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 00:28:33.559102|2017-10-11 00:28:33.559102
NCT02131935|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-24|||January 2010||2010-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01|1 Year|Observational [Patient Registry]|||Impaired Peripheral Endothelial Function and In-stent Restenosis|Impaired Peripheral Endothelial Function as Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis|Completed||N/A|513|Actual|Kumamoto University|||2||f||||f||||||||||2017-10-11 00:28:33.701629|2017-10-11 00:28:33.701629
NCT02131922|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-05|||September 2009||2009-09-01|May 2014|2014-05-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|PerioBP||Study of the Effects of Intensive Treatment of Periodontitis on Blood Pressure Control|Study of the Effects of Intensive Treatment of Periodontitis on Blood Pressure Control and Vascular Function|Unknown status|Recruiting|N/A|100|Anticipated|Jagiellonian University||2|||f||||f||||||||||2017-10-11 00:28:33.809288|2017-10-11 00:28:33.809288
NCT02131909|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-05-19|||February 2014||2014-02-01|January 2016|2016-01-01||||August 2016|Anticipated|2016-08-01||Interventional|PC MIROIR||PC MIROIR : Effects of Mirror Therapy in Children With Hemiplegic Cerebral Palsy|PC MIROIR : Effects of Mirror Therapy in Children With Hemiplegic Cerebral Palsy|Recruiting||N/A|32|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 00:28:33.93968|2017-10-11 00:28:33.93968
NCT02131896|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2017-02-09|||December 2014||2014-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effects of Mediterranean Diet on Remission, Lipid Profile, Weight and Body Composition in Children and Adolescents With Newly Diagnosed Type 1 Diabetes|The Effects of Mediterranean Diet on Remission, Lipid Profile, Weight and Body Composition in Children and Adolescents With Newly Diagnosed Type 1 Diabetes|Recruiting||N/A|150|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 00:28:34.060263|2017-10-11 00:28:34.060263
NCT02131883|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-03-28|||February 2014||2014-02-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|CHAG||Outcome of Cognitive Behavioral Therapy for Patients With Severe Health Anxiety Treated in Group Only. A RCT.|Outcome of Cognitive Behavior Therapy for Patients With Severe Health Anxiety Treated in Group Only. A Randomised Controlled Trial. The CHAG-Trial. Categorical and Dimensional Characteristics of Personality Pathology and Predictors of Outcome|Active, not recruiting||N/A|84|Actual|Psychiatric Research Unit, Region Zealand, Denmark||2|||f||||f||||||||||2017-10-11 00:28:34.178255|2017-10-11 00:28:34.178255
NCT02131870|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-08-13||||||August 2014|2014-08-01||||July 2014|Actual|2014-07-01||Interventional|||Study of the Iron Absorption From Capsules Containing Lactobacilli and Iron||Completed||N/A|||Probi AB||2|||f||||f||||||||||2017-10-11 00:28:34.29345|2017-10-11 00:28:34.29345
NCT02131857|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-04|||May 2014||2014-05-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|Mindfulness||The Effectiveness of a Systemic Mindfulness-based Intervention Program in a Cystic Fibrosis Clinic|The Effectiveness of a Systemic Mindfulness-based Intervention Program in a Cystic Fibrosis Clinic|Unknown status|Recruiting|N/A|24|Anticipated|Rabin Medical Center||3|||f||||f||||||||||2017-10-11 00:28:34.365859|2017-10-11 00:28:34.365859
NCT02131844|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-09-16|||August 2014||2014-08-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|July 2015|Actual|2015-07-01||Interventional|||Early Mobilization After Colorectal Surgery|Facilitation of Early Mobilization After Colorectal Surgery: A Randomized Controlled Trial|Completed||N/A|100|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 00:28:34.501505|2017-10-11 00:28:34.501505
NCT02131831|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2014-09-15|||June 2014||2014-06-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Telomeres Parameters in Cirrhosis||Unknown status|Recruiting|N/A|50|Anticipated|Meir Medical Center|||1||f||||||||||Samples With DNA|"     whole blood   "|||2017-10-11 00:28:34.653871|2017-10-11 00:28:34.653871
NCT02131818|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-12-01|||May 2014||2014-05-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term|Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term|Terminated||Phase 4|5|Actual|Mahidol University||2||The enrollment process is too difficult to complete|f||||f||||||||||2017-10-11 00:28:34.74806|2017-10-11 00:28:34.74806
NCT02131792|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2014-05-04|||June 2010||2010-06-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|June 2012|Actual|2012-06-01||Interventional|||Early Results of Slanted Recession of the Lateral Rectus Muscle for Intermittent Exotropia With Convergence Weakness|Early Results of Slanted Recession of the Lateral Rectus Muscle for Intermittent Exotropia With Convergence Weakness; A Prospective Study|Completed||N/A|31|Actual|Kyungpook National University||1|||f||||t||||||||||2017-10-11 00:28:35.007887|2017-10-11 00:28:35.007887
NCT02131779|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-02|||July 2010||2010-07-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|M-PACT||Men's Prostate Awareness Church Training|Prostate Cancer Education in African American Churches|Unknown status|Enrolling by invitation|Early Phase 1|480|Anticipated|University of Maryland||2|||f||||f||||||||||2017-10-11 00:28:35.126768|2017-10-11 00:28:35.126768
NCT02131766|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-05-11|||June 2014||2014-06-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Oversight Control in Type 1 Diabetes|Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Oversight Control in Type 1 Diabetes|Completed||N/A|42|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 00:28:35.24322|2017-10-11 00:28:35.24322
NCT02131753|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-10-25|||May 2004||2004-05-01|October 2016|2016-10-01|December 2027|Anticipated|2027-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Therapy Optimisation for the Treatment of Hairy Cell Leukemia|Therapy Optimisation for the Treatment of Hairy Cell Leukemia|Recruiting||Phase 2/Phase 3|210|Anticipated|University of Giessen||1|||f||||f||||||||No||2017-10-11 00:28:35.394096|2017-10-11 00:28:35.394096
NCT02131740|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-11-28|||March 2014||2014-03-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Eye Rubbing and Transient Change in Corneal Parameters|Relationship Between Eye Rubbing and Transient Changes in Corneal Parameters in Healthy Volunteers: A Randomised-Controlled Trial|Completed||N/A|52|Actual|Sussex Eye Hospital||2|||f||||f||||||||||2017-10-11 00:28:36.029995|2017-10-11 00:28:36.029995
NCT02131727|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-04|||February 2013||2013-02-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Hand Hygiene Randomized Cluster Intervention to Reduce Infections|The Kent State-Cuyahoga County Health Promotion Study|Completed||N/A|324|Actual|Kent State University||2|||f||||f||||||||||2017-10-11 00:28:36.199189|2017-10-11 00:28:36.199189
NCT02131714|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-05-04|||March 2014||2014-03-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|May 2014|Anticipated|2014-05-01||Interventional|PPT||Pressure Pain Threshold of Jaw Muscles in TMD Patients Submitted to a Conservative Treatment|Pressure Pain Threshold of Jaw Muscles in Patients With Facial Myofascial Pain Submitted to a Conservative Treatment : a Short-term Evaluation|Unknown status|Active, not recruiting|N/A|100|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 00:28:36.315929|2017-10-11 00:28:36.315929
NCT02131701|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2014-05-05|||October 2006||2006-10-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2008|Actual|2008-08-01||Interventional|||PPP-Botnia Exercise Intervention Study|PPP-Botnia Exercise Intervention Study|Completed||N/A|290|Actual|Folkhälsan Researech Center||2|||f||||f||||||||||2017-10-11 00:28:36.450584|2017-10-11 00:28:36.450584
NCT02131688|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2014-05-04|||May 2013||2013-05-01|March 2014|2014-03-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Phase I Study of Mitoxantrone Hydrochloride Liposome Injection|Phase I Dose Escalation Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Malignant Lymphoma|Unknown status|Recruiting|Phase 1|30|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:28:36.530171|2017-10-11 00:28:36.530171
NCT02131675|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-05-02|||October 2012||2012-10-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Detection of C-peptide in Youth With Longstanding Type 1 Diabetes Mellitus|Observational Study of C-peptide Levels in Youth With Longstanding Type 1 Diabetes Mellitus as Detected by an Ultrasensitive Assay|Completed||N/A|50|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 00:28:36.611501|2017-10-11 00:28:36.611501
NCT02131649|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-09-01|||February 2015||2015-02-01|September 2015|2015-09-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|PROPS||PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy|PROPS (PET/MRI Pre-Radiotherapy for Post-Prostatectomy Salvage)|Unknown status|Recruiting|N/A|140|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 00:28:38.488715|2017-10-11 00:28:38.488715
NCT02131636|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-02-12|2015-12-29||May 2014||2014-05-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea||Completed||Phase 3|440|Actual|Allergan||2|||f||||f||||||||||2017-10-11 00:28:38.617108|2017-10-11 00:28:38.617108
NCT02131623|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-06-10|||July 2014||2014-07-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease|Validation of the ItchRO Diaries in Pediatric Cholestatic Liver Disease|Completed||N/A|23|Actual|Shire|||1||f||||f||||||||||2017-10-11 00:28:39.015453|2017-10-11 00:28:39.015453
NCT02131610|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-05-04|||March 2013||2013-03-01|April 2014|2014-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01|5 Years|Observational [Patient Registry]|EPIOSA||Epigenetics Modifications in Obstructive Sleep Apnea|Epigenetics Modifications and Subclinical Atherosclerosis in Obstructive Sleep Apnea: The EPIOSA Study|Recruiting||N/A|350|Anticipated|Aragon Institute of Health Sciences|||2||f||||f||||||Samples Without DNA|"     serum and plasma samples.   "|||2017-10-11 00:28:39.092|2017-10-11 00:28:39.092
NCT02131597|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-09-20|||November 2014|Actual|2014-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||SGI-110 in Higher Risk Myelodysplastic Syndrome (MDS)|Phase 2 Study of SGI-110 in Patients With Higher Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:28:39.294123|2017-10-11 00:28:39.294123
NCT02131584|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-05-19|||September 2, 2014|Actual|2014-09-02|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Administration of Jakafi (Ruxolitinib) for Symptom Control of Patients With Chronic Lymphocytic Leukemia (CLL)|Administration of Jakafi (Ruxolitinib) for Symptom Control of Patients With Chronic Lymphocytic Leukemia (CLL): A Phase II Study|Active, not recruiting||Phase 2|62|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:28:39.398604|2017-10-11 00:28:39.398604
NCT02131571|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-03-15|||May 2014||2014-05-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Observational|FractaVIH||Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years|Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years: Importance of Bone Mineral Density and Bone Biomarkers|Recruiting||N/A|180|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal|||1||f||||f||||||||Undecided||2017-10-11 00:28:39.500883|2017-10-11 00:28:39.500883
NCT02131558|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-05-05|||May 2014||2014-05-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Indocyanine Green and Near-infrared Fluorescence Imaging to Detect Sentinel Lymph Nodes in Patients With Endometrial Cancer|The Feasibility and Benefits of Using Indocyanine Green and Near-infrared Fluorescence Imaging to Detect Sentinel Lymph Nodes in Patients With Endometrial Cancer|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Lahey Clinic||1|||f||||f||||||||||2017-10-11 00:28:39.588591|2017-10-11 00:28:39.588591
NCT02131545|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-04-21|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine|A Single Dose Pharmacokinetic Study of Topical and Rectal Quetiapine Compared to Oral Quetiapine in Healthy Adults|Completed||Phase 1|10|Actual|Mayo Clinic||1|||f||||f|t|f|||t|||Undecided||2017-10-11 00:28:39.687782|2017-10-11 00:28:39.687782
NCT02131532|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-08-22|2015-05-27||July 2014||2014-07-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Rehabilitation Therapy for Post-stroke Fatigue|A Feasibility Study of a Brief Psychological Intervention for Post-stroke Fatigue|Completed||Phase 1/Phase 2|12|Actual|University of Edinburgh|The aim of this single-arm pilot study was to test the feasibility of the intervention programme. This study can not inform the sample size calculation or efficacy of the intervention, which should be investigated in randomised controlled trials.|1|||f||||f||||||||||2017-10-11 00:28:39.802998|2017-10-11 00:28:39.802998
NCT02131519|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-04|2014-05-05|||January 2012||2012-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Utility of Ultrasonography During Internal Jugular Vein Catheterisation in Pediatric Patients||Completed||N/A|180|Actual|Ankara University|||1||f||||f||||||||||2017-10-11 00:28:40.389291|2017-10-11 00:28:40.389291
NCT02131506|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2016-02-01|||December 2009||2009-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CAELYX||A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer|A Phase Ib Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer|Terminated||Phase 1|11|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1||Safety reasons|f||||f||||||||||2017-10-11 00:28:40.458218|2017-10-11 00:28:40.458218
NCT02131493|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2015-11-21|||January 2015||2015-01-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer|A Open-label, Randomized Study of S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer|Recruiting||Phase 2|80|Anticipated|Zhejiang University||2|||f||||||||||||||2017-10-11 00:28:40.559838|2017-10-11 00:28:40.559838
NCT02131480|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-01-25|||June 2010||2010-06-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|January 2013|Actual|2013-01-01||Interventional|LMS02||Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma|A Multicentric Phase II Trial Studying Efficacy of Doxorubicin Associated With Trabectedin (Yondelis) in First Line Treatment on Patients With Metastatic Leiomyosarcoma (Uterus or Soft Tissue) and/or Inoperable Relapse|Completed||Phase 2|110|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 00:28:40.678453|2017-10-11 00:28:40.678453
NCT02131467|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-05-02|||September 2014||2014-09-01|February 2014|2014-02-01|September 2016|Anticipated|2016-09-01|January 2016|Anticipated|2016-01-01||Interventional|||Safety and Tolerability of Perampanel in Cervical Dystonia|An Open-label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel (E2007) in Subjects With Cervical Dystonia (SAFE-Per CD)|Unknown status|Not yet recruiting|Phase 1/Phase 2|30|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 00:28:40.793703|2017-10-11 00:28:40.793703
NCT02131454|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2016-11-29|||September 2013||2013-09-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy of Inhalation Technique Training.|Impact of Inhalation Technique Training on the Course of Asthma and Chronic Obstructive Pulmonary Disease (COPD).|Completed||N/A|100|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 00:28:40.906974|2017-10-11 00:28:40.906974
NCT02131441|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-05-02|||July 2013||2013-07-01|May 2014|2014-05-01|August 2023|Anticipated|2023-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection||Recruiting||N/A|2|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:28:41.000886|2017-10-11 00:28:41.000886
NCT02131428|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-05-19|||November 2014||2014-11-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Depression and Heart Failure Disease Progression|Depression and Heart Failure Disease Progression|Recruiting||N/A|220|Anticipated|Duke University|||1||f||||f||||||Samples With DNA|"     Samples with DNA are optional.   "|No||2017-10-11 00:28:41.234948|2017-10-11 00:28:41.234948
NCT02131415|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-03-09|||May 2014||2014-05-01|March 2017|2017-03-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Observational|ReLiAM||Real Life Assessment of Abilify Maintena|Canadian Non-Interventional Prospective Cohort Study on the Real - Life Assessment of Abilify Maintena ™ in Schizophrenia|Terminated||N/A|200|Actual|Lundbeck Canada Inc.|||1|Slow enrollment combined with positive preliminary results|f||||f||||||||||2017-10-11 00:28:41.32822|2017-10-11 00:28:41.32822
NCT02131402|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-03-02|2016-02-22||May 2014||2014-05-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Clinical Performance of Hydrogel vs. Silicone Hydrogel Contact Lenses|Non-Dispensing Fitting Study Comparing the Clinical Performance of Hydrogel vs. Silicone Hydrogel Sphere Design Contact Lenses|Completed||N/A|60|Actual|Coopervision, Inc.||3|||f||||f||||||||||2017-10-11 00:28:41.492557|2017-10-11 00:28:41.492557
NCT02131389|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-02|||April 2014||2014-04-01|May 2014|2014-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Multi-Site, Post-Market Study of the ICONACY I-Hip System|Non-Randomized, Multi-Site, Post-Market Study of the ICONACY I-Hip System (Protocol No. PS-1001)|Recruiting||N/A|500|Anticipated|Iconacy Orthopedic Implants, LLC.||1|||f||||t||||||||||2017-10-11 00:28:42.46276|2017-10-11 00:28:42.46276
NCT02131376|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-09-26|||May 9, 2014|Actual|2014-05-09|September 2017|2017-09-01|April 25, 2018|Anticipated|2018-04-25|April 25, 2018|Anticipated|2018-04-25||Interventional|||Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy|Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy|Recruiting||N/A|40|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 00:28:42.564071|2017-10-11 00:28:42.564071
NCT02131363|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-01-12|||August 2014||2014-08-01|September 2014|2014-09-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Clinical Investigation to Evaluate the Safety and Performance of a Treatment Kit for Ingrowing Toenail|A Clinical Investigation to Evaluate the Safety and Performance of a Treatment Kit for Ingrowing Toenail|Completed||N/A|36|Actual|Reckitt Benckiser Healthcare (UK) Limited||1|||f||||f||||||||||2017-10-11 00:28:42.671131|2017-10-11 00:28:42.671131
NCT02131350|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-05-02|||April 2014||2014-04-01|May 2014|2014-05-01||||March 2017|Anticipated|2017-03-01||Interventional|||Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema||Unknown status|Recruiting|Phase 4|40|Anticipated|Shinshu University||1|||f||||t||||||||||2017-10-11 00:28:42.737587|2017-10-11 00:28:42.737587
NCT02131337|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-02|||December 2010||2010-12-01|May 2014|2014-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|EFFICAS II||TactiCath® Prospective Effectiveness Pilot Study|Efficacy Study on Atrial Fibrillation Percutaneous Catheter Ablation With Contact Force Support 2|Completed||N/A|45|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 00:28:42.803603|2017-10-11 00:28:42.803603
NCT02131311|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2016-02-23|2016-01-15||April 2014||2014-04-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Intent-to-Treat (ITT) population|A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)|A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence|Completed||N/A|145|Actual|Procter and Gamble||1|||f||||f||||||||||2017-10-11 00:28:42.963967|2017-10-11 00:28:42.963967
NCT02131298|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2014-06-27|||May 2014||2014-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect Of Itraconazole On The Pharmacokinetics Of Palbociclib|A Phase 1, Open-Label, Fixed-Sequence 2-Period Study To Investigate The Effect Of Multiple Doses Of Itraconazole On The Single Dose Pharmacokinetics of Palbociclib (PD-0332991) In Healthy Volunteers|Completed||Phase 1|12|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:28:43.18306|2017-10-11 00:28:43.18306
NCT02131285|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-05-05|||January 2005||2005-01-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Stabilometric Assessment of Balance Recovery in Persons With Multiple Sclerosis|Stabilometric Assessment of Context Dependent Balance Recovery in Persons With Multiple Sclerosis: a Randomized Controlled Study|Completed||N/A|53|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||||||||||||2017-10-11 00:28:43.283563|2017-10-11 00:28:43.283563
NCT02131272|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-08-02|2017-05-31||June 11, 2014|Actual|2014-06-11|July 2017|2017-07-01|June 14, 2016|Actual|2016-06-14|June 14, 2016|Actual|2016-06-14||Interventional|||A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin|A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin|Terminated||Phase 3|42|Actual|Novo Nordisk A/S|The trial was terminated earlier than planned due to a very slow recruitment rate. Based on the low number of subjects, the conclusions should be interpreted with caution.|2|||f||||t||||||||||2017-10-11 00:28:44.046762|2017-10-11 00:28:44.046762
NCT02131259|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2017-05-19|||May 7, 2014|Actual|2014-05-07|May 2017|2017-05-01|December 28, 2016|Actual|2016-12-28|December 28, 2016|Actual|2016-12-28||Observational|||Long-term Observation PMS for Afatinib|Post Marketing Surveillance on Long Term Drug Use of GIOTRIF Tablets in Patients With Epidermal Growth Factor Receptor Mutation-positive Inoperable or Recurrent Non-small Cell Lung Cancer.|Completed||N/A|1500|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:28:44.941132|2017-10-11 00:28:44.941132
NCT02131246|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-01-16|||May 2014||2014-05-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes|A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes|Completed||Phase 1|33|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:28:46.428607|2017-10-11 00:28:46.428607
NCT02131233|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-05-17|2016-09-07||May 2014||2014-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|onceMRK|All Treated Participants|Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)|A Phase III Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Reformulated Raltegravir 1200 mg Once Daily Versus Raltegravir 400 mg Twice Daily, Each in Combination With TRUVADA™, in Treatment-Naïve HIV-1 Infected Subjects|Completed||Phase 3|802|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:28:46.550514|2017-10-11 00:28:46.550514
NCT02131220|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2017-07-29|||November 2015|Actual|2015-11-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|ERUPTION||Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction|A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow During Primary PCI for the Acute Myocardial InfartiON|Recruiting||Phase 4|360|Anticipated|Fudan University||3|||f||||t||||||||||2017-10-11 00:28:47.316234|2017-10-11 00:28:47.316234
NCT02131207|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-04-24|||September 10, 2014|Actual|2014-09-10|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||MRI Before Biopsy in Diagnosing Patients With Prostate Cancer|Novel Screening MRI for the Detection of Prostate Cancer|Recruiting||N/A|300|Anticipated|Case Comprehensive Cancer Center|||1||f||||f|f|t|f|f|f|||||2017-10-11 00:28:47.451467|2017-10-11 00:28:47.451467
NCT02131194|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2015-12-03|||June 2014||2014-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Post-Vitrectomy Lenstatin™ Study|The Post-Vitrectomy Lenstatin Study: A Prospective Randomized Double Blind Human Clinical Trial Testing the Efficacy of Lenstatin in Inhibiting Cataract Formation and Progression After Pars Plana Vitrectomy|Completed||N/A|20|Actual|Lenstatin LLC||2|||f||||f||||||||||2017-10-11 00:28:47.598498|2017-10-11 00:28:47.598498
NCT02131181|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-23|2015-02-02|||December 2013||2013-12-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01|6 Months|Observational [Patient Registry]|POD-I||Incidence, Long- Term Outcome and Factor Related to Non- Cardiac Postoperative Delirium in Elderly Patients|Incidence, Long- Term Outcome and Factor Related to Non- Cardiac Postoperative Delirium in Elderly Patients (POD-I)|Completed||N/A|400|Actual|Chiang Mai University|||1||f||||f||||||||||2017-10-11 00:28:47.715424|2017-10-11 00:28:47.715424
NCT02131168|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-04-23|||January 2011||2011-01-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|March 2021|Anticipated|2021-03-01|5 Years|Observational [Patient Registry]|ACCESS||Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study|Investigating the Epidemiology of Inflammatory Bowel Disease in Hong Kong: An Inception Cohort and Follow up Study (IBD EPI Study)|Recruiting||N/A|300|Anticipated|Chinese University of Hong Kong|||1||f||||t||||||Samples With DNA|"     One stool sample will be collected for microbiology tests 10 ml of blood will be stored for     genetic analysis   "|No||2017-10-11 00:28:47.813258|2017-10-11 00:28:47.813258
NCT02131142|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-05|2015-03-31|||August 2014||2014-08-01|March 2015|2015-03-01|July 2019|Anticipated|2019-07-01|August 2015|Anticipated|2015-08-01||Interventional|||BioFreedom US IDE Feasibility Trial|To Collect Additional Safety and Effectiveness Data for the Biosensors BioFreedom™ BA9 Drug Coated Coronary Stent in Patients With Native, de Novo Coronary Artery Disease|Active, not recruiting||Phase 2/Phase 3|72|Actual|Biosensors Europe SA||1|||f||||||||||||||2017-10-11 00:28:48.069693|2017-10-11 00:28:48.069693
NCT02131129|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-01-30|||May 2014||2014-05-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|EmeraldThunder||rTMS in First Episode Psychosis|Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study|Recruiting||Phase 2|20|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 00:28:48.414312|2017-10-11 00:28:48.414312
NCT02131116|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-02-02|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|IMT||Integrated Metacognitive Therapy in First Episode Psychosis|An Integrated Metacognitive Approach to Improve Insight and Outcomes in Early Psychosis|Active, not recruiting||N/A|20|Anticipated|Indiana University||2|||f||||f||||||||||2017-10-11 00:28:48.589197|2017-10-11 00:28:48.589197
NCT02131103|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-03|2016-01-30|||January 2014||2014-01-01|May 2014|2014-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Short- and Long Term Outcomes of Early Routine PCI With the Standard Treatment in Low-intermediate Risk ST-elevation Myocardial Infarction Patients Who Successfully Fibrinolysis.|The Short- and Long Term Outcomes of Early Routine PCI With the Standard Treatment in Low-intermediate Risk ST-elevation Myocardial Infarction Patients Who Successfully Fibrinolysis.|Completed||N/A|130|Actual|Chiang Mai University||3|||f||||t||||||||||2017-10-11 00:28:48.740832|2017-10-11 00:28:48.740832
NCT02131090|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-11-25|||November 2013||2013-11-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Comparison of Intrapartum Epidural Fixation Devices: A Randomised Controlled Trial|A Comparison of Intrapartum Epidural Fixation Devices: A Randomised Controlled Trial|Completed||N/A|160|Actual|St George's, University of London||3|||f||||f||||||||||2017-10-11 00:28:48.854336|2017-10-11 00:28:48.854336
NCT02131077|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-11-22|||January 2014||2014-01-01|May 2014|2014-05-01|August 2015|Actual|2015-08-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis|A Multi-center, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase I/II Clinical Study to Evaluate Safety and Efficacy of Allogeneic Adipose-derived Stem Cells for the Treatment of Lateral Epicondylitis|Completed||Phase 1/Phase 2|30|Actual|Anterogen Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:28:49.002771|2017-10-11 00:28:49.002771
NCT02131064|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-08-29|2016-12-03||June 30, 2014|Actual|2014-06-30|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|December 31, 2015|Actual|2015-12-31||Interventional||Intent-to-treat (ITT) population comprised all randomized participants, whether or not they received any study treatment or completed a full course of study treatment. Participants were analyzed according to their randomized treatment.|A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer|A Randomized, Multicenter, Open-Label, Two-Arm, Phase III Neoadjuvant Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Patients With HER2-Positive Breast Cancer|Active, not recruiting||Phase 3|444|Actual|Hoffmann-La Roche|The reported results are interim only.|2|||f||||||||||||||2017-10-11 00:28:49.267345|2017-10-11 00:28:49.267345
NCT02131051|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-05-05|||June 2010||2010-06-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis|Non-interventional Study: Application of Ectoin® Rhinitis Nasal Spray and Eye Drops in Patients With Allergic Rhinitis|Completed||N/A|48|Actual|Bitop AG|||2||f||||f||||||||||2017-10-11 00:28:51.607783|2017-10-11 00:28:51.607783
NCT02131038|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-05-05|||May 2009||2009-05-01|May 2014|2014-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis|Non Interventional, Open Label Trial of Ectoine Containing Nasal Spray in Comparison With Cromoglycic Acid Containing Nasal Spray in Patients With Allergic Rhinitis|Completed||N/A|50|Actual|Bitop AG|||2||f||||f||||||||||2017-10-11 00:28:51.696887|2017-10-11 00:28:51.696887
NCT02131012|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-02-20|||June 2015|Actual|2015-06-01|February 2017|2017-02-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional|Celecoxib||Intravitreal Celecoxib for Chronic Uveitis|Intravitreal Celecoxib for Chronic Uveitis: A Phase I Investigational Safety Study|Terminated||Phase 1|4|Actual|Vanderbilt University Medical Center||1||Difficulty recruiting|f||||t||||||||||2017-10-11 00:28:51.797925|2017-10-11 00:28:51.797925
NCT02130999|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-07-21|2015-12-11||May 2014||2014-05-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)|A Single Dose, Open-Label, Randomized Two-Period Crossover Study in Healthy Young Subjects to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)|Completed||Phase 4|14|Actual|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:28:51.898783|2017-10-11 00:28:51.898783
NCT02130986|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-08-08|||November 3, 2014|Actual|2014-11-03|August 2017|2017-08-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|ProACT||Procalcitonin Antibiotic Consensus Trial (ProACT)|Procalcitonin Antibiotic Consensus Trial (ProACT)|Completed||N/A|1664|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:28:52.397273|2017-10-11 00:28:52.397273
NCT02130973|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-02|2017-08-30|||August 2013||2013-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab|The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab|Active, not recruiting||Phase 4|60|Anticipated|Health Research, Inc.||2|||f||||f||||||||||2017-10-11 00:28:52.726063|2017-10-11 00:28:52.726063
NCT02130960|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-12-31|||April 2014||2014-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|September 2014|Actual|2014-09-01||Observational|||Resting Metabolic Rate Reliability|Resting Metabolic Rate Reliability|Completed||N/A|30|Actual|USDA Grand Forks Human Nutrition Research Center|||1||f||||f||||||||||2017-10-11 00:28:52.852284|2017-10-11 00:28:52.852284
NCT02130947|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-02-10|||April 2014||2014-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide|Randomized, Controlled Study of an Exercise Intervention Program for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Either Abiraterone or Enzalutamide|Withdrawn||N/A|0|Actual|UNC Lineberger Comprehensive Cancer Center||2||We were not able to accrue any participants.|f||||f||||||||||2017-10-11 00:28:52.926638|2017-10-11 00:28:52.926638
NCT02130934|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-11-10|||May 2014||2014-05-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Cardiac 3D MRI in Pediatric Cancer Patients|Left Ventricular Strain Assessment Using 3d Cardiac Magnetic Resonance Technique In Asymptomatic Pediatric Patients Who Received Cardiotoxic Chemotherapy|Withdrawn||N/A|0|Actual|University of Kentucky|||1|Slow accrual|f||||f||||||||||2017-10-11 00:28:53.029172|2017-10-11 00:28:53.029172
NCT02130921|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-05-01|||July 2014||2014-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Enhancing the Role of Commune Health Workers in HIV and Drug Control: A Randomized Controlled Trial|Enhancing the Role of Commune Health Workers in HIV and Drug Control: A Randomized Controlled Trial|Active, not recruiting||N/A|1800|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 00:28:53.118025|2017-10-11 00:28:53.118025
NCT02130908|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-03-28|||March 2011||2011-03-01|March 2016|2016-03-01||||July 2015|Actual|2015-07-01||Interventional|FISK1||A Study on the Possible Health Effects of Lean Fish, Fatty Fish and Lean Meat Intake in Non-obese Adults||Completed||N/A|45|Actual|University of Bergen||3|||f||||f||||||||||2017-10-11 00:28:53.222068|2017-10-11 00:28:53.222068
NCT02130895|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-12-01|||October 2014||2014-10-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|STOPP-RCT||Testing CDS in OSCAR EMR Using STOPP Criteria|A Mixed-method Study to Explore, Assess, and Explain the Translation of a Complex Set of Evidence-based Rules Into Practice Through Electronic Medical Record Based Decision Support: How Can STOPP Effectively be Deployed in Primary Care?|Completed||N/A|28|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:28:53.310988|2017-10-11 00:28:53.310988
NCT02130882|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-10-05|||March 13, 2014||2014-03-13|July 12, 2017|2017-07-12|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome|A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Benralizumab (MEDI-563) in Reducing Eosinophilia in Subjects With Hypereosinophilic Syndrome (HES)|Recruiting||Phase 2|25|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:28:53.406449|2017-10-11 00:28:53.406449
NCT02130856|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-04-24|||April 2014||2014-04-01|April 2017|2017-04-01|February 26, 2017|Actual|2017-02-26|February 26, 2017|Actual|2017-02-26||Interventional|||Newborn Kit to Save Lives in Pakistan|An Integrated Toolkit to Save Newborn Lives in Pakistan|Completed||Phase 3|8518|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 00:28:53.861985|2017-10-11 00:28:53.861985
NCT02130843|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-02|||June 2011||2011-06-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|TMUC||Tiemann Mounted Urodynamic Catheter Technique for Difficult Bladder Catheterization|RETROSPECTIVE STUDY ABOUT A TECHNIQUE OF INSERTION OF TIEMANN MOUNTED URODYNAMIC CATHETER FOR DIFFICULT BLADDER CATHETERIZATION IN MALES|Completed||N/A|30|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:28:54.004|2017-10-11 00:28:54.004
NCT02130830|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-08-01|||May 2014||2014-05-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Topical Anesthesia Versus Placebo to Decrease Pain in Rubber Band Ligation for Treatment of Internal Hemorrhoids|Topical Anesthesia Versus Placebo to Decrease Post Procedure Pain in Rubber Band Ligation for the Treatment of Grade I - III Symptomatic Internal Hemorrhoids. A Single Institution, Double Blinded, Placebo Controlled Trial.|Completed||Phase 3|80|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 00:28:54.104061|2017-10-11 00:28:54.104061
NCT02130817|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-05-13|||May 2014||2014-05-01|May 2016|2016-05-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01||Interventional|BelatPilot||Belatacept in Kidney Transplantation of Moderately Sensitized Patients|Belatacept for the Management of Moderately Sensitized Patients at Risk for Delayed Graft Function (DGF)|Recruiting||Phase 4|20|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 00:28:54.222356|2017-10-11 00:28:54.222356
NCT02130804|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-05-01|||July 2011||2011-07-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|TAMI||Using Salsalate to Target Adipocyte Macrophage Infiltration|Using Salsalate to Target Adipocyte Macrophage Infiltration and Reverse Metabolic Disease Risk in Obese Hispanic Young Adults|Completed||Phase 1|30|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 00:28:54.377567|2017-10-11 00:28:54.377567
NCT02130791|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-12-01|||October 2010||2010-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Phenotypic and Genotypic Markers of Performance Vulnerability to Sleep Loss|Phenotypic and Genotypic Markers of Performance Vulnerability to Sleep Loss|Completed||N/A|170|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 00:28:54.506471|2017-10-11 00:28:54.506471
NCT02130778|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-12-11|||April 2014||2014-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Natriuretic Effect of GLP-1in Healthy Non Obese Subjects|Natriuretic Effect of GLP-1 in Healthy Non Obese Subjects Followed by Oral Sodium Load: A Randomized, Placebo-controlled, Cross-over Study|Completed||Early Phase 1|15|Actual|Clinical Hospital Centre Zagreb||2|||f||||f||||||||||2017-10-11 00:28:54.589654|2017-10-11 00:28:54.589654
NCT02130765|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-04-21|||November 2014||2014-11-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|STAR-VT||Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia|Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia (STAR-VT) - G130132|Active, not recruiting||N/A|1453|Anticipated|St. Jude Medical||2|||f||||t|f|t|t|f||||No||2017-10-11 00:28:54.688065|2017-10-11 00:28:54.688065
NCT02130752|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-09-05|||October 2014||2014-10-01|September 2014|2014-09-01|October 2019|Anticipated|2019-10-01|October 2016|Anticipated|2016-10-01||Interventional|CGCT-01||Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery|Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery: a Multicenter Randomized Controlled Trial|Not yet recruiting||Phase 3|430|Anticipated|West China Hospital||2|||f||||f||||||||||2017-10-11 00:28:54.890602|2017-10-11 00:28:54.890602
NCT02130739|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-05-01|||September 2010||2010-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01|3 Days|Observational [Patient Registry]|||Horner's SD After Thoracic Epidural Block|Incidence of Transient Horner's Syndrome Following Thoracic Epidural Anesthesia for Mastectomy|Completed||N/A|450|Actual|Soonchunhyang University Hospital|||1||f||||t||||||||||2017-10-11 00:28:55.153714|2017-10-11 00:28:55.153714
NCT02130726|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-12-21|||December 2014||2014-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|STOMACH||Surgical Technique, Open Versus Minimally-invasive Gastrectomy After CHemotherapy|The STOMACH Trial: Surgical Technique, Open Versus Minimally-invasive Gastrectomy After CHemotherapy|Recruiting||N/A|200|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 00:28:55.326219|2017-10-11 00:28:55.326219
NCT02130713|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-02|||January 2012||2012-01-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Treatment of Chronic Bacterial Prostatitis|Chronic Bacterial Prostatitis: Efficacy of Short-lasting Antibiotic Therapy With Prulifloxacin (Unidrox®) in Association With Saw Palmetto Extract, Lactobacillus Sporogens and Arbutin (Lactorepens®)|Completed||Phase 4|210|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 00:28:55.52212|2017-10-11 00:28:55.52212
NCT02130700|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-02-28|||April 2014||2014-04-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer|A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of VT-464 in Patients With Metastatic Castration Resistant Prostate Cancer Who Have Previously Been Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer|Recruiting||Phase 2|48|Anticipated|Innocrin Pharmaceutical||5|||f||||f||||||||||2017-10-11 00:28:55.624217|2017-10-11 00:28:55.624217
NCT02130674|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2014-05-04|||January 2005||2005-01-01|May 2014|2014-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Optimized Therapy in Severe Traumatic Brain Injured Patients|Improvement of Therapy in Patients With Severe Traumatic Brain Injury: Differential Impact of Local and Systemic Changes and Routinely Applied Drugs|Completed||Phase 4|12|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 00:28:55.928646|2017-10-11 00:28:55.928646
NCT02130661|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-12-12|||October 2017||2017-10-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers|A Phase I, Two-part, Open-label Study to Evaluate the Pharmacokinetics of Rilapladib (SB-659032) and Its Metabolites, and to Determine the Effect of Repeat Dose Itraconazole on the Pharmacokinetics of Rilapladib in Healthy Volunteers|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:28:56.014349|2017-10-11 00:28:56.014349
NCT02130648|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-12-30|||October 2012||2012-10-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|July 2015|Anticipated|2015-07-01||Observational|||Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis|Non-invasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis by Quantitative Real Time MEMO-PCR|Unknown status|Recruiting|Early Phase 1|50|Anticipated|University Hospital, Montpellier|||1||f||||f||||||Samples With DNA|"     Samples with DNA   "|||2017-10-11 00:28:56.105585|2017-10-11 00:28:56.105585
NCT02130635|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-07-31|2017-01-10||July 1, 2014||2014-07-01|July 2017|2017-07-01|August 18, 2015|Actual|2015-08-18|August 1, 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients|A Double-Blind (Sponsor Unblind), Placebo Controlled, Randomised, Parallel Group Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of GSK2269557 Administered as a Dry Powder to COPD Patients and Assessment of Dose Response Using Sputum Biomarkers|Completed||Phase 2|64|Actual|GlaxoSmithKline||9|||f||||f||||||||||2017-10-11 00:28:56.287736|2017-10-11 00:28:56.287736
NCT02130622|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-05-10|||July 2014|Actual|2014-07-01|May 2017|2017-05-01||||December 2020|Anticipated|2020-12-01||Interventional|||Study of Promethazine for Treatment of Diabetic Gastroparesis|A Pilot, Randomized, Double-blind, Placebo-controlled Trial of Promethazine for Treatment of Diabetic Gastroparesis.|Recruiting||Phase 2|24|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-11 00:29:02.19337|2017-10-11 00:29:02.19337
NCT02130609|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-06-12|||December 2013||2013-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Skintel Integration Study|Skintel Integration Study for Use With the Elite+ Laser System|Completed||N/A|32|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:29:02.3683|2017-10-11 00:29:02.3683
NCT02130596|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-11-06|||February 2014||2014-02-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||An Acceptance-Based Behavioral Intervention vs. Nutritional Counselling for Weight Loss in Psychotic Illness|A Pilot Study of an Acceptance-Based Behavioral Intervention Versus Nutritional Counseling for Weight Loss in Psychotic Illness|Completed||N/A|16|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 00:29:02.470337|2017-10-11 00:29:02.470337
NCT02130583|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-09-29|||August 2013||2013-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|November 2016|Anticipated|2016-11-01||Interventional|STEP||Skills to Enhance Positive Affect in Suicidal Adolescents|Skills to Enhance Positive Affect in Suicidal Adolescents|Active, not recruiting||N/A|52|Actual|Brown University||2|||f||||t||||||||Yes|Data available upon completion of study by request.|2017-10-11 00:29:02.567572|2017-10-11 00:29:02.567572
NCT02130544|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-12-03|||November 2014||2014-11-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Acute Pain Management Following Video-assisted Thoracoscopic Surgery: Comparison of Lobectomy and Wedge Resection|Acute Pain Management Following Video-assisted Thoracoscopic Surgery: Comparison of Lobectomy and Wedge Resection|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:29:03.402804|2017-10-11 00:29:03.402804
NCT02130531|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2016-01-14|||April 2014||2014-04-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration|Pharmacokinetic and Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration|Completed||Phase 1|26|Actual|Acucela Inc.||2|||f||||f||||||||||2017-10-11 00:29:03.47978|2017-10-11 00:29:03.47978
NCT02130518|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-11-30|||September 2014||2014-09-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency|A Multicenter, Randomized, Double-Blind, Efficacy Study of Auriclosene Irrigation Solution on Indwelling Urinary Catheter Patency|Active, not recruiting||Phase 2|140|Anticipated|NovaBay Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:29:03.57105|2017-10-11 00:29:03.57105
NCT02130505|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-05-01|||June 2007||2007-06-01|May 2014|2014-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|INFORM||Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes|Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes|Completed||N/A|51|Actual|Sint Franciscus Gasthuis||4|||f||||f||||||||||2017-10-11 00:29:03.699677|2017-10-11 00:29:03.699677
NCT02130492|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-09-08|||May 2014||2014-05-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)|A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)|Recruiting||Phase 1|6|Anticipated|Northwell Health||1|||f||||t||||||||||2017-10-11 00:29:03.799736|2017-10-11 00:29:03.799736
NCT02130479|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-03-22|||April 2014||2014-04-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|July 2017|Anticipated|2017-07-01||Interventional|||Testing a Promising Treatment for Youth Substance Abuse in a Community Setting|Testing a Promising Treatment for Youth Substance Abuse in a Community Setting|Recruiting||Phase 1/Phase 2|204|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 00:29:03.907014|2017-10-11 00:29:03.907014
NCT02130284|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-08-30|2017-02-14||October 2014||2014-10-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|PLGM||In Clinic Evaluation of the PLGM Feature|In-Clinic Evaluation of the Predictive Low Glucose Management (PLGM) System in Adult and Pediatric Insulin Requiring Patients With Diabetes Using the Enlite 3 Sensor|Completed||N/A|80|Actual|Medtronic Diabetes||1|||f||||t||||||||||2017-10-11 00:29:06.306382|2017-10-11 00:29:06.306382
NCT02130466|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-09-22|||May 29, 2014|Actual|2014-05-29|September 2017|2017-09-01|July 10, 2021|Anticipated|2021-07-10|July 10, 2021|Anticipated|2021-07-10||Interventional|||A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)|A Phase I/II Study to Assess the Safety and Efficacy of MK-3475 in Combination With Trametinib and Dabrafenib in Subjects With Advanced Melanoma|Recruiting||Phase 1/Phase 2|219|Anticipated|Merck Sharp & Dohme Corp.||6|||t||||f||||||||||2017-10-11 00:29:04.004441|2017-10-11 00:29:04.004441
NCT02130453|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-07-27|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking|Use of Regadenoson for a Stress Echocardiogram Protocol Using Speckle Tracking Imaging|Recruiting||Phase 4|300|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 00:29:04.149938|2017-10-11 00:29:04.149938
NCT02130440|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-05-01|||November 2012||2012-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis|Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis|Completed||Phase 3|100|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||f||||||||||2017-10-11 00:29:04.354136|2017-10-11 00:29:04.354136
NCT02130427|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-09-29|||September 2010||2010-09-01|July 2017|2017-07-01||||August 2018|Anticipated|2018-08-01||Interventional|||A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy|A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy|Active, not recruiting||N/A|120|Anticipated|Abramson Cancer Center of the University of Pennsylvania||4|||f||||t||||||||||2017-10-11 00:29:04.45449|2017-10-11 00:29:04.45449
NCT02130414|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-05-18|||July 2014||2014-07-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|CYC102||PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects|A Multiple Dose, Multi-stage Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Colon Tissue Distribution of Cyclosporine Capsules (CyCol®) Compared to Intravenous Cyclosporine in Healthy Male Volunteers|Completed||Phase 1|48|Actual|Sigmoid Pharma||4|||f||||f||||||||||2017-10-11 00:29:04.54997|2017-10-11 00:29:04.54997
NCT02130401|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-09-23|||June 2014||2014-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes|Device: Investigational Study to Examine the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes|Completed||N/A|6|Actual|Scion NeuroStim||1|||f||||f||||||||||2017-10-11 00:29:04.653309|2017-10-11 00:29:04.653309
NCT02130388|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-10-20|||May 2014||2014-05-01|October 2015|2015-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in Sepsis|The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in Sepsis|Unknown status|Recruiting|Phase 1|64|Anticipated|Ohio State University||2|||f||||t||||||||||2017-10-11 00:29:04.7492|2017-10-11 00:29:04.7492
NCT02130375|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-01-27|||May 2014||2014-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Clinical and Urodynamic Effects of Minimally Laser (IncontiLaseTM) Procedure for Female Stress Urinary Incontinence|Clinical and Urodynamic Effects of Minimally Laser (IncontiLaseTM) Procedure for Female Stress Urinary Incontinence|Completed||Phase 4|35|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:29:04.853124|2017-10-11 00:29:04.853124
NCT02130362|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2017-08-14|||August 29, 2014||2014-08-29|August 2017|2017-08-01|April 30, 2030|Anticipated|2030-04-30|April 30, 2030|Anticipated|2030-04-30||Observational|CAPE||A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)|A Long-Term Non-Interventional Postmarketing Study to Assess Safety and Effectiveness of Humira® (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD) - CAPE|Recruiting||N/A|1300|Anticipated|AbbVie|||2||f||||f||||||||||2017-10-11 00:29:04.970715|2017-10-11 00:29:04.970715
NCT02130349|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-03-15|||February 2011||2011-02-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|25 Years|Observational [Patient Registry]|IBDSL||IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.|IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. A Prospective Population Based Biobank of Inflammatory Bowel Disease Patients in Zuid Limburg, The Netherlands.|Recruiting||N/A|5000|Anticipated|Maastricht University Medical Center|||3||f||||t||||||Samples With DNA|"     DNA Serum Plasma Stool Exhaled air Biopsies   "|||2017-10-11 00:29:05.531894|2017-10-11 00:29:05.531894
NCT02130336|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-12-02|||November 2012||2012-11-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|May 2015|Anticipated|2015-05-01||Interventional|||The Effects of High-intensity Aerobic Training in Patients With Metabolic Syndrome|The Effects of High-intensity Aerobic Training in Patients With Metabolic Syndrome and Its Dose Response Study|Unknown status|Recruiting|N/A|120|Anticipated|National Taiwan University Hospital||3|||f||||f||||||||||2017-10-11 00:29:05.626542|2017-10-11 00:29:05.626542
NCT02130323|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-06-23|||February 2015||2015-02-01|June 2017|2017-06-01|May 9, 2017|Actual|2017-05-09|December 21, 2016|Actual|2016-12-21||Interventional|||Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix|Phase 3 Randomized Controlled Trial of Non-inferiority of Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix|Completed||Phase 2/Phase 3|22|Actual|United States Naval Medical Center, San Diego||2|||f||||f|t|f||||||No||2017-10-11 00:29:05.755309|2017-10-11 00:29:05.755309
NCT02130310|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-09-22|||May 2014||2014-05-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers|A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers|Unknown status|Active, not recruiting|Phase 3|252|Anticipated|Macrocure Ltd.||2|||f||||t||||||||||2017-10-11 00:29:05.866983|2017-10-11 00:29:05.866983
NCT02130297|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-09-14|||May 2014||2014-05-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Post Excision/Mohs Scar Laser Resurfacing|Post Excision/Mohs Fractional CO2 Resurfacing: A Quantitative and Qualitative Scar Analysis Study|Recruiting||N/A|45|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||f||||||||||2017-10-11 00:29:06.181954|2017-10-11 00:29:06.181954
NCT02130271|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-03-22|||April 2014||2014-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients|PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients|Active, not recruiting||N/A|42|Anticipated|Massachusetts General Hospital|||2||f||||t||||||Samples With DNA|"     A blood sample will be taken from healthy subjects only at Visit 1. The blood sample will     genotyped. Genotyping will identify if the subject makes proteins that will bind the     radioactive tracer.      A blood sample will be drawn for Genotyping at Visit 2 from all subjects.   "|||2017-10-11 00:29:06.632096|2017-10-11 00:29:06.632096
NCT02130258|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-03-22|||May 2012||2012-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Somatosensory Profiling in Radicular Pain Patients And it's Correlation With Treatment Outcome|Somatosensory Profiling in Radicular Pain Patients And it's Correlation With Treatment Outcome|Active, not recruiting||N/A|23|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-11 00:29:06.759711|2017-10-11 00:29:06.759711
NCT02130245|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-04-07|||September 2013||2013-09-01|April 2015|2015-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study|Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study|Unknown status|Recruiting|N/A|600|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 00:29:06.857137|2017-10-11 00:29:06.857137
NCT02130232|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-06-30|||April 2014||2014-04-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Appropriate Gestational Weight Gain in Overweight/Obese Women|Appropriate Gestational Weight Gain in Overweight/Obese Women|Recruiting||N/A|400|Anticipated|Kaiser Permanente||2|||f||||t||||||||||2017-10-11 00:29:06.9585|2017-10-11 00:29:06.9585
NCT02130219|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-07-25|||June 2013||2013-06-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|Braincare||Clinical Value of Noninvasive Intracranial Pressure Measurement|Scientific Research and Development of Innovative Evidence Based Non-invasive Brain Diagnostic and Monitoring Solutions for Neurological and Traumatic Brain Injury Patients|Unknown status|Recruiting|Phase 2/Phase 3|45|Anticipated|Lithuanian University of Health Sciences||4|||f||||f||||||||||2017-10-11 00:29:07.065158|2017-10-11 00:29:07.065158
NCT02130206|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-11-07|||May 2014||2014-05-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Microbiology of Caries Resistance|The Microbiology of Caries Resistance. Subtitle: Functional Amyloid Formation in Streptococcus Mutans|Completed||Phase 2|79|Actual|University of Florida||4|||f||||f||||||||||2017-10-11 00:29:07.199999|2017-10-11 00:29:07.199999
NCT02130193|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-13|2017-04-04||February 13, 2014|Actual|2014-02-13|April 2017|2017-04-01|August 29, 2016|Actual|2016-08-29|August 29, 2016|Actual|2016-08-29||Interventional||Data for Part B is presented.|Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations|A Two Part, Phase IIa, Randomized, Placebo-controlled Study To Investigate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin (GSK1325756) in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations|Completed||Phase 2|102|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:29:07.598528|2017-10-11 00:29:07.598528
NCT02130180|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-07-29|||April 2014||2014-04-01|May 2014|2014-05-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|DKA Optic US||DKA Optic Ultrasound|Measurement of the Optic Nerve Sheath Diameter by Optic Ultrasound in Diabetic Ketoacidosis and the Relationship to Cerebral Edema|Unknown status|Recruiting|N/A|108|Anticipated|Children's Hospitals and Clinics of Minnesota|||3||f||||f||||||||||2017-10-11 00:29:12.077379|2017-10-11 00:29:12.077379
NCT02130167|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-05-01|||August 2012||2012-08-01|August 2012|2012-08-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Low Concentration Atropine for Myopia Progression in School Children|Low Concentrations of Atropine for Controlling Myopia Progression in School Children|Unknown status|Recruiting|N/A|30|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:29:12.178982|2017-10-11 00:29:12.178982
NCT02130154|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-04-30|||May 2013||2013-05-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Brown Adipose Tissue Activity and Age|Brown Adipose Tissue Activity Young and Older Individuals|Completed||N/A|16|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f||||||||||2017-10-11 00:29:12.297173|2017-10-11 00:29:12.297173
NCT02130141|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-01|||November 2012||2012-11-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CHOKO||The Effects of Dark Chocolate on Blood Pressure in Individuals With Mildly Elevated Blood Pressure|The Effects of Dark Chocolate on Blood Pressure in Mildly Hypertensive Individuals|Completed||N/A|30|Actual|Helsinki University||2|||f||||f||||||||||2017-10-11 00:29:12.402131|2017-10-11 00:29:12.402131
NCT02130128|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-06-03|||April 2014||2014-04-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Continuing Evaluation of the LungPoint ATV System|Continuing Evaluation of the LungPoint ATV System|Terminated||N/A|6|Actual|Broncus Medical Inc||1||Sufficient clinical evidence was gathered|f||||f||||||||||2017-10-11 00:29:12.500747|2017-10-11 00:29:12.500747
NCT02130115|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-05-02|||March 2013||2013-03-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|LABEL||LungPoint ATV for Biopsy in Patients Undergoing Lobectomy|LungPoint ATV for Biopsy in Patients Undergoing Lobectomy|Completed||N/A|12|Actual|Broncus Medical Inc||1|||f||||f||||||||||2017-10-11 00:29:12.577023|2017-10-11 00:29:12.577023
NCT02130102|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-12-30|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ModuLAAr||ModuLAAr - A Module Based and Scalable System for Silver-ager in Austria|Evaluation of ModuLAAr - a Module Based and Scalable System for Silver-ager Located in Assisted Living Homes in Austria|Completed||N/A|38|Actual|AIT Austrian Institute of Technology GmbH|||1||f||||f||||||||||2017-10-11 00:29:12.648916|2017-10-11 00:29:12.648916
NCT02130089|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-01-26|||April 2014||2014-04-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Can Dietitians Reduce Interdialytic Weight Gain in at Risk Hemodialysis Patients Through Tailored Education on Dietary Sodium and Fluid Intake?|Can Dietitians Reduce Interdialytic Weight Gain in at Risk Hemodialysis Patients Through Tailored Education on Dietary Sodium and Fluid Intake?|Completed||N/A|50|Actual|Academy of Nutrition and Dietetics||1|||f||||f||||||||||2017-10-11 00:29:12.748112|2017-10-11 00:29:12.748112
NCT02130076|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-05-01|||September 2012||2012-09-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|POET-VEF||Interruption of TNFinhibitors and Endothelial Function|The Effect of Interruption of TNFi on Endothelial Function in Patients With Rheumatoid Arthritis|Unknown status|Active, not recruiting|N/A|48|Anticipated|Radboud University|||2||f||||t||||||||||2017-10-11 00:29:12.839032|2017-10-11 00:29:12.839032
NCT02130063|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-08-18|||May 2014||2014-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|Provide||IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose|A Phase III, Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose in Subjects With Iron Deficiency Anaemia and Who Are Intolerant or Unresponsive to Oral Iron Therapy or Who Need Iron Rapidly (PROVIDE)|Completed||Phase 3|511|Actual|Pharmacosmos A/S||2|||f||||f||||||||||2017-10-11 00:29:12.92295|2017-10-11 00:29:12.92295
NCT02130050|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-04-30|||April 2014||2014-04-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Metabolic Profiling in Patients With Obstructive Sleep Apnea: From Plasma to Hypoxic Cell Model of Peripheral Monocyte|Metabolic Profiling in Patients With Obstructive Sleep Apnea: From Plasma to Hypoxic Cell Model of Peripheral Monocyte|Unknown status|Active, not recruiting|N/A|24|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples Without DNA|"     Human plasma   "|||2017-10-11 00:29:13.071121|2017-10-11 00:29:13.071121
NCT02130037|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-01|||May 2014||2014-05-01|May 2014|2014-05-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Cognitive Behavioral Therapy Via a Smartphone Application on Bulimia Nervosa and Binge Eating Disorder Symptoms|The Effect Size of Cognitive Behavioral Therapy Via a Smartphone Application on Bulimia Nervosa and Binge Eating Disorder Symptoms|Unknown status|Recruiting|N/A|40|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:29:13.167925|2017-10-11 00:29:13.167925
NCT02130011|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-10-05|||March 2014||2014-03-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional|DGRT||Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real Dose|Managing the Real Dose: Evaluating the Impact on Gastric Filling on the Delivered Radiation Dose in Gastrooesophageal Junction Tumors|Completed||N/A|20|Actual|Maastricht Radiation Oncology||2|||f||||f||||||||||2017-10-11 00:29:13.42459|2017-10-11 00:29:13.42459
NCT02129985|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-30|||February 2014||2014-02-01|April 2014|2014-04-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|T2DMRS||Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy|Effect of Short-term Intensive Insulin Sequential Exenatide Therapy on Beta Cell Function and Glycaemic Control in Patients With Newly Diagnosed Type 2 Diabetes :a Multicenter Prospective Randomized Control Study|Unknown status|Recruiting|Phase 4|100|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-11 00:29:13.612929|2017-10-11 00:29:13.612929
NCT02129972|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-08-18|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|VICCOINBODI||Colon Capsule Endoscopy in Children|Evaluation of the Video Capsule Colonoscopy for the Detection and the Control of Colon Lesions in Children Presenting Confirmed or Suspected Inflammatory Bowel Disease|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:29:13.728078|2017-10-11 00:29:13.728078
NCT02129959|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-01|||May 2014||2014-05-01|May 2014|2014-05-01||||March 2015|Anticipated|2015-03-01||Observational|||Cardiovascular Effects of the Degree of Head-down and Pneumoperitoneum During Laparoscopy|Cardiovascular Effects of the Degree of Head-down and Pneumoperitoneum During Laparoscopy|Unknown status|Not yet recruiting|N/A|180|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 00:29:13.856845|2017-10-11 00:29:13.856845
NCT02129946|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-05-26|||January 2014||2014-01-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Effect of Resistant Starch Bagels on Risk Factors of Type 2 Diabetes and Colorectal Cancer|Human Clinical Trial to Investigate the Effects of Resistant Starch Bagels on Risk Factors of Type 2 Diabetes and Colorectal Cancer in Adults at Risk for Type 2 Diabetes|Completed||N/A|25|Anticipated|University of Guelph||2|||f||||f||||||||||2017-10-11 00:29:13.964088|2017-10-11 00:29:13.964088
NCT02129933|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-11-23|||April 2014||2014-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|VICE||VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions|A Pilot Intervention Study for the Use of VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions|Completed||Phase 1|14|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 00:29:14.099409|2017-10-11 00:29:14.099409
NCT02129920|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-05-01|||February 2014||2014-02-01|April 2014|2014-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01|3 Months|Observational [Patient Registry]|RELAXED||RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke|Recurrent Embolism Lessened by Rivaroxaban, an Anti-Xa Agent of Early Dosing for Acute Ischemic Stroke and Transient Ischemic Attack With Atrial Fibrillation Study (RELAXED)|Unknown status|Recruiting|N/A|2000|Anticipated|Japan Cardiovascular Research Foundation|||1||f||||t||||||||||2017-10-11 00:29:14.236326|2017-10-11 00:29:14.236326
NCT02129907|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2015-12-15|||October 2013||2013-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|10 Weeks|Observational [Patient Registry]|||The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.|The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.|Completed||N/A|82|Actual|HaEmek Medical Center, Israel|||1||f||||t||||||||||2017-10-11 00:29:14.377958|2017-10-11 00:29:14.377958
NCT02129881|ClinicalTrials.gov processed this data on October 10, 2017|2014-05-01|2014-06-19|||April 2014||2014-04-01|June 2014|2014-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|ONETreg1||The ONE Study UK Treg Trial|The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation|Unknown status|Recruiting|Phase 1/Phase 2|12|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:29:14.526518|2017-10-11 00:29:14.526518
NCT02129868|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-02-28|||April 2014||2014-04-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|APCam09||Automated Closed-loop in Children and Adolescents With Type 1 Diabetes|An Open-label, Single-centre, Randomised, 2-period Cross-over Study to Assess the Efficacy and Safety of a Novel Automated Overnight Closed-loop Glucose Control System on Day 1 of Continuous Glucose Monitoring Sensor Insertion in Comparison to Day 3 to 4 After Sensor Insertion in Children and Adolescents With Type 1 Diabetes|Completed||N/A|13|Actual|University of Cambridge||2|||f||||t||||||||||2017-10-11 00:29:14.623005|2017-10-11 00:29:14.623005
NCT02129855|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-11-16|||July 2014||2014-07-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|CHORES-XL||Metabolic Costs of Daily Activities in Older Adults|Metabolic Costs of Daily Activities in Older Adults|Recruiting||N/A|250|Anticipated|University of Florida|||1||f||||t||||||||Undecided||2017-10-11 00:29:14.74691|2017-10-11 00:29:14.74691
NCT02129842|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-03-08|||May 2014||2014-05-01|December 2014|2014-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?|A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation|Completed||N/A|150|Anticipated|Itamar-Medical, Israel|||1||f||||f||||||||||2017-10-11 00:29:14.830313|2017-10-11 00:29:14.830313
NCT02129829|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-06-01|||October 2011||2011-10-01|June 2011|2011-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|WATCH||PROLIFICA - West African Treatment Cohort for Hepatitis B|Prevention of Liver Fibrosis and Cancer in Africa. Observational Study of Screening, Assessment and Treatment for Chronic Hepatitis B Virus Infection|Unknown status|Recruiting|N/A|1000|Anticipated|Imperial College London|||2||f||||f||||||Samples With DNA|"     Serum, plasma, urine and DNA   "|||2017-10-11 00:29:14.92486|2017-10-11 00:29:14.92486
NCT02129816|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-12-01|||May 2014||2014-05-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|BryoSoliP||Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder|Treatment of Patients With Overactive Bladder With Bryophyllum Pinnatum Versus Solifenacinsuccinat Versus Placebo: Multicenter, Prospective, Double-blind Randomized, Placebo-controlled Cross-over Study, Phase III Trial|Recruiting||Phase 2/Phase 3|30|Anticipated|University of Zurich||3|||f||||t||||||||||2017-10-11 00:29:15.163887|2017-10-11 00:29:15.163887
NCT02129803|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-01-27|||May 2015||2015-05-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis|Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis|Recruiting||N/A|30|Anticipated|Virginia Commonwealth University||2|||f||||f||t|||f|||||2017-10-11 00:29:15.280198|2017-10-11 00:29:15.280198
NCT02129790|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-30|||January 2014||2014-01-01|April 2014|2014-04-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder|Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder|Unknown status|Recruiting|N/A|10|Anticipated|University of California, Los Angeles||1|||f||||t||||||||||2017-10-11 00:29:15.378525|2017-10-11 00:29:15.378525
NCT02129777|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-02-23|2017-02-23||June 2014||2014-06-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional||Randomized set included all participants randomized in this study.|Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis|A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding and Proof of Concept Study, to Assess the Efficacy, Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of Namilumab/MT203 at 4 Different Subcutaneous Doses - Together With an Open-Label, Dose-Escalated Extension to Assess Safety and Efficacy of One Year Treatment - in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|122|Actual|Takeda||7|||f||||t||||||||||2017-10-11 00:29:15.559643|2017-10-11 00:29:15.559643
NCT02129764|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-07-19|||December 2013|Actual|2013-12-01|July 2017|2017-07-01|October 30, 2017|Anticipated|2017-10-30|July 31, 2017|Anticipated|2017-07-31||Interventional|PUSH-PATH-2||Prednisone for Heart Failure Patients With Hyperuricemia|Prednisone in Uric Acid Lowering in Symptomatic Heart Failure PATients With Hyperuricemia (PUSH-PATH Study 2)|Recruiting||Phase 2/Phase 3|180|Anticipated|Hebei Medical University||2|||f||||t||||||||||2017-10-11 00:29:18.671851|2017-10-11 00:29:18.671851
NCT02129751|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2015-01-20|||July 2015||2015-07-01|April 2014|2014-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder|A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder|Not yet recruiting||Phase 4|200|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 00:29:18.769044|2017-10-11 00:29:18.769044
NCT02129725|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-03-07|2017-01-13||April 2014||2014-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional||Subjects who consented (16) and were randomized (15).|Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.|Renin- Angiotensin and Fibrinolysis Interaction in Humans: Effect of Long-term PDE-5 Inhibition on Glucose Homeostasis. Sub-study|Completed||Phase 4|15|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||No||2017-10-11 00:29:19.007907|2017-10-11 00:29:19.007907
NCT02129712|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-04-11|||February 1, 2014|Actual|2014-02-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|CRPBT||Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors|Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors|Recruiting||N/A|40|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-10-11 00:29:19.487559|2017-10-11 00:29:19.487559
NCT02129699|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-04-24|||January 6, 2015|Actual|2015-01-06|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|SPLENDOUR||Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy|A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC|Recruiting||Phase 3|1000|Anticipated|European Thoracic Oncology Platform||2|||f||||t|f|f||||||No||2017-10-11 00:29:19.594966|2017-10-11 00:29:19.594966
NCT02129686|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-01-25|||June 2014|Actual|2014-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 15, 2016|Actual|2016-06-15||Interventional|||A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients|A Randomized Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients|Active, not recruiting||N/A|40|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||Undecided||2017-10-11 00:29:20.127858|2017-10-11 00:29:20.127858
NCT02129673|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-04-18|||May 2014||2014-05-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension|A Phase 1/2 Multicenter, Randomized, Controlled Dose-Finding Study to Evaluate the Safety and Ocular Hypotensive Efficacy of 3 Dose Levels of the VS101 Subconjunctival Latanoprost Insert for 3 Months in Subjects With Open-Angle Glaucoma or Ocular Hypertension|Active, not recruiting||Phase 1/Phase 2|70|Anticipated|ViSci Ltd.||4|||f||||f||||||||||2017-10-11 00:29:20.22288|2017-10-11 00:29:20.22288
NCT02129660|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-01-19||2015-10-22|April 2014||2014-04-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparator Study of the Effect of DRM04B and DRM 04 in Subjects With Axillary Hyperhidrosis|A Phase 2, Randomized, Double-Blind Vehicle-Controlled Comparator Study of the Effect of DRM04B and DRM04 in Subjects With Axillary Hyperhidrosis|Completed||Phase 2|105|Actual|Dermira, Inc.||5|||f||||f||||||||||2017-10-11 00:29:20.336058|2017-10-11 00:29:20.336058
NCT02129647|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-07-14|||April 2014||2014-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas|Phase II Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas|Recruiting||Phase 2|17|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 00:29:20.462093|2017-10-11 00:29:20.462093
NCT02129634|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-11-20|||December 2013||2013-12-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|SINGA-PACLI||Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial|Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial|Recruiting||N/A|136|Anticipated|Singapore General Hospital||2|||f||||f||||||||||2017-10-11 00:29:20.586132|2017-10-11 00:29:20.586132
NCT02129621|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-01|||May 2010||2010-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in Human|Prospective Study of Neutrophil Gelatinase Associated Lipocalin (NGAL)as a Biomarker of Mineralocorticoid Receiver Activity in Human: Proof of Concept.|Completed||N/A|42|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-10-11 00:29:20.797547|2017-10-11 00:29:20.797547
NCT02129608|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-09-30|2016-09-30||June 2014||2014-06-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management|A Feasibility Pilot Comparing a Non-invasive Low Level Laser Therapy (LLLT) With Lorcaserin to Reduce Central Adiposity in Overweight Individuals.|Completed||Phase 3|44|Actual|Mayo Clinic||3|||f||||f||||||||No||2017-10-11 00:29:20.890344|2017-10-11 00:29:20.890344
NCT02129595|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-08-07|||April 2014||2014-04-01|August 2016|2016-08-01|July 31, 2017|Actual|2017-07-31|April 2017|Actual|2017-04-01||Interventional|||Resveratrol and First-degree Relatives of Type 2 Diabetic Patients|Effects of Resveratrol on Insulin Sensitivity, Brown Adipose Tissue and Metabolic Profile in First-degree Relatives of Type 2 Diabetic Patients|Completed||N/A|15|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:29:21.525512|2017-10-11 00:29:21.525512
NCT02129582|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-04-27|||June 6, 2014|Actual|2014-06-06|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies|Phase I Trial of Escalated Doses of Targeted Marrow Irradiation (TMI) Combined With Fludarabine and Busulfan as Conditioning Regimen for Allogeneic Hematopoietic Progenitor Cell Transplantation|Recruiting||Phase 1|78|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|t|f|||f|||||2017-10-11 00:29:21.695722|2017-10-11 00:29:21.695722
NCT02129569|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-03-16|||November 11, 2013|Actual|2013-11-11|March 2017|2017-03-01|August 17, 2016|Actual|2016-08-17|April 11, 2015|Actual|2015-04-11||Interventional|||Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers|Family-Centered Intervention for the Transition to Living With Multiple Myeloma as a Chronic Illness|Completed||N/A|30|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:29:21.874925|2017-10-11 00:29:21.874925
NCT02129556|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-05-29|||December 2014||2014-12-01|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|August 2017|Anticipated|2017-08-01||Interventional|PANACEA||Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer|A Phase Ib/II Trial Evaluating the Efficacy of MK-3475 and Trastuzumab in Patients With Trastuzumab-resistant, HER2-positive Metastatic Breast Cancers|Active, not recruiting||Phase 1/Phase 2|58|Actual|International Breast Cancer Study Group||1|||f||||t||||||||||2017-10-11 00:29:21.999536|2017-10-11 00:29:21.999536
NCT02129543|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-08-04|||August 15, 2012|Actual|2012-08-15|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Immune Reconstitution in Stem Cell Transplant Recipients|Collection of Peripheral Blood Samples From Donors and Recipients of Blood and Marrow Transplants for Laboratory Research in Immune Reconstitution|Recruiting||N/A|200|Anticipated|University of Miami|||1||f||||f|f|f||||Samples With DNA|"     Blood Samples Marrow Samples   "|||2017-10-11 00:29:22.117868|2017-10-11 00:29:22.117868
NCT02129530|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-01-04|||March 2012||2012-03-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Community Social Mobilization for the Prevention of HIV in Young South African Women|Effect of Community Social Mobilization for the Prevention of HIV in Young South African Women|Completed||N/A|2502|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:29:22.202071|2017-10-11 00:29:22.202071
NCT02129517|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-09-28|||November 2014||2014-11-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials|Oncology Nurse IMPACT: Improving Communication With Patients About Clinical Trials|Recruiting||N/A|1262|Anticipated|Case Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 00:29:22.277408|2017-10-11 00:29:22.277408
NCT02129504|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-05-01|||September 2010||2010-09-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Two Techniques for Root Coverage With a Xenogeneic Collagen Matrix|Comparison of Two Surgical Techniques to Optimize the Treatment of Gingival Recessions Using a Gingival Graft Substitute.|Completed||N/A|20|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:29:22.406996|2017-10-11 00:29:22.406996
NCT02129491|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-05-01|||January 2014||2014-01-01|May 2014|2014-05-01|December 2021|Anticipated|2021-12-01|January 2020|Anticipated|2020-01-01|10 Years|Observational [Patient Registry]|||National Egyptian Network Pediatric Stroke and Hemiplegia Registry|National Egyptian Network Pediatric Stroke and Hemiplegia Registry|Recruiting||N/A|1000|Anticipated|Ain Shams University|||1||f||||t||||||||||2017-10-11 00:29:22.498655|2017-10-11 00:29:22.498655
NCT02129478|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-09-26|||March 2014||2014-03-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study|Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study|Completed||Phase 2|15|Actual|The Hospital for Sick Children||1|||f||||||||||||||2017-10-11 00:29:22.59851|2017-10-11 00:29:22.59851
NCT02129465|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2016-05-19|||June 2014||2014-06-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Observational|CMV||Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy|Correlates of Maternal Characteristics in CMV Infection in Pregnancy With Maternal-fetal Transmission.|Recruiting||N/A|100|Anticipated|Shaare Zedek Medical Center|||1||f||||f||||||Samples With DNA|"     whole blood, serum, plasma, peripheral blood mono-nuclear cells , DNA, RNA   "|||2017-10-11 00:29:22.686799|2017-10-11 00:29:22.686799
NCT02129452|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-05-26|||January 2013||2013-01-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||Olfactory Neuroepithelial Tissue of Alzheimer Disease|Research of Olfactory Neuroepithelial Tissue as a Potential Biomarker of Alzheimer Disease|Completed||N/A|40|Actual|Seoul National University Hospital|||4||f||||f||||||Samples With DNA|"     Tissue including olfactory neuroepithelium from nasal cavity   "|||2017-10-11 00:29:22.779114|2017-10-11 00:29:22.779114
NCT02129439|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-01-12|||April 2014||2014-04-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|SECURE||Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients|SB012 for Treatment of Active Ulcerative Colitis: Prospective Multi-centre Randomised Double-blind Placebo-controlled Phase IIa Clinical Trial to Evaluate Efficacy, Pharmacokinetics, Tolerability and Safety of SB012 Enema Administered OD|Recruiting||Phase 1/Phase 2|18|Anticipated|Sterna Biologicals GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 00:29:22.883436|2017-10-11 00:29:22.883436
NCT02129426|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-05-03|||August 2014||2014-08-01|May 2017|2017-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Outcomes During MRI Sedation With Midazolam-dexmedetomidine Versus Ketamine-dexmedetomidine|COMPARISON OF OUTCOMES DURING MRI SEDATION WITH MIDAZOLAM-DEXMEDETOMIDINE VERSUS KETAMINE-DEXMEDETOMIDINE|Recruiting||N/A|50|Anticipated|University of Louisville||2|||f||||f||||||||||2017-10-11 00:29:23.204649|2017-10-11 00:29:23.204649
NCT02129413|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-02-04|||May 2014||2014-05-01|April 2014|2014-04-01||||August 2015|Anticipated|2015-08-01||Interventional|||Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm|Safety and Performance of the Delta System in the Treatment of Vasospasm in Aneurysmal Subarachnoid Hemorrhage (aSAH) Patients|Unknown status|Recruiting|N/A|23|Anticipated|Samson NeuroSciences||1|||f||||f||||||||||2017-10-11 00:29:23.302881|2017-10-11 00:29:23.302881
NCT02129400|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-03-30|||May 2014||2014-05-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|XEPO||Influence on Erythropoetin-level by Xenon|Xenon-inhalation: Elimination of Xenon and Its Effect on Erythropoetin Levels in Blood of Healthy Volunteers|Terminated||Phase 3|36|Actual|RWTH Aachen University||16||"The analysis of the blood samples was much expensive than calculated. The recruitment had to be   stopped after 36 study participants."|f||||t||||||||||2017-10-11 00:29:23.42664|2017-10-11 00:29:23.42664
NCT02129387|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-08-28|||April 2014||2014-04-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Observational|||EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smokers|EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smokers|Recruiting||N/A|128|Anticipated|Southern Illinois University Carbondale|||1||f||||t||||||Samples With DNA|"     blood, saliva   "|||2017-10-11 00:29:23.597273|2017-10-11 00:29:23.597273
NCT02129374|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-02|||January 2014||2014-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Direct Repair Surgery for Spondylolysis of Lumbar in Young Population||Completed||N/A|163|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:29:23.71918|2017-10-11 00:29:23.71918
NCT02129361|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-01-14|||March 2014||2014-03-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Screening and Brief Intervention for Substance Misuse Following Traumatic Brain Injury|Brief Intervention for Substance Misuse Following Moderate or Severe Traumatic Brain Injury (TBI): A Randomized Controlled Trial|Enrolling by invitation||N/A|120|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-11 00:29:23.834796|2017-10-11 00:29:23.834796
NCT02129335|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-05-16|||April 2014||2014-04-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|October 2016|Actual|2016-10-01||Observational|TOGETHER||Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner|Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner (TOGETHER-study): a Prospective Multicenter Cohort Study.|Terminated||N/A|12|Actual|University Hospital, Basel, Switzerland|||1|insufficient enrollment|f||||t||||||||||2017-10-11 00:29:24.126896|2017-10-11 00:29:24.126896
NCT02129322|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-08-09|||July 2015||2015-07-01|August 2015|2015-08-01|December 2019|Anticipated|2019-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1|Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1o Prevent the Tumor Recurrence for Hepatocellular Carcinoma After Liver Transplantation: A Randomized Controlled Study|Not yet recruiting||Phase 2|100|Anticipated|Zhejiang University||2|||f||||||||||||||2017-10-11 00:29:24.208932|2017-10-11 00:29:24.208932
NCT02129309|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-06-23|||June 2014||2014-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures|Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures.|Completed||N/A|20|Actual|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:29:24.402045|2017-10-11 00:29:24.402045
NCT02129296|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2015-04-07|||September 2013||2013-09-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study|Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study|Unknown status|Recruiting|Phase 1/Phase 2|300|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 00:29:24.525025|2017-10-11 00:29:24.525025
NCT02129283|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-04-30|||May 2014||2014-05-01|April 2014|2014-04-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|ISRAEOLC||Can We Improve the Quality of Care at the End of Life in Israel?|Can We Improve the Quality of Care at the End of Life in Israel?|Unknown status|Not yet recruiting|N/A|300|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:29:24.665796|2017-10-11 00:29:24.665796
NCT02129270|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-30|||May 2014||2014-05-01|April 2014|2014-04-01||||February 2015|Anticipated|2015-02-01||Interventional|||Hematoma Block for Reduction of Distal Radius Fractures|Phase 4 Study of Hematoma Block for Reduction of Distal Radius Fractures|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|HaEmek Medical Center, Israel||2|||f||||||||||||||2017-10-11 00:29:24.78796|2017-10-11 00:29:24.78796
NCT02129257|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-06-01|||May 26, 2014|Actual|2014-05-26|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|AMALTHEA||﻿Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer|﻿Single-arm Phase II Study of Maintenance Therapy With Aflibercept After First-line Treatment With FOLFIRI Plus Aflibercept in Metastatic Colorectal Cancer Patients|Active, not recruiting||Phase 2|73|Actual|Hellenic Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 00:29:24.908947|2017-10-11 00:29:24.908947
NCT02129244|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-04-07|||October 2014||2014-10-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes|A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes|Recruiting||N/A|3000|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-11 00:29:25.086363|2017-10-11 00:29:25.086363
NCT02129231|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-05|||February 2012||2012-02-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy|Ezetimibe/Simvastatin and Rosuvastatin for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy: a Randomized, Double Blinded, Placebo Controlled Clinical Trial|Completed||Phase 2|74|Actual|University of Guadalajara||3|||f||||t||||||||||2017-10-11 00:29:25.294499|2017-10-11 00:29:25.294499
NCT02129218|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-03-16|||February 16, 2015|Actual|2015-02-16|March 2017|2017-03-01|September 22, 2017|Anticipated|2017-09-22|September 22, 2017|Anticipated|2017-09-22||Interventional|||Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer|A Pilot Study to Determine the Feasibility of a Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer|Recruiting||N/A|72|Anticipated|Case Comprehensive Cancer Center||4|||f||||f|f|f||||||||2017-10-11 00:29:25.445905|2017-10-11 00:29:25.445905
NCT02129192|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-03-01|2016-10-06||May 2014||2014-05-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional||Treated Set (TS): This subject set included all subjects who were dispensed the study drug and were documented to have taken at least one dose of the study drug.|Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use|Bioequivalence of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet Compared to Concomitant Administration of Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet and Amlodipine 5 mg Capsule in Healthy Male Subjects (an Open-label, Randomised, Single-dose, Two-sequence, Four-period Replicated Crossover Study), With Influence of Food on the Bioavailability of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet|Completed||Phase 1|72|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:29:25.760561|2017-10-11 00:29:25.760561
NCT02129179|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-05-01|||June 2014||2014-06-01|April 2014|2014-04-01||||June 2015|Anticipated|2015-06-01||Interventional|||The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure|The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|Papworth Hospital NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 00:29:26.391302|2017-10-11 00:29:26.391302
NCT02129166|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-10-03|||September 2014||2014-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Explore the Synergy of Combination TKI Therapy|Explore the Synergy of Combination TKI Therapy - A Pilot Study to Evaluate the Effect of Imatinib on Dasatinib Pharmacokinetics in Healthy Volunteers|Withdrawn||Phase 1|0|Actual|University of Florida||2||PI resigned|f||||f||||||||||2017-10-11 00:29:26.483115|2017-10-11 00:29:26.483115
NCT02129153|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-02-06|||September 1, 2014||2014-09-01|February 2017|2017-02-01|August 1, 2016|Actual|2016-08-01|June 30, 2016|Actual|2016-06-30||Interventional|LIFT||Linking Families Together Study- A Randomized Trial to Raise Parental Monitoring|Linking Families Together Study- A Randomized Trial to Raise Parental Monitoring|Completed||N/A|318|Actual|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-11 00:29:26.565371|2017-10-11 00:29:26.565371
NCT02129140|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-11-16|||April 2014||2014-04-01|November 2016|2016-11-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Observational|||Observational Study to Evaluate Ventral Incisional Hernia Repair Using a Biologic Mesh (Cook Biodesign)|Observational Study to Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biologic Mesh (Cook Biodesign) for Midline Fascial Closure Reinforcement|Recruiting||N/A|30|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||||||2017-10-11 00:29:26.673486|2017-10-11 00:29:26.673486
NCT02129127|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-04-12|||March 2014||2014-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|June 2015|Actual|2015-06-01||Interventional|ENDURE||Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial|First in Human Evaluation of the Drug-Coated Chocolate Balloon for Percutaneous Transluminal Revascularization of Infrainguinal Arterial Disease|Completed||N/A|67|Actual|TriReme Medical, LLC||1|||f||||t||||||||||2017-10-11 00:29:26.788842|2017-10-11 00:29:26.788842
NCT02129114|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-07-07|||April 2014||2014-04-01|July 2014|2014-07-01|May 2015|Anticipated|2015-05-01|December 2014|Anticipated|2014-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of Dural Repair Patch in Neurosurgical Repairs|A Multi-Center,Randomized,Non-Inferiority and Positively Controlled Clinical Trial to Evaluate the Safety and Efficacy of Dural Repair Patch in Neurosurgical Repairs|Unknown status|Recruiting|N/A|132|Anticipated|Medprin Regenerative Medical Technologies Co.,Ltd.||2|||f||||f||||||||||2017-10-11 00:29:26.880332|2017-10-11 00:29:26.880332
NCT02129101|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2017-01-20|||May 2014||2014-05-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies|Phase I/Ib Study of Azacitidine or Decitabine With Hedgehog Pathway Inhibition in Myeloid Malignancies|Active, not recruiting||Phase 1|78|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 00:29:26.987006|2017-10-11 00:29:26.987006
NCT02129088|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-07-24|||March 2014||2014-03-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Pharmacokinetic, Safety and Tolerability Study of Esketamine in Healthy Elderly and Adult Participants|An Open-Label, Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Elderly and Adult Subjects|Completed||Phase 1|34|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:29:27.124142|2017-10-11 00:29:27.124142
NCT02129075|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-11-14|||April 2014||2014-04-01|November 2016|2016-11-01||||April 2016|Actual|2016-04-01||Interventional|||CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma|A Phase II, Open-Label, Multicenter, Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients With Malignant Melanoma Pre-treated With Recombinant CDX-301, a Recombinant Human Flt3 Ligand|Active, not recruiting||Phase 2|60|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 00:29:27.204872|2017-10-11 00:29:27.204872
NCT02129062|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-11-18|2016-11-18||April 2014||2014-04-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia|A Phase 2 Study to Determine the Efficacy of the BTK Inhibitor Ibrutinib (PCI-32765) in Patients With Relapsed or Refractory Precursor-B Lymphoblastic Leukemia (B-ALL)|Terminated||Phase 2|3|Actual|National Cancer Institute (NCI)||1||Slow accrual.|f||||t||||||||||2017-10-11 00:29:27.504275|2017-10-11 00:29:27.504275
NCT02129049|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2016-03-08|||April 2014||2014-04-01|March 2016|2016-03-01||||July 2015|Actual|2015-07-01||Interventional|||Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children|Enhancing Connections Telephone Program: A Cancer Education Program for Parents|Completed||N/A|35|Actual|University of Washington||1|||f||||t||||||||||2017-10-11 00:29:27.715019|2017-10-11 00:29:27.715019
NCT02129036|ClinicalTrials.gov processed this data on October 10, 2017|2009-01-04|2014-05-01|||April 2008||2008-04-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|OCCA||Ovarian Clear Cell Adenocarcinoma Review|Retrospective Multi-institutional Survey of Clinical Characteristics in Ovarian Clear Cell Adenocarcinoma Cancer Patients|Completed||N/A|5|Actual|Cathay General Hospital|||1||f||||f||||||||||2017-10-11 00:29:27.844077|2017-10-11 00:29:27.844077
NCT02129023|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-06-10|||January 2014||2014-01-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||The Impact of Exergame on User Health|The Impact of Exergame on User Health: A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|116|Anticipated|Chang Gung University||2|||f||||f||||||||||2017-10-11 00:29:27.925876|2017-10-11 00:29:27.925876
NCT02129010|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2016-03-07|||April 2013||2013-04-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage|The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage|Completed||N/A|120|Anticipated|Cantonal Hospital of St. Gallen|||1||f||||t||||||Samples Without DNA|"     Cerebrospinal fluid   "|||2017-10-11 00:29:28.056633|2017-10-11 00:29:28.056633
NCT02128984|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-08-05|||January 2012||2012-01-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|VITJUNIOR||Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children|Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children|Completed||Phase 4|109|Actual|Laboratorios Ordesa||2|||f||||t||||||||||2017-10-11 00:29:28.27669|2017-10-11 00:29:28.27669
NCT02128802|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-05-11|||April 2014||2014-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure|Weight Reduction Surgery Followed by Kidney Transplantation for Patients With Class III Obesity and Renal Failure|Recruiting||N/A|75|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 00:29:33.737901|2017-10-11 00:29:33.737901
NCT02128971|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-05-05|||April 2014||2014-04-01|May 2014|2014-05-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo|A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo|Unknown status|Recruiting|Phase 2|108|Anticipated|Albion||6|||f||||f||||||||||2017-10-11 00:29:28.447659|2017-10-11 00:29:28.447659
NCT02128958|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2017-07-18|||September 2014||2014-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)|A Phase 2 Study in the Second-Line Treatment of Advanced Hepatocellular Carcinoma in Subjects With Child-Pugh Class B Cirrhosis|Recruiting||Phase 2|78|Anticipated|Can-Fite BioPharma||2|||f||||f||||||||||2017-10-11 00:29:28.594868|2017-10-11 00:29:28.594868
NCT02128945|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-09-12|||April 2014||2014-04-01|January 2016|2016-01-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|FLUDATEP||Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies|Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies|Completed||Phase 1|10|Actual|University Hospital, Caen||1|||f||||t||||||||||2017-10-11 00:29:28.826555|2017-10-11 00:29:28.826555
NCT02128932|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-04-27||2016-08-18|August 4, 2014|Actual|2014-08-04|April 2017|2017-04-01|September 3, 2015|Actual|2015-09-03|September 3, 2015|Actual|2015-09-03||Interventional|SUSTAIN™ 4||Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes|Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as Add on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes|Completed||Phase 3|1089|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 00:29:28.933035|2017-10-11 00:29:28.933035
NCT02128919|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2017-08-27|2016-12-17||April 2012||2012-04-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TDCSSCHIZ||Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic|Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic|Completed||N/A|33|Actual|Nathan Kline Institute for Psychiatric Research||2|||f||||f||||||||||2017-10-11 00:29:32.121798|2017-10-11 00:29:32.121798
NCT02128906|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-07-21|||December 2013||2013-12-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|(UPCI)13-056||Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design|A Randomized, Phase II Study of Definitive Radiotherapy With Concurrent Cisplatin vs. Docetaxel-cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma: an ERCC1 Biomarker Enrichment and Interaction Design|Recruiting||Phase 2|160|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:29:32.448215|2017-10-11 00:29:32.448215
NCT02128893|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-30|2014-04-30|||January 2014||2014-01-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole|A Phase 1 Randomized Open Label, Parallel Group Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole|Completed||Phase 1|24|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:29:32.592064|2017-10-11 00:29:32.592064
NCT02128880|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-10-24|||February 2015||2015-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|CARRII||Contraception and Alcohol Risk Reduction Internet Intervention Randomized Trial|A Randomized Clinical Trial of the Contraception and Alcohol Risk Reduction Internet Intervention to Reduce AEP Risk in Community Women|Completed||N/A|74|Actual|University of Virginia||2|||f||||f||||||||No||2017-10-11 00:29:32.734045|2017-10-11 00:29:32.734045
NCT02128867|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-03-10|2015-02-23||September 2013||2013-09-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety Study of Airway Clearance Techniques in Infants.|Influence of Bouncing, Assisted Autogenic Drainage (AAD) and Bouncing and AAD (BAAD) on Gastro-oesophageal Reflux ( GOR ), Oxygen Saturation (SaO2) and Heart Rate in Infants From 0 to 12 Months|Completed||N/A|159|Actual|Vrije Universiteit Brussel||3|||f||||t||||||||||2017-10-11 00:29:32.870105|2017-10-11 00:29:32.870105
NCT02128854|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-05-05|||August 14, 2014|Actual|2014-08-14|September 2016|2016-09-01|August 31, 2016|Actual|2016-08-31|July 26, 2016|Actual|2016-07-26||Interventional|TABLETS||Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills|Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills|Completed||N/A|60|Actual|Medical University of South Carolina||2|||f||||t||||||||No|There are no plans to share IPD during the analysis phase.|2017-10-11 00:29:33.134639|2017-10-11 00:29:33.134639
NCT02128841|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-08-29|||September 2012||2012-09-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|CATHAR||Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.|This is a Prospective, Open-label Phase 2 Pilot Study With Independent Evaluation of All Outcomes and a Historical Control Group to Determine if Rivaroxaban (Xarelto) is Feasible and Safe for Prevention of Major Complications in Patients Undergoing a Mechanical Aortic Heart Valve Replacement.|Suspended||Phase 2|30|Anticipated|University Hospital Inselspital, Berne||1||Awaiting results of interim analysis|f||||t||||||||||2017-10-11 00:29:33.355649|2017-10-11 00:29:33.355649
NCT02128815|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-03-15|||January 2015||2015-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|DiabCoach||Evaluating the Effect of a Diabetes Health Coach in Individuals With Type 2 Diabetes|Evaluating the Effect of a Diabetes Health Coach in Individuals With Type 2 Diabetes|Recruiting||Phase 4|370|Anticipated|McMaster University||2|||f||||f||||||||Undecided|This option is still being explored.|2017-10-11 00:29:33.599194|2017-10-11 00:29:33.599194
NCT02128789|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-10-26|||June 2011||2011-06-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ElderTree||Bring Communities and Technology Together for Healthy Aging|Bring Communities and Technology Together for Healthy Aging|Completed||N/A|600|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 00:29:33.832912|2017-10-11 00:29:33.832912
NCT02128776|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-29|||March 2011||2011-03-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||An Enhanced Medical Home for High-Risk Chronically Ill Children|Comprehensive Care Provided in an Enhanced Medical Home to Improve Outcomes and Reduce Costs for High-Risk Chronically Ill Children|Completed||N/A|201|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 00:29:33.917025|2017-10-11 00:29:33.917025
NCT02128763|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-05-01|||November 2014||2014-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 30, 2017|Anticipated|2017-10-30||Interventional|DREAM||Dry Eye Assessment and Management Study|Dry Eye Assessment and Management Study|Active, not recruiting||Phase 3|535|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:29:34.052885|2017-10-11 00:29:34.052885
NCT02128750|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-03-04|||February 2011||2011-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Echomuscle||Contrast Enhanced Ultrasound and Muscle|Echographie de Contraste Pour l'Analyse de la Perfusion Musculaire Dans l'ischémie Critique|Completed||N/A|32|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-11 00:29:34.233576|2017-10-11 00:29:34.233576
NCT02128737|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-06-09|||December 2009||2009-12-01|April 2014|2014-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Neurobehavioral Effects of Partial Sleep Deprivation|Neurobehavioral Effects of Partial Sleep Deprivation|Completed||N/A|300|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 00:29:34.321101|2017-10-11 00:29:34.321101
NCT02128724|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-09-29|||April 2013||2013-04-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|BKM120||Palliative Thoracic Radiotherapy Plus BKM120|A CR-UK Phase I Study of BKM120 in Patients With Non-small Cell Lung Cancer (NSCLC) Receiving Thoracic Radiotherapy|Active, not recruiting||Phase 1|30|Anticipated|University of Oxford||1|||f||||t||||||||||2017-10-11 00:29:34.418355|2017-10-11 00:29:34.418355
NCT02128711|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-05-02|||May 2014||2014-05-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens|Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens|Recruiting||N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||Samples With DNA|"     Explanted lung specimens from cystic fibrosis patients. This tissue, that would otherwise be     discarded, is being retained for microbiological analysis.   "|||2017-10-11 00:29:34.528531|2017-10-11 00:29:34.528531
NCT02128698|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-10-25|||March 2014||2014-03-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PAPAB||Physical Activity and Protein Supplementation After Bariatric Surgery (PAPAB)|Physical Activity and Protein Supplementation After Bariatric Surgery|Completed||N/A|50|Actual|University of Hohenheim||4|||f||||f||||||||||2017-10-11 00:29:34.630356|2017-10-11 00:29:34.630356
NCT02128685|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-02-12|||March 2016||2016-03-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage|A Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Women With Threatened Miscarriage in the First Trimester|Recruiting||Phase 3|400|Anticipated|The University of Hong Kong||2|||f||||||||||||||2017-10-11 00:29:34.737681|2017-10-11 00:29:34.737681
NCT02128672|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-03-14|||July 2015||2015-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Spinal Stimulation to Treat Low Back Pain|Extraforaminal Spinal Stimulation Compared to Conventional Spinal Cord Stimulation to Treat Axial Low Back Pain-A Pilot Study|Withdrawn||N/A|0|Actual|Mayo Clinic||2||stopped because of competing studies|f||||f||||||||||2017-10-11 00:29:34.85199|2017-10-11 00:29:34.85199
NCT02128659|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-05-01|||April 2014||2014-04-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2016|Actual|2016-03-01||Interventional|SHE Project||Sexual Health Empowerment for Cervical Health Literacy and Cancer Prevention|Sexual Health Empowerment for Cervical Health Literacy and Cancer Prevention|Active, not recruiting||N/A|261|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 00:29:34.933041|2017-10-11 00:29:34.933041
NCT02128646|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-01-17|||April 2014||2014-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair|Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair|Completed||Phase 4|40|Actual|University of Kansas Medical Center||4|||f||||f||||||||||2017-10-11 00:29:35.044192|2017-10-11 00:29:35.044192
NCT02128633|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-29|||November 2009||2009-11-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|June 2013|Actual|2013-06-01||Interventional|ECR||Effectiveness of a Homecare Dentin Hypersensitivity Gel|EFFECTIVENESS OF A HOMECARE DESENSITIZER FOR PATIENTS WITH DENTIN HYPERSENSITIVITY|Completed||Phase 2/Phase 3|126|Actual|Universidade Federal de Santa Maria||3|||f||||t||||||||||2017-10-11 00:29:35.319742|2017-10-11 00:29:35.319742
NCT02128620|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-01-04|||January 2015||2015-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Randomized Online Health Experiment for a Safer Youth Sexual Behaviour|Study on Sexually Transmitted Diseases Prevention - Introduction of a Novel Game-based Appointment System for Youth|Completed||N/A|996|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 00:29:35.506241|2017-10-11 00:29:35.506241
NCT02128607|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-08-13|||February 2014||2014-02-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Randomized Placebo Controlled Trial on the Efficacy of Sustained Natural Apophyseal Glide (SNAG) in Low Back Pain Patients|"Immediate and Short-term Effects of Mulligan Sustained Natural Apophyseal Glides for a Subgroup of Low Back Pain Patients: A Randomized Placebo Controlled Trial"|Completed||N/A|32|Actual|Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 00:29:35.615017|2017-10-11 00:29:35.615017
NCT02128594|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-05-27|||January 2012||2012-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Serosorting Intervention for HIV Negative MSM|Serosorting Intervention for HIV Negative MSM|Completed||N/A|600|Actual|University of Connecticut||1|||f||||t||||||||||2017-10-11 00:29:35.735083|2017-10-11 00:29:35.735083
NCT02128581|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-07-16|||May 2014||2014-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|March 2015|Actual|2015-03-01||Interventional|||A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake|A Dose-response Study of the Effects of Exendin-9,39 on Gastrointestinal Symptoms and Food Intake.|Active, not recruiting||Phase 1|3|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 00:29:35.828108|2017-10-11 00:29:35.828108
NCT02128568|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-12-16|||March 2014||2014-03-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Sub-Trial of the Youth Readiness Intervention (YRI): Treatment of Control Group and Addition of Stress Biomarkers|A Feasibility Trial of the Youth Readiness Intervention: A Group Psychosocial Intervention for War-affected Youth in Sierra Leone|Active, not recruiting||N/A|218|Anticipated|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 00:29:35.940639|2017-10-11 00:29:35.940639
NCT02128555|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-05-09|||January 2015||2015-01-01|December 2015|2015-12-01|May 2018|Anticipated|2018-05-01|July 2017|Anticipated|2017-07-01||Interventional|TARVA||Total Ankle Replacement Versus Arthrodesis Trial|A Randomised, Multi-centre, Non-blinded, Prospective, Parallel Group Trial of Total Ankle Replacement (TAR) Versus Ankle Arthrodesis in Patients With End Stage Ankle Osteoarthritis, Comparing Clinical Outcomes and Cost-effectiveness.|Recruiting||N/A|328|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 00:29:36.050888|2017-10-11 00:29:36.050888
NCT02128542|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-06-21|2016-06-21||June 2014||2014-06-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|VALOR-HCV|Safety analysis set: participants who received at least 1 dose of study drug|Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis|A Phase 4, Multicenter, Open Label Study to Investigate the Efficacy and Safety of an All Oral Combination of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis VALOR-HCV: Veterans Affairs alL Oral Regimen of SOF+RBV in GT2 HCV|Completed||Phase 4|66|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|1|||f||||f||||||||||2017-10-11 00:29:36.268453|2017-10-11 00:29:36.268453
NCT02128529|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-10-31|||October 2010||2010-10-01|September 2016|2016-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Cross-sectional Observational Study in Pulmonology Departments in Belgium and Luxembourg to Investigate the Epidemiology of Chronic Bronchitis in Patients Suffering From Moderate to Very Severe COPD|Completed||N/A|976|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:29:36.881339|2017-10-11 00:29:36.881339
NCT02128516|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-29|||January 2012||2012-01-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|nutralys||NUTRALYS® Pea Protein Oral Supplementation Effects on Muscle Mass|Controlled, Randomized, Parallel, Double-blind Study of the Effect of NUTRALYS® Pea Protein Supplementation Versus Whey Protein and Placebo on the Muscle Mass and Strength of Volunteers Engaged in Training|Completed||N/A|150|Actual|University of Burgundy||3|||f||||f||||||||||2017-10-11 00:29:36.959145|2017-10-11 00:29:36.959145
NCT02128503|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-04-23|||February 2013|Actual|2013-02-01|April 2017|2017-04-01|October 16, 2015|Actual|2015-10-16|October 16, 2015|Actual|2015-10-16||Interventional|||Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease|Prevalence and Clinical Course of Chronic Hepatitis B Infection in Patients With Inflammatory Bowel Disease and Rheumatologic Disease on Immunosuppressive Therapy|Terminated||N/A|430|Actual|Chinese University of Hong Kong||1||sample size recruited is not enough|f||||t||||||||No||2017-10-11 00:29:37.062246|2017-10-11 00:29:37.062246
NCT02128490|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-09-15|2016-09-15|2016-06-22|May 2014||2014-05-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional||Full Analysis Set (FAS) included all participants who were randomized and received at least 1 dose of double-blind study medication.|Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment|A Phase 2, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of Febuxostat 40 mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout and Moderate Renal Impairment|Completed||Phase 2|189|Actual|Takeda||5|||f||||t||||||||||2017-10-11 00:29:37.165085|2017-10-11 00:29:37.165085
NCT02128477|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-01-24|||October 2010|Actual|2010-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PRD-MI||Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients|Predictive Value of Periodic Repolarization Dynamics in Post-Infarction Patients: Validation Study|Completed||N/A|754|Actual|Thebiosignals.com|||1||f||||f||||||||||2017-10-11 00:29:38.64206|2017-10-11 00:29:38.64206
NCT02128464|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-07-28|||October 2012||2012-10-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Outcome of TKA Using Customized Cutting Block Compared With Conventional Intramedullary Cutting Guide|Comparison of Customized Cutting Block (Visionaire™) and Conventional Total Knee Arthroplasty: A Prospective Randomized Control Trial|Completed||Phase 4|108|Actual|Thammasat University||2|||f||||t||||||||||2017-10-11 00:29:38.745429|2017-10-11 00:29:38.745429
NCT02128451|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2015-04-05|||April 2014||2014-04-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Value of Adding Either Meperdine or Fentanyl to Clonidine-bupivacaine|The Value of Adding Either Meperdine or Fentanyl to Clonidine-bupivacaine Mixture in Patients With Lower Limb Orthopedic Surgery Using Combined Spinal Epidural Anesthesia|Completed||Phase 4|90|Actual|Tanta University||2|||f||||t||||||||||2017-10-11 00:29:38.854585|2017-10-11 00:29:38.854585
NCT02128438|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-29|||February 2007||2007-02-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Most People With Low Back Pain Have Associated Cervicothoracic Musculoskeletal Dysfunction: an Observational Study|Most People With Low Back Pain Have Associated Cervicothoracic Musculoskeletal Dysfunction: an Observational Study|Completed||N/A|940|Actual|Swami Vivekanand National Institute of Rehabilitation Training and Research|||1||f||||f||||||||||2017-10-11 00:29:38.951283|2017-10-11 00:29:38.951283
NCT02128425|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-05-06|||April 2014||2014-04-01|April 2014|2014-04-01|April 2018|Anticipated|2018-04-01|February 2017|Anticipated|2017-02-01||Interventional|||FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer|Phase II Randomized Controlled Trial of FOLFOXIRI Compared to FOLFOX in First Line Treatment of Chemo-naive Metastatic Colorectal Cancer|Recruiting||Phase 2|162|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 00:29:39.026015|2017-10-11 00:29:39.026015
NCT02128412|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-10-14|||February 2014||2014-02-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||IVUS Controlled Stenting|Expansion of Intracoronary Stents by Low Pressure Oversizing Versus High Pressure Inflation: A Randomised Intracoronary Ultrasound Controlled Study|Active, not recruiting||N/A|40|Anticipated|Sydney South West Area Health Service||2|||f||||f||||||||||2017-10-11 00:29:39.139363|2017-10-11 00:29:39.139363
NCT02128399|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-29|||June 2012||2012-06-01|July 2012|2012-07-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|||Antimicrobial Stewardship Reduces MDRO Isolates in Critically Ill Patients||Completed||N/A|978|Actual|Southeast University, China|||1||f||||||||||||||2017-10-11 00:29:39.231297|2017-10-11 00:29:39.231297
NCT02128386|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-02-20|||February 2014||2014-02-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Observational|||"Medication Adherence and True Resistance in Patients With Resistant Hypertension"|"A Study on Medication Adherence and True Resistance in Patients Referred to a Medical Outpatient Department in Germany With the Diagnosis Resistant Hypertension."|Unknown status|Recruiting|N/A|50|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||Samples Without DNA|"     Blood samples for therapeutic drug monitoring   "|||2017-10-11 00:29:39.302954|2017-10-11 00:29:39.302954
NCT02128373|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-02-16|||November 2011||2011-11-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer|A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer|Terminated||N/A|7|Actual|Case Comprehensive Cancer Center||2||Slow Accrual|f||||f||||||||||2017-10-11 00:29:39.388678|2017-10-11 00:29:39.388678
NCT02128360|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2014-11-19|||March 2015||2015-03-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian Reserve|Analysis of IVF Outcome After Minimal Stimulation vs. High Dose Stimulation for Patients With Low Ovarian Reserve|Unknown status|Not yet recruiting|N/A|200|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:29:39.51325|2017-10-11 00:29:39.51325
NCT02128347|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-07-25|||October 2014||2014-10-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effectiveness of an Online Portal for Delivery of Care to Home Dialysis Patients|Effectiveness of an Online Portal for Delivery of Care to Home Dialysis Patients|Completed||N/A|39|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 00:29:39.616536|2017-10-11 00:29:39.616536
NCT02128334|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-08-15|||September 2013||2013-09-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation|Prospective Multicenter Observational Program for Evaluation of Efficacy and Tolerability of the 6-month Depot Eligard 45 mg in Patients With Advanced Prostate Carcinoma in Routine Clinical Practice of Uro-Oncologists in the Russian Federation|Completed||N/A|645|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 00:29:39.707536|2017-10-11 00:29:39.707536
NCT02128321|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-04-29|||January 2014||2014-01-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine|A Phase 1 Open Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:29:39.916225|2017-10-11 00:29:39.916225
NCT02128308|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-04-29|||November 2013||2013-11-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents|A Open-label, Single Sequence Clinical Trial to Investigate the Pharmacokinetic Characteristics of Second-Line Anti-Tuberculosis Agents After Multiple Oral/Intramuscular Administration in Healthy Male Volunteers|Completed||Phase 1|16|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:29:40.061208|2017-10-11 00:29:40.061208
NCT02128295|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-12-02|||June 2015||2015-06-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Trial of Two Electric Breast Pumps in Mothers of Term Infants.|Randomised Trial Comparing the Efficacy and Acceptability of Two Single Electric Breast Pump in Mothers Exclusively Breast Feeding Their Healthy Term Infants.|Unknown status|Recruiting|N/A|228|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 00:29:40.175726|2017-10-11 00:29:40.175726
NCT02128282|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-10-14|||June 2014||2014-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma|A Phase I/II Study of CX-4945 in Combination With Gemcitabine and Cisplatin in the Frontline Treatment of Patients With Cholangiocarcinoma|Recruiting||Phase 1/Phase 2|100|Anticipated|Senhwa Biosciences, Inc.||2|||f||||t||||||||No||2017-10-11 00:29:40.285021|2017-10-11 00:29:40.285021
NCT02128269|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-06-14|2017-06-14||April 2014||2014-04-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome|An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome|Terminated||Phase 2|9|Actual|Alexion Pharmaceuticals||1||Screening discontinued early due to slow patient enrollment|f||||t||||||||||2017-10-11 00:29:40.433649|2017-10-11 00:29:40.433649
NCT02128256|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-12-01|||May 2014||2014-05-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||"CERAMENT™|G - Bone Healing and Re-infection Prophylaxis"|"CERAMENT™|G - Bone Healing and Re-infection Prophylaxis"|Recruiting||Phase 4|15|Anticipated|University of Lausanne Hospitals||1|||f||||t||||||||||2017-10-11 00:29:40.756799|2017-10-11 00:29:40.756799
NCT02128243|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-08-08|||September 2014||2014-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|MATEO||Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer|Randomized Controlled Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer|Recruiting||Phase 2|400|Anticipated|AIO-Studien-gGmbH||2|||f||||f||||||||||2017-10-11 00:29:40.873287|2017-10-11 00:29:40.873287
NCT02128217|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-06-14|||April 2014||2014-04-01|June 2017|2017-06-01|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Interventional|SWIFT-C||Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection|Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)|Completed||Phase 1|44|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 00:29:41.16597|2017-10-11 00:29:41.16597
NCT02128204|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-01-20|||April 2014||2014-04-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|July 2014|Actual|2014-07-01||Interventional|||The Safety and Efficacy of Using HYADERMIS LA for Wrinkle Correction|The Safety and Efficacy of Using HYADERMIS LA for Wrinkle Correction|Completed||N/A|35|Actual|SciVision Biotech Inc.||2|||f||||t||||||||||2017-10-11 00:29:41.295711|2017-10-11 00:29:41.295711
NCT02128191|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-10-12|||July 2014||2014-07-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|||No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants|Efficacy and Safety of No Treatment Compared With Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants: a Randomized, Double-blind, Placebo-controlled, Non-inferiority Clinical Trial|Recruiting||Phase 2|142|Anticipated|Samsung Medical Center||2|||f||||t||||||||No||2017-10-11 00:29:41.367013|2017-10-11 00:29:41.367013
NCT02128178|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-04-07|||November 2013||2013-11-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study|Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study|Unknown status|Recruiting|Phase 1/Phase 2|700|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 00:29:41.604986|2017-10-11 00:29:41.604986
NCT02128165|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2015-04-07|||August 2013||2013-08-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Gastric Balloon in Morbid Obesity: Prospective Study|Effect of Gastric Balloon in Morbid Obesity: Prospective Study|Unknown status|Recruiting|Phase 1/Phase 2|300|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 00:29:41.724036|2017-10-11 00:29:41.724036
NCT02128152|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-07-05|||February 2014||2014-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mobility Training Using Exoskeletons for Functional Recovery After Stroke|Effect of Mobility Training Using Robotic Exoskeletons on Functional Recovery in Individuals With Severe Stroke|Active, not recruiting||N/A|60|Anticipated|Shirley Ryan AbilityLab||1|||f||||t||||||||||2017-10-11 00:29:41.822893|2017-10-11 00:29:41.822893
NCT02128139|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-04-30|||June 2014||2014-06-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|EndoDev||Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study|Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study|Unknown status|Not yet recruiting|N/A|500|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||t||||||||||2017-10-11 00:29:41.939545|2017-10-11 00:29:41.939545
NCT02128126|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-04-04|||September 2013||2013-09-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|CervISA||Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer|A Multicenter, Open Label Phase I/II Study to Determine the Safety and Immune Modulating Effects of the Therapeutic Human Papilloma Virus 16 (HPV16) E6/E7 Long Peptides Vaccine (ISA101/ISA101b) Immunotherapy in Combination With Standard of Care Therapy (Carboplatin and Paclitaxel With or Without Bevacizumab) in Women With HPV16 Positive Advanced or Recurrent Cervical Cancer Who Have no Curative Treatment Options|Recruiting||Phase 1/Phase 2|100|Anticipated|ISA Pharmaceuticals||1|||f||||t||||||||||2017-10-11 00:29:42.042745|2017-10-11 00:29:42.042745
NCT02128113|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-01-27||2015-06-23|May 2014||2014-05-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD|A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group, Phase 2 Study of the Efficacy and Safety of RTA 408 For the Prevention of Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery|Completed||Phase 2|304|Actual|Reata Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 00:29:42.196728|2017-10-11 00:29:42.196728
NCT02128100|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-11-21|||May 2014||2014-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|BCC-RAD-13||Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer|The Effect of FOLFIRINOX and Stereotactic Body Radiation Therapy for Locally Advanced, Non-Resectable Pancreatic Cancer|Recruiting||Phase 2|28|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-10-11 00:29:42.325455|2017-10-11 00:29:42.325455
NCT02128087|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-04-12|||February 2013||2013-02-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|January 31, 2016|Actual|2016-01-31||Interventional|RATA||Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders|Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders|Completed||N/A|330|Anticipated|RAND||3|||f||||t||||||||||2017-10-11 00:29:42.45756|2017-10-11 00:29:42.45756
NCT02128074|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-04-27||2017-04-27|April 2014||2014-04-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia|A Phase 2 Pilot Study of KRX-0502 (Ferric Citrate Coordination Complex) in Treating Iron-deficiency Anemia in Patients With Stage 3-5 Non-dialysis Dependent Chronic Kidney Disease (NDD-CKD)|Completed||Phase 2|32|Actual|Keryx Biopharmaceuticals||1|||f||||f||||||||||2017-10-11 00:29:42.555289|2017-10-11 00:29:42.555289
NCT02128061|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-04-11|||August 2014||2014-08-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+|Sub-cutaneous Rituximab-miniCHOP Versus Sub-cutaneous Rituximab-miniCHOP + Lenalidomide (R2-miniCHOP) in Diffuse Large B Cell Lymphoma for Patients of 80 Years Old or More. A Multicentric Phase III Study of the LYSA Association|Recruiting||Phase 3|250|Anticipated|The Lymphoma Academic Research Organisation||2|||f||||t||||||||No||2017-10-11 00:29:42.675557|2017-10-11 00:29:42.675557
NCT02128048|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-04-29|||June 2012||2012-06-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||The Effect of Cigarette Smoking / Smoking Cessation on Skeletal Muscle Mass, Strength and Functional Capabilities|The Effect of Cigarette Smoking / Smoking Cessation on Skeletal Muscle Mass, Strength and Functional Capabilities|Completed||N/A|81|Actual|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 00:29:43.241685|2017-10-11 00:29:43.241685
NCT02128035|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-04-27|||December 2013||2013-12-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||RADIATION PROTECTion With a Pelvic Lead Shield and a Radiation Protection Cap for Operators Performing Coronary Angiography or Intervention|Radiation Protection With a Pelvic Lead Shield and a Radiation Protection Cap for Operators Performing Coronary Angiography or Intervention, a Randomized Controlled Trial|Completed||N/A|230|Actual|Population Health Research Institute||2|||f||||f||||||||||2017-10-11 00:29:43.334272|2017-10-11 00:29:43.334272
NCT02128022|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-04-08|||July 2014||2014-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Cardioprotective Effects of GLP-1 and Their Mechanisms|Investigation Into Cardioprotective Effect of Glucagon-like Peptide-1 and it's Mechanism of Action During Myocardial Ischaemia|Completed||Phase 1|32|Actual|Papworth Hospital NHS Foundation Trust||4|||f||||f||||||||||2017-10-11 00:29:43.459315|2017-10-11 00:29:43.459315
NCT02128009|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-04-30|||February 2014||2014-02-01|March 2014|2014-03-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01|6 Months|Observational [Patient Registry]|microRNA||Study on the microRNA Expression Level in Postmenopausal Osteoporosis|Study on the Molecular Mechanism in Postmenopausal Osteoporosis With Kidney Yin Deficiency Syndrome Based on miRNA Mediated Gene Translation Regulation Function by Targeting CLCF1|Unknown status|Recruiting|Phase 1|60|Anticipated|Fujian Academy of Traditional Chinese Medicine|||1||f||||t||||||||||2017-10-11 00:29:43.563912|2017-10-11 00:29:43.563912
NCT02127996|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-09-29|||March 2015||2015-03-01|September 2016|2016-09-01|July 2021|Anticipated|2021-07-01|July 2017|Anticipated|2017-07-01||Interventional|GOLD-PCI||GLP-1 Loading During Elective Percutaneous Coronary Intervention|A Study to Investigate the Protective Effects of Glucagon-like Peptide-1 (GLP-1) in Patients Undergoing Elective Angioplasty and Stenting (GOLD-PCI)|Recruiting||Phase 2|400|Anticipated|Papworth Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:29:44.769757|2017-10-11 00:29:44.769757
NCT02127983|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-04-30|||January 2009||2009-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|Triage||Engaging Informal Health Care Providers on Case Detection and Treatment Initiation Rates for TB and HIV in Rural Malawi (Triage Plus)|Engaging Informal Health Care Providers on Case Detection and Treatment Initiation Rates for TB and HIV in Rural Malawi (Triage Plus): a Cluster Randomised Health System Intervention Trial|Completed||N/A|200000|Actual|Liverpool School of Tropical Medicine||2|||f||||t||||||||||2017-10-11 00:29:44.915205|2017-10-11 00:29:44.915205
NCT02127970|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-05-11||2016-05-11|April 2014||2014-04-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections|A Phase 3b, Double-Blind, Multicenter, Randomized Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections|Completed||Phase 3|698|Actual|Durata Therapeutics Inc., an affiliate of Allergan plc||2|||f||||t||||||||||2017-10-11 00:29:45.055367|2017-10-11 00:29:45.055367
NCT02127957|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2015-07-29|||July 2013||2013-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|FKEX||Effects of an Exercise Program Among CF Patients With Dysglycemia|Effects of a Program of Aerobic and Resistance Exercises Combined in Patients With Cystic Fibrosis (CF) With Impaired Glucose Tolerance or Diabetes Related to CF Without Medication|Completed||N/A|18|Actual|Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||||2017-10-11 00:29:45.352768|2017-10-11 00:29:45.352768
NCT02127944|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-28|||April 2014||2014-04-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Observational|||Assessment of Ovarian Reserve Tests in Unexplained Infertile Women|Assessment of Ovarian Reserve Tests in Unexplained Infertile Women|Unknown status|Recruiting|N/A|80|Anticipated|Karadeniz Technical University|||2||f||||f||||||Samples Without DNA|"     SERUM SAMPLES OF PATIENTS WILL BE STORED .THE SERUM SAMPLES DO NOT CONTAIN DNA.   "|||2017-10-11 00:29:45.457161|2017-10-11 00:29:45.457161
NCT02127931|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-07-29|||March 2014||2014-03-01|July 2016|2016-07-01||||February 2017|Anticipated|2017-02-01||Interventional|||Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in Adults|Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in Adults|Active, not recruiting||N/A|100|Anticipated|CogCubed, Corp||1|||f||||f||||||||||2017-10-11 00:29:45.55352|2017-10-11 00:29:45.55352
NCT02127918|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-07-28|||July 2012||2012-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01|3 Months|Observational [Patient Registry]|ESES-Clobazam||Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment|Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment|Completed||N/A|17|Actual|Boston Children’s Hospital|||1||f||||t||||||||||2017-10-11 00:29:45.64328|2017-10-11 00:29:45.64328
NCT02127905|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-07-06|||March 2011|Anticipated|2011-03-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Unrelated HSCT in Patients With Fanconi Anemia|A Study of Total Body Irradiation, Cyclophosphamide and Fludarabine Followed by Alternated Donor Hematopoietic Cell Transplantation in Patients With Fanconi Anemia|Withdrawn||N/A|0|Actual|Children's Hospital Los Angeles||1||Study was stopped due to non-enrollment of subjects due to rarity of disease.|f||||t||||||||||2017-10-11 00:29:45.76492|2017-10-11 00:29:45.76492
NCT02127892|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-08-18|2017-07-17||January 2, 2007|Actual|2007-01-02|August 2017|2017-08-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Interventional|||SCID Bu/Flu/ATG Study With T Cell Depletion|Phase I/II Trial of Hematopoietic Stem Cell Transplant (HSCT) for Children With Severe Combined Immune Deficiency (SCID) and Without an HLA-Matched Sibling Donor|Terminated||Phase 1/Phase 2|9|Actual|Children's Hospital Los Angeles||4||Closed due to slow accrual. Nine subjects enrolled over 7 years.|f||||t|f|t|t|||||||2017-10-11 00:29:45.898939|2017-10-11 00:29:45.898939
NCT02127879|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2014-05-02|||May 2014||2014-05-01|May 2014|2014-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Intensive Transcranial Magnetic Stimulation for Negative Symptoms in Schizophrenia|High-frequency Repetitive Transcranial Magnetic Stimulation for Negative Symptoms in Schizophrenia: The Double-blind Sham-controlled Study|Unknown status|Recruiting|N/A|40|Anticipated|Brno University Hospital||2|||f||||t||||||||||2017-10-11 00:29:46.734223|2017-10-11 00:29:46.734223
NCT02127866|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-03-28|||April 2014||2014-04-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Triskel||Triple in Asthma Dose Finding|A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED, 3-WAY CROSS-OVER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A FREE COMBINATION OF 3 DOSES OF CHF 5259 (GLYCOPYRROLATE) PLUS FOSTER® 100/6 µg (FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE PLUS FORMOTEROL) IN A METERED DOSE INHALER FOR THE TREATMENT OF PATIENTS WITH UNCONTROLLED ASTHMA UNDER MEDIUM DOSES OF INHALED CORTICOSTEROIDS PLUS LONG-ACTING β2-AGONISTS|Completed||Phase 2|211|Actual|Chiesi Farmaceutici S.p.A.||4|||f||||f||||||||||2017-10-11 00:29:46.929745|2017-10-11 00:29:46.929745
NCT02127853|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-05-10|||July 2014||2014-07-01|April 2014|2014-04-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Effect of Gabapentin on Pain of the Second Cataract Surgery|The Effect of Pretreated Gabapentin on Hyeralgesia Occurring in the Second Operation in Staged Bilateral Cataract Surgery|Unknown status|Recruiting|Phase 4|70|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:29:47.19645|2017-10-11 00:29:47.19645
NCT02127840|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-28|||March 2011||2011-03-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|ISIRA||Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism|Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism|Unknown status|Recruiting|Phase 4|40|Anticipated|Charles University, Czech Republic||2|||f||||f||||||||||2017-10-11 00:29:47.383181|2017-10-11 00:29:47.383181
NCT02127827|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-04-29|||May 2014||2014-05-01|April 2014|2014-04-01||||May 2016|Anticipated|2016-05-01||Interventional|||Multiday Fully Closed Loop Insulin Delivery in Monitored Outpatient Conditions||Unknown status|Not yet recruiting|N/A|30|Anticipated|Sheba Medical Center||1|||f||||||||||||||2017-10-11 00:29:47.536788|2017-10-11 00:29:47.536788
NCT02127814|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-23|2014-04-28|||May 2010||2010-05-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|||Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile|Efficacy and Safety of the Probiotic Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile Related Infections in Hospitalized Adult Patients|Unknown status|Recruiting|N/A|100|Anticipated|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 00:29:47.656476|2017-10-11 00:29:47.656476
NCT02127801|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-04-13|||October 2014||2014-10-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants||Completed||Phase 1/Phase 2|74|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:29:47.764571|2017-10-11 00:29:47.764571
NCT02127788|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-06-17|||July 2014||2014-07-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|OLYMPE||Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology|National, Longitudinal, Multicentre and Prospective, Observational Study of the Use of Micafungin (Mycamine®) in Antifungal Prophylaxis of Invasive Fungal Infections in Medical Practice in Haematology and Onco-haematology|Completed||N/A|150|Actual|Astellas Pharma Inc|||1||f||||f||||||||Undecided||2017-10-11 00:29:47.870694|2017-10-11 00:29:47.870694
NCT02127775|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-09-19|||April 2014||2014-04-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Lesinurad Tablet Bioequivalence|A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Bioequivalence of Lesinurad Tablets From Two Manufacturing Sites in Healthy Adult Male Subjects|Completed||Phase 1|54|Actual|Ardea Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 00:29:48.023301|2017-10-11 00:29:48.023301
NCT02127762|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-09-13|||September 2012||2012-09-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|AWARE||The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy|The Effect of an Inter-Disciplinary Program, Including Mindfulness Based Stress Reduction, on Psychosocial Function, Pain and Metabolism in Patients With Painful Diabetic Peripheral Neuropathy|Completed||N/A|81|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||Undecided||2017-10-11 00:29:48.110461|2017-10-11 00:29:48.110461
NCT02127749|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-12-29|||June 2014||2014-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MISSION-2||The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia|The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia|Completed||N/A|16|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 00:29:48.229744|2017-10-11 00:29:48.229744
NCT02127736|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-09-01||||||September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin|Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin|Completed||N/A|||Philipps University Marburg Medical Center||2|||f||||||||||||||2017-10-11 00:29:48.325481|2017-10-11 00:29:48.325481
NCT02127723|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-01-12|||April 2014||2014-04-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||(Macrolane VR30) in Buttocks Reshaping and contouringCellulite (Macrolane VR30) in Buttocks Reshaping and Contouring|An Open, Non-comparative Single Center Study to Evaluate Efficacy and Safety of HA (Macrolane VR30) in Buttocks Reshaping and Contouring|Completed||Phase 4|21|Actual|Q-Med AB||1|||f||||f||||||||||2017-10-11 00:29:48.413162|2017-10-11 00:29:48.413162
NCT02127697|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-04-10|||March 2015||2015-03-01|April 2015|2015-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma|A Randomized, Double-blind, Parallel Group, 52-week Study Evaluating the Efficacy, Safety and Tolerability of NVA237 in Patients With Poorly Controlled Asthma|Withdrawn||Phase 3|0|Actual|Novartis||2|||f||||f||||||||||2017-10-11 00:29:48.673066|2017-10-11 00:29:48.673066
NCT02127684|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-07-29||||||July 2014|2014-07-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing|Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard AntiVEGF Dosing|Withdrawn||Phase 2|0|Actual|Maturi, Raj K., M.D., P.C.||2||sponsor determined study design would not produce useful results|f||||f||||||||||2017-10-11 00:29:48.795419|2017-10-11 00:29:48.795419
NCT02127671|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-04-30|||December 2013||2013-12-01|April 2014|2014-04-01||||January 2018|Anticipated|2018-01-01||Interventional|IDEAL||Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness|Comprehensive CVD Risk Reduction Trial in Persons With Serious Mental Illness|Recruiting||N/A|250|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:29:48.890167|2017-10-11 00:29:48.890167
NCT02127645|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2016-01-20|||June 2011||2011-06-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|May 2014|Actual|2014-05-01||Interventional|NERATEM||Neoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal Cancer|PILOT OBSERVATIONAL STUDY OF NEOADJUVANT 5 x 5 RADIOTHERAPY FOLLOWED BY TRANSANAL ENDOSCOPIC MICROSURGERY FOR T1-T2 EXTRAPERITONEAL RECTAL CANCER WITH CURATIVE INTENT|Active, not recruiting||Phase 3|25|Anticipated|European Association for Endoscopic Surgery||1|||f||||t||||||||||2017-10-11 00:29:49.080207|2017-10-11 00:29:49.080207
NCT02127619|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-28|||January 2001||2001-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2008|Actual|2008-01-01||Interventional|||Total Knee Replacement With the ROCC Knee|Prospective Study of Total Knee Replacement With the ROCC Knee|Completed||N/A|500|Actual|Bercovy, Michel, M.D.||1|||f||||t||||||||||2017-10-11 00:29:49.252852|2017-10-11 00:29:49.252852
NCT02127606|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-11-25|||April 2014||2014-04-01|November 2014|2014-11-01||||July 2015|Anticipated|2015-07-01||Interventional|||The Effect of Whole Body Vibration on Spasticity in Persons With Spinal Cord Injury|The Effect of Whole Body Vibration on Spasticity in Spinal Cord Injury Patients|Unknown status|Recruiting|N/A|40|Anticipated|Kessler Foundation||1|||f||||f||||||||||2017-10-11 00:29:49.3618|2017-10-11 00:29:49.3618
NCT02127593|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-10-02|||June 2013||2013-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess the Bioequivalence of NGM/EE Tablets Manufactured at 2 Different Facilities|Completed||Phase 1|101|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:29:49.45031|2017-10-11 00:29:49.45031
NCT02127580|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-02-20|||April 2014|Actual|2014-04-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01|6 Months|Observational [Patient Registry]|EASE-IT||Balloon Expandable Transcatheter Aortic Valve Implantation Without Predilation of the Aortic Valve|Balloon Expandable Transcatheter Aortic Valve Implantation Without Predilation of the Aortic Valve (EASE-IT) A Two-armed Registry|Completed||N/A|200|Actual|Institut für Pharmakologie und Präventive Medizin|||2||f||||f||||||||||2017-10-11 00:29:49.542024|2017-10-11 00:29:49.542024
NCT02127567|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-03-07|2014-11-27||April 2014||2014-04-01|April 2014|2014-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|COBWEB|Forty-one masters and doctoral students participated. Participants median age was 29 with an interquartile range of 26 to 33. Just slightly over the majority were female, 24 (58.5%). And just slightly over the majorirty were already familiar with reporting guidelines, 24 (58.5%).|The Evaluation of a CONSORT Based Online Writing Tool|The Evaluation of a CONSORT Based Online Writing Tool: a Randomized Controlled Trial|Completed||N/A|41|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:29:49.717338|2017-10-11 00:29:49.717338
NCT02127554|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-12-01|||January 2014||2014-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Long Term Results and Complications After Epistaxis Treatment|Langzeitresultate Und Komplikationen Nach Einer Epistaxisbehandlung|Completed||N/A|591|Actual|University of Zurich|||7||f||||f||||||||||2017-10-11 00:29:50.095863|2017-10-11 00:29:50.095863
NCT02127541|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-11-02|||January 2014||2014-01-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||New Imaging Procedure for the Localisation of Insulinoma and Transplanted Islet Cells|New Imaging Procedure for the Localisation of Insulinoma and Transplanted Islet Cells|Recruiting||Phase 2/Phase 3|42|Anticipated|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 00:29:50.177553|2017-10-11 00:29:50.177553
NCT02127528|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-04-15|||May 2014||2014-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|TARGET-REA||Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive Care|Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive Care: Pharmacodynamic Evaluation and Impact.|Recruiting||N/A|500|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 00:29:50.279124|2017-10-11 00:29:50.279124
NCT02127515|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-11-11|||April 2014||2014-04-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|SAFE 21||Non Invasive Prenatal Testing of Down Syndrome|Non Invasive Prenatal Testing of Down Syndrome From Maternal Blood Sample|Recruiting||N/A|2450|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:29:50.362232|2017-10-11 00:29:50.362232
NCT02127502|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-02-28|||April 2014||2014-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Observational|VENUS||VENUS: Septic Gene Expression Using SeptiCyte|VENUS: Validation of Septic Gene ExpressioN Using SeptiCyte®|Active, not recruiting||N/A|370|Anticipated|Immunexpress|||1||f||||t||||||Samples With DNA|"     Blood samples will be collected   "|No||2017-10-11 00:29:50.459464|2017-10-11 00:29:50.459464
NCT02127489|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-04-28|||June 2005||2005-06-01|April 2014|2014-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||The Effects of Single-dose Rectal Midazolam Application on Post-operative Recovery|The Effects of Single-dose Rectal Midazolam Application on Post-operative Recovery, Sedation, and Analgesia in Children Given Caudal Anesthesia Plus Bupivacaine|Completed||Phase 4|40|Actual|Karadeniz Technical University||2|||f||||f||||||||||2017-10-11 00:29:52.24993|2017-10-11 00:29:52.24993
NCT02127476|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-05-31|||July 2014||2014-07-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease|A Phase 1 Double-blind, Placebo-controlled, Single- and Multiple-ascending-dose Study of KHK6640 in Alzheimer's Disease|Completed||Phase 1|57|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||2|||f||||t||||||||||2017-10-11 00:29:52.371219|2017-10-11 00:29:52.371219
NCT02127463|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-29|||April 2014||2014-04-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|McCP2/3||Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration|Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 1.0% BID in the Treatment of Non-exudative Age-Related Macular Degeneration|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|MacuCLEAR, Inc.||2|||f||||t||||||||||2017-10-11 00:29:52.455418|2017-10-11 00:29:52.455418
NCT02127450|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-11-24|||May 2014||2014-05-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|E-CARB||Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases|Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases|Completed||N/A|525|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||t||||||Samples Without DNA|"     Enterobacteriaceae Isolates non-susceptible to carbapenem (NS -CARB)   "|Undecided||2017-10-11 00:29:52.562453|2017-10-11 00:29:52.562453
NCT02127437|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-08-25|||September 2014||2014-09-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|LIPS||Lanreotide In Polycystic Kidney Disease Study|Lanreotide In Polycystic Kidney Disease Study|Recruiting||Phase 3|180|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:29:52.632959|2017-10-11 00:29:52.632959
NCT02127424|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-05-30|||June 2014||2014-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|DICI-VIH||Targeted Nurse-driven HIV Screening in Emergency Departments|Targeted Nurse-driven HIV Screening Using Rapid Tests in Emergency Departments in the Metropolitan Paris Region|Completed||N/A|148327|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:29:52.721255|2017-10-11 00:29:52.721255
NCT02127411|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-05-08|||October 2013|Actual|2013-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|MBRP||Effectiveness of Mindfulness Based Relapse Prevention for Chronic Users of Benzodiazepines|Adaptation and Evaluation of the Mindfulness-Based Relapse Prevention Program for Cessation and/or Reduction of Benzodiazepine Chronic Use to Induce Sleep Among Women|Completed||N/A|76|Actual|Federal University of São Paulo||2|||f||||f||||||||Undecided||2017-10-11 00:29:52.798105|2017-10-11 00:29:52.798105
NCT02127398|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-05-08|||April 2016||2016-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Stool Transplants to Treat Refractory Clostridium Difficile Colitis|Fecal Microbiota Transplantation in Refractory Clostridium Difficile Colitis|Recruiting||Phase 2|10|Anticipated|Duke University||1|||f||||f||||||||||2017-10-11 00:29:52.886407|2017-10-11 00:29:52.886407
NCT02127385|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-04-29|||April 2014||2014-04-01|March 2014|2014-03-01||||April 2015|Anticipated|2015-04-01||Observational|||The Type of Hepatoglobin in IUGR|The Type of Hepatoglobin in IUGR|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||None Retained|"     Blood test for H-p genotype   "|||2017-10-11 00:29:52.973153|2017-10-11 00:29:52.973153
NCT02127372|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-09-12|2014-09-05||November 2004||2004-11-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional||All subjects who started study treatment|Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571|A Phase I - II Open Label Study of the Maximum Tolerated Dose, Safety and Efficacy of Docetaxel and Cisplatin Plus STI571 in Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|43|Actual|Duke University||1||The study was closed due to poor accrual|f||||f||||||||||2017-10-11 00:29:53.134455|2017-10-11 00:29:53.134455
NCT02127359|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-02-06|||September 2012||2012-09-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01|99 Years|Observational [Patient Registry]|||Whole-Exome Sequencing (WES) of Cancer Patients|CanSeq: Whole-Exome Sequencing (WES) of Cancer Patients|Active, not recruiting||N/A|244|Actual|Dana-Farber Cancer Institute|||1||f||||f||||||Samples With DNA|"     blood   "|||2017-10-11 00:29:53.863804|2017-10-11 00:29:53.863804
NCT02127346|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-10-02|||May 2014||2014-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Observational|||Relationship Between Chronic Periodontitis and Vitamin D and Calcium in Men|Relationship Between Chronic Periodontitis and Vitamin D and Calcium in Men|Completed||N/A|200|Actual|Damascus University|||2||f||||t||||||||||2017-10-11 00:29:53.941775|2017-10-11 00:29:53.941775
NCT02127333|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-12-14|||January 2011||2011-01-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Role of Oxygen for Vascular Dysfunction|Role of Acute and Chronic Hypoxemia for Vascular Function|Completed||N/A|38|Actual|Heinrich-Heine University, Duesseldorf|||3||f||||f||||||||||2017-10-11 00:29:54.036075|2017-10-11 00:29:54.036075
NCT02127320|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-10-11|||June 2014||2014-06-01|July 2014|2014-07-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe|A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe in Healthy Male Subjects|Completed||Phase 1|24|Actual|Hanmi Pharmaceutical Company Limited||6|||f||||f||||||||||2017-10-11 00:29:54.11275|2017-10-11 00:29:54.11275
NCT02127307|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-02-08|2017-02-08||February 2014||2014-02-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Observational|||Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.|An Open-Label, Multicenter, Phase 4 Study to Demonstrate the Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.|Completed||N/A|964|Actual|GE Healthcare|||1||f||||f||||||||||2017-10-11 00:29:54.272873|2017-10-11 00:29:54.272873
NCT02127294|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-01-12|||January 2013||2013-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Interventional|EASTFORM||Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine|Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine|Completed||N/A|258|Actual|First Hospital of Jilin University||2|||f||||f||||||||||2017-10-11 00:29:54.441461|2017-10-11 00:29:54.441461
NCT02127268|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-01-08|||April 2014||2014-04-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Thymosin-α1 in Cancer-Related Fatigue|Thymosin-α1 for Cancer-Related Fatigue in Cancer Patients Who Undergo Chemotherapy: A Randomized Controlled Trial|Recruiting||Phase 3|200|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-10-11 00:29:54.64813|2017-10-11 00:29:54.64813
NCT02127255|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-04-14|||April 2014||2014-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ACTIN||Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail|Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail|Completed||N/A|39|Actual|Beijing University of Chinese Medicine||2|||f||||f||||||||Undecided||2017-10-11 00:29:54.748834|2017-10-11 00:29:54.748834
NCT02127242|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-04-29|||April 2014||2014-04-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|||Laparoscope Combined Ureteroscopic Air-pressure Ballistic Lithotripsy to Treat Patients With Hepatolithiasis|The Study of Laparoscope Combined Ureteroscopic Air-pressure Ballistic Lithotripsy to Treat Patients With Hepatolithiasis|Unknown status|Recruiting|N/A|60|Anticipated|Zhujiang Hospital||2|||f||||t||||||||||2017-10-11 00:29:54.954256|2017-10-11 00:29:54.954256
NCT02127229|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-08-25|||April 2014||2014-04-01|August 2017|2017-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|ERCP||Cost Analysis for Endoscopic Retrograde Cholangiopancreatography (ERCP)|The Impact of Cost Itemization on Resource Utilization With ERCP|Withdrawn||N/A|0|Actual|University of Oklahoma||2||No participants enrolled; study inactivated|f||||f||||||||||2017-10-11 00:29:55.084472|2017-10-11 00:29:55.084472
NCT02127216|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2015-03-16|||June 2014||2014-06-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|MOSES||Motivation Psychology-based Smart Engagement System|Motivation Psychology-based Smart Engagement System for Improved Older Adult Chronic Disease Management|Unknown status|Active, not recruiting|N/A|88|Anticipated|Baltimore Research & Education Foundation, Inc.||5|||f||||t||||||||||2017-10-11 00:29:55.173869|2017-10-11 00:29:55.173869
NCT02127203|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-10-02|||May 2014||2014-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Nitro-oxidative Stress in Periodontitis|Assessment of Nitro - Oxidative Stress in Periodontal Disease|Completed||N/A|80|Actual|Damascus University|||4||f||||t||||||||||2017-10-11 00:29:55.265119|2017-10-11 00:29:55.265119
NCT02127190|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-05-02|||April 2014||2014-04-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Study of CXA-10 in Healthy Volunteers|A Randomized, Double-Blind, Third Party Open (Sponsor), Dose-Rising, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of CXA-10 in Healthy Volunteers|Completed||Phase 1|30|Actual|Complexa, Inc.||2|||f||||f||||||||||2017-10-11 00:29:55.386907|2017-10-11 00:29:55.386907
NCT02127177|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-28|||January 2010||2010-01-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Long-term Effects of CPAP on Lipidemia and Hs-CRP Levels in OSA Patients|Long-term Effects of Continuous Positive Airway Pressure on Lipidemia and High-sensitivity C-reactive Protein Levels in Nonobese Patients With Coronary Heart Disease and Obstructive Sleep Apnea|Completed||N/A|78|Actual|Chinese Pulmonary Vascular Disease Research Group||2|||f||||t||||||||||2017-10-11 00:29:55.474734|2017-10-11 00:29:55.474734
NCT02127164|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-12-07|||May 2014||2014-05-01|December 2015|2015-12-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Interventional|||Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries|Prospective Evaluation of Wound Management Using Vacuum Assisted Instillation Therapy in Emergent Contaminated Abdominal Surgeries|Recruiting||N/A|20|Anticipated|University of Arizona||1|||f||||f||||||||||2017-10-11 00:29:55.563294|2017-10-11 00:29:55.563294
NCT02127151|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-12-14||||||December 2015|2015-12-01||||October 2018|Anticipated|2018-10-01||Interventional|PANDA||A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer|A Single Arm Phase II Trial of BMN 673 for Inoperable, Advanced Endometrial Cancer With Retrospective PTEN, MSI and MRE11 Analysis|Withdrawn||Phase 2|0|Actual|University College, London||1||Withdrawal of Industry support for the study|f||||f||||||||||2017-10-11 00:29:55.673691|2017-10-11 00:29:55.673691
NCT02127138|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2016-05-09|||May 2015||2015-05-01|February 2016|2016-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Study of Active Transfer of Plaque Technique for Unprotected Distal Left Main Bifurcation Lesions|A Prospective Multicenter Randomized Trial Assessing the Efficacy and Safety of Active Transfer of Plaque vs. Provisional T Stenting for the Treatment of Unprotected Distal Left Main Bifurcation Lesions|Recruiting||N/A|316|Anticipated|Beijing Anzhen Hospital||2|||f||||f||||||||Undecided||2017-10-11 00:29:55.791843|2017-10-11 00:29:55.791843
NCT02127125|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-04-13|||April 2014||2014-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MicroB2||Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)|Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)|Recruiting||Phase 2|108|Anticipated|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-10-11 00:29:55.908897|2017-10-11 00:29:55.908897
NCT02127112|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-12-06|||May 2014||2014-05-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Ridge Augmentation Comparing a Block Allograft to a Demineralized Bone Matrix Allograft.|Ridge Augmentation Comparing the Clinical and Histologic Healing of a Cancellous Block Allograft Plus Optecure Containing Cortico-Cancellous Chips Versus Optecure Containing Cortico-Cancellous Chips Alone.|Completed||Phase 4|20|Actual|University of Louisville||2|||f||||t||||||||||2017-10-11 00:29:56.094379|2017-10-11 00:29:56.094379
NCT02127099|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-05-06|||May 2014||2014-05-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||The Incidence of Undiagnosed OSA Compared in Multi-ethic Races of Malaysia & the Associated Postoperative Complications|The Incidence of Undiagnosed OSA in Multi-ethic Races of Malaysia and the Associated Postoperative Complications|Unknown status|Not yet recruiting|N/A|1000|Anticipated|University of Malaya|||2||f||||t||||||||||2017-10-11 00:29:56.233573|2017-10-11 00:29:56.233573
NCT02127086|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-08-18|||March 2015||2015-03-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|June 30, 2017|Actual|2017-06-30||Interventional|||Managing Acute Pain in Critically Ill Non-communicative Palliative Care Patients|Managing Acute Pain in Critically Ill Non-communicative Palliative Care Patients|Active, not recruiting||N/A|660|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-11 00:29:56.331594|2017-10-11 00:29:56.331594
NCT02127073|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-02-12|||March 2014||2014-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer|Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer|Recruiting||Early Phase 1|40|Anticipated|Montefiore Medical Center||1|||f||||t||||||||Undecided||2017-10-11 00:29:56.507995|2017-10-11 00:29:56.507995
NCT02127047|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-07-25|||November 2013||2013-11-01|July 2017|2017-07-01|August 5, 2016|Actual|2016-08-05|July 2016|Actual|2016-07-01||Interventional|EXTYPE-1||Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes|Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes|Completed||Phase 2|24|Actual|University Hospital, Basel, Switzerland||2|||f||||||||||||||2017-10-11 00:29:56.72515|2017-10-11 00:29:56.72515
NCT02127034|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-07-09|||March 2014||2014-03-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects|A Phase 1 Study to Evaluate the Effect of Steady State Solifenacin and Mirabegron on the Steady State Pharmacokinetics of Digoxin in Healthy Subjects|Completed||Phase 1|26|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:29:56.828696|2017-10-11 00:29:56.828696
NCT02127021|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-06-06|||April 2014||2014-04-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effects of High Dose Pancreatic Enzyme Replacement Therapy After Pancreatoduodenectomy|Prospective Study for the Effects of High Dose Pancreatic Enzyme Replacement Therapy on Body Weight, Quality of Life, and Nutritional Assessment After Pancreatoduodenectomy|Recruiting||Phase 4|490|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:29:56.956098|2017-10-11 00:29:56.956098
NCT02127008|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-11-17|||February 2013||2013-02-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||The Impact of Epidural Fat Resection on Postoperative Outcomes in Posterior Surgery of Lumbar Spine||Completed||N/A|185|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:29:57.083911|2017-10-11 00:29:57.083911
NCT02126995|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2016-07-03|||June 2014||2014-06-01|December 2014|2014-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome|A 6-week, Randomized, Multicenter, Double-blind, Parallel, Flexed and Fixed-dose Study of MG01CI (Metadoxine Extended-release) Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome|Completed||Phase 2|62|Actual|Alcobra Ltd.||2|||f||||t||||||||||2017-10-11 00:29:57.161277|2017-10-11 00:29:57.161277
NCT02126982|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-12-15|||October 2012||2012-10-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Observational|SCIENCE||Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence|Comparative Study of Clinical Efficacy and Safety of Different Clopidogrel Salts in Patients With Cardiovascular Disease. A Multi-center Non-interventional Clinical Trial.|Completed||N/A|1500|Actual|University of Ioannina|||2||f||||f||||||||||2017-10-11 00:29:57.267322|2017-10-11 00:29:57.267322
NCT02126969|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-07-11|||October 2014||2014-10-01|July 2017|2017-07-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2023|Anticipated|2023-12-31||Interventional|||A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN|A Phase II Study of Docetaxel, Carboplatin With and Without Low Dose Radiation as Induction Therapy in Locally Advanced Head and Neck Cancer|Recruiting||Phase 2|72|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 00:29:57.359938|2017-10-11 00:29:57.359938
NCT02126956|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2014-04-29|||March 2009||2009-03-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Mass Balance, Pharmacokinetics, and Metabolism of 14C-labeled ACT-128800 Administered to Healthy Male Subjects|Single-center, Open-label Study With 14C-labeled ACT-128800 to Investigate the Mass Balance, Pharmacokinetics, and Metabolism Following Single Oral Administration to Healthy Male Subjects|Completed||Phase 1|6|Actual|Actelion||1|||f||||f||||||||||2017-10-11 00:29:57.513105|2017-10-11 00:29:57.513105
NCT02126943|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-29|2017-09-08|||April 1, 2014||2014-04-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|OPUS||OPsumit USers Registry|US-based, Observational, Drug Registry of Opsumit® (Macitentan) New Users in Clinical Practice|Recruiting||N/A|5000|Anticipated|Actelion|||1||f||||f||||||||||2017-10-11 00:29:57.729138|2017-10-11 00:29:57.729138
NCT02126930|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-04-06|||November 2014||2014-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CPS-INFECTIO||Pharmaceutical Consultation at Hospital Discharge and Adherence to Anti-infective Treatment|Impact of a Pharmaceutical Consultation at Hospital Discharge on Adherence to Anti-infective Treatment After Returning Home|Completed||N/A|174|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 00:29:58.26415|2017-10-11 00:29:58.26415
NCT02126917|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-28|||November 2009||2009-11-01|April 2014|2014-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER)|Single-center, Open-Label, 3-Period Crossover, Phase 1 Study to Evaluate the Pharmacokinetics of Hydrocodone Bitartrate Extended-Release (HC-ER) Capsules 50 mg When Co-Administered With Alcohol in Healthy Subjects Under Fasted Conditions|Completed||Phase 1|30|Actual|Zogenix, Inc.||3|||f||||f||||||||||2017-10-11 00:29:58.40289|2017-10-11 00:29:58.40289
NCT02126904|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2014-04-28|||January 2012||2012-01-01|April 2014|2014-04-01||||October 2013|Actual|2013-10-01||Observational|||Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept|Comparison of the Time to Recurrence After Ranibizumab or Aflibercept Loading for Age-related Macular Degeneration|Unknown status|Recruiting|N/A|200|Anticipated|Yokohama City University Medical Center|||1||f||||t||||||||||2017-10-11 00:29:58.494497|2017-10-11 00:29:58.494497
NCT02126891|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-01-23|||January 2014||2014-01-01|April 2014|2014-04-01||||January 2016|Anticipated|2016-01-01||Interventional|FACEFI||FACEFI : Cardiac Fatigue During Intense Exercises - Pilot Study|FACEFI : Cardiac Fatigue During Intense Exercises - Pilot Study|Unknown status|Recruiting|N/A|23|Anticipated|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 00:29:58.575651|2017-10-11 00:29:58.575651
NCT02126878|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2015-06-01|||April 2014||2014-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa Injection|Prospective, Randomized, Double-blinded Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa Injection|Completed||N/A|120|Actual|West Virginia University||3|||f||||f||||||||||2017-10-11 00:29:58.676347|2017-10-11 00:29:58.676347
NCT02126865|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-08-12|||May 2014||2014-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 1060469 Tablets in Healthy Subjects and Otherwise Healthy Patients With Asthma up to GINA Treatment Step 2 (Phase I, Randomised, Placebo-controlled, Double-blind Within Dose Groups)|Completed||Phase 1|131|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:29:58.755753|2017-10-11 00:29:58.755753
NCT02126852|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-04-27|||April 2014||2014-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CAMEM||Comparison of AMG and EMG to Avoid Residual Paralysis After General Anesthesia|Comparison of AMG (Acceleromyography) and EMG (Electromyography) to Avoid Postoperative Residual Paralysis After General Anesthesia|Completed||N/A|214|Actual|Technische Universität München||2|||f||||f||||||||Undecided||2017-10-11 00:29:58.84316|2017-10-11 00:29:58.84316
NCT02126839|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-01-06|2016-01-06|2015-07-13|May 2014||2014-05-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Randomized participants|A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics|A Three-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler (MDPI) Relative to Placebo in Pediatric Asthmatics|Completed||Phase 3|186|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 00:29:58.978573|2017-10-11 00:29:58.978573
NCT02126826|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-11-05|||May 2014||2014-05-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee (Randomised, Double-blind, Placebo-controlled Within the Dose Groups, Clinical Phase I)|Completed||Phase 1|58|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:29:59.623255|2017-10-11 00:29:59.623255
NCT02126813|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-10-27|||May 2014||2014-05-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|POUR-RCT||When to Perform Bladder Catheterization in Fast-track Hip and Knee Arthroplasty|Urinary Bladder Catheterization in Fast-track Hip and Knee Arthroplasty - What is the Optimal Bladder Volume? A Randomized, Controlled Study|Completed||N/A|800|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:29:59.716308|2017-10-11 00:29:59.716308
NCT02126800|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-28|||March 2014||2014-03-01|April 2014|2014-04-01|March 2019|Anticipated|2019-03-01|September 2017|Anticipated|2017-09-01||Observational|LEGACY||Rapid Medical Donation Programme for Breast Cancer|Rapid Medical Donation Programme for Breast Cancer to Examine Tumour Heterogeneity|Recruiting||N/A|60|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||t||||||Samples With DNA|"     Metastatic breast cancer   "|||2017-10-11 00:29:59.810539|2017-10-11 00:29:59.810539
NCT02126787|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-28|||September 2014||2014-09-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment|Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment of Anxiety Disorders and Comorbid Depressive or Personality Disorders|Unknown status|Not yet recruiting|N/A|123|Anticipated|Medical University of Warsaw||3|||f||||f||||||||||2017-10-11 00:29:59.885041|2017-10-11 00:29:59.885041
NCT02126761|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-07-28|||June 2014||2014-06-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above|A Phase 1, Randomized, Observer Blind, Antigen and Adjuvant Dosage-Finding Study to Evaluate the Safety and Immunogenicity of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects ≥65 Years of Age|Completed||Phase 1|196|Actual|Seqirus||7|||f||||t||||||||||2017-10-11 00:30:00.150176|2017-10-11 00:30:00.150176
NCT02126748|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-03-10|2015-02-23||December 2012||2012-12-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effectiveness of AAD and IPV to Treat Hospitalized Infants (<2years) With Acute Viral Bronchiolitis.|The Effectiveness of Assisted Autogenic Drainage (AAD) and Intrapulmonary Percussive Ventilation (IPV) to Treat Hospitalized Infants (<2years) With Acute Viral Bronchiolitis: a Randomised Clinical Trial.|Completed||N/A|103|Actual|Vrije Universiteit Brussel||3|||f||||f||||||||||2017-10-11 00:30:00.345448|2017-10-11 00:30:00.345448
NCT02126735|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-12-29|||August 2013||2013-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans|Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans|Completed||N/A|21|Actual|Vanderbilt University Medical Center|||1||f||||f||||||Samples With DNA|"     serum, white cells   "|No||2017-10-11 00:30:00.705835|2017-10-11 00:30:00.705835
NCT02126722|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-04-28|||June 2014||2014-06-01|April 2014|2014-04-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Observational|||Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy|Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy: Prospective Validation|Unknown status|Not yet recruiting|N/A|150|Anticipated|Niso Biomed S.R.L.|||2||f||||f||||||||||2017-10-11 00:30:00.78729|2017-10-11 00:30:00.78729
NCT02126709|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-04-29|||June 2014||2014-06-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy|Phase 2 Study of the Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 00:30:00.908148|2017-10-11 00:30:00.908148
NCT02126696|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-04-19|||May 2014||2014-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Observational|||Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho|Study on Non-communicable and Selected Communicable Chronic Comorbidities Among HIV-positive Patients on Anti-retroviral Therapy in Rural Lesotho and Their Association to Virologic Outcome|Completed||N/A|1754|Actual|Swiss Tropical & Public Health Institute|||1||f||||f||||||Samples Without DNA|"     Frozen human plasma   "|||2017-10-11 00:30:01.010933|2017-10-11 00:30:01.010933
NCT02126488|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-09-27|||June 2014||2014-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Adaptive Training for Balance Recovery|Perturbation Training for Fall-risk Reduction Among Older Adults|Active, not recruiting||N/A|308|Actual|University of Illinois at Chicago||3|||f||||f||||||||||2017-10-11 00:30:03.627418|2017-10-11 00:30:03.627418
NCT02126683|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-04-28|||April 2014||2014-04-01|April 2014|2014-04-01|September 2016|Anticipated|2016-09-01|February 2016|Anticipated|2016-02-01||Interventional|||The Effect of Plaquenil on Serum Inflammatory Markers and Goiter in Euthyroid Young Women With Hashimoto's Thyroiditis|The Effect of Plaquenil on Serum Inflammatory Markers and Goiter in Euthyroid Young Women With Hashimoto's Thyroiditis|Unknown status|Active, not recruiting|N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:30:01.098104|2017-10-11 00:30:01.098104
NCT02126670|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-01-25|2015-11-24||April 2014||2014-04-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis||Completed||Phase 2|100|Actual|Promius Pharma, LLC||4|||f||||||||||||||2017-10-11 00:30:01.197551|2017-10-11 00:30:01.197551
NCT02126657|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-04-28|||May 2014||2014-05-01|April 2014|2014-04-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Acne Scars|Phase 2 Study of the The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Acne Scars|Unknown status|Not yet recruiting|Phase 2|10|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 00:30:01.956467|2017-10-11 00:30:01.956467
NCT02126644|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-04-28|||May 2014||2014-05-01|April 2014|2014-04-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging|Phase 2 Study of the Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging|Unknown status|Not yet recruiting|Phase 2|10|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 00:30:02.087757|2017-10-11 00:30:02.087757
NCT02126631|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-06-25|||July 2014||2014-07-01|June 2014|2014-06-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Sternal ECG Patch Comparison Trial|Comparison of a Sternal ECG Patch With a Standard Recording System for Holter Monitoring|Unknown status|Not yet recruiting|N/A|50|Anticipated|Bardy Diagnostics, Inc.|||1||f||||f||||||||||2017-10-11 00:30:02.238918|2017-10-11 00:30:02.238918
NCT02126618|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-07-05|||May 2014||2014-05-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||The Effect of Diuresis During 20-minute Pad Test on the Estimation of the Severity of Stress Urinary Incontinence|The Effect of Diuresis During 20-minute Pad Test on the Estimation of the Severity of Stress Urinary Incontinence|Unknown status|Recruiting|N/A|3000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 00:30:02.362058|2017-10-11 00:30:02.362058
NCT02126605|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-28|||July 2014||2014-07-01|April 2014|2014-04-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Accuracy of Blood Glucose Detection by Diabetes Alert Dogs|Accuracy of Blood Glucose Detection by Diabetes Alert Dogs|Unknown status|Not yet recruiting|N/A|16|Anticipated|University of Virginia|||1||f||||t||||||||||2017-10-11 00:30:02.487023|2017-10-11 00:30:02.487023
NCT02126592|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-04-28|||March 2013||2013-03-01|January 2014|2014-01-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Observational|||The Secretion of Incretin Hormones in Patients With Polycystic Ovary Syndrome|The Secretion of Incretin Hormones in Patients With Polycystic Ovary Syndrome|Unknown status|Recruiting|N/A|100|Anticipated|RenJi Hospital|||2||f||||f||||||Samples Without DNA|"     only plasma   "|||2017-10-11 00:30:02.594498|2017-10-11 00:30:02.594498
NCT02126579|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-09-14|||April 2014||2014-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MEL60||Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists|Open Label, Randomized, Phase I/II Study of a Long Peptide Vaccine Plus TLR Agonists for Resected Stage IIb-IV Melanoma. (MEL60)|Recruiting||Phase 1/Phase 2|58|Anticipated|University of Virginia||8|||f||||t||||||||||2017-10-11 00:30:02.691301|2017-10-11 00:30:02.691301
NCT02126566|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-12-23|||July 2014||2014-07-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Multiclear Treatment for Striae Distensae - A Pilot Study|Phase 2 Study of Multiclear Treatment for Striae Distensae - A Pilot Study|Completed||Phase 2|14|Actual|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 00:30:02.851219|2017-10-11 00:30:02.851219
NCT02126553|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-11-28|||November 2014||2014-11-01|November 2016|2016-11-01||||November 2022|Anticipated|2022-11-01||Interventional|||Lenalidomide Maintenance With High Risk (HR) Acute Myeloid Leukemia (AML) in Remission|Phase II Study of Lenalidomide Maintenance in Patients With High Risk Acute Myeloid Leukemia (AML) in Remission|Recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:30:02.943976|2017-10-11 00:30:02.943976
NCT02126540|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-12-15|||September 2015||2015-09-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|COMBINE-II||Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries|A Non-randomized, Multi-center Feasibility Trial of the Avinger Pantheris System, an Atherectomy Device That Provides Directional Visualization and Imaging While Removing Plaque in Diseased Lower Extremity Arteries|Withdrawn||N/A|0|Actual|Avinger, Inc.||1|||f||||t||||||||||2017-10-11 00:30:03.102954|2017-10-11 00:30:03.102954
NCT02126527|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2016-08-25|||August 2013||2013-08-01|April 2014|2014-04-01||||September 2014|Anticipated|2014-09-01||Interventional|||Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer|Phase I Study of Auranofin and Sirolimus in Adult Patients With Non-Small Cell Lung Cancer|Withdrawn||Phase 1|0|Actual|Mayo Clinic||1||no participants enrolled|f||||t||||||||||2017-10-11 00:30:03.224072|2017-10-11 00:30:03.224072
NCT02126514|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2014-06-13|||May 2014||2014-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|AZD3293hADME||A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293|A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion After Oral Administration of [14C]-AZD3293 to Healthy Male Subjects|Completed||Phase 1|12|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 00:30:03.384162|2017-10-11 00:30:03.384162
NCT02126501|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-06-06|||December 2013||2013-12-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparing Weaning of Nasal Continuous Positive Airway Pressure (CPAP) From Preterm Infants|Randomized Control Trial of Weaning NCPAP From Preterm Infants: Sudden Wean Versus Weaning by Gradually Decreasing Pressure|Completed||N/A|70|Actual|Maimonides Medical Center||2|||f||||f||||||||||2017-10-11 00:30:03.508171|2017-10-11 00:30:03.508171
NCT02126475|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2015-02-03|||April 2014||2014-04-01|February 2015|2015-02-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|PEDUPARK||Temporal Expectations in Parkinson's Disease|L'Expectation Temporelle Dans la Maladie de Parkinson : étude Oculomotrice Psychophysique et Par électroencéphalographie|Unknown status|Recruiting|N/A|40|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||||||2017-10-11 00:30:03.758789|2017-10-11 00:30:03.758789
NCT02126462|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-28|2017-05-30|||November 2014||2014-11-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults|Randomized, Controlled, Phase 1 Study to Assess Safety and Immunogenicity of Co-administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 Adjuvanted With Alhydrogel® and Gluco-pyranosylphospho-lipid A in Gabonese Adults|Completed||Phase 1|32|Actual|Baylor College of Medicine||3|||f||||t||||||||Undecided||2017-10-11 00:30:03.886362|2017-10-11 00:30:03.886362
NCT02126449|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-01-08|||February 2014||2014-02-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|DIRECT||DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer|DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer|Recruiting||Phase 2/Phase 3|250|Anticipated|Leiden University Medical Center||2|||f||||t||||||||||2017-10-11 00:30:04.026138|2017-10-11 00:30:04.026138
NCT02126436|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-03-16|||October 2014||2014-10-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Acupuncture for the Treatment of Phantom Limb Syndrome|Acupuncture for the Treatment of Phantom Limb Syndrome: A Randomised Controlled Trial (Feasibility Study)|Completed||N/A|15|Actual|London South Bank University||2|||f||||f||||||||||2017-10-11 00:30:04.229792|2017-10-11 00:30:04.229792
NCT02126423|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-05-31|||May 2014||2014-05-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Resistance to Antibiotics in Patients Receiving Eye Injections|Prospective Study on Antimicrobial Resistance Rates Following Repeated Courses of Topical Antibiotics for Intravitreal Injection|Completed||N/A|40|Actual|NJ Retina|||2||f||||f||||||Samples Without DNA|"     Conjunctival and nasopharyngeal swabs are procured from each patient.   "|No||2017-10-11 00:30:04.343936|2017-10-11 00:30:04.343936
NCT02126410|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-08-11|||March 2014||2014-03-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Associations Between Self-Reported Sleep Duration and Sarcopenia in Community-Dwelling Older Adults|Associations Between Self-Reported Sleep Duration and Sarcopenia in Community-Dwelling Older Adults|Completed||N/A|488|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:30:04.435517|2017-10-11 00:30:04.435517
NCT02126397|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-07-08|||May 2013||2013-05-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Comparative Study of Endometrial Polypectomy Performed With Bipolar Electrode Versapoint and Laser Diode. A Randomised Controlled Trial.|Comparative Study of Endometrial Polypectomy Performed With Bipolar Electrode Versapoint and Laser Diode. A Randomised Controlled Trial.|Completed||N/A|98|Anticipated|Maimónides Biomedical Research Institute of Córdoba||2|||f||||t||||||||||2017-10-11 00:30:04.508975|2017-10-11 00:30:04.508975
NCT02126384|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-29|||May 2014||2014-05-01|April 2014|2014-04-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Interventional|PNEUMOVACB||Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response|Analysis of the Response of Healthy Adults to a 23-valent Pneumococcal Polysaccharide Vaccine to Identify the B Cell Subsets Responsible for the Production of IgM, IgG2 and IgA Anti-pneumococcal Capsular Polysaccharides|Unknown status|Not yet recruiting|N/A|24|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 00:30:04.599936|2017-10-11 00:30:04.599936
NCT02126371|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-06-13|||May 2014||2014-05-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects|LP0058-1005 - A Phase I, Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects When Administered as an Immediate and Modified Release Formulation|Completed||Phase 1|24|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-11 00:30:04.733882|2017-10-11 00:30:04.733882
NCT02126358|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-10-17|||May 2014||2014-05-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)|A Multicenter, Randomized, Placebo-controlled, Double-blind, Phase III Trial to Evaluate the Efficacy and Safety of the Fix-dose Combination Therapy With Gemigliptin 50mg and Rosuvastatin 20mg With Type 2 Diabetes and Dyslipidemia|Completed||Phase 3|290|Actual|LG Life Sciences||3|||f||||f||||||||||2017-10-11 00:30:04.81831|2017-10-11 00:30:04.81831
NCT02126345|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-02-09|||May 2014|Actual|2014-05-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Observational|||MASTER SL Clinical Study|A Prospective, Observational, Multi-centre, Cohort Study of the MASTER SL Femoral Stem and the DELTA TT Acetabular Cup in Patients With Degenerative Disease of the Hip|Recruiting||N/A|150|Anticipated|Limacorporate S.p.a|||1||f||||||||||||||2017-10-11 00:30:04.958323|2017-10-11 00:30:04.958323
NCT02126332|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-05-26|||April 2014||2014-04-01|May 2014|2014-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|EPIPAN||Epidural Analgesia for Pancreatitis (Epipan Study)|A MULTICENTER, RANDOMIZED, CONTROLLED STUDY OF EPIDURAL ANALGESIA FOR SEVERE ACUTE PANCREATITIS|Unknown status|Recruiting|Phase 4|148|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:30:05.151709|2017-10-11 00:30:05.151709
NCT02126319|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-02-21|2014-08-12||October 1998||1998-10-01|February 2017|2017-02-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Facilitating Participation in a Prostate Cancer Risk Assessment Program|Facilitating Participation in a Prostate Cancer Family Risk Assessment Program|Completed||N/A|128|Actual|Fox Chase Cancer Center||2|||f||||f||||||||No||2017-10-11 00:30:05.315872|2017-10-11 00:30:05.315872
NCT02126306|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-10-22|2014-04-30||January 2006||2006-01-01|January 2006|2006-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Beta Glucosylceramide for Treatment of NASH|Beta Glucosylceramide for Treatment of Non Alcoholic Steatohepatitis|Completed||Phase 1/Phase 2|23|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:30:06.070471|2017-10-11 00:30:06.070471
NCT02126111|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-11-05|||October 2010||2010-10-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|GRAMAL||Efficacy of a Depigmented Extract of Phleum in Local Allergic Rhinitis|Efficacy of a Depigmented Extract of Phleum in the Treatment of Local Allergic Rhinitis|Completed||Phase 2|56|Actual|Plaza del Hospital Civil||2|||f||||t||||||||No||2017-10-11 00:30:07.999471|2017-10-11 00:30:07.999471
NCT02126293|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-03-10|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant|Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant|Completed||Phase 3|40|Actual|Hamilton Health Sciences Corporation||2|||f||||f||||||||||2017-10-11 00:30:06.294655|2017-10-11 00:30:06.294655
NCT02126280|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-04-28|||November 2012||2012-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|MAPA||Monocyte Activation in Preclinical Atherosclerosis|Cross-sectional Clinical Study of the Individual Profile of Activation of Circulating Blood Monocytes in Subjects With Preclinical Atherosclerosis.|Completed||N/A|170|Actual|Institute for Atherosclerosis Research, Russia|||3||f||||t||||||Samples Without DNA|"     Whole blood taken with anticoagulants for immediate monocyte isolation to be seeded in cell     culture, and for preparation of plasma samples to be frozen for lipid analysis.   "|||2017-10-11 00:30:06.4149|2017-10-11 00:30:06.4149
NCT02126267|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-04-27|||January 2013||2013-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of Techniques for Scaling and Root Planing and One Stage Full Mouth Disinfection|Clinical and Microbiological Evaluation of Techniques for Scaling and Root Planing Per Quadrant and One Stage Full Mouth Disinfection Associated With Azithromycin or Chlorhexidine: Randomized Controlled Trial|Completed||N/A|77|Actual|Centro Universitario de Lavras||6|||f||||f||||||||||2017-10-11 00:30:06.533323|2017-10-11 00:30:06.533323
NCT02126254|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-07-06|||April 2014||2014-04-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|HFNICAS||Optimization of the Treatment of Acute HF by a Non Invasive Cardiac System-a Randomized Control Trial|Optimization of the Treatment of Acute Heart Failure by a Non Invasive Cardiac System-Randomized Control Trial|Completed||N/A|5|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 00:30:06.641197|2017-10-11 00:30:06.641197
NCT02126241|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2015-08-05|||April 2014||2014-04-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|NICaS-CRT||Non-Invasive Cardiac Output Measurement for CRT Optimization|The Use of Impedance-Based Non-invasive Cardiac Output Measurement (NICaS) for Optimizing Cardiac Resynchronization Therapy: a Pilot Clinical Trial.|Completed||N/A|42|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 00:30:06.751248|2017-10-11 00:30:06.751248
NCT02126228|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-04-27|||November 2012||2012-11-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01|1 Month|Observational [Patient Registry]|||no Antibiotics for Elective Cesarean With Low Risk of Infection|A Randomized Controlled Trial on Antibiotics Application For Low Infection-risked Elective Cesarean|Completed||N/A|212|Actual|Shandong University|||1||f||||t||||||||||2017-10-11 00:30:06.877181|2017-10-11 00:30:06.877181
NCT02126215|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-01-04|||July 2014||2014-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||An MRI Study of Post-operative Delirium in Patients Undergoing Major Surgery|"Blue Cerebrovascular Reactivity (CVR) Maps as a Marker for Post-operative Delirium (POD) in Patients Undergoing Abdominal Aortic Aneurysm (AAA) Surgery: A Pilot Study: Addition of Other Patients Being Admitted to SSCU After Major Surgery"|Recruiting||N/A|20|Anticipated|University of Manitoba|||1||f||||f||||||||||2017-10-11 00:30:06.976087|2017-10-11 00:30:06.976087
NCT02126202|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-04-27|||August 2009||2009-08-01|January 2014|2014-01-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|80+||Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes|Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes: The Octogenarians Study|Unknown status|Recruiting|Phase 4|200|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-11 00:30:07.127674|2017-10-11 00:30:07.127674
NCT02126189|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-04-20|||November 2013||2013-11-01|April 2015|2015-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study|An Epidemiological Study of Mucosal Squamous Cell Carcinomas of the Head and Neck|Unknown status|Recruiting|N/A|600|Anticipated|Queensland Centre of Excellence for Head and Neck Cancer|||1||f||||f||||||Samples With DNA|"     Participants are asked to give their consent for researchers to obtain tissue from tumour     blocks. This tissue is taken as part of their normal care and treatment. If consent is given,     formalin-fixed paraffin embedded (FFPE) tissue samples will be used to determine HPV status.   "|||2017-10-11 00:30:07.261151|2017-10-11 00:30:07.261151
NCT02126176|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-03-28|||May 2014||2014-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|2 Weeks|Observational [Patient Registry]|||Protopic Adherence and Efficacy in Korean Eczema Patient||Completed||N/A|50|Actual|Pusan National University Hospital|||1||f||||f||||||||||2017-10-11 00:30:07.405553|2017-10-11 00:30:07.405553
NCT02126163|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2016-03-23|||April 2014||2014-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Promoting Responsible Drinking: An Internet-based, Interactive Computer Tailored Intervention|Promoting Responsible Drinking: An Internet-based, Interactive Computer Tailored Intervention|Completed||N/A|1000|Actual|Pro-Change Behavior Systems||2|||f||||f||||||||No||2017-10-11 00:30:07.489164|2017-10-11 00:30:07.489164
NCT02126150|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-12-07|||September 2010||2010-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|UNICORN||United Coronary Biobanks|United CORoNary Biobanks|Completed||N/A|2000|Actual|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     Plasma, peripheral blood mononuclear cells and whole blood is stored.   "|||2017-10-11 00:30:07.586575|2017-10-11 00:30:07.586575
NCT02126137|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2015-11-03|||October 2013||2013-10-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|EZE-1||Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection|A Pilot Study of the Effect of Ezetimibe in Patients With Chronic Hepatitis C Infection|Recruiting||Phase 1|20|Anticipated|Pontificia Universidad Catolica de Chile||1|||f||||f||||||||||2017-10-11 00:30:07.660464|2017-10-11 00:30:07.660464
NCT02126124|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2017-02-05|||April 2014||2014-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.|A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) (With the H-ADD Coil) Intended as an Aid to Smoking Cessation.|Recruiting||Phase 3|224|Anticipated|Brainsway||2|||f||||t||||||||||2017-10-11 00:30:07.773053|2017-10-11 00:30:07.773053
NCT02126098|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2014-04-27|||May 2014||2014-05-01|April 2014|2014-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01|30 Months|Observational [Patient Registry]|||Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis|Cohort Study of Chinese Patients With Pulmonary Vasculitis|Not yet recruiting||N/A|100|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||Samples With DNA|"     serum lymphocytes urine   "|||2017-10-11 00:30:08.149477|2017-10-11 00:30:08.149477
NCT02126085|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-05-22|||April 2014||2014-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|SIESTA||Sedation vs. Intubation for Endovascular Stroke TreAtment|Sedation vs. Intubation for Endovascular Stroke TreAtment|Completed||N/A|150|Actual|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-11 00:30:08.29257|2017-10-11 00:30:08.29257
NCT02126072|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-04-25|||January 2012||2012-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2012|Actual|2012-02-01||Interventional|E-GUT||Effects of Ethanol on Gut Wall Integrity|The Effects of Ethanol on Gut Wall Integrity as Measured by I-FABP and LBP|Completed||N/A|15|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 00:30:08.437775|2017-10-11 00:30:08.437775
NCT02126059|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2016-02-14|||January 2014||2014-01-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Complementary Interventions on Patients With Dementia: Comparative and Longitudinal Research|The Health Effects of Cognitive Stimulation, Reminiscence, and Aroma-massage Complementary Interventions on Different Behavior Patterns of Patients With Dementia: Comparative and Longitudinal Research|Completed||N/A|120|Actual|National Cheng-Kung University Hospital||4|||f||||t||||||||||2017-10-11 00:30:08.562841|2017-10-11 00:30:08.562841
NCT02126046|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2015-04-15|||September 2012||2012-09-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major||Unknown status|Recruiting|N/A|30|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||||||||||||2017-10-11 00:30:08.708873|2017-10-11 00:30:08.708873
NCT02126033|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2014-04-27||||||April 2014|2014-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||Telomeres Parameters in Celiac Disease||Unknown status|Not yet recruiting|N/A|40|Anticipated|Meir Medical Center||1|||f||||||||||||||2017-10-11 00:30:08.86292|2017-10-11 00:30:08.86292
NCT02126020|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2017-04-05|||November 2014||2014-11-01|April 2017|2017-04-01|April 3, 2017|Anticipated|2017-04-03|April 3, 2017|Actual|2017-04-03||Interventional|||Topical Infliximab in Autoimmune Eyes With Keratoprosthesis|Topical Infliximab in Autoimmune Eyes With Keratoprosthesis|Withdrawn||Phase 1/Phase 2|0|Actual|Massachusetts Eye and Ear Infirmary||1||No patients met eligibility criteria. The study has been closed.|f||||f||||||||No||2017-10-11 00:30:08.976523|2017-10-11 00:30:08.976523
NCT02126007|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-06-01|||October 2014||2014-10-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Fatigue Management in HIV|Fatigue Management in HIV: A Sleep and Circadian Rhythm Pilot Intervention|Completed||N/A|53|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:30:09.140475|2017-10-11 00:30:09.140475
NCT02125994|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2014-04-28|||March 2014||2014-03-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Effect of 0.5% vs 0.375% Ropivacaine on Autonomous Nervous System|Comparison of the Effect of Ropivacaine 0.5% vs 0.375% on the Autonomous Nervous System During Shoulder Surgery in Beach Chair Position|Unknown status|Recruiting|N/A|100|Anticipated|Larissa University Hospital||2|||f||||f||||||||||2017-10-11 00:30:09.269728|2017-10-11 00:30:09.269728
NCT02125981|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-04-24|||September 2014||2014-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy|A Prospective Randomized Double-blinded Clinical Trial About the Efficacy of Oral Limaprost Administration Following Surgery for Cervical Myelopathy|Recruiting||Phase 3|160|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:30:09.36387|2017-10-11 00:30:09.36387
NCT02125968|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-04-26|||January 2014||2014-01-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Therapeutic Effects of Video Game Play Therapy on Patients With Chronic Low Back Pain|Therapeutic Effects of Video Game Play Therapy on Patients With Chronic Low Back Pain:Randomized-Controlled Clinical Trail|Unknown status|Recruiting|Phase 4|70|Anticipated|Taipei Medical University||2|||f||||f||||||||||2017-10-11 00:30:09.472655|2017-10-11 00:30:09.472655
NCT02125955|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-05-08|||February 2014||2014-02-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Prebiotic Intake on Adiposity, Satiety and Gut Microbiota in Overweight and Obese Children|Effect of Prebiotic Intake on Adiposity, Satiety and Gut Microbiota in Overweight and Obese Children|Active, not recruiting||N/A|42|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 00:30:09.621085|2017-10-11 00:30:09.621085
NCT02125942|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2017-05-11|||April 2014||2014-04-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment|Pilot Study of Central Meditation and Imagery Therapy for Borderline Personality Disorder|Completed||Phase 1/Phase 2|15|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:30:09.767328|2017-10-11 00:30:09.767328
NCT02125929|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2015-08-04|||April 2014||2014-04-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms|Comparative Study of the Efficacy and Safety Outcomes of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neuroendocrine Tumors|Completed||N/A|156|Actual|Peking Union Medical College Hospital||3|||f||||f||||||||||2017-10-11 00:30:09.86026|2017-10-11 00:30:09.86026
NCT02125916|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-09-11|||July 2014||2014-07-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients|Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients|Completed||N/A|32|Actual|University of Aarhus||4|||f||||||||||||||2017-10-11 00:30:09.980167|2017-10-11 00:30:09.980167
NCT02125903|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-01-23|||May 2013||2013-05-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy|Randomized Controlled Study: Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy Relating to Early Mobilization and Analgesia|Completed||N/A|44|Actual|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-10-11 00:30:10.075567|2017-10-11 00:30:10.075567
NCT02125890|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-11-01|||July 2014||2014-07-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|TARAA||Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms|The Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms|Recruiting||Phase 3|25|Anticipated|Regina Qu'Appelle Health Region||1|||f||||f||||||||No||2017-10-11 00:30:10.156443|2017-10-11 00:30:10.156443
NCT02125877|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-26|2017-07-22|2016-08-24||July 8, 2014|Actual|2014-07-08|July 2017|2017-07-01|February 24, 2016|Actual|2016-02-24|February 24, 2016|Actual|2016-02-24||Interventional|||Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)|A Randomized, Open-label, Multicenter, Two Arm, Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)|Completed||Phase 2|173|Actual|Novartis||2|||f||||f||||||||||2017-10-11 00:30:10.313851|2017-10-11 00:30:10.313851
NCT02125864|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-01-19|||April 2014||2014-04-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Eylea-2014||Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept|Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept in Patients With Exudative Age-related Macular Degeneration|Completed||Phase 4|16|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 00:30:11.82271|2017-10-11 00:30:11.82271
NCT02125851|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-04-25|||January 2014||2014-01-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of Esophageal Clearance Times of Oral Budesonide Preparations|Comparison of Esophageal Clearance Times of Oral Budesonide Preparations|Completed||N/A|24|Actual|Walter Reed National Military Medical Center||2|||f||||t||||||||||2017-10-11 00:30:11.918413|2017-10-11 00:30:11.918413
NCT02125838|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-02-08|2015-08-30||May 2013||2013-05-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Laryngeal Mask Supreme During Laparoscopic Gynecologic Surgery|Application of Endotracheal Intubation and Laryngeal Mask Supreme Without Neuromuscular Blocker in Laparoscopic Gynecologic Surgery|Completed||N/A|108|Actual|Dokuz Eylul University||2|||f||||f||||||||||2017-10-11 00:30:12.0458|2017-10-11 00:30:12.0458
NCT02125825|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-01-08|||July 2014||2014-07-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|Kinesia-D||Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration|Kinesia-D Phase II In-Clinic Continuous Assessment Study|Completed||N/A|14|Actual|Great Lakes NeuroTechnologies Inc.|||1||f||||||||||||||2017-10-11 00:30:12.565831|2017-10-11 00:30:12.565831
NCT02125812|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-05-29|||August 2011||2011-08-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis|Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis: Double-blind Controlled Clinical Trial|Completed||Phase 4|40|Actual|Facultad Nacional de Salud Publica||2|||f||||f||||||||||2017-10-11 00:30:12.652342|2017-10-11 00:30:12.652342
NCT02125799|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-10-02|||October 2012||2012-10-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Accelerated rTMS for Treatment-Resistant Major Depression|A Pilot Trial on the Effectiveness and Tolerability of Accelerated High Frequency Repetitive Transcranial Magnetic Stimulation for Treating Resistant Major Depression|Completed||Phase 2/Phase 3|20|Actual|Douglas Mental Health University Institute||1|||f||||f||||||||||2017-10-11 00:30:12.759903|2017-10-11 00:30:12.759903
NCT02125786|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-09-12|||May 7, 2014|Actual|2014-05-07|September 2017|2017-09-01|September 2025|Anticipated|2025-09-01|September 2022|Anticipated|2022-09-01||Interventional|||A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma|A Phase II Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma|Recruiting||Phase 2|99|Anticipated|St. Jude Children's Research Hospital||4|||f||||f|t|f||||||||2017-10-11 00:30:12.84318|2017-10-11 00:30:12.84318
NCT02125773|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-02-24|||April 2014|Actual|2014-04-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|September 2016|Actual|2016-09-01||Interventional|CCTG 599||Pre-exposure Prophylaxis Accessibility Research and Evaluation 2|CCTG 599: Pre-exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE) 2|Active, not recruiting||N/A|200|Anticipated|California Collaborative Treatment Group||2|||f||||f||||||||||2017-10-11 00:30:12.990043|2017-10-11 00:30:12.990043
NCT02125760|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-02-15|||March 2011||2011-03-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional|RETORNUS||Respiratory Muscle Training in Subacute Stroke Patients|The RETORNUS Study: Dual Training to Restore the Function of Respiratory Muscles in Stroke Patients|Completed||N/A|129|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 00:30:13.088122|2017-10-11 00:30:13.088122
NCT02125747|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-01-11|||December 2011||2011-12-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|TRESEPOCAS||Respiratory Therapy in COPD Exacerbations|Effectiveness of Respiratory Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Completed||N/A|35|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 00:30:13.201907|2017-10-11 00:30:13.201907
NCT02125734|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-03-14|2015-12-14||April 2014||2014-04-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|FAVOR||Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients|A Randomized, Multicenter, Open-label, Cross-over Study to Assess Lung Function and Patient Preference After a 4 Week Treatment Each With QVA149 vs. Tiotropium in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD) and Moderate to Severe Airflow Limitation Who Are on a Tiotropium Therapy (FAVOR Study)|Completed||Phase 4|88|Actual|Novartis||2|||f||||f||||||||||2017-10-11 00:30:13.327973|2017-10-11 00:30:13.327973
NCT02125721|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-01-24|||June 2012||2012-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria|Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria|Active, not recruiting||N/A|15|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 00:30:13.870029|2017-10-11 00:30:13.870029
NCT02125708|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-11-28|||January 2017||2017-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Core-temperature Monitoring in Patients With PPROM|Core-temperature Monitoring in Patients With PPROM for Early Detection of Chorioamnionitis - a Pilot Study|Not yet recruiting||N/A|20|Anticipated|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 00:30:13.951725|2017-10-11 00:30:13.951725
NCT02125695|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-09-27|||May 2014||2014-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Pilot Tape Harvesting Study|A Pilot Study to Evaluate Using Tape Harvesting to Collect Ribonucleic Acid From the Upper Epidermis of Healthy Volunteers and Subjects With Discoid Lupus, Subjects With Subacute Cutaneous Lupus, and Subjects With Atopic Dermatitis|Completed||N/A|37|Actual|Biogen|||3||f||||f||||||Samples With DNA|"     Specimens collected from skin taping and blood sampling.   "|||2017-10-11 00:30:14.040181|2017-10-11 00:30:14.040181
NCT02125682|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2014-04-28|||January 2012||2012-01-01|April 2014|2014-04-01||||December 2014|Anticipated|2014-12-01||Interventional|HDL PROTECT||The HDL Particle Protection Study|Atorvastatin Action on Oxidative Stress and Inflammation in Type II Diabetes: The HDL Particle Protection Study|Unknown status|Recruiting|Phase 4|16|Anticipated|Hotel Dieu de France Hospital||2|||f||||t||||||||||2017-10-11 00:30:14.123475|2017-10-11 00:30:14.123475
NCT02125656|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-05-07|||February 2014||2014-02-01|May 2015|2015-05-01|May 2015|Anticipated|2015-05-01|July 2014|Actual|2014-07-01||Interventional|HIIT||Use of High Intensity Interval Training as a Strategy to Minimize the Insulin Resistance Observed in Sleep Deprivation|Use of High Intensity Interval Training as a Strategy to Minimize the Insulin Resistance Observed in Sleep Deprivation|Unknown status|Active, not recruiting|N/A|15|Anticipated|Federal University of São Paulo||4|||f||||t||||||||||2017-10-11 00:30:14.353505|2017-10-11 00:30:14.353505
NCT02125643|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-06-02|||August 2014|Actual|2014-08-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||EIMD Mechanisms Causing Force Loss|The Underlying Mechanisms From Exercise-induced Muscle Damage on Force Loss|Terminated||Phase 1|3|Actual|University of Oklahoma||2||Protocol was deem insufficient to answer research question|f||||f||||||||||2017-10-11 00:30:14.424655|2017-10-11 00:30:14.424655
NCT02125630|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-27|2016-08-10|||February 2016||2016-02-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Bone Metastasis and Surgery in Breast Cancer|The Effect of Primary Surgery in Patients With Stage IV Breast Cancer With Bone Metastasis Only|Recruiting||Phase 3|288|Anticipated|Federation of Breast Diseases Societies||2|||f||||t||||||||||2017-10-11 00:30:14.527955|2017-10-11 00:30:14.527955
NCT02125617|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-11-18|||January 2014||2014-01-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|July 2016|Anticipated|2016-07-01||Observational|uPARCRPC||Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer|uPAR in Blood From Zytiga® (Abiraterone) Treated Patients With Castration Resistant Prostate Cancer - a Predictive Marker of Response?|Terminated||N/A|3|Actual|Rigshospitalet, Denmark|||1|Poor recruition|f||||t||||||Samples Without DNA|"     Blood plasma   "|||2017-10-11 00:30:14.611779|2017-10-11 00:30:14.611779
NCT02125604|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-03-07|2017-03-07||June 2014||2014-06-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|TOLERATE||Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany|A Multicenter, Open-Label, Single-Arm Study to Evaluate Gastrointestinal Tolerability in Subjects With Relapsing-Remitting Multiple Sclerosis Receiving Dimethyl Fumarate (TOLERATE)|Completed||Phase 4|214|Actual|Biogen||1|||f||||f||||||||||2017-10-11 00:30:14.730184|2017-10-11 00:30:14.730184
NCT02125591|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-05-21|||August 2015||2015-08-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|CN-NINM||Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Full Trial)|Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury: A Randomized, Double-Blinded, Sham-Controlled, Prospective Trial|Withdrawn||N/A|0|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||f||||||||||2017-10-11 00:30:17.19755|2017-10-11 00:30:17.19755
NCT02125578|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-25|||March 2008||2008-03-01|April 2014|2014-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Dose-Ranging, Parallel-Group Study of PEGylated Interferon Beta-1a (BIIB017) in Healthy Volunteers|Completed||Phase 1|69|Actual|Biogen||3|||f||||||||||||||2017-10-11 00:30:17.307018|2017-10-11 00:30:17.307018
NCT02125565|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-29|||December 2012||2012-12-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Radial ABG Sampling: A RCT of Lidocaine Local Anaesthesia|Radial Artery Blood Gas Sampling: A Randomised Controlled Trial of Lidocaine Local Anaesthesia|Completed||N/A|43|Actual|James Paget University Hospital NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:30:17.446307|2017-10-11 00:30:17.446307
NCT02125552|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-07-03|||May 2014||2014-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|USgIV||Ultrasound Guided IV Access in a Pediatric Emergency Department|A Randomized Control Trial of Ultrasound Guided IV Access in the Pediatric Emergency Department|Active, not recruiting||N/A|163|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 00:30:17.560249|2017-10-11 00:30:17.560249
NCT02125539|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-07-24|||September 2014||2014-09-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment|Navigating My Journey (NmJ): A Relapse Prevention Program for Adolescents -- Field Trial|Completed||Phase 2|160|Actual|Inflexxion, Inc.||2|||f||||t||||||||||2017-10-11 00:30:17.676438|2017-10-11 00:30:17.676438
NCT02125526|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-01-31|||August 2014||2014-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SEMPER FI||Intra-aortic Balloon Pump in Extensive Myocardial Infarction With Persistent Ischemia|Survival Improvement in Extensive Myocardial Infarction With PERsistent Ischemia Following Intra-aortic Balloon Pump Implantation|Recruiting||N/A|100|Anticipated|Catharina Ziekenhuis Eindhoven||2|||f||||t||||||||||2017-10-11 00:30:17.796977|2017-10-11 00:30:17.796977
NCT02124993|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-01-07|||April 2013||2013-04-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|June 2014|Actual|2014-06-01||Observational|FPQ||The Effect of Sleeve Gastrectomy on Food Preference|The Effect of Sleeve Gastrectomy on Food Preference|Completed||N/A|15|Actual|Pennington Biomedical Research Center|||1||f||||f||||||||||2017-10-11 00:30:23.049966|2017-10-11 00:30:23.049966
NCT02125513|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-10-03|||January 2014||2014-01-01|October 2014|2014-10-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|GOGER-01||Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer|Randomized Phase II Study of 3 vs 6 Courses of Neoadjuvant Carboplatin-paclitaxel Chemotherapy in Stage IIIC or IV Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma|Unknown status|Recruiting|Phase 2|220|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||||2017-10-11 00:30:17.90335|2017-10-11 00:30:17.90335
NCT02125500|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-06-28|||August 2014||2014-08-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection|Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir (GS-5885) Fixed-dose Combination in NS3/4A Protease Inhibitor-experienced Subjects With HCV Genotype 1 Infection and HIV Co-infection|Completed||Phase 2|68|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 00:30:18.007461|2017-10-11 00:30:18.007461
NCT02125487|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-06-22|||December 2013||2013-12-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|HS-CBE||Hybrid Simulation in Teaching Clinical Breast Examination|The Use of Hybrid Simulation (HS) of the Breast in Teaching Clinical Breast Examination (CBE) to Medical Students.|Completed||N/A|82|Actual|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-11 00:30:18.101976|2017-10-11 00:30:18.101976
NCT02125474|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-10-07|||November 2013||2013-11-01|May 2014|2014-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate|Efficacy of Peptide Receptor Radionuclide Therapy for Metastatic Inoperable Neuroendocrine Tumors Using 177-Lu-DOTA 0, Tyr 3 Octreotate|Recruiting||Phase 2|39|Anticipated|Instituto Nacional de Cancerologia, Columbia||1|||f||||t||||||||||2017-10-11 00:30:18.24658|2017-10-11 00:30:18.24658
NCT02125461|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-06-22|||May 7, 2014|Actual|2014-05-07|June 2017|2017-06-01|July 9, 2019|Anticipated|2019-07-09|February 13, 2017|Actual|2017-02-13||Interventional|PACIFIC||A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer|A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-centre, International Study of MEDI4736 as Sequential Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Concurrent Chemoradiation Therapy (PACIFIC)|Active, not recruiting||Phase 3|713|Actual|AstraZeneca||2|||f||||t|t|f||||||||2017-10-11 00:30:18.385809|2017-10-11 00:30:18.385809
NCT02125448|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-11-06|||October 2013||2013-10-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Observational|PRIOR||PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer|Preoperative Identification of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer (PRIOR)|Recruiting||N/A|50|Anticipated|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     At the UMC Utrecht, the resection specimens after esophagectomy will be kept in our     institute's biobank, according to standard clinical practice.      At M.D. Anderson Cancer Center biopsy and blood samples will be collected for all patients.   "|||2017-10-11 00:30:19.059252|2017-10-11 00:30:19.059252
NCT02125435|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-25|||January 2011||2011-01-01|April 2014|2014-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects|Completed||Phase 1|65|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:30:19.197202|2017-10-11 00:30:19.197202
NCT02125422|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2015-05-27|||November 2013||2013-11-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|tDCSHV||Neurophysiological Study of tDCS Effects in Healthy Volunteers|Neurophysiological Study of tDCS Effects in Healthy Volunteers|Completed||Phase 1|18|Actual|University Hospital of Liege||1|||f||||t||||||||||2017-10-11 00:30:19.29889|2017-10-11 00:30:19.29889
NCT02125409|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-05-02|||May 2014||2014-05-01|May 2014|2014-05-01||||May 2015|Anticipated|2015-05-01||Interventional|||Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action|Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action.|Unknown status|Not yet recruiting|Phase 3|40|Anticipated|Aragon Institute of Health Sciences||2|||f||||t||||||||||2017-10-11 00:30:19.385478|2017-10-11 00:30:19.385478
NCT02125396|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-06-09|||May 2015||2015-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|ARTC-HCC||Adjuvant Radiotherapy Comparing TACE for Curative HCC|Adjuvant Radiotherapy Comparing Transarterial Chemoembolization for Curative Hepatocellular Carcinoma: a Randomized Controlled Trials|Recruiting||Phase 3|150|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-11 00:30:19.498261|2017-10-11 00:30:19.498261
NCT02125383|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-03-09|||April 2014||2014-04-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|ParkinStim||ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease|ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease Phase I|Completed||N/A|9|Actual|Great Lakes NeuroTechnologies Inc.||2|||f||||f||||||||||2017-10-11 00:30:19.593809|2017-10-11 00:30:19.593809
NCT02125370|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-12-03|||April 2014||2014-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Experiences of Pregnant Women Who Use NRT in Pregnancy as Part of a Quit Attempt|Experiences of Pregnant Women Who Use NRT in Pregnancy as Part of a Quit Attempt|Completed||N/A|15|Actual|University of Nottingham|||1||f||||f||||||||||2017-10-11 00:30:19.709801|2017-10-11 00:30:19.709801
NCT02125357|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-02-01|||September 2014|Actual|2014-09-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Sequencing Abiraterone and Enzalutamide in mCRPC|A Randomized Phase II Study of Sequencing Abiraterone Acetate and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 2|202|Actual|British Columbia Cancer Agency||2|||f||||f||||||||||2017-10-11 00:30:19.799339|2017-10-11 00:30:19.799339
NCT02124980|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-06-28|||November 2015||2015-11-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Automated Recovery Line for Medication Assisted Treatment|Automated Recovery Line for Medication Assisted Treatment|Completed||N/A|60|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 00:30:23.124921|2017-10-11 00:30:23.124921
NCT02125344|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-07-10|||December 2014|Actual|2014-12-01|July 2017|2017-07-01|January 30, 2017|Actual|2017-01-30|November 2016|Actual|2016-11-01||Interventional|||A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)|A Randomized Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)|Completed||Phase 3|961|Actual|German Breast Group||2|||f||||t||||||||||2017-10-11 00:30:19.893845|2017-10-11 00:30:19.893845
NCT02125331|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-07-13|||April 2014||2014-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MISSION||Measurement of NonInvasive Blood Pressure in Neonates Through Adults and Special Populations|Measurement of NonInvasive Blood Pressure With DINAMAP SuperSTAT and Datex-Ohmeda With Intra-arterial Blood Pressure in Neonates Through Adults and Special Populations|Enrolling by invitation||N/A|100|Anticipated|GE Healthcare||2|||f||||f||||||||||2017-10-11 00:30:20.027489|2017-10-11 00:30:20.027489
NCT02125318|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-02-23|||May 2014||2014-05-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders|A Phase 2, Open Label Efficacy and Safety Study of Anagrelide Controlled Release (CR) in Subjects With Thrombocytosis Secondary to Essential Thrombocythemia and Other Myeloproliferative Neoplasms (MPN)|Completed||Phase 2|18|Actual|Galena Biopharma, Inc.||1|||f||||f||||||||||2017-10-11 00:30:20.107049|2017-10-11 00:30:20.107049
NCT02125305|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-28|||August 2013||2013-08-01|April 2014|2014-04-01||||January 2014|Actual|2014-01-01||Interventional|ME01||Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the Elderly|A Phase I Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in Elderly Healthy Male Volunteers|Completed||Phase 1|12|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 00:30:20.221215|2017-10-11 00:30:20.221215
NCT02125292|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-04-01|2015-03-12||June 2014||2014-06-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||All participants who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment|Taste Assessment Study of SHP429 in Healthy Adult Subjects|A Phase 1, Open-label, Randomized, 3-period Crossover Taste Assessment Study to Characterize the Palatability of SHP429 When the Contents Are Sprinkled Onto Soft Foods or Emptied Into a Cup and Administered With Water in Healthy Adult Subjects|Completed||Phase 1|18|Actual|Shire||3|||f||||||||||||||2017-10-11 00:30:20.299323|2017-10-11 00:30:20.299323
NCT02125279|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-12-16|||May 2014||2014-05-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis|A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 Months of Age) With Mild to Moderate Plaque Psoriasis|Recruiting||Phase 4|100|Anticipated|Galderma||1|||f||||t||||||||Undecided||2017-10-11 00:30:20.841048|2017-10-11 00:30:20.841048
NCT02125266|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-12-07||2016-12-07|April 2014||2014-04-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Preliminary Efficacy Study of V404 PDS in Uveitis|A Prospective, Multi-Center, Randomized, Controlled Clinical Trial Designed to Evaluate the Safety and Preliminary Efficacy of V404 PDS in Chronic Noninfectious Uveitis|Terminated||Phase 1/Phase 2|7|Actual|Forsight Vision4||2||Study terminated due to unacceptable frequency of drug related adverse events|f||||f||||||||No||2017-10-11 00:30:21.114814|2017-10-11 00:30:21.114814
NCT02125253|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2015-10-05||2014-07-09|January 2014||2014-01-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis|A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis|Completed||Phase 3|811|Actual|Amneal Pharmaceuticals, LLC||3|||f||||t||||||||||2017-10-11 00:30:21.206314|2017-10-11 00:30:21.206314
NCT02125240|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-01-03|||September 2014||2014-09-01|January 2017|2017-01-01|July 2021|Anticipated|2021-07-01|December 2017|Anticipated|2017-12-01||Interventional|ICWIP||Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma|Icotinib as an Adjuvant Therapy for Stage II-IIIA Adenocarcinoma With EGFR Mutation: A Placebo-controlled, Randomized, Double-blind, Phase III Study|Recruiting||Phase 3|300|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 00:30:21.306946|2017-10-11 00:30:21.306946
NCT02125227|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-10-08|||April 2014||2014-04-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy Volunteers|A Randomized, Open-label, Single-dose, 2-Way Cross-over Study to Compare the Safety and the Pharmacokinetic Characteristics of the Co-administration of Rosuvastatin and Metformin SR and YH14755 and to Investigate the Effect of Food on the Pharmacokinetics of YH14755|Completed||Phase 1|56|Actual|Yuhan Corporation||4|||f||||f||||||||||2017-10-11 00:30:21.463187|2017-10-11 00:30:21.463187
NCT02125214|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-05-29|||January 2014||2014-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Fractal||Alteration of Temporal Organization of EEG Microstate Sequences During Propofol-induced Loss of Consciousness|Alteration of Temporal Organization of EEG Microstate Sequences During Propofol-induced Loss of Consciousness|Completed||N/A|20|Actual|University Hospital, Geneva||1|||f||||t||||||||||2017-10-11 00:30:21.585479|2017-10-11 00:30:21.585479
NCT02125201|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-03-10|||June 2014||2014-06-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention|Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention|Recruiting||Phase 4|50|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-11 00:30:21.683496|2017-10-11 00:30:21.683496
NCT02125188|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-06-04|||January 2014||2014-01-01|June 2017|2017-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery|Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery|Completed||Phase 4|60|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-11 00:30:21.770144|2017-10-11 00:30:21.770144
NCT02125175|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-01-26|||January 2014||2014-01-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|August 2016|Anticipated|2016-08-01||Interventional|BIOPROP20||BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer|BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer|Active, not recruiting||Phase 2|55|Actual|The Clatterbridge Cancer Centre NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:30:21.846305|2017-10-11 00:30:21.846305
NCT02125162|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-08-14|||April 2014||2014-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161|A Single-dose, Randomized, 3-period, Crossover Study to Evaluate the Relative Bioavailability of BCX4161 Formulated as a Soft Gelatin Capsule to BCX4161 Formulated as a Hard Gelatin Capsule and the Effect of Food on BCX4161 Pharmacokinetics|Completed||Phase 1|28|Actual|BioCryst Pharmaceuticals||3|||f||||f||||||||||2017-10-11 00:30:21.927543|2017-10-11 00:30:21.927543
NCT02125149|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-06-28|||September 2014||2014-09-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||The Expecting Study|Prenatal Physical Activity Intervention|Recruiting||N/A|234|Anticipated|Arkansas Children's Hospital Research Institute||2|||f||||f||||||||||2017-10-11 00:30:22.012125|2017-10-11 00:30:22.012125
NCT02125136|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-06-12|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|May 1, 2020|Anticipated|2020-05-01||Interventional|NEOLAP||Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer|Prospective Randomized Multicenter Phase II Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer|Recruiting||Phase 2|168|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-10-11 00:30:22.098416|2017-10-11 00:30:22.098416
NCT02125123|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-07-24|||April 2014||2014-04-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Oral Nutritional Supplementation in Children|Oral Nutritional Supplementation in Children With Picky Eating Behaviors|Terminated||N/A|26|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-11 00:30:22.20125|2017-10-11 00:30:22.20125
NCT02125110|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-05-19|||April 2014||2014-04-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|November 2016|Anticipated|2016-11-01||Interventional|PERINE||PERINE : Effect of Prenatal Exposure to Neurotoxicants on the Developing Brain : an MRI Study|Effect of Prenatal Exposure to Neurotoxicants on the Developing Brain: an MRI Study|Recruiting||N/A|110|Anticipated|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 00:30:22.282369|2017-10-11 00:30:22.282369
NCT02125097|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-07-05|||December 2013||2013-12-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|Barrel||The Reverse Barrel™ VRD Intracranial Aneurysm Trial|Multi-center Non-randomized Clinical Investigation of the Reverse Medical Barrel™ Vascular Reconstruction Device (VRD) for Adjunctive Treatment to Embolic Coils for Wide Neck Intracranial Bifurcation and Branch Aneurysms|Unknown status|Recruiting|N/A|20|Anticipated|Reverse Medical Corporation||1|||f||||t||||||||||2017-10-11 00:30:22.369518|2017-10-11 00:30:22.369518
NCT02125084|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-01-05|||October 2014||2014-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer|Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer: A Phase I Study With a Maximum Tolerated Dose Expansion Cohort|Active, not recruiting||Phase 1|38|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 00:30:22.467072|2017-10-11 00:30:22.467072
NCT02125071|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-10-16|||November 2013||2013-11-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|LT||Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation|An Exploratory Clinical Trial to Evaluate the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation|Completed||N/A|20|Actual|Seoul St. Mary's Hospital|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 00:30:22.567022|2017-10-11 00:30:22.567022
NCT02125058|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-01-20|||April 2014||2014-04-01|April 2015|2015-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Intracutaneous Versus Transcutaneous Sutures in the Face (IC vs TC Sutures)|Randomized Controlled Trial for the Cosmetic Result of Intracutaneous Versus Transcutaneous Sutures After Dermatologic Surgery in the Face|Completed||N/A|142|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 00:30:22.636431|2017-10-11 00:30:22.636431
NCT02125045|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-05-07|||February 2014||2014-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Sublingual L-GSH Supplementation in Male Subjects With Smoking Habit and/or Hypertension|Medium Term Effect of Sublingual L-glutathione (L-GSH) Supplementation on Flow Mediated Dilation and Oxidative Stress Markers in Male Subjects With Smoking Habit and/or Arterial Hypertension|Completed||Phase 3|16|Actual|Niguarda Hospital||2|||f||||f||||||||||2017-10-11 00:30:22.712408|2017-10-11 00:30:22.712408
NCT02125032|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-08-30|||May 2014||2014-05-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Transcranial Low Voltage Pulsed Electromagnetic Fields (T-PEMF) in Patients With Parkinson's Disease||Active, not recruiting||N/A|98|Actual|Odense University Hospital||2|||f||||||||||||||2017-10-11 00:30:22.797095|2017-10-11 00:30:22.797095
NCT02125019|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-08-07|||September 25, 2013|Actual|2013-09-25|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer|Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer|Recruiting||N/A|32|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 00:30:22.871461|2017-10-11 00:30:22.871461
NCT02125006|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-08-10|||October 2013||2013-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|InDepth||The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain|The Effect of an Inter-Disciplinary Program, Including Mindfulness-Based Stress Reduction, on Psychosocial Function, Pain Perception, Disability and Quality of Life in Breast Cancer Survivors With Chronic Neuropathic Pain|Active, not recruiting||N/A|118|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 00:30:22.955278|2017-10-11 00:30:22.955278
NCT02124967|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-12-10|||April 2014||2014-04-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||A Mosque-Based Intervention to Promote Physical Activity in South Asian Muslim Women|Exploring the Feasibility, Acceptability, and Effectiveness of a Mosque-Based Intervention to Promote Physical Activity in South Asian Muslim Women: A Pilot Study|Completed||N/A|28|Actual|Women's College Hospital||1|||f||||f||||||||Undecided||2017-10-11 00:30:23.211345|2017-10-11 00:30:23.211345
NCT02124954|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-09-30|||May 2014||2014-05-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Preliminary Drug Drug Interaction Study With TA-8995|A Phase I, Open Label Study to Assess the Effects of TA-8995 on the Pharmacokinetics of Midazolam and Digoxin in Healthy Male Subjects|Completed||Phase 1|18|Actual|Xention Ltd||2|||f||||f||||||||||2017-10-11 00:30:23.289882|2017-10-11 00:30:23.289882
NCT02124941|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-06-26|||February 2014||2014-02-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 13C-MRS||Recruiting||Phase 1|30|Anticipated|Yale University||2|||f||||||||||||||2017-10-11 00:30:23.395341|2017-10-11 00:30:23.395341
NCT02124928|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-09-17|||September 2012||2012-09-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|VUCAP||Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis|Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis|Recruiting||N/A|400|Anticipated|Wilhelminenspital Vienna|||1||f||||f||||||Samples With DNA|"     whole blood serum carotid artery plaque   "|||2017-10-11 00:30:23.53617|2017-10-11 00:30:23.53617
NCT02124915|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-08-22|||February 2013|Actual|2013-02-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|CAD||Influence of Socket Volume on Prosthesis Performance|Influence of Socket Volume on Prosthesis Performance|Completed||N/A|9|Actual|University of Washington|||1||f||||f||||||||||2017-10-11 00:30:23.647731|2017-10-11 00:30:23.647731
NCT02124902|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-06-08|||July 7, 2014|Actual|2014-07-07|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity|A Co-clinical Trial in Triple Negative Breast Cancer Patients With Genoproteomic Discovery|Recruiting||Phase 2|70|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||No||2017-10-11 00:30:23.810689|2017-10-11 00:30:23.810689
NCT02124876|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-08-22|||June 2013||2013-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|AM-PM||Accommodating for Residual Limb Fluid Volume Change|Accommodating for Residual Limb Fluid Volume Change|Recruiting||N/A|50|Anticipated|University of Washington|||1||f||||f||||||||||2017-10-11 00:30:24.026197|2017-10-11 00:30:24.026197
NCT02124863|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-12-22|2015-02-23||September 2013||2013-09-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Influence of IPV on GOR in Infants From 0 to 12 Months.|Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR) in Infants From 0 to 12 Months.|Completed||N/A|67|Actual|Vrije Universiteit Brussel||1|||f||||t||||||||||2017-10-11 00:30:24.095102|2017-10-11 00:30:24.095102
NCT02124837|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-12-01|||April 2014||2014-04-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Intervention Study on Break Activities and Workers´ Psychological and Physiological Health & Performance|An Intervention Study to Investigate the Effect of Different Types of Break Activities on Workers´ Psychological and Physiological Health & Job Performance|Completed||N/A|200|Actual|University of Tampere||3|||f||||f||||||||||2017-10-11 00:30:24.371098|2017-10-11 00:30:24.371098
NCT02124824|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-05-16|||September 1, 2014|Actual|2014-09-01|May 2017|2017-05-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Contribution of Endothelin-1 to Exercise Intolerance in Heart Failure|Contribution of Endothelin-1 to Exercise Intolerance in HF|Recruiting||Early Phase 1|40|Anticipated|VA Office of Research and Development||2|||f||||f|t|f|||f|||No||2017-10-11 00:30:24.45359|2017-10-11 00:30:24.45359
NCT02124811|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2016-12-09|||February 2015||2015-02-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Minocycline Augmentation to Clozapine|A Pilot Study of Minocycline Augmentation to Clozapine in Individuals With Treatment Resistant Schizophrenia|Completed||Phase 4|14|Actual|Emory University||2|||f||||f||||||||||2017-10-11 00:30:24.540743|2017-10-11 00:30:24.540743
NCT02124798|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-04-25|2017-03-02|2015-08-13|May 20, 2014|Actual|2014-05-20|April 2017|2017-04-01|April 13, 2015|Actual|2015-04-13|April 13, 2015|Actual|2015-04-13||Interventional|||A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector|An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|95|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:30:24.643325|2017-10-11 00:30:24.643325
NCT02124785|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-11-16|||May 2015||2015-05-01|November 2015|2015-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®|Long-term Persistence of Hepatitis A Antibodies in Healthy Adults, Primed 21 to 25 Years Earlier With GSK Biologicals' Hepatitis A Vaccine Havrix® (SB208109) in Studies HAV-112 (208109/108) or HAV-123 (208109/114)|Withdrawn||Phase 4|0|Actual|GlaxoSmithKline||1||"This study has been cancelled before initiation due to company's prioritisation decisions   linked to resources restrictions."|f||||||||||||||2017-10-11 00:30:25.024452|2017-10-11 00:30:25.024452
NCT02124772|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-08-31|||January 15, 2015|Actual|2015-01-15|August 2017|2017-08-01|October 15, 2020|Anticipated|2020-10-15|October 15, 2020|Anticipated|2020-10-15||Interventional|||Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations|An Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor Trametinib in Children and Adolescents Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Children and Adolescents With Cancers Harboring V600 Mutations|Recruiting||Phase 1|142|Anticipated|Novartis||4|||f||||f|t|f||||||||2017-10-11 00:30:25.140012|2017-10-11 00:30:25.140012
NCT02124759|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-04-13|||April 2014||2014-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MicroB1||Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)|Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)|Recruiting||Phase 2|36|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 00:30:25.319922|2017-10-11 00:30:25.319922
NCT02124746|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-08-03|||April 30, 2014|Actual|2014-04-30|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia|Open-label Study to Assess the Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia|Active, not recruiting||Phase 2|105|Anticipated|Gilead Sciences||4|||f||||f|t|f||||||||2017-10-11 00:30:25.474768|2017-10-11 00:30:25.474768
NCT02124733|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-01-31|||April 2014||2014-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses|Simultaneous Incubation/Illumination Versus Short Aminolevulinate Preincubation for Painless Photodynamic Therapy of Actinic Keratoses|Recruiting||Phase 3|24|Anticipated|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 00:30:25.638345|2017-10-11 00:30:25.638345
NCT02124720|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Using Mobile Technology to Reduce Stereotypy|Using Mobile Technology to Reduce Stereotypy in Children With Autism Spectrum Disorders|Recruiting||N/A|30|Anticipated|Université de Montréal||1|||f||||f||||||||||2017-10-11 00:30:25.774694|2017-10-11 00:30:25.774694
NCT02124707|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-07-01|||April 2014||2014-04-01|July 2016|2016-07-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN|LCCC 1330 - A Phase II Study of Weekly Carboplatin, Paclitaxel and Cetuximab for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 2|38|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:30:25.893245|2017-10-11 00:30:25.893245
NCT02124694|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-06-12|||April 2014||2014-04-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|HTUG-IPT||Iwankapiya-Healing: Historical Trauma Practice and Group IPT for American Indians|Iwankapiya-Healing: Historical Trauma Practice and Group IPT for American Indians|Unknown status|Recruiting|N/A|70|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-10-11 00:30:26.022274|2017-10-11 00:30:26.022274
NCT02124681|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-06-02|||April 2014||2014-04-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|REHNIS||Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer|Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer|Completed||Phase 1|34|Actual|University of Pittsburgh||2|||f||||f||f|||t|||No||2017-10-11 00:30:26.138252|2017-10-11 00:30:26.138252
NCT02124668|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-08-17|||September 30, 2014|Actual|2014-09-30|August 2017|2017-08-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|||A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy|A Phase 2, Multicenter, Single-arm, Open Label Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy|Completed||Phase 2|30|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:30:26.253298|2017-10-11 00:30:26.253298
NCT02124655|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-26|||September 2012||2012-09-01|April 2014|2014-04-01||||June 2013|Actual|2013-06-01||Interventional|||Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an in Situ Model of Oral Biofilm Growth.|Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an in Situ Model of Oral Biofilm Growth: a Randomised Clinical Trial.|Completed||Phase 4|15|Actual|University of Santiago de Compostela||1|||f||||f||||||||||2017-10-11 00:30:26.36277|2017-10-11 00:30:26.36277
NCT02124616|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2014-04-25|||April 2014||2014-04-01|April 2014|2014-04-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01|5 Years|Observational [Patient Registry]|||National Registry for Egyptian Pediatric Neuromuscular Diseases|National Registry for Egyptian Pediatric Neuromuscular Diseases|Recruiting||N/A|200|Anticipated|Ain Shams University|||1||f||||t||||||||||2017-10-11 00:30:26.587072|2017-10-11 00:30:26.587072
NCT02124603|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-12-15|2015-07-20||April 2014||2014-04-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Microbiological Evaluation of the Ocular Flora Before Cataract Surgery|Evaluation of Ocular Flora in Patients Undergoing Cataract Surgery. An Observational Study|Completed||N/A|120|Actual|SIFI SpA|||1||f||||f||||||Samples Without DNA|"     Conjunctival and palpebral swab of the eye undergoing surgery   "|||2017-10-11 00:30:26.699153|2017-10-11 00:30:26.699153
NCT02124590|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-06-15|||June 2014||2014-06-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Oral Carnitine Supplementation on MRS-derived Mitochondrial Function|The Effect of Oral Carnitine Supplementation on MRS-derived Mitochondrial Function|Completed||N/A|14|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:30:26.873753|2017-10-11 00:30:26.873753
NCT02124577|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-12-17|||May 2014||2014-05-01|April 2014|2014-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01|8 Weeks|Observational [Patient Registry]|||Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLD|Development of Kinetic Biomarkers of Liver Fibrosis Based on Stable Isotope Mass Spectrometry Techniques for Measuring Nonalcoholic Fatty Liver Disease NAFLD)|Not yet recruiting||N/A|50|Anticipated|University of California, San Diego|||1||f||||f||||||Samples With DNA|"     Stored specimen The specimens (serum, plasma, urine, stool, saliva, liver tissue, and DNA)     collected as part of this study will be kept in Dr. Loomba' s locked research freezer at the     Clinical Teaching Facility (CTF-building A).All collected data and patient charts will be     maintained at the CTF building in a locked computer file with access available to the     principal and study investigators only.      All samples and data will be labeled with a code number. The name, address, social security     number, date of birth and other personal identifiers will not be available on the sample, and     we will not give out any information that identifies the patient to the researchers who use     these samples and data.   "|||2017-10-11 00:30:26.955366|2017-10-11 00:30:26.955366
NCT02124564|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-10-05|||April 2014|Actual|2014-04-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures|Multicenter, Open-Label, Long-Term Study to Investigate the Safety of Conversion to Lacosamide at Doses up to 600 mg/Day as Monotherapy in Japanese Adults With Partial-Onset Seizures With or Without Secondary Generalization|Active, not recruiting||Phase 3|10|Anticipated|UCB Pharma||1|||f||||f||||||||||2017-10-11 00:30:27.044837|2017-10-11 00:30:27.044837
NCT02124551|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-02-09|||April 2014||2014-04-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Comparing Pleth Variability Index (PVI) Measurements at Different Sensing Locations|Comparing PVI Measurements at Different Sensing Locations|Recruiting||N/A|55|Anticipated|University of California, Irvine|||1||f||||t||||||||||2017-10-11 00:30:27.162215|2017-10-11 00:30:27.162215
NCT02124538|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-25|||April 2013||2013-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:30:27.279599|2017-10-11 00:30:27.279599
NCT02124525|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2014-04-24|||February 2013||2013-02-01|April 2014|2014-04-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Interventional|NACNOS||N-acetylcysteine for Tobacco Smoking|The Efficacy of N-acetylcysteine as a Cessation Treatment for Tobacco Smoking and Oxidative Stress Reduction|Unknown status|Recruiting|Phase 3|32|Anticipated|Universidade Estadual de Londrina||2|||f||||t||||||||||2017-10-11 00:30:27.338752|2017-10-11 00:30:27.338752
NCT02124512|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-09-11|||March 2015||2015-03-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Blood Lipopolysaccharide (LPS) Rifaximin Study|Dietary Fat, Lipoprotein and Lipopolysaccharide: Role in Insulin Resistance|Recruiting||Phase 2|40|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 00:30:27.435907|2017-10-11 00:30:27.435907
NCT02124499|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-10-04|||January 2012||2012-01-01|October 2016|2016-10-01|January 2028|Anticipated|2028-01-01|January 2023|Anticipated|2023-01-01||Observational|||Genetic Variants and Perioperative Morbidity and Mortality|Genetic Variants and Perioperative Morbidity and Mortality|Recruiting||N/A|20000|Anticipated|University Hospital Inselspital, Berne|||1||f||||t||||||Samples With DNA|"     whole blood (plasma and cells) or mucosal swab   "|||2017-10-11 00:30:27.529959|2017-10-11 00:30:27.529959
NCT02124486|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-04-25|||March 2014|Actual|2014-03-01|April 2017|2017-04-01|October 2022|Anticipated|2022-10-01|October 2018|Anticipated|2018-10-01||Interventional|IIH:WT||An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH|A Randomised Controlled Trial of Bariatric Surgery Versus a Community Weight Loss Programme for the Sustained Treatment of Idiopathic Intracranial Hypertension: the IIH:WT Trial|Recruiting||N/A|90|Anticipated|University of Birmingham||4|||f||||t||||||||||2017-10-11 00:30:27.627034|2017-10-11 00:30:27.627034
NCT02124473|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2014-04-24|||August 2013||2013-08-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Addition of Homeopathy in Patients With Resistant Arterial Hypertension|Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Homeopathy in Resistant Arterial Hypertension|Completed||Phase 2|79|Actual|Macmillan Research Group UK||2|||f||||t||||||||||2017-10-11 00:30:27.882455|2017-10-11 00:30:27.882455
NCT02124460|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-02-24|2016-10-28||June 2014||2014-06-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||Connect 4 Health: An Intervention to Improve Childhood Obesity Outcomes|Improving Childhood Obesity Outcomes: Testing Best Practices of Positive Outliers|Completed||N/A|721|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:30:28.006535|2017-10-11 00:30:28.006535
NCT02124447|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-07-09|||June 2014||2014-06-01|July 2015|2015-07-01|June 2015|Anticipated|2015-06-01|August 2014|Anticipated|2014-08-01||Interventional|||Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy|Comparison of Efficacy and Patient Tolerability of Four Commercially Available Bowel Purgatives for Screening and Surveillance Colonoscopy: A Single Tertiary Medical Center Experience.|Withdrawn||N/A|0|Actual|Medical College of Wisconsin||4||Protocol issues. Modifications potentially will be undertaken and resubmitted to IRB|f||||f||||||||||2017-10-11 00:30:28.661102|2017-10-11 00:30:28.661102
NCT02124434|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2014-04-24|||February 2014||2014-02-01|April 2014|2014-04-01||||October 2015|Anticipated|2015-10-01|1 Year|Observational [Patient Registry]|||Laparoscopic Sleeve Gastrectomy - A Prospective Study of Weight Loss, Comorbidities and Patients' Quality of Life|Laparoscopic Sleeve Gastrectomy - A Prospective Study of Weight Loss, Comorbidities and Patients' Quality of Life|Unknown status|Recruiting|N/A|150|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-11 00:30:28.783546|2017-10-11 00:30:28.783546
NCT02124421|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2017-10-04|||April 2014||2014-04-01|October 2017|2017-10-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|CRS/HIPEC||Outcomes in CRS/HIPEC as Initial Treatment of Ovarian, Fallopian Tube and Primary Peritoneal Cancer|Phase II Randomized Study: Cytoreductive Surgery (CRS) With/Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Adjuvant Chemotherapy as Initial Treatment of Ovarian, Fallopian Tube, & Primary Peritoneal Cancer|Recruiting||Phase 2|48|Anticipated|Mercy Medical Center||2|||f||||f||||||||||2017-10-11 00:30:28.891015|2017-10-11 00:30:28.891015
NCT02124408|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2015-04-27|||November 2013||2013-11-01|April 2014|2014-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||Mobile Phone Personalized Intervention for Diabetes||Unknown status|Recruiting|N/A|500|Anticipated|Ningbo Beilun District Traditional Chinese Medicine Hospital||2|||f||||||||||||||2017-10-11 00:30:29.033736|2017-10-11 00:30:29.033736
NCT02124395|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-12-13|||August 2013||2013-08-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|5 Years|Observational [Patient Registry]|||Health-related Quality of Life in Rare Kidney Stone|Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium|Recruiting||N/A|320|Anticipated|New York University School of Medicine|||4||f||||t||||||||||2017-10-11 00:30:29.120254|2017-10-11 00:30:29.120254
NCT02124382|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-25|||March 2012||2012-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Observational|||Living Donor Liver Transplantation in Children|Living Donor Liver Transplantation in Children: Surgical and Immunological Results in 250 Recipients at Université Catholique de Louvain.|Completed||N/A|500|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-10-11 00:30:29.245741|2017-10-11 00:30:29.245741
NCT02124369|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-07-26|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|July 2017|Actual|2017-07-01||Interventional|PRICKLE||Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)|Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE) - A Single-centre Phase 2a Study of Gemcitabine Plus Nab-paclitaxel for Borderline Unresectable Locally Advanced Pancreatic Cancer|Terminated||Phase 2|9|Actual|Cambridge University Hospitals NHS Foundation Trust||1||Poor accrual|f||||f||||||||||2017-10-11 00:30:29.319029|2017-10-11 00:30:29.319029
NCT02124356|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-10-02|||April 2014||2014-04-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Functional Performance Following Emergency High-risk Abdominal Surgery|Functional Performance Following Emergency High-risk Abdominal Surgery|Completed||N/A|50|Actual|Hvidovre University Hospital|||1||f||||t||||||||||2017-10-11 00:30:29.428089|2017-10-11 00:30:29.428089
NCT02124343|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-10-10|||March 2014||2014-03-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Exercise and Neutrophil Function in COPD|A Pilot Study to Examine the Effect of Acute Exercise on Neutrophil Function in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|20|Actual|Hywel Dda Health Board||1|||f||||f||||||||||2017-10-11 00:30:29.50046|2017-10-11 00:30:29.50046
NCT02124330|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-03-08|||June 2013|Actual|2013-06-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Protein Sorbent Properties of Montmorillonite in Vitro and in Vivo Models|Protein Sorbent Properties of Montmorillonite in Vitro and in Vivo Models|Completed||N/A|35|Actual|IRCCS Burlo Garofolo||4|||f||||f||||||||||2017-10-11 00:30:29.583599|2017-10-11 00:30:29.583599
NCT02124317|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-12-21|||April 2014||2014-04-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|December 2016|Actual|2016-12-01||Interventional|NAPSPAC||Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer|Phase II Trial of Nab-paclitaxel Plus S-1 in First-line Treatment of Patients With Advanced Pancreatic Cancer|Active, not recruiting||Phase 2|60|Actual|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 00:30:29.691242|2017-10-11 00:30:29.691242
NCT02124304|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-01-11|2015-09-22||April 2014||2014-04-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CervEMG||Cervical Activation During Elastic and Manual Resistance|EMG Activation of Cervical Musculature During Therapeutic Exercise With Thera-Band(R) Resistance Versus Manual Resistance|Completed||N/A|30|Actual|Sport and Spine Rehab Clinical Research Foundation||2|||f||||f||||||||||2017-10-11 00:30:29.816852|2017-10-11 00:30:29.816852
NCT02124291|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-04-24|||June 2014||2014-06-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|VitHatSZMC||Effect of Assisted Hatching on Vitrified Embryo Transfer Clinical Outcome|Effect of Assisted Hatching on Vitrified Embryo Transfer Clinical Outcome|Terminated||N/A|18|Actual|Shaare Zedek Medical Center||2||Insufficient enrollment|f||||t||||||||||2017-10-11 00:30:30.134221|2017-10-11 00:30:30.134221
NCT02124278|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-04-28|||February 2014||2014-02-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PUL-042 Inhalation Solution in Healthy Subjects|Completed||Phase 1|42|Actual|Pulmotect, Inc.||2|||f||||f||||||||||2017-10-11 00:30:30.212058|2017-10-11 00:30:30.212058
NCT02124252|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-02-22|||January 2016||2016-01-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Community-Driven Cervical Cancer Prevention in Western Kenya|Evaluation of a Community-Driven Cervical Cancer Prevention Strategy in Western Kenya|Recruiting||N/A|7200|Anticipated|Duke University||3|||f||||f||||||||Undecided||2017-10-11 00:30:30.346531|2017-10-11 00:30:30.346531
NCT02124239|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-06-13|||April 2014||2014-04-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions|A Phase I, Multi-centre, Open-label, Uncontrolled, Non-randomised Study to Evaluate the Systemic Exposure and Safety of Ingenol Mebutate When Applied to Full Face, Balding Scalp or an Area of Approximately 250 cm2 on the Arm in Subjects With Actinic Keratosis|Completed||Phase 1|79|Actual|LEO Pharma||3|||f||||f||||||||||2017-10-11 00:30:30.440457|2017-10-11 00:30:30.440457
NCT02124226|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-05-19|||February 2017||2017-02-01|May 2016|2016-05-01||||April 2018|Anticipated|2018-04-01||Interventional|||Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma|Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma: a Randomized Controlled Trial|Not yet recruiting||Phase 3|102|Anticipated|Universita degli Studi di Catania||2|||f||||t||||||||||2017-10-11 00:30:30.51866|2017-10-11 00:30:30.51866
NCT02124213|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-12-16|||September 2014||2014-09-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PET||A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male Volunteers|Open Label Adaptive Design Study To Evaluate D1 Receptor Occupancy (ro) Following Single Dose Of Pf-06412562, Using Positron Emission Tomography (Pet) With Ligand [11c]sch23390 In Healthy Male Subjects|Completed||Phase 1|5|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:30:30.58289|2017-10-11 00:30:30.58289
NCT02124200|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-06-09|||January 2013||2013-01-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|VAPECIG||High Cessation Rates in Smokers Using Personal Vaporizers|High Cessation Rates in Smokers Using Personal Vaporizers: A Prospective 6-month Pilot Study|Completed||Phase 4|40|Actual|Universita degli Studi di Catania||1|||f||||||||||||||2017-10-11 00:30:30.657359|2017-10-11 00:30:30.657359
NCT02124187|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-10-25|||December 2016||2016-12-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|scarid||Smoking Cessation And Reduction in Depression||Not yet recruiting||Phase 4|129|Anticipated|Universita degli Studi di Catania||3|||f||||t||||||||||2017-10-11 00:30:30.716699|2017-10-11 00:30:30.716699
NCT02124174|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-02-23|||January 2012||2012-01-01|February 2017|2017-02-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS|Maintenance Therapy With Azacitidine and Valproic Acid After Allogeneic Stem Cell Transplant in Patients With High-Risk Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)(Version 1_06 Jan 2012)|Recruiting||Phase 2|50|Anticipated|Loyola University||1|||f||||t||||||||||2017-10-11 00:30:30.840238|2017-10-11 00:30:30.840238
NCT02124161|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-05-23|2016-05-23||September 2014||2014-09-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Safety population included all participants who received at least 1 dose of vaccination.|Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.|A Phase 4, Randomized, Double-blind Trial To Evaluate The Immunogenicity And Safety Of A 13-valent Pneumococcal Conjugate Vaccine When Administered Concomitantly With Seasonal Inactivated Influenza Vaccine In Adults 50 Years And Older Who Received 1 Or More Doses Of 23-valent Pneumococcal Polysaccharide Vaccine Prior To Study Enrollment.|Completed||Phase 4|882|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:30:30.992292|2017-10-11 00:30:30.992292
NCT02124148|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-08-22|||June 18, 2014|Actual|2014-06-18|August 2017|2017-08-01|April 27, 2019|Anticipated|2019-04-27|April 27, 2019|Anticipated|2019-04-27||Interventional|||A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer|A Phase 1b Trial of LY2606368 in Combination With Chemotherapy or Targeted Agents in Advanced and/or Metastatic Tumors|Recruiting||Phase 1|205|Anticipated|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 00:30:36.137859|2017-10-11 00:30:36.137859
NCT02124135|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-08-15|||May 2014||2014-05-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Eat Out With KP: A Pilot to Improve the Impact of Dietary Advice for Families|Eat Out With KP: A Pilot to Improve the Impact of Dietary Advice for Families|Completed||N/A|94|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 00:30:36.297885|2017-10-11 00:30:36.297885
NCT02124122|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-03-09|2016-12-16||March 2015||2015-03-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru|Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru|Completed||Phase 1|60|Actual|Tulane University||2|||f||||t||||||||Undecided||2017-10-11 00:30:36.409145|2017-10-11 00:30:36.409145
NCT02124109|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-10-05|||April 3, 2014||2014-04-03|February 6, 2017|2017-02-06|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Observational|||The Genetic Basis of Acquired Heart Disease in Africa|The Genetic Basis of Acquired Heart Disease in Africa|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:30:36.711224|2017-10-11 00:30:36.711224
NCT02124096|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-06-30|||March 27, 2014||2014-03-27|February 15, 2017|2017-02-15|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs|Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:30:36.798895|2017-10-11 00:30:36.798895
NCT02124083|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-07-18|||April 16, 2014||2014-04-16|July 13, 2017|2017-07-13|December 13, 2016|Actual|2016-12-13|December 13, 2016|Actual|2016-12-13||Interventional|||Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1|Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1|Completed||Phase 1/Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:30:36.869706|2017-10-11 00:30:36.869706
NCT02124070|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-06-30|||March 26, 2014||2014-03-26|November 6, 2015|2015-11-06|November 6, 2015|Actual|2015-11-06|November 6, 2015|Actual|2015-11-06||Interventional|||Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis|Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis|Withdrawn||Phase 1/Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:30:36.955349|2017-10-11 00:30:36.955349
NCT02124057|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-06-30|||April 2, 2014||2014-04-02|April 27, 2017|2017-04-27|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy|Evaluation of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy|Recruiting||N/A|75|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:30:37.103257|2017-10-11 00:30:37.103257
NCT02124044|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-25|2017-04-13|2017-03-01||February 2014||2014-02-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|||Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV|Safety, Tolerability, and Efficacy of Daclatasvir and Asunaprevir, With or Without BMS-791325, in Subjects Coinfected With HIV-HCV|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)|"One subject did not complete 24 weeks of study drug due to a HCV viral load rebound on treatment (at week 6) and was deemed a non-responder. This met the criteria for stopping study medications.
Nine subjects completed 24 weeks of therapy."|2|||f||||f|t|f||||||Yes|NIH Biomedical Translational Research Information System|2017-10-11 00:30:37.313433|2017-10-11 00:30:37.313433
NCT02124031|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-10-22|||December 2013||2013-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01|1 Year|Observational [Patient Registry]|IMPACTAR||Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR)|Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis|Completed||N/A|10241|Actual|Iniciativa Mexicana de Pacientes con Osteoartritis y Artritis Reumatoide|||1||f||||f||||||||||2017-10-11 00:30:37.774426|2017-10-11 00:30:37.774426
NCT02123303|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-08-31|||November 2010||2010-11-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|OH||Orthostatic Hypotension Among Veterans|The Incidence of Orthostatic Hypotension Among Veterans|Completed||N/A|300|Actual|James J. Peters Veterans Affairs Medical Center|||1||f||||f||||||||||2017-10-11 00:30:46.371424|2017-10-11 00:30:46.371424
NCT02124018|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-12-14|||April 2014||2014-04-01|December 2014|2014-12-01|April 2019|Anticipated|2019-04-01|April 2016|Anticipated|2016-04-01|3 Years|Observational [Patient Registry]|PRESERVE-EF||Risk Stratification in Patients With Preserved Ejection Fraction|Post Myocardial Infarction Risk Stratification for Sudden Cardiac Death in Patients With Preserved Ejection Fraction: PRESERVE-EF|Recruiting||N/A|1000|Anticipated|University of Athens|||1||f||||t||||||||||2017-10-11 00:30:37.839875|2017-10-11 00:30:37.839875
NCT02124005|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2017-07-29|||July 2013|Actual|2013-07-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of the Minimum Effective Concentration of Bupivacaine (EC50) in Femoral Block for Analgesia by Ultrasound After Knee Surgery|Evaluation of the Minimum Effective Concentration of Bupivacaine (EC50) in Femoral Block for Analgesia by Ultrasound After Knee Surgery|Completed||Phase 4|45|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 00:30:37.930828|2017-10-11 00:30:37.930828
NCT02123992|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-09-06|||April 2014||2014-04-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|Harmony 522||Study of the Elevate Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse|A Prospective, Safety and Efficacy Cohort Study of Elevate® Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse Repair|Terminated||Phase 4|99|Actual|ASTORA Women's Health||2||Astora business is closing|f||||f||||||||Yes|Data will be shared at a later data by the American Urogynecology Society aggregated with other data extracted from a national registry database.|2017-10-11 00:30:38.007176|2017-10-11 00:30:38.007176
NCT02123979|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-08-06|||November 2015||2015-11-01|August 2015|2015-08-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model|A Double-Blind, Placebo-Controlled, Randomized, Parallel Group Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Opioid Analgesia Using the Oral Surgery Model of Acute Pain in Healthy Volunteers|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|East Carolina University||2|||f||||f||||||||||2017-10-11 00:30:38.141609|2017-10-11 00:30:38.141609
NCT02123966|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-11-29|||May 2014||2014-05-01|November 2016|2016-11-01|October 2021|Anticipated|2021-10-01|February 2018|Anticipated|2018-02-01||Interventional|||An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease|An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease|Recruiting||Phase 2|31|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:30:38.247721|2017-10-11 00:30:38.247721
NCT02123953|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-24|||October 2008||2008-10-01|April 2014|2014-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male Participants|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male Subjects|Completed||Phase 1|60|Actual|Takeda||6|||f||||f||||||||||2017-10-11 00:30:38.330388|2017-10-11 00:30:38.330388
NCT02123940|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-02-05|||February 2014||2014-02-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|WIN IN WEAN||Treatment Strategy in Patients With High-risk of Postextubation Distress in ICU Based on a Lung Ultrasound Score Versus Standard Strategy|Treatment Strategy in Patients With High-risk of Postextubation Distress in ICU Based on a Lung Ultrasound Score Versus Standard Strategy|Recruiting||Phase 3|640|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:30:38.413342|2017-10-11 00:30:38.413342
NCT02123927|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-24|||September 2007||2007-09-01|April 2014|2014-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of TAK-438 in Healthy Male Participants|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of the Safety, Tolerability and Pharmacokinetics of TAK-438 in Healthy Male Subjects|Completed||Phase 1|108|Actual|Takeda||13|||f||||f||||||||||2017-10-11 00:30:38.699424|2017-10-11 00:30:38.699424
NCT02123914|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-08-01|||January 2012||2012-01-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Exercises on Physiological Changes and Clinical Symptoms in Allergic Rhinitis Patients|Effects of Chronic Exercise Training and Vitamin C Supplementation on Physiological Changes and Symptoms in Allergic Rhinitis Patients|Completed||N/A|27|Actual|Chulalongkorn University||2|||f||||f||||||||||2017-10-11 00:30:38.810336|2017-10-11 00:30:38.810336
NCT02123901|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2015-09-15|||December 2013||2013-12-01|August 2013|2013-08-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||The Effect of Walking Meditation Training on Glycemic Control and Vascular Function in Patients With Type 2 Diabetes|THE EFFECT OF WALKING MEDITATION TRAINING ON GLYCEMIC CONTROL AND VASCULAR FUNCTION IN PATIENTS WITH TYPE 2 DIABETES|Completed||N/A|33|Actual|Chulalongkorn University||2|||f||||||||||||||2017-10-11 00:30:38.895483|2017-10-11 00:30:38.895483
NCT02123888|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-02-06|||June 2011||2011-06-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SCART||Simultaneous CBCT Acquisition During Arc Radiotherapy|Simultaneous Cone Beam Computed Tomography (CBCT) Acquisition During Arc Radiotherapy|Unknown status|Recruiting|N/A|75|Anticipated|The Christie NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 00:30:39.009068|2017-10-11 00:30:39.009068
NCT02123875|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-04-24|||December 2011||2011-12-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|ATTEND||ATTEND-Family-led Rehabilitation After Stroke in India|Family-led Rehabilitation After Stroke in India|Completed||N/A|104|Actual|Christian Medical College and Hospital, Ludhiana, India||2|||f||||f||||||||||2017-10-11 00:30:39.127081|2017-10-11 00:30:39.127081
NCT02123862|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-01-15|||April 2014||2014-04-01|January 2015|2015-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|||Cultured Circulating Tumor Cells in Prostate and Other Cancers|Cultured Circulating Tumor Cells - Development of a Novel Platform for Drug Discovery and in Vitro Chemosensitivity Testing in Prostate and Other Cancers|Recruiting||N/A|220|Anticipated|Comprehensive Cancer Centers of Nevada|||5||f||||f||||||Samples With DNA|"     -  Fifteen (15) cc whole blood (two - 7.5 cc tubes) will be collected and processed for          research tests.        -  Patients with prostate, breast or colorectal cancer will have an additional ten (10) cc          whole blood collected for commercial CTC assay as part of standard care.   "|||2017-10-11 00:30:39.199942|2017-10-11 00:30:39.199942
NCT02123849|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2016-10-19|||June 2014||2014-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers|The Effect of Intermittent Versus Continuous Dose Aspirin (ASA) on Nasal Epithelium Gene Expression in Current Smokers|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 00:30:39.300517|2017-10-11 00:30:39.300517
NCT02123836|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2015-06-17|||April 2014||2014-04-01|June 2015|2015-06-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome|Pilot Study of Expanded, Activated Haploidentical Natural Killer Cell Infusions for Non-B Lineage Acute Leukaemia and Myelodysplastic Syndrome|Recruiting||Phase 1|20|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 00:30:39.425731|2017-10-11 00:30:39.425731
NCT02123823|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-09-05|||May 15, 2014|Actual|2014-05-15|September 2017|2017-09-01|October 9, 2017|Anticipated|2017-10-09|October 6, 2017|Anticipated|2017-10-06||Interventional|||BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer|A Phase Ib/II Randomized Study of BI 836845 in Combination With Exemestane and Everolimus Versus Exemestane and Everolimus Alone in Women With Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 1|164|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:30:39.536512|2017-10-11 00:30:39.536512
NCT02123810|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-07-20|||April 2014||2014-04-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|WeCAN||Quality of Chest Compressions After a Night Shift|Weaker Chest Compression After Nightshift : The We CAN Study.|Completed||N/A|46|Actual|Bistro Study Group||2|||f||||f||||||||||2017-10-11 00:30:39.817782|2017-10-11 00:30:39.817782
NCT02123797|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-07-18|||August 2014||2014-08-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology|Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology|Recruiting||N/A|450|Anticipated|Baptist Memorial Health Care Corporation|||2||f||||f||||||||||2017-10-11 00:30:39.926331|2017-10-11 00:30:39.926331
NCT02123784|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-07-01|||April 2014||2014-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|MARK-GEROT||Biomarkers for the Surgical Treatment of Rotator Cuff Tears|Biomarkers for the Surgical Treatment of Rotator Cuff Tears|Recruiting||N/A|100|Anticipated|Balgrist University Hospital|||1||f||||f||||||Samples With DNA|"     blood, muscle, tendon, capsule, synovial liquid   "|||2017-10-11 00:30:40.017262|2017-10-11 00:30:40.017262
NCT02123771|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-25|||May 2013||2013-05-01|April 2014|2014-04-01||||March 2014|Actual|2014-03-01||Observational|||Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections|Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections|Unknown status|Recruiting|Phase 1|100|Anticipated|National University Hospital, Singapore|||1||f||||f||||||Samples Without DNA|"     Stool samples(solid/semi-solid) between 1-5 g will be collected and tested using ELISA for     the presence of the H. pylori GGT antigen using monoclonal antibodies against GGT.   "|||2017-10-11 00:30:40.116654|2017-10-11 00:30:40.116654
NCT02123758|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-05-26|||July 9, 2014|Actual|2014-07-09|May 2017|2017-05-01|January 12, 2018|Anticipated|2018-01-12|January 12, 2018|Anticipated|2018-01-12||Interventional|||A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer|A Drug-Drug Interaction, Safety and Efficacy Study With JNJ-56021927 (ARN-509) and Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1|59|Actual|Aragon Pharmaceuticals, Inc.||2|||f||||f||f||||||||2017-10-11 00:30:40.215436|2017-10-11 00:30:40.215436
NCT02123745|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-05-27|2014-04-28||February 2014||2014-02-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||ivWatch Model 400: Device Validation for Infiltrated Tissues||Completed||N/A|71|Actual|ivWatch, LLC||1|||f||||t||||||||||2017-10-11 00:30:40.357486|2017-10-11 00:30:40.357486
NCT02123732|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-03-05|||July 2014||2014-07-01|March 2017|2017-03-01||||February 2017|Actual|2017-02-01||Interventional|||Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus|Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus|Active, not recruiting||Phase 1/Phase 2|20|Actual|Laniado Hospital||2|||f||||f||||||||||2017-10-11 00:30:40.604697|2017-10-11 00:30:40.604697
NCT02123719|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-04-24|||January 2013||2013-01-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Observational|||Laparoscopic Incisional Hernia Repair in Liver Transplant Patients|Outcomes Analysis of Laparoscopic Incisional Hernia Repair and Risk Factors for Hernia Recurrence in Liver Transplant Patients|Completed||N/A|112|Actual|Medical University Innsbruck|||2||f||||f||||||||||2017-10-11 00:30:40.693693|2017-10-11 00:30:40.693693
NCT02123693|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2014-09-15|||June 2014||2014-06-01|September 2014|2014-09-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||The Role of Osteopathic Treatment in the Axial Variations of the Lumbar Spine: RCT||Unknown status|Recruiting|N/A|30|Anticipated|European Institute for Evidence Based Osteopathic Medicine||3|||f||||||||||||||2017-10-11 00:30:40.772783|2017-10-11 00:30:40.772783
NCT02123680|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2015-06-01|||April 2014||2014-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|CLBPEXPECT||Chronic Low Back Pain Patients' Expectations Toward Physiotherapy|Non-specific Chronic Low Back Pain Patients' Expectations Toward Physiotherapy and Physiotherapists: An Interpretive Socio-anthropological Study on Ill Persons' Experience|Completed||N/A|20|Actual|Haute Ecole Cantonale Vaudoise de Santé|||1||f||||f||||||||||2017-10-11 00:30:40.864895|2017-10-11 00:30:40.864895
NCT02123667|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-07-20|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|February 28, 2017|Actual|2017-02-28||Observational|ATLANTIS||AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)|AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS); Multinational, Multicentre, Non-pharmacological Intervention, Cross-sectional and Longitudinal Study.|Active, not recruiting||N/A|900|Anticipated|Chiesi Farmaceutici S.p.A.|||2||f||||t||||||Samples With DNA|"     Optional bronchoscopy with endobronchial and trans-bronchial biopsy will be applicable in     selected sites only in EU and US. Total number of inflammatory cells and quantification of     specific cells including eosinophils, T cells and macrophages will be performed. Gene     expression profiles (including RNA) will be performed at a later date for future analysis on     the pathobiology of asthma which will be defined in future specific protocols   "|||2017-10-11 00:30:40.943531|2017-10-11 00:30:40.943531
NCT02123654|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-09-16|||April 2014||2014-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C|A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Treatment-Naive and IFN Experienced Subjects With Genotype 1 Chronic Hepatitis C|Completed||Phase 3|297|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 00:30:41.066127|2017-10-11 00:30:41.066127
NCT02123641|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-24|2017-09-22|||April 2014||2014-04-01|September 2017|2017-09-01|June 2028|Anticipated|2028-06-01|June 2028|Anticipated|2028-06-01||Interventional|LISA||Physical Activity as Intervention Against Age-related Loss of Muscle Mass and Function|Physical Activity as Intervention Against Age-related Loss of Muscle Mass and Function|Active, not recruiting||N/A|451|Actual|Bispebjerg Hospital||3|||f||||t||||||||||2017-10-11 00:30:41.219978|2017-10-11 00:30:41.219978
NCT02123628|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-22|||June 2007||2007-06-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|June 2010|Actual|2010-06-01||Interventional|C H R O N O S||Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis|Six- Versus Twelve-Week Therapy for Non-Surgically-Treated Diabetic Foot Osteomyelitis: A Multicenter Open-Label Controlled Randomized Study|Completed||Phase 4|40|Actual|Tourcoing Hospital||2|||f||||f||||||||||2017-10-11 00:30:41.324357|2017-10-11 00:30:41.324357
NCT02123615|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2015-06-22|||January 2016||2016-01-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|ASISinPI||ASIS for GAMMAGARD in Primary Immunodeficiency|ASIS for GAMMAGARD in Primary Immunodeficiency|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|ASIS Corporation||20|||f||||t||||||||||2017-10-11 00:30:41.4244|2017-10-11 00:30:41.4244
NCT02123602|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-01-23|||April 2014||2014-04-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Core Stabilization for the Treatment of Anterior Knee Pain|The Effects of a Trunk Strengthening Program on Anterior Knee Pain in an Adolescent Athletic Population: a Randomized Clinical Trial|Recruiting||N/A|50|Anticipated|Youngstown State University||2|||f||||f||||||||||2017-10-11 00:30:42.150673|2017-10-11 00:30:42.150673
NCT02123589|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-23|||April 2014||2014-04-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||The Psychological Effects of Different Sedation Protocol on Mechanically Ventilated Critically Ill Adults.|The Psychological Effects of Different Sedation Protocol on Mechanically Ventilated Critically Ill adults-a Prospective, Randomized and Controlled Trial|Unknown status|Not yet recruiting|Phase 4|150|Anticipated|West China Hospital||3|||f||||f||||||||||2017-10-11 00:30:42.231798|2017-10-11 00:30:42.231798
NCT02123576|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-05-01|||April 2014||2014-04-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline|Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline: A Placebo Controlled, Blinded Pilot Study|Terminated||N/A|12|Actual|University of Virginia||2||Poor enrollment of study population|f||||f||||||||||2017-10-11 00:30:42.310911|2017-10-11 00:30:42.310911
NCT02123563|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-23|||June 2012||2012-06-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|MCGTDO||Mechanical-chemical Gingival Therapy in Diabetics and/or Obese|Evaluation of Mechanical-chemical Gingival Therapy in Diabetic, Obese or Diabese Subjects: Quantitative and Qualitative Analysis of Local and General Aspects.|Completed||Phase 4|240|Actual|University of Taubate||2|||f||||f||||||||||2017-10-11 00:30:42.404667|2017-10-11 00:30:42.404667
NCT02123550|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-04-20|||January 2014||2014-01-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2014|Actual|2014-12-01||Observational|||Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection|Doppler Ultrasound Imaging of Plastic Surgery Patients for Deep Venous Thrombosis Detection: A Prospective Controlled Study.|Recruiting||N/A|1000|Anticipated|Swanson Center|||1||f||||t||||||||||2017-10-11 00:30:42.480264|2017-10-11 00:30:42.480264
NCT02123537|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-09-06|||June 2014||2014-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Treating Foot Drop in People With Multiple Sclerosis Using Electrical Stimulation|Functional Electrical Stimulation to Treat Foot Drop in People With Multiple Sclerosis|Completed||N/A|10|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 00:30:42.549822|2017-10-11 00:30:42.549822
NCT02123524|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-12-06|||November 2014||2014-11-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|RASET||Rivaroxaban Anticoagulation for Superficial Vein Thrombosis|A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis|Recruiting||Phase 3|600|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-11 00:30:42.635674|2017-10-11 00:30:42.635674
NCT02123511|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-03-21|||April 2014|Actual|2014-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy|A Randomized, Double-Blind Pilot Study of N-Acetylcysteine Mucoadherent Rinse Versus Placebo for Thickened Secretions and Mucositis Secondary to Chemoradiotherapy in the Management of Head and Neck Malignancies|Active, not recruiting||N/A|18|Actual|Mayo Clinic||2|||f||||||||||||||2017-10-11 00:30:42.874481|2017-10-11 00:30:42.874481
NCT02123498|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-09-22||||||April 2014|2014-04-01||||May 2015|Actual|2015-05-01||Interventional|ETDLPR||The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux|The Study of the Diagnosis of Eustachian Tube Dysfunction (ETD): Identifying the Relationship of Ear Fullness to Laryngopharyngeal Reflux (LPR)|Withdrawn||Phase 4|0|Actual|Loma Linda University||1||IRB not approved|f||||t||||||||||2017-10-11 00:30:43.040381|2017-10-11 00:30:43.040381
NCT02123485|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-11-13|||November 2014||2014-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|TMS||the Antidepressant Effect of rTMS as add-on to ECT|The Antidepressant Efficacy of Repetitive Transcranial Magnetic Stimulation ( rTMS) as add-on to Electroconvulsive Therapy (ECT). A Double Blind Randomized Controlled Trial.|Recruiting||Phase 4|56|Anticipated|University of Aarhus||2|||f||||t||||||||No||2017-10-11 00:30:43.18951|2017-10-11 00:30:43.18951
NCT02123290|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-06-21|||January 2016||2016-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax|A Proof-of-Concept, Open Label Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of Single Doses of DSM265 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-Infection Over a 35-Day-Extended Observation Period|Completed||Phase 2|45|Actual|Medicines for Malaria Venture||2|||f||||t||||||||||2017-10-11 00:30:46.460351|2017-10-11 00:30:46.460351
NCT02123472|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-06-19|2015-05-08||May 2014||2014-05-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants|A Randomized, Open-label, Two-period, Two-treatment, Two-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of Two Oral Preparations in Suspension With 125 mg/5 ml of Cephalexin (Keflex® Pediatrico Made in Mexico by Eli Lilly y Compañía de México, S.A. de C.V. vs. Keflex® Pediatrico Made in Italy by Facta Farmaceutici S.p.A. for Eli Lilly y Compañía de México, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:30:43.315424|2017-10-11 00:30:43.315424
NCT02123459|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-05-08|2015-05-08||May 2014||2014-05-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of Cephalexin Suspension in Healthy Participants|A Randomized, Open-label, Two-period, Two-treatment, Two-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of Two Oral Preparations in Suspension With 250 mg/5 ml of Cephalexin (Keflex® Liquido Made in Mexico by Eli Lilly y Compañía de México, S.A. de C.V. vs. Keflex® Liquido Made by Antibioticos do Brasil Ltda for Eli Lilly y Compañía de México, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:30:43.650168|2017-10-11 00:30:43.650168
NCT02123446|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-06-19|2015-05-08||April 2014||2014-04-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of Cephalexin Capsules in Healthy Participants|A Randomized, Open-label, Two-period, Two-treatment, Two-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of Two Oral Preparations in Capsules With 250 mg of Cephalexin (Keflex® Made in Mexico by Eli Lilly y Compañía de México, S.A. de C.V. vs. Keflex® Made in Italy by Facta Farmaceutici S.p.A. for Eli Lilly y Compañía de México, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:30:44.037682|2017-10-11 00:30:44.037682
NCT02123433|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2014-04-23|||December 2011||2011-12-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|PCV13HIV2011||Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults|Serological Response to Antipneumococcal Vaccination and Consequent Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Positive Adults: a Prospective Study Using 13-valent Conjugate Vaccine|Completed||Phase 3|50|Actual|University of Siena||1|||f||||||||||||||2017-10-11 00:30:44.370139|2017-10-11 00:30:44.370139
NCT02123420|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-23|||November 2011||2011-11-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Platform Switching vs Regular Platform Implants. One Year Results From a RCT|Platform Switching vs Regular Platform Implants. One Year Results From a RCT|Completed||N/A|18|Actual|Università degli Studi di Sassari||2|||f||||f||||||||||2017-10-11 00:30:45.137415|2017-10-11 00:30:45.137415
NCT02123407|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-04-23|||December 2013||2013-12-01|April 2014|2014-04-01||||June 2014|Anticipated|2014-06-01||Interventional|||Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer|Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer：a Prospective Randomized Study|Unknown status|Recruiting|Phase 3|30|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 00:30:45.271956|2017-10-11 00:30:45.271956
NCT02123394|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-06-09|||May 2014||2014-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|Mckenzie||Efficacy of the Mckenzie Method in Patients With Chronic Non-Specific Low Back Pain|Efficacy of the Mckenzie Method in Patients With Chronic Non-Specific Low Back Pain: A Randomized Placebo-Controlled Trial|Completed||N/A|148|Actual|Universidade Cidade de Sao Paulo||2|||f||||f||||||||||2017-10-11 00:30:45.436859|2017-10-11 00:30:45.436859
NCT02123381|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2015-11-18|||April 2014||2014-04-01|November 2015|2015-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma|Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Middle or Lower Thoracic Esophageal Squamous Cell Carcinoma|Recruiting||Phase 2|100|Anticipated|Sichuan Cancer Hospital and Research Institute||1|||f||||t||||||||||2017-10-11 00:30:45.583345|2017-10-11 00:30:45.583345
NCT02123368|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-01-05|||May 2012||2012-05-01|April 2014|2014-04-01|February 2015|Anticipated|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells|Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Actual|Clinica Universidad de Navarra, Universidad de Navarra||3|||f||||t||||||||||2017-10-11 00:30:45.739886|2017-10-11 00:30:45.739886
NCT02123355|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2014-04-24|||August 2014||2014-08-01|April 2014|2014-04-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery|The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery,A Randomized Controlled Study|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Shaanxi Provincial People's Hospital||2|||f||||f||||||||||2017-10-11 00:30:45.908805|2017-10-11 00:30:45.908805
NCT02123342|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2015-05-25|||June 2014||2014-06-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|myPAtHS||SMS Reminders for Exercise Among Older Adults. Malaysian Physical Activity for Health Study|Promoting Exercise Among Older Malaysians Using SMS Reminders. The Malaysian Physical Activity for Health Study (myPAtHS): A Randomized Controlled Trial|Completed||N/A|43|Actual|University of Malaya||2|||f||||||||||||||2017-10-11 00:30:46.023798|2017-10-11 00:30:46.023798
NCT02123316|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2016-03-30|||January 2010||2010-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|ECRL1||Subcutaneous Immunotherapy With Dermatophagoides Pteronyssinus in Local Allergic Rhinitis|Assessment of the Effectiveness of a Dermatophagoides Pteronyssinus Extract, Rated in Units of Mass and Administered Subcutaneously for the Treatment of Local Allergic Rhinitis. Randomized, Double-blind, Placebo-controlled Study.|Completed||Phase 2|36|Actual|Plaza del Hospital Civil||2|||f||||t||||||||||2017-10-11 00:30:46.252521|2017-10-11 00:30:46.252521
NCT02123277|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-07-20|||May 2014||2014-05-01|July 2015|2015-07-01|May 2017|Anticipated|2017-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Long Term Evaluation of Tubal Expansion on Obstructive Dysfunctions of Eustachian Tube|Long Term Evaluation of Tubal Expansion on Obstructive Dysfunctions of Eustachian Tube|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 00:30:46.5748|2017-10-11 00:30:46.5748
NCT02123264|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-02-21|||May 2014||2014-05-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|AZAR||Zoledronic Acid in Rheumatoid Arthritis|Randomized Clinical Trial on the Prevention of Radiographic Progression With Zoledronic Acid in Patients With Early Rheumatoid Arthritis and Low Disease Activity|Recruiting||Phase 3|94|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 00:30:46.665249|2017-10-11 00:30:46.665249
NCT02123238|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-09-14|||April 2014||2014-04-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Positioning of Surgical Patients With Sleep Apnea|Non-Supine Positioning in Treatment of Surgical Patients With Obstructive Sleep Apnea|Withdrawn||N/A|0|Actual|Englewood Hospital and Medical Center||3||no funding|f||||f||||||||||2017-10-11 00:30:47.24694|2017-10-11 00:30:47.24694
NCT02123225|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-09-19|||December 2013||2013-12-01|September 2017|2017-09-01|May 12, 2017|Actual|2017-05-12|November 2016|Actual|2016-11-01||Observational|||Is the STOP-BANG Predictive of Worsening OSA in the Early Postop Period in Patients Undergoing TJA?|Is the STOP-BANG Predictive of Worsening Obstructive Sleep Apnea in the Early Postoperative Period in Patients Undergoing Total Joint Arthroplasty?|Completed||N/A|93|Actual|United States Naval Medical Center, San Diego|||1||f||||f||||||||||2017-10-11 00:30:47.342068|2017-10-11 00:30:47.342068
NCT02123212|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-03-25|||February 2013||2013-02-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Best-C||Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C|Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C|Completed||N/A|29607|Actual|National Opinion Research Center||3|||f||||f||||||||||2017-10-11 00:30:47.458257|2017-10-11 00:30:47.458257
NCT02123199|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-24|||April 2012||2012-04-01|April 2014|2014-04-01||||December 2013|Actual|2013-12-01||Observational|INHALE||Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD|Prospective Observational Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD|Completed||N/A|103|Actual|Novartis|||1||f||||||||||||||2017-10-11 00:30:47.594692|2017-10-11 00:30:47.594692
NCT02123186|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2016-10-31|||October 2013||2013-10-01|April 2016|2016-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Newborn Screening for Spinal Muscular Atrophy|Newborn Screening for Spinal Muscular Atrophy|Completed||N/A|120267|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:30:47.691099|2017-10-11 00:30:47.691099
NCT02123173|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-12-03|||May 2014||2014-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Hemodynamic Changes During One Lung Ventilation in Non-intubated Vedio-assisted Thoracoscopic Operations|Hemodynamic Changes and Fluid Responsiveness During One Lung Ventilation: Comparison in Non-intubated and Intubated Vedio-assisted Thoracoscopic Operations|Completed||N/A|71|Actual|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 00:30:47.781715|2017-10-11 00:30:47.781715
NCT02123160|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-08-21|||November 2013||2013-11-01|August 2017|2017-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Dyadic Therapy for Mothers and Children|Dyadic Therapy for Mothers and Children|Terminated||Phase 1|2|Actual|New York State Psychiatric Institute||2||Loss of staff|f||||t||||||||||2017-10-11 00:30:47.868424|2017-10-11 00:30:47.868424
NCT02123147|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-08-07|||July 2014||2014-07-01|August 2017|2017-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Examining the Immunological Process of Autoimmune Patients|Examining the Immunological Process of Autoimmune Patients|Withdrawn||N/A|0|Actual|University of Florida|||2|due to the lack of funding to continue|f||||f||||||||||2017-10-11 00:30:47.988193|2017-10-11 00:30:47.988193
NCT02123134|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-09-18|||April 2014||2014-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Safety Study of ATX-101 for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age|A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age|Completed||Phase 3|55|Actual|Kythera Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 00:30:48.094012|2017-10-11 00:30:48.094012
NCT02123121|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-05-17|||September 2015||2015-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|REVIVE||Resveratrol to Enhance Vitality and Vigor in Elders|Phase IIa Study of Resveratrol to Enhance Mitochondrial and Physical Function in Older Adults|Recruiting||Phase 2|60|Anticipated|University of Florida||3|||f||||t||||||||||2017-10-11 00:30:48.303375|2017-10-11 00:30:48.303375
NCT02123108|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-04-23|||January 2011||2011-01-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA Following Liver Transplantation|Safety and Efficacy of Immunosuppression With Basiliximab, Delayed Dose Tacrolimus Plus Enteric Coated Mycophenolic Acid, Versus Standard Dose Tacrolimus, Enteric Coated Mycophenolic Acid Plus Corticosteroids in Patients Undergoing Orthotopic Liver Transplantation (OLT)|Unknown status|Recruiting|Phase 4|60|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:30:48.480519|2017-10-11 00:30:48.480519
NCT02123082|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-11-03|||April 2014||2014-04-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes|Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes|Recruiting||N/A|300|Anticipated|University of California, Irvine||2|||f||||t||||||||||2017-10-11 00:30:48.627715|2017-10-11 00:30:48.627715
NCT02123069|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-09-07|||April 2013||2013-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Vascular Function and Uterine Fibroids|Sympathetic Nerve Activity and Vascular Function in Women With Uterine Leiomyomata|Recruiting||N/A|40|Anticipated|Mayo Clinic|||2||f||||f||||||Samples With DNA|"     Whole blood and serum      No DNA extraction from samples is planned.   "|||2017-10-11 00:30:48.761343|2017-10-11 00:30:48.761343
NCT02123056|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-08-29|||October 2014||2014-10-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects|Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects|Recruiting||Phase 4|248|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-11 00:30:48.962026|2017-10-11 00:30:48.962026
NCT02123043|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-03-15|||October 2014||2014-10-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|February 7, 2017|Actual|2017-02-07||Interventional|||Motor Learning-based Wheelchair Propulsion Training for Older Adults|The Effect of Motor Learning-based Wheelchair Propulsion Training on Wheeling Biomechanics and Gross Mechanical Efficiency in Older Adults: A Randomized Controlled Trial|Active, not recruiting||N/A|35|Actual|University of British Columbia||3|||f||||f||||||||No||2017-10-11 00:30:49.145804|2017-10-11 00:30:49.145804
NCT02123030|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-11-21|||January 2011||2011-01-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||A Micro/Nano Device for Exhaled Breath Analysis|A Micro/Nano Device for Exhaled Breath Analysis|Recruiting||N/A|1000|Anticipated|James Graham Brown Cancer Center|||2||f||||t||||||Samples Without DNA|"     Breathe samples   "|||2017-10-11 00:30:49.279006|2017-10-11 00:30:49.279006
NCT02123017|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-01-27|2015-12-18||April 2014||2014-04-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||All patients adhered to the one set of study-level eligibility criteria.|Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy|An Observer-blinded, Dose-finding Study to Investigate the Safety, Efficacy, and Patient Preference of Lactulose for Oral Solution With Bisacodyl for Cleansing of the Colon as a Preparation for Colonoscopy in Adults|Completed||Phase 2|32|Actual|Cumberland Pharmaceuticals||3|||f||||t||||||||||2017-10-11 00:30:49.397382|2017-10-11 00:30:49.397382
NCT02123004|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2015-02-24|||April 2014||2014-04-01|February 2015|2015-02-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|TIGERCAVE||Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function|Comparison of The Influence of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function For Patients With ST-Segment Elevation Myocardial Infarction Receiving Emergency Percutaneous Coronary Intervention|Unknown status|Not yet recruiting|Phase 4|350|Anticipated|Jinan Central Hospital||2|||f||||t||||||||||2017-10-11 00:30:49.982408|2017-10-11 00:30:49.982408
NCT02122991|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-08-15|||July 2013||2013-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Observational|||Cardiovascular, Cerebrovascular, and Cognitive Function in Spinal Cord Injury|Cardiovascular, Cerebrovascular, and Cognitive Function in SCI|Active, not recruiting||N/A|61|Actual|James J. Peters Veterans Affairs Medical Center|||2||f||||f||||||||||2017-10-11 00:30:50.129412|2017-10-11 00:30:50.129412
NCT02122978|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-04-24|||November 2013||2013-11-01|April 2014|2014-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Comparing Mindfulness Based Cognitive Therapy and Mindfulness Based Self-compassion Therapy in a Psoriasis Sample|Comparing Mindfulness Based Cognitive Therapy and Mindfulness Based Self-compassion Therapy: Understanding What Works Psychologically and Physiologically in a Randomized Study in Dermatology|Unknown status|Active, not recruiting|N/A|94|Actual|St Vincent's University Hospital, Ireland||3|||f||||f||||||||||2017-10-11 00:30:50.226965|2017-10-11 00:30:50.226965
NCT02122965|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-23|||December 2012||2012-12-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|||The Effect of Medication Review in High-risk Emergency Department Patients|The Effect of Medication Review in High-risk Emergency Department Patients: Evaluation of a Quality Improvement Program|Completed||N/A|10805|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:30:50.327782|2017-10-11 00:30:50.327782
NCT02122952|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-08-01|||May 5, 2014|Actual|2014-05-05|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1|Phase I Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 Delivering AVXS-101|Active, not recruiting||Phase 1|15|Actual|AveXis, Inc.||2|||f||||t||||||||||2017-10-11 00:30:50.415997|2017-10-11 00:30:50.415997
NCT02122939|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-05-30|||September 2013||2013-09-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram in Elderly Volunteers|An Open-label, Single Dosing Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram After Oral Administration in Elderly Volunteers|Completed||Phase 1|12|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 00:30:50.541738|2017-10-11 00:30:50.541738
NCT02122926|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-04-24|||December 2011||2011-12-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|IDID||Intensive Discharge Intervention in Diabetes|Effects of an Intensive Discharge Intervention on Medication Adherence, Glycemic Control, and Readmission Rates in Patients With Type 2 Diabetes|Completed||N/A|180|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 00:30:50.622678|2017-10-11 00:30:50.622678
NCT02122913|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-01-27|||April 2014|Actual|2014-04-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Oral TRK Inhibitor LOXO-101 for Treatment of Advanced Adult Solid Tumors|A Phase 1 Study of the Oral TRK Inhibitor LOXO-101 in Adult Patients With Solid Tumors|Recruiting||Phase 1|108|Anticipated|Loxo Oncology, Inc.||1|||t||||f|t|f||||||No||2017-10-11 00:30:50.732894|2017-10-11 00:30:50.732894
NCT02122900|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-06-09|||June 2013||2013-06-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|BAV||Prospective Balloon Aortic Valvuloplasty|Assessment of the Role of Balloon Aortic Valvuloplasty in the Management of Patients With Aortic Stenosis|Completed||N/A|100|Actual|Baylor Research Institute|||1||f||||t||||||||||2017-10-11 00:30:50.888571|2017-10-11 00:30:50.888571
NCT02122887|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-01-12|||March 2014||2014-03-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Peace-Building Interventions for Israeli and Palestinian Youth|Peace-Building Interventions for Israeli and Palestinian Youth: Effects on Biological and Behavioral Markers of Empathy, Prejudice, and Dialogue|Completed||N/A|118|Actual|Bar-Ilan University, Israel||2|||f||||t||||||||||2017-10-11 00:30:50.99888|2017-10-11 00:30:50.99888
NCT02122874|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-04-24|||January 2013||2013-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients||Completed||Phase 3|60|Actual|Hospital General Universitario Elche||2|||f||||||||||||||2017-10-11 00:30:51.113812|2017-10-11 00:30:51.113812
NCT02122861|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-08-16|||May 30, 2014|Actual|2014-05-30|August 2017|2017-08-01|August 11, 2020|Anticipated|2020-08-11|December 31, 2017|Anticipated|2017-12-31||Interventional|||Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1|A Phase 1, Open-Label Clinical Trial Evaluating the Safety, Tolerability and Immunogenicity of Intradermally Administered ID-LV305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1|Active, not recruiting||Phase 1|47|Actual|Immune Design||1|||f||||t||||||||||2017-10-11 00:30:51.220817|2017-10-11 00:30:51.220817
NCT02122848|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2015-04-20|||April 2014||2014-04-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Exercise Tolerance in Patients With Decompensated Heart Failure|Effects of Bilevel Positive Airway Pressure on Exercise Tolerance in Patients With Decompensated Heart Failure|Completed||N/A|16|Actual|Hospital Sirio-Libanes||1|||f||||t||||||||||2017-10-11 00:30:51.353776|2017-10-11 00:30:51.353776
NCT02122835|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2015-11-11|||February 2012||2012-02-01|May 2015|2015-05-01||||September 2014|Actual|2014-09-01||Interventional|||Exercise, Heart Failure, and Type 2 Diabetes|Vascular and Metabolic Responses to Exercise Training in Heart Failure With or Without Type 2 Diabetes|Withdrawn||N/A|0|Actual|Duke University||2||Lack of funding/patient availability|f||||||||||||||2017-10-11 00:30:51.447834|2017-10-11 00:30:51.447834
NCT02122822|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-12-10|||July 2013||2013-07-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|July 2015|Actual|2015-07-01||Interventional|||Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96|Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96|Active, not recruiting||Phase 1|20|Actual|Cure&Sure Biotech Co., LTD||1|||f||||t||||||||||2017-10-11 00:30:51.546025|2017-10-11 00:30:51.546025
NCT02122809|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-06-16|||February 2014||2014-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Phase I Study of Chiauranib in Patients With Advanced Solid Tumors|Phase I Safety and Pharmacokinetics Study of Chiauranib in Patients With Advanced Solid Tumors|Completed||Phase 1|18|Actual|Chipscreen Biosciences, Ltd.||1|||f||||f||||||||No||2017-10-11 00:30:51.644238|2017-10-11 00:30:51.644238
NCT02122783|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-01-31|||January 2013||2013-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Comparison of the Functional Walking Outcomes of Two Settings of a Commercially Available AFO in Adult Stroke Patients|Comparison of the Functional Walking Outcomes of Two Settings of a Commercially Available Ankle Foot Orthosis in Adult Stroke Patients|Active, not recruiting||N/A|5|Actual|Albert Einstein Healthcare Network||2|||f||||t|f|t|f|||||No||2017-10-11 00:30:51.842054|2017-10-11 00:30:51.842054
NCT02122770|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-09-04|||April 1, 2014|Actual|2014-04-01|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|January 1, 2016|Actual|2016-01-01||Interventional|||Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Patients With Advanced Solid Tumors|A Phase 1 Study to Evaluate the Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|52|Actual|Takeda||2|||f||||t||||||||||2017-10-11 00:30:51.924246|2017-10-11 00:30:51.924246
NCT02122757|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-05-27|||September 2013||2013-09-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|ANODEM||Anodal Transcranial Direct Current Stimulation of the Visual Cortex Versus Sham Stimulation in the Episodic Migraine|Randomised Sham-controlled Trial of Anodal Transcranial Direct Current Stimulation (tDCS) for the Prevention of Episodic Migraine|Unknown status|Recruiting|Phase 3|30|Anticipated|University Hospital of Liege||2|||f||||f||||||||||2017-10-11 00:30:52.058548|2017-10-11 00:30:52.058548
NCT02122744|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-05-27|||September 2013||2013-09-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|||RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine|Randomised Placebo Controlled Trial of rTMS Quadri Pulse Over Visual Cortex for the Prevention of Chronic Migraine|Completed||Phase 3|30|Actual|University Hospital of Liege||2|||f||||t||||||||||2017-10-11 00:30:52.141802|2017-10-11 00:30:52.141802
NCT02122731|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-04-23|||November 2010||2010-11-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Amiloride for Resistant Hypertension|Southern Danish Hypertension and Diabetes Study (SDHDS) With Amiloride|Completed||Phase 4|80|Actual|Odense University Hospital||1|||f||||f||||||||||2017-10-11 00:30:52.217429|2017-10-11 00:30:52.217429
NCT02122718|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-09-14|||May 2014||2014-05-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|September 2018|Anticipated|2018-09-01||Interventional|XILO-FIST||Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack|Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack|Recruiting||Phase 4|464|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||t||||||||||2017-10-11 00:30:52.318702|2017-10-11 00:30:52.318702
NCT02122705|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-02-05|||May 2012||2012-05-01|September 2015|2015-09-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|VPIA||A Case Series of VPIA Using Remifentanil for Labour and Delivery|A Case Series of Vital Signs-controlled, Patient Assisted Intravenous Analgesia (VPIA) Using Remifentanil for Labour and Delivery|Completed||N/A|29|Actual|KK Women's and Children's Hospital|||1||f||||t||||||||No||2017-10-11 00:30:52.453013|2017-10-11 00:30:52.453013
NCT02122692|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-06-18|||March 2014||2014-03-01|June 2014|2014-06-01||||June 2014|Actual|2014-06-01||Interventional|||Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects|Interventional, Open-label, One-sequence Crossover Study to Evaluate the Effect of Multiple Doses of Itraconazole (Inhibitor of CYP3A4/5) on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects|Completed||Phase 1|20|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 00:30:52.77734|2017-10-11 00:30:52.77734
NCT02122679|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2016-11-23|||December 2014||2014-12-01|November 2016|2016-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass|A Randomized Trial Investigating the Effect of Tranexamic Acid on Platelet Aggregation Following Infant Cardiopulmonary Bypass|Withdrawn||Phase 4|0|Actual|Emory University||2|||f||||t||||||||||2017-10-11 00:30:52.917295|2017-10-11 00:30:52.917295
NCT02122666|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-10-31|||March 2014||2014-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|COMP-SR||Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome|Modulating Physiologic Effects Of Phospholipid Metabolism In Obesity And Diabetes; AIM 4: Composition and Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome|Recruiting||N/A|100|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples With DNA|"     whole blood and frozen tissue   "|Undecided||2017-10-11 00:30:53.031358|2017-10-11 00:30:53.031358
NCT02122653|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-04-23|||August 2012||2012-08-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Evaluation and Training of Muscle Fitness in Pre-frail Individuals||Completed||N/A|42|Actual|Chang Gung University||3|||f||||t||||||||||2017-10-11 00:30:53.164303|2017-10-11 00:30:53.164303
NCT02122640|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2014-04-23|||September 2012||2012-09-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Observational|ECO/TOR||Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department|Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department|Completed||N/A|||Comitato Etico di Area Vasta Sud Est|||1||f||||f||||||||||2017-10-11 00:30:53.263234|2017-10-11 00:30:53.263234
NCT02122627|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-08-31|||March 2014||2014-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PRECOVID||Vitamin D Supplementation in Patients With COPD|Prevention of Exacerbations in Patients With COPD Through Vitamin D Supplementation: a Randomized Controlled Trial|Recruiting||N/A|240|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-10-11 00:30:53.322919|2017-10-11 00:30:53.322919
NCT02122614|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2015-04-14|||April 2014||2014-04-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Home-monitoring and Adherence of Patients With COPD to Long-term Rehabilitation|The Role of Home-monitoring in the Adherence of Patients With Chronic Obstructive Pulmonary Disease to Long-term Rehabilitation|Completed||N/A|32|Actual|Aveiro University||2|||f||||f||||||||||2017-10-11 00:30:53.451164|2017-10-11 00:30:53.451164
NCT02122601|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-09-07|||April 2014||2014-04-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee|An Open-label, Single Arm, Multi-center, Phase 3 Study to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee|Completed||Phase 3|174|Actual|LG Life Sciences||1|||f||||||||||||||2017-10-11 00:30:53.53848|2017-10-11 00:30:53.53848
NCT02122588|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-07-03|||June 30, 2014|Actual|2014-06-30|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|OVATAR||OVArian Cancer Non-Interventional Study - OVATAR|OVArian Cancer Non-Interventional Study. Treatment hAbits and Epidemiology of BRCA in Russian Federation - OVATAR|Active, not recruiting||N/A|500|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:30:53.610266|2017-10-11 00:30:53.610266
NCT02122575|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-06-30|||April 16, 2014||2014-04-16|February 10, 2017|2017-02-10|January 14, 2016|Actual|2016-01-14|January 14, 2016|Actual|2016-01-14||Observational|||Effect of Fasting on the NLRP3 Inflammasome|Pilot Study to Evaluate the Effect of Fasting on the NLRP3 Inflammasome|Completed||N/A|23|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:30:53.795118|2017-10-11 00:30:53.795118
NCT02122562|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-23|2017-06-30|||March 20, 2014||2014-03-20|May 17, 2017|2017-05-17|August 13, 2018|Anticipated|2018-08-13|August 13, 2018|Anticipated|2018-08-13||Interventional|||The Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder|The Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder|Recruiting||Phase 2|60|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:30:53.897091|2017-10-11 00:30:53.897091
NCT02122549|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-05-30|2017-02-07||April 2014||2014-04-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|HWD|Hospitalized patients at risk for sudden cardiac arrest.|Hospital Wearable Defibrillator Inpatient Study|Hospital Wearable Defibrillator Inpatient Study|Completed||N/A|59|Actual|Zoll Medical Corporation||1|||f||||f||||||||||2017-10-11 00:30:54.068815|2017-10-11 00:30:54.068815
NCT02122536|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-04-22|||July 2012||2012-07-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2012|Actual|2012-11-01||Interventional|||Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles|Split-Face, Double-blind, Single Center, Prospective Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA|Completed||N/A|45|Actual|YMD Eye and Face||2|||f||||||||||||||2017-10-11 00:30:54.308735|2017-10-11 00:30:54.308735
NCT02122523|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-04-23|||January 2013||2013-01-01|April 2014|2014-04-01||||January 2014|Actual|2014-01-01||Interventional|||Sentinel Lymph Node (SLN) in Colorectal Carcinoma (CRC) With a Near-infrared (NIR)-Dye|In Vivo Study to Determine the Efficacy of Sentinel Node Mapping in Patients With Colon Carcinoma Using Near-infrared Laparoscopy|Completed||N/A|25|Actual|VU University Medical Center||2|||f||||f||||||||||2017-10-11 00:30:54.407066|2017-10-11 00:30:54.407066
NCT02122510|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-12-14|||March 2013||2013-03-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Transverse Abdominal Block for Analgesia in Casarean Section|The Value of Preemptive Dexmedetomidine Transversus Abdominis Plane (TAP) Block in Patients Undergoing Elective Cesarean Section Under General Anesthesia.|Completed||N/A|120|Anticipated|Tanta University||2|||f||||t||||||||||2017-10-11 00:30:54.523801|2017-10-11 00:30:54.523801
NCT02122497|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-22|||January 2011||2011-01-01|April 2014|2014-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|BIAS||The Use of Cardiovascular Biomarkers in Abdominal Aortic Surgery|The Use of Cardiovascular Biomarkers in Abdominal Aortic Surgery: Possibility of Risk Assessment and Stratification|Unknown status|Recruiting|N/A|500|Anticipated|Wilhelminenspital Vienna|||3||f||||f||||||Samples With DNA|"     whole blood samples   "|||2017-10-11 00:30:54.657554|2017-10-11 00:30:54.657554
NCT02122484|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-11-08|||November 2013||2013-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Colchicine in Coronary Artery Bypass Graft (CABG)|Study of Anti-inflammatory Treatment With Colchicine in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery to Reduce Reperfusion Damage|Completed||Phase 4|60|Actual|G.Gennimatas General Hospital||2|||f||||t||||||||||2017-10-11 00:30:54.809016|2017-10-11 00:30:54.809016
NCT02122471|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-04-26||2016-04-26|April 2014||2014-04-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|CIC||12-Week Study of Plecanatide for CIC (The National CIC3 Study)|A National, Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation|Completed||Phase 3|1410|Actual|Synergy Pharmaceuticals Inc.||3|||f||||f||||||||||2017-10-11 00:30:54.963333|2017-10-11 00:30:54.963333
NCT02122458|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-09-26|||August 1, 2015|Actual|2015-08-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|November 30, 2018|Anticipated|2018-11-30||Interventional|||Blast Exposed Veterans With Auditory Complaints|Blast-exposed Veterans With Auditory Complaints|Recruiting||Phase 1|468|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||||2017-10-11 00:30:55.661753|2017-10-11 00:30:55.661753
NCT02122445|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2016-01-11|2015-09-23||April 2014||2014-04-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|KT_LBP_EMG||Cramer Sports Motion Tape and Low Back Pain EMG|Effectiveness of Cramer Sports Motion Tape on Low Back Pain Patients' Pain and Muscle Activation|Completed||N/A|20|Actual|Sport and Spine Rehab Clinical Research Foundation||1|||f||||f||||||||||2017-10-11 00:30:55.835904|2017-10-11 00:30:55.835904
NCT02122432|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-06-19|||April 2014||2014-04-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TELEDERMATO||Teledermatology Versus Usual Care on Delay Before Diagnosis and Treatment of Dermatologic Conditions|Impact of Teledermatology Versus Usual Care on Delay Before Diagnosis and/or Treatment of Dermatologic Conditions in General Practice|Completed||N/A|109|Actual|University Paris 7 - Denis Diderot||2|||f||||f||||||||||2017-10-11 00:30:56.171795|2017-10-11 00:30:56.171795
NCT02122419|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-08-04|||April 2014||2014-04-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|||The Effect of Patient Position on Postdural Puncture Headache|Phase IV Study of Application Position During Spinal Anesthesia|Completed||N/A|100|Actual|Diskapi Yildirim Beyazit Education and Research Hospital|||2||f||||f||||||||||2017-10-11 00:30:56.286584|2017-10-11 00:30:56.286584
NCT02122406|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-08-16|2016-05-10||January 2014||2014-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|DEAR||Depression and Anxiety in Rheumatoid Arthritis|Depression and Anxiety in Rheumatoid Arthritis: Prevalence and Relation With Disease Activity|Completed||N/A|200|Actual|University of Pavia|||1||f||||f||||||||No||2017-10-11 00:30:56.407437|2017-10-11 00:30:56.407437
NCT02122393|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-27|||April 2002||2002-04-01|April 2014|2014-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression|A Randomised, Controlled Evaluation of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression|Completed||Phase 3|45|Actual|University of Melbourne||3|||f||||f||||||||||2017-10-11 00:30:56.64344|2017-10-11 00:30:56.64344
NCT02122380|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-10-31|||February 2016||2016-02-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome|The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome|Recruiting||Phase 4|34|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-10-11 00:30:56.756904|2017-10-11 00:30:56.756904
NCT02122367|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-23|||April 2014||2014-04-01|April 2014|2014-04-01||||March 2015|Anticipated|2015-03-01||Interventional|||Study of Stroke Volume Variation and Pleth Variability Index as Predictors of Fluid Responsiveness|Validation of Stroke Volume Variation and Pleth Variability Index as Predictors of Fluid Responsiveness in Patients Undergoing Robot Assisted Thyroidectomy|Unknown status|Recruiting|Phase 4|48|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||1|||f||||||||||||||2017-10-11 00:30:56.881881|2017-10-11 00:30:56.881881
NCT02122354|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-12-02|||April 2014||2014-04-01|December 2014|2014-12-01||||June 2014|Actual|2014-06-01||Interventional|||Triggers and Responses to Simulator Sickness in Videogame Players|Data Collection and Analysis on Simulator Sickness Case Parameters in Susceptible Videogame Players|Completed||N/A|90|Actual|University of Southern California||1|||f||||f||||||||||2017-10-11 00:30:56.979111|2017-10-11 00:30:56.979111
NCT02122341|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-03-22|||April 2014||2014-04-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Clinical Evaluation of BackStop in Patients Undergoing Ureteroscopic Lithotripsy|Post FDA-Approval Clinical Evaluation of BackStopTM in Patients Undergoing Ureteroscopic Lithotripsy: A Prospective, Randomized Clinical Trial|Completed||N/A|35|Actual|University of Southern California||2|||f||||f||||||||Undecided||2017-10-11 00:30:57.070265|2017-10-11 00:30:57.070265
NCT02122328|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-03-08|||June 2010||2010-06-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome|USFetus Randomized Clinical Trial: Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome|Recruiting||N/A|542|Anticipated|University of Southern California||2|||f||||t||||||||||2017-10-11 00:30:57.186767|2017-10-11 00:30:57.186767
NCT02122315|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2014-04-22|||February 2013||2013-02-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Dry Needling in Post-operative Shoulder Pain|EFFECTIVENESS OF THE INCLUSION OF TRIGGER POINT DRY NEEDLING INTO A MULTIMODAL PHYSICAL THERAPY PROGRAM FOR POST-OPERATIVE SHOULDER PAIN|Completed||N/A|20|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 00:30:57.425374|2017-10-11 00:30:57.425374
NCT02122302|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-08-11|||May 2014||2014-05-01|August 2014|2014-08-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Online Health Assessment to Support Comprehensive Care|Online Health Assessment to Support Comprehensive Care|Unknown status|Enrolling by invitation|N/A|80|Anticipated|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-10-11 00:30:57.513579|2017-10-11 00:30:57.513579
NCT02122289|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-04-11|||April 2014||2014-04-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Interventional|MUSE||Muco Smartphone Exacerbation|Interest of the New Technologies to Detect précocément a Respiratory Exacerbation at Patients Reached by Cystic Fibrosis.|Completed||Early Phase 1|45|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:30:57.588234|2017-10-11 00:30:57.588234
NCT02122276|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-23|||January 2010||2010-01-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Continuous Passive Motion on the Spinal Circuitries and Its Adaptation in Patients With Spasticity Resulting From Upper Motor Neuron Lesions||Completed||N/A|7|Actual|Chang Gung University||1|||f||||t||||||||||2017-10-11 00:30:57.65402|2017-10-11 00:30:57.65402
NCT02122263|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-04-22|||April 2014||2014-04-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Transient Elastography of the Liver ( Fibroscan ) and Bariatric Surgery|Transient Elastography of the Liver ( Fibroscan ) and Bariatric Surgery|Unknown status|Not yet recruiting|N/A|60|Anticipated|Ziv Hospital|||1||f||||f||||||||||2017-10-11 00:30:57.713181|2017-10-11 00:30:57.713181
NCT02122250|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-12-02|||October 2014||2014-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Web-based Support for People With Type 2 Diabetes|Developing and Testing Accessible Web-based Support for Patient Self-management of Diabetes|Completed||N/A|1041|Actual|University of Southampton||2|||f||||||||||||||2017-10-11 00:30:57.777353|2017-10-11 00:30:57.777353
NCT02122224|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-23|||December 2013||2013-12-01|April 2014|2014-04-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Breakfast Consumption in Preschoolers: Satiety, Diet Quality and Memory||Unknown status|Recruiting|N/A|80|Anticipated|Purdue University||4|||f||||f||||||||||2017-10-11 00:30:57.921373|2017-10-11 00:30:57.921373
NCT02122211|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-09-07|||April 2014||2014-04-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Choline Dehydrogenase and Sperm Function: Effects of Betaine|Choline Dehydrogenase and Sperm Function: Effects of Betaine|Completed||Phase 1|6|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 00:30:58.042858|2017-10-11 00:30:58.042858
NCT02122198|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-12-05|||June 2014||2014-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women|Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women|Recruiting||N/A|34|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 00:30:58.135192|2017-10-11 00:30:58.135192
NCT02122185|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-09-28|||June 2014||2014-06-01|September 2017|2017-09-01||||February 2018|Anticipated|2018-02-01||Interventional|||Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Randomized Placebo Controlled Phase II Trial of Metformin in Conjunction With Chemotherapy Followed by Metformin Maintenance Therapy in Advanced Stage Ovarian, Fallopian Tube and Primary Peritoneal Cancer|Recruiting||Phase 2|160|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-11 00:30:58.249211|2017-10-11 00:30:58.249211
NCT02122172|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-09-28|||October 30, 2013|Actual|2013-10-30|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Afatinib in Advanced Refractory Urothelial Cancer|Afatinib Dimaleate in Treating Patients With Advanced Refractory Urothelial Cancer|Recruiting||Phase 2|95|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-11 00:30:58.400333|2017-10-11 00:30:58.400333
NCT02122159|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-07-14|||March 2013||2013-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration|A Phase I/II, Open-Label, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Geographic Atrophy Secondary to Myopic Macular Degeneration|Withdrawn||Phase 1/Phase 2|0|Actual|University of California, Los Angeles||1||Study to be revised. Future plans to be determined.|f||||t||||||||No||2017-10-11 00:30:58.495114|2017-10-11 00:30:58.495114
NCT02122133|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2016-12-22|||May 2015||2015-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01|3 Days|Observational [Patient Registry]|CARE||CARE: A Prospective Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400|CARE: A Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400|Terminated||N/A|67|Actual|Penumbra Inc.|||2|Business decision to focus on other studies. No safety concern|f||||f||||||||||2017-10-11 00:30:58.661825|2017-10-11 00:30:58.661825
NCT02122120|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2014-04-23|||January 2007||2007-01-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01|12 Months|Observational [Patient Registry]|||The Value of Aritficial Diet and Complex Care in Home Nutrition|Home Enteral Nutrition (HEN) Reduces Complications, Length of Stay and Health-care Costs: Results From the Multicenter Study.|Completed||N/A|456|Actual|Stanley Dudrick's Memorial Hospital|||1||f||||t||||||||||2017-10-11 00:30:58.732222|2017-10-11 00:30:58.732222
NCT02122107|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-05-16|||April 8, 2014|Actual|2014-04-08|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History|Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History|Recruiting||N/A|540|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||Samples With DNA|"     Blood, saliva or buccal sample for APOE analysis   "|||2017-10-11 00:30:58.81342|2017-10-11 00:30:58.81342
NCT02122094|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-09-26|||May 2013||2013-05-01|October 2015|2015-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities|Implementation of a Sexual Health Intervention for YMSM in Two Vietnamese Cities|Completed||N/A|1166|Actual|National Development and Research Institutes, Inc.||1|||f||||t||||||||||2017-10-11 00:30:58.894601|2017-10-11 00:30:58.894601
NCT02122068|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-05-11|||April 2014||2014-04-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers|Central Meditation and Imagery Therapy for Major Depressive Disorder in Family Dementia Caregivers|Completed||Phase 1/Phase 2|26|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:31:00.839378|2017-10-11 00:31:00.839378
NCT02122055|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-04-22|||June 2014||2014-06-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU.|Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU, A Randomized Controlled Study.|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Tianjin Third Central Hospital||2|||f||||f||||||||||2017-10-11 00:31:00.98215|2017-10-11 00:31:00.98215
NCT02122042|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-22|||May 2014||2014-05-01|April 2014|2014-04-01||||May 2017|Anticipated|2017-05-01||Interventional|||Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery|Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery - Randomized Prospective Trial|Unknown status|Not yet recruiting|Phase 1|62|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 00:31:01.100417|2017-10-11 00:31:01.100417
NCT02122029|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-22|||February 2003||2003-02-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Lifestyle vs.Surgery for Morbid Obesity Treatment|A Nine-Year Follow-up of Intensive Lifestyle Intervention vs Surgery to Treat Morbidly Obese Women: a Non-randomized Human Subject Research.|Completed||Phase 3|29|Actual|Harokopio University||2|||f||||t||||||||||2017-10-11 00:31:01.201425|2017-10-11 00:31:01.201425
NCT02122016|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-04-22|||June 2011||2011-06-01|April 2014|2014-04-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Comparison of Two Different Types of Mechanical Ventilation Weaning in Patients in the ICU|Weaning With Smartcare in Mechanically Ventilated Patients in the ICU - a Controlled and Randomized Study|Completed||Phase 4|70|Actual|Hospital Israelita Albert Einstein||2|||f||||f||||||||||2017-10-11 00:31:01.30368|2017-10-11 00:31:01.30368
NCT02122003|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2017-08-25|||September 2016||2016-09-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|SOAP||Second Line Sorafenib After Pazopanib in Patients With RCC|Activity and Safety of Second Line SOrafenib After Pazopanib in Patients With Metastatic Renal Cell Carcinoma (SOAP Study)|Recruiting||Phase 2|44|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-11 00:31:01.397892|2017-10-11 00:31:01.397892
NCT02121990|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-06-02|||April 21, 2014||2014-04-21|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|A Phase 1 Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|Active, not recruiting||Phase 1|17|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:31:01.544321|2017-10-11 00:31:01.544321
NCT02121977|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-09-06|||April 2014||2014-04-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|Embrace||Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse|A Prospective, Safety and Efficacy Cohort Study of Elevate® Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse Repair|Terminated||Phase 4|285|Actual|ASTORA Women's Health||2||Astora business is closing|f||||f||||||||Yes||2017-10-11 00:31:01.693661|2017-10-11 00:31:01.693661
NCT02121964|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-05-23|||August 2013||2013-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Capsulectomy vs Capsulotomy With Repair in Direct Anterior Total Hip Arthroplasty|Anterior Capsulectomy Versus Capsulotomy With Repair in Direct Anterior Total Hip Arthroplasty|Enrolling by invitation||N/A|120|Anticipated|Emory University||2|||f||||f||||||||||2017-10-11 00:31:03.022901|2017-10-11 00:31:03.022901
NCT02121951|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2014-04-22|||May 2014||2014-05-01|April 2014|2014-04-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01||Interventional|QLB||Quadratus Lumborum Block for Percutaneous Nephrostomy|Quadratus Lumborum Block Versus Local Anesthetic Infiltration Combined With Monitored Anesthesia Care for Percutaneous Nephrostomy|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|National Cancer Institute, Egypt||2|||f||||t||||||||||2017-10-11 00:31:03.1688|2017-10-11 00:31:03.1688
NCT02121938|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2016-06-17|||April 2014||2014-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Dynamics of the Microbiome in the Premature Infant|Dynamics of the Microbiome in the Premature Infant|Completed||N/A|30|Actual|Duke University|||1||f||||f||||||Samples Without DNA|"     Blood, stool, serum, breastmilk   "|||2017-10-11 00:31:03.320043|2017-10-11 00:31:03.320043
NCT02121925|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-08-31|||May 2014||2014-05-01|September 2015|2015-09-01|July 31, 2017|Actual|2017-07-31|June 30, 2017|Actual|2017-06-30|3 Years|Observational [Patient Registry]|ONC003||Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up|LUNG CAncerREgistry: An Open Registry to Measure the Impact of Adding RNA Expression Testing (myPlan Lung Cancer) on Referral Decisions and to Assess Disease-free Survival With Long-term Follow-up in Newly Diagnosed Early Stage Lung Adenocarcinoma Patients|Terminated||N/A|227|Actual|Myriad Genetic Laboratories, Inc.|||1|Company decision to terminate|f||||f||||||Samples With DNA|"     Formalin-fixed paraffin-embedded (FFPE) tissue from blocks or slides of prostatic     adenocarcinoma biopsies.   "|||2017-10-11 00:31:03.422506|2017-10-11 00:31:03.422506
NCT02121899|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-08-31|||April 2015||2015-04-01|September 2015|2015-09-01|July 31, 2017|Actual|2017-07-31|June 30, 2017|Actual|2017-06-30|3 Years|Observational [Patient Registry]|ONC006||Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)|LUNG CAncerREgistry: An Open Registry to Measure the Impact of Adding RNA Expression Testing (myPlan Lung Cancer) on Treatment Decisions and to Assess Disease-free Survival With Long-term Follow-up in Newly Diagnosed Early Stage Lung Adenocarcinoma Patients (LUNG CARE Registry)|Terminated||N/A|44|Actual|Myriad Genetic Laboratories, Inc.|||1|company decision to terminate|f||||f||||||Samples With DNA|"     Formalin-fixed paraffin-embedded (FFPE) tissue from blocks or slides of prostatic     adenocarcinoma biopsies.   "|||2017-10-11 00:31:03.598404|2017-10-11 00:31:03.598404
NCT02121886|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2014-04-23|||December 2010||2010-12-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Parietal Peritoneum as a Substitute Graft for Venous Reconstruction in HPB Surgery|To Evaluate the Safety and Outcome of the Parietal Peritoneum as a Substitute Graft for Venous Reconstruction in Hepatobiliary and Pancreatic Surgery|Unknown status|Recruiting|N/A|40|Anticipated|Beaujon Hospital||1|||f||||f||||||||||2017-10-11 00:31:03.672225|2017-10-11 00:31:03.672225
NCT02121873|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-22|||July 2011||2011-07-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|September 2011|Actual|2011-09-01||Observational|||The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage|The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage|Completed||N/A|6|Actual|Atossa Genetics, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood, nipple aspirate fluid, ductal lavage fluid   "|||2017-10-11 00:31:03.75751|2017-10-11 00:31:03.75751
NCT02121860|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-01-27|2015-09-25||April 2014||2014-04-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Subjects with normal hepatic function were matched for weight, age, and gender to subjects with severe hepatic impairment. The subjects mean age was 56 years. In all subject groups, more male than female subjects, with no female subjects in the moderate hepatic impairment group. The majority of subjects were White (92%).|PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers|An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Hepatic Impairment and in Matched Healthy Volunteers|Completed||Phase 1|37|Actual|Conatus Pharmaceuticals Inc.||4|||f||||f||||||||||2017-10-11 00:31:04.055465|2017-10-11 00:31:04.055465
NCT02121847|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-04-12|2015-12-07||April 2014||2014-04-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|IMPACT||Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy||Completed||Phase 4|40|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:31:04.927435|2017-10-11 00:31:04.927435
NCT02121821|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-04-22|||May 2014||2014-05-01|April 2014|2014-04-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Interventional|||Impact Evaluation of the Pilot SMS Mother Reminder System|Impact Evaluation of the Pilot SMS Mother Reminder System|Unknown status|Not yet recruiting|N/A|11454|Anticipated|African Strategies for Health||2|||f||||t||||||||||2017-10-11 00:31:05.50858|2017-10-11 00:31:05.50858
NCT02121795|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-09-08|2016-08-11||May 6, 2014|Actual|2014-05-06|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|August 12, 2015|Actual|2015-08-12||Interventional||Safety Analysis Set: all randomized participants who received at least one dose of study drug.|Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF|A Phase 3, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Positive Subjects Who Are Virologically Suppressed on Regimens Containing FTC/TDF|Active, not recruiting||Phase 3|668|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||t|t|f||||||||2017-10-11 00:31:05.738951|2017-10-11 00:31:05.738951
NCT02121782|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-08-12|||May 2014||2014-05-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)|A Randomized, Open-label (Part A) or Double-blind (Part B), Active-controlled (Part B) Phase I/IIa Study to Investigate the Safety, Tolerability, and Immunogenicity of GC3110A (Quadrivalent Influenza Vaccine)|Completed||Phase 1/Phase 2|84|Actual|Green Cross Corporation||3|||f||||t||||||||||2017-10-11 00:31:07.124653|2017-10-11 00:31:07.124653
NCT02121756|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-02-02|||July 2014||2014-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dipyridamole for Immune Activation in HIV|A Phase I/II Pilot Study of Dipyridamole as a Modulator of Immune Activation and Systemic Inflammation in HIV-1-Infected Subjects on Antiretroviral Therapy- DAIDS-ES ID 11987|Recruiting||Phase 1/Phase 2|40|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:31:07.294403|2017-10-11 00:31:07.294403
NCT02121743|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-05-23|||April 2014||2014-04-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|PROBIOCOL||Use of a Biological Mesh (StratticeTM) for the Prevention of Parastomal Hernia After Colorectal Surgery With Colostomy|Prospective, Multicenter, Randomized, Parallel Group Clinical Study Evaluating the Efficacy of a Biological Mesh (StratticeTM) for the Prevention of Parastomal Hernia After Colorectal Surgery With Colostomy|Recruiting||Phase 3|108|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||t||||||||||2017-10-11 00:31:07.429111|2017-10-11 00:31:07.429111
NCT02121730|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-04-25|||August 2014||2014-08-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|FRISC||Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions|Identification of Key Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais, Normandy and Picardy Regions|Recruiting||N/A|2800|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||||No||2017-10-11 00:31:07.572576|2017-10-11 00:31:07.572576
NCT02121717|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-07-23|||May 2014||2014-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|CMAP||Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients|Phase III Study of Chiglitazar in Patients With Type 2 Diabetes Mellitus and Insufficient Glycemic Control Despite Diet and Exercise -- A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial|Active, not recruiting||Phase 3|534|Anticipated|Chipscreen Biosciences, Ltd.||3|||f||||t||||||||||2017-10-11 00:31:07.714232|2017-10-11 00:31:07.714232
NCT02121704|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-11-05|||May 2014||2014-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|MEXICO||Magnetic Endoscope Imaging in Colonoscopy: Influence on Propofol Dosage||Completed||N/A|334|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-11 00:31:07.893023|2017-10-11 00:31:07.893023
NCT02121691|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-06-15|||April 2013||2013-04-01|June 2017|2017-06-01||||December 2013|Actual|2013-12-01||Interventional|||Faith-Based Initiative to Promote Health in Appalachia|Appalachia Community Cancer Network II Centers for Reducing Cancer Disparities: Faith-Based Initiative to Promote Health in Appalachia|Completed||N/A|669|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-11 00:31:07.994449|2017-10-11 00:31:07.994449
NCT02121678|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-05-11|||April 2014||2014-04-01|August 2015|2015-08-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Resistance and Aerobic Exercise in CIDP or MMN|Effect of Resistance and Aerobic Exercise on Muscle Strength, Aerobic Capacity and Quality of Life in Patients Treated With Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) or Multifocal Motor Neuropathy (MMN)|Completed||N/A|23|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:31:08.080096|2017-10-11 00:31:08.080096
NCT02121665|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-07-26|||July 2014||2014-07-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients.|Effect of Probiotic Lozenges as an Adjunct to Non Surgical Periodontal Therapy in Chronic Periodontitis Patients: A Randomized Double Blind Placebo Controlled Clinical and Biochemical Study.|Completed||Phase 3|42|Actual|CD Pharma India Pvt. Ltd.||2|||f||||f||||||||||2017-10-11 00:31:08.18346|2017-10-11 00:31:08.18346
NCT02121652|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-08|||April 2014||2014-04-01|January 2016|2016-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer|Translating CBT-Insomnia for Lung Cancer Into Practice: A RCT|Completed||N/A|58|Actual|State University of New York at Buffalo||2|||f||||t||||||||Undecided||2017-10-11 00:31:08.26096|2017-10-11 00:31:08.26096
NCT02121639|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-10-12|||January 2014||2014-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|ProCAID||Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy|An Open Label Phase I/Randomised, Double Blind Phase II Study in Metastatic Castration Resistant Prostate Cancer of AZD5363 In Combination With Docetaxel and Prednisolone Chemotherapy (ProCAID)|Recruiting||Phase 1/Phase 2|168|Anticipated|University Hospital Southampton NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:31:08.490916|2017-10-11 00:31:08.490916
NCT02121626|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-10-19|||April 2014||2014-04-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|June 2016|Actual|2016-06-01||Observational|FOCCUS||"The FOCCUS Study: Focusing on Cancers Chemotherapys' Untreated Symptoms"|"The FOCCUS Study: Focusing on Cancer Chemotherapys' Untreated Symptoms"|Active, not recruiting||N/A|248|Actual|Royal Marsden NHS Foundation Trust|||1||f||||t||||||Samples With DNA|"     Blood and Stool Samples will be collected for translational analysis.   "|Undecided||2017-10-11 00:31:08.602325|2017-10-11 00:31:08.602325
NCT02121613|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-09-01|||April 2014||2014-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PERLES||PERmixon® in LUTS Evaluation Study (PERLES)|PERMIXON® 160 mg Hard Capsule Versus Placebo in the Treatment of Symptomatic Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia|Completed||Phase 4|833|Actual|Pierre Fabre Medicament||3|||f||||||||||||||2017-10-11 00:31:08.69149|2017-10-11 00:31:08.69149
NCT02121600|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-03-09|||September 2014||2014-09-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|||18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer|Assessment of CRPC Response Through Comprehensive Characterization Using Novel Biomarkers (PET CRPC)|Active, not recruiting||N/A|66|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 00:31:08.966706|2017-10-11 00:31:08.966706
NCT02121587|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-05-28|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|OsteoMAP||Osteopathy, Mindfulness and Acceptance-based Programme for Patients With Persistent Pain|Stage 2 Delivery and Evaluation of an Integrated Osteopathy, Mindfulness and Acceptance-based Programme for Patients With Persistent Pain|Completed||N/A|255|Actual|The British School of Osteopathy|||1||f||||t|f|f||||||No|Anonymised grouped data results are anticipated to be published in late 2017. They can also be obtained by contacting H.Abbey@bso.ac.uk|2017-10-11 00:31:09.082689|2017-10-11 00:31:09.082689
NCT02121574|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-01-11|||September 2014||2014-09-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Accuracy of Zero-flux and Ingestible Thermometers|A Study To Determine The Accuracy Of Zero-Flux And Ingestible Thermometers In The Perioperative Setting|Completed||N/A|30|Actual|Brighton and Sussex University Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 00:31:09.179191|2017-10-11 00:31:09.179191
NCT02121561|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-06-30|||April 2014||2014-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Examining the Effectiveness of Self-Acceptance Group Therapy|Examining the Effectiveness of Self-Acceptance Group Therapy|Completed||N/A|35|Actual|University of Mississippi Medical Center||1|||f||||f||||||||||2017-10-11 00:31:09.28226|2017-10-11 00:31:09.28226
NCT02121392|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2016-11-02|||October 2014||2014-10-01|November 2016|2016-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Epidural Catheter With or Without Adductor Canal Nerve Block for Postoperative Analgesia Following Total Knee Arthroplasty|Continuous Adductor Canal Block With Epidural Analgesia for Total Knee Arthroplasty: A Prospective, Randomized, Double-blinded, Placebo-Controlled Trial|Recruiting||N/A|100|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 00:31:12.452044|2017-10-11 00:31:12.452044
NCT02121548|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-04-25|||October 10, 2011|Actual|2011-10-10|April 2017|2017-04-01|February 17, 2015|Actual|2015-02-17|July 7, 2014|Actual|2014-07-07||Interventional|SUCCESS||Using CHWs and HPV Home Tests to Increase Cervical Cancer Screening in Minority Populations|Research Project of the South Florida Center for Reducing Cancer Disparities (SUCCESS): Testing CHWs and HPV Self-Sampling to Increase Cervical Cancer Screening Among Minority Immigrants in Miami-Dade County:|Completed||N/A|601|Actual|University of Miami||3|||f||||t||||||||||2017-10-11 00:31:09.377818|2017-10-11 00:31:09.377818
NCT02121535|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-03-01|2016-10-06||April 2014||2014-04-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Treated set (TS): TS included all subjects who were dispensed with the study drugs and were documented to have taken at least 1 dose of the study drugs. Safety analyses were conducted on the TS.|Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use|Bioequivalence of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet Compared to Concomitant Administration of Telmisartan 80 mg/Amlodipine 5 mg Fixed-dose Combination Tablet and Hydrochlorothiazide 12.5 mg Tablet in Healthy Male Subjects : an Open-label, Randomised, Single-dose, Two-sequence, Four-period Replicated Crossover Study|Completed||Phase 1|72|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:31:09.494603|2017-10-11 00:31:09.494603
NCT02121522|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-06-10|2016-04-07||June 2014||2014-06-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional||Treated set (TS): All patients who were dispensed study medication and were documented to have taken at least one dose of study drug.|A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration|A Single Arm Open Label Study to Evaluate the Pharmacodynamics and Safety of a 4 wk Treatment With BI 144807 in Patients With Newly Diagnosed Wet Age Related Macular Degeneration (wAMD)|Completed||Phase 2|14|Actual|Boehringer Ingelheim|The trial was ended earlier as per protocol as the preliminary data showed that the likelihood to meet the trial’s primary efficacy endpoint would have been low even if the patient recruitment had been continued.|1|||f||||||||||||||2017-10-11 00:31:10.034816|2017-10-11 00:31:10.034816
NCT02121509|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-06-23|2016-06-23||May 2014||2014-05-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||The treated set (TS) included all subjects who had taken at least 1 dose of study medication.|Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects|Bioequivalence of a Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release (2.5 mg/750 mg) Compared With the Free Combination of Linagliptin and Metformin Extended Release Tablets in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Trial)|Completed||Phase 1|74|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:31:10.31956|2017-10-11 00:31:10.31956
NCT02121496|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-07-25|||March 2014||2014-03-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Social Circumstances, Parenting Techniques, and Infant Development|Social Circumstances, Parenting Techniques, and Infant Development|Active, not recruiting||N/A|60|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 00:31:10.958855|2017-10-11 00:31:10.958855
NCT02121483|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-07-28|2016-07-28||June 2014||2014-06-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||Treated Set (TS): The TS included all patients who were allocated trial medication and had received trial medication (empagliflozin).|Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus|An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus|Completed||Phase 1|27|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:31:11.103995|2017-10-11 00:31:11.103995
NCT02121470|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2015-08-10|||February 2014||2014-02-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|||NGAL As An Aid for the Diagnosis of Acute Kidney Injury in Intensive Care|The NGAL Test™ As An Aid for the Diagnosis of AKI in an Intensive Care Population, US|Completed||N/A|252|Actual|BioPorto Diagnostics|||1||f||||f||||||Samples Without DNA|"     Urine, K3-EDTA Plasma, Li-Heparin Plasma   "|||2017-10-11 00:31:11.654036|2017-10-11 00:31:11.654036
NCT02121457|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-04-22|||May 2011||2011-05-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Brazil Nuts Effects on Selenium Status and Cognitive Performance|Effects of Brazil Nuts Consumption on Selenium Status and Cognitive Performance in Older Adults With Mild Cognitive Impairment: a Randomized Controlled Pilot Trial|Completed||N/A|31|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:31:11.728733|2017-10-11 00:31:11.728733
NCT02121444|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-08-11|||June 2014||2014-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Observational|BETAEVAL||BAY86-5046 (Betaseron), Non Interventional Studies|BETAEVAL - The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated With Betaferon®|Completed||N/A|151|Actual|Bayer|||1||f||||f||||||||||2017-10-11 00:31:11.807382|2017-10-11 00:31:11.807382
NCT02121431|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-04-04|||April 2014||2014-04-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|TPAS||Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention|Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction|Recruiting||N/A|400|Anticipated|University of South Carolina||2|||f||||f||||||||||2017-10-11 00:31:12.044136|2017-10-11 00:31:12.044136
NCT02121418|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-05-04|||June 2014||2014-06-01|May 2017|2017-05-01||||February 8, 2017|Actual|2017-02-08||Interventional|||Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm|Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly Acute Myeloid Leukemia (AML) and Advanced Myelodysplastic Syndrome (MDS)|Active, not recruiting||N/A|30|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 00:31:12.159324|2017-10-11 00:31:12.159324
NCT02121405|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-04-04|||October 2015||2015-10-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|PSSR||Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM|Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy Versus Conventional Preoperative Radiochemotherapy for Locally Advanced Rectal Cancer With MRI Negative Circumferential Margin|Recruiting||Phase 3|350|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-10-11 00:31:12.303749|2017-10-11 00:31:12.303749
NCT02121379|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-05-30|||May 2014||2014-05-01|May 2014|2014-05-01|October 2015|Anticipated|2015-10-01|May 2015|Anticipated|2015-05-01||Interventional|||Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy||Unknown status|Recruiting|N/A|40|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 00:31:12.564044|2017-10-11 00:31:12.564044
NCT02121353|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-05-09|||November 2013||2013-11-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration|A Pilot Phase 1/2, Double Blind, Parallel Group, Controlled Study of the Safety, Tolerability and Preliminary Efficacy Evaluation of Intravitreally Administered Pfenex Ranibizumab Biosimilar Versus Lucentis for the Treatment of Neovascular AMD|Completed||Phase 1/Phase 2|25|Actual|Pfenex, Inc||2|||f||||t||||||||||2017-10-11 00:31:12.762472|2017-10-11 00:31:12.762472
NCT02121340|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-06-29|||May 2014||2014-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CC-DDR||Collaborative Care for Depression and Diabetic Retinopathy in African Americans|Collaborative Care for Depression and Diabetic Retinopathy in African Americans|Active, not recruiting||N/A|40|Anticipated|Thomas Jefferson University||2|||f||||f||||||||||2017-10-11 00:31:12.865316|2017-10-11 00:31:12.865316
NCT02121327|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-08-29|||September 2010|Actual|2010-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|||The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke|Disease Management Program (DMP) Stroke Trial|Active, not recruiting||N/A|321|Actual|Hiroshima University||2|||f||||f||||||||||2017-10-11 00:31:12.962064|2017-10-11 00:31:12.962064
NCT02121314|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2015-04-07|||July 2013||2013-07-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|FASTFOOD||HRZE Fasted/Fed in Newly Diagnosed TB|The Influence of Fasting and Food on the Pharmacokinetics of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol in Newly Diagnosed TB Patients|Completed||Phase 2|20|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 00:31:13.072912|2017-10-11 00:31:13.072912
NCT02121288|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2014-10-14|||December 2014||2014-12-01|October 2014|2014-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|PAD||Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients|A Randomized, Open-Label, Parallel, Multi-Center, Phase IV Study to Assess the Effect of Ticagrelor vs Clopidogrel on Adenosine-Induced Myocardial Blood Flow in Peripheral Artery Disease (PAD)Patients|Withdrawn||Phase 4|0|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:31:13.252812|2017-10-11 00:31:13.252812
NCT02121275|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-07-24|||January 2012||2012-01-01|July 2017|2017-07-01||||July 2018|Anticipated|2018-07-01||Observational|||Lung Ultrasound for the Detection of Pulmonary Atelectasis in the Perioperative Period|Lung Ultrasound for the Detection of Pulmonary Atelectasis in the Perioperative Period|Recruiting||N/A|44|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 00:31:13.355058|2017-10-11 00:31:13.355058
NCT02121262|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2017-07-16|||December 31, 2016|Actual|2016-12-31|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Patients With Diabetic Macular Edema|Dexamethasone Posterior Segment Drug Delivery System Versus Laser Photocoagulation in Patients With Diabetic Macular Edema|Recruiting||Phase 3|356|Anticipated|Allergan||2|||f||||f||||||||||2017-10-11 00:31:13.456675|2017-10-11 00:31:13.456675
NCT02121249|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-08-15|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2014|Actual|2014-04-01||Interventional|||Clinical Trial of Minimally Invasive Robotic Spine Surgery|Randomized Comparative Trial of Minimally Invasive Robotic vs. Freehand in Short Adult Degenerative Spinal Fusion Surgeries|Active, not recruiting||N/A|40|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:31:13.59426|2017-10-11 00:31:13.59426
NCT02121236|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-03-14|||April 2014||2014-04-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|||Diagnostic Accuracy of Ultrasonography in Detecting Benign Radiolucent Lesions|Diagnostic Accuracy of Ultrasonography in Detecting Benign Radiolucent Lesions Compared to CBCT Imaging and Histological Examination|Completed||N/A|25|Actual|Damascus University|||1||f||||t||||||||||2017-10-11 00:31:13.690364|2017-10-11 00:31:13.690364
NCT02121223|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-22|||April 2014||2014-04-01|April 2014|2014-04-01|July 2015|Anticipated|2015-07-01|May 2015|Anticipated|2015-05-01||Interventional|POST-STEMI||POST-dilatation to Improve Outcomes in Acute STEMI Patients Undergoing Primary With OCT Assessment|A Prospective, Multi-center,Randomized Controled Trial of POST-dilatation to Improve Outcomes in Acute STEMI Patients Undergoing Primary PCI After Thrombus Aspiration and DES Implantation With OCT Assessment|Unknown status|Not yet recruiting|N/A|40|Anticipated|Second Affiliated Hospital, School of Medicine, Zhejiang University||2|||f||||t||||||||||2017-10-11 00:31:13.787222|2017-10-11 00:31:13.787222
NCT02121210|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-05-23|2017-05-23|2016-01-06|June 2014||2014-06-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SARIL-RA-ONE|Randomized population that included any participant who signed an informed consent and was allocated to a randomized treatment regardless of whether the treatment kit was used or not.|To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)|An Open-label, Randomized, Parallel Group Study Assessing the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Active Rheumatoid Arthritis|Completed||Phase 3|132|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 00:31:13.939596|2017-10-11 00:31:13.939596
NCT02121197|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-22|2016-01-19|||August 2014||2014-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|ARTES||Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.|A Collaborative Retrospective Trial on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients With Diabetic Macular Edema (DME). THE EUROPEAN DME REGISTRAR STUDY (ARTES)|Completed||N/A|321|Actual|Association for Innovation and Biomedical Research on Light and Image|||1||f||||f||||||||||2017-10-11 00:31:14.364766|2017-10-11 00:31:14.364766
NCT02121184|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-10-03|||April 2014||2014-04-01|October 2017|2017-10-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes|A Clinical Trial Evaluating the Interaction of Rapid Hydration and the Rate of Oxytocin Labor Augmentation on Fetal Heart Rate Changes and Maternal Fetal Outcomes|Recruiting||N/A|380|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 00:31:14.488461|2017-10-11 00:31:14.488461
NCT02121171|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2015-07-18|||September 2010||2010-09-01|July 2015|2015-07-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma|Comparative Evaluation of Combined Trabeculotomy-trabeculectomy Versus Combined Trabeculotomy-trabeculectomy With Subconjunctival Implantation of Collagen Matrix Implant for Primary Congenital Glaucoma.|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|National Centre of Ophthalmology named after academician Zarifa Aliyeva||2|||f||||t||||||||||2017-10-11 00:31:14.596083|2017-10-11 00:31:14.596083
NCT02121158|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-08-14|||August 7, 2015|Actual|2015-08-07|August 2017|2017-08-01|August 1, 2019|Anticipated|2019-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|I-70||Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly|CSP #592 - Efficacy and Safety of ICD Implantation in the Elderly|Recruiting||N/A|100|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|f|||||2017-10-11 00:31:14.675068|2017-10-11 00:31:14.675068
NCT02121145|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2014-04-19|||October 2013||2013-10-01|April 2014|2014-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|Ty21a-ASC||Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid Vaccines|Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid Vaccines Against Non-typhoid Salmonellae|Recruiting||Phase 4|100|Anticipated|Helsinki University Central Hospital||4|||f||||t||||||||||2017-10-11 00:31:14.791859|2017-10-11 00:31:14.791859
NCT02121132|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-04-04|||May 2014||2014-05-01|April 2017|2017-04-01|October 2020|Anticipated|2020-10-01|April 2020|Anticipated|2020-04-01|6 Months|Observational [Patient Registry]|POWER||Pediatric Obesity Weight Evaluation Registry (POWER) Study|Establishment of the Pediatric Obesity Weight Evaluation Registry (POWER): A Prospective Pilot Project of Children and Adolescents Presenting for Weight Management|Recruiting||N/A|10000|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 00:31:14.896265|2017-10-11 00:31:14.896265
NCT02121119|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-05-22|||September 2013||2013-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Lidocaine Versus Bupivacaine in Ambulatory Continuous Block With Elastomeric Pump|Sciatic Popliteal Nerve Block in Foot Surgery: Lidocaine Versus Bupivacaine in Ambulatory Continuous Block With Elastomeric Pump|Completed||Phase 4|70|Actual|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||Undecided||2017-10-11 00:31:15.100556|2017-10-11 00:31:15.100556
NCT02121106|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-10-27|||September 2013||2013-09-01|October 2016|2016-10-01||||September 2016|Actual|2016-09-01||Interventional|||Remote Cognitive Remediation|Remote Cognitive Remediation for Psychosis|Recruiting||N/A|100|Anticipated|Queen's University||2|||f||||f||||||||||2017-10-11 00:31:15.18597|2017-10-11 00:31:15.18597
NCT02121093|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-21|||May 2014||2014-05-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Effect of Vibration Stimulation Applied to Different Frequencies in Cortical Excitability and Muscular Function: Randomised Clinical Trial|Effect of Vibration Stimulation Applied to Different Frequencies in Cortical Excitability and Muscular Function: Randomised Clinical Trial|Unknown status|Not yet recruiting|N/A|80|Anticipated|Universidade do Vale do Paraíba||2|||f||||t||||||||||2017-10-11 00:31:15.29615|2017-10-11 00:31:15.29615
NCT02121080|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-03-10|||May 2014||2014-05-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers||Completed||Phase 1|132|Actual|Regeneron Pharmaceuticals||5|||f||||f||||||||||2017-10-11 00:31:15.377402|2017-10-11 00:31:15.377402
NCT02121067|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-24|2017-04-24||September 2014||2014-09-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|LNG-IUS||LNG-IUS at 2 Weeks Postpartum|Intrauterine Contraceptive Insertion at Two-weeks Postpartum: A Study of Acceptability and Short-term Outcomes|Completed||Phase 4|50|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 00:31:15.458106|2017-10-11 00:31:15.458106
NCT02121054|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-09-21|||September 2013||2013-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Observational|||Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease|Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease|Recruiting||N/A|2000|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-11 00:31:15.637826|2017-10-11 00:31:15.637826
NCT02121041|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-12-19|2016-10-25||May 2014||2014-05-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Interventional|||Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study|Comparative Effectiveness of Ambulatory Blood Pressure Monitoring vs Usual Care for Diagnosing and Managing Hypertension: A Pilot Study|Completed||N/A|28|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-11 00:31:15.838188|2017-10-11 00:31:15.838188
NCT02121028|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-09-22|||January 2015||2015-01-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|MyRIAD||Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease|Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease|Recruiting||N/A|175|Anticipated|University of Miami|||1||f||||f||||||||||2017-10-11 00:31:16.114789|2017-10-11 00:31:16.114789
NCT02121015|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-05-18|||May 2016||2016-05-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Online Collaborative Learning Intervention to Prevent Perinatal Depression|Online Collaborative Learning Intervention to Prevent Perinatal Depression|Active, not recruiting||N/A|210|Actual|University of Illinois at Chicago||2|||f||||||||||||||2017-10-11 00:31:16.289365|2017-10-11 00:31:16.289365
NCT02121002|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-06-23||2015-06-23|April 2014||2014-04-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee|A Multi-Center, Double-Blind, Vehicle-Controlled, Parallel-Group Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% in the Treatment of Subjects With Osteoarthritis of the Knee|Completed||Phase 3|1176|Actual|Amneal Pharmaceuticals, LLC||3|||f||||t||||||||||2017-10-11 00:31:16.425052|2017-10-11 00:31:16.425052
NCT02120989|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2015-04-28|||May 2014||2014-05-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|REST||Researching Effective Sleep Treatments (Project REST)|A Pilot Study Examining the Effectiveness of Partner-Assisted Cognitive Behavioral Therapy for Insomnia|Completed||N/A|8|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 00:31:16.607219|2017-10-11 00:31:16.607219
NCT02120976|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-04-29|||April 2014||2014-04-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252|A Phase 1, Randomized, Single-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Single Oral Doses of JTT-252 in Healthy Subjects (Part I); in Conjunction With an Open-label Study to Evaluate the Effect of Food on the PK of JTT-252 in Healthy Subjects (Part II); and an Open-label Study to Evaluate the Safety, Tolerability, PK and Pharmacodynamics (PD) of Single Oral Doses of JTT-252 in Type 2 Diabetic Subjects (Part III)|Terminated||Phase 1|85|Actual|Akros Pharma Inc.||9|||f||||f||||||||||2017-10-11 00:31:16.718965|2017-10-11 00:31:16.718965
NCT02120963|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-02-01|||November 2013|Actual|2013-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RAFatigueRCT||Fatigue in People With Rheumatoid Arthritis- Randomized Controlled Trial|The Effect of Person-centered Physical Therapy on Fatigue Related Variables in Persons With Rheumatoid Arthritis- Randomized Controlled Trial|Recruiting||N/A|70|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-11 00:31:16.873895|2017-10-11 00:31:16.873895
NCT02120937|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-05-17|||March 2014||2014-03-01|September 2015|2015-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Mindfulness in Mood Dysregulated Youth|Neural Basis of Mindfulness in Mood Dysregulated Youth|Completed||N/A|10|Actual|University of Cincinnati||1|||f||||f||||||||No||2017-10-11 00:31:17.347711|2017-10-11 00:31:17.347711
NCT02120924|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2015-10-26|||July 2013||2013-07-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea|A Multicenter, Double-blind, Randomized, Parallel-group, Vehicle-Controlled Study to Evaluate the Safety and Clinical Equivalence of a Generic Azelaic Acid Gel, 15% and the Reference Listed Finacea® (Azelaic Acid) Gel, 15% in Patients With Moderate Facial Rosacea.|Completed||Phase 3|1008|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-11 00:31:17.45913|2017-10-11 00:31:17.45913
NCT02120911|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-05-30|||January 2014||2014-01-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|TRAP||Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma|Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+Esophageal Carcinoma: the TRAP Study|Completed||Phase 1/Phase 2|40|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-11 00:31:17.651043|2017-10-11 00:31:17.651043
NCT02120898|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-04-23|||October 2013||2013-10-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Subjects With Actinic Keratoses|A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of Generic Imiquimod Cream, 2.5% and Zyclara® (Imiquimod) Cream, 2.5% in Subjects With Actinic Keratoses|Completed||Phase 3|600|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-11 00:31:17.780526|2017-10-11 00:31:17.780526
NCT02120885|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-10-30|||May 2013||2013-05-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|Gastric cancer||An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial||Recruiting||Phase 3|70|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:31:17.962102|2017-10-11 00:31:17.962102
NCT02120872|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-19|||February 2013||2013-02-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Platelet Rich Fibrin Combined With Simvastatin for Treatment of Intrabony Defect in Chronic Periodontitis|Platelet - Rich Fibrin Combined With 1.2mg Simvastatin for the Treatment of 3 - Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial|Completed||Phase 2|90|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||t||||||||||2017-10-11 00:31:18.083004|2017-10-11 00:31:18.083004
NCT02120859|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2014-04-20|||October 2012||2012-10-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|OCTOPUS-2||Optical Coherence Tomography to Investigate FFR-Guided DEB-only Elective Coronary Angioplasty|Fractional Flow Reserve - Guided Elective Coronary Angioplasty Using Paclitaxel - Eluting Balloons With Provisional Stent Implantation: A Phase 4 Feasibility Study With 6-Month Follow-up by Optical Coherence Tomography|Completed||Phase 4|50|Actual|University of Jena||2|||f||||t||||||||||2017-10-11 00:31:18.188698|2017-10-11 00:31:18.188698
NCT02120846|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-08-07|||January 2014||2014-01-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|KAROL||Effects of Flywheel Resistance Training on Cognitive Function in Stroke Patients|Effects of Flywheel Resistance Training on Cognitive Function in Stroke Patients|Completed||N/A|29|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 00:31:18.320795|2017-10-11 00:31:18.320795
NCT02120443|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-06-23|2014-04-22||January 2014||2014-01-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||ivWatch Model 400: Device Validation for Non-Infiltrated Tissues|ivWatch Model 400: Device Validation for Non-Infiltrated Tissues|Completed||N/A|43|Actual|ivWatch, LLC||1|||f||||t||||||||||2017-10-11 00:31:28.31859|2017-10-11 00:31:28.31859
NCT02120833|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-01-12|2015-06-30||March 2014||2014-03-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin|A Multi-Center Clinical Trial to Evaluate the Efficacy of an Over-the-Counter Cream in the Management of Mild to Moderate Atopic Dermatitis in Infants and Toddlers|Completed||Phase 3|51|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 00:31:18.736189|2017-10-11 00:31:18.736189
NCT02120820|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-08-08|||April 15, 2013|Actual|2013-04-15|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|June 30, 2017|Actual|2017-06-30||Interventional|MT-MSE||Effect of Massage Therapy in a Multisensory Environment for Intellectual Disabilities|An Evaluation of the Clinical Efficacy of Massage Therapy in a Multisensory Environment for Residents With Severe and Profound Intellectual Disabilities|Completed||N/A|240|Anticipated|The Hong Kong Polytechnic University||4|||f||||t|f|f||||||||2017-10-11 00:31:24.159559|2017-10-11 00:31:24.159559
NCT02120807|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-07-18|||April 2014|Actual|2014-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas|A Phase I Trial of Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas|Recruiting||Phase 1|34|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:31:24.273224|2017-10-11 00:31:24.273224
NCT02120794|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-06-16|||June 2014||2014-06-01|June 2017|2017-06-01|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Interventional|||Threshold Suspend in Pediatrics at Home|Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes|Completed||N/A|201|Actual|Medtronic Diabetes||1|||f||||t||||||||||2017-10-11 00:31:24.388564|2017-10-11 00:31:24.388564
NCT02120781|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-01-30|||March 2014||2014-03-01|January 2017|2017-01-01|December 21, 2016|Actual|2016-12-21|April 2016|Actual|2016-04-01||Interventional|||Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia|Completed||Phase 2|20|Anticipated|Fibrocell Technologies, Inc.||2|||f||||f||||||||||2017-10-11 00:31:24.607066|2017-10-11 00:31:24.607066
NCT02120768|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-04-22|||March 2014||2014-03-01|April 2014|2014-04-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Role of Barrier Resection in Local Control for Extremity Recurrent Soft Tissue Sarcomas|Phase III Study of The Role of Barrier Resection in Local Control in Treatment of Extremity Soft Tissue Sarcomas|Recruiting||Phase 3|400|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 00:31:24.730752|2017-10-11 00:31:24.730752
NCT02120755|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2016-03-01||||||March 2016|2016-03-01||||October 2014|Actual|2014-10-01||Interventional|||A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds|A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds|Withdrawn||Phase 4|0|Actual|Liventa Bioscience||2||Never Started|f||||t||||||||||2017-10-11 00:31:24.831421|2017-10-11 00:31:24.831421
NCT02120742|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2015-09-28|||April 2014||2014-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|June 2014|Actual|2014-06-01||Interventional|||The Impact Of Text Message (SMS) Reminders On Helmet Use Among Motorcycle Drivers In Dar Es Salaam, Tanzania|The Impact Of Text Message (SMS) Reminders On Helmet Use Among Motorcycle Drivers In Dar Es Salaam, Tanzania|Completed||N/A|391|Actual|Amend||3|||f||||t||||||||||2017-10-11 00:31:24.914147|2017-10-11 00:31:24.914147
NCT02120729|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-04-07|||March 2014||2014-03-01|April 2015|2015-04-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|CYP-GUIDES||Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCT|Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCT|Recruiting||N/A|1500|Anticipated|Hartford Hospital||2|||f||||t||||||||||2017-10-11 00:31:24.984388|2017-10-11 00:31:24.984388
NCT02120703|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-19|2014-04-22|||February 2011||2011-02-01|April 2014|2014-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Pregabalin Compared to Gabapentin for Pain Control in Lumbar Disc Surgery|Gabapentin vs. Pregabalin for Post Operative Pain in Lumbar Microdiscectomy: a Randomized Controlled Trial.|Completed||Phase 3|78|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-11 00:31:25.164354|2017-10-11 00:31:25.164354
NCT02120690|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2014-04-22|||June 2014||2014-06-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|TNS-FMA||Trigeminal Nerve Stimulation (TNS) in the Treatment of Fibromyalgia|Trigeminal Nerve Stimulation (TNS) as a Complementary Strategy in the Treatment of Fibromyalgia, Open Label Study|Unknown status|Not yet recruiting|Phase 1/Phase 2|40|Anticipated|Santa Casa Medical School||2|||f||||f||||||||||2017-10-11 00:31:25.240906|2017-10-11 00:31:25.240906
NCT02120677|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-10-03|||May 2014|Actual|2014-05-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Topical Itraconazole in the Treatment of Basal Cell Carcinoma|A Pilot Study Investigating Antitumorigenic Potential of Topical Itraconazole in the Treatment of Basal Cell Carcinoma|Recruiting||Early Phase 1|15|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 00:31:25.348388|2017-10-11 00:31:25.348388
NCT02120664|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-01-20|2016-09-30||April 2014||2014-04-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All subjects receiving at least one dose of florbetapir|Florbetapir Calibration to the Centiloid Scale|A Multicenter, Multicountry Study to Calibrate Florbetapir (18F) PET Imaging Data to the Centiloid Scale Based on 11C-PiB|Completed||Phase 1|35|Actual|Avid Radiopharmaceuticals||2|||f||||f||||||||||2017-10-11 00:31:25.473512|2017-10-11 00:31:25.473512
NCT02120651|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-04-22|||January 2012||2012-01-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|February 2013|Actual|2013-02-01||Interventional|TISSUCOL||Fibrin Monomer Compared With Hemostatic Sponge in the Integrity of the Graft During Tympanoplasty|Effect of the Fibrin Monomer in the Integrity of the Graft During Tympanoplasty Compared With the Effect of the Hemostatic Sponge|Completed||Phase 3|80|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-11 00:31:25.893403|2017-10-11 00:31:25.893403
NCT02120638|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2014-04-21|||April 2014||2014-04-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide|Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide|Unknown status|Recruiting|Phase 3|100|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-11 00:31:25.974846|2017-10-11 00:31:25.974846
NCT02120625|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-20|2017-04-26|2016-09-21||December 2013||2013-12-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational||adults from USA|Technical Efficacy of a Direction Specific Radiofrequency Device in the Performance of Lumbar Medial Branch Neurotomies|Technical Efficacy of a Direction Specific Radiofrequency Device in the Performance of Lumbar Medial Branch Neurotomies - an MRI and EMG Confirmation Study|Completed||N/A|8|Actual|Nimbus Concepts, LLC|Key sub-I who performed paraspinous EMG became very ill and could not continue, and the sponsor limited funding and desire to continue after 6 reported subjects had completed their involvement in the study.||1||f||||f||||||||||2017-10-11 00:31:26.123186|2017-10-11 00:31:26.123186
NCT02120612|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-21|2017-02-06|||April 2014||2014-04-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program|Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program|Recruiting||N/A|150|Anticipated|Edward-Elmhurst Health System|||2||f||||f||||||||||2017-10-11 00:31:26.494742|2017-10-11 00:31:26.494742
NCT02120599|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-11-09|||March 2014||2014-03-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|Mamachiponde||Interventions for Moderate Malnutrition in Pregnancy|Randomized Controlled Trial of the Impact of Treating Moderately Malnourished Women in Pregnancy|Completed||N/A|1867|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-10-11 00:31:26.606247|2017-10-11 00:31:26.606247
NCT02120586|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-07-17|||January 2014||2014-01-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Preventive Physiotherapy Intervention in Elderly People With Sarcopenia|Effects and Costs of Preventive Physiotherapy Intervention in Institutionalized Elderly People With Sarcopenia: A Randomized Controlled Trial|Completed||N/A|91|Actual|University of Valencia||3|||f||||f||||||||||2017-10-11 00:31:26.738491|2017-10-11 00:31:26.738491
NCT02120573|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-04-21|||January 2010||2010-01-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy of CPR Teaching in Mass Training|Evaluation of Teaching Methods in Mass CPR Training in Different Groups of the Society|Completed||N/A|2000|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-10-11 00:31:26.855233|2017-10-11 00:31:26.855233
NCT02120560|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-12-10|||July 2014||2014-07-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Anticoagulation in AF Ablation and Effects on Neurocognitive Function|Uninterrupted Versus Interrupted Anticoagulation in Atrial Fibrillation Ablation - Cerebral Thromboemboli and Neurocognitive Performance|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:31:26.973248|2017-10-11 00:31:26.973248
NCT02120547|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-08-19|||March 2014||2014-03-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment|An Open Label, Phase 1 Study to Evaluate the Effect of Mile and Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Cenicriviroc (CVC)|Completed||Phase 1|31|Actual|Tobira Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 00:31:27.159688|2017-10-11 00:31:27.159688
NCT02120534|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-12-14|||March 2013||2013-03-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Observational|||Serum CD14 and CD88 Mointoring in ICU|The Predictive Values of Serum Soluble CD14 Subtype and CD88 Monitoring in Critically Ill Patients.|Completed||N/A|80|Actual|Tanta University|||2||f||||t||||||||||2017-10-11 00:31:27.281568|2017-10-11 00:31:27.281568
NCT02120521|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-12-14|||April 2013||2013-04-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||Serum STREM and MNDA Mointoring in ICU|The Predictive Values of Serum STREM and Its Correlation With MNDA Monitoring in Critically Ill Patients.|Completed||N/A|120|Actual|Tanta University|||2||f||||t||||||||||2017-10-11 00:31:27.395363|2017-10-11 00:31:27.395363
NCT02120508|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-04-18|||August 2012||2012-08-01|April 2014|2014-04-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Functional Neuroimage in Assessment of Post-stroke Aphasia|Phase 2 Study of rTMS Application in Aphasic Patients Evaluated With fMRI|Unknown status|Recruiting|N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 00:31:27.508218|2017-10-11 00:31:27.508218
NCT02120495|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-11-19|||May 2011||2011-05-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Application of Digital Techniques in Intraoral Condylectomy Via Coronoid Process Resection|Application of Digital Techniques in Intraoral Condylectomy Via Coronoid Process Resection|Unknown status|Recruiting|N/A|21|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 00:31:27.645469|2017-10-11 00:31:27.645469
NCT02120482|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-03-22|||October 2014||2014-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study|Semiselective Immunoadsorption and Membrane Filtration for Desensitization in ABO-incompatible Kidney Transplantation - a Phase 2 Pilot Study|Recruiting||Phase 2|10|Anticipated|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 00:31:27.770701|2017-10-11 00:31:27.770701
NCT02120456|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-06-14||2016-04-18|May 2014||2014-05-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis|Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis|Completed||Phase 1/Phase 2|224|Actual|LEO Pharma||4|||f||||f||||||||||2017-10-11 00:31:28.104133|2017-10-11 00:31:28.104133
NCT02120430|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2014-04-18|||June 2008||2008-06-01|April 2014|2014-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Promoting Child Development Practices in the First Year of Life Through a Video Administered at Two Different Times|Promoting Effective Child Development Practices in the First Year of Life Through a Video Administered at Two Different Times. A Randomized Controlled Trial|Completed||Phase 3|105|Actual|IRCCS Burlo Garofolo||2|||f||||t||||||||||2017-10-11 00:31:28.669598|2017-10-11 00:31:28.669598
NCT02120417|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-07-10|2017-02-06||May 2014|Actual|2014-05-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|February 2016|Actual|2016-02-01||Interventional||The Intent-to-Treat (ITT) population consisted of all participants randomized to the study.|A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer|A Randomized, Double-Blind, Phase 2 Study of Ruxolitinib or Placebo in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-Negative Breast Cancer|Terminated||Phase 2|149|Actual|Incyte Corporation||2||"The study was terminated as other related studies of ruxolitinib did not provide sufficient   efficacy to warrant continuation."|f||||f||||||||||2017-10-11 00:31:28.809436|2017-10-11 00:31:28.809436
NCT02120404|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2017-06-27|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|THANE||Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock|Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock|Recruiting||Phase 2|45|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-10-11 00:31:30.235328|2017-10-11 00:31:30.235328
NCT02120391|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-06-15|||February 2014||2014-02-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application|Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application|Recruiting||N/A|99|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 00:31:30.334536|2017-10-11 00:31:30.334536
NCT02120378|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2015-03-27|||April 2014||2014-04-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01|3 Months|Observational [Patient Registry]|||Fetal Viability Estimation in Egypt|Correlation Between Fetal Gestational Age, Viability and Survival Rates in Egypt|Unknown status|Recruiting|N/A|1000|Anticipated|Woman's Health University Hospital, Egypt|||1||f||||f||||||||||2017-10-11 00:31:30.44826|2017-10-11 00:31:30.44826
NCT02120365|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-04-25|||March 2016|Actual|2016-03-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence|Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence|Suspended||Phase 2|50|Anticipated|Yale University||3||Funding issues|f||||f|t|f||||||No||2017-10-11 00:31:30.529943|2017-10-11 00:31:30.529943
NCT02120352|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-06-06||2015-12-10|April 1, 2014||2014-04-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|December 10, 2015|Actual|2015-12-10||Interventional|||A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects|A Phase IIb Study Evaluating a Long-Acting Intramuscular Regimen of GSK1265744 Plus TMC278 For The Maintenance of Virologic Suppression Following an Induction of Virologic Suppression on an Oral Regimen of GSK1265744 Plus Abacavir/Lamivudine in HIV-1 Infected, Antiretroviral Therapy-Naive Adult Subjects|Active, not recruiting||Phase 2|309|Actual|ViiV Healthcare||3|||f||||t||||||||||2017-10-11 00:31:30.677072|2017-10-11 00:31:30.677072
NCT02120339|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-11-08|||May 2014||2014-05-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Carvedilol PAH A Pilot Study of Efficacy and Safety|Beta Blockers in Pulmonary Arterial Hypertension (PAH) A Pilot Study of Efficacy and Safety|Completed||Phase 2|5|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-11 00:31:31.079471|2017-10-11 00:31:31.079471
NCT02120326|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-05-02|||May 5, 2014|Actual|2014-05-05|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Medis||Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine|Randomised Double-blind Evaluation of the Prophylactic Efficacy of Transcranial Direct Current Stimulation (tDCS) in Chronic Migraine|Recruiting||N/A|60|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 00:31:31.191843|2017-10-11 00:31:31.191843
NCT02120313|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-05-19|||April 2014||2014-04-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Inpatient Versus Outpatient Rehabilitation After TKA|Inpatient Versus Outpatient Rehabilitation Following Total Knee Arthroplasty|Completed||N/A|42|Actual|University of Rostock||2|||f||||f||||||||||2017-10-11 00:31:31.339179|2017-10-11 00:31:31.339179
NCT02120300|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-10-13|2016-08-16||April 2014||2014-04-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Safety Analysis Set: participants who received at least 1 dose of study drug.|Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders|A Phase 2b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders|Completed||Phase 2|122|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|3|||f||||f||||||||||2017-10-11 00:31:31.495106|2017-10-11 00:31:31.495106
NCT02120287|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-08-28|||May 2014||2014-05-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme|Multicenter Phase II Study of Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Multiforme|Recruiting||Phase 2|40|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:31:33.084548|2017-10-11 00:31:33.084548
NCT02120274|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2016-08-23|||March 2014||2014-03-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C|Randomized Clinical Trial to Assess the Effectiveness of Vitamin D and Vitamin B12 Supplementation in Combination With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C.|Terminated||Phase 4|85|Actual|Federal University of São Paulo||2||"New Brazilian Guidelines for Viral Hepatitis C and Coinfetions. It does not include the   treatment of chronic HCV Metavir < F3 and abandon the use of interferon."|f||||f||||||||||2017-10-11 00:31:33.222378|2017-10-11 00:31:33.222378
NCT02120261|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-11-07|||May 2014||2014-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|USAMPS||Using Saline for Myofascial Pain Syndromes (USAMPS)|Using Saline for Myofascial Pain Syndromes (USAMPS)|Terminated||Phase 4|51|Actual|The University of Texas Health Science Center, Houston||2||lack of activity, Primary researcher moved to another institution|f||||t||||||||No||2017-10-11 00:31:33.327381|2017-10-11 00:31:33.327381
NCT02120248|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-21|||July 2005||2005-07-01|April 2014|2014-04-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||The Effect of Varied Intensities of Breastfeeding Peer Support on Duration of Breastfeeding Among Oregon WIC Participants|The Effect of Varied Intensities of Breastfeeding Peer Support on Duration of Breastfeeding Among Oregon WIC Participants|Completed||N/A|1948|Actual|Oregon WIC Program||3|||f||||f||||||||||2017-10-11 00:31:33.405667|2017-10-11 00:31:33.405667
NCT02120235|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-04-03|||February 2014||2014-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Observational|||Investigating Lysosomal Storage Diseases in Minority Groups||Recruiting||N/A|20000|Anticipated|O & O Alpan LLC|||1||f||||||||||Samples With DNA|"     Blood   "|||2017-10-11 00:31:33.465949|2017-10-11 00:31:33.465949
NCT02120222|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-07-11|||May 27, 2014|Actual|2014-05-27|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|July 31, 2018|Anticipated|2018-07-31||Interventional|KPT-330||Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery|A Phase 1 Expansion Cohort Evaluating the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Unresectable Melanoma|Recruiting||Phase 1|20|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:31:33.53736|2017-10-11 00:31:33.53736
NCT02120209|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-17|||April 2013||2013-04-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|EPRIC||Prediction of Falls in Older Inpatients Hospitalized at Angers University Hospital|Nurse Screening Tool for Fall Risk : Prediction of Falls in Older Inpatients Hospitalized at Angers University Hospital|Completed||N/A|1300|Actual|University Hospital, Angers|||1||f||||f||||||||||2017-10-11 00:31:33.630587|2017-10-11 00:31:33.630587
NCT02120196|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-10-17|||January 2014||2014-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SBP||Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis|Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis|Recruiting||Phase 3|100|Anticipated|Tanta University||2|||f||||t||||||||||2017-10-11 00:31:33.690014|2017-10-11 00:31:33.690014
NCT02120183|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-07-03|||September 2013||2013-09-01|July 2014|2014-07-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Investigating the Effects of a Psycho-educational Support Group Therapy on Cancer Caregivers' Burden and Quality of Life|Investigating the Effects of a Psycho-educational Support Group Therapy on Cancer Caregivers' Burden and Quality of Life|Unknown status|Recruiting|N/A|80|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 00:31:33.789438|2017-10-11 00:31:33.789438
NCT02120170|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-21|||April 2014||2014-04-01|April 2014|2014-04-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Prophylactic Clip Application for Colon Polypectomy in Patients With Anticoagulation|The Effect of Prophylactic Clip Application for Colon Polypectomy in Patients With Anticoagulation: Prospective Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|356|Anticipated|Soonchunhyang University Hospital||2|||f||||t||||||||||2017-10-11 00:31:33.876134|2017-10-11 00:31:33.876134
NCT02120157|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-08-09|||August 2014||2014-08-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||Phase II Trial of Myeloablative Conditioning & Transplantation of Partially HLA-mismatched Marrow With Post-transplant Cyclophosphamide for Peds Pts w/ Hematologic Malignancies|Pediatric Blood & Marrow Transplant Consortium (PBMTC) Multi-center Phase II Pilot Trial of Myeloablative Conditioning and Transplantation of Partially HLA-mismatched T Cell Replete Bone Marrow With Post-transplantation Cyclophosphamide for Pediatric Patients With Hematologic Malignancies|Recruiting||Phase 2|31|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:31:34.140532|2017-10-11 00:31:34.140532
NCT02120144|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-09-21|||May 2014||2014-05-01|March 2014|2014-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|OBI||Effect of Observation Plus Imagination of Gait on Stride Variability in Young and Older Adults|Effect of Observation Plus Imagination of Gait on Stride Variability in Young and Older Adults|Completed||N/A|60|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 00:31:34.354641|2017-10-11 00:31:34.354641
NCT02120131|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-17|||February 2012||2012-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Observational|||Trapezoidal Flap vs. Envelope Flap in Mandibular Third Molar Extraction.|Trapezoidal Flap Versus Envelope Flap in Impacted Mandibular Third Molar Extraction|Completed||N/A|52|Actual|University of Firenze and Siena, Napoli, Italy|||2||f||||f||||||||||2017-10-11 00:31:34.423984|2017-10-11 00:31:34.423984
NCT02120118|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-06-08|||February 2014||2014-02-01|October 2014|2014-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors|A Phase II Clinical Trial Evaluating the Safety and Efficacy of Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors|Withdrawn||Phase 2|0|Actual|Shin Kong Wu Ho-Su Memorial Hospital||1||Taiwan FDA asked for seperating this protocol into one disease site per protocol.|f||||t||||||||||2017-10-11 00:31:34.489511|2017-10-11 00:31:34.489511
NCT02120105|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-03-10|||September 2012||2012-09-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Observational|||Cystine Capacity Clinical Study (CysCap)|Cystine Capacity Clinical Study (CysCap)|Active, not recruiting||N/A|30|Actual|New York University School of Medicine|||1||f||||f||||||||||2017-10-11 00:31:34.576549|2017-10-11 00:31:34.576549
NCT02120092|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-17|||October 2010||2010-10-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man|The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man|Completed||Phase 2|89|Actual|Medical University of Vienna||4|||f||||t||||||||||2017-10-11 00:31:34.730902|2017-10-11 00:31:34.730902
NCT02120066|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-18|||January 2011||2011-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Interventional|||Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm||Completed||N/A|22|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 00:31:34.954409|2017-10-11 00:31:34.954409
NCT02120053|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-10-02|||October 2013||2013-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PANORAMIX||Interest of Bone Substitute Material in Immediate Complete Denture|Interest of Bone Substitute Material in Immediate Complete Denture: a Controlled Randomized Clinical Trial|Active, not recruiting||Phase 2/Phase 3|37|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:31:35.054181|2017-10-11 00:31:35.054181
NCT02120040|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-11-16|||May 2014||2014-05-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|PsychoVHL||Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System||Active, not recruiting||N/A|42|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:31:35.178118|2017-10-11 00:31:35.178118
NCT02120027|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-01-18|2016-11-18||February 2014||2014-02-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|IRIS-4|Baseline analysis was performed on the ITT population (n=556). The ITT population includes all randomised patients who took at least one dose of study drug.|52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)|A 52-Week, Double-blind, Randomised, Placebo-controlled, Parallel-group Phase III Study With Re-randomisations at Week 25 to Evaluate the Efficacy and Safety of Oral Ibodutant 10 mg Once Daily in Female Patients With Irritable Bowel Syndrome With Diarrhoea (IBS-D)|Terminated||Phase 3|558|Actual|Menarini Group|The Sponsor decided on 03 September 2015 to prematurely terminate the study because of negative results of the contemporaneous sister study NAK-06 and the definitely lower than expected overall (ibodutant/placebo) response rate at week 24.|2||"Because of negative results of the sister study NAK-06 and the low overall response rate at   week 24."|f||||f||||||||||2017-10-11 00:31:35.304031|2017-10-11 00:31:35.304031
NCT02120014|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-08-29|||April 2014||2014-04-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Blood Volume and Hemodynamic Analysis in Patients With Chronic Heart Failure|A Prospective Study to Determine the Association of Quantitated Blood and Plasma (Intravascular) Volume to Right Heart Hemodynamics, Venous Capacitance, and Regulatory Neurohormones in Patients With Chronic Heart Failure of Reduced and Preserved Ejection Fraction|Recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 00:31:36.625264|2017-10-11 00:31:36.625264
NCT02120001|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-04-13|2017-02-08||June 2014||2014-06-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy Study on Silver-coated ETT Cleaned With a Novel Device|Silver-coated Endotracheal Tube Cleaned With a Novel Mechanism for Secretion Removal: a Randomized Controlled Clinical Study.|Completed||N/A|40|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:31:36.717959|2017-10-11 00:31:36.717959
NCT02119988|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-07-09|||June 2014||2014-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis|Transjugular Intrahepatic Portosystemic Shunt (TIPS) Using Covered Stents Combined With Variceal Embolization in the Prevention of Variceal Rebleeding for Patients With Cirrhosis : a Prospective, Open-labeled, Randomized, Controlled Trial|Recruiting||N/A|118|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-11 00:31:37.032111|2017-10-11 00:31:37.032111
NCT02119975|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-18|||August 2011||2011-08-01|April 2014|2014-04-01||||December 2011|Actual|2011-12-01||Interventional|||A Working Memory Training to Decrease Rumination in Depressed and Anxious Individuals|A Working Memory Training to Decrease Rumination in Depressed and Anxious Individuals: A Double-blind Randomized Controlled Trial|Completed||N/A|98|Actual|Erasmus Medical Center||2|||f||||||||||||||2017-10-11 00:31:37.35087|2017-10-11 00:31:37.35087
NCT02119962|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-18|||June 2013||2013-06-01|April 2014|2014-04-01||||September 2014|Anticipated|2014-09-01||Interventional|||A Working Memory Training in Burnout Patients||Unknown status|Recruiting|N/A|||Erasmus Medical Center||2|||f||||||||||||||2017-10-11 00:31:37.442157|2017-10-11 00:31:37.442157
NCT02119949|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-08-20|||May 2012||2012-05-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Working Memory Training for Substance Dependent Individuals|A Randomized Double-blind Placebo-controlled Trial to Working Memory Training in Substance Abusers|Completed||N/A|180|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-11 00:31:37.5307|2017-10-11 00:31:37.5307
NCT02119923|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-18|||April 2011||2011-04-01|April 2014|2014-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Tackling Depression and Anxiety: A Working Memory Intervention|Effects of Working Memory Training in a Depressed and Anxious Sample|Completed||N/A|240|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 00:31:37.719654|2017-10-11 00:31:37.719654
NCT02119910|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-03-16|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Technology-supported Behavioral Feeding Intervention|Development of a Manual-based, Technology-supported, Behavioral Feeding Intervention|Completed||N/A|20|Actual|Emory University||2|||f||||f||||||||||2017-10-11 00:31:37.804507|2017-10-11 00:31:37.804507
NCT02119338|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-01-04|||February 2014||2014-02-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||5-ALA in Recurrent Glioma|Barrow ALA Trial for Recurrent Gliomas|Recruiting||N/A|60|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||1|||f||||f||||||||||2017-10-11 00:31:49.526287|2017-10-11 00:31:49.526287
NCT02119897|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-01-25|||April 2014||2014-04-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|November 2015|Actual|2015-11-01||Interventional|||Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients|Feasibility Study Evaluating Extraorally Delivered Low Level Light Therapy (LLLT) for the Prevention of Oropharyngeal Mucositis in Pediatric Patients Undergoing Myeloablative Hematopoietic Cell Transplantation|Completed||N/A|13|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 00:31:37.872792|2017-10-11 00:31:37.872792
NCT02119858|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-07-13|||July 25, 2014|Actual|2014-07-25|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery|A Prospective Investigation of Near Infrared Fluorescence Imaging of Pelvic Lymph Nodes Using Indocyanine Green on the da Vinci Surgical System During Radical Prostatectomy and Pelvic Lymphadenectomy for Localized Prostate Cancer|Active, not recruiting||N/A|20|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:31:38.15926|2017-10-11 00:31:38.15926
NCT02119845|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-21|||August 2012||2012-08-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001|A Prospective Clinical Evaluation of the TVA FLEX-1 Device Protocol FLEX-1-001|Completed||N/A|16|Actual|TVA Medical Inc.||1|||f||||f||||||||||2017-10-11 00:31:38.325499|2017-10-11 00:31:38.325499
NCT02119832|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-21|||April 2013||2013-04-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)|A Prospective Clinical Evaluation of the TVA FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction|Completed||N/A|17|Actual|TVA Medical Inc.||1|||f||||f||||||||||2017-10-11 00:31:38.424565|2017-10-11 00:31:38.424565
NCT02119819|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2015-12-23||2015-12-23|April 2014||2014-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes|Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes|Completed||Phase 2|420|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 00:31:38.546175|2017-10-11 00:31:38.546175
NCT02119806|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2015-11-30|||January 2016||2016-01-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Decreasing the Incidence of Delirium After Cardiac Surgery|Decreasing the Incidence of Delirium After Cardiac Surgery|Not yet recruiting||Phase 4|200|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 00:31:38.788351|2017-10-11 00:31:38.788351
NCT02119793|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2015-10-01|||May 2015||2015-05-01|October 2015|2015-10-01||||August 2016|Anticipated|2016-08-01||Interventional|||Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE® Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study||Unknown status|Enrolling by invitation|N/A|66|Anticipated|LG Life Sciences||1|||f||||||||||||||2017-10-11 00:31:38.895095|2017-10-11 00:31:38.895095
NCT02119780|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2015-10-01|||May 2014||2014-05-01|October 2015|2015-10-01||||October 2014|Actual|2014-10-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region||Unknown status|Active, not recruiting|N/A|83|Anticipated|LG Life Sciences||2|||f||||||||||||||2017-10-11 00:31:38.967579|2017-10-11 00:31:38.967579
NCT02119767|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-04-03|||July 2014||2014-07-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|CS1||Study to Detect Biomarker Gradients in Coronary Arteries Using the Liquid Biopsy System|Study to Detect Biomarker Gradients in Coronary Arteries Using the Liquid Biopsy System|Active, not recruiting||N/A|70|Anticipated|PlaqueTec Ltd|||2||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 00:31:39.050025|2017-10-11 00:31:39.050025
NCT02119754|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-09-24|||October 2013||2013-10-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers|Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X|Completed||Phase 2|15|Actual|PluroGen Therapeutics, Inc||1|||f||||f||||||||||2017-10-11 00:31:39.144146|2017-10-11 00:31:39.144146
NCT02119741|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-18|2015-10-02|||May 2014||2014-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Observational|||Reconstruction of Interdental Papilla Using Hyaluronic Acid|The Role of Hyaluronic Acid in Reconstruction of Interdental Papilla in The Esthetic Zone|Completed||N/A|30|Actual|Damascus University|||1||f||||t||||||||||2017-10-11 00:31:39.277655|2017-10-11 00:31:39.277655
NCT02119728|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-04-19||||||April 2016|2016-04-01||||January 2017|Anticipated|2017-01-01||Interventional|||Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity|A Randomized Multicenter Phase II Study Using HPPH With PDT Versus Standard of Care Surgery for Patients With T1/T2 Squamous Cell Carcinoma of the Oral Cavity|Withdrawn||Phase 2|0|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-11 00:31:39.404383|2017-10-11 00:31:39.404383
NCT02119715|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-17|||February 2011||2011-02-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy|A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF as Supportive Therapy to Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy|Completed||Phase 2|182|Actual|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:31:39.597479|2017-10-11 00:31:39.597479
NCT02119702|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-08-22|||April 2014||2014-04-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|AMP Up||Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)|Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)|Recruiting||N/A|850|Anticipated|Harvard School of Public Health|||2||f||||f||||||Samples With DNA|"     Plasma, serum, peripheral blood monocuclear cells (PBMCs), urine, throat wash/gargle, saliva,     and vaginal swabs.   "|||2017-10-11 00:31:39.732954|2017-10-11 00:31:39.732954
NCT02119689|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-09-01|||October 30, 2011|Actual|2011-10-30|September 2017|2017-09-01|June 30, 2020|Anticipated|2020-06-30|June 30, 2019|Anticipated|2019-06-30|4 Years|Observational [Patient Registry]|RAAS||Vascular Reparative Mechanism in Diabetes|Vascular Reparative Mechanism by ACE2/Ang-(1-7) in Diabetes|Active, not recruiting||N/A|78|Anticipated|University of Alabama at Birmingham|||2||f||||f|f|f||||||||2017-10-11 00:31:39.915844|2017-10-11 00:31:39.915844
NCT02119676|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-05-12|2017-02-10||March 2014||2014-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional||The intent-to-treat (ITT) population consisted of participants that were randomized in the study.|Study of Ruxolitinib in Colorectal Cancer Patients|A Randomized, Double-Blind Study of Ruxolitinib or Placebo in Combination With Regorafenib in Subjects With Relapsed or Refractory Metastatic Colorectal Cancer|Terminated||Phase 2|396|Actual|Incyte Corporation|Substudy 1 was terminated for futility at interim analysis and Substudy 2 was terminated per sponsor decision.|2||"Substudy 1 was terminated for futility at interim analysis and Substudy 2 was terminated per   sponsor decision."|f||||t||||||||||2017-10-11 00:31:40.071272|2017-10-11 00:31:40.071272
NCT02119663|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-05-10|2017-02-06||June 2014|Actual|2014-06-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|February 2016|Actual|2016-02-01||Interventional||The intent-to-treat (ITT) population consisted of all participants randomized to the study.|A Study of Ruxolitinib in Pancreatic Cancer Patients|A Randomized, Double-Blind, Phase 3 Study of the JAK 1/2 Inhibitor Ruxolitinib or Placebo in Combination With Capecitabine in Subjects With Advanced or Metastatic Adenocarcinoma of the Pancreas Who Have Failed or Are Intolerant to First-Line Chemotherapy (The JANUS 2 Study)|Terminated||Phase 3|86|Actual|Incyte Corporation|The study was terminated prior to the final analysis at the recommendation of the Data Monitoring Committee based on the review of efficacy in the 18424-362 (JANUS 1).|2||"The safety committee found no safety issues but recommended halting the study based on a lack   of efficacy in a similar trial. The sponsor terminated the trial."|f||||t||||||||||2017-10-11 00:31:42.391018|2017-10-11 00:31:42.391018
NCT02119650|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-08-18|2017-02-10||February 11, 2014|Actual|2014-02-11|August 2017|2017-08-01|June 21, 2016|Actual|2016-06-21|February 11, 2016|Actual|2016-02-11||Interventional||The intent-to-treat (ITT) population consisted of participants that were randomized in the study.|Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer|A Randomized, Double-Blind Phase 2 Study of Ruxolitinib or Placebo in Combination With Pemetrexed/Cisplatin and Pemetrexed Maintenance for Initial Treatment of Subjects With Nonsquamous Non-Small Cell Lung Cancer That Is Stage IIIB, Stage IV, or Recurrent|Terminated||Phase 2|76|Actual|Incyte Corporation|The study was terminated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.|2||"The study was terminated as other related studies of ruxolitinib did not provide sufficient   efficacy to warrant continuation."|f||||t||||||||||2017-10-11 00:31:43.651758|2017-10-11 00:31:43.651758
NCT02119637|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-07-06|||April 3, 2014||2014-04-03|January 11, 2017|2017-01-11|April 1, 2019|Anticipated|2019-04-01|January 6, 2019|Anticipated|2019-01-06||Observational|||Effects of Transcranial Magnetic Stimulation (TMS) on Somatosensory Perception|Effects of Transcranial Magnetic Stimulation (TMS) on Somatosensory Perception|Recruiting||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:31:44.636646|2017-10-11 00:31:44.636646
NCT02119624|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-06-30|||March 27, 2014||2014-03-27|January 30, 2017|2017-01-30|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Observational|||Neural Substrates of Approach-Avoidance Conflict|Neural Substrate of Approach-Avoidance Conflict|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:31:44.729362|2017-10-11 00:31:44.729362
NCT02119611|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-07-28|||March 25, 2014||2014-03-25|March 9, 2017|2017-03-09|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Deep Brain Stimulation Therapy in Movement Disorders|Deep Brain Stimulation Therapy in Movement Disorders|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:31:45.286439|2017-10-11 00:31:45.286439
NCT02119598|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2014-12-01|||February 2014||2014-02-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|FACT||Feasibility of AmbulanCe-based Telemedicine (FACT) Study|Technical and Clinical Feasibility of Third Generation In-ambulance Telemedicine: Feasibility of AmbulanCe-based Telemedicine (FACT) Study|Completed||N/A|43|Actual|Universitair Ziekenhuis Brussel|||1||f||||f||||||||||2017-10-11 00:31:45.373258|2017-10-11 00:31:45.373258
NCT02119585|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-12-15|||February 2014||2014-02-01|December 2014|2014-12-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Observational|SPPLIT||Analysis of Respiratory System Mechanics and Inflammatory Response During Orthotopic Liver Transplantation (SPPLIT Trial)|Observational Study to Analyze Respiratory System Mechanics Changes and Inflammatory Responses During Orthotopic Liver Transplantation (SPPLIT Trial)|Unknown status|Recruiting|N/A|30|Anticipated|University of Turin, Italy|||1||f||||f||||||Samples With DNA|"     Blood samples at four time points during OLT   "|||2017-10-11 00:31:45.439835|2017-10-11 00:31:45.439835
NCT02119572|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-18||||||April 2014|2014-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Impact of Peer Support on Diabetes in China|Impact of Peer Support on Diabetes in China: a Multi-center, Cluster Randomized Controlled Trial|Unknown status|Recruiting|N/A|400|Anticipated|Zhongda Hospital||2|||f||||t||||||||||2017-10-11 00:31:45.536209|2017-10-11 00:31:45.536209
NCT02119559|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-12-02|||September 2012||2012-09-01|September 2012|2012-09-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|CIRCUTEC||Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma|Assessment of Circulating Tumor Cells as an Early Predictive Marker of Response to a First Line Treatment Based on an Anti-Human Epidermal Growth Factor Receptor (HER), Cetuximab, in Patients With Inoperable Recurrent and/or Metastatic Head-and-neck Squamous-cell Carcinoma.|Recruiting||N/A|115|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 00:31:45.650502|2017-10-11 00:31:45.650502
NCT02119546|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2014-04-18|||May 2010||2010-05-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease|Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease|Completed||N/A|19|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:31:45.746654|2017-10-11 00:31:45.746654
NCT02119533|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-07-13|||May 2013|Actual|2013-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|February 2016|Actual|2016-02-01||Observational|CAPIT||Concussion and Post Traumatic Stress in Traumatic Brain Injury|Prospective Study of Concussion and PTSD in Structurally Brain Injured, Non-Structurally Brain Injured and Non-Brain Injured Trauma Victims in Bellevue HHC|Terminated||N/A|1|Actual|New York University School of Medicine|||1|PI has left the institution.|f||||f||||||||||2017-10-11 00:31:45.838123|2017-10-11 00:31:45.838123
NCT02119520|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-17|||February 2013||2013-02-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||PLATELET RICH FIBRIN COMBINED WITH 1.2% ATORVASTATIN FOR TREATMENT OF INTRABONY DEFECTS IN CHRONIC PERIODONTITIS||Completed||Phase 2|96|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||||||||||||2017-10-11 00:31:46.099868|2017-10-11 00:31:46.099868
NCT02119507|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-01-26|||April 2013||2013-04-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Curodont Repair in Patients With Early Approximal Carious Lesions|Effect of Curodont Repair in Patients With Early Approximal Carious Lesions: A Mono-centre, Controlled, Single-blinded, Randomised, Post-marketing Study|Completed||N/A|25|Actual|Credentis AG||2|||f||||f||||||||||2017-10-11 00:31:46.203108|2017-10-11 00:31:46.203108
NCT02119494|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-04-02|||June 2014||2014-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|7 Months|Observational [Patient Registry]|POPE||Phenotypes of COPD in Central and Eastern Europe|POPE-Study: Phenotypes Of COPD in Central and Eastern Europe Study|Completed||N/A|3504|Actual|Masaryk University|||1||f||||t||||||||||2017-10-11 00:31:46.323939|2017-10-11 00:31:46.323939
NCT02119481|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-08-16|||May 2014||2014-05-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Interventional|||Effects of Mindfulness Meditation and Stress Management After Breast Cancer|Effects of Mindfulness Meditation and Stress Management Training on Perceived Stress, Psychological Well-being, and Sleep Quality Among Patients Diagnosed With Breast Cancer|Active, not recruiting||N/A|142|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 00:31:46.616744|2017-10-11 00:31:46.616744
NCT02119455|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-12-08|||April 2014||2014-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Biomarkers of Orthodontic Tooth Movement With Fixed Appliances and Vibration Appliance Therapy|Biomarkers of Orthodontic Tooth Movement With Fixed Appliances and Vibration Appliance Therapy: A Randomized Clinical Trial|Recruiting||N/A|40|Anticipated|UConn Health||4|||f||||t||||||||||2017-10-11 00:31:46.936371|2017-10-11 00:31:46.936371
NCT02119442|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-06-03|||August 2013||2013-08-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves|Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves|Recruiting||N/A|5|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 00:31:47.075466|2017-10-11 00:31:47.075466
NCT02119429|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-06-17|||April 2014||2014-04-01|December 2014|2014-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pumpkin Seed Oil Supplementation in Premenopausal Women|The Effect of Pumpkin Seed Oil Supplementation on Blood Pressure in Premenopausal Women|Completed||Phase 2|50|Actual|Texas Woman's University||2|||f||||t||||||||||2017-10-11 00:31:47.150454|2017-10-11 00:31:47.150454
NCT02119416|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-04-18|||August 2011||2011-08-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Gender Difference in Response to Caffeine in Children and Adolescents|Sex and Pubertal Stage Differences in Cardiovascular Responses to Caffeine in Children|Completed||N/A|101|Actual|State University of New York at Buffalo||3|||f||||f||||||||||2017-10-11 00:31:47.218371|2017-10-11 00:31:47.218371
NCT02119403|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-04-17|||July 2013||2013-07-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|HHN||Hand Held Nitrous Oxide Delivery Device|Safety and Efficacy of Hand Held Nitrous, a Device That Delivers 16 Grams of Nitrous Oxide Over 120 Seconds of Inhalation Time.|Unknown status|Recruiting|N/A|250|Anticipated|Strata Medical Innovations||1|||f||||t||||||||||2017-10-11 00:31:47.288868|2017-10-11 00:31:47.288868
NCT02119390|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-08-01|||April 2014||2014-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Medication Adherence in Human Immunodeficiency Virus (HIV)|Targeting Enhanced Adherence to Medication: A Pilot Study in Adolescents and Young Adults With Human Immunodeficiency Virus (HIV)|Completed||N/A|33|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-10-11 00:31:47.357876|2017-10-11 00:31:47.357876
NCT02119377|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-05-05|||August 2013||2013-08-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||First Australian National Trans Mental Health Study|A Mixed-Methods Study of Mental Health and Associated Factors in Transgender and Transsexual (Trans) People|Completed||N/A|946|Actual|Curtin University|||1||f||||f||||||||||2017-10-11 00:31:47.430993|2017-10-11 00:31:47.430993
NCT02119364|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-04-17|||October 2013||2013-10-01|April 2014|2014-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Working Memory Training for Children With Cerebral Palsy|Computer Based Working Memory Training in Children With Cerebral Palsy (CP)|Unknown status|Recruiting|N/A|115|Anticipated|Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-11 00:31:47.507728|2017-10-11 00:31:47.507728
NCT02119325|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2015-05-11|2014-06-05||September 2013||2013-09-01|April 2015|2015-04-01||||October 2013|Actual|2013-10-01||Interventional|||The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population|The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population|Completed||N/A|96|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:31:49.623091|2017-10-11 00:31:49.623091
NCT02119312|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-02-10|||June 2010||2010-06-01|February 2017|2017-02-01||||December 2025|Anticipated|2025-12-01|1 Year|Observational [Patient Registry]|GS||Malaria Clinical Trials Center General Screening|General Screening for Eligibility to Participate in Treatment, Prevention and Vaccine Trials at the Seattle Malaria Clinical Trials Center|Recruiting||N/A|3500|Anticipated|Fred Hutchinson Cancer Research Center|||1||f||||f||||||||||2017-10-11 00:31:50.18685|2017-10-11 00:31:50.18685
NCT02119299|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-07-14|2016-10-26||March 2014||2014-03-01|July 2017|2017-07-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|SMART||Safety and Efficacy of the SMART Device for Overweight and Obese Adults|A Prospective, Single Arm, Multicenter Study Evaluating the Safety and Weight Loss Efficacy of the SMART Device + DVD Weight Loss Education for Overweight and Obese Adults|Completed||N/A|76|Actual|Scientific Intake Limited Co.|Lower percentage of TBL reported due to initial endpoint specifications.|1|||f||||f||||||||||2017-10-11 00:31:50.28168|2017-10-11 00:31:50.28168
NCT02119286|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-03-21|2014-12-04||October 2013||2013-10-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2|A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2|Completed||Phase 3|620|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:31:50.693048|2017-10-11 00:31:50.693048
NCT02119273|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-03-24|||September 2014||2014-09-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Systemic Corticosteroids in the Perioperative Management of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)|Systemic Corticosteroids in the Perioperative Management of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)|Recruiting||Phase 4|24|Anticipated|Loma Linda University||2|||f||||f||||||||||2017-10-11 00:31:51.383274|2017-10-11 00:31:51.383274
NCT02119260|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-01-20|||June 2014||2014-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients|A Sponsor Un-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat, Ascending Doses of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients|Completed||Phase 1|32|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 00:31:51.475323|2017-10-11 00:31:51.475323
NCT02119247|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-07-31|||April 2014||2014-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule for Oral Inhalation Via Aerolizer® Device|OPEN-LABEL, RANDOMIZED, 2-WAY CROSS-OVER, SINGLE DOSE STUDY IN HEALTHY VOLUNTEERS TO INVESTIGATE THE PHARMACOKINETICS OF CHF 6001 DPI ADMINISTERED USING THE MULTI-DOSE RESERVOIR NEXThaler® DEVICE OR THE CAPSULE FOR ORAL INHALATION VIA AEROLIZER® DEVICE|Completed||Phase 1|44|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 00:31:51.590399|2017-10-11 00:31:51.590399
NCT02119234|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2015-03-20|||March 2014||2014-03-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TRIPLE 4||Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients|Open-label, Randomized, 3-way Cross-over, Placebo Controlled, Single Dose Clinical Pharmacology Study in COPD Patients After Inhalation of CHF 5993 pMDI Using the Standard Actuator With or Without AeroChamber Plus Flow-Vu VHC Spacer|Completed||Phase 1|36|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||||2017-10-11 00:31:51.667189|2017-10-11 00:31:51.667189
NCT02119221|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-10-27|||February 2014||2014-02-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||Copanlisib Mass Balance Study|Single Center, Open-label, Non-randomized, Non-placebo-controlled Study to Investigate the Metabolism, Excretion Pattern, Mass Balance, Safety, Tolerability and Pharmacokinetics After Single Intravenous Administration of 12 mg [14C]Copanlisib (BAY 80-6946) in Healthy Male Subjects|Completed||Phase 1|6|Actual|Bayer||1|||f||||f||||||||||2017-10-11 00:31:51.743701|2017-10-11 00:31:51.743701
NCT02119208|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-04-16|||May 2014||2014-05-01|April 2014|2014-04-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Effects of the Intensity and the Timing of the Physical Activity in a Primary School||Unknown status|Not yet recruiting|N/A|30|Anticipated|Université de Montréal||1|||f||||t||||||||||2017-10-11 00:31:51.823491|2017-10-11 00:31:51.823491
NCT02119195|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-16|||May 2003||2003-05-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|May 2003|Actual|2003-05-01||Interventional|SEALCOMP||Increasing Composite Restorations Sealants|Increasing Longevity of Composite Restorations With Defective Margins With Sealants. Controlled Clinical Trial 10 Years Follow-up|Completed||N/A|20|Actual|University of Chile||3|||f||||t||||||||||2017-10-11 00:31:51.88353|2017-10-11 00:31:51.88353
NCT02119182|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2017-05-12|||February 2014||2014-02-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|TRACK-TBI||Transforming Research and Clinical Knowledge in Traumatic Brain Injury|Transforming Research and Clinical Knowledge in Traumatic Brain Injury|Recruiting||N/A|3000|Anticipated|University of California, San Francisco|||3||f||||f|f|f||||Samples With DNA|"     Plasma, Serum, DNA, and RNA will be collected at the time of injury. Plasma, Serum, and RNA     will be collected at Day 3 and Day 5 if patient is in the hospital, and at 2 weeks and 6     months post-injury. Samples will be banked at -80 degrees Celsius.   "|No||2017-10-11 00:31:51.971809|2017-10-11 00:31:51.971809
NCT02119169|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-10-17|||March 2014||2014-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HH||Pigtail Catheter: a Less Invasive Option for Pleural Drainage of Recurrent Hepatic Hydrothorax|Pigtail Catheter: a Less Invasive Option for Pleural Drainage of Recurrent Hepatic Hydrothorax|Recruiting||N/A|30|Anticipated|Tanta University||1|||f||||t||||||||||2017-10-11 00:31:52.322941|2017-10-11 00:31:52.322941
NCT02119156|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-09-18|||May 13, 2014|Actual|2014-05-13|September 2017|2017-09-01|December 13, 2018|Anticipated|2018-12-13|December 13, 2018|Anticipated|2018-12-13||Interventional|||Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients|An Open-label, Non-randomized, 52-Week Study to Evaluate Treatment Holidays and Rebound Phenomenon After Treatment With Belimumab 10 mg/kg in Systemic Lupus Erythematosus Subjects|Active, not recruiting||Phase 3|163|Anticipated|GlaxoSmithKline||3|||t||||f||||||||||2017-10-11 00:31:52.421753|2017-10-11 00:31:52.421753
NCT02119143|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-07-29|||April 2014||2014-04-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Micronutrient Supplementation and Incidence of Common Cold|Influence of Micronutrient Supplementation on Duty Days Lost Due to Flu/Common Cold, Immune System, Oxidative Stress and Wellbeing in a Cohort of Middle Management Employees|Completed||N/A|82|Actual|Green Beat||2|||f||||t||||||||||2017-10-11 00:31:52.545874|2017-10-11 00:31:52.545874
NCT02119130|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-01-30|||November 2014|Actual|2014-11-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|June 2018|Anticipated|2018-06-01||Interventional|||Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa|Quantiferon Gold Test for Detecting TB Infection in HIV/AIDS Patients in South Africa|Recruiting||N/A|3000|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 00:31:52.638067|2017-10-11 00:31:52.638067
NCT02119117|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-01-08|||April 2014||2014-04-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Aneuploidy Rates in Advanced Maternal Age Patients Supplemented With Coenzyme Q10 (CoQ10) Versus Those That Are Not: a Pilot Study|Blastocyst Aneuploidy Rates From Advanced Maternal Age Patients Supplemented With Coenzyme Q10 (CoQ10) Versus Those That Are Not: a Pilot Study|Recruiting||N/A|30|Anticipated|Reproductive Endocrinology Associates of Charlotte||2|||f||||f||||||||||2017-10-11 00:31:52.779955|2017-10-11 00:31:52.779955
NCT02119104|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-04-05|2017-04-05||March 2014||2014-03-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational||In total, 1087 participants were registered in this study. Of the 1087 participants, 16 participants were excluded from the safety analysis for the reasons of protocol violation.|Prevenar (13v) Infant Drug Use Investigation|Prevenar (13v) Infant Drug Use Investigation (Regulatory Post Marketing Commitment Plan)|Completed||N/A|1087|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 00:31:52.890175|2017-10-11 00:31:52.890175
NCT02119091|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-17|||April 2014||2014-04-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers|A Double-center, Randomized, Double-blinded, 2-way Crossover, Placebo-controlled Study: Comparison of Single Oral Dose 400mg Moxifloxacin-induced QT Prolongation Between Healthy Chinese Volunteers and Caucasian Volunteers|Unknown status|Recruiting|Phase 1|80|Anticipated|Peking University Third Hospital||2|||f||||f||||||||||2017-10-11 00:31:53.195862|2017-10-11 00:31:53.195862
NCT02119078|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-17|||January 2014||2014-01-01|April 2014|2014-04-01||||January 2017|Anticipated|2017-01-01||Interventional|||Acute Care for Elders (ACE) Program at OHSU Hospital|Acute Care for Elders (ACE) Program at OHSU Hospital|Unknown status|Recruiting|N/A|300|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 00:31:53.33847|2017-10-11 00:31:53.33847
NCT02119065|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-09-21|||January 30, 2014|Actual|2014-01-30|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT|PET/CT-Derived Hepatopulmonary Shunt Fraction Following Yttrium-90 Radioembolization|Active, not recruiting||N/A|6|Actual|Ohio State University Comprehensive Cancer Center|||1||f||||t|f|f||||||||2017-10-11 00:31:53.430108|2017-10-11 00:31:53.430108
NCT02119052|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-18|||January 2009||2009-01-01|January 2014|2014-01-01||||September 2013|Actual|2013-09-01||Interventional|||Effects of Somatostatin on Liver in ADPKD|Effect of Long-acting Somatostatin on Liver in Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 2/Phase 3|35|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 00:31:53.521215|2017-10-11 00:31:53.521215
NCT02119039|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-12-21|||July 2014||2014-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Effect of CACICOL20 on Corneal Epithelial Healing After Cross-linking in Patients With Keratoconus|Effect of CACICOL20 on Corneal Epithelial Healing After Cross-linking in Patients With Keratoconus|Completed||Phase 4|40|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 00:31:53.586285|2017-10-11 00:31:53.586285
NCT02119026|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-05-06|||February 2011||2011-02-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|PASSION||Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer|A Phase II Study to Assess Efficacy and Safety of Capecitabine and Irinotecan Plus Bevacizumab Followed by Capecitabine and Oxaliplatin Plus Bevacizumab or the Reverse Sequence in Patients With Metastatic Colorectal Cancer|Unknown status|Recruiting|Phase 2|120|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 00:31:53.663335|2017-10-11 00:31:53.663335
NCT02119013|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2014-04-17|||January 2009||2009-01-01|January 2014|2014-01-01||||September 2013|Actual|2013-09-01||Interventional|||Effects of Somatostatin on ADPKD Heart|EFFECT OF SOMATOSTTIN ON EARLY DIASTOLIC LEFT VENTRICULAR FUNCTION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A MATCHED-COHORT, SPECKLE-TRACKING ECHOCARDIOGRAPHIC STUDY|Completed||Phase 2/Phase 3|35|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 00:31:53.794909|2017-10-11 00:31:53.794909
NCT02119000|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2015-08-10|||August 2015||2015-08-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|||Comparison of Two Types of Bowel Preparation for Inpatient Colonoscopy||Unknown status|Recruiting|Phase 4|310|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 00:31:53.876297|2017-10-11 00:31:53.876297
NCT02118987|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2017-02-06|||July 2014||2014-07-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization|Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization|Recruiting||Phase 1|10|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:31:53.964338|2017-10-11 00:31:53.964338
NCT02118974|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-01-18|||May 2014||2014-05-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||Randomized Clinical Trial Comparing Conventional Laparoscopic and Robot-Assisted Laparoscopic Hysterectomy|Randomized Clinical Trial Comparing Conventional Laparoscopic and Robot-Assisted Laparoscopic Hysterectomy|Completed||N/A|144|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||No||2017-10-11 00:31:54.05777|2017-10-11 00:31:54.05777
NCT02118961|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2016-11-24|2016-05-16||April 2014||2014-04-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents|Confirmatory Study to Evaluate the Immunogenicity of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP Vaccine, BK1301) as a Booster in Adolescents|Completed||Phase 3|446|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 00:31:54.137192|2017-10-11 00:31:54.137192
NCT02118948|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-08-26|||April 2014||2014-04-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Development of a Novel HIV Risk Reduction Intervention for Abused Women|Development of a Novel HIV Risk Reduction Intervention for Abused Women|Completed||N/A|86|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 00:31:54.518268|2017-10-11 00:31:54.518268
NCT02118935|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-06-22|||April 2014||2014-04-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance|Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance|Completed||N/A|161|Actual|Mead Johnson Nutrition||2|||f||||f||||||||||2017-10-11 00:31:54.596945|2017-10-11 00:31:54.596945
NCT02118922|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-17|||June 2013||2013-06-01|April 2014|2014-04-01||||February 2016|Anticipated|2016-02-01||Observational|||A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia|A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia|Unknown status|Recruiting|N/A|28|Anticipated|Massachusetts General Hospital|||4||f||||f||||||||||2017-10-11 00:31:54.788062|2017-10-11 00:31:54.788062
NCT02118909|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-02-22|||May 2014||2014-05-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects|A Two-Part Study to Evaluate the Effect of CYP3A4 Inhibition (Itraconazole-Part 1) and CYP1A2 Inhibition (Ciprofloxacin - Part 2) on the Single-Dose Pharmacokinetics of Pracinostat in Healthy Nonsmoking Subjects|Completed||Phase 1|32|Actual|Helsinn Healthcare SA||2|||f||||f||||||||||2017-10-11 00:31:54.879809|2017-10-11 00:31:54.879809
NCT02118896|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-17|2016-02-15|2016-01-07||January 2003||2003-01-01|February 2016|2016-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||The baseline analysis population consisted of the Full Analysis Set (FAS) population. The FAS included all subjects who received at least one dose of study drug, MR4, while participating in one of the phase II PK or phase III studies and at least one dose of MR4 during this study.|Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant|A Long-term Follow up Study to Evaluate the Safety and Efficacy in Transplant Recipients Treated With Modified Release Tacrolimus, FK506E (MR4), Based Immunosuppression Regimen|Completed||Phase 3|850|Actual|Astellas Pharma Inc|No Kaplan-Meier estimates for PMR-EC-1210 due to the short subject participation period and the low number of subjects.|1|||f||||f||||||||||2017-10-11 00:31:55.169172|2017-10-11 00:31:55.169172
NCT02118883|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-07-14|||April 2014||2014-04-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Dehydration, Rehydration, and Blood Viscosity|Randomized, Double-blind, Parallel Arm Study of the Effect of Essentia Water, an Electrolyzed High-pH Bottled Water, on Serial Blood Viscosity and Other Hydration Biomarkers in Healthy Subjects|Completed||N/A|100|Actual|Essentia Water, LLC||2|||f||||f||||||||||2017-10-11 00:32:05.793061|2017-10-11 00:32:05.793061
NCT02118870|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-09-24|||June 10, 2014|Actual|2014-06-10|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2017|Actual|2017-09-01||Interventional|REDUCE||Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent|Randomized Evaluation of Short-term DUal Anti Platelet Therapy in Patients With Acute Coronary Syndrome Treated With the COMBO Dual-therapy stEnt|Active, not recruiting||Phase 4|1500|Actual|Diagram B.V.||2|||f||||t||||||||||2017-10-11 00:32:05.958521|2017-10-11 00:32:05.958521
NCT02118857|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-18|||January 2013||2013-01-01|April 2014|2014-04-01|January 2016|Anticipated|2016-01-01|September 2014|Anticipated|2014-09-01|3 Weeks|Observational [Patient Registry]|MRMOVVD||Microbiota and Related Metabolome in Omnivore, Vegetarian or Vegan Diets|Microorganisms in Foods and in Humans: Study of the Microbiota and the Related Metabolome as Affected by Omnivore, Vegetarian or Vegan Diets|Unknown status|Recruiting|N/A|150|Anticipated|University of Bari|||1||f||||f||||||Samples With DNA|"     Feces, urine and saliva samples   "|||2017-10-11 00:32:06.057559|2017-10-11 00:32:06.057559
NCT02118844|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-07-29|||July 2014||2014-07-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|August 2015|Anticipated|2015-08-01||Interventional|BaChiBloPro1||Laparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical Conditions|Laparoscopic Bariatric Surgery: Impact of the Level of Neuromuscular Blockade on Surgical Conditions - Comparison Between Moderate and Deep Neuromuscular Blockade|Unknown status|Recruiting|Phase 4|92|Anticipated|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-11 00:32:06.157095|2017-10-11 00:32:06.157095
NCT02118831|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-04-13|2016-01-27||March 2012||2012-03-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF|Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients With Neovascular Age-related Macular Degeneration|Completed||Phase 1/Phase 2|56|Actual|California Retina Consultants||3|||f||||f||||||||||2017-10-11 00:32:06.286382|2017-10-11 00:32:06.286382
NCT02118818|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-07-27|||February 2014||2014-02-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01|5 Years|Observational [Patient Registry]|RECHARGE||RhEumatiC Heart diseAse Genetics|Next Generation Sequencing Approach to the Study of Rheumatic Heart Disease|Recruiting||N/A|1000|Anticipated|Brigham and Women's Hospital|||2||f||||f||||||Samples With DNA|"     The investigators are collecting blood for DNA analysis from all subjects as well as heart     valve tissue from subjects who undergo cardiac surgery.   "|||2017-10-11 00:32:06.645755|2017-10-11 00:32:06.645755
NCT02118805|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-03-11|||October 2013||2013-10-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|QUESST||Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders|Quantitative Ultrasonography and Electrical Impedance Myography: Speech and Swallowing Technologies for Use in Neurological Disorders|Recruiting||N/A|200|Anticipated|Beth Israel Deaconess Medical Center|||6||f||||f||||||||||2017-10-11 00:32:06.736693|2017-10-11 00:32:06.736693
NCT02118792|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-01-12|2017-01-05|2016-02-16|March 2014||2014-03-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Intent to Treat (ITT) population included all participants who were randomized and received study drug.|Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis|A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis|Completed||Phase 3|764|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:32:06.856763|2017-10-11 00:32:06.856763
NCT02118779|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-07-13|||April 2, 2014|Actual|2014-04-02|July 2017|2017-07-01|October 17, 2016|Actual|2016-10-17|March 29, 2016|Actual|2016-03-29||Interventional|OPTIMISTIC||Observational Prolonged Trial in Myotonic Dystrophy Type 1|Observational Prolonged Trial in Myotonic Dystrophy Type 1 to Improve Quality of Life Standards, a Target Identification Collaboration|Completed||N/A|255|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 00:32:07.611986|2017-10-11 00:32:07.611986
NCT02118766|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-01-12|2017-01-09|2016-02-16|March 2014||2014-03-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Intent to treat population included all randomized participants who received the study drug.|Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis|A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis|Completed||Phase 3|763|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:32:08.129256|2017-10-11 00:32:08.129256
NCT02118753|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-01-11|||March 2014||2014-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|EPLICARD||The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium|The Effect of Eplerenone on Ischemia Reperfusion Injury in Human Myocardium (EPLICARD Study)|Completed||N/A|24|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 00:32:09.066035|2017-10-11 00:32:09.066035
NCT02118740|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-01-27|||June 2015||2015-06-01|January 2017|2017-01-01|April 30, 2018|Anticipated|2018-04-30|December 30, 2017|Anticipated|2017-12-30|1 Week|Observational [Patient Registry]|iCell||Bone Marrow Collection in Healthy Volunteers (iCell)|Bone Marrow Collection in Healthy Volunteers|Recruiting||N/A|15|Anticipated|Amarna Stem Cells BV|||1||f||||f||||||Samples With DNA|"     A stem cell specimen will be retained to enable verification in the future   "|Yes|The bone marrow characteristics shall be published as part of the preclinical studies and in particular as a request of the METC|2017-10-11 00:32:09.165959|2017-10-11 00:32:09.165959
NCT02118727|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-05-09|||July 2017|Anticipated|2017-07-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|TAME||Therapy in Amyotrophic Lateral Sclerosis With Memantine at 20 mg BID (TAME)|Multi-centered Double Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Memantine at 20 mg BID in Patients With ALS Currently Taking Riluzole|Not yet recruiting||Phase 2|90|Anticipated|University of Kansas Medical Center||2|||f||||t|t|f||||||||2017-10-11 00:32:09.336389|2017-10-11 00:32:09.336389
NCT02118714|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-07-28|||April 6, 2015||2015-04-06|July 2017|2017-07-01|May 30, 2019|Anticipated|2019-05-30|December 12, 2017|Anticipated|2017-12-12||Interventional|||Atrasentan Spermatogenesis and Testicular Function|A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function|Recruiting||Phase 2|20|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-11 00:32:09.494221|2017-10-11 00:32:09.494221
NCT02118701|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-05-18|||January 2014||2014-01-01|May 2015|2015-05-01||||May 2015|Actual|2015-05-01||Interventional|||SHARED DECISION MAKING IN LONG-TERM CARE FACILITIES|SHARED DECISION MAKING ON A 'LIFE-AND-CARE PLAN' IN LONG-TERM CARE FACILITIES|Completed||N/A|40|Actual|Radboud University||1|||f||||||||||||||2017-10-11 00:32:09.632281|2017-10-11 00:32:09.632281
NCT02118688|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-10-26|||March 2011||2011-03-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium|Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium: A Four-arm Prospective, Randomized, Double-blind, Placebo-controlled Pilot Study|Terminated||Phase 4|5|Actual|Rochester General Hospital||4||Lack of enrollment|f||||t||||||||||2017-10-11 00:32:09.728217|2017-10-11 00:32:09.728217
NCT02118675|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-05-02|||January 2014||2014-01-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|Tanita||Tanita BIA System Validation|Tanita® BIA System Validation|Completed||N/A|150|Actual|Pennington Biomedical Research Center|||2||f||||f||||||||||2017-10-11 00:32:09.840674|2017-10-11 00:32:09.840674
NCT02118662|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-09-18|||March 2014||2014-03-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|July 2015|Actual|2015-07-01||Interventional|EE-Work||Energy Expenditure During Seated, Seated Cycling, and Treadmill Walking Work Conditions (EE-Work)|Energy Expenditure During Seated, Seated Cycling, and Treadmill Walking Work Conditions (EE-Work)|Active, not recruiting||N/A|16|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 00:32:09.944584|2017-10-11 00:32:09.944584
NCT02118649|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2016-07-12|||April 2014||2014-04-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game||Recruiting||N/A|100|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 00:32:10.084741|2017-10-11 00:32:10.084741
NCT02118636|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-03-03|||October 2009||2009-10-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2013|Actual|2013-09-01||Observational|||Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms|Prospective Observational Study of Breast Cancer Patients Starting Therapy With an AI to Evaluate Mechanisms Underlying Development of Aromatase Inhibitor Associated Musculoskeletal Symptoms|Completed||N/A|75|Actual|University of Michigan Cancer Center|||1||f||||f||||||Samples With DNA|"     Whole blood is being collected at baseline for DNA extraction. Serum is being collected at     baseline and after 3, 6, and 12 months.   "|||2017-10-11 00:32:10.202444|2017-10-11 00:32:10.202444
NCT02118623|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-10-25|||January 2014||2014-01-01|October 2016|2016-10-01||||February 2017|Anticipated|2017-02-01||Interventional|||Internet-Based Interventions for Bipolar Disorder (MoodSwings 2)|1/2-A Randomized Trial of Internet-Based Interventions for Bipolar Disorder|Active, not recruiting||N/A|300|Anticipated|University of Melbourne||3|||f||||t||||||||||2017-10-11 00:32:10.297738|2017-10-11 00:32:10.297738
NCT02118610|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-05-16|||September 2014||2014-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity|Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity|Recruiting||N/A|60|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-11 00:32:10.413139|2017-10-11 00:32:10.413139
NCT02118597|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-10-18|2016-06-15||May 2014||2014-05-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational||Analysis was performed on all enrolled participants.|An Observational Study Examining the Use of Triple Combination Therapy With Boceprevir, Peginterferon Alfa-2a and Ribavirin in the Re-Treatment of Chronic Hepatitis C Patients|Non-interventional Study to Observe Triple Combination Therapy With Boceprevir or Simeprevir Plus Peginterferon Alfa-2a Plus Ribavirin for Re-treatment of Chronic Hepatitis C in Hungary (IMPERIAL)|Terminated||N/A|19|Actual|Hoffmann-La Roche|||1|Study terminated due to the Sponsor's decision.|f||||||||||Samples Without DNA|"     Blood serum used to analyze levels of hepatitic c virus (HCV) ribonucleic acid (RNA)   "|||2017-10-11 00:32:10.513524|2017-10-11 00:32:10.513524
NCT02118584|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-03-15|||September 30, 2014|Actual|2014-09-30|March 2017|2017-03-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies|An Open-Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase II/III Studies|Recruiting||Phase 3|2625|Anticipated|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 00:32:11.130101|2017-10-11 00:32:11.130101
NCT02118571|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-06-20|||November 2013||2013-11-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|CIAS PRO||Schizophrenia Cognition Scale Development|Schizophrenia Cognition Scale Development: Item Development and Psychometric Validation of a Novel Patient Reported Outcome (PRO) Measure for Research and Clinical Application|Completed||N/A|102|Actual|New England Research Institutes|||1||f||||f||||||None Retained|"     No biospecimens collected   "|||2017-10-11 00:32:13.388823|2017-10-11 00:32:13.388823
NCT02118558|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-17|||June 2014||2014-06-01|April 2014|2014-04-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Negative Pressure Wound Therapy -PREVENA in Prevention of Infections After Total Knee Arthroplasty (TKA)||Unknown status|Not yet recruiting|Phase 2|||Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:32:13.548794|2017-10-11 00:32:13.548794
NCT02118545|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-03-07|||April 2014||2014-04-01|September 2015|2015-09-01||||February 2016|Actual|2016-02-01||Observational|||Von Willebrand Factor to Predict Postoperative Outcome|Preoperative Von Willebrand Factor to Predict Postoperative Liver Dysfunction and Morbidity After Liver Resection|Completed||N/A|133|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 00:32:13.62052|2017-10-11 00:32:13.62052
NCT02118532|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-12-29|||March 2014||2014-03-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population|The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population|Completed||N/A|143|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-10-11 00:32:13.723075|2017-10-11 00:32:13.723075
NCT02118519|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-02-23|||January 2014||2014-01-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Mesenchymal Stem Cells in Knee Cartilage Injuries|Use of Mesenchymal Stem Cells for the Repair of Articular Cartilage Disorder of Knee Using Intra-articular Injection of Mesenchymal Cells Alone or Mesenchymal Cells With Platelet Lysate|Completed||Phase 2|13|Actual|University of Jordan||2|||f||||f||||||||||2017-10-11 00:32:13.86923|2017-10-11 00:32:13.86923
NCT02118506|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-04-16|||December 2012||2012-12-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Mental Practice in Gait of Individuals With Parkinson Disease: Randomized Clinical Trial|Immediate Effects of Mental Practice in Gait of Individuals With Parkinson Disease: Randomized Clinical Trial|Completed||N/A|20|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||||2017-10-11 00:32:13.966532|2017-10-11 00:32:13.966532
NCT02118493|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-12-02|||December 2015||2015-12-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|July 2016|Anticipated|2016-07-01||Interventional|||Endo-biliary Laser Excision of Biliary Stenoses|Endo-biliary Laser Excision of Biliary Stenoses: Initial Experience and Feasibility|Withdrawn||N/A|0|Actual|University of Florida||1||The protocol has been withdrawn for re-evaluation.|f||||f||||||||||2017-10-11 00:32:14.049915|2017-10-11 00:32:14.049915
NCT02118480|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-02-06|||June 2012||2012-06-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Improving Functional Disability and Cognition in Parkinson Disease: Randomized Controlled Trial|Improving Functional Disability and Cognition in Parkinson Disease: Randomized Controlled Trial|Completed||N/A|44|Actual|University of Deusto||2|||f||||t||||||||||2017-10-11 00:32:14.147266|2017-10-11 00:32:14.147266
NCT02118467|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-02-09|||May 2014||2014-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Vasoactive Drugs in Intensive Care Unit|A Randomized Double Blind Trial of Vasoactive Drugs for the Management of Shock in the ICU|Recruiting||Phase 4|836|Anticipated|University of Chicago||2|||f||||t||||||||Undecided||2017-10-11 00:32:14.240288|2017-10-11 00:32:14.240288
NCT02118454|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-06-05|||April 2014||2014-04-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|MASHIndia||Antiretroviral Adherence and Quality-of-life Support for HIV+ Patients in India With Twice-daily Interactive Voice Response (IVR) Calls With Health and Mental Health Messaging Compared to Weekly IVR Survey Only Control Condition: The Mobile-messaging Adherence and Support for Health Study, India.|ART Adherence Behaviour and Practices Among HIV Positives in Kolkata, India-a Pilot Project|Completed||N/A|400|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:32:14.394254|2017-10-11 00:32:14.394254
NCT02118441|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-04-21|2015-03-03||August 2013||2013-08-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|art-line||Ultrasound-guided Versus Direct Palpation Radial Artery Catheter Insertion Among Cardiac Anesthesiologists|A Comparison of Ultrasound-Guided Versus Direct Palpation For Radial Artery Catheterization Among Cardiac Anesthesiologists|Completed||N/A|129|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:32:14.495519|2017-10-11 00:32:14.495519
NCT02118415|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-09-19|||March 2014||2014-03-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)|Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)|Recruiting||Phase 2|90|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-10-11 00:32:14.874412|2017-10-11 00:32:14.874412
NCT02118402|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-04-08|||July 2014||2014-07-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Iro'n'Pre||Iron and Prebiotics Fortification in Kenyan Infants|In Home Iron Fortification in Kenyan Infants: Effect of Co-supplementation With Galactooligosaccharides (GOS) on the Gut Microbiota Composition and the Effectiveness of Iron Supplementation|Completed||N/A|155|Actual|Swiss Federal Institute of Technology||3|||f||||t||||||||||2017-10-11 00:32:14.965178|2017-10-11 00:32:14.965178
NCT02118389|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-04-17|||October 2013||2013-10-01|October 2013|2013-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure|The Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure in Patients With Obesity|Completed||N/A|20|Actual|Shanghai 10th People's Hospital||1|||f||||t||||||||||2017-10-11 00:32:15.056901|2017-10-11 00:32:15.056901
NCT02118376|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-04-16|||August 2014||2014-08-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status|Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status in Female Patients With Type 2 Diabetes and Obesity|Unknown status|Not yet recruiting|N/A|20|Anticipated|Shanghai 10th People's Hospital||1|||f||||t||||||||||2017-10-11 00:32:15.11994|2017-10-11 00:32:15.11994
NCT02118363|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-05-11|||April 2014||2014-04-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|INTERACTION||INTERACTION, Monitoring of Stroke Patients in Hospital and Home Environment|Proof of Concept Study of the INTERACTION Technology, Monitoring of Stroke Patients in Hospital and Home Environment|Recruiting||N/A|15|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-11 00:32:15.201943|2017-10-11 00:32:15.201943
NCT02118350|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-16|||April 2012||2012-04-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Mat Pilates Training on Blood Pressure of Hypertensive Individuals|Effect of Mat Pilates Training on Blood Pressure of Hypertensive Individuals|Completed||N/A|44|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 00:32:15.547855|2017-10-11 00:32:15.547855
NCT02118337|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-07-11|||May 19, 2014|Actual|2014-05-19|July 2017|2017-07-01|January 29, 2021|Anticipated|2021-01-29|January 29, 2021|Anticipated|2021-01-29||Interventional|||A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies|A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies|Recruiting||Phase 1/Phase 2|96|Anticipated|MedImmune LLC||8|||f||||f||||||||||2017-10-11 00:32:15.667604|2017-10-11 00:32:15.667604
NCT02118324|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-03-13|||March 2014||2014-03-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Interventional|||Exergaming Intervention in ALL Patients|The Effect of a Home-based Fitness Intervention on Cardiometabolic Risk Profile in Acute Lymphoblastic Leukemia (ALL) Patients|Completed||N/A|35|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:32:15.852531|2017-10-11 00:32:15.852531
NCT02118311|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-06-14|||June 2016||2016-06-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Treg Cells for AGVHD in Non-myeloablative UCB Transplant|T Regulatory Cell for Suppression of Acute Graft-vs-Host-Disease in Recipients of a Non-Myeloablative Umbilical Cord Blood Transplantation for Treatment of Hematological Malignancies|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||2||Changing study design. Will replace with a different protocol.|f||||t||||||||||2017-10-11 00:32:15.949347|2017-10-11 00:32:15.949347
NCT02118298|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-05-11|||April 2014||2014-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Allocentric Memory in MS and Resting State Functional MRI|Allocentric Memory as a Novel Measure of Cognitive Inefficiency: Sensitivity in Multiple Sclerosis (MS) Subjects and Relationship With Resting State Functional MRI|Completed||N/A|120|Actual|Yale University|||2||f||||f||||||||Undecided||2017-10-11 00:32:16.055709|2017-10-11 00:32:16.055709
NCT02118285|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-08-23|||July 28, 2014|Actual|2014-07-28|August 2017|2017-08-01|November 12, 2015|Actual|2015-11-12|November 12, 2015|Actual|2015-11-12||Interventional|||Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Indoleamine-2,3-dioxygenase (IDO) Inhibition With INCB024360 and Intraperitoneal Delivery of Allogeneic Natural Killer Cells for Women With Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Completed||Phase 1|2|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f||||||||2017-10-11 00:32:16.124963|2017-10-11 00:32:16.124963
NCT02118272|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-03-02|||July 2014||2014-07-01|March 2016|2016-03-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|K-06||Clinical Study Evaluating the Outcomes of a New Knee System With a Physiological Rollback Mechanism|A Multicentre, Prospective Clinical Study Evaluating the Outcomes of a New Knee System With a Physiological Rollback Mechanism|Recruiting||N/A|156|Anticipated|Limacorporate S.p.a||1|||f||||f||||||||||2017-10-11 00:32:16.216898|2017-10-11 00:32:16.216898
NCT02118259|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-05-05|||May 2014||2014-05-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Rev-EHPAD||Impact of Multidisciplinary Review of Drug Prescriptions on Patient Safety in a Residence for Dependent Elderly|Impact of Multidisciplinary Review of Drug Prescriptions on Patient Safety in a Residence for Dependent Elderly|Completed||N/A|49|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-11 00:32:16.29719|2017-10-11 00:32:16.29719
NCT02118246|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-16|||October 2012||2012-10-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|||The Effects of Dry Needling & Kinesio Tape on Anterior Knee Pain|The Clinical Effects of Dry Needling & Kinesio Tape on Myofascial Trigger Point in the Vastus Lateralis Muscle in Subjects With PFPS|Completed||N/A|30|Actual|University of Social Welfare and Rehabilitation Science||2|||f||||t||||||||||2017-10-11 00:32:16.478605|2017-10-11 00:32:16.478605
NCT02118233|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-03-06|||April 2014||2014-04-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|||Cognitive Outcome After Carotid Surgery|Cognitive Outcome After Carotid Surgery|Recruiting||N/A|56|Anticipated|Lahey Clinic|||3||f||||t||||||||||2017-10-11 00:32:16.576213|2017-10-11 00:32:16.576213
NCT02118220|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-12-02|||May 2014||2014-05-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Anesthesia on Pediatric Surgical Patients With a History of Concussion - Phase I|Effects of Anesthesia on Pediatric Surgical Patients With a History of Concussion - Phase I|Completed||Phase 1|125|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-11 00:32:16.700176|2017-10-11 00:32:16.700176
NCT02118207|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-16|||October 2013||2013-10-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Exercise and Repetitive Diving|The Impact of Predive Exercise on Repetitive SCUBA Diving|Completed||N/A|16|Actual|University Hospital of Split||2|||f||||f||||||||||2017-10-11 00:32:16.807028|2017-10-11 00:32:16.807028
NCT02118194|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-04-08|||October 2013||2013-10-01|April 2015|2015-04-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Observational|VA_ReWalk2||Home/Work, Community Mobility Skills in the ReWalk Exoskeleton in Persons With SCI|Assessment of Home/Work Simulation Tasks and Community Mobility Skills in the ReWalk Powered Exoskeleton in Persons With Spinal Cord Injury|Unknown status|Recruiting|N/A|40|Anticipated|James J. Peters Veterans Affairs Medical Center|||1||f||||f||||||||||2017-10-11 00:32:16.896903|2017-10-11 00:32:16.896903
NCT02118181|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-12-02|||February 2014||2014-02-01|April 2014|2014-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|HMB||Assessment of Physical Performance With A Supplementation Containing HMB in a Sample of Old Women in Good Health|Role of Oral Supplementation of Proteins and β-hydroxy-β-methyl Butyrate (HMB) in a Sample of Older Women in Good Health|Completed||N/A|80|Actual|University of Padova||2|||f||||t||||||||||2017-10-11 00:32:16.997123|2017-10-11 00:32:16.997123
NCT02118168|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-08-21|||September 2013||2013-09-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Observational|ISST-002 EF-UP||Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002|OBSERVATIONAL STUDY FOR THE EXTENDED FOLLOW-UP OF THE PATIENTS ENROLLED IN THE PHASE II THERAPEUTIC CLINICAL TRIAL ISS T-002|Completed||N/A|93|Actual|Istituto Superiore di Sanità|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-11 00:32:17.064651|2017-10-11 00:32:17.064651
NCT02118155|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-17|||October 2011||2011-10-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|LILT||Low-intensity Laser Therapy in the Treatment of Gingival Recession|Connective Tissue Graft Associated or Not With Low Intensity Laser Therapy: A Randomized Clinical Trial|Completed||N/A|40|Actual|UPECLIN HC FM Botucatu Unesp||2|||f||||t||||||||||2017-10-11 00:32:17.168399|2017-10-11 00:32:17.168399
NCT02118142|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-08-11|||March 2014||2014-03-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21|Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21|Completed||N/A|23|Actual|UNC Nutrition Research Institute||2|||f||||f||||||||||2017-10-11 00:32:17.256322|2017-10-11 00:32:17.256322
NCT02118129|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'.|Knowledge, Attitudes, Intake and Blood Levels of Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'.|Completed||N/A|105|Actual|University of Guelph||2|||f||||f||||||||No||2017-10-11 00:32:17.354529|2017-10-11 00:32:17.354529
NCT02118116|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-10-19|||June 2014||2014-06-01|January 2014|2014-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Safety and Effectiveness of Gatekeeper Training in First Nations Communities||Withdrawn||N/A|0|Actual|University of Manitoba||3||unable to recruit participants due to political issues|f||||f||||||||||2017-10-11 00:32:17.441218|2017-10-11 00:32:17.441218
NCT02118103|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-04-16|||May 2014||2014-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Impact of Spinal Manipulation on Leg Movement in Lumbar Spinal Stenosis Patients|The Impact of Spinal Manipulation on Lower Extremity Motor Control in Lumbar Spinal Stenosis Patients: a Single-blind Randomized Before-after Trial|Unknown status|Enrolling by invitation|N/A|24|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:32:17.558911|2017-10-11 00:32:17.558911
NCT02118090|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-03-23|||May 2014||2014-05-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|CRePViCam||Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:|Assessing Chloroquine Resistance of Plasmodium Vivax in Malaria Endemic Area|Completed||Phase 4|73|Actual|Institut Pasteur, Cambodia||2|||f||||f||||||||||2017-10-11 00:32:17.659793|2017-10-11 00:32:17.659793
NCT02118077|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-17|||April 2001||2001-04-01|April 2014|2014-04-01||||April 2004|Actual|2004-04-01||Interventional|PC6||Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer|A Prospective, Randomized, Double-blind, Placebo-controlled, Group Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer.|Completed||Phase 3|154|Actual|Cancer Advances Inc.||2|||f||||||||||||||2017-10-11 00:32:17.753745|2017-10-11 00:32:17.753745
NCT02118064|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-17|||March 2001||2001-03-01|January 2014|2014-01-01||||December 2002|Actual|2002-12-01||Interventional|CC6||Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma|A Multinational, Multicenter, Open-label, Single-arm, Phase II Study of G17DT Immunogen in Combination With Irinotecan in Metastatic Colorectal Carcinoma Refractory to Previous Irinotecan-based Chemotherapy.|Completed||Phase 2|161|Actual|Cancer Advances Inc.||1|||||||||||||||||2017-10-11 00:32:17.81742|2017-10-11 00:32:17.81742
NCT02118051|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-06-09|||September 2013||2013-09-01|September 2016|2016-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.|Prospective Randomized Study for the Evaluation of Controlled Ovarian Stimulation With Corifollitropin Alpha in Patients With Expected or Poor Ovarian Response in IVF Cycles|Completed||Phase 3|234|Actual|Instituto de Investigacion Sanitaria La Fe||2|||f||||t||||||||||2017-10-11 00:32:17.892195|2017-10-11 00:32:17.892195
NCT02118038|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-01-10|||November 2014||2014-11-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2016|Actual|2016-12-01||Observational|HELP-MOM||Emotional and Cardiac Impact of Postpartum Haemorrhage|Emotional and Cardiac Impact of Postpartum Haemorrhage. Observational Study HELP-MOM.|Active, not recruiting||N/A|329|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     Serum and plasma   "|||2017-10-11 00:32:17.994455|2017-10-11 00:32:17.994455
NCT02118025|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-04-16|||January 2006||2006-01-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|November 2008|Actual|2008-11-01||Observational|||Coronary Bypass Grafting With Minimal Extracorporeal Circulation System Versus Off-pump Coronary Surgery|Prospective Randomized Comparison of Coronary Bypass Grafting With Minimal Extracorporeal Circulation System (MECC) Versus Off-pump Coronary Surgery. New Insights Into Inflammatory Cytokines.|Completed||N/A|230|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||2||f||||f||||||||||2017-10-11 00:32:18.066033|2017-10-11 00:32:18.066033
NCT02118012|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-10-05|||March 20, 2014||2014-03-20|September 19, 2017|2017-09-19|September 20, 2016|Actual|2016-09-20|March 20, 2014|Actual|2014-03-20||Interventional|||Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C|Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C|Completed||Phase 1|27|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:32:18.14703|2017-10-11 00:32:18.14703
NCT02117986|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-06-02|||April 2014||2014-04-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients|Clinical and Microbiological Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients|Unknown status|Recruiting|Phase 4|200|Anticipated|Hospital Barros Luco Trudeau||2|||f||||t||||||||||2017-10-11 00:32:18.321834|2017-10-11 00:32:18.321834
NCT02117973|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-04-16|||June 2014||2014-06-01|February 2014|2014-02-01||||June 2016|Anticipated|2016-06-01||Interventional|||iAssist vs. Conventional Instrumentation in Total Knee Arthroplasty Using the Persona Knee System Among Patients With BMI>=30: Radiographic, Clinical and Economic Outcomes||Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:32:18.454564|2017-10-11 00:32:18.454564
NCT02117960|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-04-07|||December 2011||2011-12-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Assessing the Effects of Omega-3 Supplementation on Serum HSP27, HSP70, YKL40, BMP-4 Levels in Male Patient With CAD|Assessing the Effects of Omega-3 Supplementation on Serum HSP27, HSP70, YKL40, BMP-4 Levels in Male Patient With Coronary Artery Disease|Completed||Phase 4|21|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:32:18.528207|2017-10-11 00:32:18.528207
NCT02117947|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-02-13|||July 2004|Actual|2004-07-01|February 2017|2017-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Counseling to Reduce Children's SHS Exposure: A Trial With Maternal Smokers|Behavioral Counseling to Reduce Children's Secondhand Smoke Exposure: A Trial With Maternal Smokers|Completed||N/A|300|Actual|Temple University||2|||f||||f|f|f||||||No||2017-10-11 00:32:18.612743|2017-10-11 00:32:18.612743
NCT02117934|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-08-29||2017-02-06|April 2014||2014-04-01|August 2017|2017-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine|A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age|Completed||Phase 3|8374|Actual|Dynavax Technologies Corporation||2|||f||||t||||||||||2017-10-11 00:32:18.715933|2017-10-11 00:32:18.715933
NCT02117921|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-03-03|||February 2014||2014-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain|Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain|Recruiting||N/A|20|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-10-11 00:32:19.073437|2017-10-11 00:32:19.073437
NCT02117908|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-06-21|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|CPAP-RFP||Study of the Application of CPAP to Reduce Complications and Improve Lung Cancer Ablation Radiofrequency Treatment|Application of CPAP to Reduce Complications and Improve Treatment of Radiofrequency Ablation of Lung Cancer Under Conscious Sedation. A Randomized Study|Recruiting||N/A|40|Anticipated|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 00:32:19.169548|2017-10-11 00:32:19.169548
NCT02117895|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-08-10|||January 2014||2014-01-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail|A Prospective RCT Study of Distal Pancreatectomy Combined With Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail|Recruiting||Phase 3|180|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 00:32:19.260363|2017-10-11 00:32:19.260363
NCT02117882|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-16|||January 2013||2013-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Observational|||Minimally Invasive Lateral Approach for Sinus Augmentation: a Split-mouth Randomized Clinical Trial.|Minimally Invasive Lateral Approach for Sinus Augmentation: a Split-mouth Randomized Clinical Trial.|Completed||N/A|15|Actual|University of Firenze and Siena, Napoli, Italy|||2||f||||t||||||||||2017-10-11 00:32:19.367483|2017-10-11 00:32:19.367483
NCT02117869|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-06-08|||May 2014||2014-05-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of Low Furanocoumarin Grapefruit Hybrid Juice Consumption on Midazolam Pharmacokinetics|The Effect of Low Furanocoumarin Grapefruit Hybrid Juice Consumption on Midazolam Pharmacokinetics|Completed||Phase 4|12|Actual|University of Florida||3|||f||||f||||||||||2017-10-11 00:32:19.434165|2017-10-11 00:32:19.434165
NCT02117648|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-09-17|||April 2014||2014-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||A Study of LY2835219 in Participants With Cancer|Effects of CYP3A Inhibition by Clarithromycin on the Pharmacokinetics of LY2835219 and Its Metabolites in Cancer Patients|Completed||Phase 1|40|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:32:22.848723|2017-10-11 00:32:22.848723
NCT02117856|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-12-02|||November 2002||2002-11-01|December 2014|2014-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Complete Lower Dentures on 1 or 2 Implants|A Randomized Clinical Trial Comparing Patient Satisfaction and Prosthetic Outcomes With Mandibular Implant Overdentures Retained by 1 or 2 Implants|Unknown status|Active, not recruiting|N/A|86|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:32:19.525266|2017-10-11 00:32:19.525266
NCT02117843|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-06-24|||July 2013||2013-07-01|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|December 2017|Anticipated|2017-12-01||Interventional|||The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization|A Prospective, Multi-center, Single Armed Registry to Evaluate The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization|Recruiting||N/A|1200|Anticipated|Beijing AmsinoMed Medical Device Co., Ltd||1|||f||||t||||||||No||2017-10-11 00:32:19.645673|2017-10-11 00:32:19.645673
NCT02117830|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-06-13|||April 2014||2014-04-01|June 2014|2014-06-01||||May 2014|Actual|2014-05-01||Interventional|||A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects|A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects|Completed||Phase 1|54|Anticipated|Repros Therapeutics Inc.||4|||f||||f||||||||||2017-10-11 00:32:19.737508|2017-10-11 00:32:19.737508
NCT02117817|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-03-18|||February 2015||2015-02-01|March 2015|2015-03-01||||February 2015|Anticipated|2015-02-01||Interventional|||Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer|A Phase I Trial of BKM120 in Combination With Weekly Nabpaclitaxel (Abraxane®) in Patients With Advanced Solid Tumors Followed by a Dose Expansion Phase in Patients With Recurrent Endometrial or Recurrent Ovarian Cancer|Withdrawn||Phase 1|0|Actual|Rutgers, The State University of New Jersey||1||Research cancelled|f||||f||||||||||2017-10-11 00:32:19.820037|2017-10-11 00:32:19.820037
NCT02117804|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-05-20|||June 2014||2014-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Early Screen for Discharge Planning in Community Hospitals|Validating Discharge Planning Decision Support in a Regional Community Hospital|Completed||N/A|225|Actual|Mayo Clinic|||2||f||||f||||||||||2017-10-11 00:32:19.918915|2017-10-11 00:32:19.918915
NCT02117791|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-09-19|||July 16, 2014|Actual|2014-07-16|September 2017|2017-09-01|January 16, 2024|Anticipated|2024-01-16|September 30, 2022|Anticipated|2022-09-30||Observational|JPMS-CTEPH||Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )|Drug Use Investigation of Riociguat for ChronicThromboembolic Pulmonary Hypertension (CTEPH)|Recruiting||N/A|420|Anticipated|Bayer|||1||f||||||||||||||2017-10-11 00:32:20.019674|2017-10-11 00:32:20.019674
NCT02117778|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-02-02|||March 2014|Actual|2014-03-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of Pulmonary Function and Efficacy of Different Nerve Block Catheters for Shoulder Surgery|A Comparative Pulmonary Function Study of Continuous Supraclavicular, Suprascapular, and Interscalene Nerve Catheters After Total Shoulder Arthroplasty|Completed||N/A|75|Actual|Benaroya Research Institute||3|||f||||t||||||||||2017-10-11 00:32:20.226438|2017-10-11 00:32:20.226438
NCT02117765|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-05-24|||March 2015||2015-03-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|UST1D||Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D|Phase I/II Study of Ustekinumab in Patients With New-onset Type 1 Diabetes|Active, not recruiting||Phase 1/Phase 2|20|Actual|University of British Columbia||1|||f||||t||||||||||2017-10-11 00:32:20.370312|2017-10-11 00:32:20.370312
NCT02117752|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-09-12|||April 2014||2014-04-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Dermal Tolerability of Dapsone Gel in Healthy Volunteers||Completed||Phase 1|237|Actual|Allergan||2|||f||||f||||||||||2017-10-11 00:32:20.562327|2017-10-11 00:32:20.562327
NCT02117739|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-09-12|||April 2014||2014-04-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Photoallergy Potential of Dapsone Gel in Healthy Volunteers||Completed||Phase 1|58|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:32:20.683573|2017-10-11 00:32:20.683573
NCT02117726|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-07-15|||May 2014||2014-05-01|July 2014|2014-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Impact of Various Sedation Regimens on the Incidence of Delirium|Impact of Various Sedation Regimens on the Incidence of Post-sedation Delirium in Patients Receiving Mechanical Ventilation|Unknown status|Not yet recruiting|Phase 4|320|Anticipated|Shandong Provincial Hospital||2|||f||||||||||||||2017-10-11 00:32:20.810352|2017-10-11 00:32:20.810352
NCT02117713|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-04-19|||March 16, 2015|Actual|2015-03-16|April 2017|2017-04-01|October 19, 2018|Anticipated|2018-10-19|October 19, 2018|Anticipated|2018-10-19||Interventional|IMAGINE-II||An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome|A Multicenter Extension Study to Evaluate the Long-Term Safety and Durability of the Therapeutic Effect of LUM001, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome|Active, not recruiting||Phase 2|36|Anticipated|Shire||1|||f||||f||||||||||2017-10-11 00:32:20.978349|2017-10-11 00:32:20.978349
NCT02117700|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-03-30|||April 2015||2015-04-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Fatty Liver Disease in Obese Children|Effect of N-acetyl Cysteine on Non Alcoholic Fatty Liver Disease in Obese Children|Not yet recruiting||Phase 2|54|Anticipated|Nemours Children's Clinic||3|||f||||t||||||||||2017-10-11 00:32:21.10264|2017-10-11 00:32:21.10264
NCT02117687|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-01-22|2016-01-22||May 2014||2014-05-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye||Completed||Phase 4|80|Actual|Allergan||2|||f||||f||||||||||2017-10-11 00:32:21.259392|2017-10-11 00:32:21.259392
NCT02117661|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-09-18|||January 2015||2015-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|ECoM||Carnitine for the Treatment of Atherosclerosis.|ECoM Study: Effect of Carnitine Supplementation on Progression of Carotid Plaque in the Metabolic Syndrome.|Active, not recruiting||Phase 2|177|Actual|Queen's University||2|||f||||t||||||||||2017-10-11 00:32:22.74486|2017-10-11 00:32:22.74486
NCT02117635|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-08-29|||June 2014||2014-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|PISCES-II||Pilot Investigation of Stem Cells in Stroke Phase II Efficacy|A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.|Active, not recruiting||Phase 2|23|Actual|ReNeuron Limited||1|||f||||t||||||||||2017-10-11 00:32:22.961943|2017-10-11 00:32:22.961943
NCT02117622|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-08-01|||July 24, 2015|Actual|2015-07-24|July 2017|2017-07-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Observational|||A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India|A Multi-centre, Prospective, Open-label, Single-arm, Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India|Completed||N/A|1056|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 00:32:23.313248|2017-10-11 00:32:23.313248
NCT02117609|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-10-06|||May 2012||2012-05-01|October 2015|2015-10-01||||June 2015|Actual|2015-06-01||Interventional|PRESAGE-T2||Effect of a New High-protein Oral Supplement on Functional Parameters in Patients in Nursing Homes|Effet d'Une supplémentation Avec Une Nouvelle préparation hyperprotéinée et Hypercalorique Sur l'évolution Des paramètres Fonctionnels, Nutritionnels et Cognitifs Chez la Personne âgée en Institution|Completed||Phase 2|110|Actual|Lactalis||2|||f||||t||||||||||2017-10-11 00:32:23.503063|2017-10-11 00:32:23.503063
NCT02117583|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-03-31|||April 2014||2014-04-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers|An Open-Label, Randomized, 2-Cohort, Single-Dose, Crossover Study To Estimate The Effects Of Food On Oxycodone Pharmacokinetics Following Oral Administration Of 40 Mg Doses Of Pf 00345439 Formulation K Taken Whole Or After Chewing In Healthy Volunteers|Completed||Phase 1|34|Actual|Pain Therapeutics||4|||f||||f||||||||||2017-10-11 00:32:23.71224|2017-10-11 00:32:23.71224
NCT02117570|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-12-05|2016-12-05||July 2014||2014-07-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||All participants who received at least 1 vaccination|A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.|A Phase 2, Placebo-controlled, Randomised, Observer-blinded Trial To Evaluate The Safety, Tolerability And Immunogenicity Of A Clostridium Difficile Vaccine Administered As A 3-dose Regimen In Healthy Adults Aged 50 To 85 Years|Completed||Phase 2|185|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 00:32:23.918498|2017-10-11 00:32:23.918498
NCT02117557|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-17|||April 2014||2014-04-01|April 2014|2014-04-01|April 2022|Anticipated|2022-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Safety Study of Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer|A Prospective Randomized Controlled Trial Comparing Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer|Recruiting||Phase 2|198|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 00:32:29.682342|2017-10-11 00:32:29.682342
NCT02117544|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2015-08-14|2015-07-21||April 2014||2014-04-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||This analysis population includes all randomized and treated subjects.|Multifocal High ADD Contact Lens Proof of Concept Trial|Evaluation of Visual Performance With a Multifocal High ADD Soft Contact Lens Design|Completed||N/A|268|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:32:29.931139|2017-10-11 00:32:29.931139
NCT02117518|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-04-22|||May 2014||2014-05-01|April 2014|2014-04-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Observational|||Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients|Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients|Unknown status|Not yet recruiting|N/A|50|Anticipated|Migal Galilee Research Institute|||1||f||||f||||||None Retained|"     Blood samples   "|||2017-10-11 00:32:30.235813|2017-10-11 00:32:30.235813
NCT02117505|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2014-06-25|||April 2014||2014-04-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult Participants|A Single-Dose, Open-Label, Randomized, Crossover Study to Assess the Relative Bioavailability of Two JNJ-54781532 Tablet Formulations Under Fed Conditions in Healthy Adult Subjects|Completed||Phase 1|20|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:32:30.328756|2017-10-11 00:32:30.328756
NCT02117492|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-09-19|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Randomized Trial Comparing Horizontal and Vertical Vaginal Cuff Closure|A Randomized Trial Comparing Horizontal and Vertical Vaginal Cuff Closure|Completed||N/A|70|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 00:32:30.427334|2017-10-11 00:32:30.427334
NCT02117479|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-06-09|2017-02-09||March 2014|Actual|2014-03-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional||The intent-to-treat (ITT) population consisted of all participants randomized to the study.|Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)|A Randomized, Double-Blind, Phase 3 Study of the JAK1/2 Inhibitor, Ruxolitinib or Placebo in Combination With Capecitabine in Subjects With Advanced or Metastatic Adenocarcinoma of the Pancreas Who Have Failed or Are Intolerant to First-Line Chemotherapy (The JANUS 1 Study)|Terminated||Phase 3|321|Actual|Incyte Corporation|The study was terminated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation at the recommendation of the Data Monitoring Committee.|2||The study was terminated early based on the results of the planned interim analysis.|f||||t||||||||||2017-10-11 00:32:30.59389|2017-10-11 00:32:30.59389
NCT02117466|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-08-01|||April 2014||2014-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|IMPACT-CRC||Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer|Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer|Recruiting||Phase 1/Phase 2|85|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 00:32:32.753585|2017-10-11 00:32:32.753585
NCT02117453|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-01-10|||October 2014||2014-10-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|October 2019|Anticipated|2019-10-01||Interventional|STATVAS||Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides|Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides|Recruiting||Phase 3|180|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-11 00:32:32.859003|2017-10-11 00:32:32.859003
NCT02117440|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2017-09-14|||April 2014||2014-04-01|September 2017|2017-09-01|January 1, 2023|Anticipated|2023-01-01|January 1, 2022|Anticipated|2022-01-01||Observational|||Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer|Using Functional Image and Circulating Molecular Markers to Predict Tumor Control and Thoracic Toxicity in Treatment of Lung Cancer|Recruiting||N/A|140|Anticipated|Indiana University|||1||f||||t|f|f||||Samples With DNA|"     buffy coat, plasma and serum samples   "|||2017-10-11 00:32:32.952537|2017-10-11 00:32:32.952537
NCT02117414|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-16|2016-10-15|2015-07-20||April 2014||2014-04-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access|Evera MRI Clinical Study|Completed||N/A|275|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f||||||||||2017-10-11 00:32:33.147793|2017-10-11 00:32:33.147793
NCT02117401|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-07-14|||January 2012||2012-01-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients|A Prospective, Multi-center, Randomized Controlled Study of Neuromuscular Blocking Effect and Safety of Mivacurium Chloride in Pediatric Patients|Completed||Phase 4|1152|Actual|Jiangsu Nhwa Pharmaceutical Co., Ltd.||16|||f||||t||||||||||2017-10-11 00:32:34.033464|2017-10-11 00:32:34.033464
NCT02117388|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-12-05|||September 2013||2013-09-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatments for Insomnia: Mediators, Moderators and Quality of Life|Treatments for Insomnia: Mediators, Moderators and Quality of Life|Recruiting||N/A|200|Anticipated|Stanford University||3|||f||||f||||||||Undecided||2017-10-11 00:32:34.183224|2017-10-11 00:32:34.183224
NCT02117375|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-09-05|||January 2014||2014-01-01|September 2016|2016-09-01|July 2022|Anticipated|2022-07-01|July 2017|Anticipated|2017-07-01||Interventional|EMISEP||EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients|EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients|Recruiting||N/A|100|Anticipated|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 00:32:35.196582|2017-10-11 00:32:35.196582
NCT02117362|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-01-31|||March 2014||2014-03-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma|Phase IB Study of a Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma|Recruiting||Phase 1|22|Anticipated|Providence Health & Services||4|||f||||f|t|f||||||No||2017-10-11 00:32:35.308199|2017-10-11 00:32:35.308199
NCT02117349|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-09-26|||December 2014||2014-12-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Efficacy Study of Raplixa™ (Fibrin Sealant [Human]) to Treat Surgical Bleeding in Children|A Phase 2, Randomized, Single-Blind, Controlled Trial of Topical Raplixa™ (Fibrin Sealant [Human]) in Intraoperative Surgical Hemostasis in a Pediatric Population|Recruiting||Phase 2|87|Anticipated|Mallinckrodt||2|||f||||t||||||||||2017-10-11 00:32:35.460951|2017-10-11 00:32:35.460951
NCT02117336|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-09-02|||June 2014||2014-06-01|September 2014|2014-09-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)|A Phase I/Ib Study of P1446A-05 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).|Suspended||Phase 1|36|Anticipated|Piramal Enterprises Limited||1||Sponsor decision not related to patient safety|f||||f||||||||||2017-10-11 00:32:35.674007|2017-10-11 00:32:35.674007
NCT02117323|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-04-21|||September 2011||2011-09-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|OCT||Corneal Opacities in Children|Observational Study on Corneal Opacities in Children|Unknown status|Recruiting|N/A|60|Anticipated|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 00:32:35.805607|2017-10-11 00:32:35.805607
NCT02117310|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-04-13|2017-03-01||March 2015||2015-03-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ICG||ICG Use in Angiography for Nasoseptal Flap Harvest|Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Sphenopalatine Artery Location and Patency in Harvesting and Positioning a Pedicled Nasoseptal Mucosal Flap in Endoscopic Endonasal Cranial Base Surgery|Completed||N/A|5|Actual|Ohio State University||1|||f||||f||||||||||2017-10-11 00:32:35.917148|2017-10-11 00:32:35.917148
NCT02117297|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-05-05|||November 2011||2011-11-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||SCT Plus Immune Therapy in Average Risk AML/MDS|Allogeneic Stem Cell Transplantation Following by Targeted Immune Therapy) (Gemtuzumab Ozogamicin) in Average Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome (AML/MDS)(IND 111024)|Recruiting||Phase 2|26|Anticipated|New York Medical College||1|||f||||f|t|f||||||Undecided||2017-10-11 00:32:36.101305|2017-10-11 00:32:36.101305
NCT02117284|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-01-09|||January 2014||2014-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01|1 Day|Observational [Patient Registry]|REST-PET||Rubidium Elution System Performance Testing|Rubidium Elution System Performance Testing|Recruiting||N/A|7500|Anticipated|Ottawa Heart Institute Research Corporation|||1||f||||t||||||||||2017-10-11 00:32:36.210572|2017-10-11 00:32:36.210572
NCT02115399|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-07-23|||April 2014||2014-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Observational|||ADRN Barrier/Immunoprofiling Exploratory Pilot Study|ADRN Barrier/Immunoprofiling Exploratory Pilot Study (ADRN-04)|Completed||N/A|150|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||f||||||Samples With DNA|"     Whole blood, skin tissue   "|||2017-10-11 00:33:02.939433|2017-10-11 00:33:02.939433
NCT02117271|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-03-27|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||The Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure on Appearance and Age|"BEAUTY CPAP: The Impact of the Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure on Appearance and Age: a Randomized Crossover Placebo-controlled Study"|Completed||N/A|30|Actual|Nucleo Interdisciplinar da Ciencia do Sono||2|||f||||f||||||||||2017-10-11 00:32:36.404755|2017-10-11 00:32:36.404755
NCT02117258|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-06-29|||April 2014||2014-04-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|July 2016|Actual|2016-07-01||Interventional|ZIPANG||Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma|Randomized Phase II Study of Gemcitabine Plus Z-360 in Metastatic Pancreatic Adenocarcinoma Compared With Gemcitabine Plus Placebo ( ZIPANG Study )|Completed||Phase 2|167|Actual|Zeria Pharmaceutical||4|||f||||t||||||||||2017-10-11 00:32:37.102257|2017-10-11 00:32:37.102257
NCT02117245|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-01-06|||December 2011||2011-12-01|January 2015|2015-01-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Observational|||Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers|Phase I Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers|Completed||N/A|14|Actual|Mirati Therapeutics Inc.|||1||f||||f||||||Samples With DNA|"     Pharmacodynamic analysis   "|||2017-10-11 00:32:37.205172|2017-10-11 00:32:37.205172
NCT02117232|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-02-15|||March 2014||2014-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||"Effectiveness and Safety of the Colonoscopy With Visualization Balloon"|"A Randomized Controlled Trial to Evaluate Effectiveness and Safety of the Colonoscopy With the Visualization Balloon"|Recruiting||N/A|216|Anticipated|Mercy Medical Center||2|||f||||t||||||||||2017-10-11 00:32:37.280159|2017-10-11 00:32:37.280159
NCT02117219|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-10-04|||May 20, 2014|Actual|2014-05-20|September 2017|2017-09-01|May 8, 2020|Anticipated|2020-05-08|May 8, 2020|Anticipated|2020-05-08||Interventional|||Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome|A Phase 1 Study to Evaluate the Safety and Tolerability of MEDI4736 as Monotherapy or in Combination With Tremelimumab With or Without Azacitidine in Subjects With Myelodysplastic Syndrome After Treatment With Hypomethylating Agents|Recruiting||Phase 1|73|Anticipated|MedImmune LLC||3|||f||||f|t|f||||||||2017-10-11 00:32:37.408648|2017-10-11 00:32:37.408648
NCT02117206|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-04-15|||November 2005||2005-11-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|March 2012|Actual|2012-03-01||Interventional|||Protective Effects of L-arginine During Reperfusion by Femoropopliteal Bypass for Lower Limb Ischemic Syndrome in Humans|Protective Effects of L-arginine During Reperfusion by Femoropopliteal Bypass for Lower Limb Ischemic Syndrome in Humans|Completed||Phase 4|60|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 00:32:37.599524|2017-10-11 00:32:37.599524
NCT02117193|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-10-27|2016-05-10||October 2013||2013-10-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Combined and Isolated Effects of Sleep Deprivation and Alcohol Intake on Exercise Performance in Humans.|Combined and Isolated Effects of Sleep Deprivation and Alcohol Intake on Cardiorrespiratory, Neuromuscular and Hormonal Responses in Healthy Males.|Completed||N/A|10|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||No||2017-10-11 00:32:37.72643|2017-10-11 00:32:37.72643
NCT02117167|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-05-02|||April 23, 2014|Actual|2014-04-23|May 2017|2017-05-01|February 2022|Anticipated|2022-02-01|October 2020|Anticipated|2020-10-01||Interventional|SAFIR02_Lung||SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profils in Metastatic NSCLC Patients|Intergroup Trial UNICANCER UC 0105-1305/ IFCT 1301: SAFIR02_Lung - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Non-small Cell Lung Cancer|Recruiting||Phase 2|650|Anticipated|UNICANCER||4|||f||||t||||||||Undecided||2017-10-11 00:32:38.244263|2017-10-11 00:32:38.244263
NCT02117154|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2014-10-20|||June 2013||2013-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Relationship Between HbA1c, Fasting Plasma Glucose, Post-prandial Glucose and Other Measures of Glycemic Control|Relationship Between HbA1c, Fasting Plasma Glucose, Post-prandial Glucose and Other Measures of Glycemic Control in Malaysian Type 2 Diabetes Mellitus Patients|Completed||N/A|100|Actual|University of Malaya|||1||f||||f||||||||||2017-10-11 00:32:38.798221|2017-10-11 00:32:38.798221
NCT02117141|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-15|||June 2002||2002-06-01|April 2014|2014-04-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules|A Pilot Study in Healthy Volunteers to Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release (HC-ER) Capsules, in Both Fed and Fasted States|Completed||Phase 1|12|Actual|Zogenix, Inc.||2|||f||||f||||||||||2017-10-11 00:32:38.893992|2017-10-11 00:32:38.893992
NCT02117128|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-03-03|||April 2014||2014-04-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Efficacy and Safety of Using Tranexamic Acid by Different Means to Reduce Blood Loss During Total Knee Replacement|The Efficacy and Safety of Using Tranexamic Acid by Different Means to Reduce Blood Loss During Total Knee Replacement: a Randomized, Double-blind, Controlled Trial|Completed||Phase 4|150|Actual|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:32:38.983002|2017-10-11 00:32:38.983002
NCT02117115|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-06-10|||June 2014||2014-06-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|GVHD||Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation|Early Post-transplant Contrast-enhanced Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Early Phase 1|21|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 00:32:39.105482|2017-10-11 00:32:39.105482
NCT02117102|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-04-15|||May 2014||2014-05-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|BLST||Effect of Use of a New Technique for Pediatric Urine Collection in ER|Effect of Use of a New Technique for Pediatric Urine Collection on the Length of Stay in the Emergency Department: Prospective Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|170|Anticipated|Jeju National University Hospital||2|||f||||t||||||||||2017-10-11 00:32:39.220748|2017-10-11 00:32:39.220748
NCT02117089|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-11-21|||October 2013||2013-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Upper Limb Rehabilitation After Stroke Assisted With a Hybrid Electrical Stimulation (ES)-Robot System|Biomechatronic System Using Electromyography (EMG)-Driven Neuromuscular Electrical Stimulation (NMES) for Upper Limb Rehabilitation|Recruiting||N/A|30|Anticipated|The Hong Kong Polytechnic University||1|||f||||t||||||||||2017-10-11 00:32:39.317355|2017-10-11 00:32:39.317355
NCT02117076|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-06-28|||April 2014||2014-04-01|June 2016|2016-06-01||||June 2016|Actual|2016-06-01||Interventional|||Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome|Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome|Terminated||Phase 4|5|Actual|University of South Florida||2||Recruitment not successful due to overly restrictive inclusion/exclusion criteria.|f||||f||||||||||2017-10-11 00:32:39.409485|2017-10-11 00:32:39.409485
NCT02117063|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-12-16|||April 2012||2012-04-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|CBS002||Go Girls! Fitness Support Group Intervention Effectiveness Study|Go Girls! Fitness Support Group Intervention Effectiveness Study|Recruiting||N/A|35|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-11 00:32:39.511808|2017-10-11 00:32:39.511808
NCT02117050|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-11-28|2016-11-28||June 2014||2014-06-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|RESOunD||RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate|RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate. A 24-week, Prospective, Open-label, Multicenter Trial Evaluating Treatment Satisfaction in Subjects With Relapsing Forms of Multiple Sclerosis Following Treatment Change From Tecfidera™ to Rebif® 44 mcg Subcutaneously (sc) Three Times Weekly (Tiw)|Terminated||Phase 4|1|Actual|EMD Serono|The study was prematurely terminated due to enrollment issues. Only 1 subject was enrolled in this study, but did not receive any dose. Neither efficacy nor safety analysis was done for the study.|1||recruitment challenges|f||||||||||||||2017-10-11 00:32:39.661055|2017-10-11 00:32:39.661055
NCT02117037|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-04-13|||June 2014||2014-06-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|February 2017|Actual|2017-02-01||Interventional|||Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes|Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes|Active, not recruiting||N/A|180|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:32:40.079575|2017-10-11 00:32:40.079575
NCT02117024|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-04-21|||July 2014||2014-07-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer|A Phase 2, Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Viagenpumatucel-L (HS-110) in Combination With Low Dose (Metronomic) Cyclophosphamide Versus Chemotherapy Alone in Patients With Non-Small Cell Lung Adenocarcinoma After Failure of Two or Three Previous Treatment Regimens for Advanced Disease|Active, not recruiting||Phase 2|123|Anticipated|Heat Biologics||2|||f||||t||||||||||2017-10-11 00:32:40.176065|2017-10-11 00:32:40.176065
NCT02117011|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-06-05|||June 2013||2013-06-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Effects of a Structured Exercise Program on Cancer-Related Fatigue in Women Receiving Radiation Therapy for Breast Cancer|Effects of a Structured Exercise Program on Cancer-Related Fatigue in Women Receiving Radiation Therapy for Breast Cancer|Active, not recruiting||N/A|30|Anticipated|Georgetown University||2|||f||||f||||||||||2017-10-11 00:32:40.348203|2017-10-11 00:32:40.348203
NCT02116998|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-05-25|||September 2014||2014-09-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of GEN-004, a Pneumococcal Protein Subunit Vaccine, on Colonization Following Intranasal Challenge With S. Pneumoniae|Completed||Phase 2|98|Actual|Genocea Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 00:32:40.419459|2017-10-11 00:32:40.419459
NCT02116985|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-04-14|||November 2013||2013-11-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|DLTCI||Dual-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy (DLTCI)|Dual-Loop Target Controlled Infusion of Propofol and Remifentanil Guided by Narcotrend Index in Laparoscopic Cholecystectomy|Completed||Phase 4|64|Actual|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-11 00:32:40.5241|2017-10-11 00:32:40.5241
NCT02116972|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-08-08||2017-08-08|April 2014||2014-04-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee|A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee|Completed||Phase 2|310|Actual|Flexion Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 00:32:40.62224|2017-10-11 00:32:40.62224
NCT02116959|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-01-09|||April 2014||2014-04-01|January 2015|2015-01-01|July 2017|Anticipated|2017-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Alternating Systemic Chemotherapy and Intra-Arterial Melphalan Chemotherapy in Children With Intra-Ocular Retinoblastoma|A Pilot Study Evaluating the Safety of Alternating Systemic Chemotherapy and Intra-Arterial Melphalan Chemotherapy in Children With Newly Diagnosed Advanced Intra-Ocular Retinoblastoma|Unknown status|Recruiting|N/A|42|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:32:40.802408|2017-10-11 00:32:40.802408
NCT02116946|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-05-15|||March 2014||2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PHS||Plasma Injections Plus Exercise for Patellar Tendinopathy|Intratendinous Injections of Platelet Rich Plasma With or Without Leukocyte Enrichment for Patellar Tendinopathy: a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|University of British Columbia||3|||f||||t||||||||||2017-10-11 00:32:40.930248|2017-10-11 00:32:40.930248
NCT02116933|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-05-12|||March 2013||2013-03-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|GAASC||Grafting of Autologous Adipose Stromal Cell Trial|Grafting of Autologous Adipose Stromal Cell Trial|Unknown status|Recruiting|Phase 2|20|Anticipated|Tower Outpatient Surgical Center||2|||f||||f||||||||||2017-10-11 00:32:41.0724|2017-10-11 00:32:41.0724
NCT02116920|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-04-15|||May 2013||2013-05-01|April 2014|2014-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|PODBT||HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening|Evaluation of the Diagnostic Performance of HPV E6/E7 mRNA Versus Oncogenic HPV DNA as a Secondary Triage Test for VIA Positive Women in Cervical Cancer Screening Program|Unknown status|Recruiting|N/A|1000|Anticipated|Tata Memorial Hospital|||1||f||||t||||||Samples With DNA|"     Cervical Biopsy and Endo-cervical Brushing   "|||2017-10-11 00:32:41.179488|2017-10-11 00:32:41.179488
NCT02116907|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-11-02|||May 2014||2014-05-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects||Completed||Phase 1|7|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-11 00:32:41.255955|2017-10-11 00:32:41.255955
NCT02116894|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-09-12|||August 2014||2014-08-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|REGAL-1||Safety Study of Regorafenib With PF-03446962 to Treat Colorectal Cancer|Phase Ib Study of the Combination Regorafenib With PF-03446962 in Patients With Refractory Metastatic Colorectal Cancer (REGAL-1 Trial)|Completed||Phase 1|11|Actual|Duke University||1|||f||||t||||||||||2017-10-11 00:32:41.325797|2017-10-11 00:32:41.325797
NCT02116881|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-08-03|||January 2015||2015-01-01|August 2017|2017-08-01|March 1, 2016|Actual|2016-03-01|March 1, 2016|Actual|2016-03-01||Observational|||Incisional Hernia and Adhesion-Related Bowel Obstruction|Incisional Hernia and Adhesion-Related Bowel Obstruction After Open and Laparoscopic Colorectal Surgery: A Prospective Cohort Study|Terminated||N/A|18|Actual|The Cleveland Clinic|||2||f||||f||||||||||2017-10-11 00:32:41.41413|2017-10-11 00:32:41.41413
NCT02116868|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-03-07|||March 2014||2014-03-01|March 2016|2016-03-01||||March 2016|Anticipated|2016-03-01||Interventional|||Pupillary Reflex Measurement to Guide Intraoperative Analgesia During Laparoscopic Surgery|Usefulness of Pupillary Reflex on Remifentanil and Morphine Consumption During Laparoscopic Surgery. A Bicentric, Prospective, Randomized, Controlled Trial.|Recruiting||N/A|100|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-10-11 00:32:41.495983|2017-10-11 00:32:41.495983
NCT02116855|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-15|||June 2014||2014-06-01|April 2014|2014-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||Individualized Prophylaxis for Severe Hemophilia A Children|Individualized Tertiary Low Dose Prophylaxis for Severe Hemophilia A Children With Arthropathy in China|Unknown status|Not yet recruiting|N/A|50|Anticipated|Beijing Children's Hospital||1|||f||||||||||||||2017-10-11 00:32:41.606146|2017-10-11 00:32:41.606146
NCT02116842|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-16|||December 2012||2012-12-01|April 2014|2014-04-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Minimum Effective Dose (MED) & Epidural Bupivacaine|Comparison of the ED95 Dose of 0.075% and 0.1% Bupivacaine for Labour Analgesia in Primigravida.|Unknown status|Recruiting|Phase 4|100|Anticipated|University of Leeds||2|||f||||t||||||||||2017-10-11 00:32:41.672343|2017-10-11 00:32:41.672343
NCT02116829|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-16|||September 2013||2013-09-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Is There Room for Butter in a Healthy Diet?|Is There Room for Butter in a Healthy Diet? - A Randomized Controlled Dietary Human Intervention|Completed||N/A|50|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 00:32:41.761237|2017-10-11 00:32:41.761237
NCT02116816|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-07-24|||April 2014||2014-04-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Absorption Profiles of Three Polyphenol Preparations With and Without Pollen Shell Covering|Investigation Into Polyphenol Absorption Profiles|Completed||N/A|40|Actual|University of Hull||1|||f||||f||||||||||2017-10-11 00:32:41.841694|2017-10-11 00:32:41.841694
NCT02116803|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-03-07|||May 28, 2014|Actual|2014-05-28|March 2017|2017-03-01|November 28, 2016|Actual|2016-11-28|November 28, 2016|Actual|2016-11-28||Interventional|||An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective|An Open Label, Multi-center, Extension Study to Evaluate Long-term Safety and Tolerability of Dovitinib in Patients With Solid Tumors, Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored, Single Agent Dovitinib Studies, Which Have Fulfilled the Requirements for the Primary Objective, and Are Benefitting From Continued Dovitinib Treatment as Assessed by the Investigator|Completed||Phase 2/Phase 3|12|Actual|Novartis||2|||f||||f||||||||||2017-10-11 00:32:41.910357|2017-10-11 00:32:41.910357
NCT02116790|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-10-09|||May 2014||2014-05-01|October 2014|2014-10-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects|Study of the Efficacy of Co-administration of an NSAID With a Dopamine Agonist in the Alleviation of Acute Cutaneous Inflammatory Pain in Healthy Subjects|Withdrawn||Phase 2|0|Actual|Northwestern University||4|||f||||f||||||||||2017-10-11 00:32:41.997309|2017-10-11 00:32:41.997309
NCT02116777|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-09-12|||May 16, 2014|Actual|2014-05-16|September 2017|2017-09-01||||October 31, 2018|Anticipated|2018-10-31||Interventional|||Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies|A Phase 1/2 Study of BMN 673, an Oral Poly(ADP-Ribose) Polymerase Inhibitor, Plus Temozolomide in Children With Refractory or Recurrent Malignancies|Recruiting||Phase 1/Phase 2|148|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:32:42.11152|2017-10-11 00:32:42.11152
NCT02116764|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-07-13|||March 26, 2014||2014-03-26|July 12, 2017|2017-07-12|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995|Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:32:42.330937|2017-10-11 00:32:42.330937
NCT02116751|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-12-06|||April 2014||2014-04-01|April 2014|2014-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|ComorVIH||Frequency and Clinical Significance of Renal and Bone Toxicity in HIV-infected Patients|Frequency and Clinical Significance of Renal and Bone Toxicity in HIV-infected Patients: Role of Classical Factors, HIV Infection, and Antiretroviral Therapy|Completed||N/A|306|Actual|Asociacion para el Estudio de las Enfermedades Infecciosas|||1||f||||f||||||||||2017-10-11 00:32:42.429575|2017-10-11 00:32:42.429575
NCT02114853|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2014-04-12|||April 2014||2014-04-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|January 2015|Anticipated|2015-01-01||Observational|ORPICU||Oxidative Monitoring in ICU Patients.|Oxidative Monitoring in ICU Patients.|Unknown status|Recruiting|N/A|150|Anticipated|University of Thessaly|||1||f||||f||||||Samples Without DNA|"     plasma   "|||2017-10-11 00:33:14.325286|2017-10-11 00:33:14.325286
NCT02116738|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-04-15|||June 2013||2013-06-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Modified Limberg Procedure Versus Lateral Advancement Flap With Burrow's Triangle Procedure in the Treatment of Pilonidal Sinus|Interventional Study of the Relatively New Surgical Techniques on the Treatment of Pilonidal Sinus Disease|Completed||N/A|1|Actual|Ankara Mevki Military Hospital||1|||f||||f||||||||||2017-10-11 00:32:42.514005|2017-10-11 00:32:42.514005
NCT02116712|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-11-28|||August 2014||2014-08-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)|The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)|Completed||Phase 1|9|Actual|Baylor College of Medicine||1|||f||||t||||||||No|The subject is aware of his/her data at the time of the study. They are told if they are/are not using the correct technique for MDI. There is no more data to share with the subject.|2017-10-11 00:32:43.036049|2017-10-11 00:32:43.036049
NCT02116699|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-09-23|||November 2013||2013-11-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Oropharyngeal Administration of Mother's Colostrum for Premature Infants|Oropharyngeal Administration of Mother's Colostrum: Health Outcomes of Premature Infants|Recruiting||N/A|622|Anticipated|NorthShore University HealthSystem||2|||f||||t||||||||Undecided||2017-10-11 00:32:43.134983|2017-10-11 00:32:43.134983
NCT02116686|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-03-30|||June 2013||2013-06-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||ECG Derived Respiration for Automated Screening of Sleep Disordered Breathing in Chronic Heart Failure Patients|ECG Derived Respiration for Automated Screening of Sleep Disordered Breathing in Chronic Heart Failure Patients|Completed||N/A|100|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 00:32:43.294503|2017-10-11 00:32:43.294503
NCT02116673|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-09-22|||July 2014||2014-07-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Influence of Cognitive Rest on Minor Traumatic Brain Injury|The Influence of Cognitive Rest and Graduated Return to Usual Activities on Minor Traumatic Brain Injury|Completed||N/A|120|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-11 00:32:43.393153|2017-10-11 00:32:43.393153
NCT02116660|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-08-04|||September 3, 2014|Actual|2014-09-03|August 2017|2017-08-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|RANIA||Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)|Switching From Regimens Consisting of a RTV-Boosted Protease Inhibitor Plus TDF/FTC to a Combination of Raltegravir Plus Nevirapine and Lamivudine in HIV Patients With Suppressed Viremia and Impaired Renal Function (RANIA Study) (Pilot Study) Protocol MK-0518-284-02|Completed||Phase 2|11|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:32:43.47521|2017-10-11 00:32:43.47521
NCT02116647|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2015-09-27|||November 2012||2012-11-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Role of Psychoanalysis in Prevention of Girl Child Maltreatment and Neglect|Role of Psychoanalysis in Prevention of Girl Child Maltreatment and Neglect: A Randomized Controlled Trial|Completed||N/A|134|Actual|Macmillan Research Group UK||2|||f||||t||||||||||2017-10-11 00:32:43.599766|2017-10-11 00:32:43.599766
NCT02116634|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2016-01-13|||May 2015||2015-05-01|January 2016|2016-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis|Phase 1, 2 Study of Mesenchymal Stem Cells Injection in ALS (Amyotrophic Lateral Sclerosis) Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Alzahra Hospital, Iran||1||Because economic problems|f||||t||||||||||2017-10-11 00:32:43.684285|2017-10-11 00:32:43.684285
NCT02116621|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-05-12|||July 2014||2014-07-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|February 1, 2017|Actual|2017-02-01||Interventional|PREEMPT||N-of-1 Trials Using mHealth in Chronic Pain|N-of-1 Trials Using mHealth in Chronic Pain Aka PREEMPT (Personalized Research for Monitoring Pain Treatment)|Completed||N/A|215|Actual|University of California, Davis||2|||f||||f||||||||No||2017-10-11 00:32:43.777709|2017-10-11 00:32:43.777709
NCT02116608|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-09-26|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Treatment of Tracheostomy Granulomas|Treatment of Tracheostomy Granulomas|Enrolling by invitation||Phase 4|18|Actual|University of Colorado, Denver||3|||f||||t|t|f|||t|||||2017-10-11 00:32:44.047427|2017-10-11 00:32:44.047427
NCT02116595|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-07-25|||January 2015||2015-01-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|June 2015|Actual|2015-06-01||Interventional|||Urine pH and Diet Net Acid Load|Alterations in Urine pH With Differing Diet Net Acid Loads|Withdrawn||N/A|0|Actual|University of California, San Francisco||2||not funded|f||||t||||||||||2017-10-11 00:32:44.175278|2017-10-11 00:32:44.175278
NCT02116582|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-08-29|2017-04-07||April 11, 2014|Actual|2014-04-11|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|May 8, 2016|Actual|2016-05-08||Interventional||The analysis population consisted of the Safety Analysis Set (SAF). The SAF consisted of all participants who took at least 1 dose of study drug.|A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer|A Multi-center, Single Arm Study of Enzalutamide in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer Previously Treated With Abiraterone Acetate|Active, not recruiting||Phase 4|215|Actual|Astellas Pharma Inc|The study is still ongoing, the data presented is for data available up to the data cut-off date for primary completion (08 May 2016).|1|||f||||f|t|f|||t|||||2017-10-11 00:32:44.285896|2017-10-11 00:32:44.285896
NCT02116569|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-09-23|||April 2014||2014-04-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma|A Phase I Study of JNJ-54761414 (Daratumumab) in Japanese Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|9|Actual|Janssen Pharmaceutical K.K.||2|||f||||f||||||||||2017-10-11 00:32:45.462631|2017-10-11 00:32:45.462631
NCT02116556|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-11-03|||April 2013||2013-04-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RIFA-AAH||Effects of Rifaximin in Patients With Acute Alcoholic Hepatitis|Effects of Rifaximin Treatment in Patients With Acute Alcoholic Hepatitis: A Comparative Pilot Study|Enrolling by invitation||Phase 2|29|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||||2017-10-11 00:32:45.604038|2017-10-11 00:32:45.604038
NCT02116543|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-12-01|||May 2014||2014-05-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||TD-6450 MAD Study in HCV Infected Subjects|A Double-Blinded, Randomized, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Antiviral Activity of TD-6450, a NS5A Inhibitor, in Treatment Naïve Subjects With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)|Completed||Phase 1|47|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||||2017-10-11 00:32:45.737341|2017-10-11 00:32:45.737341
NCT02116530|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-06-07|2016-12-07||August 2014||2014-08-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional||All participants who started the treatment.|Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy|Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 3|401|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 00:32:45.901537|2017-10-11 00:32:45.901537
NCT02116517|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-04-15|||August 2011||2011-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|GTE-LDL||Effects of Green Tea Extract on Obese Women With High Level of LDL|Phase 3 Study; Effects of Green Tea Extract on Obese Women With High Level of Low Density Lipoprotein (LDL): a Randomized, Double-blinded, and Cross-over Placebo-controlled Clinical Trial|Completed||Phase 3|73|Actual|National Yang Ming University||2|||f||||f||||||||||2017-10-11 00:32:47.301405|2017-10-11 00:32:47.301405
NCT02116504|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-11-24|||April 2014||2014-04-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|April 2016|Actual|2016-04-01||Interventional|ABI-RA||Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients|Multi-center Prospective European Cohort Study in Patients With Rheumatoid Arthritis or Juvenile Idiopathic Arthritis Planned to be Treated Independently of the Present Study, With the First Line of Adalimumab, Etanercept, Infliximab Therapy or With Rituximab or Tocilizumab (After Anti-Tumor Necrosis Factor Therapy or Another Biotherapy or in First Line)|Active, not recruiting||N/A|156|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-11 00:32:47.390385|2017-10-11 00:32:47.390385
NCT02116491|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2014-04-15|||March 2014||2014-03-01|April 2014|2014-04-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Interventional|||Visual Sputum Suctioning System Tests in Mechanically Ventilated Patients|Test of a Novel Visual Sputum Suctioning System in Mechanically Ventilated Patients|Unknown status|Recruiting|Phase 1|40|Anticipated|First Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||||2017-10-11 00:32:47.476732|2017-10-11 00:32:47.476732
NCT02116478|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-10-11|||August 2014||2014-08-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Gastrocnemius Recession vs. Conservative Treatment for Chronic Plantar Fasciitis|Gastrocnemius Recession vs. Conservative Treatment for Chronic Plantar Fasciitis. A Randomized Controlled Trial.|Active, not recruiting||N/A|40|Actual|Oslo University Hospital||1|||f||||f||||||||Undecided||2017-10-11 00:32:47.565775|2017-10-11 00:32:47.565775
NCT02116465|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-14|||March 2014||2014-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|LCD18K||Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration|Open-label, Two-treatment, 4-period Replicated Crossover Study in Healthy Subjects to Investigate the Plasma Pharmacokinetics of Levodopa and Carbidopa After Oral Administration of Single Doses of Two Fixed-dose Combination Products|Completed||Phase 1|12|Actual|Desitin Arzneimittel GmbH||4|||f||||f||||||||||2017-10-11 00:32:47.644967|2017-10-11 00:32:47.644967
NCT02116452|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-15|||November 2011||2011-11-01|February 2011|2011-02-01||||February 2014|Actual|2014-02-01||Interventional|PIPA||Prebiotics in Prevention of Atopy|Effects of GOS/PDX Supplemented Formula in Preventing and Modifying the History of Allergy and Acute Infections in a Population of Infants at Risk of Atopy|Completed||Phase 3|380|Actual|Federico II University||3|||f||||f||||||||||2017-10-11 00:32:47.717118|2017-10-11 00:32:47.717118
NCT02116439|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-11-30|||November 2015||2015-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|ASAU||Evaluation of the Manifestation of Patient Aggresivity in an Emergency Department|Evaluation of the Manifestation of Patient Aggresivity in an Emergency Department|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 00:32:47.783654|2017-10-11 00:32:47.783654
NCT02116426|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-03-30|||July 2015||2015-07-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Observational|SCA COP||Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome|The Role of Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome|Recruiting||N/A|440|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 00:32:47.875387|2017-10-11 00:32:47.875387
NCT02116413|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-01-18|||May 2014||2014-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|FC-Rev||Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?|Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?|Completed||N/A|145|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 00:32:47.981152|2017-10-11 00:32:47.981152
NCT02116400|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-05-23|||January 2017||2017-01-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|DECISIDAIRE||Neuropsychological Characterization of Patients With Bipolar Disorder and a History of Suicide Attempt|Neuropsychological Characterization of Patients With Bipolar Disorder and a History of Suicide Attempt|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes|||2|The primary investigator moved.|f||||f||||||Samples Without DNA|"     Leftover serum samples will be stored in the Nîmes University Hospital Biothèque.   "|||2017-10-11 00:32:48.100767|2017-10-11 00:32:48.100767
NCT02116387|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-09-29|||July 4, 2014|Actual|2014-07-04|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|IMOOVE IT||Traditional Rehabilitation Versus Rehabilitation With the Imoove® Device for Spinal Musculoskeletal Disorders|Traditional Rehabilitation Versus Rehabilitation With the Imoove® Device for Spinal Musculoskeletal Disorders: a Randomised Controlled Trial|Active, not recruiting||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 00:32:48.181906|2017-10-11 00:32:48.181906
NCT02116374|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2016-07-11|||December 2014||2014-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|MICROGUT||Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients|Correlation Between Microbiota Biodiversity of HIV Seropositive Patients With Their Clinical and Immunological Status (ANRS EP 55 MICROGUT).|Completed||N/A|80|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||t||||||Samples With DNA|"     Stool sample   "|||2017-10-11 00:32:48.290462|2017-10-11 00:32:48.290462
NCT02116361|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2017-02-02|||April 2014||2014-04-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females|BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females|Completed||Phase 2|258|Actual|Allergan||3|||f||||f||||||||||2017-10-11 00:32:50.268055|2017-10-11 00:32:50.268055
NCT02116348|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-15|2014-04-15|||April 2014||2014-04-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy|Effect of Nerve Growth Factor (Cerebrolysin) Therapy on Neurodevelopment, Sleep Pattern and Quality of Life in Children With Traumatic Brain Injury and Cerebral Palsy|Unknown status|Recruiting|Phase 2|100|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:32:50.413273|2017-10-11 00:32:50.413273
NCT02116335|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-09-14|||June 2015||2015-06-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|End-Stress||Endothelin Receptor Function and Acute Stress|Endothelin Receptor Function and Acute Stress (End-Stress)|Recruiting||N/A|320|Anticipated|Augusta University||2|||f||||t||||||||Yes||2017-10-11 00:32:50.502882|2017-10-11 00:32:50.502882
NCT02116322|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-06-23|2017-05-25||April 2014||2014-04-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study|EUS-guided Fine Needle Tissue Acquisition of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study|Terminated||N/A|4|Actual|Johns Hopkins University||1||"The study stopped as the used needle was difficult to maneuver in the corkscrew method being   studied so no more participants were included."|f||||t||||||||||2017-10-11 00:32:50.600501|2017-10-11 00:32:50.600501
NCT02116296|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-15|||March 2010||2010-03-01|April 2014|2014-04-01||||June 2013|Actual|2013-06-01||Interventional|||Multi-component, Kindergarten-based, Family-involved Intervention for the Prevention of Childhood Obesity:The ToyBox-study|Multifactorial Evidence Based Approach Using Behavioural Models in Understanding and Promoting Fun, Healthy Food, Play and Policy for the Prevention of Obesity in Early Childhood|Completed||N/A|||Harokopio University||1|||f||||||||||||||2017-10-11 00:32:50.862997|2017-10-11 00:32:50.862997
NCT02116283|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-11-04|||March 2014||2014-03-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Mobi-Smoke||Mobile Sensing of Smoking Behavior|Mobile Sensing of Smoking Behavior|Completed||N/A|2|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:32:50.928049|2017-10-11 00:32:50.928049
NCT02116270|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-08-02|||September 2013||2013-09-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|September 2016|Anticipated|2016-09-01||Interventional|IRIS||Accelerated Immunosenescence and Chronic Kidney Disease|Accelerated Immunosenescence and Chronic Kidney Disease|Recruiting||N/A|282|Anticipated|Centre Hospitalier Universitaire de Besancon||4|||f||||f||||||||No||2017-10-11 00:32:51.105334|2017-10-11 00:32:51.105334
NCT02116257|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-06-23|||November 2013||2013-11-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV||Completed||N/A|108|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:32:51.226159|2017-10-11 00:32:51.226159
NCT02116244|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-02-09||2017-02-09|May 2014||2014-05-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Civamide Nasal Solution for the Treatment of Dry Eye|A Phase II, Open-label, Tolerability and Efficacy Study of Civamide Nasal Solution, 0.01%, in Patients With Dry Eye Syndrome|Completed||Phase 2|31|Actual|Winston Laboratories||1|||f||||f||||||||No||2017-10-11 00:32:51.317939|2017-10-11 00:32:51.317939
NCT02116231|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-15|||April 2014||2014-04-01|April 2014|2014-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma|Phase II Study Comparing Intensity Modulated Radiotherapy (IMRT) in Combination With Concurrent Chemotherapy and IMRT Alone for Stage II Nasopharyngeal Carcinoma|Not yet recruiting||Phase 2|80|Anticipated|Cancer Hospital of Guangxi Medical University||2|||f||||t||||||||||2017-10-11 00:32:51.446127|2017-10-11 00:32:51.446127
NCT02116218|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-15|||March 2014||2014-03-01|April 2014|2014-04-01||||December 2014|Anticipated|2014-12-01||Interventional|||Assessment of Cancer Pain in Emergency Department in Traditional Chinese Medicine|Assessment of Cancer Pain in Emergency Department in Traditional Chinese Medicine (TCM): A Study Protocol for a Clinical Trial|Unknown status|Recruiting|N/A|60|Anticipated|Changhua Christian Hospital||2|||f||||t||||||||||2017-10-11 00:32:51.615193|2017-10-11 00:32:51.615193
NCT02116205|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-03-28|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 7, 2016|Actual|2016-12-07||Interventional|||Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever|A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity of Hantaan/Puumala Virus DNA Vaccine Administered to Healthy Adult Volunteers Using the TDS-IM Electroporation Delivery Device for Prevention of Hemorrhagic Fever With Renal Syndrome|Active, not recruiting||Phase 2|132|Anticipated|U.S. Army Medical Research and Materiel Command||4|||f||||f||||||||||2017-10-11 00:32:51.775692|2017-10-11 00:32:51.775692
NCT02116192|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-09-09|||April 2014||2014-04-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|July 2016|Actual|2016-07-01||Interventional|NAFLD||Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents|Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents|Active, not recruiting||N/A|28|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 00:32:51.900952|2017-10-11 00:32:51.900952
NCT02116179|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-10-19|||July 2014||2014-07-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients|DVD-based HIV/HCV Intervention for Drug-Involved Latino Criminal Justice Clients|Completed||N/A|201|Actual|University of Delaware||2|||f||||t||||||||No||2017-10-11 00:32:52.018147|2017-10-11 00:32:52.018147
NCT02116166|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-08-30|||May 2014||2014-05-01|October 2015|2015-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia|Claude D. Pepper Older Americans Independence Center (OAIC); Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia|Completed||N/A|10|Actual|University of Florida|||2||f||||t||||||Samples With DNA|"     Skeletal muscle biopsy   "|||2017-10-11 00:32:52.098133|2017-10-11 00:32:52.098133
NCT02116153|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-04-14|||June 2014||2014-06-01|April 2014|2014-04-01||||December 2015|Anticipated|2015-12-01||Observational|||Mi-RNAs and Specificity of Hs-TnT in Symptomatic ED Patients|Clinical Use of Mi-RNAs to Improve Specificity of High-sensitivity Troponin T in Symptomatic Patients Presenting to the ED|Unknown status|Not yet recruiting|N/A|||University Hospital Heidelberg|||1||f||||f||||||||||2017-10-11 00:32:52.187604|2017-10-11 00:32:52.187604
NCT02116140|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-01-09|||July 2012||2012-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|AMEND||ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea.|Effects of Long Term Adaptive Servo Ventilation Therapy on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea. The AMEND Sub-study|Recruiting||N/A|60|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 00:32:52.260304|2017-10-11 00:32:52.260304
NCT02116127|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-07-27|||April 2014||2014-04-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy: A Pilot Study|Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy: A Pilot Study|Completed||N/A|20|Actual|Women's College Hospital||2|||f||||f||||||||||2017-10-11 00:32:52.415873|2017-10-11 00:32:52.415873
NCT02116114|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-04-14|||May 2014||2014-05-01|April 2011|2011-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of Aquatic Physical Training Program on Cardiorespiratory Variables in Patients With COPD|Effects of Aquatic Physical Training Program on Cardiorespiratory Variables in Patients With COPD|Unknown status|Not yet recruiting|N/A|24|Anticipated|Universidade Metodista de Piracicaba||2|||f||||t||||||||||2017-10-11 00:32:52.68032|2017-10-11 00:32:52.68032
NCT02116101|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2014-04-15|||March 2013||2013-03-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Intestinal Health and Blood Lipid Adjustment|Evaluation of the Effect of Momchilovtsi Yogurt on Intestinal Health and Blood Lipid Adjustment in Human Subjects|Completed||N/A|120|Actual|Bright Dairy & Food Co., Ltd||2|||f||||t||||||||||2017-10-11 00:32:52.77679|2017-10-11 00:32:52.77679
NCT02116088|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-03-14|||October 2012||2012-10-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Prevention and Intervention of Externalizing Problem Behavior in School: Development and Evaluation of a Teacher Coaching.|Prevention and Intervention of Externalizing Problem Behavior in School: Development and Evaluation of a Teacher Coaching.|Active, not recruiting||N/A|53|Anticipated|University of Cologne||2|||f||||t||||||||||2017-10-11 00:32:52.881937|2017-10-11 00:32:52.881937
NCT02116075|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-06-01|||January 2015||2015-01-01|June 2015|2015-06-01||||November 2016|Anticipated|2016-11-01||Interventional|||Caudal Corticosteroid vs. Dextrose Injection for Lumbosacral Radicular Pain.||Unknown status|Recruiting|Phase 2|50|Anticipated|VA Long Beach Healthcare System||2|||f||||||||||||||2017-10-11 00:32:52.998022|2017-10-11 00:32:52.998022
NCT02116062|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-09-07|||June 2014|Actual|2014-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Robotic Surgery of the Ocular Surface|Robotic Microsurgery of the Ocular surfaceProspective Human Feasibility Study|Recruiting||N/A|15|Anticipated|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-10-11 00:32:53.213517|2017-10-11 00:32:53.213517
NCT02116049|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-04-06|||August 2009||2009-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Intervention to Assist MSM Disclose HIV Status to Casual Sex Partners|Intervention to Assist MSM Disclose HIV Status to Casual Sex Partners|Completed||N/A|340|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 00:32:53.324356|2017-10-11 00:32:53.324356
NCT02116036|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-07-23|||September 2014||2014-09-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RAPS||Rivaroxaban for Antiphospholipid Antibody Syndrome|Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis|Unknown status|Recruiting|Phase 4|150|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||||2017-10-11 00:32:53.428024|2017-10-11 00:32:53.428024
NCT02116023|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-10-27|||March 2014||2014-03-01|October 2014|2014-10-01||||July 2014|Actual|2014-07-01||Interventional|POAS||The Effects of Processed Whole Orange on Subjective Ratings of Satiety|The Effect of Different Doses of Processed Whole Orange on Subjective Ratings of Satiety|Completed||N/A|30|Actual|PepsiCo Global R&D||3|||f||||f||||||||||2017-10-11 00:32:53.562472|2017-10-11 00:32:53.562472
NCT02115425|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-09-28|||April 2014||2014-04-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|Samsung||Calibrate Samsung's BIA to Meseaure Body Composition|Samsung Bioimpedance System Calibration Study|Completed||N/A|421|Actual|Pennington Biomedical Research Center|||2||f||||f||||||||||2017-10-11 00:33:02.742315|2017-10-11 00:33:02.742315
NCT02116010|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-07-23|||July 2015||2015-07-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Interventional|PHAGOBURN||Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients|Phase I/II Clinical Trial Randomized, Multicentric, Open Label, Standard of Care (Silver Sulfadiazine) Controlled Aiming at Assessing Tolerance and Efficacy of Local Bacteriophage Treatment of Wound Infections Due to E. Coli or P. Aeruginosa in Burned Patients Using Pherecydes Pharma Anti-Escherichia Coli and Anti-Pseudomonas Aeruginosa Bacteriophages GMP Produced Cocktails . This Project is a European Research & Development (R&D) Project Funded by the European Commission Under the 7th Framework Programme for Research and Development Involving 7 Clinical Sites in EU.|Unknown status|Recruiting|Phase 1/Phase 2|||Pherecydes Pharma||4|||f||||t||||||||||2017-10-11 00:32:53.658116|2017-10-11 00:32:53.658116
NCT02115997|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-07-11|||July 6, 2015|Actual|2015-07-06|July 2017|2017-07-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis||Recruiting||Phase 4|30|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:32:53.825702|2017-10-11 00:32:53.825702
NCT02115984|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-06-11|2014-05-12||May 2010||2010-05-01|April 2014|2014-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||"Study of the Safety and Leukostimulatory Activity of the Preparation Panagen in Patients With Breast Cancer"|"Double-blind Multicenter Placebo-controlled Study of the Safety and Leukostimulatory Activity of the Preparation Panagen in Patients With Breast Cancer"|Completed||Phase 2|80|Actual|Panagen, Limited Liability Company||2|||f||||f||||||||||2017-10-11 00:32:53.959743|2017-10-11 00:32:53.959743
NCT02115971|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-07-19|||September 2013||2013-09-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Jumping Exercises Approach in Individuals With Chronic Ankle Instability|The Effect of a 12-week Training Jumping Exercises Program in Individuals With Chronic Ankle Instability: Randomized Controlled Trial Pilot Study|Terminated||N/A|10|Actual|Balgrist University Hospital||2||The recruitment process could not provide us with enough participants|f||||f||||||||||2017-10-11 00:32:54.291909|2017-10-11 00:32:54.291909
NCT02115958|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-06-01|||March 2014||2014-03-01|April 2014|2014-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine|Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic of the Nasopharynx|Completed||Phase 1/Phase 2|40|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f||||t||||||||||2017-10-11 00:32:54.414976|2017-10-11 00:32:54.414976
NCT02115945|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-15|||February 2013||2013-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Femoral and Epidural Block After Total Knee Arthroplasty|COMPARISON OF CONTINUOUS FEMORAL NERVE BLOCK AND PATIENT CONTROLLED EPIDURAL ANALGESIA AFTER TOTAL KNEE ARTHROPLASTY|Completed||Early Phase 1|40|Actual|Adnan Menderes University||2|||f||||t||||||||||2017-10-11 00:32:54.534395|2017-10-11 00:32:54.534395
NCT02115932|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-09-26|||July 2014||2014-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|DPN-QoL||Effect of Physical Therapy in Improving the Health of Patients With Diabetic Peripheral Neuropathy|The Effectiveness of Strength and Balance Training in Patients With Diabetic Peripheral Neuropathy on Quality of Life and Functional Status: a Randomized Controlled Trial With Cost-utility Analysis|Active, not recruiting||N/A|260|Anticipated|National University Health System, Singapore||2|||f||||t||||||||||2017-10-11 00:32:54.67757|2017-10-11 00:32:54.67757
NCT02115919|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2016-08-17|||April 2014||2014-04-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety Study of Multikine in the Treatment of Perianal Warts|Phase 1 Study of Multikine in the Treatment of Perianal Warts|Terminated||Phase 1|4|Actual|United States Naval Medical Center, San Diego||2||Unable to enroll prospective subject for dose escalation|f||||f||||||||No||2017-10-11 00:32:54.810033|2017-10-11 00:32:54.810033
NCT02115906|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-09-26|||August 2014||2014-08-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|||Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly|Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly - a 31P/1H Magnetic Resonance Spectroscopy Pilot Study|Recruiting||Phase 4|24|Anticipated|Medical University of Vienna|||2||f||||t||||||||||2017-10-11 00:32:54.945911|2017-10-11 00:32:54.945911
NCT02115893|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-03-15|||April 2014||2014-04-01|October 2014|2014-10-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|NO-how||Nitrate Supplementation; Duration|The Effect of Nitrate Supplementation on Sports Performance: Duration of Supplementation|Completed||Phase 4|20|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 00:32:55.122008|2017-10-11 00:32:55.122008
NCT02115880|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-05-27|||May 2014||2014-05-01|May 2014|2014-05-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|PRODO||PRimary Prevention Of Depression in Offspring of Depressed Parents|PRimary Prevention Of Depression in Offspring of Depressed Parents|Unknown status|Recruiting|N/A|100|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 00:32:55.246475|2017-10-11 00:32:55.246475
NCT02115867|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-06-08|||April 2013||2013-04-01|April 2014|2014-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effect of a Probiotic on Diverticular Symptoms|Assessment of the Probiotic Symprove as a Dietary Supplement in Patients With Symptomatic Diverticular Disease|Completed||Phase 3|143|Actual|King's College Hospital NHS Trust||2|||f||||f||||||||No||2017-10-11 00:32:55.379058|2017-10-11 00:32:55.379058
NCT02115854|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-15|||December 2010||2010-12-01|April 2014|2014-04-01||||April 2014|Actual|2014-04-01|1 Year|Observational [Patient Registry]|||Labial Biopsy in Patients With Tuberculosis Disease|The Value of Labial Biopsy in 65 Patients With Tuberculosis Disease|Completed||N/A|65|Actual|Hopital Lariboisière|||1||f||||||||||||||2017-10-11 00:32:55.482231|2017-10-11 00:32:55.482231
NCT02115841|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-14|||August 2013||2013-08-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Effect of Transcutaneous Nerve Stimulation on Primary Motor Cortex to Modulate Cortical Excitability and Hemodynamic Response During Implicit Motor Learning: A TMS and NIRS Study||Unknown status|Recruiting|N/A|48|Anticipated|Chang Gung University||2|||f||||t||||||||||2017-10-11 00:32:55.568419|2017-10-11 00:32:55.568419
NCT02115412|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-07-14|||July 2014||2014-07-01|July 2014|2014-07-01||||April 2015|Anticipated|2015-04-01||Observational|||Validation of Medication Non-adherence Model (UK)|Validation of Medication Non-adherence Model (UK)|Unknown status|Recruiting|N/A|750|Anticipated|Philips Healthcare|||1||f||||f||||||||||2017-10-11 00:33:02.858578|2017-10-11 00:33:02.858578
NCT02115815|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-08-29|2016-07-15||April 2014||2014-04-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||As-treated Population (ATP): Participants who received any study investigational product were included in the ATP population.|A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults|A Phase 1a Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults|Completed||Phase 1|246|Actual|MedImmune LLC||7|||f||||t||||||||||2017-10-11 00:32:55.844537|2017-10-11 00:32:55.844537
NCT02115802|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-02-21|||May 2014||2014-05-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||LFP Correlates of Movement Disorders|Local Field Potential Correlates of Motor Behavior and Pathological Signs in Movement Disorders for Development of Closed Loop Stimulation Systems|Recruiting||N/A|10|Anticipated|Colorado Neurological Institute||1|||f||||t||||||||||2017-10-11 00:32:57.884291|2017-10-11 00:32:57.884291
NCT02115789|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-04-06|||June 2012||2012-06-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Observational|||Perceptions of Aesthetic Outcomes of Zigzag and Linear Scars|Perceptions of Aesthetic Outcomes of Zigzag and Linear Scars|Completed||N/A|876|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 00:32:58.007527|2017-10-11 00:32:58.007527
NCT02115776|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-05-26|||January 2014||2014-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental Procedures|A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental Procedures|Completed||N/A|266|Actual|University of Santiago de Compostela||5|||f||||f||||||||||2017-10-11 00:32:58.088522|2017-10-11 00:32:58.088522
NCT02115763|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-06-02|||April 2014|Actual|2014-04-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effects of Caffeine on Pain-Based Pacing During a Cycling Time-Trial|The Effects of Caffeine on Pain-Based Pacing During a Cycling Time-Trial|Completed||Phase 1|15|Actual|University of Oklahoma||1|||f||||f||||||||||2017-10-11 00:32:58.25848|2017-10-11 00:32:58.25848
NCT02115750|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-10-07||2016-10-07|May 2014||2014-05-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|October 2015|Actual|2015-10-01||Interventional|CHS-0214-02||Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)|A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate|Completed||Phase 3|647|Actual|Coherus Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 00:32:58.393973|2017-10-11 00:32:58.393973
NCT02115737|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-11-16|||December 2013||2013-12-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Group Treatment for Adolescents With Depression|Group Treatment for Adolescents With Depression|Terminated||N/A|11|Actual|Sunnybrook Health Sciences Centre||2||Insufficient recruitment|f||||t||||||||||2017-10-11 00:32:58.846276|2017-10-11 00:32:58.846276
NCT02115724|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-09-14|||April 2014||2014-04-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|NO-Stress||Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)|Effect of Low Childhood Socioeconomic Status (SES) on Adult Endothelial Function and Nitric Oxide Bioavailability in Vivo and ex Vivo|Recruiting||N/A|340|Anticipated|Augusta University||2|||f||||t||||||||Yes||2017-10-11 00:32:58.927335|2017-10-11 00:32:58.927335
NCT02115711|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-05-02|||April 2014||2014-04-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|SEHAT||Study of a Community Based Approach to Control Cardiovascular Risk Factors in India|A Community Based Approach to Promote Cardiovascular Risk Factor Control in India, Project SEHAT: A Cluster Randomized Controlled Trial|Completed||N/A|1242|Actual|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-11 00:32:59.041984|2017-10-11 00:32:59.041984
NCT02115698|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-09-22|||April 2014||2014-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CALM||Counteracting Age-related Loss of Skeletal Muscle Mass (CALM)|Counteracting Age-related Loss of Skeletal Muscle Mass|Recruiting||N/A|66|Anticipated|Bispebjerg Hospital||5|||f||||t||||||||||2017-10-11 00:32:59.15698|2017-10-11 00:32:59.15698
NCT02115685|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-12-26|||April 2014||2014-04-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|March 2018|Anticipated|2018-03-01||Interventional|||Sympathetic-Somatomotor Coupling in Human Spinal Cord Injury|Sympathetic-Somatomotor Coupling in Human Spinal Cord Injury|Recruiting||N/A|40|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 00:32:59.290949|2017-10-11 00:32:59.290949
NCT02115672|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-08-11|||November 2014||2014-11-01|December 2014|2014-12-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia|Phase I/II Study Using Imatinib and s.c. BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia (CML) Patients in First Chronic Phase Achieving Less Than Optimal Response With Imatinib.|Withdrawn||Phase 1/Phase 2|0|Actual|Sheba Medical Center||1||loss of support|f||||f||||||||||2017-10-11 00:32:59.40447|2017-10-11 00:32:59.40447
NCT02115659|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-04-16|||April 2014||2014-04-01|April 2014|2014-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Randomized Controlled Trial of Triptolide-Containing Formulation for Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Unknown status|Recruiting|Phase 3|100|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||||2017-10-11 00:32:59.477915|2017-10-11 00:32:59.477915
NCT02115646|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-04-18|||December 2011||2011-12-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Fractionated Carbon Dioxide Laser and Burn Scar Contractures: Evaluation of Post-Treatment Scar Function and Appearance|Fractionated Carbon Dioxide Laser and Burn Scar Contractures: Evaluation of Post-Treatment Scar Function and Appearance|Completed||N/A|36|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 00:32:59.726143|2017-10-11 00:32:59.726143
NCT02115633|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-09-26|||May 2016||2016-05-01|September 2017|2017-09-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|||"A Wearable Balance Booster - Stepping Closer to the Market"|"A Wearable Balance Booster - Stepping Closer to the Market"|Completed||Phase 2|31|Actual|RxFunction Inc.||2|||f||||f||t|t|f||||||2017-10-11 00:32:59.834684|2017-10-11 00:32:59.834684
NCT02114450|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-01-31|||March 2014||2014-03-01|January 2016|2016-01-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|H2-NeuroExo||Human-Machine System for the H2 Lower Limb Exoskeleton|Human Machine Interface System With the H2 Lower Limb Exoskeleton for Rehabilitation|Recruiting||N/A|60|Anticipated|University of Houston||2|||f||||f||||||||No||2017-10-11 00:33:18.130671|2017-10-11 00:33:18.130671
NCT02115620|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-03-08|||March 2014||2014-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|November 2015|Actual|2015-11-01||Interventional|||Telemedicine Technology Demonstration Project for Heart Failure|Demonstration Project Using Technology to Improve Health Outcomes for Hospitalized Patients With Heart Failure Discharged to Skilled Nursing Homes|Active, not recruiting||N/A|12|Actual|Providence Health & Services||1|||f||||f||||||||||2017-10-11 00:32:59.918082|2017-10-11 00:32:59.918082
NCT02115607|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-10-17|||March 2014||2014-03-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy|Quantitative Subharmonic Breast Imaging: Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy|Recruiting||N/A|50|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 00:33:00.012829|2017-10-11 00:33:00.012829
NCT02115594|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-10-06|||April 2014||2014-04-01|April 2014|2014-04-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|ENCORE305||Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer|A Phase 2, Randomized, Double-Blind, Multicenter Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|Syndax Pharmaceuticals||2||Internal decision|f||||t||||||||||2017-10-11 00:33:00.128489|2017-10-11 00:33:00.128489
NCT02115581|ClinicalTrials.gov processed this data on October 10, 2017|2008-12-22|2014-03-14|2008-12-22||September 2006||2006-09-01|March 2014|2014-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy|Effect of Coenzyme Q10 (Ubiquinone) Supplementation on Ventricular Function of Children With Idiopathic Dilated Cardiomyopathy.A Randomised Clinical Trial|Completed||Phase 4|38|Actual|University of Tehran||2|||f||||t||||||||||2017-10-11 00:33:00.244308|2017-10-11 00:33:00.244308
NCT02115568|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-14|||January 2014||2014-01-01|April 2014|2014-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01|3 Years|Observational [Patient Registry]|||Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203|A Registry to Assess the Ongoing Safety for Subjects That Have Been Randomized and Completed a Juventas Sponsored Heart Failure Protocol Under IND # 14203|Unknown status|Active, not recruiting|N/A|165|Anticipated|Juventas Therapeutics, Inc.|||1||f||||f||||||||||2017-10-11 00:33:01.146884|2017-10-11 00:33:01.146884
NCT02115555|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-04-27|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Advancing Diabetes Management in Adolescents Using Health Information Technology|Advancing Diabetes Management in Adolescents Using Health Information Technology|Completed||N/A|129|Actual|Indiana University||3|||f||||t||||||||Yes|Data will be shared via presentation and publications.|2017-10-11 00:33:01.272445|2017-10-11 00:33:01.272445
NCT02115542|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-08-18|||April 10, 2014|Actual|2014-04-10|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Single Agent Regorafenib in Refractory Advanced Biliary Cancers|Multi Institutional Phase II Trial of Single Agent Regorafenib in Refractory Advanced Biliary Cancers|Recruiting||Phase 2|39|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 00:33:01.383013|2017-10-11 00:33:01.383013
NCT02115529|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-12-01|||April 2014||2014-04-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|January 2015|Actual|2015-01-01||Interventional|Cesamet||Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet|A Randomized Controlled Trial of Cesamet(R) (Nabilone) for the Prevention of Postoperative Nausea and Vomiting in Elective Surgery|Completed||Phase 2|331|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-10-11 00:33:01.533483|2017-10-11 00:33:01.533483
NCT02115516|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-05-12|||April 2014||2014-04-01|February 2016|2016-02-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis|Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis|Completed||Phase 1|67|Actual|Sanaria Inc.||12|||f||||t||||||||||2017-10-11 00:33:01.660755|2017-10-11 00:33:01.660755
NCT02115503|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-07-31|||July 2014||2014-07-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01|3 Years|Observational [Patient Registry]|DSA||A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients|A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients|Active, not recruiting||N/A|52|Actual|Databean|||3||f||||t||||||||||2017-10-11 00:33:01.806562|2017-10-11 00:33:01.806562
NCT02115490|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2015-09-26|||April 2014||2014-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Bisphosphonates Effects On Alveolar Bone Among Osteoporotic Women|The Effect of Orally Administered Bisphosphonates in the Treatment of Osteoporosis on the Alveolar Bone Using Panoramic and Cone-Beam CT Imaging: A Case-control Study|Completed||N/A|60|Actual|Damascus University|||2||f||||t||||||||||2017-10-11 00:33:02.175165|2017-10-11 00:33:02.175165
NCT02115477|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2016-02-20|||April 2014||2014-04-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|LASEC||Lymphedema After Primary Surgery for Endometrial Cancer|Prevalence, Complications and Risk Factors for Lymphedema After Pelvic and Paraaortic Lymphadenectomy in Primary Radical Surgery for Early Stage Endometrial Carcinoma.|Recruiting||N/A|260|Anticipated|University Hospital, Linkoeping|||2||f||||f||||||||||2017-10-11 00:33:02.274057|2017-10-11 00:33:02.274057
NCT02115464|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-03-06|||September 2014||2014-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALMERA||Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy|A Phase II Study to Investigate a Combination of Metformin With Chemo-Radiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer|Recruiting||Phase 2|94|Anticipated|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-10-11 00:33:02.468035|2017-10-11 00:33:02.468035
NCT02115451|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-04-24|||January 2007||2007-01-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Nonsurgical or Surgical Treatment of ACL Injuries|Dynamic Stability of the ACL Deficient Knee|Completed||N/A|143|Actual|Oslo University Hospital|||2||f||||f||||||||||2017-10-11 00:33:02.600989|2017-10-11 00:33:02.600989
NCT02115438|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2014-04-14|||March 2010||2010-03-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||A Cohort Study for Occupational Stress Induced Early Embryonic Death||Completed||N/A|3405|Actual|Peking University Third Hospital|||1||f||||||||||||||2017-10-11 00:33:02.689649|2017-10-11 00:33:02.689649
NCT02115386|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2016-08-11|||December 2015||2015-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MACS1532||Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib|Open-label Multicenter Trial to Evaluate the Improvement of Chronic Low-grade Adverse Events Experienced by Patients With Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) With Optimal Response to Imatinib When Switched From Imatinib to Nilotinib Treatment|Recruiting||Phase 3|40|Anticipated|Novartis||1|||f||||f||||||||||2017-10-11 00:33:03.100716|2017-10-11 00:33:03.100716
NCT02115373|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-02-27|||May 2014||2014-05-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||c-Met Second-Line Hepatocellular Carcinoma|A Multicenter, Single Arm, Phase Ib/II Study to Evaluate Efficacy, Safety, and PK of MSC2156119J as Monotherapy in Subjects With MET+ Advanced Hepatocellular Carcinoma With Child Pugh Class A Liver Function Who Have Failed Sorafenib Treatment|Active, not recruiting||Phase 1/Phase 2|49|Actual|Merck KGaA||1|||f||||||||||||||2017-10-11 00:33:03.207767|2017-10-11 00:33:03.207767
NCT02115360|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2016-08-29|||April 2014||2014-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Epidural Calcitonin in Lower Limb Amputation|The Pre-emptive Value of Epidural Calcitonin in Patients With Lower Limb Amputation. A Double Blinded Randomized Study|Completed||N/A|60|Actual|Tanta University||2|||f||||t||||||||Undecided||2017-10-11 00:33:03.293137|2017-10-11 00:33:03.293137
NCT02115347|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2015-04-15|||September 2014||2014-09-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)|A Phase 1, Non-randomized, Open-label, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Subjects With Hepatic Impairment and the Healthy Subjects With Normal Hepatic Function|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 00:33:03.411179|2017-10-11 00:33:03.411179
NCT02115334|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-02-25|||May 2011||2011-05-01|June 2011|2011-06-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Development and Effectiveness of Home-based Programs for Preschool Children With Developmental Delay|Development and Effectiveness of Home-based Programs for Preschool Children With Developmental Delay:a Randomized Controlled Trial.|Completed||N/A|60|Actual|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-11 00:33:03.50161|2017-10-11 00:33:03.50161
NCT02115321|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-03-01|2016-02-19||May 2014||2014-05-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)|A Phase II/III Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic Hepatitis C Virus Infection With Advanced Cirrhosis and Child-Pugh (CP)-B Hepatic Insufficiency|Completed||Phase 2/Phase 3|40|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:33:03.616464|2017-10-11 00:33:03.616464
NCT02115308|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-03-15|||August 2014||2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging|Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging|Recruiting||Phase 4|40|Anticipated|Aspire Foundation||1|||f||||f||||||||||2017-10-11 00:33:04.112758|2017-10-11 00:33:04.112758
NCT02115295|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-06-22|||May 2014|Actual|2014-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML)|Phase II Study of Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML)|Recruiting||Phase 2|308|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:33:04.202088|2017-10-11 00:33:04.202088
NCT02115282|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-14|2017-08-01|||March 29, 2014|Actual|2014-03-29|July 2017|2017-07-01||||July 31, 2017|Anticipated|2017-07-31||Interventional|||Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic|A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer|Recruiting||Phase 3|600|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 00:33:04.609556|2017-10-11 00:33:04.609556
NCT02115269|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-05-04|2017-05-04||June 2014||2014-06-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|PRESTO|Safety set included all enrolled patients who have taken at least one dose of IndoProCaf|IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice|IndoProCaf (Difmetre®) Effervescent Tablets Effectiveness in Acute Treatment of Primary Headaches (Migraine and/or Episodic Tension-type Headache) and Patients' Satisfaction With the Treatment in Routine Clinical Practice in Ukraine and Kazakhstan|Completed||N/A|759|Actual|Abbott|||1||f||||f||||||||||2017-10-11 00:33:08.207966|2017-10-11 00:33:08.207966
NCT02115256|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2017-05-14|2017-03-31||July 2014||2014-07-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline|Intravenous Terbutaline Versus Intravenous Nitroglycerine for External Cephalic Version: A Double-Blinded Randomized Controlled Trial in Nulliparous Women|Terminated||Phase 2/Phase 3|6|Actual|Icahn School of Medicine at Mount Sinai||2||difficult recruitment|f||||f||||||||||2017-10-11 00:33:08.557899|2017-10-11 00:33:08.557899
NCT02115243|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2016-11-23|||May 2014||2014-05-01|November 2016|2016-11-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity Melanoma|A Phase I Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity Melanoma|Active, not recruiting||Phase 1|44|Anticipated|Duke University||1|||f||||t||||||||||2017-10-11 00:33:08.925757|2017-10-11 00:33:08.925757
NCT02115230|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2014-04-13|||April 2014||2014-04-01|April 2014|2014-04-01||||July 2016|Anticipated|2016-07-01||Interventional|||Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction|Transcatheter Renal Denervation in Heart Failure With Normal Left Ventricular Ejection Fraction - a Safety and Efficacy Study of Irrigated Radiofrequency Catheter|Unknown status|Recruiting|N/A|40|Anticipated|InCor Heart Institute||2|||f||||f||||||||||2017-10-11 00:33:09.001881|2017-10-11 00:33:09.001881
NCT02115217|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-02-03|||February 2014||2014-02-01|February 2015|2015-02-01|May 2015|Anticipated|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Kinesiotaping on Ankle Stability|Effect of Kinesiotaping on Ankle Stability in a Population of Elite Basketball Players|Unknown status|Active, not recruiting|N/A|30|Anticipated|Clinique Romande de Readaptation||1|||f||||||||||||||2017-10-11 00:33:09.082683|2017-10-11 00:33:09.082683
NCT02115204|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-06-18|||June 2000||2000-06-01|June 2015|2015-06-01|August 2010|Actual|2010-08-01|August 2005|Actual|2005-08-01||Interventional|||4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF|Adjuvant Chemotherapy of Breast Cancer: Sequential Chemotherapy vs. Standard Therapy. Prospective Randomised Comparison of 4 x Epirubicin and Cyclophosphamide (EC) --> 4 x Docetaxel (Doc) vs. 6 x CMF / CEF in Patients With 1 to 3 Positive Lymph Nodes|Completed||Phase 3|2011|Actual|West German Study Group||2|||f||||t||||||||||2017-10-11 00:33:09.171575|2017-10-11 00:33:09.171575
NCT02115191|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2015-03-23|||April 2014||2014-04-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||2-octyl Cyanoacrylate for Closure of Urethrocutaneous Fistula.|Use of 2-octylcyanoacrylate for Closure Urethrocutaneous Fistulas After Urethroplasty for Hypospadias|Completed||Phase 3|42|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-11 00:33:09.259236|2017-10-11 00:33:09.259236
NCT02115178|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-04-10|||August 2011||2011-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Observational|||Haemodynamic Effects During Anorectal Surgery: a Comparison of the Jack -Knife and Lithotomy Position|Haemodynamic Effects During Anorectal Surgery in Spinal Anaesthesia With Low Dose Hyperbaric Bupivacaine : a Comparison of the Jack -Knife and Lithotomy Position|Completed||N/A|155|Actual|Lithuanian University of Health Sciences|||1||f||||f||||||||||2017-10-11 00:33:09.338267|2017-10-11 00:33:09.338267
NCT02115165|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-06-08|||May 2014||2014-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2017|Anticipated|2017-05-01||Interventional|CABA-GCT||A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors|A Prospective Phase II Trial of Cabazitaxel in Male Patients With Chemotherapy Pre-treated Metastatic Nonseminomatous Germ-cell Tumors|Recruiting||Phase 2|34|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||t||||||||||2017-10-11 00:33:09.411632|2017-10-11 00:33:09.411632
NCT02115152|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-04-14|||June 2014||2014-06-01|April 2014|2014-04-01||||June 2018|Anticipated|2018-06-01||Interventional|||Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer|Phase II Neoadjuvant Trial of Capecitabine, Cyclophosphamide and Epirubicin for Patients With Axillary Lymph Node Positive Stage II-III Operable Breast Cancer|Not yet recruiting||Phase 2|100|Anticipated|Guangxi Medical University||2|||f||||f||||||||||2017-10-11 00:33:09.489163|2017-10-11 00:33:09.489163
NCT02115139|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-02-23|||April 2014||2014-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GRAY-B||GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases|A Multicenter, Single Arm, Phase 2 Clinical Study on the Combination of Radiation Therapy and Ipilimumab, for the Treatment of Patients With Melanoma and Brain Metastases|Active, not recruiting||Phase 2|58|Actual|Grupo Español Multidisciplinar de Melanoma||1|||f||||f||||||||||2017-10-11 00:33:09.582265|2017-10-11 00:33:09.582265
NCT02115126|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-10-31|||December 2016||2016-12-01|October 2016|2016-10-01|January 2025|Anticipated|2025-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant|A Randomized Phase II Trial to Evaluate an EBV Derived Dendritic Cell (DC) Vaccine When Administered Alone or Co-administered With the TLR9 Agonist, DUK-CPG-001, in EBV+ Lymphoma in the Setting of Autologous Stem Cell Transplant|Withdrawn||Phase 2|0|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:33:09.753885|2017-10-11 00:33:09.753885
NCT02115100|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-09-20|||March 18, 2014|Actual|2014-03-18|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ASAF||Treatment of Atrial Fibrillation in Patients by Pulmonary Vein Isolation in Combination With Renal Denervation or Pulmonary Vein Isolation Only|Treatment of Atrial Fibrillation in Patients With High Sympathetic Activity by Pulmonary Vein Isolation in Combination With Renal Denervation or Pulmonary Vein Isolation Only; an International Randomized, Controlled Trial|Recruiting||N/A|138|Anticipated|Diagram B.V.||2|||f||||t||||||||||2017-10-11 00:33:09.98932|2017-10-11 00:33:09.98932
NCT02115087|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-14|||September 2010||2010-09-01|April 2014|2014-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|UGRSB||Efficacy Study of Rectus Sheath Block to Control Postoperative Pain|The Effect of Ultrasound Guided Rectus Sheath Block on Postoperative Analgesia After Laparotomy With Transverse Incision in Children|Completed||Phase 4|40|Actual|Cukurova University||2|||f||||f||||||||||2017-10-11 00:33:10.136629|2017-10-11 00:33:10.136629
NCT02115074|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-07-19|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|October 2020|Anticipated|2020-10-01|July 2016|Actual|2016-07-01||Interventional|FLUVABREX||Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas|Phase I Study of Fluvastatin-Celebrex Association for Optico-chiasmatic Low Grade Gliomas and High Grade Gliomas Localized Outside the Brainstem, Relapsed or Refactory, in Children or Young Adults|Suspended||Phase 1|35|Anticipated|Centre Oscar Lambret||1||Analysis before next stage (extension cohort)|f||||t|f|f||||||||2017-10-11 00:33:10.228436|2017-10-11 00:33:10.228436
NCT02115061|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-11|||August 2013||2013-08-01|August 2012|2012-08-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||Gastric Varices Treatment: Coil + Cyanoacrylate Versus Cyanoacrylate|Gastric Varices Treatment: Coil + Cyanoacrylate Versus Cyanoacrylate|Unknown status|Recruiting|Phase 1|28|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:33:10.3337|2017-10-11 00:33:10.3337
NCT02115035|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-08-26|||July 2014||2014-07-01|August 2014|2014-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib|A Phase II Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib (VMRB) in Patients With Relapsed or Refractory Multiple Myeloma Who Have Activated BRAF Mutation|Withdrawn||Phase 1/Phase 2|0|Actual|University of Arkansas||1||Funding issues|f||||t||||||||||2017-10-11 00:33:10.578102|2017-10-11 00:33:10.578102
NCT02115022|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2017-01-30|||July 2014||2014-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01|2 Years|Observational [Patient Registry]|EUSPACT||EUS vs. MDCT in Pancreatic Malignancy|Endoscopic UltraSound in Potentially Resectable PAncreatic Malignancy - Does it Bear the Weight of the Rapidly Evolving Technology of Computer Tomography?|Recruiting||N/A|300|Anticipated|Clinical Hospital Colentina|||1||f||||f||||||||||2017-10-11 00:33:10.654431|2017-10-11 00:33:10.654431
NCT02115009|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2014-05-05|||June 2014||2014-06-01|April 2014|2014-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|SARA31143||The Sacroiliac Joint With SIJ Nerve Entrapments and Chronic Low Back Pain|Comparative Study of The Relationship Between the Sacroiliac Joint (SIJ) and Lumbopelvic Configurations With SIJ Nerve Entrapments and Chronic Low Back Pain|Not yet recruiting||N/A|200|Anticipated|Carmel Medical Center|||1||f||||t||||||||||2017-10-11 00:33:10.758942|2017-10-11 00:33:10.758942
NCT02114996|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2014-04-13|||April 2014||2014-04-01|April 2014|2014-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Can a Vocal Stimulus Provoke Spontaneous Breathing in an Ischemic Stroke Patient Dependent on Mechanical Ventilation?|Phase 1 - Vocal Stimuli to Provoke Spontaneous Breathing|Unknown status|Not yet recruiting|N/A|60|Anticipated|The Baruch Padeh Medical Center, Poriya|||1||f||||f||||||||||2017-10-11 00:33:10.832136|2017-10-11 00:33:10.832136
NCT02114983|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-13|2016-05-29|||January 2015||2015-01-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||General Practitioner-performed Compression Ultrasound for Deep Vein Thrombosis|Precision and Diagnostic Accuracy of General Practitioner-performed Compression Ultrasound for Proximal Symptomatic Deep Vein Thrombosis|Completed||N/A|1000|Actual|Azienda Sanitaria Locale ASL 6, Livorno|||1||f||||f|||||||"     d-dimer   "|||2017-10-11 00:33:10.901486|2017-10-11 00:33:10.901486
NCT02114970|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-08-13|||June 2012||2012-06-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Comparing Paper-based and Tablet-delivered Informed Consent for Older Adults|Comparing Paper-based and Tablet-delivered Informed Consent for Older Adults|Completed||N/A|40|Actual|Weill Medical College of Cornell University||3|||f||||t||||||||||2017-10-11 00:33:10.985672|2017-10-11 00:33:10.985672
NCT02114957|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-04-14|||January 2013||2013-01-01|April 2014|2014-04-01||||April 2013|Actual|2013-04-01||Interventional|||Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)|Single Oral Dose Pharmacokinetics of Decursin/Decursinol Angelate in Healthy Adult Men and Women|Completed||Early Phase 1|20|Actual|Texas Tech University Health Sciences Center||1|||f||||f||||||||||2017-10-11 00:33:11.438019|2017-10-11 00:33:11.438019
NCT02114944|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-01-19|||April 2014|Actual|2014-04-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Treatment of Dyspnea in Do-not-intubate Patients|Treatment of Dyspnea in Do-not-intubate (DNI) Patients|Recruiting||N/A|400|Anticipated|Tufts Medical Center|||4||f||||f||||||||||2017-10-11 00:33:11.528188|2017-10-11 00:33:11.528188
NCT02114931|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-03-13|2017-03-13||April 2014||2014-04-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis|An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|467|Actual|Amgen||1|||f||||f||||||||||2017-10-11 00:33:11.725549|2017-10-11 00:33:11.725549
NCT02114918|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-01-13|||April 2013||2013-04-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|AMP-OCD||Attention Training for Childhood Obsessive Compulsive Disorder|Attention Training for Childhood Obsessive Compulsive Disorder|Completed||N/A|47|Actual|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-11 00:33:12.910298|2017-10-11 00:33:12.910298
NCT02114905|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-06-02|||November 2013||2013-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study|Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study|Active, not recruiting||N/A|13|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-10-11 00:33:13.035228|2017-10-11 00:33:13.035228
NCT02114892|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-10-25|2014-12-02||April 2012||2012-04-01|October 2016|2016-10-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional||Sample size was calculated in accordance of Jeyaseelan’s clinical trial formula with a statistical confidence of 95%, statistical power of 80%, obtaining a total of 12 patients per group including 20% of expected loss.|Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion|Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion|Completed||Phase 2|24|Actual|University of Guadalajara||2|||f||||f||||||||||2017-10-11 00:33:13.181098|2017-10-11 00:33:13.181098
NCT02114879|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-10-20|||May 2014||2014-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EMR||Enhanced Medical Rehabilitation in Older Adults|Enhanced Medical Rehabilitation in Older Adults|Recruiting||N/A|252|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 00:33:14.177742|2017-10-11 00:33:14.177742
NCT02114866|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-12|||November 2012||2012-11-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Quality of Handover to a Post Anaesthesia Care Unit in a Children's Hospital||Completed||N/A|441|Actual|University of Witten/Herdecke|||1||f||||f||||||||||2017-10-11 00:33:14.27655|2017-10-11 00:33:14.27655
NCT02114840|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2016-04-13|||April 2014||2014-04-01|April 2016|2016-04-01|September 2019|Anticipated|2019-09-01|April 2014|Actual|2014-04-01||Interventional|PROQUAP||Pronator Quadratus Preservation Following Volar Plate Fixation. RCT|Preservation vs (Repair or Not Repair) Pronator Quadratus in the Volar Plating of Distal Radial Fracture. Randomized Controlled Clinical Trial|Recruiting||N/A|150|Anticipated|Universidad de la Frontera||3|||f||||f||||||||Yes||2017-10-11 00:33:14.393|2017-10-11 00:33:14.393
NCT02114827|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-07-17|||April 2014||2014-04-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy of a Patient Education Video|Efficacy of a Patient Education Video|Terminated||N/A|9|Actual|Virginia Commonwealth University||2||study closed due to slow accrual|f||||t||||||||||2017-10-11 00:33:14.520008|2017-10-11 00:33:14.520008
NCT02114814|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-12|||November 2011||2011-11-01|April 2014|2014-04-01||||April 2016|Anticipated|2016-04-01||Interventional|||A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community|A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community|Unknown status|Recruiting|N/A|156|Anticipated|University of North Carolina, Greensboro||2|||f||||t||||||||||2017-10-11 00:33:14.843629|2017-10-11 00:33:14.843629
NCT02114801|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-04-11|||March 2012||2012-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Mechanical Control of Plaque in Patients With Cerebral Palsy: A Randomized Clinical Trial|Mechanical Control of Plaque in Patients With Cerebral Palsy: A Randomized Clinical Trial|Completed||N/A|40|Actual|Federal University of the Valleys of Jequitinhonha and Mucuri||3|||f||||t||||||||||2017-10-11 00:33:14.965489|2017-10-11 00:33:14.965489
NCT02114788|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-12|||March 2013||2013-03-01|April 2014|2014-04-01||||September 2013|Actual|2013-09-01||Observational|||Interactive Sections Of An Internet-Based Intervention Increase Patient Empowerment: A Study With Chronic Back Pain Patients|INTERACTIVE SECTIONS OF AN INTERNET-BASED INTERVENTION INCREASE PATIENT EMPOWERMENT: A RANDOMIZED CONTROLLED STUDY WITH CHRONIC BACK PAIN PATIENTS|Completed||N/A|50|Actual|University of Lugano|||2||f||||||||||||||2017-10-11 00:33:15.068454|2017-10-11 00:33:15.068454
NCT02114775|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-10-26|||March 2015||2015-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Growth Hormone or Sildenafil as Therapies for Fatigue in Mild- Traumatic-brain-injury (MTBI)|Growth Hormone or Sildenafil as Therapies for Fatigue in MTBI|Active, not recruiting||Phase 1|100|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-11 00:33:15.13976|2017-10-11 00:33:15.13976
NCT02114762|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-09-06|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|April 30, 2017|Actual|2017-04-30|November 23, 2016|Actual|2016-11-23||Interventional|||Balloon Dilation in Selected Subjects With Refractory Eustachian Tube Dysfunction|Balloon Dilation in Selected Subjects With Refractory Eustachian Tube Dysfunction|Completed||N/A|13|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 00:33:15.242963|2017-10-11 00:33:15.242963
NCT02114749|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-04-10|||February 2014||2014-02-01|April 2014|2014-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|MAPO-RCVQ||Development of Tools for Respiration and Circulation Exploration|Development of Tools for Respiration and Circulation Studies and Exploration, Their Mutual Interactions and the Functions Involved in the Daily Life in Healthy Volunteers|Recruiting||N/A|200|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 00:33:15.333912|2017-10-11 00:33:15.333912
NCT02114736|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-04-12|||March 2014||2014-03-01|April 2014|2014-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke|A Randomized Controlled Trial of Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke|Recruiting||Phase 4|20|Anticipated|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-10-11 00:33:15.444297|2017-10-11 00:33:15.444297
NCT02114723|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-11-11|||February 2014||2014-02-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Effectiveness of Medical Taping Concept in Primary Dysmenorrhea|Assessment of Mediacal Taping Concept Self-applied, in the Treatment of Primary Dysmenorrhea|Completed||N/A|129|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||||2017-10-11 00:33:15.563557|2017-10-11 00:33:15.563557
NCT02114710|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2014-04-14|||May 2009||2009-05-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock|Study of Little Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock|Completed||Phase 3|240|Actual|Nanjing PLA General Hospital||2|||f||||f||||||||||2017-10-11 00:33:15.697493|2017-10-11 00:33:15.697493
NCT02114697|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-12-21|||April 2014||2014-04-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging|Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging|Enrolling by invitation||Phase 4|100|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 00:33:15.801695|2017-10-11 00:33:15.801695
NCT02114684|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-07-18|||November 2013|Actual|2013-11-01|July 2017|2017-07-01|July 17, 2017|Actual|2017-07-17|July 2017|Actual|2017-07-01||Interventional|IMPRESS||Improving Retreatment Success (IMPRESS)|An Open Label Randomized Controlled Clinical Trial Comparing a 24Week Oral Regimen Containing Moxifloxacin With a 24 Week Standard Drug Regimen for the Treatment of Smear-positive Pulmonary Tuberculosis in Patients Previously Treated for TB|Completed||Phase 1/Phase 2|197|Actual|Centre for the AIDS Programme of Research in South Africa||2|||f||||f||||||||||2017-10-11 00:33:16.047499|2017-10-11 00:33:16.047499
NCT02114671|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-06-24|||April 2014||2014-04-01|June 2014|2014-06-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||A Study to Investigate the Phototoxic Potential of Faldaprevir|A Randomised, Assessor-blind, Placebo and Active Controlled, Parallel Group Study to Assess the Phototoxic Potential of Faldaprevir (Administered Orally, Once Daily) for 6 Days in Healthy Male and Female Subjects|Withdrawn||Phase 1|0|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:33:16.16176|2017-10-11 00:33:16.16176
NCT02114658|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-08-01|||April 15, 2014|Actual|2014-04-15|August 2017|2017-08-01|August 2, 2016|Actual|2016-08-02|February 23, 2015|Actual|2015-02-23||Interventional|||Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients|A Multi-center, Single-arm, Open-label Phase II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Sorafenib in Japanese Patients With Anaplastic Thyroid Carcinoma or Locally Advanced or Metastatic Medullary Thyroid Carcinoma|Completed||Phase 2|18|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-11 00:33:16.261763|2017-10-11 00:33:16.261763
NCT02114645|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-13|||April 2014||2014-04-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|February 2015|Anticipated|2015-02-01||Interventional|||The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes|To Evaluate the Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes in Both GnRH Agonist and GnRH Antagonist Treated Ovarian Stimulation Protocols|Unknown status|Not yet recruiting|N/A|100|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||4|||f||||t||||||||||2017-10-11 00:33:16.384592|2017-10-11 00:33:16.384592
NCT02114632|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2014-04-13|||January 2007||2007-01-01|April 2014|2014-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD)|A Double Blind, Placebo Controlled Trial of Effectiveness of Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Treatment of Children With Attention Deficit/Hyperactivity Disorder|Completed||Phase 1/Phase 2|89|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 00:33:16.522412|2017-10-11 00:33:16.522412
NCT02114619|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2014-04-14|||May 2013||2013-05-01|April 2014|2014-04-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Comparative Study of Different I-131 Doses in Graves' Disease|The Effect of Different Calculated Doses of I-131 in Treatment of Patients With Grave's Disease|Unknown status|Recruiting|N/A|450|Anticipated|Mashhad University of Medical Sciences||3|||f||||t||||||||||2017-10-11 00:33:16.63613|2017-10-11 00:33:16.63613
NCT02114606|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-05-15|||July 2015||2015-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge|Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge|Enrolling by invitation||N/A|100|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||t|f||f|||No|No plans to share data|2017-10-11 00:33:16.770248|2017-10-11 00:33:16.770248
NCT02114593|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2015-10-17|||June 2014||2014-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ladnaan - an Evaluation of a Parent Support Program for Somali Parents|Evaluation of a Parent Support Program to Promote Somali Parent's and Children's Mental Health|Completed||N/A|130|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 00:33:16.884941|2017-10-11 00:33:16.884941
NCT02114580|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-13|||May 2014||2014-05-01|March 2014|2014-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Brain Plasticity Following Aerobic Exercise in Patient With Mild Cognitive Impairment: Neuroimaging Study|Brain Plasticity Following Aerobic Exercise in Patient With Mild Cognitive Impairment: Neuroimaging Study|Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 00:33:16.996821|2017-10-11 00:33:16.996821
NCT02114567|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-07-15|||January 2014||2014-01-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Is it Necessary to Set External PEEP in AECOPD Patients|Neural Triggering and Cycling-off of Pressure Support Ventilation Improves Synchrony and Reduces Inspiratory Effort in Chronic Obstructive Pulmonary Disease.|Completed||N/A|12|Actual|Southeast University, China||2|||f||||t||||||||||2017-10-11 00:33:17.085419|2017-10-11 00:33:17.085419
NCT02114554|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-04-13|||January 2014||2014-01-01|April 2014|2014-04-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Mitochondrial nt3243 A>G Mutation in Taiwan|Clinical Characteristics and Prognostic Factors of Mitochondrial nt3243 A>G Mutation in Taiwan|Unknown status|Recruiting|N/A|40|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:33:17.158114|2017-10-11 00:33:17.158114
NCT02114541|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-08-28|||May 2012||2012-05-01|August 2017|2017-08-01|December 12, 2016|Actual|2016-12-12|December 12, 2014|Actual|2014-12-12||Observational|MHICC3ROW||Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes|Global Observational Study to Evaluate the Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes|Completed||N/A|228|Actual|Montreal Heart Institute|||1||f||||f||||||||||2017-10-11 00:33:17.244051|2017-10-11 00:33:17.244051
NCT02114528|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-11-13|||October 2014||2014-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|AVATAR||Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention|Antiarrhythmic Therapy Versus Catheter Ablation as First Line Treatment for AICD Shock Prevention: A Randomized Vanguard Pilot Trial|Terminated||Phase 4|40|Anticipated|Ottawa Heart Institute Research Corporation||2||Low recruitment. Pilot trial.|f||||t||||||||||2017-10-11 00:33:17.364209|2017-10-11 00:33:17.364209
NCT02114515|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-10-28|||July 2014||2014-07-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PArTNER||PATient Navigator to rEduce Readmissions|PATient Navigator to rEduce Readmissions|Active, not recruiting||N/A|1300|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-11 00:33:17.453817|2017-10-11 00:33:17.453817
NCT02114502|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-07-09|||September 2014||2014-09-01|July 2014|2014-07-01||||September 2018|Anticipated|2018-09-01||Interventional|||Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma|Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Myeloma|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:33:17.561176|2017-10-11 00:33:17.561176
NCT02114489|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-05-15|||June 2014||2014-06-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis|Double Blind Randomized Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis Stage 1 and 2|Terminated||Phase 3|8|Actual|University of Lausanne Hospitals||2||Troubles recruiting patients|f||||t||||||||||2017-10-11 00:33:17.696523|2017-10-11 00:33:17.696523
NCT02114476|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2015-07-04|||March 2014||2014-03-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Effect of Implantable Contraception on Type-2 DM and Metabolic Syndrome in Women With History of Gestational DM|Effect of Implantable Progestin-only Contraception on the Incidence of Type 2 Diabetes and Metabolic Syndrome in Thai Women With History of Gestational Diabetes|Unknown status|Recruiting|Phase 2|260|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 00:33:17.809437|2017-10-11 00:33:17.809437
NCT02114463|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-03-11|||March 2014||2014-03-01|March 2015|2015-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of Two Kinds of Postoperative Analgesia After Amputation|Comparison of Two Kinds of Postoperative Analgesia After Amputation:a Randomized Clinical Trial|Unknown status|Recruiting|Phase 4|36|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-11 00:33:17.968275|2017-10-11 00:33:17.968275
NCT02114437|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-03-11|||March 2014||2014-03-01|March 2015|2015-03-01|March 2015|Anticipated|2015-03-01|July 2014|Actual|2014-07-01||Interventional|CLTCI||Closed-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy|Closed-Loop Target Controlled Infusion of Propofol and Remifentanil Guided by Narcotrend Index in Laparoscopic Cholecystectomy|Unknown status|Recruiting|Phase 4|38|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-11 00:33:18.278779|2017-10-11 00:33:18.278779
NCT02114424|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-13|||May 2014||2014-05-01|April 2014|2014-04-01|February 2016|Anticipated|2016-02-01|June 2015|Anticipated|2015-06-01||Interventional|POSAS||Night Balance for Positional Obstructive Sleep Apnea Syndrome (POSAS)|Night Balance for Positional Obstructive Sleep Apnea Syndrome (POSAS) A Prospective, Randomized, Controlled Open Trial in Daily Clinical Practice|Unknown status|Not yet recruiting|Phase 2/Phase 3|100|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-10-11 00:33:18.396933|2017-10-11 00:33:18.396933
NCT02114411|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2014-04-14|||June 2014||2014-06-01|April 2014|2014-04-01|June 2016|Anticipated|2016-06-01|October 2015|Anticipated|2015-10-01||Observational|||Gastropanel for Gastric Atrophy and Cancer Risk Assessment|Gastropanel *for Early Detection of Gastric Atrophy and Gastric Cancer Risk|Unknown status|Not yet recruiting|N/A|250|Anticipated|Biohit Healthcare Ltd|||1||f||||t||||||||||2017-10-11 00:33:18.508745|2017-10-11 00:33:18.508745
NCT02114398|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-02-06|||October 2013||2013-10-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Physiotherapy Efficiency on Child Asthma|Physiotherapy Efficiency With Caycedian Sophrology on Child Asthma: Randomized, Controlled Study|Completed||N/A|74|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:33:18.59569|2017-10-11 00:33:18.59569
NCT02114372|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-09-22|||February 5, 2014|Actual|2014-02-05|September 2017|2017-09-01|March 30, 2022|Anticipated|2022-03-30|August 20, 2020|Anticipated|2020-08-20||Observational|CHARIOT:PRO||Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study|Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort Study (PRO)|Recruiting||N/A|700|Anticipated|Janssen Research & Development, LLC|||5||f||||f||f||||Samples With DNA|"     Blood, saliva, and urine specimens will be collected.   "|||2017-10-11 00:33:18.773939|2017-10-11 00:33:18.773939
NCT02114359|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-10-05|||February 2014||2014-02-01|October 2017|2017-10-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer|Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study|Recruiting||Phase 3|246|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:33:18.866922|2017-10-11 00:33:18.866922
NCT02114346|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-04-11|||July 2013||2013-07-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||High Dose Atorvastatin for Preventing Contrast-induced Nephropathy|Evaluating the Effect of High Dose Atorvastatin (80 mg/d) Comparing With Placebo in Preventing Contrast-induced Nephropathy in Patients Undergoing Computed Tomography Coronary Angiography|Completed||Phase 2/Phase 3|250|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 00:33:19.259942|2017-10-11 00:33:19.259942
NCT02114333|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-02-28|||May 2014||2014-05-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds|A Comparison of the Immunogenicity and Descriptive Safety of a Live Attenuated Herpes Zoster Vaccine and the Glaxo Smith Kline (GSK) Herpes Zoster Recombinant HZ/su Candidate Vaccine in 50-59 Year Old and 70-85 Year Old Vaccine Recipients|Active, not recruiting||Phase 1|160|Actual|University of Colorado, Denver||4|||f||||f||||||||No||2017-10-11 00:33:19.335966|2017-10-11 00:33:19.335966
NCT02114320|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-12-02|||March 2014||2014-03-01|April 2014|2014-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Clinical Outcomes of EUS-guided Biliary Drainage Using Partially or Fully Covered Metallic Stents|Multicenter Study of EUS-guided Biliary Drainage Using Partially Covered With a Dedicated Introducer or Fully Covered Antimigration Metallic Stents|Completed||Phase 3|32|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 00:33:19.421147|2017-10-11 00:33:19.421147
NCT02114307|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2014-04-11|||March 2014||2014-03-01|February 2014|2014-02-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|RVI||REVITIVE for the Treatment of Patients With Venous Insufficiency|REVITIVE for the Treatment of Patients With Venous Insufficiency|Unknown status|Recruiting|N/A|20|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 00:33:19.494991|2017-10-11 00:33:19.494991
NCT02114294|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-03-04|||October 2014||2014-10-01|April 2014|2014-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Hip Strengthening Versus Quadriceps Based Training for Patellofemoral Pain Syndrome|Does Isolated Hip Strengthening for Patellofemoral Pain Syndrome Give Better Long Term Results Than Traditional Quadriceps Based Training? A Randomised Controlled Trial.|Recruiting||N/A|150|Anticipated|Sorlandet Hospital HF||3|||f||||t||||||||||2017-10-11 00:33:19.591565|2017-10-11 00:33:19.591565
NCT02114281|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-07-22|||September 2014||2014-09-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|NEPHRODENT||Oral and Dental Health Status in Patients Suffering From Chronic Kidney Disease|Oral and Dental Health Status in Patients Suffering From Chronic Kidney Disease|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 00:33:19.718283|2017-10-11 00:33:19.718283
NCT02113943|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-02-23|||April 2014||2014-04-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|MBBCitalopram||Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation|Etude Comparative Monocentrique, randomisée, en Cross-over, en Double Aveugle, Contre Placebo, de l'Action du Citalopram Sur Les paramètres Cognitifs de la Motivation|Completed||Phase 2|24|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 00:33:27.23023|2017-10-11 00:33:27.23023
NCT02114268|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-10-05|2016-07-26||April 2014||2014-04-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||The As-treated Population included participants who receive any study investigational product.|A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults|A Phase 1, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults|Completed||Phase 1|342|Actual|MedImmune LLC|Physical examination parameters of participants were not evaluated.|6|||f||||f||||||||||2017-10-11 00:33:19.855903|2017-10-11 00:33:19.855903
NCT02114255|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-11-09|||May 2014||2014-05-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effects of BCG on Influenza Induced Immune Response|The Effects of BCG-vaccination on the Immune Response Induced by Influenza-vaccination in Healthy Volunteers. A Pilot Proof-of-principle Study.|Completed||Phase 2/Phase 3|40|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 00:33:21.504778|2017-10-11 00:33:21.504778
NCT02114242|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-10-27|||December 2013||2013-12-01|October 2014|2014-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|BIOPARK||Biomarkers in Parkinsonian Syndromes|Development of Biomarkers for the Diagnosis and Prognosis of Parkinsonian Syndromes Running Head: Biomarkers in Parkinsonian Syndromes|Recruiting||N/A|100|Anticipated|University Hospital, Bordeaux|||3||f||||f||||||Samples With DNA|"     -  Cerebrospinal fluid        -  Whole blood        -  Plasma        -  Serum        -  Urine   "|||2017-10-11 00:33:21.590235|2017-10-11 00:33:21.590235
NCT02114229|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-11|2017-07-12|||May 14, 2014|Actual|2014-05-14|July 2017|2017-07-01|May 31, 2027|Anticipated|2027-05-31|May 31, 2023|Anticipated|2023-05-31||Interventional|SJATRT||Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors|Phase 2 Study of Alisertib as a Single Agent in Recurrent or Progressive Central Nervous System (CNS) Atypical Teratoid Rhabdoid Tumors (AT/RT) and Extra-CNS Malignant Rhabdoid Tumors (MRT) and in Combination Therapy in Newly Diagnosed AT/RT|Recruiting||Phase 2|180|Anticipated|St. Jude Children's Research Hospital||3|||f||||t|t|f||||||||2017-10-11 00:33:21.69949|2017-10-11 00:33:21.69949
NCT02114216|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2016-04-24|2015-05-25||March 2013||2013-03-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease|Symptomatic Gastroesophageal Reflux Disease is Associated With Increased TRPV1 and PAR2 mRNA Expression Levels in the Esophageal Mucosa|Completed||N/A|75|Actual|Seoul National University Bundang Hospital||3|||f||||f||||||||Undecided||2017-10-11 00:33:21.891946|2017-10-11 00:33:21.891946
NCT02114190|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-08-17|||April 2014||2014-04-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|June 2016|Actual|2016-06-01||Interventional|||Family-Based Mindful Eating Intervention for Overweight Adolescents|Adaptation and Evaluation of a Family-Based Mindful Eating Intervention for Overweight Adolescents|Completed||N/A|66|Actual|Oregon Research Institute||2|||f||||t||||||||||2017-10-11 00:33:22.489053|2017-10-11 00:33:22.489053
NCT02114177|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-03-14|2016-01-19||April 2014||2014-04-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis|A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of a 12- or 8-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naïve and -Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection Without Cirrhosis|Completed||Phase 3|310|Actual|Janssen Infectious Diseases BVBA||2|||f||||t||||||||||2017-10-11 00:33:22.615131|2017-10-11 00:33:22.615131
NCT02114164|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-09-18|||August 2016||2016-08-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of CO2 Exchange Patterns During Robotic Prostatectomies|A Comparative Study of CO2 Exchange Patterns Between Valve-free Trocar (AirSeal®) Versus Standard Trocar (Endopath®) During Robotic Prostatectomies|Recruiting||N/A|100|Anticipated|OhioHealth||2|||f||||f||||||||||2017-10-11 00:33:23.257591|2017-10-11 00:33:23.257591
NCT02114151|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-03-07|2016-01-21||April 2014||2014-04-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis|A Phase 3, Multicenter, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of a 12-Week Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection and Cirrhosis|Completed||Phase 3|103|Actual|Janssen Infectious Diseases BVBA||1|||f||||t||||||||||2017-10-11 00:33:23.381786|2017-10-11 00:33:23.381786
NCT02114138|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-09-18|||July 2015||2015-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|NavigateAKI||Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury|Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury Subtitle: Urinary Molecular and Metabolic Signature of Postoperative Acute Kidney Injury (NavigateAKI)|Recruiting||N/A|200|Anticipated|University of Florida|||2||f||||f|f|f||||Samples Without DNA|"     urine samples blood samples   "|||2017-10-11 00:33:23.852059|2017-10-11 00:33:23.852059
NCT02114125|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-04-11|||February 2012||2012-02-01|April 2014|2014-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of the Physical Activity and Cognitive Training Program|The Effects of Physical Activity and Cognitive Training in Improving Cognitive Function of Institutionalized Older Residents|Unknown status|Recruiting|N/A|270|Anticipated|National Taiwan University Hospital||6|||f||||t||||||||||2017-10-11 00:33:25.744173|2017-10-11 00:33:25.744173
NCT02113748|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-11|||April 2014||2014-04-01|April 2014|2014-04-01||||April 2015|Anticipated|2015-04-01||Interventional|||Downhill Walking Training in COPD|Downhill Walking to Enhance Training Effects in Patients With COPD|Unknown status|Recruiting|N/A|42|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 00:33:28.704398|2017-10-11 00:33:28.704398
NCT02114112|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2014-04-10|||January 2011||2011-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|November 2012|Actual|2012-11-01||Interventional|||E-23596 - Use of NCPAP Cycling to Wean Preterm Infants|Randomised Controlled Trial to Study the Effect of Nasal Continuous Positive Airway Pressure (NCPAP) Cycling on Successful Weaning When Compared With Nasal Continuous Positive Airway Pressure (NCPAP) in Premature Infants of 25-28 Weeks Gestation|Terminated||N/A|30|Actual|University of Calgary||2||"Due to new respiratory quality control initiative introduced in the NICU, recruitment for the   study was stopped."|f||||f||||||||||2017-10-11 00:33:25.898113|2017-10-11 00:33:25.898113
NCT02114099|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-28|2014-04-14|||June 2007||2007-06-01|April 2014|2014-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease|An Open Label, Non-comparative Phase II Trial to Evaluate the Effects of Atorvastatin on the Persistent Coronary Arterial Aneurysm in Children With Kawasaki Disease: Safety and Efficacy|Unknown status|Recruiting|Phase 2|20|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 00:33:25.984413|2017-10-11 00:33:25.984413
NCT02114086|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-08-30|||January 2013||2013-01-01|August 2016|2016-08-01|March 2029|Anticipated|2029-03-01|January 2027|Anticipated|2027-01-01||Observational|||IORT-Boost-Study, Prospective Observational Study for Intraoperative Radiotherapy of the Breast as a Boost|Prospective Observational Study for Intraoperative Radiotherapy (IORT) of the Breast as a Boost|Recruiting||N/A|200|Anticipated|Kantonsspital Münsterlingen|||1||f||||f||||||||||2017-10-11 00:33:26.072281|2017-10-11 00:33:26.072281
NCT02114073|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2015-04-17|||April 2014||2014-04-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|BCATS||Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure|Comparison of Effect of Cyclosporine Ophthalmic Emulsion 2% and Betamethasone Eye Drop on Intraocular Pressure, Conjunctival Hyperemia and Subjective Dry Eye Symptoms Following Trabeculectomy in Open Angle Glaucoma Patients|Completed||Phase 2|40|Anticipated|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:33:26.163833|2017-10-11 00:33:26.163833
NCT02114047|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-03-22|||February 2014||2014-02-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Pulmonary Perfusion Heterogeneity in Patients With CTEPH Using Functional PET Imaging|Evaluation of Pulmonary Perfusion Heterogeneity in Patients With Chronic Thromboembolic Pulmonary Hypertension Using Functional PET Imaging|Completed||N/A|5|Actual|Massachusetts General Hospital|||1||f||||f||||||||No|Since imaging data can be identifying, researchers will need to write to the investigators and submit to IRB review if they would like to obtain raw imaging data.|2017-10-11 00:33:26.396871|2017-10-11 00:33:26.396871
NCT02114034|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-12-15|||September 2013||2013-09-01|December 2016|2016-12-01|September 2032|Anticipated|2032-09-01|September 2032|Anticipated|2032-09-01||Observational|COBRAPed||Cohort Analysis of Clinical and Biological Severe Childhood Asthma|Cohort Analysis of Clinical and Biological Severe Childhood Asthma|Recruiting||N/A|676|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     -  whole blood        -  serum        -  Bronchoalveolar lavage fluid        -  bronchial brushing and washing specimens   "|No||2017-10-11 00:33:26.458216|2017-10-11 00:33:26.458216
NCT02114021|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-14|||March 2012||2012-03-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effect of Betamethasone Gel and Lidocaine Jelly on Sore Throat, Cough and Hoarseness of|Effect of Betamethasone Gel and Lidocaine Jelly Applied Over Tracheal Tube Cuff on Post Operative Sore Throat, Cough and Hoarseness of Voice on the Patients|Completed||Phase 3|99|Actual|Tehran University of Medical Sciences||3|||f||||t||||||||||2017-10-11 00:33:26.544901|2017-10-11 00:33:26.544901
NCT02114008|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2014-04-14|||April 2013||2013-04-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Residual Gastric Volume in Morbidly Obesa Diabetics. A Comparison of 3 Hour Versus Hour Fasting.|Residual Gastric Volume in Morbidly Obesa Diabetics. A Comparison of 3 Hour Versus Hour Fasting.|Completed||N/A|8|Actual|Cuiaba University||2|||f||||t||||||||||2017-10-11 00:33:26.739181|2017-10-11 00:33:26.739181
NCT02113995|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-12|2014-04-14|||April 2012||2012-04-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Clinical Evaluation, Organic Response in Obesity Patients Subjected to Vertical Videolaparoscopy Gastroplasty With or Without Perioperative Cares Recommended by the Acerto Project. Randomized Study.|Clinical Evaluation, Organic Response in Obesity Patients Subjected to Vertical Videolaparoscopy Gastroplasty With or Without Perioperative Cares Recommended by the Acerto Project.|Completed||N/A|20|Actual|Cuiaba University||2|||f||||t||||||||||2017-10-11 00:33:26.809967|2017-10-11 00:33:26.809967
NCT02113982|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-07-06|||September 2014||2014-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia|SL-401 in Patients With Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)|Recruiting||Phase 1/Phase 2|120|Anticipated|Stemline Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 00:33:26.891753|2017-10-11 00:33:26.891753
NCT02113969|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-11-17|||September 2013||2013-09-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol|Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol|Unknown status|Recruiting|N/A|294|Anticipated|Servicio de Salud Metropolitano Sur Oriente||1|||f||||f||||||||||2017-10-11 00:33:27.011825|2017-10-11 00:33:27.011825
NCT02113956|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-08-29|||June 2014||2014-06-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|G2G||Harnessing the Power of Text Messaging to Invigorate AMSM HIV Preventive Behavior|Harnessing the Power of Text Messaging to Invigorate AMSM HIV Preventive Behavior|Completed||N/A|302|Actual|Center for Innovative Public Health Research||2|||f||||f||||||||No||2017-10-11 00:33:27.137404|2017-10-11 00:33:27.137404
NCT02113930|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-07-05|||July 2013||2013-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Observational|Lympho-4||Idiopathic CD4 Lymphocytopenia|Analysis of Clinical and Immunological Characteristics, as Well as Pathophysiological Mechanisms in a French Cohort of Patients With Idiopathic CD4 Lymphocytopenia|Recruiting||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     Serum; plasma, peripheral blood mononuclear cells and DNA.   "|||2017-10-11 00:33:27.297124|2017-10-11 00:33:27.297124
NCT02113917|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-08-25|||January 2010||2010-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Observational|HLH-genes||Children and Adult Hemophagocytic Syndrome (HLHa)|The Formation of a Cohort of HLHa Patients in Order to Study Their Physiopathological Characteristics|Active, not recruiting||N/A|204|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     whole blood and serum   "|||2017-10-11 00:33:27.387907|2017-10-11 00:33:27.387907
NCT02113904|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-08-11|||January 27, 2014|Actual|2014-01-27|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|December 20, 2016|Actual|2016-12-20||Interventional|AntiTNF-SN||Clinical Trial Using Humira in Netherton Syndrome|Phase II Clinical Trial Using Humira in Netherton Syndrome|Active, not recruiting||Phase 2|11|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t|f|f||||||||2017-10-11 00:33:27.472115|2017-10-11 00:33:27.472115
NCT02113891|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-02-24|||February 2015||2015-02-01|February 2015|2015-02-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|TAMARCIN||Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation|Treatment of Subclinical Antibody-mediated Acute Rejection in Kidney Transplant Recipients With the Complement Inhibitor Eculizumab.|Withdrawn||Phase 1/Phase 2|0|Actual|Assistance Publique - Hôpitaux de Paris||1||disengagement of the sponsor Alexion Pharmaceuticals|f||||t||||||||||2017-10-11 00:33:27.557638|2017-10-11 00:33:27.557638
NCT02113878|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-05-19|||October 2014||2014-10-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck|A Phase Ib Study of BKM120 With Weekly Cisplatin and Radiotherapy in High Risk Locally Advanced Squamous Cell Cancer of the Head and Neck|Recruiting||Phase 1|46|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No|There are no plans to share the IPD. Cumulative data will be published however.|2017-10-11 00:33:27.653804|2017-10-11 00:33:27.653804
NCT02113865|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-03-06|||October 2013||2013-10-01|April 2014|2014-04-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Observational|||Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients|"Obtención de un Panel de puntuación (Score System) Para la predicción de Riesgo Individualizado y la detección Precoz de Carcinoma Hepatocelular (HCC) en Sujetos Coinfectados VIH/VHC"|Completed||N/A|45|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal|||3||f||||||||||Samples With DNA|"     Serum, plasma, white cells   "|||2017-10-11 00:33:27.764214|2017-10-11 00:33:27.764214
NCT02113852|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-02-28|||August 2013||2013-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01|2 Years|Observational [Patient Registry]|CHOICE||Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients|Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients|Completed||N/A|250|Actual|Guangdong Association of Clinical Trials|||1||f||||t||||||Samples With DNA|"     blood,tumor and adjacent normal tissue samples   "|||2017-10-11 00:33:27.832599|2017-10-11 00:33:27.832599
NCT02113839|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-08-19|||April 2014||2014-04-01|April 2014|2014-04-01|May 2015|Actual|2015-05-01|August 2014|Actual|2014-08-01||Interventional|DPE||Dyspnea in COPD: Relationship With Exacerbations Frequency|Breathlessness Perception in COPD: Relationship With Exacerbation Frequency|Completed||N/A|34|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 00:33:27.902393|2017-10-11 00:33:27.902393
NCT02113826|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-04-22|||April 2014||2014-04-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Pazopanib for Metastatic Alveolar Soft Part Sarcoma|A Phase II Trial of Pazopanib in Patients With Metastatic Alveolar Soft Part Sarcoma|Terminated||Phase 2|6|Actual|Seoul National University Hospital||1||Low accrual rate|f||||f||||||||||2017-10-11 00:33:28.015772|2017-10-11 00:33:28.015772
NCT02113813|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-07-26|||April 23, 2014|Actual|2014-04-23|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations|An Open-label, Phase 1 Dose Escalation Study of Oral ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations|Active, not recruiting||Phase 1|133|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-10-11 00:33:28.092588|2017-10-11 00:33:28.092588
NCT02113800|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-01-05|||August 2015||2015-08-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|EVINEC||Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study|Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study|Recruiting||Phase 2|40|Anticipated|AIO-Studien-gGmbH||1|||f||||f||||||||||2017-10-11 00:33:28.21312|2017-10-11 00:33:28.21312
NCT02113787|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-04-13|||February 2014||2014-02-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Switchability Study Between Brand and Generic Topiramate|A Clinical Pharmacokinetics Comparing Brand and Generic Topiramate in Epilepsy Patients : A Open-label,Randomised, Three-period Crossover Study|Active, not recruiting||Phase 4|24|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:33:28.304046|2017-10-11 00:33:28.304046
NCT02113774|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2014-04-14|||April 2014||2014-04-01|April 2014|2014-04-01||||April 2019|Anticipated|2019-04-01||Interventional|||The Impact of Antimicrobial Treatment for Asymptomatic Bacteriuria in Renal Transplant Patients||Not yet recruiting||Phase 4|||Rabin Medical Center||2|||f||||||||||||||2017-10-11 00:33:28.437681|2017-10-11 00:33:28.437681
NCT02113761|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-02-01|||January 2014||2014-01-01|February 2017|2017-02-01|December 21, 2016|Actual|2016-12-21|July 2015|Actual|2015-07-01||Observational|AFACART||Non Invasive Mapping Before Ablation for Atrial Fibrillation.|Non Invasive Mapping Before Ablation for Atrial Fibrillation: the Afacart Study.|Completed||N/A|100|Actual|Brugmann University Hospital|||1||f||||t||||||||||2017-10-11 00:33:28.600804|2017-10-11 00:33:28.600804
NCT02113735|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-09-25|||August 2014|Anticipated|2014-08-01|September 2017|2017-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Safety and Efficacy Study of Acthar in Subjects With ARDS|A Randomized, Double-blind, Placebo-controlled, Parallel Group Safety and Efficacy Study of H.P. Acthar® Gel (Acthar) in Subjects With Acute Respiratory Distress Syndrome (ARDS)|Withdrawn||Phase 2|0|Actual|Mallinckrodt||6||A company decision was made not to proceed with the study.|f||||t||||||||||2017-10-11 00:33:28.841848|2017-10-11 00:33:28.841848
NCT02113722|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-03-29|||July 2014||2014-07-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Reduce-SCD||Is Left Stellate Ganglionectomy Beneficial to Patients With Life Threatening Ventricular Arrhythmias|Does Left Cardiac Sympathectomy Stellate Ganglionectomy Confer an Added Benefit Over Optimal Medical Therapy in the Reduction of Therapy Delivered From an Implanted Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death|Withdrawn||N/A|0|Actual|Princess Alexandra Hospital, Brisbane, Australia||2||Study already undertaken at another centre|f||||t||||||||No|Data is de-identified and will not be shared.|2017-10-11 00:33:28.948583|2017-10-11 00:33:28.948583
NCT02113709|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2014-04-14|||January 2010||2010-01-01|April 2014|2014-04-01|June 2014|Anticipated|2014-06-01|October 2012|Actual|2012-10-01||Interventional|||Determining the Efficacy of Full-time Occlusion Therapy in Severe Amblyopia at Different Ages|Determining the Efficacy of Full-time Occlusion Therapy in Severe Amblyopia at All Ages|Unknown status|Active, not recruiting|N/A|115|Actual|Mughal Eye Trust Hospital||1|||f||||t||||||||||2017-10-11 00:33:29.04305|2017-10-11 00:33:29.04305
NCT02113696|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-07-04|||May 2014||2014-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Intake of Omega 3 in Morbidly Obese Patients|The Effect of ω-3 Polyunsaturated Fatty Acids (Eicosapentaenoic Acid and Docosahexanoic Acid) on Morbidly Obese Patients|Completed||N/A|46|Actual|Pontificia Universidade Católica do Rio Grande do Sul||2|||f||||t||||||||||2017-10-11 00:33:29.136029|2017-10-11 00:33:29.136029
NCT02113683|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-03-10|||May 2014||2014-05-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MMS-TM||Validation of MMS Test for Cancer Monitoring|Validation of MMS Test to Detect Active Tumor Growth of Different Cancer Types Before and After Therapy, as Well as for Subsequent Relapse Control in Comparison to Conventional Methods|Recruiting||N/A|100|Anticipated|MedInnovation GmbH|||1||f||||f||||||||||2017-10-11 00:33:29.245298|2017-10-11 00:33:29.245298
NCT02113670|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-10-04|||March 2015|Actual|2015-03-01|October 2017|2017-10-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Changes in ALPP in Women With SUI Following Air Instillation|Changes in Abdominal Leak Point Pressures in Women Stress Urinary Incontinence Following Intravesical Air Instillation During Urodynamic Study|Completed||N/A|8|Actual|Meir Medical Center||1|||f||||f||||||||||2017-10-11 00:33:29.323743|2017-10-11 00:33:29.323743
NCT02113657|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-06-07|||August 2014|Actual|2014-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer|A Feasibility Study To Determine T-cell Responses To Neoantigens Following Treatment With Ipilimumab In Men With Metastatic Castration-Resistant Prostate Carcinoma|Recruiting||Early Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:33:29.405035|2017-10-11 00:33:29.405035
NCT02113644|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-08-30|||April 2014||2014-04-01|August 2017|2017-08-01|April 2029|Anticipated|2029-04-01|April 2029|Anticipated|2029-04-01||Observational|||Prevent CardioKids|Prevent CardioKids|Recruiting||N/A|240|Anticipated|Maastricht University Medical Center|||2||f||||f||||||||||2017-10-11 00:33:29.503989|2017-10-11 00:33:29.503989
NCT02113631|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2017-03-13|||September 2011||2011-09-01|March 2017|2017-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir|Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir and Re-assessment of Treatment Duration in Patients With Chronic Hepatitis C|Completed||N/A|50|Actual|Louis Stokes VA Medical Center||2|||f||||t||||||||||2017-10-11 00:33:29.609259|2017-10-11 00:33:29.609259
NCT02113618|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-08-31|||October 2013||2013-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|COGALC||Effect of Cognitive Training on Alcohol Use Outcomes|The Effects of Cognitive Training on Alcohol Consumption, Cognition and Craving in Alcohol Use Disorder|Completed||N/A|50|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 00:33:29.717024|2017-10-11 00:33:29.717024
NCT02113605|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-12-01|||April 2014||2014-04-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|CBT||Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders|Exposure-Based CBT for Children With Functional Gastrointestinal Disorders - Development of a Protocol|Completed||N/A|20|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 00:33:29.84224|2017-10-11 00:33:29.84224
NCT02113592|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-06-09|||March 2014||2014-03-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PPACT-UH3||Pain Program for Active Coping & Training|Collaborative Care for Chronic Pain in Primary Care|Enrolling by invitation||N/A|2000|Anticipated|Kaiser Permanente||2|||f||||t||||||||No||2017-10-11 00:33:29.977258|2017-10-11 00:33:29.977258
NCT02113579|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-05-26|2015-04-30||March 2014||2014-03-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Test on a New Experimental Mouth Rinse for Relieving Tooth Sensitivity|Assessment of a Potassium Oxalate Containing Formulation for the Relief of Dentinal Hypersensitivity|Completed||N/A|375|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 00:33:30.098799|2017-10-11 00:33:30.098799
NCT02113566|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2015-12-01|||February 2013||2013-02-01|December 2015|2015-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|DOMS||A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness|A Double-Blind, Repeat-Dose, Parallel Group Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness.|Completed||Phase 4|60|Actual|Jean Brown Research||2|||f||||t||||||||||2017-10-11 00:33:30.628145|2017-10-11 00:33:30.628145
NCT02113553|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-08-05|||May 2013||2013-05-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve|ANTI-MULLERIAN HORMONE (AMH) AS A MARKER OF OVARIAN RESERVE IN YOUNG BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY + GnRH ANALOGUE|Unknown status|Recruiting|Phase 2|80|Anticipated|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-11 00:33:30.708576|2017-10-11 00:33:30.708576
NCT02113540|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2014-04-10|||January 2012||2012-01-01|April 2014|2014-04-01||||May 2014|Anticipated|2014-05-01||Interventional|CIN||Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography|Atorvastatin and Prevention of Contrast Induced Nephropathy Following Coronary Angiography|Unknown status|Recruiting|Phase 3|||Isfahan University of Medical Sciences||3|||f||||||||||||||2017-10-11 00:33:30.785505|2017-10-11 00:33:30.785505
NCT02113527|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-09-01|||April 2014||2014-04-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|November 2014|Actual|2014-11-01||Observational|DYSMOT-RIII||Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia|Evaluation of Gastric Emptying Time, Gastric Electrical Activity and Gastrointestinal Peptides to Identify Dyspeptic Patients With Epigastric Pain Syndrome From Those With Postprandial Distress Syndrome According to the Rome III Proposed Subdivision of Functional Dyspepsia|Completed||N/A|75|Actual|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis|||3||f||||f||||||Samples With DNA|"     breath specimen, whole blood, serum, white cells.   "|||2017-10-11 00:33:30.857149|2017-10-11 00:33:30.857149
NCT02113514|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-04-27|||May 2005||2005-05-01|April 2015|2015-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Community Awareness, Resources and Education (CARE I): Project 3|Community Awareness, Resources and Education (CARE I): Project 3|Completed||N/A|2394|Actual|Ohio State University Comprehensive Cancer Center|||2||f||||t||||||Samples Without DNA|"     Cervical mucus will be collected for Human Papillomavirus (HPV) assays and stored for     potential other assays related to HPV. Serum will be drawn for HPV serology and stored for     future analysis.   "|||2017-10-11 00:33:30.949068|2017-10-11 00:33:30.949068
NCT02113501|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-10|||April 2005||2005-04-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study|Optimized Treatment Strategy for HighGradeT1 (HGT1) Bladder Cancer Based on Substaging (Depth of Lamina Propria Invasion): a Prospective Observational Cohort Study|Completed||N/A|200|Actual|Hospital Universitari Vall d'Hebron Research Institute|||2||f||||f||||||Samples With DNA|"     paraffin embedded blocks of transurethral resection (TUR) samples   "|||2017-10-11 00:33:31.029101|2017-10-11 00:33:31.029101
NCT02113488|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-04-10|||October 2013||2013-10-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Observational|AU2||Causes of Nonattendance at Scheduled Outpatient Appointments|Case-control Study: Causes of Nonattendance at Clinical Medicine Scheduled Outpatient Appointments in a University General Hospital|Unknown status|Active, not recruiting|N/A|450|Anticipated|Hospital Italiano de Buenos Aires|||3||f||||f||||||||||2017-10-11 00:33:31.099039|2017-10-11 00:33:31.099039
NCT02113475|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-03-18|||April 2014||2014-04-01|March 2015|2015-03-01|January 2021|Anticipated|2021-01-01|March 2020|Anticipated|2020-03-01||Observational|VETTOR||Venous Thrombectomy/Thrombolysis Outcome Registry|A Patient Outcome Study After Pharmacomechanical Catheter-directed Thrombolysis and Standard Treatment for Venous Thrombosis|Recruiting||N/A|1800|Anticipated|Heart and Vascular Outcomes Research Institute|||1||f||||t||||||||||2017-10-11 00:33:31.163957|2017-10-11 00:33:31.163957
NCT02113462|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-10|||January 2009||2009-01-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Triglyceride/High-density Lipoprotein Cholesterol Ratio in Chronic Kidney Disease|The Prospective Cohort Study to Investigate the Role of Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio To Predict Cardiovascular Outcomes in Chronic Kidney Disease.|Completed||N/A|197|Actual|Gulhane School of Medicine|||1||f||||f||||||||||2017-10-11 00:33:31.255091|2017-10-11 00:33:31.255091
NCT02113449|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2015-04-09|2014-10-02||November 2013||2013-11-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Market Potential of Carbon Dioxide Nasal Spray|A Study to Assess the Market Potential of a Carbon Dioxide Nasal Spray in Congested Subjects|Completed||Phase 2|147|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:33:31.357512|2017-10-11 00:33:31.357512
NCT02113436|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-03-28|2016-12-05||May 1, 2014||2014-05-01|February 2017|2017-02-01|October 1, 2016|Actual|2016-10-01|June 1, 2016|Actual|2016-06-01||Interventional|||Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma|Clinical Assessment of Fluticasone Propionate/ Salmeterol Xinafoate HFA MDI in 6-month to 4-year-old Japanese Patients With Bronchial Asthma|Completed||Phase 4|300|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:33:32.525911|2017-10-11 00:33:32.525911
NCT02113423|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-10|||January 1996||1996-01-01|April 2014|2014-04-01|March 2011|Actual|2011-03-01|June 2009|Actual|2009-06-01||Interventional|||Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma|Superiority of Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma|Completed||N/A|168|Actual|Fujian Cancer Hospital||1|||f||||f||||||||||2017-10-11 00:33:33.834968|2017-10-11 00:33:33.834968
NCT02113410|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-10-09|||March 2014||2014-03-01|October 2015|2015-10-01|January 2016|Anticipated|2016-01-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Chair Yoga on Elders With Osteoarthritis|Effect of Sit 'N' Fit Chair Yoga on Community-Dwelling Elders With Osteoarthritis|Unknown status|Active, not recruiting|N/A|120|Anticipated|Florida Atlantic University||2|||f||||t||||||||||2017-10-11 00:33:33.913163|2017-10-11 00:33:33.913163
NCT02113397|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-08-01|||April 2014||2014-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung|Comparative Evaluation of Bacterial Diversity and Richness in CF Lung in Patients Who Use Cycled Every Other Month Tobramycin Inhalation Powder (TOBI™ Podhaler™) Or Continuous Alternating Therapy With Tobramycin Inhalation Powder (TOBI™ Podhaler™) and Inhaled Colistimethate|Terminated||Phase 4|1|Actual|Dartmouth-Hitchcock Medical Center||2||Insufficient enrollment|f||||f||||||||||2017-10-11 00:33:33.996019|2017-10-11 00:33:33.996019
NCT02113384|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-10-14|||September 2012||2012-09-01|October 2015|2015-10-01|January 2028|Anticipated|2028-01-01|January 2017|Anticipated|2017-01-01|5 Years|Observational [Patient Registry]|LARC-EX||Locally Advanced Rectal Cancer - Exfoliated Peritoneal Tumor Cells|Prospective Observational Study of Exfoliated Peritoneal Tumor Cells in Locally Advanced Rectal Cancer|Recruiting||N/A|160|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Tumor tissue, peritoneal lavage samples, blood specimen.   "|||2017-10-11 00:33:34.078841|2017-10-11 00:33:34.078841
NCT02113371|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-03-14|||October 2011||2011-10-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Evaluation of COMmunity of Practice And Safety Support (COMPASS) for Home Care Workers|Creating Health and Safety Communities of Practice for Home Care Workers|Active, not recruiting||N/A|260|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 00:33:34.182528|2017-10-11 00:33:34.182528
NCT02113358|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-12-02|||April 2014||2014-04-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Comparison of Stroke Volume Variation-guided Normovolemic and Restrictive Fluid Management During Craniotomy: a Randomized Controlled Trial|Comparison of Stroke Volume Variation-guided Normovolemic and Restrictive Fluid Management During Craniotomy: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:33:34.276568|2017-10-11 00:33:34.276568
NCT02113345|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-04-09|||April 2014||2014-04-01|April 2014|2014-04-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|M&Mresearch||The Relationship Between Metamemory and Memory in Old Age|The Relationship Between Metamemory and Memory in Old Age|Unknown status|Enrolling by invitation|N/A|60|Anticipated|The University of Hong Kong||1|||f||||f||||||||||2017-10-11 00:33:34.36222|2017-10-11 00:33:34.36222
NCT02113332|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-02-01|||January 2013||2013-01-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections|Addition of Liraglutide to Overweight Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections (MDI) With Inadequate Glycaemic Control|Completed||Phase 2|124|Actual|Vastra Gotaland Region||2|||f||||t||||||||||2017-10-11 00:33:34.459778|2017-10-11 00:33:34.459778
NCT02113319|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-04-11|||April 2007||2007-04-01|January 2009|2009-01-01||||May 2012|Actual|2012-05-01||Interventional|DasaCBF||Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia|An Open-Label, Multicenter, Phase II Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia Refractory to Conventional Chemotherapy or in Molecular Relapse. Intergroupe Français Des leucémie aiguë myéloblastique|Completed||Phase 2|27|Actual|University Hospital, Angers||1|||f||||f||||||||||2017-10-11 00:33:34.701458|2017-10-11 00:33:34.701458
NCT02113306|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-11|||July 2014||2014-07-01|April 2014|2014-04-01||||December 2015|Anticipated|2015-12-01||Interventional|t-VNSext||Does Transcutaneous Vagal Nerve Stimulation Improves Fear Extinction in Humans|Does Transcutaneous Vagal Nerve Stimulation Improves Fear Extinction in Humans|Unknown status|Not yet recruiting|N/A|50|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:33:34.77896|2017-10-11 00:33:34.77896
NCT02113293|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-05-19|||March 2014||2014-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||CyclASol® Phase 1 Study|A Phase 1, Two Period, Double-blind, Randomised, Placebo-controlled, Cross- Over Study Investigating the Safety, Local Tolerability and Systemic Exposure of Cyclosporine A and Placebo (Vehicle) Following Single and Multiple Ocular Doses of CyclASol® and Placebo in Healthy Volunteers (CYS-001).|Completed||Phase 1|18|Actual|Novaliq GmbH||2|||f||||f||||||||||2017-10-11 00:33:34.86224|2017-10-11 00:33:34.86224
NCT02113280|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-04-13|||December 2015||2015-12-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DEMAND||DEMAND - DEgenerative Meniscal Tears - Arthroscopy vs. Dedicated Exercise|Randomised Controlled Trial Comparing Arthroscopy With Physiotherapy for Degenerative Meniscal Tears|Not yet recruiting||N/A|200|Anticipated|Northumbria Healthcare NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:33:34.964194|2017-10-11 00:33:34.964194
NCT02113267|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-05-08|||April 2014||2014-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.|Treatment of Eosinophilic Esophagitis With Mometason Furoat Aerosol: a Randomised, Placebo-controled Phase II Study for Evaluation of Treatment Effect on Group Level Including Symtom Questionnaires|Enrolling by invitation||Phase 2|42|Anticipated|Vastra Gotaland Region||2|||f||||t||||||||||2017-10-11 00:33:35.068538|2017-10-11 00:33:35.068538
NCT02113254|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-10-22|||February 2014||2014-02-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|MAIS||Study of the Macular Pigment by the Consumption of Corn With Strong Content in Zeaxanthine|Study of Modification of the Density of the Macular Pigment by the Consumption of Corn With Strong Content in Zeaxanthine|Completed||N/A|9|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-11 00:33:35.172238|2017-10-11 00:33:35.172238
NCT02113241|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-05-26|||April 2014||2014-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion|Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion|Completed||Phase 4|24|Actual|University of Guadalajara||2|||f||||f||||||||||2017-10-11 00:33:35.254955|2017-10-11 00:33:35.254955
NCT02113228|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-12-02|||March 2013||2013-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Energy Metabolism in Patients With Short Bowel Syndrome|Assessment of Energy Metabolism in Patients With Short Bowel Syndrome Using the Doubly Labeled Water Method|Completed||N/A|22|Actual|University of Sao Paulo|||2||f||||f||||||||||2017-10-11 00:33:35.373664|2017-10-11 00:33:35.373664
NCT02113215|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-05-10|||December 2011||2011-12-01|May 2016|2016-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Very Low Density Lipoprotein Turnover in Young and Elderly Individuals|Very Low Density Lipoprotein Turnover in Young and Elderly Individuals|Terminated||N/A|24|Actual|The University of Texas Medical Branch, Galveston|||4|PI left UTMB|f||||f||||||Samples With DNA|"     Blood samples and muscle biopsies will be collected.   "|||2017-10-11 00:33:35.456084|2017-10-11 00:33:35.456084
NCT02113202|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-01-08|||March 2014||2014-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|FLUOFAP||Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW|Visualization of a VEGF-targeted Near-Infrared Fluorescent Tracer in Patients With Familial Adenomatous Polyposis During Fluorescence Endoscopy A Single Center Pilot Intervention Study|Completed||Phase 1|17|Actual|University Medical Center Groningen||3|||f||||t||||||||||2017-10-11 00:33:35.534294|2017-10-11 00:33:35.534294
NCT02113189|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-05-04|||April 2014||2014-04-01|February 2016|2016-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Impact of Walking Practice on Persons With PD|The Long Term Impact of Walking Practice on Functional Mobility and Quality of Life in Persons With Parkinson's Disease|Terminated||N/A|7|Actual|University of Texas Southwestern Medical Center||3||Inadequate funding to continue the study|f||||f||||||||||2017-10-11 00:33:35.615398|2017-10-11 00:33:35.615398
NCT02113176|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-04-09|||January 2010||2010-01-01|April 2014|2014-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage||Recruiting||Phase 1/Phase 2|80|Anticipated|University at Buffalo||2|||f||||t||||||||||2017-10-11 00:33:35.685726|2017-10-11 00:33:35.685726
NCT02113163|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-10|||March 2014||2014-03-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA|An Open-label, Single and Repeat Single Ascending Dose Escalation Study to Compare the Pharmacokinetics of Metformin Eicosapentaenoate With Metformin Hydrochloride and Icosapent Ethyl Following Oral Administration to Healthy Volunteers|Unknown status|Recruiting|Phase 1|32|Anticipated|Thetis Pharmaceuticals LLC||2|||f||||t||||||||||2017-10-11 00:33:35.771264|2017-10-11 00:33:35.771264
NCT02113150|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2014-04-09|||May 2013||2013-05-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery|A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery|Completed||Phase 4|37|Actual|Turkiye Yuksek Ihtisas Education and Research Hospital||2|||f||||t||||||||||2017-10-11 00:33:35.869417|2017-10-11 00:33:35.869417
NCT02113137|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-11|||September 2013||2013-09-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Oral Hygiene Procedures on Reduction of Oral Malodor|Effects of Various Oral Hygiene Procedures on the Reduction of Oral Malodor in Periodontally Healthy Patients|Completed||Phase 4|30|Actual|Tokyo Medical and Dental University||2|||f||||t||||||||||2017-10-11 00:33:35.956996|2017-10-11 00:33:35.956996
NCT02113124|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-11-17|2015-08-27||December 2013||2013-12-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Association of Amino Acid Prevalence and Chronic Brain Injury|Association of Amino Acid Prevalence and Chronic Brain Injury|Completed||N/A|43|Actual|The Transitional Learning Center, Galveston, TX|No limitations reported||2||f||||f||||||Samples Without DNA|"     Whole blood, oral tissue swab, fecal matter   "|||2017-10-11 00:33:36.05996|2017-10-11 00:33:36.05996
NCT02113111|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-09-03|||April 2014||2014-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Observational|TheraFast||Effects of Fasting on Self Efficacy|The Effects of Therapeutic Fasting on Self Efficacy Measures - a Prospective Observational Trial|Completed||N/A|120|Actual|Universität Duisburg-Essen|||1||f||||f||||||||||2017-10-11 00:33:36.272835|2017-10-11 00:33:36.272835
NCT02113098|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-10|||February 2014||2014-02-01|April 2014|2014-04-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Effects of Treadmill Gait Training With Loading in Individuals With Stroke|Effects of Treadmill Gait Training With Adding Load on Lower Limb of Individuals With Stroke|Unknown status|Recruiting|N/A|40|Anticipated|Universidade Federal do Rio Grande do Norte||2|||f||||t||||||||||2017-10-11 00:33:36.365291|2017-10-11 00:33:36.365291
NCT02113085|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-04-10|||February 2012||2012-02-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||My Life: Evaluation of Self-determination Enhancement for Adolescents in Foster Care|My Life: Evaluation of Self-Determination Enhancement for Adolescents in Foster Care|Unknown status|Recruiting|N/A|186|Anticipated|Portland State University||1|||f||||f||||||||||2017-10-11 00:33:36.466803|2017-10-11 00:33:36.466803
NCT02113072|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-12-03|||April 2014||2014-04-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics.|Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics, a Randomized Clinical Trial, Double-blind, Placebo Controlled.|Completed||Phase 3|60|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 00:33:36.549265|2017-10-11 00:33:36.549265
NCT02113059|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2016-11-04|||November 2012||2012-11-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Observational|||Platelets in Liver Regeneration|"Involvement of Platelets and Platelet Derived Growth Factors in Postoperative Liver Regeneration, Liver Dysfunktion and Morbidity in Patients Undergoing Hepatectomy"|Recruiting||N/A|40|Anticipated|Medical University of Vienna|||1||f||||f||||||Samples With DNA|"     Plasma, serum, platelet and tissue preparation   "|||2017-10-11 00:33:36.649516|2017-10-11 00:33:36.649516
NCT02113046|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-04-09|||October 2009||2009-10-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Pancreatic Stump Closure After Distal Pancreatic Resection|Prospective Randomized Study to Decrease Pancreatic Fistula Rate|Terminated||N/A|47|Actual|Tampere University Hospital||2||interim analysis does not show good results|f||||f||||||||||2017-10-11 00:33:36.730698|2017-10-11 00:33:36.730698
NCT02113033|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-01-06|||October 2014||2014-10-01|January 2017|2017-01-01||||March 2016|Actual|2016-03-01||Interventional|VANGUARD||VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients|VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients|Active, not recruiting||Phase 2|20|Anticipated|LivaNova||1|||f||||t||||||||||2017-10-11 00:33:36.804761|2017-10-11 00:33:36.804761
NCT02113020|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-10-20|||February 2014||2014-02-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects|A Randomized, Double-blind, Single-dose, 4 × 4 Crossover Phase I Study to Examine the Effects of TAK-233 on the Urethral Function in Healthy Female Subjects|Completed||Phase 1|24|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:33:36.879801|2017-10-11 00:33:36.879801
NCT02113007|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-12-14|2016-12-14||July 2014||2014-07-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma|Phase II Study of High-Dose Rituximab Combined With Temozolomide as Treatment for Patients With Primary CNS Lymphoma|Terminated||Phase 2|2|Actual|SCRI Development Innovations, LLC|Two (2) subjects were enrolled in the safety lead-in part of the study. The study closed early due to slow accrual.|1||Closed early due to slow accrual.|f||||f||||||||||2017-10-11 00:33:36.972655|2017-10-11 00:33:36.972655
NCT02112994|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-05-17|||May 2014||2014-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy Study of Sebelipase Alfa in Patients With Lysosomal Acid Lipase Deficiency|A Multicenter, Open-Label Study of Sebelipase Alfa in Patients With Lysosomal Acid Lipase Deficiency|Active, not recruiting||N/A|31|Actual|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-10-11 00:33:37.226136|2017-10-11 00:33:37.226136
NCT02112981|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2015-04-06|||June 2014||2014-06-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|meriT-V||BioMime Vs. Xience Randomised Control Clinical Study|A Prospective, Active Control Open Label, Multicentre Randomized Clinical Trial for Comparison Between BioMime Sirolimus Eluting Stent of and Xience Everolimus Eluting Stent to Evaluate Efficacy and Safety in Coronary Artery Disease|Recruiting||Phase 4|258|Anticipated|Meril Life Sciences Pvt. Ltd.||2|||f||||f||||||||||2017-10-11 00:33:37.365674|2017-10-11 00:33:37.365674
NCT02112968|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-11-19|||December 2014||2014-12-01|November 2014|2014-11-01|May 2017|Anticipated|2017-05-01|February 2016|Anticipated|2016-02-01||Interventional|||A Prospective Safety and Effectiveness Study of a New High Repetition Rate Excimer Laser Using LASIK for the Correction of Ammetropia and Presbyopia||Unknown status|Not yet recruiting|Phase 4|97|Anticipated|Technolas Perfect Vision GmbH||3|||f||||f||||||||||2017-10-11 00:33:37.458793|2017-10-11 00:33:37.458793
NCT02112955|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-11-07|||May 2014||2014-05-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|SESSMP||A Self-efficacy Enhancing Stroke Self-management Program for Community-dwelling Stroke Survivors|A Randomized Controlled Trial of the Effectiveness of a Nurse-led Self-efficacy Enhancing Stroke Self-management Program for Community-dwelling Stroke Survivors|Completed||N/A|128|Actual|Queensland University of Technology||2|||f||||f||||||||No||2017-10-11 00:33:37.541101|2017-10-11 00:33:37.541101
NCT02112942|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-01-25|||March 2014||2014-03-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects|A Phase I Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects|Terminated||Phase 1|48|Actual|Merck Sharp & Dohme Corp.||3||"Early termination of IDX21459 was due to integration of Merck's HCV antiviral pipeline has   resulted in revisions of the clinical development plan."|f||||f||||||||||2017-10-11 00:33:37.642318|2017-10-11 00:33:37.642318
NCT02112929|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-06-02|||April 2012||2012-04-01|June 2016|2016-06-01||||March 2017|Anticipated|2017-03-01||Interventional|||Regional Lung Imaging Using Hyperpolarized Xenon Gas|Regional Lung Imaging and Modelling to Quantify Anatomy, Ventilation and Perfusion Using Hyperpolarized Xenon Gas MR and Thoracic CT Imaging|Recruiting||Phase 1|40|Anticipated|Oxford University Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 00:33:37.726556|2017-10-11 00:33:37.726556
NCT02112903|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-11-12|||April 2014||2014-04-01|November 2014|2014-11-01||||September 2014|Actual|2014-09-01||Interventional|||Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women|Interventional, Randomised, Double-blind 4-way Crossover Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women|Completed||Phase 1|40|Actual|H. Lundbeck A/S||4|||f||||f||||||||||2017-10-11 00:33:39.412756|2017-10-11 00:33:39.412756
NCT02112890|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-01-16|||December 2014||2014-12-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico|Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico|Completed||N/A|2000|Actual|GlaxoSmithKline|||1||f||||||||||Samples With DNA|"     Stored serum samples of the selected subjects obtained from the ENSANUT 2012   "|||2017-10-11 00:33:39.555572|2017-10-11 00:33:39.555572
NCT02112877|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-01-13|||April 2014||2014-04-01|January 2017|2017-01-01|July 2021|Anticipated|2021-07-01|September 2017|Anticipated|2017-09-01||Interventional|VIRTUS||VIRTUS: An Evaluation of the Veniti Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction|VIRTUS-OUS Safety and Efficacy of the Veniti Vici™ Venous Stent System (Veniti, Inc.) When Used to Treat Clinically Significant Chronic Non-malignant Obstruction of the Iliofemoral Venous Segment|Recruiting||N/A|200|Anticipated|Veniti||1|||f||||t||||||||||2017-10-11 00:33:39.659686|2017-10-11 00:33:39.659686
NCT02112864|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-12-19|||May 2014||2014-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Dexamethasone for Reduction of Post Thoracotomy Pain Syndrome|Impact of Dexamethasone on the Post Operative Inflammatory Response and on the Occurrence of Post Thoracotomy Pain Syndrome|Recruiting||N/A|60|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||Yes||2017-10-11 00:33:39.943296|2017-10-11 00:33:39.943296
NCT02112851|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-10-29|||March 2014||2014-03-01|October 2014|2014-10-01||||December 2014|Anticipated|2014-12-01||Interventional|POGR||Processed Orange and the Glycemic Response|A Randomized, Placebo-controlled, Double-blind, Crossover Trial to Investigate the Effects of Acute Processed Whole Orange Consumption on Postprandial Glycemic Responses in Healthy Men|Unknown status|Recruiting|N/A|33|Anticipated|PepsiCo Global R&D||3|||f||||f||||||||||2017-10-11 00:33:40.064992|2017-10-11 00:33:40.064992
NCT02112838|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-08-01|||October 2014||2014-10-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy|A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy|Active, not recruiting||Phase 2|75|Anticipated|Rigel Pharmaceuticals||3|||f||||t||||||||||2017-10-11 00:33:40.157645|2017-10-11 00:33:40.157645
NCT02112825|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-03-03|||July 2013||2013-07-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PACE||Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease|Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease|Completed||N/A|40|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:33:40.269371|2017-10-11 00:33:40.269371
NCT02112812|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-10|||December 2012||2012-12-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease|A Study on Clinical Response Following Eradication Therapy of Helicobacter Pylori Infection in Parkinson's Disease|Completed||N/A|82|Actual|National University of Malaysia||1|||f||||f||||||||||2017-10-11 00:33:40.344409|2017-10-11 00:33:40.344409
NCT02112799|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-03-03|||April 2014||2014-04-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients|A Phase 1 Dose-Ranging Study to Assess the Safety, Pharmacokinetics and Initial Antiviral Efficacy of NVR 3-778 in Healthy Volunteers and Patients With Chronic Hepatitis B|Active, not recruiting||Phase 1|84|Anticipated|Novira Therapeutics, Inc.||4|||f||||t||||||||||2017-10-11 00:33:40.424885|2017-10-11 00:33:40.424885
NCT02112786|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-01-22|||January 2015||2015-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Neuromodulation Implantation Settings Variation for Overactive Bladder|Intermittent Versus Continuous Stimulation in Bilateral Sacral Neuromodulation for Overactive Bladder|Withdrawn||N/A|0|Actual|Loma Linda University||2|||f||||t||||||||||2017-10-11 00:33:40.507387|2017-10-11 00:33:40.507387
NCT02112773|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-10-19|||February 2015||2015-02-01|April 2014|2014-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||ADenoVirus Initiative Study in Epidemiology in UK|Epidemiological, Prospective, Multicentric, Open Study To Assess The Characteristics And Frequency Of Adenoviral Conjunctivitis As Diagnosed With The Point Of Care AdenoPlus® Test In Patients Suffering From Acute Conjunctivitis|Completed||N/A|31|Actual|NicOx|||1||f||||f||||||||||2017-10-11 00:33:40.593048|2017-10-11 00:33:40.593048
NCT02112760|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2014-04-10|||June 2011||2011-06-01|April 2014|2014-04-01||||December 2012|Actual|2012-12-01||Interventional|||Specific Stabilization Exercise With Ultrasound Feedback For Patient With Recurrent Low Back Pain|Specific Stabilization Exercise With Ultrasound Feedback For Patient With Recurrent Low Back Pain|Completed||N/A|72|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 00:33:40.660033|2017-10-11 00:33:40.660033
NCT02112747|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-09-13|||September 2013||2013-09-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Adherence to Colon Cancer Screening (ACCS)|Ohio Colorectal Cancer Prevention Initiative: Adherence to Colon Cancer Screening (ACCS) Project:Your Personal Prescription For Colorectal Cancer Screening.|Active, not recruiting||N/A|1900|Actual|Ohio State University Comprehensive Cancer Center||4|||f||||t||||||||||2017-10-11 00:33:40.728001|2017-10-11 00:33:40.728001
NCT02112734|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-08-12|||December 2014||2014-12-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|VITALITY||Can Vitamin D Supplementation in Infants Prevent Food Allergy in the First Year of Life? The VITALITY Trial|Can Vitamin D Supplementation in Infants Prevent Food Allergy in the First Year of Life? The VITALITY Trial.|Recruiting||Phase 4|3012|Anticipated|Murdoch Childrens Research Institute||2|||f||||t||||||||||2017-10-11 00:33:40.893601|2017-10-11 00:33:40.893601
NCT02112721|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-12-06|||May 2014||2014-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Can Vitamin D Supplementation Prevent Type 2 Diabetes?|Can Vitamin D Supplementation Prevent Type 2 Diabetes by Improving Insulin Sensitivity and Secretion in Overweight Humans?|Completed||Phase 4|55|Actual|Monash University||2|||f||||f||||||||||2017-10-11 00:33:40.97501|2017-10-11 00:33:40.97501
NCT02112708|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-11|||October 2009||2009-10-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Cognitive Behavioral Therapy (REBT/CBT) Evaluation for Dysthymia in the Practice of Clinical Social Work at Primary Care|Evaluation of the Effectiveness of Rational Emotive Behavioral Therapy (REBT/CBT) as an Intervention Tool in Clinical Social Work Consultation to Primary Care.|Completed||N/A|129|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 00:33:41.078933|2017-10-11 00:33:41.078933
NCT02112695|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-04-27|||September 15, 2014|Actual|2014-09-15|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|September 30, 2017|Anticipated|2017-09-30||Interventional|||Opioid System Cerebral Activity in Endurance Sportswomen - Addiction or Denutrition ? [11C]Diprenorphine PET Study|Opioid System Cerebral Activity in Endurance Sportswomen - Addiction or Denutrition ? [11C]Diprenorphine PET Study|Recruiting||N/A|45|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f|f|f||||||No||2017-10-11 00:33:41.167498|2017-10-11 00:33:41.167498
NCT02112682|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-04-20|||June 2014||2014-06-01|March 2017|2017-03-01|June 2027|Anticipated|2027-06-01|June 2027|Anticipated|2027-06-01||Interventional|||Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy|The Value of Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy. A Dutch Randomized Controlled Multicentre Trial.|Recruiting||N/A|878|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:33:41.280409|2017-10-11 00:33:41.280409
NCT02112669|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-08-01|||April 2014||2014-04-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||A Multi Center, Study to Evaluate the Safety and Efficacy of the VasQ External Support Device for Arteriovenous Fistulas|A Prospective, Multi Center, Study to Evaluate the Safety and Efficacy of the VasQ External Support Device for Brachiocephalic Arteriovenous Fistula|Active, not recruiting||N/A|60|Actual|Laminate Medical Technologies||2|||f||||||||||||||2017-10-11 00:33:41.431558|2017-10-11 00:33:41.431558
NCT02112656|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-06-21|||June 2014||2014-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|OPTIMA||Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)|A Phase III, Randomized, Double Blind, Dummy-Controlled Study of ThermoDox® (Lyso-Thermosensitive Liposomal Doxorubicin-LTLD) in Hepatocellular Carcinoma (HCC) Using Standardized Radiofrequency Ablation (RFA) Treatment Time ≥ 45 Minutes for Solitary Lesions ≥ 3 cm to ≤ 7 cm|Recruiting||Phase 3|550|Anticipated|Celsion||2|||f||||t||||||||||2017-10-11 00:33:41.51586|2017-10-11 00:33:41.51586
NCT02112643|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-08-02|||June 2014||2014-06-01|August 2014|2014-08-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|S-ITEDS||Selenium in Mild Thyroid Eye Disease in North America|Selenium - ITEDS: A North American Study|Unknown status|Recruiting|N/A|151|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-11 00:33:43.504133|2017-10-11 00:33:43.504133
NCT02112630|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-09-21|||May 2013||2013-05-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Boceprevir in End Stage Renal Disease (ESRD)|Prospective, Single-Center, Open Label, Pilot Study of Safety and Efficacy of Triple Anti-Viral Therapy With Pegylated Interferon, Ribavirin, and Boceprevir in Patients With Genotype 1 Chronic HCV With End Stage Renal Disease|Withdrawn||N/A|0|Actual|Columbia University||2||Poor enrollment|f||||f||||||||||2017-10-11 00:33:43.670828|2017-10-11 00:33:43.670828
NCT02112617|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-04-14|||June 2014||2014-06-01|April 2017|2017-04-01|March 2028|Anticipated|2028-03-01|March 2024|Anticipated|2024-03-01||Interventional|||Phase II Study of Proton Radiation Therapy for Neuroblastoma|Phase II Study of Proton Radiation Therapy for Neuroblastoma|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 00:33:43.786922|2017-10-11 00:33:43.786922
NCT02112604|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-03-16|||July 2011||2011-07-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Predictors of Upper Airway Function and Sleep-disordered Breathing in the Critically Ill|Determining Predictors of Adequate Upper Airway Function in Ventilated Patients|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 00:33:43.88759|2017-10-11 00:33:43.88759
NCT02112591|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|November 2016|Anticipated|2016-11-01||Interventional|S-TOTvsTOT||Transobturator Subtrigonal Tape vs Transobturator Suburethral Tape for Stress Urinary Incontinence|Efficacy and Safety of Transobturator Subtrigonal Tape vs Transobturator Tension-free Suburethral Tape for the Correction of Stress Urinary Incontinence|Recruiting||Phase 3|68|Anticipated|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||||2017-10-11 00:33:43.988982|2017-10-11 00:33:43.988982
NCT02112578|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin|" National, Phase III, Radomized, Double-Blind, Double -Dummy, Controlled, Parallel to Evaluate Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) Soft Gel Capsules in the Control of Acute Vertigo Symphtoms From Peripheral Origin"|Recruiting||Phase 3|292|Anticipated|Apsen Farmaceutica S.A.||2|||f||||f||||||||No||2017-10-11 00:33:44.094342|2017-10-11 00:33:44.094342
NCT02112565|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-09-08|||June 13, 2016|Actual|2016-06-13|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists|A Phase I, Dose-Escalation, Safety and Tolerability Study of COH29 in Patients With Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy Exists|Recruiting||Phase 1|27|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:33:44.240819|2017-10-11 00:33:44.240819
NCT02112552|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2015-02-10|||May 2013||2013-05-01|February 2015|2015-02-01||||June 2016|Anticipated|2016-06-01||Interventional|||Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer|A Pilot Phase II Trial of Intravenous Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation in Patients With Advanced Stage Uterine Serous Carcinoma|Unknown status|Recruiting|Phase 2|17|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 00:33:44.357993|2017-10-11 00:33:44.357993
NCT02112539|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2017-04-02|||March 2014||2014-03-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Aggreguide A-100 ADP Assay Evaluation|Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Effect of ADP Blocking Drugs on Platelet Aggregation on the AggreGuide A-100 Instrument|Completed||N/A|150|Actual|Aggredyne, Inc.|||1||f||||f||||||||No||2017-10-11 00:33:44.66128|2017-10-11 00:33:44.66128
NCT02112526|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-10|2016-02-24|||July 2014||2014-07-01|November 2015|2015-11-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||ACP-196, a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma|An Open-label, Phase 1b Study of ACP 196 in Subjects With Relapsed or Refractory de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma|Active, not recruiting||Phase 1|20|Anticipated|Acerta Pharma BV||1|||f||||f||||||||||2017-10-11 00:33:44.761603|2017-10-11 00:33:44.761603
NCT02112513|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-08-21|||November 2012||2012-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|November 8, 2016|Actual|2016-11-08||Observational|||The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome|The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome|Active, not recruiting||N/A|160|Actual|Indiana University|||4||f||||t||||||Samples With DNA|"     We will obtain serum and saliva for estriol measurement before or within 2 hours of antenatal     corticosteroid administration and about 24 hours after each dose is given.      Women who consent to an optional PK portion of the study will have plasma samples obtained     pre-dose and then on a schedule of approximately 0.5-2, 4-8, 10-15, 22-24 hours after the     first dose and then 6-8, 24, and 48 hours after the 2nd dose. One sample will be collected in     each of these times.      A sample of whole blood will be obtained for DNA isolation. At the time of delivery,     umbilical cord blood will be collected before being discarded for DNA and plasma. If we are     unable to obtain umbilical cord blood, a buccal swab will be collected from the baby for DNA     extraction.   "|||2017-10-11 00:33:44.894757|2017-10-11 00:33:44.894757
NCT02112500|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2016-01-08|||February 2014||2014-02-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|STELLAR||Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure|A Pilot Study for the Efficacy and Safety of Mesenchymal Stem Cell in Acute Severe Respiratory Failure.|Recruiting||Phase 2|10|Anticipated|Asan Medical Center||1|||f||||t||||||||||2017-10-11 00:33:44.991047|2017-10-11 00:33:44.991047
NCT02112487|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-04-12|||June 1, 2014||2014-06-01|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH|An Extension of AC-055-310, a Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the French, Italian and Spanish Versions of the PAH-SYMPACT™|Active, not recruiting||Phase 3|160|Anticipated|Actelion||1|||f||||f||||||||||2017-10-11 00:33:45.757592|2017-10-11 00:33:45.757592
NCT02112474|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-06-30|||November 2014||2014-11-01|June 2015|2015-06-01|November 2016|Anticipated|2016-11-01|June 2016|Anticipated|2016-06-01||Interventional|||The Pain Suppressive Effect of Alternative Spinal Cord Stimulation Frequencies|The Pain Suppressive Effect of Low Frequency Spinal Cord Stimulation Versus High Frequency Spinal Cord Stimulation|Unknown status|Recruiting|N/A|30|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:33:45.956157|2017-10-11 00:33:45.956157
NCT02112461|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-05-15|||May 2010||2010-05-01|February 2017|2017-02-01|April 2017|Actual|2017-04-01|March 2016|Actual|2016-03-01||Interventional|SCP||Hospice and End-of-life Symptom Monitoring & Support Using an Automated System Designed for Family Caregivers|Enhancing End-of-Life and Bereavement Outcomes Among Cancer Caregivers: Symptom Care by Phone for Hospice Caregiver Support and Cancer Symptom Relief|Completed||N/A|365|Actual|University of Utah||2|||f||||t||||||||No||2017-10-11 00:33:46.096444|2017-10-11 00:33:46.096444
NCT02112448|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-04-28|2017-01-19||June 2014||2014-06-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery|Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery|Completed||N/A|78|Actual|Advocate Health Care||2|||f||||t||||||||No||2017-10-11 00:33:46.181818|2017-10-11 00:33:46.181818
NCT02112435|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-05-01|||August 2014||2014-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SOMNYX||Comparative Efficacy Study of Titratable Versus Active Mandibular Advancement Splint in Sleep Apnea|Comparative Study of Efficacy of Titratable Mandibular Advancement Splint Versus Active Mandibular Advancement Splint to Treat Patients With Obstructive Sleep Apnea|Recruiting||N/A|100|Anticipated|Université de Montréal||2|||f||||f||||||||||2017-10-11 00:33:46.501752|2017-10-11 00:33:46.501752
NCT02112422|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-04-29|||April 2014||2014-04-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Role of Timing of Dexamethasone Administration on Pain Scores and Quality of Recovery in Cesarean Section.|The Role of Timing of Dexamethasone Administration on Pain Scores and Quality of Recovery in Cesarean Section.|Completed||N/A|40|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:33:46.634332|2017-10-11 00:33:46.634332
NCT02112409|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2015-06-03|||February 2014||2014-02-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Intraoperative Cell Salvage and Hemodilution Technique in Scoliosis Surgery|Autologous Blood Transfusion Technique in Idiopathic Scoliosis Surgery - a Comparison Between Intraoperative Cell Salvage With Hemodilution Techniques Versus Cell Salvage Technique Alone|Completed||N/A|44|Actual|University of Malaya||2|||f||||t||||||||||2017-10-11 00:33:46.727141|2017-10-11 00:33:46.727141
NCT02112396|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-04-09|||August 2008||2008-08-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|CRAFT||Community Reinforcement and Family Training (CRAFT) for Treatment-resistant Individuals With Alcohol Use Disorders|Psychosocial Intervention for Relatives of Individuals Suffering From Chronic Alcohol Dependence|Completed||N/A|89|Actual|University of Luebeck||2|||f||||f||||||||||2017-10-11 00:33:46.814873|2017-10-11 00:33:46.814873
NCT02112383|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2017-03-05|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Group Versus Internet-based Cognitive Behavior Therapy for Procrastination|Group Versus Internet-based Cognitive Behavior Therapy for Procrastination|Completed||N/A|90|Actual|Stockholm University||2|||f||||||||||||Undecided||2017-10-11 00:33:46.898396|2017-10-11 00:33:46.898396
NCT02112370|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-04-25|2016-06-07||May 2014||2014-05-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|REBT|All patients referred for BABA robotic or endoscopic thyroidectomy at Seoul National University Bundang Hospital|Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy|Phase 3 Study of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy|Completed||Phase 3|148|Actual|Seoul National University Hospital|"Single-institution study
We did not directly examine the vasoconstrictive properties of epinephrine in helping reduce bleeding.
Issue regarding importance of statistical vs. clinical significance of the pain score remains to be addressed"|2|||f||||t||||||||Undecided||2017-10-11 00:33:47.018221|2017-10-11 00:33:47.018221
NCT02112357|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-16|||February 2014||2014-02-01|April 2014|2014-04-01||||August 2015|Anticipated|2015-08-01||Observational|FOrMAT||Feasibility of a Molecular Characterisation Approach to Treatment|FOrMAT - Feasibility of a Molecular Characterisation Approach to Treatment|Unknown status|Recruiting|N/A|200|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Both fresh frozen tissue and formalin-fixed paraffin-embedded (FFPE) tumour samples will be     obtained.      Biopsies may be taken at entry to the study and/or at the time of radiological response     assessment. Each patient can have a maximum of 3 research biopsies in this study.      Up to 35 ml of blood will be collected at study entry to provide normal germline DNA and for     possible additional biomarker analysis. If the patient has consented to optional blood sample     collection, then additional blood samples will also be collected at the time of radiological     response assessment to study molecular changes that occur during treatment.   "|||2017-10-11 00:33:47.717201|2017-10-11 00:33:47.717201
NCT02112344|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-04-09|||July 2007||2007-07-01|April 2014|2014-04-01|July 2015|Anticipated|2015-07-01|September 2010|Actual|2010-09-01||Interventional|||A Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and Neck|A Phase I Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and Neck|Unknown status|Active, not recruiting|Phase 1/Phase 2|19|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 00:33:47.820756|2017-10-11 00:33:47.820756
NCT02112331|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-04-25|||April 2014||2014-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|August 2015|Actual|2015-08-01||Interventional|ARCHILACT||Influence of Physical Treatments of Human Milk on the Kinetics of Gastric Lipolysis in Preterm Newborns|Influence of Physical Treatments of Human Milk on the Kinetics of Gastric Lipolysis in Preterm Newborns|Completed||N/A|20|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 00:33:47.913789|2017-10-11 00:33:47.913789
NCT02112318|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-04-09|||January 2011||2011-01-01|March 2014|2014-03-01|May 2015|Anticipated|2015-05-01|December 2014|Anticipated|2014-12-01||Observational|CASAF||CArdioversion of Short Duration Atrial Fibrillation|Study of ECG-derived Atrial Fibrillatory Rate for Prediction of the Outcome of Cardioversion of Short Duration Atrial Fibrillation|Unknown status|Recruiting|N/A|100|Anticipated|Region Skane|||1||f||||||||||||||2017-10-11 00:33:48.023336|2017-10-11 00:33:48.023336
NCT02112305|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-11-15|||January 2014||2014-01-01|November 2014|2014-11-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Compare Efficacy Nebulized and Intravenous Magnesium Sulphate in Thai Children|Comparison Efficacy of Nebulized Magnesium Sulphate to Intravenous Magnesium Sulphate in Children With Severe Acute Asthma|Unknown status|Active, not recruiting|N/A|40|Anticipated|Queen Sirikit National Institute of Child Health||2|||f||||f||||||||||2017-10-11 00:33:48.119388|2017-10-11 00:33:48.119388
NCT02112292|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-05-22|||April 2014||2014-04-01|May 2017|2017-05-01|April 16, 2015|Actual|2015-04-16|April 16, 2015|Actual|2015-04-16||Interventional|Sweed||The Role of the Endocannabinoid System in Sweet Taste Intensity and Liking|The Role of the Endocannabinoid System in Sweet Taste Intensity and Liking|Completed||N/A|10|Actual|Wageningen University||6|||f||||f||||||||||2017-10-11 00:33:48.224306|2017-10-11 00:33:48.224306
NCT02112279|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-01-07|||April 2014||2014-04-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|FMT||Reduction of C-Difficile Infection Using Stool Transplant|Reduction of C-Difficile Infection Using Fecal Microbiota Transplant|Unknown status|Recruiting|Phase 1|10|Anticipated|Providence Holy Cross Medical Center||1|||f||||f||||||||||2017-10-11 00:33:48.346485|2017-10-11 00:33:48.346485
NCT02112058|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-04-09|||February 2007||2007-02-01|April 2014|2014-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|SHM||The Supporting Healthy Marriage Evaluation|The Supporting Healthy Marriage Evaluation|Completed||N/A|6298|Actual|MDRC||2|||f||||||||||||||2017-10-11 00:33:50.860146|2017-10-11 00:33:50.860146
NCT02112266|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-05-09|||April 2014||2014-04-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Depression Online Assessment and Therapy|Online Assessment for Therapy Expectation and Quality of Life and Online Therapy of Depression|Completed||N/A|272|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 00:33:48.444127|2017-10-11 00:33:48.444127
NCT02112253|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2014-12-30|||March 2013||2013-03-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome|Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome - A Pilot Study|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|The University of Western Australia||5|||f||||t||||||||||2017-10-11 00:33:48.58593|2017-10-11 00:33:48.58593
NCT02112240|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-07-14|||May 2013||2013-05-01|July 2016|2016-07-01||||February 2017|Anticipated|2017-02-01||Interventional|||Feasibility Study to Develop Sentinel Lymph Node Mapping in Rectal Cancer Patients|Novel Sentinel Lymph Node Mapping Technique in Early Stage Rectal Cancer|Withdrawn||N/A|0|Actual|University of Virginia||1||No accrual. New study opening with modified technique.|f||||t||||||||||2017-10-11 00:33:48.781755|2017-10-11 00:33:48.781755
NCT02112227|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-09-21|||March 2015||2015-03-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|PACT-HF||Patient-centered Care Transitions in Heart Failure: A Pragmatic Cluster Randomized Trial|Patient-centered Care Transitions in Heart Failure: A Pragmatic Cluster|Unknown status|Recruiting|N/A|4000|Anticipated|Population Health Research Institute||2|||f||||f||||||||||2017-10-11 00:33:48.911882|2017-10-11 00:33:48.911882
NCT02112214|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-02-20|||June 2014|Actual|2014-06-01|February 2017|2017-02-01|December 2027|Anticipated|2027-12-01|December 2027|Anticipated|2027-12-01||Interventional|HELPER||Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population|Effect of Helicobacter Pylori Eradication on Gastric Cancer Prevention in Korea: a Randomized Controlled Clinical Trial|Recruiting||Phase 3|11000|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 00:33:49.018095|2017-10-11 00:33:49.018095
NCT02112201|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-05-11|||September 2013||2013-09-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||The ProGirls Study|Preventing HIV/STI Risk Behavior in Girls With Delinquency, Drug Abuse, & Trauma|Recruiting||N/A|400|Anticipated|Oregon Research Institute||2|||f||||f||||||||||2017-10-11 00:33:49.184022|2017-10-11 00:33:49.184022
NCT02112188|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-03-09|||April 2014|Actual|2014-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Adaptation of Individual Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients|Adaptation of Individual Meaning-Centered Psychotherapy for Chinese|Active, not recruiting||N/A|12|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 00:33:49.292064|2017-10-11 00:33:49.292064
NCT02112175|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-10-27|||April 2014||2014-04-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|December 2017|Anticipated|2017-12-01||Interventional|ARUMM||Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM|Phase 3B, Randomized Trail of Revlimid® (Lenalidomide) Versus Placebo Maintenance Therapy Following Melphalan Prednisone Velcade (Bortezomib) Induction Therapy In Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 3|46|Actual|Celgene Corporation||2|||f||||t||||||||||2017-10-11 00:33:49.415521|2017-10-11 00:33:49.415521
NCT02112162|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-12-07|||June 2014||2014-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2015|Actual|2015-03-01||Interventional|||Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery|Pilot Study of Gene Expression and FDG-PET/MR Biomarkers for Evaluation of Response to Neoadjuvant Therapy for Locally Advanced Rectal Cancer|Terminated||Phase 1|2|Actual|Washington University School of Medicine||1||Loss of funding|f||||f||||||||||2017-10-11 00:33:49.650264|2017-10-11 00:33:49.650264
NCT02112149|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-07-11|||February 2013||2013-02-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors|Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors|Completed||Phase 3|200|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 00:33:49.724376|2017-10-11 00:33:49.724376
NCT02112136|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-08-17|||December 2014||2014-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GeneQuest||Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD|Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in Autosomal Dominant Polycystic Kidney Disease (ADPKD): The GeneQuest Study|Recruiting||N/A|1450|Anticipated|University Hospital, Brest||1|||f||||t||||||||||2017-10-11 00:33:49.800635|2017-10-11 00:33:49.800635
NCT02112123|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-08-15|||April 2014||2014-04-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Icariin to Prevent Corticosteroid-related Memory Changes|Icariin to Prevent Corticosteroid-related Memory Changes|Completed||Phase 1|24|Actual|University of Texas Southwestern Medical Center||6|||f||||t||||||||||2017-10-11 00:33:50.147521|2017-10-11 00:33:50.147521
NCT02112110|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-06-25|||April 2014||2014-04-01|April 2014|2014-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Absolute Bioavailability of BMS-791325|Study of the Absolute Oral Bioavailability of BMS-791325 in Healthy Subjects|Completed||Phase 1|8|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:33:50.262167|2017-10-11 00:33:50.262167
NCT02112097|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-06-22|||January 2016||2016-01-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|ASISinPP||ASIS for Enbrel in Plaque Psoriasis|ASIS for Enbrel in Plaque Psoriasis|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|ASIS Corporation||13|||f||||t||||||||||2017-10-11 00:33:50.395445|2017-10-11 00:33:50.395445
NCT02112084|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-05-15|||May 2010||2010-05-01|February 2017|2017-02-01|April 30, 2017|Actual|2017-04-30|March 2016|Actual|2016-03-01||Interventional|DPM||An Individualized Grief Intervention for Spouses of Cancer Patients After the Patient's Death|Enhancing End-of-Life and Bereavement Outcomes Among Cancer Caregivers: Individualized Dual Process Intervention for Bereaved Partners After Cancer Death|Completed||N/A|237|Actual|University of Utah||2|||f||||t||||||||No||2017-10-11 00:33:50.637033|2017-10-11 00:33:50.637033
NCT02112071|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-07-23|||October 2009||2009-10-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Interventional|DKD-EXT||Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.|Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.|Completed||N/A|122|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:33:50.73711|2017-10-11 00:33:50.73711
NCT02112045|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-08-18|||January 20, 2015|Actual|2015-01-20|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|April 15, 2018|Anticipated|2018-04-15||Interventional|||A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation|A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation|Recruiting||Phase 2|176|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||||2017-10-11 00:33:51.029493|2017-10-11 00:33:51.029493
NCT02112032|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-08-17|||August 2014||2014-08-01|August 2017|2017-08-01|December 2023|Anticipated|2023-12-01|April 2017|Actual|2017-04-01||Interventional|||Treatment of Advanced Melanoma With MK-3475 and Peginterferon|Phase 1 Study of Anti-PD-1 Antibody MK-3475 and Peginterferon Alfa-2b for Advanced Melanoma|Active, not recruiting||Phase 1|32|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 00:33:51.171069|2017-10-11 00:33:51.171069
NCT02112019|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-05-09|||June 2014|Actual|2014-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome|Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome; A Randomised Controlled Pilot Study|Active, not recruiting||N/A|50|Actual|VU University Medical Center||3|||f||||t||||||||||2017-10-11 00:33:51.334142|2017-10-11 00:33:51.334142
NCT02112006|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-03-21|||April 2014||2014-04-01|October 2015|2015-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparing Two Injection Sites of Local Anesthetic for Hand Surgery|A Comparison Of Distal Peripheral Nerve Blockade Versus Traditional Proximal Approaches For Hand Surgery|Completed||N/A|60|Actual|Ochsner Health System||2|||f||||f||||||||||2017-10-11 00:33:51.439884|2017-10-11 00:33:51.439884
NCT02111967|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-08-12|||March 2014||2014-03-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin|Adequacy of Serum Vitamin B12 Measurement in Type 2 Diabetic Patients Treated With Metformin in Comparison to Holotranscobalamin Measurement|Completed||N/A|50|Actual|University Hospital, Basel, Switzerland|||2||f||||t||||||None Retained|"     All blood samples investigated in this study will be destroyed one week after withdrawal. All     patient information obtained as a result of the study will be regarded as confidential and     made anonymous using a unique study ID number instead of name and surname of the patient.   "|||2017-10-11 00:33:51.777131|2017-10-11 00:33:51.777131
NCT02111954|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-05-20|||April 2014||2014-04-01|May 2017|2017-05-01|October 28, 2016|Actual|2016-10-28|October 28, 2016|Actual|2016-10-28||Observational|||Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients|PET/CT Study of GRP Receptors With Ga-68-NODAGA-MJ9 in Prostate Cancer Compared to F-18-FCH PET / CT|Completed||N/A|60|Actual|University of Lausanne Hospitals|||1||f||||f||||||||No||2017-10-11 00:33:51.870518|2017-10-11 00:33:51.870518
NCT02111928|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-10-05|||December 2013||2013-12-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||NovaTears® Eye Drops Observational Study|NovaTears® Observational Study|Completed||N/A|30|Actual|Novaliq GmbH|||1||f||||f||||||||||2017-10-11 00:33:52.065453|2017-10-11 00:33:52.065453
NCT02111915|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-09-17|||October 2014||2014-10-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|THPP-P||Thinking Healthy Program - Peer Delivered (Pakistan)|Thinking Healthy Program - Peer Delivered in Pakistan|Unknown status|Recruiting|Phase 2/Phase 3|560|Anticipated|University of Liverpool||2|||f||||t||||||||||2017-10-11 00:33:52.147954|2017-10-11 00:33:52.147954
NCT02111902|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-08-28|||September 2011|Anticipated|2011-09-01|August 2017|2017-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|VIDA||Vitamin D Ancillary Study in 5 Populations of African Origin|Determinants and Consequences of Low Vitamin D in Populations of African Descent|Withdrawn||N/A|0|Actual|Loyola University|||1|"At the direction of our IRB, this project was incorporated into an existing study, LU#200038,   NCT#02925156"|f||||f||||||Samples With DNA|"     Blood Serum Urine   "|||2017-10-11 00:33:52.258958|2017-10-11 00:33:52.258958
NCT02111889|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-04-06|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|December 2015|Actual|2015-12-01||Interventional|PIKTURE||Tumor Kinase Inhibitor Concentrations Measured by PET|Measurement of Tumor Kinase Inhibitor Concentrations Using PET Imaging in Patients With Advanced Solid Malignancies|Completed||N/A|8|Actual|VU University Medical Center||1|||f||||t||||||||||2017-10-11 00:33:52.353139|2017-10-11 00:33:52.353139
NCT02111876|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-04-09|||September 2012||2012-09-01|April 2014|2014-04-01||||July 2014|Anticipated|2014-07-01||Observational|||Systematic Follow-up of Patients Surviving an Episode of Acute Hypercapnic Respiratory Failure in the ICU|Systematic Follow-up of Patients Surviving an Episode of Acute Hypercapnic Respiratory Failure in the ICU|Unknown status|Recruiting|N/A|60|Anticipated|Ligue Pulmonaire Genevoise|||1||f||||f||||||||||2017-10-11 00:33:52.441363|2017-10-11 00:33:52.441363
NCT02111486|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-10-17|||October 2015||2015-10-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Certain Breakfasts on Appetite Control|A Randomized, Controlled, Cross-over Study of the Effect of Certain Breakfasts on Appetite Control.|Withdrawn||N/A|0|Actual|St. Boniface General Hospital Research Centre||3||Funding withdrawn|f||||f||||||||||2017-10-11 00:34:03.355035|2017-10-11 00:34:03.355035
NCT02111863|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-08-21|2017-07-21||February 21, 2014|Actual|2014-02-21|August 2017|2017-08-01|July 21, 2016|Actual|2016-07-21|July 21, 2016|Actual|2016-07-21||Interventional|||Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma|A Phase II Study of Cell Transfer Therapy for Metastatic Melanoma Using 41BB Selected Tumor Infiltrating Lymphocytes Plus IL-2 Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1||Study terminated due to low accrual and change in research focus.|f||||t|t|f||||||||2017-10-11 00:33:52.529654|2017-10-11 00:33:52.529654
NCT02111837|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-09|||November 2009||2009-11-01|April 2014|2014-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Specific Lipid Fractions-enriched Infant Formulae|Multicenter, Randomized, Double-blind, Parallel-group, Reference-controlled, Safety Pilot Study to Evaluate the Effects of Specific Lipid Fractions-enriched Infant Formulae in Infants Aged 0-4 Months|Completed||N/A|199|Actual|Nestlé||3|||f||||f||||||||||2017-10-11 00:33:52.886686|2017-10-11 00:33:52.886686
NCT02111824|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-09-28|||November 2014||2014-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|MIMIG||A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy|A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy|Recruiting||Phase 1|36|Anticipated|The Methodist Hospital System||3|||f||||t|f|t|t|f||||||2017-10-11 00:33:52.958879|2017-10-11 00:33:52.958879
NCT02111811|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-05-30|||May 19, 2014|Actual|2014-05-19|May 2017|2017-05-01|November 30, 2017|Anticipated|2017-11-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Reducing the Burden of Depression Related Disability|Reducing the Burden of Depression on Employment: Improving Function and Work|Active, not recruiting||N/A|250|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 00:33:53.071265|2017-10-11 00:33:53.071265
NCT02111798|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-09-07|||July 2014||2014-07-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence|Bupropion-Enhanced CM for Cocaine Dependence|Recruiting||Phase 2/Phase 3|200|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:33:53.158067|2017-10-11 00:33:53.158067
NCT02111785|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-10-25|||March 2014||2014-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|DECS||Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma|The DECS Trial: DExamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma|Recruiting||Phase 2/Phase 3|300|Anticipated|University of Virginia||4|||f||||t||||||||||2017-10-11 00:33:53.255795|2017-10-11 00:33:53.255795
NCT02111772|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-08|||September 2013||2013-09-01|April 2014|2014-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluating the Asthmatic Response to an Experimental Infection With Rhinovirus in the Atopic|Evaluating the Asthmatic Response to an Experimental Infection With Rhinovirus in the Atopic Host|Recruiting||N/A|24|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-11 00:33:53.365118|2017-10-11 00:33:53.365118
NCT02111759|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-11-09|||May 2014||2014-05-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|FIRM||The Effect of Knee Flexion Angle for Graft Fixation During Single-Bundle Anterior Cruciate Ligament Reconstruction|The Effect of Knee Flexion Angle for Graft Fixation During Single-Bundle Anterior Cruciate Ligament Reconstruction - A Multicentre, Patient and Assessor Blinded, Stratified, Two-arm Parallel Group Superiority Trial|Active, not recruiting||N/A|204|Actual|University of Toronto Orthopaedic Sports Medicine||2|||f||||f||||||||||2017-10-11 00:33:53.563395|2017-10-11 00:33:53.563395
NCT02111746|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-10-20|||November 2013||2013-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PAIN||PAIN - Postoperative Analgesia INvestigation|A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control|Recruiting||Phase 4|280|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Yes|De-identified data will be made available following IRB approval|2017-10-11 00:33:53.647569|2017-10-11 00:33:53.647569
NCT02111733|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-04-08|||June 2013||2013-06-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|TnT-HD||Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value?|Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value?|Completed||N/A|43|Actual|Université de Sherbrooke||1|||f||||f||||||||||2017-10-11 00:33:53.752687|2017-10-11 00:33:53.752687
NCT02111720|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-06-16|||July 2013||2013-07-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|D2F||Disclosure to Family|Maybe, Maybe Not: Deciding to Disclose HIV Status to Family|Recruiting||N/A|450|Anticipated|University of South Florida||2|||f||||t||||||||||2017-10-11 00:33:53.833343|2017-10-11 00:33:53.833343
NCT02111707|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-09-14|||April 2014||2014-04-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)|Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)|Recruiting||Phase 4|534|Anticipated|University of Alberta||2|||f||||||||||||||2017-10-11 00:33:53.944196|2017-10-11 00:33:53.944196
NCT02111694|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-10-28|||June 2013||2013-06-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|OBS||Influence of Bottle-Type on Infant Feeding Behaviors|Influence of Bottle-Type on Infant Feeding Behaviors|Completed||N/A|29|Actual|Drexel University||1|||f||||f||||||||||2017-10-11 00:33:54.044611|2017-10-11 00:33:54.044611
NCT02111681|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-05-16|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer|Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:33:54.121323|2017-10-11 00:33:54.121323
NCT02111668|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-05-13|||February 2013||2013-02-01|February 2013|2013-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01|1 Day|Observational [Patient Registry]|||Thoracic Aortic Dilatation Syndromes|Thoracic Aortic Dilatation Syndromes - Diagnostic, Incidences, Morbidity, Mortality and Socioeconomical Observations.|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Biobank with plasma, serum and Whole blood.   "|||2017-10-11 00:33:54.225316|2017-10-11 00:33:54.225316
NCT02111655|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-06-17|||September 1, 2012||2012-09-01|June 2017|2017-06-01|September 29, 2015|Actual|2015-09-29|September 29, 2015|Actual|2015-09-29||Interventional|METTRO||Improving Arteriovenous Fistula Patency|Second Generation Surveillance Techniques to Prevent Thrombosis and Increase Assisted Primary Patency in Native Arteriovenous Fistula. A Prospective Controlled Trial.|Completed||N/A|212|Actual|Hospital Infanta Sofia||2|||f||||t||||||||No||2017-10-11 00:33:54.329194|2017-10-11 00:33:54.329194
NCT02111642|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-04-10|||June 2014||2014-06-01|April 2015|2015-04-01||||June 2015|Anticipated|2015-06-01||Interventional|||Effect of a Risk Calculator on Patient Satisfaction With the Decision for Midurethral Sling During Prolapse Surgery|Effect of a New Risk Calculator on Patient Satisfaction With the Decision for Concomitant Midurethral Sling During Prolapse Surgery|Unknown status|Active, not recruiting|N/A|42|Actual|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-11 00:33:54.452195|2017-10-11 00:33:54.452195
NCT02111629|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-10|||May 2012||2012-05-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge|Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge. Bogotá D. C. Colombia.|Completed||Phase 3|118|Actual|Universidad Nacional de Colombia||1|||f||||t||||||||||2017-10-11 00:33:54.540315|2017-10-11 00:33:54.540315
NCT02111616|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-01-19|||December 2013||2013-12-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study|Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study|Completed||N/A|37|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 00:33:54.616686|2017-10-11 00:33:54.616686
NCT02111603|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-04-08|2015-10-16||April 2014||2014-04-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|August 2014|Actual|2014-08-01||Interventional||13 subjects were accrued. One subject withdrew from the study after the pre-drug activities, but before the treatment activities.|Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids|Ability of Mayo Clinic HPLC Method to Measure Fecal Bile Acids to Demonstrate Response to Colesevelam in Patients With Diarrhea Predominant Irritable Bowel Syndrome|Completed||Phase 4|13|Actual|Mayo Clinic||1|||f||||f||||||||Yes|Data already published in PMID: 25594801|2017-10-11 00:33:54.707669|2017-10-11 00:33:54.707669
NCT02111590|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2015-09-18|||January 2014||2014-01-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Immunoglobulin Dosage and Administration Form in CIDP and MMN|The Influence of Immunoglobulin Dosage and Administration on Development of Hemolytic Anemia and Variation on Muscle Strength in Patients With CIDP and MMN|Completed||N/A|36|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-11 00:33:55.02785|2017-10-11 00:33:55.02785
NCT02111577|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-04-24|||April 2014||2014-04-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Interventional|VIABLE||Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer|A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy|Recruiting||Phase 3|1170|Anticipated|Sotio a.s.||2|||f||||t||||||||Undecided||2017-10-11 00:33:55.164989|2017-10-11 00:33:55.164989
NCT02111564|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-09-22|||June 2, 2014|Actual|2014-06-02|September 2017|2017-09-01|May 25, 2018|Anticipated|2018-05-25|May 25, 2018|Anticipated|2018-05-25||Interventional|MARINER||A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients|Medically Ill Patient Assessment of Rivaroxaban Versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk|Recruiting||Phase 3|12000|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 00:33:56.212406|2017-10-11 00:33:56.212406
NCT02111551|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-06-14|||June 2015||2015-06-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Phase I Nicotinic Agonist Treatment Trial for Autism|Phase I Nicotinic Agonist Treatment Trial for Autism|Terminated||Phase 1|2|Actual|University of Colorado, Denver||3||difficult to find participants and no funding|f||||t||||||||||2017-10-11 00:34:02.758548|2017-10-11 00:34:02.758548
NCT02111538|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-08-29|||February 2014||2014-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BIVAmyloid||Body Composition in Systemic Amyloidosis|Prognostic Value of Phase Angle in Systemic Immunoglobulin Light-chain (AL) Amyloidosis|Recruiting||N/A|200|Anticipated|IRCCS Policlinico S. Matteo|||1||f||||t||||||||||2017-10-11 00:34:02.866888|2017-10-11 00:34:02.866888
NCT02111525|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-10-13|||June 2014||2014-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|FLOOD||Fluid Status of Outpatients With Dyspnea|Fluid Status of Outpatients With Dyspnea|Completed||N/A|156|Actual|Intersection Medical, Inc.|||1||f||||f||||||||||2017-10-11 00:34:02.996117|2017-10-11 00:34:02.996117
NCT02111512|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-05-27|||September 2014||2014-09-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|SNIFFLE-2||Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 Study|Phase 4 Study to Assess the Safety of Nasal Influenza Immunisation in Egg Allergic Children - a Multicentre Observational Study|Completed||Phase 4|779|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 00:34:03.075104|2017-10-11 00:34:03.075104
NCT02111499|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-06-06|||March 2014||2014-03-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test|A Randomized, Controlled, Observer-blind Psoriasis Plaque Test to Investigate the Anti-psoriatic Efficacy, Tolerability and Safety (Skin Atrophy) of LAS41004 Formulations in Patients With Mild to Moderate Plaque Psoriasis|Completed||Phase 1/Phase 2|18|Actual|Almirall, S.A.||6|||f||||f||||||||||2017-10-11 00:34:03.219144|2017-10-11 00:34:03.219144
NCT02111473|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-09|||May 2009||2009-05-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism|Phase 4 Study of Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism|Completed||Phase 4|49|Actual|Gulhane School of Medicine||1|||f||||f||||||||||2017-10-11 00:34:03.453242|2017-10-11 00:34:03.453242
NCT02111460|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-09-11|||October 2013||2013-10-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma|Multicentre Randomization Clinic Trial of Systemic Chemotherapy Combined With Loco-regional Radiotherapy vs. Chemotherapy Alone for Initially Untreated Distant Metastatic Nasopharyngeal Carcinoma With Chemosensitivity|Recruiting||Phase 3|204|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:34:03.52975|2017-10-11 00:34:03.52975
NCT02111447|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2017-02-13|||January 2014||2014-01-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI|Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI: Comparative Study Using Propofol, Sevoflurane and Isoflurane|Terminated||Phase 4|16|Actual|State University of New York at Buffalo||4||Not enough participants|f||||f||||||||No||2017-10-11 00:34:03.609543|2017-10-11 00:34:03.609543
NCT02111434|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2014-04-10|||July 2013||2013-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment|Phase 4 Study of Effect of Testosteron Treatment on the Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism|Completed||Phase 4|150|Actual|Gulhane School of Medicine||1|||f||||f||||||||||2017-10-11 00:34:03.808318|2017-10-11 00:34:03.808318
NCT02111421|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-04-18|||June 2015|Actual|2015-06-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||The Optimal Dose of Dexmedetomidine Sedation for Postpartum Parturients and Nonpregnant Women|The Optimal Dose of Dexmedetomidine Sedation for Postpartum Parturients and Nonpregnant Women During Spinal Anaesthesia|Completed||Phase 4|60|Actual|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-11 00:34:03.877081|2017-10-11 00:34:03.877081
NCT02111408|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-02-24|||March 2014||2014-03-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|February 2017|Actual|2017-02-01||Observational|||Stroke - Sleep Disorders, Dysfunction of the Autonomic Nervous System and Depression|Stroke - Sleep Disorders, Dysfunction of the Autonomic Nervous System and Depression|Active, not recruiting||N/A|114|Actual|Glostrup University Hospital, Copenhagen|||1||f||||f||||||Samples With DNA|"     Whole blood, plasma, serum   "|Undecided||2017-10-11 00:34:03.954226|2017-10-11 00:34:03.954226
NCT02111382|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-12-01|||August 2014||2014-08-01|December 2014|2014-12-01|August 2016|Anticipated|2016-08-01|December 2015|Anticipated|2015-12-01||Interventional|||Electroencephalography Activity in Individuals With Nonspecific Chronic Low Back Pain After Cranial Osteopathic Manipulative Treatment|Electroencephalography Activity in Individuals With Nonspecific Chronic Low Back Pain After Cranial Osteopathic Manipulative Treatment: Study Protocol of a Randomized, Controlled Crossover Trial|Unknown status|Recruiting|N/A|81|Anticipated|University of Brasilia||3|||f||||t||||||||||2017-10-11 00:34:04.02567|2017-10-11 00:34:04.02567
NCT02111369|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-03-25|2016-02-24||May 2014||2014-05-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Propranolol and Botulinum Toxin for Essential Vocal Tremor|Propranolol and Botulinum Toxin for Essential Vocal Tremor|Completed||Phase 4|18|Actual|Emory University|The study lacks a placebo or control group, with participants representing their own internal controls. Additionally, inter-rater reliability among listeners for the CAPE-V outcome measure analysis was low.|1|||f||||t||||||||||2017-10-11 00:34:04.150037|2017-10-11 00:34:04.150037
NCT02111356|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-04-09|||April 2014||2014-04-01|April 2014|2014-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|PH001||Determine Functions of Pinhole Glasses on the Eyes|Quantative Analysis of Functional Changes by the Pinhole Glasses|Unknown status|Active, not recruiting|N/A|30|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||1|||f||||t||||||||||2017-10-11 00:34:04.406638|2017-10-11 00:34:04.406638
NCT02111343|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-04-07|||October 2009||2009-10-01|April 2014|2014-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|CBAT||The Effectiveness of Computerized Auditory Training Programme on Children With Auditory Processing Disorder|Pilot Study: The Effectiveness of Computerized Auditory Training Programme on Children With Auditory Processing Disorder|Completed||N/A|39|Actual|National University Health System, Singapore||2|||f||||f||||||||||2017-10-11 00:34:04.501798|2017-10-11 00:34:04.501798
NCT02111330|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-03-07|||March 2014||2014-03-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||"Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) After Multiple Oral Doses in Healthy Volunteers"|"Randomized, Double Blind, Placebo Controlled, Parallel Groups Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) After Multiple Oral Doses in Healthy Volunteers"|Completed||Phase 1|16|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||6|||f||||f||||||||||2017-10-11 00:34:04.596817|2017-10-11 00:34:04.596817
NCT02111317|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-04-07|||October 2013||2013-10-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects|A Phase 1, Open-label, Single-Sequence, Crossover Drug Interaction Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:34:04.718682|2017-10-11 00:34:04.718682
NCT02111304|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-09-24|||June 2014||2014-06-01|April 2014|2014-04-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Interventional|POC||Efficacy of iOWH032 in Dehydrating Cholera|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Two-Part Trial to Evaluate the Efficacy, Safety, and Tolerability of iOWH032 in the Treatment of Acute Dehydrating Diarrhea in Adult and Pediatric Patients With Cholera|Withdrawn||Phase 2|0|Actual|PATH||2||Trial was never initiated due to PATH executive decision.|f||||t||||||||||2017-10-11 00:34:04.837181|2017-10-11 00:34:04.837181
NCT02111291|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2016-02-16|||April 2014||2014-04-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Santyl Applications to Diabetic Foot Ulcers|Clinical Outcomes Associated With Enzymatic Debridement of Diabetic Foot Ulcers for Up To 12 Weeks With Clostridial Collagenase (Santyl®) Ointment|Completed||Phase 4|215|Actual|Healthpoint||2|||f||||f||||||||||2017-10-11 00:34:04.991652|2017-10-11 00:34:04.991652
NCT02111278|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-12-22|||May 2012||2012-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Lumbar Manipulation and Exercise for the Treatment of Acute Low Back Pain in Adolescents|Lumbar Manipulation and Exercise for the Treatment of Acute Low Back Pain in Adolescents: a Randomized Controlled Trial|Completed||N/A|35|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 00:34:05.144796|2017-10-11 00:34:05.144796
NCT02111265|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-09|2014-04-10|||April 2014||2014-04-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||THe Comparison of Target Controlled Infusion of Propofol or Etomidate at General Anesthesia in Geriatric Patients|The Comparison of Efficacy and Safety of Target Controlled Infusion of Propofol or Etomidate at General Anesthesia in Geriatric Patients ——A Randomized Controlled Trial.|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Second Affiliated Hospital of Xi'an Jiaotong University||2|||f||||f||||||||||2017-10-11 00:34:05.263731|2017-10-11 00:34:05.263731
NCT02111252|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-06-30|2015-04-14||March 2014||2014-03-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||The population included all participants who received treatment (full analysis set: FAS).|A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects|An Open-label Phase 1/2 Study to Evaluate the Safety and Immunogenicity of a Single Intramuscular Injection of TAK-850 in Healthy Adult Subjects|Completed||Phase 1/Phase 2|55|Actual|Takeda||1|||f||||f||||||||||2017-10-11 00:34:05.372683|2017-10-11 00:34:05.372683
NCT02111239|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-10-21|||June 2011||2011-06-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Preoperative Imaging in DIEP Flap Breast Reconstruction|Preoperative Imagining in DIEP Flap Breast Reconstruction: A Randomized Controlled Trial Evaluating Cost and Patient-Reported Outcomes|Active, not recruiting||N/A|60|Actual|Sunnybrook Health Sciences Centre||3|||f||||f||||||||||2017-10-11 00:34:05.938763|2017-10-11 00:34:05.938763
NCT02111226|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-07-13|||January 2012||2012-01-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|DREAM-GLOBAL||Detecting and Treating High Blood Pressure in Aboriginal Population and Low and Middle Income Countries|DREAM-GLOBAL: Diagnosing hypeRtension - Engaging Action and Management in Getting LOwer Bp in Aboriginal and LMIC - A Research Proposal|Recruiting||N/A|360|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-11 00:34:06.056456|2017-10-11 00:34:06.056456
NCT02111174|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2017-03-30|||March 2015||2015-03-01|March 2017|2017-03-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|||Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy|A Pilot Randomized Sham-Controlled Trial of MC5-A Calmare Therapy (Scrambler Therapy) in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)|Completed||N/A|30|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||No||2017-10-11 00:34:06.441793|2017-10-11 00:34:06.441793
NCT02111161|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-09-29|||April 2014||2014-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|INSTINCT||Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial|Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial|Completed||Phase 2|100|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:34:06.549064|2017-10-11 00:34:06.549064
NCT02111148|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-07-19|||May 2014||2014-05-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|PROM||Vaginal Fluid Wash in Pre-labour Rupture of Membranes|Urea and Creatinine Versus Nitrazine Test in Vaginal Fluid Wash in Diagnosed Pre Labour Rupture of Membranes|Recruiting||N/A|105|Anticipated|Beni-Suef University||3|||f||||f||||||||||2017-10-11 00:34:06.665919|2017-10-11 00:34:06.665919
NCT02111135|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-07-16|||April 2014||2014-04-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|IPV005||Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life|Phase II, Observer-blind, Randomized Study on the Safety, Reactogenicity, Immunogenicity and Impact on Intestinal Shedding of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) or a Single Dose of Standard Trivalent Inactivated Poliovirus Vaccine (t-IPV) When Given Concomitantly With the Third Dose of Bivalent Oral Poliovirus Vaccine (b-OPV) to Infants Early in Life|Completed||Phase 2|240|Actual|Vaxtrials S.A.||2|||f||||t||||||||||2017-10-11 00:34:06.767494|2017-10-11 00:34:06.767494
NCT02111122|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-08|||April 2014||2014-04-01|April 2014|2014-04-01|August 2016|Anticipated|2016-08-01|April 2016|Anticipated|2016-04-01||Interventional|PD-Xyrem||Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease|A Phase II, Prospective, Randomized, Double-blind, Crossover Placebo-controlled Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease|Unknown status|Recruiting|Phase 2|16|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 00:34:06.862605|2017-10-11 00:34:06.862605
NCT02111109|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-05-29|||July 2014||2014-07-01|May 2015|2015-05-01||||May 2017|Anticipated|2017-05-01||Observational|MICROSHOCK||An Observational Pilot Study of the Effects of Traumatic Haemorrhagic Shock and Resuscitation on the Microcirculation||Unknown status|Recruiting|N/A|50|Anticipated|King's College Hospital NHS Trust|||1||f||||f||||||Samples Without DNA|"     Blood / plasma / urine   "|||2017-10-11 00:34:06.979731|2017-10-11 00:34:06.979731
NCT02111096|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-12-23||2015-12-23|April 2014||2014-04-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus|A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 2|174|Actual|Eli Lilly and Company||3||"The overall benefit-risk profile did not support continued development of LY2409021 for type 2   diabetes."|f||||f||||||||||2017-10-11 00:34:07.101717|2017-10-11 00:34:07.101717
NCT02111083|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-05-04|2015-05-04||May 2014||2014-05-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants|Evaluation of the Bioequivalence of Two Formulations of Insulin Lispro in Healthy Subjects|Completed||Phase 1|38|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:34:07.310402|2017-10-11 00:34:07.310402
NCT02111070|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-09|||September 2012||2012-09-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects|Open-label, Phase I Clinical Trial to Assess the Immunogenicity and Safety of the 'IL-YANG Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects|Completed||Phase 1|44|Actual|Il-Yang Pharm. Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:34:07.803396|2017-10-11 00:34:07.803396
NCT02111057|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-03-13|||September 2013||2013-09-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Perioperative Flare in RA: Characterization of Clinical and Biological Features|Perioperative Flare in RA: Characterization of Clinical and Biological Features|Recruiting||N/A|200|Anticipated|Hospital for Special Surgery, New York|||1||f||||f|f|f||||Samples With DNA|"     During surgery, the subjects' surgeon will take samples of the tissue removed as part of     their surgery from their joint. Specifically for THR, the femoral head will be collected     intraoperatively from standardized anatomic sites, (fovea and capsular reflection). For TKR,     tissue samples of the patella cartilage, distal femur and proximal tibia, and synovium from     the suprapatellar pouch will be collected intraoperatively.   "|No||2017-10-11 00:34:07.87325|2017-10-11 00:34:07.87325
NCT02111044|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-06-15|||April 2014||2014-04-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|POC||Phase II Study With ITF2984 in Acromegalic Patients|A Randomized, Multicenter, Phase II Study to Investigate Efficacy and Safety of ITF2984 in Acromegalic Patients|Completed||Phase 2|48|Actual|Italfarmaco||4|||f||||f||||||||||2017-10-11 00:34:07.95311|2017-10-11 00:34:07.95311
NCT02111031|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-06-18|||January 2016||2016-01-01|June 2015|2015-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01|9 Months|Observational [Patient Registry]|||Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients|Registry to Demonstrate the Clinical Utility of CELLSEARCH® Circulating Tumor Cell (CTC) Test in Medicare-Eligible Metastatic Breast Cancer Patients|Withdrawn||N/A|0|Actual|Janssen Diagnostics, LLC|||1|The company decided not to start the study.|f||||f||||||||||2017-10-11 00:34:08.092147|2017-10-11 00:34:08.092147
NCT02111018|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-06-22|||March 2014||2014-03-01|June 2015|2015-06-01||||June 2016|Anticipated|2016-06-01||Interventional|||Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis||Unknown status|Recruiting|Phase 2|30|Anticipated|CytoSorbents, Inc||2|||f||||f||||||||||2017-10-11 00:34:08.163715|2017-10-11 00:34:08.163715
NCT02111005|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-03-15|||April 2015||2015-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|||Smoking Influence on Apoptosis in Periodontitis|Influence of Smoking on Fibroblast Apoptosis in Patients With Chronic and Aggressive Periodontitis|Completed||N/A|80|Actual|Damascus University|||4||f||||t||||||||||2017-10-11 00:34:08.245516|2017-10-11 00:34:08.245516
NCT02110992|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-01-04|||April 2014||2014-04-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck|A Phase I Pilot Study of SBRT and Concurrent Docetaxel for Reirradiation of Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 1|30|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-11 00:34:08.320028|2017-10-11 00:34:08.320028
NCT02110979|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-08-05|||April 2014||2014-04-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Validation of a Patient Decision Aid for Type 2 Diabetes|Validation of a Patient Decision Aid for Type 2 Diabetes|Completed||N/A|200|Anticipated|EPI-Q||2|||f||||f||||||||||2017-10-11 00:34:08.415949|2017-10-11 00:34:08.415949
NCT02110966|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-10-30|||April 2014||2014-04-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis|Efficacy of the Combination Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis: a Randomized Clinical Trial.|Completed||Phase 4|56|Actual|Universidad Autonoma de San Luis Potosí||2|||f||||f||||||||||2017-10-11 00:34:08.602857|2017-10-11 00:34:08.602857
NCT02110953|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-04-12|||January 2016|Actual|2016-01-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver|Phase I Study of Drug-Eluting Irinotecan Beads (DEBIRI) in Refractory Metastatic Colorectal Cancer With Liver-Only or Liver-Predominant Disease|Recruiting||Phase 1|30|Anticipated|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 00:34:08.71529|2017-10-11 00:34:08.71529
NCT02110940|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-02-23|||August 2015||2015-08-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Neurodynamic Mobilization Exercise on Lower Limb Pain in Patients With Rheumatoid Arthritis.|The Effect of Neural Mobilization Exercise on Lower Limb Pain in Patients With Rheumatoid Arthritis.|Recruiting||N/A|40|Anticipated|The Hong Kong Polytechnic University||2|||f||||f||||||||No||2017-10-11 00:34:08.812257|2017-10-11 00:34:08.812257
NCT02110927|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-10-23|||February 2014||2014-02-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Microcurrent and Aerobic Exercise Effects in Abdominal Fat|Microcurrent and Aerobic Exercise Effects in Glycerol, Catecholamines, Energetic Source and Muscle Activity|Completed||N/A|100|Actual|Escola Superior de Tecnologia da Saúde do Porto||2|||f||||t||||||||||2017-10-11 00:34:08.90357|2017-10-11 00:34:08.90357
NCT02110914|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-04-12|||May 2014||2014-05-01|April 2017|2017-04-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|||A Coaching Intervention to Young Adults With Cystic Fibrosis|Coach to Cope. Coaching Young Adults With Cystic Fibrosis - a Feasibility Study|Completed||N/A|40|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:34:09.010555|2017-10-11 00:34:09.010555
NCT02110901|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-06-15||2017-06-06|July 2014|Actual|2014-07-01|June 2017|2017-06-01||||December 2016|Actual|2016-12-01||Interventional|||A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)|Multicenter, Double-Blind, Placebo-Controlled Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease|Active, not recruiting||Phase 3|300|Anticipated|Proteon Therapeutics||2|||f||||t||||||||||2017-10-11 00:34:09.103482|2017-10-11 00:34:09.103482
NCT02110888|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-10-10|||February 2013||2013-02-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|||"Subcutaneous Peripheral Nerve Stimulation (PNS) as Hybrid Stimulation After Failure of Spinal Cord Stimulation (SCS) to Control the Back Pain Component in Failed Back Surgery Syndrome (FBSS) Patients.(CUMPNS Study)"||Recruiting||N/A|5|Anticipated|Poitiers University Hospital||2|||f||||||||||||||2017-10-11 00:34:09.276067|2017-10-11 00:34:09.276067
NCT02110875|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-10-17|||June 2013||2013-06-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|VITDC||Strength and Balance in Gender- and Age-Matched Controls|"Strength and Balance in Gender- and Age-Matched Controls: SubStudy to The Effects of Vitamin D on Balance in Parkinson's Disease"|Completed||N/A|25|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 00:34:09.362681|2017-10-11 00:34:09.362681
NCT02110862|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-01-27|||January 2012||2012-01-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|SKIPO||Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis|Scintigraphic Evaluation of IPAA Function in CU Patients|Completed||N/A|21|Actual|Odense University Hospital|||1||f||||f||||||||||2017-10-11 00:34:09.448268|2017-10-11 00:34:09.448268
NCT02110849|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-04-06|||January 2013||2013-01-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Actual|2016-04-01|12 Months|Observational [Patient Registry]|||Prostate Cancer Parameters for Patients Receiving Proton Treatment|Longitudinal Study for the Evaluation of Safety and Efficacy Parameters in Prostate Cancer Patients Treated at IU Health Proton Therapy Center (IUHPTC)|Withdrawn||N/A|0|Actual|Indiana University|||1|Closure of IU Health Proton Facility|f||||t||||||||No|No data collected|2017-10-11 00:34:09.528754|2017-10-11 00:34:09.528754
NCT02110836|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-08-04|||April 2014||2014-04-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|September 2014|Actual|2014-09-01||Interventional|||The Impact of Sucrose Ingestion During Exercise on Liver and Muscle Glycogen Concentration.||Completed||N/A|14|Actual|Northumbria University||2|||f||||f||||||||||2017-10-11 00:34:09.609857|2017-10-11 00:34:09.609857
NCT02110823|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-05-16|||March 2008||2008-03-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|SVRII||Single Ventricle Reconstruction Extension Study (SVR II) - Pediatric Heart Network|Single Ventricle Reconstruction Extension Study (A Study Conducted by the Pediatric Heart Network)|Active, not recruiting||N/A|325|Actual|New England Research Institutes|||1||f||||t||||||Samples With DNA|"     The SVR II study will collect biological specimens to bank in an established biorepository as     a resource for future, hypothesis-driven studies from families who provide separate informed     consent. When possible, blood will be drawn, processed, and stored in such a way as to permit     both genetic studies and studies of serum biomarkers. The intent is to obtain blood from     study subjects and parents (i.e., trios). When obtaining blood is not possible, however,     saliva will be obtained so that at least genetic information can be stored for future     studies.   "|||2017-10-11 00:34:09.692571|2017-10-11 00:34:09.692571
NCT02110810|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-03-23|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|Indomethacin||Indomethacin Decreases Post-ERCP Pancreatitis|Rectal Indomethacin Decreases the Incidence of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography in High-risk Patients|Completed||Phase 3|160|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-11 00:34:09.750607|2017-10-11 00:34:09.750607
NCT02110797|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-07-05|||December 2009||2009-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|OSRETT||Osteoporosis in RETT Syndrome|Osteoporosis in RETT Syndrome. Understanding the Mechanisms and Identification of Biomarkers.|Active, not recruiting||N/A|98|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:34:09.846084|2017-10-11 00:34:09.846084
NCT02110784|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-06-13|||June 18, 2014|Actual|2014-06-18|June 2017|2017-06-01|April 30, 2017|Actual|2017-04-30|November 23, 2016|Actual|2016-11-23||Interventional|||Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria|Proof of Concept Study of Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria|Terminated||Phase 2|27|Actual|sigma-tau i.f.r. S.p.A.||1||Low recruitment|f||||f||||||||||2017-10-11 00:34:09.934345|2017-10-11 00:34:09.934345
NCT02110771|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-03-02|||May 2012||2012-05-01|September 2015|2015-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy Study of GAÏA Program Cognitive Remediation of Facial Affects Processing in Schizophrenia|Efficacy Study of GAÏA Program Cognitive Remediation of Facial Affects Processing in Schizophrenia|Completed||N/A|33|Actual|Hôpital le Vinatier||2|||f||||f||||||||||2017-10-11 00:34:10.065822|2017-10-11 00:34:10.065822
NCT02110745|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-03-12|||March 2014||2014-03-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effect of Induction Technique on Postoperative Pain and Agitation|THE EFFECT OF DIFFERENT INDUCTION TECHNIQUES ON POSTOPERATIVE PAIN AND AGITATION IN CHILDREN|Completed||Phase 4|2|Anticipated|Mustafa Kemal University||2|||f||||f||||||||||2017-10-11 00:34:10.295445|2017-10-11 00:34:10.295445
NCT02110732|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-02-27|||January 2011||2011-01-01|February 2017|2017-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil|Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil After Randomized, Double-blind, Placebo-controlled Oral Administration|Completed||N/A|40|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 00:34:10.398287|2017-10-11 00:34:10.398287
NCT02110719|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-08-15|||March 2014||2014-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|July 2015|Actual|2015-07-01||Interventional|Pain||Decreasing Narcotics in Advanced Pelvic Surgery|Decreasing Narcotics in Advanced Pelvic Surgery: A Randomized Study|Completed||Phase 4|138|Actual|Hartford Hospital||2|||f||||f||||||||No||2017-10-11 00:34:10.479403|2017-10-11 00:34:10.479403
NCT02110706|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-03-01|||May 2014||2014-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis|B Cell Targeted Treatment In Myasthenia Gravis (BeatMG): A Phase II Trial of Rituximab In Myasthenia Gravis|Active, not recruiting||Phase 2|50|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:34:10.598526|2017-10-11 00:34:10.598526
NCT02110680|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-03-14|||March 2016||2016-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TENSOAB||Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms|Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms|Withdrawn||Phase 2|0|Actual|Meir Medical Center||2|||f||||||||||||||2017-10-11 00:34:10.854766|2017-10-11 00:34:10.854766
NCT02110667|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-05-02|||April 2014||2014-04-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|January 2016|Actual|2016-01-01||Observational|||Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy||Completed||N/A|15|Actual|University of Vermont Medical Center|||1||f||||t||||||||||2017-10-11 00:34:10.938306|2017-10-11 00:34:10.938306
NCT02110654|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-08|||June 2014||2014-06-01|March 2014|2014-03-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery|Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery: a 9-month Randomized, Open-label, Controlled Study|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:34:11.016789|2017-10-11 00:34:11.016789
NCT02110641|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-04-24|||November 2013|Actual|2013-11-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|November 2016|Actual|2016-11-01||Interventional|LEAN 2||Lifestyle, Exercise and Nutrition Study 2 (LEAN 2)|Lifestyle, Exercise and Nutrition (LEAN) Study 2|Active, not recruiting||N/A|51|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:34:11.126043|2017-10-11 00:34:11.126043
NCT02110628|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-12-04|||August 2014||2014-08-01|December 2014|2014-12-01|August 2019|Anticipated|2019-08-01|August 2016|Anticipated|2016-08-01||Interventional|WCGCC-1202||Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy|Jejunal Pouch for Postoperative Quality of Life Following Roux-en-Y Reconstruction of Radical Total Gastrectomy: a Multicenter Randomized Controlled Trial (WCGCC-1202)|Recruiting||Phase 3|588|Anticipated|West China Hospital||2|||f||||f||||||||||2017-10-11 00:34:11.229493|2017-10-11 00:34:11.229493
NCT02110615|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-03-21|||December 2011||2011-12-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Mass in Motion Kids in the Clinical Setting|MA Childhood Obesity Research Demonstration (CORD) Project|Completed||N/A|3765|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:34:11.381705|2017-10-11 00:34:11.381705
NCT02110602|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-10-05|||April 2014||2014-04-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Dietary Intake and Circulating Levels of Branched Chain Amino Acids|Short-term Dietary Intake and Branched Chain Amino Acids|Completed||N/A|5|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:34:11.467786|2017-10-11 00:34:11.467786
NCT02110589|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-09|||August 2014||2014-08-01|April 2014|2014-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Tonicity Monitor For Epilepsy and Hypertonic Disorders|Investigation Into the Efficacy and Application of Non-invasive Sensor Technology to Produce a Community-based Seizure Alarm/Monitor for Epilepsy and Episodic Hyperexcitability Disorders.|Unknown status|Not yet recruiting|N/A|35|Anticipated|Vikel Ltd||5|||f||||f||||||||||2017-10-11 00:34:11.54909|2017-10-11 00:34:11.54909
NCT02110563|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2017-08-03|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|August 3, 2017|Actual|2017-08-03||Interventional|||Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma|Phase I, Multicenter, Cohort Dose Escalation Trial to Determine the Safety, Tolerance, and Maximum Tolerated Dose of DCR-MYC, a Lipid Nanoparticle (LNP)-Formulated Small Inhibitory RNA (siRNA) Oligonucleotide Targeting MYC, in Patients With Refractory Locally Advanced or Metastatic Solid Tumor Malignancies, Multiple Myeloma, or Lymphoma|Terminated||Phase 1|74|Anticipated|Dicerna Pharmaceuticals, Inc.||1||Sponsor Decision|f||||f||||||||||2017-10-11 00:34:11.71488|2017-10-11 00:34:11.71488
NCT02110550|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-10-02|||May 2014||2014-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Evaluation of a New Design of Crowns in the Posterior Teeth|Evaluation of IPS E.Max-CAD Endocrown in Molars Compared to the Conventional Design|Completed||N/A|40|Actual|Damascus University||2|||f||||t||||||||||2017-10-11 00:34:11.846826|2017-10-11 00:34:11.846826
NCT02110537|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2014-04-08|||March 2014||2014-03-01|April 2014|2014-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Acupuncture in Persistent Atrial Fibrillation|Clinical Trial to Evaluate the Antiarrhythmic Effects of Acupuncture for Drug Resistant Persistent Atrial Fibrillation: Randomized, Participant and Assessor Blinded, Sham-controlled, Clinical Trial|Unknown status|Recruiting|N/A|80|Anticipated|Kyunghee University Medical Center||2|||f||||f||||||||||2017-10-11 00:34:11.963415|2017-10-11 00:34:11.963415
NCT02110524|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-02-25|||December 2011||2011-12-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|September 2012|Actual|2012-09-01||Interventional|||CVI Drug Coated Balloon First In Human Trial|Prospective, Controlled, Multi-Center, Open, Single Arm Study for the Treatment of Subjects Presenting De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using a Paclitaxel-Coated Percutaneous Angioplasty Catheter|Completed||N/A|80|Actual|Spectranetics Corporation||1|||f||||f||||||||||2017-10-11 00:34:12.221769|2017-10-11 00:34:12.221769
NCT02110511|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-04-09|||August 2011||2011-08-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|BFE||"Body Responses to Bean Physical Form and Beano"|Effects of Bean Form and Digestive Enzyme Availability on Postprandial Responses|Completed||N/A|14|Actual|Purdue University||6|||f||||f||||||||||2017-10-11 00:34:12.347502|2017-10-11 00:34:12.347502
NCT02110498|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2016-10-07|||March 2014||2014-03-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Early Detection of Pancreatic Cystic Neoplasms|Early Detection of Pancreatic Cystic Neoplasms|Recruiting||N/A|3000|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"     Pancreatic cyst fluid, blood   "|||2017-10-11 00:34:12.480183|2017-10-11 00:34:12.480183
NCT02110472|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-09-26|||May 2014||2014-05-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Investigation of the Presbia Flexivue Microlens™|Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes|Active, not recruiting||Phase 3|412|Anticipated|PresbiBio, LLC||1|||f||||f||||||||||2017-10-11 00:34:12.729352|2017-10-11 00:34:12.729352
NCT02110459|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-06-16|||April 2013||2013-04-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment|An Open-label, Non-randomized, Monocenter, Single-dose, Phase I Study to Evaluate Pharmacokinetics and Safety of POL7080 Administered as Single Intravenous Infusion to Subjects With Renal Impairment|Completed||Phase 1|48|Actual|Polyphor Ltd.||6|||f||||f||||||||||2017-10-11 00:34:12.883871|2017-10-11 00:34:12.883871
NCT02110446|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-01-31|||February 2014||2014-02-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|SS-1||Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome|Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome - A Randomized Control Trial|Recruiting||Phase 2|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-11 00:34:12.989188|2017-10-11 00:34:12.989188
NCT02110433|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-05-15|||December 2013||2013-12-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|March 2017|Actual|2017-03-01||Interventional|HELP||Heart Failure Educational and Follow up Platform|Heart Failure Educational and Follow up Platform|Active, not recruiting||N/A|330|Actual|Centre Hospitalier René Dubos||3|||f||||t||||||||No||2017-10-11 00:34:13.139223|2017-10-11 00:34:13.139223
NCT02110420|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-10-13|||February 2014||2014-02-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001|A Phase 1, Randomized, Two-part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001 in Healthy Subjects|Completed||Phase 1|96|Actual|Celgene||14|||f||||f||||||||||2017-10-11 00:34:13.282723|2017-10-11 00:34:13.282723
NCT02110407|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-07-26|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|January 2017|Actual|2017-01-01||Interventional|||Modulation of Visual-Spatial Learning in Healthy Young Adults by tDCS|Modulation of Visual-Spatial Learning in Healthy Young Adults by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms|Completed||N/A|24|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:34:13.415873|2017-10-11 00:34:13.415873
NCT02110394|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-07-04|||June 2012||2012-06-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|NORMA||Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia|Observational Program for Evaluation of Ribomustin Use in the First Line Therapy of Chronic Lymphocytic Leukemia|Completed||N/A|190|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 00:34:13.506887|2017-10-11 00:34:13.506887
NCT02110381|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-02-07|2017-02-07||September 2014||2014-09-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial|Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial|Terminated||N/A|32|Actual|University of Michigan|small sample size|2||It was a pilot study and we enrolled sufficient numbers to evaluate the proposed outcomes.|f||||||||||||||2017-10-11 00:34:13.700772|2017-10-11 00:34:13.700772
NCT02110368|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-06-25||2014-06-25|March 2014||2014-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions|An Open-Label, Randomized, Balanced, Single-Dose, Two Treatment, Four Period, Two Sequence Replicate Design, Bioequivalence Study Of Testosterone Topical Gel, 1.62% Metered Pump, Manufactured By Amneal Pharmaceuticals LLC With AndroGel (Testosterone Gel) 1.62% Metered-Dose Pump, Marketed By Abbvie Inc., In Testosterone-Deficient (Hypogonadal) Adult Male Subjects Under Fasting Conditions|Completed||Phase 3|32|Actual|Amneal Pharmaceuticals, LLC||2|||f||||t||||||||||2017-10-11 00:34:14.185693|2017-10-11 00:34:14.185693
NCT02110355|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-07-12|||December 19, 2014|Actual|2014-12-19|June 2017|2017-06-01|August 17, 2021|Anticipated|2021-08-17|April 15, 2018|Anticipated|2018-04-15||Interventional|||A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma|A Phase 1b/2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 232 Combined With Trametinib and Dabrafenib or Trametinib in Adult Subjects With Metastatic Cutaneous Melanoma|Recruiting||Phase 1/Phase 2|138|Anticipated|Amgen||3|||f||||f||||||||||2017-10-11 00:34:14.294042|2017-10-11 00:34:14.294042
NCT02110342|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-07-21|||May 2014||2014-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The Body|A Phase One Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] PF-04449913 In Healthy Male Volunteers|Completed||Phase 1|6|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:34:14.43623|2017-10-11 00:34:14.43623
NCT02110329|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-07|||May 2010||2010-05-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|Code Barre||Simultaneaous Detection of Quantitative Somatic Alterations Using the Qantitative Multiplex Pcr of Short Fluorescent Fragments Method (QMPSF) in Stage II-III Colon Cancer: a Prospective Study|Simultaneous Detection of Somatic Quantitative Molecular Alterations Using the Qantitative Multiplex Pcr of Short Fluorescent Fragments Method (QMPSF) in Stage II-III Colon Cancer: a Prospective Study|Completed||N/A|401|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 00:34:14.534454|2017-10-11 00:34:14.534454
NCT02110316|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-09-01|||June 2015||2015-06-01|February 2016|2016-02-01||||June 2016|Actual|2016-06-01||Interventional|||Bioavailability of Voriconazole|Bioavailability of Voriconazole in Critically Ill Patients|Withdrawn||Phase 4|0|Actual|University Medical Center Groningen||1||no eligible patients; study stopped without inclusion|f||||f||||||||||2017-10-11 00:34:14.626294|2017-10-11 00:34:14.626294
NCT02110303|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-05-02|||March 2015||2015-03-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Interventional|DIAMOND||DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury|Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease|Active, not recruiting||Phase 2/Phase 3|220|Actual|University of Edinburgh||4|||f||||f||||||||||2017-10-11 00:34:14.733161|2017-10-11 00:34:14.733161
NCT02110290|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-09-01|||October 2010||2010-10-01|September 2017|2017-09-01||||August 2016|Actual|2016-08-01||Observational|||Effects of an Adapted Ski/Snowboarding Program on Quality of Life in Children With Physical Disabilities|Effects of Adapted Skiing and Snowboarding on Quality of Life in Children With Physical Disabilities|Active, not recruiting||N/A|86|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 00:34:14.836263|2017-10-11 00:34:14.836263
NCT02110277|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-07|||March 2014||2014-03-01|January 2014|2014-01-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Photoacoustic Imaging of the Ovary|Photoacoustic Imaging of the Ovary|Recruiting||N/A|40|Anticipated|UConn Health||1|||f||||t||||||||||2017-10-11 00:34:14.93547|2017-10-11 00:34:14.93547
NCT02110264|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-04-07|||June 2015||2015-06-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|IPOD||Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)|Depot Pharmacotherapies for Opioid-Dependent Offenders: Outcomes and Costs|Recruiting||Phase 3|150|Anticipated|University of California, Los Angeles||3|||f||||t||||||||||2017-10-11 00:34:15.036305|2017-10-11 00:34:15.036305
NCT02110251|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-04-03|||September 2011||2011-09-01|April 2015|2015-04-01||||January 2016|Anticipated|2016-01-01||Interventional|PEARL||Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial Disease|Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial Disease With Critical Limb Ischemia or Tissue Loss. A Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Catharina Ziekenhuis Eindhoven||2|||f||||f||||||||||2017-10-11 00:34:15.217945|2017-10-11 00:34:15.217945
NCT02110238|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-05-16|2016-03-01||March 2014||2014-03-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional||All but 1 subject who discontinued after being randomized to Euflexxa but unable to tolerate the injection procedure. This subject did not receive any of the study device via injection.|Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA|Multicenter, Randomized, Double-Blind, Parallel Controlled Non-Inferiority Clinical Trial Comparing 3 Weekly Intra-articular Injections of SUPARTZ® vs 3 Weekly Intra-articular Injections of Euflexxa® for Treatment of Knee OA|Completed||Phase 3|421|Actual|Bioventus LLC||2|||f||||f||||||||No||2017-10-11 00:34:15.345449|2017-10-11 00:34:15.345449
NCT02110225|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-03-16|||January 2014||2014-01-01|March 2015|2015-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|Lumos||A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)|A 24 Week Phase Ib/II, Multicenter, Randomized, Double-masked, Vehicle Controlled, Parallel Group, Dose Ranging Study With a 24 Week Follow-up Period to Evaluate the Safety and Potential Efficacy of Two Doses (60 and 180 µg/ml) of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drops Solution Versus Vehicle in Patients With Typical Retinitis Pigmentosa (RP)|Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Actual|Dompé Farmaceutici S.p.A||3|||f||||t||||||||||2017-10-11 00:34:15.708225|2017-10-11 00:34:15.708225
NCT02110212|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2014-06-27||2014-05-15|April 2011||2011-04-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|December 2011|Actual|2011-12-01||Interventional|||Femtosecond Laser for Cataract Surgery|A Prospective, Randomized Study of Cataract Surgery With the Assistance of the OptiMedica Femtosecond Laser System Compared to Standard Surgical Procedure of Continuous Curvilinear Capsulorhexis and Ultrasonic Phacoemulsification|Terminated||Phase 3|17|Actual|Abbott Medical Optics||2||FDA approval received for product, no additional study subjects required.|f||||f||||||||||2017-10-11 00:34:15.832599|2017-10-11 00:34:15.832599
NCT02110186|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-07|||July 2012||2012-07-01|April 2014|2014-04-01|June 2019|Anticipated|2019-06-01|July 2015|Anticipated|2015-07-01||Interventional|LIDH||Lumbar Intervertebral Disc Herniation|A Prospective, Comparative Study to Evaluate Effectiveness and Safety of Dynamic Stabilization in Treatment of Lumbar Disc Herniation|Recruiting||N/A|195|Anticipated|Third Military Medical University||3|||f||||f||||||||||2017-10-11 00:34:15.929321|2017-10-11 00:34:15.929321
NCT02110160|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-07-28|||September 2013||2013-09-01|July 2017|2017-07-01||||September 2017|Anticipated|2017-09-01||Observational|||18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET/CT) For The Evaluation Of Response To Therapy In Bone-Dominant Metastatic Breast Cancer|18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET/CT) For The Evaluation Of Response To Therapy In Bone-Dominant Metastatic Breast Cancer|Recruiting||N/A|75|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-11 00:34:16.033938|2017-10-11 00:34:16.033938
NCT02104596|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-16|||May 2014||2014-05-01|April 2014|2014-04-01||||April 2016|Anticipated|2016-04-01||Interventional|||Intraarticular Xylitol Injections for Knee Osteoarthritis|Intraarticular Xylitol Injections for Knee Osteoarthritis|Unknown status|Not yet recruiting|Phase 4|96|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 00:35:59.478764|2017-10-11 00:35:59.478764
NCT02110147|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-06-29|2017-02-06||April 2014|Actual|2014-04-01|June 2017|2017-06-01|September 8, 2016|Actual|2016-09-08|December 2014|Actual|2014-12-01||Interventional|||Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria|Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria|Completed||Phase 3|4|Actual|Wellstat Therapeutics||1|||f||||f||||||||||2017-10-11 00:34:16.129556|2017-10-11 00:34:16.129556
NCT02110134|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-07-29|||December 2013||2013-12-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma|A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma|Completed||N/A|6|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:34:18.027952|2017-10-11 00:34:18.027952
NCT02110121|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-06-12|||February 2014||2014-02-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos|Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos|Completed||N/A|63|Actual|Cynosure, Inc.||2|||f||||f||||||||||2017-10-11 00:34:18.137269|2017-10-11 00:34:18.137269
NCT02110108|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-07-29|||March 2014||2014-03-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study for the RevLite Laser System for Facial Solar Lentigines|Study for the RevLite Laser System for Facial Solar Lentigines|Completed||N/A|9|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:34:18.227809|2017-10-11 00:34:18.227809
NCT02110095|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-01-30|||January 2014||2014-01-01|July 2016|2016-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos|Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos|Completed||N/A|20|Anticipated|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:34:18.313681|2017-10-11 00:34:18.313681
NCT02110082|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-04-17|||April 2014||2014-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer|A Phase 1b, Open-label, Multicenter Study of Urelumab (BMS-663513) in Combination With Cetuximab in Subjects With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|66|Actual|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-11 00:34:18.406852|2017-10-11 00:34:18.406852
NCT02110069|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-07-11|||June 14, 2017|Actual|2017-06-14|July 2017|2017-07-01|December 2026|Anticipated|2026-12-01|June 2021|Anticipated|2021-06-01||Interventional|||A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors|A Randomized Phase 2 Study of Vincristine Versus Sirolimus to Treat High Risk Kaposiform Hemangioendothelioma (KHE).|Recruiting||Phase 2|50|Anticipated|Boston Children’s Hospital||2|||f||||t|t|f||||||||2017-10-11 00:34:18.544184|2017-10-11 00:34:18.544184
NCT02110056|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-07-04|||March 2014||2014-03-01|July 2017|2017-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Modulation of Visual-Spatial Learning in Healthy Older Adults by tDCS|Modulation of Visual-Spatial Learning in Healthy Older Adults by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms|Completed||N/A|32|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:34:18.714467|2017-10-11 00:34:18.714467
NCT02110043|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-07-26|||March 2014||2014-03-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS|Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms|Active, not recruiting||N/A|21|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:34:18.818277|2017-10-11 00:34:18.818277
NCT02110030|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-04-08|||January 2013||2013-01-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|TENSIC||Effectiveness of Two Electrotherapy Techniques to Treat Subacromial Impingement Syndrome|Effectiveness of Two Electrotherapy Techniques to Treat Subacromial Impingement Syndrome|Completed||N/A|42|Actual|Camilo Jose Cela University||2|||f||||f||||||||||2017-10-11 00:34:18.945449|2017-10-11 00:34:18.945449
NCT02110017|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2015-02-04|||September 2013||2013-09-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|IRM-COG||Exploration of Neural Bases in Social Cognition|Exploration of Neural Bases in Social Cognition|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-11 00:34:19.20435|2017-10-11 00:34:19.20435
NCT02110004|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-06-09|||March 2014||2014-03-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man|Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man|Completed||Phase 1|30|Actual|Biosense Webster, Inc.||1|||f||||t||||||||||2017-10-11 00:34:19.367231|2017-10-11 00:34:19.367231
NCT02109991|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-07-19|||March 2014||2014-03-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety, Tolerability and Performance Profile of the Colospan Device CG-100 in Patients Undergoing Colorectal Surgery|A Prospective, Multi-center, Single-arm, Open-label Study Designed to Evaluate Safety, Tolerability and Performance Profile of the Colospan Device CG-100 in Patients Undergoing Colorectal Surgery|Active, not recruiting||N/A|60|Actual|Colospan Ltd.||1|||f||||||||||||||2017-10-11 00:34:19.495315|2017-10-11 00:34:19.495315
NCT02109978|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-03-21|||April 2013||2013-04-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|RetroMASTER||RetroMASTER - Retrospective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes|Retrospective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes:|Completed||N/A|562|Actual|NIHR Exeter Clinical Research Facility|||2||f||||t||||||Samples With DNA|"     At Visit 1 a fasting blood sample (approximately 35 mls) will be taken for DNA extraction,     and to measure for markers of the progression of diabetes or response to diabetes medication     and for secondary markers that may predict response. A urine sample is also collected to     measure for biomarkers.   "|||2017-10-11 00:34:19.635916|2017-10-11 00:34:19.635916
NCT02109965|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-12-20|||July 2014||2014-07-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Dexmedetomidine on Microcirculation in Severe Sepsis|The Effect of Dexmedetomidine on the Microcirculation in Patients With Severe Sepsis and Septic Shock|Recruiting||Phase 4|60|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:34:19.772926|2017-10-11 00:34:19.772926
NCT02109952|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-03-09|||January 2009||2009-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|12 Months|Observational [Patient Registry]|||Biomechanics of Metastatic Defects in Bone|The Purpose of This Study is to Monitor Fracture Risk Associated With Bone Tumors in Cancer Patients|Recruiting||N/A|245|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-11 00:34:19.890392|2017-10-11 00:34:19.890392
NCT02109939|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-09-15|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|RCT||Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic|A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic|Completed||Phase 4|1303|Actual|Assurex Health Inc.||2|||f||||f||||||||||2017-10-11 00:34:20.010386|2017-10-11 00:34:20.010386
NCT02109926|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-11-30|||January 2015||2015-01-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|TESTIS||A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor|A Multicentric Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures During Antenatal and Early Postnatal Periods and the Risk to Develop a Testicular Germ Cell Tumor During Adulthood|Recruiting||N/A|1500|Anticipated|Centre Leon Berard|||3||f||||f||||||Samples With DNA|"     plasma and buffy coat   "|||2017-10-11 00:34:20.257754|2017-10-11 00:34:20.257754
NCT02109913|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-03-30|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane|Phosphatidylinositol 3-kinase (PI3K) Pathway Analysis in Tumor Tissue and Circulating DNA to Obtain Further Insight in the Efficacy of Everolimus When Combined With Exemestane: A Side-study Protocol Attached to Standard Treatment With Everolimus and Exemestane for Postmenopausal Patients With Hormone Receptor-positive Advanced Metastatic Breast Cancer, Who Have Progressed on Anastrozole or Letrozole|Active, not recruiting||N/A|175|Anticipated|VU University Medical Center||1|||f||||t||||||||||2017-10-11 00:34:20.504268|2017-10-11 00:34:20.504268
NCT02109900|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-08|||February 2014||2014-02-01|April 2014|2014-04-01||||June 2014|Anticipated|2014-06-01||Observational|||Prognostic Value of Progesterone on Oocyte Retrieval Day for In Vitro Fertilization Outcome|Prognostic Value of Progesterone Levels on Oocyte Retrieval Day for Outcome of Intracytoplasmic Sperm Injection|Unknown status|Active, not recruiting|N/A|180|Anticipated|Acibadem University|||1||f||||||||||||||2017-10-11 00:34:20.769375|2017-10-11 00:34:20.769375
NCT02109887|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-02-05|||June 2014||2014-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP)|Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP)|Recruiting||N/A|100|Anticipated|Asan Medical Center|||3||f||||f||||||||||2017-10-11 00:34:20.849335|2017-10-11 00:34:20.849335
NCT02109874|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-04-25|||December 2008||2008-12-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|December 2010|Actual|2010-12-01||Interventional|C-011-404||A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404)|A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS 404 When Administered as a Single Adjuvant Amount With Different Antigen Amounts in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection|Completed||Phase 1|40|Actual|Aeras||5|||f||||t||||||||||2017-10-11 00:34:20.942494|2017-10-11 00:34:20.942494
NCT02109848|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-04-21|||June 2011||2011-06-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Observational Study of Keratoconus and Post-keratoplasty Eyes|Observational Study of Keratoconus and Post-keratoplasty Eyes|Unknown status|Recruiting|N/A|50|Anticipated|Oregon Health and Science University|||3||f||||f||||||||||2017-10-11 00:34:21.171749|2017-10-11 00:34:21.171749
NCT02109835|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2015-05-18|||September 2012||2012-09-01|May 2015|2015-05-01|July 2017|Anticipated|2017-07-01|July 2015|Anticipated|2015-07-01||Observational|PROCEED||Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects|Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects: Evaluation of the Role of CT Coronary Angiography and Novel Bio-markers of Endothelial Dysfunction and Vascular Inflammation|Unknown status|Recruiting|N/A|250|Anticipated|British Cardiac Research Trust|||1||f||||t||||||Samples With DNA|"     Plasma and serum will be separated from the blood sample collected within half an hour. These     samples will be labelled with the unique random number assigned to each patient recruited to     the study. The link file with the random numbers and patient identifiers will be kept on     single computer with restricted access to only members of the research team. Only the     completely anonymised samples will be sent to the labs for analysis. 5 mls of whole blood     with cells will also be stored.   "|||2017-10-11 00:34:21.263925|2017-10-11 00:34:21.263925
NCT02109822|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|STOP-OB-13||Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF|Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis|Completed||N/A|220|Actual|University of Washington|||1||f||||f||||||||Yes|Data will be available once the primary manuscripts are published. Data without identifiers will be available through the Cystic Fibrosis Therapeutics Development Network Coordinating Center once an application to use the data is approved.|2017-10-11 00:34:21.394727|2017-10-11 00:34:21.394727
NCT02109809|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-06-13|||July 2014||2014-07-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Low-Dose Total Lymphoid Irradiation in Treating Patients With Refractory Chronic Graft-versus-Host Disease After Donor Stem Cell Transplant|A Phase I Study: Low-Dose Total Lymphoid Irradiation in the Treatment of Refractory Chronic Graft Versus Host Disease|Terminated||N/A|4|Actual|Wake Forest University Health Sciences||1||Slow Accruals|f||||f|f|f||||||||2017-10-11 00:34:21.519346|2017-10-11 00:34:21.519346
NCT02109796|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-10-28|||February 2015||2015-02-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|tDCS(HE)||Effects of tDCS on Quadriceps Strength After Stroke|a Controlled, Randomized Study Evaluating the Immediate Effect of One tDCS Session on Quadriceps Strength in Hemiparetic Patients.|Recruiting||N/A|30|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||t||||||||||2017-10-11 00:34:21.616304|2017-10-11 00:34:21.616304
NCT02109783|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-11-30|||June 2014||2014-06-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|GMC-AP||Caffeine, Genetic Variation and Athletic Performance|Genetic Modifiers of Caffeine Intake and Athletic Performance|Active, not recruiting||N/A|100|Anticipated|University of Toronto||3|||f||||f||||||||||2017-10-11 00:34:21.726775|2017-10-11 00:34:21.726775
NCT02109770|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-09-21|||October 2012||2012-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|Microdel Triad||Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA|Development of Non-invasive Prenatal Test for Microdeletion/Duplication and Other Genetic Syndromes Based on Fetal DNA Isolated From Maternal Blood|Recruiting||N/A|200|Anticipated|Natera, Inc.|||1||f||||f||||||Samples With DNA|"     -  Maternal blood sample        -  Affected child blood sample        -  Unaffected sibling blood sample        -  Father buccal or blood sample   "|||2017-10-11 00:34:21.829688|2017-10-11 00:34:21.829688
NCT02109757|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-04-07|||March 2014||2014-03-01|April 2014|2014-04-01||||October 2015|Anticipated|2015-10-01||Interventional|||Evaluation of Hearing Protection Fit Testing Program|Evaluation of Hearing Protection Fit Testing Program|Unknown status|Recruiting|N/A|200|Anticipated|United States Air Force||2|||f||||t||||||||||2017-10-11 00:34:21.941566|2017-10-11 00:34:21.941566
NCT02109731|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2015-03-25|2015-03-12||January 2009||2009-01-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||All subjects have a diagnosis of OSA and are not currently receiving CPAP therapy|Upper Airway Physical Therapy for the Treatment of Obstructive Sleep Apnea|Upper Airway Physical Therapy for the Treatment of Obstructive Sleep Apnea|Completed||N/A|15|Actual|University of Rochester||1|||f||||t||||||||||2017-10-11 00:34:22.254876|2017-10-11 00:34:22.254876
NCT02109718|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-04-09|||January 2009||2009-01-01|April 2014|2014-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Trial Comparing the Efficacy and Safety of Open Dressing With Petrolatum Jelly vs. Standard Gauze Dressing With Silver Sulfadiazine|A Randomized Controlled Clinical Trial Comparing The Efficacy and Safety of Open Dressing With Petrolatum Jelly vs. Standard Gauze Dressing With Silver Sulfadiazine in the Treatment of Filipino Adults Aged 18-45 Years Old With Superficial Partial Thickness Burns Less Than or Equal to 10% Total Surface Area Who Are Seen at the Philippine General Hospital Burn Outpatient Clinic|Completed||Phase 3|50|Actual|University of the Philippines||2|||f||||t||||||||||2017-10-11 00:34:22.485407|2017-10-11 00:34:22.485407
NCT02109705|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-12-08|||March 2014||2014-03-01|December 2014|2014-12-01||||February 2015|Anticipated|2015-02-01||Observational|PGNEURO||Porphyromonas Gingivalis and Alzheimer`s Disease|Porphyromonas Gingivalis - a Responsible Pathogen in Alzheimer`s Disease?|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital Muenster|||3||f||||f||||||Samples With DNA|"     GCF, Liquor, Serum   "|||2017-10-11 00:34:22.593447|2017-10-11 00:34:22.593447
NCT02109692|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-01-08|||May 2014||2014-05-01|January 2015|2015-01-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|biodystromirs||Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies|Quantification of Muscle Specific microRNAs in the Serum of Patients With Duchenne Muscular Dystrophy (DMD) and Becker (BMD) : Evaluation of the Inters-est of These Biomarkers in Patients Care|Recruiting||N/A|186|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 00:34:22.688846|2017-10-11 00:34:22.688846
NCT02109679|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2016-01-26|||May 2014||2014-05-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects|Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects (an Open-label, Randomised, Two-sequence Crossover Study)|Completed||Phase 1|16|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:34:22.791765|2017-10-11 00:34:22.791765
NCT02109666|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-04-17|||March 2008||2008-03-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|ACTION||Long Term Experience With Abatacept in Routine Clinical Practice|Long Term Experience With Abatacept in Routine Clinical Practice|Completed||N/A|2364|Actual|Bristol-Myers Squibb|||1||f||||f||||||None Retained|"     Whole blood (Spanish sub study only)   "|||2017-10-11 00:34:22.878496|2017-10-11 00:34:22.878496
NCT02109653|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-02-11|||June 2015||2015-06-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC|A Phase II, Single Arm, Open-label, Multicenter, Study of Oral LGX818 in Patients With BRAF V600 Mutant, Advanced Non-small Cell Lung Cancer (NSCLC) That Have Progressed During or After at Least One Prior Chemotherapy|Withdrawn||Phase 2|0|Actual|Array BioPharma||1||Study never started - transferred to Array.|f||||f||||||||||2017-10-11 00:34:23.02155|2017-10-11 00:34:23.02155
NCT02108912|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-06-21|||March 2014||2014-03-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Metabolic Costs of Walking Post Stroke|The Impact of Gait Training on the Metabolic Costs of Walking and Cardiorespiratory Capacity in Persons Post Stroke|Completed||N/A|16|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-11 00:34:32.130772|2017-10-11 00:34:32.130772
NCT02109640|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-02-08|2016-11-23||October 2014||2014-10-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|TACS||A Comparison of Targinact vs. Oxycodone on Gut Function After Colorectal Surgery|A Randomized Blinded Pilot Study to Compare Targinact vs. Oxycodone in Early Return of Gastrointestinal Function After Colorectal Surgery|Completed||Phase 3|50|Actual|University of Edinburgh||2|||f||||t||||||||No||2017-10-11 00:34:23.120878|2017-10-11 00:34:23.120878
NCT02109627|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-06-07|||January 2015||2015-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML|Phase Ib Study of Ficlatuzumab With High Dose Cytarabine (HiDAC) in Relapsed and Refractory AML|Recruiting||Phase 1|24|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 00:34:23.713444|2017-10-11 00:34:23.713444
NCT02109614|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-09-12|||May 2014||2014-05-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|EAVaLL||Early Aortic Valve Lipoprotein(a) Lowering Trial|A Pilot,Randomized Controlled-trial of Lipoprotein(a) Lowering for the Prevention of Aortic Valve Disease-translating Genomic Knowledge for Cardiovascular Prevention|Recruiting||Early Phase 1|238|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 00:34:23.857407|2017-10-11 00:34:23.857407
NCT02109601|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-06-16|||November 2013||2013-11-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Patient-Centered Tablets: Applications for Inpatient Admissions|Tablet Computers for Hospitalized Adults: a Novel Approach to Increasing Patient Engagement With Their Electronic Personal Health Records|Completed||N/A|98|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:34:23.975337|2017-10-11 00:34:23.975337
NCT02109588|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-11-13|||March 2014||2014-03-01|October 2013|2013-10-01|April 2018|Anticipated|2018-04-01|August 2014|Actual|2014-08-01||Interventional|||Early Prevention of Childhood Obesity: an Active Pregnancy|Early Prevention of Childhood Obesity: an Active Pregnancy|Recruiting||N/A|1100|Anticipated|Technical University of Madrid||2|||f||||t||||||||||2017-10-11 00:34:24.067321|2017-10-11 00:34:24.067321
NCT02109575|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-03-23|||September 2013||2013-09-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|DTRT||Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)|Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)|Recruiting||N/A|480|Anticipated|Medical College of Wisconsin|||1||f||||f|f|t|f||f|Samples With DNA|"     Whole Blood   "|||2017-10-11 00:34:24.190733|2017-10-11 00:34:24.190733
NCT02109562|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-09-09||2015-08-07|April 2014||2014-04-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)|Completed||Phase 3|259|Actual|Indivior Inc.||3|||f||||f||||||||||2017-10-11 00:34:24.349867|2017-10-11 00:34:24.349867
NCT02109549|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-05-31|||March 2014||2014-03-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|Metformin||Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.|Influence of Metformin Use on Treatment Outcome in NSCLC Patients|Completed||N/A|70|Actual|Maastricht Radiation Oncology|||3||f||||f||||||||||2017-10-11 00:34:24.508172|2017-10-11 00:34:24.508172
NCT02109536|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-02-14|||February 2014||2014-02-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Use of Magnetic Endoscopic Imagers During Colonoscopy for Loop Recognition and Resolution|The Use of Magnetic Endoscopic Imagers During Colonoscopy for Loop Recognition and Resolution|Recruiting||N/A|800|Anticipated|Queen's University|||1||f||||f||||||||||2017-10-11 00:34:24.593306|2017-10-11 00:34:24.593306
NCT02109523|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-04-12|||March 2014||2014-03-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Improving Adherence to Medication After Coronary Artery Bypass Surgery (CABG) in Older Adults||Completed||Phase 2|288|Actual|Qazvin University Of Medical Sciences||2|||f||||||||||||||2017-10-11 00:34:24.679995|2017-10-11 00:34:24.679995
NCT02109510|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-07|||November 2012||2012-11-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Comparative Study of Nonintubated Anesthesia Versus Intubated General Anesthesia in Single Port Thoracoscopic Bullectomy|Comparative Study of Single Port Thoracoscopic Bullectomy Under Nonintubated Local and Sedation Anesthesia Versus Intubated General Anesthesia for Primary Spontaneous Pneumothorax.|Completed||N/A|40|Actual|Korea University||2|||f||||t||||||||||2017-10-11 00:34:24.79136|2017-10-11 00:34:24.79136
NCT02109497|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-03-29|2015-11-17||May 2014||2014-05-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Phase 1 Study to Determine the Effects of PBT2 on the Pharmacokinetic Profile of Caffeine|A Phase 1, Single Centre, Open Label, Two-period Study in Healthy Volunteers to Determine the Effect of PBT2 on the Pharmacokinetics of Caffeine|Completed||Phase 1|18|Actual|Prana Biotechnology Limited||1|||f||||f||||||||||2017-10-11 00:34:24.889655|2017-10-11 00:34:24.889655
NCT02109471|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-04-21|||June 2011||2011-06-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Observational Study of Corneal Opacities in Adults|Observational Study of Corneal Opacities in Adults|Unknown status|Recruiting|N/A|150|Anticipated|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 00:34:25.433198|2017-10-11 00:34:25.433198
NCT02109458|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-03-13|2016-10-27||September 2013||2013-09-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Pilot Study of Navigational Bronchoscopy and Transthoracic Needle Biopsy|Navigational Bronchoscopy and Transthoracic Needle Biopsy for the Diagnosis of Peripheral Pulmonary Nodules: A Safety and Feasibility Pilot|Completed||N/A|24|Actual|Johns Hopkins University||1|||f||||f||||||||No||2017-10-11 00:34:25.513654|2017-10-11 00:34:25.513654
NCT02109445|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-05-08|2017-03-24|2015-12-07|September 3, 2014|Actual|2014-09-03|May 2017|2017-05-01|November 6, 2014|Actual|2014-11-06|November 6, 2014|Actual|2014-11-06||Interventional|||Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies|Phase 1/2 Study Of Pf-03084014 In Combination With Gemcitabine And Nab-paclitaxel In Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma|Terminated||Phase 2|3|Actual|Pfizer|Due to early termination of the study, only 3 participants were enrolled. Phase 2 was not carried out. As such, there is limited data for Phase 1 and no data for Phase 2.|3||"The study was terminated on 24JUN15 due to change in strategy of PF-03084014 development.No   safety/efficacy concerns were behind the reason of trial termination"|f||||t||||||||||2017-10-11 00:34:25.737831|2017-10-11 00:34:25.737831
NCT02109432|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-01-15|||May 2014||2014-05-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PD-ST||Short-term Behavior Change With Pedal Desk Installation|Short-term Behavior Change With Pedal Desk Installation|Terminated||N/A|6|Actual|Pennington Biomedical Research Center||1||Continued development of technology|f||||f||||||||||2017-10-11 00:34:26.353673|2017-10-11 00:34:26.353673
NCT02109406|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-10-16||2014-07-15|May 2014||2014-05-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPD|A Randomized, Double Blind, Chronic Dosing (14 Days), Three Period, Placebo Controlled, Cross Over, Multi Center Study to Assess Efficacy and Safety of Two Dose Levels of AZD2115 MDI in Subjects With Moderate to Severe COPD|Completed||Phase 2|30|Anticipated|Pearl Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 00:34:26.505814|2017-10-11 00:34:26.505814
NCT02109393|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-12-05|||April 2014||2014-04-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PSP-MIRTLoko||Rehabilitation in Patients With Progressive Supranuclear Palsy|Rehabilitation in Patients With Progressive Supranuclear Palsy: Effectiveness of Two Intensive Protocols|Completed||N/A|24|Actual|Ospedale Generale Di Zona Moriggia-Pelascini||2|||f||||t||||||||Undecided||2017-10-11 00:34:26.5824|2017-10-11 00:34:26.5824
NCT02109380|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-04-27|||June 2014||2014-06-01|April 2015|2015-04-01||||April 2015|Actual|2015-04-01||Interventional|||Bed-rest, Muscle Mass and Insulin Sensitivity|The Impact of Short-term Bed-rest on Skeletal Muscle Mass and Insulin Sensitivity in Healthy, Young Men|Completed||N/A|15|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 00:34:26.663911|2017-10-11 00:34:26.663911
NCT02109367|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-02-10|||February 2014||2014-02-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Observational|||Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass|Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass|Recruiting||N/A|30|Anticipated|Southern Illinois University|||1||f||||t||||||None Retained|"     fluid sample infused and collected from the cul-de-sac   "|Undecided||2017-10-11 00:34:26.745948|2017-10-11 00:34:26.745948
NCT02109354|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2014-04-04|||June 2013||2013-06-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|HVTN 097||Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults|Phase 1b Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of the Vaccine Regimen ALVAC-HIV (vCP1521) Followed by AIDSVAX® B/E in Healthy, HIV-1 Uninfected Adult Participants in South Africa|Unknown status|Active, not recruiting|Phase 1|100|Anticipated|HIV Vaccine Trials Network||3|||f||||t||||||||||2017-10-11 00:34:26.835873|2017-10-11 00:34:26.835873
NCT02109341|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-02-02|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|NabucCO||Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer|Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|148|Actual|Gruppo Oncologico Italiano di Ricerca Clinica||2|||f||||t||||||||||2017-10-11 00:34:27.070478|2017-10-11 00:34:27.070478
NCT02109328|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-07|||April 2014||2014-04-01|April 2014|2014-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Alisertib in Chemotherapy-pretreated Urothelial Cancer|A Phase 2 Study of the Aurora Kinase A Inhibitor Alisertib (MLN8237) in Patients With Relapsed or Refractory Transitional-cell Carcinoma of the Bladder and Urothelial Tract|Not yet recruiting||Phase 2|130|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-11 00:34:27.196114|2017-10-11 00:34:27.196114
NCT02109315|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-07|||May 2014||2014-05-01|April 2014|2014-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|DIAB-01||Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.|Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 00:34:27.311547|2017-10-11 00:34:27.311547
NCT02109302|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-07||||||April 2014|2014-04-01||||April 2018|Anticipated|2018-04-01||Interventional|||Primary Premature Ejaculation Genetics|Identification Des Bases moléculaires de l'éjaculation prématurée Primaire|Not yet recruiting||N/A|70|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||||||||||||2017-10-11 00:34:27.407377|2017-10-11 00:34:27.407377
NCT02109289|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-02-06|||April 2014||2014-04-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Etanercept in Rheumatoid Arthritis and Vascular Inflammation|Pilot Open-label Study of the Effect of Etanercept on Vascular Inflammation in Patients With Active Rheumatoid Arthritis|Terminated||Phase 4|5|Actual|Innovaderm Research Inc.||1||Recruitment difficulties|f||||f||||||||No||2017-10-11 00:34:27.500472|2017-10-11 00:34:27.500472
NCT02108691|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-05-06|2015-05-06||May 2014||2014-05-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Intake of Glycin Max (L.) Merr. Peel Extract on Body Fat and Body Weight||Completed||Phase 2/Phase 3|80|Actual|Hanyang University||2|||f||||t||||||||||2017-10-11 00:34:34.033107|2017-10-11 00:34:34.033107
NCT02109276|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-09-26|||April 2014||2014-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of the Effect of Aspheric Lenses in Patients With Fuch's Dystrophy|Contrast Sensitivity and Higher Order Aberrations After Spheric and Aspheric Intraocular Lens Implantation for Patients With Mild to Moderate Fuch's Endothelial Dystrophy.|Withdrawn||N/A|0|Actual|Queen's University||2||not enough participants|f||||f||||||||||2017-10-11 00:34:27.595975|2017-10-11 00:34:27.595975
NCT02109263|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-04-21|||June 2013||2013-06-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ACTISUCROSE||Prevention of the Procedural Pain in the Newborn|Breastfeeding Versus Saccharose for Prevention of the Procedural Pain in the Newborn|Completed||N/A|114|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 00:34:27.683812|2017-10-11 00:34:27.683812
NCT02109250|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-04-28|||April 2014||2014-04-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01|16 Months|Observational [Patient Registry]|CaprelsaReg||CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice|CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice|Completed||N/A|10|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 00:34:27.766903|2017-10-11 00:34:27.766903
NCT02109237|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-05-01|||May 2014||2014-05-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3|The Prevalence and Treatment of Sleep Disorders in Lung Transplant Recipients With BOS 2 & 3 and the Influence on Quality of Life and Daytime Activity.|Recruiting||N/A|75|Anticipated|The Prince Charles Hospital||2|||f||||t||||||||Yes||2017-10-11 00:34:27.889187|2017-10-11 00:34:27.889187
NCT02109224|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-08-18|||September 2014||2014-09-01|April 2015|2015-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection|Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma|Terminated||Phase 1|72|Actual|National Cancer Institute (NCI)||1||Inadequate accrual rate|f||||||||||||||2017-10-11 00:34:28.002509|2017-10-11 00:34:28.002509
NCT02109211|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-12-05|||May 2014||2014-05-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Does Altering Magill Forceps Affect Nasal Intubation Time|Does Altering The Magill Forceps Angle By 45 Degrees Alter Nasal Intubation Time In Pediatric Dental Surgery Patients?|Completed||N/A|133|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 00:34:28.154168|2017-10-11 00:34:28.154168
NCT02109198|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-05-29|||June 2015||2015-06-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Pilot Trial)|Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Pilot Phase)|Withdrawn||N/A|0|Actual|U.S. Army Medical Research and Materiel Command||2||protocol withdrawn|f||||f||||||||||2017-10-11 00:34:28.236702|2017-10-11 00:34:28.236702
NCT02109185|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-08|||September 2013||2013-09-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers|A Randomized, Double-Blind, Multiple-Dose Trial of Mometasone Nasal Spray, 50 μg (Mylan), Nasonex® Nasal Spray, 50 μg (MSD-US), Nasonex® Nasal Spray Suspension, 50 μg (MSD-EU) & Placebo for Treatment of the Signs & Symptoms of Seasonal Allergic Rhinitis in 1,520 Male & Female Volunteers|Completed||Phase 1|1307|Actual|Mylan Pharmaceuticals||4|||f||||f||||||||||2017-10-11 00:34:28.343501|2017-10-11 00:34:28.343501
NCT02109172|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2017-01-17|2016-10-13||April 2014||2014-04-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Cross-Over Study of QD and BID Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|64|Actual|Theravance Biopharma R & D, Inc.|The study was designed to evaluate whether a lower dose (44) BID would achieve a greater response than a higher dose (175) QD.|3|||f||||f||||||||No||2017-10-11 00:34:28.458292|2017-10-11 00:34:28.458292
NCT02109159|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-10-27|2016-06-07||December 2014||2014-12-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|DIFFUSION||Dissemination of Findings Fast Using Online-videos Trial|A Randomize Controlled Trial of the Effect of Emotional Content on the Extent to Which an On-line Medical Educational Video is Forwarded.|Completed||N/A|8353|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 00:34:28.969806|2017-10-11 00:34:28.969806
NCT02109146|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-01-24|||January 1, 2014||2014-01-01|January 2017|2017-01-01||||July 30, 2017|Anticipated|2017-07-30||Interventional|||Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma||Recruiting||N/A|150|Anticipated|Zhejiang University||2|||f||||||||||||||2017-10-11 00:34:29.314116|2017-10-11 00:34:29.314116
NCT02109133|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2015-06-21|2015-04-15||May 2014||2014-05-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Impacts of Surgical Visibility Through Deep Neuromuscular Blockade on Intraocular Pressure in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy||Completed||N/A|67|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:34:29.408549|2017-10-11 00:34:29.408549
NCT02109120|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-08|||February 2012||2012-02-01|September 2013|2013-09-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01|7 Days|Observational [Patient Registry]|MMP9MPCE||MMP-9 Monitoring Particulate Cerebral Embolisation|Dynamic Changes of MMP9 Concentration Cross Carotid Endarterectomy Monitoring Particulate Cerebral Embolisation|Completed||N/A|48|Actual|Peking Union Medical College Hospital|||1||f||||t||||||Samples Without DNA|"     serum,Freeze-saving -80℃   "|||2017-10-11 00:34:29.862321|2017-10-11 00:34:29.862321
NCT02109107|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-12-31|2015-12-31||October 2013||2013-10-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study of Low Level Laser Light Therapy on Circumference Reduction|An Evaluation of the Effect of the Erchonia® Zerona 6 Headed Scanner (EZ6) Six-week Treatment Protocol on Circumference Reduction of the Waist, Hips, Thighs and Upper Abdomen Clinical Study Protocol|Completed||N/A|54|Actual|Erchonia Corporation||1|||f||||f||||||||||2017-10-11 00:34:29.949588|2017-10-11 00:34:29.949588
NCT02109094|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-03-19|||February 2014||2014-02-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Investigating Markers of Energy Metabolism in Pregnant Women With Insulin Resistance|Investigating Markers of Energy Metabolism in the CNS and Periphery in Pregnant Women With Varying Degrees of Insulin Resistance|Completed||N/A|48|Actual|Yale University|||2||f||||f||||||Samples With DNA|"     whole blood, urine, cerebrospinal fluid, cord blood   "|||2017-10-11 00:34:30.225694|2017-10-11 00:34:30.225694
NCT02109081|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-04-11|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dexamethasone and Postoperative Delirium|Dexamethasone and Postoperative Delirium|Recruiting||Phase 4|400|Anticipated|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||||2017-10-11 00:34:30.299142|2017-10-11 00:34:30.299142
NCT02109068|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-04-08|||January 2011||2011-01-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|LEAN||Lifestyle, Exercise and Nutrition Study 1|Lifestyle, Exercise and Nutrition (LEAN) Study 1|Completed||Phase 3|100|Actual|Yale University||3|||f||||t||||||||||2017-10-11 00:34:30.410231|2017-10-11 00:34:30.410231
NCT02109055|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-08|||April 2014||2014-04-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Interventional|||Application of Exercises Based on the Pilates in Coronary Artery Bypass Grafting|Application of Exercises Based on the Pilates Method on the Functional Capacity in Postoperative Surgery Coronery Artery Bypass Grafting: Randomized Clinical Trial|Unknown status|Recruiting|N/A|30|Anticipated|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||||2017-10-11 00:34:30.507018|2017-10-11 00:34:30.507018
NCT02109029|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-05-14|||April 2014||2014-04-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study of LY2505541 and Human Insulin Concentrations in Fat Tissue|Use of Open-Flow Microperfusion to Measure LY2605541 and Human Insulin Concentrations in Adipose Tissue Interstitial Fluid|Completed||Phase 1|24|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 00:34:30.709095|2017-10-11 00:34:30.709095
NCT02109016|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-07-21||2017-07-21|April 2014||2014-04-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations|A Single Arm, Open-label, Phase 2 Study to Assess the Efficacy and Safety of Lucitanib Given Orally as a Single Agent to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations|Completed||Phase 2|18|Actual|Clovis Oncology, Inc.||1|||f||||t||||||||||2017-10-11 00:34:30.796274|2017-10-11 00:34:30.796274
NCT02109003|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-05-30|||April 2014||2014-04-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Efficiency of a Mechanical Device in Controlling Tracheal Cuff Pressure in Intubated Critically Ill Patients|Efficiency of PressureEasy in Controlling Tracheal Cuff Pressure in Intubated Critically Ill Patients|Completed||N/A|18|Actual|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-11 00:34:30.931683|2017-10-11 00:34:30.931683
NCT02108990|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-12-21|||September 2013||2013-09-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Acetaminophen and Social Processes|Acetaminophen and Social Pain in Borderline Personality Disorder|Active, not recruiting||Phase 2|30|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-11 00:34:31.231411|2017-10-11 00:34:31.231411
NCT02108977|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-07-11|2016-04-08||April 2014||2014-04-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|EVTGC|We define baseline participants as those who enrolled in the study and participated in the knowledge pre-test.|Evaluation of Videoconferencing Versus Telephone Genetic Counseling|Evaluation of Videoconferencing vs Telephone Genetic Counseling Consultations|Completed||N/A|38|Actual|VA Office of Research and Development|We did not achieve the study sample that we hoped to achieve. Patients randomized to the telephone arm participated in the study, whereas patients randomized to the videoconferencing arm often dropped out of the study.|2|||f||||f||||||||||2017-10-11 00:34:31.345268|2017-10-11 00:34:31.345268
NCT02108964|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-07-24|||June 17, 2013|Actual|2013-06-17|July 2017|2017-07-01|July 25, 2019|Anticipated|2019-07-25|February 11, 2018|Anticipated|2018-02-11||Interventional|||A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies|A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies|Recruiting||Phase 1/Phase 2|220|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-11 00:34:31.674472|2017-10-11 00:34:31.674472
NCT02108938|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-10-31|||April 2014||2014-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|May 2015|Actual|2015-05-01||Observational|||Brain-Gut Interactions in Crohn's Disease|Characterizing Brain-Gut Interaction in Patients With Crohn's Disease Using Advanced Neuroimaging Tools|Active, not recruiting||N/A|20|Anticipated|University of Wisconsin, Madison|||2||f||||f||||||||||2017-10-11 00:34:31.975827|2017-10-11 00:34:31.975827
NCT02108925|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-03-16|||April 2014||2014-04-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease Patients|Oxygen Supply and Ventilation During Physical Exercise in Patients With Chronic Obstructive Pulmonary Disease|Active, not recruiting||N/A|16|Actual|LHL Helse||1|||f||||f||||||||No||2017-10-11 00:34:32.048095|2017-10-11 00:34:32.048095
NCT02108899|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-10-04|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Retrieval Practice and Schizophrenia|Retrieval Practice in Patients With Schizophrenia : an Exploratory Study Using Descriptive Stories|Recruiting||N/A|50|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 00:34:32.214906|2017-10-11 00:34:32.214906
NCT02108886|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-03-03|||December 2011||2011-12-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|July 2014|Actual|2014-07-01||Interventional|EAU2-Mtlk||Pilot Study Testing a New Strategy for Management of Spontaneous Preterm Birth|Pilot Study Testing a New Strategy for Management of Spontaneous Preterm Birth.|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 00:34:32.303938|2017-10-11 00:34:32.303938
NCT02108873|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-06|2015-03-19|||May 2014||2014-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|AU1||Factors Associated With Nonattendance at Scheduled Outpatient Appointments in a University General Hospital|Factors Associated With Nonattendance at Scheduled Outpatient Appointments in a University General Hospital|Completed||N/A|10000|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 00:34:32.412172|2017-10-11 00:34:32.412172
NCT02108860|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-08-03|||April 2015||2015-04-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)|Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) (ABROGATE)|Recruiting||Phase 3|150|Anticipated|University of South Florida||2|||f||||t|t|f|||t|||||2017-10-11 00:34:32.526423|2017-10-11 00:34:32.526423
NCT02108847|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-11-10|||April 2014||2014-04-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Ultrasound Guided Fascia Iliaca Block for Pain Control After Elective Hip Replacement Surgery|Ultrasound Guided Fascia Iliaca Block for Postoperative Analgesia After Elective Total Hip Arthroplasty|Completed||N/A|42|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 00:34:32.80863|2017-10-11 00:34:32.80863
NCT02108834|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-01-19|||April 2014||2014-04-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Interventional|||Regional Anesthesia for Thyroidectomy|Randomized Controlled Trial of Regional Anesthesia in Combination With General Anesthesia for Thyroidectomy|Unknown status|Recruiting|N/A|79|Anticipated|Guangzhou First People's Hospital||2|||f||||t||||||||||2017-10-11 00:34:32.897927|2017-10-11 00:34:32.897927
NCT02108821|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-07-18|||September 2014||2014-09-01|July 2017|2017-07-01|July 11, 2017|Actual|2017-07-11|May 30, 2017|Actual|2017-05-30||Interventional|FMT||Fecal Microbiota Transplantation in Pediatric Patients|A Study of Fecal Microbiota Transplantation in Pediatric Patients With Relapsed Inflammatory Bowel Disease.|Completed||Phase 1|23|Actual|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-10-11 00:34:33.001379|2017-10-11 00:34:33.001379
NCT02108808|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-01-04|||April 2014||2014-04-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Ticagrelor on Fractional Flow Reserve|Differential Effect of Ticagrelor vs Prasugrel or Clopidogrel Loading on Fractional Flow Reserve|Completed||Phase 4|76|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 00:34:33.10112|2017-10-11 00:34:33.10112
NCT02108795|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-07-14|||April 2014||2014-04-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||The Effect of Remifentanil Infusion During Emergence on the Incidence of Emergence Delirium|The Effect of Remifentanil Infusion During Emergence on the Incidence of Emergence Delirium After Sevoflurane Anesthesia in Pediatric Strabismus Surgery|Unknown status|Recruiting|N/A|86|Anticipated|Yeungnam University College of Medicine||2|||f||||t||||||||||2017-10-11 00:34:33.215399|2017-10-11 00:34:33.215399
NCT02108782|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-07-18|||October 2014||2014-10-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors|Phase II Study of Dovitinib (TKI-258) in Progressive, Well-Differentiated Pancreatic Neuroendocrine Tumors With and Without Prior VEGF-Inhibitor Therapy|Withdrawn||Phase 2|0|Actual|Academic and Community Cancer Research United||1|||f||||t||||||||||2017-10-11 00:34:33.320234|2017-10-11 00:34:33.320234
NCT02108769|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-07|||October 2013||2013-10-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Yogic Breathing Changes Salivary Components|Induction of Salivary Neuromodulators by Chanting and Breathing Exercise|Completed||N/A|20|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 00:34:33.416367|2017-10-11 00:34:33.416367
NCT02108756|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-08|||February 2014||2014-02-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding||Unknown status|Recruiting|N/A|272|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-11 00:34:33.537863|2017-10-11 00:34:33.537863
NCT02108743|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-12-29|||June 2014||2014-06-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension|Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension|Withdrawn||Phase 2|0|Actual|American Medical Association Foundation||2||Lack of funding|f||||t||||||||||2017-10-11 00:34:33.639946|2017-10-11 00:34:33.639946
NCT02108730|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-04-08|||March 2011||2011-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|non-focal CHI||Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism|Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism|Completed||N/A|14|Actual|University Medicine Greifswald|||1||f||||||||||||||2017-10-11 00:34:33.739025|2017-10-11 00:34:33.739025
NCT02108717|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-05-06|||April 2014||2014-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Telemedicine||The Feasibility Study for Real-time Remote CT Reading for Suspected Acute Appendicitis Using iPhone|The Feasibility Study for Remote CT Reading for Suspected Acute Appendicitis Using iPhone With Remote Control System in Realtime Under the Ambient Bright.|Completed||N/A|16|Actual|Hanyang University||2|||f||||f||||||||||2017-10-11 00:34:33.834944|2017-10-11 00:34:33.834944
NCT02108704|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-12-10|||December 2013||2013-12-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Helicobacter Pylori Eradication Study in Parkinson's Disease|Helicobacter Pylori Eradication in Parkinson's Disease: A Double-blind Randomised Placebo Controlled Trial|Active, not recruiting||N/A|78|Anticipated|University of Malaya||2|||f||||f||||||||||2017-10-11 00:34:33.939526|2017-10-11 00:34:33.939526
NCT02108678|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-05-23|||September 2013||2013-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ACT||One-Day Intervention for Depression and Impairment in Migraine Patients|One-Day Intervention for Depression and Impairment in Migraine Patients|Active, not recruiting||N/A|104|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 00:34:34.379529|2017-10-11 00:34:34.379529
NCT02108665|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-10-05|||January 2013|Actual|2013-01-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|April 2016|Actual|2016-04-01||Interventional|||Magnetic Resonance Imaging (MRI) Hysterosalpingography Versus Radiographic Hysterosalpingography in Female Infertility|Magnetic Resonance Imaging Hysterosalpingography Versus Radiographic Hysterosalpingography in Female Infertility|Completed||N/A|40|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 00:34:34.482372|2017-10-11 00:34:34.482372
NCT02108652|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-08-02|2016-07-01||May 31, 2014|Actual|2014-05-31|August 2017|2017-08-01|May 25, 2018|Anticipated|2018-05-25|May 31, 2015|Actual|2015-05-31||Interventional||Cohort 2 Safety Evaluable Population included all participants who received any amount of study drug.|A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)|A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer|Active, not recruiting||Phase 2|310|Actual|Hoffmann-La Roche||1|||t|||||t|f||||||||2017-10-11 00:34:34.601055|2017-10-11 00:34:34.601055
NCT02108639|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-07-09|||April 2014||2014-04-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet|An Open-label, Multiple-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Fixed Dose Combination Formulation of DCV, ASV, and BMS-791325 in Subjects With Normal Renal Function and Subjects With Mild, Moderate, Severe, and End-stage Renal Dysfunction|Completed||Phase 1|41|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:34:35.604847|2017-10-11 00:34:35.604847
NCT02108626|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-05-04|||March 2014||2014-03-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Electronic Cigarettes in Daily Dependent Smokers|A Behavioral Assessment of Electronic Cigarettes in Reducing Cue- and Withdrawal-induced Craving in Daily Dependent Smokers|Completed||Phase 4|43|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 00:34:35.755409|2017-10-11 00:34:35.755409
NCT02108613|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2014-04-07|||April 2014||2014-04-01|April 2014|2014-04-01|March 2017|Anticipated|2017-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Living Well on Androgen Deprivation Therapy|Living Well on Androgen Deprivation Therapy: A Comprehensive Approach to Prostate Cancer Survivorship|Unknown status|Not yet recruiting|N/A|100|Anticipated|British Columbia Cancer Agency||2|||f||||t||||||||||2017-10-11 00:34:35.853305|2017-10-11 00:34:35.853305
NCT02108600|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-06-23|||June 2014||2014-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Tocilizumab for Renal Graft Inflammation|A Phase II Trial of the Efficacy and Safety of Tocilizumab for Treatment of Inflammation in the Renal Allograft|Recruiting||Phase 2|48|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:34:35.970683|2017-10-11 00:34:35.970683
NCT02108587|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-10-19|||December 2016||2016-12-01|October 2016|2016-10-01||||March 2017|Anticipated|2017-03-01||Interventional|||Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer|Staging of Upper Tract Urothelial Cancer With Optical Coherence Tomography|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center||1||Funding unavailable|f||||t||||||||||2017-10-11 00:34:36.095486|2017-10-11 00:34:36.095486
NCT02108574|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-12-19|||April 2014||2014-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay Fever|A Double-blind, Placebo-controlled, Randomized Single-centre Crossover Park Study Assessing Rhinix™ Nasal Filters|Completed||N/A|69|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:34:36.169934|2017-10-11 00:34:36.169934
NCT02108561|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-07-13|||April 2014||2014-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Breast Cancer Tumor Heterogeneity|Does Breast Tumor Heterogeneity Necessitate Additional HER2 Testing on the Surgical Specimens?|Recruiting||N/A|110|Anticipated|Anne Arundel Health System Research Institute|||1||f||||f||||||||||2017-10-11 00:34:36.27508|2017-10-11 00:34:36.27508
NCT02108548|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2015-03-26|||April 2014||2014-04-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects|A Phase 1 Ascending Single and Multiple Oral Dose Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects, Including a Food Effect Cohort|Terminated||Phase 1|89|Actual|Astellas Pharma Inc||7||Gastrointestinal safety findings|f||||f||||||||||2017-10-11 00:34:36.375501|2017-10-11 00:34:36.375501
NCT02108535|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2016-01-25|||November 2013||2013-11-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|ARGENTUM||Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns|Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns|Completed||Phase 4|100|Actual|University of Sorocaba||2|||f||||f||||||||No||2017-10-11 00:34:36.501589|2017-10-11 00:34:36.501589
NCT02108522|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-09-08|||June 2014||2014-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|CHARMS||Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant|Administration of Most Closely HLA-matched Multivirus-specific Cytotoxic T-Lymphocytes for the Treatment of EBV, CMV, Adenovirus, HHV6, and BK Virus Infections Post Allogeneic Stem Cell Transplant|Recruiting||N/A|80|Anticipated|ViraCyte||1|||f||||t||||||||||2017-10-11 00:34:36.620196|2017-10-11 00:34:36.620196
NCT02108509|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-09-19|||May 2014||2014-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Bone Disease in Chronic Pancreatitis: A Complex Phenomenon|Bone Disease in Chronic Pancreatitis: A Complex Phenomenon|Recruiting||N/A|70|Anticipated|University of Nebraska|||1||f||||t||||||||||2017-10-11 00:34:36.746836|2017-10-11 00:34:36.746836
NCT02108496|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2016-12-20|||July 2014||2014-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:34:36.87228|2017-10-11 00:34:36.87228
NCT02108470|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-12-01|||March 2014||2014-03-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|OHRQoL||A Randomized Cross-over Clinical Trial to Evaluate the Use of Oral Health-Related Quality of Life in Dental Practice|A Randomized Cross-over Clinical Trial to Evaluate the Use of Oral Health-Related Quality of Life in Dental Practice|Completed||N/A|144|Actual|University of Malaya||2|||f||||f||||||||||2017-10-11 00:34:37.015126|2017-10-11 00:34:37.015126
NCT02108457|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-07|2017-07-28|||February 2014||2014-02-01|July 2017|2017-07-01||||January 2017|Actual|2017-01-01||Interventional|||[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers|[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers|Active, not recruiting||Early Phase 1|17|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:34:37.1098|2017-10-11 00:34:37.1098
NCT02108444|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2014-07-22|||January 2007||2007-01-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|||Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients|Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients With Hepatitis B Virus Infection|Completed||Phase 4|107|Actual|Peking University|||2||f||||t||||||Samples With DNA|"     serum hepatitis B virus DNA   "|||2017-10-11 00:34:37.210181|2017-10-11 00:34:37.210181
NCT02108431|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-06|||February 2013||2013-02-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Prospective Randomized Trial Comparing Urinary Diversion After Robot-assisted Radical Prostatectomy|Superior Postoperative Patient Comfort in Suprapubic Drainage Versus Transurethral Catheterization Following Robot-assisted Radical Prostatectomy: A Prospective Randomized Clinical Trial|Completed||N/A|160|Actual|St. Antonius Hospital Gronau||2|||f||||f||||||||||2017-10-11 00:34:37.305726|2017-10-11 00:34:37.305726
NCT02108418|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-12-18|||April 2014||2014-04-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers|A Phase 1, Randomized, Open-label, 2-way Crossover Study in Healthy East Asian and Caucasian Volunteers to Evaluate the Relative Bioavailability of A New Capsule Formulation of TG-2349 Compared to the Original Formulation of TG-2349 Oral Solution|Completed||Phase 1|24|Actual|TaiGen Biotechnology Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:34:37.410186|2017-10-11 00:34:37.410186
NCT02108405|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2014-04-08|||May 2013||2013-05-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||The Value of Memory B Cells Marker (CD27) and Howell Jelly Bodies Detrection in Critically Ill Patients|The Value of Memory B Cells Marker (CD27) and Howell Jelly Bodies Detrection in Critically Ill Patients|Completed||N/A|96|Actual|Tanta University|||2||f||||t||||||||||2017-10-11 00:34:37.512508|2017-10-11 00:34:37.512508
NCT02108392|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-05-11|||January 2014||2014-01-01|May 2016|2016-05-01||||December 2019|Anticipated|2019-12-01||Observational|||Characterization of Pseudoxanthoma Elasticum|Characterization of Patients With Pseudoxanthoma Elasticum|Recruiting||N/A|100|Anticipated|University Hospital, Bonn|||1||f||||t||||||Samples With DNA|"     whole blood samples   "|||2017-10-11 00:34:37.596879|2017-10-11 00:34:37.596879
NCT02108379|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-11-10|||May 2014||2014-05-01|March 2014|2014-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Compliance and Usability Study Evaluating RHINIX™ Nasal Filters|An Open-label Outpatient In-season Study Assessing Compliance and Usability of Rhinix™ Nasal Filters|Completed||N/A|1073|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 00:34:37.68023|2017-10-11 00:34:37.68023
NCT02108366|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-07-24|||March 2014||2014-03-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment of Severe Influenza A Infection|A Randomized Controlled Trial on the Treatment of Severe Influenza A Infection|Recruiting||Phase 3|100|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 00:34:37.761869|2017-10-11 00:34:37.761869
NCT02108353|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-05-24|||January 2015||2015-01-01|May 2017|2017-05-01|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29||Interventional|||Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers|Multicenter, Randomized, Double-blind, Placebo Controlled Trial of 2 mg Melatonin for Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers|Completed||Phase 3|46|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 00:34:37.874889|2017-10-11 00:34:37.874889
NCT02108340|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-02-11|||September 2013||2013-09-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Comparative Study of Microwave Radiometry and Ultrasonography for the Diagnosis of Acute Appendicitis|Comparative Study of Microwave Radiometry and Ultrasonography for the Diagnosis of Acute Appendicitis|Recruiting||N/A|40|Anticipated|Hippocration General Hospital||1|||f||||f||||||||Undecided||2017-10-11 00:34:37.996509|2017-10-11 00:34:37.996509
NCT02108327|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-05-08|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|TKA||Blood Loss Between Surgical Blade and Unipolar Electrocautery in TKA|Comparison of Blood Loss Between Surgical Blade and Unipolar Electrocautery in Primary Total Knee Arthroplasty|Completed||N/A|80|Actual|Thammasat University||2|||f||||t||||||||||2017-10-11 00:34:38.082476|2017-10-11 00:34:38.082476
NCT02108314|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-09-29|||February 2014||2014-02-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Video-assisted Intervention for Increasing Mammography Uptake in Private Primary Care in Singapore|Physician-led Video-assisted Intervention for Increasing Mammography Uptake in Private Primary Care Practice in Singapore: A Cluster-Randomized Trial|Completed||N/A|448|Actual|National University Health System, Singapore||2|||f||||t||||||||||2017-10-11 00:34:38.156873|2017-10-11 00:34:38.156873
NCT02108301|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-04-10|||December 2011||2011-12-01|April 2014|2014-04-01||||June 2013|Actual|2013-06-01||Interventional|||Hepatitis C in Renal Transplant Recipients|Hepatitis C in Renal Transplant Recipients - Safety and Efficacy of a Conversion of Immunosuppression to High-dose Cyclosporine A and Its Impact on Hepatitis C Virus-replication, Parameters of Liver Function and Glucose Tolerance. An Open Label Trial.|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-10-11 00:34:38.225636|2017-10-11 00:34:38.225636
NCT02108288|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-04-02|2015-03-23||April 2014||2014-04-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers||Completed||Phase 1|30|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:34:38.300279|2017-10-11 00:34:38.300279
NCT02107170|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-04-23|||February 2014||2014-02-01|April 2017|2017-04-01||||December 2018|Anticipated|2018-12-01||Interventional|||Effects of Anesthetics on Postoperative Cognitive Function of Patients Undergoing Endovascular Repair of Aortic Aneurysm and Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities.|Comparison of Intravenous Anesthetics and Volatile Anesthetics on Postoperative Cognitive Dysfunction of Patients Undergoing Endovascular Repair of Aortic Aneurysm and Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities.|Recruiting||Phase 4|400|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-11 00:34:38.634515|2017-10-11 00:34:38.634515
NCT02107157|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-07-29|||July 2013||2013-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Clinical and Histological Evaluation of the Picosure 755nm Laser With Cap Array for Facial Rejuvenation|Clinical and Histological Evaluation of the Picosure 755nm Laser With Cap Array for Facial Rejuvenation|Completed||N/A|27|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:34:38.714136|2017-10-11 00:34:38.714136
NCT02107144|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2016-03-05|||April 2014||2014-04-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|PATMOS||The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease|The Study to Assess the Effect of Trimetazidine on Index of Microcirculatory Resistance (IMR), Measured by Coronary Pressure and Temperature Wire, in Patients With Stable Coronary Artery Disease|Recruiting||Phase 4|50|Anticipated|Clinical Hospital Center Zemun||2|||f||||t||||||||||2017-10-11 00:34:38.836016|2017-10-11 00:34:38.836016
NCT02107131|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-12-13|||May 2014||2014-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ERASER||Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab|Evaluation of ReAding Speed, Contrast Sensitivity, and Work Productivity in Working Individuals With Diabetic Macular Edema Following Treatment With Intravitreal Ranibizumab|Active, not recruiting||Phase 2/Phase 3|40|Actual|California Retina Consultants||1|||f||||f||||||||||2017-10-11 00:34:38.935172|2017-10-11 00:34:38.935172
NCT02107118|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-05-22|||May 2015||2015-05-01|May 2015|2015-05-01|February 2022|Anticipated|2022-02-01|March 2020|Anticipated|2020-03-01||Interventional|||Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men|H-34570: PHASE I Study: The Use of Autologous Adipose Tissue-Derived Mesenchymal Stem Cell (AdMSC) for the Improvement of Erectile and Cardiac Function in Aging Men|Withdrawn||Phase 1|0|Actual|Baylor College of Medicine||2||Contract issues|f||||f||||||||||2017-10-11 00:34:39.009362|2017-10-11 00:34:39.009362
NCT02107105|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-10-07|||May 2014||2014-05-01|October 2016|2016-10-01||||May 2019|Anticipated|2019-05-01||Observational|||Quality of Life (QOL) Following Surgical Treatment for Rectal Cancer|Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer|Recruiting||N/A|330|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 00:34:39.08012|2017-10-11 00:34:39.08012
NCT02107079|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-03|||January 2012||2012-01-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|Melaform||The Relative Bio-availability of Oral and Oromucosal Melatonin in Different Formulations in Healthy Human Volunteers.|The Relative Bio-availability of Oral and Oromucosal Melatonin in Different Formulations in Healthy Human Volunteers. A Three-phased Cross-over Study.|Completed||N/A|10|Actual|Utrecht University||3|||f||||||||||||||2017-10-11 00:34:39.302192|2017-10-11 00:34:39.302192
NCT02107066|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-04-03|||May 2009||2009-05-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|WALC||Women's Activity and Lifestyle Study in Connecticut|Impact of Exercise on Ovarian Cancer Prognosis|Completed||Phase 3|144|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:34:39.382604|2017-10-11 00:34:39.382604
NCT02107053|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-02-07|||April 2014||2014-04-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Pomegranate Juice (PJ) on Oxidative Stress Biomarkers During Treatment With IV Iron During One Dialysis Session|The Effect of Pomegranate Juice on Oxidative Stress Biomarkers During Treatment With IV Iron During One Dialysis Session|Completed||N/A|25|Actual|Western Galilee Hospital-Nahariya||3|||f||||f||||||||||2017-10-11 00:34:41.062913|2017-10-11 00:34:41.062913
NCT02108275|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-04-06|||August 2013||2013-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:34:41.214983|2017-10-11 00:34:41.214983
NCT02108262|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-12-13||2016-12-13|August 2014||2014-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.|A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction.|Completed||Phase 2|1267|Actual|CSL Behring||3|||f||||t||||||||||2017-10-11 00:34:41.278302|2017-10-11 00:34:41.278302
NCT02108249|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-12-08|||April 2014||2014-04-01|December 2014|2014-12-01||||December 2016|Anticipated|2016-12-01||Observational|||Annex™ Adjacent Level System for Treatment of Adjacent Level Disease||Unknown status|Recruiting|N/A|60|Anticipated|Spine Wave|||2||f||||||||||||||2017-10-11 00:34:41.850126|2017-10-11 00:34:41.850126
NCT02108236|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2015-03-25|||May 2014||2014-05-01|March 2015|2015-03-01||||October 2015|Anticipated|2015-10-01||Interventional|||Effectiveness and Safety of Acupuncture for Obesity and Over-weight People||Unknown status|Recruiting|N/A|110|Anticipated|Heilongjiang University of Chinese Medicine||2|||f||||f||||||||||2017-10-11 00:34:41.937912|2017-10-11 00:34:41.937912
NCT02108223|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-03-02|2014-05-14||January 2009||2009-01-01|March 2015|2015-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|LH||The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI|In This Study, the Addition of rLH, Increasing the Dose of rFSH and the Control Groups Regarding the Results of IVF in These Patients.|Completed||Phase 4|137|Actual|Sisli Etfal Training & Research Hospital||3|||f||||t||||||||||2017-10-11 00:34:42.016931|2017-10-11 00:34:42.016931
NCT02108197|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-04-04|||April 2014||2014-04-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Sleep Apnea and Gestational Diabetes|Obstructive Sleep Apnea and Gestational Diabetes : Incidence and Effects of Continuous Positive Airway Pressure Treatment on Glucose Metabolism|Recruiting||N/A|80|Anticipated|Ramathibodi Hospital||2|||f||||f||||||||||2017-10-11 00:34:42.45606|2017-10-11 00:34:42.45606
NCT02108184|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-02-23|||February 2014||2014-02-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy|Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy of Treatment of Helicobacter Pylori Infection in Korea|Recruiting||Phase 4|264|Anticipated|Incheon St.Mary's Hospital||4|||f||||t||||||||||2017-10-11 00:34:42.530576|2017-10-11 00:34:42.530576
NCT02108171|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2016-02-13|2015-02-10||March 2014||2014-03-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Intranasal Dexmedetomidine Premedication|A Randomised Controlled Trial of Intranasal Dexmedetomidine as Premedication for Suspension Laryngoscopy|Completed||N/A|81|Actual|Guangzhou First People's Hospital||2|||f||||t||||||||||2017-10-11 00:34:43.347645|2017-10-11 00:34:43.347645
NCT02108158|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-11-05|||April 2014||2014-04-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines|A Randomized, Evaluator-blinded, Comparative Study to Evaluate the Efficacy and Safety of Different Injection Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines|Completed||Phase 4|62|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-11 00:34:52.463331|2017-10-11 00:34:52.463331
NCT02108145|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-12-19|||July 2014||2014-07-01|April 2014|2014-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma|Percutaneous Bilateral Versus Unilateral Metal Stent Placement for Hilar Cholangiocarcinoma : A Prospective Open-label Randomized Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|70|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-11 00:34:52.543558|2017-10-11 00:34:52.543558
NCT02108132|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2014-04-05|||August 2014||2014-08-01|April 2014|2014-04-01|February 2016|Anticipated|2016-02-01|August 2015|Anticipated|2015-08-01||Interventional|||Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia|Allogenic Mesenchymal Stem Cells in Hemophilia: a Pilot Study|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|Cairo University||1|||f||||t||||||||||2017-10-11 00:34:52.629953|2017-10-11 00:34:52.629953
NCT02108119|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-06-15|||May 2, 2014|Actual|2014-05-02|June 2017|2017-06-01|November 30, 2015|Actual|2015-11-30|November 30, 2015|Actual|2015-11-30||Interventional|||The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome||Completed||Phase 2|197|Actual|Probi AB||2|||f||||||||||||||2017-10-11 00:34:52.70975|2017-10-11 00:34:52.70975
NCT02108106|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-10-21|||March 2014||2014-03-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|AG-348 SAD||A Phase I Study of AG-348 in Healthy Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Safety, Pharmacokinetic and Pharmacodynamic Study of Orally Administered AG-348 in Healthy Volunteers|Completed||Phase 1|48|Actual|Agios Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:34:52.773326|2017-10-11 00:34:52.773326
NCT02108093|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2014-12-24|||December 2014||2014-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|RAP||The Effect on Cerebral Oxygenation of Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit in Cardiac Surgery Patients|The Effect on Cerebral Oxygenation of Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit in Cardiac Surgery Patients: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|220|Anticipated|Amphia Hospital||2|||f||||f||||||||||2017-10-11 00:34:52.848899|2017-10-11 00:34:52.848899
NCT02108080|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-10-05|||March 13, 2014||2014-03-13|September 29, 2017|2017-09-29|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Characterization Imaging Instruments in Alcoholics and Non-Alcoholics|Characterization Imaging Instruments in Alcoholics and Non-Alcoholics|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:34:53.064265|2017-10-11 00:34:53.064265
NCT02108054|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-08|2017-10-05|||March 4, 2014||2014-03-04|September 29, 2017|2017-09-29|December 1, 2021|Anticipated|2021-12-01|December 1, 2021|Anticipated|2021-12-01||Observational|||Behavioral and Functional MRI Task Development, Implementation, and Testing|Behavioral and Functional MRI Task Development, Implementation, and Testing|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:34:53.143924|2017-10-11 00:34:53.143924
NCT02108041|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-08-03|||March 7, 2014||2014-03-07|May 30, 2017|2017-05-30|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Observational|||Personalized Medicine Decision-Making in a Virtual Clinical Setting|Medical Decision-Making in a Virtual Clinical Setting|Recruiting||N/A|260|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:34:53.227352|2017-10-11 00:34:53.227352
NCT02108028|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-06-30|||March 13, 2014||2014-03-13|June 15, 2017|2017-06-15|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer|An Exploratory Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer and Other Chronic Illnesses|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:34:53.308259|2017-10-11 00:34:53.308259
NCT02108015|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-06-30|||March 5, 2014||2014-03-05|September 5, 2014|2014-09-05|December 1, 2016|Actual|2016-12-01|September 5, 2014|Actual|2014-09-05||Interventional|||Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8|Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8|Terminated||Phase 1|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:34:53.398584|2017-10-11 00:34:53.398584
NCT02108002|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-09-21|||March 5, 2014||2014-03-05|December 5, 2016|2016-12-05|December 31, 2018|Anticipated|2018-12-31|December 1, 2017|Anticipated|2017-12-01||Interventional|||Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)|Pilot Study of the Effect of Vorinostat on Nervous System Hemangioblastomas In Von Hippel-Lindau Disease|Enrolling by invitation||Phase 1|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:34:53.469793|2017-10-11 00:34:53.469793
NCT02107989|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-06-30|||February 11, 2014||2014-02-11|December 6, 2016|2016-12-06|July 29, 2020|Anticipated|2020-07-29|July 29, 2020|Anticipated|2020-07-29||Observational|||Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy|Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:34:53.543297|2017-10-11 00:34:53.543297
NCT02107976|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-06-30|||February 11, 2014||2014-02-11|June 28, 2017|2017-06-28|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Observational|||Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes|Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:34:53.619921|2017-10-11 00:34:53.619921
NCT02107963|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-05|2017-07-06|||February 6, 2014||2014-02-06|January 31, 2017|2017-01-31|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors|A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors|Completed||Phase 1|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:34:53.702809|2017-10-11 00:34:53.702809
NCT02107950|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-07-31|||November 2013||2013-11-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Interventional|||Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma|A Randomized, Open-label, Parallel Group, Multi-center Phase II Clinical Trial DCVAC/OvCa Added to Standard Chemotherapy in Women With Relapsed Platinum Sensitive Epithelial Ovarian Carcinoma|Active, not recruiting||Phase 2|60|Anticipated|Sotio a.s.||2|||f||||t||||||||||2017-10-11 00:34:53.804829|2017-10-11 00:34:53.804829
NCT02107937|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-07-31|||November 2013||2013-11-01|January 2016|2016-01-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma|A Randomized, Open-label, Three-arm, Multi-center Phase II Trial of Addition of DCVAC/OvCa to First Line Standard Chemotherapy in Women With Newly Diagnosed Epithelial Ovarian Carcinoma|Active, not recruiting||Phase 2|99|Actual|Sotio a.s.||3|||f||||t||||||||||2017-10-11 00:34:53.937845|2017-10-11 00:34:53.937845
NCT02107924|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-11-24|||April 2014||2014-04-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Use of Antibiotic Carrier in Acute Periprosthetic Infections (APPI) of Total Knee Replacements|Use of Antibiotic Contained Calcium Sulfate Carrier in Acute Periprosthetic Infections(APPI) of Total Knee Replacements|Withdrawn||N/A|0|Actual|Sharp HealthCare|||2|No Funding|f||||f||||||||||2017-10-11 00:34:54.072075|2017-10-11 00:34:54.072075
NCT02107911|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-05-27|||March 2014||2014-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Factors Affecting the Intention to Take nPEP Among Thai MSM|Factors Affecting the Intention to Take Non-occupational HIV Post-exposure Prophylaxis Among Thai Men Who Have Sex With Men|Completed||N/A|450|Actual|South East Asia Research Collaboration with Hawaii|||1||f||||f||||||||||2017-10-11 00:34:54.188056|2017-10-11 00:34:54.188056
NCT02107898|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-09-27|2015-12-23||March 2014||2014-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)|A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Alirocumab in Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Lipid Modifying Therapy|Completed||Phase 3|216|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 00:34:54.493348|2017-10-11 00:34:54.493348
NCT02107885|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-10-16|||March 2014||2014-03-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.|A Phase 1, Double-blind, Randomized, Placebo-controlled Single Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DS-1971a in Healthy Male Subjects|Completed||Phase 1|64|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 00:34:55.895514|2017-10-11 00:34:55.895514
NCT02107872|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-09-28|||April 2014||2014-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500||Completed||Phase 1|55|Actual|Regeneron Pharmaceuticals||5|||f||||f||||||||||2017-10-11 00:34:56.004588|2017-10-11 00:34:56.004588
NCT02107859|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-09-18|||May 2014||2014-05-01|May 2017|2017-05-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Study of Ataluren (PTC124) in Cystic Fibrosis|An Open-Label Safety and Efficacy Study for Patients With Nonsense Mutation Cystic Fibrosis Previously Treated With Ataluren (PTC124)|Terminated||Phase 3|61|Actual|PTC Therapeutics||1||CF Data from CF study 021 did not meet end points.|f||||t||||||||||2017-10-11 00:34:56.115988|2017-10-11 00:34:56.115988
NCT02107846|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-09-27|||April 2014||2014-04-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||An Open-Label, Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112|A Phase 2a, Open-Label, Sequential Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112 (Plant Recombinant Human Glucocerebrosidase) in Enzyme Replacement Therapy-Naïve Subjects With Gaucher Disease|Completed||Phase 2|10|Actual|Protalix||4|||f||||f||||||||No||2017-10-11 00:34:56.274435|2017-10-11 00:34:56.274435
NCT02107833|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-08-04|||July 2014||2014-07-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Evaluate the Safety and Pharmacokinetics of Oral OPRX-106 (TNFR-Fc Fusion Protein) in Healthy Volunteers|A Phase 1, Randomized, Parallel-Design, Open-Label Study to Evaluate the Safety and Pharmacokinetics of Oral OPRX-106 (TNFR-Fc Fusion Protein) in Healthy Volunteers|Completed||Phase 1|18|Actual|Protalix||3|||f||||f||||||||||2017-10-11 00:34:56.361049|2017-10-11 00:34:56.361049
NCT02107820|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-06-02|||May 2014||2014-05-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Does Bladder Training Improve the Efficacy of Nerve Stimulation in Women With Refractory Overactive Bladders|Does Bladder Training (BT) Improve the Efficacy of Percutaneous Tibial Nerve Stimulation (PTNS) in Women With Refractory Overactive Bladder (OAB) - A Randomised Controlled Study|Recruiting||N/A|84|Anticipated|Plymouth Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 00:34:56.45538|2017-10-11 00:34:56.45538
NCT02107807|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-05-05|||April 2014||2014-04-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine|A Phase III, Stratified, Randomized, Controlled, Observer-Blind, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Doses of aH5N1when Administered to Adult and Elderly Subjects With and Without Immunosuppressive Conditions|Completed||Phase 3|539|Actual|Seqirus||4|||f||||f||||||||||2017-10-11 00:34:56.571716|2017-10-11 00:34:56.571716
NCT02107794|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-04-06|||December 2012||2012-12-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Shared Decision Making in Graves Disease - Graves Disease (GD) Choice|Shared Decision Making in Graves Disease - Graves Disease (GD) Choice|Completed||N/A|93|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:34:56.745113|2017-10-11 00:34:56.745113
NCT02107781|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-04-26|||March 2012||2012-03-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Intra-abdominal Pressure Monitoring in Patients With Open Abdomen Undergoing Early Closure|A Prospective Observational Study of Continuous Intra-abdominal Pressure Monitoring in Patients With Postoperative Open Abdomen Undergoing Early Intervention and Closure|Completed||N/A|17|Actual|Michigan State University|||1||f||||f||||||||Yes|Data analysis is currently being done with plans to write a manuscript. Completing data abstraction on retrospective cohort of patients who had an open abdomen prior to start of this study. Will compare the two cohorts then report our findings.|2017-10-11 00:34:56.840392|2017-10-11 00:34:56.840392
NCT02107768|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-02-03|||January 2011||2011-01-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Aerobic Exercise in Early Subacute Stroke|Effects of Twice-Weekly Intense Aerobic Exercise in Early Subacute Stroke: A Randomized Controlled Trial.|Completed||N/A|56|Actual|Ostergotland County Council, Sweden||2|||f||||f||||||||||2017-10-11 00:34:56.928328|2017-10-11 00:34:56.928328
NCT02107755|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-11-14|||July 2014||2014-07-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma|A Phase 2 Study Using Stereotactic Ablative Radiation Therapy and Ipilimumab in Patients With Oligometastatic Melanoma|Active, not recruiting||Phase 2|8|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:34:57.010937|2017-10-11 00:34:57.010937
NCT02107742|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-12-28|||February 2014||2014-02-01|December 2016|2016-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Influence of Injection Speed on Pain During Administration of Local Anaesthetic.|The Influence of Injection Speed on Pain During Administration of Local Anaesthetic.|Completed||N/A|36|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-10-11 00:34:57.117809|2017-10-11 00:34:57.117809
NCT02107729|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-07-28|||February 2014||2014-02-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Importance of Needle Gauge for Pain During Injection of Local Anaesthetic|The Importance of Needle Gauge for Pain During Injection of Local Anaesthetic|Completed||N/A|36|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 00:34:57.221385|2017-10-11 00:34:57.221385
NCT02107716|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-05-26|||February 2014||2014-02-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Will Adjusting the pH of Lidocaine Reduce the Pain During Injection of Local Anaesthetic?|Will Adjusting the pH of Lidocaine Reduce the Pain During Injection of Local Anaesthetic?|Completed||N/A|32|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-10-11 00:34:57.30559|2017-10-11 00:34:57.30559
NCT02107703|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-06-14|||July 2014||2014-07-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2017|Actual|2017-02-01||Interventional|MONARCH 2||A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer|MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 3|630|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 00:34:57.411076|2017-10-11 00:34:57.411076
NCT02107690|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-06-20|||February 2014||2014-02-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Influence of Lidocaine Temperature on Pain During Subcutaneous Administration|The Influence of Lidocaine Temperature on Pain During Subcutaneous Administration|Completed||N/A|36|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||Undecided||2017-10-11 00:34:58.005938|2017-10-11 00:34:58.005938
NCT02107677|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-08-15|||August 2012||2012-08-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Specificity Study of Diagnostic for Early Detection of Dengue Infection|Determination of Estimated Specificity of DENV Detect NS1 ELISAs|Completed||N/A|300|Actual|InBios International, Inc.|||1||f||||||||||Samples Without DNA|"     serum   "|||2017-10-11 00:34:58.089761|2017-10-11 00:34:58.089761
NCT02107664|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-11-11|||December 2013||2013-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|PRAIS||The Palliative Radiotherapy And Inflammation Study - PRAIS|The Palliative Radiotherapy And Inflammation Study: Palliative Radiotherapy of Bone Metastasis. Classification, Inflammatory Biomarkers, and Longitudinal Clinical Follow-up|Recruiting||N/A|1000|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"     Genetic and Cytokine Analyses   "|||2017-10-11 00:34:58.168461|2017-10-11 00:34:58.168461
NCT02107651|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-04-23|||January 2013||2013-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Reporting of Adverse Events in Patients Treated With New Oral Anticoagulants|Serious Adverse Events in Patients Treated With New Oral Anticoagulants Are Underreported|Completed||N/A|20|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 00:34:58.282788|2017-10-11 00:34:58.282788
NCT02107638|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-09-28|||April 15, 2014|Actual|2014-04-15|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of Osteopathic Manipulative Medicine on Parkinson Disease|Effect of Osteopathic Manipulative Medicine on Motor Function, Balance, and Neuroprotective Serum Markers in Parkinson Disease|Recruiting||N/A|50|Anticipated|New York Institute of Technology||2|||f||||f|f|f||||||||2017-10-11 00:34:58.367563|2017-10-11 00:34:58.367563
NCT02101697|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-10-24|||July 2014||2014-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|August 2017|Anticipated|2017-08-01||Interventional|DRISTI||Reducing AIDS Stigma Among Health Professionals in India|Reducing AIDS Stigma Among Health Professionals in India|Recruiting||N/A|3640|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:36:38.05782|2017-10-11 00:36:38.05782
NCT02107625|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-08-19|||August 2013||2013-08-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|KRIBS||Traditional Dietary Advice Versus a Low FODMAP Diet Intake in IBS Patients|A Multi-centre, Randomized, Single-blind, Comparative Trial: Traditional Dietary Advice Versus a Low FODMAP Diet Intake in IBS Patients|Completed||N/A|75|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 00:34:58.506156|2017-10-11 00:34:58.506156
NCT02107612|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-04-08|||July 2004||2004-07-01|April 2014|2014-04-01|July 2007|Actual|2007-07-01|April 2006|Actual|2006-04-01||Interventional|||Randomized Study For Minimally Invasive Splinted Implants|Development of Minimally Invasive Splinted Dental Implants to Stabilize Mandibular Overdentures, a Randomized Clinical Trial|Completed||N/A|43|Actual|University of Concepcion, Chile||2|||f||||f||||||||||2017-10-11 00:34:58.679043|2017-10-11 00:34:58.679043
NCT02107599|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2015-06-17|2015-05-29||March 2014||2014-03-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Feasibility of Florbetapir Quantitation in Europe|A Study to Evaluate the Improvement in Reader Accuracy When Using a Read Method That Incorporates Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Visual Interpretation of Amyvid Brain Scans|Completed||Phase 4|96|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 00:34:58.825531|2017-10-11 00:34:58.825531
NCT02107586|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-12-05|||January 2015||2015-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Outcomes Between Biceps Tenotomy and Tenodesis in the Treatment of the Long Head of the Biceps Pathology|Biceps Tenotomy or Tenodesis in Treating Long Head of the Biceps Pathology: a Prospective Randomized Controlled Trial|Recruiting||N/A|64|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-11 00:34:59.136389|2017-10-11 00:34:59.136389
NCT02107573|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-12-05|||January 2015||2015-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparing the Outcomes Between Rotator Cuff Repair With and Without Suprascapular Nerve Decompression|Will Routine Suprascapular Nerve Release During Arthroscopic Rotator Cuff Repair Improve Patient Outcomes?|Recruiting||N/A|35|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-11 00:34:59.260062|2017-10-11 00:34:59.260062
NCT02107560|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-05-23|||April 2014||2014-04-01|April 2014|2014-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Results of Bile and Blood Culture in Patients With Acute Cholangitis|A Comparison of Results With Bile and Blood Culture in Patients With Acute Cholangitis According to Severity|Terminated||N/A|3|Actual|Seoul National University Hospital|||1|Because of small number of enrolled patients, we terminated this study.|f||||t||||||||||2017-10-11 00:34:59.369807|2017-10-11 00:34:59.369807
NCT02107547|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-10-28|||January 2015||2015-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Outcomes of Biceps Tenodesis or Labral Repair for Treatment of Type 2 Superior Labrum Anterior and Posterior Lesions|Evaluation of Biceps Tenodesis vs Labral Repair for Type 2 Superior Labrum Anterior and Posterior Lesions, A Randomized Controlled Trial|Recruiting||N/A|64|Anticipated|University of Chicago||2|||f||||f||||||||No||2017-10-11 00:34:59.44004|2017-10-11 00:34:59.44004
NCT02107534|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-03|||January 2012||2012-01-01|April 2014|2014-04-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Group-based Training for Parents of Children With Dyslexia|Evaluation of a Group-based Training for Parents of Children With Dyslexia|Unknown status|Active, not recruiting|N/A|42|Anticipated|University of Heidelberg Medical Center||2|||f||||t||||||||||2017-10-11 00:34:59.525772|2017-10-11 00:34:59.525772
NCT02107521|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-11-17|||April 2014||2014-04-01|August 2014|2014-08-01||||October 2014|Actual|2014-10-01||Interventional|||IMSI in Couples With Previous Implantation Failures|The Effect of the Intracytoplasmic Morphologically Selected Sperm Injection in Couples With Previous Implantation Failure After Intracytoplasmic Sperm Injection|Terminated||N/A|25|Actual|Sapientiae Institute||2||broken equipment|f||||f||||||||||2017-10-11 00:34:59.601934|2017-10-11 00:34:59.601934
NCT02107508|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-09|||January 2013||2013-01-01|April 2014|2014-04-01||||December 2014|Anticipated|2014-12-01||Observational|||The Relationship Between Activity Energy Expenditure and Body Composition in School-age Children||Unknown status|Recruiting|N/A|100|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||||||2017-10-11 00:34:59.685081|2017-10-11 00:34:59.685081
NCT02107495|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-04-18|||March 2014||2014-03-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting|Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting|Terminated||N/A|191|Actual|Samsung Electronics|||3|Optimize calibration|f||||f||||||Samples Without DNA|"     Retaining plasma specimens   "|||2017-10-11 00:34:59.763433|2017-10-11 00:34:59.763433
NCT02107482|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-03-02|2016-09-28||December 2011||2011-12-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis|Bilateral Comparator, Sham-Light Source Controlled, Assessor Blinded Clinical Trial of Localized Narrow Band-Ultraviolet B (NB-UVB) (Levia®) Treatment for Plaque-type Psoriasis|Completed||N/A|21|Actual|Tufts Medical Center||2|||f||||f||||||||No||2017-10-11 00:34:59.849973|2017-10-11 00:34:59.849973
NCT02107469|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-02-23|||June 2014||2014-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|VEDICINE||A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral Polyneuropathy|A Randomized Placebo-compared Study on Efficiency of Two Different Administration Forms of Phyllanthus Niruri and Sida Cordifolia in Patients With Diabetic Peripheral Polyneuropathy|Completed||N/A|98|Actual|Rosenberg European Academy of Ayurveda||3|||f||||t||||||||||2017-10-11 00:35:00.060564|2017-10-11 00:35:00.060564
NCT02107456|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-07|||July 2012||2012-07-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Dry Needling on Myofascial Trigger Point|The Long Term Effect of Dry Needling on Myofascial Trigger Point in the Upper Trapezius Muscle.|Completed||N/A|33|Actual|University of Social Welfare and Rehabilitation Science||1|||f||||t||||||||||2017-10-11 00:35:00.179237|2017-10-11 00:35:00.179237
NCT02107443|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-06-01|||June 26, 2014|Actual|2014-06-26|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|COACH||Improving Communication in Older Cancer Patients and Their Caregivers|Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers|Active, not recruiting||Phase 1/Phase 2|1056|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 00:35:00.248587|2017-10-11 00:35:00.248587
NCT02107430|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-11-21|||March 2012||2012-03-01|June 2015|2015-06-01|September 2018|Anticipated|2018-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer|Randomized, Open-label, Parallel-group, Multi-centre Phase II Clinical Trial of Active Cellular Immunotherapy With Preparation DCVAC/PCa in Patients With Localized High-risk Prostate Cancer After Primary Radiotherapy|Active, not recruiting||Phase 2|62|Actual|Sotio a.s.||2|||f||||f||||||||Yes|data to be shared on EMA website|2017-10-11 00:35:00.358181|2017-10-11 00:35:00.358181
NCT02107417|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-02-12|||June 2014||2014-06-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|CIPN||Study of TENS in Reducing Symptoms of Peripheral Neuropathy Induced by Chemotherapy|The Use of Transcutaneous Electrical Nerve Stimulation (Tens) in Reducing Symptoms of Peripheral Neuropathy Induced by Antineoplastic Chemotherapy|Recruiting||N/A|64|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 00:35:00.441751|2017-10-11 00:35:00.441751
NCT02107404|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-05-23|||April 2012|Actual|2012-04-01|June 2015|2015-06-01|May 22, 2017|Actual|2017-05-22|June 2015|Actual|2015-06-01||Interventional|||Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer|Randomized, Open-label, Parallel-group, Multi-centre Phase II Clinical Trial With Active Cellular Immunotherapy DCVAC/PCa in Patients With Localized Prostate Cancer After Primary Radical Prostatectomy|Completed||Phase 2|150|Anticipated|Sotio a.s.||2|||f||||f||||||||||2017-10-11 00:35:00.696521|2017-10-11 00:35:00.696521
NCT02107391|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-05-23|||March 2012|Actual|2012-03-01|June 2015|2015-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer|Randomized, Open-label, Parallel-group, Multi-centre Phase II Clinical Trial of Active Cellular Immunotherapy With Preparation DCVAC/PCa in Combination With Hormone Therapy in Patients With Metastatic Prostate Cancer|Completed||Phase 2|63|Actual|Sotio a.s.||2|||f||||f||||||||||2017-10-11 00:35:00.803327|2017-10-11 00:35:00.803327
NCT02107378|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-11-29|||January 2014||2014-01-01|January 2016|2016-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma|A Randomized, Open-label, Parallel Group, Multi-center Phase II Clinical Trial Evaluating Effect of Addition of DCVAC/OvCa to Standard Chemotherapy in Women With Relapsed Platinum (Pt)-Resistant Epithelial Ovarian Carcinoma|Terminated||Phase 2|22|Actual|Sotio a.s.||2||sponsor decision|f||||t||||||||Undecided||2017-10-11 00:35:00.922672|2017-10-11 00:35:00.922672
NCT02107365|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-01-23|||November 2013||2013-11-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)|Pilot Study to Assess Efficacy and Safety of a Quadruple Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Non-responders to Pegylated Interferon-Ribavirin Regimen|Completed||Phase 2|60|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 00:35:01.062196|2017-10-11 00:35:01.062196
NCT02107352|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-05-02|||December 2013||2013-12-01|May 2016|2016-05-01||||June 2017|Anticipated|2017-06-01|3 Months|Observational [Patient Registry]|||Effect of Anti-craving Medication on Cognitive Functions in Alcohol Dependence: an ERP Study||Recruiting||N/A|80|Anticipated|Brugmann University Hospital|||4||f||||t||||||||||2017-10-11 00:35:01.218467|2017-10-11 00:35:01.218467
NCT02107339|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-07-07|2016-07-07||March 2014||2014-03-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|July 2016|Actual|2016-07-01||Interventional|||Methadone and Hydromorphone For Spinal Surgery|Methadone and Hydromorphone For Spinal Surgery|Active, not recruiting||Phase 4|120|Actual|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||||2017-10-11 00:35:01.309138|2017-10-11 00:35:01.309138
NCT02107326|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-11-04|||May 2014||2014-05-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes|Webdia Study: Use of Smartphones to Improve Diabetes Control and Quality of Life in Children With Type 1 Diabetes|Recruiting||N/A|50|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 00:35:01.822196|2017-10-11 00:35:01.822196
NCT02107313|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-02-28|2015-11-17||May 2014||2014-05-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2|A Phase 1, Single Centre, Randomised, 2 Period Crossover Study to Determine the Effect of Food on the Pharmacokinetic Profile of a Single Dose of PBT2 Administered Orally to Healthy Volunteers|Completed||Phase 1|18|Actual|Prana Biotechnology Limited||2|||f||||f||||||||||2017-10-11 00:35:01.94185|2017-10-11 00:35:01.94185
NCT02107300|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-09-12|||November 2013||2013-11-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy|NeutraSal in the Management of Xerostomia in Obstructive Sleep Apnea Syndrome (OSAS) Patients Utilizing Continuous Positive Airway Pressure (CPAP) Therapy|Active, not recruiting||N/A|32|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 00:35:02.223701|2017-10-11 00:35:02.223701
NCT02107287|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-09-26|||August 2011||2011-08-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer|Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer|Completed||N/A|105|Actual|McGill University Health Center||1|||f||||f||||||||||2017-10-11 00:35:02.303254|2017-10-11 00:35:02.303254
NCT02107274|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-07-09|2014-05-06||November 2011||2011-11-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of Azithromycin in Treatment of Bronchiectasis|Efficacy of Azithromycin in Treatment of Bronchiectasis|Completed||Phase 4|78|Actual|Penang Hospital, Malaysia||2|||f||||t||||||||||2017-10-11 00:35:04.178868|2017-10-11 00:35:04.178868
NCT02106754|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-06-01|||September 2012|Actual|2012-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Alcohol Screening & Brief Lntervention in Juvenile Justice: Filling the Gap|Alcohol Screening & Brief Lntervention in Juvenile Justice: Filling the Gap|Recruiting||N/A|675|Anticipated|University of Rhode Island||3|||f||||t|f|f||||||No||2017-10-11 00:35:13.321983|2017-10-11 00:35:13.321983
NCT02107261|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-09-29|||March 2014||2014-03-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand|A Placebo-Controlled, Double-Blind, Randomized, Cross Over Pilot Study Of The Efficacy And Tolerability Of Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand|Recruiting||Phase 2|20|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 00:35:04.691892|2017-10-11 00:35:04.691892
NCT02107248|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-04-18|||June 2014||2014-06-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Supine Sleeping After Total Hip Replacement|The Need for Supine Position Advise During Sleep in the First 8 Week After a Total Hip Replacement to Prevent Hip Dislocation|Active, not recruiting||N/A|456|Actual|Orthopedisch Centrum Oost Nederland||2|||f||||t||||||||Undecided||2017-10-11 00:35:04.827651|2017-10-11 00:35:04.827651
NCT02107235|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-06-22|||January 2014||2014-01-01|June 2017|2017-06-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer|Phase I Study of Platinum-based Chemoradiotherapy (CRT) With Oral Rigosertib in Patients With Intermediate or High-risk Head and Neck Squamous Cell Carcinoma|Completed||Phase 1|2|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 00:35:04.933159|2017-10-11 00:35:04.933159
NCT02107222|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-03-31||||||March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|PALP-COPD||The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD)|A Multicenter Randomized Control Trial (RCT) to Determine Safety and Efficacy of PALP™ for ECCO2-R in Conjunction With Liberation From Mechanical Ventilation (MV) Compared to MV Alone in COPD Exacerbation and Respiratory Failure|Withdrawn||N/A|0|Actual|Maquet Cardiopulmonary AG||2||"This action is an internal decision that was not made because of any pending regulatory action   for these products."|f||||t||||||||||2017-10-11 00:35:05.112738|2017-10-11 00:35:05.112738
NCT02107209|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-11-10|||April 2013||2013-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|BLVR||Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema|Evaluation of Bronchoscopic Biological Lung Volume Reduction Therapy in Pulmonary Emphysema Patients|Completed||Phase 2|15|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 00:35:05.233047|2017-10-11 00:35:05.233047
NCT02107196|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-11-18|2016-06-21||March 2014||2014-03-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|IRIS-3|Baseline analysis was performed on the ITT population (n=535). The ITT population includes all randomised patients who took at least one dose of study drug.|12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)|A 12-Week Double-blind, Randomised, Placebo-controlled, Parallel Group Phase III Study, Followed by a 4-Week Randomised Withdrawal Period to Evaluate the Efficacy and Safety of Oral Ibodutant 10 mg Once Daily in Female Patients With Irritable Bowel Syndrome With Diarrhea|Completed||Phase 3|535|Actual|Menarini Group||2|||f||||f||||||||||2017-10-11 00:35:05.444666|2017-10-11 00:35:05.444666
NCT02107183|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-07-18|||June 2014||2014-06-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|RINO||Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial|Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial|Completed||N/A|500|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 00:35:06.531255|2017-10-11 00:35:06.531255
NCT02107027|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-06-29|||March 2013||2013-03-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|July 2016|Actual|2016-07-01||Interventional|EVACIRC||Pulmonary Veins Circular Ablation Catheter Evaluation for Atrial Fibrillation|Pulmonary Veins Circular Ablation Catheter Evaluation for Atrial Fibrillation|Active, not recruiting||N/A|58|Actual|Association de Recherche pour le Traitement des Arythmies Cardiaques||2|||f||||t||||||||||2017-10-11 00:35:06.68288|2017-10-11 00:35:06.68288
NCT02107014|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-02-28|2016-12-28||March 2014||2014-03-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|LDN-IM||Low Dose Naltrexone (LDN) Immune Monitoring|Low Dose Naltrexone (LDN) Immune Monitoring|Completed||N/A|9|Actual|University of Alabama at Birmingham|No placebo control drug used - participants were only advised that placebo may be used during the trial.|1|||f||||f||||||||||2017-10-11 00:35:06.874648|2017-10-11 00:35:06.874648
NCT02107001|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-11-30|||March 2014||2014-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|UPP||Lung Ultrasound in Pleuritic Chest Pain|Lung Ultrasound in Pleuritic Chest Pain: a Multicenter, Prospective, Diagnostic Accuracy Study.|Completed||N/A|400|Anticipated|University of Milan|||1||f||||f||||||||||2017-10-11 00:35:08.676759|2017-10-11 00:35:08.676759
NCT02106988|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-11-07|||January 2015||2015-01-01|November 2016|2016-11-01||||January 2022|Anticipated|2022-01-01||Interventional|||Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma|Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Patients With Stage I/II Nasal NK Cell Lymphoma|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:35:08.804292|2017-10-11 00:35:08.804292
NCT02106975|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-05-03|||April 2014||2014-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CITRIS-ALI||Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury|Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury|Recruiting||Phase 2|170|Anticipated|Virginia Commonwealth University||2|||f||||t|t|f||||||No||2017-10-11 00:35:08.983006|2017-10-11 00:35:08.983006
NCT02106962|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-08-25|2016-07-28||April 2014||2014-04-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||dialysis subjects using arteriovenous fistula for dialysis access|Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients|The Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients|Completed||Phase 4|17|Actual|California Institute of Renal Research||2|||f||||f||||||||||2017-10-11 00:35:09.119507|2017-10-11 00:35:09.119507
NCT02106949|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-10-28|||August 2014||2014-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Short Message System (SMS) Monitoring Intended for the Suicidal Patients|Short Message System (SMS) Monitoring Intended for the Suicidal Patients: Study of Efficiency|Recruiting||Phase 3|530|Anticipated|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 00:35:09.369996|2017-10-11 00:35:09.369996
NCT02106936|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-06-30|||March 5, 2014||2014-03-05|June 20, 2017|2017-06-20|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Observational|||Depotentiation in People With Focal Hand Dystonia|Depotentiation in Focal Hand Dystonia Patients|Terminated||N/A|6|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:35:09.524318|2017-10-11 00:35:09.524318
NCT02106923|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-01-19|2017-01-19||April 2014||2014-04-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional||Treated set which included all subjects who were dispensed study medication and were documented to have taken at least one dose of study drug.|Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets|Relative Bioavailability of Two Newly Developed FDC Tablet Strengths (10 mg/1000 mg and 5mg/750mg) of Empagliflozin/Metformin Extended Release Compared With the Free Combination of Empagliflozin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)|Completed||Phase 1|72|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:35:09.706783|2017-10-11 00:35:09.706783
NCT02106910|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-05-16|||October 2014||2014-10-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy|Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy|Enrolling by invitation||N/A|374|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f|f|t|t||f|Samples With DNA|"     Paraffin embedded esophageal tissue samples obtained by the cytosponge.   "|No||2017-10-11 00:35:10.436926|2017-10-11 00:35:10.436926
NCT02106897|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-08-02|||April 2014||2014-04-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 in Healthy Volunteers and Participants With Systemic Lupus Erythematosus|A Single-Ascending-Dose and Multiple-Ascending-Dose Study of BIIB059 in Healthy Volunteers and Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|109|Actual|Biogen||10|||f||||f||||||||||2017-10-11 00:35:10.549726|2017-10-11 00:35:10.549726
NCT02106884|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-05-02|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|QOLINPAC||Quality of Life Study in Patients With Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine in Combination With Nab-paclitaxel|Randomized Crossover Trial to Assess the Effects and Quality of Life in Patients With Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine in Combination With Nab-paclitaxel: QOLINPAC|Active, not recruiting||Phase 2|146|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||No||2017-10-11 00:35:10.682502|2017-10-11 00:35:10.682502
NCT02106871|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-04-05|||April 2014||2014-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PCC||Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer|Phase I Assessment of NO Mediated Signaling in Cancer Cachexia|Recruiting||Phase 1|40|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-11 00:35:10.803949|2017-10-11 00:35:10.803949
NCT02106858|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-09-29|||June 25, 2014|Actual|2014-06-25|September 2017|2017-09-01|May 7, 2019|Anticipated|2019-05-07|May 7, 2019|Anticipated|2019-05-07||Observational|StivargaPMS||Stivarga Regulatory Post-Marketing Surveillance Study in Korea|Stivarga® Regulatory Post-Marketing Surveillance Study in Korea|Recruiting||N/A|190|Anticipated|Bayer|||1||f||||f||||||||||2017-10-11 00:35:10.89879|2017-10-11 00:35:10.89879
NCT02106845|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-08-08|||April 22, 2014|Actual|2014-04-22|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|April 27, 2015|Actual|2015-04-27||Interventional|||Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.|A Phase I, Multi-center, Non-randomized, Open Label, Drug-drug-interaction Study to Determine the Effect of Multiple Doses of Regorafenib (BAY 73-4506) on the Pharmacokinetics of Probe Substrates of Transport Proteins P-gp (Digoxin; Group A) and BCRP (Rosuvastatin; Group B) in Patients With Advanced Solid Malignant Tumors|Active, not recruiting||Phase 1|42|Actual|Bayer||2|||f||||f|f|f||||||||2017-10-11 00:35:10.988428|2017-10-11 00:35:10.988428
NCT02106832|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-09-04|2017-08-02||April 30, 2014|Actual|2014-04-30|September 2017|2017-09-01|October 19, 2016|Actual|2016-10-19|September 13, 2016|Actual|2016-09-13||Interventional|RESPIRE 2||Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)|Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.|Completed||Phase 3|521|Actual|Bayer||4|||f||||f|t|f||||||||2017-10-11 00:35:11.141244|2017-10-11 00:35:11.141244
NCT02106819|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-01-30|||April 2014||2014-04-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Emotional Communication Disorders in Cerebellar Disease|Disorders of Emotional Communication in Patient With Cerebellar Dysfunction|Completed||N/A|56|Actual|University of Florida|||2||f||||f||||||||||2017-10-11 00:35:12.744904|2017-10-11 00:35:12.744904
NCT02106806|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-03|||May 2011||2011-05-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|October 2011|Actual|2011-10-01||Interventional|||Zinc Supplementation on Markers of Oxidative Stress in Post Operative Colorectal Cancer During Chemotherapy Cycles|Zinc Supplementation on Markers of Oxidative Stress in Post Operative Colorectal Cancer During Chemotherapy Cycles|Completed||N/A|55|Actual|University of Sao Paulo||4|||f||||f||||||||||2017-10-11 00:35:12.842831|2017-10-11 00:35:12.842831
NCT02106793|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2016-03-31|||March 2015||2015-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Mitomicin C for Prevention Postoperative Endoscopic Sinus Surgery Synechia and QOL in Chronic Rhinosinusitis|Comparing Effect of Mitomicin C Versus Placebo for Prevention of Postoperative Endoscopic Sinus Surgery Synechia and Impact on Quality of Life in Thai Patients With Chronic Rhinosinusitis|Recruiting||Phase 3|388|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 00:35:12.943655|2017-10-11 00:35:12.943655
NCT02106780|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-04-04|||August 2011||2011-08-01|April 2014|2014-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate the Effect of ASP1707 on the Bodies of Healthy Male Subjects After a Single Dose of Radioactive ASP1707|An Open Label Study to Evaluate the Pharmacokinetics of ASP1707 After a Single Oral Dose of 14C-labeled ASP1707 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:35:13.06201|2017-10-11 00:35:13.06201
NCT02106767|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-12-01|||November 2014||2014-11-01|December 2015|2015-12-01|March 2016|Anticipated|2016-03-01|August 2015|Actual|2015-08-01||Interventional|||The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin|The Effects of Single-Dose Rifampin on the Pharmacokinetics of Rosuvastatin in Healthy White and Asian Volunteers|Active, not recruiting||Phase 1|16|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:35:13.201163|2017-10-11 00:35:13.201163
NCT02106728|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-07-25|2015-12-23||January 2012||2012-01-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|MFGT||Multi-Family Group Therapy for Adult Eating Disorders|A Comparison of Family Supportive Counseling and Multi-Family Therapy Group for People With Eating Disorders and Their Family Members: A Randomized Controlled Trial|Completed||N/A|117|Actual|University Health Network, Toronto|Lacked random assignment to MFT or SFT. Sample size of pilot was small and subsample of individuals were smaller in SFT than MFT. We may not have had statistical power to determine all differences in MFT and SFT groups. Sample not generalized.|2|||f||||f||||||||No|There is no plan or REB approval to share the IPD data. IPD will be kept confidential and destroyed as per UHN data policy when the study is concluded.|2017-10-11 00:35:13.596998|2017-10-11 00:35:13.596998
NCT02106715|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2014-04-03|||March 2014||2014-03-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|Cycle||Overuse Injuries in Road Cyclists, Prevalence and Prevention|Overuse Injuries in Road Cyclists, Prevalence and Prevention|Unknown status|Recruiting|N/A|400|Anticipated|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-11 00:35:14.318671|2017-10-11 00:35:14.318671
NCT02106702|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-06-15|||February 2010||2010-02-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|NAV||The Navigator Project|Navigator-Enhanced Case Management for HIV-Infected Jail Inmates Reentering the Community|Completed||N/A|271|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:35:14.403299|2017-10-11 00:35:14.403299
NCT02106689|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-05-30|||February 2014||2014-02-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Needle-Free Injections of Gonadotropins for Superovulation|Needle Free Injections of Gonadotropins for Patients Undergoing Superovulation - A Randomized, Pilot Study|Terminated||N/A|2|Actual|University of British Columbia||2||This study is terminated due to an inability to recruit a sufficient number of participants.|f||||f||||||||||2017-10-11 00:35:14.479998|2017-10-11 00:35:14.479998
NCT02106676|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-11-24|||March 2012||2012-03-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Androgen Metabolism and Reproductive Outcome|Androgen Metabolism and Reproductive Outcome|Completed||N/A|400|Actual|Medical University of Graz|||2||f||||f||||||||||2017-10-11 00:35:14.604711|2017-10-11 00:35:14.604711
NCT02106663|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-06-05|||July 2012||2012-07-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|PAF||Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation|Evaluating the Efficacy of Circumferential Pulmonary Vein Ablation (CPVA) Versus Segmental Pulmonary Vein Isolation (SPVI) in Paroxysmal Atrial Fibrillation|Recruiting||N/A|100|Anticipated|University of California, San Diego||2|||f||||f||||||||No||2017-10-11 00:35:14.717436|2017-10-11 00:35:14.717436
NCT02106650|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-03-10|||July 2014||2014-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 2, Single Arm, Open Label Study of Folotyn in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With PTCL|A Phase 2, Single-Arm, Open-Label, Multicenter, Study of Folotyn® (Pralatrexate Injection) in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL)|Recruiting||Phase 2|37|Anticipated|Spectrum Pharmaceuticals, Inc||1|||f||||||||||||||2017-10-11 00:35:14.847314|2017-10-11 00:35:14.847314
NCT02106637|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-03|||June 2014||2014-06-01|April 2014|2014-04-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS|Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Concomitant With Nurse-Led Support, in Patients After an Acute Coronary Syndrome (ACS)|Not yet recruiting||N/A|300|Anticipated|Sheba Medical Center||2|||f||||t||||||||||2017-10-11 00:35:14.99004|2017-10-11 00:35:14.99004
NCT02106624|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2016-08-04|||March 2015||2015-03-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||A Trial to Assess the Effect of High Nitrogen Intake in Critically Ill Patients|The Efficacy and Safety of High Nitrogen Intake in Critically Ill Patients: a Randomized and Controlled Trial|Recruiting||Phase 4|80|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-11 00:35:15.128561|2017-10-11 00:35:15.128561
NCT02106585|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2014-10-03|||March 2014||2014-03-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects|Phase 1, Randomized, Single-blind, Placebo-controlled Dose Escalation Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of JTT-251 Single Oral Doses in Healthy Subjects (Part Ia) and in Type 2 Diabetic Subjects (Part Ib) and Randomized, Open-label, Crossover Study Evaluating Effect of Food on PK in Healthy Subjects (Part II)|Completed||Phase 1|94|Actual|Akros Pharma Inc.||9|||f||||f||||||||||2017-10-11 00:35:15.598961|2017-10-11 00:35:15.598961
NCT02106572|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-04|2017-07-12|||February 2015||2015-02-01|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|TIM||Therapeutic Instillation of Mistletoe|Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study|Recruiting||Phase 3|546|Anticipated|Abnoba Gmbh||2|||f||||f||||||||||2017-10-11 00:35:15.771265|2017-10-11 00:35:15.771265
NCT02106559|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-02-01|||September 2014||2014-09-01|February 2016|2016-02-01||||August 2017|Anticipated|2017-08-01||Interventional|||Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy|A Pilot Study of Pleural Photodynamic Therapy for Patients With Pleural Malignancy|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:35:16.144468|2017-10-11 00:35:16.144468
NCT02106533|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-07|||August 2011||2011-08-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|June 2012|Actual|2012-06-01||Interventional|||Aerobic Exercise on Ventilatory Efficiency in CAD Patients|Effect of Aerobic Exercise Training on Ventilatory Efficiency in Patients With Coronary Artery Disease|Completed||Phase 2|123|Actual|Hospital TotalCor||3|||f||||t||||||||||2017-10-11 00:35:17.104495|2017-10-11 00:35:17.104495
NCT02106520|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-11-19|||April 2014||2014-04-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|ALEGORI||Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)|Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)|Terminated||Phase 2/Phase 3|80|Actual|Hospices Civils de Lyon||4||DSMB's decision following the first step analysis|f||||t||||||||||2017-10-11 00:35:17.211432|2017-10-11 00:35:17.211432
NCT02106507|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-05-17|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate|Phase 1b Study of ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate|Active, not recruiting||Phase 1|9|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:35:17.313308|2017-10-11 00:35:17.313308
NCT02106494|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-10-31|2016-09-01|2016-07-07|March 2014||2014-03-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Patients with a histologically or cytologically confirmed cancer diagnosis were scheduled to receive first cycle single day highly emetogenic chemotherapy (HEC)|A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC|A Phase 3 Clinical Study Protocol: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Study of APF530 500 mg SC, Fosaprepitant 150 mg IV, and Dexamethasone vs. Ondansetron 0.15 mg/kg IV, Fosaprepitant 150 mg IV, and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy|Completed||Phase 3|942|Actual|Heron Therapeutics||2|||f||||f||||||||No||2017-10-11 00:35:17.421885|2017-10-11 00:35:17.421885
NCT02106468|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-04-26|||May 2013||2013-05-01|March 2014|2014-03-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional|||The Efficacy of Omega-3 in Treatment of Atrophic/Erosive Lichen Planus|The Efficacy of Omega-3 in Treatment of Atrophic/Erosive Lichen Planus and Improvement of Quality of Life: A Randomized, Double Blind, Controlled Study|Completed||Phase 2|30|Actual|October 6 University||2|||f||||t||||||||||2017-10-11 00:35:18.307481|2017-10-11 00:35:18.307481
NCT02106455|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-07-30|||May 27, 2013|Actual|2013-05-27|July 2017|2017-07-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|||Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance −|Benet 17.5 mg Tablets Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) - 48-week Surveillance −|Completed||N/A|2500|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:35:18.419905|2017-10-11 00:35:18.419905
NCT02106442|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-09-27|||May 27, 2013|Actual|2013-05-27|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate Tablets|36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Benet 75 mg Tablets|Active, not recruiting||N/A|500|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:35:18.525777|2017-10-11 00:35:18.525777
NCT02106429|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-11-11|||March 2014||2014-03-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|PACE||Platelet Activity in Vascular Surgery and Cardiovascular Events|Platelet Activity in Vascular Surgery and Cardiovascular Events|Recruiting||N/A|385|Anticipated|New York University School of Medicine|||1||f||||t||||||Samples With DNA|"     Blood will be obtained from the patient using standard aseptic phlebotomy techniques at 3     time points throughout the study. This will be pre-operatively, at post-op day 2 and at the     30-day follow up. A questionnaire, urine specimen and endothelial function test will be     performed as well.   "|||2017-10-11 00:35:18.637273|2017-10-11 00:35:18.637273
NCT02106403|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-01-26|2015-01-26||May 2014||2014-05-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray|A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray|Completed||N/A|50|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:35:18.864196|2017-10-11 00:35:18.864196
NCT02106377|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2014-04-07|||February 2014||2014-02-01|April 2014|2014-04-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|||Using in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Steroid Treatment in Dry Eye Disease|The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease|Unknown status|Recruiting|N/A|50|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||f||||||||||2017-10-11 00:35:19.446656|2017-10-11 00:35:19.446656
NCT02106364|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-03-25|||February 2015||2015-02-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|November 2015|Anticipated|2015-11-01||Interventional|||A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus|A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study|Withdrawn||Phase 3|0|Actual|Eli Lilly and Company||2||Lilly's decision to cancel this trial is due to regulatory uncertainty in China.|f||||t||||||||||2017-10-11 00:35:19.538486|2017-10-11 00:35:19.538486
NCT02106351|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-07-25|||April 2014||2014-04-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|PUL||Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children|A Phase III, Multicentre, Double Blind, Prospective, Randomised, Controlled, Multiple Treatment Study Assessing Efficacy And Safety Of DYSPORT® Used In The Treatment Of Upper Limb Spasticity In Children|Recruiting||Phase 3|210|Anticipated|Ipsen||3|||f||||t||||||||||2017-10-11 00:35:19.865946|2017-10-11 00:35:19.865946
NCT02106338|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-06-09|||June 2014||2014-06-01|September 2014|2014-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.|Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123 Administered Orally to Healthy Adults|Completed||Phase 1|36|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 00:35:20.156635|2017-10-11 00:35:20.156635
NCT02106312|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-26|||November 2010||2010-11-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|DOREMY||Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas|Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas|Recruiting||Phase 2|80|Anticipated|The Netherlands Cancer Institute||1|||f||||f|f|f||||||||2017-10-11 00:35:20.382151|2017-10-11 00:35:20.382151
NCT02106299|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-03|||January 2014||2014-01-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety and Efficacy Study of Regen Sling to Treatment SUI|A Multi-Center, Randomized, Controlled Clinical Trial of the Safety and Efficacy of Regen Sling Treatment for Female Patients With Stress Urinary Incontinence|Unknown status|Recruiting|Phase 3|178|Anticipated|Medprin Regenerative Medical Technologies Co.,Ltd.||2|||f||||f||||||||||2017-10-11 00:35:20.57976|2017-10-11 00:35:20.57976
NCT02106286|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-07|||February 2011||2011-02-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Beta-blockade on Cardiopulmonary Exercise Testing|The Influence of Beta-blockade on Cardiopulmonary Function Measured by Cardiopulmonary Exercise Testing|Completed||Early Phase 1|55|Actual|Aintree University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:35:20.690903|2017-10-11 00:35:20.690903
NCT02106273|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2014-04-03|||April 2011||2011-04-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Observational|||The Use of LMA-Proseal and Endobronchial Blocker for One Lung Anesthesia, Case Series|The Use of LMA-Proseal and Endobronchial Blocker for One Lung Anesthesia, Case Series.|Completed||Phase 4|29|Actual|Mahidol University|||1||f||||f||||||||||2017-10-11 00:35:20.797782|2017-10-11 00:35:20.797782
NCT02106260|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-05-21|||March 2014||2014-03-01|May 2014|2014-05-01||||April 2014|Actual|2014-04-01||Interventional|||First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts|A Phase I/IIa Open-label First-in-Human Study to Assess Safety and Pharmacokinetics and Explore Biomarker Effects of Topical Ionic Contra-viral Therapy (ICVT) Comprised of CLS003 in Subjects With Cutaneous Warts|Completed||Phase 1/Phase 2|12|Actual|Cutanea Life Sciences, Inc.||1|||f||||f||||||||||2017-10-11 00:35:21.017961|2017-10-11 00:35:21.017961
NCT02106247|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-07-09|||April 2014||2014-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Young Healthy Male Volunteers (Randomised, Double-blind, Placebo-controlled Within Dose Groups Phase I Trial)|Completed||Phase 1|36|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:35:21.122288|2017-10-11 00:35:21.122288
NCT02106234|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-10-05|||April 2014||2014-04-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|July 2016|Actual|2016-07-01||Interventional|AMACING||A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?|Randomised Controlled Trial Evaluating Prophylactic Intravenous Hydration for the Prevention of Contrast Induced Nephropathy|Completed||N/A|660|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:35:21.247039|2017-10-11 00:35:21.247039
NCT02106221|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-07-28|||July 2011||2011-07-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional|TOPMED||Transforming Outcomes for Patients Through Medical Home Evaluation & reDesign|Transforming Outcomes for Patients Through Medical Home Evaluation & reDesign|Completed||Phase 3|65500|Actual|Care Management Plus||2|||f||||t||||||||||2017-10-11 00:35:21.387825|2017-10-11 00:35:21.387825
NCT02106208|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-08-29|||April 2014||2014-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|HDL||Study of the Impact of Dairy Fat on Cardiovascular Health.|Study of the Impact of Dairy Fat on Cardiovascular Health.|Active, not recruiting||N/A|90|Anticipated|Laval University||5|||f||||f||||||||||2017-10-11 00:35:21.505495|2017-10-11 00:35:21.505495
NCT02106195|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-10-09||2014-10-09|April 2014||2014-04-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Safety and Tolerability Study of KD025 Treatment in Subjects With Moderately Severe Psoriasis Vulgaris|A Phase 2a, Open-Label Study to Evaluate the Safety and Tolerability of KD025 Treatment in Subjects With Moderately Severe Psoriasis Vulgaris Who Have Failed First-Line Therapy|Completed||Phase 2|8|Actual|Kadmon Corporation, LLC||1|||f||||f||||||||||2017-10-11 00:35:21.633724|2017-10-11 00:35:21.633724
NCT02106182|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-03-08|||January 2, 2014|Actual|2014-01-02|March 2017|2017-03-01|August 1, 2016|Actual|2016-08-01|March 2, 2016|Actual|2016-03-02||Interventional|BPH||Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia|A Multi-center, Prospective, Open-label, Single-arm, 12-weeks, Phase IV Trial to Evaluate the Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia|Completed||Phase 4|135|Actual|JW Pharmaceutical||1|||f||||t||||||||||2017-10-11 00:35:21.738717|2017-10-11 00:35:21.738717
NCT02106169|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-07-05|||November 2014||2014-11-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|EducAA||Impact of the Therapeutic Education on the Quality of Life of the Child Suffering of Food Allergy IgE-mediated|Impact of the Therapeutic Education on the Quality of Life of the Child From 8 to 12 Years Old (and His Family) Suffering of Food Allergy IgE-mediated.|Active, not recruiting||N/A|46|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:35:21.874563|2017-10-11 00:35:21.874563
NCT02106156|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-08-02|2016-08-02||January 2008||2008-01-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)|Noninterventional Study on the Quality Assurance of the Therapy of Chronic Hepatitis C With Peg-(40kd)-Interferon Alfa-2a (Pegasys®) and Ribavirin (e.g. Copegus®) With Main Focus Gastroenterologists - a Project in BNG (Association of German Resident Gastroenterologists), Part III|Completed||N/A|10228|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:35:22.044248|2017-10-11 00:35:22.044248
NCT02106143|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-05-10|||September 2014||2014-09-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|Lobectomy||RejuvenAir™ System Lobectomy Safety and Histology Study|A Prospective Study of RejuvenAir™ System Radial Spray Cryotherapy to Determine Safety and Histological Effect in the Lung|Completed||N/A|11|Actual|CSA Medical, Inc.||1|||f||||t||||||||No||2017-10-11 00:35:24.933845|2017-10-11 00:35:24.933845
NCT02106130|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-04-03|||May 2013||2013-05-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||A Drug Interaction Study of Mosapride and Rebamipide|A Randomized, Open-label, Multiple Dose, Two-treatment, Two-period, Two-sequence Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Mosapride Citrate and Rebamipide After Oral Administration in Healthy Volunteers|Completed||Phase 1|40|Actual|IlDong Pharmaceutical Co Ltd||4|||f||||f||||||||||2017-10-11 00:35:25.050429|2017-10-11 00:35:25.050429
NCT02106117|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-04-01|||December 2012||2012-12-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|AENEASII||Exhaled Breath Analysis in the Early Detection of Aspergillosis|The Application of an Electronic Nose in the Early Detection of Aspergillosis II|Unknown status|Recruiting|N/A|150|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     Throat Swabs for microbiome analysis Serum samples for Galactomannan detection.   "|||2017-10-11 00:35:25.16171|2017-10-11 00:35:25.16171
NCT02106104|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-05-16|||March 2014||2014-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|RENALIS||Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes|A Phase 4, Monocenter, Randomized, Double-blind, Comparator-controlled, Parallel-group, Mechanistic Intervention Trial to Assess the Effect of 8-week Treatment With the Dipeptidyl Peptidase-4 Inhibitor (DPP-4i) Linagliptin Versus the Sulfonylurea (SU) Derivative Glimepiride on Renal Physiology and Biomarkers in Metformin-treated Patients With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 4|48|Actual|VU University Medical Center||2|||f||||f||||||||Undecided||2017-10-11 00:35:25.263589|2017-10-11 00:35:25.263589
NCT02106091|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-07-19|||April 2014||2014-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL|A Pharmacodynamically-guided, Dose-escalation, Phase I Study to Assess the Safety of AFM11 (Recombinant Antibody Construct Against Human CD19 and CD3) in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL.|Recruiting||Phase 1|50|Anticipated|Affimed GmbH||1|||f||||t||||||||||2017-10-11 00:35:25.434306|2017-10-11 00:35:25.434306
NCT02106078|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-09-08|||January 2014||2014-01-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|MoodSwings 2||Internet-Based Interventions for Bipolar Disorder|2/2-A Randomized Trial of Internet-Based Interventions for Bipolar Disorder|Unknown status|Active, not recruiting|N/A|300|Anticipated|VA Palo Alto Health Care System||3|||f||||t||||||||||2017-10-11 00:35:25.56236|2017-10-11 00:35:25.56236
NCT02106065|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-06-08|||February 21, 2014|Actual|2014-02-21|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|VA CARES||VA Cultivating Access to Resources, Education, and Skills for Dementia Caregivers|Dementia Caregiver Rehabilitation: Enhancing Veteran and Family-Centered Care|Recruiting||Phase 1|150|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||No||2017-10-11 00:35:25.670276|2017-10-11 00:35:25.670276
NCT02106052|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-07-17|||March 2014||2014-03-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Exercise on Impact of Cognitive Functioning in Multiple Sclerosis Patients|The Effect of Aerobic Exercise on Cognition in Multiple Sclerosis (MS Exercise Study)|Recruiting||N/A|125|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 00:35:25.77945|2017-10-11 00:35:25.77945
NCT02106039|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-09-06|||April 2014||2014-04-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|February 28, 2017|Actual|2017-02-28||Interventional|TANDEM||Pulmonary Tuberculosis Patients With Diabetes Mellitus|Concurrent Tuberculosis and Diabetes: Clinical Monitoring, and Microbiological and Immunological Effects of Diabetes During Tuberculosis Treatment|Active, not recruiting||N/A|350|Actual|Universitas Padjadjaran||2|||f||||t||||||||||2017-10-11 00:35:25.942126|2017-10-11 00:35:25.942126
NCT02106026|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-04-02|||December 2004||2004-12-01|April 2014|2014-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Nursing Education Intervention for Maternal Breastfeeding|Effectiveness of a Nursing Education Intervention on Duration of Breastfeeding and on Post-natal Breast Complications in Primiparous Women: a Randomized Controlled Trial|Completed||N/A|314|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||||2017-10-11 00:35:26.087047|2017-10-11 00:35:26.087047
NCT02106013|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2014-04-02|||April 2008||2008-04-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Observational|||Association Between HDL Functions and Atherosclerotic Burden in Healthy Individuals|Association Between HDL Functions and Atherosclerotic Burden in Healthy Individuals|Completed||N/A|101|Actual|University of Campinas, Brazil|||3||f||||t||||||||||2017-10-11 00:35:26.190429|2017-10-11 00:35:26.190429
NCT02106000|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-05-23|||June 24, 2014|Actual|2014-06-24|May 2017|2017-05-01|December 20, 2014|Actual|2014-12-20|December 20, 2014|Actual|2014-12-20||Observational|||A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of Labour|An Enabling Study to Compare the Inhalation Profiles of Women in the Third Stage of Labour to Those of Non-pregnant Female Volunteers and to Explore Whether There Are Any Differences Which Could Impact the Delivery of an Inhaled Medicinal Product|Completed||N/A|40|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 00:35:26.298019|2017-10-11 00:35:26.298019
NCT02105987|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-11-07|2015-12-10||April 2014||2014-04-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|||A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen|201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.|Completed||Phase 3|555|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 00:35:26.487585|2017-10-11 00:35:26.487585
NCT02105974|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-04-26|2016-03-03||April 7, 2014|Actual|2014-04-07|April 2017|2017-04-01|July 8, 2015|Actual|2015-07-08|July 8, 2015|Actual|2015-07-08||Interventional|||Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A 12-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) 100/25 mcg Once Daily Compared With Vilanterol Inhalation Powder (VI) 25 mcg Once Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|1621|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:35:28.401555|2017-10-11 00:35:28.401555
NCT02105961|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-09-28|||April 24, 2014|Actual|2014-04-24|September 2017|2017-09-01|January 16, 2017|Actual|2017-01-16|January 16, 2017|Actual|2017-01-16||Interventional|||Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)|Study MEA117113: Mepolizumab vs. Placebo as Add-on Treatment for Frequently Exacerbating COPD Patients Characterized by Eosinophil Level|Completed||Phase 3|674|Actual|GlaxoSmithKline||3|||f||||t||||||||||2017-10-11 00:35:30.138595|2017-10-11 00:35:30.138595
NCT02105948|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-09-07|||April 15, 2014|Actual|2014-04-15|September 2017|2017-09-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|||Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients|Study MEA117106: Mepolizumab vs. Placebo as add-on Treatment for Frequently Exacerbating COPD Patients|Completed||Phase 3|837|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 00:35:30.55432|2017-10-11 00:35:30.55432
NCT02105935|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-07-26|||April 2014||2014-04-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Investigator Initiated Protocol for the: Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion and the Establishment of Normative Data in Youth and Adolescents Athletes|Investigator Initiated Protocol for the: Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion and the Establishment of Normative Data in Youth and Adolescents Athletes.|Recruiting||N/A|200|Anticipated|ElMindA Ltd|||2||f||||f||||||||||2017-10-11 00:35:31.120464|2017-10-11 00:35:31.120464
NCT02105922|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-05-08|||April 2014||2014-04-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Strength Training and Protein Ingestion in Old Versus Very-old|Effect of Strength Training and Protein Ingestion in Old Versus Very-old|Completed||N/A|45|Actual|Bispebjerg Hospital||3|||f||||t||||||||Yes|Yes, full data set will be available online.|2017-10-11 00:35:31.255|2017-10-11 00:35:31.255
NCT02105909|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-04-02|||May 2009||2009-05-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||GWAS in a Small Group of Metabolically Healthy Obese White Adults|Genome Wide Association Studies (GWAS) to Identify Candidate Obesity Susceptibility Genes in a Carefully Phenotyped, Metabolically Healthy Population of Obese White Adults|Completed||N/A|81|Actual|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-11 00:35:31.384304|2017-10-11 00:35:31.384304
NCT02105896|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-06-18|||November 2013||2013-11-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Clinical Evaluation of Total-Etch and Self-Etch Dental Adhesives - 6 Year Recall|Clinical Evaluation of Total-Etch and Self-Etch Dental Adhesives - 6 Year Recall|Completed||N/A|30|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 00:35:31.466072|2017-10-11 00:35:31.466072
NCT02105883|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-12-01|||April 2014||2014-04-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Identification Badge on Situation Awareness During High Fidelity Simulation|The Effect of Identification Badge on Situation Awareness During High Fidelity Simulation|Completed||N/A|28|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-11 00:35:31.545786|2017-10-11 00:35:31.545786
NCT02105870|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-04-02|||February 2012||2012-02-01|April 2014|2014-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|Intracor||A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function|A Randomized Control Trial of Intracoronary Reopro to Improve Coronary Microvascular Function|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Melbourne||2|||f||||f||||||||||2017-10-11 00:35:31.63722|2017-10-11 00:35:31.63722
NCT02105857|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-04-02|||March 2011||2011-03-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||The Effects of End-of-range Grade A+ Mobilization Following Acute Primary TKA|The Effects of End-of-range Grade A+ Mobilization Following Acute Primary TKA|Completed||N/A|32|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-11 00:35:31.719385|2017-10-11 00:35:31.719385
NCT02105844|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-07-25|||March 2014||2014-03-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|SWISS-AF||Swiss Atrial Fibrillation Cohort Study|Swiss Atrial Fibrillation Cohort Study - SWISS AF|Recruiting||N/A|2600|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 00:35:31.813458|2017-10-11 00:35:31.813458
NCT02105831|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-09-26|||February 2014||2014-02-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Observational|||Skeletal Muscle Perfusion With LVAD||Active, not recruiting||N/A|30|Anticipated|Oregon Health and Science University|||1||f||||t||||||||||2017-10-11 00:35:31.915001|2017-10-11 00:35:31.915001
NCT02105818|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-04-11|||March 2014||2014-03-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Observational|SWAMECO||Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis|Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis: a Cross-sectional Cohort Study|Completed||N/A|64|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 00:35:31.985989|2017-10-11 00:35:31.985989
NCT02105805|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-04-02|||October 2010||2010-10-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Weight Loss as Treatment in Heart Disease|Intentional Weight Loss as Treatment in Obese Patients With Ischaemic Heart Disease|Completed||N/A|30|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 00:35:32.151989|2017-10-11 00:35:32.151989
NCT02105792|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-09-22|||March 2013||2013-03-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Observational|PROMASTER||PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes|PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes|Completed||N/A|820|Actual|NIHR Exeter Clinical Research Facility|||2||f||||t||||||Samples With DNA|"     At Visit 1, a fasting blood sample (approximately 35 ml) will be collected for DNA     extraction, and to measure for markers of the progression of diabetes or response to diabetes     medication and for secondary markers that may predict response. A urine sample is also     collected to measure for biomarkers.      At Visit 2 a fasting blood sample and urine sample will be collected to measure for markers     of the response to diabetes medication and for secondary markers that may predict response.   "|No||2017-10-11 00:35:32.232949|2017-10-11 00:35:32.232949
NCT02105779|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-05-12|||December 2009||2009-12-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|May 2016|Actual|2016-05-01||Interventional|CAST||Optimizing Cognitive Remediation Outcomes in Schizophrenia|Optimizing Cognitive Remediation Outcomes in Schizophrenia|Active, not recruiting||N/A|160|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:35:32.356068|2017-10-11 00:35:32.356068
NCT02105766|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-08-16|||March 13, 2014||2014-03-13|August 15, 2017|2017-08-15|August 31, 2021|Anticipated|2021-08-31|August 31, 2021|Anticipated|2021-08-31||Interventional|||Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure|Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Sickle Cell Disease and Beta-Thalassemia in Individuals With Higher Risk of Transplant Failure|Recruiting||Phase 1/Phase 2|162|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:35:32.447891|2017-10-11 00:35:32.447891
NCT02105753|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-02-09|||October 2013||2013-10-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Tx Axillary Hyperhidrosis 1210nm Diode Laser|Treatment of Axillary Hyperhidrosis With a 1210nm Diode Laser|Unknown status|Enrolling by invitation|N/A|10|Anticipated|United States Naval Medical Center, San Diego||2|||f||||f||||||||||2017-10-11 00:35:32.582125|2017-10-11 00:35:32.582125
NCT02105740|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-02-12|2016-08-11||July 2015||2015-07-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|HPMADOP|Participated in the study, patients with cancer of the digestive tract of the Clinic Palliative Care of Brasilia Base Hospital (HBDF) who present pain ≥ 3 on the Visual Analogue Scale|Hypnosis in Pain Management, Anxiety and Depression in Oncological Patients|Hypnosis as a Complementary Practice in Pain Management, Anxiety and Depression in Oncological Patients|Completed||N/A|24|Actual|University of Brasilia|The hypnosis group were not blinded to the intervention. A short follow-up was given to each patient. The use of drugs was imbalanced among participants.|2|||f||||f||||||||No||2017-10-11 00:35:32.693939|2017-10-11 00:35:32.693939
NCT02105727|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2014-11-17|||March 2011||2011-03-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Changing Population Salt Consumption in Lithgow, Australia|A Before After Comparison of the Effectiveness of a Community-based Salt Reduction Program Done in Lithgow, Australia|Completed||N/A|991|Actual|The George Institute||1|||f||||f||||||||||2017-10-11 00:35:33.169788|2017-10-11 00:35:33.169788
NCT02105714|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-10-24|||July 2014||2014-07-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|NIDIAGDigest||Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders|Diagnosis of Neglected Tropical Diseases (NTDs) in Patients Presenting With Persistent Digestive Disorders (≥2 Weeks) in Côte d'Ivoire, Indonesia, Mali and Nepal|Completed||N/A|2800|Actual|Swiss Tropical & Public Health Institute|||1||f||||f||||||Samples With DNA|"     Ethanol-preserved human stool specimens   "|||2017-10-11 00:35:33.322971|2017-10-11 00:35:33.322971
NCT02105701|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-02-24|2016-02-03||June 2014||2014-06-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)|A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects Who Have Failed Prior Treatment With Pegylated Interferon and Ribavirin (P/R) With Chronic HCV GT1, GT4, and GT6 Infection|Completed||Phase 3|420|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:35:33.490598|2017-10-11 00:35:33.490598
NCT02105675|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-05-23|||February 2012|Actual|2012-02-01|June 2015|2015-06-01|February 20, 2017|Actual|2017-02-20|March 2014|Actual|2014-03-01||Interventional|||Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer|Randomized, Open-label, Parallel-group, Multi-centre Phase II Clinical Trial of Active Cellular Immunotherapy With Preparation DCVAC/PCa in Patients With Castrate-resistant Prostate Cancer|Completed||Phase 2|60|Anticipated|Sotio a.s.||2|||f||||f||||||||Undecided|possibly shared on EMA website|2017-10-11 00:35:35.158351|2017-10-11 00:35:35.158351
NCT02105662|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-03-01|2016-02-03||June 2014||2014-06-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO-INFXN (MK-5172-061)|A Phase III Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen Grazoprevir (GZR) and Elbasvir (EBR) in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are Co-Infected With HIV|Completed||Phase 3|218|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:35:35.321148|2017-10-11 00:35:35.321148
NCT02105649|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2015-02-02|||April 2014||2014-04-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Calf Muscle Strength and Standing Efficiency in Children With Spastic Diplegia|CALF MUSCLE STRENGTH AND STANDING EFFICIENCY IN CHILDREN WITH SPASTIC DIPLEGIA: A RANDOMIZED CONTROLLED TRIAL|Completed||N/A|30|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 00:35:35.599276|2017-10-11 00:35:35.599276
NCT02105636|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2017-01-10|2016-11-15|2016-07-28|May 2014||2014-05-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|November 2015|Actual|2015-11-01||Interventional||All Randomized Participants|Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)|An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Active, not recruiting||Phase 3|506|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-11 00:35:35.999399|2017-10-11 00:35:35.999399
NCT02105623|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-03|2016-08-24|||June 2014||2014-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|EARTH||EARly Prevention of aTHeroma Progression|EARly Prevention of aTHeroma Progression|Active, not recruiting||Phase 4|111|Actual|Asan Medical Center||2|||f||||t||||||||No|This is not a publicly funded trial.|2017-10-11 00:35:37.54895|2017-10-11 00:35:37.54895
NCT02105610|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-06-27|||April 2014||2014-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MYRIAD||Volatile Anesthetics to Reduce Mortality in Cardiac Surgery|Volatile Anesthetics to Reduce Mortality in Cardiac Surgery: A Multicentre Randomized Controlled Study|Recruiting||Phase 4|||Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-10-11 00:35:37.66574|2017-10-11 00:35:37.66574
NCT02105597|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-02-09|||August 2014||2014-08-01|February 2017|2017-02-01||||March 2015|Anticipated|2015-03-01||Interventional|iADHERE||A Smartphone Application to Improve Medication Adherence Among People With Type 2 Diabetes Mellitus in Singapore|A Smartphone Application to Improve Medication Adherence Among People With Type 2 Diabetes Mellitus in Singapore: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Singapore General Hospital||2||Poor patient recruitment|f||||f||||||||||2017-10-11 00:35:37.935935|2017-10-11 00:35:37.935935
NCT02105584|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-12-21|||April 2014||2014-04-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|OLAAC||Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation|Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage in Patients With Atrial Fibrillation|Active, not recruiting||Phase 1/Phase 2|105|Anticipated|Occlutech International AB||1|||f||||t||||||||||2017-10-11 00:35:38.072555|2017-10-11 00:35:38.072555
NCT02105571|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-09-27|||April 2011||2011-04-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|April 2015|Actual|2015-04-01||Interventional|SHIFT||Evaluation of Safety and Health Involvement For Truck Drivers|Social Support During a Randomized Trial of a Trucker Weight Loss Intervention|Active, not recruiting||N/A|452|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 00:35:38.184866|2017-10-11 00:35:38.184866
NCT02105558|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-05-13|||April 2014||2014-04-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Outcomes of Neuraxial Anesthetic Technique on the Trial of Labor After Cesarean (TOLAC)|Outcomes of Epidural Versus Combined Spinal and Epidural (CSE) Anesthetic Technique on the Success of Trial of Labor After Cesarean (TOLAC): A Pilot Study|Recruiting||N/A|60|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||f||||||||Undecided||2017-10-11 00:35:38.279685|2017-10-11 00:35:38.279685
NCT02105545|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-09-15|||January 2015||2015-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Genome Sequencing of Human Cancer Tissues|Genome Sequencing of Human Cancer Tissues|Recruiting||N/A|250|Anticipated|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-11 00:35:38.372889|2017-10-11 00:35:38.372889
NCT02105532|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-04-02|||September 2012||2012-09-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|TRIGGER||Transfusion in Gastrointestinal Bleeding|A Multi-centre, Feasibility, Cluster Randomised Controlled Trial Comparing Restrictive Versus Liberal Blood Transfusion Strategies in Adult Patients Admitted With Acute Upper Gastrointestinal Bleeding|Completed||Phase 2/Phase 3|936|Actual|NHS Blood and Transplant||2|||f||||t||||||||||2017-10-11 00:35:38.471863|2017-10-11 00:35:38.471863
NCT02105519|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-04-04|||October 2013||2013-10-01|April 2014|2014-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis|The Immunogenicity and Safety of the Seasonal Influenza Vaccine, Formulation 2013-2014, in Chronic Kidney Disease Patients Not on Dialysis|Unknown status|Recruiting|Phase 4|200|Anticipated|National Cheng-Kung University Hospital||3|||f||||f||||||||||2017-10-11 00:35:38.560145|2017-10-11 00:35:38.560145
NCT02105506|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-04-23|||September 2012||2012-09-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SAFE-T||Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses|Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses|Completed||N/A|15|Actual|UMC Utrecht||1|||f||||t||||||||||2017-10-11 00:35:38.6522|2017-10-11 00:35:38.6522
NCT02105493|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-04-02|||October 2013||2013-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|NORAO||Nitroglycerin Prevents Radial Artery Occlusion|A Novel Approach to Reduce Radial Artery Occlusion After Trans-Radial Catheterization: Post-Procedural/Pre-Hemostasis Intra-Arterial Nitroglycerin|Completed||N/A|1706|Actual|National Cardiovascular Center Harapan Kita Hospital Indonesia||2|||f||||t||||||||||2017-10-11 00:35:38.73421|2017-10-11 00:35:38.73421
NCT02105480|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-07-19|||November 2013|Actual|2013-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01|1 Day|Observational [Patient Registry]|||Automated Algorithm Based Analysis of Phonocardiograms of Newborns|Automated Algorithm Based Analysis of Phonocardiograms of Newborns|Active, not recruiting||N/A|220|Actual|CSD Labs GmbH|||1||f||||t||||||||||2017-10-11 00:35:38.839998|2017-10-11 00:35:38.839998
NCT02105467|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-03-01|2016-02-03||June 2014||2014-06-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|February 2015|Actual|2015-02-01||Interventional|||Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)|A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection.|Completed||Phase 3|421|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:35:38.943793|2017-10-11 00:35:38.943793
NCT02105454|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-03-01|2016-02-03||May 2014||2014-05-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048)|A Phase II Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 + MK-8742 + Ribavirin (R) in Subjects With Chronic Hepatitis C Virus Infection Who Failed Prior Direct Acting Antiviral Therapy|Completed||Phase 2|79|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:35:39.647949|2017-10-11 00:35:39.647949
NCT02105441|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-09-07|||March 2014||2014-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|CI and SSD||Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss|Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss|Recruiting||N/A|40|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-11 00:35:39.950169|2017-10-11 00:35:39.950169
NCT02105428|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-05-16|||July 2010||2010-07-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation|Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation|Completed||N/A|44|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:35:40.111884|2017-10-11 00:35:40.111884
NCT02105415|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-04-05|||April 2014||2014-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KEEP PACE||"Ketamine / Propofol Admixture Ketofol at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial"|"Ketamine / Propofol Admixture Ketofol at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial"|Enrolling by invitation||Phase 2/Phase 3|160|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 00:35:40.205134|2017-10-11 00:35:40.205134
NCT02105402|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-09-28|||January 2014||2014-01-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Treatment Efficacy for Developmental Motor Speech Disorders|Treatment Efficacy for Developmental Motor Speech Disorders: A PROMPT Randomized Control Trial|Completed||N/A|45|Actual|The Prompt Institute||2|||f||||t||||||||||2017-10-11 00:35:40.291432|2017-10-11 00:35:40.291432
NCT02105389|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-11-27|||January 2013||2013-01-01|November 2015|2015-11-01||||October 2013|Actual|2013-10-01||Interventional|||Yoga to Reduce Fatigue in Hospitalized Children Receiving Intensive Chemotherapy|A Feasibility Study of Yoga to Reduce Fatigue in Hospitalized Children Receiving Intensive Chemotherapy|Completed||N/A|11|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 00:35:40.378152|2017-10-11 00:35:40.378152
NCT02105376|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-05-03|||May 2014||2014-05-01|May 2015|2015-05-01||||June 2015|Anticipated|2015-06-01||Interventional|||TNS for Major Depressive Disorder: a Phase II Randomized Controlled Trial|The Effects of Trigeminal Nerve Stimulation (TNS) for the Treatment of Major Depressive Disorder: a Phase II, Randomized, Sham Controlled Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|44|Anticipated|Santa Casa Medical School||2|||f||||t||||||||||2017-10-11 00:35:40.456022|2017-10-11 00:35:40.456022
NCT02105363|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-04-02|||April 2014||2014-04-01|April 2014|2014-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|||How Much Can the Thoracic and Lumbar Skin Slide?|How Much Can the Thoracic and Lumbar Skin Slide? Unrecognized Cause of Epidural Catheter Placement Failure|Enrolling by invitation||Phase 4|400|Anticipated|Rutgers, The State University of New Jersey|||20||f||||f||||||||||2017-10-11 00:35:40.569046|2017-10-11 00:35:40.569046
NCT02105350|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-07-06|||June 2015||2015-06-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer|A Phase I Trial of MEK Inhibitor MEK 162 Combined Sequentially With Gemcitabine-Oxaliplatin (GEMOX) in Patients With Advanced Biliary Cancer|Suspended||Phase 1|12|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 00:35:40.895114|2017-10-11 00:35:40.895114
NCT02105337|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-03-10|||July 2013||2013-07-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Tegaderm and Visual Evoked Potentials|A Pilot Study: Does Tegaderm Placement on Eyes to Prevent Lagophthalmos Affect Visual Evoked Potentials Data Latency and Amplitude|Terminated||N/A|6|Actual|Rutgers, The State University of New Jersey|||1|PI leaving institution|f||||f||||||||||2017-10-11 00:35:40.995951|2017-10-11 00:35:40.995951
NCT02105311|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-08-04|||March 2014||2014-03-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Selective Laser Trabeculoplasty Versus Travoprost on Circardian Intraocular Pressure|A Prospective, Randomized Study Comparing the Effects of Selective Laser Trabeculoplasty and Travoprost on the Circadian Intraocular Pressure Variation|Completed||Phase 4|60|Actual|Prince of Songkla University||2|||f||||t||||||||No||2017-10-11 00:35:41.231996|2017-10-11 00:35:41.231996
NCT02105298|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-08-19|||September 2013||2013-09-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)|Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)|Completed||N/A|104000|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 00:35:41.32999|2017-10-11 00:35:41.32999
NCT02105285|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-11-24|2015-10-15||April 2014||2014-04-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension||Completed||Phase 3|193|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:35:41.4379|2017-10-11 00:35:41.4379
NCT02105272|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-11-18|2015-10-15||April 2014||2014-04-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension||Completed||Phase 3|237|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:35:41.937214|2017-10-11 00:35:41.937214
NCT02105259|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-08-31|||March 2014||2014-03-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|SOFIA||Internet-delivered Psychodynamic Therapy for Social Anxiety Disorder (SOFIA)|Internet-delivered Psychodynamic Therapy for Social Anxiety Disorder: A Randomized Controlled Trial|Completed||N/A|72|Actual|Linkoeping University||2|||f||||t||||||||||2017-10-11 00:35:42.420695|2017-10-11 00:35:42.420695
NCT02105246|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-12-15|||September 2014||2014-09-01|December 2014|2014-12-01||||September 2016|Anticipated|2016-09-01||Interventional|||The Healthy Heart Study|The Healthy Heart Study|Unknown status|Enrolling by invitation|N/A|454|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:35:42.516394|2017-10-11 00:35:42.516394
NCT02105233|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-05-18|||February 2014||2014-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|BMF||Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking Fluid|Brain Mimicking Fluid. Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking Fluid: a Preliminary Technical and Safety Study|Completed||Phase 1|15|Actual|St. Olavs Hospital||1|||f||||t||||||||||2017-10-11 00:35:42.634643|2017-10-11 00:35:42.634643
NCT02105220|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-03-24|||August 2013||2013-08-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|||Chest Wall Influence on Respiratory System Mechanics in Morbidly Obese Patients|Chest Wall Influence on Respiratory System Mechanics in Morbidly Obese Patients|Completed||N/A|14|Actual|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-11 00:35:42.787361|2017-10-11 00:35:42.787361
NCT02105207|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-04-05|||January 2014||2014-01-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|May 2015|Actual|2015-05-01||Interventional|||Comparison Between Lung Ultrasound and Chest Radiography for Acute Dyspnea|Comparison Between Lung Ultrasound and Chest Radiography for Differential Diagnosis of Acute Dyspnea in the Emergency Department|Completed||N/A|530|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-10-11 00:35:42.91043|2017-10-11 00:35:42.91043
NCT02105194|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2017-04-16|||January 2007||2007-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Cerebral Decompression Illness|Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Cerebral Decompression Illness|Recruiting||Phase 1|45|Anticipated|Louisiana State University Health Sciences Center in New Orleans||1|||f||||f||||||||||2017-10-11 00:35:43.048343|2017-10-11 00:35:43.048343
NCT02105181|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-06|||March 2007||2007-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Fully Covered Self-expandable Metal Stents (FCMS) in Benign Biliary Strictures|Temporary Placement of Fully Covered Self-expandable Metal Stents in Benign Biliary Strictures|Completed||N/A|92|Actual|Société Française d'Endoscopie Digestive||1|||f||||f||||||||||2017-10-11 00:35:43.158841|2017-10-11 00:35:43.158841
NCT02105168|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-06-09|||July 2009||2009-07-01|June 2016|2016-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|MSN||Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment|Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment in Patients With Lung Cancer or Melanoma|Recruiting||N/A|2200|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 00:35:43.270813|2017-10-11 00:35:43.270813
NCT02105155|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-12-20|||November 2014||2014-11-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|November 2016|Actual|2016-11-01||Interventional|Conversion||Conversion Prograf® to Advagraf® at D7 Versus D90 After Liver Transplantation|Non-inferiority and Tolerance of Conversion From Prograf® to Advagraf® at D7 Versus D90 After Liver Transplantation|Active, not recruiting||Phase 4|90|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:35:43.377665|2017-10-11 00:35:43.377665
NCT02105142|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2015-11-06|||April 2014||2014-04-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparative Effectiveness of Primary Care-based Interventions for Pediatric ADHD|Comparative Effectiveness of Primary Care-based Interventions for Pediatric ADHD|Completed||N/A|81|Actual|Indiana University||3|||f||||t||||||||||2017-10-11 00:35:43.500061|2017-10-11 00:35:43.500061
NCT02105129|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-04-26|||May 2014||2014-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523|A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Study of the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of HMPL-523|Completed||Phase 1|118|Actual|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-11 00:35:43.635975|2017-10-11 00:35:43.635975
NCT02105103|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-09-08|||October 2013||2013-10-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.|Accu-Chek® Insight Insulin Pump EU Study: A European Multicenter Study to Evaluate the Accu-Chek® Insight Insulin Pump in Routine Practice|Completed||N/A|80|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:35:43.889298|2017-10-11 00:35:43.889298
NCT02105090|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2014-10-08|||October 2014||2014-10-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy|Comparison of Novel Articaine Lozenge Versus Placebo for Upper Gastrointestinal Endoscopy in Adults. A Randomized Double-blinded Controlled Study|Unknown status|Recruiting|Phase 4|120|Anticipated|Helsinki University Central Hospital||3|||f||||f||||||||||2017-10-11 00:35:44.014524|2017-10-11 00:35:44.014524
NCT02105077|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-03-30|||March 2014||2014-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Development of a Mass-spectometry Based Method for Detecting Xenon Application in Humans|Development of a Mass-spectometry Based Method for Detecting Xenon Application in Humans|Completed||N/A|8|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||Samples With DNA|"     Whole-blood samples   "|||2017-10-11 00:35:44.168032|2017-10-11 00:35:44.168032
NCT02105064|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-03-07|||July 2011||2011-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|December 2014|Actual|2014-12-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant Obsessive-compulsive Symptoms in Patients With Schizophrenia||Completed||N/A|12|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-11 00:35:44.270059|2017-10-11 00:35:44.270059
NCT02105051|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-02||||||April 2014|2014-04-01||||April 2014|Anticipated|2014-04-01||Observational|||A Population-based Investigation of Related Factors of Birth Weight in China||Unknown status|Recruiting|N/A|||Chinese Neonatal Network|||1||f||||f||||||||||2017-10-11 00:35:44.367594|2017-10-11 00:35:44.367594
NCT02105038|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-02-10|||April 2014||2014-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Upper Extremity Immobilization and Use of a Steering Wheel Spinner Knob Following Distal Radius Fracture|Effects of Upper Extremity Immobilization and Use of a Steering Wheel Spinner Knob Following Distal Radius Fracture|Completed||N/A|24|Actual|Greenville Health System||2|||f||||f||||||||||2017-10-11 00:35:44.452136|2017-10-11 00:35:44.452136
NCT02105025|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-05-05|||December 2013||2013-12-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01|1 Week|Observational [Patient Registry]|||A Novel Clinically Usable Point Score To Prejudge The Complexity Of Colonoscopy|A Novel Clinically Usable Point Score To Prejudge The Complexity Of Colonoscopy|Completed||N/A|612|Actual|Fourth Military Medical University|||1||f||||t||||||||||2017-10-11 00:35:44.541923|2017-10-11 00:35:44.541923
NCT02105012|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-05-05|2016-10-31||April 1, 2014|Actual|2014-04-01|May 2017|2017-05-01|September 4, 2015|Actual|2015-09-04|September 1, 2015|Actual|2015-09-01||Interventional||Safety Population|Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma|Randomized, Double-Blind, Chronic Dosing (4 Weeks), Four-Period, Five-Treatment, Incomplete Block, Cross-Over, Multi-Center Study to Assess the Efficacy and Safety of Four Doses of Budesonide Inhalation Aerosol (BD MDI, PT008) Relative to Placebo MDI in Adult Subjects With Mild to Moderate Persistent Asthma|Completed||Phase 2|147|Actual|Pearl Therapeutics, Inc.||5|||f||||f|t|f||||||Yes||2017-10-11 00:35:44.632096|2017-10-11 00:35:44.632096
NCT02104999|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-02-17|||June 2014||2014-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Technical Accuracy and Userfriendliness of a Point-Of-Care C Reactive Protein Device in a Nursing Home Setting|Technical Accuracy and Userfriendliness of a Point-Of-Care C Reactive Protein (CRP) Device in Comparison With Laboratory CRP Testing in Nursing Home Residents.|Completed||N/A|99|Actual|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-11 00:35:45.253607|2017-10-11 00:35:45.253607
NCT02104986|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-03-30|||May 2014||2014-05-01|March 2016|2016-03-01|May 2024|Anticipated|2024-05-01|May 2019|Anticipated|2019-05-01||Interventional|||A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent|A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent|Recruiting||Phase 2|94|Anticipated|Centre Leon Berard||4|||f||||t||||||||||2017-10-11 00:35:45.346689|2017-10-11 00:35:45.346689
NCT02104973|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-04-02|||January 2012||2012-01-01|January 2014|2014-01-01|February 2015|Anticipated|2015-02-01|December 2012|Actual|2012-12-01||Interventional|CRECES||Obesity Prevention in Schoolchildren|Design and Evaluation of a Strategy to Prevent Overweight and Obesity in Schoolchildren in Mexico City|Unknown status|Active, not recruiting|N/A|400|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||||2017-10-11 00:35:46.245437|2017-10-11 00:35:46.245437
NCT02104960|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-01-13|||March 2013||2013-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Observational|PEAU PROOF||Study of Skin Parameters in the PROOF Cohort|Study of Skin Parameters in the PROOF Cohort|Completed||N/A|209|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     Skin   "|||2017-10-11 00:35:46.370764|2017-10-11 00:35:46.370764
NCT02104401|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-08-19|||October 2013||2013-10-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood|Pilot Study: Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood|Completed||Phase 1|10|Anticipated|Georgetown University||1|||f||||f||||||||||2017-10-11 00:36:01.109534|2017-10-11 00:36:01.109534
NCT02104947|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-09-04|2017-07-21||May 6, 2014|Actual|2014-05-06|September 2017|2017-09-01|October 20, 2016|Actual|2016-10-20|July 25, 2016|Actual|2016-07-25||Interventional||Treated set: Treated Set is defined as all patients who were administered idarucizumab.|Reversal of Dabigatran Anticoagulant Effect With Idarucizumab|A Phase III Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0g Idarucizumab (BI 655075) in Patients Treated Wtih Dabigatran Etexilate Who Have Uncontrolled Bleeding or Require Emergency Surgery or Procedures.RE-VERSE AD (A Study of the RE-VERSal Effects of Idarucizumab on Active Dabigatran) Trial|Completed||Phase 3|503|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:35:46.501544|2017-10-11 00:35:46.501544
NCT02104934|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-04-24|||March 2014||2014-03-01|July 2015|2015-07-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty|A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty|Completed||N/A|40|Actual|Changi General Hospital||2|||f||||f||||||||Undecided||2017-10-11 00:35:50.182876|2017-10-11 00:35:50.182876
NCT02104921|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-03-11|||December 2013||2013-12-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|AQUIRe||Innovative Ultrasound Technology in Neuromuscular Disease||Recruiting||N/A|240|Anticipated|Beth Israel Deaconess Medical Center|||2||f||||f||||||||||2017-10-11 00:35:50.296201|2017-10-11 00:35:50.296201
NCT02104908|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-12-30|||March 2014||2014-03-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Study of Nerve Block Anesthesia for Surgery of Hip Fracture in the Elderly|Target-controlled Propofol Infusion as a Technique of Anesthesia for Surgery of Hip Fracture Under Ultrasound Guidance Lumbar and Sacral Plexus Block or Lumbar, Sacral and Paravertebral Nerve Block in the Elderly|Unknown status|Enrolling by invitation|Phase 4|80|Anticipated|Shanghai Jiao Tong University Affiliated Sixth People’s Hospital||2|||f||||t||||||||||2017-10-11 00:35:50.411532|2017-10-11 00:35:50.411532
NCT02104895|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-07-11|2015-11-25||March 2005||2005-03-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|June 2013|Actual|2013-06-01||Interventional|||Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast Irradiation|Randomised Phase 3 Trial Of Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast Irradiation|Completed||Phase 3|520|Actual|Azienda Ospedaliero-Universitaria Careggi||2|||f||||t||||||||Undecided||2017-10-11 00:35:50.529224|2017-10-11 00:35:50.529224
NCT02104882|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-10-14|||March 2014||2014-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study|INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study|Completed||Phase 1/Phase 2|12|Actual|Universitätsmedizin Mannheim||1|||f||||f||||||||||2017-10-11 00:35:52.208526|2017-10-11 00:35:52.208526
NCT02104869|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-07-20|||April 2014||2014-04-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients|Open Label Parallel Randomized Clinical Trial to Evaluate the Immunogenicity of Three Regimens of the Trivalent Influenza Vaccine (Inactivated and Fragmented) in Kidney Transplant Recipients|Completed||Phase 4|195|Actual|Butantan Institute||4|||f||||f||||||||||2017-10-11 00:35:52.306591|2017-10-11 00:35:52.306591
NCT02104856|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-01-27|||January 2014||2014-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01|2 Years|Observational [Patient Registry]|BT Registry||Bronchial Thermoplasty Global Registry|Bronchial Thermoplasty (BT) Global Registry|Active, not recruiting||N/A|160|Anticipated|Boston Scientific Corporation|||1||f||||t||||||||||2017-10-11 00:35:52.418428|2017-10-11 00:35:52.418428
NCT02104843|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-07-17|||April 2014||2014-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin|Effect of Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Therapy on the Pharmacokinetics of Rosuvastatin|Completed||Phase 1|18|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:35:52.588683|2017-10-11 00:35:52.588683
NCT02104830|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-08-31|2015-02-05||September 2013||2013-09-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients|Multicenter Randomized Double-blind Phase III Clinical Study Comparing the Efficacy and Safety of a Single Dose Extimia® Versus Daily Filgrastim for Neutropenia Prophylaxis in Breast Cancer Patients Receiving Myelosuppressive Chemotherapy|Completed||Phase 3|135|Actual|Biocad||3|||f||||f||||||||||2017-10-11 00:35:52.71199|2017-10-11 00:35:52.71199
NCT02104817|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-08-09|||October 30, 2014|Actual|2014-10-30|August 2017|2017-08-01|November 29, 2019|Anticipated|2019-11-29|November 29, 2019|Anticipated|2019-11-29||Interventional|STRENGTH||Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia|A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)|Active, not recruiting||Phase 3|13086|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 00:35:54.233586|2017-10-11 00:35:54.233586
NCT02104804|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-05-04|2017-02-24||May 7, 2014|Actual|2014-05-07|April 2017|2017-04-01|February 26, 2016|Actual|2016-02-26|February 26, 2016|Actual|2016-02-26||Interventional||Note that 462 indicates the number of patients in the Full Analysis set (out of 466 randomized, 1 did not take study drug and 3 did not have 1 baseline or post baseline efficacy assessment).|Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control|A Multicenter, Randomized, Double-Blind, Phase 3b Trial to Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin in Combination With Metformin in Chinese Subjects in China With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Insulin Alone or on Insulin in Combination With Metformin|Completed||Phase 3|953|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:35:56.505984|2017-10-11 00:35:56.505984
NCT02104791|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-03|||May 2014||2014-05-01|April 2014|2014-04-01||||May 2015|Anticipated|2015-05-01||Observational|||Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane|Procalcitonin Has a Role to Play in Prediction of Intra-amniotic Subclinical Infection.|Unknown status|Enrolling by invitation|N/A|100|Actual|Ain Shams Maternity Hospital|||3||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 00:35:57.460384|2017-10-11 00:35:57.460384
NCT02104778|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-07-14|||April 2014||2014-04-01|July 2015|2015-07-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Effect of Dexamethasone and Epinephrine on the Duration of Sciatic Nerve Blocks With Ropivacaine|Effect of Dexamethasone and Epinephrine on the Duration of Sciatic Nerve Blocks With Ropivacaine in Ankle and Foot Surgery|Unknown status|Recruiting|N/A|90|Anticipated|Yeungnam University College of Medicine||3|||f||||t||||||||||2017-10-11 00:35:57.566032|2017-10-11 00:35:57.566032
NCT02104765|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-02-12|||June 2014||2014-06-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of LY2951742 in Healthy Japanese and Caucasian Participants|A Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY2951742 Administered Subcutaneously to Japanese and Caucasian Healthy Subjects|Completed||Phase 1|45|Actual|Eli Lilly and Company||7|||f||||f||||||||||2017-10-11 00:35:57.655102|2017-10-11 00:35:57.655102
NCT02104752|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-07-19|||July 2014||2014-07-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia|Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia|Unknown status|Recruiting|Phase 1/Phase 2|36|Anticipated|VA Greater Los Angeles Healthcare System||2|||f||||f||||||||||2017-10-11 00:35:57.752107|2017-10-11 00:35:57.752107
NCT02104739|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-05-04|||March 2014||2014-03-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effects of Antidiabetic Medications on the Postprandial State in Prediabetes|Comparative Effects of Antidiabetic Medications on Postprandial Hyperlipidemia, Free Fatty Acid Signaling, and Endothelial Dysfunction in Individuals With Prediabetes|Completed||Phase 4|16|Actual|The University of Texas Health Science Center, Houston||4|||f||||f||||||||||2017-10-11 00:35:57.91992|2017-10-11 00:35:57.91992
NCT02104726|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-02||||||April 2014|2014-04-01||||April 2016|Anticipated|2016-04-01||Interventional|||"Blind vs. Fluoroscopy-Guided Steroid Injections for Knee Osteoarthritis"|"Prospective Randomized-Controlled Two-Arm Study of Blind vs. Fluoroscopy-Guided Steroid Injections for Knee Osteoarthritis"|Unknown status|Not yet recruiting|Phase 2|128|Anticipated|Johns Hopkins University||2|||f||||||||||||||2017-10-11 00:35:58.08532|2017-10-11 00:35:58.08532
NCT02104713|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-08-29|||April 2014||2014-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Stem Cell Therapy to Improve Burn Wound Healing|A Pilot Safety Study of the Administration of Mesenchymal Stem Cells (MSC) in the Treatment of Burn Wounds|Recruiting||Phase 1|20|Anticipated|University of Miami||1|||f||||t|t|f||||||||2017-10-11 00:35:58.157884|2017-10-11 00:35:58.157884
NCT02104700|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-07-15|||April 2014||2014-04-01|July 2015|2015-07-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|Near-Rwanda||Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir|"Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir in Virologically-suppressed HIV-infected Rwandans (Near-Rwanda)"|Unknown status|Active, not recruiting|Phase 2/Phase 3|150|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 00:35:58.247821|2017-10-11 00:35:58.247821
NCT02104687|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-09-07|||April 2014||2014-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|Flow-press||Intraoperative Haemodynamic Optimization Comparing Flow and Pressure Parameters|The Influence of Intraoperative Goal-directed Hemodynamic Therapy Based on Cardiac Index Trending on the Volume of Intraoperatively Administered Fluids and Vasoactive Agents in Comparison to Standard Pressure Monitoring in Patients Undergoing Major Elective Abdominal Surgery|Completed||N/A|140|Actual|University Hospital Ostrava||2|||f||||f||||||||||2017-10-11 00:35:58.334177|2017-10-11 00:35:58.334177
NCT02104674|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-11-01|||June 2014||2014-06-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma|A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN ADULT PATIENTS WITH MILD TO MODERATE ASTHMA|Completed||Phase 3|313|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:35:58.444569|2017-10-11 00:35:58.444569
NCT02104661|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-01-09|||October 2014||2014-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|PROXIMUS||Protective Role of Oxcarbazepine in Multiple Sclerosis|OxCarbazepine as a Neuroprotective Agent in MS: A Phase 2a Trial|Recruiting||Phase 2|30|Anticipated|Queen Mary University of London||2|||f||||t||||||||No||2017-10-11 00:35:58.758954|2017-10-11 00:35:58.758954
NCT02104648|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-11-01|||April 2014||2014-04-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval|A 2 PART STUDY IN HEALTHY SUBJECTS: PART A: A MULTIPLE DOSE, RANDOMIZED, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF SUPRA-THERAPEUTIC DOSES OF RO4602522; PART B: A MULTIPLE-DOSE, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, PLACEBO CONTROLLED, POSITIVE-CONTROL, PARALLEL GROUP STUDY TO INVESTIGATE THE EFFECT OF RO4602522 ON THE QTC INTERVAL|Completed||Phase 1|203|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-10-11 00:35:59.147037|2017-10-11 00:35:59.147037
NCT02104635|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-12-01|||April 2014||2014-04-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Postpartum Empowerment: an Integrated Approach Driving Demand and Delivery of High Quality, Low-cost Postnatal Services in Kenya||Completed||N/A|109|Actual|Harvard School of Public Health||3|||f||||f||||||||||2017-10-11 00:35:59.232326|2017-10-11 00:35:59.232326
NCT02104622|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-04-12|||February 2014||2014-02-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation|Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation|Active, not recruiting||Phase 2|20|Anticipated|Shirley Ryan AbilityLab||1|||f||||t||||||||||2017-10-11 00:35:59.309068|2017-10-11 00:35:59.309068
NCT02104609|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-10-24|||April 2013||2013-04-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01|2 Months|Observational [Patient Registry]|||Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill|Pharmacokinetics of the Levonorgestrel-only Emergency Contraception Regimen in Normal-weight, Obese and Extremely Obese Users: a Pilot Study|Active, not recruiting||N/A|30|Anticipated|University of Southern California|||3||f||||t||||||||||2017-10-11 00:35:59.393188|2017-10-11 00:35:59.393188
NCT02104583|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-02-23||2017-02-23|September 2014||2014-09-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|TEMPO||Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging, Parallel Group Study to Evaluate the Effect of GS-6615 on Ventricular Arrhythmia in Subjects With Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronization Therapy-Defibrillator (CRT-D)|Completed||Phase 2|313|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 00:35:59.572899|2017-10-11 00:35:59.572899
NCT02104570|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-12-02|||February 2014||2014-02-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Muscle Fatigue and Kinesio Taping on Shoulder Position Sense|Effects of Muscle Fatigue and Kinesio Taping on Shoulder Joint Position Sense|Completed||N/A|24|Actual|University of Oregon||3|||f||||||||||||||2017-10-11 00:35:59.915014|2017-10-11 00:35:59.915014
NCT02104557|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-09-25|||March 19, 2014|Actual|2014-03-19|September 2017|2017-09-01|October 28, 2018|Anticipated|2018-10-28|October 28, 2018|Anticipated|2018-10-28||Observational|SAYANA||Post Marketing Surveillance Study For Sayana®|Post Marketing Surveillance To Observe Safety And Efficacy Of Sayana(Registered) Used For Contraception And Management Of Endometriosis-associated Pain|Recruiting||N/A|600|Anticipated|Pfizer|||2||f||||f||||||||||2017-10-11 00:36:00.006916|2017-10-11 00:36:00.006916
NCT02104544|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-12-01|||April 2014||2014-04-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Investigation of DHA Intake in Pregnant and Lactating Women in China|Investigation of DHA Intake in Pregnant and Lactating Women in China|Completed||N/A|1254|Actual|Peking University|||1||f||||t||||||Samples Without DNA|"     1. Collection of venous blood, pretreatment of blood sample, take the plasma and          erythrocyte respectively.        2. Collection of breast milk (only for women having lactated for 42±7 days)   "|||2017-10-11 00:36:00.165146|2017-10-11 00:36:00.165146
NCT02104531|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-06-23|||December 2015||2015-12-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Shoulder Motion Guided Patient Diagnostic and Treatment Classification|Shoulder Motion Guided Patient Diagnostic and Treatment Classification|Recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-11 00:36:00.232853|2017-10-11 00:36:00.232853
NCT02104518|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-10-27|||April 2014||2014-04-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Evaluation of Different G6PD Testing Platforms|Evaluation of a Point-of-care G6PD Diagnostic Test|Completed||N/A|700|Actual|PATH|||1||f||||t||||||Samples With DNA|"     Left-over venous blood will be spun down and buffy coat and extracted DNA will be stored in     labeled tubes for later G6PD genotyping and characterization.   "|||2017-10-11 00:36:00.320641|2017-10-11 00:36:00.320641
NCT02104492|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-01|||March 2014||2014-03-01|April 2014|2014-04-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple Sclerosis|Clinical Research on the Effect of a 12-week Respiratory Muscles Training Program in Persons With Relapsing-remitting Multiple Sclerosis|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Malaga||2|||f||||t||||||||||2017-10-11 00:36:00.489266|2017-10-11 00:36:00.489266
NCT02104479|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-05-05|||March 31, 2014|Actual|2014-03-31|May 2017|2017-05-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|EFFU-ASP||Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing|Open Multicenter Diagnostic Study on the Accuracy of Biomarker Testing (Galactomannan (GM), (1-3)-β-D-glucan (BDG), Aspergillus-specific Polymerase Chain Reaction (PCR) Assay) in Pleural Effusion Samples of Immunocompromised Patients With Suspected Invasive Pulmonary Aspergillosis (IPA)|Enrolling by invitation||N/A|200|Anticipated|Heidelberg University|||2||f||||f||||||Samples With DNA|"     only fungal DNA is investigated, no human DNA   "|||2017-10-11 00:36:00.591943|2017-10-11 00:36:00.591943
NCT02104466|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-05-30|||March 2015||2015-03-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|GATE-PDN||Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)|Randomized Controlled Pilot Trial of Adjunct Group Acupuncture vs Usual Care Among Patients With Painful Diabetic Neuropathy|Completed||N/A|40|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 00:36:00.661707|2017-10-11 00:36:00.661707
NCT02104453|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-11-13|||July 2014||2014-07-01|November 2014|2014-11-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Comparative Evaluation of Three Airway Maneuvers in the Unconscious Apneic Person|Comparative Evaluation of One-handed E-C Clamp Mask Holding Technique, Two-handed Mask Ventilation With Jaw Thrust, and Two-handed Mask Ventilation With Triple Airway Maneuver in the Unconscious Apneic Person|Unknown status|Recruiting|N/A|120|Anticipated|Tri-Service General Hospital||3|||f||||f||||||||||2017-10-11 00:36:00.751445|2017-10-11 00:36:00.751445
NCT02104440|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-03-29|||October 2013||2013-10-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro||Completed||Phase 2|15|Actual|Red de Terapia Celular||1|||f||||f||||||||||2017-10-11 00:36:00.831279|2017-10-11 00:36:00.831279
NCT02104388|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-07-07|||March 2014||2014-03-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Efficacy Study of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders|A Double-Masked, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study of SJP-0035 Ophthalmic Solution Compared With Placebo to Assess Safety and Efficacy of SJP-0035 Ophthalmic Solution for Corneal Epithelial Wound Healing in Patients With Moderate to Severe Corneal Epithelial Disorders|Completed||Phase 2|69|Actual|Senju Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:36:01.188085|2017-10-11 00:36:01.188085
NCT02104375|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2015-03-09|||March 2013||2013-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||L-citrulline Supplementation, Cold Exposure, & Post-Exercise Muscle Ischemia|The Effects of L-Citrulline Supplementation on Vascular and Cardiac Autonomic Responses to Cold Pressor Test Concurrent With Postexercise Muscle Ischemia|Completed||Phase 1/Phase 2|16|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 00:36:01.348487|2017-10-11 00:36:01.348487
NCT02104362|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-07-05|||February 2014|Actual|2014-02-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|June 2017|Actual|2017-06-01||Interventional|SiFEPI||Single Fraction Early Prostate Irradiation (SiFEPI)|A Phase I-II Study to Evaluate Exclusive Single-fraction Irradiation by Interstitial High Dose Rate Brachytherapy in Patients With Prostate Cancer at Low Risk or at Low Intermediate Risk of Local Recurrence|Recruiting||N/A|35|Anticipated|Centre Antoine Lacassagne||1|||f||||t||||||||||2017-10-11 00:36:01.633858|2017-10-11 00:36:01.633858
NCT02104349|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-07-21|||February 2014||2014-02-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Mindfulness Meditation for Spine Surgery Pain|Mindfulness Meditation for Spine Surgery Pain|Recruiting||N/A|50|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 00:36:01.730601|2017-10-11 00:36:01.730601
NCT02104336|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-03-18|||August 2014||2014-08-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Phase 2 Study of EPI-743 in Children With Pearson Syndrome|An Open-Label Phase 2 Safety and Efficacy Study of EPI-743 (VincerinoneTM) in Children With Pearson Syndrome|Terminated||Phase 2|10|Anticipated|Edison Pharmaceuticals Inc||1||Results from other studies did not support continuation of this trial|f||||f||||||||||2017-10-11 00:36:01.906505|2017-10-11 00:36:01.906505
NCT02104323|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-02-07|||January 2014||2014-01-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Endostatin||Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors|Recombinant Human Endostatin Injection Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors by Continuous Intravenous Pumping|Completed||Phase 2|20|Actual|Beijing Tiantan Hospital||1|||f||||t||||||||Undecided||2017-10-11 00:36:02.046817|2017-10-11 00:36:02.046817
NCT02104310|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-01-29|||April 2014||2014-04-01|January 2017|2017-01-01||||April 2018|Anticipated|2018-04-01||Interventional|||A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas|A Pilot Study Evaluating the Utility of 18F-DOPA PET for Radiotherapy Treatment Planning of Malignant Glioma Patients|Active, not recruiting||Phase 2|16|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 00:36:02.229411|2017-10-11 00:36:02.229411
NCT02104297|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2014-04-03|||April 2014||2014-04-01|April 2014|2014-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|EA||Effect of Deksmedetomidine and Remifentanil in Extubation Agitation|The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||3|||f||||f||||||||||2017-10-11 00:36:02.410178|2017-10-11 00:36:02.410178
NCT02104271|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-08-26|||January 2013||2013-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.|Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.|Completed||Phase 2|41|Actual|Barretos Cancer Hospital||2|||f||||t||||||||||2017-10-11 00:36:02.704762|2017-10-11 00:36:02.704762
NCT02104258|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2017-06-29|||March 2014||2014-03-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Rehabilitation of Acute Hamstring Injuries in Male Athletes|Rehabilitation of Acute Hamstring Injuries in Male Athletes: A Prospective Single-site Randomized Controlled Clinical Trial Comparing Two Rehabilitation Protocols With Different Emphasis on Eccentric Exercises|Recruiting||N/A|90|Anticipated|Aspetar||2|||f||||t||||||||Undecided||2017-10-11 00:36:02.848729|2017-10-11 00:36:02.848729
NCT02104245|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-12-02|||April 2014||2014-04-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|ORBIT-4||Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pulmaquin® in the Management of Chronic Lung Infections With Pseudomonas Aeruginosa in Patients With Non-Cystic Fibrosis Bronchiectasis, Including 28 Day Open-Label Extension|Completed||Phase 3|304|Actual|Aradigm Corporation||2|||f||||t||||||||||2017-10-11 00:36:03.13739|2017-10-11 00:36:03.13739
NCT02104232|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-08-24|||October 2014||2014-10-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|THPP-I||Thinking Healthy Program - Peer Delivered, India (THPP-I)|Thinking Healthy Program - Peer Delivered, India (THPP-I)|Completed||N/A|280|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 00:36:03.471102|2017-10-11 00:36:03.471102
NCT02104219|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-11-16|2015-08-25||March 2014||2014-03-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)|A Retrospective, Non-interventional, Epidemiologic Study of the Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)|Completed||N/A|32|Actual|Alexion Pharma GmbH|||1||f||||f||||||||||2017-10-11 00:36:03.584441|2017-10-11 00:36:03.584441
NCT02104193|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-02-16|||April 2014||2014-04-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Simvastatin Effect on Radiation Therapy of Brain Metastases|The Effect of Simvastatin on the Clinical Outcome of Patients With Brain Metastases Treated With Radiation Therapy: a Pilot Study|Completed||Phase 2|50|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-11 00:36:03.953762|2017-10-11 00:36:03.953762
NCT02104167|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-07-07|||September 2013||2013-09-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|||Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating|An Open-Label Clinical Study of the Safety and Efficacy of the ROI-C Anterior Cervical Interbody Fusion Device Using the VerteBRIDGE Plating System|Completed||N/A|109|Actual|LDR Spine USA|||1||f||||f||||||||||2017-10-11 00:36:04.266483|2017-10-11 00:36:04.266483
NCT02104154|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2015-02-18|||November 2013||2013-11-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting|Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting|Terminated||N/A|32|Actual|Samsung Electronics|||1|To conduct interim analysis and assess whether assay changes are recommended.|f||||f||||||Samples Without DNA|"     Retaining serum and plasma specimens   "|||2017-10-11 00:36:04.407995|2017-10-11 00:36:04.407995
NCT02104141|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-07-07|||November 2013||2013-11-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|April 2016|Actual|2016-04-01||Observational|||Retrospective/Prospective Data Collection on the LDR ROIA Interbody Fusion Device With VerteBRIDGE Plating|An Open Label, Multicenter, Clinical Study of the Safety and Efficacy of the LDR Spine ROI-A Interbody Fusion System Using the VerteBRIDGE™ Plating System|Active, not recruiting||N/A|51|Actual|LDR Spine USA|||1||f||||f||||||||No||2017-10-11 00:36:04.512525|2017-10-11 00:36:04.512525
NCT02104128|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-05-10|||January 2014||2014-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Bupropion in Depression|Effects of Bupropion in Depression|Completed||N/A|80|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 00:36:04.603306|2017-10-11 00:36:04.603306
NCT02104115|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-10-05|||March 2014||2014-03-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|EGG||Effects of Bread Gluten Content on Gastrointestinal Volumes|Effects of Bread Gluten Content on Gastrointestinal Volumes|Completed||N/A|15|Actual|University of Nottingham||3|||f||||f||||||||||2017-10-11 00:36:04.719243|2017-10-11 00:36:04.719243
NCT02104102|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-04-03|||January 2014||2014-01-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Biomedical Instrumentation in the Study of Mirror Therapy in Elderly's Hands Motor Activity|Biomedical Instrumentation in the Study of Mirror Therapy in Elderly's Hands Motor Activity|Unknown status|Recruiting|N/A|60|Anticipated|Universidade do Vale do Paraíba||2|||f||||t||||||||||2017-10-11 00:36:04.89692|2017-10-11 00:36:04.89692
NCT02104089|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2016-12-13|||January 2014||2014-01-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|April 2018|Anticipated|2018-04-01||Observational|||Post-market Observational Study Zenith® t-Branch™|Post-market Observational Study Zenith® t-Branch™ Thoracoabdominal Endovascular Graft|Recruiting||N/A|80|Anticipated|Cook Group Incorporated|||1||f||||||||||||||2017-10-11 00:36:05.023442|2017-10-11 00:36:05.023442
NCT02104076|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-02|2017-06-30||2017-06-30|September 2014||2014-09-01|June 2017|2017-06-01|January 4, 2017|Actual|2017-01-04|July 2016|Actual|2016-07-01||Interventional|||Evolution® Biliary Stent System-Fully Covered|Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered|Completed||N/A|90|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 00:36:05.133725|2017-10-11 00:36:05.133725
NCT02104063|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-09-29|||October 2013|Actual|2013-10-01|January 2015|2015-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|MRI-PET||Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]|Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET]|Recruiting||N/A|107|Anticipated|Queen Mary University of London|||1||f||||f||||||Samples Without DNA|"     Whole blood, serum, biopsy tissue of primary penile cancer lesions and metastatic lesions.   "|||2017-10-11 00:36:05.228853|2017-10-11 00:36:05.228853
NCT02104050|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-10-02||2017-04-03|April 2014||2014-04-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain|A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy|Completed||Phase 2|202|Actual|Olatec Industries LLC||2|||f||||||||||||||2017-10-11 00:36:05.328065|2017-10-11 00:36:05.328065
NCT02104037|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-04-03|||January 2012||2012-01-01|April 2014|2014-04-01||||December 2013|Actual|2013-12-01||Interventional|LIRA-CSV||Liraglutide in Spinal Fluid|Liraglutide in Spinal Fluid|Completed||N/A|8|Actual|University Hospital, Gentofte, Copenhagen||1|||f||||f||||||||||2017-10-11 00:36:05.448905|2017-10-11 00:36:05.448905
NCT02104024|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-04-03|||October 2013||2013-10-01|April 2014|2014-04-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||CEUS in Kidney and Pancreas Transplantation|Contrast Enhanced Ultrasound Scanning of Kidney and Pancreas Transplantation (Proof of Principle Study)|Unknown status|Recruiting|N/A|65|Anticipated|University of Manchester|||2||f||||f||||||||||2017-10-11 00:36:05.763192|2017-10-11 00:36:05.763192
NCT02104011|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-06-12|||May 2015||2015-05-01|June 2015|2015-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|STBETA||Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers|Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers: Pilot Trial|Unknown status|Recruiting|Phase 2|15|Anticipated|University Hospital, Bordeaux||1|||f||||t||||||||||2017-10-11 00:36:05.846105|2017-10-11 00:36:05.846105
NCT02103985|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-06-24|||May 2009||2009-05-01|June 2014|2014-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Participants|A Randomized, Open-Label, Two-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Male and Female Subjects|Completed||Phase 1|32|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 00:36:06.023303|2017-10-11 00:36:06.023303
NCT02103972|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-11-24|||July 2014||2014-07-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic Dermatitis||Active, not recruiting||N/A|126|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-11 00:36:06.107981|2017-10-11 00:36:06.107981
NCT02103959|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-02-22|||June 2014||2014-06-01|June 2014|2014-06-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|CARIN||Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography|A Prospective, Comparative, Randomized, Multi-Center, Double-Blinded, Placebo-Controlled, Phase 2a Study of the Safety and Efficacy of CMX-2043 for Periprocedural Injury Protection in Subjects Undergoing Coronary Angiography at Risk of Radio-contrast Induced Nephropathy (CARIN)|Completed||Phase 2|361|Actual|Ischemix, LLC||4|||f||||f||||||||||2017-10-11 00:36:06.194117|2017-10-11 00:36:06.194117
NCT02103946|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-04-17|||April 2014||2014-04-01|April 2014|2014-04-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|SAM||Serratus Anterior Plane Block Versus Paravertebral Block for Postmastectomy Analgesia|Serratus Anterior Muscle Plane Block Versus Paravertebral Block for Breast Cancer Resections.|Unknown status|Recruiting|Phase 4|50|Anticipated|National Cancer Institute, Egypt||2|||f||||f||||||||||2017-10-11 00:36:06.263376|2017-10-11 00:36:06.263376
NCT02103933|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2014-04-01|||April 2014||2014-04-01|April 2014|2014-04-01||||June 2014|Anticipated|2014-06-01|1 Year|Observational [Patient Registry]|||Pilot Study to Evaluate the Knowledge and Understanding on Surgery for Patients With Hysterectomy||Unknown status|Not yet recruiting|N/A|200|Anticipated|National Cancer Center, Korea|||1||f||||f||||||||||2017-10-11 00:36:06.371872|2017-10-11 00:36:06.371872
NCT02103920|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2014-04-01|||May 2011||2011-05-01|April 2014|2014-04-01||||June 2014|Anticipated|2014-06-01||Observational|||A Retrospective Immunohistochemistry Study of the Expression of Glycine/ Serine Pathway Molecules in Solid Tumors||Unknown status|Recruiting|N/A|1400|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 00:36:06.432376|2017-10-11 00:36:06.432376
NCT02103907|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-06-05|||June 2014||2014-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Randomized Controlled Trial of Dynamic Balance Training in People With Knee Osteoarthritis|The Effect of Dynamic Balance Training on Balance and Physical Function in Those With Knee Osteoarthritis|Completed||N/A|40|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:36:06.497732|2017-10-11 00:36:06.497732
NCT02103894|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-12-15|||February 2014||2014-02-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects|Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Clinically Diagnosed Tauopathies in Comparison to Healthy Subjects|Completed||Phase 1|16|Actual|Molecular NeuroImaging||1|||f||||f||||||||||2017-10-11 00:36:06.683965|2017-10-11 00:36:06.683965
NCT02103881|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-07-20|||April 2014||2014-04-01|July 2017|2017-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital|A Double Blinded Randomized Trial of Ketamine Versus Haloperidol for Severe Prehospital Agitation|Withdrawn||Phase 4|0|Actual|Minneapolis Medical Research Foundation||2|||f||||||||||||||2017-10-11 00:36:06.842101|2017-10-11 00:36:06.842101
NCT02103868|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-02-04|||October 2013||2013-10-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|ZARI||Medium Vs Low Intensity Intervention in Tobacco Cessation and Control in Zari Workers|Interventional Study to Determine the Effectiveness of Medium Intensity Verses Low Intensity Tobacco Use Prevention and Cessation Intervention in the Unorganized Sector of Zari Workers in Mumbai|Unknown status|Recruiting|N/A|400|Anticipated|Tata Memorial Hospital||3|||f||||t||||||||||2017-10-11 00:36:06.988359|2017-10-11 00:36:06.988359
NCT02103855|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-08-25|2017-03-21||June 2014||2014-06-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients|Calcineurin Inhibitors to Belatacept Switch Study to Prevent the Progression of Kidney Disease in Pancreas Transplant Alone Recipients|Completed||Phase 4|6|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 00:36:07.154299|2017-10-11 00:36:07.154299
NCT02103842|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-12-22|||March 2014||2014-03-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Omega-3 Fatty Acids to Combat Sarcopenia|Omega-3 Fatty Acids to Combat Sarcopenia|Completed||Phase 1|24|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 00:36:07.520196|2017-10-11 00:36:07.520196
NCT02103829|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-09-27|||March 2014||2014-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|February 2016|Actual|2016-02-01||Interventional|TC-PAU-1||"Quit Smoking on Your Own Brief Online Study"|"Quit Smoking on Your Own Brief Online Study"|Terminated||N/A|345|Actual|i4Health||4|||f||||f||||||||||2017-10-11 00:36:07.62171|2017-10-11 00:36:07.62171
NCT02103816|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-07-29|||October 2013||2013-10-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars|The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars|Completed||N/A|20|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:36:07.733354|2017-10-11 00:36:07.733354
NCT02103803|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-11-11|||February 2014||2014-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Assessing Eye Tracking Features Following Sports-Related Concussion|Assessing Eye Tracking Features Following Sports-Related Concussion|Completed||N/A|11|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 00:36:07.83571|2017-10-11 00:36:07.83571
NCT02103790|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-03-08|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|Tele-VAD||Installation of Non-invasive Ventilation at Home Using Telemedicine : a Pilot Study on Feasibility and Impact on Ventilation Compliance|Installation of Non-invasive Ventilation at Home Using Telemedicine : a Pilot Study on Feasibility and Impact on Ventilation Compliance|Recruiting||N/A|20|Anticipated|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||||2017-10-11 00:36:07.940035|2017-10-11 00:36:07.940035
NCT02103777|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-03|||September 2011||2011-09-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||High Versus Low Dose of Caffeine for Apnea of Prematurity|High Versus Low Dose of Caffeine for Apnea of Prematurity: A Double Blind Randomized Control Trial|Completed||Phase 3|120|Actual|Mansoura University Children Hospital||2|||f||||t||||||||||2017-10-11 00:36:08.110145|2017-10-11 00:36:08.110145
NCT02103764|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-07-04|||August 2013||2013-08-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SI-AUB-RCT||Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB|The Effectiveness of Cyclic Desogestrel Therapy for Abnormal Uterine Bleeding Associated With Anovulation: a Non-inferiority Double Blinded Randomized Control Trial|Unknown status|Recruiting|Phase 3|160|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 00:36:08.229904|2017-10-11 00:36:08.229904
NCT02103751|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-06-18|||July 2007||2007-07-01|June 2014|2014-06-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Observational|||Determination of Biomarkers of Exposure and Biomarkers of Potential Harm in Asian Adult Cigarette Smokers|A Multi-center Study to Determine the Levels of Biomarkers of Potential Harm and Biomarkers of Exposure to Cigarette Smoke in Asian Adult Smokers and Non-smokers|Completed||N/A|1069|Actual|Philip Morris Products S.A.|||1||f||||t||||||||||2017-10-11 00:36:08.337329|2017-10-11 00:36:08.337329
NCT02103738|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-02-14|||May 2013|Actual|2013-05-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|CAN-TREAT||Canadian Treat and Extend Analysis Trial With Ranibizumab|Canadian Treat and Extend Analysis Trial With Ranibizumab|Active, not recruiting||N/A|580|Actual|Novartis|||2||f||||f||||||||||2017-10-11 00:36:08.423672|2017-10-11 00:36:08.423672
NCT02103725|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-09-18|||April 2014||2014-04-01|December 2013|2013-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis|A Phase I, Multi-Centre, Randomised, Vehicle-Controlled, Double-Blinded, Explorative Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis Over a Treatment Period of Three Weeks|Completed||Phase 1|30|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 00:36:08.510852|2017-10-11 00:36:08.510852
NCT02103712|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2014-04-03|||October 2012||2012-10-01|April 2014|2014-04-01||||September 2013|Actual|2013-09-01||Observational|||Long Term Outcome of Hypospadias Repair|Long Term Outcome of Hypospadias Repair: A Comparative Study|Completed||N/A|170|Actual|The Leeds Teaching Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 00:36:08.599918|2017-10-11 00:36:08.599918
NCT02103699|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-02-19|||February 2014||2014-02-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Observational|||A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir|A Prospective Observational Study to Examine Patient Characteristics, Health Care Management, and Effectiveness Among HCV Patients Treated With Simeprevir at Various Practice Settings|Completed||Phase 4|315|Actual|Janssen Scientific Affairs, LLC|||1||f||||f||||||||||2017-10-11 00:36:08.678245|2017-10-11 00:36:08.678245
NCT02103686|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-08-28|||November 2012||2012-11-01|September 2012|2012-09-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects|A Randomized, Open-label, 3-way Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects|Completed||Phase 1|30|Actual|IlDong Pharmaceutical Co Ltd||3|||f||||||||||||||2017-10-11 00:36:08.837669|2017-10-11 00:36:08.837669
NCT02103673|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-08-02|||February 2014||2014-02-01|August 2016|2016-08-01||||September 2017|Anticipated|2017-09-01||Interventional|||DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia||Recruiting||Phase 2|90|Anticipated|Chang Gung Memorial Hospital||2|||f||||||||||||||2017-10-11 00:36:08.930259|2017-10-11 00:36:08.930259
NCT02103660|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-03-24|||April 2014||2014-04-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women|A Randomized Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women|Active, not recruiting||Phase 4|131|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 00:36:09.046536|2017-10-11 00:36:09.046536
NCT02103647|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-08-28|||May 2013||2013-05-01|April 2013|2013-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release Formulation|A Randomized, Open-label, Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release Formulation After Multiple Dosing Under Fasted Condition in Healthy Male Subjects|Completed||Phase 1|24|Actual|IlDong Pharmaceutical Co Ltd||2|||f||||||||||||||2017-10-11 00:36:09.151907|2017-10-11 00:36:09.151907
NCT02103634|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-08-04|||March 1, 2014|Actual|2014-03-01|August 2017|2017-08-01|February 3, 2017|Actual|2017-02-03|February 3, 2017|Actual|2017-02-03||Interventional|||NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer|NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer|Completed||N/A|28|Actual|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f|f|||||2017-10-11 00:36:09.22435|2017-10-11 00:36:09.22435
NCT02103621|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-09-14|||May 2014||2014-05-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|September 2017|Actual|2017-09-01||Interventional|||Assisting Obsessive Compulsive Disorder (OCD) Patients With Discontinuing Long-term Serotonin Reuptake Inhibitors (SRIs)|Discontinuation of Long-term SRIs in Obsessive Compulsive Disorder|Active, not recruiting||N/A|14|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-11 00:36:09.315833|2017-10-11 00:36:09.315833
NCT02103413|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2015-08-05|||October 2014||2014-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||EUS-guided Biliary Drainage Versus Percutanenous Transhepatic Biliary Darinage for Malignant Biliary Obstruction After Failed ERCP|Multicenter Study of EUS-guided Biliary Drainage Versus Percutanenous Transhepatic Biliary Darinage for Malignant Biliary Obstruction After Failed ERCP|Completed||N/A|66|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 00:36:11.653528|2017-10-11 00:36:11.653528
NCT02103595|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-04-03|||November 1, 2013|Actual|2013-11-01|April 2017|2017-04-01|June 30, 2014|Actual|2014-06-30|June 30, 2014|Actual|2014-06-30||Interventional|||A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.|Perception of Insertion Pain With Soft Cannula Infusion Sets: A Multicenter, Randomized, Cross-over Study to Evaluate Accu-Chek FlexLink Plus and Accu-Chek FlexLink Under Real Life Conditions.|Completed||N/A|80|Actual|Hoffmann-La Roche||2|||f||||||f||||||||2017-10-11 00:36:09.45231|2017-10-11 00:36:09.45231
NCT02103569|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-08-13|||April 2014||2014-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325|Effect of a Combination of Daclatasvir, Asunaprevir, and BMS-791325 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone Acetate in Healthy Female Subjects|Completed||Phase 1|20|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:36:09.606779|2017-10-11 00:36:09.606779
NCT02103556|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-04-01|||April 2012||2012-04-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Edible Oils in the Treatment of Constipation of Hemodialysis Patients|Double-blind Randomized Trial on the Effect of Olive Oil and Flaxseed Oil on Constipation of Hemodialysis Patients|Completed||N/A|50|Actual|Federal University of São Paulo||3|||f||||f||||||||||2017-10-11 00:36:09.680968|2017-10-11 00:36:09.680968
NCT02103543|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-02-17|||January 2014|Anticipated|2014-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Comparison of the Order of Treatment in Lumbar Spinal Stenosis|A Randomized Trial in Patients With Lumbar Spinal Stenosis, Comparing the Order of Treatment With Epidural Corticosteroid Injections and Physical Therapy|Withdrawn||N/A|0|Actual|Emory University||2||Lack of recruitment|f||||t||||||||||2017-10-11 00:36:09.759342|2017-10-11 00:36:09.759342
NCT02103530|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-01-31|||April 2014||2014-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Early Response Assessment of Induction Chemotherapy in Acute Myeloid Leukemia Patients Using F-18 FLT PET/CT|Early Response Assessment of Induction Chemotherapy in Acute Myeloid Leukemia Patients Using F-18 FLT PET/CT|Completed||N/A|10|Actual|The Catholic University of Korea||1|||f||||f||||||||||2017-10-11 00:36:09.841731|2017-10-11 00:36:09.841731
NCT02103517|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-01-01|||September 2014||2014-09-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Fish Oil and Cardiovascular Suboptimal Health|Risk and Prevention Study: Optimisation of the Preventive Strategies and Evaluation of the Efficacy of n-3 Fatty Acids in Subjects at High Cardiovascular Risk and Suboptimal Health Status|Completed||Phase 3|422|Actual|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 00:36:09.908108|2017-10-11 00:36:09.908108
NCT02103504|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-02-01|||July 2014||2014-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||DePuy Attune Total Knee Arthroplasty RSA Study|Roentgen Stereophotogrammetric Analysis (RSA) of the ATTUNETM Posterior Stabilized Fixed Bearing Knee System|Active, not recruiting||N/A|30|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 00:36:09.976794|2017-10-11 00:36:09.976794
NCT02103491|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-04-01|||June 2013||2013-06-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|SALTED||Effects of Oral Salt Supplementation on Physical Performance During a Half-ironman|Effects of Oral Salt Supplementation on Physical Performance During a Half-ironman|Completed||N/A|40|Actual|Camilo Jose Cela University||2|||f||||t||||||||||2017-10-11 00:36:10.275347|2017-10-11 00:36:10.275347
NCT02103478|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-08-25|||May 2014||2014-05-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS|A Phase1-2 Pharmacokinetic Guided Dose-Escalation and Dose-Confirmation Study of ASTX727, a Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 With Oral Decitabine in Subjects With Myelodysplastic Syndromes (MDS)|Active, not recruiting||Phase 1/Phase 2|113|Actual|Astex Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:36:10.372249|2017-10-11 00:36:10.372249
NCT02103465|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-01-22|||December 2013||2013-12-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PARROT||Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease|Late Onset Parkinson's Disease in Subjects 70 Years and Older: Possible Use of Rotigotine|Terminated||Phase 2|80|Actual|Azienda Ospedaliera Cardinale G. Panico||2||Because the rate of recruitment was very slow|f||||f||||||||No||2017-10-11 00:36:10.531298|2017-10-11 00:36:10.531298
NCT02103452|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-04-01|||October 2012||2012-10-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Edessy Stem Cell Score (ESS), Endometrium, Endometrioma|Edessy STEM CELL SCORE (ESS), Endometrium, Endometrioma|Completed||N/A|80|Actual|Al-Azhar University||2|||f||||t||||||||||2017-10-11 00:36:10.665861|2017-10-11 00:36:10.665861
NCT02103439|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-01-12|2015-05-21||September 2013||2013-09-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2014|Actual|2014-07-01||Interventional|||An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients|"Multicenter Open-label Randomized, Comparative Clinical Study to Evaluate Efficacy and Safety of Algeron (Cepeginterferon Alfa-2b, CJSC BIOCAD, Russia) With Ribavirin Compared to PegIntron (Peginterferon Alfa-2b, Schering-Plough Labo N.V., Belgium) With Ribavirin in Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients"|Active, not recruiting||Phase 3|140|Actual|Biocad||2|||f||||f||||||||||2017-10-11 00:36:10.792104|2017-10-11 00:36:10.792104
NCT02103426|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-08-03|||December 2013||2013-12-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients|A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients|Completed||Phase 1|48|Actual|Astellas Pharma Inc||10|||f||||f||||||||Undecided||2017-10-11 00:36:11.515491|2017-10-11 00:36:11.515491
NCT02103400|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2016-03-30|||March 2014||2014-03-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Physical Training Program in Patients Hospitalized for Community-acquired Pneumonia|Physical Training Program in Patients Hospitalized for Community-acquired Pneumonia|Completed||N/A|30|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-11 00:36:11.745989|2017-10-11 00:36:11.745989
NCT02103387|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-05-02|||December 2006||2006-12-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2014|Actual|2014-06-01||Interventional|||Five Sessions Intervention to Facilitate Adaptation to Breast Cancer|Five Sessions Intervention to Facilitate Adaptation to Breast Cancer|Active, not recruiting||N/A|184|Anticipated|University of Miami||3|||f||||||||||||||2017-10-11 00:36:11.83723|2017-10-11 00:36:11.83723
NCT02103374|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-04-26|||January 2012||2012-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Nebuadom||Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State|Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State|Completed||Phase 4|45|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 00:36:11.930904|2017-10-11 00:36:11.930904
NCT02103361|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-03-22|||November 2013||2013-11-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|November 2018|Anticipated|2018-11-01|2 Years|Observational [Patient Registry]|||Stelara Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project|Stelara® Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project|Recruiting||N/A|100|Anticipated|University of California, San Diego|||1||f||||f||||||||||2017-10-11 00:36:12.065674|2017-10-11 00:36:12.065674
NCT02103348|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-03-01|||September 2015||2015-09-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Observational|CAESAR||Characterizing Asthma Sputum Elasticity in the UCSF Severe Asthma Research Program|Characterizing Asthma Sputum Elasticity in the UCSF Severe Asthma Research Program|Recruiting||N/A|75|Anticipated|University of California, San Francisco|||3||f||||f||||||Samples With DNA|"     Samples of induced sputum and blood for DNA and RNA extraction, plasma, and serum will be     banked in the UCSF Airway Tissue Bank.   "|||2017-10-11 00:36:12.174827|2017-10-11 00:36:12.174827
NCT02103335|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-04-12|||June 5, 2014|Actual|2014-06-05|April 2017|2017-04-01|November 30, 2016|Actual|2016-11-30|October 3, 2016|Actual|2016-10-03||Interventional|||Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma|A Phase 1, Multicenter, Open-label, Dose-Escalation Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma|Completed||Phase 1|38|Actual|Triphase Research and Development I Corporation||1|||f||||f||||||||No||2017-10-11 00:36:12.269785|2017-10-11 00:36:12.269785
NCT02103322|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-06-25||2014-06-25|February 2014||2014-02-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions|A Randomized, Open Label, Two-Treatment, Multiple Dose, Steady State, Two-period, Cross-over, Multi-Centre Comparative Bioequivalence Study of Imatinib Mesylate Tablet 400 mg of Amneal Pharmaceuticals, USA With GLEEVEC® (Imatinib Mesylate) Tablets 400 mg Distributed by Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936 in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions|Completed||Phase 2/Phase 3|48|Actual|Amneal Pharmaceuticals, LLC||2|||f||||t||||||||||2017-10-11 00:36:12.4182|2017-10-11 00:36:12.4182
NCT02103309|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2014-10-24|2014-10-24||October 2013||2013-10-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||This analysis population includes all enrolled participants.|Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST® in Japan|Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST®|Completed||N/A|42|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:36:12.54094|2017-10-11 00:36:12.54094
NCT02103296|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-08-31|||February 2014||2014-02-01|August 2016|2016-08-01||||June 2018|Anticipated|2018-06-01||Interventional|||Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial|Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight (VLBW) Preterm Neonates: A Multi-center Randomized Clinical Trial|Recruiting||N/A|225|Anticipated|San Antonio Military Medical Center||2|||f||||t||||||||||2017-10-11 00:36:12.863405|2017-10-11 00:36:12.863405
NCT02103283|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-08-17|||October 2014||2014-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)|Phase 1, Open-Label Safety and Pharmacodynamic Study of RV001, an Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist, Administered by Intravenous (IV) Infusion in Patients With Diabetic Macular Edema (DME)|Completed||Phase 1|5|Actual|River Vision Development Corporation||1|||f||||f||||||||||2017-10-11 00:36:12.997225|2017-10-11 00:36:12.997225
NCT02103270|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-09-17|||April 2014||2014-04-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|March 2019|Anticipated|2019-03-01||Interventional|POISED||The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery|Single Center, Placebo Controlled Clinical Study in Desensitization vs Tolerance Induction in Peanut Allergy Subjects|Active, not recruiting||Phase 2|120|Actual|Stanford University||3|||f||||t||||||||||2017-10-11 00:36:13.108863|2017-10-11 00:36:13.108863
NCT02103257|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-04-27|||March 2014||2014-03-01|April 2015|2015-04-01|September 2017|Anticipated|2017-09-01|March 2016|Anticipated|2016-03-01||Interventional|||Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma|Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma: a Randomized, Open-label, Multicenter Study|Unknown status|Recruiting|Phase 4|192|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 00:36:13.19935|2017-10-11 00:36:13.19935
NCT02103244|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-04-02|||September 2014||2014-09-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Validation of an Adjusted Dosing Algorithm of Carboplatin|Pharmacokinetics of Carboplatin After Adjusted Dosing for High BMI, Low Serum Creatinine, and Maximal Renal Function|Unknown status|Not yet recruiting|Phase 4|24|Anticipated|Rijnstate Hospital||1|||f||||f||||||||||2017-10-11 00:36:13.360723|2017-10-11 00:36:13.360723
NCT02103231|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-12-02|||May 2014||2014-05-01|March 2014|2014-03-01||||September 2017|Anticipated|2017-09-01||Observational|YACHT||Young Adult Cardiovascular Health Trial|Young Adult Cardiovascular Health Trial|Unknown status|Recruiting|N/A|132|Anticipated|University of Oxford|||2||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma   "|||2017-10-11 00:36:13.448528|2017-10-11 00:36:13.448528
NCT02103218|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-12-06|||November 2012||2012-11-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|GEMM||A Risky Sex Prevention Intervention for Middle School Age Minority Girls|A Risky Sex Prevention Intervention for Middle School Age Minority Girls|Active, not recruiting||N/A|212|Actual|University of North Carolina, Greensboro||2|||f||||t||||||||||2017-10-11 00:36:13.533022|2017-10-11 00:36:13.533022
NCT02103205|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-10-25|||June 2014||2014-06-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|LIME||Effect of Infant Formula With Bovine Lactoferrin and Low Iron Concentration on Infant Health and Immune Function|Effect of Infant Formula With Bovine Lactoferrin and Low Iron Concentration on Infant Health and Immune Function|Recruiting||N/A|252|Anticipated|Umeå University||3|||f||||f||||||||||2017-10-11 00:36:13.618245|2017-10-11 00:36:13.618245
NCT02103192|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-31|||December 2013||2013-12-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Interventional|||Nutrient-Fortified Beverage Study||Completed||N/A|60|Actual|PepsiCo Global R&D||3|||f||||||||||||||2017-10-11 00:36:13.717251|2017-10-11 00:36:13.717251
NCT02103179|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-03-31|||July 2006||2006-07-01|March 2014|2014-03-01|September 2014|Anticipated|2014-09-01|April 2014|Anticipated|2014-04-01||Observational|VEGF ECC||VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)|VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway|Unknown status|Active, not recruiting|N/A|20|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||f||||||Samples Without DNA|"     Cut tissue into small pieces (~2 mm2)and wash in drops of saline (1x PBS). Place pieces     individually into LN2 in Styrofoam cup. Transfer pieces into LN2-cooled 1.5 mL cryovial. Pour     out excess LN2 from vial, then seal and keep in LN2 until freezer storage.   "|||2017-10-11 00:36:13.783679|2017-10-11 00:36:13.783679
NCT02103166|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2016-08-18|||April 2014||2014-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Role of Hyoscine Bromide in Latent and Active Labor|Randomized, Masked, Placebo-controlled Clinical Trial to Evaluate the Effects of a Single Intravenous Dose of Hyoscine Bromide on the Duration and Pain in Latent and Active Labor|Suspended||Phase 4|180|Anticipated|Hospital Clinic of Barcelona||2||Conditions of recruitment changed|f||||f||||||||||2017-10-11 00:36:14.065287|2017-10-11 00:36:14.065287
NCT02103153|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-06-12|||September 2013||2013-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Clinical Evaluation of the Picosure Laser for the Treatment of Unwanted Tattoos|Clinical Evaluation of the Picosure Laser for the Treatment of Unwanted Tattoos|Completed||N/A|44|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:36:14.14621|2017-10-11 00:36:14.14621
NCT02103140|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-02-23|||January 2012||2012-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer|An Exercise Randomized Controlled Trial Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer|Active, not recruiting||N/A|213|Actual|Georgetown University||3|||f||||f||||||||Undecided||2017-10-11 00:36:14.212102|2017-10-11 00:36:14.212102
NCT02103127|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-07-29|||July 2013||2013-07-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars|Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars|Completed||N/A|20|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:36:14.302669|2017-10-11 00:36:14.302669
NCT02103114|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-06-27|2017-04-26||June 2014||2014-06-01|June 2017|2017-06-01|July 1, 2016|Actual|2016-07-01|June 27, 2016|Actual|2016-06-27||Interventional|||Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery|Double Blind Randomized Placebo-controlled Study in Children (<6mo) Comparing the Effects of Anti-thrombin III (ATIII) or Placebo on the Coagulation System in Infants With Known Low ATIII Levels Undergoing Open Congenital Cardiac Surgery|Completed||Phase 2|45|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:36:14.405856|2017-10-11 00:36:14.405856
NCT02103101|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-08-04|||November 2014||2014-11-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|Pgp NACO||Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events|Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events|Unknown status|Recruiting|N/A|90|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-11 00:36:15.353573|2017-10-11 00:36:15.353573
NCT02103088|ClinicalTrials.gov processed this data on October 10, 2017|2014-04-01|2017-10-03|||May 2014||2014-05-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|January 2018|Anticipated|2018-01-01||Interventional|PROCAN||Sexual and Urological Rehabilitation to Men Operated for Prostate Cancer and Their Partners|PROCAN: Sexual and Urological Rehabilitation to Men Operated for Prostate Cancer and Their Partners: A Randomized Controlled Intervention Study|Recruiting||N/A|320|Anticipated|Danish Cancer Society||2|||f||||f||||||||||2017-10-11 00:36:15.460245|2017-10-11 00:36:15.460245
NCT02103075|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-03-31|||August 2002||2002-08-01|March 2014|2014-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Neuromuscular Electrical Stimulation on Median Nerve Facilitates Low Motor Cortex Excitability in Human With Spinocerebellar Ataxia||Completed||N/A|29|Actual|Chang Gung University||3|||f||||t||||||||||2017-10-11 00:36:15.567526|2017-10-11 00:36:15.567526
NCT02103062|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-03-24|2015-10-27||May 2014||2014-05-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional||Intent to Treat (ITT) Includes participants who met all eligibility criteria and received at least one dose of study drug.|Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer|A SINGLE ARM PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF Nab®-PACLITAXEL, IN SUBJECTS WITH PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER|Completed||Phase 2|41|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 00:36:15.653225|2017-10-11 00:36:15.653225
NCT02103049|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-05-16|||April 2014||2014-04-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients|The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients|Completed||Phase 4|80|Actual|University Medical Centre Ljubljana||1|||f||||f||||||||||2017-10-11 00:36:18.178305|2017-10-11 00:36:18.178305
NCT02100917|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-02-09|||January 2014||2014-01-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults||Completed||Phase 1|70|Actual|Meiji Seika Pharma Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:36:47.218046|2017-10-11 00:36:47.218046
NCT02103036|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-12-04|||March 2014||2014-03-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|March 2015|Anticipated|2015-03-01||Interventional|ECOLUM||Valuation of the Low Back Pain Treated With Different Types of Active Exercises in Women|Valuation of the Low Back Pain Treated With Different Types of Active Exercises in Women|Unknown status|Recruiting|N/A|30|Anticipated|University Rovira i Virgili||2|||f||||t||||||||||2017-10-11 00:36:18.284639|2017-10-11 00:36:18.284639
NCT02103010|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-04-21|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|PRETOXIS||Predictive Modelling for Patient Stratification According to Treatment-related Toxicity and Survival After Chemoradiation for Head and Neck Cancer||Completed||N/A|45|Actual|University Hospital, Ghent|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-11 00:36:18.526787|2017-10-11 00:36:18.526787
NCT02102997|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-09-29|||July 2013||2013-07-01|October 2015|2015-10-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01|12 Months|Observational [Patient Registry]|DTS Register||Deutsches Dual Therapy Stent Register|Deutsches Dual Therapy Stent Register|Terminated||N/A|130|Actual|OrbusNeich|||1|Low enrolment|f||||t||||||||||2017-10-11 00:36:18.603731|2017-10-11 00:36:18.603731
NCT02102984|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-03-29|||April 2014||2014-04-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Covered Versus Uncovered Biliary Stents for Biliary Malignancies|Covered Versus Uncovered Metal Stents for Biliary Malignancies - A Randomized Controlled Trial|Completed||N/A|140|Actual|Nuovo Ospedale Civile S.Agostino Estense||2|||f||||t||||||||||2017-10-11 00:36:18.818494|2017-10-11 00:36:18.818494
NCT02102971|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-03-15|||October 2014||2014-10-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||Observational Study of Biomarker During Liver Surgery|Autophagy in Liver Injury: Changes in Autophagy Biomarkers During Liver Surgery|Recruiting||N/A|70|Anticipated|University of Florida|||1||f||||f|f|f||||Samples With DNA|"     liver tissues during liver surgery   "|No||2017-10-11 00:36:18.933917|2017-10-11 00:36:18.933917
NCT02102958|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-03-31|||July 2011||2011-07-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Nonvisual Foot Examination for People With Diabetes and Visual Impairment|Nonvisual Foot Examination for People With Diabetes and Visual Impairment|Completed||N/A|57|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-10-11 00:36:19.035169|2017-10-11 00:36:19.035169
NCT02102945|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-04-21|||May 2014||2014-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest|CT Perfusion in the Prognostication of Patients in Coma Following Cardiac Arrest- A Pilot Study|Recruiting||N/A|25|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||No||2017-10-11 00:36:19.116207|2017-10-11 00:36:19.116207
NCT02102932|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-08-21|2015-08-21||May 2014||2014-05-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Treated set (TS): The TS included all subjects who were dispensed study medication and were documented to have received at least 1 dose of trial medication|Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers|Relative Bioavailability of Empagliflozin (12.5 or 5 mg)/Metformin (850 mg or 500 mg) Fixed Dose Combination Tablets Compared to Single Tablets Administered Together to Healthy Chinese Male and Female Volunteers in an Open-label, Randomised, Single-dose, Two-way Crossover Study|Completed||Phase 1|96|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:36:19.234347|2017-10-11 00:36:19.234347
NCT02102919|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-07-14|||January 2013||2013-01-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Innovative Training Program for Elderly in Need of Care Individuals|Skilling-up Exercise for Elderly in Need of Care|Completed||Phase 4|30|Actual|Bern University of Applied Sciences||2|||f||||f||||||||||2017-10-11 00:36:20.221931|2017-10-11 00:36:20.221931
NCT02102906|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-02-08|||October 2014||2014-10-01|December 2014|2014-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||TMS and Attentional Bias in Functional Motor Disorder|TMS and Attentional Bias in Functional Motor Disorder|Completed||N/A|13|Actual|University of Edinburgh||1|||f||||f||||||||||2017-10-11 00:36:20.332905|2017-10-11 00:36:20.332905
NCT02102893|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-03-25|||March 2014||2014-03-01|March 2014|2014-03-01|February 2024|Anticipated|2024-02-01|February 2019|Anticipated|2019-02-01||Observational|||Gastroenteral-Pancreatic Neuroendocrine Tumors in Taiwan|A Multi-center, Registration Study for Gastroenteral-Pancreatic Neuroendocrine Tumors in Taiwan|Enrolling by invitation||N/A|600|Anticipated|National Health Research Institutes, Taiwan|||1||f||||t||||||Samples With DNA|"     Furthermore, we will provide the check of immunohistochemical staining for the tumor tissue     of GEP-NET patients, including the functioning status (insulinoma, glucagonoma, gastrinoma,     VIPoma) and the degree of differentiation, the expression of SSTR2 or SSTR5 and the check of     possible primary site for unknown primary NET patients. This examination will provide more     accurate diagnosis for the patients and further treatment suggestion for the patients.   "|No||2017-10-11 00:36:20.42194|2017-10-11 00:36:20.42194
NCT02102880|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-12-01|||March 2015||2015-03-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||The Role of Complement Factor H Polymorphism in the Regulation of Choroidal Vascular Tone in Young Healthy Subjects|The Role of Complement Factor H Polymorphism in the Regulation of Choroidal Vascular Tone in Young Healthy Subjects|Recruiting||N/A|220|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-10-11 00:36:20.499559|2017-10-11 00:36:20.499559
NCT02102867|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-12-29|||April 2014||2014-04-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|March 2015|Actual|2015-03-01||Observational|Project DRUM||Developing Rectal USPE Measures|Evaluating User Perceptions and Experiences of Dual Compartment Microbicide Formulations. Project 5.1: Developing Rectal USPE Measures|Active, not recruiting||N/A|30|Anticipated|The Miriam Hospital|||1||f||||t||||||||||2017-10-11 00:36:20.60236|2017-10-11 00:36:20.60236
NCT02102854|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-03-22|||March 2014||2014-03-01|March 2016|2016-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Single Dose rATG for Renal Allograft Rejection|Single Dose rATG for Treatment of Acute Renal Allograft Rejection|Recruiting||Phase 4|30|Anticipated|The Methodist Hospital System||2|||f||||f||||||||Undecided||2017-10-11 00:36:20.701839|2017-10-11 00:36:20.701839
NCT02102841|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-01-05|||May 2014||2014-05-01|January 2015|2015-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Investigating Immune Mechanisms in Atopic Eczema|Investigating the Role of Skin Resident T Cells in Atopic Eczema and Responses to Antigen Challenge|Unknown status|Active, not recruiting|N/A|140|Anticipated|University College, London||3|||f||||f||||||||||2017-10-11 00:36:20.828205|2017-10-11 00:36:20.828205
NCT02102828|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-10-20|||March 2014||2014-03-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty|Efficacy of Prolonged Distal Calf Compression as Part of a Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty: a Randomized Clinical Trial in 100 Patients|Completed||Phase 4|100|Actual|TriHealth Inc.||2|||f||||f||||||||||2017-10-11 00:36:20.933699|2017-10-11 00:36:20.933699
NCT02102815|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-04|||March 2014||2014-03-01|April 2014|2014-04-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|TKA||Efficacy of Preoperative Intravenous Dexamethasone in Primary Total Knee Arthroplasty|Efficacy of Preoperative Intravenous Dexamethasone in Controlling Postoperative Pain After Primary Total Knee Arthroplasty: A Randomized Double-blinded Controlled Trial|Unknown status|Recruiting|Phase 4|60|Anticipated|Thammasat University||2|||f||||t||||||||||2017-10-11 00:36:21.02792|2017-10-11 00:36:21.02792
NCT02102802|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-05-30||2017-03-24|January 2014||2014-01-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|September 2016|Actual|2016-09-01||Interventional|||Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD|Exploring Mechanisms of Action of ±3,4-methylenedioxymethamphetamine (MDMA)- Assisted Psychotherapy for Posttraumatic Stress Disorder (PTSD)|Completed||Phase 2|10|Anticipated|Multidisciplinary Association for Psychedelic Studies||2|||f||||f||||||||||2017-10-11 00:36:21.292881|2017-10-11 00:36:21.292881
NCT02102789|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-10-28|||March 2014||2014-03-01|October 2015|2015-10-01|December 2024|Anticipated|2024-12-01|August 2020|Anticipated|2020-08-01||Interventional|||A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis|Systemic Chemotherapy With or Without Hepatic Arterial Infusion With Floxuridine in Patients With Initially Unresectable Colorectal Liver Metastasis: A Prospective, Randomised, Controlled Study|Recruiting||Phase 3|142|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:36:21.425466|2017-10-11 00:36:21.425466
NCT02102776|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intraoperative Mitomycin C, Amniotic Membrane Transplantation and Conjunctival Autograft for Primary Pterygium|Intraoperative Mitomycin C Application, Amniotic Membrane Transplantation and Conjunctival Autograft After Primary Pterygium Excision: A Multi-center Randomized Clinical Trial|Recruiting||N/A|750|Anticipated|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 00:36:21.562783|2017-10-11 00:36:21.562783
NCT02102763|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-07|||October 2008||2008-10-01|April 2014|2014-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|GRECO||Greek Childhood Obesity (GRECO) Study|Greek Childhood Obesity Study|Completed||N/A|5000|Actual|Agricultural University of Athens|||1||f||||f||||||||||2017-10-11 00:36:21.76325|2017-10-11 00:36:21.76325
NCT02102737|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-12-08|||May 2014||2014-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|GLUCIMAG2||Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique|Comparaison d'Une Nouvelle Technique de Mesure de l'insulinorésistance Par Scintigraphie Avec la Technique de référence : Utilisation du 6-DIG Comme Marqueur du Transport du Glucose.|Recruiting||Phase 2|40|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-11 00:36:21.97623|2017-10-11 00:36:21.97623
NCT02102724|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-03-01|||April 2014||2014-04-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Fish Oil for HIV-Related Inflamm-aging and Immune Senescence|Fish Oil for HIV-Related Inflamm-aging and Immune Senescence|Completed||Phase 2|38|Actual|Rush University Medical Center||2|||f||||t||||||||No||2017-10-11 00:36:22.076599|2017-10-11 00:36:22.076599
NCT02102711|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-06-27|||April 2014|Actual|2014-04-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Interventional|||Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 g|Oral Vitamin A Supplementation in Neonates With Birth Weight < 1500 g Efficacy and Tolerability in the Prevention of Bronchopulmonary Dysplasia (BDP) and Retinopathy of the Prematurity (ROP)|Completed||N/A|41|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||No||2017-10-11 00:36:22.170171|2017-10-11 00:36:22.170171
NCT02102698|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-04-04|||March 2014||2014-03-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years|Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years|Active, not recruiting||Phase 2|40|Actual|Psyadon Pharma||2|||f||||t||||||||||2017-10-11 00:36:22.277364|2017-10-11 00:36:22.277364
NCT02102685|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-21|||September 2010||2010-09-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|June 2011|Actual|2011-06-01||Interventional|||Vacuum Assisted Closure in Neck Abscess|Vacuum Assisted Closure in Deep Neck Abscess|Completed||Phase 3|28|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-11 00:36:22.425993|2017-10-11 00:36:22.425993
NCT02102672|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-04-02|||March 2014||2014-03-01|March 2014|2014-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Trimetazidine in Pulmonary Artery Hypertension|Comprehensive Evaluation of Right Ventricular Function, Ventricular Remodeling and Micro RNA Profiling in Pulmonary Artery Hypertension: Effects of a Fatty Acid Oxidation Inhibitor|Recruiting||Phase 2|25|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||||2017-10-11 00:36:22.552653|2017-10-11 00:36:22.552653
NCT02102464|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2017-08-18|2017-08-18||April 2014||2014-04-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers|Pilot Study for Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye in Contact Lens Wearers|Completed||N/A|55|Actual|TearScience, Inc.||3|||f||||f||||||||||2017-10-11 00:36:24.401843|2017-10-11 00:36:24.401843
NCT02102659|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-04-02|||March 2014||2014-03-01|March 2014|2014-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Biological Assessment of Clinical Nutrition and Its Application|This Preliminary Study Was Designed to Explore a New Biological Method for Nutritional Assessment by Measuring Oral Mucosal Epithelial Cell Apoptosis Rate and Guideline to Clinical Nutrition Support Therapy for Improving Clinical Outcome of Malnourished Patients.|Unknown status|Active, not recruiting|N/A|167|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 00:36:22.65414|2017-10-11 00:36:22.65414
NCT02102646|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-10-27|||April 2014||2014-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism|MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism in Patients With Prostate Cancer: Orchiectomy vs. Triptorelin|Completed||Phase 4|31|Actual|Herlev Hospital||2|||f||||f||||||||||2017-10-11 00:36:22.765604|2017-10-11 00:36:22.765604
NCT02102633|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2014-06-23|||May 2014||2014-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Drug Interaction Study Between Bosutinib And Dabigatran|An Open-Label, Randomized, 2-Period Crossover Study To Evaluate The Effect Of A Single Oral Dose Of Bosutinib On The Pharmacokinetics Of Dabigatran Etexilate Mesylate Administered Orally To Healthy Subjects|Completed||Phase 1|27|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:36:22.865717|2017-10-11 00:36:22.865717
NCT02102620|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-04-02|||August 2011||2011-08-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|August 2012|Actual|2012-08-01||Interventional|||Corticosteroid Intra-articular Injection in Hands Osteoarthritis|Effectiveness of Triamcinolone Hexacetonide Intra-articular Injection in Interphalangeal Joints: a 12 Weeks Randomized Controlled Trial in Osteoarthritis Hand Patients|Completed||Phase 4|60|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 00:36:22.948525|2017-10-11 00:36:22.948525
NCT02102607|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-10-23|||January 2014||2014-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Observational|Spinal||Effect of Age on the Median Effective Dose(ED50) for Motor Block With Intrathecal Ropivacaine|Effect of Age on the Median Effective Dose(ED50) for Motor Block With Intrathecal Ropivacaine|Completed||N/A|120|Actual|China Three Gorges University, Yichang, China|||1||f||||t||||||||||2017-10-11 00:36:23.041696|2017-10-11 00:36:23.041696
NCT02102594|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-06-29|||October 2014||2014-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TAVAB||Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)|Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)|Recruiting||Phase 2|18|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-11 00:36:23.125143|2017-10-11 00:36:23.125143
NCT02102581|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-30|||February 2011||2011-02-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01|14 Days|Observational [Patient Registry]|||Evaluation of Short-term Effects of Tourniquet Use in Different Ways During Total Knee Arthroplasty|Evaluation of Short-term Effects of Tourniquet Use in Different Ways During Total Knee Arthroplasty: a Randomized Controlled Trial|Completed||N/A|60|Actual|Peking Union Medical College Hospital|||1||f||||t||||||||||2017-10-11 00:36:23.259686|2017-10-11 00:36:23.259686
NCT02102568|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-01-30|||April 2014||2014-04-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|menocor||Study the Impact of Chemo-induced Menopause on the Quality of Life in Young Women of Childbearing Age and Diagnosed With Non-metastatic Breast Cancer||Recruiting||N/A|240|Anticipated|Centre Jean Perrin|||1||f||||f||||||||||2017-10-11 00:36:23.359886|2017-10-11 00:36:23.359886
NCT02102555|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-03-31|||October 2013||2013-10-01|March 2014|2014-03-01||||October 2014|Anticipated|2014-10-01||Interventional|IV||A Single Dose of Intravenous (IV) Acetaminophen Verses Placebo in the Pre-operative Setting and Outcomes on Post-operative Pain, Nausea and Vomiting|A Double-blind Randomized, Placebo-controlled Study to Determine the Effectiveness of Pre-operative IV Acetaminophen Administration in Reducing Post-operative Pain, Nausea, and Vomiting in the Outpatient Setting|Unknown status|Recruiting|Phase 3|150|Anticipated|Catholic Health Initiatives||2|||f||||f||||||||||2017-10-11 00:36:23.454514|2017-10-11 00:36:23.454514
NCT02102542|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2014-04-02|||July 2012||2012-07-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|||Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia Service|Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia Service|Completed||N/A|65|Anticipated|Mahidol University|||3||f||||f||||||||||2017-10-11 00:36:23.562253|2017-10-11 00:36:23.562253
NCT02102529|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2014-04-14|||April 2014||2014-04-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Observational|||Survey: Clinical Outcome After Bowel Resection in Women Due to Endometriosis|Survey: Clinical Outcome After Bowel Resection in Women Due to Endometriosis|Unknown status|Recruiting|N/A|30|Anticipated|Ludwig Boltzmann Institute for Operative Laparoscopy|||1||f||||f||||||||||2017-10-11 00:36:23.642444|2017-10-11 00:36:23.642444
NCT02102516|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-03-15|||March 2014||2014-03-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||SPRIX in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures|A Single Arm, Open Label Study of the Safety, Efficacy, and Pharmacokinetics of SPRIX (Intranasal Ketorolac Tromethamine) in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures|Completed||Phase 3|45|Actual|Egalet Ltd||1|||f||||t||||||||Undecided||2017-10-11 00:36:23.76818|2017-10-11 00:36:23.76818
NCT02102503|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-04-24|||October 2013||2013-10-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MIMeRiC||Motivational Interviewing and Medication Review in Coronary Heart Disease|Motivational Interviewing and Medication Review in the Secondary Prevention of Coronary Heart Disease|Active, not recruiting||N/A|417|Actual|Linneaus University||2|||f||||f||||||||||2017-10-11 00:36:23.855081|2017-10-11 00:36:23.855081
NCT02102490|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2017-05-09||2016-08-13|June 2014||2014-06-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2016|Actual|2016-04-01||Interventional|MONARCH 1||A Study Of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread|A Phase 2 Study Of LY2835219 For Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer|Active, not recruiting||Phase 2|128|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 00:36:23.963138|2017-10-11 00:36:23.963138
NCT02102477|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-09-02|||October 2014||2014-10-01|September 2016|2016-09-01|December 2027|Anticipated|2027-12-01|December 2017|Anticipated|2017-12-01||Interventional|SPCG-15||Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer|Primary Radical Prostatectomy Versus Primary Radiotherapy for Locally Advanced Prostate Cancer: an Open Randomized Clinical Trial|Recruiting||N/A|1200|Anticipated|Karolinska University Hospital||2|||f||||t||||||||Yes||2017-10-11 00:36:24.248386|2017-10-11 00:36:24.248386
NCT02102451|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-08-16|||July 2014|Actual|2014-07-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|CEASE||Control and Elimination Within Australia of Hepatitis C From People Living With HIV|A Five Year Plan of Enhanced HCV Monitoring, Primary Care-Based Workforce Development, Rapid Scale‐up of HCV Treatment and Public Health Policy Action in HIV Positive Individuals Within Australia.|Active, not recruiting||N/A|492|Actual|Kirby Institute|||1||f||||t||||||Samples With DNA|"     Dry Blood Spot -whole blood collected on filter paper and dried.      EDTA Plasma      Peripheral Blood Mononuclear Cell's (PBMC's)      Samples will be used for HCV related tests including HCV antibody, HCV RNA and HCV     genotypes/sequencing that will be performed at the central laboratory from the research     samples   "|||2017-10-11 00:36:24.945252|2017-10-11 00:36:24.945252
NCT02102438|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-31|2016-08-30|||April 2014||2014-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer|Neoadjuvant or Adjuvant Chemotherapy Without Anthracyclines for Elderly Patients Diagnosed With HER2 Positive Breast Cancer|Withdrawn||N/A|0|Actual|Instituto do Cancer do Estado de São Paulo||1||No financial support aproved|f||||f||||||||No|no data avalilable|2017-10-11 00:36:25.080734|2017-10-11 00:36:25.080734
NCT02102425|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-01-18|||March 2014||2014-03-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|October 2016|Anticipated|2016-10-01||Observational|EXIT||Effects by Omission of Bandage Over Exit Site|Effects by Omission of Bandage Over Exit Site at Patients in Peritoneal Dialysis (PD).Randomized Controlled Cross-over Study|Recruiting||N/A|35|Anticipated|Aalborg Universitetshospital|||1||f||||t||||||||||2017-10-11 00:36:25.200037|2017-10-11 00:36:25.200037
NCT02102412|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2017-07-30|||February 2005||2005-02-01|March 2014|2014-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||First in Man Aer-O-Scope|A Single-center Study to Evaluate the Safety & Performance of the Aer-O-Scope for Traveling Through the Colon in Healthy Volunteers|Terminated||Phase 1|101|Actual|GI View Ltd.||1||Changes made to device.|f||||t||||||||||2017-10-11 00:36:25.304577|2017-10-11 00:36:25.304577
NCT02102399|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-30|2015-09-23|2015-01-24||July 2013||2013-07-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||"Two different analyses were performed:
1) Between-group (Vocal Warm-up vs. Respiratory Muscle Training) comparison analysis (n=31); 2a) Within-group (Respiratory Muscle Training Baseline vs Respiratory Muscle Post-test) comparison analysis (n=17); 2b) Within-group (Vocal Warm-up Baseline vs Vocal Warm-up Post-test) comparison analysis (n=14)."|Vocal Warm-up and Respiratory Muscle Training|Vocal Warm-up and Respiratory Training in Teachers: a Randomized Clinical Trial|Completed||N/A|41|Actual|Federal University of Bahia|Small and not probabilistic sample; type I error; type II error; strike in the last week of the study; healthy worker effect.|2|||f||||f||||||||||2017-10-11 00:36:25.407273|2017-10-11 00:36:25.407273
NCT02102386|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2015-01-27|||February 2014||2014-02-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|CerOx||Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries|Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries|Terminated||N/A|13|Actual|Washington University School of Medicine|||1|Technical issues with the device under study. Sponsor terminated.|f||||f||||||||||2017-10-11 00:36:26.334111|2017-10-11 00:36:26.334111
NCT02102373|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-04-22|||March 2014||2014-03-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of Two Different Diet Regimen Prior to Colonoscopy in Children|Clear Liquid vs Low-fiber Diet in Bowel Cleansing for Colonoscopy in Children: a Randomized Trial|Completed||N/A|184|Actual|Medical University of Warsaw||2|||f||||||||||||No||2017-10-11 00:36:26.42054|2017-10-11 00:36:26.42054
NCT02102360|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-03-29|||March 2012||2012-03-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Conventional or Minimally Invasive Surgical Technique for the Treatment of Furcation Defects Using Enamel Matrix Derivative and Anorganic Bovine Bone - a Randomized Controlled Clinical Trial.||Completed||Phase 4|15|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-11 00:36:26.553287|2017-10-11 00:36:26.553287
NCT02102347|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2015-12-02|||April 2014||2014-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Phototherapy Incorporated Into an Exercise Program on Osteoarthritis of the Knee|Effect of Phototherapy Incorporated Into an Exercise Program on Osteoarthritis of the Knee|Completed||N/A|20|Actual|University of Nove de Julho||3|||f||||t||||||||||2017-10-11 00:36:26.656447|2017-10-11 00:36:26.656447
NCT02102334|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2014-03-29|||September 2010||2010-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Validity, Reliability and Reproducibility of Plain Radiographic Measurements After Total Hip Arthroplasty|Validity, Reliability and Reproducibility of Plain Radiographic Measurements After Total Hip Arthroplasty|Completed||N/A|90|Actual|Sundsvall Hospital|||1||f||||f||||||||||2017-10-11 00:36:26.753903|2017-10-11 00:36:26.753903
NCT02102321|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2014-04-01|||March 2014||2014-03-01|March 2014|2014-03-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Does Treating Hookworm Improve Productivity of Small Subsistence Farmers|A Randomized Effectiveness Trial of Hookworm Treatment of Women Smallholder Farmers to Evaluate Improved Productivity of Their Farming and/or Household Labor|Unknown status|Recruiting|N/A|300|Anticipated|Salmon, Margaret, M.D.||2|||f||||f||||||||||2017-10-11 00:36:26.846907|2017-10-11 00:36:26.846907
NCT02102308|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-03-29|||August 2012||2012-08-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Exercise Improves Executive Function and Dual-task Decrements|A Multicomponent Exercise Improves Executive Function and Dual-task Decrements in Gait Among Older Adults|Completed||N/A|29|Actual|National Yang Ming University||2|||f||||t||||||||||2017-10-11 00:36:26.966665|2017-10-11 00:36:26.966665
NCT02102295|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2014-03-29|||September 2006||2006-09-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effects of Antioxidant Dentifrice on Gingivitis|Clinical Study of an Ascorbic Acid Derivative Dentifrice in Patients With Gingivitis|Completed||Phase 3|300|Actual|Lion Corporation||2|||f||||t||||||||||2017-10-11 00:36:27.075745|2017-10-11 00:36:27.075745
NCT02102282|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2014-04-01|||October 2012||2012-10-01|March 2014|2014-03-01||||December 2022|Anticipated|2022-12-01||Observational|BRCAPRE||Breast Cancer During Pregnancy|Observational Study of Breast Cancer Diagnosed During Pregnancy|Recruiting||N/A|30|Anticipated|Hospital Universitari Vall d'Hebron Research Institute|||1||f||||f||||||Samples With DNA|"     Blood and tissue samples   "|||2017-10-11 00:36:27.220266|2017-10-11 00:36:27.220266
NCT02102269|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-06-02|||January 2014||2014-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SinSbyS&Co||Sonographic Evaluation of the Effect of Shoulder Orthosis on the Subluxation in Stroke Patients|Sonographic Evaluation of the Effect of Shoulder Orthosis on the Subluxation in Stroke Patients|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-10-11 00:36:27.327441|2017-10-11 00:36:27.327441
NCT02102256|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-03-14|||March 2014||2014-03-01|March 2017|2017-03-01||||February 2019|Anticipated|2019-02-01||Interventional|||A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients|A Feasibility Study of the Placement, Use, and Safety of the Nucleus 24 Auditory Brainstem Implant in Non-Neurofibromatosis Type 2 (NF2) Pediatric Patients|Recruiting||Phase 1|10|Anticipated|University of Southern California||1|||f||||t||||||||||2017-10-11 00:36:27.439607|2017-10-11 00:36:27.439607
NCT02102243|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-06-17|||November 2010||2010-11-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Neural Mechanism of Aldosterone-induced Insulin Resistance|The Role of Aldosterone on Sympathetic Nerve Activity and Insulin Sensitivity|Recruiting||Phase 4|2|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:36:27.536132|2017-10-11 00:36:27.536132
NCT02102230|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-07-17|||November 3, 2014|Actual|2014-11-03|July 2017|2017-07-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|CBT-I-CU||CBT-I for Cannabis Use|The Impact of CBT-I on Cannabis Cessation Outcomes|Terminated||N/A|113|Actual|VA Office of Research and Development||3||Principle Investigator as left government service|f||||t|f|f|||f|||||2017-10-11 00:36:27.6513|2017-10-11 00:36:27.6513
NCT02102217|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-12-21|||December 2015||2015-12-01|December 2015|2015-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|PRECious||the PRECious Trial: PREdiction of Complications|PREdiction of Complications: A Step-up Approach, CRP First Followed by CT-scan Imaging to Ensure Quality Control After Major Abdominal Surgery|Recruiting||N/A|1050|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 00:36:27.744205|2017-10-11 00:36:27.744205
NCT02102204|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-07-11|||March 25, 2014|Actual|2014-03-25|June 2017|2017-06-01|June 26, 2017|Actual|2017-06-26|November 4, 2016|Actual|2016-11-04||Interventional|||To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis|A Multicenter Single-arm Extension Study to Describe the Long-term Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis|Completed||Phase 3|902|Actual|Amgen||1|||f||||f||||||||||2017-10-11 00:36:28.092989|2017-10-11 00:36:28.092989
NCT02102191|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-10-05|||March 2014||2014-03-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Acute Physiological Effects of Electronic Sigarette vs Cigarette Smoking|Acute Physiological Effects of Electronic Sigarette vs Cigarette Smoking: a RCT|Completed||N/A|20|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||||2017-10-11 00:36:28.669488|2017-10-11 00:36:28.669488
NCT02102178|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-03-31|||July 2007||2007-07-01|March 2014|2014-03-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|||Occupational Therapy Modulates the Pain in Cancer Patient Under Palliative Care|Occupational Therapy Modulates the Pain in Cancer Patient Under Palliative|Completed||Phase 2|58|Actual|Barretos Cancer Hospital||2|||f||||t||||||||||2017-10-11 00:36:28.75948|2017-10-11 00:36:28.75948
NCT02102165|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-01-31|||April 2014|Actual|2014-04-01|January 2017|2017-01-01|January 2029|Anticipated|2029-01-01|April 2019|Anticipated|2019-04-01||Interventional|AURORA||AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.|AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.|Recruiting||N/A|1000|Anticipated|Breast International Group||1|||f||||t|f|f||||||||2017-10-11 00:36:28.883174|2017-10-11 00:36:28.883174
NCT02102152|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-30|||April 2014||2014-04-01|March 2014|2014-03-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|TOBI||Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection|Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection|Unknown status|Not yet recruiting|N/A|40|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 00:36:29.122929|2017-10-11 00:36:29.122929
NCT02102139|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-03-30|||May 2012||2012-05-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|DXM_Hydro||Preop Dexmedetomidine Attenuates Haemodynamic Responses to Hydrodissection|A Single Preoperative Injection of Dexmedetomidine Attenuates Haemodynamic Responses to Hydrodissection in Patients Undergoing Robotic Thyroidectomy: a Prospective Randomised Double-blinded Study|Completed||Phase 4|41|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:36:29.230218|2017-10-11 00:36:29.230218
NCT02102126|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-03-30|||September 2014||2014-09-01|March 2014|2014-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ENSURE||Effect of Renal deNervation on Arterial Stiffness and Haemodynamics in Patients With UncontRolled hypErtension (ENSURE)||Not yet recruiting||Phase 4|400|Anticipated|Shanghai 10th People's Hospital||2|||f||||||||||||||2017-10-11 00:36:29.339998|2017-10-11 00:36:29.339998
NCT02102113|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-06-06|||January 2014||2014-01-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Probing the Cannabinoid System in Individuals With a Family History of Psychosis|Probing the Cannabinoid System in Individuals With a Family History of Psychosis|Recruiting||N/A|72|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 00:36:29.436947|2017-10-11 00:36:29.436947
NCT02102100|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-04-24|||March 26, 2014|Actual|2014-03-26|April 2017|2017-04-01|July 11, 2016|Actual|2016-07-11|July 11, 2016|Actual|2016-07-11||Interventional|||The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users|Menthol's Effects on Nicotine Reinforcement in Smokers|Completed||N/A|70|Actual|Yale University||3|||f||||t||||||||Undecided||2017-10-11 00:36:29.546876|2017-10-11 00:36:29.546876
NCT02102087|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-08-09|||July 2014||2014-07-01|August 2017|2017-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device|A Matched, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination When Compared to Laboratory Standard Procedures|Completed||N/A|971|Actual|Magnolia Medical Technologies, Inc.||2|||f||||f||||||||||2017-10-11 00:36:29.660871|2017-10-11 00:36:29.660871
NCT02102074|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-12-09|||May 2012||2012-05-01|February 2013|2013-02-01|May 2015|Anticipated|2015-05-01|December 2014|Anticipated|2014-12-01||Observational|CRC||Intra-peritoneal Environmental Changes Following Surgery|Intra-peritoneal Environmental Changes Following Colorectal Surgery for Cancer|Unknown status|Recruiting|N/A|70|Anticipated|Meir Medical Center|||1||f||||t||||||Samples Without DNA|"     Fluids from abdomen drain system   "|||2017-10-11 00:36:29.767486|2017-10-11 00:36:29.767486
NCT02102061|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-05-02|||January 2013||2013-01-01|May 2016|2016-05-01||||January 2017|Anticipated|2017-01-01||Interventional|||Health and Wellness in Obesity|Health and Wellness in Obesity: Exploring the Efficacy of a New Multidisciplinary Intervention|Recruiting||N/A|40|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:36:29.87341|2017-10-11 00:36:29.87341
NCT02102048|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-03-28|||January 2009||2009-01-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|March 2014|Actual|2014-03-01||Interventional|ATAGLU||ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir|ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Boosted or Unboosted Atazanavir|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 00:36:29.989184|2017-10-11 00:36:29.989184
NCT02102035|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-03-28|||January 2011||2011-01-01|October 2013|2013-10-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||Direct and Reversed Dorsal Digital Island Flaps: A Review of 65 Cases||Completed||N/A|65|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 00:36:30.096683|2017-10-11 00:36:30.096683
NCT02102022|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-09-18|||November 2014||2014-11-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|||Ph 1 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies|Phase 1 Study of ADI PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies|Recruiting||Phase 1|148|Anticipated|Polaris Group||1|||f||||f||||||||||2017-10-11 00:36:30.199948|2017-10-11 00:36:30.199948
NCT02102009|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-05-28|||April 2014||2014-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|OFOS||Nutritional Supplementation in Adults With Chronic Respiratory Disease|Impact of Nutritional Support With an Complete Formula on Nutritional Status and Respiratory Function in Adult Patients Malnourished or at Risk of Malnutrition and Chronic Respiratory Disease..|Completed||Phase 4|99|Actual|Laboratorios Ordesa||2|||f||||t||||||||||2017-10-11 00:36:30.338997|2017-10-11 00:36:30.338997
NCT02101996|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-08-17|||June 2014||2014-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Observational|||Pilot Study to Test Dietary Fat Delivery|Pilot Study to Test Dietary Fat Delivery|Completed||N/A|9|Actual|University of Missouri-Columbia|||2||f||||f||||||Samples Without DNA|"     Plasma and muscle biopsy samples are kept in Dr. Parks' lab for further study analysis.   "|||2017-10-11 00:36:30.474365|2017-10-11 00:36:30.474365
NCT02101983|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-04-03|||May 2011||2011-05-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)|A Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia|Completed||N/A|11|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 00:36:30.579967|2017-10-11 00:36:30.579967
NCT02101970|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-04-19|||March 2014||2014-03-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women|Randomized Pilot Trial of Omega-3 Fatty Acids or Placebo in Peri- or Post-Menopausal Women at High Risk for Breast Cancer Undergoing a Weight Loss Intervention|Active, not recruiting||N/A|50|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||No|Global results will be published.|2017-10-11 00:36:30.718796|2017-10-11 00:36:30.718796
NCT02101957|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-04-01|||October 2010||2010-10-01|July 2013|2013-07-01||||July 2015|Anticipated|2015-07-01||Interventional|||Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)||Unknown status|Active, not recruiting|Phase 2/Phase 3|96|Actual|University Hospital, Angers||2|||f||||||||||||||2017-10-11 00:36:30.81974|2017-10-11 00:36:30.81974
NCT02101944|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-09-12|||September 25, 2014|Actual|2014-09-25|September 2017|2017-09-01||||December 1, 2018|Anticipated|2018-12-01||Interventional|||Wild-type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|Pilot Trial Evaluating Viral Protein Production From the Combination of Reolysin and Carfilzomib in Multiple Myeloma|Recruiting||N/A|28|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:36:30.891841|2017-10-11 00:36:30.891841
NCT02101931|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-03-30|||March 2014||2014-03-01|March 2014|2014-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ALA||A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine|A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine|Completed||Phase 3|100|Actual|Princess Al-Johara Al-Ibrahim Cancer Research Center||1|||f||||f||||||||Yes|Results will be published in per-reviewed jounal|2017-10-11 00:36:31.036411|2017-10-11 00:36:31.036411
NCT02101918|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-09-12|||June 18, 2014|Actual|2014-06-18|September 2017|2017-09-01||||December 1, 2017|Anticipated|2017-12-01||Interventional|||Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery|Perfusion CT as Predictive Biomarker in a Phase II Study of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors|Active, not recruiting||Phase 2|41|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:36:31.15532|2017-10-11 00:36:31.15532
NCT02101905|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-09-25|||March 13, 2014|Actual|2014-03-13|September 2017|2017-09-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma|Drug Distribution and Pharmacodynamic Study of Pulsatile Lapatinib in Surgically Accessible EGFR-Amplified Recurrent High-Grade Glioma|Recruiting||N/A|33|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 00:36:31.303744|2017-10-11 00:36:31.303744
NCT02101892|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-10-01|||April 2014|Actual|2014-04-01|October 2017|2017-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation|Prediction of Migraine Prevention Efficacy: Individualization of Treatment by Coupling Drug's Mode of Action With Patient's Mechanism of Pain Modulation|Completed||N/A|54|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 00:36:31.481931|2017-10-11 00:36:31.481931
NCT02101879|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-05-01|||May 2014||2014-05-01|May 2014|2014-05-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01|12 Months|Observational [Patient Registry]|||Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes|Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With First Line Trastuzumab, Pertuzumab and Taxanes Based Regimen|Unknown status|Recruiting|N/A|20|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples Without DNA|"     Blood samples for TNI & BNP will be sent before every cycle for the first 5 cycles of     treatment   "|||2017-10-11 00:36:31.579353|2017-10-11 00:36:31.579353
NCT02101866|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-07-14|||March 2014||2014-03-01|July 2016|2016-07-01||||May 2014|Actual|2014-05-01||Interventional|||A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy Volunteers|A Randomized, Single-Center, Open-Label, Two-Period, Two-Sequence, Crossover, Comparative Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Product Formulations in Healthy Volunteers|Completed||Phase 1|36|Actual|Aviragen Therapeutics||2|||f||||t||||||||||2017-10-11 00:36:31.816188|2017-10-11 00:36:31.816188
NCT02101840|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-01-08|||February 2014||2014-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Abuse Liability of Controlled-Release Oxycodone Formulations|Abuse Liability of Controlled-Release Oxycodone Formulations|Completed||Phase 4|11|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-10-11 00:36:33.41331|2017-10-11 00:36:33.41331
NCT02101827|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-07-04|||March 2014||2014-03-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Safety and Efficacy of Distending Media Infusion by Manual Syringe Method for Hysteroscopic Procedures|Safety and Efficacy of Distending Media Infusion by Manual Syringe Method for Hysteroscopic Procedures|Completed||N/A|200|Anticipated|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-10-11 00:36:33.51298|2017-10-11 00:36:33.51298
NCT02101814|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-04-11|||March 2013||2013-03-01|April 2014|2014-04-01||||May 2015|Anticipated|2015-05-01||Interventional|||Energy Balance and Inflammation in Obese Adults Bariatric Surgery Follow-up|Analysis of Neuroendocrine Regulation of Balance Energy and Inflammatory Factors in Obese Adults Submitted to Bariatric Surgery|Unknown status|Active, not recruiting|N/A|41|Anticipated|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 00:36:33.599286|2017-10-11 00:36:33.599286
NCT02101801|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-08-19|||September 2014||2014-09-01|August 2015|2015-08-01||||December 2014|Actual|2014-12-01||Interventional|||Urine Drug Levels Related to Source of Water for Irrigation for Vegetable Crops Among Healthy Israeli Volunteers||Completed||N/A|35|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:36:33.670009|2017-10-11 00:36:33.670009
NCT02101775|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-09-28|||July 21, 2014|Actual|2014-07-21|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Randomized Placebo-Controlled Phase II Trial Comparing Gemcitabine Monotherapy to Gemcitabine in Combination With AZD 1775 (MK 1775) in Women With Recurrent, Platinum Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers|Recruiting||Phase 2|100|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 00:36:36.868992|2017-10-11 00:36:36.868992
NCT02101762|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-09-12|||May 2014||2014-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters|A Clinical Study to Compare the CAUTI Rates Following ERASE CAUTI Tray Non-Silver Coated Foley Catheters Verse Silver Coated Foley Catheters|Terminated||N/A|756|Actual|Medline Industries|||2|Funding|f||||f||||||||No||2017-10-11 00:36:37.141857|2017-10-11 00:36:37.141857
NCT02101749|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2016-03-22|||November 2013||2013-11-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.|Comparative Immune Response of Intradermal and Intramuscular Preparations of|Completed||Phase 4|221|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 00:36:37.250892|2017-10-11 00:36:37.250892
NCT02101736|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-06-01|||June 2014||2014-06-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|May 2018|Anticipated|2018-05-01||Interventional|XL184||Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +)|A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 Age 16 Years or Greater|Active, not recruiting||Phase 2|21|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 00:36:37.356942|2017-10-11 00:36:37.356942
NCT02101723|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-01-12|||April 2011||2011-04-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Sprinkles With and w/o Fe on Zn Absorption in Kenyan Toddlers|Effects of Sprinkles With and Without Iron on Zinc Absorption From Local Foods in Kenyan Toddlers, Including the Gut Microbiome|Completed||N/A|63|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-10-11 00:36:37.529702|2017-10-11 00:36:37.529702
NCT02101710|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-04-16|||June 2011||2011-06-01|April 2014|2014-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects|A Randomized, Open-label, One Dose, 2-way Crossover Study to Evaluate the Bioequivalence of Elantan SR* 60 mg in Comparison With Imdur SR* 60 mg Under Fasted and Fed Conditions in Healthy Korean Male Subjects (*Sustained Release)|Completed||Phase 1|60|Actual|UCB Pharma||4|||f||||t||||||||||2017-10-11 00:36:37.738238|2017-10-11 00:36:37.738238
NCT02101684|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-02-28|||June 2014||2014-06-01|February 2017|2017-02-01|January 11, 2017|Actual|2017-01-11|January 11, 2017|Actual|2017-01-11||Interventional|Greko II||Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.|Open Label Phase II Clinical Trial of Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.|Terminated||Phase 2|10|Actual|Grupo Español de Tumores Huérfanos e Infrecuentes||1||Slow recruitment rate|f||||f||||||||||2017-10-11 00:36:38.17889|2017-10-11 00:36:38.17889
NCT02101671|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2014-03-29|||May 2014||2014-05-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Observational|||Inadequate Emergence After Laparoscopic Surgery in Trendelemburg Position|Inadequate Emergence After Anaesthesia in Laparoscopic Surgery in Trendelemburg Position|Unknown status|Not yet recruiting|N/A|140|Anticipated|Corporacion Parc Tauli|||2||f||||t||||||||||2017-10-11 00:36:38.307447|2017-10-11 00:36:38.307447
NCT02101658|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-10-27|||March 2014||2014-03-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||Evaluating Expectancy Effects in Weight Loss Measurement||Completed||N/A|59|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-10-11 00:36:38.400842|2017-10-11 00:36:38.400842
NCT02101645|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-05-12|||March 2014||2014-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Proof-of-concept Study for Bioimpedance Based Monitoring of Venous Ulcers During Galvanic Stimulation|Proof-of-concept Study for Bioimpedance Based Monitoring of Venous Ulcers During Galvanic Stimulation|Completed||N/A|6|Actual|Tampere University Hospital||1|||f||||t||||||||||2017-10-11 00:36:38.487948|2017-10-11 00:36:38.487948
NCT02101632|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-04-01|||February 2014||2014-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|BV/TMD||Myorelaxant Effect of Bee Venom(BV) Topical Skin Application in Patients With RDC/TMD Ia and Ib|Myorelaxant Effect of Bee Venom(BV) Topical Skin Application in Patients With Research Diagnostic Criteria/Temporomandibular Disorder Ia and Ib (RDC/TMD) Randomized, Double Blinded Study|Completed||N/A|79|Actual|Medical University of Silesia||2|||f||||f||||||||||2017-10-11 00:36:38.615814|2017-10-11 00:36:38.615814
NCT02101619|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-08-15|||August 2013||2013-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Assessment of Myocardial Tissue Damage in Aortic Stenosis|Assessment of Myocardial Tissue Damage in Aortic Stenosis for Risk Stratification|Completed||N/A|59|Actual|Mayo Clinic|||2||f||||||||||||||2017-10-11 00:36:38.737243|2017-10-11 00:36:38.737243
NCT02101606|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-10-24|||October 2009||2009-10-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|TIAS||Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke|Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke|Recruiting||Phase 2|20|Anticipated|University of Alberta||1|||f||||f||||||||||2017-10-11 00:36:38.833011|2017-10-11 00:36:38.833011
NCT02101593|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-03-02|||November 2014||2014-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer|A Phase 1 Study of ADI PEG 20 Plus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)|Completed||Phase 1|8|Actual|Polaris Group||1|||f||||f||||||||||2017-10-11 00:36:38.952953|2017-10-11 00:36:38.952953
NCT02101580|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-08-17|||November 2014||2014-11-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer|Phase 1B Trial of ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Advanced Pancreatic Cancer|Active, not recruiting||Phase 1|21|Anticipated|Polaris Group||1|||f||||f||||||||||2017-10-11 00:36:39.053954|2017-10-11 00:36:39.053954
NCT02101567|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2015-04-09|||May 2014||2014-05-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section|A Comparison Between Carbetocin, Oxytocin and Ergometrine in Prevention of Postpartum Haemorrhage Following Caesarean Section|Completed||Phase 4|200|Actual|Beni-Suef University||2|||f||||t||||||||||2017-10-11 00:36:39.13636|2017-10-11 00:36:39.13636
NCT02101554|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-07-27|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain|An Open-label Study To Evaluate The Safety And Pharmacokinetics Of Pf-06412528 In Children 7-17 Years For The Treatment Of Moderate-to-severe Pain|Recruiting||Phase 4|140|Anticipated|Pfizer||1|||f||||f|t|f||||||||2017-10-11 00:36:39.237361|2017-10-11 00:36:39.237361
NCT02101541|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-06-21|||February 2014||2014-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||FIRM as a Stand-alone Procedure in the Treatment of Atrial Fibrillation|Focal Impulse and Rotor Modulation (FIRM) as a Stand-alone Procedure in the Treatment of Atrial Fibrillation|Completed||N/A|33|Actual|Oslo University Hospital||1|||f||||f||||||||No||2017-10-11 00:36:39.393419|2017-10-11 00:36:39.393419
NCT02101528|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-04-01|||January 2013||2013-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|CybexPD001||Determination of Muscle Strength in Parkinsonian Patients Through the Use of an Isokinetic Dynamometer|Determination of Muscle Strength in Parkinsonian Patients Through the Use of an Isokinetic Dynamometer|Completed||N/A|40|Actual|Ospedale Generale Di Zona Moriggia-Pelascini|||2||f||||t||||||||||2017-10-11 00:36:39.495489|2017-10-11 00:36:39.495489
NCT02101502|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-29|2014-06-07|||February 2010||2010-02-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Quality Assurance of Obstetrics and Gynecology Department|Quality Assurance of Obstetrics and Gynecology Department|Completed||N/A|2300|Actual|Al-Azhar University||3|||f||||t||||||||||2017-10-11 00:36:39.690001|2017-10-11 00:36:39.690001
NCT02101489|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-02-28|||March 2014||2014-03-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|December 2015|Actual|2015-12-01||Interventional|||Precise Transvaginal Tape Placement Trial|Precise Transvaginal Tape Placement Trial|Completed||N/A|56|Actual|Loyola University||2|||f||||t||||||||Undecided||2017-10-11 00:36:39.778332|2017-10-11 00:36:39.778332
NCT02101476|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-11-19|||May 2014||2014-05-01|March 2014|2014-03-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain.|A Randomized, Open Label,Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP (Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain|Completed||Phase 4|100|Anticipated|Lotus Clinical Research, LLC||2|||f||||f||||||||||2017-10-11 00:36:39.866061|2017-10-11 00:36:39.866061
NCT02101463|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-01-07|||March 2012||2012-03-01|January 2015|2015-01-01|December 2022|Anticipated|2022-12-01|March 2022|Anticipated|2022-03-01||Interventional|MOSTEGRA||MOSTEGRA TRIAL:MO-(Dified) STE-(nt) GRA(-ft): Surgeon-modified Fenestrated-branched Stent-grafts|Surgeon-Modified Fenestrated/Branched Stent-Grafts for Treatment of Complex Aortic Aneurysms in High-Risk Patients|Recruiting||N/A|150|Anticipated|Northside Hospital, Inc.||1|||f||||t||||||||||2017-10-11 00:36:39.961201|2017-10-11 00:36:39.961201
NCT02101450|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2015-01-09|||March 2014||2014-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|||Extra-abdominal Removal of Placenta During CS|Evaluation of the Effects of Extra-abdominal Removal of the Placenta During Cesarean Section on the Amount of Bleeding Into the Abdominal Cavity.|Completed||N/A|200|Actual|Near East University, Turkey||2|||f||||t||||||||||2017-10-11 00:36:40.097167|2017-10-11 00:36:40.097167
NCT02101437|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-04-14|||January 2014||2014-01-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|June 2014|Actual|2014-06-01||Observational|||The Relationship of Platelet Micro-RNA Expression and Platelet Reactivity in Patients Under Clopidogrel or Ticagrelor Treatment||Recruiting||N/A|150|Anticipated|Taipei City Hospital|||1||f||||t||||||Samples With DNA|"     miRNA in platelet(Platelet Rich Plasma)   "|||2017-10-11 00:36:40.189863|2017-10-11 00:36:40.189863
NCT02101424|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-10-23|||May 2010||2010-05-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Monitoring of Overdose Patients With and Without Supplemental Oxygen in the Emergency Department|Monitoring of Overdose Patients With and Without Supplemental Oxygen in the Emergency Department|Completed||N/A|300|Actual|Minneapolis Medical Research Foundation|||1||f||||||||||||||2017-10-11 00:36:40.262306|2017-10-11 00:36:40.262306
NCT02101411|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-04-14|||January 2015||2015-01-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Observational|||Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)||Completed||N/A|350|Actual|Taipei City Hospital|||1||f||||t||||||||||2017-10-11 00:36:40.617725|2017-10-11 00:36:40.617725
NCT02101398|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-03-28||||||March 2014|2014-03-01||||July 2016|Anticipated|2016-07-01||Interventional|||Study of the Effect of Transcranial Stimulations in Aphasic Subject Within a Year of Their Stroke|Etude de l'Effet de Stimulations transcrâniennes en Courant Continu (tDCS) Sur Les Performances en dénomination Chez le Sujet Aphasique à Moins d'un an de Son Accident Vasculaire cérébral : Comparaison de 5 Configurations de Stimulation|Unknown status|Not yet recruiting|N/A|5|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||5|||f||||f||||||||||2017-10-11 00:36:40.726965|2017-10-11 00:36:40.726965
NCT02101385|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-05-02|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer|A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients With Triple Negative Breast Cancer: Hoosier Oncology Group BRE12-158|Recruiting||Phase 2|136|Anticipated|Hoosier Cancer Research Network||2|||f||||t||||||||No||2017-10-11 00:36:40.882588|2017-10-11 00:36:40.882588
NCT02101372|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-10-06|||January 2013||2013-01-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|AGES-CM||Intervention Module AGES|Gene and Environment in Schizophrenia- Research Groups in Madrid|Completed||N/A|55|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-11 00:36:41.166023|2017-10-11 00:36:41.166023
NCT02101359|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-11-04|2014-09-19||June 2011||2011-06-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional||"609 patients have signed the informed consent, but 18 patients were not selected and /or not randomised.
591 patients were randomised (at selection visit)."|Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery|Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery Versus Reference Group (Topical Mydriatics and Anaesthetic)|Completed||Phase 3|609|Actual|Laboratoires Thea||2|||f||||f||||||||||2017-10-11 00:36:41.268924|2017-10-11 00:36:41.268924
NCT02101346|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-02-22|||October 2014||2014-10-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|Lipophage14||A Human In Vivo Feeding Study Of The Blood Monocyte Response To Dietary Lipid Intake|A Human In Vivo Feeding Study Of The Blood Monocyte Response To Dietary Lipid Intake|Recruiting||N/A|60|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 00:36:41.652735|2017-10-11 00:36:41.652735
NCT02101333|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-08-28|||June 10, 2014|Actual|2014-06-10|August 2017|2017-08-01|December 10, 2019|Anticipated|2019-12-10|December 10, 2018|Anticipated|2018-12-10||Interventional|TOCITAKA||Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis|Efficacy and Tolerance of First-line Treatment With Tocilizumab in Active Takayasu Arteritis French Prospective Multicenter Study|Recruiting||Phase 3|15|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 00:36:41.774173|2017-10-11 00:36:41.774173
NCT02101320|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-09-19|||May 20, 2015|Actual|2015-05-20|September 2017|2017-09-01|May 20, 2018|Anticipated|2018-05-20|May 20, 2018|Anticipated|2018-05-20||Interventional|TRECAM||Hand-held Gamma Camera in the SNOLL Procedure|Contribution of a Hand-held Gamma Camera (TreCam) to the SNOLL(Occult Breast Lesion Localization Plus Sentinel Node Biopsy) Procedure in Breast Cancer|Recruiting||Phase 2|60|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:36:41.895715|2017-10-11 00:36:41.895715
NCT02101307|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-11-01|||July 2014||2014-07-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)|A Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab|Recruiting||N/A|400|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:36:42.002732|2017-10-11 00:36:42.002732
NCT02101294|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-09-23|2014-08-06||January 1997||1997-01-01|September 2014|2014-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||Study participants had a physician diagnosis of carpal tunnel syndrome, confirmed with an abnormal result from a nerve conduction velocity study, and completed all 4 testing sessions.|Study Protocol for CTS and Keyboard Controlled Randomized Trial|Study Protocol for Carpal Tunnel Syndrome and Typing Keyboard: Controlled Randomized Trial|Completed||N/A|31|Actual|Finger Relief|Recruitment was a challenge and the budget to conduct the study was extremely limited. It took ten years to collect 20 participants who completed the protocol.|1|||f||||f||||||||||2017-10-11 00:36:42.156371|2017-10-11 00:36:42.156371
NCT02101281|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-09-01|||January 20, 2014|Actual|2014-01-20|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye|An Open-label Study Evaluating Safety and Efficacy of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drops at Different Doses in Patients With Dry Eye|Completed||Phase 2|40|Actual|Dompé Farmaceutici S.p.A||2|||f||||f||||||||||2017-10-11 00:36:42.410075|2017-10-11 00:36:42.410075
NCT02101268|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-08-23||2017-01-05|June 19, 2014|Actual|2014-06-19|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|July 28, 2016|Actual|2016-07-28||Interventional|Simplify 2||Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF|A Phase 3, Randomized Study To Evaluate the Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis Who Were Treated With Ruxolitinib|Active, not recruiting||Phase 3|156|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-11 00:36:42.522393|2017-10-11 00:36:42.522393
NCT02101255|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-01-30|||July 2014||2014-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Curodont™ Repair in Patients With Early Approximal Carious Lesions|Effect of Curodont™ Repair in Patients With Early Approximal Carious Lesions: A Mono-centre, Controlled, Single-blinded, Randomised, Split-mouth, Post-marketing Study|Active, not recruiting||N/A|25|Actual|Credentis AG||2|||f||||f||||||||||2017-10-11 00:36:42.725463|2017-10-11 00:36:42.725463
NCT02101242|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-07-18|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Observational|||Regional Cerebral Oxygen Saturation Under General Anesthesia A Pilot Study|Regional Cerebral Oxygen Saturation Under General Anesthesia A Pilot Study|Active, not recruiting||N/A|60|Anticipated|Charite University, Berlin, Germany|||3||f||||f||||||||||2017-10-11 00:36:42.819477|2017-10-11 00:36:42.819477
NCT02101229|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-07-29|||May 2014||2014-05-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|WP6-1||Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital|Diabeloop WP6-1 : Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital|Completed||Phase 2/Phase 3|17|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||||2017-10-11 00:36:42.897862|2017-10-11 00:36:42.897862
NCT02101203|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2015-03-23|||July 2013||2013-07-01|March 2014|2014-03-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder|A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms|Completed||Phase 2|80|Actual|Emotional Brain NY Inc.||2|||f||||f||||||||||2017-10-11 00:36:43.099569|2017-10-11 00:36:43.099569
NCT02101190|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-01-08|2015-01-08||March 2010||2010-03-01|January 2015|2015-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment|Open-label, Single-dose, Multi-center Study, Investigating the Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment|Completed||Phase 1|16|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 00:36:43.208027|2017-10-11 00:36:43.208027
NCT02101177|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-07-22|||April 2014||2014-04-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Observational|eNTC||Evaluation of the National Treatment Program of Hepatitis C in Egypt|Evaluation of the National Treatment Program of Hepatitis C in Egypt, Using Data Coming From Two Treatment Centres.|Withdrawn||N/A|0|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||2|"Study objectives were considered as absolete regarding the arrival of new antiviral drugs in   Egypt."|f||||f||||||Samples With DNA|"     -  Plasma        -  Serum        -  PBMC   "|||2017-10-11 00:36:43.645495|2017-10-11 00:36:43.645495
NCT02101164|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-02-16|||November 2014||2014-11-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease|An Open-Label, Multicentre Trial to Evaluate the Time Associated With the Preparation and Administration of Denosumab and Pamidronate in Subjects With Solid Tumors and Metastatic Bone Disease in Canada|Withdrawn||Phase 4|0|Actual|Amgen||2|||f||||f||||||||||2017-10-11 00:36:43.770993|2017-10-11 00:36:43.770993
NCT02101151|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-03-29|||June 2012||2012-06-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|VDIS||Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE)|Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE)|Completed||N/A|87|Actual|Rashid Centre for Diabetes and Research||2|||f||||t||||||||||2017-10-11 00:36:43.885727|2017-10-11 00:36:43.885727
NCT02101138|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-07-13|||February 20, 2014||2014-02-20|July 12, 2017|2017-07-12|February 28, 2018|Anticipated|2018-02-28|December 30, 2016|Actual|2016-12-30||Interventional|||Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome|An Open-Label, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome|Active, not recruiting||Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:36:43.999768|2017-10-11 00:36:43.999768
NCT02101125|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-06-16|||March 2014||2014-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Drug Interaction Study With Rosuvastatin|A Phase 1 Open-label, Single-sequence Study to Evaluate the Effect of Concomitant Administration of BMS-986020 on the Single-dose Pharmacokinetics of Rosuvastatin in Healthy Subjects|Completed||Phase 1|26|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:36:44.097391|2017-10-11 00:36:44.097391
NCT02101112|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-02-29|2016-02-29||March 2014||2014-03-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||All randomized participants|Bioavailability of Apixaban Crushed Tablet|Relative Bioavailability of Crushed Apixaban Tablets Administered With Water or Apple Sauce Compared With Intact Tablet in Healthy Subjects|Completed||Phase 1|69|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 00:36:44.206495|2017-10-11 00:36:44.206495
NCT02101099|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2016-07-11|||March 2014||2014-03-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|CFM||Effect of Anesthesia on Force Application During Colonoscopy|Effect of Anesthesia on Force Application During Colonoscopy|Completed||N/A|102|Actual|Artann Laboratories|||1||f||||t||||||||||2017-10-11 00:36:44.68006|2017-10-11 00:36:44.68006
NCT02101086|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2014-03-28|||March 2009||2009-03-01|March 2014|2014-03-01|January 2012|Actual|2012-01-01|September 2010|Actual|2010-09-01||Interventional|||Autologous Cord Blood Transfusion in Preterm Infants|Evaluation of the Efficacy and Safety of Autologous Cord Blood Transfusions in Premature Infants|Completed||N/A|39|Actual|Ankara University||2|||f||||f||||||||||2017-10-11 00:36:44.78895|2017-10-11 00:36:44.78895
NCT02101073|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-09-19|||April 2014||2014-04-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||ALX-0061 Phase I Bioavailability Study in Healthy Volunteers|A Phase I, Open-Label Study Evaluating the Bioavailability of ALX-0061 After Subcutaneous and Intravenous Administration in Healthy Volunteers.|Completed||Phase 1|70|Actual|Ablynx||5|||f||||f||||||||||2017-10-11 00:36:44.878358|2017-10-11 00:36:44.878358
NCT02101060|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-08-22|||September 15, 2014|Actual|2014-09-15|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|February 1, 2018|Anticipated|2018-02-01||Interventional|STEEL||Strength Training and Endurance Exercise for LIFE|Effect of Exercise Training on Inflammation and Function in HIV Infected Veterans|Recruiting||N/A|40|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:36:44.970073|2017-10-11 00:36:44.970073
NCT02101047|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-02-07|||August 2015||2015-08-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Phenylephrine Dose and Mode of Administration for Spinal Anesthesia Induced Hypotension|Correlation and Effects on Cardiac Output With Intermittent Phenylephrine Administration of 50 mcg Versus 100 mcg or 100mcg/Min Prophylactic Infusion for Treatment of Hypotension in Parturients After Receiving Spinal Anesthesia for Cesarean Delivery|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||3||lack of eligible participant|f||||t||||||||||2017-10-11 00:36:45.12865|2017-10-11 00:36:45.12865
NCT02101034|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-09-27|||June 17, 2014||2014-06-17|September 2017|2017-09-01|August 31, 2022|Anticipated|2022-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||PD 0332991 and Cetuximab in Patients With Incurable SCCHN|Phase I/II Trial of the Addition of PD 0332991 to Cetuximab in Patients With Incurable SCCHN|Recruiting||Phase 1/Phase 2|72|Anticipated|Washington University School of Medicine||4|||f||||t|t|f||||||||2017-10-11 00:36:45.270414|2017-10-11 00:36:45.270414
NCT02101021|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-28|2017-04-17|||June 2, 2014|Actual|2014-06-02|April 2017|2017-04-01|April 10, 2017|Actual|2017-04-10|March 7, 2017|Actual|2017-03-07||Interventional|||Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma|A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Subjects With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma Preceded by a Dose-finding, Lead-in Phase|Terminated||Phase 3|25|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-11 00:36:45.471471|2017-10-11 00:36:45.471471
NCT02101008|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-12-21|2014-05-23||March 2010||2010-03-01|December 2015|2015-12-01||||February 2013|Actual|2013-02-01||Interventional|||Disulfiram and Chelated Zinc for the Rx of Disseminated Mets Mel That Has Failed First Line Therapy||Completed||Phase 2|12|Actual|University of Utah||1|||f||||t||||||||||2017-10-11 00:36:45.626144|2017-10-11 00:36:45.626144
NCT02100995|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-04-13||||||April 2016|2016-04-01||||January 2017|Anticipated|2017-01-01||Interventional|STOP||Simultaneously Targeting Obesity and Pain: The STOP Trial|A Randomized Clinical Trial of an Integrated Behavioral Self-management Intervention Simultaneously Targeting Obesity and Pain: The STOP Trial|Recruiting||N/A|||University of the Sciences in Philadelphia||3|||f||||f||||||||||2017-10-11 00:36:46.344137|2017-10-11 00:36:46.344137
NCT02100982|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-06-28|||June 2015||2015-06-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|ICOM-APP||Improving Communication About Patient Priorities in Multimorbidity|Developing a Customized Care Intervention to Improve Mental Health Outcomes in Multimorbidity|Active, not recruiting||N/A|60|Actual|University of Rochester||2|||f||||t||||||||Yes|Data will be made available on request once cleaned and initial analyses by primary team are completed.|2017-10-11 00:36:46.483545|2017-10-11 00:36:46.483545
NCT02100969|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-09-19|||January 2015||2015-01-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis|Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis|Recruiting||Phase 2|25|Anticipated|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-11 00:36:46.610832|2017-10-11 00:36:46.610832
NCT02100956|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-05-30|||April 2014||2014-04-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain|Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain|Recruiting||Phase 2|40|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 00:36:46.7995|2017-10-11 00:36:46.7995
NCT02100943|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-04-18|||March 2014|Actual|2014-03-01|June 2016|2016-06-01|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Observational|||Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum|Exhaled Nitric Oxide as a Biomarker of Gestational Obstructive Sleep Apnea and Persistence Postpartum|Completed||N/A|76|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-11 00:36:46.973029|2017-10-11 00:36:46.973029
NCT02100930|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-01-09|||March 2014||2014-03-01|January 2017|2017-01-01||||March 2019|Anticipated|2019-03-01||Interventional|||Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma|Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma|Recruiting||N/A|125|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:36:47.085543|2017-10-11 00:36:47.085543
NCT02100904|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-01-13|||May 2014||2014-05-01|January 2017|2017-01-01||||June 2019|Anticipated|2019-06-01||Observational|ULTRA Registry||Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry|Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry|Active, not recruiting||N/A|100|Anticipated|University of California, San Francisco|||1||f||||||||||||||2017-10-11 00:36:47.32246|2017-10-11 00:36:47.32246
NCT02100891|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-10-18|||March 2014||2014-03-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|STIR||Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors|Phase 2 Solid Tumor Immunotherapy Trial Using HLA-Haploidentical Transplant and Donor Natural Killer Cells: The STIR Trial|Recruiting||Phase 2|20|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 00:36:47.417268|2017-10-11 00:36:47.417268
NCT02100878|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-01|||March 2014||2014-03-01|April 2014|2014-04-01|March 2015|Anticipated|2015-03-01|March 2014|Actual|2014-03-01||Observational|||Exercise and Neural Response to Food Cues in Children|Effect of Exercise on the Neural Response to Food Cues and Energy Intake in Lean and Obese Adolescents|Withdrawn||N/A|0|Actual|Université Blaise Pascal, Clermont-Ferrand|||2||f||||f||||||||||2017-10-11 00:36:47.540695|2017-10-11 00:36:47.540695
NCT02100865|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-09-14|||February 2014||2014-02-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Solar Powered Oxygen Delivery|Solar Powered Oxygen Delivery: An Open-label Non-inferiority Comparison to Standard Oxygen Delivery Using Oxygen Cylinders|Completed||Phase 2|130|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 00:36:47.609202|2017-10-11 00:36:47.609202
NCT02100852|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-05-12|||March 2014||2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||TGR-1202, a PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)|A Multi-center Phase I/Ib Study Evaluating the Efficacy and Safety of TGR-1202, a Novel PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 1|30|Anticipated|TG Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 00:36:47.699203|2017-10-11 00:36:47.699203
NCT02100839|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-11-23|2015-08-31||March 2014||2014-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of AEM-28 in Healthy Subjects and Patients With Refractory Hypercholesterolemia|Completed||Phase 1/Phase 2|52|Actual|LipimetiX Development, LLC||2|||f||||t||||||||||2017-10-11 00:36:47.794968|2017-10-11 00:36:47.794968
NCT02100826|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-05-08|2015-05-08||April 2014||2014-04-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of Cephalexin in Healthy Participants|Randomized, Open-label, 2-period, 2-treatment, 2-sequence, Crossover Study to Evaluate the Bioequivalence of Single Doses of 2 Oral Preparations in Tablets With 1g of Cephalexin (Keflex® Made in Mexico by Eli Lilly vs. Keflex® Made in Italy by Facta) in Fasting Healthy Participants|Completed||Phase 1|28|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:36:48.379809|2017-10-11 00:36:48.379809
NCT02100813|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-06-13||2016-02-15|May 2014||2014-05-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis|Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis|Completed||Phase 1/Phase 2|220|Actual|LEO Pharma||4|||f||||f||||||||||2017-10-11 00:36:48.838837|2017-10-11 00:36:48.838837
NCT02100800|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-01-08|||May 2014||2014-05-01|January 2015|2015-01-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|EMPHYREM||Assessment of Emphysema Using 1.5T MRI With UTE Pulse Sequences|Assessment of Emphysema in COPD Patients Using 1.5T MR Imaging With Ultrashort Echo Time (UTE) Pulse Sequences|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 00:36:48.963901|2017-10-11 00:36:48.963901
NCT02100787|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-02-28|||April 10, 2014|Actual|2014-04-10|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|April 12, 2016|Actual|2016-04-12||Interventional|BENTLEY||Changes in Tear Osmolarity Over Time With Sustained Use of TheraTears|Evaluation of Tear Osmolarity Over Time With Sustained Use of TheraTears Lubricating Drops|Completed||N/A|18|Actual|Jenkins Eye Care||1|||f||||f||||||||||2017-10-11 00:36:49.114995|2017-10-11 00:36:49.114995
NCT02100774|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-03-27|||January 2009||2009-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|July 2010|Actual|2010-07-01||Observational|VITAGENES||Effect of Genetic Variants on Fat-soluble Vitamin Bioavailability|Effect of Genetic Variants of Intestinal Transporters of Lipophilic Micronutrients (Vitamins D, E and Carotenoids) on Absorption Efficiency of These Compounds.|Completed||N/A|45|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||t||||||Samples With DNA|"     blood, adipose tissue   "|||2017-10-11 00:36:49.221842|2017-10-11 00:36:49.221842
NCT02100761|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-31|||June 2014||2014-06-01|March 2014|2014-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients|Impact of Cytochrome P450 2C19 Genotype Polymorphism on Voriconazole Trough Concentration in Chinese Adult Patients With Invasive Pulmonary Aspergillosis: a Prospective Multicenter Research|Unknown status|Not yet recruiting|N/A|200|Anticipated|Qilu Hospital of Shandong University|||1||f||||f||||||Samples With DNA|"     The susceptibility test of aspergillosis strains to voriconazole, serum galactomannan (GM)     test, voriconazole trough levels and genotyping of CYP2C19 will be measured.   "|||2017-10-11 00:36:49.335215|2017-10-11 00:36:49.335215
NCT02100748|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2017-07-07||2017-07-07|April 2014||2014-04-01|July 2017|2017-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of TRV130 for the Treatment of Pain After Bunionectomy|A Phase 2, Multicenter, Randomized, Double-blind, Multiple-dose, Adaptive, Placebo- and Active-controlled Study of TRV130 for the Treatment of Acute Postoperative Pain After Bunionectomy|Completed||Phase 2|333|Actual|Trevena Inc.||6|||f||||t||||||||||2017-10-11 00:36:49.454503|2017-10-11 00:36:49.454503
NCT02100735|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-10-18|||January 2017||2017-01-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of an Analgosedation Protocol in Mechanically Ventilated Patients|Evaluation of an Analgosedation Protocol in Mechanically Ventilated Patients|Not yet recruiting||N/A|250|Anticipated|Tampa General Hospital||2|||f||||f||||||||||2017-10-11 00:36:49.597163|2017-10-11 00:36:49.597163
NCT02100709|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-04-28|||April 2014||2014-04-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of NIV on QoL and Exercise Capacity in a COPD Exercise Rehabilitation Program|The Effect of BiLevel Pressure Support NonInvasive Ventilation on Quality of Life and Exercise Capacity in a COPD Exercise Rehabilitation Program|Terminated||N/A|14|Actual|ResMed||2||Sample size calculation would have been overinflated; re-think study design|f||||||||||||||2017-10-11 00:36:50.133645|2017-10-11 00:36:50.133645
NCT02100696|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-06-30|||May 31, 2014|Actual|2014-05-31|June 2017|2017-06-01|January 9, 2019|Anticipated|2019-01-09|January 9, 2019|Anticipated|2019-01-09||Interventional|||A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors|Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors|Recruiting||Phase 3|800|Anticipated|Hoffmann-La Roche||5|||f||||||||||||||2017-10-11 00:36:50.310212|2017-10-11 00:36:50.310212
NCT02100683|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-03-15|||August 2014|Actual|2014-08-01|March 2017|2017-03-01|August 2022|Anticipated|2022-08-01|August 2019|Anticipated|2019-08-01||Observational|||Nit-Occlud PDA Post-Approval Study|Nit-Occlud PDA Post-Approval Study|Active, not recruiting||N/A|184|Actual|PFM Medical, Inc|||1||f||||t|f|t|f|f|f|||Undecided||2017-10-11 00:36:51.331419|2017-10-11 00:36:51.331419
NCT02100657|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-09-21|||June 2014||2014-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma|Phase I Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1|25|Anticipated|PharmaMar||1|||f||||f||||||||||2017-10-11 00:36:51.669821|2017-10-11 00:36:51.669821
NCT02100644|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-12-24|2015-11-05||April 2014||2014-04-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study -|Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study -|Completed||Phase 4|33|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:36:51.869368|2017-10-11 00:36:51.869368
NCT02100631|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-07-15|||May 2014||2014-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults|A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR|Completed||Phase 3|398|Actual|PaxVax, Inc.||2|||f||||f||||||||||2017-10-11 00:36:52.250205|2017-10-11 00:36:52.250205
NCT02100618|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-07-16|||January 2015||2015-01-01|July 2015|2015-07-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study|Evaluation of Antibody Persistence for GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||2||"Due to late study start, the possibility to enroll enough subjects dropped below the limit to   provide scientifically acceptable data, hence study was cancelled."|f||||||||||||||2017-10-11 00:36:52.384017|2017-10-11 00:36:52.384017
NCT02100605|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-02-19|||March 2014||2014-03-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PhytosunDecon||Study on Hypertonic Saline Nasal Spray|A Study to Assess the Speed of Relief From Nasal Congestion With a Hypertonic Saline Nasal Spray (Phytosun Decongestant)|Completed||N/A|50|Actual|Omega Pharma||2|||f||||t||||||||||2017-10-11 00:36:52.526237|2017-10-11 00:36:52.526237
NCT02100592|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-27|||October 2012||2012-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study|Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study|Completed||Phase 1/Phase 2|8|Actual|Ospedale Generale Di Zona Moriggia-Pelascini||1|||f||||f||||||||||2017-10-11 00:36:52.64288|2017-10-11 00:36:52.64288
NCT02100579|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-06-14|2016-09-14||March 2014||2014-03-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Ultrasound-guided Adductor Canal Block for Total Knee Replacement|Ultrasound-guided Adductor Canal Block for Total Knee Replacement: a Randomized, Double-blind Placebo Controlled Trial.|Completed||Phase 4|40|Actual|Northwestern University||2|||f||||f||||||||No||2017-10-11 00:36:52.746246|2017-10-11 00:36:52.746246
NCT02100566|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-10-10|||April 2014||2014-04-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|BEACON||Behavioral Economics for Advance Care Options|Behavioral Economics for Advance Care OptioNs|Active, not recruiting||N/A|80|Actual|Genesys Regional Medical Center||2|||f||||f||||||||||2017-10-11 00:36:53.047369|2017-10-11 00:36:53.047369
NCT02100397|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-10-02|||March 2014||2014-03-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|January 2016|Actual|2016-01-01||Interventional|||Understanding Paratyphoid Infection|Development of a Human Model of Salmonella Enterica Serovar Paratyphi A Challenge in Healthy Adult Volunteers|Active, not recruiting||N/A|80|Anticipated|University of Oxford||1|||f||||t||||||||||2017-10-11 00:36:59.179296|2017-10-11 00:36:59.179296
NCT02100553|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-03-23|||April 2014||2014-04-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|CE/BZA||Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women|A Phase 1, Open Label, Two Period, Fixed Sequence, Parallel Group Study To Estimate The Effects Of Multiple Dose Administration Of Itraconazole On The Single Dose Pharmacokinetics Of Conjugated Estrogens/Bazedoxifene In Non Obese (Bmi <30 Kg/m2) And Obese (Bmi ≥30 Kg/m2) Postmenopausal Women|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:36:53.160234|2017-10-11 00:36:53.160234
NCT02100540|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-04-13|||March 2014||2014-03-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|RDC||A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women|A Randomized, Placebo-Controlled, Double-Blind, Dose-Response, Phase 2, -Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women|Recruiting||Phase 2|60|Anticipated|Yung Shin Pharm. Ind. Co., Ltd.||3|||f||||f||||||||Undecided||2017-10-11 00:36:53.271102|2017-10-11 00:36:53.271102
NCT02100527|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-05-12|||April 2014||2014-04-01|May 2014|2014-05-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris|A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects|Withdrawn||Phase 2|0|Actual|Pfizer||2||Study canceled|f||||f||||||||||2017-10-11 00:36:53.364368|2017-10-11 00:36:53.364368
NCT02100514|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-07-20|2017-06-23||October 28, 2014|Actual|2014-10-28|July 2017|2017-07-01|July 15, 2016|Actual|2016-07-15|July 15, 2016|Actual|2016-07-15||Interventional|SPIRE-LL|Full analysis set (FAS) included all participants who were randomized.|Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events|A 52 Week Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events|Completed||Phase 3|746|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 00:36:53.519332|2017-10-11 00:36:53.519332
NCT02100501|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-02-24|||March 2011||2011-03-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Prospective Study of Comparison Between the Modified Atkins Diet and Classic Ketogenic Diet for Intractable Childhood Epilepsy||Completed||N/A|104|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 00:36:57.249879|2017-10-11 00:36:57.249879
NCT02100488|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-11-14|||March 2014||2014-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|CL4M-Controls||Improving Postprandial Glycaemia by a New Developed Closed-loop Control System - Closedloop4meals|Improving Postprandial Glycaemia by a New Developed Closed-loop Control System (Closedloop4meals). An Interdisciplinary, Investigator's Initiated Project for Optimization of Glucose Control in Type1 Diabetic Subjects|Completed||N/A|20|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||||2017-10-11 00:36:57.337401|2017-10-11 00:36:57.337401
NCT02100475|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-11-23|2016-11-23|2016-11-10|April 2014||2014-04-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|DUAL™|Baseline characteristics were presented for full analysis set (FAS = 31 subjects).|A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification|A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification (DUAL™ - Intensification)|Completed||Phase 3|31|Actual|Novo Nordisk A/S|Due to the small number of subjects in this trial, the data should be interpreted with caution.|2|||f||||f||||||||||2017-10-11 00:36:57.584562|2017-10-11 00:36:57.584562
NCT02100462|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2015-12-10|||March 2014||2014-03-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Chlorthalidone and HCTZ Impacts on Platelet Activation|Evaluation of Platelet Effects of Chlorthalidone and Hydrochlorothiazide|Recruiting||Phase 4|30|Anticipated|Creighton University||3|||f||||t||||||||||2017-10-11 00:36:58.215037|2017-10-11 00:36:58.215037
NCT02100449|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-08-09|||June 2014||2014-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Role of Lung Ultrasound and Pulsed-wave Doppler in Lung Consolidations in Mechanically Ventilated Patients|Role of Lung Ultrasound Imaging and Pulsed-wave Doppler in the Assessment of Lung Consolidations in Mechanically Ventilated Patients.|Recruiting||N/A|62|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 00:36:58.348167|2017-10-11 00:36:58.348167
NCT02100436|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2017-07-03||2017-07-03|June 11, 2014|Actual|2014-06-11|December 16, 2014|2014-12-16|March 20, 2015|Actual|2015-03-20|March 20, 2015|Actual|2015-03-20||Interventional|||Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations|A Phase II Open-Label Study in Healthy Pediatric Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine|Completed||Phase 2|270|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f|||||t|f|||f|||||2017-10-11 00:36:58.489676|2017-10-11 00:36:58.489676
NCT02100423|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2016-10-04|||September 2014||2014-09-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|May 2016|Actual|2016-05-01||Interventional|||Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients With Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)|Active, not recruiting||Phase 2|35|Actual|Case Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 00:36:58.637675|2017-10-11 00:36:58.637675
NCT02100410|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-27|2014-04-18|2014-04-18||April 2013||2013-04-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||This analysis population includes all subjects/eyes exposed to the investigational products (embossed or non-embossed lenses).|On-Eye Evaluation of Contact Lens Axis Location||Completed||N/A|50|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 00:36:58.785924|2017-10-11 00:36:58.785924
NCT02100384|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-05-05|||April 2014||2014-04-01|October 2015|2015-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Long Term Comparison of Ultrasonic and Hand Instrumentation in the Maintenance of Peri-implant Tissues: A Randomized Clinical Trial|Long Term Comparison of Ultrasonic and Hand Instrumentation in the Maintenance of Peri-implant Tissues: A Randomized Clinical Trial|Completed||N/A|64|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:36:59.278949|2017-10-11 00:36:59.278949
NCT02100371|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-07-07|||February 2014||2014-02-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome|Extension Protocol of BMS-833923 in Subjects With Basal Cell Nevus Syndrome|Completed||N/A|2|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 00:36:59.376588|2017-10-11 00:36:59.376588
NCT02100358|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-05-24|||February 2013||2013-02-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|MRC||Functional MRC With Eovist for Acute Cholecystitis|Accuracy of Functional MRC With Gadoxetate Disodium in the Diagnosis of Acute Cholecystitis: Comparison With Hepatobiliary Scintigraphy|Completed||N/A|17|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 00:36:59.46355|2017-10-11 00:36:59.46355
NCT02100345|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-05-08|||October 2014|Actual|2014-10-01|May 2016|2016-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound|Conservative Treatment of Rectosigmoid Endometriosis Monitored by Transvaginal Ultrasound|Completed||N/A|98|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 00:36:59.617202|2017-10-11 00:36:59.617202
NCT02100332|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-12-02|||November 2012||2012-11-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|PREFER||A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)|Prevalence of Comorbidities of COPD in the Exacerbator Phenotype - A Cross Sectional Disease/Condition Focused Observational Study on COPD|Completed||N/A|860|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:36:59.755349|2017-10-11 00:36:59.755349
NCT02100319|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-07-21|||April 2014||2014-04-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||"Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance Hypertension Complicated by Diabetes "|"Azilva Tablets Special Drug Use Surveillance Hypertension Complicated by Diabetes "|Completed||N/A|373|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:36:59.888905|2017-10-11 00:36:59.888905
NCT02100306|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-26|||May 2014||2014-05-01|March 2014|2014-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||The Role of Auditory Feedback in Guiding Upper Extremity Movements||Unknown status|Not yet recruiting|N/A|26|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 00:37:00.06032|2017-10-11 00:37:00.06032
NCT02100293|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-04-15|||October 2013||2013-10-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium||Completed||N/A|84|Anticipated|Seoul National University Hospital||3|||f||||f||||||||||2017-10-11 00:37:00.210012|2017-10-11 00:37:00.210012
NCT02100280|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2016-04-24|||June 2014||2014-06-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|December 2015|Actual|2015-12-01||Interventional|suga-SH||The Effect of Deep Block Versus Moderate Block on the Stress Response After Laparoscopic Gastrectomy|A Double-blinded, Randomized, Parallel Design Study to Compare the Effect of Deep Block Versus Moderate Block on the Stress Response After Laparoscopic Gastrectomy|Enrolling by invitation||Phase 4|96|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||Yes||2017-10-11 00:37:00.330884|2017-10-11 00:37:00.330884
NCT02100267|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-11-13|||April 2014||2014-04-01|March 2014|2014-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.||2|||f||||||||||||||2017-10-11 00:37:00.449861|2017-10-11 00:37:00.449861
NCT02100254|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-02-20|||October 1, 2009||2009-10-01|February 2017|2017-02-01|August 1, 2018|Anticipated|2018-08-01|September 23, 2016|Actual|2016-09-23||Interventional|||Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities|CRC Screening Thoughts and Feelings: Increasing Engagement of African Americans|Active, not recruiting||N/A|1310|Actual|Roswell Park Cancer Institute||2|||f||||f||||||||||2017-10-11 00:37:00.549859|2017-10-11 00:37:00.549859
NCT02100241|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2014-03-26|||April 2012||2012-04-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Effectiveness Analysis of Active Stretching Versus Active Stretching With Low Frequency Currents|Effectiveness Analysis of Active Stretching Versus Active Stretching With Low Frequency Currents|Completed||N/A|62|Actual|Rodríguez, Francisco Piqueras, M.D.||3|||f||||t||||||||||2017-10-11 00:37:00.693372|2017-10-11 00:37:00.693372
NCT02100228|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-02-22|||July 2014||2014-07-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|EMANATE||Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)|A Phase IV Trial To Assess The Effectiveness Of Apixaban Compared With Usual Care Anticoagulation In Subjects With Non-Valvular Atrial Fibrillation Undergoing Cardioversion|Completed||Phase 4|1500|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 00:37:00.820205|2017-10-11 00:37:00.820205
NCT02100215|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-26|||November 2013||2013-11-01|March 2014|2014-03-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Quantifying the Influence of Expert Modeling|Quantifying the Influence of Expert Modeling on Novice Nurse Competence and Self-Efficacy|Unknown status|Recruiting|N/A|60|Anticipated|Oregon Health and Science University||3|||f||||f||||||||||2017-10-11 00:37:01.301783|2017-10-11 00:37:01.301783
NCT02100202|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2014-03-26|||April 2014||2014-04-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia|Efficacy and Safety Study of Dietary Supplements (BioTurmin, BioTurmin-WD and MaQxan) on Cotinine Level and Oxidative Stress Marker in Chronic Smokers Having Mild to Moderate Hyperlipidemia|Unknown status|Not yet recruiting|N/A|60|Anticipated|Olive Lifesciences Pvt Ltd||4|||f||||t||||||||||2017-10-11 00:37:01.422114|2017-10-11 00:37:01.422114
NCT02100189|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-05-09|2016-11-01||February 2014||2014-02-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Esophageal Cytology With FISH in Detecting Esophageal Cancer|Esophageal Cancer (10030139, 10066354) Screening With FISH in Esophageal Cytology|Completed||N/A|50|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 00:37:01.546866|2017-10-11 00:37:01.546866
NCT02100176|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-26|||January 2013||2013-01-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|March 2014|Actual|2014-03-01|18 Months|Observational [Patient Registry]|MIRT-RT||MIRT and Rotigotine in the Early Stage of PD|Multidisciplinary Intensive Rehabilitation Treatment and Rotigotine in the Early Stages of Parkinson's Disease: a Randomized Controlled Study.|Unknown status|Recruiting|N/A|40|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini|||2||f||||t||||||||||2017-10-11 00:37:01.904293|2017-10-11 00:37:01.904293
NCT02100163|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-08-30|||March 2014||2014-03-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|VROT||Virtual Reality Orthopedic Trauma|Controling Pain After Orthopedic Trauma|Recruiting||N/A|300|Anticipated|National Institute of General Medical Sciences (NIGMS)||3|||f||||t||||||||||2017-10-11 00:37:02.056452|2017-10-11 00:37:02.056452
NCT02100150|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-03-27|||September 2014|Actual|2014-09-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI)|A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of NNZ-2566 in the Acute Treatment of Adolescents and Adults With Mild Traumatic Brain Injury (mTBI)|Terminated||Phase 2|32|Actual|Neuren Pharmaceuticals Limited||2|||f||||t||||||||Undecided||2017-10-11 00:37:02.165467|2017-10-11 00:37:02.165467
NCT02100137|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2014-03-26|||September 2006||2006-09-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|November 2010|Actual|2010-11-01||Observational|FAME-ENDO||Women With Asymptomatic Endometrial Hyperplasia|Women With Asymptomatic Endometrial Hyperplasia|Completed||N/A|1000|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 00:37:02.449805|2017-10-11 00:37:02.449805
NCT02100111|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-07-20|||January 1, 2005|Actual|2005-01-01|June 2017|2017-06-01|December 31, 2011|Actual|2011-12-31|December 31, 2011|Actual|2011-12-31||Observational|||An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants|RONNIE - A Multi-Center, Multi-National, Retrospective Medical Record Review to Describe Treatment Patterns and Outcomes for Patients With Locally Advanced or Metastatic Basal Cell Carcinoma|Completed||N/A|134|Actual|Hoffmann-La Roche|||1||f|||||f|f||||||||2017-10-11 00:37:02.697222|2017-10-11 00:37:02.697222
NCT02100098|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-04-17|||March 2014||2014-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|||Peripheral Nerve Block Anaesthesia for Ankle Fracture Surgery - an Exploratory Study: Is Rebound Pain a Problem?|Peripheral Nerve Block Anaesthesia for Ankle Fracture Surgery - an Exploratory Study: Is Rebound Pain a Problem?|Completed||N/A|21|Actual|Herlev Hospital|||1||f||||f||||||||||2017-10-11 00:37:02.919999|2017-10-11 00:37:02.919999
NCT02100085|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-11|||February 2014|Actual|2014-02-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation|A Single Center, Phase I Study to Follow-up on the Change of Immunogenicity and Lesion Condition in Subjects Who Have Completed the Phase I GX-188E Trial (Protocol no. GX-188E-SN)|Active, not recruiting||N/A|9|Actual|Genexine, Inc.|||1||f||||f||||||Samples Without DNA|"     plasma and PBMC (peripheral blood mononeuclear cells)   "|||2017-10-11 00:37:03.039246|2017-10-11 00:37:03.039246
NCT02100072|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-07-29|||June 2013||2013-06-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation of 1440nm Laser Assisted Selective Photothermolysis for Treatment of Axillary Hyperhidrosis|Evaluation of 1440nm Laser Assisted Selective Photothermolysis for Treatment of Axillary Hyperhidrosis|Completed||N/A|5|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:37:03.149684|2017-10-11 00:37:03.149684
NCT02100059|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-12-10|||October 2013||2013-10-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Motor and Sensory Deficits Following Partial Meniscectomy|Motor and Sensory Deficits Following Partial Meniscectomy|Completed||N/A|60|Actual|Creighton University||1|||f||||f||||||||||2017-10-11 00:37:03.245126|2017-10-11 00:37:03.245126
NCT02100046|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-05-09|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|EDONOT||Assessment of the Effectiveness of Ethosuximide in the Treatment of Traumatic Neuropathic Pain|Assessment of the Effectiveness of Ethosuximide in the Treatment of Traumatic Neuropathic Pain.|Completed||Phase 2|114|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:37:03.338393|2017-10-11 00:37:03.338393
NCT02100033|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-08-04|||October 2013||2013-10-01|August 2015|2015-08-01||||December 2016|Anticipated|2016-12-01||Interventional|||How Acupuncture Sensation Propagated to Effect the Energy of Channels||Unknown status|Recruiting|N/A|60|Anticipated|China Medical University Hospital||1|||f||||||||||||||2017-10-11 00:37:03.475646|2017-10-11 00:37:03.475646
NCT02100020|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-09-15|||May 2014||2014-05-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Implementing Physical Activity Guidelines for Adults With MS|A Community-based Randomized Controlled Trial Testing Implementation of the New Canadian Physical Activity Guidelines for Adults With Multiple Sclerosis.|Recruiting||N/A|130|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 00:37:03.599371|2017-10-11 00:37:03.599371
NCT02100007|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-09-28|2017-03-07||April 2014||2014-04-01|August 2015|2015-08-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional||The study was conducted in two parts. Fourteen (14) patients enrolled in Part 1 and 32 subjects were enrolled in Part 2.|ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors|A Phase Ib Open Label Study of the Safety and Tolerability of ME-344 Given in Combination With Topotecan (Hycamtin®) in Patients With Solid Tumors|Terminated||Phase 1/Phase 2|46|Actual|MEI Pharma, Inc.||1||lack of efficacy|f||||f||||||||||2017-10-11 00:37:03.780205|2017-10-11 00:37:03.780205
NCT02099994|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-05-27|||March 2014||2014-03-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|HIV-CORE 004||Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults|A Phase I/IIa Clinical Trial of HIV-1 Vaccines pSG2.HIVconsv DNA, MVA.HIVconsv and Ad35-GRIN in Combined Regimens in Healthy HIV-1/2-negative Adults in Nairobi.|Completed||Phase 1/Phase 2|72|Actual|University of Oxford||3|||f||||t||||||||||2017-10-11 00:37:04.319175|2017-10-11 00:37:04.319175
NCT02099981|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-09-15|||July 2016||2016-07-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients|Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients|Recruiting||Phase 1|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:37:04.501018|2017-10-11 00:37:04.501018
NCT02099968|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-05-23|||April 2014||2014-04-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Comprehensive Lifestyle Modification for Patients With Hypertension and Metabolic Syndrome: a Multicenter Randomized Controlled Trial|Intensivierte Ernährungs- Und Lebensstilmodifikation Bei Patienten Mit Bluthochdruck Und Kardiometabolischer Risikokonstellation. Eine Zweizentrische Randomisiert-kontrollierte Interventionsstudie über 6 Monate|Completed||N/A|145|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-11 00:37:04.62409|2017-10-11 00:37:04.62409
NCT02099955|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-03-06|||January 2012||2012-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Vitamin D Deficiency and Replacement on Pulmonary and Endocrine Function in SCI|Effects of Vitamin D Deficiency and Its Replacement on Pulmonary and Endocrine Function in Persons With SCI|Completed||Phase 1/Phase 2|88|Actual|James J. Peters Veterans Affairs Medical Center||3|||f||||f|t|||||||Undecided||2017-10-11 00:37:04.756383|2017-10-11 00:37:04.756383
NCT02099942|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-02-29|||March 2014||2014-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|6 Months|Observational [Patient Registry]|TAB-R||Post-Market Surveillance Registry to Monitor Performance and Safety of V8 Device|Transluminal Aortic Balloon Valvuloplasty Registry (TAB-R)|Completed||N/A|103|Actual|InterValve, Inc.|||1||f||||f||||||||||2017-10-11 00:37:04.856767|2017-10-11 00:37:04.856767
NCT02099929|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-03-26|||June 2012||2012-06-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Coffee Consumption on Glucose Metabolism|Coffee and Glucose Metabolism: Clinical, Crossover and Randomized Glucose Disposal Assay Using Stable Isotopes|Completed||N/A|14|Actual|University of Brasilia||5|||f||||t||||||||||2017-10-11 00:37:04.960065|2017-10-11 00:37:04.960065
NCT02099916|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-09-09|||October 2014||2014-10-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|DHEA||Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF|Prospective Randomized Trial on the Effect of DHEA Administration in Women With Poor Ovarian Reserve Undergoing Controlled Ovarian Stimulation for IVF. Impact on Stimulation Characteristics and and Pregnancy Outcome.|Unknown status|Not yet recruiting|Phase 2/Phase 3|50|Anticipated|University of Athens||2|||f||||t||||||||||2017-10-11 00:37:05.116718|2017-10-11 00:37:05.116718
NCT02099903|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-26|||March 2014||2014-03-01|March 2014|2014-03-01|August 2015|Anticipated|2015-08-01|December 2014|Anticipated|2014-12-01||Interventional|||Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease|Transcatheter Renal Denervation in Patients With Systolic Heart Failure Due to Chagas' Disease - a Safety and Efficacy Study.|Unknown status|Recruiting|N/A|30|Anticipated|InCor Heart Institute||2|||f||||f||||||||||2017-10-11 00:37:05.207515|2017-10-11 00:37:05.207515
NCT02099890|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-07-28|||September 2014||2014-09-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury|Neural Consequences of Chronic Inflammation in Individuals With Spinal Cord Injury and the Influence of an Anti-inflammatory Diet|Completed||Phase 3|20|Actual|Brock University||1|||f||||f||||||||||2017-10-11 00:37:05.328546|2017-10-11 00:37:05.328546
NCT02099877|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-01-25|||October 2013||2013-10-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||μ-opioid Receptor Polymorphism and Opioid Analgesia|Observational Study: The Effect of μ-opioid Receptor Genetic Polymorphism on Neuraxial Opioid Labor Analgesia|Recruiting||N/A|250|Anticipated|American University of Beirut Medical Center|||1||f||||||||||||No||2017-10-11 00:37:05.449337|2017-10-11 00:37:05.449337
NCT02099864|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-08-23|||February 5, 2014|Actual|2014-02-05|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy|Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment|Recruiting||N/A|36|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 00:37:05.574923|2017-10-11 00:37:05.574923
NCT02099851|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-10-14|||March 2014||2014-03-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study|Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study.|Active, not recruiting||N/A|6|Actual|Noblewell||1|||f||||t||||||||||2017-10-11 00:37:05.70781|2017-10-11 00:37:05.70781
NCT02099838|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-06-11|2014-04-10||January 2012||2012-01-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Based on the full analysis set: all participants who were eligible or drop-out, but eliminated participants were excluded.|Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients|The Randomized Multiple Center Trial for The Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients Who Have Bad Glycemic Control With the Initial Treatment of Sulfonylureas|Completed||Phase 4|98|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 00:37:05.832844|2017-10-11 00:37:05.832844
NCT02099812|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-04-28|||December 2012||2012-12-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|June 2013|Actual|2013-06-01||Observational|||Web-based Collection of Data on Obesity and Health Behavior|Web-based Collection of Data on Obesity and Health Behavior|Completed||N/A|1585|Actual|Virginia Polytechnic Institute and State University|||2||f||||f||||||||Undecided||2017-10-11 00:37:07.354792|2017-10-11 00:37:07.354792
NCT02099799|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-09-13|||November 17, 2015|Actual|2015-11-17|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|WEB||The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD|The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD|Recruiting||N/A|185|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 00:37:07.42015|2017-10-11 00:37:07.42015
NCT02099786|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-04-25|||April 1, 2015|Actual|2015-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|COMP-VA||Randomized Trial Comparison of Ototoxicity Monitoring Programs|Comprehensive Ototoxicity Monitoring Program for VA: A Randomized Trial|Recruiting||N/A|71|Anticipated|VA Office of Research and Development||4|||f||||f|||||f|||No||2017-10-11 00:37:07.548814|2017-10-11 00:37:07.548814
NCT02099773|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-05-11|||January 2015||2015-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||Support Staff-client Interactions With Augmentative and Alternative Communication|Support Staff's Interactions With Adults With Intellectual Disability Who Use Augmentative and Alternative Communication|Active, not recruiting||N/A|40|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||t||||||||||2017-10-11 00:37:07.658355|2017-10-11 00:37:07.658355
NCT02099760|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-06-17|||December 2013||2013-12-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Cepheid Rectal Sample Validation Study|A Validation Study of the Cepheid Xpert CT/NG for Detecting Chlamydia Trachomatis and Neisseria Gonorrhoeae in Rectal Samples|Completed||N/A|402|Actual|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"     Any leftover specimens including genital, rectal, pharyngeal, or urine may be retained.   "|||2017-10-11 00:37:07.737524|2017-10-11 00:37:07.737524
NCT02099747|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-10-12|||May 2015||2015-05-01|July 2016|2016-07-01||||December 2020|Anticipated|2020-12-01||Interventional|RACE||hATG+CsA vs hATG+CsA+Eltrombopag for SAA|A Prospective Randomized Multicenter Study Comparing Horse Antithymocyte Globuline (hATG) + Cyclosporine A (CsA) With or Without Eltrombopag as Front-line Therapy for Severe Aplastic Anemia Patients.|Recruiting||Phase 3|200|Anticipated|European Group for Blood and Marrow Transplantation||2|||f||||t||||||||||2017-10-11 00:37:07.839413|2017-10-11 00:37:07.839413
NCT02099734|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-09-05|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Germ Cell Tumor and Testicular Tumor DNA Registry|Germ Cell Tumor and Testicular Tumor DNA Registry|Recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||Samples With DNA|"     blood saliva   "|||2017-10-11 00:37:08.079486|2017-10-11 00:37:08.079486
NCT02099721|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-08-31|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Improve Sudden Cardiac Arrest Study|Improve Sudden Cardiac Arrest Study|Active, not recruiting||N/A|4222|Actual|Medtronic Cardiac Rhythm and Heart Failure||6|||f||||f||||||||||2017-10-11 00:37:08.211452|2017-10-11 00:37:08.211452
NCT02099708|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-09-23|2015-08-06||October 2010||2010-10-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||Safety analysis set: all participants who took the study drug at least once.|Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs|Takepron Capsules 15/ Orally Dispersing（OD） Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs|Completed||N/A|3502|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:37:08.515345|2017-10-11 00:37:08.515345
NCT02099695|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-07-25|||December 2015||2015-12-01|July 2016|2016-07-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis|Clinical Trial Phase III, Prospective, Randomized, Double-blind, Multicenter, National, Comparative Between Oxybutynin Chloride With Placebo to Evaluate the Efficacy and Safety for Systemic Treatment of Primary Hyperhidrosis.|Withdrawn||Phase 3|0|Actual|Cristália Produtos Químicos Farmacêuticos Ltda.||2||The company changed the strategy.|f||||f||||||||||2017-10-11 00:37:09.034945|2017-10-11 00:37:09.034945
NCT02099682|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-09-23|2015-06-05||August 2010||2010-08-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational||Safety analysis set: all participants who took the study drug at least once.|Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin|Takepron Capsules 15/ Orally Dispersing (OD) Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin|Completed||N/A|3366|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:37:09.14867|2017-10-11 00:37:09.14867
NCT02099669|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-06-06|||March 2014||2014-03-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|EnhanceRBC||Red Blood Cell Transfusion Thresholds and QOL in MDS|Red Blood Cell Transfusion Thresholds and QOL in MDS (EnhanceRBC): a Pilot, Feasibility Study|Recruiting||N/A|30|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||No||2017-10-11 00:37:10.056644|2017-10-11 00:37:10.056644
NCT02099656|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-09-04|||November 6, 2014|Actual|2014-11-06|September 2017|2017-09-01|October 13, 2016|Actual|2016-10-13|October 13, 2016|Actual|2016-10-13||Interventional|||A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma|A Phase II, Randomized, Double-Blind, Placebo-Controlled Bronchoscopy Study to Evaluate the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Patients With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication|Completed||Phase 2|64|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:37:10.195596|2017-10-11 00:37:10.195596
NCT02099630|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-07-25|||March 2014||2014-03-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01|3 Months|Observational [Patient Registry]|||Functional and Metabolic Changes in the Course of Antidepressive Treatment||Enrolling by invitation||N/A|50|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 00:37:10.465957|2017-10-11 00:37:10.465957
NCT02099435|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-01-19|||January 2015||2015-01-01|January 2017|2017-01-01|November 6, 2016|Actual|2016-11-06|November 6, 2016|Actual|2016-11-06||Observational|||Study of Hemospray for Lower Gastrointestinal Hemorrhage|A Prospective Observational Cohort Study of Hemospray for Lower Gastrointestinal Hemorrhage (APPROACH LGI)|Completed||N/A|50|Actual|Cook Group Incorporated|||1||f||||f||||||||||2017-10-11 00:37:12.444099|2017-10-11 00:37:12.444099
NCT02099617|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-05-01|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|SENIOR||Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.|Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.|Active, not recruiting||Phase 4|1200|Actual|Ceric Sàrl||2|||f||||t||||||||No||2017-10-11 00:37:10.548281|2017-10-11 00:37:10.548281
NCT02099604|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-10|||April 2014||2014-04-01|July 2017|2017-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|ViZIR||Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C|Efficacy and Safety of the Combination Vitamin D (Vit D), With Pegylated Interferon Alpha-2b (PEG-IFN)/Ribavirin (RBV) in Egyptian Patients With Untreated Chronic Hepatitis C: A Phase III Randomized Open-label Clinical Trial|Withdrawn||Phase 3|0|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2||Study objectives were considered as obsolete regarding the new AAD arrival|f||||t||||||||||2017-10-11 00:37:10.7518|2017-10-11 00:37:10.7518
NCT02099591|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-06-07|||November 2014||2014-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients|A Phase I, Open-Label, Multicentre Study to Assess the Pharmacokinetics and Safety of Naloxegol in Paediatric Patients Ages ≥ 6 Months to < 18 Years Receiving Treatment With Opioids|Recruiting||Phase 1|48|Anticipated|Kyowa Kirin Pharmaceutical Development Ltd||6|||f||||f||||||||||2017-10-11 00:37:10.87293|2017-10-11 00:37:10.87293
NCT02099578|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-12-15|||February 2013||2013-02-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effects of Strawberries on Blood Pressure in Postmenopausal Women|Daily Incorporation of Strawberries Into a Diet Favorably Improves Vascular Function and Lowers Aortic Blood Pressure in Postmenopausal Women With Prehypertension|Completed||N/A|60|Actual|Florida State University||3|||f||||f||||||||Undecided||2017-10-11 00:37:11.091348|2017-10-11 00:37:11.091348
NCT02099565|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-02-24|||May 2014||2014-05-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|OPTIMAII||Observational Prospective Study OPTIMA II - Follow-up|Observational Prospective Study to esTIMAte the Rates of Outcomes in Patients Undergoing PCI (Percutaneuos Coronary Intervention) With Drug Eluting Stent (DES) Implantation Who Take Statins (OPTIMA II) - Follow-up|Completed||N/A|572|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:37:11.209439|2017-10-11 00:37:11.209439
NCT02099552|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-08-31|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|ECP-015||Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia|Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia|Completed||N/A|150|Anticipated|Edimer Pharmaceuticals|||1||f||||f||||||||||2017-10-11 00:37:11.314428|2017-10-11 00:37:11.314428
NCT02099539|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-07-19|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|August 2017|Anticipated|2017-08-01||Interventional|||QUILT-3.005: A Study of ALT-803 in Patients With Relapsed or Refractory Multiple Myeloma|A Phase I/II Study of ALT-803 in Patients With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|57|Anticipated|Altor BioScience||1|||f||||t||||||||||2017-10-11 00:37:11.432818|2017-10-11 00:37:11.432818
NCT02099526|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-07-21|||June 2014||2014-06-01|January 2015|2015-01-01||||June 2015|Actual|2015-06-01||Observational|||Older Cancer Caregiver Needs Post Hospital Discharge|Needs of Older Caregivers of Adults With Cancer In the First 2 Weeks Following Hospital Discharge|Completed||N/A|23|Actual|Duke University|||1||f||||f||||||||||2017-10-11 00:37:11.561697|2017-10-11 00:37:11.561697
NCT02099513|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-02-21|||March 2014||2014-03-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|mHealth||The Mobile Health Platform|The Mobile Health Platform - Development and Feasibility Evaluation|Completed||N/A|6|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:37:11.634835|2017-10-11 00:37:11.634835
NCT02099500|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-07-19|||March 2014||2014-03-01|July 2017|2017-07-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections for the Treatment of Critical Limb Ischemia|An Open-label, Non-Randomized, Patient Funded, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Via Intramuscular Injections for the Treatment of Critical Limb Ischemia|Withdrawn||Phase 1|0|Actual|Ageless Regenerative Institute||1||no participants enrolled|f||||f||||||||||2017-10-11 00:37:11.711974|2017-10-11 00:37:11.711974
NCT02099487|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-05-19|||July 2013||2013-07-01|January 2014|2014-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Hypofractionated Imrt (Vmat-Ra) For Elderly Patients With Newly Diagnosed High Grade Glioma|Hypofractionated Imrt (Vmat-Ra) With Temozolomide For Elderly Patients, Unsuitable For Surgery With Newly Diagnosed High Grade Glioma|Completed||Phase 2|20|Actual|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-11 00:37:11.807045|2017-10-11 00:37:11.807045
NCT02099474|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-08-18|||June 30, 2014|Actual|2014-06-30|August 2017|2017-08-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|ANRS 160 RalFE||Evaluation of Raltegravir During the Third Trimester of Pregnancy|Evaluation of the Pharmacokinetic Properties and the Tolerance of Raltegravir During the Third Trimester of Pregnancy|Completed||Phase 2|83|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 00:37:11.88305|2017-10-11 00:37:11.88305
NCT02099461|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-08-24|2015-06-22||April 2014||2014-04-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Denosumab on Cellular Biomarkers in the Human Breast|A Randomized, Stratified, Open-label, No-treatment-controlled, Parallel Group, Multicenter Phase 1 Trial to Evaluate the Effect of Denosumab on Cellular Proliferation in the Human Breast|Completed||Phase 1|82|Actual|Amgen||3|||f||||f||||||||||2017-10-11 00:37:11.977981|2017-10-11 00:37:11.977981
NCT02099448|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-02-08|||April 2014||2014-04-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Correlation of Non-invasive Assessment, Using C.A 2.0 Device, Versus Invasive Assessment of LVEDP|Correlation of Non-invasive Assessment, Using C.A 2.0 Device, Versus Invasive Assessment of Left Ventricular End Diastolic Pressure (LVEDP)|Completed||N/A|41|Actual|CorAlert Ltd.|||1||f||||f||||||||||2017-10-11 00:37:12.360558|2017-10-11 00:37:12.360558
NCT02099422|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-03-26|||January 2013||2013-01-01|March 2014|2014-03-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Observational|TOPIC||Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome|The Randomized TOPIC Study : Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome|Unknown status|Recruiting|N/A|500|Anticipated|Hôpital de la Timone|||1||f||||f||||||||||2017-10-11 00:37:12.548707|2017-10-11 00:37:12.548707
NCT02099409|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-09-15|||January 2014||2014-01-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg|Open Label Single Center Randomized Cross Over Study to Validate Current Algorithms and Evaluate Safety and Efficacy of Closed Loop Insulin Delivery (FlorenceD2 System) in Children With Type 1 Diabetes Between 6 - 12 Years of Age|Completed||N/A|15|Actual|Centre Hospitalier du Luxembourg||2|||f||||f||||||||||2017-10-11 00:37:12.634997|2017-10-11 00:37:12.634997
NCT02099396|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-03-27|||April 2014||2014-04-01|March 2014|2014-03-01||||June 2016|Anticipated|2016-06-01||Interventional|||A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced Osteosarcoma||Unknown status|Not yet recruiting|Phase 2/Phase 3|100|Anticipated|China Association of Osteosarcoma Chemotherapy||2|||f||||||||||||||2017-10-11 00:37:12.766992|2017-10-11 00:37:12.766992
NCT02099383|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-06-22|||April 2014||2014-04-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|HYDO||BUN/Cr-based Hydration Therapy to Improve Outcomes for Dehydrated Patients With Acute Ischemic Stroke.|A Phase III Trial of BUN/Cr-based Hydration Therapy to Reduce Stroke-in-evolution and Improve Short-term Functional Outcomes for Dehydrated Patients With Acute Ischemic Stroke|Recruiting||Phase 3|244|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||Undecided||2017-10-11 00:37:12.842341|2017-10-11 00:37:12.842341
NCT02099370|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-03-17|||March 2014||2014-03-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|ADIMS||Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients|A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients.|Completed||N/A|34|Actual|University of South Florida|||1||f||||f||||||||||2017-10-11 00:37:12.93912|2017-10-11 00:37:12.93912
NCT02099357|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-08-01|||September 2014||2014-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Creatine or Vitamin D Supplementation in Persons With Spinal Cord Injury Undergoing Resistance Training|Creatine or Vitamin D Supplementation in Persons With Spinal Cord Injury Undergoing Resistance Training|Completed||N/A|14|Actual|Universidade do Porto||3|||f||||f||||||||||2017-10-11 00:37:12.998486|2017-10-11 00:37:12.998486
NCT02099344|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-06-03|2015-12-21||April 2014||2014-04-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Artegraft Versus Propaten Dialysis Grafts|A Prospective, Randomized Study of the Artegraft vs Propaten Vascular Grafts for Renal Failure Patients Requiring Dialysis Access|Terminated||Phase 4|1|Actual|Kaiser Permanente||2||Lack of enrollment|f||||f||||||||||2017-10-11 00:37:13.092555|2017-10-11 00:37:13.092555
NCT02099331|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2017-08-09|||September 2014||2014-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|DREAM||Cardiac Surgery and the Risk of Atrial Fibrillation: an Intervention Trial Evaluating Melatonin|Cardiac Surgery and the Risk of Atrial Fibrillation: an Intervention Trial Evaluating Melatonin|Recruiting||Phase 2|140|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:37:13.311053|2017-10-11 00:37:13.311053
NCT02099318|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-05-04|2016-02-01||February 2013||2013-02-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SRP||Surgical Theater's Surgery Rehearsal Platform|Evaluation of Effort and Time Efficiency of Surgical Theater's Surgery Rehearsal Platform (SRP) for Cerebral Aneurysm Clipping Surgery|Completed||N/A|40|Actual|University Hospitals Cleveland Medical Center||2|||f||||f||||||||No||2017-10-11 00:37:13.410885|2017-10-11 00:37:13.410885
NCT02099305|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-06-08|||September 2012||2012-09-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|ADAP||Randomized, School-based Effectiveness Trial of the Adolescent Depression Awareness Program|Impact of Increasing Adolescent Depression Literacy on Treatment-Seeking Behavior|Completed||N/A|17000|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:37:13.72421|2017-10-11 00:37:13.72421
NCT02099292|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-03-25|||May 2001||2001-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|May 2005|Actual|2005-05-01||Interventional|Mz-135||Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma|Eine Phase II Studie Zur Beurteilung Der Wirksamkeit Von Rituximab in Der Salvage- Und Hochdosistherapie Mit Autologer Stammzelltransplantation Bei Patienten Mit B-Zell-Non-Hodgkin-Lymphom|Completed||Phase 2|103|Actual|Johannes Gutenberg University Mainz||1|||f||||f||||||||||2017-10-11 00:37:13.970023|2017-10-11 00:37:13.970023
NCT02099279|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2015-08-31|||January 2014||2014-01-01|March 2014|2014-03-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Observational|||Prognostic Value Cardiac Dysfunction Assessed by Bedside Echocardiography in Critically Ill COPD Patients Requiring Mechanical Ventilation||Completed||N/A|53|Actual|Jinhua Central Hospital|||1||f||||f||||||||||2017-10-11 00:37:14.079318|2017-10-11 00:37:14.079318
NCT02099266|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-05-09|2017-01-27||June 2013||2013-06-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment|A Pilot Study to Determine the Safety and Efficacy of Using Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment|Completed||N/A|15|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-11 00:37:14.176829|2017-10-11 00:37:14.176829
NCT02099253|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2014-12-11|||March 2014||2014-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Influence of Age on Dexmedetomidine Pharmacodynamic|The Influence of Age on Dexmedetomidine Pharmacodynamic in Lower Extremity Surgery|Completed||Phase 4|82|Actual|Guangzhou General Hospital of Guangzhou Military Command||3|||f||||f||||||||||2017-10-11 00:37:14.829558|2017-10-11 00:37:14.829558
NCT02099240|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-03-21|||April 2014||2014-04-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PRESTO:Osteo||Patients Response to Early Switch To Oral:Osteomyelitis Study|Prospective Randomized Study to Compare Clinical Outcomes in Patients With Osteomyelitis Treated With Intravenous Antibiotics Versus Intravenous Antibiotics With an Early Switch to Oral Antibiotics|Recruiting||Early Phase 1|456|Anticipated|University of Louisville||2|||f||||t||||||||||2017-10-11 00:37:14.984526|2017-10-11 00:37:14.984526
NCT02099227|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2016-09-08|||March 2014||2014-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections|Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections|Completed||N/A|280|Actual|Advocate Health Care|||2||f||||f||||||||||2017-10-11 00:37:15.585235|2017-10-11 00:37:15.585235
NCT02099214|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-08-07|||November 2014||2014-11-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|HEMOCOEUR||Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis|Estimation of Myocardial Iron Overload by 3 Tesla MRI and Cardiac Functional Consequences in Patients With HFE Hereditary Haemochromatosis. Pilot Study|Recruiting||N/A|60|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 00:37:15.658765|2017-10-11 00:37:15.658765
NCT02099201|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-08-11|||November 2012||2012-11-01|August 2017|2017-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects|A Single-center, Double-blind, Parallel-group, Randomized, Placebo-controlled, Multiple-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects|Completed||Phase 1|65|Actual|Actelion||7|||f||||f||||||||||2017-10-11 00:37:15.787831|2017-10-11 00:37:15.787831
NCT02099188|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-05-23|||November 2013||2013-11-01|May 2017|2017-05-01|January 2024|Anticipated|2024-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients|Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors: Phase II Study of Chemotherapy, Photon and Heavy Ion Radiotherapy Integration for More Effective and Less Toxic Treatment in Inoperable Patients|Recruiting||Phase 2|25|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t||||||||||2017-10-11 00:37:15.918513|2017-10-11 00:37:15.918513
NCT02099175|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-05-23|||November 2013||2013-11-01|May 2017|2017-05-01|January 2024|Anticipated|2024-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients|Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors: Phase II Study of Chemotherapy, Surgery, Photon and Heavy Ion Radiotherapy Integration for More Effective and Less Toxic Treatment in Operable Patients|Recruiting||Phase 2|40|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t||||||||||2017-10-11 00:37:16.062501|2017-10-11 00:37:16.062501
NCT02099162|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-03-27|||April 2008||2008-04-01|March 2014|2014-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Yonsei OCT (Optical Coherence Tomography) Registry for Evaluation of Efficacy and Safety of Coronary Stenting||Recruiting||N/A|3000|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:37:16.197306|2017-10-11 00:37:16.197306
NCT02099149|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-07-23|||May 2014||2014-05-01|July 2014|2014-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days|Establishing a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged Less Than 90 Days.|Withdrawn||N/A|0|Actual|Novartis|||2||f||||f||||||||||2017-10-11 00:37:16.286735|2017-10-11 00:37:16.286735
NCT02099136|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-12-28|||September 1999||1999-09-01|December 2016|2016-12-01|December 2004|Actual|2004-12-01|September 2001|Actual|2001-09-01||Interventional|||Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers|Clinical Protocol for a Double-Blind, Placebo-Controlled, Randomized Dose-Ranging Study of Celecoxib (SC-58635) on the Acute Effect of Human UV-Irradiation|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||5|||f||||||||||||||2017-10-11 00:37:16.376247|2017-10-11 00:37:16.376247
NCT02099123|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-08-18|||July 2015||2015-07-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|STAREE||A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)|A Study of STAtins for Reducing Events in the Elderly (STAREE)|Enrolling by invitation||Phase 4|18000|Anticipated|Monash University||2|||f||||t||||||||||2017-10-11 00:37:16.524577|2017-10-11 00:37:16.524577
NCT02099097|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-02-27|||March 2014|Actual|2014-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization|Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization|Active, not recruiting||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:37:16.79533|2017-10-11 00:37:16.79533
NCT02099084|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-01-25|2016-01-25||January 2014||2014-01-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Short Bowel Syndrome and Teduglutide Versus Placebo|Acute Effects of a Glucagon-like Peptide 2 Analog, Teduglutide, on Gastrointestinal Motor Function and Permeability in Patients With Short Bowel Syndrome on Home Parenteral Nutrition|Completed||Phase 4|8|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 00:37:16.890879|2017-10-11 00:37:16.890879
NCT02099071|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-08-11|||November 2011||2011-11-01|August 2017|2017-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949|Single-center, Double-blind, Randomized, Placebo-controlled, Single-ascending Dose and Food Interaction Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Male Subjects|Completed||Phase 1|65|Actual|Actelion||8|||f||||f||||||||||2017-10-11 00:37:17.305486|2017-10-11 00:37:17.305486
NCT02099058|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2017-08-01|||April 9, 2014||2014-04-09|August 2017|2017-08-01|January 29, 2021|Anticipated|2021-01-29|July 29, 2019|Anticipated|2019-07-29||Interventional|||A Phase 1/1b Study With ABBV-399, an Antibody Drug Conjugate, in Subjects With Advanced Solid Cancer Tumors|A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABBV-399, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|292|Anticipated|AbbVie||6|||f||||f||||||||||2017-10-11 00:37:17.497538|2017-10-11 00:37:17.497538
NCT02099045|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-26|2015-01-13|||April 2014||2014-04-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|November 2015|Anticipated|2015-11-01||Observational|||Initial Patient Evaluation in the Emergency Department With Point-of-Care Ultrasonography|Initial Patient Evaluation in the Emergency Department With Point-of-Care Ultrasonography|Unknown status|Recruiting|N/A|406|Anticipated|Aarhus University Hospital|||1||f||||||||||||||2017-10-11 00:37:17.722126|2017-10-11 00:37:17.722126
NCT02099032|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-09-20|||March 2014||2014-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|VALOBAB-C||Milk Polar Lipids Consumption, Lipid Metabolism, and Inflammation in Menopausal Women|Influence of Milk Polar Lipids Intake on Lipid Metabolism, Body Composition, Inflammation and Intestinal Microbiota in Menopausal Women|Completed||N/A|59|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-11 00:37:17.823887|2017-10-11 00:37:17.823887
NCT02099019|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-01-07|||March 2014||2014-03-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Usefulness of Coronary Computed Tomography Angiography for Therapeutic Decision- Making; Revascularization||Unknown status|Recruiting|N/A|3000|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:37:17.921046|2017-10-11 00:37:17.921046
NCT02099006|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-07-14|2016-07-14||November 2013||2013-11-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Topicals||Novel Topical Therapies for the Treatment of Genital Pain|Novel Topical Therapies for the Treatment of Genital Pain|Completed||Phase 2/Phase 3|9|Actual|University of Rochester|The small number of patients recruited left this study underpowered to uncover significant effects with the medications studied.|2|||f||||f||||||||||2017-10-11 00:37:18.000818|2017-10-11 00:37:18.000818
NCT02098993|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-05-30|||May 2014||2014-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome|Unfractionated Heparin in Acute Chest Syndrome: A Pilot Feasibility Randomized Controlled Trial of Unfractionated Heparin vs. Standard of Care in Acute Chest Syndrome|Recruiting||Phase 2|20|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 00:37:18.397916|2017-10-11 00:37:18.397916
NCT02098980|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-02-03|||May 2014||2014-05-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nutritional Intervention of Type II Diabetes Mellitus by Vitamin D in Qatar|Nutritional Intervention of Type II Diabetes Mellitus by Vitamin D in Qatar|Recruiting||N/A|200|Anticipated|Supreme Council Of Health, Qatar||2|||f||||f||||||||||2017-10-11 00:37:18.539218|2017-10-11 00:37:18.539218
NCT02098954|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-02-14|||July 2014||2014-07-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers|Second Line Erlitinib Combination With Gemcitabine Cisplatinum in Non-small Cell Lung Cancer Patients Who Harbored EGFR Sensitive Mutation Developed Resistance After First Line TKI Treatment|Recruiting||Phase 2|40|Anticipated|Hunan Province Tumor Hospital||1|||f||||f||||||||||2017-10-11 00:37:20.690213|2017-10-11 00:37:20.690213
NCT02098941|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-25|||March 2014||2014-03-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Observational|||Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment|A Retrospective Study to Evaluate Retention Rate of Topiramate With That of Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment|Unknown status|Recruiting|N/A|2500|Anticipated|Seoul National University Hospital|||3||f||||f||||||||||2017-10-11 00:37:20.777363|2017-10-11 00:37:20.777363
NCT02098928|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-10-31|||April 2014||2014-04-01|March 2014|2014-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparison Between Hand-acupuncture and Electro-acupuncture Stimulation in the Treatment of Menopause|Multicenter Randomized Controlled Trial on Comparison of Efficacy Between Hand Acupuncture and Electro-acupuncture in Treatment of Menopausal Hot Flashes Symptoms|Completed||N/A|242|Actual|The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 00:37:20.883344|2017-10-11 00:37:20.883344
NCT02098915|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-01-18|||March 2014||2014-03-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Metoclopramide Pilot Trial|The Use of Metoclopramide vs. Placebo in Infants With Gastroschisis. A Pilot Double Blind Randomized Controlled Trial|Recruiting||Phase 3|30|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 00:37:20.968736|2017-10-11 00:37:20.968736
NCT02098902|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-05-28|||May 2014||2014-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Trial of a Sugar-Sweetened Beverage Intervention in Overweight Mothers and Their Children Ages 3-5|Randomized Controlled Trial of a Sugar-Sweetened Beverage Intervention in Overweight Mothers and Their Children Ages 3-5|Completed||N/A|51|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:37:21.08828|2017-10-11 00:37:21.08828
NCT02098889|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-27|||May 2012||2012-05-01|May 2012|2012-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|HBB||Safety Study of Hyoscine N Butyl Bromide in Active Management of Labor|Efficacy and Safety of Hyoscine N Butyl Bromide on the Augmentation of Labor: a Double-Blind, Placebo - Controlled Trial|Completed||Phase 4|382|Actual|Sisli Etfal Training & Research Hospital||2|||f||||f||||||||||2017-10-11 00:37:21.182059|2017-10-11 00:37:21.182059
NCT02098876|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-08-03|||May 2014||2014-05-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|SHEAR-STENT||Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels|Evaluation of WSS and Neointimal Healing Following Percutaneous Coronary Intervention of Angulated Vessels With Resolute® Integrity Zotarolimus Eluting Coronary Stent Compared to XIENCE Xpedition® Everolimus Eluting Coronary Stent|Recruiting||N/A|126|Anticipated|Emory University||2|||f||||f|f|t|f|f||||||2017-10-11 00:37:21.276144|2017-10-11 00:37:21.276144
NCT02098863|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-04-26|||April 15, 2014|Actual|2014-04-15|April 2017|2017-04-01|December 31, 2044|Anticipated|2044-12-31|December 31, 2044|Anticipated|2044-12-31|30 Years|Observational [Patient Registry]|||Sickle Cell Clinical Research and Intervention Program|Sickle Cell Clinical Research and Intervention Program|Recruiting||N/A|1300|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     All participants will be offered the option of having biological specimens collected and     saved for future research. DNA, plasma, and urine will be collected from participants and     stored at Tissue Resources at St. Jude Children's Research Hospital. This will facilitate     future high quality genotype-phenotype studies and other genetic and proteomic studies     related to variability in disease severity, treatment response, and health outcomes.   "|||2017-10-11 00:37:21.386008|2017-10-11 00:37:21.386008
NCT02098850|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-12-02|||January 2013||2013-01-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01|3 Months|Observational [Patient Registry]|ISAC||Staphylococcus Aureus Bacteraemia in Adults|A Prospective International Study of Staphylococcus Aureus Bacteraemia in Adults by the International Staphylococcus Aureus Collaboration|Unknown status|Recruiting|N/A|2000|Anticipated|University of Cologne|||1||f||||f||||||||||2017-10-11 00:37:21.704904|2017-10-11 00:37:21.704904
NCT02098837|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-07-26|||April 2014||2014-04-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)|An Open Label Study Examining the Efficacy and Cardiovascular Risk of Immediate Versus Deferred Switch From a Boosted PI to Dolutegravir (DTG) in HIV Infected Patients With Stable Virological Suppression|Active, not recruiting||Phase 4|415|Actual|St Stephens Aids Trust||2|||f||||t||||||||Undecided||2017-10-11 00:37:21.919582|2017-10-11 00:37:21.919582
NCT02098824|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-04-29|||February 2014||2014-02-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|STREAM-VCI||Symptomatic Treatment of Vascular Cognitive Impairment|Symptomatic Treatment of Vascular Cognitive Impairment|Recruiting||Phase 2/Phase 3|30|Anticipated|VU University Medical Center||3|||f||||t||||||||||2017-10-11 00:37:22.117675|2017-10-11 00:37:22.117675
NCT02098811|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-07-29|||June 2013||2013-06-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of the Safety and Efficacy of a Non-Invasive Disruption of Fat and Skin Tightening Using 1064nm and 940nm Wavelengths|Evaluation of the Safety and Efficacy of a Non-Invasive Disruption of Fat and Skin Tightening Using 1064nm and 940nm Wavelengths|Completed||N/A|10|Actual|Cynosure, Inc.||2|||f||||f||||||||||2017-10-11 00:37:22.250169|2017-10-11 00:37:22.250169
NCT02098798|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-08-16|||March 2014||2014-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Observational|||Comparison of Surveillance Colonoscopy Techniques in Patients With IBD||Completed||N/A|270|Actual|University of Calgary|||3||f||||f||||||||||2017-10-11 00:37:22.350664|2017-10-11 00:37:22.350664
NCT02098785|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-05-02|||March 2018|Anticipated|2018-03-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|NOCTUA||Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study|Phase I Clinical Trial Investigating the Effects of Caffeine Citrate on Serum Vascular Adhesion Protein -1 (VAP-1) Levels in Healthy Volunteers.|Not yet recruiting||Phase 1|63|Anticipated|University of Birmingham||1|||f||||f|f|f|||f|||Undecided||2017-10-11 00:37:22.438749|2017-10-11 00:37:22.438749
NCT02098772|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-08-28|||May 2014||2014-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|Custodiol-AV||Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol|A Prospective Randomized Double Blind Multicenter Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol|Recruiting||Phase 3|437|Anticipated|Dr. F. Köhler Chemie GmbH||2|||f||||f||||||||||2017-10-11 00:37:22.590261|2017-10-11 00:37:22.590261
NCT02098759|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-04-03|||November 2013||2013-11-01|April 2014|2014-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|EPISTOP||Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex|Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex|Recruiting||N/A|100|Anticipated|Children's Memorial Health Institute, Poland||2|||f||||t||||||||||2017-10-11 00:37:22.73668|2017-10-11 00:37:22.73668
NCT02098746|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-08-31|2016-01-11||June 2011||2011-06-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational||Baseline measures are based on the Safety Analysis Set (safety assessment population) that included all patients who received at least one dose of pioglitazone/glimepiride.|Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone|Sonias Combination Tablets LD Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone|Completed||N/A|294|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:37:22.89423|2017-10-11 00:37:22.89423
NCT02098733|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-03-16|2015-12-16||June 2011||2011-06-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||All enrolled participants with available data.|Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus|Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey on Long-term Use for in Type 2 Diabetes Mellitus|Completed||N/A|1168|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:37:23.548059|2017-10-11 00:37:23.548059
NCT02098720|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-07-21|||December 2011||2011-12-01|July 2014|2014-07-01||||March 2014|Actual|2014-03-01||Interventional|LAMP||An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)|An Open, Non-randomize, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.||1|||f||||f||||||||||2017-10-11 00:37:24.455803|2017-10-11 00:37:24.455803
NCT02098707|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-03-24|||June 2013||2013-06-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|SPPD002||Effects of a Rehabilitation Treatment on Balance in PD Evaluated With a Stabilometric Platform|Effects of a Multidisciplinary Intensive Rehabilitation Treatment (MIRT) on Balance in Patients With Parkinson's Disease Evaluated With a Stabilometric Platform|Unknown status|Recruiting|N/A|30|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini|||1||f||||t||||||||||2017-10-11 00:37:24.563048|2017-10-11 00:37:24.563048
NCT02098694|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-09-18|||June 2014|Actual|2014-06-01|September 2017|2017-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis|Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis|Completed||N/A|62|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 00:37:24.658143|2017-10-11 00:37:24.658143
NCT02098681|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-06-23|||January 2014||2014-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2015|Actual|2015-10-01|3 Months|Observational [Patient Registry]|||SPAIN Chest Wall Deformity Project (Pectus Repair)|Society for Pediatric Anesthesia Improvement Network (SPAIN) Chest Wall Deformity Project (Pectus Repair)|Active, not recruiting||N/A|350|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-11 00:37:24.757515|2017-10-11 00:37:24.757515
NCT02098668|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-09-06|||September 2013||2013-09-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Observational|PAEON||Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON|Model Driven Computation for Infertility Related Endocrinological Diseases - PAEON|Completed||N/A|123|Actual|University of Zurich|||1||f||||t||||||Samples Without DNA|"     Probes to determine hormonal parameters   "|Undecided||2017-10-11 00:37:24.860482|2017-10-11 00:37:24.860482
NCT02098655|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-03-27|||June 2013||2013-06-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|SPPD001||Analysis of the Parameters Obtained on Stabilometric Platform in Patients With PD|Analysis of the Parameters Obtained on Stabilometric Platform in Patients With Parkinson's Disease: a Basis for a Rehabilitation Perspective|Unknown status|Recruiting|N/A|42|Anticipated|Ospedale Generale Di Zona Moriggia-Pelascini|||2||f||||t||||||||||2017-10-11 00:37:24.988119|2017-10-11 00:37:24.988119
NCT02098642|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-03-24|||March 2013||2013-03-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Observational|HalluxPD001||Hallux Mobilization in Patients With Parkinson's Disease|Passive Mobilization of the Metatarsophalangeal Joint of the Hallux During a Rehabilitation Treatment in Patients With Parkinson's Disease|Completed||N/A|100|Actual|Ospedale Generale Di Zona Moriggia-Pelascini|||2||f||||t||||||||||2017-10-11 00:37:25.09715|2017-10-11 00:37:25.09715
NCT02098616|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-04-15|||July 2014||2014-07-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|RHACE 1||Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus|RHACE 1: Rapid HepAtitis C Elimination Trial - A Pilot Evaluation of Twice Daily Fixed Dose Combination Asunaprevir +Daclatasvir + BMS-791325 ± Weight Based Ribavirin in Treatment-Naïve, Non-cirrhotic Patients With Chronic Genotype 1a Hepatitis-C for Eight, Six or Four Weeks|Completed||N/A|25|Actual|Southern California Institute for Research and Education||6|||f||||f||||||||||2017-10-11 00:37:25.388342|2017-10-11 00:37:25.388342
NCT02098603|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-10-28|||January 2013||2013-01-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|DOC HEALTH||Health Protection & Promotion for Oregon Correctional Officers|Health Protection & Promotion for Oregon Correctional Officers|Completed||N/A|86|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 00:37:25.554167|2017-10-11 00:37:25.554167
NCT02098590|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-02-22|||October 2014||2014-10-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|BMGF2b||Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection|Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection|Completed||N/A|40|Actual|Radboud University||6|||f||||f||||||||||2017-10-11 00:37:25.684365|2017-10-11 00:37:25.684365
NCT02098577|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2014-03-27|||June 2013||2013-06-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|PDvsCOPD||Crossover Versus Stabilometric Platform in Parkinson's Disease|Effect of Two Different Rehabilitation Programs on Balance in Parkinsonian Patients: Crossover Versus Stabilometric Platform|Completed||N/A|60|Actual|Ospedale Generale Di Zona Moriggia-Pelascini|||2||f||||t||||||||||2017-10-11 00:37:25.855188|2017-10-11 00:37:25.855188
NCT02098564|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-04-04|||February 2014||2014-02-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||The Effect of Activity-based Training in Patients With Hand-related Injuries Grouped Using Sense of Coherence Scores|The Effect of Activity-based Training in Patients With Hand-related Injuries Grouped Using Sense of Coherence Scores|Recruiting||N/A|420|Anticipated|Odense University Hospital||6|||f||||f||||||||||2017-10-11 00:37:25.983337|2017-10-11 00:37:25.983337
NCT02098551|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2015-12-06|||February 2011||2011-02-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|November 2011|Actual|2011-11-01||Observational|||Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments|Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments to Dissect the Contribution of IgE to Chronic Allergic Skin Inflammation|Completed||N/A|30|Actual|Medical University of Vienna|||1||f||||t||||||||||2017-10-11 00:37:26.13083|2017-10-11 00:37:26.13083
NCT02098538|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-04-18|||March 2014|Actual|2014-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma|A Phase II Study of Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma|Active, not recruiting||Phase 2|38|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:37:26.215641|2017-10-11 00:37:26.215641
NCT02098525|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-27|||November 2013||2013-11-01|March 2014|2014-03-01||||December 2013|Actual|2013-12-01||Observational|||Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy|Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy|Completed||N/A|195|Actual|Mahidol University|||1||f||||f||||||||||2017-10-11 00:37:26.304354|2017-10-11 00:37:26.304354
NCT02097979|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-24|||July 2007||2007-07-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Impact of a Brief Educational Intervention on Glaucoma Adherence|The Impact of a Brief Educational Intervention on Glaucoma Adherence|Completed||N/A|||Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-11 00:37:33.951598|2017-10-11 00:37:33.951598
NCT02098512|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-07-29|||March 2014||2014-03-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients|A Multicenter Pilot Study of Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Targeted Immunotherapy in Children, Adolescents and Young Adults With Poor Risk CD30+ Hodgkin Lymphoma (HL)|Recruiting||Phase 1/Phase 2|20|Anticipated|New York Medical College||1|||f||||t||||||||||2017-10-11 00:37:26.397225|2017-10-11 00:37:26.397225
NCT02098499|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-27|||June 2013||2013-06-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial|Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial|Completed||Phase 4|68|Actual|United States Naval Medical Center, Portsmouth||2|||f||||t||||||||||2017-10-11 00:37:26.622125|2017-10-11 00:37:26.622125
NCT02098486|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2016-02-22|||March 2014||2014-03-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP|Antibiotic Prophylaxis for ERCP: a Comparison of Intravenous Ceftriaxone With Intravenous Moxifloxacin in the Prophylaxis of Cholangitis|Completed||Phase 2|86|Actual|Kangbuk Samsung Hospital||2|||f||||f||||||||No||2017-10-11 00:37:26.733844|2017-10-11 00:37:26.733844
NCT02098473|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-05-08||2016-11-10|August 31, 2014|Actual|2014-08-31|May 2017|2017-05-01|January 30, 2017|Actual|2017-01-30|February 17, 2016|Actual|2016-02-17||Interventional|||Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis|A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis|Completed||Phase 2|100|Actual|Celgene||3|||f||||||||||||||2017-10-11 00:37:26.833364|2017-10-11 00:37:26.833364
NCT02098460|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-03-27|||October 2013||2013-10-01|March 2014|2014-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject||Unknown status|Recruiting|Phase 4|250|Anticipated|Otsuka Beijing Research Institute||3|||f||||f||||||||||2017-10-11 00:37:26.988275|2017-10-11 00:37:26.988275
NCT02098447|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-03-30|||February 2014||2014-02-01|March 2017|2017-03-01|April 13, 2015|Actual|2015-04-13|April 13, 2015|Actual|2015-04-13||Interventional|||Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds|Evaluation of Electrical Auricular Vagal Nerve Stimulation Effects on Parameters of Wound Healing in Chronic Diabetic Wounds - Pilot Study|Completed||N/A|24|Actual|Medical University of Vienna||1|||f||||||||||||||2017-10-11 00:37:27.079202|2017-10-11 00:37:27.079202
NCT02098434|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2014-11-05|||October 2010||2010-10-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Ovarian Hormones and Stress Induced Drug Craving|Implication of Ovarian Hormones in the Neural Correlates of Stress Induced Drug Craving|Completed||N/A|29|Actual|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 00:37:27.193865|2017-10-11 00:37:27.193865
NCT02098421|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-06-09|||November 2014||2014-11-01|June 2017|2017-06-01|April 18, 2016|Actual|2016-04-18|April 18, 2016|Actual|2016-04-18||Interventional|||Foley Labor Induction Trial at Term and in PROM|A Randomized Trial of Foley Bulb Induction With and Without Simultaneous Use of Oxytocin|Completed||Phase 1|312|Actual|Icahn School of Medicine at Mount Sinai||4|||f||||f|t|f||||||||2017-10-11 00:37:27.28691|2017-10-11 00:37:27.28691
NCT02098408|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-03-17|||March 2014||2014-03-01|March 2016|2016-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|FOCUS||Effects of Neurocognitive and Social Cognitive Remediation in Patients at Ultra-High Risk of Psychosis|A Randomised Clinical Trial Examining Cognitive Remediation Plus Standard Treatment Versus Standard Treatment in Participants at Ultra-High Risk of Psychosis. - Effect on Cognitive Functioning, Functional Outcome and Symptomatology.|Recruiting||N/A|126|Anticipated|Mental Health Services in the Capital Region, Denmark||2|||f||||t||||||||||2017-10-11 00:37:27.380951|2017-10-11 00:37:27.380951
NCT02098395|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-12-15|2016-04-26||May 2014||2014-05-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ADJUNCT TWO™|Baseline (BL) characteristics were presented for full analysis set (FAS = 831 subjects). Out of 835 randomised subjects, 4 were excluded from FAS:1 subject each in the lira 1.8 mg, 0.6 mg and placebo arm were not exposed to trial treatment and 1 subject in the lira 1.8 mg arm had no post-BL measurements.|The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes|A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial|Completed||Phase 3|835|Actual|Novo Nordisk A/S||6|||f||||f||||||||||2017-10-11 00:37:27.541534|2017-10-11 00:37:27.541534
NCT02098382|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-07-28|||May 2013||2013-05-01|March 2014|2014-03-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Observational|||Dilapan-S Osmotic Dilator in Pre-induction of Labor|Prospective Collection of Data About the Use of the Dilapan-S Osmotic Dilator in Pre-induction of Labor in Women With/Without Caesarean Section in Their History|Completed||N/A|125|Actual|Medicem International CR s.r.o.|||1||f||||t||||||||||2017-10-11 00:37:28.897579|2017-10-11 00:37:28.897579
NCT02098356|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-07-11|||March 2014||2014-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of High Versus Low Bicarbonate Hemodialysis|Intradialytic Acid-base Changes and Organic Anion Production With High Versus Low Bicarbonate Hemodialysis|Active, not recruiting||Phase 1|20|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||f||||||||||2017-10-11 00:37:29.093055|2017-10-11 00:37:29.093055
NCT02097784|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-04-04|||March 2014||2014-03-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury|Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury|Recruiting||N/A|75|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:37:38.261749|2017-10-11 00:37:38.261749
NCT02098330|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-01-26|||March 2014||2014-03-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||The Efficacy of Steroid Therapy in Vestibular Neuritis|The Efficacy of Steroid Therapy in Vestibular Neuritis Confirmed by Head Impulse Test: Prospective Randomized Controlled Study|Unknown status|Active, not recruiting|Phase 3|60|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 00:37:29.354759|2017-10-11 00:37:29.354759
NCT02098317|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-01-13|||January 2014||2014-01-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|VitD_DHA||DHA and Vitamin D in Children With Biopsy-proven NAFLD|Efficacy and Tolerability of Vitamin D and Docosahexaenoic Acid (DHA) in Children With Biopsy Proven NAFLD|Completed||Phase 3|66|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||||||||||||2017-10-11 00:37:29.455928|2017-10-11 00:37:29.455928
NCT02098304|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-08-23|2016-02-09||May 2014||2014-05-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Eligible patients were recruited who had at least one unrestored molar identified as sound AND at least one unrestored erupting or erupted third molar coded ICDAS 1,2 or 3.|Post-Approval Clinical Study to Evaluate the Calcivis Caries Activity Imaging System|Post-Approval Clinical Study to Evaluate the Safety and Performance of the Calcivis Caries Activity Imaging System in a Clinical Setting|Completed||N/A|42|Actual|Calcivis Ltd|All 42 patients recruited to the study are included in the Safety Population, however only 31 patients were included in the Agreement Population as one or more of the images from the Calcivis System were deemed ineligible by independent review.|1|||f||||f||||||||Yes|Final Clinical Study Report issued|2017-10-11 00:37:29.693599|2017-10-11 00:37:29.693599
NCT02098291|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-26|||April 1999||1999-04-01|March 2014|2014-03-01|February 2002|Actual|2002-02-01|July 2001|Actual|2001-07-01||Interventional|PC1||An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma|Phase II, Open, Single-center Study to Determine the Antibody Response to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma|Completed||Phase 2|34|Actual|Cancer Advances Inc.||1|||f||||||||||||||2017-10-11 00:37:30.251276|2017-10-11 00:37:30.251276
NCT02098278|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-07-19||2016-07-19|March 2014||2014-03-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia|A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Chylomicronemia|Completed||Phase 2|13|Actual|Catabasis Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:37:30.351228|2017-10-11 00:37:30.351228
NCT02098265|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-08-18|||June 2010||2010-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device|A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device|Recruiting||N/A|49|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 00:37:30.482242|2017-10-11 00:37:30.482242
NCT02098252|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-11-17|||May 2014||2014-05-01|November 2016|2016-11-01||||January 2035|Anticipated|2035-01-01||Interventional|TOBAS||Treatment of Brain AVMs (TOBAS) Study|Treatment of Brain AVMs (TOBAS) Study: A Randomized Controlled Trial and Registry|Recruiting||N/A|1000|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 00:37:30.615733|2017-10-11 00:37:30.615733
NCT02098239|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2014-03-25|||August 1999||1999-08-01|March 2014|2014-03-01|May 2002||2002-05-01|April 2002|Actual|2002-04-01||Interventional|||Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.|An Open, Multiple Dose, Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.|Completed||Phase 2|41|Actual|Cancer Advances Inc.||2|||||||||||||||||2017-10-11 00:37:30.834268|2017-10-11 00:37:30.834268
NCT02098226|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-02-05|||September 2013||2013-09-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|September 2014|Actual|2014-09-01||Observational|||Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts|Method Comparison Protocol: MALDI Biotyper-Clinical Applications (MBT-CA) Phase 2|Unknown status|Recruiting|N/A|3000|Anticipated|Bruker Daltonics|||1||f||||||||||||||2017-10-11 00:37:30.94466|2017-10-11 00:37:30.94466
NCT02098213|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-02-24|||January 2015|Actual|2015-01-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis|Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis, a Randomized, Controlled, Open Multicenter Study|Recruiting||Phase 3|260|Anticipated|Association Francaise pour la Recherche Thermale||2|||f||||f||||||||||2017-10-11 00:37:31.016575|2017-10-11 00:37:31.016575
NCT02098200|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-07-28|||June 2013||2013-06-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|November 2016|Actual|2016-11-01||Interventional|PREVENT||Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™|Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™|Active, not recruiting||Phase 1|24|Anticipated|4Tech Cardio Ltd.||1|||f||||t||||||||||2017-10-11 00:37:31.208483|2017-10-11 00:37:31.208483
NCT02098187|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-09-23|||March 2014||2014-03-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ORFM-1B||Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers|Pilot 1B Study-Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers|Completed||Phase 1|16|Actual|MediBeacon||4|||f||||t||||||||No||2017-10-11 00:37:31.339576|2017-10-11 00:37:31.339576
NCT02098174|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-09-21|||November 2013||2013-11-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Pilot 1A||Pharmacokinetics of MP-3180 in Healthy Volunteers|Pharmacokinetics of MP-3180 in Healthy Volunteers|Completed||Phase 1|16|Actual|MediBeacon||1|||f||||t||||||||No||2017-10-11 00:37:31.445229|2017-10-11 00:37:31.445229
NCT02097771|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-11-18|||November 2014||2014-11-01|November 2014|2014-11-01||||July 2015|Anticipated|2015-07-01||Interventional|||Gastric Insufflation and Laryngeal Mask Airway||Unknown status|Recruiting|N/A|||Hôpital Edouard Herriot||2|||f||||||||||||||2017-10-11 00:37:38.351993|2017-10-11 00:37:38.351993
NCT02098161|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-12-05|||December 2014||2014-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Phase 2 LCL-161 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF) or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)|Open Label Phase 2 Single Agent Study of LCL-161 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)|Recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:37:31.53889|2017-10-11 00:37:31.53889
NCT02098148|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-03-24|||November 2013||2013-11-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Trial of Low-Dose Xenon For The Treatment Of Obsessive-Compulsive Disorder|A RANDOMIZED PLACEBO-CONTROLLED CROSSOVER TRIAL OF LOW-DOSE XENON FOR THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER|Withdrawn||Phase 2|0|Actual|Mclean Hospital||2||Withdrawn. Unable to set up appropriate infrastructure to support study.|f||||f||||||||||2017-10-11 00:37:31.654311|2017-10-11 00:37:31.654311
NCT02098135|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-09-14|||November 2013||2013-11-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional|||ArmeoSenso - Home Therapy and Assessment for Patients With Arm Impairments Based on Wearable Movement Sensors|Phase 1 Study of a Home Therapy and Assessment for Patients With Arm Impairments|Completed||N/A|14|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 00:37:31.738422|2017-10-11 00:37:31.738422
NCT02098122|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-05-22|||March 2013||2013-03-01|May 2017|2017-05-01|March 2020|Anticipated|2020-03-01|February 2018|Anticipated|2018-02-01||Observational|||Upper Limb Activity in Human SCI Rehabilitation|Upper Limb Activity in Human SCI Rehabilitation|Recruiting||N/A|150|Anticipated|University of Zurich|||2||f||||||||||||||2017-10-11 00:37:31.87346|2017-10-11 00:37:31.87346
NCT02098109|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-07-17|2017-06-08||August 20, 2014|Actual|2014-08-20|July 2017|2017-07-01|September 18, 2016|Actual|2016-09-18|June 10, 2016|Actual|2016-06-10||Interventional|||Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma|A Randomized, Open Label, Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) When Administered in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma|Completed||Phase 2|100|Actual|Washington University School of Medicine||2|||f||||t|t|f||||||||2017-10-11 00:37:32.036011|2017-10-11 00:37:32.036011
NCT02098096|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-11-27|||March 2014||2014-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PTOA-ECC||Negative Work Exercise for the Treatment of Knee Arthritis|Development of a Negative Work Exercise Regimen as an Intervention for Posttraumatic Osteoarthritis of the Knee|Recruiting||N/A|54|Anticipated|Washington D.C. Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-11 00:37:32.879117|2017-10-11 00:37:32.879117
NCT02098083|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-07-29|||November 2013||2013-11-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|PBE||Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes|Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke|Withdrawn||N/A|0|Actual|University of Texas Southwestern Medical Center|||1|Unable to collect data|f||||f||||||||||2017-10-11 00:37:32.99682|2017-10-11 00:37:32.99682
NCT02098070|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-08-23|||September 2014||2014-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Knee Pain Phenotypes in the Community Study|Knee Pain and Related Health in the Community Study|Enrolling by invitation||N/A|40000|Anticipated|University of Nottingham|||2||f||||t||||||Samples With DNA|"     Whole Blood Urine   "|||2017-10-11 00:37:33.080584|2017-10-11 00:37:33.080584
NCT02098057|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-09-30|||April 2014||2014-04-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Change in Permeability of the Small Intestine After Treatment With Gluten|A Pilot Study Barrier Function, Intestinal Permeability and Tight Junction Expression in Gluten Sensitive Patients With Functional Gastrointestinal Disorders|Recruiting||N/A|36|Anticipated|Mayo Clinic||2|||f||||t||||||||No|There is no plan to share Individual Patient Data at this time. Once data analysis is done at study conclusion, it will help determine feasibility for moving forward with another, similar - possibly larger, study. That said, data may be released after study conclusion.|2017-10-11 00:37:33.15777|2017-10-11 00:37:33.15777
NCT02098044|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-02-21|||November 2014||2014-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|January 2016|Actual|2016-01-01||Observational|||Knee Osteoarthritis Risk in Retired Professional Footballers|An Investigation of the Prevalence of Knee Osteoarthritis and Pain in Retired Professional Male Footballers in the United Kingdom|Enrolling by invitation||N/A|1300|Actual|University of Nottingham|||2||f||||t||||||||||2017-10-11 00:37:33.265204|2017-10-11 00:37:33.265204
NCT02098031|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-08-19|||March 2014||2014-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Improving the Nutrition Status of Infants in South-Western Uganda|Improving the Nutrition Status of 6 to 8 Months Old Children Through Diet Diversification and Better Dietary Intakes in the Kabale and Kisoro Districts in South-Western Uganda|Completed||N/A|511|Actual|University of Oslo||2|||f||||f||||||||||2017-10-11 00:37:33.339451|2017-10-11 00:37:33.339451
NCT02098018|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-08-01|||April 2015||2015-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of Stress Reduction Techniques||Completed||N/A|100|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:37:33.419535|2017-10-11 00:37:33.419535
NCT02098005|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-05-03|||January 2014||2014-01-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Pain Neuroscience Education Combined With Cognition-targeted Motor Control Training|A Modern Neuroscience Approach to Chronic Spinal Pain: Pain Neuroscience Education Combined With Cognition-targeted Motor Control Training|Completed||N/A|120|Actual|University Ghent||2|||f||||f||||||||||2017-10-11 00:37:33.491793|2017-10-11 00:37:33.491793
NCT02097992|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-07-20|2017-03-09||February 2013|Actual|2013-02-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||11|Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD|Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD|Completed||Phase 1/Phase 2|11|Actual|University of Miami|The number of patients enrolled was lower than expected.|4|||f||||t||||||||||2017-10-11 00:37:33.595662|2017-10-11 00:37:33.595662
NCT02097966|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-01-26||||||November 2015|2015-11-01||||||||Expanded Access|||EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C|A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C|No longer available||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 00:37:34.233518|2017-10-11 00:37:34.233518
NCT02097953|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-12-09|||May 2014||2014-05-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|June 2015|Actual|2015-06-01||Interventional|||Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin|Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin|Completed||Early Phase 1|12|Actual|University of Utah||1|||f||||t||||||||||2017-10-11 00:37:34.868494|2017-10-11 00:37:34.868494
NCT02097940|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-26|||March 2014||2014-03-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Influence of Sensorimotor Treatment in the Balance of Soccer|Influence of Sensorimotor Treatment in the Balance of Soccer|Completed||N/A|20|Actual|Universidade Estadual de Londrina||2|||f||||t||||||||||2017-10-11 00:37:35.008857|2017-10-11 00:37:35.008857
NCT02097927|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-08-06|||March 2014||2014-03-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Sensory-enhanced Beverages on Satiety Following Repeated Exposures|The Effect of Sensory-enhanced Beverages on Satiety Following Repeated Exposures|Completed||N/A|36|Actual|Leatherhead Food Research||3|||f||||f||||||||||2017-10-11 00:37:35.114272|2017-10-11 00:37:35.114272
NCT02097914|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-03-11|||March 2014||2014-03-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|January 2015|Actual|2015-01-01||Interventional|SFH||Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households: Texas Effectiveness Trial|Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households: Texas Effectiveness Trial|Completed||N/A|508|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 00:37:35.229692|2017-10-11 00:37:35.229692
NCT02097901|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-01-27|||March 2014||2014-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Microfracture in Rotator Cuff Injury Repair|Microfracture in Rotator Cuff Injury Repair|Suspended||N/A|100|Anticipated|Zealand University Hospital||2||Insufficient patient material|f||||t||||||||||2017-10-11 00:37:35.329728|2017-10-11 00:37:35.329728
NCT02097888|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-24|||December 2011||2011-12-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Influence of Erythropoietin on Bone Marrow Microenvironment|Influence of Erythropoietin on Bone Marrow Microenvironment: A Pilot Study|Unknown status|Recruiting|N/A|120|Anticipated|Kantonsspital Baselland Bruderholz|||1||f||||f||||||Samples Without DNA|"     Samples Without DNA - samples retained, with no potential for DNA extraction from any     retained samples (e.g., fixed tissue, plasma)   "|||2017-10-11 00:37:35.435198|2017-10-11 00:37:35.435198
NCT02097875|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-04-20|||December 2013||2013-12-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety Study of a Fluorescent Marker to Visualize Cancer Cells|A Phase 1 Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Skin Cancer|Completed||Phase 1|21|Actual|Blaze Bioscience Australia Pty Ltd||1|||f||||f||||||||||2017-10-11 00:37:35.522195|2017-10-11 00:37:35.522195
NCT02097862|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-03-15|||March 2014||2014-03-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Adipose Cells for Degenerative Disc Disease|An Open Label, Non-Randomized, Multi-Center Study To Assess The Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intra-Discally in Patients With Degenerative Disc Disease|Completed||N/A|15|Actual|Bioheart, Inc.||1|||f||||t||||||||||2017-10-11 00:37:35.640598|2017-10-11 00:37:35.640598
NCT02097849|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-05-01|2017-05-01||February 28, 2015|Actual|2015-02-28|April 2017|2017-04-01|May 2, 2016|Actual|2016-05-02|May 2, 2016|Actual|2016-05-02||Interventional|||Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.|An Open-Label Study to Assess the Immune Response to Vaccination in Tecfidera® (BG00012)-Treated Versus Interferon-Treated Subjects With Relapsing Forms of Multiple Sclerosis.|Completed||Phase 2|71|Actual|Biogen||2|||f||||f||||||||||2017-10-11 00:37:35.750185|2017-10-11 00:37:35.750185
NCT02097836|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-09-12|||September 2007||2007-09-01|September 2017|2017-09-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Interventional|CP_TT||Targeted Training for Trunk Control_case Series Cerebral Palsy|Segmental Training for Trunk Control a Pilot Study for Children With Moderate to Severe Motor Impairment.|Completed||N/A|11|Actual|University of Oregon||1|||f||||t||||||||||2017-10-11 00:37:37.39994|2017-10-11 00:37:37.39994
NCT02097823|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-02-09|2016-05-16||February 2014||2014-02-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy|A Pilot Study Comparing Olanzapine and Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients Receiving Highly Emetogenic Chemotherapy|Completed||Phase 2|15|Actual|Indiana University|This trial was a pilot study, limited by numbers of participants. Given the small numbers, during randomization (with 50/50 chance each subject randomized to group A or B) a disproportionate number of patients were randomized to group A.|2|||f||||t||||||||||2017-10-11 00:37:37.505143|2017-10-11 00:37:37.505143
NCT02097810|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-09-13|||June 2014||2014-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|STARTRK-1||Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations.|A Phase 1, Multicenter, Open-Label Study of Oral Entrectinib (RXDX-101) in Adult Patients With Locally Advanced or Metastatic Cancer Confirmed to be Positive for NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations|Recruiting||Phase 1|125|Anticipated|Ignyta, Inc.||1|||f||||f||||||||||2017-10-11 00:37:38.048114|2017-10-11 00:37:38.048114
NCT02097797|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-08-04|||May 2014||2014-05-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|IMPACT-Crohn||Impact of the Fecal Flora Transplantation on Crohn's Disease|Impact of Fecal transPlantAtion on MiCrobotia and hosT in Crohn's Disease|Recruiting||N/A|24|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:37:38.158404|2017-10-11 00:37:38.158404
NCT02097758|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-01-23|||March 2014||2014-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ASD||Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect||Recruiting||N/A|100|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-11 00:37:38.437597|2017-10-11 00:37:38.437597
NCT02097745|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-09-14|2014-10-08||June 2004||2004-06-01|September 2016|2016-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Safety population: All participants who received any part of an infusion of study medication.|A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies|An Open Label Study of the Efficacy and Safety of Re-treatments With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNFa Therapies|Completed||Phase 3|341|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:37:38.574066|2017-10-11 00:37:38.574066
NCT02097732|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-03|||April 2014||2014-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery|Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery|Active, not recruiting||Phase 2|4|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 00:37:42.445576|2017-10-11 00:37:42.445576
NCT02097719|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2015-12-09|2015-12-09||May 2014||2014-05-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension||Completed||Phase 4|100|Actual|Allergan||2|||f||||f||||||||||2017-10-11 00:37:42.569386|2017-10-11 00:37:42.569386
NCT02097706|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2016-03-01|||January 2015||2015-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Novel Drug for Borderline Personality Disorder|A Randomised Double-blind Placebo Controlled Investigation of the Efficacy of a Novel Drug as an Adjunct in Patients With Borderline Personality Disorder|Recruiting||Phase 2|30|Anticipated|The Alfred||2|||f||||t||||||||No||2017-10-11 00:37:42.830673|2017-10-11 00:37:42.830673
NCT02097693|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-24|||February 2014||2014-02-01|March 2014|2014-03-01||||February 2017|Anticipated|2017-02-01||Observational|STIM-CP||Effect of DBS on Quality of Life in Dyskinetic Cerebral Palsy|Effect of Deep Brain Stimulation in the Globus Pallidus Internus on Quality of Life in Young Patients With Dyston-dyskinetic Cerebral Palsy|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital of Cologne|||1||f||||t||||||Samples With DNA|"     EDTA-plasma for DYT1-testing   "|||2017-10-11 00:37:42.935357|2017-10-11 00:37:42.935357
NCT02097680|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-06-02|||December 2013||2013-12-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|HEPAROB||Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men|Influence of the Aromatase Inhibitor Letrozole on Heart and Liver Function in Obese Men|Unknown status|Recruiting|Phase 4|30|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 00:37:43.036701|2017-10-11 00:37:43.036701
NCT02097667|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-10-26|||March 2014||2014-03-01|May 2015|2015-05-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Observational|EVERREST||EVERREST Developing a Therapy for Fetal Growth Restriction|EVERREST - Developing a Therapy for Fetal Growth Restriction. A 6 Year Prospective Study to Define the Clinical and Biological Characteristic of Pregnancies Affected by Severe Early Onset Fetal Growth Restriction.|Recruiting||N/A|300|Anticipated|University College, London|||1||f||||f||||||Samples With DNA|"     Plasma, serum, whole blood, fixed placenta, frozen placenta, fixed placenta bed.   "|||2017-10-11 00:37:43.132701|2017-10-11 00:37:43.132701
NCT02097654|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-03-28|||March 2014||2014-03-01|March 2014|2014-03-01||||March 2015|Anticipated|2015-03-01||Observational|SENATOR||Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons|Phase 1 of a Prospective, Multinational, Cluster‐Randomized, Open Label Parallel Arm Trial With Blinded Outcome Adjudication Quantifying the Efficacy of SENATOR in Reducing Adverse Drug Reactions in Older Hospitalized Subjects|Unknown status|Recruiting|N/A|1000|Anticipated|University College Cork|||1||f||||t||||||||||2017-10-11 00:37:43.227982|2017-10-11 00:37:43.227982
NCT02097641|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-05-02|||March 15, 2014|Actual|2014-03-15|May 2017|2017-05-01|February 9, 2018|Anticipated|2018-02-09|March 9, 2017|Actual|2017-03-09||Interventional|START||Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)|Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome|Active, not recruiting||Phase 2|60|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:37:43.325063|2017-10-11 00:37:43.325063
NCT02097628|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-26|||April 2014||2014-04-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|wang002||Comparison of Two Ventilation Modes With Laryngeal Mask Airway Guardian|Comparison of Volume- and Pressure- Controlled Ventilation With Laryngeal Mask Airway Guardian in Obese Patients Undergoing Laparoscopic Gynecologic Surgery—A Perspective, Randomized, Blind Trial|Unknown status|Not yet recruiting|N/A|40|Anticipated|Tianjin Medical University General Hospital||2|||f||||t||||||||||2017-10-11 00:37:43.426058|2017-10-11 00:37:43.426058
NCT02097615|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-08-18|||May 2014||2014-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water|Clinical Trial of the Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water in the Closure of Diabetic Foot Ulcer Syndrome.|Completed||Phase 4|24|Actual|Universidad de Guanajuato||2|||f||||t||||||||||2017-10-11 00:37:43.503946|2017-10-11 00:37:43.503946
NCT02097602|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-03-04|||February 2014||2014-02-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Observational|||Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery|Can Reticulated Platelets Predict the Outcome After Noncardiac Surgery?|Completed||N/A|1000|Actual|Technische Universität München|||1||f||||t||||||||||2017-10-11 00:37:43.580898|2017-10-11 00:37:43.580898
NCT02097589|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-09-25|||June 2014||2014-06-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|StatVax||The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23|The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23|Completed||Phase 1|33|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 00:37:43.662389|2017-10-11 00:37:43.662389
NCT02097576|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-07-17|||May 2014||2014-05-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Manuka Honey Nasal Rinse Study|Effectiveness of Manuka Honey/Saline Nasal Rinses as an Adjunct to Standard Medical Therapy for Chronic Rhinosinusitis: A Prospective Clinical Trial|Withdrawn||N/A|0|Actual|University of Florida||2||Funding withdrawn.|f||||f||||||||||2017-10-11 00:37:43.787391|2017-10-11 00:37:43.787391
NCT02097563|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-24|||June 2014||2014-06-01|March 2014|2014-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|FFT||Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic Disorders|Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic Disorders|Unknown status|Not yet recruiting|Phase 2|80|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:37:43.968444|2017-10-11 00:37:43.968444
NCT02097550|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-09-16|||May 2016||2016-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|CKD eHealth||Primary Care eHealth Intervention for Improved Outcomes in Chronic Kidney Disease|Primary Care eHealth Intervention for Improved Outcomes in Chronic Kidney Disease|Active, not recruiting||Phase 1|100|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:37:44.122432|2017-10-11 00:37:44.122432
NCT02097537|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-02-27|2016-12-20||February 2014||2014-02-01|February 2017|2017-02-01||||July 2014|Actual|2014-07-01||Interventional||Subjects who have inhaled the investigational drug at least once.|Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma|Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma|Completed||Phase 3|10|Actual|Santen Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 00:37:44.235677|2017-10-11 00:37:44.235677
NCT02097524|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-05-04|||March 2014||2014-03-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)||Completed||Phase 1|105|Actual|Regeneron Pharmaceuticals||4|||f||||t||||||||||2017-10-11 00:37:44.486138|2017-10-11 00:37:44.486138
NCT02097498|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-09-27|||August 2013||2013-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||Improving Patient Safety Through Simulation Research|Improving Patient Safety Through Simulation Research: Airway Management Proficiency Study|Completed||N/A|387|Actual|Ohio State University||3|||f||||f||||||||||2017-10-11 00:37:44.703246|2017-10-11 00:37:44.703246
NCT02097485|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-03-15||2016-03-15|May 2014||2014-05-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation|A Randomised, Double-Blind, Vehicle-Controlled Study of Ovicidal Efficacy and Safety of Abametapir 0.74% Administered for the Treatment of Head Lice Infestation|Completed||Phase 2|50|Actual|Hatchtech Pty Ltd||2|||f||||f||||||||||2017-10-11 00:37:44.798478|2017-10-11 00:37:44.798478
NCT02097472|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-01-07|||April 2014||2014-04-01|April 2015|2015-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers|A Dose-Finding Study to Assess the Safety, Tolerability, and Immunogenicity of Inactivated Streptococcus Pneumoniae Whole Cell Vaccine Formulated With Alum (PATH-wSP) in Healthy Kenyan Young Adults and PCV-Primed Toddlers|Completed||Phase 1/Phase 2|304|Actual|PATH||10|||f||||t||||||||||2017-10-11 00:37:44.890156|2017-10-11 00:37:44.890156
NCT02097459|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-05-24|||March 2014||2014-03-01|May 2016|2016-05-01||||March 2024|Anticipated|2024-03-01||Interventional|||Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer|Prognostic Evaluation of Changing Endocrine Therapy in Perimenopausal and Recently Postmenopausal Women With Early-stage Hormone Receptor-Positive Breast Cancer|Recruiting||Phase 3|600|Anticipated|Peking Union Medical College Hospital||3|||f||||t||||||||||2017-10-11 00:37:45.041899|2017-10-11 00:37:45.041899
NCT02097446|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-03-24||||||March 2014|2014-03-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|GUARDIX-FL||Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy|Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy : A Prospective, Randomized, Controlled Study|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Genewel Co., Ltd||2|||f||||t||||||||||2017-10-11 00:37:45.1706|2017-10-11 00:37:45.1706
NCT02097433|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-10-02|||July 2014||2014-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Dacomitinib (PF-00299804) Pharmacokinetics In Chinese Healthy Volunteers|A Phase 1 Open-label Study To Characterize The Pharmacokinetics Of A Single 45 Mg Oral Dose Of Dacomitinib (Pf-00299804) In Healthy Chinese Subjects|Completed||Phase 1|14|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:37:45.268606|2017-10-11 00:37:45.268606
NCT02097420|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-14|||July 2014||2014-07-01|July 2017|2017-07-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Interventional|||HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve|HALO Clinical Study: A Single Arm, Prospective, Non-randomized, Multi Center Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve|Active, not recruiting||N/A|20|Anticipated|St. Jude Medical||1|||f||||t||||||||||2017-10-11 00:37:45.369885|2017-10-11 00:37:45.369885
NCT02097407|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-24|||May 2012||2012-05-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PreopDXM||Preoperative Dexmedetomidine & EC50 of Propofol|Preoperative Dexmedetomidine Reduces the EC50 of Propofol for Successful i-gelTM Insertion Without Muscle Relaxants|Completed||Phase 4|37|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:37:45.504594|2017-10-11 00:37:45.504594
NCT02097394|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-04-23|||June 2013|Actual|2013-06-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps|A Randomized Controlled Study on Combizym and Bifidobacteria to Prevent the Recurrence of Colon Polyps|Enrolling by invitation||Phase 4|200|Actual|RenJi Hospital||4|||f||||t||||||||||2017-10-11 00:37:45.608147|2017-10-11 00:37:45.608147
NCT02097381|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-26|||April 2010||2010-04-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|March 2014|Actual|2014-03-01||Interventional|||Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy|HIV Infection and Gut Mucosal Immune Function: Longitudinal Analyses of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy|Unknown status|Active, not recruiting|N/A|10|Actual|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-11 00:37:45.730816|2017-10-11 00:37:45.730816
NCT02097368|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-07-25|||April 2014||2014-04-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|January 2019|Anticipated|2019-01-01||Observational|ORDEG||Bulbar Function in Neuromuscular Patients|Prospective Evaluation of Bulbar Function in Neuromuscular Patients|Recruiting||N/A|100|Anticipated|Centre d'Investigation Clinique et Technologique 805|||1||f||||t||||||||||2017-10-11 00:37:45.88261|2017-10-11 00:37:45.88261
NCT02097355|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-10-04|||December 2014||2014-12-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2016|Actual|2016-12-01||Interventional|TriVoxHealth||Using an Online Patient Monitoring System to Improve Care for Children With Chronic Conditions|Integrated Clinical Information Sharing System: Implementation and Mixed-Methods Evaluation of a Web-based Monitoring and Management System for Patients With Chronic Conditions|Active, not recruiting||N/A|946|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 00:37:46.061437|2017-10-11 00:37:46.061437
NCT02097342|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-04-06|||December 2013||2013-12-01|April 2014|2014-04-01|January 2015|Anticipated|2015-01-01|November 2014|Anticipated|2014-11-01||Interventional|||Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus|A Randomized Double-blind Study to Evaluate the Effect of Linagliptin on Pancreatic Beta Cell Function and Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus on Metformin Monotherapy|Unknown status|Recruiting|Phase 4|30|Anticipated|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||||2017-10-11 00:37:46.77084|2017-10-11 00:37:46.77084
NCT02097329|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-06-17|||April 2014||2014-04-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food|A Phase 1, Open-Label, 3-Period Crossover Study Of The Effect Of An Antacid, A Proton Pump Inhibitor And An H2-Receptor Antagonist On Palbociclib (PD-0332991) Bioavailability Under Fed Conditions In Healthy Volunteers|Completed||Phase 1|27|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:37:46.955509|2017-10-11 00:37:46.955509
NCT02097316|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-10-24|||June 2014||2014-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Feasibility Study of the JewelPump Version 3|Feasibility Study of the JewelPump Version 3|Completed||Phase 3|21|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||||2017-10-11 00:37:47.083291|2017-10-11 00:37:47.083291
NCT02097303|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-08-19|||March 2014||2014-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|eRADicAte||Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis|Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis|Completed||Phase 2|40|Anticipated|Carolina Research Professionals, LLC||1|||f||||f||||||||||2017-10-11 00:37:47.222527|2017-10-11 00:37:47.222527
NCT02097290|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-08-02|2017-03-09||April 2014||2014-04-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|January 2016|Actual|2016-01-01||Interventional|CAPTIVATE||Evaluation of Automatic Threshold Algorithms|CAPTure Information Via Automatic Threshold Evaluation|Active, not recruiting||N/A|216|Actual|Boston Scientific Corporation|The RVAT and LVAT endpoints are compared against a performance goal rather than to a randomized control arm.|1|||f||||f||||||||||2017-10-11 00:37:47.346892|2017-10-11 00:37:47.346892
NCT02097277|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-03-22||2017-03-22|April 2014||2014-04-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Obese Adults With Type-2 Diabetes|Completed||Phase 2|120|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-10-11 00:37:48.36182|2017-10-11 00:37:48.36182
NCT02097264|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-08-13|||September 2014||2014-09-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate|A Randomised, Active Comparator, Double-blind, Multi Centre, Parallel, Phase 2a Trial, Investigating the Mechanism of Action, of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate|Withdrawn||Phase 2|0|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:37:48.515704|2017-10-11 00:37:48.515704
NCT02097251|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-02-02||||||February 2017|2017-02-01||||||||Expanded Access|||An Open-Label Treatment Protocol With UX003 rhGUS Enzyme Replacement Therapy for an Advanced Stage MPS 7 Patient|An Open-Label Treatment Protocol With UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy for an Advanced Stage Mucopolysaccharidosis Type 7 (MPS 7) Patient|No longer available||N/A|||Northwell Health|||||||||||||||||||2017-10-11 00:37:48.666114|2017-10-11 00:37:48.666114
NCT02097238|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-31|2016-11-29||August 2014||2014-08-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma|A Phase II Study of Eribulin (NSC# 707389) in Recurrent or Refractory Osteosarcoma|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 00:37:48.762396|2017-10-11 00:37:48.762396
NCT02097225|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-09-21|||May 29, 2014|Actual|2014-05-29|September 2017|2017-09-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|Phase I Study of AT13387 in Combination With Dabrafenib and Trametinib in Patients With BRAF-Mutant Melanoma and Other Solid Tumors|Recruiting||Phase 1|32|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:37:49.48434|2017-10-11 00:37:49.48434
NCT02097212|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-03-27|||March 2014||2014-03-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea|Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea|Completed||N/A|1|Actual|National Jewish Health|||1||f||||f||||||||||2017-10-11 00:37:49.670266|2017-10-11 00:37:49.670266
NCT02097199|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-01-06|||August 2014||2014-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|||IPHAAB-study Influence of Physical Activity on Atherosclerosis Biomarkers|Influence of Physical Activity on Promising Atherosclerosis Biomarkers|Completed||N/A|98|Actual|Medical University of Vienna|||1||f||||t||||||Samples Without DNA|"     whole blood   "|||2017-10-11 00:37:49.751907|2017-10-11 00:37:49.751907
NCT02097186|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-12-11|||April 2014||2014-04-01|December 2014|2014-12-01|August 2017|Anticipated|2017-08-01|April 2016|Anticipated|2016-04-01||Interventional|SAVES-F||Preconditioning Shields Against Vascular Events in Surgery|Preconditioning Shields Against Vascular Events in Surgery: A Multi-centre Feasibility Trial of Preconditioning Against Adverse Events in Major Vascular Surgery (Preconditioning-SAVES)|Unknown status|Recruiting|N/A|400|Anticipated|Mid Western Regional Hospital, Ireland||2|||f||||t||||||||||2017-10-11 00:37:49.88569|2017-10-11 00:37:49.88569
NCT02097173|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-03-13|||May 2013||2013-05-01|March 2015|2015-03-01||||October 2013|Actual|2013-10-01||Interventional|||Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen|Relative Bioavailability of Methotrexate (MTX) 50 mg/mL Administered Subcutaneously (SC) by a Disposable Autoinjector (Metoject® Prefilled Pen) Compared With Intramuscular (IM) Administration of the United States Reference Listed Drug Methotrexate Injection (USP 25 mg/mL [Hospira]) in Patients With Psoriasis|Completed||Phase 1|35|Actual|medac GmbH||2|||f||||f||||||||||2017-10-11 00:37:50.145409|2017-10-11 00:37:50.145409
NCT02097160|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-11-10|||December 2013||2013-12-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|D-KIDS||How Much Vitamin D is Needed in Milk Products to Support Vitamin D Intake and Bone Health in Children?|How Much Vitamin D is Needed in Milk Products to Support Vitamin D Intake and Bone Health in Children?|Completed||N/A|77|Actual|McGill University||3|||f||||f||||||||||2017-10-11 00:37:50.227856|2017-10-11 00:37:50.227856
NCT02097147|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-02-11|||March 2014||2014-03-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo|A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo|Completed||Phase 1|202|Actual|Forest Laboratories||4|||f||||f||||||||||2017-10-11 00:37:50.315541|2017-10-11 00:37:50.315541
NCT02097134|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-25|2017-05-05|||April 2014||2014-04-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma|A Multi-institutional Feasibility Study of Intra-arterial Chemotherapy Given in the Ophthalmic Artery of Children With Retinoblastoma|Active, not recruiting||N/A|50|Anticipated|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 00:37:50.458015|2017-10-11 00:37:50.458015
NCT02097121|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-26|||May 23, 2014|Actual|2014-05-23|July 2017|2017-07-01|June 30, 2019|Anticipated|2019-06-30|May 31, 2018|Anticipated|2018-05-31||Interventional|||OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients||Recruiting||Phase 3|108|Anticipated|Allergan||3|||f||||f|t|f||||||||2017-10-11 00:37:50.587287|2017-10-11 00:37:50.587287
NCT02097108|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-07-26|2016-06-15||May 2014||2014-05-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir|One Arm, Open Label, Interventional, Non-comparative Study to Assess Changes in Lipids and Lipoproteins in HIV Infected Women With Hyperlipidemia After Switch From Boosted Protease Inhibitor to Raltegravir|Completed||Phase 2|11|Actual|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||||2017-10-11 00:37:50.956957|2017-10-11 00:37:50.956957
NCT02097095|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-01-31|||August 2014||2014-08-01|January 2017|2017-01-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Observational|||Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972)|Substudy of GSK Protocol TB-018: Collection and Storage of Biological Samples for Evaluation of Correlates of Tuberculosis|Completed||N/A|3253|Actual|Aeras|||2||f||||f||||||Samples With DNA|"     Specimens for this sub-study are collected from an interventional Phase 2 study (TB-018 see     NCT 01755598) and later analyzed for correlates of risk to tuberculosis.      PBMC/Plasma; Whole Blood cell count; Intracellular RNA   "|No||2017-10-11 00:37:51.28139|2017-10-11 00:37:51.28139
NCT02097082|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-02-09|||October 2013||2013-10-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|SPRINT||Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System|An Evaluation of the 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System in the Treatment of de Novo SFA Lesions|Recruiting||N/A|70|Anticipated|480 Biomedical, Inc.||1|||f||||t||||||||||2017-10-11 00:37:51.366556|2017-10-11 00:37:51.366556
NCT02097069|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-23|||April 2014||2014-04-01|March 2014|2014-03-01||||April 2015|Anticipated|2015-04-01||Interventional|||Inositol Stereoisomers to Treat Gestational Diabetes|Different Effects of Inositol Stereoisomers on Insulin Sensitivity in Women With Gestational Diabetes|Unknown status|Not yet recruiting|N/A|80|Anticipated|Università degli Studi 'G. d'Annunzio' Chieti e Pescara||4|||f||||t||||||||||2017-10-11 00:37:51.539813|2017-10-11 00:37:51.539813
NCT02097056|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-05-20|2016-03-30||February 2014||2014-02-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SAVE|Safety population included all participants who received at least one dose of study treatment and had at least one postbaseline safety assessment.|Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease|Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease|Completed||Phase 4|171|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-11 00:37:51.71383|2017-10-11 00:37:51.71383
NCT02097043|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-09-29|||May 2014||2014-05-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers|A Block-randomized, Double-blind, Placebo-controlled, Single-dose, Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers|Completed||Phase 1|31|Actual|Dong-A ST Co., Ltd.||6|||f||||||||||||||2017-10-11 00:37:52.263906|2017-10-11 00:37:52.263906
NCT02097030|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-01-15|2015-08-06||March 2014||2014-03-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Clinical Evaluation of Daily Disposable Contact Lenses|Single-Center Clinical Evaluation of Daily Disposable Contact Lenses|Completed||Phase 4|35|Actual|Coopervision, Inc.||3|||f||||f||||||||||2017-10-11 00:37:52.437069|2017-10-11 00:37:52.437069
NCT02097017|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2014-03-25||||||March 2014|2014-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Prophylactic Lidocaine Spray for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Second Trimester Dilatation and Evacuation|Prophylactic Lidocaine Spray for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Second Trimester Dilatation and Evacuation|Unknown status|Not yet recruiting|Phase 4|160|Anticipated|Sheba Medical Center||3|||f||||||||||||||2017-10-11 00:37:53.614171|2017-10-11 00:37:53.614171
NCT02097004|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2017-05-08|||April 2014||2014-04-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|E+VIP||Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection|Phase4, to Compare Efficacy and Safety of Therapeutic Vaccination With Intensified Schedule Plus Pegylated Interferon Dual Therapy on Seroclearance of HBS Antigen in Patients With Complete Virological Response Induced by Entecavir|Active, not recruiting||Phase 4|111|Actual|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 00:37:53.7182|2017-10-11 00:37:53.7182
NCT02096991|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2014-03-23|||February 2014||2014-02-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Associations of Exposure to Bisphenol A With Blood Pressure and Epigenetic Change|Associations of Exposure to Bisphenol A With Blood Pressure and Epigenetic Change|Completed||N/A|60|Actual|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 00:37:53.834369|2017-10-11 00:37:53.834369
NCT02096978|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-25|||October 2010||2010-10-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Comparing Implant Stability Using Two Accepted Techniques for Implant Sites|A Randomized Controlled Clinical Study Comparing Implant Stability Using Osteotome vs. Conventional Drilling Techniques by Resonance Frequency Analysis|Completed||N/A|17|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 00:37:53.937997|2017-10-11 00:37:53.937997
NCT02096965|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-03-28|||March 2014||2014-03-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study|Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study|Completed||Phase 1|20|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:37:54.036371|2017-10-11 00:37:54.036371
NCT02096952|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-12|||May 2014||2014-05-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD|Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder Adults With Attention-Deficit/Hyperactivity Disorder|Recruiting||Phase 4|40|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:37:54.15819|2017-10-11 00:37:54.15819
NCT02096939|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-08-24|||September 2014||2014-09-01|August 2015|2015-08-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Microvascular Function in Primary Aldosteronism|Microvascular Function in Patients With Primary Aldosteronism and Essential Hypertension|Withdrawn||N/A|0|Actual|Maastricht University Medical Center|||2||f||||f||||||||||2017-10-11 00:37:54.274976|2017-10-11 00:37:54.274976
NCT02096926|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-04-06|||March 2014||2014-03-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery|Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery|Completed||Phase 4|40|Actual|Lotus Clinical Research, LLC||2|||f||||f||||||||||2017-10-11 00:37:54.352409|2017-10-11 00:37:54.352409
NCT02096913|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-03-21|||June 2013||2013-06-01|March 2017|2017-03-01||||September 2017|Anticipated|2017-09-01||Interventional|||Safety Study of Ibuprofen to Treat Acute Traumatic Spinal Cord Injury|The Rho-Inhibitor Ibuprofen for the Treatment of Acute Spinal Cord Injury: Investigation of Safety, Feasibility and Pharmacokinetics|Active, not recruiting||Phase 1|12|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 00:37:54.429535|2017-10-11 00:37:54.429535
NCT02096900|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-09-27|2017-04-19||July 2014|Actual|2014-07-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PedsPreMed|Analyses subjects who completed the study per protocol|A Comparison of Midazolam and Zolpidem as Oral Premedication in Children|A Comparison of Midazolam and Zolpidem as Oral Premedication in Children|Completed||Phase 3|86|Actual|Loma Linda University||2|||f||||t||||||||||2017-10-11 00:37:54.544686|2017-10-11 00:37:54.544686
NCT02096887|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-25|||June 2014||2014-06-01|March 2014|2014-03-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|FAILAKA||Effect of Patient Education on Compliance and Cardiovascular Risk Parameters|Effect of Patient Awareness and Education on Compliance and Cardiovascular Risk Factor Control|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Kuwait Institute for Medical Specialization||1|||f||||f||||||||||2017-10-11 00:37:55.390649|2017-10-11 00:37:55.390649
NCT02096874|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2014-03-25|||June 2013||2013-06-01|March 2014|2014-03-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema|The Effect of Bevacizumab on Peripheral Retinal Changes as Imaged by Wide -Field Fluorescein Angiography in Diabetic Macular Edema|Unknown status|Recruiting|Phase 4|50|Anticipated|King Khaled Eye Specialist Hospital||1|||f||||f||||||||||2017-10-11 00:37:55.714655|2017-10-11 00:37:55.714655
NCT02096861|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-03-28|||July 2014||2014-07-01|March 2017|2017-03-01|February 15, 2017|Actual|2017-02-15|January 2016|Actual|2016-01-01||Interventional|||Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease|A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 Compared to Remicade in Patients With Active Crohn's Disease|Completed||Phase 3|220|Actual|Celltrion||4|||f||||t||||||||||2017-10-11 00:37:55.811046|2017-10-11 00:37:55.811046
NCT02096848|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-09-01|||May 2012||2012-05-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|Microbiology||Microbiology of Otitis Media in Costarrican Children After PCV13 Introduction|IDENTIFICATION OF THE EFFECT OF THE PNEUMOCOCCAL CONJUGATED VACCINE IN COSTA RICA|Completed||N/A|387|Actual|Instituto de Atención Pediátrica|||1||f||||f||||||Samples With DNA|"     Bacteria isolated from children with otitis media   "|No||2017-10-11 00:37:55.911097|2017-10-11 00:37:55.911097
NCT02096835|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-10-09|2015-01-05||January 2014||2014-01-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|TEASP6PPONV||Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting|Transcutaneous Electrical Acupoint P6 Stimulation vs. Tropisetron Both in Combination With Dexamethasone to Prevent Postoperation Nausea and Vomiting in Women|Completed||N/A|157|Actual|Huashan Hospital||3|||f||||t||||||||||2017-10-11 00:37:56.011105|2017-10-11 00:37:56.011105
NCT02096445|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-06-09|||April 2013|Actual|2013-04-01|June 2017|2017-06-01|June 9, 2017|Actual|2017-06-09|March 10, 2017|Actual|2017-03-10||Interventional|||Neurocognitive Robot-assisted Rehabilitation of Hand Function After Stroke|Neurocognitive Robot-assisted Rehabilitation of Hand Function After Stroke|Completed||N/A|34|Actual|Swiss Federal Institute of Technology||2|||f||||t||||||||||2017-10-11 00:38:03.61874|2017-10-11 00:38:03.61874
NCT02096822|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-02-23|||April 2014||2014-04-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|BABYDOUL||Efficacy of Facilitated Tucking During Pain Procedure in Preterm Infants|Efficacy of Facilited Tucking and Non-nutritive Sucking of Sterile Water to Relieve Preterm Infants From Pain During Heel-stick Procedures.|Completed||N/A|60|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:37:56.656526|2017-10-11 00:37:56.656526
NCT02096809|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-23|2015-12-06|||March 2014||2014-03-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|August 2014|Actual|2014-08-01||Interventional|||Stability of the Cochlear Baha BI300/BA400 Implant System Loaded From 1 Week Post-surgery|Evaluation of Soft Tissue Healing and Implant Stability of Cochlear Baha BI300/BA400 Implant System Loaded From 1 Week Post-surgery After Linear Incision Without Soft Tissue Reduction.|Completed||N/A|25|Actual|Aarhus University Hospital||1|||f||||f||||||||||2017-10-11 00:37:56.761463|2017-10-11 00:37:56.761463
NCT02096796|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-09-16|||April 2014||2014-04-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Observational|||Arm Pump in Motorcross Training|Hand Strength Grip and Ergonomics of Driving as Risk Factors in the Etiology of Arm Pump in Motorcross Training|Completed||N/A|11|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||t||||||||||2017-10-11 00:37:56.894219|2017-10-11 00:37:56.894219
NCT02096783|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-11-02|||September 2014||2014-09-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer|Randomized-Controlled, Pilot Study of the Effects of a Brief, Scripted Sexual Health Intervention on Sexual Function for Women With Gynecologic Cancer|Completed||N/A|15|Actual|University of Wisconsin, Madison||4|||f||||f||||||||||2017-10-11 00:37:56.971146|2017-10-11 00:37:56.971146
NCT02096757|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2015-06-29|||June 2014||2014-06-01|June 2015|2015-06-01||||June 2017|Anticipated|2017-06-01||Interventional|OMEGA-PVI||The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention|The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:37:57.102085|2017-10-11 00:37:57.102085
NCT02096744|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-06-19|2015-06-19||March 2014||2014-03-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||All enrolled subjects in the trial were treated and were included in the treated set (TS).|Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers|A Randomized, Double-blind Study Designed to Assess the Bioequivalence and Adhesion Properties of Transdermal Clonidine-VistanexTM Compared to Transdermal Clonidine-Oppanol® Following Transdermal Administration in Healthy Male and Female Volunteers|Completed||Phase 1|56|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:37:57.284208|2017-10-11 00:37:57.284208
NCT02096731|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-12-22|2016-07-28||March 2014||2014-03-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational||"Patients who were new users of tiotropium or a long-acting beta agonist (LABA) with or without ICS. Estimates based on overall patients before propensity score matching (base cohort).
New use was defined as a first use of either bronchodilator without use of either drug of interest during the previous two years"|Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary Events|Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary Events: A Population-based Observational Study|Completed||N/A|115397|Actual|Boehringer Ingelheim|Study measures may be subject to misclassification. Diagnoses codes based on read codes and not laboratory or clinical measures. Residual confounding is possible as the analysis is dependent on only recorded information in patients’ clinical records.||5||f||||||||||||||2017-10-11 00:37:57.684786|2017-10-11 00:37:57.684786
NCT02096718|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-12-09|2015-12-09||May 2014||2014-05-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||(Treated Set) All patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment. All 30 subjects were included in the treated set (TS)|Afatinib in Subjects With Kidney Dysfunction|Pharmacokinetics, Safety and Tolerability After Single Dose Administration of Afatinib in Moderate and Severe Renal Impairment in Comparison to Subjects With Normal Renal Function (a Mono-centric, Open-label Study in Matched-group Design)|Completed||Phase 1|30|Actual|Boehringer Ingelheim|Two healthy volunteers were matched to 2 different groups i.e. subjects with moderate renal impairment and subjects with severe renal impairment.|3|||f||||||||||||||2017-10-11 00:37:58.027378|2017-10-11 00:37:58.027378
NCT02096705|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-07-11|2017-01-13||March 31, 2014|Actual|2014-03-31|July 2017|2017-07-01|January 28, 2016|Actual|2016-01-28|January 28, 2016|Actual|2016-01-28||Interventional||All Randomized Participants|Phase III Insulin Add-On Asia Regional Program - ST|A 24-week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Trial to Evaluate Efficacy and Safety of Dapagliflozin Added to Therapy of Asian Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Insulin|Completed||Phase 3|477|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:37:58.449298|2017-10-11 00:37:58.449298
NCT02096692|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2016-02-01|2015-09-18||June 2014||2014-06-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Observational|||ProMRI Study of the Iforia ICD System (Phase C)|ProMRI Study of the Iforia ICD System (Phase C)|Completed||N/A|154|Actual|Biotronik, Inc.|||1||f||||t||||||||||2017-10-11 00:37:59.084973|2017-10-11 00:37:59.084973
NCT02096679|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2015-10-01|2015-07-02||May 2014||2014-05-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD9291 in Volunteers|A Phase I, Single-centre, Non-Randomised, Open-label, Pharmacokinetic and Mass Balance Study of Orally Administered [14C]-AZD9291 in Healthy Male Volunteers|Completed||Phase 1|8|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 00:37:59.435051|2017-10-11 00:37:59.435051
NCT02096666|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-24|2017-08-11||2016-03-28|April 15, 2014|Actual|2014-04-15|August 2017|2017-08-01|December 29, 2017|Anticipated|2017-12-29|November 5, 2015|Actual|2015-11-05||Interventional|||A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects|A Multicenter, Phase 1/2, Open-Label Study Evaluating the Tolerability, Safety, Pharmacokinetics, and Efficacy of AMG 337 in Asian Subjects|Active, not recruiting||Phase 1/Phase 2|11|Actual|Amgen||1|||f||||f||||||||||2017-10-11 00:38:00.007424|2017-10-11 00:38:00.007424
NCT02096653|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-22|2017-08-18|||March 2014||2014-03-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Fluoroscopically-guided Versus Landmark-guided Sacroiliac Joint Injections|Randomized, Controlled, Double-blind, Comparative-effectiveness Study Comparing Fluoroscopically-guided and Landmark-guided Sacroiliac Joint Injections|Recruiting||N/A|124|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 00:38:00.121861|2017-10-11 00:38:00.121861
NCT02096640|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-23|||March 2014||2014-03-01|March 2014|2014-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Postoperative Inflammation and Recovery After Tracheostomy|Randomized Controlled Trial on the Effect of Percutaneous Dilatation Tracheostomy Compared to Open Surgical Tracheostomy on Postoperative Inflammation, Pulmonary Function, Peri- and Postoperative Complications and Physical Mobilization.|Not yet recruiting||N/A|150|Anticipated|Sormland County Council, Sweden||2|||f||||f||||||||||2017-10-11 00:38:00.956417|2017-10-11 00:38:00.956417
NCT02096627|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2016-08-30|||May 2014||2014-05-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery|Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery on Corneal Endothelial Cell Loss|Recruiting||N/A|720|Anticipated|Johns Hopkins University|||2||f||||f||||||||||2017-10-11 00:38:01.101179|2017-10-11 00:38:01.101179
NCT02096614|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-07-31|||April 2014||2014-04-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||Investigator Initiated Phase 1 Study of TBI-1201|Multi-center, Investigator Initiated Phase 1 Study of MAGE-A4 Specific TCR Gene Transferred T Lymphocytes With Solid Tumors|Recruiting||Phase 1|12|Anticipated|Mie University||4|||f||||t||||||||||2017-10-11 00:38:01.24183|2017-10-11 00:38:01.24183
NCT02096601|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-23||||||March 2014|2014-03-01||||December 2014|Anticipated|2014-12-01||Interventional|||A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients|A Phase I/II Pharmacokinetic (PK) Study of ND0612, a Liquid Formulation of Levodopa/Carbidopa (LD/CD), Delivered as a Continuous Subcutaneous in Parkinson's Disease (PD) Patients Treated With LD|Unknown status|Not yet recruiting|Phase 1/Phase 2|||NeuroDerm Ltd.||2|||||||f||||||||||2017-10-11 00:38:01.410945|2017-10-11 00:38:01.410945
NCT02096588|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-10-05|||May 2014||2014-05-01|October 2017|2017-10-01|April 2021|Anticipated|2021-04-01|October 2019|Anticipated|2019-10-01||Interventional|||Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin|Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin|Active, not recruiting||Phase 2|27|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 00:38:01.522396|2017-10-11 00:38:01.522396
NCT02096575|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-04-15|2016-02-12||August 2012||2012-08-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|NAB||Nitrous Oxide for Pain Management of First Trimester Surgical Abortion|Nitrous Oxide for Pain Management of First Trimester Surgical Abortion|Completed||N/A|140|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-11 00:38:01.662046|2017-10-11 00:38:01.662046
NCT02096562|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-05-23|||July 2013||2013-07-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Knee Swelling Under Use of Compression Stockings After Outpatient Surgery|Prospective Randomized Assessment of Postsurgical Swelling Applying Compression Stockings vs. Conventional Wrapping After Outpatient Surgery|Completed||N/A|27|Actual|University of Rostock||2|||f||||f||||||||||2017-10-11 00:38:02.23007|2017-10-11 00:38:02.23007
NCT02096549|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-06-26|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Observational|||Validity of Bispectral Index Monitoring During Deep Sedation|Validity of Bispectral Index Monitoring During Deep Sedation for Botulinum Toxin Injection in Children With Cerebral Palsy|Completed||N/A|22|Actual|Yeungnam University College of Medicine|||1||f||||t||||||||||2017-10-11 00:38:02.353121|2017-10-11 00:38:02.353121
NCT02096536|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-11-02|||April 2014||2014-04-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Exploring Vancomycin Disposition in Neonates|Exploring Vancomycin Disposition in Neonates: Paired Analysis of Vancomycin Concentrations Using Immunoassay and Liquid-chromatography-tandem Mass Spectrometry. Determination of Vancomycin Protein Binding and Its Covariates in Neonates|Recruiting||Phase 4|120|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 00:38:02.477312|2017-10-11 00:38:02.477312
NCT02096523|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-03-23|||February 2017||2017-02-01|February 2016|2016-02-01||||May 2019|Anticipated|2019-05-01||Interventional|||Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder|Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder|Not yet recruiting||N/A|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:38:02.615956|2017-10-11 00:38:02.615956
NCT02096510|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2016-12-20|||August 2014||2014-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia|Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia|Recruiting||Phase 1/Phase 2|10|Anticipated|Haukeland University Hospital||3|||f||||t||||||||||2017-10-11 00:38:02.751152|2017-10-11 00:38:02.751152
NCT02096497|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-21|||January 2011||2011-01-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Analysis of the Vascular Pattern of the Superficial Temporal Artery|In Vivo Analysis of the Vascular Pattern of the Superficial Temporal Artery Based on Digital Subtraction Angiography|Completed||N/A|93|Actual|University Hospital Tuebingen|||11||f||||t||||||||||2017-10-11 00:38:02.945266|2017-10-11 00:38:02.945266
NCT02096484|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-10-14|||August 2014||2014-08-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|MCT||A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation Therapy|Group Metacognitive Therapy Versus Mindfulness Meditation Therapy in a Transdiagnostic Patient Sample: A Feasibility Study|Completed||N/A|40|Actual|University of Manchester||2|||f||||t||||||||||2017-10-11 00:38:03.062506|2017-10-11 00:38:03.062506
NCT02096471|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-05-03|||June 2014||2014-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|MEK Inhibitor||MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1|A Phase 2 Trial of the MEK Inhibitor PD-0325901 in Adolescents and Adults With NF1-Associated Morbid Plexiform Neurofibromas|Active, not recruiting||Phase 2|19|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 00:38:03.195806|2017-10-11 00:38:03.195806
NCT02096458|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-02-22|2015-02-22||February 2014||2014-02-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||The population consisted of all enrolled participants.|Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets|An Open-Label Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Subjects : TAK-390MR(OD)_107|Completed||Phase 1|8|Actual|Takeda||1|||f||||f||||||||||2017-10-11 00:38:03.386504|2017-10-11 00:38:03.386504
NCT02096419|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-08-14|||February 2012||2012-02-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity|Effect of Continuous Clopidogrel Dosing Targeted After Platelet Function Testing in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention With High On-treatment Platelet Reactivity|Completed||Phase 4|87|Actual|University of Zagreb||2|||f||||f||||||||||2017-10-11 00:38:03.927934|2017-10-11 00:38:03.927934
NCT02096406|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-07-19|||April 2014||2014-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|COMPACT||Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass|COMParison of Angiotensin Converting Enzyme Inhibitor managemenT Strategies Prior to Coronary Artery Bypass Surgery (the COMPACT Trial): a Pilot Randomized Controlled Registry Study|Active, not recruiting||Phase 2|126|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 00:38:04.067339|2017-10-11 00:38:04.067339
NCT02096393|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-22|||September 2013||2013-09-01|March 2014|2014-03-01|December 2024|Anticipated|2024-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Patient Specific Instrumentation in TKR|A Prospective, Randomised Control Trial Assessing Clinical and Radiological Outcomes of Patient Specific Instrumentation In Total Knee Arthroplasty|Recruiting||N/A|100|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:38:04.217008|2017-10-11 00:38:04.217008
NCT02096380|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2014-03-22|||May 2014||2014-05-01|March 2014|2014-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|3 Years|Observational [Patient Registry]|||The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma|Randomized Trial of Comparing One Cycle With Three Cycles Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Locoregionally Advanced Nasopharyngeal Carcinoma|Not yet recruiting||Phase 2/Phase 3|120|Anticipated|First People's Hospital of Foshan|||2||f||||t||||||||||2017-10-11 00:38:04.350114|2017-10-11 00:38:04.350114
NCT02096367|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-06-08|||April 2014||2014-04-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|VIBR-AVC||Immediate Effect of Postural Muscle's Vibrations on Gait in Chronic Vascular Hemiplegia|Immediate Effect of Cervical Posterior Muscles' and Gluteus Medius Muscle's Vibrations on Gait in Chronic Vascular Hemiplegia|Completed||N/A|21|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 00:38:04.473414|2017-10-11 00:38:04.473414
NCT02096354|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-07-02|||May 2014||2014-05-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ROCKET||A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer|A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|57|Actual|EpicentRx, Inc.||2|||f||||t||||||||||2017-10-11 00:38:04.57035|2017-10-11 00:38:04.57035
NCT02096341|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-01-19|||April 2014||2014-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001|A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001|Terminated||Phase 1|2|Actual|EpicentRx, Inc.||1||Subcutaneous administration of RRx-001 is no longer of interest.|f||||f||||||||||2017-10-11 00:38:04.664937|2017-10-11 00:38:04.664937
NCT02096328|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-01-31|||October 2013||2013-10-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia|A Phase II, Open-label, Multi-center Study to Assess Pharmacokinetics (PK), Safety and Efficacy of POL7080 Co-administered With Standard of Care (SoC) Treatment in Patients With Ventilator- Associated Pneumonia (VAP) Due to Suspected or Documented Pseudomonas Aeruginosa Infection.|Terminated||Phase 2|25|Actual|Polyphor Ltd.||1|||f||||f||||||||||2017-10-11 00:38:04.738888|2017-10-11 00:38:04.738888
NCT02096315|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-01-31|||December 2013||2013-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.|A Phase II, Open-label, Multicenter Study to Assess the Tolerance, Safety, Efficacy and Pharmacokinetics/Pharmacodynamics (PK/PD) of POL7080 in the Treatment of Patients With Acute Exacerbation of Non-cystic Fibrosis Bronchiectasis Due to Pseudomonas Aeruginosa Infection Requiring Intravenous Treatment|Terminated||Phase 2|20|Anticipated|Polyphor Ltd.||1|||f||||f||||||||||2017-10-11 00:38:04.830559|2017-10-11 00:38:04.830559
NCT02096302|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-03-07|||January 2011||2011-01-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|November 2012|Actual|2012-11-01||Interventional|GO-INF||The Effects of an Infant Formula Containing Probiotic CECT7210 on Gastrointestinal Health|Evaluar el Efecto de Una fórmula Infantil Enriquecida Con el probiótico CECT7210 Sobre la Incidencia de Infecciones Gastrointestinales|Completed||Phase 4|194|Actual|Laboratorios Ordesa||2|||f||||t||||||||||2017-10-11 00:38:04.918159|2017-10-11 00:38:04.918159
NCT02096289|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-12-06|||July 2014||2014-07-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|THORIDAL||Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia|A Phase I Trial Evaluating Oral Thioridazine in Combination With Intermediate Dose Cytarabine in Patients 55 Years and Older With Acute Myeloid Leukemia Who Have Relapsed or Have Refractory Disease|Completed||Phase 1|13|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||f||||||||||2017-10-11 00:38:05.063845|2017-10-11 00:38:05.063845
NCT02096276|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-09-05|||March 1, 2014||2014-03-01|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|||Boostrix® Pregnancy Registry|Boostrix® Pregnancy Registry: a Prospective, Exploratory, Cohort Study to Detect and Describe Any Abnormal Pregnancy Outcomes in Women Intentionally or Unintentionally Vaccinated With Boostrix® During Pregnancy or Within 28 Days Preceding Conception|Active, not recruiting||N/A|800|Anticipated|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 00:38:05.14586|2017-10-11 00:38:05.14586
NCT02096237|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-03-05|||December 2013||2013-12-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|ESPIRA||Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study)|First in Man Trial to Investigate Safety and Efficacy of the New IgE Adsorber|Completed||N/A|14|Actual|Fresenius Medical Care Deutschland GmbH||2|||f||||f||||||||||2017-10-11 00:38:05.468054|2017-10-11 00:38:05.468054
NCT02096224|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-09-30|||May 2014||2014-05-01|March 2014|2014-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort|Comparison of the Effects of Sevoflurane and Desflurane on Prevention of Catheter-related Bladder Discomfort|Completed||N/A|108|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:38:05.541594|2017-10-11 00:38:05.541594
NCT02096211|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-08-14|||June 1, 2014|Actual|2014-06-01|August 2017|2017-08-01|December 1, 2021|Anticipated|2021-12-01|December 1, 2021|Anticipated|2021-12-01||Interventional|COC36mmPAS||Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)|36mm CERAMAX® Ceramic Hip System PMA PAS STUDY: Short to Mid-Term Follow-up , New Study Subjects (Ceramic Hip System, Subjects Receive CERAMAX 36mm Ceramic Acetabular Bearing Insert That Articulates With a Ceramic Femoral Head for THA)|Recruiting||N/A|170|Anticipated|DePuy Orthopaedics||1|||f||||f||||||||||2017-10-11 00:38:05.619587|2017-10-11 00:38:05.619587
NCT02096198|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|COC36mmPAS||Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement|36mm CERAMAX® Ceramic Hip System PMA PAS: Long-Term Follow-up of Previously Enrolled Investigational Device Exemption (IDE) Study Subjects|Active, not recruiting||N/A|80|Anticipated|DePuy Orthopaedics|||1||f||||f||||||||||2017-10-11 00:38:07.502247|2017-10-11 00:38:07.502247
NCT02096185|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-10-19|||May 2014||2014-05-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Is Any Additional Information Gained Regarding Margins Using 3D Tomosynthesis Vs 2D Conventional Digital Imaging When Imaging Operative Breast Specimens?|Is Any Additional Information Gained Regarding Lesion to Margin Measurement Using 3D Tomosynthesis Imaging Versus 2D Conventional Digital Imaging When Imaging Specimens of Breast Tissue Removed at Therapeutic Surgery|Enrolling by invitation||N/A|50|Actual|Sandwell & West Birmingham Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 00:38:07.596645|2017-10-11 00:38:07.596645
NCT02096172|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-09-22|||March 2014||2014-03-01|September 2014|2014-09-01||||July 2014|Actual|2014-07-01|24 Months|Observational [Patient Registry]|UTOPIA||Urine Toxicology With Pharmacogenomic Interpretation Assay: UTOPIA|Urine Toxicology With Pharmacogenomic Interpretation Assay: UTOPIA|Withdrawn||N/A|0|Actual|Renaissance RX|||1||f||||f||||||||||2017-10-11 00:38:07.672401|2017-10-11 00:38:07.672401
NCT02096159|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-08-04|||March 2014||2014-03-01|August 2016|2016-08-01|December 2023|Anticipated|2023-12-01|June 2019|Anticipated|2019-06-01||Interventional|PROPHY||Prophylactic Antibiotics or Placebo After Hypospadias Repair|Trimethoprim-sulfamethoxazole vs. Placebo After Hypospadias Repair: a Multicenter, Double-blind, Randomized Trial|Recruiting||N/A|630|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 00:38:07.73106|2017-10-11 00:38:07.73106
NCT02096146|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-01-26|||October 2014||2014-10-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|TMT||TMT Fusion Plate vs. Two Crossed Screws|TMT Fusion Plate vs. Two Crossed Screws - A Randomized Controlled Trial|Terminated||N/A|12|Actual|AO Clinical Investigation and Documentation||2||Lack of enrolment|f||||f||||||||||2017-10-11 00:38:07.842063|2017-10-11 00:38:07.842063
NCT02096133|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-01-24|||October 13, 2014||2014-10-13|January 2017|2017-01-01|November 7, 2016|Actual|2016-11-07|November 7, 2016|Actual|2016-11-07||Interventional|||Vitamin D3 and the Stress-axis in MS|Regulation of the Stress-axis by Vitamin D3 in Subjects With Multiple Sclerosis; a Double-blinded, Randomized, Placebo-controlled Study|Terminated||Phase 2|54|Actual|Academic MS Center Limburg||2||difficulties with inclusion|f||||f||||||||Undecided||2017-10-11 00:38:07.93848|2017-10-11 00:38:07.93848
NCT02096120|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-09-20|||February 2014||2014-02-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|FMD-ABRA||Full Mouth Disinfection and Antibiotics for Periodontitis in High or Moderate Disease Activity Rheumatoid Arthritis|Single Arm Pilot Study of Antimicrobial Treatment of Active Rheumatoid Arthritis Associated With Manifest Periodontitis (Translated From German: Anti-mikrobielle Behandlung Der Aktiven Rheumatoiden Arthritis Bei Manifester Parodontitis - Eine Unkontrollierte Therapie-Pilotstudie)|Active, not recruiting||N/A|8|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||Samples With DNA|"     Each 5-10 ml of whole blood, serum and RNA specimen collected in RNA stabilization tubes will     be collected at screening and start, and subsequently 1, 3 and 6 months after intervention.     Gingival crevicular fluid samples will be collected at start of treatment, after 3 and 6     months.   "|||2017-10-11 00:38:08.035929|2017-10-11 00:38:08.035929
NCT02096107|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-05-26|||February 2014|Actual|2014-02-01|December 2015|2015-12-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Novartis Everolimus Transition|Safety and Efficacy of Everolimus Transition in Minimizing Progressive Graft Dysfunction and Interstitial Fibrosis in Adult Kidney Transplant Recipients|Completed||Phase 4|60|Actual|Medical University of South Carolina||2|||f||||||||||||||2017-10-11 00:38:08.127413|2017-10-11 00:38:08.127413
NCT02096094|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-11-30|||April 2014||2014-04-01|March 2014|2014-03-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|||A Double-blind Evaluation of Adverse Effects of Bath With Wipes Impregnated With 2% Chlorhexidine Versus Placebo|A Double-blind Evaluation of Adverse Effects of Bath With Wipes Impregnated With 2% Chlorhexidine Versus Placebo|Completed||Phase 4|54|Actual|Universidad de Guanajuato||2|||f||||f||||||||||2017-10-11 00:38:08.334437|2017-10-11 00:38:08.334437
NCT02096081|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-01-27|2016-09-08||February 2014||2014-02-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional||The safety evaluation set (SES) was used and is defined as the subset of all enrolled subjects who receive the study medication. Subjects in the SES were summarized according to the treatment they received and not by the treatment to which they were randomized.|The Treatment of Glabellar Frown Lines||Completed||Phase 4|250|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||No||2017-10-11 00:38:08.4825|2017-10-11 00:38:08.4825
NCT02095470|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2014-03-20|||February 2013||2013-02-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Video Laryngoscope, New Intubation Device|Advanced Video Laryngoscope, a New Practical Intubation Device: Randomized Clinical Trial in 401 Patients|Completed||Phase 2/Phase 3|401|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:38:15.521791|2017-10-11 00:38:15.521791
NCT02096068|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-03-21|||July 2014||2014-07-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|||Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex)|Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (NEUPRODEX)|Recruiting||Phase 4|87|Anticipated|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 00:38:09.224021|2017-10-11 00:38:09.224021
NCT02096055|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-10-02|||April 2014|Actual|2014-04-01|October 2017|2017-10-01|April 2026|Anticipated|2026-04-01|April 2026|Anticipated|2026-04-01||Interventional|||Study of SGI-110 in Elderly Acute Myeloid Leukemia (AML)|Randomized Phase II Study of SGI-110 5 Days, Versus 5 Days + Idarubicin in Previously Untreated Patients >/= 70 Years With Acute Myeloid Leukemia|Recruiting||Phase 2|120|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 00:38:09.341785|2017-10-11 00:38:09.341785
NCT02096042|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-08-02|2017-08-02||April 2014|Actual|2014-04-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)|A Phase I/II Study of Weekly Schedule Of Brentuximab Vedotin Alone and In Combination With 5-Azacytidine In Cluster of Differentiation Antigen (CD30)-Positive Relapsed/Refractory Acute Myeloid Leukemia|Terminated||Phase 1/Phase 2|1|Actual|M.D. Anderson Cancer Center||2||Slow accrual.|f||||f||||||||||2017-10-11 00:38:09.438668|2017-10-11 00:38:09.438668
NCT02096029|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-12-01|||July 2014||2014-07-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|TipTop||Tobacco Intervention in Primary Care Treatment Opportunities for Providers|Brief, Novel Smoking Cessation in Primary Care: A Comparative Effectiveness Trial|Enrolling by invitation||N/A|1160|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 00:38:09.648368|2017-10-11 00:38:09.648368
NCT02096016|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-04-11|||January 2014||2014-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Observational|||HPV-test, Cervical Cancer and Follow-up|Recurrence After Surgery for Cervical Cancer - an Evaluation of the Follow-up Program.|Recruiting||N/A|50|Anticipated|University of Aarhus|||1||f||||f||||||||Yes||2017-10-11 00:38:09.733434|2017-10-11 00:38:09.733434
NCT02096003|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-03-24|||April 2014||2014-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intrathecal Hydromorphone for Pain Control After Cesarean Section|Comparison of Intrathecal Hydromorphone and Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery|Recruiting||Phase 2|50|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 00:38:09.810795|2017-10-11 00:38:09.810795
NCT02095990|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-04-09|||March 2014||2014-03-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy and Safety of a 4% Hydroquinone Cream (Melanoderm 4%) for the Treatment of Melasma: a Randomized Controlled Split-face Study|Efficacy and Safety of a 4% Hydroquinone Cream (Melanoderm 4%) for the Treatment of Melasma: a Randomized Controlled Split-face Study|Completed||Phase 3|17|Actual|Mesoestetic Pharma Group S.L.||2|||f||||f||||||||||2017-10-11 00:38:09.917729|2017-10-11 00:38:09.917729
NCT02095977|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-02-07|||July 2013||2013-07-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|||Insulation Failure in St. Jude Riata Leads|Insulation Failure in St. Jude Riata Leads: Screening and Predicting Impending Lead Failure|Recruiting||N/A|30|Anticipated|Hartford Hospital||1|||f||||t||||||||||2017-10-11 00:38:09.993458|2017-10-11 00:38:09.993458
NCT02095964|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-24|||March 2012||2012-03-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|HIRICS-X||HDL-C in Cardiac Syndrome X|HDL-Cholesterol is Inversely Related With Inflammation in Cardiac Syndrome X|Completed||N/A|710|Actual|Bursa Yüksek İhtisas Education and Research Hospital|||2||f||||t||||||||||2017-10-11 00:38:10.220473|2017-10-11 00:38:10.220473
NCT02095951|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-01-04|||June 2014||2014-06-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection|Preemptive Ethanol Lock Therapy in Pediatric Hematology/Oncology Patients With Catheter Associated Bloodstream Infection: Impact on Length of Stay and Catheter Salvage|Completed||N/A|35|Actual|Children's Hospital of Michigan||2|||f||||t||||||||Undecided||2017-10-11 00:38:10.29971|2017-10-11 00:38:10.29971
NCT02095938|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-03-24|||January 2014||2014-01-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ARB||Association of Amisulpride Response in Schizophrenia With Brain Image|Association of the Amisulpride Treatment Response in Patients With Schizophrenia With the Findings of Brain Structural Magnetic Resonance Imaging|Unknown status|Enrolling by invitation|Phase 4|20|Actual|CHA University||1|||f||||f||||||||||2017-10-11 00:38:10.441824|2017-10-11 00:38:10.441824
NCT02095925|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-01-16|||July 2008||2008-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Observational|MICA||Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism|Microparticle's Procoagulant Activity to Identify Patients With Cancer and a High Risk for Venous Thrombosis|Completed||N/A|900|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples Without DNA|"     citrated plasma   "|||2017-10-11 00:38:10.572602|2017-10-11 00:38:10.572602
NCT02095912|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-08-09|||March 2014||2014-03-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Observational|||Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients|Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients|Completed||N/A|150|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 00:38:10.691315|2017-10-11 00:38:10.691315
NCT02095899|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-07-20|||March 2014||2014-03-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|RUFPTPS||Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome|Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome. A Prospective, Randomized, Double-blind, Placebo Controlled, Monocenter Study.|Withdrawn||Phase 2|0|Actual|University of Zurich||2||Poor study patient recruitment|f||||t||||||||||2017-10-11 00:38:10.765591|2017-10-11 00:38:10.765591
NCT02095886|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-09-07|||March 25, 2014|Actual|2014-03-25|September 2017|2017-09-01|July 7, 2014|Actual|2014-07-07|July 7, 2014|Actual|2014-07-07||Interventional|||Relative Bioavailability Study With BMS-955176|Assessment of BMS-955176 Bioavailability From a Micronized Crystalline Tablet Relative to a Spray-Dried Dispersion Suspension and Assessment of Additional Experimental Formulations Relative to the Micronized Crystalline Tablet in Healthy Subjects|Completed||Phase 1|47|Actual|ViiV Healthcare||8|||f||||f||||||||||2017-10-11 00:38:10.860767|2017-10-11 00:38:10.860767
NCT02095873|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-01-15|2016-08-02||May 2014||2014-05-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|HATFF||Healthy Aging Through Functional Food|Dietary Inducers of Glyoxalase-1 for Prevention and Early-stage Alleviation of Age Related Health Disorders Through Functional Foods.|Completed||Phase 1/Phase 2|32|Actual|University of Warwick||2|||f||||t||||||||Yes||2017-10-11 00:38:10.987237|2017-10-11 00:38:10.987237
NCT02095860|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-10-09|||April 2014||2014-04-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325|An Open-label, Randomized, Crossover Study to Assess the Effect of Food on the Pharmacokinetics of Daclatasvir, Asunaprevir, and BMS-791325 Following Administration of a Single Fixed Dose Combination of DCV 3DAA FDC in Healthy Subjects|Completed||Phase 1|24|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 00:38:11.408253|2017-10-11 00:38:11.408253
NCT02095847|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-04-07||||||April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection|Use of Fluorescence Imaging and High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection in Patients With Endometrial Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:38:11.556118|2017-10-11 00:38:11.556118
NCT02095834|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-04-05|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Carfilzomib, Bendamustine, Dexamethasone in Multiple Myeloma|A Single Center Phase Ib Study of Carfilzomib, Bendamustine and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1|18|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:38:11.692719|2017-10-11 00:38:11.692719
NCT02095821|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-08-22|||February 2014||2014-02-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Observational|||Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange|Observational Study of Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange Therapy|Recruiting||N/A|20|Anticipated|Hannover Medical School|||1||f||||||||||||||2017-10-11 00:38:11.830301|2017-10-11 00:38:11.830301
NCT02095808|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-06-07|||December 2012||2012-12-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Feasibility Study Using Imaging Biomarkers in Lung Cancer|Feasibility Study Using Imaging Biomarkers in Lung Cancer|Recruiting||N/A|92|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 00:38:11.922455|2017-10-11 00:38:11.922455
NCT02095795|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-28|||March 2014||2014-03-01|March 2014|2014-03-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Effectiveness of an Exoskeleton Gait Training Versus Manual Therapy in Subacute Post Stroke Patients.|Effectiveness of an Exoskeleton Gait Training Versus Manual Therapy in Subacute Post Stroke Patients.|Unknown status|Recruiting|N/A|28|Anticipated|Habilita, Ospedale di Sarnico||2|||f||||t||||||||||2017-10-11 00:38:12.017219|2017-10-11 00:38:12.017219
NCT02095782|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-03-02|||March 2014||2014-03-01|March 2017|2017-03-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|INNOVATE||Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation|Intercalated Combination of Chemotherapy and Erlotinib in 1st Line Setting for Patients Advanced Stage Non-small-cell Lung Cancer With Low Abundant Activating EGFR Mutation(INNOVATE)|Terminated||Phase 2|10|Actual|Guangdong Association of Clinical Trials||1||Because of the very slow enrollment, this study was stopped.|f||||f||||||||||2017-10-11 00:38:12.201842|2017-10-11 00:38:12.201842
NCT02095769|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-02-20|||April 2014||2014-04-01|February 2015|2015-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01|90 Days|Observational [Patient Registry]|POETRY||Pharmacogenomic Testing Of the Elderly To Reduce Morbidity|Pharmacogenomic Testing Of the Elderly To Reduce Morbidity|Unknown status|Recruiting|N/A|280000|Anticipated|General Genetics Corporation|||1||f||||f||||||||||2017-10-11 00:38:12.307243|2017-10-11 00:38:12.307243
NCT02095756|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-07-29|||June 2013||2013-06-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma|A Randomized, Split-Face, Double-Blind Clinical Pilot Study of Combination Picosecond Alexandrite Laser and Non-Hydroquinone Topical Therapy Versus Topical Therapy Alone for the Treatment of Facial Melasma|Completed||N/A|20|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:38:12.448295|2017-10-11 00:38:12.448295
NCT02095743|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-07-19|||April 2014||2014-04-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|EPIC||Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer|Phase II Randomised Study Comparing the Tolerance of PICC Line (Peripherally Inserted Central Catheter) and Implanted Port for Adjuvant Chemotherapy in HER2-negative Early Breast Cancer|Recruiting||Phase 2|256|Anticipated|Centre Henri Becquerel||2|||f||||f||||||||||2017-10-11 00:38:12.527157|2017-10-11 00:38:12.527157
NCT02095730|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-03-21|||May 2014||2014-05-01|March 2014|2014-03-01||||May 2016|Anticipated|2016-05-01||Interventional|||Corneal Cross-Linking Comparing Variables|Study of Safety and Efficacy of Photochemically Induced Collagen Cross-Linking at an Irradiance of 18 mW/cm2 as Constant or Pulsed Treatment in Eyes With Unstable Corneas Due to Keratoconus, Ectasia, or Post-Incisional Refractive Surgery|Unknown status|Not yet recruiting|Phase 3|500|Anticipated|Crowd Health Research, LTD||4|||f||||f||||||||||2017-10-11 00:38:12.635034|2017-10-11 00:38:12.635034
NCT02095717|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-06-19|||March 2014||2014-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|CURTAXEL||Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)||Active, not recruiting||Phase 2|50|Actual|Centre Jean Perrin||2|||f||||f||||||||||2017-10-11 00:38:12.820342|2017-10-11 00:38:12.820342
NCT02095704|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-24|||May 2013||2013-05-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Pharmacokinetics of a Standard Paracetamol Tablet and Oral Solution After Oral Administration in Chinese Healthy Volunteers||Completed||Phase 1|6|Actual|Central South University||2|||f||||t||||||||||2017-10-11 00:38:12.919582|2017-10-11 00:38:12.919582
NCT02095691|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-10-30|2015-07-20||October 2013||2013-10-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|March 2014|Actual|2014-03-01||Interventional|RENABLATE-II|The Safety Analysis population which consists of all enrolled subjects who have undergone insertion of the study ablation catheter.|RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157|A Prospective, Multi-center, Non-Randomized, Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension (RENABLATE-II - 157)|Completed||Phase 1|19|Actual|Biosense Webster, Inc.||1|||f||||t||||||||||2017-10-11 00:38:13.017226|2017-10-11 00:38:13.017226
NCT02095678|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-07-26|||December 1, 2013||2013-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions|Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions|Recruiting||N/A|170|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|f|t|f|f|f|||||2017-10-11 00:38:13.58638|2017-10-11 00:38:13.58638
NCT02095665|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-02-02|||November 2014||2014-11-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SPAM||Ureteral Stent-related Pain and Mirabegron (SPAM) Trial|Ureteral Stent-related Pain and Mirabegron (SPAM) Trial|Recruiting||Phase 4|236|Anticipated|Nova Scotia Health Authority||4|||f||||f||||||||||2017-10-11 00:38:13.707139|2017-10-11 00:38:13.707139
NCT02095639|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-07-20|||August 2012|Actual|2012-08-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Observational|||Inflammation and Electroconvulsive Therapy|Does Electroconvulsive Therapy Cause Neuroinflammation? An [18F]FEPPA Positron Emission Tomography Study in Treatment Resistant Depression|Terminated||N/A|5|Actual|Centre for Addiction and Mental Health|||1|The study was terminated|f||||t||||||Samples With DNA|"     Whole blood, plasma and serum samples will be kept for analysis of genotype, peripheral     inflammatory markers and protein binding.   "|||2017-10-11 00:38:13.840708|2017-10-11 00:38:13.840708
NCT02095626|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2015-07-23|||June 2013||2013-06-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation|Pilot Study to Investigate the Clinical Effect of Orally Inhaled AP301 on Treatment of Primary Graft Dysfunction (PGD) in Mechanically Ventilated Patients After Primary Lung Transplantation|Completed||Phase 2|20|Actual|Apeptico Forschung und Entwicklung GmbH||2|||f||||t||||||||||2017-10-11 00:38:13.921826|2017-10-11 00:38:13.921826
NCT02095613|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-08-10|||May 2010||2010-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2011|Actual|2011-07-01||Interventional|||Tailored Nutrition and Food Security Interventions in Comprehensive HIV Care|A Randomized Trial of Ready-to-use-supplementary Food Compared to Corn-soy-blend+ as Food Rations for HIV-infected Adults on Antiretroviral Therapy in Rural Haiti|Completed||N/A|623|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 00:38:14.019066|2017-10-11 00:38:14.019066
NCT02095600|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-08-03|||April 2011||2011-04-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|DB-SRS||Radiosurgery for Drug Resistant Invalidating Tremor|Deep Brain Stimulation and Frameless Stereotactic Radiosurgery in the Treatment of Drug Resistant Invalidating Tremor|Active, not recruiting||N/A|6|Anticipated|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta||1|||f||||f||||||||||2017-10-11 00:38:14.098535|2017-10-11 00:38:14.098535
NCT02095587|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2017-07-28|||March 2014||2014-03-01|July 2017|2017-07-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|IPI-145-14||Duvelisib in Hepatically Impaired Subjects Compared to Healthy Subjects|A Phase 1, Open-Label, Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Duvelisib in Subjects With Chronic Hepatic Impairment Compared to Healthy Subjects|Completed||Phase 1|24|Actual|Verastem, Inc.||4|||f||||f||||||||||2017-10-11 00:38:14.172907|2017-10-11 00:38:14.172907
NCT02095574|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-08-12|||September 2014||2014-09-01|August 2014|2014-08-01|January 2015|Anticipated|2015-01-01|September 2014|Anticipated|2014-09-01||Interventional|||A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma|Disposition of [14C] ABT-199 in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) Following a Single Oral Dose Administration|Withdrawn||Phase 1|0|Actual|AbbVie||1||This study will now be conducted in healthy volunteers.|f||||f||||||||||2017-10-11 00:38:14.295813|2017-10-11 00:38:14.295813
NCT02095561|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2014-03-27|2014-03-27||July 2012||2012-07-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|EMA||Evaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening Uptake|Study of HPV Self Testing Evaluation in the Province of Jujuy, Argentina|Completed||N/A|6013|Actual|Instituto Nacional del Cáncer, Argentina||2|||f||||t||||||||||2017-10-11 00:38:14.394598|2017-10-11 00:38:14.394598
NCT02095548|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-12-08|||March 2014||2014-03-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA)|A Phase 1, Placebo-Controlled, Double-Blind, Dose-Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects|Completed||Phase 1|61|Actual|Samumed LLC||4|||f||||||||||||||2017-10-11 00:38:14.891418|2017-10-11 00:38:14.891418
NCT02095535|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-04-27|2017-04-27||April 2014||2014-04-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|Chlorhexidine||Chlorhexidine Drying Time|The Minimum ChloraPrep Drying Time Before Neuraxial Anesthesia in Elective Cesarean Delivery Patients - Prospective Observational Study|Completed||N/A|20|Actual|University of British Columbia|"Small sample size
Severe methodological assumptions (i.e. measuring of ChloraPrep drying time, lack of gold standard to assess wetness/dryness
Patient's variables could influence wetness
No enrollment of high BMI patients with skin folds"||1||f||||f||||||||||2017-10-11 00:38:15.023589|2017-10-11 00:38:15.023589
NCT02095522|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-07-06|||March 2014||2014-03-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CODEN||COlchicine Improve EnDothElial Function in Non ST Elevation Myocardial Infarction Patients|Does COlchicine Improve EnDothElial Function in Non ST Elevation Myocardial Infarction Patients?: A Prospective Randomized, Double-blind Placebo Controlled Study|Withdrawn||N/A|0|Actual|Tel-Aviv Sourasky Medical Center||2||The investigators did not find suiable patients|f||||t||||||||No||2017-10-11 00:38:15.238721|2017-10-11 00:38:15.238721
NCT02095509|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-10-19|||March 2014||2014-03-01|October 2016|2016-10-01||||March 2017|Anticipated|2017-03-01||Interventional|||Pharmacokinetics of Enoxaparin in Intensive Care Patients|Pharmacokinetics of Enoxaparin in Intensive Care Patients|Recruiting||Phase 4|40|Anticipated|Tampere University Hospital||2|||f||||f||||||||||2017-10-11 00:38:15.339329|2017-10-11 00:38:15.339329
NCT02095496|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-01-29|||October 2014||2014-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SleepICU||Efficacy of Closed-loop Ventilation to Reduced Sleep Disorders|Contribution to the Understanding of the Involvement of Mechanical Ventilation in ICU Patients Sleep Disorders|Completed||N/A|16|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||No||2017-10-11 00:38:15.433184|2017-10-11 00:38:15.433184
NCT02095457|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-20|||July 2014||2014-07-01|March 2014|2014-03-01||||July 2017|Anticipated|2017-07-01||Interventional|ROM-Shalvata||Routine Outcome Monitoring in Mental Health Outpatient|A Randomized Trial of Routine Computerized Outcome and Process Clinical Measures Monitoring in Mental Health Outpatient Services: Preparing for the Planned Public Mental Health Reform in Israel|Unknown status|Not yet recruiting|N/A|900|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 00:38:15.618275|2017-10-11 00:38:15.618275
NCT02095444|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2014-03-20|||March 2014||2014-03-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection|Phase1 Study of Recombinant Stem Cells That Repair Lung Injury in H7N9 Infected Patients|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|S-Evans Biosciences Co.,Ltd.||1|||f||||t||||||||||2017-10-11 00:38:15.723886|2017-10-11 00:38:15.723886
NCT02095431|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-05-15|||June 2013||2013-06-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|June 2015|Actual|2015-06-01||Observational|AKIB||Acute Kidney Injury Biomarkers: Diagnosis and Application in Pre-operative Period of Liver Transplantation|Acute Kidney Injury Biomarkers: Diagnosis and Application in Pre-operative Period of Liver Transplantation|Active, not recruiting||N/A|122|Anticipated|University of Sao Paulo|||1||f||||f||||||Samples Without DNA|"     blood plasma and urine   "|||2017-10-11 00:38:15.82958|2017-10-11 00:38:15.82958
NCT02095418|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-20|||February 2014||2014-02-01|March 2014|2014-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|NODAT||Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept|Open Label, Multicenter Randomized Control Study to Investigate the Incidence of NODAT (New-Onset Diabetes After Transplantation), Safety and Efficacy of Corticosteroids Early Withdrawal in Liver Transplanted Recipients|Recruiting||N/A|152|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:38:15.91557|2017-10-11 00:38:15.91557
NCT02095405|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-12-20|||February 2010||2010-02-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2012|Actual|2012-08-01||Interventional|CACOA-HEART||A Study of Caffeine on Cardiac Arrhythmias|A Prospective Placebo Controlled Randomized Study of Caffeine in Patients With Supraventricular Tachycardia Undergoing Electrophysiologic Testing.|Completed||N/A|160|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-11 00:38:16.030558|2017-10-11 00:38:16.030558
NCT02095392|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-11-30|||April 2014||2014-04-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effects of Soluble Phosphate in Humans|The Effect of Soluble Phosphate in Combination With Different Calcium Doses on Calcium and Phosphorus Metabolism in Healthy Adults|Completed||N/A|62|Actual|University of Jena||4|||f||||f||||||||||2017-10-11 00:38:16.114823|2017-10-11 00:38:16.114823
NCT02095379|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-03-20|||October 2013||2013-10-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Observational|||Oligosecretary Myeloma: Prevalence and Its Clinical Significance|Oligosecretary Myeloma: Prevalence and Its Clinical Significance|Completed||N/A|390|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:38:16.201523|2017-10-11 00:38:16.201523
NCT02095366|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-03-23|||December 2014||2014-12-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|ALGOFINE-2||Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting|Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting. A Multicenter,Randomized,Controled, Comparative, Double Blinded Study|Recruiting||Phase 4|220|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 00:38:16.278315|2017-10-11 00:38:16.278315
NCT02095353|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-02-22|||September 2014|Actual|2014-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients|Gadobenate Dimeglumine Compared to Gadobutrol for MRI Perfusion Analysis in Brain Tumor Patients|Terminated||N/A|6|Actual|University of Nebraska|||1|"FDA safety concerns with repeated use of gadolinium-based contrast; subjects received   additional dose of contrast with no direct clinical benefit"|f||||f||||||||No||2017-10-11 00:38:16.394079|2017-10-11 00:38:16.394079
NCT02095340|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-08-18|||May 2014||2014-05-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Effects of Maternal Interpretation Biases on Child Anxiety and Related Responses||Recruiting||N/A|260|Anticipated|University of Houston||2|||f|||||f|f||||||||2017-10-11 00:38:16.468243|2017-10-11 00:38:16.468243
NCT02095327|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-08-26|||July 2013||2013-07-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|FAD||Families Affected by Dementia: A Survey of Caregivers|Religion and Free Will Perceptions as Coping Mechanisms in Caregivers of Individuals With Dementia|Completed||N/A|60|Actual|University of Miami|||1||f||||f||||||||||2017-10-11 00:38:16.547316|2017-10-11 00:38:16.547316
NCT02095314|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-12-16|||March 2014||2014-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine|Antibody Persistence After Primary Doses, Immune Response and Safety After Doses of Pentabio Vaccine in Indonesian Children at 18-24 Months of Age|Completed||Phase 2/Phase 3|399|Actual|PT Bio Farma||1|||f||||f||||||||||2017-10-11 00:38:16.630117|2017-10-11 00:38:16.630117
NCT02095301|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-04-21|||January 2014||2014-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Herbal Extract Study||Completed||N/A|110|Actual|PepsiCo Global R&D||2|||f||||||||||||||2017-10-11 00:38:16.743141|2017-10-11 00:38:16.743141
NCT02095288|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-09-01|||November 2013||2013-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|1 Day|Observational [Patient Registry]|||Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A|Broad-spectrum Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in In Vitro Human Whole-blood Assay (hWBA)|Recruiting||N/A|30|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples Without DNA|"     Thirty (n=30) healthy, non-smoking male and female volunteers between the ages of 18-50 will     be included in this study. If all inclusion/exclusion criteria are met, a blood collection of     104 ml will be obtained and the study visit will be completed. If eligible, a volunteer may     participate in this study up to four separate times, but not more than two times in the same     week.   "|||2017-10-11 00:38:16.951493|2017-10-11 00:38:16.951493
NCT02086331|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-11-18|||December 2013||2013-12-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EMMU||Evaluation of Musculoskeletal Microcirculation With Ultrasound|Evaluation of Musculoskeletal Microcirculation With Ultrasound|Completed||N/A|5|Actual|Imperial College London||3|||f||||t||||||||||2017-10-11 00:40:18.199101|2017-10-11 00:40:18.199101
NCT02095275|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-20|||January 2012||2012-01-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Exploring the Relationship Among BNP, Fluid Status and Acute Kidney Injury in Critically Ill Patients|Exploring the Relationship Among Brain Natriuretic Peptide, Fluid Status and Acute Kidney Injury in Critically Ill Patients|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Serum BNP   "|||2017-10-11 00:38:17.043642|2017-10-11 00:38:17.043642
NCT02095262|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2016-11-03|||August 2011||2011-08-01|November 2016|2016-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|TAG||Gameplay as a Source of Intrinsic Motivation in a Randomized Controlled Trial of Auditory Training for Tinnitus|Auditory Games for Tinnitus Benefit: Interactive Versus Reactive Auditory Discrimination Games|Completed||Phase 1/Phase 2|60|Actual|Nottingham University Hospitals NHS Trust||3|||f||||f||||||||||2017-10-11 00:38:17.129184|2017-10-11 00:38:17.129184
NCT02095249|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-08-03|||September 2014||2014-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Prostate Hypoxia - TIC|Hypoxia and Stem Cell Content as Aggression Factors in Prostate Cancer|Recruiting||N/A|50|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 00:38:17.221842|2017-10-11 00:38:17.221842
NCT02095236|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-20|||January 2013||2013-01-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ESMERALDA||Evaluation of Intrafractional Motion of Liver Tumors Using Markers|Evaluation of Inter- and Intrafractional Motion of Liver Tumors Using Interstitial Markers and Implantable Electro-magnetic Radiotransmitters in the Context of Image-guided Radiotherapy (IGRT) - the ESMERALDA Trial|Unknown status|Recruiting|Phase 1|50|Anticipated|University Hospital Heidelberg||1|||f||||f||||||||||2017-10-11 00:38:17.32032|2017-10-11 00:38:17.32032
NCT02095223|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-12-03|2016-06-07||December 2013||2013-12-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Electromyographic Biofeedback on Quadriceps Neuromuscular Function in Patients With Quadriceps Inhibition|Effect of Electromyographic Biofeedback on Quadriceps Neuromuscular Function|Terminated||N/A|4|Actual|University of Miami||2||Difficulties with participant recruitment.|f||||f||||||||||2017-10-11 00:38:17.419438|2017-10-11 00:38:17.419438
NCT02095210|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-03-20|||April 2013||2013-04-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025|Phase 1 Study, Evaluating HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025|Unknown status|Recruiting|Phase 1|8|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-10-11 00:38:17.745577|2017-10-11 00:38:17.745577
NCT02095197|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-02-07|2016-09-22||March 2014||2014-03-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain|A Prospective Randomized Controlled Trial of Standardized C7-T1 Epidural Steroid Injections Versus Targeted Injection Via Cervical Epidural Catheter for the Treatment of Cervical Radicular Pain|Completed||Phase 4|79|Actual|Northwestern University||2|||f||||f||||||||No||2017-10-11 00:38:17.870837|2017-10-11 00:38:17.870837
NCT02095184|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-09-01|||May 25, 2015||2015-05-25|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients|GCC 1366: A Prospective Study of Neoadjuvant Non-Steroidal Aromatase Inhibitors to Evaluate Anti-Proliferative Response in Obese and Overweight Patients|Recruiting||N/A|90|Anticipated|University of Maryland||6|||f||||t||||||||||2017-10-11 00:38:18.337509|2017-10-11 00:38:18.337509
NCT02095171|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-02-09|||March 2014||2014-03-01|February 2015|2015-02-01||||December 2014|Actual|2014-12-01||Interventional|||Single Ascending Dose Study of PRX002 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of PRX002 Administered by Intravenous Infusion in Healthy Subjects|Completed||Phase 1|40|Anticipated|Prothena Biosciences Limited||2|||f||||||||||||||2017-10-11 00:38:18.452478|2017-10-11 00:38:18.452478
NCT02095158|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-21|2016-08-01|2016-08-01||April 2014||2014-04-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea|A Long-term Safety and Efficacy Study of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea|Completed||Phase 3|440|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:38:18.555108|2017-10-11 00:38:18.555108
NCT02095145|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-09-12|||May 8, 2014|Actual|2014-05-08|September 2017|2017-09-01||||February 15, 2018|Anticipated|2018-02-15||Interventional|||Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance|A Phase IIA Exploratory, Randomized, Placebo-Controlled Trial of Pomegranate Fruit Extract/POMx™ in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance|Active, not recruiting||Phase 2|30|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 00:38:18.874655|2017-10-11 00:38:18.874655
NCT02095132|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-10-03|||March 27, 2014|Actual|2014-03-27|September 2017|2017-09-01||||October 31, 2017|Anticipated|2017-10-31||Interventional|||WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors|A Phase 1/2 Study of AZD1775 (MK-1775) in Combination With Oral Irinotecan in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors|Recruiting||Phase 1/Phase 2|128|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:38:19.018872|2017-10-11 00:38:19.018872
NCT02095119|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-04-13|||July 2008||2008-07-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer|Phase I-II Study of Palliative Treatment With Nimotuzumab as a Second, Third Line or More of Treatment for Advanced or Metastatic Cervical Cancer|Completed||Phase 1/Phase 2|15|Anticipated|National Institute of Cancerología||1|||f||||t||||||||||2017-10-11 00:38:19.241704|2017-10-11 00:38:19.241704
NCT02094742|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-10-14|||May 2013||2013-05-01|March 2014|2014-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|BIG MS Pilot||BIG Molecular Screening Feasibility Study|The BIG Molecular Screening Feasibility Study:Testing the IT Infrastructure and Logistics of a Molecular Screening Program|Completed||N/A|30|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 00:38:24.547535|2017-10-11 00:38:24.547535
NCT02095093|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-03-20|||March 2014||2014-03-01|March 2014|2014-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||An Intelligent Instrument for Improved Leg Length and Hip Offset Accuracy in Total Hip Arthroplasty|Intellijoint HIP Limited Release Trial: An Intelligent Instrument for Improved Leg Length and Hip Offset Accuracy in Total Hip Arthroplasty|Unknown status|Recruiting|N/A|128|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-11 00:38:19.437367|2017-10-11 00:38:19.437367
NCT02095080|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-07-13|||August 2014||2014-08-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Determination of the UL of Leucine in Healthy Elderly Men|Determination of the Tolerable Upper Intake Level (UL) of Leucine in Healthy Elderly Men (70-75 Yrs)|Completed||N/A|6|Actual|University of British Columbia||1|||f||||t||||||||||2017-10-11 00:38:19.550852|2017-10-11 00:38:19.550852
NCT02095067|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-09-23|||June 2013||2013-06-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Videoconferencing Between Ambulances and Physician at the Emergency Medical Dispatch Center, Effects on On-Site Patient Treatment and Patterns of Referral|Telemedical Solutions in Medical Emergencies, Advantages and Disadvantages for Patients, Healthcare Professionals, and Healthcare System. Study 2: Videoconferencing Between Ambulances and Physician at the Emergency Medical Dispatch Center,|Unknown status|Recruiting|N/A|150|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:38:19.655364|2017-10-11 00:38:19.655364
NCT02095054|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-08-09|||March 19, 2014|Actual|2014-03-19|August 2017|2017-08-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|||Regorafenib and Cetuximab in Patients With Advanced Malignancy|A Phase I Trial of Regorafenib and Cetuximab in Patients With Advanced Malignancy|Active, not recruiting||Phase 1|39|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:38:19.800134|2017-10-11 00:38:19.800134
NCT02095041|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2014-03-23|||March 2014||2014-03-01|March 2014|2014-03-01||||June 2014|Anticipated|2014-06-01||Observational|||"Trends In Oxygen Saturation In Healthy Term Infants In The First Few Days Of Life: The TOST Study"||Unknown status|Recruiting|N/A|625|Anticipated|University of Calgary|||1||f||||f||||||||||2017-10-11 00:38:19.9371|2017-10-11 00:38:19.9371
NCT02095028|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-21|||April 2011||2011-04-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Dietary and Lifestyle Interventions in Obese Pregnant Women|Effects of Dietary and Lifestyle Interventions in Obese Pregnant Women From the First Trimester on Gestational Weight Gain and Pregnancy Outcomes|Completed||N/A|373|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 00:38:20.069529|2017-10-11 00:38:20.069529
NCT02095015|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-06-24|||March 2014||2014-03-01|June 2015|2015-06-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Observational|||Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)|Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric Ear, Nose and Throat (ENT) Surgery (Adenoidectomy and/or Tonsillectomy and/or Tympanostomy) (The HATT Project)|Terminated||N/A|160|Actual|Shire|||1|terminated for not meeting enrollment goals|f||||f||||||||||2017-10-11 00:38:20.183873|2017-10-11 00:38:20.183873
NCT02095002|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-21|||January 2014||2014-01-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Observational|||The Effect of Modified Valsalva Maneuver on Filling Degree of Internal Jugular Vein|The Effect of Modified Valsalva Maneuver on Filling Degree of Internal Jugular Vein|Completed||N/A|30|Actual|Fudan University|||1||f||||||||||||||2017-10-11 00:38:20.315171|2017-10-11 00:38:20.315171
NCT02094989|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-21|||January 2013||2013-01-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|EVER||ECG and VCG in Dependence of Body Posture|Prospective, Observational Controlled Trial to Assess the Statistical and the Visual Accuracy of the Individual VCG-ECG-Transformation in Dependence of Posture|Completed||N/A|46|Actual|Bern University of Applied Sciences|||1||f||||t||||||||||2017-10-11 00:38:20.371072|2017-10-11 00:38:20.371072
NCT02094963|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-06-19|||July 5, 2014|Actual|2014-07-05|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|TICA KOREA||Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management|A Randomized, Open-label, Parallel Group, Multicenter Phase IV Study to Assess Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management:TICAKOREA Trial|Active, not recruiting||Phase 4|800|Actual|Asan Medical Center||2|||f||||t||||||||No|This is not a publicly funded trial.|2017-10-11 00:38:20.595162|2017-10-11 00:38:20.595162
NCT02094950|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-07-31|||March 2014||2014-03-01|July 2017|2017-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||Acupuncture Feasibility Trial for Dyspnea in Lung Cancer|Acupuncture Feasibility Trial for Dyspnea in Lung Cancer|Active, not recruiting||Phase 1|12|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:38:20.711134|2017-10-11 00:38:20.711134
NCT02094937|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-04-25|2016-03-24||March 27, 2014|Actual|2014-03-27|April 2017|2017-04-01|August 28, 2015|Actual|2015-08-28|August 28, 2015|Actual|2015-08-28||Interventional|||A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects|201135 : A Randomised, Double-blind, Multicenter, Parallel-group Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Subjects Stepped Down From a Maintenance Therapy With RELVAR® Inhaler (FF/VI) 100/25 mcg Once-daily in Japanese Subjects|Completed||Phase 3|430|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:38:20.795502|2017-10-11 00:38:20.795502
NCT02093858|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-03-20|||April 2014||2014-04-01|March 2014|2014-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome|The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome|Not yet recruiting||N/A|212|Anticipated|Central South University|||1||f||||t||||||||||2017-10-11 00:38:40.41893|2017-10-11 00:38:40.41893
NCT02094924|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-05-12|||April 17, 2014|Actual|2014-04-17|May 2017|2017-05-01|May 23, 2014|Actual|2014-05-23|May 23, 2014|Actual|2014-05-23||Interventional|||A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323|An Open-Label, Randomised, Single Dose, Two-Way Crossover Pilot Study to Determine the Relative Bioavailability of a Fixed Dose Combination Tablet Formulation of GSK587323 (16mg Candesartan Cilexetil/12.5mg Hydrochlorothiazide) Relative to Respective Reference Dosage Atacand D in Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:38:21.530904|2017-10-11 00:38:21.530904
NCT02094911|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-19|||October 2011||2011-10-01|March 2014|2014-03-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Interventional|SLIMMER||(Cost-)Effectiveness of SLIMMER Diabetes Prevention Intervention|Implementation and (Cost-)Effectiveness of Diabetes Prevention in Dutch Primary Health Care: From SLIM to SLIMMER|Unknown status|Active, not recruiting|N/A|316|Anticipated|Wageningen University||2|||f||||f||||||||||2017-10-11 00:38:21.639392|2017-10-11 00:38:21.639392
NCT02094898|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-08-10|2017-05-03||September 2014||2014-09-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|Ketamine||Ketamine for Depression and Suicide Risk|Acute and Maintenance Intravenous Ketamine for Treatment Resistant Major Depression With Suicidal Ideation/Attempt|Completed||Phase 2|12|Actual|Mayo Clinic|Lack of placebo or other control group and small sample size.|1|||f||||f|t|f||||||||2017-10-11 00:38:21.767992|2017-10-11 00:38:21.767992
NCT02094885|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-07-26|2016-07-26||February 2014||2014-02-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||The Bioseal Vascular Study|A Prospective, Randomized, Controlled Phase IV Study to Compare Bioseal Versus Manual Compression as an Adjunct to Hemostasis in the Patients Undergoing Elective Vascular Surgery|Completed||Phase 4|252|Actual|Ethicon, Inc.||2|||f||||f||||||||||2017-10-11 00:38:22.715967|2017-10-11 00:38:22.715967
NCT02094872|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-02-17|||May 2014||2014-05-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic|Stand Up to Cancer Consortium Genomics-Enabled Medicine for Melanoma (G.E.M.M.): Using Molecularly-Guided Therapy for Patients With BRAF Wild-Type (BRAFwt) Metastatic Melanoma|Active, not recruiting||Phase 2|47|Anticipated|Yale University||1|||f||||t||||||||||2017-10-11 00:38:23.535073|2017-10-11 00:38:23.535073
NCT02094859|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-03-21|||April 2013||2013-04-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||GlucoClearTM System ICU Study|GlucoClearTM System ICU Study|Completed||N/A|50|Actual|Edwards Lifesciences|||1||f||||f||||||||||2017-10-11 00:38:23.662171|2017-10-11 00:38:23.662171
NCT02094846|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-20|||October 2012||2012-10-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of an Intervention Based on Cell Phones|Evaluation of the Effect of an Intervention Based on Cell Phones on Glycemic Control in Adults With Type 2 Diabetes Mellitus|Completed||N/A|88|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||f||||||||||2017-10-11 00:38:23.733998|2017-10-11 00:38:23.733998
NCT02094833|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-04-25|||March 2014|Actual|2014-03-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|April 2016|Actual|2016-04-01||Interventional|||DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants|Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-Hep B-PRP~T Combined Vaccine at 2, 4, and 6 Months of Age Versus Sanofi Pasteur's DTaP IPV//PRP~T Combined Vaccine at 2, 4, and 6 Months of Age + Hep B Vaccine at 1 and 6 Months of Age, in South Korean Infants Primed With Hep B at Birth|Completed||Phase 3|310|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:38:23.81628|2017-10-11 00:38:23.81628
NCT02094820|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-01-14|||May 2014||2014-05-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Psychological Wellbeing in Chronic Fatigue Syndrome|Psychological Wellbeing in Adults With Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis|Completed||N/A|61|Actual|Royal Holloway University|||1||f||||f||||||||||2017-10-11 00:38:23.935891|2017-10-11 00:38:23.935891
NCT02094807|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-04-13|||April 2014||2014-04-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|potf||Pain as Indication for Operative Treatment of Traumatic Rib Fractures|A Prospective Randomized Controlled Trial of Pain as Indication for Operative Treatment of Traumatic Rib Fractures.|Recruiting||N/A|60|Anticipated|Sahlgren´s University Hospital||2|||f||||t||||||||||2017-10-11 00:38:24.014545|2017-10-11 00:38:24.014545
NCT02094794|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-03-13|||April 29, 2014|Actual|2014-04-29|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Lymphocytic or Myelogenous Leukemia|Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) Given in Combination With Cyclophosphamide and Etoposide as Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients With High-Risk Acute Lymphocytic or Myelogenous Leukemia|Recruiting||Phase 2|46|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:38:24.131068|2017-10-11 00:38:24.131068
NCT02094781|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-12-11|||December 2013||2013-12-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males|A Randomized, Double-blind, Placebo-controlled, Three-arm Trial to Evaluate the Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males|Completed||Phase 1|18|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:38:24.24638|2017-10-11 00:38:24.24638
NCT02094768|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-02-14|||April 2014||2014-04-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|September 2016|Actual|2016-09-01||Interventional|SAMS||Soda and Milk Study|Effects of Replacing Sugar Sweetened Beverages With Milk on Metabolic Factors in Overweight and Obese Adolescents|Active, not recruiting||N/A|30|Actual|Children's Hospital & Research Center Oakland||2|||f||||f||||||||||2017-10-11 00:38:24.322855|2017-10-11 00:38:24.322855
NCT02094729|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-06-04|||September 2013||2013-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease|A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease|Completed||Phase 1|26|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-11 00:38:24.63605|2017-10-11 00:38:24.63605
NCT02094716|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-08-03||2017-08-03|April 2014|Actual|2014-04-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies|A Multicenter, Randomized, Double-Blind, Parallel Group Comparison Study of the Safety and Efficacy of Permethrin Foam, 5% Versus Permethrin Foam, 4% Versus Vehicle in Subjects With Sarcoptes Scabiei|Completed||Phase 2|130|Actual|Mylan Inc.||4|||f||||t|t|f||||||||2017-10-11 00:38:24.753841|2017-10-11 00:38:24.753841
NCT02094703|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-19|||April 2013||2013-04-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females|The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Symptomatic Non-complicated Urinary Tract Infection in Females|Unknown status|Recruiting|Phase 4|126|Anticipated|Dr Cipto Mangunkusumo General Hospital||2|||f||||||||||||||2017-10-11 00:38:24.868956|2017-10-11 00:38:24.868956
NCT02094690|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2015-03-17|||June 2013||2013-06-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Physiotherapy for Radiation-induced Trismus|Prophylactic Physiotherapy Development Of Radiation-Induced Trismus In Patients With Head And Neck Cancer: Randomized Controlled Clinical Trial|Completed||N/A|90|Actual|Federal University of Health Science of Porto Alegre||3|||f||||t||||||||||2017-10-11 00:38:24.954825|2017-10-11 00:38:24.954825
NCT02094677|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-03-09|2015-12-15||March 2014||2014-03-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Daily Disposable Comparison Study|Daily Disposable Comparison Study|Completed||Phase 4|70|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 00:38:25.063704|2017-10-11 00:38:25.063704
NCT02094651|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-10-20|||April 2014||2014-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium|Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium|Withdrawn||Phase 2|0|Actual|Boston Children’s Hospital||2||No eligible patients were enrolled|f||||t||||||||No||2017-10-11 00:38:27.658588|2017-10-11 00:38:27.658588
NCT02094638|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-02-18|||January 2014||2014-01-01|February 2016|2016-02-01||||August 2015|Actual|2015-08-01|7 Days|Observational [Patient Registry]|||Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study|Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study|Completed||N/A|30400|Anticipated|Peking University Third Hospital|||1||f||||t||||||Samples With DNA|"     biospecimen including serum, plasma, blood cells with DNA.   "|||2017-10-11 00:38:27.758861|2017-10-11 00:38:27.758861
NCT02094625|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-10-20|||March 2016||2016-03-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|February 2018|Anticipated|2018-02-01||Interventional|||NAC to Prevent Cisplatin-induced Hearing Loss|A Dose-Finding Study of N-Acetylcysteine (NAC) to Prevent Cisplatin-induced Hearing Loss in Children With Cancer|Recruiting||Phase 1|30|Anticipated|Children's Hospital Los Angeles||2|||f||||t||||||||||2017-10-11 00:38:28.177512|2017-10-11 00:38:28.177512
NCT02094612|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-06-19|2017-01-31||March 2014||2014-03-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||The population under study consists of children under age 18 who presented at 4 clinics in Northern California Kaiser Permanente for ADHD assessment. The study baseline population consists of 207 potentially eligible participants who enrolled and signed consent for the study.|Effectiveness of the Quotient® ADHD Assessment in a System of Care|Effectiveness of the Quotient® ADHD Assessment in a System of Care|Terminated||N/A|207|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-11 00:38:28.290811|2017-10-11 00:38:28.290811
NCT02094599|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-05-12|||February 2014||2014-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users|A Single-dose, Double-blind, Double-dummy, Randomized, Placebo- and Active-controlled Crossover Study to Evaluate the Abuse Potential of Dronabinol Oral Solution in Recreational Cannabinoid Users|Completed||Phase 1|43|Actual|INSYS Therapeutics Inc||1|||f||||||||||||||2017-10-11 00:38:28.788029|2017-10-11 00:38:28.788029
NCT02094586|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-07-15|||May 2014||2014-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Adults|A Phase III Randomized, Double-blind, Placebo-Controlled Three-Lot Consistency Study in Healthy Adult Volunteers to Assess Immunogenicity, and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200, Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR|Completed||Phase 3|3146|Actual|PaxVax, Inc.||2|||f||||f||||||||||2017-10-11 00:38:28.893232|2017-10-11 00:38:28.893232
NCT02094573|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-09-05|2017-05-26||June 4, 2014|Actual|2014-06-04|September 2017|2017-09-01|September 21, 2020|Anticipated|2020-09-21|February 29, 2016|Actual|2016-02-29||Interventional||Intention to Treat (ITT) Population included all participants who were randomized to each regimen regardless of whether they received study drug or adhere to the assigned dose.|A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib|A Randomized Phase 2 Study of AP26113 in Patients With ALK-positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib|Active, not recruiting||Phase 2|222|Actual|Ariad Pharmaceuticals||2|||f||||t|t|f||||||||2017-10-11 00:38:29.070184|2017-10-11 00:38:29.070184
NCT02094560|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-19|||November 2011||2011-11-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Interventional|CAP7-1||CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors|Phase II Trial of CAP7.1 in Adult Patients With Refractory Malignancies: Small Cell Lung Carcinoma, Non-Small Cell Lung Carcinoma, Biliary Carcinoma (PIITCAP)|Unknown status|Recruiting|Phase 2|150|Anticipated|CellAct Pharma GmbH||3|||f||||t||||||||||2017-10-11 00:38:30.916928|2017-10-11 00:38:30.916928
NCT02094547|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-08-05|||December 2010||2010-12-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|COGNIS||A Neurocognitive and Immunological Study of a New Formula for Healthy Infants|Evaluación Del Efecto de Una Nueva fórmula Infantil Con Ingredientes específicos Sobre el Desarrollo Neurocognitivo e inmunológico en Lactantes|Active, not recruiting||N/A|170|Actual|Laboratorios Ordesa||2|||f||||f||||||||||2017-10-11 00:38:31.032867|2017-10-11 00:38:31.032867
NCT02094534|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-06-06|2015-07-07||March 2014||2014-03-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics|A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics|Completed||Phase 2|25|Actual|Oramed, Ltd.||2|||f||||f||||||||||2017-10-11 00:38:31.141949|2017-10-11 00:38:31.141949
NCT02094521|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-01-28|||March 2014||2014-03-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects|Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects|Completed||Phase 1|122|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 00:38:31.528069|2017-10-11 00:38:31.528069
NCT02094508|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2017-06-30|||March 7, 2014||2014-03-07|December 14, 2016|2016-12-14|December 14, 2016|Actual|2016-12-14|December 28, 2015|Actual|2015-12-28||Observational|||Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda|Impact of Trimethoprim-sulfamethoxazole Prophylaxis on Malaria Infection and Immunity in Children in Uganda|Completed||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:38:31.597763|2017-10-11 00:38:31.597763
NCT02094495|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-06-24|||June 2014||2014-06-01|June 2014|2014-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Pilot Study About Tamoxifen Therapy for Breast Cancer Patients|Pilot Study to Evaluate the Knowledge and Understanding on Tamoxifen Therapy for Breast Cancer Patients|Unknown status|Recruiting|N/A|300|Anticipated|National Cancer Center, Korea|||1||f||||f||||||||||2017-10-11 00:38:31.675387|2017-10-11 00:38:31.675387
NCT02094482|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-07-14|||April 2014||2014-04-01|July 2014|2014-07-01||||April 2015|Anticipated|2015-04-01||Interventional|||Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)|Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)|Unknown status|Recruiting|N/A|55|Anticipated|Medartis AG||1|||f||||||||||||||2017-10-11 00:38:31.761386|2017-10-11 00:38:31.761386
NCT02094469|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-01-27|||December 2013||2013-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|STELLA_Ext||Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina|A Multicenter, One Group, Open-label Study to Evaluate the Safety and Efficacy of Pletaal(Cilostazol) as BID for up to 24 Weeks Exposure in Subjects With Vasospastic Angina (STELLA Extension)|Completed||Phase 3|65|Actual|Korea Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:38:31.858973|2017-10-11 00:38:31.858973
NCT02094456|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-04-07|||March 2016||2016-03-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Prophylactic Elective Clipping of Colonic Diverticula|Prophylactic Elective Clipping of Colonic Diverticula in Patients Who Have Had Sustained Lower Gastrointestinal Haemorrhage|Recruiting||N/A|24|Anticipated|King's College Hospital NHS Trust||1|||f||||f||||||||||2017-10-11 00:38:31.951874|2017-10-11 00:38:31.951874
NCT02094443|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-08-19|2016-06-30||March 2014||2014-03-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Full Analysis Set, defined as all participants who were correctly randomized.|Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option|A Multicenter, Open-label, Randomized, 2-arm, Phase II Trial of Pharmacodynamics, Pharmacokinetics and Safety of Two Dose Regimens of DEB025/Alisporivir in Combination With Ribavirin Therapy in Chronic Hepatitis C Genotype 2 and 3 Patients Who Have Previously Failed Interferon Therapy or Are Intolerant or Unable to Take Interferon.|Completed||Phase 2|52|Actual|Debiopharm International SA||2|||f||||t||||||||||2017-10-11 00:38:32.092553|2017-10-11 00:38:32.092553
NCT02094430|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-02-11|||January 2014||2014-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency|Clinical Pharmacology, Efficacy and Safety Study of FGTW in Paediatric Patients With Severe Congenital Fibrinogen Deficiency|Completed||Phase 2/Phase 3|16|Actual|Laboratoire français de Fractionnement et de Biotechnologies||1|||f||||f||||||||||2017-10-11 00:38:32.794655|2017-10-11 00:38:32.794655
NCT02094417|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-06-07|||March 2014||2014-03-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia|A Phase 2, Randomized, Open-Label, Parallel, Comparative, Dose-Finding Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia Subjects With Thrombocytopenia Refractory to Immunosuppressive Therapy|Active, not recruiting||Phase 2|32|Anticipated|Kyowa Hakko Kirin Korea Co., Ltd.||4|||f||||f||||||||||2017-10-11 00:38:33.056609|2017-10-11 00:38:33.056609
NCT02094404|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2015-05-28|||December 2013||2013-12-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Triage of Children at the Emergency Department: Manchester Triage System or Pediatric Early Warning Score?|Triage of Children at the Emergency Department: Manchester Triage System or Pediatric Early Warning Score?|Completed||N/A|727|Actual|Isala|||1||f||||f||||||||||2017-10-11 00:38:33.17818|2017-10-11 00:38:33.17818
NCT02094391|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-06-08|||March 2014||2014-03-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ILP+/-IPI||Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma|A Randomized, Open Label, Multicenter, Comparative Phase II Trial of Ipilimumab After Isolated Limb Perfusion (ILP), in Patients With In-transit Metastases Melanoma Stage IIIB and IIIC|Completed||Phase 2|4|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 00:38:33.265724|2017-10-11 00:38:33.265724
NCT02094378|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-10-15|||June 2014||2014-06-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Evaluate the Effect of Intranasal Esketamine on Cognitive Functioning in Healthy Subjects|A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study to Evaluate the Effect of Intranasal Esketamine on Cognitive Functioning in Healthy Subjects|Completed||Phase 1|24|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 00:38:33.344762|2017-10-11 00:38:33.344762
NCT02094365|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-12-22|||March 2014||2014-03-01|March 2014|2014-03-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model|A Randomised, Phase 2a, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Multiple Doses of Orally Administered ALS-008176 Against Respiratory Syncytial Virus Infection in the Virus Challenge Model|Completed||Phase 2|62|Actual|Alios Biopharma Inc.||2|||f||||f||||||||||2017-10-11 00:38:33.435926|2017-10-11 00:38:33.435926
NCT02094352|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-05-18|2017-03-21||March 24, 2014|Actual|2014-03-24|May 2017|2017-05-01|April 20, 2015|Actual|2015-04-20|April 20, 2015|Actual|2015-04-20||Interventional|||Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome|Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome|Terminated||Phase 2|3|Actual|Hospital for Special Surgery, New York||2||The study was unable to enroll efficiently despite trying various technique.|f||||t||||||||||2017-10-11 00:38:33.524888|2017-10-11 00:38:33.524888
NCT02094339|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-03-11|||March 2014||2014-03-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparison of Three Kinds of Postoperative Analgesia After Total Knee Arthroplasty|Comparison of Three Kinds of Postoperative Analgesia After Total Knee Arthroplasty :a Randomized Clinical Trial|Unknown status|Recruiting|Phase 4|45|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||3|||f||||f||||||||||2017-10-11 00:38:33.787144|2017-10-11 00:38:33.787144
NCT02094326|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-02-09|2016-01-12||March 2014||2014-03-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|SAR-FAME||Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)|A Retrospective, Multicentre Observational Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Real Life in Patients With Rheumatoid Arthritis|Completed||N/A|301|Actual|Fundación Andaluza de Reumatología|||1||f||||f||||||||||2017-10-11 00:38:33.894359|2017-10-11 00:38:33.894359
NCT02094313|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-20|||January 2008||2008-01-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effects of Atorvastatin on Human Semen and Gonadal Hormones|Effects of Decrease in Cholesterol Levels Induced by a Statin on Sperm Quality|Completed||Phase 1|17|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 00:38:34.159281|2017-10-11 00:38:34.159281
NCT02094300|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-12-12|2015-08-13|2014-03-21|December 2007||2007-12-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|February 2012|Actual|2012-02-01||Interventional|STABLE I||Zenith® Dissection Endovascular System|Zenith® Dissection Endovascular System|Completed||N/A|26|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 00:38:34.25985|2017-10-11 00:38:34.25985
NCT02094287|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-09-17|||September 2010||2010-09-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|November 2013|Actual|2013-11-01||Interventional|||Placebo Effect in the Treatment of Atopic Dermatitis|Placebo Effect in Atopic Dermatitis - Increase the Pharmacological Effect of Itching Caused by Classical Conditioning and Expectancy Processes: A Randomized Controlled Trial|Completed||N/A|166|Actual|Charite University, Berlin, Germany||4|||f||||f||||||||||2017-10-11 00:38:34.467955|2017-10-11 00:38:34.467955
NCT02094274|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-05-21|||November 2013||2013-11-01|March 2014|2014-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid|A Single-dose, Randomised, Crossover, Placebo-controlled, Double-dummy, Pharmacodynamic Clinical Trial Assessing Two Fixed Dose Combinations of Long-acting Beta-agonist (LABA) and Inhaled Corticosteroid (ICS)|Completed||Phase 1|30|Actual|Almirall, S.A.||3|||f||||f||||||||||2017-10-11 00:38:34.565842|2017-10-11 00:38:34.565842
NCT02094261|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-06-26|2016-04-28||May 20, 2014|Actual|2014-05-20|June 2017|2017-06-01|November 1, 2017|Anticipated|2017-11-01|May 1, 2015|Actual|2015-05-01||Interventional|AURA2||Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours|Phase II, Open Label, Single-arm Study to Assess Safety and Efficacy of AZD9291 in Patients With Locally Advanced/Metastatic NSCLC Whose Disease Has Progressed With Previous EGFR TKI and Whose Tumours Are EGFR and T790M Mutation Positive|Active, not recruiting||Phase 2|210|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 00:38:34.689162|2017-10-11 00:38:34.689162
NCT02094248|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-05-19|||March 2014||2014-03-01|June 2014|2014-06-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||rhTPO in Critical Patients With Thrombocytopenia|A Randomized, Open-label, Placebo-controlled, Multi-center Study to Evaluate Safety and Efficacy of Recombinant Human Thrombopoietin Among Severe Sepsis Patients With Thrombocytopenia|Unknown status|Recruiting|Phase 2/Phase 3|600|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 00:38:35.159081|2017-10-11 00:38:35.159081
NCT02094235|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-04-06|||January 2014||2014-01-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis||Completed||Phase 1/Phase 2|62|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-11 00:38:35.2513|2017-10-11 00:38:35.2513
NCT02094209|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-09-12|||January 2015||2015-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01|6 Months|Observational [Patient Registry]|FRSmartFix||Focused Registry SmartFix|Clinical Data Collection With a Novel Biofeedback Technology for Continuous Monitoring of Bone Healing|Active, not recruiting||N/A|10|Actual|AO Clinical Investigation and Documentation|||1||f||||t||||||||||2017-10-11 00:38:35.402818|2017-10-11 00:38:35.402818
NCT02094196|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-08-10|||December 2012||2012-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Observational|LeAD P5||The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders|The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders (LeAD P5)|Enrolling by invitation||N/A|60|Anticipated|Technische Universität Dresden|||3||f||||t||||||Samples With DNA|"     Bloodsample are taken for genetic analysis   "|||2017-10-11 00:38:35.486026|2017-10-11 00:38:35.486026
NCT02094183|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-07-04|||September 2011||2011-09-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Interaction Between Appetite Hormones|The Interaction Between Appetite Hormones and Their Importance for Maintenance of Weight Loss After a Low Calorie Diet|Completed||N/A|58|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 00:38:35.581659|2017-10-11 00:38:35.581659
NCT02094157|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-04-01|||December 2007||2007-12-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|PACEBRIDGE||Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation|An Open-Label Randomized Control Trial of Pre-Operative Low Molecular Weight Heparin Versus Tapered Warfarin as Bridging Therapy for Patients With Implantation of Pacemaker or Defibrillator|Terminated||Phase 3|173|Actual|McMaster University||2||Change of practice made further recruitment impossible|f||||f||||||||No||2017-10-11 00:38:35.721918|2017-10-11 00:38:35.721918
NCT02094144|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-19|||January 2008||2008-01-01|March 2014|2014-03-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|ACTIMARCH||Health Benefits of a 6-month Brisk Walking Program in Sedentary Postmenopausal Women|Health Benefits of a 6-month Brisk Walking Program in Sedentary Postmenopausal Women : a Randomized Controlled Trial|Completed||N/A|126|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 00:38:35.850167|2017-10-11 00:38:35.850167
NCT02094131|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-20|||October 2010||2010-10-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Effects of Training Using Volume and Flow-oriented Incentive Spirometry in Healthy Subjects - Case-control Study|Effects of Training Using Volume and Flow-oriented Incentive Spirometry in Healthy Subjects - Case-control Study|Completed||N/A|39|Actual|Universidade Federal de Sao Carlos||3|||f||||f||||||||||2017-10-11 00:38:36.008121|2017-10-11 00:38:36.008121
NCT02094118|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-08-29|||January 2016||2016-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications|Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications|Recruiting||Phase 1/Phase 2|170|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:38:36.098478|2017-10-11 00:38:36.098478
NCT02094105|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-03-20|||November 1999||1999-11-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2009|Actual|2009-12-01||Interventional|||Endoscopic Screening on Esophageal Cancer|Effect of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: 10-year Follow up of a Community-based, Controlled Study Among High Risk Population in China|Completed||N/A|45386|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:38:36.207689|2017-10-11 00:38:36.207689
NCT02094092|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-19|||May 2014||2014-05-01|March 2014|2014-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|PRIC-SMM||Role of ProTectis on Infant Colic and Its Effect on Infant Crying Time and Maternal Mental Health|L.Reuteri ProTectis DSM 17938 to Relieve Infant Colic and Its Effects on Infant Sleep Pattern & Maternal Mental Health. PRIC-SMM Trial|Unknown status|Not yet recruiting|N/A|60|Anticipated|Ferozsons Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 00:38:36.300283|2017-10-11 00:38:36.300283
NCT02094079|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-03-17|||March 2014||2014-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism|Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women|Completed||N/A|80|Actual|Herlev Hospital|||1||f||||t||||||||||2017-10-11 00:38:36.403875|2017-10-11 00:38:36.403875
NCT02094066|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-24|||March 2014||2014-03-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||The Effect of Tranexamic Acid for Total Hip Arthroplasty|The Effects of High Doze Tranexamic Acid Application on Hemorrhage, Blood Transfusion, Fibrin Degradation Products, and Kidney Functions for Total Hip Arthroplasty|Unknown status|Recruiting|Phase 4|60|Anticipated|TC Erciyes University||2|||f||||f||||||||||2017-10-11 00:38:36.48844|2017-10-11 00:38:36.48844
NCT02094053|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-08-21|||September 12, 2013|Actual|2013-09-12|August 2017|2017-08-01|April 21, 2017|Actual|2017-04-21|September 16, 2016|Actual|2016-09-16||Interventional|||A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.|A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.|Completed||Phase 2|36|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-11 00:38:36.586325|2017-10-11 00:38:36.586325
NCT02094040|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-19|||February 2012||2012-02-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Municipality-based Post-discharge Follow-up Visits|Effect of Municipality-based Post-discharge Follow-up Visit Including the Primary Physician on Early Re-hospitalization in High Risk People of 65+ Years. A Randomised Controlled Trial.|Completed||N/A|531|Actual|Holbaek Sygehus||2|||f||||f||||||||||2017-10-11 00:38:36.701301|2017-10-11 00:38:36.701301
NCT02094027|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-12-16|||July 2011||2011-07-01|March 2014|2014-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|BED||Bariatric Surgery and Guided Self-help for Binge Eating Disorder|The Role of Self-help in the Pre-surgical Treatment of Binge Eating Disorder in Bariatric Surgery Candidates: Implications for Weight-related and Psychological Outcome.|Terminated||N/A|150|Actual|Imperial College London||2||New evidence came to light to indicate that study was no longer relevant|f||||f||||||||Yes|The IPD has been shared with Prof. Alex Blakemore as planned, who was conducting the genetic part of the study and who is using the data in wider analysis.|2017-10-11 00:38:36.796914|2017-10-11 00:38:36.796914
NCT02094014|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-05-10|||March 2014||2014-03-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech|Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech|Completed||N/A|46|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-11 00:38:36.889345|2017-10-11 00:38:36.889345
NCT02094001|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-06-30|||May 2014|Actual|2014-05-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH|Evaluation of Right Ventricular Function and Metabolism Following Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension- Images of Rio|Completed||Phase 2|6|Actual|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 00:38:36.997901|2017-10-11 00:38:36.997901
NCT02093988|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-11-30|||August 2015||2015-08-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Topical Tranexamic Acid in Major Paediatric Spine Deformity Surgery: A Randomized Controlled Trial|Topical Tranexamic Acid in Major Paediatric Spine Deformity Surgery: A Randomized Controlled Trial|Not yet recruiting||Early Phase 1|160|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 00:38:37.082106|2017-10-11 00:38:37.082106
NCT02093975|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-12-07|||May 2014||2014-05-01|December 2015|2015-12-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Videoconferencing Between Ambulances and Physician Manned Rapid Response Vehicles, Effects on On-site Patient Treatment and Patterns of Referral|Telemedical Solutions in Medical Emergencies, Advantages and Disadvantages for Patients, Healthcare Professionals, and Healthcare System. Study 3: Videoconferencing Between Ambulances and Physician Manned Rapid Response Vehicles, Effects on On-site Patient Treatment and Pattern of Referral|Withdrawn||N/A|0|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:38:37.177783|2017-10-11 00:38:37.177783
NCT02093962|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-08-23|2017-07-13||June 2014||2014-06-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer|A Randomized Phase 2, Double-blind, Placebo-controlled, Multi-center Study Comparing Pemetrexed in Combination With TH-302 vs. Pemetrexed in Combination With Placebo as Second-line Chemotherapy for Advanced Non-Squamous, Non-Small Cell Lung Cancer|Terminated||Phase 2|265|Actual|Threshold Pharmaceuticals||2||"At the interim analysis, the futility boundary was not met and the study was stopped due to   insufficient efficacy."|f||||t||||||||||2017-10-11 00:38:37.287876|2017-10-11 00:38:37.287876
NCT02093949|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-03-22|2016-10-18||September 2013||2013-09-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|December 2014|Actual|2014-12-01||Observational|SUBSTRATE-HD||Substrate Ablation Guided by High Density Mapping in Atrial Fibrillation|Substrate Ablation Guided by Automatic High Density Mapping for the Treatment of Atrial Fibrillation|Completed||N/A|152|Actual|Hospital St. Joseph, Marseille, France|||2||f||||t||||||||||2017-10-11 00:38:38.197039|2017-10-11 00:38:38.197039
NCT02093936|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-19|||January 2005||2005-01-01|March 2014|2014-03-01||||January 2013|Actual|2013-01-01|10 Years|Observational [Patient Registry]|||Lymphocytes Cut Off Values of Induced Sputum Samples in Healthy and Non-healthy Patients- A Cross Sectional Study|Lymphocytes Cut Off Values of Induced Sputum Samples in Healthy and Non-healthy Patients- A Cross Sectional Study|Completed||N/A|1000|Actual|Tel-Aviv Sourasky Medical Center|||4||f||||f||||||||||2017-10-11 00:38:38.585684|2017-10-11 00:38:38.585684
NCT02093923|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-06-20|2016-04-20||April 2014||2014-04-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema (HAE) Subjects|A Phase 1b, Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Subjects|Completed||Phase 1|38|Actual|Shire||5|||f||||f||||||||||2017-10-11 00:38:38.686258|2017-10-11 00:38:38.686258
NCT02093910|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-11-17|||April 2014||2014-04-01|November 2014|2014-11-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy|Phase 2 Study of Concurrent Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy in Patients of Multiple Myeloma|Recruiting||Phase 2|100|Anticipated|Sun Yat-sen University||1|||f||||f||||||||||2017-10-11 00:38:39.438154|2017-10-11 00:38:39.438154
NCT02093897|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-12-05|2016-08-23||March 2014||2014-03-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Pharmacokinetic, Efficacy, and Safety Study of Recombinant Factor VIII Single Chain (rVIII-SingleChain) in Children With Severe Hemophilia A|A Phase III Open-label Pharmacokinetic, Efficacy and Safety Study of rVIII-SingleChain in a Pediatric Population With Severe Hemophilia A|Completed||Phase 3|84|Actual|CSL Behring||1|||f||||t||||||||||2017-10-11 00:38:39.538425|2017-10-11 00:38:39.538425
NCT02093884|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-01-18|||January 2014|Actual|2014-01-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|T2I||A Pilot Study Using Text Messaging to Communicate With Adolescent Females in the Pediatric Emergency Department|Texting 2 Initiate: A Pilot Study Using Text Messaging to Communicate With Adolescent Females in the Pediatric Emergency Department (T2I)|Completed||N/A|100|Actual|Columbia University||2|||f||||f||||||||No||2017-10-11 00:38:40.222106|2017-10-11 00:38:40.222106
NCT02093871|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-07-19|||August 2013||2013-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PISH-2||A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer|A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer|Suspended||Phase 1|20|Anticipated|ThermalCore Inc||1|||f||||t||||||||||2017-10-11 00:38:40.317786|2017-10-11 00:38:40.317786
NCT02093845|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-04-24|||February 10, 2014|Actual|2014-02-10|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|August 24, 2015|Actual|2015-08-24||Interventional|SORT-OUT VIII||Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII|Randomized Clinical Comparison of Everolimus-Eluting SYNERGY® and Biolimus-Eluting BioMatrix NeoFlex® Coronary Stents in Non-Selected Patients With Ischemic Heart Disease|Active, not recruiting||N/A|2800|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 00:38:40.499588|2017-10-11 00:38:40.499588
NCT02093832|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-19|||July 2013||2013-07-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Does the Femoral Head Size Can Predict the Cup Size?|Does the Femoral Head Size Can Predict the Cup Size? Retrospective Study.|Completed||N/A|83|Actual|HaEmek Medical Center, Israel|||1||f||||t||||||||||2017-10-11 00:38:40.604125|2017-10-11 00:38:40.604125
NCT02093819|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2016-02-22|2015-11-11||April 2014||2014-04-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Treated Set: This subject set included all subjects who were dispensed study medication and were documented to have taken ≥1 dose of study drug.|To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 416970 in Healthy Male Volunteers in a Partially Randomised, Single-blind, Placebo-controlled Trial, Investigation of Relative Bioavailability of BI 416970 (Open-label, Randomised, Three-way Cross-over) and Assessment of Safety and Exposure of BI 416970 in CYP2C9 Genotyped Volunteers (Open-label, Single-dose)|Completed||Phase 1|60|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:38:40.691657|2017-10-11 00:38:40.691657
NCT02093806|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2014-12-15|||January 2014||2014-01-01|December 2014|2014-12-01||||June 2015|Anticipated|2015-06-01||Observational|||Clinical Applications of Round Window Imaging Anatomy in Cochlear Implant Surgery|Clinical Applications of Round Window High Resolution Computerised Tomography Anatomy in Cochlear Implant Surgery|Unknown status|Active, not recruiting|N/A|100|Actual|Bnai Zion Medical Center|||1||f||||t||||||||||2017-10-11 00:38:41.446816|2017-10-11 00:38:41.446816
NCT02093793|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-08-04|||March 2014||2014-03-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|July 2018|Anticipated|2018-07-01||Interventional|ACCELERATE||Safety and Effectiveness Study of the Precision SCS Systems Adapted for High-Rate Spinal Cord Stimulation|A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Precision Spinal Cord Stimulator Systems Adapted for High-Rate Spinal Cord Stimulation|Recruiting||N/A|406|Anticipated|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-11 00:38:41.532946|2017-10-11 00:38:41.532946
NCT02093780|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-05-02|||March 2014||2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||"Personalized Alberta Diet for Prevention of Relapse in Ulcerative Colitis"|A Dietary Approach to Reduce the Frequency of Relapse in Ulcerative Colitis Patients: a Randomized Controlled Clinical Trial Study|Active, not recruiting||N/A|53|Anticipated|University of Alberta||2|||f||||f||||||||No||2017-10-11 00:38:41.628641|2017-10-11 00:38:41.628641
NCT02093767|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-05-02|||August 2007||2007-08-01|May 2017|2017-05-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis|Open-Label Trial of a Prebiotic Preparation Containing Inulin and Oligofructose (Synergy-1) for the Treatment of Mild to Moderate Acute Ulcerative Colitis|Completed||N/A|24|Actual|University of Alberta||2|||f||||f||||||||No||2017-10-11 00:38:41.721252|2017-10-11 00:38:41.721252
NCT02093754|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-07-11|||May 2014||2014-05-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ANRS ECHAM||Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients|Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients: a European Multicentre Study|Completed||N/A|460|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-11 00:38:41.807345|2017-10-11 00:38:41.807345
NCT02093741|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-02-09|||September 2013||2013-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)|ADVATE 2 mL (Reconstituted in 2 mL SWFI) POST-AUTHORIZATION SAFETY SURVEILLANCE STUDY|Completed||N/A|65|Actual|Baxalta US Inc.|||1||f||||f||||||||||2017-10-11 00:38:41.926974|2017-10-11 00:38:41.926974
NCT02093728|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-20|2015-06-29|||April 2014||2014-04-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers|A Phase I, Open-label, Single-center Study to Assess the Effect of the CYP3A4 Inhibitor Itraconazole and the CYP2C19 Inhibitor Fluconazole on the Pharmacokinetics of a 25 mg Single Oral Dose of Selumetinib (AZD6244; ARRY-142866) ( Hyd-Sulfate) in Healthy Volunteers Aged 18 to 45 Years|Completed||Phase 1|26|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:38:42.057974|2017-10-11 00:38:42.057974
NCT02093715|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-08-31|||July 2007||2007-07-01|June 2014|2014-06-01||||August 2020|Anticipated|2020-08-01|7 Years|Observational [Patient Registry]|||FeNO and Cytokines in Respiratory Syncytial Virus (RSV) and Non RSV Bronchiolitis in Relation to Future Asthma|FeNO and Cytokines in RSV and Non RSV Bronchiolitis in Relation to Future Asthma|Recruiting||N/A|400|Anticipated|Tel-Aviv Sourasky Medical Center|||5||f||||||||||Samples Without DNA|"     blood   "|||2017-10-11 00:38:42.180218|2017-10-11 00:38:42.180218
NCT02093702|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-08-15|2016-06-10||April 2014||2014-04-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01||Interventional|||Impact of Structured Physical Activity Education Delivery in Patients With Type 2 Diabetes Mellitus|Impact of Structured Physical Activity Education Delivery on Hemoglobin A1c Levels, Blood Pressure, Lipid Profile, Body Mass Index, Waist Circumference, and Adherence to Canadian Diabetes Association Clinical Practice Guidelines Weekly Physical Activity Recommendations for Patients With Type 2 Diabetes Mellitus: A Pilot Study.|Completed||N/A|5|Actual|Royal Victoria Hospital, Canada||2|||f||||f||||||||No||2017-10-11 00:38:42.270889|2017-10-11 00:38:42.270889
NCT02093676|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-11-19|||July 2014||2014-07-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||"Applying the New Authority Model in the Treatment of Poorly Controlled Diabetic Adolescents and Their Families"|"Development and Assessment of a Treatment Protocol for Poorly Controlled Diabetic (Type 1) Adolescents, Based on The New Authority Model"|Recruiting||N/A|45|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 00:38:42.792598|2017-10-11 00:38:42.792598
NCT02093663|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-09-01|||April 1, 2014||2014-04-01|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|PACE||Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis|A Phase 3, Multicenter, Randomized, Double-blind Study to Determine the Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis, in Both Acute and Maintenance Phases|Recruiting||Phase 3|160|Anticipated|Shire||2|||f||||||||||||||2017-10-11 00:38:42.915938|2017-10-11 00:38:42.915938
NCT02093650|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-09-23|||March 2014||2014-03-01|September 2014|2014-09-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|BCOMS||Black Cohosh Extract for Treatment of Moderate to Severe Menopausal Symptoms|Black Cohosh Extract for the Treatment of Moderate to Severe Menopausal Symptoms: a Randomized-placebo Controlled Trial|Unknown status|Recruiting|Phase 3|60|Anticipated|Navamindradhiraj University||2|||f||||t||||||||||2017-10-11 00:38:43.182253|2017-10-11 00:38:43.182253
NCT02093637|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-08-09|||August 2013|Actual|2013-08-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Rapid Extremity Pain Relief by Battlefield Acupuncture After Orthopedic Surgery|Rapid Extremity Pain Relief by Battlefield Acupuncture After Orthopedic Surgery: A Randomized Clinical Trial|Completed||N/A|279|Actual|Mike O'Callaghan Federal Hospital||3|||f||||f||||||||||2017-10-11 00:38:43.270297|2017-10-11 00:38:43.270297
NCT02093611|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-09-24|||July 2013||2013-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Examine the Effects of ATP Supplementation on Muscle Excitability and Reaction Time During and Following a Repeated Sprint Bout|Study to Examine the Effects of ATP Supplementation on Muscle Excitability and Reaction Time During and Following a Repeated Sprint Bout|Completed||N/A|42|Actual|Metabolic Technologies Inc.||2|||f||||f||||||||||2017-10-11 00:38:43.34526|2017-10-11 00:38:43.34526
NCT02093598|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-04-13|||May 2012||2012-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|POEM||POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus|"A Phase IIa Pharmacokinetic-pharmacodynamic Study to Confirm the Inhibitory Effect of Temsirolimus, Targeting the mTOR Pathway in Endometrial Carcinoma"|Completed||Phase 2|10|Actual|MedSIR||1|||f||||f||||||||||2017-10-11 00:38:43.432144|2017-10-11 00:38:43.432144
NCT02093585|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-05-11|||January 2014||2014-01-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|April 2016|Actual|2016-04-01||Interventional|TAPAS||Tenofovir Abacavir Platelet Activation Study|Changes in Coagulation and Platelet Reactivity in HIV-1 Infected Patients Switching Between Abacavir and Tenofovir Containing Antiretroviral Regimens|Active, not recruiting||Phase 4|100|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 00:38:43.521861|2017-10-11 00:38:43.521861
NCT02093572|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-12-27|||May 2014||2014-05-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Effect of Skipping Breakfast on Metabolic Function|Effect of Skipping Breakfast on Metabolic Function|Recruiting||N/A|30|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:38:43.607307|2017-10-11 00:38:43.607307
NCT02093559|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-02-13|||July 2014||2014-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|REBOOT||Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients||Completed||N/A|63|Actual|San Francisco Department of Public Health||2|||f||||f||||||||||2017-10-11 00:38:43.834442|2017-10-11 00:38:43.834442
NCT02093546|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-10-13|||August 2014||2014-08-01|October 2016|2016-10-01||||August 2019|Anticipated|2019-08-01||Observational|||Translational Companion Protocol to GOG229O|A Translational Companion Protocol to GOG229O: A Randomized Phase II Study With a Safety Lead-in to Assess the Antitumor Efficacy of the MEK Inhibitor Trametinib Alone or in Combination With GSK2141795, an AKT Inhibitor, in Patients With Recurrent or Persistent Endometrial Cancer|Active, not recruiting||N/A|25|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|||||||"     Participant undergoes blood draw and biopsy prior to start of therapy. After 28 days of     therapy, a blood draw and an additional biopsy of the same site obtained prior to beginning     cycle 2. Blood draw obtained at first tumor assessment point at pre-cycle 3 and at     progression. Participants undergo an additional blood draw at 72 hours after initiation of     therapy.   "|||2017-10-11 00:38:43.96438|2017-10-11 00:38:43.96438
NCT02093533|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-05-29|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|EAGLE||Eculizumab in Primary MPGN|EVALUATING THE MORPHOFUNCTIONAL EFFECTS OF ECULIZUMAB THERAPY IN PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: A PILOT, SINGLE ARM STUDY IN TEN PATIENTS WITH PERSISTENT HEAVY PROTEINURIA|Active, not recruiting||Phase 2|10|Anticipated|Mario Negri Institute for Pharmacological Research||1|||f||||f||||||||||2017-10-11 00:38:44.094266|2017-10-11 00:38:44.094266
NCT02093520|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-06-15|2017-05-23||May 2014||2014-05-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|May 2016|Actual|2016-05-01||Interventional|||The MiDAS ENCORE Study|MILD® Percutaneous Image-Guided Lumbar Decompression Versus Epidural Steroid Injections in Patients With Lumbar Spinal Stenosis Exhibiting Neurogenic Claudication|Active, not recruiting||N/A|302|Actual|Vertos Medical, Inc.||2|||f||||f||||||||||2017-10-11 00:38:44.245006|2017-10-11 00:38:44.245006
NCT02093507|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2014-03-20|||May 2013||2013-05-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effectiveness of Parent's Manipulation in Newborn With Metatarsus Adducts. a Randomized Controlled Trial|Effectiveness of Parent's Manipulation in Newborn With Metatarsus Adducts.a Randomized Controlled Trial|Unknown status|Recruiting|N/A|200|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 00:38:44.762832|2017-10-11 00:38:44.762832
NCT02093494|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-08-09|||January 2014||2014-01-01|August 2017|2017-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters|A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination Compared to Laboratory Standard Procedures When Collected Through Peripheral Intravenous Catheters (PIVC)|Terminated||N/A|200|Actual|Magnolia Medical Technologies, Inc.||2||Lack of enrollment|f||||f||||||||||2017-10-11 00:38:44.865417|2017-10-11 00:38:44.865417
NCT02093481|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-06-25|||February 2014||2014-02-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Dietary Fibre on Glucose Metabolism and Satiety|Intrinsic Indigestible Carbohydrates as Means to Modulate Colonic Events, With Specific Focus on Metabolism and Satiety|Completed||Early Phase 1|19|Actual|Lund University||4|||f||||f||||||||||2017-10-11 00:38:44.989566|2017-10-11 00:38:44.989566
NCT02093468|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-12-11|||June 2014||2014-06-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of MST-188 in Acute Lower Limb Ischemia|Evaluation of MST-188 in Acute Lower Limb Ischemia: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial Evaluating the Safety and Efficacy of MST-188 in Subjects With Acute Lower Limb Ischemia Receiving Catheter-Directed Recombinant Tissue Plasminogen Activator|Terminated||Phase 2|4|Actual|Mast Therapeutics, Inc.||3||Program discontinued to persue alternate indications.|f||||t||||||||||2017-10-11 00:38:45.126707|2017-10-11 00:38:45.126707
NCT02093455|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-07-21|||March 2014||2014-03-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Interventional|||Effects of Chardonnay Seed Flour on Vascular Health|Effects of Chardonnay Seed Flour on Vascular Health|Recruiting||N/A|80|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:38:45.263777|2017-10-11 00:38:45.263777
NCT02093442|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-11-03|||July 2014||2014-07-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|July 2018|Anticipated|2018-07-01||Interventional|||Endometrial Scratching for Cryopreserved Embryo Transfer|Endometrial Scratching for Cryopreserved Embryo Transfer: a Randomized Controlled Trial|Enrolling by invitation||N/A|300|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:38:45.383503|2017-10-11 00:38:45.383503
NCT02093429|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-02-03||2015-02-03|January 2014||2014-01-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)|A Randomized, Open-Label, 2-Stage Study of INCB047986 Administered Orally to Subjects With Primary Myelodysplastic Syndrome (MDS) Refractory to or Unlikely to Respond to Erythropoiesis-Stimulating Agents (ESAs)|Terminated||Phase 1/Phase 2|6|Actual|Incyte Corporation||3||Business decision.|f||||f||||||||||2017-10-11 00:38:45.506844|2017-10-11 00:38:45.506844
NCT02093416|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-01-14|||October 2013||2013-10-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Leptin Receptors in the Bariatric Surgical Population Within the University of Pittsburgh Medical System: A Cohort Study|Leptin Receptors in the Bariatric Surgical Population Within the University of Pittsburgh Medical System: A Cohort Study|Completed||N/A|50|Actual|University of Pittsburgh|||4||f||||f||||||||||2017-10-11 00:38:45.633802|2017-10-11 00:38:45.633802
NCT02093403|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-12-20|||March 2014||2014-03-01|December 2016|2016-12-01||||July 2017|Anticipated|2017-07-01||Interventional|||Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|Phase I Study of Decitabine (Dacogen) and Selinexor (KPT-330) in Acute Myeloid Leukemia|Active, not recruiting||Phase 1|25|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:38:45.714207|2017-10-11 00:38:45.714207
NCT02093390|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-06-01|2015-04-17||March 2014||2014-03-01|June 2016|2016-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects|A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Effects of Multiple Oral Doses of Fluconazole and Atorvastatin on the Pharmacokinetics of a Single Oral Dose of TAK-385 in Healthy Subjects|Completed||Phase 1|40|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:38:45.855871|2017-10-11 00:38:45.855871
NCT02093377|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-07-26|||February 2014||2014-02-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|May 2018|Anticipated|2018-05-01||Interventional|TEAM ASV-I||ASV for Sleep Apnea After Myocardial Infarction|Treatment of Sleep Apnea Early After Myocardial Infarction With Adaptive Servo-Ventilation - a Randomized Controlled Trial|Recruiting||N/A|90|Anticipated|University Hospital Regensburg||2|||f||||t||||||||||2017-10-11 00:38:47.137963|2017-10-11 00:38:47.137963
NCT02093364|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-01-05|||July 2015||2015-07-01|January 2016|2016-01-01||||May 2017|Anticipated|2017-05-01|12 Months|Observational [Patient Registry]|||A Focused Registry to Document the Use of the Short- or Long-stemmed Radial Head Prosthesis (RHP)|A Focused Registry to Document the Use of the Short- or Long-stemmed Radial Head Prosthesis (RHP)|Withdrawn||N/A|0|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 00:38:47.313296|2017-10-11 00:38:47.313296
NCT02093351|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-05|2016-04-26||September 1, 2014|Actual|2014-09-01|September 2017|2017-09-01|December 28, 2017|Anticipated|2017-12-28|April 30, 2015|Actual|2015-04-30||Interventional||All patients enrolled in Part A of the study and who received at least 1 dose of olaparib were included in the baseline analysis.|To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer|An Open-Label, Non-randomised, Parallel Group, Multicentre, Phase I Study to Assess the Safety and Effect of Olaparib at Steady State on the Pharmacokinetics of the Anti-hormonal Agents Anastrozole, Letrozole and Tamoxifen at Steady State, and the Effect of the Anti-hormonal Agents on Olaparib, Following Administration in Patients With Advanced Solid Cancer|Active, not recruiting||Phase 1|79|Actual|AstraZeneca|Data is presented for Part A of the study only as Part B was ongoing at the time of the posting of the results for Part A.|3|||f||||f||||||||||2017-10-11 00:38:47.40334|2017-10-11 00:38:47.40334
NCT02093338|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-03-19|||July 2011||2011-07-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||L.Fermentum CECT5716 in Treatment of Breast Pain|Study of Intervention Nutritional, Multicenter, Randomized, Blind, Parallel Group to Evaluate the Efficacy of Lactobacillus Fermentum CECT5716 to Reduce the Load Bacterial in Potential Pathogens in Milk of Mothers With Breast Pain|Completed||N/A|127|Actual|Biosearch S.A.||4|||f||||f||||||||||2017-10-11 00:38:48.449952|2017-10-11 00:38:48.449952
NCT02093325|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-09-16|||March 2014||2014-03-01|September 2013|2013-09-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||A Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Cancer|A Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Cancer|Unknown status|Enrolling by invitation|Phase 3|83|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:38:48.565315|2017-10-11 00:38:48.565315
NCT02093312|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-09-01|||March 2014||2014-03-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|RUMLE||Meals on Wheels, the Effect of a Home Food-delivery Service for Cancer Patients|Meals on Wheels, a Randomized Controlled Study on the Effect of a Home Food-delivery Service for Cancer Patients|Completed||N/A|40|Actual|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 00:38:48.682734|2017-10-11 00:38:48.682734
NCT02093299|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-06-28|||December 2012||2012-12-01|June 2017|2017-06-01|November 22, 2016|Actual|2016-11-22|November 22, 2016|Actual|2016-11-22|2 Years|Observational [Patient Registry]|RISCLON||RIsk of Apoplexia Cerebri in CLOpidogrel Non-responders|RIsk of Apoplexia Cerebri in CLOpidogrel Non-responders|Terminated||N/A|165|Actual|Zealand University Hospital|||1|Lack of feasiability|f||||t||||||||||2017-10-11 00:38:48.769232|2017-10-11 00:38:48.769232
NCT02093286|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-12-16|||May 2014||2014-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|||Safety Profile Following Pentabio Vaccination in Indonesian Infants|Phase IV, Study of Safety Profile Following Pentabio Vaccination in Indonesian Infants|Completed||N/A|4000|Actual|PT Bio Farma|||1||f||||f||||||||||2017-10-11 00:38:48.832932|2017-10-11 00:38:48.832932
NCT02093273|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-19|||May 2013||2013-05-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)|Phase II, Randomized, Double Blind, Prospective Intervention Study to Evaluate the Immunogenicity and Safety Profile of tOPV (Bio Farma) With Different Batch Numbers in Indonesian Infants|Completed||Phase 2|240|Actual|PT Bio Farma||2|||f||||t||||||||||2017-10-11 00:38:48.895349|2017-10-11 00:38:48.895349
NCT02093260|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2015-04-27|||May 2014||2014-05-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)|Phase II b Study of Immunogenicity and Safety of Flubio Vaccine in Infants and Children|Completed||Phase 2/Phase 3|405|Actual|PT Bio Farma||1|||f||||f||||||||||2017-10-11 00:38:48.971998|2017-10-11 00:38:48.971998
NCT02093247|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-18|||June 2014||2014-06-01|March 2014|2014-03-01||||July 2016|Anticipated|2016-07-01||Observational|||Characterize Novel Pathogen- and Host- Related Factors in Hospitalized Patients and Patients on the Emergency Department Presenting With Lower Respiratory Tract Infections and/or Sepsis||Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 00:38:49.047091|2017-10-11 00:38:49.047091
NCT02093234|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-02-21|2016-12-29||April 2014||2014-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|C4H||Changing the Healthcare Delivery Model|Changing the Healthcare Delivery Model:A Community Health Worker/Mobile Chronic Care Team Strategy|Completed||N/A|166|Actual|George Washington University||3|||f||||f||||||||Yes|De-identified participant data for all primary and secondary outcomes measures will be made available with 6 months of study completion|2017-10-11 00:38:51.09618|2017-10-11 00:38:51.09618
NCT02093221|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-01-26|||March 2014||2014-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus|A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus|Active, not recruiting||Phase 2|76|Actual|Grifols Therapeutics Inc.||6|||f||||t||||||||||2017-10-11 00:38:51.495756|2017-10-11 00:38:51.495756
NCT02093195|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-18|||December 2013||2013-12-01|March 2014|2014-03-01||||December 2015|Anticipated|2015-12-01||Interventional|BTCOPD||Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients|Phase Ⅱ Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients|Unknown status|Recruiting|Phase 2|40|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 00:38:51.684808|2017-10-11 00:38:51.684808
NCT02093182|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2016-12-21||||||December 2016|2016-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm|A Retrospective, Open-Label, Non-Randomized, Study Designed to Evaluate the Correlation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Vasospasm Patients After Sub Arachnoid Hemorrhage|Withdrawn||N/A|0|Actual|HeadSense Medical|||1|Agreement not executed between site and sponsor|f||||f||||||||||2017-10-11 00:38:51.788389|2017-10-11 00:38:51.788389
NCT02093169|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-09-22|||February 2014||2014-02-01|September 2014|2014-09-01||||June 2014|Actual|2014-06-01||Interventional|||D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer Compound|Interventional, Open-label, Positron Emission Tomography (PET) Study Investigating D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer Compound|Completed||Phase 1|12|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 00:38:51.869107|2017-10-11 00:38:51.869107
NCT02093156|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-19|||September 2013||2013-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01|1 Week|Observational [Patient Registry]|||A Predictive Score Identifies Patients With Inadequate Bowel Preparation for Colonoscopy|A Predictive Score Identifies Patients With Inadequate Bowel Preparation for Colonoscopy|Completed||N/A|605|Actual|Fourth Military Medical University|||2||f||||t||||||||||2017-10-11 00:38:52.072334|2017-10-11 00:38:52.072334
NCT02093143|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-19|||June 2009||2009-06-01|November 2008|2008-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|ENDOTANIL||Conditions of Diagnostic Panendoscopy of the Upper Airway Under Propofol Remifentanil General Anesthesia|Evaluation of the Impact of Adding Remifentanil to Propofol on the Conditions of the Diagnostic Panendoscopy of the Upper Airway Under General Anesthesia With Tubeless Spontaneous Ventilation.|Completed||Phase 3|256|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-11 00:38:52.19512|2017-10-11 00:38:52.19512
NCT02093130|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-06-14|||January 2014||2014-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Pomegranate Juice on Memory in Older Adults|Twelve-Month, Double-blind, Placebo-Controlled Study of Pomegranate Juice in Normal Aging|Recruiting||Phase 2|212|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:38:52.312125|2017-10-11 00:38:52.312125
NCT02093117|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-12-02|||August 2014||2014-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Neurosurgery Recruitment Maneuver Study|Effect of an Alveolar Recruitment Maneuver on Subdural Pressure, Brain Swelling and Cerebral Perfusion Pressure in Patients Undergoing Supratentorial Tumour Resection|Completed||N/A|22|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:38:52.436853|2017-10-11 00:38:52.436853
NCT02093104|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-05-03|||February 2014||2014-02-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|TACE||TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)|"Utilizing Intraprocedural Flow and Perfusion Dynamics as a Predictor of Response in Patients With Unresectable Hepatocellular Carcinoma Undergoing Chemoembolization and Radioembolization (Y90) Liver Embolization Perfusion TACE Study (Version 1.0) EPTS 2013-1.0"|Completed||N/A|40|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 00:38:52.551479|2017-10-11 00:38:52.551479
NCT02093091|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-17|||June 2011||2011-06-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2011|Actual|2011-10-01||Interventional|CENFPT||Clinical Evaluation of Nanoionomer Filling in Primary Teeth|Two-year Clinical Performance in Primary Teeth of Nano-filled Versus Conventional Resin Modified Glass Ionomer Restorations|Completed||N/A|29|Actual|Tanta University||2|||f||||t||||||||||2017-10-11 00:38:52.663575|2017-10-11 00:38:52.663575
NCT02093078|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-04-26|||January 2014||2014-01-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Observational|||Cognitive Aids With Roles Defined (CARD) for Obstetrical Crises: A Multisite Cohort Study|Cognitive Aids With Roles Defined (CARD) for Obstetrical Crises: A Multisite Cohort Study|Recruiting||N/A|108|Anticipated|Ottawa Hospital Research Institute|||2||f||||f||||||||||2017-10-11 00:38:52.804584|2017-10-11 00:38:52.804584
NCT02093065|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-08-24|||March 2015||2015-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Platelet Function in Patients With Hemophilia A|Decreased Platelet Function as a Cause of Increased Bleeding in Patients With Hemophilia A|Enrolling by invitation||N/A|36|Anticipated|Boston Children’s Hospital|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 00:38:52.924505|2017-10-11 00:38:52.924505
NCT02093052|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-12-19|||March 2005||2005-03-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Intervening Early With Neglected Children|Intervening Early With Neglected Children: Key Childhood Outcomes|Active, not recruiting||Phase 1/Phase 2|220|Actual|University of Delaware||3|||f||||t||||||||Undecided||2017-10-11 00:38:53.044349|2017-10-11 00:38:53.044349
NCT02093039|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-19|||May 2009||2009-05-01|March 2014|2014-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|DECIDEO||Informed Decision Users of the Health System and Participation in Organized Screening for Breast Cancer|Informed Decision Users of the Health System and Participation in Organized Screening for Breast Cancer : a Qualitative Analysis|Completed||N/A|16000|Actual|Institut de Cancérologie de la Loire||2|||f||||f||||||||||2017-10-11 00:38:53.164741|2017-10-11 00:38:53.164741
NCT02093026|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-01-23|2017-01-23||August 2002||2002-08-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Safety Population included all participants who received any part of an infusion of study medication under Study WA16855.|Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)|An Open-label Study of the Efficacy and Safety of Re-treatments With Rituximab (MabThera®/Rituxan®) in Patients With Active Rheumatoid Arthritis|Completed||Phase 2|465|Actual|Hoffmann-La Roche|The interpretation of the efficacy data over time should take into consideration that only the response of participants who continued in the study and received further courses of rituximab was captured.|1|||f||||||||||||||2017-10-11 00:38:53.341899|2017-10-11 00:38:53.341899
NCT02093013|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-03-28|||May 2004||2004-05-01|March 2017|2017-03-01|July 2007|Actual|2007-07-01|January 2007|Actual|2007-01-01||Interventional|RESPIRE||Effectiveness of an Integrated Care Program on Asthma Control and Inhaled Corticosteroids Adherence|Impact of an Integrated Care Intervention Program on Asthmatic Patients.|Completed||N/A|349|Actual|Laval University||2|||f||||f||||||||||2017-10-11 00:38:55.946233|2017-10-11 00:38:55.946233
NCT02093000|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-10-02|||November 30, 2014|Actual|2014-11-30|October 2017|2017-10-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|||A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma|A Multicenter, Prospective, Non-interventional Study of Maintenance Avastin (Bevacizumab) Following Induction Treatment With Platinum Doublet Plus Avastin in Patients With Advanced Lung Adenocarcinoma|Active, not recruiting||N/A|200|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:38:56.068941|2017-10-11 00:38:56.068941
NCT02092974|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-07-04|||April 2014||2014-04-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|LESO||Mechanism of tDCS-induced Learning Enhancement - the Role of Serotonin|Mechanism of tDCS-induced Learning Enhancement - the Role of Serotonin|Completed||Phase 1|40|Actual|Charite University, Berlin, Germany||4|||f||||f||||||||||2017-10-11 00:38:56.349105|2017-10-11 00:38:56.349105
NCT02092961|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-05-28|2014-04-25||February 2011||2011-02-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|OSKIRA 4 SS||Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study|A Phase IIB, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Fostamatinib Disodium Monotherapy Compared With Placebo or Adalimumab Monotherapy in Patients With Active Rheumatoid Arthritis: Magnetic Resonance Imaging Sub-Study|Terminated||Phase 2|198|Actual|AstraZeneca||3||"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to   Rigel Pharmaceuticals."|f||||t||||||||||2017-10-11 00:38:56.524982|2017-10-11 00:38:56.524982
NCT02092948|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-06-12|||August 22, 2013|Actual|2013-08-22|May 2016|2016-05-01|January 6, 2017|Actual|2017-01-06|January 6, 2017|Actual|2017-01-06||Interventional|||Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer|A Phase I Open Label Study to Evaluate the Tumor-targeting Properties and Safety of 124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer.|Completed||N/A|8|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 00:38:58.003001|2017-10-11 00:38:58.003001
NCT02092740|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-20|||November 2012||2012-11-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|RETESTICAPUM||REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg|Retrospective Analysis of Testicular Cancer Patients With Histopathological Analysis or Urological Treatment at the University Magdeburg 1960-2012.|Completed||N/A|2000|Actual|University of Magdeburg|||2||f||||t||||||||||2017-10-11 00:39:00.400016|2017-10-11 00:39:00.400016
NCT02092935|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-10-19||2016-10-13|April 2014||2014-04-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)|A Phase II, Randomized, Double-Blind, Active-Controlled Clinical Study to Investigate the Efficacy and Safety of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)|Completed||Phase 2|100|Actual|Summit Therapeutics||2|||f||||f||||||||||2017-10-11 00:38:58.117449|2017-10-11 00:38:58.117449
NCT02092922|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2017-09-29||2017-08-07|May 2014||2014-05-01|September 2017|2017-09-01|September 5, 2017|Actual|2017-09-05|July 2016|Actual|2016-07-01||Interventional|||A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)||Completed||Phase 2|154|Actual|Array BioPharma||1|||f||||f||||||||||2017-10-11 00:38:58.286534|2017-10-11 00:38:58.286534
NCT02092909|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-10-04|||March 2014||2014-03-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|8400-401||Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia|Phase 1/2 Open-Label, Multiple-dose, Dose-escalation Study to Evaluate the Safety and Tolerability of IMO-8400 in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia|Active, not recruiting||Phase 1/Phase 2|31|Actual|Idera Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-11 00:38:58.508778|2017-10-11 00:38:58.508778
NCT02092896|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-03-31|||March 2013||2013-03-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|T1DMLIRA||Liraglutide as add-on to Insulin in Type 1 Diabetes|Treatment With Liraglutide as add-on to Insulin in Type 1 Diabetic Patients. Effects on Glycemic Control and Counterregulation and Cognitive Performance During Hypoglycaemia|Completed||Phase 3|40|Actual|Hvidovre University Hospital||4|||f||||t||||||||||2017-10-11 00:38:58.618167|2017-10-11 00:38:58.618167
NCT02092883|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-01-06|||March 2013||2013-03-01|January 2016|2016-01-01||||July 2016|Anticipated|2016-07-01||Interventional|||Evaluation of Neuroinflammation in Children With Infantile Spasms|Neuroinflammation in Children With Infantile Spasms Measured With 11C-PK11195 Positron Emission Tomography: Response to ACTH|Recruiting||Phase 4|10|Anticipated|Wayne State University||1|||f||||||||||||||2017-10-11 00:38:58.729518|2017-10-11 00:38:58.729518
NCT02092870|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-19|||September 2013||2013-09-01|March 2014|2014-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Adipose Derived Regenerative Cellular Therapy of Chronic Wounds|Adipose Derived Regenerative Cellular Therapy of Chronic Wounds|Unknown status|Recruiting|Phase 2|25|Anticipated|Tower Outpatient Surgical Center||1|||f||||t||||||||||2017-10-11 00:38:58.836368|2017-10-11 00:38:58.836368
NCT02092857|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-24|2014-03-24||December 2009||2009-12-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants|Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants|Completed||Phase 1|89|Actual|University of Alberta||3|||f||||||||||||||2017-10-11 00:38:58.950233|2017-10-11 00:38:58.950233
NCT02092844|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-05-11|||January 2015||2015-01-01|October 2016|2016-10-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Cognitive Behavioral Therapy for Insomnia and Nocturnal Hot Flashes in Menopause|Cognitive Behavioral Therapy for Insomnia and Nocturnal Hot Flashes in Menopause|Completed||N/A|40|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-11 00:38:59.286504|2017-10-11 00:38:59.286504
NCT02092831|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-11-01|||April 2014||2014-04-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of the Effect of Formulation and Tablet Hardness on the Bioavailability of Pictilisib in Healthy Volunteers|A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF FORMULATION AND TABLET HARDNESS ON THE RELATIVE BIOAVAILABILITY OF PICTILISIB (GDC-0941) IN HEALTHY SUBJECTS|Completed||Phase 1|24|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 00:38:59.374085|2017-10-11 00:38:59.374085
NCT02092805|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-19|2014-03-19|||January 2010||2010-01-01|March 2014|2014-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||rTMS as a Treatment of Visceral Pain Secondary to Malignancy|Repetitive Transcranial Magnetic Stimulation in Visceral Pain Secondary to Malignancy|Completed||N/A|34|Actual|Assiut University||2|||f||||f||||||||||2017-10-11 00:38:59.709524|2017-10-11 00:38:59.709524
NCT02092792|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-11-01|||April 2014||2014-04-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors|A PHASE I, OPEN-LABEL STUDY EVALUATING THE SAFETY AND TOLERABILITY OF ESCALATING DOSES OF DLYE5953A IN PATIENTS WITH REFRACTORY SOLID TUMORS|Active, not recruiting||Phase 1|42|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 00:38:59.806642|2017-10-11 00:38:59.806642
NCT02092779|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-18|||March 2007||2007-03-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Growth Hormone Deficiency and Empty Sella Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study|Growth Hormone Deficiency, Empty Sella and Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study.|Completed||N/A|447|Actual|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 00:38:59.910332|2017-10-11 00:38:59.910332
NCT02092766|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-05-29|||June 2014||2014-06-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|DHART||Parenteral Artesunate Compared to Quinine as a Cause of Late Anaemia in African Children With Malaria|Parenteral Artesunate Compared to Quinine as a Cause of Late Post-treatment Anaemia in African Children With Hyperparasitaemic P. Falciparum Malaria|Completed||Phase 4|217|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 00:38:59.98453|2017-10-11 00:38:59.98453
NCT02092753|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-02-25|||March 2014||2014-03-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|KOLIBRI||Ketogenic Or LOGI Diet In a Breast Cancer Rehabilitation Intervention (KOLIBRI)|Ketogenic Or LOGI Diet In a Breast Cancer Rehabilitation Intervention (KOLIBRI)|Completed||N/A|150|Actual|Universitätsmedizin Mannheim||3|||f||||f||||||||||2017-10-11 00:39:00.182385|2017-10-11 00:39:00.182385
NCT02089373|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-08-19|||March 2014||2014-03-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Pilot Study on Usefulness of Probe-based Confocal Laser Endomicroscopy Targeted Gastric Biopsy||Completed||N/A|30|Actual|Yonsei University||2|||f||||||||||||||2017-10-11 00:39:42.565318|2017-10-11 00:39:42.565318
NCT02092727|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-01-12|||February 2014||2014-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Interventional|RaDIANT||The Reducing Disparities in Access to kidNey Transplantation (RaDIANT) Community Study|The Reducing Disparities in Access to kidNey Transplantation (RaDIANT) Community Study|Active, not recruiting||N/A|134|Actual|Emory University||2|||f||||f||||||||||2017-10-11 00:39:00.495996|2017-10-11 00:39:00.495996
NCT02092714|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-01-24|||October 2013||2013-10-01|January 2017|2017-01-01|November 16, 2019|Anticipated|2019-11-16|December 2017|Anticipated|2017-12-01||Observational|||Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors|A Pilot Study Utilizing Molecular Analysis Via Cancer CodeTM to Identify Therapeutic Targets for Patients With Advanced Neuroendocrine Tumors|Recruiting||N/A|90|Anticipated|Fox Chase Cancer Center|||1||f||||t||||||Samples With DNA|"     blood and tumor tissue   "|||2017-10-11 00:39:00.608088|2017-10-11 00:39:00.608088
NCT02092701|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-18|||October 2012||2012-10-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period|Effects of a One Year Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period|Completed||N/A|||University Hospital of Liege||1|||f||||f||||||||||2017-10-11 00:39:00.724755|2017-10-11 00:39:00.724755
NCT02092688|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-08-30|||December 2013||2013-12-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth|Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth in Women Presenting With Signs and Symptoms of Preterm Labor in Comparison to a Control Group of Asymptomatic Women With the Same Gestational Age - a Multicenter Trial|Recruiting||N/A|120|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-11 00:39:00.821764|2017-10-11 00:39:00.821764
NCT02092675|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-12-22|||March 2013||2013-03-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Endothelial Dysfunction and Chronic Obstructive Pulmonary Disease|Endothelial Dysfunction and Frequent Exacerbator Phenotype in Patient With Chronic Obstructive Pulmonary Disease|Completed||N/A|117|Actual|Clinical Hospital Centre Zagreb|||3||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 00:39:00.952472|2017-10-11 00:39:00.952472
NCT02092662|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-07-07|2015-05-14||January 2014||2014-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01|5 Weeks|Observational [Patient Registry]|AssStrFunc|groups were matched by age (p>0.1)|Objective Assessment of Upper Extremity Functioning of Stroke Patients Before and After Rehabilitation|Objective Assessment of Upper Extremity Functioning of Stroke Patients Before and After Rehabilitation|Completed||N/A|57|Actual|University of Haifa|||2||f||||t||||||||||2017-10-11 00:39:01.049214|2017-10-11 00:39:01.049214
NCT02092649|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-12-01|2015-06-01||April 2014||2014-04-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional||We expect to have a normal distribution of participants in both groups.|Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate|Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate|Completed||N/A|26|Actual|University of Guelph||2|||f||||f||||||||||2017-10-11 00:39:01.478967|2017-10-11 00:39:01.478967
NCT02092636|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-04-24|||March 2014|Actual|2014-03-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring|Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring|Completed||N/A|10|Actual|UConn Health||3|||f||||t||||||||Undecided|undecided.|2017-10-11 00:39:01.990781|2017-10-11 00:39:01.990781
NCT02092623|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-05-26|||September 2010||2010-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Interventional|||Single Incision Transvaginal Mesh in Treatment of Posterior Vaginal Wall Prolapse|Single Incision Transvaginal Mesh (Elevate® Posterior) in Treatment of Posterior Vaginal Wall Prolapse Without Concurrent Surgery - National Prospective Multicenter Study|Completed||N/A|111|Actual|Turku University Hospital||1|||f||||f||||||||||2017-10-11 00:39:02.12206|2017-10-11 00:39:02.12206
NCT02092610|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-01-12|2015-10-26||May 2014||2014-05-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System|Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System|Completed||N/A|77|Actual|Cochlear Bone Anchored Solutions||2|||f||||f||||||||||2017-10-11 00:39:02.278953|2017-10-11 00:39:02.278953
NCT02092597|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-07-27|||October 2013||2013-10-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|November 2015|Anticipated|2015-11-01||Interventional|SAFEGUARD||Safety Evaluation of Adverse Reactions in Diabetes||Unknown status|Recruiting|Phase 4|60|Anticipated|Charles University, Czech Republic||3|||f||||||||||||||2017-10-11 00:39:02.736183|2017-10-11 00:39:02.736183
NCT02092584|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-18|||December 2011||2011-12-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Effect of Omega-3 Supplementation on Serum Level and Gene Expression of IGF-1and IGFBP-3 in Men With CVD.|Effect of Omega-3 Supplementation on Serum Level and Gene Expression of IGF-1and IGFBP-3 in Men With Cardiovascular Disease.|Completed||Phase 4|31|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:39:02.855088|2017-10-11 00:39:02.855088
NCT02092571|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-09-02|||February 2014||2014-02-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women|An Open-Label, Single-Dose, Randomized, 2-Treatment, 2-Period Crossover Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings 20% (w/w) in Postmenopausal Women|Completed||Phase 1|56|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 00:39:02.952868|2017-10-11 00:39:02.952868
NCT02092558|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-19|||January 2005||2005-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|January 2009|Actual|2009-01-01||Observational|||Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder||Completed||N/A|2|Actual|Children's Hospital, Dziekanów Leśny, Poland|||2||f||||t||||||||||2017-10-11 00:39:03.059222|2017-10-11 00:39:03.059222
NCT02092545|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-12-18|||May 2014||2014-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|HOPE||Heart Obesity Prevention Education|Heart Obesity Prevention Education: Retired NFL Players Weight Management Study|Completed||N/A|7|Actual|Tampa General Hospital||1|||f||||f||||||||||2017-10-11 00:39:03.185187|2017-10-11 00:39:03.185187
NCT02092532|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-10-14|||March 2014||2014-03-01|October 2014|2014-10-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|RIVAL||Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)|Open-label, Non-randomized, Unmasked, Study of IAI in Patients Which Choroidal Neovascularization Secondary to Polypoidal Choroidal Vasculopathy (PCV)|Unknown status|Recruiting|Phase 4|20|Anticipated|Southeast Retina Center, Georgia||1|||f||||f||||||||||2017-10-11 00:39:03.311877|2017-10-11 00:39:03.311877
NCT02092519|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-07-27|||April 2013||2013-04-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses|A Prospective Multi-center Randomized Study of the Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses|Completed||Phase 4|40|Actual|Changi General Hospital||2|||f||||t||||||||||2017-10-11 00:39:03.446101|2017-10-11 00:39:03.446101
NCT02092506|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-07-06|||December 2011||2011-12-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||RCT: Triple vs Sequential vs Concomitant Therapy H Pylori|A Randomized Controlled Trial of Triple Therapy Versus Sequential Therapy Versus Concomitant Therapy as First Line Treatment for Helicobacter Pylori Infection|Completed||Phase 4|462|Actual|Changi General Hospital||3|||f||||t||||||||||2017-10-11 00:39:03.545041|2017-10-11 00:39:03.545041
NCT02092493|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-10-12|||April 2014||2014-04-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||The Effect of ScopeGuide on the Mental Workload of Endoscopist|The Effect of Magnetic Endoscopic Imaging (ScopeGuide) on the Mental Workload of Endoscopists During Colonoscopy|Withdrawn||N/A|0|Actual|University Hospital Southampton NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:39:03.642407|2017-10-11 00:39:03.642407
NCT02092480|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-04-21|||September 2014||2014-09-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|||The If I Were Jack Feasibility Trial|Increasing Boys' and Girls' Intention to Avoid Teenage Pregnancy: Feasibility Trial of an Interactive Video-drama Based Intervention in Post-primary Schools in Northern Ireland|Unknown status|Recruiting|N/A|630|Anticipated|Queen's University, Belfast||2|||f||||f||||||||||2017-10-11 00:39:03.724884|2017-10-11 00:39:03.724884
NCT02092467|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-10-03|||March 14, 2014|Actual|2014-03-14|October 2017|2017-10-01|August 8, 2019|Anticipated|2019-08-08|August 8, 2019|Anticipated|2019-08-08||Interventional|||Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis|Phase 3b/4 Randomized Safety Endpoint Study Of 2 Doses Of Tofacitinib In Comparison To A Tumor Necrosis Factor (Tnf) Inhibitor In Subjects With Rheumatoid Arthritis|Recruiting||Phase 4|4400|Anticipated|Pfizer||3|||f||||t||||||||||2017-10-11 00:39:03.869831|2017-10-11 00:39:03.869831
NCT02092454|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-05-07||2015-05-07|September 2013||2013-09-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media|Phase II, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Ages 2 Months to 12 Years Presenting With Acute Otitis Media|Completed||Phase 2|65|Actual|Otic Therapy, LLC||2|||f||||||||||||||2017-10-11 00:39:04.962811|2017-10-11 00:39:04.962811
NCT02092441|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-04-15|2015-07-03||April 2014||2014-04-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|November 2014|Actual|2014-11-01||Interventional|||Inhalation Intervention for Nausea in the Emergency Department|Inhalation Intervention for Nausea in the Emergency Department|Completed||N/A|80|Actual|Brooke Army Medical Center||2|||f||||t||||||||||2017-10-11 00:39:05.083148|2017-10-11 00:39:05.083148
NCT02092428|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-19|||April 2011||2011-04-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)|Contrast- Enhanced Whole-Heart Coronary Magnetic Resonance Angiography (MRA) at 3.0T|Unknown status|Recruiting|Phase 1|340|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 00:39:05.345876|2017-10-11 00:39:05.345876
NCT02092415|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-05-08|2015-04-22||September 2013||2013-09-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Assessment of Limb Perfusion During Junctional Tourniquet|Assessment of Limb Perfusion During Junctional Tourniquet|Completed||N/A|10|Actual|Oregon Health and Science University||1|||f||||t||||||||||2017-10-11 00:39:05.450516|2017-10-11 00:39:05.450516
NCT02092402|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-04-04|||September 2013||2013-09-01|April 2017|2017-04-01||||November 2016|Actual|2016-11-01||Interventional|||Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome|Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome|Active, not recruiting||N/A|17|Actual|Örebro University, Sweden||2|||f||||f||||||||||2017-10-11 00:39:05.59986|2017-10-11 00:39:05.59986
NCT02092389|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-01-05|2016-09-22||July 2014||2014-07-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Observational|AdaProQuo|All enrolled participants with demographic and baseline data available.|Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo|Fecal Calprotectin Levels, Quality of Life and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo|Terminated||N/A|10|Actual|AbbVie|The study was terminated due to low enrollment; therefore, safety and efficacy data should be interpreted with caution because of the small number of participants and incomplete data.||1|Recruitment below expectation|f||||f||||||||||2017-10-11 00:39:05.684464|2017-10-11 00:39:05.684464
NCT02092376|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-07-13|||March 2014||2014-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Interventional|LOAD||The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass Surgery|The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass Surgery: a Randomized Controlled, Double-blinded Clinical Supplementation Trial|Completed||Phase 4|50|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 00:39:05.894733|2017-10-11 00:39:05.894733
NCT02092363|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-05-24|||January 2014||2014-01-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer|A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer|Active, not recruiting||Phase 1|37|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:39:05.997599|2017-10-11 00:39:05.997599
NCT02092350|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-08-10|2016-02-03||March 17, 2014|Actual|2014-03-17|August 2017|2017-08-01|September 2, 2015|Actual|2015-09-02|March 11, 2015|Actual|2015-03-11||Interventional|C-SURFER||Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)|A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic Hepatitis C Virus Infection and Chronic Kidney Disease|Completed||Phase 2/Phase 3|237|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 00:39:06.12369|2017-10-11 00:39:06.12369
NCT02092337|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-18|||June 2007||2007-06-01|March 2014|2014-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Computer-Assisted Speech Training for Hearing Aid Users|Effect of Computer-Assisted Speech Training on Speech Recognition and Subjective Benefits for Hearing Aid Users With Severe to Profound Prelingual Hearing Loss|Completed||N/A|12|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 00:39:07.149243|2017-10-11 00:39:07.149243
NCT02092324|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-05-15|||May 2014||2014-05-01|May 2017|2017-05-01||||April 2019|Anticipated|2019-04-01||Interventional|||Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia|Prospective Evaluation of Ruxolitinib Efficacy for CNL/aCML Patients With Mutation of CSF3R|Recruiting||Phase 2|50|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 00:39:07.253316|2017-10-11 00:39:07.253316
NCT02092311|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-06-07|2014-04-10||January 2006||2006-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|September 2013|Actual|2013-09-01||Interventional|CMMV||Assessing the Rates of Major Complications in Combined Mini-incision Microscopic Varicocelectomy|Assessing Post-operative Rates of Recurrence, Hydrocele and Testicular Atrophy in Patients Operated With a New Approach of Varicocelectomy Named Combined Mini-incision Microscopic Varicocelectomy (CMMV)|Completed||N/A|570|Actual|Omid Fertility Center||2|||f||||f||||||||||2017-10-11 00:39:07.38014|2017-10-11 00:39:07.38014
NCT02092298|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-01-09|||May 2014||2014-05-01|January 2017|2017-01-01||||May 2019|Anticipated|2019-05-01||Interventional|||Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer|A Phase II Study of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Gastric Carcinomatosis or Positive Cytology|Active, not recruiting||Phase 2|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:39:07.614085|2017-10-11 00:39:07.614085
NCT02092272|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-02-06|||March 2014||2014-03-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Eccentric||Eccentric Exercises for Shoulder Pain|Does Providing Instructional Exercise Videos Increase Patient Adherence Compared to In-office Instruction by Physician When Using Eccentric Exercises to Treat Shoulder Pain in Adults?|Terminated||N/A|23|Actual|Mike O'Callaghan Federal Hospital||2||the PI left our facility and the new staff prefer alternate excersises|f||||f||||||||||2017-10-11 00:39:07.84174|2017-10-11 00:39:07.84174
NCT02092259|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-07-10|||January 2014||2014-01-01|June 2015|2015-06-01||||December 2015|Anticipated|2015-12-01||Observational|||A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay|A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay in Patients With Signs and Symptoms of Acute Gastroenteritis|Unknown status|Recruiting|N/A|500|Anticipated|Luminex Molecular Diagnostics|||1||f||||f||||||Samples With DNA|"     Stool   "|||2017-10-11 00:39:07.994045|2017-10-11 00:39:07.994045
NCT02092246|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-10-13|||March 2014||2014-03-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Ultrasound Guided vs Unguided Intra-articular Knee Injections|Accuracy of Ultrasound Guided Versus Unguided Intra-articular Knee Injections in a Difficult to Inject Population|Withdrawn||Phase 3|0|Actual|Mayo Clinic||2||Difficulty enrolling subjects|f||||f||||||||||2017-10-11 00:39:08.128051|2017-10-11 00:39:08.128051
NCT02092233|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-07-09|||January 2014||2014-01-01|March 2014|2014-03-01||||March 2015|Actual|2015-03-01||Observational|||A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients|A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients|Completed||N/A|1963|Actual|Luminex Molecular Diagnostics|||2||f||||f||||||Samples With DNA|"     Patient lesion swab specimens   "|||2017-10-11 00:39:08.252795|2017-10-11 00:39:08.252795
NCT02092207|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-08-08|||October 2012||2012-10-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, 12 Weeks, Phase II Clinical Study to Evaluate the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome|Completed||Phase 2|147|Actual|KT&G Life Sciences Corp||3|||f||||f||||||||||2017-10-11 00:39:08.471435|2017-10-11 00:39:08.471435
NCT02092194|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-19|||April 2014||2014-04-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||High Versus Standard Volume Hemodiafiltration in Asia|Effectiveness of High-volume Online Hemodiafiltration Compared to Standard Volume Online Hemodiafiltration. A Prospective, Multicenter, Randomized, Open-labelled Interventional Study.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Korean Hemodialysis Study Group||2|||f||||t||||||||||2017-10-11 00:39:08.570163|2017-10-11 00:39:08.570163
NCT02092181|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-07-11|||March 2014||2014-03-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|Maestro||A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)|A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease. (MAESTRO)|Recruiting||Phase 4|40|Anticipated|Burdick, Daniel, M.D.||2|||f||||f||||||||||2017-10-11 00:39:08.69787|2017-10-11 00:39:08.69787
NCT02092168|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-01-07|2015-01-07||October 2008||2008-10-01|January 2015|2015-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects|Single-dose and Steady-state Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects Compared With Those in Healthy Male Young Subjects|Completed||Phase 1|24|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 00:39:08.811741|2017-10-11 00:39:08.811741
NCT02092155|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-08-15|||January 2014||2014-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|BLAST||Biomarker Levels During Indwelling Pleural cAtheter Sample Testing|TGF-B as a Marker of Pleurodesis in Patients With Tunneled Pleural Catheters|Active, not recruiting||N/A|95|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples Without DNA|"     Pleural fluid attained during drainage of indwelling pleural catheter   "|||2017-10-11 00:39:09.144165|2017-10-11 00:39:09.144165
NCT02092129|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-05-02|||September 2013||2013-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.|Prognostic Value of Pituitary Histopathology and Plasma Hyperprolactinaemia in Predicting the Risk of Glucose Metabolic Disturbances in Patients With Acromegaly.|Active, not recruiting||N/A|79|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples Without DNA|"     blood samples   "|No||2017-10-11 00:39:09.331653|2017-10-11 00:39:09.331653
NCT02092116|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-01-11|2016-11-08||March 2014||2014-03-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|REDUC||Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV‐1 Reservoir|An Open Phase I/IIa Study to Evaluate the Safety and Effect of Therapeutic HIV-1 Immunization Using Vacc-4x + rhuGM-CSF and HIV-1 Reactivation Using Romidepsin on the Viral Reservoir in Virologically Suppressed HIV-1 Infected Adults on cART|Completed||Phase 1/Phase 2|26|Actual|Bionor Immuno AS||2|||f||||f||||||||No|Participants have not provided informed consent for their anonymized individual data to be made available beyond that described in the patient information sheet.|2017-10-11 00:39:09.434083|2017-10-11 00:39:09.434083
NCT02092103|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-04-28|||March 2014||2014-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Delayed Clamping and Milking the Umbilical Cord in Preterm Infants|Delayed Clamping and Milking the Umbilical Cord Prior to Clamping in Preterm Infants and the Effect of Neonatal Outcomes|Recruiting||N/A|240|Anticipated|TriHealth Inc.||2|||f||||f||||||||No||2017-10-11 00:39:10.148665|2017-10-11 00:39:10.148665
NCT02092090|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-08-01|||March 2014||2014-03-01|June 2015|2015-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|SSaSS||China Salt Substitute and Stroke Study|A LARGE-SCALE CLUSTER RANDOMIZED TRIAL TO DETERMINE THE EFFECTS OF SODIUM REDUCTION ON STROKE: THE CHINA SALT SUBSTITUTE AND STROKE STUDY (SSaSS)|Active, not recruiting||N/A|21000|Anticipated|The George Institute||2|||f||||t||||||||||2017-10-11 00:39:10.260999|2017-10-11 00:39:10.260999
NCT02092077|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-08-22|||April 2014||2014-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children|A Phase 2, Randomized, Open-Label, Safety and Dose-Finding Study Comparing 3 Different Doses of Weekly TV-1106 and Daily Recombinant Human Growth Hormone Therapy in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children|Terminated||Phase 2|65|Actual|Teva Pharmaceutical Industries||4||Business decision|f||||t||||||||||2017-10-11 00:39:10.361036|2017-10-11 00:39:10.361036
NCT02092064|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-18|||April 2014||2014-04-01|March 2014|2014-03-01|April 2015|Anticipated|2015-04-01|October 2014|Anticipated|2014-10-01|8 Months|Observational [Patient Registry]|||Association Between Basal Proteinuria Levels and Pregnancy Outcomes in Familial Mediterranean Fever||Unknown status|Not yet recruiting|N/A|40|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||1||f||||f||||||None Retained|"     maternal ürine protein level   "|||2017-10-11 00:39:10.529334|2017-10-11 00:39:10.529334
NCT02092051|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-01-09|||January 2014||2014-01-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections|A Randomized Trial of the Effect of Continuous Glucose Monitoring (CGM) in Individuals With Type 1 Diabetes Treated With Multiple Daily Insulin Injections (MDI)|Completed||N/A|161|Actual|Vastra Gotaland Region||2|||f||||t||||||||||2017-10-11 00:39:10.612068|2017-10-11 00:39:10.612068
NCT02092038|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-11-07|||November 2014||2014-11-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Preoperative Chemoradiation for Glioblastoma|Phase I Pilot Study of Preoperative Chemoradiation for Glioblastoma|Completed||Phase 1|1|Actual|Tampa General Hospital||1|||f||||f||||||||||2017-10-11 00:39:10.74311|2017-10-11 00:39:10.74311
NCT02092012|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-20|||March 2014||2014-03-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||Comparison of Preemptive Analgesic Effects of Dexketoprofen Versus Dexmedetomidine on Abdominal Hysterectomy Patients|Comparison of Preemptive Analgesic Effects of Dexketoprofen Versus Dexmedetomidine on the Patients That is Undergoing Abdominal Hysterectomy|Unknown status|Recruiting|Phase 4|60|Anticipated|TC Erciyes University||2|||f||||f||||||||||2017-10-11 00:39:10.904823|2017-10-11 00:39:10.904823
NCT02091999|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-08-28|||June 4, 2014|Actual|2014-06-04|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4|A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4|Recruiting||Phase 1|200|Anticipated|Astellas Pharma Inc||5|||f||||f||||||||||2017-10-11 00:39:11.08954|2017-10-11 00:39:11.08954
NCT02091986|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-02-24|2016-10-11||April 2014||2014-04-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CHASE 3|All patients randomized, defined as having a randomization code recorded on the demography case report form (CRF)|A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg|A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma|Completed||Phase 3|882|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:39:11.295996|2017-10-11 00:39:11.295996
NCT02091973|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2014-03-18|||June 2010||2010-06-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation|MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Maintenance Immunosuppressive Regimens in Kidney Transplantation|Unknown status|Recruiting|N/A|50|Anticipated|Chulalongkorn University||2|||f||||f||||||||||2017-10-11 00:39:14.105046|2017-10-11 00:39:14.105046
NCT02091960|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2017-08-31|||August 28, 2014|Actual|2014-08-28|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|February 28, 2017|Actual|2017-02-28||Interventional|||A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Subjects With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer|A Phase 2, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Subjects With HER2+ AR+ Metastatic or Locally Advanced Breast Cancer|Active, not recruiting||Phase 2|103|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:39:14.215825|2017-10-11 00:39:14.215825
NCT02091947|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-17|||November 2010||2010-11-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|FMS||Efficacy of Functional Magnetic Stimulation in Urinary Incontinence|Efficacy of Functional Magnetic Stimulation in Urinary Incontinence|Unknown status|Recruiting|Phase 2|40|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 00:39:14.522171|2017-10-11 00:39:14.522171
NCT02091934|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2016-11-11|||March 2014||2014-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Wavefront-guided PRK vs Wavefront-optimized PRK|A Prospective, Randomized Comparison of Fellow Eyes Undergoing Wavefront-guided PRK Versus Wavefront-optimized PRK Using the Alcon Allegretto Eye-Q 400 Excimer Laser|Active, not recruiting||Phase 4|50|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 00:39:14.622832|2017-10-11 00:39:14.622832
NCT02091908|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-11-03|||April 2014||2014-04-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions|Phase III, Stratified, Randomized, Controlled, Observer-Blind, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Doses of aH5N1 When Administered to Adult and Elderly Subjects With and Without Underlying Medical Conditions.|Completed||Phase 3|540|Actual|Seqirus||4|||f||||f||||||||||2017-10-11 00:39:14.822655|2017-10-11 00:39:14.822655
NCT02091895|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2015-01-07|||March 2014||2014-03-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Validation of Clinical Efficacy and Development of New Diagnostic Algorithm of Probe-based Confocal Laser Endomicroscopy in Patients With Lower Gastrointestinal Disorder||Unknown status|Recruiting|N/A|311|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 00:39:14.948631|2017-10-11 00:39:14.948631
NCT02091882|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-03-25||2015-03-25|March 2014||2014-03-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|OSMITTER||Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)|OSMITTER 316-13-206A Substudy: A Substudy to Measure the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1) System and Determine the Latency Period|Completed||Phase 4|30|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 00:39:15.098017|2017-10-11 00:39:15.098017
NCT02091856|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-02-25|2015-11-20||March 2014||2014-03-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PsiTOD||Internet-delivered Psychotherapy for Depression|Internet-delivered Cognitive-Behavioral Therapy for Depression: A Randomized Controlled Trial (PsiTOD)|Terminated||N/A|79|Actual|West University of Timisoara|1) A high drop out rate at post-test & follow-up. 2) The outcome assessments were not fully blind. 3) Participants in C-CBT & R-CBT were self-selected based on their religiousness.|3||We have recruited and treated 79 participants|f||||f||||||||||2017-10-11 00:39:15.641431|2017-10-11 00:39:15.641431
NCT02091843|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-10-31|||January 2014||2014-01-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Deep Brain Stimulation of the Amygdala for Combat Post-Traumatic Stress Disorder||Recruiting||N/A|6|Anticipated|VA Greater Los Angeles Healthcare System||2|||f||||t||||||||||2017-10-11 00:39:16.058951|2017-10-11 00:39:16.058951
NCT02091830|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-10-16|||January 2013||2013-01-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Non-surgical Treatment of Knee Osteoarthritis - a Comparison of Effects in 2200 Patients|Non-surgical Treatment of Knee Osteoarthritis - a Comparison of Effects in 2200 Patients|Completed||N/A|2262|Actual|Northern Orthopaedic Division, Denmark|||1||f||||f||||||||||2017-10-11 00:39:16.136418|2017-10-11 00:39:16.136418
NCT02091817|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2015-07-01|||November 2013||2013-11-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effect of Oxytocin on Face Perception|The Behavioral and Neural Effects of Oxytocin on Face Perception in Congenital Prosopagnosia|Suspended||Early Phase 1|100|Anticipated|Soroka University Medical Center||2||We are currently engaged in other behavioral study.|f||||f||||||||||2017-10-11 00:39:16.213023|2017-10-11 00:39:16.213023
NCT02091804|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-10-26|||September 2014||2014-09-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|P20-RP3||Beginning Relationships in a Native Community|Promoting First Relationships: A Strengths-based Primary Prevention Project in a Native Community|Active, not recruiting||N/A|34|Actual|University of Washington||2|||f||||f||||||||No||2017-10-11 00:39:16.297971|2017-10-11 00:39:16.297971
NCT02091791|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-17|||August 2002||2002-08-01|March 2014|2014-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||High Versus Low Level of Lumbar Traction in Acute Lumbar Sciatica Due to Disc Herniation|High Versus Low Level of Lumbar Traction in Acute Lumbar Sciatica Due to Disc Herniation|Completed||N/A|17|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 00:39:16.366902|2017-10-11 00:39:16.366902
NCT02091778|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-01-26|2016-01-26||August 2014||2014-08-01|March 2014|2014-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CHEXU 01||Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended.|Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended.|Completed||N/A|21|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 00:39:16.560489|2017-10-11 00:39:16.560489
NCT02091765|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-09-12|||December 2012||2012-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|KIS||RCT of an Internet-based CBT Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer|A Randomized Study of an Internet-based Cognitive Behavioral Therapy Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer.|Active, not recruiting||Phase 3|160|Anticipated|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-11 00:39:16.753704|2017-10-11 00:39:16.753704
NCT02091752|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-02-24|2016-01-05||September 2014||2014-09-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)|The ReTreatment Trial: A Phase II, Open-label, Single-arm Study of Re-treating Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event.|Terminated||Phase 2|3|Actual|Novartis||1||The study was terminated due to low enrollment.|f||||f||||||||||2017-10-11 00:39:16.895142|2017-10-11 00:39:16.895142
NCT02091739|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2016-11-22||2016-07-26|April 2014||2014-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2015|Actual|2015-08-01||Interventional|SIAXI||Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions|Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group Multicenter Study, With an Extension Period of Dose-blinded Active Treatment, to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions|Completed||Phase 3|184|Actual|Merz Pharmaceuticals GmbH||3|||f||||t||||||||||2017-10-11 00:39:17.156032|2017-10-11 00:39:17.156032
NCT02091726|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-11-16|2014-12-01||March 2014||2014-03-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Unicirc003|Volunteers|Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive|Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive|Completed||N/A|110|Actual|Simunye Primary Health Care||1|||f||||f||||||||||2017-10-11 00:39:17.308558|2017-10-11 00:39:17.308558
NCT02091713|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-17|||August 2014||2014-08-01|March 2014|2014-03-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Observational|FMS||Musculoskeletal Injuries' Prediction Tool for Military Combatants in the Israeli Defense Force|Musculoskeletal Injuries' Prediction Tool for Military Combatants in the Israeli Defense Force (FMS)|Unknown status|Not yet recruiting|N/A|300|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:39:17.52039|2017-10-11 00:39:17.52039
NCT02091700|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-03-08|||March 2017|Anticipated|2017-03-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|ORPHEE2||ObseRvation of PeripHEral rEtinal Morphology in Normals|ObseRvation of PeripHEral rEtinal Morphology in Normal|Recruiting||N/A|30|Anticipated|Optos, PLC.|||1||f||||f||||||||||2017-10-11 00:39:17.61113|2017-10-11 00:39:17.61113
NCT02091687|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-01-04|||April 2014||2014-04-01|January 2016|2016-01-01||||May 2015|Actual|2015-05-01||Observational|Longitudinal||Longitudinal Outcomes in Pediatric rTMS and CIT|Longitudinal Outcomes in Pediatric rTMS and CIT|Completed||N/A|19|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:39:17.685419|2017-10-11 00:39:17.685419
NCT02091661|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-05-26|||January 1997||1997-01-01|May 2015|2015-05-01|May 2015|Anticipated|2015-05-01|September 2001|Actual|2001-09-01||Interventional|||Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer|Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer|Suspended||Phase 3|500|Anticipated|University of Rome Tor Vergata||2||accrual too slow|f||||t||||||||||2017-10-11 00:39:17.822116|2017-10-11 00:39:17.822116
NCT02091648|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-01-04|||January 2013||2013-01-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||A Pilot Stress Management Intervention Study for High Risk Children With Asthma|A Pilot Stress Management Intervention for High Risk Children With Asthma|Completed||N/A|111|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 00:39:17.904742|2017-10-11 00:39:17.904742
NCT02091635|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-18|||August 2013||2013-08-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method|Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method|Completed||N/A|40|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:39:18.004411|2017-10-11 00:39:18.004411
NCT02091622|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-17|||August 2011||2011-08-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Increasing the Number of Patients Receiving Information About Transition to End-of-life Care|Increasing the Number of Patients Receiving Information About Transition to End-of-life Care: the Effect of a Half-day Physician and Nurse Training|Completed||N/A|1431|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 00:39:18.087388|2017-10-11 00:39:18.087388
NCT02091609|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-04-05|||May 2014||2014-05-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||a Randomized Clinical Trial Evaluating Plaque Removal Around Dental Implants|Evaluation of Plaque Removal Using Different Plaque Control Therapies Around Single Crown Dental Implants and Splinted Implant Crowns in Patients Under 3 Months Maintenance;a Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|32|Actual|University of Manitoba||2|||f||||t||||||||No||2017-10-11 00:39:18.153591|2017-10-11 00:39:18.153591
NCT02091596|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-09-24|||October 2013||2013-10-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers|Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300|Completed||Phase 2|42|Actual|PluroGen Therapeutics, Inc||2|||f||||f||||||||||2017-10-11 00:39:18.238603|2017-10-11 00:39:18.238603
NCT02091583|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-05-08|||November 2014||2014-11-01|May 2017|2017-05-01||||November 2015|Actual|2015-11-01||Interventional|||Canola Oil, Fibre and DHA Enhanced Clinical Trial|Developing and Evaluating a Novel Food Supplement, Consisting of Canola Oil, Fibre and DHA, Aiming at the Management of CVD Risk in a Population With Metabolic Syndrome|Completed||N/A|30|Actual|University of Manitoba||4|||f||||f||||||||||2017-10-11 00:39:18.351212|2017-10-11 00:39:18.351212
NCT02091570|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-10-29|||December 2013||2013-12-01|October 2014|2014-10-01||||April 2014|Actual|2014-04-01||Interventional|||Effect of Nutrition Bars on Satiety in Women|A Randomized, Controlled, Double-Blind Crossover Pilot Trial to Assess the Effects of Nutrition Bars on Subjective Ratings of Hunger and Fullness in Women|Unknown status|Recruiting|N/A|42|Anticipated|PepsiCo Global R&D||3|||f||||f||||||||||2017-10-11 00:39:18.451193|2017-10-11 00:39:18.451193
NCT02091557|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2014-06-28|||January 2011||2011-01-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||CA 125 and VAS Pain Score Changes to Diagnose Endometriosis|CA 125 and VAS Pain Score Changes Following GnRH-analog Administration as ex Adiuvantibus Criteria to Diagnose Endometriosis as Cause of Chronic Pelvic Pain.|Completed||N/A|118|Actual|University Magna Graecia|||1||f||||t||||||||||2017-10-11 00:39:18.545529|2017-10-11 00:39:18.545529
NCT02091544|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-08-30|||April 2014||2014-04-01|August 2017|2017-08-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Observational|||Etiological Factors, Risk Factors and Early Stages of Chronic Disease in Different Degrees of Childhood Overweight|Kijk op Overgewicht Bij Kinderen: Study Regarding Etiological Factors, Risk Factors and Early Stages of Chronic Disease in Different Degrees of Childhood Overweight|Recruiting||N/A|1000|Anticipated|Maastricht University Medical Center|||1||f||||f||||||Samples With DNA|"     -  urine        -  feces        -  DNA        -  liver ultrasound   "|||2017-10-11 00:39:18.62778|2017-10-11 00:39:18.62778
NCT02091531|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-10-03|||March 2014||2014-03-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients|A Phase 2 Study of the Dual mTOR Inhibitor MLN0128 in Patients With Metastatic Castration-Resistant Prostate Cancer (CRPC)|Active, not recruiting||Phase 2|9|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:39:18.735138|2017-10-11 00:39:18.735138
NCT02091518|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-10-03|||March 2014||2014-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods|Development and Evaluation of Magnetic Resonance Imaging Acquisition and Analysis Methods|Enrolling by invitation||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:39:18.819541|2017-10-11 00:39:18.819541
NCT02091505|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2014-03-17|||December 2013||2013-12-01|March 2014|2014-03-01||||May 2016|Anticipated|2016-05-01||Interventional|CRVO||Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO|Predictive Factors of Treatment Outcome After Intravitreal Injection of Lucentis (Ranibizumab) in Eyes With Macular Edema Associated With Central Retinal Vein Occlusion (CRVO)|Unknown status|Recruiting|N/A|30|Anticipated|Mie University||1|||f||||f||||||||||2017-10-11 00:39:19.046636|2017-10-11 00:39:19.046636
NCT02091492|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-09-16|||June 2014||2014-06-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|TERAFRAP||Teriparatide for Fracture Repair in Humans|Teriparatide for Fracture Repair in Humans: A Prospective, Randomized, Double-blind Placebo-controlled Pilot Study in Female and Male Patients With Proximal Humerus Fracture: The TERAFRAP Study|Withdrawn||Phase 3|0|Actual|Medical University of Vienna||2||no participants|f||||t||||||||||2017-10-11 00:39:19.154246|2017-10-11 00:39:19.154246
NCT02091479|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-03-09|||January 2013||2013-01-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|RATHER||Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage|Randomized Assay Evaluating the Risk/Benefit of Early Versus Late Resumption of Anticoagulation in Patients With Major, Non-trauma Related Hemorrhage Occurring While on Anticoagulant Treatment for a High Risk of Thrombosis.|Terminated||Phase 3|14|Actual|Centre Hospitalier Universitaire de Saint Etienne||2||inclusion rate insufficient|f||||t||||||||||2017-10-11 00:39:19.264782|2017-10-11 00:39:19.264782
NCT02091466|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-10-01|2014-03-20||March 2010||2010-03-01|September 2014|2014-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|hypothermia||Pre-warming Prevents Hypothermia in Elective Cesarean Section|Pre-warming With Thermal Gown Prevents Maternal Hypothermia in Elective Cesarean Section|Completed||N/A|40|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t||||||||||2017-10-11 00:39:19.364314|2017-10-11 00:39:19.364314
NCT02091453|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-09-02|||January 2009||2009-01-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Early Training of Attention After Acquired Brain Injury|The Protocol and Design of a Randomized Controlled Study on Attention Training in First Year After Acquired Brain Injury|Completed||N/A|109|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:39:19.67191|2017-10-11 00:39:19.67191
NCT02091440|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-02-20|||March 2014||2014-03-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|March 2015|Actual|2015-03-01||Interventional|HW005||Clinical Evaluation of HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure in Japan|Clinical Evaluation of the HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure|Active, not recruiting||N/A|6|Actual|HeartWare, Inc.||1|||f||||f||||||||||2017-10-11 00:39:19.784472|2017-10-11 00:39:19.784472
NCT02091427|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-03-02|||January 2013||2013-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||Circadian Variation of Cardiac Troponin||Completed||N/A|24|Actual|Maastricht University Medical Center|||1||f||||||||||||||2017-10-11 00:39:19.878498|2017-10-11 00:39:19.878498
NCT02091414|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-10-22|2014-10-22||August 2006||2006-08-01|October 2014|2014-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional||Intent-to-treat (ITT) population: all enrolled participants who recieved at least 1 dose of study treatment.|A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.|An Open Label Study to Evaluate the Effect of CellCept in Combination With Cyclosporine A and Steroids on Renal Function and the Prevention of Acute Rejection in Heart Transplant Patients.|Completed||Phase 3|36|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:39:19.946347|2017-10-11 00:39:19.946347
NCT02091388|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-03-03|||September 2014||2014-09-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Bioavailability of LY03004 and Risperdal® Consta®|A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|108|Actual|Luye Pharma Group Ltd.||2|||f||||f||||||||||2017-10-11 00:39:20.479105|2017-10-11 00:39:20.479105
NCT02091375|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-09-27||2016-06-17|March 2015||2015-03-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)|A Double Blind, Placebo Controlled Two-part Study to Investigate the Dose-ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome|Completed||Phase 3|120|Actual|GW Research Ltd||2|||f||||t||||||||||2017-10-11 00:39:20.608988|2017-10-11 00:39:20.608988
NCT02091362|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-18|2015-05-08||2015-05-08|March 2014||2014-03-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus|The Effect of LY2409021 on Blood Pressure and Pulse Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|194|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:39:20.733211|2017-10-11 00:39:20.733211
NCT02091349|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-05-13|||July 2010||2010-07-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|January 2011|Actual|2011-01-01||Interventional|||Tolerance and Utilization of Polydextrose, Inulin, and Soluble Corn Fiber|Tolerance and Utilization of Polydextrose, Inulin, and Soluble Corn Fiber|Completed||N/A|25|Actual|University of Illinois at Urbana-Champaign||3|||f||||f||||||||||2017-10-11 00:39:20.888961|2017-10-11 00:39:20.888961
NCT02091336|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-03-18|||January 2014||2014-01-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Oral Antidiabetic Agents in Pregnancy|Oral Antidiabetic Agents on Gestational Diabetes: Modulating Effect on Fetal Growth - a Clinical Randomized Trial|Unknown status|Recruiting|Phase 4|80|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 00:39:20.989384|2017-10-11 00:39:20.989384
NCT02091323|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-01-25|||March 2014||2014-03-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes Mellitus|Effect of Modified Laparoscopic Roux-en-Y Gastric Bypass Surgery on Type 2 Diabetics With Lower Body Mass Index in China|Recruiting||N/A|200|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-11 00:39:21.115713|2017-10-11 00:39:21.115713
NCT02091310|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-03-09|||February 2014||2014-02-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers|A Two-part Phase I Study Composed of a Randomized, Double-blind, 4-parallel Group Study to Evaluate the Effect of Multiple Oral Doses of GFT505 on the QT/QTc Interval Compared to Placebo With Moxifloxacin (400 mg in Single Oral Dose) as a Positive Control, in Healthy Male and Female Volunteers, Preceded by a Double-blind, Placebo-controlled, Safety, Tolerability and Pharmacokinetic Study in Healthy Male Volunteers in Order to Define the Supra-therapeutic GFT505 Dose in a Multiple Dosing Regimen.|Completed||Phase 1|200|Actual|Genfit||7|||f||||f||||||||||2017-10-11 00:39:21.224086|2017-10-11 00:39:21.224086
NCT02091297|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-08-04|||April 2014||2014-04-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone|Comparison of Transversus Abdominis Plane Block Versus Patient-controlled Epidural Analgesia for Patients on Buprenorphine or Methadone, After Cesarean Section|Withdrawn||N/A|0|Actual|Dartmouth-Hitchcock Medical Center||3||"two other institutions that were in the center thought they weren't going to be able to recruit   enough patients"|f||||f||||||||||2017-10-11 00:39:21.331901|2017-10-11 00:39:21.331901
NCT02091284|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2017-02-13|||November 2013|Actual|2013-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|tDCS_ALCOHOL||Bilateral Prefrontal Modulation in Alcoholism|Prefrontal Modulation by Repetitive Bilateral Transcranial Direct Current Stimulation (tDCS) in Alcoholic Inpatients|Recruiting||Phase 2|54|Anticipated|Federal University of Espirito Santo||2|||f||||f||||||||No||2017-10-11 00:39:21.442244|2017-10-11 00:39:21.442244
NCT02085759|ClinicalTrials.gov processed this data on October 10, 2017|2009-05-28|2014-03-11|||May 2009||2009-05-01|March 2014|2014-03-01||||December 2010|Actual|2010-12-01||Observational|||T-helper 2 (Th2) Cytokine Responses in Overweight/Obese Subjects|Th2 Cytokine Responses in Overweight/Obese Subjects|Completed||N/A|46|Actual|West Penn Allegheny Health System|||3||f||||f||||||||||2017-10-11 00:40:23.108469|2017-10-11 00:40:23.108469
NCT02091271|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-06-30|||October 15, 2003||2003-10-15|March 22, 2017|2017-03-22|December 31, 2018||2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Screening Protocol to Evaluate Volunteers for NIA Approved Studies|Screening Protocol to Evaluate Volunteers for NIA Approved Studies|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:39:21.549677|2017-10-11 00:39:21.549677
NCT02091258|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-09-26|||June 2014||2014-06-01|September 2015|2015-09-01|December 2020|Anticipated|2020-12-01|May 2020|Anticipated|2020-05-01||Observational|||Tooth Loss in Periodontitis Patients|Tooth Loss in Periodontitis Patients on Long-term Maintenance in Private Practice|Active, not recruiting||N/A|200|Actual|University College, London|||1||f||||f||||||||||2017-10-11 00:39:21.614014|2017-10-11 00:39:21.614014
NCT02091245|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-08-21|||March 2014||2014-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML|Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML.|Recruiting||Phase 1|28|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:39:21.671491|2017-10-11 00:39:21.671491
NCT02091232|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-04-19|||May 2014||2014-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study)|Renal Transplantation Followed By Infusion of T-Regulatory Cells Made With Belatacept Ex-Vivo|Active, not recruiting||Phase 1|8|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 00:39:21.786858|2017-10-11 00:39:21.786858
NCT02091219|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-01-12|||June 2014||2014-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune Function|The Effects of Vitamin D3 Versus 25OHD3 (HyD) on Serum Vitamin D Metabolites and Markers of Mineral Metabolism and Immune Function|Active, not recruiting||Early Phase 1|35|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:39:21.849541|2017-10-11 00:39:21.849541
NCT02091206|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-09-27||2016-06-17|October 2014||2014-10-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Interventional|||A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)|A Double Blind, Placebo Controlled Two-part Study to Investigate the Dose-ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome|Completed||Phase 2|34|Actual|GW Research Ltd||6|||f||||t||||||||||2017-10-11 00:39:21.938419|2017-10-11 00:39:21.938419
NCT02091193|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-08-08|||March 2012||2012-03-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Effects of Krill Oil on Endothelial Function in Patients With Type 2 Diabetes Mellitus|Effects of Krill Oil on Endothelial Function in Patients With Type 2 Diabetes Mellitus|Completed||N/A|47|Actual|Danbury Hospital|||2||f||||||||||Samples Without DNA|"     Only serum is retained and is discarded after specified assays are completed. No analysis     requires genetic information.   "|||2017-10-11 00:39:22.031217|2017-10-11 00:39:22.031217
NCT02091180|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2014-03-18|||January 2013||2013-01-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Mannitol Improves Cerebral Oxygen Saturation|Effect of Preoperative Mannitol Infusion on Cerebral Oxygen Saturation and Patients' Recovery After Laparoscopic Cholecystectomy|Completed||Phase 4|40|Actual|Dammam University||2|||f||||f||||||||||2017-10-11 00:39:22.119133|2017-10-11 00:39:22.119133
NCT02091167|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2017-02-13|||November 2013|Actual|2013-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|tDCS_CRACK||Bilateral Prefrontal Modulation in Crack-cocaine Addiction|Prefrontal Modulation by Repetitive Bilateral Transcranial Direct Current Stimulation (tDCS) in Crack-cocaine Addicted Inpatients.|Recruiting||Phase 2|54|Anticipated|Federal University of Espirito Santo||2|||f||||f||||||||No||2017-10-11 00:39:22.193133|2017-10-11 00:39:22.193133
NCT02091154|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-18|||March 2012||2012-03-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||How Environmental Interventions Influence Behavior in School Lunchrooms|Evaluating the Impact on Lunch Sales and Consumption of New School Lunch Guidelines and Behavioral Interventions in NYC Schools|Completed||N/A|43|Actual|Cornell University||4|||f||||f||||||||||2017-10-11 00:39:22.432951|2017-10-11 00:39:22.432951
NCT02091128|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-09-12|||March 2014||2014-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Pregnancy Chances in Classic Galactosemia|Pregnancy Chances in Classic Galactosemia|Completed||N/A|85|Actual|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-11 00:39:22.769919|2017-10-11 00:39:22.769919
NCT02091115|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-18|||July 2013||2013-07-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Consumption of Milk Drink and Constipation|Influence of the Consumption of Milk Drink With Bifidobacterium Animalis in Symptoms of Constipation.|Completed||Phase 1/Phase 2|49|Actual|Centro Universitário Univates||2|||f||||t||||||||||2017-10-11 00:39:22.841558|2017-10-11 00:39:22.841558
NCT02091102|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-07-29|||August 2013||2013-08-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluating the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles|Evaluation of the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles|Completed||N/A|20|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:39:22.921212|2017-10-11 00:39:22.921212
NCT02091089|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-07-29|||August 2013||2013-08-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluation of the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles|Evaluation of the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles|Completed||N/A|20|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 00:39:22.995021|2017-10-11 00:39:22.995021
NCT02091076|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-11-01|||March 2014||2014-03-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing|Efficacy and Safety of Wound Dressing Containing Silk Fibroin With Bioactive Coating Layer Versus Medicated Paraffin Gauze Dressing in the Treatment of Split-thickness Skin Graft Donor Sites|Completed||Phase 1/Phase 2|29|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-11 00:39:23.065999|2017-10-11 00:39:23.065999
NCT02091063|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-05-16|||April 2, 2014|Actual|2014-04-02|May 2017|2017-05-01|December 10, 2019|Anticipated|2019-12-10|February 25, 2019|Anticipated|2019-02-25||Interventional|||ACY-1215 for Relapsed/Refractory Lymphoid Malignancies|A Phase Ib/II, Open-label, Multicenter Study of the Selective HDAC6 Inhibitor, ACY-1215, for the Treatment of Patients With Relapsed or Refractory Lymphoid Malignancies|Recruiting||Phase 1/Phase 2|40|Anticipated|Columbia University||3|||f||||t|t|f||||||Undecided||2017-10-11 00:39:23.159492|2017-10-11 00:39:23.159492
NCT02091050|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-01-24|||June 2014||2014-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|March 2015|Actual|2015-03-01||Interventional|||2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy|Clinical and Dosimetric Comparison of 2D Versus 3D HDR Brachytherapy|Completed||Phase 2|60|Anticipated|AC Camargo Cancer Center||1|||f||||t||||||||||2017-10-11 00:39:23.279852|2017-10-11 00:39:23.279852
NCT02091037|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-01-31|||December 2011||2011-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||S. Aureus Colonization in Atopic Dermatitis|Staphylococcus Aureus Colonization in Atopic Dermatitis|Active, not recruiting||N/A|114|Anticipated|Columbia University|||1||f||||t||||||Samples Without DNA|"     Skin culture specimens are retained   "|||2017-10-11 00:39:23.374726|2017-10-11 00:39:23.374726
NCT02091024|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-17|||April 2011||2011-04-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava|Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava Extract in Hypercholesterolemic Korean Subjects: a Randomized Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 2/Phase 3|80|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 00:39:23.444438|2017-10-11 00:39:23.444438
NCT02091011|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-05-11|||January 27, 2014|Actual|2014-01-27|April 2017|2017-04-01|June 1, 2021|Anticipated|2021-06-01|February 2021|Anticipated|2021-02-01||Observational|||LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices|LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices.|Active, not recruiting||N/A|1600|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 00:39:23.533389|2017-10-11 00:39:23.533389
NCT02090998|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-12-13|||May 2014||2014-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines|A Comparison of the Efficacy of 5% Lidocaine Anesthetic to Provide SPGB Vs. Elavil for the Treatment of Transformed Migraine|Enrolling by invitation||Phase 4|200|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 00:39:23.770608|2017-10-11 00:39:23.770608
NCT02090972|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-03-30|||March 2014||2014-03-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|FROP||The Impact of Opioids in Fractures - a Case Control Study|Evaluation of Past Medications in Older Patients With Fractures and Patients Hospitalized for a Non-surgical Reason.|Completed||N/A|1000|Actual|Ruhr University of Bochum|||2||f||||f||||||||||2017-10-11 00:39:23.959665|2017-10-11 00:39:23.959665
NCT02090959|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-05-30|||March 2014||2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy|A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy|Active, not recruiting||Phase 3|219|Actual|PTC Therapeutics||1|||f||||t||||||||No||2017-10-11 00:39:24.051564|2017-10-11 00:39:24.051564
NCT02090946|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2014-03-14|||October 2012||2012-10-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Observational|||The Experiences of Parents Learning Physiotherapy Techniques for Their Child|The Experiences of Parents Learning Physiotherapy Techniques for Their Child|Completed||N/A|6|Actual|Western Sussex Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 00:39:24.296973|2017-10-11 00:39:24.296973
NCT02090933|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-12-28|||March 2004||2004-03-01|December 2016|2016-12-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers|Clinical Protocol for an Open Label Study of Celecoxib (SC-58635) on the Acute Effect of Human UV-Irradiation|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 00:39:24.378307|2017-10-11 00:39:24.378307
NCT02090920|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-08-09|||July 2011||2011-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor|Individualized Dosing of Nifedipine for Tocolysis in Preterm Labor|Active, not recruiting||N/A|20|Actual|Indiana University|||1||f||||t||||||Samples With DNA|"     Plasma for determination of nifedipine and oxidized nifedipine concentrations Blood for DNA   "|||2017-10-11 00:39:24.463456|2017-10-11 00:39:24.463456
NCT02090907|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-17|||May 2013||2013-05-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism|Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism|Completed||Phase 2/Phase 3|50|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 00:39:24.548939|2017-10-11 00:39:24.548939
NCT02090894|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-05-01|||March 2011||2011-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Laser Genesis||Effect of Dermal Rejuvenation on the UVB Response of Geriatric Skin|Effect of Dermal Rejuvenation on the UVB Response of Geriatric Skin|Completed||N/A|12|Actual|Indiana University||1|||f||||||||||||||2017-10-11 00:39:24.63359|2017-10-11 00:39:24.63359
NCT02090881|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-11-18|||November 2016||2016-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Measurement of Cerebral Blood Flow Using Transcranial Doppler Ultrasound in Children With Sickle Cell Disease|Comparison of a Portable and Non-Portable Ultrasound Machine in the Evaluation of Children With Sickle Cell Disease - A Pilot Study|Not yet recruiting||N/A|50|Anticipated|Imperial College Healthcare NHS Trust||1|||f||||f||||||||No||2017-10-11 00:39:24.706245|2017-10-11 00:39:24.706245
NCT02090868|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-03-17|||April 2013||2013-04-01|March 2013|2013-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||An Oral Intake Screening Tool for Patients Receiving Non-Invasive Ventilation|How the Introduction of an Oral Intake Screening Tool Can Benefit Patients Receiving Non-Invasive Ventilation|Completed||N/A|6|Actual|Imperial College London|||3||f||||f||||||||||2017-10-11 00:39:24.821102|2017-10-11 00:39:24.821102
NCT02090855|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-02-23|2014-07-18||September 2013||2013-09-01|February 2017|2017-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational||This study is to assess the images taken previously from another study, GE-067-007. No drug was administered.|Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem|A Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem.|Completed||N/A|108|Actual|GE Healthcare|The Clinical Trials NCT number is 01165554 for GE Healthcare study, GE-067-007.||1||f||||f||||||Samples Without DNA|"     Brain specimen retained. Subjects who had previously been dosed with Flutemetamol (18F)     Injection and imaged in Study GE067-007.   "|||2017-10-11 00:39:24.972245|2017-10-11 00:39:24.972245
NCT02090842|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-01-08|||February 2014||2014-02-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Milk Proteins, Ambulatory Blood Pressure and Vascular Function|Investigating the Acute and Chronic Effects of Dietary Proteins on Markers of Vascular Function, Ambulatory Blood Pressure, Insulin Resistance and Lipid Metabolism.|Completed||N/A|38|Actual|University of Reading||3|||f||||t||||||||||2017-10-11 00:39:25.313863|2017-10-11 00:39:25.313863
NCT02090829|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-08-10|||March 2014||2014-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Interventional|||Intranasal Oxytocin and Learning in Autism|Promoting Social Perceptual Learning With Oxytocin in Autism|Active, not recruiting||Phase 2|52|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:39:25.403004|2017-10-11 00:39:25.403004
NCT02090816|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-03-14|||September 2004||2004-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Observational|||Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy|Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy|Completed||N/A|10|Actual|University of Milan|||1||f||||f||||||||||2017-10-11 00:39:25.524354|2017-10-11 00:39:25.524354
NCT02090803|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2017-09-13|||August 2012||2012-08-01|March 2014|2014-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|VIRAUTO6||Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells|Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells , Prospective, Open, Multicenter Study|Completed||N/A|189|Actual|Institut de Cancérologie de la Loire|||1||f||||f||||||||||2017-10-11 00:39:25.637946|2017-10-11 00:39:25.637946
NCT02090790|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-20|||March 2014||2014-03-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||Comparison of Analgesic Consumption Between Perioperative ıv Dexamethasone and Added to Femoral Block|The Compare the Effect of Peroperative Intravenous Single Dose Dexamethasone and the Addition of Dexamethasone to Femoral Nerve Block on Postoperative Analgesic Consumption Anf Patient Comfort in Unilateral Total Knee Arthroplasty Patients|Unknown status|Recruiting|Phase 4|60|Anticipated|TC Erciyes University||3|||f||||f||||||||||2017-10-11 00:39:25.753557|2017-10-11 00:39:25.753557
NCT02090777|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-02-17|2015-11-06||May 2014||2014-05-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Participants who completed this pilot study intervention are included in the analysis.|Health Coaching for Glaucoma Patients|Health Coaching for Glaucoma Patients, Pilot Study|Completed||N/A|9|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:39:25.862111|2017-10-11 00:39:25.862111
NCT02090764|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-06-01|2016-02-25||June 2014||2014-06-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||"Baseline analysis population was consider the safety population. Safety population was defined as all patients who received at least one application of study drug.
Patient 706031 was randomised to placebo but never treated."|Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo|A Phase III 2 Arms, Multicenter, Randomised, Double-blind Study to Assess the Efficacy and Safety of Ozenoxacin 1% Cream Applied Twice Daily for 5 Days Versus Placebo in the Treatment of Patients With Impetigo|Completed||Phase 3|412|Actual|Ferrer Internacional S.A.||2|||f||||t||||||||||2017-10-11 00:39:26.052272|2017-10-11 00:39:26.052272
NCT02090751|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-07-04|||July 2014||2014-07-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Observational|||Development of a Device to Measure Dark Adaptation|A Study to Evaluate the Sensitivity and Specificity of a Device to Measure Dark Adaptation in Subjects With and Without Early Macular Disease|Completed||N/A|40|Actual|University of Manchester|||2||f||||f||||||||||2017-10-11 00:39:26.421936|2017-10-11 00:39:26.421936
NCT02090738|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-04-27|||March 2014||2014-03-01|March 2014|2014-03-01||||December 2014|Anticipated|2014-12-01||Interventional|||A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide||Withdrawn||Phase 2|0|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:39:26.613659|2017-10-11 00:39:26.613659
NCT02090725|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-08-01|||February 2004||2004-02-01|August 2016|2016-08-01||||December 2020|Anticipated|2020-12-01||Interventional|3-4DAP||Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)|Controlled Trial of 3,4-Diaminopyridine in LEMS|Enrolling by invitation||N/A|3|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 00:39:26.717574|2017-10-11 00:39:26.717574
NCT02090712|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-03-30|||January 2010||2010-01-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2015|Actual|2015-01-01|5 Years|Observational [Patient Registry]|||Sao Paulo ST Segment Elevation Myocardial Infarction (STEMI) Registry|Reperfusion Strategies in ST Elevation Myocardial Infarction Network - Sao Paulo Registry.|Enrolling by invitation||N/A|1500|Anticipated|Federal University of São Paulo|||2||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 00:39:26.863968|2017-10-11 00:39:26.863968
NCT02090699|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-07-16|||July 2013||2013-07-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|MAFIO||MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent Anemias|Quantification of Diffuse Myocardial Iron Overload Related Interstitial Fibrosis With Cardiac Magnetic Resonance Imaging in Patients With Transfusion-Dependent Anemias|Completed||N/A|42|Actual|University Health Network, Toronto|||2||f||||f||||||||||2017-10-11 00:39:26.98083|2017-10-11 00:39:26.98083
NCT02090686|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-17|||March 2014||2014-03-01|March 2014|2014-03-01||||October 2014|Anticipated|2014-10-01||Interventional|Cupping-LBP||Pulsatile Cupping in Low Back Pain|Efficacy of Pulsatile Cupping in Patients With Chronic Low Back Pain - a Randomized Controlled Study.|Unknown status|Recruiting|N/A|108|Anticipated|Charite University, Berlin, Germany||3|||f||||||||||||||2017-10-11 00:39:27.065868|2017-10-11 00:39:27.065868
NCT02090673|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2015-08-19|||February 2009||2009-02-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea|Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea|Completed||N/A|1711|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:39:27.199719|2017-10-11 00:39:27.199719
NCT02090660|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-10-31|||April 2014||2014-04-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Technique for Localization of Pulmonary Nodules Using Spy Thoracoscope System|Feasibility of a Novel Minimally Invasive Technique for Localization of Pulmonary Nodules Using the Spy Thoracoscope System|Recruiting||Phase 2|20|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 00:39:27.297776|2017-10-11 00:39:27.297776
NCT02090647|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-14|||January 2012||2012-01-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Aesthetic Evaluation of Different Abutment Materials for OsseoSpeed Implants|Aesthetic Outcome of Osseospeed Implants With Three Different Abutment Materials. A Randomized Controlled Clinical Study|Completed||N/A|90|Actual|University of Siena||5|||f||||f||||||||||2017-10-11 00:39:27.387377|2017-10-11 00:39:27.387377
NCT02090634|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-14|||April 2010||2010-04-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|iTAB||Texting to Improve Adherence in HIV+ With Bipolar Disorder|Texting to Improve Adherence in HIV+ With Bipolar Disorder|Completed||N/A|50|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:39:27.50466|2017-10-11 00:39:27.50466
NCT02090621|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-03-11|||October 2012||2012-10-01|March 2014|2014-03-01|March 2015|Actual|2015-03-01|October 2013|Actual|2013-10-01||Interventional|||Extracorporeal Photopheresis After Liver Transplant|Extracorporeal Photopheresis After Liver Transplant. Phase II Clinical Trial on Safety and Efficacy in Patients With Progressive Withdrawal of Immunosuppression|Completed||Phase 2|10|Anticipated|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||1|||f||||t||||||||||2017-10-11 00:39:27.604034|2017-10-11 00:39:27.604034
NCT02090608|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-17|||March 2012||2012-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Paricalcitol in Fabry Disease||Completed||N/A|14|Actual|Federico II University||1|||f||||||||||||||2017-10-11 00:39:27.716675|2017-10-11 00:39:27.716675
NCT02090595|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-05-17|||July 2013||2013-07-01|May 2015|2015-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Mindfulness||Mindfulness Based Cognitive Therapy for Youth With Anxiety at Risk for Bipolar Disorder|Neurofunctional Effects of Mindfulness Based Cognitive Therapy for Youth With Symptoms of Anxiety and a Familial Risk for Developing Bipolar Disorder|Completed||N/A|35|Actual|University of Cincinnati||2|||f||||t||||||||Undecided||2017-10-11 00:39:27.827218|2017-10-11 00:39:27.827218
NCT02090582|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-07-21|||April 2014|Actual|2014-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||H.O.P.E: Helping Ovarian Cancer Patients Cope|Pilot Study on H.O.P.E: Helping Ovarian Cancer Patients Cope During Disease Recurrence|Active, not recruiting||N/A|50|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 00:39:27.941019|2017-10-11 00:39:27.941019
NCT02090569|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-03-02|||April 2014||2014-04-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|ULYS||High Resolution Imaging of Cerebral Vasculature by Functional Micro-Doppler Sonography During Brain Surgery|ULtrasound Imaging in Focal Cortical dYSplasia: a New Approach to Delineating the Dysplastic Cortex During Neurosurgery|Suspended||N/A|20|Anticipated|Centre Hospitalier St Anne||1|||f||||t||||||||||2017-10-11 00:39:28.024233|2017-10-11 00:39:28.024233
NCT02090556|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-09-26|||January 31, 2012|Actual|2012-01-31|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|ASCORE||Long-term Experience With Abatacept SC in Routine Clinical Practice|Long-term Experience With Abatacept SC in Routine Clinical Practice|Active, not recruiting||N/A|2896|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:39:28.121746|2017-10-11 00:39:28.121746
NCT02090543|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-01-20|||January 2014||2014-01-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies|Rivaroxaban Versus Vitamin K-Antagonist (VKA) in Thromboprophylaxis of Patients With Atrial Fibrillation: Patient Preference Study|Completed||N/A|647|Actual|Bayer|||2||f||||f||||||||||2017-10-11 00:39:28.250713|2017-10-11 00:39:28.250713
NCT02090530|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-10-19|||November 2013||2013-11-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing|Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing|Recruiting||N/A|400|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"     Tumor Biopsy Whole Blood Serum Buccal Smear Plasma Formalin Fixed Paraffin Embedded (FFPE)     Tissue   "|||2017-10-11 00:39:28.335546|2017-10-11 00:39:28.335546
NCT02090517|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-06-27|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Laser Therapy Versus Electrosurgery For Nasal Telangiectasias|Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device|Withdrawn||N/A|0|Actual|University of California, Davis||5||Study was withdrawn because the university wanted to bill study patients for use of the laser.|f||||f||||||||||2017-10-11 00:39:28.422086|2017-10-11 00:39:28.422086
NCT02087852|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-05-17|||March 2014||2014-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Kidney Cancer DNA Registry|Kidney Cancer DNA Registry|Recruiting||N/A|750|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||Samples With DNA|"     saliva specimen      tissue (when available)   "|||2017-10-11 00:39:59.892964|2017-10-11 00:39:59.892964
NCT02090504|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2014-03-17|||February 2002||2002-02-01|March 2014|2014-03-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|GATE I||Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome|The Gamma Hydroxybutyric Acid in Alcohol-dependence Treatment Efficacy (GATE) I Trial: a Comparative Study Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome|Completed||Phase 4|127|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 00:39:28.512366|2017-10-11 00:39:28.512366
NCT02090491|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-04-06|||November 2013||2013-11-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||MENTIS Personal Health Record Rapid Pilot Research Deployment and Evaluation|MENTIS Personal Health Record Rapid Pilot Research Deployment and Evaluation|Completed||N/A|20|Actual|Northeastern University|||1||f||||f||||||||||2017-10-11 00:39:28.616304|2017-10-11 00:39:28.616304
NCT02090478|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-14|||October 2010||2010-10-01|March 2014|2014-03-01||||June 2011|Actual|2011-06-01||Interventional|||The Effect of Dietary Sugar Consumption on Sweet Taste Perception|The Effect of Dietary Sugar Consumption on Sweet Taste Perception|Completed||N/A|50|Actual|Monell Chemical Senses Center||2|||f||||f||||||||||2017-10-11 00:39:28.680741|2017-10-11 00:39:28.680741
NCT02090465|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-17|||July 2013||2013-07-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Observational|||Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks|Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate (Picato) in a Period of 8 Weeks.|Unknown status|Recruiting|N/A|1080|Anticipated|LEO Pharma|||1||f||||f||||||||||2017-10-11 00:39:28.75379|2017-10-11 00:39:28.75379
NCT02090452|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-04-23|||June 2013||2013-06-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Mobile Transmission of Prehospital Vital Signs to the Emergency Department|"Telemedical Solutions in Medical Emergencies, Advantages and Disadvantages for Patients, Healthcare Professionals, and the Healthcare System: Study 1: Mobile Transmission of Prehospital Vital Signs to the Emergency Department - Effect on Patient Outcomes, Treatment and Diagnosis"|Completed||N/A|250|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:39:28.852383|2017-10-11 00:39:28.852383
NCT02090439|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-02-10|||July 2014||2014-07-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SiloMET||Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.|Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.|Terminated||Phase 3|8|Actual|Centre Hospitalier Departemental Vendee||2||Following difficulties in patient recruitment, we were forced to stop the study prematurely.|f||||t||||||||||2017-10-11 00:39:28.934155|2017-10-11 00:39:28.934155
NCT02090426|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-07-11|||March 2014||2014-03-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Health Care Hotspotting: A Randomized Controlled Trial|Health Care Hotspotting: A Randomized Controlled Trial|Recruiting||N/A|800|Anticipated|Abdul Latif Jameel Poverty Action Lab||2|||f||||f||||||||||2017-10-11 00:39:29.00634|2017-10-11 00:39:29.00634
NCT02090413|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-11-01|2016-11-01||May 2014||2014-05-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Interventional|ASSURE||Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis|A Phase 4, Randomized, Double-Blind Study With a Safety Extension Period to Evaluate the Effect of Aspirin on Flushing Events in Subjects With Relapsing-Remitting Multiple Sclerosis Treated With Tecfidera® (Dimethyl Fumarate) Delayed-Release Capsules|Completed||Phase 4|241|Actual|Biogen||3|||f||||f||||||||||2017-10-11 00:39:29.259767|2017-10-11 00:39:29.259767
NCT02090400|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-09-08|||May 2013||2013-05-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women|Multi-centre, Randomized, Open Label Trial to Evaluate the Effects of Switching to Bazedoxifene in Comparison With Switching to Calcium and Vitamin D in Postmenopausal Women Previously Treated With Bisphosphonates|Completed||Phase 4|110|Actual|Instituto Palacios||2|||f||||t||||||||||2017-10-11 00:39:33.369458|2017-10-11 00:39:33.369458
NCT02090387|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-17|2016-07-07|||March 2014||2014-03-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects.|Evaluation of a Complete Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects During Bed Rest and Recovery.|Completed||N/A|76|Actual|Abbott Nutrition||2|||f||||f||||||||Undecided||2017-10-11 00:39:33.469556|2017-10-11 00:39:33.469556
NCT02090374|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-06-30|||March 2014||2014-03-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen|Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen: Monophosphoryl lipidA, Poly-inosine-cytosine, Poly-inosine-cytosine Stabilised With Poly-L-lysine and Carboxymethylcellulose, Resiquimod, Tuberculin and Timothy Grass Pollen|Completed||N/A|112|Actual|Imperial College London||8|||f||||f||||||||||2017-10-11 00:39:33.661657|2017-10-11 00:39:33.661657
NCT02090361|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-08-29|||June 18, 2014|Actual|2014-06-18|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MATRIGREFFE||Efficacy of Collagen-elastin Dermal Substitute in the Treatment of Loss of Cutaneous Substances With Skin Grafts|Efficacy of Collagen-elastin Dermal Substitute in the Treatment of Loss of Cutaneous Substances With Skin Grafts|Recruiting||Phase 3|118|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 00:39:33.79109|2017-10-11 00:39:33.79109
NCT02090348|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-09-03|||June 2015||2015-06-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|TECNERGY||Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl Fumarate|A Multicenter, Open-Label Study to Evaluate Fatigue in Subjects With Relapsing-Remitting Multiple Sclerosis During Treatment With Tecfidera® (Dimethyl Fumarate) Gastro-Resistant Hard Capsules (TECNERGY)|Withdrawn||Phase 4|0|Actual|Biogen||1||"The study was withdrawn for business reasons. The decision to stop the TECNERGY study was not a   result of any safety or efficacy concerns."|f||||f||||||||||2017-10-11 00:39:33.914921|2017-10-11 00:39:33.914921
NCT02090335|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-14|||May 2007||2007-05-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|InSHAPE||Health Promotion and Fitness for Younger and Older Adults With SMI|Health Promotion and Fitness for Younger and Older Adults With SMI|Completed||N/A|210|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 00:39:34.016475|2017-10-11 00:39:34.016475
NCT02090322|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-03-17|||September 2013||2013-09-01|March 2014|2014-03-01|March 2014|Anticipated|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Bevacizumab||Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1|Study of no Inferiority Between Two Doses (0.500mg and 0.625mg) of Bevacizumab Intravitreal in the Treatment of Retinopathy of Prematurity Type 1|Unknown status|Recruiting|N/A|60|Anticipated|Universidad Autonoma de San Luis Potosí||1|||f||||t||||||||||2017-10-11 00:39:34.114194|2017-10-11 00:39:34.114194
NCT02090309|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-08-27|||March 2014||2014-03-01|January 2014|2014-01-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Association Between Low Cortisol Levels and Whiplash Syndrome|The Association Between Low Cortisol Level and Whiplash Syndrome and the Effect of a Single Hydrocortisone Injection on Neck Symptoms Among Motor Vehicle Accident Victims: a Randomized Placebo Controlled Double Blinded Study|Unknown status|Recruiting|Phase 2|90|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-10-11 00:39:34.212273|2017-10-11 00:39:34.212273
NCT02090283|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-04-10|||March 2014||2014-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Open Label Extension Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa|An Open Label Extension, Multi-Center, Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa|Active, not recruiting||N/A|48|Anticipated|Scioderm, Inc.||1|||f||||f||||||||||2017-10-11 00:39:34.395273|2017-10-11 00:39:34.395273
NCT02090270|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-03-22|||March 2014||2014-03-01|January 2015|2015-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Hair Cortisol and the Risk of Stroke|Hair Cortisol and the Risk of Stroke|Completed||N/A|50|Actual|Meir Medical Center|||2||f||||f||||||Samples Without DNA|"     Hair   "|||2017-10-11 00:39:34.495316|2017-10-11 00:39:34.495316
NCT02090257|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-07-25|||March 1, 2014|Actual|2014-03-01|July 2017|2017-07-01|May 31, 2017|Actual|2017-05-31|May 31, 2016|Actual|2016-05-31||Interventional|TRANSIT||Pediatric Heart Transplantation: Transitioning to Adult Care|Pediatric Heart Transplantation: Transitioning to Adult Care|Completed||N/A|88|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 00:39:34.573042|2017-10-11 00:39:34.573042
NCT02090244|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2017-09-19|||August 2012|Actual|2012-08-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?|Förbättrar PTH Postero-lateral fusionsläkning Vid Ryggkirurgi?|Active, not recruiting||Phase 4|34|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-11 00:39:34.662542|2017-10-11 00:39:34.662542
NCT02090231|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-14|||December 2011||2011-12-01|March 2014|2014-03-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||The Effect of Repetitive Transcranial Magnetic Stimulation for Poststroke Dysphagia Recovery|Phase 2 Study of rTMS on Poststroke Dysphagia|Unknown status|Recruiting|Phase 2|50|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 00:39:34.759509|2017-10-11 00:39:34.759509
NCT02090218|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-06-27|||February 2014||2014-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|I-CAN||I-Gel in Out-of-hospital Cardiac Arrest in Norway|I-Gel Versus Current Practice in Out-of-hospital Cardiac Arrest by Paramedics in Norway - a Prospective Stepped Wedge Crossover Trial|Completed||N/A|550|Actual|Haukeland University Hospital||2|||f||||f||||||||||2017-10-11 00:39:34.852473|2017-10-11 00:39:34.852473
NCT02090205|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2016-02-01|||November 2014||2014-11-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Mechanical Ventilation During Cardiac Surgery|Mechanical Ventilation During Cardiac Surgery, a Randomized Controlled Trial|Recruiting||N/A|780|Anticipated|Ospedale San Raffaele||3|||f||||t||||||||||2017-10-11 00:39:34.947718|2017-10-11 00:39:34.947718
NCT02090192|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-16|||January 2013||2013-01-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of Whole-body Vibration in the Frail Elderly|Acute and Chronic Effects of Whole-body Vibration on Mobility, Muscle Strength, Bone and General Health Status in the Frail Elderly|Unknown status|Recruiting|N/A|160|Anticipated|Chinese PLA General Hospital||4|||f||||t||||||||||2017-10-11 00:39:35.248353|2017-10-11 00:39:35.248353
NCT02090179|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-06-23|||December 2013||2013-12-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Evaluation of Blood Brain Barrier Integrity and Structural Abnormalities in MPS IIIB Patients Using Multimodal Magnetic Resonance Imaging|Evaluation of Blood Brain Barrier Integrity and Relationship to Structural Brain Abnormalities in MPS IIIB Patients Using Cerebrospinal Fluid/Serum Albumin Index (CSF-AI) and Multimodal Magnetic Resonance Imaging|Completed||N/A|5|Actual|Alexion Pharmaceuticals|||1||f||||f||||||||||2017-10-11 00:39:35.352512|2017-10-11 00:39:35.352512
NCT02090166|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-16|||April 2014||2014-04-01|March 2014|2014-03-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Interventional|EDLC||Lung Cancer Detection by Measuring Monocyte Activity|Lung Cancer Detection and Staging by Extracellular Monitoring of Metabolic Activity Profiles of Peripheral Blood Mononuclear Cells (PBMC)|Not yet recruiting||N/A|950|Anticipated|Carmel Medical Center||1|||f||||f||||||||||2017-10-11 00:39:35.423685|2017-10-11 00:39:35.423685
NCT02090153|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-14|||July 2011||2011-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||Study of S-1 Plus LV for Advanced Gastric Cancer|Phase II Study of S-1 Plus Leucovorin (1 Week on and 1 Week Off) as First-line Treatment for Patients With Metastatic and Recurrent Gastric Cancer|Completed||Phase 2|39|Actual|Sun Yat-sen University||1|||f||||f||||||||||2017-10-11 00:39:35.607906|2017-10-11 00:39:35.607906
NCT02090140|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-09-29|||November 2015||2015-11-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|||Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects|Randomized Controlled Trial of Microfracture Versus Adipose Derived Stem Cells for the Treatment of Isolated Articular Cartilage Defects|Recruiting||N/A|90|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 00:39:35.711315|2017-10-11 00:39:35.711315
NCT02090127|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-07-27||||||July 2015|2015-07-01||||||||Expanded Access|||Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient|Expanded Access Protocol to Provide Ficlatuzumab to P05538 Patient 0001-000412|No longer available||N/A|||AVEO Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 00:39:35.851323|2017-10-11 00:39:35.851323
NCT02090114|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-05-25|||June 2014||2014-06-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|Restore||RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)|A Phase II Study to Determine Sequential Response to Bipolar Androgen Therapy (BAT) Followed by Enzalutamide or Abiraterone Post-BAT in Men With Prostate Cancer Progressing on Combined Androgen Ablative Therapies|Recruiting||Phase 2|90|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-11 00:39:35.925658|2017-10-11 00:39:35.925658
NCT02090101|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-06-19|||October 2014|Actual|2014-10-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2017|Actual|2017-05-01||Interventional|IRAFU||Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer|Phase II Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Vascularization of Liver Metastases of Metastatic Colorectal Cancer: Proof of Concept Study|Active, not recruiting||Phase 2|32|Anticipated|Centre Georges Francois Leclerc||1|||f||||t||||||||||2017-10-11 00:39:36.054007|2017-10-11 00:39:36.054007
NCT02090088|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-12-23|2014-12-23||May 2009||2009-05-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01|21 Months|Observational [Patient Registry]|NPER||Nplate® Pregnancy Exposure Registry|Nplate® Pregnancy Exposure Registry (NPER)|Terminated||N/A|4|Actual|Amgen|The number of infants born to participants was too low to draw conclusions or make comparisons to the Systematic Tracking of Real Kids (STORK) analysis or to the background rates of congenital anomalies or preterm infants in the general population.||1||f||||t||||||||||2017-10-11 00:39:36.13506|2017-10-11 00:39:36.13506
NCT02090075|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2017-04-27|||September 2014||2014-09-01|April 2017|2017-04-01|April 5, 2017|Actual|2017-04-05|December 27, 2016|Actual|2016-12-27||Interventional|||Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque|Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque|Completed||Phase 4|64|Actual|Los Angeles Biomedical Research Institute||2|||f||||f||||||||||2017-10-11 00:39:36.443015|2017-10-11 00:39:36.443015
NCT02090062|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-17|||March 2014||2014-03-01|March 2014|2014-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|||Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection|Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection|Unknown status|Not yet recruiting|N/A|60|Anticipated|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples Without DNA|"     All the lesions will be removed endoscopically or surgically and examine histologically by an     independent gastrointestinal pathologist.      Each biospecimen after ER will be detected H pylori infection status.   "|||2017-10-11 00:39:36.545731|2017-10-11 00:39:36.545731
NCT02090049|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-14|||October 2012||2012-10-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|||Appetite Regulation by a Breakfast Soft Bread|Appetite Ratings, Postprandial Glucose, Insulin and Gastrointestinal Hormone Responses After the Intake of an Enriched Fiber and Protein Breakfast Soft Bread in Healthy Adults|Completed||N/A|30|Actual|Puratos||2|||f||||f||||||||||2017-10-11 00:39:36.608279|2017-10-11 00:39:36.608279
NCT02090036|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2014-12-05|||July 2014||2014-07-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of Gametocytes|Efficacy and Safety of a Single Low-dose Primaquine Added to Standard Artemether-lumefantrine Treatment for the Clearance of Plasmodium Falciparum Gametocytes.|Completed||Phase 4|220|Actual|Muhimbili University of Health and Allied Sciences||2|||f||||t||||||||||2017-10-11 00:39:36.688352|2017-10-11 00:39:36.688352
NCT02090023|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2014-03-16|||January 2014||2014-01-01|March 2014|2014-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Long Term Prognosis of Taiwanese Patients With OSA|Long Term Prognosis of Taiwanese Patients With Obstructive Sleep Apnea|Recruiting||N/A|4000|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 00:39:36.775502|2017-10-11 00:39:36.775502
NCT02089984|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-02-01|||September 2011||2011-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders|Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders|Completed||N/A|70|Actual|Center for Psychological Consultation||1|||f||||f||||||||||2017-10-11 00:39:37.042071|2017-10-11 00:39:37.042071
NCT02089971|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-01-16|||March 2014||2014-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|||Muscle Mass and Function in Chinese Adults|Muscle Mass and Function in Chinese Adults|Completed||N/A|412|Actual|Abbott Nutrition|||1||f||||f||||||||||2017-10-11 00:39:37.116507|2017-10-11 00:39:37.116507
NCT02089958|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2016-09-15|||September 2013||2013-09-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|LIPOM||Standardization of Laparoscopic Hernia Repair|Standardization of Laparoscopic Intraperitoneal Onlay Mesh Augmentation for Incisional Hernia Repair: Impact on Clinical Outcomes and Quality-of-Life - Open Prospective Observational Multicentre Cohort Study|Completed||N/A|102|Actual|Klinikum Fulda|||1||f||||t||||||||Yes|publication|2017-10-11 00:39:37.188597|2017-10-11 00:39:37.188597
NCT02089945|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-10-14|||February 2014||2014-02-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Pilot Study of Cognitive and Functional Outcomes Following TAVI|Cognitive and Functional Outcomes Following Transcatheter Aortic Valve Implantation (TAVI): a Pilot Study|Completed||N/A|14|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-10-11 00:39:37.258907|2017-10-11 00:39:37.258907
NCT02089932|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2015-12-22|||February 2014||2014-02-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Dexmedetomidine in Different Dose Levels as Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block.|The Effects of Different Dose Levels of Peri-neural Dexmedetomidine on the Pharmacodynamic and Side Effects Profiles of Bupivacaine-induced Ultrasound-guided Femoral Nerve Block|Completed||Phase 4|60|Actual|Cairo University||4|||f||||t||||||||||2017-10-11 00:39:37.326663|2017-10-11 00:39:37.326663
NCT02089919|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-16|2015-06-01|||February 2014||2014-02-01|March 2014|2014-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients|Study of Cancer Stem Cell Vcccinie That as a Specific Antigen in Metastatic Adenocarcinoma of the Liver|Completed||Phase 1/Phase 2|40|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f||||t||||||||||2017-10-11 00:39:37.407684|2017-10-11 00:39:37.407684
NCT02089906|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-08-03|||March 2014||2014-03-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Health and Nutrition Status of Chinese Elderly|Health Status of Chinese Elderly|Completed||N/A|2834|Actual|Abbott Nutrition|||1||f||||f||||||||||2017-10-11 00:39:37.482533|2017-10-11 00:39:37.482533
NCT02089893|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2017-04-24|||February 2014||2014-02-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|||Study of the Incidence of Cilioretinal Arteries in the Hungarian Population|Study of the Incidence of Cilioretinal Arteries in the Hungarian Population|Recruiting||N/A|1000|Anticipated|Semmelweis University|||1||f||||f||||||||No||2017-10-11 00:39:37.559791|2017-10-11 00:39:37.559791
NCT02089880|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-10-03|||February 2014||2014-02-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis|Micro-processor Controlled Knee-Ankle-Foot Orthosis (C-Brace) Versus Stance-control Knee-Ankle-Foot Orthosis (SCO): Functional Outcomes in Individuals With Lower Extremity Impairment|Active, not recruiting||N/A|24|Anticipated|Shirley Ryan AbilityLab||2|||f||||||||||||||2017-10-11 00:39:37.634988|2017-10-11 00:39:37.634988
NCT02089867|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2014-03-17|||October 2006||2006-10-01|March 2014|2014-03-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Interventional|||Plant Sterols Effect on Previous Statin Therapy|A Randomized Open Label Trial to Assess the Effect of Plant Sterols Associated With Ezetimibe in LDL-cholesterol Levels in Coronary Patients Previously on Statin Therapy|Completed||Phase 2/Phase 3|47|Actual|Pontifícia Universidade Católica do Paraná||4|||f||||f||||||||||2017-10-11 00:39:37.722177|2017-10-11 00:39:37.722177
NCT02089854|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2016-11-30|||November 2014||2014-11-01|November 2016|2016-11-01||||April 2019|Anticipated|2019-04-01||Interventional|AETNBC||Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer|Evaluation of Adjuvant Endocrine Therapy for Operable ER-beta Positive, ER-alpha/PR Negative, Her-2 Negative Breast Cancer Patients|Recruiting||Phase 4|800|Anticipated|Peking Union Medical College Hospital||2|||f||||||||||||||2017-10-11 00:39:37.882426|2017-10-11 00:39:37.882426
NCT02089841|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2014-03-17|||May 2012||2012-05-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|ALE||Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.|Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Five Years After Wide Scale Use of the Drug in Tanzania.|Completed||Phase 4|140|Actual|Muhimbili University of Health and Allied Sciences||1|||f||||f||||||||||2017-10-11 00:39:37.973115|2017-10-11 00:39:37.973115
NCT02089828|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-04-16|||March 2014||2014-03-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia|Randomized Control Trial on Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia|Recruiting||N/A|50|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-11 00:39:38.067652|2017-10-11 00:39:38.067652
NCT02089815|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-04-09|||August 2013||2013-08-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Home Based Exercise in Preventing Fall and Improving Balance in Older People|Effectiveness of a Simple Designed Programme of Home Based Exercise in Preventing Fall and Improving Balance and Strength in Older People With Mild to Moderate Balance Dysfunction: A Randomized Controlled Trials|Completed||N/A|439|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 00:39:38.250268|2017-10-11 00:39:38.250268
NCT02089802|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-08-15|||February 25, 2014|Actual|2014-02-25|August 2017|2017-08-01|March 22, 2016|Actual|2016-03-22|March 22, 2016|Actual|2016-03-22||Interventional|OPERA||Optimizing Pazopanib Exposure in RCC Patients|Optimizing Pazopanib Exposure in RCC Patients Through Therapeutic Drug Monitoring Followed by Intrapatient Dose Escalation|Terminated||Phase 2|6|Actual|Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e.||1||Early termination due to lack of recruitment|f||||f||||||||||2017-10-11 00:39:38.347075|2017-10-11 00:39:38.347075
NCT02089789|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-08-22|||March 6, 2014||2014-03-06|August 15, 2017|2017-08-15|December 1, 2018|Anticipated|2018-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|||Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation|Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:39:38.447895|2017-10-11 00:39:38.447895
NCT02089776|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-06-30|||March 5, 2014||2014-03-05|May 18, 2017|2017-05-18|November 1, 2018|Anticipated|2018-11-01|November 1, 2017|Anticipated|2017-11-01||Observational|||fMRI Neurofeedback for Motor Rehabilitation|Real-time fMRI Neurofeedback for Motor Rehabilitation|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:39:38.540277|2017-10-11 00:39:38.540277
NCT02089763|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-07-27|||April 2014||2014-04-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|March 2017|Actual|2017-03-01||Interventional|||Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer|A Phase II Trial of PEG-BCT-100 as the Second-line Therapy Following Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Terminated||Phase 2|27|Actual|Bio-Cancer Treatment International Limited||1||Early termination for futility|f||||f||||||||||2017-10-11 00:39:38.619033|2017-10-11 00:39:38.619033
NCT02089750|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-03-30|||March 2014||2014-03-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01||Interventional|||Orthotic Use for Chronic Low Back Pain|Orthotic Use for Chronic Low Back Pain: A Randomized Controlled Trial|Completed||N/A|225|Anticipated|National University of Health Sciences||3|||f||||t||||||||||2017-10-11 00:39:38.71255|2017-10-11 00:39:38.71255
NCT02089737|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-02-21|2015-04-20||June 2010||2010-06-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational||3086 participants completed the survey form (5 participants did not complete it). 3085 participants were included in the safety analysis set after excluding 1 participant due to missing panitumumab treatment and AE data. From that set, 3084 participants were included in the efficacy analysis set after excluding 1 participant with missing data.|"Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene (All-patient Surveillance)"|"Vectibix for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene (All-patient Surveillance)"|Completed||N/A|3091|Actual|Takeda|The present specified drug-use survey is a one-arm observational study with no control group. Therefore, the observed outcome measures provide exploratory information regarding these endpoints; however, do not constitute verification results.||1||f||||f||||||||||2017-10-11 00:39:38.826772|2017-10-11 00:39:38.826772
NCT02089724|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2016-10-27|||March 2014||2014-03-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|December 2016|Anticipated|2016-12-01||Observational|LOVE||Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease|Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease|Recruiting||N/A|20|Anticipated|Groupe Hospitalier Pitie-Salpetriere|||1||f||||t||||||||||2017-10-11 00:39:40.045073|2017-10-11 00:39:40.045073
NCT02089711|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-15|2015-08-19|||January 2014||2014-01-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|S-2013-2||Optical Coherence Tomography (OCT) Normative Data Collection Study (S-2013-2)|Multi-center Study for Normal Database of Optic Nerve Head, Retinal Nerve Fiber Layer, and Macula Parameters With the Heidelberg Spectralis OCT, Study 2|Completed||N/A|392|Actual|Heidelberg Engineering GmbH|||1||f||||t||||||||||2017-10-11 00:39:40.138709|2017-10-11 00:39:40.138709
NCT02089698|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-15|||September 2013||2013-09-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||Parameters of 2 Phaco Tips Designs in Torsional Phacoemulsification|Mini-flared Kelman Tip and Reverse Tip With Torsional Phaco: Prospective Randomized Comparative Study|Completed||Phase 4|60|Actual|Hospital Oftalmologico de Brasilia||2|||f||||t||||||||||2017-10-11 00:39:40.197708|2017-10-11 00:39:40.197708
NCT02089685|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-09-28|||March 17, 2014|Actual|2014-03-17|September 2017|2017-09-01|June 17, 2020|Anticipated|2020-06-17|June 17, 2020|Anticipated|2020-06-17||Interventional|||Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)|A Phase 1/2 Clinical Trial to Study the Safety and Tolerability of MK-3475 + Pegylated Interferon Alfa-2b (PEG-IFN) and MK-3475 + Ipilimumab (IPI) in Subjects With Advanced Melanoma (MEL) and Renal Cell Carcinoma (RCC) (KEYNOTE 029)|Recruiting||Phase 1/Phase 2|293|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||f|t|f||||||||2017-10-11 00:39:40.277697|2017-10-11 00:39:40.277697
NCT02089672|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2015-11-14|||April 2014||2014-04-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||RF Lesion Monitoring With 8mm IntellaTip MiFi XP|Radiofrequency Ablation Lesion Monitoring Using Imbedded Micro-Electrodes Versus Standard Bipolar Electrograms|Completed||N/A|30|Actual|Emory University|||1||f||||t||||||||||2017-10-11 00:39:40.40219|2017-10-11 00:39:40.40219
NCT02089659|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-05-26|||March 26, 2014|Actual|2014-03-26|May 2017|2017-05-01|May 12, 2014|Actual|2014-05-12|May 12, 2014|Actual|2014-05-12||Interventional|||A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Doravirine (MK-1439) (MK-1439-019)|A 2-Part, Open-Label, Singe-Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 00:39:40.476355|2017-10-11 00:39:40.476355
NCT02089646|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-12-09|||September 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:39:40.537238|2017-10-11 00:39:40.537238
NCT02089633|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-07-27|||April 2014||2014-04-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|PACOX||Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC|A Study of the Safety and Efficacy of Recombinant Human Arginase 1 (PEG-BCT-100) Combined With Capecitabine and Oxaliplatin in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|17|Actual|Bio-Cancer Treatment International Limited||1|||f||||t||||||||||2017-10-11 00:39:40.57808|2017-10-11 00:39:40.57808
NCT02089620|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2015-08-07|||May 2014||2014-05-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PMS||Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome|Calcium Supplements Versus Oral Contraceptive Pills Containing Drospirenone in Treating Mild to Moderate Premenstrual Syndrome: A Double Blind Randomized Placebo Controlled Trial|Completed||Phase 3|210|Actual|Beni-Suef University||3|||f||||t||||||||||2017-10-11 00:39:40.674258|2017-10-11 00:39:40.674258
NCT02089607|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-03-29|||March 2014||2014-03-01|March 2016|2016-03-01|May 2025|Anticipated|2025-05-01|March 2020|Anticipated|2020-03-01||Interventional|IDE#2||Thoracoabdominal Aortic Aneurysms With Fenestrated and Branched Stent Grafts|Clinical Outcomes and Quality of Life Measures in Patients Treated for Thoracoabdominal Aortic Aneurysms With Fenestrated and Branched Stent Grafts|Recruiting||N/A|200|Anticipated|Mayo Clinic||1|||f||||t|f|f||||||No||2017-10-11 00:39:40.762591|2017-10-11 00:39:40.762591
NCT02089594|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-04-16|||May 2014||2014-05-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Hyperbaric Oxygen Treatment to Treat Mild Traumatic Brain Injury (mTBI)/Persistent Post-Concussion Syndrome (PPCS)|Hyperbaric Oxygen Therapy Treatment of Chronic Mild Traumatic Brain Injury (mTBI)/Persistent Post-Concussion Syndrome (PPCS)|Recruiting||Phase 3|59|Anticipated|Louisiana State University Health Sciences Center in New Orleans||2|||f||||t||||||||||2017-10-11 00:39:40.925855|2017-10-11 00:39:40.925855
NCT02089581|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-09-25|||April 2014||2014-04-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|May 2014|Actual|2014-05-01||Interventional|||A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication|An Open-label, Randomised, Crossover, Single-dose, Study in Healthy Subjects to Compare the Pharmacokinetics of Two Formulations of a Strong Pain Killer With a Marketed Reference Product in a Fasted or Fed State|Completed||Phase 1|32|Actual|Mundipharma Research Limited||4|||f||||f||||||||||2017-10-11 00:39:41.032935|2017-10-11 00:39:41.032935
NCT02089568|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-08-18|||July 2012||2012-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|POWAR||Prophylaxis Of Wound Infections- Antibiotics in Renal Donation|Are Prophylactic Antibiotics Necessary Before Laparoscopic Living Kidney Donation? A Double Blind, Randomised, Controlled Trial.|Completed||Phase 4|284|Actual|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:39:41.115912|2017-10-11 00:39:41.115912
NCT02089555|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2016-06-21|||September 2013||2013-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|A3PM||African American Alzheimer's Progression Markers - CSF and Neuro-Imaging|Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment in African Americans and Caucasians|Completed||N/A|135|Actual|Emory University|||2||f||||f||||||Samples With DNA|"     Cerebrospinal fluid, plasma, and DNA will be saved.   "|||2017-10-11 00:39:41.280141|2017-10-11 00:39:41.280141
NCT02089542|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-11-01|||October 2014||2014-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid Surgery|Development of a Clinical Protocol to Use Intra-operative Near Infra-red Fluorescent Imaging in Thyroid and Parathyroid Surgery|Completed||Phase 1/Phase 2|41|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:39:41.372341|2017-10-11 00:39:41.372341
NCT02089529|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-12-16|||January 2014||2014-01-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs|Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs: Application of Pharmacotherapeutic Conditioning in Clinical Practice.|Completed||N/A|8|Actual|University Hospital of North Norway||7|||f||||f||||||||||2017-10-11 00:39:41.462479|2017-10-11 00:39:41.462479
NCT02089516|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-04-10|||February 2014||2014-02-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Activity Monitoring in Frail Elderly Patients|Activity Monitoring in Frail Elderly Patients. A Methods Comparison Study.|Completed||N/A|18|Actual|Medical Research Foundation, The Netherlands|||1||f||||f||||||||||2017-10-11 00:39:41.571335|2017-10-11 00:39:41.571335
NCT02089490|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-14|||April 2014||2014-04-01|March 2014|2014-03-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|NEVAL||Evaluation of NEVELIA® in Terms of Safety and Efficacy for Third-degree Burns Treatment or Reconstructive Surgery|Prospective Follow-up Study for the Evaluation of the Safety and Efficacy of the Dermal Substitute NEVELIA® in the Treatment of Third-degree Burns and Reconstructive Surgery|Unknown status|Not yet recruiting|N/A|30|Anticipated|Symatese||1|||f||||f||||||||||2017-10-11 00:39:41.737999|2017-10-11 00:39:41.737999
NCT02089477|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-10-04|||March 2014||2014-03-01|October 2017|2017-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Smart-phone as a Physical Fitness Monitor - Validity, Sensitivity and Motivation InterWalk|The Smart-phone as a Physical Fitness Monitor on a Population Level - Validity and Sensitivity and Improtance of Individual Motivation for Doing Interval Walking With the InterWalk Application|Completed||N/A|37|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 00:39:41.840517|2017-10-11 00:39:41.840517
NCT02089464|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-09-19||2017-09-13|April 2014||2014-04-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|NICHE||Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial|Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke|Completed||N/A|199|Actual|Nexstim Ltd||2|||f||||t||||||||||2017-10-11 00:39:41.922484|2017-10-11 00:39:41.922484
NCT02089451|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-02-16|||March 17, 2014|Actual|2014-03-17|February 2017|2017-02-01|June 6, 2014|Actual|2014-06-06|June 6, 2014|Actual|2014-06-06||Interventional|||A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects|A Trial Comparing the Pharmacokinetic Properties of FIAsp After Different Injection Regions and Routes of Administration in Healthy Subjects|Completed||Phase 1|21|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 00:39:42.030037|2017-10-11 00:39:42.030037
NCT02089438|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-08-22|||May 2014||2014-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Interventional|CODI24||DPP-4 Inhibition, Incretins and Islet Function|Comparison of Three DPP-4 Inhibitors on 24 Hour Blood Glucose, Incretin Hormones and Islet Function in Patients With Type 2 Diabetes|Completed||Phase 4|24|Actual|Lund University||3|||f||||t||||||||||2017-10-11 00:39:42.110505|2017-10-11 00:39:42.110505
NCT02089425|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-03-02||2015-04-14|April 2014||2014-04-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.||Terminated||Phase 3|384|Actual|Kowa Research Institute, Inc.||2||Interim futility analysis|f||||||||||||||2017-10-11 00:39:42.204007|2017-10-11 00:39:42.204007
NCT02089412|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-11-02|||February 2014||2014-02-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||A Study to Determine the Effect of a High-Fat Meal on the Rate and Extent of E2006 Absorption in Healthy Subjects||Completed||Phase 1|59|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 00:39:42.357144|2017-10-11 00:39:42.357144
NCT02089399|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-04-27|||May 2014||2014-05-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers|An Open Label, Randomized, 2-Sequence, Multiple-Dose, Cross-Over Study to Investigate the Drug-Drug Interaction of Sevikar and Crestor in Healthy Adult Volunteers|Completed||Phase 1|32|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||||2017-10-11 00:39:42.419468|2017-10-11 00:39:42.419468
NCT02089386|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-03-09|||July 9, 2014|Actual|2014-07-09|March 2017|2017-03-01|June 21, 2016|Actual|2016-06-21|June 21, 2016|Actual|2016-06-21||Interventional|||Tamoxifen to Treat Barrett's Metaplasia|Tamoxifen to Treat Barrett's Metaplasia|Terminated||Early Phase 1|7|Actual|Washington University School of Medicine||1||Insufficient funding|f||||t|t|f|||f|||No||2017-10-11 00:39:42.487531|2017-10-11 00:39:42.487531
NCT02089360|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-14|||January 2014||2014-01-01|March 2014|2014-03-01||||January 2016|Anticipated|2016-01-01|5 Years|Observational [Patient Registry]|AGENDA||Adavanced Glycated Endproducts and Development of CAD|Study of Serum Level of Advanced Glycated Endproducts and Development of Coronary Atherosclerosis in Patients Undergoing Coronary Angiogram|Unknown status|Recruiting|N/A|10000|Anticipated|Shanghai Jiao Tong University School of Medicine|||1||f||||t||||||Samples With DNA|"     Blood sample is taken for all patients underwent coronary angiogram after getting informed     consent, and stored in requested condition, for measuring serum levels of different kinds of     factors.   "|||2017-10-11 00:39:42.629401|2017-10-11 00:39:42.629401
NCT02089347|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-04-28|2015-09-09||March 2014||2014-03-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old|Immunogenicity and Safety of the Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (SP306) Given Intramuscularly Compared to Diphtheria and Tetanus Toxoids Adsorbed (DT) Given Subcutaneously in Japanese Adolescents 11 - 12 Years of Age|Completed||Phase 3|534|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:39:42.717963|2017-10-11 00:39:42.717963
NCT02089334|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-09-26|||August 2014||2014-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer|A Multicenter, Open-label, Phase 1b/2 Study to Evaluate the Safety and Efficacy of RX-0201 in Combination With Everolimus to Treat Subjects With Advanced Renal Cell Carcinoma|Recruiting||Phase 1/Phase 2|23|Anticipated|Rexahn Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:39:43.272896|2017-10-11 00:39:43.272896
NCT02089321|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-13|||November 2011||2011-11-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Multiplanar Lumbopelvic Control in Patients With Low Back Pain||Completed||N/A|38|Actual|Regis University|||2||f||||f||||||||||2017-10-11 00:39:43.374209|2017-10-11 00:39:43.374209
NCT02089308|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-06-11|||March 2014||2014-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Nicotine Patch - Bioequivalence Study||Completed||Phase 1|74|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 00:39:43.432658|2017-10-11 00:39:43.432658
NCT02089295|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-03-31|||April 2014||2014-04-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions|An Open-label, Randomized, Single-dose, Three-way Crossover Study to Evaluate the Dose Proportionality of 5 Mg, 20 Mg and 40 Mg of PF-00345439 Formulation K Under Intermediate-fat Fed Conditions in Healthy Volunteers|Completed||Phase 1|18|Actual|Pain Therapeutics||3|||f||||f||||||||||2017-10-11 00:39:43.506322|2017-10-11 00:39:43.506322
NCT02089282|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-03-14|||March 2014||2014-03-01|March 2014|2014-03-01||||August 2014|Anticipated|2014-08-01|21 Days|Observational [Patient Registry]|||Clavicular Shortening Post-fracture - Does it Change? - a Prospective Study of 70 Patients||Unknown status|Recruiting|N/A|70|Anticipated|Holbaek Sygehus|||1||f||||t||||||||||2017-10-11 00:39:43.590362|2017-10-11 00:39:43.590362
NCT02089269|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2017-03-20|||December 2013||2013-12-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|TPK||Tumor Registry Pancreatic Cancer|Clinical Registry on Treatment Reality and Therapy Sequences in Patients With Metastatic or Locally Advanced Pancreatic Cancer.|Recruiting||N/A|1250|Anticipated|iOMEDICO AG|||1||f||||f||||||||No||2017-10-11 00:39:43.662854|2017-10-11 00:39:43.662854
NCT02089256|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-03-31|||June 2014||2014-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Repeated Administration of Liraglutide on Insulinogenic Indices|Effect of Repeated Administration of Liraglutide on Insulinogenic Indices|Completed||Phase 4|10|Actual|University of Tartu||1|||f||||f||||||||||2017-10-11 00:39:43.72603|2017-10-11 00:39:43.72603
NCT02089243|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-03-13|||June 2014||2014-06-01|March 2014|2014-03-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|CoRaVNStiR||Controlled Randomized Vagus Nerve Stimulation (VNS) Therapy Versus Resection (CoRaVNStiR)|Prospective Randomized Controlled Study of Vagus Nerve Stimulation Therapy in the Patients With Medically Refractory Medial Temporal Lobe Epilepsy; Controlled Randomized Vagus Nerve Stimulation Versus Resection (CoRaVNStiR)|Unknown status|Not yet recruiting|N/A|40|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 00:39:43.793424|2017-10-11 00:39:43.793424
NCT02089230|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-03-31|||August 2014|Actual|2014-08-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy|Phase I/II Trial of MEK Inhibitor MEK162 in Patients With Relapsed and or Refractory Acute Myeloid Leukemia and Patients With Poor Prognosis Acute Myeloid Leukemia Not Suitable for or Unwilling to Receive Standard Therapy|Recruiting||Phase 1/Phase 2|57|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:39:43.883875|2017-10-11 00:39:43.883875
NCT02089217|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-09-21|||December 2014||2014-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|CREST-2||Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial|Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial|Recruiting||N/A|2480|Anticipated|Mayo Clinic||4|||f||||t||||||||||2017-10-11 00:39:43.988356|2017-10-11 00:39:43.988356
NCT02089204|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2014-03-13|||June 2010||2010-06-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|February 2014|Actual|2014-02-01||Observational|||Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma|Clinical Feasibility Study of Hypoxia Imaging -Guided IMRT on the Individualized Radiotherapy of Nasopharyngeal Carcinoma|Unknown status|Enrolling by invitation|Phase 2/Phase 3|300|Anticipated|Xuzhou Medical University|||3||f||||t||||||||||2017-10-11 00:39:44.819501|2017-10-11 00:39:44.819501
NCT02089191|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2015-04-30|2015-04-30||March 2014||2014-03-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||This analysis group includes all enrolled participants.|Tear Film Stability of DAILIES® AquaComfort Plus® Contact Lenses vs. MyDay® Daily Disposable Contact Lenses|Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection|Completed||N/A|31|Actual|Alcon Research|There was a high censoring rate observed with the objective measurements and therefore there are limitations to the conclusions that may be drawn.|2|||f||||f||||||||||2017-10-11 00:39:44.924457|2017-10-11 00:39:44.924457
NCT02089178|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-14|||February 2014||2014-02-01|March 2014|2014-03-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Comparison of the Effect of Total Intravenous Anesthesia and Inhalation Anesthesia on Cancer Cell Cytotoxicity, Micrometastasis and Recurrence of Tumor in Patients Undergoing Breast Tumor Resection||Unknown status|Recruiting|N/A|200|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:39:45.123841|2017-10-11 00:39:45.123841
NCT02089165|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-06-03|||February 2014||2014-02-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|RISU||Bioavailability of Fatty Acids From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects.|Randomized, Single-center, Open-label, Blinded Endpoint Assessment Study (Cross-over Study With 3 Study Products) on Bioavailability of Fatty Acids (Plasma Lipid Fractions) From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects.|Completed||Phase 2|19|Actual|Olympic Seafood AS||3|||f||||f||||||||||2017-10-11 00:39:45.219469|2017-10-11 00:39:45.219469
NCT02089152|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-08-24|||April 2014||2014-04-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|PREMEL||A Single-blind Stepped Wedge Cluster Randomized Controlled Behaviour Change Trial to Determine Effectiveness of Prevention Programme of Melioidosis in Diabetics in Ubon Ratchathani, Northeast Thailand|A Single-blind Stepped Wedge Cluster Randomized Controlled Behaviour Change Trial to Determine Effectiveness of Prevention Programme of Melioidosis in Diabetics in Ubon Ratchathani, Northeast Thailand|Recruiting||N/A|9000|Anticipated|University of Oxford||3|||f||||f||||||||||2017-10-11 00:39:45.305451|2017-10-11 00:39:45.305451
NCT02089139|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-09-09|||May 2014||2014-05-01|September 2015|2015-09-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|EGID||Treatment of Discogenic Back Pain|Intradiscal Injection of Gelified Ethanol for the Treatment of Discogenic Back Pain|Terminated||N/A|40|Anticipated|University Hospital, Limoges||2||"The French medicines agency did not allow the continuation of the study (no patient enrolled in   this study)"|f||||f||||||||||2017-10-11 00:39:45.422475|2017-10-11 00:39:45.422475
NCT02089126|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-14|||June 2014||2014-06-01|March 2014|2014-03-01||||September 2016|Anticipated|2016-09-01||Interventional|||Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes|A Multicenter, Randomized, Placebo-controlled, Parallel Group, Double-blind, Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride Alone|Unknown status|Not yet recruiting|Phase 3|230|Anticipated|LG Life Sciences||2|||f||||f||||||||||2017-10-11 00:39:45.510062|2017-10-11 00:39:45.510062
NCT02089113|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-03-15|2016-02-29||April 2014|Actual|2014-04-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Second Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery||Completed||Phase 3|240|Actual|Ocular Therapeutix, Inc.||2|||f||||f||||||||||2017-10-11 00:39:45.593304|2017-10-11 00:39:45.593304
NCT02089100|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-08-07|||February 2014||2014-02-01|August 2017|2017-08-01|February 2023|Anticipated|2023-02-01|February 2020|Anticipated|2020-02-01||Interventional|STEREO-SEIN||Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer|Multicentric Phase III Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Metastatic Breast Cancer in First-line Treatment|Recruiting||Phase 3|280|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 00:39:45.807056|2017-10-11 00:39:45.807056
NCT02089087|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-08-04|||January 7, 2013|Actual|2013-01-07|August 2017|2017-08-01|February 3, 2017|Actual|2017-02-03|February 3, 2017|Actual|2017-02-03||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients|A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CFZ533 in Healthy Subjects and Rheumatoid Arthritis Patients|Completed||Phase 1|75|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:39:45.883096|2017-10-11 00:39:45.883096
NCT02089074|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-03-29|||November 2012|Actual|2012-11-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01||Interventional|||Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack|Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack: Adherence and Cardiovascular Events in the First Three Months|Completed||N/A|265|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 00:39:45.97684|2017-10-11 00:39:45.97684
NCT02089061|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-14|2014-08-13|||March 2014||2014-03-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Drug Interaction Statin|A Phase 1 Open-label, Single-sequence Study to Evaluate the Effect of Coadministration of BMS-919373 on the Single-dose Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects|Completed||Phase 1|26|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:39:46.066867|2017-10-11 00:39:46.066867
NCT02089048|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-04-27|||April 2, 2014|Actual|2014-04-02|March 12, 2014|2014-03-12|May 13, 2015|Actual|2015-05-13|September 9, 2014|Actual|2014-09-09||Interventional|||Auranofin PK Following Oral Dose Administration|An Open Label, Multiple Dose Study to Evaluate the Pharmacokinetics of Auranofin Following Oral Dose Administration for 7 Days to Healthy Subjects|Completed||Phase 1|15|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f|||||t|f|||f|||||2017-10-11 00:39:46.141816|2017-10-11 00:39:46.141816
NCT02089035|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2017-07-21|||May 2014||2014-05-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|RESET||Replacement of Saturated Fat in Dairy on Total Cholesterol|Replacement of Saturated Fat in Dairy on Total Cholesterol, Vascular Function, Ambulatory Blood Pressure and Cardiovascular Risk Biomarkers|Completed||N/A|54|Actual|University of Reading||2|||f||||t||||||||||2017-10-11 00:39:46.208456|2017-10-11 00:39:46.208456
NCT02089022|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-13|||January 2011||2011-01-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Analysis of Neuromuscular Responses and the Balance After the Application of Physiotherapy Resources|Analysis of Neuromuscular Responses and the Balance After the Application of Physiotherapy Resources|Completed||N/A|21|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 00:39:46.287339|2017-10-11 00:39:46.287339
NCT02089009|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-07-17|||December 2013||2013-12-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Comparison of Non-mydriatic Camera Systems in a Female Health Hospital|Comparison of Non-mydriatic Camera Systems for Screening and Follow-up Examinations -Focused on the Retinal Vessel Situation- in the Population of a Female Health Hospital|Completed||N/A|214|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-11 00:39:46.381918|2017-10-11 00:39:46.381918
NCT02088996|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-08-25|||March 2011||2011-03-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Electrical Stimulation and Chemotherapy Induced Peripheral Neuropathy|Electrical Stimulation and Chemotherapy Induced Peripheral Neuropathy.|Unknown status|Active, not recruiting|N/A|70|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 00:39:46.526281|2017-10-11 00:39:46.526281
NCT02088983|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-14|||April 2014||2014-04-01|March 2014|2014-03-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia|Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|University of Ottawa||2|||f||||||||||||||2017-10-11 00:39:46.615714|2017-10-11 00:39:46.615714
NCT02088970|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-05-31|||September 2014||2014-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|CXL||Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)|Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study.|Terminated||N/A|21|Actual|Nantes University Hospital||2||"Difficulties in reaching the desired number of patients and intermediate analysis leading to   discontinuation of the study."|f||||t||||||||||2017-10-11 00:39:46.714576|2017-10-11 00:39:46.714576
NCT02088957|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-07-05|2016-03-14|2015-07-21|March 2014||2014-03-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Demographics of the only subject included are presented below.|Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures|A Randomized, Open-label, Multicenter, Parallel-group, Exploratory Study to Evaluate the Efficacy of Intravenous Brivaracetam and Intravenous Phenytoin in Subjects Experiencing Nonconvulsive Electrographic Seizures|Terminated||Phase 2|1|Actual|UCB Pharma||2||Termination of study due to low enrollment. There were no safety issues.|f||||t||||||||||2017-10-11 00:39:47.571871|2017-10-11 00:39:47.571871
NCT02088944|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-13|||March 2014||2014-03-01|March 2014|2014-03-01||||October 2015|Anticipated|2015-10-01|8 Weeks|Observational [Patient Registry]|||a Single-center Registered Clinical Research of Chinese Patients With Moderate to Severe Crohn's Disease||Unknown status|Not yet recruiting|N/A|142|Anticipated|Nanfang Hospital of Southern Medical University|||1||f||||||||||||||2017-10-11 00:39:47.837299|2017-10-11 00:39:47.837299
NCT02088931|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-10-18|||March 2014||2014-03-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TASK||Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation|A Pilot Trial of CD4+CD127lo/-CD25+ Polyclonal Treg Adoptive Immunotherapy in Renal Transplant Recipients|Active, not recruiting||Phase 1|3|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 00:39:47.893839|2017-10-11 00:39:47.893839
NCT02088918|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-14|||October 2012||2012-10-01|March 2014|2014-03-01||||December 2012|Actual|2012-12-01||Interventional|||A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects||Completed||Phase 1|40|Actual|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||||2017-10-11 00:39:47.969012|2017-10-11 00:39:47.969012
NCT02088892|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-01-21|||March 2014||2014-03-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Clinical Challenge Study of BCG in Healthy Volunteers|A Clinical Challenge Study to Quantify BCG at the Challenge Site of Healthy Volunteers Receiving Either Intradermal BCG SSI or BCG TICE at Standard or High Dose|Completed||N/A|52|Actual|University of Oxford||5|||f||||f||||||||||2017-10-11 00:39:48.099066|2017-10-11 00:39:48.099066
NCT02088879|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-04-01|||March 2014||2014-03-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Physical Workload Identify in Chest Compression Position Using Surface Electromyogram||Completed||N/A|36|Actual|Hanyang University||2|||f||||t||||||||||2017-10-11 00:39:48.200167|2017-10-11 00:39:48.200167
NCT02088866|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-05-24|||March 2014||2014-03-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Commercial Lidocaine Patch as a Treatment for Ear-ringing|Transdermal Lidocaine as a Treatment for Tinnitus|Completed||Early Phase 1|30|Actual|University of California, Davis||1|||f||||f||||||||No|Final data was inconclusive|2017-10-11 00:39:48.271631|2017-10-11 00:39:48.271631
NCT02088853|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-03-09|||March 2014||2014-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Diet Induced Intestinal Mucosal Adaptation|Small Intestinal Adaptation to Isocaloric Diets Dominated Either by Fats or Carbohydrates|Completed||N/A|17|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 00:39:49.984268|2017-10-11 00:39:49.984268
NCT02088840|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-07-05|||January 2014||2014-01-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|4 Months|Observational [Patient Registry]|GITMO-SIGNB||Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant|A Prospective, Multicenter Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Autologous and Allogeneic Stem Cell Transplant.|Completed||N/A|2769|Actual|Gruppo Italiano Trapianto di Midollo Osseo|||1||f||||f||||||||||2017-10-11 00:39:50.127141|2017-10-11 00:39:50.127141
NCT02088827|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-04-12|||January 2015|Actual|2015-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Sedentary Behaviour on Metabolic Parameters|Effects of Sedentary Behaviour on Metabolic Parameters|Recruiting||N/A|20|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-11 00:39:50.302649|2017-10-11 00:39:50.302649
NCT02088814|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-12-09|||April 2014||2014-04-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|EPICAP||Prevention of Posttraumatic Stress Symptoms in Young Children With Burns: a Randomized Controlled Trial|Prevention of Posttraumatic Stress Symptoms in Young Children With Burns: a Randomized Controlled Trial|Recruiting||N/A|124|Anticipated|University Children's Hospital, Zurich||2|||f||||f||||||||No||2017-10-11 00:39:50.386138|2017-10-11 00:39:50.386138
NCT02088801|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-06-10|||February 2014||2014-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SWIVITII||Evaluation of Videolaryngoscopes in Difficult Airway (SWIVITII)|Phase 2 Study of Evaluation of Videolaryngoscopes in Difficult Airway (SWIVITII)|Completed||N/A|480|Actual|University Hospital Inselspital, Berne||4|||f||||f||||||||||2017-10-11 00:39:50.470016|2017-10-11 00:39:50.470016
NCT02088788|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-14|||June 2013||2013-06-01|March 2014|2014-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Reduction in Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a Radiation Protection Board|Reduction in Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a Radiation Protection Board|Unknown status|Recruiting|Phase 4|350|Anticipated|Geisinger Clinic||2|||f||||f||||||||||2017-10-11 00:39:50.561457|2017-10-11 00:39:50.561457
NCT02088775|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-01-24|||February 2014|Actual|2014-02-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer|Intrinsic Dosimetry for Radioembolization Utilizing PET-CT Imaging Data: A Prospective Registry Study|Active, not recruiting||N/A|43|Anticipated|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 00:39:50.651806|2017-10-11 00:39:50.651806
NCT02088762|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-03-30|||January 1997||1997-01-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Observational|||Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)|Impact of the Excision of Melanoma > 2mm in Thickness With 1cm Surgical Margins on Survival of the Patients in Comparison to 2 cm Surgical Margins|Completed||N/A|325|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-11 00:39:50.873463|2017-10-11 00:39:50.873463
NCT02088749|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-13|||May 2010||2010-05-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of Weight Management Programs Delivered in Large Versus Small Groups|Comparison of Weight Management Programs Delivered in Large Versus Small Groups|Completed||N/A|66|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:39:50.95892|2017-10-11 00:39:50.95892
NCT02088736|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-10-04|||June 2014||2014-06-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2017|Actual|2017-01-01||Interventional|||Intraosseous vs Intravenous Access for Cardiac Arrest Treatment|Clinical Evaluation of Intraosseous and Intravenous Access for Cardiac Arrest Treatment in Emergency Ambulances In Singapore|Recruiting||Phase 4|400|Anticipated|Singapore General Hospital||2|||f||||f||||||||||2017-10-11 00:39:51.048134|2017-10-11 00:39:51.048134
NCT02088723|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-10-19|||September 2014||2014-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|TEST||Testing the Elevation as Sleep Apnea Treatment|The Influence of Elevation of the Head of the Bed in Patients With Obstructive Sleep Apnea|Completed||N/A|52|Actual|Pulmonar||1|||f||||t||||||||||2017-10-11 00:39:51.152731|2017-10-11 00:39:51.152731
NCT02088710|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-09-24|||January 2011||2011-01-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|December 2012|Actual|2012-12-01||Observational|||Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer|Clinical Cohort of Individual Expectations, Side Effects, Quality of Life and Adherence in Postoperative Women With Estrogen Receptor Positive Breast Cancer During Endocrine Therapy|Active, not recruiting||N/A|138|Actual|Philipps University Marburg Medical Center|||1||f||||f||||||||||2017-10-11 00:39:51.237816|2017-10-11 00:39:51.237816
NCT02088697|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-13|||December 2013||2013-12-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects||Completed||Phase 1|50|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 00:39:51.329959|2017-10-11 00:39:51.329959
NCT02088684|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-07-24|||May 19, 2014|Actual|2014-05-19|July 2017|2017-07-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer|A Phase Ib/II Study of LEE011 in Combination With Fulvestrant and BYL719 or BKM120 in the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Locally Recurrent or Advanced Metastatic Breast Cancer|Active, not recruiting||Phase 1/Phase 2|70|Actual|Novartis||3|||f||||f|t|f||||||||2017-10-11 00:39:51.405761|2017-10-11 00:39:51.405761
NCT02088671|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-12-13|||June 2014||2014-06-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|December 2014|Actual|2014-12-01||Interventional|||Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia|A Prospective, Blinded, Clinical Study for Assessing the Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia (DOA)|Completed||N/A|76|Actual|NeuroWave Systems Inc.||1|||f||||f||||||||||2017-10-11 00:39:51.533925|2017-10-11 00:39:51.533925
NCT02088658|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2016-09-29|||May 2013||2013-05-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|TIDES||Technology Intensified Diabetes Education Study in African Americans|Technology Intensified Diabetes Education Study in African Americans With Type 2 Diabetes|Active, not recruiting||N/A|200|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 00:39:51.639201|2017-10-11 00:39:51.639201
NCT02088645|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-11-28|||April 2015||2015-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|Lumed||177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.|177Lu-PP-F11N for Receptor Targeted Therapy and Imaging (Theranostics) of Metastatic Medullary Thyroid Cancer - a Pilot and a Phase I Study.|Recruiting||Phase 1|24|Anticipated|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 00:39:51.729331|2017-10-11 00:39:51.729331
NCT02088632|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-05-19|||March 14, 2014|Actual|2014-03-14|May 2017|2017-05-01|October 19, 2016|Actual|2016-10-19|June 11, 2015|Actual|2015-06-11||Interventional|||Botulinum Toxin for the Treatment of Trigeminal Neuralgia|A Randomized, Double-Blind, Placebo-Controlled, Add-on Therapy Study of Xeomin (Incobotulinumtoxina) Versus Placebo in the Treatment of Trigeminal Neuralgia|Terminated||Phase 2|8|Actual|Thomas Jefferson University||2||Unable to enrolled in a timely manner.|f||||f||||||||||2017-10-11 00:39:51.824466|2017-10-11 00:39:51.824466
NCT02088619|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-09-29|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|PAM-ICD||Positive Therapy for Autonomic Function & Mood in ICD Patients|Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients|Completed||N/A|29|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 00:39:51.902286|2017-10-11 00:39:51.902286
NCT02088606|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-01-05|||March 2014||2014-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Continued Access Protocol|TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Continued Access Protocol|Completed||N/A|69|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 00:39:51.989201|2017-10-11 00:39:51.989201
NCT02088593|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-03-14|||July 2007||2007-07-01|February 2014|2014-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Simulated Dawn Med Students|The Effect of Improving Sleep and Circadian Rhythms on Affective Symptoms In First Year Medical Students|Completed||N/A|46|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 00:39:52.063077|2017-10-11 00:39:52.063077
NCT02088580|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-10-01|||October 2013||2013-10-01|September 2013|2013-09-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients|Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients|Completed||N/A|13|Actual|Medical University of South Carolina||1|||f||||f||||||||||2017-10-11 00:39:52.160068|2017-10-11 00:39:52.160068
NCT02088567|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-09-21|||January 2014||2014-01-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Amniotic Membrane in Total Knee Replacements to Reduce Scarring|A Prospective Randomized Clinical Trial Using Dehydrated Human Amnion/Chorion Membrane (dHACM) in Total Knee Replacement Patients to Reduce Post-operative Scarring.|Completed||N/A|52|Actual|MiMedx Group, Inc.||2|||f||||f||||||||||2017-10-11 00:39:52.252461|2017-10-11 00:39:52.252461
NCT02088554|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-08-17|||May 12, 2014|Actual|2014-05-12|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|July 31, 2017|Actual|2017-07-31||Interventional|PERIGON||PERIGON Pivotal Trial|Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease|Active, not recruiting||N/A|1300|Anticipated|Medtronic Cardiovascular||1|||f||||t||||||||||2017-10-11 00:39:52.321721|2017-10-11 00:39:52.321721
NCT02088541|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2017-05-25|||March 2014||2014-03-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|November 2016|Actual|2016-11-01||Interventional|SOPRA||Selinexor (KPT-330) in Older Patients With Relapsed AML|A Randomized, Open Label, Phase 2 Study of the Selective Inhibitor of Nuclear Export (Sine) Selinexor (KPT-330) Versus Specified Physician's Choice in Patients ≥ 60 Years Old With Relapsed/Refractory Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy and/or Transplantation|Active, not recruiting||Phase 2|171|Actual|Karyopharm Therapeutics Inc||2|||f||||t||||||||Yes||2017-10-11 00:39:52.621755|2017-10-11 00:39:52.621755
NCT02088528|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-14|||March 2014||2014-03-01|March 2014|2014-03-01||||March 2021|Anticipated|2021-03-01||Interventional|GPTVT||The Ghana Primary Tube Versus Trabeculectomy Study|The Ghana Primary Tube Versus Trabeculectomy Study|Recruiting||N/A|298|Anticipated|Tema Christian Eye Center||2|||f||||t||||||||||2017-10-11 00:39:52.887579|2017-10-11 00:39:52.887579
NCT02088515|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-03-02|||December 2013|Actual|2013-12-01|April 2016|2016-04-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|||Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma|Nedaplatin (Jiebaishu®) and Docetaxel in Comparison With Cisplatin and Docetaxel Regimen for the First Line Treatment of Advanced Squamous Cell Carcinoma of Lung(IIIB/IV): Randomized, Controlled, Multicentre Study|Completed||Phase 4|290|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:39:52.988748|2017-10-11 00:39:52.988748
NCT02088502|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-13|||September 2013||2013-09-01|March 2014|2014-03-01||||April 2014|Anticipated|2014-04-01||Interventional|||Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy|Comparative Evaluation of the Effect of Theophylline Plus N-acetylcysteine, Theophylline Alone, and N-acetylcysteine Alone in Preventing Contrast-induced Nephropathy in Patients With Moderate to High Risk Undergoing Coronary Angiographic Procedures|Unknown status|Recruiting|Phase 2/Phase 3|96|Anticipated|Isfahan University of Medical Sciences||3|||f||||f||||||||||2017-10-11 00:39:53.08546|2017-10-11 00:39:53.08546
NCT02088489|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-08-09|||November 2012|Actual|2012-11-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|February 2015|Actual|2015-02-01||Interventional|Cathena||Thermocool SF Catheter Versus Thermocool Catheter in Isthmus-dependent Atrial Flutter Ablation|Effectiveness and Safety of Porous Tip Irrigated Ablation Catheter Versus Conventional Irrigated Catheter in Isthmus Dependent Atrial Flutter Ablation: a Randomized Study|Completed||Phase 3|70|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 00:39:53.182212|2017-10-11 00:39:53.182212
NCT02088476|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-14|||January 2004||2004-01-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Observational|||Candidemia in a Pediatric Center and Importance of Central Venous Catheter Removal||Completed||N/A|248|Actual|Hacettepe University|||1||f||||f||||||||||2017-10-11 00:39:53.27114|2017-10-11 00:39:53.27114
NCT02088463|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-04-14|||December 2012||2012-12-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Mobilization for Post Partum Low Back Pain|Efficacy of Lumbar Mobilization on Postpartum Low Back Pain in Egyptian Females: A Randomized Control Trial|Completed||N/A|45|Actual|Cairo University||3|||f||||f||||||||||2017-10-11 00:39:53.33783|2017-10-11 00:39:53.33783
NCT02088450|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-05-10|||February 1990||1990-02-01|May 2017|2017-05-01|February 1997|Actual|1997-02-01|February 1997|Actual|1997-02-01||Interventional|Syst-Eur||Systolic Hypertension in Europe Placebo-Controlled Trial|Systolic Hypertension in Europe Trial|Terminated||Phase 2|4695|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||Yes|Syst-Eur data are available on request by other investigators, whose research is ethically approved.|2017-10-11 00:39:53.42944|2017-10-11 00:39:53.42944
NCT02088437|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-12-29|||March 2014||2014-03-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|HIP4hips||High Intensity Physiotherapy for Hip Fractures|High Intensity Physiotherapy for Hip Fractures in the Acute Hospital Setting|Completed||N/A|92|Actual|The Alfred||2|||f||||t||||||||||2017-10-11 00:39:53.505523|2017-10-11 00:39:53.505523
NCT02088424|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2014-03-13|||March 2014||2014-03-01|March 2014|2014-03-01|April 2015|Anticipated|2015-04-01|November 2014|Anticipated|2014-11-01|6 Months|Observational [Patient Registry]|||the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION|Insulin Resistance and Recurrent Abortion|Unknown status|Not yet recruiting|N/A|30|Anticipated|Ain Shams University|||2||f||||t||||||Samples Without DNA|"     whole blood   "|||2017-10-11 00:39:53.612513|2017-10-11 00:39:53.612513
NCT02088411|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2014-03-13|||November 2000||2000-11-01|March 2014|2014-03-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults|The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults: a Randomized, Double-blind, Placebo-controlled Trial.|Completed||Phase 2|150|Actual|Atrium Innovations||3|||f||||t||||||||||2017-10-11 00:39:53.723742|2017-10-11 00:39:53.723742
NCT02088398|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-09-10|||March 2014||2014-03-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects|Open-Label, Randomized, Single Dose, 3-Period Crossover to Evaluate the Relative Bioavailability and Food-Effect on Pharmacokinetics of Alternative 10 mg/mL Liquid Formulation ACY-1215 (Ricolinostat) in Healthy Subjects|Completed||Phase 1|19|Actual|Acetylon Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-10-11 00:39:53.817359|2017-10-11 00:39:53.817359
NCT02088385|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2015-02-04|||November 2013||2013-11-01|February 2015|2015-02-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers : A Pilot Study|Pilot Study of a Randomized Controlled Trial Comparing Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers|Unknown status|Recruiting|Phase 1|20|Anticipated|Changi General Hospital||2|||f||||f||||||||||2017-10-11 00:39:53.903268|2017-10-11 00:39:53.903268
NCT02088372|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-03-28|||November 2012||2012-11-01|July 2016|2016-07-01|December 2023|Anticipated|2023-12-01|December 2014|Actual|2014-12-01||Observational|VGRDE1||Prospective Multi-Center Study on Vanguard With E1 Bearing|Evaluate Clinical Performance of Vanguard Knee With E1 Bearing in Korean Patient Population|Active, not recruiting||N/A|200|Anticipated|Zimmer Biomet|||1||f||||t||||||||Yes||2017-10-11 00:39:53.989529|2017-10-11 00:39:53.989529
NCT02088359|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-07-07|||June 2012||2012-06-01|June 2012|2012-06-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Observational|||Compare of Effectiveness Cycled Light or Near Darkness on Growth Parameters in Preterm Infants||Completed||N/A|150|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital|||2||f||||||||||||||2017-10-11 00:39:54.096714|2017-10-11 00:39:54.096714
NCT02088346|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-06-23|||August 2014||2014-08-01|September 2014|2014-09-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Observational|ASAP-Tel||Acute Stroke Advancing Program Using Telemedicine|Intravenous Thrombolysis Guided by Telemedicine Consultation System for Acute Ischemic Stroke Patients in China|Unknown status|Recruiting|N/A|300|Anticipated|Xijing Hospital|||2||f||||t||||||||||2017-10-11 00:39:54.164306|2017-10-11 00:39:54.164306
NCT02088333|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-02-03|||June 2014||2014-06-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|mCRC||Effectiveness of an mHealth Colorectal Cancer Screening Intervention|A Primary Care Multilevel mHealth Colorectal Cancer Screening (mCRC) Intervention|Completed||N/A|450|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 00:39:54.252415|2017-10-11 00:39:54.252415
NCT02088320|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-02-19|||November 2013||2013-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Measurement of Pulmonary Transit Time by Echocardiography: Comparison With Cardiac MRI|Measurement of Pulmonary Transit Time by Echocardiography: Comparison With Cardiac MRI|Recruiting||N/A|75|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||||||2017-10-11 00:39:54.347688|2017-10-11 00:39:54.347688
NCT02088307|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-03-21|||June 2013||2013-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Study of the Cardiovascular Vitamin, CardioLife|Evaluation of the Metabolic and Physiological Profiles of Patients Diagnosed With Cardiovascular Disease (CVD) Following Administration of the Novel Cardiovascular Vitamin, CardioLife|Completed||N/A|21|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 00:39:54.410285|2017-10-11 00:39:54.410285
NCT02088294|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-03-30|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Guided Imagery Lifestyle Intervention to Promote Health and Prevent Diabetes in Youth|Imagine HEALTH (Healthy Eating Active Living Total Health) Study: Guided Imagery Lifestyle Intervention to Promote Health and Prevent Diabetes in Youth|Active, not recruiting||N/A|240|Anticipated|University of Southern California||4|||f||||f||||||||||2017-10-11 00:39:54.499183|2017-10-11 00:39:54.499183
NCT02088281|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2014-03-12|||November 2012||2012-11-01|October 2012|2012-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Mechanistic Study of Indigo Naturalis in Treating Psoriasis|Mechanistic Study of Indigo Naturalis in Treating Psoriasis: Local or Systemic Manipulation of Inflammation and Induction of Immunoregulation|Completed||Phase 2|20|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:39:54.597147|2017-10-11 00:39:54.597147
NCT02088268|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-10-20|||January 2014||2014-01-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PRP||Treatment of PRP on Diabetes Wound|Treatment and Evaluation of Platelet-rich-plasma on Diabetes Wound Healing|Completed||N/A|10|Actual|China Medical University Hospital||1|||f||||t||||||||||2017-10-11 00:39:54.809735|2017-10-11 00:39:54.809735
NCT02088255|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-03-07|||March 2014||2014-03-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Walking Training With Partial Body Weight Support on Static and Dynamic Surfaces in Stroke Survivers|Walking Training With Partial Body Weight Support on Static and Dynamic Surfaces in Individuals With Hemiparesis Due to Stroke|Completed||N/A|28|Actual|Universidade Cruzeiro do Sul||2|||f||||f||||||||||2017-10-11 00:39:54.887424|2017-10-11 00:39:54.887424
NCT02088242|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-12|||May 2014||2014-05-01|March 2014|2014-03-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|Astaxanthin||Physiological and Molecular Influences of Astaxanthin Supplementation on Heat Strain in Humans|Physiological and Molecular Influences of Astaxanthin Supplementation on Heat Strain in Humans|Unknown status|Not yet recruiting|N/A|34|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:39:54.981969|2017-10-11 00:39:54.981969
NCT02088229|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-01-25|||September 2012||2012-09-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema|Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema|Completed||N/A|35|Actual|University of Michigan|||1||f||||f||||||||||2017-10-11 00:39:55.19735|2017-10-11 00:39:55.19735
NCT02088216|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-07-23|||March 2014||2014-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|BENE||Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis|Effect of Long-term, High-dose N-acetylcysteine on Acute Exacerbations of Patients With Non-cystic Fibrosis Bronchiectasis: the BENE Randomized, Controlled Trial|Active, not recruiting||Phase 4|150|Anticipated|Qilu Hospital of Shandong University||2|||f||||||||||||||2017-10-11 00:39:55.272553|2017-10-11 00:39:55.272553
NCT02088203|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-09-26|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|RT2||Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)|Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.) Complex as a Dietary Supplement to Improve Carbohydrate Metabolism; Dosing, Safety and Tolerability|Recruiting||Phase 1|54|Anticipated|Pennington Biomedical Research Center||18|||f||||f||||||||||2017-10-11 00:39:55.370407|2017-10-11 00:39:55.370407
NCT02088190|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-01-16|||April 2014||2014-04-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Observational|||Effect of Aging on Bariatric Surgery-induced Changes in Metabolism and Cognition|Effect of Aging on Bariatric Surgery-induced Changes in Metabolism and Cognition|Recruiting||N/A|22|Anticipated|Ohio State University|||2||f||||t||||||||No||2017-10-11 00:39:55.542571|2017-10-11 00:39:55.542571
NCT02088177|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-08-21|2017-07-20||October 2014||2014-10-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence|Open-Label Pilot Study of Long-Acting Injectable Naltrexone Treatment for Cannabis Dependence|Completed||Phase 1/Phase 2|12|Actual|New York State Psychiatric Institute|Our study is open-label, uncontrolled and with a small sample size, and is not designed to test a priori hypotheses as to the safety, efficacy or effectiveness of our treatment intervention beyond its feasibility for further study.|1|||f||||t||||||||||2017-10-11 00:39:55.631351|2017-10-11 00:39:55.631351
NCT02088164|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2014-03-13|||February 2012||2012-02-01|March 2014|2014-03-01||||April 2012|Actual|2012-04-01||Observational|||Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men|Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men|Completed||N/A|27741|Actual|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 00:39:55.925685|2017-10-11 00:39:55.925685
NCT02088151|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-25|||June 2010||2010-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina|Selective Retinal Pigment Epithelium Laser Therapy (SRT) for Macular Disease of the Retina|Recruiting||N/A|100|Anticipated|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-10-11 00:39:55.997776|2017-10-11 00:39:55.997776
NCT02088138|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-03-12|||September 2010||2010-09-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Functional Electrical Stimulation in Cardiac Patients|Effects of Functional Electrical Stimulation on Physical Performance of Patients in Cardiac Rehabilitation|Completed||N/A|20|Actual|Universidade Federal de Santa Maria||2|||f||||t||||||||||2017-10-11 00:39:56.117361|2017-10-11 00:39:56.117361
NCT02088125|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-12|||September 2013||2013-09-01|March 2014|2014-03-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|||Dynamic Ventilatory and Asymmetry of the Chest Wall During Breath Stacking and Volume-oriented Incentive Spirometer|Dynamic Ventilatory and Asymmetry of the Chest Wall During Breath Stacking and Volume-oriented Incentive Spirometer in Patients After Stroke: Crossover Clinical Trial|Unknown status|Recruiting|N/A|12|Anticipated|Universidade Federal de Pernambuco||2|||f||||f||||||||||2017-10-11 00:39:56.227578|2017-10-11 00:39:56.227578
NCT02088112|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-09-13|||March 24, 2014|Actual|2014-03-24|September 2017|2017-09-01|June 14, 2019|Anticipated|2019-06-14|June 14, 2019|Anticipated|2019-06-14||Interventional|||MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC)|A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Gefitinib in Combination With MEDI4736 (Anti PD-L1) in Subjects With Non-Small Cell Lung Cancer(NSCLC)|Active, not recruiting||Phase 1|56|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 00:39:56.349667|2017-10-11 00:39:56.349667
NCT02088086|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-08-25|||March 2014||2014-03-01|August 2017|2017-08-01|July 15, 2017|Actual|2017-07-15|June 15, 2017|Actual|2017-06-15||Interventional|||BMI Screening and Reporting in Schools: The Fit Study|Randomized Controlled Trial of BMI Screening: Effects on Obesity, Disparities, and Body Satisfaction|Completed||N/A|36452|Actual|University of California, Berkeley||3|||f||||t||||||||||2017-10-11 00:39:56.586314|2017-10-11 00:39:56.586314
NCT02088060|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-09-14|||March 2014||2014-03-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients|A Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients|Recruiting||Phase 2|150|Anticipated|Central Institute of Mental Health, Mannheim||3|||f||||t||||||||||2017-10-11 00:39:56.892536|2017-10-11 00:39:56.892536
NCT02088047|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-09-18|||August 30, 2014|Actual|2014-08-30|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||The Effects of ProFoveate on Reducing Self-Stimulating Behaviors|The Effects of ProFoveate on Reducing Self-Stimulating Behaviors in Children Diagnosed With Autism Spectrum Disorders|Recruiting||N/A|30|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-10-11 00:39:57.070279|2017-10-11 00:39:57.070279
NCT02088021|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-04-21|||January 2014||2014-01-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|February 2015|Anticipated|2015-02-01||Interventional|PorticoALTEU||Assessment of the St. Jude Medical PorticoTM Re-sheathable Aortic Valve System - Alternative Access||Withdrawn||N/A|0|Actual|St. Jude Medical||1||Business decision|f||||t||||||||||2017-10-11 00:39:57.378108|2017-10-11 00:39:57.378108
NCT02088008|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-12|||May 2014||2014-05-01|March 2014|2014-03-01||||September 2014|Anticipated|2014-09-01||Interventional|||A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan|A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers|Unknown status|Not yet recruiting|Phase 1|54|Anticipated|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||||2017-10-11 00:39:57.461842|2017-10-11 00:39:57.461842
NCT02087995|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-07-25|2015-08-04||December 2013||2013-12-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Type 1 and Type 2 diabetes patients|Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm|Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm|Completed||N/A|51|Actual|DexCom, Inc.||1|||f||||f||||||||||2017-10-11 00:39:57.555947|2017-10-11 00:39:57.555947
NCT02087982|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-12-19|||January 2014||2014-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|ReperAge||Development of General Practitioners Screening Tool of Frail Older Old Community|Development of General Practitioners Screening Tool of Frail Older Old Community-dwellers: a Cohort Population-based Study|Completed||N/A|840|Actual|Gerontopôle des Pays de la Loire|||1||f||||t||||||||||2017-10-11 00:39:57.802734|2017-10-11 00:39:57.802734
NCT02087969|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-09-12|||April 2014||2014-04-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Triceps Surae Trigger Point Size and Muscle Extensibility|Effectiveness of Dry Needling to Decrease Trigger Point Size and Increase Soft Tissue Extensibility in the Triceps Surae Muscle as Measured Via Musculoskeletal Ultrasound|Completed||N/A|30|Actual|Duke University||2|||f||||t||||||||||2017-10-11 00:39:57.867789|2017-10-11 00:39:57.867789
NCT02087943|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-04-24|2016-10-18||June 2014||2014-06-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional||Intent to Treat (ITT) includes all participants who were randomized as specified in the protocol and received at least one dose of Investigational product (IP)|Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Atopic Dermatitis|Completed||Phase 2|191|Actual|Celgene||5|||f||||t||||||||||2017-10-11 00:39:58.071931|2017-10-11 00:39:58.071931
NCT02087930|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-13|||March 2013||2013-03-01|March 2014|2014-03-01|September 2014|Anticipated|2014-09-01|May 2014|Anticipated|2014-05-01||Interventional|||Microbiota as Potential Target for Food Allergy|Microbiota as Potential Target for Innovative Preventive and Therapeutic Strategies for Food Allergy|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Federico II University||2|||f||||||||||||||2017-10-11 00:39:59.078843|2017-10-11 00:39:59.078843
NCT02087917|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-01-05|||March 2014||2014-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia|A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia|Completed||Phase 2|376|Actual|Zhejiang Hisun Pharmaceutical Co. Ltd.||5|||f||||f||||||||||2017-10-11 00:39:59.16972|2017-10-11 00:39:59.16972
NCT02087904|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-08-25||2017-08-25|May 2014||2014-05-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis|A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis|Completed||Phase 2|288|Actual|AbbVie||4|||f||||f||||||||||2017-10-11 00:39:59.326245|2017-10-11 00:39:59.326245
NCT02087891|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-03-12|||May 2011||2011-05-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|SFN||Stress Free Now in a Corporate Call Center|Stress Free Now in a Corporate Call Center|Completed||N/A|161|Actual|The Cleveland Clinic||4|||f||||f||||||||||2017-10-11 00:39:59.61575|2017-10-11 00:39:59.61575
NCT02087878|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-13|2017-08-01|||March 31, 2014|Actual|2014-03-31|August 2017|2017-08-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|HSTCL||A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma|A Multicenter Study to Collect Samples for Future Evaluation of Biomarkers and Genetic Mutations in Patients Exposed to Adalimumab With Crohn's Disease (CD) or Ulcerative Colitis (UC) Who Developed Hepatosplenic T-Cell Lymphoma (HSTCL)|Recruiting||N/A|40|Anticipated|AbbVie|||1||f||||f||||||Samples With DNA|"     1-10 mL blood (serum) for biomarker samples; separate consent for 1- 4 mL whole blood sample     for DNA isolation. Biopsy tissue and Fine Needle Aspirate also collected. Samples will be     shipped to a designated storage facility.   "|||2017-10-11 00:39:59.716495|2017-10-11 00:39:59.716495
NCT02087865|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-09-26|||May 2014||2014-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease|Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease|Recruiting||Phase 4|90|Anticipated|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 00:39:59.811522|2017-10-11 00:39:59.811522
NCT02087839|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-12|||October 2008||2008-10-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC): Phase II|A Phase II Dose-Escalation and Safety Study of ZD6474 (ZACTIMA) Used In Combination With Radiation Therapy for Patients With Inoperable/Unresectable Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Original study did not progress to Phase II.|f||||f||||||||||2017-10-11 00:39:59.995959|2017-10-11 00:39:59.995959
NCT02087826|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-01-11|||April 2014||2014-04-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|SIGMA2MGH||Common Variation at SLC16A11 and Other Genes on the Response to a Mixed Meal Tolerance Test|A Study to Understand the Influence of Common Variation at SLC16A11 and Other Genes on the Physiologic Response to a Mixed Meal Tolerance Test (SIGMA2 MGH)|Recruiting||N/A|1000|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:40:00.103433|2017-10-11 00:40:00.103433
NCT02087813|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-12|||March 2014||2014-03-01|March 2014|2014-03-01||||March 2016|Anticipated|2016-03-01||Interventional|A1AT for NMO||Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses|A Single Center Open Label Pilot Study of Alpha1-Antitrypsin: A Novel Treatment to Mitigate Neuromyelitis Optica Attacks|Unknown status|Recruiting|Phase 1|5|Anticipated|Stanford University||2|||f||||||||||||||2017-10-11 00:40:00.209852|2017-10-11 00:40:00.209852
NCT02087800|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-11-25|||April 2014||2014-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Smoking, Stress & Allopregnanolone Response|Effect of Smoking on Stress-Induced Allopregnanolone Response in Women by Menstrual Phase|Completed||N/A|43|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-11 00:40:00.308087|2017-10-11 00:40:00.308087
NCT02087787|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-12-09|||March 2014||2014-03-01|December 2014|2014-12-01|February 2016|Anticipated|2016-02-01|October 2015|Anticipated|2015-10-01||Interventional|||Medical-legal Partnership (MLP) to Support Bone Marrow Transplant|Establishing a BMT Legal Clinic to Support Patients With Cancer Undergoing Blood or Marrow Transplant|Unknown status|Recruiting|N/A|105|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:40:00.380537|2017-10-11 00:40:00.380537
NCT02087774|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-07-25|2014-06-25||September 2013||2013-09-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Both groups were located in a rural, eastern state within 75 miles from one another|Brief Physical Activity Program to Increase Physical Fitness in Elementary School Children|The Effects of a Brief Physical Activity Program on Elementary School Students' Physical Fitness|Completed||N/A|300|Actual|Marshall University|Non-randomized, controlled design. Majority of subject were caucasian, from Appalachian region.|2|||f||||f||||||||||2017-10-11 00:40:00.471889|2017-10-11 00:40:00.471889
NCT02087761|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-03-01|||December 2015||2015-12-01|March 2016|2016-03-01||||April 2016|Anticipated|2016-04-01||Observational|||A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients|A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients|Active, not recruiting||N/A|1000|Anticipated|Luminex Molecular Diagnostics|||1||f||||f||||||Samples With DNA|"     Nasal-pharyngeal swabs   "|||2017-10-11 00:40:00.750908|2017-10-11 00:40:00.750908
NCT02087748|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-12-08|2014-10-01||March 2014||2014-03-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional||One group will use 1% diclofenac sodium gel on the left leg and placebo on the right leg for the treatment duration. The other group will use the same products, but on opposite legs.|An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS|A Randomized, Double-Blind, Within-Subject, Proof of Concept Study to Assess the Analgesic Efficacy and Safety of Voltaren Gel (1% Diclofenac Sodium) Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness|Completed||Phase 4|24|Actual|Lotus Clinical Research, LLC||2|||f||||f||||||||||2017-10-11 00:40:00.828527|2017-10-11 00:40:00.828527
NCT02087735|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-10-07|||January 2014||2014-01-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|CUPACS||Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts|Measurement of Urinary Catabolites of the Proanthocyanidines (PACs) in Healthy Young Women as Biomarkers of Consumption of Cranberry Extracts.|Completed||Phase 1|15|Actual|Laval University||3|||f||||t||||||||||2017-10-11 00:40:01.101906|2017-10-11 00:40:01.101906
NCT02087722|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-12|||August 2013||2013-08-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients|A Double-blind, Parallel Group, Randomised, Placebo Controlled, Multicenter, Bridging Study of Efficacy and Safety of KI1001 in the Improvement of Sleep Quality in ≥ 55 Years Old Insomnia Patients|Completed||Phase 3|80|Actual|Kuhnil Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:40:01.186466|2017-10-11 00:40:01.186466
NCT02087709|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-13|||May 2008||2008-05-01|March 2014|2014-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Effect of Low-calorie Diet on Serum Lipids, Adipokines, Insulin Resistance and Also Body Composition in Women With Metabolic Syndrome|Effect of Hypocaloric Diet on Biomarkers of Metabolic Profile, Insulin Resistance and Body Composition in Women With Metabolic Syndrome|Completed||N/A|30|Actual|Universidade Federal do Rio de Janeiro||1|||f||||f||||||||||2017-10-11 00:40:01.278301|2017-10-11 00:40:01.278301
NCT02087696|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-05-21|||May 2014||2014-05-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis|Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis and Candidates With a Biological Monotherapy|Unknown status|Recruiting|Phase 4|122|Anticipated|Spanish Foundation of Rheumatology||2|||f||||f||||||||||2017-10-11 00:40:01.345822|2017-10-11 00:40:01.345822
NCT02087683|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-09-12|||November 2014||2014-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Vitamin D Supplementation in Patients With Heart Failure and Vitamin D Deficiency|Effect of Vitamin D Supplementation in Patients With Heart Failure and Vitamin D Deficiency|Recruiting||N/A|60|Anticipated|Instituto Tecnologico y de Estudios Superiores de Monterey||2|||f||||f||||||||||2017-10-11 00:40:01.509571|2017-10-11 00:40:01.509571
NCT02087488|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-02-05|||March 2014||2014-03-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|AAPI||Auricular Acupuncture for Primary Insomnia|Auricular Acupuncture for Primary Insomnia|Unknown status|Recruiting|N/A|288|Anticipated|Chengdu University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 00:40:03.567562|2017-10-11 00:40:03.567562
NCT02087670|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-02-09|2014-04-22||March 2005||2005-03-01|February 2016|2016-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program|Natriuretic Brain Pro-peptid (Pro-BNP)Changes in Patients With Chronic Heart Failure Enroled in a Controlled, Supervised Exercise Protocol Within a Cardiac Rehabilitation Program|Completed||N/A|42|Actual|Grupo Rehabilitacion en Salud||2|||f||||f||||||||||2017-10-11 00:40:01.6213|2017-10-11 00:40:01.6213
NCT02087657|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-02-13|||March 2014||2014-03-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|Auto-HBO||Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation|Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplant|Active, not recruiting||N/A|20|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-11 00:40:01.894859|2017-10-11 00:40:01.894859
NCT02087644|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-05-13|||May 2014||2014-05-01|May 2014|2014-05-01||||May 2014|Actual|2014-05-01||Interventional|||CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids|A Randomized, Placebo-Controlled, Phase IIb Study of CYT003-QbG10 (CYT003), a TLR9 Agonist, in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids|Withdrawn||Phase 2|0|Actual|Cytos Biotechnology AG||2||Sponsor decision|f||||f||||||||||2017-10-11 00:40:02.141789|2017-10-11 00:40:02.141789
NCT02087631|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-02-23|||December 2014||2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Safety and Tolerability of Quetiapine in Multiple Sclerosis|A Dose-finding, Safety and Tolerability Trial of Extended-release Quetiapine in Relapsing-remitting and Progressive Multiple Sclerosis|Recruiting||Phase 1/Phase 2|36|Anticipated|University of Calgary||1|||f||||f||||||||No|consent was not obtained from subjects so data can not be shared|2017-10-11 00:40:02.240741|2017-10-11 00:40:02.240741
NCT02087618|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-13|||March 2014||2014-03-01|March 2014|2014-03-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|KodroSol||The Effect of a 36-week Tablet-based Intervention on Multiple Domains in Older Adults With Mild Cognitive Impairment|The Effect of a 36-week Tablet-based Intervention on Multiple Domains in Older Adults With Mild Cognitive Impairment (Kodro Solution)|Unknown status|Recruiting|N/A|50|Anticipated|Mt. Sinai Medical Center, Miami||2|||f||||f||||||||||2017-10-11 00:40:02.354177|2017-10-11 00:40:02.354177
NCT02087605|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-08-31|||April 2014||2014-04-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Observational|ALTAIR||Automatic Image Analyzer to Assess Retinal Vessel Caliber|Validation of the Automatic Image Analyzer to Assess Retinal Vessel Caliber (ALTAIR)|Completed||N/A|400|Actual|Fundacion para la Investigacion y Formacion en Ciencias de la Salud|||1||f||||f||||||||||2017-10-11 00:40:02.461362|2017-10-11 00:40:02.461362
NCT02087592|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-04-27|||February 2014||2014-02-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|November 2014|Actual|2014-11-01||Interventional|LIBRE||Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers|Prospective Randomized Multicenter Trial to Assess the Feasibility of a Structured Physical Exercise Training and Mediterranean-style Diet in Women With BRCA1/2 Mutations|Active, not recruiting||N/A|69|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-11 00:40:02.538512|2017-10-11 00:40:02.538512
NCT02087579|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-10-28|||February 2014||2014-02-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants|Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone|Completed||Phase 1|305|Actual|Janssen Research & Development, LLC||5|||f||||f||||||||||2017-10-11 00:40:02.662268|2017-10-11 00:40:02.662268
NCT02087566|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-13|||October 2013||2013-10-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|LZDPPT6||Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)|Single-Dose Linezolid Pharmacokinetics In Critically Ill Patients With Impaired Renal Function Especially Chronic Haemodialysis Patients|Completed||N/A|18|Actual|Damanhour University||3|||f||||t||||||||||2017-10-11 00:40:02.878646|2017-10-11 00:40:02.878646
NCT02087553|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-08-10|||January 2014||2014-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions|Harmful Effects of Red Blood Cell Transfusions Are Mediated by Iron: Pediatric ICU Aim|Recruiting||N/A|230|Anticipated|Columbia University|||2||f||||f||||||Samples Without DNA|"     Serum and plasma samples both pre- and post-transfusion samples of the transfusate   "|Undecided||2017-10-11 00:40:02.975476|2017-10-11 00:40:02.975476
NCT02087540|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-13|||May 2013||2013-05-01|March 2014|2014-03-01||||December 2014|Anticipated|2014-12-01||Interventional|||Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia|A Randomized, Double-blind, Multi-center, Factorial Phase III Clinical Trial to Evaluate the Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia|Unknown status|Recruiting|Phase 3|310|Anticipated|IlDong Pharmaceutical Co Ltd||6|||f||||||||||||||2017-10-11 00:40:03.099018|2017-10-11 00:40:03.099018
NCT02087527|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-03-09|||June 2014||2014-06-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Use of Corticosteroids in Children With Cellulitis|Use of Corticosteroids in Children Hospitalized With Cellulitis: Randomized, Double Blind, Placebo Controlled Trial|Terminated||N/A|19|Actual|Hospital General de Niños Pedro de Elizalde||2||Calculated sample size not achieved|f||||t||||||||Undecided||2017-10-11 00:40:03.237126|2017-10-11 00:40:03.237126
NCT02087514|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-09-02|||February 2014||2014-02-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Duration of Red Blood Cell Storage Prior to Transfusion|Duration of Red Blood Cell Storage Prior to Transfusion and Non-Transferrin-Bound Iron|Completed||N/A|60|Actual|Columbia University||6|||f||||t||||||||Undecided||2017-10-11 00:40:03.349762|2017-10-11 00:40:03.349762
NCT02087501|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-04-27|||April 2014||2014-04-01|April 2015|2015-04-01|April 2020|Anticipated|2020-04-01|April 2015|Actual|2015-04-01||Interventional|||HORIZON CE Pivotal Study to Treat Abdominal Aortic Aneurysm|A Prospective Open-label Non-randomized Pivotal Study to Evaluate the Safety and Performance of the Horizon™ Abdominal Aortic Aneurysm (AAA) Stent Graft System|Active, not recruiting||N/A|30|Anticipated|Endospan Ltd.||1|||f||||f||||||||||2017-10-11 00:40:03.453748|2017-10-11 00:40:03.453748
NCT02087475|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-12|||January 2011||2011-01-01|March 2014|2014-03-01|December 2024|Anticipated|2024-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin|Randomized Open-label Phase III Study Comparing Perioperative FOLFIRI Versus Adjuvant FOLFIRI in Resectable Advanced Colorectal Cancer Failed to Oxaliplatin-containing Treatment|Recruiting||Phase 3|360|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:40:03.70781|2017-10-11 00:40:03.70781
NCT02087462|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-03-13|||January 2012||2012-01-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||Electroacupuncture for Sciatica Due to Intervertebral Disc Displacement|Electroacupuncture for Sciatica Due to Intervertebral Disc Displacement|Unknown status|Recruiting|N/A|324|Anticipated|Chengdu University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-11 00:40:03.823965|2017-10-11 00:40:03.823965
NCT02087449|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-03-20|||February 2013||2013-02-01|August 2016|2016-08-01|August 2026|Anticipated|2026-08-01|June 2017|Anticipated|2017-06-01||Observational|E1Hip||Evaluate E1 Wear, Clinical Performance of E1 Liner in THA in Korean Patient Population|A Prospective Multi-center Study on E1 Acetabular Liner in THA|Active, not recruiting||N/A|100|Anticipated|Zimmer Biomet|||1||f||||t||||||||Yes||2017-10-11 00:40:03.978288|2017-10-11 00:40:03.978288
NCT02087436|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-03-20|||March 2013||2013-03-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|July 2014|Actual|2014-07-01||Interventional|taperloc||Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density|Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density|Active, not recruiting||N/A|100|Actual|Zimmer Biomet||2|||f||||t||||||||Yes||2017-10-11 00:40:04.081381|2017-10-11 00:40:04.081381
NCT02087410|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-13|||April 2014||2014-04-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Observational|||Serum Ghrelin in Polycystic Ovary Syndrome|Ghrelin in Polycystic Ovary Syndrome|Unknown status|Not yet recruiting|N/A|84|Anticipated|Ain Shams University|||2||f||||t||||||Samples Without DNA|"     blood sample   "|||2017-10-11 00:40:04.547769|2017-10-11 00:40:04.547769
NCT02087397|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-09-19|||March 2014||2014-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction.|Recruiting||Phase 1/Phase 2|100|Anticipated|Ageless Regenerative Institute||1|||f||||f||||||||Undecided||2017-10-11 00:40:04.623107|2017-10-11 00:40:04.623107
NCT02087384|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-08-05|||March 2014||2014-03-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|VACCAIN-P||HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)|Quadrivalent HPV Vaccination After Effective Treatment of Anal Intraepithelial Neoplasia in HIV+ Men|Recruiting||Phase 4|125|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 00:40:04.732893|2017-10-11 00:40:04.732893
NCT02087371|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-04-13|||January 2014||2014-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|April 2017|Actual|2017-04-01||Observational|PROCOM||Prognosis Factors of Cardiac Complications After Liver Transplantation|Prognosis Factors of Cardiac Complications After Liver Transplantation|Active, not recruiting||N/A|565|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Plasma and urines samples will be collected on 3 separate days (inclusion in the study, the     day before liver transplantion and 7 days after).   "|No||2017-10-11 00:40:04.860527|2017-10-11 00:40:04.860527
NCT02087358|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-11-11|||July 2014||2014-07-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|CASPA||Alcohol Consumption and Stress at Patients Alcohol-dependants|Alcohol Consumption and Stress at Patients Alcohol-dependants|Recruiting||N/A|140|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"     CRHR1 gene polymorphisisme   "|||2017-10-11 00:40:04.966273|2017-10-11 00:40:04.966273
NCT02087345|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-08-04|||March 2014||2014-03-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion|Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion: a Longitudinal Study With pH-impedance Monitoring|Recruiting||N/A|500|Anticipated|Brain-Gut Research Group|||1||f||||f||||||None Retained|"     gastric juice   "|||2017-10-11 00:40:05.055843|2017-10-11 00:40:05.055843
NCT02087332|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-19|||April 2014||2014-04-01|March 2014|2014-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.|Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics in Patients With Arterial Hypertension and Chronic Heart Failure|Unknown status|Not yet recruiting|Phase 4|78|Anticipated|Society of Specialists in Heart Failure||2|||f||||f||||||||||2017-10-11 00:40:05.132404|2017-10-11 00:40:05.132404
NCT02087319|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-02-29|||January 2014||2014-01-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of PRP on the Therapy for Hair Growth|Application and Evaluation of PRP on the Therapy for Hair Loss Disorder|Completed||N/A|10|Actual|China Medical University Hospital||1|||f||||t||||||||||2017-10-11 00:40:05.208291|2017-10-11 00:40:05.208291
NCT02087306|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-11-10|||March 2014||2014-03-01|August 2015|2015-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|CMX001 Adv||Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection|A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (Chimerix Study CMX001-304)|Completed||Phase 3|201|Actual|Chimerix||1|||f||||||||||||||2017-10-11 00:40:05.283005|2017-10-11 00:40:05.283005
NCT02087293|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-08-03|||June 2013||2013-06-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|March 2015|Actual|2015-03-01||Interventional|CEDAR||e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions|e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions|Unknown status|Active, not recruiting|N/A|38400|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 00:40:05.40715|2017-10-11 00:40:05.40715
NCT02087280|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-02-10|||October 2014||2014-10-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Metabolic Phenotyping in Anorexia Nervosa|Metabolic Phenotyping to Predict Risk of Relapse in Patients With Anorexia Nervosa|Withdrawn||N/A|0|Actual|Charite University, Berlin, Germany|||2|We did not receive funding|f||||f||||||Samples Without DNA|"     Biomarkers of energy metabolism   "|||2017-10-11 00:40:05.476419|2017-10-11 00:40:05.476419
NCT02087267|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-05-19|||March 2014||2014-03-01|May 2015|2015-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Lumbar Fusion With The Icotec CF/PEEK Pedicle System In Combination With The Icotec CF/PEEK TLIF Cage ETurn™|Lumbar Fusion With The Icotec CF/PEEK Pedicle System In Combination With The Icotec CF/PEEK TLIF Cage ETurn™|Unknown status|Recruiting|N/A|200|Anticipated|Sitona AG|||1||f||||f||||||||||2017-10-11 00:40:05.544818|2017-10-11 00:40:05.544818
NCT02087241|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-02-10|2016-04-26||March 2014||2014-03-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer|A Phase II Study of AZD1775 Plus Pemetrexed and Carboplatin Followed by a Randomised Comparison of Pemetrexed and Carboplatin With or Without AZD1775 in Patients With Previously Untreated Stage IV Non-Squamous Non-Small-Cell Lung Cancer|Terminated||Phase 2|22|Actual|AstraZeneca|The study was terminated on June 1, 2015 by the sponsor. The Primary Outcome Measure (Progression Free Survival) was not assessed and the randomised portion of the study was not done.|2||The sponsor decided to terminate the study.|f||||f||||||||||2017-10-11 00:40:07.464138|2017-10-11 00:40:07.464138
NCT02087228|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-01-15|||September 2013||2013-09-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Postablation||Evaluation of the Endometrial Cavity After Endometrial Ablation|Evaluation of the Endometrial Cavity After Endometrial Ablation|Terminated||N/A|25|Actual|Baylor Research Institute||2||"Sponsor and Principle Investigator mutually agreed to terminate study and patients are no   longer examined/treated"|f||||f||||||||||2017-10-11 00:40:08.62464|2017-10-11 00:40:08.62464
NCT02087215|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-11-23|||January 2014||2014-01-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|||Effect of Local Application of Boron on Diabetic Foot Ulcers|Prospective Randomized Study of Local Application of Boron on Diabetic Foot Ulcers: Effect of Healing Process|Unknown status|Recruiting|Phase 1|100|Anticipated|Bezmialem Vakif University||2|||f||||f||||||||||2017-10-11 00:40:08.711451|2017-10-11 00:40:08.711451
NCT02087202|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-03-12|||March 2014||2014-03-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Hyperalgesia and NMDA Receptor Antagonist|Hyperalgesia and NMDA Receptor Antagonist|Unknown status|Not yet recruiting|N/A|90|Anticipated|Seoul National University Bundang Hospital||3|||f||||t||||||||||2017-10-11 00:40:08.814529|2017-10-11 00:40:08.814529
NCT02087189|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-05-15|||August 2014||2014-08-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|December 2015|Actual|2015-12-01||Observational|||TD01 Master Study (Safety and Efficacy Study)|TD01 Master Study (Safety and Efficacy Study)|Active, not recruiting||N/A|44|Anticipated|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 00:40:08.996984|2017-10-11 00:40:08.996984
NCT02087176|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-05-06|2016-03-22||March 2014||2014-03-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer|A Lead-in Phase II Multicentre, Randomised, Double-Blind Study Comparing AZD1775 Plus Docetaxel and Placebo Plus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer Patients|Terminated||Phase 2|48|Actual|AstraZeneca|The sponsor terminated the study early. The study was closed on May 12, 2015. Part B of the study was not done.|2||The study was terminated early by the sponsor.|f||||f||||||||||2017-10-11 00:40:09.096532|2017-10-11 00:40:09.096532
NCT02087163|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-02-02|||February 2014||2014-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||The Use of Clear Aligners With Movement Enhacement Techniques|The Use of Clear Aligners With Movement Enhacement Techniques|Active, not recruiting||N/A|88|Actual|Align Technology, Inc.||1|||f||||t||||||||||2017-10-11 00:40:09.598083|2017-10-11 00:40:09.598083
NCT02087150|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-19|||February 1, 2014|Actual|2014-02-01|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|December 1, 2016|Actual|2016-12-01||Interventional|ELLIOTT||Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter|A Randomized Clinical Study of Safety and Efficacy for the Eustachian Tube Balloon Catheter (ELLIOTT)|Active, not recruiting||N/A|323|Actual|Acclarent||2|||f||||f|f|t|f|||||||2017-10-11 00:40:09.685635|2017-10-11 00:40:09.685635
NCT02087137|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-01-12|||May 2014||2014-05-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Functional Impact of a Memory Intervention Program|Functional Impact of a Memory Intervention Program|Completed||N/A|69|Actual|Baycrest||2|||f||||f||||||||||2017-10-11 00:40:09.796009|2017-10-11 00:40:09.796009
NCT02087124|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-07-18|||March 2014||2014-03-01|March 2014|2014-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Dose-response Effect of Whey Protein Consumed as Pre-meal on Postprandial Lipaemia in Subjects With Metabolic Syndrome|Whey Protein, Postprandial Lipaemia and Cardiovascular Disease: Evaluation of the Effect of a Pre-meal of Whey Protein on Postprandial Lipaemia in Persons With the Metabolic Syndrome and Type 2 Diabetes|Completed||N/A|20|Actual|Aarhus University Hospital||3|||f||||t||||||||||2017-10-11 00:40:09.89305|2017-10-11 00:40:09.89305
NCT02087111|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-07-11|||April 2014||2014-04-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|TIG3||Telaprevir in Genotype 3 HCV|Telaprevir in Patients With Genotype 3 HCV: Pilot Clinical Study to Evaluate Efficacy and Predictability of Therapy in Patients Who Have Failed to Respond to Pegylated Interferon and Ribavirin|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Queen Mary University of London||1|||f||||t||||||||||2017-10-11 00:40:10.000855|2017-10-11 00:40:10.000855
NCT02087098|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-09-12|||June 2014||2014-06-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|VEST||A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics|Czech Observational Study to Evaluate Quality of Life in Patients Switched to Vesicare™ (Solifenacin) From Other Antimuscarinics|Completed||N/A|2000|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 00:40:10.16617|2017-10-11 00:40:10.16617
NCT02087085|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-07-20|||May 9, 2016|Actual|2016-05-09|July 2017|2017-07-01|March 3, 2019|Anticipated|2019-03-03|September 4, 2018|Anticipated|2018-09-04||Interventional|BEACON||A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration||Active, not recruiting||Phase 2|310|Actual|Allergan||2|||f||||t|t|f||||||||2017-10-11 00:40:10.433967|2017-10-11 00:40:10.433967
NCT02087072|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2014-10-21|||October 2013||2013-10-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Collaborative Home Visits to Reduce Hospital Readmissions and Improve Medication Use During Transitions of Care|COLLABORATIVE HOME VISITS TO REDUCE HOSPITAL READMISSIONS AND IMPROVE MEDICATION USE DURING TRANSITIONS OF CARE|Unknown status|Active, not recruiting|N/A|150|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-11 00:40:10.653199|2017-10-11 00:40:10.653199
NCT02087059|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2016-05-26|2016-04-11||April 2014||2014-04-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis|A Multicenter, Open-label Clinical Study of the JAK Inhibitor Ruxolitinib (INC424) in Patients With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis|Completed||Phase 3|51|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:40:10.757483|2017-10-11 00:40:10.757483
NCT02087033|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-07|||December 2013||2013-12-01|February 2014|2014-02-01||||December 2014|Anticipated|2014-12-01||Interventional|||Use of Ritmonutra in Subjects Affected by Supraventricular Ectopic Beats Without Structural Heart Disease|A Randomized, Double-blinded, Cross-over Study on the Use of Ritmonutra, a Nutraceutical Product Composed of Omega 3 Fatty Acids, Astaxanthin, Vitamin E and Hawthorn in Subjects Affected by Supraventricular Ectopic Beats Without Structural Heart Disease|Unknown status|Recruiting|N/A|24|Anticipated|IRCCS Policlinico S. Donato||1|||f||||f||||||||||2017-10-11 00:40:11.410722|2017-10-11 00:40:11.410722
NCT02087020|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-08|||January 2013||2013-01-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|DAIR||Debridement, Antibiotics and Implant Retention in Early Periprosthetic Joint Infection: A Retrospective Cohort Study|Debridement, Antibiotics and Implant Retention in Early Periprosthetic Joint Infection: A Retrospective Cohort Study|Completed||N/A|51|Actual|Danderyd Hospital|||1||f||||f||||||||||2017-10-11 00:40:11.523868|2017-10-11 00:40:11.523868
NCT02087007|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-05-01|||November 2013||2013-11-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|STELLA||A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Pletaal(Cilostazol) in Subjects With Vasospastic Angina|Completed||Phase 3|100|Actual|Korea Otsuka Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:40:11.621774|2017-10-11 00:40:11.621774
NCT02086994|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-02-13|||March 2013||2013-03-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|carbetocin||Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol|Carbetocin in Preventing Postpartum Bleeding in Women With Severe Preeclampsia.|Completed||Phase 3|60|Actual|Benha University||2|||f||||t||||||||||2017-10-11 00:40:11.734644|2017-10-11 00:40:11.734644
NCT02086981|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2015-12-25|||February 2014||2014-02-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01|12 Months|Observational [Patient Registry]|DETEcT||The DETEcT Study - Delirium in Elderly paTiEnts Admitted to Trauma|The DETEcT Study - Delirium in Elderly paTiEnts Admitted to Trauma|Completed||N/A|672|Actual|Azienda Ospedaliero-Universitaria Careggi|||1||f||||f||||||||||2017-10-11 00:40:11.847066|2017-10-11 00:40:11.847066
NCT02086968|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-03-23|||January 1, 2014|Actual|2014-01-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|July 16, 2016|Actual|2016-07-16||Interventional|||Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass|Multicenter Randomized Open-label Controlled Study to Investigate Treatment Response of IV Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia Secondary to Inflammatory Bowel Disease or Gastric Bypass|Active, not recruiting||Phase 4|186|Actual|Luitpold Pharmaceuticals||2|||f||||f|t|f||||||No||2017-10-11 00:40:11.914727|2017-10-11 00:40:11.914727
NCT02086955|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-01-23|||February 2013||2013-02-01|January 2015|2015-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Outpatient Nurse Managed Counseling Program for Patients With Diabetic Foot Ulceration|Outpatient Nurse Managed Counseling Program for Patients With Diabetic Foot Ulceration|Unknown status|Recruiting|N/A|110|Anticipated|Zurich University of Applied Sciences||2|||f||||f||||||||||2017-10-11 00:40:11.990442|2017-10-11 00:40:11.990442
NCT02086942|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-08-27|||August 2013||2013-08-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.|Randomized, Multicenter Study of Tolerability and Efficacy of Modified Combinations of Bortezomib, Dexamethasone and Cyclophosphamide in Previously Untreated Multiple Myeloma.|Recruiting||Phase 2|94|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 00:40:12.077875|2017-10-11 00:40:12.077875
NCT02086929|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-12-29|||December 2012||2012-12-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Trazodone Once a Day in Major Depression Disorder|A Randomized, Double-blind Study Comparing the Efficacy and Safety of Trazodone OAD and Venlafaxine XR in the Treatment of Patients With Major Depressive Disorder.|Completed||Phase 3|364|Actual|Aziende Chimiche Riunite Angelini Francesco S.p.A||2|||f||||f||||||||||2017-10-11 00:40:12.178778|2017-10-11 00:40:12.178778
NCT02086916|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-07-08|||October 2011||2011-10-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|||Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection|Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection|Unknown status|Active, not recruiting|N/A|100|Anticipated|Barts & The London NHS Trust|||1||f||||f||||||Samples With DNA|"     Stool samples from recruited participants are frozen and stored. They will be batch analysed     after completion of recruitment.   "|||2017-10-11 00:40:12.326604|2017-10-11 00:40:12.326604
NCT02086903|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2017-07-11|||February 2014||2014-02-01|July 2017|2017-07-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Clopidogrel And Ticagrelor in Healthy Subjects|Pharmacodynamic Effect of Loading And Maintenance Doses Of Clopidogrel Versus Half Doses of Ticagrelor In Healthy Subjects|Completed||Phase 3|12|Actual|Dong-A University||2|||f||||t||||||||||2017-10-11 00:40:12.409969|2017-10-11 00:40:12.409969
NCT02086890|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-04-06|||August 2014||2014-08-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for the Treatment of Vision Loss Due to Retinitis Pigmentosa|Modulating Ocular/Retinal Blood Flow and Visual Function in Retinitis Pigmentosa|Active, not recruiting||Phase 1/Phase 2|21|Anticipated|Nova Southeastern University||6|||f||||t||||||||||2017-10-11 00:40:12.494013|2017-10-11 00:40:12.494013
NCT02086877|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-12-14|||January 2014||2014-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|COGWELL||COGnitive Outcomes and WELLness in Survivors of Critical Illness|COGnitive Outcomes and WELLness in Survivors of Critical Illness|Recruiting||N/A|150|Anticipated|University of Toronto|||1||f||||t||||||||No||2017-10-11 00:40:12.650325|2017-10-11 00:40:12.650325
NCT02086864|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-10-24|||March 2014||2014-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD|A Randomized, Double Blind, Placebo Controlled Study of Homeopathic Treatment of Children and Youth With Attention Deficit Hyperactivity Disorder|Recruiting||Phase 2|177|Anticipated|University of Toronto||3|||f||||t||||||||||2017-10-11 00:40:12.747939|2017-10-11 00:40:12.747939
NCT02086851|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-02-10|||September 2011||2011-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of a Structured Parent Intervention on Adolescent Weight Loss Modification Program.|Impact of a Structured Parent Intervention on Weight Loss and Behavioral Change in Overweight Adolescents Enrolled in a Lifestyle Modification Program|Completed||N/A|110|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 00:40:12.844178|2017-10-11 00:40:12.844178
NCT02086838|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-12|2015-03-17|||July 2013||2013-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Iron Supplementation Using Total Dose Infusion and Oral Routes for Treatment of Iron Deficiency Anemia in Pregnancy|Comparison Between Iron Supplementation Using Total Dose Infusion and Oral Routes for Treatment of Iron Deficiency Anemia in Pregnancy|Completed||Phase 4|212|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-11 00:40:13.00765|2017-10-11 00:40:13.00765
NCT02086825|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-03-01|||October 2015||2015-10-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure|A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure|Withdrawn||Phase 3|0|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 00:40:13.100937|2017-10-11 00:40:13.100937
NCT02086812|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-11|||February 2014||2014-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:40:13.193806|2017-10-11 00:40:13.193806
NCT02086799|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-07-29|||July 2014||2014-07-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|THINAS||Thyroid Hormones Treatment in Asthma Exacerbation|Is There a Role for Thyroid Hormones Treatment in the Set-up of Acute Moderate to Severe Asthma Exacerbation|Unknown status|Not yet recruiting|N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 00:40:13.241146|2017-10-11 00:40:13.241146
NCT02086786|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-06-14|2016-10-13||March 2014||2014-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PRISMA-2|Three of the randomized patients (70) were not dosed. Two of them due to withdrawal of consent and the third due to fulfilment of one of the study exclusion criteria (take prohibited medication). Thus, the number of patients receiving the study medication were 67; 34 in the gluteal injection group and 33 in the deltoid injection group.|Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia|Multicenter, Open-label, Two-arm, Parallel-design, Repeat-dose Clinical Trial to Evaluate the PK, Safety, and Tolerability of Four Intramuscular Injections of Risperidone ISM® 75 mg, at 28 Day Intervals in Patients With Schizophrenia|Completed||Phase 2|70|Actual|Rovi Pharmaceuticals Laboratories||2|||f||||f||||||||No||2017-10-11 00:40:13.387895|2017-10-11 00:40:13.387895
NCT02086773|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-10-12|||April 2014||2014-04-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Red Cell Transfusion Goals in Patients With Acute Leukemias|Prospective Randomized Clinical Feasibility Study of Red Cell Transfusion Goals in Patients With Acute Leukemias|Active, not recruiting||Early Phase 1|90|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:40:14.19116|2017-10-11 00:40:14.19116
NCT02086760|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-10-01|||May 2014||2014-05-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Ultrasonography Sensibilized by Oral Hydration and Hydronephrosis in Children.|Ultrasonography Sensibilized by Oral Hydration and Hydronephrosis in Children. Is it Useful for Diagnosis and Follow up?|Withdrawn||N/A|0|Actual|University Hospital, Strasbourg, France||1||no subject enrolled within one year following EC and IRB approvals.|f||||f||||||||||2017-10-11 00:40:14.28912|2017-10-11 00:40:14.28912
NCT02086747|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-03-12|||March 2013||2013-03-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Acetaminophen for Chronic Pain in Hysterectomy|The Management of Chronic Pain With Acetaminophen Four Times a Day|Completed||Phase 4|140|Actual|Mustafa Kemal University||2|||f||||f||||||||||2017-10-11 00:40:14.378165|2017-10-11 00:40:14.378165
NCT02086539|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-06-26|||April 2014||2014-04-01|June 2017|2017-06-01|July 23, 2016|Actual|2016-07-23|July 23, 2016|Actual|2016-07-23||Interventional|||Comparison of Outreach Approaches to Increase Enrollment in a Healthy Cholesterol Study|A Randomized Controlled Trial of Outreach Approaches to Increase Enrollment in the Habit Formation for Adherence to Statin Use and LDL Reduction Study|Completed||N/A|100|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 00:40:16.260109|2017-10-11 00:40:16.260109
NCT02086734|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-03-11|||January 2012||2012-01-01|March 2014|2014-03-01|January 2018|Anticipated|2018-01-01|January 2016|Anticipated|2016-01-01||Observational|||Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma|Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma|Recruiting||N/A|80|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||||2017-10-11 00:40:14.479112|2017-10-11 00:40:14.479112
NCT02086721|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-05-30|||December 2015|Actual|2015-12-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|L19-IL2||Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor|Phase I Clinical Study Combining L19-IL2 With Stereotactic Ablative Body Radiotherapy in Patients With Oligometastatic Solid Tumor.|Completed||Phase 1|18|Actual|Maastricht Radiation Oncology||1|||f||||f||||||||||2017-10-11 00:40:14.578542|2017-10-11 00:40:14.578542
NCT02086708|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-12-06|2016-10-05||June 2010||2010-06-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Pediatric and Adolescents|Ultrasound Method to Measure Fibrosis of the Liver in Children|Sonoelastography: Ultrasound Method to Measure Fibrosis of the Liver in Children|Terminated||N/A|24|Actual|Massachusetts General Hospital|This was meant to be a feasibility study to show that shear-wave sonoelastography can be performed in the pediatric age group.|1||"The technology showed rapid acceptance in the general population and we halted our feasibility   demonstration study."|f||||t||||||||Undecided||2017-10-11 00:40:14.664558|2017-10-11 00:40:14.664558
NCT02086695|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-01-27|||June 2013||2013-06-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ASPER||Early Detection of Broken Hearts in Cancer Patients|Early Detection of Broken Hearts in Cancer Patients: Bevacizumab, Sunitinib and Heart Failure|Completed||N/A|43|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"     Blood will be drawn to measure blood biomarkers to determine your heart biomarker [High     sensitivity TnT and NT-proBNP] as an indicator of early heart failure.   "|No||2017-10-11 00:40:14.873028|2017-10-11 00:40:14.873028
NCT02086669|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-04-04|||January 2000||2000-01-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2009|Actual|2009-01-01||Interventional|||Pneumatic Dilatation or Surgical Myotomy for Achalasia|Randomized Study to Compare Pneumatic Dilatation With Surgical Myotomy for Treatment of Achalasia - Long Term Follow up|Completed||Phase 2|56|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:40:15.035387|2017-10-11 00:40:15.035387
NCT02086656|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-08-23|||June 2013|Actual|2013-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|COI-B||PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES|PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES|Active, not recruiting||Phase 2|46|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-11 00:40:15.125346|2017-10-11 00:40:15.125346
NCT02086643|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2015-10-03|||December 2013||2013-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Retroclavicular Approach for Regional Anesthesia of the Upper Limb in Obese Patients|The Retroclavicular Approach for Regional Anesthesia of the Upper Limb in Patients With BMI ≥ 30 kg/m2 : A Descriptive Study|Completed||Phase 4|32|Actual|Université de Sherbrooke||1|||f||||f||||||||||2017-10-11 00:40:15.208299|2017-10-11 00:40:15.208299
NCT02086630|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-10-06|||May 2012||2012-05-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|Heart to Heart||Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline|Intervention to Increase Timely Initiation of HIV Antiretroviral Therapy (ART) Among Those Who Delay or Decline|Completed||Phase 1|95|Actual|New York University||2|||f||||f||||||||||2017-10-11 00:40:15.308532|2017-10-11 00:40:15.308532
NCT02086617|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-06-25|||March 2014||2014-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease|Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease|Completed||N/A|||North Karelia Central Hospital||1|||f||||f||||||||||2017-10-11 00:40:15.38493|2017-10-11 00:40:15.38493
NCT02086604|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-08-14|||September 18, 2014|Actual|2014-09-18|August 2017|2017-08-01|November 30, 2019|Anticipated|2019-11-30|June 9, 2017|Actual|2017-06-09||Interventional|||Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma|A Phase I Trial of Brentuximab Vedotin in Combination With Lenalidomide in Relapsed or Refractory Diffuse Large B-cell Lymphoma|Active, not recruiting||Phase 1|37|Actual|Washington University School of Medicine||3|||f||||t|t|f||||||||2017-10-11 00:40:15.474223|2017-10-11 00:40:15.474223
NCT02086591|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-10-27|2016-05-25||March 2014||2014-03-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||A Phase II Study of Doxycycline in Relapsed NHL|A Phase II Study of Doxycycline in Relapsed NHL|Terminated||Phase 2|7|Actual|University of Rochester||1||Lack of accrual|f||||t||||||||||2017-10-11 00:40:15.592535|2017-10-11 00:40:15.592535
NCT02086578|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-05-10|||March 11, 2014|Actual|2014-03-11|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions|Phase II Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions|Active, not recruiting||Phase 2|124|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:40:15.826909|2017-10-11 00:40:15.826909
NCT02086565|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-07-10|||March 2014||2014-03-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Using IT to Improve Access, Communication and Asthma in African American and Hispanic/Latino Adults|Using IT to Improve Access, Communication and Asthma in African American and Hispanic/Latino Adults|Completed||N/A|300|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:40:15.922556|2017-10-11 00:40:15.922556
NCT02086526|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-05-19|||March 2014||2014-03-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)|Targeting Pathophysiologic Pathways in Polycystic Ovary Syndrome Using a Response to Metformin Phenotype|Recruiting||Phase 1/Phase 2|150|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:40:16.358565|2017-10-11 00:40:16.358565
NCT02086513|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-03-21|||April 2014||2014-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT|Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT|Terminated||Phase 1|18|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-11 00:40:16.496437|2017-10-11 00:40:16.496437
NCT02086500|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-14|||July 2015||2015-07-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|STAAMP||Study of Tranexamic Acid During Air Medical Prehospital Transport Trial (STAAMP Trial)|Study of Tranexamic Acid During Air Medical Prehospital Transport Trial For Trauma Patients At Risk Of Hemorrhage (STAAMP Trial); Phase III Multicenter, Prospective, Randomized, Double Blind, Interventional Trial|Recruiting||Phase 3|1000|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:40:16.726515|2017-10-11 00:40:16.726515
NCT02086487|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-03-06|||March 2013||2013-03-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|NISRI||Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy|Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy (NISRI)|Terminated||Phase 4|98|Actual|King Abdullah International Medical Research Center||1||Because of many unseen obstacles resulted in poor accrual, study is terminated.|f||||t||||||||Undecided||2017-10-11 00:40:16.864452|2017-10-11 00:40:16.864452
NCT02086474|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-03-03|||May 2014||2014-05-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients|Daily Activity Quantification and Gait Pattern Analysis Before and After Intra-articular Injection of Viscosupplement Among Hip Osteoarthritis Patients|Recruiting||Phase 4|40|Anticipated|Laval University||2|||f||||t||||||||||2017-10-11 00:40:17.023138|2017-10-11 00:40:17.023138
NCT02086461|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-04-04|||May 2014||2014-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay|Pylorus Dysfunction After Esophagectomy. Effect of Pneumatic Dilatation.|Enrolling by invitation||N/A|40|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:40:17.166393|2017-10-11 00:40:17.166393
NCT02086448|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-08-18|||September 2014||2014-09-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|SOAP||Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)|Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)|Recruiting||N/A|300|Anticipated|University of Pittsburgh||4|||f||||t||||||||||2017-10-11 00:40:17.312011|2017-10-11 00:40:17.312011
NCT02086435|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2015-04-19|||March 2014||2014-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|IEME||Intracorporeal Versus Extracorporeal Morcellation: Clinical Efficacy and Safety Outcomes|A Randomized Controlled Trial on Intracorporeal Versus Extracorporeal Morcellation With Endobag Extraction in Patients Undergoing Laparoscopic Myomectomy: Clinical Efficacy and Safety Outcomes|Completed||N/A|93|Actual|University Magna Graecia||2|||f||||t||||||||||2017-10-11 00:40:17.452765|2017-10-11 00:40:17.452765
NCT02086422|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-02-25|||July 2013||2013-07-01|February 2016|2016-02-01||||July 2015|Actual|2015-07-01||Interventional|||Iatrogenic Chronotropic Incompetence and Exercise Tolerance in Heart Failure||Recruiting||N/A|||The Leeds Teaching Hospitals NHS Trust||2|||f||||||||||||||2017-10-11 00:40:17.552569|2017-10-11 00:40:17.552569
NCT02086409|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-09-21|||September 2014||2014-09-01|March 2014|2014-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|GAME-D2||GAit, MEmory, Dietary and Vitamin D|Dairy Product, Calcium & Vitamin D Supplementation and Cognitive-motor Function|Completed||Phase 2/Phase 3|40|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 00:40:17.638867|2017-10-11 00:40:17.638867
NCT02086396|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-12|||October 2011||2011-10-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Weight Loss Diet and Pumpkin Seed Flour Consumption on Obese Women|Effect of Hypoenergetic Diet Combined With Pumpkin Seed Flour Consumption on Obese Women|Completed||N/A|139|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 00:40:17.726263|2017-10-11 00:40:17.726263
NCT02086383|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-05-27|||April 2014||2014-04-01|May 2014|2014-05-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01|10 Weeks|Observational [Patient Registry]|||Physical Activity and Self-Efficacy After Pulmonary Rehabilitation|Short Term Effects of Pulmonary Rehabilitation on Level of Physical Activity and Self-Efficacy in Patients With Chronic Obstructive Pulmonary Disease.|Unknown status|Recruiting|N/A|30|Anticipated|University College, London|||1||f||||f||||||||||2017-10-11 00:40:17.817655|2017-10-11 00:40:17.817655
NCT02086370|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2015-04-19|||March 2014||2014-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|Rad_PBS||Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques|Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques. A Randomized Controlled Trial|Completed||N/A|177|Actual|University Magna Graecia||2|||f||||t||||||||||2017-10-11 00:40:17.921961|2017-10-11 00:40:17.921961
NCT02086357|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-02-19|||July 2013||2013-07-01|February 2015|2015-02-01||||December 2016|Anticipated|2016-12-01||Observational|||Investigation of Ultrasound Elastographic Techniques in Soft Tissue Pathology||Unknown status|Recruiting|N/A|500|Anticipated|The Leeds Teaching Hospitals NHS Trust|||1||f||||||||||||||2017-10-11 00:40:18.017025|2017-10-11 00:40:18.017025
NCT02086344|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2016-11-17|||February 2014||2014-02-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy|The Effect in Term of Ovarian Reserve Modification of Adding Prophylactic Bilateral Salpingectomy (PBS) to TLH for Preventing Ovarian Cancer|Recruiting||N/A|167|Anticipated|University Magna Graecia||2|||f||||t||||||||||2017-10-11 00:40:18.090471|2017-10-11 00:40:18.090471
NCT02085746|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-12|||January 2014||2014-01-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Defining Sexual Activity|Defining Sexual Activity: How Demographics May Impact Our Definition|Unknown status|Recruiting|N/A|300|Anticipated|University of South Florida|||1||f||||t||||||||||2017-10-11 00:40:23.176673|2017-10-11 00:40:23.176673
NCT02086318|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2016-12-07|||January 2012||2012-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|OvAge||A New Algorithm to Predict Ovarian Age|A New Algorithm to Predict Ovarian Age Combining Clinical, Biochemical and 3D-ultrasonographic Parameters: OvAge|Recruiting||N/A|720|Anticipated|University Magna Graecia|||1||f||||t||||||||||2017-10-11 00:40:18.303675|2017-10-11 00:40:18.303675
NCT02086305|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-08-21|||January 2013||2013-01-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional|||Transitional Palliative Care in End-stage Heart Failure|Effects of a Transitional Palliative Care Model on Patients With End-stage Heart Failure|Completed||N/A|84|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 00:40:18.429848|2017-10-11 00:40:18.429848
NCT02086292|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-09-15|||February 2014||2014-02-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Influence of Lidocaine Volume on Discomfort During Administration of Local Anesthetic|The Influence of Lidocaine Volume on Discomfort During Administration of Local Anesthetic|Completed||N/A|36|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 00:40:18.534337|2017-10-11 00:40:18.534337
NCT02086279|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2014-11-22|||March 2014||2014-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||AMH Levels Change During Treatment With GnRh Agonist|AMH Levels Change During Treatment With GnRh Agonist: A Prospective Observational Study.|Completed||N/A|67|Actual|University Magna Graecia||1|||f||||t||||||||||2017-10-11 00:40:18.638811|2017-10-11 00:40:18.638811
NCT02086266|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2014-03-11|||March 2012||2012-03-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary Incontinence|The Efficacy of Pilates Compared to Pelvic Floor Muscle Training Associated With Electrical Stimulation in the Recovery of Post-prostatectomy Urinary Incontinence: a Randomized Clinical Trial.|Completed||N/A|54|Actual|Universidade Estadual de Londrina||2|||f||||||||||||||2017-10-11 00:40:18.744449|2017-10-11 00:40:18.744449
NCT02086253|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-03-23|||February 2014||2014-02-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Endothelin||Role of Endothelin-1 in Flow-mediated Dilatation|Role of Endothelin-1 in Mediating Flow-mediated Dilatation of Conduit Arteries During Sustained Hyperemic Stimulation|Completed||N/A|8|Actual|University Hospital, Rouen||3|||f||||f||||||||||2017-10-11 00:40:18.817346|2017-10-11 00:40:18.817346
NCT02086240|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-09-15|||March 2014||2014-03-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Reproducibility of the 11C-PBR28 PET Signal|Reproducibility of the 11C-PBR28 PET Signal|Recruiting||N/A|120|Anticipated|Imperial College London||1|||f||||f||||||||||2017-10-11 00:40:18.902389|2017-10-11 00:40:18.902389
NCT02086227|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-12|||May 2013||2013-05-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)|Bioequivalence of a Test Formulation of Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories) Under Fasted Conditions|Completed||Phase 1|32|Actual|Fresenius Kabi USA, LLC||2|||f||||f||||||||||2017-10-11 00:40:19.008352|2017-10-11 00:40:19.008352
NCT02086214|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-08-24|||December 21, 2012|Actual|2012-12-21|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PROPENSIX||Pressure Therapy in the Treatment of Upper Arm of Cerebral Palsy Children|Pressure Therapy in the Treatment of Upper Arm of Cerebral Palsy Children|Recruiting||N/A|100|Anticipated|University Hospital, Lille||2|||f||||f||||||||||2017-10-11 00:40:19.099225|2017-10-11 00:40:19.099225
NCT02086201|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-05-10|||May 2014||2014-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Engage||Comparing Engage to PST for Late Life Depression|Stepped, Reward-exposure Based Therapy vs. PST in Late Life Depression|Recruiting||N/A|342|Anticipated|University of Washington||2|||f||||f||||||||Yes|We intend to share de-identified data once study is complete|2017-10-11 00:40:19.210323|2017-10-11 00:40:19.210323
NCT02086188|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-07-25|||May 2014||2014-05-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|MIRROR||Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis|Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Multiple Sclerosis (MIRROR)|Recruiting||Phase 4|40|Anticipated|EvergreenHealth||2|||f||||f||||||||||2017-10-11 00:40:19.313405|2017-10-11 00:40:19.313405
NCT02086175|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-06-21|||December 2014||2014-12-01|June 2017|2017-06-01|August 2021|Anticipated|2021-08-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma|A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma|Recruiting||Phase 2|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:40:19.453537|2017-10-11 00:40:19.453537
NCT02086162|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-12-13|||April 2014||2014-04-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|RCTEDSS||Randomized Controlled Trial (RCT) of a Motivational Decision Support System|RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses|Completed||N/A|184|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||Yes|"De-identified research data files will be made available to all researchers in both the public and private sectors for potential statistical analyses or re-analyses in accordance with the NIH data Sharing Policy: http://grants.nih.gov/grants/policy/data sharing. Data will be available 2 years after data collection is completed, or after primary papers have been accepted for publication. Data will only be transferred to other researchers under a signed data sharing agreement.
Materials and research data files will be made available, upon request, from the PI. These requests can be made via email (mary.f.brunette@dartmouth.edu)."|2017-10-11 00:40:19.560321|2017-10-11 00:40:19.560321
NCT02086149|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-09-14|||February 2014||2014-02-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Exercise for Depressed Smokers|Aerobic Exercise for Smokers With Depressive Symptomatology|Recruiting||N/A|250|Anticipated|Butler Hospital||2|||f||||f||||||||||2017-10-11 00:40:19.643718|2017-10-11 00:40:19.643718
NCT02086136|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-04-27|||September 2014||2014-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|ADVISED||Aortic Dissection Detection Risk Score Plus D-dimer in Suspected Acute Aortic Dissection|Aortic Dissection Detection Risk Score Plus D-dimer in the Diagnostic Workup of Suspected Acute Aortic Dissection: a Prospective Multicenter Study|Completed||N/A|1900|Actual|Azienda Ospedaliero-Universitaria Careggi|||1||f||||f||||||||||2017-10-11 00:40:19.722707|2017-10-11 00:40:19.722707
NCT02086123|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2014-11-06|||May 2012||2012-05-01|November 2014|2014-11-01|April 2015|Anticipated|2015-04-01|February 2015|Anticipated|2015-02-01||Interventional|||Randomized Study Comparing the Use of Epidural Analgesia to Intravenous Narcotics for Laparoscopic Colorectal Resection.|Randomized Clinical Trial Comparing the Use of Perioperative Epidural Analgesia to Conventional Intravenous Narcotics and NSAIDS for Patients Undergoing Laparoscopic Colorectal Resection|Unknown status|Active, not recruiting|Phase 2|87|Actual|University of California, Irvine||2|||f||||f||||||||||2017-10-11 00:40:19.811717|2017-10-11 00:40:19.811717
NCT02086110|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-05-24|||February 2014||2014-02-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism|A Pilot Study Examining Microbiota Composition in Children With Autism and Gastrointestinal Symptoms After Use of Bifidobacterium Infantis and Milk Oligosaccharides|Completed||N/A|15|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 00:40:19.920194|2017-10-11 00:40:19.920194
NCT02086097|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-05-06|||August 2013||2013-08-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|DTPEP||Dexketoprofen Trometamol in Postoperative Endodontic Pain|Effectiveness of Dexketoprofen Trometamol in the Management of Postoperative Endodontic Pain. Controlled Clinical Trial of Multiple Doses|Completed||Phase 4|90|Actual|Universidad Autonoma de San Luis Potosí||3|||f||||f||||||||||2017-10-11 00:40:20.068016|2017-10-11 00:40:20.068016
NCT02086084|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2015-08-18|||May 2015||2015-05-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||ECCO2R as an Adjunct to NIV in AECOPD|Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD|Recruiting||N/A|24|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:40:20.180028|2017-10-11 00:40:20.180028
NCT02086071|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2014-03-11|||May 2012||2012-05-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|GFPC-REBIOP||Feasibility of re Biopsies at Progression|Feasibility of New Biological and Histological Samples at Progression for Patients With Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)|Completed||N/A|100|Actual|Groupe Francais De Pneumo-Cancerologie||1|||f||||t||||||||||2017-10-11 00:40:20.287382|2017-10-11 00:40:20.287382
NCT02086058|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-12-17|||November 2013||2013-11-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Observational|||Gene Expression in the Overactive Bladder in Children|Gene Expression in the Bladder in Children With an Overactive Bladder and Daytime Urinary Incontinence|Recruiting||N/A|46|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Bladder biopsies from the back-wall og the bladder.   "|||2017-10-11 00:40:20.380399|2017-10-11 00:40:20.380399
NCT02086045|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-07-25|||November 2011||2011-11-01|July 2017|2017-07-01|May 15, 2017|Actual|2017-05-15|June 2013|Actual|2013-06-01||Interventional|||Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial|A NON-RANDOMIZED, CONSECUTIVE ENROLLMENT EVALUATION OF THE DESolve® NOVOLIMUS ELUTING BIORESORBABLE CORONARY SCAFFOLD SYSTEM IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS|Completed||N/A|126|Actual|Elixir Medical Corporation||1|||f||||t||||||||||2017-10-11 00:40:20.443607|2017-10-11 00:40:20.443607
NCT02086032|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2017-05-28|||January 2014||2014-01-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Different Types of Progestin on Sleeping of Menopausal Women|The Effect of Different Types of Progestin on Sleeping of Menopausal Women|Completed||N/A|100|Actual|Chiang Mai University||2|||f||||t||||||||||2017-10-11 00:40:20.560922|2017-10-11 00:40:20.560922
NCT02086019|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-07-28|||May 2014||2014-05-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|November 2017|Anticipated|2017-11-01||Interventional|RINCAL||Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes|A Prospective Randomised Controlled Trial|Recruiting||N/A|750|Anticipated|Brighton and Sussex University Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 00:40:20.641663|2017-10-11 00:40:20.641663
NCT02086006|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-02-07|||February 2011||2011-02-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|October 2016|Actual|2016-10-01||Interventional|||Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial|A NON-RANDOMIZED, CONSECUTIVE ENROLLMENT EVALUATION OF THE DESolveTM MYOLIMUS ELUTING BIORESORBABLE CORONARY STENT SYSTEM IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS|Active, not recruiting||N/A|16|Actual|Elixir Medical Corporation||1|||f||||t||||||||||2017-10-11 00:40:20.845544|2017-10-11 00:40:20.845544
NCT02085993|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-12-21|||July 2014||2014-07-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training|A Cross-sectional Study of Patients With Immune Thrombocytopenic Purpura and Caregivers to Estimate the Proportion Who Administer Romiplostim Correctly After Receipt of Home Administration Training Materials|Completed||N/A|41|Actual|Amgen|||1||f||||f||||||||||2017-10-11 00:40:20.956839|2017-10-11 00:40:20.956839
NCT02085980|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-02-07|||March 2014||2014-03-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy|Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy|Completed||N/A|30|Actual|El. En. SpA||1|||f||||t||||||||No||2017-10-11 00:40:21.173381|2017-10-11 00:40:21.173381
NCT02085967|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-11-02|||February 2014||2014-02-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion||Completed||Phase 1|106|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 00:40:21.275232|2017-10-11 00:40:21.275232
NCT02085954|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-03-01|||October 2013||2013-10-01|October 2015|2015-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|LOKOMAT||Evaluation of a Training in the Walking With Exosquelette||Completed||N/A|13|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-11 00:40:21.365172|2017-10-11 00:40:21.365172
NCT02085941|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-02-07|||February 2015||2015-02-01|February 2017|2017-02-01|February 2021|Anticipated|2021-02-01|June 2019|Anticipated|2019-06-01||Interventional|||Image-guided Cryoablation of Head, Neck and Spine Tumors|Image-guided Cryoablation of Head, Neck and Spine Tumors|Recruiting||N/A|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||Undecided||2017-10-11 00:40:21.43248|2017-10-11 00:40:21.43248
NCT02085928|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-12|||March 2012||2012-03-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Observational|||Clinical and Ultrasonographic Results of Intratissue Percutaneous Electrolysis in Lateral Epicondylitis|Clinical and Ultrasonographic Results of Intratissue Percutaneous Electrolysis (EPI Technique) in Chronic Lateral Epicondylitis: a Case Series With Prospective 12 Months Follow up|Completed||N/A|36|Actual|CEU San Pablo University|||1||f||||t||||||||||2017-10-11 00:40:21.539437|2017-10-11 00:40:21.539437
NCT02085915|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2015-09-15|||March 2014||2014-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|Per-DRISLA||Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the Cirrhosis|Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the Cirrhosis|Completed||N/A|670|Actual|Centre Hospitalier Departemental Vendee||1|||f||||f||||||||||2017-10-11 00:40:21.627168|2017-10-11 00:40:21.627168
NCT02085902|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2015-05-18|||March 2014||2014-03-01|March 2015|2015-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|VesiRop||Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?|Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?|Completed||Phase 4|120|Actual|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-11 00:40:21.75132|2017-10-11 00:40:21.75132
NCT02085889|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-07-27|||March 2014||2014-03-01|July 2015|2015-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders|Fructose and Lactose Intolerance and Malabsorption: the Relationship Between Metabolism and Symptoms in Functional Gastrointestinal Disorders|Active, not recruiting||N/A|3000|Anticipated|Brain-Gut Research Group|||1||f||||f||||||Samples Without DNA|"     blood, urine and stool   "|||2017-10-11 00:40:21.844095|2017-10-11 00:40:21.844095
NCT02085876|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-12||||||July 2013|2013-07-01||||February 2016|Anticipated|2016-02-01||Observational|IRM Stéatose||Quantitative and Qualitative MRI Study of Steatosis in Patients With Metabolic Steatopathy|Quantitative and Qualitative MRI Study of Steatosis in Patients With Metabolic Steatopathy|Unknown status|Not yet recruiting|N/A|30|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 00:40:21.937245|2017-10-11 00:40:21.937245
NCT02085863|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-01-26|||February 2014||2014-02-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together|A Randomized, Double-Blind, Placebo-Controlled, Two-way Crossover Drug-drug Interaction Study to Assess the Effect of Laquinimod 0.6 mg on the Pharmacokinetics and Pharmacodynamics of Ethinylestradiol and Levonorgestrel in Healthy Young Women|Completed||Phase 1|40|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 00:40:22.03937|2017-10-11 00:40:22.03937
NCT02085850|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-11|||March 2014||2014-03-01|March 2014|2014-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01|1 Day|Observational [Patient Registry]|||Incidence and Progression of Glaucoma in the Tema Eye Survey Cohort|Incidence and Progression of Glaucoma in the Tema Eye Survey Cohort|Unknown status|Enrolling by invitation|N/A|1375|Anticipated|Tema Christian Eye Center|||1||f||||f||||||||||2017-10-11 00:40:22.14742|2017-10-11 00:40:22.14742
NCT02085837|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-01-03|||October 2013||2013-10-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|July 2014|Actual|2014-07-01||Interventional|||Healthy Transitions in Late Stage Kidney Disease|An Open Label Randomized Controlled Study to Compare the Impact of Patient Centered Nursing Services in Addition to a Nephrologist's Usual Patient Care With Usual Nephrologist's Care in Late Stage Chronic Kidney Disease Patients.|Completed||N/A|130|Actual|Northwell Health||2|||f||||f||||||||||2017-10-11 00:40:22.222182|2017-10-11 00:40:22.222182
NCT02085824|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-13|||July 2012||2012-07-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.|Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.|Unknown status|Recruiting|N/A|60|Anticipated|Centre of Postgraduate Medical Education||3|||f||||f||||||||||2017-10-11 00:40:22.314354|2017-10-11 00:40:22.314354
NCT02085811|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-12|||June 2013||2013-06-01|June 2013|2013-06-01||||June 2014|Anticipated|2014-06-01||Observational|KIPHO||Screening for Kyphosis in the Mean Term in Patients Treated With Kyphoplasty Alone in the Management of Stable Traumatic Compression Fractures of the Thoracolumbar Spine|Screening for Kyphosis in the Mean Term in Patients Treated With Kyphoplasty Alone in the Management of Stable Traumatic Compression Fractures of the Thoracolumbar Spine|Unknown status|Recruiting|N/A|250|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 00:40:22.420124|2017-10-11 00:40:22.420124
NCT02085798|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-07-24|||February 1, 2013|Actual|2013-02-01|July 2017|2017-07-01|October 30, 2018|Anticipated|2018-10-30|April 1, 2018|Anticipated|2018-04-01||Observational|||Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)|Post-authorization, Observational Study to Assess the Evolution in the Normal Clinical Practise of Patients With Recent Diagnosis of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML), Depending on the Time of Active Treatment Initiated|Active, not recruiting||N/A|503|Actual|Celgene|||3||f||||f||||||||||2017-10-11 00:40:22.518093|2017-10-11 00:40:22.518093
NCT02085785|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-06-21|2016-11-10||February 20, 2014|Actual|2014-02-20|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|November 16, 2015|Actual|2015-11-16||Interventional|MOVE-LEAP|Individuals who completed all baseline procedures including consent are included. Those who consented to participate but did not complete all baseline procedures are not included as baseline participants.|Weight Loss Intervention for Individuals With Lower Extremity Amputation|Home-based Weight Loss Intervention for Individuals With Lower Extremity Amputation|Active, not recruiting||N/A|15|Actual|VA Office of Research and Development||3|||f||||f|f|f|||f|||Undecided||2017-10-11 00:40:22.727454|2017-10-11 00:40:22.727454
NCT02085772|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-11|||February 2014||2014-02-01|July 2013|2013-07-01||||February 2016|Anticipated|2016-02-01||Interventional|LOST||Leukocytes - ObeSity - Spontaneous Labour|Is Impaired Activation and Migration of Circulating Leukocytes Associated With Overdue Birth in Obese Women?|Unknown status|Recruiting|N/A|60|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 00:40:23.036978|2017-10-11 00:40:23.036978
NCT02085733|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-07-18|||February 2014||2014-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||Pro-calcitonin for Early Detection of Septic Arthritis|Pro-calcitonin for Early Detection of Septic Arthritis|Active, not recruiting||N/A|150|Actual|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||||2017-10-11 00:40:23.256049|2017-10-11 00:40:23.256049
NCT02085720|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-03-31|2014-03-13||September 2007||2007-09-01|March 2016|2016-03-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Prevalence of OSAS in Chinese Elderly and Its CPAP Compliance|Prevalence of Obstructive Sleep Apnea Syndrome and CPAP Adherence in the Elderly Chinese Population|Completed||N/A|819|Actual|Chinese University of Hong Kong|Subjects were chosen from the community centers and it is possible that those with more symptoms would be more eager to join the study; mre females than males; those who participated in the home sleep study were younger, with slightly higher ESS.|1|||f||||f||||||||||2017-10-11 00:40:23.331436|2017-10-11 00:40:23.331436
NCT02085707|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2016-07-18|||December 2013||2013-12-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Complications and Functional Outcome of Displaced Femoral Neck Fractures in Patients Younger Than 70 Years|Complications and Functional Outcome of Displaced Femoral Neck Fractures Treated With Internal Fixation vs Total Hip Arthroplasty in Patients Younger Than 70 Years. A Randomized Controlled Double Blind Multi Center Trial.|Recruiting||N/A|118|Anticipated|University Hospital, Akershus||2|||f||||t||||||||No||2017-10-11 00:40:23.658512|2017-10-11 00:40:23.658512
NCT02085694|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-08|||March 2014||2014-03-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Lactobacillus Brevis CD2 Preventing Oral Mucositis|A Pilot Study on the Efficacy of Lactobacillus Brevis CD2 Lozenges in Preventing Oral Mucositis by High-dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2/Phase 3|10|Anticipated|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-11 00:40:23.872139|2017-10-11 00:40:23.872139
NCT02085681|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-04-21|||May 2014||2014-05-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|DRTM||Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases|Effectiveness of Tele-medicine in Identifying Diabetic Retinopathy Cases Attending Diabetologists' Clinics Compared to the Conventional Referral System|Completed||N/A|801|Actual|Aravind Eye Care System||2|||f||||t||||||||||2017-10-11 00:40:23.945337|2017-10-11 00:40:23.945337
NCT02085668|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-17|||May 2014||2014-05-01|March 2014|2014-03-01|May 2019|Anticipated|2019-05-01|December 2015|Anticipated|2015-12-01||Interventional|||Renal Denervation in Patients With Chronic Heart Failure|A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients With Chronic Heart Failure (CHF)|Not yet recruiting||N/A|100|Anticipated|University Hospital, Saarland||2|||f||||t||||||||||2017-10-11 00:40:24.047217|2017-10-11 00:40:24.047217
NCT02085655|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-12|||April 2013||2013-04-01|April 2013|2013-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma|PA-Gemox Regimen Followed by Thalidomide Versus AspaMetDex Regimen in NKTCL Patients：a Randomized, Open-label, Phase 3 Study|Recruiting||Phase 3|264|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:40:24.168892|2017-10-11 00:40:24.168892
NCT02085642|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-08-22|||March 2015||2015-03-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|HHSCSTROKEAC||Investigation of the Use of Acupuncture for the Treatment of Spasticity in Chronic Stroke Participants|Investigation of the Use of Acupuncture for the Treatment of Spasticity in Chronic Stroke Participants|Recruiting||N/A|40|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f||||||||Yes|Plan to share data at conferences and journals related to stroke and/or physiotherapy/acupuncture|2017-10-11 00:40:24.266413|2017-10-11 00:40:24.266413
NCT02085629|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-07-21|||July 24, 2014|Actual|2014-07-24|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ONEmreg12||The ONE Study M Reg Trial|The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation - M Reg Trial|Recruiting||Phase 1/Phase 2|16|Anticipated|University of Regensburg||1|||f||||t||||||||||2017-10-11 00:40:24.350758|2017-10-11 00:40:24.350758
NCT02085616|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-10|||February 2009||2009-02-01|March 2014|2014-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|SNTQ||Effectiveness of the Swedish National Tobacco Quitline|Smoking Cessation by Telephone. Effectiveness and Cost-effectiveness of Proactive and Reactive Services at the Swedish National Tobacco Quitline (SNTQ).|Terminated||N/A|586|Actual|Uppsala University||2||Interim analysis, revealed no additional effect of proactive over reactive service.|f||||||||||||||2017-10-11 00:40:24.457981|2017-10-11 00:40:24.457981
NCT02085603|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-05-04|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|SarCaBon||SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain|SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain|Recruiting||Phase 2|62|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:40:24.541291|2017-10-11 00:40:24.541291
NCT02085590|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-05-12|||March 2014||2014-03-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Effects of BCG on Immune Response|The Effects of BCG-vaccination on the Innate Immune Response in Healthy Volunteers. Pilot Proof-of-principle Studie|Completed||Phase 2/Phase 3|20|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 00:40:24.631302|2017-10-11 00:40:24.631302
NCT02085577|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-04-27|||May 2014||2014-05-01|April 2017|2017-04-01|November 1, 2016|Actual|2016-11-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Intraoperative Ketamine on Opioid Consumption and Pain After Spine Surgery in Opioid-dependent Patients|The Effect of Intraoperative Ketamine on Opioid Consumption and Pain After Spine Surgery in Opioid-dependent Patients|Completed||Phase 4|147|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:40:24.726133|2017-10-11 00:40:24.726133
NCT02085564|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2015-06-01|||March 2014||2014-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Significance of Peritoneal Washing Cytology Before and After Neoadjuvant Chemotherapy in Patients With Esophagogastric-junction Cancer|Significance of Peritoneal Washing Cytology Before and After Neoadjuvant Chemotherapy in Patients With Esophagogastric-junction Cancer|Completed||N/A|87|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     100ml of peritoneal washings will be obtained pr. patients x 2. The first at the staging     laparoscopy, and the second initially before esophagectomy. The specimen will be analyzed for     any malignant cancer cells by an authorized pathologist. Afterwards, the specimen will be     destroyed.   "|||2017-10-11 00:40:24.848018|2017-10-11 00:40:24.848018
NCT02085551|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-09-26|||March 2014||2014-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRISM||Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery|The Prism Trial: A Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery|Recruiting||Phase 4|100|Anticipated|Penumbra Inc.||1|||f||||f||||||||||2017-10-11 00:40:26.790129|2017-10-11 00:40:26.790129
NCT02085538|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-05-18|||May 2014||2014-05-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Study Of Palbociclib (PD-0332991) In Renal Impairment|A Phase 1, Open-label, Single Dose, Parallel-group Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Renal Function|Completed||Phase 1|31|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 00:40:26.904239|2017-10-11 00:40:26.904239
NCT02085525|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-12-01|||March 2014||2014-03-01|December 2014|2014-12-01||||March 2016|Anticipated|2016-03-01||Interventional|||A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation|A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation|Withdrawn||N/A|0|Actual|University of Michigan Cancer Center||2||Lack of funding.|f||||t||||||||||2017-10-11 00:40:27.010022|2017-10-11 00:40:27.010022
NCT02085512|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2017-02-23|||April 2014||2014-04-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Prevention of PTSD III: Neurocognitive Training of Emotional Regulation|Prevention of PTSD by Neurocognitive Training of Emotional Regulation|Active, not recruiting||N/A|100|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 00:40:27.076108|2017-10-11 00:40:27.076108
NCT02085486|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-06-21|||August 2017|Anticipated|2017-08-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Ultrasound Assisted Puncture of AV Fistulas in Chronic Hemodialysis Patients|Ultrasound Assisted Puncture of AV Fistulas in Chronic Hemodialysis Patients After a Short Learning Program in Bed-side Ultrasound for Hemodialysis Nurses by an Index Nurse - an Outcome Study|Not yet recruiting||N/A|90|Anticipated|University Hospital Inselspital, Berne||2|||f||||f|f|f||||||||2017-10-11 00:40:27.248816|2017-10-11 00:40:27.248816
NCT02085460|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2016-04-28|||March 2014||2014-03-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer|Completed||Phase 2|94|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:40:27.425437|2017-10-11 00:40:27.425437
NCT02085447|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-10-17|||May 2014||2014-05-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|CAL-C||A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness|A Concierge Model of Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic (CAL-C) in Individuals With Schizophrenia at Risk for Treatment Non-adherence and for Homelessness|Active, not recruiting||N/A|30|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-10-11 00:40:27.509201|2017-10-11 00:40:27.509201
NCT02085434|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-11-20|||February 2013||2013-02-01|November 2014|2014-11-01||||November 2013|Actual|2013-11-01||Interventional|||Pediatric Practice-based Obesity Intervention to Support Families: FITLINE||Completed||Phase 1|84|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-11 00:40:27.696679|2017-10-11 00:40:27.696679
NCT02085421|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-13|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis|Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis|Not yet recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f|f|t|f|f||||||2017-10-11 00:40:27.781594|2017-10-11 00:40:27.781594
NCT02085408|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-09-16|||December 2010||2010-12-01|September 2014|2014-09-01||||February 2019|Anticipated|2019-02-01||Interventional|||Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age &gt;/= 60 Years)|Recruiting||Phase 3|747|Anticipated|Eastern Cooperative Oncology Group||2|||f||||||||||||||2017-10-11 00:40:27.950478|2017-10-11 00:40:27.950478
NCT02085395|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-03-13|||November 2007||2007-11-01|March 2014|2014-03-01|November 2010|Actual|2010-11-01|April 2010|Actual|2010-04-01||Interventional|AK||Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis|An Open Phase II Study to Assess the Efficacy and Safety of Topical SR-T100® Gel in the Treatment of Human Cutaneous Squamous Cell Carcinoma in Situ (Actinic Keratosis and Bowen's Disease)|Completed||Phase 2|27|Actual|G&E Herbal Biotechnology Co., LTD||1|||f||||t||||||||||2017-10-11 00:40:29.66205|2017-10-11 00:40:29.66205
NCT02085382|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-10|||September 2011||2011-09-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Randomized, Controlled Trial of Kangaroo Mother Care in Increasing the Rate of Weight Gain Among Neonates|A Randomized, Controlled Trial of Kangaroo Mother Care in Increasing the Rate of Weight Gain Among Low Birth Weight Neonates Admitted in Level II Neonatal Intensive Care Unit of the Philippine General Hospital|Completed||Phase 3|52|Actual|University of the Philippines||2|||f||||t||||||||||2017-10-11 00:40:29.743583|2017-10-11 00:40:29.743583
NCT02085369|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-05-11|||January 2014||2014-01-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Effect of Gastric Bypass Surgery on Cognition and Genetics|Effect of Gastric Bypass Surgery on Cognition and Genetics|Recruiting||N/A|100|Anticipated|Uppsala University|||1||f||||f||||||Samples With DNA|"     A fasted blood sample (50 mL) will be taken before and 2h after a standardized meal.      Through epigenetic study, we will analyze the changes in DNA methylation after surgery in     genes related to metabolism (at the Science for Life Laboratory (SciLifeLab) with 450K Human     Meth arrays).      In addition, blood samples from these obese patients analyzed (before and after surgery)     after ingestion of a predetermined test meal (for example, high protein) to explore changes     in metabolites profile. Metabolites in the samples will be quantified by the SciLifeLab.   "|||2017-10-11 00:40:29.819128|2017-10-11 00:40:29.819128
NCT02085356|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-03-19|||April 2014||2014-04-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Implementing a Comprehensive Prevention of Mother-to-Child Transmission of HIV Program for South African Couples|Implementing Comprehensive PMTCT and HIV Prevention for South African Couples|Active, not recruiting||N/A|1967|Actual|University of Miami||4|||f||||f||||||||Yes|Dissemination of findings will be made to the community participants and stakeholders. The US team and the South Africa team will collaborate and encourage community stakeholders to participate in dissemination and development of related research. Utilizing the data from this study, the collaborators will compile a research review document for the Government of South Africa. Successful results of this research will be used to develop a translational proposal based on empirical results. The study results will be disseminated through Dr. Peltzer, the South Africa PI. All investigators will work within the structure of the South Africa community sites to provide feedback to other medical providers and to the professional community by presentation of the results. Access to the database will be available under the supervision of the collaborators.|2017-10-11 00:40:29.936534|2017-10-11 00:40:29.936534
NCT02085343|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-10-28|||February 2013||2013-02-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|August 2017|Anticipated|2017-08-01||Interventional|||Anti-phobic and Safety Behaviors in the Treatment of Acrophobia|Anti-phobic and Safety Behaviors in the Treatment of Acrophobia|Recruiting||N/A|100|Anticipated|University of Texas at Austin||4|||f||||f||||||||Yes|De-identified data can be shared upon request to the corresponding investigator / author upon project completion. Contact Michael J. Telch, Ph.D at telch@austin.utexas.edu|2017-10-11 00:40:30.081764|2017-10-11 00:40:30.081764
NCT02085330|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-11|2014-10-01|||March 2014||2014-03-01|October 2014|2014-10-01|February 2017|Anticipated|2017-02-01|May 2016|Anticipated|2016-05-01||Interventional|||Hyperbaric Oxygen Therapy for Mild Cognitive Impairment|Hyperbaric Oxygen Therapy in Patients Suffering From Mild Cognitive Impairment and Vascular Subcortical Ischemia|Unknown status|Recruiting|N/A|60|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 00:40:30.223332|2017-10-11 00:40:30.223332
NCT02085317|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2014-03-10|||March 2006||2006-03-01|March 2014|2014-03-01|February 2010|Actual|2010-02-01|November 2009|Actual|2009-11-01||Interventional|||Microcirculatory Impairment in Patients With Leprosy|Observation of Microcirculation Impairment in Patients With Lepromatous Leprosy Using Orthogonal Polarization Spectral (OPS) Imaging and Laser Doppler Iontophoresis|Completed||N/A|20|Actual|Rio de Janeiro State University||2|||f||||t||||||||||2017-10-11 00:40:30.344082|2017-10-11 00:40:30.344082
NCT02085304|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-12-12|||October 2012||2012-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM|Phase I/II Randomized Prospective Trial for Newly Diagnosed GBM, With Upfront Gross Total Resection, Gliadel®, Followed by Temodar® With Concurrent IMRT Versus GK|Recruiting||Phase 1/Phase 2|80|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||t||||||||||2017-10-11 00:40:30.454214|2017-10-11 00:40:30.454214
NCT02085291|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-05-26|||September 2011||2011-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Targeting the Microcirculation in Resuscitation of Patients With Septic Shock|Targeting the Microcirculation in Resuscitation of Patients With Septic Shock|Completed||Phase 4|20|Actual|Southeast University, China||3|||f||||t||||||||||2017-10-11 00:40:30.603256|2017-10-11 00:40:30.603256
NCT02085278|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-08-05|||February 2014||2014-02-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Safety of Apollo Micro Catheter in Pediatric Patients|Safety of Apollo Embolization Delivery Micro Catheter in Pediatric Patients With Vascular Malformations|Completed||N/A|10|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||f||||||||||2017-10-11 00:40:30.699515|2017-10-11 00:40:30.699515
NCT02085265|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-12-21|||March 2014||2014-03-01|December 2015|2015-12-01|August 2018|Anticipated|2018-08-01|June 2017|Anticipated|2017-06-01||Interventional|SARTAN-AD||Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients|The SARTAN-AD Trial: A Randomized, Open Label, Proof of Concept Study of Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients|Recruiting||Phase 2|240|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 00:40:30.920071|2017-10-11 00:40:30.920071
NCT02085252|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-02-02||2017-02-02|June 2013||2013-06-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer|An Open-Label, Multicenter, Phase III Study to Assess the Impact of Transient Androgenic Deprivation With Enantone LP 11.25 Mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer|Completed||Phase 3|115|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:40:31.049556|2017-10-11 00:40:31.049556
NCT02085239|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-06-07|||August 2013||2013-08-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy|Comparison of Long Acting vs. Short Acting Anesthetic Agents as a Tool for Improving Pain Management Post Ultrasound Guided Breast Biopsy|Withdrawn||Phase 4|0|Actual|TriHealth Inc.||2||Study never got started; can't delete results|f||||t||||||||No||2017-10-11 00:40:31.169339|2017-10-11 00:40:31.169339
NCT02085226|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-12-04|||July 2013||2013-07-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|ACES||Art as Creative Engagement for Stroke|Can an Arts Based Creative Engagement Intervention Following Stroke Improve Psychosocial Outcomes? A Feasibility Trial of a Creative Engagement Intervention for In-patient Rehabilitation|Completed||N/A|81|Actual|University of Dundee||2|||f||||f||||||||||2017-10-11 00:40:31.291285|2017-10-11 00:40:31.291285
NCT02085213|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-05-02|||September 2014||2014-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|GOT-IT||GOT-IT Trial: Glyceryl Trinitrate for Retained Placenta|GOT-IT Trial: A Pragmatic Group Sequential Placebo Controlled Randomised Trial to Determine the Effectiveness of Glyceryl Trinitrate for Retained Placenta.|Recruiting||Phase 4|1087|Anticipated|University of Edinburgh||2|||f||||t||||||||||2017-10-11 00:40:31.404328|2017-10-11 00:40:31.404328
NCT02085200|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-10|||June 2013||2013-06-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Scapular Stabilization During Manual Horizontal Adduction Stretches and Its Effect on Increasing Posterior Shoulder Flexibility|The Effect of Scapular Stabilization During Horizontal Adduction Stretching on Passive Internal Rotation and Posterior Shoulder Tightness in Young Female Volleyball Athletes.|Completed||N/A|60|Actual|Nova Southeastern University||2|||f||||t||||||||||2017-10-11 00:40:31.54454|2017-10-11 00:40:31.54454
NCT02085187|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-10|||January 2012||2012-01-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Early Telemedicine Training in Patients With COPD|Early Telemedicine Training and Counselling After Hospitalization in Patients With Severe Chronic Obstructive Pulmonary Disease: A Feasibility Study|Completed||N/A|50|Actual|Odense University Hospital||1|||f||||f||||||||||2017-10-11 00:40:31.643787|2017-10-11 00:40:31.643787
NCT02085174|ClinicalTrials.gov processed this data on October 10, 2017|2008-01-28|2014-03-10|||April 2008||2008-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:40:31.749012|2017-10-11 00:40:31.749012
NCT02085161|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-11-09|2016-08-30||March 2014||2014-03-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional||Treated set (TS): This patient set included all patients of the Randomised set (All patients who signed informed consent form and were also randomised, regardless whether the patient was treated with study medication or not.) who were dispensed study medication and were documented to have taken any dose of study medication.|To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways|An Exploratory, 12 Week, Randomised, Partially Double-blinded, Placebo-controlled Parallel Group Trial to Explore the Effects of Once Daily Treatments of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination or Tiotropium (Both Delivered by Respimat® Inhaler), Supervised Exercise Training and Behavior Modification on Exercise Capacity and Physical Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|304|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:40:31.846932|2017-10-11 00:40:31.846932
NCT02085148|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-07-27|||April 11, 2014|Actual|2014-04-11|July 2017|2017-07-01|October 24, 2019|Anticipated|2019-10-24|October 24, 2019|Anticipated|2019-10-24||Interventional|||A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy|A Multi-center, Open-label, Non-randomized, Phase I Dose Escalation Study of Regorafenib (BAY 73-4506) in Pediatric Subjects With Solid Malignant Tumors That Are Recurrent or Refractory to Standard Therapy.|Active, not recruiting||Phase 1|77|Anticipated|Bayer||3|||f||||f|f|f||||||||2017-10-11 00:40:33.29404|2017-10-11 00:40:33.29404
NCT02085135|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-01-06||2016-01-06|February 2014||2014-02-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)|A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Tolerability of Two Titration Schedules for ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults With an Inadequate Response to Antidepressant Therapy (the FORWARD-1 Study)|Completed||Phase 3|66|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-10-11 00:40:33.437595|2017-10-11 00:40:33.437595
NCT02085122|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-11|||March 2013||2013-03-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Exercise and Noninvasive Ventilation in Heart Failure Patients|Impact of Noninvasive Ventilation With Two Levels of Pressure on Exercise Tolerance in Subjects With Heart Failure: Randomized and Controlled Clinical Trial.|Completed||N/A|24|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 00:40:33.560832|2017-10-11 00:40:33.560832
NCT02085109|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-08-04|||February 2014||2014-02-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effects of Fat and Theobromine on apoA-I|The Effects of a Diet Rich in Fat or Theobromine on Intestinal apoA-I mRNA and Protein Expression|Completed||N/A|10|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 00:40:33.828521|2017-10-11 00:40:33.828521
NCT02085096|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-05-06|||July 1997||1997-07-01|May 2016|2016-05-01|September 2005|Actual|2005-09-01|December 2002|Actual|2002-12-01||Interventional|||Problem Solving Therapy for Prostate Cancer Spousal Caregivers|Problem-Solving Therapy for Prostate Cancer Patient's Spousal Caregivers|Completed||N/A|338|Actual|University of California, San Diego||2|||f||||f||||||||No||2017-10-11 00:40:33.966847|2017-10-11 00:40:33.966847
NCT02085083|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-09-27|||July 2014||2014-07-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|IMPACT-IBD||Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease|Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease|Active, not recruiting||N/A|150|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||No||2017-10-11 00:40:34.101919|2017-10-11 00:40:34.101919
NCT02085070|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-01-31|||March 2014||2014-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||MK-3475 in Melanoma and NSCLC Patients With Brain Metastases|A Phase 2 Study of MK-3475 in Patients With Metastatic Melanoma and Non-Small Cell Lung Cancer With Untreated Brain Metastases|Recruiting||Phase 2|64|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 00:40:34.271373|2017-10-11 00:40:34.271373
NCT02085057|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-04-24|||January 2013||2013-01-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Observational|||Neural Links Between OCD and Anorexia|Shared and Unique Neural Links Between OCD and Anorexia: Investigating Biological Mechanisms of Phenotypic Expression|Completed||N/A|80|Actual|Stanford University|||4||f||||f||||||||||2017-10-11 00:40:34.434814|2017-10-11 00:40:34.434814
NCT02085044|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-03-11|||February 2012||2012-02-01|October 2013|2013-10-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|NRCI-ASPE||Non Randomized Controlled Intervention Study Comparing Two Interventions of Nutritional Supplement on Malnutrition, Health and Mortality|Non Randomized Controlled Intervention Study Comparing Two Interventions of Nutritional Supplement on Malnutrition, Health and Mortality in Children Aged 6 to 24 Month Hadjer-Lamis Region - Chad|Completed||Phase 4|5700|Actual|Médecins Sans Frontières, Switzerland||2|||f||||f||||||||||2017-10-11 00:40:34.549633|2017-10-11 00:40:34.549633
NCT02085031|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-04-08|||April 2014||2014-04-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer|Randomized Controlled Trial on Surgical Safety of Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer|Unknown status|Recruiting|Phase 2|136|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 00:40:34.640689|2017-10-11 00:40:34.640689
NCT02085018|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2015-10-08|||February 2014||2014-02-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|PPIPF||Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)|A Randomised, Placebo-controlled Trial of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)|Unknown status|Recruiting|Phase 2|60|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 00:40:34.765898|2017-10-11 00:40:34.765898
NCT02085005|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-11-17|||March 2014||2014-03-01|November 2014|2014-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|Drop and Go||Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer|Phase II Study of First-line Capecitabine Plus Oxaliplatin Plus Aflibercept for 6 Cycles Followed by Capecitabine Plus Aflibercept as Maintenance Therapy in Patients With Metastatic Colorectal Cancer: DROP and GO Trial|Withdrawn||Phase 2|0|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:40:34.903903|2017-10-11 00:40:34.903903
NCT02084992|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-01-11|||June 2014||2014-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SpanCHFIII||A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure|A Multicenter Randomized Controlled Evaluation of Heart Failure Disease Management Using Advanced Telecommunications Within a Diverse Provider Network: The Specialized Primary and Networked Care in HF (SPAN-CHF) III Trial|Recruiting||N/A|233|Anticipated|Tufts Medical Center||2|||f||||f||||||||||2017-10-11 00:40:34.998963|2017-10-11 00:40:34.998963
NCT02084979|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-03-09|||April 2014||2014-04-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||A Controlled Trial of Patient Centered Telepsychiatry Interventions|A Controlled Trial of Patient Centered Telepsychiatry Interventions|Recruiting||N/A|200|Anticipated|University of California, Davis||2|||f||||t|f|f||||||No||2017-10-11 00:40:35.163287|2017-10-11 00:40:35.163287
NCT02084966|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-01-25|||April 2014||2014-04-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Non-Invasive Evaluation of Transplant Kidney Using OCT|Non-Invasive Evaluation of Transplant Kidney Using OCT|Recruiting||N/A|400|Anticipated|Georgetown University||1|||f||||t||||||||||2017-10-11 00:40:35.284601|2017-10-11 00:40:35.284601
NCT02084953|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-07-25|||April 2014||2014-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects|A Randomized, Double-Blinded, Positive-Controlled, Placebo-Controlled, 3-Way Crossover Study to Determine the Electrocardiographic Effects of BMS-791325 in Healthy Subjects|Completed||Phase 1|59|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 00:40:35.374164|2017-10-11 00:40:35.374164
NCT02084940|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-11|||March 2014||2014-03-01|March 2014|2014-03-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Observational|||Long Acting GnRH Antagonist in PCOS Women Undergoing IVF|The Use of a Long Acting GnRH Antagonist (Degarelix) in Controlled Ovarian Hyperstimulation in PCOS Women at a Risk to Developing OHSS Undergoing IVF : a Pilot Study|Unknown status|Recruiting|N/A|20|Anticipated|Bioroma|||1||f||||f||||||||||2017-10-11 00:40:35.490451|2017-10-11 00:40:35.490451
NCT02084927|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-10|||April 2014||2014-04-01|March 2014|2014-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery|Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery -Randomized Prospective Trial|Unknown status|Not yet recruiting|Phase 1|62|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 00:40:35.609627|2017-10-11 00:40:35.609627
NCT02084914|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-10|||December 2013||2013-12-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Endometrial Scratching by Pipelle on Pregnancy Rate in Unexplained Infertility|The Effect of Endometrial Scratching by Pipelle on Pregnancy Rate in Couples With Unexplained Infertility|Unknown status|Recruiting|Phase 3|158|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:40:35.691032|2017-10-11 00:40:35.691032
NCT02084901|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2016-07-26|||March 2014||2014-03-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of Biodegradable Stents: Orsiro and BioMatrix|Comparison of Biodegradable Stents: Orsiro and BioMatrix|Completed||Phase 4|12|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:40:35.771094|2017-10-11 00:40:35.771094
NCT02084888|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-11|||January 2005||2005-01-01|March 2014|2014-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01|3 Years|Observational [Patient Registry]|||Prognostic Impact of Chronic Total Occlusions|Prognostic Impact of Chronic Total Occlusions - A Report From the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)|Completed||N/A|91154|Actual|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||||2017-10-11 00:40:35.852874|2017-10-11 00:40:35.852874
NCT02084875|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-07-09|||April 2014||2014-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers|A Phase 1, Randomized, Open Label, Single Dose, 2-Period Crossover Study To Evaluate The Effect Of Food On The Pharmacokinetics Of Tofacitinib Modified Release (MR) 11 Mg Tablets In Healthy Western And Japanese Volunteers|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:40:35.932908|2017-10-11 00:40:35.932908
NCT02084862|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-10-26|||March 2014||2014-03-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|TRACHUS||Ultrasound Guided Percutaneous Tracheostomy Compared to Bronchoscopy Guided Percutaneous Tracheostomy|Ultrasound Guided Percutaneous Tracheostomy Compared to Bronchoscopy Guided Percutaneous Tracheostomy - A Randomized Non-inferiority Trial|Completed||N/A|118|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:40:36.030338|2017-10-11 00:40:36.030338
NCT02084849|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2015-06-23|||June 1998||1998-06-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|84 Months|Observational [Patient Registry]|||ADPKD Cohort Study|The Autosomal Dominant Polycystic Kidney Disease (ADPKD) Cohort Study|Completed||N/A|624|Actual|Emory University|||2||f||||f||||||Samples With DNA|"     Whole blood, serum, urine, tissue   "|||2017-10-11 00:40:36.145038|2017-10-11 00:40:36.145038
NCT02084836|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-11|||June 2009||2009-06-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Relation of Consummatory & Anticipatory Food Reward to Obesity|Relation of Consummatory & Anticipatory Food Reward to Obesity|Unknown status|Active, not recruiting|N/A|162|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||f||||||Samples With DNA|"     Saliva   "|||2017-10-11 00:40:36.23771|2017-10-11 00:40:36.23771
NCT02084823|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2015-06-01|||March 2014||2014-03-01|March 2014|2014-03-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells|Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic Adenocarcinoma of the Lung|Completed||Phase 1/Phase 2|40|Actual|Fuda Cancer Hospital, Guangzhou||4|||f||||t||||||||||2017-10-11 00:40:36.352385|2017-10-11 00:40:36.352385
NCT02084810|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-03-24|||March 2014||2014-03-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects|A Single Centre, Randomised, Double-blind, Two-way Crossover Trial in Healthy Male Subjects Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven®|Withdrawn||Phase 1|0|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:40:36.438806|2017-10-11 00:40:36.438806
NCT02084797|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2016-04-06|2014-03-14||June 2011||2011-06-01|April 2016|2016-04-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||V2 Receptor Effects on Fluid Regulation and Performance|Revisiting the Human Sweat Gland - Does Arginine Vasopressin Modulate Sweat Sodium Concentration Via the V2 Receptor?|Completed||N/A|10|Actual|Oakland University||1|||f||||f||||||||||2017-10-11 00:40:36.519027|2017-10-11 00:40:36.519027
NCT02084784|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2015-11-17|||June 2013||2013-06-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Application of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer Research|Study of Surgical Navigation System in Detection of Sentinel Lymph Node of Early Breast Cancer Patients|Enrolling by invitation||N/A|90|Anticipated|Chinese Academy of Sciences||1|||f||||t||||||||||2017-10-11 00:40:36.783384|2017-10-11 00:40:36.783384
NCT02084771|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-03-29|||October 2014||2014-10-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Oral Salt and Water to Prevent Contrast Nephropathy|The Prevention of Acute Kidney Injury Following Contrast-Enhanced Computed Tomography: A Pilot Trial of Oral Fluid Versus Intravenous Saline|Withdrawn||Phase 4|0|Actual|Ottawa Hospital Research Institute||2||"The recruitment rate was very slow, and it was concluded that it was not feasible to do this   trial."|f||||t||||||||No||2017-10-11 00:40:36.883995|2017-10-11 00:40:36.883995
NCT02084758|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-02-03|||September 2015||2015-09-01|September 2016|2016-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Nitrate Supplementation in Chronic Obstructive Pulmonary Disease (COPD)|The Effects of Dietary Nitrate Supplementation on Metabolic Efficiency in Patients With COPD|Completed||N/A|20|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 00:40:36.98951|2017-10-11 00:40:36.98951
NCT02084745|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-08-21|||March 2014||2014-03-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|GDD-KPro||Timing of Glaucoma Drainage Device With Boston KPro Surgery|Timing of Glaucoma Drainage Device Implantation With Boston Keratoprosthesis Surgery|Recruiting||N/A|40|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 00:40:37.081073|2017-10-11 00:40:37.081073
NCT02084732|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-08-16|||October 2013||2013-10-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study|Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study|Recruiting||Phase 2|30|Anticipated|Instituto Nacional de Cancerologia, Columbia||1|||f||||t||||||||||2017-10-11 00:40:37.184696|2017-10-11 00:40:37.184696
NCT02084719|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-01-19|||March 2014||2014-03-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care||Terminated||N/A|67|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2||Slow recruitement|f||||f||||||||||2017-10-11 00:40:37.273994|2017-10-11 00:40:37.273994
NCT02084706|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-10-27|2016-07-20||March 2014||2014-03-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|J-tip||Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection|Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection|Completed||N/A|60|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 00:40:37.49477|2017-10-11 00:40:37.49477
NCT02084693|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-03-28|||December 2013||2013-12-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2016|Actual|2016-10-01||Observational|||COMPREHENSIVE® REVERSE SHOULDER Mini BasePlate|Evaluate Survivorship for the Biomet® Comprehensive® Reverse Shoulder Mini Baseplate.|Active, not recruiting||N/A|100|Anticipated|Zimmer Biomet|||1||f||||t||||||||Yes||2017-10-11 00:40:37.782716|2017-10-11 00:40:37.782716
NCT02084680|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-03-14|||June 2013||2013-06-01|March 2014|2014-03-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Intervention Trial to Measure the Effect of Individual Prenatal Information Combined With Mobile Phones|A Community Trial to Measure the Effect of Individual Prenatal Education With Mobile Phone Consultations Offered to Pregnant Women in Masindi and Kiryandongo, Western Uganda|Unknown status|Recruiting|N/A|1|Anticipated|Makerere University||2|||f||||f||||||||||2017-10-11 00:40:37.894049|2017-10-11 00:40:37.894049
NCT02084654|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-11-03|||November 2007||2007-11-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|||Exenatide and Weight Loss for Diabetes Prevention|Randomized Trial Investigating Exenatide for Diabetes Prevention in Obese, Insulin-Resistant Individuals With Prediabetes|Completed||Phase 1|66|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 00:40:37.995339|2017-10-11 00:40:37.995339
NCT02084641|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-03-09|||September 2011||2011-09-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Adipose Tissue Response to Overfeeding in Insulin Resistance-Prone vs. Insulin Sensitive Humans|Adipose Tissue Response to Overfeeding in Insulin Resistance-Prone vs. Insulin Sensitive Humans|Unknown status|Recruiting|N/A|45|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-11 00:40:38.084255|2017-10-11 00:40:38.084255
NCT02084628|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-08-04|2016-08-04||February 2015||2015-02-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent|Open-label, Multi-center Study to Evaluate the Safety, Efficacy, and Plasma Gadolinium Concentrations After an Intravenous Injection of 0.1 mL/kg Body Weight Eovist/Primovist for Enhanced Magnetic Resonance Imaging (MRI) of the Liver in Children 0 to 2 Months of Age|Terminated||Phase 3|1|Actual|Bayer|Primarily based on study 13729 along with supporting data the FDA revised Eovist labeling to remove any age restriction from indication and decided that there are no further pediatric data requested. Consequently, study was discontinued.|1||Enrollment discontinued due to rare medical condition in the age group 0 to 2 months|f||||f||||||||||2017-10-11 00:40:38.212498|2017-10-11 00:40:38.212498
NCT02084615|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2015-06-16|||August 2014||2014-08-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|August 2016|Anticipated|2016-08-01||Interventional|||Prospective Study Investigating Aspirin and Intraoperative Blood Loss and Complications Following Inguinal Hernia Repair|A Prospective, Nonrandomized, Study Comparing the Use of Aspirin and Intraoperative Blood Loss and Postoperative Complications Following Open Inguinal Hernia Repair.|Unknown status|Enrolling by invitation|N/A|300|Anticipated|Jesse Brown VA Medical Center||2|||f||||f||||||||||2017-10-11 00:40:38.607005|2017-10-11 00:40:38.607005
NCT02084602|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-06-04|||June 2014||2014-06-01|March 2014|2014-03-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|Artesunate||Assessment of Artesunate/Mefloquine in the Peruvian Amazon|Assessment of in Vivo and in Vitro Efficacy of Combined Artesunate/Mefloquine Therapy for Treatment of Uncomplicated Plasmodium Falciparum Infection in the Peruvian Amazon|Unknown status|Not yet recruiting|Phase 4|59|Anticipated|Instituto Nacional de Salud. Peru||1|||f||||t||||||||||2017-10-11 00:40:38.708015|2017-10-11 00:40:38.708015
NCT02084589|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-04-06|||June 2012||2012-06-01|April 2014|2014-04-01||||February 2014|Actual|2014-02-01||Interventional|||A Comparison Study of Patient Controlled Epidural Analgesia (PCEA) With and Without Basal Infusion Using Ropivacaine 0,15% and Fentanyl μg/ml for Pain Relief in Labor, Assessment of Efficacy and Maternal Satisfaction.||Completed||N/A|65|Actual|Attikon Hospital||2|||f||||||||||||||2017-10-11 00:40:38.816972|2017-10-11 00:40:38.816972
NCT02084576|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-03-10|||August 2013||2013-08-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|August 2013|Actual|2013-08-01||Interventional|||Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification|Comparison of Ketorolac Tromethamine 0.4% and Nepafenac 0.1% for the Prevention of Cystoid Macular Edema After Phacoemulsification: Prospective Randomized Double-masked Study|Completed||Phase 4|40|Actual|Hospital Oftalmologico de Brasilia||2|||f||||t||||||||||2017-10-11 00:40:38.908542|2017-10-11 00:40:38.908542
NCT02084563|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-11-07|||October 2012||2012-10-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|December 2014|Actual|2014-12-01||Interventional|||Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms|Evaluation of the Incidence and Prognostic Impact of Molecular and Genetic Abnormalities in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasms|Completed||Phase 2|455|Actual|Hospital Israelita Albert Einstein||3|||f||||t||||||||||2017-10-11 00:40:39.008677|2017-10-11 00:40:39.008677
NCT02084550|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-07-27|||September 2015|Actual|2015-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|July 1, 2017|Actual|2017-07-01||Interventional|AMINOPOUCH||Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative Colitis|Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative Colitis: a Randomized, Assessor-blinded, Placebo-controlled Trial|Active, not recruiting||N/A|8|Anticipated|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 00:40:39.145814|2017-10-11 00:40:39.145814
NCT02084537|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2017-05-03|||April 2014||2014-04-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|MISER||Minimally Invasive Surgery vs. Endoscopy Randomized (MISER) Trial for Symptomatic Walled-Off Pancreatic Necrosis|Minimally Invasive Surgery vs. Endoscopy Randomized (MISER) Trial for Symptomatic Walled-Off Pancreatic Necrosis|Recruiting||N/A|62|Anticipated|Florida Hospital||2|||f||||t||||||||No||2017-10-11 00:40:39.238604|2017-10-11 00:40:39.238604
NCT02084524|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-10-04|||October 2013||2013-10-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|October 2013|Actual|2013-10-01||Interventional|ANC1||ANC1 Study Impact of a Geriatric and Nutritional Evaluation for the Malnutrition and Malnutrition Risk Screening in Patients Over 70 Years With Colorectal Surgery.|ANC1 Study Impact of a Geriatric and Nutritional Evaluation for the Malnutrition and Malnutrition Risk Screening in Patients Over 70 Years With Colorectal Surgery.|Recruiting||N/A|150|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:40:39.353293|2017-10-11 00:40:39.353293
NCT02084511|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-10|2014-11-05|||March 2014||2014-03-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain|Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain (a Single-centre, Partially Double-blinded, Randomised, placebo-and Active Comparator-controlled, Single-dose, Parallel-group Study)|Completed||Phase 1|80|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:40:39.460417|2017-10-11 00:40:39.460417
NCT02084498|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-11-20|||September 2012||2012-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Advanced Carbohydrate Counting and Automated Bolus Calculation|A Randomized Controlled Large Study of Flexible Intensified Insulin Therapy (FIIT) With Carbohydrate Counting (CHC) Versus FIIT With Carbohydrate Counting and Automated Bolus Calculation (ABC)|Completed||N/A|178|Actual|Steno Diabetes Center||2|||f||||f||||||||||2017-10-11 00:40:39.599416|2017-10-11 00:40:39.599416
NCT02084485|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-13|||September 2006||2006-09-01|March 2014|2014-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||PH-797804 LPS Study in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Study to Determine the Effects of a Single Oral Dose of Ph-797804 on Induced Sputum Inflammatory Markers Following Inhaled Lipopolysaccharide (Lps) Challenge in Healthy Volunteers|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:40:39.73155|2017-10-11 00:40:39.73155
NCT02084472|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-09|||February 2013||2013-02-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Accessible and Affordable Moisturizers for Atopic Eczema|Accessible and Affordable Moisturizers for Atopic Eczema: the 2am Atopic Eczema Study|Completed||N/A|120|Actual|Red Cross War Memorial Childrens Hospital||2|||f||||f||||||||||2017-10-11 00:40:39.836207|2017-10-11 00:40:39.836207
NCT02084459|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-07-09|||February 2013||2013-02-01|July 2017|2017-07-01|July 15, 2016|Actual|2016-07-15|July 15, 2016|Actual|2016-07-15||Interventional|GSD||Guided Self-determination in the Treatment of Chronic Pain to Promote the Life Skills of the Patient|The Use of Guided Self-determination in the Treatment of Chronic Pain Patients Will Increase Life Skills and Thereby Life Quality of the Chronic Pain Patient|Completed||N/A|200|Actual|Herlev Hospital||2|||f||||f||||||||||2017-10-11 00:40:39.935927|2017-10-11 00:40:39.935927
NCT02084446|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2015-03-18|||December 2012||2012-12-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant|Everolimus in Association With Very Low-dose Tacrolimus Versus Enteric-coated Mycophenolate Sodium With Low-dose Tacrolimus in de Novo Renal Transplant Recipients - A Prospective Single Center Study|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Hospital Geral de Fortaleza||2|||f||||f||||||||||2017-10-11 00:40:40.067064|2017-10-11 00:40:40.067064
NCT02084433|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-02-22|||January 2015||2015-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|QUICK||Comparison of Intraosseous Anaesthesia Using a Computerized System (QuickSleeper) to Conventional Anesthesia|Comparison of Intraosseous Anaesthesia Using a Computerized System (QuickSleeper) to Conventional Anesthesia|Completed||N/A|158|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:40:40.217141|2017-10-11 00:40:40.217141
NCT02084420|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-06-02|||December 2012||2012-12-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment|PhaseⅢ Study of A Multicenter, Randomized, Double-blind, Active-controlled to Evaluate of Efficacy /Safety as H. Pylori Eradication Effect Between Ilaprazole/Pantoprazole|Completed||Phase 3|323|Actual|Il-Yang Pharm. Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:40:40.363097|2017-10-11 00:40:40.363097
NCT02084407|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-09-25|||November 2013||2013-11-01|March 2014|2014-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients|Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients|Completed||N/A|12|Actual|Institut de Myologie, France||3|||f||||f||||||||||2017-10-11 00:40:40.515371|2017-10-11 00:40:40.515371
NCT02084394|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-02-05|||June 2013||2013-06-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Observational|||Cerebral Blood Flow During CPB During Cardiac Surgery and the Presence of Post op Delirium|Non Invasive Monitoring of Cerebral Blood Flow During and After Cardiopulmonary Bypass to Assess and Compare for the Presence of Delirium in Post Operative Patients (DELIRIUM)|Completed||Phase 4|110|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 00:40:40.601352|2017-10-11 00:40:40.601352
NCT02084381|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-04-04|||February 2014||2014-02-01|April 2017|2017-04-01|February 2015|Actual|2015-02-01|July 2014|Actual|2014-07-01||Interventional|PERCI-MCO||PERCI- Medium Cut Off (MCO)|Permeability Enhancement to Reduce Chronic Inflammation _ Medium Cut Off (MCO) (Study no 1502)|Completed||N/A|50|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-10-11 00:40:40.696735|2017-10-11 00:40:40.696735
NCT02084368|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-09-10|||January 2014||2014-01-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Application of Combined Lumbar Plexus and Sciatic Nerve Block|Application of Combined Lumbar Plexus and Sciatic Nerve Block in Unilateral Knee Replacement|Completed||Phase 4|34|Actual|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-11 00:40:40.789376|2017-10-11 00:40:40.789376
NCT02084355|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-07|||April 2014||2014-04-01|March 2014|2014-03-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain|Efficacy and Safety of Opioid Rotation Compared With Opioid Dose Escalation in Patients With Moderate to Severe Cancer Pain - Open Label, Randomized, Prospective Study|Unknown status|Not yet recruiting|Phase 3|136|Anticipated|Gyeongsang National University Hospital||2|||f||||||||||||||2017-10-11 00:40:40.879881|2017-10-11 00:40:40.879881
NCT02084342|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2014-03-10|||December 2013||2013-12-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery|Efficacy and Safety of Desmopressin Combined With Tranexamic Acid on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery|Unknown status|Active, not recruiting|N/A|60|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:40:40.969774|2017-10-11 00:40:40.969774
NCT02084329|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2014-03-11|||March 2014||2014-03-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Balance and Mild Traumatic Brain Injury: The Effect of a Weighted Compression Vest|Balance and Mild Traumatic Brain Injury: The Effect of a Weighted Compression Vest|Unknown status|Not yet recruiting|N/A|30|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:40:41.053497|2017-10-11 00:40:41.053497
NCT02084316|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-08-16|||March 2014||2014-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|August 2014|Actual|2014-08-01||Interventional|CTN 0056||Testing and Linkage to HIV Care in China|Testing and Linkage to HIV Care in China: A Clustered Randomized Trial|Completed||Phase 2/Phase 3|360|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 00:40:41.134403|2017-10-11 00:40:41.134403
NCT02084303|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-08-04|||March 2014||2014-03-01|August 2014|2014-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|IRONMAN||Imaging Neuroinflammation in Epilepsy With Ferumoxytol MRI|Imaging Neuroinflammation in Epilepsy With Ferumoxytol MRI|Unknown status|Recruiting|N/A|20|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-10-11 00:40:41.227928|2017-10-11 00:40:41.227928
NCT02084290|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-10-27|||March 2014||2014-03-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Interventional|||Evaluating a Shared Decision Making Program for Crohn's Disease|Evaluating a Prediction Tool and Decision Aid for Patients With Crohn's Disease|Recruiting||N/A|300|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 00:40:41.309171|2017-10-11 00:40:41.309171
NCT02084277|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2014-03-09|||June 2010||2010-06-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A RCT to Compare OHRQoL Outcome for SLB and CB|A Randomized Clinical Trial to Compare Oral Health Related Quality of Life Outcome for Patients With Malocclusion Receiving Orthodontic Treatment: Before Treatment vs. During Initial Treatment; Self-ligating Brackets vs. Conventional Brackets|Unknown status|Recruiting|N/A|120|Anticipated|Mackay Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:40:41.463023|2017-10-11 00:40:41.463023
NCT02084264|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2017-08-16|||October 2014||2014-10-01|August 2017|2017-08-01|October 2024|Anticipated|2024-10-01|October 2024|Anticipated|2024-10-01||Observational|PEDSCOLI||Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis|Multicenter, Prospective, Partially Randomized, Controlled Trial of Robotic-guided vs. Freehand Corrective Surgery for Pediatric Scoliosis|Recruiting||N/A|2000|Anticipated|Mazor Robotics|||2||f||||f||||||||||2017-10-11 00:40:41.564316|2017-10-11 00:40:41.564316
NCT02084251|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2017-02-13|||February 2014||2014-02-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Clinical Trial for PB-119 in Healthy Subjects (Phase I)|Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers|Completed||Phase 1|70|Actual|PegBio Co., Ltd.||1|||f||||t||||||||||2017-10-11 00:40:41.823191|2017-10-11 00:40:41.823191
NCT02084238|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2015-10-02|2015-02-20||August 2013||2013-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Interventional|||Low-dose IL-2( Interleukin-2) Treatment in SLE|Safety and Efficiency Study of Low-dose IL-2 Treatment in Systemic Lupus Erythematosus|Completed||N/A|40|Actual|Peking University People's Hospital||1|||f||||t||||||||||2017-10-11 00:40:41.924436|2017-10-11 00:40:41.924436
NCT02084225|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2014-03-19|||January 2012||2012-01-01|March 2014|2014-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|||Ultrasound Guided Regional Anesthesia for Acute Injury in Low Resource Settings|Feasibility, Perceived Utility and Sustainability of Using Ultrasound-guided Regional Anesthesia by Local Providers in a Limited Resource Conflict Setting|Unknown status|Active, not recruiting|N/A|60|Anticipated|Salmon, Margaret, M.D.|||1||f||||f||||||||||2017-10-11 00:40:42.304106|2017-10-11 00:40:42.304106
NCT02084212|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-07|||March 2013||2013-03-01|October 2012|2012-10-01||||August 2015|Anticipated|2015-08-01||Interventional|||Study of Retinal Sensitivity by Microperimetry During Epiretinal Membrane Surgery|Study of Retinal Sensitivity by Microperimetry During Epiretinal Membrane Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 00:40:42.409515|2017-10-11 00:40:42.409515
NCT02084199|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2014-07-21|||March 2014||2014-03-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects|Study to Evaluate the Pharmacokinetics, Safety, Tolerability of 100 mg Multiple Doses of GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects|Completed||Phase 1|24|Actual|Galapagos NV||5|||f||||f||||||||||2017-10-11 00:40:42.501191|2017-10-11 00:40:42.501191
NCT02084186|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2016-10-10|||March 2014||2014-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Moxibustion for Mild and Moderate Ulcerative Colitis|The Mechanism of Moxibustion in Treating Ulcerative Colitis Based on Metabonomics|Completed||N/A|60|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-11 00:40:42.617008|2017-10-11 00:40:42.617008
NCT02084173|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-09-28|||January 2014|Actual|2014-01-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|June 2017|Actual|2017-06-01||Interventional|||Treatment of Alcohol Problems in the Elderly|Motivational Enhancement Therapy and Community Reinforcement Approach For Treating Alcohol Problems in the Elderly|Active, not recruiting||N/A|704|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 00:40:42.704681|2017-10-11 00:40:42.704681
NCT02084160|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-09|2017-08-15|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation|The Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation; a Retrospective Analysis|Recruiting||N/A|414|Anticipated|Exalenz Bioscience LTD.|||1||f||||f||||||||||2017-10-11 00:40:42.807365|2017-10-11 00:40:42.807365
NCT02084147|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-04-24|||March 7, 2013|Actual|2013-03-07|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases|PET-MRI: Evaluation, Optimization and Clinical Implementation|Recruiting||N/A|530|Anticipated|Case Comprehensive Cancer Center||1|||f||||f|f|t|f|f|f|||||2017-10-11 00:40:42.903577|2017-10-11 00:40:42.903577
NCT02084134|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-05-15|||March 2012||2012-03-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|November 21, 2016|Actual|2016-11-21||Interventional|Steroid||Peri-Operative Steriod Management in Patients|The Use of Perioperative Steroids in Patients Undergoing Transsphenoidal Resection of Pituitary Tumors or Cysts|Completed||N/A|51|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:40:43.032067|2017-10-11 00:40:43.032067
NCT02084121|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-03-17||||||March 2017|2017-03-01||||||||Expanded Access|||Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)|Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)|No longer available||N/A|||University of Louisville||||||t|||||||||||||2017-10-11 00:40:43.161693|2017-10-11 00:40:43.161693
NCT02084108|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-10|||July 2009||2009-07-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of Integrated Care to Reduce Hospitalization and Nursing Home Placement in Community Dwelling Frail Elderly|Efficacy of Integrated Care to Decrease Hospitalization and Institutionalization in Community Dwelling Frail Elderly, With Care Coordination Between Physicians, Home Nursing Services and a Community Geriatrics Unit.|Completed||N/A|301|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 00:40:43.233524|2017-10-11 00:40:43.233524
NCT02084095|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-08-02|||March 2014||2014-03-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly|The Role of Insulin-like Growth Factor-I (IGF-I) and Free Fatty Acids in Insulin Resistance, Insulin Secretion and Glucose Metabolism Abnormalities in Acromegaly|Recruiting||N/A|20|Anticipated|Carol Davila University of Medicine and Pharmacy|||1||f||||f||||||||||2017-10-11 00:40:43.334991|2017-10-11 00:40:43.334991
NCT02084082|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-06-23|2016-06-23||April 2014||2014-04-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Treated set: All randomised subjects who received 1 dose of trial medication were included in the treated set.|Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects|Bioequivalence of a Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release (5 mg/1000 mg) Compared With the Free Combination of Linagliptin and Metformin Extended Release Tablets in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Trial)|Completed||Phase 1|68|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:40:43.437643|2017-10-11 00:40:43.437643
NCT02084069|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2015-02-13|2015-01-21||January 2013||2013-01-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||All enrolled patients completed the study|Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair||Completed||Phase 3|58|Actual|Urmia University of Medical Sciences|The sample size of this study was small|2|||f||||||||||||||2017-10-11 00:40:44.257712|2017-10-11 00:40:44.257712
NCT02084056|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-06-23|2016-06-23||April 2014||2014-04-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Treated set: All randomised subjects who received 1 dose of trial medication were included in the treated set.|Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects.|Bioequivalence of a Fixed Dose Combination Tablet of Linagliptin/Metformin Extended Release (2.5 mg/1000 mg) Compared With the Free Combination of Linagliptin and Metformin Extended Release Tablets in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Trial)|Completed||Phase 1|74|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:40:44.486479|2017-10-11 00:40:44.486479
NCT02084043|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2015-06-05|||March 2014||2014-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Synchro-Neb||In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation|In Vitro Comparison of Continuous and Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation: Analysis of Inhaled and Lost Doses.|Completed||N/A|3|Actual|University Hospital St Luc, Brussels||2|||f||||f||||||||||2017-10-11 00:40:45.211016|2017-10-11 00:40:45.211016
NCT02084030|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-08-14|||March 2013||2013-03-01|August 2014|2014-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||Screening of Susceptibility Genes in Postoperative Cognitive Dysfunction(POCD)|Screening of Susceptibility Genes in Postoperative Cognitive Dysfunction After On-pump Cardiac Surgery|Unknown status|Recruiting|N/A|120|Anticipated|Xijing Hospital|||2||f||||t|||||||"     blood collected one day before surgery   "|||2017-10-11 00:40:45.316945|2017-10-11 00:40:45.316945
NCT02084017|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-07-30|||July 2014||2014-07-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|||Negative Pressure Wound Therapy for the Prevention of Surgical Site Infection Following Lower Limb Revascularization|Single Center Prospective Randomized Control Trial on Negative Pressure Wound Therapy for Primarily Closed Groin Incisions Following Lower-limb Re-vascularization to Reduce Surgical Site Infection|Unknown status|Recruiting|Phase 1/Phase 2|80|Anticipated|Western University, Canada||2|||f||||f||||||||||2017-10-11 00:40:45.47175|2017-10-11 00:40:45.47175
NCT02084004|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-06|||June 2014||2014-06-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment|Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment：an Open-label, Multicenter，Randomized, Prospective，Controlled Study|Unknown status|Not yet recruiting|Phase 2/Phase 3|310|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:40:45.591473|2017-10-11 00:40:45.591473
NCT02083991|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-11-21|||January 2013||2013-01-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|SAILOR||Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation|A Controlled Randomized, Open-label, Multi-centre Study Evaluating if a Steroid-free Immunosuppressive Protocol, Based ATG-induction, Low Tacrolimus-dose and Therapeutic Drug Monitoring of Mycophenolate Mofetil, Reduces the Incidence of New Onset Diabetes After Transplantations, in Comparison With Standard Steroid-based Protocol With Low-dose Tacrolimus.|Recruiting||Phase 4|200|Anticipated|Vastra Gotaland Region||2|||f||||t||||||||||2017-10-11 00:40:45.713316|2017-10-11 00:40:45.713316
NCT02083978|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2015-06-01|||January 2010||2010-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Bipolar Research Study Using MR Imaging|Neuromorphometry of Psychosis in Bipolar Disorder|Completed||N/A|75|Actual|Washington University Early Recognition Center|||2||f||||f||||||||||2017-10-11 00:40:45.814221|2017-10-11 00:40:45.814221
NCT02083965|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-05-23|2016-07-12||March 2014||2014-03-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetics of rFVIIIFc at Two Vial Strengths|A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetics of 2 Vial Strengths of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc; BIIB031) in Previously Treated Subjects With Severe Hemophilia A|Completed||Phase 1|19|Actual|Bioverativ Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 00:40:45.935608|2017-10-11 00:40:45.935608
NCT02083952|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-01-19|||February 2014||2014-02-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Impact of Swaddle Blanket on Gastroesophageal Reflux|Impact of Swaddle Blanket on Gastroesophageal Reflux|Unknown status|Recruiting|N/A|50|Anticipated|Valley Health System||1|||f||||f||||||||||2017-10-11 00:40:48.5022|2017-10-11 00:40:48.5022
NCT02083939|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2015-11-21|||March 2014||2014-03-01|November 2015|2015-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?|Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?|Active, not recruiting||N/A|200|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 00:40:48.607341|2017-10-11 00:40:48.607341
NCT02083926|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-07-11|||March 2014||2014-03-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Ketamine Infusion for Social Anxiety Disorder|Ketamine Infusion for Social Anxiety Disorder|Active, not recruiting||Early Phase 1|18|Actual|Yale University||2|||f||||f||||||||||2017-10-11 00:40:48.71329|2017-10-11 00:40:48.71329
NCT02083913|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-11-02|||February 2014||2014-02-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2015|Actual|2015-06-01||Interventional|TelePreSET||Prebariatric Surgery Physical Exercise Training in Telehealth|Feasibility and Impacts of a Prebariatric Surgery Exercise Training in Telehealth: a Pilot Study|Unknown status|Active, not recruiting|N/A|6|Anticipated|Université de Sherbrooke||1|||f||||f||||||||||2017-10-11 00:40:48.838169|2017-10-11 00:40:48.838169
NCT02083900|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-06|||October 2006||2006-10-01|March 2014|2014-03-01||||September 2007|Actual|2007-09-01||Interventional|||Use of Banana Leaf Dressing on Donor Site Wounds|Use of Banana Leaf Dressing on Donor Site Wounds: A Prospective Randomized Control Study|Unknown status|Active, not recruiting|Phase 2|10|Actual|University of the Philippines||2|||f||||t||||||||||2017-10-11 00:40:48.923984|2017-10-11 00:40:48.923984
NCT02083887|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-12-02|||February 2014||2014-02-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|VAC058||A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants|A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants|Completed||Phase 1|65|Actual|University of Oxford||4|||f||||t||||||||||2017-10-11 00:40:49.00369|2017-10-11 00:40:49.00369
NCT02083874|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-10|||March 2014||2014-03-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study|Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study|Unknown status|Active, not recruiting|Phase 2|5|Anticipated|The University of New South Wales||1|||f||||f||||||||||2017-10-11 00:40:49.099201|2017-10-11 00:40:49.099201
NCT02083848|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-11-02|||March 2014||2014-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|DETECT||Detection of Loco-regional Invasion of Cervical Cancer With 7 Tesla MRI|Detection of Loco-regional Invasion of Cervical Cancer With 7 Tesla MRI (DETECT)|Completed||N/A|23|Actual|UMC Utrecht||1|||f||||f||||||||||2017-10-11 00:40:49.395539|2017-10-11 00:40:49.395539
NCT02083835|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-09-13|||January 2009|Actual|2009-01-01|September 2017|2017-09-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01|6 Months|Observational [Patient Registry]|PAIN-OUT||PAIN OUT: Improvement in Postoperative PAIN OUTcome|Improvement in Postoperative Pain Outcome|Recruiting||N/A|200000|Anticipated|University of Jena|||2||f||||f||||||||||2017-10-11 00:40:49.496348|2017-10-11 00:40:49.496348
NCT02083822|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2014-09-18|||June 2011||2011-06-01|September 2014|2014-09-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|EPIRMEX||Cerebral Abnormalities Detected by MRI, Realized at the Age of Term and the Emergence of Executive Functions|Cerebral Abnormalities Detected by MRI, Realized at the Age of Term and the Emergence of Executive Functions|Unknown status|Active, not recruiting|N/A|600|Actual|University Hospital, Tours||1|||f||||t||||||||||2017-10-11 00:40:49.609594|2017-10-11 00:40:49.609594
NCT02083809|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-02-25|||October 2014||2014-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation|A Randomized Double-blinded Controlled Trial Comparing Dilation and Evacuation Outcomes With and Without Oxytocin Use|Recruiting||N/A|166|Anticipated|University of Hawaii||2|||f||||t||||||||||2017-10-11 00:40:49.728509|2017-10-11 00:40:49.728509
NCT02083796|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-10-26|||July 2013||2013-07-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Short-term Effects of Thoracic Manipulation in Shoulder Impingement|Short-term Effects of Thoracic Manipulation on Scapular Kinematics, Muscle Activity and Pain in Shoulder Impingement. A Randomized Controlled Trial|Completed||N/A|110|Actual|Universidade Federal de Sao Carlos||4|||f||||f||||||||||2017-10-11 00:40:49.833283|2017-10-11 00:40:49.833283
NCT02083783|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2015-06-12||2015-05-07|March 2014||2014-03-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)|TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHA): A Laboratory Classroom Study|Completed||Phase 3|108|Actual|Tris Pharma, Inc.||2|||f||||t||||||||||2017-10-11 00:40:49.93581|2017-10-11 00:40:49.93581
NCT02083770|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-05-06|||March 2010||2010-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Clinical Trials Education Program for Hispanic Americans|Randomized Controlled Clinical Trials Education Program for Hispanic Americans|Active, not recruiting||Phase 3|956|Actual|University of California, San Diego||2|||f||||f||||||||No||2017-10-11 00:40:50.055904|2017-10-11 00:40:50.055904
NCT02083744|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-05-18|||June 2013||2013-06-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Project Fluido: Fluid Watchers|A Self-Care Intervention for Hispanic Patients With Heart Failure|Unknown status|Active, not recruiting|N/A|42|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:40:50.265812|2017-10-11 00:40:50.265812
NCT02083731|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2015-01-06|||January 2014||2014-01-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||MSC for Treatment of CMV Infection|Mesenchymal Stem Cells for Treatment of CMV Infection After Hematopoietic Stem Cell Transplant|Unknown status|Recruiting|Phase 2|120|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||||2017-10-11 00:40:50.381495|2017-10-11 00:40:50.381495
NCT02083718|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-08|2014-03-08|||January 2014||2014-01-01|March 2014|2014-03-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function|G-CSF Mobilized Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant|Unknown status|Recruiting|Phase 2|120|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||||2017-10-11 00:40:50.509246|2017-10-11 00:40:50.509246
NCT02083705|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-01-06|||January 2014||2014-01-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Chest Compression and Sustained Inflation|Chest Compression and Sustained Inflation for Asystole or Bradycardia in Newborn Infants|Completed||N/A|10|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 00:40:50.627931|2017-10-11 00:40:50.627931
NCT02083692|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-10-18|||September 2013||2013-09-01|October 2016|2016-10-01||||May 2016|Actual|2016-05-01||Interventional|||Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling|Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling.|Completed||Early Phase 1|50|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 00:40:50.756793|2017-10-11 00:40:50.756793
NCT02083679|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-08-29|2016-08-29||July 2014||2014-07-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||The safety analysis set included all 15 subjects who were administered any dose of the trial medication.|Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer|A Phase Ib, Open-label, Dose Escalation Trial Investigating Different Doses and Schedules of Sym004 in Combination With Platinum-doublets in Subjects With Stage IV Non-small Cell Lung Cancer|Terminated||Phase 1|15|Actual|EMD Serono|The trial was prematurely discontinued and Expansion Cohort (Part 2) was not conducted as Sponsor decided to prematurely discontinue the development of Sym004. This decision was not related to any safety or efficacy findings regarding Sym004.|4||"Sponsor the return rights of the compound to the collaboration partner for further clinical   development"|f||||t||||||||||2017-10-11 00:40:50.889076|2017-10-11 00:40:50.889076
NCT02083666|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-07-27|||December 2013||2013-12-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SOBI002 Following Subcutaneous and Intravenous Administration. A Double-blind, Placebo-controlled, Randomized Within Dose Cohort, Single and Repeated Dose-escalation Study in Healthy Volunteers|Terminated||Phase 1|24|Actual|Swedish Orphan Biovitrum||2||Transient adverse events observed|f||||f||||||||||2017-10-11 00:40:52.360515|2017-10-11 00:40:52.360515
NCT02083653|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-06-19|||March 2014||2014-03-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|March 2017|Actual|2017-03-01||Interventional|||Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer|Open-label, Randomized, Controlled, Multicenter Phase II Trial Investigating 2 Sym004 Doses Versus Investigator`s Choice (Best Supportive Care, Capecitabine, 5-FU) in Subjects With Metastatic Colorectal Cancer and Acquired Resistance to Anti-EGFR Monoclonal Antibodies|Active, not recruiting||Phase 2|254|Actual|Symphogen A/S||3|||f||||t||||||||Undecided||2017-10-11 00:40:52.489138|2017-10-11 00:40:52.489138
NCT02083640|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-06-02|||March 2014||2014-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Relative Bioavailability For Palbociclib Formulations|A Phase 1, Open-Label, 6 Sequence, 3 Period, Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Estimate The Relative Bioavailability Of 3 Palbociclib Formulations|Completed||Phase 1|30|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:40:52.739959|2017-10-11 00:40:52.739959
NCT02083627|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-05-19|||February 2013||2013-02-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects|A Phase 1, Open Label, Randomized, Two-way Crossover Study to Evaluate the Effect of Multiple Doses of Fidaxomicin on the Single Dose Pharmacokinetics of Rosuvastatin in Healthy Male Subjects|Completed||Phase 1|25|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:40:52.837434|2017-10-11 00:40:52.837434
NCT02083601|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-11-20|||April 2014||2014-04-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Caring for Caregivers: Supporting Caregivers of Youth With Spinal Cord Injury|Caring for Caregivers: Supporting Caregivers of Youth With Spinal Cord Injury|Unknown status|Active, not recruiting|N/A|88|Anticipated|Shriners Hospitals for Children||2|||f||||f||||||||||2017-10-11 00:40:53.015966|2017-10-11 00:40:53.015966
NCT02083588|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-03-10|||March 2014||2014-03-01|March 2014|2014-03-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||A Prospective Trial to Explore the Efficacy of dTMS in Subjects With Fibromyalgia|A Prospective Trial to Explore the Efficacy of the H1-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Fibromyalgia|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Shalvata Mental Health Center||1|||f||||||||||||||2017-10-11 00:40:53.117371|2017-10-11 00:40:53.117371
NCT02083575|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-07|||April 2014||2014-04-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Role of Vitamin C to Augment Iron Chelation With DFP or DFX|Study of Safty and Efficacy of Adjuvant Vitamin c in Augmenting Iron Chelation|Unknown status|Not yet recruiting|Phase 2/Phase 3|50|Anticipated|Ain Shams University||2|||f||||f||||||||||2017-10-11 00:40:53.208432|2017-10-11 00:40:53.208432
NCT02083562|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-04-11|||November 2013||2013-11-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Observational|BPD-2014||Biomarkers and Volumetric Capnography in BPD|Plasma Biomarkers for the Prediction of Bronchopulmonary Dysplasia and Volumetric Capnography for Severity Assessment of Lung Disease in Preterm Infants|Recruiting||N/A|210|Anticipated|University Hospital, Basel, Switzerland|||1||f||||t||||||Samples Without DNA|"     Plasma   "|Undecided||2017-10-11 00:40:53.304513|2017-10-11 00:40:53.304513
NCT02083549|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-09-19|||April 2013||2013-04-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Observational|MTP-TEG||Evaluating URMC's Massive Transfusion Protocol|Evaluating the Efficacy of the University of Rochester Medical Center's Massive Transfusion Protocol in Trauma Level 1 Patients Utilizing Thromboelastography|Recruiting||N/A|40|Anticipated|University of Rochester|||1||f||||f||||||||||2017-10-11 00:40:53.393868|2017-10-11 00:40:53.393868
NCT02083536|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-08-09|||May 2014||2014-05-01|August 2016|2016-08-01||||May 2019|Anticipated|2019-05-01||Interventional|||LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma|A Phase I Study Using Low-Dose Fractionated Whole Abdominal Radiation Therapy (LDFWART) As A Docetaxel Chemo-Potentiator for Patients With Platinum-Resistant Recurrent Ovarian Carcinoma|Withdrawn||Phase 1|0|Actual|University of Miami||1||Study voluntarily stopped by Principal Investigator due to lack of accrual.|f||||t||||||||||2017-10-11 00:40:53.477058|2017-10-11 00:40:53.477058
NCT02083523|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-03-10|||March 2013||2013-03-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|CHOICE||Project CHOICE: Efficacy Testing of CHOICE and CHOICE+Normative Feedback Interventions|PROJECT CHOICE: Efficacy Testing of Motivational Interviewing (MI) for Adolescents Referred for Substance Use Concerns|Completed||Phase 1|48|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-11 00:40:53.558088|2017-10-11 00:40:53.558088
NCT02083510|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-05-28|||February 2014||2014-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Apolipoprotein CIII Reduction Via Colchicine|A Translational Study to Understand the Mechanism of Apolipoprotein CIII Reduction Via Colchicine|Completed||Early Phase 1|5|Actual|Scripps Translational Science Institute||1|||f||||f||||||||||2017-10-11 00:40:53.631799|2017-10-11 00:40:53.631799
NCT02083497|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-03-10|||October 2013||2013-10-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Comparison Between Rigid Functional And Elastic Bandage For Stabilizing Ankle Support During The Member Of The Chute Football|COMPARISON BETWEEN RIGID FUNCTIONAL AND ELASTIC BANDAGE FOR STABILIZING ANKLE SUPPORT DURING THE MEMBER OF THE CHUTE FOOTBALL|Unknown status|Recruiting|N/A|90|Anticipated|Universidade do Vale do Paraíba||3|||f||||t||||||||||2017-10-11 00:40:53.712598|2017-10-11 00:40:53.712598
NCT02083484|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-10-12||||||October 2016|2016-10-01||||||||Expanded Access|||Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030)|Expanded Access of MK-3475 in Metastatic Melanoma Patients With Limited to No Treatment Options|No longer available||N/A|||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 00:40:53.807025|2017-10-11 00:40:53.807025
NCT02083471|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-10-29|||April 2015||2015-04-01|October 2015|2015-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Cow's Milk and Hen's Egg Hyposensitization in Adults|Cow's Milk and Hen's Egg Hyposensitization in Adults|Unknown status|Not yet recruiting|N/A|40|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-11 00:40:53.866197|2017-10-11 00:40:53.866197
NCT02083458|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-06-13|||February 2010||2010-02-01|June 2016|2016-06-01|February 2014|Actual|2014-02-01|December 2012|Actual|2012-12-01||Interventional|||An Infraclavicular Landmark-based Approach to the Axillary Vein|A New Infraclavicular Landmark-based Approach to the Axillary Vein as an Alternative Method of Central Venous Cannulation|Completed||N/A|153|Actual|Publiczny Samodzielny Zaklad Opieki Zdrowotnej Wojewodzkie Centrum Medyczne||1|||f||||f||||||||||2017-10-11 00:40:53.941105|2017-10-11 00:40:53.941105
NCT02083445|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2014-03-07|||November 2011||2011-11-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|TCECAM||Exercise, Hypoxia and CPC in TBI Patients|Exercise, Muscle Electro-stimulation and Intermittent Hypobaric Hypoxia Program and Circulating Progenitor Cells in Traumatic Brain Injured Patients|Completed||N/A|21|Actual|University of Barcelona||3|||f||||t||||||||||2017-10-11 00:40:54.011006|2017-10-11 00:40:54.011006
NCT02083432|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-12-04|||December 2013||2013-12-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Cognitive Behavioural Treatment of Intra-oral Injection-phobia in 10-16 Year Old Children and Adolescents|Cognitive Behavioural Treatment of Intra-oral Injection-phobia in 10-16 Year Old Children and Adolescents|Active, not recruiting||N/A|60|Actual|University of Bergen||2|||f||||t||||||||||2017-10-11 00:40:54.245502|2017-10-11 00:40:54.245502
NCT02083419|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-02-07|||April 28, 2014|Actual|2014-04-28|February 2017|2017-02-01|February 2, 2017|Actual|2017-02-02|January 2017|Actual|2017-01-01||Observational|||Cardiac Resynchronization Therapy (CRT) and Left Ventricular Assist Devices (LVAD) Therapy|Study of the Effects of Cardiac Resynchronization Therapy (CRT) and Left Ventricular Assist Devices (LVAD) Therapy|Completed||N/A|6|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 00:40:54.318868|2017-10-11 00:40:54.318868
NCT02083406|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2015-03-17|2015-03-17||July 2014||2014-07-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||All subjects who received at least one dose of study drug.|Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP)|Open Label Study to Investigate the Pharmacokinetics of Prototype Formulations of OZ439 Administered With Piperaquine Phosphate in the Fasted State to Healthy Subjects|Completed||Phase 1|22|Actual|Medicines for Malaria Venture||3|||f||||f||||||||||2017-10-11 00:40:54.406551|2017-10-11 00:40:54.406551
NCT02083393|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-26|||June 2011||2011-06-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Changes of Dendritic Cells in Acute Lung Injury|Changes of Dendritic Cells in Acute Lung Injury|Completed||N/A|19|Actual|Southeast University, China|||2||f||||t||||||||||2017-10-11 00:40:54.749479|2017-10-11 00:40:54.749479
NCT02083380|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-01-30|2016-12-05||July 2014||2014-07-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.|Randomised Phase IIb Study of Efficacy, Safety, Tolerability & Pharmacokinetics of a Single Dose Regimen of Artefenomel (OZ439) in Loose Combination With Piperaquine in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria.|Completed||Phase 2/Phase 3|448|Actual|Medicines for Malaria Venture||3|||f||||t||||||||No||2017-10-11 00:40:54.856828|2017-10-11 00:40:54.856828
NCT02083367|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-05-21|||January 2013||2013-01-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Observational|||Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome|Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome|Completed||N/A|12|Actual|OSF Healthcare System|||2||f||||f||||||||||2017-10-11 00:40:56.127433|2017-10-11 00:40:56.127433
NCT02083354|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-09-05|||March 18, 2014||2014-03-18|September 2017|2017-09-01|December 20, 2018|Anticipated|2018-12-20|April 18, 2018|Anticipated|2018-04-18||Interventional|||Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma|An Open-Label, Multi-Center Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma|Recruiting||Phase 2|65|Anticipated|Novartis||1|||f||||f||||||||||2017-10-11 00:40:56.2433|2017-10-11 00:40:56.2433
NCT02083341|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-09-22|||August 2014||2014-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of External Vibration on Voice Quality in Muscle Tension Dysphonia Patients and Classically Trained Singers|Effects of External Vibration on Voice Quality in Muscle Tension Dysphonia Patients and Classically Trained Singers|Recruiting||N/A|40|Anticipated|St. Michael's Hospital, Toronto||4|||f||||f||||||||||2017-10-11 00:40:56.3854|2017-10-11 00:40:56.3854
NCT02083328|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-03-17|||July 2014||2014-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Influence of Caffeine on HRV and Exercise Performance in Spinal Cord Injury|Influence of Caffeine on Heart Rate Variability and Exercise Performance in in Tetraplegic and Paraplegic Subjects Compared to Able-bodied Subjects|Completed||N/A|35|Actual|Swiss Paraplegic Centre Nottwil||2|||f||||f||||||||||2017-10-11 00:40:56.483983|2017-10-11 00:40:56.483983
NCT02083315|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-07|||July 2013||2013-07-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Explore the Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Adult Male Subjects|Completed||Phase 1|30|Actual|Trevena Inc.||5|||f||||f||||||||||2017-10-11 00:40:56.580827|2017-10-11 00:40:56.580827
NCT02083302|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-07|||June 2010||2010-06-01|March 2014|2014-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Experimentally Testing the Effectiveness of a Campus-based Bystander Intervention|Experimentally Testing the Effectiveness of a Campus-based Bystander Intervention|Completed||N/A|4385|Actual|Rutgers, The State University of New Jersey||3|||f||||f||||||||||2017-10-11 00:40:56.671417|2017-10-11 00:40:56.671417
NCT02083289|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-01-26||2016-01-26|May 2014||2014-05-01|January 2016|2016-01-01||||December 2014|Actual|2014-12-01||Interventional|||A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)|A 28-day Double-masked, Randomized, Parallel-group, Active Controlled Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)|Completed||Phase 2|123|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 00:40:56.777837|2017-10-11 00:40:56.777837
NCT02083276|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-06-18|||March 2014||2014-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|MecillinamCT||Mecillinam for Treatment of Genital Chlamydia Infection|Mecillinam for Treatment of Genital Chlamydia Infection in Asymptomatic Men|Terminated||Phase 2|20|Actual|Oslo University Hospital||1||Treatment failure on study medication observed|f||||f||||||||||2017-10-11 00:40:56.88766|2017-10-11 00:40:56.88766
NCT02083263|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-07-03|2014-03-11||October 2012||2012-10-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis|Study of Non Invasive Ventilation With High Pressure as Airways Clearance Technique in Adults Patients With Cystic Fibrosis|Completed||N/A|32|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:40:56.988838|2017-10-11 00:40:56.988838
NCT02083250|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2017-05-08|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Fludarabine/Clofarabine/Busulfan Combined With SAHA in Acute Leukemia|Fludarabine/Clofarabine/Busulfan Combined With SAHA in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia|Recruiting||Phase 1|72|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:40:57.249067|2017-10-11 00:40:57.249067
NCT02083237|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2014-03-07|||January 2013||2013-01-01|March 2014|2014-03-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Interventional|||Evaluation of an Intervention for Living With Mild Cognitive Impairment|Evaluation of a Behavioural Intervention for People Living With Mild Cognitive Impairment|Unknown status|Recruiting|N/A|120|Anticipated|Baycrest||2|||f||||f||||||||||2017-10-11 00:40:57.363243|2017-10-11 00:40:57.363243
NCT02083224|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-06|||January 2000||2000-01-01|March 2014|2014-03-01||||December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|||Familial Cancer Registry and DNA Bank|Familial Cancer Registry and DNA Bank|Recruiting||N/A|2000|Anticipated|National University Hospital, Singapore|||1||f||||t||||||Samples With DNA|"     Blood for DNA banking and future genotyping Questionnaires regarding family history of cancer     and personal medical history will be taken.   "|||2017-10-11 00:40:57.460948|2017-10-11 00:40:57.460948
NCT02083211|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-04-13|||July 2010||2010-07-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma|"Phase III Clinical Trial: Evaluation of the Combination of Nimotuzumab and Cisplatin-Vinorelbine in First Line Chemotherapy in the Survival of Patients With Recurring-Persistent Cervical Carcinoma"|Completed||Phase 3|168|Anticipated|National Institute of Cancerología||2|||f||||t||||||||||2017-10-11 00:40:57.650755|2017-10-11 00:40:57.650755
NCT02083198|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-06-20|||September 2013|Actual|2013-09-01|June 2017|2017-06-01|April 1, 2014|Actual|2014-04-01|April 1, 2014|Actual|2014-04-01||Observational|||Effects of IV Chloride Content on Outcomes|A Comparison of High and Low Chloride Containing IV Fluid Solutions in Patients Undergoing Major Surgery and/or ICU Admission|Completed||N/A|1558|Actual|Baxter Healthcare Corporation|||2||f||||f||||||||||2017-10-11 00:40:57.737278|2017-10-11 00:40:57.737278
NCT02083185|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-11-22||2016-05-06|April 2014||2014-04-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Patients With Prostate Cancer|A Phase 2, Randomized, Open-label, Parallel Group Study to Evaluate the Safety and Efficacy of the Oral GnRH Antagonist TAK-385, Together With a Leuprorelin Observational Cohort, in Patients With Prostate Cancer|Completed||Phase 2|133|Actual|Takeda||3|||f||||f||||||||||2017-10-11 00:40:57.81353|2017-10-11 00:40:57.81353
NCT02083172|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-03-14|||July 2014||2014-07-01|November 2015|2015-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Comparing USCOM and Echocardiographic Hemodynamic Measurements in Children (CUE Study)|Evaluating Agreement Between USCOM and 2D-echocardiographic Hemodynamic Measurements in Pediatric Patients|Completed||N/A|78|Actual|McMaster University|||3||f||||f||||||||||2017-10-11 00:40:57.96409|2017-10-11 00:40:57.96409
NCT02083159|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-09-19|||March 2012||2012-03-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Observational|||C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease||Recruiting||N/A|500|Anticipated|Korea University|||1||f||||t||||||||||2017-10-11 00:40:58.089866|2017-10-11 00:40:58.089866
NCT02083146|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-04-28|||September 2012||2012-09-01|April 2014|2014-04-01||||December 2015|Anticipated|2015-12-01||Observational|||C1q/TNF-related Proteins in Coronary Artery Disease||Unknown status|Recruiting|N/A|500|Anticipated|Korea University|||1||f||||t||||||||||2017-10-11 00:40:58.165261|2017-10-11 00:40:58.165261
NCT02083133|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2014-03-07|||October 2013||2013-10-01|March 2014|2014-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|DOSE-HD||Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis|Dosing Strategies in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis (DOSE-HD Study)|Unknown status|Enrolling by invitation|N/A|496|Actual|John H. Stroger Hospital|||3||f||||f||||||||||2017-10-11 00:40:58.237367|2017-10-11 00:40:58.237367
NCT02083120|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-02-24|||April 2014||2014-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Physiology of Nasal High Flow Therapy|Efficacy and Physiology of Nasal High Flow Therapy (AIRVO2™, Fisher&Paykel) in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Hypercapnic Respiratory Failure|Recruiting||N/A|40|Anticipated|Institut für Pneumologie Hagen Ambrock eV||2|||f||||t||||||||||2017-10-11 00:40:58.31737|2017-10-11 00:40:58.31737
NCT02083107|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2015-11-22|2014-04-24||February 2013||2013-02-01|November 2015|2015-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss|COMPARISON BETWEEN RECTAL & SUBLINGUAL MISOPROSTOL BEFORE CAESARIAN SECTION TO REDUCE INTRA & POST-OPERATIVE BLOOD LOSS|Completed||Phase 2/Phase 3|636|Actual|Ain Shams University||3|||f||||t||||||||||2017-10-11 00:40:58.44645|2017-10-11 00:40:58.44645
NCT02083081|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-09-05|||May 2014||2014-05-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|Sisters||Community Intervention to Reduce Tobacco Use in Pregnant Women|Community Intervention to Reduce Tobacco Use Among Alaska Native Pregnant Women|Recruiting||Phase 1/Phase 2|320|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:40:59.001235|2017-10-11 00:40:59.001235
NCT02083068|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-10|||May 2014||2014-05-01|March 2014|2014-03-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|||Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivax|Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivax|Unknown status|Not yet recruiting|Phase 2|32|Anticipated|Malaria Vaccine and Drug Development Center||2|||f||||f||||||||||2017-10-11 00:40:59.1119|2017-10-11 00:40:59.1119
NCT02083055|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-06|||December 2012||2012-12-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Anesthetic Advantages of Dexmedetomidine for Hypotensive Anesthesia|Anesthetic Advantages of Dexmedetomidine Compared With Nitroglycerin for Hypotensive Anesthesia in Orthognathic Surgery. A Randomized Clinical Trial.|Completed||N/A|40|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 00:40:59.230741|2017-10-11 00:40:59.230741
NCT02083042|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2016-02-05|||August 2013||2013-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|CMValue||Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients|Clinical Validation of Lophius Biosciences Kit T-Track® CMV to Assess the Functionality of CMV-specific Cell-mediated Immunity (CMI) and Its Suitability to Determine a Protective Cut-off Value for CMV Reactivations/Disease in Kidney Transplant Recipients|Completed||N/A|97|Actual|Lophius Biosciences GmbH|||1||f||||t||||||||||2017-10-11 00:40:59.351698|2017-10-11 00:40:59.351698
NCT02083029|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-10|||January 2013||2013-01-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Vagal Nerve Stimulation Assessed by the Diving Reflex: An Investigation Into Mechanisms of Asthma Death|Vagal Nerve Stimulation Assessed by the Diving Reflex: An Investigation Into Mechanisms of Asthma Death|Completed||N/A|24|Actual|Hull and East Yorkshire Hospitals NHS Trust||3|||f||||f||||||||||2017-10-11 00:40:59.430871|2017-10-11 00:40:59.430871
NCT02083016|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-02-24|||April 2014||2014-04-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|December 2015|Actual|2015-12-01||Interventional|||Ultra-high Density Mapping With Multielectrode Catheter vs Conventional Point by Point Mapping for Ventricular Tachycardia Substrate Ablation|Ultra-high Density Mapping With Multielectrode Catheter vs Conventional Point by Point Mapping for Ventricular Tachycardia Substrate Ablation|Completed||Phase 4|20|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 00:40:59.524815|2017-10-11 00:40:59.524815
NCT02083003|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-07|2016-11-02|||January 2013||2013-01-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Polyamine-low Diet to Prevent Postoperative Pain After Cholecystectomy|Polyamine-low Diet to Prevent Postoperative Pain After Cholecystectomy|Terminated||Phase 4|38|Actual|Hopital Foch||2||End of commercialization of low polyamin diet|f||||f||||||||||2017-10-11 00:40:59.616555|2017-10-11 00:40:59.616555
NCT02082990|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-02-23|||December 2014||2014-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|EFAR-Spain||Primary Care-based Facilitated Access to a Web Based Brief Intervention to Reduce Alcohol Consumption|A Randomised Controlled Non-inferiority Trial of Primary Care-based Facilitated Access to a Web Based Brief Intervention to Reduce Alcohol Consumption (EFAR-Spain)|Recruiting||N/A|1000|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 00:40:59.705297|2017-10-11 00:40:59.705297
NCT02082977|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-08-25|||April 24, 2014|Actual|2014-04-24|August 2017|2017-08-01|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Interventional|||A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma|A Phase I Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma|Terminated||Phase 1|41|Actual|GlaxoSmithKline||2||"The maximal dose and schedule attained with GSK2816126 has shown insufficient evidence of   clinical activity, and does not justify further clinical investigation"|f||||f|t|f||||||||2017-10-11 00:40:59.806352|2017-10-11 00:40:59.806352
NCT02082964|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-03-08|||December 2011||2011-12-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of SCIM on Neonatal Resuscitation||Completed||N/A|48|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:40:59.968729|2017-10-11 00:40:59.968729
NCT02082951|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-06|||May 2011||2011-05-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Family Empathic Behaviour Versus Nurse Empathic Behaviour|Family Empathic Behaviour Versus Nurse Empathic Behaviour: Comparison of Anxiety Symptoms in the Preoperative Cardiac Surgery Patients|Completed||N/A|66|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 00:41:00.078937|2017-10-11 00:41:00.078937
NCT02082938|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-06|||March 2012||2012-03-01|March 2012|2012-03-01|January 2014|Actual|2014-01-01|April 2012|Actual|2012-04-01||Interventional|||The Use of Brace to Retrain Hemiparetic Gait|The Use of a Brace to Retrain Hemiparetic Gait in Patients With Genu Recurvatum: Effects on Plantar Pressure Distribution|Completed||N/A|12|Actual|Federal University of Health Science of Porto Alegre||1|||f||||f||||||||||2017-10-11 00:41:00.191412|2017-10-11 00:41:00.191412
NCT02082925|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-06|||January 2014||2014-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|SD6||Dyspnea Threshold During 6 Minutes Walk Test|Self-perception of Dyspnea Threshold During the 6-minute Walk Test (DT6): A New Tool for Individualized Exercise Training With Chronic Obstructive Pulmonary Disease Patients (COPD)|Completed||N/A|82|Actual|5 Santé||1|||f||||f||||||||||2017-10-11 00:41:00.281482|2017-10-11 00:41:00.281482
NCT02082912|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-04-09|2015-04-09||June 2010||2010-06-01|April 2015|2015-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||Only subjects that completed the study were included in analyses.|NMDA Receptors in Motor Learning in Humans||Completed||Phase 2|14|Actual|Emory University||2|||f||||f||||||||||2017-10-11 00:41:00.38954|2017-10-11 00:41:00.38954
NCT02082899|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-07-10|||February 2014||2014-02-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)|A Single Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel, Group Study to Assess the Efficacy of EBI-005 Topical Ophthalmic Solution for the Treatment of Moderate to Severe Allergic Conjunctivitis Using an Environmental Exposure Chamber (EEC) Model and Conjunctival Allergen Provocation Test (CAPT) Model|Completed||Phase 2|150|Actual|Eleven Biotherapeutics||2|||f||||f||||||||||2017-10-11 00:41:00.831881|2017-10-11 00:41:00.831881
NCT02082886|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-02-06|||February 2014||2014-02-01|February 2017|2017-02-01|January 2034|Anticipated|2034-01-01|January 2034|Anticipated|2034-01-01|10 Years|Observational [Patient Registry]|||HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis ‐ Data Registry|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis ‐ Data Registry|Recruiting||N/A|500|Anticipated|Edward-Elmhurst Health System|||1||f||||f||||||||||2017-10-11 00:41:00.922009|2017-10-11 00:41:00.922009
NCT02082873|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-01-25|||January 2015||2015-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses|A Prospective Trial of Nonconvulsive Electrographic Seizure Detection by Nurses in the Adult Neuro ICU Using a Panel of Quantitative EEG Trends|Enrolling by invitation||N/A|30|Anticipated|Duke University|||1||f||||t|f|f||||||Undecided||2017-10-11 00:41:01.03391|2017-10-11 00:41:01.03391
NCT02082860|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-12-17|||November 2012||2012-11-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria|Phase I, Multicentre, Open Label, Single Dose, Dose-ranging Clinical Trial to Investigate the Safety and Tolerability of a Gene Therapy rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria|Completed||Phase 1|8|Actual|Digna Biotech S.L.||4|||f||||t||||||||||2017-10-11 00:41:01.12474|2017-10-11 00:41:01.12474
NCT02082847|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-06|||July 2013||2013-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:41:01.26407|2017-10-11 00:41:01.26407
NCT02082834|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-03-06|||February 2013||2013-02-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Post EVAR Endoleak Detection : Model-based Iterative Reconstruction (MBIR) vs Adaptive Statistical Iterative Reconstruction (ASIR) CTA; a Prospective Study|Post EVAR Endoleak Detection : Model-based Iterative Reconstruction (MBIR) vs Adaptive Statistical Iterative Reconstruction (ASIR) CTA; a Prospective Study|Completed||N/A|90|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 00:41:01.331797|2017-10-11 00:41:01.331797
NCT02082808|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-06-05|||March 2014||2014-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects|A Phase 1, Open-Label, Crossover Study to Evaluate the Drug Interaction Between Dolutegravir and Daclatasvir in Healthy Adult Subjects|Completed||Phase 1|12|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 00:41:01.497382|2017-10-11 00:41:01.497382
NCT02082795|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-06|||March 2014||2014-03-01|March 2014|2014-03-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Investigating Women's Views on the Management of a Breech Pregnancy|Investigating Women's Views on the Management of a Breech Pregnancy|Unknown status|Not yet recruiting|N/A|15|Anticipated|Chelsea and Westminster NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 00:41:01.576121|2017-10-11 00:41:01.576121
NCT02082782|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-04-28|||May 2014||2014-05-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|COLDFIRE-2||Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases|Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - a Phase II Clinical Trial (COLDFIRE-2 Study)|Recruiting||Phase 2|29|Anticipated|VU University Medical Center||1|||f||||t||||||||||2017-10-11 00:41:01.660659|2017-10-11 00:41:01.660659
NCT02082769|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-12-30|2015-05-11||July 2011||2011-07-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||full analysis set|Safety and Efficacy of Oral Febuxostat in Subjects With Gout|A Phase 3, Randomized, Multicenter, Allopurinol-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout|Completed||Phase 3|504|Actual|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:41:01.817058|2017-10-11 00:41:01.817058
NCT02082756|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-07|||June 2014||2014-06-01|March 2014|2014-03-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment|Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment：an Open-label, Multicenter，Randomized, Prospective，Controlled Study|Unknown status|Not yet recruiting|Phase 2/Phase 3|400|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:41:02.243154|2017-10-11 00:41:02.243154
NCT02082743|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2015-08-05|||October 2013||2013-10-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Vision Care Intervention for Lower Grade School Children in Taiwan|Intervention Program for Vision Care in Lower Grade Schoolchildren|Completed||N/A|1020|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:41:02.493887|2017-10-11 00:41:02.493887
NCT02082730|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-06|||January 2013||2013-01-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|ASARM||The Feasibility, Acceptability and Clinical Utility of a New Remote-mobile Technology Intervention (ASARM) for CFS/ME in a Paediatric Population|An Initial Trial of ASARM: an Advanced Sleep and Rest Monitoring System for Treating Paediatric CFS/ME: Assessing Acceptability and Adaptation Into Current CBT Treatment Protocols|Unknown status|Recruiting|N/A|35|Anticipated|Central Manchester University Hospitals NHS Foundation Trust||3|||f||||f||||||||||2017-10-11 00:41:02.594306|2017-10-11 00:41:02.594306
NCT02082717|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-01-30|||February 2014||2014-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Neut-WKBH||The Impact of Neut During KCL Replacement on Pain and Incidence of Phlebitis|The Impact of 4% Sodium Bicarbonate Additive During Potassium Chloride Replacement on Pain and Incidence of Phlebitis for Adult Patients in a Medical Surgical Unit: A Randomized Double Blinded Controlled Study|Enrolling by invitation||Phase 4|200|Anticipated|Baptist Health South Florida||2|||f||||f||||||||||2017-10-11 00:41:02.700553|2017-10-11 00:41:02.700553
NCT02082704|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-07-11|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|August 2015|Actual|2015-08-01||Interventional|||Interactive Spaced Education to Optimize Diabetes Care|Interactive Spaced Education to Optimize Diabetes Care|Completed||N/A|456|Actual|Boston VA Research Institute, Inc.||2|||f||||f||||||||||2017-10-11 00:41:02.791077|2017-10-11 00:41:02.791077
NCT02082691|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-06||||||March 2014|2014-03-01||||||||Expanded Access|||Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma|Single Patient IND: Continued Administration of G-202 to a Patient With Advanced Hepatocellular Carcinoma Previously Treated With G-202 and Receiving Clinical Benefit|No longer available||N/A|||The University of Texas Health Science Center at San Antonio|||||||||||||||||||2017-10-11 00:41:02.895605|2017-10-11 00:41:02.895605
NCT02082678|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-05-03|||April 2014||2014-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Ondansetron for Bipolar Disorder and Alcohol Use Disorders|Ondansetron for Bipolar Disorder and Alcohol Use Disorders|Recruiting||Phase 4|70|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:41:02.951713|2017-10-11 00:41:02.951713
NCT02082665|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-07-20|||February 19, 2015||2015-02-19|July 2017|2017-07-01|August 1, 2016|Actual|2016-08-01|July 1, 2016|Actual|2016-07-01||Interventional|||Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam|An Open-label Phase 1 Study to Evaluate the Effects of Dabrafenib (GSK2118436) on the Single Dose Pharmacokinetics of an OATP1B1/1B3 Substrate and of a CYP3A4 Substrate in Subjects With BRAF V600 Mutation Positive Tumors|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:41:03.073041|2017-10-11 00:41:03.073041
NCT02082652|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-13|||October 2014||2014-10-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy|A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in HIV-Infected Ugandan Women|Completed||Phase 4|60|Actual|University of Pittsburgh||3|||f||||f||||||||||2017-10-11 00:41:03.199503|2017-10-11 00:41:03.199503
NCT02082639|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-07-16|||February 2015||2015-02-01|July 2015|2015-07-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years|Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix™) (GSK-580299) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) (GSK-208109) in Healthy Female Adolescents Aged 9-14 Years|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||3||"Because the Russian Authorities already approved the 2‐dose Cervarix™ schedule, the study was   no longer needed for registration and hence it was cancelled."|f||||||||||||||2017-10-11 00:41:03.312694|2017-10-11 00:41:03.312694
NCT02082626|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-03-29|||February 1, 2014|Actual|2014-02-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ERIBULIN||Study of Eribulin in Children With Cancer to Determine Safety|A Phase I Study of Eribulin, a Novel Microtubule Inhibitor, in Children With Refractory or Recurrent Solid Tumors|Recruiting||Phase 1|15|Anticipated|University of Oklahoma||1|||f||||t|t|f|||f|||No||2017-10-11 00:41:03.43446|2017-10-11 00:41:03.43446
NCT02082613|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-04-06|||February 2015||2015-02-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Lord´s Procedure Versus Sclerotherapy for Testicular Hydrocele; a Randomized Controlled Study|Lord´s Procedure Versus Sclerotherapy for Testicular Hydrocele; a Randomized Controlled Study.|Recruiting||N/A|200|Anticipated|Umeå University||2|||f||||f||||||||||2017-10-11 00:41:03.54981|2017-10-11 00:41:03.54981
NCT02082600|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-10|||July 2013||2013-07-01|March 2014|2014-03-01||||December 2013|Actual|2013-12-01||Interventional|||Effects of Sleep Deprivation on Blood Hormones and Inflammatory Status After Exercise Induced-muscle Damage|Effects of Sleep Deprivation on Blood Hormones and Inflammatory Status After Exercise Induced-muscle Damage|Unknown status|Active, not recruiting|N/A|10|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 00:41:03.715946|2017-10-11 00:41:03.715946
NCT02082587|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-02-07|||September 2014||2014-09-01|February 2017|2017-02-01|February 2, 2017|Actual|2017-02-02|February 2, 2017|Actual|2017-02-02||Observational|||Toronto BNB Pilot Study|Pilot Study of the Toronto Brief Neurocognitive Battery (BNB)|Completed||N/A|39|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 00:41:03.82945|2017-10-11 00:41:03.82945
NCT02082574|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-10-20|||July 2013||2013-07-01|July 2016|2016-07-01||||June 2016|Actual|2016-06-01||Observational|MICROBREAK1||Prevalence of Cerebral Small Vessel Disease in HIV Infected Patients|Prevalence of Cerebral Small Vessels Disease (CSVD) Among Patients Infected With HIV-1|Completed||N/A|655|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||t||||||||||2017-10-11 00:41:03.916395|2017-10-11 00:41:03.916395
NCT02082561|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-06|||July 2010||2010-07-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders||Completed||N/A|28|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 00:41:03.996091|2017-10-11 00:41:03.996091
NCT02082548|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-05-03|||June 2014||2014-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|IMPACT-AF||Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation|An International Multicenter Clustered Randomized Controlled Trial to imProve Treatment With AntiCoagulanTs in Patients With Atrial Fibrillation.|Active, not recruiting||N/A|2374|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 00:41:04.119036|2017-10-11 00:41:04.119036
NCT02082535|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-03-08|||February 2014||2014-02-01|March 2014|2014-03-01||||February 2017|Anticipated|2017-02-01||Observational|PTS100B||S100B as a Marker of Brain Injury of Preterm Infants|S100B as a Marker of Brain Injury of Preterm Infants|Unknown status|Recruiting|N/A|40|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:41:04.25506|2017-10-11 00:41:04.25506
NCT02082522|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-12-19|||August 2014||2014-08-01|August 2014|2014-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)|Multicenter, Open-label, Randomized, Controlled Phase III Clinical Study of the Efficacy and Safety of Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma|Terminated||Phase 3|28|Actual|Concordia Laboratories Inc.||2||Accrual rate remaining too low|f||||t||||||||Undecided||2017-10-11 00:41:04.36893|2017-10-11 00:41:04.36893
NCT02082509|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-07|||March 2014||2014-03-01|March 2014|2014-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|TRAIN-TBI||Therapeutic Resources for Attention Improvement With Neuroimaging for TBI|Therapeutic Resources for Attention Improvement With Neuroimaging for Traumatic Brain Injury|Unknown status|Recruiting|N/A|60|Anticipated|University of California, San Francisco|||2||f||||t||||||||||2017-10-11 00:41:04.596117|2017-10-11 00:41:04.596117
NCT02082496|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-05-11|||June 2014||2014-06-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|April 2016|Actual|2016-04-01||Interventional|||GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations|Exploration of the Physiological Effect of GLP-1 in Obese Adults Diagnosed With Obesity Causing Genetic Mutations|Active, not recruiting||Phase 2|50|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 00:41:04.709187|2017-10-11 00:41:04.709187
NCT02082483|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-03-29|||November 2014||2014-11-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|CADScreening||Coronary Artery Disease Screening in Kidney Transplant Candidates|Pilot Study to Determine Feasibility of a Randomized Trial of Screening for Coronary Artery Disease in Kidney Transplant Candidates|Recruiting||N/A|144|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 00:41:04.804104|2017-10-11 00:41:04.804104
NCT02082470|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-27|||April 11, 2014||2014-04-11|September 2017|2017-09-01|September 26, 2017|Actual|2017-09-26|September 26, 2017|Actual|2017-09-26||Interventional|||Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer|Feasibility and Preliminary Outcomes of Survivorship Care Planning in Ovarian Cancer|Completed||N/A|14|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 00:41:04.922449|2017-10-11 00:41:04.922449
NCT02082457|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-06-10|||December 2013||2013-12-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|YKP||Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation|Multi-center, Randomized, Double Blinded, Placebo-controlled, Phase II Trial to Assess the Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation|Completed||Phase 2|273|Actual|SK Chemicals Co.,Ltd.||4|||f||||f||||||||||2017-10-11 00:41:05.01426|2017-10-11 00:41:05.01426
NCT02082444|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-07|||November 2013||2013-11-01|March 2014|2014-03-01||||December 2013|Actual|2013-12-01||Interventional|CogniDo||Cognition Intervention Study PLUS (CogniDO PLUS)|Cognition Intervention Study PLUS (CogniDO PLUS): Short-term Effects of Lunch on Children's Executive Cognitive Functions|Completed||N/A|193|Actual|Research Institute of Child Nutrition, Dortmund||1|||f||||||||||||||2017-10-11 00:41:05.118306|2017-10-11 00:41:05.118306
NCT02082431|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-12-16|||August 2014||2014-08-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Long QT and Hearing Loss Registry|Long QT & Hearing Loss Prospective Study Registry|Recruiting||N/A|600|Anticipated|Mednax Center for Research, Education and Quality|||1||f||||f||||||||||2017-10-11 00:41:05.196216|2017-10-11 00:41:05.196216
NCT02082418|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-04-17|||March 2014||2014-03-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effects of Alpha-lactalbumin Intake on Metabolic and Cognitive Functions in Elderly|Effects of Alpha-lactalbumin on Metabolic and Cognitive Functions in Healthy Older Adults|Recruiting||N/A|40|Anticipated|Texas A&M University||3|||f||||f||||||||||2017-10-11 00:41:05.313418|2017-10-11 00:41:05.313418
NCT02082405|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-04-23|||April 2015||2015-04-01|April 2015|2015-04-01||||August 2016|Anticipated|2016-08-01||Interventional|||Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma|A Phase II Trial of Weekly Bortezomib and Dexamethasone With Oral Metronomic Cyclophosphamide in Elderly Patients With Plasma Cell Myeloma|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||1||Funding unavailable|f||||t||||||||||2017-10-11 00:41:05.45723|2017-10-11 00:41:05.45723
NCT02082392|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-06-08|2017-04-03||September 2012||2012-09-01|March 2017|2017-03-01|August 4, 2015|Actual|2015-08-04|August 2015|Actual|2015-08-01||Interventional|||Developing New Clinical Management Strategies|Developing New Clinical Management Strategies for Antidepressant Treatments|Completed||Phase 4|3|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 00:41:05.584394|2017-10-11 00:41:05.584394
NCT02082379|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-01-06|||January 2014||2014-01-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route|In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route|Completed||N/A|21|Actual|Arkansas Children's Hospital Research Institute||2|||f||||||||||||||2017-10-11 00:41:06.216495|2017-10-11 00:41:06.216495
NCT02082366|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-07-06|||March 2014||2014-03-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Microembolic Signals During CPVI (Circumferntial Pulmonary Vein Isolation) Assessed by TCD (Trans-cranial Doppler)|Microembolic Signals During CPVI (Circumferntial Pulmonary Vein Isolation) Assessed by TCD (Trans-cranial Doppler)|Completed||N/A|30|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||No||2017-10-11 00:41:06.317345|2017-10-11 00:41:06.317345
NCT02082353|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-09-14|||June 2014||2014-06-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995|Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995|Recruiting||N/A|1480|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||f||||||Samples With DNA|"     Peripheral blood, skin swabs and/or stool samples   "|||2017-10-11 00:41:06.427041|2017-10-11 00:41:06.427041
NCT02082340|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-06-29|||March 2014||2014-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Innovative Approach in Tuberculosis Care in Armenia|Innovative Approach in Tuberculosis Care in Armenia|Completed||N/A|395|Actual|American University of Armenia Fund||2|||f||||t||||||||||2017-10-11 00:41:06.766368|2017-10-11 00:41:06.766368
NCT02082327|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-06-17|||March 2014||2014-03-01|April 2014|2014-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Dose Escalation Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers With an Open-Label, Randomized, Two-Way Crossover Arm|Completed||Phase 1|31|Actual|Amicus Therapeutics||5|||f||||f||||||||||2017-10-11 00:41:06.856047|2017-10-11 00:41:06.856047
NCT02082314|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-10-12|||February 2014||2014-02-01|October 2016|2016-10-01||||April 2016|Actual|2016-04-01||Observational|RFA||Prospective Study Determining the Pain Response, Functional Interference and Quality of Life in Patients Undergoing Radiofrequency Ablation Assisted Vertebroplasty/ Cementoplasty|Prospective Study Determining the Pain Response, Functional Interference and Quality of Life in Patients Undergoing Radiofrequency Ablation Assisted Vertebroplasty/ Cementoplasty|Completed||N/A|10|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||No||2017-10-11 00:41:08.92768|2017-10-11 00:41:08.92768
NCT02082301|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-08-04|||October 2012||2012-10-01|August 2017|2017-08-01|December 1, 2017|Anticipated|2017-12-01|May 4, 2016|Actual|2016-05-04||Observational|||Oral Glucose Tolerance Testing After Gestational Diabetes|Oral Glucose Tolerance Testing After Gestational Diabetes|Active, not recruiting||N/A|150|Anticipated|MetroHealth Medical Center|||1||f||||f||||||Samples Without DNA|"     Serum for measurements of insulin, markers of inflammation   "|||2017-10-11 00:41:08.999719|2017-10-11 00:41:08.999719
NCT02082288|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-01-11|2014-10-09||December 2010||2010-12-01|January 2015|2015-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||243 infertile couples, attending the ART unit, International Islamic Center for Population Studies and Research (IICPSR), -Al- Azhar University|Edessy ICSI Outcome Embryo Score (EIOS) Efficacy|Edessy ICSI Outcome Embryo Score (EIOS) Efficacy|Completed||Phase 1/Phase 2|243|Actual|Al-Azhar University||1|||f||||t||||||||||2017-10-11 00:41:09.068336|2017-10-11 00:41:09.068336
NCT02082275|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-01-07|||February 2014||2014-02-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||OB Nest; Redefining Continuity of Care for Expectant Mothers|Implementation and Evaluation of the OB Nest Project at the Point of Care: Redefining Continuity of Care for Expectant Mothers.|Completed||N/A|300|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:41:09.205647|2017-10-11 00:41:09.205647
NCT02082262|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-02-11|2015-09-08||March 2014||2014-03-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis||Completed||Phase 3|140|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:41:09.291384|2017-10-11 00:41:09.291384
NCT02082249|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-09-05|||March 10, 2014||2014-03-10|September 2017|2017-09-01|December 27, 2023|Anticipated|2023-12-27|December 27, 2023|Anticipated|2023-12-27||Interventional|||An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications|An Open-Label Three-Part Extension Study Assessing Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications|Active, not recruiting||Phase 3|31|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-11 00:41:09.463606|2017-10-11 00:41:09.463606
NCT02082236|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-10-11|||May 2014||2014-05-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects|Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects|Completed||Phase 1|40|Actual|AcelRx Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 00:41:09.557049|2017-10-11 00:41:09.557049
NCT02082223|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-09-11|||March 2014||2014-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Interventional|iPREHAB||Individualized Preoperative Rehabilitation Pilot|Individualized Preoperative Rehabilitation (iPREHAB) Pilot|Active, not recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:41:09.677682|2017-10-11 00:41:09.677682
NCT02082210|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-07-18|||March 2014||2014-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of LY2875358 in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer|A Phase 1b/2 Study of Ramucirumab in Combination With LY2875358 in Patients With Advanced Cancer|Active, not recruiting||Phase 1/Phase 2|100|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 00:41:09.883476|2017-10-11 00:41:09.883476
NCT02082197|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-05-29|||March 2014||2014-03-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men|A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men|Withdrawn||Phase 3|0|Actual|AbbVie||1||Other - not a safety issue|f||||f||||||||||2017-10-11 00:41:10.038541|2017-10-11 00:41:10.038541
NCT02082184|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-04-28|2017-03-03||March 2014||2014-03-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|REPLACE||An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes|Randomised Controlled Study to Evaluate the Impact of Novel Glucose Sensing Technology on HbA1c in Type 2 Diabetes|Completed||N/A|302|Actual|Abbott Diabetes Care||2|||f||||f||||||||||2017-10-11 00:41:10.233743|2017-10-11 00:41:10.233743
NCT02082171|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-02-05|||October 2013||2013-10-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|MINDED||Multidomain Intervention to Prevent Disability in Elders|Multidomain Intervention to Prevent Disability in Elders|Unknown status|Recruiting|N/A|150|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-11 00:41:10.992559|2017-10-11 00:41:10.992559
NCT02082158|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-10-03|2016-06-07||July 2014||2014-07-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Participants were clinical healthcare workers at local Veterans Affairs Hospital or local University affiliate hospital.|Assessment of Novel Respiratory Protective Devices in Healthcare|Assessment of Novel Respiratory Protective Devices in Healthcare|Completed||N/A|382|Actual|National Center for Occupational Health and Infection Control||6|||f||||f||||||||||2017-10-11 00:41:11.11371|2017-10-11 00:41:11.11371
NCT02082145|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-11-18|||July 2014||2014-07-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|NERVES||Electrical Stimulation in Diabetic Peripheral Neuropathy|Electrical Stimulation in Diabetic Peripheral Neuropathy|Completed||N/A|14|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 00:41:11.664755|2017-10-11 00:41:11.664755
NCT02082132|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-09-07|||October 2013||2013-10-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|MYDIABETES||MODY in Young-onset Diabetes in Different Ethnicities|A Cross-sectional Study of Young-onset Diabetes in Two UK Ethnic Groups.|Recruiting||N/A|916|Anticipated|Imperial College London|||1||f||||f||||||Samples With DNA|"     We will be collecting blood and urine samples for routine diabetes tests as well as more     specialist tests that will help define what type of diabetes is present. We'll also collect     DNA to look for MODY (maturity onset diabetes of the young), the genetic cause of diabetes,     in some people.   "|No||2017-10-11 00:41:11.782638|2017-10-11 00:41:11.782638
NCT02082106|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-04-28|||January 2014||2014-01-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Metabolic and Physiological Stress During Skiing.|Metabolic and Physiological Stress During Alpine Skiing, Cross-country Skiing and Indoor Training in Untrained and Trained Persons.|Completed||N/A|21|Actual|Paracelsus Medical University|||1||f||||f||||||Samples With DNA|"     Blood serum, blood plasma, blood cells   "|||2017-10-11 00:41:12.088174|2017-10-11 00:41:12.088174
NCT02082093|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-04-25|||November 2015|Actual|2015-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|eNephro||Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure|Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure|Recruiting||N/A|850|Anticipated|Pharmagest Interactive||2|||f||||t||||||||No||2017-10-11 00:41:12.19608|2017-10-11 00:41:12.19608
NCT02082080|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2014-03-05|||December 2012||2012-12-01|March 2014|2014-03-01||||June 2013|Actual|2013-06-01||Interventional|||Prevention and Control of Obesity in Primary School Children in Tehran||Unknown status|Active, not recruiting|Phase 4|360|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:41:12.38492|2017-10-11 00:41:12.38492
NCT02082067|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-08-08|||March 2014||2014-03-01|August 2016|2016-08-01|March 2016|Anticipated|2016-03-01|September 2015|Anticipated|2015-09-01||Interventional|||Total Knee Prosthesis With Continuous Block of Adductor Canal and Outcome|Total Knee Arthroplasty & Outcome: A Prospective Randomized Comparison Between Adductor Canal Block and Femoral Nerve Block|Withdrawn||Phase 4|0|Actual|ASST Gaetano Pini-CTO||3|||f||||f||||||||||2017-10-11 00:41:12.478096|2017-10-11 00:41:12.478096
NCT02082054|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-05-28|||March 2014||2014-03-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study|A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older|Unknown status|Active, not recruiting|Phase 2|125|Anticipated|Magna Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-10-11 00:41:12.609851|2017-10-11 00:41:12.609851
NCT02082041|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-09-12|||June 2013||2013-06-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Measurement of Blood Perfusion in Response to Loading in Patients With Wounds||Completed||N/A|41|Actual|Michigan State University|||1||f||||f||||||||||2017-10-11 00:41:12.737229|2017-10-11 00:41:12.737229
NCT02082028|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-05-02|||June 27, 2012|Actual|2012-06-27|May 2017|2017-05-01|July 30, 2015|Actual|2015-07-30|July 30, 2015|Actual|2015-07-30||Interventional|SELF CARE||Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With Insulin|Randomized Clinical Trial on the Efficacy of Self-Monitoring Blood Glucose in the Context of a Chronic Care Model for Type 2 Diabetes Patients Treated With Oral Agents Only|Completed||N/A|241|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:41:12.819504|2017-10-11 00:41:12.819504
NCT02082002|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-12-29|||November 2013||2013-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Multidimensional Assessment of Fatigue in Multiple Sclerosis- Observational Study - Ticino|Multidimensional Assessment of Fatigue in Multiple Sclerosis- Observational Study - Ticino|Recruiting||N/A|100|Anticipated|Ospedale Civico, Lugano|||2||f||||f||||||||No||2017-10-11 00:41:13.112539|2017-10-11 00:41:13.112539
NCT02081989|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-05-30|||November 2015||2015-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Renal Denervation in Diabetes.|Effect of Renal Sympathetic Denervation on Glycemic Status Independent of Blood Pressure-lowering.|Withdrawn||Phase 4|0|Actual|Monash University||2||Unable to commence study due to closure of hospital department.|f||||f||||||||||2017-10-11 00:41:13.247104|2017-10-11 00:41:13.247104
NCT02081976|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-06|||April 2013||2013-04-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Periodontal Therapy in a Primary Prevention of Cardiovascular Disease|A Randomized, Controlled Trial to Study Effects of Periodontal Therapy in Primary Prevention of Cardiovascular Disease.|Completed||Phase 2|57|Actual|Macmillan Research Group UK||2|||f||||t||||||||||2017-10-11 00:41:13.33444|2017-10-11 00:41:13.33444
NCT02081963|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2016-03-28|||March 2014||2014-03-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis|A Randomized, Controlled Study of Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis|Active, not recruiting||Phase 4|150|Anticipated|Qilu Hospital of Shandong University||2|||f||||||||||||||2017-10-11 00:41:13.414533|2017-10-11 00:41:13.414533
NCT02081950|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-04-03|||March 2014||2014-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Single-Dose Study to Examine the Within Subject Variability of Clexane® in Healthy Adult Subjects Under Fasting Conditions|A Single-Dose Study to Examine the Within Subject Variability of Clexane® (80 mg) s.c. in Healthy Adult Subjects Under Fasting Conditions|Completed||Phase 1|14|Actual|Chemi S.p.A.||1|||f||||f||||||||||2017-10-11 00:41:13.51257|2017-10-11 00:41:13.51257
NCT02081937|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2014-03-10|||March 2014||2014-03-01|March 2014|2014-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CART-19 Immunotherapy in Mantle Cell Lymphoma|Anti-CD19 Chimeric Antigen Receptor Modified T Cells Infusion in Mantle Cell Lymphoma|Recruiting||Phase 1/Phase 2|2|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 00:41:13.586016|2017-10-11 00:41:13.586016
NCT02081924|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-08-31|||March 2014||2014-03-01|August 2016|2016-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|KisspeptPump||Reproductive Hormones During Sustained Administration of Kisspeptin|Prospective Placebo-controlled Parallel Design Physiological Study of the Natural Hormone Kisspeptin|Recruiting||Early Phase 1|76|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 00:41:13.68266|2017-10-11 00:41:13.68266
NCT02081911|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-01-29|||February 2014||2014-02-01|January 2015|2015-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Total Knee Arthroplasty Utilizing Adductor Canal Block: Effect on Quadriceps Sparing|Postoperative Pain Management Following Total Knee Arthroplasty Utilizing Adductor Canal Block: Effects on Pain Management and Quadriceps Sparing|Terminated||N/A|33|Actual|Hospital for Special Surgery, New York||3|||f||||f||||||||||2017-10-11 00:41:13.780552|2017-10-11 00:41:13.780552
NCT02081898|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-06|||June 2010||2010-06-01|March 2014|2014-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effects of Long Term Calorie Restriction on Sphingomyelin and Amino Acids|Three-year Mild Calorie Restriction Partially Protects Against Age-related Increase in Sphingomyelin and Reduces Obesity-associated Amino Acids|Completed||Phase 3|120|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:41:13.872873|2017-10-11 00:41:13.872873
NCT02081885|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-03-05|||January 2014||2014-01-01|March 2014|2014-03-01|January 2017|Anticipated|2017-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Tricalcium Phosphate and Chitosan as Bone Regenerator Versus Autologous Graft in Surgery for Mandibular Fracture|Therapeutic Efficacy of Tricalcium Phosphate and Chitosan as Bone Regenerator Versus Autologous Graft in Surgery for Mandibular Fracture|Unknown status|Recruiting|Phase 3|24|Anticipated|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-11 00:41:13.955445|2017-10-11 00:41:13.955445
NCT02081872|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-10-07|||April 2014||2014-04-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01|90 Days|Observational [Patient Registry]|UPGRADE||Utility of PharmacoGenomics for Reducing Adverse Drug Effects|Utility of PharmacoGenomics for Reducing Adverse Drug Effects|Unknown status|Recruiting|N/A|279000|Anticipated|Companion Dx Reference Lab, LLC|||1||f||||f||||||||||2017-10-11 00:41:14.074667|2017-10-11 00:41:14.074667
NCT02081859|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-05-15|2017-02-06||April 2014||2014-04-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|Embryoscope||Use of Time-lapse Morphological Kinetics in the Selection of Blastocysts|Does Use of Time-lapse Morphological Kinetics in the Selection of Blastocysts for Transfer Improve Pregnancy Rates?|Completed||N/A|300|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 00:41:14.280775|2017-10-11 00:41:14.280775
NCT02081846|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-09-28|||February 2, 2015|Actual|2015-02-02|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Hospital to Home Outcomes|Hospital to Home Outcomes (H2O): A Study to Improve the Fluidity of Transitions Between Hospital and Home|Completed||N/A|1500|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 00:41:14.701627|2017-10-11 00:41:14.701627
NCT02081833|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-01-11|||November 2013||2013-11-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||The Investigation of Methods to Capture Acute Respiratory and Gastrointestinal Infections of Children Aged 1 to 3 Years|The Investigation of Methods to Capture Acute Respiratory and Gastrointestinal Infections of Children Aged 1 to 3 Years. Feasibility Study for the Braunschweig Birth Cohort LöwenKIDS (Infections and the Development of the Immune System)|Completed||N/A|75|Actual|Helmholtz Centre for Infection Research|||1||f||||t||||||Samples With DNA|"     Parent-collected anterior-nasal swabs and stool samples   "|||2017-10-11 00:41:14.813763|2017-10-11 00:41:14.813763
NCT02081820|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-03-17|||July 2012||2012-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|6 Months|Observational [Patient Registry]|||Admission HbA1C in Aneurysmal Subarachnoid Hemorrhage|Observational Study on the Prognostic Relevance of Admission Glycated Hemoglobin (HbA1C) in Patients With Aneurysmal Subarachnoid Hemorrhage|Completed||N/A|89|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 00:41:14.912991|2017-10-11 00:41:14.912991
NCT02081807|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2017-10-03|||March 7, 2014|Actual|2014-03-07|October 2017|2017-10-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Observational|||Sequential Expansion of Comparative Effectiveness of Anticoagulants|Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study|Recruiting||N/A|99999|Anticipated|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 00:41:15.008824|2017-10-11 00:41:15.008824
NCT02081794|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-10-27|||February 2014||2014-02-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients|Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients: A Pilot Study|Completed||N/A|91|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:41:15.137639|2017-10-11 00:41:15.137639
NCT02081781|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-05|||February 2014||2014-02-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||The Factors That Affected the Outcome of Treatment of Congenital Nasolacrimal Duct Obstruction|Case Control Study of the Factors That Affected the Outcome of Treatment of Congenital Nasolacrimal Duct Obstruction|Completed||N/A|800|Actual|Cathay General Hospital|||1||f||||f||||||||||2017-10-11 00:41:15.246583|2017-10-11 00:41:15.246583
NCT02081768|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-04-19|||June 2014||2014-06-01|April 2017|2017-04-01|June 2025|Anticipated|2025-06-01|June 2024|Anticipated|2024-06-01||Interventional|||90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors|Assessment of the Efficacy of Stereotactic Intracavitary Instillation of 90yttrium Colloid for Treatment of Cystic Lesions of the Pituitary and Surrounding Areas (Sellar/Parasellar Region)|Recruiting||Phase 3|40|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 00:41:15.334185|2017-10-11 00:41:15.334185
NCT02081755|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-02-14|||March 2014||2014-03-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer|A 36 Month Multi-center, Open Label, Randomized, Comparator Study to Evaluate the Efficacy and Safety of Everolimus Immunosuppression Treatment in Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria|Recruiting||Phase 4|336|Anticipated|Baylor Research Institute||2|||f||||t||||||||No||2017-10-11 00:41:15.43808|2017-10-11 00:41:15.43808
NCT02081742|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-08-09|||February 2013|Actual|2013-02-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01|1 Day|Observational [Patient Registry]|VICOCA||Comparative Study of Colon Capsule and Virtual Colonoscopy (VICOCA)|COMPARATIVE STUDY OF THE EFFICACY OF TWO NON-INVASIVE IMAGING TECHNIQUES IN POPULATION SCREENING FOR COLORECTAL CANCER (CRC): COLON CAPSULE AND VIRTUAL COLONOSCOPY|Completed||N/A|349|Actual|Hospital Clinic of Barcelona|||1||f||||t||||||||||2017-10-11 00:41:15.604581|2017-10-11 00:41:15.604581
NCT02081729|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-05|||March 2014||2014-03-01|March 2014|2014-03-01|February 2015|Anticipated|2015-02-01|August 2014|Anticipated|2014-08-01||Observational|||Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)|Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)|Unknown status|Recruiting|N/A|181|Anticipated|Asan Medical Center|||2||f||||f||||||||||2017-10-11 00:41:15.679588|2017-10-11 00:41:15.679588
NCT02081716|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-11-17|||March 2014||2014-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT)|Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT)|Completed||N/A|88|Actual|Asan Medical Center|||2||f||||f||||||||||2017-10-11 00:41:15.772149|2017-10-11 00:41:15.772149
NCT02081703|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-07-14||2015-07-14|May 2014||2014-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery|A Phase 2 Study to Evaluate the Safety & Efficacy of Two Dose/Volume Levels of a Single Intrathecal Preoperative Administration of AYX1 Injection in Patients Undergoing Unilateral Total Knee Arthroplasty|Completed||Phase 2|120|Actual|Adynxx, Inc.||4|||f||||t||||||||||2017-10-11 00:41:15.872542|2017-10-11 00:41:15.872542
NCT02081677|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-07-19|2017-06-16||February 6, 2014|Actual|2014-02-06|July 2017|2017-07-01|June 25, 2014|Actual|2014-06-25|June 25, 2014|Actual|2014-06-25||Interventional||All subjects that were enrolled into the study lens.|One Month Daily Wear Clinical Evaluation of New Prototype Contact Lenses in Habitual and Neophyte Contact Lens Wearers|One Month Daily Wear Clinical Evaluation of Three Prototype Soft Contact Lenses in a Population of Habitual and Neophyte Contact Lens Wearers|Completed||N/A|80|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||f|f|t|f|f|t|||||2017-10-11 00:41:16.189326|2017-10-11 00:41:16.189326
NCT02081664|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-06-09|||January 2014||2014-01-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|IMCR||Feasibility of an Integrated Medical Care Program for Patients With Continuing Health Complaints After Amalgam Removal|Development and Feasibility Assessment of an Integrated Medical Care Rehabilitation Program for Patients With Continuing Health Complaints After Amalgam Removal - The IMCR Trial|Completed||N/A|21|Actual|University of Tromso||1|||f||||f||||||||||2017-10-11 00:41:17.394027|2017-10-11 00:41:17.394027
NCT02081651|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-05|||March 2014||2014-03-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Parmigiano-Reggiano Cheese as a Possible Strategy to Acquire Oral Tolerance in Children With Cow's Milk Allergy|Parmigiano-Reggiano Cheese as a Possible Strategy of Immunonutrition Able to Stimulate the Acquisition of Oral Tolerance in Childre With Cow's Milk Allergy|Unknown status|Not yet recruiting|Phase 3|90|Anticipated|Federico II University||2|||f||||||||||||||2017-10-11 00:41:17.493099|2017-10-11 00:41:17.493099
NCT02081638|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-08-19|||December 19, 2013||2013-12-19|August 18, 2017|2017-08-18|November 30, 2019|Anticipated|2019-11-30|November 30, 2019|Anticipated|2019-11-30||Interventional|||Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study|Elite Controller and ART-Treated HIV+ Statin Versus ASA Treatment Intervention Study|Recruiting||Phase 2|120|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:41:17.582377|2017-10-11 00:41:17.582377
NCT02081625|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-11-13|||June 2013||2013-06-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|November 2014|Anticipated|2014-11-01||Interventional|||Exploratory Study of NS-065/NCNP-01 in DMD|Exploratory Study of NS-065/NCNP-01 in Duchenne Muscular Dystrophy|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|National Center of Neurology and Psychiatry, Japan||1|||f||||f||||||||||2017-10-11 00:41:17.72276|2017-10-11 00:41:17.72276
NCT02081612|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-07-19|||September 2014||2014-09-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Nutrition Education Alone or With Acupuncture for Weight Loss in Breast Cancer Patients Post-Chemotherapy|Comparison of Weight Loss Among Early Stage Breast Cancer Patients Post Chemotherapy: Nutrition Education in Combination With Weight Loss Acupuncture Vs. Nutrition Education Alone|Recruiting||N/A|40|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 00:41:17.815392|2017-10-11 00:41:17.815392
NCT02080676|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-10-13|||March 2014||2014-03-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Observational|||Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow|Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow|Unknown status|Recruiting|N/A|100|Anticipated|Carmel Medical Center|||1||f||||f||||||||||2017-10-11 00:41:31.015909|2017-10-11 00:41:31.015909
NCT02081599|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-08-21|2016-11-03||January 2014||2014-01-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes|A Phase IV Study of Teneligliptin (MP-513) in Combination With Insulin in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|148|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 00:41:17.903526|2017-10-11 00:41:17.903526
NCT02081586|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-05-12|2016-04-22||May 2013||2013-05-01|May 2017|2017-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study|mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study|Completed||N/A|13|Actual|University of Pittsburgh|Pilot study with limited sample size|4|||f||||f||||||||No||2017-10-11 00:41:18.448421|2017-10-11 00:41:18.448421
NCT02081560|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-06|||November 2013||2013-11-01|March 2014|2014-03-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Colistin Pharmacokinetics in Continuous Renal Replacement Therapy|Colistimethate and Colistin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy (CRRT)|Unknown status|Recruiting|Phase 4|10|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-11 00:41:19.242836|2017-10-11 00:41:19.242836
NCT02081547|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2014-03-05|||April 2012||2012-04-01|March 2014|2014-03-01|September 2014|Anticipated|2014-09-01|March 2014|Anticipated|2014-03-01||Observational|||IPC Status as a Surgical Quality Marker in Rectal Cancer Surgery|IPC Status as a Surgical Quality Marker in Rectal Cancer Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Uppsala University|||1||f||||f||||||Samples With DNA|"     250 ml NaCl is poured in the abdominal cavity 3 times during the operation and is collected     for accurence of cancer cells with Haemathoxylin&Eosin staining and immunohistochemistry. DNA     sequencing is not performed.   "|||2017-10-11 00:41:19.360272|2017-10-11 00:41:19.360272
NCT02081534|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-06|2015-09-18|||March 2014||2014-03-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Dose Finding Study to Treat High Phosphate Levels in the Blood.|A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)|Completed||Phase 2|597|Actual|Ardelyx||7|||f||||f||||||||||2017-10-11 00:41:19.466109|2017-10-11 00:41:19.466109
NCT02081521|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-03-10|||January 2014||2014-01-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluation of a Multiple Behaviour Programme for Diarrhoea Management|Evaluation of a Multiple Behaviour Programme to Prevent and Manage Diarrhoea Among Children Under-five in Lusaka, Zambia|Completed||N/A|640|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 00:41:19.662727|2017-10-11 00:41:19.662727
NCT02081508|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-07-28|||March 2014||2014-03-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Consolidation & Interference in Multiple Sclerosis|Consolidation & Interference in Multiple Sclerosis|Completed||N/A|39|Actual|Kessler Foundation||4|||f||||f||||||||||2017-10-11 00:41:19.774357|2017-10-11 00:41:19.774357
NCT02081495|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-11-10|||August 2014||2014-08-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer|A Pivotal Bioequivalence Study of DOXIL®/CAELYX® Manufactured at a New Site in Subjects With Advanced or Refractory Solid Malignancies Including Subjects With Ovarian Cancer|Completed||Phase 1|35|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:41:19.858699|2017-10-11 00:41:19.858699
NCT02081482|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-03-18|||March 2014||2014-03-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|July 2015|Actual|2015-07-01||Interventional|MET-ONS||Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation|Study of the Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation|Active, not recruiting||N/A|20|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:41:19.973524|2017-10-11 00:41:19.973524
NCT02081469|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-08|||March 2014||2014-03-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy|Phase IV; Different Extend Treatment Duration (6 Months vs 12 Months After Chemotherapy) to Prevent HBV Relapse With Tenofovir for Prophylaxis in Patients With Malignant Tumor Combined With HBV Carrier Receiving Chemotherapy|Unknown status|Recruiting|Phase 4|120|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:41:20.099354|2017-10-11 00:41:20.099354
NCT02081443|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-03-03|2017-01-12||April 2014||2014-04-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients|In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor Mediated Signaling in Ticagrelor Treated Patients|Completed||N/A|60|Actual|University of Florida||2|||f||||t||||||||No||2017-10-11 00:41:20.270321|2017-10-11 00:41:20.270321
NCT02081430|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-11-03|||May 2013||2013-05-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Immediate Effects of Manipulation Versus Stretching on Upper Trapezius Pressure Pain Thresholds|The Immediate Effects of Cervicothoracic Manipulation vs. Stretching on Upper Trapezius Pressure Pain Thresholds and Cervical Spine Range of Motion|Completed||N/A|90|Actual|University of Nevada, Las Vegas||3|||f||||t||||||||||2017-10-11 00:41:20.60003|2017-10-11 00:41:20.60003
NCT02081404|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2017-05-24|||March 2011||2011-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study|Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study|Recruiting||N/A|126|Anticipated|Midwest Biomedical Research Foundation||2|||f||||t||||||||Yes|Participants individual participant data collected in the study will be available to other researchers upon request. Participants will be identified by participant number, age, race and gender. This information will be available at the end of the study and may be requested via email to april.higbee@va.gov.|2017-10-11 00:41:20.779131|2017-10-11 00:41:20.779131
NCT02081391|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-01-12|||January 2015||2015-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Efficacy and Safety Study of Tapentadol in the Treatment of Post-operative Acute Pain Requiring Opioid Treatment in Pediatric Participants|An Evaluation of the Efficacy and Safety of Tapentadol Oral Solution in the Treatment of Post-operative Acute Pain Requiring Opioid Treatment in Pediatric Subjects Aged From Birth to Less Than 18 Years Old|Suspended||Phase 3|200|Anticipated|Grünenthal GmbH||2||"Recruitment is closed for subjects aged 6 months and older. Younger subjects are recruited once   a respective medication dose has been implemented in the trial."|f||||t||||||||||2017-10-11 00:41:20.923261|2017-10-11 00:41:20.923261
NCT02081365|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-12-02|2016-02-17||July 2013||2013-07-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Patients were between 18 and 70 years, fluent in English, had scheduled a dental treatment appointment at the clinic, were willing and able to give informed written consent, met criteria for high dental anxiety based on the Modified Dental Anxiety Scale, and endorsed at least some oral-health related impairment.|Clinical Management of Anxiety and Access to Health Care|Clinical Management of Anxiety and Access to Health Care|Completed||N/A|151|Actual|Temple University||2|||f||||t||||||||No||2017-10-11 00:41:21.35959|2017-10-11 00:41:21.35959
NCT02081352|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-11-04|||August 2014||2014-08-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|||A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers|"Phase IV Prospective, Multi-Center, Randomized, Single-Blind, Active and Standard Care-Controlled Study of DermaPure™ in Patients With Hard to Heal Chronic, Neuropathic Diabetic Foot Ulcers With Crossover Design for Standard Care Arm"|Recruiting||Phase 4|50|Anticipated|TRx Wound Care Limited||2|||f||||f||||||||||2017-10-11 00:41:21.855785|2017-10-11 00:41:21.855785
NCT02081339|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-09-22|||March 2014||2014-03-01|September 2016|2016-09-01|March 2024|Anticipated|2024-03-01|March 2022|Anticipated|2022-03-01|5 Years|Observational [Patient Registry]|||Cohort Study of the Clinical Course of Macular Diseases in Japanese|Cohort Study of the Clinical Course of Macular Diseases in Japanese Patients|Recruiting||N/A|1000|Anticipated|Kyoto University, Graduate School of Medicine|||1||f||||f||||||||||2017-10-11 00:41:21.972765|2017-10-11 00:41:21.972765
NCT02081326|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-03-21|||June 2015||2015-06-01|March 2017|2017-03-01|July 2023|Anticipated|2023-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes|Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes|Recruiting||Phase 2|150|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:41:22.059822|2017-10-11 00:41:22.059822
NCT02081313|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-02-03|||April 2014||2014-04-01|February 2015|2015-02-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|NSnatbio||Natural History and Biological Study of Netherton Syndrome|Syndrome de Netherton : Aspects Cliniques, Physiopathologiques et Identification de Cibles thérapeutiques|Recruiting||N/A|30|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-11 00:41:22.159935|2017-10-11 00:41:22.159935
NCT02081300|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-07-10|||February 2014||2014-02-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SOAR||Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism|Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men|Completed||Phase 3|315|Actual|Lipocine Inc.||2|||f||||f||||||||||2017-10-11 00:41:22.375168|2017-10-11 00:41:22.375168
NCT02081287|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-11-19|||May 2014||2014-05-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?|Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?|Recruiting||Phase 1|30|Anticipated|San Diego Veterans Healthcare System||2|||f||||f||||||||||2017-10-11 00:41:22.492028|2017-10-11 00:41:22.492028
NCT02081274|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Influence of Tidal Volume During Mechanical Ventilation on Postoperative Clinical Outcome in Pediatric Patients Undergoing Congenital Heart Surgery|Influence of Tidal Volume During Mechanical Ventilation on Postoperative Clinical Outcome in Pediatric Patients Undergoing Congenital Heart Surgery|Completed||N/A|1000|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:41:22.617403|2017-10-11 00:41:22.617403
NCT02081261|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-06-14|||January 2014||2014-01-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Predicting Acute Kidney Injury After Coronary Artery Bypass Graft|Predicting Acute Kidney Injury After Coronary Artery Bypass Graft : a Simplified Clinical Risk Scoring Model|Completed||N/A|877|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:41:22.720691|2017-10-11 00:41:22.720691
NCT02081248|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-09-27|||December 2013|Actual|2013-12-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)|Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN #1205)|Active, not recruiting||N/A|198|Actual|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-11 00:41:22.837211|2017-10-11 00:41:22.837211
NCT02080650|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-07-31|||March 2014||2014-03-01|July 2017|2017-07-01|July 19, 2016|Actual|2016-07-19|May 19, 2016|Actual|2016-05-19||Interventional|||Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)|Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)|Completed||N/A|62|Actual|Duke University||8|||f||||f||||||||||2017-10-11 00:41:31.196782|2017-10-11 00:41:31.196782
NCT02081235|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-06-14|||June 2014||2014-06-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Incidence, Risk Factors, and Risk Model of Acute Kidney Injury in Pediatric Patients Who Undergoing Surgery for Congenital Heart Disease|Incidence, Risk Factors, and Risk Model of Acute Kidney Injury in Pediatric Patients Who Undergoing Surgery for Congenital Heart Disease|Completed||N/A|220|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:41:22.9902|2017-10-11 00:41:22.9902
NCT02081222|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-11-10|||January 2014||2014-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||The Predictability of Intraoperative Rotational Thromboelastometry on Postoperative Bleeding and Transfusion Requirements|The Predictability of Intraoperative Rotational Thromboelastometry on Postoperative Bleeding and Transfusion Requirements|Completed||N/A|119|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:41:23.089038|2017-10-11 00:41:23.089038
NCT02081209|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-06-20|||February 2014|Actual|2014-02-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Outer Thigh Study With Varied Treatment Parameters|Non-Invasive Fat Layer Reduction in the Lateral Thighs With a Cryolipolysis System Using Varied Treatment Parameters|Completed||N/A|40|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 00:41:23.165428|2017-10-11 00:41:23.165428
NCT02081196|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-06-20|||February 2014|Actual|2014-02-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Colder Flank Study|Non-Invasive Reduction of Subcutaneous Fat Layer With an Alternative Treatment Parameter|Completed||N/A|45|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 00:41:23.255997|2017-10-11 00:41:23.255997
NCT02081183|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-06-17|2014-06-17||March 2006||2006-03-01|June 2014|2014-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||No baseline analysis was performed because the study was terminated early.|A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis|A Study to Evaluate the Efficacy of CellCept, Administered in a Sequential Treatment Scheme, in Delaying Progressive Renal Damage in Patients With Lupus Nephritis|Terminated||Phase 3|16|Actual|Hoffmann-La Roche|Data were not analyzed because the study was terminated early.|2|||f||||||||||||||2017-10-11 00:41:23.346409|2017-10-11 00:41:23.346409
NCT02081170|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-06|||December 2013||2013-12-01|March 2014|2014-03-01||||December 2014|Anticipated|2014-12-01||Interventional|||The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes||Unknown status|Recruiting|N/A|16|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-11 00:41:23.732866|2017-10-11 00:41:23.732866
NCT02081157|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-03-02|||July 2012||2012-07-01|March 2017|2017-03-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Use of GalaFlex in Ptotic Breast|Use of GalaFlex in Ptotic Breast|Active, not recruiting||N/A|100|Anticipated|Galatea, Corp||1|||f||||f||||||||Undecided||2017-10-11 00:41:23.914868|2017-10-11 00:41:23.914868
NCT02081144|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-01-20|||May 2014||2014-05-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study|Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study|Completed||Phase 1|60|Actual|Yale University||2|||f||||f||||||||||2017-10-11 00:41:24.031369|2017-10-11 00:41:24.031369
NCT02081131|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-09-14|||September 2013||2013-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PLOT||Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)|A Prospective Randomized Controlled Trial Comparing Laparoscopic Versus Open Pancreatoduodenectomy for Malignant Periampullary and Pancreatic Head Lesions|Completed||N/A|64|Actual|GEM Hospital & Research Center||2|||f||||t||||||||||2017-10-11 00:41:24.177175|2017-10-11 00:41:24.177175
NCT02081118|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-08-08||2016-08-08|February 2014||2014-02-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes|A Phase II, 16-week, Double-blind, Placebo-controlled, Parallel-group, Randomised, Multicentre Trial to Assess Effect on Glycaemic Control of Three Doses of HM11260C in Subjects With Inadequately Controlled Type 2 Diabetes Receiving a Stable Dose of Metformin|Completed||Phase 2|209|Actual|Hanmi Pharmaceutical Company Limited||4|||f||||f||||||||||2017-10-11 00:41:24.337231|2017-10-11 00:41:24.337231
NCT02081105|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-01-17|||February 2014||2014-02-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|January 2017|Actual|2017-01-01||Interventional|RECRUTEX||Validation of Digital Chest-X-ray (CXR) to Assess Lung Recruitment in ARDS|Bedside Assessment of PEEP-induced Lung Recruitment by Using Digital Chest-X-ray in ARDS Patients. A Multicenter Prospective Study.|Terminated||N/A|38|Actual|Hospices Civils de Lyon||2||The study stopped because it was difficult to recruit the 130 expected patients|f||||f||||||||||2017-10-11 00:41:24.497115|2017-10-11 00:41:24.497115
NCT02081092|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-01-30|||December 2013||2013-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|PAP||Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT|Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT|Recruiting||N/A|15|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 00:41:24.606519|2017-10-11 00:41:24.606519
NCT02081079|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-04-28|2015-12-10|2015-10-21|March 2014||2014-03-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional||Safety Analysis Set: participants were enrolled and received at least 1 dose of study drug|Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection|A Phase 2, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection|Completed||Phase 2|85|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||f||||||||||2017-10-11 00:41:24.732725|2017-10-11 00:41:24.732725
NCT02081066|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-02-24|||September 2014||2014-09-01|February 2016|2016-02-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|CETP-ATHERO||Identification of CETP as a Marker of Atherosclerosis|Relationship Between Endogenous CETP Activity and Atherosclerosis Distribution in Patients With High Cardiovascular Risk|Recruiting||N/A|1800|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 00:41:25.526412|2017-10-11 00:41:25.526412
NCT02080052|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-04-12|||August 2012||2012-08-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Robot-Assisted MRI-Guided Prostate Biopsy||Completed||N/A|5|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:41:41.3944|2017-10-11 00:41:41.3944
NCT02081053|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-01-18|||January 2014||2014-01-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|EU-STAR||Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors|A Prospective, Multicenter Clinical Study to Evaluate the Clinical Outcomes of Targeted Radiofrequency Ablation and Vertebral Augmentation to Treat Painful Metastatic Vertebral Body Tumor(s)|Terminated||N/A|30|Actual|Merit Medical Systems, Inc.||1||Difficulty Enrolling|f||||f||||||||||2017-10-11 00:41:25.63575|2017-10-11 00:41:25.63575
NCT02081040|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-02-22|||September 2013||2013-09-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Observational|||Coughing in Infratentorial Brain Lesion Patients|Cross Sectional Observation Study of Cough Dysfunction in Infratentorial Brain Lesion Patients, as Assessed by M-mode Sonography|Completed||N/A|42|Actual|The Catholic University of Korea|||3||f||||f||||||||||2017-10-11 00:41:25.741307|2017-10-11 00:41:25.741307
NCT02081027|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-04-17|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders|A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders|Completed||Phase 2/Phase 3|8|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 00:41:25.841793|2017-10-11 00:41:25.841793
NCT02081014|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-05-16|2016-04-08||March 2014||2014-03-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||All randomized subjects who received at least one dose of study drug|Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes|A Randomized, Phase 2a, Blinded, 3-Way Crossover Dose-Ranging Study With G-Pen Mini™ (Glucagon Injection) to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Type 1 Diabetes Mellitus (T1DM)|Completed||Phase 2|13|Actual|Xeris Pharmaceuticals||3|||f||||f||||||||||2017-10-11 00:41:25.961669|2017-10-11 00:41:25.961669
NCT02081001|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-06-21|2016-05-13||March 2014||2014-03-01|June 2016|2016-06-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional||All randomized subjects|PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients|Comparison of Pharmacokinetic and Pharmacodynamic Profiles of G-Pump™ (Glucagon Infusion) vs. GlucaGen® Delivered Subcutaneously to Subjects With Type 1 Diabetes (T1DM)|Completed||Phase 2|19|Actual|Xeris Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:41:26.825473|2017-10-11 00:41:26.825473
NCT02080988|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-11-03|||October 2013||2013-10-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Reflexive Coughing Force in Severe Aspirators|Cross Sectional Evaluation of Coughing Force in Stroke Patients With Severe Aspiration|Completed||N/A|20|Actual|The Catholic University of Korea|||2||f||||f||||||||||2017-10-11 00:41:27.776137|2017-10-11 00:41:27.776137
NCT02080975|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-03-21|||March 2014||2014-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IN-CONTACT||Determination of Catheter Contact by Evaluation of Microelectrode Near-Field Signals|Determination of Catheter Contact by Evaluation of Microelectrode Near-Field Signals|Completed||N/A|20|Actual|Emory University||1|||f||||t||||||||No||2017-10-11 00:41:27.983916|2017-10-11 00:41:27.983916
NCT02080962|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-03-05|||January 2011||2011-01-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer|Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer: Study Phase II Clinical Trial|Terminated||Phase 2|10|Actual|Barretos Cancer Hospital||2||Low rate of recruitment.|f||||t||||||||||2017-10-11 00:41:28.094927|2017-10-11 00:41:28.094927
NCT02080949|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2014-03-05|||January 2011||2011-01-01|March 2014|2014-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases|Study Phase I Dose Escalation With Hypofractionated Stereotactic Radiotherapy in Patients With 1-3 Unresectable Brain Metastases|Withdrawn||Phase 1|0|Actual|Barretos Cancer Hospital||1||Low rate of recruitment.|f||||t||||||||||2017-10-11 00:41:28.25053|2017-10-11 00:41:28.25053
NCT02080936|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-06|||January 2014||2014-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|M2W||Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD|Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD|Completed||N/A|138|Actual|5 Santé|||1||f||||f||||||||||2017-10-11 00:41:28.381841|2017-10-11 00:41:28.381841
NCT02080923|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-06-19|||April 2014|Actual|2014-04-01|June 2017|2017-06-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Interventional|PLR||A Brief Intervention to Prevent Adolescent Dating Aggression Perpetration|A Brief Intervention to Prevent Adolescent Dating Aggression Perpetration|Completed||N/A|220|Actual|Boston University||2|||f||||t|f|f||||||No||2017-10-11 00:41:28.460022|2017-10-11 00:41:28.460022
NCT02080910|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-07-30|||June 2012||2012-06-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Psychoeducational Intervention for Stroke Family Caregivers|The Effects of a Psychoeducational Intervention on Stroke Family Caregiver Outcomes and the Use of Health and Social Services Among Stroke Survivors: A Randomized Controlled Trial|Completed||N/A|128|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:41:28.576463|2017-10-11 00:41:28.576463
NCT02080897|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-05-30|||March 2014||2014-03-01|May 2017|2017-05-01|September 2023|Anticipated|2023-09-01|September 2018|Anticipated|2018-09-01||Observational|||Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease|Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease Using the ESAS-Sarcoma Modified Questionnaire|Recruiting||N/A|100|Anticipated|Duke University|||2||f||||t||||||||||2017-10-11 00:41:28.686765|2017-10-11 00:41:28.686765
NCT02080884|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2017-05-30|||June 24, 2014|Actual|2014-06-24|May 2017|2017-05-01|December 19, 2016|Actual|2016-12-19|December 19, 2016|Actual|2016-12-19||Observational|||An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia|A MULTICENTER NON-INTERVENTIONAL STUDY EVALUATING THE BENEFIT OF THE COMBINATION OF MABTHERA (RITUXIMAB) WITH STANDARD CHEMOTHERAPEUTIC REGIMENS IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA IN HUNGARY|Completed||N/A|150|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:41:28.783315|2017-10-11 00:41:28.783315
NCT02080663|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-06|||March 2014||2014-03-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Observational|||Long-term Outcome of Proximal Row Carpectomy. Influence of the Shape of the Capitate|Long-term Outcome of Proximal Row Carpectomy. Influence of the Shape of the Capitate|Unknown status|Enrolling by invitation|N/A|60|Anticipated|University Hospital Pellenberg|||1||f||||f||||||||||2017-10-11 00:41:31.10643|2017-10-11 00:41:31.10643
NCT02080858|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2015-04-06|||May 2014||2014-05-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||Triple vs. Dual Therapy|The Effect of Ticagrelor and Apixaban With or Without Acetylsalicylic Acid on Markers of Coagulation Activation at the Site of Thrombus Formation in Vivo in Healthy Male Subjects and in an ex Vivo Perfusion Chamber Model at High and Low Shear Rate|Completed||Phase 1|40|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 00:41:29.18077|2017-10-11 00:41:29.18077
NCT02080845|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-03-06|||March 2014||2014-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Effects of a Cocoa Shot on the Human Brain 2|Effects of a Cocoa Shot on the Human Brain 2|Completed||Phase 1|24|Actual|Wake Forest University Health Sciences||4|||f||||f||||||||||2017-10-11 00:41:29.322949|2017-10-11 00:41:29.322949
NCT02080819|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-09-26|||February 2014||2014-02-01|September 2017|2017-09-01|January 21, 2017|Actual|2017-01-21|January 21, 2017|Actual|2017-01-21||Interventional|||Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse|Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse|Completed||Phase 2|131|Actual|Virginia Commonwealth University||3|||f||||t||||||||||2017-10-11 00:41:29.598828|2017-10-11 00:41:29.598828
NCT02080806|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-12-23|||October 2013||2013-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Pilot Study of Efficacy of Mechanical Insufflation Exsufflation in Stroke|Effects of Mechanical Insufflation-exsufflation in Stroke Patients With Dysphagia - Pilot Study|Completed||N/A|12|Anticipated|The Catholic University of Korea||1|||f||||t||||||||||2017-10-11 00:41:29.720216|2017-10-11 00:41:29.720216
NCT02080793|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-05|||May 2013||2013-05-01|February 2014|2014-02-01||||May 2017|Anticipated|2017-05-01||Interventional|CALIPSO||STUDY OF PREFERENCES IN MEN FACED WITH THE DIFFERENT TREATMENT OPTIONS FOR LOCALIZED PROSTRATE CANCER WITH A GOOD OR INTERMEDIATE PROGNOSIS|STUDY OF PREFERENCES IN MEN FACED WITH THE DIFFERENT TREATMENT OPTIONS FOR LOCALIZED PROSTRATE CANCER WITH A GOOD OR INTERMEDIATE PROGNOSIS|Unknown status|Recruiting|N/A|680|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:41:29.831217|2017-10-11 00:41:29.831217
NCT02080780|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-07|2014-03-07||September 2013||2013-09-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects|Phase 1, Open-label, Drug-drug Interaction Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects|Completed||Phase 1|24|Actual|Ventrus Biosciences, Inc||1|||f||||f||||||||||2017-10-11 00:41:29.942801|2017-10-11 00:41:29.942801
NCT02080767|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-11-10||||||August 2016|2016-08-01||||||||Expanded Access|||Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure|Clinical Protocol to Treat Individuals With Tecovirimat (ST-246) After Exposure to Orthopox Viruses|Available||N/A|||U.S. Army Medical Research and Materiel Command|||||||||||||||||||2017-10-11 00:41:30.192856|2017-10-11 00:41:30.192856
NCT02080754|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-09-28|||January 2014||2014-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|IRIS||Sellick Interest in Rapid Sequence Induction|Sellick Maneuver Evaluation in Rapid Sequence Induction of General Anesthesia Non Inferiority Trial|Recruiting||Phase 3|3500|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 00:41:30.302776|2017-10-11 00:41:30.302776
NCT02080741|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-12-03|||September 2014||2014-09-01|June 2014|2014-06-01||||February 2016|Anticipated|2016-02-01||Interventional|Diatolepsy||Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile|Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:41:30.433447|2017-10-11 00:41:30.433447
NCT02080728|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2014-03-05||||||April 2013|2013-04-01||||September 2014|Anticipated|2014-09-01||Interventional|||Transversus Abdominis Plane Block During Kidney Transplant Surgery|Transversus Abdominis Plane Block During Kidney Transplant Surgery: Prospective Controlled Randomized Double-blind Trial Comparing Ropivacaine 0.2% With Placebo.|Unknown status|Recruiting|Phase 4|50|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:41:30.512872|2017-10-11 00:41:30.512872
NCT02080715|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-09-11|||June 2013||2013-06-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance|A Randomized, Double-blind, Placebo-controlled Examination of the Effects of Tolcapone (TASMAR) on Vigilance in Healthy Volunteers After Sleep Deprivation|Completed||Phase 1|30|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 00:41:30.599574|2017-10-11 00:41:30.599574
NCT02080702|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-05|2016-07-12|||August 2014||2014-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|PROMEGAT||An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract|An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract.|Terminated||N/A|106|Actual|Aesculap AG|||1|Planned recruitment of 630 patients was not possible to achieve within the given time frame|f||||f||||||||No||2017-10-11 00:41:30.702965|2017-10-11 00:41:30.702965
NCT02080689|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-02-24|||May 2014||2014-05-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|PRO-IMPACT||Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery|PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]|Completed||N/A|286|Actual|GenomeDx Biosciences Corp||2|||f||||f||||||||||2017-10-11 00:41:30.849038|2017-10-11 00:41:30.849038
NCT02080637|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-05-02|||July 2015||2015-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Ambrisentan in Single Ventricle|Safety, Pharmacokinetics (PK) and Hemodynamic Effects of Ambrisentan in Single Ventricle Pediatric Patients|Recruiting||Phase 2|20|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 00:41:31.329548|2017-10-11 00:41:31.329548
NCT02080624|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-03-04|||January 2011||2011-01-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|RSW||Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome|Phase II, Randomized, Triple Blind, Intra-individually Placebo-controlled Clinical Trial to Assess the Efficacy and Safety of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome.|Completed||Phase 2|23|Actual|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||||2017-10-11 00:41:31.446433|2017-10-11 00:41:31.446433
NCT02080611|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-03-04|||January 2015||2015-01-01|March 2014|2014-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Smart Textile Technology for Scoliosis|Smart Textile Technology for Scoliosis: Aim 1|Unknown status|Not yet recruiting|N/A|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:41:31.561477|2017-10-11 00:41:31.561477
NCT02080598|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-11-18|||April 2014||2014-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Cigarette and Gastric Contents||Completed||N/A|20|Actual|Hôpital Edouard Herriot||2|||f||||||||||||||2017-10-11 00:41:31.639387|2017-10-11 00:41:31.639387
NCT02080585|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-05|||May 2012||2012-05-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Effectiveness of a Web-based, Computer-tailored, Pedometer-based Physical Activity Intervention for Adults: a Cluster-randomized Controlled Trial|Effectiveness of a Web-based, Computer-tailored, Pedometer-based Physical Activity Intervention for Adults: a Cluster-randomized Controlled Trial|Completed||N/A|274|Actual|University Ghent||2|||f||||f||||||||||2017-10-11 00:41:31.716176|2017-10-11 00:41:31.716176
NCT02080572|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-02-04|||February 2014||2014-02-01|February 2015|2015-02-01||||December 2014|Actual|2014-12-01||Observational|||Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS||Completed||N/A|22|Actual|Great Lakes NeuroTechnologies Inc.|||1||f||||f||||||||||2017-10-11 00:41:31.83393|2017-10-11 00:41:31.83393
NCT02080559|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-03-28|||July 2014||2014-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Investigating the Immune Response to 4CMenB in Infants|A Randomised, Descriptive, Open Label, Study Exploring the Relationship Between Gene Expression Signatures With Reactogenicity and Immunogenicity Following Vaccination With Serogroup B Meningococcal Vaccine (4CMenB)|Active, not recruiting||Phase 4|160|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-11 00:41:31.917806|2017-10-11 00:41:31.917806
NCT02080546|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-04-28|2016-01-22||December 2009||2009-12-01|January 2016|2016-01-01||||February 2014|Actual|2014-02-01||Interventional|||Vaginal Cuff Dehiscence and Thermal Injury During TLH|Vaginal Cuff Dehiscence and Thermal Injury at the Time of Total Laparoscopic Hysterectomy: A Review of the Duke Experience and Randomized Controlled Trial|Completed||N/A|120|Actual|Duke University||2|||f||||||||||||||2017-10-11 00:41:32.015564|2017-10-11 00:41:32.015564
NCT02080533|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-08-29|||February 2014||2014-02-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|||Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension|Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension|Completed||Phase 1/Phase 2|10|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:41:32.74967|2017-10-11 00:41:32.74967
NCT02080520|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-28|||April 2014||2014-04-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|NAPS||Nattokinase Atherothrombotic Prevention Study|Nattokinase Atherothrombotic Prevention Study|Recruiting||Phase 2|240|Anticipated|University of Southern California||2|||f||||t||||||||||2017-10-11 00:41:32.899927|2017-10-11 00:41:32.899927
NCT02080507|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-04-24|2017-01-19||March 2014||2014-03-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|rTMSECT||rTMS in Treatment Resistant Depression|rTMS in Treatment Resistant Depression|Completed||N/A|12|Actual|Emory University|The study sample was limited due to low recruitment.|2|||f||||f||||||||No|We had not planned on sharing individual data with other researchers|2017-10-11 00:41:33.067514|2017-10-11 00:41:33.067514
NCT02080494|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-07-06|||May 2012||2012-05-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Tranexamic Acid in Orthopaedic Trauma Surgery|Tranexamic Acid in Orthopaedic Trauma Surgery|Unknown status|Enrolling by invitation|N/A|100|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-11 00:41:33.404116|2017-10-11 00:41:33.404116
NCT02080481|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-04-06|2017-01-19||March 2014||2014-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Needle Guidance in Ultrasound Guided Nerve Blocks|Effect of InfinitiPlusTM Needle Guidance in Ultrasound Guided Regional Anesthesia|Completed||N/A|135|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 00:41:33.524375|2017-10-11 00:41:33.524375
NCT02080442|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-04|||May 2013||2013-05-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Balance Training for Chronic Obstructive Pulmonary Disease (COPD)|Balance Training for COPD in Pulmonary Rehabilitation (PR): An Effectiveness Study|Completed||N/A|19|Actual|West Park Healthcare Centre|||1||f||||||||||||||2017-10-11 00:41:35.944379|2017-10-11 00:41:35.944379
NCT02080429|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-05||||||March 2014|2014-03-01||||June 2015|Anticipated|2015-06-01||Interventional|||Passive Descent in Obese Nulliparous Gravidae|Can Passive Descent Increase the Spontaneous Vaginal Delivery Rate in Obese Women?|Unknown status|Not yet recruiting|N/A|540|Anticipated|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||||2017-10-11 00:41:36.037985|2017-10-11 00:41:36.037985
NCT02080416|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-06-08|||July 2014||2014-07-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors|A Pilot Trial of Nelfinavir for the Lytic Activation and Treatment of Gammaherpesvirus-Related Tumors|Terminated||Early Phase 1|1|Actual|Sidney Kimmel Comprehensive Cancer Center||1||"Very slow accrual; terminated to allow resources to be utilized more effectively on other   studies. No data analysis completed, nor any conclusions reached."|f||||t||||||||No|Study terminated; no data analysis completed|2017-10-11 00:41:36.128371|2017-10-11 00:41:36.128371
NCT02080403|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-05-25|||July 2014||2014-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis|Multi-Center Phase 3 Trial of Chlorhexidine Gluconate Chip for the Use in Subjects With Peri-Implantitis.|Recruiting||Phase 3|250|Anticipated|Dexcel Pharma Technologies Ltd.||2|||f||||f||||||||||2017-10-11 00:41:36.229638|2017-10-11 00:41:36.229638
NCT02080390|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-02-28|||September 2014||2014-09-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Strain Imaging in Breast Cancer Patients Receiving Trastuzumab|Strain Imaging in Breast Cancer Patients Receiving Trastuzumab|Active, not recruiting||N/A|100|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-11 00:41:36.382512|2017-10-11 00:41:36.382512
NCT02080377|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-12-07|||July 2014||2014-07-01|December 2015|2015-12-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|GRACES||A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS|A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS|Completed||Phase 3|23|Actual|University of Edinburgh||2|||f||||f||||||||||2017-10-11 00:41:36.504383|2017-10-11 00:41:36.504383
NCT02080364|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-05-31|||April 2015||2015-04-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|STEADFAST||Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease|Randomized, Double-blind, Placebo Controlled, Multi-center Registration Trial to Evaluate the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease Receiving Acetylcholinesterase Inhibitors and/or Memantine|Active, not recruiting||Phase 3|800|Anticipated|vTv Therapeutics||2|||f||||t|t|f||||||||2017-10-11 00:41:36.648476|2017-10-11 00:41:36.648476
NCT02080351|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-05-29|||March 2014||2014-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|SCARTA||A Simple Cognitive Task to Reduce the Build-Up of Flashbacks After a Road Traffic Accident|A Simple Cognitive Task to Reduce the Build-Up of Flashbacks After a Road Traffic Accident: A Randomised Controlled Study in an Emergency Department|Completed||N/A|71|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 00:41:38.204744|2017-10-11 00:41:38.204744
NCT02080338|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2014-03-04|||January 2010||2010-01-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|September 2014|Anticipated|2014-09-01||Interventional|Bracket slot||0.018 or 0.022 Bracket Slot System More Effective in Orthodontic Treatment?|Is the 0.018-inch or the 0.022-inch Bracket Slot System More Effective in Orthodontic Treatment? A Randomized Clinical Trial.|Unknown status|Recruiting|Phase 3|216|Anticipated|University of Dundee||2|||f||||t||||||||||2017-10-11 00:41:38.27824|2017-10-11 00:41:38.27824
NCT02080325|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-03-04|||December 2009||2009-12-01|March 2014|2014-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|ALPROsoya||Vegetarian High Protein Weight Loss Diets|Vegetarian High Protein Weight Loss Diets|Completed||N/A|20|Actual|University of Aberdeen||2|||f||||f||||||||||2017-10-11 00:41:38.368328|2017-10-11 00:41:38.368328
NCT02080312|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-02-11|2015-12-21||January 2012||2012-01-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent|Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent|Completed||N/A|6|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 00:41:38.472762|2017-10-11 00:41:38.472762
NCT02080299|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2016-11-01|||September 2013||2013-09-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation|Protection of Heart, Brain and Kidney by Remote Ischemic Preconditioning in Patients Undergoing Transcatheter Aortic Valve Implantation - a Randomized, Single-blind Study|Active, not recruiting||Phase 2|100|Actual|University Hospital, Essen||2|||f||||t||||||||No||2017-10-11 00:41:38.862881|2017-10-11 00:41:38.862881
NCT02080273|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-04|||March 2013||2013-03-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Six Month Plaque and Gingivitis Study Using Colgate Total Toothpaste|The Clinical Investigation of Colgate Total Toothpaste as Compared to Parodontax Toothpaste and Colgate Cavity Protection Toothpaste in Controlling Established Plaque and Gingivitis. (A Six Month Study)|Completed||Phase 4|135|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-10-11 00:41:39.129432|2017-10-11 00:41:39.129432
NCT02080260|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-08-28|||June 6, 2014|Actual|2014-06-06|August 2017|2017-08-01||||February 1, 2018|Anticipated|2018-02-01||Interventional|||A Study of Regorafenib in Advanced Pancreatic Cancer Patients|A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas|Active, not recruiting||Phase 2|20|Actual|Carolinas Healthcare System||1|||f||||t||||||||||2017-10-11 00:41:39.240559|2017-10-11 00:41:39.240559
NCT02080247|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-04-10|||December 2012||2012-12-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Treatment of Incontinence Associated Dermatitis in Older Children and Adults|A Randomized Controlled Clinical Study Comparing the Efficacy and Safety of Calmoseptine vs Destin Maximum Strength Diaper Rash Paste in Treatment of Incontinence Associated Dermatitis in Older Children and Adults|Completed||Phase 3|142|Actual|University of the Philippines||2|||f||||t||||||||||2017-10-11 00:41:39.363562|2017-10-11 00:41:39.363562
NCT02080234|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2016-04-18|||March 2014||2014-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL|Combination of Gemcitabine, Oxaliplatin, and Asparaginase (GELOX) With Concurrent Involved-Field Radiation Therapy for Patients With Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma:a Phase II Study|Recruiting||Phase 2|40|Anticipated|Sun Yat-sen University||1|||f||||f||||||||||2017-10-11 00:41:39.46175|2017-10-11 00:41:39.46175
NCT02080221|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-03-01|||August 2014||2014-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial|BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial|Recruiting||Phase 2|50|Anticipated|Brown University||1|||f||||t||||||||||2017-10-11 00:41:39.591297|2017-10-11 00:41:39.591297
NCT02080208|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-01-29|||February 2011||2011-02-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Which Place for High Flow Oxygen in ICU ?|Which Place for High Flow Oxygen in Intensive Care Unit ?|Completed||N/A|20|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||No||2017-10-11 00:41:39.723978|2017-10-11 00:41:39.723978
NCT02080195|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)|A Phase I/II Study of Nonmyeloablative Conditioning and Transplantation of Human Leukocyte Antigen (HLA)-Matched, Partially HLA-mismatched, HLA-haploidentical or Matched Unrelated Bone Marrow for Patients With Refractory SLE|Terminated||Phase 1/Phase 2|1|Actual|Sidney Kimmel Comprehensive Cancer Center||1||Study was unable to accrue subjects|f||||t||||||||||2017-10-11 00:41:39.824074|2017-10-11 00:41:39.824074
NCT02080182|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-04-18|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Acetylcysteine in Pediatric Acute Pyelonephritis.|Study of the Effect of Acetylcysteine on Inflammation Biomarkers in Pediatric Acute Pyelonephritis.|Completed||Phase 2|70|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:41:39.933141|2017-10-11 00:41:39.933141
NCT02080169|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-03-05|||February 2014||2014-02-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety and Efficacy of Combined Sedation With Midazolam and Dexmedetomidine in ICU Patients|Safety and Efficacy of Combined Sedation With Midazolam and Dexmedetomidine in ICU Patients|Unknown status|Recruiting|Phase 4|600|Anticipated|Qilu Hospital of Shandong University||3|||f||||f||||||||||2017-10-11 00:41:40.087856|2017-10-11 00:41:40.087856
NCT02080156|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2015-06-22|||January 2015||2015-01-01|June 2015|2015-06-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Continuous Positive Airway Pressure (CPAP) Therapy on Outcomes in Patients Undergoing Coronary Revascularization|Impact of Continuous Positive Airway Pressure Therapy on Outcomes in Patients Undergoing Coronary Revascularization|Recruiting||N/A|1200|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||||2017-10-11 00:41:40.194731|2017-10-11 00:41:40.194731
NCT02080143|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-03-15|||March 2014||2014-03-01|March 2014|2014-03-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||A Comparative Study to Evaluate Two Air-Activated Adhesive Backed Heat Patches|A Randomized, Open-Label, Comparative Study To Evaluate the Adhesion and Temperature Properties of Two Air-Activated, Adhesive Backed Heat Patches in Healthy Volunteers|Terminated||N/A|200|Actual|Chattem, Inc.||2|||f||||t||||||||No||2017-10-11 00:41:40.28707|2017-10-11 00:41:40.28707
NCT02080130|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-12-07|||February 2014||2014-02-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea|Efficacy of Two Probiotic Preparations in Children With Acute Viral Diarrhoea, Randomised Controlled Trial|Recruiting||Phase 3|150|Anticipated|Sinaloa Pediatric Hospital||3|||f||||f||||||||||2017-10-11 00:41:40.372505|2017-10-11 00:41:40.372505
NCT02080117|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation|Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation|Completed||N/A|800|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:41:40.464581|2017-10-11 00:41:40.464581
NCT02080104|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2014-03-04|||February 2014||2014-02-01|March 2014|2014-03-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|oxytocin||Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery|Intramuscular Versus Intravenous Prophylactic Oxytocin for the Third Stage of Labour Following Vaginal Delivery: A Randomised Controlled Trial|Unknown status|Recruiting|N/A|2|Anticipated|Bakirkoy Dr. Sadi Konuk Research and Training Hospital||2|||f||||f||||||||||2017-10-11 00:41:40.686204|2017-10-11 00:41:40.686204
NCT02080091|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-08-14|2015-07-15||December 2013||2013-12-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|ILUMINATE|25 patients were enrolled but only 23 received treatment.|Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies|ILUMINATE: An Open-Label, Non-Interventional Study of the Safety and Effect of Iluvien® (Fluocinolone Acetonide 190 Micrograms Intravitreal Implant in Applicator) in Patients With Chronic Diabetic Macular Edema (DME) Insufficiently Responsive to Available Therapies|Terminated||N/A|25|Actual|Alimera Sciences|||1||f||||f||||||||||2017-10-11 00:41:40.80371|2017-10-11 00:41:40.80371
NCT02080078|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-12-31|||September 2014||2014-09-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline|A Phase I, Single-center, Non-randomized, Open-label Study to Determine the Lowest Effective Theophylline Dose That Decreased Erlotinib's Diarrhea at the Standard Dose of 150 mg/Day and to Determine the Highest Erlotinib Dose in Combination With Theophylline That Can be Administered to Patients|Recruiting||Phase 1|40|Anticipated|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-10-11 00:41:41.103428|2017-10-11 00:41:41.103428
NCT02080065|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-08-27|||January 2014||2014-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Liver Transplantation|Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Liver Transplantation|Completed||N/A|573|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:41:41.250811|2017-10-11 00:41:41.250811
NCT02080039|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-11-19|||September 2012||2012-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Electrical Stimulation of Denervated Muscles After Spinal Cord Injury|Clinical Pilot Study of the Effect of Electrical Stimulation of Denervated Muscles After Spinal Cord Injury|Terminated||N/A|5|Actual|Swiss Paraplegic Centre Nottwil||1|||f||||f||||||||||2017-10-11 00:41:41.542833|2017-10-11 00:41:41.542833
NCT02080026|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-08-07|||June 2014||2014-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|BMGF1||Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxis|Identification of Pre-erythrocytic Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxis|Completed||N/A|15|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 00:41:41.643702|2017-10-11 00:41:41.643702
NCT02080013|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-04-02|||December 2011||2011-12-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Endovenous Radiofrequency Versus Laser Ablation for the Treatment of Great Saphenous Vein Reflux|Prospective, Randomized Study of Endovenous Segmental Radiofrequency Versus 1320 nm Laser Ablation for the Treatment of Great Saphenous Vein Reflux (RVLAb Study)|Completed||N/A|5|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:41:41.768121|2017-10-11 00:41:41.768121
NCT02080000|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-04-27|||February 2014||2014-02-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||R-wave Optimisation in Cardiac Resynchronisation Therapy Study|Use of the R-wave to Optimise VV Delay in Heart Failure Patients Treated With Cardiac Resynchronisation Therapy|Completed||N/A|6|Actual|The Royal Bournemouth Hospital||2|||f||||t||||||||||2017-10-11 00:41:41.862955|2017-10-11 00:41:41.862955
NCT02079974|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-11-05|||July 2014||2014-07-01|March 2014|2014-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Statins: A New Therapeutic Option for Treatment of Patients With Endometriosis|Statins: A New Therapeutic Option for Treatment of Patients With Endometriosis|Withdrawn||N/A|0|Actual|Toronto Centre for Advanced Reproductive Technology||1|||f||||f||||||||||2017-10-11 00:41:42.111937|2017-10-11 00:41:42.111937
NCT02079961|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-03-05|||January 2013||2013-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Distribution of Fortified Yoghurt in Senegal to Decrease Children's Anemia and Improve Milk Supply|Better Nutrition Through Agricultural Contracts; Better Contracts Through Nutrition Incentives: A Case Study of Utilizing a Dairy Value Chain in Northern Senegal to Reduce Anemia and Improve Milk Supply|Completed||Early Phase 1|471|Actual|International Food Policy Research Institute||2|||f||||f||||||||||2017-10-11 00:41:42.238149|2017-10-11 00:41:42.238149
NCT02079948|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-10-02|||February 2014||2014-02-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ICE||Inflammation Control For Elders: ICE Study|Role of Methotrexate in Improving Physical Function in Older Adults With Elevated Levels of Inflammation|Withdrawn||Phase 2|0|Actual|University of Florida||4||Potential participants had concerns about taking the study drug (methotrexate).|f||||t||||||||||2017-10-11 00:41:42.374988|2017-10-11 00:41:42.374988
NCT02079935|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-09-04|||March 2014||2014-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|FAKT||Treatment of Eating Disorders by Physical Activity and Nutrition Counseling|Treatment of Eating Disorders - a Randomised, Controlled, Prospective Study|Active, not recruiting||N/A|128|Actual|Norwegian School of Sport Sciences||2|||f||||t||||||||||2017-10-11 00:41:42.540602|2017-10-11 00:41:42.540602
NCT02079922|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-07-29|||March 2014||2014-03-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Multiple Dose Study Of PF-06678552 In Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PF-06678552 After Administration Of Multiple Escalating Oral Doses In Healthy Adult Subjects|Completed||Phase 1|38|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 00:41:42.729274|2017-10-11 00:41:42.729274
NCT02079909|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-05-16||2016-02-23|March 2014||2014-03-01|May 2017|2017-05-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)|A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|484|Actual|Toyama Chemical Co., Ltd.||3|||f||||t||||||||||2017-10-11 00:41:42.924559|2017-10-11 00:41:42.924559
NCT02079896|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-11-23|||May 2014||2014-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients|Safety, PK/PD, and Efficacy of NOX-H94 in Dialysis Patients With ESA-hyporesponsive Anemia: A Randomized, Double Blind, Placebo Controlled Parallel Group Study With a Single Blind Cross-over Group|Completed||Phase 1/Phase 2|33|Actual|NOXXON Pharma AG||3|||f||||f||||||||||2017-10-11 00:41:43.169006|2017-10-11 00:41:43.169006
NCT02079883|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-06-20|||May 2014||2014-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01|12 Months|Observational [Patient Registry]|ORBIT||Ocriplasmin Research to Better Inform Treatment (ORBIT)|Ocriplasmin Research to Better Inform Treatment (ORBIT)|Completed||N/A|540|Actual|ThromboGenics|||1||f||||f||||||None Retained|"     No biospecimens collected   "|||2017-10-11 00:41:43.29366|2017-10-11 00:41:43.29366
NCT02079844|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-08-09|2016-05-31||March 2014||2014-03-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||All randomized participants.|Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia|A Randomized, Double-Blind, Placebo Controlled, 3-period, Proof of Mechanism, Cross-Over Study of Roflumilast Administered up to Steady State to Evaluate the Effects of Add-on Roflumilast to Second Generation Antipsychotics on Cognitive Impairment as Well as Brain Imaging (ie, fMRI) and Electrical Activity (ie, EEG) Changes Observed in Subjects With Stable Schizophrenia|Completed||Phase 1|20|Actual|Takeda||3|||f||||f||||||||||2017-10-11 00:41:43.965069|2017-10-11 00:41:43.965069
NCT02079818|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-12-22|||June 2017||2017-06-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System|CLP 7463: Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System|Not yet recruiting||Phase 4|60|Anticipated|Penumbra Inc.||1|||f||||f||||||||||2017-10-11 00:41:45.221374|2017-10-11 00:41:45.221374
NCT02079805|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-04-24|2017-04-24||June 2014||2014-06-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Randomized Set included all randomized participants.|A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R|A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R|Completed||Phase 4|33|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:41:45.334862|2017-10-11 00:41:45.334862
NCT02079792|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-04-13|||June 2014||2014-06-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|Head Position||The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device|The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device: A Randomized, Single-blind, Parallel Trial Comparing the Lying-Head-Back Versus the Head-Down-to-Floor Positions|Completed||Phase 4|66|Actual|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 00:41:45.992654|2017-10-11 00:41:45.992654
NCT02079779|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-07-27|||May 2014||2014-05-01|July 2015|2015-07-01||||May 2016|Anticipated|2016-05-01||Interventional|||Efficacy Study of an Interactive Robot for the Rehabilitation of the Upper Limb in Acute Stroke Patients|Study of the Effectiveness of an Interactive Robot for the Rehabilitation of the Upper Limb in Acute Stroke Patients by Evaluating the 3 Fields of the ICF: a Prospective, Randomized, Controlled, Simple Blind Study|Unknown status|Recruiting|N/A|60|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 00:41:46.108257|2017-10-11 00:41:46.108257
NCT02079766|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-02-08||2017-02-08|June 2014||2014-06-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy|18F-AV-1451 and Florbetapir F 18 PET Imaging in Subjects With Repetitive Brain Trauma at High Risk for Chronic Traumatic Encephalopathy|Completed||Phase 2|40|Actual|Avid Radiopharmaceuticals||2|||f||||f||||||||||2017-10-11 00:41:46.227445|2017-10-11 00:41:46.227445
NCT02079753|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-05|||June 2011||2011-06-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2012|Actual|2012-02-01||Interventional|||Single Portable Pulse-dose-conserving Device vs. Combined Use of Stationary and Portable.|Oxygenation Using a Single Portable Pulse-dose-conserving Device Compared to Combined Use of Stationary and Portable Oxygen Delivery Devices.|Completed||Phase 3|38|Actual|Hospital Son Espases||2|||f||||t||||||||||2017-10-11 00:41:46.309179|2017-10-11 00:41:46.309179
NCT02079740|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-09-01|||March 7, 2014|Actual|2014-03-07|June 2017|2017-06-01||||September 1, 2017|Anticipated|2017-09-01||Interventional|||Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors|An Open Label, Two-Part, Phase Ib/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of the MEK Inhibitor Trametinib and the BCL2-Family Inhibitor Navitoclax (ABT-263) in Combination in Subjects With KRAS or NRAS Mutation-Positive Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|130|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:41:46.40796|2017-10-11 00:41:46.40796
NCT02079727|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-03-01|||June 12, 2014|Actual|2014-06-12|March 2017|2017-03-01|June 16, 2016|Actual|2016-06-16|October 19, 2015|Actual|2015-10-19||Interventional|||Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA|A Multicentre, Comparative, Randomised, Double-blind, Double-dummy Clinical Trial on the Efficacy and Safety of Condrosulf Versus Celebrex and Versus a Placebo in the Treatment of Knee Osteoarthritis|Completed||Phase 3|604|Actual|IBSA Institut Biochimique SA||3|||f||||f||||||||||2017-10-11 00:41:46.536452|2017-10-11 00:41:46.536452
NCT02079714|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-12-22|||January 2014||2014-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|STREAM||Streamlining Trauma Research Evaluation With Advanced Measurement|Streamlining Trauma Research Evaluation With Advanced Measurement: STREAM Study|Recruiting||N/A|1000|Anticipated|Major Extremity Trauma Research Consortium|||1||f||||t||||||||||2017-10-11 00:41:46.79494|2017-10-11 00:41:46.79494
NCT02079701|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-05|||October 2000||2000-10-01|March 2014|2014-03-01|June 2007|Actual|2007-06-01|June 2003|Actual|2003-06-01||Interventional|||Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits|Double-Blind Placebo-Controlled Clinical Effectiveness Trial of the 23-Valent Pneumococcal Vaccine Among Military Trainees At Increased Risk of Respiratory Disease|Completed||Phase 4|152723|Actual|Naval Health Research Center||2|||f||||f||||||||||2017-10-11 00:41:47.054065|2017-10-11 00:41:47.054065
NCT02079688|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-01-12|||February 2014||2014-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema|A Phase IIa, Single-centre, Randomised, Vehicle Controlled, Double-blind Trial for Assessment of Efficacy, Safety and Tolerability of the Topical Formulation SB011 Containing a Human GATA-3 Specific DNAzyme and of Systemic Absorption of hgd40 Following Application to Lesional Skin in Patients With Atopic Eczema|Completed||Phase 2|25|Actual|Sterna Biologicals GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 00:41:47.191817|2017-10-11 00:41:47.191817
NCT02079675|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-05-29|||January 2013||2013-01-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome|Multi-center, Randomized, Double Blinded, Parallel Group, Placebo-controlled, Phase II Trial to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome|Completed||Phase 2|279|Actual|SK Chemicals Co.,Ltd.||3|||f||||f||||||||||2017-10-11 00:41:47.332559|2017-10-11 00:41:47.332559
NCT02079662|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-03-27|||June 2013|Actual|2013-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Role of Lifestyle Factors in Breast Cancer-Related Outcomes|The Role of Lifestyle Factors in Breast Cancer-Related Outcomes|Recruiting||N/A|160|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|f|||||||||2017-10-11 00:41:47.419389|2017-10-11 00:41:47.419389
NCT02079649|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2015-08-07|2015-07-10||April 2014||2014-04-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||This analysis population includes all subjects who were randomized to and treated with investigational product.|Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis|A Prospective, Randomized, Double-Masked, Vehicle and Active-Controlled, Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for the Treatment of Allergic Conjunctivitis in an Environmental Exposure Chamber (EEC) Model|Completed||Phase 2|224|Actual|Alcon Research||4|||f||||f||||||||||2017-10-11 00:41:47.550316|2017-10-11 00:41:47.550316
NCT02079636|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-07-05|||March 2014||2014-03-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)|A Phase 1b Study of LY2835219 in Combination With Multiple Single Agent Options for Patients With Stage IV NSCLC|Recruiting||Phase 1|150|Anticipated|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 00:41:48.564055|2017-10-11 00:41:48.564055
NCT02079623|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-05|||November 2013||2013-11-01|March 2014|2014-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|NanoKnife||Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer|Implementation of Electroporation - NanoKnife as Treatment for Advanced Pancreatic Cancer.|Unknown status|Enrolling by invitation|Phase 3|25|Actual|Aalborg Universitetshospital||1|||f||||t||||||||||2017-10-11 00:41:48.785656|2017-10-11 00:41:48.785656
NCT02079610|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-07-21|2017-04-24||April 2014||2014-04-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases|Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases|Completed||N/A|36|Actual|Laureate Institute for Brain Research, Inc.|large proportion of patients excluded primarily because of medication status or not meeting DSM-IV-TR criteria for major depressive disorder, limiting the generalizability Patients were only followed for 1 week after the final rtfMRI-nf session|2|||f||||||||||||||2017-10-11 00:41:48.903658|2017-10-11 00:41:48.903658
NCT02079597|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-09-01|||February 2014||2014-02-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Observational|Ninj1||The Role of Ninjurin-1 During Systemic Inflammation|Prospective Study to Analyze Ninjurin-1 and Its Soluble Part During Systemic Inflammation|Completed||N/A|30|Actual|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples With DNA|"     whole blood, plasma, RNA and cDNA extracted from whole blood samples   "|||2017-10-11 00:41:49.459081|2017-10-11 00:41:49.459081
NCT02079584|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2017-03-14|||March 2013||2013-03-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01|5 Years|Observational [Patient Registry]|||Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant|Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant|Active, not recruiting||N/A|350|Anticipated|Indiana University|||2||f||||f||||||Samples With DNA|"     A blood sample will be obtained at the initial outpatient visit within 30 days (+/- 14 days)     post diagnosis and/or start of treatment and at the 180 day (+/- 14 days) follow up post     treatment visit and at each annual visit for up to 5 years.   "|No||2017-10-11 00:41:49.561222|2017-10-11 00:41:49.561222
NCT02079571|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-03-04|||May 2013||2013-05-01|March 2014|2014-03-01||||December 2014|Anticipated|2014-12-01||Interventional|||Investigation of Pulse Waves, Channel Entries, and Food Attributes in Healthy Subjects With Different Constitutions|Investigation of Pulse Waves and Channel Entries Produced in Healthy Subjects With Different Constitutions and Their Changes After Treated With Foods of Different Food Attributes|Unknown status|Recruiting|N/A|240|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:41:49.650594|2017-10-11 00:41:49.650594
NCT02079545|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-03-08|||March 2014||2014-03-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants|A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects|Completed||Phase 1|144|Actual|Janssen Research & Development, LLC||5|||f||||f||||||||||2017-10-11 00:41:49.822966|2017-10-11 00:41:49.822966
NCT02079532|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-06-30|2014-06-17||November 2006||2006-11-01|June 2016|2016-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||Safety population: all participants who received at least 1 dose of trial medication and had at least 1 safety follow-up.|A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor|An Open-label Study to Evaluate the Safety of MabThera, and Its Effect on Treatment Response, in Patients With Rheumatoid Arthritis Following Inadequate Response to a Single Anti-TNF Agent|Completed||Phase 3|302|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:41:49.960368|2017-10-11 00:41:49.960368
NCT02079519|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-06-06|2014-06-06||May 2006||2006-05-01|June 2014|2014-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Intent-to-treat population: All participants who received at least 1 dose of study drug.|A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma|Bevacizumab as Treatment for Patients With Relapsed/Refractory Multiple Myeloma|Terminated||Phase 2|10|Actual|Hoffmann-La Roche||1||The study was discontinued prematurely by the sponsor due to a lack of recruitment.|f||||||||||||||2017-10-11 00:41:50.745043|2017-10-11 00:41:50.745043
NCT02079506|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-03-04|||February 2014||2014-02-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin|An Open-label, Multiple-dosing, Two-arm, One-sequence, Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Candesartan 32 mg and Rosuvastatin 20 mg in Healthy Male Volunteers|Completed||Phase 1|40|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-11 00:41:51.103414|2017-10-11 00:41:51.103414
NCT02079480|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2016-05-10|||May 2014||2014-05-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects|Double-Blinded, Randomized, Placebo-Controlled, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986090 in Healthy Subjects|Terminated||Phase 1|130|Actual|Bristol-Myers Squibb||9|||f||||f||||||||||2017-10-11 00:41:51.293525|2017-10-11 00:41:51.293525
NCT02079467|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-03-04|||December 2013||2013-12-01|March 2014|2014-03-01|November 2014|Anticipated|2014-11-01|June 2014|Anticipated|2014-06-01||Interventional|||Unrestricted Rehabilitation Following Primary THA|Unrestricted Rehabilitation Following Primary Total Hip Arthroplasty: Implications for Patient Satisfaction and Functional Performance|Unknown status|Recruiting|N/A|10|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 00:41:51.460293|2017-10-11 00:41:51.460293
NCT02079441|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-04|||March 2014||2014-03-01|March 2014|2014-03-01||||February 2017|Anticipated|2017-02-01||Observational|||Immune Function in Offsprings of Females With Inflammatory Bowel Disease (IBD) Treated With Anti-TNF Medications During Pregnancy|Immune Function in Offsprings of Females With Inflammatory Bowel Disease (IBD) Treated With Anti-TNF Medications During Pregnancy|Unknown status|Not yet recruiting|N/A|50|Anticipated|Sheba Medical Center|||2||f||||f||||||Samples Without DNA|"     Blood tests   "|||2017-10-11 00:41:51.671778|2017-10-11 00:41:51.671778
NCT02079428|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2014-03-04|||January 2013||2013-01-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01|3 Years|Observational [Patient Registry]|CN-HF||China National Heart Failure Registry|The National Registry Study of Hospitalized Heart Failure Patients in China|Unknown status|Recruiting|N/A|10000|Anticipated|Shanghai Institute of Cardiovascular Diseases|||1||f||||t||||||||||2017-10-11 00:41:51.749935|2017-10-11 00:41:51.749935
NCT02079415|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2015-05-22|||January 2011||2011-01-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|January 2012|Actual|2012-01-01||Observational|||Infants of Diabetic Mothers: A Cohort Study|Study of Outcome of Infants of Diabetic Mothers in a Tertiary Hospital Set up|Completed||N/A|601|Actual|Security Forces Hospital|||1||f||||t||||||||||2017-10-11 00:41:51.838255|2017-10-11 00:41:51.838255
NCT02079402|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-12-08|||September 2014||2014-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|CLASSIC||Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care|Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC) - a Randomised Clinical Trial|Completed||Phase 4|153|Actual|Scandinavian Critical Care Trials Group||2|||f||||f||||||||||2017-10-11 00:41:51.924363|2017-10-11 00:41:51.924363
NCT02079389|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-05-04|||May 2013||2013-05-01|May 2013|2013-05-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum|The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum: A Prospective Randomized Trial|Completed||N/A|280|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 00:41:52.038315|2017-10-11 00:41:52.038315
NCT02079376|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-03-15|||November 2013||2013-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The DIAMOND® for the Treatment of Type 2 Diabetes|The DIAMOND® for the Treatment of Type 2 Diabetes: Can Blood Triglycerides Level be the Predictor for Therapy Efficiency A Multicentre, Prospective, Semi-randomized Study|Recruiting||N/A|45|Anticipated|Metacure||3|||f||||f||||||||||2017-10-11 00:41:52.138251|2017-10-11 00:41:52.138251
NCT02079363|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-04|2014-07-29|||August 2013||2013-08-01|July 2014|2014-07-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Observational|||DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer|"Cell-free DNA Promoter Hypermethylation in Plasma From Patients With Pancreatic Adenocarcinoma, Compared to Patients With Pancreatitis and Pancreatitis and Patients Screened for, But Not Having Pancreatic Adenocarcinoma."|Recruiting||N/A|330|Anticipated|Aalborg Universitetshospital|||4||f||||t||||||Samples With DNA|"     Cell free methylated DNA in EDTA plasma   "|||2017-10-11 00:41:52.255323|2017-10-11 00:41:52.255323
NCT02079350|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2014-03-01|||January 2011||2011-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01|1 Month|Observational [Patient Registry]|||Impact of %6 HES 130/0.4 and %4 Gelofusine Infusion on Kidney Function in the Living-donor Liver Transplantation||Completed||N/A|36|Actual|Turkiye Yuksek Ihtisas Education and Research Hospital|||2||f||||f||||||||||2017-10-11 00:41:52.364282|2017-10-11 00:41:52.364282
NCT02079337|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-07-08|||November 2013||2013-11-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Validation of Subjective Rating Scales Used to Assess Surgical Conditions in Abdominal Surgery|Validation of Subjective Rating Scales Used to Assess Surgical Conditions in Abdominal Surgery|Completed||Phase 4|14|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 00:41:52.434532|2017-10-11 00:41:52.434532
NCT02079324|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-04-29|||March 2014||2014-03-01|March 2014|2014-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|GX-051||Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer|A Single Center, Open-Label, Accelerated Titration, Dose-Escalating, Phase Ι Study to Evaluate the Safety and Tolerability of IT Injection GX-051, Stem Cell Based Gene Therapeutics in Patients With Very Advanced Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 1|12|Anticipated|Genexine, Inc.||1|||f||||f||||||||||2017-10-11 00:41:52.513773|2017-10-11 00:41:52.513773
NCT02079311|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-10-14|2015-09-01||January 2014||2014-01-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Evaluation of Core Body Temperature When Using Forced Air Warming or an Active Blanket to Prevent Perioperative Hypothermia|Evaluation of Perioperative Core Body Temperature When Using Forced Air Warming or BARRIER® EasyWarm to Prevent Inadvertent Perioperative Hypothermia: An Open-label, Randomized Non-inferiority Comparison|Completed||N/A|55|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-11 00:41:52.600841|2017-10-11 00:41:52.600841
NCT02079298|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-09-01|||April 2014||2014-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants|Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants - A Study on Interactions by Nonsteroidal Anti Inflammatory Drugs (NSAIDs) With Fluconazole in Respect of Pharmacodynamic Endpoints With Urinary Excretion of Vasoactive Endobiotics|Completed||Phase 4|80|Actual|Karolinska Institutet||4|||f||||f||||||||||2017-10-11 00:41:52.872714|2017-10-11 00:41:52.872714
NCT02079285|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2016-02-22|||April 2014||2014-04-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|FNASROSE||Prospective Evaluation of Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in the Absence of Rapid Onsite Evaluation|Prospective Evaluation of the Yield and Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy in the Absence of Rapid Onsite Evaluation|Completed||N/A|75|Actual|Kangbuk Samsung Hospital|||1||f||||t||||||||||2017-10-11 00:41:52.96153|2017-10-11 00:41:52.96153
NCT02079272|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-04-03|||November 2014||2014-11-01|April 2015|2015-04-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|REBECCA||REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity)|REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity): Evaluation of Radiation-induced Cardiotoxicity of Adjuvant Radiotherapy With Tomotherapy for Breast Cancer|Withdrawn||N/A|0|Actual|Institut de Radioprotection et de Surete Nucleaire||1|||f||||f||||||||||2017-10-11 00:41:53.034793|2017-10-11 00:41:53.034793
NCT02079259|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-03-13|||November 2013||2013-11-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|Aquadex||CVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart Failure|CVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart Failure - A Pilot Study to Optimize Individualized Volume Depletion|Completed||N/A|9|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 00:41:53.126366|2017-10-11 00:41:53.126366
NCT02079246|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-07-25|||April 7, 2014|Actual|2014-04-07|July 2017|2017-07-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Interventional|STAR Extension||Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease|An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease|Completed||Phase 3|1463|Actual|H. Lundbeck A/S||2|||f||||t||||||||||2017-10-11 00:41:53.232788|2017-10-11 00:41:53.232788
NCT02079233|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-04|||May 2010||2010-05-01|March 2014|2014-03-01||||July 2010|Actual|2010-07-01||Interventional|||Evaluation of Four Different Dosing Regimens of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers|Phase 1 Multiple Dose Trial to Assess the Safety, Tolerability and Efficacy of Four Different Dosing Regimens of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers|Completed||Phase 1|25|Actual|Sorbent Therapeutics||4|||f||||f||||||||||2017-10-11 00:41:53.85619|2017-10-11 00:41:53.85619
NCT02079220|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-07-26|||March 2014||2014-03-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer|A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer|Withdrawn||Phase 2|0|Actual|University of Pittsburgh||2||Funding for the study was withdrawn, no participants were ever recruited.|f||||t||||||||||2017-10-11 00:41:53.938846|2017-10-11 00:41:53.938846
NCT02079207|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-01-26|||December 2013||2013-12-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine|Multi-center, Randomized, Double Blinded, Phase III Trial to Assess the Immunogenicity and Safety of NBP606 in Adults 50 Years of Age and Older Who Are naïve to Pneumococcal Vaccine|Completed||Phase 3|767|Actual|SK Chemicals Co.,Ltd.||2|||f||||f||||||||||2017-10-11 00:41:54.059683|2017-10-11 00:41:54.059683
NCT02079194|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-06-16|||March 2014||2014-03-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|SMART-CHOICE||Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES|Comparison Between P2Y12 Antagonist MonotHerapy and Dual Antiplatelet Therapy in Patients UndergOing Implantation of Coronary Drug-Eluting Stents|Recruiting||N/A|3000|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 00:41:54.143371|2017-10-11 00:41:54.143371
NCT02079181|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-04-11|||January 31, 2014|Actual|2014-01-31|April 2017|2017-04-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||18F-FMAU PET/CT in Imaging Patients With Advanced Cancers|18F-FMAU for Imaging in Cancer Patients|Recruiting||N/A|30|Anticipated|University of Southern California||1|||f||||t||||||||||2017-10-11 00:41:54.269935|2017-10-11 00:41:54.269935
NCT02079168|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-06-13|||March 2014||2014-03-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults|A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults|Completed||Phase 2|16|Actual|RXi Pharmaceuticals, Corp.||2|||f||||t||||||||||2017-10-11 00:41:54.386146|2017-10-11 00:41:54.386146
NCT02079155|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-01-20|||June 2012||2012-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Robotic Athermal Nerve-Sparing Radical Prostatectomy|Prospective Single-Center Randomized Study of Robotic Athermal Nerve-Sparing Radical Prostatectomy: Laparoendoscopic Single-Site Versus Standard Approach|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center||2||Research Cancelled|f||||t||||||||||2017-10-11 00:41:54.601509|2017-10-11 00:41:54.601509
NCT02079142|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-04-26|||April 2012||2012-04-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Implementation of Evidence-based Treatments for On-campus Eating Disorders|Implementation of Evidence-based Treatments for On-campus Eating Disorders|Recruiting||N/A|165|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:41:54.741525|2017-10-11 00:41:54.741525
NCT02079129|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-06-09|||January 2014||2014-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PVL-TAVR||Paravalvular Leak for Transcatheter Valve Replacement|A Novel Imaging Approach to Assess Paravalvular Leak for Transcatheter Valve Replacement|Recruiting||N/A|50|Anticipated|Baylor Research Institute|||1||f||||t||||||||||2017-10-11 00:41:54.879119|2017-10-11 00:41:54.879119
NCT02079116|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2014-05-13|||January 2012||2012-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Ingestion of Lipids and Changes in Cerebral Blood Flow of People With Obesity|Acute Ingestion of Lipids and Alteration of Cerebral Perfusion in Obese Patients.|Completed||N/A|20|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:41:54.982315|2017-10-11 00:41:54.982315
NCT02079103|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-09-02|||March 2014||2014-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|VIRTUES||Virtual Reality Training for Upper Extremity After Stroke|Virtual Reality Based Training - a Motivating and Effective Way of Regaining Arm Motor Function After Stroke? The VIRTUES Trial: A Multi-center RCT|Completed||Phase 2|120|Actual|University of Bergen||2|||f||||f||||||||Yes||2017-10-11 00:41:55.198976|2017-10-11 00:41:55.198976
NCT02079090|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2016-11-15|||July 2014||2014-07-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Ketofol Versus Fentofol for Procedural Sedation in the Pediatric Emergency Department|Ketofol Versus Fentofol for Procedural Sedation of Children 3 to 17 Years Old: a Double-Blind Randomized Controlled Trial|Active, not recruiting||Phase 3|140|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 00:41:55.330767|2017-10-11 00:41:55.330767
NCT02079077|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-06-21|||April 2014||2014-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|IIQ||Inducing Immune Quiescence to Prevent HIV Infection in Women|Limiting HIV Target Cells by Inducing Immune Quiescence in the Female Genital Tract|Active, not recruiting||N/A|77|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-11 00:41:55.467475|2017-10-11 00:41:55.467475
NCT02079051|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-12-08|||February 2014||2014-02-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|OPTIFAST||Impact of Weight Loss on Physical Function|Impact of Medical Weight Loss on Physical Function in Severely Obese Older Adults|Completed||N/A|28|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 00:41:55.747157|2017-10-11 00:41:55.747157
NCT02079038|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-06-06|||May 2014||2014-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||The STEPS - Totalis™ Trial|A Prospective, Multi-center, Randomized Controlled Double-Blind Trial Evaluating the VertiFlex® Totalis™ Direct Decompression System Versus a Sham Surgical Procedure in Patients With Lumbar Spinal Stenosis|Active, not recruiting||N/A|120|Anticipated|VertiFlex, Incorporated||2|||f||||f||||||||||2017-10-11 00:41:55.872083|2017-10-11 00:41:55.872083
NCT02079025|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-08-02|||December 2013||2013-12-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2016|Actual|2016-12-01||Interventional|||Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer|Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer|Active, not recruiting||N/A|2000|Anticipated|Exact Imaging||2|||f||||f||||||||||2017-10-11 00:41:56.011314|2017-10-11 00:41:56.011314
NCT02079012|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-06-27|||February 2014||2014-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effects of a Walking Program in People With Mental Disorders|"Short- and Long-term Effects of a Walking Program (Join the Walk?) on Physical Activity, Physical Fitness and Subjective Well-Being With Members of a Sports Federation for People With Mental Disorders (Psylos)."|Completed||N/A|135|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:41:56.140734|2017-10-11 00:41:56.140734
NCT02078999|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-04-03|||September 2008||2008-09-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2010|Actual|2010-09-01||Observational|VAP||Biomarkers in Patients Undergoing Mechanical Ventilation|Observational Study in Patients Admitted in the Intensive Care Unit.Tracheal Bacterial Load Surveillance in Patients Undergoing Mechanical Ventilation - Assessment of Biomarkers in the Distinction Between Colonization and Infection|Completed||N/A|211|Actual|Corporacion Parc Tauli|||3||f||||f||||||Samples Without DNA|"     Bronchoalveolar lavage,biochemical lab,exhaled air.   "|||2017-10-11 00:41:56.2793|2017-10-11 00:41:56.2793
NCT02078986|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-05-27|||February 2014||2014-02-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|EMSvsHIT||Effectiveness of WB-EMS Versus HIT-Resistance Training (RT)|Comparison of the Effect of Whole-Body Electromyostimulation Versus High Intensity Resistance Exercise Training on Body Composition and Strength in Middle Aged Males|Terminated||Phase 3|50|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-11 00:41:56.399305|2017-10-11 00:41:56.399305
NCT02078973|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2017-02-28|||March 1, 2014|Actual|2014-03-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|DOVA||Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA)|The Effects of Tolvaptan on Renal Handling of Water and Sodium, Vasoactive Hormones and Circulatory System, During Basal Conditions and During Inhibition of the Nitric Oxide System in Healthy Subjects. A Dose-response Study.|Completed||Phase 2|15|Actual|Regional Hospital Holstebro||4|||f||||t||||||||||2017-10-11 00:41:56.507512|2017-10-11 00:41:56.507512
NCT02078388|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2014-03-03|||November 2013||2013-11-01|March 2014|2014-03-01||||October 2015|Anticipated|2015-10-01||Observational|||Correlation Between Genetic Variants and Long-term Cardiac Effects Induced by Doxorubicin in Breast Cancer Patients||Unknown status|Recruiting|Phase 2/Phase 3|500|Anticipated|National University Hospital, Singapore|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:42:04.174883|2017-10-11 00:42:04.174883
NCT02078960|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-07-14|||May 31, 2014|Actual|2014-05-31|July 2017|2017-07-01|July 31, 2020|Anticipated|2020-07-31|May 31, 2020|Anticipated|2020-05-31||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)|An Open-Label, Single-Group Clinical Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Mepesuccinate Given Subcutaneously as a Fixed Dose inPatients With Chronic Phase or Accelerated Phase Chronic Myeloid Leukemia Who Have Failed 2 or More Tyrosine Kinase Inhibitor Therapies|Recruiting||Phase 1/Phase 2|112|Anticipated|Teva Pharmaceutical Industries||1|||f||||t|t|f||||||||2017-10-11 00:41:56.627788|2017-10-11 00:41:56.627788
NCT02078947|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-05-30|||June 2014||2014-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|OptimEx-Clin||Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure|Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure- Clinical Study|Active, not recruiting||N/A|180|Actual|Technische Universität München||3|||f||||t||||||||||2017-10-11 00:41:56.800456|2017-10-11 00:41:56.800456
NCT02078934|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-04-23|||April 2015||2015-04-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Endoscopic Gastric Plication for Weight Loss in Morbidly Obese Patients Prior to Incisional Hernia Repair|Endoscopic Gastric Plication for Weight Loss in Morbidly Obese Patients Prior to Incisional Hernia|Unknown status|Recruiting|N/A|15|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 00:41:56.956485|2017-10-11 00:41:56.956485
NCT02078921|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-11-04|||October 2012||2012-10-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effects of Inorganic Nitrate on Cardiac Muscle in Angina|The Effects of Inorganic Nitrate on Cardiac Muscle: Physiology, Pharmacology and Therapeutic Potential in Patients Suffering From Angina|Completed||Phase 2|70|Anticipated|University of Aberdeen||2|||f||||t||||||||||2017-10-11 00:41:57.067836|2017-10-11 00:41:57.067836
NCT02078908|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-10-08|||September 2013||2013-09-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Healthy Humans. A Dose-response Study|The Effect of Sodium Nitrite on Renal Variables, Brachial and Central Blood Pressure in Healthy Humans. A Randomized, Cross Over, Placebo Controlled Dose-response Study|Completed||Phase 1|12|Actual|Regional Hospital Holstebro||4|||f||||t||||||||||2017-10-11 00:41:57.191349|2017-10-11 00:41:57.191349
NCT02078895|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-05-23|||February 2014||2014-02-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Randomization of Botox for Stent Pain and Irritative Voiding Symptoms|Prospective Randomized Evaluation of Peri-Ureteral and Intradetrusor Injection of Botulinum Toxin Type A for the Treatment of Ureteral Stent Related Pain and Irritative Voiding Symptoms|Terminated||Phase 3|15|Actual|University of California, Irvine||2||The study was terminated due to low enrollment|f||||f||||||||No||2017-10-11 00:41:57.303682|2017-10-11 00:41:57.303682
NCT02078882|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-06-19|||September 2014||2014-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PBC||Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis|Abatacept For The Treatment Of Primary Biliary Cirrhosis With An Incomplete Biochemical Response To Ursodeoxycholic Acid|Active, not recruiting||Phase 4|20|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-11 00:41:57.397089|2017-10-11 00:41:57.397089
NCT02078869|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-04|||March 2014||2014-03-01|March 2014|2014-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Uterine Contractions and Mode of Progesterone in Frozen Embryo Transfer (FET) Cycles: Randomized Clinical Trial|Uterine Contractions and Mode of Progesterone in Frozen Embryo Transfer (FET) Cycles: Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|34|Anticipated|Toronto Centre for Advanced Reproductive Technology||2|||f||||t||||||||||2017-10-11 00:41:57.485208|2017-10-11 00:41:57.485208
NCT02078856|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-10-12|||March 2014||2014-03-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Double-blind, Randomised Study of A3384 in BAM/BAD|A Phase II, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of A3384 in Patients With Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD)|Completed||Phase 2|19|Actual|Albireo||3|||f||||f||||||||||2017-10-11 00:41:57.565187|2017-10-11 00:41:57.565187
NCT02078843|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-09-05|||March 2014||2014-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|GaIN||Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors|Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors|Terminated||Phase 1/Phase 2|54|Actual|University Hospital Inselspital, Berne||1||Superiority of one imaging method|f||||f||||||||||2017-10-11 00:41:57.642722|2017-10-11 00:41:57.642722
NCT02078830|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-04-26|||October 2013||2013-10-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|EVDAI||Prospective Randomised Study for Use of CHG Dressing at Entry Site of EVD's to Reduce EVD-associated Infections|EXTERNAL VENTRICULAR DRAIN ASSOCIATED INFECTIONS STUDY (EVDAI-STUDY) - A Prospective Randomised Microbiological Study for Use of 3M™ Tegaderm™ Chlorhexidinegluconate Dressing at Entry Site of EVD's to Reduce EVD-associated Infections|Completed||N/A|57|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 00:41:57.758452|2017-10-11 00:41:57.758452
NCT02078817|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-12-14|||September 2014||2014-09-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Ketamine in Adolescents With Treatment-Resistant Depression|Open-Label Intravenous Subanesthetic Ketamine for Adolescents With Treatment-Resistant Depression|Recruiting||Phase 2|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-11 00:41:57.833514|2017-10-11 00:41:57.833514
NCT02078804|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-09-29|||March 2014||2014-03-01|November 2016|2016-11-01|December 2034|Anticipated|2034-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Colonoscopy and FIT as Colorectal Cancer Screening Test in the Average Risk Population|SCREESCO - Screening of Swedish Colons|Enrolling by invitation||N/A|200000|Anticipated|Uppsala University Hospital||3|||f||||t||||||||||2017-10-11 00:41:57.969254|2017-10-11 00:41:57.969254
NCT02077816|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2014-03-02|||August 2011||2011-08-01|March 2014|2014-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Using a Infrared Thermometer to the Early Detection of Catheter Related Infections|Using Non-contact Infrared Thermometry to Detection of Central Venous Catheter Related Infection.|Completed||N/A|39|Actual|University of Sao Paulo|||1||f||||f||||||||||2017-10-11 00:42:09.400297|2017-10-11 00:42:09.400297
NCT02078791|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-09-15|||July 2012||2012-07-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|Fibroebre||Discomfort and Psychosocial Difficulties in Fibromyalgia|Perception of Discomfort and Psychosocial Difficulties in People With Diagnosis of Fibromyalgia and Predominant Neck Pain|Completed||Phase 4|66|Actual|University Rovira i Virgili||3|||f||||t||||||||||2017-10-11 00:41:58.073454|2017-10-11 00:41:58.073454
NCT02078778|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2015-01-30|||February 2014||2014-02-01|January 2015|2015-01-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|HOSI||Central and Peripheral Blood Pressure in Treatment of Obstructive Sleep Apnea.|Central and Peripheral 24-h Blood Pressure Monitoring in Patients With Hypertension and Obstructive Sleep Apnea Before and After Treatment With Continuous Positive Airway Pressure.|Unknown status|Recruiting|N/A|20|Anticipated|Regional Hospital Holstebro||1|||f||||f||||||||||2017-10-11 00:41:58.184548|2017-10-11 00:41:58.184548
NCT02078765|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2014-10-08|||January 2014||2014-01-01|October 2014|2014-10-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Observational|HOSA||Nocturnal Blood Pressure and Hypertension - Central and Peripheral 24-h Blood Pressure.|Nocturnal Blood Pressure in Hypertension, Obstructive Sleep Apnea and Healthy Subjects - Central and Peripheral 24-h Blood Pressure|Enrolling by invitation||N/A|150|Anticipated|Regional Hospital Holstebro|||2||f||||f||||||Samples Without DNA|"     whole blood, serum, urine   "|||2017-10-11 00:41:58.302826|2017-10-11 00:41:58.302826
NCT02078752|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-07-11|||April 2014|Actual|2014-04-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||A Study Of PF-06647263 In Patients With Advanced Solid Tumors|A First-in-human Phase 1, Dose Escalation, Safety And Pharmacokinetic Study Of Pf-06647263 In Adult Patients With Advanced Solid Tumors|Completed||Phase 1|60|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:41:58.410021|2017-10-11 00:41:58.410021
NCT02078739|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-01-26|||June 2013||2013-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Tele-yoga||Tele-yoga Program in COPD and Heart Failure|Tele-Yoga for Chronic Obstructive Pulmonary Disease and Heart Failure Patients: A Pilot Study|Completed||N/A|14|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:41:58.556026|2017-10-11 00:41:58.556026
NCT02078726|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-01-19|||April 2014||2014-04-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Glucagon and Colonoscopy|Role of Glucagon in Outpatient Colonoscopy? A Prospective Double-Blind Randomized Controlled Trial|Recruiting||Phase 4|200|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:41:58.627215|2017-10-11 00:41:58.627215
NCT02078700|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2017-07-06|||July 2013||2013-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|||Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.|Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.|Completed||Phase 2|40|Actual|Arcispedale Santa Maria Nuova-IRCCS||1|||f||||f||||||||||2017-10-11 00:41:58.831883|2017-10-11 00:41:58.831883
NCT02078687|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-10-26|||October 2010||2010-10-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|April 2015|Actual|2015-04-01||Interventional|||Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition|Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Nutrition in the First Four Month After Hospital Discharge|Completed||N/A|239|Actual|University of Southern Denmark||3|||f||||t||||||||||2017-10-11 00:42:00.418479|2017-10-11 00:42:00.418479
NCT02078674|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2016-09-20||2016-09-20|March 2014||2014-03-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant|A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™|Completed||Phase 1/Phase 2|610|Actual|Novavax||8|||f||||t||||||||||2017-10-11 00:42:00.608454|2017-10-11 00:42:00.608454
NCT02078648|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-10-03|||May 2014||2014-05-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme|A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients With Recurrent Glioblastoma Multiforme (GBM)|Active, not recruiting||Phase 1/Phase 2|74|Actual|Stemline Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 00:42:00.885889|2017-10-11 00:42:00.885889
NCT02078635|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-04-25||||||April 2017|2017-04-01|October 7, 2014|Actual|2014-10-07|October 7, 2014|Actual|2014-10-07||Interventional|MRIPD#7||Magnetic Resonance Imaging-Portfolio Diet Study #7|The Canada-wide Human Nutrition Trialists' Network|Withdrawn||N/A|0|Actual|St. Michael's Hospital, Toronto||2||Study was amalgamated with another study to include exercise as another intervention.|f||||f||||||||||2017-10-11 00:42:01.043535|2017-10-11 00:42:01.043535
NCT02078622|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2016-04-18|||March 2014||2014-03-01|November 2015|2015-11-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01|24 Weeks|Observational [Patient Registry]|RTQOL||Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients With COPD|A Prospective Randomized Controlled Trial to Evaluate the Use of Respiratory Therapists (RTs) to Improve Outcomes and Quality of Life in Patients Diagnosed With COPD|Completed||N/A|114|Actual|StratiHealth|||1||f||||t||||||||||2017-10-11 00:42:01.212242|2017-10-11 00:42:01.212242
NCT02078401|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-07-01|||April 2014||2014-04-01|July 2014|2014-07-01||||August 2014|Anticipated|2014-08-01||Observational|||Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.|Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.|Unknown status|Recruiting|N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 00:42:04.055401|2017-10-11 00:42:04.055401
NCT02078609|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-10-02|||March 20, 2014|Actual|2014-03-20|October 2017|2017-10-01|September 3, 2019|Anticipated|2019-09-03|March 30, 2018|Anticipated|2018-03-30||Interventional|||A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)|A Phase I, Multicenter, Open-label Study of Oral LGH447 in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome|Recruiting||Phase 1|86|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-11 00:42:01.294931|2017-10-11 00:42:01.294931
NCT02078596|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2017-01-03|||March 1997||1997-03-01|December 2016|2016-12-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Depakote (Divalproex Sodium) for Children With Temper Dysregulation and Severe Mood Swings|Double Blind Placebo Controlled Study of Depakote (Divalproex Sodium) in Children With Temper Outbursts and Severe Mood Swings|Completed||Phase 4|15|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 00:42:01.511543|2017-10-11 00:42:01.511543
NCT02078583|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-07-15|||July 2014||2014-07-01|July 2014|2014-07-01||||June 2015|Anticipated|2015-06-01||Interventional|||The Effect of Analgesia Based Sedation Protocol on Brain Function of Critical Care Patients||Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Peking University People's Hospital||3|||f||||||||||||||2017-10-11 00:42:01.657882|2017-10-11 00:42:01.657882
NCT02078570|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-09-29|||March 2014||2014-03-01|November 2015|2015-11-01||||July 2017|Anticipated|2017-07-01||Observational|||Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol||Active, not recruiting||N/A|500|Anticipated|Provista Diagnostics, Inc|||1||f||||||||||Samples Without DNA|"     35mL or 2 1/2 tablespoons of blood will be drawn from your arm   "|||2017-10-11 00:42:01.782802|2017-10-11 00:42:01.782802
NCT02078557|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-11-02|||May 2014||2014-05-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Multiple Dose Titration Study of MK-8892 in Participants With Pulmonary Hypertension and Left Heart Disease (MK-8892-007)|A Multiple Dose Titration Trial to Study the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8892 in Patients With Pulmonary Hypertension and Left Heart Disease|Terminated||Phase 1|16|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 00:42:01.891743|2017-10-11 00:42:01.891743
NCT02078544|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-03-03|||December 2013||2013-12-01|March 2014|2014-03-01||||August 2018|Anticipated|2018-08-01||Observational|||Integrated Molecular Analysis of Cancer in Gynaecologic Oncology (IMAC-GO)||Recruiting||N/A|700|Anticipated|National University Hospital, Singapore|||1||f||||f||||||Samples With DNA|"     I. Tumour samples from patients with a diagnosis of gynaecological cancer from year 1995 to     31 July 2013 will be obtained from the pathology archives and tissue repository.      II. Blood, tumour and ascitic and pleural fluid samples will be prospectively collected.   "|||2017-10-11 00:42:01.981511|2017-10-11 00:42:01.981511
NCT02078531|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-03-03||||||March 2014|2014-03-01||||February 2016|Anticipated|2016-02-01||Observational|||A Prospective Pilot Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive and Brain Function of Breast Cancer Patients||Unknown status|Not yet recruiting|N/A|130|Anticipated|National University Hospital, Singapore|||1||f||||f||||||Samples With DNA|"     Whole blood.   "|||2017-10-11 00:42:02.077508|2017-10-11 00:42:02.077508
NCT02078518|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-03-03|||September 2013||2013-09-01|March 2014|2014-03-01||||August 2014|Anticipated|2014-08-01||Observational|||Level of Physical Activity and Its Associations With Fatigue and Quality of Life in Multiple Myeloma Survivors||Unknown status|Recruiting|N/A|75|Anticipated|National University Hospital, Singapore|||1||f||||f||||||||||2017-10-11 00:42:02.192729|2017-10-11 00:42:02.192729
NCT02078505|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-10|||April 2014||2014-04-01|March 2014|2014-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Gut Microbiome in Patients With Polycystic Ovary Syndrome|The Effect of Diet on the Microbiome of Women With Polycystic Ovary Syndrome|Unknown status|Not yet recruiting|N/A|60|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-11 00:42:02.333805|2017-10-11 00:42:02.333805
NCT02078492|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-02-25|2017-01-03||March 2014||2014-03-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Prospective Randomized Double-Blind Trial Comparing 3 Doses of Intravenous Ketorolac for Pain Management|"A Prospective Randomized Double-Blind Trial Comparing 3 Doses of Intravenous Ketorolac for Pain Management in the Emergency Department"|Completed||Phase 4|240|Actual|Maimonides Medical Center||3|||f||||f||||||||No||2017-10-11 00:42:02.476378|2017-10-11 00:42:02.476378
NCT02078479|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2014-03-01|||January 2010||2010-01-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||rTMS as a Treatment of Neuropathic Pain Secondary to Malignancy|Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain Secondary to Malignancy.|Completed||N/A|34|Actual|Assiut University||2|||f||||f||||||||||2017-10-11 00:42:02.924737|2017-10-11 00:42:02.924737
NCT02078466|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-01|2016-12-09|||March 2014||2014-03-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Assessment of Functional Ability and Follow-up at Home for Older Medical Patients|Assessment of Functional Ability and Follow-up at Home for Older Medical Patients|Completed||N/A|380|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 00:42:03.017442|2017-10-11 00:42:03.017442
NCT02078453|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-08-08|||March 2014||2014-03-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|CARDEC-1||Impact of the Radiographic Examination on Diagnosis and Treatment Decision of Caries Lesions in Primary Teeth|CARies DEtection in Children - Impact of the Radiographic Examination on Diagnosis and Treatment Decision of Caries Lesions in Primary Teeth|Active, not recruiting||N/A|250|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:42:03.131449|2017-10-11 00:42:03.131449
NCT02078440|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-08-26|||January 2014||2014-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects|Single Dose Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets Following Administration of a Weight-Adjusted Dose in Male and Female Children and Adolescent Type 2 Diabetes Mellitus Subjects VS-PEDS BA-2010-V4|Completed||Phase 1|18|Actual|VeroScience||1|||f||||t||||||||||2017-10-11 00:42:03.220816|2017-10-11 00:42:03.220816
NCT02078427|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-03-10|||June 2011||2011-06-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|AHEAD||ADVATE Hemophilia A Outcome Database (AHEAD)|ADVATE Hemophilia A Outcome Database|Recruiting||N/A|500|Anticipated|Baxalta US Inc.|||1||f||||f||||||||||2017-10-11 00:42:03.350772|2017-10-11 00:42:03.350772
NCT02078414|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2015-11-25|||March 2014||2014-03-01|November 2015|2015-11-01||||February 2015|Actual|2015-02-01||Observational|||Continued Use of Effective Contraception After Use of Emergency Contraception||Completed||N/A|7|Actual|Karolinska Institutet|||2||f||||||||||||||2017-10-11 00:42:03.931289|2017-10-11 00:42:03.931289
NCT02078375|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-08-15|||February 2014|Actual|2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRESSRA||The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis|The PRESS RA Study: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis|Suspended||N/A|50|Anticipated|Johns Hopkins University||2||Funding ended, waiting to secure additional sources|f||||f||||||||||2017-10-11 00:42:04.275163|2017-10-11 00:42:04.275163
NCT02078362|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-06-11|||September 2013||2013-09-01|June 2015|2015-06-01|May 2018|Anticipated|2018-05-01|May 2016|Anticipated|2016-05-01||Observational|||ADCC Against Gastric Cancer Cells|Evaluation of Antibody-dependent Cell Cytotoxicity (ADCC) Against Gastric Cancer Cells|Recruiting||N/A|30|Anticipated|National University Hospital, Singapore|||1||f||||f||||||Samples With DNA|"     Peripheral blood   "|||2017-10-11 00:42:04.38399|2017-10-11 00:42:04.38399
NCT02078349|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-06-21|||February 2014||2014-02-01|June 2016|2016-06-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase I Study of KPT330 in Asian Patients|An Investigator Sponsored Phase I Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Doses Followed by Dose Expansion of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Asian Patients With Advanced or Metastatic Solid Tumor Malignancies|Recruiting||Phase 1|120|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-11 00:42:04.472284|2017-10-11 00:42:04.472284
NCT02078336|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-28|||December 2013||2013-12-01|November 2013|2013-11-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|OptiSeDent||Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability|Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability|Unknown status|Recruiting|Phase 4|40|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:42:04.577662|2017-10-11 00:42:04.577662
NCT02078323|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-06-26|||February 2014||2014-02-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients|Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients|Recruiting||N/A|45|Anticipated|Augusta University||2|||f||||t||||||||||2017-10-11 00:42:04.676846|2017-10-11 00:42:04.676846
NCT02078310|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-11-25|||February 2014||2014-02-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia|A Randomized, Double-blind, Placebo-controlled, Multiple Oral Dose Escalation for Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia.|Completed||Phase 1/Phase 2|35|Actual|Intra-Cellular Therapies, Inc.||2|||f||||||||||||||2017-10-11 00:42:04.772926|2017-10-11 00:42:04.772926
NCT02078297|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-03-25|||February 2014||2014-02-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|||IL-17 Role in Variants of Psoriasis|Role of Il-17a in Difficult to Treat Variants of Psoriasis Including Palmo-plantar Psoriasis|Completed||N/A|90|Anticipated|Innovaderm Research Inc.|||6||f||||f||||||Samples With DNA|"     Skin biopsies and blood samples will be taken. Samples will be retained until final analyses     have been performed according to protocol and destroyed thereafter.   "|||2017-10-11 00:42:04.857725|2017-10-11 00:42:04.857725
NCT02078284|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-08-12|||August 2014||2014-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets|Dose Escalation Study Evaluating the Safety of Dimethyl Sulfoxide Cryopreserved Platelets Compared With Liquid Stored Platelets in Patients With Uncontrolled Bleeding|Completed||Phase 1|28|Actual|U.S. Army Medical Research and Materiel Command||8|||f||||t||||||||||2017-10-11 00:42:04.971587|2017-10-11 00:42:04.971587
NCT02078271|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-03|||January 2011||2011-01-01|March 2014|2014-03-01|May 2014|Anticipated|2014-05-01|December 2011|Actual|2011-12-01||Interventional|FIRST||Food-Based Intervention and Psychosocial Stimulation to Improve Growth & Development of < 24 Month Indonesian Children|Food-Based Intervention and Psychosocial Stimulation to Improve Growth & Development of < 24 Month Indonesian Children|Unknown status|Active, not recruiting|Phase 3|480|Actual|Indonesia University||4|||f||||f||||||||||2017-10-11 00:42:05.116938|2017-10-11 00:42:05.116938
NCT02078258|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-08-19|||September 2012||2012-09-01|August 2014|2014-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Attention Bias Modification Treatment for Major Depression Disorder in Adolescents|Attention Bias Modification Treatment for Major Depression Disorder in Adolescents: A Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|45|Anticipated|Hunan Normal University||2|||f||||f||||||||||2017-10-11 00:42:05.243538|2017-10-11 00:42:05.243538
NCT02078245|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-11-02|||August 2010||2010-08-01|November 2016|2016-11-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01|15 Years|Observational [Patient Registry]|||Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer.|Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer|Recruiting||N/A|100|Anticipated|Karolinska University Hospital|||1||f||||f||||||Samples With DNA|"     Bloodsamples   "|||2017-10-11 00:42:05.35102|2017-10-11 00:42:05.35102
NCT02078232|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-04-19|||April 2013||2013-04-01|November 2016|2016-11-01|January 23, 2017|Actual|2017-01-23|July 6, 2016|Actual|2016-07-06||Interventional|EASYFLEX||Comparison of Two Needles (19G Flex Versus 22G Standard) for Pancreatic Solid Tumors Diagnosis|Randomized, Comparative Study of 19G Flex Versus 22G Standard Needles for Pancreatic Solid Tumors Diagnosis.|Completed||N/A|124|Actual|French Society of Digestive Endoscopy||2|||f||||f||||||||No||2017-10-11 00:42:05.494419|2017-10-11 00:42:05.494419
NCT02078219|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-03-25|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia|A Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel Group, 24-Week Phase II Study to Evaluate Efficacy and Safety of RDEA3170 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg Versus Placebo and Open-Label Allopurinol 200 mg as a Reference Arm in Japanese Patients With Gout or Asymptomatic Hyperuricemia|Completed||Phase 2|381|Actual|AstraZeneca||5|||f||||t||||||||||2017-10-11 00:42:05.595085|2017-10-11 00:42:05.595085
NCT02078206|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-02-09|||April 2014||2014-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|ENRIC||Early Neurocognitive Rehabilitation in Intensive Care|Early Neurocognitive Rehabilitation in Intensive Care|Recruiting||N/A|50|Anticipated|Corporacion Parc Tauli||2|||f||||||||||||||2017-10-11 00:42:05.71648|2017-10-11 00:42:05.71648
NCT02078193|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2017-07-06|2017-05-16||November 2013||2013-11-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy of Belatacept in Reducing DSA|An Exploratory, Open-label, Single Center Study to Assess the Efficacy of NULOJIX (Belatacept) in Reducing Donor Specific Human Leukocyte Antigen (HLA) Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients|Completed||Phase 4|3|Actual|East Carolina University||1|||f||||f||||||||||2017-10-11 00:42:05.825481|2017-10-11 00:42:05.825481
NCT02078180|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-09-01|2017-07-11||April 2014||2014-04-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns|Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns|Completed||Phase 4|34|Actual|University of Michigan|The small study sample size may have masked the contribution of pharmacogenetics to bupropion metabolism.|6|||f||||f||||||||||2017-10-11 00:42:06.04872|2017-10-11 00:42:06.04872
NCT02078167|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-03|2014-03-04|||January 2009||2009-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|January 2011|Actual|2011-01-01||Interventional|||Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled Study|Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled Study|Completed||Phase 4|60|Actual|Comitato Etico di Area Vasta Sud Est|||||f||||t||||||||||2017-10-11 00:42:06.350411|2017-10-11 00:42:06.350411
NCT02078154|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-06-02|||April 2014||2014-04-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis|Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis|Terminated||N/A|6|Actual|Diagnostica Stago|||1|Decision to start a new study on DVT with another protocol|f||||t||||||Samples Without DNA|"     Plasma samples   "|||2017-10-11 00:42:06.423217|2017-10-11 00:42:06.423217
NCT02078141|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-01-17|||June 2014||2014-06-01|January 2017|2017-01-01||||May 2018|Anticipated|2018-05-01||Interventional|||18F-deoxyglucose (FDG) PET-CMD|Monocentric, Prospective, Uncontrolled Pilot Study of Extra Cardiomyocytary Fixation Profile in 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography in Patients With Dilated Cardiomyopathy.|Active, not recruiting||N/A|30|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 00:42:06.635243|2017-10-11 00:42:06.635243
NCT02078128|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-03-03|||July 2011||2011-07-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|August 2011|Actual|2011-08-01||Interventional|||To Study the Effect of β-glucans on Wound Healing|To Study the Effect of β-glucans on Wound Healing|Completed||N/A|30|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:42:06.732881|2017-10-11 00:42:06.732881
NCT02078115|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-03-03|||April 2013||2013-04-01|March 2014|2014-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01|1 Year|Observational [Patient Registry]|||Assessment of Blood Pressure Control and Target Organ Damage in Patients With Chronic Kidney Disease and Hypertension -II|Observational Study of Blood Pressure Control Pattern and the Impact on the Target Organ Damages|Unknown status|Recruiting|N/A|400|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 00:42:06.8114|2017-10-11 00:42:06.8114
NCT02078102|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-09-07|||March 11, 2014|Actual|2014-03-11|September 2017|2017-09-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma|A Phase II Trial of Prostaglandin E2 Inhibition, Using Meloxicam, Plus Filgrastim for Mobilization of Autologous Peripheral Blood Stem Cells in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma|Recruiting||Phase 2|32|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-11 00:42:06.897958|2017-10-11 00:42:06.897958
NCT02078089|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-01-27|||March 6, 2014|Actual|2014-03-06|January 2017|2017-01-01|December 11, 2014|Actual|2014-12-11|December 11, 2014|Actual|2014-12-11||Interventional|||Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain|A Phase Ib Study of Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain|Terminated||Phase 1|1|Actual|Indiana University||1||Poor Accrual|f||||t|t|f||||||||2017-10-11 00:42:07.01773|2017-10-11 00:42:07.01773
NCT02078076|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-02-23|||June 2013||2013-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère|IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère|Completed||N/A|22|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 00:42:07.127994|2017-10-11 00:42:07.127994
NCT02078063|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-11-25|||November 2013||2013-11-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Analgesia for Insertion of Intrauterine Contraception|Mepivacaine for Pain Relief at Insertion of Intrauterine Contraception|Recruiting||Phase 3|72|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:42:07.232688|2017-10-11 00:42:07.232688
NCT02078050|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-01-11|||November 2013||2013-11-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Volontary Inspiratory Muscles Measures Compared With Phrenic Nerves Magnetic Stimulations Measures|Volontary Inspiratory Muscles Measures Compared With Phrenic Nerves Magnetic Stimulations Measures|Terminated||N/A|54|Actual|Centre d'Investigation Clinique et Technologique 805||1|||f||||t||||||||||2017-10-11 00:42:07.347631|2017-10-11 00:42:07.347631
NCT02078037|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-01-06|||March 2014||2014-03-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SNICH||Systemic Normothermia in Intracerebral Hemorrhage (ICH)|Systemic Normothermia in Intracerebral Hemorrhage (ICH)|Completed||Early Phase 1|9|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-11 00:42:07.429294|2017-10-11 00:42:07.429294
NCT02078024|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-07-25|||June 2014||2014-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana|Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis in the Volta Region, Ghana.|Active, not recruiting||Phase 3|375|Anticipated|University Hospitals Cleveland Medical Center||5|||f||||t||||||||||2017-10-11 00:42:07.522875|2017-10-11 00:42:07.522875
NCT02078011|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-11-14|||April 2014||2014-04-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|HIFU-FA-001||Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound|Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU): A Feasibility Study|Active, not recruiting||N/A|20|Anticipated|University of Virginia||1|||f||||t||||||||||2017-10-11 00:42:07.621145|2017-10-11 00:42:07.621145
NCT02077998|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-01-04|||May 2015||2015-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Oxaliplatin in Treating Patients With Metastatic Breast Cancer|A Diagnostic Feasibility Trial of a [14C]Oxaliplatin Microdosing Assay for Prediction of Chemoresistance to Oxaliplatin Chemotherapy|Completed||Early Phase 1|1|Actual|University of California, Davis||1|||f||||t||||||||||2017-10-11 00:42:07.70191|2017-10-11 00:42:07.70191
NCT02077985|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-28|||October 2012||2012-10-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|SADE||Sensory Adapted Dental Environment to Enhance Oral Care for Children With ASD|Sensory Adapted Dental Environment to Enhance Oral Care for Children With Autism|Completed||N/A|45|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 00:42:07.808818|2017-10-11 00:42:07.808818
NCT02077972|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-08-06|||March 2014||2014-03-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|PTSD + WBH||Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)|Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)|Terminated||N/A|3|Actual|University of Arizona||1||Investigator transferred to the University of Wisconsin - Madison|f||||f||||||||||2017-10-11 00:42:07.899011|2017-10-11 00:42:07.899011
NCT02077959|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-02-03|||March 3, 2014|Actual|2014-03-03|February 2017|2017-02-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma|Phase I/II Study of Lenalidomide in Combination With Anti-PD-1 Monoclonal Antibody CT-011 in Patients With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|20|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:42:07.987357|2017-10-11 00:42:07.987357
NCT02077946|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-05-29|||February 10, 2014|Actual|2014-02-10|May 2017|2017-05-01|September 3, 2014|Actual|2014-09-03|September 3, 2014|Actual|2014-09-03||Observational|||A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden|A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden|Completed||N/A|1059|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 00:42:08.104978|2017-10-11 00:42:08.104978
NCT02077933|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-11-28|||May 2014||2014-05-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors|A Phase Ib Dose-finding Study of BYL719 Plus Everolimus and BYL719 Plus Everolimus Plus Exemestane in Patients With Advanced Solid Tumors, With Dose-expansion Cohorts in Renal Cell Cancer (RCC), Pancreatic Neuroendocrine Tumors (pNETs), and Advanced Breast Cancer (BC) Patients.|Active, not recruiting||Phase 1|78|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:42:08.209093|2017-10-11 00:42:08.209093
NCT02077920|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-02-15|||March 2014||2014-03-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|VAP||Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)|Prevention of Ventilator-Associated Pneumonia by Oropharyngeal and Subglottic Decontamination Via Bronchoscopy|Recruiting||Phase 2|192|Anticipated|General Hospital of Shenyang Military Region||4|||f||||t||||||||No||2017-10-11 00:42:08.361214|2017-10-11 00:42:08.361214
NCT02077907|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-02-02|||January 2014||2014-01-01|February 2015|2015-02-01||||July 2014|Actual|2014-07-01||Interventional|||Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition (MAM) in Children in Sierra Leone: a Cluster-randomised, Controlled Clinical Effectiveness Trial||Terminated||N/A|1147|Actual|Tufts University||4||Due to Ebola virus disease outbreak|f||||f||||||||||2017-10-11 00:42:08.475537|2017-10-11 00:42:08.475537
NCT02077894|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-06-30|||February 21, 2014||2014-02-21|June 21, 2017|2017-06-21|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions|Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions|Recruiting||N/A|310|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:42:08.563041|2017-10-11 00:42:08.563041
NCT02077881|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-06-16|||August 2014||2014-08-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer|A Phase I/II Study of Indoximod in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Adenocarcinoma of the Pancreas|Recruiting||Phase 1/Phase 2|98|Anticipated|NewLink Genetics Corporation||1|||f||||t||||||||||2017-10-11 00:42:08.662354|2017-10-11 00:42:08.662354
NCT02077868|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-06-22|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|March 2019|Anticipated|2019-03-01||Interventional|IMPALA||Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment|Evaluation of an Immunomodulatory Maintenance Treatment in Patients With Metastatic Colorectal Cancer With Tumor Reduction During Induction Treatment|Active, not recruiting||Phase 3|540|Anticipated|Mologen AG||2|||f||||t||||||||||2017-10-11 00:42:08.84154|2017-10-11 00:42:08.84154
NCT02077855|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-05-27|||January 2016||2016-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Value of Sonographic Diagnosis of Toddler's Fracture of the Tibia||Recruiting||N/A|100|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-11 00:42:09.170108|2017-10-11 00:42:09.170108
NCT02077842|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2016-10-27|||May 2014||2014-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Prophylactic nCPAP in the PACU Following Elective Laparotomy for Bowel Surgery|Prophylactic Nasal Continuous Positive Airway Pressure in the Post-Anaesthesia Care Unit Following Elective Laparotomy for Bowel Surgery|Completed||N/A|40|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 00:42:09.236466|2017-10-11 00:42:09.236466
NCT02077829|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-01-11|||March 2014||2014-03-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Implementation of Illness Management and Recovery in Mental Health Services|Implementation of Illness Management and Recovery in Mental Health Services: Facilitators and Barriers in the Implementation Process.|Completed||N/A|40|Actual|University Hospital, Akershus||1|||f||||f||||||||||2017-10-11 00:42:09.319964|2017-10-11 00:42:09.319964
NCT02075970|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-11-09|||June 2014||2014-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|OETNA||Optimized Erythropoietin (EPO) Treatment|Optimized EPO Treatment of Neonatal Anemia|Recruiting||Phase 2|62|Anticipated|University of Iowa||3|||f||||t||||||||||2017-10-11 00:42:32.823822|2017-10-11 00:42:32.823822
NCT02077803|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-09-02|||March 2014||2014-03-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants|A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin XR Tablet (4 x 500 mg) in Healthy Fed Subjects|Completed||Phase 1|47|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 00:42:09.594272|2017-10-11 00:42:09.594272
NCT02077777|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-12-01|||October 2012||2012-10-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||"Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an in Vivo Evaluation of the Molecular Effects on β-catenin Signaling Pathway."|"Azione Chemiopreventiva Della Mesalazina Sul Cancro Del Colon-retto: Studio Pilota Per la Valutazione Degli Effetti Molecolari in Vivo Sulla Via di Segnalazione Proliferativa Della β-catenina (Official Title in Italian Language)"|Completed||Phase 2|21|Actual|SOFAR S.p.A.||2|||f||||f||||||||No||2017-10-11 00:42:09.765236|2017-10-11 00:42:09.765236
NCT02077764|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-04-13|||September 2013||2013-09-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01|5 Years|Observational [Patient Registry]|||The GRAFT Study: Evaluation of Graft Function, Rejection and Cardiac Allograft Vasculopathy in First Heart Transplant Recipients.|The GRAFT Study: Evaluation of Graft Function, Rejection and Cardiac Allograft Vasculopathy in First Heart Transplant Recipients.|Completed||N/A|65|Actual|Aarhus University Hospital Skejby|||2||f||||t||||||Samples Without DNA|"     At each visit blood samples are taken. These will include:      1 x 10 ml EDTA-blood      1 x 10 ml Lithiumheparin-blood      1 x 10ml Koagel -blood   "|||2017-10-11 00:42:09.854544|2017-10-11 00:42:09.854544
NCT02077751|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-04-19|||May 2013||2013-05-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||BioRBC Survival in Adults With Prior Antibody Response to BioRBCs|BioRBC Survival in Adults With Prior Antibody Response to BioRBCs|Recruiting||Phase 1|4|Anticipated|University of Iowa||1|||f||||t||||||||||2017-10-11 00:42:09.966691|2017-10-11 00:42:09.966691
NCT02077738|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-03-02|||January 2011||2011-01-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||HFCWO in Prolonged Mechanical Ventilation Patients|High-frequency Chest Wall Oscillation in Prolonged Mechanical Ventilation Patients-a Randomized Controlled Trial|Completed||N/A|45|Actual|Taichung Veterans General Hospital||2|||f||||f||||||||||2017-10-11 00:42:10.147755|2017-10-11 00:42:10.147755
NCT02077725|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2014-10-21|||December 2013||2013-12-01|October 2014|2014-10-01||||December 2014|Anticipated|2014-12-01||Observational|||Measuring the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-centered Medical Home|Measure the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-entered Medical Home|Unknown status|Recruiting|N/A|100|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-11 00:42:10.261814|2017-10-11 00:42:10.261814
NCT02077712|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-04-29|||February 2014||2014-02-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|DEX-EYE||Intranasal Dexmedetomidine Sedation for Ophthalmic Examinations in Children|A Randomised Comparison of Two Intranasal Dexmedetomidine Doses for Ophthalmic Examination Following Failed Chloral Hydrate Sedation in Children|Recruiting||N/A|60|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:42:10.37113|2017-10-11 00:42:10.37113
NCT02077699|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-11-27|||March 2012||2012-03-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study|Valutazione Dell'Efficacia Di Una Preparazione Commerciale A Base Di Lactobacillus Casei Dg Nella Riduzione Della Sintomatologia Dolorosa Associata Alla Sindrome Dell' Intestino Irritabile (Sii). Studio Clinico Pilota. (Official Title in Italian Language)|Completed||Phase 4|10|Actual|SOFAR S.p.A.||1|||f||||f||||||||||2017-10-11 00:42:10.51819|2017-10-11 00:42:10.51819
NCT02077686|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-02-13|||February 2014||2014-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIMO_Travel||Diabetes and Travel: Evaluation of a Diabetes Education Module - a Randomized Controlled Trial (PRIMO_Travel)|"A Prospective Multi-center Evaluation of a Diabetes Education Module Specifically Addressing the Topic Diabetes and Travel in a Randomized Controlled Trial"|Recruiting||N/A|200|Anticipated|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||f||||||||||2017-10-11 00:42:10.633805|2017-10-11 00:42:10.633805
NCT02077673|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-05-03|||December 2013||2013-12-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01|90 Days|Observational [Patient Registry]|||Gastric Microperfusion in Patients Undergoing Gastroesophageal Resections|Robotic Assisted Laparoscopy Versus Open Gastroesophageal Resection; Effects on the Mesenteric Traction Reflex and PGI2 Levels|Completed||N/A|50|Actual|Rigshospitalet, Denmark|||2||f||||t||||||Samples Without DNA|"     Serum Tissue   "|||2017-10-11 00:42:10.782865|2017-10-11 00:42:10.782865
NCT02077660|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-03-11|||November 2011||2011-11-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|GT||Green Tea Effect on Anthropometric, Oxidation and Inflammation Parameters in Physically Active vs. Sedentary Elders|The Effect of Green Tea on Anthropometric, Oxidation and Inflammation Parameters in Physically Active Elderly Compared to Sedentary Elderly|Completed||N/A|43|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 00:42:10.914324|2017-10-11 00:42:10.914324
NCT02077647|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-01-23|||March 2014||2014-03-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|April 2015|Actual|2015-04-01|24 Months|Observational [Patient Registry]|||Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee|A Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee|Active, not recruiting||N/A|20|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 00:42:11.024721|2017-10-11 00:42:11.024721
NCT02077634|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-11-03|||May 2014||2014-05-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Interventional|SPARE||Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)|Randomized Phase-II Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)|Recruiting||Phase 2|70|Anticipated|Association of Urogenital Oncology (AUO)||2|||f||||t||||||||||2017-10-11 00:42:11.163709|2017-10-11 00:42:11.163709
NCT02077621|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-09-18|||July 2018|Anticipated|2018-07-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer|The Phase II Clinical Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer|Not yet recruiting||Phase 2|50|Anticipated|PhytoHealth Corporation||2|||f||||f|f|f||||||||2017-10-11 00:42:11.344131|2017-10-11 00:42:11.344131
NCT02077608|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-03-03|||January 2010||2010-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|August 2012|Actual|2012-08-01||Observational|||Hyaluronan in Embryo Transfer Media|Effect of Hyaluronan Enriched Embryo Transfer Media on IVF Outcome|Completed||N/A|580|Actual|Semmelweis University|||2||f||||f||||||||||2017-10-11 00:42:11.480033|2017-10-11 00:42:11.480033
NCT02077595|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-03-03|||January 2013||2013-01-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Transcutaneous Electrical Nerve Stimulation on Cortical Excitability in the Primary Motor Cortex in Healthy Adults||Completed||N/A|24|Actual|Chang Gung University||3|||f||||t||||||||||2017-10-11 00:42:11.57745|2017-10-11 00:42:11.57745
NCT02077582|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-03-03|||September 2013||2013-09-01|March 2014|2014-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|LOBI-BBB||Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability|Longitudinal Observation of Brain Ischemia and Blood Brain Barrier Permeability in the Acute Phase of Ischemic Stroke|Recruiting||N/A|410|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"     2x 2ml plasma and 2x 2ml serum per patient   "|||2017-10-11 00:42:11.651951|2017-10-11 00:42:11.651951
NCT02077569|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-05-03|||January 2014||2014-01-01|May 2017|2017-05-01|February 21, 2017|Actual|2017-02-21|February 21, 2017|Actual|2017-02-21||Interventional|STAKT||AKT Inhibitor in Oestrogen Positive Breast Cancer|The Short Term Effects of an AKT Inhibitor (AZD5363) on Biomarkers of the AKT Pathway and Anti-tumour Activity in a Breast Cancer Paired Biopsy Study|Completed||Phase 2|48|Actual|University of Nottingham||4|||f||||t||||||||No||2017-10-11 00:42:11.75815|2017-10-11 00:42:11.75815
NCT02077556|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2017-01-20|||April 2014||2014-04-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients|The Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients, and the Effect of ABCB1、CYP3A4、CYP3A5、PORGenetic Polymorphism on the Two Drugs|Recruiting||Phase 4|70|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:42:11.872116|2017-10-11 00:42:11.872116
NCT02077543|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-08-30|||October 2013||2013-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ProTool||Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma|Molecular and Cellular Print Medical Device Validation in Adult Glioma Tumors|Recruiting||Phase 1|150|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 00:42:11.979455|2017-10-11 00:42:11.979455
NCT02077530|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2017-08-16|||November 2013||2013-11-01|August 2017|2017-08-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01|10 Years|Observational [Patient Registry]|||Metabolic Syndrome Cohort in Korea||Active, not recruiting||N/A|1500|Actual|Korea University Anam Hospital|||1||f||||||||||||||2017-10-11 00:42:12.108831|2017-10-11 00:42:12.108831
NCT02077517|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-02|||January 2007||2007-01-01|March 2014|2014-03-01||||January 2014|Actual|2014-01-01||Interventional|STAVHAS||Stapled vs Hand Sewn Anastomosis in Roux en Y Gastric Bypass for Morbid Obesity: Randomized Clinical Trial|Stapled vs Hand Sewn Anastomosis in Roux en Y Gastric Bypass for Morbid Obesity: Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|400|Anticipated|Hospital Universitario Virgen de la Arrixaca||2|||f||||t||||||||||2017-10-11 00:42:12.180713|2017-10-11 00:42:12.180713
NCT02077504|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-10-24|||September 2013||2013-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|CONDUCTOME||"Glial Tumors Electromagnetic Signature Study by MagnetoEncephaloGraphy (MEG) CONDUCTOME"|Magnetoencephalographic Study of Glial Tumors Electromagnetic Signature|Recruiting||Phase 1|28|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-11 00:42:12.296983|2017-10-11 00:42:12.296983
NCT02077491|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-05-29|||April 2013||2013-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effect of Protein and Resistance Training on Muscle Mass in Acutely Ill Old Medical Patients|The Effect of Protein and Resistance Training on Muscle Mass, Muscle Strength and Functional Ability in Acutely Ill Old Medical Patients; a Randomized Controlled Trial|Completed||N/A|32|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 00:42:12.413084|2017-10-11 00:42:12.413084
NCT02077478|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-09-04|||March 2012||2012-03-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Total Intravenous Anesthesia: TCI Versus MCI|Total Intravenous Anesthesia: TCI Versus MCI, Unresolved Question|Completed||N/A|60|Actual|Università degli Studi di Ferrara||2|||f||||t||||||||||2017-10-11 00:42:12.513304|2017-10-11 00:42:12.513304
NCT02077465|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-02-09|||March 2014||2014-03-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Phase 1 Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 1|11|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 00:42:12.592523|2017-10-11 00:42:12.592523
NCT02077452|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2014-10-29|||March 2014||2014-03-01|March 2014|2014-03-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes|A Randomized, Double-blinded, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of HMS5552 in Adult Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|53|Actual|Hua Medicine Limited||5|||f||||f||||||||||2017-10-11 00:42:12.674999|2017-10-11 00:42:12.674999
NCT02077439|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-02-23|||January 2014||2014-01-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Interactive Intention-Driven Upper-Limb Training Robotic System|Trial: Interactive Intention-Driven Upper-Limb Training Robotic System|Completed||N/A|70|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-11 00:42:12.763077|2017-10-11 00:42:12.763077
NCT02077426|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-09-16|||June 2014||2014-06-01|March 2014|2014-03-01||||June 2016|Anticipated|2016-06-01||Interventional|HF-RSTS||Heart Failure and Regional Specific Exercise Training Stimulus|Heart Failure and Regional Specific Exercise Training Stimulus|Withdrawn||N/A|0|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:42:12.844316|2017-10-11 00:42:12.844316
NCT02077413|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-11-16|||March 2014||2014-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Muscle Injury Prevention & Rehabilitation in Military Personnel|Muscle Injury Prevention & Rehabilitation in Military Personnel|Completed||N/A|41|Actual|University of Florida||4|||f||||t||||||||||2017-10-11 00:42:12.926772|2017-10-11 00:42:12.926772
NCT02077400|ClinicalTrials.gov processed this data on October 10, 2017|2014-03-02|2015-07-09|||January 2006||2006-01-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Prophylactic Antibiotic in Treatment of Fingertip Amputation|The Use of Prophylactic Antibiotic in Treatment of Fingertip Amputation: A Randomized Prospective Trial|Completed||N/A|60|Actual|HaEmek Medical Center, Israel||2|||f||||||||||||||2017-10-11 00:42:13.060433|2017-10-11 00:42:13.060433
NCT02077387|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-02-02|||June 2014||2014-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|CHIC Play||Promoting Child Inhibitory Control Skills Around Food|Promoting Child Inhibitory Control Skills Around Food|Completed||N/A|72|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:42:13.157609|2017-10-11 00:42:13.157609
NCT02077374|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-07-25|2016-03-30||March 2014||2014-03-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|NAFLD||A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases|A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects With Non-Alcoholic Fatty Liver Disease and Raised Transaminases|Completed||Phase 2|38|Actual|Conatus Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 00:42:13.274544|2017-10-11 00:42:13.274544
NCT02077361|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-05-01|||April 2015||2015-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 30, 2017|Anticipated|2017-06-30||Interventional|||An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia|An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein-1 (REP1)|Active, not recruiting||Phase 1/Phase 2|6|Anticipated|University of Alberta||1|||f||||t||||||||||2017-10-11 00:42:13.761599|2017-10-11 00:42:13.761599
NCT02077348|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-02-23|||May 2014||2014-05-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.|Metabolic Signalling in Muscle- and Adipose Tissue Following Insulin Withdrawal and Growth Hormone Injection in Type I Diabetes Mellitus, a Clinical Experimental Study.|Completed||N/A|9|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 00:42:13.963001|2017-10-11 00:42:13.963001
NCT02077335|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2016-12-19|||April 2014||2014-04-01|December 2016|2016-12-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer|Phase II Study of High-dose Rate (HDR) Monotherapy for the Treatment of Low and Intermediate Risk Prostate Cancer|Active, not recruiting||Phase 2|50|Anticipated|CSSS de Gatineau||1|||f||||t||||||||||2017-10-11 00:42:14.097601|2017-10-11 00:42:14.097601
NCT02077322|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-10-12|||March 2014||2014-03-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|SYNECHIAE||Rates of Middle Meatal Synechia Formation Following Functional Endoscopic Sinus Surgery|Rates of Middle Meatal Synechia Formation Following Functional Endoscopic Sinus Surgery: A Double-Blind Randomized Controlled Trial Comparing Gloved Merocel and Silastic Middle Meatal Spacers.|Recruiting||N/A|96|Anticipated|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 00:42:14.214488|2017-10-11 00:42:14.214488
NCT02077309|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-04-10|||August 2014||2014-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|Lina-Plaque||Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus|Linagliptin as a Modulator of Vascular Inflammation in Patients With Type 2 Diabetes Mellitus|Terminated||Phase 3|4|Actual|RWTH Aachen University||2||bad recruitment of suitable participants, just 4 patients in one year|f||||f||||||||||2017-10-11 00:42:14.336679|2017-10-11 00:42:14.336679
NCT02077296|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-09-08|||March 2014||2014-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|CYTORECT||The Predictive Value of Cytokines on Response to Preoperative Chemoradiotherapy in Patients With Rectal Cancer|The Predictive Value of Cytokines on Response to Preoperative Chemoradiotherapy in Patients With Rectal Cancer|Completed||N/A|34|Actual|St. Antonius Hospital|||1||f||||t||||||Samples Without DNA|"     An extra ethylene diamine tetra acetic acid blood tube of 4 ml will be withdrawn from the     patient during a regular venapuncture or after administration of an intravenous needle     specifically before, during and just after preoperative CRT, 1 day before and 2 days after     surgery and 6 weeks after surgery. Blood samples for determination of cytokines are directly     processed.      As standard medical treatment surgery will be performed and biopsies of resection specimen     will be collected by the department of pathology, frozen, and further examined. For this     study 4 extra biopsies will be taken from resection tissue for cytokine measurements. Two     from tumour tissue and 2 from normal mucosa of each patient. These biopsies will be     snap-frozen in liquid nitrogen. Subsequently, the frozen biopsies will be grinded with a     mortar and pestle, which were cooled in liquid nitrogen, and resuspended in 100 μl ice-cold     PBS containing 10 μl/ml of a cocktail of protease inhibitors.   "|Yes||2017-10-11 00:42:14.463706|2017-10-11 00:42:14.463706
NCT02077283|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-11-19|||January 2014||2014-01-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01|3 Months|Observational [Patient Registry]|||Urinary Metabonomics of Two Major Patterns of NAFLD|Urinary Metabonomics of Two Major Patterns of NAFLD|Recruiting||N/A|114|Anticipated|ShuGuang Hospital|||3||f||||t||||||Samples Without DNA|"     midstream urina sanguinis   "|||2017-10-11 00:42:14.553005|2017-10-11 00:42:14.553005
NCT02077270|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-11-16|||January 2016||2016-01-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Pretreatment With Electroacupuncture to Reduce Discomfort|Pretreatment With Electroacupuncture to Reduce Discomfort|Not yet recruiting||N/A|60|Anticipated|Sheba Medical Center||3|||f||||f||||||||||2017-10-11 00:42:14.652847|2017-10-11 00:42:14.652847
NCT02077257|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-11-06|||March 2014||2014-03-01|November 2014|2014-11-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients|A 12-Week, Randomized, Open-Label, Multicenter Study Exploring Low-Density Lipoprotein Cholesterol Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day Compared to10 mg/Day in Chinese Patients With Acute Coronary Syndromes|Unknown status|Recruiting|Phase 4|1060|Anticipated|Committee of Cardio-Cerebral-Vascular Diseases of GSC||2|||f||||f||||||||||2017-10-11 00:42:14.766512|2017-10-11 00:42:14.766512
NCT02077244|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-09-18|||March 2014||2014-03-01|September 2014|2014-09-01|June 2017|Anticipated|2017-06-01|February 2016|Anticipated|2016-02-01||Interventional|FUT||Follow up After Intensive Care. The FUTstudy|A Randomized Controlled Trial to Evaluate the Effect of Nurse Led Follow up After Being a Patient in the Intensive Care Unit.|Unknown status|Recruiting|N/A|250|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 00:42:14.889531|2017-10-11 00:42:14.889531
NCT02077231|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-03-03|||September 2011||2011-09-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Interventional|||Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients||Completed||N/A|30|Actual|Shanghai Jinshan Hospital||2|||f||||||||||||||2017-10-11 00:42:14.988405|2017-10-11 00:42:14.988405
NCT02077218|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-04-17|||February 2014||2014-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant|Assessment of Coronary Artery Disease in Asymptomatic Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT): A Pilot Feasibility Study|Completed||N/A|20|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:42:15.089603|2017-10-11 00:42:15.089603
NCT02077205|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-28|||January 2012||2012-01-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Manualised Cognitive Behavioral Therapy of Anxiety Disorders in Children and Adolescents in Routine Care Setting||Unknown status|Recruiting|N/A|200|Anticipated|Ruhr University of Bochum||1|||f||||f||||||||||2017-10-11 00:42:15.22201|2017-10-11 00:42:15.22201
NCT02077192|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-08-21|||July 2014||2014-07-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)|A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura|Active, not recruiting||Phase 3|124|Actual|Rigel Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:42:15.317276|2017-10-11 00:42:15.317276
NCT02077179|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-04-04|||September 2014||2014-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|HIP||Health Improvement After Pregnancy (HIP) Program Randomized Control Trial|Health Improvement After Pregnancy (HIP) Program Randomized Control Trial|Terminated||N/A|43|Actual|Queen's University||2||Poor retention and recruitment,changes need to be made to the program|f||||f||||||||No||2017-10-11 00:42:15.523333|2017-10-11 00:42:15.523333
NCT02077166|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-10-02|||February 2014||2014-02-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|A Multicenter Open-Label Phase 1b/2 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Recruiting||Phase 1/Phase 2|129|Anticipated|Pharmacyclics LLC.||6|||f||||t||||||||||2017-10-11 00:42:15.623601|2017-10-11 00:42:15.623601
NCT02077153|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-02-28|||October 2012||2012-10-01|February 2014|2014-02-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|NOBITS||Nostalgia Bits (NOBITS)|Nostalgia Bits Project|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Istituto Auxologico Italiano||2|||f||||t||||||||||2017-10-11 00:42:15.855374|2017-10-11 00:42:15.855374
NCT02077127|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-03-03|||September 2011||2011-09-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Observational|MCP-1||Monocyte Chemoattractant Protein-1 2518A/G Polymorphism|Association of Monocyte Chemoattractant Protein-1 (MCP-1)2518A/G Polymorphism With Proliferative Diabetic Retinopathy in Northern Chinese Type 2 Diabetes|Completed||N/A|1043|Actual|Harbin Medical University|||1||f||||f||||||Samples With DNA|"     Blood had been stored in -80℃.   "|||2017-10-11 00:42:16.09608|2017-10-11 00:42:16.09608
NCT02077114|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-09-25|||February 2014||2014-02-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant Melanoma|Peptide Vaccination in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Patients With Unresectable Stage III or IV Malignant Melanoma A Phase I Study (First in Man)|Completed||Phase 1|10|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 00:42:16.183395|2017-10-11 00:42:16.183395
NCT02077101|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-01-16|||December 2013||2013-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|RAVVIH||Representations and Acceptability of HIV Therapeutic Vaccine in a Cohort of HIV-1 Infected Outpatients Followed at Hospital|Representations and Acceptability of HIV Therapeutic Vaccine in a Cohort of HIV-1 Infected Outpatients Followed at Hospital : Multicentric Interventional Study Qualitative and Quantitative|Completed||N/A|220|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 00:42:16.265027|2017-10-11 00:42:16.265027
NCT02077088|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-02-28|||June 2009||2009-06-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants|Double Blind, Randomised Study on the Effect of Prebiotics on Incidence of Atopic Manifestations in Infants|Completed||N/A|120|Actual|Humana Co.Ltd.||2|||f||||f||||||||||2017-10-11 00:42:16.349425|2017-10-11 00:42:16.349425
NCT02077075|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-04-07|||March 2014||2014-03-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||MyHealthCheckup Wellness Program Among Canadian Forces Military Personnel|The Effectiveness of the MyHealthCheckup Wellness Program Among Canadian Forces Military Personnel|Completed||Phase 4|117|Actual|McGill University||2|||f||||f||||||||||2017-10-11 00:42:16.429655|2017-10-11 00:42:16.429655
NCT02077062|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-03-03|||March 2013||2013-03-01|March 2014|2014-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Study of Mediators of Post Hepatectomy Liver Regeneration|Prospective Non-randomized Trial to Study Expression of Mediators of Post Hepatectomy Liver Regeneration(PHLR) and Compare With a Non-hepatectomy Group: a Pilot Study|Unknown status|Recruiting|N/A|10|Anticipated|Govind Ballabh Pant Hospital|||2||f||||||||||||||2017-10-11 00:42:16.510385|2017-10-11 00:42:16.510385
NCT02077049|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-06-04|||February 2014||2014-02-01|June 2014|2014-06-01|March 2015|Anticipated|2015-03-01|February 2015|Anticipated|2015-02-01||Interventional|||Are Serious Games Promoting Mobility an Attractive Alternative to Conventional Self-training for Elderly People?|Are Serious Games Promoting Mobility an Attractive Alternative to Conventional Self-training for Elderly People? A Randomized Controlled Trial.|Unknown status|Recruiting|N/A|128|Anticipated|Klinik Valens||2|||f||||t||||||||||2017-10-11 00:42:16.59948|2017-10-11 00:42:16.59948
NCT02077036|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-28||||||February 2014|2014-02-01||||December 2014|Anticipated|2014-12-01||Interventional|||Narcolepsy - New Potential Treatment||Unknown status|Recruiting|N/A|30|Anticipated|Karolinska University Hospital||2|||f||||||||||||||2017-10-11 00:42:16.699906|2017-10-11 00:42:16.699906
NCT02077023|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-06-04|||February 2014||2014-02-01|September 2014|2014-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|||An Observational Study of Natural History of Cardiovascular Diseases|An Observational Study of Natural History of Cardiovascular Diseases|Recruiting||N/A|5200|Anticipated|Imperial College London|||1||f||||f||||||||||2017-10-11 00:42:16.77914|2017-10-11 00:42:16.77914
NCT02077010|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-08-01|||December 1, 2017|Anticipated|2017-12-01|August 2017|2017-08-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|iMilrinone||Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population|Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population: A Randomized Controlled Trial|Not yet recruiting||Phase 2|40|Anticipated|Vanderbilt University Medical Center||2|||f||||f|t|f||||||||2017-10-11 00:42:16.86422|2017-10-11 00:42:16.86422
NCT02076997|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-06-09|||December 2013||2013-12-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|September 2016|Anticipated|2016-09-01||Interventional|||Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate|Individualized High Dose Methotrexate for the Treatment of Malignancies in Children and Adolescents With a Significant Risk for Methotrexate Toxicities|Recruiting||N/A|50|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 00:42:16.992211|2017-10-11 00:42:16.992211
NCT02076984|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-05-29|||June 2014||2014-06-01|May 2015|2015-05-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Titanium vs Absorbable Tacks for Mesh Fixation in Laparoscopic Incisional and Ventral Hernia Repair|LAPAROSCOPIC VENTRAL HERNIA REPAIR BY LIGHTWEIGHT POLYPROPYLENE MESH. A PROSPECTIVE ITALIAN MULTICENTRIC RANDOMIZED STUDY COMPARING TWO FIXATION DEVICES: TITANIUM SPIRAL TACKS vs ABSORBABLE TACKS|Recruiting||N/A|200|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 00:42:17.075263|2017-10-11 00:42:17.075263
NCT02076971|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-09-13|||January 2014||2014-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|REIVI||Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive|A Multicenter Prospective Observational Study to Evaluate Cytomegalovirus (CMV)-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients With CMV-positive Serology (R+) Prior to Transplant and Its Involvement in the Development of CMV Infection|Completed||N/A|92|Actual|Fundacio Catalana de Pneumologia|||1||f||||f||||||None Retained|"     Whole blood   "|||2017-10-11 00:42:17.197851|2017-10-11 00:42:17.197851
NCT02076958|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-05-08|||March 2011||2011-03-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|Project HEAL||Implementation of Evidence-Based Cancer Early Detection in Black Churches|Implementation of Evidence-Based Cancer Early Detection in Black Churches|Active, not recruiting||N/A|574|Anticipated|University of Maryland||2|||f||||f||||||||||2017-10-11 00:42:17.285639|2017-10-11 00:42:17.285639
NCT02076945|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-09-26|||February 2014||2014-02-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Characteristics of Popliteal Sciatic Nerve Block in Patients With and Without Diabetic Neuropathy||Completed||N/A|75|Actual|Centre Hospitalier Universitaire Vaudois||3|||f||||f||||||||||2017-10-11 00:42:17.382937|2017-10-11 00:42:17.382937
NCT02076932|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-05-31|||April 2014||2014-04-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of Physical Training on Adipose Tissue Metabolism and Insulin Sensitivity in the Menopausal Transition Phase|A Training Intervention Study in Late Pre- and Early Postmenopausal Women Investigating the Changes in Adipose Tissue Metabolism and Peripheral Insulin Sensitivity|Completed||N/A|43|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 00:42:17.458754|2017-10-11 00:42:17.458754
NCT02076919|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2016-03-04|2015-06-30||February 2014||2014-02-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||This analysis population includes all enrolled subjects.|First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration|A Randomized, Double-Masked, Vehicle-Controlled, First-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Topically Delivered LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration|Completed||Phase 1|110|Actual|Alcon Research||4|||f||||f||||||||||2017-10-11 00:42:17.580924|2017-10-11 00:42:17.580924
NCT02076906|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-06-08|||April 2014||2014-04-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors|Safety and Feasibility Study of Using MR-guided High Intensity Focused Ultrasound (HIFU) for the Ablation of Relapsed or Refractory Pediatric Solid Tumors|Recruiting||Phase 1|14|Anticipated|Children's Research Institute||1|||f||||f||||||||||2017-10-11 00:42:21.252508|2017-10-11 00:42:21.252508
NCT02076893|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-02-07|||March 2014||2014-03-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Postoperative Tramadol/Gabapentin/Ibuprofen Versus Tramadol/Placebo/Ibuprofen|A Comparison of Postoperative Tramadol/Gabapentin/Ibuprofen Versus Tramadol/Placebo/Ibuprofen in Children Undergoing Tonsillectomy|Terminated||Phase 4|64|Actual|Children's Hospitals and Clinics of Minnesota||2||Interim analysis results indicated need to recruit beyond scope of budget.|f||||t||||||||Undecided||2017-10-11 00:42:21.460014|2017-10-11 00:42:21.460014
NCT02076880|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-12-02|||November 2013||2013-11-01|September 2013|2013-09-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|SLEEVEDIAB||SLEEVEDIAB To Explore the Early and Late Metabolic Effects of Sleeve Gastrectomy in Obese Patients|Investigation of Endocrin-metabolic Modifications Related to Diabetes Improvement After Sleeve Gastrectomy in Severly Obese|Recruiting||N/A|14|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:42:21.561437|2017-10-11 00:42:21.561437
NCT02076867|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-28|||March 2014||2014-03-01|February 2014|2014-02-01||||February 2016|Anticipated|2016-02-01||Interventional|||Halifax Somatic Symptoms Disorder Trial|Halifax Somatic Symptom Disorder Trial: A Randomized Parallel Group Cross-Over Study of Intensive Short-Term Dynamic Psychotherapy Compared to Medical Treatment as Usual for Somatic Symptoms in the Emergency Department|Unknown status|Not yet recruiting|N/A|86|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 00:42:21.661493|2017-10-11 00:42:21.661493
NCT02076854|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-01-14|||October 2013||2013-10-01|February 2014|2014-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Novel Motivational Ecological Momentary Intervention for Anorexia Nervosa||Completed||N/A|12|Actual|Boston University||2|||f||||f||||||||||2017-10-11 00:42:21.761549|2017-10-11 00:42:21.761549
NCT02076841|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-01-26|||July 2013||2013-07-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|February 2016|Actual|2016-02-01||Observational|SFERA||Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen|Tolerability and Quality of Life in Patients With Multiple Sclerosis Switched to Intramuscular Interferon Beta 1a Autoinjector (Avonex® PenTM)|Completed||N/A|40|Actual|Biogen|||1||f||||f||||||||||2017-10-11 00:42:21.843738|2017-10-11 00:42:21.843738
NCT02076828|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-28|||January 2008||2008-01-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|March 2009|Actual|2009-03-01||Interventional|||Comparison of Ferrous Sulfate, Polymaltose Complex and Iron-zinc in Iron Deficiency Anemia|Comparison of Ferrous Sulfate, Polymaltose Complex and Iron-zinc in Iron Deficiency Anemia|Completed||N/A|60|Actual|Hacettepe University||3|||f||||f||||||||||2017-10-11 00:42:21.951699|2017-10-11 00:42:21.951699
NCT02076815|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-07-27|||February 2014||2014-02-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|TEAM-ET||Anagrelide Retard in Essential Thrombocythemia|A Phase III Randomized, Multicenter, Double-blind, Active Controlled Study to Compare the Efficacy and Safety of Two Different Anagrelide Formulations in Patients With Essential Thrombocythemia (TEAM-ET 2.0)|Completed||Phase 3|106|Actual|AOP Orphan Pharmaceuticals AG||2|||f||||t||||||||||2017-10-11 00:42:22.052377|2017-10-11 00:42:22.052377
NCT02076802|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-28|||December 2012||2012-12-01|February 2014|2014-02-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01|5 Years|Observational [Patient Registry]|||Regular Physical Exercise and Salt Diet on Coronary Artery Disease in Patients With Prehypertension(RESTRAIN Pre-HT)|Regular Physical Exercise and Salt Diet Effect on Progression of Coronary Disease in Patients With Prehypertension|Unknown status|Recruiting|N/A|120|Anticipated|General Hospital of Shenyang Military Region|||1||f||||t||||||||||2017-10-11 00:42:22.194218|2017-10-11 00:42:22.194218
NCT02076789|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-01-08|||March 2013||2013-03-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|DECODE||DEtect Long-term Complications After icD rEplacement: a Multicenter Italian Registry|Detect Long-term Complications After ICD Replacement: a Multicenter Italian Registry - DECODE Registry|Unknown status|Recruiting|N/A|800|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||f||||||||||2017-10-11 00:42:22.290491|2017-10-11 00:42:22.290491
NCT02076776|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-12-13|||August 2012||2012-08-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Heart-Brain Retraining for Stroke Rehabilitation|Heart-Brain Retraining: Forced Aerobic Exercise for Stroke Rehabilitation|Completed||Phase 1|22|Actual|The Cleveland Clinic||3|||f||||t||||||||||2017-10-11 00:42:22.487834|2017-10-11 00:42:22.487834
NCT02076763|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-11|||August 2011||2011-08-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Observational|||Observational Study of Acute Intermittent Porphyria Patients|Observational Study of Acute Intermittent Porphyria Patients|Completed||N/A|9|Actual|Digna Biotech S.L.|||1||f||||f||||||Samples Without DNA|"     Serum, urine   "|||2017-10-11 00:42:22.580774|2017-10-11 00:42:22.580774
NCT02076750|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2014-11-25|||March 2013||2013-03-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Weekly Vitamin D in Pediatric IBD|Weekly Vitamin D3 for Treatment of Hypovitaminosis D in Children and Adolescents With Inflammatory Bowel Disease|Completed||Phase 1/Phase 2|34|Actual|Emory University||2|||f||||f||||||||||2017-10-11 00:42:22.671394|2017-10-11 00:42:22.671394
NCT02076737|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-28|||February 2013||2013-02-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|VEOLITH||Model-based Iterative Reconstruction (MB-IR VEOTM) in Ultra Low-dose Abdominal CT Versus Adaptative Statistical Iterative Reconstruction (ASIR): A Prospective Study for Acute Renal Colic|Model-based Iterative Reconstruction (MB-IR VEOTM) in Ultra Low-dose Abdominal CT Versus Adaptative Statistical Iterative Reconstruction (ASIR): A Prospective Study for Acute Renal Colic|Completed||N/A|120|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 00:42:22.867736|2017-10-11 00:42:22.867736
NCT02076724|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-03-17|||March 2014||2014-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Reinforcement of the Abdominal Wall After Breast Reconstruction With the Pedicled TRAM-flap|Reinforcement of the Abdominal Wall With Acellular Dermal Matrix (Strattice™) After Breast Reconstruction With the Pedicled TRAM-flap|Active, not recruiting||N/A|30|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 00:42:22.977562|2017-10-11 00:42:22.977562
NCT02076711|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-11-10|||June 2013||2013-06-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|MELVAS||Myocardial Efficiency of the Left Ventricle in Asymptomatic Patients With Aortic Valve Stenosis - a Prognostic Marker and a Target for Intervention?|Myocardial Efficiency of the Left Ventricle in Asymptomatic Patients With Aortic Valve Stenosis - a Prognostic Marker and a Target for Intervention?|Completed||Phase 2|40|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 00:42:23.075347|2017-10-11 00:42:23.075347
NCT02076698|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-11-07|||March 2014||2014-03-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Interventional|FRANCE||Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy|Clinical and Medico-economical Assessment of Deep Brain Stimulation of the Anterior Nucleus of the Thalamus for the Treatment of Pharmacoresistant Partial Epilepsy|Recruiting||Phase 3|62|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 00:42:23.174835|2017-10-11 00:42:23.174835
NCT02076685|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-03-13|||November 2007||2007-11-01|March 2014|2014-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis|The Application of the N-acetyltransferase 2 (NAT2) Genotyping in Re-challenge Protocol of Isoniazid (INH) Titration in Patients With Anti-TB Medications-induced Hepatitis|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 00:42:23.455546|2017-10-11 00:42:23.455546
NCT02076672|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-04-08|||August 2014||2014-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|ABOCA1||Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population|Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population (The ABOCA Phase II Trial)|Completed||Phase 2|22|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-10-11 00:42:23.558048|2017-10-11 00:42:23.558048
NCT02076659|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-12-05|||September 2011||2011-09-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients|A Dose-finding, Pharmacokinetic Phase I Study of the Human Monoclonal Antibody-cytokine Fusion Protein F8IL10 (Dekavil) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis|Recruiting||Phase 1|36|Anticipated|Philogen S.p.A.||1|||f||||t||||||||||2017-10-11 00:42:23.652881|2017-10-11 00:42:23.652881
NCT02076646|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-10-27|||October 2013||2013-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma|A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma|Active, not recruiting||Phase 1/Phase 2|96|Anticipated|Philogen S.p.A.||3|||f||||f||||||||||2017-10-11 00:42:23.799903|2017-10-11 00:42:23.799903
NCT02076633|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-05-25|||December 2012||2012-12-01|October 2014|2014-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Intratumoral Administration of L19IL2/L19TNF|A Phase II Study of Intratumoral Application of L19IL2/L19TNF in Melanoma Patients in Clinical Stage III or Stage IV M1a With Presence of Injectable Cutaneous and/or Subcutaneous Lesions|Completed||Phase 2|21|Actual|Philogen S.p.A.||1|||f||||f||||||||||2017-10-11 00:42:23.949838|2017-10-11 00:42:23.949838
NCT02076620|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-11-14|||January 2013||2013-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours|Phase I Study of the Tumor-targeting Human L19TNFα Monoclonal Antibody-cytokine Fusion Protein in Combination With Doxorubicin in Patients With Advanced Solid Tumours|Recruiting||Phase 1|28|Anticipated|Philogen S.p.A.||1|||f||||f||||||||||2017-10-11 00:42:24.066264|2017-10-11 00:42:24.066264
NCT02076607|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-26|||March 2013||2013-03-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Thoracic And Lumbar Burst Fracture: Correlation Between Structural Changes And Clinical Outcome Of Treatment|Thoracic And Lumbar Burst Fracture: Correlation Between Structural Changes And Clinical Outcome Of Treatment|Completed||N/A|25|Actual|Hospital Ortopedico de Passo Fundo|||2||f||||f||||||||||2017-10-11 00:42:24.210308|2017-10-11 00:42:24.210308
NCT02076594|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-06-08|||January 2013||2013-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer|A Randomized Phase III Study Of Low-Docetaxel Oxaliplatin, Capecitabine (Low-Tox) Vs Epirubicin, Oxaliplatin And Capecitabine (Eox) In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer|Recruiting||Phase 3|200|Anticipated|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente||2|||f||||f||||||||||2017-10-11 00:42:24.324252|2017-10-11 00:42:24.324252
NCT02076581|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-05-28|||February 2014||2014-02-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||MyoSense- Automated Muscle Hypertonicity Classification System|MyoSense- Automated Muscle Hypertonicity Classification System|Completed||N/A|53|Actual|Great Lakes NeuroTechnologies Inc.|||4||f||||||||||||||2017-10-11 00:42:24.622389|2017-10-11 00:42:24.622389
NCT02076568|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-02-13|||February 2014||2014-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIMO_Partner||Diabetes and Partnership: Evaluation of a Diabetes Education Module|"A Prospective Multi-center Evaluation of a Diabetes Education Module Specifically Addressing the Topic Diabetes and Partnership in a Randomized Controlled Trial"|Recruiting||N/A|200|Anticipated|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||f||||||||||2017-10-11 00:42:24.715269|2017-10-11 00:42:24.715269
NCT02076555|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-02-13|||February 2014||2014-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIMO_Social||Diabetes and Social Issues: Evaluation of a Diabetes Education Module|"A Prospective Multi-center Evaluation of a Diabetes Education Module Specifically Addressing the Topic Diabetes and Social Issues in a Randomized Controlled Trial"|Recruiting||N/A|200|Anticipated|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||f||||||||||2017-10-11 00:42:24.863371|2017-10-11 00:42:24.863371
NCT02076542|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2017-02-13|||February 2014||2014-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIMO_Sports||Diabetes and Sports: Evaluation of a Diabetes Education Module|"A Prospective Multi-center Evaluation of a Diabetes Education Module Specifically Addressing the Topic Diabetes and Sports in a Randomized Controlled Trial"|Recruiting||N/A|200|Anticipated|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||f||||||||||2017-10-11 00:42:24.999279|2017-10-11 00:42:24.999279
NCT02076529|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-02-28|||October 2012||2012-10-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting|A Study About Pharmacokinetic and Pharmacodynamics of Ramosetron in Chemotherapy Induced Nausea and Vomiting|Completed||N/A|51|Actual|Chonnam National University Hospital||3|||f||||t||||||||||2017-10-11 00:42:25.109629|2017-10-11 00:42:25.109629
NCT02076516|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2014-02-28|||October 2013||2013-10-01|February 2014|2014-02-01|May 2015|Anticipated|2015-05-01|October 2014|Anticipated|2014-10-01||Interventional|PILOT-SECRET||Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL)|Pilot Evaluation Of CORACTO® (Rapamycin-Eluting Coronary Stent Delivery System) in The Treatment Of Patients With Coronary Artery Disease|Unknown status|Recruiting|Phase 3|100|Anticipated|Alvimedica||1|||f||||f||||||||||2017-10-11 00:42:25.207171|2017-10-11 00:42:25.207171
NCT02076503|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-09-28|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status|Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status|Completed||N/A|28|Actual|St. Olavs Hospital||1|||f||||f|f|f||||||||2017-10-11 00:42:25.310654|2017-10-11 00:42:25.310654
NCT02076490|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-27|||May 2014||2014-05-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Telerehabilitation Using Mirror Therapy in Patients With Phantom Limb Pain Following Lower Limb Amputation.|The PACT Trial - PAtient Centered Telerehabilitation: Effectiveness of Software-supported and Traditional Mirror Therapy in Patients With Phantom Limb Pain Following Lower Limb Amputation: Design of a Randomized Controlled Trial.|Unknown status|Enrolling by invitation|N/A|105|Anticipated|Zuyd University of Applied Sciences||3|||f||||t||||||||||2017-10-11 00:42:25.389295|2017-10-11 00:42:25.389295
NCT02076477|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-11-11|||January 2014||2014-01-01|November 2016|2016-11-01||||January 2017|Anticipated|2017-01-01||Interventional|OITROLC||The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）|The Prospective,Multicenter,Randomized Controlled Clinical Study of the Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）|Recruiting||Phase 3|420|Anticipated|Sichuan Cancer Hospital and Research Institute||2|||f||||t||||||||||2017-10-11 00:42:25.46618|2017-10-11 00:42:25.46618
NCT02076464|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-04-26|||May 2013||2013-05-01|April 2016|2016-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Using Technology to Improve Eating Disorders Treatment|Using Technology to Improve Eating Disorders Treatment|Enrolling by invitation||N/A|650|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:42:25.570146|2017-10-11 00:42:25.570146
NCT02076451|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-02-18|||February 2014||2014-02-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas|PHASE 1, OPEN-LABEL STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF DS-8273A IN SUBJECTS WITH ADVANCED SOLID TUMORS OR LYMPHOMAS|Completed||Phase 1|32|Actual|Daiichi Sankyo, Inc.||4|||f||||f||||||||||2017-10-11 00:42:25.759588|2017-10-11 00:42:25.759588
NCT02076438|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-11-22|||November 2015||2015-11-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease|Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease in Hospitalized Adults-A Double Blind Placebo Controlled Trial|Terminated||N/A|110|Actual|Rutgers, The State University of New Jersey||2||Lack of recruitment|f||||t||||||||||2017-10-11 00:42:25.851878|2017-10-11 00:42:25.851878
NCT02076425|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-12-07|||December 2013||2013-12-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Randomized Controlled Trial of PCIT-ED for Preschool Depression|A Randomized Controlled Trial of PCIT-ED for Preschool Depression|Recruiting||N/A|250|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 00:42:25.953487|2017-10-11 00:42:25.953487
NCT02076412|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-08-18||2017-08-18|November 2014||2014-11-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|FIT||A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura|Completed||Phase 3|74|Actual|Rigel Pharmaceuticals||3|||f||||t||||||||||2017-10-11 00:42:26.126598|2017-10-11 00:42:26.126598
NCT02076399|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-09-26||2017-09-26|July 14, 2014|Actual|2014-07-14|September 2017|2017-09-01|April 21, 2016|Actual|2016-04-21|April 21, 2016|Actual|2016-04-21||Interventional|FIT||A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura|Completed||Phase 3|76|Actual|Rigel Pharmaceuticals||3|||f||||t||||||||||2017-10-11 00:42:26.312247|2017-10-11 00:42:26.312247
NCT02076386|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-05-24|||March 4, 2014|Actual|2014-03-04|May 2017|2017-05-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Observational|DOL-ART||A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany|A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany (DOL-ART)|Active, not recruiting||N/A|411|Actual|ViiV Healthcare|||1||f||||f||||||||||2017-10-11 00:42:26.540785|2017-10-11 00:42:26.540785
NCT02076373|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-05-09|||March 2014||2014-03-01|May 2016|2016-05-01|December 2021|Anticipated|2021-12-01|February 2021|Anticipated|2021-02-01||Interventional|EpoRepair||Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants|Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants - a Randomized, Double-blind, Placebo-controlled, Prospective, and Multicenter Clinical Study|Recruiting||Phase 3|120|Anticipated|University of Zurich||2|||f||||t||||||||Undecided||2017-10-11 00:42:26.740884|2017-10-11 00:42:26.740884
NCT02076360|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-05-26|||August 2013||2013-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||RCT: Impact of Preop Video on Patient Preparedness for Surgery|Impact of Preoperative Patient Education Video on Patient Preparedness After Sacrocolpopexy: A Single Blind Randomized Controlled Trial|Recruiting||N/A|160|Anticipated|University of South Florida||2|||f||||t||||||||||2017-10-11 00:42:26.940348|2017-10-11 00:42:26.940348
NCT02076347|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-10-15|||February 2014||2014-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|August 2014|Actual|2014-08-01||Interventional|||Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin|Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin|Completed||N/A|489|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 00:42:27.052954|2017-10-11 00:42:27.052954
NCT02076334|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-04-13|2017-01-19||February 2014||2014-02-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Compression Garments on Exercise Performance Following Acute High Intensity Exercise|Effect of Compression Garments on Exercise Performance Following Acute High Intensity Exercise|Completed||N/A|84|Actual|University of North Carolina, Chapel Hill||4|||f||||f|f|f||||||||2017-10-11 00:42:27.15582|2017-10-11 00:42:27.15582
NCT02076321|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-12-01|||January 2014||2014-01-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effect of NSAID Use in the Acute Phase of Skeletally Immature Bone Healing: A Prospective Study|The Effect of NSAID Use in the Acute Phase of Skeletally Immature Bone Healing: A Prospective Study|Recruiting||Phase 4|350|Anticipated|University of Missouri-Columbia||2|||f||||||||||||||2017-10-11 00:42:27.621594|2017-10-11 00:42:27.621594
NCT02076308|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2015-03-03|||December 2012||2012-12-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|SMART||Acupuncture for Treatment of Frozen Shoulder Syndrome|Scientifically Merged Acupuncture and Robot-assisted Technology (SMART) for Rehabilitation of Frozen Shoulder Syndrome: First Year Project- Verification of Acupuncture and Evaluation by Magnetic Resonance Imaging Examination|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:42:27.720037|2017-10-11 00:42:27.720037
NCT02076295|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-04-14|||February 2014||2014-02-01|April 2017|2017-04-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Observational|CHONI||Cholinergic Nicotinic Receptors and Cognition in PD|[18F]Flubatine: a Novel Biomarker of Cholinergic a4ß2 Nicotinic Receptors and Cognition in Parkinson's Disease|Completed||N/A|48|Actual|University of Michigan|||2||f||||f||||||Samples With DNA|"     Saliva samples to collect DNA   "|No||2017-10-11 00:42:27.830983|2017-10-11 00:42:27.830983
NCT02076282|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-02-01|||March 2014||2014-03-01|February 2015|2015-02-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||MRI Optimization Study in Stage III NSCLC|MRI for Radiotherapy Treatment Planning of Stage III NSCLC: an MRI Optimization Study in Healthy Volunteers and Patients|Unknown status|Recruiting|N/A|30|Anticipated|UMC Utrecht|||2||f||||t||||||||||2017-10-11 00:42:27.913523|2017-10-11 00:42:27.913523
NCT02076269|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-03-06|||September 2013||2013-09-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison|Characterisation Of Very Severe Chronic Obstructive Pulmonary Disease Patients For Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry|Completed||Phase 1|15|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:42:28.015854|2017-10-11 00:42:28.015854
NCT02076256|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-10-09|||August 2013||2013-08-01|October 2014|2014-10-01||||July 2016|Anticipated|2016-07-01||Interventional|||The Influence of Helping Relationships From Significant Others on Healthy Lifestyle and Quality of Life Among Patients With Chronic Kidney Disease: A Longitudinal Study|The Influence of Helping Relationships From Significant Others on Healthy Lifestyle and Quality of Life Among Patients With Chronic Kidney Disease: A Longitudinal Study|Unknown status|Recruiting|N/A|250|Anticipated|National Cheng Kung University||2|||f||||f||||||||||2017-10-11 00:42:28.103151|2017-10-11 00:42:28.103151
NCT02076217|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-05-01|||February 2014||2014-02-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|December 2017|Anticipated|2017-12-01||Observational|||Quick Start of Highly Effective Contraception|Rates of Contraceptive Failure When Unprotected Intercourse Has Occurred 6-14 Days Prior to Contraceptive Initiation|Recruiting||N/A|1030|Anticipated|University of Utah|||1||f||||t||||||||||2017-10-11 00:42:28.392874|2017-10-11 00:42:28.392874
NCT02076204|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-08-29|||February 2014||2014-02-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Mother and Infant Home Visiting Program Evaluation-Strong Start|Mother and Infant Home Visiting Program Evaluation (MIHOPE) - Strong Start|Active, not recruiting||N/A|1059|Actual|MDRC||2|||f||||f||||||||||2017-10-11 00:42:28.505373|2017-10-11 00:42:28.505373
NCT02076191|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-01-16|||February 2014||2014-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML|Multicenter Phase I/II Trial of Ruxolitinib in Combination With Decitabine in Patients With Accelerated Phase Myeloproliferative Neoplasm (MPN) or Post-MPN AML|Recruiting||Phase 1/Phase 2|60|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 00:42:28.614103|2017-10-11 00:42:28.614103
NCT02076165|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-08-22|||September 1, 2014|Actual|2014-09-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|June 30, 2017|Actual|2017-06-30||Interventional|||Insomnia Treatment for Women Veterans|A Patient-Focused Approach to Insomnia Treatment for Women Veterans|Active, not recruiting||N/A|400|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:42:28.862448|2017-10-11 00:42:28.862448
NCT02076152|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-06-27|||February 2014||2014-02-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||FMISO PET Study of Glioblastoma|A Study to Evaluate Vascular Normalization in Patients With Recurrent Glioblastoma Treated With Bevacizumab Using FMISO PET and Vascular MRI|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:42:28.956077|2017-10-11 00:42:28.956077
NCT02076139|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-02-22|||March 2014||2014-03-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Immunogenicity of Nyaditum Resae® Probiotic to Protect From Tuberculosis|Pilot Clinical Trial, Double-blind, Randomized, Placebo Controlled and Masked to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae® Probiotic Administered to Adults With or Without Latent Tuberculosis Infection|Completed||N/A|47|Actual|Manresana de Micobacteriologia, SL||3|||f||||f||||||||||2017-10-11 00:42:29.060952|2017-10-11 00:42:29.060952
NCT02076126|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-28|2015-01-29|||March 2014||2014-03-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Determination of Lung Maturity and Prediction of RDS at Birth|Spectroscopic-chemometric Determination of Lecithin-sphingomyelin Ratio in Gastric Aspirates and Secretion From Hypopharynx at Birth, in Relation to Development of RDS|Completed||N/A|145|Actual|Holbaek Sygehus|||2||f||||t||||||Samples Without DNA|"     Gastric- and hypopharyngeal secretions   "|||2017-10-11 00:42:29.246089|2017-10-11 00:42:29.246089
NCT02076113|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-09-26|||April 1, 2014|Actual|2014-04-01|September 2017|2017-09-01|June 2023|Anticipated|2023-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Cervical Spondylotic Myelopathy Surgical Trial|Cervical Spondylotic Myelopathy Surgical Trial|Active, not recruiting||N/A|250|Anticipated|Lahey Clinic||2|||f||||t||||||||||2017-10-11 00:42:29.343322|2017-10-11 00:42:29.343322
NCT02076100|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-08-18|||March 2014||2014-03-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics of Ruzasvir (MK-8408) in Participants With Hepatitis C Infection (MK-8408-003)|A Multiple Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MK-8408 in Subjects With Hepatitis C Infection|Completed||Phase 1|22|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 00:42:29.529146|2017-10-11 00:42:29.529146
NCT02076087|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-09-06|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|ATI||Immune Characterization of Subcutaneous Adipose Tissue|Immune Characterization of Subcutaneous Adipose Tissue|Completed||N/A|19|Actual|Washington University School of Medicine|||3||f||||t||||||Samples With DNA|"     Serum and plasma samples will be obtained Abdominal and thigh subcutaneous adipose tissue     obtained during surgery   "|||2017-10-11 00:42:29.694185|2017-10-11 00:42:29.694185
NCT02076074|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-07-18|||April 2, 2014|Actual|2014-04-02|July 2017|2017-07-01|April 30, 2023|Anticipated|2023-04-30|April 30, 2023|Anticipated|2023-04-30||Interventional|||Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer|Evaluation of Single Fraction High-Gradient Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-Risk Stage 0 and I Breast Carcinoma|Recruiting||Phase 1/Phase 2|50|Anticipated|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||||2017-10-11 00:42:29.822057|2017-10-11 00:42:29.822057
NCT02076061|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-08-24|||February 2014||2014-02-01|August 2017|2017-08-01||||February 2020|Anticipated|2020-02-01||Observational|||Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study|Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) and Cardiovascular Diseases in Smokers/Ex-Smokers Attending Primary Care - Longitudinal Study|Recruiting||N/A|300|Anticipated|Lund University|||6||f||||f||||||||||2017-10-11 00:42:29.965901|2017-10-11 00:42:29.965901
NCT02076048|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-10-06|||July 2013||2013-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||LCPUFA Supplementation: A Multi-Modality Imaging Study|LCPUFA Supplementation: A Multi-Modality Imaging Study|Completed||N/A|42|Actual|University of Kansas Medical Center|||1||f||||f||||||Samples With DNA|"     cheek swab   "|||2017-10-11 00:42:30.130247|2017-10-11 00:42:30.130247
NCT02076035|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-12-30|||April 2014||2014-04-01|February 2014|2014-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Periduroscopy: Correlation Between the Outcome of Procedure and Histological-biochemical, Neuroinflammation and Genetic Factors.|A Prospective Study to Analyze, in a Population Undergoing to a Periduroscopy Approach, the Correlation Between Outcome of Procedure and Histological-biochemical Neuroinflammation and Genetic Factors|Unknown status|Recruiting|N/A|130|Anticipated|University of Parma|||1||f||||f||||||Samples With DNA|"     3 whole blood samples will be collected: before epiduroscopy, immediately after it and after     a month for genetic analyses and cytokine dosage. An epidural bioptic sample will be     performed according to usual clinical practice   "|||2017-10-11 00:42:30.226436|2017-10-11 00:42:30.226436
NCT02076022|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-06-09|||April 8, 2014|Actual|2014-04-08|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|AMP30||AMP30: Autologous Fat Grafting, Amputation Sites Pain: Randomized|Adipose Stromal Cell Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites: A Single Center Site, Prospective, Randomized, Pilot Outcomes Trial|Recruiting||N/A|30|Anticipated|University of Pittsburgh||2|||f||||t||||||||Yes|It is the Principal Investigator's intention to make subject de-identified information available to secondary investigators after all research study testing has been completed. These associated subject information will not include subject identifiers.|2017-10-11 00:42:30.333251|2017-10-11 00:42:30.333251
NCT02076009|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-07-27|2016-12-20||May 23, 2014|Actual|2014-05-23|July 2017|2017-07-01|September 29, 2020|Anticipated|2020-09-29|March 7, 2016|Actual|2016-03-07||Interventional|||A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma|Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 3|569|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 00:42:30.51178|2017-10-11 00:42:30.51178
NCT02075996|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-04-26|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|Poseidon||Non-interventional Study With Pomalidomide (Imnovid®)|Non-interventional Study of Pomalidomide (Imnovid®) in Combination With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||N/A|151|Actual|iOMEDICO AG|||2||f||||f||||||||||2017-10-11 00:42:32.644453|2017-10-11 00:42:32.644453
NCT02075983|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-27|||June 2013||2013-06-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|CUT*HIVAC001||Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes|A Phase I Clinical Trial to Assess the Safety and Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via the Intramuscular, Intradermal and Transcutaneous Routes in Healthy Male and Female Volunteers|Unknown status|Recruiting|Phase 1|30|Anticipated|Imperial College London||3|||f||||t||||||||||2017-10-11 00:42:32.725805|2017-10-11 00:42:32.725805
NCT02075957|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-27|||October 2013||2013-10-01|February 2014|2014-02-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Observational|SITRR||Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer|Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer|Unknown status|Recruiting|N/A|192|Anticipated|University Hospital, Angers|||1||f||||f||||||Samples With DNA|"     -  Three blood samples are going to be conserved : one during the week before the          operation, one four to eight weeks next to the operation and the last one, at the          relapse.        -  Biopsie of non small cell lung cancer will be conserved too.   "|||2017-10-11 00:42:32.917527|2017-10-11 00:42:32.917527
NCT02075944|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-06-25|||February 2014||2014-02-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Aerobic Exercise on Cognitive Function and Brain-derived Neurotrophic Factor in Young Adults|Effects of Aerobic Exercise on Cognitive Function and Brain-derived Neurotrophic Factor in Young Adults Aged 15-21 Years|Completed||N/A|130|Actual|University of Southern Denmark||3|||f||||t||||||||||2017-10-11 00:42:33.014969|2017-10-11 00:42:33.014969
NCT02075931|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-07-13|||February 2014||2014-02-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Collaborative-care Intervention to Promote Physical Activity After Total Knee Arthroplasty|Collaborative-care Intervention to Promote Physical Activity After Total Knee Arthroplasty|Active, not recruiting||N/A|50|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 00:42:33.086657|2017-10-11 00:42:33.086657
NCT02075918|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-09-13|||May 2014||2014-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|InTeam||Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis|Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis|Recruiting||N/A|700|Anticipated|University of North Carolina, Chapel Hill|||1||f||||t||||||Samples With DNA|"     Serum, Plasma, Whole Blood DNA, PBMCs, Urine, Stool, Liver Biopsy   "|||2017-10-11 00:42:33.157819|2017-10-11 00:42:33.157819
NCT02075905|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-12-19|||March 2014||2014-03-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management|Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management|Completed||N/A|111|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples Without DNA|"     Paraffin embedded esophageal biopsies   "|||2017-10-11 00:42:33.232044|2017-10-11 00:42:33.232044
NCT02075892|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-12-03|||August 2014||2014-08-01|August 2014|2014-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Mushroom Blend on Oxygen Kinetics|Acute Effects of a Mushroom Blend on Oxygen Kinetics, Aerobic Power and Time to Fatigue|Completed||N/A|28|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:42:33.308857|2017-10-11 00:42:33.308857
NCT02075879|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-27|||February 2013||2013-02-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of a Nurse-led Case Management Programme on Home Exercise Training for Haemodialysis Patients|The Effects of a Nurse-led Case Management Programme on Home Exercise Training for Haemodialysis Patients|Completed||N/A|113|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 00:42:33.477999|2017-10-11 00:42:33.477999
NCT02075866|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-03|||January 1998||1998-01-01|March 2014|2014-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|FinGesture||Finnish Genetic Study for Arrhythmic Events|Finnish Genetic Study for Arrhythmic Events|Recruiting||N/A|8000|Anticipated|University of Oulu|||1||f||||||||||||||2017-10-11 00:42:33.568724|2017-10-11 00:42:33.568724
NCT02075853|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-08-29|||September 2010||2010-09-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Outcomes of the Evans Calcaneal Lengthening Based on Bone Grafting Material|Outcomes of the Evans Calcaneal Lengthening Based on Bone Grafting Material|Recruiting||N/A|40|Anticipated|University of Colorado, Denver|||2||f||||||||||||||2017-10-11 00:42:33.636739|2017-10-11 00:42:33.636739
NCT02075840|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-08-25|||August 30, 2014|Actual|2014-08-30|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|February 9, 2017|Actual|2017-02-09||Interventional|ALEX||A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants|Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer|Active, not recruiting||Phase 3|303|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-11 00:42:33.731525|2017-10-11 00:42:33.731525
NCT02075827|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-27|||February 2014||2014-02-01|February 2014|2014-02-01||||October 2014|Anticipated|2014-10-01||Interventional|||Metabolic Response to Playing Video Games: Two Arm Trial|Metabolic Response to Playing Video Games: Two Arm Trial|Unknown status|Recruiting|N/A|72|Anticipated|University College, London||2|||f||||f||||||||||2017-10-11 00:42:34.744324|2017-10-11 00:42:34.744324
NCT02075801|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-27|||August 2003||2003-08-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01|10 Years|Observational [Patient Registry]|Sealant||10-years Clinical Trial of Sealed of Margin Failures|Longitudinal Results of a 10-years Clinical Trial of Sealed Margin Failures of Amalgam Restorations|Completed||N/A|32|Actual|University of Chile|||1||f||||t||||||||||2017-10-11 00:42:34.886525|2017-10-11 00:42:34.886525
NCT02075788|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-01-21|||January 2014||2014-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional|||Millet Products Study - Investigation of Glycemic Index and Satiety|Millet Products Study - Investigation of Glycemic Index and Satiety|Completed||N/A|12|Actual|University of Guelph||3|||f||||f||||||||||2017-10-11 00:42:34.986559|2017-10-11 00:42:34.986559
NCT02075775|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-04-11|||August 2012||2012-08-01|April 2017|2017-04-01|August 2037|Anticipated|2037-08-01|December 2017|Anticipated|2017-12-01|20 Years|Observational [Patient Registry]|MOONSI||MOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment.|MOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment.|Recruiting||N/A|10000|Anticipated|University of Iowa|||1||f||||t||||||||No||2017-10-11 00:42:35.115505|2017-10-11 00:42:35.115505
NCT02075762|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-09-19|||August 2013||2013-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease|Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease|Active, not recruiting||N/A|16|Anticipated|Johns Hopkins University||3|||f||||f||||||||||2017-10-11 00:42:35.329064|2017-10-11 00:42:35.329064
NCT02075749|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-07-09|||May 2013||2013-05-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparing Triamcinolone Acetonide Mucoadhesive Films With Licorice Mucoadhesive Films|Comparison of Triamcinolone Acetonide Mucoadhesive Film With Liquorice Mucoadhesive Film On Radiotherapy-Induced Oral Mucositis: A Randomized Double-Blinded Clinical Trial|Completed||Phase 1/Phase 2|60|Actual|Isfahan University of Medical Sciences||3|||f||||t||||||||||2017-10-11 00:42:35.458609|2017-10-11 00:42:35.458609
NCT02075736|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-11-23|||March 2011||2011-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||KTP Green Light Prostatectomy Compared With TUR-P in High Risk Patients|The Effect of KTP (Potassium-titanyl-phosphate) Green Light Prostatectomy (120W) Compared With TUR-P When Treating Benign Prostatic Hyperplasia in High Risk Patients, A Prospective Randomized Study|Recruiting||Phase 4|40|Anticipated|Helsinki University||2|||f||||f||||||||||2017-10-11 00:42:35.607085|2017-10-11 00:42:35.607085
NCT02075723|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-05-26|||February 2014||2014-02-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of Sleep Restriction on Metabolic Disturbances Caused by Overfeeding|Effect of Sleep Restriction on Metabolic Disturbances Caused by Overfeeding|Unknown status|Recruiting|N/A|9|Anticipated|University of Lausanne Hospitals||2|||f||||t||||||||||2017-10-11 00:42:35.757052|2017-10-11 00:42:35.757052
NCT02075710|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-09-22|||July 2013||2013-07-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Dietary Treatment Study of Fat Synthesis and Risk of Cardiovascular Disease|Lipogenesis, Lipoprotein Flux, and CVD Risk: Role of Meal Composition and Frequency|Recruiting||N/A|48|Anticipated|University of California, San Francisco||6|||f||||f||||||||||2017-10-11 00:42:35.86124|2017-10-11 00:42:35.86124
NCT02075697|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-12-26|||October 2008||2008-10-01|September 2016|2016-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01|5 Years|Observational [Patient Registry]|Biobadaderm||Spanish Registry of Systemic Treatments in Psoriasis|Spanish Registry of Systemic Treatments in Psoriasis|Recruiting||N/A|1887|Anticipated|Fundación Academia Española de Dermatología|||2||f||||f||||||||No||2017-10-11 00:42:36.040994|2017-10-11 00:42:36.040994
NCT02075684|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-06-15|||April 2013||2013-04-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Office-based Percutaneous Ultrasound-guided Renal Biopsy|Office-based Percutaneous Ultrasound-guided Renal Biopsy|Enrolling by invitation||N/A|180|Anticipated|University of California, Irvine||1|||f||||t||||||||No|We do not intend to release individual data to other researchers.|2017-10-11 00:42:36.202456|2017-10-11 00:42:36.202456
NCT02075671|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-02-22|||April 2014||2014-04-01|February 2016|2016-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Photodynamic Therapy for Papulopustular Rosacea|Photodynamic Therapy for Papulopustular Rosacea|Recruiting||Phase 4|30|Anticipated|George Washington University||3|||f||||f||||||||||2017-10-11 00:42:36.320098|2017-10-11 00:42:36.320098
NCT02075645|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-11-30|||December 2010||2010-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|Teams4Kids||Can Adherence to PALS Guidelines be Improved by Team Training of Pediatric Resuscitation Members?|Can Adherence to PALS Guidelines be Improved by Team Training of Pediatric Resuscitation Members?|Completed||N/A|300|Actual|University of Calgary||1|||f||||t||||||||||2017-10-11 00:42:37.281724|2017-10-11 00:42:37.281724
NCT02075632|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-08-28|2014-03-31||September 2006||2006-09-01|August 2014|2014-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream|A Mult-Center, Open-Label Study to Evaluate Product Duration of Use Experience With Aclometasone Diproprionate Cream|Completed||Phase 2|310|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:42:37.391215|2017-10-11 00:42:37.391215
NCT02075619|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-05-09|||March 24, 2014|Actual|2014-03-24|May 2017|2017-05-01|July 11, 2014|Actual|2014-07-11|July 11, 2014|Actual|2014-07-11||Interventional|||Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions|An Open-label, Randomized, Single Dose, Three-way Crossover, Six Sequence Pilot Study to Evaluate the Relative Bioavailability of One Amlodipine 10mg Tablet and Rosuvastatin 20mg Tablet to Two Fixed Dose Combination Tablet Formulations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Adult Male and Female Subjects Under Fasting Conditions|Completed||Phase 1|24|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:42:37.638944|2017-10-11 00:42:37.638944
NCT02075606|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-09-29|||May 2014||2014-05-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|CALM-NET||Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients|A Phase IV, Multicentre, Open Label, Single Group Exploratory Study to Assess the Clinical Value of Enumeration of Circulating Tumour Cells (CTCs) to Predict Clinical Symptomatic Response and Progression Free Survival in Patients Receiving Deep Subcutaneous Administrations of Somatuline® (Lanreotide) Autogel® to Treat the Symptoms of Functioning Midgut NeuroEndocrine Tumours (NET)|Completed||Phase 4|50|Actual|Ipsen||1|||f||||f||||||||||2017-10-11 00:42:37.7566|2017-10-11 00:42:37.7566
NCT02075593|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-06-05|||January 1, 2015||2015-01-01|June 2017|2017-06-01|October 29, 2021|Anticipated|2021-10-29|October 1, 2021|Anticipated|2021-10-01||Interventional|||ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection|ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women|Recruiting||Phase 3|25|Anticipated|ViiV Healthcare||1|||f||||f||||||||||2017-10-11 00:42:37.866579|2017-10-11 00:42:37.866579
NCT02075580|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-04-11|||September 2013||2013-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|BI-PORT||Totally Implantable Venous Access Devices: Quality of Life and Body Image|Totally Implantable Venous Access Devices (TIVAD): Impact on Quality of Life and Body Image|Recruiting||N/A|128|Anticipated|Istituto Oncologico Veneto IRCCS||2|||f||||f||||||||||2017-10-11 00:42:37.965834|2017-10-11 00:42:37.965834
NCT02075567|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-03-24|||January 2014||2014-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|ExT1DM||Exercise in Type 1 Diabetes Mellitus|Exercise and Blood Glucose Levels in Patients With Type I Diabetes - a Pilot Study|Completed||N/A|7|Actual|Medical University of Graz||1|||f||||t||||||||||2017-10-11 00:42:38.058869|2017-10-11 00:42:38.058869
NCT02075554|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-05-19|||July 2012||2012-07-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|CALIBER||Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach|Study of an Expandable Interbody Device for the Lumbar Spine|Completed||Phase 4|60|Actual|Globus Medical Inc||1|||f||||f||||||||||2017-10-11 00:42:38.148429|2017-10-11 00:42:38.148429
NCT02075541|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-05-05|||July 8, 2014|Actual|2014-07-08|May 2017|2017-05-01|April 19, 2017|Actual|2017-04-19|April 19, 2017|Actual|2017-04-19||Interventional|||A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.|An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients|Completed||Phase 2|145|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 00:42:38.240361|2017-10-11 00:42:38.240361
NCT02075528|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-27|||July 2009||2009-07-01|February 2014|2014-02-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER|Early Prediction of Clinical Response, Metabolic Change, and Pharmacokinetics in Taiwanese Patients With Schizophrenia Patients Treated by Paliperidone ER: an Open-Label Study|Completed||Phase 4|41|Actual|Taipei City Hospital||1|||f||||t||||||||||2017-10-11 00:42:38.470565|2017-10-11 00:42:38.470565
NCT02075515|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-04-20|2016-11-29|2015-11-12|August 13, 2014||2014-08-13|January 2017|2017-01-01|April 25, 2016|Actual|2016-04-25|April 29, 2015|Actual|2015-04-29||Interventional|||Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age|Consistency, Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults 50 Years of Age or Older|Completed||Phase 3|651|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 00:42:38.627031|2017-10-11 00:42:38.627031
NCT02075502|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-08-30|||February 2014||2014-02-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|GAIT||Community Walking Exercise for Patients With Peripheral Artery Disease|A Community-based Exercise Program to Improve Walking Outcomes in Patients With Peripheral Artery Disease|Recruiting||N/A|134|Anticipated|University of Minnesota - Clinical and Translational Science Institute||6|||f||||f||||||||||2017-10-11 00:42:41.824659|2017-10-11 00:42:41.824659
NCT02075476|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-08-08|||May 2013||2013-05-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||the Effectiveness Between Two Surgical Techniques for Reconstruction of Humeral Proximal Extremity Fractures or Fractures Luxation in Three or Four Fragments|Prospective, Randomized and Double Blind Study of Parallels Groups for Evaluating the Effectiveness Between Two Surgical Techniques for Reconstruction of Humeral Proximal Extremity Fractures or Fractures Luxation in Three or Four Fragments of Neer's Classification.|Active, not recruiting||N/A|40|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-11 00:42:42.062973|2017-10-11 00:42:42.062973
NCT02075463|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-05-22|2016-10-24|2016-08-04|June 1, 2014||2014-06-01|April 2017|2017-04-01|March 16, 2016|Actual|2016-03-16|March 1, 2016|Actual|2016-03-01||Interventional|||Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia|A 16-week, Phase 2a, Single-arm, Multi-center, Open-label Study to Evaluate the Safety and Efficacy of GSK1278863 After Switching From Recombinant Human Erythropoietin (rhEPO), in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Chronically Hyporesponsive to rhEPO|Terminated||Phase 2|15|Actual|GlaxoSmithKline|Due to the study terminating early, resulting in a sparse amount of data, selected parameters were not summarized.|1|||f||||t||||||||||2017-10-11 00:42:42.19291|2017-10-11 00:42:42.19291
NCT02075450|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-08-18|||July 2012||2012-07-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|QCPR||Improving the Quality of Cardiopulmonary Resuscitation (CPR) During Pediatric Cardiac Arrest|Assessing and Improving the Quality of Cardiopulmonary Resuscitation (CPR) Delivered During Simulated Pediatric Cardiac Arrest Using a Novel Pediatric CPR Feedback Device|Completed||N/A|324|Actual|Express Collaborative||4|||f||||t||||||||||2017-10-11 00:42:44.33597|2017-10-11 00:42:44.33597
NCT02075437|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-07-11|||March 2014||2014-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|FBI||Feeling and Body Investigators|Feelings and Body Investigators (FBI): Interoceptive Exposure for Child Abdominal Pain|Recruiting||N/A|126|Anticipated|Duke University||1|||f||||||||||||||2017-10-11 00:42:44.456071|2017-10-11 00:42:44.456071
NCT02075424|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-07-14|||March 2014||2014-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|RegulStress||Descriptive Study of Biological Stress and Perceived Stress at the Center 15|Descriptive Study of Biological Stress and Perceived Stress in Call Regulation Operators and Doctors When Processing a Call at the Center 15|Completed||N/A|40|Actual|Centre Hospitalier Régional Metz-Thionville||1|||f||||f||||||||||2017-10-11 00:42:44.691902|2017-10-11 00:42:44.691902
NCT02075411|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-04-13|2016-04-13||March 2014||2014-03-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Opioid Use in Single Shot Nerve Block vs Continuous Peripheral Nerve Infusion in Anterior Cruciate Ligament (ACL) Repair|A Randomized, Controlled Trial to Evaluate Opioid Usage Associated With Femoral Continuous Perineural Infusion and Femoral Single Shot Peripheral Nerve Block After a Hamstring Autograft Anterior Cruciate Ligament Repair.|Terminated||Phase 3|1|Actual|Children's Hospital of Philadelphia|Due limited enrollment and early termination of this study, analysis of outcome data was not possible.|4||Difficult to enroll, parents/subjects prefer to choose type of anesthetic block.|f||||t||||||||||2017-10-11 00:42:44.792708|2017-10-11 00:42:44.792708
NCT02075398|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-27|||December 2013||2013-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0|Evaluation of Respiration Rate Parameters During Motion in Healthy Volunteers Using a Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0|Completed||N/A|35|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 00:42:45.337671|2017-10-11 00:42:45.337671
NCT02075385|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-06-27|||July 2012||2012-07-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|November 2014|Actual|2014-11-01||Interventional|Swallowing-1||Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer|Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer|Completed||Phase 2|94|Actual|Barretos Cancer Hospital||2|||f||||t||||||||||2017-10-11 00:42:45.419867|2017-10-11 00:42:45.419867
NCT02075372|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-10|||January 2014||2014-01-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|October 2015|Actual|2015-10-01|1 Year|Observational [Patient Registry]|RECHARGE||CrossBoss and Hybrid Registry on Coronary Chronic Total Occlusions|REgistry of CrossBoss and Hybrid Procedures in FrAnce, the NetheRlands, BelGium and UnitEd Kingdom|Completed||N/A|1177|Actual|Hasselt University|||1||f||||f||||||||||2017-10-11 00:42:45.534968|2017-10-11 00:42:45.534968
NCT02075359|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-27|||May 2010||2010-05-01|February 2014|2014-02-01|April 2015|Anticipated|2015-04-01|April 2014|Anticipated|2014-04-01||Observational|LILCAL||Energy Expenditure and Physical Activity in Preschoolers|Novel Models to Predict Energy Expenditure and Physical Activity in Preschoolers|Unknown status|Active, not recruiting|N/A|150|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-10-11 00:42:45.738583|2017-10-11 00:42:45.738583
NCT02075346|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-27|||November 2013||2013-11-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|BRPMS||Bedside Respiratory Patient Monitoring System - Sensor Off Study|Sensor Off Studies Using a Nellcor Bedside Respiratory Patient Monitoring System, Configured With the Multi-functional Respiratory PCBA|Completed||N/A|18|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 00:42:45.83513|2017-10-11 00:42:45.83513
NCT02075333|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-05-11|||January 2014||2014-01-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Ingesting or Rinsing Sucrose and Sucralose on Self-control, Cognitive Performance, and Blood Glucose|The Effects of Ingesting or Rinsing Sucrose and Sucralose Solutions on Self-control, Cognitive Performance, and Blood Glucose Level|Completed||N/A|40|Actual|University of Leeds||2|||f||||f||||||||Undecided||2017-10-11 00:42:45.909016|2017-10-11 00:42:45.909016
NCT02075320|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-04-05|||February 2014||2014-02-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules|Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis Versus Chest Radiographs in Patients With Known Lung Nodules|Recruiting||N/A|100|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 00:42:46.004596|2017-10-11 00:42:46.004596
NCT02075307|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-02-14|||January 2014||2014-01-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effect of Blueberry Consumption on Metabolic Syndrome & DNA Damage|Highbush Blueberries, the DNA-damage of Obesity, Somatic Mutations and Metabolic Syndrome|Enrolling by invitation||N/A|50|Anticipated|Children's Hospital & Research Center Oakland||2|||f||||f||||||||||2017-10-11 00:42:46.111016|2017-10-11 00:42:46.111016
NCT02075294|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-10-26|||January 2010||2010-01-01|October 2014|2014-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B|Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B|Completed||N/A|242|Actual|Beijing 302 Hospital|||3||f||||t||||||||||2017-10-11 00:42:46.203758|2017-10-11 00:42:46.203758
NCT02075281|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-08-08||2016-08-08|February 2014||2014-02-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Effect of LAPS-Exendin on Body Weight in Obese Population|A 20-week, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial to Assess the Safety and Efficacy of HM11260C on Body Weight in Obese Subjects Without Diabetes|Completed||Phase 2|297|Actual|Hanmi Pharmaceutical Company Limited||5|||f||||f||||||||||2017-10-11 00:42:46.319018|2017-10-11 00:42:46.319018
NCT02075268|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-28|||January 2014||2014-01-01|February 2014|2014-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|PRAS-AM||Clinical Trial to Characterize Pharmacokinetic-pharmacodynamic (PKPD) of Prasugrel 10 mg or 30 mg in Healthy Volunteers|An Open Label, Single Dose Study to Characterize the Pharmacokinetics and Pharmacodynamics of Prasugrel in Healthy Male Adult Subjects|Unknown status|Recruiting|Phase 1|8|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-11 00:42:46.43513|2017-10-11 00:42:46.43513
NCT02075242|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-28|||January 2014||2014-01-01|February 2014|2014-02-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|OPTIMUS-A||TO Compare the Triple Drug Therapy and Dual Therapy .|Open Label, Multi-center, Randomized Study to Compare of Tacrolimus and Steroids in Combination With Mycophenolate Mofetil or Without Mycophenolate Mofetil in Liver Transplantation With Hepatitis B Virus(HBsAg) Positive|Unknown status|Recruiting|Phase 4|170|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 00:42:46.989346|2017-10-11 00:42:46.989346
NCT02075229|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-06-05|||February 2014||2014-02-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Observational|||Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS Population|A Proposal to Evaluate Revised Indications for Cochlear Implant Candidacy for the Adult CMS Population|Recruiting||N/A|90|Anticipated|American Cochlear Implant Alliance|||2||f||||f||||||||No||2017-10-11 00:42:47.089734|2017-10-11 00:42:47.089734
NCT02075216|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-27|||December 2013||2013-12-01|February 2014|2014-02-01|December 2016|Anticipated|2016-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Transurethral Myoblast Injection for Urinary Incontinence in Children With Bladder Exstrophy|Transurethral Autologous Myoblast Injection for Treatment of Urinary Incontinence in Children With Bladder Exstrophy|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Al-Azhar University||1|||f||||t||||||||||2017-10-11 00:42:47.319008|2017-10-11 00:42:47.319008
NCT02075190|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-11-17|||February 2014||2014-02-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression|Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression|Unknown status|Recruiting|N/A|150|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-11 00:42:47.58101|2017-10-11 00:42:47.58101
NCT02075177|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-05-22||||||May 2017|2017-05-01||||||||Expanded Access|||Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma|Expanded Access Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb (LXS) Oral Powder Plus Ketoconazole in Patients With Recurrent or Resistant Neuroblastoma (IND#68,254)|Available||N/A|||South Plains Oncology Consortium|||||||||||||||||||2017-10-11 00:42:47.693553|2017-10-11 00:42:47.693553
NCT02075164|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-10-03|||May 2013||2013-05-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD|Unravelling the Pathogenetic Mechanisms of Fructose in Comparison to Glucose Consumption as Multiple Hit in the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease (NAFLD) - an Exploratory Trial|Recruiting||N/A|56|Anticipated|Medical University of Vienna||4|||f||||t||||||||||2017-10-11 00:42:47.802638|2017-10-11 00:42:47.802638
NCT02075151|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-02-26|||February 2014||2014-02-01|February 2014|2014-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Bronchial Thermoplasty: Mechanism of Action and Defining Asthma Phenotype|Bronchial Thermoplasty: Mechanism of Action and Defining Asthma Phenotype|Not yet recruiting||N/A|50|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 00:42:47.933188|2017-10-11 00:42:47.933188
NCT02075138|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-04-07|||April 2014||2014-04-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Grass Observational Study|An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis|Completed||N/A|109|Actual|Circassia Limited|||1||f||||f||||||||||2017-10-11 00:42:48.091409|2017-10-11 00:42:48.091409
NCT02075125|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-07-11|2015-09-13||January 2014||2014-01-01|July 2017|2017-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction|Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-segment Elevation Myocardial Infarction|Terminated||Phase 3|39|Actual|Dong-A University|For the present single-center pilot study, the small sample size was a major limitation, and as such was insufficiently powered to assess safety.|2||Enrolling participants has halted prematurely and will not resume|f||||t||||||||||2017-10-11 00:42:48.731058|2017-10-11 00:42:48.731058
NCT02075112|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-07-13|||November 2013||2013-11-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck|A Pilot Study of Soy Isoflavone, Genistein, in Combination With Radiation Therapy and Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 1|24|Actual|Emory University||1|||f||||t||||||||||2017-10-11 00:42:49.142814|2017-10-11 00:42:49.142814
NCT02075099|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-02-10|||January 2014||2014-01-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|EVASION||Evaluation of the Efficiency of Hydration by Isotonic Solution in the Prevent of the Fainting Whole Blood Donors|Evaluation of the Efficiency of a Hydration by Isotonic Solution With or Without Muscular Exercise of the Fainting Whole Blood Donors|Completed||N/A|4825|Actual|Etablissement Français du Sang||3|||f||||f||||||||||2017-10-11 00:42:49.253459|2017-10-11 00:42:49.253459
NCT02075086|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-03-13|||July 2011||2011-07-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|ANGIOSWITCH||Angiogenic Switch in Patients With Colorectal Cancer|Angiogenic Switch as Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Grupo Hospital de Madrid||1|||f||||f||||||||||2017-10-11 00:42:49.382567|2017-10-11 00:42:49.382567
NCT02075073|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-08-16|2016-08-05||February 2014||2014-02-01|August 2017|2017-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects|A Randomised, Double-blind, Three-arm, Parallel Group, Single-dose Study to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Three Formulations of Trastuzumab (SB3, EU Sourced Herceptin® and US Sourced Herceptin®) in Healthy Male Subjects|Completed||Phase 1|109|Actual|Samsung Bioepis Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:42:49.478817|2017-10-11 00:42:49.478817
NCT02075060|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-04-04|||February 2014||2014-02-01|April 2017|2017-04-01|January 18, 2018|Anticipated|2018-01-18|January 18, 2018|Anticipated|2018-01-18||Interventional|IPOI vs IPOP||Evaluation of Immediate Preoperative Instillation (IPOI) of Mitomycin C Compared to Early Postoperative Instillation (IPOP) in Non-muscle Invasive Bladder Cancer||Recruiting||Phase 2|54|Anticipated|Poitiers University Hospital||2|||f||||t||||||||||2017-10-11 00:42:50.057783|2017-10-11 00:42:50.057783
NCT02075047|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-09-29|||May 23, 2014|Actual|2014-05-23|September 2017|2017-09-01|October 10, 2021|Anticipated|2021-10-10|October 4, 2021|Anticipated|2021-10-04||Interventional|||Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder|A Phase 3, Multicenter, Four-week, Randomized, Double-blind, Placebo-Controlled, Parallel-group Efficacy And Safety Trial Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Current Or Most Recent Episode Manic)|Recruiting||Phase 3|180|Anticipated|Pfizer||2|||f||||t|t|f||||||||2017-10-11 00:42:50.261463|2017-10-11 00:42:50.261463
NCT02075034|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-06-22|||May 2014||2014-05-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Three Dosing Schedules of Oral Rigosertib in MDS Patients|A Randomized Phase I Study to Assess the Pharmacokinetics, Tolerability, Efficacy and Pharmacodynamics of Three Dosing Schedules of Oral Rigosertib in Transfusion-dependent, Low, Intermediate 1, or Intermediate-2 Myelodysplastic Syndrome Patients Based on the International Prognostic Scoring System|Suspended||Phase 1|36|Anticipated|Onconova Therapeutics, Inc.||3||"Study suspended before enrollment and treatment of any patients; study potentially will resume   after evaluation of results from other studies"|f||||f||||||||||2017-10-11 00:42:50.440442|2017-10-11 00:42:50.440442
NCT02075021|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-08-03|2017-08-03||March 2014||2014-03-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|rev/abraxane|3 Subjects accrued and completed follow up. Data was not analyzed because PI left institution.|Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma|Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma|Terminated||Phase 1/Phase 2|3|Actual|New York University School of Medicine||1||PI left the institution|f||||t|t|f||||||||2017-10-11 00:42:50.538814|2017-10-11 00:42:50.538814
NCT02075008|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-08-07|2017-03-14||March 27, 2014|Actual|2014-03-27|August 2017|2017-08-01|March 22, 2016|Actual|2016-03-22|March 22, 2016|Actual|2016-03-22||Interventional|||Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201|An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201|Terminated||Phase 2|270|Actual|Novartis||1||"The study was prematurely terminated after core study CQGE031B2201 failed to meet the primary   objective of demonstrating superiority for QGE031 versus placebo."|f||||f||||||||||2017-10-11 00:42:50.764769|2017-10-11 00:42:50.764769
NCT02074995|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-03-03|2015-12-08||February 2014||2014-02-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study of Tolerability and Efficacy of BVS857 in Severe Burn Subjects|Multiple Ascending, Sequential, Placebo-controlled, Double-blind Study to Assess Safety, Tolerability and Efficacy of BVS857 in Severe Burn Subjects|Terminated||Phase 2|1|Actual|Novartis|Terminated study underpowered due to low enrollment (n=1 patient). No analysis can be provided|3||The study was prematurely terminated due to recruitment issues|f||||t||||||||||2017-10-11 00:42:51.218832|2017-10-11 00:42:51.218832
NCT02074982|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2017-06-23|2017-06-23||February 26, 2014|Actual|2014-02-26|June 2017|2017-06-01|June 29, 2016|Actual|2016-06-29|June 29, 2016|Actual|2016-06-29||Interventional|||Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis|A 52-week, Multicenter, Randomized, Double-blind Study of Subcutaneous Secukinumab to Demonstrate Efficacy as Assessed by Psoriasis Area and Severity Index at 16 Weeks of Treatment Compared to Ustekinumab and to Assess Long-term Safety, Tolerability and Efficacy in Subjects With Moderate to Severe Plaque Psoriasis (CLEAR)|Completed||Phase 3|676|Actual|Novartis||2|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 00:42:51.56226|2017-10-11 00:42:51.56226
NCT02074969|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-28|||October 2007||2007-10-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|December 2010|Actual|2010-12-01||Interventional|||Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures|Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures - Epidemiological Data and Rates of Complications|Completed||N/A|200|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 00:42:52.649944|2017-10-11 00:42:52.649944
NCT02074956|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-03-14|||May 2008||2008-05-01|March 2014|2014-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults|A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS 404 When Administered as Different IC31 Adjuvant Amounts With Different AERAS-404 (HyVac4) Antigen Amounts in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection|Completed||Phase 1|60|Actual|Aeras||5|||f||||t||||||||||2017-10-11 00:42:52.754264|2017-10-11 00:42:52.754264
NCT02074943|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-12-10|||April 2014||2014-04-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia|Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia: A Double-Blind, Randomized, Placebo Controlled Trial|Unknown status|Recruiting|N/A|20|Anticipated|Vancouver General Hospital||1|||f||||t||||||||||2017-10-11 00:42:53.02076|2017-10-11 00:42:53.02076
NCT02074930|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-04-14|||February 2014||2014-02-01|April 2014|2014-04-01||||April 2014|Actual|2014-04-01||Interventional|||Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen Exposure|Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen Exposure|Completed||N/A|20|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 00:42:53.110195|2017-10-11 00:42:53.110195
NCT02074917|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-03-14|||October 2012||2012-10-01|March 2014|2014-03-01|October 2015|Anticipated|2015-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Comparison of Dynamic Knee Stability and Functional Outcomes in Anatomical ACL Reconstruction at AM or Central Position|Comparison of Dynamic Knee Stability and Functional Outcomes in Anatomical Single-bundle ACL at Anteromedial or Central Tunnel Position - Prospective, Randomized and Double-blind Clinical Trial in Athletes|Unknown status|Recruiting|N/A|40|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:42:53.216317|2017-10-11 00:42:53.216317
NCT02074904|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-08-29|||May 2015||2015-05-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|TOPMRI||Topiramate's Effects on Heavy Drinking|Brain Mechanisms of Topiramate's Effects on Heavy Drinking|Recruiting||Phase 2|40|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:42:53.384909|2017-10-11 00:42:53.384909
NCT02074891|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-02-02|||October 2014||2014-10-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|SHIPP||Sustainable Healthcenter Implementation PrEP Pilot Study|Sustainable Healthcenter Implementation PrEP Pilot Study|Recruiting||N/A|1200|Anticipated|Centers for Disease Control and Prevention|||1||f||||f||||||Samples With DNA|"     Dried blood spots   "|||2017-10-11 00:42:53.51132|2017-10-11 00:42:53.51132
NCT02074878|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-08-08|||June 2014||2014-06-01|August 2017|2017-08-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|CRIZENT||CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer|A Phase IB Study of Crizotinib (XALKORI) and Sunitinib (SUTENT) in Metastatic Breast Cancer|Terminated||Phase 1|3|Actual|Baylor Breast Care Center||3||Poor accrual so the study was halted on May 16, 2017.|f||||f||||||||||2017-10-11 00:42:53.659472|2017-10-11 00:42:53.659472
NCT02074865|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-02-25|||September 2012||2012-09-01|February 2014|2014-02-01||||March 2014|Anticipated|2014-03-01||Observational|ChARLI||Children's Antibiotic Resistant Infections in Low Income Countries|Children's Antibiotic Resistant Infections in Low Income Countries|Unknown status|Recruiting|N/A|1000|Anticipated|Institut Pasteur|||1||f||||f||||||Samples With DNA|"     At birth, for therapeutic management of the newborns in the presence of a risk factor for     infection :gastric fluid, external auditory canal swabs, anal swabs, placental biopsy. Before     empirical antibiotic treatment: blood cultures, blood sampling for CRP determination.In the     presence of particular warning signs of infection chest X ray and lumbar puncture.      During the follow-up, for therapeutic management of the newborns if the child has a suspected     infection : urine samples, blood for blood cultures and Blood formula and C-reactive protein     (CRP) detrmination; rhinopharyngeal fluid samples, lumbar puncture in febrile children under     the age of three months; and thick blood smears if the child has a fever.      Samples based on the presence of particular warning signs of infection: stool samples, eye or     ear swabbing, chest X   "|||2017-10-11 00:42:53.772491|2017-10-11 00:42:53.772491
NCT02074852|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-01|||November 2012||2012-11-01|March 2014|2014-03-01||||December 2013|Actual|2013-12-01||Observational|||Comparison of Immediate Versus Delayed Removal of Urinary Catheter Following Elective Cesarean Section||Completed||N/A|300|Actual|Cairo University|||2||f||||||||||||||2017-10-11 00:42:53.884657|2017-10-11 00:42:53.884657
NCT02074839|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-05-31|||March 2014||2014-03-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation|A Phase I, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation|Active, not recruiting||Phase 1|266|Actual|Agios Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:42:53.968986|2017-10-11 00:42:53.968986
NCT02074826|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-02-12|||March 2014||2014-03-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|LOGICAL||Left Atrial Low vOltage Zone, GenetIC Markers and Outcomes in Patients After Atrial Fibrillation abLation|Analysis of the Interplay Between Genetic Risk Variants for Atrial Fibrillation and Pathological Changes That Associate With the Disease|Recruiting||N/A|1000|Anticipated|Technische Universität Dresden|||1||f||||f||||||Samples With DNA|"     Blood samples in EDTA plastic vaccutainers will be collected from the study participants for     genetic testing   "|||2017-10-11 00:42:54.095218|2017-10-11 00:42:54.095218
NCT02074813|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2016-10-24|||March 2014||2014-03-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|EMI II||Inspiratory Muscle Training During Pulmonary Rehabilitation in COPD|Effects of Inspiratory Muscle Training (IMT) on Dyspnea in COPD During Pulmonary Rehabilitation: Randomized Controlled Trial|Completed||N/A|150|Actual|University Hospital, Brest||2|||f||||f||||||||||2017-10-11 00:42:54.189043|2017-10-11 00:42:54.189043
NCT02074800|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2015-02-04|||June 2008||2008-06-01|February 2015|2015-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Participants|A Phase 1, Randomized Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Subjects|Completed||Phase 1|145|Actual|Centocor, Inc.||2|||f||||f||||||||||2017-10-11 00:42:54.290942|2017-10-11 00:42:54.290942
NCT02074787|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-27|2014-02-27|||March 2014||2014-03-01|February 2014|2014-02-01|September 2014|Anticipated|2014-09-01|May 2014|Anticipated|2014-05-01||Observational|||Imaging of Adult Burn Injuries|A Comparison of Three Non-invasive Imaging Modalities (Thermography, Laser Doppler and SIAscope) for the Assessment of Adult Burns Injuries|Unknown status|Not yet recruiting|N/A|30|Anticipated|Chelsea and Westminster NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 00:42:54.398003|2017-10-11 00:42:54.398003
NCT02074774|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-05-09|||December 2016||2016-12-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||IntellO2 vs Manual Control for Optimizing Oxygenation in Infants|Comparison of the IntellO2 - Precision Flow Automatic FiO2 Controller to Manual Control for Optimizing Oxygenation in Preterm Infants Receiving High Flow Nasal Cannula Therapy|Recruiting||N/A|30|Anticipated|Vapotherm, Inc.||2|||f||||t||||||||||2017-10-11 00:42:54.515966|2017-10-11 00:42:54.515966
NCT02074761|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-06-05|||January 2014||2014-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System|Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System|Recruiting||N/A|250|Anticipated|Zyga Technology, Inc.|||1||f||||f||||||||||2017-10-11 00:42:54.636084|2017-10-11 00:42:54.636084
NCT02074748|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-01-27|||February 2014||2014-02-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Measurement of Arch Motion After Bunion Surgery|First Ray Kinematics Following Lapidus Bunion Surgery: A Fluoroscopic Gait Study|Terminated||N/A|2|Actual|University of Minnesota - Clinical and Translational Science Institute|||2|Surgeons chose not to provide patients for testing|f||||f||||||||||2017-10-11 00:42:54.81675|2017-10-11 00:42:54.81675
NCT02074735|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-01-17|||April 2014||2014-04-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Citicoline for Alcohol Dependence|Citicoline for Alcohol Dependence|Completed||Phase 4|62|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:42:54.905721|2017-10-11 00:42:54.905721
NCT02074722|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-09-15|||March 2014||2014-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Brain-Computer Interface and Mind-Body Awareness Training|Brain-Computer Interface and Mind-Body Awareness Training|Active, not recruiting||N/A|120|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:42:55.009153|2017-10-11 00:42:55.009153
NCT02074709|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-05-26|2014-12-05||January 2014||2014-01-01|December 2014|2014-12-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional||Patient undergoing hysterectomy|TAP Block With Plain Bupivacaine Versus Wound Infiltration With Exparel for Postoperative Pain Management|Transversus Abdominis Plane (TAP) Block With Bupivacaine Versus Wound Infiltration With Liposomal Bupivacaine (Exparel) for Postoperative Pain Management After Open Total Abdominal Hysterectomy: a Prospective Randomized Controlled Trial|Completed||Phase 4|60|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:42:55.087001|2017-10-11 00:42:55.087001
NCT02074696|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-05-11|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|BDNF||BDNF and Motor Learning|The Effect of BDNF on Motor Learning|Terminated||N/A|24|Actual|University of Minnesota - Clinical and Translational Science Institute|||1|Site unable to complete full data collection/protocol|f||||t||||||Samples With DNA|"     Saliva sample for BDNF testing   "|||2017-10-11 00:42:55.322453|2017-10-11 00:42:55.322453
NCT02074683|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-04-25|||November 2013||2013-11-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Fat Grafting for Pedal Fat Pad Atrophy in Diabetics|Fat Grafting for Pedal Fat Pad Atrophy in Diabetics|Active, not recruiting||Phase 1|30|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:42:55.391042|2017-10-11 00:42:55.391042
NCT02074670|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-25|||February 2007||2007-02-01|February 2014|2014-02-01||||February 2008|Actual|2008-02-01||Interventional|||fMRI In Spinal Cord Injury Patient After Rehabilitation|FUNCTIONAL MAGNETIC RESONANCE IMAGING (fMRI) OF THE SENSORIMOTOR CORTEX IN SPINAL CORD INJURY PATIENT AFTER INTENSIVE REHABILITATION INCLUDING ROBOTIC DEVICES|Completed||N/A|7|Actual|University of Nove de Julho||1|||f||||f||||||||||2017-10-11 00:42:55.480292|2017-10-11 00:42:55.480292
NCT02074657|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-12-19|||April 2014||2014-04-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|LYDIA||"LANK-2: Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia"|"LANK-2: Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia"|Completed||Phase 2|13|Actual|Hospital Universitario La Paz||1|||f||||f||||||||||2017-10-11 00:42:55.55205|2017-10-11 00:42:55.55205
NCT02074644|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-08-02|||September 2014|Actual|2014-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia|Randomized, Evaluator-blind, Controlled Trial to Evaluate the Efficacy and Safety of Prostatic Arterial Embolization Versus a Sham Procedure for Benign Prostatic Hyperplasia With Severe LUTS Not Adequately Controlled With Alpha-blockers|Recruiting||N/A|80|Anticipated|Hospital St. Louis, Lisbon, Portugal||2|||f||||f||||||||||2017-10-11 00:42:55.633118|2017-10-11 00:42:55.633118
NCT02074631|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-02-17|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation|Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation|Recruiting||Phase 2|60|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t|t|f||||||||2017-10-11 00:42:55.764233|2017-10-11 00:42:55.764233
NCT02074618|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-03-14|||May 2011||2011-05-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Physiotherapy in Patients With Chronic Kidney Disease|Impact of Physical Therapy on Functional Capacity and Quality of Patients With Chronic Kidney Disease|Completed||N/A|8|Actual|Hospital Regional Publico do Araguaia||1|||f||||f||||||||||2017-10-11 00:42:55.930934|2017-10-11 00:42:55.930934
NCT02074605|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-26|||July 2008||2008-07-01|February 2014|2014-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Cognitive Effects of Interferon in Patients With Melanoma|A Pilot Study of Neurocognitive Function in Patients Treated With Adjuvant Interferon Alpha-2b for High-Risk Melanoma|Completed||N/A|36|Actual|University of Arizona|||2||f||||f||||||||||2017-10-11 00:42:56.018418|2017-10-11 00:42:56.018418
NCT02074592|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-27|||July 2012||2012-07-01|February 2014|2014-02-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|SAVE US||Self Assessment of Fetal Ultrasound Images|Self Assessment Vs. Expert for Fetal Ultra Sound Biometry Images|Unknown status|Recruiting|Phase 3|320|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:42:56.102647|2017-10-11 00:42:56.102647
NCT02074579|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-04-28||2017-04-28|July 2014||2014-07-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome|A Phase 2, Single-center, Randomized, Double-Blinded, Placebo-Controlled Study on the Efficacy of Daikenchuto (TU 100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome|Completed||Phase 2|101|Actual|Tsumura USA||2|||f||||f||||||||||2017-10-11 00:42:56.184974|2017-10-11 00:42:56.184974
NCT02074566|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-04-21|||March 2014||2014-03-01|April 2015|2015-04-01|October 2016|Anticipated|2016-10-01|February 2016|Anticipated|2016-02-01||Interventional|||Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: The 1-2-3 Study|A Prospective Randomized Multicentre Efficacy Study on Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: The 1-2-3 Study|Unknown status|Enrolling by invitation|N/A|222|Anticipated|Thorax Centrum Twente||3|||f||||f||||||||||2017-10-11 00:42:56.27561|2017-10-11 00:42:56.27561
NCT02074553|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-08-25|2016-08-25||February 2014||2014-02-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||The Safety Analysis Set included all participants who received at least 1 dose of the study drug and had at least 1 safety assessment after dosing.|A Study Examining the Bioequivalence of 3 Alectinib (RO5424802) Test Formulations to a Reference Formulation of in Healthy Participants|A Randomized, Open-Label, Single Dose, Cross-Over Study to Investigate the Bioequivalence of Three RO5424802 Test Formulations Versus a Reference Formulation Following Oral Administration in Healthy Subjects|Completed||Phase 1|97|Actual|Hoffmann-La Roche||8|||f||||||||||||||2017-10-11 00:42:56.424802|2017-10-11 00:42:56.424802
NCT02074540|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-26|||April 2014||2014-04-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Observational|||The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient Compliance||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 00:42:58.962942|2017-10-11 00:42:58.962942
NCT02074527|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-26|||October 2012||2012-10-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01|30 Days|Observational [Patient Registry]|CHAIN||CHAIN_brazilian Registry of Congenital HeArt Disease INtervention and Angiography|Phase 0 _ Brazilian Registry of Congenital HeArt Disease INtervention and Angiography|Unknown status|Recruiting|N/A|2000|Anticipated|Hospital do Coracao|||1||f||||t||||||||||2017-10-11 00:42:59.048234|2017-10-11 00:42:59.048234
NCT02074514|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-09-02|2016-09-02||March 2014||2014-03-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional||Safety Analysis Set: participants who received at least one dose of study drug.|Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection|A Phase 3b, Multi-Center, Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naïve Adults With Chronic Genotype 1 or 3 Hepatitis C Virus Infection|Completed||Phase 3|117|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 00:42:59.148|2017-10-11 00:42:59.148
NCT02074501|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-26|||January 2014||2014-01-01|February 2014|2014-02-01|October 2014|Anticipated|2014-10-01|February 2014|Actual|2014-02-01||Interventional|InCARE||Intervention in Informal Caregivers Who Care Older People After a Stroke: a Pilot Study in Northern Portugal|Supporting Older People's Informal CAREgivers at Home Through InCARE Programme|Unknown status|Enrolling by invitation|N/A|158|Actual|University of Minho||1|||f||||t||||||||||2017-10-11 00:42:59.903492|2017-10-11 00:42:59.903492
NCT02074488|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-12-01|||February 2014||2014-02-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Balancing Act: Impact on Falls in Older Adults With Vision Impairment|Balancing Act: Impact on Falls in Older Adults With Vision Impairment|Completed||N/A|65|Actual|University of Maine||2|||f||||f||||||||||2017-10-11 00:42:59.994511|2017-10-11 00:42:59.994511
NCT02074475|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-02|||December 2013||2013-12-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|SPIrelevance||SPI Value Relevance in Clinical Practice|GE AOA Study Spin-off: Defining the Clinically Useful Range for Surgical Pleth Index|Completed||N/A|150|Actual|Tampere University Hospital|||1||f||||f||||||||||2017-10-11 00:43:00.151111|2017-10-11 00:43:00.151111
NCT02074462|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-08-13|||January 2014||2014-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Effect of Inflammation on Voriconazole Concentration|Managing Voriconazole Exposure During Severe Infection; Effect of Inflammation on Voriconazole Metabolic Ratio|Completed||N/A|36|Actual|University Medical Center Groningen|||1||f||||f||||||Samples With DNA|"     Whole blood, serum   "|||2017-10-11 00:43:00.24236|2017-10-11 00:43:00.24236
NCT02074449|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-11-15|||December 2012||2012-12-01|February 2014|2014-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ISS||Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)|Comprehensive Characterization Of Right Ventricular Performance And Afterload In Patients With Pulmonary Arterial Hypertension Undergoing Initiation And Rapid Dose Escalation Of Treprostinil|Completed||Phase 4|15|Actual|University of Arizona|||1||f||||f||||||||||2017-10-11 00:43:00.760271|2017-10-11 00:43:00.760271
NCT02074436|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-05-22|||May 2014||2014-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PROBLEMA||PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)|Randomized Trial of Epsilon Aminocaproic Acid Versus Platelet Transfusions for the Prevention of Bleeding in Thrombocytopenic Patients With Hematological Malignancies|Recruiting||Phase 2|100|Anticipated|Emory University||2|||f||||t||||||||Undecided||2017-10-11 00:43:00.833987|2017-10-11 00:43:00.833987
NCT02074423|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-26|||March 2013||2013-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Human Clinical Trial Evaluating the Effect of MealShape™ on Blood Glucose Level Following Consumption of Standard Meal|A Randomized, Controlled, Double-blind, Cross-over Clinical Trial, Evaluating the Effect of MealShape™ on the Postprandial Glycemia After Eating Standard Food, in Healthy Volunteers.|Completed||N/A|18|Actual|Dialpha||2|||f||||t||||||||||2017-10-11 00:43:00.959783|2017-10-11 00:43:00.959783
NCT02074410|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-04-20|||January 2014||2014-01-01|October 2014|2014-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease|Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease|Suspended||Phase 2|36|Anticipated|Omeros Corporation||4||Enrollment has been suspended in this study.|f||||f||||||||||2017-10-11 00:43:01.054224|2017-10-11 00:43:01.054224
NCT02074397|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-04-29|||February 2014||2014-02-01|April 2015|2015-04-01||||April 2015|Actual|2015-04-01||Interventional|||Distant Extrafascial Injection vs Subfascial Injection for Interscalene Block: Acute Pain Outcomes and Rates of Complications||Completed||N/A|40|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 00:43:01.164204|2017-10-11 00:43:01.164204
NCT02074384|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-02-29|2015-09-10||March 2014||2014-03-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)|Understanding Patient and Provider Glucose Reporting Preferences in Type 1 Diabetes: Cloud Based Ambulatory Glucose Profile (AGP)|Completed||N/A|161|Actual|HealthPartners Institute|This is a survey of patient and clinician preference and as such is subject to traditional survey biases (social desirability, hawthorne effect, etc.).|3|||f||||f||||||||No||2017-10-11 00:43:01.275144|2017-10-11 00:43:01.275144
NCT02074371|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-03-29|||January 2012||2012-01-01|March 2016|2016-03-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Observational|CABG PRD||Postoperative Respiratory Depression After Cardiac Surgery|Perioperative Parameters to Predict Postoperative Respiratory Depression After Cardiac Surgery|Completed||N/A|44|Actual|Universidade Camilo Castelo Branco|||1||f||||f||||||||||2017-10-11 00:43:01.63872|2017-10-11 00:43:01.63872
NCT02074358|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-07-15|2015-07-15||February 2014||2014-02-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||All participants who received at least one dose of study medication.|A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects|A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects|Completed||Phase 1|43|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 00:43:03.396167|2017-10-11 00:43:03.396167
NCT02074345|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-03-24|2016-03-24||March 2014||2014-03-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Full Analysis Set (FAS) - all participants who received at least 1 dose of the study vaccination.|Phase III Study of Intramuscular TAK-816 in Healthy Infants|A Phase III, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of Intramuscular TAK-816 in Healthy Infants|Completed||Phase 3|31|Actual|Takeda||1|||f||||f||||||||||2017-10-11 00:43:04.989944|2017-10-11 00:43:04.989944
NCT02074332|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-04-28|||September 2012||2012-09-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|January 2013|Actual|2013-01-01||Interventional|||Study on Obesity Intervention With Physical Exercise Among Students in Changping District, Beijing|Development and Application of Appropriate Technology for Obesity Prevention and Control -- Study on Personalized Aerobic and Appropriate Exercise Technology|Completed||N/A|921|Actual|Peking University||2|||f||||||||||||||2017-10-11 00:43:05.440111|2017-10-11 00:43:05.440111
NCT02074319|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-09-19|||December 2013||2013-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|RECOVERY||RCT of Methotrexate Added to Treatment As Usual in Schizophrenia|A Randomised Double Blind Placebo Controlled 12 Week Trial of Methotrexate Added to Treatment As Usual in Early Schizophrenia|Completed||Phase 1|92|Actual|Pakistan Institute of Learning and Living||2|||f||||f||||||||||2017-10-11 00:43:05.527842|2017-10-11 00:43:05.527842
NCT02074306|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-04-24|||April 2016||2016-04-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|lungshield||Does UROSHIELD® Influence Bacterial Growth On Endotracheal Tubes|Does UROSHIELD® Influence Bacterial Growth On Endotracheal Tubes|Recruiting||N/A|66|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-11 00:43:05.657026|2017-10-11 00:43:05.657026
NCT02074293|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-06-22|||January 2016||2016-01-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|ASISinCD||ASIS for Botox in Cervical Dystonia|ASIS for Botox in Cervical Dystonia|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|ASIS Corporation||22|||f||||t||||||||||2017-10-11 00:43:05.79464|2017-10-11 00:43:05.79464
NCT02074280|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2014-02-26|||October 2013||2013-10-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Rifaximin Predicts the Complications of Decompensated Cirrhosis|Rifaximin Predicts the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|250|Anticipated|Shanghai Changzheng Hospital||3|||f||||t||||||||||2017-10-11 00:43:06.029597|2017-10-11 00:43:06.029597
NCT02074267|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-26|||March 2009||2009-03-01|February 2014|2014-02-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy Pain||Completed||Phase 4|40|Actual|Nang Kuang Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 00:43:06.117911|2017-10-11 00:43:06.117911
NCT02074254|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-02-26|||April 2012||2012-04-01|February 2014|2014-02-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors|Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors|Unknown status|Recruiting|N/A|350|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-11 00:43:06.36406|2017-10-11 00:43:06.36406
NCT02074241|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-27|||March 2014||2014-03-01|February 2014|2014-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Molecular Markers of Chemosensitivity for Bladder Cancer|Molecular Markers of Chemosensitivity for Locally Advanced, Recurrent and Metastatic Bladder Cancer Based on the Adjuvant Chemotherapy of Gemcitabine and Cisplatin-a Prospective Control Study|Enrolling by invitation||N/A|200|Anticipated|Southwest Hospital, China|||2||f||||t||||||Samples With DNA|"     bladder cancer specimens   "|||2017-10-11 00:43:06.461069|2017-10-11 00:43:06.461069
NCT02074228|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-02-26|||August 2012||2012-08-01|February 2014|2014-02-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD|A Study to Identify the Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in Attention Deficit Hyperactivity Disorder|Unknown status|Recruiting|Phase 4|120|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 00:43:06.558739|2017-10-11 00:43:06.558739
NCT02074215|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2014-02-26|||March 2011||2011-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease|Effects and Mechanisms of Aerobic Exercises Combined With Dual-task Training in Cognitive Function in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease|Completed||N/A|19|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:43:06.675559|2017-10-11 00:43:06.675559
NCT02074202|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-27|||February 2014||2014-02-01|February 2014|2014-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma|A Phase III, Multi-center, Single-blind, Cross-over Study to Evaluate the Efficacy and Safety of 18Ffluorocholine (18F-FCH) Comparing With 18F-fluorodeoxyglucose (18F-FDG) for Detecting Hepatocellular Carcinoma|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 00:43:06.775199|2017-10-11 00:43:06.775199
NCT02074189|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-27|||March 2014||2014-03-01|February 2014|2014-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer|Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer|Enrolling by invitation||Phase 3|200|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 00:43:06.871183|2017-10-11 00:43:06.871183
NCT02074176|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2014-02-27|||January 2011||2011-01-01|February 2014|2014-02-01||||December 2011|Actual|2011-12-01||Observational|||Plasma Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder|Plasma Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder|Unknown status|Active, not recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     mRNA,pre-pro-orexin gene   "|||2017-10-11 00:43:06.95456|2017-10-11 00:43:06.95456
NCT02074163|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-06-22|||January 2016||2016-01-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|ASISinCM||ASIS for Botox in Chronic Migraine|ASIS for Botox in Chronic Migraine|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|ASIS Corporation||19|||f||||t||||||||||2017-10-11 00:43:07.033377|2017-10-11 00:43:07.033377
NCT02074150|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-06-22|||January 2016||2016-01-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|ASISinULS||ASIS for Botox in Upper Limb Spasticity|ASIS for Botox in Upper Limb Spasticity|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|ASIS Corporation||23|||f||||t||||||||||2017-10-11 00:43:07.247892|2017-10-11 00:43:07.247892
NCT02074137|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2016-06-01|||July 2014||2014-07-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer|Multicentre, Single Arm, Open Label, Non Controlled Phase IV Clinical Trial to Evaluate Safety of Cabazitaxel (Jevtana) in Combination With Oral Prednisone (or Prednisolone) for the Treatment of Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen|Completed||Phase 4|10|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:43:07.512238|2017-10-11 00:43:07.512238
NCT02074124|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-26|||October 2012||2012-10-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Observational|||CT Perfusion Changes in GI Cancer During Adenosine Vasodilation Test|Abdominal Tissue Perfusion Changes in Esophageal and Gastric Cancer During Adenosine Vasodilation Measured With Computed Tomography (CT) Perfusion|Completed||N/A|15|Actual|University of Copenhagen|||2||f||||f||||||||||2017-10-11 00:43:07.625953|2017-10-11 00:43:07.625953
NCT02074111|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke|Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke|Recruiting||N/A|400|Anticipated|Samsung Medical Center|||3||f||||t||||||Samples With DNA|"     Blood sample   "|||2017-10-11 00:43:07.718525|2017-10-11 00:43:07.718525
NCT02074098|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-03-17|||March 2014||2014-03-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Endotracheal Intubation Using Macintosh Laryngoscope, Glidescope, Airwayscope During Chest Compression With Adjustment Height of a Bed||Completed||N/A|21|Actual|Hanyang University||2|||f||||t||||||||||2017-10-11 00:43:07.825441|2017-10-11 00:43:07.825441
NCT02074085|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-25|||March 2014||2014-03-01|February 2014|2014-02-01||||September 2014|Anticipated|2014-09-01||Observational|||Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events|Measuring the Incidence of Hospital Readmissions, Caused by Adverse Drug Events (ADE) Due to Anticoagulants in Vzw Jessa Hospital (Belgium)|Unknown status|Not yet recruiting|N/A|450|Anticipated|Hasselt University|||1||f||||f||||||||||2017-10-11 00:43:07.930153|2017-10-11 00:43:07.930153
NCT02074072|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-03-20|||March 2014||2014-03-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Endotracheal Intubation Using Three Laryngoscopes in Maternal Cardiac Arrest: a Manikin Simulation Study|Comparison of Glidescope, Pentax-AWS and Macintosh Laryngoscope for Intubation During Chest Compression in 15-30 Degree Left-Lateral Tilt: A Manikin Simulation Study of Maternal Cardiopulmonary Resuscitation|Completed||N/A|19|Actual|Hanyang University Seoul Hospital||3|||f||||f||||||||||2017-10-11 00:43:08.024146|2017-10-11 00:43:08.024146
NCT02074059|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-03-10|2016-12-21||February 2014||2014-02-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional||All randomized subjects|Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates|A Multicenter, Randomized, Open-Label, Controlled Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Preterm Neonates 29 to 34 Weeks PMA: Dose Escalation and Study Extension|Completed||Phase 2|80|Actual|Windtree Therapeutics||6|||f||||t||||||||No||2017-10-11 00:43:08.19329|2017-10-11 00:43:08.19329
NCT02074046|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-06-01|||February 2014||2014-02-01|February 2014|2014-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer|Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic Adenocarcinoma of the Pancreas|Completed||Phase 1/Phase 2|40|Anticipated|Fuda Cancer Hospital, Guangzhou||4|||f||||t||||||||||2017-10-11 00:43:10.698112|2017-10-11 00:43:10.698112
NCT02074033|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-03-26|||March 2014||2014-03-01|March 2014|2014-03-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Observational|||Errors in Prescription Antibiotics in Ventilator-associated Pneumonia|Determination of Errors in Prescription Antibiotics in Ventilator-associated Pneumonia in Unit of Intensive Care of Clinical Hospital of Federal University of Uberlandia - Brazil|Unknown status|Recruiting|N/A|130|Anticipated|Federal University of Uberlandia|||1||f||||t|||||||"     No samples will be retained for the study   "|||2017-10-11 00:43:10.793585|2017-10-11 00:43:10.793585
NCT02074020|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2015-08-11|||December 2015||2015-12-01|August 2015|2015-08-01||||June 2018|Anticipated|2018-06-01||Interventional|||CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects With Systemic Lupus Erythematosus With or Without Nephritis|Withdrawn||Phase 3|0|Actual|Anthera Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:43:10.893487|2017-10-11 00:43:10.893487
NCT02074007|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-01-23||2015-01-08|December 2013||2013-12-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)|A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years|Terminated||Phase 3|178|Actual|Arbor Pharmaceuticals, Inc.||2||primary outcome measure not met|f||||f||||||||||2017-10-11 00:43:10.981989|2017-10-11 00:43:10.981989
NCT02073994|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-23|||March 2014||2014-03-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation|A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation|Active, not recruiting||Phase 1|170|Anticipated|Agios Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:43:11.132374|2017-10-11 00:43:11.132374
NCT02073981|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-03-14|||March 2014||2014-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|May 2016|Actual|2016-05-01||Observational|J-FIRST||Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients|Japan-First-in Large Scale Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients.|Active, not recruiting||N/A|1000|Anticipated|Kyowa Hakko Kirin Co., Ltd|||1||f||||f||||||||||2017-10-11 00:43:11.23232|2017-10-11 00:43:11.23232
NCT02073968|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-26|2017-06-27|||July 2013|Actual|2013-07-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|PAINT||PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer|PET-Adjusted IMRT for NSCLC Trial (PAINT)|Active, not recruiting||Phase 2|39|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 00:43:11.29641|2017-10-11 00:43:11.29641
NCT02073955|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-27|||March 2013||2013-03-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Validation of a Community Worker Administered Stroke Symptom Questionnaire|Adaptation and Validation of a Community Worker Administered Stroke Symptom Questionnaire in a Peri-urban Pakistani Community|Completed||N/A|322|Actual|Aga Khan University|||1||f||||t||||||||||2017-10-11 00:43:11.422914|2017-10-11 00:43:11.422914
NCT02073942|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-05-01|||February 2014||2014-02-01|May 2017|2017-05-01|July 31, 2017|Anticipated|2017-07-31|March 31, 2017|Actual|2017-03-31|1 Month|Observational [Patient Registry]|||Cologne Register of Wearable Defibrillator (CRWD)||Recruiting||N/A|100|Anticipated|University of Cologne|||1||f||||||||||||||2017-10-11 00:43:11.490002|2017-10-11 00:43:11.490002
NCT02073916|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-09-12|||October 2013||2013-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|STELA||TDM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer|Phase Ib Trial of Trastuzumab Emtansine In Combination With Lapatinib Plus Abraxane In Metastatic Her 2 Neu Over-Expressed Breast Cancer Patients|Recruiting||Phase 1/Phase 2|45|Anticipated|The Methodist Hospital System||1|||f||||f||||||||||2017-10-11 00:43:11.663284|2017-10-11 00:43:11.663284
NCT02073903|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-05-05|||February 2014|Actual|2014-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC|The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC|Active, not recruiting||N/A|40|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 00:43:11.810007|2017-10-11 00:43:11.810007
NCT02073890|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-02-25|||September 2012||2012-09-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Observational|||Neurological Outcome in Patients of Traumatic Subarachnoid Haemorrhage|Incidence and Outcomes of Traumatic Subarachnoid Haemorrhage Patients: A Cross Sectional Study|Completed||N/A|117|Actual|Macmillan Research Group UK|||1||f||||t||||||||||2017-10-11 00:43:11.912157|2017-10-11 00:43:11.912157
NCT02073877|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-09-22|||February 2014||2014-02-01|February 2014|2014-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01|3 Months|Observational [Patient Registry]|BMCCS1||The Baha Microbiome Case Control Study|The Baha Microbiome Case Control Study A Molecular Bacterial Profile Of The Baha Part 1 of the Baha Microbiome Study|Unknown status|Active, not recruiting|N/A|25|Anticipated|Maastricht University Medical Center|||2||f||||t||||||Samples With DNA|"     Bacterial samples are retained.   "|||2017-10-11 00:43:11.999431|2017-10-11 00:43:11.999431
NCT02073864|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2015-08-26|||November 2013||2013-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Observational|||A Study to Evaluate the Neuro-embolic Consequences of TAVR|Neurological Complications of Contemporary Unprotected TAVR (Yale Neuro TAVR)|Completed||N/A|46|Actual|Keystone Heart|||1||f||||f||||||||||2017-10-11 00:43:12.107607|2017-10-11 00:43:12.107607
NCT02073851|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-08-26|||January 2014||2014-01-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||DEFLECT II: A Study to Evaluate the Safety and Performance of the TriGuard™HDH in Patients Undergoing TAVR|A Prospective, Single Arm Feasibility Pilot Study to Evaluate the Safety and Performance of the TriGuard™HDH Embolic Deflection Device in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR)|Completed||N/A|12|Actual|Keystone Heart||1|||f||||f||||||||||2017-10-11 00:43:12.224844|2017-10-11 00:43:12.224844
NCT02073838|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-06|||May 2015||2015-05-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML|A Phase II, Multi-center, Open Label, Randomized Study of Ribavirin and Hedgehog Inhibitor With or Without Decitabine in Acute Myeloid Leukemia (AML)|Recruiting||Phase 2|40|Anticipated|Jewish General Hospital||2|||f||||f||||||||||2017-10-11 00:43:12.328934|2017-10-11 00:43:12.328934
NCT02073825|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-09-27|||November 2014||2014-11-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|October 2015|Actual|2015-10-01||Interventional|PC||Web Intervention for Concerned Partners to Prevent Service Member Alcohol Abuse Abuse|Web Intervention for Concerned Partners to Prevent Service Member Alcohol Abuse|Completed||N/A|312|Actual|RAND||2|||f||||f||||||||||2017-10-11 00:43:12.456296|2017-10-11 00:43:12.456296
NCT02073812|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-08-27|||February 2014||2014-02-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects|A Phase 1, Randomized, Open-Label, Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects|Completed||Phase 1|26|Actual|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||1|||f||||f||||||||||2017-10-11 00:43:12.57519|2017-10-11 00:43:12.57519
NCT02073799|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-02-25|||February 2014||2014-02-01|February 2014|2014-02-01||||March 2014|Anticipated|2014-03-01||Observational|||Storage Symptom After Laser Prostatectomy|Change in Storage Symptoms Following Laser Prostatectomy: Comparison Between Potassium-titanyl-phosphate Photoselective Vaporization of the Prostate (PVP) and Holmium Laser Enucleation of the Prostate (HoLEP)|Unknown status|Recruiting|N/A|486|Anticipated|Seoul National University Hospital|||2||f||||||||||||||2017-10-11 00:43:12.662135|2017-10-11 00:43:12.662135
NCT02073786|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-02-15|||October 2014||2014-10-01|February 2014|2014-02-01||||March 2015|Anticipated|2015-03-01||Interventional|Optiscope||Rigid Video Stylet Vs Conventional Lightwand Intubation|: Rigid Video Stylet Can Provide More Successful Intubation Than Conventional Lightwand Intubation in Patients With Cervical Spine Operation : A Prospective Randomized Study|Unknown status|Recruiting|N/A|168|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:43:12.84552|2017-10-11 00:43:12.84552
NCT02073773|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2017-02-08|||January 2014||2014-01-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Combinational Rehabilitative Therapy and Functional Brain Imaging for Patients Recovering From Motor Stroke|Combinational Rehabilitative Therapy and Functional Brain Imaging for Patients Recovering From Motor Stroke|Completed||Phase 3|9|Actual|Singapore General Hospital||2|||f||||t||||||||||2017-10-11 00:43:12.957574|2017-10-11 00:43:12.957574
NCT02073760|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-08-10|||June 2014||2014-06-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|||Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2|Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2|Active, not recruiting||N/A|330|Anticipated|University of Michigan|||1||f||||f||||||||||2017-10-11 00:43:13.176161|2017-10-11 00:43:13.176161
NCT02073747|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-07-13|2017-06-10||April 2015||2015-04-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||The Various Effects of Gaseous Albuterol on Serum Lactate|The Various Effects of Gaseous Albuterol on Serum Lactate|Completed||N/A|28|Actual|University Medical Center of Southern Nevada||2|||f||||f||||||||||2017-10-11 00:43:13.28202|2017-10-11 00:43:13.28202
NCT02073734|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-04-19|||February 2013||2013-02-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP|Effects of Preoperative Dexamethasone on Postoperative Quality of Recovery Following Vaginal Reconstructive Surgery: A Randomized Controlled Trial|Completed||Phase 3|63|Actual|TriHealth Inc.||2|||f||||f||||||||No||2017-10-11 00:43:13.526377|2017-10-11 00:43:13.526377
NCT02073721|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2014-02-25|||August 2013||2013-08-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|UI||The Importance of Electrical Stimulation as a Treatment for Urinary Incontinence in Patients Prostatectomy|The Importance of Electrical Stimulation as a Treatment for Urinary Incontinence in Patients Undergoing Prostatectomy to Exercise the Pelvic Floor Muscles (MAPs): Randomised Controlled Trial, Double Blind|Completed||N/A|34|Actual|Universidade Gama Filho||2|||f||||t||||||||||2017-10-11 00:43:13.64115|2017-10-11 00:43:13.64115
NCT02073708|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-05-08|||February 2014||2014-02-01|May 2017|2017-05-01|December 2033|Anticipated|2033-12-01|December 2015|Actual|2015-12-01||Observational|||A Population-based Investigation of Asthma in the Telemark Region of Norway|A Population-based Investigation of Asthma in the Telemark Region of Norway|Active, not recruiting||N/A|2000|Anticipated|Sykehuset Telemark|||1||f||||f||||||Samples With DNA|"     Serum, citrate plasma, EDTA-plasma, whole blood, gene sequencing (next generation gene     sequencing)   "|Undecided||2017-10-11 00:43:13.728773|2017-10-11 00:43:13.728773
NCT02073695|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-05-18|||January 2013||2013-01-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ROTATE||Return of Function and External Rotation Post Proximal Humerus Fracture Fixation With Neutral Rotation Brace|Return of Function and External Rotation Post Proximal Humerus Fracture Fixation With Neutral Rotation Brace|Unknown status|Recruiting|N/A|100|Anticipated|South Devon Healthcare NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:43:13.813466|2017-10-11 00:43:13.813466
NCT02073656|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-08-30|2016-08-30||February 2014||2014-02-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional||Safety Analysis Set: participants who enrolled and received at least 1 dose of study drug.|Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection|A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Co-infection|Completed||Phase 3|335|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 00:43:14.141511|2017-10-11 00:43:14.141511
NCT02073643|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-12-13|||November 2013||2013-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Observational|SHoPPER||Study of Household Purchasing Patterns, Eating and Recreation|Delay Discounting and Household Food Choices|Active, not recruiting||N/A|204|Actual|Rush University Medical Center|||1||f||||f||||||||||2017-10-11 00:43:15.149352|2017-10-11 00:43:15.149352
NCT02073630|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-05-09|||February 2014||2014-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|GAMMA||Contribution of the Cerebellum In Sensory-motor Adaptation Via Gamma Oscillations: the Case of Dystonia|Contribution du Cervelet Dans l'Adaptation Sensori-motrice Via Les Oscillations Gamma : le Cas de la Dystonie|Completed||N/A|40|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-11 00:43:15.239019|2017-10-11 00:43:15.239019
NCT02073617|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-07-13|||January 6, 2014|Actual|2014-01-06|July 2017|2017-07-01|June 13, 2017|Actual|2017-06-13|June 22, 2016|Actual|2016-06-22||Interventional|||Aortic Valve and Root Measurements Under Real-Time 3-Dimensional Visualization During Angiography|Aortic Valve and Root Measurements Under Real-Time 3-Dimensional Visualization During Angiography|Completed||N/A|25|Actual|New York University School of Medicine||1|||f||||t|f|f|||f|||||2017-10-11 00:43:15.331393|2017-10-11 00:43:15.331393
NCT02073604|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-08-30|||March 2014||2014-03-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|MOMIC2||Role of the SMA During Unimanual and Bimanual Movements Preparation: the Mirror Movements Paradigm|Rôle de la SMA Dans la préparation Des Mouvements Uni et Bi-manuels: le Paradigme Des Mouvements en Miroir|Completed||N/A|47|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-11 00:43:15.42813|2017-10-11 00:43:15.42813
NCT02073032|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-26|||February 2011||2011-02-01|February 2014|2014-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Incidence and Risk Factors of Refeeding Syndrome|Incidence and Risk Factors of Refeeding Syndrome in Head and Neck Cancer Patients - An Observational Study|Completed||N/A|79|Actual|University of Copenhagen|||1||f||||f||||||||||2017-10-11 00:43:22.198129|2017-10-11 00:43:22.198129
NCT02073591|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-11-04|||March 2014||2014-03-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|COPES||Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® Regimen|A Phase IV, Open Label, Single Arm, Multicenter, Observational Study to Evaluate the Correlation Between PEST and SCORAD Score in the Management of Atopic Dermatitis With Use of Ceradan® Regimen in Children Aged Six Months to Six Years|Completed||N/A|58|Actual|Hyphens Pharma Pte Ltd|||1||f||||f||||||||||2017-10-11 00:43:15.498212|2017-10-11 00:43:15.498212
NCT02073578|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-09-22|||August 2012||2012-08-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|POEM||Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia|Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia|Completed||Phase 1/Phase 2|20|Actual|Ohio State University||1|||f||||f||||||||||2017-10-11 00:43:15.571103|2017-10-11 00:43:15.571103
NCT02073565|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-10-05|||February 2014||2014-02-01|October 2017|2017-10-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|HARMONEE||HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt|Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE): Assessment of a Novel DES Platform For Percutaneous Coronary Revascularization in Patients With Ischemic Coronary Disease and NSTEMI Acute Coronary Syndrome|Active, not recruiting||N/A|572|Actual|OrbusNeich||2|||f||||t||||||||||2017-10-11 00:43:15.729267|2017-10-11 00:43:15.729267
NCT02073552|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-06-24|||May 2014||2014-05-01|September 2015|2015-09-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|REPREP1||Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid.|Randomized Clinical Trial to Evaluate the Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid in Patients With Past Poor Colonic Preparation|Completed||Phase 4|472|Actual|Fundación Canaria Rafael Clavijo para la Investigación Biomédica||2|||f||||t||||||||||2017-10-11 00:43:15.969095|2017-10-11 00:43:15.969095
NCT02073539|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-20|||March 2014||2014-03-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Manikin Study of Chest Compression With One Accelerometer Feedback Device|The Method of Proper Chest Compression Depth With Conventional and One Accelerometer Feedback Device During CPR in Hospital|Completed||N/A|19|Actual|Hanyang University Seoul Hospital||3|||f||||f||||||||||2017-10-11 00:43:16.068711|2017-10-11 00:43:16.068711
NCT02073526|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-12-05|||May 2013||2013-05-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01|3 Years|Observational [Patient Registry]|||Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease|Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease|Completed||N/A|1230|Actual|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Serum, whole blood   "|||2017-10-11 00:43:16.179677|2017-10-11 00:43:16.179677
NCT02073513|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2014-02-25|||November 2009||2009-11-01|February 2014|2014-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Kinesiotaping the Hand in Cerebral Palsy|Effects of Kinesiotaping the Hand of Children With Cerebral Palsy|Completed||N/A|45|Actual|Hacettepe University||3|||f||||f||||||||||2017-10-11 00:43:16.273229|2017-10-11 00:43:16.273229
NCT02073500|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-10-14|||September 2009||2009-09-01|October 2015|2015-10-01|January 2023|Anticipated|2023-01-01|January 2017|Anticipated|2017-01-01|5 Years|Observational [Patient Registry]|PSM||Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies|Prospective Observational Study of Peritoneal Surface Malignancies (PSM) - Characterization, Models and Treatment Strategies.|Recruiting||N/A|200|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Metastatic tissue, blood specimens.   "|||2017-10-11 00:43:16.356545|2017-10-11 00:43:16.356545
NCT02073487|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-09-12|||February 2014||2014-02-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|TEAL||Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel|Randomized Open Label PhII Trial of Neoadjuvant Trastuzumab Emtansine (Te) in Combination w/Lapatinib (L) Followed by Abraxane (A) Compared w/Trastuzumab Plus Pertuzumab Followed by Paclitaxel in Her 2 Neu Over-Expressed Breast Cancer Patients|Recruiting||Phase 2|30|Anticipated|The Methodist Hospital System||2|||f||||f||||||||||2017-10-11 00:43:16.461348|2017-10-11 00:43:16.461348
NCT02073461|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-02-27|2016-09-15||March 2014||2014-03-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.|A Multicenter, Randomized, Double-blinded, Vehicle-controlled Parallel Group Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.|Completed||Phase 2|236|Actual|Galderma R&D||3|||f||||f||||||||||2017-10-11 00:43:16.740639|2017-10-11 00:43:16.740639
NCT02073448|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-02-27|2016-09-15||March 2014||2014-03-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.|A Multicenter, Randomized, Double-blinded, Active-controlled Parallel Group Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.|Completed||Phase 3|417|Actual|Galderma R&D||3|||f||||f||||||||||2017-10-11 00:43:17.687348|2017-10-11 00:43:17.687348
NCT02073435|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-08-09|||October 2010||2010-10-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|May 2015|Actual|2015-05-01||Observational|||A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation|A2ALL-Patients Safety System Improvements in Living Donor Liver Transplant|Active, not recruiting||N/A|3000|Anticipated|Northwestern University|||2||f||||t||||||||||2017-10-11 00:43:18.757488|2017-10-11 00:43:18.757488
NCT02073422|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-06-10|||October 1, 2011|Actual|2011-10-01|June 2017|2017-06-01|December 10, 2016|Actual|2016-12-10|June 10, 2014|Actual|2014-06-10||Observational|||FAMOUS-NSTEMI MRI Sub-Study|Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes - A 3.0 Tesla Stress Perfusion MRI Sub-Study (FAMOUS-NSTEMI MRI)|Completed||N/A|106|Actual|NHS National Waiting Times Centre Board|||1||f||||t||||||||||2017-10-11 00:43:18.95957|2017-10-11 00:43:18.95957
NCT02073409|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-12-20|||December 2013||2013-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|PREDICT||PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis|Cystic Fibrosis Nontuberculous Mycobacteria Diagnosis Protocol|Recruiting||N/A|60|Anticipated|National Jewish Health|||1||f||||t||||||Samples Without DNA|"     serum sputum NTM isolates   "|||2017-10-11 00:43:19.100013|2017-10-11 00:43:19.100013
NCT02073396|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-08-01|||January 2013||2013-01-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis|Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis|Recruiting||N/A|140|Anticipated|East and North Hertfordshire NHS Trust|||1||f||||t||||||||||2017-10-11 00:43:19.216142|2017-10-11 00:43:19.216142
NCT02073383|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-25|||August 2013||2013-08-01|February 2014|2014-02-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Three Techniques for Ultrasound Guided Axillary Brachial Plexus Block|Prospective Randomized Study of Three Different Techniques for Ultrasound Guided Axillary Brachial Plexus Block|Unknown status|Active, not recruiting|N/A|313|Anticipated|Federal University of São Paulo||3|||f||||f||||||||||2017-10-11 00:43:19.345853|2017-10-11 00:43:19.345853
NCT02073370|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-02-26|||January 2011||2011-01-01|February 2014|2014-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|EC0991002-E||Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics|Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics|Active, not recruiting||N/A|350|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:43:19.439536|2017-10-11 00:43:19.439536
NCT02073357|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-07-29|||July 2014||2014-07-01|July 2014|2014-07-01||||January 2019|Anticipated|2019-01-01||Interventional|||The BALANCED Anaesthesia Study|The BALANCED Anaesthesia Study A Prospective, Randomised Clinical Trial of Two Levels of Anaesthetic Depth on Patient Outcome After Major Surgery|Withdrawn||N/A|0|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-10-11 00:43:19.524524|2017-10-11 00:43:19.524524
NCT02073344|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-02-01|||March 2014||2014-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|SASinHD_005||Effect of Beginning a Renal Replacement Therapy on Obstructive Sleep Apnea in End Stage Renal Disease Patients|Prospective Interventional Study Investigating the Effect of Beginning a Renal Replacement Therapy on Obstructive Sleep Apnea and Its Correlation With Overhydration, in End Stage Renal Disease Patients|Recruiting||N/A|30|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 00:43:19.604093|2017-10-11 00:43:19.604093
NCT02073331|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-01-30|||March 2014||2014-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|RECON||Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)|A Post Market Observational Study to Obtain Additional Information on the Use of CorMatrix ECM for Pericardial Reconstruction|Enrolling by invitation||N/A|5000|Anticipated|Aziyo Biologics, Inc.|||1||f||||f||||||||||2017-10-11 00:43:19.715887|2017-10-11 00:43:19.715887
NCT02073318|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-20|2014-02-25|||December 2010||2010-12-01|February 2014|2014-02-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Effects of Balance Training in Older Adults With Dementia|Effects of Task-oriented Balance Training in Institutionalized Older Adults With Dementia|Completed||Phase 2|19|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:43:19.793497|2017-10-11 00:43:19.793497
NCT02073305|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-02-01|||June 2012||2012-06-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01|3 Years|Observational [Patient Registry]|SASinHD_003||Prognostic Impact of Sleep Apnea on Cardiovascular Morbidity and Mortality, in End Stage Renal Disease Patients|Prognostic Impact of Sleep Apnea on Cardiovascular Morbidity and Mortality, in End Stage Renal Disease Patients|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire Vaudois|||3||f||||f||||||||||2017-10-11 00:43:19.987816|2017-10-11 00:43:19.987816
NCT02073292|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-14|||March 2014||2014-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cooled Radiofrequency Ablation vs. Thermal Radiofrequency Ablation|A Randomized Controlled Trial Comparing Thermal and Cooled Radiofrequency Ablation Techniques of Thoracic Facets' Medial Branches to Manage Thoracic Pain|Recruiting||N/A|61|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 00:43:20.139553|2017-10-11 00:43:20.139553
NCT02073279|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-08-31|||August 2014||2014-08-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|||Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of SA237 as Monotherapy in Patients With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)|Active, not recruiting||Phase 3|95|Actual|Chugai Pharmaceutical||2|||f||||t||||||||||2017-10-11 00:43:20.246283|2017-10-11 00:43:20.246283
NCT02073266|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-07-25|||January 2010||2010-01-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Impact of C3F8 or SF6 Use and Length of Face-down Positioning (7 vs 14 Days Respectively) in Macular Hole Surgery||Completed||N/A|59|Actual|CHU de Quebec-Universite Laval||2|||f||||||||||||||2017-10-11 00:43:20.53543|2017-10-11 00:43:20.53543
NCT02073253|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-26|||March 2013||2013-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Noninvasive Ventilation and Thoracic-abdominal Kinematics in Heart Failure Patients|Effect of Noninvasive Ventilation in Thoracic-abdominal Kinematics of Individuals With Heart Failure Associated With Cardiomegaly: a Randomized Controlled Trial|Completed||N/A|24|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 00:43:20.615317|2017-10-11 00:43:20.615317
NCT02073240|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-08-20|||February 2014||2014-02-01|May 2014|2014-05-01|June 2017|Anticipated|2017-06-01|August 2016|Anticipated|2016-08-01||Observational|EnTIC||Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand|Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand|Unknown status|Active, not recruiting|N/A|22|Actual|Centers for Disease Control and Prevention|||2||f||||t||||||||||2017-10-11 00:43:20.72432|2017-10-11 00:43:20.72432
NCT02073019|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-07-30|||August 2014||2014-08-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers|A Phase I, Two Part Study Exploring the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effect of Ascending Doses of BL-8040 in Healthy Subjects.|Completed||Phase 1|33|Actual|BioLineRx, Ltd.||3|||f||||t||||||||||2017-10-11 00:43:22.262499|2017-10-11 00:43:22.262499
NCT02073227|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-09-08|||February 2014||2014-02-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components|A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 150 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin XR Tablet (4 x 500 mg) in Healthy Fed Subjects|Completed||Phase 1|52|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 00:43:20.837418|2017-10-11 00:43:20.837418
NCT02073214|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-25|||April 2012||2012-04-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Oral Probiotic Supplementation on the Clinical Status of Very-low-birth-weight Preterm Neonates.|Effects of Oral Probiotic Supplementation on the Clinical Status of Very-low-birth-weight Preterm Neonates. Multi-centre, Randomised, Double-blind, Placebo-controlled Clinical Study.|Completed||N/A|182|Actual|IBSS Biomed S.A.||2|||f||||f||||||||||2017-10-11 00:43:20.922523|2017-10-11 00:43:20.922523
NCT02073201|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-09-14|||September 2015|Actual|2015-09-01|September 2017|2017-09-01|June 2, 2017|Actual|2017-06-02|December 2016|Actual|2016-12-01||Observational|MIND||Development of Clinical Methods to Evaluate Neural Function in Aging|Development of Clinical Methods to Evaluate Neural Function in Aging|Completed||N/A|27|Actual|University of Florida|||3||f||||t|f|f||||||||2017-10-11 00:43:21.011711|2017-10-11 00:43:21.011711
NCT02073188|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-04-13|||June 2012||2012-06-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|iNew Trend||Comparative Study of a Smartphone-Linked Self-Monitoring System Versus a Traditional One for Improving Metabolic Control and Compliance to Self-Monitoring of Blood Glucose|Comparative Efficacy of iBGStar Glucose Meter vs. Traditional Glucose Monitoring in Improving Metabolic Control and Compliance Towards Self-Monitoring of Blood Glucose in Young Patients With Type 1 Diabetes|Completed||Phase 3|186|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:43:21.084256|2017-10-11 00:43:21.084256
NCT02073175|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-04-11|||February 2014||2014-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Development of Dietary Supplements for Mood Symptoms in Postpartum|Development of Dietary Supplements for Mood Symptoms in Postpartum|Completed||Phase 2|28|Actual|Centre for Addiction and Mental Health||5|||f||||f||||||||No||2017-10-11 00:43:21.166493|2017-10-11 00:43:21.166493
NCT02073162|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-14|||February 2014||2014-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery|REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery|Active, not recruiting||N/A|250|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-10-11 00:43:21.245364|2017-10-11 00:43:21.245364
NCT02073149|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-04-09|||June 2014||2014-06-01|February 2014|2014-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SEICK||Safe and Efficacious Iron for Children in Kenya|Comparison of Home Fortification With Two Iron Formulations in Kenyan Children Protected Against Malaria by Artemisinin-based Combination Therapy: a Placebo-controlled Non-inferiority Trial|Completed||Phase 2/Phase 3|338|Actual|London School of Hygiene and Tropical Medicine||3|||f||||f||||||||||2017-10-11 00:43:21.318784|2017-10-11 00:43:21.318784
NCT02073136|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-07-17|||March 2014||2014-03-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of a Phosphate Modified Diet on Phosphate Balance and Phosphate Metabolism in Predialysis Patients Stage 3-4|Effect of a Phosphate Modified Diet on Phosphate Balance and Phosphate Metabolism in Predialysis Patients Stage 3-4|Completed||N/A|24|Anticipated|University of Copenhagen||1|||f||||f||||||||||2017-10-11 00:43:21.408082|2017-10-11 00:43:21.408082
NCT02073123|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-03-22|||July 2014||2014-07-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma|A Phase 1/2 Study of the Concomitant Administration of Indoximod Plus Immune Checkpoint Inhibitors for Adult Patients With Advanced or Metastatic Melanoma|Recruiting||Phase 1/Phase 2|56|Anticipated|NewLink Genetics Corporation||3|||f||||||||||||||2017-10-11 00:43:21.500453|2017-10-11 00:43:21.500453
NCT02073110|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-26|||August 2013||2013-08-01|February 2014|2014-02-01||||December 2016|Anticipated|2016-12-01||Observational|||Optical Biopsy to Improve the Diagnosis of Kidney Cancer|Optical Biopsy to Improve the Diagnosis of Kidney Cancer: a Prospective, Observational, Multicentre, In-vivo Study|Unknown status|Recruiting|N/A|194|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||t||||||||||2017-10-11 00:43:21.630553|2017-10-11 00:43:21.630553
NCT02073097|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-04-07|||October 2014||2014-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma|A Phase I/II Study of Carfilzomib in Combination With R-CHOP (CR-CHOP) for Patients With Diffuse Large B-cell Lymphoma|Recruiting||Phase 1/Phase 2|50|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-11 00:43:21.730906|2017-10-11 00:43:21.730906
NCT02073084|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-04-09|||January 2014||2014-01-01|April 2015|2015-04-01||||March 2014|Actual|2014-03-01||Interventional|||A Thorough Corrected QT Interval Trial||Completed||Phase 1|56|Actual|Kowa Research Institute, Inc.||4|||f||||||||||||||2017-10-11 00:43:21.869538|2017-10-11 00:43:21.869538
NCT02073071|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-11-25|||May 2014||2014-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Observational|||Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants|Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants|Completed||N/A|139|Actual|Abbott Nutrition|||1||f||||f||||||||||2017-10-11 00:43:21.960429|2017-10-11 00:43:21.960429
NCT02073058|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-05-22|||February 2014||2014-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System|Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System|Completed||N/A|75|Actual|Abbott Diabetes Care|||1||f||||f||||||||||2017-10-11 00:43:22.045823|2017-10-11 00:43:22.045823
NCT02073045|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-10-22|||August 2013||2013-08-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery|Effect of Intensive Education on Breast Cancer Patient's Understanding of Lymphedema|Terminated||N/A|17|Actual|Case Comprehensive Cancer Center||1||research cancelled|f||||f||||||||||2017-10-11 00:43:22.119747|2017-10-11 00:43:22.119747
NCT02073006|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2015-01-14|||February 2014||2014-02-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||A Study to Evaluate the Effects of a Natural Supplement in Adults With Chronic Functional Constipation|A Randomised, Double-blind, Placebo-Controlled, Parallel Study to Evaluate the Effects of Lepicol® in Adults With Chronic, Functional Constipation|Completed||Phase 2/Phase 3|70|Actual|Atlantia Food Clinical Trials||2|||f||||f||||||||||2017-10-11 00:43:22.328662|2017-10-11 00:43:22.328662
NCT02072993|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-07-28|||March 2014||2014-03-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males|A Phase I, Single-center, Single-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral AZD1979 After Single-ascending Doses in Healthy Male Volunteers|Terminated||Phase 1|116|Actual|AstraZeneca||2||Study stopping criteria has been reached|f||||f||||||||||2017-10-11 00:43:22.424437|2017-10-11 00:43:22.424437
NCT02072980|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-04-27|2015-04-27||March 2014||2014-03-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||This analysis population includes all randomized participants.|DAILIES TOTAL1® Lubricity Post Wear|Evaluation of the Lubricity of DAILIES TOTAL1® Contact Lenses After Wear|Completed||N/A|15|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:43:22.687163|2017-10-11 00:43:22.687163
NCT02072967|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-02-19|||May 2012||2012-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma|Observational Program for Evaluation of Ribomustin and Rituximab Combined Therapy With Following Rituximab Maintenance of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma|Completed||N/A|97|Actual|Astellas Pharma Inc|||1||f||||f||||||||Undecided||2017-10-11 00:43:22.842821|2017-10-11 00:43:22.842821
NCT02072954|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-06-25||2014-06-25|November 2013||2013-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Bioequivalence Fasting Study in Patients|A Multicentric, Open Label, Randomized, Balanced, Two Treatment, Three Period, Three Sequence, Crossover, Multiple Dose, Steady State Bioequivalence Study of Asenapine Sublingual Tablets, 10 mg Manufactured by AMNEAL PHARMACEUTICALS, USA With Reference Product SAPHRIS® (Asenapine) Sublingual Tablets, 10 mg Manufactured by Catalent UK Swindon Zydis Ltd., Blagrove, Swindon, Wiltshire, SN5 8RU, UK; Distributed by Merck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, 08889, USA in Adult Human Male & Female Patients Under Fasting Condition.|Completed||Phase 2/Phase 3|48|Actual|Amneal Pharmaceuticals, LLC||2|||f||||t||||||||||2017-10-11 00:43:22.969494|2017-10-11 00:43:22.969494
NCT02072941|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-05-08|||September 2014||2014-09-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Preparing Spanish-speaking Older Adults for Advance Care Planning and Medical Decision Making (PREPARE)|Preparing Spanish-speaking Older Adults for Advance Care Planning and Medical Decision Making|Completed||N/A|445|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:43:23.055594|2017-10-11 00:43:23.055594
NCT02072915|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-11-07|||January 2014||2014-01-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||EUS-FNA With and Without Suction|Randomized Single Blind Controlled Trial of EUS-FNA With and Without Suction for Adequate Cellblock Sample Procurement of Solid Pancreatic Mass Lesions Using 25G Needle|Completed||N/A|72|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:43:23.218929|2017-10-11 00:43:23.218929
NCT02072902|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-03-02|||March 2012||2012-03-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|DBCA||Diabetes, Glucose Control, Glucose Lowering Medications, and Cancer Risk: A 10-year Population-based Historical Cohort|Diabetes, Glucose Control, Glucose Lowering Medications, and Cancer Risk: A 10-year Population-based Historical Cohort|Unknown status|Active, not recruiting|N/A|2188669|Actual|Sheba Medical Center|||4||f||||f||||||||||2017-10-11 00:43:23.29269|2017-10-11 00:43:23.29269
NCT02072889|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-02-06|||April 2012||2012-04-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Optimal Neck Angle for Internal Jugular Cannulation|Optimal Angle For Internal Jugular Cannulation|Completed||N/A|50|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-11 00:43:23.43312|2017-10-11 00:43:23.43312
NCT02072876|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-27|||March 2013||2013-03-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|AICAD||Asymptomatic Intracranial Atherosclerotic Disease in Pakistanis|Asymptomatic Intracranial Atherosclerotic Disease: Prevalence, Clinical and Lifestyle Determinants in Urban Pakistan|Completed||N/A|200|Actual|Aga Khan University|||2||f||||t||||||||||2017-10-11 00:43:23.538065|2017-10-11 00:43:23.538065
NCT02072863|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-04-28||2016-03-10|January 2014||2014-01-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma|Phase 1b/2, Multicenter, Open-label Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma|Completed||Phase 1/Phase 2|9|Actual|Amgen||1|||f||||t||||||||||2017-10-11 00:43:23.638217|2017-10-11 00:43:23.638217
NCT02072850|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-06-10|||May 2011||2011-05-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|November 2012|Actual|2012-11-01||Observational|BHF MR-MI||Detection and Significance of Heart Injury in ST Elevation Myocardial Infarction.|Cardiac Magnetic Resonance Imaging: New Pathological Insights and Their Functional and Clinical Significance in ST Elevation Acute Myocardial Infarction.|Active, not recruiting||N/A|324|Actual|NHS National Waiting Times Centre Board|||1||f||||f||||||Samples With DNA|"     Blood and urine samples have been archived.   "|||2017-10-11 00:43:23.761839|2017-10-11 00:43:23.761839
NCT02072837|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-27|||January 2012||2012-01-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Dyslipidemia-related Risk Factors in Dialysis|Dyslipidemia-related Variables as Risk Factor for Cardiovascular Disease in Patients on the End-stage of Renal Disease|Completed||N/A|96|Actual|National and Kapodistrian University of Athens|||1||f||||t||||||||||2017-10-11 00:43:23.898032|2017-10-11 00:43:23.898032
NCT02072824|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2017-10-02|||September 16, 2014|Actual|2014-09-16|October 2017|2017-10-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.|A Double-blind, Placebo-controlled, Parallel-group, Multicenter Study Of The Efficacy And Safety Of Pregabalin As Adjunctive Therapy In Children 1 Month Through <4 Years Of Age With Partial Onset Seizures|Recruiting||Phase 3|123|Anticipated|Pfizer||3|||f||||t|t|f||||||||2017-10-11 00:43:23.989558|2017-10-11 00:43:23.989558
NCT02072811|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-25|||February 2014||2014-02-01|February 2014|2014-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|PALG-AML2012||Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia|Evaluation of the Efficacy of Induction-consolidation Treatment Using a Double Induction in Patients With AML <60 Years Old, Depending on the Percentage of Blasts in the 14 Day, Residual Disease and Leukemic Hematopoietic Cells|Recruiting||Phase 3|400|Anticipated|Polish Adult Leukemia Group||5|||f||||t||||||||||2017-10-11 00:43:24.348355|2017-10-11 00:43:24.348355
NCT02072798|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-08-10|||February 2014||2014-02-01|February 2014|2014-02-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Antibiotics and Gut Microbiota Among Newborn Infants|Antibiotic Prophylaxis for Postpartum Infections Following Caesarean Section|Completed||Phase 4|42|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-11 00:43:24.461815|2017-10-11 00:43:24.461815
NCT02072785|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-27|||June 2013||2013-06-01|November 2013|2013-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|LY01609||Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia|Phase III Study of Vincristine Sulfate Liposome Or Vincristine Sulfate For Injection Combined Chemotherapy as Initial Induction Regimen In Adults Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 3|480|Anticipated|Nanjing Luye Sike Pharmaceutical Co.,Ltd.||2|||f||||t||||||||||2017-10-11 00:43:24.569324|2017-10-11 00:43:24.569324
NCT02072772|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2014-02-26|||May 2014||2014-05-01|February 2014|2014-02-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers|A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers|Not yet recruiting||N/A|450|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-10-11 00:43:24.66756|2017-10-11 00:43:24.66756
NCT02072759|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-25|2016-07-13|||March 2014||2014-03-01|June 2015|2015-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Acetylcarnitine and Metabolic Flexibility|Preservation of Metabolic Flexibility by Acetylcarnitine Formation|Completed||N/A|24|Actual|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-11 00:43:24.759849|2017-10-11 00:43:24.759849
NCT02072746|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-08-04|||February 2010|Actual|2010-02-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 1, 2011|Actual|2011-03-01||Interventional|||Zinc Supplementation in Alcoholic Cirrhosis|A Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Daily Oral Zinc Sulfate (220 mg) in Subjects With Alcoholic Cirrhosis|Active, not recruiting||N/A|30|Anticipated|University of Louisville||2|||f||||f||||||||||2017-10-11 00:43:24.836484|2017-10-11 00:43:24.836484
NCT02072733|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-04-07|||January 2015||2015-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Suitability of an Organization With an Onco-geriatric Team to a Whole Region (Region Midt) of Denmark|Oncogeriatric Intervention and Follow-up at Home to Improve Quality of Life and the Possibility to Accomplish Cancer Treatment in Multimorbid Elderly|Completed||N/A|320|Actual|University of Aarhus||1|||f||||f|f|f||||||No||2017-10-11 00:43:24.920196|2017-10-11 00:43:24.920196
NCT02072720|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-03-17|||February 2014||2014-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Angiogenic Factor Expression During Fractionated Irradiation|Pilot Study to Determine the Effect of Fractionated Radiotherapy on Expression of Pro-angiogenic Factors in Oesophagus Carcinoma|Recruiting||Early Phase 1|40|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 00:43:25.020373|2017-10-11 00:43:25.020373
NCT02072707|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-09-15|||April 2014||2014-04-01|September 2017|2017-09-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||Efficacy and Safety of Epicardial VT Ablation Using Contact Force Irrigated Tip Catheter - Pilot Study|Prospective and Randomized Study to Evaluate Efficacy and Safety of Epicardial Ventricular Tachycardia Ablation Using Contact Force Sensor Irrigated Tip Catheter - Pilot Study|Completed||N/A|30|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 00:43:25.109042|2017-10-11 00:43:25.109042
NCT02072694|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2014-05-13|||January 2012||2012-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Cerebral Blood Flow Changes in People With Obesity After Glucose Consumption|Cerebral Perfusion Changes in Obese Subjects After Administration of 75 Grams of Glucose. A SPECT, Controlled, Blinded and Randomized Study.|Completed||N/A|20|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:43:25.183445|2017-10-11 00:43:25.183445
NCT02072681|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-08-09|||March 2015||2015-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01|3 Months|Observational [Patient Registry]|MaRISS||Mild and Rapidly Improving Stroke Study|Mild and Rapidly Improving Stroke Study|Recruiting||N/A|2650|Anticipated|University of Miami|||1||f||||f||||||||||2017-10-11 00:43:25.299996|2017-10-11 00:43:25.299996
NCT02072668|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-11-02|||February 2014||2014-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Rivaroxaban in Sickle Cell Disease|The Effect of Factor Xa Inhibition, With Rivaroxaban, on the Pathology of Sickle Cell Disease|Enrolling by invitation||Phase 2|34|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 00:43:25.74537|2017-10-11 00:43:25.74537
NCT02072655|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-06-15|||January 2014||2014-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CareSSE||Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization|Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization|Completed||N/A|40|Actual|University Hospital, Angers||2|||f||||||||||||||2017-10-11 00:43:25.83976|2017-10-11 00:43:25.83976
NCT02072642|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-09-07|||April 2013|Actual|2013-04-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Light Therapy in Parkinson's Disease|Light Therapy in Parkinson's Disease : Effect on Motor Symptoms, Sleep, Circadian Rhythms, and Mood|Recruiting||N/A|44|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 00:43:25.90311|2017-10-11 00:43:25.90311
NCT02072629|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-25|||November 2009||2009-11-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|HCU:VHV/ICCM||HCU: Can VHVs Trained in ICCM Improve Care for Children|Healthy Child Uganda: Can Village Health Volunteers Trained in Integrated Community Case Management of Childhood Illness Improve Access to Care for Africa's Most Vulnerable Children?|Completed||N/A|4071|Actual|University of Calgary||1|||f||||t||||||||||2017-10-11 00:43:25.991064|2017-10-11 00:43:25.991064
NCT02072616|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-12-06|||September 2014||2014-09-01|December 2016|2016-12-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|CTC-Pancreas||Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.|Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.|Recruiting||Phase 3|142|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 00:43:26.069806|2017-10-11 00:43:26.069806
NCT02072603|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-04-27|||August 2013|Actual|2013-08-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of the HITSystem to Improve Early Infant Diagnosis Outcomes in Kenya|Evaluation of the HITSystem to Improve Early Infant Diagnosis Outcomes in Kenya|Enrolling by invitation||N/A|1000|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 00:43:26.15888|2017-10-11 00:43:26.15888
NCT02072590|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-10-18|||August 2011||2011-08-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|||Improved Diagnostics of Celiac Disease in Children|Improved Diagnostics of Celiac Disease in Children|Recruiting||N/A|2000|Anticipated|Tampere University Hospital|||1||f||||t||||||Samples With DNA|"     Whole blood, serum, intestinal mucosal biopsies   "|||2017-10-11 00:43:26.248217|2017-10-11 00:43:26.248217
NCT02072577|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-26|||June 2012||2012-06-01|May 2012|2012-05-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|||Effect of Educational Video in the Student's Knowledge|Effect of Educational Video in the Student's Knowledge About Oral Hygiene of Patients Undergoing Chemotherapy|Unknown status|Active, not recruiting|N/A|23|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 00:43:26.365037|2017-10-11 00:43:26.365037
NCT02072564|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-05-10|||November 2013||2013-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01|9 Months|Observational [Patient Registry]|||Influence of Diet and Lifestyle Factors on the Results of the IVF|Pilot Study on the Influence of the Different Components of the Diet and Different Habits (Tobacco, Alcohol, Physical Exercise, Occupation) Results of IVF-ICSI|Completed||N/A|300|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||||2017-10-11 00:43:26.445389|2017-10-11 00:43:26.445389
NCT02072551|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-04-15|||December 2012||2012-12-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|GLUCONEO||Future of Beta Cells in Adults With Genetic Abnormality Behind Neonatal Diabetes|Devenir au Long Cours de la Cellule bêta Chez Les Adultes Porteurs d'Anomalies génétiques à l'Origine du Diabète Néonatal|Active, not recruiting||N/A|17|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||||||||||||2017-10-11 00:43:26.519719|2017-10-11 00:43:26.519719
NCT02072538|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-05-09|||April 2014||2014-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01|24 Months|Observational [Patient Registry]|||Pre-discharge vs. Early Post-discharge Stress Testing and GRACE Score for Safe Discharge of ACS-patients With a Negative Hs-troponin T Result|Role of Pre-discharge vs. Early Post-discharge Stress Testing and Implementation of the GRACE Risk Score for Safe Discharge of Patients With an ACS and a Negative High Sensitivity Troponin T Result Within 3 Hours After Presentation to a Chest Pain Unit|Withdrawn||N/A|0|Actual|University Hospital Heidelberg|||2|no Sponsor|f||||f||||||||||2017-10-11 00:43:26.570221|2017-10-11 00:43:26.570221
NCT02072525|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-06-02|||April 2014||2014-04-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays|A Protocol to Collect Human Serum Samples From Healthy Adults|Completed||Phase 4|359|Actual|GlaxoSmithKline||9|||f||||||||||||||2017-10-11 00:43:26.634342|2017-10-11 00:43:26.634342
NCT02072512|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-24|||January 2014||2014-01-01|February 2014|2014-02-01|December 2016|Anticipated|2016-12-01|November 2015|Anticipated|2015-11-01||Interventional|PROOF||The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer|The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer|Unknown status|Recruiting|Phase 2|180|Anticipated|Hospital Affiliated to Military Medical Science, Beijing||2|||f||||t||||||||||2017-10-11 00:43:26.721261|2017-10-11 00:43:26.721261
NCT02072499|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-11-23|||September 2011||2011-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||KTP Green Light Prostatectomy Compared With Open Prostatectomy|The Effect of KTP (Potassium-titanyl-phosphate) Green Light Prostatectomy (180W) Compared With Open Prostatectomy When Treating Benign Prostatic Hyperplasia, a Prospective Randomized Study|Active, not recruiting||Phase 4|40|Actual|Helsinki University||2|||f||||f||||||||||2017-10-11 00:43:26.805147|2017-10-11 00:43:26.805147
NCT02072486|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-06-30|||November 18, 2013|Actual|2013-11-18|June 2017|2017-06-01|August 3, 2018|Anticipated|2018-08-03|August 3, 2018|Anticipated|2018-08-03||Interventional|||Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|Granzyme B Production as a Biomarker for the Immunomodulatory Activity of Sorafenib in HCC|Active, not recruiting||N/A|30|Actual|Roswell Park Cancer Institute||1|||f||||f||||||||||2017-10-11 00:43:26.875537|2017-10-11 00:43:26.875537
NCT02072473|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-10-18|||September 2014||2014-09-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|6 Months|Observational [Patient Registry]|||Safety and Efficacy Aspects of a Standardized Stepwise Anatomical Approach for AVNRT Ablation|Safety and Efficacy Aspects of a Standardized Stepwise Anatomical Approach for Atrio-Ventricular Nodal Re-entrant Tachycardia Ablation|Withdrawn||N/A|0|Actual|Sheba Medical Center|||1|No enrollment|f||||f||||||||No||2017-10-11 00:43:26.958422|2017-10-11 00:43:26.958422
NCT02072460|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2014-02-24|||February 2014||2014-02-01|February 2014|2014-02-01||||July 2017|Anticipated|2017-07-01||Interventional|||Vestibular and Multisensory Influence on Bodily and Spatial Representations|Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy Volunteers|Unknown status|Active, not recruiting|N/A|80|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:43:27.042607|2017-10-11 00:43:27.042607
NCT02072447|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-04-17|||March 2014||2014-03-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study|A Study to Determine the Absolute Bioavailability of YH4808 Using Simultaneous Oral Therapeutic- and [14C]-Labeled Intravenous Microdoses|Completed||Early Phase 1|8|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 00:43:27.103299|2017-10-11 00:43:27.103299
NCT02072434|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-01-03||2017-01-03|March 2014||2014-03-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ENSURE-AF||Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation|A Prospective, Randomized, Open-Label Blinded Endpoint Evaluation (PROBE) Parallel Group Study Comparing Edoxaban (DU-176b) With Enoxaparin/Warfarin Followed by Warfarin Alone in Subjects Undergoing Planned Electrical Cardioversion of Nonvalvular Atrial Fibrillation|Completed||Phase 3|2199|Actual|Daiichi Sankyo, Inc.||2|||f||||t||||||||||2017-10-11 00:43:29.065697|2017-10-11 00:43:29.065697
NCT02072421|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-03-18|2014-06-06||October 2011||2011-10-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||The MASS COMM Post-Randomization Phase Cohort Study|A Prospective, Multi-center, Non-Randomized, Single-arm, Open-label Study of Percutaneous Coronary Intervention in Community Hospitals Without Cardiac Surgery-On-Site|Completed||N/A|2879|Actual|Baim Institute for Clinical Research||1|||f||||f||||||||||2017-10-11 00:43:29.716831|2017-10-11 00:43:29.716831
NCT02072408|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-24|||February 2014||2014-02-01|February 2014|2014-02-01||||December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy||Unknown status|Recruiting|Phase 4|46|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-11 00:43:30.016173|2017-10-11 00:43:30.016173
NCT02072395|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-02-16|||February 2012||2012-02-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|GP and Band||Gastric Plication and Banding|Treatment of Morbid Obesity With Gastric Plication and Gastric Banding|Completed||Phase 2|17|Actual|Ohio State University||1|||f||||f||||||||||2017-10-11 00:43:30.21626|2017-10-11 00:43:30.21626
NCT02072382|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-08-25|||May 2013||2013-05-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||The Hypotensive Effect of Metformin in Hypertensive Patients.|The Hypotensive Effect of Simvastatin in Hypertensive Patients: a Placebo-controlled Randomized Clinical Trial With 24-h Ambulatory Blood Pressure Monitoring|Unknown status|Recruiting|Phase 4|92|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||t||||||||||2017-10-11 00:43:30.293406|2017-10-11 00:43:30.293406
NCT02072369|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-06-26|||May 2011||2011-05-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|May 2013|Actual|2013-05-01||Interventional|||Simulated Home Therapy Program for the Hand After Stroke|Simulated Home Therapy Program for the Hand After Stroke|Completed||N/A|23|Actual|Shirley Ryan AbilityLab||2|||f||||f|f|f||||||No||2017-10-11 00:43:30.388107|2017-10-11 00:43:30.388107
NCT02072356|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-03-25|||October 2010||2010-10-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery|A Humanitarian Device Exemption Treatment Protocol of TheraSphere® For Treatment of Unresectable Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|100|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:43:30.491896|2017-10-11 00:43:30.491896
NCT02072343|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-03-16|||March 2014||2014-03-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of 10 cm Catheter Mount on Malfunction of Capnometers Under the Conditions of Water||Completed||N/A|25|Anticipated|Hanyang University||2|||f||||||||||||||2017-10-11 00:43:30.586208|2017-10-11 00:43:30.586208
NCT02072330|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-24|||March 2013||2013-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.|A Randomized, Double-Blind, Multicenter, Phase 2/3 Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB (Fix-dose Combination of Azilsartan and Amlodipine) and Hydrochlorothiazide in Comparison With TAK-536CCB or Hydrochlorothiazide Monotherapy in Patients With Grade I or II Essential Hypertension|Completed||Phase 2/Phase 3|353|Actual|Takeda||5|||f||||f||||||||||2017-10-11 00:43:30.679062|2017-10-11 00:43:30.679062
NCT02072317|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-24|||November 2013||2013-11-01|February 2014|2014-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer|Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer Stage II Randomized Controlled Clinical Studies|Unknown status|Recruiting|Phase 2|140|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 00:43:30.932512|2017-10-11 00:43:30.932512
NCT02072304|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-24|||January 2014||2014-01-01|February 2014|2014-02-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|wogyeokdajim||Study of Web- Based Cognitive Behavioral Therapy for Depressed Korean Adolescents|Study of Web-based Cognitive Behavioral Therapy in Adolescent Depression; Randomized Controlled Trial for Korean Adolescents|Unknown status|Recruiting|N/A|164|Anticipated|Hallym University Medical Center||2|||f||||f||||||||||2017-10-11 00:43:31.026522|2017-10-11 00:43:31.026522
NCT02072291|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-02-28|||March 2014||2014-03-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Nifedipine Treatment on Uterine Contractility in IVF|The Influence of Nifedipine Treatment on Uterine Contractility During Frozen Embryo Transfer|Recruiting||Phase 2|90|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:43:31.163976|2017-10-11 00:43:31.163976
NCT02072278|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-08-31|||February 2014||2014-02-01|November 2014|2014-11-01||||November 2014|Actual|2014-11-01||Interventional|||Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects|Interventional, Randomised, Double-blind, Placebo-controlled, Active Comparator, Four-way Crossover Electroencephalography Study Investigating the Effects of Vortioxetine (Lu AA21004) in Healthy Male Subjects|Completed||Phase 1|32|Actual|H. Lundbeck A/S||4|||f||||f||||||||||2017-10-11 00:43:31.263195|2017-10-11 00:43:31.263195
NCT02071914|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-06-11|||February 2014||2014-02-01|June 2014|2014-06-01|July 2014|Anticipated|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||To Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model|A Randomised, Double-Blind, Placebo-Controlled, Single-Centre, Phase IIa Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model|Unknown status|Active, not recruiting|Phase 2|81|Anticipated|Celltrion||3|||f||||f||||||||||2017-10-11 00:43:36.510503|2017-10-11 00:43:36.510503
NCT02072265|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-24|||March 2014||2014-03-01|February 2014|2014-02-01||||November 2014|Anticipated|2014-11-01||Observational|||Using a Thermal Imaging System to Evaluate the Wound of Port-A and the Relationship Between Thermal Images and Infection|Utilization of a Medical Dual-spectrum Infrared Thermal Imaging System to Evaluate the Wound Healing of Permanently Implantable Venous Port (Port-A) and to Investigate the Relationship Between the Thermal Images and Subcutaneous/Bloodstream Infection|Unknown status|Not yet recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 00:43:31.374319|2017-10-11 00:43:31.374319
NCT02072252|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-08-14|||August 14, 2017|Anticipated|2017-08-14|August 2017|2017-08-01|August 14, 2017|Anticipated|2017-08-14|August 14, 2017|Anticipated|2017-08-14||Interventional|TODAY!||Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men|Mobile Phone and Internet-Based Intervention for Vulnerable Youth|Withdrawn||Phase 1/Phase 2|0|Actual|Northwestern University||2||"The app was not completed in time to conduct a clinical trial on it within the funding grant's   award period"|f||||t|f|f||||||||2017-10-11 00:43:31.477875|2017-10-11 00:43:31.477875
NCT02072239|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-01-11|||February 2014||2014-02-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|September 2014|Actual|2014-09-01||Interventional|||Angioshield First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy|First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery|Completed||N/A|13|Actual|Neograft Technologies, Incorporated||1|||f||||t||||||||No||2017-10-11 00:43:31.595982|2017-10-11 00:43:31.595982
NCT02072226|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-07-05|||May 31, 2014|Actual|2014-05-31|July 2017|2017-07-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|PRISMS||A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke|A Phase IIIB, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Alteplase in Patients With Mild Stroke: Rapidly Improving Symptoms and Minor Neurologic Deficits (PRISMS)|Terminated||Phase 3|313|Actual|Genentech, Inc.||2||The study was terminated due to slow enrollment.|f|||||t|f||||||||2017-10-11 00:43:31.729878|2017-10-11 00:43:31.729878
NCT02072213|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-24|||August 2013||2013-08-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers|A Randomized, Open-label, Single-dose, Four-sequence, Four -Period Crossover Study to Investigate The Pharmacokinetics of GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers|Completed||Phase 1|36|Actual|GL Pharm Tech Corporation||4|||f||||f||||||||||2017-10-11 00:43:32.057585|2017-10-11 00:43:32.057585
NCT02072200|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-08-05|2016-03-07||September 2013||2013-09-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||These 145 subjects received at least 1 dose of study drug and completed the study.|Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)|A New Modified-Release Tablet Formulation of Prednisone in Patients With Rheumatoid Arthritis- Multicenter, Phase IV, Interventional Study to Assess Reduction of Morning Stiffness|Completed||Phase 4|147|Actual|Mundipharma Korea Ltd||1|||f||||f||||||||||2017-10-11 00:43:32.155367|2017-10-11 00:43:32.155367
NCT02072187|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-09-28|||December 2013||2013-12-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Adjunctive Vitamin D in the Treatment of Non-remitted Depression|Adjunctive Vitamin D in the Treatment of Non-remitted Depression|Terminated||Phase 3|9|Actual|START Clinic for Mood and Anxiety Disorders||2||Difficulties with subject enrolment.|f||||t||||||||||2017-10-11 00:43:32.403432|2017-10-11 00:43:32.403432
NCT02072174|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-10-04|||February 2014||2014-02-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Clinical Trial of Efficacy of Anaferon for Children® in the Treatment of Influenza and Acute Respiratory Viral Infections in Children|International Multicenter, Double-Blind, Randomized, Parallel Group Placebo-Controlled Clinical Trial of Efficacy of Anaferon for Children® in the Treatment of Influenza and Acute Respiratory Viral Infections in Children|Recruiting||Phase 4|672|Anticipated|Materia Medica Holding||2|||f||||f||||||||||2017-10-11 00:43:32.50747|2017-10-11 00:43:32.50747
NCT02072161|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-08-27||2015-08-13|March 2014||2014-03-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy|A Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of ETC-1002 Versus Placebo in Patients With Hypercholesterolemia Receiving Ongoing Statin Therapy|Completed||Phase 2|133|Actual|Esperion Therapeutics||3|||f||||f||||||||||2017-10-11 00:43:32.88003|2017-10-11 00:43:32.88003
NCT02072148|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-03-06|||March 2014||2014-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)|The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA)|Recruiting||N/A|200|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||||2017-10-11 00:43:33.066129|2017-10-11 00:43:33.066129
NCT02072122|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-02-25|||March 2014||2014-03-01|February 2014|2014-02-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01|4 Weeks|Observational [Patient Registry]|||Estrogen and the Outer Eye in Women During Fertility Treatment|The Influence of the Hormonal Fertility Treatment of Women, on the Eye Surface and the Eye Dryness|Unknown status|Not yet recruiting|N/A|30|Anticipated|Meir Medical Center|||1||f||||t||||||Samples Without DNA|"     Blood tests (hormones level)   "|||2017-10-11 00:43:33.279325|2017-10-11 00:43:33.279325
NCT02072109|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-04-29|||June 2014||2014-06-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Observational|||Comparison of Regional Splanchnic Tissue Oxygenation Measured by NIRS in Preterm Babies Fed Bolus Versus Continuous Feeding|Evaluation of Regional Splanchnic Tissue Oxygenation Measured by NIRS (Near Infrared Spectroscopy) in Preterm Infants Receiving Bolus Versus Continuous Feeding|Unknown status|Recruiting|N/A|20|Anticipated|Meir Medical Center|||2||f||||||||||||||2017-10-11 00:43:33.356713|2017-10-11 00:43:33.356713
NCT02070081|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-09-11|||March 2014|Actual|2014-03-01|November 2016|2016-11-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Weight Loss Following Gastric Bypass or Sleeve Surgery|Patient Profiling for Successful Weight Loss After Gastric Bypass or Sleeve Surgery|Completed||N/A|55|Actual|University of Copenhagen||1|||f||||f||||||||||2017-10-11 00:44:01.013239|2017-10-11 00:44:01.013239
NCT02072096|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-10-04|2016-10-04||February 2014||2014-02-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|IMPERIUM|All randomized participants.|A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)|An Individualized treatMent aPproach for oldER patIents: A Randomized, Controlled stUdy in Type 2 Diabetes Mellitus (IMPERIUM)|Terminated||Phase 4|192|Actual|Eli Lilly and Company|The trial was terminated per protocol due to lack of feasibility. All participants completed the first 24 weeks of the study. Some participants continued into the Core study. Data was assessed from Baseline to last participant visit, up to 72 weeks.|2||The trial was terminated per protocol because of lack of feasibility.|f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 00:43:33.489039|2017-10-11 00:43:33.489039
NCT02072083|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2015-04-11|||February 2014||2014-02-01|February 2014|2014-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients|Intranasal Dexmedetomidine Versus Intranasal Midazolam-ketamine Combination for Premedication of Pediatric Patients Undergoing Strabismus Surgery|Completed||Phase 4|60|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 00:43:34.953008|2017-10-11 00:43:34.953008
NCT02072070|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-08-31|||November 2013||2013-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis|A Placebo Controlled, Double-blind, Randomized, Parallel-group, Multi-center Phase III Study to Determine the Efficacy and Safety of TissueGene-C in Patients With Degenerative Arthritis|Completed||Phase 3|163|Actual|Kolon Life Science||2|||f||||t||||||||||2017-10-11 00:43:35.083599|2017-10-11 00:43:35.083599
NCT02072057|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-06-03|||April 2014||2014-04-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.|The RUXexia Trial: An Open-label Phase II Trial of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.|Active, not recruiting||Phase 2|25|Anticipated|Kantonsspital Aarau||1|||f||||t||||||||||2017-10-11 00:43:35.186331|2017-10-11 00:43:35.186331
NCT02072044|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-04-25|||December 2013||2013-12-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma（RCC）That Have Failed Or Are Intolerant To TKIs Therapy|A Phase II Study of Anlotinib(AL3818) in Patients With Advanced Renal Cell Carcinoma(RCC) That Have Failed Or Are Intolerant To TKIs Therapy|Active, not recruiting||Phase 2|60|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||||||||||||2017-10-11 00:43:35.291716|2017-10-11 00:43:35.291716
NCT02072031|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-04-25|||December 2013||2013-12-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）|A Randomized, Positive-controlled, Multicenter, Phase II Study of Anlotinib(AL3818) in Patients With Advanced Renal Cell Carcinoma(RCC)|Active, not recruiting||Phase 2|133|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||f||||||||||2017-10-11 00:43:35.527231|2017-10-11 00:43:35.527231
NCT02072018|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-02-24|||June 2013||2013-06-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Peyronie's Disease Treatment Protocol|A Sequential, Randomized, Double-blind, Placebo-controlled, Prospective Study to Evaluate the Safety and Efficacy of the H-100 Treatment in Adult Male Volunteers With Peyronie's Disease|Completed||Phase 1|22|Actual|Hybrid Medical||2|||f||||t||||||||||2017-10-11 00:43:35.656965|2017-10-11 00:43:35.656965
NCT02072005|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-07-29|||February 2014||2014-02-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|mSMART||Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills|Mobile Application Based Personalized Solutions and Tools for Medication Adherence of Rx Pills|Completed||N/A|11|Actual|Duke University|||1||f||||f||||||||||2017-10-11 00:43:35.799945|2017-10-11 00:43:35.799945
NCT02071979|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-04-12|||April 2014||2014-04-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|March 2021|Anticipated|2021-03-01||Interventional|CMS||Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds|Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Skin Wounds|Recruiting||N/A|1500|Anticipated|Arteriocyte, Inc.||4|||f||||f||||||||||2017-10-11 00:43:35.900288|2017-10-11 00:43:35.900288
NCT02071966|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-07-25|||November 2012||2012-11-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|December 2015|Actual|2015-12-01||Interventional|TIGER-M||Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS|Effects of TIcaGREloR on Circulating Microparticles and Micro-RNAs in Patients With Non ST Elevation Acute Coronary Syndromes|Terminated||Phase 4|55|Anticipated|Catholic University of the Sacred Heart||2||slow enrollment|f||||t||||||||||2017-10-11 00:43:36.073119|2017-10-11 00:43:36.073119
NCT02071940|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-12-09|||October 2015||2015-10-01|December 2015|2015-12-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|PIANO||PLX3397 KIT in Acral aNd mucOsal Melanoma|A Phase II Trial of PLX3397 in the Treatment of KIT Mutated Advanced Acral and Mucosal Melanoma|Recruiting||Phase 2|24|Anticipated|The Christie NHS Foundation Trust||1|||f||||t||||||||No|The output of the trial will be published in the peer review journals and scientific conferences|2017-10-11 00:43:36.293853|2017-10-11 00:43:36.293853
NCT02071927|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-02-07|||March 2014|Actual|2014-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Study of the Glutaminase Inhibitor CB-839 in Leukemia|A Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Glutaminase Inhibitor CB-839 in Patients With Relapsed and/or Treatment-Refractory Leukemia|Completed||Phase 1|43|Actual|Calithera Biosciences, Inc||2|||f||||f||||||||||2017-10-11 00:43:36.412705|2017-10-11 00:43:36.412705
NCT02071901|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-07-26|||August 14, 2014|Actual|2014-08-14|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy|A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Elderly Patients With Acute Myeloid Leukemia Undergoing Remission Induction Therapy|Recruiting||Phase 2|31|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-11 00:43:36.612886|2017-10-11 00:43:36.612886
NCT02071888|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-04-29|||February 2014||2014-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors|A Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Glutaminase Inhibitor CB-839 in Patients With Advanced and/or Treatment-Refractory Hematological Malignancies|Completed||Phase 1|25|Actual|Calithera Biosciences, Inc||3|||f||||f||||||||||2017-10-11 00:43:36.740769|2017-10-11 00:43:36.740769
NCT02071875|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-03-09|||November 2013||2013-11-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|||Comparing the Nautilus NeuroWaveTM to TCD or DSA for the Detection of Vasospasm|A Non-Randomized, Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM System to Transcranial Doppler or DSA as an Aid to Diagnosing Vasospasm|Recruiting||N/A|70|Anticipated|Jan Medical, Inc.|||1||f||||f||||||||||2017-10-11 00:43:36.90313|2017-10-11 00:43:36.90313
NCT02071862|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-08-18|||February 2014||2014-02-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of the Glutaminase Inhibitor CB-839 in Solid Tumors|Ph1 Study of the Safety, PK, and PDn of Escalating Oral Doses of the Glutaminase Inhibitor CB-839, as a Single Agent and in Combination With Standard Chemotherapy in Patients With Advanced and/or Treatment-Refractory Solid Tumors|Recruiting||Phase 1|205|Anticipated|Calithera Biosciences, Inc||6|||f||||f||||||||||2017-10-11 00:43:37.030149|2017-10-11 00:43:37.030149
NCT02071849|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-03-20|2017-01-30||September 2013||2013-09-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|April 2015|Actual|2015-04-01||Interventional||16 of 20 consented participants received the device|HAART 200 Aortic Valve Annuloplasty Trial|HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction Trial|Completed||N/A|20|Actual|Biostable Science & Engineering||1|||f||||t||||||||Undecided||2017-10-11 00:43:37.347989|2017-10-11 00:43:37.347989
NCT02071836|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-01-30|||May 2014|Actual|2014-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Web Application to Reduce Heavy Drinking in First-time DWI Offenders|A Web Application to Reduce Heavy Drinking in First-time DWI Offenders|Completed||N/A|58|Actual|Behavior Therapy Associates, LLP||2|||f||||f||||||||||2017-10-11 00:43:38.243937|2017-10-11 00:43:38.243937
NCT02071823|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-12-31|2014-12-31||May 2008||2008-05-01|December 2014|2014-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules|Single Dose Crossover Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules in Healthy Male Volunteers Following Administration of a 50 mg Dose / Fasted and Fed States|Completed||Phase 1|12|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 00:43:38.355983|2017-10-11 00:43:38.355983
NCT02071810|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-11-23|2014-12-30||April 2008||2008-04-01|November 2015|2015-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067|A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Four Multiple Rising Dose Regimens of BIA 9-1067 in Healthy Male Volunteers|Completed||Phase 1|34|Actual|Bial - Portela C S.A.||5|||f||||f||||||||||2017-10-11 00:43:38.70778|2017-10-11 00:43:38.70778
NCT02071797|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-12-05|||January 2013||2013-01-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|COOLCATH||Early Targeted Brain Cooling in the Cath Lab Following Cardiac Arrest|Early Targeted Brain Cooling in the Cath Lab Following Cardiac Arrest. Randomised Controlled Trial of RhinoChill Versus Blanketrol Intra-Hospital Induction of Therapeutic Hypothermia After Cardiac Arrest|Completed||N/A|72|Actual|Basildon and Thurrock University Hospitals NHS Foundation Trust||2|||f||||t||||||||Undecided||2017-10-11 00:43:39.187293|2017-10-11 00:43:39.187293
NCT02071784|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-02-23|||January 2015||2015-01-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|NEUROVASCAD||Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)|Etude Comparative en Imagerie Par résonnance magnétique et Par Enregistrement électroencéphalographique du Couplage Neurovasculaire Dans l'Angiopathie Cadasil|Recruiting||N/A|60|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-10-11 00:43:39.272513|2017-10-11 00:43:39.272513
NCT02071771|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2015-10-13|2015-10-13||April 2014||2014-04-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||This analysis group includes all randomized subjects who had no major protocol violations excluding those who met the critical deviation criteria as specified in the Deviations and Evaluability Plan.|Visual Assessment of DAILIES® AquaComfort Plus® for Astigmatism as Compared to 1-DAY ACUVUE® MOIST® for Astigmatism|DAILIES® AquaComfort Plus® Toric - Comparative Assessment of Visual and Mechanical Performance|Completed||N/A|80|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:43:39.347649|2017-10-11 00:43:39.347649
NCT02071758|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2016-02-22|||April 2014||2014-04-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers|A Phase 1, Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the LEISH-F3 + SLA-SE Vaccine Compared to LEISH-F3 + GLA-SE Vaccine in Healthy Adult Subjects|Completed||Phase 1|39|Actual|IDRI||4|||f||||t||||||||||2017-10-11 00:43:39.576897|2017-10-11 00:43:39.576897
NCT02071745|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-22|||July 2013||2013-07-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Navigated Total Knee Arthroplasty, the Correlation to CT Scans and Clinical Results||Completed||N/A|70|Actual|Ziv Hospital|||1||f||||f||||||||||2017-10-11 00:43:39.855049|2017-10-11 00:43:39.855049
NCT02071732|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-08-02|||February 2014||2014-02-01|August 2016|2016-08-01||||December 2019|Anticipated|2019-12-01||Interventional|||Therapeutic Effect of Repetitive Transcranial Magnetic Stimulaton on Tinnitus|Repetitive Transcranial Magnetic Stimulation (rTMS) Effect on Tinnitus|Recruiting||N/A|40|Anticipated|Dongtan Sacred Heart Hospital||2|||f||||f||||||||||2017-10-11 00:43:39.94702|2017-10-11 00:43:39.94702
NCT02071719|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-07-31|||April 2012||2012-04-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients|Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients|Terminated||N/A|6|Actual|VU University Medical Center|||5||f||||f||||||||||2017-10-11 00:43:40.091471|2017-10-11 00:43:40.091471
NCT02071693|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-03-28|||December 2013||2013-12-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||A Retrospective Study of the Relationship Between White Matter Hyperintensities(WMHs) Within the Cholinergic Pathways and the Cognition of PD Patients After Bilateral STN DBS|Cholinergic Pathways Hyperintensities Scale Could Not Predict the Change of Cognitive Status of Parkinson's Disease Patients After Bilateral STN DBS.|Completed||N/A|38|Actual|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||||||2017-10-11 00:43:40.281883|2017-10-11 00:43:40.281883
NCT02071680|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-12-20|||March 2015||2015-03-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MIBG-AF||Autonomic Innervation and MIBG Imaging|Cardiac Mapping of Autonomic Atrial Innervation and Its Relation to MIBG Nuclear Imaging in Patients With Atrial Fibrillation|Completed||Phase 3|5|Actual|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 00:43:40.391382|2017-10-11 00:43:40.391382
NCT02071667|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-05-01|||September 2014||2014-09-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|||Association of Periostin Levels and Chronic Sinusitis|Association of Periostin Levels and Chronic Sinusitis|Withdrawn||N/A|0|Actual|University of Virginia|||1|Unable to recruit/enroll subjects for study.|f||||f||||||Samples Without DNA|"     Serum and paraffin embedded nasal polyp tissue samples   "|||2017-10-11 00:43:40.522298|2017-10-11 00:43:40.522298
NCT02071654|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2015-01-03|||February 2014||2014-02-01|January 2015|2015-01-01|February 2016|Anticipated|2016-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Efficacy and Safety of Venus P-valve to Treat RVOT Stenosis With Pulmonary Regurgitation|Efficacy and Safety Evaluation of Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract (RVOT) Stenosis After Congenital Heart Defect Surgical Correction Complicated With Severe Pulmonary Regurgitation|Unknown status|Recruiting|Phase 3|44|Anticipated|Venus MedTech (HangZhou) Inc.||1|||f||||t||||||||||2017-10-11 00:43:40.61739|2017-10-11 00:43:40.61739
NCT02071641|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-04-06|||October 2012||2012-10-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma|Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|5|Actual|VU University Medical Center||1|||f||||f||||||||||2017-10-11 00:43:40.733215|2017-10-11 00:43:40.733215
NCT02071628|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-02-22|||December 2013||2013-12-01|February 2014|2014-02-01||||December 2013|Actual|2013-12-01||Observational|||Study for Validation of In-vitro Turbidometric Platelet Aggregation Assay Using Human Blood in Healthy Volunteers||Completed||N/A|10|Actual|Asan Medical Center|||1||f||||||||||||||2017-10-11 00:43:40.821686|2017-10-11 00:43:40.821686
NCT02071615|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2014-04-16|||August 2013||2013-08-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|MKM||Effects of Modafinil, Caffeine and Methylphenidate in Healthy Volunteers|Effects of Modafinil, Caffeine and Methylphenidate on Functional Brain Activity and Cognitive Performance in Healthy Volunteers: a Randomized, Placebo-controlled, Double-blind fMRI Study|Completed||N/A|48|Actual|Charite University, Berlin, Germany||3|||f||||||||||||||2017-10-11 00:43:40.885844|2017-10-11 00:43:40.885844
NCT02071602|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-08-29|||October 2013||2013-10-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|BELIEVE III||CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function|CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study|Recruiting||Phase 1|60|Anticipated|Mayo Clinic||3|||f||||t||||||||||2017-10-11 00:43:40.994887|2017-10-11 00:43:40.994887
NCT02071589|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-02-22|||January 2009||2009-01-01|February 2014|2014-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|NIFEPAR_PK1||Bioavailability Of A Single Dose Of Nifedipine Oral Solution Compared To Adalat Capsules In Healthy Female Volunteers|Crossover Randomised Bioavailability Clinical Study Of A Single Dose Of Nifedipine Oral Solution From Laboratorio Reig Jofre S.A. Compared To Adalat(R) Capsules In Healthy Female Volunteers|Completed||Phase 1|36|Actual|Reig Jofre Group||2|||f||||f||||||||||2017-10-11 00:43:41.091918|2017-10-11 00:43:41.091918
NCT02071576|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-11-19|||February 2014||2014-02-01|November 2014|2014-11-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Interventional|||A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK|A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK|Unknown status|Recruiting|Phase 4|42|Anticipated|Technolas Perfect Vision GmbH||1|||f||||f||||||||||2017-10-11 00:43:41.1742|2017-10-11 00:43:41.1742
NCT02071563|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-04-24|||March 2014||2014-03-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|FAQR-Burkina||Effectiveness and Cost-Effectiveness of Four Formulations of Food Supplements for the Prevention of Wasting and Stunting in Burkina Faso|Food Aid Quality Review Phase II Effectiveness Study: Preventing MAM and Stunting in Burkina Faso|Recruiting||N/A|6000|Anticipated|Tufts University||4|||f||||t||||||||||2017-10-11 00:43:41.284352|2017-10-11 00:43:41.284352
NCT02071550|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-21|||August 2013||2013-08-01|February 2014|2014-02-01||||December 2013|Actual|2013-12-01|1 Day|Observational [Patient Registry]|NIRS AND PEEP||10cmH2O Peep Application and Cerebral Oxygenation in Laparoscopic Surgery: a Comparative Study With Invos and Foresight Devices||Completed||N/A|44|Actual|Turkiye Yuksek Ihtisas Education and Research Hospital|||2||f||||f||||||||||2017-10-11 00:43:41.385895|2017-10-11 00:43:41.385895
NCT02069691|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-20|||August 2012||2012-08-01|August 2012|2012-08-01|May 2013|Actual|2013-05-01|October 2012|Actual|2012-10-01||Interventional|||The Cycling Exercise With Virtual Reality Visual Stimulation for Rehabilitation in CVA Patients|Institutional Review Board of Chung Shan Medical University Hospital|Completed||N/A|13|Actual|Chung Shan Medical University||1|||f||||f||||||||||2017-10-11 00:44:04.273605|2017-10-11 00:44:04.273605
NCT02071537|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-08-22|||May 2014||2014-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors|A Phase 1 Study of Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors|Recruiting||Phase 1|30|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-11 00:43:41.459735|2017-10-11 00:43:41.459735
NCT02071524|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-11-07|||September 2013||2013-09-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||Evaluation of the Effects of Fluid Therapy on Respiratory Mechanics||Recruiting||N/A|40|Anticipated|Università degli Studi di Ferrara||2|||f||||t||||||||||2017-10-11 00:43:41.565006|2017-10-11 00:43:41.565006
NCT02071511|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-09-06|||January 2014||2014-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|ARDEVAT||Renal Denervation In Patient Undergoing VT Ablation:Combined Renal Denervation and VT Ablation vs. Simply VT Ablation|Renal Denervation In Patient Undergoing VT Ablation:Combined Renal Denervation and VT Ablation vs. Simply VT Ablation|Terminated||N/A|50|Actual|Universitätsklinikum Hamburg-Eppendorf||2||results of the SYMPLICITY HTN 3 trial|f||||f||||||||No||2017-10-11 00:43:41.662326|2017-10-11 00:43:41.662326
NCT02071498|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-21|||June 2012||2012-06-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|ALICE||A Spanish Pillbox App for Elderly Patients Taking Multiple Medications|Effectiveness and Utility of a Virtual Custom Tool to Reduce the Medication Errors of Patients Older Than 65 Years Pluripatologic With Complex Therapeutic Regimens|Completed||N/A|99|Actual|Universidad Miguel Hernandez de Elche||2|||f||||f||||||||||2017-10-11 00:43:41.746763|2017-10-11 00:43:41.746763
NCT02071485|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-09-15|||March 2014||2014-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Non-Invasive Brain-Computer Interface for Virtual Object Control|Non-Invasive Brain-Computer Interface for Virtual Object Control|Recruiting||N/A|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:43:41.842902|2017-10-11 00:43:41.842902
NCT02071472|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-04-25|||April 2014||2014-04-01|April 2014|2014-04-01|February 2016|Anticipated|2016-02-01|October 2015|Anticipated|2015-10-01||Interventional|DP-CONCIL||Electronic Pharmaceutical Record Used for Medication Reconciliation by a Pharmacist Associated to the Anesthesiologist Consultation|Evaluation of the Impact of an Electronic Pharmaceutical Record Used for Medication Reconciliation by a Pharmacist Associated to the Anesthesiologist Consultation|Unknown status|Active, not recruiting|N/A|1076|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 00:43:41.926475|2017-10-11 00:43:41.926475
NCT02071459|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-05|||February 2014||2014-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DOPS-AMS||Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA|Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo|Recruiting||Phase 2/Phase 3|108|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-11 00:43:42.007598|2017-10-11 00:43:42.007598
NCT02071446|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-09-27|||March 2014||2014-03-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|LFP in DBS||Local Fields Potentials Recorded From Deep Brain Stimulating Electrodes|Local Field Potentials Recorded From Deep Brain Stimulating Electrodes Implanted for the Treatment of Parkinson's Disease, Essential Tremor or Dystonia|Recruiting||N/A|50|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 00:43:42.166437|2017-10-11 00:43:42.166437
NCT02071433|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2017-01-25|||March 2014||2014-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Analgesic Efficacy of Saphenous Nerve Blockade for Outpatient Knee Anterior Cruciate Ligament Surgery|Analgesic Efficacy of Saphenous Nerve Blockade for Outpatient Knee Anterior Cruciate Ligament Surgery|Recruiting||N/A|58|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:43:42.253714|2017-10-11 00:43:42.253714
NCT02071407|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-24|||October 2013||2013-10-01|February 2014|2014-02-01||||March 2015|Anticipated|2015-03-01||Interventional|||A Clinical Trial of the Effect of Midazolam on the Cerebral Metabolism and Inflammatory Response in Patients With Moderate and Severe Traumatic Brain Injury||Unknown status|Recruiting|Phase 4|60|Anticipated|Subei People's Hospital of Jiangsu Province||2|||f||||t||||||||||2017-10-11 00:43:42.433848|2017-10-11 00:43:42.433848
NCT02071394|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-08-24|||March 2014||2014-03-01|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|CoolXenon3||Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth|Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth: A Randomised Pilot Outcomes Study (COOLXENON3 Study)|Recruiting||Phase 2|52|Anticipated|University Hospitals Bristol NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:43:42.531266|2017-10-11 00:43:42.531266
NCT02071381|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-03-26|||April 2014||2014-04-01|January 2014|2014-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects|A Randomized, Open Label, Single-Dose, 6-sequence, 3-period, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between DW330SR and DW1030 in Healthy Male Subjects|Completed||Phase 1|||Daewon Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 00:43:42.647018|2017-10-11 00:43:42.647018
NCT02071368|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-06-30|||February 2014||2014-02-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants|A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 150 mg/500 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin XR Tablet (2 x 500 mg) in Healthy Fed Subjects|Completed||Phase 1|3|Actual|Janssen Research & Development, LLC||3|||f||||f||||||||||2017-10-11 00:43:42.717451|2017-10-11 00:43:42.717451
NCT02071355|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-24|2014-09-28|||April 2014||2014-04-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Examine the Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of TMC435 in Healthy Chinese Participants|Phase I, Open Label Study to Examine the Pharmacokinetics, Safety and Tolerability of TMC435 Following Multiple Oral Doses of 100 and 150 mg q.d. in Healthy Chinese Subjects|Completed||Phase 1|32|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:43:42.823332|2017-10-11 00:43:42.823332
NCT02071342|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-02-23|||September 2013||2013-09-01|February 2014|2014-02-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Observational|ABSORB-ACS||Study of ABSORB Stent in Acute Myocardial Infarction|Study of ABSORB Stent in Acute Coronary Syndrome|Unknown status|Recruiting|N/A|300|Anticipated|Umberto I Hospital, Frosinone Italy|||1||f||||f||||||||||2017-10-11 00:43:42.911911|2017-10-11 00:43:42.911911
NCT02071329|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-10-04|||January 2014||2014-01-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge|A Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (Vaccine FP-01.1) in Healthy Volunteers Following Virus Challenge|Completed||Phase 1/Phase 2|111|Actual|Immune Targeting Systems Ltd||2|||f||||f||||||||||2017-10-11 00:43:43.004262|2017-10-11 00:43:43.004262
NCT02071316|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-24|||April 2014||2014-04-01|February 2014|2014-02-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|HEXUGI||The Use of Hexacapron in Upper Gastrointestinal Bleeding|The Use of Hexacapron in Upper Gastrointestinal Bleeding|Unknown status|Not yet recruiting|N/A|300|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-11 00:43:43.090308|2017-10-11 00:43:43.090308
NCT02071303|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-12-31|||May 2014||2014-05-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Tramadol Versus Celecoxib for Reducing Pain in Outpatient Hysteroscopy|Tramadol Versus Celecoxib for Reducing Pain Associated With Outpatient Hysteroscopy: A Randomized Double Blind Placebo-Controlled Trial|Completed||Phase 2|210|Actual|Cairo University||3|||f||||t||||||||||2017-10-11 00:43:43.18008|2017-10-11 00:43:43.18008
NCT02071290|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-01-05|||May 2015||2015-05-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Effect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic Shock|Effect of Remote Ischemic Conditioning on Neutrophil Function and the Immune-Inflammatory and Coagulation Profiles in Trauma Patients With Hemorrhagic Shock|Recruiting||Phase 1/Phase 2|40|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:43:43.268208|2017-10-11 00:43:43.268208
NCT02071277|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-04-18|||March 2014||2014-03-01|April 2017|2017-04-01|March 15, 2017|Actual|2017-03-15|January 2017|Actual|2017-01-01||Interventional|APRV/BIPAP||APRV/BIPAP With Spontaneous Breathing on Lung Protection|Impact of the Type of Pressure Controlled Mode on Lung Protection in Mechanically Ventilated Patients With Spontaneous Breathing|Completed||N/A|15|Actual|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-11 00:43:43.361011|2017-10-11 00:43:43.361011
NCT02071264|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-02-24|||August 2013||2013-08-01|February 2014|2014-02-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of an HIV Intervention Among Sex Workers in the Philippines|Effects of an HIV Intervention Among Female and Male Entertainers and Spa/Sauna Workers in the Philippines|Enrolling by invitation||N/A|200|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:43:43.480596|2017-10-11 00:43:43.480596
NCT02071251|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2015-08-22|||December 2011||2011-12-01|August 2015|2015-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery|A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery|Completed||Phase 2|105|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 00:43:43.600095|2017-10-11 00:43:43.600095
NCT02071238|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-01-12|||May 2014||2014-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Factors Affecting Risk Recall in Open Carpal Tunnel Release Surgery|Factors Affecting Risk Recall in Open Carpal Tunnel Release Surgery|Completed||N/A|140|Actual|Nova Scotia Health Authority||3|||f||||f||||||||||2017-10-11 00:43:43.679407|2017-10-11 00:43:43.679407
NCT02071212|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-01|||February 2014||2014-02-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|NOVELTY||Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With Coronary Artery Disease . The NOVELTY Study|A Single Center Phase II Assessor -Blinded RaNdomised Active Controlled Parallel-Group Trial to COmpare Ticagrelor Versus Clopidogrel on the REduction of ArteriaL STiffness and Wave Reflections in Patients With CoronarY Artery Disease. The NOVELTY Study|Recruiting||Phase 2|120|Anticipated|Hellenic Cardiovascular Research Society||2|||f||||f||||||||||2017-10-11 00:43:43.912376|2017-10-11 00:43:43.912376
NCT02071199|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-11-28|||March 2014||2014-03-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Treatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS)|Treatment of Human Gingivitis With Topical ACCS: a Two Week Safety Dose-ranging and Proof-of-principle Trial|Completed||Phase 1|54|Actual|Noveome Biotherapeutics, formerly Stemnion||3|||f||||t||||||||No||2017-10-11 00:43:43.99489|2017-10-11 00:43:43.99489
NCT02071186|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2014-02-23|||March 2014||2014-03-01|February 2014|2014-02-01||||March 2015|Anticipated|2015-03-01||Interventional|||The Effect of Non-pharmacological Novel Cognitive Interventions on Motor-Cognitive Function in Children With ADHD|The Effect of Non-pharmacological Novel Cognitive Interventions on Motor-Cognitive Function in Children With Attention Deficit Hyperactivity Disorder|Unknown status|Not yet recruiting|N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||||2017-10-11 00:43:44.082989|2017-10-11 00:43:44.082989
NCT02071173|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-06-07|||March 2014||2014-03-01|April 2017|2017-04-01|September 2022|Anticipated|2022-09-01|April 19, 2017|Actual|2017-04-19||Interventional|NAVIGATE X4||Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads|Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads: NAVIGATE X4|Active, not recruiting||N/A|2244|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 00:43:44.364322|2017-10-11 00:43:44.364322
NCT02071160|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-02-23|||January 2012||2012-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Melatonin for Neuroprotection Following Perinatal Asphyxia|Melatonin for Neuroprotection Following Perinatal Asphyxia|Completed||Phase 1/Phase 2|45|Actual|Tanta University||3|||f||||f||||||||||2017-10-11 00:43:44.704036|2017-10-11 00:43:44.704036
NCT02071147|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-05-18|||February 2014||2014-02-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||RCT of Follow up Following Cataract Extraction|Randomised Trial of Four to Six Week Follow Ups vs no Medical Follow up After Uncomplicated Cataract Extraction|Unknown status|Recruiting|N/A|400|Anticipated|South Devon Healthcare NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:43:44.82957|2017-10-11 00:43:44.82957
NCT02071134|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-11-15|||February 2014||2014-02-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01|3 Years|Observational [Patient Registry]|||Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry|Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry|Recruiting||N/A|1000|Anticipated|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 00:43:44.935641|2017-10-11 00:43:44.935641
NCT02071121|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-01-29|||December 2013||2013-12-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect|A Randomized, Double-Blinded, Placebo-Controlled, Single-Ascending-Dose (SAD) Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect|Completed||Phase 1|39|Actual|Biogen||6|||f||||f||||||||||2017-10-11 00:43:45.073606|2017-10-11 00:43:45.073606
NCT02071108|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2017-02-03|2016-06-16||January 2014||2014-01-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|DISRUPT-PAD||Safety and Performance Study of the Shockwave Lithoplasty System|Safety and Performance Study of the Shockwave Lithoplasty System|Completed||N/A|35|Actual|Shockwave Medical, Inc.||1|||f||||t||||||||||2017-10-11 00:43:45.209505|2017-10-11 00:43:45.209505
NCT02071095|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-02-10|||April 2014||2014-04-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|Poly-ICLC||Enhancement by Poly-ICLC During HIV-1 Infection|Simultaneous Disruption of Latency and Immune Enhancement by Poly-ICLC During HIV-1 Infection|Active, not recruiting||Phase 1/Phase 2|15|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 00:43:45.71658|2017-10-11 00:43:45.71658
NCT02071082|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-11-16|2016-01-21||March 2014||2014-03-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|January 2015|Actual|2015-01-01||Interventional||Safety Analysis Set: participants who were enrolled and received at least 1 dose of study drug.|Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults|A Phase 3b Open-label Study of the Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1/Hepatitis B Co-infected Adults|Completed||Phase 3|79|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||t||||||||||2017-10-11 00:43:45.887412|2017-10-11 00:43:45.887412
NCT02071069|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-11-17|||July 2013||2013-07-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer|Efficacy and Tolerance of Cetuximab Combined With Irinotecan or Fluorouracil as Maintenance Therapy in Patients With RAS-wild-type Incurable Advanced Colorectal Cancer （Confirm Study）|Recruiting||Phase 2|54|Anticipated|Shanghai Zhongshan Hospital||1|||f||||f||||||||||2017-10-11 00:43:46.695363|2017-10-11 00:43:46.695363
NCT02071056|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-03-02|||May 2014||2014-05-01|March 2016|2016-03-01||||July 2016|Anticipated|2016-07-01||Observational|||Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)|Tissue and Fluid Collection Pilot Study to Develop Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of LM in Patients With Metastatic Solid Tumor Cancer|Recruiting||N/A|22|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||||2017-10-11 00:43:46.77871|2017-10-11 00:43:46.77871
NCT02071030|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-03-03|||June 2013||2013-06-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Efficacy of Cone Beam Computed Tomography (CBCT) Compared to Panoramic Radiography Prior to Third Molar Removal|The Efficacy of Cone Beam Computed Tomography (CBCT) Compared to Panoramic Radiography Prior to Third Molar Removal; a Multicentre Randomised Controlled Trial|Completed||N/A|477|Actual|Radboud University||2|||f||||||||||||||2017-10-11 00:43:46.913226|2017-10-11 00:43:46.913226
NCT02071017|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-21|||February 2013||2013-02-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor|Application of the Simultaneous PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor From Differential Diagnosis to Prediction of Prognosis|Unknown status|Enrolling by invitation|N/A|6|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 00:43:46.974734|2017-10-11 00:43:46.974734
NCT02071004|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-24|||January 2014||2014-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||DS1040b/Aspirin Drug/Drug Interaction Study|A PHASE 1, OPEN LABEL, SINGLE DOSE STUDY, TO ASSESS THE SAFETY AND TOLERABILITY OF A SINGLE IV DOSE OF DS-1040B AFTER 5 DAYS OF ASPIRIN TREATMENT IN HEALTHY SUBJECTS|Completed||Phase 1|18|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 00:43:47.029925|2017-10-11 00:43:47.029925
NCT02069678|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-02-20|||March 2012||2012-03-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B||Completed||N/A|82|Actual|Chinese University of Hong Kong|||1||f||||f||||||||||2017-10-11 00:44:04.34551|2017-10-11 00:44:04.34551
NCT02070991|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-02-16||2017-02-16|July 2014||2014-07-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|MELODY-1||Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction|A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, 12-week Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction|Completed||Phase 2|60|Actual|Actelion||2|||f||||f||||||||||2017-10-11 00:43:47.09998|2017-10-11 00:43:47.09998
NCT02070978|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-09-07|||July 29, 2014|Actual|2014-07-29|September 2017|2017-09-01|February 5, 2018|Anticipated|2018-02-05|April 5, 2016|Actual|2016-04-05||Interventional|||Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Patients Who Participated in ADDRESS II)|A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed Protocol EMR-700461-023 (ADDRESS II)|Active, not recruiting||Phase 2|253|Actual|EMD Serono||2|||f||||t||||||||||2017-10-11 00:43:47.323818|2017-10-11 00:43:47.323818
NCT02070965|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-30|2017-01-23|2015-11-24|January 2014||2014-01-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|BDS1307|One subject signed informed consent and was randomized but was lost to follow up and, therefore, provided no baseline or post-baseline data.|DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis||Completed||Phase 2|75|Actual|Promius Pharma, LLC||3|||f||||||||||||||2017-10-11 00:43:47.570028|2017-10-11 00:43:47.570028
NCT02070952|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-02-21|||July 2013||2013-07-01|February 2014|2014-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer|Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer|Recruiting||N/A|167|Anticipated|Riverside Community Hospital, California||1|||f||||f||||||||||2017-10-11 00:43:49.972998|2017-10-11 00:43:49.972998
NCT02070939|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2015-04-16|||February 2014||2014-02-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects|A Phase 1, Randomized, Double Blind (Sponsor Open), Placebo Controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06260414 In Healthy Western And Japanese Male Subjects|Completed||Phase 1|72|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 00:43:50.087747|2017-10-11 00:43:50.087747
NCT02070926|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-02-23|||January 2006||2006-01-01|February 2014|2014-02-01||||December 2010|Actual|2010-12-01|3 Years|Observational [Patient Registry]|||The CRONOS-ADM Registry|Coronary CT Angiography Evaluation for Clinical Outcomes in Asymptomatic Patients With Type 2 Diabetes Mellitus|Completed||N/A|||Seoul St. Mary's Hospital|||2||f||||||||||||||2017-10-11 00:43:50.189894|2017-10-11 00:43:50.189894
NCT02070913|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-05-23|||September 2013||2013-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|COOL-AMI EU||COOL-AMI EU Case Series Clinical Study|A Single-Center Case Series Clinical Study to Assess the Feasibility of Integrating Therapeutic Hypothermia Using the ZOLL IVTM System as an Adjunctive Therapy to Percutaneous Coronary Intervention in Patients With AMI|Recruiting||N/A|100|Anticipated|ZOLL Circulation, Inc., USA|||1||f||||f||||||||Undecided||2017-10-11 00:43:50.262139|2017-10-11 00:43:50.262139
NCT02070900|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-20|||January 2014||2014-01-01|February 2014|2014-02-01|July 2016|Anticipated|2016-07-01|June 2015|Anticipated|2015-06-01||Interventional|E4E||Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?|Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?|Unknown status|Recruiting|N/A|704|Anticipated|WHO, Department of Maternal, Newborn, Child and Adolescent Health||2|||f||||t||||||||||2017-10-11 00:43:50.459601|2017-10-11 00:43:50.459601
NCT02070887|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-09-11|||February 2014||2014-02-01|September 2014|2014-09-01||||August 2016|Anticipated|2016-08-01||Observational|||Inhibiting COMT in Parkinson's Disease|Inhibiting COMT in Parkinson's Disease A Monocenter, Observational, Rater-blinded Trial of Entacapone in Parkinson's Disease|Unknown status|Recruiting|N/A|100|Anticipated|University of Zurich|||2||f||||t||||||||||2017-10-11 00:43:50.777027|2017-10-11 00:43:50.777027
NCT02070874|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-08-09|||April 2012|Actual|2012-04-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|TelePain||Pain and Symptom Management in Rural Communities|Palliative Care Symptom Management in Rural Communities|Completed||N/A|259|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 00:43:50.864909|2017-10-11 00:43:50.864909
NCT02070861|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2016-10-19|||March 2014||2014-03-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Non-invasive Evaluation of Volume Status Using End-tidal CO2 and Pulse Contour Analysis|Non-invasive Volume Evaluation With Endtidal CO2 and Pulse Contour Analysis (Nexfin)|Completed||N/A|30|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 00:43:50.956122|2017-10-11 00:43:50.956122
NCT02070848|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-09-05|||May 2013||2013-05-01|September 2016|2016-09-01||||May 2017|Anticipated|2017-05-01||Observational|||Muscle Blood Flow During Exercise|Muscle Blood Flow Control During Exercise in Humans: Contribution From Mechanical and Metabolic Signals and Role of the Erythrocyte.|Recruiting||N/A|20|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 00:43:51.035195|2017-10-11 00:43:51.035195
NCT02070835|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2015-08-10|||March 2013||2013-03-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of ReCell® Treating for Diabetic Foot Ulcers|ReCell® Versus Classic Skin Grafts in Treatment of Diabetic Foot Ulcers: a Comparative Randomized Controlled Trial|Unknown status|Recruiting|N/A|80|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:43:51.131813|2017-10-11 00:43:51.131813
NCT02070822|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-02-23|||August 2011||2011-08-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||3T MRI to Predict TACE Response of HCC|Combination of Dynamic Contrast-enhanced and Diffusion-weighted Imaging and Magnetic Resonance Spectroscopy in 3T MRI to Early Predict Treatment Efficacy in Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:43:51.226176|2017-10-11 00:43:51.226176
NCT02070809|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-22|2015-08-10|||December 2013||2013-12-01|August 2015|2015-08-01|October 2023|Anticipated|2023-10-01|December 2020|Anticipated|2020-12-01||Interventional|||Rapid Construction of Tissue-engineered Skin for Repairing Wounds|Multicenter Clinical Randomized Controlled Trials on Rapid Construction of Tissue-engineered Skin for Repairing Wounds|Recruiting||N/A|386|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:43:51.305492|2017-10-11 00:43:51.305492
NCT02070796|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-07-28|||February 2014||2014-02-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different Formulations|Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch (2 mg/24 h) Comparing 2 Different Formulations|Completed||Phase 1|50|Actual|UCB Pharma||2|||f||||t||||||||||2017-10-11 00:43:51.399191|2017-10-11 00:43:51.399191
NCT02070783|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-02-23|||February 2012||2012-02-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|CONEARA||Cognitive and Neural Effects of ARA290|The Effects of ARA290 on the Cognitive and Neural Processing of Emotions in Healthy Volunteers|Completed||Phase 1/Phase 2|36|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-11 00:43:51.496327|2017-10-11 00:43:51.496327
NCT02070770|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2015-05-19|||May 2014||2014-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of a Short-term Very Low Calorie Diet on Heart Rate Variability in Obese Individuals|The Effect of Short-term Adherence to a Very Low Calorie Diet on Heart Rate Variability: a Pilot Randomised Controlled Trial in Obese Men and Women|Completed||N/A|31|Actual|King's College London||2|||f||||f||||||||||2017-10-11 00:43:51.578046|2017-10-11 00:43:51.578046
NCT02070757|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-09-11|||September 23, 2014|Actual|2014-09-23|September 2017|2017-09-01|June 19, 2018|Anticipated|2018-06-19|May 28, 2018|Anticipated|2018-05-28||Interventional|ASPECT-NP||Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)|A Prospective, Randomized, Double-Blind, Multicenter, Phase 3 Study to Assess the Safety and Efficacy of Intravenous Ceftolozane/Tazobactam Compared With Meropenem in Adult Patients With Ventilated Nosocomial Pneumonia|Recruiting||Phase 3|726|Anticipated|Cubist Pharmaceuticals LLC||2|||f||||t|t|f||||||||2017-10-11 00:43:51.68798|2017-10-11 00:43:51.68798
NCT02070744|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-06-08||2017-06-08|April 2014||2014-04-01|June 2017|2017-06-01|May 27, 2016|Actual|2016-05-27|May 27, 2016|Actual|2016-05-27||Interventional|||Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion|A Phase 2, Randomized, Multicenter, Double Blind, Placebo Controlled Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-661 in Combination With Ivacaftor for 12 Weeks in Subjects With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation With an Open-Label Extension|Completed||Phase 2|40|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||t||||||||||2017-10-11 00:43:51.920319|2017-10-11 00:43:51.920319
NCT02070731|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-08-26|||February 2014||2014-02-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|TAVI||DEFLECT III: A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During TAVI|A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During Transcatheter Aortic Valve Implantation|Completed||N/A|86|Actual|Keystone Heart||2|||f||||t||||||||||2017-10-11 00:43:52.053224|2017-10-11 00:43:52.053224
NCT02070718|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-06-29|||January 2013||2013-01-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effects of a Kappa Agonist on Hot Flashes in Menopausal Women|Effects of a Kappa Agonist on Hot Flashes in Menopausal Women|Completed||Phase 1|12|Actual|University of Washington||3|||f||||f||||||||||2017-10-11 00:43:52.2849|2017-10-11 00:43:52.2849
NCT02070705|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-04-28|||January 2014||2014-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||DCE MRI in Diagnosing Patients With Pancreatic Cancer|The Use of Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in the Management of Pancreatic Cancer|Recruiting||N/A|150|Anticipated|OHSU Knight Cancer Institute||3|||f||||t||||||||||2017-10-11 00:43:52.400602|2017-10-11 00:43:52.400602
NCT02070692|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-06-13|2017-04-03||February 2014||2014-02-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users|Tamoxifen for the Treatment of Unfavorable Bleeding Patterns in Etonogestrel Contraceptive Implant Users|Completed||Phase 4|56|Actual|Oregon Health and Science University||2|||f||||f||||||||Undecided|Study under review for publication|2017-10-11 00:43:52.524399|2017-10-11 00:43:52.524399
NCT02070679|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-06-13|||February 2014||2014-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography||Completed||Phase 3|284|Actual|Urmia University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:43:52.945529|2017-10-11 00:43:52.945529
NCT02070666|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-07-29|||May 2014||2014-05-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|EPALI||Preventive Strategies in Acute Respiratory Distress Syndrome (ARDS)|Preventive Strategies in Acute Respiratory Distress Syndrome|Recruiting||N/A|400|Anticipated|Corporacion Parc Tauli||2|||f||||t||||||||||2017-10-11 00:43:53.031275|2017-10-11 00:43:53.031275
NCT02070653|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-10-26|||March 2014||2014-03-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|TicAAA||The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) Expansion|Does Ticagrelor Inhibit Growth of Small Abdominal Aortic Aneurysms? A Randomised Controlled Trial (TicAAA)|Active, not recruiting||Phase 2|145|Actual|Uppsala University||2|||f||||t||||||||||2017-10-11 00:43:53.175034|2017-10-11 00:43:53.175034
NCT02070640|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2015-09-22|2015-05-13||January 2013||2013-01-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|NIRF-C|Cholecystitis or acute cholecystitis|Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy|Near Infrared Fluorescence Cholangiography During Cholecystectomy|Completed||N/A|99|Actual|Ohio State University||1|||f||||f||||||||||2017-10-11 00:43:53.285008|2017-10-11 00:43:53.285008
NCT02070627|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-10-30|||July 2013||2013-07-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|NIRF-C Acute||Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study|Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy Sub-Study|Completed||Phase 1|6|Actual|Ohio State University||1|||f||||f||||||||||2017-10-11 00:43:53.70805|2017-10-11 00:43:53.70805
NCT02070614|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2015-08-30|||December 2013||2013-12-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Observational|||Association of CYP3A4 rs2242480 With Sufentanil Plasma Concentration and PCA Consumption|Association of CYP3A4 rs2242480 With Sufentanil Plasma Concentration and PCA Consumption|Completed||N/A|72|Actual|Huazhong University of Science and Technology|||3||f||||t||||||Samples With DNA|"     The blood samples were drawn before anesthesia，30 min and 45min after anesthesia     respectively，used for genotyping and plasma sufentanil concentration detection with high     performance liquid chromatography-mass spectrometry (HPLC-MS).   "|||2017-10-11 00:43:53.813039|2017-10-11 00:43:53.813039
NCT02070601|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-23|2014-10-16|||February 2014||2014-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:43:53.904138|2017-10-11 00:43:53.904138
NCT02070588|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-06-22|2017-04-28||February 2014||2014-02-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|TBI||Advanced MRI Applications for Mild Traumatic Brain Injury|Advanced MRI Applications for Mild Traumatic Brain Injury|Terminated||N/A|112|Actual|GE Healthcare||2||Sponsor terminated early as moving to a new larger study program|f||||f||||||||No||2017-10-11 00:43:53.957074|2017-10-11 00:43:53.957074
NCT02070575|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-03-13|||February 2014|Actual|2014-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence|Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence|Active, not recruiting||N/A|200|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"     Blood sample   "|||2017-10-11 00:43:54.344266|2017-10-11 00:43:54.344266
NCT02070562|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-02-05|||February 2014||2014-02-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|August 2015|Anticipated|2015-08-01||Observational|MuRu||Human Milk Profiles and Dietary Intake of Chinese Lactating Mothers During Early Lactation Period in Shanghai|Human Milk Profiles and Dietary Intake of Chinese Lactating Mothers During Early Lactation Period in Shanghai|Unknown status|Active, not recruiting|N/A|120|Anticipated|Dumex Baby Food Co., Ltd.|||2||f||||||||||Samples Without DNA|"     breast milk from 0-42 days postpartum   "|||2017-10-11 00:43:54.418951|2017-10-11 00:43:54.418951
NCT02070549|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-09-12|||February 12, 2014|Actual|2014-02-12|September 2017|2017-09-01||||September 30, 2017|Anticipated|2017-09-30||Interventional|||Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction|A Phase I Trial of Single Agent Trametinib (GSK1120212) in Advanced Cancer Patients With Hepatic Dysfunction|Recruiting||Phase 1|68|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:43:54.486326|2017-10-11 00:43:54.486326
NCT02070536|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-02-24|||February 2014||2014-02-01|February 2014|2014-02-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Observational|PrediRAGE||Predictive Values of Plasma Soluble RAGE Levels and RAGE Polymorphisms for the Onset of Acute Respiratory Distress Syndrome in Critically Ill Patients|Predictive Values of Plasma Soluble RAGE Levels and RAGE Polymorphisms for the Onset of Acute Respiratory Distress Syndrome in Critically Ill Patients|Unknown status|Recruiting|N/A|500|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:43:54.664719|2017-10-11 00:43:54.664719
NCT02070523|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-07-06|||December 2013||2013-12-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia:|Pegylated Liposomal Doxorubicin-contained Versus Daunorubicin-contained VDCLD Regimen in Previously Untreated Adult Patients With Acute Lymphoblastic Leukemia: Complete Remission Rates and Changes of Leukemia Stem Cells|Unknown status|Recruiting|Phase 3|200|Anticipated|Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:43:54.749052|2017-10-11 00:43:54.749052
NCT02070510|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-08-25|||February 2014||2014-02-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects|An Open-label, Single Arm, Sequential, Single Centre Trial Investigating the Influence of Oral Semaglutide (NNC0113-0217) on Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects|Completed||Phase 1|52|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 00:43:54.841292|2017-10-11 00:43:54.841292
NCT02070497|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2014-02-24|||July 2010||2010-07-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Effectiveness of Nursing Case Management for Lung Cancer Patients|The Effectiveness of Nursing Case Management for Lung Cancer Patients in a Taiwan Medical Center|Completed||Phase 2|415|Actual|National Taiwan University Hospital||3|||f||||f||||||||||2017-10-11 00:43:54.915842|2017-10-11 00:43:54.915842
NCT02070484|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-09-14|||February 2014||2014-02-01|September 2017|2017-09-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|||Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease|Efficacy of a Human Amniotic Tissue-derived Allograft, NuCel, in Patients Undergoing Posteriolateral Lumbar Fusions for Degenerative Disc Disease|Completed||N/A|6|Actual|OhioHealth||2|||f||||t||||||||||2017-10-11 00:43:55.111227|2017-10-11 00:43:55.111227
NCT02070471|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2016-05-08|||January 2014||2014-01-01|September 2015|2015-09-01||||June 2015|Actual|2015-06-01||Interventional|||Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients|A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Intravenous Single Injection LC28-0126 Immediately Before PCI (Percutaneous Coronary Intervention) in Patients With STEMI(ST-segment Elevation Myocardial Infarction)|Completed||Phase 2|60|Actual|LG Life Sciences||4|||f||||||||||||||2017-10-11 00:43:55.217778|2017-10-11 00:43:55.217778
NCT02070458|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-01-13|||October 2014||2014-10-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|January 2017|Actual|2017-01-01||Interventional|||Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia|A Phase 1 Study of MLN9708 in Combination With MEC (Mitoxantrone, Etoposide, and Intermediate-Dose Cytarabine) for Relapsed/ Refractory Acute Myelogenous Leukemia (AML)|Active, not recruiting||Phase 1|30|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:43:55.321876|2017-10-11 00:43:55.321876
NCT02070445|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-09-06|||June 2019|Anticipated|2019-06-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Observational|||Ventilation During Cardiopulmonary Bypass (CPB) for Cardiac Surgery|Ventilation During Cardiopulmonary Bypass (CPB) for Cardiac Surgery - Effect on Pulmonary Atelectasis Post-operatively, a Pilot Study|Suspended||N/A|40|Anticipated|McMaster University|||1|One of the investigators left the institution.|f||||f||||||||||2017-10-11 00:43:55.463012|2017-10-11 00:43:55.463012
NCT02070432|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-03-01|||February 2014||2014-02-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer|An Open-label Study to Investigate the Tolerability, Pharmacokinetics and Anti-tumour Effect Following Photodynamic Therapy (PDT) With Single-ascending Doses of LUZ11 in Patients With Advanced Head and Neck Cancer|Recruiting||Phase 1/Phase 2|20|Anticipated|Luzitin SA||1|||f||||f||||||||||2017-10-11 00:43:55.566298|2017-10-11 00:43:55.566298
NCT02070419|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2014-12-01|||April 2014||2014-04-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer|Trans-Arterial Chemo-Embolization (TACE) vs TACE Plus Stereotactic Body Radio Therapy (SBRT) in the Treatment of Hepatocellular Carcinoma (HCC)|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||2||Principal Investigator left institution|f||||t||||||||||2017-10-11 00:43:55.657671|2017-10-11 00:43:55.657671
NCT02070406|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-21|2017-09-12|||July 17, 2014||2014-07-17|September 2016|2016-09-01|July 17, 2020|Anticipated|2020-07-17|July 17, 2019|Anticipated|2019-07-17||Interventional|||Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies|NY-ESO-1 TCR Engineered Adoptive Cell Transfer Therapy With CTLA4 Blockade|Recruiting||Phase 1|12|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:43:55.783024|2017-10-11 00:43:55.783024
NCT02070393|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-02-03|||September 2011||2011-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Breast Sparing||Breast-Sparing Proton Therapy for Hodgkin's Disease|Breast-Sparing Proton Therapy for Hodgkin's Disease in Young Females Demonstrated By Positron Emission Tomograpy (PET) Scanning: A Pilot Study|Terminated||Early Phase 1|3|Actual|Indiana University||1||Closure of Indiana University Health Proton Center in December 2014|f||||t||||||||||2017-10-11 00:43:55.924715|2017-10-11 00:43:55.924715
NCT02070380|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-11-14|2016-07-08||February 2014||2014-02-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|BENEFIT||Crossover Comparison of MultiHance and Dotarem|Phase IV, Double Blind, Multi-Center, Randomized, Two-Arm Crossover Study to Compare 0.1 mmol/kg of MultiHance With 0.1 mmol/kg of Dotarem and 0.05 mmol/kg of MultiHance With 0.1 mmol/kg of Dotarem in MRI of the Brain|Completed||Phase 4|179|Actual|Bracco Diagnostics, Inc||4|||f||||f||||||||No||2017-10-11 00:43:56.041874|2017-10-11 00:43:56.041874
NCT02070367|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-08-08|||October 2014||2014-10-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|SARA||Somatosensory Assessment and Rehabilitation of Allodynia (SARA)|Somatosensory Assessment and Rehabilitation of Allodynia: the SARA Pilot Study|Completed||N/A|39|Actual|Hamilton Health Sciences Corporation||2|||f||||f||||||||||2017-10-11 00:43:57.710399|2017-10-11 00:43:57.710399
NCT02070354|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-02-11|||August 2009||2009-08-01|February 2016|2016-02-01||||March 2014|Actual|2014-03-01||Observational|||Physical Fitness and Nutrition Intake in Bariatric Surgery Population|Physical Fitness and Macro- and Micro- Nutrient Intake in a Morbidly Obese Bariatric Surgery Population|Completed||N/A|73|Actual|Geisinger Clinic|||6||f||||f||||||||||2017-10-11 00:43:57.827725|2017-10-11 00:43:57.827725
NCT02070341|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-09-25|||February 2014||2014-02-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Patient Tolerability and Efficacy of Bowel Preparation With Split Dose Picosalax vs. Split Dose PEG|A Randomized Controlled Trial Examining Patient Tolerability and Efficacy of Bowel Preparation With Split Dose Picosalax vs. Split Dose Polyethylene Glycol|Terminated||Phase 4|5|Actual|Queen's University||2||"Significant changes to protocol and study design, study stopped to further enrollment and new   study designed."|f||||t||||||||||2017-10-11 00:43:57.929051|2017-10-11 00:43:57.929051
NCT02070328|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-02-24|||December 2013||2013-12-01|February 2017|2017-02-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01|25 Years|Observational [Patient Registry]|Registry||Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up|Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up|Recruiting||N/A|300|Anticipated|Center for Biomedical Research, LLC|||1||f||||f||||||||||2017-10-11 00:43:58.023404|2017-10-11 00:43:58.023404
NCT02070315|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-02-15|||February 2012||2012-02-01|February 2017|2017-02-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM|Quantitative Evaluation of Liver Disease With Liver and Kidney Elastography Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine|Recruiting||N/A|1000|Anticipated|Baylor Research Institute|||1||f||||t||||||||Undecided||2017-10-11 00:43:58.168401|2017-10-11 00:43:58.168401
NCT02070302|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-09-22|2017-03-10||October 2014||2014-10-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||10 patients with bilateral CTS, diagnosed by nerve conduction studies and NMUS (with crosssectional area measurements; and percentage of nerve compression measured during mechanical stress testing), divided into control and Onabot groups. Non-dominant hands were injected under ultrasound guidance with 40 units (0.4 cc) of Onabot or normal saline.|BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome|BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome|Completed||Phase 2|10|Actual|Arizona Arthritis & Rheumatology Research, PLLC.||2|||f||||f||||||||||2017-10-11 00:43:58.262727|2017-10-11 00:43:58.262727
NCT02070289|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-08-15|||March 2014||2014-03-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)|A Phase 1 Double Blind (3rd Party Open) Randomized, Placebo Controlled, Dose Escalation Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Repeat Doses Of Pf-06372865 In Subjects Aged 18-55 (Group 1) And 56-75 Years (Group 2)|Completed||Phase 1|50|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 00:43:58.790419|2017-10-11 00:43:58.790419
NCT02070276|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-08-13|||May 2014||2014-05-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|CERU-1401||Predict Fluid Responsiveness in Spinal Anesthesia|Can Non Invasive Methods for Fluid Responsive Assessment Optimize Preventive Volemic Repletion in Order to Prevent Significant Hypotension After Spinal Anesthesia? A Randomized Trial|Recruiting||N/A|510|Anticipated|Ente Ospedaliero Cantonale, Bellinzona||3|||f||||t||||||||||2017-10-11 00:43:58.917524|2017-10-11 00:43:58.917524
NCT02070263|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-04-13|||April 2009||2009-04-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Mixed Tree Nut Food Challenges|Mixed Tree Nut Food Challenges|Enrolling by invitation||N/A|100|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||Undecided|Data has not been analyzed at thistime|2017-10-11 00:43:59.061079|2017-10-11 00:43:59.061079
NCT02070250|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-08-14|||November 2013||2013-11-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|C2H-D||Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)|Examination of a Stress Management Intervention for Cancer Patients as Delivered by Community Mental Health Professionals|Active, not recruiting||N/A|120|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 00:43:59.140241|2017-10-11 00:43:59.140241
NCT02070237|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-10-22|2015-09-23||August 2013||2013-08-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis|Comparing Anti-XA Levels in Post-Cesarean Patients With BMI >35 Undergoing Enoxaparin Thromboprophylaxis With Weight Based Dosing Twice Daily Versus Fixed Dose 40 Milligrams Daily|Completed||Phase 1|90|Actual|MemorialCare Health System||2|||f||||f||||||||||2017-10-11 00:43:59.254334|2017-10-11 00:43:59.254334
NCT02070224|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-01-23|||January 2014||2014-01-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|PRODIGE||Evaluation of the Prognostic Value of Biological Markers, Coll2-1 and Coll2-1NO2 in Patients With Symptomatic Knee Osteoarthritis|Evaluation of the Prognostic Value of Biological Markers, Coll2-1 and Coll2-1NO2 in Patients With Symptomatic Knee Osteoarthritis|Recruiting||N/A|120|Anticipated|Artialis||1|||f||||t||||||||||2017-10-11 00:43:59.763001|2017-10-11 00:43:59.763001
NCT02070211|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-21|||June 2014||2014-06-01|February 2014|2014-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.|Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome Genetically at High Risk for Psychosis: A Randomised, Double Blind, Placebo-controlled Treatment Trial.|Unknown status|Not yet recruiting|Phase 2/Phase 3|80|Anticipated|Bambino Gesù Hospital and Research Institute||2|||f||||t||||||||||2017-10-11 00:43:59.88027|2017-10-11 00:43:59.88027
NCT02070198|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-21|||December 2013||2013-12-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF|Long Acting FSH Plus GnRH Antagonist Versus Daily FSH Plus GnRH Antagonist Versus Short Agonist Regimens in Poor Responder Patients Undergoing IVF: a Randomized Study.|Unknown status|Recruiting|Phase 4|120|Anticipated|Bioroma||3|||f||||t||||||||||2017-10-11 00:43:59.991042|2017-10-11 00:43:59.991042
NCT02070185|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-21|||March 2013||2013-03-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Effect of Energy Density on Liking and on Caloric Adjustment Conditioning|Effect of Energy Density on Liking and on Caloric Adjustment Conditioning After Sweet Beverage Exposure in Children Aged 8-11 y|Completed||N/A|45|Actual|Centre des Sciences du Goût et de l'Alimentation||2|||f||||t||||||||||2017-10-11 00:44:00.121859|2017-10-11 00:44:00.121859
NCT02070172|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-21|||February 2009||2009-02-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Active and Passive Cervical Flexion-rotation Tests|A Comparison of Range of Motion During the Active and Passive Flexion-rotation Tests in Subjects Patients With Cervicogenic Headache|Completed||N/A|24|Actual|Des Moines University|||2||f||||f||||||None Retained|"     This study compares observation of neck range of motion measures during the flexion rotation     test (combining neck flexion with neck rotation) in two groups of subjects, one group has     headaches and one groups is a healthy, asymptomatic group.   "|||2017-10-11 00:44:00.232867|2017-10-11 00:44:00.232867
NCT02070159|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2014-02-21|||December 2011||2011-12-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|PRELOAD-LD||Prasugrel With Lower Dose - Loading Dose|Effect of Lower Loading Dose of Prasugrel Compared With Conventional Loading Dose of Clopidogrel and Prasugrel in Korean Coronary Artery Disease Patients Undergoing Coronary Angiography|Completed||Phase 3|43|Actual|Dong-A University||3|||f||||t||||||||||2017-10-11 00:44:00.310928|2017-10-11 00:44:00.310928
NCT02070146|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-08-17|||May 2013||2013-05-01|August 2017|2017-08-01|January 2051|Anticipated|2051-01-01|January 2050|Anticipated|2050-01-01|50 Years|Observational [Patient Registry]|PLCRC||Prospective Data Collection Initiative on Colorectal Cancer|Prospective Data Collection Initiative on Colorectal Cancer - a Prospective Observational Cohort Study -|Recruiting||N/A|10000|Anticipated|Dutch Colorectal Cancer Group|||1||f||||f||||||Samples With DNA|"     Blood and tumor tissue will be stored.   "|||2017-10-11 00:44:00.435864|2017-10-11 00:44:00.435864
NCT02070133|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2014-02-21|||May 2009||2009-05-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy of Simvastatin for the Treatment of COPD|Pilot Study on the Efficacy of Statins for the Treatment of Chronic Obstructive Pulmonary Disease|Completed||Phase 3|18|Actual|Hospital Universitari Son Dureta||2|||f||||f||||||||||2017-10-11 00:44:00.608322|2017-10-11 00:44:00.608322
NCT02070120|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-04-27|||October 2014|Actual|2014-10-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|CALIBER||Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer|CALIBER - A Phase II Randomised Feasibility Study of Chemoresection and Surgical Management in Low Risk Non Muscle Invasive Bladder Cancer|Recruiting||Phase 2|174|Anticipated|Institute of Cancer Research, United Kingdom||2|||f||||t||||||||||2017-10-11 00:44:00.703125|2017-10-11 00:44:00.703125
NCT02070107|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-08-04|||April 2014||2014-04-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection|A Phase 2 Clinical Trial of A Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Chronic Genotype 1 Hepatitis C Infection|Withdrawn||N/A|0|Actual|University of Louisville||1||Sponsored withdrew|f||||f||||||||||2017-10-11 00:44:00.931677|2017-10-11 00:44:00.931677
NCT02070068|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-12-01|||January 2014||2014-01-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Pilot Dosing and Timing Study to Optimize Imaging When Utilizing Endoscopic Fluorescence Imaging System During Laparoscopic Biliary and Hepatic Operations|A Pilot Study to Optimize Imaging When Utilizing the PINPOINT Endoscopic Fluorescence Imaging System for Identification of Biliary Anatomy During Laparoscopic Biliary and Hepatic Operations|Completed||Early Phase 1|38|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:44:01.10281|2017-10-11 00:44:01.10281
NCT02070055|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-06-12|||January 2013||2013-01-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Dietary Correlates of the Maximal Capacity for Fat Oxidation|Dietary Correlates of the Maximal Capacity for Fat Oxidation During Exercise in Males and Females.|Completed||N/A|306|Actual|University of Birmingham|||1||f||||t||||||||||2017-10-11 00:44:01.188126|2017-10-11 00:44:01.188126
NCT02070042|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-03-14|||February 2014||2014-02-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Oxybutynin and Omega-3 for OAB (Overactive Bladder)|Randomized Controlled Trial of Oxybutynin and Omega-3 Fatty Acid Supplementation Versus Oxybutynin and Placebo for Treatment of Overactive Bladder in Women|Terminated||N/A|31|Actual|TriHealth Inc.||2||Lack of participation|f||||f||||||||No||2017-10-11 00:44:01.280965|2017-10-11 00:44:01.280965
NCT02070029|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2014-10-15|||January 2013||2013-01-01|February 2014|2014-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Acupuncture for Sexual Dysfunction|Acupuncture in Premenopausal Women With Hypoactive Sexual Desire Disorder: A Prospective Cohort|Completed||N/A|15|Actual|TriHealth Inc.||1|||f||||t||||||||||2017-10-11 00:44:01.359013|2017-10-11 00:44:01.359013
NCT02070016|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-08-05|||January 2014||2014-01-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Transcranial Magnetic Stimulation for Low Back Pain|Clinical Applicaitons of Non-Invasive Brain Stimulation for the Treatment of Chronic Pain|Withdrawn||N/A|0|Actual|Stanford University||2|||f||||||||||||||2017-10-11 00:44:01.451374|2017-10-11 00:44:01.451374
NCT02070003|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-05-19|||April 2014||2014-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|PROMPT||Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT)||Enrolling by invitation||N/A|130|Anticipated|Stanford University||2|||f||||||||||||||2017-10-11 00:44:01.523033|2017-10-11 00:44:01.523033
NCT02069990|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-20|||March 2013||2013-03-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Controlled, Randomized, Four-arm Comparative, Open Label, Multi-centric Clinical Trial to Compare the Efficacy and Safety Parameters of the Once-a-week or Once-a-month Administered 7000 IU, or 30000 IU Vitamin D (Cholecalciferol) to a 1000 IU Dosage Applied Daily in Vitamin D Deficient Patients||Completed||Phase 3|89|Actual|Semmelweis University||4|||f||||f||||||||||2017-10-11 00:44:01.601525|2017-10-11 00:44:01.601525
NCT02069977|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-03-10|||February 2014||2014-02-01|March 2014|2014-03-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Study to Evaluate the Efficacy and Safety of Aripiprazole|A Multinational, Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Aripiprazole in Asian Pediatric Patients With Autism Spectrum Disorder and Behavior Problems|Unknown status|Recruiting|Phase 4|79|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 00:44:01.709962|2017-10-11 00:44:01.709962
NCT02069964|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-20|||October 2011||2011-10-01|February 2014|2014-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||A Prospective Longitudinal Cohort Study Looking at the Difference in Carotid Intima-medial Thickness Between Irradiated and Unirradiated Carotid Arteries in Patients With Head and Neck Cancer|A Prospective Longitudinal Cohort Study Looking at the Difference in Carotid Intima-medial Thickness Between Irradiated and Unirradiated Carotid Arteries in Patients With Head and Neck Cancer|Unknown status|Recruiting|N/A|60|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 00:44:01.85542|2017-10-11 00:44:01.85542
NCT02069951|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-05-09|||February 2014||2014-02-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Procedure-to-procedure Transfer Trial|A Randomised Educational Trial of Practicing One Versus Two Laparoscopic Procedural Modules in Simulator Training for Novices on Procedure-to-procedure Transferability|Completed||N/A|96|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:44:01.942146|2017-10-11 00:44:01.942146
NCT02069938|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-09-15|||March 2014||2014-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Brain Computer Interface Control of a Robotic Device|Brain Computer Interface Control of a Robotic Device|Recruiting||N/A|130|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:44:02.028527|2017-10-11 00:44:02.028527
NCT02069925|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-12-15|||February 2014||2014-02-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.|STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.|Recruiting||N/A|224|Anticipated|Yale University||2|||f||||t||||||||Undecided||2017-10-11 00:44:02.112601|2017-10-11 00:44:02.112601
NCT02069912|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-20|||November 2006||2006-11-01|February 2014|2014-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|MDCP||Multifaceted Depression and Cardiovascular Program|Multifaceted Depression and Cardiovascular Program for Low-Income Patients|Completed||N/A|108|Actual|University of Southern California||1|||f||||t||||||||||2017-10-11 00:44:02.222039|2017-10-11 00:44:02.222039
NCT02069899|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-06-22|||June 2013||2013-06-01|June 2017|2017-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody|A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody|Recruiting||N/A|35|Anticipated|NovImmune SA||1|||f||||t||||||||||2017-10-11 00:44:02.311244|2017-10-11 00:44:02.311244
NCT02069886|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-04-19|||December 2014||2014-12-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CENTAurus||Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia|A Multicenter, Open-label, Single Arm, Interventional Phase IV Study, to Evaluate the Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia|Withdrawn||Phase 4|0|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:44:02.533477|2017-10-11 00:44:02.533477
NCT02069873|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-02-20|||April 2008||2008-04-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effectiveness of Cognitive, Exposure, and Skills Group Manualized Treatments in Operations Iraqi (OIF)/Operation Enduring Freedom (OEF) Female Veterans|Phase II Efficacy Study on Group Delivery of Effective Treatments for PTSD|Completed||N/A|86|Actual|New Mexico VA Healthcare System||2|||f||||f||||||||||2017-10-11 00:44:02.605322|2017-10-11 00:44:02.605322
NCT02069860|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-02-28|||April 2016||2016-04-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|BAP||BONE ANCHORED PORT for Hemodialysis Treatment|Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment|Recruiting||N/A|25|Anticipated|Cendres+Mètaux||1|||f||||t||||||||Undecided||2017-10-11 00:44:02.704269|2017-10-11 00:44:02.704269
NCT02069847|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-08-28|||February 2014||2014-02-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy|Prospective Evaluation of the Clinical Utility of Budesonide for the Prevention of Esophageal Strictures After Endotherapy|Recruiting||Phase 2|100|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:44:02.808585|2017-10-11 00:44:02.808585
NCT02069834|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-08-27|||May 2014||2014-05-01|August 2015|2015-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|DORISS||Dolutegravir + Rilpivirine Switch Study (DORISS)|Dolutegravir + Rilpivirine Switch Study (DORISS): Pilot and Noninferiority Trial Comparing Dolutegravir + Rilpivirine vs. Continued HAART (Highly Active Antiretroviral Therapy) in Patients With Plasma HIV RNA ≤ 50 Copies/mL for at Least 2 Years|Withdrawn||Phase 2/Phase 3|0|Actual|Nantes University Hospital||2||"One of the both Funder partners decided to stop the study before the initiation : thus no   product provided and no funding to realize the study"|f||||t||||||||||2017-10-11 00:44:02.896928|2017-10-11 00:44:02.896928
NCT02069821|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-09-11|||March 2014||2014-03-01|September 2017|2017-09-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects|An Open-label, Multiple-dosing, Two-arms, One-sequence Study to Evaluate the Safety and Pharmacokinetics After Co-administration of Exforge® (Amlodipine Besylate/Valsartan) and Lipitor® (Atorvastatin Ca) in Healthy Male Volunteers|Completed||Phase 1|56|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 00:44:03.032406|2017-10-11 00:44:03.032406
NCT02069808|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-10-31|||April 2014||2014-04-01|October 2016|2016-10-01||||April 2018|Anticipated|2018-04-01||Interventional|||Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation|Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct and GnRH Agonist Trigger for Egg Bank Donation|Recruiting||Phase 4|50|Anticipated|Michigan Reproductive Medicine||2|||f||||f||||||||||2017-10-11 00:44:03.245194|2017-10-11 00:44:03.245194
NCT02069795|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-03-14|||February 2014||2014-02-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Speech Analysis as a Diagnostic Tool for Mild Traumatic Brain Injury|Utilization of Speech Analysis as a Diagnostic Tool to Objectively Evaluate Early Signs of Mild Traumatic Brain Injury: A Pilot Study|Completed||N/A|50|Actual|Methodist Sports Medicine||1|||f||||t||||||||||2017-10-11 00:44:03.384578|2017-10-11 00:44:03.384578
NCT02069782|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-08-29|||October 2012||2012-10-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|December 2018|Anticipated|2018-12-01||Interventional|MIHOPE||Mother and Infant Home Visiting Program Evaluation|Mother and Infant Home Visiting Program Evaluation (MIHOPE|Active, not recruiting||N/A|4232|Actual|MDRC||1|||f||||f||||||||||2017-10-11 00:44:03.478196|2017-10-11 00:44:03.478196
NCT02069769|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-04-15|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Interventional|||Ensuring Communication in Hospice by Oncology Study (ECHO)|Ensuring Communication in Hospice by Oncology Study (ECHO)|Completed||N/A|30|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 00:44:03.5949|2017-10-11 00:44:03.5949
NCT02069756|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-09-25|||October 2007||2007-10-01|September 2017|2017-09-01|October 2047|Anticipated|2047-10-01|October 2027|Anticipated|2027-10-01|40 Years|Observational [Patient Registry]|||DuchenneConnect Registry|DuchenneConnect: An International, Patient-Report Registry for Individuals With Duchenne/Becker Muscular Dystrophy (Member of TREAT-NMD Neuromuscular Alliance)|Recruiting||N/A|10000|Anticipated|DuchenneConnect|||1||f||||t||||||||||2017-10-11 00:44:03.700757|2017-10-11 00:44:03.700757
NCT02069743|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-02-27|||February 2014||2014-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|ePAL||Pain Management in Cancer Patients Using a Mobile Application|Pain Management in Cancer Patients Using a Mobile Application|Recruiting||N/A|110|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:44:03.800206|2017-10-11 00:44:03.800206
NCT02069730|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-02-07|||June 2014||2014-06-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|April 2019|Anticipated|2019-04-01||Interventional|||A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes|Genomic Profiling and Matched Therapy for Recurrent or Metastatic Salivary Gland Neoplasms|Recruiting||N/A|30|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 00:44:03.913|2017-10-11 00:44:03.913
NCT02069717|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-10-25|||October 2013||2013-10-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01|24 Months|Observational [Patient Registry]|||Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)|Multi-center, Prospective, Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) Add-on to Statin Therapy in Patients Who Have History of Acute Myocardial Infarction and Are Diagnosed With Metabolic Syndrome|Withdrawn||N/A|0|Actual|Daewoong Pharmaceutical Co. LTD.|||1||f||||||||||||||2017-10-11 00:44:04.048022|2017-10-11 00:44:04.048022
NCT02069704|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-09-18|||October 2014||2014-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2015|Actual|2015-10-01||Interventional|||Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients|Open Label Randomized Bioequivalence Study to Evaluate the PK and Safety Profile of Bevacizumab Biosimilar (BEVZ92) With FOLFOX or FOLFIRI vs Bevacizumab (AVASTIN®) With FOLFOX or FOLFIRI in First-line Treatment for mCRC Patients|Active, not recruiting||Phase 1|142|Actual|mAbxience S.A||2|||f||||t||||||||||2017-10-11 00:44:04.124894|2017-10-11 00:44:04.124894
NCT02069665|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2014-02-20|||December 2011||2011-12-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Effectiveness Study of Integrative Treatment for Pediatric Pneumonia|Assessing the Effectiveness of Integrative Treatment That Combines Interior and Exterior Treatment Plans in Pediatric Pneumonia: a Program by PRC National Clinical Research Base of Traditional Chinese Medicine for Major Diseases|Completed||N/A|451|Actual|Liaoning University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 00:44:04.430564|2017-10-11 00:44:04.430564
NCT02069652|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-03-26|||July 2013||2013-07-01|March 2016|2016-03-01||||December 2014|Anticipated|2014-12-01||Expanded Access|||Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention,|Chung-Ho Memorial Hospital Kaohsiung Medical University|No longer available||N/A|||Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||||||||||||2017-10-11 00:44:04.580967|2017-10-11 00:44:04.580967
NCT02069639|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-02-20|||November 2013||2013-11-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|TARC||TARC After alloSCT in Hodgkin's Lymphoma|Serum Thymus and Activation-regulated Chemokine (TARC) Level Monitoring May Predict Disease Relapse Detected by PET Scan After Reduced Intensity Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma Patients|Completed||N/A|22|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||1||f||||t||||||||||2017-10-11 00:44:04.640518|2017-10-11 00:44:04.640518
NCT02069626|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-21||||||February 2014|2014-02-01||||December 2014|Anticipated|2014-12-01||Interventional|||The Effect of Compression Time for Secure Stapling With a Linear Stapler in Laparoscopic Gastric Bypass Surgery||Unknown status|Active, not recruiting|N/A|60|Anticipated|Inonu University||3|||f||||||||||||||2017-10-11 00:44:04.716237|2017-10-11 00:44:04.716237
NCT02069613|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-02-22|||March 2014||2014-03-01|February 2017|2017-02-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)|Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)|Recruiting||N/A|200|Anticipated|Huntington Medical Research Institutes|||2||f||||f||||||Samples Without DNA|"     Blood will be retained for future analysis.   "|||2017-10-11 00:44:04.791475|2017-10-11 00:44:04.791475
NCT02069600|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-20|||January 2011||2011-01-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of CPAP Treatment in Elderly: Randomized Clinical Trial|OBSTRUCTIVE SLEEP APNEA IN THE ELDERLY. ROLE OF CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT. A Randomized Controlled Trial|Completed||Phase 3|224|Actual|Hospital Universitario La Fe||2|||f||||t||||||||||2017-10-11 00:44:04.893064|2017-10-11 00:44:04.893064
NCT02069587|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2014-02-20|||February 2014||2014-02-01|January 2014|2014-01-01|April 2015|Anticipated|2015-04-01|February 2015|Anticipated|2015-02-01||Interventional|||Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes|Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 00:44:04.982359|2017-10-11 00:44:04.982359
NCT02069574|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-02-20|||March 2014||2014-03-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Diagnosis of Periodontal Disease Using Genetic Marker in Saliva|Identification of Novel Periodontal Disease Biomarkers Using microRNA Expression in Saliva|Unknown status|Not yet recruiting|N/A|18|Anticipated|Asan Medical Center||3|||f||||f||||||||||2017-10-11 00:44:05.136153|2017-10-11 00:44:05.136153
NCT02069561|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-09-17|||January 2014||2014-01-01|September 2015|2015-09-01||||August 2015|Actual|2015-08-01||Interventional|EPAUC||Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal Cancer|Effects of Eicosapentaenoic Acid on Molecular, Metabonomics and Intestinal Microbiota Changes, in Subjects With Long-standing Inflammatory Bowel Disease|Completed||N/A|25|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||f||||||||||2017-10-11 00:44:05.230586|2017-10-11 00:44:05.230586
NCT02069548|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-10-21|||February 2014||2014-02-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|STAC1||Analysis of Three-dimensional Movements of the Head in Cervical Dystonia|Analysis of 3-D Movements of the Head in Cervical Dystonia: Comparative Assessment of the Cervical Mobility With the Mean of 3D Sensors Motion Capture Between Patients With Cervical Dystonia and Control Subjects|Completed||N/A|63|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||f||||||||||2017-10-11 00:44:05.307247|2017-10-11 00:44:05.307247
NCT02069535|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-01-05|||April 2014||2014-04-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy|An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy|Completed||Phase 2|52|Actual|ALK-Abelló A/S||1|||f||||f||||||||||2017-10-11 00:44:05.377438|2017-10-11 00:44:05.377438
NCT02069522|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-03-20|||February 2014||2014-02-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Healthy Term Infants Fed Milk-Based Formulas|Healthy Term Infants Fed Milk-Based Formulas With A Supplemental Carotenoid|Terminated||N/A|91|Actual|Abbott Nutrition||2||interim analysis findings|f||||f||||||||||2017-10-11 00:44:05.454359|2017-10-11 00:44:05.454359
NCT02069509|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-05-10|||May 2010||2010-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|6 Years|Observational [Patient Registry]|EFACTS||Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)|Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)|Recruiting||N/A|900|Anticipated|European Friedreich's Ataxia Consortium for Translational Studies|||2||f||||f||||||Samples With DNA|"     whole blood, urine, centrifugate of serum, EDTA, citrate blood   "|||2017-10-11 00:44:05.548841|2017-10-11 00:44:05.548841
NCT02069496|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-20|||February 2010||2010-02-01|August 2012|2012-08-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Observational|||Drug Use Investigation for Arepanrix® (H1N1)|Drug Use Investigation for Arepanrix® (H1N1)|Completed||N/A|3405|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 00:44:05.708334|2017-10-11 00:44:05.708334
NCT02069483|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-09-25|||April 2014||2014-04-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Testing Methods of Self-persuasion Involving Cigarette Smoking|Testing Methods of Self-persuasion Involving Cigarette Smoking|Completed||N/A|48|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:44:05.768808|2017-10-11 00:44:05.768808
NCT02069470|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-05-08|||September 2012||2012-09-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of CME on Early Cancer Diagnosis in General Practice|The Effect of Continuing Medical Education (CME) on Early Cancer Diagnosis in General Practice|Completed||N/A|689|Actual|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-11 00:44:05.846598|2017-10-11 00:44:05.846598
NCT02069457|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-07-26|||December 2013||2013-12-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Observational|||Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis|Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis|Completed||N/A|151|Actual|Beijing Friendship Hospital|||1||f||||f||||||Samples Without DNA|"     serum, plasma   "|||2017-10-11 00:44:05.928986|2017-10-11 00:44:05.928986
NCT02069444|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-21|||January 2012||2012-01-01|February 2014|2014-02-01||||October 2012|Actual|2012-10-01|1 Day|Observational [Patient Registry]|||Comparison of the Effects of Truview Laryngoscopy and Macintosh Larygonscopy on Intubation Difficulty Score, Intubation Duration and Intubation Quality in Pediatric Patients Between 2-12 Years||Completed||N/A|100|Actual|Ankara University|||2||f||||f||||||||||2017-10-11 00:44:06.042197|2017-10-11 00:44:06.042197
NCT02069431|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-06-09|||February 2016||2016-02-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Oxytocin Aging Study|Effects of Oxytocin on Physical and Cognitive Functioning in the Elders|Recruiting||Phase 1|48|Anticipated|University of Florida||2|||f||||f|t|f||||||||2017-10-11 00:44:06.107394|2017-10-11 00:44:06.107394
NCT02069418|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-19|||February 2014||2014-02-01|February 2014|2014-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|FLT-THERA||Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient|Could Positon Emission Tomography With Radiolabelled 3'-Deoxy-3'-(18)F-Fluoro-L-Thymidine be a Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patients ?|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-11 00:44:06.211667|2017-10-11 00:44:06.211667
NCT02069405|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2014-12-05|||December 2013||2013-12-01|December 2013|2013-12-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Relaxation Music to Lower Heart Rate Prior to Cardiac CT|Relaxation Music to Lower Heart Rate Prior to Cardiac CT|Completed||N/A|197|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 00:44:06.346007|2017-10-11 00:44:06.346007
NCT02069392|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-08-07|||January 2015||2015-01-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia|Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia|Completed||N/A|34|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 00:44:06.442432|2017-10-11 00:44:06.442432
NCT02069379|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-06-15|||July 2014||2014-07-01|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Endogenous Opioid Activity and Affective State in Insulin Resistant Women|Endogenous Opioid Activity and Affective State in Insulin Resistant Women|Active, not recruiting||Phase 4|38|Anticipated|University of Michigan||3|||f||||f||||||||||2017-10-11 00:44:06.555129|2017-10-11 00:44:06.555129
NCT02069366|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-12-06|||November 2014||2014-11-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|||Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder|Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder|Recruiting||N/A|120|Anticipated|Wayne State University||2|||f||||t||||||||||2017-10-11 00:44:06.684728|2017-10-11 00:44:06.684728
NCT02069353|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-10-24|||July 2015||2015-07-01|October 2016|2016-10-01||||January 2019|Anticipated|2019-01-01||Interventional|||Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest|Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest|Recruiting||Phase 1|20|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 00:44:06.815959|2017-10-11 00:44:06.815959
NCT02069340|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-04-09|||June 2016|Anticipated|2016-06-01|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|||Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid|POPULATION PHARMACOMETRICS FOR ASSESSING RISK OF BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW (BRONJ)|Withdrawn||N/A|0|Actual|University of Southern California||2|||f||||t|f|f||||||||2017-10-11 00:44:06.891915|2017-10-11 00:44:06.891915
NCT02069314|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-19|||May 2012||2012-05-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|S32||Diet and Muscle Function In Older Adults|Diet and Muscle Function In Older Adults|Completed||N/A|12|Actual|Purdue University||2|||f||||t||||||||||2017-10-11 00:44:08.682706|2017-10-11 00:44:08.682706
NCT02069301|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-04-24|||February 2014|Actual|2014-02-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|LIFE-DM||Evaluation of an Integrated Microfinance and Depression Care Program for Women|Development of an Integrated Microfinance and Depression Care Program for Women|Completed||N/A|166|Actual|RAND||2|||f||||t||||||||||2017-10-11 00:44:08.764714|2017-10-11 00:44:08.764714
NCT02069288|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-02-19||||||February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|FLUDRO||Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock|Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response, Gastric Mucosal Perfusion and Arterial Stiffness in Septic Shock|Withdrawn||Phase 3|0|Actual|Rennes University Hospital||2||Problems of drugs supply by the manufacturer|f||||f||||||||||2017-10-11 00:44:08.877606|2017-10-11 00:44:08.877606
NCT02069275|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-06-30|||April 2013||2013-04-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|SAMOVAR||Immediate Mobilization After Cardiac Catheterisation|Patients Immediate Mobilization After Coronary Angiography and Percutaneous Coronary Intervention. Is it SAfe to MObilize Patients Very eARly After Cardiac Catheterisation?|Recruiting||N/A|2000|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:44:08.96939|2017-10-11 00:44:08.96939
NCT02069262|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2014-02-19|||January 2003||2003-01-01|January 2003|2003-01-01|January 2014|Actual|2014-01-01|November 2008|Actual|2008-11-01||Interventional|||Angiography Combination Laparoscopy in Patients With Obscure Gastrointestinal Bleeding|Angiography Combination Laparoscopy in Patients With Obscure Gastrointestinal Bleeding|Completed||N/A|66|Actual|The Second People's Hospital of GuangDong Province||2|||f||||t||||||||||2017-10-11 00:44:09.062528|2017-10-11 00:44:09.062528
NCT02069249|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2017-04-28|||March 2014||2014-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sleep, Nutrition and Psychological Functioning in Kindergarten Children|Sleep, Nutrition and Psychological Functioning in Kindergarten Children: A Longitudinal Intervention Study|Recruiting||N/A|250|Anticipated|Tel Aviv University||3|||f||||f||||||||||2017-10-11 00:44:09.142381|2017-10-11 00:44:09.142381
NCT02069236|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-08-18|||February 2014||2014-02-01|February 2014|2014-02-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Comparing G6PD Tests Using Capillary Blood Versus Venous Blood|Correlation of G6PD Activity Across Different Sample Sources, and Different G6PD Testing Platforms|Completed||N/A|150|Actual|PATH||1|||f||||f||||||||||2017-10-11 00:44:09.246571|2017-10-11 00:44:09.246571
NCT02069223|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-05-15|||January 2014||2014-01-01|May 2014|2014-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Physiological Impact of Each Component of the Biliopancreatic Diversion With Duodenal Switch and Sleeve Gastrectomy|Physiological Impact of Each Component of the Biliopancreatic Diversion With Duodenal Switch and Sleeve Gastrectomy|Recruiting||N/A|45|Anticipated|Laval University||3|||f||||f||||||||||2017-10-11 00:44:09.330279|2017-10-11 00:44:09.330279
NCT02069210|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-19|||May 2014||2014-05-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients|The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients|Unknown status|Not yet recruiting|N/A|40|Anticipated|Mahidol University|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 00:44:09.520414|2017-10-11 00:44:09.520414
NCT02069197|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-08-28|||January 2014||2014-01-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|KGDobesity||Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea|Evaluation of Efficacy and Safety of Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea.|Recruiting||Phase 2|150|Anticipated|Mid-Atlantic Epilepsy and Sleep Center, LLC||3|||f||||f||||||||||2017-10-11 00:44:09.594138|2017-10-11 00:44:09.594138
NCT02069171|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-02-19|||June 2012||2012-06-01|February 2014|2014-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Cross-sectional and Questionnaire Study for Leg Lymphedema|The Cross-sectional and Questionnaire Study of Pelvic and Lower Extremity Lymphedema After Treatment of Gynecological Disease|Completed||N/A|333|Actual|National Cancer Center, Korea|||3||f||||f||||||||||2017-10-11 00:44:09.810487|2017-10-11 00:44:09.810487
NCT02069158|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-03-24|||April 2014||2014-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|IOSI-NDU-001||Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor|DOSE FINDING STUDY OF PF-05212384 WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED SOLID TUMOR|Recruiting||Phase 1|40|Anticipated|Oncology Institute of Southern Switzerland||1|||f||||f||||||||No||2017-10-11 00:44:09.874896|2017-10-11 00:44:09.874896
NCT02069145|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-08-14|||January 2014||2014-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Interventional|||Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer|A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer|Completed||Phase 1|10|Anticipated|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:44:09.97847|2017-10-11 00:44:09.97847
NCT02069132|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-04-26|||March 2013||2013-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|VIALE||Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity|Prospective Validation of IWPC Pharmacogenetic Algorithm for Estimating the Appropriate Initial Dose of Warfarin in Elderly People (65 or Older) With Heart Valves Prostheses or Non Valvular Atrial Fibrillation and Comorbidity|Active, not recruiting||N/A|376|Anticipated|"University of Campania Luigi Vanvitelli"|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:44:10.077792|2017-10-11 00:44:10.077792
NCT02069106|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-12-10|||February 2014||2014-02-01|December 2015|2015-12-01|July 2014|Anticipated|2014-07-01|May 2014|Anticipated|2014-05-01||Interventional|PrOteCT||Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction|An 8-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction in Subjects With Mixed Hyperlipoproteinemia|Withdrawn||Phase 4|0|Actual|Nordic Pharma, USA||2|||f||||f||||||||||2017-10-11 00:44:10.267199|2017-10-11 00:44:10.267199
NCT02068911|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-02-25|||April 2014||2014-04-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|Capnovivo||Concordance Between ETCO2, PTCO2 and PaCO2 in the Home-ventilated Neuromuscular Patient|Validation of the Measure of ETCO2, Compared to PTCO2 and PaCO2 in the Home-ventilated Neuromuscular Patient|Completed||N/A|28|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-11 00:44:12.249463|2017-10-11 00:44:12.249463
NCT02069093|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2016-12-20|2016-10-19||May 2014||2014-05-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||Full analysis set: The full analysis set consisted of all participants who received at least one dose of study treatment (everolimus and/or exemestane) and at least one dose of investigational treatment (dexamethasone mouth wash).|Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer|A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane|Completed||Phase 2|92|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:44:10.382861|2017-10-11 00:44:10.382861
NCT02069080|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-09-30|||January 17, 2014||2014-01-17|September 29, 2017|2017-09-29|August 31, 2018|Anticipated|2018-08-31|June 29, 2018|Anticipated|2018-06-29||Interventional|||Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor|Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor|Suspended||Early Phase 1|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:44:10.861816|2017-10-11 00:44:10.861816
NCT02069067|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-03-28|||December 2011||2011-12-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|Break-1||Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated|Multicenter Observational Study of the Incidence and Treatment Modalities of Breakthrough Cancer Pain in Patients With Chronic Cancer Pain|Recruiting||N/A|500|Anticipated|National Cancer Institute, Naples|||1||f||||f||||||||||2017-10-11 00:44:10.958975|2017-10-11 00:44:10.958975
NCT02069054|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-04-26|||September 2012||2012-09-01|February 2014|2014-02-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Observational|||Airway Inflammation and Remodeling in Asthma and COPD.|Relationship Between Airway Inflammation and Remodeling in Asthma and COPD Patients.|Completed||N/A|72|Actual|Medical University of Warsaw|||3||f||||f||||||Samples With DNA|"     induced sputum, BALF, bronchial mucosa samples, exhaled breath condensate, serum   "|||2017-10-11 00:44:11.031505|2017-10-11 00:44:11.031505
NCT02069028|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-20|||February 2014||2014-02-01|February 2014|2014-02-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Observational|||Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis|Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis|Unknown status|Active, not recruiting|N/A|30|Anticipated|King Abdullah International Medical Research Center|||3||f||||f||||||||||2017-10-11 00:44:11.285997|2017-10-11 00:44:11.285997
NCT02069015|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-11-10|||October 2013||2013-10-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|AchieveBP||Achieving Blood Pressure Control Through Enhanced Discharge|Achieving Blood Pressure Control Through Enhanced Discharge|Completed||N/A|150|Actual|Wayne State University||2|||f||||f||||||||||2017-10-11 00:44:11.357411|2017-10-11 00:44:11.357411
NCT02069002|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2015-08-13|||January 2014||2014-01-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|TOSI||Comparing Interventions for Indoor Air -Related Functional Symptoms|Psychosocial Interventions for Indoor Air -Related Functional Symptoms - Randomized Controlled Trial (RCT)|Unknown status|Recruiting|N/A|120|Anticipated|Finnish Institute of Occupational Health||3|||f||||f||||||||||2017-10-11 00:44:11.453825|2017-10-11 00:44:11.453825
NCT02068989|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-09-02|||February 2013||2013-02-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus|Stress Hyperglycemia as an Indicator for Future Diabetes Mellitus: A Prospective Cohort Study|Terminated||N/A|1|Actual|Yale University|||2||f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 00:44:11.590338|2017-10-11 00:44:11.590338
NCT02068976|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-03-03|||November 2013||2013-11-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)|Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)|Recruiting||N/A|100|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||||2017-10-11 00:44:11.667835|2017-10-11 00:44:11.667835
NCT02068963|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-02-02|||February 2014||2014-02-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Observational|||Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing|Collection of Plasma and Serum Samples From Individuals Initiating Therapy With Sofosbuvir for Chronic Hepatitis C Virus Infection for the Clinical Evaluation of the Aptima HCV Quant Dx Assay|Completed||N/A|352|Actual|Hologic, Inc.|||1||f||||f||||||Samples With DNA|"     Plasma and serum   "|||2017-10-11 00:44:11.795239|2017-10-11 00:44:11.795239
NCT02068950|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-09-23|||February 2014||2014-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Progressive Resistance Training Program in Head and Neck Cancer Patients|Feasibility of a 12-week Progressive Resistance Training Program in Head and Neck Cancer Patients During Concurrent Radiochemotherapy - a Pilot Trial|Completed||N/A|12|Actual|Herlev Hospital||1|||f||||t||||||||||2017-10-11 00:44:11.939516|2017-10-11 00:44:11.939516
NCT02068937|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-08-01|||May 2013||2013-05-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients|Effectiveness of a Diuretic Algorithm in Clinical Stability and Readmissions in Heart Failure Patients|Recruiting||N/A|270|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 00:44:12.0356|2017-10-11 00:44:12.0356
NCT02068924|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-02-21|||February 2014||2014-02-01|February 2014|2014-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Vitrification and Slow Freezing for Cryopreservation of Blastocyst|Single Embryo Transfer: Comparison of Slow Freezing and Vitrification at Blastocyst Stage|Recruiting||N/A|100|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:44:12.149657|2017-10-11 00:44:12.149657
NCT02068898|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-11-10|||December 2013||2013-12-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacokinetic Comparison of XS003 and Tasigna|"A Comparative, Proof of Concept Study, Comprising of a Pilot Phase Bioavailability Study Part and a Randomised, Cross-over Food-effect Study Part of XS003 and Originator in Healthy Male Subjects"|Completed||Phase 1|27|Actual|XSpray Microparticles||4|||f||||f||||||||||2017-10-11 00:44:12.349335|2017-10-11 00:44:12.349335
NCT02068885|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2017-09-19|||February 2014||2014-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Interventional|(FS)2||Framingham State Food Study|Dietary Composition and Energy Expenditure During Weight-Loss Maintenance|Active, not recruiting||N/A|164|Actual|Boston Children’s Hospital||3|||f||||f||||||||||2017-10-11 00:44:12.45178|2017-10-11 00:44:12.45178
NCT02068872|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-09-30|||February 2014||2014-02-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation|Pilot Study to Assess the Feasibility, Safety and Tolerability of Sleeve Gastrectomy in Morbidly Obese Patients Undergoing Orthotopic Liver Transplantation|Completed||Phase 1|1|Actual|Northwestern University||1|||f||||f||||||||||2017-10-11 00:44:12.605153|2017-10-11 00:44:12.605153
NCT02068859|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-20|||January 2014||2014-01-01|February 2014|2014-02-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1%|Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1%|Unknown status|Recruiting|Phase 3|106|Anticipated|FPR Specialty Pharmacy||2|||f||||f||||||||||2017-10-11 00:44:12.687219|2017-10-11 00:44:12.687219
NCT02068846|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-04-17|||April 2014||2014-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent|BK Virus in Salivary Gland Disease|Active, not recruiting||Phase 3|53|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:44:12.771201|2017-10-11 00:44:12.771201
NCT02068833|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-05-15|||June 2013||2013-06-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Resolution of Microalbuminuria and Dysmetabolism Following Bariatric Surgery: Prospective Study|Resolution of Microalbuminuria and Dysmetabolism Following Bariatric Surgery: Prospective Study|Unknown status|Recruiting|N/A|48|Anticipated|Laval University|||2||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 00:44:12.862586|2017-10-11 00:44:12.862586
NCT02068820|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-02-20|||September 2012||2012-09-01|February 2014|2014-02-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Interventional|||Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG|Detection of Sentinel Lymph Nodes in Patients With Endometrial Cancer Undergoing Robotic-Assisted Staging: Comparison of Isosulfan Blue and Indocyanine Green Dyes With Fluorescence Imaging|Unknown status|Recruiting|N/A|200|Anticipated|Florida Hospital||2|||f||||f||||||||||2017-10-11 00:44:12.958923|2017-10-11 00:44:12.958923
NCT02068807|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-24|||January 2011||2011-01-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|January 2013|Actual|2013-01-01||Interventional|||Evaluation of Antioxidant Activity of Oral Lutein in Preterm and Term Newborn|Evaluation of Antioxidant Activity of Oral Lutein in Preterm and Term Newborn|Completed||Phase 1/Phase 2|100|Actual|University of Siena||2|||f||||f||||||||||2017-10-11 00:44:13.05176|2017-10-11 00:44:13.05176
NCT02068794|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-03-14|||March 2014|Actual|2014-03-01|June 2016|2016-06-01|March 10, 2021|Anticipated|2021-03-10|March 10, 2021|Anticipated|2021-03-10||Interventional|||MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer|Phase I/II Trial of Intraperitoneal Administration of Adipose Tissue Derived Mesenchymal Stem Cells Infected With a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Recurrent Ovarian Cancer|Recruiting||Phase 1/Phase 2|54|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 00:44:13.133197|2017-10-11 00:44:13.133197
NCT02068781|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-05-18|||July 2014||2014-07-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Aldosterone, Microvascular Function and Salt-sensitivity|Aldosterone-induced Microvascular Dysfunction as a Cause of Salt-sensitivity in Obesity?|Completed||N/A|40|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 00:44:13.241723|2017-10-11 00:44:13.241723
NCT02068768|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-07-07|||August 2013||2013-08-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Multicenter Study of the Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating and Posterior Fixation|A Prospective, Multicenter, Open Label Clinical Study of the Safety andEfficacy of the Avenue L Interbody Spinal Fusion System Using the VerteBRIDGE Plating System and Supplemental Posterior Fixation|Recruiting||N/A|40|Anticipated|LDR Spine USA|||1||f||||f||||||||No||2017-10-11 00:44:13.320111|2017-10-11 00:44:13.320111
NCT02068755|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-02-19|||January 2002||2002-01-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01|1 Year|Observational [Patient Registry]|BiCS||Blood Products in Cardiac Surgery|The Use of Blood Products in Patients Undergoing Cardiac Surgery|Completed||N/A|31000|Actual|University of Turku|||1||f||||f||||||||||2017-10-11 00:44:13.403549|2017-10-11 00:44:13.403549
NCT02068742|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-05-23|||January 2014||2014-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|May 2017|Actual|2017-05-01||Interventional|ElderlyPOCD||Postoperative Cognitive Dysfunction in Elderly|Postoperative Cognitive Dysfunction in Elderly|Recruiting||N/A|160|Anticipated|Università degli Studi dell'Insubria||2|||f||||t||||||||||2017-10-11 00:44:13.474855|2017-10-11 00:44:13.474855
NCT02068729|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-06-14|||June 2014||2014-06-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|September 2018|Anticipated|2018-09-01||Observational|RAVINE||Comparison of Complication Rates Between Lateral Approaches to the Lumbar Spine|A Comparison of Complication Rates Between Lateral Approaches to the Lumbar Spine: K2M RAVINE® Far Lateral System Versus NuVasive XLIF®|Enrolling by invitation||N/A|222|Anticipated|K2M, Inc.|||1||f||||t||||||||||2017-10-11 00:44:13.568557|2017-10-11 00:44:13.568557
NCT02068716|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-08-10|||March 2014||2014-03-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|HAI||Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery|Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery|Active, not recruiting||N/A|13925|Anticipated|University of Michigan|||1||f||||f||||||||||2017-10-11 00:44:13.633988|2017-10-11 00:44:13.633988
NCT02068703|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-06-27|||February 2014||2014-02-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Sleep Enhancing Tools: Pilot Study|Use of Sleep Enhancing Tools Impact on Self-Reported Sleep Survey|Completed||N/A|120|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 00:44:13.706366|2017-10-11 00:44:13.706366
NCT02068690|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-20|2014-10-07|||March 2014||2014-03-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809|Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BI 425809 in Healthy Male Subjects (Partially Randomised, Single-blind, Placebo-controlled) and Investigation of Relative Bioavailability and Food Effect of BI 425809 (Open-label, Randomised, Three-way Crossover)|Completed||Phase 1|83|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:44:13.893958|2017-10-11 00:44:13.893958
NCT02068677|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-04-12|||August 2013||2013-08-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluation of Injection Techniques in Celiac Plexus Neurolysis|Evaluation of Injection Techniques in Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis (EUS-CPN)|Completed||N/A|51|Actual|Florida Hospital||2|||f||||f||||||||No||2017-10-11 00:44:13.98532|2017-10-11 00:44:13.98532
NCT02068664|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-08-16|||February 2014||2014-02-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia|An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia With Option of Prism Adaptation Treatment (PAT) Protocol|Completed||N/A|60|Actual|Kessler Foundation|||1||f||||t||||||||||2017-10-11 00:44:14.074068|2017-10-11 00:44:14.074068
NCT02068651|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-08-18|||March 2014||2014-03-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Community-based Advance Care Planning Programme for Patients With Advanced Disease|A Community-based Advance Care Planning Programme to Improve End-of-life Care in Patients With Advanced Disease: A Mixed-method Approach|Completed||N/A|239|Actual|Food and Health Bureau, Hong Kong||2|||f||||t||||||||No||2017-10-11 00:44:14.170204|2017-10-11 00:44:14.170204
NCT02068638|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-08-09|||February 2014||2014-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CARBEX1||Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes|Exercise-related Fuel Metabolism and Glucose Stability in Individuals With Type 1 Diabetes Mellitus|Completed||N/A|27|Actual|University Hospital Inselspital, Berne||4|||f||||f||||||||||2017-10-11 00:44:14.264999|2017-10-11 00:44:14.264999
NCT02068625|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-01-30|||September 2010|Actual|2010-09-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment|Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment|Recruiting||Phase 4|40|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 00:44:14.382879|2017-10-11 00:44:14.382879
NCT02068612|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-01-17|||April 2014||2014-04-01|January 2017|2017-01-01||||January 2019|Anticipated|2019-01-01||Interventional|FORCE||Enhancing Function in Later Life: Exercise and Functional Network Connectivity|Enhancing Function in Later Life: Exercise and Functional Network Connectivity|Recruiting||N/A|305|Anticipated|University of Colorado, Boulder||2|||f||||t||||||||||2017-10-11 00:44:14.499557|2017-10-11 00:44:14.499557
NCT02068599|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-07-13|||February 2014||2014-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (4% and 8% w/w Ointment) in Patients With Primary Osteoarthritis Affecting a Single Knee|Completed||Phase 2|389|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 00:44:14.594187|2017-10-11 00:44:14.594187
NCT02068586|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-10-18|||November 2014||2014-11-01|October 2016|2016-10-01||||February 2019|Anticipated|2019-02-01||Interventional|||Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma|A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma|Recruiting||Phase 2|90|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 00:44:14.766065|2017-10-11 00:44:14.766065
NCT02068573|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-05-11|||August 2012||2012-08-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|AsthmaVent||AsthmaVent - Effect of Mechanical Ventilation on Asthma Control in Children|AsthmaVent - Effect of Mechanical Ventilation on Asthma Control in Children|Completed||N/A|46|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:44:14.895924|2017-10-11 00:44:14.895924
NCT02068560|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-12-10|||May 2012||2012-05-01|February 2014|2014-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion|The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion|Completed||N/A|64|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 00:44:15.022932|2017-10-11 00:44:15.022932
NCT02068547|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-08-22|||February 2014||2014-02-01|December 2015|2015-12-01||||February 2018|Anticipated|2018-02-01||Interventional|BMAC||Bone Marrow Aspirate Concentration in Posterior Cervical Fusion|Bone Marrow Aspirate Concentration in Posterior Cervical Fusion|Enrolling by invitation||N/A|100|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:44:15.111239|2017-10-11 00:44:15.111239
NCT02068534|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-02-20|||January 2014||2014-01-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||A Qualitative and Quantitative Analysis on the Living History of Survivors From Charcoal-burning Suicide|A Qualitative and Quantitative Analysis on the Living History of Survivors From Charcoal-burning Suicide|Unknown status|Recruiting|N/A|20|Anticipated|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 00:44:15.196956|2017-10-11 00:44:15.196956
NCT02068521|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-09-26|||March 2014||2014-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|VISTA||Versartis Long-Term Safety Study of Somavaratan|An Open-Label, Long-Term Safety Study of A Long-acting Human Growth Hormone Somavaratan (VRS-317) in Children With Growth Hormone Deficiency|Recruiting||Phase 2/Phase 3|300|Anticipated|Versartis Inc.||2|||f||||t||||||||||2017-10-11 00:44:15.280339|2017-10-11 00:44:15.280339
NCT02068495|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-02-19|||June 2010||2010-06-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||"Candesartan Cilexetil/Amlodipine Combination Tablets LD, HD Special Drug Use Surveillance Hypertension: Long-Term Use"|"Unisia Combination Tablets LD, HD Special Drug Use Surveillance Hypertension: Long-Term Use"|Completed||N/A|3409|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:44:15.561382|2017-10-11 00:44:15.561382
NCT02068482|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-19|||November 2010||2010-11-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Immunohistology in USDD and Correlation Between Bacterial Flora and Phlogosis|Evaluation of Immunohistological Pattern in Patients With Uncomplicated Symptomatic Diverticular Disease and Correlation Between Intraluminal Bacterial Flora and Phlogosis|Completed||Phase 4|61|Actual|Catholic University of the Sacred Heart||3|||f||||f||||||||||2017-10-11 00:44:15.633215|2017-10-11 00:44:15.633215
NCT02068469|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-08-30|||December 2013||2013-12-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||In Vitro Diagnostic Device for the Detection of Strep A|Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A|Completed||N/A|799|Actual|IQuum, Inc.|||1||f||||f||||||Samples Without DNA|"     Throat culture swab   "|No||2017-10-11 00:44:15.715774|2017-10-11 00:44:15.715774
NCT02068456|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-06-21|||September 18, 2012|Actual|2012-09-18|June 2017|2017-06-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Observational|||Post Marketing Surveillance of Roflumilast in Korea|Post Marketing Surveillance of Roflumilast in Korea|Completed||N/A|1837|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:44:15.779362|2017-10-11 00:44:15.779362
NCT02068443|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-04-28|2016-04-28||February 2014||2014-02-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||All randomized participants.|Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy|A Phase 3 Multicenter, Randomized, Double-blind, Parallel-group, Comparative Study When Metformin Hydrochloride 500 mg is Added on to SYR-322 25 mg in Type 2 Diabetic Patients|Completed||Phase 3|374|Actual|Takeda||3|||f||||f||||||||||2017-10-11 00:44:15.886365|2017-10-11 00:44:15.886365
NCT02068430|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-09-27|||November 2008||2008-11-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection|Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection|Completed||Phase 1|6|Actual|Columbia University||1|||f||||f||||||||||2017-10-11 00:44:16.988761|2017-10-11 00:44:16.988761
NCT02068417|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-03-05|||October 2011||2011-10-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)|A Prospective, Randomised, Blinded, Placebo-controlled Pilot Study of the Treatment of Erectile Dysfunction With Extracorporeal Shockwave Therapy (ESWT)|Terminated||Phase 3|40|Actual|Storz Medical AG||2||It has been decided to improve the inclusion criteria for better study outcome|f||||t||||||||||2017-10-11 00:44:17.067314|2017-10-11 00:44:17.067314
NCT02068404|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-07-27|||April 2014||2014-04-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Nifedipine Pharmacokinetics and Pharmacodynamics When Used as a Tocolytic in Acute Threatened Preterm Labour|Nifedipine Pharmacokinetics and Pharmacodynamics When Used as a Tocolytic in Patients Hospitalized for Acute Threatened Preterm Labour|Unknown status|Recruiting|Phase 4|75|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||||2017-10-11 00:44:17.138892|2017-10-11 00:44:17.138892
NCT02068391|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-06-16|||June 1, 2015|Actual|2015-06-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|January 31, 2018|Anticipated|2018-01-31||Interventional|RISE-2||Recovery Improved in Covert Stroke With Exercise|Achieving Brain Benefits in Covert Stroke Through Aerobic Exercise|Recruiting||N/A|60|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f|f|f||||||Undecided||2017-10-11 00:44:17.238228|2017-10-11 00:44:17.238228
NCT02068378|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-02-06|||May 2014||2014-05-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ROSS-LC||Visual Feedback With Optical Sensing - A Feasibility Study|Clinical Evaluation of Visual Feedback With Optical Sensing in Lung Cancer Patients Undergoing Radiotherapy: A Feasibility Study|Unknown status|Recruiting|N/A|15|Anticipated|The Christie NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 00:44:17.496981|2017-10-11 00:44:17.496981
NCT02068365|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-07-26|||June 2013||2013-06-01|July 2016|2016-07-01||||June 2020|Anticipated|2020-06-01||Interventional|||An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy|An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy|Recruiting||Phase 4|20|Anticipated|Chinese University of Hong Kong||1|||f||||||||||||||2017-10-11 00:44:17.604639|2017-10-11 00:44:17.604639
NCT02068352|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-01-28||2016-01-28|June 2014||2014-06-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of a Topical Ointment to Treat Subjects With Atopic Dermatitis|A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis|Completed||Phase 2|94|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||f||||||||||2017-10-11 00:44:17.72067|2017-10-11 00:44:17.72067
NCT02068339|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-03-29|||February 2014||2014-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis|Completed||Phase 3|283|Actual|PharmaKing||3|||f||||t||||||||||2017-10-11 00:44:17.88835|2017-10-11 00:44:17.88835
NCT02067962|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-02-17|||March 2014||2014-03-01|February 2014|2014-02-01||||December 2017|Anticipated|2017-12-01||Interventional|GenesinJIA||Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing|Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing|Not yet recruiting||N/A|30|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 00:44:21.633379|2017-10-11 00:44:21.633379
NCT02068326|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-04-07|||September 2015||2015-09-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|M-GAB||MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial|Mentalization-Based Treatment in Groups for Adolescents With Borderline Personality Disorder (BPD) or Subthreshold BPD Versus Treatment As Usual - the M-GAB Randomized Controlled Trial|Active, not recruiting||N/A|112|Actual|Psychiatric Research Unit, Region Zealand, Denmark||2|||f||||t||||||||||2017-10-11 00:44:18.002702|2017-10-11 00:44:18.002702
NCT02068313|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-02-19|||March 2010||2010-03-01|February 2014|2014-02-01||||July 2017|Anticipated|2017-07-01||Observational|||Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers|Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers|Unknown status|Recruiting|N/A|300|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||||||||||||2017-10-11 00:44:18.144144|2017-10-11 00:44:18.144144
NCT02068300|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-04-14|||October 2013||2013-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|||The Role of 1.5-anhydro-D-glucitol as Clinical Biomarkers of Hypoglycemia in Patients With Diabetes|1,5-Anhydro-D-Glucitol Can Reflect Hypoglycemia in Patients With Well Controlled Type 2 Diabetes|Completed||N/A|51|Actual|Seoul National University Hospital|||1||f||||t||||||Samples Without DNA|"     blood, urine   "|No||2017-10-11 00:44:18.237432|2017-10-11 00:44:18.237432
NCT02068287|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-01-27|||December 2013||2013-12-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|ESMOSEPSIS||Esmolol Effects on Heart and Inflammation in Septic Shock|Anti-inflammatory and Cardiac Effects of Esmolol in Septic Shock. ESMOSEPSIS Study|Recruiting||Phase 2|25|Anticipated|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-11 00:44:18.330727|2017-10-11 00:44:18.330727
NCT02068274|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-08-04|||September 2013||2013-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|January 2017|Actual|2017-01-01||Observational|||CO2 Monitoring Study|Continuous Monitoring of Patients Treated With Opioids for Chronic Pain and Its Impact on Patient Safety. A Feasibility Trial.|Completed||N/A|17|Actual|Cantonal Hosptal, Baselland|||1||f||||f||||||||||2017-10-11 00:44:18.435452|2017-10-11 00:44:18.435452
NCT02068261|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-10-22|||January 2014||2014-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.|Computerized Working Memory Training in Adults With Substance Abuse and Executive Function Deficits: A Randomised Controlled Trial.|Unknown status|Recruiting|Phase 2|100|Anticipated|Örebro Läns Landsting||2|||f||||f||||||||||2017-10-11 00:44:18.531192|2017-10-11 00:44:18.531192
NCT02068248|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-11-07|||January 2014||2014-01-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|CHOL-META||Effect of Viscous Soluble Fibers on Serum Cholesterol Levels|Effect of Viscous Soluble Fibers on Serum Cholesterol Levels: A Series of Systematic Reviews and Meta-analyses|Active, not recruiting||N/A|1000|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-11 00:44:18.639226|2017-10-11 00:44:18.639226
NCT02068235|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-05-20|||August 2014||2014-08-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects|Single-center, Open-label, Randomized, Two-way Crossover Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects|Completed||Phase 1|17|Actual|Actelion||3|||f||||f||||||||||2017-10-11 00:44:18.716219|2017-10-11 00:44:18.716219
NCT02068222|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-12-09|2016-12-09|2016-03-03|April 2014||2014-04-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection|An Open-Label Pilot Study to Evaluate the Antiviral Activity, Safety, Tolerability, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-530, With and Without Ribavirin (RBV) in Treatment-Naïve Subjects With Genotype 3 Chronic Hepatitis C Virus (HCV) Infection|Completed||Phase 2|10|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 00:44:18.849239|2017-10-11 00:44:18.849239
NCT02068209|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2015-04-03|||May 2014||2014-05-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of the Role of Tramadol 50mg as an Analgesic During Outpatient Hysteroscopy|Role of Tramadol 50mg in Reducing Pain Associated With Outpatient Hysteroscopy: A Randomized Double Blind Placebo Controlled Trial.|Completed||Phase 2|140|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 00:44:19.13347|2017-10-11 00:44:19.13347
NCT02068196|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-04-06|||January 2014||2014-01-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|Ipi4||A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.|Phase IV Ipilimumab in Melanoma: A National, Multicenter, Interventional Study in Patients With Unresectable or Metastatic Melanoma|Active, not recruiting||Phase 4|150|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 00:44:19.229446|2017-10-11 00:44:19.229446
NCT02068183|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-01-23|||December 2013||2013-12-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||World Trade Center Adolescent Health Study|Early Identification of World Trade Center Conditions in Adolescents|Completed||N/A|402|Actual|New York University School of Medicine|||2||f||||t||||||Samples With DNA|"     A research assistant well trained in pediatric phlebotomy will collect 25 mL of blood at the     first visit, as one aliquot of 3 ml blood in a lavender top vacutainer for CBC, one aliquot     of 5 ml blood in a goldtop vacutainer for whole blood, and one 3 ml of blood in a PAX Gene     (PreAnalitycX - Hombrechtikon, Switzerland) tube for RNA isolation. One 4 ml cryovial of     whole blood will be reserved for future DNA analysis and heavy metal analysis, and another 10     ml vacutainer will be reserved for persistent organic pollutants, while the blood in the PAX     Gene will be stored for RNA isolation.   "|||2017-10-11 00:44:19.354647|2017-10-11 00:44:19.354647
NCT02068170|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-07-27|||February 2014||2014-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Observational|RISQ-PATH||Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital|Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital|Completed||N/A|178|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||Samples With DNA|"     -  1 blood sample (plasma) to measure the blood concentration of the drug        -  1 blood sample (DNA) to store in a biobank for additional research   "|||2017-10-11 00:44:19.477048|2017-10-11 00:44:19.477048
NCT02068144|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-04-07|||February 2014||2014-02-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans|The Effect of Daily Dietary Supplementation With Cranberry Extract on Modulation of Cardiovascular Risk Factors in Obese, Insulin Resistant Human Subjects|Active, not recruiting||N/A|35|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||No||2017-10-11 00:44:19.890048|2017-10-11 00:44:19.890048
NCT02068131|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-01-04|||February 2014||2014-02-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer|Phase II Study of Recombinant Anti-tumor and Anti-Virus Protein for Injection Plus Capatabine in Treating Patients With Metastatic Colorectal Cancer After Failure of Standard Treatment|Unknown status|Recruiting|Phase 2|30|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||1|||f||||f||||||||||2017-10-11 00:44:19.987847|2017-10-11 00:44:19.987847
NCT02068118|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-27|||May 2013||2013-05-01|February 2014|2014-02-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|OSICAT||Optimization of the Ambulatory Monitoring for Patients With Heart Failure by Tele-cardiology|OSICAT : Optimization of the Ambulatory Monitoring for Patients With Heart Failure by Tele-cardiology|Unknown status|Recruiting|Phase 3|870|Anticipated|Alere E-Sante||2|||f||||f||||||||||2017-10-11 00:44:20.114338|2017-10-11 00:44:20.114338
NCT02068105|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-04-18|||January 2014||2014-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study of ALKS 5461 in Healthy Volunteers|A Phase 1, Randomized, Two-part Study to Evaluate the Relative Bioavailability of Two Formulations of ALKS 5461 and the Effect of Dose Titration of ALKS 5461 in Healthy Subjects|Completed||Phase 1|104|Actual|Alkermes, Inc.||6|||f||||f||||||||||2017-10-11 00:44:20.303454|2017-10-11 00:44:20.303454
NCT02068092|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-09-28|||December 2013||2013-12-01|September 2017|2017-09-01|August 2023|Anticipated|2023-08-01|August 2022|Anticipated|2022-08-01||Interventional|Olive Oil||Olive Oil for Breast Cancer Prevention in Women at High Risk for Breast Cancer|A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast Cancer|Recruiting||N/A|100|Anticipated|The Methodist Hospital System||1|||f||||f||||||||||2017-10-11 00:44:20.378083|2017-10-11 00:44:20.378083
NCT02068079|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-11-17|||April 2014||2014-04-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma|A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma|Withdrawn||Phase 1|0|Actual|Duke University||1||Study is being revised|f||||t||||||||||2017-10-11 00:44:20.48073|2017-10-11 00:44:20.48073
NCT02068066|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-11-16|||May 2013||2013-05-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Physical Workload and Work Capacity Across Occupational Groups|Physical Workload and Work Capacity Across Occupational Groups|Completed||N/A|337|Actual|Cantonal Hosptal, Baselland|||1||f||||f||||||||||2017-10-11 00:44:20.565014|2017-10-11 00:44:20.565014
NCT02068053|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2014-05-30|||March 2014||2014-03-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020|Pharmacokinetics and Metabolism of [14C] BMS-986020 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:44:20.642055|2017-10-11 00:44:20.642055
NCT02068040|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-06-01|||January 2014||2014-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|HFPEF||Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)||Completed||N/A|7|Actual|University of California, San Diego||1|||f||||||||||||||2017-10-11 00:44:20.719729|2017-10-11 00:44:20.719729
NCT02068027|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2017-08-29|2017-03-06||March 2014||2014-03-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy|A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy|Completed||Phase 2|260|Actual|BioDelivery Sciences International||2|||f||||f||||||||||2017-10-11 00:44:20.801288|2017-10-11 00:44:20.801288
NCT02068014|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2016-03-28|||May 2014||2014-05-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01|3 Months|Observational [Patient Registry]|LSG||Standarization for Stappler Application During Sleeve Gastrectomy|Implication and Factors Influencing the Decision to Select Srapplers During Laparoscopic Sleeve Gastrectomy.|Completed||N/A|100|Actual|Assuta Medical Center|||1||f||||f||||||||||2017-10-11 00:44:21.331845|2017-10-11 00:44:21.331845
NCT02068001|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-05-22|||July 2014||2014-07-01|May 2017|2017-05-01||||September 2017|Anticipated|2017-09-01||Observational|Verrukkelijk||Changes in Food Preference and Food Cue Responsivity After Bariatric Surgery|Changes in Food Preference and Food Cue Responsivity After Bariatric Surgery|Active, not recruiting||N/A|100|Anticipated|Wageningen University|||1||f||||f||||||||||2017-10-11 00:44:21.383668|2017-10-11 00:44:21.383668
NCT02067988|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-10-26|||February 2014||2014-02-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|HEPAR_Plus||Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study|Adjuvant Hepatic Holmium-166-radioembolization in Patients With Unresectable Liver Metastases of Neuroendocrine Origin, Who Have Been Treated With Lutetium-177-dotatate|Recruiting||Phase 2|48|Anticipated|UMC Utrecht||1|||f||||t||||||||Undecided|Undecided|2017-10-11 00:44:21.457438|2017-10-11 00:44:21.457438
NCT02067975|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-05-15|||September 2014||2014-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Tryptophan MRI in People With Schizophrenia and Healthy Controls|Neuroimaging of Tryptophan Challenge in People With Schizophrenia and Healthy Controls|Recruiting||Phase 2/Phase 3|50|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-11 00:44:21.550121|2017-10-11 00:44:21.550121
NCT02067949|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-19|2015-04-03|||February 2014||2014-02-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Clinical and Economic Outcome of Simvastatin in Critically Ill Septic Patient|"The Clinical Outcome and the Cost-effectiveness Analysis of Simvastatin Plus Standard Therapy Versus Standard Therapy Alone in Critically Ill Septic Patient"|Completed||Phase 3|100|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:44:21.855199|2017-10-11 00:44:21.855199
NCT02067936|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-12-03|||February 2014||2014-02-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Walibi||Walking the Isobole of Drug Interaction|Walking the Isobole of Drug Interaction: Comparison of Hemodynamic Effects, Cerebral and Tissue Oxygenation for 4 Equipotent Combinations of Propofol and Remifentanil|Completed||N/A|87|Actual|University Medical Center Groningen||4|||f||||f||||||||||2017-10-11 00:44:21.958891|2017-10-11 00:44:21.958891
NCT02067923|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-05-17|||February 2014|Actual|2014-02-01|May 2017|2017-05-01|November 17, 2016|Actual|2016-11-17|January 2016|Actual|2016-01-01||Observational|||AbATE Follow-Up Study|ITN0127AI Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes (AbATE) Follow-Up Study|Completed||N/A|44|Actual|Yale University|||2||f||||f||||||Samples With DNA|"     blood urine   "|||2017-10-11 00:44:22.0926|2017-10-11 00:44:22.0926
NCT02067910|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-10-24|||August 2014||2014-08-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|ASAPIII||Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome|Randomized, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome (ASAP III Study = Abatacept Sjögren Active Patients Phase III Study)|Recruiting||Phase 3|88|Anticipated|University Medical Center Groningen||2|||f||||t||||||||||2017-10-11 00:44:22.171692|2017-10-11 00:44:22.171692
NCT02067897|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-11-11|||April 2014||2014-04-01|November 2014|2014-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|NAILTEST||Nonrandomized Assessment of Ingrown ToenaiLs Treated by Excision of Skinfold Rather Than Toenail|Nonrandomized Assessment of Ingrown ToenaiLs Treated by Excision of Skinfold Rather Than Toenail (NAILTEST): a Study of the Vandenbos Procedure in Children and Adolescents|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Western University, Canada|||1||f||||f||||||||||2017-10-11 00:44:22.282434|2017-10-11 00:44:22.282434
NCT02067884|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-04-18|||December 19, 2013|Actual|2013-12-19|April 2017|2017-04-01|December 19, 2018|Anticipated|2018-12-19|December 19, 2017|Anticipated|2017-12-19||Interventional|||Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery|Real Time Contrast Enhanced Ultrasound and Ultrasound-Based Elastography: Novel Techniques in Assessment of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer|Recruiting||Phase 1|50|Anticipated|University of Southern California||1|||f||||t|t|t|f|||||||2017-10-11 00:44:22.383741|2017-10-11 00:44:22.383741
NCT02067871|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-18|||March 2012||2012-03-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Treatment of Knee Osteoarthritis: Neuromuscular Electrical Stimulation and Low-level Laser.|Neuromuscular Electrical Stimulation and Low-level Laser: Combined Use for the Treatment of Knee Osteoarthritis in Elderly|Completed||N/A|44|Actual|Federal University of Rio Grande do Sul||3|||f||||f||||||||||2017-10-11 00:44:22.500761|2017-10-11 00:44:22.500761
NCT02067858|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-03-05|||April 2011||2011-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System|An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System|Terminated||N/A|4|Actual|University of Pittsburgh||1||Unable recruit subjects|f||||t||||||||||2017-10-11 00:44:22.614954|2017-10-11 00:44:22.614954
NCT02067845|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-01-04|||February 2014||2014-02-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Group-level Intervention to Reduce HIV/STI Risk for Women Who Have Sex With Women in Calgary and Toronto|Pilot-testing a Group-level Intervention to Reduce Risk for Sexual Transmission of HIV/STIs Among Lesbian, Bisexual and Queer Women and Other Women Who Have Sex With Women in Calgary and Toronto|Completed||N/A|44|Actual|University of Toronto||1|||f||||f||||||||||2017-10-11 00:44:22.700059|2017-10-11 00:44:22.700059
NCT02067832|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-04-07|||August 2013||2013-08-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Observational|ABLE-cGVHD||Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease|Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team) - Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease|Active, not recruiting||N/A|300|Anticipated|University of British Columbia|||1||f||||f||||||Samples With DNA|"     From recipient: whole blood From donor: bone marrow or apheresis product   "|||2017-10-11 00:44:22.792333|2017-10-11 00:44:22.792333
NCT02067819|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-06-02|||March 2014||2014-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome|Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome|Active, not recruiting||N/A|24|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-11 00:44:22.910124|2017-10-11 00:44:22.910124
NCT02067806|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-01-19|||November 2013||2013-11-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01|7 Days|Observational [Patient Registry]|PASS||Observational Prospective Study on 2-chloroprocaine Hydrochloride 1% Safety in Intrathecal Anaesthesia|OBSERVATIONAL PROSPECTIVE STUDY ON 2-CHLOROPROCAINE HYDROCHLORIDE 1% SAFETY IN INTRATHECAL ANAESTHESIA|Completed||N/A|394|Actual|Sintetica SA|||1||f||||f||||||||||2017-10-11 00:44:23.006518|2017-10-11 00:44:23.006518
NCT02067793|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-02-18||2016-02-18|March 2014||2014-03-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder|Phase 2, Randomized, Double-Blind, Multiple-Dose Level, Placebo Controlled, Single Intravenous Dose, Parallel Efficacy and Safety Study of NRX-1074 in Subjects With Major Depressive Disorder|Completed||Phase 2|151|Actual|Naurex, Inc||4|||f||||f||||||||||2017-10-11 00:44:23.090919|2017-10-11 00:44:23.090919
NCT02067780|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-06-17|||September 2013||2013-09-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|AECOPD||Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD|Evaluation of Two Strategies of Antibiotic Treatment With Levofloxacin in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Short Treatment-versus Treatment Guided by Markers of Inflammation|Recruiting||Phase 2|300|Anticipated|University of Monastir||3|||f||||t||||||||Undecided||2017-10-11 00:44:23.220798|2017-10-11 00:44:23.220798
NCT02067767|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-02-19|||February 2014||2014-02-01|February 2015|2015-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SWAD||Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)|Phase 2 Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults|Completed||Phase 2|53|Actual|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 00:44:23.323399|2017-10-11 00:44:23.323399
NCT02067754|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-04-25|||September 11, 2013|Actual|2013-09-11|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer|Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer|Recruiting||N/A|400|Anticipated|Samsung Medical Center|||1||f||||t||||||Samples With DNA|"     -  From each enrolled patient who meets the inclusion/exclusion criteria, blood samples          will be collected 10 mL blood sample will be collected at the baseline and every cycles          of tumor evaluation.        -  20 of 5µm unstained sections will be collected at the time of study entry.   "|||2017-10-11 00:44:23.42358|2017-10-11 00:44:23.42358
NCT02067741|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-07-13|||May 2016||2016-05-01|July 2017|2017-07-01|June 2027|Anticipated|2027-06-01|December 2018|Anticipated|2018-12-01||Interventional|||CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer|A Stratified, Multicenter Phase II Trial of Transdermal CR1447 (4-OH-testosterone) in Endocrine Responsive-HER2 Negative and Triple Negative-androgen Receptor Positive Metastatic or Locally Advanced Breast Cancer|Recruiting||Phase 2|90|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||||2017-10-11 00:44:23.524456|2017-10-11 00:44:23.524456
NCT02067728|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2016-02-22|2015-11-19||February 2014||2014-02-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|FNPA||Family Nutrition Physical Activity Tool Use During Well Child Visits|Family Nutrition, Physical Activity (FNPA) Tool: a Motivational Interviewing-based Practice Intervention to Address Pediatric Health Behaviors|Completed||N/A|430|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-11 00:44:23.704351|2017-10-11 00:44:23.704351
NCT02067715|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2015-05-29|||February 2014||2014-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effectiveness of Sealed In-office Bleaching Technique: Randomized Controlled Clinical Trial|Effectiveness of Sealed In-office Bleaching Technique: Randomized Controlled Clinical Trial|Completed||N/A|46|Actual|Universidade Federal de Sergipe||2|||f||||f||||||||||2017-10-11 00:44:24.213881|2017-10-11 00:44:24.213881
NCT02067702|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-07-03|||October 2014||2014-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Limb Cooling in Essential Tremor|Effects of Limb Cooling on Essential Tremor.|Active, not recruiting||N/A|27|Actual|University of Florida|||2||f||||t||||||||||2017-10-11 00:44:24.285751|2017-10-11 00:44:24.285751
NCT02067689|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-08-07|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|CogStim||Cognitive Stimulation Study|Neuromodulation of Cognitive Function Using Transcranial Direct Current Stimulation|Recruiting||N/A|300|Anticipated|University of Florida|||6||f||||f|f|f||||||||2017-10-11 00:44:24.364667|2017-10-11 00:44:24.364667
NCT02067663|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-10-08|||April 2014||2014-04-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study|Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study|Completed||N/A|123|Actual|University of Colorado, Denver|||2||f||||f||||||||||2017-10-11 00:44:24.555826|2017-10-11 00:44:24.555826
NCT02067650|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-01-26|||September 2013||2013-09-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Observational|||Ultrasound Findings of Finger, Wrist and Knee Joints in Mucopolysaccharidosis|Ultrasound Findings of Finger, Wrist and Knee Joints in Mucopolysaccharidosis|Enrolling by invitation||N/A|30|Anticipated|Children's Hospital of Eastern Ontario|||1||f||||f||||||||||2017-10-11 00:44:24.664124|2017-10-11 00:44:24.664124
NCT02067637|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-04-03|||March 2014|Actual|2014-03-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|DETECS||Delayed Effects of Treatment in Cancer Survivors (DETECS)|Delayed Effects of Treatment in Cancer Survivors (DETECS)|Withdrawn||N/A|0|Actual|University of Colorado, Denver|||2|Low accrual|f||||f||||||Samples Without DNA|"     Blood and urine   "|No||2017-10-11 00:44:24.78775|2017-10-11 00:44:24.78775
NCT02067624|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-05-05|||February 2014||2014-02-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Thai Massage on Patients With Wrist Extensor Muscles Latent Myofascial Trigger Points|Effects of Thai Massage on Patients With Wrist Extensor Muscles Latent Myofascial Trigger Points|Completed||N/A|62|Actual|Mae Fah Luang University Hospital||2|||f||||t||||||||||2017-10-11 00:44:24.876178|2017-10-11 00:44:24.876178
NCT02067611|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-03-10|||February 2014||2014-02-01|May 2015|2015-05-01|April 2016|Actual|2016-04-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis|A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis|Completed||Phase 2|217|Actual|Techfields Pharma Co. Ltd||2|||f||||t||||||||No||2017-10-11 00:44:24.950163|2017-10-11 00:44:24.950163
NCT02067598|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-05-05|||January 2014||2014-01-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Scapular Exercise on Patients With Scapulocostal Syndrome|Effects of Scapular Exercise on Patients With Scapulocostal Syndrome|Completed||N/A|36|Actual|Mae Fah Luang University Hospital||2|||f||||t||||||||||2017-10-11 00:44:25.087529|2017-10-11 00:44:25.087529
NCT02067585|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-02-28|2017-01-09||February 2010||2010-02-01|February 2017|2017-02-01|September 2012|Actual|2012-09-01|August 2011|Actual|2011-08-01||Interventional|||An Analysis of Lipid and Glucose Metabolism Following Bariatric Surgery|An Analysis of Lipid and Glucose Metabolism Following Bariatric Surgery|Completed||N/A|48|Actual|University of Alberta||3|||f||||f||||||||||2017-10-11 00:44:25.172714|2017-10-11 00:44:25.172714
NCT02067572|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-02-17|||March 12, 2014|Actual|2014-03-12|February 2017|2017-02-01|September 8, 2016|Actual|2016-09-08|September 8, 2016|Actual|2016-09-08||Interventional|||A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care|A Comparison of the Effectiveness of Normal Saline Mouthwash and Mouthwash Based on Tea Solution From Salvia Officinalis (SO) in Palliative Care. A Randomized Controlled Trial|Completed||N/A|88|Actual|Lovisenberg Diakonale Hospital||2|||f||||f|f|f||||||||2017-10-11 00:44:27.569887|2017-10-11 00:44:27.569887
NCT02067559|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-05-03|||March 2014||2014-03-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Preventing Post-traumatic Stress in ICU Survivors: A Pilot Randomized Controlled Trial of ICU Diaries|Preventing Post-traumatic Stress in ICU Survivors: A Pilot Randomized Controlled Trial of ICU Diaries|Completed||N/A|59|Actual|University of Manitoba||4|||f||||f||||||||||2017-10-11 00:44:27.69426|2017-10-11 00:44:27.69426
NCT02067546|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-18|||March 2014||2014-03-01|February 2014|2014-02-01||||December 2015|Anticipated|2015-12-01||Interventional|constipation||Innovative Toilet Seat Test for Patients With Symptoms of Constipation and/or Emptying Disorders|Innovative Toilet Seat Test for Patients With Symptoms of Constipation and/or Emptying Disorders|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 00:44:27.786873|2017-10-11 00:44:27.786873
NCT02067533|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-05-08|2014-12-25|||||May 2015|2015-05-01||||April 2014|Actual|2014-04-01||Interventional|||Flexion Versus Extension Soft Tissue Repair in Total Knee Arthroplasty||Completed||N/A|91|Actual|Isfahan University of Medical Sciences||2|||f||||||||||||||2017-10-11 00:44:27.873758|2017-10-11 00:44:27.873758
NCT02067507|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-11-04|||June 2012||2012-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County|Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County|Enrolling by invitation||N/A|120000|Anticipated|University of California, Los Angeles||4|||f||||f||||||||No||2017-10-11 00:44:28.171807|2017-10-11 00:44:28.171807
NCT02067494|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-03-04|||February 2014||2014-02-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|I||Myofascial Release and Kinesio Taping on Autonomic Nervous System in Low Back Pain|Myofascial Release and Kinesiotaping on Disability, Pain, Automic Nervous System and Oxidative Stress Indicators in Chronic Low Back Pain: A Randomized Controlled Clinical Trial|Completed||N/A|64|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-11 00:44:28.275349|2017-10-11 00:44:28.275349
NCT02067481|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2014-02-19|||March 2013||2013-03-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|PREDICOP-F||Effect of a Diet and Physical Activity Intervention in Breast Cancer Survivors|Effect of a Diet and Physical Activity Intervention on Body Weight and Nutritional Patterns in Overweight and Obese Breast Cancer Survivors|Completed||Phase 2|42|Actual|Institut Català d'Oncologia||1|||f||||f||||||||||2017-10-11 00:44:28.371227|2017-10-11 00:44:28.371227
NCT02067468|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-06-03|||January 2011||2011-01-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ASCUS-COL||Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia|Evaluation of Strategies for Optimal Clinical Management of Women With Atypical Squamous Cells of Undetermined Significance (ASC-US)|Completed||N/A|3000|Actual|Universidad de Antioquia||3|||f||||f||||||||||2017-10-11 00:44:28.457998|2017-10-11 00:44:28.457998
NCT02067455|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-03-31|||February 2014||2014-02-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|REVADE||REVADE : Right Ventricular Function and Exercise in Left Ventricular Assist Device Patients : Echocardiographic Study|This is a Non-randomized, Single-center, Prospective Investigation on Exercise Capacities of Left Ventricular Assist Devices Recipients|Completed||N/A|12|Actual|Rennes University Hospital||1|||f||||t||||||||||2017-10-11 00:44:28.720444|2017-10-11 00:44:28.720444
NCT02067442|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-03-17|||August 2013||2013-08-01|March 2015|2015-03-01||||July 2015|Anticipated|2015-07-01||Interventional|||Prospective, Randomized, Double Blind Study Comparing IV vs PO Acetaminophen in Patients Undergoing Lumbar Discectomy|Prospective, Randomized, Double-blind, Placebo-Controlled Study to Compare the Effects of Intravenous Versus Oral Acetaminophen on Postoperative Clinical Outcomes After Ambulatory Lumbar Discectomy|Unknown status|Recruiting|N/A|100|Anticipated|Thomas Jefferson University||2|||f||||f||||||||||2017-10-11 00:44:28.840951|2017-10-11 00:44:28.840951
NCT02067429|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-11-27|||June 2014||2014-06-01|November 2014|2014-11-01||||December 2015|Anticipated|2015-12-01||Interventional|||Limbal Relaxing Incision Versus Toric Intraocular Lens for Corneal Astigmatism During Cataract Surgery.|Limbal Relaxing Incisions Versus Toric Intraocular Lens for Keratometric Astigmatism <2.5 Diopters in Patients Undergoing Cataract Surgery and Intraocular Lens Implantation.|Unknown status|Recruiting|N/A|80|Anticipated|Sussex Eye Hospital||2|||f||||t||||||||||2017-10-11 00:44:28.930772|2017-10-11 00:44:28.930772
NCT02067416|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-09-12|||July 2012||2012-07-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer|Prospective Study To Validate The Predictive Value Of Mammostrat Score, DDR Score And TLE3 Gene When A Taxane-Based Chemo Agents Or Anthracycline-Based Chemo Agent Is Used In The Neo-Adjuvant Setting|Terminated||Phase 2|12|Actual|The Methodist Hospital System||2||Funding agent withdrew funding|f||||f||||||||No||2017-10-11 00:44:29.030104|2017-10-11 00:44:29.030104
NCT02067403|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-05-21|||March 2014||2014-03-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Diaphragmatic Electrical Activity Based Optimization Strategy During Pressure Support Ventilation|A Diaphragmatic Electrical Activity Based Optimization Strategy During Pressure Support Ventilation. Effects on Work of Breathing, Patient-ventilator Synchrony and Comparison With Neurally Adjusted Ventilatory Assist|Completed||N/A|16|Actual|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-11 00:44:29.126359|2017-10-11 00:44:29.126359
NCT02067390|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-03-21|||September 2013||2013-09-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Urinary KIM-1 After Vancomycin or Linezolid Administration|Novel Urinary Biomarkers in the Detection of Vancomycin Associated Renal Injury|Recruiting||N/A|40|Anticipated|Midwestern University|||2||f||||f||||||Samples Without DNA|"     urine   "|Undecided||2017-10-11 00:44:29.212375|2017-10-11 00:44:29.212375
NCT02067377|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-09-01|||December 2013||2013-12-01|August 2013|2013-08-01||||April 2016|Actual|2016-04-01||Interventional|SBI for COPD||Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD|A Randomized, Double Blinded, Placebo-controlled Pilot Study of Serum Bovine Immunoglobulin (SBI) for Cachexia in Patients With Advanced COPD|Completed||N/A|12|Actual|Medical University of South Carolina||3|||f||||f||||||||||2017-10-11 00:44:29.293701|2017-10-11 00:44:29.293701
NCT02067364|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-06-22|||January 2014||2014-01-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||"CRT ShuntCheck Fit & Function Study"|"CRT ShuntCheck Fit & Function Exploratory Study"|Unknown status|Recruiting|N/A|20|Anticipated|NeuroDx Development||1|||f||||t||||||||||2017-10-11 00:44:29.38624|2017-10-11 00:44:29.38624
NCT02067351|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2015-04-06|||April 2014||2014-04-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy|Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:44:29.492248|2017-10-11 00:44:29.492248
NCT02067338|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-02-18|||August 2012||2012-08-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Epidural Low Dose Morphine in Postoperative Pain After Posterior Lumbar Spinal Surgery|The Effect of Epidural Low-dose Morphine-soaked Microfibrillar Collagen Sponge in Postoperative Pain Control After Posterior Lumbar Spinal Surgery: a Randomized, Double-blind, Placebo-controlled|Completed||Phase 4|19|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 00:44:29.570103|2017-10-11 00:44:29.570103
NCT02067325|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-05-05|||February 2014||2014-02-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Thai Massage on EMG|Effects of Thai Massage on EMG|Completed||N/A|50|Actual|Mae Fah Luang University Hospital||2|||f||||t||||||||||2017-10-11 00:44:29.64242|2017-10-11 00:44:29.64242
NCT02067312|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-05-05|||February 2014||2014-02-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Traditional Thai Massage on Pain and Pain Related Parameters in Patients With Upper Back Pain|Effects of Traditional Thai Massage on Pain and Pain Related Parameters in Patients With Upper Back Pain|Completed||N/A|50|Actual|Mae Fah Luang University Hospital||2|||f||||t||||||||||2017-10-11 00:44:29.710193|2017-10-11 00:44:29.710193
NCT02067299|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-02-03|||February 2014||2014-02-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants|A Single Dose, 4-way Crossover, Placebo-controlled, Randomized Study to Investigate the Effect of JNJ-42847922 on Polysomnography (PSG) Measures in Subjects With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants|Completed||Phase 1|20|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-11 00:44:29.78554|2017-10-11 00:44:29.78554
NCT02067286|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-08-30|||January 2014||2014-01-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer|Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV|Completed||N/A|1642|Actual|IQuum, Inc.|||1||f||||f||||||Samples Without DNA|"     Nasopharyngeal swabs   "|No||2017-10-11 00:44:29.90298|2017-10-11 00:44:29.90298
NCT02067273|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-05-11|2017-04-03||February 2014||2014-02-01|May 2017|2017-05-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Transcranial Magnetic Stimulation (TMS) for CRPS|Transcranial Magnetic Stimulation for CRPS|Completed||N/A|20|Actual|Stanford University||2|||f||||||||||||||2017-10-11 00:44:29.982211|2017-10-11 00:44:29.982211
NCT02067260|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-18||||||February 2014|2014-02-01||||April 2010|Actual|2010-04-01||Interventional|||A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males|A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males|Completed||N/A|||Spencer Forrest, Inc.||2|||f||||f||||||||||2017-10-11 00:44:30.335885|2017-10-11 00:44:30.335885
NCT02067247|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-11-18|||February 2014||2014-02-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Comparison of BMD Measurement by DEXA to BeamMed Speed-of-Sound Measurement at Forearm in Patients With Gaucher Disease|Comparison of BMD Measurements by Dual Energy X-Ray Absorptiometry and Multiple Sites to BeamMed Speed-of-Sound Measurements at the Forearm in Patients With Gaucher Disease|Completed||N/A|100|Actual|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-10-11 00:44:30.413324|2017-10-11 00:44:30.413324
NCT02067234|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-05-18|||January 2015||2015-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families|A Multi-Disciplinary Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families: A Pilot Study|Withdrawn||N/A|0|Actual|Seton Healthcare Family||2||PI left institution; project closed.|f||||t||||||||||2017-10-11 00:44:30.484062|2017-10-11 00:44:30.484062
NCT02067221|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-06-21|||May 2013||2013-05-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Comparison of Surgical Outcomes Between MPCNL and RIRS|Comparison of Surgical Outcomes in the Treatment of Renal Stones Larger Than 1 Centimeters Between MPCNL and RIRS: a Single-center, Randomized, Prospective Study|Completed||N/A|70|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:44:30.606161|2017-10-11 00:44:30.606161
NCT02067208|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-11-30|||October 2014||2014-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Wedged Insoles for Management of Knee Osteoarthritis|Reduced Knee Joint Loading With Lateral and Medial Wedge Insoles for Management of Knee Osteoarthritis: a Randomized Controlled Trial|Completed||N/A|48|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 00:44:30.764181|2017-10-11 00:44:30.764181
NCT02067195|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2015-08-20|||July 2014||2014-07-01|August 2015|2015-08-01|July 2017|Anticipated|2017-07-01|March 2016|Anticipated|2016-03-01||Interventional|ATTEMPT||Aggressive hydraTion in Patients With ST -Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to prevenT Contrast-Induced Nephropathy|Aggressive Hydration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to Prevent Contrast-Induced Nephropathy, A Randomized, Controlled Trial REduction of riSk of Contrast-Induced Nephropathy followINg carDiac Catheterization 1|Unknown status|Recruiting|N/A|560|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-10-11 00:44:30.870415|2017-10-11 00:44:30.870415
NCT02067182|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-05-10|||August 2015||2015-08-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|ODIn-AF||Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation|Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation|Recruiting||Phase 4|630|Anticipated|University Hospital, Bonn||2|||f||||t||||||||||2017-10-11 00:44:30.990911|2017-10-11 00:44:30.990911
NCT02067169|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-05-30|||January 2012||2012-01-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2016|Actual|2016-05-01||Observational|ORPHAVIC||A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era.|A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. Survey of Pharmacological and Virological Resistance of Cytomegalovirus to Antiviral Therapy in Transplantation.|Active, not recruiting||N/A|408|Actual|University Hospital, Limoges|||1||f||||f||||||Samples Without DNA|"     Detection of the CMV in sang, the leukocytes, or plasma with or without the viral     quantification and/or the sample of urine of saliva or tissues, positive for research of CMV.   "|||2017-10-11 00:44:31.201875|2017-10-11 00:44:31.201875
NCT02067156|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2017-02-22|||February 2014||2014-02-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma|An Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma|Completed||Phase 2|26|Actual|GenSpera, Inc.||1|||f||||f||||||||||2017-10-11 00:44:31.388411|2017-10-11 00:44:31.388411
NCT02067143|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-08-31|||May 20, 2014|Actual|2014-05-20|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 7, 2016|Actual|2016-10-07||Interventional|||MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate|National Treatment Program of Philadelphia Chromosome-negative Adult Acute Lymphoblastic Leukemia With Pegylated Asparaginase Added to a Lineage-Targeted Risk- and Minimal Residual Disease-Oriented Strategy|Active, not recruiting||Phase 2|204|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-11 00:44:31.491109|2017-10-11 00:44:31.491109
NCT02067130|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-01-13|||October 2013||2013-10-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Utility of Fibroscan in Estimating Hepatic Iron Concentration|Utility of Transient Elastography (Fibroscan) in Estimating Hepatic Iron Concentration in Comparison to MRI in Patients With Transfusion Dependent Hemoglobinopathies|Active, not recruiting||N/A|30|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 00:44:31.754307|2017-10-11 00:44:31.754307
NCT02067117|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-02-18|||October 2010||2010-10-01|February 2014|2014-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.||Completed||Phase 4|1139|Actual|Green Cross Corporation||1|||f||||f||||||||||2017-10-11 00:44:31.829167|2017-10-11 00:44:31.829167
NCT02067104|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-05-24|||February 2014||2014-02-01|May 2016|2016-05-01||||January 2016|Actual|2016-01-01||Interventional|||Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention|A Placebo Controlled Double-Blind Study to Evaluate the Efficacy of Vismodegib as Chemoprevention of New Bcc Development in High Risk Subjects|Completed||Phase 2|10|Actual|University of Arizona||2|||f||||t||||||||||2017-10-11 00:44:31.917216|2017-10-11 00:44:31.917216
NCT02067091|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-05-26|||August 2014||2014-08-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|April 2018|Anticipated|2018-04-01||Interventional|BVS in STEMI||Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct|Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI)|Active, not recruiting||Phase 3|120|Anticipated|Haukeland University Hospital||2|||f||||t||||||||Undecided||2017-10-11 00:44:31.997083|2017-10-11 00:44:31.997083
NCT02067078|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2015-02-03|||February 2014||2014-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Hobsali||Protracted Effect of Combined Nerve Blocks After Total Knee Arthroplasty|The Effect of Protracted Saphenous Nerve and Obturator Nerve Block Versus Saphenous Nerve Block Versus Local Infiltration Analgesia on Opioid Consumption, Pain, Block Duration of Action and Mobilization After Total Knee Arthroplasty.|Completed||Phase 4|75|Actual|Regionshospitalet Silkeborg||3|||f||||t||||||||||2017-10-11 00:44:32.103105|2017-10-11 00:44:32.103105
NCT02067065|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2015-10-08|||January 2014||2014-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Non-anesthesiologist Administered Propofol Sedation for Colonoscopy - a Randomized Clinical Trial|Non-anesthesiologist Administered Propofol Sedation for Colonoscopy - a Randomized Clinical Trial|Completed||N/A|277|Actual|Hospital Beatriz Ângelo||2|||f||||t||||||||||2017-10-11 00:44:32.206481|2017-10-11 00:44:32.206481
NCT02067052|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-09-12|||July 2012||2012-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||New Strategy for the Treatment of Vulvar Cancer|New Strategy for the Treatment of Vulvar Cancer Employing Sentinel Scintigraphy, Surgery, Chemotherapy, and Radiotherapy|Recruiting||N/A|21|Anticipated|Instituto do Cancer do Estado de São Paulo|||2||f||||f||||||||||2017-10-11 00:44:32.293091|2017-10-11 00:44:32.293091
NCT02067039|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-02-01|||March 25, 2015|Actual|2015-03-25|April 2016|2016-04-01|October 21, 2016|Actual|2016-10-21|October 21, 2016|Actual|2016-10-21||Interventional|||Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)|Evaluation of Rapid HIV Self-testing Among MSM in High Prevalence Cities|Completed||N/A|2700|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 00:44:32.374042|2017-10-11 00:44:32.374042
NCT02067026|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-08-11|||January 2014||2014-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Measuring the Impact of Dietary Supplementation With a High Fiber, High Antioxidant Aleurone on Biomarkers of Cardiovascular Disease and Gut Microbiota in Adults With High Body Mass Index|Measuring the Impact of Dietary Supplementation With a High Fiber, High Antioxidant Aleurone on Biomarkers of Cardiovascular Disease and Gut Microbiota in Adults With High Body Mass Index|Completed||N/A|75|Actual|Fondazione Edmund Mach||2|||f||||f||||||||||2017-10-11 00:44:32.445211|2017-10-11 00:44:32.445211
NCT02067013|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-02-28|||July 2015||2015-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ARK||Analysis of Aqueous and Vitreous Humor|Analysis of Vitreous and Aqueous Humor for Ocular Growth Factors, Cytokines, Chemokines, and Ranibizumab Pharmacokinetics Associated With Various Retinal Disease|Recruiting||Phase 2|45|Anticipated|California Retina Consultants||2|||f||||f||||||||||2017-10-11 00:44:32.523813|2017-10-11 00:44:32.523813
NCT02066987|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-09-14|||February 2014||2014-02-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Effects of Two Volitional Interventions to Improve Oral Health Behaviour Among Iranian Adolescents|The Effects of Two Volitional Interventions to Improve Oral Health Behaviour Among Iranian Adolescents|Completed||Phase 2|1110|Actual|Qazvin University Of Medical Sciences||3|||f||||||||||||||2017-10-11 00:44:32.675298|2017-10-11 00:44:32.675298
NCT02066974|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-02-03|||January 2014||2014-01-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01|2 Years|Observational [Patient Registry]|||Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy|Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy|Unknown status|Enrolling by invitation|N/A|45|Anticipated|China Medical University, China|||1||f||||f||||||Samples With DNA|"     Fragmented DNA and RNA, Methylation   "|||2017-10-11 00:44:32.75278|2017-10-11 00:44:32.75278
NCT02066961|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-08-01|||December 31, 2013|Actual|2013-12-31|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|ASPIRE-PCa||A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer|A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk for Poor Clinical Outcomes After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-Resistant Prostate Cancer and Men With Metastatic Prostate Cancer at Initial Diagnosis|Active, not recruiting||N/A|1533|Actual|Astellas Pharma Inc|||3||f||||f||||||||||2017-10-11 00:44:32.828559|2017-10-11 00:44:32.828559
NCT02066948|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-05-31|||January 2014||2014-01-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|S38||Meal Patterning on Weight Loss With Changes to Body Comp, Muscle and Metabolic Health|Effects of Dietary Protein Patterning on wt Loss and Resistance Training-induced Changes in Body Comp, Skeletal Muscle, and Indices of Metabolic Syndrome|Completed||N/A|41|Actual|Purdue University||2|||f||||f||||||||||2017-10-11 00:44:33.204747|2017-10-11 00:44:33.204747
NCT02066935|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-09-06|||September 2015||2015-09-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|ADHEREBRAZIL||Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil Multicenter Study|Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil: Diagnosis and Associations - ADHERE BRAZIL Multicenter Study|Recruiting||N/A|1500|Anticipated|Fundação Instituto Mineiro de Estudo Pesquisa Em Nefrologi|||1||f||||f||||||||||2017-10-11 00:44:33.310084|2017-10-11 00:44:33.310084
NCT02066922|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-05-26|2015-05-26||March 2014||2014-03-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||This analysis group includes all randomized participants.|A Comparative Study of Two Daily Disposable Contact Lenses in Higher Myopia Subjects||Completed||N/A|19|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:44:33.449303|2017-10-11 00:44:33.449303
NCT02066909|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-06-23|||February 2014||2014-02-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers|A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Dose Escalation, Parallel Group Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Repeat Doses Of Pf-06649751 In Healthy Western And Japanese Subjects|Completed||Phase 1|77|Actual|Pfizer||9|||f||||f||||||||||2017-10-11 00:44:33.675167|2017-10-11 00:44:33.675167
NCT02066896|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-04-24|2017-02-22||May 2014||2014-05-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome|Low Level Laser Therapy For The Treatment Of Xerostomia In Primary Sjogren`s Syndrome|Completed||N/A|66|Actual|Federal University of São Paulo||2|||f||||f||||||||Undecided||2017-10-11 00:44:33.81405|2017-10-11 00:44:33.81405
NCT02066870|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-03-12|||January 2014||2014-01-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|September 2015|Anticipated|2015-09-01||Interventional|||Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI|Phase I Study of the Combination of Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI|Unknown status|Recruiting|Phase 1|9|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 00:44:34.135739|2017-10-11 00:44:34.135739
NCT02066857|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-05-19|2017-03-31||April 2014||2014-04-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Cast vs. Splints for Minimally Displaced Distal Radius Fractures in the Elderly|Use of Cast Versus Removable Splints for Minimally Displaced Distal Radius Fractures in Elderly Patients: A Prospective, Randomized Trial|Completed||N/A|5|Actual|Emory University|A small number of participants was analyzed due to limited enrollment and completion rates.|2|||f||||f||||||||||2017-10-11 00:44:34.255852|2017-10-11 00:44:34.255852
NCT02066818|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-02-18|||January 2008||2008-01-01|February 2014|2014-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Injectable Lidocaine Versus Lidocaine/Tetracaine Patch for the Incision and Drainage of Skin Abscesses|Injectable Lidocaine Provides Similar Analgesia Compared to Transdermal Lidocaine/Tetracaine Patch for the Incision and Drainage of Skin Abscesses: A Randomized Controlled Trial|Completed||Early Phase 1|20|Actual|East Carolina University||2|||f||||f||||||||||2017-10-11 00:44:34.848192|2017-10-11 00:44:34.848192
NCT02066805|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-05-27|||January 2014||2014-01-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark|Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark|Completed||N/A|142|Actual|Amgen|||1||f||||f||||||||||2017-10-11 00:44:34.913934|2017-10-11 00:44:34.913934
NCT02066792|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-09-05|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder|Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder|Recruiting||Early Phase 1|156|Anticipated|University of Texas at Austin||4|||f||||t||||||||||2017-10-11 00:44:34.981567|2017-10-11 00:44:34.981567
NCT02066766|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-12-06|||April 2015||2015-04-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|DiabCare Asia||A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka and Vietnam|A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka and Vietnam|Completed||N/A|1631|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 00:44:35.113824|2017-10-11 00:44:35.113824
NCT02066753|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-11-24|||February 2013||2013-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Cardiac Effects of Prolonged Hypothermia After Cardiac Arrest|The Cardiac Effects of Prolonged Hypothermia After Cardiac Arrest|Completed||N/A|100|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:44:35.199117|2017-10-11 00:44:35.199117
NCT02066740|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2015-08-14|2015-08-07||February 2014||2014-02-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study|EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study|Completed||Phase 4|34|Actual|Medtronic Endovascular||1|||f||||f||||||||||2017-10-11 00:44:35.284691|2017-10-11 00:44:35.284691
NCT02066727|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-12-11|2014-11-18||February 2014||2014-02-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|ONB||Lidocaine Combined Dexmedetomidine for Obturator Nerve Block|Effects of Dexmedetomidine as an Adjuvant on the Median Effective Concentration of Lidocaine for Obturator Nerve Block — A Perspective, Randomized，Blind Study|Completed||N/A|60|Actual|Tianjin Medical University General Hospital||2|||f||||||||||||||2017-10-11 00:44:35.459964|2017-10-11 00:44:35.459964
NCT02066714|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-10-02|||June 2013||2013-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|December 2014|Actual|2014-12-01||Observational|08RS||Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam|A Prospective Cohort Study Evaluating Prognostic Indicators and Sequelae Following Severe Hand Foot and Mouth Disease|Completed||N/A|243|Actual|Oxford University Clinical Research Unit, Vietnam|||2||f||||f||||||||||2017-10-11 00:44:35.69178|2017-10-11 00:44:35.69178
NCT02066701|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-08-01|||May 2012||2012-05-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers|Utility of Aberrant Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers|Completed||N/A|250|Actual|Mayo Clinic|||2||f||||f||||||Samples With DNA|"     Tissue and cytology brushes will be stored for the duration of the study   "|||2017-10-11 00:44:35.758687|2017-10-11 00:44:35.758687
NCT02066688|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-18|||January 2013||2013-01-01|February 2014|2014-02-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer|A Randomize Controlled Trial of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer|Recruiting||Phase 2/Phase 3|2400|Anticipated|Shanghai Jiao Tong University School of Medicine||4|||f||||t||||||||||2017-10-11 00:44:35.818388|2017-10-11 00:44:35.818388
NCT02066675|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-08-22|||February 2014||2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Interventional|TR1US||Trabectedin First Line Therapy In Unfit Sarcoma Study|SAFETY AND ACTIVITY OF TRABECTEDIN AS FIRST LINE IN ADVANCED SOFT TISSUE SARCOMA (STS) PATIENTS UNFIT TO RECEIVE STANDARD CHEMOTHERAPY: A PROSPECTIVE PHASE II STUDY WITH CLINICAL AND MOLECULAR CORRELATES|Active, not recruiting||Phase 2|24|Actual|Italian Sarcoma Group||1|||f||||t||||||||||2017-10-11 00:44:35.911861|2017-10-11 00:44:35.911861
NCT02066662|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-08-21|||July 2013||2013-07-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification|Influence of Rivaroxaban Compared to Vitamin K Antagonist Treatment Upon Development of Cardiovascular Calcification in Patients With Atrial Fibrillation and/ or Pulmonary Embolism (IRIVASC- Trial)|Recruiting||Phase 4|253|Anticipated|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 00:44:36.1207|2017-10-11 00:44:36.1207
NCT02066649|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-11-14|||February 2017||2017-02-01|November 2016|2016-11-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding|A Phase 3 Study of Carvedilol vs Variceal Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding|Withdrawn||Phase 3|0|Actual|Rutgers, The State University of New Jersey||3|||f||||f||||||||||2017-10-11 00:44:36.239436|2017-10-11 00:44:36.239436
NCT02066636|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-09-05|||February 28, 2014|Actual|2014-02-28|September 2017|2017-09-01|January 31, 2022|Anticipated|2022-01-31|January 31, 2022|Anticipated|2022-01-31||Interventional|CheckMate153||A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen|A Phase IIIb/IV Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen|Active, not recruiting||Phase 3|1380|Anticipated|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:44:36.368677|2017-10-11 00:44:36.368677
NCT02066623|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-06-26|||November 2013||2013-11-01|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01|5 Years|Observational [Patient Registry]|GABI-R||Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffold|German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis|Recruiting||N/A|4000|Anticipated|IHF GmbH - Institut für Herzinfarktforschung|||1||f||||f||||||||||2017-10-11 00:44:36.711334|2017-10-11 00:44:36.711334
NCT02066610|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-18|||March 1991||1991-03-01|February 2014|2014-02-01|June 1993|Actual|1993-06-01|June 1993|Actual|1993-06-01||Interventional|||Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amino Acid Metabolism in Infants|Effect of Parenteral and Enteral Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amino Acid Metabolism in Low Birth Weight Infants|Completed||N/A|47|Actual|Abbott Nutrition||4|||f||||f||||||||||2017-10-11 00:44:37.028201|2017-10-11 00:44:37.028201
NCT02066597|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-04-15|||November 2013||2013-11-01|April 2015|2015-04-01||||December 2014|Actual|2014-12-01||Interventional|SPADE||Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation|Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation|Terminated||Phase 2|26|Actual|Ottawa Hospital Research Institute||1||"Recommendation from the DSMB following recurrent DVT in 3/4 participants who underwent the   thrombectomy procedure."|f||||t||||||||||2017-10-11 00:44:37.111304|2017-10-11 00:44:37.111304
NCT02066584|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2014-02-18|||April 2014||2014-04-01|February 2014|2014-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||The Influence of Different Concentrations of Glucose in Culture Media on In Vitro Fertilization (IVF) Outcome of Sibling Oocytes|The Influence of Different Concentrations of Glucose in Culture Media on In Vitro Fertilization Outcome of Sibling Oocytes|Unknown status|Not yet recruiting|N/A|600|Anticipated|Hillel Yaffe Medical Center|||4||f||||f||||||||||2017-10-11 00:44:37.181285|2017-10-11 00:44:37.181285
NCT02066571|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2016-11-02|||March 2015||2015-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease|A Phase II, Double-Blind, Placebo-Controlled, Crossover Study to Assess Clinical Benefit and Safety of Droxidopa in the Treatment of Parkinson's Disease|Enrolling by invitation||Phase 2|20|Anticipated|Henry Ford Health System||2|||f||||t||||||||||2017-10-11 00:44:37.25667|2017-10-11 00:44:37.25667
NCT02066558|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-02-11|||February 2014||2014-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Carbon Monoxide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow|Basic Research on Carbon Monoxide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow in a Humane Experimental Headache Model|Completed||N/A|12|Actual|Danish Headache Center||2|||f||||f||||||||||2017-10-11 00:44:37.34939|2017-10-11 00:44:37.34939
NCT02066545|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2015-09-01||2015-08-13|April 2014||2014-04-01|September 2015|2015-09-01||||November 2014|Actual|2014-11-01||Interventional|||Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris|A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects With Acne Vulgaris|Completed||Phase 2|327|Actual|Cutanea Life Sciences, Inc.||4|||f||||||||||||||2017-10-11 00:44:37.432159|2017-10-11 00:44:37.432159
NCT02066532|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-18|2017-05-18|||June 2014||2014-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer|Phase I/II Trial of Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Columbia University||1|||f||||t|t|f||||||Undecided||2017-10-11 00:44:37.544689|2017-10-11 00:44:37.544689
NCT02066519|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-05-14|||October 2014|Actual|2014-10-01|May 2017|2017-05-01|July 3, 2019|Anticipated|2019-07-03|October 3, 2018|Anticipated|2018-10-03||Interventional|MGEX||Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis|Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis|Recruiting||N/A|42|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:44:37.675804|2017-10-11 00:44:37.675804
NCT02066506|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-03-31|||February 2011||2011-02-01|August 2012|2012-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|STARS||Study of Adaptation of the Right Ventricle to Systemic Afterload|Study of Adaptation of the Right Ventricle to Systemic Afterload|Completed||N/A|90|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 00:44:37.765134|2017-10-11 00:44:37.765134
NCT02066493|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-18|||December 2008||2008-12-01|February 2014|2014-02-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01|5 Years|Observational [Patient Registry]|||Giant Intracranial Aneurysm Registry|Giant Intracranial Aneurysm Registry|Unknown status|Recruiting|N/A|105|Anticipated|Charite University, Berlin, Germany|||1||f||||t||||||||||2017-10-11 00:44:37.856128|2017-10-11 00:44:37.856128
NCT02066480|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2015-05-18|||March 2014||2014-03-01|December 2014|2014-12-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Observational|ADOV||Improved Screening for Osteoporosis|Improved Screening for Osteoporosis in Women Between 50 and 80 Years Hospitalized in Hospital Departmental Vendee|Completed||N/A|3226|Actual|Centre Hospitalier Departemental Vendee|||1||f||||f||||||||||2017-10-11 00:44:38.003025|2017-10-11 00:44:38.003025
NCT02066467|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-02-15|||February 2014|Actual|2014-02-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01|12 Months|Observational [Patient Registry]|RallyX4||Maximizing CRT Delivery by Using MultipolAr Coronary Sinus Lead FamiLy ACUITY® X4 - RALLY X4 Study|Maximizing CRT Delivery by Using Multipolar Coronary Sinus Lead Family ACUITY® X4|Completed||N/A|864|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 00:44:38.073886|2017-10-11 00:44:38.073886
NCT02066454|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-12-08|||April 2014||2014-04-01|December 2014|2014-12-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|MYELAXAT||Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs|Evaluation of the Use of an Oral Direct Anti-Xa Anticoagulant, Apixaban, in Prevention of Venous Thromboembolic Disease in Patients Treated With IMiDs During Myeloma : a Pilot Study|Unknown status|Recruiting|Phase 3|105|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 00:44:38.383003|2017-10-11 00:44:38.383003
NCT02066441|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-05-15|||February 2014||2014-02-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Vitamin D's Effect on Physical Performance in the Elderly|The Effect of Vitamin D on Serum Vitamin D Levels, Bone Formation, Resorption, and Mineral Density, Inflammation, Flexibility, and Balance in the Elderly|Completed||N/A|101|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 00:44:38.65134|2017-10-11 00:44:38.65134
NCT02066428|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-02-18|||November 2007||2007-11-01|February 2014|2014-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS‑404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection|A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS‑404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection|Completed||Phase 1|64|Actual|Aeras||8|||f||||t||||||||||2017-10-11 00:44:38.793513|2017-10-11 00:44:38.793513
NCT02066415|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-09-26||2016-09-26|March 2014||2014-03-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Evaluate the Efficacy and Safety of AMG 334 in Chronic Migraine Prevention|Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Patients With Chronic Migraine.|Completed||Phase 2|667|Actual|Amgen||3|||f||||t||||||||||2017-10-11 00:44:38.924845|2017-10-11 00:44:38.924845
NCT02066402|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-05-05|2017-02-15||March 4, 2014|Actual|2014-03-04|May 2017|2017-05-01|April 18, 2016|Actual|2016-04-18|March 6, 2016|Actual|2016-03-06||Interventional|||Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate and Intravenous to Oral 10-Day Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections|Completed||Phase 3|598|Actual|Bayer||2|||f||||f||||||||||2017-10-11 00:44:39.2089|2017-10-11 00:44:39.2089
NCT02066389|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-06-15||2016-06-15|March 2014||2014-03-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate (MTX) in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 With Background Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response to MTX Alone|Completed||Phase 2|300|Actual|AbbVie||6|||f||||f||||||||||2017-10-11 00:44:40.101943|2017-10-11 00:44:40.101943
NCT02066363|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-10-04|||March 1, 2014||2014-03-01|October 2017|2017-10-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Interventional|||Study of Parenteral Nutrition to Patients With Gastrointestinal Cancer|Best Nutritional Care in Cancer Patients. A Comparative Randomized Study of Supplemental Parenteral Nutrition to Patients With GI Cancer Compared to Best Supportive Nutritional Care|Terminated||N/A|47|Actual|Odense University Hospital||2||Recruitment very time consuming, too few wanting participation|f||||t|f|f|||f|||||2017-10-11 00:44:40.348545|2017-10-11 00:44:40.348545
NCT02066350|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-03-15|||January 2014||2014-01-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|Diamant||Cardiovascular Risk Factors After Single Pancreas Transplantation|Assessment of Cardiovascular Risk Factors, Including Endothelial Function, After Restoration of Normoglycemia Following Single Pancreas Transplantation|Completed||N/A|35|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 00:44:40.452682|2017-10-11 00:44:40.452682
NCT02066337|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-02-19|||March 2013||2013-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Ozone Gel on Treatment of Chronic Periodontitis|Effect of Ozone Gel on Alveolar Bone Density and Superoxide Dismutase in Chronic Periodontitis: A Randomized Controlled Clinical Study|Completed||Phase 2|40|Actual|October 6 University||2|||f||||t||||||||||2017-10-11 00:44:40.535288|2017-10-11 00:44:40.535288
NCT02066324|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-03-11|||November 2013||2013-11-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|FOP||Urine Sample Collection From FOP Patients|Urine Sample Collection From Patients With Fibrodysplasia Ossificans Progressiva (FOP) for Biomarker Analysis|Completed||N/A|25|Actual|Novartis|||1||f||||f||||||Samples Without DNA|"     Urine samples   "|||2017-10-11 00:44:40.711742|2017-10-11 00:44:40.711742
NCT02066311|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-07-20|||September 2014||2014-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|NISLE||Nelfinavir in Systemic Lupus Erythematosus|Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial|Recruiting||Phase 2|43|Anticipated|Northwell Health||1|||f||||t||||||||||2017-10-11 00:44:40.781373|2017-10-11 00:44:40.781373
NCT02066298|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-07-25|||July 2014||2014-07-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|SIENA||Steroids In Eosinophil Negative Asthma|Steroids In Eosinophil Negative Asthma|Active, not recruiting||Phase 3|295|Actual|Milton S. Hershey Medical Center||6|||f||||t||||||||||2017-10-11 00:44:40.903416|2017-10-11 00:44:40.903416
NCT02066285|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-10-03|||June 2014||2014-06-01|October 2014|2014-10-01|June 2018|Anticipated|2018-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma|A Phase II Open-Label Trial of Pazopanib Administered as a Single Agent in Patients With Unresectable or Metastatic Solitary Fibrous Tumor (SFT) and Extraskeletal Myxoid Chondrosarcoma (EMC)|Recruiting||Phase 2|70|Anticipated|Grupo Espanol de Investigacion en Sarcomas||1|||f||||f||||||||||2017-10-11 00:44:41.043385|2017-10-11 00:44:41.043385
NCT02066272|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-04-06|||January 2014||2014-01-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01|2 Years|Observational [Patient Registry]|SATIMOS||Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease|Safety of Anti-TNF Antibodies, Including Biosimilars, in Treatment of Inflammatory Bowel Disease: Multicentre Cohort Observational Study (SATIMOS)|Unknown status|Recruiting|N/A|400|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology|||1||f||||t||||||||||2017-10-11 00:44:41.155097|2017-10-11 00:44:41.155097
NCT02066051|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-10-25|2015-10-25||October 2013||2013-10-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD|Intense Pulsed Light (IPL) and Meibomian Gland Expression to Treat Ocular Rosacea Secondary to Inactive Chronic Ocular Graft Versus Host Disease (GVHD)|Completed||N/A|8|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:44:45.312991|2017-10-11 00:44:45.312991
NCT02066259|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-08-04|||August 2014||2014-08-01|August 2014|2014-08-01|March 2018|Anticipated|2018-03-01|March 2016|Anticipated|2016-03-01||Observational|||OctavaColon Cancer Blood Tests OctavaGold and OctavaSilver - Blood Tests for the Help in Diagnosis of Colon Cancer Clinical Study Protocol|OctavaColon Blood Tests OctavaGold and OctavaSilver - Blood Tests for the Help in Diagnosis of Colon Cancer Clinical Study Protocol|Recruiting||N/A|1080|Anticipated|Eventus Diagnostics Ltd|||3||f||||f||||||Samples With DNA|"     Human plasma samples   "|||2017-10-11 00:44:41.257972|2017-10-11 00:44:41.257972
NCT02066246|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-10-08|||August 2013||2013-08-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Lung Function After Robot-assisted Radical Prostate Ectomy|Investigation of the Possible Advantages of the AirSeal-system Compared to Conventional CO2 Insufflation Systems in Terms of Lung Function and Hemodynamics in Robot-assisted Laparoscopic Radical Prostate Ectomy|Completed||N/A|192|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 00:44:41.340759|2017-10-11 00:44:41.340759
NCT02066233|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-06-06|2017-05-01||March 2014||2014-03-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|||Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy|Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy|Completed||N/A|100|Actual|Mayo Clinic||2|||f||||f|f|t|f|f||||No||2017-10-11 00:44:41.434628|2017-10-11 00:44:41.434628
NCT02066220|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-05-05|||June 2014||2014-06-01|May 2017|2017-05-01|April 2024|Anticipated|2024-04-01|April 2024|Anticipated|2024-04-01||Interventional|||International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma|An International Prospective Study on Clinically Standard-risk Medulloblastoma in Children Older Than 3 to 5 Years With Low-risk Biological Profile (PNET 5 MB-LR) or Average-risk Biological Profile (PNET 5 MB-SR)|Recruiting||Phase 2/Phase 3|360|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-11 00:44:41.701702|2017-10-11 00:44:41.701702
NCT02066207|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2017-08-07|||March 18, 2014|Actual|2014-03-18|March 2014|2014-03-01|May 29, 2014|Actual|2014-05-29|April 7, 2014|Actual|2014-04-07||Interventional|||CKD-337 Drug Interaction Study|Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Pharmacokinetic Interaction Between Fenofibrate and Atorvastatin in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Chong Kun Dang Pharmaceutical||3|||f||||f|f|f||||||||2017-10-11 00:44:43.480932|2017-10-11 00:44:43.480932
NCT02066194|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2017-02-16|||February 2014||2014-02-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Electroacupuncture Analgesia for EUS: a Randomized Controlled Trial|Electroacupuncture Analgesia for Endoscopic Ultrasound (EUS): a Prospective, Randomized, Double-blinded, Sham-controlled Study|Completed||Phase 2|128|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 00:44:43.57408|2017-10-11 00:44:43.57408
NCT02066181|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-09-28|||March 21, 2014|Actual|2014-03-21|September 2017|2017-09-01||||January 1, 2019|Anticipated|2019-01-01||Interventional|||Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis|A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF)|Active, not recruiting||Phase 3|83|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 00:44:43.668946|2017-10-11 00:44:43.668946
NCT02066155|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2017-03-24|||January 2013||2013-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Ongoing Diabetes Self-Management Support in Church-Based Settings|Ongoing Diabetes Self-Management Support in Church-Based Settings|Active, not recruiting||N/A|150|Anticipated|University of Michigan||3|||f||||t||||||||No||2017-10-11 00:44:44.367342|2017-10-11 00:44:44.367342
NCT02066142|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-11-30|||December 2012||2012-12-01|November 2015|2015-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|ASTOUND||Tomosynthesis (TS) Versus Ultrasonography (US) in Women With Dense Breast|Tomosynthesis (TS) Versus Ultrasonography (US) in Screening Women With Dense Breast|Recruiting||N/A|4000|Anticipated|University of Genova||2|||f||||f||||||||||2017-10-11 00:44:44.501249|2017-10-11 00:44:44.501249
NCT02066129|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-07-25|||July 2014||2014-07-01|July 2017|2017-07-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|STICS||Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations|Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations|Completed||Phase 3|254|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 00:44:44.64814|2017-10-11 00:44:44.64814
NCT02066116|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-05-17|||November 2014||2014-11-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Kinect-based Upper Limb Rehabilitation System in Stroke Patients|Effect of Kinect-based Upper Limb Rehabilitation System in Patients With Stroke: A Pilot Trial|Suspended||N/A|40|Anticipated|Seoul National University Bundang Hospital||2||enrollment is difficult|f||||f||||||||Undecided||2017-10-11 00:44:44.798306|2017-10-11 00:44:44.798306
NCT02066103|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-07-10|||January 2014||2014-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BROADWAY||Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients|Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients|Completed||N/A|20|Actual|Mercator MedSystems, Inc.||1|||f||||f||||||||||2017-10-11 00:44:44.892303|2017-10-11 00:44:44.892303
NCT02066090|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-03-04|||March 2014||2014-03-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Acupuncture for Obesity on Serum Metabolic Parameters|Effects of Acupuncture on Serum Metabolic Parameters in Pre-menopausal Obese Women: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|120|Anticipated|Kyung Hee University Hospital at Gangdong||2|||f||||f||||||||||2017-10-11 00:44:44.971922|2017-10-11 00:44:44.971922
NCT02066077|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-04-29|||January 2013||2013-01-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy|The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy: A Randomized Clinical Trial And Its Standard Technology Promotion Research|Recruiting||N/A|280|Anticipated|Shanghai Mental Health Center||7|||f||||t||||||||||2017-10-11 00:44:45.124487|2017-10-11 00:44:45.124487
NCT02066064|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-02-11|||November 2013||2013-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist|G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate - Randomized Tandem Study With Different Endoscopist|Completed||N/A|58|Actual|Smart Medical Systems Ltd.||2|||f||||f||||||||||2017-10-11 00:44:45.236198|2017-10-11 00:44:45.236198
NCT02066038|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2014-02-16|||January 2014||2014-01-01|February 2014|2014-02-01|March 2016|Anticipated|2016-03-01|April 2015|Anticipated|2015-04-01||Interventional|||Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation|A Multi-center, Open-labeled Phase 2 Study of First Line Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in ⅢB/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:44:45.499897|2017-10-11 00:44:45.499897
NCT02066025|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-02-17|||March 2014||2014-03-01|February 2014|2014-02-01|March 2018|Anticipated|2018-03-01|March 2016|Anticipated|2016-03-01||Observational|||Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test|Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test|Not yet recruiting||N/A|1425|Anticipated|Eventus Diagnostics Ltd|||3||f||||f||||||Samples With DNA|"     Human plasma samples   "|||2017-10-11 00:44:45.571645|2017-10-11 00:44:45.571645
NCT02066012|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-02-17|||February 2014||2014-02-01|February 2014|2014-02-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Observational|MEPHISTO||MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)|Impact of Dysmetabolic Iron Overload Syndrome on Polarization Capacity of Macrophages|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||3||f||||||||||||||2017-10-11 00:44:45.759003|2017-10-11 00:44:45.759003
NCT02065999|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2017-08-16|||November 2012||2012-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|SEARCH-C||Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients|Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients|Recruiting||N/A|100|Anticipated|Kirby Institute|||1||f||||f||||||Samples With DNA|"     Stored serum and peripheral blood mononuclear cells.   "|||2017-10-11 00:44:45.864238|2017-10-11 00:44:45.864238
NCT02065986|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2017-01-04|||October 2012||2012-10-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|November 2014|Actual|2014-11-01||Interventional|PROUD||Pre-exposure Option for Reducing HIV in the UK.(PROUD)|Pre-exposure Option for Reducing HIV in the UK: an Open-label Randomisation to Immediate or Deferred Daily Truvada for HIV Negative Gay Men.(PROUD)|Completed||Phase 4|544|Actual|Medical Research Council||2|||f||||t||||||||||2017-10-11 00:44:45.950988|2017-10-11 00:44:45.950988
NCT02065973|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2014-02-16|||February 2014||2014-02-01|February 2014|2014-02-01||||September 2014|Anticipated|2014-09-01||Interventional|||An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101|An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101 in Subjects With Cervical Intraepithelial Neoplasia (CIN) and High-risk Human Papillomavirus (HPV) Infection|Unknown status|Enrolling by invitation|Phase 1|18|Anticipated|PDS Biotechnology Corp.||3|||f||||t||||||||||2017-10-11 00:44:46.033518|2017-10-11 00:44:46.033518
NCT02065960|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-03-30|||February 2014||2014-02-01|March 2015|2015-03-01|June 2020|Anticipated|2020-06-01|June 2016|Anticipated|2016-06-01||Interventional|ARTEMIS||Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer|Feasibility Study of the Role of Stereotactic Body Radiotherapy for the Treatment of Early Stage Breast Cancer|Recruiting||Phase 1|32|Anticipated|Juravinski Cancer Center||1|||f||||t||||||||||2017-10-11 00:44:46.113177|2017-10-11 00:44:46.113177
NCT02065947|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-03-06|||October 2013||2013-10-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Interventional|||Three-level Injection Paravertebral Block vs General Anesthesia in Mastectomy|Three-level Injection Paravertebral Block Using Paravertebral Catheter Compared to General Anesthesia in Mastectomy Surgery|Completed||Phase 1/Phase 2|60|Actual|Ramathibodi Hospital||2|||f||||t||||||||||2017-10-11 00:44:46.214989|2017-10-11 00:44:46.214989
NCT02065934|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-07-07|||December 2013||2013-12-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|SIMACRIS||Clinical Audit of Cardio Pulmonary Resuscitation Management in Adults Patient Units of Care by in Situ Simulation|Clinical Audit of Cardio Pulmonary Resuscitation Management in Adults Patient Units of Care by in Situ Simulation|Completed||N/A|22|Actual|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-11 00:44:46.310097|2017-10-11 00:44:46.310097
NCT02065921|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-08-04|||September 2006||2006-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|||Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort|Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort COPD-Management: Eine Klinisch-epidemiologische Verlaufsbeobachtung in Hausarztpraxen|Recruiting||N/A|265|Anticipated|Cantonal Hosptal, Baselland|||1||f||||f||||||||||2017-10-11 00:44:46.395049|2017-10-11 00:44:46.395049
NCT02065908|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2016-12-07|||January 2014||2014-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Observational|||Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer|Circulating microRNAs as a Novel Biomarker of Early Cardiotoxicity in Breast Cancer Patients Treated With Anthracyclines|Completed||N/A|128|Actual|West Pomeranian Cancer Center|||1||f||||f||||||Samples Without DNA|"     5 ml of blood will be collected, 2ml of serum will be isolated from the blood and stored     below -80C till completion of the study.   "|||2017-10-11 00:44:46.476215|2017-10-11 00:44:46.476215
NCT02065882|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-06-02|||March 2013||2013-03-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency|A Prospective, Open-label, Phase I/III Study Investigating Pharmacokinetic Properties of BT524 and Efficacy and Safety of BT524 in the Treatment and Prophylaxis of Bleeding in Patients With Congenital Fibrinogen Deficiency|Recruiting||Phase 2/Phase 3|35|Anticipated|Biotest||1|||f||||f||||||||||2017-10-11 00:44:46.644914|2017-10-11 00:44:46.644914
NCT02065869|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-09-29|||December 2014|Actual|2014-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant|Phase I/II Study of CaspaCIDe T Cells From an HLA-partially Matched Family Donor After Negative Selection of TCR Alpha Beta T Cells in Pediatric Patients Affected by Hematological Disorders|Recruiting||Phase 1/Phase 2|120|Anticipated|Bellicum Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:44:46.755792|2017-10-11 00:44:46.755792
NCT02065856|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-01-13|||December 2013||2013-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|AV-X-02||An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy|An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy|Completed||Phase 2|51|Actual|ALK-Abelló A/S||1|||f||||f||||||||||2017-10-11 00:44:46.906163|2017-10-11 00:44:46.906163
NCT02065843|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2016-10-26|||March 2014||2014-03-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|||Three Anxiolytic Drugs Used in Third Molar Surgery|Comparative Study of the Effectiveness of Three Anxiolytic Drugs Used in Third Molar Surgery|Completed||Phase 2/Phase 3|30|Actual|Universidade Federal de Sergipe||4|||f||||f||||||||No|IPD will be kept not available|2017-10-11 00:44:46.985545|2017-10-11 00:44:46.985545
NCT02065830|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-07-24|||March 2014||2014-03-01|July 2014|2014-07-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|ROBOSCIEKSO||Safety Study of Outdoor and Indoor Mobility in People With Spinal Cord Injury (ROBOtics Spinal Cord Injury EKSO).|ROBOticsSpinalCordInjuryEKSO: Outdoor and Indoor Mobility in People With SCI.|Unknown status|Not yet recruiting|N/A|30|Anticipated|IRCCS San Raffaele||1|||f||||f||||||||||2017-10-11 00:44:47.092753|2017-10-11 00:44:47.092753
NCT02065817|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-01-05|||February 2014||2014-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Dose of Labeled Cholesterol for Kinetics: A Pilot Study|Dose of Labeled Cholesterol and Phenylalanine for HDL Kinetics: A Pilot Study|Completed||N/A|7|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:44:47.178548|2017-10-11 00:44:47.178548
NCT02065804|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2016-11-23|||May 2017||2017-05-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|Trigger-lap||Trigger-point Blockade in Persistent Pain After Laparoscopical Groin Hernia Repair|Trigger-point Blockade in Persistent Pain After Laparoscopically Assisted Groin Hernia Repair|Not yet recruiting||Phase 3|16|Anticipated|University of Copenhagen||2|||f||||f||||||||Yes|Data will be submitted as supplementary material in the final manuscript|2017-10-11 00:44:47.245974|2017-10-11 00:44:47.245974
NCT02065791|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-08-25|||February 17, 2014|Actual|2014-02-17|August 2017|2017-08-01|June 28, 2019|Anticipated|2019-06-28|June 28, 2019|Anticipated|2019-06-28||Interventional|CREDENCE||Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy|A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy|Active, not recruiting||Phase 3|4464|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 00:44:47.419025|2017-10-11 00:44:47.419025
NCT02065778|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2014-02-18|||December 2008||2008-12-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke|A Clinical Study of Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke|Completed||Phase 1|30|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-11 00:44:49.157779|2017-10-11 00:44:49.157779
NCT02065765|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-02-24||||||February 2017|2017-02-01||||||||Expanded Access|||International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer|An International Single-Arm Protocol to Provide Expanded Access to Ramucirumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression After Prior Fluoropyrimidine and/or Platinum-Containing Chemotherapy|No longer available||N/A|||Eli Lilly and Company|||||||||||||||||||2017-10-11 00:44:49.242002|2017-10-11 00:44:49.242002
NCT02065752|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-06-16|||February 2014||2014-02-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components|A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 50 mg/500 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin XR Tablet (2 x 500 mg) in Healthy Fed Subjects|Completed||Phase 1|2|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 00:44:49.409303|2017-10-11 00:44:49.409303
NCT02065739|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2014-04-22|||January 2014||2014-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of JNJ-42165279 in Healthy Male Participants|A Study to Investigate the Potential Effects of Repeated Administration of Itraconazole on the Pharmacokinetics of JNJ-42165279 in Healthy Male Subjects|Completed||Phase 1|16|Actual|Janssen Pharmaceutica N.V., Belgium||2|||f||||f||||||||||2017-10-11 00:44:49.502061|2017-10-11 00:44:49.502061
NCT02065726|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-09-15|||October 2013||2013-10-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Whey Protein Supplementation in Cancer Patients|Whey Protein Supplementation in Malnourished Cancer Patients: a Randomized, Controlled Trial|Recruiting||N/A|192|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-11 00:44:49.599634|2017-10-11 00:44:49.599634
NCT02065713|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2016-09-13|||August 2014||2014-08-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|GO-DACT||Efficacy of Golimumab in Combination With Methotrexate (Mtx) Versus Mtx Monotherapy, in Improving Dactylitis, in Mtx naïve Psoriatic Arthritis Patients|A Multicentre, Randomized, Double-blind, Parallel-group Study To Compare The Efficacy Of Golimumab In Combination With Methotrexate (MTX) Versus MTX Monotherapy, In Improving Dactylitis And Enthesitis, In MTX Naïve Psoriatic Arthritis Patients.|Recruiting||Phase 3|136|Anticipated|Instituto de Medicina Molecular||2|||f||||t||||||||||2017-10-11 00:44:49.703154|2017-10-11 00:44:49.703154
NCT02065687|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-08-22|||March 17, 2014|Actual|2014-03-17|August 2017|2017-08-01||||September 1, 2019|Anticipated|2019-09-01||Interventional|||Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer|A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer|Recruiting||Phase 2/Phase 3|540|Anticipated|Gynecologic Oncology Group||2|||f||||f||||||||||2017-10-11 00:44:50.576014|2017-10-11 00:44:50.576014
NCT02065674|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-06-05|||February 2014||2014-02-01|June 2015|2015-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Expanded Access|ABOMNIDDM||"Therapeutic Efficacy of Abroma Agusta in HbA1c % in NIDDM"|"Therapeutic Efficacy of Homoeopathic Mother Tincture of Abroma Agusta in Changing the Level of Glycated Hb (HbA1c %) in Diabetes Mellitus Type II (NIDDM"|Available||N/A|||Fr Muller Homoeopathic Medical College|||||f||||t||||||||||2017-10-11 00:44:52.749537|2017-10-11 00:44:52.749537
NCT02065648|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-01-31|||May 2012||2012-05-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet|NATIVE Sequence for Non-Contrast MR Angiogram Compared With Conventional Contrast Enhanced 3D MRA on 3T Verio Magnet|Completed||N/A|20|Actual|Cedars-Sinai Medical Center|||1||f||||f|f|f|||f|||No||2017-10-11 00:44:52.861853|2017-10-11 00:44:52.861853
NCT02065635|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-15|2017-01-23|||February 2014||2014-02-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of Type of General Anesthesia Maintenance on Exhaled Nitric Oxide and Eosinophil Blood Count|Investigation of Changes in the Levels of Exhaled NO and Eosinophil Blood Count in Patients Undergoing Thyroidectomy by Two Different Methods of General Anesthesia Maintenance|Recruiting||N/A|60|Anticipated|Aretaieion University Hospital||2|||f||||t||||||||||2017-10-11 00:44:52.934237|2017-10-11 00:44:52.934237
NCT02065609|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-10-31|||February 2014||2014-02-01|October 2016|2016-10-01||||February 2019|Anticipated|2019-02-01||Interventional|||89ZrTrastuzumab Breast Imaging With Positron Emission Tomography|Assessment of HER2 Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using 89 Zr-Trastuzumab|Recruiting||Early Phase 1|52|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:44:53.565516|2017-10-11 00:44:53.565516
NCT02065596|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-07-17|||April 24, 2015||2015-04-24|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hematopoietic Stem Cell Transplant for Sickle Cell Disease|Hematopoietic Stem Cell Transplant for Sickle Cell Disease|Recruiting||Phase 1/Phase 2|25|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-11 00:44:53.698117|2017-10-11 00:44:53.698117
NCT02065583|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-12-09|||December 2013||2013-12-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|AGIS||Predictive Validity of Acoustic Gastrointestinal Surveillance (AGIS) in Post-Operative Feeding|Predictive Validity of a Computer-Aided, Non-Invasive, Acoustic Gastrointestinal Surveillance (AGIS) in Post-Operative Feeding|Recruiting||N/A|100|Anticipated|VA Greater Los Angeles Healthcare System|||1||f||||t||||||||||2017-10-11 00:44:53.903788|2017-10-11 00:44:53.903788
NCT02065557|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-07-24|||October 13, 2014||2014-10-13|July 2017|2017-07-01|July 15, 2021|Anticipated|2021-07-15|May 5, 2021|Anticipated|2021-05-05||Interventional|||Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis|Recruiting||Phase 3|245|Anticipated|AbbVie||2|||f||||t||||||||||2017-10-11 00:44:54.425888|2017-10-11 00:44:54.425888
NCT02065544|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-18|||February 2012||2012-02-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|Resolution||Remission Rates of New Type 2 Diabetes With Weight Loss and Exercise|Remission Rates of New Type 2 Diabetes With Weight Loss and Exercise|Completed||N/A|12|Actual|University of Vermont||1|||f||||f||||||||||2017-10-11 00:44:54.654355|2017-10-11 00:44:54.654355
NCT02065531|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-11-23|||January 2014||2014-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Myofascial Release and Mobilization With Impulse Technique Torsion in Low Back Pain|Effects of Myofascial Soft Tissue Release and Mobilization With Impulse Technique Torsion in Subjects With Chronic Non-specific Low Back Pain: A Randomized Clinical Trial|Completed||Phase 1|64|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-11 00:44:54.736247|2017-10-11 00:44:54.736247
NCT02065518|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-10-18|||March 2014||2014-03-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|KI||Electromyostimulation and Strength Walking for Knee Injuries|Electromyostimulation and Strength Walking for Knee Injuries|Active, not recruiting||N/A|132|Anticipated|University of Tennessee||4|||f||||t||||||||||2017-10-11 00:44:54.827967|2017-10-11 00:44:54.827967
NCT02065505|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-14|||October 2013||2013-10-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Method Pilates X Pilates in Water Postural Alignment and Its Correlation With Respiratory Capacity With Hemiparesis Spastic|METHOD PILATES x PILATES IN WATER POSTURAL ALIGNMENT AND ITS CORRELATION WITH RESPIRATORY CAPACITY WITH HEMIPARESIS SPASTIC|Unknown status|Recruiting|N/A|60|Anticipated|Universidade do Vale do Paraíba||2|||f||||t||||||||||2017-10-11 00:44:54.927563|2017-10-11 00:44:54.927563
NCT02065492|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-17|2017-06-28|||February 2014||2014-02-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|AMIT||Amlodipine for Myocardial Iron in Thalassemia|Effect of L-type Calcium Channel Blocker (Amlodipine) on Myocardial Iron Deposition in Thalassemic Patients With Moderate to Severe Myocardial Iron Deposition: A Randomized Pilot Study|Completed||Phase 2/Phase 3|20|Actual|Aga Khan University||2|||f||||f||||||||Undecided||2017-10-11 00:44:55.249939|2017-10-11 00:44:55.249939
NCT02065479|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-10-11|||March 2014||2014-03-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:|A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients With Coronary Artery Disease Undergoing PCI With CYP2C19 Loss-of-function Genotypes: A Feasibility Study With Point-of-care Pharmacodynamic and Genetic Testing|Recruiting||Phase 4|50|Anticipated|University of Florida||2|||f||||t||||||||No||2017-10-11 00:44:55.340296|2017-10-11 00:44:55.340296
NCT02065466|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-04-20|||July 2014||2014-07-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases|A Pilot Study of the Combination of Nab-paclitaxel, Temozolomide and Bevacizumab in Patients With Metastatic Melanoma With Brain Metastases|Withdrawn||Phase 1/Phase 2|0|Actual|University of Arizona||1||lack of accrual|f||||t||||||||||2017-10-11 00:44:55.438587|2017-10-11 00:44:55.438587
NCT02065453|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-05-12|2015-05-20||January 2012||2012-01-01|May 2017|2017-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy|Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy|Completed||N/A|52|Actual|St. Louis University||2|||f||||f||||||||No|No plan to share data|2017-10-11 00:44:55.539201|2017-10-11 00:44:55.539201
NCT02065440|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2014-02-16|||September 2011||2011-09-01|February 2014|2014-02-01||||February 2014|Anticipated|2014-02-01||Interventional|||The Effect of Ebastine/Pseudoephedrine on Subacute Cough|The Effect of Ebastine/Pseudoephedrine on Subacute Cough :a Randomized Placebo-controlled Trial|Unknown status|Active, not recruiting|N/A|130|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:44:55.788998|2017-10-11 00:44:55.788998
NCT02065427|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2014-02-16|||May 2010||2010-05-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|January 2011|Actual|2011-01-01||Interventional|ICIAS||Intervention to Improve Social and Family Support for Caregivers of Dependent Patients. (ICIAS)|Intervention to Improve Social and Family Support for Caregivers of Dependent Patients|Completed||N/A|282|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 00:44:55.878359|2017-10-11 00:44:55.878359
NCT02065414|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-16|2014-09-04|||March 2014||2014-03-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Clinical Trial to Test the Effect of Experimental Mouth Rinse on Gum Disease|Four Weeks Clinical Efficacy of an Ethyl Lauroyl Arginate HCL (LAE) Mouth Rinse: Effect on Gingivitis|Completed||Phase 4|260|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-10-11 00:44:55.974683|2017-10-11 00:44:55.974683
NCT02065401|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-08-07|||February 2014||2014-02-01|August 2014|2014-08-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt)|A Phase 1, Open-label, Randomized, 3-Period, Relative Bioavailability Study Comparing the Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt), Each Administered as a Single Oral Dose|Withdrawn||Phase 1|0|Actual|Shire||3||This study was withdrawn until the evaluation of the nonclinical rat findings is complete.|f||||||||||||||2017-10-11 00:44:56.058252|2017-10-11 00:44:56.058252
NCT02065388|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-02-16|||September 2009||2009-09-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Pharmacogenetic Dosing of Warfarin||Completed||Phase 3|300|Actual|Academia Sinica, Taiwan||3|||f||||t||||||||||2017-10-11 00:44:56.130821|2017-10-11 00:44:56.130821
NCT02065375|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-10-30||2014-10-22|February 2014||2014-02-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery|A Multicenter, Randomized, Dose-Ranging, Double-Masked, Placebo-Controlled Phase 2 Study Evaluating the Safety and Efficacy of RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery|Completed||Phase 2|109|Actual|Reata Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:44:56.302835|2017-10-11 00:44:56.302835
NCT02065362|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-09-14|||February 2015||2015-02-01|September 2017|2017-09-01|February 2033|Anticipated|2033-02-01|February 2018|Anticipated|2018-02-01||Interventional|||TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC|Administration Of TGF-beta Resistant Cytotoxic T-Lymphocytes to Patients With EBV-positive Nasopharyngeal Carcinoma (RESIST-NPC)|Active, not recruiting||Phase 1|14|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 00:44:56.416138|2017-10-11 00:44:56.416138
NCT02065349|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-04-28|||February 2014||2014-02-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|MOBILE||A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety|A Phase 2a Enriched Enrollment Randomized Withdrawal Study to Assess Analgesic Efficacy and Safety of ASP8477 in Subjects With Peripheral Neuropathic Pain|Completed||Phase 2|132|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:44:56.559562|2017-10-11 00:44:56.559562
NCT02065336|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-06-26|||March 2014||2014-03-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study of ARC-520 in Patients With Chronic Hepatitis B Virus|A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection|Terminated||Phase 2|58|Actual|Arrowhead Pharmaceuticals||9||Company decision to discontinue trial|f||||t||||||||||2017-10-11 00:44:56.716472|2017-10-11 00:44:56.716472
NCT02065323|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-01-15||||||January 2015|2015-01-01||||August 2014|Actual|2014-08-01||Interventional|||A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT|A Randomized Open-label Phase II Study of Oral Dovitinib in Combination With Androgen Deprivation Therapy to Delay the Onset of Castration-resistant Disease in Patients With Metastatic Prostate Cancer Undergoing Primary Androgen Deprivation Therapy|Withdrawn||Phase 2|0|Actual|Comprehensive Cancer Centers of Nevada||2||Terminated due to budgetary considerations and length of development.|f||||t||||||||||2017-10-11 00:44:56.836768|2017-10-11 00:44:56.836768
NCT02065310|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-01-17|||October 2014||2014-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||N2-(1-carboxyethyl)-2'Deoxyguanosine (CEdG) a Potential Biomarker for Diabetes|Evaluation of the Internal Consistency of Measurement and Potential of a DNA-adduct as a Biomarker of Glycemic Control|Enrolling by invitation||N/A|112|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:44:56.942046|2017-10-11 00:44:56.942046
NCT02065297|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-02-13||||||July 2013|2013-07-01||||January 2015|Anticipated|2015-01-01||Observational|||Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)|Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)|Unknown status|Recruiting|N/A|240|Anticipated|Centre Hospitalier Universitaire Dijon|||4||f||||||||||||||2017-10-11 00:44:57.02149|2017-10-11 00:44:57.02149
NCT02065284|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-11-06|||February 2014||2014-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis|Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation on Walking and Cortical Activation in Patients With Multiple Sclerosis.|Completed||N/A|32|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 00:44:57.128269|2017-10-11 00:44:57.128269
NCT02065271|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-02-14|||September 2013||2013-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|Herbie||Herbal Preparation and Glucose Homeostasis|Herbal Preparation and Glucose Homeostasis|Completed||N/A|22|Actual|Wageningen University||2|||f||||f||||||||||2017-10-11 00:44:57.257471|2017-10-11 00:44:57.257471
NCT02065258|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-14|||February 2013||2013-02-01|December 2013|2013-12-01|June 2014|Anticipated|2014-06-01|February 2014|Anticipated|2014-02-01||Interventional|||Breathing Versus Aerobic Exercises on Asthma Control|Comparison Between Breathing and Aerobic Exercises on Clinical Control, Psychosocial Morbidity, Thoracoabdominal Kinematics, and Airway Inflammation in Patients With Moderate-to-severe Asthma: a Randomized Trial|Unknown status|Recruiting|N/A|48|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:44:57.360905|2017-10-11 00:44:57.360905
NCT02065245|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-08-03|||March 3, 2014|Actual|2014-03-03|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|CRATUS||AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery.|A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty.|Recruiting||Phase 1/Phase 2|65|Anticipated|University of Miami||10|||f||||t|t|f||||||||2017-10-11 00:44:57.475343|2017-10-11 00:44:57.475343
NCT02065232|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-07-23|||March 2014||2014-03-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Sentinel Lymph Node Mapping Post-Injection Site Pain|A Randomized, Double-blinded, Controlled Clinical Trial Comparing Post-injection Site Pain of Technetium-labeled Tilmanocept Versus Technetium-labeled Sulfur Colloid in Patients Undergoing Sentinel Lymph Node Mapping Procedure for Breast Cancer|Completed||Phase 4|52|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:44:57.588841|2017-10-11 00:44:57.588841
NCT02065219|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-11-23|||November 2013||2013-11-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|April 2014|Actual|2014-04-01||Interventional|Trigger-open||Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair|Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair|Completed||Phase 3|20|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 00:44:57.662341|2017-10-11 00:44:57.662341
NCT02065206|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-08-30|||May 2014||2014-05-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|STRIVES||Spreading Teen-Recorded Inspirational Videos to Engage Schoolmates|Spreading Teen-Recorded Inspirational Videos to Engage Schoolmates|Recruiting||N/A|504|Anticipated|University of Chicago|||1||f||||f||||||||||2017-10-11 00:44:57.769845|2017-10-11 00:44:57.769845
NCT02065193|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-14|||April 2013||2013-04-01|February 2014|2014-02-01||||January 2015|Anticipated|2015-01-01||Observational|China SCORE||Prevalence of Autism Spectrum Conditions in Mainland China|Social Communication Research and Epidemiological Study in China|Unknown status|Recruiting|N/A|280000|Anticipated|University of Cambridge|||14||f||||t||||||||||2017-10-11 00:44:57.840786|2017-10-11 00:44:57.840786
NCT02065180|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-05-19|||February 2014||2014-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome|The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol|Completed||Phase 4|50|Actual|Universiteit Antwerpen||2|||f||||f||||||||||2017-10-11 00:44:57.973152|2017-10-11 00:44:57.973152
NCT02065167|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-14|||February 2014||2014-02-01|February 2014|2014-02-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Interventional|ORTHO-2||Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip|Evaluation of Safety and Feasibility of Bone Marrow Derived Autologous MSCs to Enhance Bone Healing in Patients With Avascular Necrosis of the Femoral Head|Unknown status|Recruiting|Phase 2|30|Anticipated|Universidad Autonoma de Madrid||1|||f||||t||||||||||2017-10-11 00:44:58.041321|2017-10-11 00:44:58.041321
NCT02065154|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-10-23|||August 2013||2013-08-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis|Phase II Clinical Trial of the Use of Post-Transplant Cyclophosphamide for Graft Versus Host Disease (GvHD) Prophylaxis Following Matched Unrelated Donor (MUD) and Mismatched Unrelated Donor (MMUD)Hematopoietic Stem Cell Transplant (HSCT)|Recruiting||Phase 2|48|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 00:44:58.145063|2017-10-11 00:44:58.145063
NCT02065141|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-11-28|||November 2014||2014-11-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Method To Measure Protein Digestion & Absorption|Validation Of A New Method To Simultaneously Measure Protein Digestion And Absorption|Recruiting||N/A|90|Anticipated|Texas A&M University||3|||f||||f||||||||No||2017-10-11 00:44:58.240184|2017-10-11 00:44:58.240184
NCT02065128|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-07-27|||August 1, 2017|Anticipated|2017-08-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome|The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome|Withdrawn||N/A|0|Actual|St. Michael's Hospital, Toronto|||2|"Logistical challenges with research pharmacy prevented the dilution of the capsaicin. No   participants were ever recruited, enrolled, or approached."|f||||f||||||||||2017-10-11 00:44:58.322347|2017-10-11 00:44:58.322347
NCT02065115|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-02-17|||March 2013||2013-03-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study of Ice Application to Reduce Pain From Arterial Punctures|Cryoanalgesia (Ice Pack) to Reduce the Pain Associated With Arterial Blood Gas Puncture|Completed||N/A|82|Actual|St. Joseph Hospital, New Hampshire||2|||f||||t||||||||||2017-10-11 00:44:58.389255|2017-10-11 00:44:58.389255
NCT02065102|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-03-05|||November 2012||2012-11-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty|Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty|Completed||N/A|12|Actual|Royal Infirmary of Edinburgh|||1||f||||f||||||||||2017-10-11 00:44:58.632118|2017-10-11 00:44:58.632118
NCT02065089|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-03-21|||April 2018|Anticipated|2018-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Development of 'Emma'--a Pediatric IBD Quiz|Development of an Electronic Pediatric Inflammatory Bowel Disease Quiz|Not yet recruiting||N/A|200|Anticipated|Mayo Clinic||1|||f||||f|f|f||||||||2017-10-11 00:44:58.690556|2017-10-11 00:44:58.690556
NCT02065076|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-10-01|||February 2014||2014-02-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|SKIP||Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients|Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Ambulatory Pre-dialysis Outpatients : a Randomized Triple-blind Placebo-controlled Trial|Completed||Phase 4|38|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-10-11 00:44:58.789898|2017-10-11 00:44:58.789898
NCT02065063|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-10-03|||April 22, 2014|Actual|2014-04-22|October 2017|2017-10-01|October 16, 2016|Actual|2016-10-16|October 16, 2016|Actual|2016-10-16||Interventional|||A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors|A Dose-Escalation, Phase I/II, Open-Label, Three-Part Study of the MEK Inhibitor, Trametinib, Combined With the CDK4/6 Inhibitor, Palbociclib, To Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity in Subjects With Solid Tumors|Completed||Phase 2|28|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:44:58.901183|2017-10-11 00:44:58.901183
NCT02065050|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-05-08|||February 2012||2012-02-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|COACH-DM||Comprehensive Intervention to Evaluate Outcomes AND Cost in Hospitalized Surgical Patients With Diabetes Mellitus (DM)|Comprehensive Intervention to Evaluate Outcomes AND Cost in Hospitalized Surgical Patients With DM: COACH-DM|Completed||N/A|220|Actual|Brigham and Women's Hospital||2|||f||||f||||||||No|This study will not produce data that can be shared|2017-10-11 00:44:59.018437|2017-10-11 00:44:59.018437
NCT02065037|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-02-14|||June 2014||2014-06-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Impact of Warmed Carbon Dioxide Insufflation During Colonoscopy on Polyp Detection|The Impact of Warmed Carbon Dioxide Insufflation During Colonoscopy on Polyp Detection: A Randomized Controlled Trial|Terminated||N/A|229|Actual|Queen's University||2||CO2 temperature delivered revealed that warmed CO2 was not being delivered.|f||||t||||||||No||2017-10-11 00:44:59.096548|2017-10-11 00:44:59.096548
NCT02065024|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-03-28|||March 2014||2014-03-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|foodmagenpol||Food Matrix and Genetic Variability as Determinants of Bioavailability and Biological Effects of Beta-cryptoxanthin and Phytosterols|Food Matrix and Genetic Variability as Determinants of the Bioavailability and Biological Effects of a B-cryptoxanthin and Phytosterols-enriched Beverage; In Vitro and in Vivo Evaluation|Completed||Phase 1|40|Actual|Puerta de Hierro University Hospital||2|||f||||f||||||||||2017-10-11 00:44:59.185524|2017-10-11 00:44:59.185524
NCT02065011|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-03-15|||September 2013||2013-09-01|March 2017|2017-03-01|April 2034|Anticipated|2034-04-01|April 2034|Anticipated|2034-04-01||Interventional|||A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B|An Open-Label Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B|Enrolling by invitation||Phase 1/Phase 2|18|Anticipated|Sanofi||1|||f||||t||||||||||2017-10-11 00:44:59.267986|2017-10-11 00:44:59.267986
NCT02064998|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-08-31|||September 2014||2014-09-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Two Consecutive Randomized Controlled Trials Using Mobile Phone Applications for Risky Alcohol Use|Brief Alcohol Interventions With Mobile Phone Applications for University Students: Interventions Targeting Differing Risk Levels in Two Consecutive Randomized Controlled Trials|Completed||N/A|2166|Actual|Karolinska Institutet||5|||f||||f||||||||||2017-10-11 00:44:59.340525|2017-10-11 00:44:59.340525
NCT02064985|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-04-05|2015-09-02||February 2014||2014-02-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Ticagrelor China Pharmacokinetic/Pharmacodynamic Study|An Open Label, Single Centre, Randomised, Phase IV, Pharmacokinetic, Pharmacodynamic, and Safety Study to Evaluate Single and Multiple Doses of 45, 60, and 90 mg of Ticagrelor in Chinese Patients With Stable Coronary Heart Disease|Completed||Phase 4|61|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:44:59.588587|2017-10-11 00:44:59.588587
NCT02064972|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-03-24|||April 2014||2014-04-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|ALLOCEC||CEC Count Changes to Support GvHD Diagnosis.|Evaluation of Circulating Endothelial Cells (CEC) as a Marker of Endothelial Damage in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT): Correlation With the Occurrence of Graft-versus-Host Disease (GvHD)|Completed||N/A|50|Actual|Azienda Ospedaliera Spedali Civili di Brescia|||1||f||||t||||||||Yes|The datasets used and analysed during the current study will be available from the corresponding author on reasonable request after the publication of results.|2017-10-11 00:45:02.297193|2017-10-11 00:45:02.297193
NCT02064959|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-12-13|||February 2014||2014-02-01|December 2016|2016-12-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|HOPES||To Study the Effect of Early Cooling in Acute Subdural Hematoma Patients|HypOthermia for Patients Requiring Evacuation of Subdural Hematoma: a Multicenter, Randomized Clinical Trial|Recruiting||N/A|350|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||No|There is no plan to make individual participant data available.|2017-10-11 00:45:02.421543|2017-10-11 00:45:02.421543
NCT02064257|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-08-16|||October 2014||2014-10-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||The Listening Project: Tuning Into Change|The Listening Project: Tuning Into Change|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:45:11.540637|2017-10-11 00:45:11.540637
NCT02064933|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-09-14|||June 2014||2014-06-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990|Analysis of Patients Treated for Wiskott-Aldrich Syndrome Since January 1, 1990 (RDCRN PIDTC-6904)|Recruiting||N/A|541|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||f||||||Samples With DNA|"     Whole blood and tissue samples   "|||2017-10-11 00:45:02.62409|2017-10-11 00:45:02.62409
NCT02064920|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-07-05|2017-07-05||April 22, 2014|Actual|2014-04-22|July 2017|2017-07-01|July 13, 2016|Actual|2016-07-13|July 13, 2016|Actual|2016-07-13||Interventional|||Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)|A Clinical Trial to Assess Cognitive Function by Repeated Computerized Testing in Patients With Mild Alzheimer's Disease Treated With Donepezil|Completed||Phase 2|36|Actual|Merck Sharp & Dohme Corp.||2|||f||||f|t|f||||||||2017-10-11 00:45:03.062797|2017-10-11 00:45:03.062797
NCT02064907|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-03-30|2015-03-30||February 2014||2014-02-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional||The population consisted of all enrolled participants.|Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants|A Phase 1, Randomized, Open-Label, Single Center, Multiple-Dose, Two-Period, Crossover Study to Assess the Bioavailability, Safety, and Pharmacodynamics of Two 30 mg Dexlansoprazole Delayed-Release Orally Disintegrating Tablets Administered on the Tongue Relative to Oral Administration of One 60 mg Dexlansoprazole Delayed-Release Capsule in Healthy Subjects|Completed||Phase 1|52|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:45:03.345232|2017-10-11 00:45:03.345232
NCT02064894|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-04-24|2016-11-22||July 8, 2013|Actual|2013-07-08|April 2017|2017-04-01|June 22, 2015|Actual|2015-06-22|June 22, 2015|Actual|2015-06-22||Interventional|||Oral Analgesic Utilization for CHildhood Musculoskeletal Injuries|A Randomized Controlled Trial of Oral Analgesic Utilization for Pain Management of CHildhood Musculoskeletal Injuries|Completed||N/A|501|Actual|St. Justine's Hospital|High attrition rate between the time of randomization and the 120 minutes following analgesic administration; The dose of oral morphine was within the recommended range, but higher doses have been used in other trials for MSK pain relief in children.|3|||f||||t||||||||No||2017-10-11 00:45:03.937896|2017-10-11 00:45:03.937896
NCT02064881|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-02-14|||June 2014||2014-06-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy Study of Metformin Glycinate on Postprandial Lipemia|Effect of Metformin Glycinate on Postprandial Lipemia, Glycemic Control and Oxidation Markers in Type 2 Diabetes Patients|Unknown status|Not yet recruiting|Phase 2/Phase 3|72|Anticipated|Laboratorios Silanes S.A. de C.V.||2|||f||||f||||||||||2017-10-11 00:45:04.585342|2017-10-11 00:45:04.585342
NCT02064868|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-07-12|||January 31, 2014|Actual|2014-01-31|July 2017|2017-07-01|April 25, 2017|Actual|2017-04-25|March 26, 2017|Actual|2017-03-26||Interventional|RELAX-AHF-EU||Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients|A Multicenter, Prospective, Randomized, Open-label Study to Assess the Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients|Terminated||Phase 3|2653|Actual|Novartis||2||Study was terminated based on results from pivotal adult AHF study CRLX030A2301|f||||t||||||||||2017-10-11 00:45:04.742362|2017-10-11 00:45:04.742362
NCT02064855|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-08-22|||August 2014|Actual|2014-08-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Evaluation of Fusion Rate Using K2M VESUVIUS® Demineralized Fibers With K2M EVEREST® Spinal System|The Fusion Rate With K2M VESUVIUS® Demineralized Fibers Used With K2M EVEREST® Spinal System Compared to Autologous Bone Graft With Posterior Stabilization|Enrolling by invitation||N/A|204|Anticipated|K2M, Inc.|||1||f||||t||||||||||2017-10-11 00:45:05.846825|2017-10-11 00:45:05.846825
NCT02064842|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-05-15|||February 2014||2014-02-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TMC647055 in Combination With Ritonavir (Part 1) and the Co-administration of TMC435, TMC647055 and Ritonavir (Part 2) in Healthy Japanese Participants|A Phase 1, Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TMC647055 in Combination With a Pharmacokinetic Enhancer (Part 1) Followed by an Open-label, Randomized, 3-way Crossover Study to Evaluate Short-term Safety, Tolerability and Pharmacokinetics of the Coadministration of TMC435, TMC647055 and a Pharmacokinetic Enhancer, at Steady-state (Part 2) in Healthy Japanese Subjects.|Completed||Phase 1|24|Actual|Janssen R&D Ireland||9|||f||||f||||||||||2017-10-11 00:45:05.924045|2017-10-11 00:45:05.924045
NCT02064829|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-03-23|||March 2014||2014-03-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|TRIBECA||Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer|An Open-label, Randomized, Multi-center, Single-Dose, 2-Sequence, 2-Period, Crossover, Comparative Bioequivalence Study of IG-001 (Cb-paclitaxel) 260 mg/m2 Versus Nab-paclitaxel 260 mg/m2 Administered Intravenously With an Open-Label Extension of IG-001 in Patients With Metastatic or Locally Recurrent Breast Cancer|Completed||N/A|111|Actual|Sorrento Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 00:45:06.18332|2017-10-11 00:45:06.18332
NCT02064816|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-02-27|||May 2014||2014-05-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|RELIEF||A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis|Multicenter, Open-label, 12 Week, Phase IV Prospective Randomized Study Aimed at Evaluating Whether sc IFN Beta 1a (Rebif®) Administered in the Morning May Affect the Severity of Flu-like Syndrome and Patient-perceived Invisible Symptoms in Subjects With Relapsing Multiple Sclerosis|Completed||Phase 4|212|Actual|Merck KGaA||2|||f||||||||||||||2017-10-11 00:45:06.33049|2017-10-11 00:45:06.33049
NCT02064803|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-05-31|||June 2013||2013-06-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Gastric Partitioning Procedure for the Treatment of Unresectable and Obstructive Distal Gastric Cancer|Randomized Clinical Trial Comparing Gastric Partitioning Plus Gastro-entero Anastomosis Versus Gastro-entero Anastomosis Only in Patients With Unresectable and Obstructive Distal Gastric Cancer.|Recruiting||Phase 3|52|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||f||||||||||2017-10-11 00:45:06.427097|2017-10-11 00:45:06.427097
NCT02064790|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-03-08|||April 2014||2014-04-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Comparison of Gabapentin and Pregabalin for Radicular Pain|Comparison of Gabapentin and Pregabalin for Cervical and Lumbar Radicular Pain|Completed||N/A|6|Actual|Emory University|||3||f||||f||||||||||2017-10-11 00:45:06.522272|2017-10-11 00:45:06.522272
NCT02064777|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-02-14|||July 2013||2013-07-01|February 2014|2014-02-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation|Tacrolimus Disposition in Pediatric Transplantation: Influence of Age, Genetic Polymorphisms, Intestinal and Hepatic Relative Contribution on Pharmacokinetics, in Relationship With Clinical Outcomes|Unknown status|Recruiting|Phase 4|60|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-11 00:45:06.597985|2017-10-11 00:45:06.597985
NCT02064764|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-02-14|||February 2015||2015-02-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|Symplicity AF||Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation|Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation|Recruiting||N/A|245|Anticipated|Medtronic Atrial Fibrillation Solutions||2|||f||||t||||||||||2017-10-11 00:45:06.690555|2017-10-11 00:45:06.690555
NCT02064751|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-12-15|||March 2014||2014-03-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics|Noninvasive Hemodynamics for MultiPoint(TM) Pacing Programming in Cardiac Resynchronization Therapy Patients|Completed||N/A|40|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 00:45:06.86559|2017-10-11 00:45:06.86559
NCT02064738|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-09-28|||March 2014||2014-03-01|September 2016|2016-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)|A Pilot Study of the Effectiveness of a High Omega-3/Low Omega-6 Treatment Diet for Treating Aspirin-exacerbated Respiratory Disease|Recruiting||N/A|10|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 00:45:07.001781|2017-10-11 00:45:07.001781
NCT02064725|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-01-23|||September 2014||2014-09-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA|A Phase II Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Progesterone Receptor Negative Recurrent or Persistent Endometrial Carcinoma|Active, not recruiting||Phase 2|8|Actual|Kevelt AS||1|||f||||t||||||||||2017-10-11 00:45:07.174169|2017-10-11 00:45:07.174169
NCT02064712|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-10-04|||September 2014|Actual|2014-09-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates|Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates|Recruiting||N/A|238|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 00:45:07.345469|2017-10-11 00:45:07.345469
NCT02064699|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-07-17|||May 2013|Actual|2013-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|QUANTIC-R+||Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.|Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.|Active, not recruiting||N/A|75|Actual|University Hospital, Limoges|||1||f||||f||||||Samples Without DNA|"     Detection of the CMV in sang, the leukocytes, or plasma with or without the viral     quantification.   "|||2017-10-11 00:45:07.43987|2017-10-11 00:45:07.43987
NCT02064686|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-02-17|||April 2009||2009-04-01|February 2014|2014-02-01||||April 2015|Anticipated|2015-04-01||Interventional|||Exhaled Air Temperature (TAE) As A Marker Of Airway Inflammation In Asthma|EXHALED AIR TEMPERATURE (TAE) AS A MARKER OF AIRWAY INFLAMMATION IN ASTHMA|Unknown status|Recruiting|N/A|150|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||f||||||||||2017-10-11 00:45:07.569687|2017-10-11 00:45:07.569687
NCT02064673|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-05-12|||May 2014||2014-05-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy|Randomized Trial of Adjuvant Curcumin After Prostatectomy|Recruiting||Phase 3|600|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-11 00:45:07.713062|2017-10-11 00:45:07.713062
NCT02064660|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-09-02|||December 2013||2013-12-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Efficacy and Safety of Periocular Acupoint Stimulation on Myopia Progression in Children|An Integrative Medical Approach of Acupoint Stimulation for Children With Myopia : A Pilot Study|Completed||Phase 1|20|Actual|Korean Medicine Hospital of Pusan National University||1|||f||||t||||||||||2017-10-11 00:45:07.816676|2017-10-11 00:45:07.816676
NCT02064647|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-01-27|||July 2014||2014-07-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|TAAT||Evaluation of Novel Trend Arrow Adjustment Tool for Diabetes Patients Using Continuous Glucose Monitoring to Guide Insulin Bolus Adjustment (TAAT Study)|Evaluation of a Novel CGM Trend Arrow Adjustment Tool in Children & Adolescents With Type 1 Diabetes Using Insulin Pump Therapy and Continuous Glucose Monitoring (TAAT Study)|Completed||N/A|20|Actual|Children's Hospital of Eastern Ontario||3|||f||||t||||||||||2017-10-11 00:45:07.898111|2017-10-11 00:45:07.898111
NCT02064634|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-03-15|||May 2014||2014-05-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule|A Multicenter, Comparative, Open Label, Prospective Observational Study on Discontinuation of Medication Due to Gastrointestinal Adverse Effects for the Patients Being Treated for Osteoarthritis With Anti-inflammatory Analgesic Drug|Recruiting||N/A|6700|Anticipated|Green Cross Corporation|||4||f||||t||||||||Undecided||2017-10-11 00:45:07.984521|2017-10-11 00:45:07.984521
NCT02064621|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-09-01|||June 2014||2014-06-01|February 2014|2014-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CKD-330(C)||CKD-330 Drug-Drug Interaction Study (Candesartan)|A Randomized, Open-label, Multiple Doses, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction and Safety of Candesartan Between Free Combination of Candesartan and Amlodipine and Candesartan Monotherapy in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Chong Kun Dang Pharmaceutical||2|||f||||t||||||||||2017-10-11 00:45:08.061336|2017-10-11 00:45:08.061336
NCT02064244|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-06-08|||February 2014||2014-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Inferior Vena Cava (IVC) Size in Acute Renal Failure|Does the Inferior Vena Cava Size Assessment Help in the Management of Acute Kidney Injury in Critically Ill Patients?|Completed||N/A|33|Actual|University of Oklahoma|||1||f||||f||||||||||2017-10-11 00:45:11.636816|2017-10-11 00:45:11.636816
NCT02064608|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-01-06|||October 2014||2014-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|December 2016|Actual|2016-12-01||Interventional|CaNCaP02||Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer|A Phase 1 Window of Opportunity Study Investigating the Pharmacodynamic Biomarker Effects of AZD2014 (an mTOR1/2 Inhibitor) Given Prior to Radical Prostatectomy|Active, not recruiting||Phase 1|23|Anticipated|Cambridge University Hospitals NHS Foundation Trust||1|||f||||t||||||||No||2017-10-11 00:45:08.139089|2017-10-11 00:45:08.139089
NCT02064595|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-18|||January 2011||2011-01-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Open Tibia Fractures a Comparative Study Between Biplane External Fixator and Locked Intramedullary Nail|TREATMENT OF EXPOSED FRACTURES OF TIBIA: A COMPARATIVE STUDY BETWEEN BIPLANE EXTERNAL FIXATOR AND LOCKED INTRAMEDULLARY NAIL|Completed||N/A|68|Actual|Faculdade de Medicina do ABC||2|||f||||t||||||||||2017-10-11 00:45:08.218477|2017-10-11 00:45:08.218477
NCT02064582|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-05-31|||May 2014||2014-05-01|May 2016|2016-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer|Phase 2 Study of Enzalutamide and GnRH Agonist Before, During and After Radiation Therapy in Treatment of Patients With High-risk Localized Prostate Cancer|Recruiting||Phase 2|15|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 00:45:08.284246|2017-10-11 00:45:08.284246
NCT02064569|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-02-22|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients|An Open Label Dose Escalation Clinical Trial to Evaluate the Safety and the Tolerability of GS010 (rAAV2/2-ND4) in Patients With Leber Hereditary Optic Neuropathy Due to Mutations in the Mitochondrial NADH Dehydrogenase 4 Gene|Active, not recruiting||Phase 1/Phase 2|21|Anticipated|GenSight Biologics||1|||f||||t||||||||Undecided||2017-10-11 00:45:08.376907|2017-10-11 00:45:08.376907
NCT02064556|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2014-08-13|||May 2014||2014-05-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|CKD-330(A)||CKD-330 Drug-Drug Interaction Study (Amlodipine)|A Randomized, Open-label, Multiple Doses, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction and Safety of Amlodipine Between Free Combination of Amlodipine and Candesartan and Amlodipine Monotherapy in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Chong Kun Dang Pharmaceutical||2|||f||||t||||||||||2017-10-11 00:45:08.441913|2017-10-11 00:45:08.441913
NCT02064543|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-05-15|||July 2013||2013-07-01|May 2014|2014-05-01||||December 2014|Anticipated|2014-12-01||Observational|||Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism|Measurement of Gait Using the Opal APDM and an Instrumented Gait Mat in Persons With Parkinsonism|Unknown status|Recruiting|N/A|50|Anticipated|University of Texas Southwestern Medical Center|||1||f||||||||||||||2017-10-11 00:45:08.674313|2017-10-11 00:45:08.674313
NCT02064530|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-09-11|||February 2014||2014-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|TAP||Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block|Postoperative Analgesic Effects of Dexmedetomidine Added to Bupivacaine for Transversus Abdominis Plane Block for Lower Abdominal Surgery|Completed||Phase 4|90|Anticipated|TC Erciyes University||3|||f||||f||||||||||2017-10-11 00:45:08.76386|2017-10-11 00:45:08.76386
NCT02064517|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2016-06-07|||October 2014||2014-10-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Treatments of the Necrosed Immature Teeth (REV)|Randomized Comparative Test Multicentric, Forward-looking Single-blind, Between a Reference Technique and an Innovative Technic.|Recruiting||Phase 2|126|Anticipated|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 00:45:08.844339|2017-10-11 00:45:08.844339
NCT02064504|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-05-12|||February 19, 2014|Actual|2014-02-19|May 2017|2017-05-01|May 20, 2014|Actual|2014-05-20|May 20, 2014|Actual|2014-05-20||Interventional|||Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination|An Open Label, Randomised, Six-way Crossover, Single Dose Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination|Completed||Phase 1|48|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:45:08.964759|2017-10-11 00:45:08.964759
NCT02064491|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-06-21|||February 2014|Actual|2014-02-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|December 31, 2016|Actual|2016-12-31||Interventional|||Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC|Erlotinib Treatment Beyond Progression in EGFR Mutant or Patients Who Have Responded EGFR TKI in Stage IIIB/IV NSCLC|Completed||Phase 2|18|Actual|Finnish Lung Cancer Group||2|||f||||t||||||||||2017-10-11 00:45:09.059976|2017-10-11 00:45:09.059976
NCT02064478|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-08-31|||February 2014||2014-02-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Clinical Survey of Oticon Medical Ponto Implants and a Surgical Technique With Tissue Preservation|Clinical Survey of Oticon Medical Ponto Implants and a Surgical Technique With Tissue Preservation|Active, not recruiting||N/A|25|Anticipated|Oticon Medical|||2||f||||f||||||||||2017-10-11 00:45:09.156596|2017-10-11 00:45:09.156596
NCT02064465|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-05-09|||March 15, 2014|Actual|2014-03-15|May 2017|2017-05-01|July 8, 2014|Actual|2014-07-08|July 8, 2014|Actual|2014-07-08||Interventional|||The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg|A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Demonstrate the Bioequivalence of Lamotrigine Dispersible/Chewable Tablet (100mg) and Lamotrigine Compressed Tablet (100mg) in Healthy Chinese Male Subjects|Completed||Phase 1|138|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:45:09.275271|2017-10-11 00:45:09.275271
NCT02064452|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-05-11|||May 2014||2014-05-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluating an Online Parenting Support System Disseminated by Pediatric Practices|Evaluating an Online Parenting Support System Disseminated by Pediatric Practices|Active, not recruiting||N/A|600|Anticipated|Oregon Research Institute||2|||f||||f||||||||||2017-10-11 00:45:09.376678|2017-10-11 00:45:09.376678
NCT02064231|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-03-17|2014-02-25||June 2012||2012-06-01|March 2017|2017-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Clinical Investigation Examining the Performance and Handling of New 2-piece Ostomy Products in 28 People With an Ileostomy.||Completed||N/A|28|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 00:45:11.896681|2017-10-11 00:45:11.896681
NCT02064426|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2017-02-27||2017-02-27|March 2014||2014-03-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|DIALOGUE5||Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934|A Controlled, Parallel Group, Open-label, Multicenter Extension Study to Investigate Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Long-term Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis in the United States and Japan|Completed||Phase 2|88|Actual|Bayer||2|||f||||t||||||||||2017-10-11 00:45:10.18625|2017-10-11 00:45:10.18625
NCT02064413|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-12-14|||March 2014||2014-03-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Essure (Model ESS310) Placement Rate Study|A Multi-Center, United States Clinical Study to Evaluate Placement Success of the ESS310 Essure® System|Completed||Phase 3|134|Actual|Bayer||1|||f||||f||||||||||2017-10-11 00:45:10.381771|2017-10-11 00:45:10.381771
NCT02064400|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-14|2015-06-25|||February 2014||2014-02-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Pilot Study of Ultrasound in Rheumatoid Arthritis|A Pilot Study of Musculoskeletal Ultrasound Assessment in Patients With Rheumatoid Arthritis|Completed||N/A|17|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 00:45:10.491477|2017-10-11 00:45:10.491477
NCT02064374|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-05-22|||February 2014||2014-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects|A Phase I, Open Label, Parallel Group, Three Period, Fixed Sequence Crossover Study to Evaluate the Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects|Completed||Phase 1|30|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 00:45:10.707899|2017-10-11 00:45:10.707899
NCT02064361|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-13|||February 2013||2013-02-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||High Intensity Cycling Before SCUBA Diving Reduces Post-decompression Microparticle Production and Neutrophil Activation|High Intensity Cycling Before SCUBA Diving Reduces Post-decompression Microparticle Production and Neutrophil Activation|Completed||N/A|10|Actual|University Hospital of Split||1|||f||||f||||||||||2017-10-11 00:45:10.798183|2017-10-11 00:45:10.798183
NCT02064348|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-04-27|||February 2014||2014-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects|A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects: A Randomised, Double-Blind,Placebo-Controlled, Three-Arm Parallel Trial With a Nested Cross-Over Design for Positive Control With Moxifloxacin Administration|Completed||Phase 1|168|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 00:45:10.877245|2017-10-11 00:45:10.877245
NCT02064335|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-06-03|||February 2014||2014-02-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Effects of Physical Activity Coaching on Health and Behaviour Parameters in Diabetic Persons|Short and Long Term Effects of Physical Activity Coaching on Physical Activity, Physical Fitness, Subjective Well Being and Health in Diabetic Persons|Completed||N/A|48|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:45:10.970919|2017-10-11 00:45:10.970919
NCT02064322|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-03-29|||February 2014||2014-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|SAIF||SAIF: Sacroiliac Fusion Study|SAIF: Sacroiliac Fusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System|Terminated||N/A|2|Actual|Zyga Technology, Inc.|||1||f||||f||||||||||2017-10-11 00:45:11.070432|2017-10-11 00:45:11.070432
NCT02064309|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-10-25|||February 2014||2014-02-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets Within the Bioartificial Pancreas Beta-Air in Patients With Type 1 Diabetes Mellitus|An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets Within the Bioartificial Pancreas Beta-Air in Patients With Type 1 Diabetes Mellitus|Active, not recruiting||Phase 1/Phase 2|4|Actual|Uppsala University Hospital||1|||f||||t||||||||||2017-10-11 00:45:11.15651|2017-10-11 00:45:11.15651
NCT02064296|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-09-15|||December 2014||2014-12-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|October 2018|Anticipated|2018-10-01||Interventional|||Neuroimaging Approaches to Deconstructing Acupuncture for Chronic Pain|Neuroimaging Approaches to Deconstructing Acupuncture for Chronic Pain|Recruiting||N/A|100|Anticipated|University of Michigan||3|||f||||t||||||||||2017-10-11 00:45:11.249278|2017-10-11 00:45:11.249278
NCT02064283|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-12-08|||May 2007||2007-05-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Early Assessment of Treatment Response Using Functional Diffusion Mapping|Early Assessment of Treatment Response Using Functional Diffusion Mapping|Completed||N/A|20|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 00:45:11.361909|2017-10-11 00:45:11.361909
NCT02064270|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-03|||March 2014||2014-03-01|April 2017|2017-04-01|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Interventional|PICO||Study to Compare Negative Pressure Wound Therapy or Standard Dressings After Orthopedic Surgery|Prospective Randomized, Controlled Study to Assess Prevention of Incision Healing Complications in Patients Undergoing Total Knee or Hip Arthroplasty, Treated With Either Negative Pressure Wound Therapy or Standard Dressings.|Completed||N/A|526|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-10-11 00:45:11.439514|2017-10-11 00:45:11.439514
NCT02064218|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-13|||November 2007||2007-11-01|November 2007|2007-11-01||||January 2014|Actual|2014-01-01||Observational|||Emerging Biomarkers in Hypertension|Evaluation of Some Emerging Biomarkers of Cardiovascular Risk Stratification in Hypertensive Patients: a 5-years Follow-up|Unknown status|Recruiting|N/A|||University of Pavia|||2||f||||t||||||||||2017-10-11 00:45:12.196678|2017-10-11 00:45:12.196678
NCT02064205|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-04-24|2015-12-24||May 2014||2014-05-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Appetite Suppression Trial With Polydextrose|A Double Blind, Placebo Controlled, Randomized, Cross-over Study to Assess the Effects of Polydextrose on Appetite Suppression and Its Mechanisms of Action in Healthy Women With a Normal Weight and Overweight Female Participants.|Completed||Phase 2|32|Actual|TNO||2|||f||||f||||||||||2017-10-11 00:45:12.314987|2017-10-11 00:45:12.314987
NCT02064192|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-07-22|||May 2014||2014-05-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|EU-CERT-ICD||Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe|Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe|Recruiting||N/A|2500|Anticipated|University Medical Center Goettingen|||2||f||||t||||||Samples With DNA|"     Whole blood sample for genetic analysis   "|||2017-10-11 00:45:12.790591|2017-10-11 00:45:12.790591
NCT02064179|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-09-01|||April 2014||2014-04-01|September 2017|2017-09-01||||June 2015|Actual|2015-06-01||Observational|||Assessment of the Efficacy of the First Aspirin Dose in Children Undergoing Surgery for Congenital Heart Disease (CHD) Who Require Post-operative Antiplatelet Therapy|Assessment of Efficacy of the First Aspirin Dose in Children Undergoing Surgery for Congenital Heart Disease (CHD) Who Require Post-operative Antiplatelet Therapy; Evaluated by Thromboelastograph (TEG) Analysis and TEG-platelet Mapping|Active, not recruiting||N/A|75|Actual|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     Whole blood samples for immediate processing via thromboelastograph (TEG) and TEG-platelet     mapping (TEG-PM)   "|||2017-10-11 00:45:13.2182|2017-10-11 00:45:13.2182
NCT02064166|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-01-05|||February 2014||2014-02-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.|A Double-blinded Placebo-controlled Single-center Study to Evaluate the Efficacy of Intranasal Insulin 40 International Units Day as Treatment for Subjects With Parkinson Disease and Multiple System Atrophy|Completed||Phase 2|16|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 00:45:13.2985|2017-10-11 00:45:13.2985
NCT02064153|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-04-01|||July 2013||2013-07-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|March 2014|Actual|2014-03-01||Interventional|||Studying the Effect of Dialysate Temperature on Toxin Removal and Hypotension|Potential of Manipulating the Dialysate Temperature for Prevention of Intra-dialytic Hypotensive Episodes in Maintenance Hemodialysis Patients|Completed||N/A|14|Actual|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-11 00:45:13.423905|2017-10-11 00:45:13.423905
NCT02064140|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-12-01|||February 2014||2014-02-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Supported Ventilation in ARDS Patients|Reducing High Respiratory Drive to Facilitate Supported Ventilation in ARDS Patients: a Pilot Study|Completed||N/A|12|Actual|University Medical Center Nijmegen||1|||f||||f||||||||||2017-10-11 00:45:13.530689|2017-10-11 00:45:13.530689
NCT02064127|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-07-26|||March 2014||2014-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Triage of Abdominal Pain in the Emergency Department|Evaluation of Triage Criteria for Abdominal Pain in the Emergency Department|Recruiting||N/A|4000|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 00:45:13.627845|2017-10-11 00:45:13.627845
NCT02064114|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-07-11|||January 2014||2014-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SORT-AF||SORT - AF Supervised Obesity Reduction Trial for AF Ablation Patients|Supervised Obesity Reduction Trial for AF Ablation Patients|Recruiting||N/A|140|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 00:45:13.761788|2017-10-11 00:45:13.761788
NCT02064101|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-10-24|||February 2014||2014-02-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Validation of Triggered EMG Values for Pedicle Screws Using a Powered Screwdriver|Validation of Triggered EMG Values for Pedicle Screws Using a Powered Screwdriver|Completed||N/A|27|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 00:45:13.910917|2017-10-11 00:45:13.910917
NCT02064088|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-13|||November 2013||2013-11-01|February 2014|2014-02-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|TAP Bloc||Transversus Abdominis Plane Block in Pediatrics: Volume or Concentration ?|Volume or Concentration for the Transverse Abdominal Plane Block in Children Aged 1-5 Years: Analgesic Effects and Safety|Unknown status|Recruiting|N/A|70|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:45:14.046385|2017-10-11 00:45:14.046385
NCT02064075|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-02-13|||February 2013||2013-02-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||The Mortality and Changes in Quality of Life of Patients Suffering From SAH With Different Hydration Strategies|Phase 4 Prospective, Randomized, Blinded Study on the Effect of Different Hydration Strategies on Mortality and Changes in Quality of Life of Patients Suffering From Subarachnoid Haemorrhage|Completed||Phase 4|96|Actual|University of Debrecen||2|||f||||t||||||||||2017-10-11 00:45:14.158452|2017-10-11 00:45:14.158452
NCT02064062|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-05-11|||January 2015||2015-01-01|May 2016|2016-05-01||||December 2018|Anticipated|2018-12-01||Interventional|ASCAT||Autologous Stem Cells in Achilles Tendinopathy|Autologous Stem Cells in Achilles Tendinopathy|Recruiting||Phase 2|10|Anticipated|University College, London||1|||f||||f||||||||||2017-10-11 00:45:14.25959|2017-10-11 00:45:14.25959
NCT02064049|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-08-29|||October 2014||2014-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SToP-C||Surveillance and Treatment of Prisoners With Hepatitis C|A Pilot Study to Assess the Feasibility of Hepatitis C Virus (HCV) Treatment as Prevention With Interferon-free Direct Acting Antivirals (DAAs) in the Prison Setting|Recruiting||Phase 4|1200|Anticipated|Kirby Institute||1|||f||||t||||||||No||2017-10-11 00:45:14.362224|2017-10-11 00:45:14.362224
NCT02063503|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-09-26|||September 2013||2013-09-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Development of Clinical Prediction Rules for Rehabilitation in Chronic Nonspecific Low Back Pain Patients|Development of Clinical Prediction Rules for Rehabilitation in Chronic Nonspecific Low Back Pain Patients|Recruiting||N/A|500|Anticipated|Universiteit Antwerpen||3|||f||||t||||||||||2017-10-11 00:45:28.00815|2017-10-11 00:45:28.00815
NCT02064036|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-06-19|||March 2013||2013-03-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CCRO025||Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate|Whole-Pelvic Radiotherapy With a Stereotactic Body Radiotherapy Boost and Long-Term Androgen Deprivation for Unfavorable-Intermediate and High Risk Localized Adenocarcinoma of the Prostate.|Recruiting||N/A|29|Anticipated|University of California, Davis||1|||f||||t||||||||No||2017-10-11 00:45:14.487248|2017-10-11 00:45:14.487248
NCT02064023|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-12-03|||April 2014||2014-04-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Comparison of Insulin Pump and MDI for Pregestational Diabetes During Pregnancy|Comparison of Continuous Subcutaneous Insulin Infusion (CSII) With Multiple Daily Injections (MDI) for the Treatment of Pregestational Diabetes During Pregnancy|Terminated||N/A|2|Actual|University of British Columbia||2||Some sites withdrew because no contract with insulin pump supplier|f||||f||||||||||2017-10-11 00:45:14.594356|2017-10-11 00:45:14.594356
NCT02064010|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-11-09|||February 2014||2014-02-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Behavior of Orally Administered SNC-102 in Subjects With Drug-Induced Tardive Dyskinesia|Completed||Phase 2|102|Actual|Synchroneuron Inc.||3|||f||||f||||||||||2017-10-11 00:45:14.693858|2017-10-11 00:45:14.693858
NCT02063997|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-05-20||2015-02-16|March 2014||2014-03-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients|A Randomized, Double-Blind, Active and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients|Completed||Phase 2|248|Actual|CymaBay Therapeutics, Inc.||5|||f||||f||||||||||2017-10-11 00:45:14.783867|2017-10-11 00:45:14.783867
NCT02063984|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-08-14|||November 2013||2013-11-01|August 2015|2015-08-01|February 2018|Anticipated|2018-02-01|May 2017|Anticipated|2017-05-01||Interventional|SMART||Behavioral Treatment of Adolescent Substance Use|Behavioral Treatment of Adolescent Marijuana Use|Recruiting||N/A|300|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 00:45:14.980001|2017-10-11 00:45:14.980001
NCT02063971|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-13|||December 2013||2013-12-01|February 2014|2014-02-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|FILLER||Tolerance and Efficacy Evaluation of 3 Face Creams|Tolerance and Efficacy Evaluation of Three Face Creams in Subjects Undergoing to Injection Procedure With Hyaluronic Acid (Intradermal Implant)|Unknown status|Active, not recruiting|N/A|45|Actual|Derming SRL||1|||f||||t||||||||||2017-10-11 00:45:15.100872|2017-10-11 00:45:15.100872
NCT02063958|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-07-25|||February 2014||2014-02-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|February 2017|Actual|2017-02-01||Interventional|||Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors|A Phase 1, Open-label, Dose-escalation Study of SNX 5422 and Everolimus in Subjects With Neuroendocrine Tumors.|Active, not recruiting||Phase 1|19|Actual|Esanex Inc.||1|||f||||f||||||||||2017-10-11 00:45:15.201797|2017-10-11 00:45:15.201797
NCT02063945|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-13|||February 2014||2014-02-01|February 2014|2014-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders|The Assessment of Efficacy and Tolerability of Methylphenidate vs. Risperidone in the Treatment of Children and Adolescents With ADHD and Disruptive Disorders|Unknown status|Recruiting|Phase 4|70|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:45:15.462389|2017-10-11 00:45:15.462389
NCT02063932|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-02-14|||December 2013||2013-12-01|January 2014|2014-01-01||||June 2014|Anticipated|2014-06-01||Observational|||Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal Microbiome|Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal Microbiome|Unknown status|Recruiting|N/A|60|Anticipated|Shandong University|||1||f||||t||||||Samples With DNA|"     The metagenome was obtained from biopsy specimen.   "|||2017-10-11 00:45:15.574449|2017-10-11 00:45:15.574449
NCT02063919|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-06-27|||November 2013||2013-11-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Observational|||Association Between Confocal Laser Endomicroscopic (CLE) Features and Colorectal Mucosal Microbiome|Association Between Confocal Laser Endomicroscopic (CLE) Features and Colorectal Mucosal Microbiome|Completed||N/A|45|Actual|Shandong University|||1||f||||t||||||Samples With DNA|"     The mucosal metagenome was obtained from biopsy specimen.   "|||2017-10-11 00:45:15.661347|2017-10-11 00:45:15.661347
NCT02063906|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-04-27|||February 2014||2014-02-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|April 2018|Anticipated|2018-04-01||Observational|||Prognostic Relevance of Biological Subtype in Breast Cancer|Prognostic Relevance of Biological Subtype Overrides That of TNM Staging in Breast Cancer: Discordance Between Stage and Biology|Recruiting||N/A|202|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:45:15.74119|2017-10-11 00:45:15.74119
NCT02063893|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-06-01|||January 2014||2014-01-01|February 2014|2014-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Observational|CSC||Safety Study of Cancer Stem Cell Vaccinie to Treat Breast Cancer|Study of Cancer Stem Cell Vcccinie That as a Specific Antigen in Metastatic Adenocarcinoma of the Breast|Completed||Phase 1/Phase 2|40|Anticipated|Fuda Cancer Hospital, Guangzhou|||4||f||||t||||||Samples Without DNA|"     We will keep the CSC of every patient   "|||2017-10-11 00:45:15.807962|2017-10-11 00:45:15.807962
NCT02063880|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-07-28|2017-05-01||March 2013||2013-03-01|July 2017|2017-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PUSH||Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)|Urgent Versus Post-Stabilization ART in HIV-1 Infected Children With Severe Co-Infections|Completed||N/A|183|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 00:45:15.885731|2017-10-11 00:45:15.885731
NCT02063867|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-08-14|||April 2014||2014-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ABATE||Active Bathing to Eliminate Infection (ABATE Infection) Trial|Cluster-Randomized Controlled Trial of Hospitals to Reduce Healthcare-Associated Infections and Readmissions Through Routine Bathing With Antiseptic Soap and Targeted Use of Nasal Antibiotic Ointment (ABATE Infection Trial)|Active, not recruiting||N/A|53|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-10-11 00:45:16.220524|2017-10-11 00:45:16.220524
NCT02063854|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-02-07|2016-11-16||February 2014||2014-02-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Randomized set included all participants who were randomized to the study.|A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets|A Phase 2/3, Multicenter, Randomized, Double-blind, Parallel Group Comparative Study to Evaluate the Efficacy and Safety of Once-monthly Oral Administration of NE-58095DR Tablet (25 mg or 37.5 mg) Versus Once-daily Oral Administration of NE-58095IR Tablet (2.5 mg) for the Treatment of Involutional Osteoporosis|Completed||Phase 2/Phase 3|871|Actual|Takeda|The collaborator company name EA Pharma Co., Ltd. has been changed from 1st April 2016. The legacy name was Ajinomoto Pharmaceutics Co., Ltd.|7|||f||||t||||||||||2017-10-11 00:45:16.484672|2017-10-11 00:45:16.484672
NCT02063841|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-08-18|||August 2013||2013-08-01|August 2015|2015-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|D-ERCP||Digestive Endoscopy Suite Radiation Controlling Protective Strategies|A Prospective Double-blind, Randomized, Sham-controlled Trial to Evaluate the Effect of a Lead Free Drape on Scatter Radiation Exposure to Endoscopy Staff During Endoscopic Retrograde Cholangiopancreatography|Completed||Early Phase 1|2|Actual|Yale University||2|||f||||f||||||||||2017-10-11 00:45:22.596657|2017-10-11 00:45:22.596657
NCT02063828|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-08-11|||January 2015||2015-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RELAX||Reducing Lung Cancer Survivors' Anxiety and Dyspnea (RELAX)|Reducing Lung Cancer Survivors' Anxiety and Dyspnea (RELAX)|Recruiting||N/A|75|Anticipated|Wake Forest University Health Sciences||3|||f||||t|f|t||||||||2017-10-11 00:45:22.690828|2017-10-11 00:45:22.690828
NCT02063815|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-02-13|||June 2009||2009-06-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2012|Actual|2012-02-01||Interventional|||A Trial of Caries Prevention Effect of Fissure Sealants|A Randomized Controlled Trial of Caries Prevention Effect of a Glass Ionomer Sealant Versus a Resin Sealant|Completed||N/A|40|Actual|Marmara University||2|||f||||f||||||||||2017-10-11 00:45:22.78839|2017-10-11 00:45:22.78839
NCT02063789|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-05-23|||June 2014||2014-06-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia|Prospective, Non-Randomized, Open-label, Single-arm, Multi-Center Phase III Clinical Trial to Evaluate the Efficacy and Safety of IV-Globulin SN Inj.10% in the Patients Diagnosed With Immune Thrombocytopenia (ITP).|Completed||Phase 3|81|Actual|Green Cross Corporation||1|||f||||f||||||||||2017-10-11 00:45:22.974866|2017-10-11 00:45:22.974866
NCT02063776|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-08-22|||February 2014||2014-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|3H||Haemodiafiltration vs Conventional Haemodialysis in Children|The Effects of Haemodiafiltration (HDF) vs Conventional Haemodialysis (HD) on Growth and Cardiovascular Markers in Children - 3H (HDF, Hearts and Height) Study|Active, not recruiting||N/A|150|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust|||2||f||||t||||||Samples Without DNA|"     serum only   "|||2017-10-11 00:45:23.100075|2017-10-11 00:45:23.100075
NCT02063763|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-02-17|||May 2014||2014-05-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|ITP0614||TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.|Use of TPO-mimetics to Prepare for Splenectomy in Adult Patients With Primary Immune Thrombocytopenia. Brooklyn Observational Retrospective Study.|Recruiting||N/A|40|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||No||2017-10-11 00:45:23.183508|2017-10-11 00:45:23.183508
NCT02063750|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-13|||January 2011||2011-01-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|||Strengthening Exercises for Fibromyalgia|Effectiveness of Strengthening Exercises Using the Swiss Ball for Patients With Fibromyalgia: a Randomized Controlled Trial|Completed||Phase 4|60|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 00:45:23.350207|2017-10-11 00:45:23.350207
NCT02063737|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-07-14|2015-05-26||January 2014||2014-01-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|SleepTrackTXT||SleepTrackTXT Feasibility and Pilot Study|The Sleep Track Text Pilot Trial in Emergency Care Clinicians|Completed||Early Phase 1|100|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:45:23.470332|2017-10-11 00:45:23.470332
NCT02063724|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-07-07|||January 2014||2014-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|Adjuvant||HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer|Pilot Phase I HER-2 Pulsed DC Vaccine to Prevent Recurrence for Patients With HER-2 Driven High Risk Invasive Breast Cancer|Active, not recruiting||Phase 1|15|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-11 00:45:24.258004|2017-10-11 00:45:24.258004
NCT02063711|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-03-30|||February 2014||2014-02-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TRY||Acute Fetal Response to Prenatal Yoga|Acute Fetal Response to Prenatal Yoga: A Single Blinded, Randomized Controlled Trial (TRY Yoga Study)|Completed||N/A|46|Actual|University of Missouri, Kansas City||2|||f||||f||||||||||2017-10-11 00:45:24.371473|2017-10-11 00:45:24.371473
NCT02063698|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-05-23|||February 2014|Actual|2014-02-01|May 2017|2017-05-01|November 11, 2016|Actual|2016-11-11|March 2016|Actual|2016-03-01||Interventional|||Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome|A Pilot Randomized, Placebo-Controlled Study to Test Auranofin (Ridaura®) to Control the Paclitaxel-Induced Pain Syndrome (PIAPS)|Completed||N/A|30|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 00:45:24.493031|2017-10-11 00:45:24.493031
NCT02063672|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-03-30|||March 2014||2014-03-01|March 2017|2017-03-01|February 2021|Anticipated|2021-02-01|February 13, 2017|Actual|2017-02-13||Interventional|SFA ISR||Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis|A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial Comparing the Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis|Active, not recruiting||N/A|82|Actual|C. R. Bard||2|||f||||t||||||||No||2017-10-11 00:45:24.982448|2017-10-11 00:45:24.982448
NCT02063659|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-08-22|2017-04-03||March 11, 2014|Actual|2014-03-11|August 2017|2017-08-01|March 29, 2016|Actual|2016-03-29|March 29, 2016|Actual|2016-03-29||Interventional|TELECAST||Telotristat Etiprate for Carcinoid Syndrome Therapy|A Phase 3, Randomized, Placebo-controlled, Multicenter, Double-blind Study to Evaluate the Safety and Efficacy of Telotristat Etiprate (LX1606) in Patients With Carcinoid Syndrome|Completed||Phase 3|76|Actual|Lexicon Pharmaceuticals||3|||f||||t||||||||||2017-10-11 00:45:25.177362|2017-10-11 00:45:25.177362
NCT02063646|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-05-25|||February 2014||2014-02-01|October 2014|2014-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Neurophenol||Effect of a Polyphenol-rich Food Supplement on Cognitive Function in Healthy Aging Adults|Effect of a Polyphenol-rich Food Supplement on Cognitive Function in Healthy Aging Adults: Randomized, Placebo-controlled, Double-blind Clinical Trial|Completed||N/A|204|Anticipated|Neurophenols Consortium||2|||f||||f||||||||||2017-10-11 00:45:26.410188|2017-10-11 00:45:26.410188
NCT02063633|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-13|||March 2014||2014-03-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|||PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer|Radiotherapeutic Tumor Response and Normal Tissue Effect in Treating Thoracic Malignancy : as Comparing With Free-breathing Non-gating Methods.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 00:45:26.535524|2017-10-11 00:45:26.535524
NCT02063620|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-02-13|||October 2013||2013-10-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Anesthetic Agents Management on ECG Changes of Patients Who Were Operated Under RIVA|The Effect of Different Anesthetic Agents Management on Electrocardiographic Changes of Patients Who Were Operated Under Regional Intravenous Anesthesia|Completed||N/A|60|Actual|Duzce University||2|||f||||f||||||||||2017-10-11 00:45:26.65681|2017-10-11 00:45:26.65681
NCT02063607|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-12-13|||December 2013||2013-12-01|February 2014|2014-02-01|July 2016|Actual|2016-07-01|February 2015|Actual|2015-02-01||Interventional|||The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients|The Phase 1a/1b Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients|Completed||Phase 1|60|Actual|Nanogen Pharmaceutical Biotechnology Co., Ltd||2|||f||||f||||||||No||2017-10-11 00:45:26.734891|2017-10-11 00:45:26.734891
NCT02063594|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-10-09|||March 2014||2014-03-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers|Phase 1 Single Dose, Double-blind, Dose-escalation, Safety, Tolerability and Pharmacokinetic Study of NCTX (PEGylated Liposomal Iodixanol Injection) in Healthy Volunteers|Terminated||Phase 1|20|Actual|Marval Pharma Ltd.||2|||f||||f||||||||||2017-10-11 00:45:26.810827|2017-10-11 00:45:26.810827
NCT02063581|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-11-01|||February 2014||2014-02-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy Volunteers|A Phase 1, Open-Label Study to Evaluate the Effect of Formulation on the Bioavailability of Ipatasertib (GDC-0068) in Healthy Subjects|Completed||Phase 1|16|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 00:45:26.944571|2017-10-11 00:45:26.944571
NCT02063568|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-12-14|||January 2015||2015-01-01|October 2015|2015-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Use of Thromboelastometry (ROTEM) to Evaluate the Changes in Coagulation With Two Different Doses of Oxytocin Following Cesarean Delivery|The Use of Thromboelastometry (ROTEM) to Evaluate the Changes in Coagulation With Two Different Doses of Oxytocin Following Cesarean Delivery|Withdrawn||N/A|0|Actual|Duke University||2|||f||||||||||||||2017-10-11 00:45:27.123914|2017-10-11 00:45:27.123914
NCT02063555|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-08-01|||February 2014||2014-02-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Phase I Trial of DAR-901|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose, Dose-Ranging Study of the Safety and Immunogenicity of DAR-901, a Killed, Non-Tuberculous Mycobacterial Vaccine, in HIV-negative and HIV-positive Adults Who Have Previously Received BCG|Completed||Phase 1|59|Actual|Dartmouth-Hitchcock Medical Center||3|||f||||f||||||||||2017-10-11 00:45:27.232014|2017-10-11 00:45:27.232014
NCT02063542|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2014-05-27|||April 2014||2014-04-01|February 2014|2014-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Acetylcholine and Postoperative Cognitive Change in Aged Patients|Cerebrospinal Fluid Acetylcholine and Postoperative Cognitive Change in Aged Patients|Unknown status|Recruiting|N/A|100|Anticipated|RenJi Hospital|||1||f||||t||||||Samples With DNA|"     Cerebral spinal fluid   "|||2017-10-11 00:45:27.329741|2017-10-11 00:45:27.329741
NCT02063529|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2016-09-19|||February 2014||2014-02-01|September 2016|2016-09-01|February 2020|Anticipated|2020-02-01|February 2018|Anticipated|2018-02-01||Interventional|FOCULM||FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer|A Phase II Study to Evaluate the Surgical Conversion Rate in Patients Receiving FOLFOXIRI +/- Cetuximab for Unresectable Wild-Type KRAS/NRAS Colorectal Cancer With Metastases Confined to the Liver|Recruiting||Phase 2|138|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:45:27.41817|2017-10-11 00:45:27.41817
NCT02063516|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-01-10|2014-12-10||June 2013||2013-06-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|Guardian||Comparison of Clinical Performance of the Guardian Laryngeal Mask With LMA Proseal|Comparison of Clinical Performance of the Guardian Laryngeal Mask With LMA Proseal — A Perspective, Randomized，Blind Study|Completed||N/A|80|Actual|Tianjin Medical University General Hospital|We only use size-4 devices in adult patients with neuromuscular blockade, we presumed that same results would be obtained in patients who have not received neuromuscular blockade. lastly our data was not blinded causing potential source of bias.|2|||f||||t||||||||||2017-10-11 00:45:27.54091|2017-10-11 00:45:27.54091
NCT02063490|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-12|||November 2011||2011-11-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|MedAM||Nurse-led Intervention to Improve Phosphate Binder Adherence|A Nurse-led Multifactorial Intervention to Improve Phosphate Binder Adherence: Results From a One-year Clinical Trial|Completed||N/A|135|Actual|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-11 00:45:28.154218|2017-10-11 00:45:28.154218
NCT02063477|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-03-17|||November 2013||2013-11-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Oligopin® on Blood Pressure.|Effect of a French Maritim Pine Bark Extract Oligopin® on Blood Pressure: Double Blind, Crossover, Placebo-controlled Nutrition Intervention Trial|Completed||N/A|24|Actual|Technological Centre of Nutrition and Health, Spain||2|||f||||t||||||||||2017-10-11 00:45:28.258098|2017-10-11 00:45:28.258098
NCT02063464|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-07-12|||January 30, 2014||2014-01-30|November 16, 2016|2016-11-16|November 16, 2016|Actual|2016-11-16|November 16, 2016|Actual|2016-11-16||Observational|||Blood Collection From People With Ovarian Cancer|Collection of Blood From Patients With Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Completed||N/A|85|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:45:28.368246|2017-10-11 00:45:28.368246
NCT02063451|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-09-17|||February 2011||2011-02-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Neurohormonal & Behavioral Correlates of Obesity and Weight Loss||Enrolling by invitation||N/A|60|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 00:45:28.478386|2017-10-11 00:45:28.478386
NCT02063438|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-09-19|||February 2014||2014-02-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Thoracotomy Closure Technique and Postoperative Pain Study: A Randomized Controlled Trial|Thoracotomy Closure Technique and Postoperative Pain Study: A Randomized Controlled Trial|Recruiting||N/A|190|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-11 00:45:28.556645|2017-10-11 00:45:28.556645
NCT02063425|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-02-11|||February 2014||2014-02-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|August 2015|Actual|2015-08-01||Interventional|EFLUSTIM||"Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke"|"Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke"|Terminated||N/A|6|Actual|Centre Hospitalier St Anne||2||Not enough recruitment|f||||t||||||||||2017-10-11 00:45:28.653714|2017-10-11 00:45:28.653714
NCT02063412|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-02-01|||August 2013||2013-08-01|February 2017|2017-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens|The Impact of Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens in the Management of Advanced Esophago-gastric Cancer in Hong Kong|Withdrawn||N/A|0|Actual|Chinese University of Hong Kong|||4|Slow recruitment pace|f||||f||||||||||2017-10-11 00:45:28.742929|2017-10-11 00:45:28.742929
NCT02063399|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-04-16|||July 2013||2013-07-01|April 2017|2017-04-01|June 2023|Anticipated|2023-06-01|August 2016|Actual|2016-08-01||Observational|||Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis|Prospective 20,000-person Nasopharyngeal Carcinoma (NPC) Screening Programme Using Plasma Epstein-Barr Virus (EBV) DNA Analysis|Active, not recruiting||N/A|20302|Actual|Chinese University of Hong Kong|||1||f||||f||||||Samples With DNA|"     Plasma samples are retended for future study to evaluate the accuracy of sequencing-based     biomarkers   "|Undecided||2017-10-11 00:45:28.80869|2017-10-11 00:45:28.80869
NCT02063386|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-09-18|||April 2014||2014-04-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study|A Phase I, Single-centre, Open-label Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of a Single Oral Dose of 14C-labelled AZD1722 in Healthy Male Volunteers|Completed||Phase 1|26|Actual|Ardelyx||1|||f||||f||||||||||2017-10-11 00:45:28.910573|2017-10-11 00:45:28.910573
NCT02063373|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-12|||September 2012||2012-09-01|February 2014|2014-02-01||||October 2013|Actual|2013-10-01||Interventional|||Gait, Stair Climbing and Postural Stability in Knee Osteoarthritis Patients After Hyaluronic Acid Injection||Completed||Phase 3|85|Actual|University of Malaya||1|||f||||f||||||||||2017-10-11 00:45:29.040229|2017-10-11 00:45:29.040229
NCT02063360|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2017-08-07|||February 1, 2014||2014-02-01|August 2017|2017-08-01|May 13, 2014|Actual|2014-05-13|May 1, 2014|Actual|2014-05-01||Interventional|||DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)|Open-Label, Single-Sequence Study to Evaluate the Pharmacokinetic Interaction of BMS-663068 With Darunavir/Ritonavir and/or Etravirine in Healthy Subjects|Completed||Phase 1|42|Actual|ViiV Healthcare||3|||f||||f||||||||||2017-10-11 00:45:29.155144|2017-10-11 00:45:29.155144
NCT02063347|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-05-10|||November 2013||2013-11-01|July 2015|2015-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Innate Human Collateral Supply to Different Vascular Regions|Innate Human Collateral Supply to Different Vascular Regions|Completed||N/A|120|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-11 00:45:29.271769|2017-10-11 00:45:29.271769
NCT02063334|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-07-28|||February 2014||2014-02-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|VitDbol||The Effect of a High-dose Oral Vitamin D3 Bolus on Serum 25(OH)D3 and Vitamin D Receptor Target Gene Expression|The Effect of a High-dose Oral Vitamin D3 Bolus on Serum 25-hydroxyvitamin D3 and Vitamin D Receptor Target Gene Expression (VitDbol)|Completed||Phase 1|35|Actual|University of Eastern Finland||2|||f||||f||||||||||2017-10-11 00:45:29.34194|2017-10-11 00:45:29.34194
NCT02063321|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-12|||December 2012||2012-12-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|||Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak Republic|Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak Republic|Unknown status|Enrolling by invitation|N/A|762|Actual|National Institute of Endocrinology and Diabetology, Slovakia|||1||f||||t||||||||||2017-10-11 00:45:29.430937|2017-10-11 00:45:29.430937
NCT02063308|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-07-23|||February 2014||2014-02-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Oxaloacetate Pharmacokinetics and Safety|Oxaloacetate Pharmacokinetics and Safety|Completed||N/A|6|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 00:45:29.507094|2017-10-11 00:45:29.507094
NCT02062931|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-05-12|||March 2012||2012-03-01|May 2014|2014-05-01|November 2016|Anticipated|2016-11-01|May 2015|Anticipated|2015-05-01||Interventional|||Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure|Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Al-Azhar University||1|||f||||t||||||||||2017-10-11 00:45:34.049119|2017-10-11 00:45:34.049119
NCT02063295|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-07-14||2016-07-14|April 2014||2014-04-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury|Randomized, Double-Blind, Placebo Controlled, Phase 2a Trial of ZGN-440 (Subcutaneous Beloranib in Suspension), A Novel Methionine Aminopeptidase 2 Inhibitor, in Obese Subjects With Hypothalamic Injury to Evaluate Weight Reduction and Safety Over 4 Weeks Followed by an Optional 4-Week Open-Label Extension|Completed||Phase 2|14|Actual|Zafgen, Inc.||2|||f||||t||||||||||2017-10-11 00:45:29.578587|2017-10-11 00:45:29.578587
NCT02063282|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-04-20|||February 2014||2014-02-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|2 Weeks|Observational [Patient Registry]|||The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers|The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers|Completed||N/A|394|Actual|Shaare Zedek Medical Center|||2||f||||t||||||||No||2017-10-11 00:45:29.672985|2017-10-11 00:45:29.672985
NCT02063269|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-05-12|||February 2014||2014-02-01|May 2015|2015-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles|Differences of Functional Changes in Brain by Rivastigmine According to Butyrylcholinesterase Alleles in Alzheimer's Disease Patients(Rivastigmine, Imaging, and BuChE in AD: RIBA)|Unknown status|Active, not recruiting|N/A|70|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 00:45:29.750412|2017-10-11 00:45:29.750412
NCT02063256|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2014-05-25|||May 2014||2014-05-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||7 NUTS Study. Diet Modification and Male Fertility.|7 NUTS Study . A Randomized Dietary Intervention Trial on the Influence of Diet on Human Sperm Quality in Subfertile Men.|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Azienda Ospedaliera Città della Salute e della Scienza di Torino||2|||f||||f||||||||||2017-10-11 00:45:29.883893|2017-10-11 00:45:29.883893
NCT02063243|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-13|||January 2010||2010-01-01|February 2014|2014-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Intralesional Cryotherapy With a Argon Gas Based Device for the Treatment of Keloid and Hypertrophic Scars|Intralesional Cryotherapy With a Argon Gas Based Device for the Treatment of Keloid and Hypertrophic Scars|Completed||N/A|33|Actual|VU University Medical Center||1|||f||||f||||||||||2017-10-11 00:45:30.016123|2017-10-11 00:45:30.016123
NCT02063230|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2016-06-21|2015-10-05||March 2014||2014-03-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects|An Open-label, Comparative Study to Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib (AZD6244, ARRY-142886) (Hyd-Sulfate) Following Single Oral Dosing to Healthy Subjects and to Subjects With Mild, Moderate, and Severe Hepatic Impairment|Completed||Phase 1|32|Actual|AstraZeneca|In the moderate group, 2 patients received Selumetinib 25mg and are not included in sumaries for AUC and Cmax. Dose normalized parameters are more appropriate for comparisons between groups and are included for all subjects.|4|||f||||f||||||||||2017-10-11 00:45:30.17008|2017-10-11 00:45:30.17008
NCT02063204|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-13|2015-06-29|||March 2014||2014-03-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects|An Open Label Comparative Study of the Pharmacokinetics, Safety and Tolerability of Selumetinib (AZD6244, ARRY 142886) (Hyd Sulfate) Following a Single Oral Dose in Subjects With Renal Impairment and Healthy Subjects|Completed||Phase 1|24|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:45:30.806952|2017-10-11 00:45:30.806952
NCT02063191|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-11-01|||January 2014||2014-01-01|February 2014|2014-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|AF-Activate||Activation Timing and Atrial Fibrillation|Proof-of-concept Study to Assess Ventricular Activation Timing During Atrial Fibrillation, or Bundle Branch Block and Sinus Rhythm|Terminated||N/A|3|Actual|Essentia Health|||2|Methods of activation timing measurements too imprecise|f||||f||||||||||2017-10-11 00:45:30.932338|2017-10-11 00:45:30.932338
NCT02063178|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-09-14|||December 2013||2013-12-01|November 2015|2015-11-01|June 2018|Anticipated|2018-06-01|January 2017|Anticipated|2017-01-01||Interventional|FITBLUE||Dissemination of the Look Ahead Weight Management Treatment in the Military|Dissemination of the Look Ahead Weight Management Treatment in the Military|Active, not recruiting||N/A|248|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-11 00:45:31.176985|2017-10-11 00:45:31.176985
NCT02063165|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-03-30|||February 2014||2014-02-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|HOW||Healthy Oils for Women (HOW Study)|Healthy Oils for Women: Reducing Visceral Adipose Tissue in Women With Metabolic Syndrome (HOW Study)|Completed||N/A|18|Actual|Ohio State University||1|||f||||t||||||||||2017-10-11 00:45:31.395537|2017-10-11 00:45:31.395537
NCT02063152|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-08-14|||January 1995||1995-01-01|August 2017|2017-08-01||||December 2020|Anticipated|2020-12-01|25 Years|Observational [Patient Registry]|||102 Annual Pap Smear Screening Database Maintenance Project|102 Annual Pap Smear Screening Database Maintenance Project|Recruiting||N/A|300000|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 00:45:31.527681|2017-10-11 00:45:31.527681
NCT02063139|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-01-27|||February 2014||2014-02-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.|A Single (Assessor)-Blind, Randomised, Three-period, Cross-over Study to Compare the Safety of Flutiform pMDI, Fluticasone pMDI, and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years With Mild Persistent Asthma by Means of Knemometry|Completed||Phase 2|48|Actual|Mundipharma Research Limited||3|||f||||||||||||||2017-10-11 00:45:31.610188|2017-10-11 00:45:31.610188
NCT02062918|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-13|||January 2010||2010-01-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|March 2010|Actual|2010-03-01||Interventional|||Abdominal Belt Use to Treat Low Back Pain|Effectiveness of Abdominal Belt for the Chronic Low Back Pain Treatment|Completed||Phase 4|60|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 00:45:34.19833|2017-10-11 00:45:34.19833
NCT02063126|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-02-18|||January 2013||2013-01-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|ReConnect||Clinical Trial to Measure the Maximun HR After ReConnect ® Supplementation vs. Placebo in CFS.|A Randomized, Double-blind, Placebo-controlled, Comparative Clinical Trial to Measure the Maximun Heart Rate During a Cycle Ergometer Test After ReConnect® Supplementation in CFS.|Completed||Phase 2/Phase 3|80|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||||2017-10-11 00:45:31.6934|2017-10-11 00:45:31.6934
NCT02063113|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-01-20|||May 2014||2014-05-01|January 2016|2016-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|MYELOME-PA||Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.|Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.|Recruiting||N/A|100|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 00:45:31.797231|2017-10-11 00:45:31.797231
NCT02063100|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-06-29|||February 2014||2014-02-01|June 2015|2015-06-01||||July 2015|Anticipated|2015-07-01||Interventional|||Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis|Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis—a Multicentre, Prospective, Double-blind, Double-dummy, Randomized Controlled Clinical Trial|Unknown status|Recruiting|Phase 4|720|Anticipated|Chinese PLA General Hospital||5|||f||||t||||||||||2017-10-11 00:45:31.937721|2017-10-11 00:45:31.937721
NCT02063074|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-05-16|||June 2014||2014-06-01|May 2017|2017-05-01|June 2034|Anticipated|2034-06-01|June 2018|Anticipated|2018-06-01||Observational|BELLS||Bone, Endocrine and Lifestyle Longitudinal Study|Bone, Endocrine and Lifestyle Longitudinal Study|Recruiting||N/A|1000|Anticipated|University of Southern California|||1||f||||t|f|f||||Samples Without DNA|"     Blood samples will be tested for lipids, glucose, insulin, estrogens, bone biomarkers.   "|Undecided||2017-10-11 00:45:32.408348|2017-10-11 00:45:32.408348
NCT02063061|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-12-23|||February 2014||2014-02-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|August 2014|Actual|2014-08-01||Interventional|ESWTvsED||Low-energy Linear Extracorporal Shock Wave Therapy for Erectile Dysfunction.|Low-energy Linear Extracorporal Shock Wave Therapy for Erectile Dysfunction.|Completed||N/A|126|Actual|University of Southern Denmark||2|||f||||t||||||||No||2017-10-11 00:45:32.5281|2017-10-11 00:45:32.5281
NCT02063048|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-01-19|||April 2014||2014-04-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Text Messaging for Weight Loss|The Comparative Effectiveness of Clinic-Based Weight Loss Strategies|Completed||N/A|163|Actual|Denver Health and Hospital Authority||2|||f||||t||||||||||2017-10-11 00:45:32.676762|2017-10-11 00:45:32.676762
NCT02063035|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-06|2017-03-23||August 2012|Actual|2012-08-01|June 2017|2017-06-01|April 22, 2015|Actual|2015-04-22|April 22, 2015|Actual|2015-04-22||Interventional|||Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery|Topical Application of Tranexamic Acid to Reduce Postoperative Blood Loss in Posterior Approach Spinal Surgery|Completed||Phase 4|29|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:45:32.798002|2017-10-11 00:45:32.798002
NCT02063022|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-04-26|||February 2009||2009-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EW-1||Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma|Phase III Study on Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma.|Recruiting||Phase 3|220|Anticipated|Italian Sarcoma Group||2|||f||||t||||||||||2017-10-11 00:45:33.195702|2017-10-11 00:45:33.195702
NCT02063009|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-13|||October 2012||2012-10-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|ThermoD-PAC||Measurement of Cardiac Index Using an Implanted Central Venous Access Port in Patients Scheduled for Oncologic High-risk Surgery|Measurement of Cardiac Index by Transpulmonary Thermodilution Using an Implanted Central Venous Access Port: a Prospective Study in Patients Scheduled for Oncologic High-risk Surgery|Completed||N/A|33|Actual|Gustave Roussy, Cancer Campus, Grand Paris|||1||f||||f||||||||||2017-10-11 00:45:33.399552|2017-10-11 00:45:33.399552
NCT02062996|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-08-06|||June 2014||2014-06-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption|The Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption During Functional Endoscopic or Turbinate Reduction Surgery and From the Nasal Mucosa During Operative Dentistry|Withdrawn||Phase 2|0|Actual|Nationwide Children's Hospital||5||Could not receive FDA approval for IND|f||||f||||||||||2017-10-11 00:45:33.477265|2017-10-11 00:45:33.477265
NCT02062983|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-05-12|||June 2012||2012-06-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients|Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients|Suspended||N/A|50|Anticipated|National Guard Health Affairs|||1|Difficulty in enrolling patients|f||||f||||||||||2017-10-11 00:45:33.595924|2017-10-11 00:45:33.595924
NCT02062970|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-08-27|||February 2014||2014-02-01|August 2014|2014-08-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock|Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock|Unknown status|Recruiting|N/A|230|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:45:33.696582|2017-10-11 00:45:33.696582
NCT02062957|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-23|||February 2014||2014-02-01|February 2014|2014-02-01||||July 2014|Anticipated|2014-07-01||Observational|HEAF||Endovascular Function in Atrial Fibrillation (AF) Patients|Endovascular Function in Patients With Atrial Fibrillation|Unknown status|Recruiting|N/A|80|Anticipated|Beijing Chao Yang Hospital|||1||f||||t||||||||||2017-10-11 00:45:33.815797|2017-10-11 00:45:33.815797
NCT02062944|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-09-23|||March 2013||2013-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|SRL||SRL (Sirolimus) Withdrawal|Liver Transplant Tolerance Enhanced By Sirolimus Therapy|Recruiting||N/A|25|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-11 00:45:33.918104|2017-10-11 00:45:33.918104
NCT02062905|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-12-13|2016-02-29||March 2014||2014-03-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Phase 2/3 Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis|A Single Center, Randomized, Double-Masked, Vehicle Controlled Phase 2/3 Study Evaluating the Efficacy and Safety of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model (CAC™)|Completed||Phase 2|68|Actual|Ocular Therapeutix, Inc.||2|||f||||f||||||||||2017-10-11 00:45:34.301944|2017-10-11 00:45:34.301944
NCT02062892|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-12-01|||December 2013||2013-12-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DESIRE||Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients|Differentiating Sirolimus and Everolimus in Combination With Calcineurin Inhibitors in Long-term Maintenance of Kidney Transplant Patients - The Effects on Vascular Endothelial and Kidney Function. The DESIRE Study.|Withdrawn||Phase 4|0|Actual|University of Colorado, Denver||2||"Patients meeting the inclusion/ exclusion criteria did not agree to participate. It became   obvious that recruitment goals could not be met."|f||||||||||||||2017-10-11 00:45:34.610901|2017-10-11 00:45:34.610901
NCT02062879|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-08-21|2017-07-20||April 2014||2014-04-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Ketamine Patient-Controlled Analgesia for Acute Pain|Ketamine Patient-Controlled Analgesia for Acute Pain in Native Airway Multiple and Orthopedic Trauma Patients: A Randomized, Active Comparator, Blinded Trial|Terminated||Phase 3|20|Actual|University of Cincinnati||2||Withdrawals from study due to anticipated effects from study drugs|f||||f||||||||||2017-10-11 00:45:34.733447|2017-10-11 00:45:34.733447
NCT02062866|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-04-15|||April 2013||2013-04-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Purse-String Closure Vs Second Intention|Intradermal Purse-String Closure Vs Second Intention Healing|Completed||N/A|50|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 00:45:35.223963|2017-10-11 00:45:35.223963
NCT02062853|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-07-17|||November 2012||2012-11-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video|CQI Pilot Study Evaluating the Utility of an Educational Video in the Setting of Topical 5-fluorouracil Therapy to Treat Actinic Keratoses and Its Influence on Patient Satisfaction|Completed||N/A|44|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 00:45:35.307991|2017-10-11 00:45:35.307991
NCT02062840|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-08-06|||February 2014||2014-02-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Brain on Whole Body Hyperthermia: A Neuroimaging Study|The Brain on Whole Body Hyperthermia: A Neuroimaging Study|Completed||N/A|23|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 00:45:35.410061|2017-10-11 00:45:35.410061
NCT02062827|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2017-08-23|||September 2014||2014-09-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|M032-HSV-1||Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma|A Phase 1 Study of M032 (NSC 733972), a Genetically Engineered HSV-1 Expressing IL-12, in Patients With Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma|Suspended||Phase 1|36|Anticipated|University of Alabama at Birmingham||1||Updating Protocol, will resume in a few months|f||||t||||||||||2017-10-11 00:45:35.506765|2017-10-11 00:45:35.506765
NCT02062801|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-06-11|2015-05-28||January 2012||2012-01-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional|CEASE||Prophylactic Ephedrine and Combined Spinal Epidurals for Labor|Prophylactic Ephedrine to Reduce Fetal Bradycardia After Combined Spinal Epidural Labor Analgesia: a Randomized Double Blind Placebo-controlled Study|Completed||Phase 4|710|Actual|Sharp HealthCare||2|||f||||f||||||||||2017-10-11 00:45:35.610075|2017-10-11 00:45:35.610075
NCT02062788|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-04-25|||February 2014||2014-02-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of Preoperative Oral Rehydration Solution in Colectomy|Preoperative Oral Carbohydrate-rich Solution in Colorectal Cancer Patients: a Randomized Controlled Trial|Terminated||Phase 3|10|Actual|Seoul National University Hospital||2||patient enrollment was failed.|f||||f||||||||||2017-10-11 00:45:35.965986|2017-10-11 00:45:35.965986
NCT02062762|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-03-31|||February 2014||2014-02-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|IBSR-stud||Internet-based Stress Reduction Training for Students|Internet-based Stress Reduction Training for Students - a Pilot Study|Completed||N/A|88|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 00:45:36.180842|2017-10-11 00:45:36.180842
NCT02062749|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-09-25|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma|A Phase I Trial With Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma|Active, not recruiting||Phase 1|1|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:45:36.248886|2017-10-11 00:45:36.248886
NCT02062736|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-04-27|||February 2010||2010-02-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Observational|METODO||Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.|Studio Osservazionale Per Valutare l'Adeguatezza Del Dosaggio Del Metadone, Nelle Terapie di Mantenimento, in Rapporto Agli Obbiettivi di Outcome, in Pazienti Tossicodipendenti da Eroina. (METODO)|Completed||N/A|500|Actual|L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.|||1||f||||f||||||||||2017-10-11 00:45:36.347721|2017-10-11 00:45:36.347721
NCT02062723|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-02-13|||September 2010||2010-09-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|METHODE||Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMT|Prospective Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients Undergoing a Methadone Maintenance Treatment|Completed||N/A|515|Actual|L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.|||1||f||||f||||||||||2017-10-11 00:45:36.680508|2017-10-11 00:45:36.680508
NCT02062710|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-04-08|2014-09-16||January 2014||2014-01-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo|Antitussive Effect of a Naturally Flavored, Multi-Component Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo|Completed||Phase 4|22|Actual|Montefiore Medical Center||6|||f||||t||||||||||2017-10-11 00:45:36.870315|2017-10-11 00:45:36.870315
NCT02062697|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-06-30|||February 2012||2012-02-01|June 2015|2015-06-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|LUDOC||Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes.|Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes - LUDOC Study|Recruiting||N/A|50|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 00:45:37.195159|2017-10-11 00:45:37.195159
NCT02062684|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-09-14|||June 2013|Actual|2013-06-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|March 2017|Actual|2017-03-01||Interventional|||BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration|A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy|Completed||Phase 2/Phase 3|57|Actual|Anthera Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:45:37.328912|2017-10-11 00:45:37.328912
NCT02062671|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-13|||February 2014||2014-02-01|February 2014|2014-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease||Unknown status|Recruiting|N/A|12|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-11 00:45:37.495137|2017-10-11 00:45:37.495137
NCT02062658|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-11-08|2016-05-19||December 2013||2013-12-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)|Extending Ketamine's Effects in Obsessive-Compulsive Disorder (OCD) With Exposure and Response Prevention (EX/RP)|Completed||Phase 2|10|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-11 00:45:37.617687|2017-10-11 00:45:37.617687
NCT02062645|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-02-07|2016-11-15||February 2014||2014-02-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||The baseline population was the ITT (intent to treat) population defined as: met all entry criteria, received study drug and had at least one blood pressure measurement after Visit 1 (Day 0)|Study of Efficacy and Safety of CVAA489 in Hypertensive Patients|A Single-Arm Open-Label Multicenter Phase IV Clinical Trial to Explore the Blood Pressure Lowering Effect of Exforge® (Amlodipine/Valsartan: AMLO/VAL) in Hypertensive Patients|Completed||Phase 4|115|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:45:37.850521|2017-10-11 00:45:37.850521
NCT02062632|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-05-30|||April 14, 2014|Actual|2014-04-14|February 2017|2017-02-01|December 14, 2017|Anticipated|2017-12-14|December 14, 2017|Anticipated|2017-12-14||Interventional|||Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy|A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy|Active, not recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 00:45:38.273424|2017-10-11 00:45:38.273424
NCT02062619|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-11-03|||March 2014||2014-03-01|April 2016|2016-04-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Brain Mechanisms Underlying Reading Improvement in Central Alexia|Brain Mechanisms Underlying Reading Improvement in Central Alexia|Completed||N/A|23|Actual|University College, London||2|||f||||t||||||||||2017-10-11 00:45:38.46523|2017-10-11 00:45:38.46523
NCT02062606|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-06-14|||May 2014||2014-05-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|February 2018|Anticipated|2018-02-01||Observational|||MESA Rail™ AIS Study - Preservation of Curve Correction|Preservation of Thoracic Kyphosis and Coronal Curve Correction as a Function of Rod Stiffness in the Surgical Treatment of Adolescent Idiopathic Scoliosis With the Use of the K2M MESA Rail™ Deformity System|Enrolling by invitation||N/A|204|Anticipated|K2M, Inc.|||1||f||||t||||||||||2017-10-11 00:45:38.611136|2017-10-11 00:45:38.611136
NCT02062593|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-09-21|||December 2013|Actual|2013-12-01|February 2017|2017-02-01|September 2017|Actual|2017-09-01|August 2017|Actual|2017-08-01||Interventional|ORBITA||Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina|Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease|Completed||N/A|230|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 00:45:38.743268|2017-10-11 00:45:38.743268
NCT02062580|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-01-25|2016-10-25||June 2010||2010-06-01|January 2017|2017-01-01||||April 2012|Actual|2012-04-01||Interventional|||Early Versus Delayed BCG Vaccination of HIV-exposed Infants|Influence of BCG Immunization on Immune Responses and Disease Progression in South African HIV Exposed and Infected Infants|Completed||Phase 2|149|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-11 00:45:38.867518|2017-10-11 00:45:38.867518
NCT02062567|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-02-22|||February 2014||2014-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Ultrasonographic Guided Treatment of Acute Achilles Tendon Rupture. Evaluation of Two Novel Ultrasonographic Measurements||Active, not recruiting||N/A|130|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 00:45:39.212899|2017-10-11 00:45:39.212899
NCT02062554|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-05-29|||May 2006||2006-05-01|May 2015|2015-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|10 Years|Observational [Patient Registry]|BHS||Brasilia Heart Study|Brasilia Heart Study of Outcome Markers in ST-elevation Myocardial Infarction|Recruiting||N/A|1000|Anticipated|University of Campinas, Brazil|||1||f||||f||||||Samples With DNA|"     Plasma Leucocyte DNA   "|||2017-10-11 00:45:39.277416|2017-10-11 00:45:39.277416
NCT02062541|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-02-01|||June 2015||2015-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Functional Assessment and Immediate Rehabilitation of ED Admitted Elderly With Reduced Functional Performance|Effect of Functional Assessment and Immediate Rehabilitation of ED Admitted Elderly With Reduced Functional Performance|Completed||N/A|336|Actual|University of Southern Denmark||4|||f||||f||||||||||2017-10-11 00:45:39.375274|2017-10-11 00:45:39.375274
NCT02062528|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-12-08|||March 2014||2014-03-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|BOOM3||Hot Flashes and Omega 3|Evaluation de l'efficacité Des Acides Gras oméga 3 Hautement concentrés en EPA Sur Les bouffées de Chaleur, Chez Des Femmes en période de péri-ménopause et ménopause : étude Monocentrique, en Groupes parallèles, contrôlée, randomisée vs Placebo|Completed||N/A|136|Actual|Vivatech||2|||f||||f||||||||||2017-10-11 00:45:39.442019|2017-10-11 00:45:39.442019
NCT02062515|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-07-14|||February 2014||2014-02-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Interventional|||Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency|Safety Assessment of Icotinib in Advanced NSCLC Patients With Hepatic Insufficiency: A Multi-center, Open-label, Single-arm Study|Unknown status|Recruiting|Phase 2|30|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 00:45:39.516678|2017-10-11 00:45:39.516678
NCT02062502|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-03-15|2016-02-02||March 2014||2014-03-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional||All randomized participants|Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)|A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ New Seed Process (NSP) Administered Concomitantly With M-M-R™ II|Completed||Phase 3|611|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:45:39.611476|2017-10-11 00:45:39.611476
NCT02062489|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-10-12|||May 2014||2014-05-01|October 2016|2016-10-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|||Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients||Recruiting||Phase 4|688|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:45:40.144422|2017-10-11 00:45:40.144422
NCT02062476|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-02-12|||July 2013||2013-07-01|February 2014|2014-02-01||||August 2014|Anticipated|2014-08-01||Interventional|||Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy|EPIGENETIC EFFECTS ELICITED BY LACTOBACILLUS GG IN CHILDREN WITH COW'S MILK ALLERGY: A POSSIBLE EFFECT OF ATOPIC MARCH|Unknown status|Recruiting|Phase 2|20|Anticipated|Federico II University||2|||f||||||||||||||2017-10-11 00:45:40.271815|2017-10-11 00:45:40.271815
NCT02062463|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-12-18|||June 2014||2014-06-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|ELIOT||Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With Asthma|A 12 Week, Randomized, Open-Label, Parallel Group Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® (160/4.5 and 320/9 mcg) as Compared to SYMBICORT® TURBOHALER® (200/6 and 400/12 mcg) as Treatment for Adult Patients With Asthma|Completed||Phase 4|400|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 00:45:40.357527|2017-10-11 00:45:40.357527
NCT02062450|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-05-02|2015-12-09||May 2013||2013-05-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational||A total of 255 patients were included in the Global Study Cohort of which 191 had a Primary Hip surgery and 64 had a Revision Hip surgery.|Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup|Multicentre, Observational Study Evaluating the Clinical and Radiological Outcomes of Hip Arthroplasty Using the Dual Mobility Cup|Completed||N/A|379|Actual|Tornier, Inc.|||2||f||||f||||||||No||2017-10-11 00:45:40.669576|2017-10-11 00:45:40.669576
NCT02062437|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-05-02|2015-12-09||September 2013||2013-09-01|May 2016|2016-05-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Observational|CERAM|132 eligible patients were identified and contacted by the investigators: all patients were still implanted with the same THR system when contacted for study participation, including 2 patients who died before this contact: 80 patients were enrolled and completed the study per protocol at the 2-year follow-up visit without any protocol deviations.|Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair|Multicentric Observational Study Evaluating Clinical and Radiological Results of a Total Hip Arthroplasty Using a Ceramic Friction Pair|Completed||N/A|132|Actual|Tornier, Inc.|||1||f||||f||||||||||2017-10-11 00:45:43.512937|2017-10-11 00:45:43.512937
NCT02062424|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-05-29|||February 2014||2014-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|DIPI||Diet and Prevention of Ischemic Heart Disease: a Translational Approach|Diet and Prevention of Ischemic Heart Disease: a Translational Approach|Completed||N/A|222|Actual|Technical University of Denmark||3|||f||||t||||||||||2017-10-11 00:45:43.886497|2017-10-11 00:45:43.886497
NCT02062411|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-04-28|||October 2013||2013-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder|A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder|Completed||N/A|108|Actual|Peking University Sixth Hospital||3|||f||||f||||||||||2017-10-11 00:45:43.998891|2017-10-11 00:45:43.998891
NCT02062398|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-10-20|||May 2014||2014-05-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|PNP||BlueWind Medical Reprieve System for the Treatment of PNP|Safety and Performance of the BlueWind Medical Reprieve System for the Treatment of Patients With Peripheral Neuropathic Pain (PNP)|Unknown status|Active, not recruiting|N/A|20|Anticipated|Rainbow Medical||1|||f||||f||||||||||2017-10-11 00:45:44.096371|2017-10-11 00:45:44.096371
NCT02062385|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-03-17|2016-03-03||May 2014||2014-05-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||All randomized participants|Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants|Completed||Phase 3|4040|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:45:44.217905|2017-10-11 00:45:44.217905
NCT02062372|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-08-17|||December 10, 2014|Actual|2014-12-10|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Spatial Analysis and Validation of Glioblastoma on 7 T MRI|Spatial Analysis and Validation of Glioblastoma on 7 T MRI|Active, not recruiting||N/A|12|Anticipated|Maastricht Radiation Oncology||1|||f||||f||||||||||2017-10-11 00:45:45.293119|2017-10-11 00:45:45.293119
NCT02062359|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-05-19|2016-04-11||February 2014||2014-02-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma|Phase II Study of CD62L+-Derived T Lymphocytes Transduced With a T Cell Receptor Recognizing the NY-ESO-1 Antigen and Aldesleukin Following Lymphodepletion in Patients With NY-ESO-1 Expressing Melanoma|Terminated||Phase 2|2|Actual|National Institutes of Health Clinical Center (CC)|Study was closed due to poor accrual and the lower than expected expression of NY-ESO in participants screened.|1||Study was closed due to poor accrual.|f||||f||||||||No||2017-10-11 00:45:45.41795|2017-10-11 00:45:45.41795
NCT02062346|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Endothelin Antagonism in ANCA Vasculitis|The Vascular Effects of Endothelin Receptor Antagonism in Systemic Vasculitis|Recruiting||N/A|30|Anticipated|University of Edinburgh||4|||f||||f||||||||||2017-10-11 00:45:45.775872|2017-10-11 00:45:45.775872
NCT02062333|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-11-07|||January 2014||2014-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effects of the Drugs Used in Hypotensive Anaesthesia on Cochlea|The Effects of the Drugs Used in Hypotensive Anaesthesia on Cochlea|Completed||Phase 4|47|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 00:45:45.933589|2017-10-11 00:45:45.933589
NCT02062320|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-12|||October 2009||2009-10-01|February 2014|2014-02-01||||October 2011|Actual|2011-10-01||Observational|PCAPS||Establishment and Evaluation of a Post Caesarean Acute Pain Service (PCAPS)|Establishment and Evaluation of a Post Caesarean Acute Pain Service|Completed||N/A|407|Actual|Brno University Hospital|||2||f||||f||||||||||2017-10-11 00:45:46.041363|2017-10-11 00:45:46.041363
NCT02062307|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-12|||August 2012||2012-08-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Observational|||Bone Mineral Markers in Hypogonadism|Osteoprotegerin, Fibroblast Growth Factor 23 and Vitamin D3 Levels in Male Patients With Hypogonadism|Completed||N/A|92|Actual|Gulhane School of Medicine|||2||f||||f||||||Samples Without DNA|"     Serum and plasma samples   "|||2017-10-11 00:45:46.130482|2017-10-11 00:45:46.130482
NCT02062294|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-06-13|2016-01-14||July 31, 2010|Actual|2010-07-31|May 2017|2017-05-01|September 30, 2011|Actual|2011-09-30|September 30, 2011|Actual|2011-09-30||Observational|||An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients|Retrospective Review of Valganciclovir Efficacy in Preventing CMV Disease in D+/R- Liver Transplant Recipients - A Non-Interventional Program|Completed||N/A|14|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:45:46.258216|2017-10-11 00:45:46.258216
NCT02062281|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2014-02-12|||November 2013||2013-11-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults|A Phase 4, Randomized, Single-blind Trial to Evaluate Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine When Administered Simultaneously With Trivalent Inactivated Influenza Vaccine in Healthy Children Aged 3-7years and Healthy Adults 65 Aged 50-65years.|Completed||Phase 4|2225|Actual|Jiangsu Province Centers for Disease Control and Prevention||3|||f||||t||||||||||2017-10-11 00:45:46.778346|2017-10-11 00:45:46.778346
NCT02062268|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2016-08-30|||March 2014||2014-03-01|February 2014|2014-02-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Observational|KAP||The Study of KAP on Drink Driving in Jiangsu Province in China|Study of KAP and Influential Factors on Drink Driving in Public in Jiangsu Province in China|Completed||N/A|3565|Actual|Jiangsu Province Centers for Disease Control and Prevention|||5||f||||f||||||||||2017-10-11 00:45:46.895371|2017-10-11 00:45:46.895371
NCT02062255|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-10-24|||October 2013||2013-10-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Impact of COX2 on Sera Biomarkers From Obese Subjects|A Phase 0, Investigator Initiated Study, Evaluating the Impact of COX2 Inhibition on Human Sera Biomarkers From Obese Subjects|Completed||Early Phase 1|126|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-10-11 00:45:46.979469|2017-10-11 00:45:46.979469
NCT02062242|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-01|2014-02-11|||March 2013||2013-03-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Electrical Stimulation and Vaginal Palpation in Pelvic Floor Muscles Awareness|Electrical Stimulation and Vaginal Palpation in the Pelvic Floor Muscles Awareness: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|120|Anticipated|University of Sao Paulo||4|||f||||f||||||||||2017-10-11 00:45:47.096827|2017-10-11 00:45:47.096827
NCT02062229|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-12-10|||February 2012||2012-02-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|October 2013|Actual|2013-10-01||Observational|||Oxidative Stress and Lipidomics in Male Infertility|Oxidative Stress, Vitamin E and Lipidomics in Seminal Fluid as Potential Link to Infertility|Active, not recruiting||N/A|120|Anticipated|University of Roma La Sapienza|||4||f||||t||||||Samples Without DNA|"     Collection of male seminal fluid   "|||2017-10-11 00:45:47.2149|2017-10-11 00:45:47.2149
NCT02062216|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-03-13|||February 2015||2015-02-01|March 2014|2014-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|Receptors||Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis|Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis|Not yet recruiting||N/A|50|Anticipated|University of Roma La Sapienza|||2||f||||f||||||||||2017-10-11 00:45:47.305456|2017-10-11 00:45:47.305456
NCT02062203|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-03-29|||January 2014||2014-01-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of AKB-6548 on Cardiac Repolarization Intervals in Healthy Volunteers|A Phase 1, Single-Center, Partially Double-Blinded, Active and Placebo Controlled, Randomized 4-Way Crossover Study to Evaluate the Effect of AKB-6548 on Cardiac Repolarization Intervals in Healthy Volunteers|Completed||Phase 1|50|Actual|Akebia Therapeutics||4|||f||||f||||||||||2017-10-11 00:45:47.400949|2017-10-11 00:45:47.400949
NCT02062190|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-12-07|||March 2014||2014-03-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia|Effects of Reveratrol on Cardiovascular Risk Markers and Cognitive Performance in Patients With Schizophrenia: a Randomized Clinical Trilal|Completed||Phase 2|19|Actual|Federal University of Rio Grande do Sul||2|||f||||t||||||||||2017-10-11 00:45:47.516507|2017-10-11 00:45:47.516507
NCT02061995|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-12|||December 2013||2013-12-01|February 2014|2014-02-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis|Treatment of Severe Osteoporosis by Intravenous Infusion of Pre-osteoblastic Cells - An Open Pilot Study|Unknown status|Recruiting|Phase 2|20|Anticipated|Erasme University Hospital||1|||f||||t||||||||||2017-10-11 00:45:50.456068|2017-10-11 00:45:50.456068
NCT02062177|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-08-29|2014-05-13||February 2014||2014-02-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|Propofol TCI||Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy|Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy: a Randomized Double Blind Controlled Study|Completed||Phase 4|140|Actual|Università Vita-Salute San Raffaele||2|||f||||t||||||||||2017-10-11 00:45:47.644312|2017-10-11 00:45:47.644312
NCT02062164|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-09-14|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|January 2028|Anticipated|2028-01-01|January 2019|Anticipated|2019-01-01||Observational|YES||Weight Loss Surgery in Adolescents With Extreme Obesity|Effectiveness and Safety of Weight Loss Surgery in Adolescents With Extreme Obesity Within a Structured Pre- and Post-surgery Treatment Program, Subproject 3|Recruiting||N/A|60|Anticipated|University of Ulm|||2||f||||t||||||Samples With DNA|"     Samples of fasting plasma, serum, DNA, urine, visceral and subcutaneous fat will be retained.   "|||2017-10-11 00:45:47.956994|2017-10-11 00:45:47.956994
NCT02062151|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-04-25|||February 2014||2014-02-01|April 2015|2015-04-01||||July 2015|Anticipated|2015-07-01||Interventional|||Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies|Acupuncture Use in Infants Treated for Neonatal Abstinence Syndrome: a Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|University of South Florida||1|||f||||t||||||||||2017-10-11 00:45:48.129728|2017-10-11 00:45:48.129728
NCT02062138|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-05-19|||January 2014|Actual|2014-01-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||Effectiveness of Passive and Active ROM Exercises Following TKA|Effectiveness of New Interventional Approaches to Improve Physical Function Following Total Knee Arthroplasty|Completed||N/A|60|Actual|University of Rostock||3|||f||||f||||||||||2017-10-11 00:45:48.231322|2017-10-11 00:45:48.231322
NCT02062125|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-11-17|||October 2012||2012-10-01|November 2016|2016-11-01|December 2030|Anticipated|2030-12-01|October 2022|Anticipated|2022-10-01|10 Years|Observational [Patient Registry]|SSc-calcinosis||Calcinosis in a Single-Center Scleroderma Population|A Prospective, Observational Study of Calcinosis in a Single-Center Population With Scleroderma-Spectrum Disorders|Recruiting||N/A|300|Anticipated|Rutgers, The State University of New Jersey|||1||f||||f||||||||Undecided||2017-10-11 00:45:48.412908|2017-10-11 00:45:48.412908
NCT02062112|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-03-27|||February 2014||2014-02-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Tolerability of Bowel Preparation Laxative for Colonoscopy|Comparison of Patterns of Laxative Ingestion to Improve Bowel Preparation for Colonoscopy: A Pilot Randomized Trial|Recruiting||N/A|300|Anticipated|Howard University||3|||f||||||||||||||2017-10-11 00:45:49.376754|2017-10-11 00:45:49.376754
NCT02062099|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-02-11|||January 2014||2014-01-01|February 2014|2014-02-01|January 2018|Anticipated|2018-01-01|January 2016|Anticipated|2016-01-01||Interventional|NIDeCo||PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)|PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)|Recruiting||Phase 1|36|Anticipated|University Hospital, Tours||1|||f||||t||||||||||2017-10-11 00:45:49.55249|2017-10-11 00:45:49.55249
NCT02062086|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-20|||June 2014||2014-06-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|MM-DC||Estimation of Muscle Mass in Older Adults Using Deuterated Creatine|Estimation of Muscle Mass in Older Adults Using Deuterated Creatine|Recruiting||N/A|62|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 00:45:49.685353|2017-10-11 00:45:49.685353
NCT02062073|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-03-15|||January 2014||2014-01-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion|A Randomized, Controlled Study to Evaluate the Sensitizing Potential of Abametapir Lotion in Healthy Volunteers Using a Repeat Insult Patch Test Design|Completed||Phase 1|238|Actual|Hatchtech Pty Ltd||4|||f||||f||||||||||2017-10-11 00:45:49.794336|2017-10-11 00:45:49.794336
NCT02062060|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-09-09||2015-08-25|February 2014||2014-02-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation|Hatchtech Study of a Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation|Completed||Phase 3|325|Actual|Hatchtech Pty Ltd||2|||f||||f||||||||||2017-10-11 00:45:49.916902|2017-10-11 00:45:49.916902
NCT02062047|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-11|||December 2007||2007-12-01|February 2014|2014-02-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Full-mouth and Partial-mouth Scaling and Root Planing in Type 2 Diabetic Subjects|Full-mouth and Partial-mouth Scaling and Root Planing in Type 2 Diabetic Subjects: Clinical, Immunological and Microbiological Outcomes|Completed||Phase 4|60|Actual|University of Guarulhos||3|||f||||t||||||||||2017-10-11 00:45:50.027503|2017-10-11 00:45:50.027503
NCT02062021|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-04-20|||January 2014||2014-01-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|December 2014|Actual|2014-12-01||Observational|||Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease|Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease: a CALIBER Proposal Using Linked GPRD-MINAP-HES Data|Unknown status|Active, not recruiting|N/A|200000|Anticipated|University College, London|||1||f||||t||||||||||2017-10-11 00:45:50.246267|2017-10-11 00:45:50.246267
NCT02062008|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-10-01|||December 2014||2014-12-01|October 2014|2014-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications|Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 00:45:50.348538|2017-10-11 00:45:50.348538
NCT02053428|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-11-14|||June 2013||2013-06-01|January 2014|2014-01-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||Comparison of Percutaneous Image-guided Gastrostomies|Comparison of Percutaneous Image-guided Gastrostomies: A Single Centre Pilot Study|Completed||N/A|60|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 00:48:04.04526|2017-10-11 00:48:04.04526
NCT02061982|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-05-08|||November 2013||2013-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||Do It Yourself (DIY) Coffee Study; Test Effect of Coffee on Cognition in an at Home Setting|A Non Invasive Intervention Study Performed by Subjects Themselves at Home; Evaluation of Study Infrastructure by Measuring the Effect of Caffeine on Attention and Alertness|Completed||Phase 2/Phase 3|70|Actual|TNO||2|||f||||f||||||||||2017-10-11 00:45:50.697059|2017-10-11 00:45:50.697059
NCT02061969|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-08-14|||April 25, 2014||2014-04-25|August 2017|2017-08-01|April 10, 2017|Actual|2017-04-10|April 10, 2017|Actual|2017-04-10||Interventional|||ADA Linagliptin in Long Term Care|A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Long-Term Care Residents With Type 2 Diabetes|Completed||Phase 4|147|Actual|Emory University||2|||f||||t||||||||||2017-10-11 00:45:50.804219|2017-10-11 00:45:50.804219
NCT02061956|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-02-11|||January 2011||2011-01-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma|A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma|Completed||N/A|647|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-11 00:45:50.931211|2017-10-11 00:45:50.931211
NCT02061943|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-05-27|||October 2015||2015-10-01|May 2016|2016-05-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change|Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change|Withdrawn||N/A|0|Actual|Emory University|||1|Study not started|f||||f||||||||||2017-10-11 00:45:51.026255|2017-10-11 00:45:51.026255
NCT02061930|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-11|||February 2014||2014-02-01|February 2014|2014-02-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Observational|PES/WES||Evaluation of the Aesthetic Outcomes of the Single Crowns Supported by Tissue Level Implants|Evaluation of the Soft Tissue Stability Around Single Crowns Supported by Tissue Level Implants Placed in Non-augmented Healed Sites in the Anterior Maxilla: a Retrospective Study|Unknown status|Not yet recruiting|N/A|90|Anticipated|Shanghai 9th People's Hospital|||1||f||||f||||||||||2017-10-11 00:45:51.115508|2017-10-11 00:45:51.115508
NCT02061917|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-02-15|||February 2007||2007-02-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|November 2007|Actual|2007-11-01||Interventional|QoL||Switching From Usual Brand Cigarettes to a Tobacco-heating Cigarette or Snus|Switching From Usual Brand Cigarettes to a Tobacco-heating Cigarette or Snus - A Multi-center Evaluation of Health-related Quality of Life Assessments and Biomarkers of Exposure and Harm|Completed||N/A|163|Actual|R.J. Reynolds Tobacco Company||3|||f||||f||||||||No||2017-10-11 00:45:51.251094|2017-10-11 00:45:51.251094
NCT02061904|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2017-10-03|||January 2014||2014-01-01|October 2017|2017-10-01|January 2017|Actual|2017-01-01|January 2016|Actual|2016-01-01||Interventional|BMD&BIG||Bone Mineral Density Changes of the Acetabulum After Revision Hip Arthroplasty Using Bone Impaction Grafting|Prospective Exploratory Study:Bone Mineral Density Changes of the Acetabulum After Revision Hip Arthroplasty Using Bone Impaction Grafting|Completed||N/A|20|Actual|Rijnstate Hospital||5|||f||||f||||||||||2017-10-11 00:45:51.386057|2017-10-11 00:45:51.386057
NCT02061891|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-10|||November 2010||2010-11-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|VERDICT-EDI||Very Early veRsus Deferred Invasive Evaluation Using Computerized Tomography in Patients With Acute Coronary Syndromes|Entire Danish Initiative To ImrpOve Revascularization Strategies (EDITORS) - A Randomised Evaluation of Clinical Outcome After Acute or Deferred Invasive Intervention Integrated With MDCT Imaging in Patients With Acute Coronary Syndromes|Active, not recruiting||N/A|2500|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 00:45:51.493679|2017-10-11 00:45:51.493679
NCT02061878|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-08-11|||August 2014||2014-08-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects|A Randomized Controlled Study to Evaluate the Effect of Bexarotene - an RXR Agonist - on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects|Completed||Phase 1|12|Actual|ReXceptor, Inc.||2|||f||||f||||||||||2017-10-11 00:45:51.606363|2017-10-11 00:45:51.606363
NCT02061865|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-02-09|||February 2014||2014-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD||Completed||Phase 1|12|Actual|Regeneron Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:45:51.702543|2017-10-11 00:45:51.702543
NCT02061852|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-10-20|||July 2014||2014-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SIMETOL||Evaluation of the Safety of the Medical Device Simeox®|Prospective Trial for the Evaluation of Safety, Tolerability and Efficacy of the Medical Device Simeox ® Compared to Traditional Respiratory Physiotherapy Techniques for Airway Secretion Clearance|Terminated||N/A|15|Actual|Physio-Assist||2|||f||||f||||||||||2017-10-11 00:45:51.787547|2017-10-11 00:45:51.787547
NCT02061839|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-12|||March 2013||2013-03-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Prevention of Melasma Relapse During Summertime|Prevention of Melasma Relapse During Summertime|Completed||N/A|40|Actual|Centre de Pharmacologie Clinique Applique a la Dermatologie||2|||f||||f||||||||||2017-10-11 00:45:51.88175|2017-10-11 00:45:51.88175
NCT02061826|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2014-02-15|||May 2014||2014-05-01|February 2014|2014-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01|3 Years|Observational [Patient Registry]|||Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)|Establishment of Drug-induced Liver Injury Databases and Application of Circulating miRNA|Unknown status|Not yet recruiting|N/A|800|Anticipated|Beijing Ditan Hospital|||1||f||||t||||||Samples With DNA|"     whole blood, serum,plasma,PBMC   "|||2017-10-11 00:45:51.958729|2017-10-11 00:45:51.958729
NCT02061813|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-06-30|||January 2014||2014-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion|A 21-Day, Randomized, Controlled Study to Evaluate the Irritation Potential of Abametapir Lotion in Healthy Volunteers, Using a Cumulative Irritant Patch Test Design|Completed||Phase 1|37|Actual|Hatchtech Pty Ltd||4|||f||||f||||||||||2017-10-11 00:45:52.038321|2017-10-11 00:45:52.038321
NCT02053415|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-03-13|||January 2014||2014-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Krill Oil as Supplementation to Healthy Young Adults.|Study of the Effect of Krill Oil Supplement on Omega-3 Fatty Acid Index and Tolerance|Completed||N/A|35|Actual|University of Bergen||2|||f||||f||||||||||2017-10-11 00:48:04.116298|2017-10-11 00:48:04.116298
NCT02061800|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-07-13|||June 3, 2013|Actual|2013-06-03|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant|CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplant for Malignant Disease|Recruiting||Phase 1/Phase 2|25|Anticipated|Columbia University||3|||f||||t|t|f||||||||2017-10-11 00:45:52.183859|2017-10-11 00:45:52.183859
NCT02061787|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-02-18|||September 2010||2010-09-01|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31|5 Years|Observational [Patient Registry]|CPETPH||the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension|the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension|Recruiting||N/A|300|Anticipated|Chinese Pulmonary Vascular Disease Research Group|||1||f||||f||||||||No||2017-10-11 00:45:52.416298|2017-10-11 00:45:52.416298
NCT02061761|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-10-04|||February 25, 2014|Actual|2014-02-25|October 2017|2017-10-01|January 15, 2020|Anticipated|2020-01-15|June 28, 2018|Anticipated|2018-06-28||Interventional|||Safety Study of Anti-LAG-3 in Relapsed or Refractory Hematologic Malignancies|A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 (BMS-986016) in Monoclonal Antibody (BMS-986016) Administered Alone and in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Relapsed or Refractory B-Cell Malignancies|Recruiting||Phase 1/Phase 2|132|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-11 00:45:52.617569|2017-10-11 00:45:52.617569
NCT02061748|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2017-06-07|2017-03-13||October 28, 2014|Actual|2014-10-28|June 2017|2017-06-01|March 15, 2016|Actual|2016-03-15|March 15, 2016|Actual|2016-03-15||Observational||Number of selected patients (total) before propensity score matching.|The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage|The Comparative Safety and Effectiveness of Warfarin and Dabigatran Utilized in the Humana Non-Valvular Atrial Fibrillation (NVAF) Patient Population-A Retrospective Database Analysis|Completed||N/A|38499|Actual|Boehringer Ingelheim|This was retrospective study using the Humana database. Adverse events (other than the primary and secondary endpoints) were not collected per protocol.||2||f||||||||||||||2017-10-11 00:45:52.828692|2017-10-11 00:45:52.828692
NCT02061735|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-12|2015-05-05|||October 2011||2011-10-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities|Ontogeny and Quantitative Multimodal Skin Imaging of Infantile Hemangiomas|Completed||N/A|118|Actual|Children's Hospital Medical Center, Cincinnati|||3||f||||f||||||||||2017-10-11 00:45:54.085148|2017-10-11 00:45:54.085148
NCT02061722|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-05-31|||January 2013||2013-01-01|March 2016|2016-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PEARL-HD||[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET.|[PETDE10] Imaging of Phosphodiesterase 10 A (PDE10A) Enzyme Levels in the Living Human Brain of Huntington´s Disease Gene Expansion Carriers and Healthy Controls With Positron Emission Tomography|Completed||Early Phase 1|90|Actual|CHDI Foundation, Inc.||1|||f||||t||||||||||2017-10-11 00:45:54.197602|2017-10-11 00:45:54.197602
NCT02061709|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-03-19|||January 2014||2014-01-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber|A Double-Blind, Randomised, Placebo-Controlled Study to Evaluate Three Dose Regimens of Ragweed-SPIRE in Ragweed Allergic Subjects Following Challenge With Ragweed Allergen in an Environmental Exposure Chamber|Completed||Phase 2|280|Actual|Circassia Limited||4|||f||||f||||||||||2017-10-11 00:45:54.342802|2017-10-11 00:45:54.342802
NCT02061696|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-07-20|2017-07-20||January 2014||2014-01-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|ARISTOCRAT||ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System|A Randomized Controlled Trial to Assess Safety and Efficacy of AXERA 2 Access System Compared to Manual Compression|Terminated||N/A|39|Actual|Borgess Research Institute|Early termination due to device being modified and no longer available to the investigator.|2||Device was modified and no longer available to investigator|f||||f||||||||||2017-10-11 00:45:54.609671|2017-10-11 00:45:54.609671
NCT02061683|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-05-19|2014-05-19||April 2010||2010-04-01|May 2014|2014-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|LOTUS||A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension||Completed||Phase 4|263|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:45:54.978901|2017-10-11 00:45:54.978901
NCT02061670|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-01-20|||January 2014||2014-01-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma|A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Parallel-Group Study to Assess the Safety and Tolerability of Ragweed-SPIRE in Subjects With Asthma and Ragweed-Induced Rhinoconjunctivitis|Completed||Phase 2|55|Actual|Circassia Limited||3|||f||||f||||||||||2017-10-11 00:45:55.230715|2017-10-11 00:45:55.230715
NCT02061657|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-08-09|||June 2013||2013-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Impact of Misoprostol on Blood Loss In Myomectomy Operations|Phase 1 Study of Misoprostol in Reducing Intraoperative Bleeding in Myomectomy Operations|Completed||Phase 3|50|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:45:55.34699|2017-10-11 00:45:55.34699
NCT02061644|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-04-04|||March 2014||2014-03-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Spinal Anesthesia - Intraocular Pressure|Intraocular Pressure Changes After Spinal Anesthesia: Acute and Subacute Effects|Completed||N/A|40|Actual|Adiyaman University Research Hospital||1|||f||||f||||||||||2017-10-11 00:45:55.450048|2017-10-11 00:45:55.450048
NCT02061631|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-10-07|||May 2014||2014-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|DECIDE||Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck|Open Label, Non Controlled, Non Randomized, Interventional Study to Evaluate the Response Rate After Induction Therapy With DocEtaxel and CIsplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of heaD and nEck|Completed||Phase 2|35|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:45:55.538853|2017-10-11 00:45:55.538853
NCT02061618|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-04-01|||June 2014||2014-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CURE-D||Culturally Relevant Exercise for Diabetes (CURE-D)|Culturally Relevant Exercise for Diabetes (CURE-D)|Completed||N/A|29|Actual|Palo Alto Medical Foundation||2|||f||||f||||||||||2017-10-11 00:45:55.646049|2017-10-11 00:45:55.646049
NCT02061605|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-05-04|||June 2016||2016-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|LTW-KIDNEY||First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial Nephrectomy|Phase-I Feasibility Trial To Study The Safety Of Laser Tissue Welding For Sealing Resected Kidney Surfaces After Laparoscopic Partial Nephrectomy|Recruiting||Phase 1|10|Anticipated|Laser Tissue Welding, Inc.||1|||f||||t||||||||No||2017-10-11 00:45:55.755303|2017-10-11 00:45:55.755303
NCT02061592|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-08-20|2015-07-06||January 2014||2014-01-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||The analysis population consists of all randomized subjects. Randomized subjects are subjects that have signed informed consent and have been randomized to 1 of the 2 treatment arms.|Evaluation of Etafilcon A Daily Disposable Lenses|Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses|Completed||N/A|136|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 00:45:55.90387|2017-10-11 00:45:55.90387
NCT02061579|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-09-16|||January 2016||2016-01-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|IMPACT||Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study|Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study|Recruiting||N/A|300|Anticipated|Stanford University||3|||f||||f||||||||||2017-10-11 00:45:56.336742|2017-10-11 00:45:56.336742
NCT02061566|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-23|||February 2014||2014-02-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Indoxyl Sulfate Induces Leukocyte-endothelial Interactions Through Up-regulation of ICAM-1 in Acute Kidney Injury|National Taiwan University Hospital Yu-Lin Branch|Unknown status|Not yet recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples Without DNA|"     Serum BUN, Cre, ICAM-1   "|||2017-10-11 00:45:56.4624|2017-10-11 00:45:56.4624
NCT02061553|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-10-03|||June 2013||2013-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||SMS Messaging to Reduce Depression and Anxiety Following TBI|Use of SMS Messaging to Promote Emotional Health for People With Traumatic Brain Injury: A Randomized Controlled Trial|Recruiting||N/A|60|Anticipated|Albert Einstein Healthcare Network||2|||f||||f||||||||Undecided||2017-10-11 00:45:56.554915|2017-10-11 00:45:56.554915
NCT02061540|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-02-27|2016-12-21||March 2014||2014-03-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|CAMEO|Safety population included all participants who received at least 1 dose of the investigational product.|Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis|A Pilot, Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of LUM001, an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTi), in Patients With Primary Sclerosing Cholangitis|Completed||Phase 2|27|Actual|Shire||1|||f||||f||||||||||2017-10-11 00:45:56.674757|2017-10-11 00:45:56.674757
NCT02061527|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-08-16|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment|Immediate Breast Reconstruction With or Without the Use of Acellular Dermal Matrix: A Randomized Controlled Multicenter Study|Completed||Phase 4|120|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 00:45:57.047562|2017-10-11 00:45:57.047562
NCT02061514|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-01-23|||March 2014||2014-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Two Different General Anesthesia Regimes on Postoperative Sleep Quality|The Effect of Two Different General Anesthesia Regimes on Postoperative Sleep Quality|Recruiting||N/A|80|Anticipated|Aretaieion University Hospital||2|||f||||t||||||||||2017-10-11 00:45:57.197312|2017-10-11 00:45:57.197312
NCT02061501|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-06-20|||June 2014||2014-06-01|June 2014|2014-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of the Efficacy of Optometric Rehabilitation on Visual Cognitive Deficits in Children|Evaluation of the Efficacy of Optometric Rehabilitation on Visual Cognitive Deficits in Children|Unknown status|Recruiting|N/A|70|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 00:45:57.333825|2017-10-11 00:45:57.333825
NCT02061488|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-07-22|||March 2014||2014-03-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|PPA||Assessment of a New Closed-loop Algorithm in Type 1 Diabetes (Saddle Point Model Predictive Control : SP-MPC) (PPA)|Prospective, Monocentric, Crossover Randomized Trial, to Assess a New Closed-loop Algorithm in Type 1 Diabetes (Saddle Point Model Predictive Control : SP-MPC)|Completed||N/A|10|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 00:45:57.433816|2017-10-11 00:45:57.433816
NCT02061475|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-08-28|||April 2014||2014-04-01|June 2014|2014-06-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Lidocaine Patches for Attenuating the Pain of Venipuncture Intravenous Cannulation|The Efficacy and Safety of Lidocaine Patches for Attenuating the Pain of Venipuncture Intravenous Cannulation Before Surgery: a Multicenter, Randomized, Double -Blind, Placebo-controled and Parallel-group Designed Clinical Trail|Unknown status|Recruiting|Phase 2/Phase 3|240|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-11 00:45:57.528963|2017-10-11 00:45:57.528963
NCT02061462|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-11-25|||October 2014||2014-10-01|November 2014|2014-11-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|EVLP-DCD||EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs|Extracorporeal Lung Perfusion and Ventilation to Evaluate the Eligibility for Transplantation of Lungs Retrieved From Donors After Cardio-circulatory Death (DCD)|Unknown status|Recruiting|Phase 1|10|Anticipated|Policlinico Hospital||2|||f||||t||||||||||2017-10-11 00:45:57.658083|2017-10-11 00:45:57.658083
NCT02061449|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-08-03|||March 2014||2014-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma|A Pilot Study of a Novel Multimodality Immuno-Chemotherapy Platform for Patients With Advanced Cutaneous T Cell Lymphoma|Active, not recruiting||Phase 1|3|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 00:45:57.739331|2017-10-11 00:45:57.739331
NCT02061436|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-04-26|||January 2012||2012-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|1 Year|Observational [Patient Registry]|PROGRESS CTO||Prospective Global Registry for the Study of Chronic Total Occlusion Intervention|Multicenter Registry of Chronic Total Occlusion Interventions|Recruiting||N/A|2000|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-11 00:45:57.835032|2017-10-11 00:45:57.835032
NCT02061423|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-08-18|||April 8, 2014|Actual|2014-04-08|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|Neoadjuvant||HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy|Pilot Phase I HER-2 Pulsed DC Vaccine to Prevent Recurrence for Patients With HER-2 Driven High Risk Invasive Breast Cancer Post Neoadjuvant Chemotherapy|Active, not recruiting||Phase 1|7|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-11 00:45:58.062641|2017-10-11 00:45:58.062641
NCT02061410|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-10|||January 2006||2006-01-01|February 2014|2014-02-01||||November 2008|Actual|2008-11-01||Interventional|||Effects of Neuromuscular Electrical Stimulation (NMES) in Patients With Knee Osteoarthritis|Diagnosis and Treatment of Muscle Inhibition of the Extensor Muscles of the Knee in Elderly|Completed||N/A|20|Actual|Federal University of Rio Grande do Sul||1|||f||||t||||||||||2017-10-11 00:45:58.160354|2017-10-11 00:45:58.160354
NCT02061397|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-06-12|||March 2014||2014-03-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|SOS||Safety of Simvastatin in LAM and TSC|The Safety of Simvastatin (SOS) in Patients With Pulmonary Lymphangioleiomyomatosis (LAM) and With Tuberous Sclerosis Complex (TSC)|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:45:58.247131|2017-10-11 00:45:58.247131
NCT02061384|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-05-25|||August 2014||2014-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RA-2||RA-2 13-cis Retinoic Acid (Isotretinoin)|A Pilot Trial of 13-cis Retinoic Acid (Isotretinoin) for the Treatment of Men With Oligoasthenoteratozoospermia|Active, not recruiting||Phase 2|20|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 00:45:58.34203|2017-10-11 00:45:58.34203
NCT02061371|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-10|||November 2013||2013-11-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Virtual Therapy in Rehabilitation Spastic Hemiparesis|VIRTUAL THERAPY IN REHABILITATION SPASTIC HEMIPARESIS|Unknown status|Recruiting|N/A|40|Anticipated|Universidade do Vale do Paraíba||2|||f||||t||||||||||2017-10-11 00:45:58.447235|2017-10-11 00:45:58.447235
NCT02061358|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-09-17|2016-07-20||July 2014||2014-07-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|UV|Total number of randomized subjects in each cohort|Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects|Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Single-Ascending Dose Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects|Completed||Phase 1|64|Actual|Unither Virology||8|||f||||t||||||||No||2017-10-11 00:45:58.597134|2017-10-11 00:45:58.597134
NCT02061345|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-08-12|||April 2014||2014-04-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||PET Imaging in MCI Following ADT for PCa|A PET Imaging Study to Detect the Presence of Activated Microglia in the Brains of Prostate Cancer Patients Who Develop Mild Cognitive Impairment Following Androgen Deprivation Therapy|Suspended||N/A|12|Anticipated|Imperial College London|||2|Preliminary data analysis|f||||f||||||Samples With DNA|"     Blood samples for determining TSPO (Ala147Thr) polymorphism, testosterone and estrogen     hormone levels   "|||2017-10-11 00:46:02.336472|2017-10-11 00:46:02.336472
NCT02061332|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-09-29|||July 2009||2009-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DCIS6||DC Vaccine for Patients With Ductal Carcinoma In Situ|A Randomized Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With DCIS|Active, not recruiting||Phase 1/Phase 2|58|Actual|Abramson Cancer Center of the University of Pennsylvania||3|||f||||t||||||||||2017-10-11 00:46:02.423287|2017-10-11 00:46:02.423287
NCT02061319|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-09-20|||March 2014||2014-03-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|December 31, 2016|Actual|2016-12-31||Interventional|||Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure|Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure|Completed||N/A|77|Actual|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-11 00:46:02.542359|2017-10-11 00:46:02.542359
NCT02061306|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-09-12|||March 2014||2014-03-01|September 2016|2016-09-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Observational|CDGEMM||Celiac Disease Genomic Environmental Microbiome and Metabolomic Study|Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) Study|Recruiting||N/A|400|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     Infant stool and whole blood samples. Maternal stool and breast milk samples.   "|Undecided||2017-10-11 00:46:02.637198|2017-10-11 00:46:02.637198
NCT02061293|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-07-20|||June 2014||2014-06-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Interventional|||A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence|A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence|Recruiting||Phase 2|180|Anticipated|New York University School of Medicine||2|||f||||t|t|f||||||||2017-10-11 00:46:02.744751|2017-10-11 00:46:02.744751
NCT02061098|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-04-13|||February 2014||2014-02-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|POMEcardio||Effect of a Pomegranate Extract on Cardiovascular Risk Markers in Overweight Healthy Subjects|Effect of an Ellagitannin Rich Pomegranate Extract on Cardiovascular Risk Markers in Overweight Healthy Subjects. A Double-blind, Cross-over, Dose-response, Randomized, Placebo-controlled Trial (The POMEcardio Study)|Completed||Phase 1/Phase 2|50|Actual|National Research Council, Spain||2|||f||||t||||||||||2017-10-11 00:46:06.108208|2017-10-11 00:46:06.108208
NCT02061280|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-03-28|||October 2013||2013-10-01|June 2016|2016-06-01|February 17, 2017|Actual|2017-02-17|February 17, 2017|Actual|2017-02-17||Interventional|MICT||Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial|Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial|Completed||Phase 4|71|Actual|Nemours Children's Clinic||2|||f||||f||||||||Yes|We will develop a public use dataset for interested investigators once all planned analyses and studies are completed. Requests for access to data will be reviewed by a committee including representatives from Nemours and the American Lung Association Asthma Clinical Research Centers network and Data Coordinating Center to confirm oversight authority (i.e. IRB) approval and minimum standards for scientific merit. Once a request has been approved, the investigator will be sent cleaned and de-identified data in an electronic format with a dictionary of variables, and study documents and forms.|2017-10-11 00:46:02.859189|2017-10-11 00:46:02.859189
NCT02061267|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-02-19|||January 2012||2012-01-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2013|Actual|2013-12-01||Interventional|OLNAMS||Olive Oil on Nampt and Its Relation With Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome.|OLIVE OIL ON NAMPT AND ITS RELATION WITH POSTPRANDIAL INFLAMMATION AND ATHEROSCLEROSIS IN THE SETTING OF METABOLIC SYNDROME. The OLNAMS Project|Unknown status|Active, not recruiting|N/A|40|Anticipated|National Research Council, Spain||4|||f||||f||||||||||2017-10-11 00:46:03.026092|2017-10-11 00:46:03.026092
NCT02061254|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-08-31|||April 2014||2014-04-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|TEDECAD||Transient Elastography DEdicated to Cosmetology And Dermatology (TEDECAD)|Transient Elastography DEdicated to Cosmetology And Dermatology (TEDECAD)|Completed||N/A|130|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-11 00:46:03.159806|2017-10-11 00:46:03.159806
NCT02061241|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-10-16|||April 2014||2014-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Observational|IDEAL-CRT||A Comparison of Two Techniques for Choosing the Best Place to Put a Pacing Lead for Cardiac Resynchronisation Therapy|Intracardiac Haemo-dynamics and Echocardiographic Assessment to Optimise Lead Placement for CRT|Completed||N/A|22|Actual|Oxford University Hospitals NHS Trust|||1||f||||t||||||||||2017-10-11 00:46:03.278731|2017-10-11 00:46:03.278731
NCT02061228|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-10-25|||March 2014||2014-03-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|REFRESH||REFRESH: Receptivity Enhancement by Follicular-phase Renewal After Endometrial ScratcHing|Endometrial Receptivity Enhancement Through Induced Injury and Repair During Ovarian Stimulation in an Antagonist Down-regulated Cycle|Recruiting||N/A|360|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||t||||||||Undecided||2017-10-11 00:46:03.379441|2017-10-11 00:46:03.379441
NCT02061215|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-12-01|||April 2014||2014-04-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Study of CMV in Kidney Transplant Recipients|Effects of Age on Immune Risk Profile in CMV Seropositive Kidney Transplant Recipients After Release From CMV Prophylaxis|Withdrawn||N/A|0|Actual|University of Nebraska|||2||f||||t||||||||||2017-10-11 00:46:03.496699|2017-10-11 00:46:03.496699
NCT02061202|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-04-05|||March 2014||2014-03-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|IMPROVE||Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease|Inhaled Mometasone to Promote Reduction in Vasoocclusive Events|Recruiting||Phase 2|45|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 00:46:03.575368|2017-10-11 00:46:03.575368
NCT02061189|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-11-07|||March 2014||2014-03-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|December 2016|Anticipated|2016-12-01||Interventional|ExerASI||Pilot Study of an Innovative Physiotherapy in Patients With Infantile Spinal Muscular Atrophy (SMA)|Physical Exercise and Neuromuscular Diseases: Pilot Study of an Innovative Physiotherapy in Patients With Infantile Spinal Muscular Atrophy|Recruiting||N/A|30|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:46:03.685018|2017-10-11 00:46:03.685018
NCT02061176|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2016-12-19|||January 2014||2014-01-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||THD Versus Open Haemorrhoidectomy|Transanal Haemorrhoidal Dearterialization (THD) Versus Open Haemorrhoidectomy for the Treatment of Haemorrhoids. An Open Prospective Randomized Study.|Active, not recruiting||N/A|90|Anticipated|Holbaek Sygehus||2|||f||||f||||||||||2017-10-11 00:46:03.80251|2017-10-11 00:46:03.80251
NCT02061163|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2015-06-12|||February 2015||2015-02-01|June 2015|2015-06-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Contrast-Enhanced Ultrasound in Human Crohn's Disease|Evaluation of Contrast-Enhanced Ultrasound in Human Crohn's Disease|Withdrawn||Phase 1/Phase 2|0|Actual|University of Michigan||1||PI leaving UM at the end of the month|f||||t||||||||||2017-10-11 00:46:03.900543|2017-10-11 00:46:03.900543
NCT02061150|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-11|||March 2014||2014-03-01|February 2014|2014-02-01|June 2015|Anticipated|2015-06-01|February 2015|Anticipated|2015-02-01||Observational|||Neonatal Sepsis Workup for High Risk Newborns - Evaluation of Need and Ways to Prevent||Unknown status|Not yet recruiting|N/A|800|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 00:46:03.976263|2017-10-11 00:46:03.976263
NCT02061137|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-04-05|||August 2013||2013-08-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|FINGORETT||Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome|A Phase 1 Clinical Study to Assess Safety and Efficacy of Oral Fingolimod (FTY720) in Children With Rett Syndrome.|Active, not recruiting||Phase 1/Phase 2|6|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 00:46:05.823693|2017-10-11 00:46:05.823693
NCT02061124|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2015-11-20|||February 2014||2014-02-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota|Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota|Completed||N/A|50|Actual|University Hospital, Gentofte, Copenhagen||4|||f||||||||||||||2017-10-11 00:46:05.917054|2017-10-11 00:46:05.917054
NCT02061085|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-03-18|||July 2013||2013-07-01|March 2015|2015-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MERIBEL||Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment|A Phase IIa Prospective, Multicenter, Open and Not Controlled of the Efficacy and Tolerability on the First Line Treatment With Eribulin as a Unic Agent on Patients With HER2 Negative Metastatic Breast Cancer Previously Treated With Taxanes|Completed||Phase 2|53|Actual|MedSIR||1|||f||||f||||||||||2017-10-11 00:46:06.233768|2017-10-11 00:46:06.233768
NCT02061072|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-03-18|||January 2015||2015-01-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|January 2016|Actual|2016-01-01|1 Week|Observational [Patient Registry]|WAPPS||Web-based Application for the Population Pharmacokinetic Service - Phase 1|The Development of the Web-based Application for the Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo) - Phase 1|Recruiting||N/A|400|Anticipated|McMaster University|||1||f||||f||||||||||2017-10-11 00:46:06.338402|2017-10-11 00:46:06.338402
NCT02061059|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-11|||March 2014||2014-03-01|February 2014|2014-02-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes|Improving the Cost-effectiveness of Therapeutic Shoes for Diabetic Patients With a Previous Foot Ulcer Using an In-shoe Pressure Device|Unknown status|Not yet recruiting|N/A|40|Anticipated|Maastricht University||4|||f||||f||||||||||2017-10-11 00:46:06.454884|2017-10-11 00:46:06.454884
NCT02061046|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-11-30|||August 2009||2009-08-01|November 2015|2015-11-01|May 2018|Anticipated|2018-05-01|August 2009|Actual|2009-08-01||Observational|OSA_Gait||To Study the Impact of CPAP on Gait Parameters in OSA Patients|Impact of the CPAP on Gait in OSA Patients|Active, not recruiting||N/A|35|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 00:46:06.598358|2017-10-11 00:46:06.598358
NCT02061033|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-08-30|||March 2013||2013-03-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|GHMHW||Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease|GLOBAL HEMOSTATIC METHODS IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE CORRELATION WITH PATIENTS' CLINICAL STATUS AND USEFULNESS FOR TREATMENT MONITORING|Recruiting||N/A|180|Anticipated|Karolinska University Hospital|||1||f||||f||||||Samples With DNA|"     Citrated plasma and whole blood DNA samples   "|||2017-10-11 00:46:06.706554|2017-10-11 00:46:06.706554
NCT02061020|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-06-08|||January 2014||2014-01-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|VIGICANN||Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users|Pilot Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol and the Ability to Drive in Chronic or Occasional Cannabis Users|Completed||N/A|37|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-10-11 00:46:06.924294|2017-10-11 00:46:06.924294
NCT02061007|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-05-06|||October 2014||2014-10-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Biomarker Correlates of Hypoxia in Metastatic Melanoma|Biomarker Correlates of Hypoxia in Metastatic Melanoma|Withdrawn||Phase 2|0|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||no accrual|f||||f||||||||||2017-10-11 00:46:07.039393|2017-10-11 00:46:07.039393
NCT02060994|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2014-05-01|||February 2014||2014-02-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Respiratory Morbidity Among Children Who Were Born by Elective Cesarean Section After 37-38 Weeks vs. 39 Weeks and More|Respiratory Morbidity Among Children Who Were Born by Elective Cesarean Section After 37-38 Weeks vs. 39 Weeks and More|Completed||N/A|123|Actual|Hillel Yaffe Medical Center|||2||f||||f||||||||||2017-10-11 00:46:07.151496|2017-10-11 00:46:07.151496
NCT02060981|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-02-16|||February 2014||2014-02-01|February 2015|2015-02-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|PRIMA||Evaluation of a Decision Support Tool|Primary Medication Adherence Phase 2 Evaluation of a Decision Support Tool|Unknown status|Active, not recruiting|N/A|140|Anticipated|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-11 00:46:07.260437|2017-10-11 00:46:07.260437
NCT02060968|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-07-13|||June 2014|Actual|2014-06-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2017|Actual|2017-06-01||Observational|IRIS-PREMIER||IRIS-PREMIER REGISTRY|Evaluation of Effectiveness and Safety of Promus PREMIER in Routine Clinical Practice; A Multicenter, Phase-IV, Prospective Observational Study|Active, not recruiting||N/A|2006|Actual|Asan Medical Center|||1||f||||t||||||||||2017-10-11 00:46:07.369438|2017-10-11 00:46:07.369438
NCT02060955|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-06-03|||February 2014||2014-02-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan|An Open-labelled, Randomized Phase II Study to Investigate Efficacy of Autologous Lymphoid Effector Cells Specific Against Tumour-Cells (ALECSAT) in Patients With GBM Measured as Progression Free Survival Compared to Avastin/Irinotecan|Terminated||Phase 2|25|Actual|CytoVac A/S||2||Substantial design modifications required.|f||||t||||||||Undecided||2017-10-11 00:46:07.55908|2017-10-11 00:46:07.55908
NCT02060942|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-05-18|||August 2013||2013-08-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Mean Systemic Filling Pressure and Heart Performance Predicting Fluid Responsiveness|Mean Systemic Filling Pressure and Heart Performance as Predictors of Successful Fluid Responsiveness in Patients With Coronary Artery Bypass Grafting|Completed||N/A|40|Actual|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||No|No, data remain anonymized within hospital and property of PI.|2017-10-11 00:46:07.723414|2017-10-11 00:46:07.723414
NCT02060929|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-03-12|||October 2013||2013-10-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Evaluate the Pharmacokinetics of Intranasal Esketamine Administered With and Without a Nasal Guide on the Intranasal Device|An Open-Label Phase 1 Study to Evaluate the Pharmacokinetics of Intranasal Esketamine Administered With and Without a Nasal Guide on the Intranasal Device|Completed||Phase 1|14|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:46:07.853849|2017-10-11 00:46:07.853849
NCT02060916|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-02-12|||March 2011||2011-03-01|February 2014|2014-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|PAZ320||Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes|Study to Evaluate the Safety and Efficacy of PAZ320 When Added to Oral Agents or Insulin in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|24|Actual|Boston Therapeutics||1|||f||||f||||||||||2017-10-11 00:46:07.957436|2017-10-11 00:46:07.957436
NCT02060903|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-09-09||2015-08-25|February 2014||2014-02-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation|A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation|Completed||Phase 3|379|Actual|Hatchtech Pty Ltd||2|||f||||f||||||||||2017-10-11 00:46:08.029347|2017-10-11 00:46:08.029347
NCT02060877|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-10-25|||February 2014||2014-02-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|DIADISS||Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung Disease|How Burdensome is the Diagnostic Phase ? Distress and Quality of Life in Patients Suspected of Having a (Serious) Lung Disease|Completed||N/A|105|Actual|Universiteit Antwerpen|||1||f||||f||||||||No||2017-10-11 00:46:08.224751|2017-10-11 00:46:08.224751
NCT02060864|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2015-08-27|||April 2014||2014-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|AN-PEP-03||Effect of AN-PEP Enzyme on Gluten Digestion in Gluten Sensitive Individuals|Effect of the Enzyme AN-PEP on Gluten Degradation in the Stomach of Gluten-sensitive Individuals|Completed||N/A|18|Actual|DSM Food Specialties||3|||f||||t||||||||||2017-10-11 00:46:08.323589|2017-10-11 00:46:08.323589
NCT02060851|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-02-09|||February 2014||2014-02-01|January 2014|2014-01-01||||July 2014|Anticipated|2014-07-01||Interventional|||Effects of Early Short-term Intravenous Iron Supplements Combinded EPO in Preterm Infants||Unknown status|Recruiting|Phase 4|138|Anticipated|Kunshan First People's Hospital Affiliated to Jiangsu University||3|||f||||t||||||||||2017-10-11 00:46:08.450153|2017-10-11 00:46:08.450153
NCT02060838|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-02-13|2016-10-26||March 2014||2014-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||The Impact of Storage Techniques on Platelets Number and Function After Acute Normovolemic Hemodilution (ANH)||Completed||N/A|50|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:46:08.586515|2017-10-11 00:46:08.586515
NCT02060825|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-01-31|||November 2012||2012-11-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||The Use of Optical Oximetry in Determining Gastrointestinal Complications After the Hybrid Procedure||Terminated||N/A|16|Actual|Nationwide Children's Hospital|||1|Difficulty in downloading and saving data from the oximetry machine.|f||||f||||||||||2017-10-11 00:46:08.875883|2017-10-11 00:46:08.875883
NCT02060812|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-11|||November 2012||2012-11-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|SSNBANB||Axillary Nerve Block Combined With Suprascapular Nerve Block|The Effect of Sono-guided Suprascapular Nerve Block Combined With Axillary Nerve Block in Arthroscopic Rotator Cuff Repair: a Randomized Controlled Trial|Completed||N/A|48|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||||2017-10-11 00:46:08.946769|2017-10-11 00:46:08.946769
NCT02060799|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-12-16|||February 2014||2014-02-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01|30 Days|Observational [Patient Registry]|EuroDEM||European Dyspnoea Survey in the EMergency Departments|European Dyspnoea Survey in the EMergency Departments|Completed||N/A|2156|Actual|Hopital Lariboisière|||1||f||||t||||||||||2017-10-11 00:46:09.240072|2017-10-11 00:46:09.240072
NCT02060786|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2014-02-11|||October 2010||2010-10-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)|Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)|Completed||Phase 4|90|Actual|Ajou University School of Medicine||2|||f||||f||||||||||2017-10-11 00:46:09.372662|2017-10-11 00:46:09.372662
NCT02060773|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2014-02-08|||December 2012||2012-12-01|December 2012|2012-12-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Observational|||Effect of EGDT on Hepatic Perfusion in Patients With Septic Shock|Effect of EGDT on Hepatic Perfusion in Patients With Septic Shock|Unknown status|Recruiting|N/A|||Zhongda Hospital|||1||f||||f||||||||||2017-10-11 00:46:09.467156|2017-10-11 00:46:09.467156
NCT02060760|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-08-29|||February 2014||2014-02-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2016|Actual|2016-06-01|180 Days|Observational [Patient Registry]|UTROPIA||Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes|Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes|Active, not recruiting||N/A|2000|Anticipated|Minneapolis Medical Research Foundation|||1||f||||f||||||Samples Without DNA|"     Excess blood is biobanked as EDTA-plasma and heparin samples after being used for the     clinical cTnI assay according to IRB approval HSR # 07-2854   "|||2017-10-11 00:46:09.561488|2017-10-11 00:46:09.561488
NCT02060747|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-02-20|||July 1, 2013|Actual|2013-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 7, 2016|Actual|2016-10-07||Interventional|OPTIPOST||Optimization of Osteoporosis Management Among Patients Older Than 45 Years Old With Low Energy Fracture.||Completed||N/A|480|Actual|Groupe Hospitalier Paris Saint Joseph||2|||f||||t||||||||Undecided||2017-10-11 00:46:09.655306|2017-10-11 00:46:09.655306
NCT02060734|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-02-22|||October 2015||2015-10-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|January 2016|Anticipated|2016-01-01||Interventional|||Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated Disorder|Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated disorder-a Randomized Controlled Trial|Withdrawn||Phase 4|0|Actual|Hamilton Health Sciences Corporation||2||no participant recruited|f||||f||||||||No||2017-10-11 00:46:09.75125|2017-10-11 00:46:09.75125
NCT02060344|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-09-15|||January 2006||2006-01-01|January 2014|2014-01-01||||June 2013|Actual|2013-06-01||Observational|HCHS/SOL||Hispanic Community Health Study / Study of Latinos|Hispanic Community Health Study / Study of Latinos (HCHS/SOL)|Unknown status|Active, not recruiting|N/A|16400|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||Samples With DNA|"     Blood and DNA samples were collected.   "|||2017-10-11 00:46:17.362239|2017-10-11 00:46:17.362239
NCT02060721|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-06-21|||February 9, 2015|Actual|2015-02-09|June 2017|2017-06-01|September 28, 2018|Anticipated|2018-09-28|September 28, 2018|Anticipated|2018-09-28||Interventional|MERIT-2||Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension|Long Term, Multicenter, Single-arm, Open-label Extension Study of the MERIT-1 Study, to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|Active, not recruiting||Phase 2|78|Anticipated|Actelion||1|||f||||f||||||||||2017-10-11 00:46:09.858085|2017-10-11 00:46:09.858085
NCT02060708|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-04-19|||January 2015||2015-01-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Determining the Specificity of High Definition Electrical Brain Stimulation Using Simultaneous Magnetoencephalography|Measuring the Stimulated Brain: Determining the Specificity of High Definition Electrical Brain Stimulation Using Simultaneous Magnetoencephalography|Completed||N/A|16|Actual|The Hospital for Sick Children||2|||f||||||||||||||2017-10-11 00:46:10.063833|2017-10-11 00:46:10.063833
NCT02060695|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-05-02|||September 2012||2012-09-01|May 2017|2017-05-01|June 2031|Anticipated|2031-06-01|June 2030|Anticipated|2030-06-01|3 Years|Observational [Patient Registry]|||Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations|Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations|Recruiting||N/A|800|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 00:46:10.156188|2017-10-11 00:46:10.156188
NCT02060682|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-07-15|||February 2014||2014-02-01|July 2014|2014-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01|1 Day|Observational [Patient Registry]|ADVANCE-EU||Post-Market Registry of the ACIST CPM System and Navvus Catheter in Clinical Practice|Post-Market Registry of the ACIST Cardiovascular Pressure Measurement (CPM) System and Navvus Catheter in Clinical Practice-ADVANCE-EU|Unknown status|Active, not recruiting|N/A|60|Anticipated|Acist Medical Systems|||1||f||||f||||||||||2017-10-11 00:46:10.248127|2017-10-11 00:46:10.248127
NCT02060669|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-04-25|||June 20, 2010|Actual|2010-06-20|April 2017|2017-04-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer|A Phase III Trial of XELOX (Xeloda/Oxaliplatin) Followed by Xeloda Maintenance Versus Best Supportive Care (BSC) in Metastatic Colorectal Cancer|Terminated||Phase 3|10|Actual|Samsung Medical Center||2||others|f||||f||||||||||2017-10-11 00:46:10.358892|2017-10-11 00:46:10.358892
NCT02060656|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-02-10|||September 2013||2013-09-01|February 2014|2014-02-01||||February 2016|Anticipated|2016-02-01||Interventional|LEGEND||Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)|A Randomised Phase II Study Comparing LEnalidomide Plus Rituximab, GEmcitabine and Methylprednisolone (LR-GEM) to Rituximab, Gemcitabine, Methylprednisolone and cisplatiN (R-GEM-P) in Second-line Treatment of Diffuse Large B-cell Lymphoma (DLBCL).|Unknown status|Recruiting|Phase 2|92|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:46:10.449911|2017-10-11 00:46:10.449911
NCT02060643|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-02-10|||October 2011||2011-10-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||A Cross-sectional Study Looking at the Effect of Radiotherapy on Carotid Intima-medial Thickness in Head and Neck Cancer|A Cross-sectional Study Looking at the Effect of Radiotherapy on Carotid Intima-medial Thickness in Head and Neck Cancer|Completed||N/A|50|Actual|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 00:46:10.577407|2017-10-11 00:46:10.577407
NCT02060630|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-06-20|||August 2014||2014-08-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|BEST-CLI||Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia|Best Endovascular Versus Best Surgical Therapy in Patients With Critical Limb Ischemia|Recruiting||N/A|2100|Anticipated|New England Research Institutes||4|||f||||t|f|t|f|f||||No||2017-10-11 00:46:10.6889|2017-10-11 00:46:10.6889
NCT02060617|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-09-28|||April 2014||2014-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||A Comparison of Two Different Methods of Physical Therapy to Treat Acute and Subacute Low Back Pain|Impairment-Based Versus Classification-Based Physical Therapy for Acute and Subacute Low Back Pain: a Randomized Controlled Trial|Completed||N/A|23|Actual|Hendricks Regional Health||2|||f||||f||||||||||2017-10-11 00:46:11.685897|2017-10-11 00:46:11.685897
NCT02060604|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2014-02-08|||December 2012||2012-12-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration|A Randomised Controlled Trial of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration|Completed||Phase 4|60|Actual|Università degli Studi di Brescia||2|||f||||||||||||||2017-10-11 00:46:11.798781|2017-10-11 00:46:11.798781
NCT02060591|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-11|||January 2014||2014-01-01|February 2014|2014-02-01||||January 2015|Anticipated|2015-01-01||Interventional|||Comparison of Two Periarticular Injection Medications for Adjunctive Pain Management Following Total Knee Arthroplasty (TKA)||Unknown status|Recruiting|N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-11 00:46:11.932669|2017-10-11 00:46:11.932669
NCT02060578|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-12-17|||January 2014||2014-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|DELI-DEVI||Determinants of End-of-life Place of Care for Children Suffering From Cancer.|DELI-DEVI : Determinants of End-of-life Place of Care for Children Suffering From Cancer.|Completed||N/A|45|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 00:46:12.060682|2017-10-11 00:46:12.060682
NCT02060565|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-11|2017-01-23|||February 2014||2014-02-01|January 2017|2017-01-01||||January 2023|Anticipated|2023-01-01||Observational|PVNIM||Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease|Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.|Recruiting||N/A|10000|Anticipated|Association HGE CHU Bordeaux Sud|||1||f||||t||||||||||2017-10-11 00:46:12.165511|2017-10-11 00:46:12.165511
NCT02060552|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-08|2014-05-07|||January 2013||2013-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels|Diacerein Combined With Febuxostat Relieves Symptoms of Gout by Suppressing IL-1βinflammation|Completed||Phase 4|96|Actual|Tongji Hospital||3|||f||||f||||||||||2017-10-11 00:46:12.270947|2017-10-11 00:46:12.270947
NCT02060539|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2015-06-24|2015-06-03||October 2013||2013-10-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|||Multicenter Dispensing Study of Biofinity Lenses in Extended Range|Multicenter Dispensing Study of Biofinity Lenses in Extended Range|Completed||N/A|19|Actual|Coopervision, Inc.||1|||f||||f||||||||||2017-10-11 00:46:12.408737|2017-10-11 00:46:12.408737
NCT02060526|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-04-10|2017-01-11||February 2014||2014-02-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional||Intent-to-treat (ITT) population included all randomized participants.|Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease|A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease|Completed||Phase 2|21|Actual|Shire||3|||f||||t||||||||||2017-10-11 00:46:13.590682|2017-10-11 00:46:13.590682
NCT02060513|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-12-01|||August 2013||2013-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|RAMPED||Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections|Rapid Microbiological Diagnostics for MDRO Quantitative Identification and Resistance Phenotyping to Guide Antibiotic Selection in Wounded Warriors and Veterans|Completed||N/A|2298|Actual|Denver Health and Hospital Authority|||1||f||||f||||||Samples Without DNA|"     Isolates of intresting bacteria   "|||2017-10-11 00:46:15.549355|2017-10-11 00:46:15.549355
NCT02060500|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-10-10|||June 2012||2012-06-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|February 2015|Actual|2015-02-01||Interventional|||Cardiaplication: A Novel Antireflux Operation|Cardiaplication: A Prospective Observational Trial|Active, not recruiting||N/A|20|Anticipated|Emory University||1|||f||||f||||||||||2017-10-11 00:46:15.648686|2017-10-11 00:46:15.648686
NCT02060487|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-10-02|||September 22, 2014|Actual|2014-09-22|October 2017|2017-10-01|September 11, 2025|Anticipated|2025-09-11|September 11, 2025|Anticipated|2025-09-11||Interventional|AFFILIATE||Effects of Oral Sildenafil on Mortality in Adults With PAH|A Multinational, Multicenter Study To Assess The Effects Of Oral Sildenafil On Mortality In Adults With Pulmonary Arterial Hypertension (Pah)|Recruiting||Phase 4|429|Anticipated|Pfizer||3|||f||||t|t|f||||||||2017-10-11 00:46:15.745195|2017-10-11 00:46:15.745195
NCT02060474|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-01-25|||October 2014||2014-10-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Triac Trial in MCT8 Patients|Thyroid Hormone Analog Therapy of Patients With Severe Psychomotor Retardation Caused by Mutations in the MCT8 Thyroid Hormone Transporter: The Triac Trial.|Active, not recruiting||Phase 2|35|Anticipated|Erasmus Medical Center||1|||f||||t||||||||||2017-10-11 00:46:16.070082|2017-10-11 00:46:16.070082
NCT02060448|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-03-19|||November 2013||2013-11-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|NSSI||Treatment Study for Non-Suicidal Self-Injury|Exploring Two Emotion-Focused Treatment Modules in Non-Suicidal Self-Injury|Completed||N/A|13|Actual|Boston University Charles River Campus||4|||f||||f|f|f||||||No||2017-10-11 00:46:16.253829|2017-10-11 00:46:16.253829
NCT02060435|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-11|||January 2013||2013-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Observational|||Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma|The Impact of the Epstein-Barr Virus Status on Clinical Outcome in Diffuse Large B Cell Lymphoma|Completed||N/A|571|Actual|Samsung Medical Center|||3||f||||f||||||Samples With DNA|"     EBV RNA was detected by an in situ hybridization (ISH) technique using the EBV ISH kit (Leica     Microsystems, Bannockburn, IL, USA).   "|||2017-10-11 00:46:16.374891|2017-10-11 00:46:16.374891
NCT02060422|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-10|||August 2011||2011-08-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||Mindfulness-based Psychotherapy for Drug-resistant Epilepsy|Mindfulness-based Psychotherapy and Social Support Intervention for Drug-resistant Epilepsy|Completed||N/A|60|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 00:46:16.492738|2017-10-11 00:46:16.492738
NCT02060409|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-11|||January 2012||2012-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Observational|||Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome|Prognostic Molecular Markers Determined by Using Gene Expression Profiling in Patients With Myelodysplastic Syndrome|Completed||N/A|58|Actual|Samsung Medical Center|||1||f||||f||||||Samples With DNA|"     Genomic DNA extracted from bone marrow aspirate   "|||2017-10-11 00:46:16.591214|2017-10-11 00:46:16.591214
NCT02060396|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-03-17|||April 2013||2013-04-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action|Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action|Completed||Phase 1|24|Actual|Aragon Institute of Health Sciences||1|||f||||t||||||||||2017-10-11 00:46:16.695062|2017-10-11 00:46:16.695062
NCT02060370|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-03-28|||August 2014|Actual|2014-08-01|March 2017|2017-03-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)|A Phase II Study of Alternative Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma (mRCC)|Active, not recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:46:17.125208|2017-10-11 00:46:17.125208
NCT02060357|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-08-06|||November 2011||2011-11-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|OCT-DES||Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes (OCT-DES)|Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes|Completed||N/A|60|Actual|Barts & The London NHS Trust||2|||f||||t||||||||||2017-10-11 00:46:17.253083|2017-10-11 00:46:17.253083
NCT02060331|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2016-06-01|||January 2014||2014-01-01|June 2016|2016-06-01||||January 2014|Anticipated|2014-01-01||Observational|SOPPO||Severe Pelvic Organ Prolapse and Post-Obstructive Diuresis (SOPPO) Pilot Study|Severe Pelvic Organ Prolapse and Post-Obstructive Diuresis (SOPPO) Pilot Study|Withdrawn||N/A|0|Actual|Loyola University|||1|Difficult to recruit to.|f||||f||||||Samples Without DNA|"     The awake and asleep renal nocturia urine panels will require the patient to collect her     urine output into two laboratory provided basins for one twenty-four hour period. The renal     nocturia, awake urine panel will be obtained from urine collected from 0600-1800. The renal     nocturia, asleep urine panel will be obtained from urine collected from 1800-0600, ie     through the following day.   "|No||2017-10-11 00:46:17.501397|2017-10-11 00:46:17.501397
NCT02060318|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-08-31|||February 11, 2014|Actual|2014-02-11|August 2017|2017-08-01|March 7, 2016|Actual|2016-03-07|March 7, 2016|Actual|2016-03-07||Observational|CrohnReg||Regulatory T-cells and Crohn's Disease|The Effect of Infliximab Therapy in Crohn Patients on Regulatory T-cells|Completed||N/A|47|Actual|Hvidovre University Hospital|||2||f||||f||||||Samples With DNA|"     Serum, plasma, peripheral blood mononuclear cells.   "|||2017-10-11 00:46:17.613264|2017-10-11 00:46:17.613264
NCT02060305|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-03-13|||February 2014||2014-02-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis|A Pilot Study About the Safety and Efficacy of Intra-articular Bevacizumab (Avastin) for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis|Unknown status|Recruiting|Phase 4|10|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:46:17.745967|2017-10-11 00:46:17.745967
NCT02060292|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-08-10|||April 2014||2014-04-01|February 2014|2014-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|NOVASC COPD||Novel Vascular Manifestations of Chronic Obstructive Pulmonary Disease|Novel Vascular Manifestations of Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|55|Anticipated|North Bristol NHS Trust|||2||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 00:46:17.880422|2017-10-11 00:46:17.880422
NCT02060279|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-02-07|||October 2012||2012-10-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Family-based Lifestyle Intervention Program and Carotenoid Supplementation for Children With Obesity|A 6-month Family-based, Intense Lifestyle Intervention Program and Carotenoid Supplementation for Children With Obesity: A Pilot Study|Completed||N/A|25|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-10-11 00:46:18.031145|2017-10-11 00:46:18.031145
NCT02060266|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-03-27|||February 4, 2014|Actual|2014-02-04|March 2017|2017-03-01|April 28, 2014|Actual|2014-04-28|April 28, 2014|Actual|2014-04-28||Interventional|||Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects|A Single Centre, Open Label Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects|Completed||Phase 1|7|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 00:46:18.19692|2017-10-11 00:46:18.19692
NCT02060253|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-07-05|||April 2014|Actual|2014-04-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer|A Phase I Clinical Trial of Ganetespib (Heat Shock Protein 90 Inhibitor) in Combination With Paclitaxel, Trastuzumab and Pertuzumab in Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Metastatic Breast Cancer|Active, not recruiting||Phase 1|9|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-10-11 00:46:18.315052|2017-10-11 00:46:18.315052
NCT02060240|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2015-04-20|||February 2014||2014-02-01|April 2015|2015-04-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Physical Activity and Obesity|Physical Activity and Obesity: The Role of Nitric Oxide and Eicosanoids in Regulating Capillary Perfusion and Vascular Insulin Resistance|Unknown status|Recruiting|N/A|30|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 00:46:18.449087|2017-10-11 00:46:18.449087
NCT02060227|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-10-25|||February 2014||2014-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Approach to Shoulder Instability|Approach to Shoulder Instability: a Randomized, Controlled Trial|Recruiting||N/A|120|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-11 00:46:18.577454|2017-10-11 00:46:18.577454
NCT02060214|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-08-09|||January 2014||2014-01-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Development of Novel Cystometrics for Overactive Bladder|Development of Novel Cystometrics for Overactive Bladder|Recruiting||N/A|104|Anticipated|Virginia Commonwealth University|||1||f||||f||||||||||2017-10-11 00:46:18.664826|2017-10-11 00:46:18.664826
NCT02060201|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-06-09|||February 2014||2014-02-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)|A Bioequivalence Study of 2.5-mg Saxagliptin/5-mg Dapagliflozin and 5-mg Saxagliptin/10-mg Dapagliflozin Fixed Dose Combination Tablets Relative to Coadministration of Their Respective Individual Components in Healthy Subjects and a Characterization of the Effect of Food on the Fixed Dose Combination Tablets|Completed||Phase 1|72|Actual|AstraZeneca||6|||f||||f||||||||||2017-10-11 00:46:18.734751|2017-10-11 00:46:18.734751
NCT02060188|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-10-03|||March 7, 2014|Actual|2014-03-07|October 2017|2017-10-01|December 31, 2019|Anticipated|2019-12-31|March 11, 2018|Anticipated|2018-03-11||Interventional|CheckMate142||An Investigational Immuno-therapy Study of Nivolumab, and Nivolumab in Combination With Other Anti-cancer Drugs, in Colon Cancer That Has Come Back or Has Spread|A Phase 2 Clinical Trial of Nivolumab, or Nivolumab Combinations in Recurrent and Metastatic Microsatellite High (MSI-H) and Non-MSI-H Colon Cancer|Recruiting||Phase 2|340|Anticipated|Bristol-Myers Squibb||6|||f||||f|t|f||||||||2017-10-11 00:46:18.958909|2017-10-11 00:46:18.958909
NCT02060175|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-01-07|||February 2014||2014-02-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparison of the 3-month Strut Coverage After Coronary Stenting by Optical Coherence Tomography; Cilotax and DESyne||Withdrawn||Phase 4|0|Actual|Yonsei University||2||Because of the problem with Cilotax stent permission|f||||f||||||||||2017-10-11 00:46:19.22409|2017-10-11 00:46:19.22409
NCT02059837|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-10|||February 2009||2009-02-01|February 2014|2014-02-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Observational|||Clinical Analysis of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery|Retrospective Study of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery|Completed||N/A|116|Actual|Kyungpook National University|||1||f||||t||||||||||2017-10-11 00:46:22.459219|2017-10-11 00:46:22.459219
NCT02060162|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2017-05-22|||October 2013||2013-10-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa|Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa: a Collaborative Multi-country Prospective Cohort Analysis for International Epidemiologic Databases to Evaluate AIDS- Southern Africa (HIV/HBV-coinfection in IeDEA-SA)|Active, not recruiting||N/A|900|Anticipated|University of Alabama at Birmingham|||2||f||||f|f|f||||Samples With DNA|"     Specimen storage is optional and participants will provide additional informed consent. The     laboratory will store leftover blood specimens for up to 5 years for hepatitis related     serologic, immunological, and virologic studies pending availability of funding. Use of     specimens for any tests outside the realm of the goals and objectives of this study will     require additional approval by the Zambian IRB.   "|||2017-10-11 00:46:19.310511|2017-10-11 00:46:19.310511
NCT02060149|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2014-02-09|||March 2014||2014-03-01|February 2014|2014-02-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|NAEDRAP||The Effect of Nebulization of Alkaline Solution on Treating XDRAB Pneumonia With C/S Plus Minocycline|The Effect of Nebulization of Alkaline Solution on Treating Extensively Drug Resistant A. Baumannii Pneumonia With Cefoperazone and Sulbactam Plus Minocycline: A Multi-center Randomized Study|Unknown status|Not yet recruiting|Phase 1/Phase 2|90|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:46:19.433834|2017-10-11 00:46:19.433834
NCT02060136|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-02-10|||June 2013||2013-06-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Electronic Method for Recording Lower Urinary Tract Symptoms|Validation of Electronic Recording of Lower Urinary Tract Symptoms (LUTS) in Men|Completed||N/A|29|Actual|University Hospital Ostrava|||1||f||||f||||||||||2017-10-11 00:46:19.540328|2017-10-11 00:46:19.540328
NCT02060123|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-05-28|||March 2014||2014-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Qigong Intervention Program for Abused Chinese Women|A Randomized, Wait-list Controlled Trial of a Qigong Intervention Program on Telomerase Activity and Psychological Stress in Abused Chinese Women|Completed||N/A|271|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:46:19.613466|2017-10-11 00:46:19.613466
NCT02060110|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2014-02-09|||May 2010||2010-05-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01|3 Years|Observational [Patient Registry]|||MADIT-CRT LONG-TERM INTERNATIONAL FOLLOW-UP REGISTRY - EUROPE||Completed||N/A|447|Actual|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 00:46:19.711603|2017-10-11 00:46:19.711603
NCT02060097|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2016-06-11|||February 2014||2014-02-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Cocoa Flavanol on Skin Aging|Effects of 24-week Cocoa Flavanol Supplementation on Photo-aged Facial Skin|Completed||N/A|64|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:46:19.796423|2017-10-11 00:46:19.796423
NCT02060084|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2016-09-04|||January 2014||2014-01-01|January 2014|2014-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm|Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm|Completed||Phase 4|60|Actual|Kunshan First People's Hospital Affiliated to Jiangsu University||2|||f||||t||||||||No|The patients were randomly assigned to either a control group or a probiotic-supplemented group in the following manner. The randomization schedule was made available only to the pharmacist who supervised the quality, transport and storage of LCB. Infants were followed up until they were discharged from the hospital or died. They were withdrawn from the trial if severe adverse effects developed, or parents withdrew consent. The probiotic-supplemented group were orally administered LCB (Bifico, Shanghai Xinyi Pharmaceutical Inc. Shanghai), and the control group was fed with the same dose of luke warm water); both the preparations were supplied in identical containers. LCB was orally administered starting from day 2 after birth, at a dose of 0.5g (the numbers of Long Bifidobacterium, Lactobacillus acidophilus and Enterococcus faecalis in live>0.5*107CFU), twice per day, for 2 weeks.|2017-10-11 00:46:19.895721|2017-10-11 00:46:19.895721
NCT02060071|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-09|||July 2011||2011-07-01|February 2014|2014-02-01|June 2014|Anticipated|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Endothelial Progenitors in Aortic Stenosis: Association With Aortic Stenosis Progression and Severity|Endothelial Progenitors in Aortic Stenosis: Association With Aortic Stenosis Progression, Severity, Symptoms and Left Ventricular Function Assessed by 2D Strain Echocardiography|Unknown status|Recruiting|Phase 4|200|Anticipated|Kaplan Medical Center||2|||f||||t||||||||||2017-10-11 00:46:20.002682|2017-10-11 00:46:20.002682
NCT02060045|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-09|||November 2009||2009-11-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|REINA||Prevention Ventilator Associated Pneumonia|Impact of 4 Sequential Measures on the Prevention of Ventilator Associated Pneumonia in Major Heart Surgery Intensive Care Unit|Completed||N/A|1534|Actual|Hospital General Universitario Gregorio Marañon||1|||f||||f||||||||||2017-10-11 00:46:20.303905|2017-10-11 00:46:20.303905
NCT02060032|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-02-09|||February 2013||2013-02-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||1.2% Atorvastatin and 1.2% Simvastatin in Treatment of Chronic Periodontitis|COMPARATIVE EVALUATION OF CLINICAL EFFICACY OF SUBGINGIVALLY DELIVERED 1.2% ATORVASTATIN AND 1.2% SIMVASTATIN IN TREATMENT OF CHRONIC PERIODONTITIS: A RANDOMIZED CONTROLLED TRIAL|Completed||Phase 2/Phase 3|96|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||t||||||||||2017-10-11 00:46:20.402108|2017-10-11 00:46:20.402108
NCT02060019|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-12-28|||March 2014||2014-03-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects|A Phase I Clinical Trial to Investigate the Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects|Completed||Phase 1|57|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 00:46:20.517385|2017-10-11 00:46:20.517385
NCT02060006|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-04-02|||April 2014||2014-04-01|April 2014|2014-04-01|April 2015||2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial|A Double-Blind Randomized Placebo Controlled Trial for Prevention of Tuberculosis-Immune Reconstitution Inflammatory Syndrome With Non-Steroid Anti-Inflammatory Drugs (NSAIDs) in HIV-Infected Adults|Unknown status|Recruiting|Phase 3|200|Anticipated|University of Stellenbosch||2|||f||||t||||||||||2017-10-11 00:46:20.638243|2017-10-11 00:46:20.638243
NCT02059993|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-09|2015-04-08|2015-02-05||January 2009||2009-01-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||A total of 243 patients were screened between January 2009 and June 2012. Out of 97 (39.9%) patients diagnosed with OSA, 5 subjects declined to participate in the study, and 9 subjects were excluded because of the following: AHI <15 (n = 8 patients) and severe heart failure (n = 1 patient).|The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease|The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease|Completed||N/A|83|Actual|Chinese Pulmonary Vascular Disease Research Group|First, the sample size was relatively small. Second, this was a nondouble-blind study. Third, we did not use 24-hour ambulatory BP to monitor changes in BP and could not evaluate the nighttime BP.|2|||f||||t||||||||||2017-10-11 00:46:20.789915|2017-10-11 00:46:20.789915
NCT02059980|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-10-24|||August 2014||2014-08-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania|Developing Effective Response Inhibition Training for Symptom Relief in Obsessive-Compulsive and Related Disorders and Trichotillomania|Recruiting||N/A|40|Anticipated|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-10-11 00:46:21.113404|2017-10-11 00:46:21.113404
NCT02059967|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-03-18|||March 2014||2014-03-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC|A Phase I Image-Guided Adaptive Radiotherapy Study Using Active Breathing Control (ABC) and Simultaneous Integrated Boost for Patients With Inoperable Non-Small Cell Lung Cancer|Withdrawn||Phase 1|0|Actual|Virginia Commonwealth University||1||Due to no accrual.|f||||t||||||||||2017-10-11 00:46:21.240894|2017-10-11 00:46:21.240894
NCT02059954|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-04-26|||January 2014||2014-01-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|August 2016|Actual|2016-08-01||Interventional|||Vaginal vs. Laparoscopic Hysterectomy|Vaginal Hysterectomy Versus Total Laparoscopic Hysterectomy for Benign Indications: A Randomized Controlled Trial|Active, not recruiting||N/A|100|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 00:46:21.336908|2017-10-11 00:46:21.336908
NCT02059941|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-05-26|||September 30, 2012|Actual|2012-09-30|May 2017|2017-05-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2017|Anticipated|2017-07-31||Observational|||Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines|Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP)- Guidelines Development and Testing|Recruiting||N/A|780|Anticipated|University of Washington|||1||f||||f||||||||Undecided||2017-10-11 00:46:21.429909|2017-10-11 00:46:21.429909
NCT02059928|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-05-04|2017-02-20||December 2013||2013-12-01|September 2014|2014-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Twenty patients were enrolled between January 2014 and May 2015|Intraosseous Pressure Monitoring in Intensive Care Unit Patients|Intraosseous Pressure Monitoring in Intensive Care Unit Patients|Completed||N/A|20|Actual|HealthPartners Institute||1|||f||||t||||||||||2017-10-11 00:46:21.578794|2017-10-11 00:46:21.578794
NCT02059915|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-03-31|||April 2014||2014-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions|An Open-Label, Randomized, 2-Cohort, Single-Dose, Crossover Study Of 40 Mg Doses Of Pf-00345439 To Evaluate The Bioequivalence Of Modified Formulation K Vs. Original Formulation X Under Intermediate-Fat Fed Conditions And To Estimate Relative Bioavailability Under Fasting Conditions In Healthy Volunteers|Completed||Phase 1|134|Actual|Pain Therapeutics||4|||f||||f||||||||||2017-10-11 00:46:21.723254|2017-10-11 00:46:21.723254
NCT02059902|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-05-04|2017-02-20||September 2012||2012-09-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Continuous Lidocaine Infusion for Management of Perioperative Burn Pain|Continuous Lidocaine Infusion for Management of Perioperative Burn Pain|Completed||Phase 4|36|Actual|HealthPartners Institute||2|||f||||f||||||||||2017-10-11 00:46:21.819331|2017-10-11 00:46:21.819331
NCT02059889|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-12-15|||July 2014||2014-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer|Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer|Withdrawn||N/A|0|Actual|Virginia Commonwealth University||1||slow accrual|f||||t||||||||||2017-10-11 00:46:22.073683|2017-10-11 00:46:22.073683
NCT02059863|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-08-23|||March 2014||2014-03-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SPRING||SPRING Cluster Randomised Controlled Trial|SPRING (for the Millennium Development Goals): Sustainable Programme Incorporating Nutrition and Games (for Maximising Development, Growth and Survival)|Recruiting||N/A|12000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 00:46:22.25891|2017-10-11 00:46:22.25891
NCT02059850|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-02-01|||July 2014||2014-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma|A Study to Determine the Feasibility of Treating Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Using Autologous NY-ESO-1 Specific CD8+ T Cells With Cyclophosphamide Pre-conditioning But Without the Use of IL-2|Withdrawn||Phase 1|0|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 00:46:22.375097|2017-10-11 00:46:22.375097
NCT02059824|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-02-23|||March 2014||2014-03-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Normal Eyelid Sensation Distribution|Normal Eyelid Sensation Distribution|Completed||N/A|30|Actual|Duke University||1|||f||||t|f|f||||||||2017-10-11 00:46:22.520357|2017-10-11 00:46:22.520357
NCT02059811|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-10-02|||February 2014||2014-02-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study|Efficacy and Safety of the Dietary Approaches to Stop Hypertension (DASH) Diet in Adults With Moderate Chronic Kidney Disease: Pilot Study|Completed||N/A|42|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:46:22.594001|2017-10-11 00:46:22.594001
NCT02059798|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-10|||March 2014||2014-03-01|February 2014|2014-02-01|August 2016|Anticipated|2016-08-01|February 2016|Anticipated|2016-02-01|6 Months|Observational [Patient Registry]|||Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy|Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy|Unknown status|Not yet recruiting|N/A|76|Anticipated|The Catholic University of Korea|||1||f||||t||||||||||2017-10-11 00:46:22.671685|2017-10-11 00:46:22.671685
NCT02059785|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-06-16|||June 2013||2013-06-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke|Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke---Randomized, Double-blind, Placebo-controlled, Multicenter Study|Suspended||Phase 2|216|Anticipated|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:46:22.737755|2017-10-11 00:46:22.737755
NCT02059772|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-02-21|||April 30, 2014|Actual|2014-04-30|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|November 2017|Anticipated|2017-11-01||Interventional|ReCaLL||Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema|Evaluation of an Additional Therapeutic Approach to Diabetic Macular Edema by Combining Standard Therapy (Intravitreal Injection of a VEGF-inhibitor) With Micropulse Diode Laser Treatment in a Randomized, Controlled Proof of Concept Study|Active, not recruiting||Phase 4|25|Actual|GWT-TUD GmbH||2|||f||||f||||||||||2017-10-11 00:46:22.804816|2017-10-11 00:46:22.804816
NCT02059759|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-05-30|||September 2015||2015-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|IMODALS||Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2|Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2|Completed||Phase 2|36|Actual|Centre Hospitalier Universitaire de Nīmes||3|||f||||t||||||||||2017-10-11 00:46:22.877185|2017-10-11 00:46:22.877185
NCT02059746|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-04-05|||February 2014||2014-02-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Observational|JUMODA-CP||Perineal Consequences of Twin Pregnancies According to Mode of Delivery|Perineal Consequences of Twin Pregnancies According to Mode of Delivery|Completed||N/A|3039|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 00:46:23.02869|2017-10-11 00:46:23.02869
NCT02059733|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-04-27|||February 2013||2013-02-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism|Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism by 18F-DTBZ PET|Recruiting||Phase 2|130|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:46:23.113777|2017-10-11 00:46:23.113777
NCT02059720|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2015-10-07|||February 2014||2014-02-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Haplo-SCT vs ASCT With or Without Decitabine in AML CR1|Haplo-mismatch Donor Stem Cell Transplantation (SCT) Versus Autologous SCT Followed or Not by Maintenance Therapy, for Patients With Acute Myeloid Leukemia (AML) in First Remission: A Chinese Randomized Multicenter Study|Recruiting||Phase 3|212|Anticipated|The First Affiliated Hospital of Soochow University||2|||f||||||||||||||2017-10-11 00:46:23.183027|2017-10-11 00:46:23.183027
NCT02059707|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-03-08|||January 2014||2014-01-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||LARIAT RS: An Observational Study of the Performance and Safety of the LARIAT RS|LARIAT RS: An Observational Study of the Performance and Safety of the LARIAT RS Suture Delivery Device|Completed||N/A|58|Actual|SentreHEART, Inc.||1|||f||||f||||||||||2017-10-11 00:46:23.272703|2017-10-11 00:46:23.272703
NCT02059694|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-12-18||||||December 2014|2014-12-01||||July 2015|Anticipated|2015-07-01||Interventional|||Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's Surgery|The Application of Recombinant Human Hyaluronidase is Effective for the Use of Local Blocks for Eyelid Surgery|Withdrawn||N/A|0|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:46:23.481228|2017-10-11 00:46:23.481228
NCT02059681|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-01-30|||December 2013||2013-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RECARDIO||Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)|Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)|Recruiting||Phase 1|15|Anticipated|Centro Cardiologico Monzino||1|||f||||f||||||||||2017-10-11 00:46:23.606184|2017-10-11 00:46:23.606184
NCT02059668|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2017-02-15|||March 2014||2014-03-01|February 2017|2017-02-01|March 2020|Anticipated|2020-03-01|December 2017|Anticipated|2017-12-01||Observational|||Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)|Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)|Recruiting||N/A|480|Anticipated|Technische Universität Dresden|||1||f||||f||||||Samples With DNA|"     if possible fresh-frozen tumor tissues, blood samples   "|No||2017-10-11 00:46:23.743787|2017-10-11 00:46:23.743787
NCT02059655|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-05-05|||November 2014||2014-11-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|BIMA||Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)|Prostaglandin F2-alpha Eye Drops (Bimatoprost) in Thyroid Eye Disease: a Randomised Controlled Double Blind Crossover Trial|Completed||Phase 4|31|Actual|Cardiff University||2|||f||||f||||||||||2017-10-11 00:46:23.900144|2017-10-11 00:46:23.900144
NCT02059642|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-02-08|2015-12-23||March 2014||2014-03-01|March 2014|2014-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||All subjects who received at least one dose of study medication|A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )|A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared With Placebo in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2/Phase 3|300|Actual|Alcobra Ltd.||2|||f||||f||||||||||2017-10-11 00:46:24.032445|2017-10-11 00:46:24.032445
NCT02059616|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-04-29|||February 2014||2014-02-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension|A Randomized, Double-blind, Multi-center, PhaseⅡ Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Candesartan Cilexetil and Amlodipine Besylate for the Dose Selection in Patients With Essential Hypertension|Unknown status|Recruiting|Phase 2|384|Anticipated|CJ HealthCare Corporation||8|||f||||f||||||||||2017-10-11 00:46:24.842727|2017-10-11 00:46:24.842727
NCT02059603|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-10|2014-02-10|||January 2014||2014-01-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Electroacupuncture Versus Fast-track Perioperative Program for Laparoscopic Colorectal Surgery|A Randomized Clinical Trial of Electroacupuncture Versus Fast-track Perioperative Program for Reducing Duration of Postoperative Ileus and Hospital Stay After Laparoscopic Colorectal Surgery|Unknown status|Recruiting|Phase 3|164|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:46:25.057712|2017-10-11 00:46:25.057712
NCT02059590|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-07|||April 2013||2013-04-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects|A Phase 1 Open-Label Mass Balance Study to Evaluate the Pharmacokinetics of BAL8728 After A Single Intravenous Dose of 14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects|Completed||Phase 1|6|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:46:25.170224|2017-10-11 00:46:25.170224
NCT02059577|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-02-07|||November 2011||2011-11-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Nutritional and Dietary Treatment Study for Children/Adults With Autism|Nutritional and Dietary Treatment Study for Children/Adults With Autism|Completed||Phase 2|120|Actual|Arizona State University||2|||f||||f||||||||||2017-10-11 00:46:25.281765|2017-10-11 00:46:25.281765
NCT02059564|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-02-07|||December 2013||2013-12-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus|A Phase 1b, Exploratory, Randomized, Partially Single Blinded, Placebo and Open Label Controlled, Parallel Group Study to Assess the Effects of HM11260C and an Active Comparator on Gastric Emptying and Beta-Cell Response in Subjects With Type 2 Diabetes Mellitus|Unknown status|Recruiting|Phase 1|44|Anticipated|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 00:46:25.419865|2017-10-11 00:46:25.419865
NCT02059551|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-09-01|||August 2013||2013-08-01|August 2016|2016-08-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Interventional|IRM-EP2||Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism|Diagnostic Performances of Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism|Recruiting||N/A|1058|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 00:46:25.57737|2017-10-11 00:46:25.57737
NCT02059538|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-08-28|||June 2013||2013-06-01|June 2013|2013-06-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|METACARDIS||Metagenomics and Integrative Systems Medicine of Cardiometabolic Diseases|Metagenomics and Integrative Systems Medicine of Cardiometabolic Diseases|Unknown status|Recruiting|N/A|2350|Anticipated|Assistance Publique - Hôpitaux de Paris||8|||f||||f||||||||||2017-10-11 00:46:25.684795|2017-10-11 00:46:25.684795
NCT02059525|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-08-17|||July 2014||2014-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|SeTPAT||Treponema Pallidum-specific Proteomic Changes in Patients With Incident Syphilis Infection|Treponema Pallidum-specific Proteomic Changes in Patients With Incident Syphilis Infection: an Observational Study in Belgium|Active, not recruiting||N/A|150|Actual|Institute of Tropical Medicine, Belgium|||1||f||||t||||||Samples Without DNA|"     serum, plasma and urine   "|||2017-10-11 00:46:25.876107|2017-10-11 00:46:25.876107
NCT02059512|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-01|2017-09-27|||February 2013||2013-02-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|December 2016|Actual|2016-12-01||Interventional|TAMIS||Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease|Influence of the Administration of Autologous Bone Marrow Mononuclear Cells for the Duration of Functioning Aorto-coronary Bypass Grafts in the Surgical Treatment of Coronary Heart Disease|Active, not recruiting||N/A|100|Anticipated|St. Petersburg State Pavlov Medical University||3|||f||||t|f|f||||||||2017-10-11 00:46:25.963021|2017-10-11 00:46:25.963021
NCT02059486|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-13|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Impact Evaluation of the Teen Choice Program|Impact Evaluation of the Teen Choice Program|Active, not recruiting||N/A|465|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-11 00:46:26.242031|2017-10-11 00:46:26.242031
NCT02059473|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-07|||November 2013||2013-11-01|February 2014|2014-02-01|November 2017|Anticipated|2017-11-01|December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Small Acute Cuff Tears, a Randomized Study|Treatment of Small Acute Full-thickness tears-a Prospective Randomised Controlled Trial|Recruiting||N/A|50|Anticipated|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-11 00:46:26.349177|2017-10-11 00:46:26.349177
NCT02059265|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-05-04|||February 2014||2014-02-01|March 2017|2017-03-01||||January 2017|Actual|2017-01-01||Interventional|||Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer|A Phase II Trial of DCTD-Sponsored Dasatinib in Recurrent/Persistent Ovary, Fallopian Tube, Primary Peritoneal, and Endometrial Clear Cell Carcinoma Characterized for the Retention or Loss of BAF250a Expression|Active, not recruiting||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 00:46:30.739333|2017-10-11 00:46:30.739333
NCT02059447|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-12-02|||December 2013||2013-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Comparison of the Benefits of Mindfulness Based Cognitive Therapy, Relaxation Therapy and a Waiting List Control in the Management of Distress in Chronic Tinnitus Patients|A Comparison of the Benefits of Mindfulness Based Cognitive Therapy, Relaxation Therapy and a Waiting List Control in the Management of Distress in Chronic Tinnitus Patients.|Completed||N/A|75|Actual|University College London Hospitals||2|||f||||f||||||||||2017-10-11 00:46:26.547556|2017-10-11 00:46:26.547556
NCT02059421|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-05-03|||January 2014||2014-01-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Johrei Therapy and CBT-I in Facilitating Sleep in ICU Survivors|Comparative-effectiveness of Johrei Therapy and CBT-I in Facilitating Sleep in ICU Survivors|Active, not recruiting||N/A|50|Actual|University of Arizona||2|||f||||t||||||||No|There is no plan to share IPD information.|2017-10-11 00:46:26.778252|2017-10-11 00:46:26.778252
NCT02059408|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-04-18|||September 2015||2015-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Screen-and-treat Program for Chronic Kidney Disease- High Risk Persons|Can a Targeted Screen-and-treat Program for Chronic Kidney Disease Improve Blood Pressure (BP) Management Among Persons at High Risk for Complications ?|Active, not recruiting||N/A|135|Anticipated|University of California, San Francisco||3|||f||||f||||||||No|There is not currently a plan to make the IDP data available.|2017-10-11 00:46:26.866986|2017-10-11 00:46:26.866986
NCT02059382|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2014-07-29|||August 2013||2013-08-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|EXCITE||EXercise Continuation Incorporating Technology Enhancements (EXCITE) Study|EXercise Continuation Incorporating Technology Enhancements (EXCITE) Study|Completed||N/A|40|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:46:27.131735|2017-10-11 00:46:27.131735
NCT02059369|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-04-10|||August 2012||2012-08-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|ADLINE||Ablation of Complex Fractionated Electrograms With or Without Additional Linear Lesions for Persistent Atrial Fibrillation|Ablation of Complex Fractionated Electrograms With or Without Additional Linear Lesions for Persistent Atrial Fibrillation|Completed||N/A|90|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||||2017-10-11 00:46:27.225115|2017-10-11 00:46:27.225115
NCT02059356|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-03-13|||January 2014||2014-01-01|March 2015|2015-03-01||||March 2015|Actual|2015-03-01||Observational|||Ammonia Levels and Cognitive Impairment|Prevalence of High Ammonia Levels in Patients With Cognitive Impairment. Does Treatment Help?|Terminated||N/A|17|Actual|Duke University|||1|Low patient recruitment|f||||f||||||||||2017-10-11 00:46:27.299163|2017-10-11 00:46:27.299163
NCT02059343|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-11-21|||March 2014||2014-03-01|October 2014|2014-10-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|||Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)|Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)|Completed||N/A|18|Actual|Duke University|||1||f||||f||||||Samples Without DNA|"     Blood will be collected for plasma pharmacokinetic analysis.   "|||2017-10-11 00:46:27.367739|2017-10-11 00:46:27.367739
NCT02059330|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-06-23|||March 2014||2014-03-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects|A Phase 1, Open Label Study To Investigate The Effect Of Dose And Ethnicity On Palbociclib (PD-0332991) Pharmacokinetics In Japanese Healthy Volunteers|Completed||Phase 1|27|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:46:27.430516|2017-10-11 00:46:27.430516
NCT02059317|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-01-30|||January 2015||2015-01-01|September 2016|2016-09-01|September 28, 2016|Actual|2016-09-28|September 20, 2016|Actual|2016-09-20||Observational|SDL||Evaluation of Dynamic Stability in the Low Back Pain Patient|Evaluation of Dynamic Stability in the Low Back Pain Patient|Completed||N/A|70|Actual|Centre Hospitalier Universitaire de Nīmes|||6||f||||f||||||||||2017-10-11 00:46:27.527642|2017-10-11 00:46:27.527642
NCT02059304|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-12-19|||January 2012||2012-01-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Prediction of Preterm Deliveries by Cervical Length Measurement With Embryo Transfer Catheter in ICSI Patients|Can Cervical Length Measurement With Embryo Transfer Catheter Predict Preterm Deliveries in ICSI Patients?|Completed||N/A|||Acibadem University||2|||f||||t||||||||||2017-10-11 00:46:27.635066|2017-10-11 00:46:27.635066
NCT02059291|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-05-16|2016-11-21||June 28, 2014|Actual|2014-06-28|May 2017|2017-05-01|June 28, 2017|Anticipated|2017-06-28|August 25, 2015|Actual|2015-08-25||Interventional|||Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers|Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers|Active, not recruiting||Phase 3|204|Actual|Novartis||6|||f||||f||||||||||2017-10-11 00:46:27.727213|2017-10-11 00:46:27.727213
NCT02059278|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-04-21|||January 2014||2014-01-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension|A Randomized, Multicenter, Parallel-Group, Observer-Masked, Phase 3 Study to Compare the Safety and Efficacy of T-2345 Ophthalmic Solution to Xalatan (Latanoprost 0.005%) in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|335|Actual|Nephron Pharmaceuticals Corporation||2|||f||||f||||||||||2017-10-11 00:46:30.498717|2017-10-11 00:46:30.498717
NCT02058186|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-02-06|||December 2011||2011-12-01|February 2014|2014-02-01||||December 2012|Actual|2012-12-01||Interventional|||Effect of Oral Vitamin D Supplement on Atopic Dermatitis; A Clinical Trial With Staphylococcus Aureus Colonization Determination||Completed||N/A|20|Actual|Srinakharinwirot University||2|||f||||||||||||||2017-10-11 00:46:49.275733|2017-10-11 00:46:49.275733
NCT02059252|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-04-01|||August 2014||2014-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold|Proof of Concept Study Assessing Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold|Terminated||Phase 1/Phase 2|5|Actual|Smart Matrix Limited||1||Mode of application to be reconsidered by Sponsor|f||||t||||||||||2017-10-11 00:46:31.302419|2017-10-11 00:46:31.302419
NCT02059239|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-03-01|||June 4, 2014|Actual|2014-06-04|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Lymphoma Bridge Transplant Study|A Pilot Study of a Sequential Regimen of Intensive Chemotherapy Followed by Autologous or Allogeneic Transplantation for Refractory Lymphoma (Non-Hodgkin's and Hodgkin's)|Recruiting||N/A|30|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 00:46:31.403235|2017-10-11 00:46:31.403235
NCT02059226|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-27|||April 2014||2014-04-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Evaluating an Internet-based Program for Anxious Youth: a Pilot RCT|Evaluating an Internet-based Program for Anxious Youth: a Pilot RCT|Completed||N/A|94|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 00:46:31.570082|2017-10-11 00:46:31.570082
NCT02059213|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-05-02|||June 2014||2014-06-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer|A Randomized Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer|Active, not recruiting||Phase 2|60|Anticipated|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 00:46:31.741137|2017-10-11 00:46:31.741137
NCT02059200|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-07-11|||July 2013||2013-07-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|MBCL-RD||Mindfulness Based Compassionate Living in Recurrent Depression|The Effectiveness of Mindfulness Based Compassionate Living in Recurrent Depression|Completed||N/A|122|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 00:46:31.942583|2017-10-11 00:46:31.942583
NCT02059187|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-01-17|2017-01-17||February 2014||2014-02-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||The analysis population included all randomized participants.|The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006)|A Phase III Clinical Trial to Study the Safety and Efficacy of MK-1293 Compared to Lantus™ in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|531|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:46:32.071353|2017-10-11 00:46:32.071353
NCT02059174|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-01-17|2016-11-21||February 2014||2014-02-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)|A Single Dose Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-1293 and to Compare Its Pharmacologic Properties to Those of Another Basal Insulin in Subjects With Type I Diabetes|Completed||Phase 1|76|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:46:32.903913|2017-10-11 00:46:32.903913
NCT02059161|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-01-17|2017-01-17||October 2013||2013-10-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional||The analysis population included all randomized participants.|A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)|A Phase III Clinical Trial to Study the Safety and Efficacy of MK-1293 Compared to Lantus™ in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 3|508|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 00:46:33.395462|2017-10-11 00:46:33.395462
NCT02059148|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2014-11-19|||February 2014||2014-02-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of LY2835219 in Healthy Participants|Effect of Food on the Pharmacokinetics of LY2835219 in Healthy Subjects|Completed||Phase 1|25|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 00:46:34.623648|2017-10-11 00:46:34.623648
NCT02059135|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-07-11|2017-06-13||July 11, 2014|Actual|2014-07-11|July 2017|2017-07-01|November 2016|Actual|2016-11-01|May 18, 2016|Actual|2016-05-18||Interventional|PRESERVE-1|ITT Population|Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia|Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)|Completed||Phase 3|120|Actual|rEVO Biologics|Note: 6 subjects (2 in the Recombinant Human Antithrombin (ATryn) group and 4 in the placebo group) were randomized but received no treatment. These subjects are included in the ITT population but not the maternal safety population.|2|||f||||t||||||||||2017-10-11 00:46:34.742909|2017-10-11 00:46:34.742909
NCT02059122|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2017-09-22|||April 2011||2011-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Sensitivity Study of Diagnostic for Early Detection of Dengue Infection|Determination of Estimated Sensitivity for Dengue NS1 ELISAs|Active, not recruiting||N/A|250|Anticipated|InBios International, Inc.|||1||f||||||||||Samples Without DNA|"     serum   "|||2017-10-11 00:46:36.112299|2017-10-11 00:46:36.112299
NCT02059109|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-01-31|||June 2013||2013-06-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of a Training Model for the Proficient Use of the Belmont Rapid Infuser|Evaluation of a Training Model for the Proficient Use of the Belmont Rapid Infuser|Enrolling by invitation||N/A|56|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 00:46:36.201907|2017-10-11 00:46:36.201907
NCT02059096|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-08-31|||February 2014||2014-02-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|STIMASEP||Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple Sclerosis|Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple Sclerosis|Recruiting||Phase 3|66|Anticipated|University Hospital, Clermont-Ferrand||3|||f||||||||||||||2017-10-11 00:46:36.290006|2017-10-11 00:46:36.290006
NCT02059083|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-04-28|||September 2014||2014-09-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Biofeedback for Adolescent Cannabis Use Disorder|Biofeedback for Adolescent Cannabis Use Disorder|Withdrawn||Phase 1/Phase 2|0|Actual|Denver Health and Hospital Authority||2||Funding not received; study was never started|f||||f||||||||||2017-10-11 00:46:36.401869|2017-10-11 00:46:36.401869
NCT02059070|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-11-13|2014-08-25||June 2012||2012-06-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||Bupivacaine Versus Ropivacaine on Diaphragmatic Motility and Ventilatory Function|The Effect of Continuous Interscalene Brachial Plexus Block With 0.125% Bupivacaine Versus 0.2% Ropivacaine on Diaphragmatic Motility and Ventilatory Function|Completed||N/A|39|Actual|Anesthesiology WSU/DMC-NorthStar||2|||f||||t||||||||||2017-10-11 00:46:36.495045|2017-10-11 00:46:36.495045
NCT02059057|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-05-27|||December 2013||2013-12-01|May 2016|2016-05-01|June 2021|Anticipated|2021-06-01|June 2017|Anticipated|2017-06-01||Interventional|CROSSOVER||LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)|Crossover From IDE Trial CLN0009, Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study, IDE G110066|Active, not recruiting||Phase 3|102|Actual|PneumRx, Inc.||1|||f||||t||||||||||2017-10-11 00:46:36.766264|2017-10-11 00:46:36.766264
NCT02059044|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-08-04|||October 2015||2015-10-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|June 2019|Anticipated|2019-06-01||Interventional|ISTOP-ADE||Information Systems-enabled Outreach Program for Adverse Drug Events|Information Systems-enabled Outreach Program for Adverse Drug Events|Recruiting||N/A|2200|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||Undecided||2017-10-11 00:46:36.93402|2017-10-11 00:46:36.93402
NCT02059031|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-07-14|||February 2014||2014-02-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects|A Two Part, Single-center, Randomized, Open-label, Crossover Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects|Completed||Phase 1|24|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 00:46:37.069924|2017-10-11 00:46:37.069924
NCT02059018|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2015-08-17|||February 2014||2014-02-01|January 2014|2014-01-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||The Mechanisms of Diameter Changes in Retinal Vessels During Hypoxia|The Underlying Mechanisms of Diameter Changes in Retinal Vessels During Hypoxia|Completed||N/A|20|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:46:37.265597|2017-10-11 00:46:37.265597
NCT02058992|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-07|2016-06-02|2015-12-07||July 2010||2010-07-01|June 2016|2016-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational||Safety analysis set was defined as participants who were enrolled and completed the study.|Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty|Rozerem Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty|Completed||N/A|3339|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:46:37.510066|2017-10-11 00:46:37.510066
NCT02058979|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-10-24|||November 2014||2014-11-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pharmacokinetics of Bolus Versus Continuous Cefazolin Infusion in Patients Undergoing Major Surgery|Pharmacokinetics of Bolus Versus Continuous Cefazolin Infusion in Patients Undergoing Major Surgery|Completed||N/A|20|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 00:46:37.974907|2017-10-11 00:46:37.974907
NCT02058953|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-09-08|||August 2014||2014-08-01|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|13-052||CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases|Procurement of Central Nervous System and Extracranial Tumor Tissues, Cerebrospinal Fluid, and Blood From Patients With Melanoma Brain Metastases|Recruiting||N/A|50|Anticipated|University of Pittsburgh|||2||f||||t||||||Samples Without DNA|"     Peripheral blood; extracranial melanoma tissue; Cerebrospinal fluid; CNS tumor specimens;     adjacent normal CNS tissue; tissue slides/blocks from original biopsy   "|||2017-10-11 00:46:38.194068|2017-10-11 00:46:38.194068
NCT02058940|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-09-14|||August 2015||2015-08-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Intravenous Exenatide in Patients With Acute Brain Injury|Intravenous Exenatide Infusion in Critically Ill Patients With Acute Brain Injury|Completed||Phase 4|8|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 00:46:38.307263|2017-10-11 00:46:38.307263
NCT02058927|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-09-17|||May 2011||2011-05-01|September 2014|2014-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia|Immune Reconstitution to Measles Virus of HIV-1-Infected Zambian Children Initiating Antiretroviral Therapy|Completed||N/A|203|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||Samples With DNA|"     blood samples will be stored in a repository for five years beyond the end of the study     period. Some samples may be exported to the Johns Hopkins Bloomberg School of Public Health     when assays cannot be performed in Zambia.   "|||2017-10-11 00:46:38.394188|2017-10-11 00:46:38.394188
NCT02058914|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-06-06|||September 2011||2011-09-01|June 2017|2017-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|adol||Effects of Sugar Sweetened Beverage on Metabolic Health in Male and Female Adolescents|Moderate Amounts of High Fructose- or High Glucose-sweetened Beverages do Not Differentially Alter Metabolic Health in Male and Female Adolescents|Completed||N/A|40|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-10-11 00:46:38.538563|2017-10-11 00:46:38.538563
NCT02058901|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-03-17|||July 2013||2013-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.|A Phase I Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.|Recruiting||Phase 1|40|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 00:46:38.674429|2017-10-11 00:46:38.674429
NCT02058173|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-10-18|||January 2014||2014-01-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||"Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study"||Completed||Phase 4|10|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:46:49.823869|2017-10-11 00:46:49.823869
NCT02058888|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-05-02|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|ASARI||Amplification and Selection of Antimicrobial Resistance in the Intestine|Self-controlled Cohort Study of the Amplification and Selection of Antimicrobial Resistance in the Human Intestine|Completed||N/A|40|Actual|University Hospital Tuebingen|||1||f||||||||||Samples With DNA|"     Bacterial DNA from human stool samples.   "|||2017-10-11 00:46:38.801711|2017-10-11 00:46:38.801711
NCT02058875|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-01-05|||February 2014||2014-02-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|COBACAM||Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring|Comparisons Of Inflammatory Biomarkers And Cardiovascular Risk Scores Before And After Conversion To Full Dose Myfortic® Using Two Hour Neoral® Monitoring.|Withdrawn||Phase 4|0|Actual|University of Saskatchewan||3||The study funder retracted their grant funding offer before contract signed.|f||||f||||||||||2017-10-11 00:46:38.890776|2017-10-11 00:46:38.890776
NCT02058862|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-11-03|||May 2014||2014-05-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||Effect of a Home-based Electrical Stimulation on Quadriceps Function After Knee Surgery|Effects of a Superimposed Electrical Stimulation Knee Garment on Strength, Function, Inhibition, Cortical Excitability, and Patient Reported Outcomes After Knee Surgery|Recruiting||N/A|100|Anticipated|University of Kentucky|||1||f||||f||||||||||2017-10-11 00:46:39.080299|2017-10-11 00:46:39.080299
NCT02058849|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-03-15|||December 2014||2014-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck|Randomized Phase II Study of Concentrated Beet Root in Participants Being Treated for Locally Advanced Unresectable, Previously Untreated Squamous Cell Cancer of the Head and Neck|Recruiting||Phase 2|50|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 00:46:39.197404|2017-10-11 00:46:39.197404
NCT02058836|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-08-23|||November 2014||2014-11-01|August 2017|2017-08-01|October 18, 2016|Actual|2016-10-18|October 18, 2016|Actual|2016-10-18||Interventional|||Botulinum Toxin for the Management of Chronic Orchialgia|Botulinum Toxin for the Management of Chronic Orchialgia|Completed||Phase 2|8|Actual|Wake Forest University Health Sciences||2|||f||||||||||||||2017-10-11 00:46:39.315712|2017-10-11 00:46:39.315712
NCT02058823|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-03-23|||August 2013||2013-08-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|IH2||Intermittent Hypoxia 2: Cardiovascular and Metabolism|Cardiovascular and Metabolic Physiological Adaptations to Intermittent Hypoxia. Physiological Aspects and Expression of Receptors and Cellular Mediators|Active, not recruiting||Phase 4|12|Actual|University Hospital, Grenoble||4|||f||||f||||||||||2017-10-11 00:46:39.443284|2017-10-11 00:46:39.443284
NCT02058810|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-02-07|||September 2010||2010-09-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Interventional|||Nasal High Flow at Acute Hart Failure|Does the Use of Optiflow High Flow Oxygen on Patients With Acute Cardial Decompensation (NYHA Classification Stage III-IV) Allow for Quicker Improvement of the Organ Dysfunction Than Conventional Standard-Oxygen-Insufflation-Therapy?|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital Regensburg||2|||f||||f||||||||||2017-10-11 00:46:39.600353|2017-10-11 00:46:39.600353
NCT02058797|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2015-06-01|||January 2014||2014-01-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|CTFORPRO||Efficacy of Coherence Therapy for Procrastination|Efficacy of Coherence Therapy for Procrastination: a Randomized Controlled Trial|Terminated||N/A|31|Actual|University of Barcelona||2||"The Coherence Therapy intervention could not be delivered in a reliable and valid way for a   variety of reasons."|f||||f||||||||||2017-10-11 00:46:39.694783|2017-10-11 00:46:39.694783
NCT02058784|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-02-22|||February 2014||2014-02-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|HVFE||Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects|A 2-Cohort Study to Evaluate the Effect of Food and the Effect of Cigarette Smoking on the Single-Dose Bioavailability of Pracinostat in Healthy Adult Subjects|Completed||Early Phase 1|28|Actual|Helsinn Healthcare SA||2|||f||||f||||||||||2017-10-11 00:46:39.942987|2017-10-11 00:46:39.942987
NCT02058771|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-05-25|||October 2013||2013-10-01|May 2017|2017-05-01||||September 2017|Anticipated|2017-09-01||Observational|ULTIMATE||Utilising Lifemap to Investigate Malignant Arrhythmia Therapy|ULTIMATE: Utilising Lifemap to Investigate Malignant Arrhythmia ThErapy|Recruiting||N/A|60|Anticipated|University Hospitals, Leicester|||1||f||||f||||||Samples Without DNA|"     Fresh Frozen Plasma   "|||2017-10-11 00:46:40.048095|2017-10-11 00:46:40.048095
NCT02058758|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-06-08|||March 2014||2014-03-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer|Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer|Enrolling by invitation||N/A|80|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||||Undecided||2017-10-11 00:46:40.15253|2017-10-11 00:46:40.15253
NCT02058745|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-08-28|||March 1, 2014|Actual|2014-03-01|August 2017|2017-08-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|SmartCare||SmartCare: Innovations in Caregiving Interventions|SmartCare: Innovations in Caregiving Interventions|Completed||N/A|240|Actual|University of Pittsburgh||3|||f||||f||||||||||2017-10-11 00:46:40.232461|2017-10-11 00:46:40.232461
NCT02058732|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-04-21|||November 2013||2013-11-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis|Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis|Active, not recruiting||N/A|17|Anticipated|University of Michigan||2|||f||||t||||||||No||2017-10-11 00:46:40.366557|2017-10-11 00:46:40.366557
NCT02058719|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-08-29|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Immunosuppressive Effects of Smoking and HIV-1 on the Development of Lung Disease|Immunosuppressive Effects of Smoking and HIV-1 on the Development of Lung Disease.|Recruiting||N/A|210|Anticipated|University of Colorado, Denver|||7||f||||f||||||Samples Without DNA|"     Blood and bronchoscopy (BAL) samples will be collected   "|||2017-10-11 00:46:40.495808|2017-10-11 00:46:40.495808
NCT02057653|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-02-09|||November 2013||2013-11-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of Goal-Directed Intraoperative Hemodynamic Optimization Protocol|Evaluation of Goal-Directed Intraoperative Hemodynamic Optimization Protocol|Recruiting||N/A|600|Anticipated|University of California, Irvine|||2||f||||f||||||||||2017-10-11 00:47:03.438555|2017-10-11 00:47:03.438555
NCT02058706|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-03|||May 2014||2014-05-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer|Randomized Phase II Screening Trial of Enzalutamide/MDV-3100 and LHRH Analogue vs Combined Androgen Deprivation (LHRH Analogue + Bicalutamide) in Metastatic Hormone Sensitive Prostate Cancer|Recruiting||Phase 2|92|Anticipated|Barbara Ann Karmanos Cancer Institute||2|||f||||t||||||||||2017-10-11 00:46:40.587745|2017-10-11 00:46:40.587745
NCT02058693|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-12-18|||December 2010||2010-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Adjunctive Mixed Salts Amphetamine (MSA) for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (ADT)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Adjunctive, Flexible-Dose Mixed Salts Amphetamine (MSA) in Adult Outpatients With Major Depressive Disorder (MDD) Responding Inadequately to Current Antidepressant Therapy (ADT)|Completed||Phase 4|45|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 00:46:40.765177|2017-10-11 00:46:40.765177
NCT02058680|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-06-29|||April 2012||2012-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PSA||Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients|A Phase 1A/1B, Two-Stage Study of a PSA/IL-2/GM-CSF Vaccine for the Treatment of PSA Recurrent Prostate Cancer in Hormone-Naive and Hormone-Independent Patients|Active, not recruiting||Phase 1|48|Anticipated|OncBioMune, LLC||1|||f||||t||||||||||2017-10-11 00:46:40.869961|2017-10-11 00:46:40.869961
NCT02058667|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-11-11|||July 2014||2014-07-01|November 2016|2016-11-01||||December 2015|Actual|2015-12-01||Interventional|||Reirradiation With Concurrent Paclitaxel for Breast Cancer|A Phase I Study of Twice Weekly Paclitaxel and Radical Re-irradiation Using Helical Tomotherapy for Aggressive Chest Wall Recurrences of Breast Cancer|Withdrawn||Phase 1|0|Actual|University of Kentucky||1||Slow accrual|f||||t||||||||||2017-10-11 00:46:41.096003|2017-10-11 00:46:41.096003
NCT02058654|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-06-28|||December 1, 2013|Actual|2013-12-01|June 2017|2017-06-01|June 24, 2014|Actual|2014-06-24|June 1, 2014|Actual|2014-06-01||Interventional|||A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing Population|A Randomised, Double-blind, Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing Population Using Phosphorus-31 Magnetic Resonance Spectroscopy (31P MRS) and Functional Magnetic Resonance Imaging (fMRI)|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:46:41.19363|2017-10-11 00:46:41.19363
NCT02058641|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-05-12|||February 26, 2014|Actual|2014-02-26|May 2017|2017-05-01|August 18, 2014|Actual|2014-08-18|August 18, 2014|Actual|2014-08-18||Interventional|||Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)|An Open Label Study on the Effects of a Short Course of SB480848 (Darapladib) on Contents of Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|9|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:46:41.312915|2017-10-11 00:46:41.312915
NCT02058628|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-08-24|2017-03-01||February 21, 2014|Actual|2014-02-21|August 2017|2017-08-01|September 8, 2014|Actual|2014-09-08|September 8, 2014|Actual|2014-09-08||Interventional||Out of 221 randomized participants, 4 participants did not receive study medication. Hence, the Intent-to-treat (ITT) population consisted of 217 participants|Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris|A Multi-centre, Single-blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Clindamycin 1% / Benzoyl Peroxide 3% and Azelaic Acid 20% in the Topical Treatment of Mild to Moderate Acne Vulgaris|Completed||Phase 4|222|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:46:41.56965|2017-10-11 00:46:41.56965
NCT02058615|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2015-12-22|||March 2014||2014-03-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast Cancer|Living With Hope: Development and Feasibility Evaluation of a Transition Toolkit for Make Partners of Women With Breast Cancer|Completed||Phase 3|57|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 00:46:43.529677|2017-10-11 00:46:43.529677
NCT02058602|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-27|||December 3, 2013|Actual|2013-12-03|April 2017|2017-04-01|July 11, 2016|Actual|2016-07-11|July 11, 2016|Actual|2016-07-11||Interventional|||Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients|A Study to Characterise Lung Function, Airway Morphometry, Pharyngometry and Inhalation Profiles From Patients With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 1|25|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:46:43.6129|2017-10-11 00:46:43.6129
NCT02058589|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-06-15|||March 20, 2014|Actual|2014-03-20|June 2017|2017-06-01|April 13, 2017|Actual|2017-04-13|May 11, 2016|Actual|2016-05-11||Interventional|||Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant|Observer-blind Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults 18 Years of Age or Older With Renal Transplant|Completed||Phase 3|265|Actual|GlaxoSmithKline||2|||f|||||f|f||||||||2017-10-11 00:46:43.720157|2017-10-11 00:46:43.720157
NCT02058576|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-05-09|||February 11, 2014|Actual|2014-02-11|May 2017|2017-05-01|January 2, 2015|Actual|2015-01-02|January 2, 2015|Actual|2015-01-02||Interventional|||Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State|A Single-Dose, Randomised, Open-Label, Two-Period Crossover Study to Determine the Bioequivalence of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in the Fed State in Healthy Adult Male Subjects|Completed||Phase 1|77|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:46:43.937108|2017-10-11 00:46:43.937108
NCT02058563|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-05-08|2016-12-30|2015-10-29|July 1, 2014||2014-07-01|May 2017|2017-05-01|September 17, 2015|Actual|2015-09-17|May 24, 2015|Actual|2015-05-24||Interventional|||Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older|Immunogenicity and Safety Study of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Subjects Seven Years and Older (209762)|Completed||Phase 3|996|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 00:46:44.059942|2017-10-11 00:46:44.059942
NCT02058550|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-01-12|||September 2014||2014-09-01|January 2017|2017-01-01|September 2022|Anticipated|2022-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy|Phase I Pilot Study Evaluating Vaginal Dilator Use and Toxicity Following Vaginal Brachytherapy|Active, not recruiting||Phase 1|72|Actual|Stanford University||3|||f||||||||||||||2017-10-11 00:46:44.996165|2017-10-11 00:46:44.996165
NCT02058537|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-03-21|2016-03-21||February 2014||2014-02-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Bethanechol for Eosinophilic Esophagitis|Bethanechol for Treatment of Eosinophilic Esophagitis (EoE)|Terminated||Phase 2|2|Actual|University of Iowa||1||Initial PI left, study not continued|f||||t||||||||||2017-10-11 00:46:45.102528|2017-10-11 00:46:45.102528
NCT02058524|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-08-23|||June 2013||2013-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis|A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis|Terminated||Phase 1|1|Actual|University of Chicago||1||Unable to recruit and enroll eligible subjects.|f||||t||||||||||2017-10-11 00:46:45.375533|2017-10-11 00:46:45.375533
NCT02058498|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-04-28|2015-05-03||February 2014||2014-02-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Increasing Activity in Liver Transplant Patients|Increasing Physical Activity in Post Liver Transplant Patients|Completed||N/A|12|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:46:45.594757|2017-10-11 00:46:45.594757
NCT02058485|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-02-06|||January 2012||2012-01-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Dexmedetomidine Premedication in Hypertensive Patients|Does the Use of Dexmedetomidine for Premedication Provide Hemodynamic Stability in Hypertensive Patients?|Completed||Phase 3|162|Actual|Duzce University||4|||f||||f||||||||||2017-10-11 00:46:45.876692|2017-10-11 00:46:45.876692
NCT02058472|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-02-06|||December 2013||2013-12-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers|An Open Label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetic/Pharmacodynamic Characteristics and Safety Following Administration of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers|Unknown status|Active, not recruiting|Phase 1|30|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:46:45.998738|2017-10-11 00:46:45.998738
NCT02058459|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-05-01|||July 2014||2014-07-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|January 2018|Anticipated|2018-01-01||Interventional|AIRFLOW||Targeted Lung Denervation for Patients With Moderate to Severe COPD|A Sequential Two Phase Multicenter, Randomized Study to Optimize Dose Selection and Evaluate Safety After Treatment With the Holaira™ Lung Denervation System in Patients With Moderate to Severe COPD.|Active, not recruiting||Phase 2|140|Anticipated|Nuvaira, Inc.||2|||f||||t||||||||||2017-10-11 00:46:46.095072|2017-10-11 00:46:46.095072
NCT02058446|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-11-11|||October 2013||2013-10-01|February 2014|2014-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension|An Open-label, Postmarketing Study of Amlodipine/Valsartan Single-Pill Combination for the Treatment of Hypertension|Completed||Phase 4|36|Actual|TSH Biopharm Corporation Limited||1|||f||||f||||||||||2017-10-11 00:46:46.239601|2017-10-11 00:46:46.239601
NCT02058433|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-02-06|||January 2014||2014-01-01|February 2014|2014-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC)|Phase 3, Randomized, Open-label Study of the Safety of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetic Follow up Versus Conventional Dosage in First-line Treatment in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 3|140|Anticipated|Tongji University||2|||f||||t||||||||||2017-10-11 00:46:46.348234|2017-10-11 00:46:46.348234
NCT02058420|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-01|2017-01-24|||February 2014||2014-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tocotrienols and Bone Health of Postmenopausal Women|Effect of Tocotrienols on Bone Health: A Pilot Study|Active, not recruiting||Phase 1/Phase 2|78|Anticipated|Texas Tech University Health Sciences Center||3|||f||||f||||||||||2017-10-11 00:46:46.471632|2017-10-11 00:46:46.471632
NCT02058407|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-05-12|||January 28, 2014|Actual|2014-01-28|May 2017|2017-05-01|October 31, 2014|Actual|2014-10-31|October 31, 2014|Actual|2014-10-31||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects|A Randomised, Double-blind (Sponsor Unblind), Placebo-controlled, Two Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects|Terminated||Phase 1|33|Actual|GlaxoSmithKline||4||"Drug related AEs observed upon repeat dosing that with longer treatment duration could become   worse. Required action on some biomarkers not observed."|f||||f||||||||||2017-10-11 00:46:46.567225|2017-10-11 00:46:46.567225
NCT02058394|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-06|||March 2012||2012-03-01|February 2014|2014-02-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Observational|||Retained Lens Fragments After Phacoemulsification|Postoperative Events in Patients With and Without Retained Nuclear Fragments in the Anterior Vitreous After Routine Phacoemulsification|Unknown status|Active, not recruiting|N/A|500|Anticipated|Ophthalmic Consultants, Corneal and Refractive Surgery Assoicates, PC|||1||f||||f||||||||||2017-10-11 00:46:46.686172|2017-10-11 00:46:46.686172
NCT02058381|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-09-22|||May 6, 2014|Actual|2014-05-06|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|B-YOND||A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer|A Phase Ib Dose De-escalation Study of the Combination of Tamoxifen Plus Goserelin Acetate With Alpelisib (BYL719) or Buparlisib (BKM120) in Premenopausal Patients With Hormone Receptor-positive/HER2-negative Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 1|40|Actual|Novartis||2|||f||||t|f|f||||||||2017-10-11 00:46:46.781602|2017-10-11 00:46:46.781602
NCT02058368|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-04-04|||February 10, 2014||2014-02-10|April 2017|2017-04-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia|A Randomized, Double-blind, Parallel Group Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride (0.5mg) and Tamsulosin (0.2mg) With Tamsulosin (0.2mg) Monotherapy, Administered Once Daily for 2 Years, on the Improvement of Symptoms and Health Outcomes in Men With Moderate to Severe Benign Prostatic Hyperplasia|Completed||Phase 3|609|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:46:46.911076|2017-10-11 00:46:46.911076
NCT02058355|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-03-13|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Development and Evaluation of Effectiveness of an Internet-based Brief Intervention for Alcohol Use Among Brazilian College Students|Development and Evaluation of Effectiveness of an Internet-based Brief Intervention for Alcohol Use Among Brazilian College Students|Active, not recruiting||N/A|6500|Anticipated|Federal University of São Paulo||3|||f||||||||||||||2017-10-11 00:46:47.132584|2017-10-11 00:46:47.132584
NCT02058342|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-02-07|||May 2011||2011-05-01|February 2014|2014-02-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|APAH||Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study|Family-based Exercise Intervention for Children and Adolescents With Prader-Willi Syndrome|Unknown status|Recruiting|N/A|115|Anticipated|California State University, Fullerton||2|||f||||f||||||||||2017-10-11 00:46:47.240386|2017-10-11 00:46:47.240386
NCT02058329|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2014-02-06|||November 2008||2008-11-01|February 2014|2014-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Geriatric Home Visit Program to Reduce Post-Hip Fracture Complications|A Geriatric Home Visit Program to Reduce Post Hip Fracture Morbidity and Mortality|Terminated||N/A|18|Actual|Northwell Health||2||Many patients were lost to follow-up|f||||t||||||||||2017-10-11 00:46:47.391753|2017-10-11 00:46:47.391753
NCT02058316|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-03-28|||February 2013||2013-02-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study|Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study|Recruiting||N/A|300|Anticipated|Medical University of Graz|||1||f||||f||||||||||2017-10-11 00:46:47.501409|2017-10-11 00:46:47.501409
NCT02058303|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-03|||February 2014||2014-02-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of A Long Lasting Local Anesthestic for Hand, Wrist or Finger Surgery|Exparel (Bupivacaine Liposome Injectable Suspension) for Distal Upper Extremity Blocks in Orthopedic Surgery|Terminated||Phase 4|90|Actual|Ochsner Health System||2||PI leaving instutition|f||||t||||||||||2017-10-11 00:46:47.641308|2017-10-11 00:46:47.641308
NCT02058290|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-04-15|2014-02-19||December 2011||2011-12-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|IMPROVE-Lap|122 subjects were enrolled. Of these, 105 subjects received study drug: 67 subjects received IV morphine sulfate or sponsor-approved equivalent and 38 subjects received EXPAREL.|A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy|A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation of Bupivacaine, EXPAREL(R): A Phase 4 Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy (IMPROVE-Lap Colectomy)|Terminated||Phase 4|122|Actual|Pacira Pharmaceuticals, Inc||2||Slower than expected enrollment|f||||t||||||||||2017-10-11 00:46:47.804905|2017-10-11 00:46:47.804905
NCT02058277|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-06-23|||May 2014||2014-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers|An Open-Label, Randomized, 2-Period Crossover Study To Evaluate The Effect Of A Single Dose Of Aprepitant, A Moderate CYP3A Inhibitor On Bosutinib Administered Orally To Healthy Subjects|Completed||Phase 1|20|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:46:48.646239|2017-10-11 00:46:48.646239
NCT02058264|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2014-09-10|||February 2014||2014-02-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis|A Randomized, Double Blinded, Vehicle-Controlled Study to Evaluate the Safety and the Effect on Sweat Production of Topically Applied BBI-4000 in Subjects With Hyperhidrosis.|Completed||Phase 1|24|Anticipated|Brickell Biotech, Inc.||2|||f||||||||||||||2017-10-11 00:46:48.738253|2017-10-11 00:46:48.738253
NCT02058251|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-09-29|||February 2014||2014-02-01|August 2016|2016-08-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Interventional|||Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress|Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress|Completed||Phase 1|73|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 00:46:48.825098|2017-10-11 00:46:48.825098
NCT02058238|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-08-16|||October 2014||2014-10-01|August 2017|2017-08-01|January 2027|Anticipated|2027-01-01|January 2024|Anticipated|2024-01-01||Observational|||ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity|ADDRESS - Multicenter, Partially-randomized Controlled Trial of Adult Deformity Robotic vs. Freehand Surgery to Correct Adult Spine Deformity|Enrolling by invitation||N/A|2000|Anticipated|Mazor Robotics|||4||f||||f||||||||||2017-10-11 00:46:48.914038|2017-10-11 00:46:48.914038
NCT02058225|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-06-21|||March 1, 2014|Actual|2014-03-01|June 2017|2017-06-01|May 22, 2017|Actual|2017-05-22|May 22, 2017|Actual|2017-05-22||Observational|||Developing Advanced MRI Methods for Detecting the Impact of Nutrients on Infant Brain Development|Developing Advanced MRI Methods for Detecting the Impact of Nutrients on Infant Brain Development|Completed||N/A|130|Actual|Boston Children’s Hospital|||1||f||||f||||||||No||2017-10-11 00:46:49.018389|2017-10-11 00:46:49.018389
NCT02058212|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-02-07|||March 2013||2013-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|ROS||Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI)|Does Antioxidant Supplementation to Endometriotic Women Undergoing ICSI Could Alter Reactive Oxygen Species (ROS) Levels and Affect Pregnancy Outcome|Completed||Phase 2|50|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 00:46:49.097307|2017-10-11 00:46:49.097307
NCT02058199|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-01-04|||December 2014||2014-12-01|January 2015|2015-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery|A Pharmacodynamic Study of Rivaroxaban in Subjects Who Have Undergone Roux-en-Y Gastric Bypass Surgery|Terminated||Phase 1|2|Actual|State University of New York - Upstate Medical University||4||PI left the Institution; No replacement PI identified;|f||||f||||||||||2017-10-11 00:46:49.186987|2017-10-11 00:46:49.186987
NCT02058160|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-03-31|2016-12-16|2016-07-01|January 2014||2014-01-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|LixiLan-L||Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes|A Randomized, 30-week, Active-controlled, Open Label, 2- Treatment Arm, Parallel-group, Multicenter Study Comparing the Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine With or Without Metformin in Patients With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 3|736|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 00:46:49.996783|2017-10-11 00:46:49.996783
NCT02058147|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-03-31|2016-12-16|2016-06-15|February 2014||2014-02-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LixiLan-O||Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM|A Randomized, 30 Week, Active-controlled, Open-label, 3-treatment Arm, Parallel-group Multicenter Study Comparing the Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination to Insulin Glargine Alone and to Lixisenatide Alone on Top of Metformin in Patients With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 3|1170|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 00:46:54.881116|2017-10-11 00:46:54.881116
NCT02058134|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-12|||December 2013||2013-12-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2015|Actual|2015-12-01||Interventional|||The CardioPAT Project: A Randomized Trial|CardioPAT Project - Reducing the Need for Allogenic Blood Transfusion After On-pump Cardiac Surgery With Intra- and Postoperative Use of a New Device: a Randomized Trial|Terminated||N/A|68|Actual|Rigshospitalet, Denmark||2||Due to other trials in the department|f||||||||||||||2017-10-11 00:46:57.313405|2017-10-11 00:46:57.313405
NCT02058121|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-04-06|||January 2010||2010-01-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|June 2014|Actual|2014-06-01||Interventional|||An ACT Group Intervention for ED-patients|Randomised Controlled Trial With Acceptance and Commitment Therapy (ACT) for Patients With Eating Disorders - a Manualised Group Therapy to Enhance Body Acceptance|Completed||N/A|101|Actual|Örebro County Council||2|||f||||f||||||||||2017-10-11 00:46:57.422009|2017-10-11 00:46:57.422009
NCT02058108|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-08-01|||October 31, 2014|Actual|2014-10-31|August 2017|2017-08-01|December 27, 2019|Anticipated|2019-12-27|December 27, 2019|Anticipated|2019-12-27||Interventional|||Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection|A Randomized, Double-blind, 104-weeks Treatment Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Telbivudine Oral Solution and Tablets in Children and Adolescents With Compensated HBeAg-positive and Negative Chronic Hepatitis B Virus Infection|Active, not recruiting||Phase 3|53|Actual|Novartis||2|||f||||t||||||||||2017-10-11 00:46:57.559008|2017-10-11 00:46:57.559008
NCT02058095|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-08-25|||March 2014||2014-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|Aim 3||Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)|Define in Preclinical Diastolic Dysfunction (PDD) With Renal Dysfunction, the Cardiorenal and Humoral Actions of Chronic Type V Phosphodiesterase (PDEV) Inhibition|Recruiting||Phase 1/Phase 2|45|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 00:46:57.727894|2017-10-11 00:46:57.727894
NCT02058082|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-02-06|||June 2005||2005-06-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Interventional|||Testicular Versus Ejaculated Spermatozoa for IVF/ICSI in Men With High Sperm DNA Damage|Randomized Control Trial on the Use of Testicular Versus Ejaculated Spermatozoa for IVF/ICSI on Pregnancy Outcomes for Men With High Sperm DNA Damage|Completed||N/A|25|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-11 00:46:57.842472|2017-10-11 00:46:57.842472
NCT02058069|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-03-21|2016-01-14||February 2014||2014-02-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Robotic Arm Assisted Total Knee Arthroplasty|Robotic Arm Assisted Total Knee Arthroplasty|Completed||N/A|100|Actual|MAKO Surgical Corp.||1|||f||||f||||||||||2017-10-11 00:46:57.933043|2017-10-11 00:46:57.933043
NCT02058056|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-07-03|||July 2014||2014-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC|Early Prophylactic Cranial Irradiation With Hippocampal Avoidance in Patients With Limited Disease Small-cell Lung Cancer. A Multicenter Phase II Trial|Recruiting||Phase 2|42|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||||2017-10-11 00:46:58.237311|2017-10-11 00:46:58.237311
NCT02058043|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-02-06|||November 2012||2012-11-01|February 2014|2014-02-01||||April 2015|Anticipated|2015-04-01||Observational|ASLDEM DS||Study of MRI 3Tesla Infusion Without Arterial Spin Labeling Injection (ASL) in Cognitive Atypical and Comparison to the FDG-PET|Study of MRI 3 Tesla Using Arterial Spin Labeling (Without Infusion) in Cognitive Atypical Disorders and Comparison to FDG-PET|Unknown status|Recruiting|N/A|30|Anticipated|Rennes University Hospital|||1||f||||f||||||||||2017-10-11 00:46:58.372891|2017-10-11 00:46:58.372891
NCT02058030|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-08-05|||November 2013||2013-11-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||The Influence of Degree of Head Elevation on Insertion Success for ProSeal Laryngeal Mask Airway Insertion|The 3 cm of Head Elevation Provides Higher Insertion Success Than do the 6 cm of it for ProSeal Laryngeal Mask Airway Insertion in Adult Patients|Completed||N/A|80|Actual|National Medical Center, Seoul||2|||f||||t||||||||||2017-10-11 00:46:58.448373|2017-10-11 00:46:58.448373
NCT02058017|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-06-17|||November 2013||2013-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy|The Signal Transducer and Activator of Transcription (STAT)3 Pathway and the Development of STAT3 Phosphorylation Inhibitors as Cancer Therapy: Lead-In Phase I Dose-Escalating, Open-Label, Non-Randomised Study of A Weekly Regimen OPB-51602 in Advanced Refractory Solid Tumours With Enrichment Cohorts of Nasopharyngeal Carcinoma Followed By A Biomarker Study Evaluating OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy|Terminated||Phase 1|9|Actual|National University Hospital, Singapore||1||Lactic and metabolic acidosis of OPB-51602 is not tolerable|f||||t||||||||||2017-10-11 00:46:58.549456|2017-10-11 00:46:58.549456
NCT02058004|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2015-12-30|||August 2014||2014-08-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Does Cricoid Pressure Reduce the Risk of Aspiration?|Does Cricoid Pressure Reduce the Risk of Aspiration?|Completed||N/A|95|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:46:58.626817|2017-10-11 00:46:58.626817
NCT02057991|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-02-14|||January 7, 2014|Actual|2014-01-07|February 2017|2017-02-01|November 9, 2017|Anticipated|2017-11-09|November 9, 2016|Actual|2016-11-09||Interventional|||Mindfulness-Based Exercise Video in Educating Hispanic/Latino Patients With Colorectal Cancer and Their Caregivers|A Mindfulness-Based Educational Intervention For Colorectal Cancer Patients And Caregivers|Terminated||N/A|94|Actual|University of Southern California||3||Insufficient Accrual|f||||t||||||||||2017-10-11 00:46:58.714447|2017-10-11 00:46:58.714447
NCT02057978|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-02-06|||November 2013||2013-11-01|February 2014|2014-02-01|October 2019|Anticipated|2019-10-01|October 2015|Anticipated|2015-10-01|5 Years|Observational [Patient Registry]|CREDIT-II||EXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions.|A Prospective Multicenter Randomized Trial to Assess the Safety and Effectiveness of EXCEL-II Sirolimus Eluting Stent vs. EXCEL Sirolimus Eluting Stent for the Treatment of Patients With de Novo Coronary Artery Lesions .( CREDIT II Trial )|Enrolling by invitation||Phase 2|416|Anticipated|JW Medical Systems Ltd|||2||f||||t||||||None Retained|"     Endpoint Classification: Safety/Efficacy Study Enrollment: 416 cases [Anticipated]   "|||2017-10-11 00:46:58.83487|2017-10-11 00:46:58.83487
NCT02057965|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-09-06|||March 2014||2014-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MSCs||Mesenchymal Stromal Cell Therapy in Renal Recipients|Autologous Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Combination With Everolimus to Preserve Renal Structure and Function in Renal Recipients|Recruiting||Phase 2|70|Anticipated|Leiden University Medical Center||2|||f||||t||||||||||2017-10-11 00:46:59.107696|2017-10-11 00:46:59.107696
NCT02057939|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-10-21|||April 2014||2014-04-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|STREAM||Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)|Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)|Active, not recruiting||Phase 2|38|Actual|Duke University||1|||f||||t||||||||||2017-10-11 00:46:59.3607|2017-10-11 00:46:59.3607
NCT02057926|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-02-05|||November 2009||2009-11-01|February 2014|2014-02-01||||November 2011|Actual|2011-11-01||Interventional|||The Effect of Tetracycline in Degradation and Permeability of Collagen Membrane||Completed||Phase 2|10|Actual|Universitat Internacional de Catalunya||1|||f||||||||||||||2017-10-11 00:46:59.473459|2017-10-11 00:46:59.473459
NCT02057913|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-05-22|||March 2014||2014-03-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|VinCaP||A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)|A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis|Active, not recruiting||Phase 2|22|Anticipated|Institute of Cancer Research, United Kingdom||1|||f||||||||||||||2017-10-11 00:46:59.542805|2017-10-11 00:46:59.542805
NCT02057900|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-09-01|||June 2013||2013-06-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ESCORT||Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure|Transplantation of Human Embryonic Stem Cell-derived CD15+ Isl-1+ Progenitors in Severe Heart Failure|Recruiting||Phase 1|6|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 00:46:59.687114|2017-10-11 00:46:59.687114
NCT02057887|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-02-06|||July 2013||2013-07-01|February 2014|2014-02-01||||August 2014|Anticipated|2014-08-01||Interventional|||Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)||Unknown status|Recruiting|Phase 1/Phase 2|64|Anticipated|Hanmi Pharmaceutical Company Limited||4|||f||||||||||||||2017-10-11 00:46:59.783878|2017-10-11 00:46:59.783878
NCT02057874|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-08-22|||February 2014||2014-02-01|August 2016|2016-08-01|January 2021|Anticipated|2021-01-01|June 2020|Anticipated|2020-06-01||Interventional|||3-Tesla MRI Response to TACE in HCC (Liver Cancer)|Multi-Parametric 3 Tesla Magnetic Resonance Imaging (MRI) of Response to Transarterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma (HCC)|Terminated||N/A|2|Actual|Vanderbilt-Ingram Cancer Center||1||Funding unavailable|f||||t||||||||||2017-10-11 00:46:59.896843|2017-10-11 00:46:59.896843
NCT02057861|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-02-06|||January 2013||2013-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01|9 Months|Observational [Patient Registry]|||Reversal of Neuromuscular Blockade in Diabetic Patients|The Comparison of Reversal of Neuromuscular Blockade in Diabetic and Non-Diabetic Patients|Completed||N/A|45|Actual|Duzce University|||2||f||||f||||||||||2017-10-11 00:47:00.066832|2017-10-11 00:47:00.066832
NCT02057848|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-02-06|||July 2011||2011-07-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Carbohydrates to Prevent Hypoglycaemia During Physical Activity in Patients With Type 1 Diabetes|A Prospective, Randomized Trial Testing Different Regimens of Carbohydrate Administration to Prevent Hypoglycaemia During a Standardized Bout of Moderate Physical Activity in Patients With Type 1 Diabetes|Completed||N/A|37|Actual|Diabeteszentrum Bad Lauterberg im Harz||3|||f||||f||||||||||2017-10-11 00:47:00.148779|2017-10-11 00:47:00.148779
NCT02057835|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2015-11-11|2015-11-11||March 2014||2014-03-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Treated set which included all subjects who were documented to have taken study medication.|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 691751 in Healthy Asian Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 691751 in Healthy Asian Male Volunteers in a Randomised, Double-blind, Placebo-controlled Design.|Completed||Phase 1|64|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:47:00.262091|2017-10-11 00:47:00.262091
NCT02057822|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-02-06|||November 2013||2013-11-01|February 2014|2014-02-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Observational|||Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months|Cytokine Assay in Tears of Healthy Children and With Vernal Keratocunjonctivitis: Case Control Study and Monitoring of Cases at 6 Months|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-11 00:47:01.636799|2017-10-11 00:47:01.636799
NCT02057809|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2015-02-08|||January 2014||2014-01-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||"Family-centered Pediatric Rehabilitation Services in Children With Developmental Disabilities"|"Investigation of Family-centered Pediatric Rehabilitation Services Received by Children With Developmental Disabilities"|Completed||N/A|130|Actual|Chang Gung University|||2||f||||t||||||||||2017-10-11 00:47:01.778286|2017-10-11 00:47:01.778286
NCT02057796|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-07-10|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|STATIS||Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3|Systematic Empirical vs. Test-guided Anti-tuberculosis Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating Antiretroviral Therapy With CD4 Cell Counts <100/mm3: the STATIS Randomized Controlled Trial|Active, not recruiting||Phase 4|1050|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-11 00:47:01.854175|2017-10-11 00:47:01.854175
NCT02057783|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-01-20|||January 2014||2014-01-01|January 2014|2014-01-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension|Comparison of Standard Treatment by Continuous Positive Airway Pressure (CPAP) and CPAP Combined to a Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension: RAP Randomized Controlled Trial|Unknown status|Recruiting|N/A|100|Anticipated|AGIR à Dom||2|||f||||t||||||||||2017-10-11 00:47:01.957498|2017-10-11 00:47:01.957498
NCT02057770|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-04-11|||February 28, 2014|Actual|2014-02-28|April 2017|2017-04-01|November 30, 2019|Anticipated|2019-11-30|August 31, 2018|Anticipated|2018-08-31||Interventional|||Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Pilot Study of Myeloablative Allogeneic or Haploidentical Stem Cell Transplantation With High Dose PT-Cy in Relapsed/Refractory AML|Recruiting||Phase 1|75|Anticipated|Washington University School of Medicine||2|||f||||t|t|t|f|f|f|||No||2017-10-11 00:47:02.064792|2017-10-11 00:47:02.064792
NCT02057757|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-05-03|||February 2014||2014-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Evaluating the Safety, Effectiveness, and Tolerability of Nitazoxanide in Addition to Standard Care for the Treatment of Severe Acute Respiratory Illness in People Who Are Hospitalized|A Randomized Double-Blind Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Nitazoxanide Versus Placebo in Addition to Standard Care for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness|Active, not recruiting||Phase 2|290|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 00:47:02.184141|2017-10-11 00:47:02.184141
NCT02057744|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-08-16|||October 2014||2014-10-01|August 2017|2017-08-01|March 2032|Anticipated|2032-03-01|October 2022|Anticipated|2022-10-01||Observational|||MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries|Multi-center, Partially Randomized, Controlled Trial of MIS Robotic vs. Freehand in Short Adult Degenerative Spinal Fusion Surgeries|Recruiting||N/A|2000|Anticipated|Mazor Robotics|||2||f||||f||||||||||2017-10-11 00:47:02.295807|2017-10-11 00:47:02.295807
NCT02057731|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-12-01|||February 2014||2014-02-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Study of Glycogen Storage Disease Expression in Carriers|Characterizing Expression of Glycogen Storage Disease in Heterozygous Carriers|Completed||N/A|114|Actual|University of Florida|||5||f||||f||||||||Undecided||2017-10-11 00:47:02.55553|2017-10-11 00:47:02.55553
NCT02057718|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-08-31|||March 1, 2014|Actual|2014-03-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|INDIGO||Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis|Open Label Study of the Efficacy and Long Term Safety of LUM001, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Pediatric Patients With Progressive Familial Intrahepatic Cholestasis|Active, not recruiting||Phase 2|24|Anticipated|Shire||1|||f||||t|t|f||||||||2017-10-11 00:47:02.670164|2017-10-11 00:47:02.670164
NCT02057705|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-07-27|||February 2014||2014-02-01|July 2017|2017-07-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Observational|MTM||Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)|Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)|Completed||N/A|48|Actual|Valerion Therapeutics, LLC|||1||f||||f||||||Samples With DNA|"     -  5 ml sample of whole blood will be collected during the study to assess the immunity          against various AAV serotypes        -  5 ml blood sample may be obtained for peripheral blood mononuclear cells (PBMC) to          quantify X-linked myotubular myopathy gene 1 (MTM1) production        -  24-hour urine collection will be performed every 6 months in order to measure urinary          creatinine excretion        -  Slides and tissue from a previously performed muscle biopsy will be obtained for a          central review and quantification of histo- and immunohistopathological features of MTM   "|||2017-10-11 00:47:02.802545|2017-10-11 00:47:02.802545
NCT02057692|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-01-13|||November 2014||2014-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ITCH||Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome|The Evaluation of the Intestinal Bile Acid Transport (IBAT) Inhibitor LUM001 in the Reduction of Pruritus in Alagille Syndrome, a Cholestatic Liver Disease|Completed||Phase 2|36|Actual|Shire||2|||f||||t||||||||||2017-10-11 00:47:02.956124|2017-10-11 00:47:02.956124
NCT02057679|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-12-16|||February 2014||2014-02-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis|Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy Due to Acute Cholecystitis. Is it Necessary?|Recruiting||Phase 4|200|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||||2017-10-11 00:47:03.116927|2017-10-11 00:47:03.116927
NCT02057640|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2017-08-18|||May 22, 2014|Actual|2014-05-22|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|August 3, 2017|Actual|2017-08-03||Interventional|||MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma|A Phase I/II Study of MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|16|Actual|Case Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-11 00:47:03.595365|2017-10-11 00:47:03.595365
NCT02057627|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-04-19|||June 2010||2010-06-01|April 2016|2016-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction|Dyadic Intervention for Women at Risk for Postpartum Depression and Their Infants|Completed||N/A|42|Actual|Spaulding Rehabilitation Hospital||2|||f||||f||||||||||2017-10-11 00:47:03.691596|2017-10-11 00:47:03.691596
NCT02057601|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-02-05|||January 2013||2013-01-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Postoperative Analgesia for Fractured Neck of Femur With Periarticular Infiltration of Local Anaesthetic|Postoperative Analgesia Following Surgery for Fractured Neck of Femur: a Comparison of Periarticular Infiltration of Local Anaesthetic With Systemic Postoperative Analgesics|Completed||N/A|37|Actual|Cork University Hospital||2|||f||||t||||||||||2017-10-11 00:47:03.766096|2017-10-11 00:47:03.766096
NCT02057588|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-10-12|||February 2014||2014-02-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electrograms|Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electrograms|Recruiting||Phase 3|30|Anticipated|St. Jude Medical||1|||f||||f||||||||||2017-10-11 00:47:03.843896|2017-10-11 00:47:03.843896
NCT02057575|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-06|2016-01-21||2015-07-09|January 2014||2014-01-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure||Completed||Phase 2|298|Actual|Aerie Pharmaceuticals||4|||f||||||||||||||2017-10-11 00:47:03.93791|2017-10-11 00:47:03.93791
NCT02057562|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-11-18|||February 2014||2014-02-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|September 2016|Actual|2016-09-01||Observational|DECADE||Impact of Diverticular Disease on the Detection of Colon Adenomas||Active, not recruiting||N/A|1000|Actual|Technische Universität München|||1||f||||f||||||Samples Without DNA|"     Colon polyps and mucosa   "|||2017-10-11 00:47:04.037804|2017-10-11 00:47:04.037804
NCT02057549|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-07-14|2017-05-09||November 2012|Actual|2012-11-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|HATGAS||Haloperidol vs Conventional Therapy for Gastroparesis|Haloperidol vs Conventional Therapy for Gastroparesis|Terminated||Phase 4|36|Actual|The University of Texas Health Science Center, Houston||2||PI left institution|f||||f||||||||||2017-10-11 00:47:04.125249|2017-10-11 00:47:04.125249
NCT02057536|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-07-26|||January 2014||2014-01-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.|Pilot Study for the Effect of Exercise Intervention in Breast Cancer Patients With Arthralgias Receiving Aromatase Inhibitors|Terminated||N/A|30|Actual|Christiana Care Health Services||2|||f||||f||||||||||2017-10-11 00:47:04.503676|2017-10-11 00:47:04.503676
NCT02057523|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-12-03|||September 2014||2014-09-01|December 2014|2014-12-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|||Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients|Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients|Unknown status|Recruiting|Phase 4|10|Anticipated|University of Illinois at Chicago||1|||f||||f||||||||||2017-10-11 00:47:04.591968|2017-10-11 00:47:04.591968
NCT02057510|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-07-19|||February 2014||2014-02-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01|24 Months|Observational [Patient Registry]|ORARAD||Observational Study of Dental Outcomes in Head and Neck Cancer Patients|Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients|Recruiting||N/A|756|Anticipated|Carolinas Healthcare System|||1||f||||t||||||||||2017-10-11 00:47:04.719898|2017-10-11 00:47:04.719898
NCT02057497|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-05-03|||September 2017|Anticipated|2017-09-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms|An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms Related to GPCR Dependent Signalling and the FTO Gene in Healthy Volunteers and in Patients With Diabetes|Not yet recruiting||N/A|300|Anticipated|Profil Institut für Stoffwechselforschung GmbH|||3||f||||f||||||Samples With DNA|"     whole blood samples   "|||2017-10-11 00:47:04.846448|2017-10-11 00:47:04.846448
NCT02057471|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-05|||September 2009||2009-09-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|January 2011|Actual|2011-01-01||Interventional|||Intravenous Iron: Measuring Response in Anemic Surgical Patients|An Open Label Study of Intravenous Iron (FERINJECT) in Colorectal Adenocarcinoma Related Anaemia to Identify Potential Biomarkers of Responsiveness to Intravenous Iron|Completed||Phase 4|20|Actual|Nottingham University Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 00:47:05.517995|2017-10-11 00:47:05.517995
NCT02057458|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-09-13|||April 2014||2014-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CF-FLOW||Blood Flow and Vascular Function in Cystic Fibrosis|Role of Blood Flow and Vascular Function on Exercise Capacity in Cystic Fibrosis|Active, not recruiting||Phase 2|50|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 00:47:05.741352|2017-10-11 00:47:05.741352
NCT02057055|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-03-30|||February 2014||2014-02-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Surfactants on the Bacterial Composition of the Layers of the Skin|The Effect of Surfactants on the Bacterial Composition of the Layers of the Skin|Active, not recruiting||N/A|4|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:47:11.878497|2017-10-11 00:47:11.878497
NCT02057445|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-10-04|||January 2014||2014-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma|A Multicenter Pilot Study of Third Party LMP1/2-Specific Cytotoxic T Lymphocytes for Treatment of Patients With Refractory /Relapsed EBV-Associated Lymphoma A Childhood, Adolescent and Young Adult Lymphoma Cell Therapy Consortium (LCTC) Multicenter Clinical Trial|Recruiting||Phase 1|18|Anticipated|New York Medical College||2|||f||||t||||||||||2017-10-11 00:47:05.899578|2017-10-11 00:47:05.899578
NCT02057432|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-01-23|||April 2012||2012-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)|A Pilot Study to Evaluate Image-guided Breast Conserving Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)|Completed||N/A|15|Actual|Dana-Farber Cancer Institute||1|||f||||t|f|t|f|f|f|||No||2017-10-11 00:47:06.027755|2017-10-11 00:47:06.027755
NCT02057419|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-12-29|||April 2014||2014-04-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|August 2016|Actual|2016-08-01||Observational|WISH||Women's Input on Sexual Health|K24: Advancing Reproductive Health: Women's Input on Sexual Health (Project WISH)|Active, not recruiting||Phase 4|35|Actual|The Miriam Hospital|||2||f||||t||||||||||2017-10-11 00:47:06.130206|2017-10-11 00:47:06.130206
NCT02057406|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-06-20|2017-05-18||May 2014|Actual|2014-05-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|May 19, 2016|Actual|2016-05-19||Interventional|OCEAN||Omega 3 for Treatment of Depression in Patients With Heart Failure|Omega 3 for Comorbid Depression and Heart Failure Treatment|Active, not recruiting||Phase 3|108|Actual|Duke University||3|||f||||t||||||||||2017-10-11 00:47:06.222887|2017-10-11 00:47:06.222887
NCT02057393|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-06-12|2017-03-17||June 2014||2014-06-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|SPY-SN|89 subjects were enrolled, one subject retracted consent, and another was deemed ineligible after enrollment, leaving 87 evaluable participants.|Infrared Lymphangiography as a Method of Sentinel Node Identification|Infrared Lymphangiography as a Method of Sentinel Node Identification|Completed||N/A|89|Actual|Milton S. Hershey Medical Center||1|||f||||f||||||||No||2017-10-11 00:47:06.964331|2017-10-11 00:47:06.964331
NCT02057380|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-10-02||2017-10-02|April 16, 2014|Actual|2014-04-16|September 2017|2017-09-01|December 21, 2016|Actual|2016-12-21|October 14, 2016|Actual|2016-10-14||Interventional|||A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial|A Phase II Open-label Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial|Completed||Phase 2|13|Actual|Astellas Pharma Inc||12|||f||||f||||||||||2017-10-11 00:47:07.162162|2017-10-11 00:47:07.162162
NCT02057367|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-07-25|||March 2013||2013-03-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Scalp Nerve Block and Opioid Consumption in Brain Surgery|The Effect of Pre-incisional Anterior Scalp Block on Intraoperative Opioid Consumption in Adult Patients Undergoing Elective Craniotomy to Remove Tumor: A Prospective Randomized Controlled|Completed||Phase 4|100|Actual|Chiang Mai University||2|||f||||t||||||||No||2017-10-11 00:47:07.327422|2017-10-11 00:47:07.327422
NCT02057354|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-09-26|||April 2014||2014-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|EMF||Neuroimaging Study of Exercise and Memory Function|Aerobic Exercise, Neurotrophins, and fMRI of Hippocampal Function and Structure|Recruiting||N/A|80|Anticipated|Boston University||2|||f||||f|f|f||||||||2017-10-11 00:47:07.425|2017-10-11 00:47:07.425
NCT02057341|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-05-15||2017-05-15|February 2014||2014-02-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy||Completed||Phase 2|12|Actual|Array BioPharma||2|||f||||t||||||||||2017-10-11 00:47:07.533754|2017-10-11 00:47:07.533754
NCT02057328|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2014-02-05|||December 2010||2010-12-01|February 2014|2014-02-01|January 2017|Anticipated|2017-01-01|January 2015|Anticipated|2015-01-01||Interventional|TELNEB||Comparative Study of the Effects of Telmisartan and Nebivolol|Comparative Study of the Effects of Telmisartan and Nebivolol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Patients With Arterial Hypertension|Unknown status|Recruiting|Phase 4|80|Anticipated|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-11 00:47:07.639151|2017-10-11 00:47:07.639151
NCT02057315|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-07-07||2017-06-28|March 2014||2014-03-01|July 2017|2017-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine|A Randomized, Double-Blind, Cross-Over, Placebo-Controlled Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine|Completed||Phase 1/Phase 2|48|Actual|Achelios Therapeutics||2|||f||||f||||||||||2017-10-11 00:47:07.73719|2017-10-11 00:47:07.73719
NCT02057302|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-02-06|||March 2010||2010-03-01|February 2014|2014-02-01||||December 2012|Actual|2012-12-01||Interventional|||A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia|A Multicenter, Pragmatic Randomized, Double-blind, Placebo-controlled Trial of Xuezhikang Capsule for Treating Dyslipidemia: a Postmarketing Study|Completed||Phase 4|2400|Actual|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 00:47:07.838146|2017-10-11 00:47:07.838146
NCT02057276|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-02-02|2015-07-30||September 2012||2012-09-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional||After signing consent forms, two separate participants did not proceed with the study. The study was then terminated.|Repetitive TMS and Occupational Therapy in Children and Young Adults With Chronic Hemiparesis|Motor Control Enhancement Through Repetitive Transcranial Magnetic Stimulation Plus Rehabilitation in Hemiparetic Cerebral Palsy and Stroke|Terminated||N/A|2|Actual|Children's Hospital Medical Center, Cincinnati||2||Study was terminated due to low recruitment.|f||||t||||||||||2017-10-11 00:47:07.993694|2017-10-11 00:47:07.993694
NCT02057263|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-10-20|||April 2014||2014-04-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults|The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults - a Randomized Placebo-controlled Pilot Study|Completed||Phase 1|28|Actual|Massachusetts General Hospital||2|||f||||f||||||||Yes|Available upon request|2017-10-11 00:47:08.281309|2017-10-11 00:47:08.281309
NCT02057250|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-05-23|2017-05-23|2015-11-16|March 2014||2014-03-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|February 2015|Actual|2015-02-01||Interventional|SARIL-RA-EASY||To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis|A Multicenter, Randomized, Open-Label, Parallel-Group Usability Study Of The Sarilumab Auto-Injector Device And A Prefilled Syringe In Patients With Moderate To Severe Active Rheumatoid Arthritis Who Are Candidates For Anti-IL6R Therapy|Completed||Phase 3|217|Actual|Sanofi||4|||f||||t||||||||||2017-10-11 00:47:08.425009|2017-10-11 00:47:08.425009
NCT02057237|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-11-11|2015-11-11||September 2013||2013-09-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||A Safety and Feasibility Study of Mitotane in Prostate Cancer|A Safety and Feasibility Study of Mitotane in Prostate Cancer|Completed||Phase 1|1|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 00:47:09.8423|2017-10-11 00:47:09.8423
NCT02057224|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-12-01|||January 2014||2014-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Metabolic and Cardiovascular Effects of Renal Denervation|Metabolic and Cardiovascular Effects of Renal Denervation|Recruiting||Phase 4|15|Anticipated|Umeå University||1|||f||||f||||||||||2017-10-11 00:47:10.01779|2017-10-11 00:47:10.01779
NCT02057211|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-10-25|||February 2014||2014-02-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study|Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study|Suspended||Phase 2|50|Anticipated|Uppsala University Hospital||2||Updated regulations of culture procedure|f||||||||||||||2017-10-11 00:47:10.134992|2017-10-11 00:47:10.134992
NCT02057198|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-05-01|||February 2014||2014-02-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|C-Diff||Impact of Oral Antibiotic Treatment on C. Difficile|Exploratory Study of Impact of Oral Metronidazole, Vancomycin and Fidaxomicin on the Extent and Quantity of Host Carriage and Environmental Contamination With C. Difficile|Recruiting||N/A|30|Anticipated|Duke University|||3||f||||f||||||Samples Without DNA|"     Fecal specimen and perianal swab.   "|||2017-10-11 00:47:10.212033|2017-10-11 00:47:10.212033
NCT02057185|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-02-17|||April 2014||2014-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|EMATO0113||Occupational Status and Hematological Disease|Occupational Status and Hematological Disease: Effects and Counseling Needs|Active, not recruiting||N/A|141|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||No||2017-10-11 00:47:10.343354|2017-10-11 00:47:10.343354
NCT02057172|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-08-08||2016-08-08|January 2014||2014-01-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes|A Phase II, 12-week, Double-blind, Randomised, Parallel Group, Multi-centre, International Trial to Assess the Effect on Glycaemic Control of Five Doses of HM11260C Versus Placebo or Open-label Liraglutide in Subjects With Type 2 Diabetes|Completed||Phase 2|254|Actual|Hanmi Pharmaceutical Company Limited||7|||f||||f||||||||||2017-10-11 00:47:10.46219|2017-10-11 00:47:10.46219
NCT02057159|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-02-22|||February 2017||2017-02-01|February 2016|2016-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis|A Phase II Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis|Not yet recruiting||Phase 2/Phase 3|200|Anticipated|Immune Response BioPharma, Inc.||2|||f||||t||||||||||2017-10-11 00:47:10.593131|2017-10-11 00:47:10.593131
NCT02057146|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-11-02|||October 2013||2013-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic Ducts|Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic Ducts|Enrolling by invitation||N/A|50|Anticipated|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 00:47:10.812973|2017-10-11 00:47:10.812973
NCT02057133|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-07-07|||March 10, 2014|Actual|2014-03-10|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread|A Phase 1b Study of Abemaciclib in Combination With Therapies for Patients With Metastatic Breast Cancer|Recruiting||Phase 1|123|Anticipated|Eli Lilly and Company||10|||f||||f||||||||||2017-10-11 00:47:10.939926|2017-10-11 00:47:10.939926
NCT02057107|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-24|||May 2013||2013-05-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stereotactic Body Radiation Therapy (SBRT) With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Randomized Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Recruiting||Phase 2|92|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:47:11.320786|2017-10-11 00:47:11.320786
NCT02057094|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-07-19|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Protein Supplementation on Lean Body Mass Recovery From Extreme Military Training|Effect of Protein Supplementation on Lean Body Mass Recovery and Physiological Resilience Following Survive, Evade, Resist, Escape (SERE) School|Completed||N/A|71|Actual|United States Army Research Institute of Environmental Medicine||3|||f||||f||||||||||2017-10-11 00:47:11.480355|2017-10-11 00:47:11.480355
NCT02057081|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-09-18|||October 9, 2014|Actual|2014-10-09|September 2017|2017-09-01|August 31, 2019|Anticipated|2019-08-31|March 2, 2019|Anticipated|2019-03-02||Interventional|MFG-mTBI||Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI|Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI|Recruiting||N/A|300|Anticipated|VA Office of Research and Development||3|||f||||t|f|f|||f|||||2017-10-11 00:47:11.59042|2017-10-11 00:47:11.59042
NCT02057042|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-05-31|||June 1, 2015|Actual|2015-06-01|May 2017|2017-05-01|March 30, 2018|Anticipated|2018-03-30|March 30, 2018|Anticipated|2018-03-30||Interventional|||Veteran Peer-Assisted Computerized Cognitive Behavioral Therapy for Depression|Veteran Peer-Assisted Computerized Cognitive Behavioral Therapy for Depression|Enrolling by invitation||N/A|330|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 00:47:11.990514|2017-10-11 00:47:11.990514
NCT02057029|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-01-06|||January 2014||2014-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer|Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer|Completed||N/A|96|Actual|Yale University||1|||f||||t||||||||||2017-10-11 00:47:12.127135|2017-10-11 00:47:12.127135
NCT02057016|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-02-02|||February 2014||2014-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease|Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease: a Single-centre Observational Pilot Study|Completed||N/A|258|Actual|Catholic University of the Sacred Heart|||1||f||||t||||||||||2017-10-11 00:47:12.243339|2017-10-11 00:47:12.243339
NCT02057003|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-10-14|||January 2012||2012-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients|Security and Efficacy of Triple Therapy Including Direct-Acting Antivirals Against Chronic Hepatitis C Infection In HIV-Coinfected Patients In Real-Life Conditions: The Prospective HEPAVIR Cohort.|Recruiting||N/A|1000|Anticipated|Valme University Hospital|||1||f||||f||||||||||2017-10-11 00:47:12.347711|2017-10-11 00:47:12.347711
NCT02056990|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-05-01|||March 2014||2014-03-01|October 2016|2016-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|2 Years|Observational [Patient Registry]|||Screening of Athletes|Screening of Athletes for Prevention of Injury and Optimisation of Performance|Completed||N/A|15|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 00:47:12.558203|2017-10-11 00:47:12.558203
NCT02056977|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-09-10|||February 2015||2015-02-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|June 2016|Anticipated|2016-06-01||Interventional|||PEEP Levels Selected by PEEP Titration and PEEP Levels Routinely Used in Post-operative Cardiac Patients With ARDS|Comparison Between PEEP Levels Selected by Individualized PEEP Titration - Rapid Titration by EIT - and PEEP Levels Routinely Used in Post-operative Cardiac Patients With ARDS.|Unknown status|Recruiting|N/A|46|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 00:47:12.653031|2017-10-11 00:47:12.653031
NCT02056964|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-08-23|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|||HEART Pathway Implementation|The HEART Pathway: Bridging the Gap Between Operations, Research, and Education|Active, not recruiting||N/A|14717|Actual|Wake Forest University Health Sciences|||2||f||||f||||||||||2017-10-11 00:47:12.797062|2017-10-11 00:47:12.797062
NCT02056951|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-09-08|||January 2008||2008-01-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|PASTOR||Interprofessional Rehabilitation for Adults With Chronic Non-specific Low Back Pain|Interprofessional Biopsychosocial Rehabilitation to Optimize Inpatient Multidisciplinary Orthopedic Rehabilitation for Chronic Low Back Pain|Completed||N/A|536|Actual|University of Erlangen-Nürnberg||2|||f||||f||||||||||2017-10-11 00:47:12.916486|2017-10-11 00:47:12.916486
NCT02056938|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-06-08|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|February 2017|Actual|2017-02-01||Interventional|PREDICT-DGF||ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF|Prospective Multicentric, Randomized, Open-labeled, in Parallel Groups, Study to Assess the Benefit/Risk of an Induction Treatment With Anti-Thymocyte Globulins (ATG) Versus Basiliximab in Kidney Transplant Patients Displaying Low Immunological Risk But High Susceptibility to Delayed Graft Function.|Terminated||Phase 4|19|Actual|Nantes University Hospital||2||recruitment issues|f||||f||||||||||2017-10-11 00:47:13.044033|2017-10-11 00:47:13.044033
NCT02056925|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-02-06|||December 2013||2013-12-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Echocardiographic Analysis in Healthy Child.|Speckle Tracking 2D Echocardiography in Healthy Child. Comparison of Two Different Software Systems : Echopac (General Electric) and QLAB 9.0 (Philips).|Completed||N/A|163|Actual|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 00:47:13.158154|2017-10-11 00:47:13.158154
NCT02056912|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-01-13|||January 2014||2014-01-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|LIPOGENE||Identification of a New Gene Involved in Hereditary Lipodystrophy|Identification of a New Gene Involved in Hereditary Lipodystrophy - LIPOGENE|Completed||N/A|2|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-11 00:47:13.248951|2017-10-11 00:47:13.248951
NCT02056899|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2015-08-02|||June 2013||2013-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Maintenance Gabapentin to Prolong Pregnancy.|Effect of Maintenance Gabapentin Therapy on the Rate of Premature Birth in Women With Preterm Labor After Receiving Tocolysis.|Completed||Phase 1|4|Actual|University at Buffalo||1|||f||||t||||||||||2017-10-11 00:47:13.332221|2017-10-11 00:47:13.332221
NCT02056886|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-08-30|||July 2013||2013-07-01|August 2016|2016-08-01|January 2022|Anticipated|2022-01-01|January 2017|Anticipated|2017-01-01||Interventional|SAGE||Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer|Multicentric, National, Prospective, Comparative, Non Randomized Study, Assessing Medico-economic Impact of Three Strategies of Sentinel Lymph Node Analysis in Immediately Operable Breast Cancer|Recruiting||N/A|920|Anticipated|Institut Cancerologie de l'Ouest||3|||f||||t||||||||||2017-10-11 00:47:13.425073|2017-10-11 00:47:13.425073
NCT02056873|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-03-15|||May 2014||2014-05-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Tourette Syndrome Deep Brain Stimulation|The Human Thalamocortical Network in Tourette Syndrome|Recruiting||N/A|10|Anticipated|University of Florida||1|||f||||t|f|t|f|f||||||2017-10-11 00:47:13.563009|2017-10-11 00:47:13.563009
NCT02056314|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-07-20|||February 2014||2014-02-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Developing and Evaluating Effectiveness of a Reinstatement Tutorial|Developing and Evaluating Effectiveness of a Reinstatement Tutorial|Recruiting||N/A|400|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 00:47:22.092697|2017-10-11 00:47:22.092697
NCT02056860|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-03-15|||February 2014||2014-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Detecting Lung Infections Through Vibration|Feasibility and Optimization of High Frequency Oscillation (HFO) for Detection of Lung Infections|Completed||N/A|16|Actual|University of Florida|||5||f||||f||||||||Yes|Afshar-Mohajer N, Wu CY, Tsai HW, Silverman E, Davenport P, Hegde S. Optimizing an Internal Airway Percussion Device for Facilitating Exhalate Diagnostics of the Human Respiratory System. J Aerosol Med Pulm Drug Deliv. 2015 Mar 31. [Epub ahead of print] PubMed PMID: 25826647.|2017-10-11 00:47:13.667567|2017-10-11 00:47:13.667567
NCT02056847|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-03-08|||January 2014||2014-01-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|May 2016|Actual|2016-05-01||Interventional|SIPHON||to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia|Randomized, Open-label, Multi-centered Study to Evaluate the Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia(Phase 4)|Active, not recruiting||Phase 4|313|Actual|JW Pharmaceutical||2|||f||||t||||||||||2017-10-11 00:47:13.759989|2017-10-11 00:47:13.759989
NCT02056834|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-06-24|2014-04-11||March 2010||2010-03-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||chronOS Inject in Proximal Tibial Fractures|Prospective, Multi-Center, Observational Study Evaluating the Augmentation With Calcium Phosphate Cement (chronOS Inject) for Bone Defect After Internal Fixation of Proximal Tibial Fractures|Completed||N/A|36|Actual|Synthes GmbH|||1||f||||f||||||||||2017-10-11 00:47:13.888215|2017-10-11 00:47:13.888215
NCT02056821|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-01-02|||February 2014||2014-02-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke||Completed||N/A|88|Actual|Henry Ford Health System|||1||f||||f||||||||||2017-10-11 00:47:14.806233|2017-10-11 00:47:14.806233
NCT02056808|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-08-26|||November 2013||2013-11-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)|SMT C1100 - A Phase 1b, Open-label, Single and Multiple Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Paediatric Patients With Duchenne Muscular Dystrophy|Completed||Phase 1|12|Actual|Summit Therapeutics||1|||f||||t||||||||||2017-10-11 00:47:14.864841|2017-10-11 00:47:14.864841
NCT02056795|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-03-18|||January 2013||2013-01-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Study of Effects of Electroacupuncture on Balance in Subjects With Chronic Functional Ankle Instability|A Single Application of Electroacupuncture Improves Balance Greater Than Placebo Control in Subjects With Chronic Functional Ankle Instability|Completed||N/A|24|Actual|Canadian Memorial Chiropractic College||2|||f||||f||||||||||2017-10-11 00:47:14.938478|2017-10-11 00:47:14.938478
NCT02056769|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-08-02|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CT-PIPS||CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage|CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage|Recruiting||N/A|40|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 00:47:15.14673|2017-10-11 00:47:15.14673
NCT02056756|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-05-09|||April 2014||2014-04-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|September 2015|Actual|2015-09-01||Interventional|||Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma|CARFILZOMIB IN COMBINATION WITH BENDAMUSTINE AND DEXAMETHASONE IN REFRACTORY OR RELAPSED MULTIPLE MYELOMA - A MULTICENTER PHASE IB/II TRIAL OF THE EUROPEAN MYELOMA NETWORK TRIALIST GROUP (EMNTG)|Recruiting||Phase 1/Phase 2|68|Anticipated|Stichting Hemato-Oncologie voor Volwassenen Nederland||1|||f||||t||||||||||2017-10-11 00:47:15.246521|2017-10-11 00:47:15.246521
NCT02056743|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2014-02-04|||September 2013||2013-09-01|October 2013|2013-10-01||||October 2013|Actual|2013-10-01||Interventional|||Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers|Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers; Open-label, Parallel Group|Completed||Phase 1|30|Actual|Chonbuk National University Hospital||2|||f||||||||||||||2017-10-11 00:47:15.347374|2017-10-11 00:47:15.347374
NCT02056730|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-03-27|||November 2013||2013-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid|The Study of Efficacy and Safety of Calcium Sensing Receptor in Chronic Dialysis Patients|Completed||Phase 4|60|Actual|Chulalongkorn University||1|||f||||f||||||||||2017-10-11 00:47:15.44552|2017-10-11 00:47:15.44552
NCT02056717|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-04-15|||April 2014||2014-04-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Use of Dexamethasone in Uterine Artery Embolization|The Effect of Dexamethasone on Inflammatory Response After Uterine Artery Embolization|Completed||N/A|64|Actual|Severance Hospital||2|||f||||f||||||||||2017-10-11 00:47:15.554928|2017-10-11 00:47:15.554928
NCT02056704|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-06-19|||May 2012||2012-05-01|June 2015|2015-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Trial Comparing Angiography and Angiography With IVUS for Treatment of Hemodialysis Access Failures|A Prospective Randomized Feasibility Trial Comparing Angiography and Angiography With IVUS for Treatment of Hemodialysis Access Failures|Unknown status|Recruiting|Phase 4|200|Anticipated|Baylor Research Institute||2|||f||||t||||||||||2017-10-11 00:47:15.642563|2017-10-11 00:47:15.642563
NCT02056691|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-04-11|||October 2014||2014-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|EDICT||EDICT - Exercise inDuced Changes In Colorectal Cancer Tissues|Clinical and Biological Effects of a Preoperative Exercise Programme in Colorectal Tumour and Skeletal Muscle Tissues (Exercise inDuced Changes In Colorectal Cancer Tissues)|Recruiting||N/A|20|Anticipated|The Royal Bournemouth Hospital||1|||f||||t||||||||||2017-10-11 00:47:15.761979|2017-10-11 00:47:15.761979
NCT02052843|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-13|||May 2013|Actual|2013-05-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Impact Evaluation of the Steps to Success Program|Impact Evaluation of the Steps to Success Program|Active, not recruiting||N/A|595|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-11 00:48:09.306914|2017-10-11 00:48:09.306914
NCT02056678|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2016-11-02|||February 2014||2014-02-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA|Use of IV Acetaminophen Intraoperatively in Obese Patients at Risk for Obstructive Sleep Apnea Undergoing Laparoscopic Cholecystectomy|Withdrawn||Phase 4|0|Actual|The University of Texas Health Science Center at San Antonio||2||Investigator left institution|f||||f||||||||||2017-10-11 00:47:15.911092|2017-10-11 00:47:15.911092
NCT02056665|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-10-19|||January 2014||2014-01-01|October 2014|2014-10-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|A-MANECE||Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome|Randomized Clinical Trial, Placebo Compared to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome|Completed||Phase 2|32|Actual|Puerta de Hierro University Hospital||3|||f||||f||||||||||2017-10-11 00:47:17.725963|2017-10-11 00:47:17.725963
NCT02056652|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-07-12|||February 2014|Actual|2014-02-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|PoPPS||Prevention of Preterm Birth With a Pessary in Singleton Gestations|Prevention of Preterm Birth With a Pessary in Singleton Gestations|Completed||N/A|123|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:47:17.835141|2017-10-11 00:47:17.835141
NCT02056639|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-07-12|||February 2014|Actual|2014-02-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|PoPPT||Prevention of Preterm Birth With a Pessary in Twin Gestations|Prevention of Preterm Birth With a Pessary in Twin Gestations|Completed||N/A|46|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:47:17.92749|2017-10-11 00:47:17.92749
NCT02056626|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-05-05|||March 2011||2011-03-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Conditioned Pharmacotherapeutic Effects in Hypertension|Conditioned Pharmacotherapeutic Effects in Hypertension|Recruiting||Phase 4|121|Anticipated|University of Rochester||4|||f||||t||||||||||2017-10-11 00:47:18.029823|2017-10-11 00:47:18.029823
NCT02056613|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2017-10-05|||January 30, 2014||2014-01-30|December 5, 2016|2016-12-05|October 1, 2028|Anticipated|2028-10-01|October 1, 2018|Anticipated|2018-10-01||Observational|||Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products|Collection of Blood From Healthy Volunteers and Clinical Research Subjects for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:47:18.157372|2017-10-11 00:47:18.157372
NCT02056600|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2014-05-07|||March 2014||2014-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.|A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of the Combination of Gemigliptin/Metformin HCl Sustained Release 50/1000mg in Comparison to Each Component Gemigliptin 50mg and Metformin HCl Extended Release 1000mg Administered in Healthy Male Volunteers|Completed||Phase 1|24|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 00:47:18.233949|2017-10-11 00:47:18.233949
NCT02056587|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-05|||November 2011||2011-11-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional|||Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment|Everolimus (Afinitor) in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment|Completed||Phase 4|37|Actual|Kidney Cancer Research Bureau||1|||f||||t||||||||||2017-10-11 00:47:18.310066|2017-10-11 00:47:18.310066
NCT02056574|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-08-03|||November 2015||2015-11-01|March 2015|2015-03-01|April 2020|Anticipated|2020-04-01|November 2019|Anticipated|2019-11-01||Interventional|ENACT-2||Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms|Phase 2, Multicenter Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study Evaluating a Single Dose of Intravenous NA-1 in Patients With Subarachnoid Hemorrhage Undergoing Endovascular Repair of Ruptured Intracranial Aneurysms|Withdrawn||Phase 2|0|Actual|NoNO Inc.||2|||f||||t||||||||||2017-10-11 00:47:18.399375|2017-10-11 00:47:18.399375
NCT02056561|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-02-05|||January 2010||2010-01-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01|3 Days|Observational [Patient Registry]|||Effects on Immun System of Anesthesia|Investigation Of The Effects Of General Anesthesia On The Oxidant/Antioxidant System|Completed||N/A|45|Actual|Duzce University|||3||f||||f||||||Samples With DNA|"     Before induction and after the operation venous blood samples were taken.   "|||2017-10-11 00:47:18.513106|2017-10-11 00:47:18.513106
NCT02056548|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-04|||March 2014||2014-03-01|February 2014|2014-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy|Comparison of the Occurrence of HBV Reactivation According to the Duration of Preemptive Antiviral Therapy in Chronic Hepatitis B Virus Carriers Receiving Cancer Chemotherapy for Hematologic Diseases|Not yet recruiting||N/A|126|Anticipated|Seoul St. Mary's Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:47:18.703506|2017-10-11 00:47:18.703506
NCT02056535|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-02-04|||May 2010||2010-05-01|June 2013|2013-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Screening and Brief Intervention in the ED Among Mexican-origin Young Adults|Screening and Brief Intervention in the ED Among Mexican-origin Young Adults|Completed||Phase 2|698|Actual|Public Health Institute, California||3|||f||||f||||||||||2017-10-11 00:47:18.795804|2017-10-11 00:47:18.795804
NCT02056522|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2016-07-27|||July 2016||2016-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|||Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging|Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging: the MDS (Melanoma Detecting System)|Recruiting||N/A|660|Anticipated|Orlucent, Inc|||1||f||||t||||||||Undecided||2017-10-11 00:47:18.907704|2017-10-11 00:47:18.907704
NCT02056509|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-04-01|||October 2013||2013-10-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|February 2015|Actual|2015-02-01||Observational|||The Effect of Chest Compression and Ventilation Coordination During Cardiopulmonary Resuscitation.|The Effect of Chest Compression and Ventilation Coordination During Cardiopulmonary Resuscitation|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 00:47:19.054689|2017-10-11 00:47:19.054689
NCT02056496|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-04-13|||January 2014||2014-01-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|POMEkinetics||Pharmacokinetics and Bioavailability of Pomegranate Phenolics and Urolithins in Healthy Subjects.|Pharmacokinetics and Bioavailability of Pomegranate Phenolics and Gut Microbiota-derived Metabolites (Urolithins) in Overweight Subjects. Comparison Between Two Pomegranate Extracts|Completed||Phase 1|20|Actual|National Research Council, Spain||1|||f||||t||||||||||2017-10-11 00:47:19.195055|2017-10-11 00:47:19.195055
NCT02056483|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-08-05|||July 2013||2013-07-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|REBECCA||REBECCA - Research in Rehabilitation After Breast Cancer|Optimized Rehabilitation: A Randomized Study of Systematic Monitoring and Management of Breast Cancer Patients' Symptoms|Completed||N/A|50|Actual|Danish Cancer Society||2|||f||||f||||||||||2017-10-11 00:47:19.360322|2017-10-11 00:47:19.360322
NCT02056470|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-07-18|||September 2013||2013-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluate the Safety, Functionality, and the Quality of Life of Patients Who Receive the Freedom Total Knee ® System|A Prospective, Multicenter, Single Arm Adaptive-Design Study to Evaluate the Safety, Functionality, and the Quality of Life of Patients Who Receive the Freedom Total Knee ® System|Recruiting||N/A|200|Anticipated|Maxx Orthopedics Inc||1|||f||||f||||||||||2017-10-11 00:47:19.498563|2017-10-11 00:47:19.498563
NCT02056457|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-09-20|||December 2012||2012-12-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|April 2015|Actual|2015-04-01||Interventional|PACT||An Evaluation of Selected Responsible Fatherhood and Healthy Marriage Programs: Parents and Children Together|Parents and Children Together|Active, not recruiting||N/A|||Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-11 00:47:19.614159|2017-10-11 00:47:19.614159
NCT02056444|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-03-09|||February 2014||2014-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|TeACH-R||Efficacy of Intravenous Versus Topical Tranexamic Acid in Primary Total Hip Arthroplasty|Tranexamic Acid Comparison in Hip Replacement (TeACH-R) Trial: Comparative Efficacy of Intravenous Versus Topical Tranexamic Acid for Reducing Blood Loss in Elective Primary Total Hip Arthroplasty.|Completed||N/A|149|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:47:19.73315|2017-10-11 00:47:19.73315
NCT02056418|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-02-04|||January 2014||2014-01-01|February 2014|2014-02-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|EN||Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult|A Randomized, Controlled, Single-blind Study of Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Jinling Hospital, China||3|||f||||t||||||||||2017-10-11 00:47:20.00753|2017-10-11 00:47:20.00753
NCT02056405|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-12-16|||December 2015||2015-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|ILEUS||Effect of Mosapride on Postoperative Ileus in Patients Undergoing Colorectal Surgery|Effect of Mosapride on Postoperative Ileus in Patients Undergoing Colorectal Surgery|Recruiting||Phase 4|90|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||||2017-10-11 00:47:20.169906|2017-10-11 00:47:20.169906
NCT02056392|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-05|2015-10-07|2015-07-31||March 2014||2014-03-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers|A Phase I, Double-blind (Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), Placebo-controlled, Open-Label (Moxifloxacin) Positive-controlled, Randomized, Three-period Crossover Study to Assess the Effects of Single Oral Dose of Selumetinib (75 mg) on QTc Interval Compared to Placebo, Using AVELOX (Moxifloxacin) as a Positive Control, in Healthy Male Volunteers Aged 18 to 45 Years|Completed||Phase 1|54|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:47:20.352933|2017-10-11 00:47:20.352933
NCT02056379|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-02-04|||March 2014||2014-03-01|February 2014|2014-02-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|BUDEXA||Comparison Between Budesonide and Dexamethasone Treatments for Respiratory Discomfort After Extubation on Children|Comparison Between Inhaled Budesonide and Intravenous Dexamethasone Treatments for Postextubation Stridor in Children|Unknown status|Not yet recruiting|N/A|70|Anticipated|Hospital Israelita Albert Einstein||2|||f||||f||||||||||2017-10-11 00:47:21.492972|2017-10-11 00:47:21.492972
NCT02056366|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-04|||January 2010||2010-01-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|CANON||The Effect of α-lipoic Acid Treatment in Patient With Cardiac Autonomic Neuropathy|The Effect of α-lipoic Acid Treatment in Patient With Cardiac Autonomic Neuropathy by Comparing the Change of HRV Index & ANS Function:A 6month Multicenter, Randomized, Open Label Clinical Trial CANON Study|Completed||Phase 4|91|Actual|The Catholic University of Korea||2|||f||||f||||||||||2017-10-11 00:47:21.659034|2017-10-11 00:47:21.659034
NCT02056353|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-01-07|||February 2014||2014-02-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|LOGIC-2||Multicentre LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness (LOGIC-2)|LOGIC-Insulin Computerized Algorithm-guided Versus Nurse-directed Blood Glucose Control in Critically Ill Patients: the LOGIC-2 Multicentre Randomized Controlled Trial|Completed||N/A|1550|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 00:47:21.772841|2017-10-11 00:47:21.772841
NCT02056340|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-03-06|||October 2013||2013-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Statin Therapy in Acute Influenza|Statin Therapy in Acute Influenza|Recruiting||Phase 2|174|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-11 00:47:21.896905|2017-10-11 00:47:21.896905
NCT02056327|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-03-25|||November 2013||2013-11-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Evaluating Instrumentation for Dental Devices Used in Treating Sleep Apnea|Phase One Study Evaluating Instrumentation for Dental Devices Used in Treating Sleep Apnea|Completed||N/A|2|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||f||||||||||2017-10-11 00:47:22.004388|2017-10-11 00:47:22.004388
NCT02056301|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-09-23|||August 2012||2012-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Comparison Trial Between PCA and Epidural Analgesia for Pectus Excavatum Repair|A Comparison Trial Between Patient Controlled Intravenous Analgesia (PCA) and Epidural Analgesia for Pectus Excavatum Repair|Recruiting||Phase 4|64|Anticipated|Baylor College of Medicine||2|||f||||t||||||||Undecided||2017-10-11 00:47:22.194825|2017-10-11 00:47:22.194825
NCT02056288|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-01-30|||March 2011||2011-03-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Comparison of UGSB and GA to IV Narcotics and GA for Post-Op Pain in Children With Supracondylar Fractures.|A Randomized Comparison of Ultrasound Guided Supraclavicular Block(UGSB) and General Anesthesia (GA) to IV Narcotics and General Anesthesia for Postoperative Pain Relief in Children With Supracondylar Fractures.|Active, not recruiting||Phase 4|80|Anticipated|Baylor College of Medicine||2|||f||||t||||||||Undecided||2017-10-11 00:47:22.292126|2017-10-11 00:47:22.292126
NCT02056275|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-03-05|||August 2013||2013-08-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of an Oral Nutrition Supplement (ONS) in Children.|A Study of an Oral Nutrition Supplement (ONS) in Children.|Completed||N/A|256|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-11 00:47:22.423221|2017-10-11 00:47:22.423221
NCT02056262|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-01-31|||March 15, 2016|Actual|2016-03-15|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|Caries Species||Pathogenic Species and Genotypes of Bacterial Diversity in Relation to the Severity of Dental Caries|Prevalence and Identification of Pathogenic Species and Genotypes of Bacterial Diversity in Relation to the Severity of Dental Caries|Recruiting||N/A|56|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||Samples With DNA|"     Plaque and saliva samples; DNA analysis is aimed at describing microbial communities.   "|||2017-10-11 00:47:22.540312|2017-10-11 00:47:22.540312
NCT02056249|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-11-02|||June 2011||2011-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand|Evaluation of the Effect of Hypoglycemia on the Noradrenergic System With PET and a Highly Selective Norepinephrine Transporter Ligand|Enrolling by invitation||N/A|11|Anticipated|Yale University|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 00:47:22.671357|2017-10-11 00:47:22.671357
NCT02056236|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-10-13|||April 2014||2014-04-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|TELSTAR||TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation|TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation|Recruiting||N/A|172|Anticipated|University of Twente||2|||f||||t||||||||No||2017-10-11 00:47:22.764993|2017-10-11 00:47:22.764993
NCT02056223|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-06-21|||January 9, 2017|Actual|2017-01-09|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|March 2019|Anticipated|2019-03-01||Interventional|PARIDA||Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.|Paracetamol Versus Ibuprofen for Patent Ductus Arteriosus Closure in Preterm Infants. A Prospective, Randomized, Controlled, Double Blind, Multicenter Clinical Trial.|Recruiting||Phase 2/Phase 3|120|Anticipated|University of Padua||2|||f||||t||||||||||2017-10-11 00:47:22.896872|2017-10-11 00:47:22.896872
NCT02056210|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-10-22|||February 2014||2014-02-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects|Mobilization Test of BM Progenitor Cells With Plerixafor / AMD3100: Controlled Parallel Group Comparison Between Diabetic and Non Diabetic Subjects|Completed||Phase 4|20|Anticipated|University of Padova||2|||f||||f||||||||||2017-10-11 00:47:23.020207|2017-10-11 00:47:23.020207
NCT02056197|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-02-04|||May 2013||2013-05-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Influence of an Exercise for Trunk Stabilization Performed in Stable and Unstable Surfaces for Chronic Low Back Pain.|Influence of an Exercise Program for Trunk Stabilization Performed in Stable and Unstable Surfaces for Chronic Low Back Pain: Single-blind, Randomized Controlled Clinical Trial.|Unknown status|Recruiting|N/A|60|Anticipated|University of Nove de Julho||3|||f||||t||||||||||2017-10-11 00:47:23.106912|2017-10-11 00:47:23.106912
NCT02056184|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-02-04|||December 2013||2013-12-01|February 2014|2014-02-01||||January 2018|Anticipated|2018-01-01||Interventional|TURA||Targeted Ultrasound in Rheumatoid Arthritis|Targeted Ultrasound in Rheumatoid Arthritis|Recruiting||Phase 4|400|Anticipated|University of Leeds||2|||f||||t||||||||||2017-10-11 00:47:23.205679|2017-10-11 00:47:23.205679
NCT02056158|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-05-23|||December 2013||2013-12-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium|HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium|Recruiting||N/A|480|Anticipated|Weill Medical College of Cornell University|||8||f||||f||||||Samples With DNA|"     Blood samples and biopsies from the lower respiratory tract.   "|Undecided||2017-10-11 00:47:23.376505|2017-10-11 00:47:23.376505
NCT02056145|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-07-01|||October 2011||2011-10-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Ultrasound Guided Lateral Femoral Cutaneous Block (LFCNB) And Femoral Nerve Block (FNB) For Postoperative Pain Control After Hip Surgery||Unknown status|Active, not recruiting|N/A|210|Anticipated|University Hospital, Antwerp||3|||f||||f||||||||||2017-10-11 00:47:23.466285|2017-10-11 00:47:23.466285
NCT02056132|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-04-27|||February 2014||2014-02-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Breath Condensate Study in Patients With Cystic Fibrosis.|Exhaled Breath Condensate for Evaluation of Lung Infections and Exacerbations in Patient With Cystic Fibrosis.|Recruiting||N/A|50|Anticipated|University of Florida|||2||f||||t|f|f||||Samples With DNA|"     Exhaled breath condensate.   "|||2017-10-11 00:47:23.554732|2017-10-11 00:47:23.554732
NCT02055924|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-03-08|||May 2014||2014-05-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|October 2018|Anticipated|2018-10-01||Interventional|BIBLOS||Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas|A Phase Ib Study of Ibrutinib Combined With R-DHAP or R-DHAOx in Patients With B-cell Lymphomas|Recruiting||Phase 1|84|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||f||||||||||2017-10-11 00:47:25.35382|2017-10-11 00:47:25.35382
NCT02056119|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-12-26|||December 2013||2013-12-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||RCT of Mesh Versus Jet Nebulizers on Clinical Outcomes During Mechanical Ventilation in the Intensive Care Unit|Randomized Controlled Trial of Mesh Versus Jet Nebulizers on Clinical Outcomes During Mechanical Ventilation in the Intensive Care Unit|Completed||N/A|120|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 00:47:23.639135|2017-10-11 00:47:23.639135
NCT02056106|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-10-02|||January 2013||2013-01-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|INDEPTH-Uganda||Comparative Trial of Antidepressant Treatment Models in HIV Care in Uganda|Task Shifting Model of Depression Treatment to Unleash HIV Public Health Benefits|Completed||Phase 4|1252|Actual|RAND||2|||f||||t||||||||||2017-10-11 00:47:23.718147|2017-10-11 00:47:23.718147
NCT02056093|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-02-04|||September 2013||2013-09-01|February 2014|2014-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|PAVANAVA||Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist|Breathing Pattern Variability, Respiratory Discomfort and Work of Breathing in Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist|Unknown status|Recruiting|N/A|16|Anticipated|Pierre and Marie Curie University||1|||f||||f||||||||||2017-10-11 00:47:23.801512|2017-10-11 00:47:23.801512
NCT02056080|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-03-28|||January 2013||2013-01-01|February 2014|2014-02-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Observational|TRASTYVERE||Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib|Observational, Retrospective and Multicenter Study to Evaluate the Clinical Benefit of Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib|Unknown status|Recruiting|N/A|111|Anticipated|MedSIR|||1||f||||f||||||||||2017-10-11 00:47:23.902705|2017-10-11 00:47:23.902705
NCT02056067|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-03-27|||June 2009||2009-06-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Hormones and Physical Exercise (HOPE) Study|Hormones and Physical Exercise (HOPE) Study|Completed||N/A|121|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:47:24.012585|2017-10-11 00:47:24.012585
NCT02056054|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-07-11|||March 2013||2013-03-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation|De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation|Recruiting||N/A|180|Anticipated|Yale University|||7||f||||f||||||||||2017-10-11 00:47:24.216999|2017-10-11 00:47:24.216999
NCT02056041|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-06-17|||January 2004||2004-01-01|June 2014|2014-06-01||||December 2013|Actual|2013-12-01||Observational|||Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma|Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma: Validation on 336 Consecutive Hepatectomies.|Completed||N/A|336|Actual|University of Milan|||1||f||||||||||||||2017-10-11 00:47:24.341214|2017-10-11 00:47:24.341214
NCT02056028|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-04|||January 2004||2004-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|December 2012|Actual|2012-12-01|90 Days|Observational [Patient Registry]|||Bile Leak After Liver Surgery|Validation of Our Policy of Long-term Drains Maintenance After Hepatic Resection: Results of a Prospective Cohort Analysis|Completed||N/A|475|Actual|University of Milan|||1||f||||f||||||||||2017-10-11 00:47:24.426719|2017-10-11 00:47:24.426719
NCT02056015|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-01-03|||June 2015||2015-06-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Phase I Study of MLN6907 in Patients With Metastatic Colorectal|A Phase 1, First-in-Human, Single-Dose, Open-Label, Positron Emission Tomography (PET) Imaging Study of [68Ga]MLN6907 in Patients With Metastatic Colorectal Carcinoma.|Completed||Phase 1|20|Anticipated|Takeda||1|||f||||f||||||||||2017-10-11 00:47:24.519725|2017-10-11 00:47:24.519725
NCT02055989|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-04|||January 2002||2002-01-01|February 2014|2014-02-01||||December 2011|Actual|2011-12-01||Interventional|||A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx|A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx|Completed||Phase 1/Phase 2|105|Actual|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 00:47:24.744279|2017-10-11 00:47:24.744279
NCT02055963|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-11-16|||May 2014||2014-05-01|November 2016|2016-11-01||||May 2018|Anticipated|2018-05-01||Interventional|||Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer|Minocycline for Reduction of Symptom Burden After Surgery in Patients With Head and Neck Malignancy: A Randomized Study|Active, not recruiting||Phase 2|30|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 00:47:25.014385|2017-10-11 00:47:25.014385
NCT02055950|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-02-06|||July 2013||2013-07-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|PREDICTION||Pulsed Perfusion for Marginal Kidneys|A PROSPECTIVE STUDY TO COMPARE EARLY GRAFT FUNCTION OF RECIPIENTS OF SINGLE OR DUAL KIDNEY ORGANS STORED IN ICE COLD SOLUTION OR PULSED PERFUSION|Recruiting||N/A|60|Anticipated|Mario Negri Institute for Pharmacological Research|||2||f||||f||||||Samples Without DNA|"     Serum, urine.   "|||2017-10-11 00:47:25.137952|2017-10-11 00:47:25.137952
NCT02055937|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-08-18|||October 2013||2013-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2015|Actual|2015-10-01||Interventional|ISIS||Immediate Implant Breast Reconstruction|Immediate Implant Breast Reconstruction for Patients With Mastectomy Ans Post opérative Chest Wall Radiotherapy|Terminated||Phase 2|53|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||1||autorities vorbidden this dispositif in other trial|f||||t||||||||||2017-10-11 00:47:25.250076|2017-10-11 00:47:25.250076
NCT02055911|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-03|||March 2014||2014-03-01|February 2014|2014-02-01|July 2015|Anticipated|2015-07-01|March 2015|Anticipated|2015-03-01||Interventional|||Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema|Retinal Ganglion Cell Function After Repeated Intravitreous Ranibizumab in Diabetic Macular Edema|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 00:47:25.490171|2017-10-11 00:47:25.490171
NCT02055898|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2015-08-26|||April 2014||2014-04-01|November 2013|2013-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SAFFE||SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE)|Slow-wave Sleep and Daytime Functioning in Chronic Fatigue Syndrome: Effects of Sodium Oxybate|Completed||Phase 4|10|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 00:47:25.593944|2017-10-11 00:47:25.593944
NCT02055885|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-07-07|||February 2014||2014-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|February 2014|Actual|2014-02-01||Observational|RePox-1||Correction of Exercise-induced Desaturation by Acute Oxygen Supply and Exercise Responses in COPD|Does Correction of Exercice-induced Desaturation by O2 Improve Systematically Exercise Tolerance in COPD Patients ?|Completed||N/A|255|Actual|5 Santé|||2||f||||f||||||||||2017-10-11 00:47:25.683212|2017-10-11 00:47:25.683212
NCT02055872|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-10-07|||September 2014||2014-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|FADE||Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial|A Single-centre, Randomized, Double-blinded, Placebo-controlled Pilot Study to Determine the Feasibility of a Full-scale Clinical Trial to Compare the Effect of Furosemide With or Without 25% Albumin in the Diuresis of Edema in Volume-overloaded ICU Patients in the Post-resuscitation Phase of Illness.|Completed||Phase 3|46|Actual|Hamilton Health Sciences Corporation||2|||f||||f||||||||||2017-10-11 00:47:25.761519|2017-10-11 00:47:25.761519
NCT02055859|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-10-15|||April 2011||2011-04-01|October 2015|2015-10-01|November 2021|Anticipated|2021-11-01|November 2018|Anticipated|2018-11-01||Interventional|ACOUNEU||Cyberknife Radiosurgery for Patients With Neurinomas|Cyberknife Radiosurgery for Patients With Neurinomas|Recruiting||Phase 3|102|Anticipated|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta||2|||f||||f||||||||||2017-10-11 00:47:25.851797|2017-10-11 00:47:25.851797
NCT02055846|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-06-24|||March 2012||2012-03-01|December 2012|2012-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Analysis of the Mechanisms of Actions of Heat Shock Protein (Hsp27) Responsible of the Androgen-independent Evolution in Prostate Cancer|Analysis of the Mechanisms of Actions of Hsp27 Responsible of the Androgen-independent Evolution in Prostate Cancer|Terminated||N/A|59|Actual|Institut Paoli-Calmettes||1||Insufficient biological material for analysis|f||||f||||||||||2017-10-11 00:47:25.943408|2017-10-11 00:47:25.943408
NCT02055833|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-08-29|||September 2013||2013-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing Radiotherapy|Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing Radiotherapy: a Randomized, Controlled Trial|Completed||N/A|159|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-11 00:47:26.026592|2017-10-11 00:47:26.026592
NCT02055820|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-09-25|||November 17, 2013|Actual|2013-11-17|September 2017|2017-09-01|February 27, 2020|Anticipated|2020-02-27|August 31, 2017|Actual|2017-08-31||Interventional|||A Safety and Pharmacokinetics (PK) Study of Venetoclax in Participants With Non-Hodgkin's Lymphoma|A Phase Ib/II, Open-Label Study Evaluating the Safety and Pharmacokinetics of GDC-0199 (ABT-199) in Combination With Rituximab (R) or Obinutuzumab (G) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Patients With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL|Active, not recruiting||Phase 1/Phase 2|267|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-11 00:47:26.137337|2017-10-11 00:47:26.137337
NCT02055807|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-01-25|||February 2015||2015-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Role of Lung Ultrasound Imaging in the Comparison of Two Mechanical Ventilation Strategies During Laparotomy|Role of Lung Ultrasound Imaging in the Comparison of Two Mechanical Ventilation Strategies During Laparotomy.|Completed||N/A|44|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 00:47:26.405394|2017-10-11 00:47:26.405394
NCT02055794|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-10-04|||February 2014||2014-02-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|PALS||Promoting Optimal Healing After Laceration Repair Study|Promoting Optimal Healing After Laceration Repair Study - PALS Study|Completed||N/A|35|Actual|University of Michigan||3|||f||||f||||||||||2017-10-11 00:47:26.495904|2017-10-11 00:47:26.495904
NCT02055781|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-12-15|||December 2013||2013-12-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|PAC326||Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia|A Randomized Controlled Phase 3 Study of Oral Pacritinib Versus Best Available Therapy in Patients With Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis|Terminated||Phase 3|300|Anticipated|CTI BioPharma||3|||f||||t||||||||||2017-10-11 00:47:26.615418|2017-10-11 00:47:26.615418
NCT02055755|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-09-12|||April 2013||2013-04-01|September 2016|2016-09-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Observational|||WEMR With Clinical Decision Support for Diabetic Foot Ulcers|Wound Research Database With Clinical Decision Support for Patients With Diabetic Foot Ulcers|Recruiting||N/A|500|Anticipated|Winthrop University Hospital|||1||f||||f||||||||||2017-10-11 00:47:26.927353|2017-10-11 00:47:26.927353
NCT02055742|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-09-13|||March 2014||2014-03-01|September 2014|2014-09-01||||December 2016|Anticipated|2016-12-01||Observational|||Detection of Chlamydia (CT) and Gonorrhea (NG)|Clinical Study Protocol for the Illumigene® Chlamydia and Illumigene® Gonorrhea DNA Amplification Assays|Unknown status|Active, not recruiting|N/A|700|Anticipated|Meridian Bioscience, Inc.|||1||f||||f||||||Samples With DNA|"     Leftover urine samples   "|||2017-10-11 00:47:27.000217|2017-10-11 00:47:27.000217
NCT02055729|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-01-31|||May 11, 2015|Actual|2015-05-11|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|EscaFlor||Changes in Bacterial Flora Among Patients With Pelvic Bedsores: a Prospective Pilot Study|Changes in Cutaneous, Digestive and Urinary Bacterial Flora Among Patients With Pelvic Bedsores: a Prospective Pilot Study|Recruiting||N/A|55|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||Samples With DNA|"     Bedsore superficial (swabbing) and deep (punch biopsies) samples are retained; stool and     urine samples are retained. DNA extraction is aimed at describing microbial communities.   "|||2017-10-11 00:47:27.186971|2017-10-11 00:47:27.186971
NCT02055716|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-02-09|||January 2014||2014-01-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Sulforadex in Healthy Human Males MAD|A Randomised, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of Sulforadex® in Healthy Male Subjects Following Daily Dosing for 7 Days|Completed||Phase 1|18|Actual|Evgen Pharma||2|||f||||t||||||||||2017-10-11 00:47:27.311586|2017-10-11 00:47:27.311586
NCT02055703|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-11-02|||January 2014||2014-01-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil||Completed||Phase 1|195|Actual|Eisai Inc.||5|||f||||f||||||||||2017-10-11 00:47:27.398314|2017-10-11 00:47:27.398314
NCT02055690|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2017-01-31|||September 2014||2014-09-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|PAZOFOS||PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer|A Phase Ib and Randomised Phase II Trial of Pazopanib With or Without Fosbretabulin in Advanced Recurrent Ovarian Cancer|Recruiting||Phase 1/Phase 2|128|Anticipated|The Christie NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:47:27.505332|2017-10-11 00:47:27.505332
NCT02055677|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-07-17|||January 2014||2014-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Observational|VegMed 2013||Personality Profiles, Values and Empathy: Differences Between Ovo/Lacto-vegetarians and Vegans|Personality Profiles, Values and Empathy: Differences Between Ovo/Lacto-vegetarians and Vegans|Completed||N/A|10000|Actual|Charite University, Berlin, Germany|||1||f||||t||||||||||2017-10-11 00:47:27.649502|2017-10-11 00:47:27.649502
NCT02055664|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-04||||||December 2013|2013-12-01||||January 2016|Anticipated|2016-01-01||Interventional|TAPBloc Rachis||The Tap Block Technique Via the Anterior Approach in Elective Surgery of the Spine|THE TAP BLOCK TECHNIQUE VIA THE ANTERIOR APPROACH IN ELECTIVE SURGERY OF THE SPINE: Prospective, Randomised, Double Blind Trial, Comparing TAP BLOCK With Continuous Infiltration of Ropivacaine Versus Placebo|Unknown status|Recruiting|Phase 4|80|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:47:27.717608|2017-10-11 00:47:27.717608
NCT02055651|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-11-10|||August 2013||2013-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|November 2014|Actual|2014-11-01||Observational|||Cardiovascular Disease Risk Factors Prevalence Among Bayer's Employees in São Paulo, Brazil|Descriptive Observational Study of Cardiovascular Health Risk Factors in Workers of Bayer S.A. Company in São Paulo|Completed||N/A|361|Actual|Bayer|||1||f||||f||||||||||2017-10-11 00:47:27.805066|2017-10-11 00:47:27.805066
NCT02055638|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-06-14|||May 2014||2014-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|AVN009||Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder|An Exploratory Phase II Study to Determine the Safety, Tolerability and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Adults With Diagnostic and Statistical Manual Version 5 (DSM-5) Intermittent Explosive Disorder (IED)|Completed||Phase 1/Phase 2|96|Actual|Azevan Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:47:27.893177|2017-10-11 00:47:27.893177
NCT02055625|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2015-03-31|||January 2014||2014-01-01|March 2015|2015-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease|Treatment of Oral Mucosa in Patients With Graft-versus-host Disease Following Injection of Mesenchymal Stem Cells - Human Pilot Study|Recruiting||Phase 1/Phase 2|12|Anticipated|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 00:47:28.008543|2017-10-11 00:47:28.008543
NCT02055612|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-02-28|||March 2013||2013-03-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Observational|||Mobile Clinic - a Cross-sectional Epidemiological Survey|Mobile Clinic- a Cross-sectional Epidemiological Survey to Investigate the Prevalence of Wet Aged-related Macular Degeneration (wAMD) in Elderly Population in Slovak Republic|Completed||N/A|3278|Actual|Novartis|||1||f||||f||||||||||2017-10-11 00:47:28.097866|2017-10-11 00:47:28.097866
NCT02055599|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-11-01|||April 2013||2013-04-01|November 2016|2016-11-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Observational|||WEMR With Clinical Decision Support for All Wounds|Wound Research Database With Clinical Decision Support for Patients With All Wounds|Recruiting||N/A|500|Anticipated|Winthrop University Hospital|||1||f||||f||||||||||2017-10-11 00:47:28.172875|2017-10-11 00:47:28.172875
NCT02055586|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-05-08|||October 22, 2013|Actual|2013-10-22|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents|A Pilot Study of FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents|Recruiting||N/A|20|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|t|f|f|f|||||2017-10-11 00:47:28.264698|2017-10-11 00:47:28.264698
NCT02055573|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-06-02|||February 2014||2014-02-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|EarlyABCs||The Early ABCs Study|Can we Promote Early Literacy and Prevent Shaken Baby Syndrome in the Well Child Nursery?.A Randomized Controlled Study, The Early ABC Study.|Completed||N/A|300|Actual|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||||2017-10-11 00:47:28.375419|2017-10-11 00:47:28.375419
NCT02055560|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-11-01|||January 2014||2014-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|5-FU RECORD||Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients|Retrospective Data Comparison of Toxicity and Efficacy in Colorectal Cancer (CRC) Patients Managed With and Without 5-FU Exposure Optimization Testing|Enrolling by invitation||N/A|350|Anticipated|Saladax Biomedical, Inc.|||2||f||||f||||||||No||2017-10-11 00:47:28.501132|2017-10-11 00:47:28.501132
NCT02055547|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2016-08-23|||May 2013||2013-05-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)|A Single and Multiple-Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8521 in Subjects|Completed||Phase 1|61|Actual|Merck Sharp & Dohme Corp.||19|||f||||f||||||||||2017-10-11 00:47:28.625475|2017-10-11 00:47:28.625475
NCT02055534|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-06|||July 2007||2007-07-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis|Nutritional Counseling in Systemic Immunoglobulin Light-chain (AL) Amyloidosis: a Prospective Randomized, Controlled Trial.|Completed||N/A|144|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-11 00:47:28.807322|2017-10-11 00:47:28.807322
NCT02055508|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-08-17|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Interventional|POSITIVE||POSITIVE - Study (Part III) Heidelberg|Physical Exercise Program in Lung Cancer Patients With Non-operable Disease Undergoing Palliative Treatment|Active, not recruiting||N/A|232|Actual|German Cancer Research Center||2|||f||||t||||||||||2017-10-11 00:47:28.988322|2017-10-11 00:47:28.988322
NCT02055495|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-08-07|||March 2010||2010-03-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Arthroereisis Versus Lateral Column Lengthening in the Treatment of Planovalgus Feet|Prospective Comparison of Subtalar Arthroereisis To Lateral Column Lengthening for Painful Flatfeet|Completed||N/A|15|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 00:47:29.107661|2017-10-11 00:47:29.107661
NCT02055482|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-02-07|||June 2014||2014-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|DIALOGUE 3||Long-term Pre-dialysis Extension in Europe and Asia Pacific|A Controlled, Parallel Group, Open-label, Multicenter Extension Study to Investigate Efficacy and Safety of Oral BAY85-3934 and Darbepoetin Alfa Comparator in the Long Term Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease in Europe and Asia Pacific|Completed||Phase 2|166|Actual|Bayer||2|||f||||t||||||||||2017-10-11 00:47:29.195732|2017-10-11 00:47:29.195732
NCT02055469|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-04|||March 2014||2014-03-01|February 2014|2014-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Achalasia: Mechanisms Underlying Treatment Failure|Achalasia; Mechanisms Underlying Persistent Symptoms After Treatment|Unknown status|Not yet recruiting|N/A|40|Anticipated|Barts & The London NHS Trust|||1||f||||f||||||||||2017-10-11 00:47:29.529561|2017-10-11 00:47:29.529561
NCT02055456|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-12-01|||February 2014||2014-02-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Nandrolone Decanoate in the Treatment of Telomeropathies|Male Hormones for Telomere Related Diseases|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 00:47:29.616302|2017-10-11 00:47:29.616302
NCT02055443|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-07-10|||January 2014|Actual|2014-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|MID-EPIC||Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain|Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain|Completed||N/A|50|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 00:47:29.731099|2017-10-11 00:47:29.731099
NCT02055430|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-03-19|2014-02-04||March 2010||2010-03-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional||the double J arm contains 90 ureterorenal units|Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage|Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage in Children With Obstructive Anuria and Acute Renal Failure Due to Ureteral Calculi: a Prospective, Randomized Study|Completed||N/A|90|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 00:47:29.833675|2017-10-11 00:47:29.833675
NCT02055417|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2017-05-01|||December 2010||2010-12-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention|Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention|Completed||N/A|50|Actual|University of Maryland||2|||f||||f||||||||||2017-10-11 00:47:30.276913|2017-10-11 00:47:30.276913
NCT02055404|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2014-02-20|2014-02-20||February 2013||2013-02-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||The analysis population includes all enrolled participants.|On-Eye Evaluation of Contact Lens Rotation Marks||Completed||N/A|3|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:47:30.368601|2017-10-11 00:47:30.368601
NCT02055391|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-02-04|||September 2009||2009-09-01|February 2014|2014-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Weight Loss Trial for Emotional Eating|A Randomized Controlled Trial of a Novel Weight Loss Intervention for Obesity|Completed||N/A|79|Actual|Temple University||2|||f||||f||||||||||2017-10-11 00:47:30.558634|2017-10-11 00:47:30.558634
NCT02055378|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2014-02-03|||January 2011||2011-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||the Effect of Low-Concentration Atropine Combined With Auricular Acupoint Stimulation in Myopia Control|the Effect of Low-Concentration Atropine Combined With Auricular Acupoint Stimulation in Myopia Control|Completed||N/A|73|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation||2|||f||||t||||||||||2017-10-11 00:47:30.628389|2017-10-11 00:47:30.628389
NCT02055365|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-09-23|||February 2014||2014-02-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers|Effects of Persistent Innate Immune Activation on Vaccine Efficacy Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers|Active, not recruiting||N/A|8|Anticipated|Rockefeller University||1|||f||||f||||||||||2017-10-11 00:47:30.709578|2017-10-11 00:47:30.709578
NCT02055352|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-04-17|2017-01-25||May 30, 2014|Actual|2014-05-30|April 2017|2017-04-01|January 26, 2016|Actual|2016-01-26|January 26, 2016|Actual|2016-01-26||Interventional|COMBINE||Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD|24-week Study to Evaluate Efficacy and Safety of the Combination Budesonide / Indacaterol vs Fluticasone / Salmeterol in Patients With COPD|Completed||Phase 4|222|Actual|Novartis||2|||f||||f||||||||||2017-10-11 00:47:30.800549|2017-10-11 00:47:30.800549
NCT02055339|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-04-08|||February 2014||2014-02-01|April 2015|2015-04-01||||December 2015|Anticipated|2015-12-01||Interventional|CHOMP||Pilot Study Comparing Different Modes of Non-invasive Ventilation for the Oral Feeding of Preterm Infants|Comparison of Nasal Continuous Positive Airway Pressure With Low Flow Oxygen Versus Heated, Humidified High Flow Nasal Cannula for Oral Feeding of the Premature Infant (CHOMP Trial): A Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-11 00:47:31.405798|2017-10-11 00:47:31.405798
NCT02055326|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-04|||September 2009||2009-09-01|January 2014|2014-01-01|July 2011|Actual|2011-07-01|February 2011|Actual|2011-02-01||Interventional|||Yoga for Men Attempting Smoking Cessation|Complementary Treatments for Smoking Cessation|Completed||N/A|38|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 00:47:31.540779|2017-10-11 00:47:31.540779
NCT02055313|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-03-21|||May 2012||2012-05-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Observational|||Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival|The Exceptional Patient in Cancer Care|Active, not recruiting||N/A|20|Anticipated|Meir Medical Center|||1||f||||t||||||||No||2017-10-11 00:47:31.649662|2017-10-11 00:47:31.649662
NCT02055300|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-11-07|||February 2014||2014-02-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|LY03005SAD||Safety, Tolerability and Pharmacokinetics Study of LY03005|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Single Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03005|Completed||Phase 1|88|Actual|Luye Pharma Group Ltd.||9|||f||||f||||||||||2017-10-11 00:47:31.74588|2017-10-11 00:47:31.74588
NCT02055287|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-11-07|||March 2013||2013-03-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|LY03004SAD||Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder|An Open-Label, Single Ascending Dose Pharmacokinetic and Safety Study of LY03004 Following Escalating Single Intramuscular Injection in Stable Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|36|Actual|Luye Pharma Group Ltd.||4|||f||||f||||||||||2017-10-11 00:47:31.924209|2017-10-11 00:47:31.924209
NCT02055274|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-10-20|||October 2013||2013-10-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|03003MAD||Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease|A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections|Completed||Phase 1|39|Actual|Luye Pharma Group Ltd.||3|||f||||t||||||||||2017-10-11 00:47:32.041473|2017-10-11 00:47:32.041473
NCT02055261|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-02-03|||May 2009||2009-05-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pedunculopontine Nucleus Stimulation for Gait Disorders in Parkinson's Disease|Effects of Low Frequency Deep Brain Stimulation of the Pedunculopontine Nucleus on Gait and Balance Disorders of Parkinson's Disease|Completed||Phase 1/Phase 2|6|Actual|Pitié-Salpêtrière Hospital||2|||f||||t||||||||||2017-10-11 00:47:32.198886|2017-10-11 00:47:32.198886
NCT02055248|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-06-30|||January 27, 2014||2014-01-27|December 28, 2013|2013-12-28|September 4, 2017|Anticipated|2017-09-04|September 4, 2017|Anticipated|2017-09-04||Observational|||Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders|Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders|Unknown status|Recruiting|N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:47:32.339371|2017-10-11 00:47:32.339371
NCT02055235|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-07-06|||January 27, 2014||2014-01-27|October 12, 2016|2016-10-12|October 12, 2016|Actual|2016-10-12|October 19, 2015|Actual|2015-10-19||Observational|||Study of Pain Processing in Experienced Yoga Practitioners|Pain Processing and Pain Control in Experienced Yoga Practitioners|Completed||N/A|47|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:47:32.478844|2017-10-11 00:47:32.478844
NCT02055209|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-04|2017-08-22|||January 13, 2014||2014-01-13|August 4, 2017|2017-08-04|June 4, 2018|Anticipated|2018-06-04|June 4, 2018|Anticipated|2018-06-04||Observational|||Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)|GENE-FORECASTSM: Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study|Recruiting||N/A|2019|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:47:32.718245|2017-10-11 00:47:32.718245
NCT02055196|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-05-30||||||May 2014|2014-05-01||||May 2014|Actual|2014-05-01||Interventional|||Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas|A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination With Intravenous Irinotecan in Patients With Recurrent High-Grade Gliomas|Withdrawn||Phase 1|0|Actual|City of Hope Medical Center||1||New study written|f||||t||||||||||2017-10-11 00:47:32.859599|2017-10-11 00:47:32.859599
NCT02055183|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-06-06|||October 2014|Actual|2014-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01|6 Months|Observational [Patient Registry]|||BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin|Botulinum Antitoxin Patient Registry for the Evaluation of Safety and Clinical Outcomes of Pediatric and Adult Patients Following BAT Treatment for Confirmed or Suspected Exposure to Botulinum Toxin.|Enrolling by invitation||N/A|100|Anticipated|Cangene Corporation|||1||f||||f|t|f|||f|||No||2017-10-11 00:47:33.021939|2017-10-11 00:47:33.021939
NCT02055170|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2016-07-25|||June 2014||2014-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer|Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer|Recruiting||Phase 2|22|Anticipated|CancerCare Manitoba||1|||f||||f||||||||||2017-10-11 00:47:33.187534|2017-10-11 00:47:33.187534
NCT02055157|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-05-19|||January 2014||2014-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|ACH||A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia|A Phase 2, Open-label, Sequential Cohort Dose-escalation Study of BMN 111 in Children With Achondroplasia|Active, not recruiting||Phase 2|36|Actual|BioMarin Pharmaceutical||1|||f||||t||||||||||2017-10-11 00:47:33.29904|2017-10-11 00:47:33.29904
NCT02055144|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-03-04|||February 2011||2011-02-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Observational|||Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy|An Exploratory Study of the Performance of Mass-Spectrometry Based Test Veristrat in Prediction of Benefit of First Line NSCLC Patients From Treatment With Standard Chemotherapy Regimens|Recruiting||N/A|100|Anticipated|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|||2||f||||f||||||Samples With DNA|"     Serum samples, urine samples, circulating tumour cells from peripheral blood. Such samples     will be obtained before start of treatment (within 2 weeks), and at each patient's evaluation     and at progression   "|||2017-10-11 00:47:33.401425|2017-10-11 00:47:33.401425
NCT02054949|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-10-07|||April 2013||2013-04-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TRE-NAC||Treatment Resistant Epilepsy and N-Acetyl Cysteine|Pilot Study of N-acetyl Cysteine for Refractory Generalized Epilepsy in Children With Autism|Withdrawn||N/A|0|Actual|Nationwide Children's Hospital||1||no eligible subjects located|f||||t||||||||||2017-10-11 00:47:35.98058|2017-10-11 00:47:35.98058
NCT02055131|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-02-03|||November 2013||2013-11-01|February 2014|2014-02-01|March 2015|Anticipated|2015-03-01|September 2014|Anticipated|2014-09-01||Interventional|||Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis|a Comparative Study of Aspirin Either at Fixed Dose or at a Dose Titrated by Platlet Function Analyzer(PFA-100) vs Placebo in Primary Prevention of Vascular Access for Hemodialysis|Unknown status|Recruiting|Phase 4|300|Anticipated|Tunis University||3|||f||||t||||||||||2017-10-11 00:47:33.497051|2017-10-11 00:47:33.497051
NCT02055118|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-03-28|||February 2014||2014-02-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|AIM-IT||Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment|A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment|Active, not recruiting||Phase 2/Phase 3|48|Anticipated|Shire||2|||f||||t||||||||||2017-10-11 00:47:33.603537|2017-10-11 00:47:33.603537
NCT02055105|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-06-29|||March 2014||2014-03-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Modulation of Molecular Fingerprinting in Pediatric Sepsis|Modulation of Molecular Fingerprinting in Pediatric Sepsis|Unknown status|Recruiting|N/A|25|Anticipated|Phoenix Children's Hospital||1|||f||||f||||||||||2017-10-11 00:47:33.751514|2017-10-11 00:47:33.751514
NCT02055092|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-10-06|||February 2014||2014-02-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family|A Nordic Multicentre Observational Study of Persons With Young Onset Dementia and Their Families - Factors Influencing Quality of Life, Theirs Specific Needs and the Use of Healthcare Resources|Unknown status|Active, not recruiting|N/A|250|Anticipated|Norwegian Centre for Ageing and Health|||3||f||||f||||||Samples With DNA|"     Bio samples are collected for analysis and storage in a bio bank as part of the routines for     the National Registry of Dementia:        -  Blood plasma and serum for the later analysis of inflammation markers.        -  Whole blood for analysis of apolipoprotein E4-genotype.        -  Cerebrospinal fluid for dementia markers (tau-protein, amyloid).        -  Saliva cortisol.   "|||2017-10-11 00:47:33.851478|2017-10-11 00:47:33.851478
NCT02055079|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-04-08|||April 2014||2014-04-01|April 2014|2014-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|RAP||Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease|Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease - The Vienna RAP Study|Recruiting||Phase 3|68|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 00:47:33.977974|2017-10-11 00:47:33.977974
NCT02055066|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-04-20|||January 2014||2014-01-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer.|A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer Over-expressing the c-Met Protein.|Completed||Phase 1|24|Actual|arGEN-X BVBA||4|||f||||t||||||||||2017-10-11 00:47:34.099102|2017-10-11 00:47:34.099102
NCT02055053|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-03-21|||August 2013|Actual|2013-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Local Anesthesia on Post-operative Pain During Laparoscopic Inguinal Hernia Repair|A Randomized, Double-blinded, Placebo-controlled Trial of the Effects of Infusing Local Anesthesia on Post-operative Pain During Laparoscopic Inguinal Hernia Repair|Recruiting||Phase 4|70|Anticipated|Lahey Clinic||2|||f||||f||||||||||2017-10-11 00:47:35.076796|2017-10-11 00:47:35.076796
NCT02055027|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-03|||February 2008||2008-02-01|February 2014|2014-02-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Observational|||Adherence to Continuous Positive Airway Pressure Among Obstructive Sleep Apnoea Patients.|Adherence to Continuous Positive Airway Pressure Among Obstructive Sleep Apnoea Patients. An Anaesthetic Algorithmic Approach to Prevent Postoperative Complications.|Completed||N/A|90|Actual|Astes|||2||f||||f||||||||||2017-10-11 00:47:35.207404|2017-10-11 00:47:35.207404
NCT02055014|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-04-25|||July 2013||2013-07-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)|Randomisation to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)|Active, not recruiting||Phase 4|72|Anticipated|Sandwell & West Birmingham Hospitals NHS Trust||3|||f||||t||||||||||2017-10-11 00:47:35.325573|2017-10-11 00:47:35.325573
NCT02055001|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-05-27|||January 2014||2014-01-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|SHOW||Sexual Hormones and Haemostasis: Observations for Women Health|Haemostasis Evaluation Related to Sexual Hormones: Gender Perspective|Unknown status|Recruiting|N/A|50|Anticipated|University of Roma La Sapienza|||1||f||||f||||||Samples Without DNA|"     Whole blood, serum samples Urine   "|||2017-10-11 00:47:35.458514|2017-10-11 00:47:35.458514
NCT02054988|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-06-07|||January 2014||2014-01-01|June 2015|2015-06-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|CyCLOPS||"Potential Effect of Acute and Chronic Caffeine Administration on Platelet Reactivity in Patient With Coronary Artery Disease on Dual Antiplatelet Therapy"|"Potential Effect of Acute and Chronic Caffeine Administration on Platelet Reactivity in Patient With Coronary Artery Disease on Dual Antiplatelet Therapy"|Unknown status|Recruiting|N/A|240|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 00:47:35.578716|2017-10-11 00:47:35.578716
NCT02054975|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-10-07|||January 2014||2014-01-01|October 2015|2015-10-01|January 2016|Anticipated|2016-01-01|September 2015|Actual|2015-09-01||Interventional|D-Asthma||Vitamin D in Pediatric Asthma: a Randomized Controlled Open-label Pilot Trial|Prospective Open Pilot of Low vs. Higher Dose Vitamin D in D-deficient Asthmatic Children: Does Diet Predict Immune Function and Asthma Symptom Response to Vitamin D Supplementation?|Unknown status|Active, not recruiting|N/A|18|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-11 00:47:35.698273|2017-10-11 00:47:35.698273
NCT02054962|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-04-18|||June 2012||2012-06-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2016|Actual|2016-11-01||Observational|Elderly CRASH||Persistent Pain Among Elderly Experiencing Motor Vehicle Collision|Persistent Pain and Associated Functional Decline Among Elderly Experiencing Motor Vehicle Collision|Active, not recruiting||N/A|250|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     Saliva samples collected for participants 1-150. Saliva, whole blood DNA and RNA collected     for participants 151-250   "|||2017-10-11 00:47:35.839239|2017-10-11 00:47:35.839239
NCT02054936|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-12-04|||March 2014||2014-03-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Evaluation of Wound Drainage After Knee or Hip Arthroplasty|Evaluation of Wound Drainage Following Rivaroxaban (Xarelto) or Warfarin (Coumadin) for Post op Venous Thromboembolism (VTE) Prophylaxis, After Knee or Hip Arthroplasty a Randomized Study.|Withdrawn||Phase 4|0|Actual|University of Michigan||2||Change in standard of care, no possibility of recruitment|f||||f||||||||||2017-10-11 00:47:36.075842|2017-10-11 00:47:36.075842
NCT02054923|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-08-03|||March 2014||2014-03-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Routine Video-recording on Colonoscopy Quality Indicators.|The Effect of Routine Video-recording on Colonoscopy Quality Indicators: a Cluster Randomized Trial.|Completed||N/A|5200|Actual|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||f||||||||||2017-10-11 00:47:36.154184|2017-10-11 00:47:36.154184
NCT02054910|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-01-09|2016-04-22||October 2013||2013-10-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||CPB Versus Sham Treatment for Pain Management in Small Duct Chronic Pancreatitis|Randomized Single Blinded Control Trial Comparing EUS Guided Celiac Plexus Block (CPB) Versus Sham Treatment for Pain Management in Small Duct Chronic Pancreatitis|Completed||N/A|5|Actual|University of Alabama at Birmingham||2|||f||||f||||||||No||2017-10-11 00:47:36.268523|2017-10-11 00:47:36.268523
NCT02054897|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-07-28||2016-03-17|February 3, 2014|Actual|2014-02-03|July 2017|2017-07-01|May 8, 2015|Actual|2015-05-08|May 8, 2015|Actual|2015-05-08||Interventional|SUSTAIN™1||Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes|Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes|Completed||Phase 3|388|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 00:47:37.247711|2017-10-11 00:47:37.247711
NCT02054884|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-10-20|||October 2013||2013-10-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma|Phase II Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Paclitaxel in Patients With Metastatic Merkel Cell Carcinoma|Unknown status|Recruiting|Phase 2|90|Anticipated|Philogen S.p.A.||2|||f||||f||||||||||2017-10-11 00:47:39.81346|2017-10-11 00:47:39.81346
NCT02054871|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-03|||September 2013||2013-09-01|February 2014|2014-02-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|||RCT to Evaluate the Renal Protective Effects of Remote Ischaemic Preconditioning in Peripheral Angioplasty|Randomised Controlled Trial to Evaluate the Reno-protective Benefits of Remote Ischaemic Preconditioning in Patients Undergoing Infrainguinal Peripheral Angioplasty|Unknown status|Recruiting|N/A|40|Anticipated|Mid Western Regional Hospital, Ireland||4|||f||||t||||||||||2017-10-11 00:47:39.960245|2017-10-11 00:47:39.960245
NCT02054858|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-02-03|||January 2014||2014-01-01|February 2014|2014-02-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|Re-DUCE-F||Preconditioning Against Renal Damage Under Contrast Examination|Preconditioning Against Renal Damage Under Contrast Examination: a Single Centre, Randomized, Sham -Controlled Clinical Feasibility Trial|Unknown status|Recruiting|N/A|1000|Anticipated|Mid Western Regional Hospital, Ireland||2|||f||||t||||||||||2017-10-11 00:47:40.099175|2017-10-11 00:47:40.099175
NCT02054832|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-09-23|||November 2013||2013-11-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch|A Comparison of Quality of Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard and Modified Uncooked Cornstarch|Completed||N/A|11|Actual|McGill University Health Center|||1||f||||f||||||||||2017-10-11 00:47:40.327969|2017-10-11 00:47:40.327969
NCT02054819|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-08-22|||June 2013||2013-06-01|August 2017|2017-08-01|August 22, 2017|Actual|2017-08-22|August 22, 2017|Anticipated|2017-08-22||Interventional|||Treating NSCLC Minimal Stage IV With Curative Intent|A Pilot Study Treating Patients With Minimal Stage IV Non-Small Cell Lung Cancer (NSCLC) With Curative Intent|Terminated||Phase 2|14|Actual|Leo W. Jenkins Cancer Center||1||Didn't meet accrual goal, change in standard of care.|f||||t||||||||||2017-10-11 00:47:40.429096|2017-10-11 00:47:40.429096
NCT02054806|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-08-09|||February 17, 2014|Actual|2014-02-17|August 2017|2017-08-01|July 13, 2018|Anticipated|2018-07-13|July 13, 2018|Anticipated|2018-07-13||Interventional|||Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)|Phase IB Study of Pembrolizumab (MK-3475) in Subjects With Select Advanced Solid Tumors|Active, not recruiting||Phase 1|477|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 00:47:40.532418|2017-10-11 00:47:40.532418
NCT02054793|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-07-22|||June 2014||2014-06-01|July 2014|2014-07-01|July 2016|Anticipated|2016-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)|Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)|Withdrawn||Phase 1/Phase 2|0|Actual|Johns Hopkins University||1||This study was never able to open due to lack of funding from the pharmaceutical company.|f||||t||||||||||2017-10-11 00:47:40.752182|2017-10-11 00:47:40.752182
NCT02054780|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-08-16|||February 2014|Actual|2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|||Randomized Controlled Trial of Ways to Improve OVC HIV Prevention and Well-being|Randomized Controlled Trial of Ways to Improve OVC HIV Prevention and Well-being|Active, not recruiting||N/A|610|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 00:47:40.856681|2017-10-11 00:47:40.856681
NCT02054767|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2014-01-31|||August 2010||2010-08-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|November 2012|Actual|2012-11-01||Interventional|||Anesthetic Efficacy in Irreversible Pulpitis|Anesthetic Efficacy of Articaine, Lidocaine and Mepivacaine in Patients With Irreversible Pulpitis of Mandibular Molar|Completed||Phase 4|66|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 00:47:40.952421|2017-10-11 00:47:40.952421
NCT02054754|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-05-17|2016-01-25||January 2014||2014-01-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Healthy male subjects between 18 and 45 years of age with a body mass index between 18.0 and 32.0 kg/m2 or, if outside the range, considered not clinically significant by the investigator.|Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects|Assessment of Safety, Tolerability and Pharmacokinetics of Single Doses of Oral Dexanabinol in Healthy Subjects|Completed||Phase 1|40|Actual|e-Therapeutics PLC||6|||f||||t||||||||||2017-10-11 00:47:41.065695|2017-10-11 00:47:41.065695
NCT02054741|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-06-01|||May 15, 2014|Actual|2014-05-15|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer|A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy or Similar Agents for Advanced Cancer: Reducing Toxicity in Older Adults|Recruiting||N/A|700|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 00:47:41.537481|2017-10-11 00:47:41.537481
NCT02054728|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-02-03|||October 2012||2012-10-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Inspiratory Muscle Training During Right-heart Catheterization|Inspiratory Muscle Training During Right-heart Catheterization|Unknown status|Recruiting|N/A|20|Anticipated|Wissenschaftliches Institut Bethanien e.V||1|||f||||f||||||||||2017-10-11 00:47:41.731972|2017-10-11 00:47:41.731972
NCT02054715|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-08-21|2017-07-05||May 1, 2014|Actual|2014-05-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|August 31, 2016|Actual|2016-08-31||Interventional|||Multimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical Trials|Evaluation of Psychoeducation for Cancer Patients Eligible for Clinical Trials|Completed||N/A|418|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 00:47:41.846453|2017-10-11 00:47:41.846453
NCT02054702|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2015-12-01|2015-08-05|2015-06-17|February 2014||2014-02-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia|Protocol 331-13-008: An Exploratory, Multicenter, Open-label, Flexible-dose Brexpiprazole (OPC-34712) Trial in Adults With Acute Schizophrenia|Completed||Phase 3|97|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-10-11 00:47:42.544983|2017-10-11 00:47:42.544983
NCT02054689|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-24|||July 2013||2013-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fractionated Stereotactic Radiosurgery for Large Brain Metastases|PHASE I STUDY OF FRACTIONATED STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES|Recruiting||Phase 1|25|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:47:43.299477|2017-10-11 00:47:43.299477
NCT02054676|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2016-03-01|||February 2014||2014-02-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Validation of the Jawbone Anatomy Classification in Endosseous Dental Implant Treatment|Validation and Clinical Assessment of Clinical and Radiological Classification of the Jawbone Anatomy in Endosseous Dental Implant Treatment|Enrolling by invitation||N/A|80|Anticipated|Lithuanian University of Health Sciences||1|||f||||f||||||||||2017-10-11 00:47:43.398854|2017-10-11 00:47:43.398854
NCT02054663|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-03-28|||December 2013||2013-12-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?|Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not? The CAPITAL OPTI-CROSS Study.|Completed||Phase 4|60|Actual|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 00:47:43.499868|2017-10-11 00:47:43.499868
NCT02054650|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-05-24|||May 2014||2014-05-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus|Osteopathic Manipulative Treatment of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus|Terminated||N/A|23|Actual|University of North Texas Health Science Center||2||Scheduling and recruitment difficulties|f||||t||||||||No||2017-10-11 00:47:43.589868|2017-10-11 00:47:43.589868
NCT02054637|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-31|||April 2014||2014-04-01|January 2014|2014-01-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy|Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy|Unknown status|Not yet recruiting|Phase 2|10|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||t||||||||||2017-10-11 00:47:43.708723|2017-10-11 00:47:43.708723
NCT02054624|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-03-01|||August 2013||2013-08-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|Rural LEAP||Rural Lifestyle Eating and Activity Program (Rural LEAP)|Rural Lifestyle Eating and Activity Program|Active, not recruiting||N/A|508|Actual|University of Florida||3|||f||||t||||||||No||2017-10-11 00:47:43.82954|2017-10-11 00:47:43.82954
NCT02054611|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-09-03|||February 2014||2014-02-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|READS||The Educational ARDS Diagnosis Study|Randomized Educational ARDS Diagnosis Study (READS)|Completed||N/A|600|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 00:47:43.982025|2017-10-11 00:47:43.982025
NCT02054598|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-09-01|||January 2014||2014-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Improving Colon Cancer Screening for Diverse Populations|The CHOICES/OPCIONES Project: Improving Colon Cancer Screening for Diverse Populations|Completed||N/A|265|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-11 00:47:44.072772|2017-10-11 00:47:44.072772
NCT02054585|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2017-02-09|||July 15, 2014||2014-07-15|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||IV NaCl (Sodium Chloride) 0.9% Vs (Versus) IV NaCl 0.9% + 5% Dextrose in Pediatric ER for Dehydration|Intravenous Fluids With or Without Dextrose as Treatment for Dehydration in Children. What's the Formula That Will Bring to a Faster Improvement? A Prospective Randomized Double Blinded Study.|Recruiting||N/A|700|Anticipated|Carmel Medical Center||2|||f||||f||||||||No|after finishing collecting data from 700 patient data will be published analysing groups and not individuals|2017-10-11 00:47:44.192553|2017-10-11 00:47:44.192553
NCT02054572|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2017-03-03|2017-03-03||February 7, 2014|Actual|2014-02-07|March 2017|2017-03-01|August 15, 2014|Actual|2014-08-15|April 15, 2014|Actual|2014-04-15||Interventional|||Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis|An Open-label, Single-dose Study to Evaluate the Pharmacokinetics, Biotransformation and Excretion of [¹⁴C]AMG 416 in Patients With End Stage Renal Disease Receiving Dialysis|Completed||Phase 1|6|Actual|Amgen||1|||f||||f||||||||||2017-10-11 00:47:44.311402|2017-10-11 00:47:44.311402
NCT02054559|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-02-20||||||February 2016|2016-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|ASPIRE||R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL|Randomized Phase III Trial Comparing R-CHOP Alone and R-CHOP Plus Radiotherapy for Localized CD20+ Diffuse Large B-cell Lymphoma (DLBCL)|Withdrawn||Phase 3|0|Actual|Asan Medical Center||2||No consensus among trial centers regarding protocol|f||||t||||||||||2017-10-11 00:47:44.888442|2017-10-11 00:47:44.888442
NCT02054546|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-02-26|||December 2013||2013-12-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||TIMP-2 and IGFBP7 for the Prediction of the Cardiac Surgery Associated Acute Kidney Injury|Novel Biomarkers (TIMP-2 and IGFBP7) of Tubular Renal Cell Damage for the Prediction of the Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) - A Feasibility Study|Completed||N/A|110|Actual|University Hospital, Basel, Switzerland|||1||f||||t||||||||||2017-10-11 00:47:45.003496|2017-10-11 00:47:45.003496
NCT02054533|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-09-11|||February 2014||2014-02-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|PUCCINI||Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease|Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I|Completed||N/A|974|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 00:47:45.094014|2017-10-11 00:47:45.094014
NCT02054520|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-10-28|||June 2014||2014-06-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Immunotherapy Study for Patients With Stage IV Melanoma|A Phase 2b Study of Immune Checkpoint Inhibition With or Without Dorgenmeltucel-L (HyperAcute Melanoma) Immunotherapy for Stage IV Melanoma Patients|Unknown status|Recruiting|Phase 2|100|Anticipated|NewLink Genetics Corporation||6|||f||||||||||||||2017-10-11 00:47:45.254389|2017-10-11 00:47:45.254389
NCT02054507|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-04-07|||April 2013||2013-04-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Interventional|NEORIS||Prematurity Related Risks of Cognitive Impairment at School Age|Prematurity Related Risks of Cognitive Impairment at School Age With Regards to Social, Family and Care Environment|Completed||N/A|100|Actual|Maternite Regionale Universitaire||1|||f||||f||||||||||2017-10-11 00:47:45.517375|2017-10-11 00:47:45.517375
NCT02054494|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-12-09|||July 2013||2013-07-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||T1 Mapping in HIV Patients With High and Low CD4+ Cell Counts|Myocardial T1-mapping and T1-derived Extracellular Volume Fraction (ECV) in HIV-infection Patients With Chronic High and Low CD4+ Counts and in a Healthy Control Group|Recruiting||N/A|100|Anticipated|University Hospital, Bonn|||3||f||||f||||||||||2017-10-11 00:47:45.606746|2017-10-11 00:47:45.606746
NCT02054481|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-07-29|2016-07-29||February 2014||2014-02-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|November 2014|Actual|2014-11-01||Interventional||Safety Set (SAF) which Included all randomised patients who received at least 1 dose of trial medication and was based on the first treatment received.|BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab|A 48 Weeks Study of Three Different Dose Regimens of BI 655066 Administered Subcutaneously in Patients With Moderate to Severe Chronic Plaque Psoriasis (Randomised, Dose-ranging, Active-comparator-controlled (Ustekinumab), Double-blind Within Dose Groups of BI 655066)|Completed||Phase 2|166|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:47:45.71337|2017-10-11 00:47:45.71337
NCT02054468|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-05-07|||March 2012||2012-03-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ROSANNA||Rocuronium Dose Finding Study After Single-shot or Steady-state Propofol Anesthesia|Rocuronium Dose Finding Study After Single-shot or Steady-state Propofol|Completed||N/A|82|Actual|Technische Universität München||2|||f||||t||||||||||2017-10-11 00:47:46.923|2017-10-11 00:47:46.923
NCT02054455|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2014-02-03|||November 2012||2012-11-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Proton Pump Inhibitors and Gastrointestinal Symptoms|Protective Effects of Probiotic Administration on SIBO Development and Bowel Symptom Onset in GERD Patients at Long-term PPI Treatment: a Randomized Controlled Cross-sectional Study|Completed||Phase 4|100|Actual|Federico II University||4|||f||||f||||||||||2017-10-11 00:47:47.072966|2017-10-11 00:47:47.072966
NCT02054442|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-05-31|||August 2016||2016-08-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|COMMENCE||A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck|A Phase Ib-II Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. A Study of the Dutch Head and Neck Society|Recruiting||Phase 1/Phase 2|51|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-11 00:47:47.178696|2017-10-11 00:47:47.178696
NCT02054429|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-02-03|||January 2013||2013-01-01|January 2014|2014-01-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke||Recruiting||Phase 1|100|Anticipated|University at Buffalo||2|||f||||||||||||||2017-10-11 00:47:47.318565|2017-10-11 00:47:47.318565
NCT02054416|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-11-04|||October 2013||2013-10-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|ArtAssist||External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality|External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality in Underserved Philadelphia Patient Population: A Randomized Controlled Study|Recruiting||N/A|120|Anticipated|Temple University||2|||f||||t||||||||||2017-10-11 00:47:47.450209|2017-10-11 00:47:47.450209
NCT02054403|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-02-03|||April 2014||2014-04-01|February 2014|2014-02-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Observational|||Angle Closure (Glaucoma) in Caucasians|Structural and Functional Parameters in Caucasian Patients With Angle Closure on SS-OCT|Unknown status|Not yet recruiting|N/A|100|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-11 00:47:47.61772|2017-10-11 00:47:47.61772
NCT02054390|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-06-19|||February 2014||2014-02-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction|Angiotensin Converting Enzyme Inhibitor Therapy and Periprocedural Myocardial Infarction in Patients With Metabolic Syndrome|Completed||N/A|459|Actual|Ankara University|||1||f||||||||||||||2017-10-11 00:47:47.738631|2017-10-11 00:47:47.738631
NCT02054377|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-09-07|||June 2014||2014-06-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|August 2016|Actual|2016-08-01||Interventional|CFCATS2||Cystic Fibrosis- Children and Adults Tai Chi Study|Cystic Fibrosis- Children and Adults Tai Chi Study: Can Tai Chi Improve Quality of Life for People With Cystic Fibrosis and Their Carers? Second Phase Study|Active, not recruiting||N/A|51|Actual|London South Bank University||2|||f||||t||||||||||2017-10-11 00:47:47.853725|2017-10-11 00:47:47.853725
NCT02054364|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-04-26|||November 2013||2013-11-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Feasibility of Combining Family and Cognitive Therapy to Prevent Chronic Anorexia|Feasibility of Combining Family and Cognitive Therapy to Prevent Chronic Anorexia|Completed||N/A|30|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 00:47:48.021748|2017-10-11 00:47:48.021748
NCT02054351|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-06-30|||December 2013||2013-12-01|June 2017|2017-06-01|March 21, 2017|Actual|2017-03-21|March 2017|Actual|2017-03-01||Interventional|OVAR||Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)|A First-in-human Dose Escalation and Dose Finding Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)|Completed||Phase 1|72|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-10-11 00:47:48.152012|2017-10-11 00:47:48.152012
NCT02054338|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-02-03|||June 2006||2006-06-01|January 2014|2014-01-01|April 2012|Actual|2012-04-01|June 2011|Actual|2011-06-01||Interventional|VICTORIA||A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer|Phase III Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Unresectable, Locally Recurrent or Metastatic Breast Cancer After Prior Anthracycline-based Adjuvant Chemotherapy|Completed||Phase 3|1004|Actual|Pierre Fabre Medicament||2|||f||||t||||||||||2017-10-11 00:47:48.289774|2017-10-11 00:47:48.289774
NCT02054325|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-01|2016-11-30|2014-12-22||September 2012||2012-09-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins|A Randomized Triple-blind Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Sclerotherapy in Treatment of Reticular Veins at the Lower Limbs.|Completed||Phase 4|106|Actual|UPECLIN HC FM Botucatu Unesp||2|||f||||f||||||||Undecided|We intend to present data when publish the original article.|2017-10-11 00:47:48.405672|2017-10-11 00:47:48.405672
NCT02054312|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-02|2015-12-28|||October 2010||2010-10-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||Family Based Interpersonal Psychotherapy (FB-IPT) for Depressed Preadolescents|Phase II Study of Family Based Interpersonal Psychotherapy (FB-IPT) for Depressed Preadolescents|Completed||N/A|42|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 00:47:48.750101|2017-10-11 00:47:48.750101
NCT02054299|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-05-11|||April 2013||2013-04-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PG-OCT||Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1|Effects of Genetic Polymorphisms in the Organic Cation Transporter OCT1 on Cellular Uptake and Metabolism of Antidepressants and Other Organic Cationic Drugs|Completed||Phase 1|48|Actual|University Medical Center Goettingen||1|||f||||f||||||||||2017-10-11 00:47:48.837782|2017-10-11 00:47:48.837782
NCT02054286|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-01|2015-12-08|||December 2012||2012-12-01|December 2015|2015-12-01|March 2019|Anticipated|2019-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).|A Multi-center, Randomized, Double-blind, Placebo-controlled Phase I/II Trial to Compare the Safety, Tolerability and Immunogenicity of the Therapeutic THV01 Vaccination at 5.10E+6 TU (Transducing Unit) , 5.10E+7 TU (Transducing Unit) or 5.10E+8 TU (Transducing Unit) Doses to Placebo in HIV-1 Clade B Infected Patients Under Highly Active Antiretroviral Therapy (HAART)|Active, not recruiting||Phase 1/Phase 2|38|Actual|Theravectys S.A.||3|||f||||t||||||||||2017-10-11 00:47:48.969223|2017-10-11 00:47:48.969223
NCT02054260|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2014-11-18||||||November 2014|2014-11-01||||December 2015|Anticipated|2015-12-01||Interventional|||Surgicel® (Fibrillar) in Non-variceal UGI Bleeding||Unknown status|Recruiting|N/A|||Soonchunhyang University Hospital||1|||f||||||||||||||2017-10-11 00:47:49.4313|2017-10-11 00:47:49.4313
NCT02054221|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2015-07-01|||October 2013||2013-10-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency.|Compare Results of Mitral Valve Replacement or Repair in the Surgical Treatment of Obstructive Hypertrophic Cardiomyopathy With Severe Mitral Insufficiency.|Completed||N/A|82|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-11 00:47:50.273673|2017-10-11 00:47:50.273673
NCT02054208|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-05-30|||February 2014||2014-02-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease|A Double-blind, Single-center, Phase 1/2a Clinical Trial to Evaluate the Safety and Exploratory Efficacy of Intraventricular Administrations of NEUROSTEM® Versus Placebo Via an Ommaya Reservoir in Patients With Alzheimer's Disease|Recruiting||Phase 1/Phase 2|45|Anticipated|Medipost Co Ltd.||3|||f||||f|f|f||||||Undecided||2017-10-11 00:47:50.414246|2017-10-11 00:47:50.414246
NCT02054195|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2014-02-01|||August 2012||2012-08-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|PTKP||Training Model on Insertion Techniques for Postplacental Intra Uterine Device|Study of Special Guided Training Model on Insertion Techniques for Postplacental Intra Uterine Device to Prevent Expulsion|Completed||Phase 4|230|Actual|Showa University||2|||f||||f||||||||||2017-10-11 00:47:50.612499|2017-10-11 00:47:50.612499
NCT02054182|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2014-02-02|||February 2014||2014-02-01|January 2014|2014-01-01|January 2015|Anticipated|2015-01-01|November 2014|Anticipated|2014-11-01||Interventional|||Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection|Effect of Vitamin D Supplementation in Young Children With Acute Lower Respiratory Tract Infection at Dr George Mukhari Academic Hospital, Pretoria, South Africa|Unknown status|Not yet recruiting|Phase 4|320|Anticipated|University of Limpopo||2|||f||||f||||||||||2017-10-11 00:47:50.726181|2017-10-11 00:47:50.726181
NCT02054169|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-02-03|||August 2013||2013-08-01|February 2014|2014-02-01||||August 2013|Actual|2013-08-01||Observational|||Feasibility of the Modified Confusion Assessment Method for the Emergency Department (mCAM-ED)|Pilot Study on the Feasibility of the Modified Confusion Assessment Method for the Emergency Department (mCAM-ED)|Completed||N/A|340|Actual|University Hospital, Basel, Switzerland|||2||f||||f||||||||||2017-10-11 00:47:50.889155|2017-10-11 00:47:50.889155
NCT02054156|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-01|2017-03-07|||June 2014||2014-06-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|OPTIMIZE||OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis|OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial|Active, not recruiting||Phase 3|221|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 00:47:51.004173|2017-10-11 00:47:51.004173
NCT02054143|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-02-03|||November 2012||2012-11-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries|The Effect of Sevoflurane on Cerebral Vasoreactivity Ans Systemic Arteries|Completed||Phase 4|24|Actual|University of Debrecen||1|||f||||t||||||||||2017-10-11 00:47:51.296186|2017-10-11 00:47:51.296186
NCT02054117|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2015-03-04|||March 2014||2014-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Association Between Haptoglobin Genotype and Brain Swelling|Association Between Haptoglobin Genotype and the Development of Perihematomal Edema After Spontaneous Intracerebral Hemorrhage|Terminated||N/A|9|Actual|University of Florida|||1|Principal Investigator is leaving institution.|f||||f||||||||||2017-10-11 00:47:51.8176|2017-10-11 00:47:51.8176
NCT02054104|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-01|2017-08-08|||January 27, 2014||2014-01-27|August 2, 2017|2017-08-02|November 5, 2020|Anticipated|2020-11-05|November 5, 2020|Anticipated|2020-11-05||Interventional|||Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum|Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum|Suspended||Phase 1/Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-11 00:47:51.922128|2017-10-11 00:47:51.922128
NCT02054091|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-09-26|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|PreColos||Feeding Bovine Colostrum to Preterm Infants|Bovine Colostrum as Nutrition for Preterm Infants in the First Days of Life: A Pilot Feasibility Study|Completed||Phase 1/Phase 2|52|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 00:47:52.073137|2017-10-11 00:47:52.073137
NCT02054078|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-02-03|||January 2012||2012-01-01|February 2014|2014-02-01||||March 2014|Anticipated|2014-03-01||Interventional|||Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion|Efficacy and Safety of Intrapleural Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion, A Randomized, Multicenter Study|Unknown status|Recruiting|Phase 2|183|Anticipated|Tang-Du Hospital||2|||f||||t||||||||||2017-10-11 00:47:52.208972|2017-10-11 00:47:52.208972
NCT02054065|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-02-03|||February 2014||2014-02-01|January 2014|2014-01-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|||Effect of CAUTI Prevention Alert - A Randomized Control Trial|Effect of CAUTI Prevention Alert - A Randomized Control Trial|Unknown status|Not yet recruiting|N/A|10830|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 00:47:52.32682|2017-10-11 00:47:52.32682
NCT02054052|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-03-01|||January 2014||2014-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer|Intrapleural Bevacizumab Injection for Treating Malignant Pleural or Pericardial Effusion in Non-small Cell Lung Cancer|Enrolling by invitation||Phase 2|30|Anticipated|Guangzhou Medical University||1|||f||||t||||||||Undecided||2017-10-11 00:47:52.427879|2017-10-11 00:47:52.427879
NCT02054039|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-01|2014-02-23|||February 2013||2013-02-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Incentive Spirometry and Breath Stacking|Comparison Between Incentive Spirometry and Breath Stacking After Cardiac Surgery|Unknown status|Recruiting|Phase 1|118|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 00:47:52.557997|2017-10-11 00:47:52.557997
NCT02054026|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-04-13|||August 2013||2013-08-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Impact Evaluation of the Reducing the Risk Program|Impact Evaluation of the Reducing the Risk Program|Completed||N/A|2220|Actual|Mathematica Policy Research, Inc.||2|||f||||f|f|f||||||||2017-10-11 00:47:52.678784|2017-10-11 00:47:52.678784
NCT02054013|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-07-27|||February 11, 2014|Actual|2014-02-11|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia|Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia: A Prospective Randomized Trial|Active, not recruiting||N/A|101|Actual|Cantonal Hospital of St. Gallen||2|||f||||f||||||||||2017-10-11 00:47:52.800342|2017-10-11 00:47:52.800342
NCT02054000|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-02-01|||January 2011||2011-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Intracoronary Tirofiban on No-Reflow Phenomena|Effectiveness of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Completed||Phase 4|162|Actual|TC Erciyes University||2|||f||||||||||||||2017-10-11 00:47:52.905873|2017-10-11 00:47:52.905873
NCT02053987|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-11-10|||March 2014||2014-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|EESD||Enhanced Early Supported Discharge for Stroke in Camden|Evaluation of the Implementation of an Enhanced ESD Service for Stroke Survivors With Moderate to Severe Impairments and the Resulting Clinical and Cost Outcomes When Compared to Similar Patients in an Unchanged Stroke Care Pathway in a Neighbouring Borough.|Completed||N/A|1|Actual|Camden Clinical Commissioning Group||2|||f||||t||||||||||2017-10-11 00:47:53.024731|2017-10-11 00:47:53.024731
NCT02053974|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-02-01|||September 2011||2011-09-01|February 2014|2014-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Spironolactone Against Anthracycline-induced Cardiomyopathy|Protective Effects of Spironolactone Against Anthracycline Induced Cardiomyopathy|Completed||Phase 4|90|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 00:47:53.135265|2017-10-11 00:47:53.135265
NCT02053961|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-09-15|||February 2015||2015-02-01|September 2014|2014-09-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus.|The Efficacy of dTMS Among Patient Who Suffer From Tinnitus|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Brainsway||2|||f||||t||||||||||2017-10-11 00:47:53.223991|2017-10-11 00:47:53.223991
NCT02053948|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-02-03|||November 2013||2013-11-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|GSICT1126||"Pursestring Wound Closure vs Gunsight Skin Incision and Closure Technique to Reverse Stoma"|"Randomized Clinical Trial of Stoma Reversal Comparing Pursestring Wound Closure vs Gunsight Skin Incision and Closure Technique to Eliminate the Risk of Wound Infection"|Unknown status|Recruiting|N/A|60|Anticipated|Beijing Chao Yang Hospital||2|||f||||f||||||||||2017-10-11 00:47:53.319923|2017-10-11 00:47:53.319923
NCT02053935|ClinicalTrials.gov processed this data on October 10, 2017|2014-02-03|2016-08-05|||December 2013||2013-12-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects|Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects|Completed||Phase 1|15|Actual|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 00:47:53.409628|2017-10-11 00:47:53.409628
NCT02053922|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2014-02-05|||December 2012||2012-12-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)|The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section|Completed||Phase 3|270|Actual|Ain Shams University||3|||f||||t||||||||||2017-10-11 00:47:53.488872|2017-10-11 00:47:53.488872
NCT02053909|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-07-18|||September 2014||2014-09-01|July 2016|2016-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|TARGET||Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis|Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET Trial): Does Ticagrelor Improve Graft Patency After Coronary Bypass?|Recruiting||Phase 4|300|Anticipated|Boca Raton Regional Hospital||2|||f||||f||||||||||2017-10-11 00:47:53.594346|2017-10-11 00:47:53.594346
NCT02053896|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2014-02-03|||May 2011||2011-05-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||A Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease|A Phase 2 Multi-Center, Open-Label, Switch-Over Trial to Evaluate the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase|Completed||Phase 2|5|Actual|ISU Abxis Co., Ltd.|||1||f||||||||||||||2017-10-11 00:47:53.69538|2017-10-11 00:47:53.69538
NCT02053883|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-11-25|||July 2015||2015-07-01|November 2014|2014-11-01||||May 2016|Anticipated|2016-05-01||Interventional|||Cethrin in Acute Cervical Spinal Cord Injury|A Phase II/III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Cethrin in Subjects With Acute Cervical Spinal Cord Injury|Withdrawn||Phase 2/Phase 3|0|Actual|BioAxone BioSciences, Inc.||3||Compound recently partnered with another company for continued development.|f||||||||||||||2017-10-11 00:47:53.759316|2017-10-11 00:47:53.759316
NCT02053870|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-02-03|||September 2009||2009-09-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Lung Sounds as Indicators of Severity and Recovery of Lung Disease|Adventitious Lung Sounds as Indicators of Severity and Recovery of Lung Pathology and Sputum Location|Completed||N/A|98|Actual|Aveiro University||2|||f||||f||||||||||2017-10-11 00:47:53.843672|2017-10-11 00:47:53.843672
NCT02053857|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-09-26|||February 2014||2014-02-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Pilot Study of PUFA-optimized RUTF for Severe Acute Malnutrition|A Randomized, Double-blind Pilot Study of Polyunsaturated Fatty Acid-optimized Ready-to-use Therapeutic Food, Compared to Standard RUTF, in the Therapy of Severe Acute Malnutrition|Completed||N/A|141|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 00:47:53.927437|2017-10-11 00:47:53.927437
NCT02053844|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-08-18|||August 2014||2014-08-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Analyzing the Impact of the Now iKnow Health Care Price Transparency Tool|Analyzing the Impact of the Now iKnow Health Care Price Transparency Tool|Completed||N/A|81000|Actual|Harvard Pilgrim Health Care||2|||f||||f||||||||No||2017-10-11 00:47:54.218963|2017-10-11 00:47:54.218963
NCT02053831|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-03-09|||November 2011||2011-11-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Observational|||GalaFlex Mesh in Facelift|GalaFlex Mesh in Facelift|Completed||N/A|15|Actual|Galatea, Corp|||1||f||||t||||||||||2017-10-11 00:47:54.335486|2017-10-11 00:47:54.335486
NCT02053818|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-08-11|||August 2011||2011-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|PRECON2||Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.|Fast-track in Cardiac Surgery. Remifentanyl & Sufentanil Anaesthesia for CABG+/-AVR Evaluated by Recovery, Cognitive Dysfunction, Haemodynamics (PAC/TTE) and Cardiac Biochemical Markers (CKMB, TNT, Pro-BNP)|Completed||Phase 4|60|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 00:47:54.436868|2017-10-11 00:47:54.436868
NCT02053805|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-04-21|||February 2014||2014-02-01|March 2016|2016-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Prostate Cancer Screening Among Men With High Risk Genetic Predisposition|Personalized Prostate Cancer Screening Among Men With High Risk Genetic Predisposition- a Prospective Cohort Study|Recruiting||N/A|200|Anticipated|Rabin Medical Center||1|||f||||t||||||||Undecided||2017-10-11 00:47:54.599697|2017-10-11 00:47:54.599697
NCT02053779|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-07-18|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|GTMLPSGI||GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT|The Impact of a Single Dose of GnRH Agonist (Triptorelin 0,1 mg) at the Time of Implantation on the Reproductive Outcome in IVF Cycles Triggered by a GnRH Agonist Followed by a Small Bolus of HCG the Day of Oocyte Retrieval|Completed||Phase 3|328|Actual|Centre Hospitalier Universitaire Ibn Rochd||2|||f||||t||||||||||2017-10-11 00:47:55.086851|2017-10-11 00:47:55.086851
NCT02053766|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-04-29|||January 2014||2014-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Anesthesia in Patients With Mitochondrial Disease|Anesthesia in Patients With Mitochondrial Disease|Recruiting||N/A|60|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||f||||||||||2017-10-11 00:47:55.22096|2017-10-11 00:47:55.22096
NCT02053740|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-01-31|||January 2013||2013-01-01|January 2014|2014-01-01||||August 2013|Actual|2013-08-01||Interventional|||Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial||Completed||Phase 4|59|Actual|Tri-Service General Hospital||2|||f||||||||||||||2017-10-11 00:47:55.487484|2017-10-11 00:47:55.487484
NCT02053727|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-06-17|||July 2014||2014-07-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|RA||Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background|Pilot Study to Evaluate Subcutaneous Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background- a Pilot, Double-blind, Placebo-controlled, Randomized, Controlled Trial.|Recruiting||N/A|20|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:47:55.60756|2017-10-11 00:47:55.60756
NCT02053714|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-05-07|||December 2013||2013-12-01|May 2016|2016-05-01|December 31, 2015|Actual|2015-12-31|June 15, 2015|Actual|2015-06-15||Interventional|||Improving Diabetes Outcomes for Persons With Severe Mental Illness|Improving Diabetes Outcomes for Persons With Severe Mental Illness|Completed||N/A|18|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||No||2017-10-11 00:47:55.754831|2017-10-11 00:47:55.754831
NCT02053701|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-04-18|||November 2012||2012-11-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||High-field Brain Magnetic Resonance Spectroscopy|Technical Developments for High-field Brain Magnetic Resonance Spectroscopy|Active, not recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 00:47:55.860321|2017-10-11 00:47:55.860321
NCT02053688|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-02-02|||February 2013||2013-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation Study on Corneal Lens for Vision Correction|Evaluation Study on Corneal Lens for Vision Correction|Completed||N/A|40|Actual|FORSIGHT Vision3||2|||f||||t||||||||||2017-10-11 00:47:55.972939|2017-10-11 00:47:55.972939
NCT02053675|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-01-31|||May 2008||2008-05-01|May 2010|2010-05-01||||April 2013|Actual|2013-04-01||Interventional|||Hemodynamic Effects of Vasopressin in Early Septic Shock Stage|Hemodynamic Effects of Low Doses of Arginine Vasopressin in Early Septic Shock Stage|Completed||N/A|18|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-10-11 00:47:56.106342|2017-10-11 00:47:56.106342
NCT02053662|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-12|||January 21, 2014|Actual|2014-01-21|April 2017|2017-04-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Observational|||Biomarker Identification for Bladder Cancer Patients|Biomarker Identification for Bladder Cancer Patients|Recruiting||N/A|179|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||f||||||Samples With DNA|"     bladder cancer tissue samples, blood, urine   "|||2017-10-11 00:47:56.213574|2017-10-11 00:47:56.213574
NCT02053649|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-17|||January 2014||2014-01-01|April 2017|2017-04-01||||February 2018|Anticipated|2018-02-01||Interventional|||Integrated Chronotherapy for Perinatal Depression|Integrated Chronotherapy for Perinatal Depression|Recruiting||N/A|40|Anticipated|Rhode Island Hospital||2|||f||||t||||||||||2017-10-11 00:47:56.337876|2017-10-11 00:47:56.337876
NCT02053636|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-04-19|||December 2013||2013-12-01|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|March 2017|Actual|2017-03-01||Interventional|FINESSE||A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer|An Open, 3-cohort, Phase II Trial Testing Oral Administration of Lucitanib in Patients With FGFR1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer|Completed||Phase 2|76|Actual|Servier||1|||f||||t||||||||||2017-10-11 00:47:56.47433|2017-10-11 00:47:56.47433
NCT02053623|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-02-22|||April 2, 2015|Actual|2015-04-02|February 2017|2017-02-01|July 2, 2015|Actual|2015-07-02|May 21, 2015|Actual|2015-05-21||Observational|||Evaluation of a Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor|Evaluation of a Novel Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor Against Invasive Intra-Arterial Pressure Monitoring - A Pilot Study|Terminated||N/A|3|Actual|Health Parametrics Inc.|||1|Technical issues & lack of funds|f||||f||||||||||2017-10-11 00:47:56.662152|2017-10-11 00:47:56.662152
NCT02053610|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-05-30|2014-08-15||December 31, 2009|Actual|2009-12-31|May 2017|2017-05-01|August 1, 2017|Anticipated|2017-08-01|August 31, 2013|Actual|2013-08-31||Interventional|||CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)|An Open-label, Multi-center, Three Arm Randomized Study to Investigate the Safety and Efficacy on Progression-free Survival of RO5072759 + Chlorambucil (GClb) Compared to Rituximab + Chlorambucil (RClb) or Chlorambucil (Clb) Alone in Previously Untreated CLL Patients With Comorbidities.|Active, not recruiting||Phase 3|787|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:47:56.828887|2017-10-11 00:47:56.828887
NCT02053597|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-09-16|||October 2014||2014-10-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|TRIUMPH||TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen|A Phase II TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen Composed of Doxorubicin and Paclitaxel|Withdrawn||Phase 2|0|Actual|Jules Bordet Institute||1||"due to evolving scientific knowledge in the field that would make the questions being addressed   in the trial less relevant"|f||||f||||||||||2017-10-11 00:48:01.531667|2017-10-11 00:48:01.531667
NCT02053571|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-02-23|||April 2014||2014-04-01|February 2017|2017-02-01|August 4, 2016|Actual|2016-08-04|August 4, 2016|Actual|2016-08-04||Interventional|||Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure|Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure|Completed||N/A|20|Actual|Medical College of Wisconsin||1|||f||||f||||||||No||2017-10-11 00:48:01.842022|2017-10-11 00:48:01.842022
NCT02053558|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-06-15||||||June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TAP||(TAP) Block vs. Systemic Lidocaine: Effects on Recovery|Tranversus Abdominis Plane (TAP) Block vs. Systemic Lidocaine to Improve Quality of Recovery After Outpatient Laparoscopic Surgery: A Non-inferiority, Randomized, Double Blinded, Placebo Controlled Trial|Withdrawn||N/A|0|Actual|Northwestern University||2||Could not obtain dedicated ultrasound device.|f||||f||||||||||2017-10-11 00:48:01.963814|2017-10-11 00:48:01.963814
NCT02053545|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2016-07-25|||December 2013||2013-12-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion|Haplo-identical Stem Cell Transplantation (SCT) for High-Risk Hematologic Malignancies With Post-Transplant In-Vivo T-cell Depletion|Recruiting||Phase 1/Phase 2|30|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||t||||||||||2017-10-11 00:48:02.119821|2017-10-11 00:48:02.119821
NCT02053532|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-03-02|||May 2013||2013-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|March 2015|Actual|2015-03-01||Observational|||Functional Brain Imaging in PTSD|Functional Brain Imaging in PTSD|Completed||N/A|50|Actual|New York University School of Medicine|||1||f||||t||||||||||2017-10-11 00:48:02.236858|2017-10-11 00:48:02.236858
NCT02053519|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-10-25|||February 2014||2014-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|ViaDUCT||Can Vitamin D Supplementation Improve Hepatitis C Cure Rates|Can Vitamin D Supplementation Improve Hepatitis C Cure Rates : A Pilot Multicentre Randomised Controlled Clinical Trial|Completed||Phase 3|72|Actual|University of Dundee||2|||f||||t||||||||||2017-10-11 00:48:02.356219|2017-10-11 00:48:02.356219
NCT02053506|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-05-01|||January 2014||2014-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Nutrition Interventions to Support the Immune System in Response to Stress|Nutrition Support for Immune Recovery|Completed||N/A|63|Actual|United States Army Research Institute of Environmental Medicine||2|||f||||f||||||||Undecided||2017-10-11 00:48:02.503318|2017-10-11 00:48:02.503318
NCT02053493|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-10-07|2016-02-04||April 2014||2014-04-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|NEAT-HFpeF||Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction|Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction|Completed||Phase 2|110|Actual|Duke University||2|||f||||t||||||||Yes|After the study results have been published, site-specific participant data will be shared with sites upon request. Sites are expected to follow their specific institutional policies regarding sharing results with their participants.|2017-10-11 00:48:02.633991|2017-10-11 00:48:02.633991
NCT02053480|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-06-13|||December 2013||2013-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|2 Years|Observational [Patient Registry]|PKD NHS||Pyruvate Kinase Deficiency Natural History Study|Pyruvate Kinase Deficiency (PKD) Natural History Study|Active, not recruiting||N/A|250|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||No||2017-10-11 00:48:03.552474|2017-10-11 00:48:03.552474
NCT02053467|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-02-20|||January 2014||2014-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|eConsult||Building Capacity for Specialized Services Through eConsultation|Building Capacity for Specialized Services Through eConsultation|Active, not recruiting||N/A|115|Actual|Bruyere Research Institute||2|||f||||f|f|f||||||No||2017-10-11 00:48:03.741308|2017-10-11 00:48:03.741308
NCT02053454|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-05-22|||January 2014||2014-01-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy Volunteers|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose, Safety, Tolerability and Pharmacokinetics Study of ALN-TTR02 in Japanese Healthy Volunteers|Completed||Phase 1|12|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:48:03.858153|2017-10-11 00:48:03.858153
NCT02053441|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-12-08|||January 2013||2013-01-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|January 2016|Anticipated|2016-01-01||Observational|||Modulation of Muscle Protein Synthesis With Diet and Exercise in Old Aged Women|The Efficacy of Leucine Enriched-EAA Supplements vs. Whey Protein in the Modulation of Muscle Protein Synthesis, Albumin Synthesis and Leg/ Muscle Blood Flow in Older Women|Recruiting||N/A|48|Anticipated|University of Nottingham|||1||f||||f||||||Samples With DNA|"     Blood samples for Glucose and RNA analysis Muscle biopsies for protein synthesis   "|||2017-10-11 00:48:03.950153|2017-10-11 00:48:03.950153
NCT02053402|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-30|||March 2014||2014-03-01|January 2014|2014-01-01|April 2015|Anticipated|2015-04-01|January 2015|Anticipated|2015-01-01||Interventional|||Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital|Effect of Vitamin d Supplementation on the Control of Persistent Asthma in Children at Dr George Mukhari Academic Hospital, Pretoria, South Africa|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|University of Limpopo||2|||f||||f||||||||||2017-10-11 00:48:04.200923|2017-10-11 00:48:04.200923
NCT02053389|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-05-28|||November 2010||2010-11-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Testing Decision Aids About Early Stage Prostate Cancer|Promoting Shared Decision Making in Prostate Cancer Through Decision Aids|Completed||N/A|564|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 00:48:04.299137|2017-10-11 00:48:04.299137
NCT02053376|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-09-24|||January 2014||2014-01-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy|A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy|Active, not recruiting||Phase 2|37|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:48:04.403839|2017-10-11 00:48:04.403839
NCT02053363|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-10-31|||March 2014||2014-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Tranexamic Acid Dosing in Adult Spinal Deformity Surgery|Low Versus High Dose Tranexamic Acid in Adult Spinal Deformity Surgery: A Randomized, Blinded, Controlled Trial|Recruiting||Phase 2/Phase 3|60|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:48:04.488105|2017-10-11 00:48:04.488105
NCT02053350|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-06-21|||April 2015||2015-04-01|June 2017|2017-06-01|April 5, 2017|Actual|2017-04-05|April 5, 2017|Actual|2017-04-05||Interventional|||Efficacy Study of Alanyl-glutamine Supplementation for the Treatment of C. Difficile Infection|Alanyl-glutamine Supplementation of Standard Treatment of C. Difficile Infection: A Single Trial|Terminated||Phase 2|7|Actual|University of Virginia||1||Funding ended|f||||f||||||||No||2017-10-11 00:48:04.595045|2017-10-11 00:48:04.595045
NCT02053337|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-09-16|||May 2014||2014-05-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A RCT to Compare Performance of Two Foam Dressings on Patient Well-being Related Endpoints.|A Randomised Cross-over Clinical Evaluation to Compare Performance of ALLEVYN◊ Life and Mepilex™ Border Dressings on Patient Well-being Related Endpoints.|Completed||N/A|60|Actual|Smith & Nephew Medical Ltd||2|||f||||f||||||||||2017-10-11 00:48:04.679887|2017-10-11 00:48:04.679887
NCT02053324|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-06-13|||November 11, 2013|Actual|2013-11-11|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||AvidinOX + [177Lu]DOTA-biotin (or 177Lu-ST2210) Complex in Patients With Liver Metastases From Colorectal Cancer|A Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, Dosimetry, Maximum Tolerated Dose and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by Systemic IV Administration of Escalating Doses of [177Lu]DOTA-biotin in Patients With Liver Metastases From Colorectal Cancer|Recruiting||Phase 1|30|Anticipated|sigma-tau i.f.r. S.p.A.||1|||f||||t||||||||Undecided||2017-10-11 00:48:04.765442|2017-10-11 00:48:04.765442
NCT02053311|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-07-19|||August 19, 2014|Actual|2014-08-19|July 2017|2017-07-01|August 19, 2034|Anticipated|2034-08-19|August 19, 2014|Actual|2014-08-19||Interventional|||Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents|Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Previously Treated With Novel Hormonal Agents and Non-progressive Disease After Treatment With a Taxane: A Multicentre Randomized Double-blind Placebo-controlled Phase III Trial|Suspended||Phase 3|218|Anticipated|Swiss Group for Clinical Cancer Research||2||"The decision follows the results of 2 phase 3 clinical trials in metastatic, castration   resistant prostate cancer (mCRPC)."|f||||f||||||||||2017-10-11 00:48:04.883867|2017-10-11 00:48:04.883867
NCT02053298|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-12-02|||January 2014||2014-01-01|January 2014|2014-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients|Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients|Unknown status|Recruiting|Phase 4|30|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 00:48:04.988656|2017-10-11 00:48:04.988656
NCT02053285|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-08-29|||January 2014||2014-01-01|August 2014|2014-08-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer|Pilot Study of Dual-Energy Computed Tomography in Stage III Non-Small Cell Lung Cancer|Unknown status|Recruiting|N/A|20|Anticipated|Rush University Medical Center|||1||f||||f||||||||||2017-10-11 00:48:05.122683|2017-10-11 00:48:05.122683
NCT02053272|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-09-02|||February 2014||2014-02-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes|A Randomised, Double Blind, Placebo Controlled, Parallel Group, Dose Ranging Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes|Completed||Phase 2|207|Actual|GW Research Ltd||4|||f||||f||||||||||2017-10-11 00:48:05.223144|2017-10-11 00:48:05.223144
NCT02053259|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-07-11|||February 2014||2014-02-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|December 2014|Actual|2014-12-01||Interventional|WalkIT||A Walking Intervention Through Text Messaging|Walking Intervention Through Texting Study: A Factorial Trial|Active, not recruiting||N/A|100|Anticipated|Arizona State University||4|||f||||f||||||||||2017-10-11 00:48:05.385451|2017-10-11 00:48:05.385451
NCT02053246|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-03-23|||January 2014||2014-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure|Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure|Recruiting||Phase 4|40|Anticipated|University of Florida||1|||f||||f|f|f||||||Undecided||2017-10-11 00:48:05.46325|2017-10-11 00:48:05.46325
NCT02053220|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-09-08|||June 2013||2013-06-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Interventional|MOA||Mechanism of Action Trial of ColoAd1|A Phase 1 Clinical Study of Intra-tumoural Injection or Intravenous Infusion of a Group B Oncolytic Adenovirus (ColoAd1) in Patients With Cancer Who Are Candidates for Resection of Primary Tumour|Completed||Phase 1|17|Actual|PsiOxus Therapeutics Ltd||2|||f||||f||||||||||2017-10-11 00:48:05.77625|2017-10-11 00:48:05.77625
NCT02053207|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-06-20|||July 2017|Anticipated|2017-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|Cog-Train||Feasibility Study of Preoperative Cognitive Training in Cardiac Surgical Patients|The Cog-Train Feasibility Study: a Single-arm Trial Investigating the Feasibility of a Preoperative Cognitive Training Intervention (Cog-Train) in Cardiac Surgical Patients|Not yet recruiting||N/A|10|Anticipated|Papworth Hospital NHS Foundation Trust||1|||f||||f|f|f||||||No||2017-10-11 00:48:05.878776|2017-10-11 00:48:05.878776
NCT02053194|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-07-18|||March 2014||2014-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|D-PRESCRIBE||A Trial to De-prescribe Inappropriate Medications in the Community Dwelling Elderly|Developing Pharmacist-led Research to Educate and Sensitive Community Residents to the Inappropriate Prescription Burden in the Elderly|Enrolling by invitation||Phase 4|400|Anticipated|Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal||2|||f||||t||||||||||2017-10-11 00:48:05.989704|2017-10-11 00:48:05.989704
NCT02053181|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-01-31|||August 2012||2012-08-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection|A Phase 1, Open-label, Single Oral Dose Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Cadazolid in Patients With Severe Clostridium Difficile Infection (CDI)|Completed||Phase 1|6|Actual|Actelion||1|||f||||f||||||||||2017-10-11 00:48:06.07471|2017-10-11 00:48:06.07471
NCT02053168|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-04-11|||February 2014||2014-02-01|April 2017|2017-04-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|||A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair|A Prospective, Multicenter All Comers Study of a Novel Resorbable Mesh (Phasix Mesh) for Ventral or Incisional Hernia Repair|Completed||N/A|33|Actual|C. R. Bard||1|||f||||f||||||||Undecided||2017-10-11 00:48:06.178147|2017-10-11 00:48:06.178147
NCT02053155|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-12-03|||July 2013||2013-07-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Peri Operative Smoking Cessation Program|Development and Implementation of a Peri Operative Smoking Cessation Program With Computer Based Patient Education.|Completed||N/A|345|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 00:48:06.310988|2017-10-11 00:48:06.310988
NCT02053142|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-09-13|||January 2009||2009-01-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women|Prospective Study of Pharmacokinetics, Clinical and Virologic Response to Acyclovir Episodic Therapy for Genital Herpes Ulcers in HIV Negative African Women|Completed||N/A|74|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 00:48:06.407697|2017-10-11 00:48:06.407697
NCT02053129|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-09-13|||November 2011||2011-11-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|October 2012|Actual|2012-10-01||Interventional|||Evaluation of PTB Screening in ANC in Lusaka, Zambia|Pilot Evaluation of Pulmonary Tuberculosis Screening in Antenatal Clinics in Lusaka, Zambia|Completed||N/A|5033|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:48:06.541682|2017-10-11 00:48:06.541682
NCT02053116|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-03-29||2016-03-29|March 2014||2014-03-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin|A 6-week Phase 2a Randomized, Double-Blind, Placebo-Controlled Study To Assess Safety, Tolerability And Pharmacodynamics Of Oral PF-05175157 Administered With Canagliflozin In Adult Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 2|8|Actual|Pfizer||2||"On 25April2014, study was terminated before any dosing due to an AE of safety concern that   occurred in protocol B1731003 with the same drug."|f||||f||||||||||2017-10-11 00:48:06.65598|2017-10-11 00:48:06.65598
NCT02053103|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-03-29||2016-03-29|March 2014||2014-03-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin|A 6-Week Phase 2a Randomized, Double-Blind, Placebo-Controlled Study To Assess Safety, Tolerability And Pharmacodynamics Of Oral PF-05175157 In Adult Subjects With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin|Terminated||Phase 2|13|Actual|Pfizer||2||"On 25April2014, study was terminated before any dosing due to an AE of safety concern that   occurred in protocol B1731003 with the same drug."|f||||f||||||||||2017-10-11 00:48:06.751667|2017-10-11 00:48:06.751667
NCT02053090|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-09-22|||August 2014||2014-08-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Complementary and Alternative Medicine (CAM) for Fibromyalgia||Completed||N/A|431|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 00:48:06.848471|2017-10-11 00:48:06.848471
NCT02053077|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-03-31|||February 2014||2014-02-01|March 2017|2017-03-01|June 26, 2016|Actual|2016-06-26|June 2016|Actual|2016-06-01||Observational|||Risk Identification of the GlucoTab System in Routine Use|A Study to Identify Risks in Routine Use of the GlucoTab System for Glycaemic Management in Non-critically Ill Patients With Type 2 Diabetes at General Wards|Completed||N/A|152|Actual|Medical University of Graz|||1||f||||t||||||||||2017-10-11 00:48:06.934224|2017-10-11 00:48:06.934224
NCT02053064|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-06-19|||May 2013||2013-05-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|||Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy|Long-term Follow-up of Patients With Sanfilippo Type A Syndrome Who Have Previously Been Treated in the P1-SAF-301 Clinical Study Evaluating the Tolerability and Safety of the Intracerebral Administration of SAF-301.|Completed||Phase 1/Phase 2|4|Actual|LYSOGENE||1|||f||||t||||||||||2017-10-11 00:48:07.007837|2017-10-11 00:48:07.007837
NCT02053051|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-05-27|||September 2013||2013-09-01|May 2013|2013-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|ABC4D||Advanced Bolus Calculator for Type 1 Diabetes (ABC4D)|Clinical Assessment of an Advanced Bolus Calculator for Type 1 Diabetes (ABC4D)|Unknown status|Recruiting|N/A|176|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 00:48:07.125839|2017-10-11 00:48:07.125839
NCT02053038|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-02-01|||January 2014||2014-01-01|January 2017|2017-01-01|December 16, 2020|Anticipated|2020-12-16|January 19, 2017|Actual|2017-01-19||Interventional|DEFINE-FLAIR||Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation|Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR|Active, not recruiting||N/A|2500|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 00:48:07.239024|2017-10-11 00:48:07.239024
NCT02053025|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-08-26|||March 2010||2010-03-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|mycoprotein||Appetite Regulation and Mycoprotein|Appetite Regulation and Mycoprotein|Completed||N/A|50|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 00:48:07.427601|2017-10-11 00:48:07.427601
NCT02053012|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2017-03-15|||January 2014||2014-01-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Observational|||Investigating Reaction Time Among Children Who Snore||Enrolling by invitation||N/A|500|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:48:07.514928|2017-10-11 00:48:07.514928
NCT02052999|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2014-01-31|||February 2013||2013-02-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients|An Open Label Pilot Study to Evaluate the Efficacy of PAC-14028 in the Treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea|Completed||Phase 2|80|Actual|Amorepacific Corporation||3|||f||||t||||||||||2017-10-11 00:48:07.585758|2017-10-11 00:48:07.585758
NCT02052986|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-01-31||||||January 2014|2014-01-01||||January 2015|Anticipated|2015-01-01||Interventional|CARE||An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels||Unknown status|Not yet recruiting|Phase 2|100|Anticipated|New York Hospital Queens||1|||f||||||||||||||2017-10-11 00:48:07.682528|2017-10-11 00:48:07.682528
NCT02052973|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-07-20|||September 2014||2014-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy of Propolis Varnish Against Oral Biofilm|Efficacy of Brazilian Green Propolis Varnish Against Streptococcus Mutans in Saliva: a Phase II Study.|Completed||Phase 1/Phase 2|11|Actual|Federal University of Minas Gerais||1|||f||||f||||||||||2017-10-11 00:48:07.821045|2017-10-11 00:48:07.821045
NCT02052960|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-07-25|||January 2014||2014-01-01|July 2017|2017-07-01|December 15, 2017|Anticipated|2017-12-15|September 30, 2017|Anticipated|2017-09-30||Interventional|RESGEX||CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer|Randomized, Controlled, Open Label, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of CetuGEX™ Plus CT in Comparison to Cetuximab Plus CT in Patients With Stage III/IV Recurrent and/or Metastatic SCCHN|Active, not recruiting||Phase 2|240|Actual|Glycotope GmbH||2|||f||||t||||||||||2017-10-11 00:48:07.931838|2017-10-11 00:48:07.931838
NCT02052947|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-08-22|||January 2014||2014-01-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|July 2018|Anticipated|2018-07-01||Interventional|CLEM||Co-LEsions in Alzheimer Disease and Related Disorders|Co-LEsions in Alzheimer Disease and Related Disorders|Recruiting||N/A|214|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:48:08.127559|2017-10-11 00:48:08.127559
NCT02052934|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-02-09|||March 10, 2014|Actual|2014-03-10|December 7, 2016|2016-12-07|November 2, 2016|Actual|2016-11-02|November 2, 2016|Actual|2016-11-02||Interventional|||Safety of Sublingual dmLT for ETEC|A Phase 1 Dose Escalating Study of Double Mutant Heat-Labile Toxin LTR192G/L211A (dmLT) From Enterotoxigenic Escherichia Coli (ETEC) by Sublingual or Oral Immunization to Determine Safety and Immunogenicity of a Multi-dose Regimen in Adult Humans|Completed||Phase 1|80|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f|||||t|f|||f|||||2017-10-11 00:48:08.213147|2017-10-11 00:48:08.213147
NCT02052921|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2016-05-31|||November 2011||2011-11-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy|Open Randomized Study of Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy|Recruiting||Phase 2|150|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||f||||||||||2017-10-11 00:48:08.304465|2017-10-11 00:48:08.304465
NCT02052908|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-09-04|||January 27, 2014|Actual|2014-01-27|August 2017|2017-08-01||||August 23, 2017|Actual|2017-08-23||Interventional|||Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome|A Phase Ib Biomarker Trial of Naproxen in Patients at Risk for DNA Mismatch Repair Deficient Colorectal Cancer|Active, not recruiting||Phase 1|86|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-10-11 00:48:08.402722|2017-10-11 00:48:08.402722
NCT02052895|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-10-13|2016-08-04||January 2014||2014-01-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational||Subjects who didn't meet inclusion/exclusion criteria were excluded.|Utility of Presepsin in Distinguishing Between Sepsis and SIRS|Utility of Presepsin in Distinguishing Between Sepsis and SIRS (Systemic Inflammatory Response Syndrome): an Exploratory, Prospective Observational Study in Critically Ill Patients|Completed||N/A|226|Actual|Mochida Pharmaceutical Company, Ltd.|||3||f||||f||||||Samples Without DNA|"     Blood plasma Blood serum   "|||2017-10-11 00:48:08.527905|2017-10-11 00:48:08.527905
NCT02052882|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-03-08|||January 30, 2014||2014-01-30|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Romiplostim for Chemotherapy Induced Thrombocytopenia|An Open Label Phase II Study of Romiplostim for Chemotherapy Induced Thrombocytopenia|Recruiting||Phase 2|64|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:48:08.805457|2017-10-11 00:48:08.805457
NCT02052869|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-30|||January 2014||2014-01-01|January 2014|2014-01-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Spirometric Detection of Esophageal Intubation|Spirometric Detection of Esophageal Intubation|Unknown status|Not yet recruiting|N/A|60|Anticipated|University Medical Center Groningen||1|||f||||f||||||||||2017-10-11 00:48:08.948968|2017-10-11 00:48:08.948968
NCT02052856|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-09-25|||December 2012||2012-12-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Observational|||Anterior Cruciate Ligament (ACL) Tunnel Widening Comparing All-inside and Interference Screw Fixation Technique|Interference Screw Fixation Versus All-Inside Suspensory Fixation Method Comparing Radiographic Tunnel Widening in Anatomic Single Bundle Anterior Cruciate Ligament (ACL) Reconstruction.|Completed||N/A|40|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 00:48:09.046967|2017-10-11 00:48:09.046967
NCT02052830|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-13|||August 2013|Actual|2013-08-01|September 2015|2015-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Impact Evaluation of the Wise Guys Program|Impact Evaluation of the Wise Guys Program|Active, not recruiting||N/A|737|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-11 00:48:09.41288|2017-10-11 00:48:09.41288
NCT02052817|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-01-30|||December 2013||2013-12-01|January 2014|2014-01-01||||May 2014|Anticipated|2014-05-01||Interventional|||Randomized, Prospective Evaluation of the Toad Brace in Plantar Ulcer Off-loading and Healing|Randomized, Prospective Evaluation of the Toad Brace in Plantar Ulcer Off-loading and Healing|Unknown status|Recruiting|N/A|74|Anticipated|Toad Medical Corporation||2|||f||||t||||||||||2017-10-11 00:48:09.502763|2017-10-11 00:48:09.502763
NCT02052804|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-05-19|||April 2009||2009-04-01|November 2015|2015-11-01||||December 2015|Actual|2015-12-01||Observational|Alberta HEART||Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics|Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics|Active, not recruiting||N/A|700|Anticipated|University of Alberta|||1||f||||f||||||||||2017-10-11 00:48:09.619759|2017-10-11 00:48:09.619759
NCT02052791|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-03-22|||January 2014||2014-01-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246)|An Open-label Study to Assess the Safety and Tolerability of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in 396443-CS2 or 396443-CS10|Completed||Phase 1|47|Actual|Biogen||1|||t||||t||||||||||2017-10-11 00:48:09.713873|2017-10-11 00:48:09.713873
NCT02052778|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-06-15|||July 2014||2014-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||A Dose Finding Study Followed by a Safety and Efficacy Study in Patients With Advanced Solid Tumors or Multiple Myeloma With FGF/FGFR-Related Abnormalities|A Dose-Finding Phase 1 Study of TAS-120 in Patients With Advanced Solid Tumors With or Without Fibroblast Growth Factor/Receptor (FGF/FGFR)-Related Abnormalities Followed By A Phase 2 Study in Patients With Advanced Solid Tumors or Multiple Myeloma With FGF/FGFR-Related Abnormalities|Recruiting||Phase 1/Phase 2|835|Anticipated|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-10-11 00:48:09.822283|2017-10-11 00:48:09.822283
NCT02052765|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-01-30|||February 2011||2011-02-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||AnalyST & Brugada Syndrome - Feasibility Study|AnalyST & Brugada Syndrome - Feasibility Study|Completed||N/A|16|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 00:48:09.959164|2017-10-11 00:48:09.959164
NCT02052752|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-05-14|2015-01-08||February 2014||2014-02-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions|A Randomized, Double-blinded Study to Evaluate the Ability of an Acne Treatment Product to Produce Visible Improvements in Acne Lesions Over a 5 Day Period of Once-daily Use|Completed||Phase 4|90|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:48:10.102028|2017-10-11 00:48:10.102028
NCT02052739|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-04-25||2017-04-25|January 2014||2014-01-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SRSE||Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus|An Open-label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus|Completed||Phase 1/Phase 2|25|Actual|Sage Therapeutics||1|||f||||t||||||||||2017-10-11 00:48:10.703781|2017-10-11 00:48:10.703781
NCT02052726|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-06-09|||January 2014||2014-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.|A Phase 1, Placebo-controlled, Randomized, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of An Adjuvanted Clostridium Difficile Vaccine Administered As A 3-dose Regimen In Healthy Adults Aged 50 To 85 Years|Completed||Phase 1|184|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 00:48:10.844971|2017-10-11 00:48:10.844971
NCT02052713|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-05-10|||February 19, 2014|Actual|2014-02-19|May 2017|2017-05-01|December 29, 2014|Actual|2014-12-29|December 29, 2014|Actual|2014-12-29||Interventional|||Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State|A Single-Dose, Randomised, Open-Label, Two-Period Crossover Study to Determine the Bioequivalence of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in the Fasted State in Healthy Adult Male Subjects|Completed||Phase 1|78|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:48:11.001932|2017-10-11 00:48:11.001932
NCT02052687|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-05-14|||January 2014||2014-01-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453|A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453, After Multiple Topical Applications in Healthy Volunteers.|Completed||Phase 1|41|Actual|Novartis||6|||f||||f||||||||||2017-10-11 00:48:11.102773|2017-10-11 00:48:11.102773
NCT02052674|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-04-28|||March 2015||2015-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Retained Urine Volume and Bacteriuria in Traditional Versus Vented Urine Drainage Systems|Retained Urine Volume and Bacteriuria in Traditional Versus Vented Urine Drainage Systems|Withdrawn||Phase 1|0|Actual|University of Florida||2||Unable to enroll any patients in the study due to other on-going studies.|f||||f||||||||||2017-10-11 00:48:11.223478|2017-10-11 00:48:11.223478
NCT02052661|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-24|2015-07-31||February 18, 2014||2014-02-18|April 2017|2017-04-01|September 23, 2014|Actual|2014-09-23|September 23, 2014|Actual|2014-09-23||Interventional|||This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa|Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of GSK Biologicals' Hepatitis B Vaccine Engerix™-B Kinder (SKF103860) Challenge Dose in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa (SB217744) During Infancy|Completed||Phase 4|301|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:48:11.326961|2017-10-11 00:48:11.326961
NCT02052648|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-11-02|||March 2014||2014-03-01|November 2016|2016-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors|A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors|Recruiting||Phase 1/Phase 2|144|Anticipated|NewLink Genetics Corporation||4|||f||||t||||||||||2017-10-11 00:48:11.701096|2017-10-11 00:48:11.701096
NCT02052635|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-04-28|2016-03-08||September 2014||2014-09-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|NSTE-ACS||Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.|A Phase IV, Randomised, Multi-Centre, Open Label Study, Comparing Ticagrelor Versus Clopidogrel in Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Patients Undergoing Percutaneous Coronary Intervention (PCI) With Bivalirudin|Terminated||Phase 4|34|Actual|AstraZeneca|The target sample size for this study was 100 patients. But due to recruitment challenges and low enrolment,the study was terminated early with only 13 pateints randomized. No formal statistical analyses were performed.|2||"Patient recruitment challenges, low enrolment, and a forecasted inability to complete the study   in an acceptable timeframe"|f||||f||||||||||2017-10-11 00:48:11.971178|2017-10-11 00:48:11.971178
NCT02052622|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-06-06|||February 2012||2012-02-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101|Long-term, Follow-up Study of Subjects Who Completed Phase 3 Trials ATX-101-10-16 or ATX-101-10-17 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area|Completed||Phase 3|201|Actual|Kythera Biopharmaceuticals||3|||f||||f||||||||||2017-10-11 00:48:12.24225|2017-10-11 00:48:12.24225
NCT02052609|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-01-03|||February 2014||2014-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 3 Clinical Study of KHK 4827|An Extension Study of KHK4827 in Subjects With Plaque Psoriasis (Psoriasis Vulgaris, Psoriatic Arthritis), Pustular Psoriasis (Generalized) and Psoriatic Erythroderma|Completed||Phase 3|155|Actual|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||||2017-10-11 00:48:12.358724|2017-10-11 00:48:12.358724
NCT02052583|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-08-31|||March 2014||2014-03-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|September 2015|Anticipated|2015-09-01||Interventional|CARBOXHYD||Cardiac ARrest : Brain OXymetry Depending on HYpothermia Depth|Evaluation de l'oxymétrie cérébrale à Deux Niveaux d'Hypothermie thérapeutique après arrêt Cardiaque Extra-hospitalier|Unknown status|Recruiting|N/A|70|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 00:48:12.592607|2017-10-11 00:48:12.592607
NCT02052570|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-02-02|||January 2014||2014-01-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||School Reintegration After Pediatric Hematopoietic Stem Cell Transplant|School Reintegration After Pediatric Hematopoietic Stem Cell Transplant: Experiences of Children, Parents, Teachers and Providers|Withdrawn||N/A|0|Actual|Duke University|||4|Unable to meet all criteria as outlined for participants|f||||t||||||||||2017-10-11 00:48:12.692793|2017-10-11 00:48:12.692793
NCT02052557|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-01-30|||February 2013||2013-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery|The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery|Completed||Phase 4|56|Actual|Des Moines University||2|||f||||f||||||||||2017-10-11 00:48:12.758524|2017-10-11 00:48:12.758524
NCT02052544|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-05-04|2015-02-27||April 2012||2012-04-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational||144 subjects signed ICF. 4 out of 144 failed in/exclusion criteria 123 subjets are part of the AVS (all valid subjects) population. All 123 UFH treated study subjects had previous and concomitant medications and treatments.|Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device|Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device|Completed||N/A|123|Actual|DSM Nutritional Products, Inc.|||1||f||||f||||||||||2017-10-11 00:48:12.852358|2017-10-11 00:48:12.852358
NCT02052531|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-31|2015-09-11|||January 2013||2013-01-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus|A Phase II, Single Center, Double-blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of PAC-14028 Cream in Dermal Pruritus|Completed||Phase 2|74|Actual|Amorepacific Corporation||3|||f||||t||||||||||2017-10-11 00:48:13.105425|2017-10-11 00:48:13.105425
NCT02052518|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-02-28|||June 2013||2013-06-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|ECHO||Early Childhood Obesity Prevention Program|Early Childhood Obesity Prevention Program: Building Better Families and Communities|Completed||N/A|57|Actual|Connecticut Children's Medical Center||2|||f||||t||||||||Yes|When final analysis has been completed and manuscripts have been published, data will be made available upon request to other investigators|2017-10-11 00:48:13.200971|2017-10-11 00:48:13.200971
NCT02052505|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-01-04|||October 2014||2014-10-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Reducing Inappropriate Prescribing for Psychiatric Patients Using Nurse-led Medication Reviews|Reducing Inappropriate Prescribing for Psychiatric Patients Using Nurse-led Medication Reviews - an Interventional Study|Completed||N/A|411|Actual|Aalborg University||2|||f||||f||||||||||2017-10-11 00:48:13.311842|2017-10-11 00:48:13.311842
NCT02052492|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-06-18|||May 2014||2014-05-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors|A PHASE I, OPEN LABEL, DOSE-ESCALATION TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF EF-022 (MODIFIED VITAMIN D BINDING PROTEIN MACROPHAGE ACTIVATOR) IN SUBJECTS WITH ADVANCED SOLID MALIGNANCIES|Completed||Phase 1|24|Actual|Efranat Ltd.||4|||f||||||||||||||2017-10-11 00:48:13.3961|2017-10-11 00:48:13.3961
NCT02052479|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-02-02|||January 2014||2014-01-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)|Differences in Insulin Secretion and Insulin Sensitivity/Resistance in African-American and Caucasian Adolescent Females With Polycystic Ovary Syndrome|Unknown status|Recruiting|Early Phase 1|30|Anticipated|Nationwide Children's Hospital||2|||f||||||||||||||2017-10-11 00:48:13.663014|2017-10-11 00:48:13.663014
NCT02052466|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-05-06|2016-10-26||January 2014||2014-01-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Observational|||Prediction of Development of Scapular Notching Following Reverse Total Shoulder Arthroplasty|Prediction of Development of Scapular Notching Based on Glenosphere Positioning, Scapular Morphology, and Simulated Impingement-free Motion Using Three-dimensional Computed Tomography Analysis|Completed||N/A|32|Actual|The Cleveland Clinic|Relatively small sample size. Range of motion was measured at minimum 2 year follow-up, not pre-operatively.||1||f||||f||||||||No||2017-10-11 00:48:13.825925|2017-10-11 00:48:13.825925
NCT02052453|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-07-26|||February 2014||2014-02-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|3 Months|Observational [Patient Registry]|||ICD-ON Registry: Periop Management of Cardiac Devices|ICD-ON Registry: Perioperative Management of Pacemakers and Implanted Cardioverter Defibrillators|Completed||N/A|350|Actual|Edward-Elmhurst Health System|||1||f||||f||||||||||2017-10-11 00:48:14.20005|2017-10-11 00:48:14.20005
NCT02052440|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-06-15|||March 15, 2014||2014-03-15|June 2017|2017-06-01|January 1, 2017|Actual|2017-01-01|January 1, 2017|Actual|2017-01-01||Interventional|||Preventing Alcohol Withdrawal Syndrome With Oral Baclofen|Preventing Alcohol Withdrawal Syndrome With Oral Baclofen: A Randomized, Placebo Controlled Trial|Terminated||Phase 3|102|Actual|Denver Health and Hospital Authority||2||Insufficient funding to complete with low enrollment rate|f||||f||||||||No|No plan to share individual patient data|2017-10-11 00:48:14.290792|2017-10-11 00:48:14.290792
NCT02052427|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-10-26|||January 2014||2014-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2015|Actual|2015-08-01||Interventional|ATHENA II||Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)|Adipose-derived Regenerative Cells in the Treatment of Patients With Chronic Ischemic Heart Disease Not Amenable to Surgical or Interventional Revascularization II|Completed||Phase 2|3|Actual|Cytori Therapeutics||2|||f||||t||||||||||2017-10-11 00:48:14.391162|2017-10-11 00:48:14.391162
NCT02052414|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-09-01|2015-07-28||July 2012||2012-07-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|Gralise||Study of Gralise to Treat Fibromyalgia Patients|Open Labeled, Non-randomized, Study of Efficacy and Safety of Gralise in Fibromyalgia Patients.|Completed||N/A|34|Actual|The Center for Clinical Research, Winston-Salem, NC|small sample size, geographical bias, relatively short duration of treatment, open label, single arm study without a control group.|1|||f||||t||||||||No|No individual participants data will be shared with anyone who is not a member of the study staff, and all records containing individual data and their protected health information will remain confidential in accordance with the HIPAA rules.|2017-10-11 00:48:14.536309|2017-10-11 00:48:14.536309
NCT02052401|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-02-01|||February 2014||2014-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Domiciliary Intervention by Occupational Therapy to Prevent Elderly Rehospitalization|Domiciliary Intervention by Occupational Therapy After Hospital Discharge, to Prevent Rehospitalization in Elderly: Randomized Clinical Trial|Completed||Phase 3|206|Actual|Comisión Nacional de Investigación Científica y Tecnológica||2|||f||||t||||||||||2017-10-11 00:48:14.996524|2017-10-11 00:48:14.996524
NCT02052388|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-05-19|||February 2014||2014-02-01|August 2014|2014-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections|A Randomized, Double-Blind Study Comparing Three Dosing Regimens of Brilacidin to Daptomycin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)|Completed||Phase 2|215|Actual|Cellceutix Corporation||4|||f||||t||||||||||2017-10-11 00:48:15.116467|2017-10-11 00:48:15.116467
NCT02052375|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-02-05|||June 2012||2012-06-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate|Completed||Phase 1|24|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 00:48:15.236454|2017-10-11 00:48:15.236454
NCT02052362|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-02-17|||January 2014||2014-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Bioavailability of ABT-450 and ABT-267 With Ritonavir|A Phase I, Open-Label, Single Centre Study Designed to Determine the Absolute Bioavailability of ABT-450 (150 mg) and ABT-267 (25 mg) When Administered as an Oral Co-Formulated Product With Ritonavir (100 mg), ABT 450/r/ABT 267, to Healthy Adult Subjects|Completed||Phase 1|16|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 00:48:15.348077|2017-10-11 00:48:15.348077
NCT02052349|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-01-30|||November 2013||2013-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects|A Phase I, Open-Label Study to Investigate the Regional Bioavailability of ABT-333 When Delivered to Different Sites Within the Gastrointestinal Tract in Healthy Subjects|Completed||Phase 1|12|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 00:48:15.456186|2017-10-11 00:48:15.456186
NCT02052336|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-12-13|||October 2013||2013-10-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|January 2014|Actual|2014-01-01||Interventional|||Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects|An Open-label, Randomized, 6-Sequence, 3-Period Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between CJ-12420 and Clarithromycin in Healthy Male Subjects|Completed||Phase 1|24|Actual|CJ HealthCare Corporation||3|||f||||f||||||||Undecided||2017-10-11 00:48:15.556691|2017-10-11 00:48:15.556691
NCT02052323|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-01-22|||October 2013||2013-10-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Harmonized AS/MQ Efficacy Study - Thailand|Study to Determine the Efficacy of Artesunate-mefloquine Combination Therapy for the Treatment of Uncomplicated P. Falciparum Malaria in Thailand|Completed||Phase 4|48|Actual|Armed Forces Research Institute of Medical Sciences, Thailand||1|||f||||f||||||||||2017-10-11 00:48:15.653903|2017-10-11 00:48:15.653903
NCT02052310|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-05-04|||December 2013||2013-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|Himalayas||Safety and Efficacy Study for Treatment of Anemia in ESRD Newly Initiated Dialysis Patients|Phase 3, Multicenter, Randomized, Open-Label,Active-Controlled Study of the Efficacy and Safety of FG-4592 (Roxadustat) in the Treatment of Anemia in Incident-Dialysis Patients|Recruiting||Phase 3|900|Anticipated|FibroGen||2|||f||||t||||||||||2017-10-11 00:48:15.767239|2017-10-11 00:48:15.767239
NCT02052297|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-03-17|||January 2014||2014-01-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Validation and Dosimetry Study of GSK2634673F PET Ligand|Validation and Dosimetry Study of [18F]-FBA-A20FMDV2 PET Ligand for Alpha(V)beta6 in Healthy Subjects and in the Lungs of Idiopathic Pulmonary Fibrosis (IPF) Subjects (PETAL Study)|Terminated||Phase 1|15|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:48:16.154294|2017-10-11 00:48:16.154294
NCT02052284|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-03-10|||January 2014||2014-01-01|March 2015|2015-03-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||The Application of Sterile Water to the Skin of Extremely Low Birth Weight (ELBW) Infants|The Application of Sterile Water to the Skin of Extremely Low Birth Weight (ELBW) Infants|Recruiting||N/A|120|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-11 00:48:16.273721|2017-10-11 00:48:16.273721
NCT02052271|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-08-30|||May 2014||2014-05-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|ELECTRE2||Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation|Thérapeutique expérimentale du Tremblement Essentiel Par la Stimulation Transcranienne Par Courant Direct (tDCS) du Cortex Cerebelleux|Recruiting||N/A|30|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-11 00:48:16.440977|2017-10-11 00:48:16.440977
NCT02052258|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-09-11|||January 2013||2013-01-01|September 2014|2014-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence|Oxytocin in Opiate Dependence: A Double-blind, Within-subjects, Placebo-controlled Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence|Unknown status|Recruiting|Phase 1|||MacDonald, Kai, M.D.||1|||f||||||||||||||2017-10-11 00:48:16.527117|2017-10-11 00:48:16.527117
NCT02052245|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-09-12|||October 2013||2013-10-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Pre/Term Milk Profiling|Longitudinal Composition of Human Milk for Term and Preterm Infants|Completed||N/A|61|Actual|Nestlé|||2||f||||f||||||||||2017-10-11 00:48:16.604293|2017-10-11 00:48:16.604293
NCT02052232|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-06-16|||March 2014||2014-03-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study of Protein Metabolism in Healthy Older Subjects|Study of Acute Muscle Protein Metabolism in Healthy Older Subjects|Completed||N/A|39|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-11 00:48:16.674702|2017-10-11 00:48:16.674702
NCT02052219|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-07-28|||October 2014||2014-10-01|July 2015|2015-07-01|October 2021|Anticipated|2021-10-01|October 2016|Anticipated|2016-10-01||Interventional|||BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy|Withdrawn||Phase 3|0|Actual|Anthera Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:48:16.747834|2017-10-11 00:48:16.747834
NCT02052206|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-07-11|||March 2014||2014-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Accuracy Evaluation of Shoulder Replacement Surgery|Accuracy Evaluation of Shoulder Replacement Surgery With Computer-assisted 3D Planning|Recruiting||N/A|80|Anticipated|Balgrist University Hospital||2|||f||||f||||||||||2017-10-11 00:48:16.817345|2017-10-11 00:48:16.817345
NCT02052193|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-05-02|||January 2014|Actual|2014-01-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study|Evaluation of Photosensitivity in Dabrafenib or Vemurafenib Treated Metastatic Melanoma Patients - a Phase IIa/IIb Study|Terminated||Phase 2|8|Actual|University Hospital Tuebingen||2||Second cohort not opened because Simon-Two_Step model failed|f||||f||||||||||2017-10-11 00:48:16.916898|2017-10-11 00:48:16.916898
NCT02052180|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-30|||May 2013||2013-05-01|January 2014|2014-01-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Early Post-Operative Pain Control Following Wrist Operations|Bupivicaine Extended-Release Liposome Injection Versus Marcaine for Early Post-Operative Pain Control Following Wrist Operations|Unknown status|Enrolling by invitation|N/A|70|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-11 00:48:17.007377|2017-10-11 00:48:17.007377
NCT02052167|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-08-29|||April 2014||2014-04-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis|Human Factors Study for the Evaluation of the Methotrexate Prefilled Pen (50 mg/mL) for Subcutaneous Injection in Pediatric and Adolescent Patients With Juvenile Idiopathic Arthritis|Completed||Early Phase 1|30|Actual|medac GmbH||1|||f||||f||||||||||2017-10-11 00:48:17.080808|2017-10-11 00:48:17.080808
NCT02052154|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-07-31|||March 10, 2014|Actual|2014-03-10|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|July 19, 2016|Actual|2016-07-19||Interventional|SPLENEVAC||Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized Adults|Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized Adults|Active, not recruiting||Phase 2|70|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t|f|f||||||||2017-10-11 00:48:17.164793|2017-10-11 00:48:17.164793
NCT02052141|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-05-24|||March 20, 2014|Actual|2014-03-20|May 2017|2017-05-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema|A Phase 3, Multicenter, Randomized, Single-Blind, Dose-Ranging, Crossover Study to Evaluate the Safety and Efficacy of Intravenous Administration of CINRYZE® (C1 Esterase Inhibitor [Human]) for the Prevention of Angioedema Attacks in Children 6 to 11 Years of Age With Hereditary Angioedema|Completed||Phase 3|12|Actual|Shire||2|||f||||f||||||||||2017-10-11 00:48:17.265084|2017-10-11 00:48:17.265084
NCT02052128|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-06-22|||January 2014||2014-01-01|June 2015|2015-06-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|||Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers|Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Arno Therapeutics||6|||f||||t||||||||||2017-10-11 00:48:19.058172|2017-10-11 00:48:19.058172
NCT02052115|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-12-02|||January 2014||2014-01-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|BEAT||Behavioral Weight Loss and Exercise After Treatment (BEAT)|Behavioral Weight Loss and Exercise After Treatment (BEAT): Predictors of Weight Loss Success in Overweight Breast Cancer Survivors|Unknown status|Recruiting|N/A|80|Anticipated|University of Vermont||1|||f||||f||||||||||2017-10-11 00:48:19.16789|2017-10-11 00:48:19.16789
NCT02052102|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-01-04|||October 2014||2014-10-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart|A Cohort Study Assessing Cardiac Function With MRI in Left-Sided Breast Cancer Patients Treated With Deep Inspiration Breath Hold (DIBH) Technique to Improve Cardiac Sparing During Adjuvant Radiotherapy|Recruiting||Phase 2|63|Anticipated|AHS Cancer Control Alberta||3|||f||||t||||||||No||2017-10-11 00:48:19.26424|2017-10-11 00:48:19.26424
NCT02052089|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-29|||March 2009||2009-03-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Comparative Study for the Optimal Treatment Method of Lateral Epicondylosis|Prospective Randomized Clinical and Radiologic Study for the Treatment of Lateral Epicondylosis; Comparison Among PRP (Platelet-Rich Plasma) , Prolotherapy, Physiotherapy and ESWT (Extracorporeal Shockwave Therapy)|Completed||N/A|231|Actual|CM Chungmu Hospital||4|||f||||t||||||||||2017-10-11 00:48:19.357752|2017-10-11 00:48:19.357752
NCT02052076|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-07-14|||January 2013||2013-01-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Influence of the Constancy of Daily Meal Pattern on Energy Balance, Glucose Profiles an Appetite in Healthy Women|Influence of the Constancy of Daily Meal Pattern on Energy Balance, Glucose Profiles an Appetite in Healthy Women|Completed||N/A|11|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-11 00:48:19.457772|2017-10-11 00:48:19.457772
NCT02052063|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-12-06|||September 2014||2014-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Compli-STARR||Does the Stapled Transanal Rectal Resection (STARR Procedure) Has an Effect on Anal Compliance ?|Does the Stapled Transanal Rectal Resection (STARR Procedure) Has an Effect on Anal Compliance ?|Recruiting||N/A|28|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 00:48:19.543685|2017-10-11 00:48:19.543685
NCT02052050|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-06-01|||September 2012||2012-09-01|January 2014|2014-01-01|April 2015|Actual|2015-04-01|January 2014|Actual|2014-01-01||Interventional|||Core Stability Program in Colorectal Cancer Survivors|Effectiveness of Core Stability Exercises on Abdominal Deep Muscles in Colorectal Cancer Survivors|Completed||N/A|40|Actual|Universidad de Granada||2|||f||||f||||||||||2017-10-11 00:48:19.650593|2017-10-11 00:48:19.650593
NCT02052037|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-07-15|||January 2014||2014-01-01|July 2015|2015-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Egg Ingestion in Adults With Type 2 Diabetes|Egg Ingestion in Adults With Type 2 Diabetes: Effects on Glycemic Control, Anthropometry, Diet Quality and Cardiometabolic Status A Randomized, Controlled, Crossover Trial|Unknown status|Active, not recruiting|N/A|40|Anticipated|Griffin Hospital||2|||f||||f||||||||||2017-10-11 00:48:19.747204|2017-10-11 00:48:19.747204
NCT02052024|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-12-15|||May 2014||2014-05-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MAS||Myobloc Atrophy Study|Myobloc Atrophy Study|Completed||Phase 4|10|Actual|Georgetown University||2|||f||||f||||||||||2017-10-11 00:48:19.833258|2017-10-11 00:48:19.833258
NCT02052011|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-04-10|2016-11-22||April 2014||2014-04-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|RAMP-ED||Ranolazine and Microvascular Angina by PET in the Emergency Department|Ranolazine and Microvascular Angina by PET in the Emergency Department (RAMP-ED)|Completed||Phase 4|31|Actual|Yale University|Small sample size with higher than expected dropout rates.|2|||f||||t||||||||||2017-10-11 00:48:20.05872|2017-10-11 00:48:20.05872
NCT02051998|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-10-27|||June 2013||2013-06-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Observational|DSGA||Directional Spread in Geographic Atrophy|Analysis of the Directional Spread of Geographic Atrophy (GA) in Patients With Age-related Macular Degeneration (AMD)|Recruiting||N/A|130|Anticipated|University Hospital, Bonn|||1||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:48:20.529204|2017-10-11 00:48:20.529204
NCT02051985|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-29|||October 2013||2013-10-01|January 2014|2014-01-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|RE-START||Early-start Exercise Training in Subacute Heart Failure|Early-start Exercise Training After Acute Hemodynamic Decompensation in Patients With Chronic Heart Failure. A Multicenter, Randomized, Controlled Trial on Feasibility and Impact on Functional Capacity, Symptoms and Neurohumoral Activation.|Unknown status|Recruiting|N/A|200|Anticipated|Fondazione Salvatore Maugeri||2|||f||||t||||||||||2017-10-11 00:48:20.632305|2017-10-11 00:48:20.632305
NCT02051972|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-05-19|||December 2013||2013-12-01|May 2016|2016-05-01|March 2022|Anticipated|2022-03-01|June 2017|Anticipated|2017-06-01||Observational|||The LEADLESS Observational Study|Nanostim Study for a Leadless Cardiac Pacemaker System|Recruiting||N/A|1000|Anticipated|St. Jude Medical|||1||f||||t||||||||||2017-10-11 00:48:20.796798|2017-10-11 00:48:20.796798
NCT02051959|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-01-26|||May 2015||2015-05-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Long-term Effects of Transcranial Direct Current Stimulation (tDCS) on Patients With Phantom Limb Pain (PLP)|Long-Term Treatment of Patients Experiencing Phantom Limb Pain With Transcranial Direct Current Stimulation (tDCS)|Suspended||N/A|24|Anticipated|Sheba Medical Center||4||Signing a contract with the company owning the equipment|f||||f||||||||||2017-10-11 00:48:20.9688|2017-10-11 00:48:20.9688
NCT02051946|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-02-15|||May 2014||2014-05-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Novel Drug Delivery Technique Via Retroject Device|Novel Drug Delivery Technique for Glaucoma Patients|Completed||Phase 1/Phase 2|9|Actual|Duke University||3|||f||||f|t|t|t|f||||||2017-10-11 00:48:21.142813|2017-10-11 00:48:21.142813
NCT02051920|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-01-09|||November 2013||2013-11-01|January 2015|2015-01-01||||November 2014|Actual|2014-11-01|1 Month|Observational [Patient Registry]|REA-FO||Cardiac Elastography Measurement : an Intraoperative Cardiac Surgery Study|Measurement of Cardiac Elastography: an Intraoperative Cardiac Surgery Study. Cardiac Elastography in Vivo|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Caen|||1||f||||t||||||||||2017-10-11 00:48:21.385432|2017-10-11 00:48:21.385432
NCT02051907|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-01-30|||March 2014||2014-03-01|January 2014|2014-01-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|kam1403||Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis|A BLIND, CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF KAM1403 GEL TREATMENT IN PATIENTS WITH RADIATION DERMATITIS|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Kamedis Ltd.||2|||f||||f||||||||||2017-10-11 00:48:21.480531|2017-10-11 00:48:21.480531
NCT02051894|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-09-02|||September 2014||2014-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic Encephalopathy|NeoAdapt 3: An Observational Study Investigating Novel Biomarkers in the Evaluation and Treatment of Neonatal Circulatory Insufficiency in Infants Suffering From Hypoxic Ischemic Encephalopathy.|Completed||N/A|18|Actual|Brighton and Sussex University Hospitals NHS Trust|||1||f||||f||||||None Retained|"     Two blood samples of 400µl each will be obtained for each infant receiving dobutamine.      Samples for the pharmacokinetic studies will utilise micro assays to minimise the amount of     blood taken and will coincide with the taking of clinically indicated sample to reduce the     burden placed on neonates included in this study.   "|||2017-10-11 00:48:21.603742|2017-10-11 00:48:21.603742
NCT02051881|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-01-30|||May 2012||2012-05-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Identification of Nutrient Receptors Gastrointestinal Tract|The Identification and Spatial Distribution of Different Nutrient Receptors Along the Gastrointestinal (GI) Tract|Completed||N/A|40|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 00:48:21.724383|2017-10-11 00:48:21.724383
NCT02051868|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-11-03|||December 2013||2013-12-01|November 2015|2015-11-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|InterAACT||International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel|An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel in Patients With Inoperable Locally Recurrent or Metastatic Disease|Recruiting||Phase 2|80|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:48:21.808452|2017-10-11 00:48:21.808452
NCT02051855|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-07-18|||July 2014||2014-07-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||NeoAdapt 2: An Observational Study Investigating Novel Biomarkers in the Evaluation and Treatment of Neonatal Circulatory Insufficiency|NeoAdapt 2: An Observational Study Investigating Novel Biomarkers in the Evaluation and Treatment of Neonatal Circulatory Insufficiency in Infants Older Than 33 Weeks Gestational Age|Completed||N/A|25|Actual|Brighton and Sussex University Hospitals NHS Trust|||1||f||||f||||||None Retained|"     Two blood samples of 400µl each will be obtained for each infant receiving dobutamine.      Samples for the pharmacokinetic studies will utilise micro assays to minimise the amount of     blood taken and will coincide with the taking of clinically indicated sample to reduce the     burden placed on neonates included in this study.   "|||2017-10-11 00:48:21.948398|2017-10-11 00:48:21.948398
NCT02051842|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2016-06-07|||January 2014||2014-01-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis|Effect of Metadoxine on Oxidative Stress in Non-alcoholic Fatty Liver Disease Prediabetic Mexican Patients|Recruiting||Phase 4|100|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||||2017-10-11 00:48:22.061272|2017-10-11 00:48:22.061272
NCT02051829|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-04-21|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Comparison of Preoperative Screening Score for Obstructive Sleep Apnea (OSA)|Comparison of Preoperative Screening Score for OSA|Completed||N/A|1584|Actual|Astes|||1||f||||f||||||||||2017-10-11 00:48:22.341272|2017-10-11 00:48:22.341272
NCT02051816|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-04-19|2016-07-06||February 2014||2014-02-01|April 2017|2017-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|FELLOW||Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit: The FELLOW Study|Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit|Completed||N/A|150|Actual|Vanderbilt University Medical Center||4|||f||||f||||||||||2017-10-11 00:48:22.475433|2017-10-11 00:48:22.475433
NCT02051803|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-07-30|||March 2014||2014-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|WE QUIT||Women Engaging in Quitting Smoking Together (WE QUIT)|Distress Tolerance Treatment for Weight Concern in Smoking Cessation Among Women|Completed||N/A|22|Actual|Butler Hospital||2|||f||||f||||||||||2017-10-11 00:48:23.296708|2017-10-11 00:48:23.296708
NCT02051790|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-08-27|2015-08-03||March 2014||2014-03-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Evaluation of Reader Training Processes|Evaluation of Reader Training Processes by Comparing Clinical Interpretations to Centralized Expert Reads|Completed||Phase 4|241|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 00:48:23.382828|2017-10-11 00:48:23.382828
NCT02051777|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-10-06|||July 2012||2012-07-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Hospital Discharge Oral Nutrition Support Trial||Completed||N/A|120|Actual|Nutricia UK Ltd||3|||f||||f||||||||||2017-10-11 00:48:23.550584|2017-10-11 00:48:23.550584
NCT02051569|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-01-29|||August 2012||2012-08-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Serotonin and Everyday Social Interaction|Everyday Social Behavior and Mood in Individuals With a Family History of Depression. Investigating the Role of Serotonin|Completed||Early Phase 1|40|Actual|University of Groningen||2|||f||||f||||||||||2017-10-11 00:48:25.751823|2017-10-11 00:48:25.751823
NCT02051764|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-02-08||2017-02-08|May 2014|Actual|2014-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Imaging Characteristics of a Follow-up 18F-AV-1451 Scan|An Open Label, Multicenter Study, Evaluating the Imaging Characteristics of a Follow-up 18F-AV-1451 Scan in Subjects Who Have Had a Prior 18F-AV-1451 Scan|Completed||Phase 2|38|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 00:48:23.633194|2017-10-11 00:48:23.633194
NCT02051751|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-04-05|||March 5, 2014|Actual|2014-03-05|April 2017|2017-04-01|August 19, 2016|Actual|2016-08-19|August 19, 2016|Actual|2016-08-19||Interventional|||A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer|A Phase Ib Open Label Dose Finding Study of BYL719 in Combination With Paclitaxel in Advanced Solid Tumors Followed by Two Expansion Phases in Locally Advanced/Metastatic Chemotherapy Naive HER2 Negative Breast Cancer Patients (HER2- mBC) and in Recurrent and Metastatic Head-and-neck Squamous Cell Carcinoma Patients (HNSCC) Pre-treated With Platinum Based Therapy|Completed||Phase 1|19|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:48:23.728569|2017-10-11 00:48:23.728569
NCT02051738|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-06-26|||February 2014||2014-02-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy Participants|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy Subjects|Completed||Phase 1|1|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:48:23.862436|2017-10-11 00:48:23.862436
NCT02051725|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-06-27|||November 2013||2013-11-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|HANC-Pilot||Functional Impairments and Exercise in Older Adults With Low Physical Function,|"Implementation of an Active Life-style Intervention in Older People With Low Physical Function: Effect on Functional Impairments, Pilot"|Completed||N/A|65|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 00:48:23.979991|2017-10-11 00:48:23.979991
NCT02051712|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-10-28|||February 2014||2014-02-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|HOMEX-HF-P||Cardiovascular Effects of Preferred Home-based Exercise Training in Systolic Heart Failure|Cardiovascular Effects of Preferred Home-based Exercise Training and Extended Adherence Measures in Systolic Heart Failure - Pilot Study|Recruiting||Phase 3|120|Anticipated|University Medicine Greifswald||3|||f||||f||||||||||2017-10-11 00:48:24.079389|2017-10-11 00:48:24.079389
NCT02051699|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2014-01-30|||June 2012||2012-06-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01|1 Day|Observational [Patient Registry]|OA knee||One-Leg Standing Radiograph: A Novel Technique to Evaluate the Severity of OA Knee|One-Leg Standing Radiograph: A Novel Technique to Evaluate the Severity of Knee Osteoarthritis|Completed||N/A|50|Actual|Thammasat University|||2||f||||f||||||||||2017-10-11 00:48:24.195398|2017-10-11 00:48:24.195398
NCT02051686|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-03-28|||June 2013|Actual|2013-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TXA||Hemostasis in Open Acetabulum and Pelvic Ring Surgery Using Tranexamic Acid|Hemostasis in Open Acetabulum and Pelvic Ring Surgery Using Tranexamic Acid: A Prospective, Randomized, Controlled Study|Completed||N/A|33|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-10-11 00:48:24.303648|2017-10-11 00:48:24.303648
NCT02051673|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-06-29||||||June 2017|2017-06-01||||||||Expanded Access|||Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)|Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)|No longer available||N/A|||University of Louisville|||||||||||||||||||2017-10-11 00:48:24.409719|2017-10-11 00:48:24.409719
NCT02051660|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-10-25|||March 2013||2013-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||German Evaluation of the Effectiveness of the Psychological Intervention Managing Cancer and Living Meaningfully (CALM)|German Randomized Controlled Trial of the Psychotherapeutic Intervention for Advanced Cancer Patients: Managing Cancer and Living Meaningfully (CALM)|Recruiting||Phase 3|262|Anticipated|University of Leipzig||2|||f||||t||||||||||2017-10-11 00:48:24.474351|2017-10-11 00:48:24.474351
NCT02051647|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-12-03|||January 2014||2014-01-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|CoEXAM||Copeptin as a Stress Marker During a Written Examination|Copeptin as a Stress Marker During a Written Examination - the CoEXAM|Completed||N/A|42|Actual|University Hospital, Basel, Switzerland|||1||f||||f|||||||"     Serum, Li-Heparin   "|||2017-10-11 00:48:24.578013|2017-10-11 00:48:24.578013
NCT02051634|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-01-04|||October 2014||2014-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Papaya Study ID:20140628|Efficacy of Fermented Papaya Preparation on Markers of Systemic Inflammation|Completed||Phase 2|30|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 00:48:24.657001|2017-10-11 00:48:24.657001
NCT02051621|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-01-30|||August 2010||2010-08-01|January 2014|2014-01-01|August 2017|Anticipated|2017-08-01|August 2015|Anticipated|2015-08-01||Interventional|TripleA||Therapy of Atrial Flutter by Afib Ablation|Isolated Atrial Fibrillation Ablation in Patients With Isolated Atrial Flutter|Unknown status|Recruiting|N/A|100|Anticipated|University of Rostock||3|||f||||f||||||||||2017-10-11 00:48:24.760445|2017-10-11 00:48:24.760445
NCT02051608|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2017-09-11|||March 27, 2014|Actual|2014-03-27|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|July 30, 2018|Anticipated|2018-07-30||Interventional|||A Study of Gantenerumab in Participants With Mild Alzheimer Disease|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients|Active, not recruiting||Phase 3|1000|Anticipated|Hoffmann-La Roche||3|||f|||||t|f||||||||2017-10-11 00:48:24.898078|2017-10-11 00:48:24.898078
NCT02051595|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-08-31|2015-06-23||April 2014||2014-04-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||The Effects of Modified Ultrafiltration on Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery|The Effects of Modified Ultrafiltration on Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery|Completed||Early Phase 1|25|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 00:48:25.490728|2017-10-11 00:48:25.490728
NCT02051582|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-02-24|||February 2014||2014-02-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Role of the Laser Pointer in Budgeting Fluoroscopy Time and Radiation Exposure|Role of the Laser Pointer in Budgeting Fluoroscopy Time and Radiation Exposure|Completed||N/A|25|Actual|University of Florida|||2||f||||f||||||||||2017-10-11 00:48:25.660749|2017-10-11 00:48:25.660749
NCT02051543|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-09-23||||||September 2015|2015-09-01||||August 2016|Anticipated|2016-08-01||Interventional|||Investigating Affective Mechanisms of Behavioral Sleep Treatment||Withdrawn||N/A|0|Actual|Minneapolis Veterans Affairs Medical Center||1|||f||||f||||||||||2017-10-11 00:48:25.95575|2017-10-11 00:48:25.95575
NCT02051530|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-01-29|||April 2012||2012-04-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Mood, Serotonin and Social Interaction|Mood, Serotonin and Social Interaction|Completed||Early Phase 1|40|Actual|University of Groningen||2|||f||||f||||||||||2017-10-11 00:48:26.051669|2017-10-11 00:48:26.051669
NCT02051517|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-06-16|||May 2013||2013-05-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Vitreous Chemistry Analysis|Vitreous Chemistry Analysis|Completed||N/A|3|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     Vitreous fluid whole blood   "|||2017-10-11 00:48:26.154905|2017-10-11 00:48:26.154905
NCT02051504|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-09-12|||March 2010||2010-03-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|OXYDIAB||Muscle Oxygenation, Type 1 Diabetes, and Glycated Hemoglobin|Impact of Type 1 Diabetes and Glycated Haemoglobin Levels on Oxygen Delivery and Release to Active Muscle During Exercise and on Muscle Oxidation Capacity - Possible Impact on Aerobic Fitness|Completed||N/A|79|Actual|University Hospital, Lille|||4||f||||t||||||Samples With DNA|"     Whole blood, plasma, serum, and skeletal muscle (vastus lateralis) samples   "|||2017-10-11 00:48:26.229181|2017-10-11 00:48:26.229181
NCT02051491|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-05-15|||June 2013||2013-06-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|NOVEL||Non-invasive Ventilation for Extubation Success in Infants Less Than 1,250 Grams|A Randomized Controlled Trial of BiPhasic Nasal Continuous Positive Airway Pressure (BP-NCPAP) vs. Non-invasive High Frequency Ventilation (NIHFV) Following NCPAP Failure: A Pilot Study|Unknown status|Recruiting|N/A|50|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-11 00:48:26.363038|2017-10-11 00:48:26.363038
NCT02051478|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-30|||September 2012||2012-09-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Thoracic Manipulation and Mobilization for Neck Pain|CHANGES IN PRESSURE PAIN SENSITIVITY AND NECK PAIN AFTER THORACIC THRUST MANIPULATION OR NON-THRUST MOBILIZATION IN PATIENTS WITH MECHANICAL NECK PAIN|Completed||N/A|55|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 00:48:26.47261|2017-10-11 00:48:26.47261
NCT02051465|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2017-02-15|||May 2013||2013-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness and Safety of the Endoscopic Removal of Large and Flat Colonic Polyps With LumenR RetractorTM|A Randomized Controlled Trial to Evaluate Effectiveness and Safety of the Endoscopic Removal of Large and Flat Colonic Polyps With LumenR RetractorTM (LR) as a Modified Colonic Overtube|Recruiting||N/A|60|Anticipated|Mercy Medical Center||2|||f||||t||||||||||2017-10-11 00:48:26.58305|2017-10-11 00:48:26.58305
NCT02051452|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-08-03|||November 2014||2014-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Reversal of General Anesthesia With Methylphenidate|Reversal of General Anesthesia With Intravenous Methylphenidate|Enrolling by invitation||Phase 1/Phase 2|55|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 00:48:26.701733|2017-10-11 00:48:26.701733
NCT02051439|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-01-29|||January 2012||2012-01-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Party Balloon Assisted Valsalva in Diagnosis of Superficial Venous Valvular Reflux of Lower Limb|A Comparison of the Party Balloon Assisted Valsalva With Conventional Valsalva Maneuver in Diagnosis of Superficial Venous Valvular Reflux of Lower Limb|Completed||N/A|40|Actual|Mahidol University||1|||f||||f||||||||||2017-10-11 00:48:26.79252|2017-10-11 00:48:26.79252
NCT02051426|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-11-12|2014-02-26||April 2007||2007-04-01|November 2014|2014-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|NMDAR|16 participants received DSR then 1month later received placebo; whereas19 participants received placebo then 1 month later received DSR. The assessments were performed at baseline assessment day and 2 hours after the experimental treatment administration (test day1&2). Outcome analysis was D-serine versus Placebo effects for total 35 participants.|Behavioral and Cognitive Effects of the N-methyl-D-aspartate Receptor (NMDAR) Co-agonist D-serine in Healthy Humans|Behavioral and Cognitive Effects of the N-methyl-D-aspartate Receptor (NMDAR) Co-agonist D-serine in Healthy Humans|Completed||N/A|35|Actual|Herzog Hospital||2|||f||||f||||||||||2017-10-11 00:48:26.916377|2017-10-11 00:48:26.916377
NCT02051413|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-02-24|||February 2014||2014-02-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Interventional|DEPARRESTCLIN||Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)|Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder|Recruiting||Phase 4|80|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 00:48:27.2337|2017-10-11 00:48:27.2337
NCT02051400|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-30|||September 2013||2013-09-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|EMMVL||Evaluation of McGrath® MAC Video Laryngoscope|Evaluation of McGrath® MAC Using Glidescope® Ranger for Novice Providers in a Simulated Difficult Airway: A Randomised Manikin Study|Completed||N/A|39|Actual|Hanyang University||3|||f||||t||||||||||2017-10-11 00:48:27.338686|2017-10-11 00:48:27.338686
NCT02051387|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-09-30|||January 2013||2013-01-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|CBD-IS||Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study|Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study With Approved Antipsychotics in Vivo|Recruiting||Phase 1|74|Anticipated|Central Institute of Mental Health, Mannheim||7|||f||||f||||||||||2017-10-11 00:48:27.446858|2017-10-11 00:48:27.446858
NCT02051374|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-09-20|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|December 2027|Anticipated|2027-12-01|December 2019|Anticipated|2019-12-01||Interventional|NORDSTEN/DS||The NORDSTEN Study - Degenerative Spondylolisthesis|Degenerative Lumbar Spondylolisthesis: Is Only Decompression Good Enough? A Prospective Randomized Clinical Multi- Institutional Trial|Recruiting||N/A|256|Anticipated|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 00:48:27.571124|2017-10-11 00:48:27.571124
NCT02051361|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-05-17|||April 2014||2014-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Observational|Anti-Clot||Antiplatelet Therapy Following Stent Implantation|Open Label, Non Interventional, Multi-center, Observational Study to Assess the Antiplatelet Treatment Pre and Post-operatively of Stent Implantation|Completed||N/A|900|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||Undecided||2017-10-11 00:48:27.703304|2017-10-11 00:48:27.703304
NCT02051348|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-30|2015-01-14|||January 2014||2014-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion|A Single-blinded, Placebo Controlled, Crossover Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion|Completed||Phase 2/Phase 3|24|Actual|Atlantia Food Clinical Trials||2|||f||||f||||||||||2017-10-11 00:48:27.807046|2017-10-11 00:48:27.807046
NCT02051335|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-12-02|2015-05-17||January 2014||2014-01-01|September 2016|2016-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults|A Randomized, Double-Blind, Placebo Controlled, 4-Period, Cross-Over Study to Evaluate the Effects of Single Oral Administrations of Roflumilast in Combination With Donepezil on Reversing Scopolamine (Hyoscine) Induced Deficits in Psychomotor and Cognitive Function in Healthy Adults|Completed||Phase 1|27|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 00:48:27.975595|2017-10-11 00:48:27.975595
NCT02051322|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-30|||January 2014||2014-01-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Comparison of Lung Administration With Three Different Nebulizer||Unknown status|Recruiting|N/A|6|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f||||||||||||||2017-10-11 00:48:29.643405|2017-10-11 00:48:29.643405
NCT02051309|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-06-20|||March 2014||2014-03-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|||Guanfacine Clinical Trial for Smoking Cessation|Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation|Recruiting||Phase 2|250|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 00:48:29.746323|2017-10-11 00:48:29.746323
NCT02051283|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-29|||February 2014||2014-02-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC|Value of Pretreatment MRI Determined Parameters for Predicting Outcome After Radio-frequency Ablation of Hepatocellular Carcinoma|Unknown status|Not yet recruiting|N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 00:48:30.018827|2017-10-11 00:48:30.018827
NCT02051270|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-11-01|||January 2014||2014-01-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|||Cognitive Impairment and Balance in Elderly|Mild Cognitive Impairment and Balance in Elderly|Completed||N/A|82|Actual|Universidad de Granada|||1||f||||t||||||||||2017-10-11 00:48:30.110473|2017-10-11 00:48:30.110473
NCT02051257|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-01-27|||May 2014||2014-05-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma|Phase I Study of Cellular Immunotherapy Using Memory-Enriched T Cells Lentivirally Transduced to Express a CD19-Specific, Hinge-Optimized, CD28-Costimulatory Chimeric Receptor and a Truncated EGFR Following Peripheral Blood Stem Cell Transplantation for Patients With High-Risk Intermediate or High Grade B-Lineage Non-Hodgkin Lymphoma|Active, not recruiting||Phase 1|51|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 00:48:30.19565|2017-10-11 00:48:30.19565
NCT02051244|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2014-01-30|||February 2014||2014-02-01|January 2014|2014-01-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|SCI-OCT||Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?|Pilot Study That Investigates the Potential of Using OCT (Optical Coherence Tomography) Measurements of the Thickness of the Retinal Nerve Fiber Layer as a Biomarker for the Early Detection of Alzheimer's Disease.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Carmel Medical Center|||3||f||||f||||||||||2017-10-11 00:48:30.295707|2017-10-11 00:48:30.295707
NCT02051231|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-05-22|||December 2013||2013-12-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization|Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization|Completed||N/A|22|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 00:48:30.396161|2017-10-11 00:48:30.396161
NCT02051218|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-05-31|||July 2014||2014-07-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks|Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks - A Non-Inferiority Phase III Trial|Recruiting||Phase 3|1380|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||||2017-10-11 00:48:30.501937|2017-10-11 00:48:30.501937
NCT02051192|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-10-05|||January 2014||2014-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|PLET||Brief Behavioral Treatment for Anxiety in Young Children|A Brief Behavioral Treatment for Anxiety in Young Children|Completed||Phase 1/Phase 2|58|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 00:48:30.864233|2017-10-11 00:48:30.864233
NCT02051179|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2014-01-30|||August 2003||2003-08-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|REPAMLG||Longitudinal Results of a 10-Year Clinical Trial of Repair of Amalgam Restorations|Longitudinal Results of a 10-Year Clinical Trial of Repair of Amalgam Restorations|Completed||N/A|20|Actual|University of Chile|||2||f||||t||||||||||2017-10-11 00:48:30.959576|2017-10-11 00:48:30.959576
NCT02051153|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-30|||October 2009||2009-10-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|ModCog||Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls|Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls|Completed||N/A|64|Actual|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:48:31.175845|2017-10-11 00:48:31.175845
NCT02051140|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-09-01|||May 2014||2014-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Dietary Strawberry Supplementation on Older Adults|The Effect of Dietary Strawberry Supplementation on Older Adults|Completed||N/A|54|Actual|USDA Human Nutrition Research Center on Aging||2|||f||||f||||||||||2017-10-11 00:48:31.28245|2017-10-11 00:48:31.28245
NCT02051127|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-05-23|||January 2013||2013-01-01|May 2017|2017-05-01|April 3, 2017|Actual|2017-04-03|October 25, 2016|Actual|2016-10-25||Interventional|ASTI||The Effects of Physical Training on Physiological and Psychological Stress-reactions and Cognitive Function.|Sustainable Working Life With Reduced Stress Levels - The Effects of Physical Training on Physiological and Psychological Stress-reactions and Cognitive Function.|Completed||N/A|119|Actual|Vastra Gotaland Region||2|||f||||f||||||||||2017-10-11 00:48:31.384666|2017-10-11 00:48:31.384666
NCT02051114|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-10-06|||February 2014||2014-02-01|October 2016|2016-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Discovering the Antecedents of Rheumatoid Arthritis Flare|Discovering the Antecedents of Rheumatoid Arthritis Flare|Recruiting||N/A|25|Anticipated|Rockefeller University|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 00:48:31.489128|2017-10-11 00:48:31.489128
NCT02051101|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-02-08|||May 2013||2013-05-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples|Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples|Recruiting||Phase 1|100|Anticipated|University of California, Irvine||1|||f||||f||||||||||2017-10-11 00:48:31.574859|2017-10-11 00:48:31.574859
NCT02051088|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-05-13|||November 2014||2014-11-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|SWEDEPAD||Swedish Drug-elution Trial in Peripheral Arterial Disease|Swedish Drug-elution Trial in Peripheral Arterial Disease - a Multicenter, Prospective Randomized Controlled Clinical Trial Based on the Swedish Vascular Registry (SWEDVASC) Platform|Recruiting||N/A|3800|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-11 00:48:31.677301|2017-10-11 00:48:31.677301
NCT02051075|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-05-05|||March 2014||2014-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PXN||Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation|A Randomized Controlled Trial to Compare Fertilizations With Immotile Sperm After Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation|Withdrawn||Phase 4|0|Actual|Rambam Health Care Campus||2||failure to recruit|f||||f||||||||||2017-10-11 00:48:31.782833|2017-10-11 00:48:31.782833
NCT02051062|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-08-19|||October 2014||2014-10-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients|Pharmacokinetics of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) (BAT™) in Pediatric Patients With a Confirmed or Suspected Exposure to Botulinum Toxin.|Enrolling by invitation||Phase 4|10|Anticipated|Cangene Corporation||1|||f||||f||||||||||2017-10-11 00:48:31.861176|2017-10-11 00:48:31.861176
NCT02051049|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-08-04|||March 2013||2013-03-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)|Long-term Safety Follow-up Study of Patients Having Received Infusions of HepaStem|Active, not recruiting||N/A|9|Actual|Promethera Biosciences|||1||f||||t||||||||||2017-10-11 00:48:31.945051|2017-10-11 00:48:31.945051
NCT02051036|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2016-03-11|||February 2014||2014-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study|A Pilot Study on Effectiveness and Safety of Moxibustion for Benign Prostate Hyperplasia With Lower Urinary Tract Syndrome|Completed||N/A|25|Actual|Korean Medicine Hospital of Pusan National University||2|||f||||t||||||||||2017-10-11 00:48:32.029709|2017-10-11 00:48:32.029709
NCT02051023|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-01-07|||February 2014||2014-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|FML||Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)|Randomized, Double-Masked, Vehicle-controlled Phase III Trial on the Safety/Efficacy of FML® 0.1% in the Treatment of the Inflammatory Exacerbation Provoked by Exposure to an Adverse Controlled Environment in Patients With Dry Eye Disease|Completed||Phase 3|41|Actual|Instituto Universitario de Oftalmobiología Aplicada||2|||f||||f||||||||||2017-10-11 00:48:32.131723|2017-10-11 00:48:32.131723
NCT02051010|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-03-27|||May 2013||2013-05-01|March 2015|2015-03-01||||March 2015|Actual|2015-03-01||Observational|||ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?|ABC Survey: Are we Meeting the Needs of Patients With Advanced Breast Cancer (ABC) in Ireland? A Nationwide Survey|Completed||N/A|500|Actual|Cancer Trials Ireland|||1||f||||f||||||||||2017-10-11 00:48:32.226394|2017-10-11 00:48:32.226394
NCT02050997|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-10-18|||October 2013||2013-10-01|October 2016|2016-10-01||||December 2021|Anticipated|2021-12-01||Observational|||Plasma Biomarkers P-DAC, V1|Identification of Predictive Plasma Biomarkers in Pancreatic Ductal Adenocarcinoma (P-DAC Plasma Biomarker Study)|Recruiting||N/A|240|Anticipated|Cancer Trials Ireland|||2||f||||f||||||||||2017-10-11 00:48:32.324908|2017-10-11 00:48:32.324908
NCT02050984|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2014-01-29|||January 2010||2010-01-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|BASBP||Effect of Bariatric Surgery on Blood Pressure|A Prospective Study on the Effects of Bariatric Surgery on Blood Pressure in Patients With Obesity and Diabetes|Unknown status|Recruiting|N/A|40|Anticipated|Third Military Medical University|||1||f||||t||||||Samples Without DNA|"     Blood sample   "|||2017-10-11 00:48:32.469847|2017-10-11 00:48:32.469847
NCT02050971|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-30|||October 2010||2010-10-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates|Safety and Effectiveness Phase 1 Study of Autologous Umbilical Cord Blood Transfusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates|Unknown status|Enrolling by invitation|Phase 1|40|Anticipated|Pomeranian Medical University Szczecin||2|||f||||f||||||||||2017-10-11 00:48:32.59353|2017-10-11 00:48:32.59353
NCT02050958|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-04-28|||February 2014||2014-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Pilot Study of OXP001 and Brufen in Healthy Subjects|A Randomised, Open Label, Evaluator Blinded, Multiple Dose, Parallel Arm, Phase I Pilot Study of OXP001 Ibuprofen 400 mg Tablets and Brufen 400 mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions to Assess The Incidence of Upper Gastrointestinal Irritation|Completed||Phase 1|43|Actual|Oxford Pharmascience Ltd||2|||f||||f||||||||||2017-10-11 00:48:32.693853|2017-10-11 00:48:32.693853
NCT02050945|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-04-19|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effects of Physical Exercise Training in Patients With Chronic Obstructive Pulmonary Disease|The Effects of Physical Exercise Training in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|30|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 00:48:32.90029|2017-10-11 00:48:32.90029
NCT02050932|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-01-30|||November 2013||2013-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Optimization of Iron Bioavailability of Supplements Using Hepcidin Levels in Humans|The Optimization of Iron Bioavailability of Supplements Using Hepcidin Levels in Humans: Effect of the Time of Administration and Consecutive Day Administration of Commonly Used Dosages|Completed||N/A|32|Actual|Swiss Federal Institute of Technology||1|||f||||f||||||||||2017-10-11 00:48:33.014958|2017-10-11 00:48:33.014958
NCT02050919|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-05-01|||December 2013||2013-12-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma|A Phase II Study of Sorafenib With Chemotherapy, Radiation, and Surgery for High-Risk Soft Tissue Sarcomas|Recruiting||Phase 2|20|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 00:48:33.104451|2017-10-11 00:48:33.104451
NCT02050906|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-03-04|||April 2012||2012-04-01|March 2016|2016-03-01||||May 2015|Actual|2015-05-01||Interventional|IDEA-P||Intensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy|The Intensive Diet and Exercise Adherence Trial - Pilot (IDEA-P): A Feasibility Study of a Lifestyle Intervention in Men Undergoing Androgen Deprivation Therapy|Active, not recruiting||N/A|40|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:48:33.252462|2017-10-11 00:48:33.252462
NCT02050893|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-01-30|||May 2012||2012-05-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Midazolam on Fluid Responsiveness in Septic Patients||Completed||Phase 1/Phase 2|40|Actual|Southeast University, China||2|||f||||t||||||||||2017-10-11 00:48:33.387029|2017-10-11 00:48:33.387029
NCT02050880|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-09-25|||January 2014||2014-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||OCT Agreement and Crossed Precision Study|Crossed Precision Design Study of the Nidek Optical Coherence Tomography RS-3000, RS-3000 Lite and RS-3000 Advance for the Measurements of Retinal and RNFL Thickness, Optic Disc Analysis, and Pachymetry|Completed||N/A|119|Actual|Nidek Co. LTD.|||4||f||||f||||||||||2017-10-11 00:48:33.45748|2017-10-11 00:48:33.45748
NCT02050867|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-09-30|||January 7, 2014||2014-01-07|September 27, 2017|2017-09-27|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Validation of the Ask Suicide-Screening Questions (ASQ) in the Inpatient Medical Setting|Validation of the Ask Suicide-Screening Questions (ASQ) in the Inpatient Medical Setting|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:48:33.531739|2017-10-11 00:48:33.531739
NCT02050854|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-29|||December 2013||2013-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia|An Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia Who Have a History of Suboptimal Adherence and Are Currently on Treatment With Oral Aripiprazole|Completed||N/A|47|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood, Plasma   "|||2017-10-11 00:48:33.618486|2017-10-11 00:48:33.618486
NCT02050841|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-08-10|||December 2014||2014-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Octaplas Pediatric Plasma Replacement Trial|An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors.|Recruiting||Phase 4|50|Anticipated|Octapharma||1|||f||||t||||||||||2017-10-11 00:48:33.713903|2017-10-11 00:48:33.713903
NCT02050828|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2017-03-15||2015-08-24|January 2014||2014-01-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|TIME-2||The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema|A Phase 2, Randomized, Active-Controlled, Double-Masked, Multi-Center Study to Assess the Safety and Efficacy of Daily Subcutaneous AKB-9778 Administered for 3 Months, as Monotherapy or Adjunctive to Ranibizumab, in Subjects With Diabetic Macular Edema|Completed||Phase 2|144|Actual|Aerpio Therapeutics||3|||f||||f||||||||||2017-10-11 00:48:33.815846|2017-10-11 00:48:33.815846
NCT02050815|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-03-09|||March 2014||2014-03-01|March 2017|2017-03-01|August 26, 2016|Actual|2016-08-26|August 1, 2016|Actual|2016-08-01||Interventional|MEK162||MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function|A Phase I, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of MEK162 in Subjects With Mild, Moderate and Severe Hepatic Impairment|Terminated||Phase 1|27|Actual|Array BioPharma||1||"The Sponsor is terminating the study because the primary objective was achieved after 5 of the   6 subjects were assessed in the final cohort."|f||||f||||||||||2017-10-11 00:48:34.001506|2017-10-11 00:48:34.001506
NCT02050802|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-30|||August 2011||2011-08-01|January 2014|2014-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects|A Double-blind, Randomized, Placebo-controlled, Four-way Crossover Phase 1 Study Including an Open-label Positive Control (Moxifloxacin) to Assess the Effect of Repeated Daily Doses of 10 mg and 30 mg Macitentan on the QT/QTc Interval of the ECG in Healthy Male and Female Subjects|Completed||Phase 1|64|Actual|Actelion||8|||f||||f||||||||||2017-10-11 00:48:34.123396|2017-10-11 00:48:34.123396
NCT02050789|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-09-12|||July 2014||2014-07-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|FIRST||"Flexibility In Duty Hour Requirements for Surgical Trainees Trial - the FIRST Trial"|Allowing Flexibility in Surgical Resident Duty Hours Trial|Completed||N/A|152|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 00:48:34.301423|2017-10-11 00:48:34.301423
NCT02050776|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-30|||December 2008||2008-12-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Stem Cell Therapy in Limb Girdle Muscular Dystrophy|The Role of Cell Therapy in Modifying the Course of Limb Girdle Muscular Dystrophy- A Longitudinal 5-year Study|Completed||Phase 1|65|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-11 00:48:34.395951|2017-10-11 00:48:34.395951
NCT02050763|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-10-12|||February 2005||2005-02-01|January 2014|2014-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|SHARE||Assessing the Impact of an Intervention to Prevent Intimate Partner Violence and HIV in Uganda|A Cluster Randomized Trial of the Impact of an Intimate Partner Violence and HIV Prevention Intervention on Emotional, Physical and Sexual Abuse, Sexual Risk Behaviors and HIV Incidence in Rakai, Uganda|Completed||N/A|11451|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 00:48:34.478917|2017-10-11 00:48:34.478917
NCT02050750|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-08-09|||December 2013||2013-12-01|August 2017|2017-08-01||||June 2018|Anticipated|2018-06-01||Observational|||TAILORx Tissue Bank|Breast Cancer Bank of Tissue From Trial Assigning Individualized Options for Treatment (TAILORx Tissue Bank)|Recruiting||N/A|690|Anticipated|Cancer Trials Ireland|||1||f||||f||||||||||2017-10-11 00:48:34.596284|2017-10-11 00:48:34.596284
NCT02050737|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-10-18|||October 2013||2013-10-01|October 2016|2016-10-01||||December 2022|Anticipated|2022-12-01||Observational|||Plasma Biomarkers C-RAC, ICORG 12-27, V1|Identification of Plasma Biomarkers in Early Detection of Colorectal Adenocarcinoma Recurrence (C-RAC Plasma Biomarker Study)|Recruiting||N/A|130|Anticipated|Cancer Trials Ireland|||2||f||||||||||||||2017-10-11 00:48:34.726542|2017-10-11 00:48:34.726542
NCT02050724|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-02-01|||November 2013||2013-11-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|ThoHSpEkt||ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT|Thorakoskopische Handheld-SPECT Gesteuerte Ektomie Von Radioaktiv-markierten Pulmonalen Rundherden. Proof of Feasibility of Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With the Help of Free-hand SPECT.|Terminated||Phase 2|11|Actual|Cantonal Hospital of St. Gallen||2||Ende of part 1. Only few patients in part 2 enrolled|f||||t||||||||||2017-10-11 00:48:34.861632|2017-10-11 00:48:34.861632
NCT02050711|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-01-14|||May 2013||2013-05-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Effects of Pulmonary Rehabilitation on Respiratory Sounds in Patients With COPD|Effects of Pulmonary Rehabilitation on Computerized Respiratory Sounds in Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|50|Anticipated|Aveiro University||2|||f||||f||||||||||2017-10-11 00:48:34.955558|2017-10-11 00:48:34.955558
NCT02050698|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-10-11|||January 2014||2014-01-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Hard-soled Shoe Versus Short Leg Walking Cast for a Fifth Metatarsal Avulsion Fracture: A Randomized Multicenter Noninferiority Trial|Hard-soled Shoe Versus Short Leg Walking Cast for a Fifth Metatarsal Avulsion Fracture: A Randomized Multicenter Noninferiority Trial|Unknown status|Recruiting|N/A|96|Anticipated|Hallym University Kangnam Sacred Heart Hospital||2|||f||||t||||||||||2017-10-11 00:48:35.073969|2017-10-11 00:48:35.073969
NCT02050685|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-01-05|||January 2014||2014-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Comparison of Different Screening Score for Hypoxemic OSA (Obstructive Sleep Apnea) With the Results of a Polysomnography (PSG)|Comparison of Different Screening Score for Hypoxemic OSA|Completed||N/A|159|Actual|Astes|||1||f||||f||||||||||2017-10-11 00:48:35.185801|2017-10-11 00:48:35.185801
NCT02050672|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-01-29|||May 2013||2013-05-01|January 2014|2014-01-01||||December 2015|Anticipated|2015-12-01||Interventional|MI_ICSI||Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization Outcome: a Prospective, Randomized Sibling-oocyte Study|Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization Outcome: a Prospective, Randomized Sibling-oocyte Study|Unknown status|Recruiting|N/A|||AGUNCO Obstetrics and Gynecology Centre||2|||f||||||||||||||2017-10-11 00:48:35.264825|2017-10-11 00:48:35.264825
NCT02050659|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-03-09|||March 2012||2012-03-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Observational|OMEGA||Omentectomy in Radical Gastrectomy for Gastric Cancer Trial|Omentectomy in Radical Gastrectomy for Gastric Cancer Trial|Completed||N/A|100|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||||||||||||2017-10-11 00:48:35.367892|2017-10-11 00:48:35.367892
NCT02050646|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-12-19|||April 2013||2013-04-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis|The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis|Recruiting||N/A|30|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 00:48:35.432928|2017-10-11 00:48:35.432928
NCT02050633|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-02-24|||December 2014||2014-12-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|TCS8||PariS -TBI Study: Paris Severe Traumatic Brain Injury Study - 8 Years|Eight-year Outcome and Health Care After Severe Traumatic Brain Injury in the Parisian Area|Enrolling by invitation||N/A|130|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-10-11 00:48:35.544493|2017-10-11 00:48:35.544493
NCT02050620|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-12-01|||January 2014||2014-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast Cancer|A Pilot Study to Examine the Association Between Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast Cancer|Completed||N/A|45|Actual|Duke University|||1||f||||f||||||||||2017-10-11 00:48:35.63539|2017-10-11 00:48:35.63539
NCT02050607|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-01-29|||January 2014||2014-01-01|January 2014|2014-01-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Fecal Microbiota Transplantation for the Treatment of Metabolic Syndrome|Fecal Microbiota Transplantation for the Treatment of Metabolic Syndrome|Unknown status|Not yet recruiting|Phase 3|44|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 00:48:35.701851|2017-10-11 00:48:35.701851
NCT02050581|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-01-30|||January 2011||2011-01-01|January 2017|2017-01-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|Dex/Rituxan||A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone|"A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone for the Treatment of Relapsed/Refractory ITP:"|Recruiting||N/A|50|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||Undecided||2017-10-11 00:48:35.888554|2017-10-11 00:48:35.888554
NCT02050568|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-03-17|||October 2013||2013-10-01|March 2015|2015-03-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Observational|||Mechanism of Incontinence Before and After Genital Prolapse Surgery|Measuring the Mechanism of Incontinence With Urethral Pressure Reflectometry, Before and After Genital Prolapse Surgery|Unknown status|Recruiting|N/A|60|Anticipated|Herlev Hospital|||2||f||||f||||||||||2017-10-11 00:48:35.987959|2017-10-11 00:48:35.987959
NCT02050555|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-08-07|||December 2013||2013-12-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Anti-obesity Effect of Koji-extracted Beverage Fermented With Pediococcus Pentosaceus LP28|A Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Effect of Koji-extracted Beverage Fermented With Pediococcus Pentosaceus LP28|Completed||N/A|50|Anticipated|Hiroshima University||2|||f||||f||||||||||2017-10-11 00:48:36.101303|2017-10-11 00:48:36.101303
NCT02050542|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-04-20|||June 2014||2014-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|MURIELLE||Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.|Comparison of Prostate Cancer Detection Rates Obtained With Multiparametric MRI Targeted Transrectal Ultrasound Biopsies and Systematic Transrectal Ultrasound Biopsies.|Completed||N/A|108|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:48:36.20109|2017-10-11 00:48:36.20109
NCT02050529|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-29|||February 2013||2013-02-01|January 2014|2014-01-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|||Randomized Clinical Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.|Randomized Clinical Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients at a Tertiary Care Hospital of Karachi.|Unknown status|Recruiting|Phase 2/Phase 3|180|Anticipated|Dow University of Health Sciences||2|||f||||t||||||||||2017-10-11 00:48:36.302237|2017-10-11 00:48:36.302237
NCT02050516|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-01-30|||July 2013||2013-07-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Comparison of Single vs Group Embryo Culture in Micro-well Group Culture Dish|Randomized Controlled Comparison of Single Embryo Culture Versus Group Culture Using a Micro-well Group Culture Dish in Humans|Unknown status|Recruiting|N/A|160|Anticipated|Eurofertil IVF Health Center||2|||f||||f||||||||||2017-10-11 00:48:36.410404|2017-10-11 00:48:36.410404
NCT02050503|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-03-16|||December 2012||2012-12-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|CP073||Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis|Ability of Intranasal Transmucosal Fentanyl Pectin Nasal Spray to Prevent Breakthrough Pain Episodes in Patients With Radiation-induced Oropharyngeal Mucositis|Completed||N/A|33|Actual|Grupo de Investigación Clínica en Oncología Radioterapia|||1||f||||t||||||||||2017-10-11 00:48:36.510044|2017-10-11 00:48:36.510044
NCT02050490|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-11-17|||January 2014||2014-01-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|||Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-and-after-study|Effect of the Implementation of a Symptom Diary on the Symptom Care Received and the Symptom Burden Experienced by Adult Cancer Patients Treated With Chemotherapy: A Before-and-after-study|Unknown status|Recruiting|N/A|250|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-11 00:48:36.609201|2017-10-11 00:48:36.609201
NCT02050477|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2014-01-28|||June 2012||2012-06-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Clinical Study of Laparoscopic Non Banded Vertical Gastroplasty in Bariatric Surgery|Laparoscopic Non Banded Vertical (Magenstrasse and Mill) Gastroplasty In Bariatric Surgery. Morbidity and Results on Weight Loss and Associated Co-morbidities|Unknown status|Active, not recruiting|Phase 4|100|Actual|University Hospital of Liege||1|||f||||f||||||||||2017-10-11 00:48:36.692291|2017-10-11 00:48:36.692291
NCT02050464|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-05-03|||December 2013||2013-12-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01|18 Months|Observational [Patient Registry]|ProsKuopio||Computational Tools for Early Diagnosis of Memory Disorders|Virtual Physiological Human (VPH) Dementia Research Enabled by IT - Prospective Cohort Kuopio|Completed||N/A|126|Actual|University of Eastern Finland|||5||f||||f||||||Samples With DNA|"     whole blood, serum, plasma, white cells   "|||2017-10-11 00:48:36.792291|2017-10-11 00:48:36.792291
NCT02050451|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-03-27|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy|A Pilot Study of Perioperative Oral Nutrition Supplementation to Improve Nutritional Status, Post-operative Complications, Length of Stay and Readmission Rates in Patients Undergoing Radical Cystectomy|Completed||N/A|60|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 00:48:36.884483|2017-10-11 00:48:36.884483
NCT02050438|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2014-07-25|||January 2014||2014-01-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Observational|||How Total Knee Prosthesis Dessigns Influence in Quality of Live||Completed||N/A|135|Anticipated|Corporacion Parc Tauli|||1||f||||f||||||||||2017-10-11 00:48:37.007938|2017-10-11 00:48:37.007938
NCT02050425|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-11-23|||January 2014||2014-01-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Breath Analysis in Obstructive Sleep Apnoea|Exhaled Breath Analysis by Mass Spectrometry in Patients With Obstructive Sleep Apnoea - a Randomised Placebo-controlled Trial.|Completed||N/A|30|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 00:48:37.124124|2017-10-11 00:48:37.124124
NCT02050412|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-04-09|||February 2014||2014-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||A Pilot Study for the Determination of Allergenicity of Cat Dander Samples Obtained by Different Methods||Completed||N/A|20|Actual|University of Zurich||1|||f||||||||||||||2017-10-11 00:48:37.20475|2017-10-11 00:48:37.20475
NCT02048709|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-02-02|||April 2014||2014-04-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors|A Phase I Study of GDC-0919 for Adult Patients With Recurrent Advanced Solid Tumors|Completed||Phase 1|22|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 00:49:00.655455|2017-10-11 00:49:00.655455
NCT02050399|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-28|||August 2013||2013-08-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Cardiovascular Oscillations in Coronary Patients With and Without Type 2 Diabetes|Cardiovascular Oscillations at Rest and During Isometric Exercise in Coronary Patients With and Without Type 2 Diabetes|Unknown status|Recruiting|N/A|45|Anticipated|Universidade Federal de Sao Carlos||3|||f||||t||||||||||2017-10-11 00:48:37.272376|2017-10-11 00:48:37.272376
NCT02050386|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-12-16|||November 2013||2013-11-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||The Brain Alerting Mechanism Study|The Role of Brain Arousal Systems in Cognitive and Physical Decline in Normal Aging|Withdrawn||N/A|0|Actual|University of Florida|||2|Resources were refocused into another project preventing this project from starting|f||||f||||||||||2017-10-11 00:48:37.497735|2017-10-11 00:48:37.497735
NCT02050360|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-01-15|||November 2013||2013-11-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PROFIL||"As Required Oral Sildenafil in Raynaud's Phenomenon"|"Efficacy and Safety of as Required Sildenafil for Patients With Moderate to Severe Raynaud's Phenomenon (RP)"|Completed||Phase 2/Phase 3|41|Actual|University Hospital, Grenoble||3|||f||||t||||||||||2017-10-11 00:48:37.710323|2017-10-11 00:48:37.710323
NCT02050347|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2016-09-18|||April 2014||2014-04-01|September 2016|2016-09-01|February 2033|Anticipated|2033-02-01|March 2018|Anticipated|2018-03-01||Interventional|CARPASCIO||Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)|Phase I Study of Activated T Lymphocytes Expressing Chimeric Antigen Receptors for Therapy of Relapsed CD19-Positive Malignancies Post-Allogeneic Hematopoietic Stem Cell Transplantation Infused Only After Engraftment (CARPASCIO)|Recruiting||Phase 1|40|Anticipated|Baylor College of Medicine||4|||f||||t||||||||||2017-10-11 00:48:37.814059|2017-10-11 00:48:37.814059
NCT02050334|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-29|2015-04-28|2015-02-18||November 2013||2013-11-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|July 2014|Actual|2014-07-01||Interventional|||CC100: Safety and Tolerability of Single Doses|Protocol CC100A CC100: Safety and Tolerability of Single Doses|Completed||Phase 1|18|Actual|Chemigen, LLC||2|||f||||f||||||||||2017-10-11 00:48:37.969352|2017-10-11 00:48:37.969352
NCT02050321|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-03-08|2017-03-08||December 2013||2013-12-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma|A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma|Terminated||Phase 2|2|Actual|University of Arizona||1||Pharmaceutical company pulled support for the trial.|f||||t||||||||||2017-10-11 00:48:38.529526|2017-10-11 00:48:38.529526
NCT02050308|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-04-06|||May 2015||2015-05-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Web-based Smoking Cessation Program for Tribal College Students|Web-based Smoking Cessation Program for Tribal College Students|Recruiting||Phase 3|300|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 00:48:38.778036|2017-10-11 00:48:38.778036
NCT02050295|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-12-17|||February 2014||2014-02-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Nerve Block Washout|A Novel Approach to Reverse and Titrate the Clinical Effects of a Nerve Block|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 00:48:38.907295|2017-10-11 00:48:38.907295
NCT02050282|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-05-26|||February 2014||2014-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Interventional|PreBNP||Prehospital Triage of Patients With Severe Shortness of Breath Using Biomarkers|Prehospital Triage of Patients With Severe Dyspnea Using Point-of-Care N-terminal Pro-Brain Natriuretic Peptide. PreBNP Trial.|Completed||N/A|712|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:48:39.047008|2017-10-11 00:48:39.047008
NCT02050269|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|IoxRea||Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study|Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study|Completed||Phase 3|100|Actual|University Hospital, Tours||1|||f||||t||||||||||2017-10-11 00:48:39.215852|2017-10-11 00:48:39.215852
NCT02050256|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-12-10|||February 2014||2014-02-01|December 2013|2013-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Improving End-of-life Care by Continuing Medical Education and Electronic Decision Making Support for General Practitioners|Improving End-of-life Care by Continuing Medical Education and Electronic Decision Making Support for General Practitioners in Denmark - an Intervention Study|Withdrawn||N/A|0|Actual|University of Aarhus||1||due to organisational changes|f||||f||||||||||2017-10-11 00:48:39.342818|2017-10-11 00:48:39.342818
NCT02050243|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2014-01-28|||February 2014||2014-02-01|January 2014|2014-01-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Interventional|5-ALA||The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors|The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric CNS Tumors|Unknown status|Not yet recruiting|Phase 1/Phase 2|100|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 00:48:39.452947|2017-10-11 00:48:39.452947
NCT02050230|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-10-26|||January 2014||2014-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Hemodynamic Effects of Stored Blood Transfusion in Intensive Care Patients|Hemodynamic Effects of Stored Blood Transfusion in Intensive Care Patients|Terminated||Phase 4|11|Actual|Medical University of Vienna||2||Protracted recruitment of patients|f||||t||||||||||2017-10-11 00:48:39.598333|2017-10-11 00:48:39.598333
NCT02050217|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-29|||June 2013||2013-06-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||NAVA Helmet in Pediatric Respiratory Failure|Patient Ventilator Interaction During Non-invasive Ventilation Delivered With Neurally Adjusted Ventilatory Assist (NAVA-NIV) in Infants Delivered by Helmet: a Pilot Short Term Physiological Study|Unknown status|Recruiting|Phase 3|10|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||1|||f||||f||||||||||2017-10-11 00:48:39.72346|2017-10-11 00:48:39.72346
NCT02050204|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-29|||September 2009||2009-09-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|WFHS||Evaluating the Health Benefits of Workplace Policies and Practices - Phase II|Evaluating the Health Benefits of Workplace Policies and Practices - Phase II|Completed||N/A|2753|Actual|Harvard School of Public Health||4|||f||||t||||||||||2017-10-11 00:48:39.844444|2017-10-11 00:48:39.844444
NCT02050191|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2014-01-29|||July 2006||2006-07-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|May 2009|Actual|2009-05-01||Interventional|NnoLEDGE||Community Web Health Portal for Diabetes Prevention|The Primary Goal of the Phase I Research Was to Demonstrate Feasibility of Creating and Running an Incentive-based Wellness Portal for a Local Community (Princeton, NJ) That Involved Designing the System, Building a Prototype, Testing the System, and Assessing User Acceptance.|Completed||N/A|20|Actual|Griffin Hospital||1|||f||||f||||||||||2017-10-11 00:48:39.989912|2017-10-11 00:48:39.989912
NCT02050178|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-03-09|||November 2013||2013-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer|A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer|Active, not recruiting||Phase 1|26|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:48:40.083377|2017-10-11 00:48:40.083377
NCT02050165|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-01-29|||April 2012||2012-04-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Snack||Snacking, Satiety &Weight: A Randomized, Controlled Trial|Snacking, Satiety &Weight: A Randomized, Controlled Trial|Completed||N/A|34|Actual|Griffin Hospital||2|||f||||f||||||||||2017-10-11 00:48:40.192308|2017-10-11 00:48:40.192308
NCT02050152|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2014-03-25|||May 2013||2013-05-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Nitrous Oxide Induction Induces Amnesia in Pediatric Patients|Dose Response Effect of Nitrous Oxide on Amnesia in Healthy Children|Completed||N/A|90|Actual|State University of New York at Buffalo||3|||f||||f||||||||||2017-10-11 00:48:40.298201|2017-10-11 00:48:40.298201
NCT02050139|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-06-29|||February 2014||2014-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CINDY||L-Cysteine in Peritoneal Dialysis|A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY TO EVALUATE THE RENAL AND BIOHUMORAL EFFECTS OF L-CYSTEINE COMPARED TO PLACEBO IN STABLE PERITONEAL DIALYSIS PATIENTS WITH RESIDUAL DIURESIS|Completed||Phase 2|10|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-11 00:48:40.422593|2017-10-11 00:48:40.422593
NCT02050126|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-04-21|||April 2013||2013-04-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Caesarean Scar Revision With the UltraPulse|Caesarean Scar Revision With the UltraPulse|Completed||N/A|12|Actual|Lumenis Ltd.||1|||f||||f||||||||||2017-10-11 00:48:40.522879|2017-10-11 00:48:40.522879
NCT02050113|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-01-10|||March 2014||2014-03-01|January 2017|2017-01-01|March 2024|Anticipated|2024-03-01|March 2020|Anticipated|2020-03-01||Interventional|CARPE-CMD||Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices|Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices|Recruiting||N/A|50|Anticipated|University of Massachusetts, Worcester||1|||f||||t||||||||||2017-10-11 00:48:40.606742|2017-10-11 00:48:40.606742
NCT02050100|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-05-11|||January 2014||2014-01-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Observational|||Biomarkers for Diagnosis of Lung Cancer|Biomarkers for Diagnosis of Lung Cancer|Completed||N/A|300|Actual|SK Medical (Beijing) Co., Ltd.|||2||f||||f||||||Samples Without DNA|"     Two 10ml blood samples (serum and plasma) from the patient will be analyzed for protein     biomarkers associated with lung cancer diagnosis   "|||2017-10-11 00:48:40.723192|2017-10-11 00:48:40.723192
NCT02050087|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-05-30|||October 2013||2013-10-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2015|Actual|2015-12-01||Interventional|||The Role of Postoperative Immobilization After Arthroscopic Rotator Cuff Repair|The Role of Postoperative Immobilization After Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Non-inferiority Trial|Completed||N/A|120|Actual|Lovisenberg Diakonale Hospital||2|||f||||f||||||||||2017-10-11 00:48:40.807308|2017-10-11 00:48:40.807308
NCT02050074|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-10-06|||January 2014||2014-01-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ColMetInc||The Role of Metformin and Colesevelam in Human GLP-1 Secretion|The Role of Metformin and Colesevelam in Human GLP-1 Secretion|Completed||Phase 4|12|Actual|University Hospital, Gentofte, Copenhagen||6|||f||||||||||||||2017-10-11 00:48:40.884732|2017-10-11 00:48:40.884732
NCT02050061|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2014-01-29|||November 2011||2011-11-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Chronic Venous Insufficiency; Impact of Compression Stockings on Quality of Life|Chronic Venous Insufficiency; Impact of Compression Stockings on Quality of Life|Completed||N/A|100|Actual|Qassim University||2|||f||||f||||||||||2017-10-11 00:48:40.975354|2017-10-11 00:48:40.975354
NCT02050048|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-06-13|2016-03-29||January 2014||2014-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Those randomized to either the high or low volume group|High Volume Lactated Ringer's Solution and Pancreatitis|Perioperative Intravenous Administration of High Volume Lactated Ringer's Solution and the Risk of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis|Terminated||Phase 2/Phase 3|26|Actual|NorthShore University HealthSystem|Due to low study enrollment, the study was terminated early. Beacuse only 26 subjects were enrolled, the study results may not be statistically significant.|2||Study was closed prematurely due to low enrollment numbers.|f||||t||||||||||2017-10-11 00:48:41.058438|2017-10-11 00:48:41.058438
NCT02050035|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-08-29|||July 2013|Actual|2013-07-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 2017|Actual|2017-07-01||Interventional|||Exercise and Vascular Function in Chronic Kidney Disease|Exercise and Vascular Function in Chronic Kidney Disease|Completed||Phase 4|76|Actual|University of Delaware||3|||f||||f||||||||||2017-10-11 00:48:41.54104|2017-10-11 00:48:41.54104
NCT02050022|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-05-26|||April 2013||2013-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Chronic Obstructive Pulmonary Disease Biomarker Study|Clinical Implementation and Outcomes Evaluation of Blood-Based Biomarkers for Chronic Obstructive Pulmonary Disease Management|Recruiting||N/A|500|Anticipated|University of British Columbia|||2||f||||f||||||Samples With DNA|"     Plasma, serum, whole blood, sputum   "|||2017-10-11 00:48:41.672414|2017-10-11 00:48:41.672414
NCT02050009|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-01-24||||||May 2015|2015-05-01||||October 2014|Actual|2014-10-01||Interventional|||Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|The Use and Safety of Metformin, Carboplatin and Paclitaxel in Non-Diabetic Patients With Recurrent, Platinum Sensitive Ovarian Cancer and the Feasibility of Using a Core Biopsy for RNA-Seq|Withdrawn||Phase 1|0|Actual|Fox Chase Cancer Center||1||study was not initiated|f||||t||||||||||2017-10-11 00:48:41.793784|2017-10-11 00:48:41.793784
NCT02049996|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-09-07|||January 2014||2014-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|||Difference in Pain, Quality of Life Following Vaginal Hysterectomy With Vaginal Reconstruction Versus Robotic Colpopexy?|Is There a Difference in Pain and Quality of Life Following Vaginal Hysterectomy With Vaginal Reconstruction Compared to Robotic Colpopexy? A Prospective Cohort Study|Completed||N/A|78|Actual|TriHealth Inc.|||2||f||||t||||||||No||2017-10-11 00:48:41.907279|2017-10-11 00:48:41.907279
NCT02049983|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-03-10|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Levita Magnetic Grasper Device Safety and Performance Study|Levita Magnetic Grasper Device Safety and Performance Study|Completed||N/A|50|Actual|Levita Magnetics||1|||f||||||||||||||2017-10-11 00:48:42.010088|2017-10-11 00:48:42.010088
NCT02049970|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-11-07|||January 2014||2014-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of the Addition of Dexmedetomidine to Bupivacaine During Supraclavicular Brachial Plexus Blockade|Effect of the Addition of Dexmedetomidine to Bupivacaine During Supraclavicular Brachial Plexus Blockade for Forearm Surgery.|Completed||Phase 4|44|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 00:48:42.112837|2017-10-11 00:48:42.112837
NCT02049957|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-08-08|||February 13, 2014|Actual|2014-02-13|August 2017|2017-08-01|March 16, 2018|Anticipated|2018-03-16|January 31, 2018|Anticipated|2018-01-31||Interventional|||Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer|A Phase 1b/2 Study of Safety and Efficacy of MLN0128 (Dual TORC1/2 Inhibitor) in Combination With Exemestane or Fulvestrant Therapy in Postmenopausal Women With ER+/HER2- Advanced or Metastatic Breast Cancer That Has Progressed on Treatment With Everolimus in Combination With Exemestane or Fulvestrant|Recruiting||Phase 2|128|Anticipated|Takeda||2|||f||||f|t|f||||||||2017-10-11 00:48:42.239725|2017-10-11 00:48:42.239725
NCT02049944|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-01-07|||August 2013||2013-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Increased Cefazolin During Cesarean Delivery in Obese Population|Increased Cefazolin (Ancef) Dosing for Prophylaxis During Cesarean Delivery in the Obese Population|Completed||Phase 4|28|Actual|MemorialCare Health System||1|||f||||f||||||||||2017-10-11 00:48:44.725805|2017-10-11 00:48:44.725805
NCT02049931|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-05-22|2014-04-15||December 2012||2012-12-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Comparison of Treatments of Osteoporotic Compression Fracture Using Rigid Brace, Soft Brace, and no Brace|The Comparative Study for Treatment Outcomes of Osteoporotic Compression Fracture Without Neurologic Injury Using Rigid Brace, Soft Brace, and no Brace|Completed||Phase 4|60|Actual|Seoul National University Hospital||3|||f||||f||||||||||2017-10-11 00:48:44.825346|2017-10-11 00:48:44.825346
NCT02049918|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-12-23|||November 2013||2013-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Residual Sample Collection for Respiratory Viral Panel|De-identified Residual Sample Collection for the Respiratory Viral Panel on the GenMark Sample to Answer Platform (ARM 1)|Completed||N/A|1487|Actual|GenMark Diagnostics|||1||f||||f||||||Samples With DNA|"     Nasopharyngeal Swab   "|||2017-10-11 00:48:45.132258|2017-10-11 00:48:45.132258
NCT02049905|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-06-05|||January 2014||2014-01-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Phase 3 Study to Treat Patients With Soft Tissue Sarcomas|A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy|Completed||Phase 3|433|Actual|CytRx||2|||f||||t||||||||||2017-10-11 00:48:45.224325|2017-10-11 00:48:45.224325
NCT02049892|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-09-18|||December 1, 2013||2013-12-01|September 2017|2017-09-01|February 1, 2016|Actual|2016-02-01|January 1, 2016|Actual|2016-01-01||Observational|||A Comparison of Large Diameter Metal Heads vs. Small Diameter Metal Heads vs/ Dual Mobility Total Hip Replacements|A Comparison of Large Diameter Metal Heads vs. Small Diameter Metal Heads vs/ Dual Mobility Total Hip Replacements|Completed||N/A|80|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 00:48:45.612296|2017-10-11 00:48:45.612296
NCT02049879|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-02-28|||November 2008||2008-11-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Daily Activity After Corticosteroids Injection Among Knee Osteoarthritis Patients|Quantification of Daily Physical Activity After an Intra-articular Corticosteroid Injection in Patients With Knee Osteoarthritis|Completed||Phase 4|14|Actual|Laval University||1|||f||||f||||||||||2017-10-11 00:48:45.71397|2017-10-11 00:48:45.71397
NCT02049866|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-01-31|||November 19, 2014|Actual|2014-11-19|January 2017|2017-01-01|August 30, 2019|Anticipated|2019-08-30|August 30, 2019|Anticipated|2019-08-30||Interventional|||Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP|Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With Idiopathic Osteoporosis: a Phase IIB Study|Recruiting||Phase 2|41|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-11 00:48:45.806873|2017-10-11 00:48:45.806873
NCT02049853|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-05-19|||June 2013||2013-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||"The Triple A Initiative Study (Aktionsbündnis Akute Atemnot)"|A Prospective Randomized Study of Coordinated Diagnostic Pathways and Treatment Algorithms for Patients With Acute Dyspnea Including Point-of-care Testing of a Cardiac Biomarker by the Emergency Medical Service Team|Terminated||N/A|67|Actual|Klinikum Nürnberg||2||recruitment numbers lower than expected|f||||f||||||||||2017-10-11 00:48:45.936019|2017-10-11 00:48:45.936019
NCT02049840|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-04-22|||December 2013||2013-12-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|EASY||The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence|The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence|Recruiting||N/A|136|Anticipated|Coloplast A/S||1|||f||||t||||||||||2017-10-11 00:48:46.063566|2017-10-11 00:48:46.063566
NCT02049827|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-08-31|||February 2014||2014-02-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant|Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant|Unknown status|Recruiting|N/A|15|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:48:46.227219|2017-10-11 00:48:46.227219
NCT02049814|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-02-02||2017-02-02|June 2014||2014-06-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy and Safety of Voglibose Compared With Acarbose in Patients With Type 2 Diabetes|Efficacy and Safety of Voglibose Compared With Acarbose in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone: a Randomized, Open-label, Non-inferiority Study|Completed||Phase 4|494|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:48:46.325252|2017-10-11 00:48:46.325252
NCT02049801|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-01-26|||December 2014||2014-12-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|December 2019|Anticipated|2019-12-01||Interventional|||MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase I Study of MEK Inhibitor MEK162 Combined With Idarubicin and Cytarabine Induction in Patients With Relapsed/Refractory RAS-Mutated Acute Myeloid Leukemia|Active, not recruiting||Phase 1|19|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 00:48:46.455267|2017-10-11 00:48:46.455267
NCT02049788|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-28|||January 2010||2010-01-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effects of a Low Glycemic Index in Obese Children|Effects of a Low Glycemic Index Diet on Body Composition and Metabolic Syndrome Risks in Obese Thai Children: A Randomized Controlled Trial|Completed||N/A|70|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-11 00:48:46.583156|2017-10-11 00:48:46.583156
NCT02049775|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-02-18|||April 2013||2013-04-01|February 2016|2016-02-01||||April 2015|Actual|2015-04-01||Interventional|||Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)|Utility of Narrow Band Endoscopy in Predicting Short and Long Term Risk of Relapse in Patients With Quiescent Ulcerative Colitis|Recruiting||N/A|||The Leeds Teaching Hospitals NHS Trust||1|||f||||||||||||||2017-10-11 00:48:46.657335|2017-10-11 00:48:46.657335
NCT02049762|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-08-26|||June 2015||2015-06-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy|Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy|Unknown status|Recruiting|Phase 4|20|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:48:46.748013|2017-10-11 00:48:46.748013
NCT02049736|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-07-26|||December 2013||2013-12-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases|The Effect of Telbivudine on Renal Function and Proteinuria in Patients With Chronic Hepatitis B Infection and Chronic Kidney Diseases|Withdrawn||N/A|0|Actual|Chinese University of Hong Kong||1||unable to recruit patients|f||||f||||||||||2017-10-11 00:48:46.971131|2017-10-11 00:48:46.971131
NCT02049723|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-04-04|||April 2014||2014-04-01|April 2014|2014-04-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Observational|GERD||Assessment of GERD Knowledge Level Among Patients With it in Korea|How Much do Patients With Gastroesophageal Disease Know About Their Own Disease in Korea?|Unknown status|Recruiting|N/A|1000|Anticipated|Chuncheon Sacred Heart Hospital|||1||f||||f||||||||||2017-10-11 00:48:47.061001|2017-10-11 00:48:47.061001
NCT02049710|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-10-27|||June 2012||2012-06-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|TVS||Teen Video Study to Reduce Risky Driving and Sexual Behavior in Adolescents|Randomized Controlled Trial Evaluating the Effectiveness of Interactive Video Interventions to Reduce Teen Pregnancy and Teen Automobile Injuries|Unknown status|Active, not recruiting|N/A|1317|Actual|Carnegie Mellon University||2|||f||||f||||||||||2017-10-11 00:48:47.139788|2017-10-11 00:48:47.139788
NCT02049697|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-28|||April 2009||2009-04-01|January 2014|2014-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male Participants|Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 (TPI 1062) After a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|6|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||t||||||||||2017-10-11 00:48:47.359886|2017-10-11 00:48:47.359886
NCT02049684|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-09-23|||January 2013||2013-01-01|September 2014|2014-09-01||||March 2018|Anticipated|2018-03-01||Observational|||SPARC: Shoulder PAtch for Rotator Cuff Tears|SPARC: Shoulder PAtch for Rotator Cuff Tears|Recruiting||N/A|||The Leeds Teaching Hospitals NHS Trust|||2||f||||||||||||||2017-10-11 00:48:47.448015|2017-10-11 00:48:47.448015
NCT02049671|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-09-23|||July 2013||2013-07-01|September 2014|2014-09-01||||July 2016|Anticipated|2016-07-01||Observational|||Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet||Unknown status|Recruiting|N/A|||The Leeds Teaching Hospitals NHS Trust|||2||f||||||||||||||2017-10-11 00:48:47.537251|2017-10-11 00:48:47.537251
NCT02049658|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2017-03-28|||January 2014||2014-01-01|March 2017|2017-03-01|November 2074|Anticipated|2074-11-01|November 2017|Anticipated|2017-11-01||Observational|||The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients|The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients|Recruiting||N/A|2000|Anticipated|Central South University|||5||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 00:48:47.637763|2017-10-11 00:48:47.637763
NCT02049645|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2017-07-24|||January 2014||2014-01-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|November 2017|Anticipated|2017-11-01||Observational|||The Suitability of Sniff Dog as a Tool in Screening Tumors|The Suitability of Sniff Dog as a Tool in Screening Tumors-- a Prospective Observational Study|Recruiting||N/A|4000|Anticipated|Central South University|||1||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 00:48:47.735233|2017-10-11 00:48:47.735233
NCT02049632|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-08-30|||December 2013||2013-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|SENOMIC||Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis|Survival and Axillary Relapse in Breast Cancer Patients With Sentinel Node Micrometastases Who Have Not Undergone Completion Axillary Clearance - a National Cohort Study|Recruiting||N/A|452|Anticipated|Karolinska Institutet||1|||f||||t||||||||||2017-10-11 00:48:47.841482|2017-10-11 00:48:47.841482
NCT02049619|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-02-04|||May 2014||2014-05-01|February 2015|2015-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Do Pharyngeal Packs During Orthognathic Surgery Reduce Postoperative Nausea and Vomiting|Do Pharyngeal Packs During Orthognathic Surgery Reduce Postoperative Nausea and Vomiting. A Prospective Randomized Double Blind Clinical Trial.|Unknown status|Recruiting|N/A|200|Anticipated|China Medical University, China||2|||f||||t||||||||||2017-10-11 00:48:48.039666|2017-10-11 00:48:48.039666
NCT02049606|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-09-18|||February 24, 2014|Actual|2014-02-24|September 2017|2017-09-01|May 30, 2016|Actual|2016-05-30|May 11, 2015|Actual|2015-05-11||Interventional|||To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee|Double Blinded, Randomized, Active Drug Comparative, Multi-center, Phase Ⅳ Clinical Study to Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee.|Completed||Phase 4|134|Actual|PMG Pharm Co., Ltd||2|||f||||t||||||||||2017-10-11 00:48:48.146938|2017-10-11 00:48:48.146938
NCT02049593|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-06-12|||June 12, 2014|Actual|2014-06-12|June 2017|2017-06-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Phase I Trial of BMN 673 and Selected Cytotoxics in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|41|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:48:48.26491|2017-10-11 00:48:48.26491
NCT02049580|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-29|||July 2013||2013-07-01|January 2014|2014-01-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas|Multi-center, Phase II Study to Assess the Safety and Efficacy of Haploidentical Bone Marrow Transplantation Using Reduced Intensity Conditioning(RIC)Regimen and Post-transplant Cyclophosphamide,in Patients With Poor Prognosis Lymphomas|Unknown status|Recruiting|Phase 2|47|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-10-11 00:48:48.388238|2017-10-11 00:48:48.388238
NCT02049567|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-04-25|||January 2014||2014-01-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|May 2015|Actual|2015-05-01||Interventional|AIOL-2009-1||Evaluation of the FluidVision Accommodating Lens|Clinical Evaluation of the FluidVision Accommodating Intraocular Lens|Active, not recruiting||Phase 2/Phase 3|115|Anticipated|PowerVision||1|||f||||f||||||||||2017-10-11 00:48:48.519102|2017-10-11 00:48:48.519102
NCT02049554|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-08-21|||October 2013|Actual|2013-10-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2015|Actual|2015-03-01||Interventional|||Preconception Women's Health in Pediatric Practice Intervention||Completed||N/A|415|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 00:48:48.638152|2017-10-11 00:48:48.638152
NCT02049541|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-09-12|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma|A Phase I Study of BKM120 and Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma|Active, not recruiting||Phase 1|18|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:48:48.749539|2017-10-11 00:48:48.749539
NCT02049528|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-06-10|||January 2014||2014-01-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect Study|A Phase 1, Open-Label, Randomized, Crossover Study To Evaluate The Pharmacokinetics Of Single Oral Doses Of Formulated And Non-Formulated CC-122 Capsules And The Effect Of Food On The Pharmacokinetics Of CC-122 In Healthy Adult Male Subjects|Completed||Phase 1|18|Anticipated|Celgene||3|||f||||f||||||||||2017-10-11 00:48:48.931229|2017-10-11 00:48:48.931229
NCT02049515|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-07-28|||December 2013||2013-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||A Phase 3 Extension Study of Duvelisib and Ofatumumab in Patients With CLL/SLL Previously Enrolled in Study IPI-145-07|A Phase 3 Extension Study of Duvelisib and Ofatumumab in Patients With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma Previously Enrolled in Study IPI-145-07|Enrolling by invitation||Phase 3|150|Anticipated|Verastem, Inc.||2|||f||||f||||||||||2017-10-11 00:48:49.047595|2017-10-11 00:48:49.047595
NCT02049502|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-09-20|||July 2014||2014-07-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|November 30, 2017|Anticipated|2017-11-30||Interventional|||FMT in Ulcerative Colitis-Associated Pouchitis|The Use of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis-associated Pouchitis|Recruiting||Phase 2|11|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 00:48:49.300042|2017-10-11 00:48:49.300042
NCT02049489|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-09-21|||December 2013||2013-12-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma|Immunological Targeting of CD-133 in Recurrent Glioblastoma: A Multi-center Phase I Translational and Clinical Study of an Autologous CD-133 DC Vaccine|Active, not recruiting||Phase 1|20|Actual|ImmunoCellular Therapeutics, Ltd.||1|||f||||t||||||||||2017-10-11 00:48:49.381557|2017-10-11 00:48:49.381557
NCT02049476|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-02-25|||January 2014||2014-01-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of the Effectiveness of Ozurdex for the Control of Uveitis|Study of the Effectiveness of Ozurdex in Lieu of Oral Corticosteroids for the Control of Active Intermediate and Posterior Uveitis Requiring Immunosuppressive Drug Therapy|Recruiting||Phase 4|20|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 00:48:49.468285|2017-10-11 00:48:49.468285
NCT02049463|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-01-29|||February 2014||2014-02-01|January 2014|2014-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|||Advanced Analysis of the Carotid Phonoangiography and Diseases|Advanced Analysis of the Carotid Phonoangiography and Diseases|Unknown status|Not yet recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:48:49.567184|2017-10-11 00:48:49.567184
NCT02049450|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-06-19|2017-03-28||May 28, 2014|Actual|2014-05-28|June 2017|2017-06-01|April 12, 2016|Actual|2016-04-12|April 12, 2016|Actual|2016-04-12||Interventional|||Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.|A Single Arm, Multicenter, Phase IIa Study to Explore the Efficacy and Safety of Ruxolitinib (INC424) in Regularly Transfused Patients With Thalassemia|Completed||Phase 2|30|Actual|Novartis||1|||f||||f|f|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 00:48:49.792793|2017-10-11 00:48:49.792793
NCT02049437|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-07-18|||August 2014||2014-08-01|July 2017|2017-07-01|June 29, 2018|Anticipated|2018-06-29|June 29, 2018|Anticipated|2018-06-29||Interventional|IL-6||AIDS 347: IL-6 Blockade in Treated HIV Infection|AIDS 347: IL-6 Blockade in Treated HIV Infection|Active, not recruiting||Phase 1/Phase 2|34|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-10-11 00:48:50.873412|2017-10-11 00:48:50.873412
NCT02049424|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-01-28|||March 2011||2011-03-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow|Retrospective-prospective Observational Study for Data Collection of Patients Who Underwent an Haploidentical Transplantation After Non-myeloablative Conditioning Regimen|Terminated||N/A|9|Actual|Istituto Clinico Humanitas|||1|low recruitment|f||||f||||||||||2017-10-11 00:48:51.011797|2017-10-11 00:48:51.011797
NCT02049411|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-11-23|||June 2013||2013-06-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|SPMSQ-E||Ketamine and Changes of the Short Portable Mental Status Questionnaire|Changes of the Short Portable Mental Status Questionnaire (SPMSQ-E) After Ketamine Administration on Ophthalmic Surgery in Geriatric Population.|Completed||Phase 2|80|Actual|Instituto Mexicano del Seguro Social||2|||f||||f||||||||||2017-10-11 00:48:51.097204|2017-10-11 00:48:51.097204
NCT02049398|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-10-05|||January 10, 2014||2014-01-10|December 19, 2016|2016-12-19|December 23, 2015|Actual|2015-12-23|September 16, 2015|Actual|2015-09-16||Observational|||Study of Variation Over Time in the Oral Microbiome|Temporal Variation In The Oral Microbiome|Completed||N/A|41|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:48:51.263965|2017-10-11 00:48:51.263965
NCT02049372|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-01-31|||September 2011||2011-09-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|February 2012|Actual|2012-02-01|1 Year|Observational [Patient Registry]|||Complication Registry for Tonsil Surgery|Developing a Prospective Registry for Complications in Otorhinolaryngologic Surgery: Tonsil Surgery as a Pilot Cohort|Completed||N/A|794|Actual|Helsinki University|||1||f||||t||||||||||2017-10-11 00:48:51.50047|2017-10-11 00:48:51.50047
NCT02049346|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-09-12|||March 2012||2012-03-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Comparison Among Erythropoietin Stimulating Agents|Erythropoietins in Management of Anemia of End Stage Renal Disease: A Prospective Study From Qatar.|Completed||Phase 4|327|Actual|Hamad Medical Corporation||3|||f||||t||||||||||2017-10-11 00:48:51.677499|2017-10-11 00:48:51.677499
NCT02049333|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-01-29|||November 2010||2010-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Cataract Surgery vs Cataract Surgery With ECPL for Treatment of Plateau Iris Configuration or Syndrome|Phacoemulsification Versus Phacoemulsification With Endoscopic Cycloplasty (ECPL) for Treatment of Plateau Iris Configuration or Syndrome: A Prospective Randomized Clinical and Surgical Study|Completed||N/A|26|Actual|Credit Valley EyeCare||2|||f||||f||||||||||2017-10-11 00:48:51.781894|2017-10-11 00:48:51.781894
NCT02049320|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-01-31|||July 2013||2013-07-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)||Completed||N/A|38|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:48:51.862844|2017-10-11 00:48:51.862844
NCT02049307|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-09-13|||October 2014||2014-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|LIFE-HIV||Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial|Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial|Active, not recruiting||Phase 2|108|Actual|Minneapolis Medical Research Foundation||2|||f||||t||||||||||2017-10-11 00:48:51.929456|2017-10-11 00:48:51.929456
NCT02049294|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-05-03|||March 2014||2014-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis|Randomized Double Blind Placebo Controlled Trial of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis|Recruiting||Phase 2/Phase 3|24|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 00:48:52.03366|2017-10-11 00:48:52.03366
NCT02049281|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-02-09|||February 2014||2014-02-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)|A Phase I Dose Escalation Study Evaluating MK-8109 (Vintafolide) in Japanese Subjects With Advanced Solid Tumor|Terminated||Phase 1|3|Actual|Endocyte||1|||f||||f||||||||||2017-10-11 00:48:52.169755|2017-10-11 00:48:52.169755
NCT02049268|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2017-02-01|||July 2013||2013-07-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|QfMRI||Neural Mechanisms Underlying Nicotine and Alcohol Combinations|Neural Mechanisms Underlying Nicotine and Alcohol Combinations|Completed||N/A|12|Actual|Mclean Hospital||3|||f||||f|f|f||||||No|Data sharing will be considered on a case by case basis to ensure IRB compliance.|2017-10-11 00:48:52.255006|2017-10-11 00:48:52.255006
NCT02049255|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-10-31|||November 2013||2013-11-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.|Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.|Completed||Phase 4|50|Actual|Astes||2|||f||||f||||||||||2017-10-11 00:48:52.35092|2017-10-11 00:48:52.35092
NCT02049242|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2014-12-21|||January 2014||2014-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Uterine Tourniquet at Open Myomectomy|Triple Tourniquet vs. Single Tourniquet at Open Myomectomy to Reduce Blood Loss: A Prospective Randomised Controlled Trials|Completed||N/A|48|Actual|Ataturk University||2|||f||||f||||||||||2017-10-11 00:48:52.431945|2017-10-11 00:48:52.431945
NCT02049229|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-06-01|||January 2014||2014-01-01|June 2015|2015-06-01|October 2019|Anticipated|2019-10-01|October 2015|Anticipated|2015-10-01||Interventional|TIDES-ACS||Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome|Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome|Recruiting||Phase 4|1800|Anticipated|The Hospital District of Satakunta||2|||f||||t||||||||||2017-10-11 00:48:52.516204|2017-10-11 00:48:52.516204
NCT02049216|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-01-24|||August 2014||2014-08-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|FTKOA||The Effect of Flexible Tape in Knee Osteoarthritis|The Effect of Flexible Tape Versus Placebo Tape in Patients Completing a Home Exercise Program With Knee Osteoarthritis|Completed||N/A|36|Actual|The Alfred||2|||f||||f||||||||||2017-10-11 00:48:52.660471|2017-10-11 00:48:52.660471
NCT02049203|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-07-05|||January 2014||2014-01-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis|A Phase Ib Randomized, Placebo-controlled, Double-blinded Study Evaluating the Safety of Ataciguat (HMR1766) in Patients With Moderate Calcific Aortic Valve Stenosis|Completed||Phase 1|44|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:48:52.769|2017-10-11 00:48:52.769
NCT02049190|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-06-22|||February 2014||2014-02-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer|A Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer|Recruiting||Phase 1/Phase 2|75|Anticipated|Arno Therapeutics||8|||f||||t||||||||||2017-10-11 00:48:52.856097|2017-10-11 00:48:52.856097
NCT02049177|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-09-07|||November 2013||2013-11-01|September 2016|2016-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|ARCAGE-NWE||Investigation of the Role of Human Papilloma Virus (HPV) in the Prognosis of Head and Neck Cancer|Alcohol Related Cancers and Genetic Susceptibility in Europe Follow-up - North-West England|Completed||N/A|141|Actual|University of Aberdeen|||1||f||||f||||||||||2017-10-11 00:48:52.969569|2017-10-11 00:48:52.969569
NCT02049164|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2015-11-10||2015-06-05|January 2014||2014-01-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)|A Randomized, Double-blind, Placebo-controlled, Forced Titration, Dose-ranging Study of AR08 in the Treatment of Vasomotor Symptoms (VMS) in Menopausal Females: A Proof-of-Concept Study|Terminated||Phase 2|32|Actual|Arbor Pharmaceuticals, Inc.||4||Study stopping criteria met with regards to vital sign measurements post dose.|f||||f||||||||||2017-10-11 00:48:53.05786|2017-10-11 00:48:53.05786
NCT02049151|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-07-24|2016-06-30||March 2014||2014-03-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|START2|Safety Analysis Set included all subjects who had taken at least one dose of trial treatment (tecemotide [L-BLP25] or placebo), including cyclophosphamide or saline.|Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer|A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial of Tecemotide Versus Placebo in Subjects With Completed Concurrent Chemo-radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)|Terminated||Phase 3|35|Actual|EMD Serono|Sponsor discontinued development of tecemotide (L-BLP25) in NSCLC, hence the study was terminated.|2||"The study is terminated prematurely as the sponsor decided to discontinue program with   Tecemotide in NSCLC"|f||||t||||||||||2017-10-11 00:48:53.183039|2017-10-11 00:48:53.183039
NCT02049125|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-10-25|||June 2013||2013-06-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis|Urinary Biomarker NGAL in Decompensated Cirrhosis: Early Prediction of AKI and of Treatment Response|Recruiting||N/A|300|Anticipated|University of Sao Paulo|||3||f||||f||||||Samples Without DNA|"     We will store samples of urine and serum frozen at -80oC.   "|||2017-10-11 00:48:54.322712|2017-10-11 00:48:54.322712
NCT02046330|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-04-26|||November 2013||2013-11-01|April 2017|2017-04-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Deep Brain Stimulation (DBS) Therapy for Treatment Resistant Depression|Deep Brain Stimulation (DBS) Therapy for Treatment Resistant|Recruiting||N/A|10|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 00:49:29.645118|2017-10-11 00:49:29.645118
NCT02049099|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-28|2016-03-11|||March 2014||2014-03-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care|A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care|Completed||N/A|1658|Actual|Swedish Orphan Biovitrum|||1||f||||f||||||||||2017-10-11 00:48:54.592512|2017-10-11 00:48:54.592512
NCT02049086|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-12-21|||March 2014||2014-03-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SBIRT LBP||Pain Management for Veterans Filing Compensation Claims|Pain Management for Veterans Filing Compensation Claims|Active, not recruiting||N/A|120|Anticipated|Yale University||3|||f||||f||||||||||2017-10-11 00:48:54.71398|2017-10-11 00:48:54.71398
NCT02049073|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-11-01|||June 2017||2017-06-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||Prevention of Noise-induced Hearing Loss|Zonisamide and Methylprednisolone to Prevent Noise-induced Temporary Hearing Loss|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Washington University School of Medicine||3|||f||||t||||||||Undecided|undecided|2017-10-11 00:48:54.826957|2017-10-11 00:48:54.826957
NCT02049060|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-02-09|||January 2013||2013-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Interventional|||Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin|Phase I-Ib Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin as First-line Therapy in Patients With Advanced or Metastatic Cancer Suitable for a Carboplatin and Pemetrexed Regimen as Part of Their Specific Therapy|Active, not recruiting||Phase 1/Phase 2|31|Actual|Istituto Clinico Humanitas||1|||f||||f||||||||No|not planned|2017-10-11 00:48:54.966746|2017-10-11 00:48:54.966746
NCT02049047|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-07-20|||February 2011||2011-02-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|April 2014|Actual|2014-04-01||Interventional|ONC-2010-001||Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy|Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy|Active, not recruiting||Phase 2|41|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||No|not planned|2017-10-11 00:48:55.074474|2017-10-11 00:48:55.074474
NCT02049034|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-06-02|||January 2014||2014-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes|The Effect of Lixisenatide on Postprandial Lipid and Glucose Metabolism in Patients With Type 2 Diabetes|Completed||Phase 4|8|Actual|University of Surrey||2|||f||||f||||||||No|There is no plan to make the individual participant data available, however the averaged data will published on line.|2017-10-11 00:48:55.204485|2017-10-11 00:48:55.204485
NCT02049021|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-27|||February 2010||2010-02-01|January 2014|2014-01-01||||January 2014|Actual|2014-01-01||Interventional|SSURECT||Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia|Pilot Double Blind, Placebo Controlled and Randomized Study to Assess Electroconvulsive Therapy Efficacy as Augmenting Strategy to Clozapine in Super-refractory Schizophrenia|Unknown status|Recruiting|Phase 4|20|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:48:55.326825|2017-10-11 00:48:55.326825
NCT02049008|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-04-02|||January 2013||2013-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Treatment of Aggressive Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy|Clinical, Microbiological and Immunological Effects of Antimicrobial Photodynamic Therapy on Non-surgical Treatment of Aggressive Periodontitis: a Double-blind Split-mouth Randomized Controlled Clinical Trial.|Completed||Phase 4|20|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:48:55.482049|2017-10-11 00:48:55.482049
NCT02048995|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-03-27|||February 2014||2014-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|LightEyeBD||Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker|Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker|Active, not recruiting||N/A|91|Anticipated|Northwestern University|||2||f||||f||||||||||2017-10-11 00:48:55.585824|2017-10-11 00:48:55.585824
NCT02048982|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-02-04|||February 2014||2014-02-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||What Influences Physicians' Decisions - Statistics or Stories?|What Influences Physicians' Decisions - Statistics or Stories?|Unknown status|Recruiting|N/A|200|Anticipated|Weill Medical College of Cornell University||4|||f||||f||||||||||2017-10-11 00:48:55.688644|2017-10-11 00:48:55.688644
NCT02048969|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-04-13|||June 2014||2014-06-01|April 2016|2016-04-01||||June 2017|Anticipated|2017-06-01||Interventional|||Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS|Treatment of Hepatic Encephalopathy With Benzodiazepine Antagonist (Flumazenil) and Change in Cortical GABA Levels in Localized 1H-MR Spectroscopy|Recruiting||Phase 1/Phase 2|10|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 00:48:55.849149|2017-10-11 00:48:55.849149
NCT02048956|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-11-01|||January 2014||2014-01-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Hydrotherapy Intervention in Elderly With Knee Osteoarthritis|8-weeks Hydrotherapy Intervention in Patients With Knee Osteoarthritis.|Completed||N/A|34|Actual|Universidad de Granada||2|||f||||t||||||||Undecided||2017-10-11 00:48:55.990847|2017-10-11 00:48:55.990847
NCT02048943|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-01-08|||March 2015||2015-03-01|January 2015|2015-01-01||||November 2015|Anticipated|2015-11-01||Interventional|||Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer|A Phase Ib Study of Dovitinib in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced Solid Tumors and Pancreatic Cancer|Withdrawn||Phase 1|0|Actual|Roswell Park Cancer Institute||1||Lack of funding|f||||f||||||||||2017-10-11 00:48:56.119519|2017-10-11 00:48:56.119519
NCT02048930|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-01-28|||September 2012||2012-09-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Real Life Effectiveness of Easyhaler (Orion)|Effectiveness and Cost-effectiveness Evaluation of Easyhaler Versus Other Devices in a Real World Primary Care Population|Completed||N/A|24003|Actual|Research in Real-Life Ltd|||3||f||||||||||||||2017-10-11 00:48:56.230952|2017-10-11 00:48:56.230952
NCT02048917|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-08-08|||July 2014||2014-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies|Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies|Recruiting||N/A|180|Anticipated|University of Kentucky||12|||f||||t||||||||||2017-10-11 00:48:56.322761|2017-10-11 00:48:56.322761
NCT02048904|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-07-11|2017-05-01||January 2014||2014-01-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional||Total enrollment was 142 participants, with 65 completing, 7 withdrew voluntarily, and 70 were found to be ineligible. However, data was not analyzed and results are unavailable as investigator and study coordinator no longer work at the institution and did not make information available. Study was terminated prematurely.|Use of Sitagliptin to Decrease Microalbuminuria|Clinical Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Urinary Albumin to Creatinine Ratio in Patients With Overt Kidney Disease|Terminated||Phase 4|142|Actual|University of Missouri-Columbia|Study was terminated during the enrollment period due to difficulties at the study site. 65 participants had completed study by time of study termination.No data were collected or analyzed.|2||Original Principal Investigator left institution. No data analyzed.|f||||f||||||||||2017-10-11 00:48:56.477851|2017-10-11 00:48:56.477851
NCT02048891|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-05-20|2015-04-29||October 2014||2014-10-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures||Completed||Phase 4|3|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 00:48:56.616425|2017-10-11 00:48:56.616425
NCT02048878|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-12-13|||January 2014||2014-01-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|November 2016|Actual|2016-11-01||Observational|||Hyper-Arousal in Chronic Primary Insomnia|Multi-Level Assessment of Physiologic Hyper-Arousal in Chronic Primary Insomnia: A Case Control Study|Active, not recruiting||N/A|32|Anticipated|University of Chicago|||2||f||||f||||||||||2017-10-11 00:48:56.893945|2017-10-11 00:48:56.893945
NCT02048865|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-03-15|||January 2014||2014-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|AVERT||Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients|Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients: A Randomized Placebo-Controlled, Double-Blind Clinical Trial|Recruiting||Phase 2|574|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 00:48:57.594489|2017-10-11 00:48:57.594489
NCT02048852|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-08-10|||July 2014||2014-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|Menthol||Manipulating Tobacco Constituents in Female Menthol Smokers|Manipulating Tobacco Constituents in Female Menthol Smokers|Recruiting||N/A|320|Anticipated|UConn Health||4|||f||||t||||||||||2017-10-11 00:48:57.707726|2017-10-11 00:48:57.707726
NCT02048839|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-09-04|||January 2014||2014-01-01|August 2015|2015-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Long-term Effects of Lifestyle Intervention During Pregnancy in High Risk Women and in Their Offspring - Role of Environmental, Genetic and Epigenetic Factors|Long-term Effects of Lifestyle Intervention During Pregnancy in High Risk Women and in Their Offspring - Role of Environmental, Genetic and Epigenetic Factors|Completed||N/A|680|Actual|Helsinki University|||2||f||||f||||||Samples With DNA|"     Blood, saliva, hair, urine and fecal samples   "|||2017-10-11 00:48:57.830916|2017-10-11 00:48:57.830916
NCT02048800|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-10-18|||March 2014||2014-03-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|TreoPK||Treosulfan Pharmacokinetics in Children Undergoing Allogeneic HSCT|Evaluation of Treosulfan Pharmacokinetics (PK) in Children Undergoing Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)|Recruiting||N/A|90|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust|||1||f||||f||||||Samples Without DNA|"     Plasma will be stored for Treosulfan PK analysis.   "|||2017-10-11 00:49:00.089199|2017-10-11 00:49:00.089199
NCT02048787|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-12-15|||March 2014||2014-03-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.|An Open-label, Single Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of 50 mg Oral Buparlisib in Subjects With Moderate and Severe Renal Impairment Compared to Matched Control Healthy Volunteers.|Completed||Phase 1|19|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:49:00.221068|2017-10-11 00:49:00.221068
NCT02048774|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-01-25|||February 2014||2014-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|LPI||Leader Partner Interactions|Leader Partner Interactions|Completed||N/A|58|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:49:00.316594|2017-10-11 00:49:00.316594
NCT02048761|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-02-28|||August 2013||2013-08-01|February 2014|2014-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Chronic Periodontitis|Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Subjects With Chronic Periodontitis : A Randomized Controlled Clinical Trial|Unknown status|Active, not recruiting|Phase 2|65|Anticipated|Government Dental College and Research Institute, Bangalore||2|||f||||||||||||||2017-10-11 00:49:00.383399|2017-10-11 00:49:00.383399
NCT02048748|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-01-27|||February 2014||2014-02-01|January 2014|2014-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Congestive Heart Failure Home Telemonitoring|Congestive Heart Failure Home Telemonitoring : A Home Telemonitoring Service for Chronic Heart Failure Patients on Trial|Unknown status|Not yet recruiting|N/A|50|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 00:49:00.455541|2017-10-11 00:49:00.455541
NCT02048722|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-11-23|||March 2014||2014-03-01|November 2016|2016-11-01||||November 2019|Anticipated|2019-11-01||Interventional|||Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma|Multicenter, Open-Label Phase II Study of Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma|Recruiting||Phase 2|31|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 00:49:00.53795|2017-10-11 00:49:00.53795
NCT02048696|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-11-16|||February 2014||2014-02-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|EXIT-V||Effect of Exercise Training on Left Ventricular Function in Patients Post Myocardial Infarction|Effect of Exercise Training on Left Ventricular Function in Patients Post Myocardial Infarction: The EXercise Interval Training - V Study|Recruiting||N/A|20|Anticipated|Montreal Heart Institute||2|||f||||t||||||||||2017-10-11 00:49:00.718166|2017-10-11 00:49:00.718166
NCT02048683|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-10-23|||December 2013||2013-12-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SEVOBURN||A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients|A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients|Completed||Phase 2|24|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:49:00.816432|2017-10-11 00:49:00.816432
NCT02048670|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-05-23|||October 2014||2014-10-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pilot Project on External Vestibular Prosthesis in Chronic Subjective Dizziness|A Pilot Project to Investigate the Use of an External Vestibular Prosthesis Potential to Improve Clinical Management of Chronic Subjective Dizziness (CSD)|Recruiting||N/A|30|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:49:00.889436|2017-10-11 00:49:00.889436
NCT02048657|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2014-01-27|||March 2008||2008-03-01|March 2008|2008-03-01|June 2013|Actual|2013-06-01|March 2009|Actual|2009-03-01||Interventional|||The Effectiveness of Foley Airway Stylet Tool on Proseal LMA Insertion|The Efficiency of ProSeal Laryngeal Mask Airway Insertion: Compared the Techniques of Foley Airway Stylet Tool With Introducer-Tool|Completed||N/A|140|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:49:02.584151|2017-10-11 00:49:02.584151
NCT02048644|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-06-22|||March 2014||2014-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis|A Randomized, Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of 28 Day Treatment With Fostair® Pressurized Metered-dose Inhaler (pMDI) 200/12 on Biomarkers of Platelet Adhesion in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 2|20|Actual|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 00:49:02.649712|2017-10-11 00:49:02.649712
NCT02048631|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-03-20|||July 2013||2013-07-01|July 2013|2013-07-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Observational|||Analysis Of Sensory Recovery Of Donor Size And Quality Life In Oral Cancer Patients|Retrospective Analysis Of Sensory Recovery Of Donor Size And Related Quality Life In Oral Cancer Patients Receiving Free Flap Reconstruction|Completed||N/A|200|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||t||||||||||2017-10-11 00:49:02.724452|2017-10-11 00:49:02.724452
NCT02048618|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-02-21|||February 2014||2014-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease|Double-Blind, Randomized, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease With Evidence of Mucosal Ulceration|Completed||Phase 2|175|Actual|Galapagos NV||3|||f||||t||||||||||2017-10-11 00:49:02.786318|2017-10-11 00:49:02.786318
NCT02048605|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-01-23|||February 2014||2014-02-01|January 2017|2017-01-01|January 2021|Anticipated|2021-01-01|January 2016|Actual|2016-01-01||Interventional|CBT||Training of Psychosocial Skills Based on Cognitive Behavioural Therapy for Patients With Parkinson's Disease|Basel Training Study II: Training of Psychosocial Skills for Patients With Parkinson's Disease|Active, not recruiting||N/A|50|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 00:49:02.986064|2017-10-11 00:49:02.986064
NCT02048592|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-01-27|||September 2013||2013-09-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Impact of Immunonutrition on the Patients With Cystic Fibrosis|Impact of Immunonutrition on the Patients With Cystic Fibrosis|Unknown status|Recruiting|Phase 4|30|Anticipated|University Hospital, Motol||2|||f||||t||||||||||2017-10-11 00:49:03.078495|2017-10-11 00:49:03.078495
NCT02048579|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-02-08|||February 2012||2012-02-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|STAND||Increasing Academic Success in Middle School Students With ADHD|Increasing Academic Success in Middle School Students With ADHD|Completed||N/A|126|Actual|Florida International University||2|||f||||f||||||||||2017-10-11 00:49:04.698331|2017-10-11 00:49:04.698331
NCT02048566|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-10-04|||March 2014|Actual|2014-03-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|ImaCor II||Effects of Hemodynamic Monitoring Using the ImaCor Single Use Transesophageal Echocardiography Probe in Critically Ill Patients|ImaCor II Effects of Hemodynamic Monitoring Using the ImaCor Single Use Transesophageal Echocardiography Probe in Critically Ill Patients - a Randomized Controlled Trial|Recruiting||N/A|500|Anticipated|University Hospital Inselspital, Berne||4|||f||||f||||||||||2017-10-11 00:49:04.772743|2017-10-11 00:49:04.772743
NCT02048553|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-01-27|||March 2014||2014-03-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|Tab-Guide||Tablet-guided Versus Freehand (Tab-Guide) Ventriculostomy : Study Protocol to the Test Accuracy of Ventriculostomy in a Randomized Controlled Trial|Tablet-guided Versus Freehand (Tab-Guide) Ventriculostomy : Study Protocol to the Test Accuracy of Ventriculostomy in a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|320|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 00:49:04.889895|2017-10-11 00:49:04.889895
NCT02048540|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2014-04-23|||February 2009||2009-02-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell|Phase 2 Study of Neoadjuvant Bevacizumab Plus DOF Versus DOF in Local Advanced Gastric Carcinoma and Its Association With Circulating Tumor Cell|Completed||Phase 1/Phase 2|86|Actual|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-11 00:49:04.995402|2017-10-11 00:49:04.995402
NCT02048527|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-12-15|||January 2014||2014-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Single-step Versus Sequential Media in Preimplantation Embryo Development and Pregnancy Rates|Comparison of Single-step (Global) Versus Sequential Media (Origio) in Preimplantation Embryo Development and Pregnancy Rates|Completed||N/A|131|Actual|Eugonia||2|||f||||f||||||||||2017-10-11 00:49:05.122928|2017-10-11 00:49:05.122928
NCT02034318|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-03-08|||March 2009||2009-03-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|Fatigue||Fatigue and Cardiac Sympathetic Denervation in Parkinson Disease|Fatigue and Cardiac Sympathetic Denervation in Parkinson Disease|Completed||N/A|25|Anticipated|University of Miami|||1||f||||t||||||||||2017-10-11 00:52:18.226021|2017-10-11 00:52:18.226021
NCT02048514|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-01-27|||December 2008||2008-12-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms|The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms|Unknown status|Active, not recruiting|N/A|69|Actual|Endologix||1|||f||||f||||||||||2017-10-11 00:49:05.203886|2017-10-11 00:49:05.203886
NCT02048501|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-04-25|||January 2014||2014-01-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Changes in Gut Hormones, Body Composition and Energy Expenditure After Roux-en-Y|Gut Hormone, Energy Expenditure and Body Composition Change in Subjects Who Succeed or Fail to Sustain Weight Loss After Roux-en-Y Gastric Bypass|Completed||N/A|57|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:49:05.28007|2017-10-11 00:49:05.28007
NCT02048488|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-10-18|||October 2012||2012-10-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|||A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas|A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas|Active, not recruiting||Phase 1/Phase 2|72|Actual|Tesaro, Inc.||1|||f||||f||||||||||2017-10-11 00:49:05.364088|2017-10-11 00:49:05.364088
NCT02048475|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-11-24|||January 2010||2010-01-01|November 2014|2014-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Electroencephalogram During Desflurane Anaesthesia|Electroencephalogram During Increasing and Decreasing Desflurane Concentration|Withdrawn||Phase 4|0|Actual|Tampere University Hospital||1||administrative reasons.|f||||f||||||||||2017-10-11 00:49:05.46509|2017-10-11 00:49:05.46509
NCT02048462|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-11-24|||April 2014||2014-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Observational|||The Effect of Strenuous Exercise on Coagulation.|The Effect of Strenuous Exercise on Coagulation: Hemostatic Behaviour Before and After Amstel Gold Race|Completed||N/A|96|Actual|Synapse bv|||1||f||||t||||||||||2017-10-11 00:49:05.662157|2017-10-11 00:49:05.662157
NCT02048449|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-04-04|||January 2014||2014-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Inter-rater Reliability of the Reflux Finding Score Among Gastroenterologists|Inter-rater Reliability of the Reflux Finding Score Based on Endoscopic Laryngeal Findings in the Diagnosis of Laryngopharyngeal Reflux Disease|Completed||N/A|21|Actual|Chuncheon Sacred Heart Hospital|||1||f||||f||||||||||2017-10-11 00:49:05.744863|2017-10-11 00:49:05.744863
NCT02048436|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2014-01-27|||September 2013||2013-09-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Perminova Respiratory Effort Accuracy Validation 09-12-2013-Rev 2|Perminova Respiratory Effort Accuracy Validation 09-12-2013-Rev 2|Completed||N/A|20|Actual|Clinimark, LLC|||1||f||||t||||||||||2017-10-11 00:49:05.806717|2017-10-11 00:49:05.806717
NCT02048410|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-01-28|||January 2012||2012-01-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia|Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia|Completed||Phase 1/Phase 2|40|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 00:49:05.975111|2017-10-11 00:49:05.975111
NCT02048397|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-03-15|||September 2013||2013-09-01|August 2013|2013-08-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|FIM-BRO-2013||Pulmonary Rehabilitation Program (PRP) Versus PRP Plus Nutritional Supplementation in Patients With Bronchiectasis|A Pilot Study of Pulmonary Rehabilitation Program (PRP) Versus PRP Plus Nutritional Supplementation in Patients With Bronchiectasis: a Randomized Controlled Trial|Completed||N/A|30|Actual|Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud||2|||f||||f||||||||||2017-10-11 00:49:06.05269|2017-10-11 00:49:06.05269
NCT02048384|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-07-06|||January 2014||2014-01-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer|An Exploratory Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Metastatic Pancreatic Adenocarcinoma|Recruiting||Phase 1/Phase 2|22|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:49:06.144526|2017-10-11 00:49:06.144526
NCT02048371|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-05-02|||July 2014|Actual|2014-07-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|||SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing Sarcomas|A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing/Ewing-like Sarcomas|Recruiting||Phase 2|126|Anticipated|Sarcoma Alliance for Research through Collaboration||2|||f||||t||||||||||2017-10-11 00:49:06.26856|2017-10-11 00:49:06.26856
NCT02048358|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-02-05|||November 2013||2013-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients|Randomized, Double-blind, Placebo- and Active Comparator- Controlled Crossover Study in Healthy Male Subjects and an Open Label Study in Healthy Subjects and MS Patients to Assess the Safety, Pharmacokinetics and Pharmacodynamics of 2B3-201|Terminated||Phase 1|47|Actual|BBB-Therapeutics B.V.||9|||f||||f||||||||||2017-10-11 00:49:06.451294|2017-10-11 00:49:06.451294
NCT02048345|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2014-01-28|||January 2014||2014-01-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||Gastrointestinal Behavior of Posaconazol in Healthy Volunteers|Gastrointestinal Behavior of Posaconazol in Healthy Volunteers|Unknown status|Recruiting|N/A|10|Anticipated|Katholieke Universiteit Leuven||4|||f||||f||||||||||2017-10-11 00:49:06.569946|2017-10-11 00:49:06.569946
NCT02048332|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-04-26|||February 2014||2014-02-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|CTLs||Anti-virus Treatment Following Bone Marrow Transplant|Donor-Derived Anti-viral CTLs for Treatment of CMV, EBV and Adenovirus After Allogeneic Stem Cell Transplant|Recruiting||Phase 1/Phase 2|150|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 00:49:06.651217|2017-10-11 00:49:06.651217
NCT02048319|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-05-03|||December 2013||2013-12-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|November 2015|Actual|2015-11-01||Interventional|Sclerocyst||Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts|Assessing Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Dominant Hepatic Cysts: a Randomized, Double-blind, Placebo-controlled Clinical Trial.|Completed||Phase 3|34|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 00:49:06.734875|2017-10-11 00:49:06.734875
NCT02048306|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-01-28|||January 2012||2012-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Impact of Family-based Pulmonary Rehabilitation (PR) on Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their Family Members|Rehabilitation for Elderly Patients With COPD and Their Families: Promoting a Comprehensive, Integrated Intervention Based on the International Classification of Functioning, Disability and Health (ICF)|Completed||N/A|56|Actual|Aveiro University||2|||f||||f||||||||||2017-10-11 00:49:06.824674|2017-10-11 00:49:06.824674
NCT02048293|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-28|||October 2012||2012-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules|Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules Available in Colombia for Tracheal Intubation of Adult Patients, 2012-2013|Completed||Phase 4|90|Actual|Fundación Universitaria de Ciencias de la Salud||3|||f||||f||||||||||2017-10-11 00:49:06.918082|2017-10-11 00:49:06.918082
NCT02048280|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-07-29|||December 2012||2012-12-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|June 2014|Actual|2014-06-01||Interventional|||Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support|Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support|Completed||N/A|15|Actual|ProMedica Health System||1|||f||||f||||||||||2017-10-11 00:49:07.016181|2017-10-11 00:49:07.016181
NCT02048267|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2014-11-08|||January 2012||2012-01-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis|A Prospective Study of Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis|Completed||N/A|24|Actual|Postgraduate Institute of Medical Education and Research|||2||f||||||||||||||2017-10-11 00:49:07.089455|2017-10-11 00:49:07.089455
NCT02048254|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-06-10|||February 2014||2014-02-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer|A Randomized Control Trial (RCT) of Using Iodine-125 Brachytherapy Versus Intensity-modulated Radiation Therapy (IMRT) to Treat Inoperable Salivary Gland Cancer|Recruiting||Phase 3|90|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 00:49:07.185814|2017-10-11 00:49:07.185814
NCT02048228|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-04-10|||October 2014||2014-10-01|April 2014|2014-04-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01||Interventional|GI-CT||Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS|Study of Clopidogrel and Ticagrelor Anti-Platelet Treatment Using an Individualized Strategy Based on Genotyping in Chinese ACS Patients|Unknown status|Not yet recruiting|Phase 2/Phase 3|200|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 00:49:07.57155|2017-10-11 00:49:07.57155
NCT02048215|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-27|||February 2000||2000-02-01|January 2014|2014-01-01|November 2007|Actual|2007-11-01|January 2001|Actual|2001-01-01||Interventional|||Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity|Evaluation of Diet and Treatment With a Combination of Ephedrine and Caffeine on Thermogenesis, Cardiac Function and on Uncoupling Proteins Expression in Adipose and Muscle Tissue of Morbid Obese Patients Undergoing Bariatric Surgery.|Completed||Phase 3|13|Actual|Istituto Auxologico Italiano||2|||f||||f||||||||||2017-10-11 00:49:07.691184|2017-10-11 00:49:07.691184
NCT02048202|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-05-03|||January 2014||2014-01-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|clowns||Medical Clowning in the NICU (Neonatal Intensive Care Unit and Their Effects on Parents and Staff|Effects of Medical Clowning (Dream Doctors) on the Development of the Nervous System and the Relationship Between Preterm Premature Baby Parents and NICU Staff|Unknown status|Recruiting|N/A|60|Anticipated|The Baruch Padeh Medical Center, Poriya|||1||f||||f||||||||||2017-10-11 00:49:07.835782|2017-10-11 00:49:07.835782
NCT02048189|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-09-09|||March 2012||2012-03-01|September 2015|2015-09-01||||December 2015|Anticipated|2015-12-01||Interventional|TRICIDIA||Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes|Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes: Study of Insulin Sensitivity in the 2 Types of Treatment|Unknown status|Recruiting|Phase 4|60|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:49:07.962874|2017-10-11 00:49:07.962874
NCT02048176|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-02-03|||July 2011||2011-07-01|February 2016|2016-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Posterior Fossa Mutism on Quality of Life|Long-Term Impact of Posterior Fossa Mutism on Quality of Life|Completed||N/A|24|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||Undecided||2017-10-11 00:49:08.054537|2017-10-11 00:49:08.054537
NCT02048163|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-02-04|||December 2013||2013-12-01|January 2015|2015-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis|A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients|Withdrawn||Phase 4|0|Actual|Dayton Children's Hospital|||2|No subjects enrolled|f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 00:49:08.159833|2017-10-11 00:49:08.159833
NCT02047435|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-05-22|||February 2014||2014-02-01|January 2014|2014-01-01||||August 2015|Anticipated|2015-08-01||Interventional|||Integrating Lonely Elderly Patients in Workshops in a Cartoon Museum: An Efficacy Study|Integrating Lonely Elderly Patients in Workshops in a Cartoon Museum: An Efficacy Study|Unknown status|Recruiting|N/A|50|Anticipated|Research Unit Of General Practice, Copenhagen||2|||f||||f||||||||||2017-10-11 00:49:15.512786|2017-10-11 00:49:15.512786
NCT02048150|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-06-16|||March 5, 2015|Actual|2015-03-05|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer|Intra-operative Optical Imaging Utilizing Anti-PSMA (Prostate Specific Membrane Antigen) Fluorescent Antibody During Robotic Assisted Laparoscopic Prostatectomy|Recruiting||N/A|20|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 00:49:08.270439|2017-10-11 00:49:08.270439
NCT02048137|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2015-02-07|||January 2014||2014-01-01|January 2014|2014-01-01||||December 2015|Anticipated|2015-12-01||Interventional|tDCS in IBD||Transcranial Direct Current Stimulation to Reduce Chronic Pain in Patients With Chronic Inflammatory Bowel Diseases||Unknown status|Recruiting|Phase 2|20|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:49:08.384344|2017-10-11 00:49:08.384344
NCT02048124|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-08-08|||June 2014||2014-06-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Interventional|||Study Comparing the Diagnostic Yield of Solid Lesion Biopsies Performed by EUS-FNA Using the 25d ProCor Needle Versus the Standard 25g Needle|Prospective Study Comparing the Diagnostic Yield of Solid Lesion Biopsies Performed by EUS-FNA Using the 25d ProCor Needle Versus the Standard 25g Needle.|Recruiting||N/A|224|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 00:49:08.4852|2017-10-11 00:49:08.4852
NCT02048111|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-08-19|||March 2014||2014-03-01|August 2016|2016-08-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B|Pharmacokinetics, Safety and Efficacy of Recombinant Factor IX Product, IB1001, in Patients With Severe Hemophilia B|Withdrawn||Phase 3|0|Actual|Cangene Corporation||1||The study was withdrawn from the IND.|f||||t||||||||||2017-10-11 00:49:08.606931|2017-10-11 00:49:08.606931
NCT02048098|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-01-15|||January 2014||2014-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Misoprostol for Second Trimester Termination of Pregnancy|A Comparison Between Vaginal Misoprostol vs. Buccal Misoprostol For Second Trimester Termination of Pregnancy|Completed||Phase 3|130|Actual|Ataturk University||2|||f||||f||||||||||2017-10-11 00:49:08.691268|2017-10-11 00:49:08.691268
NCT02048085|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-01-31|||February 2014||2014-02-01|January 2014|2014-01-01|July 2016|Anticipated|2016-07-01|February 2016|Anticipated|2016-02-01||Interventional|TACAT||Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis|A Randomized, Open Label, Pilot Study to Assess the Pharmacodynamics Using Vefiynow and VASP Assay; and Pharmacokinetics of Ticagrelor vs Clopidogrel in Patients Undergoing PCI With History of Fibrinolysis in 24-48 Hours|Unknown status|Not yet recruiting|Phase 4|70|Anticipated|Medical Center of South Arkansas||2|||f||||f||||||||||2017-10-11 00:49:08.791822|2017-10-11 00:49:08.791822
NCT02048072|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-03-30|2016-03-01||July 2013||2013-07-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ANSG||Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS|Funktionelle Evaluation Des Autonomen Nervensystems im Zusammenhang Mit Der Erstmaligen Einnahme Von 0,5mg Fingolimod (Gilenya) Bei Patienten Mit schubförmig Verlaufender Multipler Sklerose|Completed||Phase 4|33|Actual|Cantonal Hospital of St. Gallen||1|||f||||t||||||||||2017-10-11 00:49:08.903143|2017-10-11 00:49:08.903143
NCT02048059|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-09-20||2017-09-15|April 2014||2014-04-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases|A Phase II, Open-Label, Multi-Center Study of ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases|Completed||Phase 2|72|Actual|Angiochem Inc||1|||f||||t||||||||||2017-10-11 00:49:09.162578|2017-10-11 00:49:09.162578
NCT02048046|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2014-01-27|||June 2012||2012-06-01|January 2014|2014-01-01||||June 2013|Actual|2013-06-01||Observational|||Nutrition Therapy in Adult Patients Requiring ECMO in Australia and New Zealand||Completed||N/A|109|Actual|Australian and New Zealand Intensive Care Research Centre|||1||f||||f||||||||||2017-10-11 00:49:09.311361|2017-10-11 00:49:09.311361
NCT02048033|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-24|||January 2014||2014-01-01|January 2014|2014-01-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Assessment of the Overstich Technique for the Management of Weight Regain After Gastric Bypass.|Medico-economic Evaluation of the Management of Weight Regain After Gastric Bypass by Gastrointestinal Narrowing of Jejunal Anastomosis by Endoscopic Suturing: Apollo Endosurgery OverStitch Technical|Unknown status|Not yet recruiting|Phase 3|96|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:49:09.399071|2017-10-11 00:49:09.399071
NCT02048020|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-04-19|||December 26, 2013|Actual|2013-12-26|September 2016|2016-09-01|February 6, 2018|Anticipated|2018-02-06|January 6, 2017|Actual|2017-01-06||Interventional|||Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer|Phase II Trial Of Induction Chemotherapy Followed By Attenuated Chemoradiotherapy For Locally Advanced Head And Neck Squamous Cell Carcinoma Associated With Human Papillomavirus (HPV)|Active, not recruiting||Phase 2|26|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:49:09.507318|2017-10-11 00:49:09.507318
NCT02048007|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-10-14|||November 2014||2014-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MORDOR2||Mortality Reduction After Oral Azithromycin: Morbidity Study|Evaluating Impact of Azithromycin Mass Drug Administrations on Cause-specific Mortality and Antibiotic Resistance: Morbidity Study|Recruiting||Phase 4|72000|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 00:49:09.636424|2017-10-11 00:49:09.636424
NCT02047994|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-03-08|||March 2016|Actual|2016-03-01|March 2017|2017-03-01|December 2035|Anticipated|2035-12-01|December 2033|Anticipated|2033-12-01||Interventional|GISTAR||Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality|Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality|Recruiting||Phase 4|30000|Anticipated|International Agency for Research on Cancer||2|||f||||t||||||||||2017-10-11 00:49:09.793374|2017-10-11 00:49:09.793374
NCT02047981|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-07-07|||December 2014||2014-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MORDOR||Mortality Reduction After Oral Azithromycin: Mortality Study|Evaluating Impact of Azithromycin Mass Drug Administrations on All-cause Mortality and Antibiotic Resistance: Mortality Trial|Recruiting||Phase 4|227000|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:49:09.897708|2017-10-11 00:49:09.897708
NCT02047968|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-10-28|||February 2014||2014-02-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Wake and Light Therapy to In-patients With Major Depression: Efficacy, Predictors and Patient Experiences|Wake and Light Therapy to In-patients With Major Depression: A Randomized Controlled Trail, Efficacy, Predictors and Patient Experiences|Completed||N/A|64|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:49:10.094|2017-10-11 00:49:10.094
NCT02047955|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-03-08|||March 2014|Actual|2014-03-01|March 2017|2017-03-01|January 2034|Anticipated|2034-01-01|January 2034|Anticipated|2034-01-01|20 Years|Observational [Patient Registry]|||Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty and Fracture Patients|Tornier Shoulder Outcomes Clinical Study|Recruiting||N/A|10000|Anticipated|Tornier, Inc.|||1||f||||f||||||||No||2017-10-11 00:49:10.226457|2017-10-11 00:49:10.226457
NCT02047942|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2016-03-03|||February 2014||2014-02-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|TRiCH||Telerehabilitation in Coronary Heart Disease|A Randomized Controlled Trial Comparing Home-based Training With Telemonitoring Guidance Versus Center-based Cardiac Rehabilitation in Patients With Coronary Heart Disease: the TRiCH-study|Recruiting||Phase 3|105|Anticipated|Katholieke Universiteit Leuven||3|||f||||f||||||||||2017-10-11 00:49:10.5975|2017-10-11 00:49:10.5975
NCT02047916|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2015-07-13|||July 2014||2014-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||NeoAdapt 1: A Study of Circulatory Adaptation of Newborn Infants After Birth|NeoAdapt 1: A Study of Circulatory Adaptation of Newborn Infants After Birth|Completed||N/A|50|Actual|Brighton and Sussex University Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 00:49:10.83425|2017-10-11 00:49:10.83425
NCT02047903|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-09-05|||March 5, 2014|Actual|2014-03-05|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations|An Observational Study of GIOTRIF (Afatinib) for First Line Therapy in Patients With Advanced Non Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR)-Mutations.|Active, not recruiting||N/A|156|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 00:49:10.924757|2017-10-11 00:49:10.924757
NCT02047890|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-27|2017-07-31|||May 19, 2014|Actual|2014-05-19|July 2017|2017-07-01|April 26, 2019|Anticipated|2019-04-26|January 6, 2015|Actual|2015-01-06||Interventional|||Japanese BAY1000394 Monotherapy Phase I Study|An Open-label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Japanese Subjects With Advanced Malignancies|Active, not recruiting||Phase 1|12|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-11 00:49:11.010952|2017-10-11 00:49:11.010952
NCT02047877|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2017-02-01|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Airway Inflammatory Response During Illness in Children With Respiratory Failure|Investigation of Airway Inflammatory Response During an Acute Respiratory Illness in Pediatric Patients With Respiratory Failure|Not yet recruiting||N/A|20|Anticipated|University of North Carolina, Chapel Hill|||1||f||||t||||||Samples With DNA|"     Will bank all remaining serum, tracheal secretion, and bronchial secretion de-identified for     purposes of future unknown scientific studies designed at examining respiratory secretions in     this defined pediatric population.   "|||2017-10-11 00:49:11.120132|2017-10-11 00:49:11.120132
NCT02047864|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2017-05-02|||January 2014||2014-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of Creatine Supplementation and Exercise on Bone Health|Long-term Effects of Creatine Supplementation and Exercise Training on Bone Mineral Density and Bone Strength in Postmenopausal Women|Active, not recruiting||N/A|240|Anticipated|University of Saskatchewan||2|||f||||t||||||||No||2017-10-11 00:49:11.235864|2017-10-11 00:49:11.235864
NCT02047851|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2016-11-28|||October 2014||2014-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis|Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis|Recruiting||N/A|30|Anticipated|University Hospital, Gentofte, Copenhagen||3|||f||||t||||||||||2017-10-11 00:49:11.343074|2017-10-11 00:49:11.343074
NCT02047838|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2014-11-22|||January 2007||2007-01-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Second Laparoscopic Surgery for Recurrent Unilateral Endometriomas.|Impact on Ovarian Reserve of Second Laparoscopic Surgery for Recurrent Unilateral Endometriomas: a Case-control Study.|Completed||N/A|36|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|||2||f||||f||||||||||2017-10-11 00:49:11.439581|2017-10-11 00:49:11.439581
NCT02047825|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2016-10-30|||January 2014||2014-01-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|||Upper Limbs Intervention in Multiple Sclerosis|Intervention Focused on Lower Limbs and Functionality in Patients With Multiple Sclerosis|Completed||N/A|37|Actual|Universidad de Granada||2|||f||||t||||||||Undecided||2017-10-11 00:49:11.537719|2017-10-11 00:49:11.537719
NCT02047812|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-01-24|||January 2001||2001-01-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|December 2010|Actual|2010-12-01||Observational|||The Hospital Volume Relationship in Emergency Laparotomy Outcomes|The Hospital Volume Relationship in Emergency Laparotomy Outcomes|Completed||N/A|40000|Anticipated|University of Edinburgh|||3||f||||f||||||None Retained|"     Please note with regard to enrollment: that although this study period has ended and data is     being collated, the actual number of subjects is not known at this point since data has yet     to be received. We requested data on all subjects meeting our criteria within the time frame     mentioned.   "|||2017-10-11 00:49:11.640896|2017-10-11 00:49:11.640896
NCT02047799|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2014-01-26|||April 2013||2013-04-01|April 2013|2013-04-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Vitamin D Supplementation on Blood Pressure in Elderly People|Effect of Vitamin D Supplementation on Blood Pressure in Elderly People|Completed||Phase 2|45|Actual|Universidad de Colima||2|||f||||t||||||||||2017-10-11 00:49:11.725453|2017-10-11 00:49:11.725453
NCT02047786|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-01-24|||January 2001||2001-01-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|December 2010|Actual|2010-12-01||Observational|||A Comparison of Appendicectomy Outcomes in Children Between Paediatric and General Surgical Centres in Scotland|A Comparison of Appendicectomy Outcomes in Children Between Paediatric and General Surgical Centres in Scotland|Completed||N/A|4000|Anticipated|University of Edinburgh|||2||f||||f||||||None Retained|"     Please note that the investigators are not yet in receipt of the database required for this     study. Although the study period has ended, we are not able at present to state how many     patient episodes this database has captured.   "|||2017-10-11 00:49:11.826954|2017-10-11 00:49:11.826954
NCT02047773|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-07-19|||January 2014||2014-01-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|BLTBrIV||Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations|Bacterial Load Guided Therapy for Severe Exacerbations of Bronchiectasis Requiring IntraVenous Antibiotic Therapy- BLT Br IV Study|Recruiting||Phase 4|90|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-10-11 00:49:11.916037|2017-10-11 00:49:11.916037
NCT02047760|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-05-10|||March 2014||2014-03-01|December 2015|2015-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Neuroretinal Biomarkers in Neurodegenerative Diseases|Investigation Into the Role of Neuroretinal Biomarkers in the Phenotyping of Neurodegenerative Diseases, and Potential for Tracking Progression and Monitoring Impact of Interventions, Events and Therapies.|Completed||N/A|80|Anticipated|University of Edinburgh|||2||f||||f||||||||||2017-10-11 00:49:12.050282|2017-10-11 00:49:12.050282
NCT02047747|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-08-08|2016-06-27||February 2014||2014-02-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Phase II Study of Dacomitinib in Progressive Brain Metastases|A Phase II Study to Evaluate the Efficacy, Safety, and Central Nervous System (CNS) Pharmacokinetics of the HER Family Inhibitor Dacomitinib in Progressive Brain Metastases|Terminated||Phase 2|4|Actual|University of California, San Diego||1||slow enrollment|f||||t||||||||||2017-10-11 00:49:12.13254|2017-10-11 00:49:12.13254
NCT02047734|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2017-05-24|||December 3, 2013|Actual|2013-12-03|May 2017|2017-05-01|April 13, 2017|Actual|2017-04-13|March 27, 2017|Actual|2017-03-27||Interventional|||Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)|A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients|Completed||Phase 3|1200|Anticipated|Celgene||3|||f||||t||||||||||2017-10-11 00:49:12.476508|2017-10-11 00:49:12.476508
NCT02047721|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-08-29|||February 2014||2014-02-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||The Effects of Exercise on Appetite Regulation in Overweight/Obese Individuals|The Effects of Exercise on Appetite Regulation in Overweight/Obese Individuals|Recruiting||N/A|60|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 00:49:13.308836|2017-10-11 00:49:13.308836
NCT02047708|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-11-19|||October 2014||2014-10-01|November 2014|2014-11-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|ZEBRA||Zibotentan Better Renal Scleroderma Outcome Study|A Phase II, Single Centre, Randomised, Placebo-controlled, 3-part Trial to Assess the Safety, Tolerability and Efficacy of Zibotentan in Patients With Renal Disease Secondary to Scleroderma|Unknown status|Recruiting|Phase 2|72|Anticipated|University College, London||1|||f||||t||||||||||2017-10-11 00:49:13.402413|2017-10-11 00:49:13.402413
NCT02047695|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2017-04-03|||February 2011||2011-02-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2015|Actual|2015-04-01||Observational|WOMAN||Women With Migraine With Aura Neuroimaging Study|Women With Migraine With Aura Neuroimaging (WOMAN) Study: A Population-based Study of Danish Twins|Completed||N/A|345|Actual|Odense University Hospital|||1||f||||f||||||||||2017-10-11 00:49:13.485598|2017-10-11 00:49:13.485598
NCT02047682|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2014-09-29|||February 2014||2014-02-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|IRMA10||Implementation of Physical Exercise at the Workplace (IRMA10) - Occupational Load|Implementation of Physical Exercise at the Workplace (IRMA10) - Occupational Load|Completed||N/A|36|Actual|National Research Centre for the Working Environment, Denmark||2|||f||||f||||||||||2017-10-11 00:49:13.572812|2017-10-11 00:49:13.572812
NCT02047669|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2015-09-01|||March 2014||2014-03-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|IRMA||Implementation of Physical Exercise at the Workplace (IRMA09) - Laboratory Technicians|Implementation of Physical Exercise at the Workplace (IRMA09) - Laboratory Technicians|Completed||N/A|112|Actual|National Research Centre for the Working Environment, Denmark||2|||f||||f||||||||||2017-10-11 00:49:13.651989|2017-10-11 00:49:13.651989
NCT02047656|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2016-03-30|||August 2013||2013-08-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension|A Two Part Study Including a Randomized, Double Blind, Placebo Controlled, Multiple Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LFF269 After b.i.d Dosing in Healthy Volunteers and an Open Label, Multiple Dose Pharmacokinetics Study in Hypertension Subjects|Terminated||Phase 1|93|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:49:13.736086|2017-10-11 00:49:13.736086
NCT02047643|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-24|||January 2014||2014-01-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol||Unknown status|Recruiting|N/A|30|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 00:49:13.831495|2017-10-11 00:49:13.831495
NCT02047630|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2017-07-23|||January 2014||2014-01-01|July 2017|2017-07-01|December 4, 2014|Actual|2014-12-04|December 4, 2014|Actual|2014-12-04||Interventional|||Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension||Terminated||Phase 4|60|Anticipated|CHU de Quebec-Universite Laval||2||Problem with IP supply|f||||f||||||||||2017-10-11 00:49:13.942046|2017-10-11 00:49:13.942046
NCT02047617|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-02-24|||August 2013||2013-08-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|TILT||Study of Safety and Efficacy on Neuromyopathy of Early Standing With the Assistance of Tilt Table in Critically Patients|Study of Safety and Efficacy on Neuromyopathy of Early Standing With the Assistance of Tilt Table in Critically Patients|Completed||N/A|145|Actual|Centre Chirurgical Marie Lannelongue||2|||f||||t||||||||||2017-10-11 00:49:14.038132|2017-10-11 00:49:14.038132
NCT02047604|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-04-26|||December 2013|Actual|2013-12-01|April 2017|2017-04-01|March 23, 2017|Actual|2017-03-23|February 23, 2017|Actual|2017-02-23||Interventional|||(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis|A Randomized, Double-blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Escalating Doses of SAN-300 in Patients With Active Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Anti-rheumatic Drug(s).|Completed||Phase 2|41|Actual|Valeant Pharmaceuticals International, Inc.||5|||f||||t||||||||||2017-10-11 00:49:14.140098|2017-10-11 00:49:14.140098
NCT02047591|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2016-08-16|||February 2014||2014-02-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Observational|TOUTETDOU||Study of a Therapy Without Drugs, Supplementary to an Usual Treatment for the Pains Caused by Removing the Redon's Drain From a 7 to 17 Years Old Child in Pediatric Surgery.|Study of a Therapy Without Drugs, Supplementary to an Usual Treatment for the Pains Caused by Removing the Redon's Drain From a 7 to 17 Years Old Child in Pediatric Surgery.|Recruiting||N/A|232|Anticipated|University Hospital, Limoges|||2||f||||f||||||||||2017-10-11 00:49:14.261073|2017-10-11 00:49:14.261073
NCT02047578|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-04-26|||January 2014||2014-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.|Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Childhood and Adolescent Acute Lymphoblastic Leukemia|Recruiting||Phase 2|28|Anticipated|Seoul National University Hospital||1|||f||||t||||||||Undecided||2017-10-11 00:49:14.336215|2017-10-11 00:49:14.336215
NCT02047565|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-01-14|||October 2013||2013-10-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation|A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation|Completed||Phase 1|110|Actual|Daiichi Sankyo, Inc.||5|||f||||f||||||||||2017-10-11 00:49:14.436178|2017-10-11 00:49:14.436178
NCT02047552|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2016-11-17|||January 2015||2015-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Randomized Controlled Pilot Study of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients With Functional Iron Deficiency, With and Without Oxandrolone|A Randomized Controlled Pilot Study of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients With Functional Iron Deficiency, With and Without Oxandrolone|Recruiting||Phase 2|40|Anticipated|Denver Health and Hospital Authority||4|||f||||t||||||||||2017-10-11 00:49:14.563226|2017-10-11 00:49:14.563226
NCT02047539|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-07-12|||January 2015||2015-01-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis|Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Patients With the Clinical Risk Syndrome for Psychosis|Recruiting||Early Phase 1|40|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 00:49:14.714203|2017-10-11 00:49:14.714203
NCT02047526|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-01-27|||November 2013||2013-11-01|January 2014|2014-01-01||||July 2014|Anticipated|2014-07-01||Observational|||A Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in India|A Non-interventional, Prospective Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in India|Withdrawn||N/A|0|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-11 00:49:14.8075|2017-10-11 00:49:14.8075
NCT02047513|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-01-26|||April 2015||2015-04-01|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|March 2019|Anticipated|2019-03-01||Interventional|NEONAX||Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer|Neoadjuvant Plus Adjuvant or Only Adjuvant Nab-Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer: A Prospective, Randomized, Controlled, Phase II Study of the AIO (Working Group for Medical Oncology From the German Cancer Society) Pancreatic Cancer Group|Recruiting||Phase 2|166|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-10-11 00:49:14.874367|2017-10-11 00:49:14.874367
NCT02047487|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-26|2014-01-26|||May 2013||2013-05-01|January 2014|2014-01-01|August 2018|Anticipated|2018-08-01|August 2014|Anticipated|2014-08-01|5 Years|Observational [Patient Registry]|||After Induction Chemotherapy of DP Plus DDP Concurrent Radiotherapy With and Without Bevacizumab Study|Docetaxel (T), Cisplatin (P) After Induction Chemotherapy With and Without Cisplatin (P) Concurrent Radiotherapy (X) Plus Bevacizumab (B) Phase II Clinical Study|Recruiting||N/A|120|Anticipated|Chinese PLA General Hospital|||1||f||||t||||||||||2017-10-11 00:49:15.119855|2017-10-11 00:49:15.119855
NCT02047474|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-01-18|||September 2013||2013-09-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer|Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer|Recruiting||Phase 2|46|Anticipated|Yale University||1|||f||||||||||||||2017-10-11 00:49:15.194704|2017-10-11 00:49:15.194704
NCT02047461|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-02-06|||April 2014||2014-04-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP|A Phase 2, Multicenter, Multinational, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of ALXN1101 in Pediatric Patients With Molybdenum Cofactor Deficiency (MoCD) Type A Currently Treated With Recombinant Escherichia Coli-derived Cyclic Pyranopterin Monophosphate (rcPMP)|Active, not recruiting||Phase 2|7|Actual|Alexion Pharma GmbH||1|||f||||t||||||||||2017-10-11 00:49:15.329655|2017-10-11 00:49:15.329655
NCT02047448|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-04-28|||January 2014||2014-01-01|April 2017|2017-04-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|||Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model|Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model|Completed||Phase 2/Phase 3|180|Actual|Wilkes University||2|||f||||f||||||||||2017-10-11 00:49:15.426977|2017-10-11 00:49:15.426977
NCT02047422|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-09-05|||January 2014||2014-01-01|September 2016|2016-09-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)||Withdrawn||N/A|0|Actual|Yonsei University||4||One of the diuretic which is planned to be used in the study is no longer available.|f||||t||||||||||2017-10-11 00:49:15.594956|2017-10-11 00:49:15.594956
NCT02047409|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-09-18|||October 2013||2013-10-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01|12 Months|Observational [Patient Registry]|||Prognostic Value of Sympathetic Modulation in Patients With Heart Failure|Prognostic Value of Oscillatory Pattern of Sympathetic Nerve Activity Muscle in Patients With Heart Failure|Unknown status|Recruiting|N/A|160|Anticipated|University of Sao Paulo General Hospital|||1||f||||t||||||||||2017-10-11 00:49:15.667864|2017-10-11 00:49:15.667864
NCT02047396|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-07-14|||January 2014||2014-01-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study|Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study|Recruiting||N/A|420|Anticipated|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"     Plasma, serum, and WBCs   "|||2017-10-11 00:49:15.737803|2017-10-11 00:49:15.737803
NCT02047383|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-11-02|||January 2014||2014-01-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Observational|||Hospital Stay and Respiratory Infection|Repercussion of Hospital Stay in Patients With Respiratory Infection|Completed||N/A|116|Actual|Universidad de Granada|||1||f||||t||||||||Undecided||2017-10-11 00:49:15.807694|2017-10-11 00:49:15.807694
NCT02047370|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-12-03|||January 2014||2014-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Manual Therapy in Patients With Asthma|Effects of Manual Therapy in Patients With Asthma|Suspended||N/A|60|Anticipated|Universidad de Granada||2||The sample size was not completed|f||||t||||||||||2017-10-11 00:49:15.887356|2017-10-11 00:49:15.887356
NCT02047357|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-08-15|||December 2013||2013-12-01|August 2015|2015-08-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|ROSHNI||Participatory Intervention to Reduce Maternal Depression and Under Five Child Morbidity|Participatory Intervention to Reduce Maternal Depression and Under Five Child Morbidity- A Cluster-Randomized Controlled Trial|Unknown status|Recruiting|Phase 1|600|Anticipated|Pakistan Institute of Learning and Living||2|||f||||t||||||||||2017-10-11 00:49:15.962161|2017-10-11 00:49:15.962161
NCT02047344|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-08-15|||October 2013||2013-10-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC|A Single-Arm, Open-Label, Phase II Trial Evaluating the Efficacy, Safety and Pharmacokinetics of Antroquinonol in Patients With Stage IV (Including Pleural Effusion) Non Squamous NSCLC Who Have Failed Two Lines of Anti-Cancer Therapy|Recruiting||Phase 2|60|Anticipated|Golden Biotechnology Corporation||1|||f||||t||||||||||2017-10-11 00:49:16.07005|2017-10-11 00:49:16.07005
NCT02047331|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-27|||February 2013||2013-02-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Periarticular Injection Versus Fascia Iliaca Block for Total Knee Arthroplasty|Multimodal Periarticular Injection Versus Fascia Iliaca Compartment Block for Total Knee Arthroplasty|Completed||Phase 4|66|Actual|Baskent University||2|||f||||t||||||||||2017-10-11 00:49:16.187335|2017-10-11 00:49:16.187335
NCT02047318|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-01-19|||December 2013||2013-12-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|IMAGINE||An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)|A Multicentre Extension Study to Evaluate the Long-Term Safety and Durability of the Therapeutic Effect of LUM001, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome|Active, not recruiting||Phase 2|19|Anticipated|Shire||1|||f||||f||||||||||2017-10-11 00:49:16.433868|2017-10-11 00:49:16.433868
NCT02047305|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-11-29|||January 2009||2009-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2011|Actual|2011-08-01||Interventional|||Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia|A Single-center Trial of Endoscopic Radiofrequency Ablation of Moderate and High-grade Intra-epithelial Squamous Neoplasia and Early Flat-type Squamous Cell Carcinoma Using the HALO Ablation System|Completed||N/A|100|Actual|Medtronic - MITG||1|||f||||t||||||||No||2017-10-11 00:49:16.520238|2017-10-11 00:49:16.520238
NCT02047292|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-24|||January 2014||2014-01-01|January 2014|2014-01-01|July 2016|Anticipated|2016-07-01|February 2016|Anticipated|2016-02-01||Interventional|DROMDP||Dynamic ROM Via Gait Analysis and 3D Fluoroscopy in THA With Different Head Diameters|Dynamic Range of Motion (ROM) Assessment Using Gait Analysis and Three-dimensional Fluoroscopy in Patients Treated by Total Hip Arthroplasty (THA) With Different Head Diameters|Unknown status|Recruiting|N/A|45|Anticipated|Istituto Ortopedico Rizzoli||3|||f||||f||||||||||2017-10-11 00:49:16.628965|2017-10-11 00:49:16.628965
NCT02047279|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-09-07|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|ALARM-vs-AF||Ablation and Left Atrium Reduction During Mitral Valve Surgery for Atrial Fibrillation|Left Atrium Reduction Versus no Left Atrium Reduction for Patients With Enlarged Left Atria and Persistent or Long Standing Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery|Completed||N/A|120|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-11 00:49:16.733641|2017-10-11 00:49:16.733641
NCT02047266|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2015-12-19|||January 2014||2014-01-01|December 2015|2015-12-01|June 2019|Anticipated|2019-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparative Effectiveness of the Minimally Invasive Coronary Artery Bypass Grafting|Comparative Effectiveness of the Minimally Invasive Coronary Artery Bypass Grafting (MICS CABG) Versus Off Pump (OPCABG) and on Pump Coronary Artery Bypass Grafting (ONCABG) in Patients With Multi-vessel Coronary Disease|Recruiting||N/A|150|Anticipated|Vitebsk Regional Clinical Hospital||3|||f||||t||||||||||2017-10-11 00:49:16.840134|2017-10-11 00:49:16.840134
NCT02047253|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-06-22|||April 2014|Actual|2014-04-01|June 2017|2017-06-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment|A Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Chemotherapy and Androgen Pathway Inhibitors|Active, not recruiting||Phase 2|28|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||No||2017-10-11 00:49:16.981557|2017-10-11 00:49:16.981557
NCT02047240|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-06-07|||April 2013||2013-04-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|||Renal Function Determination in Patients With Liver Cirrhosis|Renal Function Determination With Creatinine and Cystatin C Dependent Formulas Compared to Gold Standard DTPA-TC-99 (Diethylene-triamine-pentaacetate- Technetium-99) in Mexican Cirrhotic Patients|Completed||N/A|92|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||f||||||||||2017-10-11 00:49:17.098783|2017-10-11 00:49:17.098783
NCT02047227|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-07-24|2016-08-24||January 31, 2014|Actual|2014-01-31|July 2017|2017-07-01|August 31, 2015|Actual|2015-08-31|August 31, 2015|Actual|2015-08-31||Interventional|ESPART|All Randomized Subjects Set included all subjects who were randomized.|Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)|A Phase III, Randomized, Controlled, Single-blind, Multicentre, Parallel Arm Trial to Assess the Efficacy and Safety of Pergoveris® (Follitropin Alfa and Lutropin Alfa) and GONAL-f® (Follitropin Alfa) for Multifollicular Development as Part of an Assisted Reproductive Technology Treatment Cycle in Poor Ovarian Responders, as Defined by the European Society of Human Reproduction and Embryology Criteria|Completed||Phase 3|939|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-11 00:49:17.205035|2017-10-11 00:49:17.205035
NCT02047214|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-01-26|||January 2014||2014-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy|Phase 2 Dose-Escalation Study of TPI 287 in Combination With Bevacizumab in Adults With Recurrent or Progressive Glioblastoma Following a Bevacizumab-Containing Regimen|Terminated||Phase 2|17|Actual|Cortice Biosciences, Inc.||1||Due to lack of clinical benefit in the 17 subjects enrolled in the trial to date|f||||f||||||||||2017-10-11 00:49:18.171272|2017-10-11 00:49:18.171272
NCT02047201|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-03-01|||June 2013||2013-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC|Assessing Tumor Response and IMRT Treatment Planning After Induction Chemotherapy Based on FDG-PET/CT for Locally Advanced Head and Neck Squamous Cell Carcinoma.|Completed||Phase 2|40|Actual|Lithuanian University of Health Sciences||1|||f||||t||||||||Yes|3-7/07/2016 in ASCO (American Society of Clinical Oncology) Annual Meeting, Chicago|2017-10-11 00:49:18.311534|2017-10-11 00:49:18.311534
NCT02047188|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2014-01-25|||January 2010||2010-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|||Observation of Microvessels and Invasion in Early Colorectal Lesions by NBI|Observation of Microvessels and Invasion in Early Colorectal Lesions by Narrow Band Imaging:Combination With Microvessel Count and MMP-7 Expression|Completed||N/A|418|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples Without DNA|"     Samples after biopsy or resection are to be retained.   "|||2017-10-11 00:49:18.424145|2017-10-11 00:49:18.424145
NCT02047175|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-04-16|||February 2014||2014-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)|A Randomized, Open-label, Multiple-dose, Two-arm, One-sequence • Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration Telmisartan/S-amlodipine and Rosuvastatin in Healthy Volunteers|Completed||Phase 1|64|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 00:49:18.519006|2017-10-11 00:49:18.519006
NCT02047162|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-02-03|||May 2014||2014-05-01|February 2015|2015-02-01||||September 2014|Actual|2014-09-01||Interventional|||Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan|Randomized, Double-blind, Placebo-controlled Trial of the Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients in Pakistan|Completed||N/A|400|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 00:49:18.648067|2017-10-11 00:49:18.648067
NCT02047149|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-09-29|||January 2014||2014-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia|Phase I Study to Evaluate the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Patients With Chronic Myelogenous Leukemia|Terminated||Phase 1|2|Actual|University of Massachusetts, Worcester||1||Low accrual|f||||t||||||||||2017-10-11 00:49:18.788481|2017-10-11 00:49:18.788481
NCT02047136|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-02-18|||September 2013||2013-09-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DTCU||Dietary Treatment for Chronic Urticaria|Can Low Histamine Diet Reduce Symptoms of Patients With Idiopathic Urticaria?|Recruiting||N/A|78|Anticipated|Hong Kong Sanatorium & Hospital||2|||f||||t||||||||||2017-10-11 00:49:18.921002|2017-10-11 00:49:18.921002
NCT02047123|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-07-19|||November 2012||2012-11-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|flaxseed||Nutritional Intervention With Yogurt and Flaxseed in Women With Profiles Lipi|Nutritional Intervention With Yogurt and Flaxseed in Women With Profiles Lipidic to the Limit: A Randomized Controlled Trial|Completed||N/A|89|Actual|Universidad Miguel Hernandez de Elche||1|||f||||t||||||||||2017-10-11 00:49:19.036273|2017-10-11 00:49:19.036273
NCT02047110|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2016-11-15|||January 2014||2014-01-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|March 2015|Actual|2015-03-01||Interventional|||BI 655066 Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)|A 48 Weeks, Phase II, Randomized, Double-blind, Placebo-controlled, Proof of Concept and Dose Finding Study of Three Different Dose Regimens of BI 655066 Administered Subcutaneously in Patients With Ankylosing Spondylitis.|Completed||Phase 2|159|Actual|AbbVie||4|||f||||||||||||||2017-10-11 00:49:19.143234|2017-10-11 00:49:19.143234
NCT02047097|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-10-04|||November 30, 2013|Actual|2013-11-30|October 2017|2017-10-01|February 28, 2024|Anticipated|2024-02-28|February 28, 2024|Anticipated|2024-02-28|5 Years|Observational [Patient Registry]|ESTEEM||Dimethyl Fumarate (DMF) Observational Study|A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)|Recruiting||N/A|5000|Anticipated|Biogen|||1||f||||f||||||||||2017-10-11 00:49:19.408549|2017-10-11 00:49:19.408549
NCT02047084|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-04-13|||June 2013||2013-06-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01|5 Months|Observational [Patient Registry]|||Comparison of Human Allograft to Apligraf for Venous Leg Ulcers|Proposal for a Single [Multi] Center Site Randomized, Prospective Controlled Head-to-head Clinical Trial Comparing a Bioengineered Skin Substitute to a Biologically Active Human Skin Allograft for the Treatment of Venous Leg Ulcers.|Recruiting||N/A|50|Anticipated|Soluble Systems, LLC|||2||f||||t||||||||||2017-10-11 00:49:20.463686|2017-10-11 00:49:20.463686
NCT02047071|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2015-08-17|||February 2014||2014-02-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of CPAP Treatment in Women With Moderate-to-severe OSA.|Effect of Continuous Positive Airways Pressure (CPAP) in Women With Moderate-to-severe Obstructive Sleep Apnea (OSA). A Multicenter, Randomized, Controlled Trial.|Completed||N/A|307|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||f||||||||||2017-10-11 00:49:20.556399|2017-10-11 00:49:20.556399
NCT02047058|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-25|||March 2014||2014-03-01|January 2014|2014-01-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|||Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics|A Multi-center, Prospective, Observational Study of Analysis of Q Cell Markers in Patients With Newly Diagnosed Primary Glioblastoma (Phase IV)|Unknown status|Not yet recruiting|N/A|240|Anticipated|Nanfang Hospital of Southern Medical University|||1||f||||t||||||Samples With DNA|"     tumor sample   "|||2017-10-11 00:49:20.66856|2017-10-11 00:49:20.66856
NCT02047045|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-10-05|||April 2014||2014-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Effect Comparison of Electro-acupuncture and Prucalopride for Severe Chronic Constipation: a Randomized Controlled Trial|Effect Comparison of Electro-acupuncture and Prucalopride for Severe Chronic Constipation: a Multi-center Noninferiority Randomized Controlled Trial|Completed||N/A|560|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||Yes||2017-10-11 00:49:20.791969|2017-10-11 00:49:20.791969
NCT02047032|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-10-06|||April 2014||2014-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Effect of Electroacupuncture Versus PFMT Plus Solifenacin for Mixed Urinary Incontinence|Effect of Electroacupuncture Versus PFMT Plus Solifenacin for Moderate and Severe Mixed Urinary Incontinence in Female: a Multicenter, Noninferiority, Randomized Controlled Trial|Completed||N/A|500|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||Yes||2017-10-11 00:49:20.908781|2017-10-11 00:49:20.908781
NCT02047019|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-05-19|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 8, 2019|Anticipated|2019-12-08|December 8, 2019|Anticipated|2019-12-08||Interventional|||Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil|A Multicenter, Randomized, Double-Blind, Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination Taken Orally for 8 Weeks in Adult Subjects With Essential Hypertension Who Are Inadequately Controlled on 16 mg Candesartan Cilexetil Monotherapy|Withdrawn||Phase 3|0|Actual|Bayer||3||GPDC decided to terminate the study|f||||f|t|f||||||||2017-10-11 00:49:21.041919|2017-10-11 00:49:21.041919
NCT02047006|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2015-01-13|||September 2013||2013-09-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|||Dose-finding of Rivaroxaban in Hemodialysis|Finding the Optimal Dose of Rivaroxaban in Hemodialysis Patients|Completed||Phase 4|18|Actual|AZ Sint-Jan AV||1|||f||||t||||||||||2017-10-11 00:49:21.202055|2017-10-11 00:49:21.202055
NCT02046993|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2016-10-18|2015-12-14||January 2014||2014-01-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Smart Phone Based Telemonitoring on Blood Pressure Among Hypertensive Patients in Primary Care|Effect of Smart Phone Based Telemonitoring on Blood Pressure Among Hypertensive Patients in Primary Care|Completed||N/A|210|Actual|Kwong Wah Hospital|The baseline mean Clinic SBP and DBP as well as the baseline mean home SBP and DBP of both the control and intervention group were already within the optimal range.|2|||f||||t||||||||||2017-10-11 00:49:21.317033|2017-10-11 00:49:21.317033
NCT02046980|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-25|2016-02-12|2015-12-04||September 2013||2013-09-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||217 patients enrolled in the study but 8 retracted their agreements.|Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo||Completed||Phase 2|209|Actual|Keimyung University Dongsan Medical Center||3|||f||||f||||||||||2017-10-11 00:49:21.939412|2017-10-11 00:49:21.939412
NCT02046967|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-27|||November 2009||2009-11-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|LAST||Steam Ablation Versus Endovenous Laser Ablation for the Treatment of Great Saphenous Veins|Comparative Randomized Clinical Trial of Steam Ablation Versus Endovenous Laser Ablation for the Treatment of Great Saphenous Veins|Completed||N/A|237|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 00:49:22.231329|2017-10-11 00:49:22.231329
NCT02046954|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-01-25|||October 2012||2012-10-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|EVENT||EVENT - Evaluation of the Influence of hTEE|Retrospective Matched Pair Analyses for Evaluating the Influence of Hemodynamically Focussed Transesophageal Echocardiography (hTEE) on Postoperative Outcome in Cardiosurgery Patients|Completed||N/A|36|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 00:49:22.311465|2017-10-11 00:49:22.311465
NCT02046941|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-07-24|||March 1, 2014|Actual|2014-03-01|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|January 8, 2018|Anticipated|2018-01-08||Interventional|SPT||Brain Biomarkers of Response to Treatment for Apraxia of Speech|Brain Biomarkers of Response to Treatment for Apraxia of Speech|Recruiting||N/A|44|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-11 00:49:22.383886|2017-10-11 00:49:22.383886
NCT02046928|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-07-11|||February 2014||2014-02-01|December 2015|2015-12-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)|A Phase 2 Trial to Determine the Safety, Tolerability, and Efficacy of A6, a CD44 Binding Peptide, for the Treatment of Patients With Chronic Lymphocytic Leukemia|Terminated||Phase 2|5|Actual|Ångstrom Pharmaceuticals||1||Slow enrollment|f||||f||||||||||2017-10-11 00:49:22.499175|2017-10-11 00:49:22.499175
NCT02046915|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-10-25|||April 2014||2014-04-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2016|Actual|2016-08-01||Interventional|PERSPECTIVE||Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide|Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE in RelapSed Myeloma Plus rEsponse Adapted Cyclophosphamide as a Tailored InnoVativE Strategy|Active, not recruiting||Phase 2|60|Actual|University Hospital Tuebingen||1|||f||||t||||||||||2017-10-11 00:49:22.576475|2017-10-11 00:49:22.576475
NCT02029612|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-02-27|||April 2014||2014-04-01|February 2014|2014-02-01||||April 2019|Anticipated|2019-04-01||Interventional|||An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy)|An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 00:53:24.998401|2017-10-11 00:53:24.998401
NCT02046902|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-02-09|||September 2014||2014-09-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|DECIDE-PCI||Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection|Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection|Completed||N/A|695|Actual|University of Missouri, Kansas City|||2||f||||t||||||||Undecided|We would be happy to collaborate with others to run analyses, but do not plan on freely distributing our data. You can see my editorial in CCQO to understand my concerns.|2017-10-11 00:49:22.646197|2017-10-11 00:49:22.646197
NCT02046889|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-01-24|||June 2010||2010-06-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||A Bicycle Training Intervention|The Effects of a Bicycle Training Intervention on Health, Physical Activity, Sleep & Community Participation in Youth With Down Syndrome & Autism Spectrum Disorders|Completed||N/A|155|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 00:49:22.709318|2017-10-11 00:49:22.709318
NCT02046876|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2014-01-24|||January 2013||2013-01-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Swimming Adapted, Therapeutic Exercise and Health Education in the Treatment of Chronic Neck Pain||Completed||N/A|175|Actual|University of Malaga||1|||f||||t||||||||||2017-10-11 00:49:22.782911|2017-10-11 00:49:22.782911
NCT02046863|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-08-15|2016-06-27||November 2013||2013-11-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot Study for Automated Deep Brain Stimulation Programming|DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping - Phase I|Completed||N/A|7|Actual|Great Lakes NeuroTechnologies Inc.||1|||f||||||||||||||2017-10-11 00:49:22.853837|2017-10-11 00:49:22.853837
NCT02046850|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-04-28|||February 2014||2014-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers|A Phase I Open-label, Single-center Study to Assess the Effect of the CYP3A4 Inducer Rifampicin on the Pharmacokinetics of a 75 mg Single Oral Dose of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Volunteers Aged 18 to 45 Years|Completed||Phase 1|24|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:49:23.000235|2017-10-11 00:49:23.000235
NCT02046837|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-09-21|||November 2013||2013-11-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ADT Ex RCT||An Exercise Trial and Economic Analysis in Men With Prostate Cancer|A Pilot RCT and Economic Analysis of Three Exercise Delivery Methods in Men With Prostate Cancer on ADT|Active, not recruiting||Phase 2|100|Anticipated|University Health Network, Toronto||3|||f||||f||||||||||2017-10-11 00:49:23.093694|2017-10-11 00:49:23.093694
NCT02046824|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-12-15|||January 2014||2014-01-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Cell Savers and Blood Quality|The Rheologic Properties and Oxygen Transport Capacity of Red Blood Cells Processed by 3 Different Types of Cell Saving, and Its Effects on Microcirculatory Blood Flow and Tissue Oxygenation in Vivo|Terminated||N/A|200|Anticipated|University Medical Center Groningen||4|||f||||f||||||||||2017-10-11 00:49:23.178769|2017-10-11 00:49:23.178769
NCT02046811|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-08-17|||March 2015||2015-03-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Reducing Skin Cancer Risk in Childhood Cancer Survivors|Reducing Skin Cancer Risk in Childhood Cancer Survivors|Enrolling by invitation||N/A|801|Anticipated|Harvard School of Public Health||3|||f||||f||||||||No||2017-10-11 00:49:24.966068|2017-10-11 00:49:24.966068
NCT02046798|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-01-24|||July 2012||2012-07-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652|An Open Label Study to Evaluate the Pharmacokinetics of ASP3652 After a Single Oral Dose of 14C-labeled ASP3652 in Healthy Caucasian Male Subjects|Completed||Phase 1|6|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:49:25.115263|2017-10-11 00:49:25.115263
NCT02046785|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-01-24|||April 2013||2013-04-01|January 2014|2014-01-01|May 2014|Anticipated|2014-05-01|September 2013|Actual|2013-09-01||Interventional|HMDIH||Hemodynamic Measurements at Different Inclinations of the Head|Comparison of CVP Values , ΔPP and Echocardiographic at Different Angles Headwaters Before and After Volume Challenge|Unknown status|Recruiting|N/A|30|Anticipated|Federal University of Uberlandia||1|||f||||t||||||||||2017-10-11 00:49:25.200078|2017-10-11 00:49:25.200078
NCT02046772|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-07-15|2014-08-05||March 2012||2012-03-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Efficacy of the Addition of Morphine Chloride to a Low Dose of Bupivacaine as Intradural Anaesthetic for the Removal Surgery of the Hemorrhoids|Assessment of the Analgesic Efficacy of Morphine Chloride in Addition to a Low Dose Solution of Spinal Anaesthetic in Hemorrhoidectomy Compared to a Standard Dose of Spinal Local Anaesthetic. Simple Blind, Randomized, With Blinded Evaluation by Third Parties Clinical Trial.|Completed||Phase 4|63|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias||2|||f||||f||||||||||2017-10-11 00:49:25.303043|2017-10-11 00:49:25.303043
NCT02046759|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2014-01-24|||March 2012||2012-03-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Comparative Study of an Integrated Pharmaceutical Care Plan and a Routine Care in Bronchial Asthma|A Comparative Study of an Integrated Pharmaceutical Care Plan and a Routine Care in Bronchial Asthma|Completed||N/A|80|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:49:25.772083|2017-10-11 00:49:25.772083
NCT02046746|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-08-29|||November 2013||2013-11-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status|The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status and Other Outcomes|Completed||N/A|53|Actual|Abbott Nutrition||1|||f||||f||||||||||2017-10-11 00:49:25.848812|2017-10-11 00:49:25.848812
NCT02046733|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-11-01|||July 2014||2014-07-01|November 2016|2016-11-01|January 2022|Anticipated|2022-01-01|October 2019|Anticipated|2019-10-01||Interventional|STIMULI||Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease|A Randomised Open-label Phase II Trial of Consolidation With Nivolumab and Ipilimumab in Limited-stage SCLC After Chemo-radiotherapy|Recruiting||Phase 2|260|Anticipated|European Thoracic Oncology Platform||2|||f||||t||||||||No||2017-10-11 00:49:25.93556|2017-10-11 00:49:25.93556
NCT02025998|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-02-19|||December 2013||2013-12-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Development of Ibudilast for Alcohol Use Disorder|Development of Ibudilast as a Novel Treatment for Alcohol Dependence|Completed||Phase 1|24|Actual|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-11 00:54:15.087744|2017-10-11 00:54:15.087744
NCT02046720|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-03-22|||June 2010||2010-06-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Influence of Age on Bispectral Index Associated With Propofol-induced Sedation|The Influence of Age on Bispectral Index Associated With Propofol-induced Sedation|Completed||Phase 3|70|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||No||2017-10-11 00:49:26.330519|2017-10-11 00:49:26.330519
NCT02046707|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-01-24||||||April 2011|2011-04-01||||July 2014|Anticipated|2014-07-01||Interventional|||Evaluation of the Effects of Eccentric Muscle Training Versus Conventional Concentric Training in Chronic Heart Failure|Evaluation of the Effects of Eccentric Muscle Training Versus Conventional Concentric Training in Chronic Heart Failure|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:49:26.41476|2017-10-11 00:49:26.41476
NCT02046694|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-08-14|||January 2014||2014-01-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL|A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL|Recruiting||Early Phase 1|14|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:49:26.50072|2017-10-11 00:49:26.50072
NCT02046681|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-03-02|||June 2014||2014-06-01|June 2014|2014-06-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01|2 Weeks|Observational [Patient Registry]|MOSE65||Monitoring Side Effects Of Pain Medication Prescribing By Emergency Department In Patients Over 65|Monitoring Side Effects Of Pain Medication Prescribing By Emergency Department In Patients Over 65. The MOSE65 Study|Completed||N/A|1000|Anticipated|Azienda Ospedaliera S. Maria della Misericordia|||1||f||||t||||||||||2017-10-11 00:49:26.623104|2017-10-11 00:49:26.623104
NCT02046655|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-05-13|||January 2011||2011-01-01|May 2014|2014-05-01||||March 2014|Actual|2014-03-01||Interventional|||Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI|Corifollitropin Alfa Compared to Daily Rec FSH in Poor Responders Undergoing ICSI Using a GnRH Antagonist Protocol|Completed||Phase 4|80|Actual|Aristotle University Of Thessaloniki||2|||f||||||||||||||2017-10-11 00:49:26.797321|2017-10-11 00:49:26.797321
NCT02046642|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-24|||March 2013||2013-03-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Maternal Rest and Resting Positions on Amniotic Fluid|Effect of Maternal Rest and Resting Positions on Amniotic Fluid: A Randomized Prospective Study|Completed||N/A|69|Actual|Kafkas University||2|||f||||f||||||||||2017-10-11 00:49:26.881052|2017-10-11 00:49:26.881052
NCT02046629|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-08-20|||May 2014||2014-05-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers|An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Profiles of 14 mg Teriflunomide Tablet in Healthy Chinese Subjects|Completed||Phase 1|12|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:49:26.970714|2017-10-11 00:49:26.970714
NCT02046590|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-24|2017-08-01|||February 2014||2014-02-01|August 2017|2017-08-01||||June 2019|Anticipated|2019-06-01||Interventional|||RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP|A Randomized Controlled Trial (RCT) of Efficacy and Safety of Sedation Compared to General Anesthesia for Endoscopic Retrograde Cholangio-pancreatography|Recruiting||N/A|132|Anticipated|Erasme University Hospital||2|||f||||f||||||||||2017-10-11 00:49:27.33747|2017-10-11 00:49:27.33747
NCT02046577|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-10-10|||February 2014||2014-02-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Study of Vitamin D for the Prevention of Acute Respiratory Infections in Children|A Randomized, Double-blind, Controlled Trial of Vitamin D for the Prevention of Acute Respiratory Infections in Children Aged 18 to 36 Months in Santiago, Coyhaique and Punta Arenas, Chile|Completed||Phase 2|276|Actual|Pontificia Universidad Catolica de Chile||3|||f||||f||||||||Undecided||2017-10-11 00:49:27.459662|2017-10-11 00:49:27.459662
NCT02046551|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-05-19|||April 2014||2014-04-01|May 2017|2017-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers||Withdrawn||Phase 1/Phase 2|0|Actual|Yale University||2||funding lost|f||||t||||||||||2017-10-11 00:49:27.791248|2017-10-11 00:49:27.791248
NCT02046538|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-01-23|||February 2014||2014-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer|Phase II Study of Preoperative Chemotherapy With Ziv-aflibercept (Zaltrap) Followed by Postoperative Chemotherapy With or Without Ziv-aflibercept (Zaltrap) in Patients With Advanced Resectable Colorectal Cancer|Withdrawn||Phase 2|0|Actual|Weill Medical College of Cornell University||2||Investigator terminated due to funding issues|f||||t||||||||No||2017-10-11 00:49:27.883286|2017-10-11 00:49:27.883286
NCT02046525|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-08-11|||March 2014||2014-03-01|August 2015|2015-08-01|October 2015|Anticipated|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Autologous Fecal Therapy|Restoration of the Fecal Microbiome After Antimicrobial Exposure With Autologous Fecal Flora Restoration Therapy|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 00:49:27.982908|2017-10-11 00:49:27.982908
NCT02046512|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-08-11|||January 2014||2014-01-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Probiotics to Promote Intestinal Health|Randomized Controlled Trial of Lactobacillus Rhamnosus GG to Promote Intestinal Health|Unknown status|Enrolling by invitation|Phase 4|418|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 00:49:28.062764|2017-10-11 00:49:28.062764
NCT02046499|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|||A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section|A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section|Unknown status|Not yet recruiting|N/A|500|Anticipated|University of Pretoria||2|||f||||t||||||||||2017-10-11 00:49:28.151309|2017-10-11 00:49:28.151309
NCT02046486|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-01-26|||January 2014||2014-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|LIQUID||OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)|OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study|Completed||Phase 4|20|Anticipated|University of Patras||2|||f||||f||||||||||2017-10-11 00:49:28.260197|2017-10-11 00:49:28.260197
NCT02046473|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-11-09|||July 2013||2013-07-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts|3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts|Completed||N/A|18|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-11 00:49:28.355274|2017-10-11 00:49:28.355274
NCT02046460|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-12-12|||September 2013||2013-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TREAT-CAD||Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD|Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD|Recruiting||Phase 4|169|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 00:49:28.431893|2017-10-11 00:49:28.431893
NCT02046447|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-12-15|||May 2014||2014-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|NID||Neuroimaging of Dystonia|Neuroimaging of Dystonia: The Bachmann-Strauss Dystonia and Parkinson Disease Center of Excellence at the University of Florida|Active, not recruiting||N/A|60|Anticipated|University of Florida|||4||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-11 00:49:28.550188|2017-10-11 00:49:28.550188
NCT02046434|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-12-19|||January 2014||2014-01-01|December 2016|2016-12-01||||February 2015|Actual|2015-02-01||Interventional|||Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain|Phenylbutyrate Response As a Biomarker for Alpha-Synuclein Clearance From Brain|Active, not recruiting||Phase 1|40|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 00:49:28.674834|2017-10-11 00:49:28.674834
NCT02046421|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-05-10|||November 2013|Actual|2013-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|Carboplatin, Gemcitabine, and Mifepristone for Advanced Breast Cancer and Recurrent or Persistent Epithelial Ovarian Cancer|Active, not recruiting||Phase 1|31|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 00:49:28.758224|2017-10-11 00:49:28.758224
NCT02046408|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-09-05|||July 2012||2012-07-01|September 2017|2017-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Computer-Facilitated 5A's for Smoking Cessation in Primary Care|Computer-Facilitated 5A's for Smoking Cessation in Primary Care|Completed||N/A|961|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:49:28.893089|2017-10-11 00:49:28.893089
NCT02046395|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-09-28|||January 2012||2012-01-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|UFLC||Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus|Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus|Recruiting||Phase 4|30|Anticipated|Tulane University||1|||f||||t||||||||||2017-10-11 00:49:28.972921|2017-10-11 00:49:28.972921
NCT02046382|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-09-05|||January 2014||2014-01-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|||RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief|Randomized Control Trial of IV Acetaminophen for Post Cesarean Delivery Pain Relief|Completed||Phase 4|116|Anticipated|TriHealth Inc.||2|||f||||f||||||||||2017-10-11 00:49:29.087856|2017-10-11 00:49:29.087856
NCT02046356|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-10-26|||January 2014||2014-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01|2 Years|Observational [Patient Registry]|||Early Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation|Early Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation: a Multi-center Prospective Case-control Study|Unknown status|Active, not recruiting|N/A|86|Anticipated|Southwest Hospital, China|||2||f||||t||||||||||2017-10-11 00:49:29.397223|2017-10-11 00:49:29.397223
NCT02046343|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-07-27|||August 2012||2012-08-01|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|December 31, 2016|Actual|2016-12-31||Interventional|||Promotora-Led Physical Activity Intervention Trial for Latinas in Texas|ENLACE: A Promotora-Led Physical Activity Intervention Trial for Latinas in Texas|Active, not recruiting||N/A|712|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 00:49:29.512893|2017-10-11 00:49:29.512893
NCT02046317|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-11-07|||May 2011||2011-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|TUFFEN||Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles|Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles|Terminated||N/A|11|Actual|The University of Texas Health Science Center, Houston||2||No further enrolled patients, Primary researcher left the institution|f||||f||||||||||2017-10-11 00:49:29.824993|2017-10-11 00:49:29.824993
NCT02046304|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-04-04|||December 2001||2001-12-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||PP-Gemcitabine & External Beam Radiation-Sarcomas|A Phase I Study of Preoperative Concomitant Gemcitabine and External-Beam Radiation Therapy and Surgical Resection for Patients With Extremity and Trunk Soft Tissue Sarcomas|Completed||Phase 1|41|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:49:30.061537|2017-10-11 00:49:30.061537
NCT02046291|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-10-04|||April 10, 2015|Actual|2015-04-10|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety of Romiplostim (Nplate®) Following UCBT|Safety of Romiplostim (Nplate®) in Patients Who Have Failed to Achieve Platelet Engraftment Following Umbilical Cord Blood Transplant|Recruiting||Phase 1|20|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 00:49:30.227638|2017-10-11 00:49:30.227638
NCT02046278|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-08-29|||January 2014||2014-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2014|Actual|2014-08-01||Interventional|||LifeSeal™ Pilot Study in Subjects Undergoing Circular Stapled Anastomosis Created Within 10 cm of the Anal Verge|LifeSeal™ Pilot Study in Subjects Undergoing Circular Stapled Anastomosis Created Within 10 cm of the Anal Verge|Completed||N/A|70|Actual|LifeBond Ltd.||2|||f||||t||||||||||2017-10-11 00:49:30.380072|2017-10-11 00:49:30.380072
NCT02046265|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-06-28|2017-02-07||June 2014||2014-06-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|March 2016|Actual|2016-03-01||Interventional|StepUp||Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors|Step up to Prevention : A Nurse Practitioner Guided Cervical Cancer Prevention Intervention|Completed||N/A|60|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 00:49:30.508069|2017-10-11 00:49:30.508069
NCT02046252|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-07-25|||June 2010||2010-06-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone|Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone|Completed||Phase 2|200|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:49:31.0426|2017-10-11 00:49:31.0426
NCT02046239|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-09-23|||March 2013||2013-03-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Suture vs Staples for Skin Closure After Liver Resection|A Randomised Controlled Trial to Compare Subcuticular Suture vs Staples for Skin Closure After Liver Resection.|Unknown status|Recruiting|N/A|200|Anticipated|The Leeds Teaching Hospitals NHS Trust||2|||f||||||||||||||2017-10-11 00:49:31.144811|2017-10-11 00:49:31.144811
NCT02046226|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-10-08|2015-10-08||August 2013||2013-08-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Dissolved Oxygen Dressing to Improve Chronic Wound Healing After Revascularization for Critical Limb Ischemia|A Prospective, Randomized, Single-center Pilot Study of the OxyGenesys™ Dissolved Oxygen Dressing to Improve Chronic Wound Healing After Revascularization for Critical Limb Ischemia|Terminated||N/A|7|Actual|Halyard Health||2||inability to meet enrollment goals in this subject population|f||||f||||||||||2017-10-11 00:49:31.228931|2017-10-11 00:49:31.228931
NCT02046213|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2015-11-02|||February 2014||2014-02-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects|An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects|Completed||Phase 1|16|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-11 00:49:31.413635|2017-10-11 00:49:31.413635
NCT02046200|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-03-01|2016-11-03||February 2014||2014-02-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Development of Ivermectin for Alcohol Use Disorders|Repositioning Ivermectin for the Treatment of Alcohol Use Disorders|Completed||Phase 1/Phase 2|11|Actual|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-11 00:49:31.523469|2017-10-11 00:49:31.523469
NCT02046187|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-08-09|||October 2013|Actual|2013-10-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma|Phase I/II Prospective Trial for Newly Diagnosed GBM, With Upfront Gross or Subtotal Resection, Followed by Ketogenic Diet With Radiotherapy and Concurrent Temodar(R) Chemotherapy Followed by Adjuvant Temodar(R) Chemotherapy.|Terminated||Phase 1/Phase 2|14|Actual|St. Joseph's Hospital and Medical Center, Phoenix||1||excessive protocol deviations due to strict nature of diet requirements|f||||t||||||||||2017-10-11 00:49:32.594191|2017-10-11 00:49:32.594191
NCT02046174|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-05-03|||January 2014||2014-01-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Nonrandomized, Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant Colorectal Cancer|A Phase IIb, Nonrandomized, Open-Label Trial With Mouse Renal Adenocarcinoma (RENCA) Cell Containing Agarose-Agarose Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant, Metastatic Colorectal Carcinoma|Recruiting||Phase 2|120|Anticipated|The Rogosin Institute||2|||f||||t||||||||||2017-10-11 00:49:32.687978|2017-10-11 00:49:32.687978
NCT02046161|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-07-29|||January 2014||2014-01-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Comparison of Colon Cleansing Quality Between the Setting of Colon Cleansing Room and the Standard Colon Preparation in a Community Base Setting -- a Prospective Randomized Controlled Trial|Comparison of Colon Cleansing Quality Between the Setting of Colon Cleansing Room and the Standard Colon Preparation in a Community Base Setting -- a Prospective Randomized Controlled Trial|Completed||N/A|130|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:49:32.792943|2017-10-11 00:49:32.792943
NCT02046135|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-11-03|||September 2013||2013-09-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Interventional|||Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery|Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery: A Randomized Clinical Trial|Recruiting||Phase 2|200|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-11 00:49:34.091761|2017-10-11 00:49:34.091761
NCT02046122|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-08-02|||July 2014||2014-07-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Adoptive Transfer of Haplo-identical DLI for AML and MDS|Safety and Efficacy of Chemotherapy Combined With Adoptive Transfer of Human Leukocyte Antigen (HLA)-Haploidentical Donor Lymphocyte Infusion (DLI) in Older Patients With Righ-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1|30|Anticipated|Duke University||1|||f||||f||||||||||2017-10-11 00:49:34.196064|2017-10-11 00:49:34.196064
NCT02046109|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-06-21|||September 2014||2014-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|RVR||Study of the Success and Survival of Dental Composite Restorations Being Repaired Instead of Being Replaced|Replacement Versus Repair of Composite Restorations, a Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Dalhousie University||2||Because of logistic problems, we could not recruit any patient.|f||||f||||||||||2017-10-11 00:49:34.295969|2017-10-11 00:49:34.295969
NCT02046096|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-03-08|||January 2014||2014-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|CIVC||Cook IVC Filter Study|Cook IVC Filter Study|Recruiting||N/A|470|Anticipated|Cook Group Incorporated||2|||f||||||||||||||2017-10-11 00:49:34.390411|2017-10-11 00:49:34.390411
NCT02046083|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-23|||July 2013||2013-07-01|January 2014|2014-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|PITA 3||Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers|Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:49:34.523212|2017-10-11 00:49:34.523212
NCT02046070|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-01-12|||March 2014||2014-03-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|||Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma|An Open-Label, Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma Requiring Systemic Treatment|Active, not recruiting||Phase 2|148|Anticipated|Takeda||3|||f||||f||||||||||2017-10-11 00:49:34.619725|2017-10-11 00:49:34.619725
NCT02046057|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-08-08|||February 2018|Anticipated|2018-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|ENCASe||Evaluation of Needle Core Biopsy of Axillary Sentinel Lymph Node in Breast Cancer|Evaluation of Needle Core Biopsy of Axillary Sentinel Lymph Node in Breast Cancer|Suspended||N/A|50|Anticipated|Loma Linda University||1||Awaiting additional funding|f||||f|f|t|f|f||||||2017-10-11 00:49:34.788901|2017-10-11 00:49:34.788901
NCT02046044|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|DIVA-REF||Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction|Comparing the Effects of Digoxin and Ivabradine on Mortality and Morbidity in Chronic Heart Failure With Reduced Ejection Fraction and Sinus Rhythm|Unknown status|Recruiting|Phase 4|60|Anticipated|Kocaeli University||2|||f||||f||||||||||2017-10-11 00:49:34.869055|2017-10-11 00:49:34.869055
NCT02046031|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-07-13|||February 2014||2014-02-01|December 2013|2013-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.|Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.|Completed||Phase 4|4|Actual|Jiangsu Kanion Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-11 00:49:34.966167|2017-10-11 00:49:34.966167
NCT02046018|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-07-09|||October 2009||2009-10-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||Integrated Community Case Management (ICCM) Delivered by Village Health Teams in Bushenyi District in Uganda|Healthy Child Uganda: Can Village Health Volunteers Trained in Integrated Community Case Management of Childhood Illness Improve Access to Care for Africa's Most Vulnerable Children?|Completed||N/A|5000|Actual|Healthy Child Uganda||3|||f||||t||||||||||2017-10-11 00:49:35.100877|2017-10-11 00:49:35.100877
NCT02046005|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2016-11-21|||January 2014||2014-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|September 2016|Actual|2016-09-01||Interventional|PRE-RA||Personalized Risk Estimator for Rheumatoid Arthritis Family Study|Communication of Biomarker, Genetic, and Lifestyle Risk Factor Profiles for Rheumatoid Arthritis to First Degree Relatives|Active, not recruiting||N/A|238|Actual|Brigham and Women's Hospital||3|||f||||f||||||||Undecided||2017-10-11 00:49:35.178776|2017-10-11 00:49:35.178776
NCT02045992|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-09-24|||April 2013||2013-04-01|September 2014|2014-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||Arrhythmic Effects of Hight Dose Caffeine|Effect of High-dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure - a Randomized Clinical Trial|Unknown status|Recruiting|N/A|112|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 00:49:35.279737|2017-10-11 00:49:35.279737
NCT02045966|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-06-16|||February 2014||2014-02-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects|Effect of a Fixed Dose Combination Formulation of Daclatasvir/Asunaprevir/BMS-791325 on the Pharmacokinetics of a Cocktail of CYP Probe Substrates (Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, and Midazolam) and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects|Completed||Phase 1|16|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:49:35.443249|2017-10-11 00:49:35.443249
NCT02045953|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-05-12|||January 29, 2014|Actual|2014-01-29|May 2017|2017-05-01|March 13, 2014|Actual|2014-03-13|March 13, 2014|Actual|2014-03-13||Interventional|||A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer|A Randomised, Open-Label, Four Period, Crossover Study to Assess the Systemic Exposure of Fluticasone Propionate From FLIXOTIDE™ 250 HFA pMDI and of Fluticasone Propionate and Salmeterol From SERETIDE™ 250/25 HFA pMDI When Given With the VENTOLIN Mini-Spacer Compared to the Aerochamber Plus Spacer in Healthy Subjects|Completed||Phase 1|21|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:49:35.537007|2017-10-11 00:49:35.537007
NCT02045940|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-05-05|||January 20, 2014|Actual|2014-01-20|May 2017|2017-05-01|March 26, 2015|Actual|2015-03-26|March 26, 2015|Actual|2015-03-26||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses|A Randomized Double Blinded (Sponsor Unblind), Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Selective Androgen Receptor Modulator (SARM) in Single and Repeat Doses in Healthy Male Subjects|Completed||Phase 1|99|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 00:49:35.626851|2017-10-11 00:49:35.626851
NCT02045927|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-02-18|||January 2014||2014-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||BIS-Guided Sedation Monitoring|BIS-Guided Sedation Monitoring: A Prospective Randomized Study|Terminated||N/A|19|Actual|Englewood Hospital and Medical Center||2||study staff change|f||||f||||||||||2017-10-11 00:49:35.750398|2017-10-11 00:49:35.750398
NCT02045914|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01|August 2014|Anticipated|2014-08-01|April 2014|Anticipated|2014-04-01||Interventional|||Calcium Ionophore Solution Can Increase Fertilization Rate in Patients During Intracytoplasmic Sperm Injection(ICSI) Who Have Poor Ovarian Reserve?|Effect of Calcium Ionophore Solution on Fertilization Rate During ICSI Cycles of Poor Ovarian Reserve Patients|Unknown status|Recruiting|N/A|162|Anticipated|Baskent University||2|||f||||t||||||||||2017-10-11 00:49:35.84325|2017-10-11 00:49:35.84325
NCT02045901|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-04-14|||February 2014|Actual|2014-02-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|March 31, 2017|Actual|2017-03-31||Interventional|PED-301||A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents|A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents|Active, not recruiting||Phase 4|128|Anticipated|Duchesnay Inc.||2|||f||||f||||||||||2017-10-11 00:49:35.944512|2017-10-11 00:49:35.944512
NCT02045888|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-11-19|||January 2014||2014-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|RECOVER||Safety and Feasibility of ADRCs (Adipose Derived Regenerative Cells) in Patients With Grade II Hamstring Tears|Double-blind, Placebo Controlled, Multi-center Safety and Feasibility Study in Patients With Documented Grade II Hamstring Tears Treated With Intramuscularly Delivered Adipose Derived Regenerative Cells - RECOVER|Withdrawn||Phase 1/Phase 2|0|Actual|Cytori Therapeutics||3||Withdrawn (No Participants Enrolled)|f||||t||||||||||2017-10-11 00:49:36.064414|2017-10-11 00:49:36.064414
NCT02045875|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence|Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence|Unknown status|Recruiting|Phase 4|40|Anticipated|Asthma Management Systems||2|||f||||f||||||||||2017-10-11 00:49:36.173773|2017-10-11 00:49:36.173773
NCT02045862|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-09-15||2017-08-31|March 17, 2014|Actual|2014-03-17|September 2017|2017-09-01|September 8, 2016|Actual|2016-09-08|September 8, 2016|Actual|2016-09-08||Interventional|SYNERGY II||A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder|A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Multi-center Study to Evaluate the Long-Term Safety and Efficacy of Combination of Solifenacin Succinate With Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in Subjects With Overactive Bladder|Completed||Phase 3|2084|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 00:49:36.29399|2017-10-11 00:49:36.29399
NCT02045849|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-07-10|||January 28, 2014|Actual|2014-01-28|July 2017|2017-07-01|August 21, 2014|Actual|2014-08-21|August 21, 2014|Actual|2014-08-21||Interventional|||Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects|A Single-Center, Three-Part, Open Label Study to Evaluate the Relative Bioavailability of Two Formulations, Food Effect, and Interaction With Itraconazole Following Single Dose of GSK2140944 in Healthy Subjects and Effect of Food on Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of GSK2140944 in Healthy Elderly Subjects|Completed||Phase 1|46|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 00:49:36.968639|2017-10-11 00:49:36.968639
NCT02045836|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-08-07|2017-06-06|2015-11-12|March 1, 2014|Actual|2014-03-01|June 2017|2017-06-01|June 17, 2016|Actual|2016-06-17|July 2, 2015|Actual|2015-07-02||Interventional|||Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older|Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older|Completed||Phase 3|865|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 00:49:37.1045|2017-10-11 00:49:37.1045
NCT02045823|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-07-28|||January 2014||2014-01-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||OCT Agreement and Precision Study|Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Agreement and Precision Study|Completed||N/A|150|Anticipated|Topcon Medical Systems, Inc.|||3||f||||f||||||||||2017-10-11 00:49:38.197516|2017-10-11 00:49:38.197516
NCT02045810|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-03-13|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SPIinChildren||Surgical Pleth Index- Relevance in Small Children|Surgical Pleth Index - Relevance in Small Children. A Randomised Double Blinded Study|Completed||N/A|30|Actual|Tampere University Hospital||2|||f||||f||||||||||2017-10-11 00:49:38.271294|2017-10-11 00:49:38.271294
NCT02044900|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-23|||August 2012||2012-08-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01|1 Day|Observational [Patient Registry]|||Polysomnography and Heart Rate Indexes in Obstructive Sleep Apnea|Polysomnography and Heart Rate Indexes in Obstructive Sleep Apnea|Completed||N/A|50|Actual|Universidade Camilo Castelo Branco|||1||f||||f||||||||||2017-10-11 00:49:55.044246|2017-10-11 00:49:55.044246
NCT02045797|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2017-08-24|2017-06-27|2015-10-12|March 24, 2014|Actual|2014-03-24|August 2017|2017-08-01|June 29, 2015|Actual|2015-06-29|June 29, 2015|Actual|2015-06-29||Interventional||mITT population: those participants who received study treatment|Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections|A Phase II, Randomized, Two-Part, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Safety, Tolerability, and Efficacy of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections|Completed||Phase 2|126|Actual|GlaxoSmithKline||3|||f||||t||||||||||2017-10-11 00:49:38.629833|2017-10-11 00:49:38.629833
NCT02045784|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-04-18|||September 2014||2014-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Establishing the Iodine Requirement in Infancy|Establishing the Iodine Requirement in Infancy: a Double-blind Dose-response, Cross-over Balance Study|Recruiting||N/A|60|Anticipated|Swiss Federal Institute of Technology||4|||f||||f||||||||||2017-10-11 00:49:43.299713|2017-10-11 00:49:43.299713
NCT02045771|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-11-23|||March 2014||2014-03-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|BRAVE||A Pilot Study to Assess the Effectiveness of BehaviouRal ActiVation Group Program in Patients With dEpression: BRAVE|A Pragmatic Randomized Trial to Investigate the Effectiveness of BehaviouRal ActiVation Group Therapy in Reducing dEpressive Symptoms and Improving Quality of Life in Patients With Depression: BRAVE Pilot Study|Active, not recruiting||N/A|24|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-11 00:49:43.409638|2017-10-11 00:49:43.409638
NCT02045758|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-09-02|||December 2014||2014-12-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick|A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick|Unknown status|Not yet recruiting|N/A|120|Anticipated|Seventh Sense Biosystems||2|||f||||f||||||||||2017-10-11 00:49:43.492602|2017-10-11 00:49:43.492602
NCT02045745|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-03-29|||December 2013||2013-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CSM/FAP/2012||Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells|CLINICAL TRIAL PHASE I / II, PROSPECTIVE, OPEN, NONRANDOMIZED, FOR TREATMENT OF POSTOPERATIVE AIR LEAK AFTER LUNG RESECTION IN HIGH RISK PATIENTS THROUGH THE ADMINISTRATION OF MESENCHYMAL AUTOLOGOUS CELLS.|Recruiting||Phase 1/Phase 2|10|Anticipated|Red de Terapia Celular||1|||f||||f||||||||||2017-10-11 00:49:43.612497|2017-10-11 00:49:43.612497
NCT02045732|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-11-18|2016-11-18||September 2014||2014-09-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)|A Phase 1b, Double-blinded, Placebo-controlled, Randomized Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Ascending Doses Of Pf-06342674 (rn168) In Subjects With Multiple Sclerosis (ms)|Terminated||Phase 1|4|Actual|Pfizer|Due to the early termination of the study, the small enrollment number and minimal data, no statistical analyses were performed.|4||"This study terminated on April 8, 2015 due to a corporate decision and not related to the   safety or efficacy of the protocol."|f||||f||||||||||2017-10-11 00:49:43.718114|2017-10-11 00:49:43.718114
NCT02045719|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-23|2014-01-24|||December 2013||2013-12-01|January 2014|2014-01-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|cat´sclaw||Phase II Clinical Trial of Uncaria Tomentosa (Cat´s Claw) in Patients With Advanced Solid Tumors|Phase II Clinical Trial of Uncaria Tomentosa (Cat´s Claw) in Patients With Advanced Solid Tumors|Unknown status|Recruiting|Phase 2|51|Anticipated|Faculdade de Medicina do ABC||1|||f||||f||||||||||2017-10-11 00:49:44.236653|2017-10-11 00:49:44.236653
NCT02045706|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-22|||March 2011||2011-03-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Impact of Community Health Worker Training by US Health Volunteers on the Health of Rural Ugandans|A Randomized Prospective Trial to Measure Health-Related Behavioral Changes in Local Villagers Following The Implementation of a Village Health Team Program Facilitated by The Ugandan Ministry of Health and US Health Volunteers|Completed||N/A|1419|Actual|Omni Med||2|||f||||t||||||||||2017-10-11 00:49:44.334536|2017-10-11 00:49:44.334536
NCT02045693|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-06-16|||February 2014||2014-02-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Drug Interaction & Methadone & Buprenorphine|A Phase1, Open-Label, Drug-Drug Interaction Study Between Methadone and Daclatasvir/Asunaprevir/BMS-791325 3 DAA FDC + 75mg BMS-791325 and Between Buprenorphine/Naloxone and Daclatasvir/Asunaprevir/BMS-791325 3 DAA FDC +75mg BMS-791325|Completed||Phase 1|32|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:49:44.419879|2017-10-11 00:49:44.419879
NCT02045667|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-01-25|||January 2014||2014-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM)|Combining N-of-1 Trials to Estimate Population Clinical and Cost-effectiveness of Drugs Using Bayesian Hierarchical Modeling. The Case of Mexiletine for Patients With Non- Dystrophic Myotonia.|Completed||Phase 2|30|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 00:49:46.497752|2017-10-11 00:49:46.497752
NCT02045654|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|February 2014|Anticipated|2014-02-01||Observational|||Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome|Retrospective Study for Predictive Marker for Decitabine Treament in MDS Patients|Unknown status|Recruiting|N/A|1|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:49:46.636454|2017-10-11 00:49:46.636454
NCT02044172|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-06-18|||June 2001||2001-06-01|June 2015|2015-06-01|December 2020|Anticipated|2020-12-01|December 2015|Anticipated|2015-12-01||Interventional|ProtecT||Prostate Testing for Cancer and Treatment|The ProtecT Trial - Evaluating the Effectiveness of Treatments for Clinically Localised Prostate Cancer|Active, not recruiting||Phase 3|100000|Actual|University of Oxford||3|||f||||t||||||||||2017-10-11 00:50:03.542887|2017-10-11 00:50:03.542887
NCT02045641|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-11-16|||September 2013||2013-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|IMAGING||Pleural and Pericardial Effusion Following Open Heart Surgery|The Clinical Impact of an Aggressive Approach Towards Pleural and Pericardial Effusions Following Open Heart Surgery: a Step Towards Standard Guidelines|Completed||N/A|76|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 00:49:46.727339|2017-10-11 00:49:46.727339
NCT02045628|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-03-01|||November 2013||2013-11-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||The Impact of an Investment Based Intervention on Weight-loss and Beliefs About Food in Patients Post Bariatric Surgery|The Impact of an Investment Based Intervention on Weight-loss and Beliefs About Food in Patients Post Bariatric Surgery.|Active, not recruiting||N/A|212|Actual|University of Surrey||2|||f||||f||||||||Undecided||2017-10-11 00:49:46.814465|2017-10-11 00:49:46.814465
NCT02045615|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-23|||October 2013||2013-10-01|October 2013|2013-10-01||||July 2014|Anticipated|2014-07-01||Observational|||Removal Wichita Fusion Nail After Knee Arthrodesis||Unknown status|Enrolling by invitation|N/A|4|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||||||||||||2017-10-11 00:49:46.892389|2017-10-11 00:49:46.892389
NCT02045602|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-07-04|||January 2014||2014-01-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors|A Phase I, Multicenter, Open-label, Dose Escalation Study of Intravenous Administration of VCN-01 Oncolytic Adenovirus With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|VCN Biosciences, S.L.||3|||f||||f||||||||||2017-10-11 00:49:46.968191|2017-10-11 00:49:46.968191
NCT02045589|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-01-30|||January 2014||2014-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|October 2016|Actual|2016-10-01||Interventional|||A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer|A Phase I, Multicenter, Open-label, Dose Escalation Study of Intratumoral Injections of VCN-01 Oncolytic Adenovirus With Intravenous Gemcitabine and Abraxane® in Advanced Pancreatic Cancer|Active, not recruiting||Phase 1|18|Anticipated|VCN Biosciences, S.L.||1|||f||||f||||||||||2017-10-11 00:49:47.10229|2017-10-11 00:49:47.10229
NCT02045576|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-07-11|||June 2013||2013-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|POSA||RCT: Oral Appliance Therapy and Sleep Position Trainer in Patients With Position Dependant Obstructive Sleep Apnea|Positional Therapy With the Sleep Position Trainer Versus Oral Appliance Therapy in Patients With Position Dependent Obstructive Sleep Apnea; A Randomised Controlled Trial|Completed||N/A|99|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:49:47.212479|2017-10-11 00:49:47.212479
NCT02045563|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-23||||||December 2012|2012-12-01||||October 2014|Anticipated|2014-10-01||Observational|||Genetic Polymorphisms, Steatosis and Diabetes|Genetic Polymorphisms, Hepatic Steatosis and Lipid Anomalies in Diabetic Patients|Unknown status|Recruiting|N/A|587|Anticipated|Centre Hospitalier Universitaire Dijon|||3||f||||||||||||||2017-10-11 00:49:47.298365|2017-10-11 00:49:47.298365
NCT02045550|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Tolerance and Effect of a Prophylactical Treatment With Ivy Leaves Dry Extract in Recurrent Wheezy Bronchitis|Tolerance and Effect of a Prophylactical Treatment With a Cough Medicine Con-taining Ivy Leaves Dry Extract in Children With Recurrent Wheezy Bronchitis|Unknown status|Recruiting|Phase 2|60|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 00:49:47.497288|2017-10-11 00:49:47.497288
NCT02045537|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-07-31|||June 2013||2013-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|INFOHS||Retrospective Study to Determine the Incidence of Bone Fractures in HIV-infected Patients in Spain|Retrospective Study to Determine the Incidence of Bone Fractures in HIV-infected Patients in Spain|Recruiting||N/A|15000|Anticipated|Fundacion SEIMC-GESIDA|||1||f||||f||||||||||2017-10-11 00:49:47.623447|2017-10-11 00:49:47.623447
NCT02045524|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-23|||August 2011||2011-08-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers||Completed||Phase 1|4|Actual|JDP Therapeutics, Inc.||2|||f||||||||||||||2017-10-11 00:49:47.83202|2017-10-11 00:49:47.83202
NCT02045511|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-09-06|2017-04-17||February 2014||2014-02-01|September 2017|2017-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|HEARS||The Baltimore HEARS Pilot Study|The Baltimore HEARS Pilot Study: Hearing Health Care Equality Through Accessible Research & Solutions|Completed||N/A|15|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:49:47.941484|2017-10-11 00:49:47.941484
NCT02045498|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-01-23|||February 2013||2013-02-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Capnography Feedback During Cardiopulmonary Resuscitation (CPR ) on Patient's Outcome|Effect of Capnography Feedback During Cardiopulmonary Resuscitation on Quality Performance of Rescuers and Outcome of the Patient|Completed||N/A|130|Actual|Mashhad University of Medical Sciences||2|||f||||f||||||||||2017-10-11 00:49:48.391242|2017-10-11 00:49:48.391242
NCT02045485|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-01-22|||January 2006||2006-01-01|January 2014|2014-01-01||||June 2006|Actual|2006-06-01|6 Months|Observational [Patient Registry]|||P Wave and QT Dispersion in Psoriasis|Increased Risk of Atrial and Ventricular Arrhythmia in Long-lasting Psoriasis|Completed||N/A|145|Anticipated|Yuzuncu Yıl University|||1||f||||f||||||||||2017-10-11 00:49:48.48935|2017-10-11 00:49:48.48935
NCT02045472|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-05-13|||September 2014||2014-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study of VIS410 to Assess Safety and Pharmacokinetics|Double-Blind, Placebo-Controlled, Dose-Escalation Phase 1 Study in Healthy Volunteers to Evaluate the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VIS410) to Influenza Type A Hemagglutinin|Completed||Phase 1|41|Actual|Visterra, Inc.||2|||f||||f||||||||||2017-10-11 00:49:48.544919|2017-10-11 00:49:48.544919
NCT02045459|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-05-24|||May 2014||2014-05-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MOVE||Microvascular Disease Exercise Trial|Assessment of Perfusion Reserve and Effects of Exercise in Microvascular Angina|Recruiting||Phase 1/Phase 2|165|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 00:49:48.6301|2017-10-11 00:49:48.6301
NCT02045446|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-12-28|||February 2014||2014-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial|Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial|Active, not recruiting||Phase 2|29|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:49:48.753174|2017-10-11 00:49:48.753174
NCT02045433|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-04-11|||March 2014||2014-03-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer|A Phase II Study for Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer (LACC)|Recruiting||Phase 2|21|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 00:49:48.842971|2017-10-11 00:49:48.842971
NCT02045420|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-11-30|||December 2013||2013-12-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Observational|IPD||Vascular Abnormalities in Idiopathic Parkinson's Disease|Vascular Abnormalities in Idiopathic Parkinson's Disease|Active, not recruiting||N/A|30|Anticipated|University of Saskatchewan|||2||f||||f||||||||||2017-10-11 00:49:48.933317|2017-10-11 00:49:48.933317
NCT02045407|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-01-08|||January 2014||2014-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Computed Tomography Angiography to Brain Death Assessment|Computed Tomography Angiography to Brain Death Assessment|Completed||N/A|91|Actual|University of Sao Paulo|||1||f||||t||||||||||2017-10-11 00:49:49.026411|2017-10-11 00:49:49.026411
NCT02045394|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-12-02|||June 2013||2013-06-01|December 2015|2015-12-01||||October 2015|Actual|2015-10-01|18 Months|Observational [Patient Registry]|||Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study|Multicenter, Prospective, Observational Study on Epidemiology and Diagnosis of Haemoptysis|Completed||N/A|610|Actual|University of Milan|||1||f||||f||||||||||2017-10-11 00:49:49.148582|2017-10-11 00:49:49.148582
NCT02045381|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-10-13|||February 2013||2013-02-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Optimization of MRI for Radiation Therapy|Optimization of MRI for Radiation Therapy|Recruiting||N/A|160|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 00:49:49.25086|2017-10-11 00:49:49.25086
NCT02045368|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-05-22|||January 28, 2014|Actual|2014-01-28|May 2017|2017-05-01|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R|STM-02: Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R|Completed||Phase 1|41|Actual|IGF Oncology, LLC||1|||f||||t|t|f||||||No||2017-10-11 00:49:49.332026|2017-10-11 00:49:49.332026
NCT02045355|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-12-11|||February 2014||2014-02-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Effects of Fish or Meat Consumption in Elderly|Effects of Fish or Meat Consumption on Sarcopenia and Mobility in Elderly After Hip Fracture|Terminated||N/A|14|Actual|University of Bergen||2||Not enough patients to recruite.|f||||f||||||||||2017-10-11 00:49:49.559424|2017-10-11 00:49:49.559424
NCT02045342|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01||||December 2015|Anticipated|2015-12-01||Interventional|||The Effect of a Carbohydrate Drink on Cognitive Function and Exercise Performance|The Effect of a Carbohydrate Drink on Cognitive Function and Exercise Performance|Unknown status|Not yet recruiting|N/A|25|Anticipated|University of Western Ontario, Canada||2|||f||||t||||||||||2017-10-11 00:49:49.656815|2017-10-11 00:49:49.656815
NCT02045329|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-06-19|||October 2013||2013-10-01|January 2014|2014-01-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|||Impact of Mupirocin Decolonization on the Nasal Microbiome|Impact of Mupirocin Decolonization on the Nasal Microbiome|Terminated||N/A|1|Actual|VA Eastern Colorado Health Care System|||1|Logistically unable to recruit subjects prior to initiation of mupirocin treatment|f||||f||||||Samples With DNA|"     Nasal swabs   "|||2017-10-11 00:49:49.763277|2017-10-11 00:49:49.763277
NCT02045316|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-01-22|||March 2014||2014-03-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Observational|||The Expression of Aquaporin 3, 8 and 9 in Placenta in Normal and Preeclamptic Pregnancies: Perinatal and Neonatal Outcomes.|The Expression of Aquaporin 3, 8 and 9 in Placenta, Umbilical Cord and Fetal Membranes in Normal Pregnancies and Pregnancies Complicated by Preeclampsia: Perinatal and Neonatal Outcomes.|Unknown status|Not yet recruiting|N/A|210|Anticipated|Trakya University|||2||f||||t||||||||||2017-10-11 00:49:49.861646|2017-10-11 00:49:49.861646
NCT02045290|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-03-10|||January 2014||2014-01-01|March 2017|2017-03-01|February 15, 2016|Actual|2016-02-15|February 15, 2016|Actual|2016-02-15||Interventional|||Insulin Clamp Ancillary Study for Assessment of Insulin Resistance|Metformin Therapy for Overweight Adolescents With Type 1 Diabetes (T1D)--Insulin Clamp Ancillary Study for Assessment of Insulin Resistance|Completed||Phase 3|37|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-11 00:49:50.129839|2017-10-11 00:49:50.129839
NCT02045277|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-08-15|||February 2014||2014-02-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis|A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis|Completed||Phase 2|212|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||Yes||2017-10-11 00:49:50.252755|2017-10-11 00:49:50.252755
NCT02045264|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-01-06|2015-01-06||February 2014||2014-02-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||The Safety Set consisted of all subjects who had taken the single dose of icatibant.|Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers|An Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers|Completed||Phase 1|12|Actual|Shire||1|||f||||f||||||||||2017-10-11 00:49:50.407194|2017-10-11 00:49:50.407194
NCT02045251|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-01-14|||June 2013||2013-06-01|March 2013|2013-03-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection|AN OPEN-LABEL TRIAL OF REDUCED- DOSE PYLERA (BISMUTH, METRONIDAZOLE, TETRACYCLINE), AMOXICILLIN, AND ESOMEPRAZOLE IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION|Withdrawn||Phase 4|0|Actual|American University of Beirut Medical Center||1||Unavailability of clarithromycin 250 mg in the market|f||||t||||||||||2017-10-11 00:49:51.482717|2017-10-11 00:49:51.482717
NCT02045238|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-01-05|2015-01-05||July 2013||2013-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Number of patients completing the study was too low to make statistically significant comparisons.|Inhaled Hypertonic Saline Use in the Emergency Department to Treat Acute Viral Bronchiolitis|Study of the Effect of Inhaled 3% Hypertonic Saline Compared With Normal Saline (0,9%) for the Treatment of Acute Viral Bronchiolitis in a Short Stay Ward|Terminated||N/A|32|Actual|University of Sao Paulo||2||Technical difficulties (reduced staff plus university strike)|f||||f||||||||||2017-10-11 00:49:51.606467|2017-10-11 00:49:51.606467
NCT02045225|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-07-06|||February 2013||2013-02-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||HIV Prevention for HIV-Negative Men Via Reduction of Social Anxiety|An HIV Prevention Intervention for HIV-negative Men Who Have Sex With Men Via Reduction of Social Anxiety and Substance Use in Sexual Situations|Completed||Phase 1|20|Actual|Ryerson University||1|||f||||f||||||||||2017-10-11 00:49:51.976847|2017-10-11 00:49:51.976847
NCT02045212|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-12-05|||February 2014||2014-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).|A Preliminary Double Blind Clinical Study, Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).|Completed||Phase 2|23|Actual|Regenera Pharma Ltd||2|||f||||f||||||||||2017-10-11 00:49:52.106995|2017-10-11 00:49:52.106995
NCT02045199|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-04-24|||February 2014||2014-02-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy.||Completed||N/A|193|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 00:49:52.208191|2017-10-11 00:49:52.208191
NCT02045186|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-05-01|||December 2013||2013-12-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01||Interventional|||Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)|Monitoring of Oral HPV Infection in HPV-positive Oropharyngeal Squamous Cell Carcinoma During and After Chemoradiotherapy (CRT)|Terminated||N/A|1|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:49:52.319425|2017-10-11 00:49:52.319425
NCT02045173|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-10-19|||January 2014||2014-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|AIRLESS||Automate Detection of Sleep Apnea by ApneascanTM|Screening for Sleep-disordered Breathing in Routine Cardiology Practice: Validation of the Apnea + Hypopnea Detection by an Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy-defibrillator (CRT-D) With Impedance-based Respiration Sensor (ApneaScanTM)|Completed||Phase 4|41|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 00:49:52.399822|2017-10-11 00:49:52.399822
NCT02045160|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-07-31|||January 2014||2014-01-01|July 2014|2014-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy|A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy|Recruiting||N/A|1000|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 00:49:52.485307|2017-10-11 00:49:52.485307
NCT02045147|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-05-11|||October 2013||2013-10-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Home Based Care Transitions Tailored by Cognition and Patient Activation|Home Based Care Transitions Tailored by Cognition and Patient Activation: A Prudent Use of Transitional Care Resources|Completed||N/A|222|Actual|University of Nebraska||4|||f||||f||||||||No||2017-10-11 00:49:52.571746|2017-10-11 00:49:52.571746
NCT02045134|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-07-12|||September 2014||2014-09-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Polyphemus||Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery|Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery|Terminated||N/A|50|Actual|Neuromed IRCCS||2||low participation rate|f||||f||||||||No||2017-10-11 00:49:52.660261|2017-10-11 00:49:52.660261
NCT02045121|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-22|||January 2014||2014-01-01|January 2014|2014-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management|A Multicentre Randomised Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis in Patients With a Malignant Pleural Effusion|Unknown status|Recruiting|N/A|160|Anticipated|National University Hospital, Singapore||2|||f||||||||||||||2017-10-11 00:49:52.744438|2017-10-11 00:49:52.744438
NCT02045108|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-03-14|||January 2014||2014-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Cognitive Retraining and Brain Stimulation for Alcohol Use|Modifying Alcohol Approach Motivations With tDCS and Cognitive Retraining|Completed||N/A|93|Actual|The Mind Research Network||4|||f||||f||||||||||2017-10-11 00:49:52.848739|2017-10-11 00:49:52.848739
NCT02045095|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-02-14|||January 2014||2014-01-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Phase 1, Dose Escalation Study of MLN7243 in Adult Patients With Advanced Solid Tumors|A Phase 1, Open-Label, Multicenter, Dose Escalation Study to Assess the Safety and Tolerability of MLN7243, an Inhibitor of Ubiquitin-Activating Enzyme (UAE), in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|119|Anticipated|Takeda||1|||f||||t||||||||||2017-10-11 00:49:53.101184|2017-10-11 00:49:53.101184
NCT02045082|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-02-25|||October 2013||2013-10-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis|Comparison Between the Sensibility of the Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis|Terminated||Phase 4|146|Actual|CHU de Quebec-Universite Laval||2|||f||||t||||||||||2017-10-11 00:49:53.197723|2017-10-11 00:49:53.197723
NCT02045069|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-10-29|||February 2014||2014-02-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||Efficacy and Safety of Ivermectin Against Dengue Infection|A Phase II/III, Randomized, Placebo Controlled Trial of Efficacy and Safety of Ivermectin in Children and Adult Patients With Dengue Infection|Unknown status|Recruiting|Phase 2/Phase 3|360|Anticipated|Mahidol University||3|||f||||t||||||||||2017-10-11 00:49:53.28485|2017-10-11 00:49:53.28485
NCT02045056|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-03-08|||May 2014|Actual|2014-05-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease|Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease|Active, not recruiting||Early Phase 1|72|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-11 00:49:53.395198|2017-10-11 00:49:53.395198
NCT02045043|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-22|||March 2002||2002-03-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|GRADE||Genetic Risk Assessment of Defibrillator Events|Genetic Risk Assessment of Defibrillator Events: A Prospective Multicenter Observational Study|Completed||N/A|1807|Actual|University of Iowa|||1||f||||t||||||Samples With DNA|"     Blood was obtained for DNA (all subjects) and serum (subgroup of subjects)   "|||2017-10-11 00:49:53.484597|2017-10-11 00:49:53.484597
NCT02045030|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-11-15|||January 2014||2014-01-01|August 2016|2016-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer|A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer Who Have Failed First-Line Therapy|Terminated||Phase 2|14|Actual|CR-CSSS Champlain-Charles-Le Moyne||1||Drug (Aflibercept) no longuer available for the study|f||||f||||||||||2017-10-11 00:49:53.57908|2017-10-11 00:49:53.57908
NCT02045017|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-30|||February 28, 2014|Actual|2014-02-28|August 2017|2017-08-01|June 30, 2021|Anticipated|2021-06-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency|A Phase 2 Multicenter, Open-label Study to Determine the Efficacy and Safety of Pomalidomide (CC-4047) in Combination With Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Moderate or Severe Renal Impairment Including Subjects Undergoing Hemodialysis|Active, not recruiting||Phase 2|81|Actual|Celgene||1|||f||||f||||||||||2017-10-11 00:49:53.681346|2017-10-11 00:49:53.681346
NCT02045004|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-09-12|||July 14, 2015|Actual|2015-07-14|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|POCD-MRI||Cohort Study to Investigate the Association Between Changes in Brain Volume and Postoperative Cognitive Dysfunction|Association Between Changes in Cerebral Gray Matter Volume and Postoperative Cognitive Dysfunction in Elderly Patients Following Sevoflurane Anesthesia (POCD-MRI)|Recruiting||N/A|100|Anticipated|University Hospital, Basel, Switzerland|||2||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:49:53.836273|2017-10-11 00:49:53.836273
NCT02044991|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-08-04|2017-04-03||October 24, 2013|Actual|2013-10-24|August 2017|2017-08-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Interventional||The baseline analysis population comprises all participants who signed an informed consent document to participate in the trial.|Ultrasound Guided Posterior Sacroiliac Ligament Corticosteroid Injection in Pregnancy-Related Pelvic Girdle Pain|The Efficacy of Ultrasound Guided Posterior Sacroiliac Ligament Corticosteroid Injection in Pregnancy-Related Pelvic Girdle Pain: A Randomized Controlled Trial|Terminated||Phase 2|2|Actual|Loyola University|The trial was terminated in February 2017 due to poor recruitment|2||The study was halted prematurely due to poor recruitment|f||||t|t|f||||||||2017-10-11 00:49:53.96977|2017-10-11 00:49:53.96977
NCT02044978|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-06-08|||January 2014||2014-01-01|June 2015|2015-06-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Initial Fixation of Bisphosphonate-coated Dental Implants|Initial Fixation of Bisphosphonate-coated Dental Implants|Unknown status|Recruiting|Phase 2|16|Anticipated|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-11 00:49:54.420739|2017-10-11 00:49:54.420739
NCT02044965|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-03-05|||January 2015||2015-01-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder|A Clinical Trial to Determine the Extent to Which Probiotic Therapy Reduces Side Effects of Antibiotic Prophylaxis in Pediatric Neurogenic Bladder Patients With a History of Recurrent Urinary Tract Infections|Unknown status|Not yet recruiting|Phase 1/Phase 2|36|Anticipated|London Health Sciences Centre||3|||f||||f||||||||||2017-10-11 00:49:54.513755|2017-10-11 00:49:54.513755
NCT02044952|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-01-22|||January 2014||2014-01-01|January 2014|2014-01-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission|Prospective Experimental of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Jinling Hospital, China||1|||f||||t||||||||||2017-10-11 00:49:54.643573|2017-10-11 00:49:54.643573
NCT02044939|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-05-17|||July 10, 2012|Actual|2012-07-10|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Pulmonary Rehabilitation in Patients With Sarcoidosis|Pulmonary Rehabilitation in Fibrotic Pulmonary Sarcoidosis (Stage IV): Randomized Controlled Trial|Recruiting||N/A|150|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-11 00:49:54.744305|2017-10-11 00:49:54.744305
NCT02044926|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-07-20|||January 2014||2014-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Observational|||Intraductal Papillary Mucinous Neoplasm With Malignant Change|Intraductal Papillary Mucinous Neoplasm (IPMN) With Malignant Change: Prospective Study to Assess Diagnostic Performance of CT and Magnetic Resonance Imaging (MR) According to International Consensus Guidelines 2012|Terminated||N/A|54|Actual|Asan Medical Center|||1|Because patient enrollment is so difficult.|f||||t||||||||||2017-10-11 00:49:54.877448|2017-10-11 00:49:54.877448
NCT02044913|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-07-14|||March 2012||2012-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Randomized-controlled Trial of Aftercare-Coordination by Phone for Depression and Anxiety|Randomized-controlled Trial of Aftercare-Coordination by Phone for Patients With Depression and Anxiety Subsequent to an Inpatient Treatment.|Completed||N/A|218|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 00:49:54.945261|2017-10-11 00:49:54.945261
NCT02044887|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-09-04|||January 2014||2014-01-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|AFISDEMyF||Physical Activity to Patients With Dementia and Their Caregivers.|Physical Activity Program for Patients With Dementia and Their Relative Caregivers. Randomized Clinical Trial in Primary Health Care. APISDEMyF|Unknown status|Recruiting|N/A|134|Anticipated|Fundacion para la Investigacion y Formacion en Ciencias de la Salud||2|||f||||f||||||||||2017-10-11 00:49:55.11955|2017-10-11 00:49:55.11955
NCT02044861|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-06-22|||March 2014||2014-03-01|June 2015|2015-06-01||||September 2015|Anticipated|2015-09-01||Interventional|||Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies|Phase 1 Open-Label, Dose Escalation, Multi-Center Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies|Unknown status|Recruiting|Phase 1|56|Anticipated|Advanced Cancer Therapeutics||1|||f||||f||||||||||2017-10-11 00:49:55.413586|2017-10-11 00:49:55.413586
NCT02044848|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-01-19|2015-09-09||February 2014||2014-02-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus|A Randomized, Double-blind, Multiple Dose, Placebo-controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Efficacy of Secukinumab in Adult and Pediatric Patients With New-onset Type 1 Diabetes Mellitus(T1D)|Terminated||Phase 2|5|Actual|Novartis||2||This study was terminated prematurely by the Sponsor for business reasons only.|f||||f||||||||||2017-10-11 00:49:55.512519|2017-10-11 00:49:55.512519
NCT02044835|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-22|||January 2013||2013-01-01|January 2014|2014-01-01||||September 2015|Anticipated|2015-09-01||Interventional|||The Evaluation Studies of Curative Effect of Fu-zheng-qu-zhuo Oral Liquid in Treatment of Ischemic Nephropathy||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 00:49:55.725387|2017-10-11 00:49:55.725387
NCT02044822|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-03-30|2017-03-30||August 6, 2014|Actual|2014-08-06|March 2017|2017-03-01|May 17, 2016|Actual|2016-05-17|April 27, 2016|Actual|2016-04-27||Interventional||Intent-to-Treat (ITT) Analysis Set: participants who received at least 1 dose of study treatment|Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion|A Phase 2, Single Arm Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion|Terminated||Phase 2|102|Actual|Gilead Sciences|Due to the early termination of the study, efficacy data were not available for all participants, and therefore the prespecified analyses were not conducted.|1|||f||||f|t|f||||||||2017-10-11 00:49:55.827579|2017-10-11 00:49:55.827579
NCT02044809|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-05-02|||March 2014||2014-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Cannabidiol: a Novel Intervention for Cannabis Use Problems?|A Phase IIa/b, Randomised, Double-blind, Placebo-controlled, Single-site, Parallel Group Clinical Trial to Examine Cannabidiol (CBD) as a Pharmacological Treatment for Cannabis Dependence.|Active, not recruiting||Phase 2|168|Anticipated|University College, London||4|||f||||t||||||||||2017-10-11 00:49:56.642154|2017-10-11 00:49:56.642154
NCT02044796|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-04-28|||January 23, 2014|Actual|2014-01-23|April 2017|2017-04-01||||January 2018|Anticipated|2018-01-01||Interventional|||Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes|A Phase 1/2 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)|Recruiting||Phase 1/Phase 2|199|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 00:49:56.733221|2017-10-11 00:49:56.733221
NCT02044783|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-07-17|||January 2014||2014-01-01|July 2017|2017-07-01||||September 2017|Anticipated|2017-09-01||Interventional|||Identifying and Treating Physical Function Impairment in Elders|Identifying and Treating Physical Function Impairment in Elders|Enrolling by invitation||N/A|35|Anticipated|University of Colorado, Denver||2|||f||||||||||||||2017-10-11 00:49:56.890151|2017-10-11 00:49:56.890151
NCT02044770|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-04-28|||January 2014||2014-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||ENSEAL® G2 Articulating Tissue Sealer in Laparoscopic Colectomy|Initial Clinical Experience With the ENSEAL® G2 Articulating Tissue Sealer in Laparoscopic Colectomy|Completed||N/A|29|Actual|Ethicon Endo-Surgery|||1||f||||f||||||||||2017-10-11 00:49:56.983966|2017-10-11 00:49:56.983966
NCT02044757|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-12-08|||June 2013||2013-06-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Potentially Addictive Properties of Soda: A Feasibility Study|The Potentially Addictive Properties of Soda: A Feasibility Study|Completed||N/A|28|Actual|University of California, Berkeley||1|||f||||f||||||||||2017-10-11 00:49:57.077706|2017-10-11 00:49:57.077706
NCT02044744|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-04-09|||February 2014||2014-02-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PARC||Physical Activity Referrals to the Community|Primary Care Physical Activity Referrals to the Community|Unknown status|Recruiting|N/A|76|Anticipated|University of California, Berkeley||2|||f||||f||||||||||2017-10-11 00:49:57.175789|2017-10-11 00:49:57.175789
NCT02044731|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-12-08|||January 2014||2014-01-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Impact of a Childhood Obesity Intervention for African American Families|Impact of a Childhood Obesity Intervention for African American Families|Completed||N/A|19|Actual|University of California, Berkeley||1|||f||||f||||||||||2017-10-11 00:49:57.30556|2017-10-11 00:49:57.30556
NCT02044718|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-01-22|||November 2011||2011-11-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Medical Record Study on Adverse Events Requiring a Higher Level of Care in Flemish Hospitals|Medical Record Study on Adverse Events Requiring a Higher Level of Care in Flemish Hospitals|Completed||N/A|878|Actual|Hasselt University|||1||f||||f||||||||||2017-10-11 00:49:57.383792|2017-10-11 00:49:57.383792
NCT02044705|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-04-09|||September 2012||2012-09-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|AHF||Impact of Active and Healthy Families|Impact of Active and Healthy Families (Familias Activas y Saludables): A Family-Based Group Medical Appointment Model for Childhood Obesity in Federally Qualified Health Centers|Completed||N/A|55|Actual|University of California, Berkeley||2|||f||||f||||||||||2017-10-11 00:49:57.451831|2017-10-11 00:49:57.451831
NCT02044692|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-06-19|||January 2014||2014-01-01|June 2014|2014-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients|The Long-term Safety of Hunterase (Idursulfase-beta) in Hunter Syndrome(Mucopolysaccharidosis II) Patients|Recruiting||N/A|34|Anticipated|Green Cross Corporation|||1||f||||f||||||||||2017-10-11 00:49:57.540068|2017-10-11 00:49:57.540068
NCT02044679|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2016-09-15|||October 2013||2013-10-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions||Completed||N/A|82|Actual|Danone Research||3|||f||||f||||||||||2017-10-11 00:49:57.616416|2017-10-11 00:49:57.616416
NCT02044666|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-01-05|||February 2014||2014-02-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Cook Micronized Small Intestinal Submucosa (SIS) for Critical Limb Ischemia|Pilot Safety Study of Micronized Small Intestinal Submucosa (SIS) for Critical Limb Ischemia|Completed||N/A|10|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 00:49:57.692228|2017-10-11 00:49:57.692228
NCT02044640|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-06-03|||December 2013||2013-12-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Identifiable Factors That May Lead to Postoperative Nausea and Vomiting After Simple Laparoscopic Appendectomy||Withdrawn||N/A|0|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:49:57.905807|2017-10-11 00:49:57.905807
NCT02044627|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-22|||December 2013||2013-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002|A Phase 1, Open-Label,Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Esperion Therapeutics||1|||f||||f||||||||||2017-10-11 00:49:57.983864|2017-10-11 00:49:57.983864
NCT02044614|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-08-15|||May 2014||2014-05-01|April 2014|2014-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis|Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis|Terminated||N/A|1|Actual|Davita Clinical Research||1||Limited patient recruitment|f||||t||||||||||2017-10-11 00:49:58.051207|2017-10-11 00:49:58.051207
NCT02044601|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-04-22|||June 2014||2014-06-01|April 2014|2014-04-01||||June 2019|Anticipated|2019-06-01||Interventional|||Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)|Phase I/II Trial Using a Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 00:49:58.124381|2017-10-11 00:49:58.124381
NCT02044588|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-01-22|||January 2000||2000-01-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01|10 Years|Observational [Patient Registry]|||Hepatitis B Antigen Kidney Graft Into Protective Level Hepatitis B Antibody Recipients|The Outcomes of Kidney Transplantation Between Recipients Receiving Graft From Donors With Positive and Negative HBsAg|Unknown status|Recruiting|N/A|100|Anticipated|Chulalongkorn University|||2||f||||t||||||||||2017-10-11 00:49:58.226518|2017-10-11 00:49:58.226518
NCT02044575|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-07-12|||April 2014||2014-04-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study|Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study|Recruiting||N/A|20|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 00:49:58.309639|2017-10-11 00:49:58.309639
NCT02044562|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-22|||September 2013||2013-09-01|January 2014|2014-01-01|September 2014|Anticipated|2014-09-01|August 2014|Anticipated|2014-08-01||Interventional|||Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients|Study of Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemo-radiotherapy|Unknown status|Recruiting|N/A|20|Anticipated|Capital Medical University||2|||f||||f||||||||||2017-10-11 00:49:58.39852|2017-10-11 00:49:58.39852
NCT02044549|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-22|||June 2011||2011-06-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section|Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section|Completed||Phase 4|||Cairo University||2|||f||||f||||||||||2017-10-11 00:49:58.47596|2017-10-11 00:49:58.47596
NCT02044536|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-01-22|||January 2014||2014-01-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Current Practice Pattern and Effect of Training in Upper Endoscopic Biopsy|Retrospective Study of Current Practice Pattern and Effect of Training in Upper Endoscopic Biopsy|Completed||N/A|1208|Actual|Chuncheon Sacred Heart Hospital|||2||f||||f||||||||||2017-10-11 00:49:58.558464|2017-10-11 00:49:58.558464
NCT02044523|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-08-01|||January 2014||2014-01-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|ELF||Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound|Comparison of Magnetic Resonance and Ultrasound Elastography With Liver Biopsy for Noninvasive Staging of Liver Fibrosis|Recruiting||N/A|108|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||Samples Without DNA|"     Liver biopsy specimens.   "|||2017-10-11 00:49:58.631994|2017-10-11 00:49:58.631994
NCT02043639|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-04-13|||August 2013||2013-08-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||ClinicCompanion. Compared to the Use of a Goniometer|A Study of Effectiveness of clinicCompanion. Compared to the Use of a Goniometer for Range of Motion Measurement.|Terminated||N/A|30|Actual|Aurora Health Care|||1|Change in technology|f||||t||||||||||2017-10-11 00:50:10.963835|2017-10-11 00:50:10.963835
NCT02044510|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-03-21|||July 2014|Actual|2014-07-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients|A Double Blind, Randomized Placebo Controlled Trial Evaluating the Urodynamic and Clinical Efficacy of Mirabegron Among Neurogenic Bladder Patients|Enrolling by invitation||Phase 2/Phase 3|144|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 00:49:58.729385|2017-10-11 00:49:58.729385
NCT02044497|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-08-21|||May 2014||2014-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients|Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients|Recruiting||Phase 4|68|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 00:49:58.827974|2017-10-11 00:49:58.827974
NCT02044484|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-02-11|||January 2014||2014-01-01|February 2015|2015-02-01|October 2016|Anticipated|2016-10-01|June 2015|Anticipated|2015-06-01||Interventional|APTcare||HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission|HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission|Unknown status|Recruiting|N/A|2794|Anticipated|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 00:49:58.908968|2017-10-11 00:49:58.908968
NCT02044471|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-04-27|||August 2014||2014-08-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|IMPULSE||The IMPULSE Study: Pilot|The IMPULSE Pilot Study-- Investigating a Novel Synergy: Applying Ischemic Conditioning to Modulate the Altered Physiology From Contemporary continUous Flow Left Ventricular Assist Devices, to Reduce Stroke and Other Adverse Effects|Completed||N/A|20|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 00:49:59.007969|2017-10-11 00:49:59.007969
NCT02044458|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-07-15|2016-04-14||April 2013||2013-04-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Foley Catheter for Induction of Labor|A Randomized Control Trial of Foley Catheter Placement for Induction of Labor: Stylette Versus no Stylette|Completed||N/A|134|Actual|Aurora Health Care|Did not enroll enough subjects to achieve sufficient power for every test performed or to study outcomes with low event rates. Insertion time and failure may be influenced by providers comfort with insertion technique. Women were from a single site.|2|||f||||||||||||||2017-10-11 00:49:59.084089|2017-10-11 00:49:59.084089
NCT02044445|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-05-26|||November 2009||2009-11-01|May 2014|2014-05-01||||December 2013|Actual|2013-12-01||Interventional|||Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?||Completed||N/A|154|Actual|Aristotle University Of Thessaloniki||2|||f||||||||||||||2017-10-11 00:49:59.386311|2017-10-11 00:49:59.386311
NCT02044432|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-07-05|||January 2014||2014-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Interventional|OST_02||Treatment of Patients With Chronic Osteoarthritis With Ginger Kidney Compress - a Randomized, Controlled Trial|Treatment of Patients With Chronic Osteoarthritis (Gonarthrosis) With Ginger Kidney Compress - a Randomized, Controlled Trial|Enrolling by invitation||N/A|32|Anticipated|ARCIM Institute Academic Research in Complementary and Integrative Medicine||2|||f||||||||||||||2017-10-11 00:49:59.448811|2017-10-11 00:49:59.448811
NCT02044406|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2014-10-07|||January 2014||2014-01-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers in a Partially Randomised, Single-blind, Placebo-controlled Trial, and Investigation of Relative Bioavailability and the Effect of Food on the Pharmacokinetics of BI 1181181(Open-label, Randomised, Three-way Cross-over Design)|Completed||Phase 1|65|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:49:59.586013|2017-10-11 00:49:59.586013
NCT02044393|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-11-11|2015-11-11||January 2014||2014-01-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Treated Set (TS): included all subjects who were randomized and took at least one dose of study medication during the trial.|Interaction of BI 691751 With Itraconazole|Relative Bioavailability of a Single Oral Dose of BI 691751 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects (an Open-label, Randomised, Two-period, Two-sequence Crossover Study)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:49:59.674787|2017-10-11 00:49:59.674787
NCT02044380|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-02-15|2017-02-15||March 2014||2014-03-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||Treated set: This analysis set included all patients who were dispensed trial treatment (afatinib) and were documented to have taken at least one dose of afatinib.|Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations|An Open Label Trial of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)|Completed||Phase 3|14|Actual|Boehringer Ingelheim|Due to the small number of patients entered and treated in this trial (14 patients) relative to the planned enrollment goal (40 entered patients had been planned), no formal statistical analyses of efficacy data were performed.|1|||f||||||||||||||2017-10-11 00:49:59.941578|2017-10-11 00:49:59.941578
NCT02044367|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-05-01|2015-04-10||January 2014||2014-01-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||The evaluation of demographic and baseline characteristics were performed on the treated set which included all subjects who received at least 1 dose of study drug.|Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers|Relative Bioavailability of Dabigatran After Administration of Different Dosage Forms of Multiple Doses of 150 mg Dabigatran Etexilate (Hard Capsule, Granules Resolved in Reconstitution Solution, Pellets on Food) in Healthy Male Volunteers (an Open-label, Randomised, Multiple-dose, Three Way Crossover Study)|Completed||Phase 1|54|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 00:50:00.509763|2017-10-11 00:50:00.509763
NCT02044354|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2017-08-07|||May 22, 2014|Actual|2014-05-22|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 13, 2017|Actual|2017-04-13||Interventional|CABA-DOC||Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer|A Study of Patient Preference Between Cabazitaxel and Docetaxel in First-line Chemotherapy for Metastatic Castrate-resistant Prostate Cancer|Active, not recruiting||Phase 3|195|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 00:50:01.170165|2017-10-11 00:50:01.170165
NCT02044341|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-22|2015-03-19||2015-01-08|December 2013||2013-12-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|AR01006||Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media|A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years|Completed||Phase 3|304|Actual|Arbor Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:50:01.301385|2017-10-11 00:50:01.301385
NCT02044328|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-07-01|||January 2014||2014-01-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|ICAPE||Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation|Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation: a Prospective, Exploratory Study|Recruiting||Phase 2|80|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 00:50:01.580246|2017-10-11 00:50:01.580246
NCT02044315|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-21|||January 2012||2012-01-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|RISSY-ICD||Prevention of Inappropriate ICD Shocks||Completed||Phase 2/Phase 3|201|Actual|Yuksek Ihtisas Hospital||2|||f||||t||||||||||2017-10-11 00:50:01.726507|2017-10-11 00:50:01.726507
NCT02044302|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-04-06|2016-08-26||April 2014||2014-04-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Only two subjects were enrolled into 1 of the 2 blinded arms and then the study was terminated.|A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction|A Prospective Randomized Double Blind Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction|Terminated||Phase 2|2|Actual|Yale University||4|||f||||f||||||||||2017-10-11 00:50:01.86234|2017-10-11 00:50:01.86234
NCT02044289|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-02-02|||June 2014||2014-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||MR Imaging Biomarkers of Disease Response to ECT (Electroconvulsive Therapy) in Depression|MR Imaging Biomarkers of Disease Response to ECT in Depression|Completed||N/A|12|Actual|University of Arkansas|||1||f||||t||||||||||2017-10-11 00:50:02.269035|2017-10-11 00:50:02.269035
NCT02044276|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-08-30|||March 31, 2014|Actual|2014-03-31|August 2017|2017-08-01|May 16, 2018|Anticipated|2018-05-16|December 15, 2017|Anticipated|2017-12-15||Interventional|AVOID||A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia|A Randomized, Phase IIIB, Open-label, Two-arm, Multicenter, comparatiVe Study on Efficacy and Safety of Lipegfilgrastim (Lonquex, TEVA) in Comparison to Pegfilgrastim (Neulasta®, Amgen) in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia - AVOID Neutropenia|Active, not recruiting||Phase 3|101|Actual|Teva Pharmaceutical Industries||2|||f||||f|f|f||||||||2017-10-11 00:50:02.385318|2017-10-11 00:50:02.385318
NCT02044263|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-10-03|||July 2014|Actual|2014-07-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Cognitive Behavior Therapy for Insomnia Delivered by a Therapist or on the Internet|Cognitive Behavior Therapy for Insomnia Delivered by a Therapist or on the Internet: a Randomized Controlled Noninferiority Trial|Active, not recruiting||N/A|100|Anticipated|St. Olavs Hospital||2|||f||||f|f|f||||||||2017-10-11 00:50:02.684057|2017-10-11 00:50:02.684057
NCT02044250|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-10-12|||February 2014||2014-02-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)|Comparison of Clopidogrel vs. Aspirin Monotherapy Beyond Two Year After Drug-eluting Stent Implantation|Recruiting||Phase 4|5530|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:50:02.80149|2017-10-11 00:50:02.80149
NCT02044237|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-05-09|||August 2011||2011-08-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|||Online Treatment of Trichotillomania|Decoupling as Internet Based Intervention: an Randomized Controlled Study to Treat Trichotillomania|Completed||N/A|105|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 00:50:02.944822|2017-10-11 00:50:02.944822
NCT02044224|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-10-19|||January 2014||2014-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Dexmedetomidine During IRE Procedures for Solid Tumours|Effects of Dexmedetomidine on Anaesthesia During IRE Procedures for Solid Tumours|Completed||Phase 4|30|Anticipated|Uppsala University Hospital||1|||f||||f||||||||||2017-10-11 00:50:03.077154|2017-10-11 00:50:03.077154
NCT02044211|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-10-24|||February 2014||2014-02-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Blended Collaborative Care for Heart Failure and Co-Morbid Depression|Blended Collaborative Care for Heart Failure and Co-Morbid Depression|Recruiting||Phase 2/Phase 3|750|Anticipated|University of Pittsburgh||4|||f||||t||||||||||2017-10-11 00:50:03.200934|2017-10-11 00:50:03.200934
NCT02044198|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-01-08|||March 2014||2014-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria|A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria|Completed||Phase 1/Phase 2|30|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 00:50:03.343182|2017-10-11 00:50:03.343182
NCT02044185|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-04-21|||January 2014||2014-01-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|CHIP-SCT||Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation|Observational Study for Clinical Implications of HMGB1 (High-mobility Group Protein B1) in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|N/A|100|Anticipated|Seoul St. Mary's Hospital|||2||f||||f||||||Samples Without DNA|"     blood plasma biopsy tissue samples of colon   "|||2017-10-11 00:50:03.444658|2017-10-11 00:50:03.444658
NCT02044159|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-04-01|||July 2014||2014-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|STRIPES||Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study|Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study (STRIPES)|Completed||Phase 4|57|Actual|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-11 00:50:03.657566|2017-10-11 00:50:03.657566
NCT02044146|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-01-31|||September 2014||2014-09-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|October 2016|Actual|2016-10-01||Interventional|RAPID MANAGE||A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk|Reassessment of Anti-Platelet Therapy Using InDividualized Strategies - Modifying Acute CoroNary Syndrome Algorithms Based on Genetic and Demographic Evaluation: The RAPID-MANAGE Study|Active, not recruiting||Phase 2/Phase 3|120|Actual|Ottawa Heart Institute Research Corporation||3|||f||||t||||||||||2017-10-11 00:50:03.774122|2017-10-11 00:50:03.774122
NCT02044133|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-01-26|||January 2014||2014-01-01|July 2015|2015-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Monocentric Randomized Study, Assessing the Interests of the Determination of Vitamin D in Prison Population. (Vitamine D)|Monocentric Randomized Study, Assessing the Interests of the Determination of Vitamin D in Prison Population. (Vitamine D)|Completed||N/A|54|Actual|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-11 00:50:03.872486|2017-10-11 00:50:03.872486
NCT02044120|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-01-19|||May 2014||2014-05-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated, Incurable Ewing Sarcoma|ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated,Incurable Ewing Sarcoma|Recruiting||Phase 1|50|Anticipated|Sarcoma Alliance for Research through Collaboration||2|||f||||||||||||||2017-10-11 00:50:03.953269|2017-10-11 00:50:03.953269
NCT02044107|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-23|||February 2014||2014-02-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Interventional|Zinc10||The Effectiveness of Co-packaging With Zinc to Improve Treatment of Diarrhea and Pneumonia in Guatemala|Measuring the Effectiveness of Co-packaging to Improve Provider and Caregiver Behavior in the Treatment of Diarrhea With Zinc & ORS and Pneumonia With Zinc & Antibiotics for Children Under 5 Yrs From San Marcos, Guatemala|Unknown status|Not yet recruiting|N/A|320|Anticipated|Center for Studies of Sensory Impairment, Aging and Metabolism||2|||f||||f||||||||||2017-10-11 00:50:04.084839|2017-10-11 00:50:04.084839
NCT02044094|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-09-09||2015-08-07|November 2013||2013-11-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Multiple Dose Study of Blockade of Opioid Effects of Injections of Buprenorphine in Participants With Opioid Disorder|A Multiple-Dose Study of Blockade of Subjective Opioid Effects, Plasma Levels, and Safety of Subcutaneous Injections of Depot Buprenorphine (RBP-6000) in Subjects With Opioid Use Disorder|Completed||Phase 2|39|Actual|Indivior Inc.||1|||f||||f||||||||||2017-10-11 00:50:04.176588|2017-10-11 00:50:04.176588
NCT02044081|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-07-27||2016-05-17|February 2014||2014-02-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel and/or Mouth Rinse Doses to Healthy Adult Subjects|Completed||Phase 2|60|Actual|C3 Jian, LLC||4|||f||||f||||||||||2017-10-11 00:50:04.31581|2017-10-11 00:50:04.31581
NCT02044068|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-04-26|||October 2014||2014-10-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women|Prevention of Hepatitis B Virus Mother-to-Child Transmission (MTCT) From HIV-HBV Co-infected Pregnant Women by Use of Nucleosides/Nucleotides Analogues With Dual Activity During Pregnancy.|Completed||N/A|35|Actual|Hopital Lariboisière|||1||f||||f|f|f||||||No||2017-10-11 00:50:04.399538|2017-10-11 00:50:04.399538
NCT02044055|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2017-04-26|||October 2014||2014-10-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Mother-to-child Hepatitis D Transmission|Hepatitis D Virus (HDV) Mother-To-Child Transmission (MTCT) From Hepatitis B Virus (HBV)-Hepatitis D Virus (HDV) Co-infected Pregnant Women: a Retrospective Study.|Completed||N/A|54|Actual|Hopital Lariboisière|||1||f||||f||||||||No||2017-10-11 00:50:04.456442|2017-10-11 00:50:04.456442
NCT02044042|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2015-09-30|||October 2014||2014-10-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Vertical Transmission of Hepatitis C Virus|Mother-To-Child Transmission (MTCT) of Hepatitis C Virus and Spontaneous Viral Clearance in Infected Children: a Retrospective Study.|Unknown status|Recruiting|N/A|120|Anticipated|Hopital Lariboisière|||1||f||||f||||||||||2017-10-11 00:50:04.512291|2017-10-11 00:50:04.512291
NCT02044029|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-11-01|||January 2014||2014-01-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.|A SINGLE CENTER, LONGITUDINAL, NON-DRUG STUDY TO ASSESS THE ABILITY OF MUSCLE IMAGING AND OF MOTOR FUNCTION MEASURE (MFM) TO DETECT CHANGES IN DISEASE PROGRESSION IN AMBULANT SPINAL MUSCULAR ATROPHY (SMA) PATIENTS AS COMPARED TO AGE-MATCHED HEALTHY CONTROLS|Completed||N/A|38|Actual|Hoffmann-La Roche|||2||f||||||||||Samples With DNA|"     Whole blood samples taken at screening and at week 24 from patients with spinal muscular     atrophy (SMA).   "|||2017-10-11 00:50:04.574391|2017-10-11 00:50:04.574391
NCT02044016|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-08-01|||April 2014||2014-04-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||The Achilles Tendon Length Measure (ATLM) - Development and Validation|The Achilles Tendon Length Measure (ATLM) - Development and Validation|Completed||N/A|28|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 00:50:04.632547|2017-10-11 00:50:04.632547
NCT02044003|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-21|||December 2009||2009-12-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Safety & Feasibility Study of Tack-It Device for Vessel Dissection Repair|Safety & Feasibility Study of the Innovasc Tack Intravascular Staple System (Tack) for Securing Vascular Flaps Resulting From Balloon Angioplasty in the Infrainguinal Artery(Ies)|Completed||N/A|11|Actual|Intact Vascular||1|||f||||t||||||||||2017-10-11 00:50:04.709843|2017-10-11 00:50:04.709843
NCT02043990|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2014-01-21|||March 2013||2013-03-01|January 2014|2014-01-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|||Adjusted Ventilatory Assist (NAVA-NIV) in Infants: Short-term Physiological Study|Patient Ventilator Interaction During Non-invasive Ventilation Delivered With Neurally Adjusted Ventilatory Assist (NAVA-NIV) in Infants|Unknown status|Recruiting|N/A|15|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||1|||f||||t||||||||||2017-10-11 00:50:04.778153|2017-10-11 00:50:04.778153
NCT02043977|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-08-26|||June 2013||2013-06-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy and Safety Study of Propofol Infusion for Refractory Chronic Primary Insomnia|An Open Label, Pilot Study Utilizing an IV Infusion of Propofol in Male and Female Volunteers With Refractory Chronic Primary Insomnia|Completed||Phase 1|2|Actual|Life Extension Foundation Inc.||1|||f||||f||||||||||2017-10-11 00:50:06.715025|2017-10-11 00:50:06.715025
NCT02043964|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-09-19|||October 2012||2012-10-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|POLAR||Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion|Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion Among Patients With or Without Lesions at the Magnetic Resonance Imaging (Oligoclonal Profile of Tears)|Active, not recruiting||N/A|165|Actual|Lille Catholic University||1|||f||||f||||||||||2017-10-11 00:50:06.908363|2017-10-11 00:50:06.908363
NCT02043951|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-07-12|||January 2014||2014-01-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01|1 Year|Observational [Patient Registry]|LEG||Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity|A Prospective, Multicenter, Single Arm, Post-Market, Real-World Global Registry Assessing the Clinical Use and Safety of the LUTONIX Drug Coated Balloon Catheter in Arteries of the Lower Extremity (LUTONIX® Lower Extremity Global (LEG) Registry)|Terminated||Phase 3|59|Actual|C. R. Bard|||1|Originally 500 patients were planned but only 59 have been enrolled|f||||f||||||||||2017-10-11 00:50:07.055476|2017-10-11 00:50:07.055476
NCT02043925|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-07-27|||October 2010||2010-10-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||QT-prolongation in Psychiatric Hospitals|QT-prolongation in Psychiatric Hospitals|Completed||N/A|152|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-11 00:50:07.203747|2017-10-11 00:50:07.203747
NCT02043912|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-06-10|||July 2013||2013-07-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Observational|||Drug Interactions With Risk of QT-prolongation in a General Hospital|Drug Interactions With Risk of QT-prolongation in a General Hospital: an Epidemiological Point Prevalence Study|Completed||N/A|222|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-11 00:50:07.286877|2017-10-11 00:50:07.286877
NCT02043899|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-04-13|||February 2014||2014-02-01|April 2016|2016-04-01||||October 2018|Anticipated|2018-10-01||Interventional|||A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma|A Cancer Research UK Phase I/II Study to Compare [124I]Meta-Iodobenzylguanidine (mIBG) Positron Emission Tomography/Computerised Tomography (PET/CT) to [123I]mIBG Imaging in Patients With Metastatic Neuroblastoma|Recruiting||Phase 1/Phase 2|33|Anticipated|Cancer Research UK|||||f||||f||||||||||2017-10-11 00:50:07.378036|2017-10-11 00:50:07.378036
NCT02043886|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-06-27|||June 2007||2007-06-01|June 2017|2017-06-01|May 2014|Actual|2014-05-01|January 2013|Actual|2013-01-01||Interventional|||Acarbose, Postprandial Hypotension and Type 2 Diabetes|The Use of Acarbose to Treat Postprandial Hypotension in Older Adults With Type 2 Diabetes|Completed||Phase 2|15|Actual|University of British Columbia||2|||f||||f||||||||No||2017-10-11 00:50:07.467815|2017-10-11 00:50:07.467815
NCT02043873|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-22|||August 2003||2003-08-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|REPCOMP||Can Repair Increase the Useful Life of Composite Resins?|Can Repair Increase the Useful Life of Composite Resins? Clinical Trial: Triple-blind Controlled - 10 Year Follow-up|Completed||N/A|28|Actual|University of Chile|||2||f||||t||||||||||2017-10-11 00:50:07.557247|2017-10-11 00:50:07.557247
NCT02043860|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-03-30|||January 10, 2014|Actual|2014-01-10|March 2017|2017-03-01|November 7, 2016|Actual|2016-11-07|November 7, 2016|Actual|2016-11-07||Interventional|BMT-02||Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma|BMT-02: A Phase I Trial of Total Marrow Irradiation in Addition to High Dose Melphalan Conditioning Prior to Autologous Transplant for Multiple Myeloma Following Initial Induction Therapy|Terminated||Phase 1|3|Actual|University of Illinois at Chicago||1||low accrual|f||||t|t|f||||||||2017-10-11 00:50:07.634479|2017-10-11 00:50:07.634479
NCT02043847|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-03-30|||January 14, 2014|Actual|2014-01-14|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|BMT-03||Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Relapsed or Refractory Multiple Myeloma (BMT-03)|BMT-03: A Phase I Trial of Total Marrow Irradiation in Addition to High Dose Melphalan Conditioning Prior to Autologous Transplant for Patients With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 1|12|Actual|University of Illinois at Chicago||1|||f||||t|t|f||||||||2017-10-11 00:50:07.889769|2017-10-11 00:50:07.889769
NCT02043834|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-07-25|||November 2013||2013-11-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Virtual Reality-based Exercise in Older Adults|Promoting Virtual Reality-based Exercise to Prevent Falls in Older Adults: Pilot Study|Completed||N/A|33|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 00:50:07.992766|2017-10-11 00:50:07.992766
NCT02043821|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-01-23||||||January 2014|2014-01-01||||January 2016|Anticipated|2016-01-01||Interventional|||Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker|Maintenance Chemotherapy for Metastatic Colorectal Carcinoma|Unknown status|Not yet recruiting|N/A|80|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-11 00:50:08.095471|2017-10-11 00:50:08.095471
NCT02043808|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-07-01|2015-05-22||January 2014||2014-01-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||Post-PSM set|The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage|The Comparative Safety and Effectiveness of Warfarin and Dabigatran Utilized in the Department of Defense (DoD) Non-Valvular Atrial Fibrillation (NVAF) Patient Population-A Retrospective Database Analysis|Completed||N/A|25586|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 00:50:08.21839|2017-10-11 00:50:08.21839
NCT02043795|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-07-19|||December 2013||2013-12-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|DISAPEAR||Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study)|Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study)|Recruiting||N/A|24|Anticipated|Changi General Hospital||1|||f||||f||||||||||2017-10-11 00:50:08.864302|2017-10-11 00:50:08.864302
NCT02043782|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-03-30|2015-11-04||January 2014||2014-01-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Investigation of a New 1-piece Convex Ostomy Product|Investigation of a New 1-piece Convex Ostomy Product in Subjects With Ileostomy and Colostomy|Completed||N/A|38|Actual|Coloplast A/S||3|||f||||f||||||||||2017-10-11 00:50:08.976952|2017-10-11 00:50:08.976952
NCT02043769|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-12-04|||April 2012||2012-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|PESS||Pediatric Enhanced Surveillance Study|Enhanced Surveillance and 2 Year Outcomes of Children Enrolled on Antiretroviral Therapy (ART) in Public Health Facilities in the Eastern Cape Province, South Africa|Completed||N/A|396|Actual|Columbia University|||1||f||||f||||||Samples Without DNA|"     Small amounts of additional blood will be drawn at the same time as routine blood draws and     presents minimal risk to subjects (5cc of additional whole blood may be drawn from infants 1     month to 12 months of age or less than 10 kg in weight; 5 to 10 cc of additional blood may be     drawn from children older than 12 months of age or >10 kg in weight); these risks usually     include bruising at the site of the venipuncture, transient pain and a negligible chance for     infection. No more than three attempts to obtain the blood specimens will be allowed per     patient per blood collection visit. If collection of a blood sample/s fails this may be     attempted at the next scheduled visit.   "|||2017-10-11 00:50:09.28609|2017-10-11 00:50:09.28609
NCT02043756|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-21|||August 2011||2011-08-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection|Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Solid Tumor|Completed||Phase 1|20|Actual|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:50:09.386287|2017-10-11 00:50:09.386287
NCT02043743|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-21|||January 2014||2014-01-01|January 2014|2014-01-01|January 2015|Anticipated|2015-01-01|April 2014|Anticipated|2014-04-01||Interventional|||Autologous Stem Cells Transplantation in Patients With Idiopathic and Drug Induced Premature Ovarian Failure|Autologous Stem Cells Transplantation in Patients With Idiopathic and Drug Induced Premature Ovarian Failure|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|El-Rayadh Fertility Centre||1|||f||||t||||||||||2017-10-11 00:50:09.45828|2017-10-11 00:50:09.45828
NCT02043730|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-12-15|||January 2014||2014-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|March 2016|Anticipated|2016-03-01||Interventional|GAP||Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.|A Phase II Randomized Trial Comparing a Combination of Abraxane and Gemcitabine Versus Gemcitabine Alone as First Line Treatment in Locally Advanced Unresectable Pancreatic Cancer. GAP (Gemcitabine Abraxane Pancreas) Trial|Recruiting||Phase 2|124|Anticipated|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente||2|||f||||f||||||||||2017-10-11 00:50:09.54622|2017-10-11 00:50:09.54622
NCT02043717|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2017-06-25|||January 2014|Actual|2014-01-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01|1 Year|Observational [Patient Registry]|||Increased Vitamin D Reduces Pulmonary Exacerbations in CF|Increasing Vitamin D Serum Levels Reduces Pulmonary Exacerbations in Patients With Cystic Fibrosis|Completed||N/A|90|Actual|Hadassah Medical Organization|||1||f||||t|f|f||||Samples Without DNA|"     plasma   "|No||2017-10-11 00:50:09.848568|2017-10-11 00:50:09.848568
NCT02043678|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-09-06|||March 30, 2014|Actual|2014-03-30|August 2017|2017-08-01|December 23, 2019|Anticipated|2019-12-23|May 15, 2018|Anticipated|2018-05-15||Interventional|ERA 223||Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms|A Phase III Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone/Prednisolone in the Treatment of Asymptomatic or Mildly Symptomatic Chemotherapy-naïve Subjects With Bone Predominant Metastatic Castration-resistant Prostate Cancer(CRPC)|Active, not recruiting||Phase 3|806|Actual|Bayer||2|||f||||t|t|f||||||||2017-10-11 00:50:10.230576|2017-10-11 00:50:10.230576
NCT02043665|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2017-09-04|||January 2014||2014-01-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|STORM||Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200)|A Phase 1, Dose-finding and Signal-seeking Study of the Safety and Efficacy of Intravenous CAVATAK® (Coxsackievirus A21, CVA21) Alone and in Combination With Pembrolizumab in Patients With Late Stage Solid Tumours (NSCLC, Castrate-resistant Prostate Cancer, Melanoma, Bladder Cancer).|Recruiting||Phase 1|90|Anticipated|Viralytics||1|||f||||||||||||||2017-10-11 00:50:10.769998|2017-10-11 00:50:10.769998
NCT02043626|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-01-17|||August 2011||2011-08-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|H&A||Study to Evaluate the Health and Wellness Policies of the New Haven Public School District.|School Wellness Policy: RCT to Implement & Evaluate Impact on Childhood Obesity|Completed||N/A|796|Actual|Yale University||4|||f||||f||||||||||2017-10-11 00:50:11.04281|2017-10-11 00:50:11.04281
NCT02043613|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-03-26|||February 2014||2014-02-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|CONEX||Context Effects in Exercise Therapy for Knee and/or Hip Pain|Effect of Physical Surroundings on Effects From Exercise as Treatment for Hip or Knee Pain: A Double-blind Randomized Controlled Clinical Trial|Completed||N/A|103|Actual|University of Southern Denmark||3|||f||||f||||||||||2017-10-11 00:50:11.167074|2017-10-11 00:50:11.167074
NCT02043600|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-09-22|||February 2014||2014-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Randomized-controlled Trial of Yoga for Ulcerative Colitis|Randomized-controlled Trial of Yoga for Ulcerative Colitis|Completed||N/A|77|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-11 00:50:11.267381|2017-10-11 00:50:11.267381
NCT02043587|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-08-04|||January 2014||2014-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma|A Phase II Study of Punctual, Cyclic, and Intensive Chemotherapy With Liposomal Cytarabine (Depocyt®) CNS Prophylaxis for Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma|Recruiting||Phase 2|100|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:50:11.479651|2017-10-11 00:50:11.479651
NCT02043574|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-09-20|||November 17, 2014|Actual|2014-11-17|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|February 16, 2018|Anticipated|2018-02-16||Interventional|NEXIS||Nutrition and Aerobic Exercise in Chronic Stroke|Aerobic Training to Improve Energy Utilization and Antioxidant Capacity in Stroke|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 00:50:11.680607|2017-10-11 00:50:11.680607
NCT02043561|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-09-07|||December 24, 2014|Actual|2014-12-24|January 2014|2014-01-01|September 7, 2015|Actual|2015-09-07|September 7, 2015|Actual|2015-09-07||Interventional|||The Effect of Inhibitory Control Processes Induced by Rectal Distension on Impulse Control Measured by Stroop Task Performance and Intertemporal Discounting.||Completed||N/A|35|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||||2017-10-11 00:50:11.776243|2017-10-11 00:50:11.776243
NCT02043548|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-10-26|||October 2014||2014-10-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|TIM||Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis|Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis|Recruiting||Phase 2|40|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 00:50:11.846792|2017-10-11 00:50:11.846792
NCT02043535|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-04-21|||March 2014||2014-03-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|CO2 STRESS||CO2 as a Stress Agent for Perfusion Imaging|Effects of Controlled Hypercapnic Stimulation on Myocardial Blood Flow Measured With Positron Emission Tomography|Active, not recruiting||N/A|60|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 00:50:12.017103|2017-10-11 00:50:12.017103
NCT02043522|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-04-21|||December 2013||2013-12-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||123I-mIBG SPECT Imaging|Optimization of Cardiac Iodine-123 Meta-iodobenzylguanidine (123I-mIBG) SPECT Imaging|Completed||Phase 3|30|Actual|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 00:50:12.120816|2017-10-11 00:50:12.120816
NCT02043509|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-02-17|||February 2014||2014-02-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MiQuit||MiQuit Trial: Tailored Text Messages for Pregnant Women|Evaluation of a Tailored Text Message Intervention for Pregnant Smokers (MiQuit): a Pilot Trial|Completed||N/A|407|Actual|University of Nottingham||2|||f||||f||||||||No||2017-10-11 00:50:12.220136|2017-10-11 00:50:12.220136
NCT02043496|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-08-02|||December 2013||2013-12-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Integrative Cognitive-Affective Therapy for Binge Eating Disorder|Integrative Cognitive-Affective Therapy for Binge Eating Disorder|Active, not recruiting||N/A|112|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:50:12.353632|2017-10-11 00:50:12.353632
NCT02043483|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-02-16|||October 2012||2012-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Identification of Biomarkers for Obstructive Sleep Apnoea Syndrome|Obstructive Sleep Apnoea and Associated Metabolic/Cardiovascular Disorders: Understanding Mechanisms Towards Early Diagnosis and Prognosis|Completed||N/A|120|Anticipated|Universidade Nova de Lisboa|||2||f||||f||||||||||2017-10-11 00:50:12.450108|2017-10-11 00:50:12.450108
NCT02043470|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-05-15|||March 2011||2011-03-01|May 2017|2017-05-01|May 4, 2017|Actual|2017-05-04|July 2015|Actual|2015-07-01||Observational|||Retinal Oxygen Function After Radiation Therapy|Changes in Regional Retinal Oxygen Extraction and Function After Radiation Therapy|Completed||N/A|32|Actual|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 00:50:12.538064|2017-10-11 00:50:12.538064
NCT02043457|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-09-19|||August 2009||2009-08-01|September 2017|2017-09-01|December 2025|Anticipated|2025-12-01|August 2025|Anticipated|2025-08-01||Observational|||Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance|Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance|Recruiting||N/A|2000|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"     DNA that is de-indentified is stored.   "|||2017-10-11 00:50:12.608926|2017-10-11 00:50:12.608926
NCT02043444|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-08-21|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|June 2017|Actual|2017-06-01||Interventional|AzoPredHisto||Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT|Comparison of FDG PET-CT Estimated Testis Functional Value Between Patients Having Positive Testicular Sperm Cells Extraction and Patients With a Negative Extraction, in Men With Azoospermia|Recruiting||N/A|160|Anticipated|University Hospital, Toulouse||3|||f||||f||||||||||2017-10-11 00:50:12.742544|2017-10-11 00:50:12.742544
NCT02043431|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-12-15|||August 2012||2012-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|July 2015|Actual|2015-07-01|2 Years|Observational [Patient Registry]|||Electronic Medical Records and Genomics|Genetic and Electronic Medical Records to Predict Outcomes in Heart Failure Patients|Active, not recruiting||N/A|700|Actual|University of Sao Paulo General Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood, urine. Exhaled acethone   "|||2017-10-11 00:50:12.851397|2017-10-11 00:50:12.851397
NCT02043418|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2016-07-11|||November 2007||2007-11-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|PEDIACAM||Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project|Outcome at 5 Years of Early Treated HIV Infected Infants on Antiretroviral Multi-therapy in the PEDIACAM ANRS12140 Project in Cameroon|Active, not recruiting||N/A|460|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||2||f||||t||||||Samples With DNA|"     a biobank (plasma / serum stored at -80 ° C) will be established   "|||2017-10-11 00:50:12.929892|2017-10-11 00:50:12.929892
NCT02043405|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-12-05|||January 2014||2014-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Weight Loss and/or Exercise Training to Discover Muscle Lipids Related to Insulin Sensitivity|Weight Loss and/or Exercise Training to Discover Muscle Lipids Related to Insulin Sensitivity.|Recruiting||N/A|30|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 00:50:13.031251|2017-10-11 00:50:13.031251
NCT02043392|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-05-09|||May 2014||2014-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|Magnamosis||Magnamosis First-in-human Study of Feasibility and Safety|Magnetic Compression Anastomosis (Magnamosis) First-in-human Study of Feasibility and Safety|Recruiting||N/A|10|Anticipated|University of California, San Francisco||1|||f||||t||||||||No||2017-10-11 00:50:13.121874|2017-10-11 00:50:13.121874
NCT02043379|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-03-01|2016-10-14||May 2014||2014-05-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Post-bypass Prophylactic IVIG in Infants and Neonates|Intravenous Immunoglobulin for Early Prevention of Cardiopulmonary Bypass Induced Hypogammaglobulinemia in Infants and Neonates|Completed||N/A|50|Actual|University of Alabama at Birmingham||2|||f||||t||||||||No|IPD will not be shared with other individuals|2017-10-11 00:50:13.270256|2017-10-11 00:50:13.270256
NCT02043366|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-12-08|2015-08-27||February 2014||2014-02-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients|Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Postoperative Hyperalgesia Induced by Remifentanil in Patients Undergoing Lower Abdomimal Surgery|Completed||N/A|180|Actual|Tianjin Medical University General Hospital||6|||f||||t||||||||||2017-10-11 00:50:15.152682|2017-10-11 00:50:15.152682
NCT02043353|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2014-01-21|||August 2010||2010-08-01|January 2014|2014-01-01||||September 2014|Anticipated|2014-09-01||Observational|||The Natural History and Outcome of Sleep Disordered Breathing in Children|The Natural History and Outcome of Sleep Disordered Breathing in Children|Unknown status|Recruiting|N/A|2856|Anticipated|Tel-Aviv Sourasky Medical Center|||4||f||||||||||||||2017-10-11 00:50:15.669138|2017-10-11 00:50:15.669138
NCT02043327|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-21|||November 2012||2012-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|March 2013|Actual|2013-03-01||Observational|||Simulation Based Training in Colonoscopy|Simulation-based Training for Colonoscopy: Establishing Criteria for Competency|Completed||N/A|25|Actual|Rigshospitalet, Denmark|||2||f||||t||||||||||2017-10-11 00:50:15.839286|2017-10-11 00:50:15.839286
NCT02043314|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-22|||October 2008||2008-10-01|January 2014|2014-01-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|||A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers|New Strategy for Treating Latent Tuberculosis Infection in Brazil: A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers|Completed||Phase 1|28|Actual|Oswaldo Cruz Foundation||2|||f||||t||||||||||2017-10-11 00:50:15.923505|2017-10-11 00:50:15.923505
NCT02043288|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-11-13|||January 2014||2014-01-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer|A Phase III, Open-label, Randomized Study of the Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Recruiting||Phase 3|400|Anticipated|Orient Europharma Co., Ltd.||2|||f||||t||||||||No||2017-10-11 00:50:16.124582|2017-10-11 00:50:16.124582
NCT02043275|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-01-20|||April 2013||2013-04-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Resistance Training on Jump Landing Mechanics in Young Female Athletes|Effect of a Resistance Training Program on the Jump Landing Biomechanics of Young Female Athletes|Completed||N/A|40|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:50:16.326564|2017-10-11 00:50:16.326564
NCT02043262|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-06-02|||May 2012||2012-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effectiveness of Reablement in Home Dwelling Older Adults. A Randomized Controlled Trial|Evaluating Reablement for Home-dwelling Elderly in a Norwegian Municipality|Completed||N/A|61|Actual|Bergen University College||2|||f||||f||||||||No||2017-10-11 00:50:16.421801|2017-10-11 00:50:16.421801
NCT02043249|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-01-19|||January 2014||2014-01-01|November 2013|2013-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Cord Milking and Activity Of The Immune System In Preterm Infants|Cord Milking and Activity Of The Immune System In Preterm Infants|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 00:50:16.529535|2017-10-11 00:50:16.529535
NCT02043236|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-05-03|||November 2013||2013-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Strategies to Improve Bone Health in Men on ADT|A Phase II RCT of Strategies to Improve Bone Health in Men on ADT|Active, not recruiting||N/A|100|Anticipated|University Health Network, Toronto||3|||f||||f||||||||No||2017-10-11 00:50:16.61669|2017-10-11 00:50:16.61669
NCT02043223|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-09-20|||October 2013||2013-10-01|September 2016|2016-09-01||||July 2016|Actual|2016-07-01||Interventional|||Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit|Stopping Postpartum Vitamin A Supplementation: Are we Missing Concealed Benefit?|Completed||Phase 2/Phase 3|160|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||t||||||||||2017-10-11 00:50:16.705864|2017-10-11 00:50:16.705864
NCT02043210|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-09-28|||January 2014||2014-01-01|June 2017|2017-06-01|September 11, 2017|Actual|2017-09-11|August 2017|Actual|2017-08-01||Interventional|||CBT for Spanish Speakers|Computer Based Training in CBT for Spanish-speaking Substance Users|Completed||N/A|99|Actual|Yale University||2|||f||||t||||||||||2017-10-11 00:50:16.794471|2017-10-11 00:50:16.794471
NCT02043184|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-06-06|||March 2013||2013-03-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR|Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR|Completed||N/A|322|Actual|Michigan State University||4|||f||||f||||||||No|Individual participant data will not be made available.|2017-10-11 00:50:16.979914|2017-10-11 00:50:16.979914
NCT02043171|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-06-26|||August 2014||2014-08-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2|Year-long Double Blind Study on the Efficacy of a Combination of Beta-hydroxy-beta-methylbutyrate and Vitamin D With and Without Exercise on Muscular Strength and Functionality in Older Adults.|Recruiting||Phase 1|160|Anticipated|Metabolic Technologies Inc.||4|||f||||t||||||||||2017-10-11 00:50:17.081666|2017-10-11 00:50:17.081666
NCT02043158|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-03-29|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer|Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer|Active, not recruiting||N/A|240|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 00:50:17.181992|2017-10-11 00:50:17.181992
NCT02043145|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-05-15|2014-05-15||July 2008||2008-07-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational||Baseline measures were based on the Safety population that included all participants treated with BOTOX® as prescribed. Participants previously treated with survey drug (BOTOX®) were excluded.|Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea||Completed||N/A|727|Actual|Allergan|||3||f||||f||||||||||2017-10-11 00:50:17.268102|2017-10-11 00:50:17.268102
NCT02043132|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-05-19|2017-02-09||September 2013||2013-09-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|TXA||Tranexamic Acid in Reverse Total Shoulder Arthroplasty|Intravenous Tranexamic Acid to Reduce Blood Loss in Reverse Total Shoulder Arthroplasty|Completed||Phase 2/Phase 3|116|Actual|William Beaumont Hospitals||2|||f||||t||||||||No||2017-10-11 00:50:17.740002|2017-10-11 00:50:17.740002
NCT02043119|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-10-21|||January 2014||2014-01-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|BEST ABCs||BEST ABCs: Benefits and Effectiveness of Support Offered Through A Breastfeeding Clinic Study|BEST ABCs: Benefits and Effectiveness of Support Offered Through A Breastfeeding Clinic Study|Completed||N/A|472|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 00:50:18.207768|2017-10-11 00:50:18.207768
NCT02043106|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-03-05|||January 2014||2014-01-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Can Vibration Stimulation of the Foot Sole Activate Leg Muscles?|Plantar Cutaneous Stimulation Used to Elicit Muscle Activity in Individuals With Incomplete Spinal Cord Injury|Completed||N/A|8|Actual|Wilfrid Laurier University||2|||f||||f||||||||||2017-10-11 00:50:18.297992|2017-10-11 00:50:18.297992
NCT02043093|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-01-04|||August 2010||2010-08-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Effectiveness Trial of Youth Suicide Prevention Delivered by Teen Peer Leaders|Effectiveness Trial of Suicide Prevention Delivered by Teen Peer Leaders|Completed||N/A|17603|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 00:50:18.380573|2017-10-11 00:50:18.380573
NCT02043080|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-08-02|||August 2012|Actual|2012-08-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2016|Actual|2016-03-01||Interventional|||Optimizing Clinical Outcomes in HIV-Infected Adults & Children|CIDRZ 1201 - Optimizing Clinical Outcomes in HIV-Infected Adults & Children Using Xpert MTB/RIF in Zambia|Completed||N/A|1436|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 00:50:18.472143|2017-10-11 00:50:18.472143
NCT02043067|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-09-13|||October 2011||2011-10-01|December 2014|2014-12-01|May 2013|Actual|2013-05-01|September 2012|Actual|2012-09-01||Observational|||Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV|Enhanced TB Screening to Determine the Prevalence and Incidence of TB in a Cohort of HIV Clinic Patients in Lusaka, Zambia|Completed||N/A|400|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     Additional samples (10 ml blood, and 20 ml urine) will be stored in the specimen repository     at the CIDRZ laboratory for future studies. For patients who agree to provide samples for the     repository and are diagnosed with TB, isolates from positive cultures (blood, urine, and/or     sputum) will also be stored in the repository.   "|||2017-10-11 00:50:18.595792|2017-10-11 00:50:18.595792
NCT02043054|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-11-16|||January 2014||2014-01-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|LYDIA||Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)|Impact of Liraglutide on Cardiac Function and Structure in Young Adults With Type 2 Diabetes: an Open-label, Randomised Active-comparator Trial|Recruiting||Phase 3|90|Anticipated|University of Leicester||2|||f||||t||||||||||2017-10-11 00:50:18.704097|2017-10-11 00:50:18.704097
NCT02043041|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-06-24|||January 2014||2014-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Evaluation of the Quality of Self-collected Blood Spot Specimens for Laboratory HIV Testing - An InvolveMENt Sub Study|Explaining the Differences in HIV Prevalence and Incidence Between Black and White Men Who Have Sex With Men in Atlanta|Completed||N/A|45|Actual|Emory University|||3||f||||f||||||Samples With DNA|"     Dried blood spots will be collected and inspected for quality. Once quality is determined,     samples will be destroyed. No identifying information will be associated with the sample.   "|||2017-10-11 00:50:18.818226|2017-10-11 00:50:18.818226
NCT02043028|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-03-17|||August 2013||2013-08-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Kneeling Posture With a Kneeling Stool During Cardiopulmonary Resuscitation in Hospital|Kneeling Posture With a Kneeling Stool During Cardiopulmonary Resuscitation in Hospital|Completed||N/A|38|Actual|Hanyang University||2|||f||||t||||||||||2017-10-11 00:50:18.888667|2017-10-11 00:50:18.888667
NCT02043015|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-07-04|||February 2015|Actual|2015-02-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|October 2016|Actual|2016-10-01||Interventional|||Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study (Sibanye Health Project)|Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study|Completed||N/A|100|Actual|Emory University||1|||f||||f||||||||||2017-10-11 00:50:18.990025|2017-10-11 00:50:18.990025
NCT02043002|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-04-18|||April 2013||2013-04-01|January 2014|2014-01-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|||Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)|Early Changes in 18F-fluorodeoxyglucose Positron Emissions Tomography (18F-FDG-PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)|Completed||N/A|67|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 00:50:19.113938|2017-10-11 00:50:19.113938
NCT02042989|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-03-16|||June 27, 2014|Actual|2014-06-27|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies|A Phase I Study of MLN9708 and Vorinostat to Target Autophagy in Patients With Advanced p53 Mutant Malignancies|Active, not recruiting||Phase 1|68|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:50:19.183564|2017-10-11 00:50:19.183564
NCT02042976|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-02-20|||February 2014||2014-02-01|June 2014|2014-06-01||||September 2016|Actual|2016-09-01||Interventional|||Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease|A Randomised Controlled Trial of Mindfulness-based Cognitive Therapy (MBCT) for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|84|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:50:19.287994|2017-10-11 00:50:19.287994
NCT02042963|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-01-20|||March 2012||2012-03-01|January 2014|2014-01-01||||February 2021|Anticipated|2021-02-01|9 Years|Observational [Patient Registry]|KNOW-KT||KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT)|KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation : A 9-year Longitudinal Cohort Study of the Kidney Transplantation (KNOW-KT)|Enrolling by invitation||N/A|1000|Anticipated|Seoul National University Hospital|||1||f||||t||||||Samples With DNA|"     DNA, serum, urine, RNA (blood and urine)   "|||2017-10-11 00:50:19.397972|2017-10-11 00:50:19.397972
NCT02042950|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-04-07|||July 2014|Actual|2014-07-01|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma|A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma|Active, not recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:50:19.483477|2017-10-11 00:50:19.483477
NCT02042937|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-09-02|||January 2014||2014-01-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Enhancing Gluteus Maximus Recruitment|Enhancing Gluteus Maximus Recruitment: a Randomized Controlled Pilot Trial|Completed||N/A|20|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:50:19.563124|2017-10-11 00:50:19.563124
NCT02042924|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2017-06-07|2017-04-26||January 2014||2014-01-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies|Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies|Terminated||N/A|2|Actual|Masonic Cancer Center, University of Minnesota||1||Updating protocol and consents|f||||t||||||||||2017-10-11 00:50:19.647161|2017-10-11 00:50:19.647161
NCT02042911|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-12-06|2016-02-28||January 2013||2013-01-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia|A Multicenter, Open-label Phase II Study of SyB L-0501 in Patients With Chronic Lymphocytic Lymphoma|Completed||Phase 2|10|Actual|SymBio Pharmaceuticals||1|||f||||||||||||||2017-10-11 00:50:19.839938|2017-10-11 00:50:19.839938
NCT02042898|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-09-22|||January 20, 2014|Actual|2014-01-20|September 2017|2017-09-01|October 1, 2017|Anticipated|2017-10-01|April 28, 2017|Actual|2017-04-28||Interventional|TRICS-III||Transfusion Requirements in Cardiac Surgery III|An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Patients Undergoing Cardiac Surgery|Active, not recruiting||N/A|5028|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-10-11 00:50:20.517869|2017-10-11 00:50:20.517869
NCT02042885|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-10-19|||January 2014||2014-01-01|July 2014|2014-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer|A Two-part Phase 1/2a, Open-label, Dose Escalation Study to Evaluate the Tolerability and Preliminary Antitumour Activity of OPB-111001 in Patients With Advanced Cancers That Are Poorly Responsive to Standard Anticancer Treatment|Terminated||Phase 1/Phase 2|79|Anticipated|Otsuka Novel Products GmbH||4|||f||||t||||||||||2017-10-11 00:50:20.739434|2017-10-11 00:50:20.739434
NCT02042872|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-05-05|2014-03-12||May 2006||2006-05-01|May 2015|2015-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Zoledronic Acid Administration in Acute Spinal Cord Injury|The Efficacy of Zoledronic Acid in the Prevention of Bone Loss in Acute Spinal Cord Injury|Completed||Phase 4|21|Actual|James J. Peters Veterans Affairs Medical Center|The clinical trial was not randomized, it had a relatively small sample size, and 5 participants received high-dose corticosteroids in an attempt to preserve neurologic function upon that could have had a profound adverse effect on the skeleton.|2|||f||||f||||||||||2017-10-11 00:50:20.824774|2017-10-11 00:50:20.824774
NCT02042859|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-20|||February 2013||2013-02-01|January 2014|2014-01-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|EndoHPB||Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer|Pilot Study to Assess Safety and Efficacy Of An Endoscopic Bipolar Radiofrequency Probe (EndoHPB) In the Management of Unresectable Bile Duct and Pancreatic Cancer|Unknown status|Enrolling by invitation|Phase 1|40|Anticipated|Ochsner Health System||1|||f||||f||||||||||2017-10-11 00:50:21.259671|2017-10-11 00:50:21.259671
NCT02024490|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2014-01-06|||December 2012||2012-12-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Effect of Maternal and Neonatal Vitamin D Levels on Respiratory Distress Syndrome in Preterm Infants||Completed||N/A|100|Actual|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||t||||||||||2017-10-11 00:54:35.329493|2017-10-11 00:54:35.329493
NCT02042846|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-11-17|||January 2014||2014-01-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Clinical Evaluation of the SportWelding FijiAnchor® in Hand and Hand Wrist Surgery|Prospective Clinical Evaluation of the Bioabsorbable SportWelding FijiAnchor® for Ligament Repair of the Hand and Hand Wrist|Active, not recruiting||N/A|30|Anticipated|SportWelding GmbH||1|||f||||||||||||||2017-10-11 00:50:21.335114|2017-10-11 00:50:21.335114
NCT02042833|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-11-02|||May 2011||2011-05-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS)||Completed||N/A|815|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:50:21.431541|2017-10-11 00:50:21.431541
NCT02042820|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-10-27|||January 2014||2014-01-01|December 2014|2014-12-01||||July 2015|Actual|2015-07-01||Observational|||Ocular Surface Immune Response in Dry Eye Disease: Analysis of Conjunctival and Peripheral Corneal Immune Cell Alterations by In Vivo Confocal Microscopy and Clinical Correlation|Ocular Surface Immune Response in Dry Eye Disease: Analysis of Conjunctival and Peripheral Corneal Immune Cell Alterations by In Vivo Confocal Microscopy and Clinical Correlation|Completed||N/A|67|Actual|Massachusetts Eye and Ear Infirmary|||2||f||||f||||||||||2017-10-11 00:50:21.756186|2017-10-11 00:50:21.756186
NCT02042807|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-04-13|||October 2014||2014-10-01|April 2015|2015-04-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|MCS-8||To Evaluate the Effect of MCS® in Prostate Cancer Prevention|A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of MCS® in Prostate Cancer Prevention|Recruiting||Phase 2|702|Anticipated|Health Ever Bio-Tech Co., Ltd.||3|||f||||||||||||||2017-10-11 00:50:21.86235|2017-10-11 00:50:21.86235
NCT02042794|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2015-02-20|||June 2013||2013-06-01|February 2015|2015-02-01||||December 2015|Anticipated|2015-12-01||Observational|||Pringle Manoeuvre Versus Portal Vein Clamping for Liver Resection|Randomised Controlled Trial of Pringle Manoeuvre Versus Portal Vein Clamping in Patients Undergoing Liver Resection for Colorectal Liver Metastasis - A Pilot Study|Unknown status|Recruiting|N/A|80|Anticipated|The Leeds Teaching Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 00:50:21.954099|2017-10-11 00:50:21.954099
NCT02042768|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-01-20|||March 2013||2013-03-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|September 2015|Actual|2015-09-01||Observational|PD-CRAFT||Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This|An Investigation of the Effects of Different Dialysis Prescriptions on Systemic Glucose Metabolism and Mortality in Non-diabetic Peritoneal Dialysis Patients|Active, not recruiting||N/A|1600|Anticipated|Keele University|||1||f||||f||||||Samples With DNA|"     Blood stored in EDTA for assays including DNA on all PD-CRAFT patients. 10mls blood in EDTA     taken during PET on all patients eligible for glucose study.      30mls of spent dialysate stored in both filtered and unfiltered aliquots on all patients on     PD for more than 3 years.   "|||2017-10-11 00:50:22.121801|2017-10-11 00:50:22.121801
NCT02042755|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-01-18|||February 2014||2014-02-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)|Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)|Completed||N/A|19|Actual|Physiol|||1||f||||f||||||||No||2017-10-11 00:50:22.206601|2017-10-11 00:50:22.206601
NCT02042742|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2014-01-20|||April 2013||2013-04-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|PROBELTEII||Punicalagin and Hydroxytyrosol Mixture on Different Inflammatory Markers|Effects of Punicalagin and Hydroxytyrosol Mixture on Different Inflammatory Markers Related With Cardiovascular Disease: a Crossover Study in Healthy Middle-aged Volunteers|Completed||Phase 4|76|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-11 00:50:22.290851|2017-10-11 00:50:22.290851
NCT02042729|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2014-02-20|||August 2012||2012-08-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||A Phase 1 Comparative Study of E2022 Current and New Patch Formulations|A Phase 1 Comparative Study of E2022 Current and New Patch Formulations|Completed||Phase 1|34|Actual|Eisai Inc.||4|||f||||||||||||||2017-10-11 00:50:22.391992|2017-10-11 00:50:22.391992
NCT02042716|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-10-11|||December 2013||2013-12-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|BELUGA||Added Value of Supersonic Shear Imaging in the Diagnosis of White Matter Damage in Preterm Infants|Added Value of Supersonic Shear Imaging in the Diagnosis of White Matter Damage in Preterm Infants|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:50:22.506764|2017-10-11 00:50:22.506764
NCT02042703|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-21|2015-10-20|||February 2014||2014-02-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Imaging Lens Deposits in Exfoliation Syndrome|Imaging Lens Changes in Exfoliation Syndrome Using Anterior Segment OCT|Terminated||N/A|4|Actual|Duke University|||3|Unanticipated slow enrollment|f||||t||||||||||2017-10-11 00:50:22.593179|2017-10-11 00:50:22.593179
NCT02042690|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2014-01-20|||January 2014||2014-01-01|January 2014|2014-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients|A Randomised Phase III Study to Compare Haplo-identical HSCT Versus Chemotherapy in First Remission for Standard-risk Adult Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 3|300|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 00:50:22.677014|2017-10-11 00:50:22.677014
NCT02042677|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-09-22|||January 2014||2014-01-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Assessment of a Skin Barrier|User Assessment of a One-Piece Skin Barrier|Terminated||N/A|18|Actual|Hollister Incorporated|||1|Slow recruitment of participants|f||||f||||||||||2017-10-11 00:50:22.793041|2017-10-11 00:50:22.793041
NCT02042495|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Endometrial Cancer Biomarker Changes Following Exposure to Metformin|A Clinical Trial to Evaluate Endometrial Cancer Biomarker Changes Following Exposure to the Insulin Sensitizer Metformin|Withdrawn||Phase 2|0|Actual|Jewish General Hospital||1||"Did not obtain Health Canda approval for drug use in reasonable time and moved onward to new   trial"|f||||f||||||||||2017-10-11 00:50:24.347894|2017-10-11 00:50:24.347894
NCT02042664|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-08-28|||January 2011||2011-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics|Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics|Completed||Phase 3|44|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 00:50:22.877218|2017-10-11 00:50:22.877218
NCT02042651|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-03-23|||February 2014||2014-02-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|CPPESWT||A Sham Controlled Study of the Effects of Ultrasonic Shockwaves as a Treatment for Chronic Pelvic Pain|Low Intensity Extracorporeal Shockwave Therapy Against Chronic Pelvic Pain: a Randomized and Sham Controled Study|Withdrawn||N/A|0|Actual|Herlev Hospital||2||study stopped because of insuficient number of comparable patients available.|f||||t||||||||||2017-10-11 00:50:22.978407|2017-10-11 00:50:22.978407
NCT02042638|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2014-01-22|||January 2011||2011-01-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01|6 Months|Observational [Patient Registry]|||The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism||Completed||N/A|16|Actual|Gulhane School of Medicine|||1||f||||t||||||||||2017-10-11 00:50:23.078083|2017-10-11 00:50:23.078083
NCT02042625|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-07-18|||April 2014||2014-04-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Optimal Positioning of Nasopharyngeal Temperature Probes: A Prospective Cohort Study|Optimal Positioning of Nasopharyngeal Temperature Probes: A Prospective Cohort Study|Completed||N/A|36|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-10-11 00:50:23.172096|2017-10-11 00:50:23.172096
NCT02042612|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-06-24|||October 2013||2013-10-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|January 2014|Actual|2014-01-01||Interventional|CISEVOB||Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients|Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients|Completed||Phase 2|8|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 00:50:23.245987|2017-10-11 00:50:23.245987
NCT02042599|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-22|||January 2014||2014-01-01|January 2014|2014-01-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|SEVOKID||Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in ICU Patients With Acute Kidney Injury|Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in ICU Patients With Acute Kidney Injury|Unknown status|Not yet recruiting|Phase 2|12|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 00:50:23.332246|2017-10-11 00:50:23.332246
NCT02042586|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-20||||||March 2011|2011-03-01||||June 2014|Anticipated|2014-06-01||Observational|||Evaluation of Locomotor Activity Before and After Total Hip Replacement in Patients With Hip Osteoarthritis.|Evaluation of Locomotor Activity Before and After Total Hip Replacement in Patients With Hip Osteoarthritis. Use of Ganglion and Neural Network Techniques to Identify Objective Criteria for the Success of Arthroplasty|Unknown status|Recruiting|N/A|200|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-11 00:50:23.417214|2017-10-11 00:50:23.417214
NCT02042573|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-20|||November 2013||2013-11-01|January 2013|2013-01-01||||January 2015|Anticipated|2015-01-01||Interventional|TMSFOS||Preliminary Study to Investigate the Effect of rTMS and SSRI Antidepressants on Leukocyte Expression of the C-FOS and DUSP1 Genes in Patients Treated for Depression|TMSFOS: Preliminary Study to Investigate the Effect of rTMS and SSRI Antidepressants on Leukocyte Expression of the C-FOS and DUSP1 Genes in Patients Treated for Depression|Unknown status|Recruiting|Phase 4|60|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f||||||||||||||2017-10-11 00:50:23.507473|2017-10-11 00:50:23.507473
NCT02042560|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-06-03||||||November 2012|2012-11-01||||June 2014|Anticipated|2014-06-01||Interventional|||Physiopathology Study of Auto-immune Thrombopenia. Multicentre, Open, Controlled Study|Physiopathology Study of Auto-immune Thrombopenia. Multicentre, Open, Controlled Study|Unknown status|Recruiting|N/A|175|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:50:23.597955|2017-10-11 00:50:23.597955
NCT02042547|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-22|||September 2010||2010-09-01|November 2010|2010-11-01||||September 2013|Actual|2013-09-01||Observational|||Study Of Factors Favoring The Onset Of Novo Atrial Fibrillation In The Immediate Aftermath Of Coronary Artery Bypass Surgery|STUDY OF FACTORS FAVORING THE ONSET OF NOVO ATRIAL FIBRILLATION IN THE IMMEDIATE AFTERMATH OF CORONARY ARTERY BYPASS SURGERY|Completed||N/A|100|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 00:50:23.682888|2017-10-11 00:50:23.682888
NCT02042534|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-12-14|2016-08-08||January 2014||2014-01-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TripleAXEL|Modified Intention-to-treat analysis : The subject who is measured for the primary end point with IP is administered more than at least once after randomization|Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation|Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation: Acute Stroke With Xarelto to Reduce Intracranial Bleeding, Recurrent Embolic Stroke, and Hospital Stay, Phase 2, Conceptual Multicenter Trial|Completed||Phase 2|195|Actual|Asan Medical Center||2|||f||||t||||||||Undecided||2017-10-11 00:50:23.768657|2017-10-11 00:50:23.768657
NCT02042521|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-07-20|||January 2014||2014-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|CIGAR||A Dietary Supplement for Early Cigarette Withdrawal|A Dietary Supplement for Early Cigarette Withdrawal|Active, not recruiting||Phase 2|100|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 00:50:24.18694|2017-10-11 00:50:24.18694
NCT02042508|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-20||||||January 2013|2013-01-01||||February 2016|Anticipated|2016-02-01||Interventional|||Evaluation of a Hybrid Prototype Strategy (Electrostimulation of Lower Limb Muscles Associated With Voluntary Strengthening of the Upper Limbs) in Reconditioning to Effort in Patients With Chronic Paraplegia.|Evaluation of a Hybrid Prototype Strategy (Electrostimulation of Lower Limb Muscles Associated With Voluntary Strengthening of the Upper Limbs) in Reconditioning to Effort in Patients With Chronic Paraplegia.|Unknown status|Recruiting|N/A|10|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 00:50:24.274153|2017-10-11 00:50:24.274153
NCT02041520|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-07-28|2015-02-06||January 2013||2013-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients|Effect of Omega 3 Fatty Acids on Oxidative Stress in Seropositive HIV Patients|Completed||Phase 3|70|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||||2017-10-11 00:50:38.891771|2017-10-11 00:50:38.891771
NCT02042482|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-19|||May 2013||2013-05-01|January 2014|2014-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||The Effect of Combination Ultra Q10 and L-carnitine on the Course of Myelodysplastic Syndrome|The Effect of the Nutritional Supplements: Ultra Q10 and L-carnitine on the Clinical Course of Myelodysplastic Syndrome|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Kaplan Medical Center||1|||f||||f||||||||||2017-10-11 00:50:24.428769|2017-10-11 00:50:24.428769
NCT02042469|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-19|||April 2011||2011-04-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01|2 Years|Observational [Patient Registry]|||Awareness and Attitude of Cancer Patients About Participation in Clinical Research (CR) in Saudi Arabia||Completed||N/A|300|Actual|National Guard Health Affairs|||1||f||||f||||||||||2017-10-11 00:50:24.508179|2017-10-11 00:50:24.508179
NCT02042456|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2015-10-16|||April 2014||2014-04-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts|Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts|Terminated||N/A|124|Actual|GE Healthcare|||1|Change in study staff at the site, change in Sponsor direction|f||||f||||||||||2017-10-11 00:50:24.567225|2017-10-11 00:50:24.567225
NCT02042443|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-08-11|2017-07-12||February 2014||2014-02-01|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|January 2017|Actual|2017-01-01||Interventional|S1310|All eligible and analyzable patients are included.|Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery|Randomized Phase II Trial of Single Agent MEK Inhibitor Trametinib (GSK1120212) Vs 5-Fluorouracil or Capecitabine in Refractory Advanced Biliary Cancer|Completed||Phase 2|53|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 00:50:24.703169|2017-10-11 00:50:24.703169
NCT02042430|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-09-04|||December 31, 2013|Actual|2013-12-31|July 2017|2017-07-01||||March 31, 2016|Actual|2016-03-31||Interventional|||Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Pilot Study of the Immunological Effects of Neo-Adjuvant INCB024360 in Patients With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Active, not recruiting||N/A|17|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:50:28.200555|2017-10-11 00:50:28.200555
NCT02042417|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-01-20|||February 2014||2014-02-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||Comparison of POC-test-equipment With the Laboratory|Comparison of POC-test-equipment With the Standard Method (Laboratory) at ICU-patients|Unknown status|Not yet recruiting|Phase 4|||Medical University of Vienna||1|||f||||||||||||||2017-10-11 00:50:28.28766|2017-10-11 00:50:28.28766
NCT02042404|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-01-04|2015-08-17||March 2014||2014-03-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional||Both Primary Cohort and Roll-in Cohorts combined in Demographic Report|The EarLens System Long Term Safety and Efficacy Definitive Multi-Center Study|The EarLens System Long Term Safety and Efficacy Definitive Multi-Center Study|Completed||N/A|48|Actual|EarLens Corporation||1|||f||||t||||||||||2017-10-11 00:50:28.384171|2017-10-11 00:50:28.384171
NCT02042391|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-02-26|||February 3, 2015|Actual|2015-02-03|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PTLD-2||Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy|Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With 4 Courses of Rituximab SC Followed by 4 Courses of Rituximab SC, 4 Courses of Rituximab SC Combined With CHOP-21 or 6 Courses of Rituximab SC Combined With Alternating CHOP-21 and DHAOx: The PTLD-2 Trial|Recruiting||Phase 2|90|Anticipated|Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH||3|||f||||t||||||||||2017-10-11 00:50:28.885218|2017-10-11 00:50:28.885218
NCT02042378|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-06-16|||April 2014||2014-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation|A Phase 2, Open-Label Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation|Completed||Phase 2|19|Actual|Clovis Oncology, Inc.||1|||f||||t||||||||||2017-10-11 00:50:29.06509|2017-10-11 00:50:29.06509
NCT02042365|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-02-07|||February 2014||2014-02-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|SLEEVERAS||Prospective Multicentre Study Assessing the Feasibility of Enhanced Recovery After Sleeve Gastrectomy for Obesity|Prospective Multicentre Study Assessing the Feasibility of Enhanced Recovery After Sleeve Gastrectomy for Obesity|Unknown status|Not yet recruiting|N/A|150|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:50:29.172673|2017-10-11 00:50:29.172673
NCT02042352|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-01-01|||January 2014||2014-01-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||PNA FISH, PCR and Gram Staining for Detection of Bacterial Vaginosis - a Comparative Clinical Study in a Danish IVF Setting||Completed||N/A|195|Actual|Regionshospitalet Viborg, Skive|||1||f||||||||||Samples With DNA|"     Vaginal flora swabs   "|||2017-10-11 00:50:29.254683|2017-10-11 00:50:29.254683
NCT02042339|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-09-20|||December 2016||2016-12-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|December 2018|Anticipated|2018-12-01||Interventional|||Hyperbaric Oxygenation in Diabetic Ulcer|Hyperbaric Oxygenation (HBO) in Chronic Diabetic Leg Ulcer.|Not yet recruiting||Phase 3|80|Anticipated|Medical University of Graz||2|||f||||f||||||||||2017-10-11 00:50:29.32844|2017-10-11 00:50:29.32844
NCT02042326|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-08-01|||September 2014||2014-09-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|MAV-RAPA||Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations|Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations|Recruiting||Phase 2|50|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||t||||||||No||2017-10-11 00:50:29.440036|2017-10-11 00:50:29.440036
NCT02042313|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-12-15|||February 2014||2014-02-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Interventional|MIEPVBEA||Postoperative Pain Management After Minimally Invasive Esophagectomy||Recruiting||Phase 4|58|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-10-11 00:50:29.565981|2017-10-11 00:50:29.565981
NCT02040259|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-10-03|||November 2013||2013-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01|90 Days|Observational [Patient Registry]|||Trevo® Retriever Registry Post Market Surveillance|Stryker Neurovascular Trevo® Retriever Registry|Active, not recruiting||N/A|2010|Actual|Stryker Neurovascular|||1||f||||f||||||||||2017-10-11 00:50:55.429783|2017-10-11 00:50:55.429783
NCT02042300|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-07-10|||July 2014|Actual|2014-07-01|July 2017|2017-07-01|June 2023|Anticipated|2023-06-01|June 2018|Anticipated|2018-06-01|5 Years|Observational [Patient Registry]|IRIS XPEDITION||XIENCE Xpedition/Alpine in Routine Clinical Practice|Evaluation of Effectiveness and Safety of XIENCE Xpedition/Alpine in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY|Recruiting||N/A|4000|Anticipated|Asan Medical Center|||1||f||||t||||||||||2017-10-11 00:50:29.656012|2017-10-11 00:50:29.656012
NCT02042287|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-06-08|||June 2014||2014-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis|Controlled, Multicenter, Randomized Parallel Group Pilot Study With 2 Treatment Arms in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis (BV)|Recruiting||Phase 4|78|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 00:50:29.852745|2017-10-11 00:50:29.852745
NCT02042274|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-02-17|2016-10-24||October 2012||2012-10-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|March 2013|Actual|2013-03-01||Interventional|FOHS||Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health|Omega-3 Fatty Acids and Genes Interact to Influence Cardiometabolic Health.|Completed||N/A|12|Actual|University of Guelph||1|||f||||t||||||||No||2017-10-11 00:50:29.970216|2017-10-11 00:50:29.970216
NCT02042261|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-03-01|||January 2012||2012-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01|6 Months|Observational [Patient Registry]|||The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study|The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study|Completed||N/A|38|Actual|Linkoeping University|||1||f||||f||||||||||2017-10-11 00:50:30.185222|2017-10-11 00:50:30.185222
NCT02042248|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-05-01|||March 2014||2014-03-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004|IGHID 1309 -A Phase I Study to Evaluate the Kinetics of the Immunologic Response and Virologic Impact of AGS-004 in HIV-Infected Individuals Suppressed on Antiretroviral Therapy Initiated During Acute and Chronic HIV Infection|Completed||Phase 1|6|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-11 00:50:30.277568|2017-10-11 00:50:30.277568
NCT02042235|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-05-02|||January 2014||2014-01-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|EPILANG||Very Preterm Children With Language Delay and Parent Intervention|Parent-implemented Intervention for Very Preterm Children With Language Delay|Recruiting||N/A|140|Anticipated|Lille Catholic University||2|||f||||t||||||||||2017-10-11 00:50:30.409253|2017-10-11 00:50:30.409253
NCT02042222|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-01-27|||October 2013||2013-10-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|NDEPTH||Novel Dose Escalation to Predict Treatment With Hydroxyurea|Novel Dose Escalation to Predict Treatment With Hydroxyurea|Recruiting||N/A|105|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 00:50:30.638483|2017-10-11 00:50:30.638483
NCT02042209|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-07-02|||May 2010||2010-05-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|DOREMI2||Medical Telephone Triage of Emergency Calls for Thoracic Pain|Medical Telephone Triage of Emergency Calls for Thoracic Pain: Construction of a Probability Score for Acute Coronary Syndrome.|Completed||N/A|4205|Actual|University Hospital, Toulouse|||1||f||||f||||||||Undecided||2017-10-11 00:50:30.736741|2017-10-11 00:50:30.736741
NCT02042196|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-07-10|||December 2013||2013-12-01|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 2018|Anticipated|2018-12-01||Interventional|SHAPE2||Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women|Biological Mechanisms of Vascular Dysfunction With Age and Estrogen Deficiency|Active, not recruiting||Early Phase 1|100|Anticipated|University of Colorado, Denver||3|||f||||f||||||||||2017-10-11 00:50:30.813039|2017-10-11 00:50:30.813039
NCT02042183|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-01-04|||December 2013||2013-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation|A Multicentre, Randomised, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation|Completed||Phase 3|606|Actual|Sucampo Pharma Americas, LLC||2|||f||||t||||||||||2017-10-11 00:50:30.945697|2017-10-11 00:50:30.945697
NCT02042170|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-03-23|||February 2014||2014-02-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients|A Phase II, Multi-center, Randomized, Comparative, Parallel, Open, Dose Finding Study to Assess the Efficacy and Safety After 26 Week-treatment of Eutropin Plus (SR-hGH) Compared to Eutropin Inj. in Pre-pubertal Children With Idiopathic Short Stature|Completed||Phase 2|46|Actual|LG Life Sciences||3|||f||||f||||||||||2017-10-11 00:50:31.316839|2017-10-11 00:50:31.316839
NCT02042157|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-04-20|||January 2015||2015-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Quality of Life in Adults Impaired Functioning - A Randomized Controlled Trial of Bidet vs Usual Toileting|Quality of Life in Adults Impaired Functioning - A Randomized Controlled Trial of Bidet vs Usual Toileting|Terminated||N/A|18|Actual|Stanford University||4||Equipment malfunction.|f||||f||||||||||2017-10-11 00:50:31.40392|2017-10-11 00:50:31.40392
NCT02042144|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-09-12|||April 8, 2014|Actual|2014-04-08|September 2017|2017-09-01|December 1, 2017|Anticipated|2017-12-01|August 19, 2017|Actual|2017-08-19||Observational|Correlate||Safety and Effectiveness of Regorafenib|Correlate - Safety and Effectiveness of Regorafenib in Routine Clinical Practice Settings|Active, not recruiting||N/A|1034|Actual|Bayer|||1||f||||f||||||||||2017-10-11 00:50:31.50574|2017-10-11 00:50:31.50574
NCT02042131|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-08-09|2017-03-07||January 2013||2013-01-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|BISSR||Brief Interventions for Short-Term Suicide Risk Reduction in Military Populations|Brief Interventions for Short-Term Suicide Risk Reduction in Military Populations|Completed||N/A|97|Actual|University of Utah|Staffing changes at the research site resulted in a one year suspension of recruitment by the IRB and the inability to meet planned recruitment goals. In all, 97 participants were enrolled, approximately one-quarter of the original goal (N=360).|3|||f||||f||||||||||2017-10-11 00:50:31.638115|2017-10-11 00:50:31.638115
NCT02022449|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-05-29|||September 2010||2010-09-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|CTC||Stress Management Intervention for Mothers of Children With Cancer|Stress Management Intervention for At-Risk Mothers of Children With Cancer|Completed||N/A|131|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:55:00.870887|2017-10-11 00:55:00.870887
NCT02042118|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-01-31|||April 2014|Actual|2014-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|May 2015|Actual|2015-05-01||Interventional|LMAvsFMV||Randomized Clinical Trial Assessing Laryngeal Mask Airway Versus Face-mask Ventilation in Neonatal Resuscitation|Randomized Clinical Trial Assessing Laryngeal Mask Airway (LMA) Versus Face-mask Ventilation (FMV) in Neonatal Resuscitation at Mulago Hospital, Uganda|Completed||N/A|50|Actual|Centre For International Health||2|||f||||f||||||||Undecided||2017-10-11 00:50:32.178214|2017-10-11 00:50:32.178214
NCT02042105|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2017-02-28|||November 11, 2013|Actual|2013-11-11|February 2017|2017-02-01|July 6, 2016|Actual|2016-07-06|April 15, 2015|Actual|2015-04-15||Observational|C-TALK||A Prospective Epidemiologic Study of ALK-Positive NSCLC in China|A Prospective Epidemiologic and Clinical Feature Study of Non-Small Cell Lung Cancer (NSCLC) Patients With ALK Positive in China|Completed||N/A|3649|Actual|Guangdong Association of Clinical Trials|||1||f||||t||||||||||2017-10-11 00:50:32.28177|2017-10-11 00:50:32.28177
NCT02042092|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2016-02-21|||December 2013||2013-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|MUSES||Magnetic Resonance Angiography vs Ultrasonography in Systemic Large vEssel vasculitiS|A Head-to-Head Comparison of Color Doppler Ultrasonography (CDUS) and Magnetic Resonance Angiography (MRA) in Patients With Systemic Large Vessel Vasculitis (sLVV) - A Cross Sectional Study|Completed||N/A|39|Actual|Hospital of Southern Norway Trust||2|||f||||f||||||||||2017-10-11 00:50:32.350656|2017-10-11 00:50:32.350656
NCT02042079|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-01-19|||July 2012||2012-07-01|January 2014|2014-01-01||||March 2014|Anticipated|2014-03-01||Interventional|EFTR-LA||Endoscopic Full Thickness Resection With Laparoscopic Assistance|Endoscopic Full Thickness Resection With Laparoscopic Assistance, Single Center Single Arm Study|Unknown status|Recruiting|Phase 1|15|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-10-11 00:50:32.435634|2017-10-11 00:50:32.435634
NCT02042066|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2014-01-21|||January 2015||2015-01-01|January 2014|2014-01-01||||January 2016|Anticipated|2016-01-01||Interventional|RHT||Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension|Efficacy and Safety of Low Intensity- Extracorporeal Shockwave Therapy in Drug Resistant Hypertension|Unknown status|Not yet recruiting|Phase 1|10|Anticipated|Medispec||1|||f||||f||||||||||2017-10-11 00:50:32.520932|2017-10-11 00:50:32.520932
NCT02042053|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-07-13|||January 2014||2014-01-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer|Multimodality Imaging Assessment of Sipuleucel T Treatment and in Vivo Immune Response of Metastatic Castration Resistant Prostate Cancer Patients|Terminated||N/A|10|Actual|New York University School of Medicine||1||Due to PI leaving the institution|f||||t|f|f||||||||2017-10-11 00:50:32.635101|2017-10-11 00:50:32.635101
NCT02042027|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-08-03|||July 2014||2014-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions|Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions|Withdrawn||Phase 1|0|Actual|University of Utah||2||No participants enrolled|f||||t||||||||||2017-10-11 00:50:32.714959|2017-10-11 00:50:32.714959
NCT02042014|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-07-11|||January 22, 2014|Actual|2014-01-22|July 2017|2017-07-01|October 17, 2016|Actual|2016-10-17|October 17, 2016|Actual|2016-10-17||Interventional|||Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan|An Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan and Are Judged by the Investigator to Benefit From Continued QTI571 Treatment|Completed||Phase 3|8|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:50:32.815299|2017-10-11 00:50:32.815299
NCT02042001|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2014-01-20|||April 2014||2014-04-01|January 2014|2014-01-01||||September 2015|Anticipated|2015-09-01||Interventional|SWEAR||Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects|A Pilot Randomized Controlled Trial of Switch to Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus Continue Efavirenz (EFV)-Based Treatment Among Virologically Suppressed, HIV-1 Infected Subjects With Mild or Asymptomatic EFV-related Neurocognitive or Neuropsychological Side Effects|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Azienda Ospedaliera San Gerardo di Monza||2|||f||||t||||||||||2017-10-11 00:50:32.88947|2017-10-11 00:50:32.88947
NCT02041988|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2014-01-17|||February 2013||2013-02-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|January 2014|Actual|2014-01-01||Observational|||Preemptive Analgesia With Morphine Sulphate in Major Urological Surgery|Influence of Premedication With Oral Morphine Sulphate on Analgesic Consumption in Patient Undergoing Major Urological Surgery. Comparison Between Two Different Doses|Unknown status|Recruiting|N/A|40|Anticipated|University of Roma La Sapienza|||2||f||||t||||||||||2017-10-11 00:50:32.986257|2017-10-11 00:50:32.986257
NCT02041975|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-05-10|||October 2013||2013-10-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|NutriSAT||Effects of Prebiotic-based Snacks on the Gut Microbiota and Perceived 'Satisfaction'|Investigating the Effects of Prebiotic-based Snacks on Perceived Feelings of 'Satisfaction' and on the Balance of Bacteria in the Human Gut (NutriSAT)|Completed||N/A|47|Actual|University of Reading||2|||f||||f||||||||||2017-10-11 00:50:33.067436|2017-10-11 00:50:33.067436
NCT02041962|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-04-25|||July 2014||2014-07-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Implementing Health Plan-Level Care Management for Solo & Small Practices|Implementing Health Plan-Level Care Management for Solo & Small Practices|Active, not recruiting||N/A|280|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 00:50:33.254996|2017-10-11 00:50:33.254996
NCT02041936|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-08-23|||April 2014||2014-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System|Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study|Recruiting||N/A|12|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-11 00:50:33.346784|2017-10-11 00:50:33.346784
NCT02041910|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-18|||January 2014||2014-01-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|||Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia|Testicular Injection of Autologous Human Bone Marrow Derived Stem Cells for Treatment of Patients With Azoospermia|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|El-Rayadh Fertility Centre||2|||f||||t||||||||||2017-10-11 00:50:33.556841|2017-10-11 00:50:33.556841
NCT02041897|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-18|||January 2014||2014-01-01|January 2014|2014-01-01|January 2020|Anticipated|2020-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Clinical Evaluation of EUS-FNA on Diagnosis of Pancreatic Cystic Lesions|Clinical Evaluation of EUS-FNA on Diagnosis of Pancreatic Cystic Lesions----A Multiple Center,Prospective Study|Recruiting||N/A|160|Anticipated|Fourth Military Medical University||1|||f||||f||||||||||2017-10-11 00:50:33.685552|2017-10-11 00:50:33.685552
NCT02041884|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-09-02|||February 2014||2014-02-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|Ad5||CBT Through Internet and Smartphones for Adults With ADHD - a Randomized Controlled Trial|Psychological Treatment Through Internet and Smartphones for Adults With Attention Deficit Hyperactive Disorder (ADHD) - a Randomized Controlled Trial|Active, not recruiting||N/A|175|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 00:50:33.818783|2017-10-11 00:50:33.818783
NCT02041871|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-01-16|||September 2013||2013-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PROPILS||Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer|Interest of Preoperative Immunonutrition in Liver Resection for Cancer|Recruiting||Phase 4|400|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:50:33.959923|2017-10-11 00:50:33.959923
NCT02041858|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-03-02|||April 2013||2013-04-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Altered Alarm Settings on Patient Adverse Events and Alarm Signal Frequency|Effect of Altered Alarm Settings on Patient Adverse Events and Alarm Signal Frequency: A Randomized Controlled Trial Feasibility Study|Completed||N/A|22|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 00:50:34.091662|2017-10-11 00:50:34.091662
NCT02041845|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-08-12|||January 2014||2014-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer|A Randomized Phase II Study Comparing Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer|Recruiting||N/A|154|Anticipated|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 00:50:34.194606|2017-10-11 00:50:34.194606
NCT02041832|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2016-09-27|||October 2013||2013-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Detection of Subclinical Atrial Fibrillation in High Risk Patients Using Implantable Loop Recorder|Detection of Subclinical Atrial Fibrillation in High Risk Patients (> 65 Years, Hypertension, Diabetes Mellitus) Using Implantable Loop Recorder|Completed||N/A|82|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 00:50:34.336937|2017-10-11 00:50:34.336937
NCT02041819|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-03-04|||February 2014||2014-02-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus|A Phase II Trial of Neoadjuvant Chemotherapy With Nimotuzumab Plus Nanoparticle Albumin-bound Paclitaxel and Cisplatin Followed by Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of Esophagus|Withdrawn||Phase 2|0|Actual|Zhejiang University||1||No recruitment|f||||f||||||||||2017-10-11 00:50:34.446262|2017-10-11 00:50:34.446262
NCT02041806|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-18|||July 2013||2013-07-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Assessing Peripheral Nerve Block Scoring Systems for Intra-Operative and Post-Operative Analgesia|The Effectiveness of Peripheral Nerve Block Scoring Systems in Predicting the Success of a Block for Intra-Operative and Post-Operative Analgesia|Unknown status|Recruiting|N/A|40|Anticipated|The Adelaide and Meath Hospital|||1||f||||f||||||||||2017-10-11 00:50:34.539602|2017-10-11 00:50:34.539602
NCT02041793|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-06-29|||May 2010|Actual|2010-05-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Laparoscopic Cystogastrostomy Versus Endoscopic Cystogastrostomy|A Prospective Randomized Controlled Trial Comparing Laparoscopic Versus Endoscopic Drainage for Pseudocyst of the Pancreas|Completed||N/A|60|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 00:50:34.675942|2017-10-11 00:50:34.675942
NCT02041780|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-09-28|||November 2013||2013-11-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|SHEARWAVE||Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy|Non Invasive Assessment of Liver Fibrosis in Children: Evaluation of Diagnostic Performances of ShearWave Elastography (SWE) and Fibrotest®/ Fibromax® by Comparison With Fibrosis Score on Liver Biopsy|Completed||N/A|220|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:50:34.771692|2017-10-11 00:50:34.771692
NCT02041767|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2016-01-29|||December 2013||2013-12-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|ERTAPRO||Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration|Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration|Completed||Phase 4|20|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:50:34.854961|2017-10-11 00:50:34.854961
NCT02041754|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2015-03-24|||January 2014||2014-01-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Efficacy of IQP-AK-102 in Reducing Appetite|Double Blind, Randomized, Placebo-controlled, Monocentric Clinical Investigation to Evaluate Efficacy of IQP-AK-102 on Appetite Reduction in Healthy Overweight and Obese Subjects|Completed||Phase 3|40|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-11 00:50:34.950335|2017-10-11 00:50:34.950335
NCT02041741|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-05-28|||January 2014||2014-01-01|January 2014|2014-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|HAP-FLA||Improving Happiness in Flanders|Happiness in Flanders: A Randomized, Wait-List Controlled Study|Completed||N/A|10863|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||||2017-10-11 00:50:35.084009|2017-10-11 00:50:35.084009
NCT02041728|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-01-17|||January 2013||2013-01-01|January 2013|2013-01-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|||The Detection of Early Dementia With the Digital Game Memory||Completed||N/A|20|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 00:50:35.207388|2017-10-11 00:50:35.207388
NCT02041715|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-08-04|||January 2014||2014-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802|A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With An Additional Multiple-Dose Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TKM-100802 in Healthy Human Volunteers|Terminated||Phase 1|21|Actual|Arbutus Biopharma Corporation||2|||f||||t||||||||||2017-10-11 00:50:35.29128|2017-10-11 00:50:35.29128
NCT02041689|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-01-19|||January 2014||2014-01-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||A Qualitative Case Study of the Experiences of Children With Cancer as They Learn About Their Diagnosis and Treatment|A Qualitative Case Study of the Experiences of Children With Cancer as They Learn About Their Diagnosis and Treatment|Completed||N/A|4|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 00:50:35.646285|2017-10-11 00:50:35.646285
NCT02041676|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-05-02|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|KVNI||Chest Physiotherapy Technique Increasing Inspiratory Flow on Weaning From Non Invasive Ventilation|Evaluating the Impact of Chest Physiotherapy Technique Increasing Inspiratory Flow on Weaning From Non Invasive Ventilation (KVNI) Pilot Study|Completed||N/A|101|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-11 00:50:35.778722|2017-10-11 00:50:35.778722
NCT02041663|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-09-29|||February 2012||2012-02-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|SAMIRA||Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis|Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis|Recruiting||N/A|35|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:50:35.915231|2017-10-11 00:50:35.915231
NCT02041650|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-17|||March 2014||2014-03-01|January 2014|2014-01-01||||April 2016|Anticipated|2016-04-01||Interventional|||Paradigm Shift in the Treatment of Patients With ACS|Plaque Erosion: A New in Vivo Diagnosis and Paradigm Shift in the Treatment of Patients With Acute Coronary Syndrome|Unknown status|Not yet recruiting|Phase 4|250|Anticipated|Harbin Medical University||1|||f||||||||||||||2017-10-11 00:50:36.084419|2017-10-11 00:50:36.084419
NCT02041637|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-20|2017-05-02|||June 2013||2013-06-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|HASIPRO||Unknown Cause of Acute Liver Failure|Unknown Cause of Acute Liver Failure: Determination of Early Mortality Predictive Factors|Completed||N/A|72|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 00:50:36.230422|2017-10-11 00:50:36.230422
NCT02041624|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-04-15|||May 2014||2014-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|5 Years|Observational [Patient Registry]|ALTO||International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis|An International Non-Interventional Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis Treated With Oralair®.|Terminated||N/A|740|Actual|Stallergenes Greer|||1|Sponsor decision|f||||t||||||||||2017-10-11 00:50:36.329226|2017-10-11 00:50:36.329226
NCT02041611|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-11-05|||January 2014||2014-01-01|October 2014|2014-10-01||||July 2015|Anticipated|2015-07-01||Interventional|||Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas|Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas|Unknown status|Active, not recruiting|N/A|20|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:50:36.422659|2017-10-11 00:50:36.422659
NCT02041585|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-17|||October 2012||2012-10-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|January 2014|Actual|2014-01-01|30 Days|Observational [Patient Registry]|DC PROMIS||Discharge Functional Status and Rehospitalization in the Elderly|The Contribution of Low Physical Function, Emotional Function and Social Support to Rehospitalization Risk Among Older Adults|Unknown status|Active, not recruiting|N/A|300|Actual|Northwestern University|||1||f||||t||||||||||2017-10-11 00:50:36.59385|2017-10-11 00:50:36.59385
NCT02041572|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-04-28|||May 2012||2012-05-01|January 2014|2014-01-01||||December 2012|Actual|2012-12-01||Interventional|ABR||Attentional Bias Retraining in Veterans|Attentional Bias Retraining in Veterans|Unknown status|Active, not recruiting|N/A|30|Anticipated|VA Pacific Islands Health Care System||1|||f||||f||||||||||2017-10-11 00:50:36.661929|2017-10-11 00:50:36.661929
NCT02041559|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-01-17|||January 2014||2014-01-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study||Unknown status|Recruiting|N/A|1500|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 00:50:36.743409|2017-10-11 00:50:36.743409
NCT02041546|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-08-02|||September 2013||2013-09-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome|Zekai Tahir Burak Maternity Teaching Hospital|Completed||Phase 4|30|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||||||||||||2017-10-11 00:50:36.810941|2017-10-11 00:50:36.810941
NCT02041533|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-19|2017-07-25|2017-06-26||March 25, 2014|Actual|2014-03-25|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|July 1, 2016|Actual|2016-07-01||Interventional||All randomized participants|An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)|An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer|Active, not recruiting||Phase 3|1325|Actual|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-11 00:50:36.947913|2017-10-11 00:50:36.947913
NCT02041507|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2016-04-11|||February 2014||2014-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Water-aided Colonoscopy vs Air Insufflation Colonoscopy in Colorectal Cancer Screening|A Randomized, Controlled Trial Comparing Air Insufflation, Water Immersion and Water Exchange for Adenoma Detection Rate in Screening Colonoscopy|Completed||N/A|1224|Actual|Presidio Ospedaliero Santa Barbara||3|||f||||f||||||||||2017-10-11 00:50:39.482862|2017-10-11 00:50:39.482862
NCT02041494|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2016-10-24|||March 2014||2014-03-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|CVHR||Complex Ventral Hernia Repair Using Biologic or Synthetic Mesh|Study Comparing the Efficacy, Safety, and Cost of a Permanent, Synthetic Prosthetic Versus a Biologic Prosthetic in the One-stage Repair of Ventral Hernias in Clean and Contaminated Wounds.|Recruiting||Phase 2/Phase 3|330|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:50:39.604387|2017-10-11 00:50:39.604387
NCT02041481|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-08-18|||June 2014||2014-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer|A Phase I Clinical Trial of MEK162 in Combination With FOLFOX in Patients With Advanced Metastatic Colorectal Cancer Who Failed Prior Standard Therapy|Active, not recruiting||Phase 1|34|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 00:50:39.715917|2017-10-11 00:50:39.715917
NCT02041468|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-08-29|||January 2014||2014-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|||Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients|A Phase IV Multicenter Trial to Evaluate the Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib and Its Companion Diagnostic Test in Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) Patients|Active, not recruiting||N/A|29|Actual|Jewish General Hospital|||2||f||||f||||||Samples With DNA|"     The study will collect plasma, platelet-depleted plasma, tumor tissue (biopsy of a metastatic     site that has acquired resistant to treatment) and primary archived tissue.   "|||2017-10-11 00:50:39.826082|2017-10-11 00:50:39.826082
NCT02041455|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-17|||June 2010||2010-06-01|January 2014|2014-01-01|March 2014|Anticipated|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Immune-Pineal Axis Function in Fibromyalgia|Phase II Role of Immune-pineal Axis in Fibromyalgia: Noradrenergic Modulation and Chronotherapeutic Aspects|Unknown status|Recruiting|Phase 2/Phase 3|66|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||t||||||||||2017-10-11 00:50:39.914164|2017-10-11 00:50:39.914164
NCT02041442|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-06-02|||March 2014||2014-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Electrophysiologic Mapping of the Bladder|Pilot of Electrophysiologic Mapping of the Urinary Bladder|Terminated||N/A|8|Actual|Englewood Hospital and Medical Center||1||study to be redesigned based on initial results|f||||f||||||||||2017-10-11 00:50:40.012368|2017-10-11 00:50:40.012368
NCT02041429|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2017-06-30|||February 2014||2014-02-01|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca|Phase II Study of Combination Ruxolitinib (INCB018242) With Preoperative Chemotherapy for Triple Negative Inflammatory Breast Cancer Following Completion of a Phase I Combination Study in Recurrent/Metastatic Breast Cancer|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:50:40.074458|2017-10-11 00:50:40.074458
NCT02041416|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-01-25|||May 2013||2013-05-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers|Delivering the Geriatric Assessment Tool to Older Adults With Cancer Using Computer Survey Methodologies: Testing Feasibility, Reliability, and Validity of Research Electronic Data Capture (REDCap) and Support Screen (Touchscreen) Technologies|Active, not recruiting||N/A|100|Anticipated|City of Hope Medical Center|||4||f||||t||||||||||2017-10-11 00:50:40.149549|2017-10-11 00:50:40.149549
NCT02041403|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2014-01-21|||June 2012||2012-06-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||RENAL RESISTIVE INDEX POST-OPERATIVE COMPLICATIONS IN MAJOR SURGERY?|MAY RENAL RESISTIVE INDEX BE AN EARLY PREDICTIVE TOOL OF POST-OPERATIVE COMPLICATIONS IN MAJOR SURGERY?|Completed||N/A|218|Actual|Istituto Clinico Humanitas|||1||f||||f||||||||||2017-10-11 00:50:40.219597|2017-10-11 00:50:40.219597
NCT02041390|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2014-01-18|||September 2012||2012-09-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases|Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases: a Prospectively Randomized, Controlled Study|Completed||N/A|48|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 00:50:40.278241|2017-10-11 00:50:40.278241
NCT02041377|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-01-29|2015-01-30||January 2014||2014-01-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of an Karajishi TS Investigational Blood Glucose Monitoring System|User Performance of the Karajishi Contour TS Blood Glucose Monitoring System|Completed||N/A|134|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 00:50:40.359259|2017-10-11 00:50:40.359259
NCT02041364|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2014-01-18|||November 2013||2013-11-01|January 2014|2014-01-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Biomarkers of Fatigue Related to Adjuvant Chemotherapy for Breast Cancer|Biomarkers of Fatigue Related to Adjuvant Chemotherapy for Breast Cancer: Evaluation of Plasma and Lymphocyte Expression.|Unknown status|Recruiting|N/A|45|Anticipated|Faculdade de Medicina do ABC|||2||f||||f||||||||||2017-10-11 00:50:40.611482|2017-10-11 00:50:40.611482
NCT02041351|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-18|2016-01-26|||November 2013||2013-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|||Biweekly Docetaxel in Patients With Metastatic Breast Cancer.|Docetaxel in Patients With Metastatic Breast Cancer Who Have Been Heavily Pretreated, Including Prior Treatment With Paclitaxel or Docetaxel.|Completed||Phase 2|17|Actual|Centro Universitario contra el Cáncer||1|||f||||t||||||||||2017-10-11 00:50:40.687312|2017-10-11 00:50:40.687312
NCT02041338|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-11-24|||January 2014||2014-01-01|February 2014|2014-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer|Phase 2 Randomized Study of Different Neoadjuvant Regimens in Subtypes of Breast Cancer|Recruiting||Phase 2|200|Anticipated|Chinese Academy of Medical Sciences||6|||f||||f||||||||||2017-10-11 00:50:40.878869|2017-10-11 00:50:40.878869
NCT02041325|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-04-10|2016-02-09||April 2005||2005-04-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|January 2011|Actual|2011-01-01||Interventional|||Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias|Investigation of the Enhancement of the Response to Hepatitis B Vaccine by Lenalidomide (RevlimidTM, CC-5013) in Plasma Cell Dyscrasias|Completed||Phase 2|38|Actual|Boston VA Research Institute, Inc.||2|||f||||t||||||||No||2017-10-11 00:50:41.012324|2017-10-11 00:50:41.012324
NCT02041312|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-12-04|||February 2014||2014-02-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|SCGN||Serum Cholesterol and Gastric Neoplasm|Serum Cholesterol and Gastric Neoplasm: Nested Case-control Study|Recruiting||N/A|1178|Anticipated|Asan Medical Center|||1||f||||f||||||Samples Without DNA|"     endoscopic biopsy specimen of gastric mucosa surgically resected specimen of stomach   "|No||2017-10-11 00:50:41.34383|2017-10-11 00:50:41.34383
NCT02041299|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-07-17|||March 2014||2014-03-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|FIRST||Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias|The Efficacy and Safety of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias|Recruiting||Phase 4|300|Anticipated|ApoPharma||2|||f||||t||||||||||2017-10-11 00:50:41.443547|2017-10-11 00:50:41.443547
NCT02041286|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-01-29|2015-06-03||January 2014||2014-01-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System|User Performance of the Karajishi Contour Blood Glucose Monitoring System|Completed||N/A|136|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 00:50:41.624539|2017-10-11 00:50:41.624539
NCT02041273|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-03-14|||January 2014||2014-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions|A Phase 1, Open-label 6 Sequence 3 Period Crossover Study of Palbociclib (PD- 0332991) in Healthy Volunteers to Estimate the Relative Bioavailability of Palbociclib Formulations|Completed||Phase 1|36|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:50:41.866805|2017-10-11 00:50:41.866805
NCT02041260|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-07-31|||January 2014||2014-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting|A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting|Recruiting||Phase 2|36|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 00:50:41.963207|2017-10-11 00:50:41.963207
NCT02041247|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-06-16|||January 2014||2014-01-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|September 2015|Actual|2015-09-01||Interventional|||Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection|Assessment of VAC-3S Therapeutic Properties When Combined With Standard Antiretroviral Therapy (ART) in the Course of HIV-1 Infection. A European, Randomized, Double Blind Placebo-controlled Phase II Study|Active, not recruiting||Phase 2|90|Anticipated|InnaVirVax||4|||f||||t||||||||||2017-10-11 00:50:42.042952|2017-10-11 00:50:42.042952
NCT02041234|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-08-17|||February 2014||2014-02-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment|Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes vs Best Medical Treatment|Recruiting||Phase 4|40|Anticipated|Khoo Teck Puat Hospital||2|||f||||f||||||||||2017-10-11 00:50:42.139424|2017-10-11 00:50:42.139424
NCT02041221|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-04-21|2015-12-14||January 2014||2014-01-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316||Completed||Phase 1/Phase 2|64|Actual|Sun Pharma Advanced Research Company Limited||6|||f||||f||||||||||2017-10-11 00:50:42.309894|2017-10-11 00:50:42.309894
NCT02041208|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-01-17|||March 2012||2012-03-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Variability of Hemoglobin Levels After Kidney Transplantation|A Retrospective, Observational Study to Evaluate Hemoglobin Variability in Kidney Transplant Recipients With Chronic Renal Anemia.|Completed||N/A|368|Actual|Sociedad Española de Trasplante|||1||f||||f||||||||||2017-10-11 00:50:42.658201|2017-10-11 00:50:42.658201
NCT02041195|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-04-13||2015-04-13|January 2014||2014-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Phase 1b/2a Study to Evaluate Safety and Efficacy of RM-493 in Obese Patients|Staged, Phase 1b/Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety and Efficacy of RM 493, a Melanocortin 4 Receptor (MC4R) Agonist in Obese Patients Using a Once or Twice Daily Sub-Cutaneous Injection Formulation|Completed||Phase 1/Phase 2|99|Actual|Rhythm Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 00:50:42.804714|2017-10-11 00:50:42.804714
NCT02041182|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-08-19|||October 2013||2013-10-01|January 2014|2014-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Electronic Pre-visit Questionnaire to Prompt Discussions of Youth Violence in Primary Care|Use of an Electronic Pre-visit Questionnaire and Effect on Patient-provider Discussions of Youth Violence in Primary Care|Completed||N/A|183|Actual|Rhode Island Hospital||2|||f||||f||||||||||2017-10-11 00:50:42.90341|2017-10-11 00:50:42.90341
NCT02041169|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-01-16|||September 2014||2014-09-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|July 2018|Anticipated|2018-07-01||Interventional|CLASH||Lower Extremity Peripheral Arterial Disease and Exercise Ischemia|Lower Extremity Peripheral Arterial Disease and Exercise Ischemia: Walking Capacity Variability, Pain Evolution and Pathophysiological Responses. The CLASH Study.|Recruiting||N/A|40|Anticipated|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 00:50:42.969634|2017-10-11 00:50:42.969634
NCT02041156|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-09-22|||October 2011||2011-10-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|RENEXC||Effects of Different Exercise Training Programs in CKD 4-5|Long-term Effects of Basic Aerobic Training Combined With Either Resistance - or Balance Training in CKD Patients - a Comparative Study|Recruiting||N/A|150|Anticipated|Region Skane||2|||f||||f||||||||||2017-10-11 00:50:43.042818|2017-10-11 00:50:43.042818
NCT02041143|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2015-10-27|||February 2014||2014-02-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Protein Intake on Muscle Protein Synthesis Overnight|Effects of Protein Intake on Muscle Protein Synthesis and Whole Body Protein Balance During an Overnight Fast: an Exploratory Study|Completed||Phase 1|17|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 00:50:43.141335|2017-10-11 00:50:43.141335
NCT02041130|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-01-15|||October 2013||2013-10-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|RESPECT-HF||Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF)|Renal Sympathectomy in Heart Failure (the RESPECT-HF Study) - a Study of Renal Denervation for Heart Failure With Preserved Ejection Fraction|Unknown status|Recruiting|Phase 2|144|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-11 00:50:43.433103|2017-10-11 00:50:43.433103
NCT02041117|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-17|||January 2014||2014-01-01|January 2014|2014-01-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|REALM||Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging|Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging in Two Years|Unknown status|Not yet recruiting|Phase 4|160|Anticipated|Ministry of Science and Technology of the People´s Republic of China||1|||f||||f||||||||||2017-10-11 00:50:43.537551|2017-10-11 00:50:43.537551
NCT02041104|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-10-03|||February 2014||2014-02-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism|Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism in a Population With Metabolic Syndrome|Enrolling by invitation||N/A|70|Anticipated|Mlinotest Zivilska Industrija d.d.||2|||f||||f||||||||||2017-10-11 00:50:43.637224|2017-10-11 00:50:43.637224
NCT02041091|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-04-08||2016-04-08|January 2014||2014-01-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus|Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus|Terminated||Phase 3|226|Actual|Eli Lilly and Company||2||Lack of efficacy|f||||f||||||||||2017-10-11 00:50:43.744651|2017-10-11 00:50:43.744651
NCT02041078|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-02-17|||May 2011||2011-05-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Intra Versus Extrahepatic Division of Right Hepatic Vein During Rightsided Hemihepatectomy|Randomized Phase 2 Study of Intra Versus Extrahepatic Division of Right Hepatic Vein During Rightsided Hemihepatectomy|Enrolling by invitation||Phase 2|100|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:50:43.894592|2017-10-11 00:50:43.894592
NCT02041065|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-08-31|||February 2011||2011-02-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Waterjet Versus Ultrasound Dissection During Hepatic Transection|Waterjet Versus Ultrasound Dissection During Hepatic Transection|Completed||Phase 2|84|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 00:50:43.972771|2017-10-11 00:50:43.972771
NCT02041052|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-01-04|||January 2013||2013-01-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Size of the Gastric Remnant as Determinant for Delayed Gastric Emptying After Whipple Resection.|Phase Two Randomized Study of The Size of the Gastric Remnant as Determinant for Delayed Gastric Emptying After Whipple Resection.|Terminated||Phase 2|7|Actual|Karolinska University Hospital||2||Terminated due to insufficient inclusion rate.|f||||f||||||||||2017-10-11 00:50:44.047494|2017-10-11 00:50:44.047494
NCT02041039|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-04-26|||October 2010||2010-10-01|April 2017|2017-04-01||||October 2018|Anticipated|2018-10-01||Observational|||REWARD SYSTEM RESPONSES TO FOOD AROMAS||Recruiting||N/A|||Indiana University|||2||f||||t||||||||||2017-10-11 00:50:44.224424|2017-10-11 00:50:44.224424
NCT02041026|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-01-17|||February 2014||2014-02-01|January 2014|2014-01-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Interventional|||Investigating the Effects of Probiotic Yoghurt on Reducing the Levels of Aflatoxin B1 Toxin Among the School Children in Eastern Kenya|Investigating the Effects of Probiotic Yoghurt on Reducing the Levels of Aflatoxin B1 Toxin Among the School Children in Eastern Kenya|Unknown status|Not yet recruiting|N/A|60|Anticipated|Technical University of Kenya||1|||f||||t||||||||||2017-10-11 00:50:44.304721|2017-10-11 00:50:44.304721
NCT02041013|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-08-20|||November 2009||2009-11-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Talking Card for Asthma|The Talking Card for Asthma: A Recordable Audio Discharge Instruction Device to Improve Asthma Control|Completed||N/A|64|Actual|Children's Mercy Hospital Kansas City||2|||f||||||||||||||2017-10-11 00:50:44.390962|2017-10-11 00:50:44.390962
NCT02041000|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-03-15|||January 2014||2014-01-01|March 2017|2017-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Adipose Derived Cells for Chronic Obstructive Pulmonary Disease|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously in Patients With Chronic Obstructive Pulmonary Disease|Withdrawn||N/A|0|Actual|Bioheart, Inc.||1|||f||||||||||||||2017-10-11 00:50:44.479806|2017-10-11 00:50:44.479806
NCT02040987|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2014-07-02|||January 2014||2014-01-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|AZD3293TQT||AZD3293 Thorough QT Study in Healthy Male Volunteers|A Single-Center, Randomized, Double-Blinded, Placebo-Controlled, 4-way Cross-over Study to Assess the Effect of a Single Oral Dose of AZD3293 Administration on QTc Interval Compared to Placebo, Using Open-Label AVELOX (Moxifloxacin) as a Positive Control, in Healthy Male Subjects|Completed||Phase 1|52|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 00:50:44.550069|2017-10-11 00:50:44.550069
NCT02040974|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-17|||January 2007||2007-01-01|January 2014|2014-01-01|September 2014|Anticipated|2014-09-01|January 2014|Anticipated|2014-01-01|7 Years|Observational [Patient Registry]|||Allergen Immunotherapy in Allergic Patients|Long Term Follow up in Patients Using Immunotherapy: Efficacy and Impact on Quality of Life|Unknown status|Recruiting|N/A|120|Anticipated|Istanbul University|||1||f||||f||||||||||2017-10-11 00:50:44.649771|2017-10-11 00:50:44.649771
NCT02040961|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-10-28|||September 2013||2013-09-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|ETView1||Assessment of the the ETView Double-lumen Tube|Assessment of the the ETView Double-lumen Tube|Terminated||N/A|84|Actual|Hopital Foch||1||An incident, burned tube, happened before intubation. The promoter decided to stop the study.|f||||f||||||||||2017-10-11 00:50:44.724186|2017-10-11 00:50:44.724186
NCT02040948|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-11-02|||June 2013||2013-06-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Nexfin2||Accuracy of Pulse Pressure Variation and of Pleth Variability Index to Predict the Response to a Fluid Challenge|Accuracy of Pulse Pressure Variation (Nexfin) and of Pleth Variability Index (Radical 7) to Predict the Response to a Fluid Challenge: Comparison With the Reference Method (Measurement of Stroke Volume by Esophageal Doppler)|Completed||N/A|68|Actual|Hopital Foch||1|||f||||f||||||||||2017-10-11 00:50:44.803925|2017-10-11 00:50:44.803925
NCT02040935|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-09-15|||February 21, 2014|Actual|2014-02-21|September 2017|2017-09-01|July 6, 2018|Anticipated|2018-07-06|July 6, 2018|Anticipated|2018-07-06||Interventional|HOMERUS||A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC Participants|HOMERUS: A Local, Open Label, Multicentre, Phase IIIB Study, Investigating Subcutaneous Trastuzumab Administered at Home With Single Injection Device in Patients With HER2-Positive Early Breast Cancer|Active, not recruiting||Phase 3|128|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:50:44.87244|2017-10-11 00:50:44.87244
NCT02040922|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-05-03|||January 2013||2013-01-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|February 2017|Actual|2017-02-01||Observational|CERAMIC||Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota|An Observational Study of the Role of Antibiotics, Inflammation and Changes in Microbiota in the Development of Post-infective Bowel Dysfunction Following Infection With Campylobacter Jejuni or Coli|Active, not recruiting||N/A|450|Anticipated|University of Nottingham|||1||f||||f||||||Samples With DNA|"     Stool (Faeces) Whole Blood   "|No||2017-10-11 00:50:44.996609|2017-10-11 00:50:44.996609
NCT02040909|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-09-16|||July 2014||2014-07-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|NEOPROP2||Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation|Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation|Recruiting||Phase 1|160|Anticipated|Erasmus Medical Center||1|||f||||t||||||||||2017-10-11 00:50:45.091175|2017-10-11 00:50:45.091175
NCT02040896|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-10-12|||January 2014||2014-01-01|November 2014|2014-11-01||||January 2015|Actual|2015-01-01||Observational|||Who Contributes to the Ordering of CT Scans in Emergency Department Patients?|Who Contributes to the Ordering of Computed Tomography in Emergency Department Patients? A Prospective Survey Study|Completed||N/A|1500|Anticipated|Duke University|||1||f||||f||||||||||2017-10-11 00:50:45.222585|2017-10-11 00:50:45.222585
NCT02040883|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-17|||February 2014||2014-02-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|TAAS||Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia|Phase 4 Study of Efficacy and Safety of Tandospirone Combined With Atypical Antipsychotic Drugs to Improve Cognitive Function in Schizophrenia|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Guangzhou Psychiatric Hospital||2|||f||||f||||||||||2017-10-11 00:50:45.294596|2017-10-11 00:50:45.294596
NCT02040870|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-02-27|||March 7, 2014|Actual|2014-03-07|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib|A Phase I/II, Multicenter, Open-label, Single-arm Study of LDK378, Administered Orally in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib Study Type: Interventional|Active, not recruiting||Phase 1/Phase 2|103|Actual|Novartis||1|||f||||f||||||||||2017-10-11 00:50:45.394655|2017-10-11 00:50:45.394655
NCT02040857|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-01-13|||January 2014||2014-01-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer|A Phase 2 Pilot Feasibility Study of Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive Invasive Breast Carcinoma|Active, not recruiting||Phase 2|160|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:50:45.504316|2017-10-11 00:50:45.504316
NCT02040844|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-08-21|||February 2014|Actual|2014-02-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Phase III Cat-PAD Follow-on Study|An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment|Completed||N/A|430|Actual|Circassia Limited|||3||f||||f||||||||||2017-10-11 00:50:45.605825|2017-10-11 00:50:45.605825
NCT02040831|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-12-20|||September 2014||2014-09-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children|A Phase I Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2, Lot RSV#007A, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age|Completed||Phase 1|3|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 00:50:45.676285|2017-10-11 00:50:45.676285
NCT02040818|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2015-10-06|||November 2013||2013-11-01|October 2015|2015-10-01||||January 2017|Anticipated|2017-01-01||Interventional|||Treatment of Hemodialysis Catheter-Related Bacteremia|RCT for the Treatment of Hemodialysis Catheter-Related Bacteremia|Withdrawn||Phase 2/Phase 3|0|Actual|University of California, San Diego||2||no enrollment|f||||t||||||||||2017-10-11 00:50:45.75142|2017-10-11 00:50:45.75142
NCT02040792|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-07-17|2016-06-30||May 2014||2014-05-01|July 2017|2017-07-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)|A Phase 2B, 28-Day, Randomized, Double-Blind Placebo-Controlled Parallel Group Study of Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|355|Actual|Theravance Biopharma R & D, Inc.||5|||f||||f||||||||||2017-10-11 00:50:45.909352|2017-10-11 00:50:45.909352
NCT02040766|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-04-12|||December 2013||2013-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma|A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 80 or 160 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Pediatric Patients 4 Through 11 Years of Age With Persistent Asthma|Completed||Phase 3|628|Actual|Teva Pharmaceutical Industries||5|||f||||f||||||||||2017-10-11 00:50:46.527088|2017-10-11 00:50:46.527088
NCT02040753|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-01-29|||February 2014||2014-02-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Observational|||The Effect of Repeated Lifestyle Intervention on Weight Loss Maintenance|The Effect of Repeated Lifestyle Intervention on Weight Loss Maintenance|Completed||N/A|2120|Actual|University of Copenhagen|||1||f||||t||||||||||2017-10-11 00:50:46.811899|2017-10-11 00:50:46.811899
NCT02040740|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-01-15|||March 2013||2013-03-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|PAKC||Mediators of Kidney-Bone Communication in Childhood|Pubertal Assessment of Kidney-Bone Crosstalk|Completed||N/A|26|Actual|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"     Plasma DNA collected to obtain ancestry informative markers and single nucleotide     polymorphisms involved in mineral metabolism   "|||2017-10-11 00:50:47.059685|2017-10-11 00:50:47.059685
NCT02040727|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-04-16|||October 2013||2013-10-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|COMB||Effect of Resistance Training on Musculoskeletal Endocrine Interactions|Communications of Muscle and Bone|Completed||N/A|16|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:50:47.125761|2017-10-11 00:50:47.125761
NCT02040714|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-04-26|||August 2012||2012-08-01|April 2017|2017-04-01|September 2032|Anticipated|2032-09-01|September 2032|Anticipated|2032-09-01||Observational|IPSG1||Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease|Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease|Recruiting||N/A|1500|Anticipated|Texas Scottish Rite Hospital for Children|||14||f||||t||||||||No|Patient enrolled in study will be deidentified (a specific ID will be assigned to participants) in each respective site, Each site will be in charge of entering their respective data in a main database. Data analysis of this collective data will be done mainly through the host site.|2017-10-11 00:50:47.229915|2017-10-11 00:50:47.229915
NCT02040701|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-15|||May 2006||2006-05-01|January 2014|2014-01-01||||May 2014|Anticipated|2014-05-01|8 Weeks|Observational [Patient Registry]|||Sleep Disordered Breathing in Children: Inflammation and Oxidative Stress||Unknown status|Recruiting|N/A|300|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||||||||||||2017-10-11 00:50:47.515375|2017-10-11 00:50:47.515375
NCT02040688|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-15|||August 2011||2011-08-01|January 2014|2014-01-01||||November 2014|Anticipated|2014-11-01||Observational|||Sensory Integration (Processing) Disorder Among Children With Behavioral Insomnia and Children With Feeding Disorder|Sensory Integration (Processing) Disorder Among Children With Behavioral Insomnia and Children With Feeding Disorder|Unknown status|Recruiting|N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center|||3||f||||||||||||||2017-10-11 00:50:47.578136|2017-10-11 00:50:47.578136
NCT02040675|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-03-28|||February 2014||2014-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Use of NAVA-catheter Positioning Screen to Identify Different Cardiac Arrhythmias|Use of NAVA-catheter Positioning Screen to Identify Different Cardiac Arrhythmias|Completed||N/A|5|Actual|ProMedica Health System|||1||f||||f||||||||||2017-10-11 00:50:47.645122|2017-10-11 00:50:47.645122
NCT02040662|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-06-09|||January 2013||2013-01-01|June 2017|2017-06-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Comparison of Efficacy of Paravertebral and Epidural Analgesia After Videothoracoscopic Lung Lobectomy|Comparison of Continuous Epidural and Continuous Paravertebral Blockade in Postoperative Analgesia After Videothoracoscopic Lung Lobectomy|Completed||Phase 2|120|Actual|Pulmonary Hospital Zakopane||2|||f||||f||||||||||2017-10-11 00:50:47.78144|2017-10-11 00:50:47.78144
NCT02040636|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2015-03-24|||January 1999||1999-01-01|March 2015|2015-03-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis|Safety and Immunogenicity of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis Vaccine (TdcP-IPV) Compared to Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis Vaccine (TdcP-IPV) and Hepatitis B Vaccine Given Concurrently In Adolescents 11-14 Years of Age|Completed||Phase 2|277|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 00:50:48.011017|2017-10-11 00:50:48.011017
NCT02040623|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-08-17|2016-08-17||March 2014||2014-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|DROPS-2||Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)|Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions for the Treatment of Keratoconjunctivitis Sicca in Patients With Chronic Ocular Graft Versus Host Disease|Completed||Phase 2|35|Actual|Rigel Pharmaceuticals||3|||f||||f||||||||No||2017-10-11 00:50:48.152302|2017-10-11 00:50:48.152302
NCT02040610|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-02-24|||January 2014||2014-01-01|October 2016|2016-10-01|December 2025|Anticipated|2025-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer|A Phase II Study of Hypofractionated Image Guided Proton Therapy for Low and Intermediate Risk Prostate Cancer|Recruiting||Phase 2|235|Anticipated|Provision Center for Proton Therapy||2|||f||||t||||||||||2017-10-11 00:50:48.895025|2017-10-11 00:50:48.895025
NCT02040597|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-07-30|||January 2014||2014-01-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|TRIPLE10||A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.|Open-label, Non-randomized, Parallel-group Study to Investigate the Pharmacokinetics, Safety and Tolerability of a Single Dose of CHF 5993 pMDI in Subjects With Mild, Moderate and Severe Renal Impairment in Comparison With Matched Healthy Control Subjects.|Completed||Phase 1|42|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-11 00:50:49.003203|2017-10-11 00:50:49.003203
NCT02040584|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-02-07|||December 2013||2013-12-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|REDUCE||A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.|A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients. The REDUCE Study.|Completed||Phase 3|194|Actual|Novartis||2|||f||||t||||||||||2017-10-11 00:50:49.145982|2017-10-11 00:50:49.145982
NCT02040571|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-04-13|||January 2014||2014-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Performance of an Artificial Pancreas at Home in People With Type 1 Diabetes|The Impact of the Overnight Closed Loop System on Glycemia, Subsequent Day-time Metabolic Control, Insulin Delivery, Counter Regulatory Hormones, Sleep Quality, Cognition and Satisfaction With Treatment, Compared to Open Loop System (Sensor Augmented Pump Therapy) in Both the Clinical Trial Centre and in the Home Setting in Type 1 Diabetes|Completed||N/A|28|Actual|St Vincent's Hospital Melbourne||2|||f||||t||||||||||2017-10-11 00:50:49.28898|2017-10-11 00:50:49.28898
NCT02040558|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-04-04|||July 2013||2013-07-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors|A Multicenter, Open-Label, Phase 1 First in Human Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous MNK-010 in Subjects With Advanced Solid Tumors|Terminated||Phase 1|44|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-11 00:50:49.413996|2017-10-11 00:50:49.413996
NCT02040545|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-04-13|||May 21, 2010|Actual|2010-05-21|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|May 2016|Actual|2016-05-01||Observational|||Salivary Diagnostic Testing for IVF|"Venopuncture-Free IVF: Can Patient-friendly Salivary Hormone Measurements Replace Serum Monitoring of IVF Patients?"|Completed||N/A|335|Actual|Boston IVF|||1||f||||f||||||||No||2017-10-11 00:50:49.47836|2017-10-11 00:50:49.47836
NCT02040532|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-01-09|2016-10-31||January 2014||2014-01-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women|Pilot Study to Assess Tolerability and Preliminary Efficacy of a Titrated Dose of Gabapentin up to 600mg Administered at Bedtime for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women With VMS.|Completed||N/A|32|Actual|Massachusetts General Hospital|"lack of control group (important given that previous VMS medication trials have indicated modest placebo response rates)
small sample size
relatively low rate of completion (6 of 26 subjects who received medication did not reach study endpoint)"|1|||f||||f||||||||No||2017-10-11 00:50:49.563315|2017-10-11 00:50:49.563315
NCT02040519|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-04-04|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||Time of Effect Onset in Treating Overactive Bladder or Non Obstructive Urinary Retention by Sacral Neuromodulation|"Time of Onset and Time of Offset of Sacral Neuromodulation Effect - Wash in - Wash Out"|Completed||N/A|45|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 00:50:49.963506|2017-10-11 00:50:49.963506
NCT02040506|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-02-22|||February 2014||2014-02-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML|A Phase 1, Open-Label Study Evaluating the Safety, Pharmacokinetics, and Clinical Activity of IGN523 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia|Completed||Phase 1|19|Actual|Igenica Biotherapeutics, Inc.||1|||f||||f||||||||||2017-10-11 00:50:50.048326|2017-10-11 00:50:50.048326
NCT02040493|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-07-24|||September 2008||2008-09-01|July 2017|2017-07-01|October 4, 2016|Actual|2016-10-04|October 4, 2016|Actual|2016-10-04||Interventional|||Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer|Intra-Operative Radiation Therapy (IORT) Treatment Immediately Following Resection of Early Stage Breast Cancer|Terminated||N/A|75|Actual|Xoft, Inc.||1|||f||||t||||||||||2017-10-11 00:50:50.136772|2017-10-11 00:50:50.136772
NCT02040480|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-04-17|||February 2014||2014-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib|A Single Center, Randomized, Open-Label, Sequential, Single Dose, 3-Period Crossover Study to Evaluate the Bioavailability and Food Effect of a Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib, an AKT Inhibitor, in Normal Healthy Volunteers|Completed||Phase 1|18|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 00:50:50.423079|2017-10-11 00:50:50.423079
NCT02040467|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-08-14|||December 18, 2013|Actual|2013-12-18|August 2017|2017-08-01|January 31, 2024|Anticipated|2024-01-31|January 31, 2024|Anticipated|2024-01-31|10 Years|Observational [Patient Registry]|||Registry for Proton Beam Radiation Therapy|Registry for Proton Beam Radiation Therapy|Recruiting||N/A|3200|Anticipated|Washington University School of Medicine|||1||f||||f|f|f||||||||2017-10-11 00:50:50.518705|2017-10-11 00:50:50.518705
NCT02040454|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2015-01-30|||March 2014||2014-03-01|January 2015|2015-01-01|October 2016|Anticipated|2016-10-01|February 2016|Anticipated|2016-02-01||Interventional|PaciFIST-2||Paclitaxel for the Treatment of Distal Radial Artery Arteriovenous Access Fistula Stenosis (PaciFIST-2)|The Use of Intravascular Paclitaxel for the Treatment of Distal Radial Artery Arteriovenous Access Fistula Stenosis: A Randomized Study (PaciFIST-2)|Withdrawn||Phase 2|0|Actual|Englewood Hospital and Medical Center||2||required catheters not available|f||||f||||||||||2017-10-11 00:50:50.613142|2017-10-11 00:50:50.613142
NCT02040246|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-25|2014-01-16|||February 2009||2009-02-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China|Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China|Completed||Phase 4|107|Actual|RenJi Hospital||2|||f||||t||||||||||2017-10-11 00:50:55.795294|2017-10-11 00:50:55.795294
NCT02040441|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-01-30|||November 2013||2013-11-01|March 2014|2014-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIORITY||Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria|Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria|Recruiting||Phase 2/Phase 3|3500|Anticipated|Steno Diabetes Center||3|||f||||t||||||||||2017-10-11 00:50:50.715655|2017-10-11 00:50:50.715655
NCT02040428|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2017-08-14|2017-05-04|2015-09-30|January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|September 1, 2015|Actual|2015-09-01|July 1, 2015|Actual|2015-07-01||Interventional||Baseline data was summarized for the Safety Analysis Set, which consists of all subjects on whom the procedure was started.|The Fibrin Pad CV Phase III Study|A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery|Completed||Phase 3|156|Actual|Ethicon, Inc.||2|||f||||t|t|f||||||||2017-10-11 00:50:50.894343|2017-10-11 00:50:50.894343
NCT02040415|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-10-11|||March 2014||2014-03-01|October 2016|2016-10-01||||July 2014|Actual|2014-07-01||Interventional|||Phase 3 Study to Evaluate the Efficacy and Safety of DW-1030 and Eperisone HCl in Acute Back Pain Patients|A Multicenter, Randomized, Double-blinded, Parallel, Active-controlled, Phase Lll Clinical Trial to Evaluate the Efficacy and Safety of DW-1030 and Eperisone HCl in Acute Back Pain Patients|Completed||Phase 3|242|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 00:50:52.508259|2017-10-11 00:50:52.508259
NCT02040402|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-01-16|||February 2009||2009-02-01|January 2014|2014-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Immunogenicity of 3+1 Versus 2+1 Schedule for PCV7|Comparison of the Immunogenicity of the 3+1 Schedule and the 2+1 Schedule of 7-valent Pneumococcal Conjugated Vaccine in Young Chinese Infants|Completed||Phase 4|100|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 00:50:52.583262|2017-10-11 00:50:52.583262
NCT02040389|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-10-26|||March 2014||2014-03-01|November 2013|2013-11-01|June 2016|Actual|2016-06-01|February 2015|Actual|2015-02-01||Interventional|||Visual Guidelines and Tutoring in Pediatric Urological Surgery|Visual Guidelines and Tutoring in Pediatric Urological Surgery|Completed||N/A|120|Actual|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-11 00:50:52.709266|2017-10-11 00:50:52.709266
NCT02040376|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-09-20|||March 2014||2014-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Placebo Controlled Double Blind Crossover Trial of Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma|Placebo Controlled Double Blind Crossover Trial of Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma|Active, not recruiting||Phase 3|24|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 00:50:52.855199|2017-10-11 00:50:52.855199
NCT02040363|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-10-31|||January 2014||2014-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|COPDµvasc||Muscle Training Induced Angiogenesis in COPD|Impact of Different Training Modalities on Skeletal Muscle Angiogenic Response in COPD Patients - COPDµvasc Study|Completed||N/A|22|Actual|University Hospital, Montpellier||3|||f||||f||||||||||2017-10-11 00:50:52.933552|2017-10-11 00:50:52.933552
NCT02040350|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-16|||April 2012||2012-04-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning?|Study Effect of WHO Recommended Dose of Pralidoxime in the Treatment of Organophosphorus Poisoning|Completed||Phase 1|100|Actual|Sheri Kashmir Institute of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:50:54.694536|2017-10-11 00:50:54.694536
NCT02040337|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-04-25|||April 2014||2014-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Sequencing T-cells in Type I Diabetes Mellitus|Sequencing T-cell Receptor Repertoire of Auto-Antigen Specific T-cells in Type I Diabetes Mellitus|Active, not recruiting||N/A|40|Actual|Seton Healthcare Family|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:50:54.844111|2017-10-11 00:50:54.844111
NCT02040324|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-16|||November 2009||2009-11-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||Laryngeal Mask Airway in Lower Abdominal Surgery|Comparison of Lung Function in Patients After Lower Abdominal Surgery Exceeding 2hrs Under the Use of Laryngeal Mask vs. Endotracheal Tube for Airway Management|Completed||N/A|100|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 00:50:54.91047|2017-10-11 00:50:54.91047
NCT02040311|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-16|||August 2000||2000-08-01|January 2014|2014-01-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|TOBES||Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects|A Multicenter Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy and Safety of Topiramate in Weight Loss Maintenance in Obese Subjects Following Participation in an Intensive, Non-pharmacologic Weight Loss Program|Terminated||Phase 4|701|Actual|University of Copenhagen||3||Study was terminated early as sponsor wanted to develop an improved formulation.|f||||f||||||||||2017-10-11 00:50:54.980464|2017-10-11 00:50:54.980464
NCT02040298|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-04-14|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|September 2015|Actual|2015-09-01||Interventional|ReBUILD||Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis|A Phase II Randomized, Double-Blind, Parallel-Group, Placebo Controlled Crossover Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis|Completed||Phase 2|50|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:50:55.092588|2017-10-11 00:50:55.092588
NCT02040285|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-01-17|||February 2012||2012-02-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Low-dose Laxative Improves Performance and Feasibility of Computed Tomography Colonography (CTC)|Low-dose Laxative Improves Performance and Feasibility of Computed Tomography Colonography (CTC). Comparison vs Laxative Free CTC.|Completed||Phase 4|52|Actual|Azienda Policlinico Umberto I||2|||f||||||||||||||2017-10-11 00:50:55.180656|2017-10-11 00:50:55.180656
NCT02040272|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-05-11|||May 2015||2015-05-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|MARS2||MARS 2: A Feasibility Study Comparing (Extended) Pleurectomy Decortication Versus no Pleurectomy Decortication in Patients With Malignant Pleural Mesothelioma|A Study to Determine if it is Feasible to Recruit Into a Randomised Trial Comparing (Extended) Pleurectomy Decortication Versus no Pleurectomy Decortication in Patients With Malignant Pleural Mesothelioma|Recruiting||N/A|50|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:50:55.268771|2017-10-11 00:50:55.268771
NCT02040233|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2016-04-28|||January 2014||2014-01-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|PARSiFAL||Multiple Dose Study in Heart Failure of BAY 1067197|A Double Blinded, Placebo Controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics and Acute Cardiovascular Responses of a 7 Day Oral Treatment With the Partial Adenosine A1 Receptor Agonist BAY1067197 in Patients With Chronic Systolic Heart Failure: the PARSiFAL-pilot Study.|Completed||Phase 2|31|Actual|Bayer||4|||f||||f||||||||||2017-10-11 00:50:55.88585|2017-10-11 00:50:55.88585
NCT02040220|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-09-13|||January 24, 2014|Actual|2014-01-24|September 2017|2017-09-01|May 31, 2019|Anticipated|2019-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|JPMS-CRVO||Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO)|Special Drug Use Investigation of EYLEA for CRVO|Active, not recruiting||N/A|385|Actual|Bayer|||1||f||||f||||||||||2017-10-11 00:50:56.01919|2017-10-11 00:50:56.01919
NCT02040207|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-01-18|||June 2014||2014-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|AMPACT2||AM-101 in the Treatment of Post-Acute Tinnitus 2|AM-101 in the Post-Acute Treatment of Peripheral Tinnitus 2 (AMPACT2) - an Open-Label Extension to the TACTT3 Study|Completed||Phase 3|487|Actual|Auris Medical, Inc.||1|||f||||f||||||||||2017-10-11 00:50:56.115711|2017-10-11 00:50:56.115711
NCT02040194|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-09-22|||January 2014||2014-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TACTT3||AM-101 in the Treatment of Acute Tinnitus 3|Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 3|Active, not recruiting||Phase 3|750|Anticipated|Auris Medical, Inc.||2|||f||||f||||||||||2017-10-11 00:50:56.216812|2017-10-11 00:50:56.216812
NCT02040181|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2014-07-28|||January 2014||2014-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Establishment of a Creatinine Clearance Estimation Equation and Daily Creatinine Excretion Reference Table for Taiwanese|Establishment of a Creatinine Clearance Estimation Equation and Daily Creatinine Excretion Reference Table for Taiwanese|Completed||N/A|700|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:50:56.327017|2017-10-11 00:50:56.327017
NCT02040168|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-01-16|||October 2010||2010-10-01|January 2014|2014-01-01|October 2014|Anticipated|2014-10-01|January 2014|Anticipated|2014-01-01||Observational|PEDIASED||Reduce Pediatric Sedation to Reduce Mechanical Ventilation Complication in ICU|Evaluation of the Interest of a Nurse-implemented Sedation Protocol for the Reduction of the Duration of Mechanical Ventilation Complication Associated With Extended Sedation in Pediatric Intensive Care Unit.|Unknown status|Recruiting|N/A|202|Anticipated|Nantes University Hospital|||2||f||||f||||||||||2017-10-11 00:50:56.40256|2017-10-11 00:50:56.40256
NCT02040155|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-05-04|||February 2014||2014-02-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy|Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy|Completed||N/A|16|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:50:56.506719|2017-10-11 00:50:56.506719
NCT02040142|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-01-22|||November 2011||2011-11-01|March 2016|2016-03-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C|Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C|Enrolling by invitation||Phase 2|50|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 00:50:56.595045|2017-10-11 00:50:56.595045
NCT02040129|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-16|||January 2009||2009-01-01|January 2014|2014-01-01|November 2009|Actual|2009-11-01|January 2009|Actual|2009-01-01||Interventional|||Reduction of Corneal Astigmatism With Toric Intraocular Lens Implantation in Congenital Cataract|Reduction of Corneal Astigmatism With Toric Intraocular Lens Implantation : Early Results in Patients With Congenital Cataract|Completed||N/A|4|Actual|Kyungpook National University||1|||f||||t||||||||||2017-10-11 00:50:56.7033|2017-10-11 00:50:56.7033
NCT02040116|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-08-22|2016-04-26||February 2013||2013-02-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases|Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases|Completed||Phase 4|19|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 00:50:56.79884|2017-10-11 00:50:56.79884
NCT02040103|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2016-04-05|||July 2014||2014-07-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|PREVENT||Pneumatic Compression for Preventing Venous Thromboembolism|Prophylaxis of Thromboembolism in Critically Ill Patients Using Combined Intermittent Pneumatic Compression(IPC) and Pharmacologic Prophylaxis Versus Pharmacologic Prophylaxis Alone: A Multicenter Randomized Controlled Trial|Recruiting||N/A|2000|Anticipated|King Abdullah International Medical Research Center||2|||f||||f||||||||||2017-10-11 00:50:57.008439|2017-10-11 00:50:57.008439
NCT02040090|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-07-30|||April 2013||2013-04-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|KAMRAB-003||Phase II/III Study of the Safety and Effectiveness of HRIG With Co-administration of Active Rabies Vaccine in Healthy Subjects|A Prospective, Randomized, Double-Blind, Non Inferiority, Phase II/III Study of the Safety and Effectiveness of Simulated Post-Exposure Prophylaxis With Kamada Human Rabies Immune Globulin (KamRAB) With Co-administration of Active Rabies Vaccine in Healthy Subjects|Unknown status|Active, not recruiting|Phase 2/Phase 3|118|Anticipated|Kamada, Ltd.||2|||f||||f||||||||||2017-10-11 00:50:57.104968|2017-10-11 00:50:57.104968
NCT02040077|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-07-25|2017-05-05||January 2015||2015-01-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evaluation of a Computerized Opioid Overdose Prevention Program|Development and Validation of a Computerized Opioid Overdose Intervention.|Completed||N/A|75|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 00:50:57.190379|2017-10-11 00:50:57.190379
NCT02040064|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-06-08|||January 2014||2014-01-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|GEFTREM||Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients|Phase I, Open-label, Safety, Tolerability and Preliminary Efficacy Study of Tremelimumab in Combination With Gefitinib in EGFR Mutant NSCLC Patients|Completed||Phase 1|27|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 00:50:57.626322|2017-10-11 00:50:57.626322
NCT02040051|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-06-10|||June 2013||2013-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of Sound Insulation and Music Therapy on the Comfort of Mechanically Ventilated Patients Admitted to Intensive Care Unit|Randomized Clinical Trial to Assess the Effect of Sound Insulation and Music Therapy on the Comfort of Mechanically Ventilated Patients Admitted to Intensive Care Unit|Completed||N/A|82|Actual|Althaia Xarxa Assistencial Universitària de Manresa||2|||f||||t||||||||||2017-10-11 00:50:57.74439|2017-10-11 00:50:57.74439
NCT02040038|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-07-24|||July 2014||2014-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Diabetes Self-Management & Support LIVE|Diabetes Self-Management & Support LIVE (Learning in Virtual Environments)|Active, not recruiting||N/A|212|Actual|Duke University||2|||f||||t||||||||||2017-10-11 00:50:57.834531|2017-10-11 00:50:57.834531
NCT02040025|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-12-01|||April 2014||2014-04-01|December 2016|2016-12-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Observational|||Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus|Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus|Withdrawn||N/A|0|Actual|David Grant U.S. Air Force Medical Center|||1||f||||f||||||||||2017-10-11 00:50:57.932508|2017-10-11 00:50:57.932508
NCT02040012|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-17|2015-06-17|||July 2013||2013-07-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus|A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZP-531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 1|108|Anticipated|Alizé Pharma||2|||f||||f||||||||||2017-10-11 00:50:58.015451|2017-10-11 00:50:58.015451
NCT02039999|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-08-19|||February 2015||2015-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2015|Actual|2015-07-01||Interventional|||An Investigation Into the Mechanism of Inhalation Cough Challenge|An Investigation Into the Mechanism of Inhalation Cough Challenge|Completed||N/A|40|Actual|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 00:50:58.102437|2017-10-11 00:50:58.102437
NCT02039986|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-01-19|||January 6, 2014|Actual|2014-01-06|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|||Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)|Effects of Ivacaftor (Kalydeco) Treatment Upon Insulin and Incretin Secretion in Patients With Cystic Fibrosis|Recruiting||N/A|12|Anticipated|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-10-11 00:50:58.195496|2017-10-11 00:50:58.195496
NCT02039973|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2016-09-12|||January 2014||2014-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||Healthy Options: Group Psychotherapy for HIV-positive Depressed Perinatal Women.|Healthy Options: Group Psychotherapy for HIV-positive Depressed Perinatal Women.|Active, not recruiting||N/A|702|Actual|Harvard Medical School||2|||f||||t||||||||||2017-10-11 00:50:58.287942|2017-10-11 00:50:58.287942
NCT02039960|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-08-03|||November 2013||2013-11-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011|PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011|Completed||N/A|1|Actual|GlaxoSmithKline|||3||f||||f||||||||||2017-10-11 00:50:58.392545|2017-10-11 00:50:58.392545
NCT02039947|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-10-02|||February 21, 2014|Actual|2014-02-21|October 2017|2017-10-01|December 15, 2017|Anticipated|2017-12-15|May 12, 2017|Actual|2017-05-12||Interventional|||Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain|BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain|Active, not recruiting||Phase 2|126|Actual|Novartis||4|||f||||t|t|f||||||||2017-10-11 00:50:58.478158|2017-10-11 00:50:58.478158
NCT02039934|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-09-13|||July 2013||2013-07-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|HIT||Effect of High-intensity Low-volume Training on Insulin Sensitivity in Type 2 Diabetes|Effect of High-intensity Low-volume Training on Insulin Sensitivity in Patients With Type 2 Diabetes and Healthy Lean Subjects|Recruiting||N/A|60|Anticipated|German Diabetes Center||1|||f||||f||||||||||2017-10-11 00:50:58.707418|2017-10-11 00:50:58.707418
NCT02039921|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-06-28|||October 2013||2013-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|SWITCHART||Observational, Retrospective, Multicenter Study to Describe the Reasons for the Change of the Regimen of Antiretroviral Therapy in HIV Patients|Observational, Retrospective, Multicenter Study to Describe the Reasons for the Change of Antiretroviral Treatment Regimen in HIV-positive Patients Between January 2011 and July 2012 in Spanish Hospitals|Completed||N/A|250|Actual|Fundacion SEIMC-GESIDA|||1||f||||f||||||||||2017-10-11 00:50:58.82824|2017-10-11 00:50:58.82824
NCT02039908|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-08-02|||April 2013||2013-04-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Examining Tolerance to CNS Stimulants in ADHD|Examining Tolerance to CNS Stimulants in ADHD|Active, not recruiting||Phase 4|265|Actual|Florida International University||2|||f||||t||||||||||2017-10-11 00:50:58.907442|2017-10-11 00:50:58.907442
NCT02039895|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-08-01|||January 2014||2014-01-01|January 2014|2014-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HITS||Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma|Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma|Active, not recruiting||N/A|10|Anticipated|Far Eastern Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:50:58.993517|2017-10-11 00:50:58.993517
NCT02039882|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-10-03|||April 2013||2013-04-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Point of Care (POC) Biomarkers of Ischemia|Point of Care (POC) Biomarkers of Ischemia|Active, not recruiting||N/A|100|Anticipated|Virginia Commonwealth University|||3||f||||f||||||Samples Without DNA|"     peripheral blood, Plasma samples   "|||2017-10-11 00:50:59.078474|2017-10-11 00:50:59.078474
NCT02039869|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-12-07||||||December 2015|2015-12-01||||December 2015|Anticipated|2015-12-01||Interventional|CE_NERD||Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)|Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)|Withdrawn||N/A|0|Actual|Virginia Commonwealth University||2||Could not recruit patients - modifying protocol and plan resubmission to our IRB|f||||t||||||||||2017-10-11 00:50:59.160021|2017-10-11 00:50:59.160021
NCT02039843|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-07-25|||December 15, 2014|Actual|2014-12-15|July 2017|2017-07-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2020|Anticipated|2020-04-01||Interventional|SDPTSD||Can Service Dogs Improve Activity and Quality of Life in Veterans With PTSD?|Can Service Dogs Improve Activity and Quality of Life in Veterans With PTSD?|Active, not recruiting||N/A|220|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 00:50:59.369908|2017-10-11 00:50:59.369908
NCT02039830|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-02-08|||July 2012||2012-07-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|GROUP||Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women|Group Physiotherapy Compared to Individual Physiotherapy to Treat Urinary Incontinence in Aging Women: A Randomized Control Trial|Recruiting||N/A|364|Anticipated|Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal||2|||f||||f||||||||||2017-10-11 00:50:59.453551|2017-10-11 00:50:59.453551
NCT02039817|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-12-18|2015-09-20||January 2014||2014-01-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers|An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Severe Renal Impairment and in Matched Healthy Volunteers|Completed||Phase 1|16|Actual|Conatus Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-11 00:50:59.553505|2017-10-11 00:50:59.553505
NCT02039804|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2014-03-25|||March 2014||2014-03-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Sodium Hyaluronate Injection and Corticosteroids in Trochanteric Bursitis: a Randomized Controlled Study.|Sodium Hyaluronate Injection and Corticosteroids in Trochanteric Bursitis: a Randomized Controlled Study.|Unknown status|Not yet recruiting|Phase 3|30|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 00:50:59.932221|2017-10-11 00:50:59.932221
NCT02039791|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-08-17|||January 2013||2013-01-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer|Phase II Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Biotech Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-10-11 00:51:00.013019|2017-10-11 00:51:00.013019
NCT02039778|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-04-28|2017-01-25||December 2013||2013-12-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|STRONG||Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma|STRONG Trial - Stem Cell Radiotherapy (ScRT) and Temozolomide for Newly Diagnosed High-grade Glioma (HGG): A Prospective, Phase I/II Trial|Terminated||N/A|4|Actual|Beth Israel Medical Center||1||Poor Accural|f||||f||||||||||2017-10-11 00:51:00.21007|2017-10-11 00:51:00.21007
NCT02039765|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-04-27|||February 2014|Actual|2014-02-01|April 2017|2017-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.|A Prospective, Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety Following Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025% Used Four Times Daily in Healthy, Adult Subjects.|Completed||Phase 1|12|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 00:51:00.461686|2017-10-11 00:51:00.461686
NCT02039752|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-06-18|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|June 2025|Anticipated|2025-06-01|December 2024|Anticipated|2024-12-01||Observational|ASAN MV||Asan Multivessel Registry|Asan Medical Center Registry for Multivessel|Recruiting||N/A|25000|Anticipated|Asan Medical Center|||1||f||||f||||||||No|This is not a publicly funded trial.|2017-10-11 00:51:00.551211|2017-10-11 00:51:00.551211
NCT02039739|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-08-07|||July 2014||2014-07-01|August 2016|2016-08-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Observational|IRIS ORSIRO||Orsiro™ Drug Eluting Stent in Routine Clinical Practice|Evaluation of Effectiveness and Safety of Orsiro™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Active, not recruiting||N/A|1007|Actual|Asan Medical Center|||1||f||||t||||||||No|This is not a publicly funded trial.|2017-10-11 00:51:00.647062|2017-10-11 00:51:00.647062
NCT02039726|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-09-25|||April 2014||2014-04-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive|A Phase 3 Open-label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects With Tyrosine Kinase 3 - Internal Tandem Duplication (FLT3-ITD) Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed After First-line Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation|Active, not recruiting||Phase 3|367|Actual|Daiichi Sankyo, Inc.||2|||f||||t||||||||||2017-10-11 00:51:00.792952|2017-10-11 00:51:00.792952
NCT02039713|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-03-30|||July 2014|Actual|2014-07-01|March 2017|2017-03-01|June 2025|Anticipated|2025-06-01|June 2021|Anticipated|2021-06-01||Observational|IRIS DESYNE||DESyne in Routine Clinical Practice|Evaluation of Effectiveness and Safety of DESyne in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Active, not recruiting||N/A|342|Actual|Asan Medical Center|||1||f||||t||||||||No|This is not a publicly funded trial.|2017-10-11 00:51:01.133383|2017-10-11 00:51:01.133383
NCT02039700|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-05-16|||January 2014||2014-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Bioavailability of Lesinurad and Intravenous [14C]Lesinurad|A Phase 1, Open-Label Study to Assess the Absolute Bioavailability of a Single Oral Dose of Lesinurad With Respect to an Intravenous Micro Tracer Dose of [14C]Lesinurad in Healthy Adult Male Subjects|Completed||Phase 1|10|Actual|Ardea Biosciences, Inc.||1|||f||||f||||||||||2017-10-11 00:51:01.288591|2017-10-11 00:51:01.288591
NCT02039687|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-03-07|2016-11-21||January 2014||2014-01-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis|A Double Blind, Placebo Controlled Phase 2 Dose Ranging Study of the Effects of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis|Completed||Phase 2|64|Actual|Araim Pharmaceuticals, Inc.||4|||f||||t||||||||No||2017-10-11 00:51:01.391238|2017-10-11 00:51:01.391238
NCT02039674|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-03-17|||February 2014||2014-02-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|November 2016|Actual|2016-11-01||Interventional|||A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Lung Cancer (MK-3475-021/KEYNOTE-021)|A Phase I/II Study of MK-3475 (SCH900475) in Combination With Chemotherapy or Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma|Active, not recruiting||Phase 1/Phase 2|308|Anticipated|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-10-11 00:51:02.540131|2017-10-11 00:51:02.540131
NCT02039661|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-16|||November 2013||2013-11-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Lidocaine Spray for Pain Relief During Endometrial Biopsy: a Randomized, Double-blind, Placebo-controlled Clinical Trial||Completed||N/A|120|Actual|Kayseri Education and Research Hospital||2|||f||||f||||||||||2017-10-11 00:51:02.692788|2017-10-11 00:51:02.692788
NCT02039648|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-16|||March 2012||2012-03-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|RPG-I||The Influence of Rumex Acetosa L on the Intraoral Colonization With Porphyromonas Gingivalis|Proanthocyanidin- Enriched Extract From Rumex Acetosa L. as a Prophylactic Agent Against Intraoral Colonization With Porphyromonas Gingivalis|Completed||Early Phase 1|35|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 00:51:02.771118|2017-10-11 00:51:02.771118
NCT02039635|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-09|||December 2013|Actual|2013-12-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|August 2016|Actual|2016-08-01||Interventional|KRG||Korean Red Ginseng in Treating Patients With Fatigue Caused by Chemotherapy for Colorectal Cancer|A Study of Korean Red Ginseng for Evaluation of Improvement of Cancer-related Fatigue in Patients With Colorectal Cancer With Chemotherapy: A Randomized, Double-blind, Placebo-Controlled, Parallel, Multicenter Trial|Completed||N/A|438|Actual|Korea Ginseng Corporation||2|||f||||t||||||||||2017-10-11 00:51:02.862764|2017-10-11 00:51:02.862764
NCT02039622|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-15|||July 2011||2011-07-01|January 2014|2014-01-01||||December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|||Cardiovascular Toxicity Induced by Antitumoral Drugs: Risk Assessment and Early Diagnosis. CARDIOTOX Registry|Cardiovascular Toxicity Induced by Antitumoral Drugs: Risk Assessment and Early Diagnosis. CARDIOTOX Registry|Unknown status|Recruiting|N/A|3400|Anticipated|Instituto de Investigación Hospital Universitario La Paz|||1||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 00:51:02.952983|2017-10-11 00:51:02.952983
NCT02039609|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-09-15|||February 2013|Actual|2013-02-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Nutritional Metabolomics: the Search for Dietary Exposure Variables 2|Nutritional Metabolomics: the Search for Dietary Exposure Variables 2|Recruiting||N/A|200|Anticipated|Göteborg University|||4||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:51:03.057237|2017-10-11 00:51:03.057237
NCT02039596|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-01-16|||September 2012||2012-09-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Nutritional Metabolomics: the Search for Dietary Exposure Variables|Nutritional Metabolomics: the Search for Dietary Exposure Variables|Completed||N/A|53|Actual|Göteborg University||5|||f||||f||||||||||2017-10-11 00:51:03.13152|2017-10-11 00:51:03.13152
NCT02039583|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-16|||January 1995||1995-01-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2011|Actual|2011-12-01||Observational|||Impact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in England|Impact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in England: a Quasi-experimental Study|Completed||N/A|10291118|Actual|University of Edinburgh|||1||f||||f||||||||||2017-10-11 00:51:03.207187|2017-10-11 00:51:03.207187
NCT02039570|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-16|||March 2014||2014-03-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Observational|||The Relationship Between Haemorrhoids and Pelvic Vein Reflux|Investigating the Relationship Between Haemorrhoids, Internal Iliac Veins and Tributary Reflux|Unknown status|Not yet recruiting|N/A|57|Anticipated|The Whiteley Clinic|||1||f||||t||||||||||2017-10-11 00:51:03.534845|2017-10-11 00:51:03.534845
NCT02039557|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-08-06|||March 2014||2014-03-01|August 2017|2017-08-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Observational|||Long Term Follow Up Protocol for NiCord Patients|Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells|Recruiting||N/A|50|Anticipated|Gamida Cell ltd|||1||f||||f||||||||||2017-10-11 00:51:03.634799|2017-10-11 00:51:03.634799
NCT02039544|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2014-01-15|||January 2014||2014-01-01|January 2014|2014-01-01|May 2015|Anticipated|2015-05-01|January 2015|Anticipated|2015-01-01||Interventional|XB||A Study of Xuebi Formula for Diabetic Peripheral Neuropathy(Qi-deficiency and Blood-stasis)|A Randomized, Parallel-controlled, Clinical Study to Evaluate the Efficacy of Xuebi Prescription Compared With Placebo in the Treatment of Diabetic Peripheral Neuropathy(Qi Deficiency and Blood Stasis)|Unknown status|Not yet recruiting|N/A|60|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 00:51:03.793561|2017-10-11 00:51:03.793561
NCT02039531|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2015-05-04|||August 2011||2011-08-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|February 2013|Actual|2013-02-01||Interventional|||Effect Of Plasma Rich In Growth Factors In Knee Osteoarthritis|THE APPLICATION OF PLASMA RICH IN GROWTH FACTORS FOR KNEE OSTEOARTHRITIS IMPROVES THE QUALITY OF LIFE AND FUNCTIONAL CAPACITY COMPARED WITH CONVENCIONAL TREATMENT WITH VISCOSUPLEMENTATION|Completed||Phase 3|96|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias||2|||f||||f||||||||||2017-10-11 00:51:03.872785|2017-10-11 00:51:03.872785
NCT02039518|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2014-01-15|||December 2013||2013-12-01|January 2014|2014-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients|Randomized Controlled Trial of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients Receiving Etoposide Combined With Platinum Based First-line Chemotherapy|Unknown status|Recruiting|Phase 2|160|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 00:51:03.96274|2017-10-11 00:51:03.96274
NCT02039505|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-09-28|||February 4, 2014|Actual|2014-02-04|September 2017|2017-09-01|March 12, 2018|Anticipated|2018-03-12|March 12, 2018|Anticipated|2018-03-12||Interventional|||Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis|Phase III, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Examine the Efficacy, Safety, and Pharmacokinetics of Intravenous MLN0002 (300 mg) Infusion in Induction and Maintenance Therapy in Japanese Patients With Moderately or Severely Active Ulcerative Colitis|Active, not recruiting||Phase 3|278|Anticipated|Takeda||2|||f||||f||||||||||2017-10-11 00:51:04.062054|2017-10-11 00:51:04.062054
NCT02039492|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-09-28|||September 2012||2012-09-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.|Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension|Completed||N/A|38|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 00:51:04.296003|2017-10-11 00:51:04.296003
NCT02039479|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-01-16|||January 2014||2014-01-01|January 2014|2014-01-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Randomized, Placebo-controlled Multicenter Trial of Lithium Plus Treatment as Usual (TAU) for Acute Suicidal Ideation and Behavior in Patients With Suicidal Major Depressive Episode|Randomized, Placebo-controlled Multicenter Trial of Lithium Plus Treatment as Usual (TAU) for Acute Suicidal Ideation and Behavior in Patients With Suicidal Major Depressive Episode|Unknown status|Not yet recruiting|N/A|254|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 00:51:04.403547|2017-10-11 00:51:04.403547
NCT02039466|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-07-10|||January 2014||2014-01-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Effect of Pressure-controlled Ventilation on the Respiratory Complication in Patients Undergoing Laparoscopic Colectomy Compared With Volume-controlled Ventilation||Unknown status|Recruiting|Phase 4|44|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||2|||f||||||||||||||2017-10-11 00:51:04.522965|2017-10-11 00:51:04.522965
NCT02039453|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2014-01-15|||September 2013||2013-09-01|January 2014|2014-01-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Safety and Efficacy of Fentanyl Versus Pethidine During Propofol-based Sedated Colonoscopy: Prospective Randomized Study||Unknown status|Recruiting|N/A|160|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:51:04.601417|2017-10-11 00:51:04.601417
NCT02039440|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2015-02-20|||February 2014||2014-02-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||6-year Antibody Check After Third Vaccination Against Japanese Encephalitis|Neutralizing Antibody Titers 6 Years After the Third Dose of Inactivated Japanese Encephalitis Vaccine and Projected Duration of Protection|Completed||Phase 4|67|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 00:51:04.718059|2017-10-11 00:51:04.718059
NCT02039427|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-07-30|2016-12-07||January 2014||2014-01-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery|The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery|Completed||N/A|192|Actual|Yeungnam University College of Medicine|The present study has some limitations. First, the dose of dexamethasone and ketorolac may not be equipotent in terms of anti-inflammatory efficacy. Second, postoperative pain control might affect the incidence and severity of the POST.|4|||f||||t||||||||||2017-10-11 00:51:04.807081|2017-10-11 00:51:04.807081
NCT02039414|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-07-20|2016-04-28||October 2013||2013-10-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Observational|||Effects of Obesity and Physical Inactivity on Pregnancy Outcomes|Effects of Physical Activity on Maternal Lipid Metabolism, Oxidative Stress, and Neonatal Outcomes in Obese Pregnancy|Completed||N/A|40|Actual|Washington University School of Medicine|||2||f||||t||||||Samples Without DNA|"     The investigators are collecting maternal blood at 7 different time points (all in one     day/visit) during the 3rd trimester of thier pregnancy. The investigators are also collecting     cord blood when the babies are born. All of these samples are stored at -80 with patient     identification numbers.   "|||2017-10-11 00:51:05.412893|2017-10-11 00:51:05.412893
NCT02039401|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-07-26||2016-10-31|February 2014||2014-02-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|September 2015|Actual|2015-09-01||Interventional|||Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis|A Phase I/II, Open Label Study to Assess the Safety and Tolerability of VM202 in Subjects With Amyotrophic Lateral Sclerosis|Active, not recruiting||Phase 1/Phase 2|18|Anticipated|ViroMed Co., Ltd. dba VM BioPharma||1|||f||||t||||||||||2017-10-11 00:51:05.800429|2017-10-11 00:51:05.800429
NCT02039388|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-06-06|||November 2013||2013-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LUSTIC||Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma|Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma|Recruiting||N/A|200|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 00:51:05.879731|2017-10-11 00:51:05.879731
NCT02039375|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2016-02-22|||March 2014||2014-03-01|February 2016|2016-02-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|OPTIMIST||Safety Study of Post Intravenous tPA Monitoring in Ischemic Stroke|Optimal Post Tpa-Iv Monitoring in Ischemic STroke|Recruiting||Phase 1/Phase 2|50|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 00:51:06.008393|2017-10-11 00:51:06.008393
NCT02039362|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2017-04-26|||July 2012||2012-07-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy|Prevention of Hepatitis B Virus (HBV) Mother-to-Child (MTC) Transmission by Serovaccination of Newborns and Use of Tenofovir DF During the Last Trimester of Pregnancy in Mothers With HBV DNA Above 100, 000 I.U/mL|Completed||Phase 4|37|Actual|Hopital Lariboisière||1|||f||||f||||||||No||2017-10-11 00:51:06.096402|2017-10-11 00:51:06.096402
NCT02039349|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-10-05|||January 3, 2014||2014-01-03|September 28, 2017|2017-09-28|October 1, 2015|Actual|2015-10-01|October 1, 2015|Actual|2015-10-01||Interventional|||A Novel Compound for Alcoholism Treatment|A Novel Compound for Alcoholism Treatment: A Translational Strategy|Completed||Phase 1|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:51:06.17094|2017-10-11 00:51:06.17094
NCT02039336|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-07-14|||January 2014||2014-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|M13DAP||Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant Malignancies|Phase I/II Study With the Combination of Dacomitinib and PD-0325901 in Metastatic KRAS Mutation Positive Non-small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|35|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-11 00:51:06.246874|2017-10-11 00:51:06.246874
NCT02039323|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-06-17|||February 2014||2014-02-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants|A Feasibility Study to Assess Protection of Vaginal and Cervical Tissues From Ex-Vivo HIV-1 Challenge Following Oral Administration of Maraviroc and Tenofovir|Completed||Phase 1|6|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 00:51:06.34156|2017-10-11 00:51:06.34156
NCT02039310|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-07-25|||March 2012||2012-03-01|July 2017|2017-07-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy|Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy|Completed||N/A|59|Actual|University of Michigan|||1||f||||||||||Samples With DNA|"     urine, serum, psoas muscle specimen   "|||2017-10-11 00:51:06.428203|2017-10-11 00:51:06.428203
NCT02039297|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-10-31|||March 2013||2013-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|AWARE||Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)|Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)|Active, not recruiting||N/A|12000|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 00:51:06.487748|2017-10-11 00:51:06.487748
NCT02039284|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-10-03|||May 2013||2013-05-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of New Protocols in the Treatment of Upper Limb Dysfunctions in Patients With Cerebral Palsy|Efficacy of New Protocols in the Treatment of Upper Limb Dysfunctions in Patients With Cerebral Palsy|Recruiting||N/A|100|Anticipated|Chang Gung Memorial Hospital||4|||f||||t||||||||No||2017-10-11 00:51:06.578234|2017-10-11 00:51:06.578234
NCT02039271|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-12-19|||February 2014||2014-02-01|December 2016|2016-12-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Effects of Music Listening on Pain and Patient Satisfaction Within First 48 Hours After Knee Replacment Surgery|Effects of Music Listening on Pain and Patient Satisfaction Within First 48 Hours of Knee Replacement Surgery|Completed||N/A|10|Actual|Loma Linda University||2|||f||||f||||||||No|no plan to share data|2017-10-11 00:51:06.686528|2017-10-11 00:51:06.686528
NCT02039258|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-07-11|||January 2014||2014-01-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food|A Single-Dose, Open-Label, Randomized, 2-Period Crossover Study to Assess the Effect of Food Coadministration on the Pharmacokinetics of a Fixed Dose Combination Tablet of Canagliflozin (JNJ-28431754) and Metformin Extended Release in Healthy Subjects|Completed||Phase 1|24|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 00:51:06.778266|2017-10-11 00:51:06.778266
NCT02039245|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-04-01|||January 2014||2014-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose Combination|An Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics of Canagliflozin (JNJ-28431754) and Metformin Following Once-Daily Administration of 2 Canagliflozin/Metformin XR (150/1,000-mg) Fixed Dose Combination Tablets in Healthy Subjects|Completed||Phase 1|12|Actual|Janssen Research & Development, LLC||1|||f||||t||||||||||2017-10-11 00:51:06.891686|2017-10-11 00:51:06.891686
NCT02039232|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-07-25|||January 2014||2014-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy of the CarboFix Pedicle Screw System|CarboFix Pedicle Screw System|Active, not recruiting||N/A|65|Anticipated|CarboFix Orthopedics Ltd.||1|||f||||||||||||||2017-10-11 00:51:06.966859|2017-10-11 00:51:06.966859
NCT02039219|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-02-03|||November 2014||2014-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|TREAT||Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)|A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)|Recruiting||Phase 2|60|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 00:51:07.084904|2017-10-11 00:51:07.084904
NCT02039206|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2014-09-15|||February 2014||2014-02-01|September 2014|2014-09-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease|The Influence of Deep Repetitive Transcranial Magnetic Stimulation (TMS) on Cerebellar Signs in Patients With Spinocerebellar Ataxia Type 3 (SCA3 - Machado Joseph Disease)|Unknown status|Recruiting|Phase 2|20|Anticipated|Brainsway||1|||f||||t||||||||||2017-10-11 00:51:07.264662|2017-10-11 00:51:07.264662
NCT02039193|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-12-02|||August 2012||2012-08-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Microtuning a Bonafide Treatment for GAD Patients - A Randomized Controlled Trial.|Microtuning a Bonafide Treatment for GAD Patients - A Randomized Controlled Trial.|Completed||Phase 4|57|Actual|University of Zurich||3|||f||||t||||||||||2017-10-11 00:51:07.362162|2017-10-11 00:51:07.362162
NCT02039180|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-16|2014-04-23|||February 2014||2014-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|BA||Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects|A Phase 1, Open-label, Randomized, Single-dose, 3-period Cross-over, Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects|Completed||Phase 1|1|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:51:07.469395|2017-10-11 00:51:07.469395
NCT02039167|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-10-27|||January 2014||2014-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|WatchAFIB||Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease|WATCH Bleeding Episodes After Left Atrial Appendage Occlusion Versus Usual Care in Patients With Atrial FIBrillatIon and Severe to eNd-stage Chronic Kidney Disease (WatchAFIB in CKD)|Active, not recruiting||N/A|300|Anticipated|University of Magdeburg||2|||f||||t||||||||||2017-10-11 00:51:07.688471|2017-10-11 00:51:07.688471
NCT02039154|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-01|||July 2012|Actual|2012-07-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PEP||The Effect of Long Duration Exercise on the Diastolic Function of the Heart|The Effect of Long Duration Exercise on the Diastolic Function of the Heart|Completed||N/A|61|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 00:51:07.803582|2017-10-11 00:51:07.803582
NCT02039141|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-08-31|||April 2012||2012-04-01|August 2015|2015-08-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|ELSC||Diabetes Prevention Program for Obese Latino Youth|Community-Based Diabetes Prevention Program for Obese Latino Youth: Every Little Step Counts|Unknown status|Active, not recruiting|N/A|160|Anticipated|Arizona State University||2|||f||||t||||||||||2017-10-11 00:51:07.9166|2017-10-11 00:51:07.9166
NCT02039128|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-07-28|||January 2014||2014-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||KOmparison Study KOmparison Study|A Double-blind, Randomized, Placebo-controlled Study to Assess Changes in the Omega-3 Index in Erythrocytes After Twelve Weeks of Daily Intake of SuperbaTM Krill Oil or Fish Oil|Completed||N/A|240|Actual|Aker Biomarine Antarctic AS||3|||f||||f||||||||||2017-10-11 00:51:08.037548|2017-10-11 00:51:08.037548
NCT02039115|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-08-08|2017-08-08||March 2014||2014-03-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Reduction in Symptomatic Esophageal Stricture Formation|Reduction in Symptomatic Esophageal Stricture Formation Post-two Stage Complete Barrett's Excision for High Grade Dysplasia or Early Adenocarcinoma With Short-term Steroid Therapy: A Randomized, Double-blinded, Placebo-controlled, Multicenter Trial.|Terminated||Phase 4|3|Actual|Florida Hospital||2||Closed for low enrollment and the inability to complete the study.|f||||t||||||||||2017-10-11 00:51:08.165707|2017-10-11 00:51:08.165707
NCT02039102|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-22|||December 2013||2013-12-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Contraceptive Use and Respiratory Conditions Among Scottish Women|Use of Hormonal Contraceptives in Relation to Asthma and Wheezing Disorders in Scottish Women: a Population-based Cross-sectional Survey|Unknown status|Active, not recruiting|N/A|||University of Edinburgh|||2||f||||f||||||||||2017-10-11 00:51:08.697372|2017-10-11 00:51:08.697372
NCT02039089|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-11-02|||January 2014||2014-01-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects|A Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects|Completed||Phase 1|32|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-11 00:51:08.798371|2017-10-11 00:51:08.798371
NCT02039076|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-12-16|||December 2013||2013-12-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects||Completed||Phase 1|48|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-11 00:51:08.897808|2017-10-11 00:51:08.897808
NCT02039063|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-06-01|||May 14, 2014|Actual|2014-05-14|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|January 2017|Actual|2017-01-01||Interventional|||A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease|A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease|Active, not recruiting||Phase 1/Phase 2|28|Actual|Eisai Inc.||4|||f||||f|f||||f|||||2017-10-11 00:51:08.999656|2017-10-11 00:51:08.999656
NCT02039050|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-11-13|||February 2014||2014-02-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|MAN04||Evaluation of Long-Acting Muscarinic Antagonists in COPD|Proof of Concept Evaluation of Drug-Device Interaction With Aclidinium Bromide Via Genuair® and Tiotropium Bromide Via HandiHaler® in COPD Using Impulse Oscillometry|Completed||Phase 4|15|Actual|University of Dundee||2|||f||||f||||||||||2017-10-11 00:51:09.168455|2017-10-11 00:51:09.168455
NCT02039037|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-04-02|||January 2014||2014-01-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Efficacy of Acupuncture and Electroacupuncture in Patients With Chronic Nonspecific Low Back Pain: Randomized Clinical Trial|Efficacy of Acupuncture and Electroacupuncture in Patients With Chronic Nonspecific Low Back Pain: Randomized Clinical Trial|Unknown status|Recruiting|N/A|66|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:51:09.310467|2017-10-11 00:51:09.310467
NCT02039024|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-01-11|||March 2012||2012-03-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PET|Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PET|Completed||Phase 2|18|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:51:09.433463|2017-10-11 00:51:09.433463
NCT02039011|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-08-17|||February 2014||2014-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|MAN02||Ultra-long Acting Bronchodilator Therapy in Asthmatics|Proof of Concept Study to Evaluate Single and Chronic Dosing Effects of Ultra-long Acting Bronchodilator Therapy on Mannitol Challenge in Asthmatic Patients Taking Inhaled Corticosteroids|Completed||Phase 4|14|Actual|University of Dundee||2|||f||||f||||||||||2017-10-11 00:51:09.529347|2017-10-11 00:51:09.529347
NCT02038998|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-05-30|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|May 2019|Anticipated|2019-05-01||Interventional|||Randomized Study Comparing Periodic Acceleration Versus Static Position in Cerebrovascular Stroke Patients|Unicentric, Phase II, Randomized Study Comparing Periodic Acceleration Versus Static Position in Cerebrovascular Stroke Patients|Recruiting||N/A|87|Anticipated|Fundacion Rioja Salud||3|||f||||f||||||||No||2017-10-11 00:51:09.624372|2017-10-11 00:51:09.624372
NCT02038985|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-10-04|||June 2013|Actual|2013-06-01|October 2017|2017-10-01|August 16, 2016|Actual|2016-08-16|July 2016|Actual|2016-07-01||Interventional|FIREFLY||Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis|An Evaluation of Fluorescence Imaging + ICG Dye (Firefly) for Use in the Visual Diagnosis of Endometriosis: A Prospective Study|Terminated||N/A|18|Actual|Florida Hospital||1||Lack of funding|f||||f||||||||||2017-10-11 00:51:09.763201|2017-10-11 00:51:09.763201
NCT02038972|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-08-10|||January 2013||2013-01-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss|Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss|Suspended||Phase 1/Phase 2|10|Anticipated|Florida Hospital||1||Restructuring of Cell Lab|f||||t||||||||Undecided||2017-10-11 00:51:09.860747|2017-10-11 00:51:09.860747
NCT02038959|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-12-01|2016-09-28||March 2014||2014-03-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes|Using Technology to Deliver Multi-disciplinary Care to Individuals With Parkinson Disease in Their Homes: the Connect.Parkinson Study|Completed||N/A|210|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 00:51:09.958316|2017-10-11 00:51:09.958316
NCT02038231|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-07-18|||February 2014||2014-02-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|PM||Parenting Mindfully Study|Reducing Stress With Parenting-focused Mindfulness to Prevent Youth Substance Use|Active, not recruiting||N/A|100|Actual|George Mason University||2|||f||||f||||||||||2017-10-11 00:51:27.848189|2017-10-11 00:51:27.848189
NCT02038946|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-10-03|||March 6, 2014|Actual|2014-03-06|October 2017|2017-10-01|July 24, 2018|Anticipated|2018-07-24|May 17, 2017|Actual|2017-05-17||Interventional|||Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)|A Single Arm, Open-Label Phase 2 Study of Nivolumab (BMS-936558) in Subjects With Relapsed or Refractory Follicular Lymphoma (FL)|Active, not recruiting||Phase 2|116|Actual|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-11 00:51:10.519922|2017-10-11 00:51:10.519922
NCT02038933|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-09-20|2017-04-19|2016-12-05|February 10, 2014|Actual|2014-02-10|September 2017|2017-09-01|June 2, 2018|Anticipated|2018-06-02|April 8, 2016|Actual|2016-04-08||Interventional||All treated participants|Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)|A Single-Arm, Open-Label, Phase 2 Study of Nivolumab (BMS-936558) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) After Failure of Autologous Stem Cell Transplant (ASCT) or After Failure of At Least Two Prior Multi-Agent Chemotherapy Regimens in Subjects Who Are Not Candidates for ASCT|Active, not recruiting||Phase 2|161|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 00:51:10.713651|2017-10-11 00:51:10.713651
NCT02038920|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-09-28|||January 28, 2014|Actual|2014-01-28|September 2017|2017-09-01|February 21, 2019|Anticipated|2019-02-21|February 21, 2019|Anticipated|2019-02-21||Interventional|||Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease|Phase III, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Examine the Efficacy, Safety, and Pharmacokinetics of Intravenous MLN0002 (300 mg) Infusion in Induction and Maintenance Therapy in Japanese Patients With Moderately or Severely Active Crohn's Disease|Active, not recruiting||Phase 3|157|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:51:11.480494|2017-10-11 00:51:11.480494
NCT02038907|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-08-04|2016-06-18||March 28, 2014|Actual|2014-03-28|August 2017|2017-08-01|June 19, 2015|Actual|2015-06-19|June 19, 2015|Actual|2015-06-19||Interventional|NOR-107|All randomized participants.|Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine|A Phase II, Randomized, Controlled, Double-Blind, Dosage and Adjuvant Justification, Safety and Immunogenicity Trial of Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine Adjuvanted With or Without Monophosphoryl Lipid A and Aluminum Hydroxide in Adults|Completed||Phase 2|420|Actual|Takeda||14|||f||||f||||||||||2017-10-11 00:51:13.391967|2017-10-11 00:51:13.391967
NCT02038894|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-09-25|||December 2009||2009-12-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies|Comparison Of Different Anesthetic Techniques In Children Undergoing Esophagogastroduodenoscopies|Completed||N/A|179|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||f||||||||||2017-10-11 00:51:21.247591|2017-10-11 00:51:21.247591
NCT02038881|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-07-20|||April 28, 2014|Actual|2014-04-28|July 2017|2017-07-01|May 10, 2017|Actual|2017-05-10|May 10, 2017|Actual|2017-05-10||Interventional|||Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection|Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine When Increasing the Number of Injections Compared to the Standard Regimen in Immunocompromised Subjects With HIV Infection|Completed||Phase 2|87|Actual|Bavarian Nordic||3|||f||||t||||||||||2017-10-11 00:51:21.350757|2017-10-11 00:51:21.350757
NCT02038868|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-12-04|||August 2013||2013-08-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia|Double-Blind, Placebo-Controlled, Active-Referenced, Parallel-Group Comparative Study in Patients With Benign Prostatic Hyperplasia|Completed||Phase 2|320|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 00:51:21.454111|2017-10-11 00:51:21.454111
NCT02038855|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-04-27|||April 2014||2014-04-01|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|ILRP||International Latino Research Partnership|International Latino Research Partnership|Completed||N/A|360|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:51:21.542391|2017-10-11 00:51:21.542391
NCT02038842|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-05-31|||March 2014||2014-03-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|VRI01||Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers|Phase I/II Open-label Randomized Multicenter Trial to Assess Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates (MVA HIV-B/ LIPO-5; LIPO-5/MVA HIV-B; GTU®-MultiHIV B / LIPO-5; GTU®-MultiHIV B/MVA HIV-B) in Healthy Volunteers at Low Risk of HIV Infection|Completed||Phase 1/Phase 2|92|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||4|||f||||t||||||||||2017-10-11 00:51:21.650693|2017-10-11 00:51:21.650693
NCT02038829|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-08-25||2015-08-25|January 2014||2014-01-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|GOLDEN 6||A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD|A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)|Completed||Phase 2|96|Actual|Sunovion Respiratory Development Inc.||6|||f||||f||||||||||2017-10-11 00:51:21.745907|2017-10-11 00:51:21.745907
NCT02038816|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-05-19|||March 2014||2014-03-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Interventional|||Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)|A PHASE II STUDY OF Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)|Terminated||Phase 2|1|Actual|Sunnybrook Health Sciences Centre||2||accrual too slow, insufficient patients|f||||f|f|f|||f|||No||2017-10-11 00:51:21.854328|2017-10-11 00:51:21.854328
NCT02038803|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-15|||October 2013||2013-10-01|January 2014|2014-01-01||||August 2014|Anticipated|2014-08-01||Observational|PETIS||Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution|Patient Preferences and Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution (PETIS)|Unknown status|Recruiting|N/A|15|Anticipated|Rush University Medical Center|||1||f||||f||||||||||2017-10-11 00:51:22.073227|2017-10-11 00:51:22.073227
NCT02038790|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-01-31|2017-01-31||November 2013||2013-11-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||All treated participants|Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population|A Single Center, Randomized, 2 Way Cross-Over, Phase 4 Study Comparing Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 Including Ease of Use, Taste Preference, Dissolution Time, Desire to Abuse, and Overall Acceptance In Buprenorphine/Naloxone Treated Opioid Dependent Population|Completed||Phase 4|33|Actual|Indivior Inc.||2|||f||||f||||||||||2017-10-11 00:51:22.173462|2017-10-11 00:51:22.173462
NCT02038777|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-10-02|||March 25, 2014|Actual|2014-03-25|September 2017|2017-09-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies|A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Pf-04449913 (Glasdegib), An Oral Hedgehog Inhibitor, Administered As A Single Agent In Japanese Patients With Select Hematologic Malignancies And In Combination With Intensive Chemotherapy, Low-dose Ara-c, Or Azacitidine In Patients With Acute Myeloid Leukemia Or High-risk Myelodysplastic Syndrome|Recruiting||Phase 1|33|Anticipated|Pfizer||4|||f||||f|t|f||||||||2017-10-11 00:51:22.883432|2017-10-11 00:51:22.883432
NCT02038751|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-16|||January 2014||2014-01-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Phenotyping and Genotyping of Taiwanese Patients With Obstructive Sleep Apnea|The Phenotyping and Genotyping of Taiwanese Patients With Obstructive Sleep Apnea|Unknown status|Recruiting|N/A|360|Anticipated|National Taiwan University Hospital|||4||f||||t||||||Samples With DNA|"     whole blood and serum   "|||2017-10-11 00:51:23.130051|2017-10-11 00:51:23.130051
NCT02038738|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-16|||March 2014||2014-03-01|January 2014|2014-01-01||||March 2019|Anticipated|2019-03-01||Interventional|||68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors|68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors|Not yet recruiting||Phase 1/Phase 2|250|Anticipated|Ochsner Health System||1|||f||||f||||||||||2017-10-11 00:51:23.224545|2017-10-11 00:51:23.224545
NCT02038712|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-14|||June 2006||2006-06-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|December 2008|Actual|2008-12-01||Interventional|||fMRI and Ghlrein in Obesity and Binge Eating Disorder|fMRI and Ghlrein in Obesity and Binge Eating Disorder|Completed||N/A|93|Actual|New York Obesity and Nutrition Research Center||2|||f||||f||||||||||2017-10-11 00:51:23.633429|2017-10-11 00:51:23.633429
NCT02038699|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-12-18||||||October 2014|2014-10-01||||December 2015|Anticipated|2015-12-01||Interventional|||A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer|A First-in-man Phase I/II Single-agent Open-label Dose-escalation Study of Every Three-week Dosing of Oral ONC201 in Patients With Advanced Cancer and Limited Treatment Options|Withdrawn||Phase 1/Phase 2|0|Actual|Oncoceutics, Inc.||1||Protocol not activated.|f||||t||||||||||2017-10-11 00:51:23.735209|2017-10-11 00:51:23.735209
NCT02038686|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-02-01|||January 2014||2014-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2016|Actual|2016-01-01||Interventional|PFN-A||Treatment of Unstable 31.A2 and 31.A3 Trochanteric Fractures. Randomised Comparison of the Proximal Femoral Nail PFN-A Short and the PFN-A Long.||Completed||N/A|188|Actual|Corporacion Parc Tauli||2|||f||||t||||||||||2017-10-11 00:51:23.808114|2017-10-11 00:51:23.808114
NCT02038673|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-09-12|||November 5, 2013|Actual|2013-11-05|September 2017|2017-09-01|July 19, 2017|Actual|2017-07-19|July 19, 2017|Actual|2017-07-19||Interventional|||An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors|An Open-label Phase I Study of Oral ASP5878 at Single and Multiple Doses in Patients With Solid Tumors|Completed||Phase 1|86|Actual|Astellas Pharma Inc||2|||f||||f|t|f||||||||2017-10-11 00:51:23.892723|2017-10-11 00:51:23.892723
NCT02038660|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2017-06-18|||January 2014|Actual|2014-01-01|June 2017|2017-06-01|June 2023|Anticipated|2023-06-01|December 2019|Anticipated|2019-12-01||Observational|IRIS DEB||Drug-Eluting Balloon Registry in Routine Clinical Practice|Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study|Recruiting||N/A|300|Anticipated|Asan Medical Center|||1||f||||t||||||||No|This is not a publicly funded trial.|2017-10-11 00:51:24.065459|2017-10-11 00:51:24.065459
NCT02038647|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-03-30|||February 2014||2014-02-01|March 2017|2017-03-01|August 7, 2017|Anticipated|2017-08-07|August 7, 2017|Anticipated|2017-08-07||Interventional|||Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)|A Randomized, Double-blind, Placebo-controlled, Phase 2 Clinical Trial of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC).|Active, not recruiting||Phase 2|178|Actual|Takeda||2|||f||||f||||||||||2017-10-11 00:51:24.187742|2017-10-11 00:51:24.187742
NCT02038634|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-11-22|||January 2014||2014-01-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Ultrasound-guided Injection for DeQuervain's|Ultrasound-guided Injection for DeQuervain's|Recruiting||Phase 4|40|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-11 00:51:24.477791|2017-10-11 00:51:24.477791
NCT02038621|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-15|||January 2014||2014-01-01|January 2014|2014-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|GZH-001||The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer|Phase II Clinical Study of the Maintenance Therapy of Capecitabine Afer the XELOX in Treatment of Advanced Gastric Cancer|Not yet recruiting||Phase 2|224|Anticipated|The Second People's Hospital of Sichuan||2|||f||||||||||||||2017-10-11 00:51:24.576242|2017-10-11 00:51:24.576242
NCT02038608|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-09-18|||December 2014||2014-12-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|CompensationPD||Compensatory Mechanisms in Parkinson Disease (PD)|Pathophysiology of Non Motor Signs and Compensatory Mechanisms in Parkinson's Disease: Role of the Serotoninergic and Dopaminergic Lesions Studied by PET|Completed||N/A|49|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:51:24.652106|2017-10-11 00:51:24.652106
NCT02038595|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-07-16|||September 2012||2012-09-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue|The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue|Completed||Early Phase 1|10|Actual|Yale University||1|||f||||f||||||||||2017-10-11 00:51:24.730337|2017-10-11 00:51:24.730337
NCT02038582|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-05-29|||June 2013||2013-06-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa|An Evaluation of Strategies to Increase Testing and Linkages of HIV Positive Individuals to Care and HIV Negative Men to Male Circumcision in Sub-Saharan Africa|Completed||N/A|2075|Actual|University of Washington||11|||f||||f||||||||||2017-10-11 00:51:24.809418|2017-10-11 00:51:24.809418
NCT02038569|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-03-06|||January 2014||2014-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis|Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis|Recruiting||Phase 2|100|Anticipated|LEO Pharma||1|||f||||f||||||||||2017-10-11 00:51:24.938133|2017-10-11 00:51:24.938133
NCT02038556|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-05-07|||May 2013||2013-05-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Exploring the Outcomes and Financial Impact of a CBT-I Group Program Provided by Registered Nurses for Adults With Insomnia|Exploring the Outcomes and Financial Impact of a CBT-I Group Program Provided by Registered Nurses for Adults With Insomnia|Completed||N/A|60|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:51:25.122925|2017-10-11 00:51:25.122925
NCT02038543|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-30|2017-06-30||September 2013||2013-09-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||Hydroxyproline Influence on Oxalate Metabolism|Influence of Hydroxyproline Plasma Concentration on Its Metabolism to Oxalate|Completed||Phase 1/Phase 2|22|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 00:51:25.21009|2017-10-11 00:51:25.21009
NCT02038530|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-12-12|||February 2014||2014-02-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|4D||The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study|D-dimer Testing, Tailored to Clinical Pretest Probability, to Minimize Initial and Follow-up Ultrasound Imaging in Suspected Deep Vein Thrombosis: A Management Study|Recruiting||Phase 3|1500|Anticipated|McMaster University|||2||f||||t||||||||||2017-10-11 00:51:25.607813|2017-10-11 00:51:25.607813
NCT02038517|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-02-29|||June 2013||2013-06-01|February 2016|2016-02-01|December 2026|Anticipated|2026-12-01|December 2016|Anticipated|2016-12-01|10 Years|Observational [Patient Registry]|CETRA||Cirrhosis, Effects of TRAnsplantation and Diabetes|Insulin Secretion and Sensitivity in Subjects With Liver Cirrhosis Undergoing Orthotopic Liver Transplantation (OLT): Pre- and Post-OLT Analysis|Recruiting||N/A|200|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||1||f||||f||||||Samples With DNA|"     Serum, plasma, urines and DNA   "|||2017-10-11 00:51:25.767581|2017-10-11 00:51:25.767581
NCT02038504|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-06-27|||January 2013||2013-01-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|EN;NTIS||Investigating the Role of EN in NTIS Among Fistula Patients|a Prospective Study to Investigate the Role of Enteral Nutrition in Nonthyroidal Illness Syndrome Among Fistula Patients|Completed||N/A|40|Actual|Jinling Hospital, China|||1||f||||t||||||Samples Without DNA|"     whole blood   "|||2017-10-11 00:51:25.843519|2017-10-11 00:51:25.843519
NCT02038491|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-01-16|||May 2009||2009-05-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|May 2009|Actual|2009-05-01|6 Months|Observational [Patient Registry]|RICALOR||RICALOR Italian Registry for Complications During Regional Anesthesia|RICALOR - Registro Italiano Complicanze Anestesia LOco Regionale - Italian Registry for Complications During Regional Anesthesia|Completed||N/A|63692|Actual|IRCCS Policlinico S. Matteo|||1||f||||t||||||||||2017-10-11 00:51:25.89798|2017-10-11 00:51:25.89798
NCT02038478|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-06-07|||January 2014||2014-01-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Allograft for Sickle Cell Disease and Thalassemia|Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Thalassemia|Recruiting||Phase 2|50|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 00:51:25.976833|2017-10-11 00:51:25.976833
NCT02038465|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-09-07|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Cognitive Remediation of Autobiographical Memory in Schizophrenia Using SenseCam®|REMEDIATION COGNITIVE DE LA MÉMOIRE AUTOBIOGRAPHIQUE DANS LA SCHIZOPHRENIE AU MOYEN DE SENSECAM|Recruiting||N/A|80|Anticipated|University Hospital, Strasbourg, France||2|||f||||||||||||||2017-10-11 00:51:26.064917|2017-10-11 00:51:26.064917
NCT02038452|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-03-03|||April 2014||2014-04-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2016|Actual|2016-12-31||Interventional|INSTinCTS||Injection Versus Splinting in Carpal Tunnel Syndrome|Randomised, Multicentre, Open Label, Parallel Group Pragmatic Clinical Trial of Local Steroid Injection Versus Night Splinting in Mild to Moderate Carpal Tunnel Syndrome (CTS)|Active, not recruiting||Phase 4|234|Actual|Keele University||2|||f||||t||||||||||2017-10-11 00:51:26.14013|2017-10-11 00:51:26.14013
NCT02038439|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-04-07|||January 2014||2014-01-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|MPFS||Multifaceted Online Interventions to Increase Clinicians Searching of Current Best Evidence to Answer Clinical Questions|Multifaceted Online Interventions to Increase the Quantity and Quality of Searching for Current Best Evidence to Answer Clinical Questions|Completed||N/A|908|Actual|McMaster University||8|||f||||f||||||||||2017-10-11 00:51:26.227982|2017-10-11 00:51:26.227982
NCT02038426|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-06-10|||November 2013||2013-11-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||Ultrasonography Assessment of Peripheral Entheses in Axial Spondyloarthritis and in Healthy Subjects, Athletes or Not|Ultrasonography Assessment of Peripheral Entheses in Axial Spondyloarthritis and in Healthy Subjects, Athletes or Not.|Completed||N/A|90|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-11 00:51:26.310504|2017-10-11 00:51:26.310504
NCT02037308|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-01-13|||June 2010||2010-06-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|October 2010|Actual|2010-10-01||Interventional|||Glu298Asp Polymorphism and Blood Pressure|The Effects of Beetroot Bread on Postprandial Blood Pressure According to Glu298Asp Polymorphism in the eNOS Gene|Completed||N/A|14|Actual|University of Reading||2|||f||||t||||||||||2017-10-11 00:51:39.638685|2017-10-11 00:51:39.638685
NCT02038413|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-01-11|||January 2014||2014-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|October 2014|Actual|2014-10-01||Observational|Lung stage I||State of the Art Photon Therapy Versus Particle Therapy for Small Lung Tumors; a Planning Study Based on a Reference Dataset of Patients|In Silico Clinical Trial, Comparing State of the Art Photon Modalities With Proton and 12C-ion Therapy for Stage I NSCLC: A Multicentric ROCOCO Planning Study Based on a Reference Dataset of Patients|Completed||N/A|25|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-11 00:51:26.551174|2017-10-11 00:51:26.551174
NCT02038400|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-01-15|||November 2013||2013-11-01|March 2013|2013-03-01||||July 2016|Anticipated|2016-07-01||Interventional|KINETUBE||Efficacy of KNT® (KINETUBE) in Recurrent Chronic Otitis Media in Children|Evaluation of the Efficiency of KINETUBE® in the Recurrent Chronic Tubal Ear Otitis Care (Otitis Media With Effusion, Atelectatic Otitis or Retraction) in Children With an Age Range of 7-15 Years.|Unknown status|Active, not recruiting|N/A|140|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 00:51:26.626359|2017-10-11 00:51:26.626359
NCT02038387|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2014-01-14|||July 2012||2012-07-01|January 2014|2014-01-01||||December 2013|Actual|2013-12-01||Interventional|||Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)|Prospective Clinical Study on the Role of the Immune Response, in Relation to Diet, in Patients With Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD). Director Prof. V. Barnaba, Head of Internal Medicine; Principal Investigator, Prof. C. Balsano|Unknown status|Recruiting|N/A|60|Anticipated|University of Roma La Sapienza||1|||f||||||||||||||2017-10-11 00:51:26.698323|2017-10-11 00:51:26.698323
NCT02038374|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-08-29|||November 2013||2013-11-01|August 2014|2014-08-01|April 2015|Anticipated|2015-04-01|September 2014|Anticipated|2014-09-01||Interventional|||Clinico-biological Correlation of Severe Asthma in Children|Clinico-biological Correlation of Severe Asthma in Children|Unknown status|Active, not recruiting|N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 00:51:26.7849|2017-10-11 00:51:26.7849
NCT02038361|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-04-08|||February 2014||2014-02-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|February 2016|Anticipated|2016-02-01||Interventional|||Implementation of Innovative Techniques in Routine Diagnosis of Childhood Acute Leukemia: Analysis of Genome and Transcriptome by Micro-array|Implementation of Innovative Techniques in Routine Diagnosis of Childhood Acute Leukemia: Analysis of Genome and Transcriptome by Micro-array|Unknown status|Recruiting|N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:51:26.854291|2017-10-11 00:51:26.854291
NCT02038348|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-10-22|||January 2014||2014-01-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study|Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study|Unknown status|Recruiting|Phase 2|5|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 00:51:26.938306|2017-10-11 00:51:26.938306
NCT02038335|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-07-21|||February 2014|Actual|2014-02-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|June 2016|Actual|2016-06-01||Observational|Zim CHIC||HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC|HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC|Active, not recruiting||N/A|451|Actual|University of Pittsburgh|||6||f||||t||||||Samples With DNA|"     whole blood, plasma archive, vaginal swabs, serum, cervicovaginal lavage fluid   "|||2017-10-11 00:51:27.018343|2017-10-11 00:51:27.018343
NCT02038309|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2014-01-15|||January 2013||2013-01-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|November 2014|Anticipated|2014-11-01|1 Year|Observational [Patient Registry]|||Persistent Platelet Reactivity in Acute Coronary Syndrome|Persistent Platelet Reactivity in Acute Coronary Syndrome|Unknown status|Recruiting|N/A|500|Anticipated|Hopital Lariboisière|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 00:51:27.218423|2017-10-11 00:51:27.218423
NCT02038296|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2014-01-16|||January 2008||2008-01-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma||Completed||Phase 3|162|Actual|Guangdong General Hospital||3|||f||||||||||||||2017-10-11 00:51:27.301716|2017-10-11 00:51:27.301716
NCT02038283|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-05-13|||October 2009||2009-10-01|May 2016|2016-05-01|June 2012|Actual|2012-06-01|July 2010|Actual|2010-07-01||Observational|||Quality of Life of Patients With Colorectal Neoplasm and Cost-Effectiveness Analysis of Colorectal Cancer Screening|A Study on Health-related Quality of Life of Patients With Colorectal Neoplasm and Cost-Effectiveness Analysis of Colorectal Cancer Screening in Hong Kong|Completed||N/A|587|Actual|The University of Hong Kong|||6||f||||f||||||||||2017-10-11 00:51:27.375845|2017-10-11 00:51:27.375845
NCT02038270|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2014-01-14|||September 2011||2011-09-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Accuracy of Nexfin® and NIBP to Predict IBP|Evolution of the Accuracy of the Nexfin Pressure Signal Compared to Invasive and Noninvasive Arterial Blood Pressure|Completed||N/A|110|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-11 00:51:27.559207|2017-10-11 00:51:27.559207
NCT02038257|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-02-22|||January 2014||2014-01-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|MKTP||Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP|Prospective Open Label Parallel Study Comparing Use of Carbon Dioxide Laser Versus Dermabrasion for Denuding Epithelium and Collagen Dressing Versus Vaseline Impregnated Gauze for the Melanocyte Keratinocyte Transplant Procedure|Recruiting||N/A|20|Anticipated|Henry Ford Health System||4|||f||||f||||||||||2017-10-11 00:51:27.634711|2017-10-11 00:51:27.634711
NCT02038244|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-09-22|||February 2014||2014-02-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|POSITIVE||Integrative Medicine for Chronic Pain|Integrative Medicine for Chronic Pain - Process-Outcome-Study in the Context of an Internal Medicine Ward for Integrative Medicine|Completed||N/A|300|Actual|Universität Duisburg-Essen||1|||f||||f||||||||||2017-10-11 00:51:27.755709|2017-10-11 00:51:27.755709
NCT02038218|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2016-06-21|||September 2013||2013-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|DM-CHOC-PEN||Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome in Patients With Brain Tumors|A Phase II Trial: Safety and Tolerance of Intravenous 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Malignancies Involving the Central Nervous System|Completed||Phase 2|27|Actual|DEKK-TEC, Inc.||1|||f||||t||||||||Yes|As approved by the NCI|2017-10-11 00:51:27.930673|2017-10-11 00:51:27.930673
NCT02038205|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-02-22|||January 2014||2014-01-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Ultrasonographic Measurements of the Median Nerve Before and After Splinting for Carpal Tunnel Syndrome|High Resolution Ultrasonographic Measurements of the Median Nerve Before and After Wrist Splinting for Carpal Tunnel Syndrome|Completed||N/A|213|Actual|University of California, Davis|||1||f||||||||||||||2017-10-11 00:51:28.021834|2017-10-11 00:51:28.021834
NCT02038192|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2015-01-07|||October 2013||2013-10-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pilot Study of the Living With Hope Program for Family Caregivers of Persons With Dementia Residing in Long Term Care|Living With Hope: Pilot Study of the Living With Hope Program for Family Caregivers of Persons With Dementia Residing in Long Term Care Facilities|Completed||N/A|21|Actual|University of Alberta||3|||f||||f||||||||||2017-10-11 00:51:28.104038|2017-10-11 00:51:28.104038
NCT02038179|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-09-29|||July 2014||2014-07-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||UAB Center of Research Translation (CORT) Project 2: The Effects of Urate Lowing Therapy (ULT) in Inflammation, Endothelial Function, and Blood Pressure|UAB Center of Research Translation (CORT) Project 2: The Effects of Urate Lowing Therapy (ULT) in Inflammation, Endothelial Function, and Blood Pressure|Recruiting||Phase 2/Phase 3|112|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 00:51:28.221376|2017-10-11 00:51:28.221376
NCT02038166|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-09-01|||January 2015||2015-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|||Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis|Chloride Secretagogues for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (NPD Protocol)|Recruiting||N/A|20|Anticipated|University of Alabama at Birmingham|||1||f||||t||||||||||2017-10-11 00:51:28.326126|2017-10-11 00:51:28.326126
NCT02038153|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-15|2015-03-02|||December 2013||2013-12-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant|A Phase I/II Study of Lenalidomide Maintenance After Autologous Stem Cell Transplant for Elderly Patients With Acute Myeloid Leukemia (AML)|Unknown status|Recruiting|Phase 1/Phase 2|48|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 00:51:28.403405|2017-10-11 00:51:28.403405
NCT02038140|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-06-13|||March 2014||2014-03-01|June 2017|2017-06-01|March 2027|Anticipated|2027-03-01|March 2027|Anticipated|2027-03-01||Interventional|||Zimmer Trabecular Metal Total Ankle|Prospective Post Market Clinical Follow-Up (PMCF) Study of the Zimmer® Trabecular Metal™ Total Ankle|Active, not recruiting||Phase 4|120|Anticipated|Zimmer Biomet||1|||f||||f||||||||Undecided||2017-10-11 00:51:28.537733|2017-10-11 00:51:28.537733
NCT02038127|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-11-14|||January 2013||2013-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01|3 Years|Observational [Patient Registry]|GWPCI||Gangwon PCI Registry|Prospective Registry for Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention in Gangwon Province|Recruiting||N/A|5000|Anticipated|Yonsei University|||1||f||||t||||||Samples Without DNA|"     CBC, Electrolyte, Chemistry, Cardiac biomarker, Platelet function test   "|||2017-10-11 00:51:28.653822|2017-10-11 00:51:28.653822
NCT02038114|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-09-05|||September 2013||2013-09-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Impact of a Patient Education Intervention for Ambulatory Oncology Patients|The Impact of a Patient Education Intervention on Knowledge, Self-efficacy, Symptom Burden, Health Related Quality of Life and Satisfaction With the Experience of Care for Oncology Ambulatory Patients Post Completion of the Edmonton Screening Assessment System|Completed||N/A|96|Actual|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 00:51:28.744247|2017-10-11 00:51:28.744247
NCT02038101|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-06-07|||December 2014||2014-12-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||A Multi-centered Feedback and Education Intervention Designed to Reduce Inappropriate Transthoracic Echocardiograms|Feedback and Education Intervention to Reduce Inappropriate Transthoracic Echocardiograms (TTE)|Active, not recruiting||N/A|256|Anticipated|Women's College Hospital||2|||f||||f||||||||Yes|Results will be published in an academic peer-reviewed journal.|2017-10-11 00:51:28.83135|2017-10-11 00:51:28.83135
NCT02038088|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-01-27|||January 2014||2014-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01|4 Days|Observational [Patient Registry]|HBV||The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication|The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication|Completed||N/A|30|Actual|Southwest Hospital, China|||2||f||||t||||||Samples With DNA|"     serum   "|||2017-10-11 00:51:28.935864|2017-10-11 00:51:28.935864
NCT02038075|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-05-24|2015-05-02||January 2011||2011-01-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Brief Cognitive Behavioral Therapy for Military Populations|Brief Cognitive Behavioral Therapy for Military Populations|Completed||N/A|152|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 00:51:29.036511|2017-10-11 00:51:29.036511
NCT02038062|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-11-27|||May 2010||2010-05-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|NIRSFEM||Tissue Oxygenation of the Tibial Anterior Muscle After Clamping of the Femoral Artery|Influence of Sevoflurane Preconditioning on Tissue Oxygenation of the Tibial Anterior Muscle Measured by Near-infrared Spectroscopy After Clamping of the Femoral Artery for Vascular Surgery|Completed||N/A|40|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-11 00:51:29.900699|2017-10-11 00:51:29.900699
NCT02038049|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-02-22|||December 20, 2013|Actual|2013-12-20|February 2017|2017-02-01|November 22, 2016|Actual|2016-11-22|November 22, 2016|Actual|2016-11-22||Interventional|||A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis|A Randomized, Partially Blind, Placebo-controlled, Proof-of-concept Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity as Measured by Brain MRI Scans in Patients With Relapsing-remitting Multiple Sclerosis|Completed||Phase 2|8|Actual|Novartis||2|||f||||t||||||||||2017-10-11 00:51:29.971638|2017-10-11 00:51:29.971638
NCT02038036|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-10-03|||March 25, 2014|Actual|2014-03-25|October 2017|2017-10-01|April 20, 2020|Anticipated|2020-04-20|April 20, 2020|Anticipated|2020-04-20||Interventional|RESPONSE-2||Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.|Randomized, Open Label, Multicenter Phase IIIb Study Evaluating the Efficacy and Safety of Ruxolitinib Versus Best Available Therapy in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant (Response 2)|Active, not recruiting||Phase 3|149|Actual|Novartis||2|||f||||f||||||||||2017-10-11 00:51:30.076818|2017-10-11 00:51:30.076818
NCT02038023|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-01-04|||July 2013||2013-07-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women|Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Moderate to Severe Iron Deficient Anemia of Pregnancy in Women Intolerant of or Responsive to Oral Iron.|Completed||Phase 2|60|Actual|Auerbach Hematology Oncology Associates P C||1|||f||||f||||||||||2017-10-11 00:51:30.265715|2017-10-11 00:51:30.265715
NCT02038010|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-04-13|||February 2014||2014-02-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|November 2017|Anticipated|2017-11-01||Interventional|||BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx|A Phase I Study of BYL719 and Trastuzumab-MCC-DM1 in HER2-Positive Metastatic Breast Cancer Patients With Progression on Prior Trastuzumab and Taxane-Based Therapy|Active, not recruiting||Phase 1|17|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 00:51:30.355106|2017-10-11 00:51:30.355106
NCT02037997|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-02-22|||December 2013||2013-12-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC|Chemotherapy in Combination With Erlotinib, or Sequential Chemotherapy for Erlotinib for Treatment, EGFR - TKI Resistance of EGFR Mutations in Patients With NSCLC Randomized Controlled Phase II Clinical Study|Recruiting||Phase 2|80|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 00:51:30.467453|2017-10-11 00:51:30.467453
NCT02037984|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-07-26|||January 2014||2014-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)|A Phase I-II, Randomized, Double-Blind, Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Adults and Infants|Completed||Phase 1/Phase 2|341|Actual|Merck Sharp & Dohme Corp.||8|||f||||t||||||||||2017-10-11 00:51:30.739456|2017-10-11 00:51:30.739456
NCT02037971|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2014-01-14|||February 2013||2013-02-01|May 2013|2013-05-01|March 2015|Anticipated|2015-03-01|February 2014|Anticipated|2014-02-01||Interventional|EFEXO||Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus.|Effectiveness of Exercise Training in Improving Sleep in Patients With Systemic Lupus Erythematosus: A Controlled Randomized Trial.|Unknown status|Recruiting|N/A|20|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 00:51:30.829547|2017-10-11 00:51:30.829547
NCT02037958|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-15|||April 2011||2011-04-01|January 2014|2014-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic Cholecystectomy|The Laryngeal Mask Airway Supreme (TM) is an Effective Alternative to Laryngoscope-guided Tracheal Intubation for Patients Undergoing Elective Laparoscopic Cholecystectomy-- A Prospective Randomized Controlled Trial|Completed||N/A|76|Actual|Changi General Hospital||2|||f||||f||||||||||2017-10-11 00:51:30.926896|2017-10-11 00:51:30.926896
NCT02037945|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-04-04|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases|18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases|Active, not recruiting||N/A|19|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:51:31.037836|2017-10-11 00:51:31.037836
NCT02037932|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-11-05|||January 2014||2014-01-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|GELATIN||Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry|Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry|Withdrawn||Phase 4|0|Actual|Medical College of Wisconsin||1||Investigator left institution|f||||f||||||||||2017-10-11 00:51:31.122888|2017-10-11 00:51:31.122888
NCT02037919|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-07-19|||June 2014||2014-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NAPA||Nexplanon Application Post-Abortion|Immediate vs. Delayed Insertion of Nexplanon After Termination of Pregnancy Over 14-weeks Gestation (NAPA)|Active, not recruiting||N/A|150|Actual|Family Planning Associates Medical Group, LTD||2|||f||||f||||||||||2017-10-11 00:51:31.220864|2017-10-11 00:51:31.220864
NCT02037906|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-03-30|||January 2014||2014-01-01|January 2014|2014-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SWL||Escalating, Constant and Reduction Energy Output in SWL for Renal Stones|Comparison of Escalating, Constant and Reduction Energy Output in SWL for Renal Stones: Multi-arm Prospective Randomized Study.|Completed||N/A|150|Actual|Princess Al-Johara Al-Ibrahim Cancer Research Center||3|||f||||f||||||||Yes|Results will be published in per-reviewed journal|2017-10-11 00:51:31.313014|2017-10-11 00:51:31.313014
NCT02037893|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-11-19|||November 2013||2013-11-01|January 2014|2014-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media|A Four-arm, Randomized, Double-blind, Active and Placebo Controlled Study to Determine the Safety and Efficacy of a Combination Antupyrine and Benzocaine Otic Solution Compared With Antipyrine Otic Solution Alone, Benzocaine Otic Solution Alone and to Placebo Otic Solution to Relieve Pain Symptoms in Children With Acute Otitis Media.|Completed||Phase 2|112|Actual|Pernix Theraputics LLC||4|||f||||f||||||||||2017-10-11 00:51:31.413816|2017-10-11 00:51:31.413816
NCT02037880|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-11-12|||February 2014||2014-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Natural History Studies of Mucopolysaccharidosis III|Natural History Studies of Mucopolysaccharidosis III|Completed||N/A|25|Actual|Nationwide Children's Hospital|||1||f||||t||||||Samples With DNA|"     Biobanking will include:        1. Serum/Plasma        2. Cerebrospinal fluid   "|||2017-10-11 00:51:31.535173|2017-10-11 00:51:31.535173
NCT02021669|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-03-01|||April 2014||2014-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|Omega-3(2)||Omega-3 for Depression and Other Cardiac Risk Factors - 2|Omega-3 for Depression and Other Cardiac Risk Factors-2|Recruiting||Phase 2|150|Anticipated|Washington University School of Medicine||2|||f||||t||||||||No||2017-10-11 00:55:11.577899|2017-10-11 00:55:11.577899
NCT02037867|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-07-31|||May 2013||2013-05-01|July 2015|2015-07-01|May 2033|Anticipated|2033-05-01|May 2033|Anticipated|2033-05-01|20 Years|Observational [Patient Registry]|||Nottingham Community Liver Biomarkers Cohort|The Stratification of Liver Disease in the Community Using Fibrosis Biomarkers|Recruiting||N/A|2000|Anticipated|University of Nottingham|||1||f||||f||||||Samples With DNA|"     Serum, whole blood and urine samples stored a -80 degrees Celsius.   "|||2017-10-11 00:51:31.713351|2017-10-11 00:51:31.713351
NCT02037854|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-10-29|||January 2014||2014-01-01|October 2014|2014-10-01||||June 2014|Actual|2014-06-01||Interventional|||PEP-1324: Glycemic Response Testing||Unknown status|Recruiting|N/A|12|Anticipated|PepsiCo Global R&D||2|||f||||||||||||||2017-10-11 00:51:31.839518|2017-10-11 00:51:31.839518
NCT02037841|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-01-29|||March 2012||2012-03-01|January 2014|2014-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|NAP||The Impact of Implementing a Nursing-driven Clinical Pathway for Inpatient Management of Children With Asthma|The Impact of Implementing a Nursing-driven Clinical Pathway for Inpatient Management of Children Admitted to a Tertiary Care Centre With a Diagnosis of Asthma: A Randomized Controlled Trial|Completed||N/A|113|Actual|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-11 00:51:31.924474|2017-10-11 00:51:31.924474
NCT02037828|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-25|2017-08-02|||June 2014||2014-06-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|||Exhaled Breathing Condensate (EBC) Features and Lung Function Decline in Chinese Adults|The Screening and Confirmation of Protein Markers Which Can Predict the Decline of Lung Function of Chinese Adults in EBC (Exhaled Breathing Condensate )|Recruiting||N/A|2440|Anticipated|Peking University First Hospital|||4||f||||t|f|f||||Samples With DNA|"     1. EBC        2. Peripheral blood   "|||2017-10-11 00:51:32.014348|2017-10-11 00:51:32.014348
NCT02037815|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-07-29|||January 2014||2014-01-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After Craniotomy|Correlation of Measured and Calculated Serum Osmolality During Mannitol or Hypertonic Saline Infusion in Patients After Craniotomy|Completed||Phase 4|35|Actual|Capital Medical University||2|||f||||||||||||||2017-10-11 00:51:32.110769|2017-10-11 00:51:32.110769
NCT02037802|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-10-02|||March 2014||2014-03-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Caudal Epidural Catheterization in Pediatric Renal Transplant: Effect on Hemodynamics and Pain After Surgery|Caudal Extradural Catheterization in Pediatric Renal Transplant: Effect on Perioperative Hemodynamics and Pain Scoring.|Completed||N/A|60|Actual|Cairo University||2|||f||||f||||||||||2017-10-11 00:51:32.205201|2017-10-11 00:51:32.205201
NCT02037789|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-09-23|||March 2014||2014-03-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||"A Retrospective Study to Identify New Omics Biomarkers of Chronic/Persistent Low Back Pain"|"A Retrospective Study to Identify New Omics Biomarkers of Chronic/Persistent Low Back Pain"|Completed||N/A|||University of Parma|||1||f||||t||||||Samples With DNA|"     Whole blood samples will be collected from cases (patients already diagnosed with     persistent/chronic low back pain) and from controls (healthy subjects).   "|||2017-10-11 00:51:32.311562|2017-10-11 00:51:32.311562
NCT02037776|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-07-26|2017-02-16||April 3, 2014|Actual|2014-04-03|July 2017|2017-07-01|March 25, 2016|Actual|2016-03-25|March 25, 2016|Actual|2016-03-25||Interventional|||The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia|Double-blind Trial With Rikkunshito Versus Placebo on Efficacy and Safety in Patients With Functional Dyspepsia: Multi-center Study (DREAM Study)|Completed||Phase 4|128|Actual|Osaka City University||2|||f||||t||||||||||2017-10-11 00:51:32.426459|2017-10-11 00:51:32.426459
NCT02037763|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-09-22|||December 2014||2014-12-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain|A Prospective Controlled Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain|Recruiting||N/A|5000|Anticipated|University of Parma|||1||f||||t||||||Samples With DNA|"     Whole blood samples will be collected at recruitment in all enrolled patients. Blood samples     will be collected also at the 3 months and 6 months follow up visits in patients who will     develop CLBP after the episode of acute LBP.   "|||2017-10-11 00:51:33.075809|2017-10-11 00:51:33.075809
NCT02037750|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-12-10|||December 2012||2012-12-01|December 2015|2015-12-01||||December 2017|Anticipated|2017-12-01||Interventional|LINKS||Foster Teens' Risk During Transition|Foster Teens' Risk During Transition: Preventing Drug Use, HIV, & School Problems|Recruiting||Phase 2|200|Anticipated|Oregon Social Learning Center||2|||f||||f||||||||||2017-10-11 00:51:33.182883|2017-10-11 00:51:33.182883
NCT02037724|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-14|||March 2014||2014-03-01|January 2014|2014-01-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|FISRA||Fermented Iron-rich Supplement in Reducing Anemia|Fermented Iron-rich Supplement in Reducing Anemia|Unknown status|Not yet recruiting|Phase 2|120|Anticipated|University of Ghana||4|||f||||f||||||||||2017-10-11 00:51:33.354552|2017-10-11 00:51:33.354552
NCT02037711|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-08-03|||May 2013||2013-05-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Intraperitoneal Application of Levobupivacaine During Laparoscopic Surgery in Kids.|Intraperitoneal Instillation of Levobupivacaine in Laparoscopic Pediatric Procedures|Completed||Phase 4|40|Actual|Cairo University||2|||f||||f||||||||||2017-10-11 00:51:33.439934|2017-10-11 00:51:33.439934
NCT02037698|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-01-07|||January 2014||2014-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Role of CT Scan for the Successful Recanalization of Chronic Total Occlusion; a Randomized Comparison Between 3D CT-guided PCI vs. Conventional Treatment (CT-CTO Trial)||Unknown status|Recruiting|Phase 4|404|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 00:51:33.512434|2017-10-11 00:51:33.512434
NCT02037685|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-01-21|||June 2010||2010-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Improving Adherence to Statins Among Minority Populations|Improving Adherence to Cholesterol Lowering Medications Among Minority Populations in Florida: A Randomized Trial|Completed||N/A|779|Actual|University of Miami||2|||f||||f||||||||No|The IRB application did not include the use of the data for future research|2017-10-11 00:51:33.598344|2017-10-11 00:51:33.598344
NCT02037672|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-21|||September 2013||2013-09-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome|Combined Treatment With PDE-4 Inhibitor Roflumilast and Metformin Leads to Significant Weight Loss in Obese Women With Polycystic Ovary Syndrome|Completed||Phase 4|36|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-11 00:51:33.68241|2017-10-11 00:51:33.68241
NCT02037659|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-07-02|||December 2012||2012-12-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01|36 Months|Observational [Patient Registry]|||Dermabond Treatment for Gastric Variceal Bleeding|Endoscopic Ultrasound (EUS) Gastric Variceal Bleeding Database Repository|Recruiting||N/A|100|Anticipated|Indiana University|||1||f||||f||||||||||2017-10-11 00:51:33.772414|2017-10-11 00:51:33.772414
NCT02037646|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-15|||June 2012||2012-06-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Quantitative Versus Qualitative Fecal Immunochemical Tests (FIT) to Prioritize Urgency of Colonoscopy Referral|Evaluating the Effectiveness of Screening Strategies Using Quantitative Versus Qualitative Fecal Immunochemical Test (FIT) to Prioritize Urgency of Colonoscopy Referral - a Randomized Controlled Trial Protocol|Unknown status|Recruiting|N/A|700|Anticipated|University of Malaya||2|||f||||t||||||||||2017-10-11 00:51:33.849315|2017-10-11 00:51:33.849315
NCT02037633|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2014-01-15|||July 2012||2012-07-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Analgesia for Positioning Hip Fracture Patients for Spinal Anesthesia|Fascia Iliaca Compartment Block Versus Fentanyl for Positioning Patients With Hip Fractures for Central Nervous Blockade: a Randomized Trial.|Completed||N/A|41|Actual|Asklepieion Voulas General Hospital||2|||f||||f||||||||||2017-10-11 00:51:33.935482|2017-10-11 00:51:33.935482
NCT02037620|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-04-12|||January 2014||2014-01-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury|Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury|Recruiting||N/A|4|Anticipated|University of Louisville||1|||f||||f||||||||||2017-10-11 00:51:34.024902|2017-10-11 00:51:34.024902
NCT02037607|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-03-14|2017-03-14||September 2012||2012-09-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational||91 subjects received study procedures and were analyzed. 9 additional subjects were consented but withdrawn prior to completion of study procedures.|Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures|Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures|Completed||N/A|100|Actual|Indiana University|||1||f||||f||||||||||2017-10-11 00:51:34.266415|2017-10-11 00:51:34.266415
NCT02037594|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-06-13|||January 2014||2014-01-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|SPARK||Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting|Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting|Active, not recruiting||N/A|445|Anticipated|Hunter College of City University of New York||4|||f||||t||||||||||2017-10-11 00:51:34.426772|2017-10-11 00:51:34.426772
NCT02037581|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-08-07|||June 2011||2011-06-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|ICEP||Integrated Care Including Assertive Community Treatment in Early Psychosis|Integrated Care in Early Psychosis (ICEP Study): a 12-month Quasi Experimental Study With Historic Control Group|Completed||N/A|120|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-11 00:51:34.519245|2017-10-11 00:51:34.519245
NCT02037555|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-02-01|||March 2014||2014-03-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass|A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery With Cardiopulmonary Bypass|Recruiting||Phase 2|404|Anticipated|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 00:51:34.689105|2017-10-11 00:51:34.689105
NCT02037542|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-07-20|||September 2013||2013-09-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer|A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer|Completed||N/A|100|Actual|Baptist Health South Florida||1|||f||||f||||||||Undecided||2017-10-11 00:51:34.835589|2017-10-11 00:51:34.835589
NCT02037529|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-07-17|||March 2014||2014-03-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer||Recruiting||Phase 3|910|Anticipated|Academic and Community Cancer Research United||2|||f||||t||||||||||2017-10-11 00:51:34.927031|2017-10-11 00:51:34.927031
NCT02037516|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-02-04|||January 2014||2014-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Does Residual Muscular Weakness Lead to an Increase in Respiratory Complications in Bariatric Patients?|Does Residual Muscular Weakness Lead to an Increase in Respiratory Complications in Bariatric Patients?|Completed||N/A|330|Actual|Coastal Anesthesiology Consultants||2|||f||||f||||||||||2017-10-11 00:51:35.165532|2017-10-11 00:51:35.165532
NCT02029248|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-07-18|||April 2012||2012-04-01|July 2017|2017-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|MARQOL||National Study on the Quality of Life of Patients With Anorectal Malformation|National Study on the Quality of Life of Patients With Anorectal Malformation (MARQOL)|Completed||N/A|762|Actual|Nantes University Hospital|||4||f||||f||||||||||2017-10-11 00:53:32.734813|2017-10-11 00:53:32.734813
NCT02037503|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-15|||January 2014||2014-01-01|January 2014|2014-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Oral Ketamine for Suicidal Ideation|Effect of Oral Ketamine Treatment on Suicidal Ideation and Drug Resistant Major Depression, a Clinical and fMRI Study|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|Tel-Aviv Sourasky Medical Center||4|||f||||f||||||||||2017-10-11 00:51:35.25648|2017-10-11 00:51:35.25648
NCT02037490|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-07-05|||March 2014||2014-03-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Grow2Gether Pilot Study|Grow2Gether: Pilot Trial of a Peer-Based Social Media Intervention to Promote Healthy Growth During Infancy|Completed||N/A|172|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 00:51:35.341001|2017-10-11 00:51:35.341001
NCT02037477|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-08-22|2015-03-27||January 2014||2014-01-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)|Phase 3 Open-Label Crossover Pharmacodynamic Study to Evaluate the Acid-inhibitory Effect of TAK-438 20 mg With Esomeprazole 20 mg or Rabeprazole Sodium 10 mg in Healthy Adult Male Subjects|Completed||Phase 3|20|Actual|Takeda||4|||f||||f||||||||||2017-10-11 00:51:35.437375|2017-10-11 00:51:35.437375
NCT02037464|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-14|||January 2014||2014-01-01|January 2014|2014-01-01|January 2018|Anticipated|2018-01-01|June 2016|Anticipated|2016-06-01||Interventional|CAPSAICIN||CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer|CAPSAICIN Trial: A Prospective Study of Capsaicin in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance or Radical Prostatectomy|Not yet recruiting||Phase 2|100|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 00:51:37.680183|2017-10-11 00:51:37.680183
NCT02037451|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-01-14|||August 2013||2013-08-01|January 2014|2014-01-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||The Effects of Auditory Cueing on Rhythmic Movement and Cortical Excitability in Patients With Parkinson's Disease||Unknown status|Recruiting|N/A|38|Anticipated|Chang Gung University||2|||f||||t||||||||||2017-10-11 00:51:37.820583|2017-10-11 00:51:37.820583
NCT02037425|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-07-11|2015-12-11||April 2014||2014-04-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||44 subjects screened, 3 subjects failed inclusion/exclusion at screening, 9 subjects did not meet criteria after baseline. 32 subjects randomized to treatment. While 32 subjects randomized and were used for reporting demographics, two subjects didn't complete any outcome measures, therefore only 30 participants were used for endpoint analysis.|Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine|Exploratory Study of the Natural History, Clinical Outcomes, and Neuronal Endplate Changes in Subjects Reporting Short Duration vs. Long Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine|Completed||Phase 4|44|Actual|Cady, Roger, M.D.||1|||f||||f||||||||||2017-10-11 00:51:38.06403|2017-10-11 00:51:38.06403
NCT02037412|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-01-14|||February 2013||2013-02-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome||Unknown status|Recruiting|Phase 4|444|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 00:51:38.909165|2017-10-11 00:51:38.909165
NCT02037399|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-01-14|||July 2013||2013-07-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection||Unknown status|Recruiting|N/A|50|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 00:51:39.000096|2017-10-11 00:51:39.000096
NCT02037386|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-01-07|||February 2014||2014-02-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||H-Side Branch Stent, A New Stent for the Treatment of True Bifurcation Lesions||Withdrawn||Phase 1|0|Actual|Yonsei University||1||problem with balloon catheter|f||||t||||||||||2017-10-11 00:51:39.084407|2017-10-11 00:51:39.084407
NCT02037373|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-09-29|||August 2015||2015-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Post-Marketing Requirement to Evaluate the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation With Special Emphasis on Hyperfibrinolysis.|Post-Marketing Requirement Study to Evaluate the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation With Special Emphasis on Hyperfibrinolysis.|Recruiting||N/A|300|Anticipated|Octapharma|||2||f||||t||||||||||2017-10-11 00:51:39.145334|2017-10-11 00:51:39.145334
NCT02037360|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-02-09|||August 2015||2015-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mobile Mindfulness Training for Smoking Cessation||Active, not recruiting||N/A|1251|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-11 00:51:39.226535|2017-10-11 00:51:39.226535
NCT02037347|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-10-06|2016-10-06||October 2010||2010-10-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||73-year-old male.|Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis|Palifermin Treatment of Toxic Epidermal Necrolysis|Terminated||Phase 1/Phase 2|1|Actual|Yale University||1||Low enrollment numbers precluded completion of the study during a reasonable amount of time.|f||||f||||||||||2017-10-11 00:51:39.309785|2017-10-11 00:51:39.309785
NCT02037334|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-04-11|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Observational|Softcervix||Biomechanics Based Prediction of Preterm Delivery|Biomechanics Based Prediction of Preterm Delivery|Recruiting||N/A|770|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-11 00:51:39.458353|2017-10-11 00:51:39.458353
NCT02037321|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-05-26|||May 2013||2013-05-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Observational|||Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic Risk|Effect of Substituting Vegetable Protein for Animal-Protein on Cardiometabolic Risk: A Series of Systematic Reviews and Meta-Analyses of Controlled Feeding Trials to Provide Evidence-Based Guidance for Nutrition Guidelines Development|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-11 00:51:39.56814|2017-10-11 00:51:39.56814
NCT02037295|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-10-04|||January 8, 2014||2014-01-08|June 12, 2017|2017-06-12|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans|Investigation of the Gut Microbiota in Regulating Nutrient Absorption in Humans|Recruiting||Phase 1|70|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:51:39.713001|2017-10-11 00:51:39.713001
NCT02037282|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-06-30|||January 3, 2014||2014-01-03|December 2, 2014|2014-12-02|December 2, 2014|Actual|2014-12-02|December 2, 2014|Actual|2014-12-02||Interventional|||A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects|A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:51:39.785194|2017-10-11 00:51:39.785194
NCT02037269|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-08-09|||June 2014||2014-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|||LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens|A Pilot Study to Evaluate Cerenkov Luminescence Imaging for Measuring Margin and Lymph Node Status in Breast Cancer Surgical Specimens|Completed||N/A|25|Actual|Lightpoint Medical Limited|||1||f||||f||||||||No||2017-10-11 00:51:39.868844|2017-10-11 00:51:39.868844
NCT02037256|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-05-23|||July 2011||2011-07-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant|A Pilot Study of Peripheral Blood Hematopoietic Stem Cell Mobilization With the Combination of Bortezomib and G-CSF in Multiple Myeloma and Non-Hodgkin's Lymphoma Patients|Active, not recruiting||N/A|20|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 00:51:39.950124|2017-10-11 00:51:39.950124
NCT02037243|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2015-06-11|||August 2011||2011-08-01|January 2014|2014-01-01|June 2014|Actual|2014-06-01|June 2012|Actual|2012-06-01||Interventional|||Disgust and Shame Based Safe Water and Handwashing Promotion|Testing the Use of Disgust and Shame Messages in Safe Water and Handwashing Promotion in Urban Dhaka|Completed||Phase 1|420|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||t||||||||||2017-10-11 00:51:40.080053|2017-10-11 00:51:40.080053
NCT02037230|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-09-28|||January 2014||2014-01-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas|Phase 1 DOSE ESCALATION TRIAL OF THE Wee1 INHIBITOR AZD1775, IN COMBINATION WITH GEMCITABINE (+RADIATION) FOR PATIENTS WITH UNRESECTABLE ADENOCARCINOMA OF THE PANCREAS|Recruiting||Phase 1/Phase 2|36|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 00:51:40.182036|2017-10-11 00:51:40.182036
NCT02037217|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-03-07|||February 2011||2011-02-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||ExAblate Transcranial MR Guided Focused Ultrasound in the Treatment of Essential Tremor|A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Essential Tremor|Completed||Phase 1|10|Anticipated|InSightec||1|||f||||t||||||||||2017-10-11 00:51:40.438415|2017-10-11 00:51:40.438415
NCT02037191|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-06-13|||February 2014||2014-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MP3||The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade|RANDOMIZED DOUBLE-BLIND STUDY MULTICENTRIQUE TESTING THE EFFICIENCY OF the METHOTREXATE AT PATIENTS AFFECTED BY GRAVE PELADE (METHOTREXATE VERSUS PLACEBO WITH SECONDARY TREATMENT BY METHOTREXATE and PREDNISONE)|Recruiting||Phase 3|90|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 00:51:40.62156|2017-10-11 00:51:40.62156
NCT02037178|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-08-02|||October 2014||2014-10-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|DAG||Screening for Arteriopathy in General Medicine: a Preliminary Feasibility Study|Screening for Arteriopathy in General Medicine: a Preliminary Feasibility Study|Recruiting||N/A|300|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 00:51:40.761311|2017-10-11 00:51:40.761311
NCT02037165|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2014-04-30|||January 2014||2014-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers|Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB (Ultraviolet)-Irradiated Skin in Healthy Male Volunteers (a Single-blinded, Randomised, Placebo-controlled, Single-dose, Five-way Crossover Study)|Completed||Phase 1|25|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 00:51:40.8959|2017-10-11 00:51:40.8959
NCT02037152|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-10-23|||January 2014||2014-01-01|October 2014|2014-10-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Smartphone-based Mindfulness Training for Chronic Pain|Smartphone-based Mindfulness Training for Chronic Pain: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|University of California, San Francisco||2||Problems with the software intervention, PI finished training and left UCSF.|f||||f||||||||||2017-10-11 00:51:41.026495|2017-10-11 00:51:41.026495
NCT02037139|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-05-05|||July 2013||2013-07-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Hearing Health Care Service Access and Use|Primary Care Intervention Promoting Hearing Health Care Service Access and Use|Recruiting||N/A|204|Anticipated|University of California, San Francisco||3|||f||||f||||||||Undecided||2017-10-11 00:51:41.13075|2017-10-11 00:51:41.13075
NCT02037126|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-01-05|||May 2015||2015-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Psilocybin-facilitated Treatment for Cocaine Use|Psilocybin-facilitated Treatment for Cocaine Use: A Pilot Study|Recruiting||Phase 2|40|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 00:51:41.260462|2017-10-11 00:51:41.260462
NCT02037113|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-06-27|||January 2014||2014-01-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|IVUS-PAD||Outcomes of Femoro-popliteal Disease After Stent Deployment Under Intravascular Ultrasound Guidance|Outcomes of Femoro-popliteal Disease After Stent Deployment Under Intravascular Ultrasound Guidance (CRI14-007)|Active, not recruiting||N/A|8|Actual|Texas Tech University Health Sciences Center|||1||f||||t||||||||No||2017-10-11 00:51:41.389117|2017-10-11 00:51:41.389117
NCT02037100|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-01-14|||June 2007||2007-06-01|January 2014|2014-01-01||||September 2014|Anticipated|2014-09-01||Observational|||Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children|Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children|Unknown status|Recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||||||||||||2017-10-11 00:51:41.483704|2017-10-11 00:51:41.483704
NCT02037087|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-04-06|||September 2013||2013-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|SMS||The Impact of Prenatal Short Messages (SMS) on Maternal and Newborn Health|The Impact of Prenatal Short Messages on Maternal and Newborn Health|Completed||N/A|4467|Actual|Harvard School of Public Health||4|||f||||t||||||||||2017-10-11 00:51:41.553891|2017-10-11 00:51:41.553891
NCT02037074|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2015-01-09|||June 2014||2014-06-01|January 2015|2015-01-01||||December 2014|Actual|2014-12-01||Interventional|||Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics|A Double-Blind, Escalating Dose Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Repeat Doses of EVP-6308 or Placebo in Subjects With Schizophrenia on a Stable Antipsychotic Regimen|Completed||Phase 1|40|Actual|FORUM Pharmaceuticals Inc||4|||f||||||||||||||2017-10-11 00:51:41.662016|2017-10-11 00:51:41.662016
NCT02037048|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2017-08-03|||January 14, 2014|Actual|2014-01-14|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma|A Phase II Trial of Modified FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Response Based Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Adenocarcinoma of the Esophagus, Gastro-esophageal Junction, and Gastric Cardia|Recruiting||Phase 2|66|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|t|f|||f|||||2017-10-11 00:51:41.868736|2017-10-11 00:51:41.868736
NCT02037035|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-01-05|||July 2013||2013-07-01|January 2017|2017-01-01||||July 2018|Anticipated|2018-07-01||Interventional|||Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling|Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling|Recruiting||Early Phase 1|36|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 00:51:42.032288|2017-10-11 00:51:42.032288
NCT02037022|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-04-24|||November 2013||2013-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRT-P||Pivotal Response Treatment Package for Young Children With Autism|Pivotal Response Treatment Package for Young Children With Autism|Active, not recruiting||N/A|48|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 00:51:42.144879|2017-10-11 00:51:42.144879
NCT02037009|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-08-05|||November 2013||2013-11-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|SACHS||Centralised Anesthesic Monitoring in the Surgery of the Ocular Anterior Segment: Non Inferiority Study|Centralised Anesthesic Monitoring in the Surgery of the Ocular Anterior Segment: Non Inferiority Study|Completed||N/A|900|Actual|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||t||||||||||2017-10-11 00:51:42.256089|2017-10-11 00:51:42.256089
NCT02036996|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-08-01|||January 2014||2014-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of EarlySense; a Contact-less Heart and Respiration Rate Monitoring in Sleep Lap Examined|Official Title Evaluation of EarlySense; a Contact-less Heart and Respiration Rate Monitoring in Sleep Lap Examined Evaluation of EarlySense; a Contact-less Heart and Respiration Rate Monitoring in Sleep Lap Examined|Recruiting||N/A|100|Anticipated|EarlySense Ltd.|||1||f||||t||||||||||2017-10-11 00:51:42.37188|2017-10-11 00:51:42.37188
NCT02036983|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-08-05|||November 2013||2013-11-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of a Bilateral TAP Block and Preperitoneal Instillation of Local Anesthetic for a Total Extraperitoneal (TEP) Repair|Comparison of an Ultrasound Guided Bilateral Transversus Abdominis Plane Block With Dexamethasone and Preperitoneal Instillation of Local Anesthetic With Dexamethasone to a Standard Anesthetic Technique for Analgesic Efficacy and Patient Satisfaction Following a Total Extraperitoneal Bilateral Inguinal Hernia Repair: A Prospective Randomized Single Blinded Study|Completed||Phase 3|75|Actual|Indiana University||3|||f||||f||||||||||2017-10-11 00:51:42.443919|2017-10-11 00:51:42.443919
NCT02036970|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-08-03|||May 2014||2014-05-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT|A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension|Recruiting||Phase 2|208|Anticipated|Reata Pharmaceuticals, Inc.||5|||f||||t||||||||||2017-10-11 00:51:42.573129|2017-10-11 00:51:42.573129
NCT02036957|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-08-01|||February 2014||2014-02-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|B-DUOL||MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY|EFFECTIVENESS OF MARY D'UOL REPAIR BALM FOR PREVENTING AND / OR REDUCING TOXICITY SKIN IN PATIENTS WITH CANCER AND TREATMENT WITH ANY Antineoplastic Agent. RANDOM CLINICAL TRIAL.|Recruiting||Phase 1/Phase 2|86|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-11 00:51:42.955426|2017-10-11 00:51:42.955426
NCT02036749|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-10-06|||January 2014||2014-01-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Ultrasound-guided Quadratus Lumborum Block for Postoperative Pain Relief After Cesarean Delivery|Ultrasound-guided Quadratus Lumborum Block for Postoperative Pain Relief After Cesarean Delivery|Completed||N/A|40|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 00:51:45.434477|2017-10-11 00:51:45.434477
NCT02036944|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-04-01|||March 2014||2014-03-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting|Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting|Terminated||N/A|13|Actual|Providence Medical Research Center|||1|Study stopped d/t lack of enrollment and no compelling data.|f||||f||||||Samples Without DNA|"     The serum remaining from 10 mL of blood will be aliquoted and frozen at -70 degrees. If     future funding allows, these samples will be tested for autoimmune and malabsorption markers.   "|No||2017-10-11 00:51:43.0581|2017-10-11 00:51:43.0581
NCT02036931|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-14|2016-01-06|||October 2013||2013-10-01|January 2016|2016-01-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01||Observational|G7 Early Eval||A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System||Active, not recruiting||Phase 4|315|Anticipated|Zimmer Biomet|||3||f||||f||||||||||2017-10-11 00:51:43.135294|2017-10-11 00:51:43.135294
NCT02036918|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-05-16|||March 2014||2014-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer|Evaluation of Lymph Node Metastases in Men Undergoing Treatment With Sipuleucel-T for Metastatic Castrate-resistant Prostate Cancer|Recruiting||Phase 1|20|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 00:51:43.452733|2017-10-11 00:51:43.452733
NCT02036905|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-01-25|||July 2013||2013-07-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|June 2014|Actual|2014-06-01||Interventional|||Cervical and Upper Thoracic Mobilization and Manipulation for Mechanical Neck Pain|Comparing the Early Use of Cervical/Upper Thoracic Mobilization and Manipulation for Individuals With Mechanical Neck Pain.|Completed||N/A|20|Actual|Youngstown State University||2|||f||||f||||||||||2017-10-11 00:51:43.585052|2017-10-11 00:51:43.585052
NCT02036892|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-13|||February 2012||2012-02-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Interventional|||Electronically Connected Health Coaching in Type 2 Diabetes|Electronically Connected Health Coaching in Improving Type 2 Diabetes Self Management - Phase III Trial|Unknown status|Recruiting|Phase 3|115|Anticipated|York University||2|||f||||f||||||||||2017-10-11 00:51:43.70355|2017-10-11 00:51:43.70355
NCT02036879|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2015-01-06|||December 2013||2013-12-01|January 2015|2015-01-01||||December 2018|Anticipated|2018-12-01||Interventional|||Gender Disparity and Hormones in Cystic Fibrosis|Gender Disparity and Hormones in Cystic Fibrosis|Recruiting||N/A|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 00:51:43.799548|2017-10-11 00:51:43.799548
NCT02036866|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-12-10|||November 2013||2013-11-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Corticospinal Excitability and Rehab in Knee Osteoarthritis|Corticospinal Excitability and Rehab in Knee Osteoarthritis|Completed||N/A|61|Actual|Creighton University||3|||f||||f||||||||||2017-10-11 00:51:43.897264|2017-10-11 00:51:43.897264
NCT02036853|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-08-08|||January 2014||2014-01-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|GLUT1DS||An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome|An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome (GLUT1 DS)|Recruiting||Phase 2|50|Anticipated|Cook Children's Health Care System||2|||f||||t||||||||||2017-10-11 00:51:43.994603|2017-10-11 00:51:43.994603
NCT02036840|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-04-20|2015-02-12||January 2013||2013-01-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Perioperative Antibiotic Choices for Surgical Prophylaxis in Penicillin-allergic Pediatric Patients||Completed||N/A|513|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:51:44.110944|2017-10-11 00:51:44.110944
NCT02036827|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2015-02-04|||December 2013||2013-12-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of Deep Neuromuscular Blockade on Postoperative Shoulder Tip Pain After Laparoscopic Cholecystectomy|The Effect of Deep Neuromuscular Blockade on Postoperative Shoulder Tip Pain After Laparoscopic Cholecystectomy|Completed||Phase 4|108|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 00:51:44.268628|2017-10-11 00:51:44.268628
NCT02036814|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2014-01-14|||March 2007||2007-03-01|January 2014|2014-01-01|February 2011|Actual|2011-02-01|March 2008|Actual|2008-03-01||Interventional|PHPTCHP||Program for Health Promotion to Improve Therapeutic Compliance in Hypertensive Patiente|A PROGRAM OF HEALTH EDUCATION PROMOTION BY NURSING CAN IMPROVE BLOOD PRESSURE CONTROL AND QUALITY OF LIFE IN HYPERTENSIVE PATIENTS?|Completed||N/A|21|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:51:44.368044|2017-10-11 00:51:44.368044
NCT02036801|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-03-18|||June 2009||2009-06-01|March 2015|2015-03-01||||December 2014|Actual|2014-12-01||Observational|||The Specific Elastance in ARDS Patients: a Pediatric Study|The Specific Elastance in ARDS Patients. Connections Between Volutrauma and Barotrauma - A Pediatric Study|Completed||N/A|40|Anticipated|Policlinico Hospital|||2||f||||t||||||||||2017-10-11 00:51:44.443283|2017-10-11 00:51:44.443283
NCT02036788|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-03-29|||December 2013||2013-12-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Observational|||Comparison of Two Tests in the Assessment of the Accuracy of Esophageal Pressure Variations Measurement During Mechanical Ventilation||Completed||N/A|20|Actual|Policlinico Hospital|||2||f||||t||||||||||2017-10-11 00:51:44.518879|2017-10-11 00:51:44.518879
NCT02036775|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-05-12|2015-04-17||March 2014||2014-03-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Treated set which included all subjects who had been dispensed study medication and were documented to have taken at least one dose of study medication.|Pharmacokinetics and Bioavailability Study of Lasolvan Hard Capsules and Effervescent Tablets in Healthy Volunteers|An Open-label, Randomised, Multiple-dose, Three-period Crossover Study in Healthy Male and Female Volunteers to Characterise Pharmacokinetics and Assess the Relative Bioavailability of Two New Oral Formulations of Ambroxol Hydrochloride as Lasolvan® Prolonged-release Hard Capsules 75 mg and Lasolvan® Effervescent Tablets 60 mg Compared to Lasolvan® Tablets 30 mg.|Completed||Phase 1|24|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 00:51:44.616055|2017-10-11 00:51:44.616055
NCT02036762|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-01-13|||November 2011||2011-11-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||STRETCH OF RESPIRATORY MUSCLES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE|EFFECTS OF RESPIRATORY MUSCLE STRETCH ON THORACOABDOMINAL MECHANIC, FUNCTIONAL CAPACITY, PSYCHOLOGICAL AND SOCIAL ASPECTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE|Completed||Phase 2/Phase 3|24|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 00:51:45.306046|2017-10-11 00:51:45.306046
NCT02036736|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-12-19|||April 2013||2013-04-01|March 2013|2013-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Cognides||Evaluating the Influence of the Strategy Intraoperative Anesthetic (Desflurane Versus Propofol) on Cognitive and Psychomotor Functions in Output Post Interventional Room Monitoring - COGNIDES|Randomized Study Evaluating the Influence of the Strategy Intraoperative Anesthetic (Desflurane Versus Propofol) on Cognitive and Psychomotor Functions in Output Post Interventional Room Monitoring|Completed||Phase 2|60|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:51:45.511548|2017-10-11 00:51:45.511548
NCT02036723|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2016-03-30||||||March 2016|2016-03-01||||March 2016|Anticipated|2016-03-01||Interventional|GALATIR||Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration|Multicentre Double Blind Randomized Clinical Study Evaluating The Efficacy and Safety of BCD-021 (CJSC BIOCAD, Russia) and Lucentis® (Novartis Pharmaceuticals Canada Inc.) in Patients With Neovascular Wet Age-related Macular Degeneration|Withdrawn||Phase 3|0|Actual|Biocad||2|||f||||||||||||||2017-10-11 00:51:45.60519|2017-10-11 00:51:45.60519
NCT02036710|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-03-26|||November 2011||2011-11-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Observational|||Location of GLP-1 Release|Location of Glucagon-Like Peptide (GLP)-1 Release|Completed||N/A|12|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-11 00:51:45.754454|2017-10-11 00:51:45.754454
NCT02036697|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-11-04|||November 2013||2013-11-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|June 2014|Actual|2014-06-01||Interventional|||Hemodynamic Effects of Low Dose Spinal Anesthesia for Cesarean Section|Hemodynamic Effects of Low Dose Spinal Anesthesia for Cesarean Section|Terminated||N/A|30|Actual|University of Manitoba||2||Difficulty with patient recruitment.|f||||f||||||||||2017-10-11 00:51:45.837899|2017-10-11 00:51:45.837899
NCT02036684|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2017-08-22|||November 2013||2013-11-01|August 2017|2017-08-01|May 17, 2016|Actual|2016-05-17|May 17, 2016|Actual|2016-05-17||Interventional|||Prehabilitation for Prostate Cancer Surgery|A Multicentre, Pilot Randomized Controlled Trial to Examine the Effects of Prehabilitation on Functional Outcomes After Radical Prostatectomy|Completed||Phase 1/Phase 2|86|Actual|University of Guelph-Humber||2|||f||||f||||||||||2017-10-11 00:51:45.940444|2017-10-11 00:51:45.940444
NCT02036671|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-02-15|||January 2014||2014-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Interventional|NEAT||Novel Endovascular Access Trial (NEAT)|Novel Endovascular Access Trial (NEAT): A Study of the FLEX System for Percutaneous AV Fistula Creation in Hemodialysis Patients|Completed||N/A|80|Actual|TVA Medical Inc.||1|||f||||t||||||||||2017-10-11 00:51:46.027871|2017-10-11 00:51:46.027871
NCT02036658|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-14|||March 2011||2011-03-01|January 2014|2014-01-01||||August 2014|Anticipated|2014-08-01||Interventional|||Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder|fMRI of Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder|Unknown status|Active, not recruiting|N/A|108|Actual|Stanford University||3|||f||||t||||||||||2017-10-11 00:51:46.134355|2017-10-11 00:51:46.134355
NCT02036632|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-06-01|||November 2012||2012-11-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Eye Patch Therapy for Central Serous Retinopathy (CSR)|Eye Patching as a Potential Treatment Modality for and a Possible Etiological Insight on Central Serous Retinopathy|Completed||Phase 1|12|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 00:51:46.302234|2017-10-11 00:51:46.302234
NCT02036619|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-10-24|||April 2014||2014-04-01|December 2013|2013-12-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|BEDIP-N||The Belgian Diabetes in Pregnancy Study: BEDIP-N Study|Prospective and Multi-centric Study on Diabetes During Pregnancy in Belgium|Recruiting||N/A|2563|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||Samples With DNA|"     For women at risk for an heritable form of diabetes, genetic testing for MODY will be     performed.   "|||2017-10-11 00:51:46.377446|2017-10-11 00:51:46.377446
NCT02036606|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-09-07|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Observational|||Racing and Crowded Thoughts in Mood Disorders|Psychopathological and Cognitive Mechanisms of Racing and Crowded Thoughts in Mood Disorders|Recruiting||N/A|220|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||||||2017-10-11 00:51:46.472815|2017-10-11 00:51:46.472815
NCT02036593|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-01-14|||July 2008||2008-07-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|CATCH-PATH||Community Approaches to Cardiovascular Health: Pathways to Heart Health|Community Approaches to Cardiovascular Health: Pathways to Heart Health (CATCH-PATH)|Completed||N/A|695|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 00:51:46.552235|2017-10-11 00:51:46.552235
NCT02036580|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-01-04|2016-10-21||January 2014||2014-01-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Safety population|D2212C00002 J-Phase II Study|A Phase 2, Multicenter, Double-Blind Within Cohort, Dose-escalation Study to Evaluate the Safety and Tolerability of Multiple Doses of CAT-354 (Tralokinumab) in Japanese Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 2|37|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 00:51:46.768364|2017-10-11 00:51:46.768364
NCT02036567|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Pain Measurement Device|Longitudinal Observational Pilot Study to Assess the Capabilities of an Experimental Device to Objectively Measure Pain.|Enrolling by invitation||N/A|120|Anticipated|Stanford University|||3||f||||t||||||||||2017-10-11 00:51:47.374571|2017-10-11 00:51:47.374571
NCT02036554|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-09-22|||March 2013||2013-03-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PROTECT||Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients|To Evaluate Prevention Effect Of Everolimus and Low-dose Tacrolimus in Comparison With Standard-dose Tacrolimus Therapy With Mycophenolic Acid on the New Onset Diabetes Mellitus After Transplantation in the Renal Allograft Recipients|Unknown status|Recruiting|Phase 4|234|Anticipated|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-11 00:51:47.445535|2017-10-11 00:51:47.445535
NCT02036541|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-05-30|2017-05-01||January 2013||2013-01-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|||AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma|A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects With Refractory Glaucoma|Completed||N/A|65|Actual|AqueSys, Inc.||1|||f||||f||||||||||2017-10-11 00:51:47.576632|2017-10-11 00:51:47.576632
NCT02036528|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-05-13|||January 2014||2014-01-01|May 2015|2015-05-01||||December 2014|Actual|2014-12-01||Interventional|||Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers|A Phase I/II, Open Label, Controlled Study to Evaluate the Safety and Efficacy of AppliGel-G [Gentamicin Sulfate Topical Gel] for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers in Patients With Type 1 and Type 2 Diabetes|Terminated||Phase 1/Phase 2|9|Actual|Royer Biomedical, Inc.||2|||f||||f||||||||||2017-10-11 00:51:47.873931|2017-10-11 00:51:47.873931
NCT02036515|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-06-23|2017-05-19||March 12, 2014|Actual|2014-03-12|June 2017|2017-06-01|June 6, 2016|Actual|2016-06-06|June 6, 2016|Actual|2016-06-06||Interventional||All participants as treated population excludes two participants randomized to Ertugliflozin 15 mg but did not receive any treatment.|Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729) in the Treatment of Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin|Completed||Phase 3|464|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 00:51:48.023984|2017-10-11 00:51:48.023984
NCT02036502|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-09-21|||February 14, 2014|Actual|2014-02-14|September 2017|2017-09-01|August 9, 2018|Anticipated|2018-08-09|August 9, 2018|Anticipated|2018-08-09||Interventional|||A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)|A Phase I Multi-Cohort Trial of Pembrolizumab (MK-3475) in Combination With Backbone Treatments for Subjects With Multiple Myeloma.|Recruiting||Phase 1|115|Anticipated|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 00:51:49.592566|2017-10-11 00:51:49.592566
NCT02036489|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-01-11|||January 2008||2008-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia|Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute|Recruiting||Phase 4|300|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-11 00:51:49.733092|2017-10-11 00:51:49.733092
NCT02036476|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-19|||January 2014||2014-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma|Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma|Active, not recruiting||Phase 2|8|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No|There are no plans to share individual participant data. Cumulative results will be posted here and published.|2017-10-11 00:51:49.847583|2017-10-11 00:51:49.847583
NCT02036463|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-02-13|||November 2014||2014-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy|CINRG0513: A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy|Withdrawn||Phase 2|0|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||4||No funding for project.|f||||t||||||||||2017-10-11 00:51:49.929628|2017-10-11 00:51:49.929628
NCT02036450|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-02-09|||January 2014||2014-01-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|LOOP||Atrial Fibrillation Detected by Continuous ECG Monitoring|Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-risk Individuals.|Active, not recruiting||N/A|6000|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 00:51:50.011008|2017-10-11 00:51:50.011008
NCT02036437|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-02-17|||September 2013||2013-09-01|February 2014|2014-02-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Titrated Oral Misoprostol Compared to Vaginal Dinoprostone for Induction of Labor|Titrated Oral Misoprostol Compared to Vaginal Dinoprostone for Induction of Labor: a Randomized Control Trial|Unknown status|Recruiting|Phase 3|200|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 00:51:50.110777|2017-10-11 00:51:50.110777
NCT02036424|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2015-11-03|2015-08-25||January 2014||2014-01-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||23 and 27 reflect number of study eyes in each arm rather than number of subjects|Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema|A 10 Month, Single Masked, Randomized Controlled Study to Assess Anti-VEGF Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema|Completed||Phase 4|45|Actual|Maturi, Raj K., M.D., P.C.||2|||f||||t||||||||||2017-10-11 00:51:50.20436|2017-10-11 00:51:50.20436
NCT02036411|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-01-13|||September 2013||2013-09-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Does Clomiphene Citrate Used for Induction of Ovulation Effect Levels of AMH and Inhibin B|Does Clomiphene Citrate Used for Induction of Ovulation Effect Levels of AMH and Inhibin B|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Bagcilar Training and Research Hospital|||1||f||||f||||||||||2017-10-11 00:51:50.525358|2017-10-11 00:51:50.525358
NCT02036398|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-04-10|||January 2012||2012-01-01|April 2017|2017-04-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|||Tubeless Versus Standard Upper Pole Percutaneous Nephrolithotomy|Comparison of Complications Between Patients Undergoing Standard Percutaneous Nephrolithotomy With Nephrostomy Tube Placement and Tubeless Percutaneous Nephrolithotomy With Double J Stent Only Placement|Terminated||N/A|65|Actual|Rabin Medical Center||2||Difficulty in patient recruitment|f||||f||||||||||2017-10-11 00:51:50.781009|2017-10-11 00:51:50.781009
NCT02036385|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-01-13|||May 2010||2010-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:51:50.870489|2017-10-11 00:51:50.870489
NCT02036372|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-01-23|||January 2014|Actual|2014-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|PILGRIM||Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus|PILGRIM - Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus Type II|Completed||N/A|150|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||t||||||||||2017-10-11 00:51:50.911384|2017-10-11 00:51:50.911384
NCT02036359|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-01-14|||May 2012||2012-05-01|January 2014|2014-01-01||||June 2015|Anticipated|2015-06-01||Interventional|Oncology||Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca|An Open-label, Randomized, Phase II Study of Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of Stage IIIA Lung Adenocarcinoma With Epidermal Growth Factor Receptor Gene Mutation.|Unknown status|Recruiting|Phase 2|76|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:51:51.018238|2017-10-11 00:51:51.018238
NCT02036346|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-09-11|||December 2013||2013-12-01|September 2017|2017-09-01|January 2018||2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Electrolyte Profile, Nutritional Status and Ileostomy Formation.|The Effect of Ileostomy Formation on Nutritional Status and Electrolyte Profile in Rectosigmoidectomy Patients: a Prospective Randomized Trial.|Recruiting||Phase 4|130|Anticipated|Larissa University Hospital||3|||f||||t||||||||||2017-10-11 00:51:51.12874|2017-10-11 00:51:51.12874
NCT02036333|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2014-06-23|||January 2014||2014-01-01|June 2014|2014-06-01||||December 2014|Anticipated|2014-12-01||Observational|||The Role of Cerebral Oximetry in Pediatric Concussion Assessment|The Role of Cerebral Oximetry in Pediatric Concussion Assessment|Unknown status|Not yet recruiting|N/A|100|Anticipated|Johns Hopkins University|||2||f||||f||||||||||2017-10-11 00:51:51.239016|2017-10-11 00:51:51.239016
NCT02036320|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-09-03|2015-09-03||January 2014||2014-01-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Non-dispensing Fit Evaluation of Investigational Limbal Ring Soft Contact Lenses With Polyvinylpyrrolidone (PVP) in Asian Eyes||Completed||N/A|190|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 00:51:51.358249|2017-10-11 00:51:51.358249
NCT02036307|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-02-28|||April 2013||2013-04-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|May 2013|Actual|2013-05-01||Interventional|SOMA||Supplementation With Omega-3: Mechanism of Action|Supplementation With Omega-3: Mechanism of Action|Terminated||Phase 2|13|Actual|Johns Hopkins University||2||This study was suspended because there is no more funds to complete the study.|f||||f||||||||No|We do not plan to share the individual patient data.|2017-10-11 00:51:52.615963|2017-10-11 00:51:52.615963
NCT02036281|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-06-07|||January 2014||2014-01-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain|A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain|Recruiting||Phase 1|28|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-11 00:51:52.826721|2017-10-11 00:51:52.826721
NCT02036268|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-05-04|||May 2012||2012-05-01|March 2017|2017-03-01|May 2024|Anticipated|2024-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Different Levels of Patient Education for Care of Ostomy Site|A Prospective, Single-Center Study to Assess the Impact of Pre- and Post-Surgical Ostomy Care Education on Patient Outcomes and Quality of Life|Recruiting||N/A|75|Anticipated|Indiana University||3|||f||||t||||||||No||2017-10-11 00:51:52.941415|2017-10-11 00:51:52.941415
NCT02036255|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2017-03-23|||May 2015||2015-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase|Prevention of Tunneled Cuffed Catheter Malfunction With Prophylactic Use of a Taurolidine Locking Solution Containing Urokinase : a Multicentric Randomized Controlled Trial|Active, not recruiting||Phase 3|64|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||t||||||||||2017-10-11 00:51:53.047083|2017-10-11 00:51:53.047083
NCT02036242|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2014-02-01|||September 2013||2013-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|OLAA||Sole Local Anesthetic Versus Opioid Plus Local Anesthesia in Epidural Labor Analgesia|Sole Epidural Local Anesthetic Versus Opioid Plus Local Anesthetic in Epidural Labor Pain Control|Completed||Phase 4|500|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-10-11 00:51:53.162549|2017-10-11 00:51:53.162549
NCT02036229|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2015-01-10|||February 2014||2014-02-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis|a Randomised, Double Blind, Placebo Controlled, Half- Face Study to Evaluate the Effect of Topical Ivermectin Cream 0.5% on Demodicidosis|Unknown status|Recruiting|Phase 3|50|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 00:51:53.295475|2017-10-11 00:51:53.295475
NCT02036216|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-12|||January 2014||2014-01-01|January 2014|2014-01-01|March 2016|Anticipated|2016-03-01|June 2014|Anticipated|2014-06-01||Observational|||Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.|Detected the Valuable Characteristic Changes Both in Circulating Cell-free DNA and Primary Tumor in the Patients With Hepatocelluar Carcinoma.|Unknown status|Recruiting|N/A|200|Anticipated|Peking Union Medical College Hospital|||1||f||||f||||||Samples With DNA|"     Human plasma；Human blood cells without plasma; HCC tissues (frozen);   "|||2017-10-11 00:51:53.403654|2017-10-11 00:51:53.403654
NCT02036203|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-01-12|||April 2014||2014-04-01|January 2014|2014-01-01||||July 2015|Anticipated|2015-07-01||Interventional|||A Study on the Safety and Efficacy of the SCu300A IUB Compared to the TCu380 Copper IUD|A Prospective, Randomized, Single Blind, Two Arms Controlled Study of the Safety and Efficacy of the SCu300A IUB™ Spherical Copper Intrauterine Ball in Comparison to TCu 380 IUD Intra-uterine Contraceptive Device|Unknown status|Not yet recruiting|Phase 2/Phase 3|60|Anticipated|Ocon Medical Ltd.||2|||f||||||||||||||2017-10-11 00:51:53.550433|2017-10-11 00:51:53.550433
NCT02036190|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2016-06-01|||February 2012||2012-02-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Ancillary T Cell Based Studies in SPIROMICS|Ancillary T Cell Based Studies in SPIROMICS|Completed||N/A|175|Actual|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     PBMC   "|No||2017-10-11 00:51:53.665234|2017-10-11 00:51:53.665234
NCT02035800|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-10-27|||May 2013||2013-05-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|BROCAII||Bone Resorption, Osteoclastogenesis and Adalimumab|Bone Resorption, Osteoclastogenesis and Adalimumab|Recruiting||Phase 4|120|Anticipated|Université de Sherbrooke||1|||f||||t||||||||||2017-10-11 00:51:56.9708|2017-10-11 00:51:56.9708
NCT02036177|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-08-30|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|February 2017|Actual|2017-02-01||Interventional|||Multivariate Assessment of the IUB Intrauterine Device Compared With a T380A IUD|A Prospective, Randomized, Single Blind, Two Arms Controlled Study to Confirm the Safety and Verify Performance of the IUB™ SCu300A Intrauterine Device in Comparison to TCu380 IUD Intra-uterine Contraceptive Device|Completed||Phase 2/Phase 3|367|Actual|Ocon Medical Ltd.||2|||f||||f||||||||||2017-10-11 00:51:53.774078|2017-10-11 00:51:53.774078
NCT02036164|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-04-04|||January 2014||2014-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|ACT-LACC||Adjuvant Chemotherapy for Locally Advanced Cervical Cancer|Randomized Controlled Trial Comparing Concurrent Chemoradiation Versus Concurrent Chemoradiation Followed by Adjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients|Recruiting||Phase 3|500|Anticipated|Navamindradhiraj University||2|||f||||t||||||||||2017-10-11 00:51:53.887706|2017-10-11 00:51:53.887706
NCT02036151|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-01-12|||February 2009||2009-02-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Impact of Maternal Xylitol Consumption on Mutans Sterptococci|Impact of Maternal Xylitol Consumption on Mutans Sterptococci ,Plaque and Caries Levels in Children|Completed||Phase 4|60|Actual|King Abdulaziz University||2|||f||||t||||||||||2017-10-11 00:51:54.130404|2017-10-11 00:51:54.130404
NCT02036138|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-02-28|||January 2015||2015-01-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||The Efficacy of Bariatric Surgery Compared to Medical Therapy in Controlling Type2 Diabetes Mellitus in Patients With Non Morbid Obesity.||Recruiting||Phase 2/Phase 3|168|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||||2017-10-11 00:51:54.255166|2017-10-11 00:51:54.255166
NCT02036125|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2014-12-13|||October 2013||2013-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|STC-EI||Carpal Tunnel Syndrome - Randomized Clinical Trial Evaluating Effectiveness of Ultrasound in Corticosteroid Injection|Syndrome du Tunnel Carpien - Essai Clinique randomisé évaluant l'efficacité de l'Utilisation de l'échographie Lors de l'Infiltration de corticostéroïdes|Unknown status|Recruiting|N/A|50|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 00:51:54.342709|2017-10-11 00:51:54.342709
NCT02036112|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-01-12|||August 2013||2013-08-01|January 2014|2014-01-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|ELAPE||Conventional Versus Individual Extralvator Abdominoperineal Excision for Advanced Lower Rectal Cancer|Randomized Clinical Trial of Conventional Versus Individual Extralevator Abdominoperineal Excision for Locally Advanced Lower Rectal Cancer|Unknown status|Recruiting|N/A|60|Anticipated|Beijing Chao Yang Hospital||2|||f||||f||||||||||2017-10-11 00:51:54.442375|2017-10-11 00:51:54.442375
NCT02036099|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-02-09|||January 2014||2014-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|DMD-DT||Driving in Mild Dementia Decision Tool|Driving in Mild Dementia Decision Tool|Completed||N/A|68|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||No||2017-10-11 00:51:54.528338|2017-10-11 00:51:54.528338
NCT02036086|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2016-10-14|||August 2015||2015-08-01|October 2016|2016-10-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases|A Pilot Study of the Neo-adjuvant Use of Vemurafenib Plus Cobimetinib (GDC-0973) in Patients With BRAF Mutant Melanoma With Palpable Lymph Node Metastases.|Recruiting||Phase 2|20|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||Yes||2017-10-11 00:51:54.608896|2017-10-11 00:51:54.608896
NCT02036073|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-01-13|||January 2009||2009-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|June 2012|Actual|2012-06-01||Interventional|EPO||Effect of Erythropoietin on Preterm Brain Injury||Completed||Phase 4|490|Actual|Zhengzhou Children's Hospital, China||1|||f||||t||||||||||2017-10-11 00:51:54.720469|2017-10-11 00:51:54.720469
NCT02036047|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2014-11-02|||January 2014||2014-01-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Effectiveness of an Exclusive Cold Snare Polypectomy Snare for the Removal of Diminutive Colorectal Polyps||Completed||N/A|80|Actual|Showa Inan General Hospital||2|||f||||f||||||||||2017-10-11 00:51:54.952431|2017-10-11 00:51:54.952431
NCT02036034|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-01-11|||October 2010||2010-10-01|August 2011|2011-08-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Effectiveness of Modified Ophthalmic Draping Method in Preventing Carbon Dioxide Accumulation in Patient Undergoing Eye Surgery Under Local Anesthesia|Effectiveness of Modified Ophthalmic Draping Method in Preventing Carbon Dioxide Accumulation in Patient Undergoing Eye Surgery Under Local Anesthesia|Completed||Phase 1|30|Actual|University of Malaya||2|||f||||t||||||||||2017-10-11 00:51:55.061694|2017-10-11 00:51:55.061694
NCT02036021|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2014-10-30|||November 2012||2012-11-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Cost of Hospitalization in Children Who Develop Perioperative Respiratory Event|Comparison of Cost of Hospitalization in Children After General Anesthesia With and Without Perioperative Respiratory Event at a Tertiary Care Hospital in Southern Thailand|Completed||N/A|1004|Actual|Prince of Songkla University|||1||f||||t||||||||||2017-10-11 00:51:55.149049|2017-10-11 00:51:55.149049
NCT02036008|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-01-13|||August 2013||2013-08-01|January 2014|2014-01-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|||Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial|Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial|Unknown status|Recruiting|N/A|150|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 00:51:55.232723|2017-10-11 00:51:55.232723
NCT02035631|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-13|||January 2014||2014-01-01|January 2014|2014-01-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|PREDICOP||Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention|Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention|Not yet recruiting||Phase 3|2000|Anticipated|Institut Català d'Oncologia||2|||f||||f||||||||||2017-10-11 00:52:00.258431|2017-10-11 00:52:00.258431
NCT02035995|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2014-01-11|||January 2013||2013-01-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01|6 Weeks|Observational [Patient Registry]|||EVALUATION OF THE MACULAR, PERIPAPILLARY NERVE FIBER LAYER AND CHOROID THICKNESS CHANGES IN THE GESTATIONAL DIABETES MELLITUS, HEALTHY PREGNANT AND WOMEN VOLUNTEERS.|EVALUATION OF THE MACULAR, PERIPAPILLARY NERVE FIBER LAYER AND CHOROID THICKNESS CHANGES IN THE GESTATIONAL DIABETES MELLITUS, HEALTHY PREGNANT AND WOMEN VOLUNTEERS.|Completed||N/A|76|Actual|Kayseri Education and Research Hospital|||2||f||||f||||||None Retained|"     no biospecimens are to be retained   "|||2017-10-11 00:51:55.328957|2017-10-11 00:51:55.328957
NCT02035982|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-04-26|||July 2010||2010-07-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|May 2014|Actual|2014-05-01||Interventional|||Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease|A Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease in Long Term Care Setting|Completed||Phase 3|40|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 00:51:55.42985|2017-10-11 00:51:55.42985
NCT02035969|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-01-13|||December 2013||2013-12-01|January 2014|2014-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Assessment of Group Peer Support to Children With HIV in Vietnam|A Randomized Controlled Trial to Assess the Effect of Group Peer Support to Children With HIV in Relation to Adherence, Virological Treatment Failure as Well as Physical Development|Unknown status|Recruiting|N/A|520|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 00:51:55.534969|2017-10-11 00:51:55.534969
NCT02035956|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-09-27|||December 2013||2013-12-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|February 2016|Actual|2016-02-01||Interventional|||IVAC MUTANOME Phase I Clinical Trial|First-in-human Study Evaluating the Safety, Tolerability and Immunogenicity of i.n. Administration of a Personalized Vaccination With IVAC MUTANOME Vaccine w/o Initial Treatment With RBL001/RBL002 Vaccine in Patients With Advanced Melanoma|Active, not recruiting||Phase 1|15|Anticipated|Biontech RNA Pharmaceuticals GmbH||1|||f||||t||||||||||2017-10-11 00:51:55.630094|2017-10-11 00:51:55.630094
NCT02035943|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2014-01-13|||January 2008||2008-01-01|January 2014|2014-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Tight Glycemic Control and Insulin Administration During Parenteral Nutrition|Tight Glycemic Control and Insulin Administration During Parenteral Nutrition, in Critical Ill Patients|Completed||N/A|20|Actual|Policlinico Hospital||2|||f||||f||||||||||2017-10-11 00:51:55.727127|2017-10-11 00:51:55.727127
NCT02035930|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-11|||November 2010||2010-11-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Dexmedetomidine on Bispectral Index and Propofol Requirements During Different Menstrual Cycle|Effect of Dexmedetomidine on Bispectral Index and Propofol Requirements During Different Menstrual Cycle|Completed||Phase 4|110|Actual|Fudan University||1|||f||||t||||||||||2017-10-11 00:51:55.82121|2017-10-11 00:51:55.82121
NCT02035904|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2017-03-01|||January 2013||2013-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Levobupivacaine Prolonged Wound Infusion for Postoperative Pain Relief After Breast Surgery||Recruiting||Phase 4|60|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-11 00:51:55.985914|2017-10-11 00:51:55.985914
NCT02035891|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-04|2017-05-10|||December 2013|Actual|2013-12-01|May 2017|2017-05-01|June 2023|Anticipated|2023-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria|Low-dose Colchicine Intervention in Patients With Type 2 Diabetes Mellitus and Microalbuminuria: Chongqing Study|Active, not recruiting||N/A|160|Actual|Chongqing Medical University||2|||f||||t||||||||||2017-10-11 00:51:56.080005|2017-10-11 00:51:56.080005
NCT02035878|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-11|||August 2012||2012-08-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|October 2013|Actual|2013-10-01||Interventional|||Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression|Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression|Unknown status|Active, not recruiting|Phase 2|75|Actual|Acadia University||2|||f||||f||||||||||2017-10-11 00:51:56.174519|2017-10-11 00:51:56.174519
NCT02035865|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-04-20|||December 2013||2013-12-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Mood and Cognitive Outcome After Heart Transplantation (the MOODHEART Study)|Nevropsykiatri og Hjertetransplantasjon|Unknown status|Enrolling by invitation|N/A|90|Anticipated|Oslo University Hospital|||2||f||||f||||||Samples Without DNA|"     Serum and plasma   "|||2017-10-11 00:51:56.40308|2017-10-11 00:51:56.40308
NCT02035852|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-09-02|||August 2009||2009-08-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors|High Resolution Magnetic Resonance Imaging in Patients With Brain Tumors|Active, not recruiting||N/A|184|Actual|University of Texas Southwestern Medical Center|||1||f||||t||||||||||2017-10-11 00:51:56.494817|2017-10-11 00:51:56.494817
NCT02035839|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-05-23|||March 2014||2014-03-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|FROST||Finding the Optimal Cooling tempeRature After Out-of-HoSpiTal Cardiac Arrest|A Pilot Multicenter Randomized Trial on the Effectiveness of Different Levels of Cooling in Comatose Survivors of Out-of-hospital Cardiac Arrest.|Completed||N/A|150|Actual|ZOLL Circulation, Inc., USA||3|||f||||f||||||||Undecided||2017-10-11 00:51:56.601828|2017-10-11 00:51:56.601828
NCT02035826|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-12-08|||January 2014||2014-01-01|November 2013|2013-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Randomized Trial of Patient Financial Incentives to Reduce CVD Risk||Completed||N/A|53|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 00:51:56.741277|2017-10-11 00:51:56.741277
NCT02035813|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2017-06-06|||January 2014||2014-01-01|June 2017|2017-06-01||||December 2019|Anticipated|2019-12-01||Interventional|||DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).|DETECT IV - A Prospective, Multicenter, Open-label, Phase II Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).|Recruiting||Phase 2|520|Anticipated|University of Ulm||2|||f||||t||||||||||2017-10-11 00:51:56.821158|2017-10-11 00:51:56.821158
NCT02035618|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-13|||September 2010||2010-09-01|January 2014|2014-01-01||||July 2012|Actual|2012-07-01||Interventional|||Exercises Associated or Not With Manual Therapy Shoulder Impingement||Completed||N/A|46|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-10-11 00:52:00.375942|2017-10-11 00:52:00.375942
NCT02035787|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-07-17|||March 2014||2014-03-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients|Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients|Recruiting||N/A|30|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:51:57.099854|2017-10-11 00:51:57.099854
NCT02035774|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2014-06-16|||January 2014||2014-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Novel Selective Block of the Suprascapular Nerve|A Novel Selective Block of the Suprascapular Nerve|Completed||Phase 4|30|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 00:51:57.23506|2017-10-11 00:51:57.23506
NCT02035761|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-09-22|||July 2011||2011-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)|Pathogenesis and Diagnosis of Multiple System Atrophy (MSA): PET Study of Neurochemical and Autonomic Disorders in MSA|Recruiting||N/A|26|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"     DNA Banking (this is optional): Subjects will have whole blood drawn sample for DNA banking     to support genetic research of human disease and human genetic factors. About two tablespoons     (approximately 20 ml) of blood will be taken from you. The blood will be shipped to the     laboratory of Dr. Philip Low, Mayo Clinic, MN. Dr. Low's laboratory will extract the DNA.     Members of the North American MSA - Study Group and their collaborators will use the DNA to     try to find out if changes in certain genes are associated with MSA. The samples will be used     for the preparation of DNA, and possibly, an immortalized cell line. The cell line, DNA, and     accompanying data will be distributed to scientists including those in research, teaching,     and industry. The samples may be kept indefinitely. The samples and accompanying information     will be used for studying of many disorders and genetic factors, not just MSA.   "|||2017-10-11 00:51:57.343373|2017-10-11 00:51:57.343373
NCT02035748|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-11|2016-08-19|2016-08-11||April 2014||2014-04-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||This analysis population includes all subjects who were exposed to the Investigational Product (IP) (Safety Analysis Set).|Assessment of Patients Treated With JETREA® for Vitreomacular Traction|Assessment of Anatomical and Functional Outcomes in Patients Treated With Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA)|Completed||Phase 4|628|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 00:51:57.479468|2017-10-11 00:51:57.479468
NCT02035735|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-02-21|||January 2014||2014-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interest of Narrow Band Imaging in Detection of Upper Aerodigestive Cancers|Usefulness of Narrow-band Imaging to Estimate the Superficial Spread of Squamous Cell Carcinomas in Oropharynx, Hypopharynx and Larynx|Recruiting||N/A|87|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-11 00:51:58.114885|2017-10-11 00:51:58.114885
NCT02035722|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-02-20|||September 2011||2011-09-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Intravitreal Injections-related Anxiety|A Visual Approach to Reducing Anxiety and Improving Knowledge Transfer for Patients Receiving Intravitreal Injections|Completed||Phase 2/Phase 3|73|Actual|University Health Network, Toronto||3|||f||||t||||||||||2017-10-11 00:51:58.216775|2017-10-11 00:51:58.216775
NCT02035709|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-07-02|||December 2013||2013-12-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|TCI-PCA||Postoperative Pain Therapy With Hydromorphone Using TCI-PCA|Phase 4 Study of Postoperative Pain Therapy With Hydromorphone Using Patient-Controlled Target-Controlled Infusion (TCI-PCA) vs. Patient-Controlled Analgesia (PCA) After Elective Cardiac Surgery|Completed||Phase 4|50|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 00:51:58.299468|2017-10-11 00:51:58.299468
NCT02035683|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-03-28|||October 2013||2013-10-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Interventional|PETRA||PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy|Study of the Role of Metabolic Response Measured by PET/CT Scan After 1 Cycle of Chemotherapy in Patients With Advanced Non Small Cell Lung Cancer (NSCLC)|Recruiting||N/A|220|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-10-11 00:51:59.907154|2017-10-11 00:51:59.907154
NCT02035670|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2015-08-22|||January 2014||2014-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|24 Weeks|Observational [Patient Registry]|||A Two-step Method Apparently Improved the Physicians' Level of Diagnosis Decision-making for Adult Patients With FUO|A Multicenter Prospective，Randomized and Controlled Pilot Study on the Diagnostic Strategy of So-called Two-step Method in Patients With FUO|Unknown status|Recruiting|N/A|600|Anticipated|Tongji Hospital|||2||f||||t||||||||||2017-10-11 00:52:00.004158|2017-10-11 00:52:00.004158
NCT02035657|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-08-15|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma|A Proof-of-Concept Clinical Trial of Intratumoral Injection of GLA-SE, a Toll-like Receptor-4 Agonist, in Patients With Merkel Cell Carcinoma|Active, not recruiting||Phase 1|10|Anticipated|Immune Design||1|||f||||t||||||||||2017-10-11 00:52:00.089726|2017-10-11 00:52:00.089726
NCT02035644|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2014-01-12|||February 2014||2014-02-01|January 2014|2014-01-01||||February 2015|Anticipated|2015-02-01||Interventional|||Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)||Unknown status|Not yet recruiting|Phase 4|360|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-11 00:52:00.170073|2017-10-11 00:52:00.170073
NCT02035605|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-13|2017-09-04|||January 2014||2014-01-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients|A Phase 1 Single-ascending and Multiple-ascending Dose, Safety, Tolerability and Pharmacokinetics Study of Subcutaneously Administered ALN-AT3SC in Healthy Adult Volunteers and Hemophilia A or B Patients (Moderate or Severe Hemophilia)|Completed||Phase 1|51|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:52:00.437933|2017-10-11 00:52:00.437933
NCT02035592|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-09-28|||January 2014||2014-01-01|January 2017|2017-01-01|November 7, 2016|Actual|2016-11-07|November 7, 2016|Actual|2016-11-07||Interventional|CIRCLES||The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study)|The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.|Completed||N/A|144|Anticipated|University of East Anglia||3|||f||||f||||||||||2017-10-11 00:52:00.535806|2017-10-11 00:52:00.535806
NCT02035579|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-02-10|||December 2013||2013-12-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Aerobic Training for Management of Post-Concussion Syndrome in Adolescents|Aerobic Training for Management of Post-Concussion Syndrome in Adolescents|Completed||N/A|30|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 00:52:00.61676|2017-10-11 00:52:00.61676
NCT02035566|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-01-10|||February 2011||2011-02-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Telehome Monitoring for Chronic Disease Management|Effectiveness of Telehome Monitoring on Quality of Life and Health Resources Utilization Among People With Chronic Disease Residing in Rural Maryland|Completed||N/A|23|Actual|University of Maryland||2|||f||||f||||||||||2017-10-11 00:52:02.352392|2017-10-11 00:52:02.352392
NCT02035540|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-06-09|||August 2014||2014-08-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|ESPOIR||European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR|European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR|Completed||N/A|121|Actual|corlife|||1||f||||t||||||||||2017-10-11 00:52:02.528778|2017-10-11 00:52:02.528778
NCT02035527|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-03-01|||April 14, 2014|Actual|2014-04-14|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|A Phase I/II Clinical Trial of Sorafenib in Combination With Cisplatin and Docetaxel in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Active, not recruiting||Phase 1/Phase 2|3|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:52:02.638846|2017-10-11 00:52:02.638846
NCT02035514|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-12-14|||December 2013||2013-12-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis|Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis|Completed||Phase 1/Phase 2|9|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-10-11 00:52:02.773919|2017-10-11 00:52:02.773919
NCT02035501|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-01-13|||January 2014||2014-01-01|January 2014|2014-01-01||||January 2015|Anticipated|2015-01-01||Interventional|||Treatment of TNNT1-Myopathy With L-Tyrosine.|Treatment of TNNT1-Myopathy With L-Tyrosine. A Double-blind, Placebo-controlled Crossover Trial.|Unknown status|Enrolling by invitation|Phase 2|10|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 00:52:02.853055|2017-10-11 00:52:02.853055
NCT02035488|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2014-12-15|||October 2013||2013-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis|Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis|Completed||Phase 1/Phase 2|8|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 00:52:02.914105|2017-10-11 00:52:02.914105
NCT02035475|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-09-26|2016-04-05||August 2014||2014-08-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PLND||Prevention of Lymphoceles After Robotic PLND|A Pilot Clinical Trial for the Prevention of Lymphoceles After Robotic Pelvic Lymph Node Dissections for Prostate Malignancies Using the da Vinci® EndoWrist® One™ Vessel Sealer|Completed||N/A|120|Actual|OhioHealth||2|||f||||f||||||||||2017-10-11 00:52:03.006667|2017-10-11 00:52:03.006667
NCT02035449|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-10|||December 2013||2013-12-01|December 2013|2013-12-01||||December 2014|Anticipated|2014-12-01||Observational|||Video Laryngoscopy in Pre-hospital Critical Care||Unknown status|Recruiting|N/A|150|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-11 00:52:03.313346|2017-10-11 00:52:03.313346
NCT02035423|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-01-10|||January 2011||2011-01-01|January 2014|2014-01-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|CITFOMIST||Community Interventional Trial (CITFOMIST)|Community Interventional Trial (CITFOMIST) to Study the Efficacy and Compliance of Different Degrees of Vitamin D Fortified Milk|Completed||N/A|6000|Actual|Tehran University of Medical Sciences||4|||f||||t||||||||||2017-10-11 00:52:03.487801|2017-10-11 00:52:03.487801
NCT02035410|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2017-04-24|||December 2013||2013-12-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Decrease Implantation Site INFECTION (DISINFECTION I): a Randomized Controlled Trial|Phase 1 Study of Prevention of Cardiac Device Implantation Site Infection|Recruiting||N/A|352|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||No||2017-10-11 00:52:03.593382|2017-10-11 00:52:03.593382
NCT02035397|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2017-07-06|||February 2014||2014-02-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Intragastric Injections of Botox for the Treatment of Obesity|Treatment of Morbid Obesity by Intragastric Injections of Botulinum Toxin A. A Randomized, Double-blind, Placebo Controlled, Phase II-trial|Active, not recruiting||Phase 2|20|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 00:52:03.695083|2017-10-11 00:52:03.695083
NCT02035384|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-08-08|||June 4, 2014|Actual|2014-06-04|August 2017|2017-08-01|April 11, 2021|Anticipated|2021-04-11|April 1, 2018|Anticipated|2018-04-01||Observational|guardian™ 5||Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A|A Multi-centre Non-interventional Study of Safety and Efficacy of Turoctocog Alfa (rFVIII) During Long-Term Treatment of Severe and Moderately Severe Haemophilia A (FVIII =<2%)|Enrolling by invitation||N/A|70|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 00:52:03.821031|2017-10-11 00:52:03.821031
NCT02035371|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-03-08|||January 13, 2014|Actual|2014-01-13|March 2017|2017-03-01|July 24, 2014|Actual|2014-07-24|July 24, 2014|Actual|2014-07-24||Interventional|||A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes|A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes|Completed||Phase 1|41|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:52:04.042699|2017-10-11 00:52:04.042699
NCT02035358|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-09-20|||May 2015||2015-05-01|September 2016|2016-09-01||||October 2016|Anticipated|2016-10-01||Interventional|||Immunotherapy Study for Metastatic Renal Cell Cancer|A Phase I Study of HyperAcute-Renal (HAR) Immunotherapy In Patients With Metastatic Renal Cell Cancer|Active, not recruiting||Phase 1|18|Anticipated|NewLink Genetics Corporation||1|||f||||||||||||||2017-10-11 00:52:04.172283|2017-10-11 00:52:04.172283
NCT02035345|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-11-01|2016-08-30||January 2014||2014-01-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|March 2015|Actual|2015-03-01||Interventional|||Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment|Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment|Terminated||Phase 4|15|Actual|Massachusetts General Hospital||1||Extended Carboplatin Infusion did not Reduce Frequency of Hypersensitivity Reactions|f||||t||||||||||2017-10-11 00:52:04.319836|2017-10-11 00:52:04.319836
NCT02035332|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-09-23|2015-08-21|2014-08-20|May 2011||2011-05-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|November 2012|Actual|2012-11-01||Interventional||Enrolled Subjects|A Two-Phase Clinical Study of the Minerva AURORA Ablation System|A Two-Phase Clinical Study of the Minerva AURORA Ablation System|Completed||N/A|23|Actual|Minerva Surgical, Inc.||1|||f||||t||||||||||2017-10-11 00:52:04.578155|2017-10-11 00:52:04.578155
NCT02035319|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-08-21|||January 2014||2014-01-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|||Effect of Laser Treatment on Capillary Malformations|Effect of Laser Treatment on Capillary Malformations Using Skin Imaging and Analysis|Withdrawn||N/A|0|Actual|Children's Hospital Medical Center, Cincinnati|||1|No enrollments|f||||f||||||||||2017-10-11 00:52:04.75826|2017-10-11 00:52:04.75826
NCT02035306|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-08-15|||February 2014||2014-02-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Usefulness of Non-invasive Pulse Co-oximetry Haemaglobin Measurements in Critically Ill Black Patients|Usefulness of Non-invasive Pulse Co-oximetry Haemaglobin Measurements in Critically Ill Black Patients|Completed||N/A|149|Actual|Chris Hani Baragwanath Academic Hospital||1|||f||||f||||||||||2017-10-11 00:52:04.826527|2017-10-11 00:52:04.826527
NCT02035293|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-01-13|||January 2014||2014-01-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PEP||Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)|Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 3|750|Anticipated|University Hospital, Brest||1|||f||||t||||||||||2017-10-11 00:52:04.898512|2017-10-11 00:52:04.898512
NCT02035280|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-02-06|||December 2013||2013-12-01|February 2017|2017-02-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Observational|||Prospective Evaluation of Elderly Deformity Surgery|Prospective Evaluation of Elderly Deformity Surgery: A Prospective Observational, Multicenter Study|Active, not recruiting||N/A|233|Actual|AOSpine International|||1||f||||t||||||||||2017-10-11 00:52:04.996339|2017-10-11 00:52:04.996339
NCT02035267|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2015-07-31|||December 2013||2013-12-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Safety Study of ATX-101 in Subjects With Varying Chin Sizes|A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects With Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4|Completed||Phase 3|93|Actual|Kythera Biopharmaceuticals||4|||f||||f||||||||||2017-10-11 00:52:05.25083|2017-10-11 00:52:05.25083
NCT02035254|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-04-07|||November 2013||2013-11-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Multidisciplinary e-Health Program to Promote Regular Physical Activity|Evaluating a Multidisciplinary e-Health Program to Promote Regular Physical Activity Among Individuals at Increased Risk of Cardiovascular Disease.|Completed||N/A|93|Actual|McGill University||2|||f||||f||||||||||2017-10-11 00:52:05.356424|2017-10-11 00:52:05.356424
NCT02035241|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-02-09|||March 2014||2014-03-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|AFC-SPICES||Effect of Herbs and Spices on Metabolic Regulation and Appetite in Healthy Subjects|Investigation on Effect of Herbs and Spices on Glucose and Insulin Responses, Anti-inflammatory Properties, Antioxidative Capacity and Satiety in Healthy Subjects|Completed||Phase 1/Phase 2|21|Actual|Lund University||6|||f||||f||||||||||2017-10-11 00:52:05.437358|2017-10-11 00:52:05.437358
NCT02035228|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-02-18|||March 2013||2013-03-01|February 2014|2014-02-01||||January 2014|Actual|2014-01-01||Interventional|||Abdominal Functional Electrical Stimulation to Reduce Hyperinflation in Chronic Obstructive Pulmonary Disease Patients|Abdominal Functional Electrical Stimulation to Reduce Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease: A Feasibility Study|Completed||N/A|7|Actual|Liberate Medical||2|||f||||||||||||||2017-10-11 00:52:05.54805|2017-10-11 00:52:05.54805
NCT02034695|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-09-05|||September 2010||2010-09-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|September 2016|Actual|2016-09-01||Observational|QoC RAMP||Evaluation of Quality of Care - Risk Assessment Management Programme, HA|Evaluation of Quality of Care - Risk Assessment Management Programme, HA|Completed||N/A|2496|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 00:52:11.152148|2017-10-11 00:52:11.152148
NCT02035215|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-03-19|||January 2014||2014-01-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia|Efficacy and Safety of Co-administration of Omacor Plus Atorvastatin Compared With Atorvastatin Monotherapy in Patients With Type Ⅱb Dyslipidemia: a Multicenter, Double-blind, Randomized, Active-controlled, Parallel, Phase Ⅲ Study|Unknown status|Recruiting|Phase 3|80|Anticipated|Kuhnil Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 00:52:05.666768|2017-10-11 00:52:05.666768
NCT02035202|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-05-19|||October 2013||2013-10-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness|Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness|Completed||N/A|255|Actual|University of California, San Diego||3|||f||||t||||||||||2017-10-11 00:52:05.77424|2017-10-11 00:52:05.77424
NCT02035189|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-03-02|||October 2013||2013-10-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients|Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients and Its Performance as an Adjunct in the Diagnosis and Prognostication of Infectious Processes|Completed||N/A|100|Actual|University of Arkansas|||1||f||||f||||||||||2017-10-11 00:52:05.875374|2017-10-11 00:52:05.875374
NCT02035176|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-11-21|||February 2014||2014-02-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|OATS||Novel Measure of Social Deficits in Children|Oregon Animation Test for Social Reciprocity (OATS)|Unknown status|Recruiting|N/A|120|Anticipated|Oregon Health and Science University|||3||f||||f||||||||||2017-10-11 00:52:05.970391|2017-10-11 00:52:05.970391
NCT02035163|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-04-24|||July 2012||2012-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Atrial Fibrillation Prevention in Post Coronary Artery Bypass Graft Surgery With Cryoablation for Ganglionic Plexi|Atrial Fibrillation Prevention in Post Coronary Artery Bypass Graft Surgery With Cryoablation for Ganglionic Plexi|Recruiting||N/A|62|Anticipated|Seoul St. Mary's Hospital||2|||f||||f||||||||No||2017-10-11 00:52:06.062129|2017-10-11 00:52:06.062129
NCT02035150|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-10|||March 1998||1998-03-01|January 2014|2014-01-01|December 2002|Actual|2002-12-01|February 2000|Actual|2000-02-01||Interventional|||Effect of Different Fiber Breakfasts on Appetite and Weight Change in Overweight Subjects|The Effect of Ingesting Breakfasts Varying in Fiber on Appetite and Weight Change in Overweight Subjects|Completed||N/A|36|Actual|New York Obesity and Nutrition Research Center||3|||f||||f||||||||||2017-10-11 00:52:06.145926|2017-10-11 00:52:06.145926
NCT02035137|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-08-11|||July 2014||2014-07-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|N2011-01||131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinistat|NANT 2011- 01: Randomized Phase II Pick the Winner Study of 131I-MIBG, 131I-MIBG With Vincristine and Irinotecan, or 131I-MIBG With Vorinostat for Resistant/Relapsed Neuroblastoma|Recruiting||Phase 2|105|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||3|||f||||t||||||||||2017-10-11 00:52:06.240361|2017-10-11 00:52:06.240361
NCT02035124|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-02-10|||April 2014||2014-04-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel|Cabazitaxel With BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer Following Treatment With Docetaxel: Phase II Study With Safety Lead-in Cohort|Withdrawn||Phase 2|0|Actual|SCRI Development Innovations, LLC||1||Study withdrawn due to slow accrual. No patients were enrolled.|f||||f||||||||||2017-10-11 00:52:06.407311|2017-10-11 00:52:06.407311
NCT02035111|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-04-13|||March 2014||2014-03-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.|To Evaluate the Safety and the Efficacy of Tianshu Capsule Treating Migraine in a Randomized, Placebo-Controlled, Double-blind, Multicenter Study.|Completed||Phase 4|947|Actual|Jiangsu Kanion Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-11 00:52:06.508008|2017-10-11 00:52:06.508008
NCT02035098|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-01-13|||March 2011||2011-03-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Improving Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial|The Effectiveness of the Quality Program Pac-IficO to Improve Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial|Completed||Phase 2/Phase 3|504|Actual|Arcispedale Santa Maria Nuova-IRCCS||1|||f||||f||||||||||2017-10-11 00:52:06.625538|2017-10-11 00:52:06.625538
NCT02035085|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-08-16|||September 2016||2016-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|CS-1000||19F Hot Spot MRI of Human Adipose-derived Stem Cells for Breast Reconstruction|This is a First-in-man, Phase I Study Utilizing 19F Magnetic Resonance Imaging (MRI) to Track Autologous, Adipose Derived Stem Cells.|Recruiting||Phase 1|6|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 00:52:06.69387|2017-10-11 00:52:06.69387
NCT02035072|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-07-19|||November 2010||2010-11-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.|Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.|Completed||Phase 2|40|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-11 00:52:06.7756|2017-10-11 00:52:06.7756
NCT02035059|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2016-10-24|||February 2014||2014-02-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|GDMPredict||Predictability of Gestational Diabetes Mellitus in First and Second Trimester|Predictability of Gestational Diabetes Mellitus in First and Second Trimester, Using Novel Biomarkers, and the Development of New Biomarkers by Quantitative Proteomic Analysis|Recruiting||N/A|550|Anticipated|University Hospital, Basel, Switzerland|||1||f||||t||||||Samples Without DNA|"     Blood Saliva   "|||2017-10-11 00:52:06.857242|2017-10-11 00:52:06.857242
NCT02034331|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-03-06|||December 2012||2012-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||IR and Microvascular Blood Flow in SCI|Insulin Resistance and Microvascular Blood Flow in Spinal Cord Injury|Completed||N/A|68|Actual|James J. Peters Veterans Affairs Medical Center||4|||f||||f||||||||Undecided||2017-10-11 00:52:18.104001|2017-10-11 00:52:18.104001
NCT02035046|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-01-13|||December 2013||2013-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|HEPHYGI||Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter|Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter|Completed||N/A|250|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:52:06.955069|2017-10-11 00:52:06.955069
NCT02035033|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2014-01-10|||January 2014||2014-01-01|January 2014|2014-01-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01|1 Day|Observational [Patient Registry]|TSHPTHCA||The Relationship Between Ca Intake , Blood Level of Ca, PTH, TSH, Vitamin D, and Urine Ca, P and Cardiac Calcium Scoring|The Relationship Between Calcium and Cardiac Calcium Scoring|Unknown status|Not yet recruiting|N/A|500|Anticipated|Carmel Medical Center|||3||f||||t||||||||||2017-10-11 00:52:07.063684|2017-10-11 00:52:07.063684
NCT02035020|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-12|2017-04-20|||May 2013||2013-05-01|April 2017|2017-04-01|July 30, 2014|Actual|2014-07-30|July 30, 2014|Actual|2014-07-30||Interventional|||A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients|A Phase IIa Clinical Trial to Test the Safety and Efficacy of Interferon Gamma Treatment in Elevating Frataxin Levels in Friedreich's Ataxia (FRDA) Patients|Completed||Phase 2|10|Actual|Azienda Policlinico Umberto I||1|||f||||f||||||||||2017-10-11 00:52:07.143709|2017-10-11 00:52:07.143709
NCT02035007|ClinicalTrials.gov processed this data on October 10, 2017|2009-10-02|2015-06-25|||July 2009||2009-07-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Transpulmonary Thermodilution Measurements in Patients With Heart Diseases|Transpulmonary Thermodilution Measurements in Patients With Heart Diseases|Completed||Phase 4|70|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 00:52:07.232694|2017-10-11 00:52:07.232694
NCT02034994|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-10|||February 2014||2014-02-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Combining Primary and Secondary Prevention for Reduction of Excessive Weight Gain in School|Combining Primary and Secondary Prevention for Reduction of Excessive Weight Gain in School|Unknown status|Not yet recruiting|Phase 3|1200|Anticipated|Rio de Janeiro State University||2|||f||||t||||||||||2017-10-11 00:52:07.307924|2017-10-11 00:52:07.307924
NCT02034981|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-02-16|||August 2013||2013-08-01|February 2016|2016-02-01|July 2019|Anticipated|2019-07-01|December 2016|Anticipated|2016-12-01||Interventional|AcSé||Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1|AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.|Recruiting||Phase 2|488|Anticipated|UNICANCER||1|||f||||t||||||||||2017-10-11 00:52:07.401365|2017-10-11 00:52:07.401365
NCT02034968|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-03-04|||February 2014||2014-02-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma|Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma|Withdrawn||Phase 2|0|Actual|Zhejiang University||1||No recruitment|f||||f||||||||||2017-10-11 00:52:07.492447|2017-10-11 00:52:07.492447
NCT02034955|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-09-20|||July 2013||2013-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Prostatectomy Adaptive Radiation Therapy (ART)|A Feasibility Study of Post-operative Adaptive Radiation Therapy for Localized Prostate Cancer|Active, not recruiting||N/A|20|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 00:52:07.566983|2017-10-11 00:52:07.566983
NCT02034929|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-09-12|||January 2014||2014-01-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||EndoCuff-assisted Versus Standard Colonoscopy for Adenoma Detection|A Randomized Controlled Study to Compare EndoCuff-assisted With Standard Colonoscopy for the Detection of Adenomas|Completed||N/A|500|Actual|Helios Albert-Schweitzer-Klinik Northeim||2|||f||||||||||||||2017-10-11 00:52:07.835408|2017-10-11 00:52:07.835408
NCT02034903|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-13|||November 2013||2013-11-01|January 2014|2014-01-01||||November 2015|Anticipated|2015-11-01||Interventional|||Effect of Feed Warming Method on Feeding Tolerance in the Preterm Infant Born at Less Than 30 Weeks Gestation|Effect of Feed Warming Method on Feeding Tolerance in the Preterm Infant Born at Less Than 30 Weeks Gestation|Unknown status|Recruiting|N/A|86|Anticipated|Advocate Center for Pediatric Research||2|||f||||t||||||||||2017-10-11 00:52:08.199556|2017-10-11 00:52:08.199556
NCT02034890|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-04-04|||July 2015||2015-07-01|April 2016|2016-04-01||||March 2017|Anticipated|2017-03-01||Interventional|||Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection|Is Intra - Neobladder Installations of Hyaluronic Acid, Effective in Reducing Neobladder Orthotropic Reconstruction Post-operative Urinary Tract Infections?|Withdrawn||Phase 4|0|Actual|Rabin Medical Center||2||Difficulty in recruiting patients|f||||t||||||||||2017-10-11 00:52:08.2847|2017-10-11 00:52:08.2847
NCT02034877|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-05-23|2016-05-23||August 2014||2014-08-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Safety population included all participants who received 1 dose of 13vPnC vaccination.|13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India|A Phase 4/3, Open-label, Single-arm, Multicenter Study To Describe The Safety And Immunogenicity Of 13-valent Pneumococcal Conjugate Vaccine In Adults 50 To 65 Years Of Age And In Children 6 To 17 Years Of Age In India|Completed||Phase 4|1200|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 00:52:08.382919|2017-10-11 00:52:08.382919
NCT02034864|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-06-27|||February 2014||2014-02-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|LC OSTEO||Comparison of the Effectiveness of 2 Manual Therapies Administered by Osteopaths on Functional Outcome in Sub-acute and Chronic Low Back Pain|Comparison of the Effectiveness of 2 Manual Therapies Administered by Osteopaths on Functional Outcome in Sub-acute and Chronic Low Back Pain Less Than 1 Year Duration: a Randomised Controlled Trial|Active, not recruiting||N/A|400|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:52:09.076821|2017-10-11 00:52:09.076821
NCT02034851|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-11-24|||April 2013||2013-04-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01|6 Months|Observational [Patient Registry]|DEXCAR-0212||Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection|Phase 3- Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection Episode as Renal Damage Prevention Strategy. DEXCAR|Unknown status|Recruiting|N/A|180|Anticipated|Institut Investigacio Sanitaria Pere Virgili|||2||f||||t||||||||||2017-10-11 00:52:09.172743|2017-10-11 00:52:09.172743
NCT02034838|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-09-21|||January 2014||2014-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional|||Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study|Microboosting of Atazanavir 300 mg With 50 mg Versus 100 mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study|Completed||Phase 1|12|Actual|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-10-11 00:52:09.302786|2017-10-11 00:52:09.302786
NCT02034825|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-02-26|||January 2013||2013-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|ASSESS-D||Multi-site Decision Impact Study for Decipher|ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery|Completed||N/A|50|Anticipated|GenomeDx Biosciences Corp|||1||f||||f||||||||||2017-10-11 00:52:09.389714|2017-10-11 00:52:09.389714
NCT02034812|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-02-26|||July 2013||2013-07-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|DECIDE3||Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists|GenomeDx Decipher Test for Metastatic Disease Prognosis in Prostate Cancer for Patients With Adverse Pathology Post Radical Prostatectomy: Does it Impact Radiation Oncologist' Treatment Recommendations?|Completed||N/A|25|Actual|GenomeDx Biosciences Corp|||1||f||||f||||||||||2017-10-11 00:52:09.513949|2017-10-11 00:52:09.513949
NCT02034786|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-02-03|||March 2015||2015-03-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|LipAge||Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid|Phase I Study of a Filler Agent Composed of Mesenchymal Stem Cells Obtained From Autologous Adipose Tissue Associated With Hyaluronic Acid|Unknown status|Not yet recruiting|Phase 1|25|Anticipated|Cryopraxis Criobiologia Ltda.||2|||f||||f||||||||||2017-10-11 00:52:09.693636|2017-10-11 00:52:09.693636
NCT02034773|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-10|||May 2013||2013-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule|A Phase 1, Three-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of CC-220 and to Evaluate the Relative Bioavailability of a Formulated CC-220 Capsule in Healthy Subjects|Completed||Phase 1|64|Actual|Celgene||8|||f||||f||||||||||2017-10-11 00:52:09.807398|2017-10-11 00:52:09.807398
NCT02034760|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-10-03|||January 2014||2014-01-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|CALM||Counteracting Age-related Loss of Skeletal Muscle Mass|Counteracting Age-related Loss of Skeletal Muscle Mass|Recruiting||N/A|205|Anticipated|Bispebjerg Hospital||5|||f||||t||||||||||2017-10-11 00:52:09.931918|2017-10-11 00:52:09.931918
NCT02034747|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-02-26|||November 2013||2013-11-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|COSMOS||A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients|A Multicenter, Randomized, Comparison, Open-label, Phase IV Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients|Completed||Phase 4|150|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 00:52:10.067866|2017-10-11 00:52:10.067866
NCT02034734|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-10|||September 2012||2012-09-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study to Investigate the Appearance and Disappearance of ASP3652 in Blood and Spinal Fluid in Healthy Male Subjects|A Phase I, Open-label Study to Investigate the Safety, Tolerability and Plasma and Cerebrospinal Fluid Pharmacokinetics and Pharmacodynamics of Multiple Doses of ASP3652 in Healthy Young Caucasian Male Subjects|Completed||Phase 1|14|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 00:52:10.202434|2017-10-11 00:52:10.202434
NCT02034721|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-12-12|||December 2013||2013-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Protein and Recovery From Exercise-induced Muscle Damage|Influence of Protein-amino Acid Supplementation on Recovery From Exercise-induced Muscle Damage in NASCAR Pit Crew Athletes|Completed||N/A|30|Actual|Appalachian State University||2|||f||||f||||||||||2017-10-11 00:52:10.287029|2017-10-11 00:52:10.287029
NCT02034708|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-11-09|2016-09-02||June 2014||2014-06-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|REMIND|All patients receiving at least one injection of contrast agent and with one valid assessment of the primary outcome|Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors|Intra-individual Cross-over Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/ Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors|Completed||Phase 4|279|Actual|Guerbet||2|||f||||f||||||||||2017-10-11 00:52:10.397534|2017-10-11 00:52:10.397534
NCT02034682|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-04-23|||January 2014||2014-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy|The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy|Completed||N/A|40|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 00:52:11.284389|2017-10-11 00:52:11.284389
NCT02034669|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-10|||February 2013||2013-02-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment|A Phase II Study of Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Completely Acute Spinal Cord Injury.|Unknown status|Recruiting|Phase 1/Phase 2|48|Anticipated|Tri Phuoc Biotechnology., JSC||2|||f||||t||||||||||2017-10-11 00:52:11.410818|2017-10-11 00:52:11.410818
NCT02034656|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-01-10|||July 2010||2010-07-01|January 2014|2014-01-01|November 2014|Anticipated|2014-11-01|March 2014|Anticipated|2014-03-01||Observational|||Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)|Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA): A Retrospective Feasibility Study|Unknown status|Recruiting|N/A|125|Anticipated|Seoul St. Mary's Hospital|||1||f||||t||||||||||2017-10-11 00:52:11.613997|2017-10-11 00:52:11.613997
NCT02034643|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-09-15|||October 2013||2013-10-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|TEE||Transesophageal Echocardiography(TEE) Probe Insertion and Tracheal Cuff Pressure|Increase of Tracheal Cuff Pressure During Transesophageal Echocardiography Probe Insertion: Double-lumen Tube Versus Single-lumen Tube|Completed||N/A|44|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 00:52:11.767128|2017-10-11 00:52:11.767128
NCT02034630|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-04-26|||January 2014||2014-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in GRD|Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Genetic Rare Disease|Recruiting||Phase 1/Phase 2|5|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 00:52:11.862121|2017-10-11 00:52:11.862121
NCT02034617|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-12-10|||January 2014||2014-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|LiMoNid||Evaluation of a Parent-Infant Interaction Model|Evaluation of a Parent-Infant Interaction Model in the Neonatal Intensive Care|Recruiting||N/A|126|Anticipated|Linkoeping University||2|||f||||f||||||||No||2017-10-11 00:52:11.987352|2017-10-11 00:52:11.987352
NCT02034604|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-02-12|||December 2013||2013-12-01|January 2014|2014-01-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia||Unknown status|Recruiting|Phase 4|204|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:52:12.142222|2017-10-11 00:52:12.142222
NCT02034591|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-05-16|2016-05-16||October 2011||2011-10-01|May 2016|2016-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||All randomized participants|Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects|Bioavailability of Apixaban Oral Solution Administered Through a Nasogastric Tube in the Presence of Boost® Plus and Apixaban Administered as Crushed Tablet Through a Nasogastric Tube Relative to Apixaban Oral Solution in Healthy Subjects|Completed||Phase 1|37|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 00:52:12.294536|2017-10-11 00:52:12.294536
NCT02034578|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-06-09|2016-05-03||July 2011||2011-07-01|June 2016|2016-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||All participants who received study drug were analyzed.|Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects|Study of Apixaban Oral Solution Bioavailability When Administered Through a Nasogastric Tube in Healthy Subjects|Completed||Phase 1|75|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 00:52:13.003193|2017-10-11 00:52:13.003193
NCT02034565|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2016-07-07|2016-07-07||February 2010||2010-02-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||All randomized participants|Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects|Study of Bioavailability of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects|Completed||Phase 1|48|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:52:13.507806|2017-10-11 00:52:13.507806
NCT02034552|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-14|2017-06-30||December 30, 2013|Actual|2013-12-30|August 2017|2017-08-01|June 17, 2018|Anticipated|2018-06-17|July 15, 2016|Actual|2016-07-15||Interventional|||A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)|A Randomized Open-label Phase IIa Study Evaluating Quantified Bone Scan Response Following Treatment With Radium-223 Dichloride Alone or in Combination With Abiraterone Acetate or Enzalutamide in Subjects With Castration-resistant Prostate Cancer Who Have Bone Metastases|Active, not recruiting||Phase 2|68|Actual|Bayer||3|||f||||f|t|f||||||||2017-10-11 00:52:13.877325|2017-10-11 00:52:13.877325
NCT02034539|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2014-01-10|||October 2013||2013-10-01|January 2014|2014-01-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|||VADOplex Critical Limb Ischemia Study|Prospektive, Randomisierte Und Kontrollierte Studie Zum Einfluss Des VADOplex-Systems Auf Die Lebensqualität im Rahmen Der Behandlung Der Chronisch-kritischen Extremitätenischämie im Stadium IV Nach Fontaine|Unknown status|Recruiting|Phase 2/Phase 3|38|Anticipated|Asklepios Kliniken Hamburg GmbH||2|||f||||f||||||||||2017-10-11 00:52:15.132253|2017-10-11 00:52:15.132253
NCT02034526|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2017-05-08|||May 2014||2014-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|DANPACEII||Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome.|A Randomised Controlled Trial of Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome and Dual Chamber Pacemaker.|Recruiting||N/A|900|Anticipated|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 00:52:15.219113|2017-10-11 00:52:15.219113
NCT02034513|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-07-12|2017-01-11||January 5, 2014|Actual|2014-01-05|July 2017|2017-07-01|January 11, 2016|Actual|2016-01-11|January 11, 2016|Actual|2016-01-11||Interventional|SWITCH 1|Baseline results are based on the full analysis set (FAS), which included all randomised subjects.|A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes|A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes (SWITCH 1)|Completed||Phase 3|501|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:52:15.339482|2017-10-11 00:52:15.339482
NCT02034487|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-10|||January 1990||1990-01-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|February 2013|Actual|2013-02-01||Observational|||Delayed Puberty in Boys; Clinical and Biochemical Characteristics and Effect of Testosterone Treatment|Delayed Puberty in Boys; Clinical and Biochemical Characteristics and Effect of Testosterone Treatment - Retrospective Experience From a Single Tertiary Referral Centre 1990-2013|Completed||N/A|451|Actual|Rigshospitalet, Denmark|||1||f||||||||||Samples With DNA|"     serum and white cells   "|||2017-10-11 00:52:16.739758|2017-10-11 00:52:16.739758
NCT02034474|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-03-28|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia|Tocilizumab, An IL-6 Receptor Antibody, As Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 4|59|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 00:52:16.841765|2017-10-11 00:52:16.841765
NCT02034461|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-08-11|||April 2013||2013-04-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Micro-Electrodes Implanted in a Human Nerve|Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Sensory Feedback Useful for Controlling a Prosthetic Device?|Enrolling by invitation||N/A|12|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-11 00:52:16.960867|2017-10-11 00:52:16.960867
NCT02034448|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-10|2015-01-12|||November 2013||2013-11-01|January 2015|2015-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|CRRT||CRRTNet Registry- A Prospective Observational Registry|CRRTNet Outcome Registry|Recruiting||N/A|2000|Anticipated|AKI Critical Care Research Foundation|||1||f||||f||||||||||2017-10-11 00:52:17.072447|2017-10-11 00:52:17.072447
NCT02034435|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-09-13|||October 2013||2013-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism|Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism|Recruiting||N/A|57|Anticipated|Vanderbilt University Medical Center||4|||f||||t||||||||||2017-10-11 00:52:17.202163|2017-10-11 00:52:17.202163
NCT02034422|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-07-21|||February 1, 2014|Actual|2014-02-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|February 1, 2018|Anticipated|2018-02-01||Interventional|||Understanding the Exercise-Hypertension Paradox|Understanding the Exercise-Hypertension Paradox: Implication for Rehabilitation|Recruiting||N/A|72|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 00:52:17.32432|2017-10-11 00:52:17.32432
NCT02034409|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-09-21|||May 29, 2015|Actual|2015-05-29|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|March 31, 2019|Anticipated|2019-03-31||Interventional|PLUS+OA||A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis|A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis|Recruiting||Phase 1/Phase 2|180|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|f|||||2017-10-11 00:52:17.446189|2017-10-11 00:52:17.446189
NCT02034396|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-12-21|||May 2011||2011-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Clinical Implications of Genetic Variations of Venous Stasis Ulceration|Clinical Implications of Genetic Variations of Venous Stasis Ulceration|Recruiting||N/A|1125|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:52:17.564473|2017-10-11 00:52:17.564473
NCT02034383|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-02-12|||March 2014||2014-03-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet|Macronutrient Absorption From Almonds: The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet|Completed||N/A|18|Anticipated|USDA Beltsville Human Nutrition Research Center||5|||f||||f||||||||||2017-10-11 00:52:17.662702|2017-10-11 00:52:17.662702
NCT02034370|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-11-28|||March 2014||2014-03-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01|1 Week|Observational [Patient Registry]|||Effect of Interscalene Block on Obstructive Sleep Apnea in Shoulder Surgery Patients|Influence of Inter-scalene Blockade on Postoperative Episodic Desaturation in Patients at High Risk of Obstructive Sleep Apnea (OSA)|Withdrawn||N/A|0|Actual|University of Michigan|||1|Inclusion criteria not met at preoperative clinic visit screening. No eligible participants.|f||||t||||||||||2017-10-11 00:52:17.784014|2017-10-11 00:52:17.784014
NCT02034357|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2016-03-23|||June 2011||2011-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|August 2013|Actual|2013-08-01||Interventional|||Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease|Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease|Completed||N/A|89|Actual|University of Miami||1|||f||||t||||||||||2017-10-11 00:52:17.874989|2017-10-11 00:52:17.874989
NCT02034344|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-12-15|||October 2013||2013-10-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers|Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers|Completed||Early Phase 1|77|Actual|Janssen Research & Development, LLC|||3||f||||f||||||||||2017-10-11 00:52:17.954186|2017-10-11 00:52:17.954186
NCT02034305|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-03-29|||January 2014||2014-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy|Pilot Study of Cough Peak Flow And Airway Clearance in Pediatric Patients With Neuromuscular Disease|Recruiting||N/A|15|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 00:52:18.284365|2017-10-11 00:52:18.284365
NCT02034292|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2014-08-28|||January 2014||2014-01-01|December 2013|2013-12-01||||September 2014|Anticipated|2014-09-01||Interventional|TG1C||Safety Study of APD-791 With Aspirin and/or Clopidogrel|Phase I Study to Assess the Safety of APD-791 When Co-administered With Aspirin|Unknown status|Not yet recruiting|Phase 1|88|Anticipated|IlDong Pharmaceutical Co Ltd||9|||f||||f||||||||||2017-10-11 00:52:18.353528|2017-10-11 00:52:18.353528
NCT02034279|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-05-17|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|February 10, 2017|Actual|2017-02-10|December 31, 2016|Actual|2016-12-31||Interventional|INFECIR2||The INFECIR-2 Albumin Prevention Study|Albumin Administration in the Prevention of Hepatorenal Syndrome and Death in Patients With Cirrhosis, Bacterial Infections Other Than Spontaneous Bacterial Peritonitis and High Risk of Hospital Mortality|Terminated||Phase 4|136|Actual|EASL - CLIF Consortium||2||Low recruitment rate and expiration of the study drug|f||||t||||||||Undecided|Undecided yet|2017-10-11 00:52:18.44984|2017-10-11 00:52:18.44984
NCT02034266|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-04-26|||January 2014||2014-01-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Effect of Omega-3 Supplementation on Nerve Structure and Function in Type 1 Diabetes|Phase 2 Study of the Effects of Omega-3 Fatty Acid Supplementation on Nerve Structure and Function in Type 1 Diabetes Mellitus - A Clinical Pilot Study|Completed||Phase 2|40|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 00:52:18.562683|2017-10-11 00:52:18.562683
NCT02034253|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-11-29|||January 2014||2014-01-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|DUP||Glutamate, Brain Connectivity and Duration of Untreated Psychosis|Glutamate, Brain Connectivity and Duration of Untreated Psychosis|Recruiting||N/A|134|Anticipated|University of Alabama at Birmingham|||2||f||||f||||||Samples With DNA|"     Genes related to glutamate, n-acetyl-aspartate, dopamine, schizophrenia, and treatment     response to antipsychotic medication will be collected.   "|||2017-10-11 00:52:18.660389|2017-10-11 00:52:18.660389
NCT02034240|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-04-19|||January 2014||2014-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01|5 Weeks|Observational [Patient Registry]|||Neutrophil Gelatinase Associated Lipocalin (NGAL) in Urine: Can This Prove to be a Biomarker for Acute Kidney Injury in Patients With Sepsis?|Secretion of Neutrophil Gelatinase Associated Lipocalin in Septic Patients and the Development of Acute Kidney Injury|Completed||N/A|21|Actual|Sygehus Lillebaelt|||1||f||||t||||||||||2017-10-11 00:52:18.751419|2017-10-11 00:52:18.751419
NCT02034227|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-11-19|||April 2012||2012-04-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia|An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia|Terminated||Phase 1/Phase 2|6|Actual|Spirogen||2|||f||||||||||||||2017-10-11 00:52:18.811925|2017-10-11 00:52:18.811925
NCT02034214|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-09|||February 2006||2006-02-01|January 2014|2014-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|SHAZ!||Shaping the Health of Adolescents in Zimbabwe|Economic Opportunity for Zimbabwean Adolescent Orphans|Completed||N/A|367|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 00:52:18.902922|2017-10-11 00:52:18.902922
NCT02034201|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-08-17|||February 2014||2014-02-01|August 2017|2017-08-01|May 19, 2016|Actual|2016-05-19|May 19, 2016|Actual|2016-05-19||Interventional|||Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence||Completed||Phase 1|19|Actual|University of Arkansas||2|||f||||||||||||||2017-10-11 00:52:18.999082|2017-10-11 00:52:18.999082
NCT02034188|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-08-08|||January 2014||2014-01-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis|Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis|Completed||Phase 1/Phase 2|20|Actual|Translational Biosciences||1|||f||||t||||||||||2017-10-11 00:52:19.124247|2017-10-11 00:52:19.124247
NCT02034175|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-04-28|||January 2014||2014-01-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01|1 Day|Observational [Patient Registry]|||Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing|Comparison of the Somnarus Sleep Apnea Diagnostic Technology SomnaPatch With Polysomnography in Sleep Disordered Breathing|Completed||N/A|190|Actual|Somnarus Inc|||1||f||||f||||||||||2017-10-11 00:52:19.249397|2017-10-11 00:52:19.249397
NCT02034162|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-09-16|2016-07-21||December 2014||2014-12-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants|A Double-Blind, Randomized, Multi-Center, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Single Dose of a 500-mg Chewable Tablet of Mebendazole in the Treatment of Soil-Transmitted Helminth Infections (Ascaris Lumbricoides and Trichuris Trichiura) in Pediatric Subjects|Completed||Phase 3|295|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 00:52:19.348316|2017-10-11 00:52:19.348316
NCT02034136|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2014-01-10|||February 2014||2014-02-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Ginsenoside Improve Metabolic Syndrome|Effects of Ginsenoside Supplementation on Insulin Resistance and Cardiometabolic Risk Factors in Men With Metabolic Syndrome: a Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|60|Anticipated|CHA University||2|||f||||t||||||||||2017-10-11 00:52:20.074515|2017-10-11 00:52:20.074515
NCT02034123|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-09-21|||February 4, 2014|Actual|2014-02-04|September 2017|2017-09-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|||Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma|A Phase I Open-label, Dose Escalation Study to Investigate The Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2879552 Given Orally in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma|Terminated||Phase 1|24|Actual|GlaxoSmithKline||2||The risk benefit in relapsed refractory SCLC does not favor continuation of the study|f||||f||||||||||2017-10-11 00:52:20.186311|2017-10-11 00:52:20.186311
NCT02034110|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-08-31|||March 12, 2014|Actual|2014-03-12|August 2017|2017-08-01|August 1, 2020|Anticipated|2020-08-01|June 1, 2020|Anticipated|2020-06-01||Interventional|||Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers|A Phase II, Open-label, Study in Subjects With BRAF V600E-Mutated Rare Cancers With Several Histologies to Investigate the Clinical Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib|Recruiting||Phase 2|225|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-11 00:52:21.949375|2017-10-11 00:52:21.949375
NCT02034097|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-05-15|||April 2014||2014-04-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer|A Phase II Study to Evaluate Foretinib in Genomic Subpopulations of Subjects With Non-Small-Cell Lung Cancer (NSCLC)|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||3||"GSK has decided to terminate the Product Development of foretinib and conclude our Development   Agreement with Exelixis"|f||||f||||||||||2017-10-11 00:52:22.139734|2017-10-11 00:52:22.139734
NCT02034084|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-04-22|||March 2011||2011-03-01|January 2014|2014-01-01|June 2014|Actual|2014-06-01|March 2013|Actual|2013-03-01||Interventional|||A Comparison of Left and Right Radial Approach for Percutaneous Coronary Procedures||Completed||N/A|1400|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 00:52:22.217092|2017-10-11 00:52:22.217092
NCT02034071|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-08-30|||April 2014||2014-04-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome|A Dose Titration Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Extension|Completed||Phase 1/Phase 2|13|Actual|Essentialis, Inc.||2|||f||||t||||||||||2017-10-11 00:52:22.288608|2017-10-11 00:52:22.288608
NCT02034058|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-06-20|||December 2013||2013-12-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Interventional|WEAVE||Post Market Surveillance Study of the Wingspan Stent System|WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study|Recruiting||N/A|389|Anticipated|Stryker Neurovascular||1|||f||||f||||||||||2017-10-11 00:52:22.381525|2017-10-11 00:52:22.381525
NCT02034045|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-04-15|||June 2013||2013-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|EPIC||Expanding Paramedicine in the Community|The Expanding Paramedicine in the Community (Study)|Active, not recruiting||N/A|467|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:52:22.735297|2017-10-11 00:52:22.735297
NCT02034032|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-04-10|||January 2014||2014-01-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to TKA|A Randomized Controlled Trial of Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to Total Knee Arthroplasty|Active, not recruiting||N/A|50|Anticipated|Regenerative Sciences, LLC||2|||f||||f||||||||No||2017-10-11 00:52:22.828127|2017-10-11 00:52:22.828127
NCT02033993|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-04-06|||January 27, 2014|Actual|2014-01-27|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.|A Multicentre Randomized Phase II Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advanced Urothelial Cancer Progressing on or After a Platinum Containing Regimen.|Active, not recruiting||Phase 2|199|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 00:52:23.167479|2017-10-11 00:52:23.167479
NCT02033980|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2016-05-08|||May 2016||2016-05-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy of NICE Classification in the Histological Evaluation of Colorectal Lesions|Efficacy of NICE Classification in the Histological Evaluation of Colorectal Lesions ----- a Multicenter Study in China|Recruiting||N/A|400|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||Undecided||2017-10-11 00:52:23.317174|2017-10-11 00:52:23.317174
NCT02033967|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-04-22|||January 2014||2014-01-01|April 2016|2016-04-01||||January 2015|Actual|2015-01-01||Interventional|||Vasodilator-induced Hypovolemia in Living Liver Donors|Vasodilator-induced Hypovolemia in Living Liver Donors: Central Venous Pressure-guided vs Stroke Volume Variation-guided Technique|Completed||N/A|54|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:52:23.397466|2017-10-11 00:52:23.397466
NCT02033954|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-06-22|||July 2014||2014-07-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01|30 Days|Observational [Patient Registry]|OCCLUDE-II||Evaluation of Peripheral EOS for the Peripheral Embolization Treatment to Rapidly OccluDe Venous or Arterial BleEding|PrOspective, MultiCenter Study for the Evaluation of PerformanCe of the ArtVentive Medical Group Peripheral EndoLuminal OcclUsion SystemTM for the Peripheral Embolization Treatment to Rapidly OccluDe Venous or Arterial BleEding - OCCLUDE II|Unknown status|Recruiting|N/A|40|Anticipated|ArtVentive Medical Group, Inc.|||1||f||||t||||||||||2017-10-11 00:52:23.485486|2017-10-11 00:52:23.485486
NCT02033928|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-09-21|||April 2014||2014-04-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Observational|||Comprehensive Frailty Assessment|Comprehensive Frailty Assessment|Active, not recruiting||N/A|111|Actual|Ohio State University Comprehensive Cancer Center|||2||f||||f||||||||||2017-10-11 00:52:23.696817|2017-10-11 00:52:23.696817
NCT02033915|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2014-01-09|||October 2011||2011-10-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Effectiveness of Interactive Discussion Group Intervention About Suicide Risk Identification and Assessment for Clinical Nurses|The Effectiveness of Interactive Discussion Group Intervention to Improve Nurses' Abilities of Risk Identification and Assessment on People With Suicide Attempt or Self-harm Behavior|Completed||N/A|111|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 00:52:23.775722|2017-10-11 00:52:23.775722
NCT02033902|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-03-28|||April 2014||2014-04-01|March 2014|2014-03-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Observational|||A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years|A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years|Unknown status|Not yet recruiting|N/A|500|Anticipated|Eisai Inc.|||1||f||||f||||||||||2017-10-11 00:52:23.847238|2017-10-11 00:52:23.847238
NCT02033889|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-08-28|||December 13, 2013|Actual|2013-12-13|August 2017|2017-08-01|August 3, 2017|Actual|2017-08-03|August 3, 2017|Actual|2017-08-03||Interventional|||A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 26-Week Multicenter Study With a 78-Week Extension To Evaluate The Efficacy And Safety Of Ertugliflozin In Subjects With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy.|Completed||Phase 3|621|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 00:52:24.041246|2017-10-11 00:52:24.041246
NCT02033876|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-08-03|||October 2013||2013-10-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin|Effect of Delayed-Release Ursodeoxycholic Acid on Insulin Sensitivity, Gastric Emptying and Body Weight in Overweight or Obese Patients With Type 2 Diabetes on Metformin Treatment|Completed||Phase 2|24|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:52:24.17508|2017-10-11 00:52:24.17508
NCT02033863|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-06-22|||July 2014||2014-07-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01|30 Days|Observational [Patient Registry]|OCCLUDE-I||Evaluation of PerformanCe of the Peripheral EOS in the Treatment of Varicocele or Pelvic Congestion SynDromE|PrOspective, MultiCenter Study for the Evaluation of PerformanCe of the ArtVentive Medical Group Peripheral EndoLuminal OcclUsion SystemTM in the Treatment of Varicocele or Pelvic Congestion SynDromE - OCCLUDE I|Unknown status|Enrolling by invitation|N/A|40|Anticipated|ArtVentive Medical Group, Inc.|||2||f||||t||||||||||2017-10-11 00:52:24.271499|2017-10-11 00:52:24.271499
NCT02033850|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2016-07-14|||November 2012||2012-11-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|RehAtt||Rehabilitation of Attention in Patients With MCI and Brain Subcortical Vascular Changes Using the APT-II|The Rehabilitation of Attention in Patients With Mild Cognitive Impairment and Brain Subcortical Vascular Changes Using the Attention Process Training-II|Completed||N/A|46|Actual|Azienda Ospedaliero-Universitaria Careggi||2|||f||||t||||||||No||2017-10-11 00:52:24.360805|2017-10-11 00:52:24.360805
NCT02033837|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-08-18|||January 2013||2013-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT|Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT With 0.275-sec Gantry Rotation Speed|Completed||N/A|309|Actual|Kumamoto University|||1||f||||||||||||||2017-10-11 00:52:24.455676|2017-10-11 00:52:24.455676
NCT02033824|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-10-04|||April 2014||2014-04-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring|A Multicenter Prospective Randomized Clinical Trial Using Dehydrated Human Amnion/Chorion Membrane dHACM in Decompressive Craniectomy Patients to Reduce Postoperative Scarring|Active, not recruiting||N/A|40|Anticipated|MiMedx Group, Inc.||2|||f||||f||||||||||2017-10-11 00:52:24.528249|2017-10-11 00:52:24.528249
NCT02033811|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-10-19|||January 2014||2014-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|12 Months|Observational [Patient Registry]|||MitraClip® Registry|MitraClip® Registry - an Observational Study of Percutaneous Mitral Valve Repair Using the MitraClip® System|Recruiting||N/A|200|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 00:52:24.624176|2017-10-11 00:52:24.624176
NCT02033798|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-15|||February 2014||2014-02-01|January 2014|2014-01-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia|Impact of Medical Treatment for Benign Prostatic Hyperplasia on Chronic Renal Failure|Unknown status|Not yet recruiting|N/A|34|Anticipated|The Catholic University of Korea||1|||f||||t||||||||||2017-10-11 00:52:24.715191|2017-10-11 00:52:24.715191
NCT02033785|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-09|||February 2014||2014-02-01|January 2014|2014-01-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01|1 Year|Observational [Patient Registry]|||Functional Changes of Urogenital System After Holmium Laser Prostatectomy|Prospective Cohort Study of Holmium Laser Prostatectomy For Observing Functional Changes in Benign Prostate Hyperplasia Patients|Unknown status|Not yet recruiting|N/A|86|Anticipated|The Catholic University of Korea|||1||f||||t||||||||||2017-10-11 00:52:24.826136|2017-10-11 00:52:24.826136
NCT02033772|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-02-21|||August 2013||2013-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Prospective Data Collection of Patients < 6 Months of Age Undergoing Thoracoscopic Surgery||Enrolling by invitation||N/A|20|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 00:52:24.927867|2017-10-11 00:52:24.927867
NCT02033759|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-10-27|||June 2014||2014-06-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|September 2016|Actual|2016-09-01||Interventional|||Patient Anxiety Associated With Lymphedema Surveillance Method|A Study of Patient Anxiety Associated With Lymphedema Surveillance: Comparing Volumetric Analysis and Bio-Impedance Analysis|Active, not recruiting||N/A|45|Actual|Mercy Integrative Medicine||2|||f||||f||||||||Yes|POSTER PRESENTATION AT ACRM CONFERENCE CHICAGO NOV 2016|2017-10-11 00:52:25.014016|2017-10-11 00:52:25.014016
NCT02033746|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-04-28|||August 2015||2015-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Opiate Craving Reduction Study Using Post-detox Patients on Suboxone and Use of TEAS as Adjunctive Treatment|A Crossover Study Using Transdermal Electroacupuncture as Adjunctive Treatment to Reduce Opiate Cravings in Post-Detox Outpatients Receiving Buprenorphine-Naloxone|Recruiting||N/A|12|Anticipated|Mclean Hospital||2|||f||||f||||||||||2017-10-11 00:52:25.145425|2017-10-11 00:52:25.145425
NCT02033733|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-04|2014-01-09|||January 2014||2014-01-01|January 2014|2014-01-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Observational|||When Cooling a Patient After Cardiac Arrest, Does Use of a Neuromuscular Blocking Agent Make Your Job Easier?|Post-arrest Therapeutic Hypothermia. Does Use of Neuromuscular Blockers Achieve Faster Cooling Time?|Unknown status|Not yet recruiting|N/A|400|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||||2017-10-11 00:52:25.260034|2017-10-11 00:52:25.260034
NCT02033720|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-04|2014-01-09|||January 2014||2014-01-01|January 2014|2014-01-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Observational|||Study of Survivors of Different Types of Cardiac Arrest and Their Neurological Recovery|Neurological Outcomes After Cardiac Arrest in Pulseless Electrical Activity in Comparison to Asystole. Are All Non-shockable Rhythms the Same?|Unknown status|Not yet recruiting|N/A|400|Anticipated|Lawson Health Research Institute|||3||f||||f||||||||||2017-10-11 00:52:25.424711|2017-10-11 00:52:25.424711
NCT02033707|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-10-31|||April 2014||2014-04-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Effects of Hallucinogens and Other Drugs on Mood and Performance|Phase I Study Characterizing Effects of Hallucinogens and Other Drugs on Mood and Performance|Active, not recruiting||Phase 1|20|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:52:25.59088|2017-10-11 00:52:25.59088
NCT02033694|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-06-08|||February 2014|Actual|2014-02-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|LRP||The Lipid-Rich Plaque Study|The Lipid-Rich Plaque (LRP) Study|Active, not recruiting||N/A|1562|Actual|InfraReDx|||3||f||||t||||||||Undecided||2017-10-11 00:52:25.709426|2017-10-11 00:52:25.709426
NCT02033681|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2014-01-09|||September 2013||2013-09-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||"Optimal Time Delay of Epinephrine Injection With One-per-mil Tumescent Solution"|"Optimal Time Delay of Epinephrine Injection With One-per-mil Tumescent Solution to Visualize Operation Field in Hand Surgery Without Tourniquet"|Unknown status|Enrolling by invitation|N/A|12|Anticipated|Indonesia University||2|||f||||t||||||||||2017-10-11 00:52:25.862129|2017-10-11 00:52:25.862129
NCT02033668|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-05-12|||January 22, 2014|Actual|2014-01-22|May 2017|2017-05-01|July 15, 2014|Actual|2014-07-15|July 15, 2014|Actual|2014-07-15||Interventional|||Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers|A Randomized, Open Label, Parallel-Group Study to Estimate Bioavailability and to Assess the Pharmacokinetic Profile, Safety and Tolerability of GSK933776 Administered by Subcutaneous or Intramuscular Injection Relative to Intravenous Administration to Healthy Volunteers|Completed||Phase 1|36|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:52:25.955937|2017-10-11 00:52:25.955937
NCT02033655|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-06-19|||March 2014||2014-03-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|POWR-UP||A High Protein Weight Loss Intervention for Sarcopenic Obesity in Women|A High Protein Weight Loss Intervention for Sarcopenic Obesity in Women|Recruiting||N/A|110|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 00:52:26.063943|2017-10-11 00:52:26.063943
NCT02033642|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-03-04|||August 2012||2012-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|HealthU||A Family-Based Weight Loss Intervention for Youth With Intellectual Disability|A Family-Based Weight Loss Intervention for Youth With Intellectual Disability|Completed||N/A|36|Actual|University of Massachusetts, Boston||2|||f||||t||||||||||2017-10-11 00:52:26.152838|2017-10-11 00:52:26.152838
NCT02033629|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-01-20|||August 2014||2014-08-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Low Remifentanil Target Controlled Infusions for Cardiac Surgery|Early Extubation After Cardiac Surgery: What Is the Appropriate Target Remifentanil Effect-Site Concentration?|Recruiting||Phase 3|75|Anticipated|Dammam University||3|||f||||t||||||||||2017-10-11 00:52:26.235963|2017-10-11 00:52:26.235963
NCT02033603|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-12-31|||January 2014||2014-01-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Adductor Canal Versus Femoral Nerve Block for Analgesia Post Total Knee Arthroscopy|A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Femoral Nerve Block for Analgesia Post Total Knee Arthroplasty|Unknown status|Recruiting|N/A|30|Anticipated|Changi General Hospital||2|||f||||f||||||||||2017-10-11 00:52:26.515165|2017-10-11 00:52:26.515165
NCT02033577|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-03-16|||August 2011||2011-08-01|March 2015|2015-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|BMI>50||Effects of Long Biliopancreatic Limb Versus Long Alimentary Limb in Superobesity, a Randomized Study|Effects of Long Biliopancreatic Limb vs Long Alimentary Limb in Superobesity|Unknown status|Recruiting|N/A|200|Anticipated|Aleris Obesity||2|||f||||t||||||||||2017-10-11 00:52:26.680601|2017-10-11 00:52:26.680601
NCT02033564|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-09|||June 2012||2012-06-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Incidence of Sore Throat With Traditional Intubation Blades or Glidescope Blade|Does the Incidence of Sore Throat Increase With the Use of a Traditional Intubation Blade or the Glidescope|Completed||N/A|151|Actual|Albany Medical College||2|||f||||f||||||||||2017-10-11 00:52:26.774004|2017-10-11 00:52:26.774004
NCT02033551|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-09-26|||December 2013||2013-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors|An Extension Study to Evaluate the Safety of Veliparib as Single Agent Therapy or in Combination With Chemotherapy in Subjects With Solid Tumors|Completed||Phase 1|47|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 00:52:26.875768|2017-10-11 00:52:26.875768
NCT02033538|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-03-04|||January 2014||2014-01-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus|A Phase II Trial of Neoadjuvant Chemotherapy With Nanoparticle Albumin-bound Paclitaxel and Fluorouracil Followed by Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of Esophagus|Withdrawn||Phase 2|0|Actual|Zhejiang University||1||This clinical trial was closed due to slow recruitment of patients.|f||||f||||||||||2017-10-11 00:52:26.999854|2017-10-11 00:52:26.999854
NCT02033525|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-05-30|||January 2014||2014-01-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|May 2017|Actual|2017-05-01||Interventional|||Mesenchymal Stromal Cells for Degenerative Meniscus Injury|A Phase I-IIa Safety and Efficacy Pilot Clinical Trial of Intraarticular Administration of Autologous Mesenchymal Cells for Meniscus Injury|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Banc de Sang i Teixits||2|||f||||f||||||||||2017-10-11 00:52:27.087493|2017-10-11 00:52:27.087493
NCT02033512|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-01-09|||January 2003||2003-01-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|January 2004|Actual|2004-01-01||Interventional|THRT||TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS|NANOSTRUCTURED TRANSDERMAL HORMONE REPLACEMENT THERAPY RELIEVING MENOPAUSAL SYMPTOMS: A CONFOCAL RAMAN SPECTROSCOPY STUDY|Completed||Phase 2|66|Actual|University Potiguar||1|||f||||t||||||||||2017-10-11 00:52:27.18681|2017-10-11 00:52:27.18681
NCT02033486|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-10-26|||March 2014||2014-03-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Digital Breast Tomosynthesis Guided Tomographic Optical Breast Imaging (TOBI)|Digital Breast Tomosynthesis Guided Tomographic Optical Breast Imaging (TOBI)|Recruiting||N/A|375|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:52:27.379966|2017-10-11 00:52:27.379966
NCT02033473|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2014-11-07|||January 2014||2014-01-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|APELINS||Effect of Apelin on Insulin Sensitivity: Proof of Concept in Healthy Volunteers|Effect of Apelin on Insulin Sensitivity: Proof of Concept in Healthy Volunteers|Completed||Phase 1|16|Actual|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-11 00:52:27.464526|2017-10-11 00:52:27.464526
NCT02033460|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-10|||January 2011||2011-01-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Manual Therapy Versus Manual Therapy and Exercise and Education in Chronic Neck Pain|Manual Therapy vs Manual Therapy and Exercise vs Manual Therapy and Exercise and Education in Patients With Chronic Neck Pain|Completed||N/A|50|Actual|Universidad Rey Juan Carlos||3|||f||||f||||||||||2017-10-11 00:52:27.551388|2017-10-11 00:52:27.551388
NCT02033447|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-05-08|||December 2013||2013-12-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|MAGNABLATE I||Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men|Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men|Completed||Early Phase 1|12|Actual|University College London Hospitals||1|||f||||t||||||||||2017-10-11 00:52:27.637424|2017-10-11 00:52:27.637424
NCT02033434|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2014-01-09|||March 2014||2014-03-01|January 2014|2014-01-01|September 2014|Anticipated|2014-09-01|May 2014|Anticipated|2014-05-01||Interventional|PRECINKT||Pre-hospital Care With Intra-Nasal Ketamine for Transport (PRECINKT): A Pilot Study|Pre-hospital Care With Intra-Nasal Ketamine for Transport (PRECINKT): A Pilot Study|Unknown status|Not yet recruiting|Phase 1|30|Anticipated|University of Calgary||1|||f||||t||||||||||2017-10-11 00:52:27.710549|2017-10-11 00:52:27.710549
NCT02033408|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-03-27|||January 2014||2014-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FMT||Manipulating the Microbiome in IBD by Antibiotics and FMT|Manipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT): a Randomized Controlled Trial|Recruiting||Phase 4|28|Anticipated|Shaare Zedek Medical Center||3|||f||||t||||||||||2017-10-11 00:52:27.894453|2017-10-11 00:52:27.894453
NCT02033395|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-09|||January 2014||2014-01-01|January 2014|2014-01-01||||January 2016|Anticipated|2016-01-01||Observational|||A Correlation Between Hair Cortisol Levels and the Development of Post Traumatic Stress Disorder (PTSD)|A Correlation Between Hair Cortisol Levels and the Development of Post Traumatic Stress Disorder (PTSD)|Unknown status|Not yet recruiting|N/A|60|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:52:28.075859|2017-10-11 00:52:28.075859
NCT02033382|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-07-12|||July 2012||2012-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|July 2017|Actual|2017-07-01||Observational|||Biomarkers in First Episode Schizophrenia|Biomarkers in First Episode Schizophrenia|Active, not recruiting||N/A|40|Actual|New York University School of Medicine|||2||f||||t||||||Samples With DNA|"     -  Whole Blood        -  DNA        -  Saliva        -  Serum        -  Plasma   "|||2017-10-11 00:52:28.168306|2017-10-11 00:52:28.168306
NCT02033356|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-04-03|||January 2014||2014-01-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||ED95 of Lidocaine 1.0% for Filling the Adductor Canal|An Estimate of the ED95 of Lidocaine 1.0% for Filling the Adductor Canal When Placing an Adductor Canal Block in Healthy Volunteers|Completed||Phase 2|40|Actual|Rigshospitalet, Denmark||6|||f||||t||||||||||2017-10-11 00:52:28.350555|2017-10-11 00:52:28.350555
NCT02033343|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-12-07|||October 2013||2013-10-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|CALYPSO||Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy.|Phase I Feasibility Study of Prostate Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator Adaptation and Radiofrequency Tracking (Calypso)|Active, not recruiting||N/A|30|Anticipated|Royal North Shore Hospital||1|||f||||t||||||||||2017-10-11 00:52:28.435464|2017-10-11 00:52:28.435464
NCT02033330|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2014-01-09|||July 2013||2013-07-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional|||Assessment of Bioavailability of Phenolics From an Orange Peel Extract|Assessment of Bioavailability of Phenolics From an Orange Peel Extract|Completed||N/A|11|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 00:52:28.51621|2017-10-11 00:52:28.51621
NCT02033317|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-01-25|2015-11-11|2014-10-30|August 2008||2008-08-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis|An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Hemodialysis Patients|Terminated||Phase 2|6|Actual|Relypsa, Inc.|The initial intent was to enroll 12-24 adult male and female participants on hemodialysis into the study. Due to significant recruitment challenges, the study was discontinued after six participants were enrolled in the study.|1||Study terminated due to slow enrollment|f||||f||||||||||2017-10-11 00:52:28.600357|2017-10-11 00:52:28.600357
NCT02033304|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-05-06|||February 2014||2014-02-01|January 2013|2013-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Factors Predicting Postoperative Cesarean Section Pain|Analysis of Factors Predicting Postoperative Pain and Wound Hyperalgesia After Cesarean Section|Completed||N/A|229|Actual|Rabin Medical Center|||1||f||||f||||||||||2017-10-11 00:52:28.77549|2017-10-11 00:52:28.77549
NCT02033291|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-10-21|||February 2014||2014-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Observational|||Blood-brain Barrier Quantification in Cerebral Small Vessel Disease|Blood-Brain Barrier Permeability Quantification in Cerebral Small Vessel Disease -- Reproducibility of Dynamic Contrast-enhanced MRI|Completed||N/A|17|Actual|Maastricht University Medical Center|||2||f||||t||||||||||2017-10-11 00:52:28.844873|2017-10-11 00:52:28.844873
NCT02033278|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-09-19|||January 2014||2014-01-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.|Multicenter Phase II-III Clinical Trial, Double-blind, Randomized, Controlled Placebo for to Assess the Efficacy of Intracoronary Infusion of Autologous Adult Stem Cells Mononuclear Marrow Unexpanded on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.|Recruiting||Phase 2/Phase 3|51|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||t||||||||||2017-10-11 00:52:28.921959|2017-10-11 00:52:28.921959
NCT02033265|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-02-11|||August 2013|Actual|2013-08-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity|Perineural Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity on Block Performance Time, Failure Rate and Incidence of Acute Complications|Recruiting||N/A|300|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||||2017-10-11 00:52:29.020445|2017-10-11 00:52:29.020445
NCT02033252|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-08-31|||January 2014||2014-01-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|||Acupuncture for Rhinitis Complicated With Asthma|Acupuncture for Persistent Allergic Rhinitis Complicated With Asthma, A Randomized Controlled Pilot Trial|Unknown status|Recruiting|N/A|30|Anticipated|Korean Medicine Hospital of Pusan National University||2|||f||||||||||||||2017-10-11 00:52:29.120358|2017-10-11 00:52:29.120358
NCT02033239|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-01-16|||January 2014||2014-01-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacodynamic Response of FIAsp in Subjects With Type 1 Diabetes|Completed||Phase 1|46|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:52:29.200729|2017-10-11 00:52:29.200729
NCT02033226|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-12-21|||March 2012||2012-03-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Interventional|||Clinical, Anti-Inflammatory And Anti-Infective Properties Of Amniotic Membranes Used For Guided Tissue Regeneration|Evaluation of Clinical, Anti-Inflammatory and Anti-Infective Properties of Amniotic Membranes Used For Guided Tissue Regeneration in Contained Defects|Completed||Phase 3|54|Actual|SVS Institute of Dental Sciences||2|||f||||t||||||||||2017-10-11 00:52:29.275388|2017-10-11 00:52:29.275388
NCT02033213|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-04-23|2014-01-19||June 2011||2011-06-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial|Intraoperative Volume Restriction in Esophageal Carcinoma Surgery: an Exploratory Randomized Clinical Trial|Completed||N/A|16|Actual|Klinički Bolnički Centar Zagreb|Small number of participants due to small overall number of patients with esophageal cancer treated in our hospital.|2|||f||||f||||||||||2017-10-11 00:52:29.359394|2017-10-11 00:52:29.359394
NCT02033200|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-03-02|2015-03-02||January 2014||2014-01-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||healthy male adults between the ages of 18 and 45|Safety Study Looking at the Effects of Stendra on Vision|A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Parallel Study to Assess the Effects of Avanafil (STENDRA™) on Multiple Parameters of Vision, Including, But Not Limited to Visual Acuity, Intraocular Pressure, Pupillometry, and Color Vision Discrimination, in Healthy Male Subjects|Completed||Phase 4|80|Actual|VIVUS, Inc.||2|||f||||f||||||||||2017-10-11 00:52:29.886679|2017-10-11 00:52:29.886679
NCT02033187|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-09|||July 2012||2012-07-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients|Phase 4 Study of the Impact of Daily Bathing With Chlorhexidine-gluconate Impregnated Bathing Cloths on Nosocomial Infections in Critically Ill Patients|Completed||Phase 4|12000|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 00:52:30.626406|2017-10-11 00:52:30.626406
NCT02033174|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-01-23|2016-02-28||January 2001||2001-01-01|January 2017|2017-01-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Effects of Alcoholic Beverages in Pro-inflammatory and Antioxidant Profile After an Oral Fat Diet|Effects of Acute and Chronic Red Wine Intake in the Expression of Pro-inflammatory and Prothrombotic Factors in Circulating Monocytes|Completed||N/A|16|Actual|Instituto de Investigación Sanitaria Gregorio Marañón||2|||f||||t||||||||No||2017-10-11 00:52:30.727915|2017-10-11 00:52:30.727915
NCT02033161|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-01-09|||March 2012||2012-03-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study|Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study|Completed||N/A|29|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 00:52:30.951905|2017-10-11 00:52:30.951905
NCT02033148|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-11-04|||August 2014||2014-08-01|November 2014|2014-11-01||||June 2016|Anticipated|2016-06-01||Interventional|||Icotinib Hydrochloride in Treating Patients With Advanced Cancers|A Phase 1 Study to Evaluate the Safety and Pharmacokinetic Profile of Icotinib in Patients With Advanced Cancers|Withdrawn||Phase 1|0|Actual|Roswell Park Cancer Institute||1||changes in study design by sponsor not acceptable for participating|f||||f||||||||||2017-10-11 00:52:31.038758|2017-10-11 00:52:31.038758
NCT02033135|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-09|||June 2012||2012-06-01|January 2014|2014-01-01|August 2017|Anticipated|2017-08-01|April 2015|Anticipated|2015-04-01||Interventional|PESETA||Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis|Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis (PESETA)|Unknown status|Recruiting|Phase 4|84|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:52:31.117267|2017-10-11 00:52:31.117267
NCT02033122|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-01-09|||July 2012||2012-07-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|ETA1||Effect of Aerobic Training in Moderate or Severe Asthmatic Patients|Effect of Aerobic Training on Bronchial Hyperresponsiveness and Systemic Inflammation in Patients With Moderate or Severe Asthma: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|58|Anticipated|Instituto de Investigação em Imunologia||2|||f||||f||||||||||2017-10-11 00:52:31.209756|2017-10-11 00:52:31.209756
NCT02033109|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-08-11|||May 2014||2014-05-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use|A Phase 1, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Acceptability of PC-1005 Microbicide Gel Formulation in HIV-seronegative Women|Completed||Phase 1|35|Actual|Population Council||2|||f||||t||||||||||2017-10-11 00:52:31.322963|2017-10-11 00:52:31.322963
NCT02033096|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-01-06|||October 2008||2008-10-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Follow-up, Blinded-Outcomes Trial of Subjects Having Received IMP in Clinical Trial 64,185-202|A 4-Year Follow-up, Blinded-Outcomes Trial of Subjects Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-202 Trial Number: 64,185-203 Trial Phase:|Completed||Phase 2|42|Actual|InfaCare Pharmaceuticals Corporation|||4||f||||||||||||||2017-10-11 00:52:31.403562|2017-10-11 00:52:31.403562
NCT02033083|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-12-06|||December 2013||2013-12-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation|Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation: A Randomized Controlled Trial|Completed||N/A|180|Actual|Planned Parenthood of New York City, Inc.||2|||f||||t||||||||||2017-10-11 00:52:31.484838|2017-10-11 00:52:31.484838
NCT02033070|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-09|||November 2013||2013-11-01|January 2014|2014-01-01||||November 2015|Anticipated|2015-11-01|2 Years|Observational [Patient Registry]|HALO||Patient Registry: Radio Frequency Ablation of Barrett's Esophagus Using HALO System|Single Center Patient Registry Using Radio Frequency Ablation of Barrett's Esophagus Using HALO System|Unknown status|Not yet recruiting|N/A|||Ochsner Health System|||1||f||||f||||||Samples Without DNA|"     Serum from Biopsy   "|||2017-10-11 00:52:31.560491|2017-10-11 00:52:31.560491
NCT02033057|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-09|||October 2012||2012-10-01|October 2012|2012-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Muscular Electrostimulation of the Sedated and Mechanically Ventilated Critically Ill Patient. Analysis of the Effect on Acquired Muscular Weakness and Its Clinical Consequences.|Muscular Electrostimulation of the Sedated and Mechanically Ventilated Critically Ill Patient. Analysis of the Effect on Acquired Muscular Weakness and Its Clinical Consequences.|Unknown status|Recruiting|Phase 4|40|Anticipated|Hospital Universitario La Fe||1|||f||||f||||||||||2017-10-11 00:52:31.629867|2017-10-11 00:52:31.629867
NCT02033044|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-01-09|||April 2010||2010-04-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Cognitive Rehabilitation Versus Psychoeducation in Psychosocial Functioning of Borderline Personality Disorder|Randomized Controlled Trial Comparing the Effects on Psychosocial Functioning of Cognitive Rehabilitation Versus Psychoeducation in Borderline Personality Disorder|Completed||N/A|70|Actual|Hospital San Carlos, Madrid||2|||f||||t||||||||||2017-10-11 00:52:31.704786|2017-10-11 00:52:31.704786
NCT02033031|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-09|||August 2012||2012-08-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion|Treatment With Anti-vascular Endothelial Growth Factor in Patients With Branch Retinal Vein Occlusion: 5 Years of Clinical Experience|Completed||Phase 3|28|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 00:52:31.794287|2017-10-11 00:52:31.794287
NCT02033018|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-01-09|||October 2013||2013-10-01|January 2014|2014-01-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|AflibxMyopia||Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization|Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization|Unknown status|Recruiting|Phase 4|20|Anticipated|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-10-11 00:52:31.872415|2017-10-11 00:52:31.872415
NCT02032979|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-08-10|||February 2014|Actual|2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2014|Actual|2014-10-01||Interventional|||Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2|Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:52:32.03567|2017-10-11 00:52:32.03567
NCT02032966|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-07-06|||April 2011||2011-04-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||Surgical Versus Nonsurgical Treatment of Fibular Fractures: A Prospective Randomized Study|Outcomes Following Surgical Versus Nonsurgical Treatment of Fibular Fractures Following Operative Fixation of Unstable Medial Malleolus Fractures: A Prospective Randomized Study|Unknown status|Enrolling by invitation|N/A|150|Anticipated|University of Tennessee||3|||f||||f||||||||||2017-10-11 00:52:32.119317|2017-10-11 00:52:32.119317
NCT02032953|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-03-21|||December 2013||2013-12-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia|Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia|Active, not recruiting||Phase 4|24|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-10-11 00:52:32.19871|2017-10-11 00:52:32.19871
NCT02032940|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-03-17|||April 2013||2013-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|MRAtSLIP||Non-Enhanced Magnetic Resonance Angiography With the t-SLIP Technique|Non-Enhanced Magnetic Resonance Angiography With the t-SLIP Technique|Recruiting||N/A|200|Anticipated|Miami Cardiac and Vascular Institute|||2||f||||t||||||||No||2017-10-11 00:52:32.305083|2017-10-11 00:52:32.305083
NCT02032927|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-04-18|||June 2013|Actual|2013-06-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Treatment of Chronic Pain From Osteoarthritis|A COMPARATIVE STUDY BETWEEN TWO PHARMACOLOGICAL ASSOCIATIONS OXYCODONE/NALOXONE AND CODEINE / PARACETAMOL IN TREATMENT OF MODERATE-SEVERE CHRONIC PAIN DUE TO OSTEOARTHRITIS OF KNEE AND/OR HIP|Withdrawn||Phase 4|0|Actual|IRCCS Policlinico S. Matteo||2|||f||||f||||||||||2017-10-11 00:52:32.392049|2017-10-11 00:52:32.392049
NCT02032914|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-02-26|||January 2014||2014-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01|3 Months|Observational [Patient Registry]|||Prevalence of Colon Cancer in Pyogenic Liver Abscess|The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess|Completed||Phase 4|62|Actual|Inje University|||1||f||||f||||||||||2017-10-11 00:52:32.511911|2017-10-11 00:52:32.511911
NCT02032901|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-09-29|2015-08-12||January 2014||2014-01-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|ALLY 3||Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV|A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection|Completed||Phase 3|173|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:52:32.612351|2017-10-11 00:52:32.612351
NCT02032888|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2015-09-24|2015-08-21||February 2014||2014-02-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional||All participants who received at least 1 dose of active study therapy.|A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.|A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)|Completed||Phase 3|238|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 00:52:33.248978|2017-10-11 00:52:33.248978
NCT02032875|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2016-12-15|2015-08-18||March 2014||2014-03-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|November 2014|Actual|2014-11-01||Interventional|ALLY 1|All participants who received at least 1 dose of active study therapy.|Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant|A Phase 3 Evaluation of Daclatasvir, Sofosbuvir, and Ribavirin in Genotype 1-6 Chronic Hepatitis C Infection Subjects With Cirrhosis Who May Require Future Liver Transplant and Subjects Post-Liver Transplant|Completed||Phase 3|116|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 00:52:35.294756|2017-10-11 00:52:35.294756
NCT02032862|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-07-20|||December 2013||2013-12-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating|Multicentric, Randomized, Double Blind Study for Assessment of Efficacy and Tolerability of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating|Terminated||Phase 4|107|Actual|Bioforce AG||2||Insufficient recruitment rate|f||||f||||||||||2017-10-11 00:52:36.352171|2017-10-11 00:52:36.352171
NCT02032849|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2014-08-13|||February 2014||2014-02-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Air-impingement Manipulation to Clear Subglottic Secretion Compared With Drainage Tube in Prolonged Intubated Patients|Air-impingement Manipulation to Clear Subglottic Secretion Compared With Drainage Tube in Prolonged Intubated Patients, a Randomized Controlled Trial.|Unknown status|Recruiting|N/A|240|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-11 00:52:36.432526|2017-10-11 00:52:36.432526
NCT02032836|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-09|2017-07-30|||March 10, 2014|Actual|2014-03-10|July 2017|2017-07-01|September 21, 2017|Anticipated|2017-09-21|January 7, 2015|Actual|2015-01-07||Interventional|||Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)|A Multi-center, Open-label, Randomized Cross-over Study to Compare the Acute Tolerability and Pharmacokinetics of BAYQ6256 (Iloprost; Ventavis) Inhalation Using the I-Neb Nebulizer and the FOX Nebulizer in Patients With Pulmonary Arterial Hypertension|Active, not recruiting||Phase 1/Phase 2|27|Actual|Bayer||2|||f||||f|f|f||||||||2017-10-11 00:52:36.52782|2017-10-11 00:52:36.52782
NCT02032810|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-08-18|||January 7, 2014|Actual|2014-01-07|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma|A Phase 1 Study of HDAC Inhibitor Panobinostat (LBH 589) Administered in Combination With Ipilimumab in Subjects With Unresectable Stage III or Stage IV Melanoma|Active, not recruiting||Phase 1|17|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 00:52:42.514766|2017-10-11 00:52:42.514766
NCT02032797|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-09|||November 2012||2012-11-01|January 2014|2014-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|PROFETA-5||Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.|Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.|Unknown status|Recruiting|Phase 4|300|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 00:52:42.597114|2017-10-11 00:52:42.597114
NCT02032771|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-09-15|||January 2014||2014-01-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Impact of M22 Synergistic Sequential Treatment (SST)|Impact of M22 Synergistic Sequential Treatment (SST) Using Intense Pulsed Light and Fractional Non-ablative Photothermolysis on Skin Texture|Completed||N/A|33|Actual|Lumenis Ltd.||1|||f||||f||||||||||2017-10-11 00:52:42.751959|2017-10-11 00:52:42.751959
NCT02032758|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-06-10|2016-05-05||January 2014||2014-01-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study of Arm and Putter Movement in Golfers With Golfer's Cramp|Golfer's Cramp: Correlation of Wrist Movements and Surface EMG With Putter Movements|Completed||Phase 4|38|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 00:52:42.820543|2017-10-11 00:52:42.820543
NCT02032745|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2017-02-17|||August 2011||2011-08-01|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Observational|AGO-Austria||Genomic Signatures to Predict Treatment Response|Prospective Validation of Genomic Signatures to Predict Treatment Response in the Axillary Nodes After Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer|Recruiting||N/A|277|Anticipated|Medical University of Graz|||2||f||||t||||||Samples With DNA|"     Breast cancer tissue   "|||2017-10-11 00:52:43.052311|2017-10-11 00:52:43.052311
NCT02032732|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-07-06|||December 2013||2013-12-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Observational|||Utilization of Leukocyte Esterase in the Diagnosis of Pediatric Joint Infections|Utilization of Leukocyte Esterase in the Diagnosis of Pediatric Joint Infections|Unknown status|Enrolling by invitation|N/A|120|Anticipated|University of Tennessee|||2||f||||f||||||||||2017-10-11 00:52:43.122709|2017-10-11 00:52:43.122709
NCT02032719|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-09|||January 2013||2013-01-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Improved Self Management in Uncontrolled Systolic Hypertension|Investigating Improved Self Management in Uncontrolled Systolic Hypertension|Unknown status|Recruiting|Phase 3|65|Anticipated|York University||2|||f||||f||||||||||2017-10-11 00:52:43.187844|2017-10-11 00:52:43.187844
NCT02032706|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-03-04|2014-04-28||June 2013||2013-06-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||36 subjects were studied at baseline, 5 were dropped due to not meeting the required continuation criteria, 1 was dropped due to not following the protocol requirements. Follow-up PSG studies were conducted and data are available from the 30 participants who completed the study.|Validation of Safety and Efficacy for Night Shift Therapy|Validation of Safety and Efficacy for Night Shift Therapy|Completed||N/A|36|Actual|Advanced Brain Monitoring, Inc.||1|||f||||f||||||||||2017-10-11 00:52:43.415507|2017-10-11 00:52:43.415507
NCT02032693|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-05-22|||December 2013||2013-12-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Everycell's Effect on DNA Damage, Inflammation, and Stress|The Effect of Dietary Supplementation on DNA Damage, Inflammation, Stress, and Related Factors Important in Somatic and Stem Cell Senescence in Healthy Adults|Completed||N/A|30|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 00:52:43.713956|2017-10-11 00:52:43.713956
NCT02032680|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-05-31|||August 19, 2015|Actual|2015-08-19|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Comparison of E-health vs. In-person MFG|Comparison of E-Health vs. In-Person Delivered Family Psychoeducation Treatment|Recruiting||N/A|284|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||Undecided||2017-10-11 00:52:43.844442|2017-10-11 00:52:43.844442
NCT02032667|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2015-05-05|||September 2013||2013-09-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Exercise Games and Physical Activity: Can a Home-based Exergame System Increase Physical Activity?|Exercise Games and Physical Activity: Does Multi-player Online Play Improve Adherence?|Completed||N/A|72|Actual|University of Victoria||2|||f||||f||||||||||2017-10-11 00:52:43.959304|2017-10-11 00:52:43.959304
NCT02032641|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-01-24|2016-04-05||June 2013||2013-06-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Baseline characteristics refer to brows, not participants, as each participant underwent treatment of one brow and the other brow was a control.|Evaluation of Non-Ablative Laser for Treatment of Direct Brow Lift Scars|Evaluation of Non-Ablative Laser for Treatment of Direct Brow Lift Scars|Completed||N/A|9|Actual|University of Miami||2|||f||||f||||||||No|Submitted for publication but no individual participant data released|2017-10-11 00:52:44.258704|2017-10-11 00:52:44.258704
NCT02032628|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-01|||January 2014||2014-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|GEM||DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise|DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise|Active, not recruiting||N/A|276|Actual|University of Colorado, Boulder||4|||f||||t||||||||||2017-10-11 00:52:44.486299|2017-10-11 00:52:44.486299
NCT02032615|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-11-23|||April 2014||2014-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|LBWR||Let's be Well Red: Efficacy of Gudness Bars in Improving the Hemoglobin and Hematocrit Levels of Anemic Subjects|Let's Be Well Red (LBWR)|Completed||N/A|358|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:52:44.564712|2017-10-11 00:52:44.564712
NCT02032602|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-08-15|||January 2014||2014-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Dry Needling on Myofascial Trigger Points in Older Adults With Nonspecific Shoulder Pain|Efficacy of Dry Needling on Myofascial Trigger Points in Adults Over 65 Years Old With Non-specific Shoulder Pain: Single Blind Randomized Controlled Clinical Trial|Completed||N/A|66|Actual|University of Alcala||2|||f||||t||||||||||2017-10-11 00:52:44.790801|2017-10-11 00:52:44.790801
NCT02032589|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-01-09|||January 2014||2014-01-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Testing the Efficacy of Self-Generation Treatment Protocol|Exploring the Effects of a Memory Intervention on Memory and Everyday Life Activities With Persons With MS|Unknown status|Not yet recruiting|N/A|40|Anticipated|Kessler Foundation||2|||f||||f||||||||||2017-10-11 00:52:44.878205|2017-10-11 00:52:44.878205
NCT02032576|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2014-01-07|||January 2008||2008-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Predictors of the Response and Relapse/Recurrence After ECT for Depressed Patients||Completed||Phase 4|170|Actual|Kaohsiung Kai-Suan Psychiatric Hospital||1|||f||||t||||||||||2017-10-11 00:52:44.973199|2017-10-11 00:52:44.973199
NCT02032563|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-07-23|||December 2013||2013-12-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy|Study of the (Intravenously Injected) Indocyanine Green Distribution in Tumour Bearing Breasts and in Axillary Pieces of Dissection of Patients Who Have Received Neoadjuvant Therapy for Histologically Proven Mammary Cancer|Unknown status|Recruiting|Phase 2|20|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 00:52:45.085832|2017-10-11 00:52:45.085832
NCT02032550|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-04-28|||June 2013||2013-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment Preference and Patient Centered Prostate Cancer Care|Treatment Preference and Patient Centered Prostate Cancer Care|Active, not recruiting||N/A|800|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:52:45.186906|2017-10-11 00:52:45.186906
NCT02032537|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-08|||November 2014||2014-11-01|January 2014|2014-01-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Interventional|||Efficacy of Calmmax Cream in the Management of Chronic Uremic Pruritus||Unknown status|Not yet recruiting|N/A|28|Anticipated|Shaare Zedek Medical Center||2|||f||||||||||||||2017-10-11 00:52:45.300359|2017-10-11 00:52:45.300359
NCT02032524|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-06-01|||February 2014||2014-02-01|June 2017|2017-06-01|May 2020|Anticipated|2020-05-01|April 2020|Anticipated|2020-04-01||Interventional|NEO-EXT||NeoGAA Extension Study|An Open-Label, Multicenter, Multinational Extension Study Of The Long-Term Safety And Pharmacokinetics Of Repeated Biweekly Infusions Of NeoGAA In Patients With Pompe Disease|Enrolling by invitation||Phase 2/Phase 3|21|Anticipated|Sanofi||3|||f||||t||||||||||2017-10-11 00:52:45.399772|2017-10-11 00:52:45.399772
NCT02032511|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-01-05|||September 2013||2013-09-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Comparison of RAM Cannula Nasal Continuous Positive Airway Pressure Versus Infant Flow Nasal Continuous Positive Airway Pressure (NCPAP)|Comparison of RAM Cannula NCPAP Versus Infant Flow NCPAP|Terminated||N/A|19|Actual|University of Michigan|||2|No appreciable difference noted between methods of delivery|f||||||||||||||2017-10-11 00:52:45.535809|2017-10-11 00:52:45.535809
NCT02032498|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2014-07-23|||July 2013||2013-07-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Evaluation of Two Techniques for the SLN Detection in BC Patients|Evaluation of Near- InfraRed Imaging of ICG in Comparison With the Lymphoscintigraphic Technique Using Intramammary and Peritumoral Injection of 99mTc-HSA-Nanocolloids for the SLN Detection in BC Patients.|Unknown status|Recruiting|Phase 2|214|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 00:52:45.589063|2017-10-11 00:52:45.589063
NCT02032485|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2014-10-14|||March 2013||2013-03-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|OC-AP-ICG-IV||Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer|Feasibility Study of the (Intravenously Injected) Indocyanine Green (ICG) Imaging of Tumoral Implants in Patients With Peritoneal Carcinomatosis From Colorectal Cancer|Completed||Phase 2|10|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 00:52:45.753773|2017-10-11 00:52:45.753773
NCT02032472|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-01-07|||January 2010||2010-01-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|APOF||Efficiency of Monitoring and Control Program of Hypertension Through Pharmacy Offices. APOF Project|Efficiency Program Monitoring and Control of Hypertension Through Pharmacy Offices. APOF Project|Completed||N/A|677|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 00:52:45.830288|2017-10-11 00:52:45.830288
NCT02032290|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-01-08|||February 2014||2014-02-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel||Unknown status|Not yet recruiting|Phase 4|88|Anticipated|Azienda Policlinico Umberto I||2|||f||||||||||||||2017-10-11 00:52:47.46424|2017-10-11 00:52:47.46424
NCT02032459|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-01-08|||April 2007||2007-04-01|January 2014|2014-01-01||||September 2007|Actual|2007-09-01||Observational|||Vitamin D and Pregnancy: Camden Study|Vitamin D Status in Pregnant Women|Completed||N/A|1141|Actual|Rowan University|||1||f||||f||||||Samples With DNA|"     Blood and urine collection: Fasting (>8 h) maternal blood samples were collected at entry to     care and week 28 of gestation. Blood specimens were also collected at 1-hour of the 50g     glucose challenge test. Fasting blood samples collected at each visit were immediately     refrigerated and centrifuged at 4oC. Plasma and serum were preserved from each patient (at     -70oC) until assayed. 20 ml of urine was collected at entry to care and week 28 in metal free     plastic containers and stored at -70oC.   "|||2017-10-11 00:52:45.907278|2017-10-11 00:52:45.907278
NCT02032446|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-10-04|||September 2013||2013-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|PTC-UC-MSC||Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease|UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC) FOR THE TREATMENT OF SEVERE (GRADE III-IV) STEROID-RESISTANT GRAFT VERSUS HOST DISEASE (GvHD): A PHASE I/II TRIAL|Recruiting||Phase 1/Phase 2|47|Anticipated|A.O. Ospedale Papa Giovanni XXIII||1|||f||||t||||||||Yes|interim analysis|2017-10-11 00:52:45.995791|2017-10-11 00:52:45.995791
NCT02032433|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-03-21|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Interventional|||Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment|CTN-0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment|Completed||Phase 4|772|Actual|New York University School of Medicine||2|||f||||t|t|f||||||Yes|Data from this study will be available to researchers on the website, http://datashare.nida.nih.gov/ after the study is complete and the data analyzed. This website will not include information that can identify individual study participants.|2017-10-11 00:52:46.11651|2017-10-11 00:52:46.11651
NCT02032420|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-12-20|2016-10-25||October 2012||2012-10-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of the STAR Maneuver on UGRA Training|A Double Blinded Randomized Controlled Trial on the Effects of Four Sequential Maneuvers on Ultrasound Guided Nerve Block Performance|Completed||N/A|35|Actual|University of New Mexico||2|||f||||f||||||||||2017-10-11 00:52:46.242825|2017-10-11 00:52:46.242825
NCT02032407|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-08-11|2015-06-15||December 2013||2013-12-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional||Modified Intent-to treat population included all enrolled participants who received at least one application of study treatment and had at least one post-Baseline efficacy assessment.|A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris||Completed||Phase 4|68|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:52:46.559442|2017-10-11 00:52:46.559442
NCT02032394|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-08|||July 2013||2013-07-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|February 2014|Anticipated|2014-02-01||Interventional|||Effect of Chlorhexidine on Bacteriuria|Comparison of the Effect of Applying Povidone-iodine and Chlorhexidine Solutions for Perinea Washing on Bacteriuria Rate and Type in Patients With Urinary Catheter in Intensive Care Unit|Unknown status|Recruiting|Phase 4|105|Anticipated|Mashhad University of Medical Sciences||3|||f||||f||||||||||2017-10-11 00:52:46.834745|2017-10-11 00:52:46.834745
NCT02032381|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-10-11|||January 2014||2014-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|RESPPEDHEM||Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.|Prospective Study of Late Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.|Recruiting||N/A|500|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:52:46.9386|2017-10-11 00:52:46.9386
NCT02032368|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-08|||July 2010||2010-07-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence|Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence|Completed||N/A|57|Actual|Guangdong General Hospital||2|||f||||t||||||||||2017-10-11 00:52:47.02059|2017-10-11 00:52:47.02059
NCT02032355|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-09|||January 2014||2014-01-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Observational|||The Feasibility of PetCO2 Prediction Hypotension Under Spinal Anesthesia for Cesarean Section|The Feasibility of PetCO2 Prediction Hypotension Under Spinal Anesthesia for Cesarean Section|Unknown status|Recruiting|N/A|6|Anticipated|Fudan University|||1||f||||||||||||||2017-10-11 00:52:47.081906|2017-10-11 00:52:47.081906
NCT02032342|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-04-03|||January 2014||2014-01-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Selective Lobar Blockade and Bronchial Blockers|Selective Lobar Blockade: A Randomized Trial of Three Bronchial Blockers|Unknown status|Recruiting|Phase 2|60|Anticipated|Dammam University||4|||f||||t||||||||||2017-10-11 00:52:47.14782|2017-10-11 00:52:47.14782
NCT02032329|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-08|||January 2014||2014-01-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device|FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|customKYnetics||1|||f||||f||||||||||2017-10-11 00:52:47.235154|2017-10-11 00:52:47.235154
NCT02032316|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-01-13|||March 2014||2014-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|URIPRENE||Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy|URIPRENE: Feasibility Study to Evaluate the Preliminary Safety and Effectiveness of the Uriprene Stent Following Uncomplicated Ureteroscopy|Completed||Phase 1|8|Actual|Adva-Tec||1|||f||||t||||||||||2017-10-11 00:52:47.307121|2017-10-11 00:52:47.307121
NCT02032303|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-01-08|||February 2014||2014-02-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .||Unknown status|Not yet recruiting|Phase 4|88|Anticipated|Azienda Policlinico Umberto I||2|||f||||||||||||||2017-10-11 00:52:47.378948|2017-10-11 00:52:47.378948
NCT02020915|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-03-19|||October 2007||2007-10-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Ultrasound Guided Lateral Sphincterotomy: Long Term Results|Ultrasound Guided Lateral Sphincterotomy: Long Term Results|Unknown status|Recruiting|N/A|28|Anticipated|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 00:55:20.395426|2017-10-11 00:55:20.395426
NCT02032277|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-07-21||2017-03-02|April 2, 2014||2014-04-02|July 2017|2017-07-01|September 28, 2026|Anticipated|2026-09-28|March 18, 2016|Actual|2016-03-18||Interventional|||A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer|A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvant Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer (TNBC)|Active, not recruiting||Phase 3|624|Anticipated|AbbVie||3|||f||||t||||||||||2017-10-11 00:52:47.577982|2017-10-11 00:52:47.577982
NCT02032264|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-03-16|||December 2013||2013-12-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|nexgen||Next Generation Sequencing Screening for Embryonic Ploidy Status|Evaluation of the Efficacy of Next Generation Sequencing in Predicting Embryonic Karyotype and Subsequent Pregnancy Outcomes in in Vitro Fertilization Cycles (IVF)|Completed||N/A|309|Actual|Reproductive Medicine Associates of New Jersey||2|||f||||f||||||||||2017-10-11 00:52:48.150004|2017-10-11 00:52:48.150004
NCT02032251|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-08|||December 2009||2009-12-01|October 2009|2009-10-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Reduction of Sperm DNA Fragmentation by Oral Ginger|Reduction of Sperm DNA Fragmentation by Oral Ginger (Zingiberofficinale) Extract Treatment|Completed||Phase 2|71|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 00:52:48.376988|2017-10-11 00:52:48.376988
NCT02032238|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-07-12|2017-01-19||March 2013||2013-03-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema|Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema|Terminated||N/A|12|Actual|OD-OS GmbH||2||The number of anticipated participants was not achieved|f||||||||||||||2017-10-11 00:52:48.471974|2017-10-11 00:52:48.471974
NCT02032225|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-12-06|||February 2014||2014-02-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Generation of a Cellular Model of CADASIL From Skin Fibroblasts|Obtention d'un modèle Cellulaire de la Maladie CADASIL à Partir de Fibroblastes cutanés de Patients|Enrolling by invitation||N/A|10|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples Without DNA|"     Skin biopsies will be collected to derive fibroblasts. These will be retained and     reprogrammed to iPS cells (also to be retained). iPS cells will be differentiated in vascular     smooth muscle cells.   "|||2017-10-11 00:52:48.701125|2017-10-11 00:52:48.701125
NCT02032212|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-04-25|2016-02-12||December 2013||2013-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|May 2014|Actual|2014-05-01||Interventional|||A Bioavailability Study of Nicotine Delivered by an Electronic Vapour Product|A Randomised, Crossover, Relative Bioavailability Study of Nicotine Delivered by an Electronic Vapour Product, a Nicotine Inhalator and a Conventional Cigarette|Completed||Phase 1|12|Actual|Imperial Tobacco Group PLC||4|||f||||f||||||||No||2017-10-11 00:52:48.794004|2017-10-11 00:52:48.794004
NCT02032199|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-08|||April 2011||2011-04-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Observational|||Quality of Life Following Gastric Bypass Surgery.|A Prospective Analysis of Changes in Health-Related Quality of Life Following Roux-en-Y Gastric Bypass.|Completed||N/A|121|Actual|Odense University Hospital|||1||f||||||||||||||2017-10-11 00:52:49.290977|2017-10-11 00:52:49.290977
NCT02032186|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-03-10|||March 2014||2014-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy|A Randomized Clinical Trial of Oral Magnesium Supplementation In Pregnancy for the Prevention of Preterm Birth and Perinatal and Maternal Morbidity|Unknown status|Recruiting|Phase 3|3000|Anticipated|Professor Fernando Figueira Integral Medicine Institute||2|||f||||t||||||||||2017-10-11 00:52:49.364259|2017-10-11 00:52:49.364259
NCT02032160|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-02-05|||May 2014||2014-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||"A Study to Characterise Immune Responses Following Immunisations With Fendrix or Engerix B Hepatitis B Vaccines"|Study to Generate Exploratory Training Data Characterising Innate/ Adaptive Immune Responses Following 1st & 3rd Intra-muscular Immunisations With Fendrix/Engerix B Vaccines in Healthy Adult Males With no Pre-existing Immunity to Hep B|Completed||N/A|30|Actual|University of Surrey||2|||f||||f||||||||||2017-10-11 00:52:49.578532|2017-10-11 00:52:49.578532
NCT02032147|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2014-01-08|||March 2009||2009-03-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Treatment of Cerebral Radiation Necrosis (CRN) With Nerve Growth Factor (NGF)||Completed||N/A|30|Actual|Fudan University|||2||f||||||||||||||2017-10-11 00:52:49.663866|2017-10-11 00:52:49.663866
NCT02032134|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-07-27|||July 2015||2015-07-01|July 2015|2015-07-01|September 2016|Anticipated|2016-09-01|October 2015|Anticipated|2015-10-01||Interventional|MICE||Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia|Experimental Protocol for the Infusion of Platelets,Cryopreserved With Dimethyl Sulphoxide (DMSO) and Obtained From Multiple Donors Buffy Coats, in Patients With Severe Thrombocytopenia|Unknown status|Recruiting|Phase 4|15|Anticipated|University of Palermo||1|||f||||t||||||||||2017-10-11 00:52:49.729147|2017-10-11 00:52:49.729147
NCT02032121|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-09-08|||October 2007||2007-10-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors|Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors|Completed||N/A|6|Actual|University of Miami||1|||f||||f||||||||||2017-10-11 00:52:49.820052|2017-10-11 00:52:49.820052
NCT02027051|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-24|||January 2014||2014-01-01|January 2014|2014-01-01|January 2017|Anticipated|2017-01-01|June 2014|Anticipated|2014-06-01||Observational|||Etude génétique Des Arméniens|Etude génétique Des Arméniens|Unknown status|Recruiting|N/A|500|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples With DNA|"     Saliva samples   "|||2017-10-11 00:54:02.518592|2017-10-11 00:54:02.518592
NCT02032108|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-08|||March 2013||2013-03-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|LIDI||Effects of Lifestyle Education Programs on Diabetes Control in Rwanda|Effects of Lifestyle Education Programs on Diabetes Control Among Diabetic Patients at Kigali University Teaching Hospital Rwanda|Completed||N/A|250|Actual|Kigali University Teaching Hospital||1|||f||||f||||||||||2017-10-11 00:52:49.899424|2017-10-11 00:52:49.899424
NCT02032095|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-02-03|||November 2013||2013-11-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.|The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.|Completed||Phase 2/Phase 3|17|Actual|Japan Blood Products Organization||1|||f||||f||||||||||2017-10-11 00:52:49.969674|2017-10-11 00:52:49.969674
NCT02032082|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-03-13|||January 2014||2014-01-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Rule of Carbone Monoxyde in the Ex Vivo Lung Perfusion Reconditionning||Active, not recruiting||N/A|40|Actual|University Hospital of Mont-Godinne||2|||f||||||||||||||2017-10-11 00:52:50.038207|2017-10-11 00:52:50.038207
NCT02032069|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-03-13|||January 2013||2013-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Pneumoproteins Expression in the Organ Donor|Pneumoproteins Expression in the Organ Donor|Completed||N/A|20|Actual|University Hospital of Mont-Godinne|||2||f||||f||||||Samples With DNA|"     lung tissues and serum   "|||2017-10-11 00:52:50.105652|2017-10-11 00:52:50.105652
NCT02032056|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2014-06-18|||September 2013||2013-09-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|ProbiComp||Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period|The Effect of Probiotics in Reducing Infections and Allergic Manifestations in Young Children During the Complementary Feeding Period|Terminated||N/A|40|Actual|University of Copenhagen||3||Changes in study design|f||||f||||||||||2017-10-11 00:52:50.174744|2017-10-11 00:52:50.174744
NCT02032043|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-11-21|||February 2014||2014-02-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)|Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast|Recruiting||N/A|16000|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples Without DNA|"     Study procedures include collection of finger prick blood that will be tested for     microfilaremia and for serology testing (antigenemia and antibody testing). Investigators     will also collect skin snips (small superficial skin biopsies) to detect Onchocerca     microfilariae, and stool samples to detect parasitic worm eggs indicative of STH infections.      All assays will be performed in Ivory Coast(filarial serology tests, MF smears, stool     examinations).   "|||2017-10-11 00:52:50.268477|2017-10-11 00:52:50.268477
NCT02032030|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-06-01|||July 2012||2012-07-01|June 2017|2017-06-01|July 2022|Anticipated|2022-07-01|July 2020|Anticipated|2020-07-01|1 Year|Observational [Patient Registry]|SATISFY-SOS||Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys|SATISFY-SOS: Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys|Recruiting||N/A|36000|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 00:52:50.370327|2017-10-11 00:52:50.370327
NCT02032017|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-08|||October 2013||2013-10-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation.|Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation Compared to the Anterolateral Approach.|Unknown status|Recruiting|N/A|30|Anticipated|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-11 00:52:50.508253|2017-10-11 00:52:50.508253
NCT02032004|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-10-27|||January 2014||2014-01-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|DREAM HF-1||Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.|Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic)|Recruiting||Phase 3|600|Anticipated|Mesoblast, Ltd.||2|||f||||t||||||||Yes||2017-10-11 00:52:50.632938|2017-10-11 00:52:50.632938
NCT02031991|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-08-14|||January 2014||2014-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)|Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study Of PF-06439535 And Bevacizumab Sourced From US And EU Administered To Healthy Male Volunteers|Completed||Phase 1|102|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:52:50.945452|2017-10-11 00:52:50.945452
NCT02031978|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-11-07|||July 2013||2013-07-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|December 2018|Anticipated|2018-12-01||Observational|||Feeding My Baby - A National WIC Study|Women, Infant, and Children (WIC) Infant-Toddler Feeding Practices Study - II (ITFPS-2)|Active, not recruiting||N/A|4435|Anticipated|USDA Food and Nutrition Service|||1||f||||f||||||||||2017-10-11 00:52:51.192446|2017-10-11 00:52:51.192446
NCT02031965|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-05-26|||December 2013||2013-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery|A Phase I Study of Intratumoral/Peritumoral Herpes Simplex Virus-1 Mutant HSV1716 in Patients With Refractory or Recurrent High Grade Gliomas (HGG)|Terminated||Phase 1|2|Actual|Pediatric Brain Tumor Consortium||1|||f||||||||||||||2017-10-11 00:52:51.268007|2017-10-11 00:52:51.268007
NCT02031952|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-04|2014-01-08|||December 2005||2005-12-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|December 2010|Actual|2010-12-01||Interventional|||Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma|Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma ----A Prospective Randomized Controlled Clinical Trail|Completed||N/A|87|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:52:51.364972|2017-10-11 00:52:51.364972
NCT02031939|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-04-25|||January 2014||2014-01-01|April 2017|2017-04-01|January 2023|Anticipated|2023-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer|Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer|Recruiting||Phase 3|556|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:52:51.440704|2017-10-11 00:52:51.440704
NCT02031926|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-08|||November 2012||2012-11-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of Correct PEP Use With the Time|Evaluation of the Reproductibility of the Pressure Generated by a Positive Expiratory Pressure Device|Completed||N/A|30|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||||||||||||2017-10-11 00:52:51.546394|2017-10-11 00:52:51.546394
NCT02031913|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-10-13|||January 2013||2013-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01|20 Years|Observational [Patient Registry]|||Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD|Association Between Insulin Resistance and Hepatic Fibrosis in Combined Chronic Hepatitis B and Non-alcoholic Fatty Liver Disease|Recruiting||N/A|500|Anticipated|Seoul National University Boramae Hospital|||2||f||||f||||||Samples Without DNA|"     We intended to collect sera from registered subjects, but no biospecimens are to be retained     yet.   "|No||2017-10-11 00:52:51.638492|2017-10-11 00:52:51.638492
NCT02031900|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-03-21|||October 2013||2013-10-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||High Resolution Optical Imaging of the Esophagus Using the NvisionVLE™ Imaging System||Completed||N/A|10|Actual|NinePoint Medical|||1||f||||||||||||||2017-10-11 00:52:51.757876|2017-10-11 00:52:51.757876
NCT02031887|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-07|||October 2008||2008-10-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|February 2013|Actual|2013-02-01||Interventional|||Effect of a Starter Formula With Synbiotics on Stool Microbiota in Infants After Normal or Caesarean Section Delivery|Effect of a Starter Formula With Synbiotics on Stool Microbiota in Infants After Normal or Caesarean Section Delivery|Terminated||N/A|430|Actual|Nestlé||2||"South African Health Authorities now promote that HIV positive mothers should receive   anti-retroviral drugs and breastfeed their infants."|f||||f||||||||||2017-10-11 00:52:51.836199|2017-10-11 00:52:51.836199
NCT02031874|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-04-23|||December 2009||2009-12-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|September 2010|Actual|2010-09-01||Observational|||Immunogenicity of Inactivated Swine H1N1 Vaccine In HIV Infected Children - The Miami Cohort Study|Immunogenicity of Inactivated Swine H1N1 Vaccine In HIV Infected Children - The Miami Cohort Study|Completed||N/A|33|Actual|University of Miami|||1||f||||f||||||Samples With DNA|"     Frozen PBMC for future experiments as per results.   "|||2017-10-11 00:52:51.927308|2017-10-11 00:52:51.927308
NCT02031861|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-02-03|||February 2014||2014-02-01|April 2014|2014-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension|Random, Open Label, Active Comparator-controlled Parallel Study to Evaluate the Efficacy of Nifedipine Controlled-released Tablets (Xin Ran) in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 4|38|Actual|Shanghai Shyndec Pharmaceutical Co.,Ltd.||2|||f||||f||||||||||2017-10-11 00:52:52.028325|2017-10-11 00:52:52.028325
NCT02031848|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-07|||September 2008||2008-09-01|January 2014|2014-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Brain Function Predictors And Outcome Of Weight Loss And Weight Loss Maintenance|Brain Function Predictors And Outcome Of Weight Loss And Weight Loss Maintenance|Completed||N/A|137|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 00:52:52.755997|2017-10-11 00:52:52.755997
NCT02031835|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-05-31|||March 2012||2012-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Body Weight Supported Treadmill Training as Physical Therapy Treatment to Spinal Cord Injury Patients|Body Weight Supported Treadmill Training as Physical Therapy Treatment to Spinal Cord Injury Patients|Recruiting||N/A|50|Anticipated|University of Ioannina||1|||f||||f||||||||||2017-10-11 00:52:52.87216|2017-10-11 00:52:52.87216
NCT02031822|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-06-19|||June 2014||2014-06-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|GON||Two US-guided Techniques for Greater Occipital Nerve Blocks|Evaluation of Two Ultrasound-guided Techniques for Greater Occipital Nerve Injections of Local Anesthetic and Steroid for Treatment of Primary Headaches|Recruiting||N/A|40|Anticipated|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-11 00:52:52.98698|2017-10-11 00:52:52.98698
NCT02031809|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-08|||January 2014||2014-01-01|January 2014|2014-01-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Observational|||Multicentric Study VATS Major Introperative Complications|Analysis of the Most Common Major Intraoperative Complications During Video-assisted Thoracoscopic Surgery (VATS) Anatomical Resections - On Behalf of MITIG-ESTS|Unknown status|Active, not recruiting|N/A|2000|Anticipated|University Hospital, Gasthuisberg|||2||f||||f||||||||||2017-10-11 00:52:53.107754|2017-10-11 00:52:53.107754
NCT02031796|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-05-21|||February 2014||2014-02-01|May 2015|2015-05-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|CAVAREC||Cardiac Vascular Reconstruction DynaCT for TAVI Procedures|Cardiac Vascular Reconstruction (CAVAREC) DynaCT for 3D Assessment of Aortic Valve During TAVI Procedures|Unknown status|Recruiting|N/A|22|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 00:52:53.202187|2017-10-11 00:52:53.202187
NCT02031783|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-07-08|||November 2013||2013-11-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Glucose:Fructose Versus Glucose Carbohydrate Ingestion and Endurance Performance||Completed||N/A|74|Actual|Nestlé||2|||f||||||||||||||2017-10-11 00:52:53.303553|2017-10-11 00:52:53.303553
NCT02031770|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-04-29|||January 2014||2014-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Metabolic Acidosis and Vascular Function in Patients With Chronic Kidney Disease|Effect of Treatment of Metabolic Acidosis on Vascular Function in Patients With Chronic Kidney Disease: A Pilot Study|Completed||N/A|20|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 00:52:53.39646|2017-10-11 00:52:53.39646
NCT02031757|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-04-04|||December 2013||2013-12-01|October 2013|2013-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Controlled-perturbation Gait Training on Gait Rehabilitation and Fear of Falling in Individuals With Gait Impairments|The Effectiveness of Controlled-perturbation Gait Training on Gait Rehabilitation and Fear of Falling in Individuals With Gait Impairments.|Not yet recruiting||N/A|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 00:52:53.51691|2017-10-11 00:52:53.51691
NCT02031432|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-05-10|||December 2013||2013-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|CORAL XT||CORAL XT - Open-label Extension Trial of the CORAL Trial|An Open-label, Multi-site Trial to Describe the Safety and Tolerability of Oral Cebranopadol Administered for 26 Weeks in Subjects With Cancer-related Pain Who Have Completed Treatment in the KF6005/07 Trial.|Completed||Phase 3|76|Actual|Grünenthal GmbH||1|||f||||f||||||||||2017-10-11 00:53:03.603416|2017-10-11 00:53:03.603416
NCT02031744|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-03-10|||January 22, 2014|Actual|2014-01-22|March 2017|2017-03-01|January 6, 2016|Actual|2016-01-06|January 6, 2016|Actual|2016-01-06||Interventional|||A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer|A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Onartuzumab (MetMAb) in Combination With Erlotinib as Second- or Third-Line Treatment for Patients With MET-Positive Incurable Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 3|530|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:52:53.628091|2017-10-11 00:52:53.628091
NCT02031731|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-03-10|||January 13, 2014|Actual|2014-01-13|March 2017|2017-03-01|April 14, 2014|Actual|2014-04-14|April 14, 2014|Actual|2014-04-14||Interventional|||The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors|A PHASE I STUDY OF THE PHARMACOKINETICS AND SAFETY OF ONARTUZUMAB IN CHINESE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS|Completed||Phase 1|30|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:52:53.74483|2017-10-11 00:52:53.74483
NCT02031718|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-02-26|||January 2014||2014-01-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone|Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone|Completed||N/A|98|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 00:52:53.870818|2017-10-11 00:52:53.870818
NCT02031705|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-04-24|||July 2012||2012-07-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Cavotricuspid Isthmus Ablation in Patients Without History of Typical Flutter During Ablation|Effect of Cavotricuspid Isthmus Ablation in Patients Without History of Typical Flutter During Ablation for Paroxysmal Atrial Fibrillation|Recruiting||Phase 3|486|Anticipated|Seoul St. Mary's Hospital||2|||f||||f||||||||No||2017-10-11 00:52:53.968294|2017-10-11 00:52:53.968294
NCT02031692|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-11-22|||December 2013||2013-12-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in BPPV|Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in Benign Paroxysmal Positional Vertigo: A Prospective Multicenter Randomized Trial|Recruiting||Phase 4|2018|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 00:52:54.069567|2017-10-11 00:52:54.069567
NCT02031679|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-06-13|2017-04-04||January 2014|Actual|2014-01-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Participants were randomized to AZD1981 or placebo at the end of placebo-run in, not at baseline. Values below reflect randomized subjects.|Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines|A Phase IIa, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of the CRTh2 Antagonist AZD1981 in Patients With Chronic Idiopathic Urticaria (CIU) Who Are Refractory to H1 Antihistamines|Completed||Phase 2|38|Actual|Johns Hopkins University|Among the limitations of this study are the small number of subjects, short duration of therapy and washout periods, and the lack of skin tissue biopsies to correspond with peripheral blood leukocyte findings.|2|||f||||f||||||||No||2017-10-11 00:52:54.209065|2017-10-11 00:52:54.209065
NCT02031666|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-10-19|||December 2013||2013-12-01|October 2016|2016-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 in Healthy Male Participants|A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 Under Fasted Conditions in Healthy Male Subjects|Completed||Phase 1|120|Actual|Aragon Pharmaceuticals, Inc.||8|||f||||f||||||||||2017-10-11 00:52:54.817434|2017-10-11 00:52:54.817434
NCT02031653|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2015-02-12|||January 2014||2014-01-01|January 2014|2014-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Comparison Between Invasive Pressure Flow Study and Non-invasive Penile Cuff Test||Unknown status|Recruiting|N/A|193|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:52:54.913851|2017-10-11 00:52:54.913851
NCT02031627|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-04-26|||December 2013||2013-12-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device|Physiologic Response to Varying Lymphoedema Compression Programs With the Flexitouch System|Recruiting||N/A|30|Anticipated|Tactile Medical||3|||f||||f||||||||||2017-10-11 00:52:55.648466|2017-10-11 00:52:55.648466
NCT02031614|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-08|||January 2014||2014-01-01|January 2014|2014-01-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||The Immunomodulatory Effects of Phlebotomy|The Immunomodulatory Effects of Phlebotomy|Unknown status|Not yet recruiting|N/A|10|Anticipated|Radboud University||1|||f||||t||||||||||2017-10-11 00:52:55.764504|2017-10-11 00:52:55.764504
NCT02031601|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-03-28|||January 2014||2014-01-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|TCL-1||Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer|Randomised, Controlled Study Comparing Chemotherapy Plus Intercalated EGFR-Tyrosine Kinase Inhibitors Combination Therapy With EGFR-Tyrosine Kinase Inhibitors Alone Therapy as First-line Treatment for Patients With Non-Small-Cell Lung Cancer|Recruiting||Phase 4|250|Anticipated|Qilu Hospital of Shandong University||2|||f||||||||||||||2017-10-11 00:52:55.872549|2017-10-11 00:52:55.872549
NCT02027038|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2014-01-01|||August 2011||2011-08-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Pelvic Belt Effects on Osseous Anatomy, Muscule Activation and Ground Reaction Forces||Completed||N/A|42|Actual|University of Leipzig||2|||f||||f||||||||||2017-10-11 00:54:04.482295|2017-10-11 00:54:04.482295
NCT02031588|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-12-08|||December 2012||2012-12-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Observational|EVOTAR||Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.|Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.|Terminated||N/A|77|Actual|Assistance Publique - Hôpitaux de Paris|||4|lack of recruitement|f||||f||||||Samples With DNA|"     Stool samples will be collected on 4 separate days for patients treated with antibiotics:      T0: before treatment begins T1: at the end of treatment or discharge from the hospital T2:     3-6 months after the end of treatment T3: 10-14 months after the end of treatment For     patients receiving sequentially ceftriaxone followed by a FQ, an additional sample will be     collected at the end of ceftriaxone treatment.      In the reference group, stool samples will be collected:      T0: at inclusion in the study T1: at hospital discharge The purpose is to study the bacterial     DNA contained in the stool. No analysis will be performed on the human patient DNA.      Changes in the gut microflora will be analysed by metagenomics deep sequencing performed by     Dushko Ehrlich (INRA, France).   "|||2017-10-11 00:52:55.974714|2017-10-11 00:52:55.974714
NCT02031575|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-08-17|||January 2014||2014-01-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Interventional|SMART||Study on Mhealth and Reproductive Health in Teens|Study on Mhealth and Reproductive Health in Teens|Completed||N/A|1419|Actual|Harvard University||3|||f||||||||||||||2017-10-11 00:52:56.054365|2017-10-11 00:52:56.054365
NCT02031562|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-01-08|||October 2009||2009-10-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Geriatrics Balance and Low Back Pain Study|Geriatric Balance and Low Back Pain and Balance Assessment and Management|Completed||N/A|169|Actual|Logan College of Chiropractic||2|||f||||t||||||||||2017-10-11 00:52:56.137499|2017-10-11 00:52:56.137499
NCT02031549|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-03-04|||January 2014||2014-01-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Observational|||Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation|Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation|Completed||N/A|40|Actual|Fertility Center of Las Vegas|||1||f||||f||||||||||2017-10-11 00:52:56.241557|2017-10-11 00:52:56.241557
NCT02031523|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-11-18|||October 2013||2013-10-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis|A Randomized, Double-blind, Placebo-controlled Post-marketing Study to Assess the Treatment Effect of Sanjie Analgesic Capsule in Treating Endometriosis - Associated Pain|Unknown status|Recruiting|Phase 4|400|Anticipated|Jiangsu Kanion Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-11 00:52:56.414441|2017-10-11 00:52:56.414441
NCT02031510|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-04-03|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Dexmedetomidine in Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy|Dexmedetomidine as an Adjuvant to Bupivacaine in Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy: Multicentre Study|Completed||Phase 1/Phase 2|195|Actual|Dammam University||3|||f||||t||||||||||2017-10-11 00:52:56.583868|2017-10-11 00:52:56.583868
NCT02031497|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2017-03-02|||October 2012||2012-10-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|SEDULC||Comparison of the Effects of a 12-Week Consumption of Two Carbonated Beverages on Insulin Sensitivity||Completed||N/A|60|Actual|Institute For European Expertise in Physiology||2|||f||||f||||||||||2017-10-11 00:52:56.67288|2017-10-11 00:52:56.67288
NCT02031484|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2016-10-05|||July 2016||2016-07-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial|Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial|Enrolling by invitation||N/A|50|Anticipated|Bardy Diagnostics, Inc.|||1||f||||f||||||||||2017-10-11 00:52:56.789347|2017-10-11 00:52:56.789347
NCT02031471|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-06-23|2016-11-01||January 2014||2014-01-01|June 2017|2017-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||The full analysis set (FAS) consisted of all participants included in the study who received at least one dose of subcutaneous tocilizumab.|TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra Treatment|TOSCARA: An Open-label, Single Arm Study to Evaluate the Efficacy, Safety and Tolerability of Tocilizumab (TCZ) Subcutaneous in TCZ-naïve Patients With Active Rheumatoid Arthritis|Completed||Phase 3|57|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:52:56.888172|2017-10-11 00:52:56.888172
NCT02031458|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-04-07|2016-10-24|2016-06-15|January 2014||2014-01-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|November 2016|Actual|2016-11-01||Interventional|BIRCH|Efficacy evaluable population included all enrolled participants who received any dose of the study drug (atezolizumab) during the study treatment period.|A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II, Multicenter, Single-Arm Study OF Atezolizumab In Patients With PD-L1-Positive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|659|Actual|Hoffmann-La Roche|The data was up to primary completion date.|1|||f||||||||||||||2017-10-11 00:52:59.79898|2017-10-11 00:52:59.79898
NCT02031445|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-05-05|||August 2014||2014-08-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|C012013||Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% in Pediatric Subjects With Mild to Moderate Atopic Dermatitis Followed by an Open Label Extension|Terminated||Phase 2|73|Actual|AKARI Therapeutics||2||Interim analysis showed lack of efficacy|f||||f||||||||||2017-10-11 00:53:03.483794|2017-10-11 00:53:03.483794
NCT02031042|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-09-09|||October 2010||2010-10-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer|Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer|Completed||N/A|224|Actual|Stockholm South General Hospital|||1||f||||f||||||||No||2017-10-11 00:53:06.766707|2017-10-11 00:53:06.766707
NCT02031419|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-09-27|||December 18, 2013|Actual|2013-12-18|September 2017|2017-09-01|December 15, 2019|Anticipated|2019-12-15|December 15, 2019|Anticipated|2019-12-15||Interventional|||Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma|A Phase 1B, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma.|Recruiting||Phase 1|170|Anticipated|Celgene||3|||f||||f||||||||||2017-10-11 00:53:03.768785|2017-10-11 00:53:03.768785
NCT02031406|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-08-14|||January 2014||2014-01-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|February 2014|Actual|2014-02-01||Interventional|||Impact of Pharmacist Post-discharge Phone Calls on Hospital Readmission and Patient Medication Literacy and Adherence|Impact of Pharmacist Post-discharge Phone Calls on Hospital Readmission and Patient Medication Literacy and Adherence|Terminated||N/A|155|Actual|Cedars-Sinai Medical Center||2||"This trial was started, but data collection was inadequate. Analysis was thus terminated.   Further exploration of this research question is being planned."|f||||||||||||||2017-10-11 00:53:03.916376|2017-10-11 00:53:03.916376
NCT02031393|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-30|||September 2009||2009-09-01|December 2013|2013-12-01|July 2014|Anticipated|2014-07-01|January 2014|Actual|2014-01-01|9 Months|Observational [Patient Registry]|||Establishing First Trimester Markers for the Identification of High Risk Twin|Establishing First Trimester Sonographic, Biochemical and Clinical Markers for the Identification of High Risk Twin in the First Trimester|Unknown status|Active, not recruiting|N/A|300|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||Samples Without DNA|"     Maternal serum   "|||2017-10-11 00:53:03.988709|2017-10-11 00:53:03.988709
NCT02031380|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-12-06|||April 2014||2014-04-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||iDropper Usability in Glaucoma|Improving Ophthalmic Medication Adherence|Withdrawn||Phase 1|0|Actual|Care Team Solutions||1||Funding|f||||t||||||||||2017-10-11 00:53:04.05429|2017-10-11 00:53:04.05429
NCT02031367|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-08|2014-01-08|||March 2014||2014-03-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater Trochanteric Pain Syndrome|Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater|Unknown status|Not yet recruiting|Early Phase 1|50|Anticipated|C.R.Darnall Army Medical Center||2|||f||||t||||||||||2017-10-11 00:53:04.158804|2017-10-11 00:53:04.158804
NCT02031354|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-04-21|||January 2014||2014-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure|"Prospective Pre-post Pilot Study on the Effects of Dietary Chloride Supplementation on Neurohormonal and Diuretic Function in Patients With Heart Failure"|Recruiting||N/A|50|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 00:53:04.259664|2017-10-11 00:53:04.259664
NCT02031341|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-12-08|||January 2014||2014-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|PEAKS||Peripheral Insulin Uptake in Type 2 Diabetes Mellitus and in Non-Diabetic Individuals|Peripheral Insulin Uptake in Type 2 Diabetes Mellitus and in Non-Diabetic Individuals|Completed||N/A|100|Anticipated|VU University Medical Center|||2||f||||f||||||Samples With DNA|"     Blood will be collected   "|||2017-10-11 00:53:04.34234|2017-10-11 00:53:04.34234
NCT02031328|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|2STAR||Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer|Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 00:53:04.402968|2017-10-11 00:53:04.402968
NCT02031315|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-09|||January 2014||2014-01-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01|72 Months|Observational [Patient Registry]|DOUALA-SD||Epidemiology of Sudden Death in Cameroon|Sudden Death in Sub-Saharan Africa: Design and Protocol of The DOUALA-SD Prospective Survey|Unknown status|Recruiting|N/A|240000|Anticipated|Cameroon Resuscitation Council|||1||f||||t||||||||||2017-10-11 00:53:04.586816|2017-10-11 00:53:04.586816
NCT02031302|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-07-28|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2017|Actual|2017-05-01||Observational|RESPOND||RESPOND Post Market Study|RESPOND: Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes|Active, not recruiting||N/A|1064|Actual|Boston Scientific Corporation|||2||f||||f|f|f||||||||2017-10-11 00:53:04.683392|2017-10-11 00:53:04.683392
NCT02031289|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-04|||December 2013||2013-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.|Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.|Recruiting||Phase 4|1000|Anticipated|University of Zurich||3|||f||||t||||||||||2017-10-11 00:53:04.778256|2017-10-11 00:53:04.778256
NCT02031276|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-11-30||2016-11-30|February 2014||2014-02-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.|A Phase II, Multicenter, Randomized, Double-blind, Multiple Dose, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of BI 655066/ABBV-066 (Risankizumab), an IL-23 p19 Antagonist Monoclonal Antibody, in Patients With Moderately to Severely Active Crohn's Disease, Who Are naïve to, or Were Previously Treated With Anti-TNF Therapy|Completed||Phase 2|121|Actual|AbbVie||5|||f||||t||||||||||2017-10-11 00:53:04.906702|2017-10-11 00:53:04.906702
NCT02031263|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-08-15|||February 2014||2014-02-01|August 2014|2014-08-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Efficacy of Bronchial Thermoplasty in Korean|Efficacy of Bronchial Thermoplasty in Korean Patients With Severe Asthma|Unknown status|Recruiting|Phase 4|9|Anticipated|Asan Medical Center||1|||f||||t||||||||||2017-10-11 00:53:05.09427|2017-10-11 00:53:05.09427
NCT02031250|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-09-05|||February 2014||2014-02-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer|Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer|Recruiting||Phase 2|80|Anticipated|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 00:53:05.179528|2017-10-11 00:53:05.179528
NCT02031224|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-01-24|||March 2008||2008-03-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|KETOPROG||Supplemented Very Low Protein Diet and the Progression of Chronic Kidney Disease|Effect of Very Low Protein Diet Supplemented With Ketoanalogues of the Essential Amino Acids on the Progression of Chronic Kidney Disease|Completed||Phase 4|250|Actual|Anemia Working Group Romania||2|||f||||t||||||||||2017-10-11 00:53:05.36628|2017-10-11 00:53:05.36628
NCT02031211|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-10-12|||June 2014||2014-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial|Etanercept for the Treatment of Chronic Regional Pain Syndrome|Withdrawn||N/A|0|Actual|Stanford University||2||No participants enrolled.|f||||||||||||||2017-10-11 00:53:05.468339|2017-10-11 00:53:05.468339
NCT02031198|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-03-15|||January 2014||2014-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|FUNDAMANT||18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease|"An 18-months Open Label Phase I Follow-up Study on Patients With Alzheimer's Disease Who Have Completed the AADvac1 Phase I Study AXON CO 18700"|Completed||Phase 1|25|Actual|Axon Neuroscience SE||1|||f||||t||||||||||2017-10-11 00:53:05.546326|2017-10-11 00:53:05.546326
NCT02031185|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-04-12|||March 2014||2014-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Wearable mHealth Device to Promote Teenagers' Physical Activity|A Wearable mHealth Device to Promote Teenagers' Physical Activity: A Pilot RCT|Completed||N/A|40|Actual|Seattle Children's Hospital||3|||f||||f||||||||||2017-10-11 00:53:05.62984|2017-10-11 00:53:05.62984
NCT02031172|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-08-19|||March 2014||2014-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Effects of Sustained Reading on the Ocular Surface|Effects of Sustained Reading on the Ocular Surface|Terminated||N/A|34|Actual|University of Rochester|||3|PI is moving to a different institution.|f||||f||||||||||2017-10-11 00:53:05.700976|2017-10-11 00:53:05.700976
NCT02031159|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2014-05-15|||October 2013||2013-10-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Correlation, Accuracy, Precision and Practicability of Zero Heat Flux Temperature Monitoring|Correlation, Accuracy, Precision and Practicability of Zero Heat Flux Method in Comparison With Sublingual and Nasopharyngeal Temperature Measurement|Completed||N/A|120|Actual|University of Schleswig-Holstein|||1||f||||t||||||||||2017-10-11 00:53:05.771073|2017-10-11 00:53:05.771073
NCT02031146|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-05-24|||August 2013||2013-08-01|May 2017|2017-05-01||||June 2019|Anticipated|2019-06-01||Interventional|||Lumbar Puncture and Syphilis Outcome|Lumbar Puncture and Syphilis Outcome|Recruiting||N/A|280|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 00:53:06.046231|2017-10-11 00:53:06.046231
NCT02031133|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-11-17|||January 2014||2014-01-01|November 2014|2014-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Long-term Extension to Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C|Long-term Extension to a Phase 2, Open-Label, Clinical Trial of Miravirsen Sodium in Null Responders to Pegylated-Interferon Alpha Plus Ribavirin in Subjects With Chronic Hepatitis C (CHC) Virus Genotype 1 Infection|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|Santaris Pharma A/S|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 00:53:06.136145|2017-10-11 00:53:06.136145
NCT02031120|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2014-01-08|||January 2014||2014-01-01|January 2014|2014-01-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01|2 Years|Observational [Patient Registry]|DHC||Management of Drug Hypersensitivity in Children|Improved Management Based on Pathophysiology of Drug Hypersensitivity in Childhood|Recruiting||N/A|250|Anticipated|University Hospital, Geneva|||1||f||||t||||||Samples With DNA|"     whole blood, serum, white cells   "|||2017-10-11 00:53:06.218949|2017-10-11 00:53:06.218949
NCT02031107|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-05-11|||September 2013||2013-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Randomized Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation|Randomized Controlled Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation in Subacute Stroke|Completed||N/A|41|Actual|University Hospital, Geneva||3|||f||||f||||||||||2017-10-11 00:53:06.299585|2017-10-11 00:53:06.299585
NCT02031094|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-10-15|||January 2014||2014-01-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|EAGLE||Energy Expenditure and Regeneration Following Liver Resection Resection|The Effect of Liver Regeneration on Resting Energy Expenditure After Liver Resectional Surgery|Completed||N/A|28|Actual|University of Edinburgh|||2||f||||f||||||||||2017-10-11 00:53:06.404002|2017-10-11 00:53:06.404002
NCT02031081|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2016-08-18|||March 2014||2014-03-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Prucalopride Versus Placebo in Gastroparesis|Prucalopride Versus Placebo in Gastroparesis: Randomized Placebo-controlled Crossover Trial|Recruiting||Phase 2/Phase 3|30|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 00:53:06.478985|2017-10-11 00:53:06.478985
NCT02031068|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-04-07|||December 2013||2013-12-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Exercise for Adolescents Following Sport-Related Concussion: A Randomized Control Trial|Active Rehabilitation for Slow to Recover Adolescents Following Sport-Related Concussion: A Randomized Control Trial|Unknown status|Recruiting|N/A|30|Anticipated|University of British Columbia||2|||f||||||||||||||2017-10-11 00:53:06.568289|2017-10-11 00:53:06.568289
NCT02031055|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-06-15|||February 2014||2014-02-01|June 2017|2017-06-01|June 17, 2015|Actual|2015-06-17|November 2014|Actual|2014-11-01||Interventional|||Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors|A Phase 1, Open-label Study to Evaluate the Mass Balance of Orally Administered FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors|Completed||Phase 1|8|Actual|Taiho Oncology, Inc.||2|||f||||f||||||||||2017-10-11 00:53:06.666268|2017-10-11 00:53:06.666268
NCT02027025|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2017-05-23|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|September 1, 2017|Anticipated|2017-09-01|April 28, 2017|Actual|2017-04-28||Interventional|||Study of SPARC1103 in Subject With Spasticity||Active, not recruiting||Phase 2|135|Anticipated|Sun Pharma Advanced Research Company Limited||3|||f||||f||||||||||2017-10-11 00:54:04.614035|2017-10-11 00:54:04.614035
NCT02031029|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-03-30|||December 2013|Actual|2013-12-01|March 2017|2017-03-01|December 18, 2015|Actual|2015-12-18|December 18, 2015|Actual|2015-12-18|2 Years|Observational [Patient Registry]|||Character Traits and Stress in Suspected Prostate Cancer|A Questionnaire Study by Elevated Prostate Specific Antigen (PSA): Do Men Where Subsequent Assessment Shows Prostate Cancer, Higher Levels of Neuroticism and Stress Compared to Those Who do Not Get the Diagnosis?|Terminated||N/A|51|Actual|Helse Stavanger HF|||1|Stopped by the sponsor due to discrepancies in the recruitment process.|f||||f|f|f||||Samples With DNA|"     Blood samples   "|No||2017-10-11 00:53:06.993633|2017-10-11 00:53:06.993633
NCT02031016|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-10-15|||February 2014||2014-02-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|REFLECT||Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain|A Randomised Clinical Trial Evaluating the Effect of Remifentanil vs Fentanyl During Cardiac Surgery on the Incidence of Chronic Thoracic Pain|Completed||Phase 4|126|Actual|St. Antonius Hospital||2|||f||||||||||||||2017-10-11 00:53:07.073911|2017-10-11 00:53:07.073911
NCT02031003|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-01-07|||September 2010||2010-09-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|9055A1-2000||Effect of Infant Formulas Containing a New Fat Blend or the New Fat Blend Plus Fiber in Healthy Term Infants|Effect of an Infant Formula With High 2-Palmitic Vegetable Oil or an Identical Formula Supplemented With Oligofructose on Stool Composition and Stool Characteristics in Healthy Term Infants in Taiwan|Completed||N/A|220|Actual|Nestlé||4|||f||||f||||||||||2017-10-11 00:53:07.196435|2017-10-11 00:53:07.196435
NCT02030990|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-12-07|||August 2014||2014-08-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements|The Use of Intraoperative Mitomycin-C During Photorefractive Keratectomy and Its Effect on Postoperative Topical Steroid Requirements|Recruiting||Phase 2/Phase 3|300|Anticipated|United States Naval Medical Center, San Diego||3|||f||||t||||||||||2017-10-11 00:53:07.281532|2017-10-11 00:53:07.281532
NCT02030977|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2014-01-07|||June 2012||2012-06-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis|The Effects of Resveratrol Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis|Completed||Phase 2/Phase 3|50|Actual|National Nutrition and Food Technology Institute||2|||f||||||||||||||2017-10-11 00:53:07.396922|2017-10-11 00:53:07.396922
NCT02030964|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-08-11|||December 2013||2013-12-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|DFMO||N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan|N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan for Patients With Relapsed or Refractory Neuroblastoma|Active, not recruiting||Phase 1|30|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-10-11 00:53:07.471478|2017-10-11 00:53:07.471478
NCT02030951|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-01-13|||January 2014||2014-01-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Measurement of Feeding Experience for Infants With Non-Oral Feedings|Measurement of Feeding Experience for Infants With Non-Oral Feedings|Terminated||N/A|27|Actual|Medical College of Wisconsin|||1|Funding completed|f||||f||||||||||2017-10-11 00:53:07.60659|2017-10-11 00:53:07.60659
NCT02030938|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-05-26|||December 2013||2013-12-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery|SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery|Completed||N/A|35|Actual|Sofregen Medical, Inc.||1|||f||||f||||||||||2017-10-11 00:53:07.673224|2017-10-11 00:53:07.673224
NCT02030925|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-07-28||2016-07-27|February 2014||2014-02-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors|A Phase 2a Study to Evaluate the Effect of IW-3718 Administered Orally for 4 Weeks in Patients With GERD Not Completely Responsive to Proton Pump Inhibitors|Completed||Phase 2|93|Actual|Ironwood Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 00:53:07.756355|2017-10-11 00:53:07.756355
NCT02030912|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-08|||December 2009||2009-12-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|ANTIRESDEV||Effect of Minocycline & Amoxicillin on Antibiotic Resistant Bacteria and Indigenous Microbiotas|Phase 4 Study Into the Effect of Minocycline and Amoxicillin Administration of the Prevalence of Antibiotic Resistant Bacteria and on the Indigenous Oral, Faecal, Cutaneous and Nasal Microbiotas|Completed||Phase 4|42|Actual|Helperby Therapeutics Ltd||3|||f||||f||||||||||2017-10-11 00:53:07.858436|2017-10-11 00:53:07.858436
NCT02030899|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-09-07|||December 2013||2013-12-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|CAP_2014||The Comparison Between the Stand-alone Cage and the Autologous Iliac Bone Graft/Anterior Plating in the Single-level Surgical Treatment of the Cervical Spine|The Comparison Between the Stand-alone Cage and the Autologous Iliac Bone Graft/Anterior Plating in the Single-level Surgical Treatment of the Cervical Spine|Recruiting||Phase 4|90|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:53:07.950203|2017-10-11 00:53:07.950203
NCT02030886|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2015-11-16|||December 2013||2013-12-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients|A Single-center, Open Label, Prospective Study Assessing the 24-hour IOP Patterns Using SENSIMED Triggerfish® in Ocular Hypertensive Patients Newly Converted to Glaucomatous Disease Versus Stable Ocular Hypertensive Patients|Terminated||N/A|20|Actual|Sensimed AG||1||Low recruitment rate|f||||f||||||||||2017-10-11 00:53:08.071978|2017-10-11 00:53:08.071978
NCT02030873|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2015-05-04|||January 2014||2014-01-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of Virtual Simulation Training in Mastoidectomy|The Effect of Virtual Simulation Training With the Visible Ear Simulator on Mastoidectomy Performance of Otorhinolaryngology Trainees|Completed||N/A|40|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:53:08.153914|2017-10-11 00:53:08.153914
NCT02029807|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-12-01|||January 2014||2014-01-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Comparison of Physiological Variables During Blood Donation|Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume During Blood Donation|Completed||N/A|50|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 00:53:22.435204|2017-10-11 00:53:22.435204
NCT02030860|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-07-31|||January 2014||2014-01-01|July 2017|2017-07-01||||December 2015|Actual|2015-12-01||Interventional|||A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer|A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer|Active, not recruiting||N/A|15|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:53:08.233228|2017-10-11 00:53:08.233228
NCT02030847|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-08-14|||January 2014||2014-01-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia|Phase II Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or RefractoryAcute Lymphoblastic Leukemia|Active, not recruiting||Phase 2|30|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 00:53:08.302195|2017-10-11 00:53:08.302195
NCT02030834|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-06-29|||February 5, 2014|Actual|2014-02-05|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas|Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas|Recruiting||Phase 2|57|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-10-11 00:53:08.375527|2017-10-11 00:53:08.375527
NCT02030821|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-07-18|||January 2015||2015-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||TXA vs. Amicar in Total Knee and Hip Arthroplasty|TXA (Tranexamic Acid) vs. Amicar (Aminocaproic Acid) in Total Knee and Hip Arthroplasty- Effectiveness, Safety, and Cost Analysis|Recruiting||Phase 4|400|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 00:53:08.461711|2017-10-11 00:53:08.461711
NCT02030808|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-09-08|||January 2014||2014-01-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Remifentanil Without Muscle Relaxant for Thoracotomy|Target-Controlled Infusion of Remifentanil Without Muscle Relaxant Allows Acceptable Surgical Conditions During Thoracotomy|Completed||Phase 2|66|Actual|Dammam University||2|||f||||t||||||||||2017-10-11 00:53:08.572251|2017-10-11 00:53:08.572251
NCT02030795|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-04-03|||January 2014||2014-01-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Techniques for Lung Deflation With Arndt® Blocker|Lung Deflation With Arndt® Blocker During Video-Assisted Thoracoscopy: A Comparison of the Disconnection Technique With a Continuous Bronchial Suction|Completed||Phase 2|58|Actual|Dammam University||2|||f||||t||||||||||2017-10-11 00:53:08.6643|2017-10-11 00:53:08.6643
NCT02030782|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-01-07|||October 1999||1999-10-01|December 2008|2008-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|YPIC||Youth Partners in Care: Depression and Quality Improvement|Youth Partners in Care: Depression & Quality Improvement|Completed||N/A|418|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||t||||||||||2017-10-11 00:53:08.75127|2017-10-11 00:53:08.75127
NCT02030769|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-03-28|||January 2014||2014-01-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer|Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer|Completed||N/A|1000|Actual|Xijing Hospital of Digestive Diseases||2|||f||||t||||||||||2017-10-11 00:53:08.866891|2017-10-11 00:53:08.866891
NCT02030756|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-04-02|||July 2014||2014-07-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals|Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.|Completed||N/A|144|Actual|Vibrant Ltd.||2|||f||||f||||||||Yes||2017-10-11 00:53:08.961064|2017-10-11 00:53:08.961064
NCT02030743|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-12-08|||February 2014||2014-02-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||A Study of Visual Attention Training to Improve Balance and Mobility|A Study of Visual Attention Training to Improve Balance and Mobility|Completed||N/A|30|Actual|University of Waterloo||2|||f||||f||||||||||2017-10-11 00:53:09.205289|2017-10-11 00:53:09.205289
NCT02030730|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-07|||March 2012||2012-03-01|March 2012|2012-03-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||RCT of Brief Universal Parenting Program to Prevent Child Behavioural and Emotional Difficulties in Greece|A Randomised Controlled Trial of the Efficacy of Triple P (Positive Parenting Program) Seminar Series as a Universal Parenting Intervention for the Prevention of Emotional and Behavioural Difficulties in Greek Children Aged 2 to 12.|Completed||N/A|124|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 00:53:09.298927|2017-10-11 00:53:09.298927
NCT02030717|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-06-03|||February 2012||2012-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ASA||Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma|Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma|Completed||Phase 2/Phase 3|120|Actual|Umeå University||2|||f||||t||||||||||2017-10-11 00:53:09.419077|2017-10-11 00:53:09.419077
NCT02030704|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-01-07|||February 2008||2008-02-01|January 2014|2014-01-01||||December 2015|Anticipated|2015-12-01||Observational|||CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes|Comprehensive 'Bio-Imaging' Using Quantitative Coronary Plaque Composition Assessment and the High-sensitive Troponin T for the Prediction of Cardiac Outcomes.|Unknown status|Recruiting|N/A|900|Anticipated|University Hospital Heidelberg|||1||f||||f||||||||||2017-10-11 00:53:09.510503|2017-10-11 00:53:09.510503
NCT02030691|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-07-22|||May 2014||2014-05-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|TONIPEP||Tolerance of nHFPV Versus nCPAP in Neonatal Respiratory Distress|Tolerance of Nasal High Frequency Percussive Ventilation Versus Nasal CPAP in Neonatal Respiratory Distress in Term and Preterm (> 33 Weeks of Gestation) Neonates|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 00:53:09.598443|2017-10-11 00:53:09.598443
NCT02030678|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-08-13|||July 2014||2014-07-01|July 2014|2014-07-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer|To Evaluate the Clinical Effect of Irinotecan Monotherapy in Treatment of Local Recurrence or Metastatic Breast Cancer Patients Who Accepted at Least 2 Kinds of Chemotherapy Regimens Including Antharcycline or Taxanes.|Unknown status|Recruiting|Phase 2/Phase 3|35|Anticipated|Liaoning Tumor Hospital & Institute||1|||f||||t||||||||||2017-10-11 00:53:09.70246|2017-10-11 00:53:09.70246
NCT02030665|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-07-27|||February 2013||2013-02-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|MTP4||Marijuana Treatment Project 4|Individualized Assessment and Treatment for Marijuana Dependence: Treatment Mechanisms|Active, not recruiting||N/A|275|Anticipated|UConn Health||4|||f||||f||||||||||2017-10-11 00:53:09.78421|2017-10-11 00:53:09.78421
NCT02030652|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-08-17|||January 2014||2014-01-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Impact of Synchronized Nasal Intermittent Positive Pressure Ventilation Using NAVA in Preterm Infants With RDS|Impact of Synchronized Nasal Intermittent Positive Pressure Ventilation Using Non Invasive Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants With Respiratory Distress|Unknown status|Recruiting|N/A|56|Anticipated|Hospital Israelita Albert Einstein||2|||f||||f||||||||||2017-10-11 00:53:09.870475|2017-10-11 00:53:09.870475
NCT02030639|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-06-22|||January 2014||2014-01-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Metabolism and Excretion of [14C]-Rigosertib After Infusion to Volunteers|Phase I Study of the Metabolism and Excretion of [14C]-Rigosertib After Single-dose Administration as 24-hour Continuous Intravenous Infusion to Healthy Volunteers|Completed||Phase 1|6|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 00:53:09.95524|2017-10-11 00:53:09.95524
NCT02030626|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-12-08|||January 2013||2013-01-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of the Efficacy of rTMS and tDCS of the Motor Cortex in Patients With Chronic Neuropathic Pain|Comparison of the Efficacy of Repetitive Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation of the Motor Cortex in Patients With Neuropathic Pain Due to Chronic Radiculopathy|Completed||Phase 4|35|Actual|Hospital Ambroise Paré Paris||2|||f||||f||||||||||2017-10-11 00:53:10.084849|2017-10-11 00:53:10.084849
NCT02030613|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-07-03|||October 1, 2013|Actual|2013-10-01|June 2017|2017-06-01|March 30, 2017|Actual|2017-03-30|February 28, 2017|Actual|2017-02-28||Interventional|Etaplus||Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis|Determination of the Effective Individual Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis|Completed||N/A|126|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:53:10.306166|2017-10-11 00:53:10.306166
NCT02030600|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-07-12|2016-12-02||January 6, 2014|Actual|2014-01-06|July 2017|2017-07-01|December 4, 2015|Actual|2015-12-04|December 4, 2015|Actual|2015-12-04||Interventional|SWITCH 2|Full analysis set included all randomised subjects. One subject was excluded from the analysis due to unsigned casebook.|A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes|A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (SWITCH 2)|Completed||Phase 3|721|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:53:10.438416|2017-10-11 00:53:10.438416
NCT02030587|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2017-04-22|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|LARFA||Laparoscopic Adrenalectomy Versus Radiofrequency Ablation|Laparoscopic Adrenalectomy Versus Radiofrequency Ablation for Aldosterone-producing Adenoma: a Prospective Randomized Controlled Trial|Active, not recruiting||N/A|36|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:53:11.742645|2017-10-11 00:53:11.742645
NCT02030574|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-07-25|2015-10-27||July 2014||2014-07-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin|BrUOG 300: Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin|Terminated||Phase 2|2|Actual|Brown University|The study has been terminated secondary to low accrual and an interest in opening up a different trial; more tailored to Physician interests and patient need.|1||"The study is being closed to accrual secondary to low accrual and an interest in opening up a   different trial."|f||||t||||||||||2017-10-11 00:53:11.851665|2017-10-11 00:53:11.851665
NCT02030561|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-06-21|||January 2014||2014-01-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer|Phase I/II Study of Expanded, Activated Autologous Natural Killer Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer|Recruiting||Phase 1/Phase 2|29|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-11 00:53:12.058471|2017-10-11 00:53:12.058471
NCT02030548|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2017-09-20|||November 2013||2013-11-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Bleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet Therapy|Bleeding in Patients Undergoing Urgent CABG During Dual Antiplatelet Therapy Including the New P2Y12 Receptor Inhibitors Prasugrel and Ticagrelor|Terminated||N/A|144|Actual|Medical University of Graz|||1|enrolment behind expectation|f||||f||||||||||2017-10-11 00:53:12.187332|2017-10-11 00:53:12.187332
NCT02030535|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-06-19|2015-06-19|2014-06-25|January 2014||2014-01-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Treated set (TS): This patient set included all randomised patients who were administered study medication.|Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers|A Randomised, Placebo-controlled, Double-blind, Single Dose, Cross-over Study to Evaluate the Efficacy and Safety of Orally Inhaled Tiotropium + Olodaterol as Both a Fixed Dose Combination and a Free Combination (Both Delivered by the Respimat® Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|53|Actual|Boehringer Ingelheim|"Additional secondary endpoints were listed in the original protocol. Those endpoints are of exploratory nature only and were not considered relevant for trial conclusions. For more information see tab “Full Text Review”, section “More Information."|3|||f||||||||||||||2017-10-11 00:53:12.293032|2017-10-11 00:53:12.293032
NCT02030522|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-12-18|||November 2013||2013-11-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma|Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma|Unknown status|Recruiting|N/A|200|Anticipated|University of South Florida||1|||f||||f||||||||||2017-10-11 00:53:13.24833|2017-10-11 00:53:13.24833
NCT02030509|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-08-08|||February 2014||2014-02-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Observational|||Quick Diagnostic Program for Head and Neck Cancer||Completed||N/A|196|Actual|Corporacion Parc Tauli|||2||f||||f||||||||||2017-10-11 00:53:13.371487|2017-10-11 00:53:13.371487
NCT02030496|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-05-12|||January 2013|Actual|2013-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|VIPER||Volar Internal Plate Fixation vs. Plaster in Extra- Articular Distal Radial Fractures|Volar Internal Plate Fixation vs. Plaster in Extra- Articular Distal Radial Fractures|Completed||N/A|90|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 00:53:13.44271|2017-10-11 00:53:13.44271
NCT02030483|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-02-13|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PD + RD||Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma|A Phase 1 Open-Label Study of the Safety and Efficacy of PD 0332991 (Palbociclib) in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Terminated||Phase 1|9|Actual|Weill Medical College of Cornell University||1||"The company providing one of the study drugs withdrew its support due to low enrollment.   Therefore, we had to close the study due to lack of funding."|f||||f||||||||||2017-10-11 00:53:13.550694|2017-10-11 00:53:13.550694
NCT02030470|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-09-07|||June 2014|Actual|2014-06-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology|Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology|Recruiting||Phase 4|36|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 00:53:13.644445|2017-10-11 00:53:13.644445
NCT02030457|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-07-08|||December 2013||2013-12-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults|A Randomized, Open-Label, 3-Period Crossover, Single-Dose Clinical Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Beclomethasone Dipropionate (160 and 320 mcg) Delivered Via Breath-Actuated Inhaler (BAI) and Metered-Dose Inhaler (MDI) in Healthy Adult Subjects|Completed||Phase 1|72|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 00:53:13.725434|2017-10-11 00:53:13.725434
NCT02030444|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-06-15|||August 2014|Actual|2014-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ExtStaging||Extensive Staging in Lung Cancer|Randomized Study Comparing Standard Staging of Lung Cancer With Extended Staging Including EBUS-TBNA and PET-MRI|Recruiting||N/A|150|Anticipated|St. Olavs Hospital||2|||f||||f||||||||||2017-10-11 00:53:13.802531|2017-10-11 00:53:13.802531
NCT02030431|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-10-19|||March 2014||2014-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Dynaloc for Treatment of Femoral Neck Fractures|Dynaloc vs. Multiple Cancellous Screws for Treatment of Femoral Neck Fractures|Terminated||N/A|150|Anticipated|Aarhus University Hospital||2||overweight of hard-ware removals in the Dynaloc group|f||||t||||||||||2017-10-11 00:53:13.874839|2017-10-11 00:53:13.874839
NCT02030418|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-11-10|||February 2014||2014-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The LEADLESS Pacemaker IDE Study (Leadless II)|Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker|Suspended||N/A|1567|Anticipated|St. Jude Medical||1||Reports of Battery Anomalies|f||||t||||||||||2017-10-11 00:53:14.033393|2017-10-11 00:53:14.033393
NCT02030405|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-01-20|2017-01-20||March 2014||2014-03-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 2 Study of Single-Agent MLN9708 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia With Mutated Nucleophosmin-1|Terminated||Phase 2|4|Actual|Stanford University||1||Regulatory|f||||t|t|f||||||No||2017-10-11 00:53:14.285569|2017-10-11 00:53:14.285569
NCT02030392|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-03-24|||April 2014||2014-04-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|Stop-FAP||A Randomized-controlled Study of a Cognitive-behavioral Intervention for Children With Functional Abdominal Pain|"Stop the Pain-A Multicenter, Randomized-controlled Study of a Cognitive-behavioral Intervention for Children With Functional Abdominal Pain"|Active, not recruiting||N/A|127|Actual|University of Potsdam||2|||f||||t||||||||||2017-10-11 00:53:14.594197|2017-10-11 00:53:14.594197
NCT02030379|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-07-06|||July 2013||2013-07-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Developing an Online Clinical Trial Specific Question Prompt List|Developing an Online Clinical Trial Specific Question Prompt List|Terminated||N/A|8|Actual|Virginia Commonwealth University||3||Funding unavailable|f||||t||||||||||2017-10-11 00:53:14.712701|2017-10-11 00:53:14.712701
NCT02030366|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-06||||||December 2013|2013-12-01||||December 2015|Anticipated|2015-12-01||Observational|||Chromatic Multifocal Pupillometer for Detection and Follow-up of Acute Head Injury|A Portable Chromatic Multifocal Pupillometer for Objective Early Detection and Follow-up of Changes in Intracranial Pressure in Patients With Acute Head Injury|Unknown status|Not yet recruiting|N/A|40|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 00:53:14.81311|2017-10-11 00:53:14.81311
NCT02030353|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-01-19|||January 2014||2014-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors|Feasibility of Using Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors: a Randomized Pilot Study|Completed||N/A|35|Actual|UNC Lineberger Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 00:53:14.895283|2017-10-11 00:53:14.895283
NCT02030340|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-01-06|||December 2013||2013-12-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Observational|ACWF||Comparison of Air Charged Catheters With Water Filled Catheters for Urodynamic Study|In Vivo Comparison of Air Charged Catheters With Water Filled Catheters for Intravesical and Intrarectal Pressures Recording During Urodynamic Study|Unknown status|Recruiting|N/A|36|Anticipated|UMC Utrecht|||1||f||||t||||||||||2017-10-11 00:53:15.002039|2017-10-11 00:53:15.002039
NCT02030327|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-01-25|||January 2014||2014-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Proteomics in Multiple Trauma to Identify Organ Failure|Analysis of Predictive Parameters by Proteomics for Early Diagnosis of Organ Dysfunction in Multiple Trauma Patients - A Pilot Study|Recruiting||N/A|85|Anticipated|Universitätsklinikum Köln|||3||f||||f||||||Samples Without DNA|"     serum (blood) and urine   "|||2017-10-11 00:53:15.155195|2017-10-11 00:53:15.155195
NCT02030314|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-13|||July 2013||2013-07-01|June 2017|2017-06-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|||The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone|The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone|Withdrawn||Phase 4|0|Actual|Virginia Commonwealth University||1||The patient population changed. Unable to find patients that meet study criteria|f||||f||||||||||2017-10-11 00:53:15.246727|2017-10-11 00:53:15.246727
NCT02030301|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-07-13|||December 2013||2013-12-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults|A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Phase 1/2 Trial to Evaluate the Safety and Efficacy of Herpes Simplex Virus, Type 2 Therapeutic DNA Vaccines in Symptomatic HSV-2-Seropositive Adults|Completed||Phase 1/Phase 2|165|Actual|Vical||7|||f||||t||||||||||2017-10-11 00:53:15.375703|2017-10-11 00:53:15.375703
NCT02030288|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-04-24|||February 19, 2015|Actual|2015-02-19|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|RAAST||Relational Agent for Alcohol Screening and Treatment|Relational Agent to Improve Alcohol Screening and Treatment in Primary Care: RCT|Recruiting||N/A|180|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 00:53:15.508635|2017-10-11 00:53:15.508635
NCT02030275|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-06-20|||November 2013||2013-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults|A Multi-Center, Prospective, Randomized, Double-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery on Transverse Hypertrophic Scars on the Lower Abdomen Resulting From Previous Surgeries in Healthy Adults|Completed||Phase 2|25|Actual|RXi Pharmaceuticals, Corp.||2|||f||||t||||||||||2017-10-11 00:53:15.619341|2017-10-11 00:53:15.619341
NCT02030262|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2016-03-04|||December 2013||2013-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Study of Impact of Air vs SF6 20% on Visual Acuity Improvement After Epiretinal Membrane Stripping|Study of the Impact of Air Versus SF6 20% on Visual Acuity Improvement After Epiretinal Membrane Stripping|Completed||N/A|32|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 00:53:15.714515|2017-10-11 00:53:15.714515
NCT02030249|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-11-09|||January 2014||2014-01-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Interventional|||Sub-Study of the PREVIEW Study Australia|Sub-Study of the PREVIEW Study Australia: Effects of Weight Loss on Appetite, Bone Mass and Muscle Strength|Active, not recruiting||N/A|292|Anticipated|University of Sydney||2|||f||||f||||||||||2017-10-11 00:53:15.814655|2017-10-11 00:53:15.814655
NCT02030236|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2014-03-03|||March 2014||2014-03-01|March 2014|2014-03-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||CAERvest® - A Novel Endothermic Hypothermic Device for Core Body Cooling. Safety and Efficacy Testing.|CAERvest® - A Novel Endothermic Hypothermic Device for Core Body Cooling. Safety and Efficacy Testing.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Bodychillz Ltd||1|||f||||f||||||||||2017-10-11 00:53:15.965028|2017-10-11 00:53:15.965028
NCT02030223|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-07|2015-01-14|||January 2014||2014-01-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Transversus Abdominis Plane Block and Inguinal Hernia Repair|The Analgesic Efficacy of the Ultrasound Guided Transversus Abdominis Plane Block After Inguinal Hernia Repair With a Mesh.|Unknown status|Recruiting|Phase 2|70|Anticipated|Aretaieion University Hospital||2|||f||||t||||||||||2017-10-11 00:53:16.057628|2017-10-11 00:53:16.057628
NCT02030210|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2014-01-07|||July 2013||2013-07-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||CP4ACS - Delphi Study to Determine Appropriateness of STEMI Quality Indicators in Belgium|Quality of Care for STEMI - Patients. a Research to Determine Appropriateness of STEMI Quality Indicators in Belgium, a RAND/UCLA Modified Delphi Study|Completed||N/A|32|Actual|European Pathway Association|||3||f||||f||||||||||2017-10-11 00:53:16.141591|2017-10-11 00:53:16.141591
NCT02030197|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-12-01|||February 2014||2014-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CRISP||Impact of CRISP on Self-Efficacy, Loneliness, and Depression|Effects of an Educational Socialization Program Designed to Improve Self-Efficacy and Subsequent Effects on Decreasing Loneliness and Depression Among People With Multiple Sclerosis|Completed||N/A|118|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 00:53:16.213698|2017-10-11 00:53:16.213698
NCT02030184|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-06-03|||June 2017|Anticipated|2017-06-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas|Phase I/II Dose Escalation Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas as a Single Agent and in Combination With Topotecan|Withdrawn||Phase 1/Phase 2|0|Actual|University of Maryland||1||PI has left the study institution.|f||||t|t|f||||||||2017-10-11 00:53:16.292556|2017-10-11 00:53:16.292556
NCT02030171|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-01-06|||April 2009||2009-04-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|PLURICLEF||Effect of Three Therapeutics Strategies on Patients With a Chronic Back Pain (PLURICLEF).|Effect of Three Therapeutic Strategies on the Restriction of the Participation of Patients With a Chronic Back Pain : Multidisciplinary is it the Key Component ?|Unknown status|Active, not recruiting|Phase 4|158|Actual|University Hospital, Angers||3|||f||||f||||||||||2017-10-11 00:53:16.379656|2017-10-11 00:53:16.379656
NCT02029794|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-05-01|||March 2014||2014-03-01|May 2017|2017-05-01|December 29, 2015|Actual|2015-12-29|June 30, 2014|Actual|2014-06-30||Interventional|ASPIRE||ASPIRE Pilot: Comparing Self-collected HPV Testing With Visual Inspection With Acetic Acid Screening for Cervical Cancer|ASPIRE Pilot: Determining Optimal Cervical Cancer Screening in a Low-resource Setting: A Randomized Controlled Trial Comparing Self-collected HPV Testing With Visual Inspection With Acetic Acid (VIA) Screening in Kampala, Uganda|Completed||N/A|500|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:53:22.53559|2017-10-11 00:53:22.53559
NCT02030158|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-01-07|||January 2015||2015-01-01|January 2014|2014-01-01|June 2016|Anticipated|2016-06-01|July 2015|Anticipated|2015-07-01||Observational|||Statistical Analysis Plan for an Individual Patient Data Meta-analysis of Three, International Trials Comparing Protocolised With Usual Resuscitation in Patients Presenting to the Emergency Department With Severe Sepsis and Septic Shock|Statistical Analysis Plan for an Individual Patient Data Meta-analysis of Three, International, Multicentre, Randomised, Controlled Trials Comparing Protocolised With Usual Resuscitation in Patients Presenting to the Emergency Department With Severe Sepsis and Septic Shock|Unknown status|Not yet recruiting|N/A|4210|Anticipated|Australian and New Zealand Intensive Care Research Centre|||2||f||||||||||||||2017-10-11 00:53:16.466361|2017-10-11 00:53:16.466361
NCT02030145|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2014-01-07|||February 2007||2007-02-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Thoracic Lymphatic Pump Techniques for Reducing Lung Volumes in Persons With Chronic Obstructive Pulmonary Disease|Thoracic Lymphatic Pump Techniques for Reducing Lung Volumes in Persons With Chronic Obstructive Pulmonary Disease|Withdrawn||N/A|0|Actual|A.T. Still University of Health Sciences||2||PI relocated|f||||f||||||||||2017-10-11 00:53:16.779177|2017-10-11 00:53:16.779177
NCT02030132|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-03-28|||January 2014||2014-01-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Way to Be Active V (Framing vs. Forgiveness)|A Randomized Trial of Behavioral Economic Interventions to Improve Physical Activities: Framing vs. Forgiveness|Completed||N/A|288|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 00:53:16.869002|2017-10-11 00:53:16.869002
NCT02030106|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-09-08|||October 2013||2013-10-01|September 2017|2017-09-01|June 1, 2017|Actual|2017-06-01|February 3, 2017|Actual|2017-02-03||Observational|M&M||Motherhood and Microbiome|Revealing the Role of the Cervico-vaginal Microbiome in Spontaneous Preterm Birth|Completed||N/A|2000|Actual|University of Pennsylvania|||2||f||||f||||||Samples With DNA|"     Women will self-collect samples of their cervicovaginal fluid using large cotton swabs.      Subjects who have had a previous preterm birth will also have cervical cells collected in the     same manner that cells are collected for a routine pap smear.   "|||2017-10-11 00:53:17.057915|2017-10-11 00:53:17.057915
NCT02030093|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-10-05|||December 9, 2013|Actual|2013-12-09|October 2017|2017-10-01|January 12, 2017|Actual|2017-01-12|June 27, 2016|Actual|2016-06-27||Observational|||Telephone-Based Continuing Care for Alcohol Dependence|Evaluation Study of the Effectiveness of a High- Versus Low-frequency Telephone-based and Sort Message-based (Sms) Continuing Care Provided to Patients Who Have Achieved a 12 Week In-patient Treatment for Alcohol Dependence|Completed||N/A|317|Actual|University of Bern|||4||f||||f||||||||||2017-10-11 00:53:17.123311|2017-10-11 00:53:17.123311
NCT02030067|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2017-04-11|||December 2013||2013-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies|A Phase 1, Open-Label, Dose-Ranging, Safety and Pharmacokinetic Study to Determine the Maximum Tolerated Dose of RX-3117 Administered Orally as a Single-Agent to Subjects With Advanced Malignancies|Recruiting||Phase 1/Phase 2|72|Anticipated|Rexahn Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 00:53:17.302215|2017-10-11 00:53:17.302215
NCT02030054|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-12-03|||January 2015||2015-01-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|gRANADa||Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)|Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors|Unknown status|Not yet recruiting|Phase 4|150|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 00:53:17.39009|2017-10-11 00:53:17.39009
NCT02030041|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-02-12|2016-09-20||December 2013||2013-12-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy|Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy|Completed||Phase 3|33|Actual|Postgraduate Institute of Medical Education and Research|The limitations include short duration of follow up and lack of direct supervision of exercise program. Although participants didn’t perform exercise under direct supervision, adherence to exercise program was monitored by pedometer readings weekly.|3|||f||||t||||||||No||2017-10-11 00:53:17.481498|2017-10-11 00:53:17.481498
NCT02030028|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-09-11|||November 2014||2014-11-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||ACTH Gel Therapy in Rheumatoid Arthritis|Open Label Study to Evaluate Efficacy and Safety of Short-Term, Adjunctive Adrenocorticotropic Hormone (ACTH) Gel in Rheumatoid Arthritis|Recruiting||N/A|20|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 00:53:17.968656|2017-10-11 00:53:17.968656
NCT02030015|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-08-16|||March 2014||2014-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|Syner-G||Synergistic Enteral Regimen for Treatment of the Gangliosidoses|Synergistic Enteral Regimen for Treatment of the Gangliosidoses (Syner-G)|Active, not recruiting||Phase 4|6|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t|t|f||||||||2017-10-11 00:53:18.05931|2017-10-11 00:53:18.05931
NCT02030002|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-04-10|||October 2013||2013-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||"Evaluation of a Flash-free Adhesive Resin for Orthodontic Bracket Bonding"|"Use of a Flash-free Adhesive Resin for Orthodontic Bracket Bonding: a Clinical Study of Bonding Time, Bond Survival, and Adhesive Remnant Cleanup"|Active, not recruiting||N/A|45|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 00:53:18.160144|2017-10-11 00:53:18.160144
NCT02029989|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-01-27|2014-04-15||February 2010||2010-02-01|January 2017|2017-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness|Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?|Completed||N/A|121|Actual|University of Minnesota - Clinical and Translational Science Institute|Limitations include: 1) Short time duration to achieve metabolic outcome goals, 2) Smaller than anticipated sample size, 3) High number of subjects lost to follow up after 12-months.|2|||f||||f||||||||||2017-10-11 00:53:18.233018|2017-10-11 00:53:18.233018
NCT02029976|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-11-11|||April 2014||2014-04-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||School Nurse-directed Secondary Obesity Prevention for Elementary School Children|School Nurse-directed Secondary Obesity Prevention for Elementary School Children|Recruiting||N/A|350|Anticipated|Temple University||2|||f||||f||||||||No||2017-10-11 00:53:18.5882|2017-10-11 00:53:18.5882
NCT02029963|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-05-19|||February 2014||2014-02-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Can Magnetic Brain Stimulation Help Prevent Relapse in Depression?|The Efficacy of Repetitive Transcranial Magnetic Stimulation in Relapse Prevention of Major Depressive Disorder|Enrolling by invitation||N/A|45|Anticipated|University of Manitoba||3|||f||||t||||||||||2017-10-11 00:53:18.673556|2017-10-11 00:53:18.673556
NCT02029950|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-09-12|||December 16, 2013|Actual|2013-12-16|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome|A Phase I Study of Pomalidomide Given at the Time of Lymphocyte Recovery Following Induction Timed Sequential Chemotherapy With Cytarabine, Daunorubicin, and Etoposide (AcDVP16) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) and High-Risk MDS|Recruiting||Phase 1|63|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 00:53:20.534122|2017-10-11 00:53:20.534122
NCT02029937|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-09-11|||January 2014||2014-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia|High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: A Randomized, Multicenter Trial of Accuracy, Yield, and Clinical Impact|Recruiting||Phase 2|1300|Anticipated|Anandasabapathy, Sharmila, M.D.||2|||f||||t||||||||||2017-10-11 00:53:20.725277|2017-10-11 00:53:20.725277
NCT02029924|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-31|||December 2013||2013-12-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|||A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes|A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes|Completed||Phase 1|37|Actual|Adocia||2|||f||||f||||||||||2017-10-11 00:53:20.824133|2017-10-11 00:53:20.824133
NCT02029911|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-10-06|2015-08-27|2014-08-20|June 2011||2011-06-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|November 2012|Actual|2012-11-01||Interventional||Subjects Treated|A Multi-Center, Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System|A Multi-Center, Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System|Completed||N/A|63|Actual|Minerva Surgical, Inc.||1|||f||||t||||||||||2017-10-11 00:53:20.904763|2017-10-11 00:53:20.904763
NCT02029898|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-08-29|||February 2014||2014-02-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|July 2016|Actual|2016-07-01||Interventional|REAGI||Remifentanil for General Anesthesia in the Context of Immaturity|Adaptation to Neonatal Life After an Anesthetic Protocol Using Remifentanil for General Anesthesia for Caesarean Section in a Context of Prematurity - REAGI Protocol|Active, not recruiting||Phase 1/Phase 2|53|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 00:53:21.148846|2017-10-11 00:53:21.148846
NCT02029885|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-01-06|||August 2014||2014-08-01|January 2016|2016-01-01|March 2018|Anticipated|2018-03-01|March 2016|Anticipated|2016-03-01||Interventional|WAVE_IV||Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension|Wave IV Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension|Recruiting||N/A|132|Anticipated|Kona Medical Inc.||2|||f||||t||||||||||2017-10-11 00:53:21.298124|2017-10-11 00:53:21.298124
NCT02029872|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-08-16|||January 2014||2014-01-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|SUSTAIN||Stop Community MRSA Colonization Among Patients|Stop Community MRSA Colonization Among Patients (SUSTAIN)|Completed||Phase 4|77|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:53:21.746799|2017-10-11 00:53:21.746799
NCT02029859|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-06-02|||April 2011||2011-04-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Interventional|GOS||Sleep Apnea, Obesity and Pregnancy|Sleep Apnea, Obesity and Pregnancy|Completed||N/A|205|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 00:53:21.859912|2017-10-11 00:53:21.859912
NCT02029846|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-04-17|2017-04-17||April 2013|Actual|2013-04-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Glycemia in Diabetic Elders Trial|Glycemia in Diabetic Elders Trial|Terminated||Phase 4|2|Actual|Johns Hopkins University||2||No sufficient numbers of eligible participants|f||||f||||||||||2017-10-11 00:53:21.955847|2017-10-11 00:53:21.955847
NCT02029833|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-08-01|||March 2013||2013-03-01|August 2017|2017-08-01||||November 2016|Actual|2016-11-01||Interventional|COMIT2||Canola Oil Multi-Centre Intervention Trial II|Effects of Oleic Acid Enriched and Regular Canola Oil on Body Composition and Lipid Metabolism in Participants With Metabolic Syndrome|Active, not recruiting||N/A|125|Actual|University of Manitoba||3|||f||||f||||||||||2017-10-11 00:53:22.193485|2017-10-11 00:53:22.193485
NCT02029820|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-06|||August 2012||2012-08-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|REPRECIN||RenalGuard System for Prevention of Contrast Induced Nephropathy|RenalGuard System for Prevention of Contrast Induced Nephropathy - A Randomized Trial|Unknown status|Recruiting|Phase 3|210|Anticipated|Hospital Sao Lucas da PUCRS||2|||f||||f||||||||||2017-10-11 00:53:22.324069|2017-10-11 00:53:22.324069
NCT02020902|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-05-12|||March 2013||2013-03-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Post Marketing Surveillance for Contac Bien Z in Japan|Contac Bien Z Adverse Effect Survey|Completed||N/A|1552|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 00:55:20.493891|2017-10-11 00:55:20.493891
NCT02029781|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-05-29|||September 2013||2013-09-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Interventional|APPLE||The Laparoscopic Appendicitis Score; a Multicenter Validation Study|APPLE Study (APPendicitis and Laparoscopic Evaluation) Study; Multicenter Prospective Validation of the Laparoscopic APPendicitis (LAPP) Score|Terminated||N/A|342|Actual|University Medical Center Groningen||1||Delayed/poor inclusion rate.|f||||t||||||||Undecided||2017-10-11 00:53:22.673258|2017-10-11 00:53:22.673258
NCT02029755|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2015-05-24|2014-11-21||December 2013||2013-12-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|TAP||Transversus Abdominis Plane Block Versus Local Anesthetic Infiltration for Pain Control in the Abdominal Surgery|Ultrasound-guided-transversus Abdominis Plane(TAP) Block Versus Local Anesthetic(LA) Infiltration—the Effectiveness of Post-operative Pain Control in the Abdominal Surgery|Completed||N/A|108|Actual|Taipei Medical University Hospital||3|||f||||t||||||||||2017-10-11 00:53:22.874183|2017-10-11 00:53:22.874183
NCT02029742|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-01-26|||September 2013||2013-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HABIT||Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT|Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT|Completed||Phase 2|60|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 00:53:23.409732|2017-10-11 00:53:23.409732
NCT02029729|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-01-28|||December 2013||2013-12-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|DISCOVER||RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER|An Open-Label, Single-Center, Dose-Escalation, Phase 1 Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RTA 408 in the Treatment of Patients With Advanced Solid Tumors|Completed||Phase 1|11|Actual|Reata Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 00:53:23.534118|2017-10-11 00:53:23.534118
NCT02029716|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2014-11-04|||December 2013||2013-12-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||RTA 408 Lotion in Healthy Volunteers|A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RTA 408 Lotion in Healthy Volunteers|Completed||Phase 1|109|Actual|Reata Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-11 00:53:23.634137|2017-10-11 00:53:23.634137
NCT02029703|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-03-10|2017-01-18||August 2012||2012-08-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Optimization of Synvisc-One for Knee OA|Investigating the Efficacy of Synvisc-One® (Hylan G-F 20) as Adjunctive Therapy for Patients With Knee Osteoarthritis (OA) Requiring Physical Therapy|Terminated||N/A|42|Actual|The Cleveland Clinic|"Ability to receive HA injections without physical therapy.
FDA approval of Gel-One, the sole one-time injection on the market at the beginning of the study
AAOS Guidelines not supporting the use of HA's for knee OA"|2||Enrollment Goals not met|f||||f||||||||||2017-10-11 00:53:23.739287|2017-10-11 00:53:23.739287
NCT02029690|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-09-23|||April 2014||2014-04-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|August 2019|Anticipated|2019-08-01||Interventional|TRAP||Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin|Phase 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ADIPemCis) (TRAP Study)|Recruiting||Phase 1|88|Anticipated|Polaris Group||1|||f||||f||||||||||2017-10-11 00:53:24.20241|2017-10-11 00:53:24.20241
NCT02029677|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-01-06|||September 2008||2008-09-01|January 2014|2014-01-01|September 2014|Anticipated|2014-09-01|March 2014|Anticipated|2014-03-01||Observational|||Appetite Suppression / Hormone Study Control Group|Putative Hormonal Mechanisms of Appetite Suppression Following LAGB: A Pilot Study|Unknown status|Enrolling by invitation|N/A|10|Anticipated|Oregon Weight Loss Surgery, LLC|||1||f||||f||||||Samples Without DNA|"     Each time these hormone assays are performed, aliquots of plasma will be frozen at -80C:        -  Total immunoreactive ghrelin - Plasma will be assayed in duplicate for immunoreactive          ghrelin concentration using a commercial radioimmunoassay (RIA)        -  Lipids - Plasma total cholesterol, TG, HDL-C, and LDL-C will be measured        -  Glucose and insulin - Plasma glucose concentrations will be measured in triplicate using          the glucose oxidase method. Plasma insulin will be measured in duplicate using a          modification of a double antibody radioimmunoassay        -  Adiponectin and other gut hormones - Adiponectin, PYY3,36 and GLP-1 will be measured          using a commercial RIA. Pancreatic polypeptide (PP) will be measured using a commercial          RIA   "|||2017-10-11 00:53:24.334651|2017-10-11 00:53:24.334651
NCT02029664|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2016-10-23|||January 2014||2014-01-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Gait Control of Stroke Patients Using Visual Feedback||Recruiting||N/A|64|Anticipated|National Rehabilitation Center, Seoul, Korea||1|||f||||f||||||||||2017-10-11 00:53:24.432079|2017-10-11 00:53:24.432079
NCT02029638|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-09-08|||January 2014||2014-01-01|September 2017|2017-09-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Interventional|||BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance|Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance (ITN054ST)|Terminated||Phase 2|4|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Slow accrual|f||||t||||||||||2017-10-11 00:53:24.687986|2017-10-11 00:53:24.687986
NCT02029625|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2016-03-24|||February 2014||2014-02-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|NVP-1205||Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe|A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe in Healthy Male Volunteers|Completed||Phase 1|41|Actual|Navipharm Corporation||2|||f||||f||||||||No||2017-10-11 00:53:24.868099|2017-10-11 00:53:24.868099
NCT02029599|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2015-10-07|||March 2014||2014-03-01|October 2015|2015-10-01||||August 2015|Actual|2015-08-01||Interventional|||The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis|A Phase 2 Randomised, Double-blind, Placebo-controlled Multiple Ascending Dose Study Evaluate the Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis|Completed||Phase 2|240|Actual|Maoxiang Group Jilin Pharmaceutical Co., Ltd.||3|||f||||t||||||||||2017-10-11 00:53:25.138144|2017-10-11 00:53:25.138144
NCT02029586|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-03-30|||January 2013||2013-01-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, 12 Weeks, Therapeutic Exploratory Phase 2 Clinical Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Except Cirrhosis|Terminated||Phase 2|18|Actual|KT&G Life Sciences Corp||2||Lack of recruitment|f||||||||||||||2017-10-11 00:53:25.257884|2017-10-11 00:53:25.257884
NCT02029573|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-08-15|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|ART||Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma|Phase II Study of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma|Completed||Phase 2|36|Actual|King Fahad Medical City||1|||f||||t||||||||||2017-10-11 00:53:25.383365|2017-10-11 00:53:25.383365
NCT02029560|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-03-08|||October 2013||2013-10-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01|3 Months|Observational [Patient Registry]|CV||Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System|Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia|Recruiting||N/A|400|Anticipated|JW Pharmaceutical|||1||f||||f||||||||||2017-10-11 00:53:25.499165|2017-10-11 00:53:25.499165
NCT02029547|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-10-22|||October 2014||2014-10-01|October 2014|2014-10-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians|Evaluation of Computer-Based Training to Educate Japanese Physicians in the Methods of Interpreting Florbetapir (18F) PET Scans|Withdrawn||N/A|0|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 00:53:25.605886|2017-10-11 00:53:25.605886
NCT02029534|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2016-06-15|||August 2013||2013-08-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)|Intensive Statin Therapy Effect on Incidence of Post-Operative Atrial Fibrillation|Recruiting||Phase 4|200|Anticipated|Creighton University||2|||f||||t||||||||||2017-10-11 00:53:25.719856|2017-10-11 00:53:25.719856
NCT02029521|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-01-16|2014-06-20||March 2011||2011-03-01|January 2016|2016-01-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional||Pediatric cystic fibrosis patients, ages 15 months to 10 years|Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients|Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis for Growth Failure|Completed||N/A|47|Actual|Brigham Young University|This trial was limited to one site. The number was relatively small. Since PFT's were not done on children under the age of 5, there is even smaller number of participants contributing PFT data.|2|||f||||f||||||||||2017-10-11 00:53:25.914398|2017-10-11 00:53:25.914398
NCT02029508|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-06|||October 2012||2012-10-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|BPPV||The Treatment of Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo|The Effectiveness Comparison of Three Different Methods for the Treatment of Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo: Prospective, Double Blinded, Randomized, Multicenter Clinical Trial|Completed||Phase 3|99|Actual|Asan Medical Center||3|||f||||f||||||||||2017-10-11 00:53:29.03103|2017-10-11 00:53:29.03103
NCT02029495|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-04-07|2016-11-08|2016-03-14|March 2014||2014-03-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|AMVISION-1||Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis|A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1|Terminated||Phase 3|478|Actual|Valeant Pharmaceuticals International, Inc.||3||Sponsor Decision|f||||t||||||||Yes||2017-10-11 00:53:29.149488|2017-10-11 00:53:29.149488
NCT02029482|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-06|||April 2010||2010-04-01|January 2014|2014-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects|Single-center, Double-blind, Placebo-controlled, Randomized, Parallel-group, Up-titration Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Increasing Doses of ACT-128800 in Healthy Male and Female Subjects|Completed||Phase 1|16|Actual|Actelion||2|||f||||f||||||||||2017-10-11 00:53:30.475099|2017-10-11 00:53:30.475099
NCT02029469|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2014-08-15|||October 2007||2007-10-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Ascension® Humeral Resurfacing Arthroplasty Follow-Up Study|Ascension® Humeral Resurfacing Arthroplasty Follow-Up Study|Terminated||N/A|59|Actual|Ascension Orthopedics, Inc.||1||Study was terminated due to PI leaving the institution|f||||f||||||||||2017-10-11 00:53:30.701981|2017-10-11 00:53:30.701981
NCT02029456|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2014-01-07|||June 2011||2011-06-01|January 2014|2014-01-01|August 2014|Anticipated|2014-08-01|March 2014|Anticipated|2014-03-01||Interventional|||Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism|Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism: AYKAN Trial|Unknown status|Recruiting|Phase 4|30|Anticipated|Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital||1|||f||||f||||||||||2017-10-11 00:53:30.793539|2017-10-11 00:53:30.793539
NCT02029443|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-12-14|||January 2014||2014-01-01|December 2016|2016-12-01||||January 2019|Anticipated|2019-01-01||Interventional|||ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia|A Phase 1/2, Multicenter, Open-label, and Dose-escalation Study of ACP-196 in Subjects With Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia|Active, not recruiting||Phase 1/Phase 2|286|Anticipated|Acerta Pharma BV||1|||f||||f||||||||||2017-10-11 00:53:30.882268|2017-10-11 00:53:30.882268
NCT02029430|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-10-18|||January 2014||2014-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma|An Open-Label Pilot Phase 2 Study to Investigate Efficacy, Safety, and Intratumoral Kinetics of ALDOXORUBICIN in HIV-Infected Patients With Kaposi's Sarcoma|Completed||Phase 2|16|Actual|CytRx||1|||f||||f||||||||||2017-10-11 00:53:30.979918|2017-10-11 00:53:30.979918
NCT02029417|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-04-05|2016-03-01||July 2014||2014-07-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional||All treated and eligible patients|Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|OAG and Decitabine for Newly Diagnosed Acute Myeloid Leukemia Patients Greater Than or Equal to 65 Years of Age|Terminated||Phase 2|2|Actual|Roswell Park Cancer Institute|Due to the study's early termination and low accrual no statistical inference of the primary aims were carried forth.|1||Major revisions needed in study|f||||t||||||||||2017-10-11 00:53:31.070915|2017-10-11 00:53:31.070915
NCT02029404|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-04-07|||December 2013||2013-12-01|October 2014|2014-10-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Approach to Continuous Sciatic Nerve Block for Orthopedic Procedures in Day Surgery With Two Different Techniques|Approach to Continuous Sciatic Nerve Block for Orthopedic Procedures in Day Surgery With Two Different Techniques|Completed||N/A|84|Actual|Ospedale di Circolo - Fondazione Macchi||2|||f||||t||||||||||2017-10-11 00:53:31.478602|2017-10-11 00:53:31.478602
NCT02029391|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-07|||October 2013||2013-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Kinesio Taping in Subjects With Myofascial Pain Syndrome: a Randomized Controlled Trial|Kinesio Taping on Short Term Changes in Subjects With Myofascial Pain Syndrome: a Randomized Controlled Trial|Completed||N/A|31|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:53:31.569193|2017-10-11 00:53:31.569193
NCT02029378|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-09-22|||September 2014||2014-09-01|September 2014|2014-09-01|March 2016|Anticipated|2016-03-01|October 2015|Anticipated|2015-10-01||Interventional|ICA-GBS||Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study|Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study|Unknown status|Recruiting|Phase 2|30|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||t||||||||||2017-10-11 00:53:31.655135|2017-10-11 00:53:31.655135
NCT02029365|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-03-09|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|TCA2||Transversal, Controlled and Not Randomized Study, Laying on the Desire of Children and Eating Disorders in a Population of Infertile Women|Single-center Study, Transversal, Controlled and Not Randomized, Laying on the Desire of Children and Eating Disorders in a Population of Infertile Women|Terminated||N/A|71|Actual|Nantes University Hospital||2||recruitment difficulties|f||||f||||||||||2017-10-11 00:53:31.751928|2017-10-11 00:53:31.751928
NCT02029352|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-05-17|||November 2014||2014-11-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Topical Green Tea Ointment in Treatment of Superficial Skin Cancer|Topical Sinecatechins Ointment in Treatment of Primary Superficial Basal Cell Carcinoma: a Double Blind, Randomized, Placebo-controlled Trial.|Completed||Phase 2/Phase 3|42|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 00:53:31.844274|2017-10-11 00:53:31.844274
NCT02029339|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2014-07-31|||January 2007||2007-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|Triple-tube||Continuous Topical Instillation for Open Abdomen in the Septic Patients With Complicated Intra-abdominal Infections|Continuous Topical Triple-tube Instillation and Suction for for Open Abdomen in the Septic Patients With Complicated Intra-abdominal Infections|Completed||N/A|32|Actual|Southeast University, China||2|||f||||t||||||||||2017-10-11 00:53:31.978273|2017-10-11 00:53:31.978273
NCT02029326|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-02-20|||February 1, 2010|Actual|2010-02-01|February 2017|2017-02-01|August 26, 2015|Actual|2015-08-26|January 2015|Actual|2015-01-01||Observational|||Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab||Completed||N/A|30|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 00:53:32.090263|2017-10-11 00:53:32.090263
NCT02029313|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2015-04-27|||November 2013||2013-11-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma|A Randomized, Open-label, Single-Dose, 2-Treatment, 2-Way, 2-Period Crossover Study to Compare the Safety and the Pharmacokinetic Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium) Tablet 10mg in Healthy Male Korean Subjects|Completed||Phase 1|40|Anticipated|PharmaKing||2|||f||||t||||||||||2017-10-11 00:53:32.157061|2017-10-11 00:53:32.157061
NCT02029300|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-05-24|||November 2013||2013-11-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Comparison of Nasal Versus Oral Fiberoptic Intubation in Children|A Randomized Comparison of Nasal Versus Oral Fiberoptic Intubation in Children Less Than Two Years of Age|Completed||N/A|100|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-11 00:53:32.237806|2017-10-11 00:53:32.237806
NCT02029287|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-21|2017-04-07|||December 2013||2013-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01|12 Months|Observational [Patient Registry]|HCF-CMP-CHF||Hospital-Community-Family-Care Management Platform for Chronic Heart Failure|Remote Prevention and Treatment Based on Community Under the Guidance of Regional Central Hospital for Patients With Chronic Heart Failure|Recruiting||N/A|1000|Anticipated|Northern Jiangsu Province People's Hospital|||1||f||||t||||||||||2017-10-11 00:53:32.361477|2017-10-11 00:53:32.361477
NCT02029261|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-11-08|||May 2014||2014-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Observational Study of Insulin Resistance and Muscle Wasting After Burn Injury|Project 4: Molecular Mechanisms in Burn-induced Insulin Resistance in Humans|Recruiting||N/A|24|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples Without DNA|"     whole blood, plasma, isolated leukocytes, skeletal muscle, fat, skin   "|Yes|Data provided to the journal as required for publication|2017-10-11 00:53:32.648297|2017-10-11 00:53:32.648297
NCT02029235|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-01-10|||February 2015||2015-02-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Post-operative Analgesia in Elective, Soft-tissue Hand Surgery|Post-operative Analgesia in Elective, Soft-tissue Hand Surgery: A Randomized, Double Blind Comparison of Acetaminophen/Ibuprofen Versus Acetaminophen/Hydrocodone|Enrolling by invitation||Phase 4|150|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||No||2017-10-11 00:53:32.943265|2017-10-11 00:53:32.943265
NCT02029222|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-03-27|||December 2013||2013-12-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients.|In Silico Clinical Trial on Re-irradiation Lung Cancer, Comparing Photon, Proton and 12C-ion Therapy: A Multicentric ROCOCO Planning Study Based on a Reference Dataset of Patients.|Active, not recruiting||N/A|25|Anticipated|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-11 00:53:33.031979|2017-10-11 00:53:33.031979
NCT02029209|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-12-14|||December 2013||2013-12-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer||Active, not recruiting||Phase 2/Phase 3|110|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-11 00:53:33.441177|2017-10-11 00:53:33.441177
NCT02029196|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-01-31|2016-11-23||December 2013|Actual|2013-12-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study to Evaluate the Safety Profile of an e-Vapour Product|A Randomised, Parallel Group, Multi-centre Study to Evaluate the Safety Profile of the ITG EVP G1 Product|Completed||N/A|408|Actual|Imperial Tobacco Group PLC||2|||f||||f||||||||Undecided||2017-10-11 00:53:33.547922|2017-10-11 00:53:33.547922
NCT02029183|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2014-01-06|||December 2013||2013-12-01|January 2014|2014-01-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|SAHS||Screening and Treatment of SAHS in Patients With Acute Ischemic Stroke|Screening and Treatment of in Sleep Apnea Hypopnea Syndrome（SAHS)Patients With Acute Ischemic Stroke|Unknown status|Recruiting|N/A|120|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 00:53:33.891013|2017-10-11 00:53:33.891013
NCT02029170|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-10-08|||January 2014||2014-01-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Early Weightbearing Versus Non-weightbearing After Operative Treatment of an Ankle Fracture|Early Weightbearing Versus Non-weightbearing After Operative Treatment of an Ankle Fracture: A Randomized Multicenter Non-inferiority Trial|Unknown status|Recruiting|N/A|192|Anticipated|Hallym University Medical Center||2|||f||||t||||||||||2017-10-11 00:53:34.005094|2017-10-11 00:53:34.005094
NCT02029144|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-02-09|||December 2013||2013-12-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Observational Study of Dydrogesterone in Cycle Regularization|Dydrogesterone in Cycle Regularization in Abnormal Uterine Bleeding - Ovulation Dysfunction (AUB-O) Patients: A Prospective, Observational Study|Completed||N/A|114|Actual|Fudan University|||1||f||||f||||||||||2017-10-11 00:53:34.191801|2017-10-11 00:53:34.191801
NCT02029131|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-02-22|||January 2014||2014-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|September 2014|Actual|2014-09-01||Interventional|||Exercise and Low Back Pain|Effects of a Home-based Exercise Program on Low Back Pain in Employees|Completed||N/A|226|Actual|Hannover Medical School||2|||f||||f||||||||||2017-10-11 00:53:34.25861|2017-10-11 00:53:34.25861
NCT02029118|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2014-09-07|||October 2012||2012-10-01|September 2014|2014-09-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|AASAP||Acupoint Application in Patients With Stable Angina Pectoris (AASAP)|Effect of Acupoint Application With Herbal Medicine in Patients With Stable Angina Pectoris: Randomized, Controlled,Double Blind Clinical Study|Unknown status|Recruiting|Early Phase 1|200|Anticipated|Chengdu University of Traditional Chinese Medicine||4|||f||||t||||||||||2017-10-11 00:53:34.333537|2017-10-11 00:53:34.333537
NCT02029105|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-06|||January 2004||2004-01-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|December 2010|Actual|2010-12-01||Observational|||Serum Biomarkers in Diagnosis of Mesothelioma|PREDICTING MALIGNANT MESOTHELIOMA BY ANALYZING HYALURONAN, OSTEOPONTIN, C-ERC/MESOTHELIN, N-ERC/MESOTHELIN AND SYNDECAN-1 SERUM LEVELS|Completed||N/A|230|Actual|Eskisehir Osmangazi University|||1||f||||t||||||Samples Without DNA|"     Serum samples of the patients   "|||2017-10-11 00:53:34.503072|2017-10-11 00:53:34.503072
NCT02029092|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-09-26|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|12 Months|Observational [Patient Registry]|||BIOFLOW III Satellite-ELADIS Orsiro Stent System|BIOTRONIK- Safety and Performance Registry for an All Comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice III- ELADIS|Completed||N/A|404|Actual|C.E.M. Biotronik, S.A.|||1||f||||f||||||||||2017-10-11 00:53:34.595743|2017-10-11 00:53:34.595743
NCT02029079|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-01-10|||August 2013||2013-08-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Food and Beverage Based Nutritional Supplements in Recipients of Home Care Services at Risk of Malnutrition|The Effect of Food and Beverage Based Nutritional Supplements in Recipients of Home Care Services at Risk of Malnutrition|Completed||N/A|38|Actual|Haukeland University Hospital||2|||f||||f||||||||||2017-10-11 00:53:34.710303|2017-10-11 00:53:34.710303
NCT02029066|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-08-10|||November 2013||2013-11-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis|An Open-label, Single Dose, Pharmacokinetic Study of SR-T100 Gel (Containing 2.3% Solamargine in Solanum Undatum Plant Extract) in Patients With Actinic Keratosis|Completed||Phase 1|2|Actual|G&E Herbal Biotechnology Co., LTD||1|||f||||f||||||||||2017-10-11 00:53:34.796324|2017-10-11 00:53:34.796324
NCT02029053|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-12-14|||January 2014||2014-01-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness|VR101: A Pilot Study to Evaluate the Preliminary Feasibility and Safety of a Lubricating Intravaginal Ring to Relieve the Symptoms of Vaginal Dryness|Completed||Early Phase 1|21|Actual|J3 Bioscience, Inc.||1|||f||||t||||||||No||2017-10-11 00:53:34.873437|2017-10-11 00:53:34.873437
NCT02029040|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-05-03|||December 2013||2013-12-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis|A Randomized Trial of Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in The Emergency Department|Completed||N/A|52|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 00:53:34.984495|2017-10-11 00:53:34.984495
NCT02029027|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-06|||August 2012||2012-08-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Interest of Intravaginal Electro-stimulation at Home by GYNEFFIK® Compared to Usual Care in Incontinent Patients With Prior Perineal Reeducation|Evaluation de l'intérêt de l'électrostimulation Intra-vaginale à Domicile Par Rapport à Une Prise en Charge Habituelle Dans la Prise en Charge de Patientes Incontinentes Ayant bénéficié d'Une rééducation périnéale|Unknown status|Active, not recruiting|Phase 4|163|Actual|Effik||2|||f||||t||||||||||2017-10-11 00:53:35.081788|2017-10-11 00:53:35.081788
NCT02029014|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-03-16|||March 2014||2014-03-01|March 2014|2014-03-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|||Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin|Evaluation of Safety and Efficacy of the New Generation of Left Appendage Closure With the LAmbre Device in AF Patients Not Suitable for Use of Warfarin|Unknown status|Recruiting|Phase 3|154|Anticipated|Lifetech Scientific (Shenzhen) Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:53:35.181269|2017-10-11 00:53:35.181269
NCT02029001|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-11-02|||February 2014||2014-02-01|July 2016|2016-07-01|November 2019|Anticipated|2019-11-01|February 2017|Anticipated|2017-02-01||Interventional|MOST||Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: My Own Specific Treatment|A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors|Recruiting||Phase 2|560|Anticipated|Centre Leon Berard||2|||f||||t||||||||||2017-10-11 00:53:35.317734|2017-10-11 00:53:35.317734
NCT02028988|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-02-13|||January 2014||2014-01-01|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Enzalutamide + External Beam Rt For Prostate|Enzalutamide With External Beam Radiation for Intermediate Risk Prostate Cancer: A Phase II Study|Active, not recruiting||Phase 2|64|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:53:35.592765|2017-10-11 00:53:35.592765
NCT02028975|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-01-06||||||July 2012|2012-07-01||||July 2014|Anticipated|2014-07-01||Interventional|||Search for Biological Markers of Orosensory Perception of Fatty Acids in Healthy Subjects and Possible Modifications in Patients With Type 2 Diabetes and in Obese Non-diabetic Patients.|Search for Biological Markers of Orosensory Perception of Fatty Acids in Healthy Subjects and Possible Modifications in Patients With Type 2 Diabetes and in Obese Non-diabetic Patients.|Unknown status|Recruiting|N/A|90|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f||||||||||||||2017-10-11 00:53:35.696739|2017-10-11 00:53:35.696739
NCT02028962|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-01-06|||October 2013||2013-10-01|January 2014|2014-01-01|November 2014|Anticipated|2014-11-01|August 2014|Anticipated|2014-08-01||Interventional|||Computer Tailored Program for Smoking Cessation Among Romanian Adults|Development, Implementation and Evaluation of a Computer Tailored Program for Smoking Cessation Among Romanian Adults|Unknown status|Recruiting|N/A|640|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy||2|||f||||t||||||||||2017-10-11 00:53:35.795143|2017-10-11 00:53:35.795143
NCT02028949|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-04-21|||November 22, 2012|Actual|2012-11-22|April 2017|2017-04-01|February 5, 2016|Actual|2016-02-05|November 2015|Actual|2015-11-01||Interventional|||Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study|LIDA-B: Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study|Completed||Phase 1|15|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 00:53:35.883261|2017-10-11 00:53:35.883261
NCT02028936|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-12-03|||October 2013||2013-10-01|October 2013|2013-10-01||||June 2014|Actual|2014-06-01||Interventional|Fijus Raisol||Study of the Impact of the Regular Consumption of Polyphenol-rich Grape Juice on the Biological Parameters of Oxidative Stress and on Endothelial Function in Healthy Subjects|Study of the Impact of the Regular Consumption of Polyphenol-rich Grape Juice on the Biological Parameters of Oxidative Stress and on Endothelial Function in Healthy Subjects: a Prospective Randomised Double-blind Study|Completed||N/A|100|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 00:53:35.962989|2017-10-11 00:53:35.962989
NCT02028923|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-11-18|||April 2014||2014-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|EMGEL||Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic Wounds|Phase III Study Evaluating the Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic Wounds|Terminated||Phase 3|126|Actual|Institut Curie||2||Recruiting patients too low|f||||f||||||||||2017-10-11 00:53:36.036485|2017-10-11 00:53:36.036485
NCT02028910|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-12-03|||January 2014||2014-01-01|October 2012|2012-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Ondangapi||Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter|Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter|Terminated||Phase 3|20|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:53:36.130636|2017-10-11 00:53:36.130636
NCT02028897|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-01-07||||||January 2015|2015-01-01||||January 2015|Anticipated|2015-01-01||Interventional|||Comparison of Alternative Embryo Culture Systems|Comparison of Alternative Embryo Culture Systems|Withdrawn||N/A|0|Actual|Fertility Center of Las Vegas||2|||f||||f||||||||||2017-10-11 00:53:36.219777|2017-10-11 00:53:36.219777
NCT02028689|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-02-13|||October 2013||2013-10-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Metformin and Furosemide Drug-Drug Interaction Study|A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate Potential Pharmacokinetic Interaction Between Lesinurad and Metformin and Between Lesinurad and Furosemide in Health Adult Male Subjects|Completed||Phase 1|23|Actual|Ardea Biosciences, Inc.||2|||f||||f||||||||||2017-10-11 00:53:39.179942|2017-10-11 00:53:39.179942
NCT02028884|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2017-09-27|||February 2014||2014-02-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Efficacy and Safety Study as Add-on Therapy of SA237 to Treat NMO and NMOSD|A Multicenter, Randomized, Addition to Baseline Treatment, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of SA237 in Patients With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)|Recruiting||Phase 3|70|Anticipated|Chugai Pharmaceutical||2|||f||||t||||||||||2017-10-11 00:53:36.297452|2017-10-11 00:53:36.297452
NCT02028871|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-07-27|||July 2014||2014-07-01|July 2017|2017-07-01|October 1, 2017|Anticipated|2017-10-01|July 2016|Actual|2016-07-01||Interventional|||Intranasal Insulin for Weight Management During Smoking Cessation||Recruiting||Phase 2|40|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-10-11 00:53:36.465119|2017-10-11 00:53:36.465119
NCT02028858|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-06-23|||November 2013||2013-11-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Cannabis and Parkinson's Disease Tremor: A Natural History Study|Cannabis and Parkinson's Disease Tremor: A Natural History Study|Completed||N/A|11|Actual|Bastyr University|||1||f||||f||||||||No||2017-10-11 00:53:36.549897|2017-10-11 00:53:36.549897
NCT02028845|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2016-01-04|||January 2014||2014-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Loop-tipped Guidewire in Selective Biliary Cannulation|Loop-tipped Guidewire in Selective Biliary Cannulation: a Prospective, Randomized, Controlled Trial|Completed||N/A|200|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-11 00:53:36.606984|2017-10-11 00:53:36.606984
NCT02028832|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-03|||February 2013||2013-02-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|February 2016|Actual|2016-02-01||Interventional|PIM||Pediatric Integrative Medicine Trial Pilot|Pilot Study of Pediatric Integrative Medicine in Pediatric Oncology, General Pediatrics and Pediatric Cardiology|Completed||Phase 3|872|Actual|University of Alberta||2|||f||||t||||||||Undecided||2017-10-11 00:53:36.681013|2017-10-11 00:53:36.681013
NCT02028819|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-10-31|||January 2012||2012-01-01|October 2016|2016-10-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Expanded Access|||Compassionate Use of Ibalizumab for the Treatment of HIV Infection|Compassionate Use of Ibalizumab for the Treatment of HIV Infection|No longer available||N/A|||University of Colorado, Denver|||||||||||||||||||2017-10-11 00:53:36.75524|2017-10-11 00:53:36.75524
NCT02028806|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2016-11-18|||February 2013||2013-02-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer|Phase Ⅱ Trial to Investigate the Efficacy and Safety of mFOLFIRINOX in Patients With Metastatic Pancreatic Cancer in China|Recruiting||Phase 2|40|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:53:36.977033|2017-10-11 00:53:36.977033
NCT02028793|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2014-08-27|||November 2013||2013-11-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Work Pressure for Pharmacist With Home Pharmaceutical Care|Factors Related to Work Pressure and Turnover Intention for Pharmacists With Home Pharmaceutical Care|Completed||N/A|160|Anticipated|Taichung Veterans General Hospital|||1||f||||f||||||||||2017-10-11 00:53:37.061845|2017-10-11 00:53:37.061845
NCT02028780|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2016-01-13|2015-11-13||January 2014||2014-01-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Treated Set (TS): : This subject set included all subjects who received the idarucizumab or placebo.|Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects|Randomised, Double-blind Within Dose Groups, Placebo-controlled Phase I Trial in Healthy Japanese Male Volunteers to Investigate Safety, Tolerability and Pharmacokinetics of Different Doses of BI 655075 (Part 1) and to Explore the Effective Dose of BI 655075 to Reverse Dabigatran Anticoagulant Activity (Part 2).|Completed||Phase 1|80|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:53:37.15358|2017-10-11 00:53:37.15358
NCT02028767|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2015-06-26|2015-06-26||January 2014||2014-01-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Treated set (TS): includes all subjects who were dispensed study medication and were documented to have received at least 1 dose of study medication.|Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets|Bioequivalence of Empagliflozin/Metformin (12.5mg/500mg) Fixed Dose Combination Tablets Compared to Tablets Administered Together in Healthy Male and Female Volunteers Under Fed Conditions (an Open Label, Randomised, Single Dose, Two Period, Two Sequence Crossover Study)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:53:37.948726|2017-10-11 00:53:37.948726
NCT02028754|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-06|2014-03-19|2014-03-19||July 2011||2011-07-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|RLOTUS||A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms||Completed||Phase 4|180|Actual|Allergan||2|||f||||f||||||||||2017-10-11 00:53:38.323745|2017-10-11 00:53:38.323745
NCT02028741|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2014-01-06|||January 2011||2011-01-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Immediate Effects of Thoracic Transverse Mobilization in Patients With Primary Complaint of Mechanical Neck Pain: A Pilot Study||Completed||N/A|41|Actual|University of Puget Sound||2|||f||||f||||||||||2017-10-11 00:53:38.76291|2017-10-11 00:53:38.76291
NCT02028728|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-09-28|||March 2014|Actual|2014-03-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01|18 Months|Observational [Patient Registry]|||BIOFLOW III Satellite-Italy Orsiro Stent System|Safety and Performance Registry for an All Comers Patient Population With the Limus Eluting Orsiro Stent Within Daily Clinical Practice III-Italy|Completed||N/A|609|Actual|Biotronik Italia S.p.A.|||1||f||||f||||||||||2017-10-11 00:53:38.848002|2017-10-11 00:53:38.848002
NCT02028715|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-07-11|||January 2014||2014-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy of IV Acetaminophen for Pain Management|Efficacy of IV Acetaminophen for Pain Management Following Major Gynecologic Surgery: Effect on Opioid Rescue, Return of Bowel Function, Cost and Length of Hospital Stay.|Completed||Phase 4|67|Actual|Aultman Health Foundation||2|||f||||f||||||||||2017-10-11 00:53:38.971257|2017-10-11 00:53:38.971257
NCT02028702|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-02-05|||June 2012||2012-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Alternative Treatments for Menopausal Women|Alternative Treatments for Menopausal Women: The Efficacy of a Novel Red Clover Treatment on Menopausal Women.|Completed||N/A|61|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 00:53:39.068698|2017-10-11 00:53:39.068698
NCT02028676|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-06-04|2014-01-15||March 2007||2007-03-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|ARROW|All participants who were randomized were included except those who were randomised in error (main enrollment: 1 child HIV-uninfected, 2 on main phase of tuberculosis treatment; cotrimoxazole secondary randomization: 2 children receiving dapsone prophylaxis not cotrimoxazole).|Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa|A Randomised Trial of Monitoring Practice and Induction Maintenance Drug Regimens in the Management of Antiretroviral Therapy in Children With HIV Infection in Africa|Completed||Phase 4|1206|Actual|Medical Research Council||9|||f||||t||||||||||2017-10-11 00:53:39.357805|2017-10-11 00:53:39.357805
NCT02028663|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-05|2014-08-06|||May 2013||2013-05-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis|A Double-Blind, Randomized, Dose-finding Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis|Completed||Phase 2|206|Actual|CJ HealthCare Corporation||4|||f||||f||||||||||2017-10-11 00:53:44.150561|2017-10-11 00:53:44.150561
NCT02028650|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2016-07-12|||February 2005||2005-02-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|February 2013|Actual|2013-02-01||Observational|||Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation|HLA-mismatched Peripheral Hematopoietic Stem Cells Infusion in the Treatment of Leukemia Patients Relapse After HLA- Matched Allogeneic Stem Cell Transplantation: A Randomized Clinical Trial|Completed||N/A|20|Actual|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences|||2||f||||t||||||Samples With DNA|"     the blood and bone marrow samples before and after transplantation and DSI   "|||2017-10-11 00:53:44.229939|2017-10-11 00:53:44.229939
NCT02028637|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-01-04|||July 2009||2009-07-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.|Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.|Completed||N/A|59|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||t||||||||||2017-10-11 00:53:44.310191|2017-10-11 00:53:44.310191
NCT02028624|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2014-01-04|||September 2009||2009-09-01|January 2014|2014-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis|Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis: a Randomized Controlled Trial|Completed||N/A|48|Actual|Harokopio University||3|||f||||f||||||||||2017-10-11 00:53:44.392988|2017-10-11 00:53:44.392988
NCT02028611|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-01-04|||June 2013||2013-06-01|January 2014|2014-01-01||||July 2013|Actual|2013-07-01||Observational|||Comparison of Gray-scale Inverted Rib Series With Conventional Ones in Rib Fracture Detection by Emergency Physicians and Medical Students||Completed||N/A|55|Actual|Hanyang University|||1||f||||||||||||||2017-10-11 00:53:44.486735|2017-10-11 00:53:44.486735
NCT02028598|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-09-12|||January 2014||2014-01-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males|A Randomized, Open-labeled, 6-sequence, 3-period, 3-treatment Crossover Study to Evaluate the Effect of Co-administration of Clomipramine HCl (Condencia Tab.) 15mg and Sildenafil Citrate (Viagra Tab.) 100mg on the Safety and Pharmacokinetic/Pharmacodynamic Properties of Clomipramine and Sildenafil Compared to the Effects After Single Oral Administration in Healthy Male Volunteers|Completed||Phase 1|30|Actual|CTC Bio, Inc.||6|||f||||f||||||||||2017-10-11 00:53:44.553813|2017-10-11 00:53:44.553813
NCT02028585|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2013-12-30|||April 2012||2012-04-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Effects of Low Fat Milk Consumption on Metabolic Syndrome|Effects of Low-fat Milk Consumption on Metabolic and Atherogenic Biomarkers in Korean Adults With Metabolic Syndrome: a Randomized Controlled Trial|Completed||N/A|58|Actual|Ministry of Food and Drug Safety, Korea||2|||f||||||||||||||2017-10-11 00:53:44.654662|2017-10-11 00:53:44.654662
NCT02028572|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-12-28|||February 2013||2013-02-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|STR_FN||Structure Function Correlation in Primary Open Angle Glaucoma|A Cross Sectional Study of Correlation Between Retinal Nerve Fibre Thickness Measured by Optical Coherence Tomography and Humphrey Visual Fields in Early and Moderate Open Angle Glaucoma|Completed||N/A|130|Actual|Vasan Eye Care Hospital|||1||f||||f||||||||||2017-10-11 00:53:44.733905|2017-10-11 00:53:44.733905
NCT02028559|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2015-05-31|||January 2014||2014-01-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones|Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones|Unknown status|Enrolling by invitation|N/A|15|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 00:53:44.813189|2017-10-11 00:53:44.813189
NCT02028546|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-01-05|||January 2013||2013-01-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo Study|The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo Study|Completed||N/A|22|Actual|Srinakharinwirot University||2|||f||||||||||||||2017-10-11 00:53:44.889996|2017-10-11 00:53:44.889996
NCT02028533|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-07-20|||July 2014||2014-07-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|COOOL||Cocaine Opioid Oxytocin Option - Limited|Chronic Intranasal Oxytocin as an Adjunct to Methadone Maintenance Treatment in Patients With Co-occuring Opioid Use Disorder and Cocaine Use: A 2-week Pilot Study|Completed||Phase 1|30|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 00:53:44.954485|2017-10-11 00:53:44.954485
NCT02028507|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-06-24|||March 2014||2014-03-01|June 2016|2016-06-01|July 2020|Anticipated|2020-07-01|September 2019|Anticipated|2019-09-01||Interventional|PEARL||Phase III Study of Palbociclib (PD-0332991) in Combination With Endocrine Therapy (Exemestane or Fulvestrant) Versus Chemotherapy (Capecitabine) in Hormonal Receptor (HR) Positive/HER2 Negative Metastatic Breast Cancer (MBC) Patients With Resistance to Non-steroidal Aromatase Inhibitors|Phase III Study of Palbociclib (PD-0332991) in Combination With Endocrine Therapy (Exemestane or Fulvestrant) Versus Chemotherapy (Capecitabine) in Hormonal Receptor (HR) Positive/HER2 Negative Metastatic Breast Cancer (MBC) Patients With Resistance to Non-steroidal Aromatase Inhibitors|Recruiting||Phase 3|600|Anticipated|Spanish Breast Cancer Research Group||2|||f||||t||||||||||2017-10-11 00:53:45.250224|2017-10-11 00:53:45.250224
NCT02028494|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-06-19|||August 2013||2013-08-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|CAP7/7||Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer|Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer|Unknown status|Recruiting|N/A|350|Anticipated|Latin American & Caribbean Society of Medical Oncology||2|||f||||t||||||||||2017-10-11 00:53:45.422838|2017-10-11 00:53:45.422838
NCT02028481|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-10-26|||December 2013||2013-12-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Air Tamponade in Macular Holes < 400 μm|Air Tamponade in Macular Holes < 400 μm|Completed||N/A|13|Actual|Helse Stavanger HF||1|||f||||f||||||||No||2017-10-11 00:53:45.509872|2017-10-11 00:53:45.509872
NCT02028468|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-09-04|||February 2014||2014-02-01|September 2017|2017-09-01||||February 2018|Anticipated|2018-02-01||Interventional|||Anterolateral Watson Jones Approach Versus Transgluteal Approach for Uncemented Hemi- Arthroplasty in Displaced Femoral Neck Fracture||Active, not recruiting||N/A|150|Anticipated|Sorlandet Hospital HF||2|||f||||||||||||||2017-10-11 00:53:45.600941|2017-10-11 00:53:45.600941
NCT02028455|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-06-12|||January 2014||2014-01-01|June 2017|2017-06-01|January 2032|Anticipated|2032-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia|Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-02: A Phase 1/2 Feasibility and Safety Study of CD19-CAR T Cell Immunotherapy for CD19+ Leukemia|Recruiting||Phase 1/Phase 2|80|Anticipated|Seattle Children's Hospital||3|||f||||t||||||||||2017-10-11 00:53:45.685908|2017-10-11 00:53:45.685908
NCT02028442|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-05-10|||September 2012||2012-09-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|EVOLVE||Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients|A Clinical Study Of Enadenotucirev Administered by Sub-Acute Fractionated Intravenous Injection: Dose Escalation in Metastatic Epithelial Solid Tumours and Randomised Controlled Trial in Metastatic Colorectal Cancer|Active, not recruiting||Phase 1/Phase 2|161|Anticipated|PsiOxus Therapeutics Ltd||1|||f||||t||||||||||2017-10-11 00:53:45.782887|2017-10-11 00:53:45.782887
NCT02028429|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2014-01-03|||July 2012||2012-07-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.|To Study The Proof of Concept in The Improvement of Cognition and Quality of Life in Cirrhotic Patients With Minimal Hepatic Encephalopathy by Means of a Pharmacological Intervention With Sildenafil (A Phosphodiesterase-5 Inhibitor).|Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 00:53:45.867828|2017-10-11 00:53:45.867828
NCT02028416|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-04-03|||September 2013||2013-09-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ATG||Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia|Protocol for Comparison of Two Different Regimens of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia|Recruiting||N/A|60|Anticipated|National Institute of Blood Disease Center, Pakistan||2|||f||||t||||||||No|All data saved at research department of NIBD under supervision of PI|2017-10-11 00:53:45.951979|2017-10-11 00:53:45.951979
NCT02028403|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-10-10|||June 2014||2014-06-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy|Safety, Pharmacokinetics and Immunotherapeutic Activity of an Anti-PD-L1 Antibody (BMS-936559) in HIV-1 Infected Participants on Suppressive cART: A Phase I, Double-Blind, Placebo-Controlled, Ascending Single Dose Study|Completed||Phase 1|8|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||t||||||||||2017-10-11 00:53:46.143076|2017-10-11 00:53:46.143076
NCT02028390|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Overlaying a Visual Wound Trace Onto Its Thermal Image in a Wound Clinic|Scout Overlay-Trace-On-Thermal Feature in a Wound Clinic Setting: A Prospective Study|Completed||N/A|31|Actual|Wound Vision||1|||f||||f||||||||||2017-10-11 00:53:46.258391|2017-10-11 00:53:46.258391
NCT02028377|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-11-01|||January 2013||2013-01-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma|Evaluation of the Novel Imaging Modality Simultaneous Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) in Patients With Pancreatic Adenocarcinoma|Enrolling by invitation||N/A|100|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 00:53:46.366542|2017-10-11 00:53:46.366542
NCT02028364|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-09-01|||January 2014||2014-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|PEARL||Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women|Pet Imaging as a Biomarker of Everolimus Added Value in Hormone Refractory postmenopausaL Women|Recruiting||Phase 2|46|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 00:53:46.449813|2017-10-11 00:53:46.449813
NCT02028351|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2014-01-03|||January 2008||2008-01-01|January 2014|2014-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Vision Measured by the Vimetrics CVA Compared With Chart Testing Under Similar Luminance and Contrast Conditions|Comparison of Vision Measured by the Vimetrics Central Vision Analyzer With That Measured by logMAR Acuity Chart Testing Under Similar Conditions of Luminance and Contrast|Completed||N/A|150|Actual|Sinclair Technologies, LLC|||3||f||||t||||||||||2017-10-11 00:53:46.565376|2017-10-11 00:53:46.565376
NCT02028338|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-02-09|||March 2014||2014-03-01|September 2015|2015-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Phase 2a Study of Dapivirine Ring in Adolescent Females|Phae 2A Study of a Vaginal Ring Containing Dapivirine in Adolescent Females|Completed||Phase 2|96|Actual|International Partnership for Microbicides, Inc.||2|||f||||f|t|f||||||No||2017-10-11 00:53:46.644972|2017-10-11 00:53:46.644972
NCT02028325|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-10-04|2016-08-05||December 2013||2013-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2014|Actual|2014-10-01||Interventional|Fluorescein||Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions|Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions|Terminated||Phase 4|136|Actual|Indiana University||1||Lack of enrollment. No new subjects had been enrolled for nearly a year.|f||||t||||||||||2017-10-11 00:53:46.756894|2017-10-11 00:53:46.756894
NCT02028312|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-03-17|||January 2014||2014-01-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Interventional|||A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®||Withdrawn||Phase 4|0|Actual|Holprovision||2||Per Sponsor|f||||f||||||||||2017-10-11 00:53:46.914273|2017-10-11 00:53:46.914273
NCT02028299|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-01-03|||April 2010||2010-04-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography|Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography|Completed||N/A|38|Actual|George Washington University||1|||f||||f||||||||||2017-10-11 00:53:46.99523|2017-10-11 00:53:46.99523
NCT02028286|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-04-11|||January 2014||2014-01-01|April 2014|2014-04-01||||March 2014|Actual|2014-03-01||Interventional|||A 21 Day Pharmacokinetics Study in Papulopustular Rosacea|A Phase 1, Open Label, Multiple Center Study to Evaluate the Pharmacokinetics of Once-Daily CLS001 Topical Gel Under Maximal Use Conditions Administered for 21 Days in Subjects With Papulopustular Rosacea|Completed||Phase 1|25|Actual|Cutanea Life Sciences, Inc.||1|||f||||f||||||||||2017-10-11 00:53:47.07325|2017-10-11 00:53:47.07325
NCT02028273|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-05-29|||June 2012||2012-06-01|January 2014|2014-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|NG||Hippocampal Neurogenesis in Human Subjects|Hippocampal Neurogenesis in Human Subjects (Pilot Study)|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Texas Southwestern Medical Center|||3||f||||t||||||||||2017-10-11 00:53:47.153679|2017-10-11 00:53:47.153679
NCT02028260|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-11-02|||January 2014||2014-01-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|||Modafinil Versus Placebo for Hypoactive Delirium in the Critically Ill|Modafinil vs. Placebo for Hypoactive Delirium in the Critically Ill: A Randomized, Controlled Trial|Withdrawn||Phase 3|0|Actual|Brigham and Women's Hospital||2||unable to enroll|f||||t||||||||||2017-10-11 00:53:47.228301|2017-10-11 00:53:47.228301
NCT02028247|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-11-28|||July 2014||2014-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TAASD||Psychotherapy for Anxiety in Children With Autism Spectrum Disorder|2/3 Treatment of Anxiety in Autism Spectrum Disorder|Recruiting||Phase 3|201|Anticipated|University of South Florida||3|||f||||t||||||||||2017-10-11 00:53:47.311458|2017-10-11 00:53:47.311458
NCT02028234|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-06|||February 2014||2014-02-01|January 2014|2014-01-01|April 2016|Anticipated|2016-04-01|March 2015|Anticipated|2015-03-01||Interventional|dOPPLER||"Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors -Trial dOPPLER-"|"Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors"|Unknown status|Not yet recruiting|Phase 4|150|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 00:53:47.70761|2017-10-11 00:53:47.70761
NCT02028221|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-04-05|||March 2014||2014-03-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk|Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk|Recruiting||Phase 2|150|Anticipated|University of Arizona||2|||f||||t||||||||||2017-10-11 00:53:47.808655|2017-10-11 00:53:47.808655
NCT02028208|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-09-22|||November 2013||2013-11-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study|Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study|Unknown status|Recruiting|Phase 2|60|Anticipated|Allerderm||1|||f||||f||||||||||2017-10-11 00:53:47.91234|2017-10-11 00:53:47.91234
NCT02028195|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2014-07-03|||May 2013||2013-05-01|July 2014|2014-07-01||||April 2017|Anticipated|2017-04-01||Interventional|||Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme|The CORE-trial: a Pragmatic Randomized Controlled Trial in Primary Care Investigating Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme Offered Population-wide to 30-49 Years|Unknown status|Recruiting|N/A|11000|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 00:53:47.999147|2017-10-11 00:53:47.999147
NCT02028182|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-03|||February 2013||2013-02-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Evaluation of Lyral® Dose Response Study|Clinical Evaluation of Hydroxyisohexyl 3-cyclohexene Carboxaldehyde (Lyral®) Dose Response Study|Completed||Phase 2|22|Actual|Allerderm||1|||f||||f||||||||||2017-10-11 00:53:48.10048|2017-10-11 00:53:48.10048
NCT02028169|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-03-16|2017-03-16||January 2014||2014-01-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)|To Observe the Impacts of Anti-TNF's Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis|Completed||N/A|120|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 00:53:48.229778|2017-10-11 00:53:48.229778
NCT02028156|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-11-05|||January 2014||2014-01-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Feeding Intolerance in Formula-Fed Infants|Evaluation of Feeding Intolerance in Formula-Fed Infants: A Non-Randomized, Single-Group, Multi-Center Study|Terminated||N/A|3|Actual|Abbott Nutrition||1||Low enrollment|f||||f||||||||||2017-10-11 00:53:49.063893|2017-10-11 00:53:49.063893
NCT02028143|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-01-06|||November 2013||2013-11-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|ICE||ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation|ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation|Unknown status|Recruiting|N/A|20|Anticipated|Wellmont CVA Heart Institute||2|||f||||f||||||||||2017-10-11 00:53:49.162468|2017-10-11 00:53:49.162468
NCT02028130|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-06-02|||July 2013||2013-07-01|June 2014|2014-06-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|LEIO-AF||Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation: A Safety and Feasibility Study|The Safety and Feasibility of Concomitant Left Atrial Appendage Electrical Isolation and Occlusion in the Treatment of Persistent Atrial Fibrillation|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 00:53:49.27714|2017-10-11 00:53:49.27714
NCT02028117|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-02-15|||January 2014||2014-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|OCTAVE||Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer Patients|A Clinical Study Of Enadenotucirev: Dose Finding and Proof of Concept in Platinum-Resistant Epithelial Ovarian Cancer.|Recruiting||Phase 1/Phase 2|35|Anticipated|PsiOxus Therapeutics Ltd||1|||f||||t||||||||||2017-10-11 00:53:49.356936|2017-10-11 00:53:49.356936
NCT02028104|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-09-23|||January 2010||2010-01-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||Stem Cell Therapy in Traumatic Brain Injury|Open Label Study of Autologous Bone Marrow Mononuclear Cells in Traumatic Brain Injury|Completed||Phase 1|43|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||No||2017-10-11 00:53:49.461723|2017-10-11 00:53:49.461723
NCT02028091|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-01-04|||September 2012||2012-09-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements|Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements|Completed||N/A|100|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 00:53:49.553051|2017-10-11 00:53:49.553051
NCT02028078|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-09-09|||January 2014||2014-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PILOT_EGP||Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia|An Open, Non-randomized, Single-center Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemic Clamp in Type 1 Diabetes Mellitus Subjects|Completed||Phase 2|20|Actual|Medical University of Graz||1|||f||||t||||||||||2017-10-11 00:53:49.689196|2017-10-11 00:53:49.689196
NCT02028065|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-06-05|2015-09-01||January 3, 2014|Actual|2014-01-03|June 2017|2017-06-01|July 1, 2014|Actual|2014-07-01|July 1, 2014|Actual|2014-07-01||Interventional||All participants as treated (APaT) - All randomized participants who received at least one dose of study treatment, with each participant included in arm corresponding to treatment actually received.|A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101)|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Incidence of Hypersensitivity After Repeated Single Dose Administration of Sugammadex (MK-8616) in Healthy Subjects|Completed||Phase 1|382|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 00:53:49.884655|2017-10-11 00:53:49.884655
NCT02028052|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-02-14|||April 2012||2012-04-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|ROSE||Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE)|Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE) by Cytopathologist|Terminated||N/A|37|Actual|Duke University||2||similar study data published|f||||f|f|f||||||||2017-10-11 00:53:50.28547|2017-10-11 00:53:50.28547
NCT02028039|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-01-03|||December 2013||2013-12-01|January 2014|2014-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)|Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) With IPI-145|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:53:50.365153|2017-10-11 00:53:50.365153
NCT02028026|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2016-11-07|||April 2013||2013-04-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives|The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||2||Inability to recruit eligible subjects|f||||f||||||||||2017-10-11 00:53:50.431512|2017-10-11 00:53:50.431512
NCT02028013|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-04-07|||January 2013||2013-01-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Observational|||Management of Sexual Dysfunction With Bioresonance Technique|Management of Male Sexual Dysfunction With Bioresonance Technique, a New Egyptian Device|Unknown status|Recruiting|N/A|600|Anticipated|Man Clinic for Andrology, Male Infertility and Sexual Dysfunction|||1||f||||t||||||||||2017-10-11 00:53:50.514409|2017-10-11 00:53:50.514409
NCT02028000|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-07-31|||January 2012||2012-01-01|July 2014|2014-07-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|Skin||Postoperative Pain and Skin Closure Methods After Cesarean Section|Post-Operative Pain and Skin Closure Methods After Cesarean Section|Unknown status|Recruiting|N/A|150|Anticipated|Wake Forest University Health Sciences||3|||f||||f||||||||||2017-10-11 00:53:50.576701|2017-10-11 00:53:50.576701
NCT02027987|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-01-02|||October 2013||2013-10-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|VPA||Traumatic Neuroprotection and Epilepsy Prevention of Valproate Acid|Clinical Study on the Neuroprotection and Epilepsy Prevention of Valproate Acid Administered After Severe Traumatic Brain Injury|Unknown status|Recruiting|Phase 1|160|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 00:53:50.669016|2017-10-11 00:53:50.669016
NCT02027974|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-05-12|||December 2013||2013-12-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Post-Market Study of the ICONACY Hip System|ICONACY Hip Clinical Data Acquisition (13-1-M-239)|Withdrawn||N/A|0|Actual|Iconacy Orthopedic Implants, LLC.||2|||f||||t||||||||||2017-10-11 00:53:50.80035|2017-10-11 00:53:50.80035
NCT02027961|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-05-23|||December 20, 2013|Actual|2013-12-20|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone|A Phase 1 Open-label Study of Safety and Tolerability of MEDI4736 in Subjects With Metastatic or Unresectable Melanoma in Combination With Dabrafenib and Trametinib or With Trametinib Alone|Active, not recruiting||Phase 1/Phase 2|68|Actual|MedImmune LLC||3|||f||||f||||||||||2017-10-11 00:53:50.89734|2017-10-11 00:53:50.89734
NCT02027948|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-01-03|||December 2013||2013-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer|A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer|Recruiting||N/A|36|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:53:51.252289|2017-10-11 00:53:51.252289
NCT02027584|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-01-02|||November 2008||2008-11-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|NEO-CHOLIN||Observational Study of Choline, Its Metabolites, and Phospholipids in Preterm Infants|Supply of Term and Preterm Neonates With Choline, Lipids and Vitamines|Completed||N/A|414|Actual|University Hospital Tuebingen|||4||f||||f||||||||||2017-10-11 00:53:56.292506|2017-10-11 00:53:56.292506
NCT02027935|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-08-01|||January 22, 2015|Actual|2015-01-22|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4|Phase II Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4 for Patients With Metastatic Melanoma|Recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 00:53:51.381017|2017-10-11 00:53:51.381017
NCT02027922|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-07-11|||November 2013||2013-11-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Clinical Effectiveness of Various Professionally Applied Fluoride Prophylaxes in Groups at High Risk|Randomized Clinical Trial Comparing the Clinical Effectiveness of Various Professionally Applied Fluoride Prophylaxes in Deciduous Teeth in Groups at High Risk|Unknown status|Recruiting|N/A|180|Anticipated|Medical University of Warsaw||3|||f||||f||||||||||2017-10-11 00:53:51.510485|2017-10-11 00:53:51.510485
NCT02027909|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-01-02|||November 2011||2011-11-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|CRIPS||A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction|A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction.|Unknown status|Recruiting|N/A|21|Anticipated|Wellmont CVA Heart Institute||3|||f||||f||||||||||2017-10-11 00:53:51.633163|2017-10-11 00:53:51.633163
NCT02027896|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-08-24|||March 2014||2014-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|HIP ATTACK||HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial|HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial|Recruiting||N/A|1200|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-11 00:53:51.799392|2017-10-11 00:53:51.799392
NCT02027883|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-05-22|2014-06-24||January 2011||2011-01-01|May 2017|2017-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|VF||Comparison of VF Induction Techniques During Medtronic ICD Implant (VF) (ICD)|Comparison of Ventricular Fibrillation Induction Techniques During Medtronic Implantable Cardioverter Defibrillator Implant|Completed||N/A|100|Actual|Wellmont CVA Heart Institute||2|||f||||f||||||||No||2017-10-11 00:53:52.277906|2017-10-11 00:53:52.277906
NCT02027870|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-02|||January 2014||2014-01-01|January 2014|2014-01-01|June 2019|Anticipated|2019-06-01|June 2015|Anticipated|2015-06-01|5 Years|Observational [Patient Registry]|CREDIT-III||EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)|A Prospective Multicenter Single-Arm Observational Registry Study to Assess the Safety and Efficacy of EXCEL-II With Sirolimus Eluting Stent for the Treatment of Patients With de Novo Coronary Artery . (CREDIT-III Trial)|Recruiting||Phase 2/Phase 3|621|Anticipated|JW Medical Systems Ltd|||1||f||||t||||||None Retained|"     According to the CREATE (Multi - Center Registry of Excel Biodegradable Polymer Drug Eluting     Stent) registration results show that ExcelTM drug-eluting stents implanted an average of 12     months, target lesion (TLF) the failure rate of 6.7%.Will this study expected target lesion     group stent failure rate estimate of 6.7%, the target is 9.5%;Test hypothesis: bilateral     0.05% 0.05%, master degree, clinical follow-up requirements is more than 95%, this research     need at least 829 patients, remove the CREDIT II randomized controlled study can provide the     number of cases of test group 208 examples, this study still need to be included in the 621     patients.   "|||2017-10-11 00:53:53.368516|2017-10-11 00:53:53.368516
NCT02027857|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-01-02|||January 2014||2014-01-01|January 2014|2014-01-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|EIT||Comparison of the Application in Traumatic Brain Edema Between EIT and Non-invasive ICP Monitoring|Comparison of the Application in Traumatic Brain Edema Between Electrical Impedance Tomography and Non-invasive Intracranial Pressure Monitoring|Unknown status|Not yet recruiting|N/A|60|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 00:53:53.496114|2017-10-11 00:53:53.496114
NCT02027844|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2015-10-04|2015-06-23||December 2013||2013-12-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Cartoon Distraction and Parental Presence on Anxiety in Pediatric Anesthesia|Cartoon Distraction and Parental Presence During Induction of Anesthesia on Preoperative Anxiety and Postoperative Behavior Change in Children Undergoing General Anesthesia|Completed||N/A|117|Actual|Yeungnam University College of Medicine|Parental anxiety was assessed using a self-reporting rating scale. we did't measure the baseline temperament of children using a validated behavioral assessment tool and were unable to calculate the ‘use of parents’ item of the mYPAS.|3|||f||||f||||||||||2017-10-11 00:53:53.655864|2017-10-11 00:53:53.655864
NCT02027831|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-07-23|||December 2013||2013-12-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG|Near-infrared Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After Intravenous Injection of Indocyanine Green (a Feasibility Study)|Unknown status|Recruiting|Phase 2|10|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 00:53:54.222383|2017-10-11 00:53:54.222383
NCT02027818|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-10-14|||January 2014||2014-01-01|December 2013|2013-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy|Study of the (Intravenously Injected) Indocyanine Green Distribution in the Margins of Breast Cancer After Tumorectomy|Completed||Phase 2|20|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 00:53:54.322086|2017-10-11 00:53:54.322086
NCT02027805|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-06-03|||March 5, 2014|Actual|2014-03-05|June 2017|2017-06-01|November 3, 2016|Actual|2016-11-03|September 7, 2016|Actual|2016-09-07||Interventional|||Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD|A Phase I/II Multicentric Study to Determine the Safety and Efficacy of a Combination of Anti-CD3 & Anti-CD7 Ricin A Immunotoxins (T-Guard) for the Treatment of Steroid-resistant Acute Graft-versus-Host Disease.|Completed||Phase 1/Phase 2|20|Actual|Xenikos||1|||f||||t||||||||||2017-10-11 00:53:54.402471|2017-10-11 00:53:54.402471
NCT02027792|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-08-18|||January 2014||2014-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|KoGon||Cabbage Leaf Wraps in Osteoarthritis of the Knee|Randomised Controlled Trial on the Efficacy of Cabbage Leaf Wraps in Symptomatic Primary Osteoarthritis of the Knee|Completed||N/A|81|Actual|Universität Duisburg-Essen||3|||f||||f||||||||||2017-10-11 00:53:54.510301|2017-10-11 00:53:54.510301
NCT02027779|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-03|||January 2014||2014-01-01|January 2014|2014-01-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A|An Open Label Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A|Unknown status|Recruiting|Phase 3|150|Anticipated|Green Cross Corporation||2|||f||||f||||||||||2017-10-11 00:53:54.598681|2017-10-11 00:53:54.598681
NCT02027766|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-05-05|||January 2014||2014-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Stretching and Pain Sensitivity|Local and Systemic Changes in Pain Sensitivity After 4 Weeks of Calf Muscle-tendon Stretching: A Randomised Trial|Completed||N/A|40|Actual|Frederiksberg University Hospital||2|||f||||||||||||||2017-10-11 00:53:54.695866|2017-10-11 00:53:54.695866
NCT02027753|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2015-08-26|||December 2013||2013-12-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|TED||Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy|Efficacy and Safety of TrEating Type 2 Diabetic Patients With Inadequate Response to Metformin and DPP-4 Inhibitors by Adding Basal Insulin Therapy (Insulin Glargine)|Completed||Phase 4|109|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:53:54.77395|2017-10-11 00:53:54.77395
NCT02027740|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-01-03|||January 2009||2009-01-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Almond Intervention in Type 2 Diabetes Mellitus|Effect of Almond Supplementation on Glycemic and Cardiovascular Risk Factors in Asian Indians in North India With Type 2 Diabetes Mellitus: A 24-week Prospective Cohort Study|Completed||N/A|50|Actual|Diabetes Foundation, India||1|||f||||t||||||||||2017-10-11 00:53:54.858949|2017-10-11 00:53:54.858949
NCT02027727|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-07-18|||November 2013||2013-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|May 2017|Actual|2017-05-01||Observational|||Individualized Infiximab Dosing-Proof of Concept Study|Individualized Infiximab Dosing-Proof of Concept Study|Active, not recruiting||N/A|56|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-11 00:53:54.929852|2017-10-11 00:53:54.929852
NCT02027714|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-03-23|||April 2011||2011-04-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|EPIC||Enhanced HIV Prevention in Couples: Feasibility Study #1|Enhanced HIV Prevention in Discordant Couples in Lesotho: Feasibility Study #1|Completed||N/A|230|Actual|Columbia University|||3||f||||f||||||||||2017-10-11 00:53:55.000433|2017-10-11 00:53:55.000433
NCT02027701|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-09-18|||July 30, 2014|Actual|2014-07-30|September 2017|2017-09-01|July 10, 2017|Actual|2017-07-10|July 10, 2017|Actual|2017-07-10||Interventional|||Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)|Multicenter, Open-label Extension Study to Investigate the Long-term Safety and Efficacy of IgPro20 in Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Subjects Completing Study IgPro20_3003|Completed||Phase 3|82|Actual|CSL Behring||1|||f||||t||||||||||2017-10-11 00:53:55.104382|2017-10-11 00:53:55.104382
NCT02027688|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2015-12-01|||July 2014||2014-07-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Feeding Progression in Preterm Infants|Feeding Progression in Preterm Infants|Completed||N/A|55|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 00:53:55.253069|2017-10-11 00:53:55.253069
NCT02027675|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-04-28|||April 2014||2014-04-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MERIIT||Meal-Exercise Challenge and Physical Activity Reduction Impact on Immunity and Inflammation|Meal-Exercise Challenge and Physical Activity Reduction Impact on Immunity and Inflammation|Completed||N/A|42|Actual|Universidade do Porto||2|||f||||f||||||||||2017-10-11 00:53:55.329587|2017-10-11 00:53:55.329587
NCT02027662|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-06-09|||January 2014||2014-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|OsvaRenNEW||Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules|Study to Investigate Efficacy and Safety Equivalence of OsvaRen® Tablets and OsvaRen® Granules|Completed||Phase 2/Phase 3|61|Actual|Fresenius Medical Care Deutschland GmbH||2|||f||||f||||||||||2017-10-11 00:53:55.420428|2017-10-11 00:53:55.420428
NCT02027649|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2017-07-18|||January 2014|Actual|2014-01-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|July 2014|Actual|2014-07-01|2 Years|Observational [Patient Registry]|||Detection of K14 in Bladder Cancer With a Non Invasive Technique|K14 in Urothelial Cells as a Pronostic and Diagnostic Marker in Bladder Cancer Patients Using a Non Invasive Technique.|Terminated||N/A|400|Actual|Corporacion Parc Tauli|||2|Absence of positive results|f||||t||||||Samples Without DNA|"     Urine   "|||2017-10-11 00:53:55.523233|2017-10-11 00:53:55.523233
NCT02027636|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-06-02|||May 2011||2011-05-01|June 2016|2016-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|CERED||Comparative Effectiveness Research for Eliminating Disparities|UPR-CHA Research Center of Excellence- Supplement|Completed||N/A|257|Actual|Massachusetts General Hospital||3|||f||||f||||||||||2017-10-11 00:53:55.597976|2017-10-11 00:53:55.597976
NCT02027623|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-04-03|||December 2013||2013-12-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|LBP||Spinal Control During Functional Activities to Improve Low Back Pain Outcomes|Spinal Control During Functional Activities to Improve Low Back Pain Outcomes|Active, not recruiting||N/A|154|Actual|Washington University School of Medicine||2|||f||||t||||||||Undecided||2017-10-11 00:53:55.69809|2017-10-11 00:53:55.69809
NCT02027610|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-11-17|||October 2014||2014-10-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants|Newborn Vitamin A Supplementation, Gut Microbiota and Vaccine Response During the Second Year of Life in Bangladeshi Infants|Completed||N/A|258|Actual|USDA, Western Human Nutrition Research Center|||1||f||||f||||||Samples With DNA|"     Infant specimens containing DNA isolated from periferal blood mononuclear cells (PBMC) will     be retained for future analyses. Maternal specimens containing DNA from cheek swabs will be     retained for future analyses.   "|||2017-10-11 00:53:56.028223|2017-10-11 00:53:56.028223
NCT02027597|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-03|||October 2008||2008-10-01|January 2014|2014-01-01|August 2011|Actual|2011-08-01|December 2010|Actual|2010-12-01||Interventional|AOTSM||Improving Oral Health With Serious Games|Improving Oral Health With Serious Games|Completed||N/A|161|Actual|University of Washington||3|||f||||f||||||||||2017-10-11 00:53:56.160757|2017-10-11 00:53:56.160757
NCT02027571|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-11-03|||October 2013||2013-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PROP-ABC||Pathobiology and Reversibility of Prediabetes in a Biracial Cohort|Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC)|Active, not recruiting||N/A|223|Actual|University of Tennessee||1|||f||||t||||||||No|Group data will be published after completion of study and analysis of results. Individual participant-level information will not be shared.|2017-10-11 00:53:56.40387|2017-10-11 00:53:56.40387
NCT02027558|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-08-22|||January 1, 2014|Actual|2014-01-01|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans|Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans|Active, not recruiting||N/A|120|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:53:56.503346|2017-10-11 00:53:56.503346
NCT02027545|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-07-14|||October 5, 2015|Actual|2015-10-05|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|April 5, 2018|Anticipated|2018-04-05||Interventional|PROM-IS||Promoting Veteran-Centered Colorectal Cancer Screening|Promoting Veteran-Centered Colorectal Cancer Screening|Enrolling by invitation||N/A|440|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:53:56.599629|2017-10-11 00:53:56.599629
NCT02027532|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2015-07-06|||October 2009||2009-10-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin|Prevention of Infection in Surgical Treatment of Closed Fractures: A Comparative Study of Cefazolin Versus Vancomycin|Unknown status|Enrolling by invitation|N/A|600|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-11 00:53:56.69622|2017-10-11 00:53:56.69622
NCT02027519|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-09-29|||December 2013||2013-12-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|EPIC||Enhanced HIV Prevention in Couples: Feasibility Study #3|Enhanced HIV Prevention in Serodiscordant Couples Study #3: Feasibility of Home-based Partner Self Testing for HIV|Completed||N/A|53|Actual|Columbia University|||1||f||||f||||||None Retained|"     HIV rapid tests will be conducted using self-collected oral mucosa transudate. These tests     use oral ﬂuid and do not require blood drawing. Oral swab samples will not be stored.     Following the completion of the self-testing, study staff will conduct conﬁrmatory standard     HIV testing.      Following self-testing procedures, conﬁrmatory rapid testing will be conducted using whole     blood ﬁnger-stick. Blood samples from confirmatory tests will not be stored. If there is a     discrepancy between the two tests, the individual will be counseled and referred for re-test     in 4-6 weeks.   "|||2017-10-11 00:53:56.805972|2017-10-11 00:53:56.805972
NCT02027506|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-03|2014-01-03|||February 2014||2014-02-01|January 2014|2014-01-01|January 2015|Anticipated|2015-01-01|October 2014|Anticipated|2014-10-01||Observational|ECG||Diagnostic Value of Electrocardiographic St-t Wave Changes in Patients With Chronic Stable Angina|DIAGNOSTIC VALUE OF ELECTROCARDIOGRAPHIC ST-T WAVE CHANGES IN LEAD aVL IN PATIENTS WITH CHRONIC STABLE ANGINA|Unknown status|Not yet recruiting|N/A|150|Anticipated|Alexandria University|||1||f||||f||||||||||2017-10-11 00:53:56.91173|2017-10-11 00:53:56.91173
NCT02027493|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2014-01-03|||February 2009||2009-02-01|January 2014|2014-01-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV|Safety and Efficacy of Hansenula-Derived Pegylated-Interferon Alpha-2a and Ribavirin Customized Combination Therapy in Egyptian Children With Chronic Hepatitis C Infection|Completed||N/A|46|Actual|National Liver Institute, Egypt||2|||f||||t||||||||||2017-10-11 00:53:57.977817|2017-10-11 00:53:57.977817
NCT02027480|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2015-12-22|||March 2014||2014-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|iMACS||Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study|Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: Establishment of a Prospective Cohort, iMACS Study|Completed||N/A|685|Actual|Columbia University|||1||f||||t||||||Samples With DNA|"     Blood and urine samples will be collected from study participants at 4 different points     during their 12 months of participation. 15 mL of blood and 10 mL of urine will collected via     venipuncture at baseline, 2 months, 6 months, and 12 months. Specimens will be retained for     10 years.   "|||2017-10-11 00:53:58.326661|2017-10-11 00:53:58.326661
NCT02027467|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-05-03|||February 2014||2014-02-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|Hematoalive||Study to Assess the Effect of StemAlive® Supplement on the Levels of Stem Cells in Human Volunteers|Assessment of the Effect of StemAlive® Herbal Supplement on the Levels of Circulating Hematopoietic Stem Cells in Human Volunteers|Completed||N/A|23|Actual|Vedic Lifesciences Pvt. Ltd.||2|||f||||f||||||||||2017-10-11 00:53:58.45668|2017-10-11 00:53:58.45668
NCT02027454|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-06-12|||January 2014||2014-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction|A Study to Evaluate the Effect of GSK1265744 150mg Administered Orally Every 12h x 3 Doses on Cardiac Conduction as Assessed by 12-lead Electrocardiogram Compared to Placebo and a Single Oral Dose of Moxifloxacin|Completed||Phase 1|42|Actual|ViiV Healthcare||6|||f||||f||||||||||2017-10-11 00:53:58.552055|2017-10-11 00:53:58.552055
NCT02027441|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-03-23|||September 2012||2012-09-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|August 2013|Actual|2013-08-01||Observational|EPIC||Enhanced Prevention in Couples: Feasibility Study #2|Enhanced HIV Prevention in Serodiscordant Couples in Lesotho: Feasibility Study #2|Completed||N/A|191|Actual|Columbia University|||1||f||||f||||||None Retained|"     HIV rapid tests will also be conducted using whole blood ﬁnger-stick.Blood will be collected     speciﬁcally for this study. Specimens will not be stored. All rapid HIV test kits will be     labeled using a unique participant identiﬁcation number. Participant names will not be     included on the label.   "|||2017-10-11 00:53:58.703512|2017-10-11 00:53:58.703512
NCT02027428|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-08-15|||February 11, 2014|Actual|2014-02-11|August 2017|2017-08-01|June 29, 2018|Anticipated|2018-06-29|September 29, 2017|Anticipated|2017-09-29||Interventional|aboundsqm||Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer|A Phase III, Randomized, Open-Label, Multi-Center, Safety and Efficacy Study to Evaluate Nab-Paclitaxel (Abraxane®) as Maintenance Treatment After Induction With Nab-Paclitaxel Plus Carboplatin in Subjects With Squamous Cell Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 3|426|Actual|Celgene||2|||f||||t||||||||||2017-10-11 00:53:58.834567|2017-10-11 00:53:58.834567
NCT02027415|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-01-06|||December 2013||2013-12-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Effect of Juice Types on the Responses to Air Pollution|Effects of Oral Nitrate Supplementation on Vascular and Pulmonary Oxidative Stress Markers Following Traffic Pollution Exposure|Completed||N/A|24|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 00:53:59.259903|2017-10-11 00:53:59.259903
NCT02027402|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2014-11-30|2014-11-23||November 2013||2013-11-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Drainage in Laparoscopic Cholecystectomy|To Drain or Not to Drain in Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder ; a Multicenter Randomized Controlled Trial|Completed||N/A|198|Actual|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-11 00:53:59.370049|2017-10-11 00:53:59.370049
NCT02027389|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2015-09-24|||January 2014||2014-01-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Impact of Rapid Detection of MRSA|Clinical and Economic Impact of a Rapid Test for Detection of Methicillin-resistant Staphylococcus Aureus (MRSA) From Sterile Sites (the Alere&#8482; PBP2a)|Unknown status|Recruiting|N/A|240|Anticipated|Mayo Clinic|||2||f||||f||||||||||2017-10-11 00:53:59.692737|2017-10-11 00:53:59.692737
NCT02027363|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2014-01-02|||January 2010||2010-01-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Maintenance Treatment With Capecitabine in Colorectal Cancer Patients|Maintenance Treatment With Capecitabine Versus Observation After First Line Chemotherapy in Patients With Metastatic Colorectal Cancer: a Randomized Phase II Study|Unknown status|Active, not recruiting|Phase 2|245|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 00:53:59.869925|2017-10-11 00:53:59.869925
NCT02027350|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2016-11-03|||December 2013||2013-12-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||New Methods to Diagnose Constrictive Pericarditis|Pressure-Volume Analysis of Constrictive Pericarditis|Withdrawn||N/A|0|Actual|Mayo Clinic||1||due lack of subjects|f||||f||||||||||2017-10-11 00:53:59.957125|2017-10-11 00:53:59.957125
NCT02027337|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2014-11-20|||December 2013||2013-12-01|January 2014|2014-01-01|October 2015|Anticipated|2015-10-01|March 2015|Anticipated|2015-03-01||Interventional|||Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants|The Changes of Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives With Antiandrogenic Activity, Correction by Antioxidants|Unknown status|Recruiting|Phase 4|200|Anticipated|Tyumen State Medical Academy||7|||f||||t||||||||||2017-10-11 00:54:00.055345|2017-10-11 00:54:00.055345
NCT02027324|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-01-11|||June 2015||2015-06-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|CAPISSI||Prevention of Surgical Site Infection After Cesarean Delivery|Chlorhexidine-Alcohol Vs. Povidone-Iodine for Prevention of Surgical Site Infection After Cesarean Delivery: A Randomized Trial|Withdrawn||N/A|0|Actual|Brigham and Women's Hospital||2||Another study with similar methods was recently published|f||||t||||||||||2017-10-11 00:54:00.184844|2017-10-11 00:54:00.184844
NCT02027311|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-06-09|2014-05-03||April 2013||2013-04-01|June 2015|2015-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Etomidate vs. Midazolam for Sedation During ERCP|Etomidate With Meperidine vs Midazolam With Meperidine for Sedation During Endodscopic Retrograde Cholangiopancreatogram (ERCP)|Completed||Phase 4|63|Actual|Cheju Halla General Hospital|"To standardize proper sedation level we used Ramsay Sedation Scale but this scale could be calculated subjectively.
Double blindness was not applied strictly because of quite different pharmacodynamics of two experimental drugs."|2|||f||||t||||||||||2017-10-11 00:54:00.28043|2017-10-11 00:54:00.28043
NCT02027298|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-01-05|||November 2013||2013-11-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study|Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study|Withdrawn||Phase 2|0|Actual|The Cleveland Clinic||1||No Enrollment|f||||f||||||||||2017-10-11 00:54:00.562115|2017-10-11 00:54:00.562115
NCT02027285|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-01-07|||February 2013||2013-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|MIAO50||"Nutrition, Health and Quality of Life: Development of New Formulations of Traditional Products of the Made in Italy Diet Optimized for Consumers With an Age Over 50 Years (MIAO 50)"|Nutritional Trial With Fortified Milk in 65+ Years Old Subjects|Completed||N/A|48|Actual|University of Bologna||2|||f||||f||||||||||2017-10-11 00:54:00.637428|2017-10-11 00:54:00.637428
NCT02027272|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-04-19|2016-04-19||February 2012||2012-02-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PRESIDEX||Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES):|Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES): A Randomized Clinical Trial Evaluating Corticosteroid Efficacy to Augment Standard Therapy and Shorten Recovery.|Terminated||N/A|1|Actual|University of Mississippi Medical Center||2||Difficulty recruiting, only one participant in 18 months, rarity of event|f||||f||||||||||2017-10-11 00:54:00.899963|2017-10-11 00:54:00.899963
NCT02027259|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-01-31|||January 2012||2012-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BA-MEDIC||Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits|Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits|Active, not recruiting||N/A|50|Anticipated|Providence VA Medical Center||2|||f||||f||||||||||2017-10-11 00:54:01.092263|2017-10-11 00:54:01.092263
NCT02027246|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-03-10|||December 2008||2008-12-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|August 2012|Actual|2012-08-01||Interventional|||Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury|Autologous Bone Marrow Mononuclear Cell Therapy for Spinal Cord Injury|Completed||Phase 1|166|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-11 00:54:01.163003|2017-10-11 00:54:01.163003
NCT02027233|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-02-24|||January 2014||2014-01-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|FLUVAC EV-03||Clinical Trial to Assess the Influenza Vaccination for Seasonal 2013-2016|Efficiency in Population of Influenza Vaccination for Seasonal 2013-2016 for Flu Prevention of the Hospitalized Adults|Recruiting||N/A|2000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 00:54:01.240566|2017-10-11 00:54:01.240566
NCT02027220|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-21|2014-01-02|||December 2013||2013-12-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma|Phase Ⅱ Study of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma|Unknown status|Recruiting|Phase 2|60|Anticipated|Second Affiliated Hospital of Soochow University||1|||f||||t||||||||||2017-10-11 00:54:01.336631|2017-10-11 00:54:01.336631
NCT02027207|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-07-26|||December 2012||2012-12-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|SCVB||Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh|An Individually Randomized, Placebo-controlled Trial to Measure the Protection Conferred by a Single Dose Regimen of Bivalent, Killed, Whole Cell Oral Cholera Vaccine (Shanchol™) in Dhaka, Bangladesh|Unknown status|Recruiting|Phase 3|204438|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-11 00:54:01.440602|2017-10-11 00:54:01.440602
NCT02027194|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2015-03-12|||June 2012||2012-06-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis|Effects of Chinese Herbal Medicine for Treatment of Allergic Rhinitis: A Randomized Controlled Trial|Completed||Phase 1/Phase 2|298|Actual|The Hong Kong Polytechnic University||3|||f||||f||||||||||2017-10-11 00:54:01.53337|2017-10-11 00:54:01.53337
NCT02027181|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-10-30|||August 2011||2011-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|FreeO2-Hypox||Automatic Administration of Oxygen During Respiratory Distress|Automation of the Oxygen's Administration in Spontaneous Ventilation (FreeO2) During the Hypoxemic Acute Respiratory Distress|Completed||Phase 1|190|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 00:54:01.639976|2017-10-11 00:54:01.639976
NCT02027168|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2015-01-22|||February 2013||2013-02-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women|Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women|Terminated||N/A|1|Actual|Clear Passage Therapies, Inc|||1||f||||f||||||||||2017-10-11 00:54:01.726217|2017-10-11 00:54:01.726217
NCT02027155|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2016-03-14|||December 2013||2013-12-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09|A Phase I, Randomized, Double-blind, Placebo-controlled, Rising-dose Study to Assess the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of Single IV Doses of AR09 in Healthy Subjects|Terminated||Phase 1|17|Actual|Arbor Pharmaceuticals, Inc.||2||Study stopping criteria was met|f||||t||||||||||2017-10-11 00:54:01.809565|2017-10-11 00:54:01.809565
NCT02027142|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-05-01|||May 2012||2012-05-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Sleep Quality, Daytime Sleepiness and Insomnia in Patients With Endometriosis: a Case-control Study.|Symptomatic Endometriosis of the Posterior Cul-de-sac is Associated With Impaired Sleep Quality, Excessive Daytime Sleepiness and Insomnia: a Case-control Study.|Completed||N/A|290|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|||2||f||||f||||||||||2017-10-11 00:54:01.907144|2017-10-11 00:54:01.907144
NCT02027129|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-08-14|||January 2014||2014-01-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Physiological Study of Low-frequency HFO/HFO-TGI and High-frequency HFO|Comparison of Cardio-respiratory Variables Between Low-frequency High Frequency Oscillation With/Without Tracheal Gas Insufflation and High-frequency High-frequency Oscillation in Severe ARDS.|Completed||Phase 1|17|Actual|University of Athens||1|||f||||f||||||||||2017-10-11 00:54:02.008296|2017-10-11 00:54:02.008296
NCT02027116|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2017-08-04|||January 2014||2014-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2015|Actual|2015-07-01||Interventional|VGX-6150-01||Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection|Multi-center, Open-label, Dose Escalation, Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection|Completed||Phase 1|18|Actual|GeneOne Life Science, Inc.||3|||f||||f||||||||||2017-10-11 00:54:02.112086|2017-10-11 00:54:02.112086
NCT02027103|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-02|||January 2012||2012-01-01|January 2014|2014-01-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients|Comparative Effects of Metformin and Pioglitazone on Fetuin-A and Osteoprotegerin Concentrations in Patients With Newly Diagnosed Diabetes: A Randomized Clinical Trial|Completed||N/A|102|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 00:54:02.193424|2017-10-11 00:54:02.193424
NCT02027090|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2015-05-21|||January 2014||2014-01-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease|High Dose Versus Routine Dose Icotinib in Pretreated Non-small Cell Lung Cancer Patients With Stable Disease: a Phase II Randomized Study|Unknown status|Active, not recruiting|Phase 2|64|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 00:54:02.26325|2017-10-11 00:54:02.26325
NCT02027077|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-04-13|||February 2014||2014-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluating a Small Change Approach to Preventing Long Term Weight Gain in Overweight and Obese Adults|A Randomized Controlled Trial Evaluating a Small Change Approach to Preventing Long Term Weight Gain in Overweight and Obese Adults|Active, not recruiting||N/A|344|Anticipated|Queen's University||2|||f||||f||||||||||2017-10-11 00:54:02.345607|2017-10-11 00:54:02.345607
NCT02027064|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-09-27|||October 2013||2013-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT||Recruiting||Phase 4|40|Anticipated|Peking University People's Hospital||1|||f||||||||||||||2017-10-11 00:54:02.440974|2017-10-11 00:54:02.440974
NCT02027012|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2014-01-02|||January 2014||2014-01-01|January 2014|2014-01-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|REDUCE-HTN-CN||Treatment of Resistant Hypertension by Renal Denervation in China|Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter in China|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 00:54:04.732563|2017-10-11 00:54:04.732563
NCT02026999|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2014-01-01|||January 2012||2012-01-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01|1 Day|Observational [Patient Registry]|||Sugammadex Versus Neostigmine Use in Patients Undergoing Septoplasty Operations|Phase IV Study of the Use of Sugammadex Versus Neostigmine in Septoplasty Operations|Completed||N/A|88|Actual|Ankara University|||1||f||||f||||||||||2017-10-11 00:54:04.808103|2017-10-11 00:54:04.808103
NCT02026973|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2016-03-14|||March 2014||2014-03-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Impact of Endogenous E2 on SSI and GH Rebound|Impact of Endogenous Estrogen on Somatostatin Inhibition and Growth Hormone Rebound in Older Women|Completed||Phase 1|62|Actual|Mayo Clinic||4|||f||||f||||||||||2017-10-11 00:54:04.938562|2017-10-11 00:54:04.938562
NCT02026960|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2017-01-04|||March 2014||2014-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|March 2016|Actual|2016-03-01||Interventional|||RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)|RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)|Active, not recruiting||N/A|20|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 00:54:05.089161|2017-10-11 00:54:05.089161
NCT02026947|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2014-04-09|||February 2014||2014-02-01|April 2014|2014-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|AttenPsyc||Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.|Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.|Withdrawn||Phase 2|0|Actual|Niuvanniemi Hospital||2||"We did not commence the trial because there were no patients who could fulfill the inclusion   criteria."|f||||f||||||||||2017-10-11 00:54:05.16372|2017-10-11 00:54:05.16372
NCT02026934|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2016-11-18|||March 2013||2013-03-01|November 2016|2016-11-01||||||||Expanded Access|||CliniMACS® CD34+ Reagent System for Expanded Access Use|CliniMACS® CD34+ Reagent System for Expanded Access Use|No longer available||N/A|||Dana-Farber Cancer Institute|||||||||||||||||||2017-10-11 00:54:05.243524|2017-10-11 00:54:05.243524
NCT02026921|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-31|||June 2004||2004-06-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|March 2006|Actual|2006-03-01||Interventional|||A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer|A Phase II Study of Docetaxel and Carboplatin as Second Line Chemotherapy in First Relapse of Platinum Sensitive Epithelial Ovarian Cancer|Completed||Phase 2|74|Actual|Nordic Society for Gynaecologic Oncology||1|||f||||f||||||||||2017-10-11 00:54:05.321688|2017-10-11 00:54:05.321688
NCT02026895|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-03-04|||December 2013||2013-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|VISLISI||Virulence of Staphylococcus Lugdunensis in Severe Infections|Virulence of Staphylococcus Lugdunensis in Severe Infections|Completed||N/A|82|Actual|University Hospital, Strasbourg, France||1|||f||||t||||||||||2017-10-11 00:54:06.845087|2017-10-11 00:54:06.845087
NCT02026882|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-10-02|||December 2013||2013-12-01|October 2017|2017-10-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||Supreme LMA Use in Urgent Caesarean Section|Supreme Laryngeal Mask Use in Urgent Caesarean Section|Completed||N/A|619|Actual|QuanZhou Women and Children's Hospital||1|||f||||t||||||||||2017-10-11 00:54:06.915772|2017-10-11 00:54:06.915772
NCT02026869|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-02|2014-01-02|||January 2013||2013-01-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|June 2013|Actual|2013-06-01||Interventional|VMPCO||Vaginal Administration of Metformin in PCOS Patients.|Impact of Vaginal Administration of Metformin in Women With PCOS.|Unknown status|Active, not recruiting|Early Phase 1|200|Actual|Assiut University||2|||f||||f||||||||||2017-10-11 00:54:06.988123|2017-10-11 00:54:06.988123
NCT02026856|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-04-07|||December 2013||2013-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|Se-AOX||Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis|Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis|Completed||N/A|4|Actual|Pavol Jozef Safarik University|||4||f||||t||||||||||2017-10-11 00:54:07.06543|2017-10-11 00:54:07.06543
NCT02026843|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2016-08-29|||April 2012||2012-04-01|August 2016|2016-08-01|April 2022|Anticipated|2022-04-01|April 2020|Anticipated|2020-04-01||Observational|||Analysis of Angiogenic Factor Levels in Eyes With Diabetic Retinopathy|Analysis of Angiogenic Protein and Anti-angiogenic Levels in Eyes With Diabetic Retinopathy.|Recruiting||N/A|100|Anticipated|Kyungpook National University|||2||f||||t||||||Samples Without DNA|"     certain protein levels in aqueus humor   "|No||2017-10-11 00:54:07.148873|2017-10-11 00:54:07.148873
NCT02026830|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2015-03-10|||January 2014||2014-01-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Observational|TURK-DAY||The Microbiologic Profile of Diabetic Foot Infections in Turkey - TURK-DAY|The Microbiologic Profile of Diabetic Foot Infections in Turkey (TURK-DAY): Prospective Multicenter Cohort Study|Completed||N/A|447|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi|||1||f||||f||||||||||2017-10-11 00:54:07.224872|2017-10-11 00:54:07.224872
NCT02026817|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2014-03-10|||December 2013||2013-12-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg|An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 750/10 mg and Coadministration of Metformin SR 750 mg and Rosuvastatin 10 mg in Healthy Volunteers|Completed||Phase 1|36|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 00:54:07.303557|2017-10-11 00:54:07.303557
NCT02026804|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2015-01-20|||January 2013||2013-01-01|January 2015|2015-01-01||||December 2015|Anticipated|2015-12-01||Observational|||Prevalence ， Associated Factors and Influences of Prenatal Mental Disorders||Unknown status|Recruiting|N/A|5000|Anticipated|Zhejiang Provincial Natural Science Foundation of China|||1||f||||||||||Samples With DNA|"     plasma, serum, white cells, placenta tissue   "|||2017-10-11 00:54:07.393274|2017-10-11 00:54:07.393274
NCT02026791|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-11-02|||December 2013||2013-12-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Comparison of the Clinical Efficacy Between I-gel and LMA-Supreme, the Two Most Recently Developed Supraglottic Airway Devices, in Elderly Patients||Completed||N/A|106|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:54:07.46225|2017-10-11 00:54:07.46225
NCT02026778|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-01-13|||December 2013||2013-12-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Comparison of the Effect of Ondansetron and Combined Ondansetron and Betahistine on Postoperative Nausea and Vomiting After Gynecological Laparoscopy||Unknown status|Recruiting|N/A|168|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 00:54:07.673156|2017-10-11 00:54:07.673156
NCT02026765|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-12-08|||November 2013||2013-11-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Clinical Outcomes About Heparin Surface Modified Aspheric Lens|Clinical Outcomes About Heparin Surface Modified Aspheric Lens|Completed||N/A|20|Actual|Wenzhou Medical University||2|||f||||t||||||||||2017-10-11 00:54:07.760781|2017-10-11 00:54:07.760781
NCT02026752|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-02-22|||January 2014||2014-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|February 2015|Actual|2015-02-01||Observational|||Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay|Collection of Plasma Samples From Human Immunodeficiency Virus (HIV) Type 1 (HIV-1) Infected Individuals for the Clinical Evaluation of the Aptima HIV-1 Quant Dx Assay|Completed||N/A|468|Actual|Gen-Probe, Incorporated|||1||f||||f||||||Samples With DNA|"     plasma   "|||2017-10-11 00:54:07.849856|2017-10-11 00:54:07.849856
NCT02026739|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-12-31|||September 2013||2013-09-01|December 2013|2013-12-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||The Optimal Intraoperative Supplemental Oxygen Administration During Minimally Invasive Esophagectomy|The Impact of Different Intraoperative Supplemental Oxygen Administration on the Pulmonary Function Following Minimally Invasive Esophagectomy: A Prospective Randomized Controlled Clinical Trial|Unknown status|Recruiting|N/A|120|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 00:54:07.970117|2017-10-11 00:54:07.970117
NCT02026726|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-03-25|||November 2011||2011-11-01|March 2016|2016-03-01||||December 2018|Anticipated|2018-12-01||Observational|||Do Oral Steroid Dose Packs Predict How Well Epidural Steroid Injections Will Work?|Oral Steroid Dose Pack Used As A Predictor For The Effectiveness Of Epidural Steroid Injections|Recruiting||N/A|150|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||f||||||||||2017-10-11 00:54:08.108333|2017-10-11 00:54:08.108333
NCT02026713|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-06-07|||July 2014||2014-07-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|June 2015|Actual|2015-06-01||Interventional|COPTER||Potential Impact of Cigarette Smoking on Platelet Reactivity in Patients on Dual Antiplatelet Therapy With P2Y12 Inhibitors|"Impact of Cigarette Smoking on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With P2Y12 Inhibitors - Trial COPTER -"|Unknown status|Recruiting|Phase 4|150|Anticipated|University of Roma La Sapienza||3|||f||||f||||||||||2017-10-11 00:54:08.212037|2017-10-11 00:54:08.212037
NCT02026700|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2014-01-02|||February 2014||2014-02-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Bariederm Cream in Chronic Contact Dermatitis|Bariederm Cream in Chronic Contact Dermatitis|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 00:54:08.311114|2017-10-11 00:54:08.311114
NCT02026687|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-11-09|||March 2014||2014-03-01|November 2016|2016-11-01||||April 2016|Actual|2016-04-01||Interventional|Speed||Recovery and Analgesia After Surgery for Gynecological Cancer|Will Intrathecal Analgesia Contribute to a Faster Recovery Compared With Epidural Analgesia After Open Surgery for Gynecological Cancer. An Open Controlled Randomized Study.|Active, not recruiting||Phase 4|80|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-11 00:54:08.407552|2017-10-11 00:54:08.407552
NCT02026674|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2014-01-13|||December 2013||2013-12-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||Reliability of Home Uroflowmetery Using a Disposable Digital Device|Reliability of Home Uroflowmetery Using a Disposable Digital Device in Comparison to Standard Clinical Uroflowmetry in Men With LUTS|Unknown status|Recruiting|N/A|30|Anticipated|Flometrica Ltd.||1|||f||||f||||||||||2017-10-11 00:54:08.486799|2017-10-11 00:54:08.486799
NCT02026661|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2015-07-04|||January 2014||2014-01-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Effectiveness of Intracytoplasmic Sperm Injection and Laser Assisted Hatching on in Vitro Fertilization Outcomes of Patients With Different Causes of Infertility||Completed||N/A|375|Actual|Far Eastern Memorial Hospital|||4||f||||||||||||||2017-10-11 00:54:08.586764|2017-10-11 00:54:08.586764
NCT02026648|ClinicalTrials.gov processed this data on October 10, 2017|2014-01-01|2016-09-05|||January 2014||2014-01-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Observational|||Outcome of Women With Cervical Cancer||Completed||N/A|81|Actual|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-10-11 00:54:08.648467|2017-10-11 00:54:08.648467
NCT02026635|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-02-04|||September 2013||2013-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|CONFIRM-HF||Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF)|Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in Heart Failure Patients (CONFIRM-HF)|Withdrawn||N/A|0|Actual|Thomas Jefferson University|||1|No subjects enrolled|f||||f||||||||||2017-10-11 00:54:08.704544|2017-10-11 00:54:08.704544
NCT02026622|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-08-31|||February 2013||2013-02-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|EMPHILINE||Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion|Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion|Completed||N/A|76|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-11 00:54:08.767813|2017-10-11 00:54:08.767813
NCT02026414|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-09-23|||January 2014||2014-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|May 2015|Actual|2015-05-01||Interventional|||Effects of PrimaVie and Exercise Training on Human Skeletal Muscle (PrimaVie)|Effects of PrimaVie and Exercise Training on Human Skeletal Muscle Adaptation|Active, not recruiting||N/A|40|Anticipated|Natreon, Inc.||1|||f||||f||||||||||2017-10-11 00:54:10.504994|2017-10-11 00:54:10.504994
NCT02026609|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2017-04-14|||May 2013||2013-05-01|April 2017|2017-04-01|January 27, 2015|Actual|2015-01-27|January 27, 2015|Actual|2015-01-27||Observational|||Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)|Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)|Terminated||N/A|3|Actual|University of Arkansas|||1|Lack of patient accrual|f||||t||||||Samples With DNA|"     Serum, plasma, and PBMCs   "|||2017-10-11 00:54:08.850665|2017-10-11 00:54:08.850665
NCT02026596|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-01-01|||March 2013||2013-03-01|January 2014|2014-01-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01|6 Months|Observational [Patient Registry]|||SpareBrain - Mechanisms and Prevention of Secondary Brain Injury in Subarachnoid Haemorrhage|Observational Study on Mechanisms and Prevention of Secondary Brain Injury in Subarachnoid Haemorrhage|Unknown status|Recruiting|N/A|100|Anticipated|Tampere University Hospital|||1||f||||t|||||||"     -  Blood samples        -  Cerebrospinal fluid samples        -  Microdialysate samples (from the extracellular fluid of the brain)        -  Tissue samples   "|||2017-10-11 00:54:08.951801|2017-10-11 00:54:08.951801
NCT02026583|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-02-15|||December 2013|Actual|2013-12-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients|A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients|Recruiting||Phase 2|60|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-11 00:54:09.039303|2017-10-11 00:54:09.039303
NCT02026570|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-02|||June 2013|Actual|2013-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|March 2015|Actual|2015-03-01||Interventional|||Enhancement of Residual Limb Proprioception and Rehabilitation Training Methods With a Vibrotactile Device.|Enhancement of Residual Limb Proprioception and Rehabilitation Training Methods With a Vibrotactile Device.|Active, not recruiting||N/A|6|Anticipated|Southern California Institute for Research and Education||3|||f||||f||||||||||2017-10-11 00:54:09.111946|2017-10-11 00:54:09.111946
NCT02026557|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-07-24|||January 1994|Actual|1994-01-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|December 2009|Actual|2009-12-01||Observational|||Mortality Among Children With Congenital Heart Defects in Norway|Mortality Among Children With Congenital Heart Defects in Norway|Completed||N/A|15000|Actual|Sorlandet Hospital HF|||1||f||||f||||||||||2017-10-11 00:54:09.204712|2017-10-11 00:54:09.204712
NCT02026544|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-31|||December 2013||2013-12-01|December 2013|2013-12-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||Effect of Low Frequency Ultrasound on Kidney Function|Evaluation of the Effect of Low Frequency Therapeutic Ultrasound (LOTUS) on Kidney Function in Chronic Kidney Disease|Unknown status|Recruiting|N/A|20|Anticipated|Sonogenix||1|||f||||f||||||||||2017-10-11 00:54:09.259831|2017-10-11 00:54:09.259831
NCT02026531|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-09-28|||November 2010||2010-11-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Novel MRI Techniques in the Evaluation of Pulmonary Vascular Disease|Novel MRI Techniques in the Evaluation of Pulmonary Vascular Disease|Completed||Phase 1/Phase 2|9|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 00:54:09.339764|2017-10-11 00:54:09.339764
NCT02026518|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2014-11-17|||January 2014||2014-01-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel Syndrome||Completed||Phase 4|100|Actual|Shahid Beheshti University of Medical Sciences||4|||f||||t||||||||||2017-10-11 00:54:09.443363|2017-10-11 00:54:09.443363
NCT02026505|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-31|||March 2014||2014-03-01|December 2013|2013-12-01||||December 2016|Anticipated|2016-12-01||Observational|||Evaluation of Cardiotoxic Effects of Bortezomib|Prospective Assessment of the Cardiac Effects the Proteasome Inhibitor Bortezomib in Patients Undergoing Therapy for Multiple Myeloma|Unknown status|Not yet recruiting|N/A|20|Anticipated|Oregon Health and Science University|||1||f||||t||||||Samples Without DNA|"     Whole blood and serum for batch analysis. Once the assays have been completed, the samples     will be discarded.   "|||2017-10-11 00:54:09.603051|2017-10-11 00:54:09.603051
NCT02026492|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-03-16|||June 2013||2013-06-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Exercise Challenge in a Cold Chamber|Exercise-induced Bronchoconstriction in a Cold Chamber Compared to Methacholine Challenge|Completed||N/A|79|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 00:54:09.674914|2017-10-11 00:54:09.674914
NCT02026479|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2013-12-31|||January 2014||2014-01-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Sudden Hearing Loss Multi-center Clinical Trial|Glucocorticoid Postauricular Injection Treatment for Sudden Hearing Loss: a Multi-center, Opened, Randomized, Controlled Clinical Trial|Unknown status|Not yet recruiting|N/A|300|Anticipated|Peking University People's Hospital||3|||f||||||||||||||2017-10-11 00:54:09.774653|2017-10-11 00:54:09.774653
NCT02026466|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-10-12|||December 2013||2013-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|OPEN-CTO||Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion|Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion (OPEN CTO)|Active, not recruiting||N/A|1000|Anticipated|Saint Luke's Health System|||1||f||||f||||||||||2017-10-11 00:54:09.854575|2017-10-11 00:54:09.854575
NCT02026453|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-10-05|2017-04-25||January 2014||2014-01-01|October 2017|2017-10-01|October 2016|Actual|2016-10-01|February 2014|Actual|2014-02-01||Interventional|||Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy|Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy|Completed||N/A|306|Actual|Cedars-Sinai Medical Center|"Powered on intermediate endpoints
Only used one site
Could not practicably mask arm allocation"|3|||f||||f||||||||||2017-10-11 00:54:09.956991|2017-10-11 00:54:09.956991
NCT02026440|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-31|||December 2013||2013-12-01|December 2013|2013-12-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Observational|||Evaluation of An Oral Fluid Collection Device|Collection and Testing of Human Oral Fluid Samples/VioOne OF Sample Collection Device|Unknown status|Recruiting|N/A|250|Anticipated|Avioq, Inc.|||2||f||||f||||||||||2017-10-11 00:54:10.347644|2017-10-11 00:54:10.347644
NCT02026427|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-08-06|||August 2010||2010-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Observational|UriRet||Urinary Retention in Orthopedic Patients|The Incidence of Urinary Retention in Orthopedic Patients Under Spinal Anesthesia|Completed||N/A|200|Anticipated|Military Institute of Medicine, Poland|||2||f||||f||||||||||2017-10-11 00:54:10.439325|2017-10-11 00:54:10.439325
NCT02026401|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-03-27||2017-03-27|February 2014||2014-02-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis|A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis|Completed||Phase 2|45|Actual|NGM Biopharmaceuticals, Inc||3|||f||||f||||||||||2017-10-11 00:54:10.599046|2017-10-11 00:54:10.599046
NCT02026388|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-08-03|||May 2013||2013-05-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Rare Kidney Stone Consortium Biobank|Rare Kidney Stone Consortium Biobank, Rare Diseases Clinical Research Network|Recruiting||N/A|400|Anticipated|Mayo Clinic|||4||f||||t||||||Samples With DNA|"     Urine, blood and tissue samples   "|||2017-10-11 00:54:10.715931|2017-10-11 00:54:10.715931
NCT02026362|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-01-16|||July 2013||2013-07-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|HCC DC CTL||Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).|Randomized, Open-label, Multi-center Clinical Trial to Compare the Efficacy and Safety of MASCT Group' and 'Non-treatment Group' in Patient Undergone Curative Resection( RFA or Operation) for Hepatocellular Carcinoma .MASCT That Expresses Multiple Antigens Specific Cellular Therapy,Autologous Immune Cytotoxic of T-lymphocytes(CTL) Induced by Dendritic Cell(DC) Loaded With Multiple Antigens|Suspended||Phase 1/Phase 2|100|Anticipated|SYZ Cell Therapy Co..||2||Interim analysis|f||||f||||||||||2017-10-11 00:54:10.819678|2017-10-11 00:54:10.819678
NCT02026349|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-10-20||2015-10-20|January 2014||2014-01-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza (T705US316)|Completed||Phase 3|860|Actual|MDVI, LLC||2|||f||||f||||||||||2017-10-11 00:54:10.934964|2017-10-11 00:54:10.934964
NCT02026336|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2013-12-31|||June 2011||2011-06-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||E-nose and Inflammatory Asthma Phenotypes|Inflammatory Asthma Phenotypes Discrimination by an Electronic Nose Breath Analyzer|Completed||N/A|52|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||t||||||||||2017-10-11 00:54:11.59757|2017-10-11 00:54:11.59757
NCT02026323|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2014-09-05|||January 2014||2014-01-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|October 2014|Anticipated|2014-10-01||Interventional|||The Effect of Acupuncture on Insulin Sensitivity Polycystic Ovary Syndrome|Effect of Acupuncture on Insulin Sensitivity in Women With Polycystic Ovary Syndrome and Insulin Resistance: Study Protocol of a Prospective Observational Study|Unknown status|Enrolling by invitation|N/A|112|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 00:54:11.693158|2017-10-11 00:54:11.693158
NCT02026310|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2016-01-26|||January 2014||2014-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment|Efficacy/Safety Study of Adding Glimepiride to Type 2 Diabetes Patients With Inadequate Glycemic Control Based on Combination With Metformin And Basal Insulin|Completed||N/A|40|Actual|Chongqing Medical University||2|||f||||t||||||||||2017-10-11 00:54:11.801875|2017-10-11 00:54:11.801875
NCT02026297|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2017-04-18|||July 2014|Actual|2014-07-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|TA TEG||Tranexamic Acid and Thromboelastography During Cesarean Delivery|The Influence of Prophylactic Tranexamic Acid on Thromboelastography During Cesarean Delivery: A Randomized, Double-Blind, Placebo-Controlled Trial|Active, not recruiting||Phase 2|60|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 00:54:11.897071|2017-10-11 00:54:11.897071
NCT02026284|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2013-12-31|||February 2010||2010-02-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Observational|||Factors Affecting Anesthesia Preferences of Gravid Women|Factors Affecting Anesthesia Preferences of Gravid Women Who Are to Deliver by Caesarean Section|Completed||N/A|750|Actual|Ankara University|||1||f||||f||||||||||2017-10-11 00:54:11.973557|2017-10-11 00:54:11.973557
NCT02026271|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-02-13|||June 2015||2015-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma|A Phase I Study of Ad-RTS-hIL-12, an Inducible Adenoviral Vector Engineered to Express hIL-12 in the Presence of the Activator Ligand Veledimex in Subjects With Recurrent or Progressive Glioblastoma or Grade III Malignant Glioma|Recruiting||Phase 1|48|Anticipated|Ziopharm||1|||f||||t||||||||||2017-10-11 00:54:12.053605|2017-10-11 00:54:12.053605
NCT02026258|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-07-31|2017-04-05||December 2011||2011-12-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Efficiency of Piezotome-Corticision Assisted Orthodontics|Efficiency of Piezotome-Corticision Assisted Orthodontics in Alleviating Mandibular Anterior Crowding - A Randomized Controlled Clinical Trial|Completed||N/A|41|Actual|UConn Health|Hi attrition rate|2|||f||||t||||||||||2017-10-11 00:54:12.158743|2017-10-11 00:54:12.158743
NCT02026245|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-01-19|||August 2016|Actual|2016-08-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Comparison of Two Electronic Gloves in the Measurement of Joint Movement in Patients With Rheumatoid Arthritis|A Comparison of Two Electronic Goniometric Gloves in the Measurement of Joint Movement in Patients With Rheumatoid Arthritis|Enrolling by invitation||N/A|12|Anticipated|University of Ulster||2|||f||||f||||||||No|IPD may be considered available at a later date, anonymised.|2017-10-11 00:54:12.648554|2017-10-11 00:54:12.648554
NCT02026232|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2016-10-31|||March 2012||2012-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MetaHcQ||Metabolic Effects of Hydroxychloroquine|Metabolic Effects of Hydroxychloroquine|Recruiting||N/A|30|Anticipated|Washington University School of Medicine||2|||f||||f||||||||Undecided||2017-10-11 00:54:12.774212|2017-10-11 00:54:12.774212
NCT02026219|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2015-09-30|||October 2013||2013-10-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction|Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in Acute Coronary Syndrome Patients: The Index of MIcrocirculatory Resistance After PCI in STEMI Patients (TIME Study)|Completed||Phase 4|76|Actual|Inha University Hospital||2|||f||||t||||||||||2017-10-11 00:54:12.907404|2017-10-11 00:54:12.907404
NCT02026206|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-02-20|2014-01-02||October 2011||2011-10-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Low-level Light Therapy for Primary Dysmenorrhea|Skin Adhesive Low-level Light Therapy for Primary Dysmenorrhea: A Double-blind Randomized Controlled Trial|Completed||Phase 3|88|Actual|Pusan National University||2|||f||||t||||||||||2017-10-11 00:54:13.00927|2017-10-11 00:54:13.00927
NCT02026193|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2015-05-20|2015-04-29||January 2014||2014-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|||IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing||Completed||N/A|11|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 00:54:13.2937|2017-10-11 00:54:13.2937
NCT02026180|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-07-12|||December 2013||2013-12-01|July 2014|2014-07-01||||June 2014|Actual|2014-06-01||Interventional|||Micropuncture vs. Standard Common Femoral Artery Access|Randomized Comparison of Micropuncture vs. Standard Common Femoral Artery Access for Reducing Vascular Access Complications|Terminated||N/A|552|Anticipated|North Texas Veterans Healthcare System||2||low incidence of primary endpoint|f||||f||||||||||2017-10-11 00:54:13.499265|2017-10-11 00:54:13.499265
NCT02026167|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2017-05-02|||December 2012||2012-12-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SCI-Care||Spinal Cord Injury Collaborative Care Study|SCI-CARE (Northwest Regional Spinal Cord Injury Site Specific Project)|Completed||N/A|174|Actual|University of Washington||2|||f||||f||||||||No||2017-10-11 00:54:13.567553|2017-10-11 00:54:13.567553
NCT02026154|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2014-05-05|||October 2012||2012-10-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Observational|||Finding Early Predictors of Myocardial Dysfunction|Finding Early Predictors of Myocardial Dysfunction in Patients With Hypertension - Pilot Study.|Completed||N/A|120|Actual|Medical Universtity of Lodz|||1||f||||t||||||Samples Without DNA|"     blood plasma   "|||2017-10-11 00:54:13.641809|2017-10-11 00:54:13.641809
NCT02026141|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2016-05-10|2015-05-26||December 2013||2013-12-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Can Dexmedetomidine For Procedural Sedation In Knee Arthroplasty Reduce Postoperative Pain? A Randomized Control Study|Can Dexmedetomidine For Procedural Sedation In Knee Arthroplasty Reduce Postoperative Pain? A Randomized Control Study|Completed||Phase 4|40|Actual|University of Saskatchewan||2|||f||||t||||||||||2017-10-11 00:54:13.709039|2017-10-11 00:54:13.709039
NCT02026128|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2015-04-21|||March 2012||2012-03-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Optical Coherence Tomography (OCT) in Uveitis|Objective Grading of Intraocular Inflammation in Uveitis Using Optical Coherence Tomography|Unknown status|Active, not recruiting|N/A|30|Anticipated|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 00:54:13.929216|2017-10-11 00:54:13.929216
NCT02026115|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2015-05-26|||January 2014||2014-01-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Computerized PAINRelieveIt Protocol for Cancer Pain Control in Hospice|Computerized PAINRelieveIt Protocol for Cancer Pain Control in Hospice|Unknown status|Enrolling by invitation|N/A|380|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 00:54:13.996024|2017-10-11 00:54:13.996024
NCT02026102|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-12-02|||September 2014||2014-09-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|August 2016|Actual|2016-08-01||Interventional|||A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)|A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)|Active, not recruiting||N/A|15|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 00:54:14.11733|2017-10-11 00:54:14.11733
NCT02026089|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-03-03|||October 2017|Anticipated|2017-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine|Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine|Not yet recruiting||Phase 4|100|Anticipated|University of Colorado, Denver||2|||f||||f|f|f||||||No||2017-10-11 00:54:14.360688|2017-10-11 00:54:14.360688
NCT02026076|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-12-30|||May 2012||2012-05-01|November 2013|2013-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Manual Unloading of the Lumbar Spine: Can it Predict Responders to Mechanical Traction?|Manual Unloading of the Lumbar Spine: Can it Predict Response to Mechanical Traction? A Study or Reliability and Criterion Referenced Predictive Validity|Completed||N/A|30|Actual|UConn Health||1|||f||||f||||||||||2017-10-11 00:54:14.440277|2017-10-11 00:54:14.440277
NCT02026063|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-07-12|||January 14, 2014|Actual|2014-01-14|July 2017|2017-07-01||||June 2018|Anticipated|2018-06-01||Interventional|TELEPATH||Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms|A Multicenter, Long-term Extension Study to Further Evaluate the Safety and Tolerability of Telotristat Etiprate (LX1606)|Active, not recruiting||Phase 3|71|Actual|Lexicon Pharmaceuticals||2|||f||||t||||||||||2017-10-11 00:54:14.519225|2017-10-11 00:54:14.519225
NCT02026050|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2015-03-03|||January 2014||2014-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Analgesic Effect of Intra-articular Dexamethasone and Dexamethasone Added to Bupivacaine in Interscalene Brachial Plexus|Phase 4 Study of Comparison of Postoperative Analgesic Effect of Intra-articular Dexamethasone and Dexamethasone Added to Bupivacaine in Interscalene Brachial Plexus Blockade for Arthroscopic Shoulder Surgery|Completed||Phase 4|75|Actual|TC Erciyes University||3|||f||||f||||||||||2017-10-11 00:54:14.701815|2017-10-11 00:54:14.701815
NCT02026037|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-09-19|||April 2013||2013-04-01|September 2017|2017-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Reducing PTSD in Hospitalized Burn Patients|A Brief Intervention to Reduce PTSD in Acutely Burned Hospital Patients|Completed||N/A|16|Actual|University of Southern California||1|||f||||f||||||||||2017-10-11 00:54:14.801115|2017-10-11 00:54:14.801115
NCT02026024|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-01-31|||October 2013||2013-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|IBCT2||Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients|Clinical and Genetic Variations Study of Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients|Completed||N/A|10|Actual|Chang Gung Memorial Hospital|||1||f||||f||||||Samples With DNA|"     DNA for sequencing   "|||2017-10-11 00:54:14.881922|2017-10-11 00:54:14.881922
NCT02026011|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-10-25|||December 2013||2013-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Naltrexone for Individuals of East Asian Descent|Optimizing Naltrexone for Individuals of East Asian Descent|Completed||Phase 2|72|Actual|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-11 00:54:14.947979|2017-10-11 00:54:14.947979
NCT02025985|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2017-05-25|||January 2014||2014-01-01|May 2017|2017-05-01|March 22, 2017|Actual|2017-03-22|February 13, 2017|Actual|2017-02-13||Interventional|SIGN||Phase II Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies & Metastatic Breast Cancer|A Phase II, Open-label Study of Efficacy and Safety of the Selective Inhibitor of Nuclear Export/SINE™ Compound KPT-330 (Selinexor) in Patients With Advanced Gynaecologic Malignancies and Metastatic Breast Cancer|Completed||Phase 2|116|Actual|Karyopharm Therapeutics Inc||4|||f||||t||||||||||2017-10-11 00:54:15.201806|2017-10-11 00:54:15.201806
NCT02025959|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-08-30|||August 2013||2013-08-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SIESTA||Sleep for Inpatients: Empowering Staff to Act|Sleep for Inpatients: Empowering Staff to Act|Recruiting||N/A|300|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 00:54:15.460191|2017-10-11 00:54:15.460191
NCT02025946|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2015-08-11||||||August 2015|2015-08-01|January 2026|Anticipated|2026-01-01|January 2021|Anticipated|2021-01-01||Observational|||Observational Study of Total Ankle Arthroplasty and Tibiotalar Arthrodesis|Observational Study of Total Ankle Arthroplasty and Tibiotalar Arthrodesis|Withdrawn||N/A|0|Actual|Integra LifeSciences Services|||2||f||||t||||||||||2017-10-11 00:54:15.544241|2017-10-11 00:54:15.544241
NCT02025933|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-05-22|||August 2014||2014-08-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Project Healthy Eating in Children. A Study on the Health Effects of Fish Intake in Overweight Children|Title in Norwegian: Ung og Frisk. En Studie av Helseeffekter av Fiskeinntak i Overvektige Barn.|Terminated||N/A|25|Actual|University of Bergen|||3|We were unable to recruit a sufficient number of participants|f||||f||||||Samples With DNA|"     Whole blood for DNA analysis   "|||2017-10-11 00:54:15.640029|2017-10-11 00:54:15.640029
NCT02025920|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-10-25|||January 2014||2014-01-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2015|Actual|2015-06-01||Observational|||Project Healthy Eating in Adults. A Study on the Health Effects of Fish Intake in Overweight Adults (FINS)|Title in Norwegian: Sunn og Frisk. En Studie av Helseeffekter av Fiskeinntak i Overvektige Voksne (FINS)|Active, not recruiting||N/A|300|Anticipated|University of Bergen|||3||f||||f||||||Samples With DNA|"     Whole blood will be collected for DNA analysis   "|||2017-10-11 00:54:15.714262|2017-10-11 00:54:15.714262
NCT02025907|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-10-28|2016-07-22||February 2014||2014-02-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||mITT (modified intent-to-treat) population included all randomized participants who received at least 1 dose of double-blind study drug. A total of 3 participants were excluded from the mITT population due to potential misconduct and GCP compliance issues.|A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin|A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy|Completed||Phase 4|218|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:54:15.808033|2017-10-11 00:54:15.808033
NCT02025894|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2017-03-06|||June 2010|Actual|2010-06-01|December 2013|2013-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|ONCOCIP||Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study|Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study|Completed||N/A|3032|Actual|Institut de Cancérologie de la Loire|||1||f||||f||||||||||2017-10-11 00:54:16.314261|2017-10-11 00:54:16.314261
NCT02025881|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2016-06-08|||September 2013||2013-09-01|June 2016|2016-06-01|September 2022|Anticipated|2022-09-01|September 2018|Anticipated|2018-09-01||Interventional|HR MB-5||Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma|Phase I / II Study of Sequential High-dose Chemotherapy With Stem Cell Support in Children Younger Than 5 Years of Age With High-risk Medulloblastoma|Recruiting||Phase 1/Phase 2|50|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||t||||||||||2017-10-11 00:54:16.451584|2017-10-11 00:54:16.451584
NCT02025868|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2017-02-16|||March 2013||2013-03-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|August 2016|Actual|2016-08-01||Interventional|THILAO||Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa|"Systematic Adherence Intervention Phase Before Switching to 3rd-line ART in Patients With 2nd-line ART Virologic Failure in Sub-Saharan Africa : a Phase 2b Non-randomized Study."|Active, not recruiting||Phase 2|201|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 00:54:16.545608|2017-10-11 00:54:16.545608
NCT02025855|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-30|2014-01-15|||January 2014||2014-01-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit|Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit|Unknown status|Enrolling by invitation|Phase 4|46|Anticipated|Henry Ford Health System||2|||f||||f||||||||||2017-10-11 00:54:16.662763|2017-10-11 00:54:16.662763
NCT02025842|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2013-12-31|||January 2000||2000-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01|62 Months|Observational [Patient Registry]|HBV/HCC||Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma|Long-term Nucleoside/Nucleotide Treatment of Hepatitis B Virus HBeAg-negative Genotype D Patients and Risk of Hepatocellular Carcinoma:Evidence From the CLEO Cohort Study|Completed||N/A|306|Actual|Azienda Ospedaliera San Camillo Forlanini|||2||f||||t||||||||||2017-10-11 00:54:16.747927|2017-10-11 00:54:16.747927
NCT02025829|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-02-03|2016-12-06||February 2014||2014-02-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||IL-17 Neutrophils in CF Lung Inflammation|The Role of IL-17 Neutrophils in CF Lung Inflammation|Completed||N/A|14|Actual|University Hospitals Cleveland Medical Center|||2||f||||f|f|f||||Samples With DNA|"     peripheral white cells, serum, sputum white cells, sputum supernatants   "|||2017-10-11 00:54:16.816414|2017-10-11 00:54:16.816414
NCT02025803|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2017-06-12|||November 2012||2012-11-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors|A Phase 1, Open-Label, Non-randomized, Dose-Escalating Safety, Tolerability, and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|60|Anticipated|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-10-11 00:54:17.141834|2017-10-11 00:54:17.141834
NCT02025790|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2013-12-31|||December 2013||2013-12-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01||Interventional|||POEM Versus Pneumatic Dilatation in Achalasia Cardia|A Prospective Trial Comparing POEM to Pneumatic Dilatation for Treatment of Achalasia Cardia|Unknown status|Recruiting|N/A|140|Anticipated|Asian Institute of Gastroenterology, India||2|||f||||f||||||||||2017-10-11 00:54:17.208487|2017-10-11 00:54:17.208487
NCT02025777|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-31|2016-03-02|||May 2014||2014-05-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|UC||Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis Disease|Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis Disease|Completed||N/A|30|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-11 00:54:17.430165|2017-10-11 00:54:17.430165
NCT02025764|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-06-20|||August 2013||2013-08-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01|1 Month|Observational [Patient Registry]|||The Clinical Feature of Ulcer Base Over Time After Prophylactic Argon Plasma Coagulation in Colonic EMR|The Clinical Feature of the Exposed Vessels in Ulcer Base Over Time After Prophylactic Argon Plasma Coagulation in Colonic Endoscopic Mucosal Resection|Completed||N/A|40|Actual|Soonchunhyang University Hospital|||1||f||||f||||||||||2017-10-11 00:54:17.515425|2017-10-11 00:54:17.515425
NCT02025751|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2017-06-12||2017-05-30|April 2014|Actual|2014-04-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis|Phase 3 Companion Study of Intranasal Metoclopramide in Men With Symptomatic Diabetic Gastroparesis|Completed||Phase 3|53|Actual|Evoke Pharma||2|||f||||f||||||||Undecided||2017-10-11 00:54:17.591816|2017-10-11 00:54:17.591816
NCT02025738|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2015-05-05|||January 2014||2014-01-01|May 2015|2015-05-01||||December 2015|Anticipated|2015-12-01||Interventional|MAGNET||Perioperative Management of Patients With Cardiac Implantable Electronic Devices|Perioperative MAnaGement of patieNts With Cardiac Implantable Electronic Devices: Randomized Controlled Pilot Trial (MAGNET Trial)|Unknown status|Not yet recruiting|N/A|150|Anticipated|Rambam Health Care Campus||3|||f||||||||||||||2017-10-11 00:54:17.784804|2017-10-11 00:54:17.784804
NCT02025725|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2017-06-12||2017-05-30|April 2014||2014-04-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis|Phase 3 Study of Intranasal Metoclopramide in Women With Symptomatic Diabetic Gastroparesis|Completed||Phase 3|205|Actual|Evoke Pharma||2|||f||||f||||||||No||2017-10-11 00:54:17.877308|2017-10-11 00:54:17.877308
NCT02025712|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2013-12-29||||||December 2013|2013-12-01||||August 2016|Anticipated|2016-08-01||Interventional|||Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer|A Phase II Open-label Pilot Study Evaluating the Maintenance Therapy With Exemestane Plus Everolimus After Induction Chemotherapy in Patients With Hormone-receptor Positive Metastatic Breast Cancer|Unknown status|Not yet recruiting|Phase 2|35|Anticipated|Organisation for Oncology and Translational Research||1|||f||||t||||||||||2017-10-11 00:54:18.082688|2017-10-11 00:54:18.082688
NCT02025699|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-01-12|||February 2014||2014-02-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|TailoredT||Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis|Observational Multi-center, Prospective Study to Characterize Novel pathogen-and Host-related Factors in Hospitalized Patients and Patients on the Emergency Department Presenting With Lower Respiratory Tract Infections and/or Sepsis.|Completed||N/A|1200|Actual|MeMed Diagnostics Ltd.|||3||f||||t||||||Samples Without DNA|"     Blood samples Nasopharyngeal samples   "|No||2017-10-11 00:54:18.186732|2017-10-11 00:54:18.186732
NCT02025686|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-30|||March 2012||2012-03-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO)|Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO)|Completed||N/A|16|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 00:54:18.273066|2017-10-11 00:54:18.273066
NCT02025673|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2013-12-30|||August 2013||2013-08-01|December 2013|2013-12-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Observational|||Study of Betatrophin Levels in Patients With Type 2 Diabetes and Gestational Diabetes and Healthy Subjects|Study of Betatrophin Levels in Patients With Type 2 Diabetes and Gestational Diabetes and Healthy Subjects|Unknown status|Active, not recruiting|N/A|200|Actual|Qingdao University|||3||f||||t||||||Samples Without DNA|"     Whole blood serum   "|||2017-10-11 00:54:18.352874|2017-10-11 00:54:18.352874
NCT02025660|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-25|2014-03-19|||August 2013||2013-08-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|MISS||Efficacy of Mw Vaccine in Treatment of Severe Sepsis|"Does Immune-modulation Improve the Survival in Patients With Severe Sepsis? A Proof of the Concept Study"|Completed||Phase 2/Phase 3|50|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 00:54:18.442425|2017-10-11 00:54:18.442425
NCT02025647|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2015-09-21|2015-07-17||January 2014||2014-01-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||An Evaluation of Innerview™, a Web-based Tool to Support the Integration of Mental Health in the Primary Care Setting|An Open, Non-Randomized, Evaluation of Innerview™, an MHCDS Tool Used to Report Symptoms and Functioning Related to Common Mental Health Disorders in the Primary Care Setting|Completed||N/A|139|Actual|Pearson/Clinical Assessment|||1||f||||f||||||||||2017-10-11 00:54:18.55341|2017-10-11 00:54:18.55341
NCT02025621|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-11-18|||July 2014||2014-07-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|LEVO-CTS||Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass|A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass|Completed||Phase 3|880|Actual|Tenax Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 00:54:19.188632|2017-10-11 00:54:19.188632
NCT02025608|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-01-23|||December 2013||2013-12-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|AUTOREST||Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome|Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome: AUTOREST, a Case-control Study and a Randomized, Double-blind, Placebo-controlled, Parallel-group, 4-week, Multicenter Study of 0.25mg Pramipexole vs. Placebo in Patients With RLS|Completed||Phase 4|20|Actual|Ospedale Regionale di Lugano||2|||f||||t||||||||||2017-10-11 00:54:19.383639|2017-10-11 00:54:19.383639
NCT02025595|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-05-09|||December 2013||2013-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Obesity and Brain: Genes and Environment|The Role of Central Reward and Satiety Centers in the Etiology of Obesity: Genetic and Environmental Influences|Completed||N/A|92|Actual|VU University Medical Center|||2||f||||f||||||||||2017-10-11 00:54:19.472198|2017-10-11 00:54:19.472198
NCT02025582|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2016-04-21|||December 2013||2013-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Kinesio Taping Effectiveness on Idiopathic Toe Walking|The Effectiveness and Efficacy of Kinesio Taping Method on Muscle Elasticity in Children Who Toe Walk|Completed||Early Phase 1|10|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:54:19.55555|2017-10-11 00:54:19.55555
NCT02025569|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2013-12-30|||January 2008||2008-01-01|December 2013|2013-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Effect of Strain-counterstrain on Ankle Instability|The Effectiveness of Strain Counterstrain in the Treatment of Patients With Chronic Ankle Instability: a Randomized Clinical Trial|Terminated||N/A|27|Actual|Long Island University||2||Data collection was terminated due to unavailability of additional participants.|f||||f||||||||||2017-10-11 00:54:19.633904|2017-10-11 00:54:19.633904
NCT02025556|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-03-26|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of High Frequency Episodic Migraine|Completed||Phase 2|319|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 00:54:19.71563|2017-10-11 00:54:19.71563
NCT02025543|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-03-13|||December 2013||2013-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content|Confounder-Corrected Quantitative Magnetic Resonance Imaging (MRI) Biomarker of Hepatic Iron Content|Recruiting||N/A|200|Anticipated|University of Wisconsin, Madison|||2||f||||f||||||||Yes|Case report forms will be coded with a unique study identification number and sent to with the coordinating center by courier. Images will be shared shared using secure FTP server.|2017-10-11 00:54:19.885759|2017-10-11 00:54:19.885759
NCT02025530|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-10-24|||April 2014||2014-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Observational|MiNESS||The Midlands and North of England Stillbirth Study|The Midlands and North of England Stillbirth Study - A Case-Control Study of Modifiable Factors in Late Stillbirth|Active, not recruiting||N/A|1035|Actual|University of Manchester|||2||f||||f||||||None Retained|"     Hair   "|||2017-10-11 00:54:19.995435|2017-10-11 00:54:19.995435
NCT02025517|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2013-12-27|||August 2012||2012-08-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Gait Training With Cognitive Tasks in Parkinson's Disease|Immediate Effects of Treadmill Gait Training Combined With Cognitive Tasks in Individuals With Parkinson's Disease: Randomized Controlled Trial|Completed||N/A|22|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||t||||||||||2017-10-11 00:54:20.100058|2017-10-11 00:54:20.100058
NCT02025504|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2015-03-31|||April 2014||2014-04-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|C3PO||Carolina-ColoWrap® in Colonoscopy Performance and Outcomes Study|Efficacy of ColoWrap® Abdominal Binder in Improving Performance and Tolerance of Colonoscopy: a Randomized, Sham-Controlled, Blinded Clinical Trial|Completed||N/A|350|Actual|ColoWrap, LLC||2|||f||||t||||||||||2017-10-11 00:54:20.203067|2017-10-11 00:54:20.203067
NCT02025491|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2013-12-30|||April 2011||2011-04-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|||Liposomal Amphotericin in Disseminated Leishmaniasis|Efficacy Study of Liposomal Amphotericin in Disseminated Leishmaniasis|Completed||Phase 3|20|Actual|Hospital Universitário Professor Edgard Santos||1|||f||||f||||||||||2017-10-11 00:54:20.332875|2017-10-11 00:54:20.332875
NCT02025478|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-08-26|||May 2013||2013-05-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|MILK||Human Breastmilk in Children Receiving a Bone Marrow Transplant|A Pilot Study of Enteral Donor Human Milk in Young Children Receiving Bone Marrow Transplantation|Completed||Phase 1/Phase 2|11|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 00:54:20.433796|2017-10-11 00:54:20.433796
NCT02025465|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-08|||December 2013||2013-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control|Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control|Recruiting||Phase 4|150|Anticipated|CAMC Health System||2|||f||||f||||||||||2017-10-11 00:54:20.507449|2017-10-11 00:54:20.507449
NCT02025257|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-01-02|||December 2013||2013-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Exercise in Patients With Coronary Artery Disease Aged 80 Years or Older|Effects of Exercise in Patients With Coronary Artery Disease Aged 80 Years or Older - a Randomized Controlled Trial|Recruiting||N/A|62|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-11 00:54:22.260814|2017-10-11 00:54:22.260814
NCT02025452|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2017-03-23|||March 2014||2014-03-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis|Rapid Diagnostics and Probiotic Therapy for Paediatric Acute Gastroenteritis - a Randomized, Factorial, Controlled, Placebo-controlled, Pilot Trial|Completed||Phase 4|76|Actual|Hamilton Health Sciences Corporation||4|||f||||f||||||||||2017-10-11 00:54:20.605071|2017-10-11 00:54:20.605071
NCT02025439|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-04-22|||February 2014||2014-02-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness|Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness|Active, not recruiting||N/A|4|Actual|Edward Hines Jr. VA Hospital||3|||f||||t||||||||||2017-10-11 00:54:20.811085|2017-10-11 00:54:20.811085
NCT02025426|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2017-03-23|||September 2012||2012-09-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Phenylephrine Versus Ephedrine in Pre-eclampsia|Impact of Vasopressor Administration on Maternal and Neonatal Outcomes in Women With Pre-eclampsia|Recruiting||Phase 4|40|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 00:54:20.936676|2017-10-11 00:54:20.936676
NCT02025413|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-12-30|||November 2011||2011-11-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CTC-EMT||Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method|Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method|Completed||N/A|46|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:54:21.043299|2017-10-11 00:54:21.043299
NCT02025400|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2013-12-31|||July 2012||2012-07-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Internet Enhanced, Patient-Centered Orthopedic Care: A Prospective, Randomized, Controlled Pilot Trial|Phase I Study Comparing Internet Delivered Home Exercise Programs to Standard Orthopedic Care and Outpatient Physical Therapy.|Completed||Phase 1|24|Actual|Charlotte Sports Medicine Institute, PA||2|||f||||f||||||||||2017-10-11 00:54:21.160468|2017-10-11 00:54:21.160468
NCT02025387|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2013-12-27|||December 2013||2013-12-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Physical Activity in Patients With Gynecological Surgery||Unknown status|Recruiting|Phase 3|64|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:54:21.328682|2017-10-11 00:54:21.328682
NCT02025374|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-31|||August 2013||2013-08-01|December 2013|2013-12-01|March 2014|Anticipated|2014-03-01|August 2013|Actual|2013-08-01||Interventional|||Hyperbaric Bupivacaine and Hyperbaric Levobupivacaine in C/S|The Comparison of Hyperbaric Bupivacaine Plus Fentanyl and Hyperbaric Levobupivacaine Plus Fentanyl Administered Intrathecally in Patients Undergoing Elective Cesarean Section|Unknown status|Recruiting|Phase 4|60|Anticipated|Balikesir University||2|||f||||f||||||||||2017-10-11 00:54:21.416596|2017-10-11 00:54:21.416596
NCT02025361|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-30|||February 2009||2009-02-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy|Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy|Completed||Phase 4|422|Actual|Bagcilar Training and Research Hospital||2|||f||||f||||||||||2017-10-11 00:54:21.522382|2017-10-11 00:54:21.522382
NCT02025348|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-01-26|||January 2014||2014-01-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Explore the Performance of IntelliCap.|A Randomised, Open-label, 4-way Crossover Study in Healthy Subjects to Explore the Performance of IntelliCap® by Comparing Pharmacokinetic Profiles of a Probe Drug.|Completed||Early Phase 1|20|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 00:54:21.616016|2017-10-11 00:54:21.616016
NCT02025335|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-09-24|||March 2014||2014-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ACE-KT||Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients|Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients (ACE-KT)|Completed||N/A|199|Actual|Asan Medical Center|||2||f||||f||||||||||2017-10-11 00:54:21.71691|2017-10-11 00:54:21.71691
NCT02025309|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2013-12-30|||July 2013||2013-07-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Intraoperative Methylprednisolone and Sugammadex|Does Intraoperatively Administered Methylprednisolone Prolong the Neuromuscular Blocade Reversal Effect of Sugammadex?|Completed||Phase 4|120|Actual|Ankara University||2|||f||||f||||||||||2017-10-11 00:54:21.884594|2017-10-11 00:54:21.884594
NCT02025296|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-10-11|||December 2013||2013-12-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care|Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care: a Randomized Controlled Trial|Completed||N/A|100|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-10-11 00:54:21.978766|2017-10-11 00:54:21.978766
NCT02025283|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2013-12-30|||January 2010||2010-01-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|RFNaTDD||Efficacy of Radiofrequency Nucleoplasty and Targeted Disc Decompression in Lumbar Radiculopathy|The Comparison of the Efficacy of Radiofrequency Nucleoplasty and Targeted Disc Decompression in Lumbar Radiculopathy: A Retrospective Review|Completed||N/A|73|Actual|Ankara University|||2||f||||f||||||||||2017-10-11 00:54:22.058188|2017-10-11 00:54:22.058188
NCT02025270|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-06-28|||October 2012||2012-10-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||MSCs For Treatment of Azoospermic Patients|Using of Bone Marrow Derived Mesenchymal Stem Cells For Treatment of Azoospermic Patients|Recruiting||Phase 1/Phase 2|100|Anticipated|Al-Azhar University||1|||f||||t||||||||Yes||2017-10-11 00:54:22.15574|2017-10-11 00:54:22.15574
NCT02019199|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-07-07|||November 2011||2011-11-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Magnetic Resonance Imaging (MRI) in Motion|Magnetic Resonance Imaging ( MRI) for Radiation Therapy Treatment Planning Evaluation of Lung, Liver and Pancreatic Motion.|Completed||N/A|25|Actual|Duke University|||1||f||||f||||||||||2017-10-11 00:55:43.988958|2017-10-11 00:55:43.988958
NCT02025244|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2015-11-23|||November 2010||2010-11-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||EUS-FNA Versus KHB in Diagnostics of Upper Gastrointestinal Submucosal Tumors|Endosonography-Guided Fine-Needle-Aspiration (EUS-FNA) Versus Key Hole Biopsy (KHB) in Diagnostics of Upper Gastrointestinal Submucosal Tumors - a Randomized Trial|Recruiting||N/A|52|Anticipated|Vitkovice Hospital||2|||f||||t||||||||||2017-10-11 00:54:22.363031|2017-10-11 00:54:22.363031
NCT02025231|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-02-06|||December 2011||2011-12-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Image Guided Reirradiation of High-grade Glioma|Image Guided Reirradiation of High-grade Glioma - a Phase I/II Dose Escalation Study|Terminated||Phase 1/Phase 2|31|Actual|Rigshospitalet, Denmark||1||Slow accrual|f||||f||||||||||2017-10-11 00:54:22.450402|2017-10-11 00:54:22.450402
NCT02025218|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-05-02|||January 2014||2014-01-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|IRENE||Iressa Re-challenge in Advanced NSCLC EGFR-mutated Patients|Iressa Re-challenge in Advanced NSCLC EGFR Mutated Patients Who Responded to an EGFR-TKI Used as First-line or Previous Treatment (NVALT 16)|Terminated||Phase 2|21|Actual|VU University Medical Center||1|||f||||t||||||||||2017-10-11 00:54:22.544299|2017-10-11 00:54:22.544299
NCT02025192|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-08-10|||December 2013||2013-12-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase 1b Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer|A Phase 1b, Open-label Study to Assess the Safety and Tolerability of Tucatinib (ONT-380) Combined With Capecitabine and Trastuzumab, Alone and in Combination in HER2+ Metastatic Breast Cancer|Active, not recruiting||Phase 1|60|Actual|Cascadian Therapeutics Inc.||3|||f||||t||||||||||2017-10-11 00:54:22.770073|2017-10-11 00:54:22.770073
NCT02025179|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-21|2017-09-12|||January 2013||2013-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)|12 Month Open-Label Extension Study of the Effect of Teriparatide on Bone in People With Chronic SCI|Active, not recruiting||Phase 2|40|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 00:54:22.887958|2017-10-11 00:54:22.887958
NCT02025166|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2013-12-30|||January 2014||2014-01-01|December 2013|2013-12-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Comparison Between Two Analgesic Methods for Pain Relief Following Surgical Abortion|Comparison Between Two Analgesic Methods for Pain Relief Following Surgical Abortion|Unknown status|Not yet recruiting|N/A|82|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 00:54:22.967246|2017-10-11 00:54:22.967246
NCT02025153|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2017-08-18|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|TAHP||Comprehensive Pain Programme to Determine Mechanism of Transition of Acute to Chronic Postsurgical Pain|Comprehensive Pain Programme to Determine Mechanism of Transition of Acute to Chronic Postsurgical Pain- Functional Brain Imaging, Quantitative Sensory Testing, Psychological and Genetic Screening: Prospective Cohort Study|Completed||N/A|216|Actual|KK Women's and Children's Hospital||3|||f||||t||||||||||2017-10-11 00:54:23.063415|2017-10-11 00:54:23.063415
NCT02025140|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-09-01|||September 2013||2013-09-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|STA machine||Computer Controlled Local Anesthesia in Children|Comparison of The Computer Controlled Local Anesthesia and The Conventional Inferior Alveolar Nerve Block in Primary Molars Pulptomies|Completed||Phase 1|91|Actual|King Abdulaziz University||3|||f||||t||||||||||2017-10-11 00:54:23.135881|2017-10-11 00:54:23.135881
NCT02025127|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-08-15|||January 2014||2014-01-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Randomized Controlled Study of Enteral Nutrition in Septic Shock|A Randomized Controlled Study of Enteral Nutrition in Septic Shock|Recruiting||N/A|64|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-11 00:54:23.219971|2017-10-11 00:54:23.219971
NCT02025114|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2017-09-10|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Selumetinib in Combination With Gefitinib in NSCLC Patients|A Phase IB/II, Open Label, Multicenter Study of Selumetinib Administered Orally in Combination With Gefitinib in Patients With EGFR-mutated Non-small Cell Lung Cancer Who Have Developed Acquired Resistance of EGFR Inhibitor Treatment|Recruiting||Phase 1/Phase 2|38|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:54:23.312318|2017-10-11 00:54:23.312318
NCT02025101|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2013-12-29|||January 2014||2014-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Observational|||Characterization of Slow Coronary Flow||Unknown status|Not yet recruiting|N/A|90|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 00:54:23.406499|2017-10-11 00:54:23.406499
NCT02025088|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2013-12-29|||December 2013||2013-12-01|December 2013|2013-12-01|November 2014|Anticipated|2014-11-01|August 2014|Anticipated|2014-08-01||Interventional|||Comparison of Treatments for Atrophic Acne Scars|Comparison of Non-ablative Fractional Erbium Laser 1340nm and Microneedling for the Treatment of Atrophic Acne Scars: a Randomized Clinical Trial.|Unknown status|Recruiting|N/A|23|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 00:54:23.47359|2017-10-11 00:54:23.47359
NCT02025075|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-04-25|2017-03-09||January 2014||2014-01-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Hemodynamic and Respiratory Variations During Laparoscopic Surgery With and Without Deep Neuromuscular Blockade.|A Prospective, Double-blind, Randomized, Crossover Design Study to Compare the Hemodynamic and Respiratory Variations During Laparoscopic Surgery in Patients With and Without Deep Neuromuscular Blockade.|Completed||N/A|37|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:54:23.574061|2017-10-11 00:54:23.574061
NCT02024685|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2015-11-09|||August 2013||2013-08-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial|Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial|Terminated||N/A|76|Actual|Case Comprehensive Cancer Center||2||Funding unavailable|f||||t||||||||||2017-10-11 00:54:33.318|2017-10-11 00:54:33.318
NCT02025062|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-10-16|||September 2013||2013-09-01|December 2013|2013-12-01|September 2018|Anticipated|2018-09-01|February 2017|Anticipated|2017-02-01||Interventional|EGéSOR||Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients|Impact of Comprehensive Geriatric Assessment on Malnutrition, Functional Status and Survival in Elderly Patients With Head and Neck Squamous Cell Carcinomas (HNSCCs): a Randomized Controlled Multicenter Clinical Trial|Recruiting||N/A|704|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 00:54:23.935183|2017-10-11 00:54:23.935183
NCT02025049|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-25|2015-06-22|||December 2013||2013-12-01|December 2013|2013-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||DP-b99 in the Treatment of Acute High-risk Pancreatitis|Pilot Trial of Intravenous DP-b99 in the Treatment of First-ever Episode of Non-obstructive Acute High-risk Pancreatitis|Terminated||Phase 2|10|Actual|D-Pharm Ltd.||2||Slow recruitment|f||||f||||||||||2017-10-11 00:54:24.015189|2017-10-11 00:54:24.015189
NCT02025036|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2016-07-02|||October 2014||2014-10-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|CRTCOESC||Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer|Three-arm Phase III Trial Comparing Radiotherapy With Different Chemotherapy Regimens for Esophageal Cancer|Recruiting||Phase 3|630|Anticipated|The First Affiliated Hospital of Henan University of Science and Technology||3|||f||||t||||||||Undecided||2017-10-11 00:54:24.088602|2017-10-11 00:54:24.088602
NCT02025023|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2017-05-25|||December 2013||2013-12-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|CTS||Chalazia Treatment Study|Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study|Recruiting||Phase 3|120|Anticipated|University of Washington||4|||f||||f||||||||||2017-10-11 00:54:24.196546|2017-10-11 00:54:24.196546
NCT02025010|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-10-04|||December 2013||2013-12-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Ph II Trial of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With CRPC With Correlative Assessment of Hormone Intermediates.|Phase II Clinical Trial of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer With Correlative Assessment of Hormone Intermediates.|Active, not recruiting||Phase 2|60|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:54:24.285164|2017-10-11 00:54:24.285164
NCT02024997|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-10-29|||January 2013||2013-01-01|October 2014|2014-10-01||||September 2014|Actual|2014-09-01||Interventional|||Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study|Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study|Completed||Early Phase 1|15|Actual|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-11 00:54:24.376637|2017-10-11 00:54:24.376637
NCT02024984|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-03-10|||November 2013||2013-11-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||Luteal Phase Versus Follicular Phase Administration of Clomiphene Citrate in PCOS, A Randomized Controlled Trial|Luteal Phase Versus Follicular Phase Administration of Clomiphene Citrate in PCOS, A Randomized Controlled Trial|Unknown status|Recruiting|Phase 1|90|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-11 00:54:24.435853|2017-10-11 00:54:24.435853
NCT02024971|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2016-09-29|2016-09-29||July 2010||2010-07-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational||Safety analysis set|Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus|Metact® Combination Tablets Special Drug Use Surveillance Survey on Long-term Use for Type 2 Diabetes Mellitus|Completed||N/A|1103|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:54:26.408862|2017-10-11 00:54:26.408862
NCT02024958|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2013-12-28|||May 2014||2014-05-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Observational|ICALIC||New Indirect Calorimetry Device for Energy Expenditure Measurement|Development and Validation of a New Indirect Calorimetry Device for Energy Expenditure Measurement in ICU Patients: The ICALIC International Multicentric Study|Unknown status|Not yet recruiting|N/A|182|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 00:54:27.591822|2017-10-11 00:54:27.591822
NCT02024945|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2013-12-28|||November 2010||2010-11-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome|Evaluation of Health-Related Quality of Life in Patients With Overactive Bladder Syndrome (OAB) Treated With Propiverine, and Its Efficacy and Tolerance in Daily Practice in Belgian General Practitioners and Urologists|Completed||Phase 4|437|Actual|Takeda|||1||f||||f||||||||||2017-10-11 00:54:27.690264|2017-10-11 00:54:27.690264
NCT02024932|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2017-08-17|2017-04-12||February 4, 2014|Actual|2014-02-04|August 2017|2017-08-01|April 13, 2016|Actual|2016-04-13|April 13, 2016|Actual|2016-04-13||Interventional|||Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy|A Two-part Placebo-controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy (SBMA)|Completed||Phase 2|37|Actual|Novartis||6|||f||||t||||||||||2017-10-11 00:54:27.816899|2017-10-11 00:54:27.816899
NCT02024919|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-29|2015-05-05|||June 2012||2012-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Diltiazem on Coronary Artery Ectasia|Short Term Effect of Diltiazem on Myocardial Perfusion in Patients With Isolated Coronary Artery Ectasia- a Prospective Clinical Study|Completed||N/A|60|Actual|Ankara University||2|||f||||||||||||||2017-10-11 00:54:29.268159|2017-10-11 00:54:29.268159
NCT02024906|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2015-09-21|||February 2015||2015-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants|Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 00:54:29.439218|2017-10-11 00:54:29.439218
NCT02024893|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-21|2013-12-28|||January 2014||2014-01-01|December 2013|2013-12-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01|12 Months|Observational [Patient Registry]|||Range of Motion, Humeral Retroversion and Rotator Cuff (RC) Muscle Strength of the Shoulder in Overhead Athletes|Range of Motion, Humeral Retroversion and RC Muscle Strength in the Shoulder of Overhead Athletes|Unknown status|Not yet recruiting|N/A|80|Anticipated|Wingate Institute|||3||f||||f||||||||||2017-10-11 00:54:29.573897|2017-10-11 00:54:29.573897
NCT02024880|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2016-11-01|||January 2014||2014-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer|A Randomized Single-blind Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer|Recruiting||Phase 4|720|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:54:29.679846|2017-10-11 00:54:29.679846
NCT02024867|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2015-09-17|2014-09-08||February 2010||2010-02-01|September 2015|2015-09-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|||Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage|Randomized Non-inferiority Trial of 3 Versus 10 Days of Trimethoprim-Sulfamethoxazole in Community-Associated Skin Abscesses After Surgical Drainage|Completed||N/A|249|Actual|State University of New York at Buffalo||2|||f||||f||||||||||2017-10-11 00:54:29.822902|2017-10-11 00:54:29.822902
NCT02024854|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-09|||February 1, 2014|Actual|2014-02-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation|Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation. A Randomized Controlled Trial|Recruiting||N/A|136|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 00:54:30.810404|2017-10-11 00:54:30.810404
NCT02024841|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2016-11-02|||December 2013||2013-12-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis|Feasibility Study of Intraperitoneal Docetaxel Combined With Intravenous Cisplatin and Oral TS-ONE for Gastric Cancer Patients With Peritoneal Carcinomatosis|Recruiting||Phase 1|18|Anticipated|The University of Hong Kong||1|||f||||t||||||||No||2017-10-11 00:54:31.000106|2017-10-11 00:54:31.000106
NCT02024828|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-26|||July 2006||2006-07-01|May 2011|2011-05-01|April 2012|Actual|2012-04-01|January 2011|Actual|2011-01-01||Interventional|PRO||Testing Four Feeding Approaches to Oral Feeding in Preterm Infants|Feeding Readiness in Preterm Infants|Completed||N/A|109|Actual|Children's Hospital Medical Center, Cincinnati||4|||f||||t||||||||||2017-10-11 00:54:31.147607|2017-10-11 00:54:31.147607
NCT02024815|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-28|||September 2011||2011-09-01|December 2013|2013-12-01|June 2015|Anticipated|2015-06-01|September 2013|Actual|2013-09-01||Interventional|||Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma.|Comparable Investigation of One Fraction Radiotherapy (8 Gy x 1) and Multifraction Radiotherapy (3 Gy x 10) of Painful Bone Destructions in Patients With Multiple Myeloma.|Unknown status|Enrolling by invitation|Phase 3|100|Anticipated|Lithuanian University of Health Sciences||2|||f||||t||||||||||2017-10-11 00:54:31.261846|2017-10-11 00:54:31.261846
NCT02024802|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-28|2014-07-03|||January 2014||2014-01-01|July 2014|2014-07-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Compounded Pain Creams and Patient Perception|Clinical Trial: Transdermal Compounded Pain Creams and Patient Pain Perception|Withdrawn||N/A|0|Actual|Marwood LowCost Pharmacy|||1||f||||f||||||||||2017-10-11 00:54:31.357603|2017-10-11 00:54:31.357603
NCT02024789|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2016-11-01|||May 2014||2014-05-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)|A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF RG1662 IN ADULTS AND ADOLESCENTS WITH DOWN SYNDROME (CLEMATIS)|Completed||Phase 2|173|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:54:31.456033|2017-10-11 00:54:31.456033
NCT02024776|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2017-03-06|||February 1, 2014|Actual|2014-02-01|March 2017|2017-03-01|January 30, 2017|Actual|2017-01-30|August 30, 2016|Actual|2016-08-30||Interventional|||Effectiveness of Prehabilitation Program for High-risk Patients Underwent Abdominal Surgery|The Effectiveness of Tailored Physical Training Intervention (Prehabilitation) in High-risk Patients Underwent Major Abdominal Surgery on Postoperative Complications: Randomized Controlled Trial|Completed||N/A|141|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 00:54:31.677755|2017-10-11 00:54:31.677755
NCT02024763|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2013-12-27|||September 1999||1999-09-01|December 2013|2013-12-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Educational Program and Schoolchildren's Energy Expenditure|Effect of an Educational Program on Schoolchildren's Energy Expenditure During Physical Education Classes|Completed||N/A|352|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 00:54:31.793554|2017-10-11 00:54:31.793554
NCT02024750|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2017-08-10|||September 2014||2014-09-01|August 2017|2017-08-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Interventional|||Tailored Diabetes Self-Management Resources|Family-Centered Tailoring of Pediatric Diabetes Self-Management Resources|Completed||N/A|214|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 00:54:31.880896|2017-10-11 00:54:31.880896
NCT02024737|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2015-09-28|||February 2014||2014-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|SILO2||SILO2 (Signal Intensity Lung washOut)|A Pilot Study to Establish the Sensitivity of MR Imaging Markers to Changes in Regional Lung Function and Gas Washout in Patients With Mild-moderate COPD|Completed||N/A|5|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 00:54:31.995858|2017-10-11 00:54:31.995858
NCT02024724|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2017-06-14|2017-05-11||November 2013||2013-11-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|||Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain|Phase 4 Study Comparing of Dexamethasone to Triamcinolone for Ultrasound-guided Trigeminal Nerve Block: A Randomized Controlled Trial.|Completed||Phase 4|60|Actual|Northwestern University||2|||f||||f||||||||No||2017-10-11 00:54:32.095244|2017-10-11 00:54:32.095244
NCT02024711|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2015-06-01|||December 2013||2013-12-01|June 2015|2015-06-01||||December 2014|Actual|2014-12-01||Interventional|||EYEFILL® C. -US Viscoelastic Clinical Investigation|EYEFILL® C.-US Viscoelastic Clinical Investigational Protocol- For Institutional Review Boards / Ethical Review Committees and Clinical Investigators|Completed||Phase 3|284|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 00:54:32.587267|2017-10-11 00:54:32.587267
NCT02024698|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2016-04-18|2016-02-24||January 2014||2014-01-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist|Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist|Completed||Phase 4|43|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 00:54:32.730571|2017-10-11 00:54:32.730571
NCT02024659|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2014-10-09|||September 2010||2010-09-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|December 2011|Actual|2011-12-01||Interventional|||Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal Polyps|Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps|Completed||Phase 2/Phase 3|57|Actual|Beijing Tongren Hospital||2|||f||||t||||||||||2017-10-11 00:54:33.584091|2017-10-11 00:54:33.584091
NCT02024633|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2015-07-14|||December 2013||2013-12-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer|Phase I, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Icotinib Combined With Gemcitabine as First-line Treatment in Locally Advanced, Unresectable or Metastatic Pancreatic Cancer|Unknown status|Recruiting|Phase 1|24|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 00:54:34.009439|2017-10-11 00:54:34.009439
NCT02024620|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-12-14|||March 2014||2014-03-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Mobile Apps for the Treatment of Depression|Evaluation of Mood Coach in the Treatment of Major Depressive Disorder|Withdrawn||N/A|0|Actual|Central Arkansas Veterans Healthcare System||2||The mobile phone app upon which the study was based was not available.|f||||t||||||||||2017-10-11 00:54:34.13437|2017-10-11 00:54:34.13437
NCT02024594|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2013-12-27|||October 2009||2009-10-01|December 2013|2013-12-01||||July 2010|Actual|2010-07-01||Interventional|||Comparison of Effect of Nitrous Oxide-Oxygen Conscious Sedation and Cognitive-behavioral Therapy on Children's Anxiety in Dentistry||Completed||N/A|45|Actual|Mashhad University of Medical Sciences||3|||f||||f||||||||||2017-10-11 00:54:34.429078|2017-10-11 00:54:34.429078
NCT02024581|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-16|||February 2016||2016-02-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||A Dose Range-Finding Phase 2 Trial of a Botanical Drug for the Treatment of Molluscum Contagiosum in Pediatric Subjects|A Single-center, Double-blind, Placebo-controlled, Randomized Safety and Efficacy Trial of a Botanical Drug Product, East Indian Sandalwood Oil (EISO), at One Dose Level for the Treatment of Molluscum Contagiosum in Pediatric Subjects|Recruiting||Phase 2|60|Anticipated|ViroXis Corporation||2|||f||||f||||||||||2017-10-11 00:54:34.521045|2017-10-11 00:54:34.521045
NCT02024568|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-26|||December 2013||2013-12-01|December 2013|2013-12-01|May 2015|Anticipated|2015-05-01|March 2015|Anticipated|2015-03-01||Interventional|||Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia|Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia|Unknown status|Not yet recruiting|Phase 2|38|Anticipated|Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-10-11 00:54:34.66357|2017-10-11 00:54:34.66357
NCT02024555|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2017-06-27|||March 2014||2014-03-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|March 2019|Anticipated|2019-03-01||Interventional|||Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis|Investigation of the Efficacy of Antimycobacterial Therapy on Pulmonary Sarcoidosis Phase II Randomized, Double-blind, Placebo-controlled Trial|Recruiting||Phase 2|128|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 00:54:34.800301|2017-10-11 00:54:34.800301
NCT02024542|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-25|2017-07-06|||February 2011||2011-02-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Metabolic Responses to Bariatric Surgery|Genetic and Biochemical Characteristics of Medically-Complicated Obesity and Response to Bariatric Surgery|Recruiting||N/A|500|Anticipated|University of California, Davis|||2||f||||f||||||Samples Without DNA|"     Blood, urine, feces, liver, adipose tissue, GI tissue   "|||2017-10-11 00:54:34.964965|2017-10-11 00:54:34.964965
NCT02024529|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2016-07-27|||December 2013||2013-12-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||AP-004-A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee|A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of a Single Intra-articular Injection of AmpionTM (<5 Kilodalton Ultrafiltrate of 5% Human Serum Albumin) in Adults With Pain Due to Osteoarthritis (OA) of the Knee|Completed||Phase 3|538|Actual|Ampio Pharmaceuticals. Inc.||2|||f||||t||||||||||2017-10-11 00:54:35.102491|2017-10-11 00:54:35.102491
NCT02024516|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2013-12-30|||January 2013||2013-01-01|December 2013|2013-12-01||||December 2013|Anticipated|2013-12-01||Interventional|||The Effect of Concentrated Pomegranate Juice Consumption on Lipid Profile and Inflammatory Factors in Patients With Type 2 Diabetes||Unknown status|Recruiting|N/A|||Ahvaz Jundishapur University of Medical Sciences||1|||f||||||||||||||2017-10-11 00:54:35.181313|2017-10-11 00:54:35.181313
NCT02024503|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-25|2013-12-30|||September 2013||2013-09-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Observational|||A Longitudinal Study of Multimodal Resonance Imaging in Stroke Patients|A Longitudinal Study of Multimodal Resonance Imaging in Stroke Patients|Unknown status|Recruiting|N/A|800|Anticipated|Zhongda Hospital|||2||f||||f||||||Samples With DNA|"     Extraction of DNA from the blood of patients.   "|||2017-10-11 00:54:35.265389|2017-10-11 00:54:35.265389
NCT02024477|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-08-28|||November 2013||2013-11-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients|Effect of Saxagliptin (DPP-4 Inhibitor) on Endothelial Progenitor Cells (EPCs) as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early Type 2 Diabetes Patients|Active, not recruiting||Phase 4|42|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-11 00:54:35.396861|2017-10-11 00:54:35.396861
NCT02024464|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-05-09|||August 2011||2011-08-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery|A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery|Active, not recruiting||N/A|300|Anticipated|Ivantis, Inc.||2|||f||||f||||||||No||2017-10-11 00:54:35.477062|2017-10-11 00:54:35.477062
NCT02024451|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-02-03|||January 2014||2014-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Radial Shock Wave and Acupuncture for Myofascial Pain|Comparison of the Effect of Radial Shock Wave and Acupuncture in the Treatment of Myofascial Pain Syndrome|Completed||N/A|68|Actual|Shin Kong Wu Ho-Su Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:54:35.683603|2017-10-11 00:54:35.683603
NCT02024438|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2015-09-24|||December 2013||2013-12-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer|The Safety and Effect of Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX6 as First-line Chemotherapy for Advanced Gastric Cancer|Recruiting||Phase 3|240|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||f||||||||||2017-10-11 00:54:35.781989|2017-10-11 00:54:35.781989
NCT02024425|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-27|2015-11-18|||September 2013||2013-09-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|ALIBIRDII||Functional Bioactive Supplement Effect in Lost Weight Treatment|A Randomized, Double-blind Trial to Evaluate the Effect of a Functional Bioactive Supplement Associated With a Hypocaloric Equilibrated Diet to Treatment of Obese and Overweight Individuals|Completed||Phase 4|109|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-11 00:54:35.902722|2017-10-11 00:54:35.902722
NCT02024412|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2015-09-24|||November 2013||2013-11-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC|The Safety and Effect of Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX6 as First-line Chemotherapy for Advanced Colorectal Cancer|Recruiting||Phase 3|240|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||f||||||||||2017-10-11 00:54:36.013815|2017-10-11 00:54:36.013815
NCT02024399|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2013-12-26|||August 2004||2004-08-01|December 2013|2013-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Cardiovascular Risk Factors, Body Composition, Fitness Levels And Quality Of Life In Overweight And Obese 8-17 Year Olds|Pilot Study of 10 Week Exercise and Nutrition Program for Children Who Are Overweight / Obese.|Completed||N/A|48|Actual|Stony Brook University||1|||f||||t||||||||||2017-10-11 00:54:36.104427|2017-10-11 00:54:36.104427
NCT02024386|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-03-01|2016-12-19||January 2014||2014-01-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude|The Effect of Riociguat on Gas Exchange, Exercise Performance, and Pulmonary Artery Pressure During Acute Altitude Exposure|Completed||Phase 4|28|Actual|Duke University||3|||f||||t||||||||||2017-10-11 00:54:36.21905|2017-10-11 00:54:36.21905
NCT02024373|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-10-24|||December 2013||2013-12-01|February 2016|2016-02-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma|Multi-Center, Randomized, Placebo-Controlled, Double Blind Study of the Atorvastatin: Effect on Patients With Chronic Subdural Hematoma|Completed||Phase 2|200|Actual|Oriental Neurosurgery Evidence-Based-Study Team||2|||f||||f||||||||||2017-10-11 00:54:37.327377|2017-10-11 00:54:37.327377
NCT02024360|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-21|2017-01-31|||March 2012||2012-03-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|CO-OPT||Community Outreach - Obesity Prevention Trial (CO-OPT)|Center for Research in Implementation Science and Prevention (CRISP) - Community Outreach - Obesity Prevention Trial (CO-OPT)|Active, not recruiting||N/A|300|Anticipated|Denver Health and Hospital Authority||1|||f||||f||||||||No||2017-10-11 00:54:37.494982|2017-10-11 00:54:37.494982
NCT02024347|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-07-26|||July 2013||2013-07-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|LSSM-RCT||A New Screening Strategy for Varices|A Randomized Controlled Trial of a New Screening Strategy for Varices Based on Liver and Spleen Stiffness Measurement (LSSM) in Cirrhotic Patients|Recruiting||N/A|548|Anticipated|Chinese University of Hong Kong|||2||f||||f||||||||No||2017-10-11 00:54:37.576531|2017-10-11 00:54:37.576531
NCT02024334|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-25|||June 2013||2013-06-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|JIA||Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis|Study of Therapeutic Effects and Side Effects of Leflunomide in Methotrexate Refractory Juvenile Idiopathic Arthritis|Unknown status|Recruiting|Phase 4|30|Anticipated|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:54:37.67374|2017-10-11 00:54:37.67374
NCT02024321|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-27|||January 2013||2013-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|TPN||Study on Blood Glucose Variations in Tumor Patients Before and After Total Parenteral Nutrition|Phase 1: Select Tumor Patients to be Observed Phase 2: Observe the Blood Glucose Values During TPN Phase 3: Sort Data|Completed||N/A|86|Actual|Chinese Academy of Medical Sciences|||1||f||||t||||||||||2017-10-11 00:54:37.778971|2017-10-11 00:54:37.778971
NCT02024295|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-05-28|||December 2013||2013-12-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis|Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis|Unknown status|Recruiting|Phase 4|118|Anticipated|Zhejiang Hisun Pharmaceutical Co. Ltd.||2|||f||||f||||||||||2017-10-11 00:54:37.971594|2017-10-11 00:54:37.971594
NCT02024282|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-02-16|||January 2013||2013-01-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ERNIE2||Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care|"Validation of a Vital Signs and Symptoms Decision Tree and the Effect of a Point-of- Care CRP Test, Oxygen Saturation, a Brief Intervention and a Parent Leaflet on Diagnosing, Antibiotic Prescribing Rate and Parental Satisfaction in Acutely Ill Children in Primary Care."|Completed||N/A|8962|Actual|Katholieke Universiteit Leuven||4|||f||||f||||||||||2017-10-11 00:54:38.104322|2017-10-11 00:54:38.104322
NCT02024269|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-09-15|||December 2013||2013-12-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Injected Intravitreal in Dry Macular Degeneration|Withdrawn||N/A|0|Actual|Bioheart, Inc.||1|||f||||||||||||||2017-10-11 00:54:38.230082|2017-10-11 00:54:38.230082
NCT02024256|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-25|2016-09-29|||January 2014||2014-01-01|September 2016|2016-09-01||||January 2018|Anticipated|2018-01-01||Interventional|MgSo4||Cold Magnesium Sulfate Solution for Perineal Swelling Following Vaginal Delivery|Comparison Between Treatment With Gauze Soaked With Cold Magnesium Sulfate Solution Against Gauze Soaked With Cold Water for Treatment of Perineal Swelling Following Vaginal Delivery - A Double Blind Placebo Controlled Trial|Recruiting||N/A|206|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-11 00:54:38.297557|2017-10-11 00:54:38.297557
NCT02024243|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-01-20|||October 2014||2014-10-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|miR210||Role of Tissue Oxygenation and the miR-210 Gene In Wound Healing|Tissue Oxygenation and miR-210 Role In Wound Healing|Recruiting||N/A|60|Anticipated|Ohio State University|||1||f||||f||||||Samples With DNA|"     wound tissue biopsies   "|||2017-10-11 00:54:38.389352|2017-10-11 00:54:38.389352
NCT02024230|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-03-17|||May 2014||2014-05-01|March 2015|2015-03-01||||December 2017|Anticipated|2017-12-01||Interventional|REWRAPS||Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation||Recruiting||Phase 4|1600|Anticipated|Fujita Health University||2|||f||||||||||||||2017-10-11 00:54:38.491735|2017-10-11 00:54:38.491735
NCT02024217|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-12-25|||March 2012||2012-03-01|December 2013|2013-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|NEWEAR||Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma|Phase II Study of Neoadjuvant Chemotherapy Wtih S1+Oxaliplatin (SOX) Regimen Followed by Chemoradiation Concurrent With S-1 in Patients With Potentially Resectable Gastric Carcinoma|Unknown status|Recruiting|Phase 2|40|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 00:54:38.574169|2017-10-11 00:54:38.574169
NCT02024191|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-25|2013-12-30|||December 2013||2013-12-01|December 2013|2013-12-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|GELUPO||The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy|The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients. Randomized Trial|Unknown status|Recruiting|Phase 3|80|Anticipated|Ankara Education and Research Hospital||2|||f||||f||||||||||2017-10-11 00:54:38.772285|2017-10-11 00:54:38.772285
NCT02024178|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2016-06-16|||June 2011||2011-06-01|June 2016|2016-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery|A Pilot Evaluation of the Efficacy of HistoScanning™ in Predicting the Presence and Location of Prostate Cancer in Men Undergoing Radical Prostatectomy|Completed||N/A|34|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-11 00:54:38.849149|2017-10-11 00:54:38.849149
NCT02024165|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-04-22|2015-04-01||November 2013||2013-11-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|FHR||Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability|Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability|Completed||N/A|71|Actual|OBMedical Company|||2||f||||f||||||||||2017-10-11 00:54:38.91134|2017-10-11 00:54:38.91134
NCT02024152|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-01-02|||March 2011||2011-03-01|January 2014|2014-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg||Completed||Phase 1|24|Actual|JDP Therapeutics, Inc.||4|||f||||||||||||||2017-10-11 00:54:39.164938|2017-10-11 00:54:39.164938
NCT02024139|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2016-04-11|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy of Chewing Sugarless Gum for Reduction of Orthodontic Appliance Pain|Efficacy of Chewing Sugarless Gum for Reduction of Orthodontic Fixed Appliance Activation Pain|Completed||N/A|36|Actual|Kuwait University||2|||f||||t||||||||||2017-10-11 00:54:39.241468|2017-10-11 00:54:39.241468
NCT02024126|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-07-07|||December 2013||2013-12-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|August 31, 2017|Anticipated|2017-08-31||Interventional|||Exercise Therapy in Patients With Knee Osteoarthritis|Exercise Therapy in Patients With Knee Osteoarthritis|Active, not recruiting||N/A|189|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 00:54:39.324727|2017-10-11 00:54:39.324727
NCT02024113|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-02-09|||February 2013||2013-02-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||LC-NMR Study Biomarkers to Detect Lung Cancer|Search for Biomarkers to Detect Lung Cancer by Means of a NMR Spectroscopic Analysis of Blood Plasma|Completed||N/A|646|Actual|Hasselt University|||2||f||||f||||||Samples Without DNA|"     Plasma is used to determine the metabolic profile by NMR spectroscopy   "|||2017-10-11 00:54:39.425084|2017-10-11 00:54:39.425084
NCT02024100|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-26|2016-01-03|||December 2013||2013-12-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure (Teveten_MS)|Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure in Hypertensive Patients With Metabolic Syndrome|Unknown status|Recruiting|N/A|240|Anticipated|Handok Pharmaceuticals Co., Ltd.|||1||f||||t||||||||||2017-10-11 00:54:39.508755|2017-10-11 00:54:39.508755
NCT02024087|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-07-14|||June 2014||2014-06-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|July 5, 2017|Actual|2017-07-05||Interventional|||Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma|A Phase 1b, Open Label Study of Dalantercept Plus Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Acceleron Pharma, Inc.||1|||f||||f||||||||||2017-10-11 00:54:39.584791|2017-10-11 00:54:39.584791
NCT02024074|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-02-05|||November 2013||2013-11-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients|Performance of Tc99m Sestamibi Molecular Breast Imaging (Tc-MBI) Versus Magnetic Resonance Imaging in the Diagnosis of Breast Carcinoma: A Pilot Study|Terminated||Phase 1|1|Actual|Emory University||1||Study terminated by the Sponsor due to slow enrollment|f||||t||||||||||2017-10-11 00:54:39.675224|2017-10-11 00:54:39.675224
NCT02024061|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-07-19|||September 2012||2012-09-01|July 2017|2017-07-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|TOP||Treatment of Pediatric Obesity (TOP) - A Multidisciplinary Approach Involving Adolescents and Their Peers|Tratamento da Obesidade Pedi ́Atrica (TOP) - Uma Abordagem Multidisciplinar Envolvendo Pais e Pares|Completed||N/A|99|Actual|Grupo Lusófona||2|||f||||f||||||||||2017-10-11 00:54:39.751867|2017-10-11 00:54:39.751867
NCT02024048|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-01-27|||December 2013||2013-12-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|January 2014|Actual|2014-01-01|6 Months|Observational [Patient Registry]|||Evaluation of Choroidal Thickness During Pregnancy Using Enhanced Depth Imaging Optical Coherence Tomography|Evaluation of Choroidal Thickness During Pregnancy Using Enhanced Depth Imaging Optical Coherence Tomography|Unknown status|Active, not recruiting|N/A|12|Actual|Gaia Hospital|||2||f||||f||||||||||2017-10-11 00:54:39.849944|2017-10-11 00:54:39.849944
NCT02024035|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-12-23|||November 2009||2009-11-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|March 2012|Actual|2012-03-01||Observational|ART-ORL||Protocole Advanced RadioTherapy ORL|Health Economic Evaluation of Tomotherapy and Dynamic Arctherapy in ENT Epidermoid Carcinoma|Completed||N/A|180|Actual|Centre Leon Berard|||3||f||||t||||||||||2017-10-11 00:54:39.928047|2017-10-11 00:54:39.928047
NCT02024022|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-01-26|||February 2014||2014-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||A Multicenter Single-blind Comparison Between Standard and Individualized Approach in Bowel Preparation Before Colonoscopy|A Comparison of Bowel Prep Quality and Patient Satisfaction in Outpatients Undergoing Colonoscopy Preparation With Either a Standard Bowel Preparation or an Individualized Approach Using Sodium Picosulphatge/Magnesium Citrate or 4L Polyethylene Glycol Preparation Regimens|Completed||Phase 4|185|Actual|Clinical Hospital Colentina||2|||f||||f||||||||||2017-10-11 00:54:40.06075|2017-10-11 00:54:40.06075
NCT02024009|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-07-04|||March 2016||2016-03-01|July 2017|2017-07-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|SCALOP-2||Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2|A Multi-centre Randomised Study of Induction Chemotherapy Followed by Capecitabine (+/-Nelfinavir) With High or Standard Dose Radiotherapy for Locally Advanced Non-metastatic Pancreatic Cancer|Recruiting||Phase 1/Phase 2|289|Anticipated|University of Oxford||5|||f||||t||||||||||2017-10-11 00:54:40.166339|2017-10-11 00:54:40.166339
NCT02023996|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-05-16|||December 2013|Actual|2013-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer|Pilot Trial of PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer|Recruiting||N/A|55|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:54:40.313112|2017-10-11 00:54:40.313112
NCT02023983|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-01|2017-08-01||October 2013|Actual|2013-10-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|||Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction|Official Title Verification of the Safety of Early Discharge (Within 72 Hours) in Low Risk Patients After Acute ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Open Randomized Study.|Completed||N/A|151|Actual|Municipal Hospital Ostrava|The limitation of the study is limited number of probands enrolled in one centre.|2|||f||||f||||||||||2017-10-11 00:54:40.428288|2017-10-11 00:54:40.428288
NCT02023970|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-03-07|||October 2013||2013-10-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|TRANSLINK||TRANSLINK: Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves|TRANSLINK: A Prospective, Multi-center, Multi-national, Non Randomized, Open, Study to Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves.|Recruiting||N/A|1460|Anticipated|Nantes University Hospital||3|||f||||f||||||||||2017-10-11 00:54:40.850978|2017-10-11 00:54:40.850978
NCT02023957|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-06-01|||November 2013||2013-11-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|iCAS||A Pilot With Interactive Computer-assisted Screening for Mental Health in Primary Care|Interactive Computer-assisted Screening for Mental Health in Primary Care|Completed||N/A|154|Actual|York University||2|||f||||f||||||||Undecided||2017-10-11 00:54:41.047591|2017-10-11 00:54:41.047591
NCT02023944|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2017-05-09|||November 1, 2013|Actual|2013-11-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Maintaining Cognitive Health in Aging Veterans|Maintaining Cognitive Health in Aging Veterans|Active, not recruiting||N/A|164|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 00:54:41.170854|2017-10-11 00:54:41.170854
NCT02023931|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2016-01-14|||March 2014||2014-03-01|October 2014|2014-10-01|January 2015|Actual|2015-01-01|April 2014|Actual|2014-04-01||Interventional|BSE||Broccoli Sprout Extracts in Healthy Volunteers: A Pilot Study of Nrf2 Pathway Modulation in Oral Mucosa|Broccoli Sprout Extracts in Healthy Volunteers: A Pilot Study of Nrf2 Pathway Modulation in Oral Mucosa|Completed||Early Phase 1|10|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 00:54:41.294699|2017-10-11 00:54:41.294699
NCT02023918|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2017-04-20|2016-11-09||January 2014||2014-01-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|PEGIR||Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes|Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Insulin Resistance But Without Diabetes|Completed||Phase 2|6|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 00:54:41.416765|2017-10-11 00:54:41.416765
NCT02023905|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2016-10-27|||February 2014||2014-02-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Everolimus With and Without Temozolomide in Adult Low Grade Glioma|PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) With and Without Temozolomide in the Treatment of Adult Patients With Supratentorial Low-Grade Glioma|Recruiting||Phase 2|159|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 00:54:41.65261|2017-10-11 00:54:41.65261
NCT02023892|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-05-14|||June 2014||2014-06-01|May 2014|2014-05-01||||August 2014|Anticipated|2014-08-01||Interventional|||Single Dose of Atorvastatin and Circulating Endothelial Microparticles|The Effect of Single Dose of Atorvastatin on Change of Circulating Endothelial Microparticles|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 00:54:41.746483|2017-10-11 00:54:41.746483
NCT02023879|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-08-07|2017-01-24|2015-10-08|December 16, 2013|Actual|2013-12-16|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|October 27, 2014|Actual|2014-10-27||Interventional|||Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Alirocumab in Patients With Primary Hypercholesterolemia Not Treated With a Statin|Completed||Phase 3|233|Actual|Sanofi|The systematic randomization error was not anticipated to have an impact on the power of the study. The sample size to detect a difference in efficacy endpoints was reached (it was increased to obtain additional safety data) and blind was maintained.|3|||f||||t||||||||||2017-10-11 00:54:41.84268|2017-10-11 00:54:41.84268
NCT02023853|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-09-01|||December 2013||2013-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|||Non Surgical Treatment of Periimplantitis|The Use of Erythritol Powder and Locally Derived Metronidazole for the Non-surgical Treatment of Peri-implant Mucositis and Peri-implantitis.|Completed||Phase 4|20|Actual|Proed||1|||f||||f||||||||||2017-10-11 00:54:43.096568|2017-10-11 00:54:43.096568
NCT02023840|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-09-01|||December 2013||2013-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|||The Use of Erythritol Powder and Metronidazole Gel for the Non-surgical Treatment of Periodontitis|The Use of Erythritol Powder and Locally Derived Metronidazole for the Non-surgical Treatment of Periodontitis: a Split-mouth Randomized Controlled Clinical Trial|Completed||Phase 4|20|Actual|Proed||2|||f||||f||||||||No||2017-10-11 00:54:43.271648|2017-10-11 00:54:43.271648
NCT02023827|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-09-27|||August 2013||2013-08-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Computerized Stage-Matched Intervention for Juvenile Offenders|Computerized Stage-Matched Intervention for Juvenile Offenders|Active, not recruiting||Phase 2|1000|Anticipated|Pro-Change Behavior Systems||2|||f||||t||||||||No||2017-10-11 00:54:43.37719|2017-10-11 00:54:43.37719
NCT02023814|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-24|||January 2002||2002-01-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Peripheral Blood CD34-positive Cells Enumeration as Predictor of Stem Cell Harvest|Peripheral Blood CD34+ Cells Count as Predictor of Stem Cell Harvest After Chemotherapy and G-CSF. A Single Center Experience|Completed||N/A|250|Actual|Ospedale Santa Croce-Carle Cuneo|||1||f||||f||||||||||2017-10-11 00:54:43.486746|2017-10-11 00:54:43.486746
NCT02023801|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2015-10-06|2015-08-26|2014-08-20|August 2011||2011-08-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|October 2012|Actual|2012-10-01||Interventional||Enrolled subjects|A Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System|A Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System|Completed||N/A|24|Actual|Minerva Surgical, Inc.||1|||f||||t||||||||||2017-10-11 00:54:43.556004|2017-10-11 00:54:43.556004
NCT02023788|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-04-18|||April 2014||2014-04-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study|Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study|Completed||N/A|9|Anticipated|Medipost Co Ltd.|||1||f||||f||||||||||2017-10-11 00:54:43.786011|2017-10-11 00:54:43.786011
NCT02023775|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-03-14|||March 2013||2013-03-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|May 2016|Actual|2016-05-01|5 Years|Observational [Patient Registry]|Melody™ France||Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™|Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™|Active, not recruiting||N/A|100|Anticipated|Medtronic Bakken Research Center|||1||f||||f||||||||||2017-10-11 00:54:43.895411|2017-10-11 00:54:43.895411
NCT02023762|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-24|||January 2012||2012-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Deep Sedation Instead of General Anaesthesia in Percutaneous Mitral Valve Repair Using the MitraClip® System|Safety and Feasibility of Deep Sedation Instead of General Anaesthesia in Percutaneous Mitral Valve Repair Using the MitraClip® System|Completed||N/A|21|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 00:54:44.000598|2017-10-11 00:54:44.000598
NCT02023749|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-23|||April 2012||2012-04-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Effects of Nut Consumption on Metabolic Syndrome|Effects of Nut Consumption on Metabolic Syndrome in Korean Adults - A Randomized Controlled Dietary Intervention Trial|Completed||N/A|60|Actual|Ministry of Food and Drug Safety, Korea||2|||f||||||||||||||2017-10-11 00:54:44.094443|2017-10-11 00:54:44.094443
NCT02023736|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-08-08|||December 2013||2013-12-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Interventional|||Assessing Psychotherapy Outcome With Feedback|Assessing Psychotherapy Outcome in Treatment as Usual Versus Treatment as Usual With the STIC Feedback System|Recruiting||N/A|1000|Anticipated|The Family Institute at Northwestern University||2|||f||||f||||||||||2017-10-11 00:54:44.179851|2017-10-11 00:54:44.179851
NCT02023723|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2016-08-10|||December 2013||2013-12-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of Monster Energy® Drink Consumption on ECG and Hemodynamic Parameters in Young Healthy Volunteers|Evaluation of Monster Energy® Drink Consumption on ECG and Hemodynamic Parameters in Young Healthy Volunteers|Completed||N/A|18|Actual|David Grant U.S. Air Force Medical Center||2|||f||||f||||||||||2017-10-11 00:54:44.310436|2017-10-11 00:54:44.310436
NCT02023710|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-07|||December 2013||2013-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma|A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma|Recruiting||Phase 2|182|Anticipated|Beijing Cancer Hospital||2|||f||||t||||||||||2017-10-11 00:54:44.421057|2017-10-11 00:54:44.421057
NCT02023684|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-12-27|||January 2014||2014-01-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Routine Irrigation With Ropivacaine vs. Lidocaine vs. Saline of Surgical Bed in Sleeve Gastrectomy|Routine Irrigation With Ropivacaine vs. Lidocaine vs. Saline of Surgical Bed in Sleeve Gastrectomy|Unknown status|Not yet recruiting|N/A|90|Anticipated|The Baruch Padeh Medical Center, Poriya||3|||f||||t||||||||||2017-10-11 00:54:44.915808|2017-10-11 00:54:44.915808
NCT02023671|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-24|2013-12-24|||December 2013||2013-12-01|December 2013|2013-12-01||||December 2014|Anticipated|2014-12-01||Observational|||IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE||Unknown status|Active, not recruiting|N/A|70|Actual|Azienda Ospedaliera San Giovanni Battista|||1||f||||f||||||||||2017-10-11 00:54:45.031402|2017-10-11 00:54:45.031402
NCT02023658|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-01-24|||January 2014|Actual|2014-01-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Systems Analysis and Improvement to Optimize pMTCT|Systems Analysis and Improvement to Optimize pMTCT: A Cluster Randomized Trial|Completed||N/A|36|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 00:54:45.099519|2017-10-11 00:54:45.099519
NCT02023645|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-05-26|||January 2012||2012-01-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||The Effects of a Carotenoid Intervention on Cognitive Function|The Effects of a Lutein + Zeaxanthin Intervention on Cognitive Function and Neural Efficiency|Unknown status|Active, not recruiting|N/A|120|Anticipated|University of Georgia||2|||f||||f||||||||||2017-10-11 00:54:45.185285|2017-10-11 00:54:45.185285
NCT02023632|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-09-03|||January 2014||2014-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|GOAL||GrOup-based Physical Activity for oLder Adults Trial|A Self-categorization Theory Approach to Fostering Physical Activity Adherence Among Older Adults: A Randomized Controlled Feasibility Trial.|Completed||N/A|554|Actual|University of British Columbia||3|||f||||t||||||||||2017-10-11 00:54:45.274911|2017-10-11 00:54:45.274911
NCT02023619|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-23|||July 2013||2013-07-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Corneal Epithelial and Stromal Thickness Distribution in Keratoconus|Comparison of Corneal Epithelial and Stromal Thickness Distributions Between Eyes With Keratoconus and Healthy Eyes With Corneal Astigmatism >2.0 D|Completed||N/A|40|Actual|SynsLaser Kirurgi AS|||2||f||||t||||||||||2017-10-11 00:54:45.386069|2017-10-11 00:54:45.386069
NCT02023606|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-05-12|||November 2013||2013-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M|An Open-Label, Single-Dose, Mass-Balance Study to Assess the Absorption, Metabolism, and Excretion (AME) of [14C] Labeled SPN-810M in Healthy Adult Male Volunteers|Completed||Phase 1|7|Actual|Supernus Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:54:45.450355|2017-10-11 00:54:45.450355
NCT02023593|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-11-18|||March 2012||2012-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma|Phase Ⅱ Study of FOLFIRI as Second-Line Chemotherapy for Metastatic Esophageal Carcinoma|Recruiting||Phase 2|35|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:54:45.525691|2017-10-11 00:54:45.525691
NCT02023580|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-23|||June 2014||2014-06-01|December 2013|2013-12-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|Positive View||Scale-up of an Internet-Delivered Study for HIV+ Men|Scale-up of an Internet-Delivered Randomized Controlled Trial for HIV+ Men|Unknown status|Not yet recruiting|Phase 3|1500|Anticipated|Public Health Solutions||2|||f||||t||||||||||2017-10-11 00:54:45.618265|2017-10-11 00:54:45.618265
NCT02023567|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2016-05-18|||November 2013||2013-11-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Objective Diagnostic Markers and Personalized Intervention in MDD Patients|The Establishment of the Objective Diagnostic Markers and Personalized Medical Intervention in Patients With Major Depressive Disorders (MDD)|Recruiting||N/A|2400|Anticipated|Peking University||2|||f||||t||||||||Undecided|After enrollment completion,we will decided whether share data or not.|2017-10-11 00:54:45.694294|2017-10-11 00:54:45.694294
NCT02023554|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-08-18|||December 2013||2013-12-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Drug Interaction Study of Azithromycin and Theophylline|A Pharmacokinetic Drug Interaction Study to Evaluate the Effect of Azithromycin on the Steady-State Plasma Levels of Theophylline in a Chinese Population|Completed||N/A|40|Actual|Zhujiang Hospital||2|||f||||t||||||||||2017-10-11 00:54:45.800656|2017-10-11 00:54:45.800656
NCT02023541|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-04-03|||January 2014||2014-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Proton Beam Therapy to Treat Esophageal Cancer|A Phase I Study of Proton Beam Therapy in the Treatment of Esophageal Cancer|Terminated||Phase 1|3|Actual|Washington University School of Medicine||2||Lack of insurance coverage for proton beam treatment|f||||f||||||||||2017-10-11 00:54:45.871853|2017-10-11 00:54:45.871853
NCT02023528|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-08-09|||January 2008||2008-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Dialysis Registry in Utah|Dialysis Registry in Utah|Completed||N/A|243|Actual|University of Utah|||1||f||||f||||||Samples Without DNA|"     blood   "|||2017-10-11 00:54:45.949427|2017-10-11 00:54:45.949427
NCT02023515|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-05-03|2017-03-22||December 2013||2013-12-01|May 2017|2017-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Comparison of Two Programs for Weight Loss and Impact on Metabolic Syndrome|Comparison of Two Programs for Weight Loss and Impact on Metabolic Syndrome|Completed||N/A|49|Actual|University of Kentucky||2|||f||||f||||||||No||2017-10-11 00:54:46.001971|2017-10-11 00:54:46.001971
NCT02023502|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-12-23|||November 2013||2013-11-01|December 2013|2013-12-01||||April 2015|Anticipated|2015-04-01||Observational|||Proteomic Pattern in Female Stress Urinary Incontinence: a Pilot Study|Proteomic Pattern in Female Stress Urinary Incontinence: a Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 00:54:46.230056|2017-10-11 00:54:46.230056
NCT02023489|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-03-21|||July 2013||2013-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|RISC_7T||Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations|Myocardial Lipid and Glycogen Metabolism & Cardiac Function in Patients With Impaired Glucose Tolerance or Type 2 Diabetes Mellitus and Calcium Sensing Receptor Mutations - A Cross Sectional Magnetic Resonance Spectroscopy and Imaging Study|Recruiting||N/A|90|Anticipated|Medical University of Vienna||5|||f||||t||||||||No||2017-10-11 00:54:46.314146|2017-10-11 00:54:46.314146
NCT02023476|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-01-09|||April 2010||2010-04-01|January 2014|2014-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|HEM||Neurologic Examination of Wide and Narrow Tourniquets|Nerve Function in Healthy Human Volunteers With Two Different Tourniquets|Completed||N/A|18|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 00:54:46.481923|2017-10-11 00:54:46.481923
NCT02023463|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-07-25|||April 2, 2014|Actual|2014-04-02|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer|Phase Ib Trial of Enzalutamide in Combination With Radiation Therapy and LHRH Agonist Therapy in the Management of Intermediate and High-Risk Prostate Cancer|Active, not recruiting||Phase 1|25|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 00:54:46.546098|2017-10-11 00:54:46.546098
NCT02023450|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-09-04|||December 2013||2013-12-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|||Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension||Unknown status|Recruiting|Early Phase 1|20|Anticipated|The Third Xiangya Hospital of Central South University||2|||f||||t||||||||||2017-10-11 00:54:46.636921|2017-10-11 00:54:46.636921
NCT02023437|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-05-22|||December 2013||2013-12-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract Surgery|A Prospective, Post-Market-Clinical-Follow-Up Study to Investigate the Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract Surgery|Completed||Phase 4|132|Actual|Technolas Perfect Vision GmbH||2|||f||||f||||||||||2017-10-11 00:54:46.719697|2017-10-11 00:54:46.719697
NCT02023424|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-02-03|||January 2014||2014-01-01|February 2014|2014-02-01|February 2015|Anticipated|2015-02-01|September 2014|Anticipated|2014-09-01||Interventional|||An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome|An Open Label, Exploratory Study to Investigate the Treatment Effect og Glatiramer Acetate (Copaxone ®) on Girls Woth Rett Syndrome|Unknown status|Recruiting|Phase 1|10|Anticipated|Sheba Medical Center||1|||f||||t||||||||||2017-10-11 00:54:46.787274|2017-10-11 00:54:46.787274
NCT02023411|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-04-04|||January 2014||2014-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot|To Study the Efficacy of Teriparatide in Improving Remodeling of Foot Bones in Chronic Charcot Neuroarthropathy in Patients With Diabetes Mellitus.|Active, not recruiting||Phase 2|20|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 00:54:46.875685|2017-10-11 00:54:46.875685
NCT02023398|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-09-17|||September 2013||2013-09-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||BTL-9000 High Frequency Therapy for the Waist Circumferential Reduction|Evaluation of the Effectiveness of the BTL-9000 High Frequency Therapy for the Waist Circumferential Reduction|Completed||N/A|102|Actual|BTL Industries Ltd.||2|||f||||f||||||||||2017-10-11 00:54:46.950178|2017-10-11 00:54:46.950178
NCT02023372|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-09-14|||December 2013||2013-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine|NuTech NuCel®: A Prospective, Efficacy Study of NuCel® in Patients Undergoing Fusion for One, Two or Three Level Degenerative Disease of the Lumbar Spine.|Recruiting||N/A|60|Anticipated|NuTech Medical, Inc||1|||f||||f|t|f||||||||2017-10-11 00:54:47.088667|2017-10-11 00:54:47.088667
NCT02023359|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-12-26|||December 2013||2013-12-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer|Observational Study of Everolimus in Combination With Exemestane in Postmenopausal Patients With Hormone Receptor-positive, HER 2-negative Advanced Breast Cancer|Completed||N/A|7|Actual|Novartis|||1||f||||f||||||||||2017-10-11 00:54:47.173649|2017-10-11 00:54:47.173649
NCT02023346|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-02-07|||December 2013|Actual|2013-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Prognostic Awareness and Patient-Physician Communication in Malignant Glioma|Prognostic Awareness and Patient-Physician Communication in Malignant Glioma|Active, not recruiting||N/A|95|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 00:54:49.333495|2017-10-11 00:54:49.333495
NCT02023333|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-09-08|||December 2013||2013-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma|Phase II Study of Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma|Recruiting||Phase 2|12|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:54:49.40167|2017-10-11 00:54:49.40167
NCT02023320|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-08-07|||November 2013||2013-11-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effects of Blueberry Dry Powder on Glycemic Status in Subjects With Prediabetes|A Randomized, Double-blind, Parallel Group Study to Evaluate the Effect of Blueberry Dry Powder on Prediabetes|Completed||N/A|50|Anticipated|Hiroshima University||2|||f||||f||||||||||2017-10-11 00:54:49.509138|2017-10-11 00:54:49.509138
NCT02023307|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-08-31|||February 2014||2014-02-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Use of V-Loc Suture for Mid-face Lifting in Short-flap Rhytidectomy|Use of the V-Loc Suture for Mid-Face Lifting in Short-flap Rhytidectomy|Terminated||N/A|15|Actual|Lifestyle Lift||1||Clinic Closed|f||||t||||||||||2017-10-11 00:54:49.582971|2017-10-11 00:54:49.582971
NCT02023294|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-23|||April 2011||2011-04-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|GTLEND||Conventional Laparoscopic Sleeve Gastrectomy Versus Endograb-assisted Single-port Sleeve Gastrectomy|Prospective Randomized Clinical Trial Comparing COnventional Laparoscopic Sleeve Gastrectomy Versus Endograb-assisted Single-port Sleeve Gastrectomy|Completed||N/A|30|Actual|Hospitales Universitarios Virgen del Rocío||2|||f||||t||||||||||2017-10-11 00:54:49.657464|2017-10-11 00:54:49.657464
NCT02023268|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-08-22|2016-03-08||December 2013||2013-12-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome|Phase III: Comparison of the Efficacy and Safety of T2762 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome|Completed||Phase 3|105|Actual|Laboratoires Thea||2|||f||||f||||||||||2017-10-11 00:54:49.849579|2017-10-11 00:54:49.849579
NCT02023255|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-01-23|||January 2009||2009-01-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy Participants|A Double-Blind, Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-39393406 in Healthy Subjects|Completed||Phase 1|88|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||8|||f||||f||||||||||2017-10-11 00:54:50.125816|2017-10-11 00:54:50.125816
NCT02023242|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-05-09|||October 2012||2012-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|May 2015|Actual|2015-05-01||Interventional|COMPARE||Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes|A Prospective, Multicenter, Randomized Comparison of the Hydrus to the iStent® for Lowering Intraocular Pressure in Primary Open Angle Glaucoma|Active, not recruiting||N/A|152|Actual|Ivantis, Inc.||2|||f||||f||||||||||2017-10-11 00:54:50.360816|2017-10-11 00:54:50.360816
NCT02023229|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2013-12-23|||January 2011||2011-01-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis|High-fiber High-fiber Diet and Branched Chain Aminoacids. Impact on Nutritional Status and Complications in Patients With Liver Cirrhosis|Completed||Phase 4|68|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-11 00:54:50.453218|2017-10-11 00:54:50.453218
NCT02023216|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-10-13|||May 2013||2013-05-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|NNS-GER-SO||Effects of Non-Nutritive Sucking on Gastroesophageal Reflux and Related Apneas in Symptomatic Preterm Infants|Effects of Non-nutritive Sucking on Gastroesophageal Reflux, Apneas and Bradycardias in Symptomatic Preterm Infants.|Completed||N/A|30|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||f||||||||||2017-10-11 00:54:50.539865|2017-10-11 00:54:50.539865
NCT02023203|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2013-12-23|||January 2011||2011-01-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|October 2012|Actual|2012-10-01||Interventional|PTFE||Efficacy of Macroporous Polytetrafluoroethylene Mesh in Laparoscopic Hernia Repair|Prospective Randomized Clinical Trial Comparing Microporous Polypropylene Mesh and Flexible Macroporous Polytetrafluoroethylene Mesh in Totally Extraperitoneal Laparoscopic Inguinal Hernia Repair|Completed||N/A|100|Actual|Hospitales Universitarios Virgen del Rocío||2|||f||||f||||||||||2017-10-11 00:54:50.681297|2017-10-11 00:54:50.681297
NCT02023190|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-06-07|||January 2016||2016-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation|Changes in Body Composition and Nutritional Status Assessed by Bioelectrical Impedance Vector Analysis in Cirrhotic Patients Undergoing Liver Transplantation|Recruiting||N/A|60|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||f||||||||||2017-10-11 00:54:50.792904|2017-10-11 00:54:50.792904
NCT02023177|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-11-14|||January 2008||2008-01-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Observational|||Phase Angle and Mortality in Patients With Cirrhosis|Phase Angle as a Nutritional Marker Related to Prognosis Inpatients With Cirrhosis: A Cutt-off Value for Mexican Population|Completed||N/A|249|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||f||||||||||2017-10-11 00:54:50.885987|2017-10-11 00:54:50.885987
NCT02023164|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-04-03|||July 2013||2013-07-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Multicenter Pilot Phase III Clinical Trials of JDP-205 iv Injection for the Treatment of Acute Urticaria Associated With an Acute Allergic Reaction.||Completed||Phase 3|36|Actual|JDP Therapeutics, Inc.||2|||f||||||||||||||2017-10-11 00:54:50.963182|2017-10-11 00:54:50.963182
NCT02023138|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-23|||January 2014||2014-01-01|December 2013|2013-12-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Evaluation of the Acceptability, Feasibility and Effectiveness of Two Methods of Involvement of Patients With Cognitive Disability in Clinical Guidelines Development: a Randomized Crossover Pilot Trial|Evaluation of the Acceptability, Feasibility and Effectiveness of Two Methods of Involvement of Patients With Cognitive Disability in Clinical Guidelines Development: a Randomized Crossover Pilot Trial|Unknown status|Not yet recruiting|N/A|20|Anticipated|Laval University||2|||f||||f||||||||||2017-10-11 00:54:51.1361|2017-10-11 00:54:51.1361
NCT02023125|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-08-16|2016-08-16||December 2013||2013-12-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Safety Analysis Set consisted of all participants who received at least 1 dose of study drug and had at least 1 after dosing safety assessment.|A Study Investigating the Effect of Food and Esomeprazole on the Single Oral Dose Pharmacokinetics of Alectinib (RO5424802) in Healthy Volunteers.|An Open-Label, Two-Group Study to Investigate the Effect of Food (Group 1) and Esomeprazole (Group 2) on the Single Oral Dose Pharmacokinetics of RO5424802 in Healthy Subjects|Completed||Phase 1|42|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:54:51.274443|2017-10-11 00:54:51.274443
NCT02023112|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-09-13|2016-04-07||January 2014||2014-01-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|GIFT-II||Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection|An Open-label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) Co-administered With Ribavirin (RBV) for 12 or 16 Weeks in Treatment-Naïve and Treatment-Experienced Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection With and Without Compensated Cirrhosis (GIFT-II)|Completed||Phase 3|171|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 00:54:52.260159|2017-10-11 00:54:52.260159
NCT02023099|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-09-28|2015-10-27||December 2013||2013-12-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|GIFT I||Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection|A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Treatment-Naïve and Treatment-Experienced Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection With and Without Compensated Cirrhosis (GIFT I)|Completed||Phase 3|363|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 00:54:53.953642|2017-10-11 00:54:53.953642
NCT02023086|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-01|||August 2014||2014-08-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01|2 Years|Observational [Patient Registry]|||Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients|Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Relation With Visual Field Loss in Fabry Patients|Completed||N/A|8|Actual|Université de Montréal|||2||f||||f||||||||||2017-10-11 00:54:55.048227|2017-10-11 00:54:55.048227
NCT02023073|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-01-01|||January 2017||2017-01-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01|1 Day|Observational [Patient Registry]|||Determination of Physical Parameters Relevant to Ophthalmic Lasers|Study of Physical Parameters Related to Laser Radiation and Its Interaction With Different Parts of the Human Eye|Not yet recruiting||N/A|20|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:54:55.168366|2017-10-11 00:54:55.168366
NCT02023060|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-05-18|||November 2013||2013-11-01|May 2016|2016-05-01||||November 2020|Anticipated|2020-11-01|1 Year|Observational [Patient Registry]|||Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation||Recruiting||N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:54:55.230792|2017-10-11 00:54:55.230792
NCT02023047|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-11-15|||March 2014||2014-03-01|January 2015|2015-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing|An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing|Terminated||Phase 1/Phase 2|33|Actual|RDD Pharma Ltd||2||Met primary endpoint|f||||f||||||||||2017-10-11 00:54:55.31559|2017-10-11 00:54:55.31559
NCT02023034|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2015-10-04|||February 2013||2013-02-01|December 2013|2013-12-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Virtual Exercises in Patients With Parkinson's Disease.|EFFECTIVENESS OF VIRTUAL EXERCISES ON THE FUNCTIONAL EXERCISE CAPACITY, FATIGUE AND QUALITY OF LIFE IN PATIENTS WITH PARKINSON'S DISEASE: A RANDOMIZED CLINICAL TRIAL|Completed||Phase 4|20|Actual|Faculdade Evangelica do Parana||2|||f||||f||||||||||2017-10-11 00:54:55.411674|2017-10-11 00:54:55.411674
NCT02023021|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-08-10|||January 2014||2014-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection|A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Nab-paclitaxel and Gemcitabine in Treating Patients With Pancreatic Cancer After Curative Resection|Recruiting||Phase 2|80|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-11 00:54:55.499332|2017-10-11 00:54:55.499332
NCT02023008|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-07-28|||May 2014|Actual|2014-05-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy|Convenient and Live Movement (CALM): Feasibility of Interactive Gentle Yoga for Women With Breast Cancer|Terminated||N/A|6|Actual|Wake Forest University Health Sciences||1||Study is not feasible|f||||f|f|f||||||||2017-10-11 00:54:55.615194|2017-10-11 00:54:55.615194
NCT02022995|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2016-08-01|||January 2014||2014-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients|Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients|Completed||N/A|180|Actual|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 00:54:55.740687|2017-10-11 00:54:55.740687
NCT02022982|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2017-05-19|||January 2014||2014-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|August 2017|Anticipated|2017-08-01||Interventional|||PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors|Phase I/II Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor PD-0325901 for Patients With KRAS Mutant Non-Small Cell Lung Cancer and Other Solid Tumors|Recruiting||Phase 1/Phase 2|139|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:54:55.815061|2017-10-11 00:54:55.815061
NCT02022969|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2017-08-28|||January 1, 2018|Anticipated|2018-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|MAS||Detection of SpO2-oscillations of Low Ventilated Areas|Detection of SpO2-oscillations Caused by Cyclic Recruitment and Derecruitment of Low Ventilated Areas in the Lung (Atelectasis) During Mechanical Ventilation|Not yet recruiting||N/A|40|Anticipated|Medical University of Vienna|||1||f||||t||||||None Retained|"     Spo2 Ventilation   "|||2017-10-11 00:54:55.940218|2017-10-11 00:54:55.940218
NCT02022956|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2014-03-28|||December 2013||2013-12-01|March 2014|2014-03-01||||December 2013|Actual|2013-12-01||Interventional|||Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age|An Open-label, Single-dose Study to Assess the Safety, Tolerability and Pharmacokinetic Properties of BELVIQ in Obese Adolescent Subjects Ages 12-17 (Inclusive)|Completed||Phase 1|8|Anticipated|Arena Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:54:56.018567|2017-10-11 00:54:56.018567
NCT02022943|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-11-18|||May 2012||2012-05-01|November 2016|2016-11-01|January 2030|Anticipated|2030-01-01|January 2030|Anticipated|2030-01-01|16 Years|Observational [Patient Registry]|APR||Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies|Alzheimer's Prevention Registry|Recruiting||N/A|500000|Anticipated|Banner Health|||1||f||||f||||||||||2017-10-11 00:54:56.219277|2017-10-11 00:54:56.219277
NCT02022930|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-23|2016-08-24|||January 2014||2014-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Hydros and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis|A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated With Osteoarthritis in the Knee|Completed||Phase 3|510|Anticipated|Carbylan Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 00:54:56.31304|2017-10-11 00:54:56.31304
NCT02022917|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-23|||February 2014||2014-02-01|December 2013|2013-12-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer|A Phase II Trial of Postoperative Chemotherapy Plus Adjuvant and Maintenance Bevacizumab After Neoadjuvant Chemotherapy Followed by Interval Surgery in Patients With Extensive Stage IIIC or IV Ovarian, Tubal, and Peritoneal Cancer|Unknown status|Enrolling by invitation|Phase 2|27|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 00:54:56.424246|2017-10-11 00:54:56.424246
NCT02022904|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-07-28|||May 2012||2012-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology|Development of a Novel Method to Detect Prostate Cancer Circulating Tumor Cells (CTCs) Based on Epithelial-mesenchymal Transition Biology|Withdrawn||N/A|0|Actual|Duke University||1|||f||||f||||||||||2017-10-11 00:54:56.532948|2017-10-11 00:54:56.532948
NCT02022891|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-08-05|||January 2013||2013-01-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|Drépano||Systematic Psychological and Medical Care for Children With SCD|The Impact of Systematic Psychological and Medical Care for Treatment of Pediatric Patients With SCD: : A Luxury or a Necessity?|Completed||N/A|160|Anticipated|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||f||||||||||2017-10-11 00:54:56.606876|2017-10-11 00:54:56.606876
NCT02022878|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2014-07-30|||December 2013||2013-12-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|CT-RECTOR||Computed Tomography Angiography Prediction Score for Percutaneous Revascularization of Chronic Total Occlusions|Development of Computed Tomography Angiography Prediction Score for Percutaneous Revascularization of Chronic Total Occlusions: Multicenter CT-RECTOR Registry|Completed||N/A|229|Actual|Kerckhoff Heart Center|||1||f||||f||||||||||2017-10-11 00:54:56.694471|2017-10-11 00:54:56.694471
NCT02022865|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-23|||January 2014||2014-01-01|December 2013|2013-12-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Observational|||Correlation Between Inflammatory Markers in Gingival Crevicular Fluid, Serum and Amniotic Fluids in Periodontal Pregnant Women|Correlation Between Inflammatory Markers in Gingival Crevicular Fluid, Serum and Amniotic Fluids in Periodontal Pregnant Women|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||2||f||||f||||||Samples With DNA|"     gingival crevicular fluid, serum, aminiotic fluid   "|||2017-10-11 00:54:56.793664|2017-10-11 00:54:56.793664
NCT02022852|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-23|||July 2013||2013-07-01|December 2013|2013-12-01|January 2018|Anticipated|2018-01-01|July 2015|Anticipated|2015-07-01||Interventional|||Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer|Efficacy and Safety of Neoadjuvant Chemo-chemoradio-chemo Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer: a Phase II Trial|Recruiting||Phase 2|80|Anticipated|Harbin Medical University||2|||f||||f||||||||||2017-10-11 00:54:56.858408|2017-10-11 00:54:56.858408
NCT02022839|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2013-12-22|||December 2010||2010-12-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|2 Days|Observational [Patient Registry]|||Role of Lung Ultrasound in Predicting Weaning Outcomes|B-lines at Lung Ultrasound Predicts Weaning Failure From Mechanical Ventilation|Completed||N/A|250|Actual|Hospital Moinhos de Vento|||1||f||||f||||||||||2017-10-11 00:54:56.973189|2017-10-11 00:54:56.973189
NCT02022813|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-02-03|||April 2014|Actual|2014-04-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Interventional|SPN2||Impact of Supplemental Parenteral Nutrition in ICU Patients on Metabolic, Inflammatory and Immune Responses|Impact of Supplemental Parenteral Nutrition (SPN) on Energy Balance, and Infection Rate in Intensive Care Patients: Underlying Metabolic, Inflammatory and Immune Mechanisms.|Active, not recruiting||N/A|28|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 00:54:57.181222|2017-10-11 00:54:57.181222
NCT02022800|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-07-25|||November 2013||2013-11-01|November 2015|2015-11-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|IMOTEP||Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)|Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET) in a Multidisciplinary Meeting Therapeutic Proposal When Caring for Patients Diagnosed Primary or Secondary Cerebral Tumors|Completed||N/A|85|Actual|Centre Antoine Lacassagne||1|||f||||t||||||||||2017-10-11 00:54:57.291933|2017-10-11 00:54:57.291933
NCT02022787|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-03-04|||January 2014||2014-01-01|March 2015|2015-03-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Value of Various Chemokines in the Detection and Follow up of RCC|Value of Various Chemokines in the Detection and Follow up of RCC|Unknown status|Recruiting|N/A|30|Anticipated|Carmel Medical Center|||1||f||||f||||||Samples Without DNA|"     Renal tumor tissue and patients' serum   "|||2017-10-11 00:54:57.392635|2017-10-11 00:54:57.392635
NCT02022774|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-09-21|||April 2012||2012-04-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Observational|STIFFNESS||Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion|A Single-arm, Open, Clinical Study to Evaluate the Effects of Fimasartan on Arterial Stiffness in Patients With Hypertension|Active, not recruiting||N/A|90|Actual|Boryung Pharmaceutical Co., Ltd|||1||f||||t||||||||||2017-10-11 00:54:57.492404|2017-10-11 00:54:57.492404
NCT02022761|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2015-02-03|||October 2013||2013-10-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate in Adults With Chronic Asthma|Completed||Phase 1|32|Actual|Aviragen Therapeutics||3|||f||||f||||||||||2017-10-11 00:54:57.58121|2017-10-11 00:54:57.58121
NCT02022748|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-22|2017-05-05|2017-05-05||December 29, 2013|Actual|2013-12-29|May 2017|2017-05-01|May 9, 2016|Actual|2016-05-09|May 9, 2016|Actual|2016-05-09||Interventional||All 14 randomized HD subjects after eligibility re-assessment (8 in Sequence 1 (AB) and 6 in Sequence 2 (BA)) and 13 eligibile HS are used for baseline analysis.|Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects|A Single Dose, Randomized, Open-Label, Parallel Group Study Comparing the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Ticagrelor in Hemodialyisis Patients to Subjects With Normal Renal Function|Completed||Phase 1|56|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:54:57.718512|2017-10-11 00:54:57.718512
NCT02022735|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-12-06|||September 2013||2013-09-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease|Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease.|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Miami||4|||f||||f||||||||||2017-10-11 00:54:58.324537|2017-10-11 00:54:58.324537
NCT02022709|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2017-04-25|||January 2014||2014-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients|Efficacy of Exposure and Response Prevention（ERP） and SSRIs, and Its Predictors in Obsessive-Compulsive Disorder|Recruiting||Phase 4|60|Anticipated|Shanghai Mental Health Center||2|||f||||f||||||||||2017-10-11 00:54:58.561417|2017-10-11 00:54:58.561417
NCT02022696|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-09-26|||December 16, 2013||2013-12-16|September 21, 2017|2017-09-21|September 21, 2017|Actual|2017-09-21|December 16, 2013|Actual|2013-12-16||Interventional|||Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector|Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector|Completed||Phase 1|1|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:54:58.701193|2017-10-11 00:54:58.701193
NCT02022683|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-04-06|||December 2013||2013-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Interventional|TRANSFORM||To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr EBV|A Multi-center, Prospective, Randomized, Controlled Trial of Endobronchial Valve Therapy vs. Standard of Care in Heterogeneous Emphysema|Active, not recruiting||N/A|97|Actual|Pulmonx, Inc.||2|||f||||f||||||||||2017-10-11 00:54:58.779605|2017-10-11 00:54:58.779605
NCT02022670|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2015-06-18|2015-03-12||October 2011||2011-10-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Sodium Nitrite to Treat Arterial Aging|Clinical Translation of Nitrite Therapy to Treat Arterial Aging in Humans|Completed||Phase 1/Phase 2|33|Actual|University of Colorado, Boulder||3|||f||||t||||||||||2017-10-11 00:54:58.900817|2017-10-11 00:54:58.900817
NCT02022657|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-04-25|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|DOT-DBS||Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots|PrEP Adherence Monitoring Using Dried Blood Spots|Completed||Phase 1/Phase 2|34|Actual|University of Colorado, Denver||6|||f||||t||||||||No|No plan to share IPD|2017-10-11 00:54:59.215201|2017-10-11 00:54:59.215201
NCT02022644|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-05-04|||February 2014||2014-02-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Interventional|||Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma|A Phase I Study of Convection-Enhanced Delivery of Liposomal-Irinotecan Using Real-Time Imaging With Gadolinium In Patients With Recurrent High Grade Glioma|Enrolling by invitation||Phase 1|30|Anticipated|University of California, San Francisco||4|||f||||t||||||||||2017-10-11 00:54:59.300684|2017-10-11 00:54:59.300684
NCT02022631|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2013-12-21|||December 2013||2013-12-01|December 2013|2013-12-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|||New Alternative Formats vs Standard of SoF Tables. Non-inferiority Randomized Controlled Trial|Comparison Between Standard and New Alternative Formats of the Summary-of-Findings Tables in Cochrane Review Users. A Non-inferiority Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|300|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 00:54:59.498908|2017-10-11 00:54:59.498908
NCT02022618|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-09-22|||October 2013||2013-10-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|LOD-HTA||Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects|Target Organ Damage and Blood Pressure, Retinal Vessels, Oxidative Stress and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects (LOD-Hypertension)|Completed||N/A|454|Actual|Fundacion para la Investigacion y Formacion en Ciencias de la Salud|||1||f||||f||||||Samples With DNA|"     Human biospecimens used will be collected, stored, used, shared, and disposed of in     accordance with the informed consent signed by the subject, or under a waiver of informed     consent granted by an independent ethical review body, in accordance to Spanish Law (Ley     Orgánica de Protección de Datos de Carácter Personal (15/1999 del 13 de Diciembre, LOPD), y     en las condiciones que marca la Ley 14/2007 de investigación biomédica) of Protection of     Human Subjects.   "|||2017-10-11 00:54:59.576197|2017-10-11 00:54:59.576197
NCT02022605|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-21|2016-06-08|||December 2013||2013-12-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ERCP||Effect of Continuously Coached Practice Using EMS on ERCP Performance of Trainees|Effect of Continuously Coached Practice Using EMS on ERCP Performance of Trainees: a Prospectively Randomized, Controlled Study|Suspended||N/A|400|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 00:54:59.653398|2017-10-11 00:54:59.653398
NCT02022592|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-08-10|||June 2014||2014-06-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care|Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care|Recruiting||Phase 4|80|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:54:59.738134|2017-10-11 00:54:59.738134
NCT02022579|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-06-26|||January 2014||2014-01-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|ACRIN6702||DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer|A Multi-Center Study Evaluating the Utility of Diffusion Weighted Imaging for Detection and Diagnosis of Breast Cancer|Active, not recruiting||N/A|100|Anticipated|American College of Radiology Imaging Network||1|||f||||t||||||||Yes|see ACRIN data sharing policy : https://www.acrin.org/RESEARCHERS/POLICIES/DATAANDIMAGESHARINGPOLICY.aspx|2017-10-11 00:54:59.864924|2017-10-11 00:54:59.864924
NCT02022566|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-27|||April 2009||2009-04-01|December 2013|2013-12-01|September 2014|Anticipated|2014-09-01|April 2014|Anticipated|2014-04-01|12 Months|Observational [Patient Registry]|||The Effect of Structured Information and Individually Adapted Exercise on Levels of Physical Activity Measured by Accelerometer in Patients With Knee or Hip Osteoarthritis|The Effect of Structured Information and Individually Adapted Exercise on Levels of Physical Activity Measured by Accelerometer in Patients With Knee or Hip Osteoarthritis - an Observational Study With Control Group.|Unknown status|Recruiting|N/A|150|Anticipated|Lund University|||1||f||||||||||||||2017-10-11 00:54:59.965543|2017-10-11 00:54:59.965543
NCT02022553|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-27|||February 2006||2006-02-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Interventional|RACHEL||Procedure RACHEL in Complex Treatment of Rectal Cancer|Complex Treatment of Rectal Cancer|Unknown status|Active, not recruiting|N/A|50|Anticipated|Voronezh N.N. Burdenko State Medical Academy||2|||f||||t||||||||||2017-10-11 00:55:00.058346|2017-10-11 00:55:00.058346
NCT02022540|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-09-27|||February 2014||2014-02-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD|A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)|Completed||Phase 1|50|Actual|PanOptica, Inc.||6|||f||||t||||||||Undecided||2017-10-11 00:55:00.135443|2017-10-11 00:55:00.135443
NCT02022527|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2013-12-26|||June 2013||2013-06-01|December 2013|2013-12-01||||July 2014|Anticipated|2014-07-01||Interventional|HVP||Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis|Cost Effectiveness Analysis for Combination Of Aspirin And Warfarin Versus Warfarin Alone In Egyptian Patients With Heart Valve Prosthesis|Unknown status|Recruiting|Phase 4|300|Anticipated|Pharmacoeconomic Unit, Egypt||2|||f||||t||||||||||2017-10-11 00:55:00.280647|2017-10-11 00:55:00.280647
NCT02022514|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-04-11|||November 2013||2013-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.|Phase IIb Clinical Trial, Unicentric, Open, Randomized and Controlled to Assess the Effectiveness of Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.|Recruiting||Phase 2/Phase 3|66|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||f||||||||||2017-10-11 00:55:00.385363|2017-10-11 00:55:00.385363
NCT02022501|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-05-12|||January 2014||2014-01-01|May 2017|2017-05-01|April 21, 2016|Actual|2016-04-21|April 21, 2016|Actual|2016-04-21||Interventional|||A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration|A Phase I/II, Open-label, Dose-escalating, Sequential-cohort Study Assessing the Safety, Tolerability, Pharmacokinetics and Bioactivity of a Single Intravitreal Injection of DE-120 Injectable Solution for the Treatment of Late Stage Exudative Age-related Macular Degeneration|Completed||Phase 1/Phase 2|10|Actual|Santen Inc.||3|||f||||f||||||||||2017-10-11 00:55:00.479065|2017-10-11 00:55:00.479065
NCT02022488|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-26|||February 2012||2012-02-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Sevoflurane Induced Emergence Agitation|Prevention of Emergence Agitation in Children After Sevoflurane Anesthesia With Ketamine-midazolam Combination: A Prospective Randomized Clinical Trial|Completed||Phase 4|78|Actual|Yeditepe University Hospital||3|||f||||f||||||||||2017-10-11 00:55:00.564368|2017-10-11 00:55:00.564368
NCT02022475|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2015-07-20|||December 2013||2013-12-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Vitamin D Treatment on Fatigue|Effect of Peroral Vitamin D Versus Placebo on Self-reported Fatigue in Adults With Low 25-hydroxy-vitamin D Levels|Completed||Phase 3|120|Actual|University of Zurich||2|||f||||t||||||||||2017-10-11 00:55:00.654915|2017-10-11 00:55:00.654915
NCT02022462|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-04-06|||April 2014|Actual|2014-04-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|September 2015|Actual|2015-09-01||Interventional|Bridge||Project Bridge: Peer Health Navigator Intervention|"A Randomized Controlled Trial of The Bridge, a Peer Health Navigation Intervention"|Active, not recruiting||N/A|151|Actual|University of Southern California||2|||f||||f||||||||No||2017-10-11 00:55:00.76248|2017-10-11 00:55:00.76248
NCT02022436|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-10-04|||May 2012|Actual|2012-05-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Evaluation of Predictors of Aortic Aneurysm Growth and Rupture|Aortic Wall Behavior as a Predictor of Aortic Aneurysm Growth and Rupture|Recruiting||Phase 2|75|Anticipated|University of Pittsburgh||2|||f||||t|t|f|||t|||||2017-10-11 00:55:00.949447|2017-10-11 00:55:00.949447
NCT02022423|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-02-07|||September 2014||2014-09-01|February 2017|2017-02-01||||June 2018|Anticipated|2018-06-01||Interventional|PAD||Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease|Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease|Recruiting||N/A|200|Anticipated|University of Michigan||4|||f||||f||||||||||2017-10-11 00:55:01.058098|2017-10-11 00:55:01.058098
NCT02022410|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-06-01|||September 2013||2013-09-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01|1 Year|Observational [Patient Registry]|||CAS and Length of Hospital Stay After TKA|Cumulated Ambulation Score and Length of Hospital Stay After TKA|Completed||N/A|73|Actual|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 00:55:01.160408|2017-10-11 00:55:01.160408
NCT02022397|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-08-06|||March 2012||2012-03-01|August 2015|2015-08-01||||December 2016|Anticipated|2016-12-01|1 Day|Observational [Patient Registry]|PeScho||Automated Assessment of Difficult Airway With Facial Recognition Techniques|Automatic Assessment of Difficult Ventilation and Intubation From Automatic Face Analysis and Artificial Intelligence|Unknown status|Recruiting|N/A|6000|Anticipated|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 00:55:01.236521|2017-10-11 00:55:01.236521
NCT02022384|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-11-24|||December 2013||2013-12-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Observational|||Immunophenotyping From Blood of Patients With Malignant Gliomas|Immunophenotyping From Blood From Patients With Glioblastoma and Anaplastic Astrocytoma Before and During Chemoradiation as Well as During Adjuvant Chemotherapy|Recruiting||N/A|50|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||Samples With DNA|"     whole blood, serum, plasma   "|||2017-10-11 00:55:01.318646|2017-10-11 00:55:01.318646
NCT02022371|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2017-05-08|||September 2014|Actual|2014-09-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PROGENY||Prostate Cancer Genomic Heterogeneity||Completed||Phase 1/Phase 2|50|Actual|University College London Hospitals||1|||f||||||||||||||2017-10-11 00:55:01.457016|2017-10-11 00:55:01.457016
NCT02022358|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-06-03|||July 2007||2007-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?|A Randomised, Cross-over Phase II Study to Investigate the Efficacy and Safety of Glucarpidase for Routine Use After High Dose Methotrexate in Patients With Bone Sarcoma|Terminated||Phase 2|34|Actual|University College, London||2||Recruitment almost complete, has been slow and challenging|f||||t||||||||||2017-10-11 00:55:01.577539|2017-10-11 00:55:01.577539
NCT02022345|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-05-24|||August 2010||2010-08-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|PCI-CAMPOS||Safety and Efficacy of PCI at California Hospitals Without Onsite Cardiac Surgery|PCI California Audit Monitored Pilot With Offsite Surgery|Completed||N/A|5609|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 00:55:01.721201|2017-10-11 00:55:01.721201
NCT02022319|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2016-04-08|||November 2013||2013-11-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Observer Variation of Shear Wave Elastography|Intra- and Inter-observer Variation of Thyroid Shear Wave Elastography - a Variability Study|Completed||N/A|72|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 00:55:01.866745|2017-10-11 00:55:01.866745
NCT02022306|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-09-25|||February 2014||2014-02-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||TD-6450 SAD and MAD in Healthy Subjects|A Double-Blinded, Randomized, Placebo-Controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of TD-6450, a NS5A Inhibitor, in Healthy Subjects|Completed||Phase 1|111|Actual|Theravance Biopharma R & D, Inc.||3|||f||||f||||||||||2017-10-11 00:55:01.948805|2017-10-11 00:55:01.948805
NCT02022293|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-05-05|||January 2017|Actual|2017-01-01|May 2017|2017-05-01|January 2024|Anticipated|2024-01-01|December 2023|Anticipated|2023-12-01||Interventional|||Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis|Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis: A Multicenter, Double-blind, Placebo-Controlled, Randomized Trial|Recruiting||Phase 2|324|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:55:02.049055|2017-10-11 00:55:02.049055
NCT02022280|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-02-27|||March 2013||2013-03-01|February 2014|2014-02-01||||May 2014|Anticipated|2014-05-01||Interventional|PPI||Effect of Proton Pump Inhibitors on Endothelial Function|Do Proton Pump Inhibitors (PPIs) Increase Cardiovascular Risk? Effect of PPIs on Endothelial Function and ADMA.|Unknown status|Recruiting|Phase 1|20|Anticipated|Stanford University||2|||f||||||||||||||2017-10-11 00:55:02.199727|2017-10-11 00:55:02.199727
NCT02022267|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-20|||October 2011||2011-10-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|February 2012|Actual|2012-02-01||Observational|||Gait Analysis in Ponseti Clubfoot|Results of Gait Analysis Including Oxford Foot Model in Children With Clubfoot Treated With the Ponseti Method|Completed||N/A|51|Actual|Orthopedic Hospital Vienna Speising|||2||f||||f||||||||||2017-10-11 00:55:02.32584|2017-10-11 00:55:02.32584
NCT02022254|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-03-31|||December 17, 2013|Actual|2013-12-17|March 2017|2017-03-01|August 28, 2014|Actual|2014-08-28|August 28, 2014|Actual|2014-08-28||Interventional|||Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects|An Open-label, One-sequence Cross Over, Single Centre Trial, Investigating the Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects|Completed||Phase 1|24|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 00:55:02.438497|2017-10-11 00:55:02.438497
NCT02022241|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2013-12-20|||July 2012||2012-07-01|December 2013|2013-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome|Repeated Injection of GnRH Agonist for Triggering Final Oocyte Maturation in Patients at High Risk of Ovarian Hyperstimulation Syndrome in GnRH Antagonist Protocol|Unknown status|Recruiting|N/A|80|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||f||||||||||2017-10-11 00:55:02.571|2017-10-11 00:55:02.571
NCT02022228|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2013-12-20|||July 2012||2012-07-01|October 2013|2013-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome|Dual Trigger With GnRH Agonist and Human Chorionic Gonadotropin for Final Oocyte Maturation in Patients at High Risk of Ovarian Hyperstimulation Syndrome in GnRH Antagonist Protocol|Unknown status|Recruiting|N/A|200|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||f||||||||||2017-10-11 00:55:02.718771|2017-10-11 00:55:02.718771
NCT02022215|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2017-03-22|||December 19, 2013|Actual|2013-12-19|March 2017|2017-03-01|March 1, 2016|Actual|2016-03-01|October 28, 2015|Actual|2015-10-28||Interventional|||Efficacy and Safety Study of ME1111 in Patients With Onychomycosis|A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of ME1111 in Patients With Mild to Moderate Onychomycosis|Completed||Phase 2|304|Actual|Meiji Seika Pharma Co., Ltd.||3|||f||||f||||||||||2017-10-11 00:55:02.838052|2017-10-11 00:55:02.838052
NCT02022202|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-03-21|||February 2013|Actual|2013-02-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BEAUTY||Breast Cancer Genome Guided Therapy Study (BEAUTY)|Breast Cancer Genome Guided Therapy Study (BEAUTY)|Active, not recruiting||N/A|200|Anticipated|Mayo Clinic|||1||f||||t||||||Samples With DNA|"     Breast cancer tissue and blood specimens   "|||2017-10-11 00:55:02.975099|2017-10-11 00:55:02.975099
NCT02022189|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2015-09-19|||October 2013||2013-10-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Review of Kidney Biopsies of Dent Disease Patients|Systematic Review of Clinical Biopsies of Dent Disease Patients|Completed||N/A|20|Anticipated|Mayo Clinic|||1||f||||t||||||||||2017-10-11 00:55:03.06231|2017-10-11 00:55:03.06231
NCT02022176|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-01-02|||March 2008||2008-03-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Modulation of Metabolic Rate by Inorganic Nitrate|Dietary Inorganic Nitrate: Effects on Metabolic Rate, Reactive Oxygen Species Production, Glucose Uptake and Primary Myotube Respiration.|Completed||N/A|55|Actual|Karolinska Institutet||4|||f||||||||||||||2017-10-11 00:55:03.167764|2017-10-11 00:55:03.167764
NCT02022163|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-09-24|||December 2013||2013-12-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.|Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.|Completed||Phase 1|100|Actual|Medicago||5|||f||||t||||||||||2017-10-11 00:55:03.281495|2017-10-11 00:55:03.281495
NCT02022150|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-06-07|||December 2012||2012-12-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|Paracentesis||Body Composition Analysis in Cirrhotic Undergoing Paracentesis|Body Composition Analysis in Cirrhotic Patients With Ascites Undergoing Paracentesis Paracentesis|Recruiting||N/A|20|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||t||||||||||2017-10-11 00:55:03.588853|2017-10-11 00:55:03.588853
NCT02022137|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-06-07|||October 2013||2013-10-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|August 2015|Actual|2015-08-01||Interventional|||Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy|Evaluation of the Effect of a Cereal Bar With Added Agave Fructans or Lactitol or Lactose, in Patients With Minimal Hepatic Encephalopathy|Completed||N/A|30|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||3|||f||||t||||||||||2017-10-11 00:55:03.718818|2017-10-11 00:55:03.718818
NCT02022124|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-01-21|||November 2013||2013-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Open Label Placebo in the Treatment of Low Back Pain|Open Label Placebo in the Treatment of Low Back Pain|Completed||Phase 2|83|Actual|Hospital de Egas Moniz||2|||f||||t||||||||||2017-10-11 00:55:03.816929|2017-10-11 00:55:03.816929
NCT02022111|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-07-11|||March 2014||2014-03-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|INDEPENDENT||INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) Study|INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) Study|Active, not recruiting||N/A|488|Actual|Emory University||2|||f||||t||||||||||2017-10-11 00:55:03.904362|2017-10-11 00:55:03.904362
NCT02022098|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-09-22|||October 2013||2013-10-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial|A Phase I/II Randomized Study to Determine the Maximum Tolerated Dose, Safety, Pharmacokinetics and Antitumor Activity of Debio 1143 Combined With Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.|Active, not recruiting||N/A|118|Anticipated|Debiopharm International SA||2|||f||||t||||||||||2017-10-11 00:55:04.019548|2017-10-11 00:55:04.019548
NCT02022085|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-03|2016-08-24||June 2014||2014-06-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|February 2016|Actual|2016-02-01||Interventional||ITT population, includes all subjects who received the surgical intervention.|Post-market Clinical Follow-up of a Magnetic Bone Conduction Implant (Cochlear Baha Attract System)|Post-market Clinical Follow-up of a Magnetic Bone Conduction Implant (Cochlear Baha Attract System)|Active, not recruiting||N/A|54|Actual|Cochlear Bone Anchored Solutions||1|||f||||f||||||||||2017-10-11 00:55:04.238906|2017-10-11 00:55:04.238906
NCT02022072|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-07-27|||May 2013||2013-05-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|CVassist||Evaluation of Vital Capacity|Measurement of Assisted Vital Capacity to Appreciate the Level of Recruitment in Neuromuscular Diseases|Terminated||Phase 2|66|Actual|Centre d'Investigation Clinique et Technologique 805||1||With 50 patients, the measure of assist vital capacity has been validated|f||||f||||||||||2017-10-11 00:55:05.277164|2017-10-11 00:55:05.277164
NCT02022059|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2013-12-26|||December 2013||2013-12-01|December 2013|2013-12-01|May 2015|Anticipated|2015-05-01|January 2015|Anticipated|2015-01-01||Interventional|Xylonut||Prospective Monocentric Study on the Efficacy of Lidocain Spray for Patient Comfort During Nasogastric Tube Insertion in Enteral Nutrition|Prospective Monocentric Study on the Efficacy of Lidocain Spray for Patient Comfort During Nasogastric Tube Insertion in Enteral Nutrition: the Xylonut Trial|Unknown status|Recruiting|Phase 3|68|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 00:55:05.366126|2017-10-11 00:55:05.366126
NCT02022046|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-07-19|||April 2014||2014-04-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|childhoodCKD||Methylation Biosignature in Childhood Chronic Kidney Disease|Methylation Biosignature in Childhood Chronic Kidney Disease: the Link Among Asymmetric Dimethylarginine, Homocysteine, and Cardiovascular Disease|Completed||N/A|69|Actual|Chang Gung Memorial Hospital|||1||f||||t||||||||||2017-10-11 00:55:05.469723|2017-10-11 00:55:05.469723
NCT02022033|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-09-11|||February 2014||2014-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial|BrUOG 295:Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial|Recruiting||Phase 2|25|Anticipated|Brown University||1|||f||||t||||||||||2017-10-11 00:55:05.552951|2017-10-11 00:55:05.552951
NCT02022020|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-12-08|2016-10-05||January 2014||2014-01-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational||Patients who received treatment at two countries (United States and Canada).|Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa|An Observational Study Assessing the Management of Gastrointestinal and Urogenital Bleeding Events in Patients With Atrial Fibrillation Treated With Dabigatran Etexilate|Completed||N/A|220|Actual|Boehringer Ingelheim|Limitations of the data sources included completeness of information available in terms of potential lack of outcome data, medical history data and co-medications. Key limitations: 1. Generalizability. 2. Data quality. 3. Data availability.||1||f||||||||||||||2017-10-11 00:55:05.660731|2017-10-11 00:55:05.660731
NCT02022007|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-05-25|2016-11-09||March 2014||2014-03-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|BMS-AZPCOS|All participants had PCOS and were glucose impaired|Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis|Metabolic and Endocrine Effects of Combination of Metformin and DPP-4 Inhibitor Saxagliptin Compared to Saxagliptin or Metformin XR Monotherapy in Patients With PCOS and Impaired Glucose Regulation: A Single-blinded Randomized Pilot Study|Completed||Phase 3|38|Actual|Woman's|"Study limitations were the small number of patients and the short interval (16 weeks) of drug treatment.
Surrogate measures derived from the OGTT were used to estimate insulin sensitivity and secretion. ."|3|||f||||t||||||||No||2017-10-11 00:55:06.35046|2017-10-11 00:55:06.35046
NCT02021994|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-12-20|||June 2013||2013-06-01|December 2013|2013-12-01||||September 2013|Actual|2013-09-01||Observational|||BPM Cuff： 15-24cm, 20-34cm, 30-44cm, 40-48cm, 22-42cm||Completed||N/A|85|Actual|Andon Health Co., Ltd|||2||f||||||||||||||2017-10-11 00:55:07.179534|2017-10-11 00:55:07.179534
NCT02021981|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-07-12|||October 2013||2013-10-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Observational|IHO:BP||Improving Health Outcomes: Blood Pressure|Improving Health Outcomes: Blood Pressure Program in Practice Sites Located in the Chicago Metropolitan Area and in Maryland|Active, not recruiting||N/A|10|Anticipated|American Medical Association|||10||f||||f||||||||||2017-10-11 00:55:07.22968|2017-10-11 00:55:07.22968
NCT02021968|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-12-14|||November 2013||2013-11-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults|A Phase 1 Evaluation of the Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV003 to Protect Against Infection With Attenuated DENV-2, rDEN2∆30-7169|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 00:55:07.325373|2017-10-11 00:55:07.325373
NCT02021955|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-05-02|||February 11, 2015|Actual|2015-02-11|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|InCasE||Integrating Care After Exacerbation of COPD|Integrating Care After Exacerbation of COPD (InCasE)|Enrolling by invitation||N/A|465|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Undecided||2017-10-11 00:55:07.420487|2017-10-11 00:55:07.420487
NCT02021929|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-07-05|||March 2014||2014-03-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|SHPS||Sorafenib for Hepatopulmonary Syndrome|Sorafenib in Patients With Hepatopulmonary Syndrome: A Double-Blind Randomized Clinical Trial|Recruiting||Phase 2|30|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:55:07.636099|2017-10-11 00:55:07.636099
NCT02021916|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2013-12-20|||July 2005||2005-07-01|December 2013|2013-12-01||||January 2020|Anticipated|2020-01-01||Observational|LCTB||Louisville Cooperative Tissue Biorepository|Louisville Cooperative Tissue Biorepository of the James Graham Brown Cancer Center Tissue Collection Consent|Recruiting||N/A|5000|Anticipated|University of Louisville|||1||f||||t||||||Samples With DNA|"     Collection of normal or abnormal tissue at the time of surgery from consented subjects.     Collection of blood and urine the day of consent or day of surgery.   "|||2017-10-11 00:55:09.402138|2017-10-11 00:55:09.402138
NCT02021903|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-02-21|||May 2012||2012-05-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|HYPOSOMNPARK||Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies|Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies: the Model of an Oral Glucose Load|Recruiting||N/A|24|Anticipated|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-11 00:55:09.465744|2017-10-11 00:55:09.465744
NCT02021890|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2013-12-20|||September 2011||2011-09-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|July 2012|Actual|2012-07-01||Interventional|BALLANDO||Efficacy Study of Standard Ballroom and Latin Dance Program in Type 2 Diabetes and Obesity|A Standard Ballroom and Latin Dance Program to Improve Fitness and Adherence to Physical Activity in Individuals With Type 2 Diabetes and Obesity|Completed||N/A|100|Actual|University of Bologna||2|||f||||f||||||||||2017-10-11 00:55:09.563506|2017-10-11 00:55:09.563506
NCT02021877|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-05-22|||February 2011||2011-02-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Observational|||Evidence Based Diagnostics and Treatment Planning Solution for Traumatic Brain Injuries|Evidence Based Diagnostics and Treatment Planning Solution for Traumatic Brain Injuries - the TBIcare Project|Completed||N/A|396|Actual|Turku University Hospital|||2||f||||f||||||Samples With DNA|"     Serum and plasma samples for proteomic, metabolomic and genetic analyses.   "|||2017-10-11 00:55:09.645128|2017-10-11 00:55:09.645128
NCT02021864|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-01-19|||January 2014||2014-01-01|January 2014|2014-01-01||||October 2014|Anticipated|2014-10-01||Interventional|||Vitamin D Treatment and Hypocalcemic Pregnant Women|Effect of Treatment of Vitamin D Deficiency During Pregnancy on Hypocalcemia|Unknown status|Recruiting|N/A|120|Anticipated|Sina Hospital, Iran||2|||f||||t||||||||||2017-10-11 00:55:09.724566|2017-10-11 00:55:09.724566
NCT02021851|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-19|||July 2011||2011-07-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Prevention of Nausea and Vomiting in Patients After Surgery|THE EFFECT OF THE COMBINATION OF DEXAMETHASONE WITH ONDANSETRON VERSUS DEXAMETHASONE WITH APREPITANT TO PREVENT POSTOPERATIVE NAUSEA AND VOMITING IN PATIENTS UNDERGOING LAPAROSCOPIC SURGERY|Completed||Phase 4|67|Actual|Yeditepe University Hospital||2|||f||||f||||||||||2017-10-11 00:55:09.809791|2017-10-11 00:55:09.809791
NCT02021838|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-04-21|||January 2014||2014-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative|Evaluation of the Domestic Violence Homicide Prevention Initiative|Enrolling by invitation||N/A|7|Anticipated|Yale University|||7||f||||f||||||||||2017-10-11 00:55:09.893458|2017-10-11 00:55:09.893458
NCT02021825|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-12-19|||March 2009||2009-03-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders|Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders|Unknown status|Recruiting|Phase 4|50|Anticipated|Xuanwu Hospital, Beijing||1|||f||||t||||||||||2017-10-11 00:55:09.981554|2017-10-11 00:55:09.981554
NCT02021812|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-08-29|2017-07-07||January 2014|Actual|2014-01-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|August 2016|Actual|2016-08-01||Interventional|||Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms|Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms|Active, not recruiting||N/A|31|Actual|W.L.Gore & Associates||1|||f||||t||||||||||2017-10-11 00:55:10.189073|2017-10-11 00:55:10.189073
NCT02021799|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-12-19|||August 2012||2012-08-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Under-nutrition on the Human Microbiota|The Effect of Nutrition on the Microbiome in Pregnant Women and the Use of Micronutrient Supplemented Probiotic Yogurt to Improve Outcomes|Completed||N/A|77|Actual|Western University, Canada||5|||f||||f||||||||||2017-10-11 00:55:10.6376|2017-10-11 00:55:10.6376
NCT02021786|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-03-01|||January 2014||2014-01-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A web-and Mobile Phone-based Intervention in 4-year-olds: a Population-based Randomized Controlled Trial|A Web- and Mobile Phone-based Intervention to Prevent Obesity in 4-year-olds (MINISTOP): a Population-based Randomized Controlled Trial|Completed||N/A|315|Actual|Karolinska Institutet||2|||f||||t||||||||No||2017-10-11 00:55:10.723959|2017-10-11 00:55:10.723959
NCT02021773|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-03-26|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Assessment of LBR-101 In Chronic Migraine|A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group, Multi-Dose Study Comparing the Efficacy and Safety of Subcutaneous LBR-101 With Placebo for the Preventive Treatment of Chronic Migraine|Completed||Phase 2|277|Actual|Teva Pharmaceutical Industries||3|||f||||||||||||||2017-10-11 00:55:10.818996|2017-10-11 00:55:10.818996
NCT02021760|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-02-08|||May 2013||2013-05-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|RECOND||Reduction in Infarct Size by Remote Per-postconditioning in Patients With ST-elevation Myocardial Infarction|Reduction in Infarct Size by Remote Per-postconditioning in Patients With ST-elevation Myocardial Infarction in Stockholm (RECOND)|Completed||N/A|120|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 00:55:11.027036|2017-10-11 00:55:11.027036
NCT02021747|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-23|||January 2014||2014-01-01|May 2017|2017-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Biologic Basis Of Increased Susceptibility Of Smokers To Pulmonary Infection With Mycobacterium Tuberculosis|Biologic Basis Of Increased Susceptibility Of Smokers To Pulmonary Infection With Mycobacterium Tuberculosis|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University|||4|Research Changed Directions|f||||t||||||Samples With DNA|"     Blood Biological material from the lungs   "|Yes|All results of the proposed studies will be published in international peer-reviewed scientific journals, presented at meetings in Qatar, the regional and international conferences, and disseminated through the local Qatari media, seminars and lectures for high school and college students. The original data will be available to interested investigators using the conventional standards of biomedical science.|2017-10-11 00:55:11.123124|2017-10-11 00:55:11.123124
NCT02021734|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-23|||January 2012||2012-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Genetics of Mendelian Diseases in Qatar|Genetics of Mendelian Diseases in Qatar|Recruiting||N/A|400|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||Samples With DNA|"     Blood   "|No||2017-10-11 00:55:11.203692|2017-10-11 00:55:11.203692
NCT02021721|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-23|||November 2012||2012-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Next Generation DNA Sequencing in Patients With Idiopathic Male Infertility|Next Generation DNA Sequencing in Patients With Idiopathic Male Infertility|Recruiting||N/A|500|Anticipated|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"     Blood   "|Undecided||2017-10-11 00:55:11.274937|2017-10-11 00:55:11.274937
NCT02021708|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-04-27|||January 2013||2013-01-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Effect of Shisha Smoking on the Biology of the Airway Epithelium in Qatar|Effect of Shisha Smoking on the Biology of the Airway Epithelium in Qatar|Completed||N/A|64|Actual|Weill Medical College of Cornell University|||3||f||||t||||||Samples With DNA|"     Blood   "|Undecided||2017-10-11 00:55:11.349949|2017-10-11 00:55:11.349949
NCT02021695|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-23|||September 2013||2013-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes|DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes|Recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"     Blood   "|Undecided||2017-10-11 00:55:11.427411|2017-10-11 00:55:11.427411
NCT02021682|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-15|||December 2013||2013-12-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease|CNS and Plasma Amyloid-Beta Kinetics in Alzheimers's Disease; A Blood Isotope Labeled Amyloid-beta Test for Alzheimer's Disease.|Enrolling by invitation||N/A|80|Anticipated|Washington University School of Medicine|||2||f||||t||||||Samples Without DNA|"     Plasma and cerebro spinal fluid   "|No|No plan to share IPD at this time|2017-10-11 00:55:11.497049|2017-10-11 00:55:11.497049
NCT02021630|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-10-20|||December 2012||2012-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|Collateral||The Collateral Impact of Bariatric Surgery on Families|The Collateral Impact of Bariatric Surgery on Families|Completed||N/A|97|Actual|Geisinger Clinic|||3||f||||f||||||Samples Without DNA|"     urine   "|Undecided||2017-10-11 00:55:12.18724|2017-10-11 00:55:12.18724
NCT02021617|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-12-19|||November 2013||2013-11-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Infusion Flow Rates and Blood Sampling|A Study Comparing Infusion Flow Rates Using the Proximal Humerus and Proximal Tibia Intraosseous Vascular Access Insertion Sites and Comparing Intraosseous and Venous Blood for Laboratory Specimen Sampling|Unknown status|Enrolling by invitation|N/A|20|Actual|Vidacare Corporation||1|||f||||f||||||||||2017-10-11 00:55:12.283926|2017-10-11 00:55:12.283926
NCT02021604|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-08-31|||December 2013||2013-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Fluorodopa F 18 in Congenital Hyperinsulinism|The Use of Fluorodopa F 18 Positron Emission Tomography Combined With Computed Tomography in Congenital Hyperinsulinism|Recruiting||Phase 1|50|Anticipated|Cook Children's Health Care System||1|||f||||t||||||||||2017-10-11 00:55:12.37312|2017-10-11 00:55:12.37312
NCT02021591|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-06-07|||December 2013|Actual|2013-12-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effectiveness Study of Interactive Web Application for Problem Solving in Diabetes Management|Randomized Clinical Trial of Health Information Technology for Problem Solving in Diabetes Management|Active, not recruiting||N/A|240|Anticipated|Columbia University||2|||f||||t||||||||Undecided||2017-10-11 00:55:12.500581|2017-10-11 00:55:12.500581
NCT02021578|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-04-07|||December 2014||2014-12-01|April 2017|2017-04-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|FDP||A Family Depression Prevention Program|Family Cognitive Behavioral Prevention of Depression in Youth and Parents|Recruiting||N/A|300|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-10-11 00:55:12.611251|2017-10-11 00:55:12.611251
NCT02021552|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-12-05|||June 2013||2013-06-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|||Genetic Polymorphisms & The Risk for Sepsis After Trauma|Genetic Polymorphisms & The Risk for Sepsis After Trauma|Completed||N/A|357|Actual|University of Washington|||1||f||||f||||||Samples With DNA|"     White blood cells extracted from discarded blood samples   "|Yes|De-identified samples and data will be available to other investigators at the discretion of the Principal Investigator.|2017-10-11 00:55:12.837727|2017-10-11 00:55:12.837727
NCT02021539|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-06-16|||February 2014|Actual|2014-02-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|ElastoMAP||The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery|The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery|Terminated||N/A|66|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 00:55:12.919222|2017-10-11 00:55:12.919222
NCT02021526|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-26|||December 2014||2014-12-01|December 2013|2013-12-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)|Treatment Development of Triheptanoin for Glucose Transporter Type I Deficiency|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 00:55:13.023772|2017-10-11 00:55:13.023772
NCT02021513|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2013-12-19|||January 2012||2012-01-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus|Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus|Completed||Phase 2|50|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 00:55:13.127493|2017-10-11 00:55:13.127493
NCT02021500|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-10-31|||January 2014||2014-01-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.|MPACT Extension Study: Multicenter, Survival Data Collection in Subjects Previously Enrolled in Protocol CA046|Completed||N/A|40|Actual|Celgene Corporation|||1||f||||f||||||||||2017-10-11 00:55:13.213979|2017-10-11 00:55:13.213979
NCT02021487|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-09-07|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|Prok-Idm||Prokinecitine in Acute Myocardial Infarction|Pilot Study Prok-Idm: Interest of Dosage of Prokinecitine in Acute Myocardial Infarction|Recruiting||N/A|200|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 00:55:13.357321|2017-10-11 00:55:13.357321
NCT02021474|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-01-26|||September 2015||2015-09-01|January 2015|2015-01-01||||September 2016|Anticipated|2016-09-01||Interventional|||A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis|Phase II Study to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis|Unknown status|Not yet recruiting|Phase 2|130|Anticipated|BioHealthonomics Inc.||2|||f||||f||||||||||2017-10-11 00:55:13.420114|2017-10-11 00:55:13.420114
NCT02021461|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-02-24|2014-01-09||December 2012||2012-12-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||A total of 38 subjects were screened. All of these subjects were randomised and completed the trial|Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours|Double-blind Study in Paediatric Epileptic Subjects Aged From 5 to Less Than 8 Years to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours|Completed||Phase 2|38|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 00:55:13.498231|2017-10-11 00:55:13.498231
NCT02021448|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-09-07|||December 2013|Actual|2013-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB -|Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB -|Recruiting||N/A|350|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 00:55:13.706277|2017-10-11 00:55:13.706277
NCT02021435|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2014-01-08|||April 2014||2014-04-01|January 2014|2014-01-01||||March 2016|Anticipated|2016-03-01||Interventional|||Tibet Salt Reduction Study|Using Salt Substitute to Reduce Population Blood Pressure in Tibet: Tibet Salt Reduction Study|Unknown status|Not yet recruiting|N/A|4500|Anticipated|Beijing Jishuitan Hospital||2|||f||||t||||||||||2017-10-11 00:55:13.805681|2017-10-11 00:55:13.805681
NCT02021422|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-01-30|||June 2013||2013-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy|A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy Regimens in Metastatic Pancreatic Ductal Adenocarcinoma Patients|Active, not recruiting||Phase 1|13|Actual|Baylor Research Institute||1|||f||||t||||||||||2017-10-11 00:55:13.889062|2017-10-11 00:55:13.889062
NCT02021409|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2015-12-11|||January 2014||2014-01-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|DIALOGUE 2||Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934|A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Darbepoetin Alfa) in the Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment in Europe and Asia Pacific|Completed||Phase 2|126|Actual|Bayer||4|||f||||t||||||||||2017-10-11 00:55:14.152281|2017-10-11 00:55:14.152281
NCT02021396|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-06-23|||January 2014||2014-01-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|Splash||Benefit of Prophylactic Embolization of the Splenic Salvage|Benefit of Prophylactic Embolization of the Splenic Salvage in Trauma Patients at High Risk of Splenectomy.|Unknown status|Recruiting|N/A|120|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 00:55:14.446374|2017-10-11 00:55:14.446374
NCT02021383|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-01-06|||March 2012||2012-03-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|L2W||Lose 2 Win A Novel Method to Motivate Weight Loss Maintenance Among College Students|"Lose 2 Win Contests: A Novel Method to Motivate Weight Loss Maintenance Among College Students"|Unknown status|Active, not recruiting|N/A|144|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-11 00:55:14.564737|2017-10-11 00:55:14.564737
NCT02021370|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-09-13||2015-12-02|February 2014||2014-02-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|DIALOGUE 1||15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)|A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific|Completed||Phase 2|121|Actual|Bayer||6|||f||||t||||||||||2017-10-11 00:55:14.675249|2017-10-11 00:55:14.675249
NCT02021357|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-02-04|||January 2014||2014-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Proprioceptive Treatment for Temporomandibular Dysfunction|The Influence of Proprioceptive Treatment for the Intensity of Pain, Muscle Activity, Level of Severity and Mandible Mobility in Individuals With Temporomandibular Dysfunction: Clinical Trial, Randomized, Controlled, Double-Blind|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-11 00:55:15.193475|2017-10-11 00:55:15.193475
NCT02021344|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2013-12-19|||September 2009||2009-09-01|December 2013|2013-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Mental Health First Aid for College Students|Mental Health First Aid for College Students: A Multi-campus Randomized Control Trial of a Community Health Intervention|Completed||N/A|2543|Actual|University of Michigan||4|||f||||f||||||||||2017-10-11 00:55:15.288288|2017-10-11 00:55:15.288288
NCT02021331|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-06-08|2017-03-20||December 2012|Actual|2012-12-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|3i||The Effect of Immediate Implant Placement and Provisionalization in the Esthetic Zone|The Effect of Immediate Implant Placement and Provisionalization in The Esthetic Zone: A Randomized Clinical Trial|Terminated||N/A|5|Actual|University of Michigan||2||Low enrollment so sponsor stopped funding the study (did not renew)|f||||f||||||||||2017-10-11 00:55:15.373322|2017-10-11 00:55:15.373322
NCT02021318|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-07-26|||March 12, 2014|Actual|2014-03-12|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|December 2018|Anticipated|2018-12-01||Interventional|Dolomites||Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa|A Phase 3, Randomized, Open-Label, Active-Controlled Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis|Recruiting||Phase 3|570|Anticipated|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 00:55:15.767837|2017-10-11 00:55:15.767837
NCT02021305|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2013-12-20|||February 2013||2013-02-01|December 2013|2013-12-01|February 2017|Anticipated|2017-02-01|February 2014|Anticipated|2014-02-01||Observational|TLR-4||The Role of TLR-4 Polymorphisms in Children With Urinary Track Infections|The Role of TLR-4 Asp299Gly and Thr399Ile Polymorphisms in Children With Urinary Tack Infections|Unknown status|Recruiting|N/A|160|Anticipated|Aristotle University Of Thessaloniki|||2||f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 00:55:16.449315|2017-10-11 00:55:16.449315
NCT02021279|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2016-10-21|||June 2014||2014-06-01|October 2016|2016-10-01||||January 2020|Anticipated|2020-01-01||Interventional|||ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study|Evaluation of the Use of Transvaginal Resorbable Biologic Mesh as Compared to Traditional Non-Mesh Surgical Repair for Treating Pelvic Floor Disorders|Recruiting||Phase 4|162|Anticipated|ACell Inc.||2|||f||||t||||||||||2017-10-11 00:55:16.730922|2017-10-11 00:55:16.730922
NCT02021266|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-28||||||June 2017|2017-06-01||||||||Expanded Access|Boost||Single Patient Expanded Access Protocol: Metabolic Boost|Single Patient Expanded Access Protocol: Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders|No longer available||N/A|||University of Louisville|||||||||||||||||||2017-10-11 00:55:16.898899|2017-10-11 00:55:16.898899
NCT02021253|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-06-13|||April 2013||2013-04-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|LIPROCES||Influence of Probiotics Administration Before Liver Resection in Liver Disease|Circulating Endotoxemia After Liver Resection for Hepatocellular Carcinoma in Liver Disease - Influence of Preoperative Administration of Probiotics|Recruiting||N/A|64|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 00:55:16.975461|2017-10-11 00:55:16.975461
NCT02021240|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-19|||December 2013||2013-12-01|December 2013|2013-12-01|April 2016|Anticipated|2016-04-01|October 2015|Anticipated|2015-10-01||Interventional|||Ketamine in Post-operative Dental Pain and Recovery|Effects of Ketamine in Post-operative Pain and Recovery Outcomes in Bilateral Third Molar Surgery Under General Anaesthesia|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|The University of Hong Kong||3|||f||||f||||||||||2017-10-11 00:55:17.068356|2017-10-11 00:55:17.068356
NCT02021227|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-19|||December 2013||2013-12-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|RehabVent||Early Chair Sitting Exercise in Mechanically Ventilated Critically Ill Patients.|Effects of Chair Sitting Exercise Intervention on Weaning From Mechanical Ventilation and Mortality of Critically Ill Patients With Acute Respiratory Failure: a Randomised Controlled Trial.|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:55:17.17887|2017-10-11 00:55:17.17887
NCT02021214|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-12-01|||March 2014||2014-03-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effects of Methylphenidate (Ritalin®) on the Neural Basis of Anxiety|Effects of Methylphenidate (Ritalin®) on the Neural Basis of Anxiety: a Placebo-controlled fMRI Study in Healthy Male Subjects|Completed||Early Phase 1|24|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 00:55:17.301323|2017-10-11 00:55:17.301323
NCT02021201|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2013-12-19|||July 2008||2008-07-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia|The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia, a Comparative Study|Terminated||Phase 4|1|Actual|University of Copenhagen||1||No suitable patients could be recruited in the available time period|f||||t||||||||||2017-10-11 00:55:17.410021|2017-10-11 00:55:17.410021
NCT02021188|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-08-23|||August 2014||2014-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|VISION||Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography|The Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography Study|Completed||N/A|42|Actual|University of Cambridge|||2||f||||f||||||Samples With DNA|"     Carotid artery plaques   "|||2017-10-11 00:55:17.498063|2017-10-11 00:55:17.498063
NCT02021175|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-12-01|||June 2016||2016-06-01|December 2015|2015-12-01||||June 2017|Anticipated|2017-06-01||Interventional|||Korean Youth Smoking Cessation Study|Adaptation and Development of a Web and Cell Phone Quit Smoking Treatment for Korean Youth|Not yet recruiting||N/A|240|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 00:55:17.585671|2017-10-11 00:55:17.585671
NCT02021162|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-05-01|||November 2013||2013-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|GLT||Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis|Open-label, Single-blinded, Observational, Prospective, 24-months, Longitudinal, Controlled Study to Assess the Efficacy of Gilenya® on Development of Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis.|Active, not recruiting||N/A|50|Actual|University at Buffalo|||2||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:55:17.681662|2017-10-11 00:55:17.681662
NCT02021149|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-07-23|||July 2014||2014-07-01|July 2015|2015-07-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Enhancing Psychotherapy for Mood Disorders With Whole Body Hyperthermia||Terminated||N/A|3|Actual|University of Arizona||3||Investigator transferred to the University of Wisconsin - Madison|f||||f||||||||||2017-10-11 00:55:17.7746|2017-10-11 00:55:17.7746
NCT02021136|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-12-29|||October 2013||2013-10-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|ROTOR||Efficacy and Safety of Rebel Reliever Brace in Patients With Symptomatic Medial Knee Osteoarthritis|Efficacy and Safety of Rebel Reliever Brace in Medial Femorotibial Knee Osteoarthritis. Phase 3, Multicenters, Randomised and Controlled Study With 2 Parallel Groups.|Completed||Phase 3|67|Actual|Thuasne||2|||f||||t||||||||||2017-10-11 00:55:17.884796|2017-10-11 00:55:17.884796
NCT02021123|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2014-10-27|||August 2014||2014-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ADOPT||Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)|Pharmacokinetics of Anidulafungin (Ecalta ®) Given Intravenously as Prophylaxis to Obese Patients With Risk of Invasive Fungal Infection Undergoing Gastric Bypass Surgery.|Completed||Phase 4|8|Actual|Radboud University||1|||f||||f||||||||||2017-10-11 00:55:17.970496|2017-10-11 00:55:17.970496
NCT02021110|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-04-06|||December 2013||2013-12-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CURSOR||Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease|An International, Multicenter, Randomized Controlled Clinical Trial Assessing the Efficacy of Ursodeoxycholic Acid as a Volume Reducing Treatment in Symptomatic Polycystic Liver Disease|Completed||Phase 2|34|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 00:55:18.07766|2017-10-11 00:55:18.07766
NCT02021097|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-12-19|||February 2012||2012-02-01|December 2013|2013-12-01|February 2016|Anticipated|2016-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception|A Multicenter, Randomized, Open-labe, Controlled Study to Evaluate the Efficacy and Safety of the Combined Levonorgestrel(LNG) 100mcg and Ethinyl Estradiol(EE) 20mcg for Oral Contraception|Unknown status|Recruiting|Phase 3|1008|Anticipated|Regenex Pharmaceutical, China||2|||f||||f||||||||||2017-10-11 00:55:18.187552|2017-10-11 00:55:18.187552
NCT02021084|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-10-06|||December 2013||2013-12-01|October 2016|2016-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colchicine for Familial Mediterranean Fever.||Withdrawn||N/A|0|Actual|Rambam Health Care Campus||2||no patient enroled|f||||f||||||||||2017-10-11 00:55:18.323271|2017-10-11 00:55:18.323271
NCT02021071|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-10-07|2015-12-22||December 2013||2013-12-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Virtual Path Planning for Image-guided Needle Interventions|Evaluation of Adding Virtual Path Planning to the Philips FD20 XperGuide to Reduce Radiation Dose During Image-guided Needle Interventional Procedures.|Completed||N/A|24|Actual|Philips Healthcare|||2||f||||f||||||||Undecided||2017-10-11 00:55:18.434519|2017-10-11 00:55:18.434519
NCT02021058|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-01-30|||December 12, 2013|Actual|2013-12-12|January 2017|2017-01-01|August 23, 2016|Actual|2016-08-23|April 2016|Actual|2016-04-01||Interventional|||Study in Unsettled Infants Experiencing Feeding Intolerance|Effect of an Experimental Infant Formula in Unsettled Infants Experiencing Feeding Intolerance|Completed||N/A|259|Actual|Nestlé||2|||f||||f|f|f||||||Undecided||2017-10-11 00:55:18.736166|2017-10-11 00:55:18.736166
NCT02021045|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-03-03|||September 2013||2013-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Observational|||Cerebral Microembolism During Hemodialysis|Quantity, Quality and Laterality of Cerebral Microembolism During Veno-Venous Hemodialysis.|Completed||N/A|40|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 00:55:18.81286|2017-10-11 00:55:18.81286
NCT02021032|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-09-23|||February 2006||2006-02-01|September 2015|2015-09-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|||Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)|Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)|Recruiting||Phase 4|250|Anticipated|Medifocus, Inc.||1|||f||||f||||||||||2017-10-11 00:55:18.889151|2017-10-11 00:55:18.889151
NCT02021019|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-05-12|||January 2014||2014-01-01|May 2015|2015-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease|Renal Denervation to Improve Outcomes in Patients With End-stage Renal|Unknown status|Active, not recruiting|N/A|100|Anticipated|Baker IDI Heart and Diabetes Institute||2|||f||||f||||||||||2017-10-11 00:55:19.001433|2017-10-11 00:55:19.001433
NCT02021006|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2017-06-28|||December 2013||2013-12-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|PREDICT||Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract|Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract|Recruiting||Phase 3|436|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||Undecided||2017-10-11 00:55:19.068437|2017-10-11 00:55:19.068437
NCT02020993|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-01-03|||December 2013||2013-12-01|January 2014|2014-01-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Observational|NT-proBNP||Urine NT-ProBNP in Neonatal Respiratory Distress|The Prognostic Value of Urine NT-ProBNP in Neonatal Respiratory Distress|Unknown status|Recruiting|N/A|150|Anticipated|Ankara University|||2||f||||f||||||Samples Without DNA|"     Urine NT-proBNP   "|||2017-10-11 00:55:19.198691|2017-10-11 00:55:19.198691
NCT02020980|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-26|||April 2014||2014-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|RELIEF||RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke|A Prospective, Observational Study to Assess Pain Relief After 4 Botulinum Toxin Type A (BoNT-A) Injection Cycles in Patients With Post-stroke Lower Limb Spasticity|Active, not recruiting||N/A|186|Actual|Ipsen|||1||f||||f||||||||||2017-10-11 00:55:19.313008|2017-10-11 00:55:19.313008
NCT02020967|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-11-30|||November 2013||2013-11-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|ACROSCREEN||Programme of Acromegaly Screening in Patients With Associated Somatic Disorders|Programme of Acromegaly Screening in Patients With Associated Somatic Disorders, Who Are Observed at the Moscow Board of Health Endocrinology Dispensary and Endocrinology Hospital at First Moscow State Medical University for the Purpose of Early Identification of the Disease.|Completed||N/A|367|Actual|Ipsen|||1||f||||f||||||||||2017-10-11 00:55:19.626165|2017-10-11 00:55:19.626165
NCT02020954|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-03-23|||January 2013||2013-01-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|Becker-HS||Prospective Becker-Heart-Study|Prospective Cohort Study of Patients With Mutations in the Dystrophin Gene (X Linked Dilated Cardiomyopathy and Becker Muscular Dystrophy)|Unknown status|Recruiting|N/A|100|Anticipated|Institut de Myologie, France|||1||f||||t||||||Samples With DNA|"     Whole blood, serum   "|||2017-10-11 00:55:19.721441|2017-10-11 00:55:19.721441
NCT02020941|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-09-14|2016-09-14||September 2013||2013-09-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy|A Phase 2 Study of Carfilzomib and Bone Metabolism in Patients With Multiple Myeloma in First Relapse or Refractory to First Line Therapy|Terminated||Phase 2|10|Actual|Indiana University||1||Slow accrual|f||||t||||||||||2017-10-11 00:55:19.843337|2017-10-11 00:55:19.843337
NCT02020928|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-19|||January 2015||2015-01-01|September 2013|2013-09-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|lasertherapy||Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation?|Laser Therapy Prevents Mucositis Oral in Patients Undergoing to Chemotherapy for Bone Marrow Transplantation? A Randomized Clinical Trial.|Unknown status|Enrolling by invitation|Phase 3|36|Anticipated|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||f||||||||||2017-10-11 00:55:20.298932|2017-10-11 00:55:20.298932
NCT02020876|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-19|||August 2012||2012-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Observational|DECIDE||Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations|GenomeDx Decipher Test for Metastatic Disease in Prostate Cancer for Patients With Adverse Pathology Post Radical Prostatectomy: Does it Impact Physician Decision Making?|Completed||N/A|21|Actual|GenomeDx Biosciences Corp|||1||f||||f||||||||||2017-10-11 00:55:20.759206|2017-10-11 00:55:20.759206
NCT02020863|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-04-20|2016-03-08||November 2012||2012-11-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Closed-Loop Fluid Administration System Using Hemodynamic Monitors|Closed-Loop Fluid Administration System Using Hemodynamic Monitors|Completed||N/A|40|Actual|University of California, Irvine||1|||f||||t||||||||Undecided||2017-10-11 00:55:20.848458|2017-10-11 00:55:20.848458
NCT02020850|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-07-02|||February 2014||2014-02-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Observational|TBI||Young Toe-Brachial Index Assessment|Determining the Normal Toe-Brachial Index in Young Adults|Unknown status|Recruiting|N/A|100|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 00:55:21.106728|2017-10-11 00:55:21.106728
NCT02020824|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-10-29|||April 2014||2014-04-01|October 2015|2015-10-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|CTRLSTRESS||Virtual Reality and Concept of Control in the Treatment of Acrophobia|Virtual Reality and Concept of Control in the Treatment of Acrophobia by Exposure to Virtual Environments: Comparative Test|Unknown status|Recruiting|N/A|60|Anticipated|Qualissima||3|||f||||f||||||||||2017-10-11 00:55:21.263747|2017-10-11 00:55:21.263747
NCT02020811|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-19|||November 2013||2013-11-01|May 2013|2013-05-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|IV||Safety and Efficacy of Immages System in Patients Recieving IV Therapy|A Study to Assess the Functionality of Pro-IV's IMMAGES Infusion System in Patients Hospitalized in Bait Balev, Receiving Intravenous Therapy|Unknown status|Recruiting|N/A|50|Anticipated|PRo-IV||1|||f||||f||||||||||2017-10-11 00:55:21.379712|2017-10-11 00:55:21.379712
NCT02020798|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-10-29|||December 2013||2013-12-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Glycemic Response Testing||Completed||N/A|38|Actual|PepsiCo Global R&D||2|||f||||||||||||||2017-10-11 00:55:21.457376|2017-10-11 00:55:21.457376
NCT02020785|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-10-08|||January 2014||2014-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SODA-POP||Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23|Randomized Cross-over Study Examining the Effects of Phosphorus Additives on Urinary Albumin Excretion and Fibroblast Growth Factor-23|Completed||N/A|31|Actual|Geisinger Clinic||2|||f||||f||||||||||2017-10-11 00:55:21.523156|2017-10-11 00:55:21.523156
NCT02020772|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-12-01|||December 2013||2013-12-01|November 2016|2016-11-01|December 2021|Anticipated|2021-12-01|August 2021|Anticipated|2021-08-01||Interventional|||Coordinating Teams in Primary Health Care.|Coordination Between General Practitioners and Physical Therapists in Primary Health Care for Musculoskeletal Pain: Effect on Sick Leave and Referral to Specialist Care.|Recruiting||N/A|880|Anticipated|Norwegian University of Science and Technology||4|||f||||f||||||||||2017-10-11 00:55:21.624728|2017-10-11 00:55:21.624728
NCT02020759|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-03-31|||December 2013||2013-12-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Observational|||Neurological Monitoring During Extracorporeal Membrane Oxygenation|Multimodal Neurological Monitoring in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO) - a Prospective Observational Pilot Study.|Recruiting||N/A|40|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 00:55:21.747131|2017-10-11 00:55:21.747131
NCT02020746|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-08-02|||August 2014||2014-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds|A Multicenter, International, Prospective, Randomized, Vehicle Controlled, Assessor Blinded Study Performed in Subjects With Hard to Heal Wounds, to Evaluate the Efficacy and Safety of Enzymatic Debridement With EscharEx|Recruiting||Phase 2|96|Anticipated|MediWound Ltd||2|||f||||||||||||||2017-10-11 00:55:21.87447|2017-10-11 00:55:21.87447
NCT02020733|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2013-12-24|||June 2012||2012-06-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of Pain During Hysterosalpingography With The Use Of Balloon Catheter Versus Metal Cannula||Completed||N/A|194|Actual|Etlik Zubeyde Hanim Womens' Health and Teaching Hospital||2|||f||||||||||||||2017-10-11 00:55:21.997813|2017-10-11 00:55:21.997813
NCT02020720|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-03-15|||January 2014||2014-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||18F-DOPA-PET in Planning Surgery in Patients With Gliomas|Evaluating the Impact of 18F-DOPA-PET on Neurosurgical Planning for Gliomas|Recruiting||N/A|90|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 00:55:22.09601|2017-10-11 00:55:22.09601
NCT02020707|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-07-11|||March 2014||2014-03-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers|Targeted Complex Therapy for Advanced Melanoma and Gynecologic Cancers: Nab-Paclitaxel (Abraxane)/Bevacizumab Complex (AB-Complex)|Suspended||Phase 1|36|Anticipated|Mayo Clinic||1||melanoma cohort - per study design|f||||t||||||||||2017-10-11 00:55:22.253874|2017-10-11 00:55:22.253874
NCT02020694|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-02-02|||December 2011||2011-12-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Vitamin D Supplementation for the Prevention of Cardiovascular Risk|The Role of Vitamin D Supplementation in the Prevention of Cardiovascular Risk Factors|Completed||Phase 4|60|Actual|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-11 00:55:22.378863|2017-10-11 00:55:22.378863
NCT02020681|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2016-01-26|||September 2013||2013-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions|Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions: A Mono-centre, Split-mouth, Double-blinded, Placebo Controlled, Randomised, Post Marketing Clinical Study|Completed||N/A|40|Actual|Credentis AG||2|||f||||f||||||||||2017-10-11 00:55:22.468562|2017-10-11 00:55:22.468562
NCT02020668|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-05-06|||May 2014||2014-05-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient|Phase II Study of Physiotherapy in Rheumatoid Arthritis: Randomized Single Blind Wait-list Controlled Trial|Unknown status|Not yet recruiting|Phase 2|82|Anticipated|Macmillan Research Group UK||2|||f||||t||||||||||2017-10-11 00:55:22.565436|2017-10-11 00:55:22.565436
NCT02020655|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-12-01|||November 2014||2014-11-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Measurement of Cytokines (IL-1α) After Shear- Force Application at the Skin|Measurement of Cytokines (IL-1α) After Shear- Force Application at the Skin|Completed||N/A|10|Actual|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-11 00:55:22.651587|2017-10-11 00:55:22.651587
NCT02020642|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-02-01|||October 2013||2013-10-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|SASinTx||Effect of Renal Transplantation on Obstructive Sleep Apnea in End Stage Renal Disease Patients (SASinTx)|Prospective Interventional Study Investigating the Effect of Renal Transplantation on Obstructive Sleep Apnea and Its Correlation to Nocturnal Rostral Fluid Shift, in End Stage Renal Disease Patients|Recruiting||N/A|36|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||||2017-10-11 00:55:22.730301|2017-10-11 00:55:22.730301
NCT02020629|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-12-12|||December 2013||2013-12-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|||Study on Lixisenatide and Counterregulation to Hypoglycemia|Effect of Lixisenatide on Glucagon Secretion During Hypoglycemia in Patients With Insulin-treated Type 2 Diabetes|Completed||Phase 4|18|Actual|Lund University||1|||f||||f||||||||||2017-10-11 00:55:22.820656|2017-10-11 00:55:22.820656
NCT02020603|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2016-01-20|||January 2012||2012-01-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding|Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps in Comparison With Argon Plasma Coagulation for Acute Peptic Ulcer Bleeding|Completed||N/A|151|Actual|Kyunghee University Medical Center||2|||f||||f||||||||||2017-10-11 00:55:23.062743|2017-10-11 00:55:23.062743
NCT02020590|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-04-11|||February 2014||2014-02-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Phase 1/2a Study on Allogeneic Osteoblastic Cells Implantation in Delayed-Union Fractures|A Pilot Phase 1/2a, Multicentre, Open Proof-of-concept Study on the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Implantation in Non-infected Delayed-Union Fractures|Recruiting||Phase 1/Phase 2|35|Anticipated|Bone Therapeutics S.A||1|||f||||t||||||||||2017-10-11 00:55:23.152231|2017-10-11 00:55:23.152231
NCT02020577|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-01|2016-01-14||December 2013||2013-12-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|January 2015|Actual|2015-01-01||Interventional||Treated set: This patient set includes all patients enrolled in the trial who were documented to have taken at least one dose of study medication.|Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours|A Phase Ib Dose Escalation Study of Afatinib in Combination With Cetuximab in Patients With Advanced Solid Tumours|Completed||Phase 1|58|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:55:23.266195|2017-10-11 00:55:23.266195
NCT02020564|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-30|||December 2012||2012-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment|Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment: A Randomized Clinical Trial|Recruiting||N/A|80|Anticipated|Kessler Foundation||1|||f||||f||||||||||2017-10-11 00:55:24.414803|2017-10-11 00:55:24.414803
NCT02020551|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-24|||May 2013||2013-05-01|December 2013|2013-12-01||||August 2013|Actual|2013-08-01||Interventional|||Lidocaine 10% Spray Reduces Pain During Intrauterine Device Insertion||Completed||N/A|223|Actual|Kayseri Education and Research Hospital||2|||f||||f||||||||||2017-10-11 00:55:24.512235|2017-10-11 00:55:24.512235
NCT02020538|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-12-13|||February 2014||2014-02-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Interventional|LICRA||Limiting IV Chloride to Reduce AKI After Cardiac Surgery|Does Varying the Chloride Content of Intravenous Fluid Alter the Risk of Acute Kidney Injury After Cardiac Surgery?|Unknown status|Recruiting|Phase 4|1000|Anticipated|Bayside Health||2|||f||||f||||||||||2017-10-11 00:55:24.610647|2017-10-11 00:55:24.610647
NCT02020525|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-08-16|||December 2004||2004-12-01|August 2014|2014-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Blood Transfusions and Immune Response|The Impact of Lowering Transfusion Trigger on Patient Immune Response During Major Abdominal Surgery|Completed||N/A|58|Actual|Aretaieion University Hospital||2|||f||||t||||||||||2017-10-11 00:55:24.724816|2017-10-11 00:55:24.724816
NCT02020512|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2014-06-24|2014-06-24||July 2011||2011-07-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|LOTUSDI||A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension||Completed||Phase 4|87|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:55:24.840116|2017-10-11 00:55:24.840116
NCT02020499|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2015-09-29|||August 2014||2014-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|TAPAS||Predictive Factors Study|Non-interventional, Observational, Long Term Study to Evaluate Common Therapeutic Algorithms and Possible Predictive Parameters for Somatuline Autogel (ATG) Treatment in Patients With Acromegaly.|Terminated||N/A|5|Actual|Ipsen|||1|Poor enrolment|f||||f||||||||||2017-10-11 00:55:25.026281|2017-10-11 00:55:25.026281
NCT02020486|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-02-27|||December 2013||2013-12-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects|A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects|Completed||Phase 1|20|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 00:55:25.15449|2017-10-11 00:55:25.15449
NCT02020473|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-18|||February 2013||2013-02-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Informed Consents for Withholding/Withdrawing Life Support in Intensive Care Units||Completed||N/A|348|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 00:55:25.252067|2017-10-11 00:55:25.252067
NCT02020460|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-02-06|||June 2012||2012-06-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|DDCS||Clinical Evaluation of Direct Dorsal Column Stimulation|A Clinical Evaluation of Direct Dorsal Column Stimulation for the Management of Chronic, Medically Refractory Neuropathic Pain|Terminated||N/A|6|Actual|Duke University||2||low accrual|f||||f||||||||||2017-10-11 00:55:25.334685|2017-10-11 00:55:25.334685
NCT02020447|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-18|||December 2013||2013-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:55:25.444342|2017-10-11 00:55:25.444342
NCT02020434|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-03-10|||January 2014||2014-01-01|August 2014|2014-08-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency|A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency|Completed||Phase 1|32|Anticipated|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||1|||f||||f||||||||||2017-10-11 00:55:25.495186|2017-10-11 00:55:25.495186
NCT02020421|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-11-07|||December 2013||2013-12-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|NORTHSTAR||NOn-invasive Repeated THerapeutic STimulation for Aphasia Recovery|NOn-invasive Repeated THerapeutic STimulation for Aphasia Recovery|Recruiting||N/A|90|Anticipated|Thiel, Alexander, M.D.||3|||f||||t||||||||||2017-10-11 00:55:25.60359|2017-10-11 00:55:25.60359
NCT02020408|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-05-17|||May 2011||2011-05-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Monoamine Contributions to Neurocircuitry in Eating Disorders|Monoamine Contributions to Neurocircuitry in Eating Disorders|Completed||Phase 4|88|Actual|University of California, San Diego||1|||f||||t||||||||||2017-10-11 00:55:25.741279|2017-10-11 00:55:25.741279
NCT02020395|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-18|||June 2009||2009-06-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|December 2009|Actual|2009-12-01||Interventional|||Effect of a Test Meal on Satiation Hormones in Obese and Normal Weight Adolescents|Effect of a Test Meal on Satiation Hormones in Obese and Normal Weight Adolescents|Completed||Phase 1|30|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 00:55:25.832061|2017-10-11 00:55:25.832061
NCT02020382|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-05-31|||December 2013||2013-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|MicroMICI||Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases|Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Disease|Active, not recruiting||N/A|325|Actual|Assistance Publique - Hôpitaux de Paris||6|||f||||f||||||||Undecided||2017-10-11 00:55:25.917826|2017-10-11 00:55:25.917826
NCT02020369|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-05-15|2016-07-12||April 2014||2014-04-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors|A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors to Factor VIII or IX|Completed||Phase 3|27|Actual|rEVO Biologics||2|||f||||t||||||||No||2017-10-11 00:55:26.041116|2017-10-11 00:55:26.041116
NCT02020356|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-04-14|||April 2013||2013-04-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PRE-MUSICAL||Music Therapy in Alzheimer's Disease|Impact of Music Therapy on Prescription of Neuroleptics in Alzheimer's Disease ou Related Symptoms Associated With Disruptive Behaviours.|Terminated||N/A|35|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-11 00:55:26.59313|2017-10-11 00:55:26.59313
NCT02020343|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-08-17|||January 2014||2014-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Insulin Resistance in the Control of Intestinal Lipid Metabolism|Insulin Resistance in the Control of Intestinal Lipid Metabolism|Completed||Early Phase 1|22|Actual|University of Missouri-Columbia|||3||f||||f||||||Samples With DNA|"     DNA will be collected for future determination of genotypes that impact taste senstivity   "|||2017-10-11 00:55:26.688601|2017-10-11 00:55:26.688601
NCT02020330|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-06-30|||January 2014||2014-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|April 2015|Actual|2015-04-01||Interventional|AL3vs5||Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day|An Open-label Randomized Controlled Trial to Evaluate the Effectiveness and Safety of a 3 Day Versus 5 Day Course of Artemether-lumefantrine for the Treatment of Uncomplicated Falciparum Malaria in Myanmar|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-11 00:55:26.769567|2017-10-11 00:55:26.769567
NCT02020317|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2015-06-05|||January 2014||2014-01-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions|Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions|Completed||N/A|3341|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 00:55:26.845202|2017-10-11 00:55:26.845202
NCT02020304|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-07-25|2017-07-25||August 29, 2013|Actual|2013-08-29|July 2017|2017-07-01|May 4, 2014|Actual|2014-05-04|May 4, 2014|Actual|2014-05-04||Interventional|||Combined Spinal-Epidural Temperature and Duration of Action|Effect of Temperature of Combined Spinal Epidural Dosing on Duration|Completed||N/A|58|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 00:55:26.988201|2017-10-11 00:55:26.988201
NCT02020291|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-02-01|||June 2013||2013-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer|Phase I Dose Escalating Study to Evaluate the Safety, Tolerability, Anti-Tumour Activity and Pharmacokinetic and Pharmacodynamic Profiles of Foxy-5 in Patients With Metastatic Breast, Colon or Prostate Cancer|Completed||Phase 1|31|Actual|WntResearch AB||1|||f||||t||||||||||2017-10-11 00:55:27.279532|2017-10-11 00:55:27.279532
NCT02020278|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-09-21|||April 2016||2016-04-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia|A Phase 3b, Multicenter, Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia Who Have Previously Participated in a Trial of Titrated Oral SAMSCA® (Tolvaptan)|Active, not recruiting||Phase 3|3|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t||||||||||2017-10-11 00:55:27.354009|2017-10-11 00:55:27.354009
NCT02020265|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2013-12-30|||February 2013||2013-02-01|December 2013|2013-12-01|February 2015|Anticipated|2015-02-01|June 2014|Anticipated|2014-06-01||Interventional|||fMRI Based EEG Neurofeedback as a Method of Enhancing Emotional Resilience Among Soldiers|Longitudinal Study of the Effect of Neurofeedback Training on Soldiers Emotional Regulation Ability and Mental Resilience to Stress.|Unknown status|Recruiting|N/A|120|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||||2017-10-11 00:55:27.498369|2017-10-11 00:55:27.498369
NCT02020252|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-07-24|||November 26, 2013|Actual|2013-11-26|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Effect of Multi-Media Enrollment|A Pilot Investigation to Examine the Effect of a Multi-Media, Computer Based Tool (Talking Touchscreen) on Enrollment in Adult Oncology-Specific Clinical Trials at an Academic Medical Center|Recruiting||N/A|120|Anticipated|University of Chicago|||1||f||||f||||||||||2017-10-11 00:55:27.589938|2017-10-11 00:55:27.589938
NCT02020239|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-10-27|||December 2013||2013-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Physical Activity Intervention Flexibility on the Time Course of Changes in Body Composition and Metabolism|The Effect of Physical Activity Intervention Flexibility on the Time Course of Changes in Body Composition and Metabolism|Active, not recruiting||N/A|60|Anticipated|University of Birmingham||3|||f||||f||||||||||2017-10-11 00:55:27.657564|2017-10-11 00:55:27.657564
NCT02020213|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-12-11|||December 2013||2013-12-01|December 2013|2013-12-01||||December 2014|Actual|2014-12-01||Interventional|Posaconazole||Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection.|Effectiveness of Posaconazole as Salvage Treatment After 2 Weeks of Preemptive Antifungal Treatment|Withdrawn||Phase 4|0|Actual|Taichung Veterans General Hospital||1|||f||||f||||||||||2017-10-11 00:55:29.657329|2017-10-11 00:55:29.657329
NCT02020200|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2013-12-23|||January 2014||2014-01-01|December 2013|2013-12-01||||December 2014|Anticipated|2014-12-01||Interventional|||The Effect of Methylphenidate on Cognitive Abilities of Adults With Bipolar Disorder|A Crossover Study on the Effect of Methylphenidate (MPH) on Cognitive Abilities of Adults With Bipolar Disorder (BD), During Remission or Depressed State, Compared With Healthy Adults and Adults With Attention Deficit Hyperactivity Disorder (ADHD).|Unknown status|Not yet recruiting|N/A|40|Anticipated|Shalvata Mental Health Center||1|||f||||||||||||||2017-10-11 00:55:29.737658|2017-10-11 00:55:29.737658
NCT02020187|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-05-11|||September 2013||2013-09-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Aerobic Training in Patients With Congenital Myopathies|Aerobic Training in Patients With Congenital Myopathies|Completed||N/A|16|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:55:29.819956|2017-10-11 00:55:29.819956
NCT02020174|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-09-28|||July 2013||2013-07-01|September 2016|2016-09-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01|20 Years|Observational [Patient Registry]|TPR||The Preeclampsia Registry|The Preeclampsia Registry|Recruiting||N/A|20000|Anticipated|Preeclampsia Foundation|||1||f||||t||||||None Retained|"     Biospecimens are not currently being collected, however, participants are asked for their     permission to be contacted about providing a biospecimen in the future. It is not certain yet     what type of biospecimen may be collected.   "|Yes|Data may be shared with proper internal and ethical approval|2017-10-11 00:55:29.901634|2017-10-11 00:55:29.901634
NCT02020161|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-11-10|||June 2012||2012-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Clinical Guidelines for APL Treatment||Recruiting||Phase 4|200|Anticipated|PETHEMA Foundation||1|||f||||f||||||||||2017-10-11 00:55:29.984073|2017-10-11 00:55:29.984073
NCT02020135|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-02-21|2016-12-28||October 2013||2013-10-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||An Open-label Extension Study of PSMA ADC 2301 in mCRPC|An Open-label Treatment Extension of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)|Completed||Phase 2|9|Actual|Progenics Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 00:55:30.190705|2017-10-11 00:55:30.190705
NCT02020122|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-10-01|||January 2014|Actual|2014-01-01|October 2017|2017-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation Profiles||Completed||N/A|5|Actual|Rambam Health Care Campus||3|||f||||t||||||||||2017-10-11 00:55:30.718478|2017-10-11 00:55:30.718478
NCT02020109|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-09-16|||September 2013||2013-09-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia|Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia (CLL)|Recruiting||N/A|100|Anticipated|Maastricht Radiation Oncology|||1||f||||t||||||||Undecided||2017-10-11 00:55:30.823726|2017-10-11 00:55:30.823726
NCT02020096|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-02-18|||November 2013||2013-11-01|December 2013|2013-12-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Ultrasound Plus Nerve Stimulator Versus Nerve Stimulator Guided Lumbar Plexus Block|A Randomized Comparison of Ultrasound Plus Nerve Stimulator Guided Lumbar Plexus Block to Conventional Nerve Stimulator Guided Technique Using Winnie Approach|Completed||Phase 4|48|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 00:55:30.921254|2017-10-11 00:55:30.921254
NCT02020083|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-08-23|||February 2013||2013-02-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Observational|TDF-PTP||Placental Transfer of Tenofovir|Study of Placental Transfer of Tenofovir and Its Factors of Variability Using the Human Placental Perfusion Model|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Tissue samples will be collected. The expression levels of several efflux transporters     (ABCC2/MRP2, ABCC4/MRP4, ABCC10/MRP7) and an uptake transporter (hOAT3) will be determined to     explain the variability of placental transfer.   "|||2017-10-11 00:55:31.021816|2017-10-11 00:55:31.021816
NCT02020070|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-07-26|||December 18, 2013|Actual|2013-12-18|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy|A Phase 2 Study Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy|Active, not recruiting||Phase 2|16|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:55:31.139053|2017-10-11 00:55:31.139053
NCT02020057|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2013-12-18|||February 2006||2006-02-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|August 2010|Actual|2010-08-01||Interventional|||Comparison of Highly Cross-Linked and Conventional Polyethylene in Total Knee Arthroplasty|Comparison of Highly Cross-Linked and Conventional Polyethylene in Posterior Cruciate-Substituting Total Knee Arthroplasty in the Same Patients|Completed||N/A|319|Actual|Ewha Womans University||2|||f||||t||||||||||2017-10-11 00:55:31.235249|2017-10-11 00:55:31.235249
NCT02020044|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-18|||September 2012||2012-09-01|December 2013|2013-12-01||||December 2015|Anticipated|2015-12-01||Interventional|||Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)|Prospective Clinical Study on Postoperative Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)|Unknown status|Recruiting|N/A|200|Anticipated|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-10-11 00:55:31.309962|2017-10-11 00:55:31.309962
NCT02020031|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-10-04|2016-10-04||December 2013||2013-12-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|VIDACARE|Although 22 subjects were enrolled, 2 subjects were withdrawn from the study following an intra-operative decision not to proceed with a full revision. Baseline demographics are provided for the subjects who completed the study.|Regional Prophylactic Vancomycin in Revision Total Knee Replacement|Regional Prophylactic Vancomycin in Revision Total Knee Replacement|Completed||Phase 2/Phase 3|22|Actual|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-11 00:55:31.436118|2017-10-11 00:55:31.436118
NCT02020018|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-08-28|||December 2013||2013-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Negative Pressure Wound Therapy for Prevention of Poststernotomy Infection|Negative Pressure Wound Therapy for Prevention of Wound Infection After Heart Surgery|Recruiting||N/A|950|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 00:55:31.809148|2017-10-11 00:55:31.809148
NCT02019992|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-18|||September 2013||2013-09-01|December 2013|2013-12-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Observational|||Investigation of Plasma Mitochondrial DNA Level in Septic Patients|Plasma Levels of Mitochondrial DNA in Patients Presenting to ICU With Sepsis|Unknown status|Recruiting|N/A|20|Anticipated|Central South University|||3||f||||t||||||Samples With DNA|"     plasma   "|||2017-10-11 00:55:31.991669|2017-10-11 00:55:31.991669
NCT02019979|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-12-22|||December 2013||2013-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|METRO||Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)|Metformin With a Carbohydrate Restricted Diet In Combination With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) - METRO Study|Terminated||Phase 2|16|Actual|Beth Israel Medical Center||1||PI left the institution|f||||f||||||||||2017-10-11 00:55:32.08197|2017-10-11 00:55:32.08197
NCT02019966|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-08-18|||August 2014||2014-08-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy||Recruiting||N/A|1000|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-11 00:55:32.181067|2017-10-11 00:55:32.181067
NCT02019953|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-03-06|||July 2012||2012-07-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Health Promoting Programs on Cardiovascular Disease Risk|Effects of Health-Promoting Programs on Cardiovascular Disease Risk: JHS|Completed||N/A|375|Actual|University of Mississippi Medical Center||5|||f||||t|f|f||||||No||2017-10-11 00:55:32.25815|2017-10-11 00:55:32.25815
NCT02019940|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-02-04|||January 2014||2014-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD)|An Investigation of the Effects of Riluzole in Patients With Post-Traumatic Stress Disorder (PTSD)|Recruiting||Phase 1|20|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 00:55:32.35989|2017-10-11 00:55:32.35989
NCT02019927|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-04-06|||July 2013||2013-07-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TES||Electric Stimulation of the Eye to Improve Vision After Trauma|Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Function After Ocular Trauma|Active, not recruiting||N/A|120|Actual|Wills Eye||3|||f||||t||||||||No||2017-10-11 00:55:32.456072|2017-10-11 00:55:32.456072
NCT02019914|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-12-10|||July 2013||2013-07-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Effects of CPAP Therapy on PTSD Symptoms|Effects of Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea on PTSD Symptoms|Completed||N/A|59|Actual|Veterans Medical Research Foundation|||1||f||||f||||||||||2017-10-11 00:55:32.575986|2017-10-11 00:55:32.575986
NCT02019901|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-05-18|||January 2014||2014-01-01|May 2017|2017-05-01|March 8, 2017|Actual|2017-03-08|November 2016|Actual|2016-11-01||Interventional|||GotNet Study, The Gothenburg Nurse-led Tight Control Study|A Randomized, Controlled Study Evaluating the Efficacy of Person-centered, Tight Control Nurse-led Clinic of Patients With Established Rheumatoid Arthritis and Moderate to High Disease Activity Compared to Patients Receiving Regular Care|Completed||N/A|70|Actual|Vastra Gotaland Region||2|||f||||f||||||||||2017-10-11 00:55:32.823305|2017-10-11 00:55:32.823305
NCT02019875|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-05-02|||June 2014||2014-06-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||CYP3A4 Induction and Mineral Homeostasis|Hormonal Regulation of CYP3A|Recruiting||N/A|120|Anticipated|University of Washington||6|||f||||f||||||||||2017-10-11 00:55:33.039697|2017-10-11 00:55:33.039697
NCT02019862|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-04-15|||January 2014||2014-01-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||TRJ Post Market Clinical Follow Up|TRJ PMCF Köln: 2-years Results|Completed||N/A|100|Actual|Aesculap AG|||1||f||||f||||||||||2017-10-11 00:55:33.173002|2017-10-11 00:55:33.173002
NCT02019849|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-01-25|||January 2012|Actual|2012-01-01|January 2017|2017-01-01|June 2023|Anticipated|2023-06-01|December 2012|Actual|2012-12-01||Observational|||Post Market Clinical Follow-Up of Plasmafit® Cup||Active, not recruiting||N/A|100|Actual|Aesculap AG|||1||f||||f||||||||||2017-10-11 00:55:33.248981|2017-10-11 00:55:33.248981
NCT02019836|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-26|||March 2012||2012-03-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01|1 Year|Observational [Patient Registry]|||Comparison of Maternal and Neonatal Vitamin D Levels in Term Neonates With and Without Early Onset Sepsis||Completed||N/A|50|Actual|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||t||||||||||2017-10-11 00:55:33.353367|2017-10-11 00:55:33.353367
NCT02019823|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-11-10|||June 2012||2012-06-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|*StAR||Effectiveness of SMS-text Message Support for Patients With Hypertension to Improve Blood Pressure|SMS-text Adherence Support (StAR*) Study, a Randomized Three-arm Open Parallel Group Trial to Evaluate the Effects of a Structured Programme of Hypertension Treatment Adherence Support Delivered Remotely Through SMS-text Messages on Blood Pressure at 12 Months as Compared With Usual Care.|Completed||N/A|1372|Actual|University of Oxford||3|||f||||f||||||||||2017-10-11 00:55:33.479776|2017-10-11 00:55:33.479776
NCT02019810|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-08-14|||October 2014||2014-10-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|DEBITC||Impact of Cardiac Blood Flow on Cerebral Blood Flow in Patients With Severe Traumatic Brain Injury||Unknown status|Recruiting|Phase 2|20|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 00:55:33.592868|2017-10-11 00:55:33.592868
NCT02019797|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-18|||January 2014||2014-01-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Desflurane-induced Myocardial Protection|Desflurane-induced Myocardial Protection in Aortic Valve Surgery: A Pilot Study|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Keio University||2|||f||||t||||||||||2017-10-11 00:55:33.721925|2017-10-11 00:55:33.721925
NCT02019784|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-11-10|||January 2015||2015-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|RIFSYS||Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy|A Placebo Controlled Single Centre Double Blind Randomised Trial to Investigate the Efficacy of Rifaximin Versus Placebo in Improving Systemic Inflammation and Neutrophil Malfunction in Patients With Cirrhosis and Chronic Hepatic Encephalopathy|Completed||Phase 4|38|Actual|King's College Hospital NHS Trust||2|||f||||f||||||||||2017-10-11 00:55:33.834831|2017-10-11 00:55:33.834831
NCT02019771|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-08-16|||January 2014||2014-01-01|August 2017|2017-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men|Prevalence of Gonorrhea and Chlamydia Infections in Multiple Anatomical Sites in HIV-infected Men Who Have Sex With Men at an HIV Clinic in Omaha, Nebraska|Completed||N/A|150|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 00:55:33.933513|2017-10-11 00:55:33.933513
NCT02019758|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-05-15|||October 2014||2014-10-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis|Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis|Recruiting||N/A|200|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-11 00:55:34.02392|2017-10-11 00:55:34.02392
NCT02019745|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-09-13|||June 2014||2014-06-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers|Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers|Recruiting||N/A|100|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     Whole blood, urine, nasal lavage fluid, nasal epithelial cells   "|||2017-10-11 00:55:34.15439|2017-10-11 00:55:34.15439
NCT02019732|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-01-09|||January 2013||2013-01-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States|Burden of Mild Outcomes Due to Influenza in the United States, July 2000 Through April 2009 and October 2010 to May 2011|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 00:55:34.269519|2017-10-11 00:55:34.269519
NCT02019706|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-21|2017-10-05|||November 26, 2013||2013-11-26|September 26, 2017|2017-09-26|August 15, 2018|Anticipated|2018-08-15|August 15, 2018|Anticipated|2018-08-15||Interventional|||Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome|Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome|Recruiting||Phase 2|80|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:55:34.593252|2017-10-11 00:55:34.593252
NCT02019693|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-09-22|||December 13, 2013||2013-12-13|September 21, 2017|2017-09-21|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer|A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer|Recruiting||Phase 2|22|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:55:34.724462|2017-10-11 00:55:34.724462
NCT02019680|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-06-30|||December 10, 2013||2013-12-10|May 9, 2017|2017-05-09|May 9, 2017|Actual|2017-05-09|May 9, 2017|Actual|2017-05-09||Observational|||Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood Vessels|Effects of Dietary Blackcurrant Extract and PCSO-524 (PernaCanaliculus Supercritical Oil) on Endothelial Function and Biomarkers of Vascular Health|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:55:34.864344|2017-10-11 00:55:34.864344
NCT02019641|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-20|2017-08-04|||November 26, 2013||2013-11-26|July 27, 2017|2017-07-27|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease|The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease|Recruiting||Phase 2|60|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 00:55:35.139011|2017-10-11 00:55:35.139011
NCT02019628|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-23|||November 2009||2009-11-01|December 2013|2013-12-01|November 2011|Actual|2011-11-01|April 2011|Actual|2011-04-01||Interventional|||Enhanced Natural Killer Cell Activity and RBAC|Enhancement of Natural Killer Cell Activity in Healthy Adults by Rice Bran Arabinoxylan Compound, a Novel Oligosaccharide|Completed||N/A|20|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 00:55:35.23513|2017-10-11 00:55:35.23513
NCT02019615|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-03-29|||February 2013||2013-02-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|tDCS in MCS||tDCS in MCS: Repeated Stimulations|Repeated tDCS in Chronic Minimally Conscious State Patients : a Sham-controlled Randomized Double Blind Study|Completed||N/A|20|Actual|University Hospital of Liege||2|||f||||t|f|f||||||||2017-10-11 00:55:35.318347|2017-10-11 00:55:35.318347
NCT02019602|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-03-07|||January 2014||2014-01-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|CRIB||A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta|A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)|Completed||Phase 1|16|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 00:55:35.388806|2017-10-11 00:55:35.388806
NCT02019576|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-05-02|||May 2014||2014-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib|A Phase II, Multi-Centre Study, of Stereotactic Radiotherapy for Oligo-Progression in Metastatic Renal Cell Cancer Patients Receiving 1st Line Sunitinib Therapy|Recruiting||Phase 2|68|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 00:55:35.724576|2017-10-11 00:55:35.724576
NCT02019563|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-02-05|2015-07-20||September 2010||2010-09-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|MTA/FS|The MTA/FS group consisted of 100 incisors in 40 subjects (19 males; 21 females) and the RCT group consisted of 72 primary incisors in 30 subjects (14 males; 16 females).|MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial|Mineral Trioxide Aggregate/Ferric Sulfate Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial|Completed||Phase 2|70|Actual|The Hospital for Sick Children|Limitations of the study design included no blinding of personnel providing treatment or raters assessing clinical and radiographic outcomes.|2|||f||||f||||||||||2017-10-11 00:55:35.887395|2017-10-11 00:55:35.887395
NCT02019550|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-01-13|2017-01-13||March 2014||2014-03-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Full Analysis Set (FAS) included all relapsing remitting multiple sclerosis subjects who received at least 1 injection of Rebif using either Rebif Rebidose or Rebiject II and had at least 1 post-baseline evaluation/assessment.|Rebif® Rebidose® Versus Rebiject II® Ease-of-Use|A Phase IV, Randomized, Prospective, US-based, Multicenter, Cross-over Study Evaluating Subject Ease-of-use With Rebif® Rebidose® and Rebiject II® Autoinjectors in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) Treated With REBIF® 44 mcg Subcutaneously Three Times a Week|Completed||Phase 4|97|Actual|EMD Serono||2|||f||||f||||||||||2017-10-11 00:55:36.293377|2017-10-11 00:55:36.293377
NCT02019537|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-12-19|||January 2014||2014-01-01|May 2015|2015-05-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Subacromial Injection of Allogeneic Platelet Rich Plasma (PRP) for Shoulder Impingement Syndrome||Completed||N/A|60|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 00:55:37.556562|2017-10-11 00:55:37.556562
NCT02019524|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-10-16|||September 2013||2013-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|J65||Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients|Phase Ib Trial of Two Folate Binding Protein (FBP) Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|San Antonio Military Medical Center||3|||f||||t||||||||||2017-10-11 00:55:37.634363|2017-10-11 00:55:37.634363
NCT02019511|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-04-18|||October 2013||2013-10-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Observational|||Safety Study of High-dose Methylprednisolone in Fast-track Total Knee Arthroplasty|Safety Aspects of High-Dose Methylprednisolone in Fast-track Total Knee Arthroplasty|Completed||N/A|6000|Anticipated|Rigshospitalet, Denmark|||3||f||||t||||||||||2017-10-11 00:55:37.768518|2017-10-11 00:55:37.768518
NCT02019498|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-08-02|||April 2014||2014-04-01|February 2016|2016-02-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|Relaxback||Effectiveness of App-based Relaxation for Patients With Chronic Low Back Pain (Relaxback)|A Randomized Pragmatic Trial About the Effectiveness of an App Based Relaxation Technique for Patients With Chronic Low Back Pain|Terminated||N/A|50|Actual|Charite University, Berlin, Germany||2||Recruitment problems|f||||f||||||||||2017-10-11 00:55:37.951881|2017-10-11 00:55:37.951881
NCT02019485|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2013-12-18|||July 2010||2010-07-01|December 2013|2013-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy Subjects|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess Bioequivalence of a New Tapentadol Extended-Release (TRF) 100-mg Tablet With Respect to a Tapentadol Extended-Release (PR2) 100-mg Tablet Under Fasted Conditions in Healthy Subjects|Completed||Phase 1|64|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 00:55:38.114396|2017-10-11 00:55:38.114396
NCT02019472|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-08-16|2017-08-16|2016-07-04|April 4, 2014|Actual|2014-04-04|August 2017|2017-08-01|August 17, 2016|Actual|2016-08-17|August 17, 2016|Actual|2016-08-17||Interventional|SIRROUND-H||A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis|A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis|Completed||Phase 3|559|Actual|Janssen Research & Development, LLC||3|||f||||t||f||||||||2017-10-11 00:55:38.264891|2017-10-11 00:55:38.264891
NCT02019459|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-08-02|||November 2014||2014-11-01|August 2016|2016-08-01||||August 2018|Anticipated|2018-08-01||Interventional|||Very Low Nicotine Cigarettes in Smokers With Schizophrenia|Very Low Nicotine Cigarettes in Smokers With Schizophrenia|Recruiting||Phase 2|80|Anticipated|Brown University||2|||f||||t||||||||||2017-10-11 00:55:40.78647|2017-10-11 00:55:40.78647
NCT02019446|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-02-16|||July 2018|Anticipated|2018-07-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Laser Treatment for Onychomycosis in Diabetes|Evaluating the Effectiveness of Laser Treatment for Onychomycosis of the Hallux in Patients With Diabetes: A Randomized Controlled Trial|Not yet recruiting||N/A|60|Anticipated|BCDiabetes.Ca||2|||f|||||f|t|f|f||||Undecided|There is no initial plan to share IPD at the moment|2017-10-11 00:55:40.883535|2017-10-11 00:55:40.883535
NCT02019433|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-01-25|||July 2012||2012-07-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®|Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®|Terminated||N/A|5|Actual|Aesculap AG|||1||f||||f||||||||||2017-10-11 00:55:41.019803|2017-10-11 00:55:41.019803
NCT02019420|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-09-28|||January 6, 2014|Actual|2014-01-06|September 2017|2017-09-01|October 2, 2018|Anticipated|2018-10-02|October 2, 2018|Anticipated|2018-10-02||Interventional|||Tedizolid Phosphate (TR-701 FA) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)|A Phase 3 Randomized Double-blind Study Comparing TR-701 FA and Linezolid in Ventilated Gram-positive Nosocomial Pneumonia|Recruiting||Phase 3|726|Anticipated|Cubist Pharmaceuticals LLC||2|||f||||t||||||||||2017-10-11 00:55:41.123133|2017-10-11 00:55:41.123133
NCT02019407|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-07-13|||December 2013||2013-12-01|July 2014|2014-07-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Prospective Randomized Study on Clinical Effectiveness of Carvo-Tricuspid Isthmus Block in Patients With Paroxysmal Atrial Fibrillation||Unknown status|Recruiting|N/A|50|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:55:41.370648|2017-10-11 00:55:41.370648
NCT02019394|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-03-20|||December 2013||2013-12-01|March 2014|2014-03-01||||February 2014|Actual|2014-02-01||Interventional|||Absolute Bioavailability of Lu AE58054 in Healthy Subjects|Interventional, Open-label Study Investigating the Absolute Bioavailability of Lu AE58054 After Multiple Oral Dosing and a Single Radio-labelled Intravenous Micro-dose as Well as the Contribution of Cytochrome P450 2D6 to the Exposure of Lu AE58054 in Healthy Subjects|Completed||Phase 1|10|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 00:55:41.458645|2017-10-11 00:55:41.458645
NCT02019381|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-12-20|||September 2013||2013-09-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study the Effects of Vitamin D and Calcium Supplementation at Tolerable Upper Limit Doses on Calcium Metabolism.|The Effects of Vitamin D and Calcium Supplementation at Tolerable Upper Limit Doses on Calcium Metabolism in Postmenopausal White Women.|Completed||N/A|132|Actual|Winthrop University Hospital||2|||f||||f||||||||Undecided||2017-10-11 00:55:41.529123|2017-10-11 00:55:41.529123
NCT02019368|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-08-17|||November 2013||2013-11-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Antioxidant Effect of Aged Garlic Extract|A Randomized, Double-blind, Placebo Controlled, Crossover Study to Evaluate the Antioxidant Effect of Aged Garlic Extract in Heavy Smokers|Completed||N/A|60|Actual|Hiroshima University||3|||f||||f||||||||||2017-10-11 00:55:41.607162|2017-10-11 00:55:41.607162
NCT02019355|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-05-18|||October 2013||2013-10-01|December 2013|2013-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|AK||Actinic Keratosis Study|The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions|Completed||Early Phase 1|132|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:55:41.67987|2017-10-11 00:55:41.67987
NCT02019342|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-10-31|||June 2011||2011-06-01|October 2016|2016-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|MAP-ALIVE||Study to Determine the Impact of Intraoperative Blood Pressure Management on Postoperative Outcomes (MAP-ALIVE)|Mean Arterial Pressure Alert Level Impact on Vital Endpoint: the MAP-ALIVE Study|Withdrawn||N/A|0|Actual|Washington University School of Medicine|||2|unable to implement the intervention|f||||f||||||||||2017-10-11 00:55:41.77964|2017-10-11 00:55:41.77964
NCT02019329|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-11-01|||January 2014||2014-01-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone|A SINGLE-CENTER, RANDOMIZED, INVESTIGATOR/SUBJECT-BLIND, MULTIPLE-DOSE, PLACEBO-CONTROLLED, PARALLEL STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF RO5545965 IN PATIENTS WITH SCHIZOPHRENIA ON RISPERIDONE.|Completed||Phase 1|32|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:55:41.889905|2017-10-11 00:55:41.889905
NCT02019316|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-17|||January 2014||2014-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||BioSteel Supplementation and Performance|The Effect of BioSteel Sports Drink Supplementation on Muscular Fatigue, Cognitive Function, and Recovery Following Sprint Interval Exercise|Unknown status|Not yet recruiting|Phase 1|15|Anticipated|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 00:55:41.982506|2017-10-11 00:55:41.982506
NCT02019303|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-10-24|||February 2014||2014-02-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer|Ultrasound Guided Core Needle Biopsy Versus Fine Needle Aspiration of Morphologically Abnormal Axillary Lymph Node in Patients With New Diagnosis or Suspected Diagnosis of Invasive Breast Carcinoma|Recruiting||N/A|100|Anticipated|University of Utah||1|||f||||t||||||||||2017-10-11 00:55:42.094476|2017-10-11 00:55:42.094476
NCT02019290|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-11-01|||February 2014||2014-02-01|November 2016|2016-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.|A SINGLE CENTER, OPEN LABEL, FIXED SEQUENCE STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE BITOPERTIN ON SINGLE DOSE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY VOLUNTEERS|Withdrawn||Phase 1|0|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:55:42.164607|2017-10-11 00:55:42.164607
NCT02019264|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-05-30|||January 2014|Actual|2014-01-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|CAMELLIA-TIMI||A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors|Active, not recruiting||Phase 4|12000|Actual|Eisai Inc.||2|||f||||t||||||||||2017-10-11 00:55:42.359158|2017-10-11 00:55:42.359158
NCT02019251|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2014-11-17|||December 2013||2013-12-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|DIAL1001005||Lung Transplant Subjects Using 19F MRI|Evaluation of Regional Lung Function in Lung Transplant Recipients Using 19F Magnetic Resonance Imaging of Inert Perfluorinated Gases Mixed With Oxygen|Completed||Phase 1|6|Actual|Duke University||1|||f||||t||||||||||2017-10-11 00:55:43.606039|2017-10-11 00:55:43.606039
NCT02019238|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-08-19|||August 2013||2013-08-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|RASTA XT||Second Study to Assess Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial Fibrillation|Second Randomization Study to Assess Efficacy of Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial Fibrillation: RASTA XT Study|Terminated||N/A|56|Actual|University of Pennsylvania||2||PI discretion|f||||t||||||||||2017-10-11 00:55:43.688397|2017-10-11 00:55:43.688397
NCT02019225|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-06-28|||December 18, 2013|Actual|2013-12-18|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|January 31, 2017|Actual|2017-01-31||Interventional|TiME||A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration|Time to Reduce Mortality in End-Stage Renal Disease (TiME) Trial|Terminated||N/A|7053|Actual|University of Pennsylvania||2||Insufficient separation in session duration between randomized treatment groups|f||||t||||||||||2017-10-11 00:55:43.757058|2017-10-11 00:55:43.757058
NCT02019212|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-04-12|||June 2013||2013-06-01|April 2017|2017-04-01|October 27, 2016|Actual|2016-10-27|October 27, 2016|Actual|2016-10-27||Observational|||Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin|Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-tetrofosmin|Completed||N/A|4000|Anticipated|Ottawa Heart Institute Research Corporation|||1||f||||f||||||||||2017-10-11 00:55:43.834164|2017-10-11 00:55:43.834164
NCT02019186|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2015-02-02|||December 2013||2013-12-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes|Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes|Completed||Phase 4|9|Actual|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-11 00:55:44.061711|2017-10-11 00:55:44.061711
NCT02019160|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-05-01|||September 2014||2014-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effectiveness of Dental Caries Arrest Treatment in Primary Teeth Using AgNO3 Followed by NaF Varnish|Effectiveness of Biannual Application of Silver Nitrate Solution Followed by Sodium Fluoride Varnish in Arresting Early Childhood Caries in Preschool Children: a 30-month, Randomised, Double-blind, Non-inferiority Trial|Active, not recruiting||Phase 3|1070|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 00:55:44.258261|2017-10-11 00:55:44.258261
NCT02019147|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-11-16|||March 2012||2012-03-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|BiHiVE2||BiHiVE2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.|BiHiVE 2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.|Active, not recruiting||N/A|500|Actual|University College Cork|||2||f||||t||||||Samples With DNA|"     Umbilical cord blood   "|||2017-10-11 00:55:44.366083|2017-10-11 00:55:44.366083
NCT02019134|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-07-20|||March 31, 2014|Actual|2014-03-31|July 2017|2017-07-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|Relaxneck||Effectiveness of App-based Relaxation for Patients With Chronic Neck Pain|A Randomized Pragmatic Trial About the Effectiveness of an App Based Relaxation Technique for Patients With Chronic Neck Pain|Completed||N/A|220|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 00:55:44.455889|2017-10-11 00:55:44.455889
NCT02019121|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-06-26|||October 2013||2013-10-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Dexmedetomidine and Renal Transplants|Dexmedetomidine and Renal Transplants|Active, not recruiting||N/A|5000|Anticipated|University of California, Davis|||1||f||||f||||||||||2017-10-11 00:55:44.547483|2017-10-11 00:55:44.547483
NCT02019108|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-10-02|||May 2014|Actual|2014-05-01|October 2017|2017-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Gait Modification Treatment for Knee Osteoarthritis|Effects of Toe-out Gait Modification on Clinical and Biomechanical Measures in People With Knee Osteoarthritis|Recruiting||N/A|80|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:55:44.603246|2017-10-11 00:55:44.603246
NCT02019095|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2015-02-01|||December 2013||2013-12-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Clinical and Biological Markers in Acute Respiratory Failure|Clinical and Biological Markers in Ventilator-associated Pneumonia and the Acute Respiratory Distress Syndrome|Completed||N/A|55|Actual|University of Athens|||1||f||||t||||||Samples Without DNA|"     Bronchoalveolar Lavage Fluid   "|||2017-10-11 00:55:44.706381|2017-10-11 00:55:44.706381
NCT02019082|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-12-23|||March 2011||2011-03-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Electrical Stimulation and Expression of VEGF and NO in Diabetic Foot Ulcer|The Effect of Low-intensity Direct Current on the Expression of Vascular Endothelial Growth Factor and Nitric Oxide in Diabetic Foot Ulcers|Completed||N/A|20|Actual|Tarbiat Modarres University||2|||f||||t||||||||||2017-10-11 00:55:44.822967|2017-10-11 00:55:44.822967
NCT02019069|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-06-12|||February 2014||2014-02-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome|A Phase II Study of CPX-351 for Treatment of AML or Higher Risk MDS Relapsed or Refractory to Prior Therapy With Hypomethylating (HMA) Agent|Recruiting||Phase 2|33|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 00:55:44.901801|2017-10-11 00:55:44.901801
NCT02019056|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-04-27|||November 2010||2010-11-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis|A Multicenter, Randomized, Double-blind, Placebo-controlled,Phase 2 Study to Evaluate the Efficacy, Safety of MG in Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis|Completed||Phase 2|90|Actual|PharmaKing||4|||f||||t||||||||||2017-10-11 00:55:45.004641|2017-10-11 00:55:45.004641
NCT02019043|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-08-15|||February 1, 2015|Actual|2015-02-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Evaluation of Enhanced Syphilis Screening Among HIV-positive Men|Enhanced Syphilis Screening Among HIV-positive Men (ESSAHM): Evaluation of a Clinic-based Intervention|Completed||N/A|3131|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 00:55:45.163517|2017-10-11 00:55:45.163517
NCT02019030|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-04-27|||December 2013|Actual|2013-12-01|April 2017|2017-04-01|January 3, 2017|Actual|2017-01-03|January 3, 2017|Actual|2017-01-03||Observational|||Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode|Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode - An Observational Study|Terminated||N/A|5|Actual|Olympus Corporation of the Americas|||1|Not meeting enrollment goals|f||||f||||||||||2017-10-11 00:55:45.241528|2017-10-11 00:55:45.241528
NCT02019017|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-03-16|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||Botox Injection in Treatment of Cluster Headache|Endoscopic Block of the Sphenopalatine Ganglion With Botulinum Toxin in Intractable Cluster Headache - Safety Issues|Completed||Phase 1/Phase 2|10|Actual|Norwegian University of Science and Technology||2|||f||||t|f|f||||||||2017-10-11 00:55:45.319216|2017-10-11 00:55:45.319216
NCT02019004|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-12-05|||November 2013||2013-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles|Treatment of Forehead/Glabellar Rhytide Complex With Onabotulinum Toxin A Versus Incobotulinum Toxin A Injection: A Split-face, Double-blinded, Randomized Control Trial|Active, not recruiting||N/A|20|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-11 00:55:45.623496|2017-10-11 00:55:45.623496
NCT02018991|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-26|||October 2010||2010-10-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Late Acquired Malaposition and Different Polymers|Incidence and Predictors for Late Acquired Stent Malaposition of Drug-Eluting-Stents With Second-Generation Permanent and Biodegradable Polymer-Coatings - a Prospective, Randomized Comparison Using Optical Coherence Tomography|Completed||Phase 4|69|Actual|Medical University of Vienna||3|||f||||f||||||||||2017-10-11 00:55:45.736824|2017-10-11 00:55:45.736824
NCT02018978|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-12-01|||October 2013||2013-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comprehensive Triaged HIV Prevention in Tanzania|Phase II RCT of Comprehensive Triaged HIV Prevention: Tanzania|Active, not recruiting||Phase 2|739|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 00:55:45.81159|2017-10-11 00:55:45.81159
NCT02018965|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-03-21|||November 2011||2011-11-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Niacin on Immune Activation : a Proof-of-concept Study|Role of Extended-release Niacin on Immune Activation in HIV-infected Patients Treated With Antiretroviral Therapy: a Proof-of-concept Study|Active, not recruiting||Phase 2|20|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 00:55:45.901286|2017-10-11 00:55:45.901286
NCT02018952|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-03-24|||January 2014||2014-01-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|SEPT'ECHO||Ultrasonography Assessment of Septic Arthritis on Native Joint|Ultrasonography Assessment of Septic Arthritis on Native Joint: a Descriptive, Exploratory, Prospective, Multicentric Trial|Completed||N/A|28|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 00:55:45.992425|2017-10-11 00:55:45.992425
NCT02018939|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2014-03-27|||March 2010||2010-03-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.|Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.|Completed||Phase 3|24|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-10-11 00:55:46.084531|2017-10-11 00:55:46.084531
NCT02018926|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-09-06||2017-08-29|December 2013||2013-12-01|September 2017|2017-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS|A Phase I/II, Multi-Center Study of Mocetinostat (MGCD0103) in Combination With Azacitidine in Subjects With Intermediate or High Risk Myelodysplastic Syndrome (MDS)|Completed||Phase 1/Phase 2|18|Actual|Mirati Therapeutics Inc.||1|||f||||t||||||||||2017-10-11 00:55:46.16513|2017-10-11 00:55:46.16513
NCT02018913|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-17|||April 2014||2014-04-01|December 2013|2013-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study||Not yet recruiting||N/A|140|Anticipated|Maastricht University Medical Center|||1||f||||||||||||||2017-10-11 00:55:46.272281|2017-10-11 00:55:46.272281
NCT02018900|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-12-22|||November 2013||2013-11-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|CRIB||The Effects of the Synbiotic Ecologic 825/scFOS on Intestinal Barrier Function and Immune Modulation|The Effects of the Synbiotic Ecologic 825/scFOS on Intestinal Barrier Function|Completed||Phase 4|20|Actual|Maastricht University Medical Center||2|||f||||||||||||||2017-10-11 00:55:46.328294|2017-10-11 00:55:46.328294
NCT02018887|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2015-03-10|||December 2013||2013-12-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of LY2969822 in Healthy Participants|A Single- and Multiple-Ascending Dose, Safety, Tolerability,Pharmacokinetic and Pharmacodynamic Study of LY2969822 in Healthy Subjects|Completed||Phase 1|106|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 00:55:46.414171|2017-10-11 00:55:46.414171
NCT02018874|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-07-11|||September 2013||2013-09-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|INPAKT||A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine|A Phase Ib, Open-label, Dose Escalation Study of the Safety, Tolerability and Efficacy of LY2780301 (a p70/AKT Inhibitor) in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer|Completed||Phase 1|52|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 00:55:46.581194|2017-10-11 00:55:46.581194
NCT02018861|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-16|||March 2015||2015-03-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib (INCB039110) in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)|A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib (INCB039110) in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)|Active, not recruiting||Phase 1/Phase 2|87|Actual|Incyte Corporation||3|||f||||f||||||||Undecided||2017-10-11 00:55:46.673875|2017-10-11 00:55:46.673875
NCT02018848|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-11-11|||October 2013||2013-10-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Internet-delivered Attention Training for Obsessive-Compulsive Disorder|Internet-delivered Attention Training for Obsessive-Compulsive Disorder|Completed||N/A|108|Actual|Humboldt-Universität zu Berlin||2|||f||||||||||||||2017-10-11 00:55:46.823376|2017-10-11 00:55:46.823376
NCT02018835|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-08-06|||December 2012||2012-12-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Exercise Stress MRI to Evaluate Aortic Function (Compliance, Distensibility, Pulse Wave Velocity) and Left Ventricular Function : Validation in Healthy Volunteers and in Selected Patients. A Pilot Study.|Exercise Stress MRI to Evaluate Aortic Function (Compliance, Distensibility, Pulse Wave Velocity) and Left Ventricular Function : Validation in Healthy Volunteers and in Selected Patients. A Pilot Study.|Unknown status|Recruiting|N/A|90|Anticipated|Assistance Publique Hopitaux De Marseille||5|||f||||f||||||||||2017-10-11 00:55:46.931922|2017-10-11 00:55:46.931922
NCT02018822|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-09-30|||June 2013||2013-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluate the Effectiveness of an Experimental Urethane Dimethacrylate Resin Based Dental Composite Material|Clinical Evaluation of an Experimental Urethane Dimethacrylate Resin Based Composite|Active, not recruiting||N/A|50|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 00:55:47.037585|2017-10-11 00:55:47.037585
NCT02018809|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-08-15|2017-04-14||January 2014||2014-01-01|August 2017|2017-08-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Social Forces to Improve Statin Adherence (Study A)|Using Social Support To Improve Medication Adherence In Statin Users With Diabetes|Completed||N/A|200|Actual|University of Pennsylvania|The interventions lasted only 3 months; differences in adherence might emerge over a longer period of time. The primary outcome of pill-bottle-measured adherence has limitations, including bottle malfunction.|4|||f||||f||||||||||2017-10-11 00:55:47.133932|2017-10-11 00:55:47.133932
NCT02018796|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-08-11|||October 2013||2013-10-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan|Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Kazakhstan: A Study of 600 µg Sublingual Misoprostol Following 200 mg Mifepristone for Abortion up to 70 Days Gestation|Completed||N/A|290|Actual|Gynuity Health Projects|||1||f||||f||||||||||2017-10-11 00:55:47.669057|2017-10-11 00:55:47.669057
NCT02018783|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-17|||April 2013||2013-04-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Single Application of Desensitizing Pastes as Dentin Sensitivity Treatment|Clinical Evaluation of the Effectiveness of Immediate Relief Obtained With Desensitizing Creams - A Controlled, Randomized, Triple Masked, Split-Mouth Clinical Trial|Completed||N/A|138|Actual|Federal University of São Paulo||4|||f||||||||||||||2017-10-11 00:55:47.776218|2017-10-11 00:55:47.776218
NCT02018757|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-05-25|||January 2014||2014-01-01|May 2014|2014-05-01||||December 2015|Anticipated|2015-12-01||Interventional|SEATH||Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC|Clinical Application Study of Transarterial Chemoembolization Containing Arsenic Trioxide in the Treatment of Hepatocellular Carcinoma|Unknown status|Not yet recruiting|Phase 2|250|Anticipated|First Hospital of China Medical University||2|||f||||t||||||||||2017-10-11 00:55:47.964922|2017-10-11 00:55:47.964922
NCT02018744|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-10-06|||October 2013||2013-10-01|October 2014|2014-10-01|September 2019|Anticipated|2019-09-01|September 2014|Actual|2014-09-01|5 Years|Observational [Patient Registry]|EVAS-Global||Multicenter, Observational Registry to Assess Outcomes With the Nellix® System for Abdominal Aortic Aneurysm Repair|Multicenter, Observational, Post-Market, Real World Registry to Assess Outcomes of Patients Treated With the Nellix® System for Endovascular Abdominal Aortic Aneurysm Repair|Active, not recruiting||N/A|300|Actual|Endologix|||1||f||||t||||||||||2017-10-11 00:55:48.083862|2017-10-11 00:55:48.083862
NCT02018731|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-05-13|||June 2013||2013-06-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|September 2014|Actual|2014-09-01||Interventional|||L-citrulline and Metformin in Becker's Muscular Dystrophy|Pilot Study to Assess the Efficacy of L-Citrulline and Metformin in Adults With Becker's Muscular Dystrophy|Completed||Phase 2|20|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 00:55:48.208896|2017-10-11 00:55:48.208896
NCT02018718|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-06-06|||March 2013||2013-03-01|December 2013|2013-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Development and Validation Phase of Diffusion Tensor Imaging and Arterial Spin Labelling at 3 Tesla Using a Long-term Effort Model Applicable to Skeletal Muscle Characterization.||Completed||N/A|25|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 00:55:48.299821|2017-10-11 00:55:48.299821
NCT02018705|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-05-21|||August 2013||2013-08-01|July 2014|2014-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|POEM 3||Retrospective Comparison of Peroral Endoscopic Myotomy (POEM) With Laparoscopic Heller Myotomy (LHM)|Comparison of Peroral Endoscopic Myotomy (POEM) With Laparoscopic Heller Myotomy (LHM) for Treatment of Achalasia, a Retrospective Multicenter Study|Terminated||N/A|47|Actual|Universitätsklinikum Hamburg-Eppendorf|||2|data income too low|f||||f||||||||||2017-10-11 00:55:48.378355|2017-10-11 00:55:48.378355
NCT02018692|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-04-25|||January 1, 2018|Anticipated|2018-01-01|April 2017|2017-04-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa|The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa|Not yet recruiting||Phase 1/Phase 2|30|Anticipated|Sheba Medical Center||2|||f||||f|f|f||||||||2017-10-11 00:55:48.480019|2017-10-11 00:55:48.480019
NCT02018679|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2013-12-17|||March 2011||2011-03-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Interventional|||Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Basal Cell Carcinoma|Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Nodular Basal Cell Carcinoma in Asian: A Prospective, Randomized Study With 12 Months Follow-up|Completed||Phase 1|34|Actual|Dong-A University||2|||f||||f||||||||||2017-10-11 00:55:48.568267|2017-10-11 00:55:48.568267
NCT02018666|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-17|||January 2012||2012-01-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study Comparing Two Ventilation Modes NAVA (Neurally Adjusted Ventilatory Assist) Mode and Spontaneous Breathing With Inspiratory Pressure Support (IPS) Mode in Consecutive Patients Hospitalized for Acute Respiratory Failure Requiring Mechanical Ventilation With Endotracheal Tube.|ZEPHYR: Multicenter, Prospective, Randomized, Open-label Study in Consecutive Patients Hospitalized for Acute Respiratory Failure Requiring Mechanical Ventilation With Endotracheal Tube. This Study Compared Two Ventilation Modes: NAVA Mode and Spontaneous Breathing With Inspiratory Pressure Support (the Latter is Considered as the Reference Ventilation Mode).|Completed||N/A|129|Actual|Clinact||2|||f||||||||||||||2017-10-11 00:55:48.649333|2017-10-11 00:55:48.649333
NCT02018640|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-01-12|||December 2013||2013-12-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|MAW Phase 2||Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2|Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2|Completed||N/A|39|Actual|Mayo Clinic|||1||f||||t||||||||||2017-10-11 00:55:49.065466|2017-10-11 00:55:49.065466
NCT02018627|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-21|||April 2014||2014-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon|Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon|Active, not recruiting||Phase 2/Phase 3|30|Anticipated|Massachusetts General Hospital||2|||f||||t|t|f||||||||2017-10-11 00:55:49.130294|2017-10-11 00:55:49.130294
NCT02018614|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-07-04|||January 2014||2014-01-01|July 2014|2014-07-01|January 2015|Anticipated|2015-01-01|October 2014|Anticipated|2014-10-01||Observational|ALGOPLUS LE||International Validation Study Of The Algoplus Scale In Five Languages|INTERNATIONAL VALIDATION STUDY OF THE ALGOPLUS SCALE IN FIVE LANGUAGES|Unknown status|Recruiting|N/A|250|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-11 00:55:49.220487|2017-10-11 00:55:49.220487
NCT02018601|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-01-29|||September 2013||2013-09-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Intercostal Nerves Block in the Midaxillary Line Versus Paravertebral Block for no Reconstructive Breast Surgery|Intercostal Nerves Block in the Midaxillary Line Versus Paravertebral Block, Ultrasound Guided Blocks for no Reconstructive Breast Surgery. Randomized Trial|Recruiting||Phase 4|120|Anticipated|Complexo Hospitalario Universitario de A Coruña||2|||f||||t||||||||||2017-10-11 00:55:49.310388|2017-10-11 00:55:49.310388
NCT02018588|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-04-27|||December 2013||2013-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tryptophan Requirement of Healthy School Age Children|Tryptophan Requirement of Healthy School Age Children Determined by the Indicator Amino Acid Oxidation Method|Recruiting||N/A|7|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||No||2017-10-11 00:55:49.405034|2017-10-11 00:55:49.405034
NCT02018575|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-11-11|||December 2013||2013-12-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Metabolic Availability of Lysine From White Maize|Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Lysine From White Maize Protein, in Young Adult Men|Completed||Phase 1|7|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 00:55:49.482104|2017-10-11 00:55:49.482104
NCT02018562|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-08-15|||February 2015||2015-02-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|February 2017|Actual|2017-02-01||Interventional|BLUSA||Evaluation of a Tracheostomy Tube That Enables Communication|Prospective Evaluation of a Tracheostomy Tube That Enables Communication in Ventilator Dependent Patients - A Pilot Study|Completed||N/A|50|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:55:49.551998|2017-10-11 00:55:49.551998
NCT02018549|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-03-28|||December 2013||2013-12-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PIF3||An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI|An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler Dry Powder Inhaler (DPI) Device|Completed||Phase 2|72|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-11 00:55:49.624459|2017-10-11 00:55:49.624459
NCT02018536|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-06-16|||October 2013||2013-10-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.|A Phase 1, Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GSK2336805 (Part 1), Followed by an Open-label, Randomized, 4-way Crossover Study to Evaluate Short-term Safety, Tolerability and Pharmacokinetics of the Co-administration of TMC435 and GSK2336805 at Steady-state (Part 2), in Healthy Japanese Subjects|Completed||Phase 1|48|Actual|Janssen R&D Ireland||7|||f||||f||||||||||2017-10-11 00:55:49.702461|2017-10-11 00:55:49.702461
NCT02018523|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-04-08|||June 2014||2014-06-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer|A Pilot Study of Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer After First-line Chemotherapy|Active, not recruiting||Phase 1|30|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 00:55:49.921754|2017-10-11 00:55:49.921754
NCT02018510|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-12-23|||January 2014||2014-01-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117|A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers|Completed||Phase 1|49|Actual|Rockefeller University||15|||f||||t||||||||No||2017-10-11 00:55:50.101906|2017-10-11 00:55:50.101906
NCT02018497|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2017-08-21|||January 1995||1995-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|June 2018|Anticipated|2018-06-01|15 Years|Observational [Patient Registry]|EHAR||Essential Hypotension and Allostasis Registry|Essential Arterial Hypotension and Allostasis Registry|Recruiting||N/A|5000|Anticipated|CES University|||1||f||||f||||||||||2017-10-11 00:55:50.278253|2017-10-11 00:55:50.278253
NCT02018484|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-08-18|||December 2013||2013-12-01|March 2016|2016-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PSI-PUC||Positioning of the Tibial Cut in Unicompartmental Medial Knee Replacement by Using Patient Specific Cutting Guides.|Positioning of the Tibial Cut in Unicompartmental Medial Knee Replacement by Using Patient Specific Cutting Guides.|Completed||N/A|32|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 00:55:50.506932|2017-10-11 00:55:50.506932
NCT02018471|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-20|||April 2012||2012-04-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Psychological Counselling in Diagnostic Screening|Management of Anxiety Related to Diagnostic Screenings: an Exploratory Pilot Study|Completed||N/A|43|Actual|Istituto Oncologico Veneto IRCCS||1|||f||||f||||||||||2017-10-11 00:55:50.581056|2017-10-11 00:55:50.581056
NCT02018263|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-01-23|||October 2013||2013-10-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans||Active, not recruiting||N/A|36|Anticipated|Yale University||3|||f||||||||||||||2017-10-11 00:55:51.98664|2017-10-11 00:55:51.98664
NCT02018458|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-01-12|||May 2014||2014-05-01|January 2016|2016-01-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer|Pilot Safety Trial of Preoperative Chemotherapy Combined With Dendritic Cell Vaccine in Patients With Locally Advanced, Triple-Negative Breast Cancer or ER-Positive, Her2-Negative Breast Cancer|Recruiting||Phase 1/Phase 2|20|Anticipated|Baylor Research Institute||2|||f||||t||||||||||2017-10-11 00:55:50.672071|2017-10-11 00:55:50.672071
NCT02018445|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-06-28|||November 2013||2013-11-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion|Efficacy and Safety of Integra Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion|Completed||N/A|36|Actual|SeaSpine, Inc.||1|||f||||f||||||||||2017-10-11 00:55:50.776349|2017-10-11 00:55:50.776349
NCT02018432|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-17|||December 2013||2013-12-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Strategy to Improve Adherence of Roflumilast|Adherence to Therapy in COPD Patients Under Dose Escalation of Roflumilast|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 00:55:50.848447|2017-10-11 00:55:50.848447
NCT02018419|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-04-01|||March 2014||2014-03-01|April 2015|2015-04-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|MBC||Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients|In-Situ Cancer Vaccine: Phase I/IIb, Open-Label Study to Assess Safety of AllostimTM in Combination With Cryoablation in Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane and Capecitabine|Withdrawn||Phase 1/Phase 2|0|Actual|Immunovative Therapies, Ltd.||3||changing indication from breast cancer to metastatic colorectal cancer|f||||t||||||||||2017-10-11 00:55:50.941232|2017-10-11 00:55:50.941232
NCT02018406|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-07-13|||December 2013||2013-12-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury||Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 00:55:51.03348|2017-10-11 00:55:51.03348
NCT02018393|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-20|||January 2014||2014-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|||Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors|Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients|Unknown status|Not yet recruiting|N/A|20|Anticipated|Hospital Universitario La Paz|||2||f||||||||||||||2017-10-11 00:55:51.132095|2017-10-11 00:55:51.132095
NCT02018380|ClinicalTrials.gov processed this data on October 10, 2017|2009-06-29|2013-12-16|||August 2006||2006-08-01|December 2013|2013-12-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Shock Absorbing Insoles on Knee Pain and Walking in Persons With Knee Osteoarthritis|Immediate Effects of Shock Absorbing Insoles on Knee Pain, Functional Mobility, and Lower Extremity Biomechanical Characteristics in Persons With Knee Osteoarthritis|Completed||Phase 2|60|Actual|Winston Salem State University||1|||f||||f||||||||||2017-10-11 00:55:51.212738|2017-10-11 00:55:51.212738
NCT02018367|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-09-11|||September 2012||2012-09-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma|Accuracy, Yield and Clinical Impact of a Low-Cost High Resolution Microendoscope in the Early Diagnosis of Esophageal Adenocarcinoma|Recruiting||Phase 2|100|Anticipated|Anandasabapathy, Sharmila, M.D.||2|||f||||t||||||||||2017-10-11 00:55:51.295743|2017-10-11 00:55:51.295743
NCT02018354|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-09-25|||January 2014||2014-01-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|STAbiLiTY||Standard ACL Reconstruction vs ACL + Lateral Extra-Articular Tenodesis Study|Multicenter Randomized Clinical Trial Comparing Anterior Cruciate Ligament Reconstruction With and Without Lateral Extra-articular Tenodesis in Individuals Who Are At High Risk of Graft Failure.|Active, not recruiting||N/A|624|Actual|Western University, Canada||2|||f||||f||||||||||2017-10-11 00:55:51.386675|2017-10-11 00:55:51.386675
NCT02018341|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-12-20|||June 2013||2013-06-01|December 2013|2013-12-01|February 2014|Anticipated|2014-02-01|October 2013|Anticipated|2013-10-01||Interventional|||The Homeogenomic Trial|"A Randomized Double-blind Placebo Controlled Homeopathic Pathogenetic Trial (HPT) on Healthy Volunteers Proving XX in the Potency of 30C, The Homeogenomic Trial"|Withdrawn||N/A|0|Actual|University of Washington||2||Funding withdrawn|f||||f||||||||||2017-10-11 00:55:51.490821|2017-10-11 00:55:51.490821
NCT02018328|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-12-13|||January 2014||2014-01-01|December 2014|2014-12-01||||December 2015|Anticipated|2015-12-01||Interventional|CurHP||The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection|The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection|Unknown status|Not yet recruiting|N/A|150|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 00:55:51.567282|2017-10-11 00:55:51.567282
NCT02018315|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-26|||January 2012||2012-01-01|December 2013|2013-12-01|March 2014|Anticipated|2014-03-01|January 2013|Actual|2013-01-01||Interventional|||Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)|Clinical Trial of Citric Acid Cycle Stimulation in Energy-deficiency States: Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) (NMTUT 2010B)|Unknown status|Active, not recruiting|Phase 1|14|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 00:55:51.652568|2017-10-11 00:55:51.652568
NCT02018302|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-26|||January 2013||2013-01-01|December 2013|2013-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Expanded Access|||Post Study Continuation of C7 for G1D|Post Study Continuation of C7 for G1D|Available||N/A|||University of Texas Southwestern Medical Center|||||||||f||||||||||2017-10-11 00:55:51.74727|2017-10-11 00:55:51.74727
NCT02018289|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-20|||October 2007||2007-10-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Interventional|||Effect of Triclosan-coated Suture on Superficial SSI||Completed||Phase 3|106|Actual|Hospital General Universitario Elche||2|||f||||||||||||||2017-10-11 00:55:51.845317|2017-10-11 00:55:51.845317
NCT02018276|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-01-30|||December 2013||2013-12-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Thyroid Surgery||Completed||N/A|135|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:55:51.920753|2017-10-11 00:55:51.920753
NCT02018237|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-03-22|||March 2012||2012-03-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Fructose||High Fructose Corn Syrup|The Effect of High Fructose Corn Syrup Feeding in Nonalcoholic Fatty Liver Disease|Completed||N/A|47|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:55:52.149964|2017-10-11 00:55:52.149964
NCT02018224|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-09-15|||October 1998||1998-10-01|September 2014|2014-09-01||||March 2014|Actual|2014-03-01||Interventional|||Achilles Tendon Rupture, Comparison Two Different Operative Techniques. Prospective Randomized Controlled Trial. 14 Years Follow-up.|Achilles Tendon Rupture, Comparison Two Different Operative Techniques. Prospective Randomized Controlled Trial. 14 Years Follow-up.|Completed||N/A|55|Actual|University of Oulu||2|||f||||f||||||||||2017-10-11 00:55:52.224794|2017-10-11 00:55:52.224794
NCT02018211|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-06-25|||December 2012||2012-12-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Neuromuscular Electrical Stimulation Via the Peroneal Nerve Reduces Muscle Soreness Following Intermittent Exercise|Neuromuscular Electrical Stimulation Via the Peroneal Nerve Reduces Muscle Soreness Following Intermittent Exercise|Completed||N/A|21|Actual|Firstkind Ltd||1|||f||||f||||||||||2017-10-11 00:55:52.301601|2017-10-11 00:55:52.301601
NCT02018198|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-09-30|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|May 2020|Anticipated|2020-05-01||Observational|||FebriDx Evaluation for Acute Community Acquired Febrile Upper Respiratory Infection|Clinical Performance of FebriDx in Patients Being Evaluated for Acute Community Acquired Febrile Respiratory Infection|Active, not recruiting||N/A|1225|Anticipated|Rapid Pathogen Screening|||1||f||||f||||||||||2017-10-11 00:55:52.386279|2017-10-11 00:55:52.386279
NCT02018185|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-19|||January 2014||2014-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|rTMS||Study of Magnetic Brain Stimulation in Treatment of Obsessive Compulsive Disorder|The Efficacy of Deep Repetitive Transcranial Magnetic Stimulation in Treatment of Obsessive Compulsive Disorder, a Double Blind Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-11 00:55:52.461086|2017-10-11 00:55:52.461086
NCT02018172|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-05-11|||July 2014||2014-07-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|ZOMAXEPT||Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device||Terminated||N/A|3|Actual|Ferring Pharmaceuticals|||1|Terminated due to lack of recruitment and difficulty in the selection of sites|f||||f||||||||||2017-10-11 00:55:52.53708|2017-10-11 00:55:52.53708
NCT02018159|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-08-25|||January 2014||2014-01-01|August 2017|2017-08-01|May 12, 2016|Actual|2016-05-12|February 12, 2016|Actual|2016-02-12||Observational|||An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos||Completed||N/A|738|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 00:55:52.6089|2017-10-11 00:55:52.6089
NCT02018146|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-01-27|||June 2015||2015-06-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|MASK||Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Surgery|Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Patients With Predicted Difficult to Mask Ventilate|Recruiting||N/A|20|Anticipated|University of Louisville||2|||f||||f||||||||||2017-10-11 00:55:52.881526|2017-10-11 00:55:52.881526
NCT02018133|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-06-30|||December 2009||2009-12-01|June 2015|2015-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients||Completed||Phase 3|8|Actual|University of Illinois at Chicago||1|||f||||f||||||||||2017-10-11 00:55:52.991284|2017-10-11 00:55:52.991284
NCT02018120|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-20|||May 2012||2012-05-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Platelet Rich Fibrin in the Treatment of Multiple Gingival Recessions|Comparison of Platelet Rich Fibrin and Connective Tissue Graft in Treatment of Multiple Gingival Recessions|Completed||N/A|26|Actual|Ege University||2|||f||||f||||||||||2017-10-11 00:55:53.506327|2017-10-11 00:55:53.506327
NCT02018107|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-02-27|||January 2014||2014-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||PET/CT-Assessment of Liver Tumor Ablation|PET/CT-Guided Liver Tumor Ablation: Intraprocedural Assessment of Results Using Ammonia Perfusion PET|Recruiting||N/A|75|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 00:55:53.604277|2017-10-11 00:55:53.604277
NCT02018094|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-12-14|||October 2013||2013-10-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|ASSIT||The Amputation Surgical Site Infection Trial (ASSIT)|A Randomised Control Trial to Determine Whether a 5 Day Course of Antibiotics is More Clinically and Cost Effective Than a 24 Hour Prophylactic Course for the Prevention of Surgical Site Infection Following Lower Limb Amputation|Unknown status|Recruiting|Phase 4|164|Anticipated|University of Hull||4|||f||||t||||||||||2017-10-11 00:55:53.719843|2017-10-11 00:55:53.719843
NCT02018081|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-03-04|||March 2012||2012-03-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|LEVO-PHARM||Pharmacokinetics of Levofloxacin in Intensive Care Unit|Population Pharmacokinetics of Levofloxacin in Intensive Care Patients With Severe Community-acquired Pneumonia.|Completed||Phase 4|52|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-11 00:55:53.884182|2017-10-11 00:55:53.884182
NCT02018068|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-12-02|||December 2013||2013-12-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|MICREL||"Postoperative Patient-controlled Perineural Analgesia After Orthopedic Surgery by Remote Control Versus Bedside Care"|Postoperative Patient-controlled Perineural Analgesia After Orthopedic Surgery: A Medico-economic Comparative Evaluation of Patient Management by Remote Control Versus Bedside Care|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 00:55:53.981898|2017-10-11 00:55:53.981898
NCT02018055|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-05-26|||February 2014||2014-02-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Compare Efficacy and Safety of Clopidogrel vs Ticagrelor in Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention; TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI|A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs Ticagrelor in Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention; TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI|Unknown status|Recruiting|N/A|3288|Anticipated|The Catholic University of Korea|||2||f||||t||||||||||2017-10-11 00:55:54.114262|2017-10-11 00:55:54.114262
NCT02018042|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-10-27|||September 2013||2013-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata|An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata|Active, not recruiting||Phase 2|15|Anticipated|Columbia University||1|||f||||t||||||||Undecided||2017-10-11 00:55:54.212977|2017-10-11 00:55:54.212977
NCT02018029|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-20|||March 2013||2013-03-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|PREFAC-CRT||Predictives Factors of Cardiac Resynchronization Therapy: a Multimodal Analysis Using 2D Speckle Tracking Echocardiography Coupled With MIBG Myocardial Scintigraphy and Heart Failure Biomarkers|Predictives Factors of Cardiac Resynchronization Therapy: a Multimodal Analysis Using 2D Speckle Tracking Echocardiography Coupled With MIBG Myocardial Scintigraphy and Heart Failure Biomarkers|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 00:55:54.394611|2017-10-11 00:55:54.394611
NCT02018016|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-12-16|||January 2001||2001-01-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|December 2010|Actual|2010-12-01||Observational|||The Hospital Volume Relationship in Appendicectomy Outcomes|The Hospital Volume Relationship in Appendicectomy Outcomes|Completed||N/A|40000|Anticipated|University of Edinburgh|||3||f||||f||||||None Retained|"     Please note with regard to enrollment: that although this study period has ended and data is     being collated, the actual number of subjects is not known at this point since data has yet     to be received. We requested data on all subjects meeting our criteria within the time frame     mentioned.   "|||2017-10-11 00:55:54.513345|2017-10-11 00:55:54.513345
NCT02018003|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-20|||January 2014||2014-01-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|||The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Cervical Cancer Research|The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Stage Cervical Cancer|Unknown status|Not yet recruiting|N/A|180|Anticipated|Peking University|||1||f||||t||||||||||2017-10-11 00:55:54.631601|2017-10-11 00:55:54.631601
NCT02017990|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-02-28|||October 1999||1999-10-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|August 2012|Actual|2012-08-01||Observational|||Plasma Marine n-3 Polyunsaturated Fatty Acids and Patient and Graft Survival|The Levels of Marine n-3 Polyunsaturated Fatty Acids in Plasma Phospholipids as a Prognostic Marker of Mortality and Graft Loss Endpoints in Renal Transplant Recipients.|Completed||N/A|2002|Actual|Oslo University Hospital|||1||f||||f||||||Samples Without DNA|"     Plasma phospholipids.   "|||2017-10-11 00:55:54.72178|2017-10-11 00:55:54.72178
NCT02017977|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-12-16|||January 2001||2001-01-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|December 2010|Actual|2010-12-01||Observational|||Geographic Influences on Emergency Laparotomy Outcomes|Geographic Influences on Emergency Laparotomy Outcomes|Completed||N/A|40000|Anticipated|University of Edinburgh|||9||f||||f||||||||||2017-10-11 00:55:54.853649|2017-10-11 00:55:54.853649
NCT02017964|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-05-15|||December 2013||2013-12-01|May 2017|2017-05-01||||December 31, 2016|Actual|2016-12-31||Interventional|||Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma|A Phase II Study for the Treatment of Non-metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age|Completed||Phase 2|26|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 00:55:54.966877|2017-10-11 00:55:54.966877
NCT02017951|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-12-16|||January 2001||2001-01-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|December 2010|Actual|2010-12-01||Observational|||Geographic Influences on Appendicectomy Outcomes|Geographic Influences on Appendicectomy Outcomes|Completed||N/A|40000|Anticipated|University of Edinburgh|||9||f||||f||||||||||2017-10-11 00:55:55.292427|2017-10-11 00:55:55.292427
NCT02017938|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2013-12-17|||August 2013||2013-08-01|December 2013|2013-12-01|July 2016|Anticipated|2016-07-01|October 2014|Anticipated|2014-10-01||Interventional|||Establishing the Central and Peripheral Fatigue Indexes and VR Based Anti-fatigue Training Paradigm for Individuals With Parkinson Disease||Unknown status|Recruiting|N/A|90|Anticipated|Chang Gung University||5|||f||||t||||||||||2017-10-11 00:55:55.403396|2017-10-11 00:55:55.403396
NCT02017925|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-04-12|||October 2013||2013-10-01|April 2017|2017-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation|Pulmonary Rehabilitation in Locally Advanced Non-Small Cell Lung Cancer|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:55:55.498361|2017-10-11 00:55:55.498361
NCT02017912|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-07-19|||May 2014||2014-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|NurOwn||Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS|A Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study to Evaluate Safety and Efficacy of Transplantation of Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors (MSC-NTF) in Patients With ALS|Completed||Phase 2|48|Actual|Brainstorm-Cell Therapeutics||2|||f||||t||||||||||2017-10-11 00:55:55.606082|2017-10-11 00:55:55.606082
NCT02017886|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-05-10|||November 2013||2013-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Salivary IgA and Cytokines Response to Dietary Supplementation of Lactobacillus Reuteri|Salivary IgA and Cytokines Response to Dietary Supplementation of Lactobacillus Reuteri|Completed||N/A|47|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 00:55:55.829418|2017-10-11 00:55:55.829418
NCT02017873|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-05-26|||December 2013||2013-12-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|BLESMOK||Longevity and Effectiveness of Bleaching in Healthy and Smokers Patients|"Evaluation of the Effectiveness and Longevity Post Whitening Carbamide Peroxide 10% in Smokers and Nonsmokers. Double-blind Multicenter Clinical Trial. "|Completed||Phase 4|120|Actual|University of Chile||2|||f||||t||||||||||2017-10-11 00:55:55.917503|2017-10-11 00:55:55.917503
NCT02017860|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-07-14|||January 16, 2014|Actual|2014-01-16|July 2017|2017-07-01|January 13, 2020|Anticipated|2020-01-13|January 13, 2020|Anticipated|2020-01-13||Interventional|||Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.|An Open Label, Multi-center Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study and Are Judged by the Investigator to Benefit From Continued Everolimus Treatment|Active, not recruiting||Phase 2|4|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-11 00:55:56.018337|2017-10-11 00:55:56.018337
NCT02017847|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2016-08-03|||November 2013||2013-11-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|GEN100||Intensity of Physical Activity Measured by Activity Monitors in Elderly Persons|Assessment of Intensity Cut Off Points for Physical Activity Measured by Activity Monitors in Elderly Persons|Completed||N/A|150|Actual|Norwegian University of Science and Technology|||1||f||||t||||||||||2017-10-11 00:55:56.104247|2017-10-11 00:55:56.104247
NCT02017834|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-12-01|||February 2012||2012-02-01|December 2013|2013-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|HS2||Does the Harmonic Scalpel Reduce Blood Loss and OR Time in Major Head and Neck Cancer Surgery Undergoing Major Surgery for Oral Cavity Squamous Cell Carcinoma?|Does the Harmonic Scalpel Reduce Operating Time and Blood Loss in Patients Undergoing Major Surgery for Oral Cavity Squamous Cell Carcinoma? A Prospective, Randomized Trial.|Completed||N/A|36|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 00:55:56.174244|2017-10-11 00:55:56.174244
NCT02017821|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2014-08-12|||August 2012||2012-08-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||The Effect of Aerobic Endurance Training in Patients With Drug Addiction|The Effect of Aerobic Endurance Training in Patients With Drug Addiction|Completed||N/A|24|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 00:55:56.260131|2017-10-11 00:55:56.260131
NCT02017808|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-12-01|||February 2014||2014-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|GAO||Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months|A Prospective, Observational, Single-blinded, Longitudinal Optical Coherence Tomography Study of Effect of Copaxone (Glatiramer Acetate) on Retinal Nerve Fiber Layer Thickness in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months|Completed||N/A|100|Actual|University at Buffalo|||2||f||||f||||||||||2017-10-11 00:55:56.327557|2017-10-11 00:55:56.327557
NCT02017795|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-05-25|||August 2014||2014-08-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|asthma||Asthma Self-management Via Application of Telehealth|Managing Asthma With Tele-health Technology: A Feasibility Study|Active, not recruiting||N/A|100|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 00:55:56.395633|2017-10-11 00:55:56.395633
NCT02017782|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-16|||April 2013||2013-04-01|April 2013|2013-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|XDOZ||Controlled Human Exposure to Indoor Air, Dust and Ozone|Controlled Human Exposure to Indoor Air, Dust and Ozone|Completed||N/A|24|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 00:55:56.472396|2017-10-11 00:55:56.472396
NCT02017769|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-10-25|||May 2014||2014-05-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||MRI in Diagnosing and Monitoring CIDP|Magnetic Resonance Imaging and Ultrasound Imaging of Peripheral Nerves in Patients Treated With Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.|Completed||N/A|39|Actual|University of Aarhus|||3||f||||f||||||||||2017-10-11 00:55:56.568202|2017-10-11 00:55:56.568202
NCT02017756|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-16|||January 2012||2012-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|CARE-II||Chinese Atherosclerosis Risk Evaluation- Phase II|A Phase II Study of Chinese Atherosclerosis Risk Evaluation: Investigation of Carotid Atherosclerotic Disease in Patients With Ischemic Cerebrovascular Events|Unknown status|Recruiting|N/A|1000|Anticipated|Tsinghua University|||1||f||||t||||||||||2017-10-11 00:55:56.639079|2017-10-11 00:55:56.639079
NCT02017743|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-16|||December 2012||2012-12-01|December 2013|2013-12-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|TREBECA||Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism|Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism - An Observational Study|Unknown status|Recruiting|N/A|200|Anticipated|Trio Grup Clinical Research|||1||f||||f||||||||||2017-10-11 00:55:56.78923|2017-10-11 00:55:56.78923
NCT02017730|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2015-07-03|||January 2014||2014-01-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers|An Open-Label Study To Evaluate The Safety and Tolerability Of A Novel LPA1 Receptor Positron Emission Tomography (PET) Ligand [11C]BMT-136088 And To Assess Receptor Occupancy In Human Lung Following Oral Administration Of BMS-986020 In Healthy Subjects|Completed||Phase 1|20|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 00:55:57.06037|2017-10-11 00:55:57.06037
NCT02017717|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-17|2017-08-24|||January 27, 2014|Actual|2014-01-27|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|January 10, 2017|Actual|2017-01-10||Interventional|CheckMate 143||A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients|A Randomized Phase 3 Open Label Study of Nivolumab Versus Bevacizumab and Multiple Phase 1 Safety Cohorts of Nivolumab or Nivolumab in Combination With Ipilimumab Across Different Lines of Glioblastoma|Active, not recruiting||Phase 3|626|Actual|Bristol-Myers Squibb||3|||f||||t|t|f||||||||2017-10-11 00:55:57.165071|2017-10-11 00:55:57.165071
NCT02017704|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-02-08|||October 2013||2013-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|CORRECT||Chemoradiation or Brachytherapy for Rectal Cancer|Chemoradiation OR Brachytherapy for RECTal Cancer|Active, not recruiting||Phase 2|138|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||Undecided||2017-10-11 00:55:57.391708|2017-10-11 00:55:57.391708
NCT02017691|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-04-16|||December 2013||2013-12-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|COSGOD||Cerebral Oxygenation to Guide Supplemental Oxygen|Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition After Birth (COSGOD) - a Prospective Two-centre Randomized Controlled Pilot Feasibility Study|Completed||Phase 1/Phase 2|60|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 00:55:57.515049|2017-10-11 00:55:57.515049
NCT02017678|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2014-09-15|||January 2014||2014-01-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|||Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin|A Single-arm, Open-label, Phase 2 Study of JX-594 (Thymidine Kinase-Deactivated Vaccinia Virus Plus GM-CSF) Administered by 5 Weekly Intravenous (IV) Infusions in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin|Withdrawn||Phase 2|0|Actual|Mount Sinai Hospital, Canada||1|||f||||t||||||||||2017-10-11 00:55:57.589344|2017-10-11 00:55:57.589344
NCT02017665|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-04-25|||October 2013||2013-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|6 Months|Observational [Patient Registry]|SNIP||Singapore Neurologic Infections Program|Singapore Neurologic Infections Program|Active, not recruiting||N/A|400|Anticipated|Singapore General Hospital|||1||f||||f||||||Samples With DNA|"     Blood, cerebrospinal fluid, throat/nasopharyngeal swabs, urine and rectal swabs or stool     samples wil be stored for maximum 10 years.All samples will be de-identified and coded   "|||2017-10-11 00:55:57.689832|2017-10-11 00:55:57.689832
NCT02017639|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-04-06|||January 2014||2014-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Sarilumab Effect on the Pharmacokinetics of Simvastatin|A Multi-center, Open-label, 2-treatment, Single-sequence Clinical Study to Evaluate the Effects of a Single 200 mg Subcutaneous Injection of Sarilumab on the Pharmacokinetics of a Single 40 mg Oral Dose of Simvastatin, With Optional 1-year Extension of Open Label Treatment of Sarilumab, in Patients With Rheumatoid Arthritis|Completed||Phase 1|19|Actual|Sanofi||1|||f||||t||||||||||2017-10-11 00:55:57.813878|2017-10-11 00:55:57.813878
NCT02017626|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2015-06-18|||August 2013||2013-08-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||FAST-Fish -Food Allergy Specific Treatment for Fish Allergy.|FAST-Fish -Food Allergy Specific Treatment for Fish Allergy.|Completed||Phase 1/Phase 2|15|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 00:55:57.894662|2017-10-11 00:55:57.894662
NCT02017613|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-06-23|||November 2013||2013-11-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PI3K||Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies|A Phase I, Dose Escalation Study to Evaluate Safety and Efficacy of RP6530, a Dual PI3K Delta/Gamma Inhibitor, in Patients With Relapsed or Refractory Hematologic Malignancies|Completed||Phase 1|35|Actual|Rhizen Pharmaceuticals SA||1|||f||||t||||||||No||2017-10-11 00:55:57.974727|2017-10-11 00:55:57.974727
NCT02017600|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-28|||August 2013||2013-08-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus|A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus|Terminated||Phase 2|48|Actual|Nang Kuang Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:55:58.050861|2017-10-11 00:55:58.050861
NCT02017587|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-02-25|||December 2013||2013-12-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection|Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection|Unknown status|Recruiting|N/A|40|Anticipated|Vaccine and Gene Therapy Institute, Florida|||1||f||||f||||||Samples With DNA|"     plasma/serum PBMC   "|||2017-10-11 00:55:58.147776|2017-10-11 00:55:58.147776
NCT02017574|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-02-23|2016-10-17||October 2013||2013-10-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke|Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke|Completed||N/A|24|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 00:55:58.219707|2017-10-11 00:55:58.219707
NCT02017561|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-04-19|||January 2014||2014-01-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|MET-DIME||Metformin in the Diastolic Dysfunction of Metabolic Syndrome|Metformin in the Diastolic Dysfunction of Metabolic Syndrome: MET-DIME Trial|Active, not recruiting||Phase 2|54|Actual|Universidade do Porto||2|||f||||t||||||||||2017-10-11 00:55:58.470865|2017-10-11 00:55:58.470865
NCT02017548|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-01|||January 2014||2014-01-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|November 2016|Actual|2016-11-01||Interventional|||Default Options in Advance Directives|Default Options in Advance Directives|Active, not recruiting||N/A|270|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-10-11 00:56:00.343198|2017-10-11 00:56:00.343198
NCT02017535|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-06-10|||June 2012||2012-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PTAD GIA||An Adaptive Treatment Strategy for Adolescent Depression-Continuation|A Personalized Approach to Achieving a Sustained Response to Treatment for Adolescent Depression|Completed||Phase 1/Phase 2|45|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:56:00.440703|2017-10-11 00:56:00.440703
NCT02017522|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-04-14|||December 2013||2013-12-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Non-Invasive Characterization in Cardiac Sarcoidosis|Non-Invasive Characterization in Cardiac Sarcoidosis|Active, not recruiting||N/A|8|Anticipated|University of Michigan||1|||f||||f||||||||No||2017-10-11 00:56:00.517505|2017-10-11 00:56:00.517505
NCT02017509|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-06-13|||September 2013||2013-09-01|June 2017|2017-06-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Observational|||Immunoscore in Rectal Cancer|A Study to Determine the Immunopheotype of Locally Advanced Rectal Adenocarcinoma and Its Correlation With the Efficacy of Neoadjuvant Chemoradiotherapy|Recruiting||N/A|86|Anticipated|Providence Health & Services|||1||f||||f||||||Samples With DNA|"     Patients who enroll in the study will all undergo a biopsy as part of their standard of care     evaluation. Biopsies samples will be obtained and sent to pathology for paraffin embedded     blocks for diagnostic evaluation and for subsequent research. Patients will also have tissue     stored in RNA later for subsequent microarray analysis.   "|Yes|This project is being done to contribute pathology samples and patient outcome data to a larger data set intended to validate an algorithm to predict patient outcome based on pathology data obtained at diagnosis. As part of this project, pre-existing samples will be used. There will be new slides made from the samples that will be stained to identify immune response. Pathology analysis and images of the slides will be provided (without patient identifiers) along with de-identified patient outcome data to a central coordinating center.|2017-10-11 00:56:00.607868|2017-10-11 00:56:00.607868
NCT02017496|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-12-16|||October 2013||2013-10-01|December 2013|2013-12-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Observational|NeoBCT||Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment|Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment|Unknown status|Recruiting|N/A|50|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Sampling of primary tumor DNA and RNA is not included as a study specific procedure, but if     the patient is included in a different ongoing protocol with tumor sampling, there is     approval/allowance for using tumor tissue for the purpose of the current study     (characteristics of the primary tumor that may predict residual tumor pattern and BCT     success)   "|||2017-10-11 00:56:00.723554|2017-10-11 00:56:00.723554
NCT02017483|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-16|||July 2013||2013-07-01|December 2013|2013-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Explore the Association Between the Emotion Recognition and the Attention Processing Under the Emotional Stimuli in ADHD|Explore the Association Between the Emotion Recognition and the Attention Processing Under the Emotional Stimuli in ADHD|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 00:56:00.788645|2017-10-11 00:56:00.788645
NCT02017470|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2014-11-20|||September 2013||2013-09-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|WHH||A Culture-Centered Approach to Promoting Women's Heart Health in Singapore|A Culture-Centered Approach to Promoting Women's Heart Health in Singapore|Unknown status|Active, not recruiting|N/A|300|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 00:56:00.86117|2017-10-11 00:56:00.86117
NCT02017444|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-04|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|IIH:DT||Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.|Lowering Intracranial Pressure in Idiopathic Intracranial Hypertension: Assessing the Therapeutic Efficacy and Safety of an 11β-hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017). Phase II Study.|Completed||Phase 2|31|Actual|University of Birmingham||2|||f||||t||||||||Undecided||2017-10-11 00:56:01.061926|2017-10-11 00:56:01.061926
NCT02017431|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-09-27|||January 2014|Actual|2014-01-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|DE3||Air Pollution and Allergens - Attenuation of Health Effects Particle Reduction|Strengthening the Case for Ongoing Reduction of Exposure to Traffic-Related Air Pollution|Completed||N/A|13|Actual|University of British Columbia||4|||f||||f||||||||||2017-10-11 00:56:01.268451|2017-10-11 00:56:01.268451
NCT02017418|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2015-05-26|||February 2012||2012-02-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effects of a Zeaxanthin Intervention on Visuomotor Function|The Effects of a Zeaxanthin Intervention on Visuomotor Function|Completed||N/A|102|Actual|University of Georgia||2|||f||||f||||||||||2017-10-11 00:56:01.375262|2017-10-11 00:56:01.375262
NCT02017392|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2013-12-16|||December 2013||2013-12-01|December 2013|2013-12-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|||A RCT of Compound Lidocaine Cream to Prevent Postoperative Agitation in Patients With Endotracheal Intubation for GA|A Randomized Controlled Study of Compound Lidocaine Cream to Prevent Postoperative Agitation in Patients With Endotracheal Intubation for General Anesthesia|Unknown status|Not yet recruiting|Phase 4|2000|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 00:56:01.60104|2017-10-11 00:56:01.60104
NCT02017379|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-05-15|||June 2014||2014-06-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.|Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.|Terminated||N/A|4|Actual|Texas Tech University Health Sciences Center, El Paso||3||Could not recruit any subjects|f||||t|f|||||||No||2017-10-11 00:56:01.715181|2017-10-11 00:56:01.715181
NCT02017366|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2013-12-19|||February 2014||2014-02-01|December 2013|2013-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|EFECTS||Design of the EFECTS Trial|Design of the EFECTS Trial, Investigating the Influence of Postoperative Enteral Feeding in Esophageal Cancer paTients on Survival|Not yet recruiting||N/A|150|Anticipated|University Hospital, Gasthuisberg||2|||f||||f||||||||||2017-10-11 00:56:01.827214|2017-10-11 00:56:01.827214
NCT02017353|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-10-24|||October 2013||2013-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma|Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma|Completed||Phase 2|7|Actual|University Hospital, Gasthuisberg||1|||f||||f||||||||||2017-10-11 00:56:01.931212|2017-10-11 00:56:01.931212
NCT02017340|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-03-03|||April 24, 2013|Actual|2013-04-24|March 2017|2017-03-01|December 16, 2016|Actual|2016-12-16|December 16, 2016|Actual|2016-12-16||Interventional|NILVAD||A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease|A European Multicentre Double-blind Placebo-controlled Phase III Trial of Nilvadipine in Mild to Moderate Alzheimer's Disease|Completed||Phase 3|511|Actual|St. James's Hospital, Ireland||2|||f||||t||||||||||2017-10-11 00:56:02.03503|2017-10-11 00:56:02.03503
NCT02017327|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-03-16|||December 2013||2013-12-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose|Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01% and Lumigan® 0.03% Unit Dose, in Patients With Primary Open Angle Glaucoma or Ocular Hypertension, Stabilized by Lumigan® 0.01% With Ocular Surface Intolerance|Recruiting||Phase 4|396|Anticipated|Laboratoires Thea||3|||f||||f||||||||||2017-10-11 00:56:02.218813|2017-10-11 00:56:02.218813
NCT02017314|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-16|||November 2013||2013-11-01|December 2013|2013-12-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||VAS Correlation With BMI|Correlation of Postoperative VAS Values and Body Mass Index in Patients Undergoing Abdominal Surgery: A Clinical Trial|Unknown status|Recruiting|Phase 4|100|Anticipated|Istanbul University||5|||f||||t||||||||||2017-10-11 00:56:02.310121|2017-10-11 00:56:02.310121
NCT02017301|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-10-06|||November 2012||2012-11-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2016|Actual|2016-04-01||Observational|||Vector Analysis of Body Composition in Hospitalized Cirrhotic Patients|Influence of Acute Decompensation on Body Composition Determined by Bioelectrical Impedance Vector Analysis|Active, not recruiting||N/A|79|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||f||||||Samples Without DNA|"     Serum and plasma samples   "|No||2017-10-11 00:56:02.385024|2017-10-11 00:56:02.385024
NCT02017288|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-19|2017-06-30|||November 17, 2013||2013-11-17|March 7, 2017|2017-03-07|February 28, 2021|Anticipated|2021-02-28|February 28, 2021|Anticipated|2021-02-28||Observational|||Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan|Natural History Of Oral Cancer Precursor Lesions: A Prospective Cohort Study|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:56:02.453757|2017-10-11 00:56:02.453757
NCT02017275|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-03-10|||November 2013||2013-11-01|March 2016|2016-03-01||||September 2015|Actual|2015-09-01||Interventional|PANDA-III||"Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in Real-World Practice"|"A Prospective, Multicenter, RAndomized, CoNtrolled, Study Comparing the Safety and Efficacy Between BuMA eG Based BioDegradable Polymer Stent and EXCEL Biodegradable Polymer Sirolimus-eluting Stent in ReAl-World Practice (PANDA-III)"|Completed||Phase 4|2348|Actual|Sino Medical Sciences Technology Inc.||2|||f||||t||||||||||2017-10-11 00:56:02.579823|2017-10-11 00:56:02.579823
NCT02017262|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-03-31|||September 2013|Actual|2013-09-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Group Self-Management of Depression and Medical Illness|Group Self-Management for Persons With Depression and Medical Illness|Completed||N/A|76|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 00:56:02.686167|2017-10-11 00:56:02.686167
NCT02017249|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-09-10|||March 2014||2014-03-01|September 2015|2015-09-01||||September 2015|Actual|2015-09-01||Interventional|ArginineGBM||Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme|A Double-Blinded Randomized Placebo-Controlled Trial Exploring the Efficacy of Oral ARginine Supplementation to Improve Cellular Immune Function in Patients With Glioblastoma Multiforme|Completed||Phase 1|1|Actual|Inova Health Care Services||2|||f||||f||||||||||2017-10-11 00:56:02.804603|2017-10-11 00:56:02.804603
NCT02017236|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-10-29|||November 2013||2013-11-01|December 2013|2013-12-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|HMPL-504||A Food Effect Phase I Study of the Volitinib in Healthy Subjects|A Single Center, Open-label, Randomized, Four-Sequence, Four-period Crossover Study to Investigate Food Effect on the Pharmacokinetics of Single Dose of Volitinib in Healthy Subjects|Completed||Phase 1|25|Actual|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-11 00:56:02.899496|2017-10-11 00:56:02.899496
NCT02017210|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-05|||November 2013||2013-11-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ISOS||Insulin-sensitive Obesity: Lessons From Longitudinal Data|Insulin-sensitive Obesity: Prospective and Interventional Studies|Completed||N/A|68|Actual|Garvan Institute of Medical Research||1|||f||||f|f|f||||||||2017-10-11 00:56:03.08455|2017-10-11 00:56:03.08455
NCT02017197|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-11-21|||August 2014||2014-08-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|WARFA||Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil|Therapeutic Equivalence Between Branded and Generic Warfarin Sodium Tablets in Adult Patients With Atrial Fibrillation in Brazil - Crossover Randomized Controlled Equivalence Trial|Completed||Phase 4|100|Actual|Federal University of São Paulo||6|||f||||f||||||||||2017-10-11 00:56:03.297851|2017-10-11 00:56:03.297851
NCT02017184|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2013-12-19|||December 2013||2013-12-01|December 2013|2013-12-01||||December 2014|Anticipated|2014-12-01||Interventional|Drager||Non-invasive Sensor for Core Temperature Measurement|Non-invasive Sensor for Core Temperature Measurement|Unknown status|Not yet recruiting|N/A|12|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 00:56:03.42223|2017-10-11 00:56:03.42223
NCT02017171|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-03-06|||February 2014|Actual|2014-02-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes|PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D|Active, not recruiting||Phase 3|530|Actual|Joslin Diabetes Center||2|||f||||t||||||||||2017-10-11 00:56:03.512048|2017-10-11 00:56:03.512048
NCT02017158|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-29|||September 2011|Actual|2011-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Virtual Sprouts: Web-based Gardening Games to Teach Nutrition and Combat Obesity|Virtual Sprouts: Web-based Gardening Games to Teach Nutrition and Combat Obesity|Completed||N/A|180|Actual|University of Southern California||2|||f||||f||||||||No||2017-10-11 00:56:03.69942|2017-10-11 00:56:03.69942
NCT02017132|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2013-12-16|||April 2013||2013-04-01|December 2013|2013-12-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Effect of Pomegranate Extract Intake on Body Composition and Blood Pressure.|The Effect of Pomegranate Extract on Anthropometric, Physiological and Biochemical Parameters in Human Volunteers: an 8 Week Parallel, Double Blinded, Placebo Controlled, Randomised Trial.|Unknown status|Active, not recruiting|N/A|55|Actual|Queen Margaret University||2|||f||||t||||||||||2017-10-11 00:56:03.914369|2017-10-11 00:56:03.914369
NCT02017119|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-08-18|||January 2011||2011-01-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients|Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients: Impact on the Recurrence of Encephalopathy, Tolerance and Adherence to Treatment, Costs, and Quality of Life|Completed||Phase 2|40|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-11 00:56:04.009833|2017-10-11 00:56:04.009833
NCT02017106|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2013-12-19|||April 2006||2006-04-01|December 2013|2013-12-01||||April 2009|Actual|2009-04-01||Interventional|EVLTAP||Concomitant or Sequential Phlebectomy After Endovenous Laser Therapy for Varicose Veins|Randomized Clinical Trial of Concomitant or Sequential Phlebectomy After Endovenous Laser Therapy for Varicose Veins|Completed||N/A|50|Actual|University of Hull||2|||f||||f||||||||||2017-10-11 00:56:04.100131|2017-10-11 00:56:04.100131
NCT02017093|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-12-09|2015-05-27||January 2009||2009-01-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|July 2012|Actual|2012-07-01||Interventional|||Error Enhancement of the Velocity Component|Error Enhancement of the Velocity Component in the Course of Stroke Patients' Reaching Movements - A Pilot Study|Completed||N/A|7|Actual|University of Haifa||2|||f||||f||||||||||2017-10-11 00:56:04.228157|2017-10-11 00:56:04.228157
NCT02017080|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2015-01-05|||January 2014||2014-01-01|January 2015|2015-01-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Observational|||Fetal Thyroid Ultrasound And Fetal Thyroid Hormones|Efficacy Of Non Invasive Diagnostic Procedures In Evaluating The Influence Of Maternal Autoimmune Thyroid Gland Disease On Fetus|Recruiting||N/A|300|Anticipated|University of Belgrade|||3||f||||f||||||||||2017-10-11 00:56:04.607239|2017-10-11 00:56:04.607239
NCT02017067|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-16|||April 2012||2012-04-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||The Effect of Exercise Training in the Community-dwelling Adults With Chronic Disorders|The Effect of Exercise Training in the Community-dwelling Adults With Chronic Disorders|Completed||N/A|58|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:56:04.729778|2017-10-11 00:56:04.729778
NCT02017054|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-17|||January 2015||2015-01-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Month|Observational [Patient Registry]|||Feasibility and Outcomes of Repetitive Radial Approach|Feasibility and Outcomes of Repetitive Radial Approach|Withdrawn||N/A|0|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:56:04.836241|2017-10-11 00:56:04.836241
NCT02017041|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-02-02|||January 2014||2014-01-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Using mHealth to Aid Opioid Medication Adherence Pilot Study|Using mHealth to Aid Opioid Medication Adherence Pilot Study|Completed||N/A|9|Actual|Care Team Solutions|||1||f||||t||||||||||2017-10-11 00:56:04.916306|2017-10-11 00:56:04.916306
NCT02017028|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-17|||January 2015||2015-01-01|May 2016|2016-05-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30|1 Day|Observational [Patient Registry]|||Correlation Between Endothelial Function and Trans Radial-procedural Events|Correlation Between Endothelial Function and Trans Radial-procedural Events|Completed||N/A|60|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:56:04.998306|2017-10-11 00:56:04.998306
NCT02017015|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-08-28|2016-04-06||December 24, 2013|Actual|2013-12-24|August 2017|2017-08-01|August 3, 2016|Actual|2016-08-03|June 1, 2015|Actual|2015-06-01||Interventional|PANC-001|Intent to Treat (ITT) population includes all enrolled participants|Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer|A PHASE 2, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ABI-007 PLUS GEMCITABINE IN CHINESE PATEINTS WITH METASTATIC PANCREATIC ADENOCARCINOMA|Completed||Phase 2|83|Actual|Celgene||1|||f||||f|t|f|||t|||||2017-10-11 00:56:05.114722|2017-10-11 00:56:05.114722
NCT02017002|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-06-27|||March 2014||2014-03-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer|Comparison of Ivor Lewis and Tri-incision Approaches in Performing Minimally|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:56:05.672258|2017-10-11 00:56:05.672258
NCT02016989|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2013-12-16|||November 2013||2013-11-01|December 2013|2013-12-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|CACICOL||Matrix Therapy And Bacterial Keratitis|REGENERATING AGENT (OTR4120) AND BACTERIAL KERATITIS : A RANDOMISED TRIAL|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:56:05.780503|2017-10-11 00:56:05.780503
NCT02016976|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2013-12-19|||January 2014||2014-01-01|December 2013|2013-12-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation||Unknown status|Not yet recruiting|N/A|40|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 00:56:05.87616|2017-10-11 00:56:05.87616
NCT02016963|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-12-01|2014-03-13||January 2008||2008-01-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection|An Open-Label Study to Evaluate the Immunogenicity and Safety of Raxibacumab (Human Monoclonal Antibody to B. Anthracis Protective Antigen) Administered in Healthy Subjects|Completed||Phase 2/Phase 3|20|Actual|Human Genome Sciences Inc.||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:56:06.005346|2017-10-11 00:56:06.005346
NCT02016950|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-02-10|||June 2014||2014-06-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Long-term Pacemaker Arrhythmia Analysis|East Sussex Long-term Pacemaker Arrhythmia Analysis|Completed||N/A|2551|Actual|Eastbourne General Hospital|||1||f||||f||||||||||2017-10-11 00:56:07.157887|2017-10-11 00:56:07.157887
NCT02016937|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-16|||January 2011||2011-01-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01|1 Year|Observational [Patient Registry]|lactation||Mother Lactation in The Postpartum Period|Effects of Different Anesthesia Protocols on Mother Lactation in The Postpartum Period|Completed||N/A|84|Actual|Duzce University|||4||f||||f||||||||||2017-10-11 00:56:07.262941|2017-10-11 00:56:07.262941
NCT02016924|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-10-03|||January 16, 2014|Actual|2014-01-16|October 2017|2017-10-01|December 2024|Anticipated|2024-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects|A Phase 2/3, Multicenter, Open-label, Multicohort, Two-Part Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co), Administered With Background Regimen (BR) in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects|Recruiting||Phase 2/Phase 3|100|Anticipated|Gilead Sciences||8|||f||||t|t|f||||||||2017-10-11 00:56:07.364938|2017-10-11 00:56:07.364938
NCT02016911|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-12-27|||December 2013||2013-12-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment|Investigation of Pharmacokinetics, Safety and Tolerability of Oral Semaglutide (NNC0113-0217) in Subjects With Mild, Moderate and Severe Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Completed||Phase 1|56|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:56:07.574397|2017-10-11 00:56:07.574397
NCT02016898|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-03-14|||March 2014||2014-03-01|March 2017|2017-03-01|January 17, 2017|Actual|2017-01-17|January 2017|Actual|2017-01-01||Interventional|||The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device|The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device|Completed||Phase 2|100|Actual|Duke University||2|||f||||f||||||||||2017-10-11 00:56:07.669956|2017-10-11 00:56:07.669956
NCT02016885|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-09-15||2015-10-22|November 2013||2013-11-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Dose-Ranging Study of the Effect of DRM04B in Subjects With Axillary Hyperhidrosis|A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of DRM04B in Subjects With Axillary Hyperhidrosis|Completed||Phase 2|198|Actual|Dermira, Inc.||5|||f||||f||||||||||2017-10-11 00:56:07.748352|2017-10-11 00:56:07.748352
NCT02016872|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-04-07|||December 16, 2013||2013-12-16|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients|Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients|Recruiting||N/A|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 00:56:07.895672|2017-10-11 00:56:07.895672
NCT02016859|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2013-12-15|||January 2014||2014-01-01|December 2013|2013-12-01|November 2014|Anticipated|2014-11-01|May 2014|Anticipated|2014-05-01|6 Months|Observational [Patient Registry]|||Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients||Unknown status|Not yet recruiting|N/A|500|Anticipated|Rambam Health Care Campus|||3||f||||t||||||Samples Without DNA|"     blood and serum   "|||2017-10-11 00:56:08.012168|2017-10-11 00:56:08.012168
NCT02016846|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2013-12-22|||January 2014||2014-01-01|December 2013|2013-12-01||||January 2015|Anticipated|2015-01-01||Interventional|||Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes||Unknown status|Not yet recruiting|Phase 3|36|Anticipated|Rabin Medical Center||2|||f||||||||||||||2017-10-11 00:56:08.098313|2017-10-11 00:56:08.098313
NCT02016833|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-04-29|||October 2013||2013-10-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity|Phase 0 Study for the Development of Immunological Assays for the Evaluation of WT-1, Survivin and HPV16 E7 Tumor Antigens Specific Immune Responses in Cancer Patients|Completed||N/A|15|Actual|PX Biosolutions|||1||f||||f||||||Samples With DNA|"     PBMCs isolated from whole blood   "|||2017-10-11 00:56:08.190509|2017-10-11 00:56:08.190509
NCT02016820|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-05-10|||November 2014||2014-11-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of Acid Suppression Medication on Pediatric Microbiome|Effect of Proton Pump Inhibitors on the Colonic Microbiome in Children|Recruiting||N/A|30|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-11 00:56:08.278289|2017-10-11 00:56:08.278289
NCT02016807|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-16|||January 2013||2013-01-01|December 2013|2013-12-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial|Treatment and Prevention of Oral and Alimentary Mucositis Using Polymerized Cross-Linked High Potency Sucralfate as a Single Agent Therapy|Unknown status|Active, not recruiting|Phase 4|180|Anticipated|Ashley Downs Bioscience|||6||f||||t||||||||||2017-10-11 00:56:08.3888|2017-10-11 00:56:08.3888
NCT02016794|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-07-06|||February 2014||2014-02-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|January 2016|Actual|2016-01-01|6 Months|Observational [Patient Registry]|ACIS||A Focused Registry on Anterior Cervical Interbody Spacer ACIS|A Focused Registry on Anterior Cervical Interbody Spacer Procedures in Patients With Cervical Spine Degeneration|Completed||N/A|9|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 00:56:08.513354|2017-10-11 00:56:08.513354
NCT02016781|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-29|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)|A Multi-Center Biologic Assignment Trial Comparing Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients w/Intermediate-2 & High Risk Myelodysplastic Syndrome (BMT CTN #1102)|Recruiting||Phase 2|400|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-11 00:56:08.587945|2017-10-11 00:56:08.587945
NCT02016768|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2016-09-29|||January 2014||2014-01-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Decompressive Cervical Surgery and Hypertension|Decompressive Cervical Surgery for Antihypertensive Effect in Patients With Cervical Spondylosis and Hypertension-A Cohort Study|Recruiting||N/A|50|Anticipated|Peking University First Hospital|||1||f||||t||||||||||2017-10-11 00:56:08.800109|2017-10-11 00:56:08.800109
NCT02016755|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-09-14|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia|A Phase IIB Pilot Study to Confirm the Feasibility and Tolerability of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia|Active, not recruiting||Phase 2|10|Actual|AnGes USA, Inc.||1|||f||||f|t|f||||||||2017-10-11 00:56:08.902141|2017-10-11 00:56:08.902141
NCT02016742|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-03-11|||December 2013||2013-12-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 1 Study of the Pharmacokinetics of RDC5 in Healthy Volunteers|A Phase I, Open-label, Randomised, 3-way Crossover Study to Characterise and Compare the Pharmacokinetics, Safety and Tolerability of RDC5 Given as a Single Dose to Healthy Volunteers|Completed||Phase 1|15|Actual|Chronos Therapeutics Ltd||4|||f||||f||||||||||2017-10-11 00:56:08.983145|2017-10-11 00:56:08.983145
NCT02016729|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-08-23|||April 1, 2014|Actual|2014-04-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|April 19, 2017|Actual|2017-04-19||Interventional|||A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia|A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 232 Alone and in Combination With Trametinib in Adult Subjects With Relapsed/Refractory Acute Myeloid Leukemia|Completed||Phase 1|36|Actual|Amgen||2|||f||||f||||||||||2017-10-11 00:56:09.059338|2017-10-11 00:56:09.059338
NCT02016716|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-31||2015-06-22|December 3, 2013|Actual|2013-12-03|May 2017|2017-05-01|December 8, 2014|Actual|2014-12-08|September 8, 2014|Actual|2014-09-08||Interventional|||A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis|A Multicenter, Randomized, Multiple-dose Phase 3 Study to Evaluate the Noninferiority of Romosozumab at a 90 mg/mL Concentration Compared With a 70 mg/mL Concentration in Postmenopausal Women With Osteoporosis|Completed||Phase 3|294|Actual|Amgen||4|||f||||f||||||||||2017-10-11 00:56:09.144126|2017-10-11 00:56:09.144126
NCT02016703|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-07-18|||March 2006||2006-03-01|December 2013|2013-12-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Gastrointestinal Tolerance of Erythritol-containing Beverages in Young Children|Gastrointestinal Tolerance of Erythritol-containing Beverages in Young Children|Completed||N/A|185|Actual|Cargill||4|||f||||t||||||||||2017-10-11 00:56:09.26107|2017-10-11 00:56:09.26107
NCT02016690|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-02-10|2016-12-16||December 2013||2013-12-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational||Participants enrolled via consecutive enrollment method who had a completed CRF. Participants were excluded if there was enrollment at a non-contracting institution or beyond the contracted number; duplicate enrollment; no palivizumab administration; or if palivizumab administration began outside of the investigation period.|Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®|Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®|Completed||N/A|312|Actual|AbbVie|The study population was a very specific, defined group, observed in the context of daily practice.The results of this study of the safety and effectiveness of palivizumab may not be applicable to the general population of healthy infants in Japan.||1||f||||f||||||||No||2017-10-11 00:56:09.391295|2017-10-11 00:56:09.391295
NCT02016677|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-12-22|||December 2013||2013-12-01|October 2015|2015-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy|An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy|Terminated||N/A|5|Actual|Orbix Medical Ltd.|||1|Slow enrollment rate. Low scientific value|f||||t||||||||||2017-10-11 00:56:10.450373|2017-10-11 00:56:10.450373
NCT02016664|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-02-28|||April 2014||2014-04-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Plasma Concentration of Ketamine and Norketamine .|Plasma Concentration of Ketamine and Norketamine in Patients on Oral Ketamine for Chronic Neuropathic Pain : A Pilot Study.|Completed||N/A|12|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 00:56:10.557136|2017-10-11 00:56:10.557136
NCT02016651|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2013-12-16|||January 2012||2012-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Positioning and Gastric Aspiration in Ventilated Premature Infants|Positioning and Gastric Aspiration in Ventilated Premature Infants|Completed||N/A|34|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 00:56:10.676417|2017-10-11 00:56:10.676417
NCT02016638|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-19|||March 2013||2013-03-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|||Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes|Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes|Unknown status|Recruiting|N/A|200|Anticipated|All India Institute of Medical Sciences, New Delhi||1|||f||||t||||||||||2017-10-11 00:56:10.764555|2017-10-11 00:56:10.764555
NCT02016625|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-04-21|2016-01-21||December 2013||2013-12-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||treated set (TS): included all subjects who took at least one dose of study medication during the treatment period.|Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus|Investigation of Potential Drug-drug Interactions Between Faldaprevir and Immunosuppressants (Cyclosporine and Tacrolimus) in Healthy Male and Female Subjects (Open-label, Fixed-sequence Trial)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 00:56:10.900153|2017-10-11 00:56:10.900153
NCT02013895|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-11||||||December 2013|2013-12-01||||||||Expanded Access|GSA||Accuracy and Reliability of GSA for Remnant Liver Function|Accuracy and Reliability of GSA for Remnant Liver Function in Scheduled Hepatectomized Patients|Available||N/A|||Kochi University|||||||||||||||||||2017-10-11 00:56:58.635471|2017-10-11 00:56:58.635471
NCT02016599|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-24|||September 2017|Anticipated|2017-09-01|August 2017|2017-08-01|September 2022|Anticipated|2022-09-01|August 2021|Anticipated|2021-08-01||Observational|||Effects of Transitional Circulation in ELBW Infants|Delineating the Effects of Transitional Circulation Physiology on Extremely Low Birth Weight (ELBW) Infants|Recruiting||N/A|200|Anticipated|Baylor College of Medicine|||2||f||||f|f|f||||Samples Without DNA|"     Blood samples will be taken to assess the lactate levels. These samples will be destroyed     once analysis is complete.   "|||2017-10-11 00:56:11.850246|2017-10-11 00:56:11.850246
NCT02016586|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-05-23|||November 2013||2013-11-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||Breastfeeding Intervention Study|Breastfeeding Intervention Study|Completed||N/A|228|Actual|Abbott Nutrition||2|||f||||f||||||||No||2017-10-11 00:56:11.987404|2017-10-11 00:56:11.987404
NCT02016573|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2016-07-20|||December 2013||2013-12-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|RDNP-2012-02||Renal Denervation for Uncontrolled Hypertension|Renal Denervation for Uncontrolled Hypertension|Withdrawn||Phase 4|0|Actual|Baker IDI Heart and Diabetes Institute||2||No participants enrolled into study and protocol has been superseded|f||||f||||||||No|No data available|2017-10-11 00:56:12.117035|2017-10-11 00:56:12.117035
NCT02016560|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-08-23|||December 2013||2013-12-01|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|||Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects|An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease|Completed||Phase 2/Phase 3|383|Actual|Avid Radiopharmaceuticals||4|||f||||f||||||||||2017-10-11 00:56:12.210237|2017-10-11 00:56:12.210237
NCT02016547|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2014-04-24|||September 2013||2013-09-01|April 2014|2014-04-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|TURANDOT||Thrombectomy Under Reopro Versus Alteplase to Treat Stoke|Thrombectomy Under Reopro Versus Alteplase and Neurologic Deficit Outcome Trial|Terminated||Phase 4|40|Anticipated|SOS Attaque Cérébrale||2|||f||||t||||||||||2017-10-11 00:56:12.33507|2017-10-11 00:56:12.33507
NCT02016534|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-06-28||2017-06-28|February 2014||2014-02-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors|A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors|Terminated||Phase 2|60|Actual|Amgen||1||Amgen decision following interim review of efficacy and safety data from the AMG 337 program.|f||||f||||||||||2017-10-11 00:56:12.432932|2017-10-11 00:56:12.432932
NCT02016521|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2015-08-24|||January 2014||2014-01-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Cooling Fabrics and Exercise Performance in Endurance Athletes|"Keep Cool: a Randomized Trial on the Effect of Wearing a Garment Made of Cooling Fabrics on Thermoregulatory, Cardiorespiratory, and Perceptual Responses to Exercise in Endurance-trained Athletes"|Completed||N/A|20|Actual|McGill University||2|||f||||f||||||||||2017-10-11 00:56:12.69929|2017-10-11 00:56:12.69929
NCT02016508|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2013-12-20|||March 2013||2013-03-01|December 2013|2013-12-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration|Intravitreal Injection of Human Bone Marrow Derived Mesenchymal Stem Cell in Patients With Dry Age-related Macular Degeneration(AMD)|Unknown status|Recruiting|Phase 1/Phase 2|1|Anticipated|Al-Azhar University||1|||f||||||||||||||2017-10-11 00:56:12.770222|2017-10-11 00:56:12.770222
NCT02016495|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2013-12-16||||||October 2013|2013-10-01||||February 2013|Actual|2013-02-01||Interventional|||Efficacy of Magnesium and Alpha Lipoic Acid Supplementation in Reducing Premature Uterine Contractions||Completed||Phase 4|||AGUNCO Obstetrics and Gynecology Centre||2|||f||||||||||||||2017-10-11 00:56:12.841485|2017-10-11 00:56:12.841485
NCT02016482|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-16|2017-04-25|2016-10-21||January 2014||2014-01-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis|A Phase 3, Multicenter, Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Adalimumab for Treatment of Nail Psoriasis in Patients With Chronic Plaque Psoriasis|Completed||Phase 3|217|Actual|AbbVie|Due to study design, a high percentage of participants randomized to the placebo arm early escaped from Period A and thus participated for a shorter duration than did participants in the active treatment arm.|2|||f||||f||||||||||2017-10-11 00:56:12.950163|2017-10-11 00:56:12.950163
NCT02016469|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-15|||December 2013||2013-12-01|December 2013|2013-12-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of Pectin on Flora Intestinal Colonization and Maintenance After Fecal Transplantation|A Randomized, Controlled, Single-blind Study of Effects of Pectin on Flora Intestinal Colonization and Maintenance After Fecal Transplantation to Patients With Inflammatory Bowel Disease|Unknown status|Recruiting|N/A|30|Anticipated|Jinling Hospital, China||3|||f||||t||||||||||2017-10-11 00:56:14.917032|2017-10-11 00:56:14.917032
NCT02016456|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2017-08-31|||October 2014||2014-10-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|TDEP||TMS Treatment for Depression in the National Health Service|An Evaluation of Transcranial Magnetic Stimulation in the National Health Service|Completed||N/A|29|Actual|Institute of Mental Health Nottingham||2|||f||||f||||||||||2017-10-11 00:56:15.006272|2017-10-11 00:56:15.006272
NCT02016443|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-04-21|||November 2013||2013-11-01|October 2013|2013-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Tizanidine and Pain After Herniorrhaphy|Investigation of the Effectiveness of Tizanidine on Pain After Herniorrhaphy|Completed||Phase 4|30|Actual|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-11 00:56:15.088719|2017-10-11 00:56:15.088719
NCT02016430|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2016-12-20|||December 2013||2013-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|GRADY||Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)|Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)|Recruiting||Phase 1/Phase 2|90|Anticipated|The Cleveland Clinic||3|||f||||t||||||||||2017-10-11 00:56:15.191213|2017-10-11 00:56:15.191213
NCT02016417|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-15|2014-04-15|||May 2014||2014-05-01|December 2013|2013-12-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma|Phase II Study Comparing Gemcitabine Plus Cisplatin to Docetaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma|Not yet recruiting||Phase 2|120|Anticipated|Cancer Hospital of Guangxi Medical University||2|||f||||t||||||||||2017-10-11 00:56:15.297327|2017-10-11 00:56:15.297327
NCT02016404|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-13|||June 2013||2013-06-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The Effect of a Low Sodium-High Potassium Salt on Blood Pressure in Vietnamese Adults|The Effect of a Low Sodium-High Potassium Salt on Blood Pressure in Vietnamese Adults|Completed||N/A|180|Actual|Wageningen University||2|||f||||f||||||||||2017-10-11 00:56:15.410563|2017-10-11 00:56:15.410563
NCT02016391|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-12-16|||December 2013||2013-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours|Effects of Dexmedetomidine on Periprocedural Pain During Radiofrequency Ablation of Liver and Kidney Tumours|Completed||Phase 4|50|Actual|Uppsala University Hospital||1|||f||||f||||||||||2017-10-11 00:56:15.497028|2017-10-11 00:56:15.497028
NCT02016378|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-04-17|||January 2014||2014-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents|EEG/Event-related Brain Potential Risk Markers as Predictors and Outcomes of SUD Treatment in Adolescents|Recruiting||Phase 3|80|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 00:56:15.577429|2017-10-11 00:56:15.577429
NCT02016365|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-05-11|||February 2012||2012-02-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Dox/Urso||Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis|A Phase II Multicenter Pilot Study of the Safety and Efficacy of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis|Completed||Phase 2|55|Actual|Umeå University||1|||f||||f||||||||||2017-10-11 00:56:15.661854|2017-10-11 00:56:15.661854
NCT02016352|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-05-13|||March 2013||2013-03-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|PROLIPHYC||Cerebrospinal Fluid Proteome in Hydrocephalus|Cerebrospinal Fluid Proteome in Hydrocephalus|Completed||N/A|100|Actual|University Hospital, Toulouse||2|||f||||f||||||||Undecided||2017-10-11 00:56:15.810918|2017-10-11 00:56:15.810918
NCT02016339|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-20|||June 2007||2007-06-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Intensive Versus Standard Follow up to Improve Continuous Positive Airway Pressure (CPAP) Compliance|Intensive Versus Standard Follow up to Improve Continuous Positive Airway Pressure Compliance: The Greek Experience|Completed||N/A|2836|Actual|University of Crete||2|||f||||f||||||||||2017-10-11 00:56:15.891915|2017-10-11 00:56:15.891915
NCT02016326|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-12-13|||November 2012||2012-11-01|December 2013|2013-12-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||I-Scan Vs High Definition White Light (Main Study)|A Randomized Controlled Trial Comparing High-definition White Light Colonoscopy to I-scan Enhanced Colonoscopy for Adenoma Detection in a Population at Increased Risk of Colorectal Cancer (Main Study)|Unknown status|Recruiting|N/A|1500|Anticipated|University of Calgary||3|||f||||f||||||||||2017-10-11 00:56:15.959098|2017-10-11 00:56:15.959098
NCT02016313|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-12-03|||May 2014||2014-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Physiotherapy on Cervicogenic Somatic Tinnitus|Evaluation of the Effect of Cervical Spine Treatment in Tinnitus Patients|Completed||N/A|40|Actual|Universiteit Antwerpen||2|||f||||f||||||||||2017-10-11 00:56:16.067932|2017-10-11 00:56:16.067932
NCT02016300|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-09-29|||January 2013||2013-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|Mfxbracing||Effects of Unloader Bracing in Clinical Outcome and Cartilage Physiology Following Microfracture of Chondral Defects|Effects of Unloader Bracing in Clinical Outcome and Articular Cartilage Physiology Following Microfracture of Isolated Chondral Defects|Active, not recruiting||N/A|20|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 00:56:16.145382|2017-10-11 00:56:16.145382
NCT02016287|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-13|||December 2013||2013-12-01|December 2013|2013-12-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer|Sequential Paclitaxel Chemotherapy and Radiotherapy as First Line Treatment for Elderly Metastatic Esophageal Squamous Cell Cancer:: a Phase II Single Center Prospective Clinical Trial|Unknown status|Recruiting|Phase 2|50|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 00:56:16.236074|2017-10-11 00:56:16.236074
NCT02016274|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-13|||December 2013||2013-12-01|December 2013|2013-12-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer|Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as First Line Treatment for Metastatic Esophageal Squamous Cell Cancer:: a Phase II Single Center Prospective Clinical Trial|Unknown status|Recruiting|Phase 2|70|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 00:56:16.329107|2017-10-11 00:56:16.329107
NCT02016261|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-07-20|||December 2013||2013-12-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine|Open Label, Non-comparative Study to Evaluate Cognitive Functioning in Remitted Depression Outpatients During Long-term Preventive Treatment With Fluvoxamine|Completed||Phase 4|50|Actual|Moscow Research Institute of Psychiatry||1|||f||||f||||||||||2017-10-11 00:56:16.416091|2017-10-11 00:56:16.416091
NCT02016248|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-09-22|||June 2012||2012-06-01|September 2015|2015-09-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer|Prospective Evaluation of CyberKnife Stereotactic Body Radiotherapy for Localized Prostate Cancer: Risk Stratified Monotherapy Versus Boost|Recruiting||N/A|167|Anticipated|MemorialCare Health System||2|||f||||f||||||||||2017-10-11 00:56:16.512448|2017-10-11 00:56:16.512448
NCT02016235|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-08-04|||September 2014||2014-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Role Of Phosphorus And FGF 23 In Patients With Dent Disease|Role Of Phosphorus And FGF 23 In Patients With Dent Disease|Recruiting||Phase 1/Phase 2|40|Anticipated|Mayo Clinic||3|||f||||t||||||||||2017-10-11 00:56:16.654128|2017-10-11 00:56:16.654128
NCT02016222|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-09-19|||April 2011||2011-04-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|LARMES||Tear Analysis in the Diagnosis of Multiple Sclerosis|Tear Analysis in the Diagnosis of Primary Progressive Forms of Multiple Sclerosis|Completed||N/A|80|Actual|Lille Catholic University||1|||f||||f||||||||||2017-10-11 00:56:16.783837|2017-10-11 00:56:16.783837
NCT02016209|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-14|||January 2014||2014-01-01|December 2013|2013-12-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer|Phase II Study of Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin/Cisplatin in Stage Ⅱ B and IIIA Non-small Cell Lung Cancer Patients|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Zhejiang University||1|||f||||f||||||||||2017-10-11 00:56:19.111725|2017-10-11 00:56:19.111725
NCT02016196|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-02-21|||September 2013||2013-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRPET||Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS|Double Blind Randomized Study, Comparing Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS|Recruiting||Phase 3|188|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||Undecided||2017-10-11 00:56:19.192255|2017-10-11 00:56:19.192255
NCT02016170|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-08-22|2016-08-22||March 2014||2014-03-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SWAP3||Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor|Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor: The SWAP (SWitching Anti Platelet)-3 Study|Completed||N/A|82|Actual|University of Florida||3|||f||||t||||||||No||2017-10-11 00:56:19.433908|2017-10-11 00:56:19.433908
NCT02016157|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-12-18|||September 2011||2011-09-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Moxifloxacin in Situ Gel to Treat Periodontal Pocket.|Moxifloxacin In Situ Gel as an Adjunct in the Treatment of Periodontal Pocket: A Randomized Clinical Trial.|Completed||Phase 4|6|Actual|Sri Hasanamba Dental College and Hospital||1|||f||||t||||||||||2017-10-11 00:56:19.816064|2017-10-11 00:56:19.816064
NCT02016144|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2013-12-14|||October 2012||2012-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Optimal Length of Pre-inserted ETT for Nasal Fiber Optic Intubation|Optimal Length of the Pre-inserted Endotracheal Tube for Obtaining Good View of Laryngeal Opening for Nasal Fibreoptic Intubation|Completed||N/A|150|Actual|Seoul National Uinversity Dental Hospital|||1||f||||t||||||||||2017-10-11 00:56:19.905598|2017-10-11 00:56:19.905598
NCT02016131|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2015-05-26|||January 2012||2012-01-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Observational|||CQDSA in Evaluation of Prognosis After EVAR|Application of Color-coded Quantitative Digital Subtraction Angiography in Evaluation of Prognosis After Endovascular Repairment of Abdominal Aortic Aneurysm|Completed||N/A|49|Actual|Shanghai Zhongshan Hospital|||2||f||||f||||||||||2017-10-11 00:56:20.101143|2017-10-11 00:56:20.101143
NCT02016118|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-02-11|||January 2014||2014-01-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|March 2014|Anticipated|2014-03-01||Observational|RAISC-RUTI||Retrospective Analysis of Ialuril vs. Standard of Care in Recurrent Urinary Tract Infections|INTRAVESICAL ADMINISTRATION OF COMBINED HYALURONIC ACID (HA) AND CHONDROITIN SULPHATE (CS) vs. STANDARD OF CARE FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS (RUTIs)|Unknown status|Recruiting|N/A|500|Anticipated|Study Group for Urogenital Diseases, Italy|||2||f||||f||||||||||2017-10-11 00:56:20.226861|2017-10-11 00:56:20.226861
NCT02016105|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2017-04-24|2017-02-22|2016-03-08|December 2013||2013-12-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|July 2015|Actual|2015-07-01||Interventional|ADACCESS|The Full analysis set (FAS) consists of all randomized patients to whom a study treatment was assigned.|Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira|A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Adalimumab (GP2017) and Humira® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis|Completed||Phase 3|465|Actual|Sandoz|none reported|2|||f||||t||||||||Undecided||2017-10-11 00:56:20.387742|2017-10-11 00:56:20.387742
NCT02016092|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2016-03-10|||December 2013||2013-12-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|March 2016|Actual|2016-03-01||Observational|DISCOVERY-PD||Biomarker Discovery in Parkinson's Disease|Proteomics, Metabolomics, Lipidomics and Genetic Analysis for Biomarker DISCOVERY in Parkinson's Disease|Active, not recruiting||N/A|400|Actual|The Parkinson's Institute|||2||f||||f||||||Samples With DNA|"     Blood & Urine Specimen Collection: Up to 20mL of venous blood samples will be collected for     plasma multi-omic analysis, as well as optional genetic, analyses.      Urine samples (~50ml) will be collected via sterile urine cup and transferred into     appropriate urine tube for multi-omic analysis.      All Samples may be saved for future studies, if consented.   "|No|Individual participant data will not be made available, summary datasets may be published in peer-review journals.|2017-10-11 00:56:21.919532|2017-10-11 00:56:21.919532
NCT02016079|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-14|||March 2010||2010-03-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Omega-3 Supplementation on Child Behavior Problems|Randomized Controlled Trial of Omega-3 on Child Behavior Problems|Completed||Phase 2/Phase 3|200|Actual|Joint Child Health Project, Mauritius||2|||f||||t||||||||||2017-10-11 00:56:22.003908|2017-10-11 00:56:22.003908
NCT02016066|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2017-02-03|||December 2013||2013-12-01|November 2016|2016-11-01|April 2014|Anticipated|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 in Japanese Healthy Participants|A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Japanese Subjects to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 Following Single Intravenous Administration|Withdrawn||Phase 1|0|Actual|Janssen Pharmaceutical K.K.||2||Study terminated due to business decision|f||||f||||||||||2017-10-11 00:56:22.262732|2017-10-11 00:56:22.262732
NCT02016053|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-08-11|||December 2013||2013-12-01|November 2014|2014-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Incidence and Spectrum of Acute Kidney Injury in Cirrhotics and Assessment of New Biomarkers as Early Predictors of Acute Kidney Injury||Completed||N/A|450|Actual|Institute of Liver and Biliary Sciences, India|||2||f||||f||||||||||2017-10-11 00:56:22.406892|2017-10-11 00:56:22.406892
NCT02016040|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-04-18|||March 17, 2013|Actual|2013-03-17|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Focal Therapy Using HIFU for Localised Prostate Cancer|Focal Therapy Using High Intensity Focused Ultrasound (ABLATHERM®) for Localised Prostate Cancer|Active, not recruiting||Phase 2/Phase 3|25|Actual|Jewish General Hospital||1|||f||||t||||||||||2017-10-11 00:56:22.479582|2017-10-11 00:56:22.479582
NCT02016027|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-12-14|||September 2013||2013-09-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|CF2013||Pharmacological Effect of Carica Papaya Leaves Mother Tincture in Healthy Individuals Blood Parameter|Pharmacological Effect of Carica Folia Mother Tincture in Healthy Individual's Blood Parameter.|Unknown status|Enrolling by invitation|Phase 1|60|Anticipated|Fr Muller Homoeopathic Medical College||1|||f||||t||||||||||2017-10-11 00:56:22.590137|2017-10-11 00:56:22.590137
NCT02016014|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-02-28|||January 2014||2014-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Effectiveness of the Use of a Mobile Tool in Improving Lifestyles|Effectiveness of the Use of a Mobile Tool Added to a Standard Intervention in Improving Lifestyles in Adults|Completed||N/A|833|Actual|Fundacion para la Investigacion y Formacion en Ciencias de la Salud||2|||f||||f||||||||||2017-10-11 00:56:22.655437|2017-10-11 00:56:22.655437
NCT02016001|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2014-08-11|||April 2013||2013-04-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|DMFT||Effective Fluoride Concentration In Toothpaste For Dental Caries Prevention|Identification of Effective Fluoride Concentration In Toothpaste For Dental Caries Prevention; A Randomized Controlled Trial|Unknown status|Recruiting|N/A|380|Anticipated|Dow University of Health Sciences||2|||f||||t||||||||||2017-10-11 00:56:22.742297|2017-10-11 00:56:22.742297
NCT02015988|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2016-08-03|||January 2014||2014-01-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|September 2016|Anticipated|2016-09-01||Interventional|||Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome|Effectiveness and Tolerability of Early Initiation of Combined Lipid -Lowering Therapy Included Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus, Hypertriglyceridemia and Acute Coronary Syndrome|Active, not recruiting||Phase 4|60|Anticipated|Dnipropetrovsk State Medical Academy||2|||f||||f||||||||||2017-10-11 00:56:22.847269|2017-10-11 00:56:22.847269
NCT02015975|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-09-30|||May 1, 2013|Actual|2013-05-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|March 31, 2018|Anticipated|2018-03-31|2 Years|Observational [Patient Registry]|||Clinical Outcome After Treatment of Patellar Fractures With Locking Plates|Clinical Outcome After Treatment of Patellar Fractures With Locking Plates|Active, not recruiting||N/A|20|Anticipated|Diakoniekrankenhaus Friederikenstift|||1||f||||f||||||||||2017-10-11 00:56:22.958065|2017-10-11 00:56:22.958065
NCT02015962|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-12-14|||October 2013||2013-10-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|EIPS||Comparison of Enteral Versus Intravenous Potassium Supplementation|Comparison of Enteral Versus Intravenous Potassium Supplementation in Hypokalemia in Post Cardiac Surgery Pediatric Cardiac Intensive Care Patients - Prospective Open Label Randomized Control Trial|Unknown status|Recruiting|Phase 4|40|Anticipated|Aga Khan University||2|||f||||f||||||||||2017-10-11 00:56:23.030543|2017-10-11 00:56:23.030543
NCT02015949|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-01-09|||February 2014||2014-02-01|May 2016|2016-05-01||||January 2017|Actual|2017-01-01||Interventional|||The Relationship Between Traumatic Brain Injury and Dopamine (a Chemical in the Brain)|The Control of Brain Networks After Traumatic Brain Injury: a Neuroimaging and Neuropsychological Study of Dopamine and Cognition|Completed||Phase 4|40|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 00:56:23.144974|2017-10-11 00:56:23.144974
NCT02015936|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-05-23|||December 12, 2013|Actual|2013-12-12|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 14, 2015|Actual|2015-09-14||Interventional|||Physical Activity for Advanced Stage Cancer Patients|Physical Activity for Advanced Stage Cancer Patients|Active, not recruiting||N/A|10|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|f|f||||||||2017-10-11 00:56:23.254466|2017-10-11 00:56:23.254466
NCT02015923|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-02-28|||December 2013||2013-12-01|March 2016|2016-03-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|CCRe-IV||Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases|Multicenter Randomized Study in Patients With Colorectal Cancer With Unresectable Metastases. Impact of Resection vs no Resection of the Primary Tumour as a Survival Factor|Recruiting||Phase 4|336|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 00:56:23.351744|2017-10-11 00:56:23.351744
NCT02015910|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-11-08|2016-04-22||January 2014||2014-01-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers|Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers|Terminated||Phase 4|1|Actual|Georgetown University|Data was collected for one subject but could not be analyzed due to insufficient enrollment.|2||Terminated by the sponsor due to slow enrollment|f||||t||||||||No|Data was not collected for use in future research and will not be shared.|2017-10-11 00:56:23.590341|2017-10-11 00:56:23.590341
NCT02015897|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-04-07|||January 2014||2014-01-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Physical Therapy on Breast Cancer Related Lymphedema|Effect of Physical Therapy on Breast Cancer Related Lymphedema; A Multicenter, Randomized, Single-blind, Equivalence Trial|Enrolling by invitation||N/A|160|Anticipated|Hospital of South West Denmark||2|||f||||t||||||||No||2017-10-11 00:56:23.84502|2017-10-11 00:56:23.84502
NCT02015884|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-10-22|||May 2013||2013-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|PREVURGO||Antisocial Behavior on Healthcare Professionals in an Emergency Unit.|Impact of a Program to Prevent the Risk of Antisocial Behavior and Attacks of Patients or Attendant on Healthcare Workers in an Ophthalmic Emergency Unit.|Completed||N/A|58465|Actual|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-11 00:56:23.920952|2017-10-11 00:56:23.920952
NCT02015871|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-08-21|||January 2014||2014-01-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|August 1, 2017|Actual|2017-08-01||Interventional|PandaExtension||An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer|An Extension Long-Term Safety and Tolerability Trial of Degarelix, Following a 1-year Open-Label, Multi-Centre, Randomised, Parallel-group Trial in Which the Efficacy and Safety of Degarelix One-month Dosing Regimen Was Compared With Goserelin in Chinese Patients With Prostate Cancer Requiring Androgen Ablation Therapy|Completed||Phase 3|206|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-11 00:56:23.986413|2017-10-11 00:56:23.986413
NCT02015858|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-10-28|||June 2013||2013-06-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|Pain Drain||Pain During Chest Tube Withdrawal: Evaluation Using Pan Monitor|Pain During Chest Tube Withdrawal: Evaluation Using Pan Monitor in Patients With or Without Epidural Anesthesia|Completed||N/A|100|Actual|Hopital Foch|||2||f||||f||||||||||2017-10-11 00:56:24.064795|2017-10-11 00:56:24.064795
NCT02015845|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-18|||November 2013||2013-11-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|AVO||Evaluation of Accuvein in Obese Patients|Evaluation of Accuvein in Obese Patients|Terminated||N/A|26|Actual|Hopital Foch||2||recrutment difficulties|f||||f||||||||||2017-10-11 00:56:24.144992|2017-10-11 00:56:24.144992
NCT02015832|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-08-24|||February 6, 2014|Actual|2014-02-06|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|March 28, 2017|Actual|2017-03-28|5 Years|Observational [Patient Registry]|||A Trial to Evaluate a New Strategy in the Functional Assessment of 3-vessel Disease Using the SYNTAX II Score in Patients Treated With PCI|A Single-arm Trial to Evaluate the Effectiveness of PCI of de Novo 3-vessel Disease Applying the SYNTAX Score II With Pressure Wire Functional Assessment and IVUS Guidance, Using an Everolimus-eluting Stent With Biodegradable Abluminal Coating|Active, not recruiting||N/A|454|Actual|ECRI bv|||1||f||||t||||||||||2017-10-11 00:56:24.219172|2017-10-11 00:56:24.219172
NCT02015819|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-07-06|||October 7, 2014|Actual|2014-10-07|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas|A Phase I Study of Cytosine Deaminase-Expressing Neural Stem Cells in Combination With Oral 5-Fluorocytosine and Leucovorin for the Treatment of Recurrent High-Grade Gliomas|Active, not recruiting||Phase 1|18|Anticipated|City of Hope Medical Center||1|||f||||t|t|f||||||||2017-10-11 00:56:24.368028|2017-10-11 00:56:24.368028
NCT02015806|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-01-07|||March 2014||2014-03-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|REMIND||Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices|Assessing the Impact of Low-Touch Devices on Medication Adherence|Completed||N/A|53480|Actual|Brigham and Women's Hospital||14|||f||||||||||||||2017-10-11 00:56:24.47145|2017-10-11 00:56:24.47145
NCT02015793|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-04-08|2016-03-09||December 2013||2013-12-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease|A Phase 2, Randomized, Double-Blind, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Two Adalimumab Dosing Regimens in Chinese Subjects With Moderately to Severely Active Crohn's Disease and Elevated High-Sensitivity C-reactive Protein|Completed||Phase 2|30|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 00:56:24.66013|2017-10-11 00:56:24.66013
NCT02015780|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2014-01-24|||December 2013||2013-12-01|January 2014|2014-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasiglifam (TAK-875) Compared to Placebo as Add-on to Preexisting Antihyperglycemic Therapy Over 16 Weeks With 36-week Extension in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or Stage 5 on Dialysis|Withdrawn||Phase 3|0|Actual|Takeda||2||Due to potential concerns about liver safety (See Detailed Description)|f||||f||||||||||2017-10-11 00:56:25.786889|2017-10-11 00:56:25.786889
NCT02015767|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-06-21|||February 1, 2013|Actual|2013-02-01|May 2017|2017-05-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Observational|||Patient Registry of Roflumilast In Real Life|Patient Registry of Roflumilast In Real Life|Completed||N/A|1950|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 00:56:25.95521|2017-10-11 00:56:25.95521
NCT02015741|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-10-28|||November 2013||2013-11-01|October 2016|2016-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|||Comparability of Bispectral Index and NeuroSENSE in Aged Patients|Comparability of Bispectral Index and NeuroSENSE in Aged Patients|Withdrawn||N/A|0|Actual|Hopital Foch|||1|recruitment difficulties|f||||f||||||||||2017-10-11 00:56:26.2773|2017-10-11 00:56:26.2773
NCT02015728|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-12-14|||December 2013||2013-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|SEED||Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors|The Feasibility of Selecting Patient-Specific Biologically Targeted Therapy With Sorafenib, Everolimus, Erlotinib or Dasatinib for Pediatric Patients With Refractory Or Recurrent Brain Tumors|Active, not recruiting||N/A|20|Anticipated|Seattle Children's Hospital||4|||f||||t||||||||||2017-10-11 00:56:26.365072|2017-10-11 00:56:26.365072
NCT02015715|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-02-28|||December 2013||2013-12-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian Participants|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6864018 Following Oral Administration in Asian Healthy Subjects|Completed||Phase 1|48|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:56:26.501145|2017-10-11 00:56:26.501145
NCT02015702|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2013-12-13|||January 2013||2013-01-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Educational Intervention to Increase Physician Satisfaction and Effectiveness With a New Electronic Health Record|Interventions to Increase Physician Effectiveness and Acceptance of a Electronic Health Record System|Completed||N/A|44|Actual|The Reading Hospital and Medical Center||2|||f||||f||||||||||2017-10-11 00:56:26.625137|2017-10-11 00:56:26.625137
NCT02015689|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2013-12-18|||May 2012||2012-05-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Altruistically Framed Messages and Impact on Parents' Reported Willingness to Immunize Their Children|Altruistically Framed Messages and Impact on Parents' Reported Willingness to Immunize Their Children|Completed||N/A|802|Actual|Indiana University||4|||f||||f||||||||||2017-10-11 00:56:26.745349|2017-10-11 00:56:26.745349
NCT02015676|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-02-26|2014-12-01||July 2001||2001-07-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer|'A Study of the Effect of First Line Treatment With Paclitaxel and Myocet in Combination With Herceptin on Overall Tumor Response in Patients With Metastatic or Locally Advanced Breast Cancer and HER2 Overexpression.'|Completed||Phase 1/Phase 2|69|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:56:26.879389|2017-10-11 00:56:26.879389
NCT02015663|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-02-08|2015-12-11||January 2014||2014-01-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles|A 24-week, Open-label, Parallel-group, Interventional Phase IV Study Comparing Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles for the Treatment of Pulmonary Pseudomonas Aeruginosa in Patients With Cystic Fibrosis|Terminated||Phase 4|32|Actual|Novartis|Due to premature termination, summaries and analyses planned in the protocol were eliminated in the statistical analysis plan prior to database lock. No inferential analysis will be provided.|2|||f||||f||||||||||2017-10-11 00:56:27.581356|2017-10-11 00:56:27.581356
NCT02015650|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2015-04-29|||April 2014||2014-04-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck|Randomized Phase IV Trial to Compare Cetuximab With Concomitant Radiation Therapy With Concomitant Mitomycin-C and 5-Fluorouracil With Radiation Therapy for Locally Advanced Squamous Cell Carcinomas of the Head and Neck|Unknown status|Recruiting|Phase 4|70|Anticipated|Medical University Innsbruck||2|||f||||f||||||||||2017-10-11 00:56:28.454802|2017-10-11 00:56:28.454802
NCT02015637|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-04-06||2016-03-14|January 2014||2014-01-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea|A Comparative Evaluation of the Single-dose Efficacy of Oral Delafloxacin Versus the Single-dose Efficacy of an Intramuscular Injection of Ceftriaxone in Subjects With Uncomplicated Urogenital Gonorrhea|Terminated||Phase 3|460|Actual|Melinta Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 00:56:28.562773|2017-10-11 00:56:28.562773
NCT02015624|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-04-08|||December 2013||2013-12-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|EYESHOT||EYESHOT (EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian Coronary Care Units)|EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs Registry|Completed||N/A|2597|Actual|Heart Care Foundation|||1||f||||f||||||||||2017-10-11 00:56:28.753673|2017-10-11 00:56:28.753673
NCT02015611|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-02-27|||December 2013|Actual|2013-12-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|EVIDENCE||Vitamin D and Muscle Function Study|Lay Title - Exploring VItamin D's Effects on NeuromusCular Endpoints Study; Grant Title - Trial of Vitamin D Supplementation and Neuromuscular Function in Older Adults|Recruiting||N/A|200|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 00:56:29.296502|2017-10-11 00:56:29.296502
NCT02015598|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-01-06|||December 2013||2013-12-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnoea Syndrome|Comparison of Oral Intake of Antioxidant Carbocysteine and Nasal Continuous Positive Airway Pressure (CPAP) for Treating in Moderate and Severe Obstructive Sleep Apnoea Syndrome Patients : a Randomized Clinical Trial|Completed||N/A|40|Actual|Guangzhou Institute of Respiratory Disease||2|||f||||f||||||||||2017-10-11 00:56:29.450893|2017-10-11 00:56:29.450893
NCT02015585|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-04-05|||August 2013||2013-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of Influence of Two Treatment Protocols on Mandibular Movements and Condyle-fossa Relation|Evaluation of Mandibular Movements and Condyle-fossa Relation From Two Treatment Protocols. A Randomized Clinical Trial.|Active, not recruiting||N/A|30|Actual|Federal University of Pelotas||3|||f||||f||||||||||2017-10-11 00:56:29.547981|2017-10-11 00:56:29.547981
NCT02015572|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2017-02-10|||January 2016||2016-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2016|Actual|2016-06-01||Interventional|GoBack||Retention in Physically Demanding Jobs With Low Back Pain: A Randomised Controlled Trial (GoBack)|Retention in Physically Demanding Jobs With Low Back Pain: A Randomised Controlled Trial (GoBack)|Active, not recruiting||N/A|302|Actual|Frederiksberg University Hospital||2|||f||||t||||||||||2017-10-11 00:56:29.644779|2017-10-11 00:56:29.644779
NCT02015559|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-04-25|||October 8, 2014||2014-10-08|September 2016|2016-09-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus|Phase II Randomized Trial of Mugard Compared With Best Supportive Care for Prevention and Treatment of Stomatitis in Women With Hormone Receptor Positive Breast Cancer Initiating Treatment With Everolimus-based Endocrine Therapy.|Recruiting||Phase 2|66|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 00:56:29.758577|2017-10-11 00:56:29.758577
NCT02015546|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-03-25|2014-12-30||December 2012||2012-12-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone|A Randomized, Double-Blind, 8-week Comparing Safety and Tolerability of Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone|Completed||Phase 3|70|Actual|Duke University||3|||f||||f||||||||||2017-10-11 00:56:29.877831|2017-10-11 00:56:29.877831
NCT02015533|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2014-02-28|||December 2013||2013-12-01|February 2014|2014-02-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy Participants|A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Japanese Subjects to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 Following Single Intravenous Administration|Unknown status|Not yet recruiting|Phase 1|12|Anticipated|Janssen Pharmaceutical K.K.||2|||f||||f||||||||||2017-10-11 00:56:30.360275|2017-10-11 00:56:30.360275
NCT02015520|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-09-13|||January 2014||2014-01-01|September 2017|2017-09-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis|A Phase IIb, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Evaluate the Efficacy and Safety of Clazakizumab in Subjects With Moderate to Severe Active Rheumatoid Arthritis Who Have Experienced an Inadequate Response to TNF Inhibitors|Completed||Phase 2|143|Actual|Vitaeris INC||5|||f||||f||||||||||2017-10-11 00:56:30.462937|2017-10-11 00:56:30.462937
NCT02015507|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-03-25|||January 2014||2014-01-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor|An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on the Multiple-Dose Pharmacokinetics of Ivacaftor and on the Multiple-Dose Pharmacokinetics of VX-661 Administered in Combination With Ivacaftor|Completed||Phase 1|34|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-11 00:56:30.644944|2017-10-11 00:56:30.644944
NCT02015494|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-03-05|||March 2014||2014-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention|Phase 1 Study of the Safety and Immunogenicity of VAX2012Q: A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years|Unknown status|Active, not recruiting|Phase 1|316|Actual|VaxInnate Corporation||7|||f||||t||||||||||2017-10-11 00:56:30.728995|2017-10-11 00:56:30.728995
NCT02015481|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2017-07-21|2017-07-21||February 2014||2014-02-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|HOPEMD||Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients|Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients|Completed||Phase 2|25|Actual|Bioblast Pharma Ltd.||1|||f||||f||||||||||2017-10-11 00:56:30.934976|2017-10-11 00:56:30.934976
NCT02015468|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-08-06|||January 2012||2012-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Value of Early Mobilization and Physiotherapy Following Wrist Fractures Treated by Volar Plating|The Value of Early Mobilization and Physiotherapy Following Wrist Fractures Treated by Volar Plating|Active, not recruiting||N/A|120|Anticipated|University Hospital, Akershus||2|||f||||f||||||||||2017-10-11 00:56:31.367993|2017-10-11 00:56:31.367993
NCT02015455|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-06-09|||April 2014||2014-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|LIRE||Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports|Lumbar Imaging With Reporting of Epidemiology: A Pragmatic Cluster Randomized Trial|Active, not recruiting||N/A|250000|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-11 00:56:31.456294|2017-10-11 00:56:31.456294
NCT02015442|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-11-18|||January 2014||2014-01-01|October 2013|2013-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effect of Sucrose on Liver Fat|Effect of Eucaloric High and Low Sucrose Diets on Liver Fat in Healthy Adult Men With Liver Fat Levels Below 5%|Completed||N/A|15|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 00:56:31.571111|2017-10-11 00:56:31.571111
NCT02015429|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-12|||December 2007||2007-12-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Yellow Pea Protein and Fibre Added to a High-carb Meal on Glycemic Response and Food Intake||Completed||N/A|15|Actual|University of Toronto||4|||f||||t||||||||||2017-10-11 00:56:31.655817|2017-10-11 00:56:31.655817
NCT02015416|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-08-15|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer|A Phase 1 Open Label, Multicenter, Multiple Ascending Dose Trial Evaluating the Safety, Tolerability and Immunogenicity of Intramuscular Recombinant NY-ESO-1 Protein With GLA-SE Adjuvant in Patients With Unresectable or Metastatic Cancer|Completed||Phase 1|13|Actual|Immune Design||1|||f||||t||||||||||2017-10-11 00:56:31.776904|2017-10-11 00:56:31.776904
NCT02015403|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2016-11-21|||December 2013||2013-12-01|March 2015|2015-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed|TO COMPARE THE EFFICACY OF N -ACETYLCYSTEINE AND STANDARD THERAPY VERSUS STANDARD THERAPY IN THE PREVENTION OF ISCHEMIC HEPATITIS AND SURVIVAL POST UPPER GI BLEED|Completed||N/A|250|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 00:56:31.899747|2017-10-11 00:56:31.899747
NCT02015390|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-02-17|||October 2013||2013-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparative Efficacy of the Masquelet Versus Titanium Mesh Cage Techniques for the Treatment of Large Long Bone Defects|The Comparative Efficacy of the Masquelet Versus Titanium Mesh Cage Reconstruction Techniques for the Treatment of Large Long Bone Deficiencies|Recruiting||N/A|30|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 00:56:31.982183|2017-10-11 00:56:31.982183
NCT02015377|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-29|||September 2007||2007-09-01|March 2017|2017-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|FAME||Food, Adolescence, Mood, and Exercise|Food, Adolescence, Mood and Exercise|Completed||N/A|100|Actual|University of Southern California||2|||f||||t|f|f||||||Undecided||2017-10-11 00:56:32.089203|2017-10-11 00:56:32.089203
NCT02015364|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-02-22|||February 2014||2014-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization|Non-operative Treatment of Acute Achilles Tendon Rupture, Early Controlled Mobilization Compared With Immobilization: A Blinded Randomized, Controlled Trial|Active, not recruiting||N/A|130|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 00:56:32.184648|2017-10-11 00:56:32.184648
NCT02015351|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-12|||September 2012||2012-09-01|December 2013|2013-12-01|June 2014|Anticipated|2014-06-01|October 2013|Actual|2013-10-01||Interventional|||Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study|Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization in Vogt-Koyanagi-Harada Disease - A Prospective Study|Unknown status|Active, not recruiting|N/A|9|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 00:56:32.327634|2017-10-11 00:56:32.327634
NCT02015338|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-03-01|||February 2014||2014-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Observational|||Comparing the Location of the Motor Cortex in Children Using Two Methods|Comparing the Location of the Motor Cortex in Children Using Two Methods: EEG and TMS|Completed||N/A|47|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-11 00:56:32.433728|2017-10-11 00:56:32.433728
NCT02015325|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-18|||June 2013||2013-06-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Evaluate the Effect of Planet Water Foundation's Clean Water, Sanitation and Hygiene Intervention|Assessing the Health Impact of Safe Water, Sanitation, and Hygiene Education in the Developing World|Unknown status|Recruiting|N/A|828|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-10-11 00:56:32.531259|2017-10-11 00:56:32.531259
NCT02015312|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-12-09|||April 2013||2013-04-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|TAME-AL||A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)|A Randomised Trial for the Treatment of Cardiac AMyloid Light-chain Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)|Active, not recruiting||Phase 2|38|Actual|University Hospital Heidelberg||2|||f||||t||||||||||2017-10-11 00:56:32.647774|2017-10-11 00:56:32.647774
NCT02015299|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-05-17|||March 2014||2014-03-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|RELEASE||Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes|Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes|Completed||Phase 3|45|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 00:56:32.782117|2017-10-11 00:56:32.782117
NCT02015286|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-04-20|||March 2014||2014-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS UAE||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East|"Easypod Connect: A Regional, Multicentre, Observational Study to Evaluate Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment"|Completed||N/A|7|Actual|Merck KGaA|||1||f||||t||||||||||2017-10-11 00:56:32.926999|2017-10-11 00:56:32.926999
NCT02015273|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2016-08-09|||February 2014||2014-02-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Taiwan (ECOS TWN)|"Easypod Connect: a Multinational, Multicentre, Observational Study to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using easypodTM Electromechanical Device for Growth Hormone Treatment"|Completed||N/A|35|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 00:56:33.049853|2017-10-11 00:56:33.049853
NCT02015260|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-05-01|||September 2001||2001-09-01|December 2013|2013-12-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts|A Randomised, Multicentre, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy, Safety and Tolerability of Three Dose Regimens of Topical Nitric Oxide in Patients With Anogenital Warts|Completed||Phase 2|299|Actual|University of Aberdeen||4|||f||||f||||||||No||2017-10-11 00:56:33.156196|2017-10-11 00:56:33.156196
NCT02015247|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-11-19|||December 2013||2013-12-01|August 2013|2013-08-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Functional Capacity After Computer Assisted Periacetabular Osteotomy in Patients With Hip Dysplasia|Functional Capacity After Computer Assisted Periacetabular Osteotomy in Patients With Hip Dysplasia|Completed||N/A|41|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 00:56:33.243037|2017-10-11 00:56:33.243037
NCT02015234|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-06-08|2017-05-22||December 2013||2013-12-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|BESTFIT-OLE||12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients|A 12-Month, Multicenter, Open-Label Extension Study (F202) to Evaluate the Long-term Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia|Completed||Phase 3|158|Actual|Tonix Pharmaceuticals, Inc.||1|||f||||f||||||||Undecided||2017-10-11 00:56:33.338735|2017-10-11 00:56:33.338735
NCT02015221|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-10-21|2016-07-12||November 2013||2013-11-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional||Participants with bilateral disease received both treatment. The participate was randomly assigned a treatment to the right leg and were instructed to wear the other treatment on their left leg.|Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort|Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort|Completed||N/A|81|Actual|Tactile Medical|Participants could have either unilateral or bilateral disease. Bilateral participants had treatment randomly assigned to the right leg. The left leg received the treatment not assigned to their right leg (i.e: right leg - Grp A: Left Leg - Grp B).|2|||f||||f||||||||||2017-10-11 00:56:33.834003|2017-10-11 00:56:33.834003
NCT02015208|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-09-23|||April 2014||2014-04-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia|A Phase I/II Trial of Ruxolitinib (Jakafi) in Patients With Chronic Lymphocytic Leukemia Who Are Unfit for Conventional First-line Therapy Due to Age or 17p Deletions|Completed||Phase 1/Phase 2|13|Actual|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 00:56:34.199269|2017-10-11 00:56:34.199269
NCT02015195|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-04-10|2015-01-26||June 2013||2013-06-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||one patient treated with ammonia - adverse local skin reaction - this treatment arm therefore withdrawn from study|Effective Treatments for Jellyfish Stings|Efficacy of Topical Agents in the Treatment of Chrysaora Chinensis Stings|Completed||N/A|97|Actual|Stanford University||7|||f||||f||||||||||2017-10-11 00:56:34.2953|2017-10-11 00:56:34.2953
NCT02015182|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-04-14|||September 2011||2011-09-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Bupivacaine Pharmacokinetics Following TAP Block|Bupivacaine Pharmacokinetics in Children Following Transversus Abdominis Plane Block|Completed||N/A|20|Actual|The Hospital for Sick Children|||1||f||||f||||||Samples Without DNA|"     Blood (serum)   "|||2017-10-11 00:56:34.82049|2017-10-11 00:56:34.82049
NCT02015169|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-02-16|||July 9, 2012|Actual|2012-07-09|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis|Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis|Recruiting||Phase 2|32|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 00:56:34.892646|2017-10-11 00:56:34.892646
NCT02015156|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-04-21|||January 2014||2014-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)|Phase 1, Double-Blind, Randomized, Parallel-Group, Single-Dose, 2-Arm, Safety Study Of PF-05280014 And Trastuzumab Sourced From The US Administered To Healthy Male Volunteers|Completed||Phase 1|162|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:56:34.978511|2017-10-11 00:56:34.978511
NCT02015143|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2013-12-12|||January 2012||2012-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|March 2014|Anticipated|2014-03-01||Observational|CAFE-BD||A Comprehensive Assessment and Follow up Descriptive Study on Bipolar Disorder||Unknown status|Enrolling by invitation|N/A|970|Anticipated|Peking University|||2||f||||f||||||||||2017-10-11 00:56:35.118045|2017-10-11 00:56:35.118045
NCT02015130|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-09-18|||October 2013||2013-10-01|September 2017|2017-09-01|October 2025|Anticipated|2025-10-01|October 2025|Anticipated|2025-10-01||Interventional|ITT||Individually Tailored Treatment of Type 2 Diabetes|Individually Tailored Treatment of Type 2 Diabetes|Enrolling by invitation||N/A|2246|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 00:56:35.187386|2017-10-11 00:56:35.187386
NCT02015091|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-18|2017-10-05|||December 12, 2013||2013-12-12|September 8, 2016|2016-09-08|September 8, 2016|Actual|2016-09-08|May 1, 2015|Actual|2015-05-01||Interventional|||Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults|VRC 314: A Phase 1, Open-Label, Clinical Trial With Experimental Controlled Human Malaria Infections (CHMI) to Evaluate Safety and Durability of Protection Following Intravenous and Intramuscular Administration of PFSPZ Vaccine in Malaria-Naive Adults|Completed||Phase 1|40|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-11 00:56:37.115555|2017-10-11 00:56:37.115555
NCT02015078|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2017-06-30|||November 7, 2013||2013-11-07|May 12, 2017|2017-05-12|June 22, 2015|Actual|2015-06-22|June 22, 2015|Actual|2015-06-22||Observational|||Black Family Eating Behaviors Study|Black Family Eating Behaviors Study|Completed||N/A|350|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:56:37.210328|2017-10-11 00:56:37.210328
NCT02015065|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-14|2017-09-12|||September 18, 2013||2013-09-18|August 24, 2017|2017-08-24|August 31, 2023|Anticipated|2023-08-31|September 15, 2022|Anticipated|2022-09-15||Interventional|||Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors|Phase II Trial of Vandetanib (ZD6474, Caprelsa(R) in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors|Active, not recruiting||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:56:37.278497|2017-10-11 00:56:37.278497
NCT02015039|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-01-24|||December 3, 2013||2013-12-03|September 13, 2016|2016-09-13|September 13, 2016|Actual|2016-09-13|September 13, 2016|Actual|2016-09-13||Interventional|||Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp|Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp|Completed||Phase 1/Phase 2|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 00:56:37.370229|2017-10-11 00:56:37.370229
NCT02015013|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-13|2017-07-13|||November 19, 2013||2013-11-19|July 12, 2017|2017-07-12|January 1, 2019|Anticipated|2019-01-01|October 31, 2017|Anticipated|2017-10-31||Observational|||Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models|Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models|Recruiting||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:56:37.538531|2017-10-11 00:56:37.538531
NCT02014987|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-04-09|||July 2013||2013-07-01|April 2015|2015-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Running Related Injury Among Novice Runners|The Initial Running Volume and Running Related Injury Among Novice Runners|Unknown status|Recruiting|Early Phase 1|160|Anticipated|Northern Orthopaedic Division, Denmark||1|||f||||f||||||||||2017-10-11 00:56:37.708158|2017-10-11 00:56:37.708158
NCT02014974|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-09-29|||October 2011||2011-10-01|September 2017|2017-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|INORMUS||InterNational ORthopaedic MUlticenter Study in Fracture Care|INORMUS 5,000: Large Observational Study of Orthopedic Trauma Patients|Completed||N/A|4822|Actual|McMaster University|||2||f||||t||||||||||2017-10-11 00:56:37.909498|2017-10-11 00:56:37.909498
NCT02013882|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-02-08|||January 2014||2014-01-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||1-1-12 Wash-in for Desflurane Low Flow Anesthesia|1-1-12 Wash-in for Desflurane Low Flow Anesthesia|Completed||N/A|106|Actual|Khon Kaen University|||1||f||||f||||||||||2017-10-11 00:56:58.715911|2017-10-11 00:56:58.715911
NCT02014961|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-05-13|||April 2015||2015-04-01|May 2015|2015-05-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01||Interventional|||Worm Study: Modifier Genes in Sudden Cardiac Death|Worm Study: Identification of Modifier Genes in a Unique Founder Population With Sudden Cardiac Death|Recruiting||N/A|223|Anticipated|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-11 00:56:38.027069|2017-10-11 00:56:38.027069
NCT02014948|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-12-12|||June 2013||2013-06-01|December 2013|2013-12-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Vibratory Therapy for Patients With Chronic Low Back Pain|Implementation of a Physiotherapy Intervention for Patients With Chronic Low Back Pain|Unknown status|Recruiting|N/A|30|Anticipated|Laboratório de Engenharia de Reabilitação Sensorio Motora||1|||f||||t||||||||||2017-10-11 00:56:38.139466|2017-10-11 00:56:38.139466
NCT02014935|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-12-18|||July 2013||2013-07-01|December 2013|2013-12-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Immediate Effect of Laser on Spasticity|Immediate Effect of Low Intensity Laser on the Spastic Muscle Fatigued.|Unknown status|Recruiting|N/A|30|Anticipated|Laboratório de Engenharia de Reabilitação Sensorio Motora||1|||f||||t||||||||||2017-10-11 00:56:38.283453|2017-10-11 00:56:38.283453
NCT02014922|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2015-03-09|||December 2013||2013-12-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|DUNLIN||A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)|A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products|Completed||Phase 4|33|Actual|University of Waterloo||2|||f||||f||||||||||2017-10-11 00:56:38.389212|2017-10-11 00:56:38.389212
NCT02014909|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-07-21|||January 2014||2014-01-01|July 2017|2017-07-01|June 5, 2017|Actual|2017-06-05|May 25, 2017|Actual|2017-05-25||Interventional|||A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors|Part I and Part II A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors Alone or With Chemotherapy|Completed||Phase 1|64|Actual|Celldex Therapeutics||5|||f||||t||||||||||2017-10-11 00:56:38.521929|2017-10-11 00:56:38.521929
NCT02014896|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-08-09|||December 2013||2013-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|BASE||Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)|Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)|Recruiting||N/A|1400|Anticipated|Ischemia Care LLC|||4||f||||t||||||Samples Without DNA|"     Biospecimen will be whole blood samples.   "|||2017-10-11 00:56:38.667599|2017-10-11 00:56:38.667599
NCT02014883|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-04-30|||December 2013||2013-12-01|January 2014|2014-01-01|April 2018|Anticipated|2018-04-01|May 2015|Anticipated|2015-05-01||Interventional|GLUT-HEP||Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS|Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS|Recruiting||Phase 2|20|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 00:56:38.979687|2017-10-11 00:56:38.979687
NCT02014870|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-12|||June 2013||2013-06-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers|A Phase I, Open-label, Ascending Dose Study to Determine the Safety and Reactogenicity of a Wild Type Seasonal A/California/ H1N1 2009 Influenza Challenge Virus in Healthy Volunteers, Following a Single Intranasal Administration|Completed||Phase 1|29|Actual|Immune Targeting Systems Ltd||3|||f||||t||||||||||2017-10-11 00:56:39.102209|2017-10-11 00:56:39.102209
NCT02014857|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-12|||May 2012||2012-05-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Evaluation of GCF MMP-1, -8 and Growth Factor Levels in Smokers With Periodontal Health|Evaluation of GCF MMP-1, -8 and Growth Factor Levels in Smokers With Periodontal Health|Completed||Early Phase 1|32|Actual|Ege University|||2||f||||f||||||None Retained|"     Gingival crevicular fluid   "|||2017-10-11 00:56:39.217911|2017-10-11 00:56:39.217911
NCT02014844|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-01-04|||March 2014||2014-03-01|September 2015|2015-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma|An Open-Label Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of Aldoxorubicin in Subjects With Unresectable Glioblastoma Whose Tumors Have Progressed Following Prior Treatment With Surgery, Radiation and Temozolomide|Completed||Phase 2|28|Anticipated|CytRx||1|||f||||f||||||||||2017-10-11 00:56:39.294029|2017-10-11 00:56:39.294029
NCT02014831|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-02-24|||February 2016||2016-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PENILANE||Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)|A Randomized Phase II Study to Evaluate the Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma|Withdrawn||Phase 2|0|Actual|Centre Leon Berard||2||Industry decline to supply study drug|f||||t||||||||No||2017-10-11 00:56:39.389791|2017-10-11 00:56:39.389791
NCT02014818|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-08-29|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN Studies In Patients With Stable Angina Managed as Elective Case|Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN Studies In Patients With Stable Angina Managed as Elective Case : MECHANISM-Elective|Active, not recruiting||Phase 4|104|Actual|Kobe University||2|||f||||t||||||||||2017-10-11 00:56:39.507045|2017-10-11 00:56:39.507045
NCT02014805|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-12|||July 2013||2013-07-01|December 2013|2013-12-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma|A Multi-institutional, Randomized Controlled Trial of Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma|Recruiting||Phase 3|210|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:56:39.595314|2017-10-11 00:56:39.595314
NCT02014792|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-03-29|||August 2014||2014-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Heart Rate Variability & Fatty Acid Status: Haemodialysis Patients|Heart Rate Variability and Omega-3 Fatty Acid Status in Haemodialysis Patients: an Observational Pilot Study|Completed||N/A|52|Actual|King's College London|||1||f||||f||||||Samples Without DNA|"     Blood Plasma Washed and isolated red blood cells   "|||2017-10-11 00:56:39.68314|2017-10-11 00:56:39.68314
NCT02014779|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-03-14|||January 2014||2014-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|FoBeMA||Internet-Based Relapse Prevention vs Face to Face Therapy at an Employee Assistance Program|Internet-Based Relapse Prevention With Therapist Support vs Face to Face Therapy at an Employee Assistance Program: A Randomized Controlled Non-inferiority Trial|Terminated||N/A|1|Actual|Karolinska Institutet||2||Only 1 participant recruited to study. Qs addressed in other ongoing studies.|f||||f||||||||||2017-10-11 00:56:39.761329|2017-10-11 00:56:39.761329
NCT02014766|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2013-12-12|||November 2013||2013-11-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Supraclavicular Versus Interscalene Block|A Randomized Comparison of Ultrasound-guided Supraclavicular and Interscalene Block After Shoulder Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Cheju Halla General Hospital||2|||f||||f||||||||||2017-10-11 00:56:39.963378|2017-10-11 00:56:39.963378
NCT02014753|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-05-26|||February 2014||2014-02-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|MECHANISM-AMI||Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial InfarctionTreatment of ST-elevation Acute Myocardial Infarction|Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial Infarction: MECHANISM-AMI|Active, not recruiting||Phase 4|100|Anticipated|Iwate Medical University|||2||f||||f||||||||||2017-10-11 00:56:40.067014|2017-10-11 00:56:40.067014
NCT02014740|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-03-02|||March 2014||2014-03-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes|Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes|Completed||Phase 4|100|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 00:56:40.172434|2017-10-11 00:56:40.172434
NCT02014727|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-02-01|||January 2014||2014-01-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|AMA1-DiCo||Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults|Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults:a Staggered Phase Ia/Ib, Randomised, Double-blind, Multi-Centre Trial|Completed||Phase 1|66|Actual|Institut National de la Santé Et de la Recherche Médicale, France||4|||f||||t||||||||||2017-10-11 00:56:40.257271|2017-10-11 00:56:40.257271
NCT02014714|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-18|||December 2013||2013-12-01|December 2013|2013-12-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea|Randomized Comparison Study of Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea|Unknown status|Recruiting|Phase 1|40|Anticipated|University of Malaya||2|||f||||t||||||||||2017-10-11 00:56:40.379633|2017-10-11 00:56:40.379633
NCT02014701|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2013-12-12|||August 2012||2012-08-01|December 2013|2013-12-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.|Incremental Utility of Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery and Risk Area in Patients With Non-ST Segment Elevation Myocardial Infarction.|Unknown status|Recruiting|N/A|100|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-11 00:56:40.490854|2017-10-11 00:56:40.490854
NCT02014688|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-08-19|||December 2013||2013-12-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|S-2013-3||Optical Coherence Tomography (OCT) Normative Data Collection Study|Multi-center Study for Normal Database of Optic Nerve Head, Retinal Nerve Fiber Layer, and Macula Parameters With the Heidelberg Spectralis OCT, Study 3|Completed||N/A|166|Actual|Heidelberg Engineering GmbH|||4||f||||t||||||||||2017-10-11 00:56:40.584997|2017-10-11 00:56:40.584997
NCT02014675|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-03-09|||March 2014||2014-03-01|March 2017|2017-03-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01|5 Years|Observational [Patient Registry]|SD01 Registry||SD01 Registry (SD01 ICD Lead)|SD01 Registry (SD01 ICD Lead)|Active, not recruiting||N/A|280|Anticipated|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 00:56:40.667133|2017-10-11 00:56:40.667133
NCT02014662|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-05-12|||January 14, 2014|Actual|2014-01-14|May 2017|2017-05-01|July 2, 2014|Actual|2014-07-02|July 2, 2014|Actual|2014-07-02||Interventional|||A Methodology Study to Assess Muscle Damage After Eccentric Exercise|A Pilot Study to Measure Force Recovery and Protein Synthetic Rates After Unilateral Eccentric Exercise in Healthy Males Volunteers Unaccustomed to Eccentric Exercise|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 00:56:40.775921|2017-10-11 00:56:40.775921
NCT02014636|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-05-22|||December 27, 2013|Actual|2013-12-27|May 2017|2017-05-01|February 9, 2019|Anticipated|2019-02-09|August 12, 2018|Anticipated|2018-08-12||Interventional|||Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)|A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and MK 3475 in Patients With Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|248|Actual|Novartis||2|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 00:56:41.021931|2017-10-11 00:56:41.021931
NCT02014623|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-01-16|||February 2014||2014-02-01|January 2014|2014-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis|Immunological Mechanisms of Oralair® (5 Grass Mix Sublingual Allergen Immunotherapy Tablet) in Patients With Seasonal Allergic Rhinitis|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Bayside Health||2|||f||||f||||||||||2017-10-11 00:56:41.14159|2017-10-11 00:56:41.14159
NCT02014610|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-12|||January 1997||1997-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|CALIBER||White Blood Cell Counts and Onset of Cardiovascular Diseases: a CALIBER Study|Leukocyte Counts and Initial Presentation of Cardiovascular Diseases: a CALIBER Study|Unknown status|Active, not recruiting|N/A|800000|Anticipated|University College, London|||1||f||||t||||||||||2017-10-11 00:56:41.255559|2017-10-11 00:56:41.255559
NCT02014597|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-12-23|||May 2015||2015-05-01|December 2016|2016-12-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|HOCD||Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without Glaucoma|Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients With and Without Glaucoma|Recruiting||N/A|140|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 00:56:41.335194|2017-10-11 00:56:41.335194
NCT02014584|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-01-17|2016-11-10||July 2014||2014-07-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia|A Prospective Study of Sexual Function in Men Taking Dutasteride for the Treatment of Androgenetic Alopecia|Completed||Phase 3|117|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:56:41.543921|2017-10-11 00:56:41.543921
NCT02014571|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-05-09|||December 26, 2013|Actual|2013-12-26|May 2017|2017-05-01|January 15, 2015|Actual|2015-01-15|July 3, 2014|Actual|2014-07-03||Interventional|||Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.|A Randomized, Single Blind, Dose Escalation, Placebo-Controlled Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.|Completed||Phase 1|37|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 00:56:44.864826|2017-10-11 00:56:44.864826
NCT02014558|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-05-24||2016-11-16|October 9, 2013|Actual|2013-10-09|May 2017|2017-05-01|December 1, 2017|Anticipated|2017-12-01|November 24, 2015|Actual|2015-11-24||Interventional|||Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 1/2 Open-Label, Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Active, not recruiting||Phase 1/Phase 2|258|Actual|Astellas Pharma Inc||2|||t||||f||||||||Undecided||2017-10-11 00:56:45.01218|2017-10-11 00:56:45.01218
NCT02014545|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-08-14|||January 2016|Actual|2016-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer|Phase II Trial Evaluating the Addition of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer|Suspended||Phase 2|50|Anticipated|Wake Forest University Health Sciences||2||Pending resolution of study drug issues|f||||t|t|f||||||||2017-10-11 00:56:45.313829|2017-10-11 00:56:45.313829
NCT02014532|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-18|||March 2012||2012-03-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Role of Leukotriene Receptor Antagonists in Treatment of Chronic Periodontitis|The Effect Of SRP With Adjunctive Systemic Therapy Of Leukotriene Receptor Antagonist-Montelukast On The Serum C Reactive Protein Levels & Clinical Parameters In Chronic Periodontitis Patients - A Randomized Controlled Trial|Completed||Phase 4|60|Actual|Tatyasaheb Kore Dental College||2|||f||||t||||||||||2017-10-11 00:56:45.407174|2017-10-11 00:56:45.407174
NCT02014506|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-03-24|||January 2017|Actual|2017-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents|Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents|Recruiting||Phase 1/Phase 2|30|Anticipated|Asan Medical Center||1|||f||||t||||||||||2017-10-11 00:56:45.650316|2017-10-11 00:56:45.650316
NCT02014493|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-05-02|||January 2014||2014-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Changes in Respiratory Effort in Preterm Infants|Respiratory Effort in Preterm Infants in the Transition From Continuous Positive Airway Pressure (CPAP) to High Flow Nasal Cannulae (HFNC)|Completed||N/A|21|Actual|St. Olavs Hospital||2|||f||||f||||||||||2017-10-11 00:56:45.773699|2017-10-11 00:56:45.773699
NCT02014480|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-11-18|2013-12-19||February 2013||2013-02-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-Blind, 3-Way, Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium 62.5 mcg, Vilanterol 25 mcg, and Umeclidinium/Vilanterol 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|207|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:56:45.980105|2017-10-11 00:56:45.980105
NCT02014467|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-09-08|2016-03-31||January 2014||2014-01-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Denosumab China Phase III Study|A Twelve-Month Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Chinese Postmenopausal Women With Osteoporosis at Increased Risk of Fracture|Completed||Phase 3|486|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 00:56:46.622292|2017-10-11 00:56:46.622292
NCT02014454|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-07-06|||November 2013||2013-11-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|DROP-PROP||Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature|Safety and Efficacy of Propranolol Eye Drops in Newborns With Retinopathy of Premature (DROP-PROP)|Completed||Phase 2|23|Actual|Azienda Ospedaliero, Universitaria Meyer||1|||f||||f||||||||||2017-10-11 00:56:48.109934|2017-10-11 00:56:48.109934
NCT02014441|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-06-14|2016-12-15||April 7, 2014|Actual|2014-04-07|June 2017|2017-06-01|December 29, 2017|Anticipated|2017-12-29|January 25, 2016|Actual|2016-01-25||Interventional||Safety analysis set (all participants who received at least 1 dose of talimogene laherparepvec)|Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec|A Phase 2, Multicenter, Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec in Subjects With Unresected, Stage IIIB to IVM1c Melanoma|Active, not recruiting||Phase 2|61|Actual|Amgen||1|||f||||f||||||||||2017-10-11 00:56:48.290204|2017-10-11 00:56:48.290204
NCT02014428|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-12||||||December 2013|2013-12-01||||April 2013|Actual|2013-04-01||Interventional|||Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis||Completed||Phase 4|||AGUNCO Obstetrics and Gynecology Centre||2|||f||||||||||||||2017-10-11 00:56:49.44555|2017-10-11 00:56:49.44555
NCT02014415|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-01-03|||December 2013||2013-12-01|January 2017|2017-01-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01|5 Years|Observational [Patient Registry]|||Alpha-1 Antitrypsin Deficiency Adult Liver Study|Alpha-1 Antitrypsin Deficiency Adult Clinical and Genetic Linkage Study|Recruiting||N/A|120|Anticipated|St. Louis University|||3||f||||t||||||Samples With DNA|"     Samples of serum, plasma, and blood for genetic testing (Induced Pluripotent Stem Cells (iPS     cells), microRNA and DNA) will be collected from subjects at defined time points. In     addition, samples of liver tissue will be collected from participants in the Liver Biopsy     Group.   "|Yes|"Based on study group assignment, participants will be given a copy of their test results as follows:
Liver Biopsy Group- liver biopsy pathology, diagnostic abdominal ultrasound, pulmonary function testing, and routine clinical laboratory testing.
Known Severe Liver Disease Group- diagnostic abdominal ultrasound, pulmonary function testing, and routine clinical laboratory testing.
Post Liver Transplant Group- pulmonary function testing."|2017-10-11 00:56:49.651861|2017-10-11 00:56:49.651861
NCT02014402|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-05-17|2017-03-30||December 2013||2013-12-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery|A Prospective, Randomized, Double-blind, Phase II Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Vascular, Hepatic, Soft Tissue, and Spinal Open Surgeries|Completed||Phase 2|181|Actual|Grifols Biologicals Inc.||4|||f||||f||||||||||2017-10-11 00:56:49.83084|2017-10-11 00:56:49.83084
NCT02014389|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-01-01|||December 2013||2013-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer|Objective Perimetry in Normal Subjects,Glaucoma Patients and Retinal Dystrophy Patients|Recruiting||N/A|200|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 00:56:52.8543|2017-10-11 00:56:52.8543
NCT02014376|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2014-06-26|||January 2014||2014-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa|A Phase 2B, Multi-center, Randomized, Double-Blind, Vehicle Controlled Study of the Effectiveness and Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa|Completed||Phase 2|48|Anticipated|Scioderm, Inc.||3|||f||||f||||||||||2017-10-11 00:56:52.951647|2017-10-11 00:56:52.951647
NCT02014363|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-11-15|2016-09-26||October 2013||2013-10-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ETS6103-003||Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)|Double Blind, Non-inferiority Study to Evaluate the Antidepressant Activity of ETS6103 Compared to Amitriptyline in Treating Major Depressive Disorder in Patients With Unsatisfactory Response to Selective Serotonin Re-uptake Inhibitors.|Completed||Phase 2|164|Actual|e-Therapeutics PLC||4|||f||||f||||||||||2017-10-11 00:56:53.076564|2017-10-11 00:56:53.076564
NCT02014350|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-17||||||December 2013|2013-12-01||||March 2020|Anticipated|2020-03-01||Observational|||Outcomes Following Delta Xtend Reverse Shoulder System||Enrolling by invitation||N/A|||Rothman Institute Orthopaedics|||1||f||||||||||||||2017-10-11 00:56:53.993854|2017-10-11 00:56:53.993854
NCT02014337|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-07-21|||January 2014||2014-01-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors|Phase 1 Study of Mifepristone in Combination With Eribulin in Patients With Locally Advanced/Metastatic Breast or Other Specified Solid Tumors, With a Dose Expansion Cohort in Patients With Triple Negative Breast Cancer.|Active, not recruiting||Phase 1|37|Actual|Corcept Therapeutics||1|||f||||f||||||||||2017-10-11 00:56:54.078861|2017-10-11 00:56:54.078861
NCT02014324|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-10-17|||May 2013||2013-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01|4 Weeks|Observational [Patient Registry]|SCORE||Single Scope Staging of Lung Cancer With Endosonography|Complete Endosonographic Staging of Lung Cancer: a Systematic Single Scope Approach|Completed||N/A|215|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||t||||||||||2017-10-11 00:56:54.180856|2017-10-11 00:56:54.180856
NCT02014311|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-04-10|||October 2013||2013-10-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|March 2017|Actual|2017-03-01||Interventional|CATCH2||CArdiac cT in the Treatment of Acute CHest Pain 2 - Myocardial CT Perfusion|Myocardial Perfusion 320 MDCT Guided Treatment Strategy for the Clinical Management of Patient With Recent Acute-onset Chest Pain. A Randomized Controlled Trial|Active, not recruiting||N/A|600|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 00:56:54.269115|2017-10-11 00:56:54.269115
NCT02014298|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2013-12-12|||January 2012||2012-01-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Non Ablative Fractional Laser Treatment of Burn Scars|LONG-TERM AND CONTINUED IMPROVEMENT OF MATURE BURN SCARS IN RESPONSE TO NONABLATIVE FRACTIONAL LASER - A RANDOMIZED CONTROLLED TRIAL WITH HISTOLOGICAL EVALUATION|Completed||N/A|20|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 00:56:54.381536|2017-10-11 00:56:54.381536
NCT02013869|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-08-29|||May 2015||2015-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LF||Low Flow Anaesthesia|Low Flow Anaesthesia; Cost-effectiveness of the Flow-I Anaesthesia Machine, a Comparison to Established Anaesthesia Delivery Unit|Recruiting||Phase 4|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:56:58.801396|2017-10-11 00:56:58.801396
NCT02014285|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-08-11|||November 2012||2012-11-01|August 2017|2017-08-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Observational|MUSCULAR||Muscle Ultrasound Signifies Condition Upgrade Leading Approach to Recovery|Muscle Ultrasound Signifies Condition Upgrade Leading Approach to Recovery|Completed||N/A|1|Actual|Wake Forest University Health Sciences|||1||f||||t|f|f||||Samples Without DNA|"     Muscle tissue and serum/plasm   "|||2017-10-11 00:56:54.591124|2017-10-11 00:56:54.591124
NCT02014272|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2014-06-16|2014-06-16||September 2012||2012-09-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Analysis population included all randomized participants.|A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers|An Open Label, Single Dose, 2-Way Cross-Over Randomized Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 (Contains 150 Mg Rifampicin And 75 Mg Isoniazid Per Tablet) To An Equivalent Dose Of Single Drug Reference Preparations Of Rifampicin And Isoniazid Following Oral Administration In Healthy Adults Under Fasting Conditions|Completed||Phase 1|28|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:56:54.682642|2017-10-11 00:56:54.682642
NCT02014259|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2014-11-10|||December 2013||2013-12-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function|Investigation of Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function|Completed||Phase 1|71|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:56:55.118391|2017-10-11 00:56:55.118391
NCT02014246|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-09-28|||February 12, 2003||2003-02-12|September 26, 2017|2017-09-26|December 31, 2017||2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Genetic Characterization of Movement Disorders and Dementias|Genetic Characterization of Movement Disorders and Dementias|Recruiting||N/A|12000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:56:55.211861|2017-10-11 00:56:55.211861
NCT02014233|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-05-19|||June 2013||2013-06-01|May 2016|2016-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Short Term Omega-3 Supplementation on Performance|The Effect of Short Term Omega-3 Supplementation on Exercise Performance and Neuromuscular Function.|Completed||N/A|30|Actual|University of Toronto||2|||f||||f||||||||No||2017-10-11 00:56:55.304826|2017-10-11 00:56:55.304826
NCT02014220|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-11||||||December 2013|2013-12-01||||December 2008|Actual|2008-12-01||Interventional|||The Food Intake, Satiety and Blood Glucose After Ingestion of Potato Chips Produced From Three Potato Cultivars||Completed||N/A|||University of Toronto||5|||f||||||||||||||2017-10-11 00:56:55.437198|2017-10-11 00:56:55.437198
NCT02014207|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-11||||||December 2013|2013-12-01||||January 2007|Actual|2007-01-01||Interventional|||The Effect of Potato Fries Processing on Food Intake, Satiety and Blood Glucose||Completed||N/A|||University of Toronto||5|||f||||||||||||||2017-10-11 00:56:55.522875|2017-10-11 00:56:55.522875
NCT02014194|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-05-10|||November 2013||2013-11-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Attentional Bias and Attentional Bias Modification Treatment in Obsessive-compulsive Disorder|Attentional Bias and Attentional Bias Modification Treatment in Obsessive-compulsive Disorder|Recruiting||N/A|30|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 00:56:55.602706|2017-10-11 00:56:55.602706
NCT02014181|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-01-06|||July 2012||2012-07-01|April 2012|2012-04-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Flaxseed Modulates Inflammation and Oxidative Stress in CF|Flaxseed Modulates Oxidative Stress and Inflammatory Biomarkers in Stable Patients With Cystic Fibrosis and Healthy Controls|Completed||Phase 1|10|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 00:56:55.689912|2017-10-11 00:56:55.689912
NCT02014168|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-04-29|||January 2014||2014-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza Vaccine|A Phase I Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and the Viroflu® Seasonal Influenza Vaccine|Terminated||Phase 1|3|Actual|University of Oxford||2||Futility|f||||f||||||||||2017-10-11 00:56:55.797605|2017-10-11 00:56:55.797605
NCT02014155|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2017-04-24|||August 2013|Actual|2013-08-01|April 2017|2017-04-01|January 1, 2015|Actual|2015-01-01|November 1, 2014|Actual|2014-11-01||Interventional|||Inspiratory Muscle Training and Respiratory Electromyographic Activity in COPD|Effects of Inspiratory Muscle Training on Respiratory Electromyographic Activity in Patients With COPD Participants and Non-participants of a Pulmonary Rehabilitation Program|Completed||N/A|20|Actual|University of Santa Cruz do Sul||4|||f||||f||||||||||2017-10-11 00:56:55.889356|2017-10-11 00:56:55.889356
NCT02014142|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-01-16||2017-01-09|December 2013||2013-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma|A Phase 2 Single-Masked, Randomized Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma|Completed||Phase 2|86|Actual|Mati Therapeutics Inc.||2|||f||||||||||||||2017-10-11 00:56:55.993316|2017-10-11 00:56:55.993316
NCT02014129|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-08-31|||December 2013||2013-12-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2015|Actual|2015-04-01||Interventional|||A Study of LY2835219 in Japanese Participants With Advanced Cancer|A Phase 1 Study of LY2835219 in Japanese Patients With Advanced Cancer|Active, not recruiting||Phase 1|12|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 00:56:56.142982|2017-10-11 00:56:56.142982
NCT02014116|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-07-21|||November 26, 2013|Actual|2013-11-26|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|April 7, 2017|Actual|2017-04-07||Interventional|||A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body|A Phase 1 Study of LY3009120 in Patients With Advanced or Metastatic Cancer|Active, not recruiting||Phase 1|50|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 00:56:56.260201|2017-10-11 00:56:56.260201
NCT02014103|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-03-11|||March 2015||2015-03-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients|Evaluation of Clinical and Safety Outcomes Associated With Conversion From Brand-Name to Generic Tacrolimus Products in High Risk Transplant Recipients|Completed||Phase 4|71|Actual|University of Cincinnati||3|||f||||f||||||||||2017-10-11 00:56:56.389706|2017-10-11 00:56:56.389706
NCT02014090|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-05|2013-12-11|||March 2008||2008-03-01|December 2013|2013-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Acute Hemodynamic and Biological Effects of ECP and Exercise|Acute Cardiovascular Effects of External Counterpulsation (ECP) in Comparison With Physical Exercise in Healthy Individuals|Completed||N/A|20|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 00:56:56.775488|2017-10-11 00:56:56.775488
NCT02014077|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||VATS ( Video-Assisted Thoracoscopy) Compared to Reinsertion of a Thoracostomy Tube for Persistent Haemothorax|VATS( Video-Assisted Thoracoscopy ) Compared to Reinsertion of a Thoracostomy Tube for Persistent Haemothorax A Single Center Prospective Randomized Study|Recruiting||N/A|100|Anticipated|University of Cape Town||2|||f||||t||||||||||2017-10-11 00:56:56.861227|2017-10-11 00:56:56.861227
NCT02014064|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2016-05-10|||August 2009||2009-08-01|May 2016|2016-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety Study to Assess Atomoxetine With MA Abusers and Healthy Controls|A Study to Assess the Cardiovascular, Cognitive and Subjective Effects of Atomoxetine in Combination With Intravenous Methamphetamine|Completed||Phase 1|41|Actual|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-11 00:56:56.951326|2017-10-11 00:56:56.951326
NCT02014051|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-10-17|2016-07-26||March 2013||2013-03-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)|Phase I Clinical Trial of SyB C-1101 in Patients With Myelodysplastic Syndrome|Completed||Phase 1|10|Actual|SymBio Pharmaceuticals||1|||f||||||||||||||2017-10-11 00:56:57.075095|2017-10-11 00:56:57.075095
NCT02014038|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2013-12-11|||May 2011||2011-05-01|December 2013|2013-12-01|December 2031|Anticipated|2031-12-01|December 2012|Actual|2012-12-01|20 Years|Observational [Patient Registry]|||Ultrarunners Longitudinal TRAcking Study (ULTRA)|Ultrarunners Longitudinal TRAcking Study (ULTRA)|Enrolling by invitation||N/A|2452|Actual|Stanford University|||1||f||||f||||||||||2017-10-11 00:56:57.581029|2017-10-11 00:56:57.581029
NCT02014025|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2015-08-08|||March 2013||2013-03-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Laparoscopic Hepatectomy Versus Open Hepatectomy for PHC|Laparoscopic Hepatectomy Versus Open Hepatectomy for PHC With a Tumor Size of 5-10cm:a Prospective Case-control Study|Completed||N/A|335|Actual|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 00:56:57.648423|2017-10-11 00:56:57.648423
NCT02014012|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-04-10|||April 2013||2013-04-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||PWV for Cardiovascular Complication After Cardiac Surgery|Evaluation of Pulse Wave Velocity as a Predictive Factor for Postoperative Cardiovascular Complication After Cardiac Surgery: a Prospective Study|Completed||N/A|60|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 00:56:57.742859|2017-10-11 00:56:57.742859
NCT02013999|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-06-26|||October 2013||2013-10-01|June 2017|2017-06-01|November 24, 2014|Actual|2014-11-24|November 24, 2014|Actual|2014-11-24||Interventional|||The Development of Upper Extremity Rehabilitation Program Using Virtual Reality for the Stroke Patients|Mobile Game-based Virtual Reality Rehabilitation Program for Upper Limb Dysfunction After Ischemic Stroke|Completed||N/A|33|Actual|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-11 00:56:57.889979|2017-10-11 00:56:57.889979
NCT02013973|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-12-11|||March 2013||2013-03-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|AMH||Predictive Value of AMH in IVF; a Prospective RCT|Predictive Value of AMH (AMH=Anti Müllerian Hormone ) in IVF (IVF=In Vitro Fertilization ); a Prospective Randomized Controlled Trial|Completed||N/A|308|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-11 00:56:58.106689|2017-10-11 00:56:58.106689
NCT02013960|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-12-11|||January 2014||2014-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Misoprostol vs. Sublingual Misoprostol and Laminaria For Second Trimester Termination of Pregnancy|Comparison Between Sublingual Misoprostol vs. Sublingual Misoprostol and Laminaria For Second Trimester Termination of Pregnancy|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 00:56:58.21434|2017-10-11 00:56:58.21434
NCT02013947|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-04-26|||November 2013||2013-11-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|November 2013|Actual|2013-11-01||Interventional|||Effects of Moderate Altitude Training on Metabolic Parameters in Voluntary Study Participants With Metabolic Syndrome|Randomized Controlled Trial to Analyze the Effects of Moderate Altitude Training on Metabolic Parameters in Voluntary Study Participants With Metabolic Syndrome.|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Pure Mountain Solda||2|||f||||t||||||||||2017-10-11 00:56:58.289632|2017-10-11 00:56:58.289632
NCT02013934|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2013-12-11|||October 2013||2013-10-01|December 2013|2013-12-01||||April 2014|Anticipated|2014-04-01||Interventional|||Probiotics in Prevention of Common Cold|Benefit and Tolerability of a Probiotic Product in Subjects With Increased Susceptibility to Common Cold|Unknown status|Recruiting|Phase 2|312|Anticipated|Probi AB||2|||f||||t||||||||||2017-10-11 00:56:58.367891|2017-10-11 00:56:58.367891
NCT02013921|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-08-31|||December 2013||2013-12-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|APQ||Interest of Daily Physical Activity After Cancer Treatment|Evaluation du Niveau d'activité Physique Quotidien, Chez Des Patientes Porteuses d'un Cancer du Sein en période Post thérapeutique|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Limoges|||1||f||||f||||||||||2017-10-11 00:56:58.452415|2017-10-11 00:56:58.452415
NCT02013908|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-12-03|||December 2013||2013-12-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Acupuncture for Pain Control in the Emergency Department|Acupuncture for Non-emergent Acute Musculoskeletal Pain and Primary Headache in an Emergency Department Setting: a Parallel, Randomized, Controlled Pilot Trial|Terminated||N/A|17|Actual|Korean Medicine Hospital of Pusan National University||2||Low recruitment rate (17 patients;43% enrollment for 2 years).|f||||t||||||||||2017-10-11 00:56:58.54058|2017-10-11 00:56:58.54058
NCT02013856|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-12-01|||July 2014||2014-07-01|November 2015|2015-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|FLAVASCULAR||The Effects of Apple Derived Flavanols on Cardiovascular Disease Risk (FLAVASCULAR Study)|The Effects of Apple Derived Flavanols on Cardiovascular Disease Risk|Completed||N/A|42|Actual|Quadram Institute||4|||f||||f||||||||||2017-10-11 00:56:58.945103|2017-10-11 00:56:58.945103
NCT02013843|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-03-28|||March 2013||2013-03-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||"Treatment of Overweight and Obese Children -Using the Holbaek-Method in a Municipality Based Treatment Program."|"Treatment of Overweight and Obese Children - the Holbaek-Method in a Municipality Based Treatment Program."|Completed||N/A|1007|Actual|Holbaek Sygehus||1|||f||||t||||||||||2017-10-11 00:56:59.095669|2017-10-11 00:56:59.095669
NCT02013830|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-05-07|2014-05-07||May 2005||2005-05-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||All enrolled participants who received at least 1 dose of study drug.|A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer|A Single-arm, Open-label Study of Avastin Plus Xeloda on Objective Treatment Response in Patients With Advanced or Metastatic Liver Cancer Who Have Had no Previous Cytotoxic Chemotherapy|Completed||Phase 2|45|Actual|Hoffmann-La Roche|Nonserious adverse events presented in this record include all adverse events reported during the study, not just nonserious events.|1|||f||||||||||||||2017-10-11 00:56:59.212067|2017-10-11 00:56:59.212067
NCT02013817|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-07-11|2014-07-22||October 11, 2005|Actual|2005-10-11|July 2017|2017-07-01|September 24, 2012|Actual|2012-09-24|September 24, 2012|Actual|2012-09-24||Interventional||Intent-To-Treat (ITT) population: all participants who received at least one dose of study medication.|CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy|CHAIROS - Effect of Early Brief Intensification by Chemoimmunotherapy With FCR Followed by FR and Rituximab Maintenance on Clinical Response in Chemo-naïve Patients With B-CLL|Completed||Phase 2|43|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:56:59.852528|2017-10-11 00:56:59.852528
NCT02013804|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-10-04|||December 19, 2013|Actual|2013-12-19|September 2017|2017-09-01|May 18, 2017|Actual|2017-05-18|May 18, 2017|Actual|2017-05-18||Interventional|||A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies|A Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies|Completed||Phase 1|58|Actual|MedImmune LLC||1|||f||||f||||||||||2017-10-11 00:57:00.71548|2017-10-11 00:57:00.71548
NCT02013791|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2017-07-26|||April 29, 2014|Actual|2014-04-29|July 2017|2017-07-01|April 1, 2019|Anticipated|2019-04-01|April 1, 2019|Anticipated|2019-04-01||Interventional|||Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease|A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease|Recruiting||Phase 2|32|Anticipated|Allergan||12|||f||||t|t|f||||||||2017-10-11 00:57:00.832027|2017-10-11 00:57:00.832027
NCT02013778|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-12|2016-12-06|||November 2013||2013-11-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Interventional|||Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC|Phase I-II Clinical Trial of the Safety and Preliminary Efficacy of Hydroxychloroquine Combined With Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma|Recruiting||Phase 1/Phase 2|49|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 00:57:01.025061|2017-10-11 00:57:01.025061
NCT02013765|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-09-22|2014-07-24||January 2001||2001-01-01|September 2014|2014-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Full analysis set (FAS) includes all participants who received study treatment.|A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer|An Open-label Pilot Study of the Effect of Second-line Treatment With Herceptin Monotherapy on Time to Disease Progression in Patients With Metastatic Urothelial Cancer and HER2 Overexpression|Terminated||Phase 2|5|Actual|Hoffmann-La Roche||1||Trial was terminated prematurely because of recruitment difficulties.|f||||||||||||||2017-10-11 00:57:01.140569|2017-10-11 00:57:01.140569
NCT02013752|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2015-03-18|||March 2015||2015-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||The Effect of the Modified Perineal Protection Device During Delivery|Randomized Controlled Trial (RCT) of Primiparous Women Using the Modified Perineal Protection Device|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Helsingborgs Hospital||2|||f||||f||||||||||2017-10-11 00:57:01.46924|2017-10-11 00:57:01.46924
NCT02013739|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-11|||May 2011||2011-05-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|||Description of Insulin Resistance in Patients With Chronic Heart Failure|Description of Insulin Resistance and Explanatory Variables in Patients With Chronic Heart Failure|Completed||N/A|80|Actual|Hasselt University|||2||f||||f||||||||||2017-10-11 00:57:01.566398|2017-10-11 00:57:01.566398
NCT02013726|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-08-22|||April 2015||2015-04-01|August 2014|2014-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue|Pilot Study: Dedicated Dual Head Molecular Breast Imaging Compared to Breast Tomosynthesis for Evaluation of Patients With Type 3 or 4 Mammographic Breast Density|Withdrawn||N/A|0|Actual|Gamma Medica, Inc.||1|||f||||f||||||||||2017-10-11 00:57:01.656375|2017-10-11 00:57:01.656375
NCT02013713|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2015-02-12|||November 2014||2014-11-01|February 2015|2015-02-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Observational|FH Care||French Observatory of Familial Hypercholesterolemia in Cardiology|French Observatory of Familial Hypercholesterolemia in Cardiology|Recruiting||N/A|200|Anticipated|French Cardiology Society|||1||f||||f||||||||||2017-10-11 00:57:01.87476|2017-10-11 00:57:01.87476
NCT02011399|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2013-12-09|||February 2011||2011-02-01|December 2013|2013-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Brain Computer Interfaces (Mu Rhythm Learning)|EEG-based Brain Computer Interface and Mu Rhythm for Computer Access|Terminated||N/A|7|Actual|University of Michigan|||1|Training procedure was not effective.|f||||f||||||||||2017-10-11 00:57:39.84636|2017-10-11 00:57:39.84636
NCT02013687|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-01-25|2016-11-21||October 2013||2013-10-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults|A Phase 1 Study of the Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults|Completed||Phase 1|44|Actual|Fraunhofer, Center for Molecular Biotechnology||4|||f||||t||||||||Undecided||2017-10-11 00:57:02.145062|2017-10-11 00:57:02.145062
NCT02013674|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-09-13|||November 2013||2013-11-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|March 2, 2017|Actual|2017-03-02||Interventional|Trident||The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)|A Phase II, Randomized, Blinded, Study of the Safety and Efficacy of Transendocardial Injection of Allogeneic Human Mesenchymal Stem Cells (hMSCs) (20 Million or 100 Million Total MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction.|Active, not recruiting||Phase 2|30|Actual|University of Miami||2|||f||||t|t|f||||||||2017-10-11 00:57:02.986025|2017-10-11 00:57:02.986025
NCT02013661|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-16|||June 2011||2011-06-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Clinical Evaluation of Sutures in Periodontal Surgery|Clinical Evaluation of Four Types of Suture in Periodontal Surgery|Completed||Early Phase 1|40|Actual|Universitat Internacional de Catalunya|||1||f||||f||||||||||2017-10-11 00:57:03.083767|2017-10-11 00:57:03.083767
NCT02013648|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-01-30|||July 2014||2014-07-01|January 2017|2017-01-01|May 2023|Anticipated|2023-05-01|December 2020|Anticipated|2020-12-01||Interventional|||Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)|Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™) in Adult Patients With Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)|Recruiting||Phase 3|277|Anticipated|University of Ulm||2|||f||||t||||||||||2017-10-11 00:57:03.179925|2017-10-11 00:57:03.179925
NCT02013635|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-11-09|||July 2011||2011-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|PHRC-TVC||Thrombin Generation and Thrombus Degradation in Cerebral Venous Thrombosis : Clinical and Radiological Correlations|Study of Thrombin Generation and Thrombus Degradation in Cerebral Venous Thrombosis : Correlation With Clinical and Radiological Evolution|Completed||N/A|232|Actual|University Hospital, Rouen|||1||f||||f||||||Samples With DNA|"     plasma, serum and whole blood   "|||2017-10-11 00:57:03.559026|2017-10-11 00:57:03.559026
NCT02013622|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-02-26|2015-09-04||November 2013||2013-11-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia|Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia|Completed||Phase 3|49|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 00:57:03.735574|2017-10-11 00:57:03.735574
NCT02013609|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-02-26|2015-09-04||November 2013||2013-11-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment|Protocol 331-13-003: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC 34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment.|Completed||Phase 3|48|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 00:57:04.295861|2017-10-11 00:57:04.295861
NCT02013596|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-01-13|||December 2013||2013-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TRIP||Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum|Effect of Transcutaneous Electrical Acupoint Stimulation(TEAS) on the Hepatic and Renal Function Impaired by Pneumoperitoneum: a Prospective, Randomized Controlled Trial|Completed||N/A|168|Actual|Fourth Military Medical University||3|||f||||t||||||||||2017-10-11 00:57:05.100952|2017-10-11 00:57:05.100952
NCT02013583|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-26|||December 2013||2013-12-01|December 2013|2013-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|||The Glucose Transporter Type I Deficiency (G1D) Registry|The Glucose Transporter Type I Deficiency (G1D) Registry|Recruiting||N/A|750|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-11 00:57:05.210712|2017-10-11 00:57:05.210712
NCT02013557|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-01-05|||January 2014||2014-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes|Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes|Terminated||N/A|57|Actual|University of South Florida||2||Resources allocated elsewhere.|f||||t||||||||No||2017-10-11 00:57:05.40278|2017-10-11 00:57:05.40278
NCT02013544|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-05-30|2017-03-15|2015-07-10|February 2014||2014-02-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional||Baseline Analysis Population corresponds to the Safety Population which includes all subjects who received any amount of prasterone or placebo, and who have any safety information available.|Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause||Completed||Phase 3|558|Actual|EndoCeutics Inc.||2|||f||||f||||||||||2017-10-11 00:57:05.511513|2017-10-11 00:57:05.511513
NCT02013531|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-02-26|2015-08-04|2015-04-30|November 2013||2013-11-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms|Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms|Completed||Phase 3|37|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 00:57:06.33931|2017-10-11 00:57:06.33931
NCT02013518|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-12-11|||September 2013||2013-09-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Cognitive Behavioural Therapy for Persons With MCI or Mild Dementia|Cognitive Behavioural Therapy for Persons With Mild Cognitive Impairment or Dementia in the Early Stages|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 00:57:06.933909|2017-10-11 00:57:06.933909
NCT02013505|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-10-03|||February 2013||2013-02-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Validated Educational Video Intervention Improves the Quality of Bowel Preparation for Colonoscopy|A Validated Educational Video Intervention Improves the Quality of Bowel Preparation for Colonoscopy.|Terminated||N/A|298|Actual|University of Missouri-Columbia||2||Study expired; Investigator left facility.|f||||f||||||||No||2017-10-11 00:57:07.058884|2017-10-11 00:57:07.058884
NCT02013492|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-09-28|||January 2014||2014-01-01|September 2016|2016-09-01||||May 2017|Anticipated|2017-05-01||Interventional|||Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery|A Pilot Study of Beta-Blockers in Patients With Advanced Cancer|Recruiting||N/A|35|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 00:57:07.144939|2017-10-11 00:57:07.144939
NCT02013479|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-06-06|||June 2014||2014-06-01|June 2016|2016-06-01|September 2020|Anticipated|2020-09-01|June 2019|Anticipated|2019-06-01||Interventional|CATALYST||Selenium Supplementation in Autoimmune Thyroiditis|The Chronic Autoimmune Thyroiditis Quality Of Life Selenium Trial|Recruiting||N/A|472|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 00:57:07.275175|2017-10-11 00:57:07.275175
NCT02013466|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-11|||October 2008||2008-10-01|December 2013|2013-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|ArenA||Amino Acid Bioavailability in Healthy Elderly After Intake of an Oral Nutritional Supplement|Amino Acid Bioavailability in Healthy Elderly After Bolus Intake of a High Whey-protein, Leucine-rich, Low-caloric Oral Nutritional Supplement|Completed||Phase 1|12|Actual|Nutricia Research||1|||f||||f||||||||||2017-10-11 00:57:07.396933|2017-10-11 00:57:07.396933
NCT02013453|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2014-12-01|||December 2013||2013-12-01|December 2014|2014-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer|A Phase II Randomized Trial Evaluating the Use of Proton Pump Inhibitors (PPIs) in Conjunction With Chemotherapy, in Patients With Recurrent Unresectable or Metastatic Cancers of the Head and Neck|Withdrawn||Phase 2|0|Actual|University of Michigan Cancer Center||3||Lack of funding|f||||t||||||||||2017-10-11 00:57:07.490874|2017-10-11 00:57:07.490874
NCT02013427|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-15|||October 2014||2014-10-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial|BRAIN MECHANISMS FOR CLINICAL PLACEBO IN CHRONIC PAIN: A Partially-Blind Randomized Clinical Trial of Placebo and Chronic Back Pain|Recruiting||Phase 4|82|Anticipated|Northwestern University||3|||f||||t||||||||No||2017-10-11 00:57:07.59082|2017-10-11 00:57:07.59082
NCT02013401|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-16|||October 2013||2013-10-01|December 2013|2013-12-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|MIBLS||Transmission of Mother-Infant Stress Communication|Transmission of Discrimination-Related Stress Reactivity and Reduction From Mother to Infant|Unknown status|Recruiting|N/A|56|Anticipated|University of Massachusetts, Boston|||1||f||||f||||||||||2017-10-11 00:57:07.764508|2017-10-11 00:57:07.764508
NCT02013388|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-11-03|2015-03-05||February 2014||2014-02-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|SNO2||MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects|Completed||Phase 1|49|Actual|Nivalis Therapeutics, Inc.||8|||f||||t||||||||||2017-10-11 00:57:07.873754|2017-10-11 00:57:07.873754
NCT02013375|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-04-19|||February 5, 2014|Actual|2014-02-05|April 2017|2017-04-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|SCD-Haplo||SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD|SCD-Haplo: A Phase II Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease|Active, not recruiting||Phase 2|110|Actual|University of Illinois at Chicago||1|||f||||t|t|f|||f|||||2017-10-11 00:57:09.185097|2017-10-11 00:57:09.185097
NCT02013362|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-08-31|||December 2013||2013-12-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|||Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma|Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|26|Anticipated|Mundipharma K.K.||1|||f||||t||||||||||2017-10-11 00:57:09.271282|2017-10-11 00:57:09.271282
NCT02013349|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-07-25|||April 22, 2014|Actual|2014-04-22|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|October 2015|Actual|2015-10-01||Interventional|||DESolve Post-Approval Study|POST-MARKET EVALUATION OF DESolve® NOVOLIMUS ELUTING BIORESORBABLE CORONARY SCAFFOLD SYSTEM IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS|Active, not recruiting||N/A|102|Actual|Elixir Medical Corporation||1|||f||||f||||||||||2017-10-11 00:57:09.353538|2017-10-11 00:57:09.353538
NCT02013336|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-02-02|||December 2013||2013-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors|Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors|Recruiting||Phase 1|30|Anticipated|South Plains Oncology Consortium||1|||f||||t|t|f||||||||2017-10-11 00:57:09.443456|2017-10-11 00:57:09.443456
NCT02013323|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-11|||March 2013||2013-03-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Clinical and Microbiological Efficacy of Systemic Ayurvedic Immunomodulator Septilin in the Treatment of Chronic Periodontitis|Clinical and Microbiological Efficacy of Systemic Ayurvedic Immunomodulator Septilin in the Treatment of Chronic Periodontitis-- A Randomized Controlled Clinical Trial.|Completed||Phase 2|60|Actual|Government Dental College and Research Institute, Bangalore||2|||f||||t||||||||||2017-10-11 00:57:09.539881|2017-10-11 00:57:09.539881
NCT02013310|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-12-01||2015-12-01|December 2013||2013-12-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|PRIME||HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)|A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing HT-0712 With Placebo in Subjects With Age-Associated Memory Impairment (AAMI)|Completed||Phase 2|119|Actual|Dart NeuroScience, LLC||2|||f||||f||||||||||2017-10-11 00:57:09.619274|2017-10-11 00:57:09.619274
NCT02013297|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-08-02|||December 3, 2013|Actual|2013-12-03|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|SBRT||Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)|Hypofractionated Stereotactic Radiation Treatments (SBRT) on Children, Teenagers and Young Adults Malignant Tumors|Recruiting||N/A|80|Anticipated|Centre Leon Berard||1|||f||||t||||||||||2017-10-11 00:57:09.726273|2017-10-11 00:57:09.726273
NCT02013284|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-07-25|||November 2013||2013-11-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Is Our Microbiome a Predictor of Cardiac Risk|Is Our Microbiome a Predictor of Cardiac Risk?|Recruiting||N/A|200|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Blood (50 cc) and stool samples will be collected on consenting participants. Participants     will have the option of allowing us to store samples for future research   "|||2017-10-11 00:57:09.930131|2017-10-11 00:57:09.930131
NCT02013258|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-07-27|||March 2015||2015-03-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Oxytocin Trial in Prader-Willi Syndrome|Oxytocin Trial in Prader-Willi Syndrome|Completed||Phase 1|24|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 00:57:10.125031|2017-10-11 00:57:10.125031
NCT02013245|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-02-06|2016-03-15||January 2013||2013-01-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|MTBVAC||Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.|Phase I Double Blind, Randomized, Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC in Comparison With BCG in Elispot TB(ESAT-6, CFP10, PPD)- and HIV- Negative Volunteers|Completed||Phase 1|36|Actual|Biofabri, S.L|This is a first-in-human Phase 1 trial designed to evaluate the safety and tolerability profile of MTBVAC in comparison to BCG.|4|||f||||t||||||||Undecided||2017-10-11 00:57:10.234736|2017-10-11 00:57:10.234736
NCT02013232|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-11|||February 2013||2013-02-01|December 2013|2013-12-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|||Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia|Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study|Unknown status|Recruiting|N/A|120|Anticipated|Beijing HuiLongGuan Hospital||4|||f||||t||||||||||2017-10-11 00:57:10.722572|2017-10-11 00:57:10.722572
NCT02013219|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-07-13|||April 3, 2014|Actual|2014-04-03|July 2017|2017-07-01|January 18, 2019|Anticipated|2019-01-18|December 1, 2018|Anticipated|2018-12-01||Interventional|||A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)|A Phase 1b Study of the Safety and Pharmacology of Atezolizumab (Anti-PD-L1 Antibody) Administered With Erlotinib or Alectinib in Patients With Advanced Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1|52|Actual|Hoffmann-La Roche||4|||f||||f|t|f||||||||2017-10-11 00:57:10.836788|2017-10-11 00:57:10.836788
NCT02013206|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2014-12-12|2014-12-12||September 2006||2006-09-01|December 2014|2014-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy|An Parallel Phase II Study of Tarceva (Erlotinib) in Patients With Advanced Non-small Cell Lung Cancer (Stage IIIB/IV) Not Pre-treated by Chemotherapy Including Dose Escalation to Toxicity in Current and Former Smokers|Completed||Phase 2|52|Actual|Hoffmann-La Roche|Treatment was ongoing for 3 patients at the time of the Clinical Study Report (CSR) cut-off. In the addendum to the CSR, there were no findings for these 3 patients that deviated from those observed in the original report.|2|||f||||f||||||||||2017-10-11 00:57:12.926327|2017-10-11 00:57:12.926327
NCT02013193|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-10-08|||January 2014||2014-01-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|May 2016|Actual|2016-05-01||Interventional|RANGER-SFA||Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries|Prospective, Randomized, Multicentre Clinical Study of the Hemoteq Ranger™ Paclitaxel-Coated PTA Balloon Catheter (Ranger DCB) in Comparison to Uncoated PTA Balloons in Femoropopliteal Lesions|Active, not recruiting||N/A|105|Actual|Hemoteq AG||2|||f||||t||||||||No||2017-10-11 00:57:13.572362|2017-10-11 00:57:13.572362
NCT02013180|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2014-02-03|||July 2012||2012-07-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection|Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection|Completed||N/A|480|Actual|Bagcilar Training and Research Hospital|||2||f||||||||||Samples Without DNA|"     serum, prostatic tissue   "|||2017-10-11 00:57:13.809703|2017-10-11 00:57:13.809703
NCT02013167|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-08-18|2017-07-12|2016-10-14|January 3, 2014|Actual|2014-01-03|August 2017|2017-08-01|March 14, 2017|Actual|2017-03-14|December 29, 2015|Actual|2015-12-29||Interventional|||Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)|A Phase 3, Randomized, Open Label Study Investigating the Efficacy of the BiTE Antibody Blinatumomab Versus Standard of Care Chemotherapy in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (TOWER Study)|Terminated||Phase 3|405|Actual|Amgen||2||"Decision by Evidence Generation Team 18Feb16 to prematurely discontinue LTFU as per DMC   recommendation & Amgen acceptance that study had met primary endpoint"|f||||t||||||||||2017-10-11 00:57:13.945192|2017-10-11 00:57:13.945192
NCT02012738|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-05-12|||October 2013||2013-10-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Treatment of Trauma and Violence in the Townships of South Africa|MemoTV: Epigenetic, Neural and Cognitive Memories of Traumatic Stress and Violence in Former Offenders of the Townships of South Africa|Completed||N/A|45|Actual|University of Konstanz||4|||f||||t||||||||||2017-10-11 00:57:22.061583|2017-10-11 00:57:22.061583
NCT02013154|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-01-27|||January 2014||2014-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of DKN-01 in Combination With Paclitaxel|A Five Part, Phase 1, Multi-center, Open-label Study of DKN-01 in Combination With Weekly Paclitaxel; Part A: A Dose-Escalation Study in Patients With Relapsed or Refractory (R/R) Esophageal Cancer (EC) or Gastro-esophageal Junction (GEJ) Tumors; Part B: An Expansion Cohort in Patients With R/R EC or GEJ Tumors; Part C: An Expansion Cohort in Patients With R/R Esophageal or GEJ Adenocarcinoma; Part D: An Expansion Cohort in Patients With R/R Esophageal Squamous Cell Cancer; Part E: An Expansion Cohort in Patients With R/R Gastric Adenocarcinoma With Wnt Signaling Alterations|Recruiting||Phase 1|152|Anticipated|Leap Therapeutics, Inc.||6|||f||||f||||||||||2017-10-11 00:57:16.15995|2017-10-11 00:57:16.15995
NCT02013141|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-07-17|||December 2014|Actual|2014-12-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Telavancin Pediatric PK Study (Ages >3 Months to 17 Years)|An Open-Label Study of the Pharmacokinetics of a Single Dose of Telavancin in Pediatric Subjects Aged 3 Months to 17 Years|Recruiting||Phase 4|36|Anticipated|Theravance Biopharma Antibiotics, Inc.||1|||f||||f||||||||||2017-10-11 00:57:16.373673|2017-10-11 00:57:16.373673
NCT02013128|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-09-07|||December 2013||2013-12-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Ublituximab + Ibrutinib in Select B-cell Malignancies|A Multi-center Phase II Study With Safety Run-in Evaluating the Efficacy and Safety of Ublituximab in Combination With Ibrutinib in Patients With Select B-Cell Malignancies|Active, not recruiting||Phase 1/Phase 2|62|Actual|TG Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 00:57:16.484123|2017-10-11 00:57:16.484123
NCT02013115|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-02-10|||January 2015||2015-01-01|December 2013|2013-12-01||||January 2017|Anticipated|2017-01-01||Interventional|Budesonide||Curosurf/Budesonide for Infants With Respiratory Distress Syndrome|Curosurf/Budesonide for Infants With Respiratory Distress Syndrome|Unknown status|Recruiting|N/A|300|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-11 00:57:16.616051|2017-10-11 00:57:16.616051
NCT02013102|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-11|||March 2013||2013-03-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|DREAM||A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome|A Randomized, Controlled, Multi-center Collaborative Phase Ⅳ Study to Evaluate the Safety and Efficacy of Decitabine in Myelodysplastic Syndrome|Unknown status|Recruiting|Phase 4|240|Anticipated|Cttq||2|||f||||t||||||||||2017-10-11 00:57:16.719259|2017-10-11 00:57:16.719259
NCT02013089|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-08-27|||December 2013||2013-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|GITIC||A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study|A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers|Recruiting||N/A|50|Anticipated|Sun Yat-sen University||6|||f||||f||||||||||2017-10-11 00:57:16.81722|2017-10-11 00:57:16.81722
NCT02013076|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2014-07-18|||January 2011||2011-01-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|DOORWAY||Determinants Of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth|Determinants Of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth|Completed||N/A|1011|Actual|St. Justine's Hospital|||1||f||||t||||||Samples With DNA|"     Saliva for cotinine and for DNA and nasopharyngeal samples for viral analysis.   "|||2017-10-11 00:57:16.980748|2017-10-11 00:57:16.980748
NCT02013063|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2016-10-17|||August 2012||2012-08-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|SPUtNIk||Single Pulmonary Nodule Investigation|Accuracy and Cost-Effectiveness of Dynamic Contrast Enhanced Computed Tomography in the Characterisation of Solitary Pulmonary Nodules|Recruiting||N/A|375|Anticipated|University Hospital Southampton NHS Foundation Trust|||1||f||||t||||||||No|there is no plan to share individual patient data|2017-10-11 00:57:17.095648|2017-10-11 00:57:17.095648
NCT02013050|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-07-28|2017-02-17||December 2013||2013-12-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|||A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer|A Phase 2,Double-Blind, Randomized, Placebo-Controlled, Dose Escalating, Multicenter Study of SGX942 For the Attenuation of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|111|Actual|Soligenix||2|||f||||f||||||||||2017-10-11 00:57:17.262142|2017-10-11 00:57:17.262142
NCT02013037|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-08-17|||November 2012||2012-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|DUET||The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation|The De-novo Use of Eculizumab Alongside Conventional Therapy in Presensitized Patients Receiving Cardiac Transplantation: An Open-Label, Investigator-Initiated Pilot Trial: [The DUET Cardiac Trial]|Enrolling by invitation||Phase 4|20|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 00:57:19.375866|2017-10-11 00:57:19.375866
NCT02013024|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-02-04|||September 2011||2011-09-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of Vitrification Versus Slow Freezing on Day 3: a Randomised Controlled Trial.||Completed||N/A|417|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 00:57:19.523852|2017-10-11 00:57:19.523852
NCT02012998|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-09-08|||January 2014|Actual|2014-01-01|September 2017|2017-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA|An Open-label, Controlled, Multi-centre Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO to Explore the Anamnestic Immune Response in Healthy Children Vaccinated 10 Years Ago With a Primary Series (3 Doses) of Either HEXAVAC or INFANRIX HEXA|Completed||Phase 3|751|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:57:19.702137|2017-10-11 00:57:19.702137
NCT02012985|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-10-14|||December 2013||2013-12-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria|A Phase 1/2, Randomised, Placebo-controlled, Double-blind, Multi-centre Study to Evaluate the Efficacy and Safety of OC5 to Reduce Urinary Oxalate in Subjects With Primary Hyperoxaluria|Completed||Phase 1/Phase 2|28|Actual|OxThera||2|||f||||f||||||||||2017-10-11 00:57:19.827171|2017-10-11 00:57:19.827171
NCT02012959|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2017-07-14|||November 2014||2014-11-01|July 2017|2017-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia|A Phase 3b, Multicenter, Open-label, Randomized Withdrawal Trial of the Effects of Titrated Oral SAMSCA ® (Tolvaptan) on Serum Sodium, Pharmacokinetics, and Safety in Children and Adolescent Subjects Hospitalized With Euvolemic or Hypervolemic Hyponatremia|Recruiting||Phase 3|100|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-10-11 00:57:20.073849|2017-10-11 00:57:20.073849
NCT02012946|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2013-12-11|||December 2013||2013-12-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Interventional|||Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery||Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Azienda Policlinico Umberto I||2|||f||||||||||||||2017-10-11 00:57:20.289087|2017-10-11 00:57:20.289087
NCT02012933|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-11|2015-04-20||||||April 2015|2015-04-01||||||||Expanded Access|||3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)|3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenia|Available||N/A|||Oregon Health and Science University|||||||||||||||||||2017-10-11 00:57:20.371393|2017-10-11 00:57:20.371393
NCT02012920|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-09-20|||December 2011|Actual|2011-12-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer|A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Seviteronel in Subjects With Castration-Resistant Prostate Cancer|Recruiting||Phase 2|200|Anticipated|Innocrin Pharmaceutical||2|||f||||f|t|f||||||||2017-10-11 00:57:20.475426|2017-10-11 00:57:20.475426
NCT02012894|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-10|||June 2009||2009-06-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2011|Actual|2011-09-01||Observational|||Laparoscopic Sleeve Gastrectomy and Gastroesophageal Acid Reflux|Physiopathologic Evaluation of Esophageal Function After Laparoscopic Sleeve Gastrectomy|Completed||N/A|65|Actual|University of Turin, Italy|||2||f||||f||||||||||2017-10-11 00:57:20.650371|2017-10-11 00:57:20.650371
NCT02012881|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2014-06-25|||October 2013||2013-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|LCoMotion||LCoMotion. Learning, Cognition and Motion. Effect of a Four Month School-based Cluster-randomized Intervention||Completed||N/A|870|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 00:57:20.755496|2017-10-11 00:57:20.755496
NCT02012868|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-10|||March 2012||2012-03-01|November 2013|2013-11-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Observational|||The Prevalence of Obstructive Sleep Apnoea in Patients Prior to and One Year After Bariatric Surgery|The Prevalence of Obstructive Sleep Apnoea in Patients Prior to and One Year After Bariatric Surgery|Unknown status|Enrolling by invitation|N/A|63|Anticipated|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 00:57:20.871556|2017-10-11 00:57:20.871556
NCT02012855|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-05-02|||August 2013||2013-08-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Different Types of Carbohydrates Consumed After Exercise on Blood Fat Levels|Effect of Exercise and Glycemic Index of Carbohydrate Feeding on Postprandial Lipid Metabolism|Completed||N/A|23|Actual|University of Saskatchewan||4|||f||||f||||||||No||2017-10-11 00:57:21.003702|2017-10-11 00:57:21.003702
NCT02012842|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-05-30|||May 2014||2014-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Metabolic Syndrome and Periodontitis|The Effect of Periodontal Treatment on Quality of Life in Patients With Metabolic Syndrome|Active, not recruiting||N/A|158|Actual|Federal University of Rio Grande do Sul||2|||f||||t||||||||||2017-10-11 00:57:21.242169|2017-10-11 00:57:21.242169
NCT02012829|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2013-12-10|||December 2011||2011-12-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|Hem-FMG||Influence of a Brief Intervention on CRC Screening|Brief Intervention to Improve Colorectal Cancer Screening|Completed||N/A|45|Actual|University Paris 7 - Denis Diderot||2|||f||||f||||||||||2017-10-11 00:57:21.342156|2017-10-11 00:57:21.342156
NCT02012816|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-06-03|||June 2014||2014-06-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia|The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia: an Impact Evaluation|Completed||N/A|725|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 00:57:21.422675|2017-10-11 00:57:21.422675
NCT02012803|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-05-27|||April 2009||2009-04-01|May 2015|2015-05-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Achilles Tendon Rupture, Conservative vs. Operative Treatment: Prospective Randomized Controlled Trial|Conservative vs. Operative Treatment of Achilles Tendon Rupture, Prospective Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-11 00:57:21.500328|2017-10-11 00:57:21.500328
NCT02012777|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-06-06|||June 2010||2010-06-01|June 2017|2017-06-01|April 3, 2013|Actual|2013-04-03|November 2012|Actual|2012-11-01||Interventional|||Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease|Propanolol Effect on Red Cell Adhesion in Non-Asthmatic Children With Sickle Cell Disease: A Dose Finding Study|Terminated||Phase 1|9|Actual|University of Miami||3||Inability to recruit patients into the study.|f||||t||||||||Yes||2017-10-11 00:57:21.74873|2017-10-11 00:57:21.74873
NCT02012764|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-06-29|||January 2007||2007-01-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|CCP||The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ?|The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ?|Recruiting||N/A|4000|Anticipated|University of Leeds|||1||f||||t||||||Samples With DNA|"     DNA sample currently retained as part of a sub-study for a departmental tissue bank.   "|||2017-10-11 00:57:21.854508|2017-10-11 00:57:21.854508
NCT02012751|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-10-27|||October 2014||2014-10-01|June 2016|2016-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Nevus Doctor Clinical Decision Support|Nevus Doctor Clinical Decision Support Program for Pigmented Skin Lesions and Melanoma|Completed||N/A|49|Actual|University Hospital of North Norway||1|||f||||f||||||||||2017-10-11 00:57:21.962928|2017-10-11 00:57:21.962928
NCT02012699|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-05-05|||November 2013||2013-11-01|May 2017|2017-05-01|December 2099|Anticipated|2099-12-01|December 2099|Anticipated|2099-12-01|80 Years|Observational [Patient Registry]|iCaRe2||Integrated Cancer Repository for Cancer Research|Integrated Cancer Repository for Cancer Research|Recruiting||N/A|9999|Anticipated|University of Nebraska|||1||f||||f|f|f||||Samples With DNA|"     Questionnaire: baseline, follow up and annually. Blood: obtain 30 ml of blood at enrollment,     annually and at recurrence. Urine: donate a urine sample at enrollment and follow up     appointments. Access to leftover tissue: release a portion of leftover tissue collected and     saved from surgery/biopsy.      Urine: obtain 1/4 cup of urine at enrollment date. Additional 1/4 cup of urine may be     collected at follow up visits.      Tissue procurement and banking of excess biological materials. This includes but not limited     to tumor tissue and/or metastatic cancer tissue and/or paraffin embedded tissue collected and     saved from biopsy and/or surgery done in the past or future, from registry participants.   "|Yes|All data and/or specimen request have to be made to the PI of the center and follow the Human Subject Protection guidelines and policy.|2017-10-11 00:57:22.37301|2017-10-11 00:57:22.37301
NCT02012686|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-05-12|2014-02-28||November 2013||2013-11-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Transcutaneous Electrical Nerve Stimulation on Posterior Neck Pain After Thyroidectomy|The Effect of Transcutaneous Electrical Nerve Stimulation for Reduction of Posterior Neck Pain After Thyroidectomy|Completed||N/A|100|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:57:23.02069|2017-10-11 00:57:23.02069
NCT02012673|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-06-26|||January 2014||2014-01-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|RECOIL||A Safety and Feasibility Study of Re-treating Patients With Severe Emphysema With the RePneu LVRC System.|The Safety and Feasibility of Re-treating Patients With Severe Emphysema With the RePneu LVRC System: a Pilot Study.|Completed||N/A|8|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 00:57:23.44849|2017-10-11 00:57:23.44849
NCT02012660|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-04-28|||February 2014||2014-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Relationship Between Heat Wave and Hyponatremia|Relationship Between Heat Wave and Moderate to Severe Hyponatremia in the Emergency Departement of Primary and Tertiary Care Teaching Hospital.|Completed||N/A|28734|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 00:57:23.553447|2017-10-11 00:57:23.553447
NCT02012647|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-06-09|||August 2013||2013-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Subthalamic Deep Brain Stimulation (DBS) in Parkinson's Disease|Evaluating Cortical Physiology Following Unilateral and Bilateral Subthalamic Deep Brain Stimulation in Parkinson's Disease|Completed||Early Phase 1|4|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 00:57:23.684575|2017-10-11 00:57:23.684575
NCT02012634|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-11-11|||January 2013||2013-01-01|November 2014|2014-11-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01||Observational|MACRO||Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer|A Multi-center, III Phase，Randomized Controlled Clinical Study of Capecitabine Metronomic Chemotherapy After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer|Recruiting||Phase 3|340|Anticipated|Xijing Hospital|||1||f||||f||||||Samples With DNA|"     10 ml blood sample is taken before randomization   "|||2017-10-11 00:57:23.822338|2017-10-11 00:57:23.822338
NCT02012621|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-12-05|||December 2013||2013-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|2104||Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy|Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy.|Recruiting||N/A|1000|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 00:57:23.978514|2017-10-11 00:57:23.978514
NCT02012608|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-08-30|||June 2014||2014-06-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Glutamine for the Prevention of Radiation Toxicity in Subjects Undergoing Breast Conserving Therapy|Glutamine for the Prevention of Radiation Toxicity in Subjects Undergoing Breast|Recruiting||Phase 2|60|Anticipated|University of Arkansas||2|||f||||t||||||||||2017-10-11 00:57:24.073382|2017-10-11 00:57:24.073382
NCT02012595|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-05-31|||October 2013||2013-10-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||[11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease|[11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease|Completed||N/A|24|Actual|University of Aarhus|||2||f||||t||||||||||2017-10-11 00:57:24.172971|2017-10-11 00:57:24.172971
NCT02012582|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-02-08|2015-12-29||November 2009||2009-11-01|February 2016|2016-02-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|NOSTRA||Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury|An Exploratory Phase 2 a Study to Assess Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of VAS203 in Patients With Moderate and Severe Traumatic Brain Injury|Completed||Phase 2|32|Actual|Vasopharm GmbH||4|||f||||t||||||||No||2017-10-11 00:57:24.276126|2017-10-11 00:57:24.276126
NCT02012569|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-04-21|||November 2013||2013-11-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|EHTIC||Determine the Haemostatic Efficacy of TT-173, Reducing the Bleeding Time in the Donor Site of Skin Grafting|A Phase II Randomized, Controlled, Single Blind Study to Evaluate the Haemostatic Efficacy and Safety of TT-173 Applied in the Donor Site of Patients Undergoing Skin Graft|Completed||Phase 2|78|Actual|Thrombotargets Europe S.L||2|||f||||t||||||||Undecided||2017-10-11 00:57:25.286832|2017-10-11 00:57:25.286832
NCT02012556|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-10|||May 2008||2008-05-01|December 2013|2013-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients|A Phase 1 Study to Evaluate the Pharmacokinetics and the Pharmacodynamics of TH9507 Administered Subcutaneously Once Daily for 14 Consecutive Days in HIV Positive Patients|Completed||Phase 1|18|Actual|Theratechnologies||1|||f||||f||||||||||2017-10-11 00:57:25.384857|2017-10-11 00:57:25.384857
NCT02012543|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2014-11-02|||November 2013||2013-11-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Agar Administration on Defecation and Fecal Condition in Chronic Constipated Patients||Completed||N/A|100|Actual|Showa Inan General Hospital||1|||f||||f||||||||||2017-10-11 00:57:25.467971|2017-10-11 00:57:25.467971
NCT02012530|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-12-10|||January 2014||2014-01-01|December 2013|2013-12-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|||PRP vs HA Intra-articular Knee Injections for Cartilage Defects|A Cohort Comparison Study Comparing Platelet Rich Plasma vs Hyaluronic Acid Intra-articular Knee Injections for Early Cartilage Defects in the Knee|Unknown status|Not yet recruiting|N/A|100|Anticipated|Shetty-Kim Research Foundation||2|||f||||t||||||||||2017-10-11 00:57:25.540934|2017-10-11 00:57:25.540934
NCT02012517|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-13|||January 2014||2014-01-01|December 2013|2013-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Antibiotic Prophylaxis in Prosthetic Breast Reconstructions|Antibiotic Prophylaxis in Prosthetic Breast Reconstructions|Not yet recruiting||Phase 4|160|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:57:25.618197|2017-10-11 00:57:25.618197
NCT02012504|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-12-10|||June 2013||2013-06-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Observational|||Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients|Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients Who Meet Comorbidity of Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)|Unknown status|Recruiting|Early Phase 1|50|Anticipated|Shanghai Zhongshan Hospital|||2||f||||t||||||||||2017-10-11 00:57:25.697255|2017-10-11 00:57:25.697255
NCT02012491|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-07-06|||January 2014||2014-01-01|July 2017|2017-07-01|June 15, 2019|Anticipated|2019-06-15|May 15, 2017|Actual|2017-05-15||Interventional|PreFaiR||Comparative Effectiveness of Pregnancy Failure Management Regimens|Comparative Effectiveness of Pregnancy Failure Management Regimens|Active, not recruiting||Phase 3|300|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 00:57:25.775361|2017-10-11 00:57:25.775361
NCT02012465|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-09|||September 2013||2013-09-01|December 2013|2013-12-01||||August 2014|Anticipated|2014-08-01||Interventional|||Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients|Validation of Insulin Protocol for Prevention and Management of Hyperglycemia in Oncology Patients With Diabetes Receiving High Dose Glucocorticoid Therapy|Unknown status|Enrolling by invitation|Early Phase 1|40|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 00:57:25.929461|2017-10-11 00:57:25.929461
NCT02012452|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-09-06|2016-01-28||December 2014||2014-12-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Tobacco Treatment as Augmentation for Cognitive Processing Therapy for PTSD|Tobacco Treatment as Augmentation to Cognitive Processing Therapy for PTSD|Terminated||N/A|19|Actual|VA Office of Research and Development||2||PI moving outside VA- grant not transferable|f||||t||||||||No||2017-10-11 00:57:26.014807|2017-10-11 00:57:26.014807
NCT02012439|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-05-10|||October 2013||2013-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|April 2015|Actual|2015-04-01||Interventional|||Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic Pain|The Efficacy and Mechanisms of Cognitive Therapy Compared to Mindfulness-Based Cognitive Therapy in Multiple Sclerosis (MS) Pain|Active, not recruiting||Phase 1/Phase 2|32|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 00:57:26.541084|2017-10-11 00:57:26.541084
NCT02012426|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-31|||January 2014||2014-01-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|SWSS||The Effect of a Multi-component Weight Management Program on Appetite, Food Preference and Body Weight|The Effect of a Multi-component Weight Management Program on Appetite, Food Preference and Body Weight|Completed||N/A|96|Actual|University of Leeds||2|||f||||f||||||||||2017-10-11 00:57:26.610844|2017-10-11 00:57:26.610844
NCT02012413|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-04-23|||November 2012|Actual|2012-11-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Pulsed Signal Therapy in Patella Chondromalacia|Effect of Pulsed Signal Therapy in Patella Chondromalacia. Randomized Prospective Trial.|Completed||N/A|41|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 00:57:26.71172|2017-10-11 00:57:26.71172
NCT02012400|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-05-10|||August 2011||2011-08-01|May 2017|2017-05-01|June 30, 2015|Actual|2015-06-30|June 30, 2015|Actual|2015-06-30||Interventional|||Effects of Regular Exercise on Adult Asthma|Effects of Regular Exercise on Physical Fitness, Asthma Control and Quality of Life of Adult Asthmatics|Completed||N/A|131|Actual|University of Oulu||2|||f||||f||||||||||2017-10-11 00:57:26.801471|2017-10-11 00:57:26.801471
NCT02012387|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-05-02|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Interventional|CUN-OMAL-UCOL||Efficacy Study of Omalizumab in Cholinergic Urticaria|Multicenter Randomized, Double-blind, Placebo-controlled Parallel Clinical Trial to Assess Efficacy and Safety of Omalizumab (Xolair®) in a New Indication: Cholinergic Urticarial|Active, not recruiting||Phase 2|24|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||3|||f||||t||||||||||2017-10-11 00:57:26.895315|2017-10-11 00:57:26.895315
NCT02012374|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-12-09|||March 2012||2012-03-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|August 2015|Actual|2015-08-01||Interventional|||Overcoming Learned Non-Use in Chronic Aphasia|Overcoming Learned Non-Use in Chronic Aphasia: Behavioral, fMRI and QoL Outcomes|Active, not recruiting||N/A|24|Anticipated|University of Massachusetts, Amherst||2|||f||||t||||||||||2017-10-11 00:57:27.006575|2017-10-11 00:57:27.006575
NCT02012361|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-08-26|||October 2014||2014-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Inspired Helium for Ischemic Protection During Knee Replacement Surgery|Inspired Helium for Ischemic Protection During Knee Replacement Surgery|Completed||Phase 1|40|Actual|University of Florida||2|||f||||f||||||||No||2017-10-11 00:57:27.101392|2017-10-11 00:57:27.101392
NCT02012348|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-03-30|||December 2013||2013-12-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Analysis of the Effect of Antimicrobial Soap on Bacterial Survival|Analysis of the Effect of Antimicrobial Soap on Bacterial Survival|Completed||N/A|10|Actual|University of California, San Diego||3|||f||||f||||||||||2017-10-11 00:57:27.21051|2017-10-11 00:57:27.21051
NCT02012335|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-03-18|||January 2014||2014-01-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Ketamine Use in Electroconvulsive Therapy|Ketamine Use in Electroconvulsive Therapy: Clinical, Cognitives and Neurotrophic Outcomes|Withdrawn||N/A|0|Actual|Hospital de Clinicas de Porto Alegre||2||Methodologicals and logistics issues.|f||||f||||||||||2017-10-11 00:57:27.2942|2017-10-11 00:57:27.2942
NCT02012322|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-17|||November 2008||2008-11-01|December 2013|2013-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||UCSD Q10 and Aging Study|Coenzyme Q10 and Aging: A Planning Grant|Completed||N/A|44|Actual|University of California, San Diego||6|||f||||f||||||||||2017-10-11 00:57:27.451409|2017-10-11 00:57:27.451409
NCT02012309|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-08-29|||August 2014||2014-08-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses|Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses|Recruiting||N/A|120|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 00:57:27.566355|2017-10-11 00:57:27.566355
NCT02012296|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-09-20|||December 2013||2013-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer|A Phase I/II Trial of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Mifepristone for Patients With Metastatic Castration Resistant Prostate Cancer (CRPC)|Recruiting||Phase 1/Phase 2|108|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 00:57:27.687966|2017-10-11 00:57:27.687966
NCT02012283|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-17|||November 2012||2012-11-01|May 2017|2017-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Influence of Spices on Mixed Vegetable Intake Including Brassica Vegetables|Influence of Spices on Mixed Vegetable Intake Including Brassica|Completed||N/A|20|Actual|University of California, Los Angeles||4|||f||||f||||||||No||2017-10-11 00:57:27.816096|2017-10-11 00:57:27.816096
NCT02012270|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-02-26|||February 2012||2012-02-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|АНЕУРИЗМА||Aneurysma Hernia Study - Incidence of Incisional Hernias After Abdominal Aortic Aneurysm Repair|Prospective Case-control Study on the Incidence of Incisional Hernias at 12 Months After Closure of Midline Laparotomies in Patients Treated for Abdominal Aortic Aneurysm|Unknown status|Recruiting|N/A|240|Anticipated|University of Belgrade|||2||f||||f||||||||||2017-10-11 00:57:27.892882|2017-10-11 00:57:27.892882
NCT02012257|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-10|||September 2012||2012-09-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Success Rate of Anterior Middle Superior Alveolar (AMSA) Nerve Block in Three Different Sites of Injection||Completed||N/A|40|Actual|Shahid Beheshti University of Medical Sciences||3|||f||||t||||||||||2017-10-11 00:57:27.986274|2017-10-11 00:57:27.986274
NCT02012244|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2016-01-10|||January 2014||2014-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Postoperative Pain Management on Immune Function After Laparoscopic Resection of Colorectal Cancer||Completed||N/A|60|Actual|Severance Hospital||2|||f||||f||||||||||2017-10-11 00:57:28.072595|2017-10-11 00:57:28.072595
NCT02012231|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-05-03||2016-04-05|February 2014||2014-02-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional|||Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.|A Phase I/IIa Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients With Advanced, Unresectable Solid Tumors|Terminated||Phase 1/Phase 2|5|Actual|Plexxikon||1|||f||||f||||||||||2017-10-11 00:57:28.168224|2017-10-11 00:57:28.168224
NCT02012218|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-11-30|2015-09-04||November 2013||2013-11-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy|A Phase 3b, Multicenter, Open-label Exploratory Trial to Evaluate the Efficacy, Safety, and Subject Satisfaction With Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy|Completed||Phase 3|61|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 00:57:28.304105|2017-10-11 00:57:28.304105
NCT02012205|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-03-31|||April 2014||2014-04-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Wet Cupping in Non-specific Low Back Pain|Safety and Efficacy of Wet Cupping on Persistent Non-specific Low Back Pain: A Randomized, Controlled, Open-label, Parallel-group|Completed||N/A|80|Actual|National Center for Complementary and Alternative Medicine, Saudi Arabia||2|||f||||t||||||||||2017-10-11 00:57:29.105661|2017-10-11 00:57:29.105661
NCT02012192|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-12-05|||June 2014||2014-06-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer|A Two-part, Multicentre, International Phase I and II Trial Assessing the Safety and Efficacy of the Hsp90 Inhibitor Ganetespib in Combination With Paclitaxel Weekly in Women With High-grade Serous, High-grade Endometrioid, or Undifferentiated, Platinum-resistant Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Suspended||Phase 1/Phase 2|222|Anticipated|Medical University Innsbruck||2||production of IMP has stopped|f||||t||||||||||2017-10-11 00:57:29.190027|2017-10-11 00:57:29.190027
NCT02012179|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-03-31|||January 2014||2014-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|SODIUM-HF||SODIUM-HF: Study of Dietary Intervention Under 100 MMOL in Heart Failure|The Long Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients With Heart Failure|Recruiting||Phase 3|1000|Anticipated|University of Alberta||2|||f||||t||||||||No||2017-10-11 00:57:29.292473|2017-10-11 00:57:29.292473
NCT02012166|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-08-18|||July 2005||2005-07-01|August 2015|2015-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)|A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, 3-Period, 4 Treatment Incomplete Crossover Study to Assess the Effects of Single Oral Doses of L-001241689 on Glucagon-Induced Glycemic Excursion in Healthy Male Subjects Following Intravenous Administration of Glucagon, Sandostatine® and Insulin|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||7|||f||||f||||||||||2017-10-11 00:57:29.470157|2017-10-11 00:57:29.470157
NCT02012153|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-11-16|||December 2013||2013-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Mesenchymal Stromal Cells in Kidney Transplant Recipients|AUTOLOGOUS MESENCHYMAL STROMAL CELLS TO INDUCE TOLERANCE IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS|Recruiting||Phase 1|6|Anticipated|Mario Negri Institute for Pharmacological Research||1|||f||||f||||||||||2017-10-11 00:57:29.609717|2017-10-11 00:57:29.609717
NCT02012140|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-12-10|||January 2014||2014-01-01|December 2013|2013-12-01||||January 2015|Anticipated|2015-01-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI||Unknown status|Not yet recruiting|Phase 4|200|Anticipated|LifeBridge Health||1|||f||||f||||||||||2017-10-11 00:57:29.706539|2017-10-11 00:57:29.706539
NCT02012127|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-07-28|||September 2013||2013-09-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|ACRO-POLIS||Description of the Association of Signs and Symptoms Present at Acromegaly Diagnosis|Description of the Associations of Sign-and-symptom at Acromegaly Diagnosis.|Completed||N/A|648|Actual|Ipsen|||1||f||||t||||||||||2017-10-11 00:57:29.785104|2017-10-11 00:57:29.785104
NCT02012114|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-12-10|||December 2011||2011-12-01|December 2013|2013-12-01|May 2015|Anticipated|2015-05-01|December 2011|Actual|2011-12-01||Interventional|Crystobs||A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications|A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications|Unknown status|Recruiting|N/A|90|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 00:57:29.895193|2017-10-11 00:57:29.895193
NCT02012101|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2014-06-23|||March 2013||2013-03-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Non-invasive Mechanical Ventilation as a Rescue Therapy to Relieve Dyspnea in Patients With Stable Severe COPD|The Efficacy of Non-invasive Mechanical Ventilation as a Rescue Therapy for Relieving Dyspnea in Patients With Stable Severe COPD|Completed||N/A|18|Actual|Guangzhou Institute of Respiratory Disease||2|||f||||f||||||||||2017-10-11 00:57:30.045823|2017-10-11 00:57:30.045823
NCT02012088|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-12-15|||October 2013||2013-10-01|December 2016|2016-12-01|August 2021|Anticipated|2021-08-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb|Phase II, Randomised, Multicentre Study With Two Treatment Arms (R-COMP Versus R-CHOP) in Newly Diagnosed Elderly Patients (≥60 Years) With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb.|Active, not recruiting||Phase 2|91|Actual|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||2|||f||||t||||||||||2017-10-11 00:57:30.150389|2017-10-11 00:57:30.150389
NCT02012075|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-10|||December 2013||2013-12-01|December 2013|2013-12-01||||February 2015|Anticipated|2015-02-01||Interventional|||A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure|Efficacy and Safety Comparison of Extended-Release Carvedilol Sulfate and Sustained-release Metoprolol Succinate in Patients With Heart Failure|Unknown status|Recruiting|Phase 3|316|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-11 00:57:30.658401|2017-10-11 00:57:30.658401
NCT02012062|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-10|||July 2012||2012-07-01|December 2013|2013-12-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Phase Ⅲ Study of Neoadjuvant TPF Chemotherapy Followed by Radiotherapy and Concurrent Nimotuzumab or Cisplatin for Locoregionally Advanced Nasopharyngeal Carcinoma (NPC).||Recruiting||Phase 3|320|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 00:57:30.82204|2017-10-11 00:57:30.82204
NCT02012049|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-10|||August 2009||2009-08-01|December 2013|2013-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Bioequivalence Test for Risperdal 2mg of Janssen Korea|Bioequivalence Test for Risperdal OD Tab. 2mg of Janssen Korea|Completed||Phase 1|36|Actual|Janssen Korea, Ltd., Korea||2|||f||||f||||||||||2017-10-11 00:57:30.972374|2017-10-11 00:57:30.972374
NCT02012036|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-11-03|||July 2013||2013-07-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|OPTIC-III||Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice|Prospective Non-Interventional Study To Optimize Photodynamic TUR-B In Clinical Practice|Completed||N/A|400|Actual|Ipsen|||1||f||||f||||||||||2017-10-11 00:57:31.079171|2017-10-11 00:57:31.079171
NCT02012023|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-08-21|||January 2014||2014-01-01|July 2016|2016-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|CTI||Use of One Kind of Controllable Tube Ileostomy in the Low Rectal Cancer|Use of One Kind of Controllable Tube Ileostomy to Protect Anastomotic Leakage in the Low Rectal Cancer.|Completed||N/A|80|Actual|First Affiliated Hospital of Zhejiang University||2|||f||||t||||||||Yes||2017-10-11 00:57:31.188981|2017-10-11 00:57:31.188981
NCT02012010|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-08-10|||December 6, 2013|Actual|2013-12-06|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|June 30, 2017|Actual|2017-06-30||Interventional|||Comparison of Infusion Methods for Hysteroscopic Procedures|Comparison of Manual Syringe Infusion Method and Conventional Pump Infusion Method for Hysteroscopic Procedures: a Randomized Controlled Trial.|Completed||N/A|100|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:57:31.300526|2017-10-11 00:57:31.300526
NCT02011997|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2013-12-13|||December 2013||2013-12-01|December 2013|2013-12-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|cVATS||Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion|Comparison of Video-assisted Thoracoscopic Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion|Not yet recruiting||Phase 3|500|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 00:57:31.381406|2017-10-11 00:57:31.381406
NCT02011984|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-02-10|||December 2013||2013-12-01|February 2015|2015-02-01|February 2017|Anticipated|2017-02-01|March 2016|Anticipated|2016-03-01|2 Years|Observational [Patient Registry]|RECAM||Multicentric Non-randomized Investigation of RESISTANT Camouflage Stent-system|Multicentric Non-randomized Investigation of RESISTANT Camouflage Stent-system in Peripheral Superficial Femoral Arteries|Unknown status|Recruiting|N/A|120|Anticipated|Eucatech AG|||1||f||||f||||||||||2017-10-11 00:57:31.487003|2017-10-11 00:57:31.487003
NCT02011971|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-08-23|||February 2012|Actual|2012-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy|Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy|Recruiting||Phase 1/Phase 2|30|Anticipated|Stanford University||4|||f||||f||||||||||2017-10-11 00:57:31.730254|2017-10-11 00:57:31.730254
NCT02011958|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-10-06|||July 2014||2014-07-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|August 2016|Actual|2016-08-01||Interventional|||Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.|A Randomized Trial of Ambisome Monotherapy and Combination of Ambisome and Miltefosine for the Treatment of VL in HIV Positive Patients in Ethiopia Followed by Secondary VL Prophylactic Treatment With Pentamidine.|Active, not recruiting||Phase 3|132|Anticipated|Drugs for Neglected Diseases||2|||f||||t||||||||||2017-10-11 00:57:31.875076|2017-10-11 00:57:31.875076
NCT02011945|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-09-13|||February 7, 2014|Actual|2014-02-07|September 2017|2017-09-01|August 9, 2019|Anticipated|2019-08-09|August 8, 2019|Anticipated|2019-08-08||Interventional|||A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia|A Phase 1B Dose Escalation Study to Investigate the Safety, Tolerability and Preliminary Efficacy for the Combination Dasatinib (BMS-354825) Plus Nivolumab (BMS-936558) in Patients Chronic Myeloid Leukemia (CML)|Active, not recruiting||Phase 1|69|Anticipated|Bristol-Myers Squibb||1|||f||||f|t|f||||||||2017-10-11 00:57:32.005483|2017-10-11 00:57:32.005483
NCT02011932|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2013-12-13|||July 2010||2010-07-01|December 2013|2013-12-01|July 2030|Anticipated|2030-07-01|June 2011|Actual|2011-06-01||Observational|||Prospective Observational Study of Disease Progression in Chronic Hepatitis C|Observational Study of Disease Progression and Risk Factors in Chronic Hepatitis C Caused by Plasma Donation|Active, not recruiting||N/A|133|Actual|Beijing YouAn Hospital|||2||f||||t||||||Samples With DNA|"     whole blood, serum, plasma,liver biopsies specimens,   "|||2017-10-11 00:57:32.166304|2017-10-11 00:57:32.166304
NCT02011906|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-10|||October 2013||2013-10-01|December 2013|2013-12-01|August 2015|Anticipated|2015-08-01|April 2015|Anticipated|2015-04-01||Interventional|||The Effects of Omega 3 and Vitamin E Supplementation on the Serum Antioxidant Enzymes and Gene Expressions of PGC-1a, h TERT, FOXOs and SIRTs in CAD Patients||Unknown status|Enrolling by invitation|Phase 4|20|Anticipated|Tehran University of Medical Sciences||3|||f||||t||||||||||2017-10-11 00:57:32.363153|2017-10-11 00:57:32.363153
NCT02011893|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-05-17|2017-02-01||December 2013||2013-12-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2016|Actual|2016-01-01||Interventional|SUNBURST||SUNBURST (Success Using Neuromodulation With BURST) Study|Success Using Neuromodulation With BURST (SUNBURST™) Study|Completed||N/A|173|Actual|St. Jude Medical||2|||f||||f||t||||||||2017-10-11 00:57:32.492608|2017-10-11 00:57:32.492608
NCT02011880|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-10||||||September 2013|2013-09-01||||||||Expanded Access|||Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer|Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer|Temporarily not available||N/A|||Shanghai University of Traditional Chinese Medicine|||||f||||||||||||||2017-10-11 00:57:32.924467|2017-10-11 00:57:32.924467
NCT02011854|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-12|||October 2013||2013-10-01|December 2013|2013-12-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Acupuncture for Post-stroke Shoulder-hand Syndrome|Acupuncture and Traditional Chinese Medicine Combined With Rehabilitation Therapy for Post-stroke Shoulder-hand Syndrome in Community Hospital: a Multicenter，Randomized，Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|90|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 00:57:33.107538|2017-10-11 00:57:33.107538
NCT02011841|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients|Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients: A Prospective, Multicenter, Randomized, Open-label, Controlled Phase III Study|Withdrawn||Phase 3|0|Actual|Seoul National University Hospital||2||We failed to recruit patients|f||||f||||||||||2017-10-11 00:57:33.222207|2017-10-11 00:57:33.222207
NCT02011828|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-08-09|||May 2009||2009-05-01|August 2016|2016-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Ergocalciferol Therapy in Calcidiol Deficient, Hemodialysis Patients on Therapeutic Doses of Paricalcitol|Ergocalciferol Therapy in Calcidiol Deficient, Hemodialysis Patients on Therapeutic Doses of Paricalcitol|Completed||Phase 1|58|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 00:57:33.322205|2017-10-11 00:57:33.322205
NCT02011815|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-04-26|||November 2013||2013-11-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Exploring Biological Linkage Between Circadian Disruption and Cancer Progression|A Prospective Study of Exploring Possible Biological Linkage Between Circadian Disruption and Cancer Progression|Recruiting||N/A|236|Anticipated|Seoul National University Hospital|||1||f||||t||||||Samples With DNA|"     Whole blood, serum Saliva Urine   "|||2017-10-11 00:57:33.407578|2017-10-11 00:57:33.407578
NCT02011802|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-06-19|||December 2013|Actual|2013-12-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|SORKYSA||Sorbact TM: Effect of a Microbial Binding Dressing on Wound Healing After Pilonidal Sinus Excision|Sorbact TM: Effect of a Microbial Binding Dressing on Wound Healing After Pilonidal Sinus Excision|Active, not recruiting||N/A|250|Actual|University Hospital, Strasbourg, France||2|||f||||f|f|f||||||No||2017-10-11 00:57:33.525439|2017-10-11 00:57:33.525439
NCT02011789|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-09|||April 2007||2007-04-01|December 2013|2013-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Metabolism And Health Effects Of Citrus Limonoids in Hypercholesterolemic Humans|A Pilot Study To Determine The Metabolism And Health Effects Of Citrus Limonoids in Hypercholesterolemic Human Subjects|Completed||N/A|10|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 00:57:33.675453|2017-10-11 00:57:33.675453
NCT02011776|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-07-07|||March 2013||2013-03-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01|8 Weeks|Observational [Patient Registry]|||A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome|A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome|Completed||N/A|35|Actual|Santen Pharmaceutical(China) Co.,LTD|||2||f||||f||||||||||2017-10-11 00:57:33.830986|2017-10-11 00:57:33.830986
NCT02011763|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-09-29|||December 2013||2013-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Interventional|||Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents|Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) Administered 6 Months Apart in Healthy Toddlers, Children and Adolescents Aged 12 Months to 15 Years in China|Completed||Phase 4|355|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:57:33.946911|2017-10-11 00:57:33.946911
NCT02011750|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-10-24|||March 2013||2013-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia|Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii|Active, not recruiting||Phase 4|109|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:57:34.053434|2017-10-11 00:57:34.053434
NCT02011737|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-10|||February 2014||2014-02-01|December 2013|2013-12-01|April 2015|Anticipated|2015-04-01|February 2015|Anticipated|2015-02-01||Interventional|||Naftopidil 75mg for Improving Clearance of Urinary Stones|The Effectiveness and Safety of Naftopidil 75mg for Improving Clearance of Ureteral and Renal Stones After Shockwave Lithotripsy: Prospective Randomized Controlled Study|Unknown status|Not yet recruiting|Phase 4|130|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:57:34.193548|2017-10-11 00:57:34.193548
NCT02011711|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-01-12|||November 2013||2013-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Modulation of Immunity by Hormonal Contraceptives|Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives|Completed||N/A|90|Actual|Stanford University|||3||f||||f||||||||No||2017-10-11 00:57:34.436503|2017-10-11 00:57:34.436503
NCT02011698|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-12|||October 2013||2013-10-01|December 2013|2013-12-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Absorbable Sutures , Non Absorbable Sutures or Biologic Fibrin Glue for Protesic Mesh Fixing in Lichtenstein Technique for Primitive Groin Hernia Repair: a Randomized Prospective Multicentric Trial|Absorbable Sutures , Non Absorbable Sutures or Biologic Fibrin Glue for Protesic Mesh Fixing in Lichtenstein Technique for Primitive Groin Hernia Repair: a Randomized Prospective Multicentric Trial|Unknown status|Recruiting|N/A|900|Anticipated|Ospedale di Circolo - Fondazione Macchi||3|||f||||f||||||||||2017-10-11 00:57:34.562496|2017-10-11 00:57:34.562496
NCT02011685|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-12-07|||December 2013||2013-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors|Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors|Recruiting||N/A|450|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 00:57:35.315846|2017-10-11 00:57:35.315846
NCT02011672|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-09-08|||November 2013||2013-11-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Milk Ingredients on Glucose Regulation and Inflammation|Effect of Milk Ingredients on Glucose Regulation and Inflammation in Overweight Subjects|Completed||N/A|40|Actual|NIZO Food Research||2|||f||||f||||||||||2017-10-11 00:57:35.420487|2017-10-11 00:57:35.420487
NCT02011659|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-12|||November 2013||2013-11-01|December 2013|2013-12-01||||November 2015|Anticipated|2015-11-01||Interventional|PONV||Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy|A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy|Unknown status|Recruiting|Phase 3|128|Anticipated|National Health Insurance Service Ilsan Hospital||1|||f||||t||||||||||2017-10-11 00:57:35.528877|2017-10-11 00:57:35.528877
NCT02011646|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-02-04|||November 2013||2013-11-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Healthy Body Study|Testing a Healthy Weight Intervention in Adolescents|Terminated||N/A|80|Actual|Icahn School of Medicine at Mount Sinai||2||The PI changed institutions|f||||f||||||||||2017-10-11 00:57:35.617268|2017-10-11 00:57:35.617268
NCT02011633|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-03-10|||October 2013||2013-10-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg|An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 500/10 mg and Coadministration of Metformin SR 500 mg and Rosuvastatin 10 mg in Healthy Volunteers|Completed||Phase 1|72|Actual|Hanmi Pharmaceutical Company Limited||4|||f||||f||||||||||2017-10-11 00:57:35.722054|2017-10-11 00:57:35.722054
NCT02011620|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-13|||February 2014||2014-02-01|December 2013|2013-12-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Influence of Nitrates on Bone Remodeling and Endothelial Function in Patients With Type 2 Diabetes Mellitus|Influence of Nitrates on Bone Remodeling and Endothelial Function in Patients With Type 2 Diabetes Mellitus.|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Tameside Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 00:57:35.824067|2017-10-11 00:57:35.824067
NCT02011607|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-14|2017-06-07|||January 2013||2013-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|SEDLine||Incidence of Adverse Airway Events in High Risk Patients Undergoing Upper GI Endoscopy Under Anesthesia|Incidence of Adverse Airway Events in High Risk Patients Undergoing Upper GI Endoscopy Under Anesthesia|Recruiting||N/A|500|Anticipated|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 00:57:35.94494|2017-10-11 00:57:35.94494
NCT02011594|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2015-02-11|||January 2014||2014-01-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma|Phase II Study of Maintenance Treatment of Nimotuzumab Versus No Maintenance for Advanced Esophageal Carcinoma|Withdrawn||Phase 2|0|Actual|Zhejiang University||2||There was no participants enrolled in this clinical trial.|f||||f||||||||||2017-10-11 00:57:36.018485|2017-10-11 00:57:36.018485
NCT02011581|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-04-28|||October 2011||2011-10-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|24Hr||Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People|Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People|Completed||N/A|16|Actual|Washington University School of Medicine|||1||f||||t||||||Samples Without DNA|"     Blood samples, adipose tissue samples and muscle samples   "|||2017-10-11 00:57:36.09715|2017-10-11 00:57:36.09715
NCT02011568|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-04-26|||August 2013||2013-08-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|CAPITALCHILL||Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients|Therapeutic Hypothermia Following Out-of-Hospital Cardiac Arrest - A Randomized Trial Comparing Mild and Moderate Therapeutic Hypothermia (CAPITAL CHILL)|Recruiting||N/A|340|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 00:57:36.159429|2017-10-11 00:57:36.159429
NCT02011542|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-08|||September 2013||2013-09-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Probiotic (Visbiome) for Gulf War Illness|Probiotics (Visbiome) for Gulf War Illness|Terminated||Phase 2/Phase 3|29|Actual|University of Utah||2||"Changing Collaborator for the study. Requested to close original registration. New registration   completed reflecting new collaborator."|f||||t||||||||||2017-10-11 00:57:37.007211|2017-10-11 00:57:37.007211
NCT02011529|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-10-01|||November 2013||2013-11-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||TEAMcare for Diabetes in Mental Health Centers|A Team Approach to Improve the Quality of Diabetes Care for Patients With Schizophrenia|Completed||N/A|35|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 00:57:37.081427|2017-10-11 00:57:37.081427
NCT02011516|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-06-12|2016-11-23||December 2013||2013-12-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Baclofen Effects on Marijuana Dependence|A Randomized Placebo-controlled Study of Baclofen on Brain and Behavioral Outcomes in Marijuana Dependence|Completed||Phase 2|47|Actual|University of Pennsylvania|Sample size too sample to draw conclusions. No subject was able to provide a negative cannabis urine throughout treatment. A caveat is that cannabis stays in the urine for 6 weeks after final use.|2|||f||||f||||||||||2017-10-11 00:57:37.227542|2017-10-11 00:57:37.227542
NCT02011503|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-03-21|||March 2014||2014-03-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Use of dHACM in the Treatment of Venous Leg Ulcers|A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers|Active, not recruiting||N/A|120|Anticipated|MiMedx Group, Inc.||2|||f||||f||||||||||2017-10-11 00:57:37.517402|2017-10-11 00:57:37.517402
NCT02011490|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-06-02|2015-01-29||December 11, 2013|Actual|2013-12-11|June 2017|2017-06-01|June 6, 2014|Actual|2014-06-06|June 6, 2014|Actual|2014-06-06||Interventional||This table includes all 33 subjects who participated in study. Subjects who participated in both Part 1 and Part 2 are represented only once in this table. 1 participant was in severe renal insufficiency group in Part 1 and moderate renal insufficiency group in Part 2 and is allocated to severe renal insufficiency group in this table.|Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105)|An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-8616 in Subjects With Moderate and Severe Renal Insufficiency|Completed||Phase 1|33|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 00:57:37.65169|2017-10-11 00:57:37.65169
NCT02011477|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-09|||March 2013||2013-03-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|NM||Hypoalgesic Effects Neural Mobilization Techniques|Comparison of Hypoalgesic Effects of Neural Stretching Versus Neural Gliding: a Randomized Clinical Trial|Completed||Early Phase 1|45|Actual|Universidad Rey Juan Carlos||3|||f||||f||||||||||2017-10-11 00:57:38.834427|2017-10-11 00:57:38.834427
NCT02011464|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-07-07|2016-06-06||December 2013||2013-12-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evaluation Exparel Delivered in Knee Replacement|Evaluation of the Efficacy of Exparel Delivered Into the Posterior Capsule During Knee Replacement|Completed||Phase 4|20|Actual|Maimonides Medical Center||2|||f||||f||||||||||2017-10-11 00:57:38.95735|2017-10-11 00:57:38.95735
NCT02011451|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-09-23|||December 2015||2015-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis|Safety and Neuroprotective Effects of Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis|Withdrawn||Phase 2|0|Actual|Louisiana State University Health Sciences Center in New Orleans||2||unable to enroll|f||||t||||||||||2017-10-11 00:57:39.321752|2017-10-11 00:57:39.321752
NCT02011438|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-12-16|||June 2012||2012-06-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms|Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms|Completed||Phase 2|49|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 00:57:39.434486|2017-10-11 00:57:39.434486
NCT02011425|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-05-01|||February 2014||2014-02-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||The Effects of Oral Appliance Therapy on Masseter Muscle Activity in Obstructive Sleep Apnea|The Effects of Mandibular Advancement Appliance Therapy on Masseter Muscle Activity During Sleep in Obstructive Sleep Apnea Patients: a Study in Clinical Practice|Completed||N/A|25|Anticipated|Université de Montréal||2|||f||||f||||||||Undecided||2017-10-11 00:57:39.564448|2017-10-11 00:57:39.564448
NCT02011412|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-02-22|||October 2013||2013-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Intermountain Risk Score and Trauma|The Intermountain Risk Score's Association With Mortality Prediction in Trauma Patients|Completed||N/A|400|Actual|Intermountain Health Care, Inc.|||2||f||||f||||||||||2017-10-11 00:57:39.728107|2017-10-11 00:57:39.728107
NCT02011386|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2013-12-10|||December 2013||2013-12-01|December 2013|2013-12-01|July 2021|Anticipated|2021-07-01|July 2016|Anticipated|2016-07-01||Observational|MANGO||Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis|Improved Monitoring and Prediction of Clinical Response and Disease Course During Golimumab Therapy of Patients With Axial Spondyloarthritis|Not yet recruiting||N/A|50|Anticipated|Hvidovre University Hospital|||1||f||||t||||||||||2017-10-11 00:57:39.968923|2017-10-11 00:57:39.968923
NCT02011373|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-08-17|||November 6, 2013||2013-11-06|May 2017|2017-05-01|March 6, 2018|Anticipated|2018-03-06|March 6, 2018|Anticipated|2018-03-06||Interventional|PRO-COLLE||Efficacy of IFABONDTM Synthetic Glue for Fixation of Implanted Material in Laparoscopic Sacrocolpopexy: a Prospective Multicenter Study|Efficacy of IFABONDTM Synthetic Glue for Fixation of Implanted Material in Laparoscopic Sacrocolpopexy: a Prospective Multicenter Study|Active, not recruiting||N/A|70|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 00:57:40.134636|2017-10-11 00:57:40.134636
NCT02011360|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-12-13|||May 2014||2014-05-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Prader-Willi Syndrome Macronutrient Study|Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)|Completed||N/A|10|Actual|Duke University||2|||f||||||||||||||2017-10-11 00:57:40.289333|2017-10-11 00:57:40.289333
NCT02011347|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-04-05|||July 2013||2013-07-01|April 2017|2017-04-01|October 7, 2015|Actual|2015-10-07|October 7, 2015|Actual|2015-10-07||Interventional|LoopKeta||Ketamine and Closed-Loop Anesthesia System|Influence of Ketamine on a Closed-Loop Anesthesia System|Terminated||Phase 3|67|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 00:57:40.416659|2017-10-11 00:57:40.416659
NCT02011334|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-11-01|||July 2014||2014-07-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.|A MULTICENTER, OPEN LABEL STUDY TO EVALUATE EFFICACY AND SAFETY OF TOCILIZUMAB GIVEN SUBCUTANEOUSLY IN MONOTHERAPY AND IN COMBINATION WITH NON-BIOLOGIC DMARDS IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS IN LATIN AMERICA|Completed||Phase 3|285|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:57:40.504453|2017-10-11 00:57:40.504453
NCT02011321|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-10|||March 2014||2014-03-01|December 2013|2013-12-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|CLEVAS||Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)|Clevidipine for Vasospasm After Subarachnoid Hemorrhage|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Henry Ford Health System||1|||f||||f||||||||||2017-10-11 00:57:40.630954|2017-10-11 00:57:40.630954
NCT02011308|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-11-23|||January 2011||2011-01-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)|The Effect of KTP Green Light Prostatectomy (120W) Compared With TUR-P When Treating Benign Prostatic Hyperplasia (BPH), a Prospective Randomized Study|Completed||Phase 4|217|Actual|Helsinki University||2|||f||||f||||||||||2017-10-11 00:57:40.771702|2017-10-11 00:57:40.771702
NCT02011295|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-07-27|||December 2013||2013-12-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|April 27, 2018|Anticipated|2018-04-27||Interventional|BMAC||Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions|Bone Marrow Aspirate Concentrate Supplementation to Microfracture in the Treatment of Osteochondral Lesions of the Talus|Recruiting||N/A|30|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 00:57:40.857907|2017-10-11 00:57:40.857907
NCT02011282|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-03-27|||October 2013||2013-10-01|August 2014|2014-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Electro-Neuro-Muscular Stimulation in ICU|Electro-Neuro-Muscular Stimulation in Hospitalized Intensive Care Patients|Completed||N/A|25|Actual|University of Thessaly||2|||f||||t||||||||||2017-10-11 00:57:40.96016|2017-10-11 00:57:40.96016
NCT02011269|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-05-05|||March 2014||2014-03-01|May 2015|2015-05-01||||January 2015|Anticipated|2015-01-01||Interventional|||TSO for Plaque Psoriasis|A Randomized, Blinded, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis|Withdrawn||Phase 2|0|Actual|Coronado Biosciences, Inc.||3||Study not conducted|f||||f||||||||||2017-10-11 00:57:41.045296|2017-10-11 00:57:41.045296
NCT02011256|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-08|||September 2013|Actual|2013-09-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|NOTICE||Early Detection Of Atrial Fibrillation In Patients With Transient Ischemic Attack|Early Detection Of Atrial Fibrillation In Patients With Transient Ischemic Attack - A Prospective Study|Active, not recruiting||N/A|150|Anticipated|University of Southern Denmark||1|||f||||t||||||||||2017-10-11 00:57:41.140685|2017-10-11 00:57:41.140685
NCT02011243|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-03-25|||January 2014||2014-01-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|GIRDH||Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players|Evaluation of the Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players Occurring Over One Training Season|Completed||N/A|86|Actual|Centre Hospitalier Universitaire de Nīmes|||4||f||||f||||||||||2017-10-11 00:57:41.386517|2017-10-11 00:57:41.386517
NCT02011230|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-08-10|||August 2013||2013-08-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Measuring Pain and Hydration After Tonsillectomy|Pain Control as a Function of Hydration Status in the Post Tonsillectomy Patient.|Terminated||N/A|57|Actual|TriHealth Inc.||2||IRB closed study: irregularities in documentation of informed consent, HIPAA|f||||t||||||||No|Study terminated|2017-10-11 00:57:41.501745|2017-10-11 00:57:41.501745
NCT02011217|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-12-09|||August 2013||2013-08-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|S2RBAM||The Effects of Rye Crisp Bread on Appetite and Metabolic Function|The Effects of Rye Crisp Bread on Subjective Appetite and Metabolic Function After Short-term Consumption|Completed||N/A|25|Actual|Swedish University of Agricultural Sciences||3|||f||||f||||||||||2017-10-11 00:57:41.602346|2017-10-11 00:57:41.602346
NCT02011204|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-05-10|||November 2013||2013-11-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Study of Electrical Impedance Myography (EIM) in ALS|Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance|Completed||N/A|106|Actual|Skulpt, Inc.|||3||f||||f||||||||||2017-10-11 00:57:41.733943|2017-10-11 00:57:41.733943
NCT02011191|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-12-12|||December 2006||2006-12-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Biotin Deficiency and Restless Legs Syndrome|Biotin Deficiency and Restless Legs Syndrome: Evidence for a Causal Relationship From Randomized, Double-Blind, Placebo-Controlled Trial|Completed||N/A|49|Actual|Saint Patrick Hospital||2|||f||||t||||||||||2017-10-11 00:57:41.844659|2017-10-11 00:57:41.844659
NCT02011178|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-03-10|||March 2014||2014-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|PROMISE||Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best Medicine|Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best Medicine; a Prospectivee, Randomized, Multicenter Study|Withdrawn||N/A|0|Actual|Karolinska Institutet||2||No subjects have been enrolled|f||||t||||||||||2017-10-11 00:57:41.936206|2017-10-11 00:57:41.936206
NCT02011165|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-12-16|||October 2013||2013-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||An Objective Evaluation of Postoperative Positioning in Macular Hole Surgery|An Objective Evaluation of Postoperative Positioning in Macular Hole Surgery|Completed||N/A|43|Actual|Helse Stavanger HF|||2||f||||f||||||||||2017-10-11 00:57:42.029065|2017-10-11 00:57:42.029065
NCT02011152|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2013-12-12|||December 1998||1998-12-01|December 2013|2013-12-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01|3 Months|Observational [Patient Registry]|||Spinal Anesthesia Magnesium Infusion|The Effect of Intravenous Magnesium Sulfate Infusion on Sensory Spinal Block and Postoperative Pain Score in Abdominal Hysterectomy|Completed||N/A|40|Anticipated|Karadeniz Technical University|||1||f||||f||||||||||2017-10-11 00:57:42.108829|2017-10-11 00:57:42.108829
NCT02011139|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-11-17|||October 2013||2013-10-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Cognitive-behavioral (CBT) in ESRD Patients With Depression|Effectiveness of Cognitive-behavioral Group Therapy for Enhancing Mental Health and Quality of Life in Maintenance Hemodialysis Patients|Completed||N/A|15|Actual|Seoul National University Boramae Hospital||2|||f||||t||||||||||2017-10-11 00:57:42.170031|2017-10-11 00:57:42.170031
NCT02011126|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-02-08|||June 2014||2014-06-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors|A Phase II Study of Imetelstat (GRN163L, NSC# 754228) in Children With Relapsed or Refractory Solid Tumors|Withdrawn||Phase 2|0|Actual|Children's Oncology Group||1||IND no longer available.|f||||||||||||||2017-10-11 00:57:42.26158|2017-10-11 00:57:42.26158
NCT02011113|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-09-12|2015-08-06||December 2013||2013-12-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional||Safety Population included all participants who received at least one dose of study medication|Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma|A Phase 2, Multicenter, Single-arm, Open-label Study in Japan to Evaluate the Efficacy and Safety of Pomalidomide (CC-4047) in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma|Completed||Phase 2|36|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 00:57:42.360314|2017-10-11 00:57:42.360314
NCT02011100|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-12-02|||December 2013||2013-12-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Interventional|Carnorisk||Effect of Carnosine on Diabetes and Cardiovascular Risk Factors|Randomised Placebo Controlled Study of the Effect of Carnosine Diabetes and Cardiovascular Risk Factors|Unknown status|Active, not recruiting|N/A|30|Anticipated|Slovak Academy of Sciences||2|||f||||f||||||||||2017-10-11 00:57:44.696933|2017-10-11 00:57:44.696933
NCT02011087|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-07-28|||February 2014|Actual|2014-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy|Investigating the Prognostic Importance of Bioelectrical Impedance Phase Angle in Adults Treated for Small Cell Lung Cancer|Terminated||N/A|1|Actual|Wake Forest University Health Sciences||1||Slow Accruals|f||||f|f|f||||||||2017-10-11 00:57:44.837126|2017-10-11 00:57:44.837126
NCT02011074|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-11-17|||March 2013||2013-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Perioperative Changes of Heart Rate Variability Related to Anxiety and Depressiveness in Patients Undergoing General Anesthesia|Perioperative Changes of Heart Rate Variability Related to Anxiety and Depressiveness in Psychologically Normal Patients Undergoing General Anesthesia|Completed||N/A|60|Actual|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 00:57:44.942419|2017-10-11 00:57:44.942419
NCT02011061|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-11-05|||October 2013||2013-10-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|C-Sub320||Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography|Prospective International Study of Coronary Substraction Using 320 Row-detector CT|Completed||N/A|182|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 00:57:45.069713|2017-10-11 00:57:45.069713
NCT02011048|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-03-28|||November 2013||2013-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|GIVINA||Giant Ventral Incisional Hernia: Abdominal Wall Function, Respiratory Performance and Quality of Life|Giant Ventral Incisional Hernia: Characteristics of Abdominal Muscle-matrix, and Effect of Hernia Repair on Abdominal Wall Function, Respiratory Performance and Quality of Life|Completed||N/A|36|Actual|Bispebjerg Hospital|||2||f||||f||||||Samples With DNA|"     Skeletal muscle biopsy, connective tissue biopsy, whole blood serum   "|||2017-10-11 00:57:45.172769|2017-10-11 00:57:45.172769
NCT02011035|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-03-25|||November 2013||2013-11-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Evaluating the Clinical Efficacy and Safety of Colflex|Evaluating the Clinical Efficacy and Safety of Colfelx|Completed||Phase 1|20|Actual|University of Manitoba|||1||f||||t||||||||||2017-10-11 00:57:45.286513|2017-10-11 00:57:45.286513
NCT02011022|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-10|||May 2009||2009-05-01|December 2013|2013-12-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|HDMTX||Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Lymphoblastic Malignancies|Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Significant Impact Factors and Establishment of a Clinically Relevant Model|Completed||N/A|291|Actual|The Children's Hospital of Zhejiang University School of Medicine||2|||f||||f||||||||||2017-10-11 00:57:45.357928|2017-10-11 00:57:45.357928
NCT02011009|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-12-10|||November 2013||2013-11-01|December 2013|2013-12-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|Calires||"Evaluation of Therapeutic Management in ESBL-infected Patients or Carriers by Providing and Sharing a Free Tool - the ESBL toolKITand Interventional Study of a Prospective Cohort of HIV+ Patients Searching for Possible Sexual Transmission Factors in ESBL Carriers"|"Evaluation of Therapeutic Management in ESBL-infected Patients or Carriers by Providing and Sharing a Free Tool - the ESBL toolKIT and Interventional Study of a Prospective Cohort of HIV+ Patients Searching for Possible Sexual Transmission Factors in ESBL (Extended-spectrum ß-lacatamase-producing Bacteria) Carriers"|Unknown status|Recruiting|N/A|150|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:57:45.451822|2017-10-11 00:57:45.451822
NCT02010996|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-09-30|2014-09-30||December 2013||2013-12-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Preventing Seroma Formation After Stripping Saphenous Vein in Coronary Bypass|Preventing Seroma Formation After Stripping Saphenous Vein in Coronary Bypass - a Randomized Control Clinical Trial|Completed||N/A|72|Actual|Changhai Hospital||2|||f||||f||||||||||2017-10-11 00:57:45.52891|2017-10-11 00:57:45.52891
NCT02010983|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-07-10|||October 2013||2013-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Achalasia and Dysplasia|Screening for Dysplasia in Longstanding Idiopathic Achalasia: a Prospective Study|Recruiting||N/A|80|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-11 00:57:46.008796|2017-10-11 00:57:46.008796
NCT02010970|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2014-04-25|||December 2013||2013-12-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|AZD3293DDI||A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate|A Phase I, Single-center, Open-label, 3-group, Fixed-sequence Study to Assess the Effect of Itraconazole, a Potent CYP3A4 Inhibitor, or Diltiazem, a Moderate CYP3A4 Inhibitor, on the Pharmacokinetics of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a CYP3A4/CYP3A5 Substrate, in Healthy Young Male and Female Volunteers|Completed||Phase 1|56|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 00:57:46.103285|2017-10-11 00:57:46.103285
NCT02010957|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-10|||June 2014||2014-06-01|December 2013|2013-12-01|June 2020|Anticipated|2020-06-01|May 2018|Anticipated|2018-05-01||Interventional|FAMIAN||Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia|￼Combined 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and 123I-Iodometomidate (123I-IMTO) Imaging for Adrenal Neoplasia|Not yet recruiting||Phase 2/Phase 3|220|Anticipated|Wuerzburg University Hospital||1|||f||||t||||||||||2017-10-11 00:57:46.220077|2017-10-11 00:57:46.220077
NCT02010944|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2013-12-10|||September 2012||2012-09-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels|An Open-label, Parallel Group, Randomized, Two-sequence, Three-way Crossover Study to Assess the Relative Bioavailability of Solifenacin Succinate and Mirabegron Fixed-dose Combination Tablets Compared to Co-administration of Single Entity Tablets at Three Dose Strengths in Healthy Male and Female Subjects|Completed||Phase 1|72|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 00:57:46.354653|2017-10-11 00:57:46.354653
NCT02010931|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-07-09|||September 2013||2013-09-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Observational|||Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients|A Retrospective Analysis of Hematological Relapse Free Survival and Overall Survival in Adult Patients With Philadelphia-Negative B-Precursor Acute Lymphoblastic Leukemia in Complete Hematological Remission With Minimal Residual Disease|Completed||N/A|310|Actual|Amgen|||1||f||||f||||||||||2017-10-11 00:57:46.469658|2017-10-11 00:57:46.469658
NCT02010918|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-12-10|||February 2009||2009-02-01|December 2013|2013-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis|A Phase III, Multicenter, Randomized, Parallel, Open Label and Comparative Study to Evaluate the Efficacy of 500 mg Glucosamine Sulfate (GS) / 400 mg Chondroitin Sulfate (CS)Capsules and 1500 mg GS / 1200 mg CS Sachet Compared With Cosamin DS® Capsule in Treatment of Knee Osteoarthritis..|Completed||Phase 3|922|Actual|Ache Laboratorios Farmaceuticos S.A.||3|||f||||t||||||||||2017-10-11 00:57:46.606894|2017-10-11 00:57:46.606894
NCT02010905|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2015-12-21|||December 2013||2013-12-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|Redefine||Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System|Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System|Recruiting||Phase 2|120|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:57:46.713278|2017-10-11 00:57:46.713278
NCT02010892|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-05-05|||February 2014||2014-02-01|May 2016|2016-05-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Observational|ETTAA||Effective Treatments for Thoracic Aortic Aneurysms (ETTAA Study): A Prospective Cohort Study|Effective Treatments for Thoracic Aortic Aneurysms (ETTAA Study): A Prospective Cohort Study|Recruiting||N/A|2200|Anticipated|Papworth Hospital NHS Foundation Trust|||4||f||||t||||||||||2017-10-11 00:57:46.853637|2017-10-11 00:57:46.853637
NCT02010879|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-04-23|||December 2013||2013-12-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|PFA100||The Impact of Platelet Functions on Spontaneous Ductal Closure in Preterm Infants|The Impact of Platelet Count, Platelet Mass Index and Platelet Function Evaluated by Platelet Function Analyzer (PFA-100) on Spontaneous Ductal Closure in Preterm Infants|Completed||N/A|80|Anticipated|Ankara University|||1||f||||f||||||||||2017-10-11 00:57:46.957674|2017-10-11 00:57:46.957674
NCT02010866|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-09-28|||January 2014||2014-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reaching Out to Distressed Medical Residents, Fellows and Faculty|Reaching Out to Distressed Medical Residents, Fellows, and Faculty Through the OHSU Resident and Faculty Wellness Program Interactive Screening Program (ISP)|Recruiting||N/A|4000|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-10-11 00:57:47.044709|2017-10-11 00:57:47.044709
NCT02010853|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-03-12|||December 2013|Actual|2013-12-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ICTUS||Transient Global Amnesia (TGA). Exploratory Study of the Default Mode Network During the Acute Phase|Transient Global Amnesia (TGA) Exploratory Study of the Default Mode Network in Resting State Functional MRI (fMRI) During the Acute Phase|Completed||N/A|43|Actual|University Hospital, Toulouse||2|||f||||t||||||||No||2017-10-11 00:57:47.148525|2017-10-11 00:57:47.148525
NCT02010840|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-12-01|||July 2014||2014-07-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||The Effect of a Father Inclusive Psychoeducation Program on Postnatal Depression|The Effect of a Father Inclusive Psychoeducation Program on Postnatal Depression: a Randomized Controlled Trial|Recruiting||N/A|1152|Anticipated|The University of Hong Kong||3|||f||||t||||||||||2017-10-11 00:57:47.243185|2017-10-11 00:57:47.243185
NCT02010827|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-11-30|||November 2013||2013-11-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Observational|EGP_Glucagon||Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion|Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion|Completed||N/A|20|Actual|University Hospital, Gentofte, Copenhagen|||2||f||||t||||||Samples With DNA|"     hole blood, serum, white cells, urine   "|||2017-10-11 00:57:47.345715|2017-10-11 00:57:47.345715
NCT02010814|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-07-31|||January 2012||2012-01-01|July 2014|2014-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|1 Day|Observational [Patient Registry]|||Characterization of a Prospective Cohort of Women With PCOS|Metabolic and Endocrinological Characterization of a Prospective Cohort of Women With PCOS|Recruiting||N/A|500|Anticipated|Odense University Hospital|||1||f||||f||||||Samples With DNA|"     Blood and urine samples   "|||2017-10-11 00:57:47.441654|2017-10-11 00:57:47.441654
NCT02010801|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-12|||April 2012||2012-04-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors|Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors|Completed||N/A|20|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 00:57:47.521688|2017-10-11 00:57:47.521688
NCT02010788|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2016-09-21|||February 2014||2014-02-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea||Completed||N/A|523|Actual|Allergan|||1||f||||f||||||||||2017-10-11 00:57:47.596291|2017-10-11 00:57:47.596291
NCT02010775|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2017-07-20|||January 20, 2014|Actual|2014-01-20|July 2017|2017-07-01|December 13, 2017|Anticipated|2017-12-13|March 7, 2017|Actual|2017-03-07||Interventional|||Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy||Active, not recruiting||Phase 2|188|Actual|Allergan||5|||f||||t||||||||||2017-10-11 00:57:47.673239|2017-10-11 00:57:47.673239
NCT02010762|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-10|2015-01-13|||December 2013||2013-12-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|DETECT||The Effect of Vitamin D3 to Maintain Surgical Remission in Postoperative Crohn's Disease|The Effect of Vitamin D3 to Maintain Surgical Remission in Postoperative Crohn's Disease: a Placebo-controlled Randomized Trial|Unknown status|Recruiting|Phase 4|136|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 00:57:47.796684|2017-10-11 00:57:47.796684
NCT02010749|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-12-09|||October 2010||2010-10-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Protein Concentration in Infant Formula: A Follow-up Study of Growth at 2 Years of Age|Protein Concentration in Infant Formula: A Follow-up Study of Growth at 2 Years of Age|Completed||N/A|267|Actual|Nestlé|||2||f||||f||||||Samples Without DNA|"     stool   "|||2017-10-11 00:57:48.041352|2017-10-11 00:57:48.041352
NCT02010736|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-13|||September 2012||2012-09-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|SCP||Loading Gait in Spatic Cerebral Palsy|Immediate Effects of a Single Treadmill Gait Training Session With Additional Loading on Kinematic Gait Parameters in Children With Spastic Cerebral Palsy|Completed||N/A|20|Actual|Universidade Federal do Rio Grande do Norte||1|||f||||f||||||||||2017-10-11 00:57:48.126081|2017-10-11 00:57:48.126081
NCT02010723|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-12-12|||June 2006||2006-06-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Surgery Versus Sclerotherapy for Isolated Accessory Great Saphenous Vein Varicosis|Comparison of Surgery Versus Foam Sclerotherapy for Isolated Accessory Great Saphenous Vein Varicosis|Completed||Phase 4|40|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 00:57:48.211605|2017-10-11 00:57:48.211605
NCT02010710|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-12-13|||January 2010||2010-01-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|August 2013|Actual|2013-08-01||Interventional|INFANT||Use of Decision Support in the Management of Labour|A Multicentre Randomised Controlled Trial of an Intelligent System to Support Decision Making in the Management of Labour Using the Cardiotocogram|Unknown status|Active, not recruiting|N/A|46000|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 00:57:48.30682|2017-10-11 00:57:48.30682
NCT02010697|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-06-13|||December 2013||2013-12-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|Project BEST||Nonsmokers Helping Smokers Quit|Mail Campaigns That Target Smokers or Nonsmokers Who Live With Smokers|Completed||Phase 3|3102|Actual|University of California, San Diego||3|||f||||f||||||||||2017-10-11 00:57:48.440893|2017-10-11 00:57:48.440893
NCT02010684|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-05-27|2015-02-13||April 2009||2009-04-01|May 2015|2015-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|MADE-IT||Mood and Diabetes Empowerment & Improvement Training|University of California, Los Angeles (UCLA)/Drew Project EXPORT: Mood and Diabetes Empowerment & Improvement Training (MADE IT)|Completed||N/A|121|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:57:48.540784|2017-10-11 00:57:48.540784
NCT02010671|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-05-24|||September 2013||2013-09-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Observational|||Survey of Women's Choice of Delivery Before Consulting With Her Obstetrician|Understanding a Woman's Choice of Mode of Delivery Before Initial Consult With Her Obstetrician After Having One Prior Cesarean Section|Terminated||N/A|8|Actual|University of California, Davis|||1|Inadequate enrollment|f||||f||||||||No||2017-10-11 00:57:49.164263|2017-10-11 00:57:49.164263
NCT02010658|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2013-12-09|||April 2013||2013-04-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Cognitive Aid on Adherence to Perioperative Guidelines|Effect of Cognitive Aid on Adherence to Perioperative Guidelines|Completed||N/A|111|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 00:57:49.261503|2017-10-11 00:57:49.261503
NCT02010645|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-11-15|||March 2014||2014-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)|Phase II Study of Eltrombopag in Combination With Decitabine in Subjects With Advanced Myelodysplastic Syndrome|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 00:57:49.334364|2017-10-11 00:57:49.334364
NCT02010632|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-04-16|2015-03-30||August 2013||2013-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products|Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products in Thai Healthy Volunteers|Completed||Phase 1|32|Actual|Khon Kaen University||2|||f||||t||||||||||2017-10-11 00:57:49.489958|2017-10-11 00:57:49.489958
NCT02010619|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-08-15|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Internet Delivered CBT for Body Dysmorphic Disorder|Internet Delivered Cognitive Behavior Therapy for Body Dysmorphic Disorder - a Randomized Controlled Trial|Completed||N/A|94|Actual|Karolinska Institutet||2|||f||||||||||||||2017-10-11 00:57:49.779604|2017-10-11 00:57:49.779604
NCT02010606|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-06-05|||December 2013||2013-12-01|May 2017|2017-05-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma|Phase I Trial of Vaccination With Autologous Dendritic Cells Pulsed With Lysate Derived From an Allogeneic Glioblastoma Stem-like Cell Line for Patients With Newly Diagnosed or Recurrent Glioblastoma|Active, not recruiting||Phase 1|40|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-11 00:57:49.881446|2017-10-11 00:57:49.881446
NCT02010593|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-08-29||2017-02-06|December 2013||2013-12-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women|Phase 2a Safety Study of a Vaginal Matrix Ring Containing Dapivirine in a Postmenopausal Femal Population|Completed||Phase 2|96|Actual|International Partnership for Microbicides, Inc.||2|||f||||f|t|f||||||||2017-10-11 00:57:50.039971|2017-10-11 00:57:50.039971
NCT02010580|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-12-02|||January 2014||2014-01-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|Osphena||Effects of Ospemifene on Pelvic Vascularity and Blood Flow|The Effects of Vaginal Ospemifene on Pelvic Organ Vascularity and Blood Flow in Postmenopausal Women|Withdrawn||N/A|0|Actual|University of Oklahoma|||1|Never received necessary funding.|f||||f||||||||||2017-10-11 00:57:50.175408|2017-10-11 00:57:50.175408
NCT02010554|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-11-30|||December 2013||2013-12-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|MIMS||Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS|Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS|Completed||N/A|40|Actual|University of Missouri, Kansas City||2|||f||||f||||||||||2017-10-11 00:57:50.436225|2017-10-11 00:57:50.436225
NCT02010541|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-02-12|||December 2013||2013-12-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Observational|||The Influence of Technology, Education and Psychological Support on Metabolic Control in Children With T1D|The Influence of Diabetes Related Technology, Education and Psychological Support on Metabolic Control in Young Children With Type 1 Diabetes|Unknown status|Active, not recruiting|N/A|40|Anticipated|University Medical Centre Ljubljana|||2||f||||f||||||||||2017-10-11 00:57:50.563548|2017-10-11 00:57:50.563548
NCT02010528|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-02-12|||December 2013||2013-12-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Diabetes Distress, Psychological Well-being and Family Hardiness in Parents of Children and Adolescents With T1D|Diabetes Distress,Psychological Well-being and Family Hardiness in Parents of Children and Adolescents With Type 1 Diabetes|Completed||N/A|300|Anticipated|University Medical Centre Ljubljana|||2||f||||f||||||||||2017-10-11 00:57:50.66816|2017-10-11 00:57:50.66816
NCT02010515|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-09|||January 2008||2008-01-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||An Arrhythmia Risk Predictor Trial|Clinical-Electrophysiological Risk Marker Trial Goettingen|Completed||N/A|282|Actual|University Medical Center Goettingen|||1||f||||f||||||||||2017-10-11 00:57:50.773543|2017-10-11 00:57:50.773543
NCT02010502|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-05-03|||August 2013||2013-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|December 2013|Actual|2013-12-01||Interventional|||Beet Root Supplement Trial|Effects of Two Forms of Beetroot Juice Supplementation on Exercise Performance in Cyclists|Active, not recruiting||N/A|12|Actual|University of Manitoba||3|||f||||t||||||||||2017-10-11 00:57:50.886212|2017-10-11 00:57:50.886212
NCT02010489|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-09-15|||July 2014||2014-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||The Impact of a Pre-Operative Exercise Program on Fitness Outcomes Following Bariatric Surgery|The Impact of a Pre-Operative Exercise Program on Fitness Outcomes Following Bariatric Surgery|Active, not recruiting||N/A|70|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 00:57:50.988181|2017-10-11 00:57:50.988181
NCT02010476|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-05-11|||November 2013||2013-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|1 Day|Observational [Patient Registry]|ADDM||Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men|Cerebrospinal Fluid Changes in Insulin-Resistant Men|Completed||N/A|58|Actual|University of Eastern Finland|||2||f||||f||||||Samples With DNA|"     whole blood, serum, plasma, white cells, urine, cerebrospinal fluid   "|||2017-10-11 00:57:51.234531|2017-10-11 00:57:51.234531
NCT02010463|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-15|||October 2011||2011-10-01|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Neuroimaging Study of Factors Related to Exercise|Neuroimaging Studies of Reward, Impulsivity, and Adherence to an Exercise Program|Active, not recruiting||N/A|200|Anticipated|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 00:57:51.327231|2017-10-11 00:57:51.327231
NCT02010450|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-04-15|||October 2013||2013-10-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Re-enforcing Safe Sleep Practices for Caregivers With Tangible Incentives|Re-enforcing Safe Sleep Practices for Caregivers With Tangible Incentives: Pilot Testing of the MSSC Physician Safe Sleep Taskforce Caregiver Incentive Toolkit|Completed||N/A|152|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 00:57:51.417999|2017-10-11 00:57:51.417999
NCT02010437|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-12-02|||January 2014||2014-01-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|January 2015|Anticipated|2015-01-01||Interventional|EVCA||RCT Comparing Standard Cannula Delivered FS, UGFS and ClariVein® in the Management of SVI|A Randomised Clinical Trial Comparing Standard Cannula Delivered Foam Sclerotherapy, Catheter Directed Foam Sclerotherapy and ClariVein® Mechanochemical Ablation in the Management of Superficial Venous Insufficiency.|Withdrawn||Phase 4|0|Actual|University of Hull||3||Study design has been substantially revised and a new registration will be made in the future.|f||||t||||||||||2017-10-11 00:57:51.509989|2017-10-11 00:57:51.509989
NCT02010424|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-12-04|||January 2014||2014-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|WOW||Evaluation of Group Culture in WOW Dishes of Human Embryos in Order to Optimize the Single Embryo Transfer (SET) Strategy.|Multicentric Clinical Trial to Improve Blastocyst Utilisation Rate (in Relation to 2 PN Embryos) by Group Culture of Human Embryos in WOW Dishes.|Unknown status|Recruiting|N/A|158|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 00:57:51.613984|2017-10-11 00:57:51.613984
NCT02010411|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-11|||June 2004||2004-06-01|December 2013|2013-12-01|October 2005|Actual|2005-10-01|October 2004|Actual|2004-10-01||Interventional|||Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis|Effects of Prolastin Aerosol Therapy on Bacterial Density in the Airways of Patients With Cystic Fibrosis|Terminated||Phase 2|17|Actual|Université de Sherbrooke||1||Technical problems with measure of CFU's. Outcomes published: PMID:16986483|f||||f||||||||||2017-10-11 00:57:51.730665|2017-10-11 00:57:51.730665
NCT02010398|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-27|||July 2013||2013-07-01|March 2017|2017-03-01|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|CTSM||Effects of the Cross-Training in Patients With Multiple Sclerosis|Neurophysiological, Dynamometric, Functional and Clinical Assessment of the Cross-Training Effect in Patients With Multiple Sclerosis|Completed||N/A|45|Actual|Università degli Studi di Sassari||4|||f||||t||||||||||2017-10-11 00:57:51.861971|2017-10-11 00:57:51.861971
NCT02010385|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-11-01|||February 2013||2013-02-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Investigation of the Effects of Obesity Surgery on Appetitive Behaviour|Investigation of the Effects of Obesity Surgery on Appetitive Behaviour - Impact of Gut Hormones|Recruiting||N/A|30|Anticipated|University College Dublin||2|||f||||t||||||||||2017-10-11 00:57:51.987552|2017-10-11 00:57:51.987552
NCT02010372|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-02-23|||December 2013||2013-12-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|OASIS||Optimizing Application And Support Of Immunization Information Systems (OASIS)|Optimizing the Practical Application of Immunization Information System Use in Primary Care Practices|Completed||N/A|31|Actual|University of Rochester||3|||f||||f||||||||||2017-10-11 00:57:52.097845|2017-10-11 00:57:52.097845
NCT02010359|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-07-06|||June 2014||2014-06-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Interventional|FAIR||Fish Oils and Adipose Inflammation Reduction||Completed||Phase 4|29|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 00:57:52.20454|2017-10-11 00:57:52.20454
NCT02010346|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-07-18|||January 2005||2005-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Timing on Orthodontic Treatment|The Effect of Timing on Orthodontic Treatment - Studied by Randomized Clinical Settings|Active, not recruiting||N/A|120|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-11 00:57:52.29216|2017-10-11 00:57:52.29216
NCT02010333|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-09-09||2015-08-25|April 2013||2013-04-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation||Completed||Phase 2|22|Actual|Hatchtech Pty Ltd||1|||f||||||||||||||2017-10-11 00:57:52.409811|2017-10-11 00:57:52.409811
NCT02010320|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-12-02|||January 2014||2014-01-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|OPTIMAL||Computer Guided Doing of Tacrolimus in Renal Transplantation|Prospective Testing of Pharmacokinetic Population Models for Dosing of Transplanted Patients|Completed||Phase 4|80|Actual|University of Oslo School of Pharmacy||2|||f||||f||||||||||2017-10-11 00:57:52.496048|2017-10-11 00:57:52.496048
NCT02010307|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-13|||January 2014||2014-01-01|December 2013|2013-12-01|October 2015|Anticipated|2015-10-01|January 2015|Anticipated|2015-01-01||Interventional|||Polymorphonuclear Cells' Sensitivity to Aggregatibacter Actinomycetemcomitans Bacteria in Patients With Aggressive Periodontitis||Unknown status|Not yet recruiting|N/A|75|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||||2017-10-11 00:57:52.601909|2017-10-11 00:57:52.601909
NCT02010294|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-03-24|||January 2014||2014-01-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|StreptoPedia||Invasive Group A Streptococcus (GAS) Infection in Children: Bacterial Virulence Factors and Detection of Host Immunological and/or Genetic Factors of Predisposition to Infections|Invasive Group A Streptococcus (GAS) Infection in Children: Bacterial Virulence Factors and Detection of Host Immunological and/or Genetic Factors of Predisposition to Infections|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     serum   "|||2017-10-11 00:57:52.762332|2017-10-11 00:57:52.762332
NCT02010268|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-01-16|||September 2013||2013-09-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Interventional|CALPROPREMA||Use of Faecal Calprotectin to Predict Enteropathy of the Preterm Neonates|Evaluation of a Clinico-biological Predictive Score of Enterocolitis and Enteropathy of the Preterm Neonates. Usefulness of the Rapid Assay of the Faecal Calprotectin.|Active, not recruiting||N/A|122|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 00:57:53.0285|2017-10-11 00:57:53.0285
NCT02010255|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-05-11|2016-05-11||January 2014||2014-01-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional||Safety Analysis Set: participants who were enrolled and received at least one dose of study drug|Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant|A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected With Chronic HCV Who Have Advanced Liver Disease or Are Post-Liver Transplant|Completed||Phase 2|334|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|14|||f||||t||||||||||2017-10-11 00:57:53.398898|2017-10-11 00:57:53.398898
NCT02010242|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-03-27|||October 2013||2013-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria|A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria|Completed||Phase 2|200|Anticipated|Genkyotex Innovation SAS||2|||f||||t||||||||||2017-10-11 00:58:04.141605|2017-10-11 00:58:04.141605
NCT02010229|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-05-02|||November 4, 2013|Actual|2013-11-04|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|November 30, 2016|Actual|2016-11-30||Observational|Paccreta||Clinical Situations at High Risk of Placenta Accreta / Percreta|Clinical Situations at High Risk of Placenta Accreta / Percreta: Impact of Diagnostic Methods and Management on Maternal Morbidity.|Active, not recruiting||N/A|674|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 00:58:04.582918|2017-10-11 00:58:04.582918
NCT02010216|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-09-22|2014-07-29||March 2010||2010-03-01|September 2014|2014-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of RoActemra/Actemra (Tocilizumab) in Adult Patients With Rheumatoid Arthritis (SVOBODA Programme)|Non-Randomized Phase IV Trial on Efficacy and Safety of Actemra in the Treatment of Adult Patients With Rheumatoid Arthritis|Completed||Phase 4|23|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:58:04.685342|2017-10-11 00:58:04.685342
NCT02010203|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-04-21|||December 2013||2013-12-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT|A Phase 1/2, Placebo-Controlled, Randomized Study to Evaluate the Safety, Immune Response and Clinical Activity of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer Who Have Undergone Transurethral Resection of Bladder Tumor (TURBT)|Active, not recruiting||Phase 1/Phase 2|110|Anticipated|Heat Biologics||5|||f||||t||||||||||2017-10-11 00:58:04.88645|2017-10-11 00:58:04.88645
NCT02010190|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-07-26|||December 2013||2013-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Vascular Assessment in Adult Survivors of Childhood Cancer|Vascular Assessment in Adult Survivors of Childhood Cancer|Completed||N/A|394|Actual|St. Jude Children's Research Hospital|||2||f||||f||||||||||2017-10-11 00:58:05.064797|2017-10-11 00:58:05.064797
NCT02010177|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-05-18|||December 2013||2013-12-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|||Clinical Outcome of Patients With Low-gradient Severe Aortic Stenosis|Clinical Outcome of Patients With Low Ejection Fraction or Low-gradient Severe Aortic Stenosis|Recruiting||N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 00:58:05.16459|2017-10-11 00:58:05.16459
NCT02010164|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-02-28|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||CoQ10 Treatment to Improve Fertility in Elderly Patients|THE EFFECT OF COQ10 SUPPLEMENTATION ON FOLLICULAR CELLS' BIOLOGY/PROPERTIES IN ELDERLY IVF PATIENTS|Recruiting||N/A|100|Anticipated|Hadassah Medical Organization||3|||f||||||||||||||2017-10-11 00:58:05.235018|2017-10-11 00:58:05.235018
NCT02010151|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-02-14|||March 2015||2015-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Can Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation Improve Survival of out-of Hospital Cardiac Arrest?|Population Based Intervention Trial of Dispatcher-Activated Neighborhood Access Defibrillation and Cardiopulmonary Resuscitation|Recruiting||N/A|3776|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:58:05.353392|2017-10-11 00:58:05.353392
NCT02010138|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-01-05|||July 2013||2013-07-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Extent of ILM Removal and Its Impact on Outcomes of MH Surgery|Extent of Internal Limiting Membrane Removal and Its Impact on Outcomes of Macular Hole Surgery|Completed||N/A|65|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 00:58:05.452729|2017-10-11 00:58:05.452729
NCT02010125|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-10-26|||November 2013||2013-11-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Feasibility Trial Using Imaging and Biochemical Technologies to Measure Knee Cartilage Composition in Acute ACL Injury|A Multi-Center Feasibility Trial Establishing Imaging and Biochemical Technologies as Measures of Knee Cartilage Composition Following Acute ACL Injury|Active, not recruiting||N/A|90|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     Urine, Whole Blood, Synovial Fluid   "|Undecided|undecided at this point. If there are any queries, can contact at maben@ucsf.edu|2017-10-11 00:58:05.538051|2017-10-11 00:58:05.538051
NCT02010112|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-12-03|||January 2014||2014-01-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori|Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results|Completed||Phase 3|193|Actual|Exalenz Bioscience LTD.||1|||f||||f||||||||||2017-10-11 00:58:05.627325|2017-10-11 00:58:05.627325
NCT02010099|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-06-01|||November 2013||2013-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||A Prospective, Randomized, Three Arms, Open Label Study Comparing the Safety and Efficacy of Two Formulations of PP110 to the Active Comparator Preparation-H® Cream in the Treatment of Bleeding Hemorrhoids Grades 2-3||Completed||Phase 2/Phase 3|101|Actual|Peritech Pharma Ltd.||3|||f||||f||||||||||2017-10-11 00:58:05.739525|2017-10-11 00:58:05.739525
NCT02010086|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-05-17|||December 2011|Actual|2011-12-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2015|Actual|2015-11-01||Interventional|SEBASTIEN JR||Schema, Emotion and Behavior-Based Therapy for School Children|Cognitive Behavioral Therapy for Core Autism Symptoms in School-Age Children|Active, not recruiting||N/A|44|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 00:58:05.88568|2017-10-11 00:58:05.88568
NCT02010073|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-12-10|||February 2014||2014-02-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|LUNG-SAFE||Large Observational Study to UNderstand the Global Impact of Severe Acute Respiratory FailurE|A Multicentre, Prospective, Observational, 4-week Inception Cohort Study Being Carried Out by the Acute Respiratory Failure Section of ESICM|Completed||N/A|14000|Actual|European Society of Intensive Care Medicine|||1||f||||f||||||||||2017-10-11 00:58:06.347119|2017-10-11 00:58:06.347119
NCT02010060|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-08-14|||February 2014||2014-02-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|I-CAN||Aerobic Training and Non-Exercise Physical Activity|The Intervention Composed of Aerobic Training and Non-Exercise Physical Activity (I-CAN)|Completed||N/A|45|Actual|East Carolina University||3|||f||||f||||||||||2017-10-11 00:58:06.461798|2017-10-11 00:58:06.461798
NCT02010047|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-08-04|||December 2013||2013-12-01|July 2014|2014-07-01|August 18, 2015|Actual|2015-08-18|August 18, 2015|Actual|2015-08-18||Interventional|PCRTALK||Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients|A Study to Compare the Performance of a qPCR-based Assay to Immunohistochemistry (IHC) and Fluorescence in Situ Hybridization (FISH) in the Detection of Anaplastic Lymphoma Kinase (ALK) Fusion Mutations in Formalin Fixed Paraffin-embedded (FFPE) Tissue From Non-small Cell Lung Cancer (NSCLC) Patients.|Completed||N/A|166|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 00:58:06.569301|2017-10-11 00:58:06.569301
NCT02010034|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-01-30|||August 2013||2013-08-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury|Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury|Enrolling by invitation||N/A|15|Anticipated|Children's Medical Center Dallas||1|||f||||t||||||||||2017-10-11 00:58:06.662869|2017-10-11 00:58:06.662869
NCT02010021|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-07-03|||January 2014||2014-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.|Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.|Active, not recruiting||N/A|18|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 00:58:06.753507|2017-10-11 00:58:06.753507
NCT02010008|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-07-01|||May 2010||2010-05-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Screening Mammography and Latinas: A Multilevel Intervention|Understanding and Preventing Breast Cancer Disparities in Latinas: Screening Mammography and Latinas: A Multilevel Intervention|Completed||N/A|540|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 00:58:06.837758|2017-10-11 00:58:06.837758
NCT02009995|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-10-21|||February 2014||2014-02-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|DARE-Bands||The Diabetes Aerobic and Resistance Bands Exercise (DARE-Bands) Trial|The Diabetes Aerobic and Resistance Bands Exercise (DARE-Bands) Trial|Recruiting||N/A|72|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 00:58:06.936742|2017-10-11 00:58:06.936742
NCT02009982|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-09-16|2016-09-16||December 2013||2013-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Ablate-NCS||Cardioneuroablation for Neurocardiogenic Syncope|Cardioneuroablation for Neurocardiogenic Syncope|Completed||N/A|3|Actual|Emory University||2|||f||||t||||||||No|No due to limited data set and study ending.|2017-10-11 00:58:07.095133|2017-10-11 00:58:07.095133
NCT02009969|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-12-10|||September 2013||2013-09-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|SCANMRI||Serial Comparisons of Abdominal and Neurological MRI Scans|Serial Comparisons of Abdominal and Neurological MRI Scans of Patients With Refractory Psychosis Disorders|Recruiting||N/A|40|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 00:58:07.537374|2017-10-11 00:58:07.537374
NCT02009956|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-02-07|||February 2014||2014-02-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||EXCELLA Post-Approval Study|POST MARKETING STUDY OF THE ELIXIR DESyne® NOVOLIMUS ELUTING CORONARY STENT SYSTEM AND THE DESyne® BD NOVOLIMUS ELUTING CORONARY STENT SYSTEM IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS|Active, not recruiting||N/A|100|Anticipated|Elixir Medical Corporation||2|||f||||f||||||||||2017-10-11 00:58:07.655522|2017-10-11 00:58:07.655522
NCT02009943|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-11-17|||February 2017||2017-02-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||A Randomized Pilot Study of Ferric Carboxymaltose as Compared to Iron Sucrose for the Treatment of Functional Iron Deficiency Associated With Surgical Critical Illness|A Randomized Pilot Study of Ferric Carboxymaltose as Compared to Iron Sucrose for the Treatment of Functional Iron Deficiency Associated With Surgical Critical Illness|Suspended||Phase 1|30|Anticipated|Denver Health and Hospital Authority||3||Inadequate funds|f||||f||||||||||2017-10-11 00:58:07.770898|2017-10-11 00:58:07.770898
NCT02009930|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-11-10|||October 2013||2013-10-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Observational|||Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service|Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service|Terminated||N/A|37|Actual|David Grant U.S. Air Force Medical Center|||1|Failure to recruit enough subjects|f||||t||||||||||2017-10-11 00:58:07.882844|2017-10-11 00:58:07.882844
NCT02009917|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-07-13|||October 2013||2013-10-01|July 2017|2017-07-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Observational|||Non- Essential Amino Acid Requirements and Metabolism in Humans|Application of Indicator Amino Acid Oxidation Technique to Determine Non-essential Amino Acids/Nitrogen Requirements in Adult Humans|Completed||N/A|6|Actual|University of British Columbia|||1||f||||t||||||Samples Without DNA|"     Breath and urine samples   "|||2017-10-11 00:58:07.974272|2017-10-11 00:58:07.974272
NCT02009904|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-11-15|||January 2013||2013-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Simple Breath Test to Examine Phenylalanine Metabolism|Use of a Simple Breath Test to Examine Phenylalanine Metabolism in Children With Phenylketonuria (PKU)|Completed||Early Phase 1|20|Actual|University of British Columbia|||1||f||||t||||||Samples Without DNA|"     Breath samples from both groups (children with PKU and healthy controls)   "|||2017-10-11 00:58:08.049131|2017-10-11 00:58:08.049131
NCT02009124|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-09-13|||August 2012||2012-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Stem Cell Therapy in Spinal Cord Injury|Open Label Study of Autologous Bone Marrow Mononuclear Cells in Spinal Cord Injury|Recruiting||Phase 2|500|Anticipated|Neurogen Brain and Spine Institute||2|||f||||t||||||||||2017-10-11 00:58:17.544607|2017-10-11 00:58:17.544607
NCT02009891|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-09-21|||June 2012||2012-06-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Use of Predictive Model to Assist Patients Having an Embryo Transfer After IVF|The Application of a Validated Patient and Clinic Specific Predictive Model to Reduce the Incidence of Multiple Births Resulting From Fresh In Vitro Fertilization Cycles|Completed||N/A|200|Actual|Ottawa Fertility Centre|||2||f||||f||||||||||2017-10-11 00:58:08.133715|2017-10-11 00:58:08.133715
NCT02009878|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-04-08|2016-04-08||November 2013||2013-11-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||The baseline analysis population comprised of all participants who had taken one dose of the study medication.|A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)|A Phase 1b, Multicenter, Pilot, Randomized, Double-blind Trial to Determine the Pharmacokinetics and Pharmacodynamics of Orally Administered Tolvaptan 3.75, 7.5, and 15 mg Tablets in Subjects With Syndrome of Inappropriate Antidiuretic Hormone Secretion|Completed||Phase 1/Phase 2|30|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||f||||||||||2017-10-11 00:58:08.239421|2017-10-11 00:58:08.239421
NCT02009865|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-05-17|2015-12-11||December 2013||2013-12-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|EVOLVEII||Epanova® for Lowering Very High Triglycerides II (EVOLVE II)|A 12-Week, Randomized, Double-Blind, Olive Oil-Controlled Phase 3 Study to Assess the Efficacy and Safety of EPANOVA™ in Subjects With Severe Hypertriglyceridemia (EVOLVE II)|Completed||Phase 3|379|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:58:08.937222|2017-10-11 00:58:08.937222
NCT02009852|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-09|||January 2014||2014-01-01|December 2013|2013-12-01||||December 2014|Anticipated|2014-12-01|3 Years|Observational [Patient Registry]|microRNA-29b||The Role of microRNA-29b in the Oral Squamous Cell Carcinoma|The Role of microRNA-29b in the Oral Squamous Cell Carcinoma|Unknown status|Not yet recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     tissue, serum, saliva   "|||2017-10-11 00:58:09.575498|2017-10-11 00:58:09.575498
NCT02009839|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-05-19|||July 2005||2005-07-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Web-Based CBT Protocol for Treatment of Selective Mutism|Effectiveness of a Web-Based CBT Protocol for Treatment of Selective Mutism in Singapore|Completed||N/A|38|Actual|National Healthcare Group, Singapore||2|||f||||f||||||||||2017-10-11 00:58:09.653282|2017-10-11 00:58:09.653282
NCT02009826|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-08-30|||November 2013||2013-11-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|PANS||Psychosis-Associated Neuroinflammation in Schizophrenia|Phase 0 Clinical Protocol: A Longitudinal and Multimodal Exploratory Study to Evaluate a Neuroinflammatory Hypothesis in Patients With Schizophrenia Compared to Young Healthy Subjects|Completed||N/A|106|Actual|Universiteit Antwerpen|||2||f||||f||||||Samples Without DNA|"     Plasma samples   "|||2017-10-11 00:58:09.923946|2017-10-11 00:58:09.923946
NCT02009813|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-11-30|||March 2013||2013-03-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|HOTAIR2||Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session.|Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session.|Completed||N/A|9|Actual|University of Adelaide||1|||f||||f||||||||||2017-10-11 00:58:10.021217|2017-10-11 00:58:10.021217
NCT02009800|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-02|||November 2013||2013-11-01|March 2017|2017-03-01||||December 2020|Anticipated|2020-12-01||Interventional|ICI-VPH||ICI-VPH: Impact of HPV Immunisation Schedules Against HPV|ICI-VPH: Impact Des Calendriers d'Immunisation Contre Les HPV|Active, not recruiting||Phase 3|3364|Actual|CHU de Quebec-Universite Laval||2|||f||||t||||||||||2017-10-11 00:58:10.125896|2017-10-11 00:58:10.125896
NCT02009787|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2013-12-09|||December 2013||2013-12-01|December 2013|2013-12-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia|Effect of Vitamin D and Statins on Plasma Lipid Profiles in Chinese Patients With Hypercholesterolemia|Unknown status|Recruiting|N/A|56|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 00:58:10.211371|2017-10-11 00:58:10.211371
NCT02009774|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-11-05|||January 2014||2014-01-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|ADOPTION||Accuracy of the Optical Diagnosis of Small Colonic Polyps Using the Nice Classification||Completed||N/A|380|Actual|Technische Universität München|||2||f||||f||||||Samples Without DNA|"     Colon polyps   "|||2017-10-11 00:58:10.315143|2017-10-11 00:58:10.315143
NCT02009761|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-09-28|||December 2013||2013-12-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).|Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of Open Label Study With Multiple (and for Non Responders) Escalating Subcutaneous Doses of BI 655064 Once a Week in Patients With Chronic Primary Immune Thrombocytopenic Purpura.|Terminated||Phase 1|6|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:58:10.418408|2017-10-11 00:58:10.418408
NCT02009748|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-06-03|||December 2013||2013-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|||Vitamin D Supplementation in Cirrhotic Patients|Vitamin D Supplementation in Cirrhotic Patients: A Randomized, Multi-center, Double-blind, Placebo Controlled Trial to Evaluate Vitamin D Supplementation on Serum 25-hydroxyvitamin D Levels in Cirrhotic Patients|Completed||Phase 2|36|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 00:58:10.506407|2017-10-11 00:58:10.506407
NCT02009735|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2013-12-12|||June 2012||2012-06-01|December 2013|2013-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Virosensor -Based Real-time Diagnosis of Enterovirus 71 and Influenza Virus|Virosensor -Based Real-time Diagnosis of Enterovirus 71 and Influenza Virus|Unknown status|Recruiting|N/A|600|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 00:58:10.587225|2017-10-11 00:58:10.587225
NCT02009722|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-06-23|2016-03-15||January 2014||2014-01-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose|Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose|Completed||Phase 4|84|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 00:58:10.70022|2017-10-11 00:58:10.70022
NCT02009111|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-12-06|||March 2008||2008-03-01|December 2013|2013-12-01||||December 2012|Actual|2012-12-01||Interventional|||Dyadic, Skills-Based Primary Prevention for Partner Violence in Perinatal Parents||Completed||Phase 2|706|Actual|New York University||2|||f||||f||||||||||2017-10-11 00:58:17.638168|2017-10-11 00:58:17.638168
NCT02009709|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-12-10|||October 2013||2013-10-01|December 2015|2015-12-01||||January 2017|Anticipated|2017-01-01||Interventional|||Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2|Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2 in Eyes With Keratoconus or Ectasia|Recruiting||Phase 1|100|Anticipated|Mack Eye Center||2|||f||||f||||||||||2017-10-11 00:58:11.181558|2017-10-11 00:58:11.181558
NCT02009696|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-10-29|2015-06-17||December 2013||2013-12-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Observational|||ProMRI Study of the Entovis Pacemaker System (Phase B)||Completed||N/A|221|Actual|Biotronik, Inc.|||1||f||||t||||||||||2017-10-11 00:58:11.3191|2017-10-11 00:58:11.3191
NCT02009683|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-27|||May 2014||2014-05-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|MULTI-AF||Multimodality Prediction of Success of Atrial Fibrillation Rhythm Control Strategy|Multimodality Prediction of Success of Atrial Fibrillation Rhythm Control Strategy|Recruiting||N/A|220|Anticipated|Maastricht University Medical Center|||1||f||||t||||||Samples With DNA|"     Blood biomarkers and SNPs   "|||2017-10-11 00:58:11.628637|2017-10-11 00:58:11.628637
NCT02009670|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2015-11-24|||February 2014||2014-02-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Inulin,SCFA Production and Metabolic Response|SCFA Production and Their Metabolic Effects After Inulin Ingestion|Completed||N/A|15|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 00:58:11.709952|2017-10-11 00:58:11.709952
NCT02009644|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-08-21|||November 2013||2013-11-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms|A Phase II Clinical Study of the Safety and Performance of the Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms|Unknown status|Recruiting|N/A|150|Anticipated|Bolton Medical||1|||f||||t||||||||||2017-10-11 00:58:11.820577|2017-10-11 00:58:11.820577
NCT02009631|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2014-12-11|||November 2013||2013-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors|A Randomized, Placebo-Controlled Crossover Study to Evaluate the Effect of Veliparib (ABT-888) on Cardiac Repolarization in Subjects With Relapsed or Refractory Solid Tumors|Completed||Phase 1|45|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 00:58:12.04223|2017-10-11 00:58:12.04223
NCT02009618|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-12-11|||January 2013||2013-01-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||The Effects of Rifaximin Therapy in Irritable Bowel Syndrome|The Effects of Rifaximin Therapy in Patients Pre-Diagnosed With Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo Controlled Study|Completed||N/A|500|Actual|Bezmialem Vakif University||2|||f||||f||||||||||2017-10-11 00:58:12.148025|2017-10-11 00:58:12.148025
NCT02009605|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2015-03-04|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer|An Open-label, Single-armed Pilot Study to Evaluate the Efficacy of Icotinib in Previously Treated Non/Light-smoking Patients With Squamous Lung Cancer|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Zhejiang University||1|||f||||t||||||||||2017-10-11 00:58:12.246563|2017-10-11 00:58:12.246563
NCT02009592|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-05-15|||June 2013||2013-06-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients|The Efficacy of Antibiotic Rifaximin on the Lipopolysaccharides (LPS) and Related Cytokine Levels in Non Alcoholic Fatty Liver Disease Patients|Completed||N/A|42|Actual|Bezmialem Vakif University||2|||f||||f||||||||||2017-10-11 00:58:12.35644|2017-10-11 00:58:12.35644
NCT02009579|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-07-28|||March 2014||2014-03-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|December 2017|Anticipated|2017-12-01||Interventional|||ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer|"BGOG-cx1/ENGOT-cx1: Randomized Double-blind Phase II Study Comparing 3-weekly Carboplatin + Paclitaxel With or Without Concomitant and Maintenance Nintedanib (NINTEDANIB) in Advanced or Recurrent Cervical Carcinoma."|Recruiting||Phase 2|120|Anticipated|Belgian Gynaecological Oncology Group||2|||f||||t||||||||||2017-10-11 00:58:12.484506|2017-10-11 00:58:12.484506
NCT02009566|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-02-26|||July 2013||2013-07-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|||Healthy Volunteer Visibility Study of Micromachined Tags for the Detection of Surgical Sponges|Healthy Volunteer Visibility Study of Micromachined Tags for the Detection of Surgical Sponges|Withdrawn||Early Phase 1|0|Actual|University of Michigan||1||Initial PI Dr. Marentis left the University of Michigan hospital|f||||f||||||||No||2017-10-11 00:58:12.679359|2017-10-11 00:58:12.679359
NCT02009553|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-09|||December 2013||2013-12-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|||Pre-procedural Information Sheet Reduces Anxiety of Patients Before Urodynamic Studies|Pre-procedural Information Sheet Reduces Anxiety of Patients Before Urodynamic Studies|Unknown status|Recruiting|N/A|104|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||||||2017-10-11 00:58:12.752264|2017-10-11 00:58:12.752264
NCT02009540|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2013-12-08|||December 2013||2013-12-01|December 2013|2013-12-01||||January 2014|Anticipated|2014-01-01||Interventional|||Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity|Efficacy of Peri-trigonal Onabotulinumtoxin Injections in the Treatment of Refractory Idiopathic Detrusor Overactivity (IDO): A Single-blind, Randomised Controlled Trial Comparing Peri-trigonal Injections vs Injection of the Bladder Body.|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|University Hospital of Limerick||2|||f||||f||||||||||2017-10-11 00:58:12.856831|2017-10-11 00:58:12.856831
NCT02009527|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2015-04-17|||January 2012||2012-01-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional|||Arginase Inhibition in Ischemia-reperfusion Injury|Effect of Arginase Inhibition on Endothelial Function Induced by Ischemia-reperfusion in Patients With Coronary Artery Disease|Completed||Phase 1|24|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 00:58:12.991211|2017-10-11 00:58:12.991211
NCT02009514|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2013-12-08|||October 2002||2002-10-01|December 2013|2013-12-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Interventional|||Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients|Glucose Control During Glucose Containing And Glucose Free Hemodialysate Evaluated By Continuous Glucose Monitoring In Type 2 Diabetic Patients|Completed||Phase 4|10|Actual|Tampere University Hospital||1|||f||||f||||||||||2017-10-11 00:58:13.099209|2017-10-11 00:58:13.099209
NCT02009501|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2015-06-17|||November 2013||2013-11-01|April 2015|2015-04-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds|A Prospective, Open, Comparative, Randomized Single-center Study to Evaluate the Effect of V.A.C. VeraFlo™ Therapy With .125% Dakins vs V.A.C. Ulta™ Therapy on Biofilm Removal/Disruption/Elimination in Chronically Infected Wounds|Completed||N/A|20|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||f||||||||||2017-10-11 00:58:13.186173|2017-10-11 00:58:13.186173
NCT02009488|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2017-03-01|||September 2014||2014-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)|A Double-Blind, Placebo-Controlled, Randomized, Parallel Groups, Multicenter Study to Investigate the Effects of Canagliflozin on Insulin Sensitivity, Hepatic Fat Content and Beta Cell Function in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|59|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 00:58:13.297644|2017-10-11 00:58:13.297644
NCT02009475|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-10-23|||February 2014||2014-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Effect of Two Exercise Training Protocols on Physiological and Biochemical Parameters in Congestive Heart Failure||Completed||N/A|29|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 00:58:13.436472|2017-10-11 00:58:13.436472
NCT02009462|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-08-03|||December 2013||2013-12-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Artefill for the Treatment of HIV-associated Facial Lipoatrophy|Artefill for the Treatment of HIV-associated Facial Lipoatrophy|Active, not recruiting||Phase 1|30|Anticipated|AIDS Research and Treatment Center of the Treasure Coast||1|||f||||t||||||||||2017-10-11 00:58:13.514105|2017-10-11 00:58:13.514105
NCT02009449|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-03-13|||November 2013||2013-11-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|||A Phase 1 Study of AM0010 in Patients With Advanced Solid Tumors|A Phase 1, Open-Label Dose Escalation First-in-Human Study to Evaluate the Tolerability, Safety, Maximum Tolerated Dose, Preliminary Clinical Activity and Pharmacokinetics of AM0010 in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|350|Actual|ARMO BioSciences||24|||f||||f||||||||||2017-10-11 00:58:13.593043|2017-10-11 00:58:13.593043
NCT02009436|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-03-24|||June 2014||2014-06-01|March 2015|2015-03-01||||November 2016|Anticipated|2016-11-01||Interventional|||Inhaled Azacitidine in Patients With Advanced Non-small Cell Lung Cancer|Phase I Study of Inhaled Vidaza® in Patients With Advanced NSCLC|Unknown status|Recruiting|Phase 1|36|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 00:58:13.917577|2017-10-11 00:58:13.917577
NCT02009423|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2013-12-09|||January 2014||2014-01-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|March 2014|Anticipated|2014-03-01||Interventional|||Masitinib vs Placebo - Phase III Study to Compare the Efficacy and Safety of Masitinib to Placebo in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence|A Prospective, Multicenter, Randomised, Double-blinded, Placebo-controlled, Two-parallel Groups, Phase III Study to Compare the Efficacy and Safety of Masitinib to Placebo in Patients With Localized, Primary Gastrointestinal Stromal Tumor (GIST) After Complete Surgery and With High Risk of Recurrence|Unknown status|Not yet recruiting|Phase 3|330|Anticipated|AB Science||2|||f||||t||||||||||2017-10-11 00:58:14.024486|2017-10-11 00:58:14.024486
NCT02009410|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-06-19|||November 2013||2013-11-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2|A Double-blind, Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2|Withdrawn||Phase 4|0|Actual|Abbott||2|||f||||f||||||||||2017-10-11 00:58:14.130981|2017-10-11 00:58:14.130981
NCT02009397|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-09|2016-11-21|||February 2012||2012-02-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients|A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients|Recruiting||Phase 1/Phase 2|42|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-10-11 00:58:14.253646|2017-10-11 00:58:14.253646
NCT02009371|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-10-19|||January 2013||2013-01-01|June 2015|2015-06-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||A Clinical Study of Light Therapy on Depressive Episodes of Bipolar Disorder||Completed||N/A|80|Actual|Peking University||2|||f||||||||||||||2017-10-11 00:58:14.446832|2017-10-11 00:58:14.446832
NCT02009358|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-02-22|||March 2010||2010-03-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Mental Health Promotion Interventions Among Migrant Workers in China|Mental Health Promotion Interventions for Reducing Self-reported Depression and Improving Rates of Early Detection of Depression Among Migrant Workers in China, a Cluster Randomised Controlled Trial|Completed||N/A|913|Actual|Peking University||1|||f||||t||||||||||2017-10-11 00:58:14.537774|2017-10-11 00:58:14.537774
NCT02009345|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-06-20|||November 2013||2013-11-01|June 2014|2014-06-01|November 2020|Anticipated|2020-11-01|November 2016|Anticipated|2016-11-01|15 Years|Observational [Patient Registry]|FHCanada||Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada|Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada|Recruiting||N/A|6000|Anticipated|McGill University Health Center|||1||f||||f||||||Samples With DNA|"     Plasma and Buffy coat for DNA extraction DNA stock samples   "|||2017-10-11 00:58:14.629093|2017-10-11 00:58:14.629093
NCT02009332|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2017-07-18|||April 9, 2014|Actual|2014-04-09|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer|A Combined Phase 1 and Phase 2 Study of Albumin-bound Rapamycin Nanoparticles (Nab-rapamycin, ABI-009) in the Treatment of BCG Refractory or Recurrent Nonmuscle Invasive Transitional Cell Bladder Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Aadi, LLC||1|||f||||t||||||||||2017-10-11 00:58:14.716359|2017-10-11 00:58:14.716359
NCT02009319|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-09-08|||August 2013||2013-08-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Endobronchial Ultrasound Elastography: the Utility of Strain Ratio for Lymph Node Staging in Lung Cancer Patients|Endobronchial Ultrasound Elastography: the Utility of Strain Ratio for Lymph Node Staging in Lung Cancer Patients|Completed||N/A|33|Actual|The University Clinic of Pulmonary and Allergic Diseases Golnik|||1||f||||t||||||Samples With DNA|"     EBUS TBNA lymph node specimen - a part of routine diagnostic procedure   "|||2017-10-11 00:58:14.803724|2017-10-11 00:58:14.803724
NCT02009306|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-07-31|||January 23, 2017|Actual|2017-01-23|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Nasal Fentanyl and Buccal Midazolam for Dying Patients|Can Nasal Fentanyl and Buccal Midazolam Give Better Symptom Control for Dying Patients When Compared With Standard Subcutaneous Medication? Pilot Randomised Controlled Trial and Qualitative Interview Study.|Recruiting||Phase 4|20|Anticipated|Gloucestershire Hospitals NHS Foundation Trust||2|||f||||t|f|f|||f|||||2017-10-11 00:58:14.889848|2017-10-11 00:58:14.889848
NCT02009293|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-12-21|||December 2013||2013-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|Cough-IPF||The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis|Observational Study of the Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis|Completed||N/A|43|Actual|Erasmus Medical Center|||1||f||||t||||||||||2017-10-11 00:58:15.141777|2017-10-11 00:58:15.141777
NCT02009280|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2016-08-16|||November 2013||2013-11-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Comparison of Propofol Based Total Intravenous Anesthesia and Sevoflurane Based Balanced Anesthesia on Renal Protection During Lung Transplantation Under Extracorporeal Membrane Oxygenation - A Prospective, Randomized Trial||Completed||Phase 4|60|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 00:58:15.297774|2017-10-11 00:58:15.297774
NCT02009267|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-02-01|||November 2013||2013-11-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Nuss Procedure: Clinical Options in Pediatric Pain Management?||Completed||N/A|32|Actual|Nationwide Children's Hospital|||3||f||||f||||||||||2017-10-11 00:58:15.407134|2017-10-11 00:58:15.407134
NCT02009254|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-08||||||December 2013|2013-12-01||||January 2007|Actual|2007-01-01||Interventional|||The Effect of Mashed Potato Composition on Food Intake, Satiety and Blood Glucose||Completed||N/A|||University of Toronto||3|||f||||f||||||||||2017-10-11 00:58:15.51584|2017-10-11 00:58:15.51584
NCT02009241|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-12-09|||November 2013||2013-11-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Pulmonary Rehabilitation in Lymphangioleiomyomatosis|Evaluation of the Impact of a Pulmonary Rehabilitation Program on Exercise Capacity in Patients With Lymphangioleiomyomatosis|Completed||N/A|40|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 00:58:15.604687|2017-10-11 00:58:15.604687
NCT02009228|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-08|||June 2011||2011-06-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst.|Single-Port Compared With Conventional Laparoscopic Cystectomy for Ovarian Dermoid Cysts|Completed||Phase 3|70|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 00:58:15.735382|2017-10-11 00:58:15.735382
NCT02009215|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-09-23|||February 2014||2014-02-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|START-IPT||School-Based Treatment With ACT to Reduce Transmission|'SCHOOL-BASED TREATMENT WITH ACT TO REDUCE TRANSMISSION' (START-IPT): Evaluation of the Community Impact of Intermittent Preventive Treatment for Malaria in Ugandan Children: a Cluster Randomised Trial|Completed||Phase 4|10746|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 00:58:15.877023|2017-10-11 00:58:15.877023
NCT02009202|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-05-18|||November 2012||2012-11-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Preparation Prior to Colonoscopy in Children|Preparation Prior to Colonoscopy in Children|Completed||N/A|71|Actual|Skane University Hospital||2|||f||||f||||||||||2017-10-11 00:58:16.029311|2017-10-11 00:58:16.029311
NCT02009189|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-10|||November 2012||2012-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Taurolidine Lock in Long Term Parenteral Nutrition|The Value of Taurolidine Lock in Long Term Parenteral Nutrition|Completed||Phase 4|30|Anticipated|Stanley Dudrick's Memorial Hospital||3|||f||||f||||||||||2017-10-11 00:58:16.141442|2017-10-11 00:58:16.141442
NCT02009176|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-08|||March 2013||2013-03-01|December 2013|2013-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Laparoscope Anatomical and Aon-anatomical Hepatectomy|The Prospective, Randomized Case-control(RCT) Research of Laparoscope Anatomical and Aon-anatomical Hepatectomy Treat HCC|Recruiting||N/A|110|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 00:58:16.25094|2017-10-11 00:58:16.25094
NCT02009163|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-03-02|2016-01-28||January 2014||2014-01-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional||The Open-label Safety Population (OSP) was defined as all participants who had taken at least 1 dose of SPD489 in the open-label period and who had a post-baseline safety assessment. Seven participants were enrolled but not treated and thus not included in the OSP.|Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder|A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized-withdrawal Study to Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder|Completed||Phase 3|418|Actual|Shire||2|||f||||f||||||||||2017-10-11 00:58:16.430454|2017-10-11 00:58:16.430454
NCT02009150|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2017-09-18|||April 2014|Actual|2014-04-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Observational|||Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment in Women at High Risk for Breast Cancer.|"Evaluation of REAL IMAGING'S 3D Functional Metabolic Imaging and Risk Assessment (3D MIRA) System in Women at High Risk for Breast Cancer"|Active, not recruiting||N/A|236|Actual|Real Imaging Ltd.|||1||f||||||||||||||2017-10-11 00:58:17.408601|2017-10-11 00:58:17.408601
NCT02009137|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2015-03-04|||December 2013||2013-12-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety Study of EVERA to Augment Small Breast|A Randomized-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Breast Augmentation With EVERA(Korean External Soft Tissue Expansion System) as Compared to AESTES (American External Soft Tissue Expansion|Completed||N/A|34|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 00:58:17.46355|2017-10-11 00:58:17.46355
NCT02009098|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2015-04-20|||October 2014||2014-10-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|October 2015|Anticipated|2015-10-01||Interventional|APIPICS||RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section|Antibiotic Prophylaxis and Intervention for Postpartum Infections Following Caesarean Section|Withdrawn||Phase 4|0|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-11 00:58:17.896795|2017-10-11 00:58:17.896795
NCT02009085|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-03-19|||June 2013||2013-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.|Pilot Study to Asses the Identification of Melanoma in Skin Lesions.|Active, not recruiting||N/A|126|Actual|Orlucent, Inc|||1||f||||t||||||||||2017-10-11 00:58:18.008215|2017-10-11 00:58:18.008215
NCT02009072|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2014-01-05|||April 2010||2010-04-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|October 2010|Actual|2010-10-01||Interventional|||Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery|Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery|Completed||N/A|150|Actual|Minia University||2|||f||||t||||||||||2017-10-11 00:58:18.069502|2017-10-11 00:58:18.069502
NCT02009059|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-10-28|||November 2013||2013-11-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|November 2015|Anticipated|2015-11-01||Observational|||Accuracy of Non-invasive Temperature Measurement in Deep Hypothermia|Accuracy of Non-invasive Temperature Measurement in Deep Hypothermia; a Prospective Cohort Study|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 00:58:18.151175|2017-10-11 00:58:18.151175
NCT02009033|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2013-12-06|||September 2011||2011-09-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery|Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery. A Randomised Clinical Study|Completed||Phase 4|40|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 00:58:18.34378|2017-10-11 00:58:18.34378
NCT02009020|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-07|||July 2012||2012-07-01|December 2013|2013-12-01||||April 2013|Actual|2013-04-01||Observational|||Evaluation of a Non-invasive Device to Measure Blood Pressure and Difference in Pulse Pressure (dPP) Intraoperatively||Completed||N/A|26|Actual|Johannes Gutenberg University Mainz|||1||f||||||||||||||2017-10-11 00:58:18.413548|2017-10-11 00:58:18.413548
NCT02008994|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-03-20|||September 2013||2013-09-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer|A Phase II Pilot Study Utilizing Genomic and Proteomic Profiling to Find Potential Targets and Influence Treatments for Patients With Metastatic Breast Cancer|Terminated||Phase 2|5|Actual|Sanford Health||1||Resignation of Principal Investigator|f||||t||||||||||2017-10-11 00:58:18.588926|2017-10-11 00:58:18.588926
NCT02008981|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2015-11-18|||December 2013||2013-12-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Herbal Products on Platelet Function and Clotting|A Randomized, Double Blind, Placebo-controlled Crossover Study on the Effect of Commonly Used Herbal Products on Platelet Function and Coagulation Profile of Healthy Volunteers|Completed||Phase 3|75|Actual|Singapore General Hospital||3|||f||||f||||||||||2017-10-11 00:58:18.693324|2017-10-11 00:58:18.693324
NCT02008968|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-10|||December 2013||2013-12-01|December 2013|2013-12-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|||Effect of Allopurinol Treatment on Insulin Resistance||Unknown status|Recruiting|N/A|130|Anticipated|Istanbul Medeniyet University||3|||f||||f||||||||||2017-10-11 00:58:18.808705|2017-10-11 00:58:18.808705
NCT02008955|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-10|||September 2012||2012-09-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Lysine Requirements of Elderly Female Subjects 65-75 Years Old.||Completed||N/A|13|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 00:58:18.905865|2017-10-11 00:58:18.905865
NCT02008942|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-02-09|2015-06-29||January 2014||2014-01-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|RITE|All patients that received at least 1 dose of study drug|Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients|Reliable Inhibition of Thrombocyte Activity: Comparison of PL2200 Aspirin Capsules, 325 mg and Enteric-Coated Aspirin (RITE Study)|Completed||Phase 3|57|Actual|PLx Pharma||2|||f||||f||||||||||2017-10-11 00:58:18.990038|2017-10-11 00:58:18.990038
NCT02008929|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2015-11-30|||August 2014||2014-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|MG4101||to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)|A Single Center, Open-label, Phase II Clinical Trial to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell) in Hepatocellular Carcinoma After Curative Resection|Completed||Phase 2|5|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 00:58:19.194713|2017-10-11 00:58:19.194713
NCT02008747|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-07|||January 2011||2011-01-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||Atrial Fibrillation and Neuropathic Pain After Thoracotomy and Continuous Application of Magnesium Sulphate.|Effects of Prophylactic Administration of Magnesium Sulfate on the Incidence of Atrial Fibrillation and Chronic Neuropathic Pain After Thoracotomy for Lung Resection.|Completed||N/A|100|Actual|Dr. Horst Schmidt Klinik GmbH||2|||f||||f||||||||||2017-10-11 00:58:23.593883|2017-10-11 00:58:23.593883
NCT02008734|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-06-08|||January 2014||2014-01-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|POP||Randomized Phase II Study to Assess PD 0332991 in Breast Cancer|Randomized Short-term Pre-surgical Study to Assess the Effects of PD 0332991 in Early Breast Cancer Patients|Completed||Phase 2|132|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t||||||||||2017-10-11 00:58:23.69198|2017-10-11 00:58:23.69198
NCT02008916|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2017-04-20|||January 14, 2014|Actual|2014-01-14|April 2017|2017-04-01|December 12, 2017|Anticipated|2017-12-12|December 12, 2017|Anticipated|2017-12-12||Interventional|MEASURE 3||16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients|A Randomized, Double-blind, Placebo-controlled Phase III Study of Secukinumab to Demonstrate the Efficacy at 16 Weeks and to Assess the Long-term Safety, Tolerability and Efficacy up to 3 Years in Subjects With Active Ankylosing Spondylitis|Active, not recruiting||Phase 3|226|Actual|Novartis||3|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 00:58:19.293726|2017-10-11 00:58:19.293726
NCT02008903|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-04-26|||January 2009||2009-01-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|May 2018|Anticipated|2018-05-01||Observational|||Esophageal String Test in Eosinophilic Esophagitis|Phase 2 Study of Esophageal String Test in Diagnosing Eosinophilic Esophagitis|Recruiting||N/A|440|Anticipated|University of Colorado, Denver|||3||f||||f||||||||||2017-10-11 00:58:21.614014|2017-10-11 00:58:21.614014
NCT02008890|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2017-08-16|||December 26, 2013|Actual|2013-12-26|August 2017|2017-08-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Palmoplantar Pustular Psoriasis Efficacy and Safety wIth Secukinumab|A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab to Demonstrate Efficacy as Assessed by Palmoplantar Pustulosis Psoriasis Area and Severity Index (ppPASI) at 16 Weeks of Treatment, Compared to Placebo, and to Assess Long-term Safety, Tolerability, and Efficacy in Subjects With Moderate to Severe Chronic Palmoplantar Pustular Psoriasis|Completed||Phase 3|237|Actual|Novartis||3|||f||||f||||||||||2017-10-11 00:58:21.778213|2017-10-11 00:58:21.778213
NCT02008864|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2015-03-30|||August 2011||2011-08-01|March 2015|2015-03-01||||September 2012|Actual|2012-09-01||Interventional|||Evaluating the Effect of Senna in Uremic Pruritus|Phase II Study of the Effect of Senna Alexandrina Mill. on Uremic Pruritus and Serum IL-2, INF-δ and TNF-α Levels of Hemodialysed Patients|Completed||N/A|60|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 00:58:22.227953|2017-10-11 00:58:22.227953
NCT02008851|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-12-10|||December 2013||2013-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes|A Phase 1, Open-Label Safety and Tolerability Study of an Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease|Terminated||Phase 1|1|Actual|Tengion||1||Lack of funding|f||||t||||||||||2017-10-11 00:58:22.323398|2017-10-11 00:58:22.323398
NCT02008838|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2013-12-10|||April 2012||2012-04-01|December 2013|2013-12-01||||November 2012|Actual|2012-11-01||Interventional|||Effects of Synbiotic Supplementation in Metabolic Syndrome||Completed||Phase 2/Phase 3|38|Actual|National Nutrition and Food Technology Institute||2|||f||||||||||||||2017-10-11 00:58:22.61798|2017-10-11 00:58:22.61798
NCT02008825|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-12-10|||January 2014||2014-01-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Interventional|ViSiGi||Evaluation of the ViSiGiTM Calibration System|Evaluation of the ViSiGiTM Calibration System for Effectiveness With Sleeve Visual Delineation at Various Suction Levels.|Unknown status|Not yet recruiting|Phase 1|22|Anticipated|St. Luke's Hospital and Health Network, Pennsylvania||2|||f||||t||||||||||2017-10-11 00:58:22.709361|2017-10-11 00:58:22.709361
NCT02008812|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2013-12-12|||August 2011||2011-08-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Ad Sensor-based Real-time Diagnosis of Adenovirus|Ad Sensor-based Real-time Diagnosis of Adenovirus|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 00:58:22.860055|2017-10-11 00:58:22.860055
NCT02008799|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2015-04-07|||January 2013||2013-01-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia|Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia|Unknown status|Recruiting|N/A|20|Anticipated|Man Clinic for Andrology, Male Infertility and Sexual Dysfunction||1|||f||||f||||||||||2017-10-11 00:58:22.958758|2017-10-11 00:58:22.958758
NCT02008786|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2015-03-24|||June 2014||2014-06-01|July 2014|2014-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|SAFER-SCAD||Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD|The Effects of Statin and Angiotensin-converting Enzyme Inhibitor on Coronary Flow Reserve, indEx of Microcirculatory Resistance, and Symptoms in Patients With Spontaneous Coronary Artery Dissection (SAFER-SCAD) Study|Unknown status|Recruiting|Phase 4|40|Anticipated|Cardiology Research UBC||2|||f||||f||||||||||2017-10-11 00:58:23.056681|2017-10-11 00:58:23.056681
NCT02008760|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2013-12-10|||February 2013||2013-02-01|December 2013|2013-12-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|||QOL, ADL and Pain Before and After Intervention With N3 From Krill With D3.|Survey of Chronic Pain Patients' Self-rated Quality of Life, ADL Function and Pain Before and After Intervention With Omega 3 Fatty Acids From Krill With Vitamin D3|Unknown status|Enrolling by invitation|Phase 1|55|Actual|Hospitalet Valdemar||2|||f||||t||||||||||2017-10-11 00:58:23.510749|2017-10-11 00:58:23.510749
NCT02008721|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2016-12-28|||January 2014||2014-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|PROMESA||Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach|Double-blind, Randomised, Placebo-controlled Parallel Group Study to Investigate the Effect of EGCG Supplementation on Disease Progression of Patients With Multiple System Atrophy (MSA)|Completed||Phase 3|92|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 00:58:23.791582|2017-10-11 00:58:23.791582
NCT02008708|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-03-02|||January 2011||2011-01-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Microfinance Intervention to Improve Health of Trauma Survivors in DRC|Microfinance Intervention to Improve Health of Trauma Survivors in DRC|Completed||N/A|878|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 00:58:23.919827|2017-10-11 00:58:23.919827
NCT02008695|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-03-01|||August 2012||2012-08-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Youth and Adult Microfinance to Improve Resilience Outcomes in Democratic Republic of Congo|Youth and Adult Microfinance to Improve Resilience Outcomes in Democratic Republic of Congo|Active, not recruiting||N/A|984|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 00:58:24.002824|2017-10-11 00:58:24.002824
NCT02008682|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-01-26|2015-11-18||December 2013||2013-12-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||Safety analysis set included all subjects receiving at least one dose of investigational product.|The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes|The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes.(LIRA-DPP-4 CHINA™)|Completed||Phase 4|368|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:58:24.086157|2017-10-11 00:58:24.086157
NCT02008669|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-08-22|||November 2013||2013-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|June 9, 2017|Actual|2017-06-09||Observational|NUTRISEP||Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis|Evaluation of the Nutritional Status of Patients With Multiple Sclerosis and Relationship With Fatigue|Active, not recruiting||N/A|360|Actual|Lille Catholic University|||1||f||||f||||||Samples Without DNA|"     Biological analysis in serum: magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.   "|||2017-10-11 00:58:24.701098|2017-10-11 00:58:24.701098
NCT02008656|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-09-26|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management|A Phase II Multicenter Randomized Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management|Recruiting||Phase 2|300|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 00:58:24.825431|2017-10-11 00:58:24.825431
NCT02008643|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-07-26|||February 2014||2014-02-01|March 2016|2016-03-01|April 2016|Actual|2016-04-01|February 2014|Actual|2014-02-01||Interventional|||Health Related Quality of Life in Children With Food Allergy: Comparison to Controls and Other Chronic Diseases|Health Related Quality of Life in Children With Food Allergy: Comparison to Healthy Children and Children With Other Chronic Diseases|Completed||N/A|861|Actual|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 00:58:25.110482|2017-10-11 00:58:25.110482
NCT02008630|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-09-26|||January 2013||2013-01-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Animal-assisted Interventions in Health Promotion for Elderly With Dementia|Animal-assisted Interventions in Health Promotion for Elderly With Dementia; Impact on Factors Related to Risk of Falls|Completed||N/A|122|Actual|Norwegian University of Life Sciences||3|||f||||f||||||||||2017-10-11 00:58:25.213833|2017-10-11 00:58:25.213833
NCT02008617|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-03-08|2017-03-08||December 2013|Actual|2013-12-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Analgesic Benefits of Genicular Nerve Blocks of the Posterior Knee for Patients Undergoing ACL Reconstruction|Analgesic Benefits of Genicular Nerve Blocks of the Posterior Knee for Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction|Terminated||Phase 4|18|Actual|Northwestern University|Early termination leading to small numbers of subjects analyzed|2||The study was terminated due to lack of subject recruitment|f||||f||||||||No||2017-10-11 00:58:25.37026|2017-10-11 00:58:25.37026
NCT02008604|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-06-29|||May 2014||2014-05-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|GUTSTROKE||Influence of Stroke on the Composition of Intestinal Microbiota|Influence of Stroke on the Composition of Intestinal Microbiota (GUTSTROKE)|Recruiting||N/A|26|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||Samples With DNA|"     Stool samples, Blood samples   "|||2017-10-11 00:58:25.729429|2017-10-11 00:58:25.729429
NCT02008591|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-01-20|||November 26, 2013|Actual|2013-11-26|January 2017|2017-01-01|January 27, 2016|Actual|2016-01-27|January 27, 2016|Actual|2016-01-27||Interventional|||Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes|Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes|Completed||Phase 4|120|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-11 00:58:25.812961|2017-10-11 00:58:25.812961
NCT02008578|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-08-12|||December 2013||2013-12-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)|Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)|Completed||Phase 1|31|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 00:58:25.895985|2017-10-11 00:58:25.895985
NCT02008565|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-08-12|||February 2014||2014-02-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CAPABLe||Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe)|Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe): a Randomized Placebo Controlled Trial|Completed||Phase 3|294|Actual|NICHD Pelvic Floor Disorders Network||4|||f||||t||||||||No||2017-10-11 00:58:26.014545|2017-10-11 00:58:26.014545
NCT02008552|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-09-13|||October 18, 2013|Actual|2013-10-18|September 2017|2017-09-01|October 18, 2018|Anticipated|2018-10-18|October 18, 2018|Anticipated|2018-10-18||Interventional|MEDIAGENE||Study of the Effect of the Benfluorex|Research for Genetic Factors Involved in the Individual Susceptibility to Develop a Valvulopathy During a Medicinal Exposure in the Benfluorex.|Recruiting||N/A|600|Anticipated|University Hospital, Brest||1|||f||||t||||||||||2017-10-11 00:58:26.154204|2017-10-11 00:58:26.154204
NCT02008539|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-03-23|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|September 7, 2016|Actual|2016-09-07|September 7, 2016|Actual|2016-09-07||Interventional|TREAT-ME 1||Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101|Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101|Terminated||Phase 1/Phase 2|13|Actual|Apceth GmbH & Co. KG||1||"Enrollment terminated after 13 patients (14 planned); further patients did not meet eligibility   criteria to receive autologous IMP"|f||||t||||||||||2017-10-11 00:58:26.262149|2017-10-11 00:58:26.262149
NCT02008526|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-06-16|2017-04-04||January 2014||2014-01-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM|Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM|Completed||N/A|286|Actual|Friends Research Institute, Inc.||3|||f||||t||||||||No||2017-10-11 00:58:26.345311|2017-10-11 00:58:26.345311
NCT02008513|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-06-23|||June 2013||2013-06-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006|A Randomized, Controlled, Parallel Group, Double-blind, Multi-centre, Phase IIb Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in the AFFITOPE® AD02 Phase II Study AFF006.|Terminated||Phase 2|194|Actual|Affiris AG||2||Study AFF006A was early terminated by the sponsor based on the results of study AFF006.|f||||t||||||||||2017-10-11 00:58:26.942024|2017-10-11 00:58:26.942024
NCT02008500|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-10|||July 2013||2013-07-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparison Of Clinical Efficacy Of A Herbal And A Non-Herbal Mouthwash On Dentinal Hypersensitivity|COMPARISON OF CLINICAL EFFICACY OF A HERBAL AND A NON HERBAL MOUTHWASH ON DENTINAL HYPERSENSITIVITY: A TRIPLE MASKED RANDOMIZED CONTROLLED CLINICAL TRIAL|Completed||Phase 2|120|Actual|Government Dental College and Research Institute, Bangalore||3|||f||||t||||||||||2017-10-11 00:58:27.204823|2017-10-11 00:58:27.204823
NCT02008487|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-04-04|||April 2013||2013-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|RGN107||Wound Powder for Pressure Ulcers at End-of-life|Novel Wound Powder RGN107 to Reduce Wound Odor, Pain and Exudate at End-of-life|Completed||N/A|50|Actual|Medical University of South Carolina||1|||f||||t||||||||Yes|Data will be shared upon request and findings will be disseminated through publications and presentations.|2017-10-11 00:58:27.322041|2017-10-11 00:58:27.322041
NCT02008474|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-08-29|||January 2014||2014-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||SHARE Study 4: Financial Incentives for Weight Loss|Using a State-wide Initiative to Disseminate Effective Behavioral Weight Loss Strategies: Study 4|Completed||Phase 3|120|Actual|The Miriam Hospital||4|||f||||f||||||||||2017-10-11 00:58:27.4398|2017-10-11 00:58:27.4398
NCT02008461|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2015-09-21|||June 2013||2013-06-01|September 2015|2015-09-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias||Unknown status|Recruiting|Phase 2|60|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-11 00:58:27.53453|2017-10-11 00:58:27.53453
NCT02008448|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2015-09-21|||June 2013||2013-06-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation||Unknown status|Recruiting|Phase 2|160|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-11 00:58:27.652804|2017-10-11 00:58:27.652804
NCT02008435|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-09-12|||April 2013||2013-04-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Increasing the Effectiveness of the Diabetes Prevention Program|Increasing the Effectiveness of the Diabetes Prevention Program Through If-then Plans and Mental Practice: A Parallel Randomized Trial|Active, not recruiting||N/A|154|Anticipated|McGill University||2|||f||||f||||||||||2017-10-11 00:58:27.770796|2017-10-11 00:58:27.770796
NCT02008422|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-06|||August 2013||2013-08-01|August 2013|2013-08-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer|A Randomized, Open and Control Clinical Study of Endostar Injection Concomitant With SOX Protocols in Treating Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|Xinjiang Medical University||2|||f||||t||||||||||2017-10-11 00:58:27.915858|2017-10-11 00:58:27.915858
NCT02008409|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2015-08-03|||November 2011||2011-11-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of Safety and Efficacy of the EndoLift Liver Retractor|Evaluation of Safety and Efficacy of the EndoLift Liver Retractor: a Pilot Study of a New Internal Laparoscopic Liver Retraction Device|Withdrawn||N/A|0|Actual|Duke University||1||"The study was terminated. Six subjects were consented & all were withdrawn before any study   activities took place."|f||||f||||||||||2017-10-11 00:58:28.011813|2017-10-11 00:58:28.011813
NCT02008396|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-08-07|||February 2014||2014-02-01|March 2017|2017-03-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||MDMA-assisted Therapy for Social Anxiety in Autistic Adults|Placebo-controlled, Randomized, Blinded, Dose Finding Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults|Completed||Phase 2|12|Actual|Multidisciplinary Association for Psychedelic Studies||2|||f||||f||||||||||2017-10-11 00:58:28.123399|2017-10-11 00:58:28.123399
NCT02008383|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-04-29|||January 2014||2014-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|CaboMAb||Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer|Cabozantinib (XL184) With Panitumumab in Subjects With KRAS Wild-Type Metastatic Colorectal Cancer and Cabozantinib Monotherapy in Subjects With MET Amplified Treatment-Refractory Colorectal Cancer|Recruiting||Phase 1|50|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 00:58:28.25749|2017-10-11 00:58:28.25749
NCT02008370|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-06-22|||November 2013||2013-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Exparel in Minimally Invasive Cardiac Surgery|The Use of Exparel for Extended Pain Control in Minimally Invasive Cardiac Surgery|Terminated||Phase 4|9|Actual|Maimonides Medical Center||1||Lack of available participants that meet criteria|f||||f||||||||No||2017-10-11 00:58:28.366607|2017-10-11 00:58:28.366607
NCT02008344|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2015-10-20||2015-10-20|December 2013||2013-12-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza|Completed||Phase 3|1161|Actual|MDVI, LLC||2|||f||||f||||||||||2017-10-11 00:58:29.06416|2017-10-11 00:58:29.06416
NCT02008331|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-06|||April 2013||2013-04-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effect of the Synbiotic Probinul-Neutro® on Gastrointestinal Symptoms and Plasma p-Cresol Level in Chronic Renal Failure|EFFECT OF SHORT-TERM TREATMENT WITH THE SYNBIOTIC PROBINUL-NEUTRO® ON GASTROINTESTINAL SYMPTOMS AND CIRCULATING PLASMA p-CRESOL LEVEL IN PATIENTS WITH CHRONIC RENAL FAILURE: A RANDOMIZED DOUBLE BLIND PILOT STUDY.|Completed||Phase 4|30|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 00:58:29.878482|2017-10-11 00:58:29.878482
NCT02008318|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-07-12||2016-08-13|March 2014||2014-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Interventional|||A Study of LY2157299 in Participants With Myelodysplastic Syndromes|Phase 2/3 Study of Monotherapy LY2157299 Monohydrate in Very Low-, Low-, and Intermediate-Risk Patients With Myelodysplastic Syndromes|Active, not recruiting||Phase 2/Phase 3|140|Anticipated|Eli Lilly and Company||3|||f||||t||||||||||2017-10-11 00:58:29.999505|2017-10-11 00:58:29.999505
NCT02008305|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-02-08|||November 2013||2013-11-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|MINIRAD||Comparison of Two Protocols of Optimization of X Ray Radiations in Pediatric Interventional Neuroradiology|Comparison of Two Protocols of Optimization of X Ray Radiations in Pediatric Interventional Neuroradiology|Terminated||N/A|2|Actual|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f||||||||||2017-10-11 00:58:30.171663|2017-10-11 00:58:30.171663
NCT02008292|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-12-15|||September 2013||2013-09-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|nic_physo||Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors|Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors|Recruiting||N/A|130|Anticipated|Yale University||1|||f||||f||||||||No||2017-10-11 00:58:30.271935|2017-10-11 00:58:30.271935
NCT02008279|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-09-29|||December 2013||2013-12-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants|A Phase 1 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of CNTO3157 Following an Escalating Single SC Dose to Healthy Japanese and Caucasian Subjects or a Single Intravenous Dose to Healthy Caucasian Subjects|Completed||Phase 1|40|Actual|Janssen Research & Development, LLC||7|||f||||f||||||||||2017-10-11 00:58:30.411347|2017-10-11 00:58:30.411347
NCT02008266|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-06|||September 2011||2011-09-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis|Case Study of the Treatment of Early Rheumatoid Arthritis in Algerian Patients in Both the Private and Public Healthcare Sectors.|Completed||N/A|532|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 00:58:30.538375|2017-10-11 00:58:30.538375
NCT02008253|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2013-12-06|||April 2010||2010-04-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|||Intrastromal Corneal Ring for Ectasia After Refractive Surgery (Anel)|Intrastromal Corneal Ring Segment Implantation for Ectasia After Refractive Surgery|Completed||N/A|29|Actual|Instituto de Olhos de Goiania|||1||f||||t||||||||||2017-10-11 00:58:30.61894|2017-10-11 00:58:30.61894
NCT02008240|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-08|2015-02-16|||August 2011||2011-08-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET|Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET.A Randomized Controlled Trial|Completed||Phase 2|160|Actual|Aljazeera Hospital||2|||f||||t||||||||||2017-10-11 00:58:30.729229|2017-10-11 00:58:30.729229
NCT02008227|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-06-27|2017-05-08||March 11, 2014|Actual|2014-03-11|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|July 7, 2016|Actual|2016-07-07||Interventional|OAK|SP-Intent to Treat (ITT) analysis set included all randomized ITT participants regardless of whether they received any study drug.|A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy|A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Docetaxel in Patients With Non-Small Cell Lung Cancer After Failure With Platinum Containing Chemotherapy|Active, not recruiting||Phase 3|1225|Actual|Hoffmann-La Roche||2|||f||||t|t|f||||||||2017-10-11 00:58:31.263872|2017-10-11 00:58:31.263872
NCT02008214|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2013-12-06|||December 2013||2013-12-01|December 2013|2013-12-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients|Efficacy of Pentoxyfylline Addition to a Treatment Scheme Based on Interferon Alpha and Ribavirin on Hepatitis C Virus Coinfected HIV Patients, Considering Interleukin 28B Polymorphism rs12979860|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Centro Universitario de Ciencias de la Salud, Mexico||2|||f||||f||||||||||2017-10-11 00:58:40.479853|2017-10-11 00:58:40.479853
NCT02008201|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2014-12-12|||May 2012||2012-05-01|December 2013|2013-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|D-status||Vitamin D Status and Supplementation in Athletes|Vitamin D Status and Supplementation in Elite Athletes|Completed||Phase 3|153|Actual|Wageningen University||4|||f||||f||||||||||2017-10-11 00:58:40.586763|2017-10-11 00:58:40.586763
NCT02008188|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2015-04-02|||December 2013||2013-12-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes (Italy)|Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes|Unknown status|Active, not recruiting|N/A|12|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-11 00:58:40.68028|2017-10-11 00:58:40.68028
NCT02008175|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-12|||January 2012||2012-01-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|PED-CXL||Conventional Collagen Crosslinking in Young Keratoconus|Evaluation of Conventional Collagen Crosslinking in Young Keratoconus.|Completed||N/A|21|Actual|Vasan Eye Care Hospital||1|||f||||f||||||||||2017-10-11 00:58:40.761707|2017-10-11 00:58:40.761707
NCT02008162|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2013-12-06|||November 2009||2009-11-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Observational|||Bronchoreversibility and Radiologic Morphology of Emphysema|Response to Bronchodilation With Tiotropium Plus Salbutamol Correlates With Radiologic Morphology of the Lung in COPD of the Emphysematous Phenotype|Unknown status|Recruiting|N/A|60|Anticipated|University of Rome Tor Vergata|||1||f||||f||||||||||2017-10-11 00:58:40.941922|2017-10-11 00:58:40.941922
NCT02008149|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-08-15|||November 1, 2014|Actual|2014-11-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|FES-R||FES Rowing for Skeletal Health After SCI|Using Musculoskeletal Models to Assess FES Rowing for Skeletal Health After SCI|Recruiting||N/A|10|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 00:58:41.111998|2017-10-11 00:58:41.111998
NCT02008136|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-11-02|||March 2016||2016-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||New Approaches in Evaluating Patients' Response to Botulinum Toxins in the Treatment of Chronic Neck Pain and Back Pain|New Approaches in Evaluating Patients' Response to Botulinum Toxins in the Treatment of Chronic Neck Pain and Back Pain|Recruiting||Phase 1|60|Anticipated|VA Connecticut Healthcare System||1|||f||||t||||||||No||2017-10-11 00:58:41.2074|2017-10-11 00:58:41.2074
NCT02008123|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-08-01|||August 2013||2013-08-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant|Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant|Withdrawn||Phase 2|0|Actual|Dent Neuroscience Research Center||1||Inclusion/Exclusion criteria was too stringent to enroll patients at this site.|f||||f||||||||||2017-10-11 00:58:41.3035|2017-10-11 00:58:41.3035
NCT02008110|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-07|2016-02-03|||December 2011||2011-12-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|July 2014|Actual|2014-07-01||Interventional|CHANCE-HF||Carbohydrate Antigen 125-guided Therapy in Heart Failure|A Randomized Controlled Trial of Carbohydrate Antigen 125-guided Therapy Among Patients Recently Discharged for Acute Heart Failure: Effect on 1-year Mortality or Readmission for Acute Heart Failure (CHANCE-HF).|Completed||Phase 4|360|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||t||||||||||2017-10-11 00:58:41.407639|2017-10-11 00:58:41.407639
NCT02008097|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-03-22|||October 2013|Actual|2013-10-01|May 2015|2015-05-01|September 1, 2015|Actual|2015-09-01|August 31, 2015|Actual|2015-08-31||Interventional|||Clinical Benefits of B-Flow Ultrasound|Evaluation of Clinical Benefits of B-Flow With the LOGIQ E9 Ultrasound System|Completed||N/A|180|Actual|University of Washington||6|||f||||f||||||||||2017-10-11 00:58:41.504257|2017-10-11 00:58:41.504257
NCT02008084|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2016-01-26|||December 2013||2013-12-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Pilot Study to Evaluate the Lipid Effects of TRIA-662|A Randomized, Double-blind, Placebo-controlled, Forced Dose-escalation, Multi-center Pilot Study to Evaluate the Lipid Regulating Effects of TRIA-662 (1-methylnicotinamide Chloride)|Completed||Phase 2|71|Actual|Cortria Corporation||3|||f||||f||||||||||2017-10-11 00:58:41.61203|2017-10-11 00:58:41.61203
NCT02008071|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2015-07-21|||March 2013||2013-03-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|STEP||Effects of a Minimal-Contact Lifestyle Intervention on Physical Activity, Diet, and Body Weight|Effects of a Minimal-Contact Lifestyle Intervention on Physical Activity, Diet, and Body Weight|Completed||N/A|57|Actual|University of Tennessee||2|||f||||t||||||||||2017-10-11 00:58:41.784703|2017-10-11 00:58:41.784703
NCT02008058|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-03-15|||December 2013||2013-12-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|February 2019|Anticipated|2019-02-01||Observational|||Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer|LCCC 1231: Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer|Recruiting||N/A|220|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 00:58:41.872968|2017-10-11 00:58:41.872968
NCT02008045|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-10-26|||April 2009||2009-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Observational|||MR Imaging of Perinatal Brain Injury|Advanced MR Imaging of Perinatal Brain Injury: Correlation With Neurocognitive Outcome|Recruiting||N/A|300|Anticipated|University of Pittsburgh|||2||f||||f||||||||Yes|"Materials generated under the project will be disseminated in accordance with the University of Pittsburgh and NIH policies. Depending on such policies, materials may be transferred to others under the terms of a material transfer agreement.
Publication of data shall occur during the project, if appropriate, or at the end of the project, consistent with normal scientific practices. Research data which documents, supports and validates research findings will be made available after the main findings from the final research data set have been accepted for publication. Such research data will be redacted to prevent the disclosure of personal identifiers."|2017-10-11 00:58:41.991225|2017-10-11 00:58:41.991225
NCT02008032|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-09-13|||December 2013||2013-12-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Breast Augmentation|Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Breast Augmentation|Recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 00:58:42.085653|2017-10-11 00:58:42.085653
NCT02008019|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-08-04|||August 14, 2014|Actual|2014-08-14|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|CHONRAD||A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas|A Randomized Prospective, Multicentric, Open Label, Phase II Study Aiming to Evaluate the Efficacity and Safety of EVEROLIMUS as Neo-adjuvant Therapy in Patients With Primary or Relapsed Chondrosarcomas|Suspended||Phase 2|57|Anticipated|Centre Leon Berard||3||The study was suspended since july 27th 2016 because of unavailability of Everolimus|f||||t||||||||||2017-10-11 00:58:42.173583|2017-10-11 00:58:42.173583
NCT02007824|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-04-04|||August 2013||2013-08-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Clinical Trial to Evaluate Ultrasonic Surgical Device in Chronic Pressure Ulcer|Clinical Trial to Evaluate Efficacy and Safety of Ultrasonic Surgical Device (ULSC-12D)in Chronic Pressure Ulcer|Completed||N/A|30|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:58:44.788347|2017-10-11 00:58:44.788347
NCT02008006|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-08-03|||July 9, 2014|Actual|2014-07-09|August 2016|2016-08-01|January 2022|Anticipated|2022-01-01|July 2018|Anticipated|2018-07-01||Interventional|BENEFIT||BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)|A Multicenter Phase II Study Evaluating BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Prior to Autologous Stem Cell Transplant for First and Second Chemosensitive Relapses in Patients With Follicular Lymphoma|Recruiting||Phase 2|50|Anticipated|Centre Leon Berard||1|||f||||t||||||||||2017-10-11 00:58:42.332106|2017-10-11 00:58:42.332106
NCT02007993|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-07-31|||November 2013||2013-11-01|December 2013|2013-12-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Photodynamic Therapy in Adolescents Halitosis|Photodynamic Therapy as Novel Treatment for Halitosis in Adolescents: Crontolled Clinical Trial|Unknown status|Recruiting|N/A|130|Anticipated|University of Nove de Julho||5|||f||||t||||||||||2017-10-11 00:58:42.694627|2017-10-11 00:58:42.694627
NCT02007980|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-07-04|||December 2013||2013-12-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Indwelling Stent Discoloration Project|Examining the Underlying Factors That Cause Ureteral Stent Discoloration in Japanese and Canadian Ureteral Stents|Recruiting||N/A|70|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 00:58:42.828696|2017-10-11 00:58:42.828696
NCT02007967|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-12-20|||December 2013||2013-12-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation|Can Non-Contrast Magnetic Resonance Angiography Accurately Define Arterial Access and Aortic Root Anatomy in Patients Referred for Transcatheter Aortic Valve Implantation?|Terminated||N/A|12|Actual|University of Michigan|||1|Difficulty enrolling patients|f||||f||||||||||2017-10-11 00:58:42.969334|2017-10-11 00:58:42.969334
NCT02007954|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-07-12|2017-04-12||February 2014||2014-02-01|July 2014|2014-07-01|November 18, 2016|Actual|2016-11-18|August 11, 2015|Actual|2015-08-11||Interventional|DEBDOX||Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma|Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma (DEBDOX)|Completed||Phase 2|24|Actual|Yale University||1|||f||||t||||||||||2017-10-11 00:58:43.131098|2017-10-11 00:58:43.131098
NCT02007941|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-12-04|||April 2014||2014-04-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects|An Open-label, Non-randomized, Parallel-group Design Clinical Trial for Comparative Evaluation of Pharmacokinetics After CKD-501 Between Patients With Renal Impairment and Control Subjects With Normal Renal Function|Completed||Phase 1|28|Actual|Chong Kun Dang Pharmaceutical||3|||f||||f||||||||||2017-10-11 00:58:43.773955|2017-10-11 00:58:43.773955
NCT02007928|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-02-09|||April 2013||2013-04-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Interventional|||Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic|Assessment of Incidence of Adverse Events in a Naive Pediatric Population Treated With an (Typical and Atypical) Antipsychotic Drug Over 12 Months Follow-up|Active, not recruiting||Phase 4|200|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 00:58:43.857429|2017-10-11 00:58:43.857429
NCT02007902|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-07-28|||January 2014||2014-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Observational|ProHémie||Plasma Protein Levels and Very Preterm Birth|Early Plasma Protein Levels and Neonatal Hemodynamics: a Prospective Evaluation in Very Preterm Infants|Completed||N/A|125|Actual|Centre Hospitalier Universitaire de la Réunion|||1||f||||f||||||||||2017-10-11 00:58:44.054074|2017-10-11 00:58:44.054074
NCT02007889|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2013-12-05|||November 2013||2013-11-01|December 2013|2013-12-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis|The Effect of L-carnitine on the Prevention of Renal Scarring in Children With Acute Pyelonephritis|Unknown status|Recruiting|Phase 3|78|Anticipated|Shahid Beheshti University||2|||f||||||||||||||2017-10-11 00:58:44.142241|2017-10-11 00:58:44.142241
NCT02007876|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-02-01|||June 2013||2013-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|MAT||Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients|Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients|Withdrawn||N/A|0|Actual|University of Michigan||2||Difficulty enrolling|f||||t||||||||||2017-10-11 00:58:44.250215|2017-10-11 00:58:44.250215
NCT02007863|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-11-20|2015-07-01||August 2008||2008-08-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia|Treatment Protocol: Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia Using Conditioning Regimen Without Radiation|Completed||N/A|2|Actual|University of Miami|THERE ARE NO SPECIFIC RESEARCH QUESTIONS IN THIS PROTOCOL. This protocol merely provides UCB as a stem cell treatment modality to pediatric patients who may require it after a conditioning regimen that excludes Total Body Irradiation.|1|||f||||t||||||||||2017-10-11 00:58:44.356668|2017-10-11 00:58:44.356668
NCT02007850|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-07-29|||February 2014||2014-02-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|February 2015|Anticipated|2015-02-01||Interventional|||Effect of Mode of Femoral Nerve Analgesia on Quadriceps Muscle Strength|Effect of Continuous Femoral Analgesia on Quadriceps Muscle Strength-0.2% Ropivacaine Continuous Infusion Versus Patient Controlled Femoral Analgesia|Unknown status|Recruiting|N/A|36|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 00:58:44.572554|2017-10-11 00:58:44.572554
NCT02007837|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-11-23|||January 2018||2018-01-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|4P||Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial|Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia (4P) - a Randomised, Placebo-controlled, Double-blind Clinical Trial|Not yet recruiting||Phase 3|440|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-11 00:58:44.681497|2017-10-11 00:58:44.681497
NCT02007811|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-03-24|||November 2013||2013-11-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|B-cell therapy||Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination|Prospective, Open-label, Multicentre Clinical Trial, Phase I/IIa, to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates CD3+-Depleted, CD19+-Enriched, Cryopreserved (Single Administration After Day 120 Following Allogeneic Stem Cell Transplantation (SCT), Donor-identical) in 4 Groups With Escalating Doses for Immune Response Enhancement, Measured as Response to a Antedated Single Vaccination|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||t||||||||||2017-10-11 00:58:44.882412|2017-10-11 00:58:44.882412
NCT02007798|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2014-01-11|||January 2014||2014-01-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Small-dose Dexmedetomidine Effects on Recovery Profiles of Supratentorial Tumors Patients From General Anesthesia|Randomized, Parallelled and Double-blinded Trial of Small-dose Dexmedetomidine Effects on Recovery Profiles of Supratentorial Tumors Patients From General Anesthesia|Unknown status|Recruiting|N/A|150|Anticipated|China Medical University, China||3|||f||||t||||||||||2017-10-11 00:58:45.005456|2017-10-11 00:58:45.005456
NCT02007785|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-10-15|||February 2014||2014-02-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study of the Effect of the Cognitive Orientation to Daily Occupational Performance (CO-OP) on Cognitive Impairment in Parkinson's Disease|Determining the Applicability of the Cognitive Orientation to Daily Occupational Performance (CO-OP) as a Meta-Cognitive Rehabilitation Strategy for Individuals With Parkinson's Disease-Related Cognitive Impairment|Completed||N/A|6|Actual|University of Manitoba||1|||f||||||||||||||2017-10-11 00:58:45.127771|2017-10-11 00:58:45.127771
NCT02007772|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-07-14|||November 2009||2009-11-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TIBICO||Effectiveness of TNI vs. BiPAP in Chronic Global Insufficiency in COPD Patients|Effectiveness of TNI (Nasal High-flow) vs. BiPAP (Biphasic Positive Airway Pressure) in Chronic Global Insufficiency in COPD (Chronic Obstructive Pulmonary Disease) Patients|Recruiting||N/A|100|Anticipated|University of Leipzig||2|||f||||f||||||||||2017-10-11 00:58:45.232983|2017-10-11 00:58:45.232983
NCT02007759|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-07-17|||November 2013||2013-11-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates|Randomized Treatment of Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates|Terminated||N/A|12|Actual|Sanford Health||2||Difficulty with recruiting patients; poor quality of EMG|f||||t||||||||||2017-10-11 00:58:45.392743|2017-10-11 00:58:45.392743
NCT02007746|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-08-21|||July 2012||2012-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Liver Fibrosis in Sickle Cell Disease|Assessment of Liver Fibrosis in Patients With Sickle Cell Disease|Recruiting||N/A|30|Anticipated|University of Miami|||2||f||||f||||||||||2017-10-11 00:58:45.475359|2017-10-11 00:58:45.475359
NCT02007720|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-07-05|||March 12, 2014|Actual|2014-03-12|July 2017|2017-07-01|June 16, 2017|Actual|2017-06-16|March 27, 2017|Actual|2017-03-27||Interventional|RELAX-AHF-ASIA||Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF|A Multicenter, Randomized, Double-blind, Placebo Controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients|Terminated||Phase 3|872|Actual|Novartis||2||Study was terminated based on results from pivotal adult AHF study CRLX030A2301|f||||t|f|||||||||2017-10-11 00:58:45.666448|2017-10-11 00:58:45.666448
NCT02007707|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-05-05|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Interventional|Tobacco LHW||A Family-Based Approach To Reduce Smoking in Vietnamese Men|A Family-Based Approach To Reduce Smoking in Vietnamese Men|Completed||N/A|214|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 00:58:46.178221|2017-10-11 00:58:46.178221
NCT02007694|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-07-06|||March 2013||2013-03-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants|Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants|Completed||Phase 2/Phase 3|56|Actual|VU University of Amsterdam||3|||f||||||||||||||2017-10-11 00:58:46.270285|2017-10-11 00:58:46.270285
NCT02007681|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-06|||September 2013||2013-09-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||What is in Fact the Contribution of Reducing Time Spent in Sedentary Behaviors on Daily Energy Expenditure? A Doubly Labeled Water Study|The Effects of Shifting Sedentary Behaviors to Light Activities on Energy Expenditure: A Randomized Controlled Trial in Sedentary Adults|Completed||N/A|10|Actual|Technical University of Lisbon||2|||f||||t||||||||||2017-10-11 00:58:46.392064|2017-10-11 00:58:46.392064
NCT02007668|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-30|2013-12-05|||August 2013||2013-08-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Is Kinesio Taping More Effective Than Medical Adhesive Tape in Patients With Chronic Non-specific Low Back Pain?|Is Kinesio Taping More Effective Than Medical Adhesive Tape in Patients With Chronic Non-specific Low Back Pain? A Randomized Controlled Trial|Completed||N/A|60|Actual|Paulista University||3|||f||||f||||||||||2017-10-11 00:58:46.526851|2017-10-11 00:58:46.526851
NCT02007655|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-10-03|||August 31, 2013|Actual|2013-08-31|October 2017|2017-10-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Observational|||Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation|Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation|Active, not recruiting||N/A|5500|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 00:58:46.623157|2017-10-11 00:58:46.623157
NCT02007460|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-05|||January 2010||2010-01-01|December 2013|2013-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|Hiphop||The Influence of High Impact Exercise on Musculoskeletal Health in Older Men|The Influence of High Impact Exercise on Musculoskeletal Health in Older Men|Completed||N/A|50|Actual|Loughborough University||2|||f||||f||||||||||2017-10-11 00:58:48.912647|2017-10-11 00:58:48.912647
NCT02007642|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-04-20|||October 2013||2013-10-01|October 2013|2013-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|PATHOQUEST1||Evaluation of High Throughput Sequencing for Screening of Pathogens in Immunocompromised Patients With Suspected Infectious Disease.|Performance Assessment of High Throughput Sequencing for the Detection of Pathogens in Immunocompromised Patients With Suspected Infectious Disease.|Completed||N/A|250|Anticipated|Pathoquest|||1||f||||f||||||Samples With DNA|"     DNA sample by patient   "|||2017-10-11 00:58:46.734681|2017-10-11 00:58:46.734681
NCT02007629|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-01-19|||February 2014||2014-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|RESPITE||Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor|An Open-label, International, Multicenter, Single-arm, Uncontrolled, Phase IIIb Study of Riociguat in Patients With Pulmonary Arterial Hypertension (PAH) Who Demonstrate an Insufficient Response to Treatment With Phosphodiesterase-5 Inhibitors (PDE-5i)|Completed||Phase 3|61|Actual|Bayer||1|||f||||f||||||||||2017-10-11 00:58:46.819369|2017-10-11 00:58:46.819369
NCT02007616|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-05-27|||January 2011||2011-01-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Cognitive Aging and Training With Video-games|Compensation Factors of Cognitive Ageing: Using Computer Technology to Reduce Cognitive Decline in Ageing|Completed||N/A|30|Actual|Universidad Nacional de Educación a Distancia||2|||f||||t||||||||||2017-10-11 00:58:46.984516|2017-10-11 00:58:46.984516
NCT02007603|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-05-29|||August 2013|Actual|2013-08-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|February 2015|Actual|2015-02-01||Interventional|||Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients|Multiple-dose Pharmacokinetics of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid During Haemodialysis in Longterm Haemodialysis Patients|Completed||Phase 3|16|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 00:58:47.071853|2017-10-11 00:58:47.071853
NCT02007590|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-06|2017-01-11|||February 2014||2014-02-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|ACCORD||Aerosure and Six Minute Walk Distance in Severe COPD|Does High-frequency Airflow Oscillation, Delivered Using Aerosure, Increase Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease?|Recruiting||N/A|50|Anticipated|Actegy Ltd.||3|||f||||t||||||||||2017-10-11 00:58:47.153279|2017-10-11 00:58:47.153279
NCT02007577|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2016-04-01|2016-04-01||July 2010||2010-07-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Beneficial Effect of Salicylates: Insulin Action, Secretion or Clearance?|Beneficial Effect of Salicylates: Insulin Action, Secretion or Clearance?|Completed||N/A|41|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 00:58:47.250846|2017-10-11 00:58:47.250846
NCT02007564|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2014-07-13|||June 2009||2009-06-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|LIFE||Legacy Intervention Family Enactment (LIFE)|Legacy Intervention Family Enactment|Completed||N/A|164|Actual|University of Alabama, Tuscaloosa||2|||f||||f||||||||||2017-10-11 00:58:47.506551|2017-10-11 00:58:47.506551
NCT02007551|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-05-26|||May 2013||2013-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|RelAte||Evaluating the RelAte Mealtime Program as an Intervention to Treat Social Isolation and Improve Cooking Behaviour Among Older Adults Living Alone|RelAte: An Investigator-blinded, Randomised, 8-week, Parallel-group, Controlled Stepped Wedge Design Study to Evaluate the Effectiveness of a Complex Nutritional, Cooking and Social Intervention Against a Control Group in the Improvement of Dietary Self-efficacy and Energy Intake Among Older Adults Living Alone.|Completed||N/A|100|Actual|University of Dublin, Trinity College||1|||f||||f||||||||||2017-10-11 00:58:47.60087|2017-10-11 00:58:47.60087
NCT02007538|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-12-05|||May 2013||2013-05-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Observational|||Thin Prep Versus Traditional Cytological Procedure for Lung Cancer|Assessment of Adequacy and Characteristics Molecular of the Sample Obtained by Fine-needle Aspiration (FNA) Cytology Lung, Mounted With Thin Prep Compared to the Conventional Smear, in the Diagnosis of Lung Cancer.|Unknown status|Recruiting|N/A|60|Anticipated|Università degli Studi di Ferrara|||2||f||||f||||||||||2017-10-11 00:58:47.780609|2017-10-11 00:58:47.780609
NCT02007525|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2015-12-11|||February 2013||2013-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease|Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease: A Pilot Study|Terminated||N/A|7|Actual|University of Michigan||2||Insufficient enrollment; non-interest by target sample|f||||||||||||||2017-10-11 00:58:47.907344|2017-10-11 00:58:47.907344
NCT02007486|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-02-10|||January 2014||2014-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Pathophysiological Mechanisms of Activity-Related Dyspnea in Heart Failure: A Pilot Study|Pathophysiological Mechanisms of Activity-Related Dyspnea in Heart Failure: A Pilot Study|Active, not recruiting||N/A|32|Anticipated|McGill University|||4||f||||f|f|f||||||No||2017-10-11 00:58:48.63547|2017-10-11 00:58:48.63547
NCT02007473|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-09-08|||July 2013||2013-07-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma|A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma|Completed||N/A|8|Actual|Maco Productions S.A.S.|||1||f||||f||||||||||2017-10-11 00:58:48.73356|2017-10-11 00:58:48.73356
NCT02007447|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-06-20|||June 2015||2015-06-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|August 2015|Actual|2015-08-01||Interventional|OXYASD||Oxytocin in Adolescents With Autism Spectrum Disorders|Oxytocin in Adolescents With Autism Spectrum Disorders|Suspended||Phase 2/Phase 3|30|Anticipated|University of Sao Paulo General Hospital||2||Most of our patients had no willingness to participate in the survey|f||||f||||||||Undecided|We didn't decided yet|2017-10-11 00:58:49.151418|2017-10-11 00:58:49.151418
NCT02007434|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-07-06|2015-06-12||December 2013||2013-12-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Safety analysis set|Patient Experience Study of Deoxycholic Acid Injection|A Single Center, Double-blind, Parallel-group, Two Factor Patient-Experience Management Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area|Completed||Phase 3|84|Actual|Kythera Biopharmaceuticals||8|||f||||f||||||||||2017-10-11 00:58:49.300142|2017-10-11 00:58:49.300142
NCT02007421|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-18|||September 2010||2010-09-01|December 2013|2013-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|SPANC||Study of the Prevention of Anal Cancer|The Natural History of Anal Human Papillomavirus Infection and Anal Cellular Abnormalities in Homosexual Men|Recruiting||N/A|600|Anticipated|Kirby Institute||2|||f||||f||||||||||2017-10-11 00:58:52.123574|2017-10-11 00:58:52.123574
NCT02007408|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2013-12-05|||May 2013||2013-05-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Comparison of Lidocaine Spray and Paracervical Block Application for Pain Relief During First-trimester Surgical Abortion: a Randomized, Double-blind, Placebo-controlled Trial||Completed||N/A|108|Actual|Kayseri Education and Research Hospital||4|||f||||f||||||||||2017-10-11 00:58:52.320907|2017-10-11 00:58:52.320907
NCT02007395|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-05|||June 2013||2013-06-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational|||Prospective Study on Polypectomy Complications: SPoC.||Completed||N/A|5170|Actual|Valduce Hospital|||1||f||||||||||||||2017-10-11 00:58:52.427488|2017-10-11 00:58:52.427488
NCT02007369|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2016-11-16|2015-07-09||January 2014||2014-01-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Relapse Prevention Through Social Networking Groups|Effectiveness of Using Social Networking Service to Prevent Smoking Relapse Among Self-reported Quitters: A Pilot Randomized Control Trial|Completed||N/A|136|Actual|The University of Hong Kong|Most subjects had already quit for a few weeks before joining the RCT, so the present RCT did not examine if the intervention helped subjects manage smoking urges at the early stage of quitting. Also, the pilot RCT had small sample size.|3|||f||||t||||||||No||2017-10-11 00:58:52.512373|2017-10-11 00:58:52.512373
NCT02007356|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-07-06|||December 2014||2014-12-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|CCS||A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®|A Phase I/II Single-center Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®|Recruiting||Phase 2|6|Anticipated|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 00:58:52.93698|2017-10-11 00:58:52.93698
NCT02007343|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-10-28|||June 2013||2013-06-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|May 2016|Actual|2016-05-01||Observational|GRAND-ABC||Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals|The Attributable Burden and Costs of Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria in Dutch Hospitals|Active, not recruiting||N/A|4050|Anticipated|UMC Utrecht|||2||f||||f||||||||||2017-10-11 00:58:53.026456|2017-10-11 00:58:53.026456
NCT02007330|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-06-05|||November 2013||2013-11-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||The Effect of Systemic Lidocaine Infusion to Postoperative Pain and Quality of Recovery After Laparoscopic Hernia Repair in Children||Completed||N/A|66|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:58:53.141179|2017-10-11 00:58:53.141179
NCT02007317|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-03-28|||November 2013||2013-11-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study|A Single Center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R in Patients With Basal Cell Carcinoma (BCC) Prior to Tumor Excision- a Phase II Study|Recruiting||Phase 2|30|Anticipated|Oshadi Drug Administration||1|||f||||f||||||||||2017-10-11 00:58:53.294983|2017-10-11 00:58:53.294983
NCT02007304|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-05|||November 2012||2012-11-01|December 2013|2013-12-01||||July 2014|Anticipated|2014-07-01||Interventional|||Effects of Panax Ginseng and Salvia Miltiorrhiza Supplementation on Vascular Function|Effects of Panax Ginseng and Salvia Miltiorrhiza Supplementation on Preventing Arterial Stiffening Effects Induced by Acute and Chronic Eccentric Exercise|Unknown status|Recruiting|N/A|48|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 00:58:53.408462|2017-10-11 00:58:53.408462
NCT02007278|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-04-13|2017-02-23||January 3, 2014|Actual|2014-01-03|April 2017|2017-04-01|February 22, 2016|Actual|2016-02-22|February 22, 2016|Actual|2016-02-22||Interventional|GLOBE|Randomized set|Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride|Glycemic Excursions in Type 2 Diabetic Patients Treated With Vildagliptin and Metformin (GalvusMet) Versus Glimepiride and Metformin|Completed||Phase 4|40|Actual|Novartis||2|||f||||f|f|f||||||Undecided||2017-10-11 00:58:54.260511|2017-10-11 00:58:54.260511
NCT02007265|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2015-11-23|||April 2012||2012-04-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||"Post-stroke Triage DOC: Simple Screening for Depression, Obstructive Sleep Apnea and Cognitive Impairment"|"Post-stroke Triage DOC: Simple Screening for Depression, Obstructive Sleep Apnea and Cognitive Impairment"|Completed||N/A|1504|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-10-11 00:58:54.997806|2017-10-11 00:58:54.997806
NCT02007252|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-09-29|2016-09-29||December 2013||2013-12-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|AAA||ACZ885 for the Treatment of Abdominal Aortic Aneurysm|A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study of Subcutaneous ACZ885 for the Treatment of Abdominal Aortic Aneurysm|Terminated||Phase 2|65|Actual|Novartis||2||"The results of a third interim analysis (ad hoc) indicated a lack of efficacy and futility in   continuing the trial."|f||||f||||||||||2017-10-11 00:58:55.106105|2017-10-11 00:58:55.106105
NCT02007239|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-02-15|||December 2013||2013-12-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)|Cytokine Blockade With Tocilizumab in Patients With Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis|Recruiting||Phase 2|10|Anticipated|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-10-11 00:58:55.751994|2017-10-11 00:58:55.751994
NCT02007226|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-08-31|||February 2012||2012-02-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Observational|CAC||Coronary Artery Calcification Score and Risk Factors for Coronary Artery Disease in Persons With Spinal Cord Injury|Coronary Artery Calcification (CAC) Score and Risk Factors for Coronary Artery Disease in Persons With Spinal Cord Injury(SCI)|Recruiting||N/A|100|Anticipated|James J. Peters Veterans Affairs Medical Center|||1||f||||f||||||Samples With DNA|"     Serum and Plasma   "|||2017-10-11 00:58:55.89003|2017-10-11 00:58:55.89003
NCT02007213|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-09-21|||November 20, 2013||2013-11-20|September 18, 2017|2017-09-18|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Development of a Proxy Motor Outcome Measure in Young Children With Neuromuscular Disease|Development of a Proxy Motor Outcome Measure in Young Children With Neuromuscular Disease|Recruiting||N/A|260|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 00:58:56.012483|2017-10-11 00:58:56.012483
NCT02007200|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-09-01|2016-07-07||July 2009||2009-07-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||55 patients were enrolled. 3 patients did not undergo treatment. 13 patients had insufficient tissue and were therefore not evaluable. Only the 39 evaluable patients were included in the analysis.|Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery|A Phase II Trial of Preoperative Soy Isoflavone Supplementation and Molecular Markers in the Prevention of Head and Neck Squamous Carcinoma|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 00:58:56.121006|2017-10-11 00:58:56.121006
NCT02007187|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-10-09|||December 2013||2013-12-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|||Danhong Injection in the Treatment of Unstable Angina Pectoris|A Randomized, Double-blind, Multicenter, Parallel Controlled Clinical Trial of Danhong Injection in the Treatment of Unstable Angina Pectoris|Recruiting||Phase 4|160|Anticipated|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 00:58:56.495598|2017-10-11 00:58:56.495598
NCT02007174|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-05|||March 2012||2012-03-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Bevacizumab Injection for Recurrent Pterygium|Triple Subconjunctival Bevacizumab Injection for Early Recurrent Pterygium. One Year Follow-up|Completed||Phase 1|38|Actual|Instituto de Oftalmología Fundación Conde de Valenciana||1|||f||||t||||||||||2017-10-11 00:58:56.922299|2017-10-11 00:58:56.922299
NCT02007161|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-10|||December 2013||2013-12-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|DDD13DICLO||Supersaturation and Precipitation of Diclofenac in the Stomach of Healthy Volunteers|Supersaturation and Precipitation of Diclofenac in the Stomach of Healthy Volunteers|Unknown status|Not yet recruiting|N/A|10|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 00:58:57.021885|2017-10-11 00:58:57.021885
NCT02007148|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-08-02|||November 2013||2013-11-01|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|October 2018|Anticipated|2018-10-01||Interventional|MICADO||MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer|MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer Patients Previously Treated With Fluoropyrimidine and Platinum Agents MiCADO Study|Recruiting||Phase 2|51|Anticipated|International Group of Endovascular Oncology||1|||f||||f||||||||||2017-10-11 00:58:57.11379|2017-10-11 00:58:57.11379
NCT02007135|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-10-14|||November 2013||2013-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Observational|||Comparison of Pneumatic and Electromagnetic Muscle Vibrators to Stimulate Muscle Proprioceptors|Comparison of fMRI Compatible Pneumatic and Electromagnetic Muscle Vibrators to Stimulate Muscle Proprioceptors|Completed||N/A|10|Actual|Katholieke Universiteit Leuven|||1||f||||t||||||||||2017-10-11 00:58:57.275374|2017-10-11 00:58:57.275374
NCT02007122|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-29|||December 2013|Actual|2013-12-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Multiple-dose Pharmacokinetics of Ceftaroline During Continuous and Intermittent Renal Replacement Therapy in Patients Requiring Renal Replacement Therapy|Multiple-dose Pharmacokinetics of Ceftaroline During Continuous and Intermittent Renal Replacement Therapy in Patients Requiring Renal Replacement Therapy|Recruiting||Phase 4|25|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 00:58:57.364912|2017-10-11 00:58:57.364912
NCT02007109|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-02-03|||January 2014||2014-01-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Use of Baxter Animated Retching Faces (BARF) Scale to Measure Nausea in Children Who Speak Spanish|Use of Baxter Animated Retching Faces (BARF) Scale to Measure Nausea in Children Who Speak Spanish|Recruiting||N/A|140|Anticipated|Baylor College of Medicine|||1||f||||f||||||||Undecided||2017-10-11 00:58:57.524289|2017-10-11 00:58:57.524289
NCT02007083|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-11-24|||November 2013||2013-11-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|October 2025|Anticipated|2025-10-01||Interventional|NORDSTEN/SST||The NORDSTEN Studies/ The Spinal Stenosis Study|"Comparison of Different Surgical Treatments for Lumbar Spinal Stenosis. A Randomized Controlled Trial Comparing the Clinical and Radiological Results Using Spinous Process Osteotomy, Bilateral Laminotomy and Unilateral Laminotomy With Crossover"|Recruiting||N/A|465|Anticipated|Haukeland University Hospital||3|||f||||t||||||||||2017-10-11 00:58:58.384534|2017-10-11 00:58:58.384534
NCT02007070|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-04-12|2016-05-31||February 28, 2014|Actual|2014-02-28|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|July 9, 2015|Actual|2015-07-09||Interventional|||Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025)|An Open-label, Non-randomized, Multi-center Phase Ib Study of MK-3475 in Subjects With PD-L1 Positive Advanced Non-small Cell Lung Cancer|Completed||Phase 1|38|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 00:58:58.584045|2017-10-11 00:58:58.584045
NCT02007057|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-02-06|||November 2013||2013-11-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effectiveness of Suprascapular Nerve Block in Arthroscopic Shoulder Surgery|Prospective Randomized Comparative Study of the Effectiveness of Suprascapular Nerve Block in Arthroscopic Shoulder Surgery|Completed||Phase 4|74|Actual|Hospital Ambroise Paré Paris||2|||f||||t||||||||||2017-10-11 00:58:59.256532|2017-10-11 00:58:59.256532
NCT02007044|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-08-21|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Ibrutinib Versus Ibrutinib + Rituximab (i vs iR) in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL)|Randomized Study of Ibrutinib Versus Ibrutinib Plus Rituximab (i Versus iR) in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL)|Recruiting||Phase 2|208|Anticipated|M.D. Anderson Cancer Center||4|||f||||t|t|f||||||||2017-10-11 00:58:59.385372|2017-10-11 00:58:59.385372
NCT02007031|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-10|||January 2010||2010-01-01|December 2013|2013-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|ColdHTN||Cardiovascular Responses to Cold in Hypertension|Cardiovascular Responses to Cold Exposure in Hypertension|Completed||N/A|91|Actual|University of Oulu|||2||f||||f||||||||||2017-10-11 00:58:59.564271|2017-10-11 00:58:59.564271
NCT02007018|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-03-02|||January 2015||2015-01-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NEPTUNE||Negative Pressure Wound Therapy Use to Decrease Surgical Nosocomial Events in Colorectal Resections|Negative Pressure Wound Therapy Use to Decrease Surgical Nosocomial Events in Colorectal Resections|Recruiting||N/A|300|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||No||2017-10-11 00:58:59.689123|2017-10-11 00:58:59.689123
NCT02007005|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-05-05|||January 2004||2004-01-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|February 2012|Actual|2012-02-01||Interventional|||Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer|Dose-Escalation-Study With abnobaVISCUM® Fraxini 2 (AVF2) as Intravesical Instillation in Patients With Superficial Bladder Cancer According to ICH/GCP (International Conference on Harmonisation/Good Clinical Practice) - Guidelines: a Phase Ib/IIa Study|Completed||Phase 1/Phase 2|37|Actual|Abnoba Gmbh||1|||f||||f||||||||||2017-10-11 00:58:59.832006|2017-10-11 00:58:59.832006
NCT02006992|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-11|||March 2000||2000-03-01|December 2013|2013-12-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Growth of Infants Fed Hydrolysate Formulas|Growth of Infants Fed Hydrolysate Formulas|Completed||N/A|195|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-11 00:58:59.965514|2017-10-11 00:58:59.965514
NCT02006979|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-04-20|||January 15, 2016|Actual|2016-01-15|April 2017|2017-04-01|May 25, 2016|Actual|2016-05-25|May 25, 2016|Actual|2016-05-25||Interventional|||Acute Exercise Cardioprotection From Doxorubicin|The Effects of Exercise Before Doxorubicin Chemotherapy on Cardiac Function|Completed||Phase 2|24|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:59:00.166064|2017-10-11 00:59:00.166064
NCT02006966|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-04|||December 2013||2013-12-01|December 2013|2013-12-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|||The Impact of Intraoperative Systemic Lidocaine Infusion on Chronic Postoperative Pain After Video-assisted Thoracic Surgery (VATS)||Unknown status|Recruiting|N/A|168|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 00:59:00.277671|2017-10-11 00:59:00.277671
NCT02006953|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-16|||August 2011||2011-08-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|November 2018|Anticipated|2018-11-01||Interventional|||Bolus Versus Continuous Feeding Regimens Post Gastrostomy Tube Placement|Bolus Versus Continuous Feeding Regimens Post Gastrostomy Tube Placement|Recruiting||N/A|113|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 00:59:00.377818|2017-10-11 00:59:00.377818
NCT02006927|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-04-30|||July 2014|Actual|2014-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|May 2015|Actual|2015-05-01||Interventional|||A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile Function|A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Neural Regeneration and Erectile Function|Terminated||N/A|3|Actual|William Beaumont Hospitals||1||Lack of Enrollment|f||||t|f|t|t|f|f|||No||2017-10-11 00:59:00.674738|2017-10-11 00:59:00.674738
NCT02006914|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-12-05|||June 2005||2005-06-01|December 2013|2013-12-01|April 2012|Actual|2012-04-01|May 2010|Actual|2010-05-01||Observational|||Novel Therapy for Glucose Intolerance in HIV Disease|Novel Therapy for Glucose Intolerance in HIV Disease|Completed||N/A|47|Actual|Stony Brook University|||2||f||||t||||||Samples With DNA|"     Fat and muscle biopsy samples   "|||2017-10-11 00:59:00.777255|2017-10-11 00:59:00.777255
NCT02006901|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-04-07|||January 2014||2014-01-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Comparative Effectiveness of Microdecompression and Laminectomy for Central Lumbar Spinal Stenosis|Comparative Effectiveness of Microdecompression and Laminectomy for Central Lumbar Spinal Stenosis - An Observational Study|Completed||N/A|721|Actual|St. Olavs Hospital|||2||f||||f||||||||||2017-10-11 00:59:00.888329|2017-10-11 00:59:00.888329
NCT02006875|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-12-10|||January 2013||2013-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||rTMS Study to Improve Functional Performance for Patients With Stroke|The Potential Benefit of 1-Hz rTMS to Improve Gross Motor Function After Stroke: A Randomized Controlled Trial.|Completed||Phase 3|60|Actual|Taipei Medical University WanFang Hospital||2|||f||||f||||||||||2017-10-11 00:59:01.141934|2017-10-11 00:59:01.141934
NCT02006862|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-03-13|||January 2014||2014-01-01|August 2014|2014-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|VIOLET||eVAluatIon of OLanzapine TreatmEnT|Olanzapine in Standard Clinical Practice. 6-month Efficacy and Safety Monitoring|Completed||N/A|468|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 00:59:01.307944|2017-10-11 00:59:01.307944
NCT02006849|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-04-27|||January 2014||2014-01-01|April 2016|2016-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||ACTH Treatment of APOL1- Associated Nephropathy|ACTH Treatment of APOL1- Associated Nephropathy|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||2||no enrollment|f||||f||||||||||2017-10-11 00:59:01.410355|2017-10-11 00:59:01.410355
NCT02006836|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-05-25|2013-12-21||January 2013||2013-01-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||We chose the petients who met the inclusion/exclusion criteria and completed the study for the final analysis.|Glycemic Responses to Majia Pomelos in Type 2 Diabetic Patients|Glycemic Index & Glycemic Responses to Majia Pomelos|Completed||N/A|59|Actual|Huazhong University of Science and Technology||4|||f||||t||||||||||2017-10-11 00:59:01.54847|2017-10-11 00:59:01.54847
NCT02006823|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-12-11|||March 2012||2012-03-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C|Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C|Completed||N/A|20|Actual|Duke University|||1||f||||f||||||||||2017-10-11 00:59:02.179268|2017-10-11 00:59:02.179268
NCT02006810|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-07-25|||July 2013||2013-07-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|NUTREND||Development of Endothelial Biomarkers|Development of Endothelial Biomarkers for Use in Cohort Studies. Comparison With Reference Biomarkers.|Recruiting||N/A|60|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 00:59:02.267557|2017-10-11 00:59:02.267557
NCT02006797|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Interventional|REPHVIM||Communication Between Hospital and Community Pharmacists: Impact on Drug Management at Discharge|Impact of Drug Reconciliation at Discharge and Pharmaceutical Communication Between Hospital and Community Pharmacists on Drug Related Problems: Study Protocol for a Cluster Randomized Cross-over Trial|Unknown status|Recruiting|N/A|1176|Anticipated|University Hospital, Tours||2|||f||||f||||||||||2017-10-11 00:59:02.385449|2017-10-11 00:59:02.385449
NCT02006784|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-05-01|||September 2013|Actual|2013-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2014|Actual|2014-04-01||Observational|||Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)|Pilot Study in Children With Systemic Lupus Erythematosus (SLE) to Assess Flares and to Measure Traditional and Novel Blood Biomarkers and Antibody Titers Following Receipt of Inactivated Influenza Vaccine (IIV)|Completed||N/A|17|Actual|Vanderbilt University Medical Center|||1||f||||f||||||Samples Without DNA|"     Serum Blood   "|||2017-10-11 00:59:02.60678|2017-10-11 00:59:02.60678
NCT02006771|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-01-06|||January 2014||2014-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Cultural Meal and Postprandial Oxidative Stress|A Randomized Crossover Trial to Compare the Changes of Postprandial Oxidative Stress After Consumption of Meals From Different Cultures in Healthy Chinese Adults|Completed||N/A|33|Actual|Chinese University of Hong Kong||4|||f||||t||||||||||2017-10-11 00:59:02.982222|2017-10-11 00:59:02.982222
NCT02006758|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-03-15|||November 2013||2013-11-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Observational Study of the EnligHTN Renal Denervation System in Europe|EnligHTN European Observational Study|Active, not recruiting||N/A|68|Actual|St. Jude Medical|||1||f||||f||||||||No||2017-10-11 00:59:03.076519|2017-10-11 00:59:03.076519
NCT02006745|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-04-10|||January 2014||2014-01-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|CHAT||Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)|Open Label, Randomised, Pilot Trial of Pegylated Interferon, Ribavirin & Telaprevir vs Pegylated Interferon & Ribavirin Alone in Response Guided Treatment of Acute Hepatitis C Genotype 1 Virus Infection in Patients With HIV-1 Co-infection|Completed||Phase 3|20|Actual|St Stephens Aids Trust||2|||f||||f||||||||Undecided||2017-10-11 00:59:03.183635|2017-10-11 00:59:03.183635
NCT02006732|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-12-10|2015-10-23||November 2013||2013-11-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)|A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium+ Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|809|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 00:59:03.350883|2017-10-11 00:59:03.350883
NCT02006719|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-09-07|2017-04-18|2015-03-17|November 2013||2013-11-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|AC|All participants who received at least 1 administration of study drug (1 participant excluded)|Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder|A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder|Completed||Phase 2|322|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:59:04.980921|2017-10-11 00:59:04.980921
NCT02006706|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-07-17|2014-10-31||August 10, 2006|Actual|2006-08-10|July 2017|2017-07-01|November 23, 2007|Actual|2007-11-23|November 23, 2007|Actual|2007-11-23||Interventional||Per-protocol (PP) population: The 14 enrolled participants who were compliant with the protocol and not lost to follow-up.|A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy|An Open-label Study to Evaluate the Effect of MabThera in Combination With Methotrexate on Disease Activity in Patients With Active Rheumatoid Arthritis After DMARD Treatment Failure|Completed||Phase 3|15|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:59:05.888066|2017-10-11 00:59:05.888066
NCT02006693|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-07-11|||January 2014||2014-01-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Evaluation of the XEN Implant in Moderate POAG Subjects|Post Market Multicentric Evaluation of the AqueSys XEN Implant in Moderate Primary Open Angle Glaucoma Subjects|Active, not recruiting||Phase 4|200|Anticipated|AqueSys, Inc.||2|||f||||t||||||||||2017-10-11 00:59:06.158876|2017-10-11 00:59:06.158876
NCT02006680|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-09-03|||December 2013||2013-12-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Markers of Pubertal Suppression During Therapy for Precocious Puberty|Markers of Adequate Pubertal Suppression During Supprelin LA Therapy for Central Precocious Puberty|Unknown status|Recruiting|N/A|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||None Retained|"     Serum will be collected at four different time points.   "|||2017-10-11 00:59:06.28539|2017-10-11 00:59:06.28539
NCT02006667|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-02-09|2014-07-29||January 2001||2001-01-01|February 2015|2015-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Full analysis set (FAS) included all enrolled participants who received study treatment.|A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer|An Open-label Pilot Study Evaluating the Effect of a Combination Regimen of Herceptin, Cisplatin, and Gemcitabine on Time to Disease Progression in Patients With Metastatic Urothelial Cancer|Completed||Phase 2|13|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 00:59:06.374394|2017-10-11 00:59:06.374394
NCT02006654|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-30|||March 2014||2014-03-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|STARBRIGHT||Lu AE58054 in Patients With Mild to Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor|Randomised, Double-blind, Parallel-group, Placebo-controlled Study of Lu AE58054 in Patients With Mild to Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor|Completed||Phase 3|734|Actual|H. Lundbeck A/S||2|||f||||t||||||||||2017-10-11 00:59:06.730854|2017-10-11 00:59:06.730854
NCT02006641|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-30|||February 2014||2014-02-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|STARBEAM||Lu AE58054 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil|Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil|Completed||Phase 3|858|Actual|H. Lundbeck A/S||3|||f||||t||||||||||2017-10-11 00:59:07.242157|2017-10-11 00:59:07.242157
NCT02006628|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-02-22|||February 2014||2014-02-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder|A Double-blind, Randomised, Placebo-controlled, Parallel Group Study of GWP42003 as Adjunctive Therapy in First Line Treatment of Schizophrenia or Related Psychotic Disorder|Completed||Phase 2|88|Actual|GW Research Ltd||2|||f||||f||||||||No||2017-10-11 00:59:07.757924|2017-10-11 00:59:07.757924
NCT02006615|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2013-12-05|||July 2013||2013-07-01|December 2013|2013-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||The Role of Primary Motor Cortex and Prefrontal Cortex for Facilitation of Motor System and Working Memory|The Role of Primary Motor Cortex and Prefrontal Cortex for Facilitation of Motor System and Working Memory in Stroke, Parkinson, and Elderly Patients|Unknown status|Recruiting|N/A|150|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 00:59:07.912493|2017-10-11 00:59:07.912493
NCT02006602|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-12|||December 13, 2013|Actual|2013-12-13|May 2017|2017-05-01|January 22, 2014|Actual|2014-01-22|January 22, 2014|Actual|2014-01-22||Interventional|||Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions|An Open-label, Randomised, Single Dose, Two-way Crossover Pilot Study to Determine the Relative Bioavailability of One 16mg Tablet Formulation of Candesartan Cilexetil (GW615775) Relative to One 16mg Reference Tablet of Candesartan Cilexetil (Atacand) in Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 00:59:08.003212|2017-10-11 00:59:08.003212
NCT02006589|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-12|||December 11, 2013|Actual|2013-12-11|May 2017|2017-05-01|January 22, 2014|Actual|2014-01-22|January 22, 2014|Actual|2014-01-22||Interventional|||Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions|An Open-label, Randomised, Single Dose, Two-way Crossover Pilot Study to Determine the Relative Bioavailability of One 8mg Tablet Formulation of Candesartan Cilexetil (GW615775) Relative to One 8mg Reference Tablet of Candesartan Cilexetil (Atacand) in Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:59:08.089038|2017-10-11 00:59:08.089038
NCT02006576|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-07-20|||January 2014||2014-01-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|March 31, 2017|Actual|2017-03-31||Interventional|PIE||Prostaglandin Inhibition for Emphysema|Proof-of-concept Study to Demonstrate Inhibition of Prostaglandin E (PGE) Production and Associated Biological Effects in the Lower Respiratory Tract by Ibuprofen.|Active, not recruiting||Phase 2|82|Actual|University of Nebraska||3|||f||||t||||||||||2017-10-11 00:59:08.201849|2017-10-11 00:59:08.201849
NCT02006563|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-04-11|||June 8, 2011|Actual|2011-06-08|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Observational|||Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors|Evaluation of Metabolic Tumor Volumes in Radiation of Primary Brain Tumors|Active, not recruiting||N/A|22|Actual|University of Miami|||1||f||||t|f|f||||||No||2017-10-11 00:59:08.337924|2017-10-11 00:59:08.337924
NCT02006550|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-07-19|||June 16, 2010|Actual|2010-06-16|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Interrogation of Wnt, Notch and Hedgehog Activity in Primary Tumor Samples|Interrogation of Wnt, Notch and Hedgehog Activity in Primary Tumor Samples|Recruiting||N/A|250|Anticipated|University of Miami|||1||f|||||f|f||||||||2017-10-11 00:59:08.419297|2017-10-11 00:59:08.419297
NCT02006537|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-05-05|||January 31, 2014|Actual|2014-01-31|May 2017|2017-05-01|May 27, 2014|Actual|2014-05-27|May 27, 2014|Actual|2014-05-27||Interventional|||A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects|A Study to Evaluate the Effect of Age, Food and Gender on Tolerability and Pharmacokinetics of GSK2256294 Following a Single Oral Administration in Healthy Fed and Fasted Elderly Subjects. This Study Will Also Evaluate the Biliary Metabolites in Healthy Young Males Following a Single Dose of GSK2256294|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 00:59:08.496394|2017-10-11 00:59:08.496394
NCT02006524|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-05-11|||October 2013||2013-10-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Screening for Silent Atrial Fibrillation During Influenza Vaccination|Screening for Silent Atrial Fibrillation During Influenza Vaccination|Completed||N/A|3269|Actual|UMC Utrecht||1|||f||||t||||||||||2017-10-11 00:59:08.600367|2017-10-11 00:59:08.600367
NCT02006511|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-12-09|||December 2013||2013-12-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Incisional Negative Pressure Dressing on Clean Closed Groin Incisions|Incisional Negative Pressure Dressing on Clean Closed Groin Incisions in High Risk Patients|Unknown status|Not yet recruiting|N/A|200|Anticipated|University of Maryland||2|||f||||f||||||||||2017-10-11 00:59:08.692962|2017-10-11 00:59:08.692962
NCT02006498|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-01-06|||June 2012||2012-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)|A Randomised, Double-blind, Placebo-controlled, Phase II, Single-centre Study to Assess the Safety and Efficacy of Silymarin 700 mg Capsules TID for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)|Completed||Phase 2|99|Actual|University of Malaya||2|||f||||f||||||||||2017-10-11 00:59:08.792417|2017-10-11 00:59:08.792417
NCT02006485|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-09-07|||December 2013||2013-12-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies|A Phase I/Ib Study Evaluating the Efficacy and Safety of Ublituximab, a Third-Generation Anti-CD20 Monoclonal Antibody, in Combination With TGR-1202, a Novel PI3k Delta Inhibitor; and Ibrutinib or Bendamustine, in Patients With B-cell Malignancies.|Recruiting||Phase 1|140|Anticipated|TG Therapeutics, Inc.||3|||f||||t||||||||||2017-10-11 00:59:08.895883|2017-10-11 00:59:08.895883
NCT02006472|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2016-09-09|||February 2014||2014-02-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease|A Phase 2, Dose-Finding, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Study, Evaluating the Safety and Efficacy of Pridopidine 45 mg, 67.5 mg, 90 mg, and 112.5 mg Twice-Daily Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease|Completed||Phase 2|408|Actual|Teva Pharmaceutical Industries||5|||f||||t||||||||||2017-10-11 00:59:09.020033|2017-10-11 00:59:09.020033
NCT02006459|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-11-30|||September 2013||2013-09-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2014|Actual|2014-09-01||Observational|Px-GIGD||Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal|Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal|Completed||N/A|20|Anticipated|University Hospital, Gentofte, Copenhagen|||1||f||||f||||||Samples With DNA|"     plasma, serum and buffycoat   "|||2017-10-11 00:59:09.21929|2017-10-11 00:59:09.21929
NCT02006446|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-01-19|||December 2013|Actual|2013-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01|1 Day|Observational [Patient Registry]|VATES||Relationship Between Sperm Head Vacuoles and Sperm DNA Alterations in Infertile Men|Are Sperm Head Vacuoles Associated With Sperm Nuclear Alterations?|Completed||N/A|200|Actual|University Hospital, Rouen|||1||f||||f||||||Samples Without DNA|"     spermatozoa   "|||2017-10-11 00:59:09.278189|2017-10-11 00:59:09.278189
NCT02006433|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-09-19|||December 2013||2013-12-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury With Deep Brain Stimulation|Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury With Deep Brain Stimulation|Completed||N/A|12|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 00:59:09.385508|2017-10-11 00:59:09.385508
NCT02006420|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-01-27|||December 2013||2013-12-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ARFI||Scleroderma ARFI Imaging of the Skin|Acoustic Radiation Force Impulse/Shear Wave Velocity Imaging of the Skin in Scleroderma and Other Rheumatologic Diseases|Completed||N/A|45|Actual|University of Michigan||2|||f||||t||||||||No||2017-10-11 00:59:09.467801|2017-10-11 00:59:09.467801
NCT02006407|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-11-11|2016-04-05||June 2013||2013-06-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors|A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors|Terminated||N/A|5|Actual|University of Michigan Cancer Center||1||Trial closed due to low accrual|f||||t||||||||||2017-10-11 00:59:09.545781|2017-10-11 00:59:09.545781
NCT02006394|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-10|||January 2012||2012-01-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Novel Dietary Interventions for Treating Insulin Resistance||Completed||N/A|41|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 00:59:09.703232|2017-10-11 00:59:09.703232
NCT02006381|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2015-09-18|||December 2013||2013-12-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Oxytocin Levels in Typically Developing Boys|Ontogenic Measurement of Plasma Oxytocin in Typically Developing Boys Using Extracted and Unextracted EIA Methods|Completed||N/A|60|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||||||2017-10-11 00:59:09.775752|2017-10-11 00:59:09.775752
NCT02006368|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2017-08-03|||October 2013||2013-10-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Brrr||Assessment of Whole Blood Cold Stored Platelets|Assessment of Whole Blood Cold Stored Platelets|Completed||N/A|31|Actual|Bloodworks (Puget Sound Blood Center)||1|||f||||f||||||||||2017-10-11 00:59:09.84432|2017-10-11 00:59:09.84432
NCT02006355|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-05-13|||April 2014||2014-04-01|May 2014|2014-05-01|August 2017|Anticipated|2017-08-01|April 2016|Anticipated|2016-04-01||Interventional|GLASGOW||Continuous Local Anesthesia Versus Continuous Femoral Nerve Bloc After Total Knee Arthroplasty: Impact on Mean Discharge Aptitude Delay|Continuous Local Anesthesia Versus Continuous Femoral Nerve Bloc After Total Knee Arthroplasty: Impact on Mean Discharge Aptitude Delay|Unknown status|Recruiting|Phase 4|250|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 00:59:10.079101|2017-10-11 00:59:10.079101
NCT02005952|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-04|||February 2010||2010-02-01|May 2009|2009-05-01|June 2012|Actual|2012-06-01|March 2011|Actual|2011-03-01|1 Day|Observational [Patient Registry]|||Effectiveness of Two Methods for Quality Control in Primary Care Spirometry|Effectiveness of Two Methods for Quality Control in Primary Care Spirometry|Completed||N/A|3000|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||3||f||||f||||||||||2017-10-11 00:59:17.273496|2017-10-11 00:59:17.273496
NCT02006342|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-04-10|2017-04-10||November 2012||2012-11-01|April 2017|2017-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|GT-COG|All who were enrolled|Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis|Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis: A Pilot Study|Completed||N/A|40|Actual|The University of Texas Health Science Center, Houston|The study had a limited sample size; therefore, the results cannot definitively answer the research question. Also, because a convenience sample was used, there might be selection bias.|2|||f||||f||||||||||2017-10-11 00:59:10.163998|2017-10-11 00:59:10.163998
NCT02006329|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-04|||January 2014||2014-01-01|December 2013|2013-12-01||||November 2014|Anticipated|2014-11-01||Interventional|||Treatment of Non Alcoholic Fatty Liver Disease With Lifestyle Modification and Acupuncture||Unknown status|Not yet recruiting|N/A|60|Anticipated|Ziv Hospital||2|||f||||||||||||||2017-10-11 00:59:10.480056|2017-10-11 00:59:10.480056
NCT02006316|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-17|2014-05-13|||January 2000||2000-01-01|May 2014|2014-05-01|March 2010|Actual|2010-03-01|April 2008|Actual|2008-04-01||Observational|||Beneficial Effects of Microsurgical Varicocelectomy on Semen Parameters for Causes Other Than Infertility|Beneficial Effects of Microsurgical Varicocelectomy on Semen Parameters in Patients Who Underwent Surgery for Causes Other Than Infertility|Completed||N/A|121|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 00:59:10.563206|2017-10-11 00:59:10.563206
NCT02006303|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2014-11-03|||December 2013||2013-12-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients|Prostatic Artery Embolization Versus 532 nm Green Light Laser Photoselective Vaporization of the Prostate for Treating Catheter-Dependent Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Study|Unknown status|Recruiting|Phase 4|73|Anticipated|Royal Victoria Hospital, Canada||2|||f||||t||||||||||2017-10-11 00:59:10.657903|2017-10-11 00:59:10.657903
NCT02006290|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-09-30|||March 2014||2014-03-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease|A Phase 1b, Randomized, Subject And Investigator-Blinded, Sponsor-Open, Placebo Controlled, Cross-Over Efficacy, Safety And Tolerability Study Of Single Oral Split Dose Administration Of PF-06412562 In Subjects With Parkinson's Disease|Completed||Phase 1|19|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:59:10.775595|2017-10-11 00:59:10.775595
NCT02006277|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2014-04-11|||December 2013||2013-12-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule Formulation|A Phase 1, Open-label, Crossover Taste And Pharmacokinetic Study In Healthy Adult Volunteers To Evaluate The Palatability And Estimate The Bioavailability Of Three Prototype Formulations Of Crizotinib|Completed||Phase 1|21|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:59:10.861857|2017-10-11 00:59:10.861857
NCT02006264|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-03-23|||November 2013||2013-11-01|March 2015|2015-03-01||||December 2014|Actual|2014-12-01||Interventional|TDF IVR-001||Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring|Phase 1 Safety and Pharmacokinetic Study of Polyurethane Tenofovir Disoproxil Fumarate Vaginal Ring|Completed||Phase 1|30||Albert Einstein College of Medicine, Inc.||2|||f||||||||||||||2017-10-11 00:59:10.954924|2017-10-11 00:59:10.954924
NCT02006251|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-05|2015-07-09|||November 2013||2013-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:59:11.028291|2017-10-11 00:59:11.028291
NCT02006238|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-06-19|||February 2014||2014-02-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|Flash||A Comparison of Farabloc Fabric With Placebo on Alleviation Hot Flash in Menopausal Women|A Comparison of Farabloc Fabric With Placebo on Alleviation Hot Flash in Menopausal Women|Unknown status|Recruiting|N/A|50|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 00:59:11.075843|2017-10-11 00:59:11.075843
NCT02006225|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-04|||February 2014||2014-02-01|April 2013|2013-04-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|GCSF||Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients.|GCSF Plus Plerixafor as First-line Treatment for Autologous Stem Cells Harvest in Children With Malignant Diseases in Need for High-dose Chemotherapy With Stem Cell Rescue.|Not yet recruiting||Phase 4|30|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 00:59:11.194539|2017-10-11 00:59:11.194539
NCT02006212|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-04-24|||January 2014||2014-01-01|January 2016|2016-01-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Impact of Cerebral Monitoring on Neurologic Outcome in Cardiac Surgery||Completed||N/A|1500|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-11 00:59:11.280775|2017-10-11 00:59:11.280775
NCT02006199|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-10-12|||October 2013||2013-10-01|December 2013|2013-12-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Effect of Mindfulness Based Treatment for Obsessive-compulsive Disorder|Effect of Mindfulness Based Treatment for Obsessive-compulsive Disorder|Withdrawn||N/A|0|Actual|Seoul National University Hospital||2||Withdrawal of the administrative reason|f||||f||||||||No||2017-10-11 00:59:11.35442|2017-10-11 00:59:11.35442
NCT02006186|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-04-12|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Pilot and Feasibility Bicycle Train Study|Pilot Study on Bicycle Trains to Improve Children's Physical Activity|Completed||N/A|54|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 00:59:11.426287|2017-10-11 00:59:11.426287
NCT02006173|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-04-27||||||April 2016|2016-04-01||||July 2015|Actual|2015-07-01||Interventional|||Safety and Efficacy Study of Lidocaine Mixed Hyaluronate on Nasolabial Folds Correction|Safety and Efficacy Study of Hya-Dermis Mixed With Lidocaine Injection for the Improvement of Nasolabial Folds|Withdrawn||N/A|0|Actual|SciVision Biotech Inc.||2|||f||||f||||||||||2017-10-11 00:59:11.496248|2017-10-11 00:59:11.496248
NCT02006160|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-04-12|||December 2011||2011-12-01|January 2016|2016-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Dalfampridine on Cognition in Multiple Sclerosis|Effects of Dalfampridine on Cognition in Multiple Sclerosis|Completed||Phase 2/Phase 3|74|Actual|State University of New York at Buffalo||2|||f||||f||||||||||2017-10-11 00:59:11.576558|2017-10-11 00:59:11.576558
NCT02006147|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-04-11|||July 2014||2014-07-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase I/II Trial to Find Maximum Tolerated Dose (MTD) and Dose Limiting Toxicities (DLT) of TLC399 (ProDex) in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)|A Phase I/II Trial of TLC399 (ProDex) in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO): An Open-label, Sequential Dose Escalation Phase I Part to Determine Maximum Tolerated Dose (MTD) and Dose Limiting Toxicities (DLTs) Followed by a Single-masked, Randomized Part to Evaluate Efficacy and Tolerability|Recruiting||Phase 1/Phase 2|30|Anticipated|Taiwan Liposome Company||3|||f||||||||||||||2017-10-11 00:59:11.657048|2017-10-11 00:59:11.657048
NCT02006134|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-05-01|||January 2013||2013-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|PedVas||Pediatric Vasculitis Initiative|Chronic Childhood Vasculitis: Characterizing the Individual Rare Diseases to Improve Patient Outcomes|Recruiting||N/A|1600|Anticipated|University of British Columbia|||6||f||||f||||||Samples With DNA|"     Serum, plasma, biopsy tissue, urine, DNA   "|||2017-10-11 00:59:11.770221|2017-10-11 00:59:11.770221
NCT02006121|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-08-10|||December 2013||2013-12-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|June 2016|Actual|2016-06-01||Interventional|TOLEDO||Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease|Multicenter,Parallel-group,Double-blind,Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Apomorphine sc Infusion in Parkinson's Disease Patients With Motor Complications Not Well Controlled on Medical Treatment|Active, not recruiting||Phase 3|107|Actual|Britannia Pharmaceuticals Ltd.||2|||f||||f||||||||Yes||2017-10-11 00:59:13.769511|2017-10-11 00:59:13.769511
NCT02006108|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-05-23|2017-04-11||November 27, 2012|Actual|2012-11-27|April 2017|2017-04-01|April 11, 2017|Actual|2017-04-11|April 11, 2017|Actual|2017-04-11||Interventional|||Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance|Non-invasive MR Imaging Diagnosis of Transplant Rejection|Completed||N/A|21|Actual|Stanford University||1|||f||||f||||||||Undecided||2017-10-11 00:59:13.871404|2017-10-11 00:59:13.871404
NCT02006095|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-02-20|||November 2012||2012-11-01|February 2015|2015-02-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Neuroimaging Correlates of Memory Decline Following Carotid Interventions||Unknown status|Recruiting|N/A|100|Anticipated|Stanford University|||1||f||||t||||||||||2017-10-11 00:59:14.130179|2017-10-11 00:59:14.130179
NCT02006082|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2013-12-04|||April 2012||2012-04-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Readmissions to Hospital Among Patients With COPD After Telemedicine Video Consultation - a Pilot Project|Readmissions to Hospital and Patient Satisfaction Among Patients With Chronic Obstructive Pulmonary Disease After Telemedicine Video Consultation - a Pilot Project|Completed||N/A|99|Actual|Helse Stavanger HF|||1||f||||t||||||||||2017-10-11 00:59:14.243216|2017-10-11 00:59:14.243216
NCT02006043|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-07-01|||December 2013||2013-12-01|July 2015|2015-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)|A Phase II, Open, Single Arm Trial to Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Line Treatment in Advanced or Recurrent NSCLC With EGFR Wild Type and Without C-met Expression|Unknown status|Recruiting|Phase 2|54|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 00:59:16.674815|2017-10-11 00:59:16.674815
NCT02006030|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-08-17|||June 2014||2014-06-01|September 2016|2016-09-01|September 19, 2016|Actual|2016-09-19|September 19, 2016|Actual|2016-09-19||Interventional|TACE||Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma|Randomized, Open Label, Phase 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|40|Anticipated|Polaris Group||1|||f||||f||||||||||2017-10-11 00:59:16.775265|2017-10-11 00:59:16.775265
NCT02006017|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-08-31|||September 30, 2013||2013-09-30|August 2017|2017-08-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Interventional|||Do Clinicians Want Recommendations?|Do Clinicians Want Recommendations? A Randomized Trial Comparing Evidence Summaries With and Without Evidence Based Recommendations|Completed||N/A|467|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 00:59:16.868841|2017-10-11 00:59:16.868841
NCT02006004|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-10-13|||January 2012||2012-01-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Epidemiologic Registry PETHEMA LMA 2013|Epidemiologic Registry of Patients Diagnosed With Acute Myeloid Leukemia (PETHEMA LMA 2013)|Completed||N/A|1000|Actual|PETHEMA Foundation|||1||f||||f||||||||||2017-10-11 00:59:16.938128|2017-10-11 00:59:16.938128
NCT02005991|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-04-15|||November 2013||2013-11-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377|A Phase 1, Open-Label Study To Evaluate 5-HT2a Receptor Occupancy As Measured By Positron Emission Tomography (PET) With Ligand [11C]MDL100907 Following Single Oral Dose Administration Of PP-05212377 (SAM-760) In Healthy Subjects|Completed||Phase 1|4|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 00:59:17.004166|2017-10-11 00:59:17.004166
NCT02005978|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-09-17|||April 2013||2013-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Brain-gut Interaction in Irradiated Patients With Acromegaly|Incretin Effect and Gastrointestinally Mediated Glucose Disposal in Cranially Irradiated Patients With Acromegaly|Active, not recruiting||N/A|36|Anticipated|Rigshospitalet, Denmark|||3||f||||f||||||Samples Without DNA|"     Blood samples   "|No||2017-10-11 00:59:17.088216|2017-10-11 00:59:17.088216
NCT02005939|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-04|||April 2012||2012-04-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|POM-01Expl||Effect of Biophenol-rich Pomegranate Extract Intake on Blood Pressure, Hormones, Body Composition and Quality of Life in Healthy Volunteers.|Effect of Pomegranate Extract Intake on Anthropometric, Metabolic and Hormonal Parameters in Human Volunteers: a Double Blinded, Placebo Controlled, Randomised, Exploratory 4 Week Trial.|Completed||N/A|29|Actual|Queen Margaret University||2|||f||||t||||||||||2017-10-11 00:59:17.328725|2017-10-11 00:59:17.328725
NCT02005926|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-06-16|||May 2010||2010-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph Nodes|Phase II Trail of Removing Sonographic Abnormal Lymph Node in Sentinel Lymph Node Biopsy of Breast Cancer Patient|Completed||Phase 2|200|Anticipated|Peking University||1|||f||||f||||||||||2017-10-11 00:59:17.53799|2017-10-11 00:59:17.53799
NCT02005913|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-04|||January 2014||2014-01-01|December 2013|2013-12-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence|A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence|Not yet recruiting||N/A|600|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 00:59:17.633325|2017-10-11 00:59:17.633325
NCT02005900|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-12-04|||June 2011||2011-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.|Double-blind, Placebo-controlled, Randomized 48 Weeks of Duration Study. The Effect of the Administration of Docosahexaenoic Acid on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in Patients With HIV Infection Under High Activity Antiretroviral Treatment|Completed||Phase 3|66|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 00:59:17.729529|2017-10-11 00:59:17.729529
NCT02005887|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-05-29|||February 2014||2014-02-01|May 2017|2017-05-01|August 2022|Anticipated|2022-08-01|August 2017|Anticipated|2017-08-01||Interventional|TREND||TRial on the Endocrine Activity of Neoadjuvant Degarelix|A Randomized Phase II Trial Evaluating the Endocrine Activity and Efficacy of Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Receiving Letrozole for Primary Endocrine Responsive Breast Cancer|Active, not recruiting||Phase 2|51|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-10-11 00:59:17.84292|2017-10-11 00:59:17.84292
NCT02005874|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2013-12-06|||November 2013||2013-11-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||A Study To Investigate The Effects Of A Low Humidity Environment And Visual Tasking On Tear Film Protein Composition|A Study To Investigate The Effects Of A Low Humidity Environment And Visual Tasking On Tear Film Protein Composition|Completed||N/A|16|Actual|Inflamax Research Incorporated|||2||f||||f||||||Samples With DNA|"     Samples with DNA (Tears) - samples retained, with no intention for extraction of DNA but     rather protein and cytokine analysis will be conducted from the tear collection   "|||2017-10-11 00:59:17.982975|2017-10-11 00:59:17.982975
NCT02005861|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-08-21|||April 2013||2013-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|BMDC||"One-step Bone Marrow Mononuclear Cell Transplantation in Talar Osteochondral Lesions"|"One-step Bone Marrow Mononuclear Cell Transplantation in Talar Osteochondral Lesions"|Active, not recruiting||N/A|140|Anticipated|Istituto Ortopedico Rizzoli||1|||f||||t||||||||||2017-10-11 00:59:18.065728|2017-10-11 00:59:18.065728
NCT02005848|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-06-08|||April 2014||2014-04-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes|Phase II Study to Evaluate the Efficacy and Safety of Human, Alpha-1 Antitrypsin (AAT) [Glassia®] in the Treatment of New Onset Type-1 Diabetes|Active, not recruiting||Phase 2|71|Actual|Kamada, Ltd.||3|||f||||t||||||||||2017-10-11 00:59:18.151814|2017-10-11 00:59:18.151814
NCT02005835|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-04|||November 2013||2013-11-01|December 2013|2013-12-01|August 2016|Anticipated|2016-08-01|May 2015|Anticipated|2015-05-01||Interventional|PURE||Promoting Uptake and Retention of Option B+ in Malawi|Improving Uptake and Retention in PMTCT Services Through Novel Approaches in Family Supported Care and in Community Peer Outreach Support in Malawi|Unknown status|Recruiting|N/A|1050|Anticipated|Lighthouse Trust||3|||f||||f||||||||||2017-10-11 00:59:18.252366|2017-10-11 00:59:18.252366
NCT02005822|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-06-17|||October 2013||2013-10-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|CONCERT 2||Congenital Cytomegalovirus: Efficacy of Antiviral Treatment|The Leiden CONCERT Study 2.0 Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Non-Randomized Trial With Historical Control Group|Unknown status|Recruiting|Phase 3|40|Anticipated|Leiden University Medical Center||2|||f||||t||||||||||2017-10-11 00:59:18.370803|2017-10-11 00:59:18.370803
NCT02005809|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-04|||March 2013||2013-03-01|December 2013|2013-12-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|SLEGD||Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm|Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm|Unknown status|Recruiting|Phase 3|268|Anticipated|Kosin University Gospel Hospital||2|||f||||t||||||||||2017-10-11 00:59:18.508387|2017-10-11 00:59:18.508387
NCT02005796|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-05-19|||December 2013||2013-12-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Bioavailability of Anthocyanins of Blue Potatoes as Compared With Bilberries|Bioavailability of Anthocyanins of Blue Potatoes as Compared With Bilberries|Completed||N/A|14|Actual|University of Turku||3|||f||||f||||||||||2017-10-11 00:59:18.609549|2017-10-11 00:59:18.609549
NCT02005783|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-12-29|||October 2013||2013-10-01|May 2015|2015-05-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|DIPE||Study of Danggui Buxue Decoction in Preventing Neutropenia|Adjuvant Treatment of EC/TC Versus EC/TC Plus Danggui Buxue Decoction in Breast Cancer：A Prospective, Randomized Trial|Completed||Phase 2|50|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 00:59:18.687521|2017-10-11 00:59:18.687521
NCT02005770|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-06-17|||March 2014||2014-03-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Anesthesia and Circulating Tumor Cells in Breast Cancer|Does Anesthesia Technique Affect the Presence of Circulating Tumor Cells in Primary Breast Carcinoma? A Randomised Controlled Trial.|Recruiting||Phase 4|231|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 00:59:18.812151|2017-10-11 00:59:18.812151
NCT02005757|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-06-24|||November 2013||2013-11-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|AMOLED||Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)|Open Label, Multicenter, Randomized Study to Assess the Efficacy and Safety of Mizoribine in Active Rheumatoid Arthritis Patients Unsuccessfully Treated With Disease-modifying Antirheumatic Drug|Unknown status|Recruiting|Phase 2|60|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||t||||||||||2017-10-11 00:59:18.938095|2017-10-11 00:59:18.938095
NCT02005744|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-07-01|||March 2014||2014-03-01|May 2014|2014-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function|A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function Compared With Normal Hepatic Function|Completed||Phase 1|26|Actual|Chong Kun Dang Pharmaceutical||4|||f||||t||||||||||2017-10-11 00:59:19.085485|2017-10-11 00:59:19.085485
NCT02005731|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-06-10|||November 2012||2012-11-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|LISW||Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction|A Prospective Multicenter Pilot Study to Assess the Safety and Efficacy of Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' in Patients With Erectile Dysfunction|Completed||N/A|58|Actual|Initia|||1||f||||f||||||||||2017-10-11 00:59:19.173552|2017-10-11 00:59:19.173552
NCT02005705|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-07-12|||December 2013||2013-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.|Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.|Terminated||N/A|17|Actual|Yale University||2||Inadequate recruitment|f||||f||||||||||2017-10-11 00:59:19.339179|2017-10-11 00:59:19.339179
NCT02005692|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-08-10|2014-07-19||December 2013||2013-12-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||All subjects who successfully completed the study.|A Pilot Study to Assess the DynaSense System|A Pilot Study to Assess the DynaSense System|Completed||N/A|70|Actual|Leaf Healthcare, Inc.||1|||f||||f||||||||||2017-10-11 00:59:19.438675|2017-10-11 00:59:19.438675
NCT02005679|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-09-19|||June 2011||2011-06-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|MMS-LS||Mini-Mental State (MMS-LS) and Sign Language|Transposition of the Mini-Mental State in Sign Language|Recruiting||N/A|185|Anticipated|Lille Catholic University||1|||f||||f||||||||||2017-10-11 00:59:19.672954|2017-10-11 00:59:19.672954
NCT02005666|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-02-01|||November 2013||2013-11-01|February 2017|2017-02-01|September 28, 2016|Actual|2016-09-28|September 28, 2016|Actual|2016-09-28||Interventional|||To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel|A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris|Completed||Phase 3|850|Actual|Cadila Healthcare Limited||3|||f||||t||||||||||2017-10-11 00:59:19.914724|2017-10-11 00:59:19.914724
NCT02005653|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-06|||February 2009||2009-02-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|September 2011|Actual|2011-09-01||Interventional|||Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection|Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection: Double Blind Randomised Clinical Trial (RCT) to Study the Efficacy of Different Co-administration and Sequential Administration|Completed||Phase 4|146|Actual|Indian Council of Medical Research||4|||f||||t||||||||||2017-10-11 00:59:20.1481|2017-10-11 00:59:20.1481
NCT02005640|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-03-18|||December 2011||2011-12-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Transcatheter Heart Valve (THV) Sizing and Leakage After Transcatheter Aortic Valve Implantation (TAVI) Before and After Establishing Routine Preprocedure Multi Slice Computerized Tomography (MSCT) Aortic Assessment. A Retrospective Registry Study|Transcatheter Heart Valve (THV) Sizing and Leakage After Transcatheter Aortic Valve Implantation (TAVI) Before and After Establishing Routine Preprocedure Multi Slice Computerized Tomography (MSCT) Aortic Assessment. A Retrospective Registry Study|Completed||N/A|150|Actual|Aarhus University Hospital Skejby|||2||f||||f||||||||||2017-10-11 00:59:20.254766|2017-10-11 00:59:20.254766
NCT02005627|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-09-27|||December 2013||2013-12-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|April 2015|Actual|2015-04-01||Interventional|Pollen+||Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study|Randomised Placebo-controlled Study of Grass Pollen Allergen Immunotherapy Tablet (AIT) for Seasonal Rhinitis: Time Course of Nasal, Cutaneous and Immunological Outcomes|Unknown status|Active, not recruiting|Phase 2|46|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 00:59:20.332863|2017-10-11 00:59:20.332863
NCT02005614|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-04-24|||November 2013||2013-11-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection|A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection|Active, not recruiting||N/A|39|Actual|Yale University||1|||f||||t||||||||||2017-10-11 00:59:20.459522|2017-10-11 00:59:20.459522
NCT02005601|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-07-27|2017-03-15||November 2013||2013-11-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?|Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?|Completed||Phase 4|106|Actual|Hospital for Special Surgery, New York||2|||f||||||||||||||2017-10-11 00:59:20.57641|2017-10-11 00:59:20.57641
NCT02005588|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-07-27|||December 2013||2013-12-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Treatment of Iron Deficiency Anemia With Pregnancy|Comparison Between Aminoacid Chelated Iron and Iron Salt in Treatment of Iron Deficiency Anemia With Pregnancy|Completed||Early Phase 1|150|Actual|Cairo University||2|||f||||f||||||||||2017-10-11 00:59:21.133255|2017-10-11 00:59:21.133255
NCT02005562|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2015-10-12|2014-06-12||May 2006||2006-05-01|October 2015|2015-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||Intent-to-treat (ITT) population, all randomized renal transplant recipients who received at least 1 dose of MMF.|OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.|A Randomized Study Comparing the Incidence of Acute Clinical or Subclinical Rejection With Two Dosing Regimens of CellCept in de Novo Renal Transplant Recipients Receiving Induction, Cyclosporine and Brief Steroid Therapy|Completed||Phase 3|252|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:59:21.379948|2017-10-11 00:59:21.379948
NCT02005549|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-06-30|2014-05-07||February 2006||2006-02-01|May 2014|2014-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||Intent-to-treat (ITT) population. All participants who received at least one dose of study drug.|A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer|A Phase II Study of Bevacizumab With Docetaxel and Capecitabine in the Neoadjuvant Setting for Breast Cancer Patients|Completed||Phase 2|18|Actual|Hoffmann-La Roche|Nonserious adverse events presented in this record include all adverse events reported during the study, not just nonserious events.|1|||f||||||||||||||2017-10-11 00:59:22.784226|2017-10-11 00:59:22.784226
NCT02005536|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-03-27|2015-03-17||December 2013||2013-12-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan|Immunogenicity and Safety of IMOVAX POLIO® Subcutaneous as a Booster Given in Pre-school Age Children in Japan|Completed||Phase 4|60|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 00:59:23.242708|2017-10-11 00:59:23.242708
NCT02005523|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-02-04||||||February 2015|2015-02-01||||October 2014|Actual|2014-10-01||Interventional|||Study of RNS60 on Pain and Function After Hip Labral Repair|Study of RNS60 on Post-operative Pain and Function in Patients Undergoing Hip Labral Repair or Reconstruction Surgery|Withdrawn||Phase 2|0|Actual|Revalesio Corporation||2|||f||||||||||||||2017-10-11 00:59:23.625015|2017-10-11 00:59:23.625015
NCT02005510|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-02-21|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women|Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women|Enrolling by invitation||N/A|17600|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 00:59:23.714379|2017-10-11 00:59:23.714379
NCT02005497|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-05-02|||December 2013||2013-12-01|May 2017|2017-05-01|April 30, 2018|Anticipated|2018-04-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Increasing Implementation of Evidence-based Interventions at Low-wage Worksites|Increasing Implementation of Evidence-based Interventions at Low-wage Worksites|Active, not recruiting||N/A|75|Anticipated|University of Washington||3|||f||||f||||||||||2017-10-11 00:59:23.824266|2017-10-11 00:59:23.824266
NCT02005484|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2014-07-23|2014-06-09||January 2004||2004-01-01|July 2014|2014-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||Intent-to-treat (ITT) population: all participants who signed informed consent for the study.|A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression|An Open-label Pilot Study of Herceptin Monotherapy on Objective Treatment Response in Patients With Metastatic or Locally Advanced Gastric Cancer Who Had Disease Progression During Platinum-based or 5-fluoropyrimidine-based Chemotherapy|Terminated||Phase 2|6|Actual|Hoffmann-La Roche|Due to slow patient recruitment, the study was prematurely terminated.|1||Study terminated due to slow patient recruitment.|f||||||||||||||2017-10-11 00:59:23.94426|2017-10-11 00:59:23.94426
NCT02005471|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2017-09-25|||March 17, 2014|Actual|2014-03-17|September 2017|2017-09-01|September 21, 2018|Anticipated|2018-09-21|May 8, 2017|Actual|2017-05-08||Interventional|||A Study of Venetoclax in Combination With Rituximab Compared With Bendamustine in Combination With Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia|A Multicenter, Phase III, Open-Label, Randomized Study in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia to Evaluate the Benefit of GDC-0199 (ABT-199) Plus Rituximab Compared With Bendamustine Plus Rituximab|Active, not recruiting||Phase 3|389|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-11 00:59:24.347372|2017-10-11 00:59:24.347372
NCT02005458|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-03-28|||December 2013|Actual|2013-12-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|March 2017|Actual|2017-03-01||Interventional|||Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy|Multi-center, Randomized, Open-labeled, Positive-controlled, Phase Ⅱ Study to Evaluate Efficacy and Safety of YPEG-rhG-CSF, Once-per-cycle, Comparing to PEG-rhG-CSF, Once-per-cycle, in Chemotherapy-induced Neutropenia of Patients With Malignancies Receiving Myelosuppressive Chemotherapy.|Active, not recruiting||Phase 2|80|Actual|Xiamen Amoytop Biotech Co., Ltd.||4|||f||||f||||||||||2017-10-11 00:59:24.800104|2017-10-11 00:59:24.800104
NCT02005445|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-09-21|||October 1, 2014|Actual|2014-10-01|September 2017|2017-09-01|March 30, 2018|Anticipated|2018-03-30|December 29, 2017|Anticipated|2017-12-29||Interventional|||Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation|Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation|Recruiting||N/A|50|Anticipated|VA Office of Research and Development||2|||f||||f|f|t|f|f|f|||||2017-10-11 00:59:24.948374|2017-10-11 00:59:24.948374
NCT02005432|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2013-12-06|||February 2012||2012-02-01|December 2013|2013-12-01||||November 2014|Anticipated|2014-11-01||Interventional|||PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy|Three Arm, Prospective, Single-blind, Randomized Study Comparing Ranibizumab Plus Green Diode Laser Versus Ranibizumab Plus Pattern Scan Laser (Pascal) Versus Ranibizumab (Monotherapy) for Proliferative Diabetic Retinopathy.|Unknown status|Active, not recruiting|Phase 4|31|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 00:59:25.07727|2017-10-11 00:59:25.07727
NCT02005419|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2016-08-10|||December 2013||2013-12-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection|A Phase II, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of the Combination of Gemcitabine and Metformin in Treating Patients With Pancreatic Cancer After Curative Resection|Recruiting||Phase 2|300|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 00:59:25.218709|2017-10-11 00:59:25.218709
NCT02005406|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-12-21|||June 2012||2012-06-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01|1 Year|Observational [Patient Registry]|WNJ||Testing the Efficacy and Safety of the WEI Nasal Jet|Efficacy and Safety of the WEI Nasal Jet|Completed||N/A|49|Actual|Fudan University|||1||f||||t||||||Samples Without DNA|"     •Patients receiving various types of surgeries under sedation, especially for procedures of     colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde cholangiopancreatography     (ERCP) cystoscopy and other brief surgeries you are interested in the study.   "|||2017-10-11 00:59:25.372654|2017-10-11 00:59:25.372654
NCT02005393|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-02-08|2015-08-17||October 2013||2013-10-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|FICE||Study Comparing Flexible Spectral-Imaging Color Enhancement (FICE) With Olympus Narrow Band Imaging (NBI)|A Concurrence Study of Diagnostic Visualization Comparing Flexible Spectral-Imaging Color Enhancement (FICE) With Olympus Narrow Band Imaging (NBI)|Completed||N/A|20|Actual|Fujifilm Medical Systems USA, Inc.||1|||f||||f||||||||||2017-10-11 00:59:25.471151|2017-10-11 00:59:25.471151
NCT02005380|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2013-12-06|||November 2013||2013-11-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation|Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation|Completed||N/A|20|Actual|German-Jordanian University|||2||f||||f||||||||||2017-10-11 00:59:25.752838|2017-10-11 00:59:25.752838
NCT02005367|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-04|||June 2011||2011-06-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Novel Person-Centered Treatment Component for Substance Use Treatment|Outcome of a Novel Person-Centered Treatment Component for Substance Use Treatment|Completed||N/A|643|Actual|Hampton VA Medical Center||3|||f||||t||||||||||2017-10-11 00:59:25.845228|2017-10-11 00:59:25.845228
NCT02005341|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-01-02|||October 2011||2011-10-01|January 2017|2017-01-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||NanOss Bioactive With Autograft and Bone Marrow Aspirate in the Posterolateral Spine|A Prospective, Nonrandomized Study to Assess Lumbar Fusion With Instrumented Posterolateral Gutter Fusions Using NanOss Bioactive|Withdrawn||N/A|0|Actual|Pioneer Surgical Technology, Inc.||2||A change in research priorities after a merger|f||||f||||||||No||2017-10-11 00:59:26.130276|2017-10-11 00:59:26.130276
NCT02005328|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-04-14|||December 2013||2013-12-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia|Study of the Effect and Safety of Three New Oral Sprays and a Reference Marketed Oral Spray in the Relief of Drug-induced Xerostomia Associated With Hyposialia.|Completed||N/A|40|Actual|Pierre Fabre Medicament||1|||f||||||||||||||2017-10-11 00:59:26.203254|2017-10-11 00:59:26.203254
NCT02005315|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-04-13|||September 2013||2013-09-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer|A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer|Active, not recruiting||Phase 1|30|Actual|OncoMed Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 00:59:26.29613|2017-10-11 00:59:26.29613
NCT02005302|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-04|||January 2013||2013-01-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition|Study of Vitamin D2 Virus 1,25(OH)2-Vitamin D3 and Normal Protein Diet Virus Low Protein Diet in the Treatment of CKD-MBD and Malnutrition for Progressive CKD Patients|Unknown status|Enrolling by invitation|Phase 4|600|Anticipated|Beijing Friendship Hospital||4|||f||||t||||||||||2017-10-11 00:59:26.40117|2017-10-11 00:59:26.40117
NCT02005289|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-10-04|||December 23, 2013|Actual|2013-12-23|October 2017|2017-10-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL|A Phase II Study of MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)/Prolymphocytic Leukemia (PLL), Including Those Who Have Relapsed on Ibrutinib, or Patients With Untreated CLL/SLL/PLL and an Open Pilot Study for Patients With Richters Transformation (RT)|Recruiting||Phase 2|40|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-11 00:59:26.601632|2017-10-11 00:59:26.601632
NCT02005276|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-03-10|||February 2014||2014-02-01|November 2013|2013-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Way to Be Active 2 (Lotteries)|A Randomized Trial of Behavioral Economic Interventions to Improve Physical Activities: Lottery Incentives|Completed||N/A|209|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 00:59:26.799886|2017-10-11 00:59:26.799886
NCT02005263|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-09-18|||December 2013||2013-12-01|September 2017|2017-09-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Hysteroscopic Assessment of Fallopian Tubal Patency|Hysteroscopic Assessment of Fallopian Tubal Patency|Recruiting||N/A|1000|Anticipated|University of Mississippi Medical Center||1|||f||||f||||||||||2017-10-11 00:59:26.947496|2017-10-11 00:59:26.947496
NCT02005250|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-06-06|||February 2012||2012-02-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|March 2019|Anticipated|2019-03-01||Observational|||Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism|Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism|Recruiting||N/A|300|Anticipated|Odense University Hospital|||10||f||||f||||||Samples Without DNA|"     blood, urine   "|No||2017-10-11 00:59:27.085922|2017-10-11 00:59:27.085922
NCT02005237|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-06-23|||December 2013||2013-12-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|AERCONN||Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain Connectivity|Randomized Controlled Trial Investigating the Effects of a Standardized Aerobic Exercise Intervention on Cognitive Function and Brain Connectivity in Relapsing-remitting Multiple Sclerosis|Completed||N/A|68|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-11 00:59:27.231988|2017-10-11 00:59:27.231988
NCT02005224|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2013-12-06|||August 2012||2012-08-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|LCHF||Effect of Low-carbohydrate/High-fat Diet on Glucose Tolerance and Lipid Profile in Lean, Healthy Women|Effect of Low-carbohydrate/High-fat Diet on Glucose Tolerance and Lipid Profile in Lean, Healthy Women|Completed||N/A|17|Actual|Atlantis Medical University College||1|||f||||t||||||||||2017-10-11 00:59:27.360582|2017-10-11 00:59:27.360582
NCT02005211|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-04|2016-09-16|2015-10-13||December 2013||2013-12-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Part 1 - Single Ascending Dose - healthy adults, Part 2 - Multiple Ascending Doses - healthy elderly|A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Healthy Japanese Male and Non-Fertile Female Volunteers Including Elderly|Completed||Phase 1|114|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 00:59:27.469339|2017-10-11 00:59:27.469339
NCT02005198|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-01-04|||March 2014||2014-03-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)|Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)|Completed||N/A|98|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 00:59:28.408725|2017-10-11 00:59:28.408725
NCT02005185|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-06-09|||November 2013||2013-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Human Subject Study on the Cognitive Effects of Anesthesia on Children Anesthetized Prior to 5 Years Old|Is Pediatric Anesthesia Associated With Long-term Hippocampal Dysfunction?|Recruiting||N/A|300|Anticipated|University of California, San Francisco|||4||f||||f||||||||||2017-10-11 00:59:28.495159|2017-10-11 00:59:28.495159
NCT02005172|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-11-30|||November 2013||2013-11-01|November 2015|2015-11-01|May 2016|Anticipated|2016-05-01|March 2016|Anticipated|2016-03-01||Interventional|||Validation of an iPhone-based Event Recorder for Arrhythmia Detection|Validation of an iPhone-based Event Recorder for Arrhythmia Detection|Recruiting||N/A|40|Anticipated|University at Buffalo||1|||f||||f||||||||||2017-10-11 00:59:28.591391|2017-10-11 00:59:28.591391
NCT02005159|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-08-04|||March 2011||2011-03-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|BACTERIEMIA||Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae|Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST and Pharmacokinetic/Pharmacodynamic) in Prognosis of Bacteremia by Enterobacteriaceae|Completed||N/A|1064|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:59:28.688942|2017-10-11 00:59:28.688942
NCT02005146|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-04-30|||December 2013||2013-12-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs|Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs|Completed||N/A|86|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||||||2017-10-11 00:59:28.821454|2017-10-11 00:59:28.821454
NCT02005133|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-02-27|||November 2013||2013-11-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics|A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics|Terminated||N/A|188|Actual|Novartis|||2||f||||f||||||||||2017-10-11 00:59:28.977906|2017-10-11 00:59:28.977906
NCT02005120|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2013-12-19|||December 2013||2013-12-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC|Phase II Study of Intrapleural Administration of Bevacizumab Versus Recombinant Human Endostatin (Endostar) for Refractory Malignant Pleural Effusions in Advanced Non-small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|20|Anticipated|Zhejiang University||2|||f||||f||||||||||2017-10-11 00:59:29.117088|2017-10-11 00:59:29.117088
NCT02005107|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-04-04|||December 2013||2013-12-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|VLX||Venlafaxine PK Following Bariatric Surgery|A Comparison of Immediate and Extended Release Venlafaxine Following Bariatric Surgery|Completed||Phase 4|12|Actual|North Dakota State University||2|||f||||f||||||||||2017-10-11 00:59:29.230681|2017-10-11 00:59:29.230681
NCT02005094|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-06-27|||November 2013||2013-11-01|June 2014|2014-06-01||||August 2015|Anticipated|2015-08-01||Observational|||The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung Disease|The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung Disease|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-11 00:59:29.32051|2017-10-11 00:59:29.32051
NCT02005081|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-12-03|||October 2013||2013-10-01|December 2013|2013-12-01||||October 2017|Anticipated|2017-10-01||Interventional|||Baxter: Actifuse SHAPE vs DBX in ACC|A Prospective Study Using Actifuse SHAPE Versus Autograft With Demineralized Bone Matrix to Achieve Bone Fusion in Anterior Cervical Corpectomy (ACC)|Unknown status|Recruiting|N/A|40|Anticipated|Wayne State University||2|||f||||t||||||||||2017-10-11 00:59:29.413768|2017-10-11 00:59:29.413768
NCT02005068|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-08-06|||April 2013||2013-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Ceftaroline in the Treatment of Bone and Joint Infections|Ceftaroline in the Treatment of Bone and Joint Infections|Withdrawn||Phase 4|0|Actual|Orlando Health, Inc.||3||Failed to enroll any patients despite study modifications|f||||f||||||||||2017-10-11 00:59:29.517324|2017-10-11 00:59:29.517324
NCT02005055|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-03|||January 2003||2003-01-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|||High Dose Rate Brachytherapy for Treatment of Keloids|Prospective Evaluation of the Use of High-dose-rate Brachytherapy for the Treatment of Recalcitrant Keloids|Completed||N/A|43|Actual|VU University Medical Center|||1||f||||f||||||||||2017-10-11 00:59:29.62732|2017-10-11 00:59:29.62732
NCT02005042|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-05-02|||November 2013||2013-11-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Physical Activity and Daily Experiences Study|Developing a Real-time, Ecologically Sensitive Physical Activity Intervention Using Smartphones and Bluetooth-enabled Pedometers: Feasibility and Initial Efficacy|Unknown status|Active, not recruiting|N/A|37|Actual|Penn State University||3|||f||||f||||||||||2017-10-11 00:59:29.711839|2017-10-11 00:59:29.711839
NCT02005029|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-12-15|2016-10-03||April 2013||2013-04-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Erythromycin in Parkinson's Disease|Erythromycin in Parkinson's Disease: A Pilot Study of Its Effects on Levodopa Pharmacokinetics and Pharmacodynamics|Completed||N/A|18|Actual|Virginia Commonwealth University|An overall limitation was the small sample size.|2|||f||||t||||||||||2017-10-11 00:59:29.813761|2017-10-11 00:59:29.813761
NCT02005016|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-08-07|||October 1, 2013|Actual|2013-10-01|August 2017|2017-08-01|September 30, 2018|Anticipated|2018-09-30|September 1, 2018|Anticipated|2018-09-01||Interventional|||Dosage and Predictors of Naming Treatment Response in Aphasia|Dosage and Predictors of Naming Treatment Response in Aphasia|Recruiting||Phase 1/Phase 2|60|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-11 00:59:30.534642|2017-10-11 00:59:30.534642
NCT02005003|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-11-17|||November 2013||2013-11-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Cognitive and Metabolic Effects of a Probiotic Supplement|Placebo-controlled Randomized Trial of Cognitive and Metabolic Effects of a Probiotic Supplement|Unknown status|Recruiting|N/A|20|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-11 00:59:30.776773|2017-10-11 00:59:30.776773
NCT02004990|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-01-27|2016-05-17||January 2014||2014-01-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Dental Office Prevention Strategies for Children|Dental Office Prevention Strategies for Children: 10% Povidone Iodine (PI) Cleansing Prior to Fluoride Varnish (FV) Application|Completed||N/A|12|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-11 00:59:30.948226|2017-10-11 00:59:30.948226
NCT02004977|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-07-14|||February 2013||2013-02-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|breakFAST!||Improving High School Breakfast Environments|Improving High School Breakfast Environments|Active, not recruiting||N/A|800|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 00:59:31.158569|2017-10-11 00:59:31.158569
NCT02004951|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-06-07|||March 2014|Actual|2014-03-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|BATTLE||BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions|BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions|Active, not recruiting||N/A|186|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 00:59:31.423222|2017-10-11 00:59:31.423222
NCT02004938|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-05-01|||January 2014||2014-01-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Observational|||Internal Jugular Ultrasound Measures During Respiration in Children|Characteristics of the Internal Jugular Vein by Ultrasonography During Respiration in Children|Completed||N/A|40|Actual|University of Louisville|||1||f||||f||||||||||2017-10-11 00:59:31.567912|2017-10-11 00:59:31.567912
NCT02004925|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-04-22|||January 2014||2014-01-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Accuracy of Ultrasonography for the Diagnosis of Pneumoperitoneum in the Emergency Department|Accuracy of Ultrasonography for the Diagnosis of Pneumoperitoneum in the Emergency Department|Completed||N/A|20|Actual|Azienda Ospedaliero-Universitaria Careggi|||2||f||||f||||||||||2017-10-11 00:59:31.64157|2017-10-11 00:59:31.64157
NCT02004912|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-11-25|||September 2012||2012-09-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evaluation of an MNCH Mentoring Intervention in Karnataka|Monitoring and Evaluation of an MNCH Mentoring Intervention in Two Districts of Karnataka|Completed||N/A|295|Actual|Karnataka Health Promotion Trust||2|||f||||f||||||||Yes|Peer-reviewed publications and end-of-project workshop held in February 2016|2017-10-11 00:59:31.721943|2017-10-11 00:59:31.721943
NCT02004899|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-05-10|||December 2013||2013-12-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||Trial of Onset of Epidural Pain Relief With Low Dose Bupivacaine and Different Doses of Fentanyl in Laboring Women|Onset of Labor Epidural Analgesia With Low Dose Bupivacaine and Different Doses of Fentanyl: a Randomized Double Blinded Clinical Trial.|Completed||Phase 3|105|Actual|Lawson Health Research Institute||3|||f||||f||||||||No|IPD will not be available|2017-10-11 00:59:31.810789|2017-10-11 00:59:31.810789
NCT02004886|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-04-06|2014-01-31||August 11, 2006|Actual|2006-08-11|April 2017|2017-04-01|February 7, 2007|Actual|2007-02-07|February 7, 2007|Actual|2007-02-07||Interventional|||A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)|A Multi-Center, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Panel Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|74|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-10-11 00:59:31.92494|2017-10-11 00:59:31.92494
NCT02004873|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-11-08|2016-05-16||November 2013||2013-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2015|Actual|2015-05-01||Interventional||All subjects enrolled in the study|Micra Transcatheter Pacing Study|Micra Transcatheter Pacing Study|Active, not recruiting||Phase 3|744|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||t||||||||||2017-10-11 00:59:32.929503|2017-10-11 00:59:32.929503
NCT02004860|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-12-06|||January 2014||2014-01-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|Disease||Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis|Phase 3 : Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis on Adult Face|Recruiting||Phase 3|240|Anticipated|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 00:59:33.807553|2017-10-11 00:59:33.807553
NCT02004847|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-11-17|2015-08-12||September 2013||2013-09-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Full Aanalysis Set (FAS)|Blue Light for Treating Psoriasis Vulgaris|Monocenter, Randomized, Double Blinded, Intraindividual, Exploratory Study of Effectiveness and Safety of 3 Months Treatment With 2 Peak Intensities of 453nm Blue Light for the Treatment of Mild Plaque Type Psoriasis Vulgaris|Completed||N/A|47|Actual|Philips Light and Health||2|||f||||f||||||||||2017-10-11 00:59:33.931582|2017-10-11 00:59:33.931582
NCT02004834|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-01-20|||August 2013||2013-08-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine|A Combination of Levobupivacaine and Lidocaine for Paravertebral Block in Breast Cancer Patients Undergoing Quadrantectomy Causes Greater Hemodynamic Oscillations Than Levobupivacaine Alone|Active, not recruiting||Phase 4|80|Anticipated|University Hospital Dubrava||2|||f||||f||||||||||2017-10-11 00:59:34.726113|2017-10-11 00:59:34.726113
NCT02004821|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-09-27|||December 2013||2013-12-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Clinical Trial in Constitutional Thinness|Génomique de la résistance à la Prise de Poids Dans la Maigreur Constitutionnelle|Completed||N/A|60|Actual|Nestlé||1|||f||||f||||||||||2017-10-11 00:59:34.828811|2017-10-11 00:59:34.828811
NCT02004808|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-12-03|||February 2014||2014-02-01|July 2012|2012-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Neutrophil Extracellular Traps and Sickle Cell Disease||Not yet recruiting||N/A|15|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"     10CC of peripheral venous blood will be collected from each patient at several time points:     at diagnosis ,during pain crisis , at Hydroxyurea treatment.   "|||2017-10-11 00:59:34.898069|2017-10-11 00:59:34.898069
NCT02004795|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-12-03|||November 2013||2013-11-01|November 2013|2013-11-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01||Interventional|||BNCT and IG-IMRT for Recurrent Head and Neck Cancer|A Phase I/II Trial of Boron Neutron Capture Therapy (BNCT) Combined With Image-guided Intensity Modulated Radiotherapy (IG-IMRT) for Locally Recurrent Head and Neck Cancer|Recruiting||Phase 1/Phase 2|28|Anticipated|Taipei Veterans General Hospital, Taiwan||1|||f||||t||||||||||2017-10-11 00:59:34.973225|2017-10-11 00:59:34.973225
NCT02004782|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-01-13|||June 2014||2014-06-01|January 2015|2015-01-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|BERST||Barretts oEsophageal Resection With Steroid Therapy Trial|Reduction in Symptomatic Oesophageal Stricture Formation Post-two Stage Complete Barrett's Excision for High Grade Dysplasia or Early Adenocarcinoma With Short-term Steroid Therapy: A Randomized, Doubleblind, Placebo-controlled, Multicentre Trial.|Recruiting||Phase 4|126|Anticipated|Western Sydney Local Health District||2|||f||||t||||||||||2017-10-11 00:59:35.06109|2017-10-11 00:59:35.06109
NCT02004769|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-11-17|||November 2013||2013-11-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer|Phase II Study of Trastuzumab in Combination With Chemotherapy (Docetaxel Plus Capecitabine) For First Line Treatment of Her2-Positive Advanced Gastric or Gastro-Esophageal Junction Cancer|Completed||Phase 2|67|Actual|Sun Yat-sen University||1|||f||||t||||||||Yes||2017-10-11 00:59:35.137385|2017-10-11 00:59:35.137385
NCT02004756|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2016-01-29|||January 2010||2010-01-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Mechanisms of Dysfunction and the Influence of Exercise on Cardiac and Musculoskeletal Function|Mechanisms of Dysfunction and the Influence of Exercise on Cardiac and Musculoskeletal Function in Children After the Fontan Procedure|Terminated||Phase 1/Phase 2|10|Actual|The Hospital for Sick Children||2||Feasibility issues|f||||f||||||||||2017-10-11 00:59:35.230394|2017-10-11 00:59:35.230394
NCT02004743|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-08-09|||January 2013||2013-01-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Early Prevention of Post Traumatic Stress Disorder|Program Development in Guideline Development, Early Recognition and Specialized Treatment of Post Traumatic Stress Disorder (PTSD) at Sunnybrook Health Sciences Center, Canada's Largest Trauma Center|Completed||N/A|99|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||Undecided||2017-10-11 00:59:35.310867|2017-10-11 00:59:35.310867
NCT02004730|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-11-18|||December 2013||2013-12-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears|Italian Diffuse/Multivessel Disease ABSORB Prospective Registry Under the Auspices of Società Italiana di Cardiologia Invasive-GISE (IT-DISAPPEARS)|Unknown status|Recruiting|Phase 4|1000|Anticipated|Istituto Clinico Sant'Ambrogio||3|||f||||t||||||||||2017-10-11 00:59:35.42038|2017-10-11 00:59:35.42038
NCT02004717|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-04-10|||October 2013|Actual|2013-10-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors|Phase 1, Open-label Study to Assess the Safety, Tolerability, and Pharmacokinetics of DS-8895a in Subjects With Advanced Solid Tumors|Completed||Phase 1|37|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-11 00:59:35.609754|2017-10-11 00:59:35.609754
NCT02004704|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-06-01|||December 2013||2013-12-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency|A Long-Term Study to Assess the Ongoing Safety and Efficacy of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency|Enrolling by invitation||Phase 2|17|Anticipated|Sanofi||1|||f||||t||||||||||2017-10-11 00:59:35.697057|2017-10-11 00:59:35.697057
NCT02004678|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-12-04|||September 2013||2013-09-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus|Phase I, Single-Blind, Placebo-Controlled, Randomized, Two-Part, Sequential, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus|Completed||Phase 1|40|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 00:59:36.110973|2017-10-11 00:59:36.110973
NCT02004665|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2013-12-04|||December 2013||2013-12-01|December 2013|2013-12-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01|12 Months|Observational [Patient Registry]|||Incidence and Prognostic Value of DELIRIUM in Patients With Acute CORonary synDrome: an observatIonal Study|Incidence and Prognostic Value of DELIRIUM in Patients With Acute CORonary synDrome: an observatIonal Study by the DELIRIUM-CORDIS Investigators.|Unknown status|Recruiting|N/A|400|Anticipated|Ospedale San Donato|||1||f||||f||||||||||2017-10-11 00:59:36.25976|2017-10-11 00:59:36.25976
NCT02004652|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-09-29|||November 2013||2013-11-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery|A Randomized, Controlled, Double-blind Efficacy and Tolerability Study Of Prucalopride For The Treatment Of Postoperative Ileus In Patients Undergoing Gastrointestinal Surgery|Completed||Phase 2|110|Actual|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 00:59:36.368989|2017-10-11 00:59:36.368989
NCT02004639|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2013-12-04|||March 2013||2013-03-01|December 2013|2013-12-01||||March 2014|Anticipated|2014-03-01||Interventional|||Trismus Prevention, Diagnosis and Management: Radiotherapy Planning, Early Detection, and Physical Therapy Intervention|Taiwan: Institutional Review Board|Unknown status|Active, not recruiting|N/A|60|Anticipated|Far Eastern Memorial Hospital||4|||f||||||||||||||2017-10-11 00:59:36.492329|2017-10-11 00:59:36.492329
NCT02004626|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-07-15|||January 2015||2015-01-01|July 2015|2015-07-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.|Study Phase III, Randomized, Double-blind, Multicenter, National, to Evaluate the Non-inferiority in Efficacy of Investigational Product Regarding the Comparator Product, in Debridement of Devitalized Tissue in Uninfected Pressure Ulcers.|Withdrawn||Phase 3|0|Actual|Cristália Produtos Químicos Farmacêuticos Ltda.||2|||f||||f||||||||||2017-10-11 00:59:36.585332|2017-10-11 00:59:36.585332
NCT02004613|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-02-03|||June 2013||2013-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DexCardiac||Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery|Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery|Recruiting||Phase 4|965|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-11 00:59:36.696825|2017-10-11 00:59:36.696825
NCT02004600|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-09-29|||December 2013||2013-12-01|September 2015|2015-09-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB|Bicentric, Open and Pilot Study Evaluating the Efficiency and the Tolerance of the Photodynamic Therapy in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary Dystrophic Epidermolysis Bullosa|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nice||1||health statement of pre-screenined patients were too bad for being enrolled in the study|f||||f||||||||||2017-10-11 00:59:36.808111|2017-10-11 00:59:36.808111
NCT02004587|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-07-10|||September 2013||2013-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers|A Single-center, Open-label Trial, Investigating the Pharmacokinetics, Pharmacodynamics and the Safety Profile After a Single Oral Dose of Gemigliptin (Investigational Product) in Healthy Subjects and Subjects With Mild or Moderate Hepatic Impairment and After Multiple Oral Dose in Healthy Subjects|Completed||Phase 1|28|Anticipated|LG Life Sciences||3|||f||||f||||||||||2017-10-11 00:59:36.897311|2017-10-11 00:59:36.897311
NCT02004561|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-04-25|||January 2012|Actual|2012-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01|24 Months|Observational [Patient Registry]|||Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, Gastric Bypass Surgeries|Outcomes Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, and Gastric Bypass Surgeries in Obese Adolescents|Recruiting||N/A|26|Anticipated|Yale University|||2||f||||f||||||||No||2017-10-11 00:59:37.141854|2017-10-11 00:59:37.141854
NCT02004548|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-12-28|||May 2013||2013-05-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Phase I Clinical Study of Metatinib Tromethamine Tablet|A Phase I, Multiple Dose Escalation Clinical Trial of Metatinib Tromethamine Tablet in Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|18|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 00:59:37.244708|2017-10-11 00:59:37.244708
NCT02004535|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-05-03|||April 2006||2006-04-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Clinical Study of Cochlear Implants in Adults With Asymmetrical Hearing Loss|Clinical Study of Cochlear Implants in Adults With Asymmetrical Hearing Loss|Active, not recruiting||N/A|59|Actual|Washington University School of Medicine||1|||f||||f||||||||No||2017-10-11 00:59:37.361549|2017-10-11 00:59:37.361549
NCT02004522|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-09-06|||November 2013||2013-11-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|May 19, 2017|Actual|2017-05-19||Interventional|||A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)|A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (DUO)|Active, not recruiting||Phase 3|300|Anticipated|Verastem, Inc.||2|||f||||t||||||||||2017-10-11 00:59:37.478736|2017-10-11 00:59:37.478736
NCT02004509|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-09-08|||February 2015||2015-02-01|September 2014|2014-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|SILENT||SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial||Not yet recruiting||Phase 4|2054|Anticipated|InCor Heart Institute||2|||f||||t||||||||||2017-10-11 00:59:37.842272|2017-10-11 00:59:37.842272
NCT02004496|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-12-09|||December 2013||2013-12-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PatAPP1||Randomized Controlled Single-blind Trial to Evaluate the Mobile Tracking of Symptoms in Ambulatory Breast Cancer Patients||Terminated||N/A|139|Actual|University of Zurich||3||"Termination due to relevant update of the operation system. Adaption of the application was not   foreseen in the intervention study."|f||||t||||||||||2017-10-11 00:59:37.94112|2017-10-11 00:59:37.94112
NCT02004483|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-09-22|||August 2010||2010-08-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PCI-Strain||Analysis of Myocardial Layer Specific Systolic and Diastolic Function During and After PCI|Comprehensive Analysis of Myocardial Layer Specific Systolic and Diastolic Function in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention|Completed||N/A|19|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 00:59:38.047219|2017-10-11 00:59:38.047219
NCT02004470|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-01-03|||January 2014||2014-01-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||Lavage and Suction of the Right Upper Quadrant to Reduce Post Laparoscopic Shoulder Pain|Lavage and Suction of the Right Upper Quadrant to Reduce Post Laparoscopic Shoulder Pain: A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-11 00:59:38.142149|2017-10-11 00:59:38.142149
NCT02004457|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-03-08|||March 2013||2013-03-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Interventional|HIV Engage||Engaging HIV Patients in Primary Care by Promoting Acceptance|Engaging HIV Patients in Primary Care by Promoting Acceptance|Completed||N/A|43|Actual|Butler Hospital||2|||f||||f||||||||||2017-10-11 00:59:38.238275|2017-10-11 00:59:38.238275
NCT02004444|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-01-28|||October 2010||2010-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01|1 Day|Observational [Patient Registry]|JCV in MS||JC Virus Reactivation in Multiple Sclerosis|JC Virus Reactivation in Multiple Sclerosis|Completed||N/A|50|Actual|Beth Israel Deaconess Medical Center|||5||f||||f||||||Samples With DNA|"     Blood, Urine, and Cerebrospinal Fluid   "|||2017-10-11 00:59:38.320273|2017-10-11 00:59:38.320273
NCT02004431|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-11-04|||January 2014||2014-01-01|September 2014|2014-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|4P||Peri-operative Psychology and Post-operative Pain Study|A Case-control Study of Peri-operative Psychological State and Acute and Chronic Post-operative Pain|Completed||N/A|200|Anticipated|Plymouth Hospitals NHS Trust|||2||f||||f||||||||||2017-10-11 00:59:38.407658|2017-10-11 00:59:38.407658
NCT02004418|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-12-31|||March 2014||2014-03-01|December 2015|2015-12-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland|A Prospective Single-Arm Phase I/II Study Using 11C-Choline PET Scans for Dose Escalated Hypofractionated Image Guided Inversely Planned Intensity Modulated External Beam Radiotherapy With Boost to PET Defined Dominant Intraprostatic Lesions and as a Predictive Factor for Biochemical Disease-Free Survival in Patients With Localized Prostate Cancer|Recruiting||Phase 1/Phase 2|63|Anticipated|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 00:59:38.516385|2017-10-11 00:59:38.516385
NCT02004405|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-06|||July 2010||2010-07-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises|The Study of Heart Rate Variability in Patients With Fibromyalgia - Effects of Strengthening Exercises|Completed||Phase 4|66|Actual|Federal University of Espirito Santo||2|||f||||t||||||||||2017-10-11 00:59:38.628798|2017-10-11 00:59:38.628798
NCT02004392|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-05-02|||June 2014||2014-06-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025|A 26-Week Extension Study of the Safety and Clinical Effects of EVP-6124 in Subjects With Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication|Terminated||Phase 3|348|Actual|FORUM Pharmaceuticals Inc||2||Study has been suspended due to clinical hold.|f||||t||||||||||2017-10-11 00:59:38.73085|2017-10-11 00:59:38.73085
NCT02004379|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-07-14|||November 2013||2013-11-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01|12 Months|Observational [Patient Registry]|||Register of Telaprevir and Boceprevir in Routine Clinical Practice||Completed||N/A|1553|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||||||2017-10-11 00:59:38.948513|2017-10-11 00:59:38.948513
NCT02004366|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-03-08|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Linagliptin Inpatient Trial|Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes|Completed||Phase 4|295|Actual|Emory University||5|||f||||t||||||||||2017-10-11 00:59:39.230125|2017-10-11 00:59:39.230125
NCT02004353|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-10-05|||July 2011||2011-07-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|June 2019|Anticipated|2019-06-01|2 Years|Observational [Patient Registry]|IROS||Observation of Benefits for Patients Implanted With a Hearing Implant of the Company Cochlear|Cochlear-Implanted Recipient Observational Study|Recruiting||N/A|1500|Anticipated|Cochlear|||1||f||||f||||||||||2017-10-11 00:59:39.358837|2017-10-11 00:59:39.358837
NCT02003768|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2014-07-13|||October 2013||2013-10-01|July 2014|2014-07-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||The Effect of Pnemoperitoneum on Intracranial Pressure and Cerebral Oxygenation During Laparoscopic Surgery According to Anesthesia Agents: Propofol Based Total Intravenous Anesthesia vs Desflurane Anesthesia||Withdrawn||N/A|0|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 00:59:51.56893|2017-10-11 00:59:51.56893
NCT02004340|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2015-02-12|||November 2013||2013-11-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Transcutaneous Auricular Vagus Nerve Stimulation for Pediatric Epilepsy|Transcutaneous Auricular Vagus Nerve Stimulation as a Complementary Treatment for Pediatric Epilepsy|Unknown status|Recruiting|N/A|120|Anticipated|China Academy of Chinese Medical Sciences||3|||f||||t||||||||||2017-10-11 00:59:39.567959|2017-10-11 00:59:39.567959
NCT02004327|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-06-25|||December 2013||2013-12-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer|Randomized, Open-label, Single Dose, Crossover Phase I Clinical Study to Evaluate the Pharmacokinetics of DW1029M 300 mg, 600 mg and 1200 mg After Oral Administration in Healthy Male Volunteer|Completed||Phase 1|6|Actual|Dong Wha Pharmaceutical Co. Ltd.||3|||f||||f||||||||||2017-10-11 00:59:39.676306|2017-10-11 00:59:39.676306
NCT02004314|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-03|||October 2009||2009-10-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Chloroquine as a Modulator of T Cell Immune Activation|Chloroquine as a Modulator of T Cell Immune Activation to Improve CD4 Recovery in HIV-infected Participants Receiving Antiretroviral Therapy: A Proof-of-concept Study|Completed||N/A|19|Actual|CIHR Canadian HIV Trials Network||1|||f||||t||||||||||2017-10-11 00:59:39.77582|2017-10-11 00:59:39.77582
NCT02004301|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2014-04-09|||January 2014||2014-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Investigate Delayed-release Tablets|A Pilot Pharmacoscintigraphic Clinical Study to Investigate the Behaviour of Delayed-release Tablets Consisting of a Diclofenac Potassium Core Coated With Barrier Granules, in Healthy Volunteers|Completed||Phase 1|12|Actual|Bio-Images Research Ltd||2|||f||||f||||||||||2017-10-11 00:59:39.846115|2017-10-11 00:59:39.846115
NCT02004288|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-03-23|||December 2013||2013-12-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Role of Lactobacillus Reuteri in Children and Adolescents With Anorexia Nervosa|The Role of Lactobacillus Reuteri in Nutritional Recovery and Treatment of Constipation in Children and Adolescents With Anorexia Nervosa - Randomised, Double Blind, Placebo Controlled Study|Completed||Phase 2/Phase 3|30|Actual|BioGaia AB||2|||f||||f||||||||Undecided||2017-10-11 00:59:39.92121|2017-10-11 00:59:39.92121
NCT02004275|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-09-29|||February 2014||2014-02-01|September 2017|2017-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Refractory Multiple Myeloma|A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients With Multiple Myeloma Refractory to Lenalidomide and Proteasome Inhibitor-Based Therapy|Suspended||Phase 1/Phase 2|132|Anticipated|Alliance for Clinical Trials in Oncology||2||DSMB recommendation to revise study design|f||||t||||||||||2017-10-11 00:59:40.027839|2017-10-11 00:59:40.027839
NCT02004262|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-04-27|||January 2014||2014-01-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|ECLIPSE||Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting|A Phase 2B, Randomized, Controlled, Multicenter, Open-Label Study of the Efficacy and Immune Response of GVAX Pancreas Vaccine (With Cyclophosphamide) and CRS 207 Compared to Chemotherapy or to CRS-207 Alone in Adults With Previously-Treated Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|303|Actual|Aduro Biotech, Inc.||3|||f||||||||||||||2017-10-11 00:59:43.787592|2017-10-11 00:59:43.787592
NCT02004249|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-10-05|||December 2013||2013-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 00:59:44.066266|2017-10-11 00:59:44.066266
NCT02004223|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-08-31|||January 2014||2014-01-01|August 2016|2016-08-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|BOOSTER||Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer|Phase I Dose Escalation Study of Stereotactic BOOST for Prostate cancER|Recruiting||Phase 1|60|Anticipated|Royal North Shore Hospital||1|||f||||t||||||||||2017-10-11 00:59:44.83044|2017-10-11 00:59:44.83044
NCT02004210|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2016-04-26|||April 2013||2013-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma|A Randomized, Multi-center, Open Label, Phase 3 Trial Comparing Conventional TACE and Transarterial Radioembolization in Patients With Unilobar Advanced Hepatocellular Carcinoma|Withdrawn||Phase 3|0|Actual|Seoul National University Hospital||2||No participants were enrolled.|f||||f||||||||||2017-10-11 00:59:44.922452|2017-10-11 00:59:44.922452
NCT02004197|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-12-05|||January 2010||2010-01-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Quadruple and Phytomedicine-based Therapies in H. Pylori Infection|Phytomedicine-based and Quadruple Therapies in Helicobacter Pylori Infection. A Comparative Randomized Trial|Completed||Phase 2/Phase 3|176|Actual|Shifa Ul Mulk Memorial Hospital||2|||f||||t||||||||||2017-10-11 00:59:45.026827|2017-10-11 00:59:45.026827
NCT02004184|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-12-12|||December 2013||2013-12-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|IDA||Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy|Maintenance Pemetrexed Therapy After Induction Chemotherapy Versus Pemetrexed at Progression in Advanced Non-Small-Cell Lung Cancer: A Randomized Phase III Study|Recruiting||Phase 3|765|Anticipated|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-10-11 00:59:45.151378|2017-10-11 00:59:45.151378
NCT02004171|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-10-17|||December 2013||2013-12-01|November 2014|2014-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation|Electronic Nicotine Delivery Devices (ENDDs) or Nicotine Inhaler for Smoking Cessation|Withdrawn||N/A|0|Actual|New York State Psychiatric Institute||2||No participants enrolled. Changed requirements for studying e-cigarettes.|f||||t||||||||||2017-10-11 00:59:45.238424|2017-10-11 00:59:45.238424
NCT02004158|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-05-02|2017-03-22||November 2013||2013-11-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|PEACE II||Positive Psychology to Improve Healthy Behaviors After an Acute Coronary Syndrome|Study of a Positive Psychology Program to Improve Healthy Behaviors After an Acute Coronary Syndrome: Proof of Concept Study|Completed||N/A|23|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 00:59:45.321399|2017-10-11 00:59:45.321399
NCT02004145|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-04-18|||October 2013||2013-10-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|HOPE||Trial of a Positive Psychology Intervention in Major Depressive Disorder|Trial of a Positive Psychology Intervention to Reduce Suicide Risk in Patients With Major Depression|Completed||N/A|65|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 00:59:45.531238|2017-10-11 00:59:45.531238
NCT02004132|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-07-29|2014-07-29||December 2013||2013-12-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All enrolled participants who received a dose of study drug.|A Study of Axiron® in Healthy Participants|A Phase 1, Single-Dose Study to Evaluate Testosterone on Clothing After Axiron® Use in Healthy Male Subjects|Completed||Phase 1|12|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 00:59:45.737374|2017-10-11 00:59:45.737374
NCT02004119|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-03-15|||November 2013||2013-11-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 2 Study of KHK4577|Randomized Double-blind Placebo-controlled Study of KHK4577 in Patients With Atopic Dermatitis|Completed||Phase 2|93|Actual|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||||2017-10-11 00:59:46.005186|2017-10-11 00:59:46.005186
NCT02004106|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-03-08|||December 31, 2013|Actual|2013-12-31|March 2017|2017-03-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|||A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors|An Open-Label, Multi-Center, Dose-Escalation, Phase I Study With an Expansion Phase, to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6895882, an Immunocytokine, Consisting of a Variant of Interleukin-2 (IL-2v) Targeting Carcinoembryonic Antigen (CEA) Administered Intravenously, in Patients With Advanced and/or Metastatic Solid Tumors|Completed||Phase 1|110|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 00:59:46.075959|2017-10-11 00:59:46.075959
NCT02004093|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2014-11-25|2014-07-31||December 2005||2005-12-01|November 2014|2014-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||All participants who received randomized treatment (All Treated Population, for Efficacy Analyses); 1 participant was randomized to the chemotherapy arm but received pertuzumab+chemotherapy and is thus included in this arm for all analyses.|A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer|A Randomized, Open-label Study of the Effect of Omnitarg in Combination With Carboplatin-based Chemotherapy Versus Carboplatin-based Therapy Alone on Treatment Response in Patients With Platinum-sensitive Recurrent Ovarian Cancer|Completed||Phase 2|149|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 00:59:46.216292|2017-10-11 00:59:46.216292
NCT02004080|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-03-18|||October 2013||2013-10-01|March 2015|2015-03-01|September 2018|Anticipated|2018-09-01|December 2015|Anticipated|2015-12-01|12 Months|Observational [Patient Registry]|CREACTIVE||CREACTIVE - Collaborative REsearch on ACute Traumatic Brain Injury in intensiVe Care Medicine in Europe|CREACTIVE - Collaborative REsearch on ACute Traumatic Brain Injury in intensiVe Care Medicine in Europe|Recruiting||N/A|10000|Anticipated|Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva|||1||f||||f||||||||||2017-10-11 00:59:47.133599|2017-10-11 00:59:47.133599
NCT02004067|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-02-14|||January 2013||2013-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease|Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease|Completed||Phase 4|100|Actual|Federal University of São Paulo||2|||f||||f||||||||Undecided||2017-10-11 00:59:47.313188|2017-10-11 00:59:47.313188
NCT02004054|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2013-12-05|||December 2012||2012-12-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|PCT-NORB||Interest of Dynamic Measures of the Pupil in Optic Neuritis|Interest of Dynamic Measures of the Pupil in Optic Neuritis|Completed||N/A|30|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||1||f||||f||||||||||2017-10-11 00:59:47.400358|2017-10-11 00:59:47.400358
NCT02004041|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-06-01|||December 2013||2013-12-01|January 2015|2015-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Proof of Concept, Antipruritic Study of the Neurokinin-1 Receptor Antagonist VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis|Completed||Phase 2|69|Actual|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 00:59:47.465269|2017-10-11 00:59:47.465269
NCT02004028|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-02-01|||December 2013||2013-12-01|December 2016|2016-12-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Window of Opportunity Study of VS-6063 (Defactinib) in Participants With Surgical Resectable Malignant Pleural Mesothelioma.|An Open Label Window of Opportunity Phase II Study of the FAK Inhibitor Defactinib VS-6063 in Participants With Surgical Resectable Malignant Pleural Mesothelioma.|Completed||Phase 2|30|Actual|Verastem, Inc.||1|||f||||t|t|f||||||||2017-10-11 00:59:47.56106|2017-10-11 00:59:47.56106
NCT02004015|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-02-10|||November 2013||2013-11-01|March 2015|2015-03-01||||April 2015|Actual|2015-04-01||Interventional|CURARES||Assessment Study of the Effect of NMBA on Bowel Peristalsis|Effect of an Induction Dose of Non Depolarizing Neuro Muscular Blocking Agents (NMBA) on Ultrasound Bowel Peristalsis.|Terminated||Phase 4|50|Actual|Fondation Ophtalmologique Adolphe de Rothschild||3|||f||||f||||||||||2017-10-11 00:59:47.628239|2017-10-11 00:59:47.628239
NCT02004002|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-10-10|||December 2013||2013-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Protein Intake & Insulin Action|Dietary Protein Intake, Insulin Sensitivity and β-cell Function|Completed||N/A|15|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 00:59:47.708409|2017-10-11 00:59:47.708409
NCT02003989|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-10-20|||May 2013||2013-05-01|May 2016|2016-05-01||||August 2015|Actual|2015-08-01||Observational|OCTIHIV||Revealing Increased Axonal Loss in Treated HIV Patients|Revealing Increased Axonal Loss in Treated HIV Patients|Completed||N/A|156|Actual|Fondation Ophtalmologique Adolphe de Rothschild|||2||f||||f||||||||||2017-10-11 00:59:47.907589|2017-10-11 00:59:47.907589
NCT02003976|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-11-30|||September 2014||2014-09-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone|A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone|Recruiting||N/A|72|Anticipated|Western University, Canada||2|||f||||t||||||||Undecided||2017-10-11 00:59:47.999846|2017-10-11 00:59:47.999846
NCT02003963|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-04-22|2017-01-23||November 2013||2013-11-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|Klub Kinect||Social Exergaming for Healthy Weight in Adolescent Girls|Klub Kinect: Social Exergaming for Healthy Weight in Adolescent Girls|Completed||N/A|41|Actual|Pennington Biomedical Research Center||2|||f||||f|f|f||||||No||2017-10-11 00:59:48.14957|2017-10-11 00:59:48.14957
NCT02003950|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-10-14|||March 2013||2013-03-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||Pre- and Post-restriction Chocolate Candy Consumption|Effect of Three-Week Chocolate Candy Restriction on Pre- and Post-restriction Chocolate Candy Consumption in Healthy Adults|Completed||N/A|50|Actual|Purdue University||6|||f||||f||||||||||2017-10-11 00:59:49.133093|2017-10-11 00:59:49.133093
NCT02003937|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-10-28|||September 2009||2009-09-01|October 2015|2015-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Aerobic Training in Patients With Spinal Muscular Atrophy Type III|Aerobic Training Improves Oxidative Capacity, But Not Function in Spinal Muscular Atrophy III|Completed||N/A|15|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 00:59:49.234428|2017-10-11 00:59:49.234428
NCT02003924|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-09-05|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|June 2017|Actual|2017-06-01||Interventional|PROSPER||Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer|Prosper: A Multinational, Phase 3, Randomized, Double-blind, Placebo-controlled, Efficacy And Safety Study Of Enzalutamide In Patients With Nonmetastatic Castration-resistant Prostate Cancer|Active, not recruiting||Phase 3|1396|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 00:59:49.376174|2017-10-11 00:59:49.376174
NCT02003911|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-05-16|||October 2013||2013-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Azithromycin for Children Hospitalized With Asthma|A Double-Blind, Randomized, Placebo-Controlled Trial of Azithromycin in Children Hospitalized With Acute Asthma Exacerbations|Recruiting||Phase 4|214|Anticipated|Montefiore Medical Center||2|||f||||t||||||||Undecided||2017-10-11 00:59:50.50508|2017-10-11 00:59:50.50508
NCT02003898|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-09-15|||November 26, 2013|Actual|2013-11-26|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Post Approval Study of the Threshold Suspend Feature With the Medtronic MiniMed® 530G Insulin Pump|Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System|Active, not recruiting||N/A|426|Actual|Medtronic Diabetes||1|||f||||f|f|t|f|f|f|||||2017-10-11 00:59:50.616475|2017-10-11 00:59:50.616475
NCT02003885|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-03-04|||January 2014||2014-01-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Desflurane on Cardiac Function During Cardiac Surgery: Tissue Doppler Imaging of Mitral Valve Annular Velocity|Effect of Desflurane on Left Ventricular Function in Remifentanil-based Anesthesia for Cardiac Surgery: Tissue Doppler Imaging of Mitral Valve Annular Velocity|Unknown status|Recruiting|N/A|14|Anticipated|Konkuk University Medical Center||1|||f||||t||||||||||2017-10-11 00:59:50.77714|2017-10-11 00:59:50.77714
NCT02003872|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-12-21|||January 2015||2015-01-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Long Term Effect of Adjustable Spaatz 3 Intragastric Balloon on Weight Loss|The Long Term Effect of Adjustable Spaatz 3 Intragastric Balloon on Weight Loss|Terminated||N/A|9|Actual|Sheba Medical Center||1||Stopeed due to lack of recruitment|f||||t||||||||||2017-10-11 00:59:50.869379|2017-10-11 00:59:50.869379
NCT02003859|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-30|2014-11-18|||November 2010||2010-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Predictive Value of pCLE Findings in Pediatric IBD|Predictive Value of pCLE Findings in Pediatric IBD|Completed||N/A|24|Actual|Scientific Center of Children's Health RAMS|||1||f||||f||||||None Retained|"     Optical biopsy   "|||2017-10-11 00:59:50.95161|2017-10-11 00:59:50.95161
NCT02003846|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-06-27|||November 2013||2013-11-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Comparing Bubble and Ventilator Nasal CPAP in Preterm Infants|Comparing the Effects of Bubble Nasal CPAP Versus Ventilator Nasal CPAP in Preterm Infants|Completed||N/A|18|Actual|Maimonides Medical Center|||1||f||||f||||||||||2017-10-11 00:59:51.026768|2017-10-11 00:59:51.026768
NCT02003833|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-11-18|||September 2013||2013-09-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||Poly-L-lactic Acid for Skin Quality|Randomized, Controlled, Multi-Centered, Double-Blind Investigation of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic) for Improving Facial Wrinkles and Skin Quality|Completed||Phase 4|40|Actual|Sadick Research Group||2|||f||||f||||||||||2017-10-11 00:59:51.097419|2017-10-11 00:59:51.097419
NCT02003820|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-08-05|||July 2014||2014-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Using Video Modeled Social Stories to Improve Oral Hygiene in Children With Autism Spectrum Disorder|Using Video Modeled Social Stories to Improve Oral Hygiene in Children With Autism|Completed||N/A|19|Actual|Yale University||2|||f||||f||||||||||2017-10-11 00:59:51.200286|2017-10-11 00:59:51.200286
NCT02003807|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-02|||July 2013||2013-07-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Incidence and Predictive Factor of Irritable Bowel Syndrome After Acute Diverticulitis in Korea||Completed||N/A|102|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 00:59:51.312522|2017-10-11 00:59:51.312522
NCT02003794|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-08-02|||May 2013||2013-05-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|IVIS||Randomized Controlled Study of the Effectiveness of IV Fluid Infusion in Patients With Acute Ischemic Stroke (IVIS)|Randomized Controlled Study of the Effectiveness of IV Fluid Infusion in Patients With Acute Ischemic Stroke (IVIS)|Terminated||Phase 3|120|Anticipated|Chulalongkorn University||2||More progressive stroke in one arm|f||||t||||||||||2017-10-11 00:59:51.39624|2017-10-11 00:59:51.39624
NCT02003781|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-12-06|||October 2013||2013-10-01|December 2016|2016-12-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Observational|||Individualized Prevention Strategy for High Risk Patients in Cardiovascular Disease: Prospective Cohort Study (Cardiovascular and Metabolic Disease Etiology Research Center - HIgh Risk Cohort) CMERC-HI||Recruiting||N/A|4000|Anticipated|Yonsei University|||1||f||||f||||||Samples With DNA|"     serum, whole blood, urine, DNA   "|||2017-10-11 00:59:51.493817|2017-10-11 00:59:51.493817
NCT02003742|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-02|||September 2013||2013-09-01|December 2013|2013-12-01||||July 2016|Anticipated|2016-07-01||Interventional|||Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH|Efficacy and Safety of a Single Transrectal Ultrasound(TRUS)-Guided Intraprostatic Injection of NX-1207 in Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Phase III European Study|Unknown status|Recruiting|Phase 3|340|Anticipated|Recordati Industria Chimica e Farmaceutica S.p.A.||2|||f||||f||||||||||2017-10-11 00:59:51.711342|2017-10-11 00:59:51.711342
NCT02003729|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-06-01|||March 2014||2014-03-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||SIESTA: Home Sleep Study With ApneaDx™ for the Diagnosis of Obstructive Sleep Apnea|SIESTA: Home Sleep Study With ApneaDx™ for the Diagnosis of Obstructive Sleep Apnea: A Pragmatic Randomized Controlled Trial|Unknown status|Recruiting|N/A|250|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-11 00:59:51.808116|2017-10-11 00:59:51.808116
NCT02003716|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-11-11|||September 2013||2013-09-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||DeFRA Questionnaire as an Anamnestic Form|"Use of the DeFRA Questionnaire as a Primary Anamnestic Form Through a Large Scale Screening of the Population"|Completed||N/A|767|Actual|Valmontone Hospital|||1||f||||f||||||||||2017-10-11 00:59:51.8896|2017-10-11 00:59:51.8896
NCT02003703|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-10-24|||May 2015||2015-05-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|CORE-HIV||Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .|Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV : A Randomised Trial|Recruiting||Phase 3|150|Anticipated|Universidad de Valparaiso||2|||f||||f||||||||||2017-10-11 00:59:51.949706|2017-10-11 00:59:51.949706
NCT02003690|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-08-10|||February 2014||2014-02-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|DBT||Dialectical Behavior Therapy (DBT) for Adolescents With Bipolar Disorder|Dialectical Behavior Therapy (DBT) for Adolescents With Bipolar Disorder|Recruiting||Phase 2|100|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 00:59:52.044205|2017-10-11 00:59:52.044205
NCT02003677|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-01-16|||November 2013||2013-11-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes|Completed||Phase 1|67|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 00:59:52.140787|2017-10-11 00:59:52.140787
NCT02003664|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-09-06|||November 2013||2013-11-01|September 2016|2016-09-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|CURE||A Study of Baclofen ER|A Randomized Placebo-controlled Study of Baclofen ER on Brain and Behavioral Outcomes in Cocaine Dependence|Withdrawn||Phase 2|0|Actual|University of Pennsylvania||2||This study never started due to delays in medication development|f||||t||||||||||2017-10-11 00:59:52.214653|2017-10-11 00:59:52.214653
NCT02003651|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-12-12|||November 2013||2013-11-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Echinacea and Acute Respiratory Illness|Efficacy of Ingesting Gaia Herb's Quick Defense Product in Reducing Acute Respiratory Illness Symptomatology in Women: a 12-Week, Double Blind, Placebo-Controlled Randomized Trial|Completed||N/A|40|Actual|Appalachian State University||2|||f||||f||||||||||2017-10-11 00:59:52.287275|2017-10-11 00:59:52.287275
NCT02003638|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-06-24|2014-05-22||March 2012||2012-03-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|AVANT||Assessment Of Vascular Health After Niacin Therapy (AVANT)|A 12-WEEK STUDY EVALUATING THE EFFECTS OF NIACIN ON VASCULAR HEALTH ASSESSED BY FLUORODEOXYGLUCOSE-PET/CT AND CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND MICROPARTICLES|Completed||N/A|9|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 00:59:52.357493|2017-10-11 00:59:52.357493
NCT02003625|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-07-19|||October 2013||2013-10-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Meloxicam vs Placebo for Mobilization|Non-steroidal Anti-inflammatory Drugs (Meloxicam) to Mobilize Hematopoietic Stem Cells: A Phase II Randomized Trial|Recruiting||Phase 2|100|Anticipated|Massachusetts General Hospital||2|||||||t||||||||||2017-10-11 00:59:52.703578|2017-10-11 00:59:52.703578
NCT02003612|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-01-24|||October 2013||2013-10-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Observational|||Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia|An Analysis of Historical Data on Hematological Remission and Survival Among Adult Patients With Relapsed / Refractory B-Precursor Acute Lymphoblastic Leukemia|Completed||N/A|2373|Actual|Amgen|||1||f||||f||||||||||2017-10-11 00:59:52.819794|2017-10-11 00:59:52.819794
NCT02003599|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-05-26|||May 2014||2014-05-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy|Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy|Completed||N/A|52|Actual|Universidade do Vale do Sapucai||2|||f||||f||||||||||2017-10-11 00:59:52.908452|2017-10-11 00:59:52.908452
NCT02003586|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-04-08|||December 2013||2013-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effect of a Plant-based Ingredient on Generalized Hormonal Responses|Effect of a Plant-based Ingredient on Generalized Hormonal Responses|Completed||N/A|12|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-11 00:59:53.10029|2017-10-11 00:59:53.10029
NCT02003573|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2016-12-14|||January 2014||2014-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)|An Open Label, Phase I, Dose Escalation Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics, and Efficacy of Volasertib in Combination With Decitabine in Patients >= 65 Years With Acute Myeloid Leukemia|Terminated||Phase 1|127|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 00:59:53.207811|2017-10-11 00:59:53.207811
NCT02003560|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2014-08-12|||December 2006||2006-12-01|August 2014|2014-08-01|March 2024|Anticipated|2024-03-01|March 2019|Anticipated|2019-03-01||Interventional|APERT||Accelerated Partial Breast Irradiation With 3D-CRT and IMRT|Accelerated Partial Breast Irradiation After Breast Conserving Surgery for Low-risk Invasive Breast Cancer: 3D Conformal Radiotherapy (3D-CRT) and Intensity Modulated Radiotherapy (IMRT) - Prospective Phase II Study|Active, not recruiting||Phase 2|90|Anticipated|National Institute of Oncology, Hungary||1|||f||||f||||||||||2017-10-11 00:59:53.330804|2017-10-11 00:59:53.330804
NCT02003547|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2014-05-01|||September 2013||2013-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects|A Single Centre, Placebo-Controlled, Double-Masked, Sequential Designed Study to Evaluate 3 Ophthalmic Formulations of AMA0076 in Healthy Subjects|Completed||Phase 1|21|Actual|Amakem, NV||4|||f||||f||||||||||2017-10-11 00:59:53.423108|2017-10-11 00:59:53.423108
NCT02003534|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2014-06-24|2014-06-24||July 2010||2010-07-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|APOTUS||A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension||Completed||Phase 4|376|Actual|Allergan||1|||f||||f||||||||||2017-10-11 00:59:53.518492|2017-10-11 00:59:53.518492
NCT02003521|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2014-10-27|||November 2013||2013-11-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Impact of Lung Flute Therapy on Asthma|Impact of Lung Flute Therapy on Asthma|Completed||N/A|48|Actual|Medical Acoustics LLC|||1||f||||f||||||Samples With DNA|"     Sputum   "|||2017-10-11 00:59:53.696485|2017-10-11 00:59:53.696485
NCT02003508|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-02-23|||January 2014||2014-01-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|Impress||Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination|Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination|Recruiting||N/A|400|Anticipated|The Alfred|||1||f||||f||||||Samples With DNA|"     Penile sampling for HPV DNA   "|||2017-10-11 00:59:53.807595|2017-10-11 00:59:53.807595
NCT02003495|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-09-19|||October 2013||2013-10-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine|Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine in Healthy Subjects 2 Months to 6 Years of Age in China|Completed||Phase 3|2195|Actual|Beijing Minhai Biotechnology Co., Ltd||5|||f||||f||||||||||2017-10-11 00:59:53.924429|2017-10-11 00:59:53.924429
NCT02003482|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-09-29|||May 9, 2006|Actual|2006-05-09|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer|Prospective Observational Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer|Active, not recruiting||N/A|39|Actual|University of Miami|||2||f||||f||||||||||2017-10-11 00:59:54.479505|2017-10-11 00:59:54.479505
NCT02003469|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-02-21|||April 2009||2009-04-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|PROTECTII||Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II|Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II|Completed||N/A|67|Actual|University of Michigan||1|||f||||t|f|f||||||No||2017-10-11 00:59:54.651712|2017-10-11 00:59:54.651712
NCT02003456|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-02-20|||December 2013|Actual|2013-12-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging|Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging|Completed||Early Phase 1|30|Actual|University of Michigan||1|||f||||t|t|f|||f|||No||2017-10-11 00:59:54.786481|2017-10-11 00:59:54.786481
NCT02003443|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-05-27|||August 2013||2013-08-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|AKP||Acupressure for Knee Pain in Older Adults|Acupressure for the Treatment of Pain in Older Adults With Symptomatic Knee Osteoarthritis|Completed||N/A|150|Actual|University of Michigan||3|||f||||f||||||||||2017-10-11 00:59:54.892831|2017-10-11 00:59:54.892831
NCT02003430|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-04-03|||September 2013||2013-09-01|April 2017|2017-04-01|October 7, 2017|Anticipated|2017-10-07|October 7, 2017|Anticipated|2017-10-07||Observational|||Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers|Functional Assessment and Radiation Adherence/Toxicity in Older and Younger Patients With Non-Ovarian Gynecological Cancers|Active, not recruiting||N/A|15|Actual|UNC Lineberger Comprehensive Cancer Center|||2||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 00:59:55.008916|2017-10-11 00:59:55.008916
NCT02003417|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-05-15|||June 2012||2012-06-01|May 2017|2017-05-01|May 4, 2018|Anticipated|2018-05-04|July 2016|Actual|2016-07-01||Observational|||Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy|A Multicenter Study to Evaluate Cardiovascular Risk Factors and Receipt of Primary and Preventive Care in Prostate Cancer Patients Who Receive Definitive Radiation Therapy and Androgen Deprivation Therapy.|Active, not recruiting||N/A|101|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||f||||||||No||2017-10-11 00:59:55.144285|2017-10-11 00:59:55.144285
NCT02003404|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-10-05|2014-09-15||November 2013||2013-11-01|October 2016|2016-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational||Must have ostomy of any type.|Preliminary Study of Peel Force and Discomfort of Removal of Adhesive Barriers in Normal and Peristomal Skin|Preliminary Study of Peel Force and Discomfort of Removal of Adhesive Barriers in Normal and Peristomal Skin|Completed||N/A|17|Actual|Hollister Incorporated|Small sample size may not be generalizable to the population.||2||f||||f||||||||||2017-10-11 00:59:55.283833|2017-10-11 00:59:55.283833
NCT02003391|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-06-27|2016-05-17||December 2013||2013-12-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Intent to treat population included participants who received study medication and had at least one on-therapy study visit.|Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure|Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTrav® in Patients Previously Uncontrolled on a Beta-blocker|Completed||Phase 4|157|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 00:59:55.531914|2017-10-11 00:59:55.531914
NCT02003378|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-02|||September 2013||2013-09-01|December 2013|2013-12-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|RAP||Comparison of Physiologic Response With Rate Adaptive Pacing Driven by Minute Ventilation and Accelerometer|Comparison of Physiologic Response With Rate Adaptive Pacing Driven by Minute Ventilation and Accelerometer|Unknown status|Recruiting|N/A|100|Anticipated|Albany Medical College||2|||f||||f||||||||||2017-10-11 00:59:55.951338|2017-10-11 00:59:55.951338
NCT02003365|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-08-10||2015-08-10|November 2013||2013-11-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the Knee|An Open-label, Single Administration Study to Characterize the Local Duration of Exposure of Triamcinolone Acetonide From FX006 in Patients With Osteoarthritis (OA) of the Knee|Completed||Phase 2|50|Actual|Flexion Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 00:59:56.059905|2017-10-11 00:59:56.059905
NCT02003352|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-01-30|2016-01-26||March 2014||2014-03-01|January 2017|2017-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|PTSD-TBI||Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries|Evaluation of the Effectiveness of a Novel Brain and Vestibular Rehabilitation Treatment Modality in PTSD Patients Who Have Suffered Combat Related Traumatic Brain Injuries|Completed||N/A|98|Actual|Carrick Institute for Graduate Studies||1|||f||||t||||||||No||2017-10-11 00:59:56.221964|2017-10-11 00:59:56.221964
NCT02003339|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-01-31|||November 2013||2013-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|ICY||Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium|Pilot Prospective Study on Interest of Functional MRI in Early Assessment of Radioembolization Efficiency in Patients Suffering From Hepatocellular Carcinoma|Recruiting||N/A|25|Anticipated|Center Eugene Marquis||1|||f||||f||||||||||2017-10-11 00:59:56.434871|2017-10-11 00:59:56.434871
NCT02003326|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-10-03|||November 2013|Actual|2013-11-01|October 2017|2017-10-01|October 2017|Actual|2017-10-01|October 2017|Actual|2017-10-01||Interventional|AMIS||Strain and Blood Inflammatory Markers as Prognostic Tools for ARDS AMIS (ARDS - Markers of Inflammation - Strain)|Strain and Blood Inflammatory Markers as Prognostic Tools for ARDS AMIS (ARDS - Markers of Inflammation - Strain)|Terminated||N/A|6|Actual|Centre Hospitalier Universitaire de Nice||1||low number of patients enrolled|f||||f||||||||||2017-10-11 00:59:56.546955|2017-10-11 00:59:56.546955
NCT02003313|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-09-19|||November 2013||2013-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine|Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine in More Than 2 Years Old Children and Adults|Completed||Phase 3|1260|Actual|Beijing Minhai Biotechnology Co., Ltd||2|||f||||f||||||||||2017-10-11 00:59:56.633131|2017-10-11 00:59:56.633131
NCT02003300|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2013-12-05|||April 2005||2005-04-01|December 2004|2004-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||An Improved Method for the Measurement of Oxygen and Anaesthetic Agent Uptake in Patients Using the Foldes-Biro Equation|The Modified Foldes-Biro Equation Used in Patients Under General Anaesthesia for the Measurement of Oxygen and Anaesthetic Agent Uptake|Completed||N/A|30|Actual|Bayside Health|||||f||||f||||||||||2017-10-11 00:59:56.746969|2017-10-11 00:59:56.746969
NCT02003287|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2015-03-05|||November 2013||2013-11-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Comparing FEES to VFSS in Diagnosing Laryngeal Penetration and Aspiration in Infants in the NICU|Determining the Efficacy of Using FEES Compared to VFSS to Diagnose Laryngeal Penetration and Aspiration in Infants in the Neonatal Intensive Care Unit (NICU)|Completed||N/A|25|Actual|Baylor Research Institute||2|||f||||f||||||||||2017-10-11 00:59:56.834183|2017-10-11 00:59:56.834183
NCT02003274|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-03|2017-06-29|||October 2013||2013-10-01|March 2017|2017-03-01|October 31, 2017|Anticipated|2017-10-31|October 2016|Actual|2016-10-01||Interventional|||Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial Pancreas|Meal Glucose Regulation in Type 1 Diabetes on Insulin Pump Therapy: Towards a Better Understanding of the Glucose-Insulin System.|Active, not recruiting||N/A|20|Anticipated|Azienda Ospedaliera Universitaria Integrata Verona||2|||f||||f||||||||||2017-10-11 00:59:56.921523|2017-10-11 00:59:56.921523
NCT02003261|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-11-02|||November 2013||2013-11-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|||Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP Study)|An Assessor-blinded, Randomized, 20-week, Parallel-group, Superiority Study to Compare the Efficacy of Transdiagnostic Cognitive Behavioral Therapy Versus Waiting-list in Depressive and Anxiety Symptoms of Depressive and Anxiety Disorders|Recruiting||Phase 3|104|Anticipated|National Center of Neurology and Psychiatry, Japan||2|||f||||t||||||||||2017-10-11 00:59:57.025394|2017-10-11 00:59:57.025394
NCT02003248|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-08-18|||November 2013||2013-11-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Pallidotomy in the Treatment of Dyskinesia of Parkinson's Disease||Recruiting||Phase 1|5|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 00:59:57.121794|2017-10-11 00:59:57.121794
NCT02003235|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2017-07-18|||October 2013|Actual|2013-10-01|July 2017|2017-07-01|July 15, 2017|Actual|2017-07-15|July 15, 2017|Actual|2017-07-15||Interventional|||Assessment of Device for Treatment of Amblyopia||Completed||N/A|35|Actual|Visior Technologies Ltd.||1|||f||||f||||||||||2017-10-11 00:59:57.191268|2017-10-11 00:59:57.191268
NCT02003196|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-03-22|||February 2014||2014-02-01|March 2016|2016-03-01||||February 2019|Anticipated|2019-02-01||Observational|IBIS-VIRUS||Effects of Viral Reactivation on Outcomes of Brain-injured Patients ( IBIS-VIRUS)|Effects of Viral Reactivation on Outcomes of Brain-injured Patients ( IBIS-VIRUS)|Recruiting||N/A|500|Anticipated|Nantes University Hospital|||1||f||||||||||||||2017-10-11 01:00:04.734839|2017-10-11 01:00:04.734839
NCT02003183|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-06-14|||March 2013||2013-03-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|TBI and CTE||Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy|FDDNP-PET Imaging in Persons at Risk for Chronic Traumatic Encephalopathy|Active, not recruiting||Phase 2|50|Anticipated|University of California, Los Angeles||1|||f||||t||||||||||2017-10-11 01:00:04.883188|2017-10-11 01:00:04.883188
NCT02003170|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-07-20|||May 2012||2012-05-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Etiology and Early Diagnosis of Neurodevelopmental Disorders|Etiology and Early Diagnosis of Neurodevelopmental Disorders|Recruiting||N/A|500|Anticipated|University of Arkansas|||1||f||||f||||||Samples With DNA|"     Blood, urine, cerebrospinal fluid, muscle, and skin samples may be retained.   "|||2017-10-11 01:00:05.028096|2017-10-11 01:00:05.028096
NCT02003157|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-01-14|||June 2011||2011-06-01|October 2011|2011-10-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|HYPNOART||Efficacy of Hypnosis During Embryo Transfer Procedure on Clinical Pregnancy Rate for Patients Undergoing Assisted Reproductive Technology IVF or ICSI||Completed||N/A|460|Actual|University Hospital, Angers||2|||f||||||||||||||2017-10-11 01:00:05.155193|2017-10-11 01:00:05.155193
NCT02003144|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-02-01|||January 2015||2015-01-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients|A Phase III, Open-label, Extension Trial of ECU-NMO-301 to Evaluate the Safety and Efficacy of Eculizumab in Patients With Relapsing Neuromyelitis Optica (NMO)|Enrolling by invitation||Phase 3|132|Anticipated|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-10-11 01:00:05.277438|2017-10-11 01:00:05.277438
NCT02003131|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-08-08|||December 2013||2013-12-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis|Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis|Withdrawn||Phase 1/Phase 2|0|Actual|Translational Biosciences||2||No enrollment|f||||t||||||||||2017-10-11 01:00:05.783147|2017-10-11 01:00:05.783147
NCT02003105|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-09-11|||June 2014||2014-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:00:06.039883|2017-10-11 01:00:06.039883
NCT02003092|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-09-26|||August 2013||2013-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||RX-5902 Treatment of Subjects With Triple Negative Breast Cancer|A Multi-Center, Dose Finding, Open Label, Phase 1 Study of RX-5902 in Subjects With Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|20|Anticipated|Rexahn Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 01:00:06.10126|2017-10-11 01:00:06.10126
NCT02003079|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-11-19|||September 2013||2013-09-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Observational|||Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis||Completed||N/A|113|Actual|St. Paul's Hospital, Canada|||1||f||||||||||||||2017-10-11 01:00:06.253706|2017-10-11 01:00:06.253706
NCT02003066|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-11-27|||November 2013||2013-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of Goal-directed Fluid Therapy Using Stroke Volume Variation in Patients Undergoing Free Flap Reconstruction After Head and Neck Cancer Resection||Recruiting||N/A|62|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:00:06.352981|2017-10-11 01:00:06.352981
NCT02003040|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-09-25|||September 2014||2014-09-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Observational|||Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions|Role of the Mespere Venus 1000 in Predicting Heart Failure Hospital Readmissions|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Mespere Lifesciences Inc.|||1||f||||f||||||||||2017-10-11 01:00:06.578242|2017-10-11 01:00:06.578242
NCT02003027|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-09-21|||June 2013||2013-06-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Botulinum Toxin Injection to Prevent VT Storm|Endomyocardial Botulinum Toxin Injection Can Decrease the Number of Episodes of VT Storm: Pilot Study|Unknown status|Recruiting|Phase 1|15|Anticipated|Meshalkin Research Institute of Pathology of Circulation||1|||f||||f||||||||||2017-10-11 01:00:06.681254|2017-10-11 01:00:06.681254
NCT02003014|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-09-21|2015-12-07||February 2009||2009-02-01|September 2016|2016-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational||The safety analysis set was defined as all participants who were enrolled and completed the study.|"Pioglitazone Tablets Special Drug Use Surveillance Combined Use of Biguanides / Long-term Treatment"|"Actos Tablets Special Drug Use Surveillance Combined Use of Biguanides / Long-term Treatment"|Completed||N/A|899|Actual|Takeda|||1||f||||f||||||||||2017-10-11 01:00:06.804628|2017-10-11 01:00:06.804628
NCT02003001|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-09-24|||June 2013||2013-06-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Botulinum Toxin Injection to Prevent Ventricular Arrhythmias|Endomyocardial Botulinum Toxin Injection Can Prevent Ventricular Arrhythmias: Pilot Study|Unknown status|Recruiting|Phase 1|30|Anticipated|Meshalkin Research Institute of Pathology of Circulation||1|||f||||f||||||||||2017-10-11 01:00:07.647341|2017-10-11 01:00:07.647341
NCT02002988|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-09-21|||June 2013||2013-06-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation|Endomyocardial Botulinum Toxin Injection Can Prevent Drug-Resistant Paroxysmal Atrial Fibrillation: Pilot Study|Unknown status|Recruiting|Phase 1|30|Anticipated|Meshalkin Research Institute of Pathology of Circulation||1|||f||||t||||||||||2017-10-11 01:00:07.775298|2017-10-11 01:00:07.775298
NCT02002975|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2013-12-01|||October 2007||2007-10-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||"Pioglitazone Special Drug Use Surveillance Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"|"Actos Tablets Special Drug Use Surveillance Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"|Completed||N/A|18197|Actual|Takeda|||1||f||||f||||||||||2017-10-11 01:00:07.881942|2017-10-11 01:00:07.881942
NCT02002962|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-09-21|||June 2013||2013-06-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|June 2015|Actual|2015-06-01||Interventional|||Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter|Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter to Prevent Post-procedural Atrial Fibrillation|Unknown status|Recruiting|Phase 2|60|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 01:00:07.984016|2017-10-11 01:00:07.984016
NCT02002949|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-03-08|||February 2014||2014-02-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01||Interventional|CHDvsSDHD||Conventional Hemodialysis Vs Short Daily Hemodialysis for Patients Coming From Peritoneal Dialysis (HAPD/CAPD)|Cost-Utility of Conventional Hemodialysis (CHD) Vs Short Daily Hemodialysis (SDHD) for Patients Coming From Peritoneal Dialysis (HAPD/CAPD): A Randomized Controlled Trial|Recruiting||N/A|144|Anticipated|Azienda Ospedaliero-Universitaria Consorziale||2|||f||||t||||||||||2017-10-11 01:00:08.100739|2017-10-11 01:00:08.100739
NCT02002936|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2017-01-05|2016-10-19||August 2013||2013-08-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study|Phase I Clinical Trial of SyB C-1101 in Patients With Myelodysplastic Syndrome - Extension Study|Completed||Phase 1|1|Actual|SymBio Pharmaceuticals||1|||f||||||||||||||2017-10-11 01:00:08.462512|2017-10-11 01:00:08.462512
NCT02002923|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-09-21|||June 2013||2013-06-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation|Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation|Unknown status|Recruiting|Phase 2|160|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-11 01:00:08.726043|2017-10-11 01:00:08.726043
NCT02002910|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-01-26|||October 2013|Actual|2013-10-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|November 2015|Actual|2015-11-01||Observational|||Japan Study of Distal Evaluation of Functional Significance of Intra-arterial Stenosis Narrowing Effect|Japan Study of Distal Evaluation of Functional Significance of Intra-arterial Stenosis Narrowing Effect|Completed||N/A|421|Actual|Associations for Establishment of Evidence in Interventions|||1||f||||t||||||||||2017-10-11 01:00:08.827414|2017-10-11 01:00:08.827414
NCT02002884|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-09-21|||March 2014|Actual|2014-03-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|July 3, 2017|Actual|2017-07-03||Interventional|XARA||Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy|Prospective, Multicenter, Randomized, Double-blind, Parallel-group, Dose-response Study of Three Doses Xeomin® (incobotulinumtoxinA, NT 201) for the Treatment of Upper Limb Spasticity Alone or Combined Upper and Lower Limb Spasticity in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy|Active, not recruiting||Phase 3|351|Actual|Merz Pharmaceuticals GmbH||3|||f||||t||||||||||2017-10-11 01:00:09.017984|2017-10-11 01:00:09.017984
NCT02002871|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-06-24|2015-03-16||October 2013||2013-10-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Blue Light for Treating Eczema|Monocenter, Randomized, Intraindividual, Open Label, Exploratory Study Comparing 4 Weeks of Treatment With 453nm Blue Light With no Treatment in Patients With Eczema|Completed||N/A|21|Actual|Philips Light and Health||2|||f||||f||||||||||2017-10-11 01:00:09.229692|2017-10-11 01:00:09.229692
NCT02002858|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-07-06|||October 2014||2014-10-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|November 2016|Actual|2016-11-01||Interventional|SDAT||Smoking Cessation for Depression and Anxiety Treatment|Integrated Smoking Cessation Treatment for Emotional Dysregulation|Completed||Phase 1|12|Actual|University of Houston||2|||f||||t||||||||||2017-10-11 01:00:09.718368|2017-10-11 01:00:09.718368
NCT02002845|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-12-08|||October 2013||2013-10-01|December 2015|2015-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System in Non-Tumor Based TORS Procedures|A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System in Non-Tumor Based TORS Procedures|Completed||N/A|285|Actual|Intuitive Surgical|||1||f||||f||||||||||2017-10-11 01:00:09.826903|2017-10-11 01:00:09.826903
NCT02002832|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2014-05-14|||December 2013||2013-12-01|April 2014|2014-04-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01|7 Days|Observational [Patient Registry]|||A Clinical Trial of Lurasidone in Treatment of Schizophrenia|A Randomized, Double-blind, Double-dummy, Parallel-group and Multicenter Study to Investigate Lurasidone in Treatment of Schizophrenia Compared With Risperidone|Unknown status|Recruiting|N/A|380|Anticipated|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.|||2||f||||f||||||Samples With DNA|"     blood,urine   "|||2017-10-11 01:00:09.93285|2017-10-11 01:00:09.93285
NCT02002819|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-07-01|||June 2014||2014-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|LEV-AD||Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability|Phase 2a Levetiracetam Trial for AD-Associated Network Hyperexcitability|Recruiting||Phase 2|36|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:00:10.066301|2017-10-11 01:00:10.066301
NCT02002806|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-03-05|||January 2012||2012-01-01|March 2017|2017-03-01|December 2024|Anticipated|2024-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control|A Randomized Controlled Trial of Intraoperative Chemical Splanchnicectomy for Patients With Resected Pancreatobiliary Malignancies|Active, not recruiting||N/A|150|Anticipated|Indiana University||2|||f||||t||||||||No||2017-10-11 01:00:10.21349|2017-10-11 01:00:10.21349
NCT02002793|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-12-01|||August 2013||2013-08-01|December 2013|2013-12-01|August 2017|Anticipated|2017-08-01|September 2016|Anticipated|2016-09-01||Interventional|||Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP|Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP|Unknown status|Recruiting|N/A|40|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-11 01:00:10.321607|2017-10-11 01:00:10.321607
NCT02002780|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-02|||January 2011||2011-01-01|December 2013|2013-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Recognizing and Treating Psychosocial Stress Among Children With Complex Heart Problems|Recognizing and Treating Psychosocial Stress Among Children With Complex Heart Problems|Withdrawn||Phase 2|0|Actual|The Hospital for Sick Children||2||Study not started, investigator left the institution|f||||f||||||||||2017-10-11 01:00:10.460551|2017-10-11 01:00:10.460551
NCT02002767|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2014-06-27|||December 2013||2013-12-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment|A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment|Completed||Phase 1|19|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 01:00:10.576155|2017-10-11 01:00:10.576155
NCT02002741|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2017-03-13|||August 1, 2014|Actual|2014-08-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants|Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants: A Pilot, Double Blind, Randomized, Placebo-control Trial|Recruiting||Phase 2/Phase 3|50|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||No||2017-10-11 01:00:10.771068|2017-10-11 01:00:10.771068
NCT02002728|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2013-12-06|||November 2006||2006-11-01|December 2013|2013-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01|14 Months|Observational [Patient Registry]|||Comparison of Early Caries Detection in Children Utilizing an Electrical Conductance Device and the Gold Standard of Visual-tactile Technique.||Completed||N/A|200|Actual|Ortek Therapeutics, Inc.|||1||f||||t||||||||||2017-10-11 01:00:10.893453|2017-10-11 01:00:10.893453
NCT02002715|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-02|||January 2012||2012-01-01|December 2013|2013-12-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|||Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients|Randomised, Open-label, Parallel-group Study of Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients|Unknown status|Recruiting|Phase 4|75|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||3|||f||||t||||||||||2017-10-11 01:00:10.987362|2017-10-11 01:00:10.987362
NCT02002702|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2015-09-11|2015-08-03||January 2014||2014-01-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||The analysis was performed on safety population defined as all randomized participants received any amount of study drug and had at least one post-baseline safety assessment.|Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients|A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Assess the Safety, Tolerability and Pharmacokinetics of Serelaxin When Added to Standard Therapy in Japanese Acute Heart Failure Patients|Completed||Phase 2|46|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:00:11.107937|2017-10-11 01:00:11.107937
NCT02002689|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-04-25|2016-03-23||February 2014||2014-02-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SIGNATURE||LDE225 for Patients With PTCH1 or SMO Mutated Tumors|Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module - 5 LDE225 for Patients With PTCH1 or SMO Mutated Tumors|Terminated||Phase 2|10|Actual|Novartis|The study was closed for accrual when the sponsor realized that not enough patients will be recruited for any meaningful stat analysis even if the study were kept open beyond the original planned accrual window.|1||Low enrollment|f||||f||||||||||2017-10-11 01:00:12.23522|2017-10-11 01:00:12.23522
NCT02002663|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-03-01|||August 2013||2013-08-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|GR-CWI||Continuous Local Anesthetic and Steroid Infusion in Abdominal Surgery|Efficacy of the Intralesional Infusion of Local Anesthetic and Steroids After Major Abdominal Surgery: a Randomized Double Blind Phase III Trial|Completed||Phase 3|120|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-11 01:00:12.751468|2017-10-11 01:00:12.751468
NCT02002650|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-05-27|2016-04-17||December 2013||2013-12-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|Indomethacin||Rectal Indomethacin to Prevent Post-ERCP Pancreatitis|Routine Rectal Indomethacin Given Before Procedure Reduced Overall Pancreatitis in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP): A Multi-center, Single-blinded, Randomized Controlled Trial|Completed||N/A|2600|Actual|Fourth Military Medical University|Firstly, patients could not be blinded to the treatment assignment. Secondly, it remains unclear if patients with prior EST will benefit from rectal indomethacin. Thirdly, the findings need to be validated in different clinical settings.|2|||f||||t||||||||||2017-10-11 01:00:12.896002|2017-10-11 01:00:12.896002
NCT02002637|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-04-26|||November 2013||2013-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|September 2015|Actual|2015-09-01||Interventional|||Feasibility of the Latella Implant System for Medial Osteoarthritis (OA)|Evaluation of the Latella Implant System for Lateralization of the Iliotibial Band to Offload the Medial Condyle for Pain Relief in Patients With Medial Osteoarthritis - A Safety Study|Terminated||N/A|11|Actual|Cotera, Inc.||1||Sponsor election|f||||||||||||||2017-10-11 01:00:13.274095|2017-10-11 01:00:13.274095
NCT02002624|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2013-12-05|||September 2011||2011-09-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Visio||Patient-Specific Versus Conventional Instrumentation in TKA|RCT Multicenter Comparison of Patient-Specific Versus Conventional Instrumentation in Primary TKA|Completed||N/A|140|Actual|Cochin Hospital||2|||f||||t||||||||||2017-10-11 01:00:13.381769|2017-10-11 01:00:13.381769
NCT02002611|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-07-01|||December 2013||2013-12-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Drug-drug Interaction Study(Lobeglitazone, Warfarin)|Open Label, Randomized, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Lobeglitazone and Warfarin in Healthy Subjects|Completed||Phase 1|24|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 01:00:13.463487|2017-10-11 01:00:13.463487
NCT02002598|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2017-06-16|||November 2013||2013-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma|Phase I/II Study of Carfilzomib in Combination With Bendamustine and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma|Recruiting||Phase 1/Phase 2|34|Anticipated|Columbia University||1|||f||||t|t|f||||||Undecided||2017-10-11 01:00:13.591455|2017-10-11 01:00:13.591455
NCT02002585|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2013-12-01|||November 2013||2013-11-01|December 2013|2013-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|KPS||Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease|Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease (Kidney Protection Study - KPS Study)|Recruiting||Phase 2|60|Anticipated|Charles University, Czech Republic||2|||f||||f||||||||||2017-10-11 01:00:13.718856|2017-10-11 01:00:13.718856
NCT02002572|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2016-08-01|||June 2011||2011-06-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SIMOVI-IRM||Quantification, Analysis and Simulation of Facial Mimics Movements|Quantification, Analysis and Simulation of Facial Mimics Movements|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:00:13.858743|2017-10-11 01:00:13.858743
NCT02002559|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2013-12-05|||April 2006||2006-04-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Narrow Band Imaging (NBI) Against Lugol for Squamous Esophageal Cancer|Endoscopic Surveillance Comparing Narrow Band Imaging (NBI) Against Lugol Chromoendoscopy for Detection of Synchronous Superficial Squamous Esophageal Neoplasia Among High Risk Patients|Completed||N/A|180|Actual|Chinese University of Hong Kong|||2||f||||f||||||||||2017-10-11 01:00:13.983036|2017-10-11 01:00:13.983036
NCT02002546|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-02|2015-09-03|||January 2014||2014-01-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|December 2014|Actual|2014-12-01||Observational|||Usefulness of a 2-hour Delta Troponin-I During the ED Identification and Exclusion of Acute Myocardial Infarction|Usefulness of a 2-hour Delta Troponin-I During the ED Identification and Exclusion of Acute Myocardial Infarction|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Chattanooga-Hamilton County Hospital Authority|||1||f||||f||||||||||2017-10-11 01:00:14.059756|2017-10-11 01:00:14.059756
NCT02002520|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-30|2014-01-21|||January 2014||2014-01-01|January 2014|2014-01-01|November 2014|Anticipated|2014-11-01|September 2014|Anticipated|2014-09-01||Observational|||Epigenetic Influences on Post-Surgical Acute and Chronic Pain|An Exploratory Study of the Epigenetic Influences on Post-Surgical Acute and Chronic Pain|Unknown status|Recruiting|N/A|120|Anticipated|The University of Hong Kong|||2||f||||f||||||Samples With DNA|"     RNA and DNA   "|||2017-10-11 01:00:14.27282|2017-10-11 01:00:14.27282
NCT02002507|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-05-10|||January 2015||2015-01-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Jugular Venous Flow Neurosurgical Patients|Effect of Different Surgical Positions on the Cerebral Venous Drainage: an Ultrasound Study on Neurosurgical Patients|Recruiting||N/A|100|Anticipated|University Health Network, Toronto|||2||f||||t||||||||||2017-10-11 01:00:14.377237|2017-10-11 01:00:14.377237
NCT02002494|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-07-20|||June 2013||2013-06-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Jugular Venous Flow Healthy Volunteers|Effect of Different Surgical Positions on the Cerebral Venous Drainage: an Ultrasound Study on Healthy Volunteers|Completed||N/A|28|Actual|University Health Network, Toronto|||1||f||||t||||||||||2017-10-11 01:00:14.511423|2017-10-11 01:00:14.511423
NCT02002481|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-05-02|||December 2013||2013-12-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|flights||Comparison of the Quality of CPR by Professional Helpers (Emergency Physicians / Paramedics) During Flights|Vergleich Der Qualität Der Kardiopulmonalen Reanimation Durch Professioneller Helfer (Notärzte / Rettungsassistenten) während Lufttransporten|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital of Cologne||2|||f||||f||||||||||2017-10-11 01:00:14.619527|2017-10-11 01:00:14.619527
NCT02002468|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-09-14|||October 2012||2012-10-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|October 2014|Actual|2014-10-01||Interventional|||Follow-up of Abnormal and Inadequate Smear-test Results|Follow-up of Abnormal and Inadequate Test Results in the Danish Cervical Cancer Screening Program.|Active, not recruiting||N/A|125000|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:00:14.760396|2017-10-11 01:00:14.760396
NCT02002455|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-10-20|||December 2013||2013-12-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|Flucipro||Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI|Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma|Completed||Phase 2|26|Actual|Turku University Hospital||1|||f||||f||||||||Undecided||2017-10-11 01:01:28.949309|2017-10-11 01:01:28.949309
NCT02002442|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-10-18|||November 2013||2013-11-01|October 2016|2016-10-01||||June 2016|Actual|2016-06-01||Interventional|||Dental Implants and Mouth Rinse|Comparison of the Effect of the Preoperative Use of Chlorhexidine, Essential Oil, and Cetylpyridinium Chloride Mouthwashes on Bacterial Contamination During Dental Implant Placement: A Randomized Controlled Clinical Trial|Completed||Phase 2|30|Actual|Tufts University School of Dental Medicine||4|||f||||f||||||||||2017-10-11 01:01:29.045947|2017-10-11 01:01:29.045947
NCT02002429|ClinicalTrials.gov processed this data on October 10, 2017|2013-12-01|2016-08-29|||December 2013||2013-12-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Medial Branch Blocks vs. Intra-articular Injections: Randomized, Controlled Study|Medial Branch Blocks vs. Intra-articular Injections: Randomized, Controlled Study Comparing Lumbar Facet Radiofrequency Denervation Using Diagnostic Injections.|Active, not recruiting||N/A|225|Actual|Johns Hopkins University||3|||f||||f||||||||No||2017-10-11 01:01:29.132783|2017-10-11 01:01:29.132783
NCT02002416|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-29|||January 2006||2006-01-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma|Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma: the Comparison Between the Primary and Metastatic Lesions, Early Stage and Advanced Stage|Unknown status|Active, not recruiting|N/A|200|Actual|Sun Yat-sen University|||2||f||||f||||||Samples Without DNA|"     Paraffin-embedded tumor tissue   "|||2017-10-11 01:01:29.244154|2017-10-11 01:01:29.244154
NCT02002403|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2013-12-05|||January 2011||2011-01-01|November 2013|2013-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema|A Randomized, Placebo-Controlled, Parallel Treatment Group, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema|Completed||Phase 2|34|Actual|St. Michael's Hospital, Toronto||3|||f||||||||||||||2017-10-11 01:01:29.642968|2017-10-11 01:01:29.642968
NCT02002390|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2014-09-16|||October 2012||2012-10-01|September 2014|2014-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Efficacy and Safety of FTY720 for Acute Stroke|Efficacy and Safety of FTY720 for the Treatment of Acute Stroke|Unknown status|Recruiting|Phase 2|87|Anticipated|Tianjin Medical University General Hospital||2|||f||||t||||||||||2017-10-11 01:01:29.745275|2017-10-11 01:01:29.745275
NCT02002377|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-10-04|||April 2014||2014-04-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|SHIFT-2||Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections|The SHIFT-2 Study: Use of Intravitreal Aflibercept in Wet Age Related Macular Degeneration (AMD) Patients With an Incomplete Response to Routine Ranibizumab Injections|Recruiting||Phase 4|200|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-11 01:01:29.850865|2017-10-11 01:01:29.850865
NCT02002364|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2014-05-20|||November 2013||2013-11-01|May 2014|2014-05-01||||December 2014|Anticipated|2014-12-01||Interventional|||Comparison of a Single Use (Ambu aScope) and a Reusable Flexible Optical Scope for Intubation Through a Supraglottic Airway Device (Aura-i)|A Comparison Between Flexible Single Use Endoscopes (Ambu aScopes) and Reusable Flexible Endoscopes Used as a Standard of Car When Intubation the Trachea Via an Aura-I Supraglottic Airway Device|Unknown status|Recruiting|N/A|100|Anticipated|Rigshospitalet, Denmark||2|||f||||||||||||||2017-10-11 01:01:30.002946|2017-10-11 01:01:30.002946
NCT02002351|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2016-03-29|||December 2013||2013-12-01|January 2015|2015-01-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01|12 Months|Observational [Patient Registry]|||Prospective Study on Rehabilitation Patients With Pulmonary Hypertension and Other Pulmonary Diseases||Completed||N/A|450|Actual|Paracelsus Harz Clinic Bad Suderode.|||1||f||||f||||||||||2017-10-11 01:01:30.112076|2017-10-11 01:01:30.112076
NCT02002338|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-30|2013-11-30|||February 2013||2013-02-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Observational|||Different Surgical Techniques for Pterygium Surgery|Epidemiological Profile and Comparison Between Different Surgical Techniques for Pterygium Surgery|Completed||N/A|38|Actual|Instituto de Olhos de Goiania|||1||f||||t||||||||||2017-10-11 01:01:30.187876|2017-10-11 01:01:30.187876
NCT02002325|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-04-05|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|THAWS||THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)|THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)|Recruiting||Phase 3|300|Anticipated|National Cerebral and Cardiovascular Center||2|||f||||t||||||||||2017-10-11 01:01:30.263945|2017-10-11 01:01:30.263945
NCT02002312|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-08-12|||August 2011||2011-08-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer|Phase II Study Of Lutetium-177 Labeled Chimeric Monoclonal Antibody Girentuximab (177Lu-DOTA-girentuximab) in Patients With Advanced Renal Cell Cancer|Completed||Phase 2|14|Actual|Radboud University||1|||f||||t||||||||||2017-10-11 01:01:30.375223|2017-10-11 01:01:30.375223
NCT02002299|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-11-29|||August 2013||2013-08-01|July 2013|2013-07-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01|14 Days|Observational [Patient Registry]|CRC1||Does Surface Tell us About the Invasive Front in Colorectal Cancer|Prospective Study of Colorectal Cancer Comparing the Surface With the Invasive Front|Unknown status|Recruiting|N/A|150|Anticipated|Zealand University Hospital|||1||f||||f||||||Samples Without DNA|"     Surgical resection specimens of colorectal cancers   "|||2017-10-11 01:01:30.464786|2017-10-11 01:01:30.464786
NCT02002286|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-29|||August 2011||2011-08-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses|Pilot Study: Safety and Efficacy Study of Tripterygium Wilfordii Hook F Extract in cART-Treated HIV Patients With Poor Immune Responses|Completed||N/A|23|Actual|Peking Union Medical College||2|||f||||t||||||||||2017-10-11 01:01:30.541545|2017-10-11 01:01:30.541545
NCT02002273|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-03-28|||January 2014||2014-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of Regulated Pleural Pressure on Air Leak and Fluid Drainage Following Pulmonary Resections: A Multicenter Randomized Trial|The Effect of Regulated Pleural Pressure on The Duration of Air Leak and Fluid Drainage Following Pulmonary Anatomic Resections: A Multicenter Randomized Trial|Withdrawn||N/A|0|Actual|Ospedali Riuniti Ancona||2|||f||||||||||||||2017-10-11 01:01:30.617552|2017-10-11 01:01:30.617552
NCT02002260|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-10-04|||February 2013||2013-02-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|SHiPP||Stopping Heavy Periods Project|Levonorgestrel Intrauterine System Versus Oral Contraceptives for Heavy Menses|Recruiting||N/A|59|Anticipated|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||||2017-10-11 01:01:30.689393|2017-10-11 01:01:30.689393
NCT02002247|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2017-10-02|||January 2015||2015-01-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|SUSTAINCSX||SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).|SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial). A Multicentre Randomized Controlled Trial of High Dose Sodium-selenite Administration in High Risk Cardiac Surgical Patients|Recruiting||Phase 3|1400|Anticipated|Clinical Evaluation Research Unit at Kingston General Hospital||2|||f||||t||||||||||2017-10-11 01:01:30.775652|2017-10-11 01:01:30.775652
NCT02002234|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-02-16|||January 2002||2002-01-01|February 2014|2014-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|HeMMI||Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial|Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial|Terminated||Phase 3|29|Actual|University of the Philippines||2||Recruitment for the study was terminated due to slow recruitment|f||||||||||||||2017-10-11 01:01:30.942597|2017-10-11 01:01:30.942597
NCT02002221|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-02-02|2016-02-02||December 2013||2013-12-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients|A 12-week, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Equa (Vildagliptin) 50 mg Bid as an add-on Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|156|Actual|Novartis||2|||f||||||||||||||2017-10-11 01:01:31.038131|2017-10-11 01:01:31.038131
NCT02002208|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-10-17|2016-07-12||October 2013||2013-10-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Effect of OC000459 on Moderate to Severe Atopic Dermatitis|A Study of the Effect of OC000459 on Signs and Symptoms in Subjects With Moderate to Severe Atopic Dermatitis: A Randomised Double Blind Placebo Controlled Parallel Group Study|Completed||Phase 2|142|Actual|Atopix Therapeutics, Ltd.||2|||f||||f||||||||No||2017-10-11 01:01:31.773701|2017-10-11 01:01:31.773701
NCT02002195|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2015-04-16|||November 2013||2013-11-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Observational|MATURE||Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer|Modified Folinic Acid-Fluorouracil-Oxaliplatin (FOLFOX) Followed by Capecitabine as First-line Chemotherapy for Elderly or Frail Patients With Metastatic or Recurrent Gastric Cancer|Unknown status|Recruiting|N/A|47|Anticipated|International Group of Endovascular Oncology|||1||f||||f||||||||||2017-10-11 01:01:32.139532|2017-10-11 01:01:32.139532
NCT02002182|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-12-15|||December 2013||2013-12-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer|Window of Opportunity Trial of Neoadjuvant ADXS 11-001 Vaccination Prior to Robot -Assisted Resection of HPV-Positive Oropharyngeal Squamous Cell Carcinoma|Recruiting||Phase 2|30|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 01:01:32.275409|2017-10-11 01:01:32.275409
NCT02002169|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2013-12-09|||December 2012||2012-12-01|December 2013|2013-12-01|November 2014|Anticipated|2014-11-01|July 2014|Anticipated|2014-07-01||Interventional|HIPPO-SAT||Hemodialysis Infection Prevention Using Polysporin Ointment With Shower Technique in Satellite Centres Pilot Study|Hemodialysis Infection Prevention Using Polysporin Ointment With Shower Technique in Satellite Centres (HIPPO SAT) Pilot Study|Unknown status|Recruiting|N/A|78|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:01:32.399296|2017-10-11 01:01:32.399296
NCT02002156|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-09-29|||June 2014||2014-06-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|August 2016|Actual|2016-08-01||Interventional|BAM||A Study of the Interaction Between BCG And MenC Immunisation: BAM|A Pilot Study of the Impact of BCG Administration on the Immunogenicity of Serogroup C Meningococcal Conjugate Vaccine in Healthy Infants|Active, not recruiting||Phase 4|28|Actual|University of Oxford||3|||f||||f||||||||||2017-10-11 01:01:32.556061|2017-10-11 01:01:32.556061
NCT02002143|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2016-12-07|||January 2014||2014-01-01|December 2016|2016-12-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|GAP||GMVs in Primary Care: An RCT of Group-Based Versus Individual Appointments to Reduce HbA1c in Older People|Group Medical Visits (GMVs) in Primary Care: An RCT of Group-Based Versus Individual Appointments to Reduce HbA1c in Older People|Recruiting||N/A|128|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 01:01:32.663898|2017-10-11 01:01:32.663898
NCT02002130|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-10-31|||January 2015||2015-01-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|GABA||The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes|The Use of Glutamic Acid Decarboxylase (GAD)and Gamma-Amino Butyric Acid(GABA)in the Treatment of Type I Diabetes.|Recruiting||Phase 1|95|Anticipated|University of Alabama at Birmingham||3|||f||||t||||||||||2017-10-11 01:01:32.866652|2017-10-11 01:01:32.866652
NCT02002117|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-07-28|||January 2012||2012-01-01|July 2014|2014-07-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Observational|||Genotyping of Non-small Cell Lung Cancer|Genotyping of Non-small Cell Lung Cancer Cells - A Study of Taiwan Lung Cancer Clinical Trial Consortium (TALCC)|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     tissue and plasma   "|||2017-10-11 01:01:33.026298|2017-10-11 01:01:33.026298
NCT02002104|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-11-29|||September 2010||2010-09-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Observational|||Endothelialized ePTFE Graft by Nanobiotechnology|Endothelialized ePTFE Graft by Nanobiotechnology|Completed||N/A|6|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 01:01:33.126314|2017-10-11 01:01:33.126314
NCT02002091|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-03-18|||January 2009||2009-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Prevalence of Morbidity in Newly Diagnosed type2 Diabetes in Adults|Prevalence of Micro and Macroangiopathy in Newly Diagnosed type2 Diabetic Adults in Suburban Area of Algiers|Completed||N/A|327|Actual|University of Algiers|||1||f||||t||||||Samples Without DNA|"     Blood. Urines. Tissue (kidney) for few patients.   "|||2017-10-11 01:01:33.196456|2017-10-11 01:01:33.196456
NCT02002078|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-11-28|||February 2007||2007-02-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Caustic Esophageal Burns in Children and High Doses of Methylprednisolone|High Doses of Methylprednisolone in the Management of Caustic Esophageal Burns in Children|Completed||Phase 4|83|Actual|Sisli Etfal Training & Research Hospital||1|||f||||f||||||||||2017-10-11 01:01:33.32983|2017-10-11 01:01:33.32983
NCT02002065|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2016-07-12|||October 2008||2008-10-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Observational|||The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children|The Phase IV, Open-labelled, Follow-up Study to Evaluate the Five-year Immune Persistence of One Injection of Inactivated or Attenuated Alive Hepatitis A Vaccine in Healthy Chinese Children|Completed||N/A|332|Actual|Sinovac Biotech Co., Ltd|||2||f||||f||||||Samples Without DNA|"     Serum samples were taken from subjects.   "|||2017-10-11 01:01:33.456078|2017-10-11 01:01:33.456078
NCT02002052|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2016-09-08|||May 2014||2014-05-01|September 2016|2016-09-01||||January 2020|Anticipated|2020-01-01||Interventional|FLAIR||Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial|Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial|Recruiting||Phase 2|64|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 01:01:33.545989|2017-10-11 01:01:33.545989
NCT02002039|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-10-12|||June 2012||2012-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Neuroprotective Role of Erythropoietin in Perinatal Asphyxia|Erythropoietin in Perinatal Asphyxia: A Randomized Placebo Controlled Trial|Completed||Phase 2/Phase 3|100|Actual|Sheri Kashmir Institute of Medical Sciences||2|||f||||t||||||||No||2017-10-11 01:01:33.655243|2017-10-11 01:01:33.655243
NCT02002026|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-03-14|||November 2013||2013-11-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa|Uterine Artery Ligation to Minimize Blood Loss in Patients With Central Placenta Previa|Completed||N/A|52|Actual|Minia Maternity University Hospital||2|||f||||t||||||||||2017-10-11 01:01:33.731354|2017-10-11 01:01:33.731354
NCT02002013|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-03-09|||April 2014||2014-04-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|Fluid-TRIPS||The Fluid Translation of Research Into Practice Study|The Fluid Translation of Research Into Practice Study (Fluid-TRIPS): An International Cross-Sectional Survey of Fluid Resuscitation Practice|Completed||N/A|2000|Actual|The George Institute for Global Health, Australia|||1||f||||f||||||||||2017-10-11 01:01:33.943783|2017-10-11 01:01:33.943783
NCT02002000|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2013-12-09|||December 2013||2013-12-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|DOVID||Chronic Pain and Vitamin D|Chronic Pain and Vitamin D: a Randomized Pilot Study in General Practice|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 01:01:34.047061|2017-10-11 01:01:34.047061
NCT02001974|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-06-30|||January 2012||2012-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|||Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)|Phase Ib Pilot Study to Evaluate Reparixin in Combination With Chemotherapy With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)|Completed||Phase 1|33|Actual|Dompé Farmaceutici S.p.A||3|||f||||t||||||||||2017-10-11 01:01:34.380454|2017-10-11 01:01:34.380454
NCT02001961|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-29|2013-11-29|||January 2014||2014-01-01|November 2013|2013-11-01||||June 2014|Anticipated|2014-06-01||Observational|||Pathophysiology of Dilated Cardiomyopathy|Using Novel Blood and Imaging Biomarkers to Better Understand the Pathophysiology of Paediatric Dilated Cardiomyopathy|Unknown status|Not yet recruiting|N/A|20|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust|||2||f||||t||||||Samples Without DNA|"     Blood plasma (>400 UL) will be collected in heparinised tubes plasma will be extracted and     the cell fraction discarded. Plasma will be stored at 80°C prior to transport on dry ice, via     protected courier.   "|||2017-10-11 01:01:34.524157|2017-10-11 01:01:34.524157
NCT02001948|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-11-29|||July 2009||2009-07-01|November 2013|2013-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Intrathecal Morphine for Inguinal Hernia Repair.|The Comparison of Two Different Doses of Morphine Added to Spinal Bupivacaine for Inguinal Hernia Repair.|Completed||Phase 4|46|Actual|Ankara University||2|||f||||f||||||||||2017-10-11 01:01:34.656178|2017-10-11 01:01:34.656178
NCT02001935|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-08-19|||September 2013||2013-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Association Between CytochromeP4501A2 and CytochromeP4502E1 Gene Polymorphisms and Metabolism of Theophylline|Association Between CytochromeP4501A2(CYP1A2) and CytochromeP4502E1(CYP2E1) Gene Polymorphisms and Metabolism of Theophylline in a Chinese Population|Completed||N/A|102|Actual|Zhujiang Hospital||1|||f||||t||||||||||2017-10-11 01:01:34.783327|2017-10-11 01:01:34.783327
NCT02001922|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-05-18|||March 2013||2013-03-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Soins intégrés BPCO (Broncho-pneumopathie Chronique Obstructive) en Valais - Mieux Vivre Avec ma BPCO (COPD Integrated Care Program Valais - Living Well With COPD)|COPD Integrated Care Program Valais - Living Well With COPD, a Pilot Study Assessing Feasibility, Acceptability and Effectiveness in the Canton of Valais, Switzerland|Completed||N/A|57|Actual|Centre Hospitalier du Centre du Valais||2|||f||||f||||||||||2017-10-11 01:01:34.887432|2017-10-11 01:01:34.887432
NCT02001909|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-28|2015-08-12|||December 2013||2013-12-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Neomycin on the Pharmacokinetics of Regorafenib|Single-center, Open-label, Non-randomized, Two-period Sequential Treatment Study to Assess the Effect of Neomycin on the Pharmacokinetics of Regorafenib in Healthy Male Subjects|Completed||Phase 1|27|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:01:35.005096|2017-10-11 01:01:35.005096
NCT02001896|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-28|||December 2013||2013-12-01|November 2013|2013-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation|A Randomized, Open-label Phase III Study of First-line Treatment With Erlotinib Intercalated With Gemcitabine/ Cisplatin or Carboplatin Therapy Versus Erlotinib in Stage IIIB/IV NSCLC Patients With EGFR Mutation|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Xinjiang Medical University||2|||f||||f||||||||||2017-10-11 01:01:35.166478|2017-10-11 01:01:35.166478
NCT02001883|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2013-12-04|||November 2013||2013-11-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|ADHERENCE||Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients|Randomized Trial of the Association Between Low-Dose Statins and Nutraceuticals in High-intEnsity Statin-intoleRant patiENts With Very High Risk Coronary Artery diseasE|Unknown status|Recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 01:01:35.312572|2017-10-11 01:01:35.312572
NCT02001870|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-17|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|July 2017|Anticipated|2017-07-01||Interventional|AMPAGE||Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years|Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years|Recruiting||N/A|600|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 01:01:35.420417|2017-10-11 01:01:35.420417
NCT02001857|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-08-24|||September 2013||2013-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|February 2017|Actual|2017-02-01||Interventional|||Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.|Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.|Completed||Phase 4|200|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:01:35.571326|2017-10-11 01:01:35.571326
NCT02001831|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-11-28|||January 2014||2014-01-01|November 2013|2013-11-01|January 2015|Anticipated|2015-01-01|August 2014|Anticipated|2014-08-01||Interventional|||Multi-ingredient Nutrition Supplement in Older Adults|Effect of a Nutrition Supplement Containing Fish Oil, Whey Protein, Vitamin D, and Resveratrol, on Muscular and Cognitive Function in Older Adults|Unknown status|Not yet recruiting|N/A|50|Anticipated|University College Dublin||2|||f||||f||||||||||2017-10-11 01:01:35.758164|2017-10-11 01:01:35.758164
NCT02001818|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-05-18|||April 2014||2014-04-01|November 2013|2013-11-01|December 2021|Anticipated|2021-12-01|May 2018|Anticipated|2018-05-01||Interventional|PInNACLe||Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia|Phase II Study of Nilotinib Plus Pegylated Interferon Alfa-2b as First-line Therapy in Chronic Phase Chronic Myelogenous Leukaemia Aiming to Maximize Complete Molecular Response and Major Molecular Response.|Recruiting||Phase 2|100|Anticipated|Australasian Leukaemia and Lymphoma Group||1|||f||||t||||||||||2017-10-11 01:01:35.861126|2017-10-11 01:01:35.861126
NCT02001805|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2013-11-28|||December 2010||2010-12-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Marathon Runners Compared to Sedentary Matched Control Subjects|Fitness, Glucosemetabolism, Cognitive Function, Bodycomposition and Muscular Function in Active Runners and Matched Controls|Unknown status|Recruiting|N/A|200|Anticipated|Rigshospitalet, Denmark|||2||f||||t||||||Samples With DNA|"     Whole blood, plasma, muscle tissue   "|||2017-10-11 01:01:35.961938|2017-10-11 01:01:35.961938
NCT02001792|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-14|2014-11-13|||April 2012||2012-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|PACSO||Patient Positioning During Colonoscopy: Effects on Safety and Diagnostic Outcome||Completed||N/A|412|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-11 01:01:36.046897|2017-10-11 01:01:36.046897
NCT02001779|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-02-12|||October 2013|Actual|2013-10-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|IRCSMBO||IRS(Irradiation Stent) vs. CS(Conventional Stent) Insertion in Inoperable Malignant Biliary Obstruction|Study of Stent Insertion Combined With or Without Brachytherapy in Patients With Inoperable Malignant Biliary Obstruction|Completed||N/A|328|Actual|Zhongda Hospital||2|||f||||t||||||||No||2017-10-11 01:01:36.127897|2017-10-11 01:01:36.127897
NCT02001766|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-06-15|||February 2013||2013-02-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||ATP Release and Sympathetic Nerve Activity in Patients With Type II Diabetes|ATP Release and Sympathetic Nerve Activity in Patients With Type II Diabetes|Unknown status|Recruiting|Phase 1/Phase 2|45|Anticipated|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-10-11 01:01:36.238408|2017-10-11 01:01:36.238408
NCT02001753|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-23|2014-04-03|||December 2013||2013-12-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Impact of Cardiac Magnetic Resonance Imaging on Endothelial Function in Type 2 Diabetes|Impact of Cardiac Magnetic Resonance Imaging on Endothelial Function in Type 2 Diabetes|Completed||Phase 4|88|Actual|Wuhan General Hospital of Guangzhou Military Command||3|||f||||t||||||||||2017-10-11 01:01:36.395411|2017-10-11 01:01:36.395411
NCT02001740|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-11-21|||December 2012||2012-12-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||An RCT in Treatment of Adhesive Capsulitis Arthrographic Joint Distention With Local Anesthetic Alone|Treatment of Adhesive Capsulitis: A Randomized Placebo-Controlled Trial Comparing Arthrographic Joint Distention With Steroid and Local Anesthetic Versus Arthrographic Joint Distention With Local Anesthetic Alone|Completed||Phase 4|108|Actual|Queen's University||2|||f||||||||||||||2017-10-11 01:01:36.461059|2017-10-11 01:01:36.461059
NCT02001727|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-11-19|||March 2012||2012-03-01|November 2014|2014-11-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||HEP-FYN 12-Years Follow-up|Long-term Effect of Screening and Eradication of Helicobacter Pylori in the General Population - HEP-FYN 12-years Follow-up|Unknown status|Active, not recruiting|N/A|10000|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 01:01:36.545241|2017-10-11 01:01:36.545241
NCT02001701|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2016-01-30|||November 2013||2013-11-01|January 2016|2016-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|RELEASE||Intravitreal Gas for Vitreomacular Adhesion|Intravitreal Injection of Expansile Sulfa Hexafluoride Gas for Symptomatic Vitreomacular Adhesion|Withdrawn||N/A|0|Actual|Northern California Retina Vitreous Associates||1||No patients were enrolled.|f||||f||||||||Undecided||2017-10-11 01:01:36.755775|2017-10-11 01:01:36.755775
NCT02001688|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2016-06-14|||April 2014||2014-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||"Phase II, Safety and ELF Study of Kamada-API for Inhalation"|Phase II, Double-blind, Placebo-controlled Study to Explore the ELF and Plasma Concentration as Well as Safety of Inhaled Alpha-1 Antitrypsin in Alpha-1 Antitrypsin Deficiency Subjects|Completed||Phase 2|24|Actual|Kamada, Ltd.||3|||f||||||||||||||2017-10-11 01:01:36.85852|2017-10-11 01:01:36.85852
NCT02001675|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-12-04|||December 2012||2012-12-01|November 2013|2013-11-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Both Metabolic and Functional Effects Induced by Two Neuromuscular Electrical Stimulation Protocols: A Comprehensive Approach Using Magnetic Resonance Imaging and Spectroscopy|Comparison of Both Metabolic and Functional Effects Induced by Two Neuromuscular Electrical Stimulation Protocols: A Comprehensive Approach Using Magnetic Resonance Imaging and Spectroscopy|Unknown status|Active, not recruiting|N/A|60|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:01:36.945389|2017-10-11 01:01:36.945389
NCT02001662|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-12-05|||May 2013||2013-05-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Adductor Canal Block and Arthroscopic Knee Surgery, High Pain Responders|The Analgesic Efficacy of the Adductor Canal Blockade in High Pain Responders After Arthroscopic Knee Surgery - a Randomized Clinical Trial|Completed||Phase 4|50|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-11 01:01:37.00868|2017-10-11 01:01:37.00868
NCT02001649|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-10-07|||December 2013||2013-12-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|VGTSA||Genetic Variants Associated With Adolescent Suicide Attempts|Genetic Variants Associated With Adolescent Suicide Attempts: a Candidate-gene Association Study.|Completed||N/A|250|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 01:01:37.083862|2017-10-11 01:01:37.083862
NCT02001636|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-27|||November 2011||2011-11-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|EPEAB||Effect of Protein Supplementation After Bariatric Surgery|Impact of Protein Supplementation After Bariatric Surgery - a Randomized, Controlled, Double Blind Pilot Study|Completed||N/A|35|Actual|University of Hohenheim||2|||f||||||||||||||2017-10-11 01:01:37.164749|2017-10-11 01:01:37.164749
NCT02001623|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-06-30|||November 2013||2013-11-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|||Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors|First-in-human, Dose-escalating Safety Study of Tissue Factor Specific Antibody Drug Conjugate Tisotumab Vedotin (HuMax® TF ADC) in Patients With Locally Advanced and/or Metastatic Solid Tumors Known to Express Tissue Factor|Active, not recruiting||Phase 1/Phase 2|144|Anticipated|Genmab||1|||f||||t||||||||||2017-10-11 01:01:39.666518|2017-10-11 01:01:39.666518
NCT02001610|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-02-06|||March 2014|Actual|2014-03-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Acidophilus Pearls Fecal Recovery Study|Clinical Trial of the Viability of LAB and Bifidobacteria From Acidophilus Pearls in Human Stool Samples|Completed||N/A|13|Actual|University of Florida||2|||f||||f|f|f||||||No||2017-10-11 01:01:39.835735|2017-10-11 01:01:39.835735
NCT02001597|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-12-04|||March 2013||2013-03-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|TRUS-RP||Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical Prostatectomy|Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical Prostatectomy|Completed||N/A|20|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 01:01:39.911021|2017-10-11 01:01:39.911021
NCT02001584|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-07-04||||||July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy Adults||Completed||Phase 1|||Gedeon Richter Plc.||2|||f||||||||||||||2017-10-11 01:01:39.988108|2017-10-11 01:01:39.988108
NCT02001571|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-28|||August 2009||2009-08-01|November 2013|2013-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function|A Phase 1 Single Dose Open-Label Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function|Completed||Phase 1|24|Actual|Cougar Biotechnology, Inc.||3|||f||||f||||||||||2017-10-11 01:01:40.081987|2017-10-11 01:01:40.081987
NCT02001545|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-11-13|||February 2014||2014-02-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|RE-ACT||REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients|REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients|Completed||N/A|814|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:01:40.279237|2017-10-11 01:01:40.279237
NCT02001532|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-05-12|||May 2014||2014-05-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|May 2016|Actual|2016-05-01||Observational|||Arterial Stiffness and Complication Risk in Type 2 Diabetes|Arterial Stiffness and Complication Risk in Type 2 Diabetes|Active, not recruiting||N/A|140|Actual|University of Aarhus|||2||f||||f|||||||"     Whole blood Serum/plasma Urine   "|||2017-10-11 01:01:40.3626|2017-10-11 01:01:40.3626
NCT02001519|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-11-29|||March 2012||2012-03-01|November 2013|2013-11-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|PACER||Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy|A Phase ll Trial of Impact of Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer Not Achieving Clinical CR After 4 Cycles of Neoadjuvant Adriamycin Plus Cyclophosphamide|Completed||Phase 2|88|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 01:01:41.519483|2017-10-11 01:01:41.519483
NCT02001103|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-07-11|||January 2014||2014-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia|Memantine add-on for Improving Cognitive Impairments and Negative Symptoms in Patients With Schizophrenia|Recruiting||Phase 3|120|Anticipated|National Taiwan University Hospital||3|||f||||f||||||||||2017-10-11 01:01:46.102762|2017-10-11 01:01:46.102762
NCT02001506|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-08-26|||November 2012||2012-11-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Neo-shorter||Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer|A Randomized Phase III Trial of Neoadjuvant Chemotherapy With 3 Cycles of FEC Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Adriamycin Plus Cyclophosphamide Followed by 4 Cycles of Docetaxel in Node-positive Breast Cancer|Completed||Phase 3|250|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:01:41.628776|2017-10-11 01:01:41.628776
NCT02001493|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-06-22|||January 2014||2014-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Observational|||Metabolomic Profiling in Renal Cell Carcinoma|Observational Prospective Study to Analyze a Metabolomic Profile and to Explore it as Prognostic Factor in Patients With Renal Cell Carcinoma (mRCC)|Unknown status|Recruiting|N/A|60|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||t||||||None Retained|"     urine and blood   "|||2017-10-11 01:01:41.718868|2017-10-11 01:01:41.718868
NCT02001480|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-01-19|||October 2013||2013-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease||Completed||N/A|60|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 01:01:41.811038|2017-10-11 01:01:41.811038
NCT02001467|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-05-04|||November 2013||2013-11-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||The Effects of Simulation-based Ultrasound Training on Continuity of Care in Managing Pre-mature Onset of Labor||Completed||N/A|12|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:01:41.892433|2017-10-11 01:01:41.892433
NCT02001454|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-11-27|||November 2013||2013-11-01|November 2013|2013-11-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Quality of Pain Management at the Ziv Medical Center|Quality of Pain Management at the Ziv Medical Center|Unknown status|Recruiting|N/A|400|Anticipated|Ziv Hospital|||2||f||||t||||||||||2017-10-11 01:01:41.972157|2017-10-11 01:01:41.972157
NCT02001441|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-12-02|||August 2013||2013-08-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|AIM||UCLA Fitness and Memory Study|Physical Activity Levels and Hippocampal Sub-region Structure in MCI|Terminated||N/A|30|Anticipated|University of California, Los Angeles|||1|Fitness Tracking Device No Longer Available|f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:01:42.040243|2017-10-11 01:01:42.040243
NCT02001428|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-02-17|||May 2014||2014-05-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Malaria in Early Life Study|Intermittent Screening and Treatment for the Control of Malaria in the First Year of Life in Papua, Indonesia: A Cluster Randomized Controlled Trial|Recruiting||N/A|756|Anticipated|Gadjah Mada University||2|||f||||t||||||||||2017-10-11 01:01:42.126035|2017-10-11 01:01:42.126035
NCT02001415|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-23|2016-04-21|||November 2013||2013-11-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|DLTCAM||Efficacy Study of Different Lens Treatments on Chinese Adolescent Myopia|Randomized Controlled Trial of Different Lens Treatments on Chinese Adolescent Myopia|Recruiting||N/A|120|Anticipated|Peking University People's Hospital||3|||f||||t||||||||||2017-10-11 01:01:42.243058|2017-10-11 01:01:42.243058
NCT02001402|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-27|||August 2008||2008-08-01|November 2013|2013-11-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Observational|||Chinese Health Investigation of Nurse Aging||Unknown status|Enrolling by invitation|N/A|2|Anticipated|Peking University First Hospital|||1||f||||t||||||||||2017-10-11 01:01:42.341854|2017-10-11 01:01:42.341854
NCT02001389|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-10-09|||October 2013||2013-10-01|October 2014|2014-10-01||||June 2014|Actual|2014-06-01||Interventional|||Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308|A Phase 1, Open-Label, Multiple Ascending Dose, [18F]MNI-659 PET-Imaging Study to Evaluate PDE10A Occupancy After Dosing With EVP-6308 in Healthy Subjects|Completed||Phase 1|14|Actual|FORUM Pharmaceuticals Inc||4|||f||||||||||||||2017-10-11 01:01:42.396535|2017-10-11 01:01:42.396535
NCT02001376|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-12-03|||April 2011||2011-04-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Health Promotion Project for Workers at National Taiwan University Hospital|A Health Promotion Project for Workers at National Taiwan University Hospital|Unknown status|Recruiting|N/A|240|Anticipated|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-11 01:01:42.593979|2017-10-11 01:01:42.593979
NCT02001363|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-02-04|||November 2013||2013-11-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury|Protective Effect of Glucagonlike Peptide-1 on Reperfusion Injury in Patients With Acute Myocardial Infarction|Recruiting||N/A|90|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 01:01:42.705556|2017-10-11 01:01:42.705556
NCT02001350|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-10-14|||November 2013||2013-11-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Carotid Ultrasound Study|Carotid Ultrasound Study|Completed||N/A|23|Actual|Noblewell|||1||f||||f||||||||||2017-10-11 01:01:42.843637|2017-10-11 01:01:42.843637
NCT02001337|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-09-20|||May 2013||2013-05-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Observational|EXPAND||Examination of the Pancreas in New-onset Diabetes|Examination of the Pancreas in New-onset Diabetes (EXPAND Study)|Active, not recruiting||N/A|1000|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     60ml of whole blood. 5ml urine sample for pregancy testing (if necessary). Stool and saliva     samples may be collected.   "|||2017-10-11 01:01:42.927345|2017-10-11 01:01:42.927345
NCT02001324|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-03-10|||March 2013||2013-03-01|March 2016|2016-03-01||||July 2015|Actual|2015-07-01||Interventional|||HMB- Data Collection Methods|Patient-based Outcomes for Heavy Menstrual Bleeding: Comparisons of Treatments and Methods of Data Collection|Terminated||N/A|42|Actual|Women and Infants Hospital of Rhode Island||2||this pilot project is no longer funded|f||||f||||||||||2017-10-11 01:01:43.025183|2017-10-11 01:01:43.025183
NCT02001311|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-27|||January 2014||2014-01-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||Effect of Chlorhexidine Gel on Bacterial Count During Fixed Orthodontic Treatment|Effect of Chlorhexidine Gel on Bacterial Count and Orthodontic Brackets During Fixed Orthodontic Treatment; In-vivo & In-vitro Study|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|King Abdulaziz University||1|||f||||t||||||||||2017-10-11 01:01:43.116349|2017-10-11 01:01:43.116349
NCT02001285|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-27|||October 2013||2013-10-01|November 2013|2013-11-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Double-lumen Endobronchial Intubation|Comparison of the Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Ordinary Tracheal and Double-lumen Endobronchial Intubation During Propofol-remifentanil Total Intravenous Anesthesia|Unknown status|Recruiting|N/A|50|Anticipated|Jeju National University School of Medicine||2|||f||||||||||||||2017-10-11 01:01:43.27555|2017-10-11 01:01:43.27555
NCT02001272|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-31|||December 2013|Actual|2013-12-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|EWOC-1||EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer|EWOC-1 Trial: Multicenter, Randomized Trial of Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer|Recruiting||Phase 2|240|Anticipated|Hospices Civils de Lyon||3|||f||||t||||||||||2017-10-11 01:01:43.370748|2017-10-11 01:01:43.370748
NCT02001259|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-05-04|||January 2014|Actual|2014-01-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy of Epidural Steroid for Controlling Pain After Primary TKA|Efficacy of Epidural Steroid in Controlling Postoperative Pain After Primary Total Knee Arthroplasty: A Randomized Double-blinded Controlled Trial|Completed||Phase 4|108|Actual|Thammasat University||2|||f||||t||||||||||2017-10-11 01:01:43.690201|2017-10-11 01:01:43.690201
NCT02001246|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-11-14|||January 2014||2014-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Two Anger Management Programs for Teens.|An Exploratory Study of Two Intervention Programs for Anger Management for Teens.|Terminated||N/A|35|Actual|University of Utah||2||We were unable to recruit sufficient numbers of participants to complete the study.|f||||f||||||||No||2017-10-11 01:01:43.820913|2017-10-11 01:01:43.820913
NCT02001233|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-05-20|||March 2013||2013-03-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Observational|||A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine|An Open-labelled, Multicentered, Follow-up Study for a Phase III, Efficacy Trial to Evaluate the Two-year Efficacy, Safety, and Immune Persisitence of Inactivated Enterovirus Type 71 (EV71) Vaccine|Completed||N/A|10077|Actual|Sinovac Biotech Co., Ltd|||2||f||||f||||||Samples With DNA|"     Serum samples will be taken from 1200 subjects in the immunogenicity subgroup 26 months after     the first vaccination.      Throat and anal swab samples will be taken from the cases with Hand, Foot and mouth disease     for the detection of PCR assays and the isolation of EV71.   "|||2017-10-11 01:01:43.915383|2017-10-11 01:01:43.915383
NCT02001220|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-03-09|||January 2015||2015-01-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|RELEASE||Screening Frequency Trial to Identify Weaning Candidates|LibeRation From MEchanicaL VEntilAtion and ScrEening Frequency Trial: The RELEASE Trial|Active, not recruiting||N/A|50|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:01:44.030003|2017-10-11 01:01:44.030003
NCT02001207|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-11-18|||July 2013||2013-07-01|December 2013|2013-12-01||||June 2015|Anticipated|2015-06-01||Observational|||Salivary Cortisol in Intensive Care Unit|Association of Salivary Cortisol Levels and Outcome of Critically Ill Patients in the Intensive Care Unit|Unknown status|Recruiting|N/A|90|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 01:01:44.158054|2017-10-11 01:01:44.158054
NCT02001194|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-10-01|||February 2014||2014-02-01|November 2013|2013-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Way to Be Active I (Teams)|A Randomized Trial of Behavioral Economic Interventions to Improve Physical Activities: Team Incentives|Completed||N/A|304|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 01:01:44.419984|2017-10-11 01:01:44.419984
NCT02001181|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-09-16|2015-09-16||December 2013||2013-12-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||The full analysis set included all participants who were randomized and received at least 1 dose of study drug.|Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)|A Phase 2a, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Pilot Efficacy, Safety, Tolerability, And Pharmacokinetics Of 2% Tofacitinib Ointment In Subjects With Mild To Moderate Atopic Dermatitis|Completed||Phase 2|69|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:01:44.596094|2017-10-11 01:01:44.596094
NCT02001168|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-26|||October 2013||2013-10-01|November 2013|2013-11-01|October 2022|Anticipated|2022-10-01|December 2020|Anticipated|2020-12-01||Interventional|||Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB|Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin: a Randomized, PhaseⅢ and Open Clinical Study of Non-small Cell Lung Cancer in PhaseⅠB|Active, not recruiting||Phase 3|392|Anticipated|Xinjiang Medical University||4|||f||||t||||||||||2017-10-11 01:01:45.403245|2017-10-11 01:01:45.403245
NCT02001155|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-11-08|||July 2013||2013-07-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Observational|||Comparing the Effect of the Water Drinking Test on Intraocular Pressure|Comparing the Effect of the Water Drinking Test on Intraocular Pressure in Patients With Prior Trabeculectomy or Tube Shunt Surgeries|Completed||N/A|40|Actual|Wills Eye|||2||f||||f||||||||Yes|A manuscript is currently under development.|2017-10-11 01:01:45.554559|2017-10-11 01:01:45.554559
NCT02001142|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-06-21|||November 2013||2013-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Effect of Exercise on Metabolic Health|Effect of Exercise on Novel Insulin Signaling Events in Human Muscle|Recruiting||N/A|40|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 01:01:45.681688|2017-10-11 01:01:45.681688
NCT02001129|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-11-26|||August 2013||2013-08-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||Improving Follow-Up Adherence in a Primary Eye Care Setting|Improving Follow-Up Adherence in a Primary Eye Care Setting: A Prospective, Randomized Controlled Trial|Completed||N/A|100|Actual|Wills Eye||3|||f||||f||||||||No||2017-10-11 01:01:45.86976|2017-10-11 01:01:45.86976
NCT02001116|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-08-24|||October 2013||2013-10-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Improving the Quality of Paediatric Hospital Care in the Kyrgyz Republic|Improving the Quality of Paediatric Hospital Care in the Kyrgyz Republic: Evaluation of the Impact of the Intervention|Completed||Phase 2/Phase 3|4626|Actual|WHO Collaborating Centre for Maternal and Child Health, Trieste||2|||f||||t||||||||||2017-10-11 01:01:46.001091|2017-10-11 01:01:46.001091
NCT02001090|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-09-18|||December 2013|Actual|2013-12-01|September 2017|2017-09-01|April 29, 2014|Actual|2014-04-29|April 29, 2014|Actual|2014-04-29||Observational|||Vascular Function on the First Day After Cardiac Surgery|Vascular Function on the First Day After Cardiac Surgery|Completed||N/A|25|Actual|Norwegian University of Science and Technology|||1||f||||f|f|f||||||||2017-10-11 01:01:46.233596|2017-10-11 01:01:46.233596
NCT02001077|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-11-27|||February 2009||2009-02-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|SPIN||Sleep and Pain Interventions in Fibromyalgia|Sleep and Pain Interventions in Fibromyalgia: Hyperalgesia and Central Sensitization|Completed||N/A|113|Actual|University of Florida||3|||f||||f||||||||||2017-10-11 01:01:46.335272|2017-10-11 01:01:46.335272
NCT02001064|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-10-30|||October 2013||2013-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Care4Today v2.0 Application for Improving Adherence to HIV Medications|Pilot Study of Care4Today v.2.0 Application for Improving Adherence to HIV Medications|Completed||N/A|65|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:01:46.445081|2017-10-11 01:01:46.445081
NCT02001051|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-09-07|||November 19, 2013||2013-11-19|September 6, 2017|2017-09-06|July 1, 2020|Anticipated|2020-07-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism|Randomized Control Trial of Adrenalectomy Versus Observation for Subclinical Hypercortisolism|Active, not recruiting||Phase 2|4|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:01:46.57015|2017-10-11 01:01:46.57015
NCT02001038|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-01-29|||February 2013||2013-02-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Survey of Current Management of Orthopaedic Complications in CMT Patients|Survey of Current Management of Orthopaedic Complications in Charcot Marie Tooth Disease Patients|Completed||N/A|16|Actual|University College London Hospitals|||1||f||||f||||||||||2017-10-11 01:01:46.730966|2017-10-11 01:01:46.730966
NCT02001025|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-11-27|||November 2013||2013-11-01|November 2013|2013-11-01||||December 2014|Anticipated|2014-12-01||Observational|||Performance of Bioabsorbable Vascular Scaffolds (Absorb) Compared to Xience Stents - an Optical Coherence Tomography Study||Unknown status|Recruiting|N/A|60|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 01:01:46.855042|2017-10-11 01:01:46.855042
NCT02001012|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-07-05|||January 2014||2014-01-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|CAN KNOW||P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine|Artemether-lumefantrine vs Chloroquine in Patients With Acute Uncomplicated P. Knowlesi Malaria: a Randomized Open Label Trial in Sabah, Malaysia (CAN KNOW Trial)|Completed||Phase 3|123|Actual|Menzies School of Health Research||2|||f||||f||||||||||2017-10-11 01:01:46.95552|2017-10-11 01:01:46.95552
NCT02000999|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-06-01|||November 2013||2013-11-01|June 2015|2015-06-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Observational|||Diagnosis of Bile Duct Strictures|The Diagnostic Yield of Malignancy Comparing Cytology, FISH and Molecular Analysis of Cell Free Cytology Brush Supernatant in Patients With Biliary Strictures Undergoing Endoscopic Retrograde Cholangiography (ERC): A Prospective Study|Unknown status|Recruiting|N/A|110|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 01:01:47.105714|2017-10-11 01:01:47.105714
NCT02000986|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-11-19|||August 2012||2012-08-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors|Effect of Non-Pharmacologic Interventions on Risk Factors of Cardiovascular Disease in Survivors of Childhood Leukemia, Lymphoma and Brain Tumor|Withdrawn||N/A|0|Actual|Virginia Commonwealth University||1||Slow accrual|f||||t||||||||||2017-10-11 01:01:47.197593|2017-10-11 01:01:47.197593
NCT02000973|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-04-20|2014-03-06||November 2013||2013-11-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Effects of Epidural Local Anesthetics on Propofol Induction|Effects of Thoracic Epidural Anesthesia With Different Local Anesthetics on Propofol Induction|Completed||Phase 4|80|Actual|First Hospital of China Medical University||4|||f||||t||||||||||2017-10-11 01:01:47.335205|2017-10-11 01:01:47.335205
NCT02000960|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2016-05-30|||April 2014||2014-04-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|February 2016|Actual|2016-02-01||Interventional|Glut1C7||Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome|A Controlled N-of-1 Before-and-after Study to Determine Safety and Efficacy Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome|Active, not recruiting||Phase 2|3|Anticipated|University of British Columbia||1|||f||||t||||||||||2017-10-11 01:01:47.861299|2017-10-11 01:01:47.861299
NCT02000947|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-09-22|||October 25, 2013|Actual|2013-10-25|September 2017|2017-09-01|November 21, 2018|Anticipated|2018-11-21|November 21, 2018|Anticipated|2018-11-21||Interventional|D4190C00006||A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer|A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer|Active, not recruiting||Phase 1/Phase 2|459|Actual|MedImmune LLC||4|||f||||f|t|f||||||||2017-10-11 01:01:48.002443|2017-10-11 01:01:48.002443
NCT02000934|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-08-10|||December 31, 2013||2013-12-31|August 2017|2017-08-01|May 30, 2019|Anticipated|2019-05-30|May 30, 2019|Anticipated|2019-05-30||Interventional|||A Study of TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies|An Open-Label, Dose Escalation, Phase 1, First-in-Human Study of TAK-659 in Adult Patients With Advanced Solid Tumor and Lymphoma Malignancies|Recruiting||Phase 1|182|Anticipated|Takeda||1|||f||||f||||||||||2017-10-11 01:01:48.454071|2017-10-11 01:01:48.454071
NCT02000921|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-02-14|2016-11-30||December 2013||2013-12-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors|Models for Tobacco Productive Evaluation: Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors|Completed||N/A|136|Actual|University of Minnesota - Clinical and Translational Science Institute|Exploratory study due to small number of participants. Only used first generation of electronic cigarette products.|3|||f||||t||||||||No||2017-10-11 01:01:48.595246|2017-10-11 01:01:48.595246
NCT02000895|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-08-24|||July 2011||2011-07-01|August 2017|2017-08-01|January 2024|Anticipated|2024-01-01|August 2023|Anticipated|2023-08-01|10 Years|Observational [Patient Registry]|||Early Detection of Progressive Kidney Disease in Preterm Infants|Early Detection of Progressive Kidney Disease in Preterm Infants|Enrolling by invitation||N/A|200|Anticipated|University of Miami|||3||f||||f||||||Samples Without DNA|"     Urine Cord Blood Umbilical cords   "|||2017-10-11 01:01:49.233385|2017-10-11 01:01:49.233385
NCT02000882|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-09-29|||May 29, 2014|Actual|2014-05-29|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||STAR Cape+BKM120 MBC With Brain Met|Phase II Multicenter Single-arm Study of BKM120 Plus Capecitabine for Breast Cancer Patients With Brain Metastases|Active, not recruiting||Phase 2|10|Actual|US Oncology Research||1|||f||||t||||||||||2017-10-11 01:01:49.34044|2017-10-11 01:01:49.34044
NCT02000869|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-11-27|||January 2014||2014-01-01|November 2013|2013-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Impact of Arterial Stiffness and Central Aortic Blood Pressure on Kidney Transplant Outcomes.|Impact of Pre- and Post-transplant Arterial Stiffness and Central Aortic Blood Pressure on Post-kidney Transplant Cardiovascular and Allograft Outcomes.|Unknown status|Not yet recruiting|N/A|120|Anticipated|Louisiana State University Health Sciences Center Shreveport|||1||f||||f||||||||||2017-10-11 01:01:49.460564|2017-10-11 01:01:49.460564
NCT02000856|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-12-03|||November 2013||2013-11-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|BEET-PAH||BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension|BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension|Completed||N/A|15|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 01:01:49.566414|2017-10-11 01:01:49.566414
NCT02000843|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-10-02|||December 2013||2013-12-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Tympanoplasty Using Conchal Cavum Approach and Conchal Pericondrium|Tympanoplasty -- Conchal Cavum Approach|Completed||N/A|96|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 01:01:49.707008|2017-10-11 01:01:49.707008
NCT02000830|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-02-09|||August 2013||2013-08-01|February 2016|2016-02-01||||August 2017|Anticipated|2017-08-01||Observational|JASMINE_205||Follow up Study of Patients Having Participated in Clinical Trial 64,185-204|A 48-52 Month Blinded-Outcomes Follow up Study of Patients Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-204|Enrolling by invitation||N/A|90|Anticipated|InfaCare Pharmaceuticals Corporation|||3||f||||t||||||||||2017-10-11 01:01:49.851683|2017-10-11 01:01:49.851683
NCT02000817|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-09-28|||March 12, 2014|Actual|2014-03-12|September 2017|2017-09-01|September 24, 2021|Anticipated|2021-09-24|October 26, 2018|Anticipated|2018-10-26||Interventional|||Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients|A Single Blind, Randomised, Placebo Controlled, Repeat Dose, Dose Escalating Study Investigating Safety, Tolerability Pharmacokinetics, Pharmacodynamics and the Beta-Cell Preserving Effect of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients|Active, not recruiting||Phase 2|40|Anticipated|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 01:01:49.984325|2017-10-11 01:01:49.984325
NCT02000804|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-05-12|||October 23, 2013|Actual|2013-10-23|May 2017|2017-05-01|January 4, 2014|Actual|2014-01-04|January 4, 2014|Actual|2014-01-04||Interventional|||Darapladib China PK|A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of 160 mg Enteric-coated Micronised Free Base Darapladib in Healthy Chinese Subjects.|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:01:50.190499|2017-10-11 01:01:50.190499
NCT02000791|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-12-03|||December 2013||2013-12-01|November 2013|2013-11-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Interventional|cLMA||Does Laryngoscopic Tecnique Facilitate cLMA Insertion?|Does Laryngoscopic Tecnique Facilitate cLMA Insertion?|Unknown status|Not yet recruiting|Phase 4|180|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||2|||f||||f||||||||||2017-10-11 01:01:50.300858|2017-10-11 01:01:50.300858
NCT02000778|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-03-28|||November 2013||2013-11-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||EC17 for Intraoperative Imaging in Occult Ovarian Cancer|A Pilot & Feasibility Study of the Imaging Potential of EC17 in Subjects Undergoing Intraoperative Detection of Occult Ovarian Carcinoma|Active, not recruiting||Phase 1|10|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:01:50.419442|2017-10-11 01:01:50.419442
NCT02000765|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-07-10|||November 8, 2013|Actual|2013-11-08|July 2017|2017-07-01|November 30, 2013|Actual|2013-11-30|November 30, 2013|Actual|2013-11-30||Interventional|||A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects|An Open-Label, Non-Randomized, Two-Period, Cross-Over, Mass Balance Study to Investigate the Recovery, Excretion and Pharmacokinetics of 14C-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects (BTZ115774)|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 01:01:50.524652|2017-10-11 01:01:50.524652
NCT02000752|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-09-25|2015-07-04||April 2011||2011-04-01|September 2015|2015-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Influence of Acupuncture in the Placental Expulsion Time|Influence of Acupuncture in the Placental Expulsion Time|Completed||N/A|120|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias||2|||f||||f||||||||||2017-10-11 01:01:50.633705|2017-10-11 01:01:50.633705
NCT02000739|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-07-10|||January 2014||2014-01-01|July 2014|2014-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|GENIUS||Genetically-informed Therapies for Patients With Metastatic Cancer|Phase II GENIUS Trial of GENetically-Informed Therapies for Patients With previoUSly Treated Refractory Metastatic Cancer|Withdrawn||Phase 4|0|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 01:01:50.997318|2017-10-11 01:01:50.997318
NCT02000726|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-11-18|||July 2013||2013-07-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Neuroimaging Predictors of Antidepressant Treatment Outcome||Withdrawn||Phase 2|0|Actual|University of Michigan||1||Lack of funding to complete the trial phase of the study.|f||||f||||||||||2017-10-11 01:01:51.104695|2017-10-11 01:01:51.104695
NCT01999049|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-04-23|||April 2014||2014-04-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Observational|||Observational Study of the Argus® II Retinal Prosthesis System|Observational Study of the Argus® II Retinal Prosthesis System|Unknown status|Recruiting|N/A|10|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 01:02:15.262131|2017-10-11 01:02:15.262131
NCT02000713|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-04-21|||October 2013||2013-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)|Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)|Recruiting||N/A|25|Anticipated|University of Michigan||2|||f||||t|f|||||||No||2017-10-11 01:01:51.240409|2017-10-11 01:01:51.240409
NCT02000700|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-03-01|||March 2014||2014-03-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus|Open-Label, Multicenter, Multiple Oral Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents ≥10 to <18 Years of Age With Type 2 Diabetes Mellitus and Currently on a Stable Dose of Metformin|Completed||Phase 1|17|Actual|Janssen Research & Development, LLC||2|||f||||||||||||||2017-10-11 01:01:51.392138|2017-10-11 01:01:51.392138
NCT02000674|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-07-28|||December 2013||2013-12-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|CURASMUR||Succinylcholine vs Rocuronium for Prehospital Emergency Intubation|Succinylcholine vs Rocuronium for Prehospital Emergency Intubation : a Randomized Trial|Unknown status|Recruiting|Phase 4|1300|Anticipated|Centre Hospitalier Universitaire de la Réunion||2|||f||||t||||||||||2017-10-11 01:01:51.660885|2017-10-11 01:01:51.660885
NCT02000661|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-03-24|||January 2014||2014-01-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Interventional|FFR-SELECT||Routine Versus Selective Use of FFR to Guide PCI|A Randomized Comparative Effectiveness Study of Routine Versus Selective Use of Fractional Flow Reserve (FFR) to Guide Non-Emergent Percutaneous Coronary Intervention (PCI)|Terminated||Phase 4|261|Actual|Cardiology Research UBC||2||Stopped early by DSMB due to slow enrollment - obtained data to be analyzed|f||||f||||||||||2017-10-11 01:01:51.847562|2017-10-11 01:01:51.847562
NCT02000648|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2016-07-25|||January 2012||2012-01-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01|2 Years|Observational [Patient Registry]|||Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand|Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand|Recruiting||N/A|500|Anticipated|Chulalongkorn University|||1||f||||f||||||||No||2017-10-11 01:01:51.952668|2017-10-11 01:01:51.952668
NCT02000635|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-02-29|||December 2014||2014-12-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Observational|Ciné LEPTO||Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique|Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique|Recruiting||N/A|50|Anticipated|University Hospital Center of Martinique|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:01:52.047974|2017-10-11 01:01:52.047974
NCT02000622|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-08-22|||March 27, 2014|Actual|2014-03-27|August 2017|2017-08-01|December 21, 2018|Anticipated|2018-12-21|December 9, 2016|Actual|2016-12-09||Interventional|OlympiAD||Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.|A Phase III, Open Label, Randomised, Controlled, Multi-centre Study to Assess the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.|Active, not recruiting||Phase 3|302|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:01:52.360223|2017-10-11 01:01:52.360223
NCT02000609|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-03-28|||December 2013||2013-12-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|NEXThaler||"A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of Nexthaler Dry Powder Inhaler in COPD Patients"|Phase II, Partial Blind, Randomized, Placebo Controlled, 5-way Cross-over Study to Evaluate the Pharmacodynamics of BDP(Beclomethasone Diproprionate)/B17MP (Beclomethasone-17-Monoproprionate) and FORMOTEROL FUMARATE (FF) Across Two Different Dose Levels of CHF 1535 NEXThaler DPI (Dry Powder Inhaler) and CHF 1535 pMDI (Pressurized Metered-dose Inhaler)in Adult COPD (Chronic Obstructive Pumonary Disease) Patients|Completed||Phase 2|49|Actual|Chiesi Farmaceutici S.p.A.||5|||f||||f||||||||||2017-10-11 01:01:52.92145|2017-10-11 01:01:52.92145
NCT02000596|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-03-01|||January 2014||2014-01-01|March 2016|2016-03-01|January 2025|Anticipated|2025-01-01|January 2024|Anticipated|2024-01-01||Interventional|||1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.|1303GCC: Phase II Study of Trastuzumab and Pertuzumab Alone and in Combination With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over With HER2/Neu Overexpressed Locally Advanced and/or Metastatic Breast Carcinoma|Terminated||Phase 2|2|Actual|University of Maryland||3||funding withdrawn by sponsor|f||||t||||||||||2017-10-11 01:01:53.055333|2017-10-11 01:01:53.055333
NCT02000583|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-09-27|||November 2013||2013-11-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|APEx||Alzheimer's Prevention Through Exercise|Effect of Aerobic Exercise on Pathophysiology of PreClinical Alzheimer's Disease|Recruiting||N/A|100|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 01:01:53.202242|2017-10-11 01:01:53.202242
NCT02000570|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-08-08|||October 2013||2013-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Dynamic Preload Indicators in Sitting Position|Abilities of Dynamic Preload Dependence Indicators to Predict Fluid Responsiveness During Neurosurgery in Sitting Position|Recruiting||N/A|30|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 01:01:53.36952|2017-10-11 01:01:53.36952
NCT02000557|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-12-04|||October 2012||2012-10-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01|1 Month|Observational [Patient Registry]|STFP||Photographic Analysis of Soft Tissue Facial Profile in Patients With Class II Malocclusion|Photographic Analysis Of Soft Tissue Facial Profile In Patients With Class II Malocclusion|Completed||N/A|60|Actual|Academy of Interdisciplinary Dental Education and Research|||1||f||||t||||||||||2017-10-11 01:01:53.552905|2017-10-11 01:01:53.552905
NCT02000544|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2013-12-03|||October 2013||2013-10-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|MECC MODULAR||Clinical Evaluation of a Modular Extracorporeal Circulation Circuit|Clinical Evaluation Study of a Novel Modular Extracorporeal Circulation Circuit in Open Heart Surgery|Unknown status|Recruiting|Phase 3|100|Anticipated|AHEPA University Hospital||1|||f||||f||||||||||2017-10-11 01:01:53.709642|2017-10-11 01:01:53.709642
NCT02000531|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2015-12-09|2015-12-09||January 2014||2014-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population|Ensure Extension Study to Assess the PFS of First-Line Erlotinib (Tarceva®) and Erlotinib After the Time of Disease Progression in Chinese Population Enrolled in the Ensure Trial|Completed||Phase 4|45|Actual|Hoffmann-La Roche||2|||f||||f||||||||||2017-10-11 01:01:53.912922|2017-10-11 01:01:53.912922
NCT02000518|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-03|||July 2012||2012-07-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01|6 Weeks|Observational [Patient Registry]|CK-INF||Emergency Radiotherapy in Metastatic Spinal Cord Compression of Patients With Non-small Cell Lung Cancer|Phase 1 Study of Neurological Outcome After Emergency Radiotherapy in Metastatic Spinal Cord Compression|Completed||N/A|15|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-11 01:01:55.13231|2017-10-11 01:01:55.13231
NCT02000505|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2015-05-02|||November 2013||2013-11-01|May 2015|2015-05-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|frequenz||Comparison of the Quality of CPR by Lay Rescuers With and Without Feedback Devices|Comparison of the Quality of CPR by Lay Rescuers With and Without Telephone Instructions by a Simulated Rescue Coordination Center|Unknown status|Recruiting|N/A|240|Anticipated|University Hospital of Cologne||4|||f||||f||||||||||2017-10-11 01:01:55.264731|2017-10-11 01:01:55.264731
NCT02000492|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-10-25|||September 2013||2013-09-01|October 2016|2016-10-01||||June 2016|Actual|2016-06-01||Interventional|||Frequent Ballgames Training for 9-11 Year Old Schoolchildren|Intense School Based Physical Activity - Physiological, Cognitive and Sociological Aspects|Completed||N/A|423|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 01:01:55.422145|2017-10-11 01:01:55.422145
NCT02000479|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2013-12-08|||April 2011||2011-04-01|December 2013|2013-12-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Influence of Exercise Therapy on Insulin Resistance in Patients With Heart Failure|Influence of Exercise Therapy on Insulin Resistance in Patients With Heart Failure|Completed||N/A|29|Actual|Hasselt University||2|||f||||f||||||||||2017-10-11 01:01:55.515713|2017-10-11 01:01:55.515713
NCT02000466|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2014-10-23|||November 2013||2013-11-01|October 2014|2014-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||FluLaval® Quadrivalent Pregnancy Registry|FluLaval® Quadrivalent Pregnancy Registry: a Prospective, Exploratory, Cohort Study to Detect and Describe Any Abnormal Pregnancy Outcomes in Women Intentionally or Unintentionally Vaccinated With FluLaval® Quadrivalent During Pregnancy or Within 28 Days Preceding Conception|Withdrawn||N/A|0|Actual|GlaxoSmithKline|||1|"GSK has merged all individual pregnancy registries, which are terminated, for its seasonal   influenza vaccines into one combined registry, EPI-FLU-039 VS US PR."|f||||||||||||||2017-10-11 01:01:55.597214|2017-10-11 01:01:55.597214
NCT02000453|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-05-09|||December 20, 2013|Actual|2013-12-20|May 2017|2017-05-01|August 8, 2014|Actual|2014-08-08|August 8, 2014|Actual|2014-08-08||Interventional|||Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.|An Open Label, Experimental Medicine Investigation of the Safety and Tolerability of 400 mg b.i.d. GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.|Terminated||Phase 1|2|Actual|GlaxoSmithKline||1||"GSK has elected to terminate development principally as a result of the statin drug-drug   interaction (DDI) study."|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:01:55.705605|2017-10-11 01:01:55.705605
NCT02000440|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-27|2017-05-11|2017-03-01|2016-06-24|July 1, 2014||2014-07-01|March 2017|2017-03-01|May 11, 2016|Actual|2016-05-11|February 29, 2016|Actual|2016-02-29||Interventional||Losmapimod 7.5 mg BID / 15 mg BID|A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)|Study of Losmapimod to Reduce Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis (FSGS)|Completed||Phase 2|17|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 01:01:55.865133|2017-10-11 01:01:55.865133
NCT02000427|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-07-12|2017-07-12|2015-12-22|January 3, 2014|Actual|2014-01-03|July 2017|2017-07-01|January 6, 2017|Actual|2017-01-06|May 20, 2015|Actual|2015-05-20||Interventional|||Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia|A Phase 2 Single Arm, Multicenter Trial to Evaluate the Efficacy of the BiTE Antibody Blinatumomab in Adult Subjects With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia (Alcantara Study)|Completed||Phase 2|45|Actual|Amgen||1|||f||||t|t|f||||||||2017-10-11 01:01:56.826184|2017-10-11 01:01:56.826184
NCT02000414|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-01-31|||September 2013||2013-09-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|September 2017|Anticipated|2017-09-01||Interventional|DAPTODP||Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Peritoneal Infection|Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Patients With Peritoneal Dialysis and Peritoneal Infection|Recruiting||N/A|12|Anticipated|University Hospital, Caen||1|||f||||t||||||||||2017-10-11 01:01:57.688253|2017-10-11 01:01:57.688253
NCT02000401|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-12-03|||May 2012||2012-05-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain|To Evaluate the Efficacy, Tolerability, and Safety of Intranasal Ketorolac Tromethamine (Sprix) as an Option for Acute (up to 5 Days) Pain Management Adult Interstitial Cystitis Patients Experiencing a Flare of Pain|Completed||Phase 4|15|Actual|Citrus Valley Medical Research, Inc.||1|||f||||f||||||||||2017-10-11 01:01:57.801243|2017-10-11 01:01:57.801243
NCT02000388|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-12-03|||February 2012||2012-02-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management of Post-Vasectomy Pain|Efficacy and Safety of Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management Tool for Adult Male Patients With Post-Vasectomy Pain|Unknown status|Enrolling by invitation|Phase 4|15|Anticipated|Citrus Valley Medical Research, Inc.||2|||f||||f||||||||||2017-10-11 01:01:57.907257|2017-10-11 01:01:57.907257
NCT02000375|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-09-28|||March 2013||2013-03-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ARTT||A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)|A Phase II Non Randomized Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)|Terminated||Phase 2|20|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1||Due to slow recruitment and recent new published data|f||||f||||||||||2017-10-11 01:01:58.052249|2017-10-11 01:01:58.052249
NCT02000362|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-09-05|||August 2014||2014-08-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)|An Open-labelled, Multi Center, Comparative Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease|Recruiting||Phase 1/Phase 2|24|Anticipated|Kang Stem Biotech Co., Ltd.||1|||f||||t||||||||||2017-10-11 01:01:58.304521|2017-10-11 01:01:58.304521
NCT02000349|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-11-16|||September 2013||2013-09-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Frozen-thawed Embryo Transfers and Fresh Embryo Transfers With Whole Chromosome Analysis Using Next Generation Sequencing||Active, not recruiting||Phase 2|186|Anticipated|Reprogenetics||2|||f||||t||||||||||2017-10-11 01:01:58.527827|2017-10-11 01:01:58.527827
NCT02000336|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-03-23|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|CORRA||Comparison of the Effectiveness of Two Different Dosages of Cortisone Compared to Placebo in Rheumatoid Arthritis|Comparison of the Efficacy and Safety of Two Different Starting Dosages of Prednisolone in Early Active Rheumatoid Arthritis: a Randomized, Placebo Controlled Trial|Active, not recruiting||Phase 3|386|Actual|Ruhr University of Bochum||3|||f||||t||||||||||2017-10-11 01:01:58.71502|2017-10-11 01:01:58.71502
NCT02000323|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-26|||August 2012||2012-08-01|November 2013|2013-11-01|August 2017|Anticipated|2017-08-01|September 2016|Anticipated|2016-09-01||Interventional|||Early Enteral Nutrition in Severe Acute Pancreatitis|Early Enteral Nutrition in Severe Acute Pancreatitis|Unknown status|Recruiting|N/A|60|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-11 01:01:58.98401|2017-10-11 01:01:58.98401
NCT02000310|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-09-27|||November 2013||2013-11-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Molecular and Cellular Mechanisms of Lysosomal Storage Diseases|Investigation of Molecular and Cellular Mechanisms of Lysosomal Storage Diseases|Recruiting||N/A|80|Anticipated|O & O Alpan LLC|||1||f||||f||||||||||2017-10-11 01:01:59.115569|2017-10-11 01:01:59.115569
NCT02000297|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-10-13|||October 2013||2013-10-01|October 2014|2014-10-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|||Outcome Comparison of Allograft and Synthetic Bone Substitute in High Tibial Osteotomy|Outcome Comparison of Allogenic Cancellous Bone and a New Synthetic Bone Substitute (geneX®) in Filling the Bone Defect Created With Medial Open Wedge High Tibial Osteotomy|Unknown status|Recruiting|Phase 4|60|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:01:59.232138|2017-10-11 01:01:59.232138
NCT02000284|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-09-13|||October 2012|Actual|2012-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Mito||Mitochondrial Dysfunction in Autism Spectrum Disorder|Defining Subgroups of Mitochondrial Disease and Dysfunction in Autism Spectrum Disorder|Recruiting||N/A|450|Anticipated|University of Arkansas|||6||f||||f||||||Samples With DNA|"     Biochemical Measures        1. Mitochondrial Energetics        2. Redox Metabolism        3. ATP Measurement        4. Mitochondrial Copy Number        5. Clinical Laboratory Testing        6. Urine Testing        7. Stool Testing        8. Teeth Collection        9. Saliva Collection   "|||2017-10-11 01:01:59.347943|2017-10-11 01:01:59.347943
NCT02000271|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2014-10-15|||January 2013||2013-01-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Does Vaginal Packing Influence Patient Outcomes Following Vaginal Reconstructive Surgery?|Does Vaginal Packing Influence Patient Outcomes Following Vaginal Reconstructive Surgery? A Randomized Controlled Trial|Completed||N/A|77|Actual|TriHealth Inc.||2|||f||||||||||||||2017-10-11 01:01:59.468977|2017-10-11 01:01:59.468977
NCT02000258|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-26|||March 2003||2003-03-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|September 2010|Actual|2010-09-01||Interventional|||Effect of Tunnel Placements on Clinical and MRI Findings Two Years After ACL Reconstruction With DB Technique|Effect of Tunnel Placements on Clinical and MRI Findings Two Years After Anterior Cruciate Ligament Reconstruction With Double-Bundle Technique|Completed||N/A|75|Actual|Tampere University Hospital||2|||f||||t||||||||||2017-10-11 01:01:59.571048|2017-10-11 01:01:59.571048
NCT02000245|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-04-18|||October 2013||2013-10-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Sympathy and Touch on Anxiety of Patients Undergoing Fiberoptic Bronchoscopy|Effects of Sympathy and Touch on Anxiety of Patients Undergoing Fiberoptic Bronchoscopy|Completed||N/A|267|Actual|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 01:01:59.687191|2017-10-11 01:01:59.687191
NCT02000232|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-26|||January 2013||2013-01-01|November 2013|2013-11-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01|2 Years|Observational [Patient Registry]|||Impact of Unapproved Drug Initiative on Colchicine Use|Impact of Unapproved Drug Initiative on Colchicine Use|Unknown status|Recruiting|N/A|250|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 01:01:59.789522|2017-10-11 01:01:59.789522
NCT02000219|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-09-26|||May 2014||2014-05-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis|A Phase 2 Open-label Multi-centre Study to Evaluate the Efficacy and Safety of Oxabact® to Reduce Plasma Oxalate in Subjects With Primary Hyperoxaluria Who Are on Dialysis|Recruiting||Phase 2|8|Anticipated|OxThera||1|||f||||f||||||||||2017-10-11 01:01:59.864409|2017-10-11 01:01:59.864409
NCT02000206|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-11-26|||February 2014||2014-02-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|KET-001||Comparison of Propofol/Alfentanil With Propofol/Ketamine|Safety and Efficacy of Sedation for Flexible Fiberoptic Bronchoscopy: Comparison of Propofol/Alfentanil With Propofol/Ketamine|Unknown status|Not yet recruiting|N/A|80|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 01:01:59.978629|2017-10-11 01:01:59.978629
NCT02000193|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-05-31|||November 2013||2013-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|FANCY||Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer|Maintenance Hormone Therapy With Fulvestrant After First-Line Chemotherapy for Postmenopausal Hormone-receptor-positive (HR) Positive Advanced Breast Cancer: A Multicenter, Prospective Phase II Study|Active, not recruiting||Phase 2|58|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 01:02:00.091327|2017-10-11 01:02:00.091327
NCT02000167|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-06-22|||May 2012||2012-05-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment|Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment|Completed||N/A|51|Actual|University of Arkansas|||2||f||||t||||||||||2017-10-11 01:02:00.27918|2017-10-11 01:02:00.27918
NCT02000154|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-02-14|2016-12-11||December 2014||2014-12-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study|Phase I Clinical Trial of SyB L-1101 in Patients With Myelodysplastic Syndrome - Extension Study|Completed||Phase 1|1|Actual|SymBio Pharmaceuticals||1|||f||||||||||||||2017-10-11 01:02:00.411324|2017-10-11 01:02:00.411324
NCT02000141|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-12-15|||January 2014||2014-01-01|December 2015|2015-12-01|January 2034|Anticipated|2034-01-01|December 2024|Anticipated|2024-12-01||Observational|ACER/AMN||The Australian Colonic Advanced Mucosal Neoplasia and Endoscopic Resection Study|The Australian Colonic Advanced Mucosal Neoplasia and Endoscopic Resection Study - a Prospective Observational Cohort Study|Recruiting||N/A|2000|Anticipated|Western Sydney Local Health District|||1||f||||t||||||||||2017-10-11 01:02:00.711401|2017-10-11 01:02:00.711401
NCT02000128|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-04-19|||November 2013||2013-11-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Fluid Management Guided by Bioimpedance Analysis in Peritoneal Dialysis(PD) Patients.|A Prospective, Randomized Controlled Study of Bioimpedance Analysis(BIA) Guided Fluid Management in Peritoneal Dialysis Patients.|Completed||N/A|240|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:02:00.833037|2017-10-11 01:02:00.833037
NCT02000115|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-03-17|||May 2014||2014-05-01|March 2017|2017-03-01|September 2022|Anticipated|2022-09-01|September 2018|Anticipated|2018-09-01||Interventional|PORTICO IDE||Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial|Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial|Recruiting||N/A|758|Anticipated|St. Jude Medical||2|||f||||t||||||||||2017-10-11 01:02:00.969369|2017-10-11 01:02:00.969369
NCT02000102|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-11-17|||September 2013||2013-09-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab||Completed||N/A|14|Actual|Stanford University|||1||f||||||||||||||2017-10-11 01:02:02.892849|2017-10-11 01:02:02.892849
NCT02000089|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-03-13|||January 2014||2014-01-01|March 2017|2017-03-01|December 2023|Anticipated|2023-12-01|October 2021|Anticipated|2021-10-01||Observational|CAPS5||The Cancer of the Pancreas Screening-5 CAPS5)Study|The Cancer of the Pancreas Screening-5 CAPS5)Study|Recruiting||N/A|2500|Anticipated|Johns Hopkins University|||9||f||||t|t|f||||Samples With DNA|"     approximately 40 ml of blood approximately 5-20 ml pancreas juice approximately 10 ml saliva     (optional) pancreas cyst fluid (if available)   "|No||2017-10-11 01:02:02.994225|2017-10-11 01:02:02.994225
NCT02000063|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-09-29|||August 2012||2012-08-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|ATAHC Recall||Australian Trial in Acute Hepatitis C Recall Study|Long-term Outcomes Following Treatment of Recently Acquired Hepatitis C Virus Infection.|Completed||N/A|50|Actual|Kirby Institute|||1||f||||f||||||Samples With DNA|"     Stored serum and peripheral blood mononuclear cells.   "|||2017-10-11 01:02:03.327261|2017-10-11 01:02:03.327261
NCT02000050|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-07-20|||July 2013||2013-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|COLORE||Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)|Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma|Recruiting||Phase 2|50|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-11 01:02:03.43877|2017-10-11 01:02:03.43877
NCT02000037|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-11-26|||October 2013||2013-10-01|November 2013|2013-11-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|REFLEX-IR||Interest in the Medium Term of an Infrared Reflexotherapy on Overweight or Class I Obese People|Interest in the Medium Term of an Infrared Reflexotherapy on Overweight or Class I Obese People|Unknown status|Recruiting|N/A|87|Anticipated|Institut Pasteur de Lille||3|||f||||f||||||||||2017-10-11 01:02:03.564177|2017-10-11 01:02:03.564177
NCT02000024|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-04-07|||December 2011||2011-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|||Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes|Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes|Completed||N/A|225|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 01:02:03.708166|2017-10-11 01:02:03.708166
NCT01999647|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2013-12-02|||December 2011||2011-12-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy of Ultrasound-Guided Local Anesthetic Injection Into or Around the Sciatic Nerve for Lower Limb Anesthesia|Intraneural Injection of Ropivacaine for Subgluteal Sciatic Nerve Block Leads to Faster Onset and Higher Success Rates: a Randomized, Controlled Trial|Completed||N/A|64|Actual|University of Parma||2|||f||||f||||||||||2017-10-11 01:02:08.199296|2017-10-11 01:02:08.199296
NCT02000011|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-07-06|||December 2013||2013-12-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|epigac||Interest of a Geriatric Intervention Plan Associated to a Comprehensive Geriatric Assessment on Autonomy, Quality of Life and Survival of Patients Aged 70 Years Old and More Surgically Treated for a Resectable Cancer (Thoracic, Digestive or Urologic). Randomized Multicentric Study|Interest of a Geriatric Intervention Plan Associated to a Comprehensive Geriatric Assessment on Autonomy, Quality of Life and Survival of Patients Aged 70 Years Old and More Surgically Treated for a Resectable Cancer (Thoracic, Digestive or Urologic). Randomized Multicentric Study|Recruiting||N/A|380|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:02:03.817735|2017-10-11 01:02:03.817735
NCT01999998|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-05-18|||August 2013||2013-08-01|May 2015|2015-05-01||||April 2016|Anticipated|2016-04-01||Interventional|||FDG PET-CT for Lymphoma Radiotherapy Planning Version 1.3|A Pilot Study to Optimise the Use of FDG PET-CT and Deformable Image Co-registration for Lymphoma Radiotherapy Planning|Unknown status|Recruiting|N/A|20|Anticipated|The Leeds Teaching Hospitals NHS Trust||1|||f||||||||||||||2017-10-11 01:02:03.929093|2017-10-11 01:02:03.929093
NCT01999985|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-08-18|||December 31, 2013|Actual|2013-12-31|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 21, 2017|Actual|2017-03-21||Interventional|||Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)|Phase I Trial Evaluating Safety and Tolerability of the Irreversible Epidermal Growth Factor Receptor Inhibitor Afatinib (BIBW 2992) in Combination With the SRC Kinase Inhibitor Dasatinib for Patients With Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1|25|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-11 01:02:04.164758|2017-10-11 01:02:04.164758
NCT01999972|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-09-28|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|February 2017|Actual|2017-02-01||Interventional|||A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors|A Phase 1b, Open Label, Dose Escalation Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of Axitinib (Ag-013736) In Combination With Crizotinib (Pf-02341066) In Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|52|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:02:04.315782|2017-10-11 01:02:04.315782
NCT01999959|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-11-26|||January 2010||2010-01-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Effect of Pertubation on Pregnancy Rates Before Intrauterine Insemination Treatment||Completed||Phase 2|180|Actual|Gazi University||2|||f||||||||||||||2017-10-11 01:02:04.480658|2017-10-11 01:02:04.480658
NCT01999946|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-06-14|||June 27, 2014|Actual|2014-06-27|June 2017|2017-06-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|XOR||Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry|Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry|Recruiting||Phase 4|255|Anticipated|New York University School of Medicine||3|||f||||t|t|f|||f|||No||2017-10-11 01:02:04.562347|2017-10-11 01:02:04.562347
NCT01999933|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-02|||November 2013||2013-11-01|November 2013|2013-11-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer|Clinical Study on Docetaxel Plus Cisplatin(TP) Regimen Combined With Postoperative Radiotherapy for Stage Ia2- IIb Cervical Cancer|Recruiting||Phase 2/Phase 3|600|Anticipated|Fourth Military Medical University||3|||f||||t||||||||||2017-10-11 01:02:04.68718|2017-10-11 01:02:04.68718
NCT01999907|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-01-08|||November 2013||2013-11-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|DIVA-pilot||Vitamin D to Reduce Colds and Asthma Attacks in Young Children|Vitamin D vs. Placebo in the Prevention of Viral-induced Exacerbations in Preschoolers With Asthma: a Pilot RCT|Completed||Phase 2|22|Actual|St. Justine's Hospital||2|||f||||t||||||||||2017-10-11 01:02:04.925005|2017-10-11 01:02:04.925005
NCT01999894|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2014-01-31|2014-01-31||November 2009||2009-11-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Open-label Study of Safety and Tolerability of Memantine in Children With Autism|An Open-label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism|Completed||Phase 2|102|Actual|Forest Laboratories||1|||f||||f||||||||||2017-10-11 01:02:05.102831|2017-10-11 01:02:05.102831
NCT01999881|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-02-18|||December 2013||2013-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|July 2015|Actual|2015-07-01||Interventional|||Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients|Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients|Completed||N/A|21|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-11 01:02:05.47146|2017-10-11 01:02:05.47146
NCT01999868|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-01-18|||February 2014||2014-02-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|PAUSE||Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris|Efficacy of Ustekinumab (Anti-IL-12/23) Followed by Abatacept (CTLA4-Ig) for the Treatment of Psoriasis Vulgaris (ITN059AI)|Active, not recruiting||Phase 2|108|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 01:02:05.593004|2017-10-11 01:02:05.593004
NCT01999855|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-09-07|||December 2013|Actual|2013-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2015|Actual|2015-09-01||Interventional|||Frequency of Dysphonia in Asthmatic Patients|Evaluation of the Frequency of Dysphonia by Subjective and Objective Methods in Asthmatic Patients|Terminated||N/A|137|Actual|University Hospital, Strasbourg, France||2||technical problem|f||||f||||||||||2017-10-11 01:02:05.717515|2017-10-11 01:02:05.717515
NCT01999842|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-05-26|||November 25, 2013|Actual|2013-11-25|May 2017|2017-05-01|January 19, 2015|Actual|2015-01-19|February 1, 2014|Actual|2014-02-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age|An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age|Completed||Phase 1|424|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:02:05.79375|2017-10-11 01:02:05.79375
NCT01999829|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-03-13|||October 2013||2013-10-01|August 2015|2015-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo|Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo|Completed||Phase 3|110|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:02:05.913691|2017-10-11 01:02:05.913691
NCT01999816|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-10-26|||September 2008||2008-09-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PUPS||Pressure Ulcer Prevention Study in SCI|Lifestyle Redesign for Pressure Ulcer Prevention in Spinal Cord Injury|Completed||Phase 3|170|Actual|University of Southern California||2|||f||||t||||||||Yes|We will submit de-identified data to ICPSR|2017-10-11 01:02:06.031242|2017-10-11 01:02:06.031242
NCT01999803|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-01-26|||September 2014||2014-09-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS|A Phase I, Randomised, Double-blind, Placebo-controlled Study in Patients With Amyotrophic Lateral Sclerosis to Further Assess the Safety and Tolerability of Intracerebroventricular Administration of sNN0029 Infusion Solution|Terminated||Phase 1|15|Actual|Newron Sweden AB||2||"Issues with development and supply of infusion system for delivery of IMP. Lack of favorable   benefit risk ratio in sNN0029-003 study (review of interim data)."|f||||t||||||||||2017-10-11 01:02:06.193049|2017-10-11 01:02:06.193049
NCT01999790|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2013-11-25|||March 2012||2012-03-01|November 2013|2013-11-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy|Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy|Unknown status|Recruiting|N/A|40|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 01:02:06.320546|2017-10-11 01:02:06.320546
NCT01999777|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-09-19||2016-06-15|November 2013||2013-11-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU|A Randomized, Double-Blind, Placebo Controlled Trial Examining the Safety and Efficacy of Midazolam Intranasal Spray (USL261) for the Treatment of Intermittent Bouts of Increased Seizure Activity in the Epilepsy Monitoring Unit (EMU)|Completed||Phase 3|62|Actual|Proximagen, LLC||2|||f||||t||||||||||2017-10-11 01:02:06.426098|2017-10-11 01:02:06.426098
NCT01999764|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-06-16||2015-06-16|November 2013||2013-11-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation|Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation|Completed||Phase 2|43|Actual|QLT Inc.||3|||f||||f||||||||||2017-10-11 01:02:06.620439|2017-10-11 01:02:06.620439
NCT01999751|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-08-29|||October 2012||2012-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01|1 Year|Observational [Patient Registry]|||Study to Monitor Patients With Pacemakers or ICDs Who Undergo MRI Scans|SMDC CRM-MRI Prospective Case Series|Active, not recruiting||N/A|500|Anticipated|Essentia Health|||1||f||||f||||||||||2017-10-11 01:02:06.721795|2017-10-11 01:02:06.721795
NCT01999738|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-08-21|||October 2013||2013-10-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors|A Phase I A/B Study of the Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|93|Actual|Endocyte||7|||f||||f|t|f||||||||2017-10-11 01:02:06.831042|2017-10-11 01:02:06.831042
NCT01999725|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-01-07|||January 2014||2014-01-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788|A Randomized, Double-Blind, Placebo-Controlled, Ascending One-Day (Single and Divided Dose) Safety, Tolerability, and Pharmacokinetic Study of EDP-788 in Healthy Adult Volunteers|Completed||Phase 1|80|Actual|Enanta Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:02:06.981694|2017-10-11 01:02:06.981694
NCT01999712|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-07-20|||July 2013||2013-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Right Ventricular Failure After Implantation of Left Ventricular Assist Devices|Right Ventricular Failure After Implantation of Left Ventricular Assist Devices|Suspended||N/A|120|Anticipated|Emory University|||1|Investigator and study currently in transition to new institution.|f||||f||||||Samples Without DNA|"     Serum and plasma will be stored for biomarkers analysis   "|||2017-10-11 01:02:07.06615|2017-10-11 01:02:07.06615
NCT01999699|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-08-28|||November 2013||2013-11-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||A Study of the Immune Response to Heplisav in Healthy Older Adults|A Phase 1 Systems Biology Study to Investigate Immune Correlates of the Response to an Experimental Hepatitis B Vaccine (HEPLISAV) in Healthy Adults 50 to 70 Years of Age.|Completed||Phase 1|25|Actual|Dynavax Technologies Corporation||1|||f||||f||||||||||2017-10-11 01:02:07.155063|2017-10-11 01:02:07.155063
NCT01999686|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-05-02|||October 2014||2014-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|POSITIF||PCOS Treatment Using DLBS3233, Metformin, and Combination of Both|Polycystic Ovary Syndrome Treatment Using DLBS3233, Metformin, and Combination of Both, and Its Relation to Fertility|Recruiting||Phase 3|186|Anticipated|Dexa Medica Group||3|||f||||f||||||||||2017-10-11 01:02:07.246515|2017-10-11 01:02:07.246515
NCT01999673|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-04-19|||December 2013||2013-12-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|SUNRISE||Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer|SUNRISE: A Phase III, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Previously Treated Stage IIIb/IV Non-Squamous Non Small-Cell Lung Cancer|Completed||Phase 3|582|Anticipated|Peregrine Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:02:07.500493|2017-10-11 01:02:07.500493
NCT01999660|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-02-24|||November 2013||2013-11-01|November 2013|2013-11-01|January 2019|Anticipated|2019-01-01|January 2016|Anticipated|2016-01-01||Observational|||Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™|Prospective National Post-marketing Surveillance for the Investigation of the Efficacy and Safety of SpaceOAR™ to Maintain Space Between the Rectum and Prostate During Radiation Therapy|Recruiting||N/A|250|Anticipated|CS Diagnostics GmbH|||1||f||||f||||||||||2017-10-11 01:02:08.111219|2017-10-11 01:02:08.111219
NCT01999634|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-01-30|||November 2013||2013-11-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|MTM-COLON-II||Monitoring by Microdialysis of Postoperative Complications After Proctectomy|Evaluation of Microdialysis to Monitor Postoperative Outcomes After Proctectomy|Recruiting||Phase 3|30|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||t||||||||||2017-10-11 01:02:08.417749|2017-10-11 01:02:08.417749
NCT01999621|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-11-25|||December 2010||2010-12-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|CBP-DO||Determinants of Intensity of Care of Lung Cancer Patients With Organ Failure|Determinants of Intensity of Care of Lung Cancer Patients With Organ Failure|Completed||N/A|140|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-11 01:02:08.536198|2017-10-11 01:02:08.536198
NCT01999608|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-06-01|||August 2013||2013-08-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Observational|||Vitamin D Deficiency and Ovarian Reserve Among Infertile Patients|Vitamin D Deficiency and Ovarian Reserve Among Infertile Patients. A Cross-sectional Analysis|Completed||N/A|283|Actual|Universitair Ziekenhuis Brussel|||2||f||||f||||||||||2017-10-11 01:02:08.614372|2017-10-11 01:02:08.614372
NCT01999595|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-02|||November 2013||2013-11-01|November 2013|2013-11-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|TENS||The Antalgic Effect of Pulse Frequency and Pad Size of TENS on Blunt Pressure Pain|The Effect of Pulse Frequency and Pad Size of Transcutaneous Electrical Nerve Stimulation (TENS) on Experimental Blunt Pressure Pain in Healthy Participants|Unknown status|Enrolling by invitation|Phase 4|180|Anticipated|Chang Gung University||6|||f||||f||||||||||2017-10-11 01:02:08.719761|2017-10-11 01:02:08.719761
NCT01999582|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-02-14|||November 2013||2013-11-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis|A Phase 2 Multicenter, Randomized, Open-Label , Multiple-Dose Study of Intravenous and Subcutaneous Administration of Sotatercept (ACE-011) in Subjects With End-Stage Kidney Disease on Hemodialysis Switched From Erythropoeisis Stimulating Agents With Staggered Dose Group Escalation in Part 1 Followed by a Parallel Group, Active Controlled Study of Selected Dose(s) and Regimen(s) in Part 2: To Evaluate the Pharmacokinetics, Safety, Tolerability, Efficacy, Dosing Regimen, and Pharmacodynamics of Sotatercept|Completed||Phase 2|49|Actual|Celgene||2|||f||||f||||||||||2017-10-11 01:02:08.896784|2017-10-11 01:02:08.896784
NCT01999556|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-07-26|||November 2013||2013-11-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia|LCI-HEM-SPEC-001: Tissue Collection for Familial Acute Myelogenous Leukemia Genetic Analysis|Recruiting||N/A|20|Anticipated|Carolinas Healthcare System|||2||f||||t||||||||||2017-10-11 01:02:09.175475|2017-10-11 01:02:09.175475
NCT01999543|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-02-21|||November 2013||2013-11-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Post-prandial Glucose in Healthy Indian Subjects|Effect of Plant-based Ingredient in Different Food Formats on Post-prandial Glucose in Healthy Indian Subjects|Completed||N/A|120|Actual|Unilever R&D||4|||f||||f||||||||||2017-10-11 01:02:09.275255|2017-10-11 01:02:09.275255
NCT01999530|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-12-21|||November 2013||2013-11-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study|Exploring the Effects of Prazosin on Basal Dopamine in Healthy Humans: A [11C]-(+)-PHNO PET Pilot Study|Active, not recruiting||Phase 1|6|Anticipated|Centre for Addiction and Mental Health||1|||f||||t||||||||Yes||2017-10-11 01:02:09.384019|2017-10-11 01:02:09.384019
NCT01999517|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2017-03-21|||June 2013||2013-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CoNaN||Contrast Nephropathy and Nitrates|Contrast Nephropathy and Nitrates|Recruiting||Phase 4|400|Anticipated|Mt. Sinai Medical Center, Miami||2|||f||||t||||||||||2017-10-11 01:02:09.495673|2017-10-11 01:02:09.495673
NCT01999504|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2014-10-16|||October 2013||2013-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|FooA2||Gut Hormone Response After Paleolithic-type Meals|Gut Hormone Response After Two Paleolithic-type Meals Compared to a Modern-type Meal Composed According to WHO Guidelines|Completed||N/A|24|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-11 01:02:09.605227|2017-10-11 01:02:09.605227
NCT01999478|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-06-09|||February 2008||2008-02-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|BRP||Novel Biophotonics Methodology for Colon Cancer Screening|Novel Biophotonics Methodology for Colon Cancer Screening|Completed||N/A|4000|Anticipated|Boston Medical Center|||1||f||||f||||||||No||2017-10-11 01:02:09.737013|2017-10-11 01:02:09.737013
NCT01999465|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-03-01|||November 2013|Actual|2013-11-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||NMES Efficacy on Patients With NBPP|Neuromuscular Electrical Stimulation (NMES) Efficacy on Patients With Neonatal Brachial Plexus Palsy (NBPP)|Recruiting||N/A|30|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 01:02:09.821369|2017-10-11 01:02:09.821369
NCT01999452|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2016-09-06|||October 2015||2015-10-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|SwePaD||The Swedish Study on Paleolithic Diet for Type 2 Diabetes|The Swedish Study on Paleolithic Diet for Type 2 Diabetes|Recruiting||Phase 3|150|Anticipated|Lund University Hospital||2|||f||||f||||||||||2017-10-11 01:02:09.920593|2017-10-11 01:02:09.920593
NCT01999439|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-12-15|||January 2014||2014-01-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||EoE(Eosinophilic Esophagitis)|Quantitative MRI Evaluation of Esophageal Remodeling/Response to Treatment in Children and Adolescents With Eosinophilic Esophagitis Presenting With Dysphagia|Completed||N/A|10|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-11 01:02:10.045473|2017-10-11 01:02:10.045473
NCT01999426|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2013-11-26|||July 2006||2006-07-01|November 2013|2013-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Efficacy of Emergency On-call Respiratory Physiotherapy Services in the Paediatric Intensive Care Unit|Safety and Efficacy of Emergency On-call Respiratory Physiotherapy Services in the Paediatric Intensive Care Unit|Completed||N/A|93|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:02:10.145693|2017-10-11 01:02:10.145693
NCT01999413|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-10-25|||November 2013||2013-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|FAMYLY||Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients|Pilot Study of the Efficacy and Tolerance of the Adjunction of a Fish Oil Emulsion to Daunorubicin and Cytarabine Chemotherapy for the Treatment of Acute MYeloblastic Leukemia of Younger Patients With High-risk Cytogenetics|Completed||Phase 2|30|Actual|French Innovative Leukemia Organisation||1|||f||||t||||||||No||2017-10-11 01:02:10.246237|2017-10-11 01:02:10.246237
NCT01999400|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-05-02|2016-11-07||April 2012||2012-04-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|September 2015|Actual|2015-09-01||Interventional|||Correlation of Mesalamine Pharmacokinetics With Local Availability|Correlation of Mesalamine Pharmacokinetics With Local Availability|Completed||N/A|30|Actual|University of Michigan|Evaluation of healthy volunteers that may not reflect patients with inflammatory bowel disease.|6|||f||||||||||||||2017-10-11 01:02:10.358407|2017-10-11 01:02:10.358407
NCT01999387|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2013-12-02|||June 2013||2013-06-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|OIT followup||Follow up of Patients After Oral Immunotherapy for Cow's Milk, Eggs and Peanuts||Unknown status|Recruiting|N/A|500|Anticipated|Assaf-Harofeh Medical Center|||1||f||||t||||||Samples Without DNA|"     Blood tests   "|||2017-10-11 01:02:10.81974|2017-10-11 01:02:10.81974
NCT01999348|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-26|2015-11-03|2015-11-03||November 2013||2013-11-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting||Completed||N/A|1553|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:02:11.168995|2017-10-11 01:02:11.168995
NCT01999335|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-06-20|||November 2013||2013-11-01|June 2017|2017-06-01|December 22, 2017|Anticipated|2017-12-22|September 30, 2017|Anticipated|2017-09-30||Interventional|||A Study of Oprozomib, Pomalidomide, and Dexamethasone in Subjects With Primary Refractory or Relapsed and Refractory Multiple Myeloma|Phase 1b/3 Multicenter Study of Oprozomib, Pomalidomide, and Dexamethasone in Primary Refractory or Relapsed and Refractory Multiple Myeloma Subjects|Active, not recruiting||Phase 1|33|Actual|Amgen||2|||f||||t||||||||||2017-10-11 01:02:11.497792|2017-10-11 01:02:11.497792
NCT01999309|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-05-04|||October 2013||2013-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Simvastatin Addition for Patients With Recent-onset Schizophrenia|Simvastatin Addition for Patients With Recent-onset Schizophrenia|Recruiting||Phase 3|250|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-11 01:02:11.802785|2017-10-11 01:02:11.802785
NCT01999296|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-07-15|||October 2013||2013-10-01|July 2015|2015-07-01||||December 2015|Anticipated|2015-12-01|30 Days|Observational [Patient Registry]|||Prospective Evaluation of the Use of Thunderbeat Vessel Sealing Device in Laparoscopic Surgery||Unknown status|Active, not recruiting|N/A|250|Anticipated|Cantonal Hosptal, Baselland|||1||f||||f||||||||||2017-10-11 01:02:12.091544|2017-10-11 01:02:12.091544
NCT01999283|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-25|||July 2010||2010-07-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Pilates/Yoga||Effect of Group Pilates and Yoga Exercise Classes for Chronic Cervical Pain|Effect of Group Pilates and Yoga Exercise Classes on Function, Range of Motion, Endurance, Postural Position, Medication Use and Balance in Adults With Chronic Cervical Pain|Completed||N/A|88|Actual|Wayne State University||3|||f||||f||||||||||2017-10-11 01:02:12.196597|2017-10-11 01:02:12.196597
NCT01999270|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-10-19|||April 2013||2013-04-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors|Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors, A Feasibility Study|Completed||Phase 1|6|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 01:02:12.324969|2017-10-11 01:02:12.324969
NCT01999257|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-08-14|||July 2014||2014-07-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent.|Assessing the Outcomes of Web-based Pre-test Educational Module for Carrier Genetic Screening in Individuals of Ashkenazi Jewish Descent|Completed||N/A|60|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 01:02:12.437514|2017-10-11 01:02:12.437514
NCT01999244|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-09-21|||December 2013||2013-12-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Impact of Self-Monitoring Technology and Interventionist Contact on Weight Loss|Impact of Self-Monitoring Technology and Interventionist Contact on Weight Loss|Completed||N/A|80|Actual|The Miriam Hospital||3|||f||||f||||||||||2017-10-11 01:02:12.542056|2017-10-11 01:02:12.542056
NCT01999062|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-09-21|||March 2013||2013-03-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2017|Actual|2017-01-01||Interventional|||Automated Breast Radiation Therapy Using an MR-Guided Process|Automated Breast Radiation Therapy Using an MR-Guided Process|Active, not recruiting||N/A|160|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:02:15.172033|2017-10-11 01:02:15.172033
NCT01999036|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-05-10|||November 2004||2004-11-01|May 2016|2016-05-01||||January 2018|Anticipated|2018-01-01||Observational|SHARE||Save Hearts in Arizona Registry and Education (SHARE) Project||Recruiting||N/A|20000|Anticipated|University of Arizona|||1||f||||||||||||||2017-10-11 01:02:15.331757|2017-10-11 01:02:15.331757
NCT01999231|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-03-26|2015-01-07||September 2013||2013-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional||Aged from 18 to 40 years old, the male to female ratio of cases is 1:1 in each group . Body mass index should be in the range of 20 to 27 .|Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10|Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10|Completed||Phase 1|32|Actual|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.|If the operator don't have standard measurement of transverse diameter and the vertical diameter of induration or redness ,we get unreliable data .The participant lost any follow-up will lead to small numbers of subjects analyzed.|4|||f||||f||||||||||2017-10-11 01:02:12.671095|2017-10-11 01:02:12.671095
NCT01999218|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-06-08|||December 16, 2013|Actual|2013-12-16|June 2017|2017-06-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|||Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)|A Phase III, Multicenter, Randomized, Double-Blind, Active-Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Ertugliflozin (MK-8835/PF-04971729) Compared With the Addition of Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin|Completed||Phase 3|1326|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 01:02:13.280856|2017-10-11 01:02:13.280856
NCT01999205|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-12-07|||November 2013||2013-11-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|MTB||Moving To Business: Promoting Physical Activity and Reducing Sedentary Behavior in Office-based Companies in Finland|Moving To Business: Promoting Physical Activity and Reducing Sedentary Behavior in Office-based Companies in Finland (MTB)|Completed||N/A|396|Actual|UKK Institute||1|||f||||f||||||||||2017-10-11 01:02:13.397298|2017-10-11 01:02:13.397298
NCT01999192|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2017-07-25|2017-03-16||October 2013||2013-10-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|986|8 subjects of 321 who had no post-baseline assessment were excluded from the Full Analysis Set (FAS), (one subject [1.3%] in the placebo group, three subjects [3.6%] in Dose Level 1 Tregalizumab group, two subjects [2.5%] in Dose Level 2 Tregalizumab group, and two subjects [2.6%] in Dose Level 3 Tregalizumab group).|Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis|A 24-week Phase IIb, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of Tregalizumab (BT061) in Combination With Methotrexate in the Treatment of Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Alone, Followed by a 24-week Extension Phase: T Cell REgulating Arthritis Trial 2b (TREAT 2b)|Terminated||Phase 2|321|Actual|Biotest|Due to the lack of efficacy the Extension Phase of the study was terminated early.|4||Lack of efficacy|f||||t||||||||||2017-10-11 01:02:13.506668|2017-10-11 01:02:13.506668
NCT01999179|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-01-31|||June 2014||2014-06-01|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis|Pilot Study of Post-thrombotic Syndrome & Predictors of Recurrence in Cancer Patients With Catheter-related Thrombosis|Recruiting||N/A|56|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 01:02:14.282736|2017-10-11 01:02:14.282736
NCT01999166|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-01-09|||December 2013||2013-12-01|January 2015|2015-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|Exorhum||Phenotype/Genotype Correlation in a Family With Early Onset Osteoarthritis|Phenotype/Genotype Correlation in a Family With Early Onset Osteoarthritis: Contribution of Genetic in the Diagnosis and Early Management of Patients.|Recruiting||N/A|5|Anticipated|University Hospital, Caen|||1||f||||||||||||||2017-10-11 01:02:14.402926|2017-10-11 01:02:14.402926
NCT01999153|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-06-13|||December 2013||2013-12-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ROPI||Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site|Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site|Recruiting||Phase 3|88|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 01:02:14.484878|2017-10-11 01:02:14.484878
NCT01999140|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-06-27|||June 2005||2005-06-01|June 2017|2017-06-01|June 2030|Anticipated|2030-06-01|October 2018|Anticipated|2018-10-01|1 Day|Observational [Patient Registry]|||Implantable Cardioverter Defibrillator (ICD Registry)|Implantable Cardioverter Defibrillator (ICD Registry)|Recruiting||N/A|1750|Anticipated|American College of Cardiology|||1||f||||t||||||||||2017-10-11 01:02:14.583331|2017-10-11 01:02:14.583331
NCT01999101|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-09-28|||October 2013||2013-10-01|November 2014|2014-11-01|June 2016|Actual|2016-06-01|January 2015|Actual|2015-01-01||Interventional|||Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients|A Safety Pilot Study of Px-104 in Non-alcoholic Fatty Liver Disease (NAFLD) Patients|Completed||Phase 2|12|Actual|Phenex Pharmaceuticals AG||1|||f||||f||||||||||2017-10-11 01:02:14.77819|2017-10-11 01:02:14.77819
NCT01999088|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-25|||May 2009||2009-05-01|November 2013|2013-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Health Benefits of Functional Meat (With n-3 Fatty Acids and Rosemary Extract) on Low Risk for Cardiovascular Disease People|Randomized, Double-blind, Cross-over Placebo-controlled Study to Assess the Functional Meat Products With n-3 and Rosemary Extract Fluid in Biochemical Markers of Cardiovascular Disease Related Risk in Subjects at Low Risk for Cardiovascular Disease|Completed||Phase 4|44|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-11 01:02:14.89723|2017-10-11 01:02:14.89723
NCT01999075|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-08-18|||March 2013||2013-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|STEADFAST||Stacking Exercises Aid the Decline in FVC and Sick Time|Stacking Exercises Attenuate the Decline in Forced Vital Capacity and Sick Time (STEADFAST)|Active, not recruiting||Phase 4|110|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-11 01:02:15.013421|2017-10-11 01:02:15.013421
NCT01999023|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-25|||December 2013||2013-12-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of Low Protein Formula on Renal Function, Oxidative Stress and Antioxidant Capacities in CKD Patients|The Effects of Low Protein Formula on Renal Function, Oxidative Stress and Antioxidant Capacities in Patients With Chronic Kidney Disease|Unknown status|Not yet recruiting|N/A|120|Anticipated|Taichung Veterans General Hospital||2|||f||||f||||||||||2017-10-11 01:02:15.424365|2017-10-11 01:02:15.424365
NCT01999010|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-01-04|||November 2014||2014-11-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MHTV||Mental Health Telemetry for Self-Management in Major Depression|Mental Health Telemetry for Self-Management in Major Depression|Completed||N/A|27|Actual|Sunnybrook Health Sciences Centre||3|||f||||f||||||||||2017-10-11 01:02:15.521387|2017-10-11 01:02:15.521387
NCT01998997|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-12-23|||March 2014||2014-03-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Family Intervention for Delirium Prevention|A Family Intervention to Decrease Delirium: a Pilot Study|Completed||N/A|79|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:02:15.608004|2017-10-11 01:02:15.608004
NCT01998984|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-08-18||2015-08-27|January 2014||2014-01-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis|Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis|Completed||Phase 2|223|Actual|LEO Pharma||4|||f||||t||||||||||2017-10-11 01:02:15.688419|2017-10-11 01:02:15.688419
NCT01998971|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-08-17|||February 18, 2014|Actual|2014-02-18|August 2017|2017-08-01|October 27, 2018|Anticipated|2018-10-27|October 27, 2018|Anticipated|2018-10-27||Interventional|||A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma|An Open-Label, Multicenter, Phase 1b Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Regimens for the Treatment of Subjects With Multiple Myeloma|Recruiting||Phase 1|250|Anticipated|Janssen Research & Development, LLC||6|||f||||t||f||||||||2017-10-11 01:02:15.775071|2017-10-11 01:02:15.775071
NCT01998958|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-06-06||2016-04-20|January 2014||2014-01-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|SYNAPSE||A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression|A Double-Blind, Doubly-Randomized, Placebo-Controlled Study of Intranasal Esketamine in an Adaptive Treatment Protocol to Assess Safety and Efficacy in Treatment-Resistant Depression (SYNAPSE)|Completed||Phase 2|108|Actual|Janssen Research & Development, LLC||5|||f||||f||||||||||2017-10-11 01:02:16.089831|2017-10-11 01:02:16.089831
NCT01998945|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-08-13|||December 2013||2013-12-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||Back on My Feet: Emotional Recovery From Fall Injury|Back on My Feet: Emotional Recovery From Fall Injury|Completed||Phase 1/Phase 2|22|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 01:02:16.325037|2017-10-11 01:02:16.325037
NCT01998932|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-06-29|||November 2013||2013-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|MOJITO||Predictive of Biomarkers of Healing in Chronic Venous Ulceration of the Lower Limb|Clinical Study to Identify Biological Markers to Predict Wound Healing in Patients With Chronic Venous Ulceration of the Lower Limb|Completed||N/A|28|Actual|Imperial College London|||1||f||||f||||||Samples With DNA|"     Human serum Human urine Human venous ulcer fluid   "|||2017-10-11 01:02:16.419862|2017-10-11 01:02:16.419862
NCT01998919|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-12-12|2014-04-07||August 2006||2006-08-01|December 2014|2014-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||Full Analysis Set (FAS): all randomized participants. For analysis, participants were assigned the treatment group to which they were randomized, regardless of the treatment they actually received.|A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.|A Randomised, Placebo-controlled, Double-blind Phase II of Sequential Administration of Tarceva (Erlotinib) or Placebo in Combination With Gemcitabine/Platinum as First-line Treatment in Patients With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC).|Completed||Phase 2|154|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:02:16.556375|2017-10-11 01:02:16.556375
NCT01998906|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-10-24|2014-07-18||May 2002||2002-05-01|October 2014|2014-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Safety population: all participants who were randomized for the main study or registered for the observational parallel study and who received study medication at least once. Groups were analyzed as randomized/registered. Age was missing for 1 participant in the HER2+ TC treatment group.|A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer|A Randomized, Open-label Study of the Effect of Paclitaxel, Doxorubicin, and CMF Neoadjuvant Chemotherapy, With and Without Herceptin, on Tumor Response in Women With HER2-positive Breast Cancer|Completed||Phase 3|330|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 01:02:17.925788|2017-10-11 01:02:17.925788
NCT01998893|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2014-11-17|2014-10-30||January 1997||1997-01-01|October 2014|2014-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||Intent to treat (ITT) population included all participants with at least 1 application of study treatment.|A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma|Clinical Response in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma After Treatment With Anti-CD20 Antibody IDEC C2B8 (MabThera)|Completed||Phase 2|38|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:02:19.274814|2017-10-11 01:02:19.274814
NCT01998880|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-05-30|2014-01-16||December 22, 2009|Actual|2009-12-22|May 2017|2017-05-01|August 1, 2017|Anticipated|2017-08-01|August 1, 2012|Actual|2012-08-01||Interventional||Baseline measures are based on the participants who were included in the Stage 1b analysis.|CLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1b)|An Open-label, Multi-center, Three Arm Randomized Study to Investigate the Safety and Efficacy on Progression-free Survival of RO5072759 + Chlorambucil (GClb) Compared to Rituximab + Chlorambucil (RClb) or Chlorambucil (Clb) Alone in Previously Untreated CLL Patients With Comorbidities|Active, not recruiting||Phase 3|787|Actual|Hoffmann-La Roche|To date only an abbreviated CSR has been produced for Stage 1b.|3|||f||||||||||||||2017-10-11 01:02:20.070753|2017-10-11 01:02:20.070753
NCT01998867|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-02-12|||August 2013||2013-08-01|February 2015|2015-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Fasting Predictors of OGTT and MMTT Response|Identification of Fasting Biomarkers That Predict Responses to the Oral Glucose Tolerance Test (OGTT) and Mixed Meal Tolerance Test (MMTT)|Active, not recruiting||N/A|1000|Anticipated|Health Diagnostic Laboratory, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood and serum   "|||2017-10-11 01:02:22.117002|2017-10-11 01:02:22.117002
NCT01998854|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-03-09|||February 2013||2013-02-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Observational|||Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation|Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation|Terminated||N/A|4|Actual|Gynesonics|||1|Investigational device changes|f||||f||||||||||2017-10-11 01:02:22.21045|2017-10-11 01:02:22.21045
NCT01998841|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-09-25|||December 31, 2013|Actual|2013-12-31|September 2017|2017-09-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Interventional|||A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer Disease (AD), Including a Placebo-Treated Noncarrier Cohort|A Double-Blind, Placebo-Controlled Parallel-Group Study in Preclinical PSEN1 E280A Mutation Carriers Randomized to Crenezumab or Placebo, and in Nonrandomized, Placebo-Treated Noncarriers From the Same Kindred, to Evaluate the Efficacy and Safety of Crenezumab in the Treatment of Autosomal-Dominant Alzheimer's Disease|Active, not recruiting||Phase 2|300|Anticipated|Genentech, Inc.||3|||f||||||||||||||2017-10-11 01:02:22.335361|2017-10-11 01:02:22.335361
NCT01998828|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-04-26||2016-04-26|February 2014||2014-02-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia|A Phase 2, Open-label, Randomized Study to Evaluate the Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia|Terminated||Phase 2|39|Actual|Gilead Sciences||4|||f||||f||||||||||2017-10-11 01:02:22.4381|2017-10-11 01:02:22.4381
NCT01998815|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-02-01|||March 2015||2015-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|RAMOSPHYSSURG||Role and Mechanisms of Obesity Surgery - Physical Activity and Other Predictors of Hospital Stay, Recovery and Complications After Obesity Surgery|Role and Mechanisms of Obesity Surgery - Physical Activity and Other Predictors of Hospital Stay, Recovery and Complications After Obesity Surgery|Active, not recruiting||N/A|40|Actual|Göteborg University|||1||f||||t||||||||||2017-10-11 01:02:22.572585|2017-10-11 01:02:22.572585
NCT01998802|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-06-10|||January 2014||2014-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|EBI-005||Phase 3 Study of EBI-005 in Dry Eye Disease|A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease|Completed||Phase 3|670|Actual|Eleven Biotherapeutics||2|||f||||t||||||||||2017-10-11 01:02:22.661828|2017-10-11 01:02:22.661828
NCT01998789|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-08-09|||October 2013||2013-10-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|June 2018|Anticipated|2018-06-01||Interventional|||Everolimus Post Orthotopic Liver Transplant|A Single Center, Open-label, Randomized, Controlled Pilot Trial to Evaluate the Efficacy and Safety of Everolimus Conversion Versus Standard Immunosuppression in Liver Transplant Recipients|Recruiting||Phase 2|50|Anticipated|Columbia University||2|||f||||f|t|f||||||||2017-10-11 01:02:22.843669|2017-10-11 01:02:22.843669
NCT01998776|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-07-28|||April 2013||2013-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel Bleeding|A Double-blind, Randomized, Placebo Controlled Trial of Misoprostol for Healing of Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding (MISO-SB Study)|Recruiting||Phase 2/Phase 3|82|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:02:22.978018|2017-10-11 01:02:22.978018
NCT01998763|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-01-20|||November 2013||2013-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2014|Actual|2014-05-01||Interventional|||Vitamin D Intervention Trial in Healthy Chinese, Phase II|Knowledge Innovation Project of CAS - Genetic and Nutritional Association Studies on Metabolism-related Diseases in Chinese Population -- Vitamin D Intervention Study|Completed||Phase 1|448|Actual|Chinese Academy of Sciences||2|||f||||t||||||||Undecided||2017-10-11 01:02:23.122781|2017-10-11 01:02:23.122781
NCT01998750|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2016-09-09|||February 2014||2014-02-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|GECO||Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.|Study to Identify Rare Genetic Variants Causing Severe Early Childhood Obesity|Recruiting||N/A|200|Anticipated|Boston Children’s Hospital|||1||f||||f||||||Samples With DNA|"     Saliva or blood   "|Yes|Deidentified data will be deposited in public databases at the end of the study|2017-10-11 01:02:23.219795|2017-10-11 01:02:23.219795
NCT01998737|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-08-18|2016-11-04||November 2013||2013-11-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|1 Day|Observational [Patient Registry]|||Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX|Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX|Completed||N/A|1011|Actual|Bone Index Finland Ltd|||2||f||||f||||||||||2017-10-11 01:02:23.341135|2017-10-11 01:02:23.341135
NCT01998724|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-02-23|||August 2012||2012-08-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|LEAP||Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial|Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial|Recruiting||N/A|90|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||t||||||||||2017-10-11 01:02:23.759201|2017-10-11 01:02:23.759201
NCT01998711|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-25|||October 2004||2004-10-01|September 2005|2005-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Impact of a Memory Group for Older Adults Reporting Memory Difficulties|Memory Group Intervention for Mild Cognitive Impairment: Impact of a Memory Group for Older Adults Reporting Memory Difficulties.|Completed||N/A|62|Actual|Bayside Health||2|||f||||f||||||||||2017-10-11 01:02:23.858824|2017-10-11 01:02:23.858824
NCT01998698|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-01-14|||March 2013||2013-03-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Monovision vs Multifocal Lens Insertion in Cataract Patients|Monovision Correction Versus Multifocal Lens Insertion Following Emulsification Cataract Surgery|Completed||N/A|60|Actual|Democritus University of Thrace||2|||f||||t||||||||||2017-10-11 01:02:23.936748|2017-10-11 01:02:23.936748
NCT01998685|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-11-05|||June 2013||2013-06-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|December 2013|Actual|2013-12-01||Interventional|||Prothrombotic Factors and Anaesthesia in Prostate Cancer|Prothrombotic Factors , Angiogenic Growth Factor and Different Anaesthetic Techniques in Cancer Patients Undergoing Prostatectomy|Completed||N/A|200|Actual|Regina Elena Cancer Institute||2|||f||||f||||||||||2017-10-11 01:02:24.017651|2017-10-11 01:02:24.017651
NCT01998672|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-11-03|||February 2012||2012-02-01|November 2014|2014-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Multiple Ascending Oral Dose Phase I Study With Px-102|A Double-blind, Randomised, Placebo-controlled, Dose-escalation Study of the Safety, Tolerability and Pharmacokinetics of Increasing Multiple Oral Doses of Px-102 to Healthy Subjects|Completed||Phase 1|42|Actual|Phenex Pharmaceuticals AG||2|||f||||f||||||||||2017-10-11 01:02:24.111958|2017-10-11 01:02:24.111958
NCT01998659|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-11-03|||September 2011||2011-09-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Single Ascending Oral Dose Phase I Study With Px-102|A Double-blind, Randomized, Placebo-controlled, Dose-escalation Study of the Safety, Tolerability and Pharmacokinetics of Increasing Single Oral Doses of Px-102 to Healthy Subjects|Completed||Phase 1|54|Actual|Phenex Pharmaceuticals AG||2|||f||||f||||||||||2017-10-11 01:02:25.664704|2017-10-11 01:02:25.664704
NCT01998646|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2013-11-25|||August 2010||2010-08-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP4058 Following Single Oral Doses|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacoknetics of ASP4058 Following Single Oral Doses in Healthy Subjects|Completed||Phase 1|130|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 01:02:25.790705|2017-10-11 01:02:25.790705
NCT01998633|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-02-07|||December 2013|Actual|2013-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RICHI||Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)|Reduced-Intensity Conditioning for Children and Adults With Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (RICHI) (BMT CTN #1204)|Active, not recruiting||Phase 2|46|Actual|Medical College of Wisconsin||1|||f||||t||||||||Yes|Findings will be published in a manuscript.|2017-10-11 01:02:25.888927|2017-10-11 01:02:25.888927
NCT01998620|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2014-05-28|||November 2013||2013-11-01|May 2014|2014-05-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis|Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis|Unknown status|Recruiting|Phase 4|240|Anticipated|Zhejiang Hisun Pharmaceutical Co. Ltd.||3|||f||||f||||||||||2017-10-11 01:02:26.035897|2017-10-11 01:02:26.035897
NCT01998607|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2015-06-15|||February 2013||2013-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw|Survey of Oncology Practitioners Prescribing XGEVA® in Europe to Evaluate Their Knowledge of XGEVA® Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw|Completed||N/A|420|Anticipated|Amgen|||2||f||||f||||||||||2017-10-11 01:02:26.146414|2017-10-11 01:02:26.146414
NCT01998594|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-12-12|||August 2013||2013-08-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|MTF||Use of FlexHD as Post Trapeziectomy Spacer|Use of FlexHD as a Post-Trapeziectomy Spacer in Patients Treated for Thumb Basal Joint Arthritis|Active, not recruiting||Phase 4|30|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 01:02:26.236139|2017-10-11 01:02:26.236139
NCT01998581|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-25|2017-01-27|2016-07-26||November 2013||2013-11-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|August 2014|Actual|2014-08-01||Interventional||Safety Population: Subject who received at least 1 treatment|A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement|A Multicenter, Double-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement|Completed||N/A|225|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:02:26.328365|2017-10-11 01:02:26.328365
NCT01998568|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-23|2016-08-08|||November 2013||2013-11-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||The Intraocular Pressure Measured by Different Tonometers in Corneal Edema|The Variation of the Intraocular Pressure Measured by Different Tonometers in Patients With Clinical Corneal Edema|Recruiting||N/A|50|Anticipated|Prince of Songkla University|||1||f||||t||||||||No||2017-10-11 01:02:26.892974|2017-10-11 01:02:26.892974
NCT01998555|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2014-08-11|||December 2013||2013-12-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Web-based Psychological Intervention to Coronary Artery Heart Disease Patients|Development and Evaluation of a Web-based Group Cognitive-behavioral Therapy Program for Coronary Artery Heart Disease Patients|Unknown status|Active, not recruiting|N/A|30|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:02:27.009399|2017-10-11 01:02:27.009399
NCT01998542|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-08-07|||December 2013||2013-12-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|HNC||Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck|Phase I/II, Randomized Double-Blinded, Placebo-Controlled Study Designed To Evaluate Safety, Tolerability of an Individualized Cancer Vaccine (AllovaxTM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck.|Active, not recruiting||Phase 1/Phase 2|52|Anticipated|Immunovative Therapies, Ltd.||2|||f||||t||||||||||2017-10-11 01:02:27.114678|2017-10-11 01:02:27.114678
NCT01998529|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-09-15|||August 20, 2014|Actual|2014-08-20|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy|A Phase I Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy|Recruiting||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:02:27.309013|2017-10-11 01:02:27.309013
NCT01998516|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-09-19|||December 2013||2013-12-01|September 2017|2017-09-01|July 31, 2017|Actual|2017-07-31|December 31, 2016|Actual|2016-12-31||Observational|||Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder|Emotional Intelligence in Schizophrenia and Bipolar I Disorder: a Comparison Between Patients, Their Siblings, and Healthy Controls|Completed||N/A|350|Actual|Medical University Innsbruck|||5||f||||f||||||||||2017-10-11 01:02:27.434683|2017-10-11 01:02:27.434683
NCT01998503|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-11-25|||December 2007||2007-12-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis|Induction Therapy With Bortezomib and Dexamethasone Followed by Autologous Stem Cell Transplantation Versus Autologous Stem Cell Transplantation Alone in the Treatment of AL Amyloidosis|Completed||Phase 3|56|Actual|Nanjing University School of Medicine||2|||f||||t||||||||||2017-10-11 01:02:27.517007|2017-10-11 01:02:27.517007
NCT01998490|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-09-26|||January 2013||2013-01-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Animal-assisted or Robot-assisted Interventions in Health Promotion for Elderly With Dementia|Animal-assisted or Robot-assisted Interventions in Health Promotion for Elderly With Dementia: Impact on Factors Related to the Risk of Falls, on Evidence Based Practice and on the Relatives' Burden|Completed||N/A|88|Actual|Norwegian University of Life Sciences||3|||f||||f||||||||||2017-10-11 01:02:27.658235|2017-10-11 01:02:27.658235
NCT01998477|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-04-19|2015-01-16||October 2013||2013-10-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications|A Phase III, Observer-Blind, Randomized Multicenter Study to Evaluate the Safety of Trivalent Subunit Influenza Vaccines, Produced Either in Mammalian Cell Culture (TIVc) or in Embryonated Eggs (TIV), in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications|Completed||Phase 3|430|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:02:27.819146|2017-10-11 01:02:27.819146
NCT01998464|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-04-21|||January 2014||2014-01-01|April 2015|2015-04-01||||January 2016|Anticipated|2016-01-01||Observational|||Optical Coherence Tomography (OCT) in Retinal Vasculitis|Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Retinal Vasculitis|Unknown status|Recruiting|N/A|35|Anticipated|Oregon Health and Science University|||1||f||||||||||||||2017-10-11 01:02:29.302753|2017-10-11 01:02:29.302753
NCT01998451|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-03-06|||December 2012||2012-12-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Discovery of the Double Sphincter in Gallbladder|The Discovery of the Double Sphincter in Gallbladder|Recruiting||Phase 4|150|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 01:02:29.557919|2017-10-11 01:02:29.557919
NCT01998438|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-01-29|2016-01-29||September 2012||2012-09-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Prospective Trial of Tranexamic Acid in Cardiac Surgery|A Randomized Double-blinded Trial to Explore the Optimum Dose of Tranexamic Acid in Cardiopulmonary Bypass Cardiac Surgery|Completed||Phase 4|955|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||3|||f||||t||||||||||2017-10-11 01:02:29.689354|2017-10-11 01:02:29.689354
NCT01998425|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2015-07-29|||November 2013||2013-11-01|October 2013|2013-10-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Observational|||Circulating Fibrocytes in Non-small Cell Lung Cancer.||Unknown status|Recruiting|N/A|60|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-11 01:02:30.039462|2017-10-11 01:02:30.039462
NCT01998412|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-10-28|||December 2013||2013-12-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|IRISS||Iluvien Registry Safety Study|An Open Label, Registry Study of the Safety of Iluvien® 190 Micrograms Intravitreal Implant in Applicator|Recruiting||N/A|800|Anticipated|Alimera Sciences|||1||f||||f||||||||||2017-10-11 01:02:30.154966|2017-10-11 01:02:30.154966
NCT01998399|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-02-16|2016-01-08||August 2014||2014-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TCAP||Ticagrelor in Severe Community Acquired Pneumonia|Randomized Trial of Ticagrelor for Severe Community Acquired Pneumonia|Terminated||Phase 2|25|Actual|Vanderbilt University Medical Center||2||poor enrollment, unable to meet recruitment goals|f||||t||||||||No||2017-10-11 01:02:30.239716|2017-10-11 01:02:30.239716
NCT01998386|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-11-23|||November 2013||2013-11-01|September 2013|2013-09-01|September 2017|Anticipated|2017-09-01|March 2014|Anticipated|2014-03-01||Interventional|||Tooth Whitening With Hydrogenperoxide in Adolescents|Tooth Whitening With Hydrogenperoxide in Adolescents - Controlled Clinical Trial|Unknown status|Recruiting|N/A|64|Anticipated|University of Nove de Julho||4|||f||||t||||||||||2017-10-11 01:02:30.783868|2017-10-11 01:02:30.783868
NCT01998373|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-23|||January 2006||2006-01-01|November 2013|2013-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Group Training and Quality of Life and Reduction of Pain in Rheumatoid Arthritis Patients|The Effect of Group Training on the Quality of Life and Reduction of Pain in Rheumatoid Arthritis Patients|Completed||N/A|60|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:02:30.90914|2017-10-11 01:02:30.90914
NCT01998360|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2015-11-16|2013-11-27||October 2013||2013-10-01|November 2015|2015-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Rapid, Minimally-invasive Voluntary Adult Male Circumcision|Rapid, Minimally-invasive Voluntary Adult Male Circumcision: a Quasi-experimental Study|Completed||N/A|100|Actual|Simunye Primary Health Care||2|||f||||f||||||||||2017-10-11 01:02:31.022481|2017-10-11 01:02:31.022481
NCT01998347|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2015-11-18|||November 2013||2013-11-01|November 2015|2015-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer|Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer: an Open-label, Randomised Phase 3 Trial.|Withdrawn||Phase 3|0|Actual|Shantou University Medical College||2||slow enrollment|f||||t||||||||||2017-10-11 01:02:31.448272|2017-10-11 01:02:31.448272
NCT01998334|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2013-11-23|||July 2012||2012-07-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis|Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis|Unknown status|Recruiting|N/A|30|Anticipated|Ruijin Hospital||3|||f||||t||||||||||2017-10-11 01:02:31.567878|2017-10-11 01:02:31.567878
NCT01998321|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2013-11-23|||December 2012||2012-12-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||PSI for Bilateral Simultaneous TKA in Sever Varus|Bilateral Simultaneous Total Knee Arthroplasty in Patients With Severe Articular Deformities|Completed||N/A|100|Actual|October 6 University||2|||f||||t||||||||||2017-10-11 01:02:31.712354|2017-10-11 01:02:31.712354
NCT01998308|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2015-09-28|||December 2012||2012-12-01|September 2015|2015-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01|24 Months|Observational [Patient Registry]|||Comparison Between Four Types of Single Dose Hyaluronic Acid Injection in Patients With Knee Osteoarthritis|Intra-articular Hyaluronic Acid Knee Injection: Randomized Control Trial.|Recruiting||N/A|200|Anticipated|October 6 University|||4||f||||t||||||||||2017-10-11 01:02:31.842385|2017-10-11 01:02:31.842385
NCT01998295|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-03-15|||May 2012||2012-05-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|PCT||Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine|Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine Among Children With Uncomplicated P. Falciparum Malaria Five Years After Wide Scale Use of the Drug in Tanzania|Completed||Phase 4|45|Actual|Muhimbili University of Health and Allied Sciences||1|||f||||f||||||||||2017-10-11 01:02:31.986766|2017-10-11 01:02:31.986766
NCT01998282|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-03-09|||October 2013||2013-10-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Evaluation of a Project to Distribute Water Filters and Cook Stoves in Western Rwanda--Phase 1B|Assessing the Impact of Water Filters and Improved Cook Stoves on Drinking Water and Quality and Indoor Air Pollution: A Matched Cohort Study in Rwanda|Completed||N/A|1035|Actual|London School of Hygiene and Tropical Medicine|||2||f||||f||||||||||2017-10-11 01:02:32.128276|2017-10-11 01:02:32.128276
NCT01998269|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-04-01|2015-01-21||November 2013||2013-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|MeDS||A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS)|A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS), an Assessment for Use in Clinical Settings Among English and Spanish-speaking Patients With Hypertension and Diabetes.|Completed||N/A|210|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 01:02:32.210692|2017-10-11 01:02:32.210692
NCT01998256|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-09-12|||December 2013||2013-12-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|CBRAVO||Clinical Benefit of Rigourous AV Delay Optimization in Patients With a Dual Chamber Pacemaker|A Prospective, Patient Blinded, Cross-over Study of the Effect on Clinical Outcomes of AV Optimization in All Comer Ambulatory Patients With a Dual Chamber Pacemaker - The Role of Atrial Function and Interatrial Conduction Delay|Completed||N/A|28|Actual|Jessa Hospital||2|||f||||t||||||||||2017-10-11 01:02:32.409073|2017-10-11 01:02:32.409073
NCT01998230|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-10-14|||February 2014||2014-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer|Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer: a Randomized Clinical Trial|Completed||Phase 3|280|Actual|Henan Cancer Hospital||2|||f||||t||||||||||2017-10-11 01:02:32.848076|2017-10-11 01:02:32.848076
NCT01998217|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-02-02|||September 2012||2012-09-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone||Completed||Phase 4|60|Actual|Changhai Hospital||2|||f||||t||||||||||2017-10-11 01:02:32.937076|2017-10-11 01:02:32.937076
NCT01998204|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-23|||January 2012||2012-01-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Requirement of Propofol for Induction of Unconsciousness in Patients With Parkinson's Disease||Completed||N/A|62|Actual|Changhai Hospital|||2||f||||t||||||||||2017-10-11 01:02:33.077549|2017-10-11 01:02:33.077549
NCT01998191|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-25|||February 2014||2014-02-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Avoidable Mortality Case Note Review Trial|A Randomized Controlled Trial to Assess the Best Method for Evaluating Avoidable Mortality in Hospitals Using Retrospective Record Review.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Imperial College London||3|||f||||t||||||||||2017-10-11 01:02:33.1749|2017-10-11 01:02:33.1749
NCT01998165|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-11-13|||November 2013||2013-11-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Ultiva (Remifentanil Hydrochloride) in Pediatric Participants General Anesthetised|An Open-Label Study to Evaluate the Efficacy and Safety of JNJ-268229 in Pediatric Subjects General Anesthetised|Completed||Phase 3|80|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 01:02:33.342234|2017-10-11 01:02:33.342234
NCT01998152|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-05-04|||November 2013||2013-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|COLONUT||Individualized Nutritional Counselling During Chemotherapy for Colorectal Cancer (COLONUT)|The Effect of Individualized NUTritional Counselling on Muscle Mass and Treatment Outcome in Patients With Metastatic COLOrectal Cancer Undergoing Chemotherapy: the COLONUT Study|Recruiting||N/A|110|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 01:02:33.488986|2017-10-11 01:02:33.488986
NCT01998139|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-23|||May 2014||2014-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis|Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis|Recruiting||N/A|450|Anticipated|Weill Medical College of Cornell University|||2||f||||t||||||Samples With DNA|"     Blood   "|Undecided||2017-10-11 01:02:33.610289|2017-10-11 01:02:33.610289
NCT01998126|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-06-13|||December 2013||2013-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer|Evaluation of Combination Checkpoint Inhibitor Plus Targeted Inhibitor (Erlotinib or Crizotinib) for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer: Phase Ib With Expansion Cohorts|Active, not recruiting||Phase 1|14|Actual|University of Utah||4|||f||||t||||||||||2017-10-11 01:02:33.738145|2017-10-11 01:02:33.738145
NCT01998113|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-03-23|||March 2013||2013-03-01|November 2013|2013-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review|Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. A Systematic Review and Meta-analysis of Randomized Controlled Trials Comparing These Drugs Either vs Insulin or vs Each Other.|Completed||N/A|2509|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||6||f||||f||||||||||2017-10-11 01:02:33.908079|2017-10-11 01:02:33.908079
NCT01998100|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2015-12-28|||September 2010||2010-09-01|December 2015|2015-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)||Completed||Phase 3|28|Actual|University of Texas at Austin||2|||f||||t||||||||||2017-10-11 01:02:34.112442|2017-10-11 01:02:34.112442
NCT01998087|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-03|||June 2014||2014-06-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Proactive Breastfeeding Support in First Time Mothers|The Effect of Written Information and Support Phone Calls for First Time Mothers on Breastfeeding Rates: A Randomized Controlled Trial|Active, not recruiting||N/A|400|Actual|University Hospital of Split||3|||f||||f||||||||Yes||2017-10-11 01:02:34.873349|2017-10-11 01:02:34.873349
NCT01998074|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-11-27||||||November 2013|2013-11-01||||November 2013|Actual|2013-11-01||Interventional|Paradice||Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy|Evaluation of the Efficacy of a New Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy|Completed||N/A|||United Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:02:34.993969|2017-10-11 01:02:34.993969
NCT01998061|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2013-12-19|||December 2013||2013-12-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression|Phase II Study of Continuation of Tyrosine Kinase Inhibitor (TKI) With or Without Chemotherapy Beyond Gradual Progression in Advanced Non-small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|20|Anticipated|Zhejiang University||2|||f||||f||||||||||2017-10-11 01:02:35.169058|2017-10-11 01:02:35.169058
NCT01998048|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2015-05-24|||November 2013||2013-11-01|May 2015|2015-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||Operative Treatment of Traumatic Anteroinferior Shoulder Instability in Young Male Patients|Operative Treatment of Traumatic Anteroinferior Shoulder Instability in Young Male Patients. The Outcome of Arthroscopic Bankart vs. Open Latarjet Stabilization Surgery, a Randomized Controlled Trial.|Recruiting||N/A|120|Anticipated|Turku University Hospital||2|||f||||t||||||||||2017-10-11 01:02:35.300329|2017-10-11 01:02:35.300329
NCT01998035|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-08-25|||November 2013||2013-11-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies|Phase I/IIa Study of the Oral 5-Azacitidine in Combination With the Histone Deacetylase Inhibitor Romidepsin for the Treatment of Patients With Replapsed and Refractory Lymphoid Malignancies|Recruiting||Phase 1/Phase 2|60|Anticipated|Columbia University||7|||f||||t||||||||||2017-10-11 01:02:35.451103|2017-10-11 01:02:35.451103
NCT01998022|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-10-02|||April 2013||2013-04-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|H3C||Hypertension of Our Patients: Knowledge, Control, Comorbidity|Hypertension of Our Patients: Knowledge, Control, Comorbidity|Completed||N/A|383|Actual|Groupe Hospitalier de la Region de Mulhouse et Sud Alsace|||1||f||||f||||||||||2017-10-11 01:02:35.603434|2017-10-11 01:02:35.603434
NCT01998009|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-02-04|||May 2011||2011-05-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|SIT||Study of In-home Tests for Colorectal Cancer|Performance Characteristics of Immunochemical and Guaiac FOBT|Completed||N/A|1382|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-10-11 01:02:35.687828|2017-10-11 01:02:35.687828
NCT01997996|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-11-25|||May 2011||2011-05-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Observational|ProViS||ProViS (Prolift+M and Vita Sexualis) Study|ProViS (Prolift+M TM and Vita Sexualis) Study|Completed||N/A|18|Actual|Cantonal Hospital of St. Gallen|||1||f||||t||||||||||2017-10-11 01:02:35.796876|2017-10-11 01:02:35.796876
NCT01997983|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2016-04-11|||November 2013||2013-11-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients|Pilot Study Evaluating Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in Interstitial Cystitis Patients|Completed||Phase 1/Phase 2|15|Actual|UroGen Pharma Ltd.||1|||f||||t||||||||||2017-10-11 01:02:35.900245|2017-10-11 01:02:35.900245
NCT01997970|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-02|2016-05-10|||February 2014||2014-02-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|InphactUm||NEAT - Prevention and Treatment of Overweight and Obesity.|Non-exercise Activity Thermogenesis (NEAT) - Prevention and Treatment of Overweight and Obesity|Completed||N/A|80|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 01:02:36.03277|2017-10-11 01:02:36.03277
NCT01997957|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-25|||October 2013||2013-10-01|November 2013|2013-11-01||||September 2016|Anticipated|2016-09-01||Interventional|SOON||A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC|A Randomized Controled Trial of Oral S-1 in Combination With Sequential Hepatic Arterial Infusion of Oxaliplatin After Transarterial Chemoembolization in Patients With Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|110|Anticipated|Beijing Cancer Hospital||2|||f||||f||||||||||2017-10-11 01:02:36.162476|2017-10-11 01:02:36.162476
NCT01997944|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-11-14|||November 2013||2013-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients|Phase Ib Study of Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein in Chronic Hepatitis B Patients|Completed||Phase 1/Phase 2|32|Actual|Beijing Bio-Fortune Ltd.||2|||f||||f||||||||||2017-10-11 01:02:36.305197|2017-10-11 01:02:36.305197
NCT01997931|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-25|||September 2004||2004-09-01|November 2013|2013-11-01|July 2005|Actual|2005-07-01|June 2005|Actual|2005-06-01||Interventional|||The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients|The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients|Completed||N/A|50||Bayside Health|||||f||||f||||||||||2017-10-11 01:02:36.891204|2017-10-11 01:02:36.891204
NCT01995305|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-21||||||November 2013|2013-11-01||||||||Expanded Access|||Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents|Exome Sequencing of Fanconi Anemia Children and the Their Parents|Available||N/A|||Chinese Academy of Medical Sciences|||||f||||||||||||||2017-10-11 01:03:12.697052|2017-10-11 01:03:12.697052
NCT01997918|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2014-12-03|||October 2013||2013-10-01|December 2014|2014-12-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Observational|||Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCT|Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Relapse After a First Allogeneic HSCT: a Retrospective Cohort Study by the German Cooperative Transplant Study Group|Unknown status|Enrolling by invitation|N/A|60|Anticipated|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-11 01:02:37.006146|2017-10-11 01:02:37.006146
NCT01997905|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-10-27|2016-01-27||January 2014||2014-01-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Stroke Feasibility Study|Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated|Completed||Phase 1/Phase 2|13|Actual|AtriCure, Inc.||1|||f||||f||||||||||2017-10-11 01:02:37.105149|2017-10-11 01:02:37.105149
NCT01997892|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-06-03|2014-04-17||August 2012||2012-08-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|TRANSFORM|The Primary Analysis Set included all participants who received at least one dose of darbepoetin alfa who completed 26 weeks post-switch on darbepoetin alfa, did not receive another erythropoiesis stimulating agent during this period and had at least one hemoglobin value per month recorded for a minimum of any 4 months post-switch.|TRANSFORM - Observational Cohort Study of Darbepoetin Alfa Use in European Union (EU) Hemodialysis Patients Switched From PEG Epoetin Beta|TRANSFORM - Observational Cohort Study of Aranesp Use in EU Haemodialysis Patients Switched From Mircera|Completed||N/A|1027|Actual|Amgen|||1||f||||f||||||||||2017-10-11 01:02:37.623695|2017-10-11 01:02:37.623695
NCT01997879|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-09-12|||November 2013||2013-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers|An Open-label Study Assessing the Ocular and Systemic Safety and Systemic Absorption of AR-13324 Ophthalmic Solution, 0.02% in Healthy Volunteers|Completed||Phase 1|18|Actual|Aerie Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:02:38.1903|2017-10-11 01:02:38.1903
NCT01997866|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-05-16|||January 2015||2015-01-01|May 2017|2017-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effects of Treating Sleep Apnea in Patients With Congestive Heart Failure|Effects of Treating Sleep Apnea in Patients With Congestive Heart Failure|Withdrawn||N/A|0|Actual|University of Florida||1||Re-evaluate inclusion/exclusion criteria|f||||f||||||||||2017-10-11 01:02:38.274413|2017-10-11 01:02:38.274413
NCT01997853|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-24|||July 2012||2012-07-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|omega3||Omega-3 Fatty Acids in Chronic Periodontitis.|Effect of Scaling & Root Planing (SRP) Combined With Therapy Of Omega-3 Fatty Acid on Clinical Parameters and Serum Levels of C-Reactive Protein (CRP) in Chronic Periodontitis - A Randomised Control Trial.|Completed||Phase 4|60|Actual|Tatyasaheb Kore Dental College||2|||f||||t||||||||||2017-10-11 01:02:38.374199|2017-10-11 01:02:38.374199
NCT01997840|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-08-31|||March 1, 2014|Actual|2014-03-01|August 2017|2017-08-01|May 31, 2019|Anticipated|2019-05-31|February 28, 2019|Anticipated|2019-02-28||Interventional|||ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma|A Phase 1B/2 Multi-Center, Open Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of ACY-1215 (RICOLINOSTAT) in Combination With Pomalidomide and Low-Dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|100|Actual|Celgene||1|||f||||f||||||||||2017-10-11 01:02:38.489101|2017-10-11 01:02:38.489101
NCT01997827|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-12-01|||October 2013||2013-10-01|December 2015|2015-12-01|October 2025|Anticipated|2025-10-01|October 2015|Anticipated|2015-10-01||Interventional|MIZE-F||Minimal Invasive Rehabilitation of Tooth Loss in the Anterior Segment|Clinical Performance of Porcelain-fused-to-metal and All-ceramic Resin-bonded Fixed Dental Prostheses in the Anterior Segment - a Randomized Controlled Pilot Study.|Withdrawn||N/A|0|Actual|University Hospital Heidelberg||2||Lack of Participants|f||||t||||||||||2017-10-11 01:02:38.665005|2017-10-11 01:02:38.665005
NCT01997814|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-27|||March 2012||2012-03-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|Septilin||Role of Herbal Immunomodulators in the Treatment of Chronic Periodontitis|EFFECT OF SRP WITH ADJUNCTIVE THERAPY OF HERBAL IMMUNOMODULATORS ON THE SERUM C REACTIVE PROTEIN (CRP) LEVELS & CLINICAL PARAMETERS IN CHRONIC PERIODONTITIS PATIENTS - A RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED, CLINICAL TRIAL.|Completed||Phase 4|60|Actual|Tatyasaheb Kore Dental College||2|||f||||||||||||||2017-10-11 01:02:38.776783|2017-10-11 01:02:38.776783
NCT01997801|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-24|||December 2013||2013-12-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|KEThyRobot||Ketamine in Robot-assisted Thyroidectomy|The Efficacy of Intraoperative Ketamine in Patients Undergoing Robot-assisted Thyroidectomy|Unknown status|Not yet recruiting|N/A|64|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:02:38.952098|2017-10-11 01:02:38.952098
NCT01997788|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-07-01|||August 2013||2013-08-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|EMPON||The Intrathecal Morphine for Nephrectomy|The Efficacy of Intrathecal Morphine in Patients Undergoing Open Nephrectomy|Completed||N/A|46|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:02:39.085271|2017-10-11 01:02:39.085271
NCT01997775|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2016-09-29|||August 2013||2013-08-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Metformin in Stage IV Lung Adenocarcinoma|A Phase II Trial to Examine the Effect of Metformin on Plasma IL-6 Level in Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|13|Actual|National Cheng-Kung University Hospital||1||Difficult enrollment|f||||f||||||||No||2017-10-11 01:02:39.212691|2017-10-11 01:02:39.212691
NCT01997762|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-05-09|||May 2014||2014-05-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?|Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?|Unknown status|Recruiting|Phase 4|112|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-11 01:02:39.340405|2017-10-11 01:02:39.340405
NCT01997749|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-07-17|||May 2013||2013-05-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Effects of a Ketogenic Diet on Acute Stroke|The Effect of a Ketogenic Diet on Blood Glucose, Function and Disease Progress in Acute Stroke Patients|Completed||Phase 1|64|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-11 01:02:39.479184|2017-10-11 01:02:39.479184
NCT01997736|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-05-25|||November 22, 2013|Actual|2013-11-22|May 2017|2017-05-01|June 1, 2016|Actual|2016-06-01|September 15, 2015|Actual|2015-09-15||Interventional|||Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation|A Pilot Study Evaluating the Safety and Effectiveness of the Toray Satake Balloon Thermal Ablation System for the Treatment of Paroxysmal Atrial Fibrillation|Completed||N/A|41|Actual|Toray Industries (America), Inc.||1|||f||||t||||||||||2017-10-11 01:02:39.602912|2017-10-11 01:02:39.602912
NCT01997723|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-05-20|2013-12-09||August 2011||2011-08-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Interventional||Consenting adult men and women of self-identified African American ethnicity meeting inclusion/exclusion criteria were included.|Comparative Effectiveness Research to Enhance Outcomes in African-Americans With Obstructive Sleep Apnea|Comparative Effectiveness Research to Enhance Outcomes in African-Americans With Obstructive Sleep Apnea|Completed||N/A|75|Actual|University of Illinois at Chicago|This trial did not compare different portable devices for diagnostic accuracy compared to polysomnography (gold standard).|1|||f||||t||||||||||2017-10-11 01:02:39.734174|2017-10-11 01:02:39.734174
NCT01997710|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-03-10|||October 2013||2013-10-01|March 2016|2016-03-01|December 2026|Anticipated|2026-12-01|December 2016|Anticipated|2016-12-01||Interventional|MIZE-S||Minimal Invasive Rehabilitation of Tooth Loss in the Posterior Segment (MIZE-S)|Clinical Performance of Two Different Designs of All-ceramic Resin-bonded Fixed Dental Prostheses in the Posterior Segment - a Randomized Controlled Pilot Study.|Active, not recruiting||N/A|30|Anticipated|University Hospital Heidelberg||2|||f||||t||||||||||2017-10-11 01:02:40.025265|2017-10-11 01:02:40.025265
NCT01997697|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-04-04|||November 2013||2013-11-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Reduction of Emotional Eating After a Behavior Change Program in Obesity|Predictive Factors of the Reduction of Emotional Eating After a Behavior Change Program Among Individuals With Obesity of Class II and Class III.|Unknown status|Recruiting|N/A|138|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 01:02:40.11992|2017-10-11 01:02:40.11992
NCT01997684|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-11-18|||July 2013||2013-07-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Colonic Stenting With Elective Surgery Versus Emergency Surgery in the Management of Acute Malignant Colonic Obstruction|Colonic Stenting With Elective Surgery Versus Emergency Surgery in the Management of Acute Malignant Colonic Obstruction: a Multicentre, Prospective, Open Label, Cohort Study|Recruiting||N/A|200|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 01:02:40.230652|2017-10-11 01:02:40.230652
NCT01997671|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-11-28|||September 2011||2011-09-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Adequacy of the Indication of Lipid Lowering Treatment in Primary Prevention|Effectiveness of an Intervention to Improve the Adequacy of the Indication of Lipid Lowering Treatment in Primary Prevention: Randomized Clinical Trial|Completed||N/A|60000|Actual|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-10-11 01:02:40.395059|2017-10-11 01:02:40.395059
NCT01997658|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-05-11|||October 2014||2014-10-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Preoperative Glucocorticoid Use in Major Hepatectomy|Preoperative Glucocorticoid Use in Major Hepatectomy - A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|200|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 01:02:40.488569|2017-10-11 01:02:40.488569
NCT01997645|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-11-22|||November 2013||2013-11-01|November 2013|2013-11-01||||June 2015|Anticipated|2015-06-01||Interventional|LIFTRAF||Surgical Treatment of High Perianal Fistulas|Ligation of Intersphincteric Fistula Tract (LIFT) Versus Rectal Advanced Mucosal Flap (RAF) in Surgical Treatment of High Perianal Fistulas|Unknown status|Recruiting|N/A|140|Anticipated|University Hospital Hradec Kralove||2|||f||||t||||||||||2017-10-11 01:02:40.606971|2017-10-11 01:02:40.606971
NCT01997632|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2015-11-09|||November 2013||2013-11-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|IPV-004||Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults|Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults|Completed||Phase 1|120|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:02:40.731819|2017-10-11 01:02:40.731819
NCT01997619|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-24|2013-11-24|||November 2011||2011-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Observational|||Biological Mesh Repair of Complex Hernias in High Risk Patients|Biological Mesh Repair of Complex Ventral Hernias in High Risk Patients|Completed||N/A|16|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 01:02:40.824229|2017-10-11 01:02:40.824229
NCT01997606|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-09-23|||November 2013||2013-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|Purotex covers||House Dust Mite Allergen Reduction in Bedding: Purotex Impregnated Covers of Bekaert Textiles|Cross-over Study of the Impact of Purotex Covers on the Concentration of House Dust Mite Allergen in Bedding and the Quality of Life in Patients With Allergic Rhinitis to House Dust Mite.|Completed||N/A|20|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:02:40.924243|2017-10-11 01:02:40.924243
NCT01997593|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2015-03-25|||November 2013||2013-11-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected|Evaluate the Analgesic Effect of Intraperitoneal Infiltration of Ropivacaine in Children Undergoing Laparoscopic Surgery|Completed||Phase 2|70|Actual|Tongji Hospital||1|||f||||f||||||||||2017-10-11 01:02:41.010278|2017-10-11 01:02:41.010278
NCT01997580|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-22|||July 2013||2013-07-01|November 2013|2013-11-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder|Phase 4 Study of Escitalopram Treatment and Biomarkers in Major Depressive Disorder|Recruiting||Phase 4|600|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 01:02:41.102386|2017-10-11 01:02:41.102386
NCT01997372|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-12-02|||December 2010||2010-12-01|December 2013|2013-12-01|November 2015|Anticipated|2015-11-01|December 2013|Anticipated|2013-12-01||Interventional|||Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia|Different Doses of Anti-thymocyte Globin With 2.5 or 3.75mg/kg to Treat Child Severe Aplastic Anemia|Unknown status|Recruiting|Phase 4|100|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 01:02:44.535275|2017-10-11 01:02:44.535275
NCT01997567|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-05-11|2016-05-11||July 2013||2013-07-01|May 2016|2016-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Preemptive Femoral & Lateral Femoral Cutaneous Nerve Blocks for THA Acute Pain|Are Preemptive Femoral and Lateral Femoral Cutaneous Nerve Blocks Given Immediately Prior to Hip Arthroscopy(THA) Effective for Acute Postoperative Pain Management?|Terminated||N/A|3|Actual|Rush University Medical Center||2||Subject recruitment is too difficult and we foresee that this will not improve|f||||f||||||||No|No data to Share|2017-10-11 01:02:41.258894|2017-10-11 01:02:41.258894
NCT01997554|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-09-11|||March 2012||2012-03-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||Validation of a New TSH Test|Validation of a New TSH Test for Early Screening of Hypothyroidism|Completed||N/A|1654|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-11 01:02:41.496993|2017-10-11 01:02:41.496993
NCT01997541|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-11-27|||June 2013||2013-06-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Insertion Depth Comparison of Tracheal Tubes||Completed||N/A|76|Actual|Kyung Hee University Hospital at Gangdong|||2||f||||||||||||||2017-10-11 01:02:41.589496|2017-10-11 01:02:41.589496
NCT01997528|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-22|||November 2013||2013-11-01|November 2013|2013-11-01||||November 2014|Anticipated|2014-11-01||Interventional|||Gas Transfer on ILA-Activve|Efficiency of Gas Exchange Using a Miniaturized Pump Driven Veno-venous Extracorporeal Gas Exchange Device (ILA-Activve)|Unknown status|Recruiting|N/A|10|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 01:02:41.67176|2017-10-11 01:02:41.67176
NCT01997515|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-03-06|||November 2013||2013-11-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study|Ketamine Effect on Recovery and Respiratory Outcomes After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study|Active, not recruiting||Phase 4|82|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-11 01:02:41.777569|2017-10-11 01:02:41.777569
NCT01997502|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-05-24|||November 26, 2013|Actual|2013-11-26|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb|Prospective Observational Study Characterizing Noninvasive Hemoglobin (SpHb) Measured With Pulse CO-Oximetry Technology in a Variety of Surgical Cases|Recruiting||N/A|300|Anticipated|University of California, Davis|||1||f||||f|f|t|f|f||||No||2017-10-11 01:02:41.888266|2017-10-11 01:02:41.888266
NCT01997489|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-10-26|||September 2001||2001-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2013|Actual|2013-09-01||Interventional|||Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.|Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients|Completed||Phase 4|39|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 01:02:42.009873|2017-10-11 01:02:42.009873
NCT01997476|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-08-08|||September 2012||2012-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease|Evaluation of Combined Endoscopic Ultrasound Ductal Evaluation Before & After Secretin Stimulation in One EUS Session for the Diagnosis of Exocrine Pancreas Disease|Recruiting||N/A|200|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-11 01:02:42.092941|2017-10-11 01:02:42.092941
NCT01997463|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-10-25|||August 2014||2014-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SAMS||Supervised Asthma Medication in Schools (SAMS)|The Cost Effectiveness of School-Based Supervised Asthma Therapy|Completed||Phase 4|442|Actual|University of Arizona||2|||f||||t||||||||||2017-10-11 01:02:42.176329|2017-10-11 01:02:42.176329
NCT01997450|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-09-20|||December 2, 2013|Actual|2013-12-02|September 2017|2017-09-01|April 13, 2018|Anticipated|2018-04-13|April 13, 2018|Anticipated|2018-04-13||Observational|ICICLE||A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age|A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age|Suspended||N/A|8760|Anticipated|MedImmune LLC|||2|Study recruitment has been suspended.|f||||f||||||Samples With DNA|"     A nasal swab specimen will be collected and tested for influenza and other viral pathogens.   "|||2017-10-11 01:02:42.253094|2017-10-11 01:02:42.253094
NCT01997437|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-01-25|2014-01-03||December 2013||2013-12-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Laryngo-Tracheal Tissue-Engineered Clinical Transplantation|Clinical Trial Evaluation of Stem-cell Based Bioartificial Airway Transplantation for Patients With Benign and Malignant Laryngo-tracheal Diseases|Active, not recruiting||N/A|6|Actual|Kuban State Medical University||1|||f||||t||||||||||2017-10-11 01:02:42.356843|2017-10-11 01:02:42.356843
NCT01997424|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-11-27|||May 2013||2013-05-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND DIABETES MELLITUS|ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND DIABETES MELLITUS|Unknown status|Recruiting|N/A|340|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||||2017-10-11 01:02:42.566882|2017-10-11 01:02:42.566882
NCT01997411|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-03-03|2016-09-02||November 2013||2013-11-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes|Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes|Completed||Phase 2/Phase 3|48|Actual|Jaeb Center for Health Research||2|||f||||f||||||||||2017-10-11 01:02:42.808226|2017-10-11 01:02:42.808226
NCT01997398|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-12-02|2015-06-23||November 2012||2012-11-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational||Patients who underwent bilateral GPi DBS surgery under general anesthesia|DBS Under General Anesthesia: Comparison To The Standard Technique|DBS Under General Anesthesia Without Neurophysiology: Initial Experience and Comparison To The Standard Technique|Completed||N/A|35|Actual|St. Joseph's Hospital and Medical Center, Phoenix|||1||f||||f||||||||||2017-10-11 01:02:44.166231|2017-10-11 01:02:44.166231
NCT01997385|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-01-21|||June 2012||2012-06-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||The Clinical Effects of Korean Adapted APD in Automated Peritoneal Dialysis Patients|The Clinical Effects of Korean Adapted APD in Automated Peritoneal Dialysis Patients|Completed||Phase 4|1075|Actual|Fresenius Medical Care Korea||2|||f||||f||||||||No||2017-10-11 01:02:44.397376|2017-10-11 01:02:44.397376
NCT01997359|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-12-15|||June 2012||2012-06-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01|12 Months|Observational [Patient Registry]|LSTART||Multi-level Determinants of Starting ART Late: Aim 3|Multi-level Determinants of Starting ART Late in Sub-Saharan Africa (LSTART Study): A Case-control Study to Identify Individual-level Risk Factors for Late ART Initiation in Ethiopia|Completed||N/A|1214|Actual|Columbia University|||2||f||||f||||||||||2017-10-11 01:02:44.645423|2017-10-11 01:02:44.645423
NCT01997346|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-12-15|||November 2011||2011-11-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|LSTART||Multi-level Determinants of Starting ART Late: Aim 2|Multi-level Determinants of Late ART Initiation in Sub-Saharan Africa (LSTART Study): A Cross-sectional Qualitative Situation Analysis at 4 HIV Care and Treatment Clinics in Ethiopia|Completed||N/A|136|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 01:02:44.783605|2017-10-11 01:02:44.783605
NCT01997333|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-08-29|||November 2013||2013-11-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|METRIC||Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer|A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)|Active, not recruiting||Phase 2|327|Actual|Celldex Therapeutics||2|||t||||t||||||||||2017-10-11 01:02:44.894349|2017-10-11 01:02:44.894349
NCT01997320|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-10-09|||November 2013||2013-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|83+||Effect of Strength Training and Protein Supplementation on Muscles in the Very-old|Effect of Strength Training and Protein Supplementation on the Muscle Function in Very Old Nursinghome Residents|Completed||N/A|30|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 01:02:45.356331|2017-10-11 01:02:45.356331
NCT01997307|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-14|2015-12-21|||April 2014||2014-04-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|Ladies ACS||The LADIES Acute Coronary Syndromes Study|Age at Menopause and Severity of Coronary Artery Disease Among Postmenopausal Women With Acute Coronary Syndromes|Completed||N/A|675|Actual|Arcispedale Santa Maria Nuova-IRCCS|||4||f||||t||||||||||2017-10-11 01:02:45.4567|2017-10-11 01:02:45.4567
NCT01997294|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-10-09|||January 2013||2013-01-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction|Sequential Therapy of Atorvastatin Improving Tissue Reperfusion and Clinical Outcomes of ST-elevated Acute Myocardial Infarction Study（The STRAIT Study）|Active, not recruiting||N/A|1200|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 01:02:45.529165|2017-10-11 01:02:45.529165
NCT01997281|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-06-30|||December 2013||2013-12-01|June 2014|2014-06-01|July 2014|Anticipated|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||The Effect of Dietary Fiber-enriched Cereals on Glycemic Control and Secretion of Gut Hormones|The Effect of Dietary Fiber-enriched Cereals on Glycemic Control and Secretion of Gut Hormones|Unknown status|Active, not recruiting|N/A|15|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:02:45.622412|2017-10-11 01:02:45.622412
NCT01997268|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-11-22||||||November 2016|2016-11-01||||December 2014|Actual|2014-12-01||Interventional|||The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)|A Randomized, Double-Blind, Placebo-Controlled 12-Week Study to Determine the Efficacy of EPA+DHA (SC401B) on Hypertriglyceridemia (TG ≥ 500 mg/dL and ≤ 2000 mg/dL)|Withdrawn||Phase 3|0|Actual|Sancilio and Company, Inc.||4||Study never initiated. IND placed on Hold|f||||f||||||||||2017-10-11 01:02:45.715433|2017-10-11 01:02:45.715433
NCT01997255|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-05-04|||April 2014||2014-04-01|December 2015|2015-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)|An Open-Label Controlled Study of Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome|Withdrawn||Phase 2|0|Actual|Baylor College of Medicine||1||Site did not want to pursue study|f||||t||||||||||2017-10-11 01:02:45.80845|2017-10-11 01:02:45.80845
NCT01997242|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-14|2014-04-24|||June 2013||2013-06-01|September 2013|2013-09-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01|1 Month|Observational [Patient Registry]|SAS registry||The Surgery After Stenting (SAS) Registry|A Multicenter Registry of Consecutive Patients Undergoing Cardiac and Noncardiac Surgery or Operative Endoscopic/Endovascular Procedures After Implantation of a Coronary Stent|Unknown status|Recruiting|N/A|500|Anticipated|Arcispedale Santa Maria Nuova-IRCCS|||1||f||||t||||||||||2017-10-11 01:02:45.890272|2017-10-11 01:02:45.890272
NCT01997229|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-03-01||2017-03-01|December 2013||2013-12-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)|Completed||Phase 3|125|Actual|Alexion Pharmaceuticals||2|||f||||f||||||||No||2017-10-11 01:02:45.983154|2017-10-11 01:02:45.983154
NCT01997216|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-12-17|2013-12-17||October 2012||2012-10-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||This reporting group includes all enrolled participants exposed to study product.|Multifocal Lens Design Evaluation|Multifocal Lens Design Evaluation (US)|Completed||N/A|42|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:02:47.864496|2017-10-11 01:02:47.864496
NCT01997203|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-27|||April 2012||2012-04-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|VD-HCV||Long Term Vitamin D Therapy in HCV Treated Patients|Effect of Long-term Vitamin D Therapy on IL-6, Visfatin and Hyaluronic Acid in Hepatitis C Virus Patients' Assessment|Terminated||Phase 3|100|Actual|Ain Shams University||2||complete patients samples required|f||||t||||||||||2017-10-11 01:02:48.13181|2017-10-11 01:02:48.13181
NCT01997190|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-12-30|||October 2013||2013-10-01|December 2016|2016-12-01|October 2020|Anticipated|2020-10-01|December 2015|Actual|2015-12-01||Interventional|MpeTK01||Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion|A Phase I Study of Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion|Active, not recruiting||Phase 1|19|Anticipated|Advantagene, Inc.||1|||f||||t||||||||||2017-10-11 01:02:48.303559|2017-10-11 01:02:48.303559
NCT01997177|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-11-22|||March 2013||2013-03-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Assessment of Competence in Colonoscopy Using Motion Capture|Assessment of Competence in Colonoscopy Using Motion Capture|Completed||N/A|21|Actual|Rigshospitalet, Denmark|||2||f||||t||||||||||2017-10-11 01:02:48.409007|2017-10-11 01:02:48.409007
NCT01997164|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-01-11|||November 2014||2014-11-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||"Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (Wet) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)"|An Open-Label, Dose-Escalation Study of the Safety and Tolerability of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular AMD or DME|Completed||Phase 1|20|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:02:48.50966|2017-10-11 01:02:48.50966
NCT01997151|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-11-22|||December 2011||2011-12-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Promoting Health During Pregnancy: A Multiple Behavior Computer Tailored Intervention|Promoting Health During Pregnancy: A Multiple Behavior Computer Tailored Intervention|Completed||N/A|374|Actual|Pro-Change Behavior Systems||2|||f||||f||||||||||2017-10-11 01:02:48.617406|2017-10-11 01:02:48.617406
NCT01997138|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-09-18|||March 2016||2016-03-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy|Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy -a Double Blind, Placebo Controlled Study Using Microdialysis Technique|Withdrawn||Phase 4|0|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:02:48.70675|2017-10-11 01:02:48.70675
NCT01997125|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-08-22|||November 2013||2013-11-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Reanimation in Tetraplegia|Reanimation in Tetraplegia|Recruiting||N/A|5|Anticipated|Ohio State University||1|||f||||f||||||||||2017-10-11 01:02:48.80574|2017-10-11 01:02:48.80574
NCT01997112|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-08-04|||January 2014||2014-01-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Interventional|PATH-BP||PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study|PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study|Recruiting||Phase 4|100|Anticipated|University of Edinburgh||2|||f||||t||||||||||2017-10-11 01:02:48.915179|2017-10-11 01:02:48.915179
NCT01997099|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-11-04|||November 2013||2013-11-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|Work Smart||"A Workflow and Satisfaction Study Evaluating the Implementation of a New Smart Ambulatory Infusion System"|"A Workflow and Satisfaction Study Evaluating the Implementation of a New Smart Ambulatory Infusion System: Work Smart Study"|Completed||N/A|62|Actual|Smiths Medical, ASD, Inc.|||5||f||||f||||||||||2017-10-11 01:02:49.035128|2017-10-11 01:02:49.035128
NCT01997086|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-04-19|||October 2013||2013-10-01|April 2017|2017-04-01|August 2023|Anticipated|2023-08-01|August 2023|Anticipated|2023-08-01||Interventional|||Percutaneous Transforaminal Endoscopic Discectomy vs Microendoscopic Discectomy for Treatment of Lumbar Disc Herniation|Percutaneous Transforaminal Endoscopic Discectomy (PTED) Versus Microendoscopic Discectomy (MED) for the Treatment of Lumbar Disc Herniation: A Prospective Randomized Controlled Study|Active, not recruiting||Phase 4|125|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 01:02:49.144506|2017-10-11 01:02:49.144506
NCT01997073|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-05-24|||October 2013|Actual|2013-10-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Observational|||One Lung Ventilation|Effect of One-Lung Ventilation on Respiratory Gas Heat Content|Completed||N/A|40|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 01:02:49.242914|2017-10-11 01:02:49.242914
NCT01997060|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-01-29|||January 2014||2014-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Physiological Factors That Influence Maintenance of Lifestyle Changes and Weight Loss - a Longitudinal Study|Physiological Factors That Influence Maintenance of Lifestyle Changes and Weight Loss - a Longitudinal Study|Completed||N/A|80|Actual|University of Copenhagen||1|||f||||t||||||||||2017-10-11 01:02:49.315373|2017-10-11 01:02:49.315373
NCT01997047|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-09-19|||October 2012|Actual|2012-10-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Observational|||Diagnosing Pneumonia Under Low-resource Conditions|Improving the Diagnosis of Pediatric Pneumonia at Hospital and Village Levels: A Multi-centre Indian Study|Completed||N/A|502|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 01:02:49.442662|2017-10-11 01:02:49.442662
NCT01997034|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-01-29|||November 2013||2013-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Physiological Factors That Influence Maintenance of Lifestyle Changes and Weight Loss - a Cross-sectional Study|Physiological Factors That Influence Maintenance of Lifestyle Changes and Weight Loss - a Cross-sectional Study|Completed||N/A|80|Actual|University of Copenhagen|||1||f||||t||||||Samples With DNA|"     Whole blood, muscle and fat tissue.   "|||2017-10-11 01:02:49.54903|2017-10-11 01:02:49.54903
NCT01997021|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-07-17|||November 2013||2013-11-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|B-WELL||Effects of Interrupting Sedentary Time on Glycemic Control in Older Overweight and Obese Adults|Effects of Interrupting Sedentary Time on Glycemic Control in Older Overweight and Obese Adults|Active, not recruiting||N/A|25|Anticipated|University of Colorado, Denver||6|||f||||f||||||||||2017-10-11 01:02:49.672357|2017-10-11 01:02:49.672357
NCT01997008|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-03-05|||May 2014||2014-05-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|ORCHID||Optimizing Resilience and Coping in HIV Via Internet Delivery|Optimizing Resilience and Coping in HIV Via Internet Delivery|Completed||N/A|22|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:02:49.846161|2017-10-11 01:02:49.846161
NCT01996995|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-08-31|||March 2015|Actual|2015-03-01|August 2017|2017-08-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|LASER-1||Laser Therapy for Onychomycosis in Patients Wih Diabetes at Risk for Diabetic Foot Complications|Laser Therapy for Onychomycosis in Patients Wih Diabetes at Risk for Diabetic Foot Complications|Completed||N/A|64|Actual|Medical Research Foundation, The Netherlands||2|||f||||f||||||||||2017-10-11 01:02:49.981298|2017-10-11 01:02:49.981298
NCT01996982|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-04-25|||March 2014||2014-03-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study of a New Clinical Device for Reducing Body Core Temperature|Study of a New Clinical Device for Reducing Body Core Temperature|Terminated||N/A|7|Actual|Seton Healthcare Family||1||The Prinicipal Investigator left the organization and decided to close the trial|f||||f||||||||Undecided||2017-10-11 01:02:50.277774|2017-10-11 01:02:50.277774
NCT01996969|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-03-26|||October 2013||2013-10-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|June 2015|Actual|2015-06-01||Interventional|||Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer|Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer: A Prospective Explorative Study|Active, not recruiting||N/A|117|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 01:02:50.379411|2017-10-11 01:02:50.379411
NCT01996956|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2013-11-21|||May 2013||2013-05-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Prediction of Fluid Responsiveness by NICOM (Non-invasive Cardiac Output Monitoring) in Children With Congenital Heart Disease After Cardiac Surgery||Completed||N/A|30|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 01:02:50.471901|2017-10-11 01:02:50.471901
NCT01996943|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-05-12|||September 2012||2012-09-01|May 2016|2016-05-01||||July 2019|Anticipated|2019-07-01||Interventional|HOLIDAY||The HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) Study|Investigating the Effects of Ethanol on Atrial Fibrillation Susceptibility and Pathogenesis|Recruiting||N/A|50|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:02:50.549065|2017-10-11 01:02:50.549065
NCT01996930|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-06-21|||December 2013||2013-12-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|STOP||Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites|A Prospective, Randomised Controlled Trial to Determine the Safety and Efficacy of Steroid Impregnated Tape Compared to Standard Therapy With Silver Nitrate in the Treatment of Over-granulating Peritoneal Dialysis Catheter Exit Sites|Recruiting||Phase 3|80|Anticipated|University Hospital Birmingham NHS Foundation Trust||2|||f||||f||||||||No||2017-10-11 01:02:50.665601|2017-10-11 01:02:50.665601
NCT01996917|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-01-24|||August 2014||2014-08-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|Prineo||Use of Prineo in Breast Reduction Surgery|Use of Prineo™ for Wound Closure in Breast Reduction Surgery|Active, not recruiting||N/A|21|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:02:50.806977|2017-10-11 01:02:50.806977
NCT01996904|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-01-24|2013-12-06||March 2009||2009-03-01|January 2014|2014-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||One goal of the power analysis study design that was conducted was to test the null hypothesis, that the ASES score of two groups would be equal after undergoing treatment. The primary outcome measure was the ASES score and the secondary outcome measure includes ultrasound diagnosis until 24 months follow-up to evaluate subscapularis integrity.|Prospective Randomized Comparative Study of Outcome of Subscapularis Tear|A Prospective Randomized Comparative Study of 191 Subscapularis Tear: Clinical and Radiologic Outcome - Arthroscopic Repair vs Debridement|Completed||N/A|191|Actual|CM Chungmu Hospital|Limitation of this study was the low retention of patients during follow-up period. Our cases only yielded 75% retention of patients after twenty-four-months follow-up and this might act as a bias in our study.|2|||f||||t||||||||||2017-10-11 01:02:50.891886|2017-10-11 01:02:50.891886
NCT01996891|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-08-02|||January 2014||2014-01-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|AIR||Asthma (and Dietary) Inflammation Reduction|Effects of an Anti-Inflammatory Diet on Pulmonary Function in Pediatric Asthma|Terminated||N/A|14|Actual|Boston Children’s Hospital||2||Unable to recruit adequate number of participants and high attrition rate|f||||f||||||||||2017-10-11 01:02:51.131535|2017-10-11 01:02:51.131535
NCT01996878|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-11-22|||February 2006||2006-02-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|February 2007|Actual|2007-02-01||Observational|||Genetic Polymorphism and Parkinson's Disease in Taiwanese|Association Analysis of Single Nucleotide Polymorphisms and the Incidence of Parkinson's Disease in a Hospital-based Case-control Study in Taiwan|Completed||N/A|334|Actual|Changhua Christian Hospital|||2||f||||||||||Samples With DNA|"     Collect 10 mL peripheric blood for DNA extraction   "|||2017-10-11 01:02:51.251489|2017-10-11 01:02:51.251489
NCT01996865|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-08-29|||April 2, 2014|Actual|2014-04-02|August 2017|2017-08-01|March 8, 2023|Anticipated|2023-03-08|February 1, 2021|Anticipated|2021-02-01||Interventional|MAGNIFY||Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.|A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-Agent Maintenance Versus Rituximab in Subjects With Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma|Recruiting||Phase 3|500|Anticipated|Celgene||2|||f||||t||||||||||2017-10-11 01:02:51.367272|2017-10-11 01:02:51.367272
NCT01996852|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-07-24|||July 2013||2013-07-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Improving Erectile Function and Quality of Life After Prostate Cancer Treatment|Improving Erectile Function and Quality of Life After Prostate Cancer Treatment|Terminated||N/A|34|Actual|Case Comprehensive Cancer Center||2||Slow accrual|f||||t||||||||||2017-10-11 01:02:51.780962|2017-10-11 01:02:51.780962
NCT01996839|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-02-08|||December 2013||2013-12-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery|Loteprednol Etabonate Ophthalmic Gel, 0.38% (BID and TID) Versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery|Completed||Phase 3|514|Actual|Bausch & Lomb Incorporated||4|||f||||f||||||||||2017-10-11 01:02:51.959593|2017-10-11 01:02:51.959593
NCT01996826|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-04-06|||April 2014||2014-04-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival|A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival|Recruiting||Phase 1/Phase 2|90|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||Yes||2017-10-11 01:02:52.092859|2017-10-11 01:02:52.092859
NCT01996813|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-05-29|2014-05-29||December 2013||2013-12-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||All patients were > 18 years old, had body mass index (BMI) > 30, and had various medical comorbidities|Compression Stocking Use in Shoulder Arthroscopy in Beach Chair|The Effect of Compression Stockings on Cerebral Desaturation Events in Obese Patients Undergoing Shoulder Arthroscopy in the Beach Chair Position: an Observational Study|Completed||N/A|23|Actual|Loyola University|||1||f||||t||||||||||2017-10-11 01:02:52.273025|2017-10-11 01:02:52.273025
NCT01995903|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-04-21|||April 2012|Actual|2012-04-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Developing a Discrimination Model to Diagnose ALS|Developing a Discrimination Model to Diagnose ALS Using Advanced MRI Techniques|Completed||N/A|50|Actual|University of Michigan||2|||f||||t|f|||||||No||2017-10-11 01:03:04.875874|2017-10-11 01:03:04.875874
NCT01996800|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-09-30|||August 2013||2013-08-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Chiropractic and Neuromuscular Reeducation as a Treatment for Autism Symptoms|The Effects of Spinal Manipulative Therapy and Neuromuscular Reeducation on the Presentation of Autistic Symptoms in Children|Terminated||Phase 1|8|Actual|Southern California University of Health Sciences||2||Insufficient faculty and staff.|f||||t||||||||No||2017-10-11 01:02:52.76693|2017-10-11 01:02:52.76693
NCT01996787|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-26|||June 2013||2013-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Clinical Study of Visibility Tinted Clariti Contact Lens|The Clinical Performance of the Clariti Contact Lens (Including Handling Tint) for Daily Wear|Completed||N/A|38|Actual|Sauflon Pharmaceuticals Ltd||2|||f||||f||||||||||2017-10-11 01:02:52.879221|2017-10-11 01:02:52.879221
NCT01996774|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-08-18|||February 2012||2012-02-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|TOY||Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance|Immunologic Profile of Children and Teenagers With Severe Allergy to Peanuts and Nuts After Induction of Tolerance: a Pilot Project|Completed||N/A|70|Actual|Lille Catholic University|||3||f||||||||||Samples Without DNA|"     Blood, serum, saliva   "|||2017-10-11 01:02:53.00138|2017-10-11 01:02:53.00138
NCT01996761|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-05-10|||January 2011||2011-01-01|May 2016|2016-05-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|E-COMPASS||Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke|Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke|Completed||Phase 4|71|Actual|Samsung Medical Center||2|||f||||||||||||||2017-10-11 01:02:53.085319|2017-10-11 01:02:53.085319
NCT01996748|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-04-25|2016-12-21||February 2012||2012-02-01|April 2017|2017-04-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|||Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema|A Multicenter, Randomized, Parallel, Double-blind, Clinical Trial Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in Patients With Otic Eczema|Completed||Phase 3|135|Actual|Salvat||2|||f||||f||||||||||2017-10-11 01:02:53.199659|2017-10-11 01:02:53.199659
NCT01996735|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2014-01-09|||April 2013||2013-04-01|February 2013|2013-02-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Ticagrelor and Adenosine|The Effect of Ticagrelor on the Adenosine System|Completed||Phase 4|14|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 01:02:53.552307|2017-10-11 01:02:53.552307
NCT01996709|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-05-26|2015-05-26||December 2013||2013-12-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||This analysis group includes all subjects who were exposed to a study regimen.|Effectiveness of a Marketed One-Step Peroxide Lens Care Solution in Symptomatic Contact Lens Wearers|Effectiveness of a Marketed One-Step Peroxide Lens Care Solution in Symptomatic Contact Lens Wearers|Completed||N/A|142|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:02:53.642594|2017-10-11 01:02:53.642594
NCT01996696|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-01-04|||September 2014||2014-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|PREMIUM||Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate|Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate|Recruiting||Phase 2|104|Anticipated|AHS Cancer Control Alberta||2|||f||||t||||||||No||2017-10-11 01:02:54.014979|2017-10-11 01:02:54.014979
NCT01996683|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2015-01-13|||November 2014||2014-11-01|January 2015|2015-01-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)|A Randomized Prospective Comparative Study of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)|Unknown status|Not yet recruiting|N/A|50|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 01:02:54.176654|2017-10-11 01:02:54.176654
NCT01996670|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-21|||January 2007||2007-01-01|January 2007|2007-01-01||||December 2012|Actual|2012-12-01||Observational|||Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS||Completed||N/A|683|Actual|Xiangya Hospital of Central South University|||3||f||||t||||||||||2017-10-11 01:02:54.293861|2017-10-11 01:02:54.293861
NCT01996657|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-04-09|2017-04-09||January 2013||2013-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|3D-INTENSITY||D-Dimer Determined Anticoagulation INTENSITY in Patients With Mechanical Valve Replacement|D-dimer Levels Determined the Intensity of Anticoagulation Therapy to Improve Outcomes in Patients With Mechanical Valve Replacement|Completed||N/A|772|Actual|Wuhan Asia Heart Hospital|||3||f||||t||||||Samples Without DNA|"     Plasma   "|Undecided||2017-10-11 01:02:54.385593|2017-10-11 01:02:54.385593
NCT01996631|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-11-26|||June 2013||2013-06-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||The Impact of EDCs Relative Markers and Reproductive Hormone in Taiwanese Women|Serum Markers of OS, Inflammation, and EDCs and Impact on the Menstrual Cycle and Reproductive Hormone in Taiwanese Women|Unknown status|Active, not recruiting|N/A|400|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 01:02:55.651704|2017-10-11 01:02:55.651704
NCT01996618|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-04-30|||January 2014||2014-01-01|November 2013|2013-11-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|RSVP||Study to Reduce Symptoms of Premature Beats With Ranolazine|Reduction of Symptomatic Ventricular Premature Beats With Ranolazine|Unknown status|Recruiting|Phase 4|72|Anticipated|Walter Reed National Military Medical Center||2|||f||||t||||||||||2017-10-11 01:02:55.734003|2017-10-11 01:02:55.734003
NCT01996605|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-05-30|||June 2014||2014-06-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Spinal Oxytocin in Healthy Volunteers|Efficacy of Intrathecal Oxytocin in Human Volunteers|Recruiting||Phase 2|36|Anticipated|Wake Forest University Health Sciences||3|||f||||t||||||||||2017-10-11 01:02:55.870235|2017-10-11 01:02:55.870235
NCT01996579|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-02-17|||November 2013||2013-11-01|February 2017|2017-02-01|September 12, 2016|Actual|2016-09-12|September 12, 2016|Actual|2016-09-12||Interventional|PREVAIL||Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study|A Phase 2 Randomized Controlled Trial to Determine the Efficacy of Lactoferrin for the Prevention of Nosocomial Infections.|Completed||Phase 2|214|Actual|Queen's University||2|||f||||f||||||||Yes|Upon request only|2017-10-11 01:02:56.053992|2017-10-11 01:02:56.053992
NCT01996566|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-10-14|||January 2013||2013-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Observational|||Fatty Acid Taste Thresholds: Caproic, Lauric, Oleic, Linoleic, Linolenic|Fatty Acid Taste Thresholds: Caproic, Lauric, Oleic, Linoleic, Linolenic|Completed||N/A|30|Anticipated|Purdue University|||1||f||||f||||||Samples With DNA|"     Saliva will be collected to obtain DNA for analysis of genes for fatty acid receptors and     their potential correlation with sensitivity.   "|||2017-10-11 01:02:56.167781|2017-10-11 01:02:56.167781
NCT01996553|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-08-08|||April 2013||2013-04-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||The Prevalence of Radial Artery Occlusion in Diagnostic Cardiac Catheterization and Percutaneous Intervention|The Prevalence of Radial Artery Occlusion in Diagnostic Cardiac Catheterization and Percutaneous Intervention|Completed||N/A|172|Actual|Jesse Brown VA Medical Center|||1||f||||t||||||||||2017-10-11 01:02:56.250435|2017-10-11 01:02:56.250435
NCT01996540|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-06-27|||August 2012||2012-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.|The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.|Active, not recruiting||N/A|394|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||||2017-10-11 01:02:56.336504|2017-10-11 01:02:56.336504
NCT01996527|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-04-13|||May 2012||2012-05-01|April 2017|2017-04-01|January 1, 2016|Actual|2016-01-01|November 23, 2015|Actual|2015-11-23||Interventional|||3T MRI Biomarkers of Glioma Treatment Response|Early Detection of Glioma Treatment Response Using MRI-Based Biomarkers|Terminated||Early Phase 1|7|Actual|Vanderbilt-Ingram Cancer Center||1||PI left institution|f||||t||||||||||2017-10-11 01:02:56.491226|2017-10-11 01:02:56.491226
NCT01996514|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-26|||November 2010||2010-11-01|November 2013|2013-11-01||||August 2011|Actual|2011-08-01||Interventional|||Food Advertisements, Satiety and Food Intake in Children|Effect of Food Advertisements on Satiety and Meal-Time Food Intake in 9-14 y Old Boys and Girls|Completed||N/A|59|Actual|University of Toronto||4|||f||||f||||||||||2017-10-11 01:02:56.642081|2017-10-11 01:02:56.642081
NCT01996501|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-26||||||November 2013|2013-11-01||||January 2009|Actual|2009-01-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition|An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Olanzapine Orally Disintegrating 5mg Tablets (Test Formulation; Torrent Pharmaceuticals Ltd., India) Versus Zyprexa® Zydis® 5 mg Tablets (Reference Formulation; Eli Lilly and Company, USA) in Healthy Human Volunteers Under Fed Condition|Completed||Phase 1|||Torrent Pharmaceuticals Limited||1|||f||||||||||||||2017-10-11 01:02:56.756199|2017-10-11 01:02:56.756199
NCT01996488|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-21||||||November 2013|2013-11-01||||January 2009|Actual|2009-01-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fasting Condition|An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Olanzapine Orally Disintegrating 5mg Tablets (Test Formulation; Torrent Pharmaceuticals Ltd., India) Versus Zyprexa® Zydis® 5 mg Tablets (Reference Formulation; Eli Lilly and Company, USA) in Healthy Human Volunteers Under Fasting Condition.|Completed||Phase 1|||Torrent Pharmaceuticals Limited||1|||f||||||||||||||2017-10-11 01:02:56.829355|2017-10-11 01:02:56.829355
NCT01996475|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-26||||||November 2013|2013-11-01||||May 2008|Actual|2008-05-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed Condition|An Open Label, Randomized, 2-Period, 2-Treatment, Crossover, Single-Dose Bioequivalence Study of Escitalopram Oxalate Tablet 20mg [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Lexapro® (Escitalopram Oxalate Tablet 20mg) [Reference Formulation, Forest Laboratories Inc, USA] in Healthy Human Volunteers Under Fed Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited||1|||f||||||||||||||2017-10-11 01:02:56.969966|2017-10-11 01:02:56.969966
NCT01996462|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-21||||||November 2013|2013-11-01||||May 2008|Actual|2008-05-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting Condition|An Open Label, Randomised, 2-Period, 2-Treatment, Crossover, Single-Dose Bioequivalence Study of Escitalopram Oxalate Tablet Containing Escitalopram (20mg) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Lexapro® Tablet (20mg) [Reference Formulation, Forest Laboratories, USA] in Healthy Human Volunteers Under Fasting Condition|Completed||Phase 1|||Torrent Pharmaceuticals Limited||1|||f||||||||||||||2017-10-11 01:02:57.113965|2017-10-11 01:02:57.113965
NCT01996449|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-10-24|||July 2013||2013-07-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension|The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension|Recruiting||N/A|3|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 01:02:57.203555|2017-10-11 01:02:57.203555
NCT01996436|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-10-25|||August 2016||2016-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|IVT||The Intra-arterial Vasospasm Trial|The Intra-arterial Vasospasm Trial- A Multi-center Randomized Study|Recruiting||Phase 4|330|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||t||||||||No||2017-10-11 01:02:57.374596|2017-10-11 01:02:57.374596
NCT01996423|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-02-28|||April 2014||2014-04-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|VIDATOPIC||Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis|Impact of Vitamin D Supplementation on Clinical Severity and Immunologic Tolerance of Pediatric Atopic Dermatitis|Completed||N/A|101|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 01:02:57.586823|2017-10-11 01:02:57.586823
NCT01996410|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-09-29|2016-07-15||November 2013||2013-11-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients|The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients|Terminated||N/A|10|Actual|OhioHealth||8||Low enrollment.|f||||||||||||||2017-10-11 01:02:57.724726|2017-10-11 01:02:57.724726
NCT01996397|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-03-30|||May 2013||2013-05-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|CCI impact||Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy|Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy|Completed||N/A|34|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 01:02:58.195447|2017-10-11 01:02:58.195447
NCT01996384|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-10-04|||November 2013||2013-11-01|October 2017|2017-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study|Acupuncture Augmentation of Lidocaine for the Treatment of Provoked, Localized vulvodynia-a Feasibility and Acceptability Pilot Study|Completed||Phase 1|19|Actual|Oregon College of Oriental Medicine||2|||f||||f||||||||||2017-10-11 01:02:58.319662|2017-10-11 01:02:58.319662
NCT01996371|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-12-02|||January 2014||2014-01-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Radiographic and Clinical Outcomes Following Unilateral or Bilateral Posterior Fixation in MI-TLIF|Radiographic and Clinical Outcomes Following Unilateral or Bilateral Posterior Fixation in Minimally Invasive Transforaminal Lumbar Interbody Fusions|Recruiting||N/A|90|Anticipated|Ohio State University||3|||f||||f||||||||||2017-10-11 01:02:58.477523|2017-10-11 01:02:58.477523
NCT01996358|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-04-03|||August 2015||2015-08-01|April 2017|2017-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy|Comparing Intubating Conditions Using Succinylcholine or Rocuronium/Sugammadex for Rigid Bronchoscopy: a Randomized Study|Suspended||N/A|150|Anticipated|Dr. Horst Schmidt Klinik GmbH||3|||f||||||||||||||2017-10-11 01:02:58.593159|2017-10-11 01:02:58.593159
NCT01996345|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-09-25|||October 2016||2016-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Vaginal Pessary Versus Expectant Management for Placenta Previa|Vaginal Pessary Versus Expectant Management for the Prevention of Delivery Prior to 36 Weeks in Women With Placenta Previa|Recruiting||N/A|140|Anticipated|Mednax Center for Research, Education and Quality||2|||f||||t||||||||||2017-10-11 01:02:58.708944|2017-10-11 01:02:58.708944
NCT01996332|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2014-06-09|2014-06-09||April 2004||2004-04-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Intent-to-treat (ITT) population defined as all participants included to each of three cohorts based on prior chemotherapy treatment received: first-line monotherapy (for whom conventional chemotherapy was not indicated), second-line monotherapy, and third or subsequent lines of treatment.|A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|An Open-label Study of the Effect of Tarceva Monotherapy on Treatment Response in Patients With Advanced Non-small Cell Lung Cancer for Whom Tarceva Monotherapy is Considered the Best Option|Completed||Phase 2|1805|Actual|Hoffmann-La Roche|Nonserious adverse events presented in this record include all adverse events reported during the study, not just nonserious events.|1|||f||||||||||||||2017-10-11 01:02:58.957712|2017-10-11 01:02:58.957712
NCT01996319|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-03-07|2016-01-25||April 2014||2014-04-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|MOVE||Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.|MOVE - A Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|194|Actual|Novartis||2|||f||||||||||||||2017-10-11 01:03:00.066377|2017-10-11 01:03:00.066377
NCT01996306|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-07-26|||December 2013||2013-12-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|AXEPT||A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC|A Multinational, Randomized, Phase III Study of XELIRI With/Without Bevacizumab Versus FOLFIRI With/Without Bevacizumab As Second-line Therapy in Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 3|650|Actual|Epidemiological and Clinical Research Information Network||2|||f||||t||||||||||2017-10-11 01:03:01.05586|2017-10-11 01:03:01.05586
NCT01996293|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-09-21|||September 2013||2013-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Observational|PK-LAPB||Pregnant Women Taking Lamictal for Bipolar Disorder|Pharmacokinetics of Lamotrigine in Pregnant and Postpartum Women With Bipolar Disorder|Recruiting||N/A|10|Anticipated|Northwestern University|||1||f||||f||||||Samples With DNA|"     Blood serum specimen will be obtained to measure lamotrigine and estradiol levels. Standard     of care labs will be obtained on every participant that is eligible and signs informed     consent. Participants will not have more than 50 ml of blood drawn every 8 weeks.     Participants will also have the option to have blood drawn for DNA banking.      Participants in the study that elect to receive analgesia for pain related to labor and have     a spinal-epidural at Northwestern University will have CSF stored and banked for future     analysis.   "|Undecided||2017-10-11 01:03:01.312185|2017-10-11 01:03:01.312185
NCT01996280|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-08-04|||December 2012||2012-12-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|CTMI||A Randomized Clinical Trial of Culturally Tailored MI|A Randomized Clinical Trial of Culturally Tailored Motivational Interviewing|Active, not recruiting||N/A|301|Actual|Northeastern University||2|||f||||f||||||||||2017-10-11 01:03:01.433585|2017-10-11 01:03:01.433585
NCT01995318|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-03-02|||July 2013||2013-07-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|KINACAS||Effectiveness of Kinesiotaping in the Treatment of Acute Ankle Sprains|Effectiveness of Kinesiotaping in the Treatment of Acute Ankle Sprains|Completed||N/A|73|Actual|Etimesgut Military Hospital||2|||f||||f||||||||||2017-10-11 01:03:12.593186|2017-10-11 01:03:12.593186
NCT01996267|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-02-02|||December 2013||2013-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|TRAIN-2||Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2|Optimizing Neoadjuvant Systemic Treatment for HER2 Positive Breast Cancer - the TRAIN-2 Study|Active, not recruiting||Phase 3|437|Actual|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-10-11 01:03:01.558214|2017-10-11 01:03:01.558214
NCT01996254|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-06-13|||October 2013||2013-10-01|June 2017|2017-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System|A Randomized, Double-Blinded, Placebo-Controlled, Multicenter Pilot Study of the SPRINT Peripheral Nerve Stimulation (PNS) System for the Treatment of Post-Amputation Pain|Recruiting||Phase 2|54|Anticipated|SPR Therapeutics, LLC||2|||f||||f||||||||||2017-10-11 01:03:01.810746|2017-10-11 01:03:01.810746
NCT01996241|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2017-06-22|||January 2014||2014-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|Samata||Evaluation of an Intervention for Adolescent Girls in Karnataka|Evaluation of an Intervention Supporting Adolescent Girls From Marginalized Communities to Complete Secondary Schooling|Recruiting||N/A|2275|Anticipated|Karnataka Health Promotion Trust||2|||f||||f||||||||Yes|Data will be anonymised and made available for secondary analyses on request, following publication of trial findings.|2017-10-11 01:03:02.002094|2017-10-11 01:03:02.002094
NCT01996228|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-03-18|||November 2013||2013-11-01|March 2014|2014-03-01||||October 2015|Anticipated|2015-10-01||Interventional|||Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy|Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Tianhe Stem Cell Biotechnologies Inc.||1|||f||||||||||||||2017-10-11 01:03:02.120277|2017-10-11 01:03:02.120277
NCT01996215|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2016-11-22|||April 2014||2014-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Brain Connectivity in Age-Related Macular Degeneration|Cognitive Changes and Brain Connectivity in Age-Related Macular Degeneration|Active, not recruiting||N/A|300|Anticipated|Duke University|||2||f||||f||||||||||2017-10-11 01:03:02.261237|2017-10-11 01:03:02.261237
NCT01996202|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-05-22|||November 2013||2013-11-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma|A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma|Active, not recruiting||Phase 1|24|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 01:03:02.377712|2017-10-11 01:03:02.377712
NCT01996189|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-21|||May 2012||2012-05-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Arterial Puncture Using Insulin Syringe is Less Painful Than Standard Syringe|Arterial Puncture Using Insulin Syringe is Less Painful Than Standard Syringe, a Randomized Crossover Study|Completed||Phase 2|50|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 01:03:02.500798|2017-10-11 01:03:02.500798
NCT01996176|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-08-02|||November 2013||2013-11-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Take a Stand! - an Intervention to Reduce Occupational Sitting Time|Take a Stand ! - a Cluster Randomized Controlled Intervention Study at Four Office-based Workplaces Aiming to Reduce Occupational Sitting Time|Completed||N/A|337|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 01:03:02.618124|2017-10-11 01:03:02.618124
NCT01996163|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-26|||December 2013||2013-12-01|November 2013|2013-11-01||||December 2014|Anticipated|2014-12-01||Observational|||The Effect of Gender on the Consumption of Pain Medication in Infants Undergoing Craniosynostosis Repair or Untethering of Cord in ITU|The Effect of Gender on the Consumption of Pain Medication in Infants Undergoing Craniosynostosis Repair or Untethering of Cord in ITU|Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||||||||||||2017-10-11 01:03:02.7193|2017-10-11 01:03:02.7193
NCT01996150|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-07-10|||January 2014||2014-01-01|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Bleach Bath Treatment of Adults With Atopic Dermatitis|Assessing the Impact of Bleach Baths on Itch, Cutaneous Inflammation, Microbial Flora and Skin Barrier Function in Adult Atopic Dermatitis Subjects|Completed||N/A|58|Actual|University of Rochester||1|||f||||f||||||||||2017-10-11 01:03:02.79334|2017-10-11 01:03:02.79334
NCT01996137|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-02-17|||April 2017|Anticipated|2017-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|VASSTII||VASSTII: An Exploratory Clinical Study on a VASST IITreadmill System for Post Stroke Gait Rehabilitation.|An Exploratory Clinical Study on a Variable Speed and Sensing Treadmill (VASST II) System for Hemiparetic Gait Rehabilitation After Stroke|Recruiting||Phase 1/Phase 2|11|Anticipated|Tan Tock Seng Hospital||1|||f||||t|f|f||||||No||2017-10-11 01:03:02.901283|2017-10-11 01:03:02.901283
NCT01996124|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-11-11|||November 2013||2013-11-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients|Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients in Stable Conditions. Pilot Study|Completed||Phase 4|40|Actual|University of Milan||2|||f||||t||||||||||2017-10-11 01:03:02.998593|2017-10-11 01:03:02.998593
NCT01996111|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-06-12|||September 2013||2013-09-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|dHACM||Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis|A Prospective, Randomized, Controlled, Blinded, Comparative Study of Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis|Terminated||N/A|14|Actual|MiMedx Group, Inc.||4||Change in Regulatory Status|f||||f||||||||||2017-10-11 01:03:03.103714|2017-10-11 01:03:03.103714
NCT01996085|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-04-06|||January 2013||2013-01-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|FINE-PATH||Non-invasive Haemodynamic Assessment in Hypertension|The Usefulness of Non-invasive Assessment of Haemodynamic Profile in the Diagnosis and Treatment of Hypertension|Unknown status|Recruiting|N/A|140|Anticipated|Military Institute of Medicine, Poland||2|||f||||f||||||||||2017-10-11 01:03:03.320273|2017-10-11 01:03:03.320273
NCT01996072|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-06-11|||November 2013||2013-11-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||EC17 for Intraoperative Imaging for Parathyroidectomy|A Pilot & Feasibility Study of the Imaging Potential of EC17 in Subjects Undergoing Parathyroidectomy for Primary Hyperparathyroidism.|Active, not recruiting||Phase 1|10|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:03:03.510643|2017-10-11 01:03:03.510643
NCT01996059|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-21|||July 2012||2012-07-01|November 2013|2013-11-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Interventional|FJINS||Functional Jejunal Interposition Improve Nutritional Status After Total Gastrectomy|A Multi-center Pilot Randomized Controlled Trial Examining the Differences of Nutritional Status of Patients Undergoing Functional Jejunal Interposition Or Roux-en-Y After Total Gastrectomy for Gastric Cancer|Recruiting||Phase 3|500|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 01:03:03.594355|2017-10-11 01:03:03.594355
NCT01996046|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-07-13|||September 2013||2013-09-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||FDG PET/CT in Breast Cancer Bone Mets|18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET/CT) for the Evaluation of Response to Therapy in Bone-dominant Metastatic Breast Cancer|Recruiting||N/A|75|Anticipated|University of Pennsylvania|||1||f||||t||||||||||2017-10-11 01:03:03.700598|2017-10-11 01:03:03.700598
NCT01996033|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-03-15|||October 2013||2013-10-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|||EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension|This is a Post Market, Multi-center, Open Label, Observational Study. Approximately 500 Subjects With Uncontrolled Hypertension Will Undergo Renal Artery Ablation|Active, not recruiting||N/A|25|Actual|St. Jude Medical|||1||f||||f||||||||No||2017-10-11 01:03:03.800485|2017-10-11 01:03:03.800485
NCT01996020|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-05-19|||September 2012||2012-09-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Observational|||Measurement of Cerebral Flow Using Transfontanellar Doppler in Infants Under Cardiopulmonary Bypass|Intraoperative Trans-fontanel Cerebral Ultrasonography in Infants During Pediatric Cardiac Surgery Under Cardiopulmonary Bypass|Completed||N/A|43|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 01:03:03.905406|2017-10-11 01:03:03.905406
NCT01996007|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-11-06|||March 2014||2014-03-01|November 2015|2015-11-01||||August 2015|Actual|2015-08-01||Observational|||Understanding Pneumococcal Carriage and Disease|Cross-sectional Study to Establish the Point Prevalence of Serotype 19A Pneumococcal Nasopharyngeal Carriage of Fully Vaccinated Children Aged 13-48 Months Following Introduction of PCV13.|Completed||N/A|1200|Actual|University of Oxford|||2||f||||t||||||Samples Without DNA|"     Bacteria grown from nasopharyngeal swabs Serum   "|||2017-10-11 01:03:03.980099|2017-10-11 01:03:03.980099
NCT01995994|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-05-19|||June 2012||2012-06-01|November 2013|2013-11-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Observational|||Continuous Glucose Monitoring System in Intensive Care Unit|Continuous Glucose Monitoring System in Intensive Care Unit - Preliminary Study Evaluating Accuracy|Completed||N/A|23|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 01:03:04.086465|2017-10-11 01:03:04.086465
NCT01995981|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-06-23|||December 2013||2013-12-01|June 2015|2015-06-01||||December 2015|Anticipated|2015-12-01||Observational|PREDICT||Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS|Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS|Unknown status|Recruiting|N/A|30|Anticipated|Radboud University|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:03:04.155584|2017-10-11 01:03:04.155584
NCT01995968|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-07-31|||November 2013||2013-11-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2015|Actual|2015-07-01|1 Week|Observational [Patient Registry]|REPERE||Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.|Antenatal Detection of Fetal Growth Restriction : Determinants and Consequences for Stillbirths Rate.|Unknown status|Active, not recruiting|N/A|480|Anticipated|University Hospital, Grenoble|||2||f||||f||||||||||2017-10-11 01:03:04.263093|2017-10-11 01:03:04.263093
NCT01995955|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-03-22|||June 2013||2013-06-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|EVACORY||Evaluation of Coronary Microvascular Dysfunction (EVACORY)|The Proposed Study is to Validate a New Non-invasive Imaging Technique for Evaluation of Cardiac Microciculation in Coronary Artery Disease With a Comparison With Validated Technique Invasive, Which is Measure of Index of Myocardial Resistance|Recruiting||N/A|45|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 01:03:04.408896|2017-10-11 01:03:04.408896
NCT01995942|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-03-08|||June 7, 2013|Actual|2013-06-07|March 2017|2017-03-01|February 2, 2022|Anticipated|2022-02-02|February 2, 2017|Actual|2017-02-02||Observational|MARVEL||Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial|Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer|Active, not recruiting||N/A|246|Actual|Royal Marsden NHS Foundation Trust|||2||f||||f||||||Samples With DNA|"     Histopathology samples taken after rectal tumour removal surgery will be analysed using     micrarray techniques. The pathological tissue microarrays (TMAs) will be generated using the     Alphelys Tissue Arrayer Minicore®3 system. Markers that will be evaluated will be initially     directed at epithelial to mesenchymal (EMT) transition pathways, as our preliminary studies     suggest that this phylogenetically conserved molecular program has important roles in tumour     dissemination and resistance to conventional chemotherapy.   "|||2017-10-11 01:03:04.497997|2017-10-11 01:03:04.497997
NCT01995929|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-21|||September 2012||2012-09-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Observational|||Functional Endoscopy in Neurogenic Dysphagia|Transnasal Endoscopic Evaluation of Swallowing: Functional Esophagoscopy Using an Ultrathin Video Endoscope in Neurogenic Dysphagia|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital Muenster|||1||f||||f||||||||||2017-10-11 01:03:04.631315|2017-10-11 01:03:04.631315
NCT01995916|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-09-19|||August 2013||2013-08-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|WIMM||Wellness Intervention for Menstrual Mood Disorders|Intervention for Menstrual Mood Disorders & Early Life Abuse: BioPsych Mechanisms|Recruiting||N/A|140|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 01:03:04.73879|2017-10-11 01:03:04.73879
NCT01995890|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2013-11-22|||December 2012||2012-12-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal Eyes|Effect of Nepafenac Eye Drops on Intraocular Pressure - a Randomized Prospective Study|Completed||Phase 4|327|Actual|Dr T V Patel Eye Institute||2|||f||||t||||||||||2017-10-11 01:03:04.982137|2017-10-11 01:03:04.982137
NCT01995877|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-05-01|||October 2010||2010-10-01|May 2017|2017-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Evaluation of the Influence of Body Position on the Inferior Vena Cava (IVC) Diameter|Evaluation of the Influence of Body Position on the Inferior Vena Cava (IVC) Diameter|Terminated||N/A|2|Actual|University of Michigan|||1|Poor recruitment, PI leaving university|f||||t||||||||No||2017-10-11 01:03:05.079356|2017-10-11 01:03:05.079356
NCT01995864|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-07-19|||February 2014||2014-02-01|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|June 2017|Actual|2017-06-01||Interventional|CTI-TS RCT||Critical Time Intervention-Task Shifting: Randomized Controlled Trial|A Pilot Multi-center Randomized Controlled Trial of Critical Time Intervention - Task Shifting (CTI-TS) Versus Usual Care for People With Psychotic Disorders|Active, not recruiting||N/A|110|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 01:03:05.177818|2017-10-11 01:03:05.177818
NCT01995851|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-05-25|||October 2013||2013-10-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Observational|RELATIVES||Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools|Randomized Evaluation of Live Attenuated vs.Trivalent Inactivated Influenza Vaccines in Schools (RELATIVES)Pilot Study|Completed||N/A|902|Anticipated|Dalhousie University|||2||f||||t||||||||||2017-10-11 01:03:05.289016|2017-10-11 01:03:05.289016
NCT01995838|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2015-06-25||2015-06-25|November 2013||2013-11-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia|Completed||Phase 2|616|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 01:03:05.37515|2017-10-11 01:03:05.37515
NCT01995812|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-21|||March 2012||2012-03-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|Ola Hou||Ola Hou i ka Hula: Hula and Hypertension|Ola Hou i ka Hula: A Pilot Study to Investigate Hula and Hypertension Control|Completed||N/A|59|Actual|University of Hawaii||2|||f||||||||||||||2017-10-11 01:03:05.620254|2017-10-11 01:03:05.620254
NCT01995799|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-11-21|||June 2013||2013-06-01|November 2013|2013-11-01||||June 2015|Anticipated|2015-06-01||Interventional|IRNMAN||IRon Nanoparticle Enhanced MRI in the Assessment of Myocardial infarctioN|ASSESSMENT OF CELLULAR INFLAMMATION FOLLOWING ACUTE MYOCARDIAL INFARCTION Application Of Ultrasmall Superparamagnetic Particles Of Iron Oxide|Unknown status|Recruiting|Phase 2|80|Anticipated|University of Edinburgh||3|||f||||f||||||||||2017-10-11 01:03:05.693972|2017-10-11 01:03:05.693972
NCT01995786|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-04-06|||January 2012||2012-01-01|April 2016|2016-04-01||||December 2014|Actual|2014-12-01||Interventional|||Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy||Completed||N/A|200|Actual|Regina Elena Cancer Institute||2|||f||||f||||||||||2017-10-11 01:03:05.938731|2017-10-11 01:03:05.938731
NCT01995773|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-26|||December 2011||2011-12-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Observational|Healthy women||Glucose Metabolism and Quality of Life in Healthy Women|Glucose Metabolism, Adrenal Function, Cortisol Metabolism, Body Composition Physical Activity, and Quality of Life in Healthy Women|Completed||N/A|40|Actual|Odense University Hospital|||1||f||||f||||||Samples Without DNA|"     blood and urine samples   "|||2017-10-11 01:03:06.036832|2017-10-11 01:03:06.036832
NCT01995760|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2014-09-02|||November 2013||2013-11-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?|The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?|Completed||N/A|123|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:03:06.147755|2017-10-11 01:03:06.147755
NCT01995747|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-26|||February 2012||2012-02-01|November 2013|2013-11-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Observational|h4B12PBMC||The Effect of Anti-CεmX on IgE Production|The Effect of Humanized Anti-CεmX Antibody (h4B12) on IgE Production in the PBMC Isolated From Atopic Dermatitis Patients|Completed||N/A|52|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:03:06.231651|2017-10-11 01:03:06.231651
NCT01995734|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-12-26||||||December 2015|2015-12-01||||||||Expanded Access|ACCESS||An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly|An ACromegaly, Open-label, Multi-CEnter, Safety Monitoring Program for Treating Patients With SOM230 (Pasireotide) LAR Who Have Need to Receive Medical Therapy (ACCESS)|Approved for marketing||N/A|||Novartis|||||||||||||||||||2017-10-11 01:03:06.337515|2017-10-11 01:03:06.337515
NCT01995721|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-20|||February 2014||2014-02-01|November 2013|2013-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children|Phase III, Single-center Clinical Trial to Evaluate the 4-valent HPV Vaccine for the Treatment and Prevention of Recurrent Respiratory Papillomatosis in Children|Unknown status|Not yet recruiting|Phase 3|20|Anticipated|National Institute of Child Health, Hungary||1|||f||||f||||||||||2017-10-11 01:03:06.573317|2017-10-11 01:03:06.573317
NCT01995708|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-07-05|||January 31, 2014|Actual|2014-01-31|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation|A Phase I Trial of Vaccination With CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation|Recruiting||Phase 1|20|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:03:06.715391|2017-10-11 01:03:06.715391
NCT01995695|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-07-26|||October 2013||2013-10-01|July 2016|2016-07-01||||January 2016|Actual|2016-01-01||Interventional|||Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults|Phase 1 Evaluation of the Safety and Immunogenicity of Live Influenza A Vaccine H7N9 (6-2) AA ca Recombinant (A/Anhui/1/2013 (H7N9) x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H7N9 Disease in the Event of a Pandemic|Completed||Phase 1|48|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||f||||||||||2017-10-11 01:03:06.845141|2017-10-11 01:03:06.845141
NCT01995682|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-08-06|||December 2013||2013-12-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|NLA||Feasibility Clinical Study of NLA Tool-US|Evaluate the Feasibility of the NLA Tool, a Combined Assessment of Nutritional and Physical Functional Status, to Provide Personalized Advice for the Independence and Mobility of Elderly|Completed||N/A|154|Actual|Nestlé|||1||f||||f||||||None Retained|"     No biospecimens are to be collected or retained.   "|||2017-10-11 01:03:06.956268|2017-10-11 01:03:06.956268
NCT01995669|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-09-11|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Lenalidomide and GA101 in Relapsed Indolent Non-Hodgkin's Lymphoma|A Phase I/II Study of Lenalidomide and Obinutuzumab (GA101) in Relapsed Indolent Non-Hodgkin's Lymphoma|Recruiting||Phase 1/Phase 2|72|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-11 01:03:07.037423|2017-10-11 01:03:07.037423
NCT01995656|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2014-07-11|||December 2013||2013-12-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of LY3108743 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|44|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 01:03:07.149089|2017-10-11 01:03:07.149089
NCT01995643|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-02-06|||October 2013||2013-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|GSE2||Acute Effects of Grape Seed Extract on Insulin Sensitivity and Oxidative Stress and Inflammation Markers.|Effect of Grape Seed Extract on Modulation of Oxidative Stress/ Inflammation/ Insulin Sensitivity Induced by High Fat-carbohydrate Meal in Healthy Human Subjects|Active, not recruiting||N/A|15|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||||2017-10-11 01:03:07.250204|2017-10-11 01:03:07.250204
NCT01995630|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-06-27|||November 2013||2013-11-01|June 2017|2017-06-01|June 26, 2016|Actual|2016-06-26|June 2016|Actual|2016-06-01||Interventional|||Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients|Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients: A Randomized Clinical Trial|Completed||N/A|62|Actual|Medical University of Graz||4|||f||||f||||||||||2017-10-11 01:03:07.348633|2017-10-11 01:03:07.348633
NCT01995617|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-12-10|||November 2013||2013-11-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of GEN-004, a Streptococcus Pneumoniae Protein Subunit Vaccine, in Adult Subjects|Completed||Phase 1|90|Actual|Genocea Biosciences, Inc.||3|||f||||f||||||||||2017-10-11 01:03:07.442239|2017-10-11 01:03:07.442239
NCT01995604|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-06-12|||September 2013||2013-09-01|June 2014|2014-06-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face|A Single Center, Double Blinded, Placebo Controlled, Randomized, Split Face Study to Evaluate the Efficacy of dHACM (Dehydrated Human Amnion Chorion Membrane) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face|Withdrawn||N/A|0|Actual|MiMedx Group, Inc.||2|||f||||t||||||||||2017-10-11 01:03:07.556443|2017-10-11 01:03:07.556443
NCT01995591|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-01-11|||January 2013||2013-01-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2013|Actual|2013-02-01||Observational|2068||Indocyanine Green (ICG) in the ex Vivo Detection of Sentinel Lymph Node (SLN)in Colon Cancer|Prospective Open-label Study Using ex Vivo Injection of ICG to Detect SLN in Patients With Colon Cancer|Completed||N/A|20|Actual|Jules Bordet Institute|||1||f||||f||||||||||2017-10-11 01:03:07.64318|2017-10-11 01:03:07.64318
NCT01995578|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-12-14|||December 2013||2013-12-01|December 2016|2016-12-01||||November 2018|Anticipated|2018-11-01||Interventional|||Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse|A Single Arm Phase II Trial of Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse|Recruiting||Phase 2|32|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:03:07.723709|2017-10-11 01:03:07.723709
NCT01995565|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-25|||July 2011||2011-07-01|July 2011|2011-07-01||||July 2014|Anticipated|2014-07-01||Observational|||Regional Cerebral Hemodynamics Related to Global Hemodynamics|Impact of Systemic Hemodynamic Changes on Cerebral Perfusion and Oxygenation|Unknown status|Recruiting|N/A|64|Anticipated|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-11 01:03:07.869411|2017-10-11 01:03:07.869411
NCT01995552|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-09-12|||April 2014||2014-04-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|INSPIRE-ELR||IdeNtifying High riSk Patients Post Myocardial Infarction With REduced Left Ventricular Function Using External Loop Recorders (INSPIRE-ELR Study)|IdeNtifying High riSk Patients Post Myocardial Infarction With REduced Left Ventricular Function Using External Loop Recorders (INSPIRE-ELR Study)|Active, not recruiting||N/A|250|Actual|Medtronic BRC||1|||f||||f||||||||||2017-10-11 01:03:08.027238|2017-10-11 01:03:08.027238
NCT01995539|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-03-08|||December 2012||2012-12-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in India|Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in India|Completed||N/A|180|Actual|Medtronic Diabetes||1|||f||||f||||||||||2017-10-11 01:03:08.174459|2017-10-11 01:03:08.174459
NCT01995526|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-01-15|||December 2013||2013-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Insulin Peglispro in Healthy Male Japanese Participants|A Single Dose Study to Evaluate the Pharmacokinetics and Glucodynamics of Insulin Peglispro (LY2605541) in Healthy Male Japanese Subjects|Completed||Phase 1|10|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:03:08.323199|2017-10-11 01:03:08.323199
NCT01995500|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-05-28|||January 2014||2014-01-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2015|Actual|2015-09-01||Interventional|NIREUS||Angiography Study of BioNIR Drug Eluting Stent System (NIREUS)|BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study|Active, not recruiting||Phase 2|300|Anticipated|Medinol Ltd.||2|||f||||t||||||||||2017-10-11 01:03:08.724566|2017-10-11 01:03:08.724566
NCT01995487|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-05-28|||January 2014||2014-01-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 28, 2016|Actual|2016-08-28||Interventional|BIONICS||Study of BioNIR Drug Eluting Stent System in Coronary Stenosis|BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial|Active, not recruiting||Phase 2|1906|Anticipated|Medinol Ltd.||2|||f||||t||||||||||2017-10-11 01:03:08.896081|2017-10-11 01:03:08.896081
NCT01995474|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-11-21|||February 2010||2010-02-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Simple Technique to Improve Diagnostic Yield in EUS-FNA|Eliminating the Residual Negative Pressure in the EUS-FNA Needle Before Withdrawal Enhances the FNA Cytology Yield|Completed||N/A|60|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 01:03:09.05231|2017-10-11 01:03:09.05231
NCT01995461|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-10-22|2015-09-22||May 2013||2013-05-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Bilateral Transforaminal Epidural Steroid Injections for Degenerative Lumbar Spinal Stenosis|Effectiveness of Bilateral Transforaminal Epidural Steroid Injections in Degenerative Lumbar Spinal Stenosis Patients With Neurogenic Claudication: A Prospective Outcome Study|Terminated||N/A|26|Actual|Marshfield Clinic Research Foundation||1||biostatistician determined 20 subjects would be adequate to perform statistics|f||||f||||||||||2017-10-11 01:03:09.156772|2017-10-11 01:03:09.156772
NCT01995448|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-02-23|||November 2013||2013-11-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|SEPTIFLUX2||Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis|Prognostic Interest of Leucocyte Immunophenotyping Using Multiparameter 8-color Flow Cytometry During the Acute Phase of Sepsis|Completed||N/A|1000|Actual|University Hospital, Limoges|||1||f||||f||||||Samples With DNA|"     Residue of blood further to NFS.   "|||2017-10-11 01:03:09.394103|2017-10-11 01:03:09.394103
NCT01995435|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-09-03|||February 2015||2015-02-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Refraction Determination Analysis||Completed||N/A|30|Actual|Lee, Steven, M.D.||2|||f||||||||||||||2017-10-11 01:03:09.517587|2017-10-11 01:03:09.517587
NCT01995422|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-03-30|||December 2011||2011-12-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|2DPAP||Effect of Physical Activity on Depressive Symptoms With a 5 Month Follow-up|Effects of Physical Activity Program on the Emotional and Cognitive Dynamics in Major Depressive Disorder Patients|Completed||N/A|16|Actual|Laboratory Motricité, Interactions, Performance||1|||f||||t||||||||||2017-10-11 01:03:09.600638|2017-10-11 01:03:09.600638
NCT01995409|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-09-23|||September 2013||2013-09-01|September 2014|2014-09-01||||September 2014|Anticipated|2014-09-01||Interventional|||Mothers Learning About Second-hand Smoke - MLASS Study|Mothers Learning About Second-hand Smoke - MLASS Study|Unknown status|Recruiting|N/A|||The Leeds Teaching Hospitals NHS Trust|||||f||||||||||||||2017-10-11 01:03:09.705773|2017-10-11 01:03:09.705773
NCT01995396|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2016-09-26|||February 2014||2014-02-01|September 2016|2016-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|HAPIrect||Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study|Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study|Recruiting||N/A|340|Anticipated|Landstinget Västmanland||2|||f||||t||||||||||2017-10-11 01:03:09.791188|2017-10-11 01:03:09.791188
NCT01995383|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-11-03|||November 2013||2013-11-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.|A Single Oral Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Subjects Including a Single Intravenous Microdose of RO6836191|Completed||Phase 1|88|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-11 01:03:11.627966|2017-10-11 01:03:11.627966
NCT01995370|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-12-03|||October 2013||2013-10-01|December 2013|2013-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|CSPS・com||Cilostazol Stroke Prevention Study for Antiplatelet Combination|Cilostazol Stroke Prevention Study for Antiplatelet Combination|Unknown status|Recruiting|Phase 3|4000|Anticipated|Japan Cardiovascular Research Foundation||2|||f||||t||||||||||2017-10-11 01:03:11.760432|2017-10-11 01:03:11.760432
NCT01995357|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-02-02|2015-01-19||October 2013||2013-10-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Influence of Baseplate Adhesive on the Degree of Leakage|The Influence of Base Plate Adhesive Type, Shape and Application on Degree of Leak-age - a Randomized Controlled Trial in Subjects With Ileostomy and Colostomy|Completed||N/A|22|Actual|Coloplast A/S||6|||f||||f||||||||||2017-10-11 01:03:11.907109|2017-10-11 01:03:11.907109
NCT01995344|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-21|||October 2013||2013-10-01|November 2013|2013-11-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|METILDA||TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment|A Randomised Phase II Study in Metastatic Melanoma to Evaluate the Efficacy of Adoptive Cellular Therapy With Tumour Infiltrating Lymphocytes (TIL) and Assessment of High Versus Low Dose Interleukin-2|Not yet recruiting||Phase 2|90|Anticipated|The Christie NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:03:12.357853|2017-10-11 01:03:12.357853
NCT01995331|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-21|||March 2012||2012-03-01|November 2013|2013-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia|Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 01:03:12.463857|2017-10-11 01:03:12.463857
NCT01995292|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2014-11-05|||October 2013||2013-10-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||"Comparison of Two Different Types of Spray as You go Technique for Awake Fiberoptic Intubation"|"Comparative Clinical Trial of Conventional and Modified Spray as You go Technique With the Enk Fiberoptic Atomizer Set for Awake Fiberoptic Intubation (Atomizer Study)"|Completed||N/A|100|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-11 01:03:12.816479|2017-10-11 01:03:12.816479
NCT01995279|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-25|||November 2013||2013-11-01|November 2013|2013-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|EARPIB||Ear Acupuncture Reducing Pain and Improving Balance|The Effects of a Single Session of Ear Acupuncture in Pain Sensation and Body Balance|Unknown status|Recruiting|N/A|80|Anticipated|Universidade Cruzeiro do Sul||2|||f||||f||||||||||2017-10-11 01:03:13.06978|2017-10-11 01:03:13.06978
NCT01995266|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-03-22||2017-03-22|February 2014||2014-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual|A Phase 3, Open-Label Study With Daclatasvir And Asunaprevir (DUAL) for Subjects With Genotype 1b Chronic Hepatitis C (HCV) Infection Who Are Intolerant or Ineligible to Interferon Alfa Therapies With or Without Ribavirin|Completed||Phase 3|159|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 01:03:13.193002|2017-10-11 01:03:13.193002
NCT01995253|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-21|||September 2012||2012-09-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Interventional|||A Smartphone Application to Evaluate Energy Expenditure and Duration of Moderate-intensity Activities|A Smartphone Application to Evaluate Energy Expenditure and Duration of Moderate-intensity Activities|Completed||N/A|16|Actual|Institut National de la Recherche Agronomique||2|||f||||t||||||||||2017-10-11 01:03:13.44029|2017-10-11 01:03:13.44029
NCT01995240|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-03-17|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|REMP||Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study|Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study|Completed||N/A|23|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 01:03:13.536594|2017-10-11 01:03:13.536594
NCT01995227|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-04-01|||December 2013||2013-12-01|April 2015|2015-04-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||An Individualized Anti-Cancer Vaccine Study in Patients With HCC|An Individualized Anti-Cancer Vaccine (AlloVaxTM) Study in Patients With Refractory Hepatocellular Carcinoma (HCC)|Withdrawn||Phase 1/Phase 2|0|Actual|Immunovative Therapies, Ltd.||1||Study site change|f||||t||||||||||2017-10-11 01:03:13.671506|2017-10-11 01:03:13.671506
NCT01995214|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-11-21|||June 2013||2013-06-01|November 2013|2013-11-01||||December 2013|Anticipated|2013-12-01||Interventional|||Sevoflurane and Propofol Anesthesia on Postoperative Delirium|Comparison of Sevoflurane and Propofol Anesthesia on Postoperative Delirium in Geriatric Patients|Unknown status|Recruiting|Phase 4|500|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 01:03:13.807505|2017-10-11 01:03:13.807505
NCT01995188|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-10-02|||December 16, 2013|Actual|2013-12-16|October 2017|2017-10-01|November 9, 2016|Actual|2016-11-09|November 9, 2016|Actual|2016-11-09||Interventional|||A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer|A Phase Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of DNIB0600A in Combination With Carboplatin (With or Without Bevacizumab) in Patients With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer|Completed||Phase 1|41|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 01:03:14.246634|2017-10-11 01:03:14.246634
NCT01995175|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-09-25|||December 1, 2013||2013-12-01|September 2017|2017-09-01|October 22, 2021|Anticipated|2021-10-22|October 20, 2017|Anticipated|2017-10-20||Interventional|||A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age|A Prospective, Epidemiological Study to Assess the Disease Burden of RSV Associated, Suspected LRTIs From 0 to 2 Years and Population Attributable Risk Percent of RSV LRTI on the Development of Recurrent Wheeze and Asthma From 0 to 6 Years|Active, not recruiting||N/A|2400|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 01:03:14.413427|2017-10-11 01:03:14.413427
NCT01995162|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-21|||April 2013||2013-04-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||A Smartphone Application to Evaluate Energy Expenditure and Duration of Activities in Free-living Conditions (eMouve2)|A Smartphone Application to Evaluate Energy Expenditure and Duration of Moderate-intensity Activities in Free-living Conditions (eMouve 2)|Completed||N/A|24|Actual|Institut National de la Recherche Agronomique||1|||f||||t||||||||||2017-10-11 01:03:14.589135|2017-10-11 01:03:14.589135
NCT01995149|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2013-11-25|||June 2010||2010-06-01|November 2013|2013-11-01||||September 2012|Actual|2012-09-01||Interventional|||Effect of Weight Loss on Cholesterol Metabolism in Hereditary Hypercholesterolemias and Overweight or Obesity.|Effect of Weight Loss on Lipids Concentration and Cholesterol Metabolism in Overweight and Obese Subjects With Primary Hypercholesterolemia.|Completed||N/A|78|Actual|Instituto Aragones de Ciencias de la Salud||1|||f||||f||||||||||2017-10-11 01:03:14.676236|2017-10-11 01:03:14.676236
NCT01995136|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-10-05|2015-06-25||September 2013||2013-09-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||This analysis population includes all enrolled subjects minus any subjects with all missing data and/or critical protocol deviation/s.|Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma|Investigation of the Effect of Travoprost Ophthalmic Solution of Lowering Intraocular Pressure in Patients With Normal Tension Glaucoma|Completed||Phase 4|32|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 01:03:14.764766|2017-10-11 01:03:14.764766
NCT01995123|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-07-07|||September 8, 2014|Actual|2014-09-08|July 2017|2017-07-01|December 28, 2018|Anticipated|2018-12-28|December 28, 2018|Anticipated|2018-12-28||Interventional|||Behavioral Activation for Smoking Cessation in PTSD|Behavioral Activation for Smoking Cessation in Veterans With PTSD|Recruiting||N/A|120|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 01:03:15.160728|2017-10-11 01:03:15.160728
NCT01995110|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2014-04-23|||March 2011||2011-03-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|August 2012|Actual|2012-08-01||Interventional|||Postprandial Blood Cell Transcriptome of Normal Weight and Obese Subjects to 3 Caloric Doses of a High-fat Meal|Identification of Nutritional Health Biomarkers for Metabolic Flexibility in Blood - a Randomized, Postprandial, Caloric Dose-response Strategy|Completed||N/A|14|Actual|Agroscope Liebefeld-Posieux Research Station ALP||2|||f||||t||||||||||2017-10-11 01:03:15.308251|2017-10-11 01:03:15.308251
NCT01995084|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2015-01-13|||May 2012||2012-05-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|HYPE||In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study|In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study|Completed||N/A|32|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 01:03:15.540095|2017-10-11 01:03:15.540095
NCT01995058|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-02-19|||December 2013||2013-12-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer|A Randomized Phase 2 Study of Cabozantinib (XL184) in Combination With Abiraterone in Chemotherapy Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer|Terminated||Phase 2|54|Actual|Exelixis||4||Study stopped after results of cabozantinib Phase 3 CRPC study XL184-307.|f||||f||||||||||2017-10-11 01:03:15.877017|2017-10-11 01:03:15.877017
NCT01995045|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2017-02-16|2016-12-27||July 2012||2012-07-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Postoperative Pain Control Following Vitreoretinal Surgery|The Effects of Triamcinolone Acetonide With Retrobulbar Anesthesia on Postoperative Pain Control Following Vitreoretinal Surgery|Completed||Phase 4|58|Actual|Emory University||2|||f||||t||||||||||2017-10-11 01:03:16.089222|2017-10-11 01:03:16.089222
NCT01995032|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-08-12|||October 2013||2013-10-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|||L-citrulline and Metformin in Duchenne's Muscular Dystrophy|"A Double Blind Randomised Placebo Controlled Efficacy and Safety Study of L-citrulline and Metformin in Ambulant Children Aged Between 7 and 10 Years With Duchenne's Muscular Dystrophy"|Completed||Phase 3|47|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 01:03:16.487598|2017-10-11 01:03:16.487598
NCT01995019|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-05-18|||December 10, 2013|Actual|2013-12-10|May 2017|2017-05-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||Arthralgia of the Temporomandibular Joint. Pain Relief Following One Intra-articular Injection of Methylprednisolone|PhaseIV Study of Intra-articular Methylprednisolone in TMJ Arthralgia|Completed||Phase 4|56|Actual|Uppsala University||2|||f||||t||||||||||2017-10-11 01:03:16.602466|2017-10-11 01:03:16.602466
NCT01995006|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-04-16|||January 2014||2014-01-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Metamizole (Dipyrone) on Renal Function in Salt-depleted Healthy Subjects|Effect of Metamizole on Renal Function in Salt-depleted Healthy Subjects Single-center, Randomized, Open, Controlled Parallel-group Study to Investigate the Effects of Oral Metamizole or Naproxen on Renal Function in Healthy Male Salt-depleted Subjects|Completed||Phase 1|15|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 01:03:16.729293|2017-10-11 01:03:16.729293
NCT01994993|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-04-26|||December 2013||2013-12-01|April 2017|2017-04-01|April 20, 2017|Actual|2017-04-20|February 1, 2017|Actual|2017-02-01||Interventional|SCAMP||Antibiotic Safety (SCAMP)|Antibiotic Safety in Infants With Complicated Intra-Abdominal Infections (SCAMP Trial)|Completed||Phase 2/Phase 3|284|Anticipated|Duke University||5|||f||||t||||||||||2017-10-11 01:03:16.850075|2017-10-11 01:03:16.850075
NCT01994980|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-11-17|||December 2013||2013-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|DATE||Duration of Antibiotic Treatment for Early VAP (DATE) Trial|A Randomized Clinical Trial of 4 vs. 8 Days of Definitive Antibiotic Therapy for Early Ventilator-Associated Pneumonia in the Surgical Intensive Care Unit|Recruiting||N/A|100|Anticipated|Denver Health and Hospital Authority||2|||f||||t||||||||||2017-10-11 01:03:17.047161|2017-10-11 01:03:17.047161
NCT01994967|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-07-18|||November 2016|Actual|2016-11-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Phase III, Evaluate Noninferiority Between Levobupivacaine and Bupivacaine in Spinal Anesthesia.|Study Phase III to Evaluate the Noninferiority of Heavy Levobupivacaine 50% Enantiomeric Excess (Levobupivacaine S75:R25) Compared to Racemic Heavy Bupivacaine (Bupivacaine S50:R50) in Spinal Anesthesia for Lower Limb Orthopedic Procedures|Withdrawn||Phase 3|0|Actual|Cristália Produtos Químicos Farmacêuticos Ltda.||2||Another regulatory way was defined.|f||||t||||||||||2017-10-11 01:03:17.13303|2017-10-11 01:03:17.13303
NCT01994954|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-07-21|||November 2013||2013-11-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Randomized Trial of Outpatient Oxygen Weaning Strategies in Premature Infants||Enrolling by invitation||N/A|146|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 01:03:17.240857|2017-10-11 01:03:17.240857
NCT01994941|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-11-30|||August 2013||2013-08-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome|Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome|Completed||Phase 4|133|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 01:03:17.361917|2017-10-11 01:03:17.361917
NCT01994928|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-03-23|||November 2013||2013-11-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Preoxygenation in the Intensive Care Unit Using a Nose-mouth Mask Versus High-flow Nasal Cannula Oxygen.|Prospective Randomised Study on Preoxygenation in the Intensive Care Unit Using a Nose-mouth Mask Versus High Flow Nasal Cannula Oxygen.|Completed||N/A|40|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||||||||||||2017-10-11 01:03:17.471878|2017-10-11 01:03:17.471878
NCT01994915|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|COPD||Effects of Occupational Therapy in COPD|Effects on Functionality of Occupational Therapy Added to Physiotherapy in Severe COPD Patients|Active, not recruiting||N/A|35|Anticipated|Universidad de Granada||2|||f||||t||||||||||2017-10-11 01:03:17.553424|2017-10-11 01:03:17.553424
NCT01994902|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-12-08|2015-11-03||November 2013||2013-11-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Only subjects in the intention to treat population are included in the baseline population. These were the only subjects who tested the products.|Investigation of Newly Developed Ostomy Products in Subjects With Ileostomy|Investigation of Newly Developed 1-and 2-piece Convex Ostomy Products in Subjects With Ileostomy.|Completed||N/A|129|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 01:03:17.8019|2017-10-11 01:03:17.8019
NCT01994889|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-09-25|||December 9, 2013|Actual|2013-12-09|September 2017|2017-09-01|February 15, 2018|Anticipated|2018-02-15|February 15, 2018|Anticipated|2018-02-15||Interventional|ATTR-ACT||Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy|A Multicenter, International, Phase 3, Double-blind, Placebo-controlled, Randomized Study To Evaluate The Efficacy, Safety, And Tolerability Of Daily Oral Dosing Of Tafamidis Meglumine (Pf-06291826) 20 Mg Or 80 Mg In Comparison To Placebo In Subjects Diagnosed With Transthyretin Cardiomyopathy (ttr-cm)|Active, not recruiting||Phase 3|446|Actual|Pfizer||3|||f||||t|t|f||||||||2017-10-11 01:03:18.153655|2017-10-11 01:03:18.153655
NCT01994876|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2014-02-26|2014-02-26||September 2012||2012-09-01|February 2014|2014-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy|Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy|Completed||N/A|18|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 01:03:18.454607|2017-10-11 01:03:18.454607
NCT01994863|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-03-10|2015-02-19||September 2012||2012-09-01|March 2015|2015-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Performance Investigation of a New 1-piece Ostomy Product Compared to Standard of Care 1-piece in Subjects With Ileostomy|An Open-labeled, Randomised, Controlled, Comparative, Cross-over Study Investigating the Safety and Performance of a New 1-piece Ostomy Product Compared to Standard Care 1-piece in Subjects With Ileostomy|Terminated||Phase 2|23|Actual|Coloplast A/S|Early termination leading to small number of subjects analyzed|2||Problems with product performance|f||||f||||||||||2017-10-11 01:03:18.707566|2017-10-11 01:03:18.707566
NCT01994850|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-07-05|||November 2013|Actual|2013-11-01|July 2017|2017-07-01||||July 2017|Actual|2017-07-01||Interventional|||A Phase I/II Study Of Brentuximab Vedotin In Combination With Multi-Agent Chemotherapy As Front-Line Treatment In Patients With CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, And Grey Zone Lymphomas|A Phase I/II Study Of Brentuximab Vedotin In Combination With Multi-Agent Chemotherapy As Front-Line Treatment In Patients With CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, And Grey Zone Lymphomas|Active, not recruiting||Phase 1/Phase 2|32|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:03:18.966323|2017-10-11 01:03:18.966323
NCT01994837|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-12-18||2015-12-18|November 2013||2013-11-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)|A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)|Completed||Phase 2|32|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 01:03:19.073356|2017-10-11 01:03:19.073356
NCT01994824|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-10-28|||January 2014||2014-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Preemptive Therapy of GVHD|Preemptive Therapy of Graft-vs-Host Disease Using Rabbit Antithymocyte Globulin|Suspended||Phase 2|160|Anticipated|University of Calgary||1||"Toxicity concern upon preliminary analysis, requiring putting study on hold and re-doing the   preliminary analysis with longer follow up."|f||||f||||||||||2017-10-11 01:03:19.22809|2017-10-11 01:03:19.22809
NCT01994811|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-12-12|||April 2013||2013-04-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|ECHORN||Eastern Caribbean Health Outcomes Research Network (ECHORN)|Eastern Caribbean Health Outcomes Research Network (ECHORN)|Recruiting||N/A|4400|Anticipated|Yale University|||1||f||||t||||||Samples With DNA|"     Blood and Saliva samples   "|Yes|A Data Access and Scientific Review Committee (DASR), was been established to oversee requests for research collaboration (e.g. ancillary studies, secondary data analyses, etc.) to ensure they are within the scope of ECHORN's research mandate. Per the ECHORN Data Access Policy, data from ECHORN's research studies will be available to only internal ECHORN researchers for up to 3 years post data collection completion. Following that period, de-identified, limited ECHORN datasets will be made available for public access.|2017-10-11 01:03:19.361665|2017-10-11 01:03:19.361665
NCT01994798|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-04-22|||November 2013||2013-11-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01|30 Days|Observational [Patient Registry]|RXRegistry||Rapid Exchange Devices Observational Registry.|Prospective, Non-randomized, Multicentre, Observational Registry to Assess Clinically Relevant Benefit of Performing the Whole PTA Procedure Using the Rapid Exchange (RX) Devices.|Active, not recruiting||N/A|525|Anticipated|Terumo Europe N.V.|||1||f||||t||||||||||2017-10-11 01:03:19.486514|2017-10-11 01:03:19.486514
NCT01994785|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-05-30|2017-04-20||November 2013||2013-11-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Use of Capnography in EGD and Colonoscopy With Moderate Sedation.|Does the Use of Capnography in Routine EGD and Colonoscopy Targeting Moderate Sedation With a Benzodiazepine and Opioid Improve Safety?|Completed||N/A|452|Actual|The Cleveland Clinic||4|||f||||t||||||||No||2017-10-11 01:03:19.621518|2017-10-11 01:03:19.621518
NCT01994772|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-11-21|||January 2014||2014-01-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|HYPERION||Therapeutic Hypothermia After Cardiac Arrest in Non Shockable Rhythm|Therapeutic Hypothermia After Cardiac Arrest in Non Shockable Rhythm at Rescue Arrival: The HYPERION Study|Recruiting||N/A|584|Anticipated|Centre Hospitalier Departemental Vendee||2|||f||||t||||||||||2017-10-11 01:03:20.176084|2017-10-11 01:03:20.176084
NCT01994759|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2017-03-01|||September 1, 2013|Actual|2013-09-01|March 2017|2017-03-01|December 1, 2016|Actual|2016-12-01|July 1, 2015|Actual|2015-07-01||Interventional|||Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof.|Optimal Treatment of Plantar Fasciitis: A Randomized Clinical Trial Using Physical Training, Glucocorticoid Injections or a Combination Thereof.|Completed||Phase 4|90|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-10-11 01:03:20.432704|2017-10-11 01:03:20.432704
NCT01994746|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-10-07|2016-05-26||November 2013||2013-11-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Safety population|Effectiveness and Safety of Intranasal Glucagon for Treatment of Hypoglycemia in Adults|Efficacy and Safety of Intranasal Glucagon for Treatment of Insulin Induced Hypoglycemia in Adults With Diabetes|Completed||Phase 3|77|Actual|Jaeb Center for Health Research||2|||f||||f||||||||||2017-10-11 01:03:20.587436|2017-10-11 01:03:20.587436
NCT01994733|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2015-06-22|||January 2014||2014-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|TARGET||Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)|Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET): Intensive vs Liberalized Phosphate Control in Hemodialysis Recipients|Completed||Phase 2|104|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:03:20.959831|2017-10-11 01:03:20.959831
NCT01994720|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-05-12|2017-03-07||January 7, 2014|Actual|2014-01-07|May 2017|2017-05-01|March 2, 2016|Actual|2016-03-02|March 2, 2016|Actual|2016-03-02||Interventional|SOCRATES||[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]|A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.|Completed||Phase 3|13307|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 01:03:21.419477|2017-10-11 01:03:21.419477
NCT01994707|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2016-03-13|||August 2013||2013-08-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Remote Ischemic Preconditioning of Human Myocardium|Remote Ischemic Preconditioning of Human Myocardium|Recruiting||Phase 2|120|Anticipated|Medical University of Silesia||2|||f||||f||||||||||2017-10-11 01:03:26.747815|2017-10-11 01:03:26.747815
NCT01994694|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2015-11-17|||November 2014||2014-11-01|July 2015|2015-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Risk Perception in Adults With Attention Deficit and Hyperactivity Disorder (ADHD)|Risk Perception in Adults With Attention Deficit and Hyperactivity Disorder (ADHD)|Completed||N/A|60|Actual|Shaare Zedek Medical Center|||2||f||||f||||||||||2017-10-11 01:03:26.932602|2017-10-11 01:03:26.932602
NCT01994681|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-12-04|||October 2013||2013-10-01|December 2013|2013-12-01||||October 2014|Anticipated|2014-10-01||Observational|||Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air|Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air|Unknown status|Recruiting|N/A|100|Anticipated|Rauscher, Gregory E., M.D. PA|||2||f||||||||||||||2017-10-11 01:03:27.048213|2017-10-11 01:03:27.048213
NCT01994668|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2014-02-28|||January 2014||2014-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects|A Phase 1, Randomized Single-blind (Subject-blind), Placebo Controlled Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects|Completed||Phase 1|8|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:03:27.237524|2017-10-11 01:03:27.237524
NCT01994655|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2013-11-20|||August 2008||2008-08-01|November 2013|2013-11-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Chinese Health Ivvestigation Of Nurse Aging||Unknown status|Active, not recruiting|Phase 1/Phase 2|2000|Anticipated|Peking University First Hospital||1|||f||||f||||||||||2017-10-11 01:03:27.343636|2017-10-11 01:03:27.343636
NCT01994642|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-20|2017-09-22|||November 2013||2013-11-01|September 2017|2017-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes|A Randomized, Double-Blind, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspension (Par) Compared to CIPRODEX® (Ciprofloxacin 0.3%/Dexamethasone 0.1%) Sterile Otic Suspension (Alcon) in the Treatment of Acute Bacterial Otitis Media in Children With Patent Tympanostomy Tubes|Terminated||Phase 3|203|Actual|Par Pharmaceutical, Inc.||3||"FDA's draft guidance (revised March 2015) provided two options for determining bioequivalence:   1) in-vitro or 2) in-vivo studies"|f||||f||||||||||2017-10-11 01:03:27.442599|2017-10-11 01:03:27.442599
NCT01994616|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-19|||January 2009||2009-01-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Observational|||Prospective Evaluation of the Use of Intralesional Cryotherapy for Treatment of Keloid and Hypertrophic Scars|Intralesional Cryotherapy for Treatment of Keloid Scars: a Prospective Evaluation|Completed||N/A|30|Actual|VU University Medical Center|||1||f||||f||||||||||2017-10-11 01:03:28.530422|2017-10-11 01:03:28.530422
NCT01994603|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-01-13|||December 2012||2012-12-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Expansion to Interdisciplinary HIV Prevention in Women|Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women|Completed||N/A|41|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-11 01:03:28.629895|2017-10-11 01:03:28.629895
NCT01994590|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-06-13|||May 19, 2014|Actual|2014-05-19|June 2017|2017-06-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Interventional|||Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)|A Phase II Study of Dovitinib (TKI258) Combined With Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer Evaluating Markers of FGF and AR Signaling in Bone Marrow and Plasma|Terminated||Phase 2|4|Actual|M.D. Anderson Cancer Center||1||Sponsor stopped supplying study drug|f||||f|t|f||||||||2017-10-11 01:03:28.72589|2017-10-11 01:03:28.72589
NCT01994577|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-03-30|||May 2013||2013-05-01|March 2017|2017-03-01|November 2016|Anticipated|2016-11-01|August 2013|Actual|2013-08-01||Observational|ROMI-3||Optimum Troponin Cutoffs for ACS in the ED|Determining the Optimum Treatment Cutoffs for Cardiac Troponin Assays in Patients Presenting to the Emergency Department With Suspected Cardiac Ischemia|Withdrawn||N/A|0|Actual|McMaster University|||1||f||||f||||||Samples Without DNA|"     In accordance with the Third Universal Definition of MI and recommendations by both Canadian     and international expert groups, we will collect and measure blood for cTnI and hs-cTn     measurements at ED presentation and 3 hours later for patients who currently would only     undergo a single cTn measurement and 6 hours later if serial cTn measurements are required.     This does not preclude cTn measurements for clinical purposes at any additional times of     choosing by the EP.   "|||2017-10-11 01:03:28.836434|2017-10-11 01:03:28.836434
NCT01994564|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-19|||November 2012||2012-11-01|July 2012|2012-07-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Observational|||Prevalence of Dyschromatopsia in Glaucoma Patients|Prevalence of Dyschromatopsia in Glaucoma Patients|Withdrawn||N/A|0|Actual|Massachusetts Eye and Ear Infirmary|||1||f||||f||||||||||2017-10-11 01:03:28.957692|2017-10-11 01:03:28.957692
NCT01994538|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-08-24|||April 24, 2014|Actual|2014-04-24|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Seven vs. 14 Days Treatment for Male Urinary Tract Infection|Seven vs. 14 Days Treatment for Male Urinary Tract Infection|Recruiting||N/A|290|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 01:03:29.054011|2017-10-11 01:03:29.054011
NCT01994512|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-12-16|||October 2006||2006-10-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2012|Actual|2012-06-01||Interventional|SSSS||Swedish Spinal Stenosis Study|Swedish Spinal Stenosis Study. An RCT Comparing Decompression With Fusion to Decompression Only in Lumbar Spinal Stenosis With or Without Degenerative Olisthesis.|Completed||N/A|245|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 01:03:29.360167|2017-10-11 01:03:29.360167
NCT01994499|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-10-07|||January 2014||2014-01-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|VIDMED||Randomized Study Comparing Pleural Drainage by Videothoracoscopy to Medical Drainage in Infectious Pleural Effusion|Randomized Study Comparing Pleural Drainage by Videothoracoscopy to Medical Drainage in Infectious Pleural Effusion|Recruiting||N/A|50|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 01:03:29.449466|2017-10-11 01:03:29.449466
NCT01994486|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-02-20|2015-02-20||December 2013||2013-12-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|STEADFAST|HCV GENOTYPE 1 -NON-CIRRHOTIC ADULTS|Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1|Open-Label Study to Evaluate the Safety and Tolerability of Telaprevir in Combination With Sofosbuvir in Treatment Naive Subjects Chronically Infected With Hepatitis C Virus Genotype 1|Completed||Phase 2|20|Actual|University of Florida||1|||f||||t||||||||||2017-10-11 01:03:29.58053|2017-10-11 01:03:29.58053
NCT01994473|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-02-06|||October 2013||2013-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SEP-363856||Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia|A 2-Part Randomized Single-Blind, Placebo-Controlled, Ascending Multiple Oral Dose and Open-Label Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia|Completed||Phase 1|48|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 01:03:30.171462|2017-10-11 01:03:30.171462
NCT01994460|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-12-27|||January 2014||2014-01-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis|Substitution of Ethambutol With Linezolid During the Intensive Phase of Treatment of Pulmonary Tuberculosis: A Prospective, Multicenter, Randomized, Open-label Phase II Trial|Unknown status|Recruiting|Phase 2|429|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 01:03:30.279505|2017-10-11 01:03:30.279505
NCT01994447|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-10-24|||November 2013||2013-11-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TRAIN||The Train Study: Parental Understanding of Informed Consent|"Traditional Research Nurses Versus an Innovative Undergraduate Research Assistant Program: Parental Understanding of Informed Consent  (the TRAIN Study)"|Terminated||N/A|12|Actual|University of Calgary||2||Change in study consent process at study site so that study had to be terminated|f||||f||||||||||2017-10-11 01:03:30.4057|2017-10-11 01:03:30.4057
NCT01994434|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-11-19|||March 2000||2000-03-01|August 2012|2012-08-01|November 2012|Actual|2012-11-01|October 2011|Actual|2011-10-01||Interventional|||Ulnar Nerve Deep Branch Compression by a Ganglion||Completed||N/A|9|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 01:03:30.500226|2017-10-11 01:03:30.500226
NCT01994421|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-17|||September 2012||2012-09-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Effects of Kinesiotape on Quadriceps and Hamstring Muscle Strength|Effects of Kinesiotape on Quadriceps and Hamstring Muscle Strength|Completed||N/A|52|Actual|University Hospital, Geneva||1|||f||||||||||||||2017-10-11 01:03:30.585527|2017-10-11 01:03:30.585527
NCT01994408|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-01-30|||November 2013||2013-11-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Default BP Medication Intensification|Automatic Medication Increase Protocol in the Treatment of Elevated Blood Pressure|Terminated||Phase 1/Phase 2|3|Actual|Cedars-Sinai Medical Center||1||slow enrollment|f||||f||||||||||2017-10-11 01:03:30.698864|2017-10-11 01:03:30.698864
NCT01994382|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-07-14|||August 2013||2013-08-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 1/2A Dose Escalation Study in CLL, SLL or NHL|A Phase 1/2A Open-Label, Multi-Dose, Multi-Center Escalation and Exploratory Study of Cerdulatinib (PRT062070) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) or B Cell or T Cell Non-Hodgkin Lymphoma (NHL)|Recruiting||Phase 1/Phase 2|283|Anticipated|Portola Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:03:30.98148|2017-10-11 01:03:30.98148
NCT01994369|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-06-11|||May 2014||2014-05-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17)|A Pilot & Feasibility Study of the Imaging Potential of EC17 in Subjects Undergoing Surgery Presenting Breast Cancer|Active, not recruiting||Phase 1|10|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:03:31.259579|2017-10-11 01:03:31.259579
NCT01994356|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-19|||January 2011||2011-01-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Physician Self Disclosure of IUC Use|Pilot Study of Physician Self-disclosure of Personal Intrauterine Contraceptive Use Versus Usual Counseling|Completed||N/A|132|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 01:03:31.388086|2017-10-11 01:03:31.388086
NCT01994343|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-11-01|||November 2013||2013-11-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Pain in Women With Chronic Pelvic Pain|Musculoskeletal Disturbances in Women With Chronic Pelvic Pain|Active, not recruiting||N/A|60|Anticipated|Universidad de Granada|||2||f||||t||||||||Undecided||2017-10-11 01:03:31.510174|2017-10-11 01:03:31.510174
NCT01994330|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-04-04|||June 2009||2009-06-01|April 2017|2017-04-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery|Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery|Completed||Phase 4|13|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 01:03:31.641659|2017-10-11 01:03:31.641659
NCT01994317|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-08-14|||November 2013||2013-11-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion|Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion|Completed||N/A|196|Actual|Planned Parenthood League of Massachusetts||2|||f||||t||||||||||2017-10-11 01:03:31.775186|2017-10-11 01:03:31.775186
NCT01994304|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-09-26|||June 2012||2012-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01||Interventional|||Assessment and Evaluation of the Safe Childbirth Checklist --Phase II|Assessment and Evaluation of the Safe Childbirth Checklist --Phase II Rajasthan, India|Completed||N/A|200000|Actual|Public Health Foundation of India||2|||f||||f||||||||||2017-10-11 01:03:31.882358|2017-10-11 01:03:31.882358
NCT01994291|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-08-23|2016-07-05||November 2013||2013-11-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema|A Phase 2, Randomized, Double-Masked, Placebo-Controlled, Parallel Group, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist (PF-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema|Terminated||Phase 2|199|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:03:32.064719|2017-10-11 01:03:32.064719
NCT01994278|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-11-19|||December 2012||2012-12-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Comparison of Soft Toothbrush and Brushless Cleaner in Their Ability to Remove Plaque From Teeth|Comparison of Soft Toothbrush and Brushless Cleaner in Their Ability to Remove Plaque From Teeth|Completed||N/A|15|Actual|Peri-Swab, LLC||1|||f||||f||||||||||2017-10-11 01:03:33.473874|2017-10-11 01:03:33.473874
NCT01994265|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2016-10-24|||October 2014||2014-10-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Interventional|GIRAF||Cognitive Impairment Related to Atrial Fibrillation Prevention Trial|Randomized Clinical Trial for the Prevention of Cognitive Impairment in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin|Recruiting||Phase 4|200|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:03:33.564869|2017-10-11 01:03:33.564869
NCT01994252|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-08-09|||August 2013||2013-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|RAFT-PermAF||Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation|Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation|Recruiting||N/A|200|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 01:03:33.740064|2017-10-11 01:03:33.740064
NCT01994239|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-11-20|||December 2012||2012-12-01|November 2013|2013-11-01|June 2025|Anticipated|2025-06-01|December 2017|Anticipated|2017-12-01||Interventional|GETUG-AFU22||Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy|A Multicenter Randomised Phase II Study Comparing the Efficiency of a HT Concomitant With RT vs RT Alone in the Salvage of Patients With a Detectable PSA After Prostatectomy|Recruiting||Phase 2|120|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-11 01:03:33.911353|2017-10-11 01:03:33.911353
NCT01993862|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-04-11|||March 17, 2014|Actual|2014-03-17|April 2017|2017-04-01|August 12, 2016|Actual|2016-08-12|August 5, 2016|Actual|2016-08-05||Interventional|SDD for ICD||Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant|Safety and Cost Effectiveness of Same Day Discharge After Implantable Cardioverter-Defibrillator Implant Versus Next Day Discharge|Completed||N/A|266|Actual|St. Jude Medical||2|||f||||f||||||||Undecided||2017-10-11 01:03:39.788182|2017-10-11 01:03:39.788182
NCT01994213|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-19|||October 2011||2011-10-01|November 2013|2013-11-01|November 2017|Anticipated|2017-11-01|November 2015|Anticipated|2015-11-01||Interventional|||A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor|A Randomized, Single-arm, Open-label, Multicenter, Phase II Study of Famitinib as First/Second Line Treatment in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor|Recruiting||Phase 2|63|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||f||||||||||2017-10-11 01:03:34.126267|2017-10-11 01:03:34.126267
NCT01994200|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-02-22|||September 2014||2014-09-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|ITCA-ThyCa||Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients|Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) For Newly Diagnosed Thyroid Cancer Patients: Randomized Controlled Trial|Withdrawn||Phase 1/Phase 2|0|Actual|Jewish General Hospital||2|||f||||f||||||||||2017-10-11 01:03:34.21318|2017-10-11 01:03:34.21318
NCT01994187|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-11-20|||July 2013||2013-07-01|September 2013|2013-09-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01|12 Months|Observational [Patient Registry]|RECAS||Revascularization of Extracranial Carotid Artery Stenosis|the Clinic Registration Study of Carotid Stenosis Revascularization|Unknown status|Recruiting|N/A|2100|Anticipated|Xuanwu Hospital, Beijing|||1||f||||t||||||||||2017-10-11 01:03:34.315818|2017-10-11 01:03:34.315818
NCT01994174|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-09-12|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01|4 Weeks|Observational [Patient Registry]|||Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics|Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics|Recruiting||N/A|30|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-10-11 01:03:34.441132|2017-10-11 01:03:34.441132
NCT01994161|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2013-11-20|||December 2012||2012-12-01|October 2013|2013-10-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01|12 Months|Observational [Patient Registry]|||Clinical Registration Trial of Intracranial Stenting for Patients With Symptomatic Intracranial Artery Stenosis(CRTICAS)|Clinical Registration Trial of Intracranial Stenting for Patients With Symptomatic Intracranial Artery Stenosis:A Prospective Multi-center, Registry Trial|Unknown status|Recruiting|N/A|840|Anticipated|Xuanwu Hospital, Beijing|||1||f||||t||||||||||2017-10-11 01:03:34.562864|2017-10-11 01:03:34.562864
NCT01994135|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-12-03|||August 2014||2014-08-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Carbohydrase-inhibiting Polyphenols on Glycaemic Response in Vivo|Effects of Carbohydrase-inhibiting Polyphenols on Glycaemic Response in Vivo|Completed||N/A|26|Actual|University of Leeds||3|||f||||t||||||||||2017-10-11 01:03:34.959114|2017-10-11 01:03:34.959114
NCT01994122|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-06-16|||August 2014||2014-08-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Mental Health and Resilience in Emerging Adulthood|Mental Health and Resilience in Emerging Adulthood|Terminated||N/A|14|Actual|University of Tromso|||2|The study has been terminated because of recruitment difficulties and lack of further funding|f||||f||||||||||2017-10-11 01:03:35.077918|2017-10-11 01:03:35.077918
NCT01994109|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-05-01||2017-02-09|November 2013||2013-11-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2016|Actual|2016-01-01||Interventional|MYSTICOL||Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects|A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC® (Part A) Followed by Open-Label, Multiple-Treatment With MYOBLOC® (Part B) in the Treatment of Troublesome Sialorrhea in Adult Subjects|Completed||Phase 3|157|Actual|US WorldMeds LLC||3|||f||||f||||||||||2017-10-11 01:03:35.163847|2017-10-11 01:03:35.163847
NCT01994096|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-10-29|||November 2013||2013-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Optimal Dosage of Caspofungin in Critically Ill Patients|Pharmacokinetics and Optimal Dosage of Caspofungin in Critically Ill Patients With Suspected Invasive Candidiasis|Completed||Phase 4|20|Actual|University Medical Center Groningen||1|||f||||||||||||||2017-10-11 01:03:35.37695|2017-10-11 01:03:35.37695
NCT01994083|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-09-02|||November 2013||2013-11-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study of Multiple Oral Doses of IX-01 in Healthy Men|A Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of IX-01 in Healthy Male Subjects|Completed||Phase 1|48|Actual|Ixchelsis Limited||2|||f||||f||||||||||2017-10-11 01:03:35.467816|2017-10-11 01:03:35.467816
NCT01994070|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-06-10|||November 2013||2013-11-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation|A Randomized Crossover Trial to Evaluate Electrical Versus Chemical Cardioversion in Patients With Acute Atrial Fibrillation|Completed||Phase 3|86|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:03:35.613048|2017-10-11 01:03:35.613048
NCT01994057|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-08-08|||September 2013||2013-09-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib and Erlotinib, in NSCLC Patients Treatment|Retrospective Study Based on Somatic Mutations and Genetic Polymorphisms Related to Individual Variations of Drug Effect and Adverse Drug Reaction of EGFR-TKIs,Gefitinib and Erlotinib in Non-small Cell Lung Cancer Treatment.|Recruiting||N/A|200|Anticipated|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"     1. FFPE samples of tissue needle biopsy were used for EGFR mutation detection.        2. EDTA-whole blood was centrifuged at 4000rpm*10min,plasma was separated within four hours          for somatic mutation detection.The remaining samples were used for germline mutation          detection. All the blood samples were frozen in -80℃ until analysis.   "|||2017-10-11 01:03:35.7559|2017-10-11 01:03:35.7559
NCT01994044|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-11-22|||July 1999||1999-07-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2005|Actual|2005-10-01||Interventional|||Randomized WAD Study|Treating Selected Chronic WAD Patients: Cervical Fusion or Multidimensional Rehabilitation. A Randomized Study|Completed||N/A|||Spinal Surgery Clinic, Strängnäs||2|||f||||t||||||||||2017-10-11 01:03:35.881299|2017-10-11 01:03:35.881299
NCT01994031|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-08-26|||August 2014||2014-08-01|August 2014|2014-08-01||||July 2015|Anticipated|2015-07-01||Interventional|||Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments|Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments|Unknown status|Recruiting|Phase 4|36|Anticipated|Nanjing Luye Sike Pharmaceutical Co.,Ltd.||6|||f||||t||||||||||2017-10-11 01:03:36.046574|2017-10-11 01:03:36.046574
NCT01994018|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-11-19|||November 2011||2011-11-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake|Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake|Unknown status|Recruiting|N/A|120|Anticipated|OSF Healthcare System|||2||f||||f||||||||||2017-10-11 01:03:36.176131|2017-10-11 01:03:36.176131
NCT01994005|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-19|||October 2012||2012-10-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Randomized Controlled Trial of Adjunctive Social Media for More Effective Contraceptive Counseling|Randomized Controlled Trial of Adjunctive Social Media for More Effective Contraceptive Counseling|Completed||N/A|144|Actual|New York Presbyterian Hospital||2|||f||||t||||||||||2017-10-11 01:03:36.29747|2017-10-11 01:03:36.29747
NCT01993992|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2015-07-07|||December 2013||2013-12-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Parental Anxiety and Its Relationship With Pediatric Patients' Post-operative Responses|Parental Anxiety and Its Relationship With Pediatric Patients' Post-operative Responses|Unknown status|Active, not recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:03:36.42224|2017-10-11 01:03:36.42224
NCT01993979|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-19|||May 2012||2012-05-01|November 2013|2013-11-01|May 2022|Anticipated|2022-05-01|May 2020|Anticipated|2020-05-01||Interventional|POUT||A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)|A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer|Recruiting||Phase 3|345|Anticipated|Institute of Cancer Research, United Kingdom||2|||f||||t||||||||||2017-10-11 01:03:36.519504|2017-10-11 01:03:36.519504
NCT01993966|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-11-19|||January 2014||2014-01-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|1 Day|Observational [Patient Registry]|||EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells|Mechanism of (-)-Epigallocatechin -3-gallate (EGCG) to Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells|Unknown status|Not yet recruiting|N/A|25|Anticipated|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-11 01:03:36.82869|2017-10-11 01:03:36.82869
NCT01993953|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-19|||February 2011||2011-02-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||BodyPump and Personal Training - Changes in Muscle Strength and Body Composition|BodyPump and Personal Training - Changes in Muscle Strength and Body Composition|Completed||N/A|144|Actual|Norwegian School of Sport Sciences||4|||f||||f||||||||||2017-10-11 01:03:36.964419|2017-10-11 01:03:36.964419
NCT01993940|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-04-19|2017-04-19||November 4, 2013|Actual|2013-11-04|May 2016|2016-05-01|June 9, 2015|Actual|2015-06-09|June 9, 2015|Actual|2015-06-09||Interventional||The Intent-to-treat (ITT) population included all randomized participants. Three participants (one in the naldemedine arm and two in the placebo arm) were excluded due to double enrollment at different sites.|Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy|Completed||Phase 3|553|Actual|Shionogi Inc.||2|||f||||t||||||||||2017-10-11 01:03:37.099697|2017-10-11 01:03:37.099697
NCT01993914|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-11-14|||February 2011||2011-02-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|MTHFR||Prevalence of MTHFR Polymorphisms in Venous Disease|Prevalence of MTHFR Polymorphisms in Venous Disease With or Without Concomitant Thrombosis|Completed||N/A|90|Actual|Health Diagnostic Laboratory, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood and serum   "|||2017-10-11 01:03:38.155788|2017-10-11 01:03:38.155788
NCT01993901|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-07-08|||August 2014||2014-08-01|July 2014|2014-07-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||The Influence of CSRT-led Telephone Follow-up on ESAS Scores in Patients Who Have Been Treated With Lung SBRT|The Influence of Clinical Specialist Radiation Therapist (CSRT)-Led Telephone Follow-up on Edmonton Symptom Assessment Scale (ESAS) Scores in Patients Who Have Been Treated With Lung Stereotactic Body Radiation Therapy (SBRT)|Unknown status|Not yet recruiting|N/A|140|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-11 01:03:38.233886|2017-10-11 01:03:38.233886
NCT01993888|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-05-31|2016-04-08|2014-08-20|October 2013||2013-10-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||The EVARREST® Fibrin Sealant Patch Liver Study|A Phase III Randomized, Controlled, Superiority Study Evaluating EVARREST® Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During Hepatic Surgery|Completed||Phase 3|102|Actual|Ethicon, Inc.|"The study could not be blinded due to difference in groups
The efficacy was limited to one bleeding site to minimize the variability in assessing the primary endpoint
The sample may not be sufficient to detect a difference in clinical outcomes."|2|||f||||t||||||||||2017-10-11 01:03:38.383033|2017-10-11 01:03:38.383033
NCT01993875|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-07-07||2015-07-07|October 2013||2013-10-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation|A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Pharmacodynamics, Pharmacokinetics, and Tolerability of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation|Completed||Phase 3|164|Actual|Sucampo Pharma Americas, LLC||2|||f||||f||||||||||2017-10-11 01:03:39.636398|2017-10-11 01:03:39.636398
NCT01993836|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-11-23|||November 2013||2013-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MADCO-PC||Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care|Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care|Recruiting||Phase 4|140|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 01:03:40.06078|2017-10-11 01:03:40.06078
NCT01993823|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-03-03|2016-12-21||May 2013||2013-05-01|March 2017|2017-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||ITT population: Randomized patients who had at least one efficacy evaluation after starting treatment|Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis|A Phase III, Multicenter, Randomized, Double-blind, Parallel Group, Active Treatment-controlled Study Assessing the Safety and Efficacy of G238 Compared to Clotrimazole 1% Otic Solution in Patients With Otomycosis|Completed||Phase 3|190|Actual|Salvat||2|||f||||||||||||||2017-10-11 01:03:40.191794|2017-10-11 01:03:40.191794
NCT01993810|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-06-10|||February 2014||2014-02-01|June 2016|2016-06-01||||December 2020|Anticipated|2020-12-01||Interventional|||Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer|Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC|Recruiting||Phase 3|560|Anticipated|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 01:03:40.55119|2017-10-11 01:03:40.55119
NCT01993797|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-12-12|||January 2010||2010-01-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Observational|||Lung Ultrasound in Diagnosis and Management of Bronchiolitis Bronchiolitis|Lung Ultrasound: a Useful Tool in Diagnosis and Management of Bronchiolitis?|Unknown status|Active, not recruiting|N/A|80|Anticipated|S. Giacomo Hospital|||1||f||||t||||||||||2017-10-11 01:03:40.794832|2017-10-11 01:03:40.794832
NCT01993784|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-11-20|||August 2013||2013-08-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|||Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.|Phase IIa Study of Nimotuzumab in Second or Late- Line Treatment of Patients With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinomas|Unknown status|Recruiting|Phase 1/Phase 2|9|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 01:03:40.879677|2017-10-11 01:03:40.879677
NCT01993771|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-03-29|||September 2013||2013-09-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Observational|||Monitoring of Anaesthesic Depth in the Cerebral Cortex Using Bispectral Bilateral System.|Monitoring of Anaesthetic Depth at Different Locations in the Cerebral Cortex Using Bispectral Bilateral System|Completed||N/A|25|Actual|Parc de Salut Mar|||1||f||||f||||||||||2017-10-11 01:03:40.961909|2017-10-11 01:03:40.961909
NCT01993758|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-05-20|||November 2013||2013-11-01|May 2014|2014-05-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficacy of Lower Tourniquet Pressure During Total Knee Arthroplasty|The Efficacy of Using Lower Tourniquet Pressure During Total Knee Arthroplasty: Comparison With Conventional Tourniquet Pressure Group|Unknown status|Recruiting|N/A|160|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:03:41.042477|2017-10-11 01:03:41.042477
NCT01993745|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-11-20|||May 2008||2008-05-01|November 2013|2013-11-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Observational|||The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)|The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)|Completed||N/A|106|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 01:03:41.166501|2017-10-11 01:03:41.166501
NCT01993732|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-02-15|||October 2003||2003-10-01|February 2017|2017-02-01|December 2041|Anticipated|2041-12-01|December 2041|Anticipated|2041-12-01||Interventional|||Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function|Ovarian Tissue Cryopreservation As A Means Of Preserving Ovarian Function in Females Undergoing Therapeutic Procedures That Will Potentially Lead To The Irreversible Loss of Ovarian Function|Active, not recruiting||N/A|15|Actual|Medical College of Wisconsin||1|||f||||f||||||||||2017-10-11 01:03:41.265337|2017-10-11 01:03:41.265337
NCT01993719|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-22|2017-08-24|||November 19, 2013||2013-11-19|August 1, 2017|2017-08-01|September 28, 2029|Anticipated|2029-09-28|October 27, 2028|Anticipated|2028-10-27||Interventional|||Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma|A Phase II Study for Metastatic Melanoma Using High Dose Chemotherapy Preparative Regimen Followed by Cell Transfer Therapy Using Tumor Infiltrating Lymphocytes Plus IL-2 With the Administration of Pembrolizumab in the Retreatment Arm|Recruiting||Phase 2|64|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:03:41.387287|2017-10-11 01:03:41.387287
NCT01993706|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-21|2017-10-05|||November 19, 2013||2013-11-19|February 27, 2015|2015-02-27|February 27, 2015|Actual|2015-02-27|February 27, 2015|Actual|2015-02-27||Interventional|||Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults|VRC 602: A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIV MAB060-00-AB (VRC01),Administered Intravenously or Subcutaneously to Healthy Adults|Completed||Phase 1|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:03:43.211792|2017-10-11 01:03:43.211792
NCT01993693|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-11-17|||October 2012||2012-10-01|June 2014|2014-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Wearable Therapeutic Ultrasound Study for Knee Osteoarthritis|Wearable Therapeutic Ultrasound Study|Terminated||N/A|15|Actual|ZetrOZ, Inc.||2|||f||||f||||||||||2017-10-11 01:03:43.302203|2017-10-11 01:03:43.302203
NCT01993680|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-09-29|||June 2012||2012-06-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|April 2015|Actual|2015-04-01||Interventional|||Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment|A Monocentric Randomized, Controlled, Double Blind, Crossover Phase II Trial to Show Non-inferiority of the Effect of Pyridostigmine Bromide vs. Fludrocortisone on Symptoms of Autonomic Dysregulation in Parkinson`s Disease|Unknown status|Active, not recruiting|Phase 2|18|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 01:03:43.397718|2017-10-11 01:03:43.397718
NCT01993667|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-11-28|||March 2012||2012-03-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing|Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing|Completed||Phase 4|130|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 01:03:43.486856|2017-10-11 01:03:43.486856
NCT01993654|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-08-12|||September 2011||2011-09-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions|In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions|Terminated||N/A|17|Actual|Massachusetts Eye and Ear Infirmary|||5|Study was terminated due to low recruitment.|f||||f||||||||No|Study data was not analyzed due to sample size and no statistical power.|2017-10-11 01:03:43.559853|2017-10-11 01:03:43.559853
NCT01993641|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-02-22||2016-09-12|December 2013||2013-12-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|May 2015|Actual|2015-05-01||Interventional|MEI-005||Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA|A Phase II Simon Two-Stage Study of the Addition of Pracinostat to a Hypomethylating Agent (HMA) in Patients With Myelodysplastic Syndrome (MDS) Who Have Failed to Respond or Maintain a Response to the HMA Alone|Completed||Phase 2|45|Actual|Helsinn Healthcare SA||1|||f||||f||||||||Yes||2017-10-11 01:03:43.66984|2017-10-11 01:03:43.66984
NCT01993628|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-18|||October 2013||2013-10-01|November 2013|2013-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))|Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD)|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Strasbourg, France||2|||f||||||||||||||2017-10-11 01:03:43.822193|2017-10-11 01:03:43.822193
NCT01993615|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-12-19|||March 2013||2013-03-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial|A Supervised Physical Therapy Program vs. Arthroscopic Surgery for Femoroacetabular Impingement: A Randomized Clinical Trial|Completed||N/A|80|Actual|Madigan Army Medical Center||2|||f||||t||||||||Yes|Any data sharing must go through a Data Sharing Agreement approved by the US Defense Health Agency|2017-10-11 01:03:43.929005|2017-10-11 01:03:43.929005
NCT01993602|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-03-07|||January 2011||2011-01-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Lung Expansion Technics on Chest Wall Mechanics and Preventing Pulmonary Complication After Abdominal Surgery|COMPARISON OF LUNG EXPANSION TECHNICS ON THORACOABDOMINAL MECHANICS AND THEIR INFLUENCE ON THE INCIDENCE OF PULMONARY COMPLICATIONS AFTER ABDOMINAL SURGERY: A RANDOMIZED AND CONTROLLED CLINICAL TRIAL|Completed||N/A|171|Actual|University of Sao Paulo General Hospital||5|||f||||f||||||||||2017-10-11 01:03:44.022391|2017-10-11 01:03:44.022391
NCT01993589|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2013-11-20|||November 2012||2012-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Paracetamol, Dexketoprofen Trometamol, Lidocaine Spray, Pethidine and Diclofenac Sodium Application for Pain Relief During Fractional Curettage||Completed||N/A|144|Actual|Kayseri Education and Research Hospital||6|||f||||f||||||||||2017-10-11 01:03:44.234283|2017-10-11 01:03:44.234283
NCT01993576|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2014-10-14|||January 2013||2013-01-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|EC2075||ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.|Histological Study of the (Intravenously Injected) ICG Distribution in Tumor Bearing Breasts and in Axillary Pieces of Dissection.|Completed||Phase 1/Phase 2|10|Anticipated|Jules Bordet Institute||1|||f||||t||||||||||2017-10-11 01:03:44.363056|2017-10-11 01:03:44.363056
NCT01993563|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-04-01|||September 2014||2014-09-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|GMI||Graded Motor Imagery for Patients Within a Year After Stroke.|The Effect of a Graded Motor Imagery Approach for Stroke Patients Within a Year After Stroke|Recruiting||N/A|66|Anticipated|IRCCS San Camillo, Venezia, Italy||2|||f||||t||||||||||2017-10-11 01:03:44.478543|2017-10-11 01:03:44.478543
NCT01993550|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-03-09|||March 2013||2013-03-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Telephone Support Program for Lung Cancer Patients and Their Family Caregivers|Telephone Symptom Management for Advanced Lung Cancer Patients and Caregivers|Completed||N/A|262|Actual|Indiana University||2|||f||||f||||||||No||2017-10-11 01:03:44.616668|2017-10-11 01:03:44.616668
NCT01993537|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-03-02|||January 2013||2013-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Role of Vitamin D in the Pathophysiology of Chronic Failure|The Role of Vitamin D in the Pathophysiology of Chronic Failure: Insight in to Mechanisms of Action and Implications for Vitamin D Supplementation|Completed||Phase 4|91|Actual|Ottawa Heart Institute Research Corporation||4|||f||||t||||||||||2017-10-11 01:03:44.732715|2017-10-11 01:03:44.732715
NCT01993524|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-11-20|||March 2009||2009-03-01|November 2013|2013-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Supplementation of Standard Antibiotic Therapy With Oral Probiotics for Bacterial Vaginosis|Efficacy and Safety Assessment of prOVag Dietary Supplement in Recurrent Bacterial Vaginitis. Multi-centre, Randomized, Double-blind, Placebo-controlled Clinical Study.|Completed||N/A|594|Actual|IBSS Biomed S.A.||2|||f||||f||||||||||2017-10-11 01:03:44.875252|2017-10-11 01:03:44.875252
NCT01993511|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2013-11-20|||June 2010||2010-06-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Changes in Glucose Metabolism After Roux-en-Y Gastric Bypass|Changes in Glucose Metabolism After Roux-en-Y Gastric Bypass|Unknown status|Recruiting|N/A|24|Anticipated|Hvidovre University Hospital|||3||f||||t||||||Samples Without DNA|"     Serum and plasma.   "|||2017-10-11 01:03:45.005199|2017-10-11 01:03:45.005199
NCT01993498|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-05-27|||February 2012||2012-02-01|May 2015|2015-05-01|March 2026|Anticipated|2026-03-01|March 2022|Anticipated|2022-03-01||Interventional|CANTO||Breast Cancer Toxicity|A Cohort to Quantify and to Predict Treatment Related Chronic Toxicities in Patients With Non-metastatic Breast Cancer|Recruiting||N/A|20000|Anticipated|UNICANCER||1|||f||||f||||||||||2017-10-11 01:03:45.14183|2017-10-11 01:03:45.14183
NCT01993485|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-06-03|||June 2013||2013-06-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||The Effect of Transaortic Valve Replacement on the Endothelial Integrity and Function|The Effect of Transaortic Valve Replacement on the Endothelial Integrity and Function|Completed||N/A|61|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 01:03:45.291447|2017-10-11 01:03:45.291447
NCT01993472|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2013-11-20|||November 2013||2013-11-01|November 2013|2013-11-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|AGCRC-013||Study of Andrographolides With or Without Capecitabine to Treat Colorectal Cancer|Andrographolides With or Without Capecitabine for Elderly Patients With Locally Advanced or Recurrent or Metastasis Inoperable Colorectal Cancer: a Randomized, Open-label Trial.|Unknown status|Not yet recruiting|Phase 2|308|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 01:03:45.403112|2017-10-11 01:03:45.403112
NCT01993459|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-01-24|||February 2014||2014-02-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|WOLII||The Effects of Midazolam on the Quality of Postoperative Recovery|A Randomized Controlled Trial on the Effects of Midazolam on the Quality of Postoperative Recovery in Patients|Completed||Phase 4|192|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-11 01:03:45.545726|2017-10-11 01:03:45.545726
NCT01993446|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-04-14|||October 2013||2013-10-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||A Safety and Efficacy Study of DRM02 in Subjects With Rosacea|A Randomized, Double-blind, Vehicle Controlled Study of the Safety and Efficacy of Topical DRM02 in Subjects With Rosacea|Completed||Phase 2|30|Actual|Dermira, Inc.||2|||f||||f||||||||||2017-10-11 01:03:45.690134|2017-10-11 01:03:45.690134
NCT01993433|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-04-14|||October 2013||2013-10-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis|A Randomized, Double-blind, Vehicle Controlled Study of the Safety and Efficacy of Topical DRM02 in Subjects With Plaque Psoriasis|Completed||Phase 2|23|Actual|Dermira, Inc.||2|||f||||f||||||||||2017-10-11 01:03:45.779887|2017-10-11 01:03:45.779887
NCT01993420|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-04-14|||October 2013||2013-10-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis|A Randomized, Double-blind, Vehicle Controlled Study of the Safety and Efficacy of Topical DRM02 in Subjects With Atopic Dermatitis|Completed||Phase 2|21|Actual|Dermira, Inc.||2|||f||||f||||||||||2017-10-11 01:03:45.868318|2017-10-11 01:03:45.868318
NCT01993407|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2015-09-23|||June 2012||2012-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Training Executive Functions to Facilitate Recovery Following Traumatic Brain Injury|Training Executive Functions to Facilitate Recovery Following Traumatic Brain Injury|Completed||N/A|28|Actual|Kessler Foundation||2|||f||||t||||||||||2017-10-11 01:03:45.954545|2017-10-11 01:03:45.954545
NCT01993394|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2013-11-20|||October 2011||2011-10-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Hyperoxia and Hypergravity on Lung Ventilation and Perfusion|Influence of Hyperoxia and Hypergravity on Pulmonary Ventilation and Perfusion|Completed||N/A|20|Actual|Direction Centrale du Service de Santé des Armées||1|||f||||f||||||||||2017-10-11 01:03:46.02849|2017-10-11 01:03:46.02849
NCT01993381|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-06-13|||November 2013||2013-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting|Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting(CINV)|Recruiting||N/A|80|Anticipated|The Catholic University of Korea|||1||f||||f||||||Samples Without DNA|"     blood sampling   "|Undecided||2017-10-11 01:03:46.123781|2017-10-11 01:03:46.123781
NCT01993368|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-09-29|||November 2013||2013-11-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|PAG||Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis|Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis|Unknown status|Recruiting|N/A|60|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 01:03:46.2148|2017-10-11 01:03:46.2148
NCT01993355|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-06-15|||March 2013||2013-03-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|CLBP-HUVH||Chronic Low Back Pain: A Multidisciplinary Approach|A Multidisciplinary Approach to Treat and Rehabilitate Patients With Chronic Low Back Pain|Completed||N/A|66|Actual|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||f||||||||||2017-10-11 01:03:46.342418|2017-10-11 01:03:46.342418
NCT01993342|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-19|||October 2013||2013-10-01|November 2013|2013-11-01|March 2014|Anticipated|2014-03-01|November 2013|Anticipated|2013-11-01||Observational|||Determination of Adipocytokine in Synovial Fluid of Osteoarthritis Patients|Determination of Adipocytokine in Synovial Fluid of Osteoarthritis Patients With Joint Pain and Effusion|Unknown status|Recruiting|N/A|35|Anticipated|Hospital Parc Taulí, Sabadell|||1||f||||f||||||Samples Without DNA|"     Synovial fluid   "|||2017-10-11 01:03:46.63542|2017-10-11 01:03:46.63542
NCT01993329|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-04-14|||December 31, 2013|Actual|2013-12-31|April 2017|2017-04-01|February 28, 2014|Actual|2014-02-28|February 28, 2014|Actual|2014-02-28||Interventional|||A Study to Evaluate the Effect of Gefapixant (AF-219/MK-7264) on Methacholine Hyper-reactivity in Subjects With Asthma|A Randomised, Double-Blind, Double-Dummy, Placebo-Controlled, Three-Way Cross-over Study to Evaluate the Effect of AF-219 on Methacholine Hyper-reactivity in Subjects With Asthma|Completed||Phase 1|20|Actual|Afferent Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 01:03:46.759848|2017-10-11 01:03:46.759848
NCT01993316|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-11-22|||December 2013||2013-12-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Neurofeedback Using TMS as an Assessment Tool|Validating of Neurofeedback Practice by Utilizing TMS as an Assessment Tool|Unknown status|Not yet recruiting|N/A|20|Anticipated|Beersheva Mental Health Center||1|||f||||f||||||||||2017-10-11 01:03:46.864954|2017-10-11 01:03:46.864954
NCT01993303|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2013-11-20|||January 2004||2004-01-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|||Direct Comparison of 2D Cardiac PET With 3D Cardiac PET|Direct Comparison of 2D Cardiac PET With 3D Cardiac PET Using a 3D Monte-Carlo Scatter COrrection Algorithm|Completed||N/A|19|Actual|Cardiovascular Imaging Technologies|||1||f||||f||||||||||2017-10-11 01:03:46.992359|2017-10-11 01:03:46.992359
NCT01993290|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-07-20|||April 2013||2013-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|||USG Brachial Plexus Block for Upper Extremity Surgery|Ultrasound-guided Brachial Plexus Block With the Single-penetration Multiple-injection-technique for Upper Extremity Surgery|Completed||N/A|120|Anticipated|Bispebjerg Hospital||3|||f||||t||||||||||2017-10-11 01:03:47.095774|2017-10-11 01:03:47.095774
NCT01993277|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2014-12-16|||December 2013||2013-12-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||Evaluating Neuromodulation Technologies in Early Recovery|A Comparator Trial Evaluating Three Neuromodulation Technologies' Effectiveness in Early Recovery From Substance Abuse Disorders as Compared to Relaxation Therapy|Unknown status|Not yet recruiting|N/A|200|Anticipated|Behavioral Health of the Palm Beaches||4|||f||||t||||||||||2017-10-11 01:03:47.241949|2017-10-11 01:03:47.241949
NCT01993264|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-12-19|||October 2013||2013-10-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|January 2015|Actual|2015-01-01||Observational|||Fetal Cardiac Strain Imaging Research|Standardization Of A Novel Method To Assess Fetal Cardiac Function: Myocardial Deformation Analysis|Recruiting||N/A|60|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-10-11 01:03:47.362571|2017-10-11 01:03:47.362571
NCT01993251|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-08-18|||June 2014||2014-06-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SOMELIA||Does Melatonin Restore Sleep Architecture in Autistic Children|Does Melatonin Restore Sleep Architecture in Autistic Children?|Recruiting||Phase 2|60|Anticipated|Hospices Civils de Lyon||4|||f||||t||||||||||2017-10-11 01:03:47.44551|2017-10-11 01:03:47.44551
NCT01993238|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-03-25|2014-03-25||November 2013||2013-11-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Intent-to-Treat|Evaluation of Procedural Analgesia for Liposonix Treatment|An Evaluation of Procedural Analgesia for Out-Patient Liposonix Treatment|Completed||N/A|11|Actual|Valeant Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:03:47.581589|2017-10-11 01:03:47.581589
NCT01993225|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-09-29|||January 2014||2014-01-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%||Completed||Phase 3|120|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-10-11 01:03:47.813727|2017-10-11 01:03:47.813727
NCT01993212|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-09-29|||January 2014||2014-01-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%||Completed||Phase 3|120|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-10-11 01:03:47.93744|2017-10-11 01:03:47.93744
NCT01993199|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2013-11-19|||May 2010||2010-05-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|April 2013|Actual|2013-04-01||Interventional|||Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors|Prospective Study: Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors|Unknown status|Active, not recruiting|N/A|40|Anticipated|Hanyang University Seoul Hospital||1|||f||||f||||||||||2017-10-11 01:03:48.059191|2017-10-11 01:03:48.059191
NCT01993186|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-02-06|||April 2014|Actual|2014-04-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study to Assess the Safety and Efficacy of UX007 in Subjects With Glucose Transporter Type 1 Deficiency Syndrome|Active, not recruiting||Phase 2|40|Anticipated|Ultragenyx Pharmaceutical Inc||2|||f||||t||||||||||2017-10-11 01:03:48.12872|2017-10-11 01:03:48.12872
NCT01993173|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-05-18|||November 2013||2013-11-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|February 2014|Actual|2014-02-01||Interventional|||Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.|Immunogenicity and Safety of Sanofi Pasteur's Tdap Combined Vaccine (ADACEL) as a Booster Dose, Versus Local DT Vaccine in Healthy Children or Versus Local Td Vaccine in Healthy Adolescents and Adults in China|Completed||Phase 3|1440|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:03:48.292662|2017-10-11 01:03:48.292662
NCT01993160|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-01-12|||December 2013||2013-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer|18F-FCH-PET/MR in Staging of High-Risk Prostate Cancer: A Multiparametric Approach|Completed||N/A|50|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:03:48.401428|2017-10-11 01:03:48.401428
NCT01993147|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-06-15|||October 2013||2013-10-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|FDEC||Functional Differences in Effortful Control|Functional Differences in Effortful Control|Active, not recruiting||N/A|180|Anticipated|University of Michigan||3|||f||||f||||||||||2017-10-11 01:03:48.498809|2017-10-11 01:03:48.498809
NCT01993134|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-11-18|||December 2011||2011-12-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|November 2013|Actual|2013-11-01||Interventional|EAPRTS||Efficacy Assessment of Two Antibiotic Prophylaxis Regimens in Oral and Maxillofacial Trauma Surgery|Efficacy Assessment of Two Antibiotic Prophylaxis Regimens in Oral and Maxillofacial Trauma Surgery.|Unknown status|Recruiting|Phase 2|75|Anticipated|Universidade Federal do Rio Grande do Norte||2|||f||||t||||||||||2017-10-11 01:03:48.620084|2017-10-11 01:03:48.620084
NCT01993121|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2013-11-18|||September 2002||2002-09-01|November 2013|2013-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Exercise and Type 2 Diabetes: Gender and Endothelial Function|Exercise and Type 2 Diabetes: Gender and Endothelial Function|Completed||N/A|40|Actual|University of Colorado, Denver||1|||f||||f||||||||||2017-10-11 01:03:48.727071|2017-10-11 01:03:48.727071
NCT01993108|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-06-15|||October 2013||2013-10-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|NMAS||Control of Cognition|Control of Cognition: Naltrexone, Methylphenidate, and ADHD Study|Active, not recruiting||N/A|75|Actual|University of Michigan||3|||f||||f||||||||||2017-10-11 01:03:48.824697|2017-10-11 01:03:48.824697
NCT01993095|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-02-21|||October 2013||2013-10-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||FlexToBa for People With Multiple Sclerosis|Improving Functional Performance in Persons With MS Via Physical Activity DVD Intervention|Completed||N/A|50|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||No||2017-10-11 01:03:48.929206|2017-10-11 01:03:48.929206
NCT01993082|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-01-11|||January 2014||2014-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|August 2016|Anticipated|2016-08-01||Interventional|FAST||Fitness, Cellular Aging, and Caregiver Stress Study|The Effects of Exercise and Life Stress on Telomere Maintenance and Cardiovascular Disease Risk|Active, not recruiting||N/A|70|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:03:49.032463|2017-10-11 01:03:49.032463
NCT01993069|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-05-01|||October 2013||2013-10-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Yoga Training for Returning Veterans With Headache|Yoga Training for Returning Veterans With Headache|Terminated||N/A|20|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 01:03:49.127916|2017-10-11 01:03:49.127916
NCT01993056|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-22|||August 2011||2011-08-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Influence of 11+ on Injury Incidence and FMS-Score in Veteran Soccer Players||Completed||N/A|265|Actual|Saarland University||2|||f||||||||||||||2017-10-11 01:03:49.198522|2017-10-11 01:03:49.198522
NCT01993043|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-02-28|||October 2010||2010-10-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|5 Years|Observational [Patient Registry]|||39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity|Comparison of Vision and Development Outcomes in Laser- and Bevacizumab-Treated Infants With Retinopathy of Prematurity|Recruiting||N/A|150|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-10-11 01:03:49.275261|2017-10-11 01:03:49.275261
NCT01993030|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-06-02|2015-05-07||August 2013||2013-08-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of HQ® Matrix Medical Wound Dressing for Healing of Donor Site Wounds|Randomized, Active-controlled, Single-blind, Parallel Two-group Trial of HQ® Matrix Medical Wound Dressing and Sidaiyi® Wound Dressing for the Treatment of Donor Site Wounds|Completed||N/A|71|Actual|Zhejiang Xingyue Biotechnology Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:03:49.53409|2017-10-11 01:03:49.53409
NCT01993017|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-07-14|||November 2013||2013-11-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|CODIACSQoL||Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes|Depression Screening RCT in ACS Patients: Quality of Life and Cost Outcomes|Active, not recruiting||N/A|1500|Actual|Columbia University||3|||f||||t||||||||||2017-10-11 01:03:49.954738|2017-10-11 01:03:49.954738
NCT01993004|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-04-20|||July 2013||2013-07-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells|Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells|Completed||N/A|24|Actual|Rutgers, The State University of New Jersey|||3||f||||f||||||Samples With DNA|"     peripheral blood   "|||2017-10-11 01:03:50.098689|2017-10-11 01:03:50.098689
NCT01992991|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-02-17|||December 2013||2013-12-01|February 2014|2014-02-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|tDCS-ICH||Transcranial Stimulation for Upper Limb Training of Individuals With Sequelae From Intracranial Hemorrhage|Transcranial Direct Current Stimulation for Upper Limb Training of Individuals With Sequelae From Intracranial Hemorrhage|Unknown status|Active, not recruiting|N/A|16|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:03:50.189121|2017-10-11 01:03:50.189121
NCT01992978|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-11-22|||November 2013||2013-11-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis|The Influence of Radiofrequency-assisted Hepatectomy on the Perioperative Outcomes and the Long-term Prognosis of HCC With Cirrhosis：A Prospective Randomized Controlled Trial|Recruiting||N/A|200|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 01:03:50.294132|2017-10-11 01:03:50.294132
NCT01992965|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-05-06|||April 2014||2014-04-01|May 2014|2014-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Effect of Real-time Continuous Glucose Monitoring on Glucose Control and Outcomes of Critically Ill Patients|Effect of Real-time Continuous Glucose Monitoring on Glucose Control and Outcomes of Critically Ill Patients|Unknown status|Recruiting|N/A|144|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-11 01:03:50.420069|2017-10-11 01:03:50.420069
NCT01992952|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-08-21|||May 2014|Actual|2014-05-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|June 2018|Anticipated|2018-06-01||Interventional|FAKTION||Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer|A Phase 1b/2 Randomised Placebo Controlled Trial of Fulvestrant +/- AZD5363 in Postmenopausal Women With Advanced Breast Cancer Previously Treated With a Third Generation Aromatase Inhibitor|Recruiting||Phase 1/Phase 2|150|Anticipated|Velindre NHS Trust||2|||f||||t||||||||||2017-10-11 01:03:50.542762|2017-10-11 01:03:50.542762
NCT01992939|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-02-01|||November 2013||2013-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Heat on Blood and Oxygen Flow Readings Part 2|The Effect of Heat on Blood and Oxygen Flow Readings Part 2|Completed||N/A|51|Actual|VA Pittsburgh Healthcare System||2|||f||||t||||||||||2017-10-11 01:03:50.749057|2017-10-11 01:03:50.749057
NCT01992926|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-01-21|||November 2013||2013-11-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial|Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial|Completed||N/A|109|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 01:03:50.844754|2017-10-11 01:03:50.844754
NCT01992913|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-09-12|||June 12, 2015|Actual|2015-06-12|September 2017|2017-09-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|BEST Vet||Building Employment Skills Through Therapy for Veterans|Integrated Cognitive Behavior Therapy to Improve Work Outcomes in Schizophrenia|Recruiting||N/A|96|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:03:50.923218|2017-10-11 01:03:50.923218
NCT01992900|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-11-04|||November 2013||2013-11-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|||A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria|A Phase II, Open-label, Multicentre, Pharmacokinetic, Pharmacodynamics and Safety Study of a New Paediatric Eurartesim Dispersible Formulation and Crushed Film Coated Eurartesim Tablet, in Infant Patients With P. Falciparum Malaria|Completed||Phase 2|300|Actual|sigma-tau i.f.r. S.p.A.||2|||f||||t||||||||Undecided||2017-10-11 01:03:51.044457|2017-10-11 01:03:51.044457
NCT01992887|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-05-11|||March 2012||2012-03-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|August 2014|Actual|2014-08-01|24 Months|Observational [Patient Registry]|PARC||Pre-ART Retention in Care in Tanzania|Retention and Engagement in Care of Patients Prior to ART Initiation in the Kagera Region of Tanzania|Completed||N/A|948|Actual|Columbia University|||3||f||||f||||||||||2017-10-11 01:03:51.16981|2017-10-11 01:03:51.16981
NCT01992874|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-07-06|2016-04-05||November 30, 2013|Actual|2013-11-30|July 2017|2017-07-01|February 28, 2015|Actual|2015-02-28|May 31, 2014|Actual|2014-05-31||Interventional||Safety analysis set included all subjects who received at least one dose of investigational medicinal product (IMP).|Relative Bioavailability of Pimasertib in Cancer Patients|A Multi-Center, Open-Label, Single 60 mg Dose, Two Period, Two Sequence Cross-Over Trial to Investigate the Relative Bioavailability of Two Solid Oral Pimasertib Formulations in Cancer Patients|Completed||Phase 1|38|Actual|EMD Serono||2|||f||||f||||||||||2017-10-11 01:03:51.302926|2017-10-11 01:03:51.302926
NCT01992861|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-06-27|||February 14, 2014||2014-02-14|June 2017|2017-06-01||||September 2021|Anticipated|2021-09-01||Interventional|||MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer|MRI- and PET-Predictive-Assay of Treatment Outcome in Cancer of the Cervix|Recruiting||N/A|237|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 01:03:52.302054|2017-10-11 01:03:52.302054
NCT01992848|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-04-24|||November 2013|Actual|2013-11-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|||MAP-Calcification: MicroRNAs as Potential Biomarkers for Coronary Artery Calcification|A Case-control Study of MicroRNAs a Potential Biomarkers for Coronary Artery Calcification (CAC) - An Additional Substudy to Determine the Relationship Between CAC and Bone Mineral Density and Markers of Bone Metabolism|Completed||N/A|45|Actual|University of Surrey||1|||f||||t||||||||||2017-10-11 01:03:52.485025|2017-10-11 01:03:52.485025
NCT01992835|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-05-31|||November 2013||2013-11-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Resolution of Allergic Inflammation|Resolution of Allergic Inflammation: Identification and Kinetics of Specific Lipid Mediators During Nasal Allergen Challenge|Completed||N/A|20|Actual|University Hospital, Strasbourg, France||2|||f||||||||||||||2017-10-11 01:03:52.585912|2017-10-11 01:03:52.585912
NCT01992822|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-09-18|||November 2013||2013-11-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Pain Sensitivity of Subjects With Fibromyalgia Before and After Repetitive Transcranial Magnetic Stimulation Treatment|Experimental Pain Sensitivity of Subjects With Fibromyalgia Before and After rTMS Treatment in Relation to the Clinical Improvement|Completed||N/A|72|Actual|Centre Hospitalier Esquirol||1|||f||||f||||||||||2017-10-11 01:03:52.675196|2017-10-11 01:03:52.675196
NCT01992809|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-19|||September 2009||2009-09-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|OMEGA 3 NASH||Omega 3 Supplementation in Fatty Liver|Polyunsaturated Fatty Acid (Pufa) Omega 3 in the Reduction of the Inflammatory Component of the Nonalcoholic Steatohepatitis (Nash):Randomized Placebo Controlled Study|Completed||Phase 3|60|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 01:03:52.797077|2017-10-11 01:03:52.797077
NCT01992796|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-11-19|||January 2014||2014-01-01|November 2013|2013-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|SartSep||Angiotensin II Antagonist in Severe Sepsis|Phase III Study of Irbersartan for the Early Treatment of Severe Sepsis Patients|Unknown status|Not yet recruiting|Phase 3|300|Anticipated|University of Salerno||2|||f||||t||||||||||2017-10-11 01:03:52.881239|2017-10-11 01:03:52.881239
NCT01992783|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-08-14|||August 2013||2013-08-01|August 2015|2015-08-01||||November 2013|Actual|2013-11-01||Interventional|||Resistant Starch, Antioxidant Status and Insulin Resistance|The Effect of Resistant Starch Supplementation on Antioxidant Status and Insulin Resistance in Overweight and Obese Adults|Completed||N/A|21|Actual|Urmia University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:03:52.992923|2017-10-11 01:03:52.992923
NCT01992770|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-11-19|||September 2013||2013-09-01|September 2013|2013-09-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|STEP-UP||A Stepped-care Model of Tailored Behavioural Medicine Pain Intervention in Primary Care|STEP-UP - A Randomised Controlled Trial for the Study of a Stepped-care Model Including a Tailored Behavioural Medicine Pain Intervention in Primary Care|Not yet recruiting||N/A|364|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-11 01:03:53.086216|2017-10-11 01:03:53.086216
NCT01992757|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-08-18|||November 2013||2013-11-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|TEG FF||Thromboelastography-derived Functional Fibrinogen Levels|Comparison of Thromboelastography-derived Functional Fibrinogen Levels During and After Cardiopulmonary Bypass|Completed||N/A|51|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 01:03:53.201522|2017-10-11 01:03:53.201522
NCT01992744|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-05-29|||May 2012||2012-05-01|October 2013|2013-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|BDNF||BDNF Pregnancy Study|Peripheral Serum BDNF Levels and Poor Birth Outcomes|Completed||N/A|32|Actual|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     - Brain-Derived Neurotrophic Factor   "|||2017-10-11 01:03:53.405862|2017-10-11 01:03:53.405862
NCT01992731|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-03-25|||December 2014||2014-12-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||IUI vs. IVF/ICSI in Women Aged 38-42 Years: a Prospective Randomized Controlled Trial.|IUI vs. IVF/ICSI in Women Aged 38-42 Years: a Prospective Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|138|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||t||||||||||2017-10-11 01:03:53.522486|2017-10-11 01:03:53.522486
NCT01992718|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-11-02|||November 2013||2013-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography|What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography|Active, not recruiting||Early Phase 1|49|Actual|University of Michigan||2|||f||||t||||||||No||2017-10-11 01:03:53.61884|2017-10-11 01:03:53.61884
NCT01992705|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-07-28|||March 2014||2014-03-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|GCC 1324||Borderline Pancreas Study: FOLFIRINOX +SBRT|Neoadjuvant FOLFIRINOX and Stereotactic Body Radiotherapy (SBRT) Followed by Definitive Surgery for Patients With Borderline Resectable Pancreatic Adenocarcinoma: A Single-Arm Pilot Study|Recruiting||Early Phase 1|20|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-11 01:03:53.71041|2017-10-11 01:03:53.71041
NCT01992692|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-19|||January 2012||2012-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson's Disease||Completed||N/A|62|Actual|Changhai Hospital|||2||f||||t||||||||||2017-10-11 01:03:53.842137|2017-10-11 01:03:53.842137
NCT01992679|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-12-11|||October 2013||2013-10-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis|Body Weight Supported Treadmill Training in Advanced Multiple Sclerosis|Completed||Phase 1/Phase 2|24|Anticipated|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-11 01:03:53.921842|2017-10-11 01:03:53.921842
NCT01992666|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-12-01|||October 2013||2013-10-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|GENIAL||GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus|GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus|Completed||N/A|271|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 01:03:54.041035|2017-10-11 01:03:54.041035
NCT01992653|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-09-11|||November 29, 2013|Actual|2013-11-29|September 2017|2017-09-01|December 27, 2018|Anticipated|2018-12-27|December 27, 2018|Anticipated|2018-12-27||Interventional|||A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma|A Phase Ib/II Study Evaluating the Safety, Tolerability and Anti-Tumor Activity of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With B-Cell Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1/Phase 2|85|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 01:03:54.203355|2017-10-11 01:03:54.203355
NCT01992640|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-06-18|||December 2013||2013-12-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Recovery After Laparoscopic Surgery|Recovery After Laparoscopic Surgery|Completed||N/A|25|Actual|Herlev Hospital|||1||f||||f||||||||||2017-10-11 01:03:54.408796|2017-10-11 01:03:54.408796
NCT01992627|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2013-11-19|||October 2013||2013-10-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|HILT||Clinical Trial for High Intensity Laser Therapy (HILT) for Elbow Epicondylosis|A Prospective Randomized Clinical Trial of High Intensity Laser Therapy for Elbow Epicondylosis|Unknown status|Recruiting|N/A|40|Anticipated|CM Chungmu Hospital||1|||f||||t||||||||||2017-10-11 01:03:54.495212|2017-10-11 01:03:54.495212
NCT01992614|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2014-03-27|||December 2013||2013-12-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Single Dose Study Of PF-06678552 In Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PF-06678552 After Fed And Fasted Administration Of Single Escalating Oral Doses In Healthy Subjects|Completed||Phase 1|24|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:03:54.598726|2017-10-11 01:03:54.598726
NCT01992601|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-11-22|||November 2012||2012-11-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|YH16410 DDI||A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer|A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer|Completed||Phase 1|48|Actual|Yuhan Corporation||4|||f||||f||||||||||2017-10-11 01:03:54.726845|2017-10-11 01:03:54.726845
NCT01992588|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-11-07|||November 2013||2013-11-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes|Completed||Phase 1|48|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:03:54.840221|2017-10-11 01:03:54.840221
NCT01992575|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-04-21|||January 2014||2014-01-01|April 2015|2015-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||OCT in Retinal Vein Occlusions|Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Retinal Vein Occlusions|Unknown status|Recruiting|N/A|35|Anticipated|Oregon Health and Science University|||1||f||||||||||||||2017-10-11 01:03:54.946699|2017-10-11 01:03:54.946699
NCT01992562|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-09-11|||January 2014|Actual|2014-01-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy|A Phase 4, Randomized, Double-blind, Placebo-controlled, Cross-over Clinical Trial of a Single Shot of Intrathecal Ziconotide for the Treatment of Chronic, Medically Refractory Pain From Painful Peripheral Neuropathy or Myelopathy|Withdrawn||Phase 4|0|Actual|OhioHealth||2||Logistical issues with study process and recruitment|f||||f||||||||||2017-10-11 01:03:55.078908|2017-10-11 01:03:55.078908
NCT01992549|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-10-19|||April 2014||2014-04-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII|Extension Study for Patients Who Completed GENA-05 (NuProtect)- to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII|Recruiting||Phase 3|100|Anticipated|Octapharma||1|||f||||t||||||||||2017-10-11 01:03:55.215538|2017-10-11 01:03:55.215538
NCT01992536|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-08-31|2016-04-14|2015-04-17|December 2013||2013-12-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional|||Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)|Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)|Completed||Phase 2|194|Actual|Novartis||9|||f||||f||||||||||2017-10-11 01:03:55.570192|2017-10-11 01:03:55.570192
NCT01992523|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2015-03-04|2014-09-25||November 2013||2013-11-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )|Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )|Completed||Phase 3|82|Actual|Careggi Hospital||2|||f||||t||||||||||2017-10-11 01:04:04.299915|2017-10-11 01:04:04.299915
NCT01992510|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-12-19|||January 2012||2012-01-01|December 2013|2013-12-01||||January 2013|Actual|2013-01-01||Observational|||The Effect of Postural Changes on Intraocular Pressure in Silicone Oil-filled Eyes||Completed||N/A|22|Actual|Kyungpook National University|||2||f||||||||||||||2017-10-11 01:04:04.718453|2017-10-11 01:04:04.718453
NCT01992497|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-05-03|||December 2013||2013-12-01|May 2016|2016-05-01||||April 2017|Anticipated|2017-04-01||Interventional|||Cesarean Section Study|Effect,Tolerance and Safety of a Supplementation With a Probiotic in Healthy Newborn Term Infants Born by Cesarean Section Over a 12 Months Period Study|Recruiting||N/A|740|Anticipated|Nestlé||4|||f||||f||||||||||2017-10-11 01:04:04.795062|2017-10-11 01:04:04.795062
NCT01992484|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2013-11-19|||August 2012||2012-08-01|November 2013|2013-11-01||||June 2015|Anticipated|2015-06-01||Observational|ATLANTIS-ACS||Platelet Function in Patients With an Acute Coronary Syndrome|Association Between the Antiplatelet Drug Efficacy/Safety and Platelet Function in Patients Treated With Novel Platelet Inhibitors Due to an Acute Coronary Syndrome|Unknown status|Recruiting|N/A|1000|Anticipated|Medical University of Vienna|||1||f||||t||||||||||2017-10-11 01:04:04.881927|2017-10-11 01:04:04.881927
NCT01992471|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-12-01|||November 2013||2013-11-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Observational|||Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing|Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing|Active, not recruiting||N/A|197|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     blood sample   "|||2017-10-11 01:04:04.957285|2017-10-11 01:04:04.957285
NCT01992458|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2013-11-19|||January 2012||2012-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|DAI-PP||Primary Prevention ICD French Registry|Observatoire Multicentrique Français Des Porteurs de Défibrillateur Automatique Implantable en Prévention Primaire (Cardiopathie Ischémique ou Cardiomyopathie Dilatée)|Completed||N/A|5576|Actual|Clinique Pasteur|||1||f||||t||||||||||2017-10-11 01:04:05.069712|2017-10-11 01:04:05.069712
NCT01992432|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-07-06|||September 30, 2013|Actual|2013-09-30|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|Brain fMRI-BC||Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)|A Pilot Study of Structural and Functional Brain Magnetic Resonance Imaging Findings of Chemotherapy Toxicity in Older Women With Breast Cancer|Recruiting||N/A|25|Anticipated|City of Hope Medical Center|||1||f||||t||||||||||2017-10-11 01:04:05.236037|2017-10-11 01:04:05.236037
NCT01992419|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-12-06|||November 2013||2013-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01|1 Year|Observational [Patient Registry]|OCAR||Evaluation of Out-of-Hospital Cardiac Arrest Recognition by Non-physicians Dispatchers in a French Emergency Dispatch Call Center|Evaluation of Cardiac Arrest Recognition by Non-physicians Dispatchers in the Paris Fire Brigade Emergency Call Dispatch Center|Completed||N/A|300|Anticipated|Fire Brigade Of Paris Emergency Medicine Dept|||1||f||||f||||||||||2017-10-11 01:04:05.351933|2017-10-11 01:04:05.351933
NCT01992406|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-07-15|||November 2013||2013-11-01|July 2015|2015-07-01||||November 2016|Anticipated|2016-11-01|6 Months|Observational [Patient Registry]|||Feasibility, Safety and Outcome of Transrectal Hybrid-NOTES Anterior Resection|Feasibility, Safety and Outcome of Transrectal Hybrid-NOTES Anterior Resection|Unknown status|Recruiting|N/A|60|Anticipated|Cantonal Hosptal, Baselland|||1||f||||f||||||||||2017-10-11 01:04:05.442254|2017-10-11 01:04:05.442254
NCT01992393|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-01-27|||September 2013||2013-09-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)|Targeted Self-Management for Epilepsy and Serious Mental Illness|Completed||N/A|44|Actual|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 01:04:07.365149|2017-10-11 01:04:07.365149
NCT01992380|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-06-06|||November 2013||2013-11-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of 18F-AV-1451 in Healthy Volunteers and Cognitively Impaired Subjects|Test-Retest Reproducibility of 18F-AV-1451 Injection for Brain Imaging of Tau in Healthy Volunteers and Cognitively Impaired Subjects.|Completed||Phase 1|24|Actual|Avid Radiopharmaceuticals||3|||f||||f||||||||||2017-10-11 01:04:07.477038|2017-10-11 01:04:07.477038
NCT01992367|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-10-31|||August 2013||2013-08-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003|A Phase 1, Randomised, Double Blind, Placebo Controlled, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of ASLAN003 in Healthy Subjects|Completed||Phase 1|61|Actual|Aslan Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:04:07.576301|2017-10-11 01:04:07.576301
NCT01992354|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-06-26|||November 2013||2013-11-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Development of an Integrated PET/MR System, Accessories and Components|Development of an Integrated PET/MR System, Accessories and Components|Terminated||N/A|3|Actual|GE Healthcare||1||Low enrollment|f||||f||||||||||2017-10-11 01:04:07.666003|2017-10-11 01:04:07.666003
NCT01992341|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2014-09-19|||July 2012||2012-07-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2013|Actual|2013-08-01||Interventional|||AMG 386 Drug-Drug Interaction Study With Paclitaxel|An Open-Label, Pharmacokinetic Drug-Drug Interaction (DDI) Study of AMG 386 in Combination With Paclitaxel in Adult Subjects With Advanced Solid Tumors|Completed||Phase 1|35|Actual|Amgen||1|||f||||t||||||||||2017-10-11 01:04:07.738782|2017-10-11 01:04:07.738782
NCT01992328|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-04-28|||December 2013||2013-12-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|IVIG||IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency|IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency|Active, not recruiting||Phase 3|30|Anticipated|Ajou University School of Medicine||1|||f||||t||||||||||2017-10-11 01:04:07.83627|2017-10-11 01:04:07.83627
NCT01992315|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2013-11-19|||March 2014||2014-03-01|November 2013|2013-11-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Investigation of A-ECM for the Correction of Soft Tissue Defects|Investigation of Decellularized Adipose Derived-ECM for the Correction of Acquired Soft Tissue Deformities of the Body and Face|Unknown status|Not yet recruiting|Phase 1|12|Anticipated|Aegeria Soft Tissue LLC||1|||f||||t||||||||||2017-10-11 01:04:07.959719|2017-10-11 01:04:07.959719
NCT01992302|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-18|||June 2004||2004-06-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients|Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients|Completed||N/A|289|Actual|Hospital Clinic of Barcelona|||2||f||||||||||||||2017-10-11 01:04:08.113485|2017-10-11 01:04:08.113485
NCT01992289|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-08-31|||March 2014||2014-03-01|August 2017|2017-08-01|March 2025|Anticipated|2025-03-01|March 2025|Anticipated|2025-03-01||Observational|ECP-002e||Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002|Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002|Active, not recruiting||N/A|10|Actual|Edimer Pharmaceuticals|||1||f||||f||||||||||2017-10-11 01:04:08.227958|2017-10-11 01:04:08.227958
NCT01992276|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-03-03|||December 2013||2013-12-01|March 2014|2014-03-01|February 2015|Anticipated|2015-02-01|October 2014|Anticipated|2014-10-01||Interventional|||Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection|Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of CR8020 and CR6261 in Hospitalized Patients With Influenza A Infection|Withdrawn||Phase 2|0|Actual|Crucell Holland BV||3||Due to preliminary efficacy results from an influenza challenge trial|f||||t||||||||||2017-10-11 01:04:08.486313|2017-10-11 01:04:08.486313
NCT01992263|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-04-05|||June 2017|Anticipated|2017-06-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|||Vitamin D Supplementation and TB|A Trial of Vitamin D Supplementation Among Tuberculosis Patients in South India|Not yet recruiting||N/A|200|Anticipated|Cornell University||4|||f||||t|f|f||||||||2017-10-11 01:04:08.839282|2017-10-11 01:04:08.839282
NCT01992250|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-08-11|||November 2013||2013-11-01|May 2017|2017-05-01|June 2023|Anticipated|2023-06-01|December 2021|Anticipated|2021-12-01||Interventional|FROST||Cryoablation of Small Breast Tumors in Early Stage Breast Cancer|Freezing Alone Instead of Resection Of Small Breast Tumors: A Study of Cryoablation in the Management of Early Stage Breast Cancer|Recruiting||N/A|200|Anticipated|Sanarus Technologies, Inc.||2|||f||||f||||||||||2017-10-11 01:04:08.979134|2017-10-11 01:04:08.979134
NCT01992237|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-02-07|||October 2013||2013-10-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|MEEP||Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients|Pilot Study of Measuring Energy Expenditure in ECMO Patients Under Consideration of Type of Ventilation and to Approximate Cardiac Output|Recruiting||N/A|40|Anticipated|Charite University, Berlin, Germany|||1||f||||t||||||Samples With DNA|"     Whole blood will be obtained for metabolomic analyses.   "|||2017-10-11 01:04:09.127981|2017-10-11 01:04:09.127981
NCT01992224|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-18|||July 2012||2012-07-01|November 2013|2013-11-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Effect of Early Mechanical Ventilation to Severe Acute Pancreatitis|Effect of Early Mechanical Ventilation to Severe Acute Pancreatitis|Unknown status|Recruiting|N/A|2|Anticipated|Ruijin Hospital||2|||f||||f||||||||||2017-10-11 01:04:09.237839|2017-10-11 01:04:09.237839
NCT01992211|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-07-12|||December 15, 2016|Actual|2016-12-15|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|April 28, 2017|Actual|2017-04-28||Interventional|||Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin|Randomized, Open, Cross-over, Single Dose Study to Evaluate the PK, Safety/Tolerability of BCWP_C003 Compared to Coadministration of Rosuvastatin and Metformin SR, and the Food Effect on the PK of BCWP_C003 in Healthy Volunteers|Completed||Phase 1|35|Actual|BC World Pharm Co. Ltd.||6|||f||||t||||||||||2017-10-11 01:04:09.336592|2017-10-11 01:04:09.336592
NCT01992198|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-18|||July 2012||2012-07-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis|Escalade or Deseacalade Antibiotic Use in Severe Acute Pancreatitis|Unknown status|Recruiting|Phase 4|60|Anticipated|Ruijin Hospital||2|||f||||f||||||||||2017-10-11 01:04:09.469843|2017-10-11 01:04:09.469843
NCT01992185|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-02-12|2015-12-11||August 2013||2013-08-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Photocil (Topical) for the Treatment of Vitiligo|Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Vitiligo|Completed||N/A|15|Actual|Applied Biology, Inc.||2|||f||||f||||||||||2017-10-11 01:04:09.589192|2017-10-11 01:04:09.589192
NCT01992172|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2016-02-25|2015-12-11||August 2013||2013-08-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Photocil (Topical) for the Treatment of Atopic Dermatitis|Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Atopic Dermatitis|Completed||N/A|7|Actual|Applied Biology, Inc.||2|||f||||f||||||||||2017-10-11 01:04:09.855971|2017-10-11 01:04:09.855971
NCT01992159|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-05-31||2015-09-11|October 12, 2012|Actual|2012-10-12|May 2017|2017-05-01|June 17, 2015|Actual|2015-06-17|October 9, 2014|Actual|2014-10-09||Interventional|||Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis|A Randomized, Double-blind, Placebo-controlled, Multi-dose Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis|Completed||Phase 2|252|Actual|Amgen||4|||f||||f||||||||||2017-10-11 01:04:10.109447|2017-10-11 01:04:10.109447
NCT01992146|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-11-23|||November 2015||2015-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of High-dose Naloxone Infusion on Pain and Hyperalgesia in Patients Following Groin-Hernia Repair.|Effect of High-dose Naloxone Infusion on Pain and Hyperalgesia in Patients Following Groin-Hernia Repair. A Randomized, Placebo-controlled, Double-blind Crossover Study|Recruiting||Phase 2|16|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:04:10.251411|2017-10-11 01:04:10.251411
NCT01992133|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2013-11-18|||June 2011||2011-06-01|November 2013|2013-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effects of Vitamin D Supplementation on Glucose Metabolism in Women With Former Gestational Diabetes Mellitus|The Effects of Vitamin D Supplementation on Blood Glucose and Markers of Metabolic Syndrome in Women With Vitamin D Deficiency and Previous Gestational Diabetes Mellitus|Completed||N/A|26|Actual|Penang Medical College||2|||f||||t||||||||||2017-10-11 01:04:10.356416|2017-10-11 01:04:10.356416
NCT01992120|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-12-07|||November 2013||2013-11-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome|Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome|Terminated||N/A|40|Actual|New York University School of Medicine||2||Key Personnel left institution|f||||f||||||||||2017-10-11 01:04:10.518219|2017-10-11 01:04:10.518219
NCT01992107|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-11-02|2015-03-16||November 2013||2013-11-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old|A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years|Completed||Phase 3|2333|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:04:10.722043|2017-10-11 01:04:10.722043
NCT01992094|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-11-02|2015-02-27||November 2013||2013-11-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older|A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age|Completed||Phase 3|2680|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:04:12.744927|2017-10-11 01:04:12.744927
NCT01992081|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-04-19|||May 2014||2014-05-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|PROactive||"Study to Evaluate the Impact of the PROactive Telecoaching Program on Physical Activity in Patients With COPD."|"A 6-month Multicenter Randomized Trial to Evaluate the Impact of the PROactive Telecoaching Program on Physical Activity in Patients With COPD"|Withdrawn||Phase 4|0|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:04:14.866934|2017-10-11 01:04:14.866934
NCT01992068|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-04-04|||September 2013||2013-09-01|April 2017|2017-04-01|December 12, 2016|Actual|2016-12-12|December 12, 2016|Actual|2016-12-12||Observational|||Pilot Study: Utilizing Manometry to Assess Radiation-Induced Changes in Esophageal Function|Prospective Pilot Study of High-resolution Manometry to Assess Radiation-induced Changes in Esophageal Function in Patients With Lung Cancer|Terminated||N/A|5|Actual|UNC Lineberger Comprehensive Cancer Center|||1|Closure due to low accrual|f||||t||||||||||2017-10-11 01:04:14.94474|2017-10-11 01:04:14.94474
NCT01992055|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-03-02|||December 2013||2013-12-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Outcomes Following Neuropsychological Intervention in Acquired Brain Injury Outpatients With Executive Dysfunction|Functional Outcomes Following Neuropsychological Intervention in Acquired Brain Injury Outpatients With Executive Dysfunction|Enrolling by invitation||N/A|36|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 01:04:15.032392|2017-10-11 01:04:15.032392
NCT01992042|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-06-20|||February 2014||2014-02-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer|Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer|Recruiting||Phase 2|40|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:04:15.123026|2017-10-11 01:04:15.123026
NCT01992029|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-01-08|||June 2014||2014-06-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Observational|MIRSLA||Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis|Etude de l'Expression Des Micro-RNA Comme Biomarqueur Diagnostic et Pronostic Dans la Sclérose Latérale Amyotrophique|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Bordeaux|||4||f||||f||||||Samples With DNA|"     Whole blood Cerebrospinal fluid muscle   "|||2017-10-11 01:04:15.220733|2017-10-11 01:04:15.220733
NCT01992016|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-04-27|||April 7, 2014|Actual|2014-04-07|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|April 23, 2014|Actual|2014-04-23||Interventional|||A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine|A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine|Active, not recruiting||N/A|11|Actual|University of Colorado, Denver||2|||f||||t||||||||No||2017-10-11 01:04:15.365095|2017-10-11 01:04:15.365095
NCT01992003|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-04-08|||January 2014||2014-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Butterfly Sensor With Rev K Version|Assessing the Accuracy of the Butterfly Sensor With RevK Version for Non-Invasive Hemoglobin Monitoring|Terminated||Phase 4|9|Actual|University of California, San Francisco|||1|Interim analysis indicated accuracy unchanged from previous versions|f||||t||||||||||2017-10-11 01:04:15.467241|2017-10-11 01:04:15.467241
NCT01991990|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-10-14|2015-10-14||May 2014||2014-05-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Includes all the randomized participants.|A Pharmacodynamic Study to Evaluate Neutrophil Distribution Kinetics and Function Following Single-Dose RoActemra/Actemra (Tocilizumab) in Healthy Volunteers|A Single Blind Phase IV Pharmacodynamic Study to Evaluate Neutrophil Distribution Kinetics and Function Following Single-Dose Tocilizumab Treatment in Healthy Subjects|Completed||Phase 4|18|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:04:15.568398|2017-10-11 01:04:15.568398
NCT01991977|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-05-17|||December 2013|Actual|2013-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy|Evaluating the Impact of 18F-DOPA-PET on Radiotherapy Planning for Newly Diagnosed Gliomas|Recruiting||Phase 2|150|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:04:16.27094|2017-10-11 01:04:16.27094
NCT01991964|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-21|||December 2013||2013-12-01|November 2013|2013-11-01||||January 2015|Anticipated|2015-01-01||Interventional|||The Yield of Laryngeal Ultrasound in the Diagnosis of Laryngomalacia|The Yield of Laryngeal Ultrasound in the Diagnosis of Laryngomalacia|Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 01:04:16.427725|2017-10-11 01:04:16.427725
NCT01991951|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-21|||July 2013||2013-07-01|November 2013|2013-11-01|July 2017|Anticipated|2017-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation|Prospective Randomized Study of Incidence of Thromboembolic and Bleeding Events According to the Period of Warfarin Use Before and After Catheter Ablation of Paroxysmal Atrial Fibrillation in Low Risk Patients|Unknown status|Recruiting|N/A|520|Anticipated|Korea University Anam Hospital||2|||f||||||||||||||2017-10-11 01:04:16.494766|2017-10-11 01:04:16.494766
NCT01991938|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-01-26|||November 2013||2013-11-01|January 2016|2016-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma|A Phase I Dose Escalation Study of VS-5584, a Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma|Terminated||Phase 1|75|Actual|Verastem, Inc.||1||Lack of recruitment and the company's decision to de-prioritize 5584 development|f||||f||||||||No||2017-10-11 01:04:16.600195|2017-10-11 01:04:16.600195
NCT01991925|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-18|||January 2014||2014-01-01|November 2013|2013-11-01||||March 2014|Anticipated|2014-03-01||Observational|||Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis|Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis|Unknown status|Not yet recruiting|N/A|130|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:04:16.731681|2017-10-11 01:04:16.731681
NCT01991912|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2014-01-28|||June 2009||2009-06-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|||Irrigation Endoscopic Decompressive Laminotomy|Irrigation Endoscopic Decompressive Laminotomy. A New Endoscopic Unilateral Approach for Bilateral Lumbar Decompression: A Blinded Non-randomized Controlled Trial.|Completed||N/A|80|Actual|Cairo University||1|||f||||f||||||||||2017-10-11 01:04:16.915089|2017-10-11 01:04:16.915089
NCT01991899|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-07-07|||February 2015||2015-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.|Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.|Completed||Phase 3|1560|Actual|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||2|||f||||t||||||||||2017-10-11 01:04:17.100691|2017-10-11 01:04:17.100691
NCT01991886|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-08-11|||January 2014||2014-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Using Nasal High Flow From Birth in Premature Infants - a Pilot Study|A Pilot Study to Determine the Feasibility of the Use of Nasal High Flow From Birth in Premature Infants Born at Less Than or Equal to 30 Week Gestational Age.|Completed||N/A|28|Actual|Ashford and St. Peter's Hospitals NHS Trust||1|||f||||f||||||||Undecided||2017-10-11 01:04:17.200565|2017-10-11 01:04:17.200565
NCT01991873|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-06-12|||April 2014||2014-04-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|PanaMa||Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer|Randomized Phase II Study for Evaluation of Efficacy and Safety of Maintenance Treatment With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction Treatment With mFOLFOX6 Plus Panitumumab and Re-induction With mFOLFOX6 Plus Panitumumab in Case of Progression for First-line Treatment of Patients With Metastatic Colorectal Cancer|Recruiting||Phase 2|380|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-10-11 01:04:17.292726|2017-10-11 01:04:17.292726
NCT01991860|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-07-28||2016-07-28|August 2013||2013-08-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||US Phase III Study of APD421 in PONV|Randomized, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Prophylaxis Against Post-operative Nausea and Vomiting|Completed||Phase 3|364|Actual|Acacia Pharma Ltd||2|||f||||t||||||||||2017-10-11 01:04:17.404557|2017-10-11 01:04:17.404557
NCT01991847|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-12-01|||November 2013||2013-11-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|F-PROTECT||Tertiary Prevention by Exercise in Colon Cancer Therapy|Feasibility Study of the PROTECT-trial (The Potential and Role Of Tertiary Prevention by Exercise in Colon Cancer Therapy)|Unknown status|Recruiting|N/A|50|Anticipated|Technische Universität München||1|||f||||t||||||||||2017-10-11 01:04:17.481838|2017-10-11 01:04:17.481838
NCT01991834|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-04-24|||September 2013||2013-09-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Antibiotic Prophylaxis in Gynecologic Laparoscopy|Antibiotic Prophylaxis in Gynecologic Laparoscopy|Completed||N/A|114|Actual|Universidade do Vale do Sapucai||2|||f||||f||||||||||2017-10-11 01:04:17.585727|2017-10-11 01:04:17.585727
NCT01991821|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-01-09|||July 2013||2013-07-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||European Phase III Study of APD421 in PONV|Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Prophylaxis Against Post-operative Nausea and Vomiting|Completed||Phase 3|368|Actual|Acacia Pharma Ltd||2|||f||||f||||||||||2017-10-11 01:04:17.697592|2017-10-11 01:04:17.697592
NCT01991808|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-04-11|||October 2013||2013-10-01|April 2016|2016-04-01||||October 2017|Anticipated|2017-10-01||Interventional|||Suitability of DCE-MRI for Detection of Vascular Changes After VBT|A Pilot Study to Assess the Suitability of DCE-MRI for Detection of Vascular Changes After Vaginal Brachytherapy|Recruiting||Phase 1|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:04:17.782692|2017-10-11 01:04:17.782692
NCT01991795|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-08-22|||February 10, 2014|Actual|2014-02-10|August 2017|2017-08-01|November 26, 2018|Anticipated|2018-11-26|November 26, 2018|Anticipated|2018-11-26||Interventional|THEMIS||A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus|A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients With Type 2 Diabetes Mellitus (THEMIS - Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study)|Active, not recruiting||Phase 3|19349|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 01:04:18.167023|2017-10-11 01:04:18.167023
NCT01991782|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-12-26|||June 2012||2012-06-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Impact of Telemedicine on Orthopaedic Trauma Patients With Closed Fractures|The Impact of Telemedicine on Orthopaedic Trauma Patients With Closed Fractures|Completed||N/A|20|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 01:04:21.470159|2017-10-11 01:04:21.470159
NCT01991769|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-06-13|||February 2012||2012-02-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|December 2012|Actual|2012-12-01||Interventional|||Negative Postprandial Effect on Endothelium After a Not-healthy Meal in Type 2 Diabetes as Affected by Training|Negative Postprandial Effect on Endothelium After a Not-healthy Meal in Type 2 Diabetes as Affected by Training|Completed||N/A|20|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 01:04:21.571472|2017-10-11 01:04:21.571472
NCT01991756|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-01-13|||April 2014||2014-04-01|January 2015|2015-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|ELEVATE||Safety and Performance of Altura Endograft in Abdominal Aortic Aneurysm (AAA) Endovascular Repair|ELEVATE International: Kissing Endografts for Peripheral AAA Exclusion|Enrolling by invitation||N/A|50|Anticipated|Altura Medical Inc.|||1||f||||f||||||||||2017-10-11 01:04:21.789569|2017-10-11 01:04:21.789569
NCT01991743|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-01-31|||May 2011||2011-05-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Trial Comparing Combined Spinal- Epidural Dosing Strategies for External Cephalic Version|A Randomized Controlled Trial Comparing Combined Spinal- Epidural Dosing Strategies for External Cephalic Version|Recruiting||Phase 4|226|Anticipated|Northwestern University||4|||f||||f||||||||No||2017-10-11 01:04:21.87014|2017-10-11 01:04:21.87014
NCT01991717|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-01-20|||December 2013||2013-12-01|January 2014|2014-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Victus Versus Conventional|An Open-label Investigator-masked Study Comparing Femtosecond Laser Assisted With Conventional Phacoemulsification Cataract Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Augenabteilung Allgemeines Krankenhaus Linz||2|||f||||||||||||||2017-10-11 01:04:21.969152|2017-10-11 01:04:21.969152
NCT01991704|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-18|||October 2011||2011-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|March 2013|Actual|2013-03-01||Observational|||Incubation of Alcohol Craving During Abstinence|The Neural Mechanisms of the Incubation of Cue-induced Craving in Alcohol Dependence|Completed||N/A|99|Actual|National Institute on Drug Dependence, China|||1||f||||t||||||None Retained|"     The blood samples of all participants were collected at each point of withdrawal.   "|||2017-10-11 01:04:22.064731|2017-10-11 01:04:22.064731
NCT01991691|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2016-05-22|||September 2013||2013-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Tablet-based Patient Reported Outcome|Pilot Study for Tablet-based Questionnaire of Patient-reported Outcomes From Patients Undergoing Chemotherapy (TabPRO I)|Completed||N/A|57|Actual|University Hospital, Bonn||1|||f||||f||||||||||2017-10-11 01:04:22.143962|2017-10-11 01:04:22.143962
NCT01991678|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-10-05|||November 2013|Actual|2013-11-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|May 2017|Actual|2017-05-01||Interventional|||A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)|An Open-Label, Parallel-Group, Multicenter, Phase 1 Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients With Advanced or Metastatic Solid Tumors and Hepatic Impairment|Completed||Phase 1|25|Actual|Nektar Therapeutics||3|||f||||f||||||||||2017-10-11 01:04:22.239473|2017-10-11 01:04:22.239473
NCT01991665|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2017-05-02|||January 2014||2014-01-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|RISPOSTA||R. I. S. POS. T. A|Randomised Italian Sonography for Occiput POSition Trial Ante Vacuum|Recruiting||N/A|1400|Anticipated|University of Bologna||2|||f||||t||||||||||2017-10-11 01:04:22.319243|2017-10-11 01:04:22.319243
NCT01991652|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-11-14|||January 2014||2014-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||Collaborative Wilms Tumour Africa Project|Collaborative Wilms Tumour Africa Project|Recruiting||Phase 4|400|Anticipated|VU University Medical Center|||1||f||||t||||||||No||2017-10-11 01:04:22.446346|2017-10-11 01:04:22.446346
NCT01991639|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-02-02|||January 2014||2014-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Healthy Life for Frail Malnourished Seniors Performed Together With Trained Lay Buddies|"Nutrition Intervention and Physical Training in Malnourished, Frail, Community-dwelling, Elderly Subjects Carried Out by Trained Lay Buddies"|Completed||N/A|80|Actual|Medical University of Vienna||2|||f||||f||||||||Yes||2017-10-11 01:04:22.564539|2017-10-11 01:04:22.564539
NCT01991626|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-09-22|||September 2013||2013-09-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation of the Effects of an Exogenous Phytase on Iron Absorption From LNS Added to Complementary Foods|Evaluation of the Effects of an Exogenous Phytase on Iron Absorption From Lipid Nutrient Supplements Added to Complementary Foods|Completed||N/A|47|Actual|Swiss Federal Institute of Technology||10|||f||||f||||||||||2017-10-11 01:04:22.747782|2017-10-11 01:04:22.747782
NCT01991613|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-09-21|||December 2013||2013-12-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Early Protein Supplementation of Human Milk in Extremely Low Birth Weight Infants|Early Liquid Protein Supplementation of Human Milk in Extremely Low Birth Weight Infants|Completed||Phase 2|43|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 01:04:22.873568|2017-10-11 01:04:22.873568
NCT01991600|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-18|||May 2006||2006-05-01|November 2013|2013-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Pilot Study to Assess the Influence of Dietary Organic Acids on Iron Absorption.|A Pilot Study to Assess the Influence of Dietary Organic Acids on Iron Absorption.|Completed||Early Phase 1|71|Actual|Medical Research Council||2|||f||||f||||||||||2017-10-11 01:04:22.983781|2017-10-11 01:04:22.983781
NCT01991587|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-09-24|||October 2013||2013-10-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults|Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent Virus-like-particle (VLP) Influenza Vaccine in Adults|Completed||Phase 1/Phase 2|120|Actual|Medicago||4|||f||||t||||||||||2017-10-11 01:04:23.105215|2017-10-11 01:04:23.105215
NCT01991574|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-02-03|||April 2009||2009-04-01|February 2017|2017-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.|Study of the Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus.|Completed||Early Phase 1|30|Actual|Medical Research Council||3|||f||||f||||||||||2017-10-11 01:04:23.263939|2017-10-11 01:04:23.263939
NCT01991561|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-09-24|||June 2013||2013-06-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.|Immunogenicity, Safety, Tolerability of a Plant-made H5 VLP Influenza Vaccine.|Completed||Phase 2|390|Actual|Medicago||6|||f||||t||||||||||2017-10-11 01:04:23.426709|2017-10-11 01:04:23.426709
NCT01991548|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-05-11|2015-08-28||November 2013||2013-11-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||User Evaluation of the MiniMed 640G Insulin Pump|A User Evaluation of the MiniMed® 640G Insulin Pump and Guardian® Link Transmitter|Completed||N/A|52|Actual|Medtronic Diabetes||1|||f||||f|f|t|t||t|||No||2017-10-11 01:04:23.681928|2017-10-11 01:04:23.681928
NCT01991535|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-10-29||||||October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Response to NonInvasive Mechanical Ventilation According to the Breathing Pattern|Response to NonInvasive Mechanical Ventilation According to the Breathing Pattern|Unknown status|Not yet recruiting|N/A|10|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||||f||||f||||||||||2017-10-11 01:04:24.02424|2017-10-11 01:04:24.02424
NCT01991509|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-03-03|||October 2013||2013-10-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Bioavailability of IV and SC LBR-101|A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study Assessing the Safety, Tolerability and Pharmacokinetics of Two Different Doses of LBR-101 Given Intravenously and Subcutaneously|Completed||Phase 1|36|Actual|Teva Pharmaceutical Industries||6|||f||||f||||||||||2017-10-11 01:04:24.337231|2017-10-11 01:04:24.337231
NCT01991483|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-11-20|||December 2013||2013-12-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of LY2928057 in Hemodialysis Participants|A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2928057 in Hemodialysis Patients|Completed||Phase 1|20|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 01:04:24.482665|2017-10-11 01:04:24.482665
NCT01991470|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-01-11|||March 2015||2015-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||CEP249 Pediatric Accuracy Study|A Performance Evaluation of the Enlite™ and Enlite 3 Glucose Sensor to Support Use in Children|Completed||N/A|191|Actual|Medtronic Diabetes||1|||f||||f||||||||||2017-10-11 01:04:24.636014|2017-10-11 01:04:24.636014
NCT01991457|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2016-12-27|||September 2013||2013-09-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Interventional|FluTBI||Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia|Single Arm Phase II Study of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia (ALL) in Older Patients Using Fludarabine and Total Body Irradiation (FluTBI) Regimen|Recruiting||Phase 2|20|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 01:04:24.782764|2017-10-11 01:04:24.782764
NCT01991444|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-04-04|||February 2014|Actual|2014-02-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01|12 Months|Observational [Patient Registry]|CGA-TAVI||CGA-TAVI Registry to Evaluate the Predictive Value of a CGA in Predicting TAVI Outcomes|Registry Study to Evaluate the Predictive Value of a Comprehensive Geriatric Assessment With Regard to the Outcome of a Transcatheter Aortic Valve Implantation.|Completed||N/A|72|Actual|Institut für Pharmakologie und Präventive Medizin|||1||f||||f||||||||Undecided||2017-10-11 01:04:24.943104|2017-10-11 01:04:24.943104
NCT01991431|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-02-20|||February 2013|Actual|2013-02-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01|30 Days|Observational [Patient Registry]|ROUTE||ROUTE Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve|Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve|Completed||N/A|303|Actual|Institut für Pharmakologie und Präventive Medizin|||1||f||||f||||||||||2017-10-11 01:04:25.063414|2017-10-11 01:04:25.063414
NCT01991418|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-02-14|||May 2013||2013-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)|Early Warning Study of Plasma Thioredoxin Reductase Activity in Non-small Cell Lung Cancers Received Surgery|Completed||N/A|165|Actual|Hunan Province Tumor Hospital|||1||f||||f||||||Samples With DNA|"     3-4 ml whole blood was obtained and then centrifuged and stored at -20℃.   "|||2017-10-11 01:04:25.170008|2017-10-11 01:04:25.170008
NCT01991405|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-05-22|||August 2013||2013-08-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|MCI||Memory Aid - Working Memory Training in Patients With Mild Cognitive Impairment.|Memory Aid - Computer Based Working Memory Training in Elderly With Mild Cognitive Impairment (MCI). A Randomized, Controlled Trial.|Unknown status|Recruiting|N/A|90|Anticipated|Sorlandet Hospital HF||1|||f||||f||||||||||2017-10-11 01:04:25.257309|2017-10-11 01:04:25.257309
NCT01991392|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2013-11-24|||November 2012||2012-11-01|November 2013|2013-11-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Is Nasogastric Tube Necessary After Pancreaticoduodenectomy?|Is Nasogastric Tube Necessary After Pancreaticoduodenectomy?|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:04:25.528827|2017-10-11 01:04:25.528827
NCT01991366|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-08-08|||October 2013||2013-10-01|August 2014|2014-08-01||||October 2014|Anticipated|2014-10-01||Observational|||Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI?|Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction?|Unknown status|Active, not recruiting|N/A|800|Anticipated|Medstar Health Research Institute|||3||f||||f||||||||||2017-10-11 01:04:25.741511|2017-10-11 01:04:25.741511
NCT01991353|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-04-18|||July 2015||2015-07-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||Platelet Rich Plasma Study With Meniscal Repair|Prospective, Double Blind, Randomized Trial: Meniscal Repair With or Without Augmentation Utilizing Platelet Rich Plasma.|Withdrawn||N/A|0|Actual|Simon Fraser Orthopaedic Fund||2||Lack of funding|f||||f||||||||||2017-10-11 01:04:25.819833|2017-10-11 01:04:25.819833
NCT01991340|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-18|||November 2008||2008-11-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast Cancer|H.E.R.O.S. Study: Observational Study to Assess the Cardiac Safety Profile of Trastuzumab in Patients With HER2-positive Breast Cancer.|Completed||N/A|657|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:04:25.953214|2017-10-11 01:04:25.953214
NCT01991327|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-08-07|||May 2014||2014-05-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males|AN OPEN-LABEL, MULTIPLE DOSE STUDY TO ASSESS THE DRUG-DRUG INTERACTIONS OF ANDROXAL WITH CYTOCHROME P450 ISOENZYMES IN HEALTHY MALE SUBJECTS|Completed||Phase 1|30|Actual|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 01:04:26.065242|2017-10-11 01:04:26.065242
NCT01991314|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-03-31|2016-11-15||December 2011||2011-12-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate|Treatment of Iron Deficiency Anaemia in Adults and Adolescents With Inflammatory Bowel Disease Using Ferrous Sulphate: Tolerance and Effects on Haemoglobin, Mood, Quality of Life and Fatigue|Completed||Phase 4|90|Actual|Queen Mary University of London|Findings may not be generalizable. Trial not blinded. We studied patients who had tolerated oral iron before or were naïve to it. Only half of patients returned tablet containers for counting. Questionnaires used not validated for young people.|1|||f||||f||||||||No||2017-10-11 01:04:26.149326|2017-10-11 01:04:26.149326
NCT01991301|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-12-01|||November 2014||2014-11-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Carfilzomib for the Prevention of Graft Versus Host Disease|The Safety and Efficacy of Carfilzomib -a Novel Proteasome Inhibitor- for the Prevention of Acute Graft Versus Host Disease|Recruiting||Phase 1|30|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 01:04:26.5685|2017-10-11 01:04:26.5685
NCT01991288|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2013-11-21|||November 2012||2012-11-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Analgesic Efficacy of Saphenous Nerve Block in Total Knee Replacement|Does Saphenous Nerve Block Improve Analgesia After Total Knee Replacement When Used in Combination With Local Infiltration Analgesia? A Prospective Randomised Double Blinded Trial.|Completed||Phase 4|20|Actual|Cork University Hospital||2|||f||||t||||||||||2017-10-11 01:04:26.663906|2017-10-11 01:04:26.663906
NCT01991275|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-07-01|||November 2013||2013-11-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|RoboITMProst||Intrathecal Morphine in Robot-assisted Prostatectomy|The Efficacy of Intrathecal Morphine in Patients Undergoing Robot-assisted Prostatectomy|Completed||N/A|30|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:04:26.757547|2017-10-11 01:04:26.757547
NCT01991262|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2016-07-20|||April 2015||2015-04-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|Help-B||A Nationwide Epidemiological, Educational Support Program for Improving Treatment Adherence in Patients With HBV|A Nationwide Epidemiological, Non-Interventional Study Evaluating an Educational Support Program for Improving Treatment Adherence in Patients With Hepatitis B Viral Infection|Withdrawn||N/A|0|Actual|Carmel Medical Center|||4|the support group need to have some change|f||||t||||||||||2017-10-11 01:04:26.834975|2017-10-11 01:04:26.834975
NCT01991249|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-04-08|||February 2014||2014-02-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|February 2016|Anticipated|2016-02-01||Interventional|||Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia|Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia|Unknown status|Recruiting|N/A|50|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:04:26.903762|2017-10-11 01:04:26.903762
NCT01991236|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-03-05|||April 2013||2013-04-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Video-Based Education for Dermatology Patients on Systemic Corticosteroids|The Efficiency and Effectiveness of Video-Based Education for Dermatology Patients Qualifying for Chronic Treatment With Systemic Corticosteroids|Completed||N/A|75|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:04:26.993221|2017-10-11 01:04:26.993221
NCT01991223|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-03-18|||November 2013||2013-11-01|March 2014|2014-03-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|CRBDEX||Dexmedetomidine for Catheter-related Bladder Discomfort|Efficacy of Dexmedetomidine for the Therapy of Catheter-related Bladder Discomfort|Unknown status|Recruiting|Phase 4|114|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:04:27.081421|2017-10-11 01:04:27.081421
NCT01991210|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-08-17||2017-08-17|February 6, 2014|Actual|2014-02-06|August 2017|2017-08-01|August 17, 2016|Actual|2016-08-17|August 17, 2016|Actual|2016-08-17||Interventional|||A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)|A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating the Safety and Activity of DNIB0600A Compared to Pegylated Liposomal Doxorubicin Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer|Terminated||Phase 2|95|Actual|Genentech, Inc.||2||The primary objective of PFS did not meet pre-specified criteria.|f||||||||||||||2017-10-11 01:04:27.176475|2017-10-11 01:04:27.176475
NCT01991197|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2017-04-26|||April 2014||2014-04-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|DIP||Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.|Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.|Completed||Phase 2|20|Actual|University College Dublin||2|||f||||t||||||||||2017-10-11 01:04:28.858658|2017-10-11 01:04:28.858658
NCT01991184|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.|AN OPEN-LABEL, PHASE I, DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF GDC-0853 IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA|Active, not recruiting||Phase 1|24|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 01:04:29.030396|2017-10-11 01:04:29.030396
NCT01991171|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2014-10-21|||May 2013||2013-05-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|EKTAQRIH||Effectiveness of the Kinesio Taping® in Muscle Activation|Effectiveness of the Kinesio Taping® in Activation of Quadriceps Muscle and Reflex Inhibition of Hamstrings Muscle: Randomized Controlled Trial|Completed||N/A|48|Actual|Paulista University||3|||f||||f||||||||||2017-10-11 01:04:29.14697|2017-10-11 01:04:29.14697
NCT01991158|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-06-11|||November 2013||2013-11-01|June 2016|2016-06-01|November 2020|Anticipated|2020-11-01|December 2016|Anticipated|2016-12-01||Interventional|||GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma|An Open, Single-center, Phase II Clinical Trial for Treatment of Untreated Extranodal NK/T Cell Lymphoma With High Dose of Methotrexate in Combination With Gemcitabine, Pegaspargase and Dexamethasone (GAD-M Regimen)|Active, not recruiting||Phase 2|30|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 01:04:29.310729|2017-10-11 01:04:29.310729
NCT01991132|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-05-18|||December 2013||2013-12-01|June 2014|2014-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Validating the Diagnostic Accuracy of Mediview 2.0 Software as an Image Analysis Tool of Meibomian Glands|Validating the Diagnostic Accuracy of Mediview 2.0 Software as an Image Analysis Tool of Meibomian Glands|Completed||N/A|100|Actual|Singapore National Eye Centre||1|||f||||f||||||||||2017-10-11 01:04:29.668575|2017-10-11 01:04:29.668575
NCT01991119|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-17|||May 2011||2011-05-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation|Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation After DC Cardioversion|Completed||N/A|98|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 01:04:29.758131|2017-10-11 01:04:29.758131
NCT01991106|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-09-01|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Effects of Exercise Intensity in Obese Children and Adolescents|A Multi-centre Randomized Controlled Trial Examining the Effects of High Intensity Interval Training on Cardio-metabolic Outcomes in Obese Children and Adolescents|Completed||N/A|100|Actual|Norwegian University of Science and Technology||4|||f||||f|f|f||||||||2017-10-11 01:04:30.063815|2017-10-11 01:04:30.063815
NCT01991093|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-03-13|||June 2014||2014-06-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Multiple Electrode Aggregometry & Clopidogrel Resistance|The Role of Multiple Electrode Aggregometry in Detection of Clopidogrel Resistance in Diabetic Patients With Coronary Artery Disease and Prediction of Clinical Outcomes. A Comparative-method, Non Interventional, Single Center Study.|Completed||N/A|280|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 01:04:30.265748|2017-10-11 01:04:30.265748
NCT01991080|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-05-03|||December 2013||2013-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Relationship Between Relaxation or Wheat Germ Juice to the Immune Indices and Quality of Life (QoL) in Colorectal Cancer Patients on Adjuvant Chemotherapy|Examining the Relationship Between Relaxation Combined With Biofeedback or Wheat Germ Juice to the Immune Indices and Quality of Life Measures in Patients With Colorectal Cancer Who Receive Prophylactic Chemotherapy After Surgery|Recruiting||N/A|200|Anticipated|Rambam Health Care Campus||2|||f||||f|f|f||||||No||2017-10-11 01:04:30.395858|2017-10-11 01:04:30.395858
NCT01991067|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-04-18|||July 2014||2014-07-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients|Characterization of Humoral and Cellular Immunity for Tick-borne Encephalitis (TBE) Vaccination in Allogeneic Blood and Marrow Graft Recipients: a Pilot Study|Recruiting||Phase 2|52|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:04:30.519592|2017-10-11 01:04:30.519592
NCT01991054|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-07-16|||December 2013||2013-12-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|VDD||The Effects of Vitamin D Supplementation on Patients With Type 2 Diabetes and Vitamin D Deficiency|A Prospective, Double Blind, Randomized, Phase 4, Clinical Trial of The Effects of Vitamin D Supplementation on Patients With Type 2 Diabetes and Vitamin D Deficiency|Unknown status|Recruiting|Phase 4|180|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-11 01:04:30.636459|2017-10-11 01:04:30.636459
NCT01991041|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-05-03|||June 2008||2008-06-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|||European Registry of Anti-Epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS)|European Registry of Anti-epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS).|Completed||N/A|109|Actual|Eisai Inc.|||2||f||||||||||||||2017-10-11 01:04:30.793463|2017-10-11 01:04:30.793463
NCT01991028|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-02-06|||April 2014||2014-04-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Investigate Lung Deposition of Radiolabelled OligoG|An Open Label, Randomised, Two-way Crossover Scintigraphic Study to Investigate Lung Deposition of Radiolabelled OligoG Delivered as a Dry Powder and as a Nebulised Solution in Cystic Fibrosis Patients|Completed||Phase 2|10|Actual|Bio-Images Research Ltd||2|||f||||f||||||||||2017-10-11 01:04:30.990692|2017-10-11 01:04:30.990692
NCT01991015|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-02-06|||November 2013||2013-11-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Goals of Care Discussions for Hospitalized Patients With Advanced Cancer|Gender Differences in Inpatient Goals of Care Discussions in Patients With Advanced Cancer|Completed||N/A|43|Actual|Northwestern University|||1||f||||f||||||||||2017-10-11 01:04:31.090768|2017-10-11 01:04:31.090768
NCT01991002|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-11-24|||July 2012||2012-07-01|November 2013|2013-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||14/21 Diet-walking in the Park|Prospective Interventional Study of the Impact of 3-step Diet With Complimentary Exercise Program|Unknown status|Active, not recruiting|N/A|80|Anticipated|Assuta Hospital Systems||1|||f||||f||||||||||2017-10-11 01:04:31.161396|2017-10-11 01:04:31.161396
NCT01990989|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2013-11-18|||January 2014||2014-01-01|November 2013|2013-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|CPASS||Clopidogrel Pharmacogenetic Score System|Clopidogrel Pharmacogenetic Score System Established for Chinese Patients|Unknown status|Not yet recruiting|N/A|500|Anticipated|Chinese PLA General Hospital|||1||f||||t||||||Samples With DNA|"     DNA extracted from peripheral whole blood   "|||2017-10-11 01:04:31.265164|2017-10-11 01:04:31.265164
NCT01990976|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-07-27|||May 2012||2012-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|FSHD3||Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.|Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.|Completed||N/A|15|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     Muscles   "|||2017-10-11 01:04:31.385664|2017-10-11 01:04:31.385664
NCT01990963|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-05-23|||January 2010||2010-01-01|May 2017|2017-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Brain Densitometric Assessment With Axial Computerized Tomography After Severe Brain Trauma.|Brain Densitometric Assessment With Axial Computerized Tomography After Severe Brain Trauma.|Active, not recruiting||N/A|60|Anticipated|Università degli Studi dell'Insubria|||1||f||||t||||||||||2017-10-11 01:04:31.483126|2017-10-11 01:04:31.483126
NCT01990950|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-05-09|||March 2014||2014-03-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Fenestrated AAA Endovascular Graft Post-Approval Study|Evaluation of the Long-term Safety and Performance of the Zenith® Fenestrated AAA Endovascular Graft Post-Approval Study|Active, not recruiting||N/A|21|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 01:04:31.561536|2017-10-11 01:04:31.561536
NCT01990937|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2014-10-27|||October 2013||2013-10-01|October 2014|2014-10-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Oral Midazolam for Sedation in Esophagogastroduodenoscopy(EGD)|Effectiveness of Oral Midazolam for Sedation in Patients Undergoing Upper Gastrointestinal Endoscopy|Unknown status|Recruiting|Phase 4|260|Anticipated|Phramongkutklao College of Medicine and Hospital||2|||f||||f||||||||||2017-10-11 01:04:31.648016|2017-10-11 01:04:31.648016
NCT01990924|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-18|||October 2012||2012-10-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Low Rate Fluoroscopy to Reduce Radiation Dose During Coronary Angiography and Intervention|Low Rate Fluoroscopy at Reducing Operator and Patient Radiation Dose During Transradial Coronary Diagnostic Angiography and Interventions|Completed||N/A|385|Actual|Laval University||2|||f||||f||||||||||2017-10-11 01:04:31.742457|2017-10-11 01:04:31.742457
NCT01990911|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2015-04-28|||March 2013||2013-03-01|April 2015|2015-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|RDPAF||Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study|Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study|Unknown status|Recruiting|N/A|100|Anticipated|Pace Clinic||2|||f||||t||||||||||2017-10-11 01:04:31.949034|2017-10-11 01:04:31.949034
NCT01990898|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-04-07|2016-10-26||November 2013||2013-11-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|CIC||Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action|Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action|Completed||Phase 2|26|Actual|The Cleveland Clinic||1|||f||||t||||||||||2017-10-11 01:04:32.097553|2017-10-11 01:04:32.097553
NCT01990885|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-17|2017-08-16|||December 2013||2013-12-01|August 2017|2017-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.|A Two-Part, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Systemic Exposure of Single Escalating Administrations and Repeated Administration of BL-7010 in Well-Controlled Celiac Patients|Completed||Phase 1/Phase 2|40|Actual|BioLineRx, Ltd.||5|||f||||||||||||||2017-10-11 01:04:32.275311|2017-10-11 01:04:32.275311
NCT01990872|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-21|||October 2012||2012-10-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|VitD-Ca||Inter-relationship Between Vitamin D Requirements and Calcium Intake in Older Adults|Randomized Controlled Trial to Explore the Inter-relationship Between Vitamin D Requirements and Calcium Intake|Completed||N/A|125|Actual|University College Cork||4|||f||||t||||||||||2017-10-11 01:04:32.385739|2017-10-11 01:04:32.385739
NCT01990859|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2016-02-12|2015-04-30||December 2013||2013-12-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|May 2014|Actual|2014-05-01||Interventional||All participants in the study who received at least one dose of treatment with ipilimumab were summarized.|Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients|Phase 2 Study of Ipilimumab in Japanese Subjects With Unresectable or Metastatic Melanoma|Completed||Phase 2|20|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 01:04:32.520915|2017-10-11 01:04:32.520915
NCT01990846|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-03-09|||March 2014||2014-03-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled Assessment of the Safety, Tolerability and Pharmacokinetics of Escalating Single and Repeat Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects|Completed||Phase 1|68|Actual|Autoimmune Technologies, LLC||6|||f||||f||||||||||2017-10-11 01:04:33.256516|2017-10-11 01:04:33.256516
NCT01990833|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-11-21|||January 2012||2012-01-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Molecular Characteristics of the Persistent Intestinal Fistulae After Glue Application||Completed||N/A|22|Actual|Jinling Hospital, China|||1||f||||f||||||Samples Without DNA|"     Plasmas and fistula tissues   "|||2017-10-11 01:04:33.360973|2017-10-11 01:04:33.360973
NCT01990820|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2017-08-27|||March 2009||2009-03-01|August 2017|2017-08-01|September 29, 2016|Actual|2016-09-29|September 29, 2016|Actual|2016-09-29||Interventional|||Study for the Management of Pediatric Chronic Rhinosinusitis With or Without Balloon Sinuplasty|A Randomized Trial of the Management of Pediatric Chronic Rhinosinusitis With or Without Balloon Sinusplasty|Completed||N/A|25|Actual|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||||2017-10-11 01:04:33.421999|2017-10-11 01:04:33.421999
NCT01990807|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2013-11-20|||October 2012||2012-10-01|November 2013|2013-11-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia|Philadelphia -Negative High-risk Children Acute Lymphoblastic Leukemia(ALL) Treatment:Induction Therapy:Vincristine(V),Idarubicin(I),L-asparaginase(L),Dexamethasone(D);Consolidation:V+Daunorubicin(D)+L+D, Methotrexate,Cytarabine|Unknown status|Recruiting|Phase 4|20|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 01:04:33.527476|2017-10-11 01:04:33.527476
NCT01990794|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-10-03|2014-07-30||June 2012||2012-06-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Observational||Our pair-wise comparisons had a power of 80% to detect a mean increase in RBC count of 0.34 million (sgma =0.2 million; n=5) and a mean increase of Hgb of 0.85 g/dL (sigma =0.5 g/dL; n=5), which are less than the minimum increases detected in the males that experienced polycythemia in Davis and Fields (1958).|90‐Day Cobalt Supplementation Study to Investigate the Cobalt Body Burden in Ten Healthy Adult Volunteers|A 90-Day Cobalt Supplementation Study to Investigate the Cobalt Body Burden in Ten Healthy Adult Volunteers|Completed||N/A|13|Actual|Cardno ChemRisk|The primary limitation of our study was its small sample size. We believe the study was sufficiently robust because we evaluated effects on hematologic and thyroid variables, both of which have been identified as sensitive markers of cobalt exposure.||1||f||||t||||||Samples With DNA|"     whole blood, serum and urine   "|||2017-10-11 01:04:33.682328|2017-10-11 01:04:33.682328
NCT01990781|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-02|2016-11-04|||December 2013||2013-12-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Intravenous Lidocaine and Dexamethasone Combination on Postoperative Sore Throat, Cough and Hoarseness.|Combined Effect of Intravenous Lidocaine and Dexamethasone on Postoperative Sore Throat, Cough and Hoarseness. A Randomized Controlled Trial|Completed||Phase 4|180|Actual|B.P. Koirala Institute of Health Sciences||4|||f||||f||||||||||2017-10-11 01:04:35.852655|2017-10-11 01:04:35.852655
NCT01990768|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-10-03|||May 2015||2015-05-01|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|TXA||Prehospital Tranexamic Acid Use for Traumatic Brain Injury|Prehospital Tranexamic Acid Use for Traumatic Brain Injury|Active, not recruiting||Phase 2|967|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 01:04:35.968603|2017-10-11 01:04:35.968603
NCT01990755|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2013-11-15|||May 2010||2010-05-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|NEDT||Neurobiology of Eating Disorders Treatments|Lack of Efficacy of Psychological and Pharmacological Treatments of Eating Disorders: Neurobiological Background|Completed||N/A|112|Actual|University of Turin, Italy||3|||f||||f||||||||||2017-10-11 01:04:36.121406|2017-10-11 01:04:36.121406
NCT01990729|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-11-15|||July 2010||2010-07-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Efficacy and Safety of ARTRA (Glucosamine Plus Chondroitin Sulfate Combination) in Treatment of Chronic Low Back Pain|Efficacy and Safety of ARTRA (Glucosamine Plus Chondroitin Sulfate Combination) in Treatment of Non-specific Chronic Low Back Pain of Lumbosacral Localization in Ambulatory Care|Completed||N/A|10000|Actual|Unipharm, Inc.|||1||f||||f||||||||||2017-10-11 01:04:36.299038|2017-10-11 01:04:36.299038
NCT01990716|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-02-21|||February 2013||2013-02-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MICILIP||Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel Diseases|Quantitative Analysis of Lipid Mediators in Colonic Biopsies From Patients With Inflammatory Bowel Diseases and From Control Patients.|Completed||N/A|124|Actual|University Hospital, Toulouse||2|||f||||f|f|f||||||No||2017-10-11 01:04:36.385056|2017-10-11 01:04:36.385056
NCT01990703|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-05-16|2017-03-27||January 2014||2014-01-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|BLIS||BLIS - Breastfeeding Levonorgestrel IUD Study|Randomized Controlled Trial of Early Versus Standard Postpartum Insertion of the Levonorgestrel IUD to Assess Breast Feeding Outcomes (BLIS - Breastfeeding Levonorgestrel IUD Study)|Completed||Phase 4|285|Actual|University of Utah|Inability to blind, loss to follow-up, and lack of long-term infant and childhood outcomes. We had a smaller final sample than intended despite meeting enrollment goals.|2|||f||||t||||||||No||2017-10-11 01:04:36.475903|2017-10-11 01:04:36.475903
NCT01990690|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-01-12|||January 2014||2014-01-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|ao&uoh||Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial|Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial|Completed||Phase 4|202|Actual|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-11 01:04:36.786716|2017-10-11 01:04:36.786716
NCT01990677|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-05-26|2017-04-12||October 2013||2013-10-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional||Two individuals in the treatment group and one in the placebo group were lost to follow-up.|Eplerenone for the Treatment of Central Serous Chorioretinopathy|Eplerenone for the Treatment of Central Serous Chorioretinopathy|Completed||N/A|108|Actual|Wills Eye||4|||f||||f||||||||||2017-10-11 01:04:36.885374|2017-10-11 01:04:36.885374
NCT01990664|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-01-28|2015-12-21||November 2013||2013-11-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||The analysis population consists of all subjects that were enrolled into the study|Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact Lenses|A Multi-Center Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-Fit Into Spherical or Toric Senofilcon A Contact Lenses|Completed||N/A|199|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 01:04:37.228379|2017-10-11 01:04:37.228379
NCT01990651|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-11-15|||September 2011||2011-09-01|November 2013|2013-11-01||||December 2014|Anticipated|2014-12-01||Observational|||Study of Use of CTC in NSCLC|The Use of Circulating Tumor Cells in Non-Small Cell Lung Cancer: Novel Isolation Methods and Clinical Applications|Unknown status|Recruiting|N/A|30|Anticipated|University of Virginia|||1||f||||t||||||||||2017-10-11 01:04:37.515961|2017-10-11 01:04:37.515961
NCT01990638|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-11-15|||November 2004||2004-11-01|November 2013|2013-11-01|May 2005|Actual|2005-05-01|April 2005|Actual|2005-04-01||Observational|||Effects of Exercise Therapy on Ventricular and Endothelial Function in Patients After Coronary Artery Bypass Surgery|Effects of Exercise Therapy on Ventricular and Endothelial Function in Patients After Coronary Artery Bypass Surgery|Completed||N/A|51|Actual|National Taiwan University Hospital|||2||f||||f||||||Samples Without DNA|"     fasting glucose   "|||2017-10-11 01:04:37.602852|2017-10-11 01:04:37.602852
NCT01990625|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-09-27|||April 2014||2014-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country Settings|Global Network First Look: A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country Settings|Completed||N/A|45038|Actual|NICHD Global Network for Women's and Children's Health||2|||f||||t||||||||||2017-10-11 01:04:37.672258|2017-10-11 01:04:37.672258
NCT01990612|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-08-14|||March 2014||2014-03-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|ARRIVE||A Randomized Trial of Induction Versus Expectant Management|Induction in Nulliparous Women at 39 Weeks to Prevent Adverse Outcomes: A Randomized Controlled Trial|Recruiting||N/A|6000|Anticipated|The George Washington University Biostatistics Center||2|||f||||t||||||||||2017-10-11 01:04:37.794898|2017-10-11 01:04:37.794898
NCT01990599|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-11-15|||July 2012||2012-07-01|November 2013|2013-11-01||||June 2013|Actual|2013-06-01||Interventional|||Airway Management for Trigeminal Thermal Coagulation|Airway Management in Patients Undergoing Thermal Ganglion Gasseri Coagulation, a New Method - Preliminary Results|Completed||N/A|5|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 01:04:38.099353|2017-10-11 01:04:38.099353
NCT01990586|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-11-15||||||November 2013|2013-11-01||||September 2010|Actual|2010-09-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions|An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Rabeprazole Sodium Delayed Release Tablets 20 mg (Test, Torrent Pharmaceuticals Limited., India) Versus Aciphex® (Rabeprazole Sodium) Delayed Release Tablets 20 mg (Reference, Eisai Inc., USA) in Healthy Human Volunteers Under Fed Condition.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 01:04:38.171965|2017-10-11 01:04:38.171965
NCT01990573|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-04-04|||June 2013||2013-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MEPA II||Methadone in Pediatric Anesthesiology II|Methadone in Pediatric Anesthesia II|Recruiting||N/A|60|Anticipated|Washington University School of Medicine||3|||f||||f||||||||Undecided||2017-10-11 01:04:38.234979|2017-10-11 01:04:38.234979
NCT01990560|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-09-29|||November 2013||2013-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism|Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism|Completed||Phase 4|8|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 01:04:38.336934|2017-10-11 01:04:38.336934
NCT01990547|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-02-09||||||February 2016|2016-02-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational|ViRTICo-BP||Virtual Reality Therapy and Imaging in Combat Veterans With Blast Injury and Posttraumatic Stress Disorder|The ViRTICo-BP Trials: Virtual Reality Therapy and Imaging in Combat Veterans With Blast Injury and Posttraumatic Stress Disorder|Completed||N/A|88|Anticipated|Walter Reed National Military Medical Center|||4||f||||t||||||||||2017-10-11 01:04:38.449122|2017-10-11 01:04:38.449122
NCT01990534|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-03-23|2017-03-23||March 2014||2014-03-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|March 2016|Actual|2016-03-01||Interventional||Safety population included all enrolled participants who received at least 1 dose of brentuximab vedotin.|A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma|A Single-arm Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin Lymphoma Who Are Not Suitable for Stem Cell Transplantation or Multiagent Chemotherapy|Active, not recruiting||Phase 4|60|Actual|Takeda||1|||f||||f||||||||||2017-10-11 01:04:38.621329|2017-10-11 01:04:38.621329
NCT01990521|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Prostate Screening Study Using MRI in BRCA Carriers|Screening Male BRCA Mutation Carriers: Effectiveness of Multispectral 3T Magnetic Resonance Imaging|Recruiting||N/A|60|Anticipated|Toronto Sunnybrook Regional Cancer Centre||1|||f||||f||||||||||2017-10-11 01:04:39.707305|2017-10-11 01:04:39.707305
NCT01990508|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-10-02|||January 2014||2014-01-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Randomized Trial of Financial Incentives to Reduce Sugar-sweetened Beverage Purchases by Low-income, Latino Families|Randomized Trial of Financial Incentives to Reduce Sugar-sweetened Beverage Purchases by Low-income, Latino Families|Completed||N/A|216|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:04:39.805012|2017-10-11 01:04:39.805012
NCT01990495|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-06-22|||November 1, 2013|Actual|2013-11-01|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|PERFECT||Exercise to Prevent Muscle Mass and Functional Loss in Elderly Dialysis Patients|Exercise to Prevent Muscle Mass and Functional Loss in Elderly Dialysis Patients|Recruiting||Early Phase 1|46|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 01:04:39.88727|2017-10-11 01:04:39.88727
NCT01990482|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2016-04-21|||November 2013||2013-11-01|November 2013|2013-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Influence of Coffee Intake on Postoperative Bowel Function After Comprehensive Staging Surgery for Gynecological Malignancies: A Randomized Controlled Trial.||Completed||N/A|118|Actual|Erzincan Military Hospital||2|||f||||||||||||||2017-10-11 01:04:40.000583|2017-10-11 01:04:40.000583
NCT01990469|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-04-18|||January 2014||2014-01-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin||Completed||Phase 3|219|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 01:04:40.124434|2017-10-11 01:04:40.124434
NCT01990456|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-11-05|||September 2014||2014-09-01|November 2014|2014-11-01||||December 2015|Anticipated|2015-12-01||Interventional|SOLVE ARDS||Strategies for Optimal Lung Ventilation in ECMO for ARDS: The SOLVE ARDS Study|Strategies for Optimal Lung Ventilation in ECMO for ARDS: The SOLVE ARDS Study|Unknown status|Recruiting|N/A|20|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-11 01:04:40.203529|2017-10-11 01:04:40.203529
NCT01990443|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-03-27|||June 2013||2013-06-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Absolute Bioavailability of Reslizumab in Healthy Subjects|A Randomized, Open-Label, Parallel-Group, Single-Dose Study to Characterize the Absolute Bioavailability of Reslizumab (220 mg) Following Subcutaneous Administration to Healthy Subjects|Completed||Phase 1|75|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 01:04:40.322315|2017-10-11 01:04:40.322315
NCT01990430|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2014-01-12|||January 2013||2013-01-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|BHVBC||Behavioural Changes in Breast Cancer Patients|Integrative Exercise and Life Style Intervention Increase Leisure Time Activity in Breast Cancer Patients.|Unknown status|Recruiting|N/A|60|Anticipated|Universidad Politecnica de Madrid||2|||f||||t||||||||||2017-10-11 01:04:40.430753|2017-10-11 01:04:40.430753
NCT01990417|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2013-11-14|||December 2010||2010-12-01|November 2013|2013-11-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|EPSHF||Evaluation of Passive Stretching in the Hamstrings Flexibility|Evaluation of Passive Stretching in the Hamstrings Flexibility of Who Practice Exercises|Completed||N/A|1|Actual|Fortaleza University||1|||f||||t||||||||||2017-10-11 01:04:40.580719|2017-10-11 01:04:40.580719
NCT01990404|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-05-17|||July 2013||2013-07-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|MEOPA-PA||Efficacy of Premixed Nitrous Oxide and Oxygen in Elderly Patient With Out-of-hospital Severe Acute Pain|Efficacy of Premixed Nitrous Oxide and Oxygen in Elderly Patient With Out-of-hospital Severe Acute Pain: a Randomized Double-blind Study|Terminated||Phase 2/Phase 3|43|Actual|University Hospital, Toulouse||2||inadequate recruitment|f||||f||||||||||2017-10-11 01:04:40.670956|2017-10-11 01:04:40.670956
NCT01990391|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2013-11-20|||September 2011||2011-09-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities|Effect of Brazil Nut Consumption in the Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities in Hypertensive and Dyslipidemic Subjects|Completed||N/A|125|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 01:04:40.786237|2017-10-11 01:04:40.786237
NCT01990378|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-11-15||||||November 2013|2013-11-01||||September 2010|Actual|2010-09-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fasted Conditions|An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Rabeprazole Sodium Delayed Release Tablets 20 mg (Test, Torrent Pharmaceuticals Limited., India) Versus Aciphex® (Rabeprazole Sodium) Delayed Release Tablets 20 mg (Reference, Eisai Inc., USA) in Healthy Human Volunteers Under Fasting Condition.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 01:04:40.868455|2017-10-11 01:04:40.868455
NCT01990365|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-10-18|||January 2012||2012-01-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||The Influence of Vertebral Mobility on Low Back Pain in Patients With Acute Osteoporotic Vertebral Fractures|The Influence of Vertebral Mobility on Low Back Pain in Patients With Acute Osteoporotic Vertebral Fractures|Recruiting||N/A|300|Anticipated|Tomidahama Hospital|||1||f||||f||||||||||2017-10-11 01:04:40.948256|2017-10-11 01:04:40.948256
NCT01990352|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-05-23|||November 5, 2013|Actual|2013-11-05|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Correlate BRCA1 Protein Expression With Response to DNA Damaging Chemotherapy|A Single Arm Phase II Trial to Assess Association of BRCA1 Protein Expression With Overall Response Rate in Patients With Metastatic Breast Cancer on Pegylated Liposomal Doxorubicin|Suspended||Phase 2|50|Anticipated|University of Arizona||1||"PI has halted accrual and is currently re-evaluating the study to determine if study   recruitment/enrollment should continue."|f||||t||||||||||2017-10-11 01:04:41.144683|2017-10-11 01:04:41.144683
NCT01990339|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-09-23|2014-11-04||December 2008||2008-12-01|September 2016|2016-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|LEGEND|Efficacy analysis set included all enrolled participants with data available (8 patents were excluded for medical reasons; 41 were excluded for other reasons), 1402 patients who did not visit the study site after initial prescription and 861 patients whose questionnaires were not reviewed at either Week 2 or Week 4 were also excluded.|Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms|"Takepron Specified Drug-use Survey Gastroesophageal Reflux Disease With Dyspepsia Symptoms"|Completed||N/A|14965|Actual|Takeda|There were no control groups in this single-arm study. The observed subjective symptom improvement rates and frequency of adverse drug reactions may be used in an exploratory manner to understand drug use but cannot be treated as verified results.||1||f||||f||||||||||2017-10-11 01:04:41.235868|2017-10-11 01:04:41.235868
NCT01990326|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-02-26|||November 2013||2013-11-01|July 2014|2014-07-01||||June 2014|Actual|2014-06-01||Interventional|||Safety and Feasibility Study of XAF5 Gel for Reduction of Submental Fat|A Phase 2a, Randomized, Double-blind, Placebo-controlled Study of XAF5 Gel for Reduction of Submental Fat|Suspended||Phase 2|27|Actual|Topokine Therapeutics, Inc.||2||Feasibility cohorts competed. Efficacy cohort not initiated for business reasons|f||||f||||||||||2017-10-11 01:04:41.588312|2017-10-11 01:04:41.588312
NCT01990313|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-01-09|||October 2013||2013-10-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|BrainRadio||Neural Signatures of Parkinson's Disease|Neural Signatures of Tremor, Bradykinesia and Freezing in the Subthalamic Region on Parkinson's Disease and Their Acute and Long-Term Modulation by Subthalamic Deep Brain Stimulation.|Completed||N/A|10|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 01:04:41.649957|2017-10-11 01:04:41.649957
NCT01990300|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-07-23|||November 28, 2011|Actual|2011-11-28|July 2017|2017-07-01|March 31, 2015|Actual|2015-03-31|March 31, 2015|Actual|2015-03-31||Observational|||Alogliptin/Pioglitazone (Liovel) Liovel Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus|Long-term Use of Alogliptin/Pioglitazone Combination Tablets in Patients With Type 2 Diabetes Mellitus|Completed||N/A|3281|Actual|Takeda|||1||f||||f||||||||||2017-10-11 01:04:41.807554|2017-10-11 01:04:41.807554
NCT01990274|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-11-24|||October 2013||2013-10-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|XACT||The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa|The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa- a Randomized Controlled Trial (XACT)|Completed||N/A|875|Actual|University of Cape Town||2|||f||||t||||||||||2017-10-11 01:04:42.05991|2017-10-11 01:04:42.05991
NCT01990261|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-08-08|2016-06-17||May 2013||2013-05-01|June 2016|2016-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|STAR|Analysis was performed on all enrolled participants.|A Study to Assess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy Treatment|The Survival of Non-Small Cell Lung Carcinoma EGFR Non-mutated (Wild Type) Patients Treated With Erlotinib (TARceva) After the Failure of at Least One Chemotherapy Regimen|Terminated||N/A|33|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:04:42.182096|2017-10-11 01:04:42.182096
NCT01990248|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2017-09-26|||March 23, 2013|Actual|2013-03-23|September 2017|2017-09-01|July 26, 2016|Actual|2016-07-26|July 26, 2016|Actual|2016-07-26||Observational|||An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)|ZeSS: A Prospective Observational Safety Study of Patients With BRAF-V600 Mutation-positive Unresectable or Metastatic Melanoma Treated With Vemurafenib (Zelboraf®)|Completed||N/A|339|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:04:42.653222|2017-10-11 01:04:42.653222
NCT01990235|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-05-22|||January 2013||2013-01-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|PREPARE||Improving Advance Care Planning by Preparing Diverse Seniors for Decision Making|Improving Advance Care Planning by Preparing Diverse Seniors for Decision Making|Recruiting||N/A|500|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:04:42.941729|2017-10-11 01:04:42.941729
NCT01990222|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Leveraging Mobile Health Technology to Optimize Early Stimulant Medication Treatment: A Feasibility Pilot|Leveraging Mobile Health Technology to Optimize Early Stimulant Medication Treatment: A Feasibility Pilot|Recruiting||N/A|30|Anticipated|University of California, Los Angeles|||1||f||||f||||||||||2017-10-11 01:04:43.070975|2017-10-11 01:04:43.070975
NCT01990209|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-06-08|||March 2014||2014-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)|A Phase II Study With Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)|Recruiting||Phase 2|86|Anticipated|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 01:04:43.188079|2017-10-11 01:04:43.188079
NCT01990196|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-09-07|||September 23, 2014|Actual|2014-09-23|September 2016|2016-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer|Randomized, Open-label, Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With and Without SRC or MEK Inhibition on the Development of EMT in Prostate Cancer|Recruiting||Phase 2|45|Anticipated|Jonsson Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 01:04:43.355291|2017-10-11 01:04:43.355291
NCT01990183|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-02-11|||July 2013||2013-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|CareToy||CareToy - A Modular Smart System for Infants' Rehabilitation at Home Based on Mechatronic Toys|CareToy - A Modular Smart System for Infants' Rehabilitation at Home Based on Mechatronic Toys|Completed||N/A|44|Actual|IRCCS Fondazione Stella Maris||2|||f||||t||||||||||2017-10-11 01:04:43.512142|2017-10-11 01:04:43.512142
NCT01990170|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-08-18|||November 2013||2013-11-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Longterm Outcomes of Venous Ulcers After Foam Sclerotherapy|Long-term Healing and Recurrence of Chronic Venous Ulcerations Following Ultrasound-guided Foam Sclerotherapy|Completed||N/A|67|Actual|Heart of England NHS Trust|||1||f||||f||||||||||2017-10-11 01:04:43.628811|2017-10-11 01:04:43.628811
NCT01990157|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-02-27|||November 2013|Actual|2013-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2015|Actual|2015-12-01||Interventional|||Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis|Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis in Which Methotrexate (MTX) Treatment is Not Effective|Completed||Phase 1/Phase 2|18|Actual|Theramab LLC||1|||f||||f||||||||||2017-10-11 01:04:43.720463|2017-10-11 01:04:43.720463
NCT01990144|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-11-15|||November 2011||2011-11-01|November 2013|2013-11-01|February 2016|Anticipated|2016-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL|Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma: a Phase II Multicenter Study of the Fondazione Italiana Linfomi (FIL)|Unknown status|Recruiting|Phase 2|49|Anticipated|Fondazione Italiana Linfomi ONLUS||1|||f||||t||||||||||2017-10-11 01:04:43.833255|2017-10-11 01:04:43.833255
NCT01990131|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-08-08|||October 2013||2013-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|CATS||Computerized Anxiety Treatment for Suicide|Suicide Risk Prevention Among Patients With Anxiety Psychopathology|Completed||N/A|74|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 01:04:44.098277|2017-10-11 01:04:44.098277
NCT01990118|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-04|2013-11-15|||November 2004||2004-11-01|November 2013|2013-11-01|May 2006|Actual|2006-05-01|December 2005|Actual|2005-12-01||Interventional|||Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients|A Randomized, Multi-center, Open Label Trial to Establish the Therapeutic Equivalence Between Neoral® and Gengraf® in Stable Renal Allograft Recipients [Gengraf Conversion Study]|Completed||Phase 4|106|Actual|Penang Hospital, Malaysia||2|||f||||t||||||||||2017-10-11 01:04:44.19958|2017-10-11 01:04:44.19958
NCT01990105|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-03-06|||November 2013||2013-11-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Observational|FinFib2||Treatment of Atrial Fibrillation in Finland|Treatment of Atrial Fibrillation in Finland - the FinFib 2 Study|Completed||N/A|1013|Actual|Finnish Cardiac Society|||1||f||||f||||||||||2017-10-11 01:04:44.318513|2017-10-11 01:04:44.318513
NCT01990092|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2016-01-15|||November 2013||2013-11-01|January 2016|2016-01-01|March 2018|Anticipated|2018-03-01|August 2016|Anticipated|2016-08-01||Interventional|MEDIAN||The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy|Active, not recruiting||N/A|238|Actual|Pamlab, Inc.||2|||f||||f||||||||||2017-10-11 01:04:44.459287|2017-10-11 01:04:44.459287
NCT01990079|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-09-15|||December 2013||2013-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|QUIT4EVER||Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD|Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD|Completed||N/A|15|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:04:44.647818|2017-10-11 01:04:44.647818
NCT01990066|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-12-23|||March 2014||2014-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Home Based Exercise Program for Elderly Cancer Patients|Single Institution Randomized Controlled Study of a Home Based Exercise Program to Reduce Functional Decline, Cancer Related Fatigue (CRF and Improve Quality of Life for the Elderly Gynecologic Oncology Patient)|Terminated||N/A|8|Actual|Duke University||2||Difficulty recruiting adequate enrollment|f||||t||||||||||2017-10-11 01:04:44.764862|2017-10-11 01:04:44.764862
NCT01990053|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-02-13|||April 2014||2014-04-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Pilot Study Assessing Computerized Cognitive Behavioral Therapy for Depression|Pilot Study Assessing Computerized Cognitive Behavioral Therapy for Depression|Active, not recruiting||N/A|128|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 01:04:44.86245|2017-10-11 01:04:44.86245
NCT01990040|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-01-05|||June 2014||2014-06-01|January 2017|2017-01-01|December 2029|Anticipated|2029-12-01|December 2028|Anticipated|2028-12-01|10 Years|Observational [Patient Registry]|||A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome|A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome|Recruiting||N/A|1310|Anticipated|Shire|||2||f||||f||||||||||2017-10-11 01:04:44.994308|2017-10-11 01:04:44.994308
NCT01990027|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-10-06|||April 2014||2014-04-01|October 2015|2015-10-01|April 2024|Anticipated|2024-04-01|April 2024|Anticipated|2024-04-01|10 Years|Observational [Patient Registry]|SKSC||Swiss Kidney Stone Cohort (SKSC)|Swiss Kidney Stone Cohort (SKSC)|Recruiting||N/A|3000|Anticipated|The Swiss National Centre of Competence in Research Kidney Control of Homeostasis|||1||f||||t||||||Samples With DNA|"     Whole blood; serum; urine   "|||2017-10-11 01:04:45.612788|2017-10-11 01:04:45.612788
NCT01990014|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-11-15|||June 2011||2011-06-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Observational|||Craniectomy Protocol|Multicenter Clinical Study Evaluating the Functional Prognosis and Quality of Life at Least 2 Years in Patients Treated With Decompressive Craniectomy for Malignant Sylvian Ischemic Stroke|Completed||N/A|62|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 01:04:45.749823|2017-10-11 01:04:45.749823
NCT01990001|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-09-22|||August 2012||2012-08-01|November 2013|2013-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Randomized Trial of Provider‐Assisted Versus Patient‐Initiated Enrollment in the Bedsider.Org Online Contraceptive Reminder Tool|Randomized Trial of Provider‐Assisted Versus Patient‐Initiated Enrollment in the Bedsider.Org Online Contraceptive Reminder Tool|Completed||N/A|118|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:04:45.834257|2017-10-11 01:04:45.834257
NCT01989988|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-11-15|||January 2013||2013-01-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|DMBSS||DMBSS-A Randomized Trial of Different Laparoscopic Gastric Bypass Surgery in Patients With Obesity-related T2DM|A Randomized Trial Study of Different Laparoscopic Gastric Bypass Surgery in Patients With Obesity-related T2DM|Unknown status|Active, not recruiting|N/A|60|Anticipated|Min-Sheng General Hospital||3|||f||||t||||||||||2017-10-11 01:04:45.947126|2017-10-11 01:04:45.947126
NCT01989975|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-11-15|||May 2013||2013-05-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||CareLink Connect - Technical Evaluation Study|A Multi-center, Non-randomized Study in Subjects With Diabetes Mellitus Treated With Sensor-Augmented Pump Therapy to Evaluate the Performance and Safety of CareLink Connect Transferring Pump Data to Web Connected Devices Via CareLink|Completed||N/A|40|Actual|Medtronic|||1||f||||f||||||||||2017-10-11 01:04:46.047825|2017-10-11 01:04:46.047825
NCT01989962|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-10-13|||February 2014||2014-02-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|June 2016|Anticipated|2016-06-01||Interventional|E4E||E4E-Health Professional Education for Improving Care for Canadian Aboriginal Populations|Phase 2: Evaluation of Education for Equity (E4E)--Exploring How Health Professional Education Can Reduce Disparities in Chronic Disease Care and Improve Outcomes for Indigenous Populations|Unknown status|Active, not recruiting|Phase 2|860|Anticipated|Queen's University||2|||f||||f||||||||||2017-10-11 01:04:46.209373|2017-10-11 01:04:46.209373
NCT01989949|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-11-20|||November 2012||2012-11-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|BAL||Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women|Phase 1, Open-Label, Safety and Pharmacokinetic Study to Assess Bronchopulmonary Disposition of Intravenous TP-434 in Healthy Men and Women|Completed||Phase 1|20|Actual|Tetraphase Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 01:04:46.382044|2017-10-11 01:04:46.382044
NCT01989936|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-20|||January 1999||1999-01-01|November 2013|2013-11-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan|A Multicenter, Double - Blind, Randomized, Placebo - Controlled Parallel Group Study of the Efficacy and Safety of Oral Eletriptan (40 and 80mg) Given for the Treatment of Acute Migraine in Subjects Discontinued From Oral Sumatriptan|Completed||Phase 3|446|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 01:04:46.525204|2017-10-11 01:04:46.525204
NCT01989923|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-04-14|||June 2013|Actual|2013-06-01|April 2017|2017-04-01|April 13, 2017|Actual|2017-04-13|April 13, 2017|Actual|2017-04-13||Interventional|||Smoking Cessation in Women With Gynecological Conditions|Immediate Smoking Cessation for Patients at Risk for Cervical Dysplasia, Cervical Cancer and Lower Genital Tract Dysplasia and Cancer - A Feasibility Study Comparing Nicotine Replacement Therapy With the Electronic Nicotine Delivery System.|Completed||N/A|31|Actual|University of Oklahoma||2|||f||||f||||||||||2017-10-11 01:04:46.812383|2017-10-11 01:04:46.812383
NCT01989910|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-01-05|||September 2013||2013-09-01|November 2013|2013-11-01||||December 2015|Actual|2015-12-01||Interventional|||Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients|An Open Label, Randomized, Parallel Design Estimation Pilot Study to Compare the Efficacy and Safety of Raltegravir-based Versus Efavirenz-based Combination Therapy in Treatment-naïve Patients With HIV-1 Infection|Completed||Phase 4|107|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-11 01:04:46.932966|2017-10-11 01:04:46.932966
NCT01989897|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-11-15|||March 2013||2013-03-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests|Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Ohio State University||1|||f||||t||||||||||2017-10-11 01:04:47.092585|2017-10-11 01:04:47.092585
NCT01989884|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-02-09|||November 2013||2013-11-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|Ortataxel||An Efficacy Study Of Ortataxel In Recurrent Glioblastoma|Multicenter, Single Arm, Open-Label Phase II Trial On The Efficacy Of Ortataxel In Recurrent Glioblastoma|Suspended||Phase 2|64|Anticipated|Mario Negri Institute for Pharmacological Research||1||the number of patients for the interim analysis was reached|f||||f||||||||||2017-10-11 01:04:47.220298|2017-10-11 01:04:47.220298
NCT01989871|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-14|||December 2013||2013-12-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Adjusted Individual Oral Feeding for Improving Short and Long Term Outcomes of Preterm Infants|Adjusted Individual Oral Feeding for Improving Short and Long Term Outcomes of Preterm|Unknown status|Not yet recruiting|N/A|60|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 01:04:47.351478|2017-10-11 01:04:47.351478
NCT01989663|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-07-26|||November 2013||2013-11-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|FAME 04||A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04|A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04|Completed||Phase 1|78|Actual|CONRAD||5|||f||||||||||||||2017-10-11 01:04:52.456824|2017-10-11 01:04:52.456824
NCT01989858|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-01-28|||November 2010||2010-11-01|July 2010|2010-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ITACA-S2||ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)|ITACA-S2(Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach:Comparison of the Efficacy of a Peri-operative Versus a Post-operative Chemotherapy Treatment in Patients With Operable Gastric Cancer and Assessment of the Benefit of a Post-operative Chemo-radiotherapy.|Terminated||Phase 3|1180|Actual|Mario Negri Institute for Pharmacological Research||4||lack of clinical cases|f||||t||||||||||2017-10-11 01:04:47.517102|2017-10-11 01:04:47.517102
NCT01989845|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-01-06|||October 2013||2013-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer|Prospective, Multicenter Study Investigating Efficacy and Safety of Oral Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism in Korean Patients With Cancers|Completed||Phase 4|127|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:04:47.714677|2017-10-11 01:04:47.714677
NCT01989832|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-15|||February 2013||2013-02-01|February 2013|2013-02-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Observational|EPHEGREN||Pharmaco-economical Study in Kidney Transplantation|Pharmaco-economical Study in Kidney Transplantation|Recruiting||N/A|1000|Anticipated|University Hospital, Limoges|||1||f||||f||||||||||2017-10-11 01:04:47.843066|2017-10-11 01:04:47.843066
NCT01989819|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-08-19|||September 2012||2012-09-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|September 2016|Anticipated|2016-09-01|12 Months|Observational [Patient Registry]|NeuroSenSS||Primary Sjögren Syndrome||Recruiting||N/A|55|Anticipated|University Hospital, Limoges|||3||f||||f||||||||||2017-10-11 01:04:47.941975|2017-10-11 01:04:47.941975
NCT01989806|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-08-10|||December 2013||2013-12-01|August 2014|2014-08-01|May 2015|Anticipated|2015-05-01|February 2015|Anticipated|2015-02-01||Interventional|||Robotic-assisted Locomotor Training on Mobility and Cardiopulmonary Function in Patients Suffering From Spinal Cord Injury|Investigation on the Effect of Robotic-assisted Body Weight Supported Treadmill Training on Walking and Cardiopulmonary Recovery in Patients Suffering From Incomplete Spinal Cord Injury|Unknown status|Recruiting|N/A|80|Anticipated|Kowloon Hospital, Hong Kong||2|||f||||f||||||||||2017-10-11 01:04:48.134774|2017-10-11 01:04:48.134774
NCT01989793|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-03-13|||July 2013|Actual|2013-07-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study of Muscle Strength Maintenance in Older Adults|A Study of Muscle Strength Maintenance in Older Adults|Completed||Phase 2|37|Actual|Johns Hopkins University||2|||f||||t||||||||Undecided||2017-10-11 01:04:48.257113|2017-10-11 01:04:48.257113
NCT01989780|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-04-18|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|BOOSTER||Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer|Bevacizumab Plus Paclitaxel Optimization Study With Interventional Maintenance Endocrine Therapy in Advanced or Metastatic ER-positive HER2-negative Breast Cancer -BOOSTER Trial, a Multicenter Randomized Phase II Study-|Active, not recruiting||Phase 2|160|Anticipated|Japan Breast Cancer Research Group||2|||f||||t||||||||No||2017-10-11 01:04:48.380895|2017-10-11 01:04:48.380895
NCT01989767|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2013-11-20|||November 2011||2011-11-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2012|Actual|2012-10-01||Interventional|PKRW||Application of Psychiatric Knowledge in the Rehabilitation Process in Return to Work.|Application of Psychiatric Knowledge in the Rehabilitation Process in Return to Work.|Completed||N/A|317|Actual|Region MidtJylland Denmark||2|||f||||t||||||||||2017-10-11 01:04:48.516355|2017-10-11 01:04:48.516355
NCT01989754|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-07-10|||January 16, 2014|Actual|2014-01-16|July 2017|2017-07-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|CANVAS-R||A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus|A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|5813|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 01:04:48.63239|2017-10-11 01:04:48.63239
NCT01989728|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-14|||November 2004||2004-11-01|November 2013|2013-11-01|December 2010|Actual|2010-12-01|October 2005|Actual|2005-10-01||Interventional|PRW||Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence|Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence|Completed||N/A|1121|Actual|Region MidtJylland Denmark||2|||f||||f||||||||||2017-10-11 01:04:49.514785|2017-10-11 01:04:49.514785
NCT01989715|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2014-07-23|||October 2013||2013-10-01|July 2014|2014-07-01|May 2015|Anticipated|2015-05-01|November 2014|Anticipated|2014-11-01||Interventional|||Body Posture Assessment Considering Jaws Position Before and After Orthognathic Surgery on Adult Patient.|Body Posture Assessment Considering Jaws Position Before and After Orthognathic Surgery on Adult Patient.|Unknown status|Recruiting|N/A|27|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:04:51.217581|2017-10-11 01:04:51.217581
NCT01989702|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-14|||October 2010||2010-10-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effect of a Probiotic-based Product on Blood Pressure|The Effect of a Probiotic-based Product on Blood Pressure and Other Known Risk Factors Linked to Cardiovascular Diseases.|Completed||N/A|142|Actual|Probi AB||3|||f||||||||||||||2017-10-11 01:04:51.297887|2017-10-11 01:04:51.297887
NCT01989689|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2014-12-12|2014-12-12||August 2010||2010-08-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|EVIP||Etanercept and Vascular Function in Psoriasis|Etanercept and Vascular Function in Psoriasis|Completed||Phase 2|24|Actual|Emory University||2|||f||||t||||||||||2017-10-11 01:04:51.391897|2017-10-11 01:04:51.391897
NCT01989650|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-02-12|||February 2012||2012-02-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The Effect of Taking Break During Colonoscopy Session on Adenoma Detection, a Prospective, Randomized Control Study|The Effect of Taking Break During Colonoscopy Session on Adenoma Detection, a Prospective, Randomized Control Study|Completed||N/A|1379|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:04:52.55639|2017-10-11 01:04:52.55639
NCT01989637|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-05-26|||July 2013||2013-07-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Strawberries on Cardiovascular Disease Risk|Effects of a Freeze Dried Strawberry Powder on Postprandial Vascular Function and Blood Markers of Cardiovascular Risk|Completed||N/A|34|Actual|Penn State University||2|||f||||f||||||||||2017-10-11 01:04:52.642758|2017-10-11 01:04:52.642758
NCT01989624|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-01-10|||October 2013||2013-10-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2015|Actual|2015-12-01||Observational|APACH||PAncreatic Adenocarcinoma in Hospital|PAncreatic Adenocarcinoma in Hospital|Active, not recruiting||N/A|1204|Actual|Centre Hospitalier Departemental Vendee|||1||f||||f||||||||||2017-10-11 01:04:52.732128|2017-10-11 01:04:52.732128
NCT01989611|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-10-07|||June 2014||2014-06-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|PrEPBrasil||Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.|Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.|Unknown status|Active, not recruiting|N/A|400|Anticipated|Oswaldo Cruz Foundation||1|||f||||f||||||||||2017-10-11 01:04:52.926276|2017-10-11 01:04:52.926276
NCT01989585|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2017-09-12|||October 25, 2013|Actual|2013-10-25|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|Phase I/II Study of Dabrafenib, Trametinib, and Navitoclax in BRAF Mutant Melanoma and Other Solid Tumors|Recruiting||Phase 1/Phase 2|68|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 01:04:53.247311|2017-10-11 01:04:53.247311
NCT01989572|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-07-30|2014-07-22||December 1999||1999-12-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional||All patients regardless of eligibility and treatment status|Sargramostim and/or Vaccine Therapy in Preventing Disease Recurrence in Patients With Advanced Melanoma|"A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma"|Completed||Phase 3|815|Actual|National Cancer Institute (NCI)||6|||f||||t||||||||||2017-10-11 01:04:53.491568|2017-10-11 01:04:53.491568
NCT01989559|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-18|2015-01-23|||October 2002||2002-10-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery|A Pilot Study to Assess the Immunologic Response to Booster Vaccination With a Modified gp100 Melanoma Peptide (209-2M) Vaccine in Previously Vaccinated HLA-A2.1+ Patients With Melanoma|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 01:04:54.892843|2017-10-11 01:04:54.892843
NCT01989546|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-16|2017-09-12|||November 8, 2013||2013-11-08|June 13, 2017|2017-06-13|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Interventional|||Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations|Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations|Completed||Phase 1/Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:04:54.987033|2017-10-11 01:04:54.987033
NCT01989533|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-19|2017-09-12|||October 30, 2013||2013-10-30|August 31, 2017|2017-08-31|February 1, 2020|Anticipated|2020-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers|Phase I Study of Safety and Immunogenicity of Ad4-HIV Vaccine Vectors in Healthy Volunteers|Recruiting||Phase 1|440|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:04:55.088511|2017-10-11 01:04:55.088511
NCT01989520|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-06-24|||January 2014||2014-01-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study to Investigate Relative Bioavailability of up to Five Different Formulations of AZD5069|An Open-label, Single Centre Relative Bioavailability Study With an Adaptive Design Comparing up to 5 Solid Oral AZD5069 Formulations After Single Dose Administration to Healthy Volunteers|Completed||Phase 1|36|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 01:04:55.174698|2017-10-11 01:04:55.174698
NCT01989507|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-08-25|||April 2014|Actual|2014-04-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|January 2019|Anticipated|2019-01-01||Interventional|VLNC||Very Low-Nicotine Cigarettes in Smokers With SUD|Very Low-Nicotine Cigarettes in Smokers With SUD: Smoking, Substance Use Effects|Recruiting||Phase 2|250|Anticipated|Brown University||2|||f||||f||||||||||2017-10-11 01:04:55.266653|2017-10-11 01:04:55.266653
NCT01989494|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2016-08-12|||November 2013||2013-11-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Study of the Physical Activity in Anesthesiologists|Evaluation of the Physical Activity Associated With Clinical Work in Anesthesia Residents and Attendings|Completed||N/A|45|Anticipated|Brigham and Women's Hospital|||3||f||||f||||||||||2017-10-11 01:04:55.383556|2017-10-11 01:04:55.383556
NCT01989481|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-03-23|||November 2013||2013-11-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Observational|||Predicting the Outcome of Total Knee Arthroplasty and Spinal Surgeon|Prospective Study of Risk Factors and Outcomes Following Total Knee Arthroplasty and Spinal Surgeon|Unknown status|Recruiting|N/A|2000|Anticipated|Beijing Jishuitan Hospital|||1||f||||f||||||Samples With DNA|"     Blood samples collected from Peripheral Venous Blood； Tissues collected from the operation   "|||2017-10-11 01:04:55.475097|2017-10-11 01:04:55.475097
NCT01988727|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-04-14|||April 2014||2014-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:05:06.14152|2017-10-11 01:05:06.14152
NCT01989468|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-02-10|||April 10, 2014|Actual|2014-04-10|February 2017|2017-02-01|January 22, 2018|Anticipated|2018-01-22|January 22, 2018|Anticipated|2018-01-22||Interventional|||24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis|A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3 Years in Subjects With Active Psoriatic Arthritis|Active, not recruiting||Phase 3|414|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:04:55.657702|2017-10-11 01:04:55.657702
NCT01989455|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2014-12-04|2014-11-28||November 2013||2013-11-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Healthy volunteers|A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers|A Single Center, Phase I, Double-blind, Placebo-controlled Evaluation of the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Deferiprone Administered by Intravenous Infusion to Healthy Male and Female Volunteers|Completed||Phase 1|64|Actual|ApoPharma||4|||f||||t||||||||||2017-10-11 01:04:55.947437|2017-10-11 01:04:55.947437
NCT01989442|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2015-01-14|||November 2013||2013-11-01|January 2015|2015-01-01|January 2015|Anticipated|2015-01-01|June 2014|Actual|2014-06-01||Interventional|NIV||Nasal Mask and Prong Use in Non-invasive Ventilation for Newborns|Efficacy and Safety of Nasal Mask and Prong Use in Non-invasive Ventilation for Newborns|Unknown status|Recruiting|N/A|100|Anticipated|Ankara University||2|||f||||t||||||||||2017-10-11 01:04:57.627984|2017-10-11 01:04:57.627984
NCT01989429|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-12-01||2015-12-01|October 2013||2013-10-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients|A Randomized, Double-blind, Parallel Group Phase III Multi-center Trial to Compare Twice Daily Topical Application of M518101, Daivonex® and Vehicle in Patients With Plaque Psoriasis III|Completed||Phase 3|788|Actual|Maruho Europe Limited||3|||f||||f||||||||||2017-10-11 01:04:57.757292|2017-10-11 01:04:57.757292
NCT01989416|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2015-11-30|||December 2013||2013-12-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Effectiveness of Chlorhexidine Wipe for Prevention of Multidrug-resistant Organisms in Intensive Care Unit Patients|Effectiveness of Chlorhexidine Wipe for Prevention of Multidrug-resistant Organisms in Intensive Care Unit Patients|Completed||Phase 3|481|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 01:04:57.885719|2017-10-11 01:04:57.885719
NCT01989403|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-14|||February 2006||2006-02-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|August 2012|Actual|2012-08-01|5 Years|Observational [Patient Registry]|||Alternative and Integrative Therapy for Lumbar Disk Herniation|The Long-term Course of Patients Undergoing Alternative and Integrative Therapy for Lumbar Disk Herniation: A Prospective Observational Study|Completed||N/A|128|Actual|Jaseng Hospital of Korean Medicine|||1||f||||t||||||||||2017-10-11 01:04:58.006424|2017-10-11 01:04:58.006424
NCT01989390|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-14|||September 2013||2013-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:04:58.127765|2017-10-11 01:04:58.127765
NCT01989377|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-14|||October 2013||2013-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:04:58.171997|2017-10-11 01:04:58.171997
NCT01989364|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-15|2013-11-15|||January 2011||2011-01-01|November 2013|2013-11-01|January 2018|Anticipated|2018-01-01|February 2016|Anticipated|2016-02-01|1 Day|Observational [Patient Registry]|IMAP||Repetitive Functional Imaging in Locally Advanced Cervical Cancer|Multicenter Validation of Repetitive Functional Imaging in Locally Advanced Cervical Cancer|Recruiting||N/A|50|Anticipated|Aarhus University Hospital|||1||f||||t||||||||||2017-10-11 01:04:58.229651|2017-10-11 01:04:58.229651
NCT01989351|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-02-06|||March 2013||2013-03-01|February 2017|2017-02-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Observational|||Predisposition to Persistent Pain After Orthopaedic Surgery: Genetic Aspects|LA PREDISPOSIZIONE AL DOLORE PERSISTENTE POST OPERATORIO IN AMBITO ORTOPEDICO: ASPETTI GENETICI|Completed||N/A|130|Anticipated|ASST Gaetano Pini-CTO|||2||f||||f||||||Samples Without DNA|"     Blood plasma   "|||2017-10-11 01:04:58.365669|2017-10-11 01:04:58.365669
NCT01989338|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-11-14|||March 2012||2012-03-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Observational|||Effects of Hallux Valgus Deformity on Rear Foot Position, Pain, Function, and Quality of Life in Women|Effects of Hallux Valgus Deformity on Rear Foot Position, Pain, Function, and Quality of Life in Women|Completed||N/A|27|Actual|Hacettepe University|||1||f||||f||||||||||2017-10-11 01:04:58.484696|2017-10-11 01:04:58.484696
NCT01989325|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-07-27||2016-04-15|November 2013||2013-11-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma||Completed||Phase 2|77|Actual|Array BioPharma||2|||f||||f||||||||||2017-10-11 01:04:58.650704|2017-10-11 01:04:58.650704
NCT01989299|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-05-17|||October 2014||2014-10-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|2 Years|Observational [Patient Registry]|VIP-HF||Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients With Heart Failure and Preserved Ejection Fraction|Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients With Heart Failure and Preserved Ejection Fraction (VIP-HF)|Enrolling by invitation||Phase 2|250|Anticipated|University Medical Center Groningen|||1||f||||t||||||||||2017-10-11 01:04:58.965892|2017-10-11 01:04:58.965892
NCT01989286|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-11-01|||November 2013||2013-11-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Postural Assessment in Plagiocephaly|Postural Assessment in Children With Non-synostotic Plagiocephaly|Completed||N/A|104|Actual|Universidad de Granada|||1||f||||t||||||||Undecided||2017-10-11 01:04:59.109447|2017-10-11 01:04:59.109447
NCT01989273|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-02-04|||August 2012||2012-08-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Observational|||Detection and Management of Non‐Compressible Hemorrhage by Vena Cava Ultrasonography|Detection and Management of Non‐Compressible Hemorrhage by Vena Cava Ultrasonography|Recruiting||N/A|400|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-10-11 01:04:59.225203|2017-10-11 01:04:59.225203
NCT01989260|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2013-11-14|||December 2013||2013-12-01|November 2013|2013-11-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Post-operative Ovarian Adhesion Study in Women With Endometriosis|Effectiveness of Anti-adhesive Gel in Preventing Post Operative Ovarian Adhesions in Women With Pelvic Endometriosis: A Double Blind Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|50|Anticipated|University College London Hospitals||1|||f||||t||||||||||2017-10-11 01:04:59.333246|2017-10-11 01:04:59.333246
NCT01989247|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-03-07|||June 2013||2013-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|September 2014|Actual|2014-09-01||Interventional|||How to Cope With Anxiety and Depression. A Randomized Controlled Trial.|Self-management of Depression and Anxiety. A Randomized Controlled Trial.|Completed||N/A|853|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:04:59.444098|2017-10-11 01:04:59.444098
NCT01989234|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-12-03||2014-12-03|October 2013||2013-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation||Completed||Phase 2|334|Actual|SK Life Science||4|||f||||t||||||||||2017-10-11 01:04:59.825053|2017-10-11 01:04:59.825053
NCT01989221|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-05-11|||November 2012||2012-11-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Sancuso® for Gastroparesis: An Open Label Study.|Sancuso® in Patients With Nausea and/or Vomiting From Gastroparesis: An Open Label Study.|Unknown status|Recruiting|Phase 3|40|Anticipated|Temple University||2|||f||||t||||||||||2017-10-11 01:05:00.088018|2017-10-11 01:05:00.088018
NCT01989195|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-11-03|2015-09-01||May 2013||2013-05-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease|Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease|Completed||Phase 1/Phase 2|6|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 01:05:00.299686|2017-10-11 01:05:00.299686
NCT01989182|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-05-02|||September 2013|Actual|2013-09-01|January 2017|2017-01-01|March 2017|Actual|2017-03-01|May 2016|Actual|2016-05-01||Interventional|SVS||The Spiration Valve System for the Treatment of Severe Emphysema|The Spiration Valve System for the Treatment of Severe Emphysema|Completed||N/A|101|Actual|Spiration, Inc.||2|||f||||f||||||||||2017-10-11 01:05:00.62337|2017-10-11 01:05:00.62337
NCT01989169|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2014-12-16|2014-12-16||November 2013||2013-11-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects|A Phase 1, Randomized, Open Label, Crossover Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Shire||2|||f||||||||||||||2017-10-11 01:05:00.760921|2017-10-11 01:05:00.760921
NCT01989156|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-02-17|2016-12-21||December 2013||2013-12-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional||"Study population = all randomized subjects who had at least one post randomization product use experience and at least one valid biomarker of exposure measurement.
160 randomized subjects: 80 in mTHS 2.2, 41 in mCC and 39 in SA arms"|Reduced Exposure Study Using THS 2.2 Menthol (5 Days in a Confinement Setting, Then 86 Days in an Ambulatory Setting)|A Randomized, Controlled, Multi-center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Smokers Switching to THS 2.2 Menthol or Smoking Abstinence Compared to Smoking Menthol Conventional Cigarettes, for 91 Days|Completed||N/A|160|Actual|Philip Morris Products S.A.|Analysis of Primary Outcomes required data from the PP set at Baseline, Day 5 (MHBMA, 3-HPMA, S-PMA, and COHb), and Day 90 (Total NNAL). Differences in the number of participants for each outcome is due to missing data at baseline or at Day5/90.|3|||f||||f|f|f||||||No||2017-10-11 01:05:01.150342|2017-10-11 01:05:01.150342
NCT01989143|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-04-29|||December 2013||2013-12-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.|A Phase 1, Randomzied, Double-blind, Third-party Open Placebo-controlled, Dose Escalating Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Intravenous And Multiple Subcutaneous And Intravenous Doses Of Pf-06480605 In Healthy Subjects|Completed||Phase 1|92|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 01:05:01.951353|2017-10-11 01:05:01.951353
NCT01989130|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-03-10|2016-02-23||October 2013||2013-10-01|November 2013|2013-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED|Evaluation of the Cepheid Xpert CT/NG For Management of STI in the ED: Immediate V. Delayed Test Results|Completed||N/A|70|Actual|George Washington University||2|||f||||f||||||||||2017-10-11 01:05:02.136797|2017-10-11 01:05:02.136797
NCT01989117|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-05-01|||November 2013||2013-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Effectiveness of Osteopathy in the Preoperative Treatment of Postoperative Pain in Patients Undergoing Total Knee Replacement|Prospective Non-randomized Comparative Study Evaluating the Effectiveness of Osteopathy in the Preoperative Treatment of Postoperative Pain in Patients Undergoing Total Knee Replacement in Osteoarthritis Indication|Completed||N/A|70|Actual|Hospital Ambroise Paré Paris|||2||f||||||||||||||2017-10-11 01:05:02.509912|2017-10-11 01:05:02.509912
NCT01989104|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-04-20|||December 2013||2013-12-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Cadence and Intensity in Children and Adolescents (CADENCE-KIDS)|Cadence and Intensity in Children and Adolescents (CADENCE-KIDS)|Completed||N/A|150|Anticipated|Pennington Biomedical Research Center|||3||f||||f||||||||||2017-10-11 01:05:02.599402|2017-10-11 01:05:02.599402
NCT01988714|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-05-12|||September 2009||2009-09-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|SECT||Cognitive Remediation of Schizophrenia in a Community Mental Health Setting|Cognitive Remediation of Schizophrenia in a Community Mental Health Setting|Recruiting||N/A|120|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:05:06.186037|2017-10-11 01:05:06.186037
NCT01989091|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-02-24|||July 2012|Actual|2012-07-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy Study to Evaluate B-Lock™ as an Antimicrobial Lock Solution in Dialysis Patients With a CVC|Multi-Center, Prospective, Randomized, Open-Label, Sponsor-Blinded, Active-Control (Heparin) Clinical Investigation to Evaluate the Safety and Effectiveness of B-Lock™ as an Antimicrobial Catheter Lock Solution in Dialysis Patients With a Central Venous Catheter|Terminated||Phase 3|270|Actual|Great Lakes Pharmaceuticals Inc.||2||Did not meet predetermined primary endpoint|f||||t||||||||||2017-10-11 01:05:02.678057|2017-10-11 01:05:02.678057
NCT01989078|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-07-14|||December 2012||2012-12-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SCD-Losartan||Losartan for Sickle Cell Kidney Disease|Losartan Treatment for Sickle Cell Chronic Kidney Disease|Completed||Early Phase 1|24|Actual|Emory University||1|||f||||t|t|f||||||||2017-10-11 01:05:02.835119|2017-10-11 01:05:02.835119
NCT01989065|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-12-01|||September 2014||2014-09-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|HLP4U||Healthy Lifestyles Program for You (HLP4U): Augmenting Childhood Obesity Treatment.|Healthy Lifestyles Program for You (HLP4U): Augmenting Childhood Obesity Treatment Through Provider-to-parent Text Messaging.|Completed||N/A|101|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:05:02.956456|2017-10-11 01:05:02.956456
NCT01989052|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-08-02|||May 2014||2014-05-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|March 2015|Actual|2015-03-01||Interventional|||Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma|A Phase 1/2 Unblinded Trial of Carboxyamidotriazole Orotate (CTO) Alone or in Combination With Lomustine for Bevacizumab-Naïve Adult Patients With Recurrent Malignant Glioma|Terminated||Phase 1|9|Actual|Duke University||4||This study was terminated early due to funding issues prior to completion of phase I|f||||f||||||||||2017-10-11 01:05:03.08705|2017-10-11 01:05:03.08705
NCT01989039|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-11-19|||August 2013||2013-08-01|November 2013|2013-11-01|July 2014|Anticipated|2014-07-01|May 2014|Anticipated|2014-05-01||Observational|||IR, Inflammatory and Cardiovascular Markers in PCOS Among Obese and Non-obese Women||Unknown status|Recruiting|N/A|800|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 01:05:03.269129|2017-10-11 01:05:03.269129
NCT01989026|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-07-14|||October 2013||2013-10-01|October 2013|2013-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Randomized Trial of Providing BCG Vaccination Immediately|Reducing Mortality at the Neonatal Intensive Care Unit in Guinea-Bissau: A Randomized Trial of Providing BCG Vaccination Immediately|Unknown status|Recruiting|Phase 4|1064|Anticipated|Bandim Health Project||2|||f||||t||||||||||2017-10-11 01:05:03.358074|2017-10-11 01:05:03.358074
NCT01989013|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-07-11|||February 2014||2014-02-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy|Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy|Recruiting||N/A|9|Anticipated|Zia, Al Raza||1|||f||||f||||||||||2017-10-11 01:05:03.497884|2017-10-11 01:05:03.497884
NCT01989000|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-07-26|||November 2013||2013-11-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|MIPA||The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome|The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome|Recruiting||N/A|95|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 01:05:03.62273|2017-10-11 01:05:03.62273
NCT01988987|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-12-28|||February 2013||2013-02-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Evaluating for Type-2 Diabetes in the Very Early Postpartum Period|Evaluating for Type-2 Diabetes in the Very Early Post-Partum Period|Recruiting||N/A|500|Anticipated|Winthrop University Hospital|||1||f||||f||||||||Undecided||2017-10-11 01:05:03.741392|2017-10-11 01:05:03.741392
NCT01988974|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-03-22|||November 2013||2013-11-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Feasibility Testing of the Alert for Atrial Fibrillation Program|Feasibility Testing of the Alert for Atrial Fibrillation Program|Completed||N/A|80|Actual|Mayo Clinic||2|||f||||t||||||||No||2017-10-11 01:05:03.83328|2017-10-11 01:05:03.83328
NCT01988961|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-01-04|||December 2013||2013-12-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis|A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis|Completed||Phase 2|103|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 01:05:04.061884|2017-10-11 01:05:04.061884
NCT01988948|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-08-30|||October 2013||2013-10-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|DyPAVIR||Dynamics of Human PApilloma Virus Interactions; Internet-based Students HeAlth Research Enterprise|Impact de la Vaccination Sur la Distribution Des génotypes de Papillomavirus (HPV) et Suivi de la Dynamique Intra-individuelle de l'Infection et Des Co-infections Dans Une Population d'étudiantes âgées de 18 à 20 Ans|Completed||N/A|49|Actual|Institut Pasteur||1|||f||||f||||||||Undecided||2017-10-11 01:05:04.281665|2017-10-11 01:05:04.281665
NCT01988935|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-09-05|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Integrated PTSD and Smoking Treatment|Integrated PTSD and Smoking Treatment|Recruiting||N/A|80|Anticipated|University of Texas at Austin||2|||f||||t||||||||||2017-10-11 01:05:04.40998|2017-10-11 01:05:04.40998
NCT01988922|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-11-22|||November 2013||2013-11-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||CYP2B6 Polymorphisms in Ketamine|Role of CYP2B6 Polymorphisms in Ketamine Metabolism and Clearance|Active, not recruiting||N/A|32|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 01:05:04.503543|2017-10-11 01:05:04.503543
NCT01988909|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-01-24|||September 2013|Actual|2013-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PAGELEC||WR 279,396 for the Treatment of Cutaneous Leishmaniasis|An Open-Label Study to Examine the Safety and Efficacy, of WR 279,396 (Paromomycin + Gentamicin Topical Cream) for the Treatment of Cutaneous Leishmaniasis in France|Completed||Phase 2|18|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:05:04.584267|2017-10-11 01:05:04.584267
NCT01988896|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-07-13|||December 27, 2013|Actual|2013-12-27|July 2017|2017-07-01|April 23, 2018|Anticipated|2018-04-23|April 23, 2018|Anticipated|2018-04-23||Interventional|||Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors|A Phase Ib Study of the Safety and Pharmacology of Atezolizumab Administered With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors|Active, not recruiting||Phase 1|153|Actual|Hoffmann-La Roche||2|||f||||f|t|f||||||||2017-10-11 01:05:04.672748|2017-10-11 01:05:04.672748
NCT01988883|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-07-27|||October 2014|Actual|2014-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Modafinil and Cognitive Function in POTS|Modafinil and Cognitive Function in Postural Tachycardia Syndrome|Active, not recruiting||Early Phase 1|47|Anticipated|Vanderbilt University Medical Center||4|||f||||f||||||||||2017-10-11 01:05:04.817135|2017-10-11 01:05:04.817135
NCT01988870|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-11-21|||December 2013||2013-12-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||IORT (Intra-operative Radiation Therapy) in Early Stage Breast Cancer|A Pilot, Single Arm, Study of the Safety and Feasibility of Single-Fraction Intraoperative Radiation Treatment (IORT) With CT-On-Rails-Guided HDR Brachytherapy for the Treatment of Early-Stage Breast Cancer|Completed||N/A|28|Actual|University of Virginia||1|||f||||t||||||||||2017-10-11 01:05:04.938064|2017-10-11 01:05:04.938064
NCT01988857|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-06-01|2016-10-18|2014-05-29|February 22, 2014|Actual|2014-02-22|June 2017|2017-06-01|May 10, 2014|Actual|2014-05-10|May 10, 2014|Actual|2014-05-10||Interventional|||Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children|Safety and Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix™) in Healthy Vietnamese Children|Completed||Phase 3|302|Actual|GlaxoSmithKline||1|||f|||||f|f||||||||2017-10-11 01:05:05.075204|2017-10-11 01:05:05.075204
NCT01988844|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-11-01|||November 2013||2013-11-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|||Upper Limbs Assessment in Children With Cerebral Palsy|Manual Dexterity and Upper Limbs Functionality Assessment in School Children With Cerebral Palsy|Completed||N/A|31|Actual|Universidad de Granada|||1||f||||t||||||||Undecided||2017-10-11 01:05:05.331126|2017-10-11 01:05:05.331126
NCT01988831|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-05-04|||June 2016||2016-06-01|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|January 2022|Anticipated|2022-01-01||Interventional|||Efficacy of Propranolol Treatment to Prevent Melanoma Progression|Phase 2 Prospective Study of the Efficacy of Propranolol on Malignant Melanoma Progression. A Randomized Placebo-controlled,Single Blind Trial|Suspended||Phase 2|450|Anticipated|University Hospital, Geneva||2||We must delay the study for some financial reasons|f||||f||||||||||2017-10-11 01:05:05.423652|2017-10-11 01:05:05.423652
NCT01988818|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-05-10|||April 2014||2014-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|Close||Prospective, Randomized Study of 2 Different Wound Dressings|A Mono-centre, Post CE-mark, Prospective-randomized Clinical Trial to Evaluate the Performance of a Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip or Knee Arthroplasty or Primary Spine Surgery in Comparison to a Standard Wound Dressing (Cosmopor E®Steril, Fa. Hartmann)|Completed||N/A|200|Actual|University of Cologne||2|||f||||f||||||||||2017-10-11 01:05:05.518981|2017-10-11 01:05:05.518981
NCT01988805|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2014-10-16|||February 2013||2013-02-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Gene Polymorphism Study of Normal Individual Inflammasome Genes|Immunological Characterization of Blood and Inflammasome Gene Segment Polymorphism Analysis of Normal Healthy Individuals|Withdrawn||N/A|0|Actual|Ohio State University|||1||f||||||||||||||2017-10-11 01:05:05.610209|2017-10-11 01:05:05.610209
NCT01988792|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-07-28|||November 2013||2013-11-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Human Milk Fortification in Very Low Birth Neonates|Human Milk Fortification and Feeding Intolerance in Very Low Birth Weight Neonates|Completed||N/A|100|Actual|University of Tennessee||2|||f||||t||||||||||2017-10-11 01:05:05.678414|2017-10-11 01:05:05.678414
NCT01988779|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-08-25|||October 2013||2013-10-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations|Oral Versus Topical Antibiotic Therapy for Treatment of Chronic Rhinosinusitis Exacerbations|Recruiting||Phase 3|70|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-11 01:05:05.763957|2017-10-11 01:05:05.763957
NCT01988766|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-11-20|||October 2012||2012-10-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|September 2013|Actual|2013-09-01||Observational|||Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement|Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement|Completed||N/A|1424|Actual|University of Chicago|||2||f||||f||||||||||2017-10-11 01:05:05.869669|2017-10-11 01:05:05.869669
NCT01988753|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-07-08|||October 2013||2013-10-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases|Utility of Shearwave Elastography (SWE) and Non-Invasive Serum Biomarkers to Detect Fibrosis in Pediatric Patients With Liver Diseases|Recruiting||N/A|500|Anticipated|Baylor College of Medicine|||1||f||||f||||||Samples Without DNA|"     1. Shearwave elastography is a non-invasive procedure to measurement liver tissue          elasticity. Images will be obtained in the right lobe of the liver through intercostal          spaces with the subject lying supine with right arm abduction. A total of 10          measurements will be obtained across the liver to obtain a more comprehensive          evaluation.        2. Biomarker Analysis      A. Blood: Blood will be drawn at the same time the IV is placed for the liver biopsy for the     purposes of the serum biomarker study. If subjects return for an additional liver biopsy in     the future or a standard of care visit they may be asked to provide an additional sample for     biomarker analysis. Blood will be processed, aliquoted and stored by pathology.      B. Tissue: Unstained slides from pathology will be prepared from leftover tissue taken during     the liver biopsy to be stained for additional biomarker analysis.   "|No||2017-10-11 01:05:05.960407|2017-10-11 01:05:05.960407
NCT01988740|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2013-11-14|||November 2013||2013-11-01|November 2013|2013-11-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Observational|IMA||Markers of Oxidative Stress in a Early Week Miscarriage: Ischemia of Modified Albumin|Markers of Oxidative Stress in a Early Week Miscarriage: Ischemia of Modified Albumin|Unknown status|Recruiting|N/A|180|Anticipated|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||1||f||||f||||||||||2017-10-11 01:05:06.060588|2017-10-11 01:05:06.060588
NCT01988701|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2015-02-26|||February 2015||2015-02-01|February 2015|2015-02-01||||December 2016|Anticipated|2016-12-01||Observational|||Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease|Lymphocyte Profiles and Activation Status in the Development of Chronic Graft-versus-Host Disease|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center|||2|Decision made by the PI to withdraw study|f||||t||||||Samples With DNA|"     Blood   "|||2017-10-11 01:05:06.27866|2017-10-11 01:05:06.27866
NCT01988688|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-05-07|||January 2014||2014-01-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Pilot Study of Deep Brain Stimulation (DBS) in Area LC for Chronic Tinnitus|Pilot Study of Deep Brain Stimulation (DBS)in Area LC for Chronic Tinnitus|Active, not recruiting||Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:05:06.361492|2017-10-11 01:05:06.361492
NCT01988675|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-08-03|||July 2004||2004-07-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Observational|||MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier|MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier|Recruiting||N/A|90|Anticipated|University of Michigan Cancer Center|||2||f||||t||||||||||2017-10-11 01:05:06.457969|2017-10-11 01:05:06.457969
NCT01988662|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-03-30|2016-09-01||April 2014||2014-04-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|UNRAVEL||UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)|A 3 Months, patient-and Rater Blinded, Randomized, Prospective Study Comparing Systemic Anti-VEGF Effects Between Ranibizumab and Aflibercept in Treatment naïve Neovascular Age-related Macular Degeneration (nAMD) Patients|Completed||Phase 4|205|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:05:06.581441|2017-10-11 01:05:06.581441
NCT01988649|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2017-02-06|||April 2015||2015-04-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Oxytocin and Pain Sensitivity and Threshold|The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold: A Randomized, Double Blinded, Crossover Volunteer Study|Withdrawn||N/A|0|Actual|Northwestern University||2||Duplicate Study|f||||f||||||||||2017-10-11 01:05:07.264118|2017-10-11 01:05:07.264118
NCT01988636|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2017-06-30|||October 29, 2013||2013-10-29|August 20, 2015|2015-08-20|August 20, 2015|Actual|2015-08-20|August 20, 2015|Actual|2015-08-20||Interventional|||Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults|Assessment of Safety and Immunogenicity of Intravenous Immunization With Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) in Healthy African Adults|Completed||Phase 1|450|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 01:05:07.383336|2017-10-11 01:05:07.383336
NCT01988623|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-02-08|||December 2012||2012-12-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Pivotal Response Treatment for Individuals With Intellectual Disabilities|Pivotal Response Treatment for Individuals With Intellectual Disabilities|Recruiting||N/A|120|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-11 01:05:07.487274|2017-10-11 01:05:07.487274
NCT01988610|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-10-03|||October 2013||2013-10-01|October 2017|2017-10-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effects of Mifepristone on Biomarkers of Metabolic Function and Neuropsychological Performance Among Middle-Aged and Older Individuals|Effects of Mifepristone on Biomarkers of Metabolic Function and Neuropsychological Performance Among Middle-Aged and Older Individuals|Completed||N/A|23|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 01:05:07.581063|2017-10-11 01:05:07.581063
NCT01988597|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-06-09|||September 2013||2013-09-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Dry Eye Symptoms and Quality of Life|Dry Eye Symptoms and Quality of Life|Completed||N/A|200|Anticipated|Singapore National Eye Centre|||1||f||||f||||||||||2017-10-11 01:05:07.657934|2017-10-11 01:05:07.657934
NCT01988584|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-06-22|||November 2013||2013-11-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|ACT for CP||Safety and Effectiveness of Banked Cord Blood or Bone Morrow Stem Cells in Children With Cerebral Palsy (CP).|Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP)|Active, not recruiting||Phase 2|20|Actual|The University of Texas Health Science Center, Houston||3|||f||||t||||||||||2017-10-11 01:05:07.751773|2017-10-11 01:05:07.751773
NCT01988571|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-05-25|||February 2014|Actual|2014-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)|Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)|Recruiting||Phase 2|250|Anticipated|Wake Forest University Health Sciences||2|||f||||t|t|f||||||||2017-10-11 01:05:07.841805|2017-10-11 01:05:07.841805
NCT01988558|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2016-10-06|||December 2013||2013-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||A Phase I/II to Assess Safety, Tolerability and Efficacy of DL-lactic Acid Syrup in Children With Recurrent Tonsillitis|A Phase I/II, Randomized, Double Blind, Placebo-controlled Study to Assess the Safety, Tolerability and Efficacy of DL-lactic Acid Syrup (Tonsitin) in Children With Recurrent Tonsillitis.|Completed||Phase 1/Phase 2|51|Actual|Yali Pharmaceuticals||2|||f||||||||||||||2017-10-11 01:05:07.948177|2017-10-11 01:05:07.948177
NCT01988545|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-11-19|||November 2013||2013-11-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow|GLP-1's Influence on Intestinal Blood Flow|Unknown status|Recruiting|N/A|8|Anticipated|University Hospital Koge||4|||f||||f||||||||||2017-10-11 01:05:08.028989|2017-10-11 01:05:08.028989
NCT01988532|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-01-17|||October 2013||2013-10-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia|Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia|Completed||N/A|381|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:05:08.132491|2017-10-11 01:05:08.132491
NCT01988519|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-01-06|||October 2013||2013-10-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|DRAPA||Randomized Controlled Trial Comparing Closed-suction Drain Versus Passive Gravity Drain Following Pancreatic Resection|Does the Type of Drain Influence the Postoperative Pancreatic Fistula Rate After Pancreatic Resection?|Completed||N/A|223|Actual|University Hospital Hradec Kralove||2|||f||||f||||||||||2017-10-11 01:05:08.210335|2017-10-11 01:05:08.210335
NCT01988506|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-12-12|||January 2014||2014-01-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|January 2017|Anticipated|2017-01-01||Interventional|TRANSREG||Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases|Induction of Regulatory t Cells by Low Dose IL2 in Autoimmune and Inflammatory Diseases: a Transnosographic Approach|Recruiting||Phase 2|132|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||No||2017-10-11 01:05:08.310206|2017-10-11 01:05:08.310206
NCT01988493|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-08-30|||January 6, 2014|Actual|2014-01-06|August 2017|2017-08-01|October 30, 2018|Anticipated|2018-10-30|February 28, 2018|Anticipated|2018-02-28||Interventional|||Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Subjects With Hepatocellular Carcinoma|A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects With MET+ Advanced Hepatocellular Carcinoma and Child-Pugh Class A Liver Function|Recruiting||Phase 1/Phase 2|90|Anticipated|Merck KGaA||2|||f||||t||||||||||2017-10-11 01:05:08.763651|2017-10-11 01:05:08.763651
NCT01988480|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-05-29|||March 2009||2009-03-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2015|Actual|2015-09-01||Interventional|SINIMAGE||Guided Surgery Versus Sinus Graft|Clinical Assessment of Innovative Procedure Using Image-guided Surgery to Avoid Sinus Lift|Active, not recruiting||N/A|60|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 01:05:08.983211|2017-10-11 01:05:08.983211
NCT01988467|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-13|||August 2011||2011-08-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||The Protective Role of the Nose During Acute Exposure to Passive Smoking.|The Protective Role of the Nose During Acute Exposure to Passive Smoking.|Completed||Phase 1|21|Actual|Hellenic Anticancer Society||2|||f||||t||||||||||2017-10-11 01:05:09.1869|2017-10-11 01:05:09.1869
NCT01988454|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-02-12|||September 2011||2011-09-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Characterization of Dyslipidemia in Adolescent Obesity|Characterization of Dyslipidemia in Adolescent Obesity|Completed||N/A|50|Actual|Health Diagnostic Laboratory, Inc.|||1||f||||f||||||Samples With DNA|"     Whole Blood and serum   "|||2017-10-11 01:05:09.379506|2017-10-11 01:05:09.379506
NCT01988441|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-03-29|||September 2013||2013-09-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01|1 Month|Observational [Patient Registry]|||The Influence of Autophagy on Fatty Liver|The Influence of Autophagy on Nonalcoholic Fatty Liver Disease|Recruiting||N/A|800|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||Samples With DNA|"     serum, WBC DNA   "|Undecided||2017-10-11 01:05:09.550295|2017-10-11 01:05:09.550295
NCT01988428|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-06-13|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|PHANTASi||Prehospital Antibiotics Against Sepsis Trial|A Prospective Randomized Controlled Trial to Investigate the Effects of Training Emergency Medical Services (EMS) Personnel in Recognizing and Initiating Treatment in the Prehospital Setting Together With Early Administration of Antibiotics for Patients Suspected of (Severe) Sepsis and Septic Shock|Completed||N/A|2672|Actual|VU University Medical Center||2|||f||||f||||||||No||2017-10-11 01:05:09.692438|2017-10-11 01:05:09.692438
NCT01988415|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-14|2016-01-06|2015-10-29||November 2013||2013-11-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||This was a paired-eye study in which treatment of 26 participants included both eyes (52 eyes total). Use of the commercial versus VSS-Rx1 OPM treatment planning software was randomized by eye. One eye of each subject received the investigational treatment and the fellow eye received the commercial treatment.|New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction for Myopia|A Prospective Study to Evaluate the Feasibility of a New Treatment Algorithm for Wavefront-Guided Lasik Correction of Myopic Refractive Errors|Completed||N/A|26|Actual|Abbott Medical Optics||1|||f||||f||||||||||2017-10-11 01:05:09.938274|2017-10-11 01:05:09.938274
NCT01988402|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-12-20|2014-12-09||December 2007||2007-12-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Does Allopurinol Prolong a Treated, Acute Gout Flare?|Does Allopurinol Prolong a Treated, Acute Gout Flare?|Completed||Phase 4|35|Actual|Wilford Hall Medical Center||2|||f||||f||||||||||2017-10-11 01:05:10.306301|2017-10-11 01:05:10.306301
NCT01988389|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-03-06|||September 2013||2013-09-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|AVAG||Effect of Apples on cardioVascular Risk And Gut Health|Effect of Apples Consumption on Blood Lipid Levels,Vascular Function and Gut Health in Moderate Hypercholesterolemic Subjects|Completed||N/A|40|Actual|University of Reading||2|||f||||t||||||||||2017-10-11 01:05:10.832844|2017-10-11 01:05:10.832844
NCT01988363|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-03-09|||June 2013||2013-06-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|GON||Greater Occipital Nerve Injection Study|Ultrasound-guided Greater Occipital Nerve Injection at Novel Proximal Location: A Clinical Series|Completed||Phase 1|15|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:05:11.029727|2017-10-11 01:05:11.029727
NCT01988350|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-11-13|||May 2013||2013-05-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Pancreatic Insufficiency Secondary to Tobacco Exposure|Pancreatic Insufficiency Secondary to Tobacco Exposure|Completed||N/A|202|Actual|Emory University|||2||f||||f||||||||||2017-10-11 01:05:11.136953|2017-10-11 01:05:11.136953
NCT01988337|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-09-28|||January 2015||2015-01-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|December 2016|Anticipated|2016-12-01||Interventional|||Lesion Progression After Icon Treatment in Young Adults|Double Blind Randomized Controlled Clinical Trial of Lesion Progression After Treatment With Icon vs. Placebo in Caries Lesions in Young Adults Over 36 Months|Recruiting||N/A|150|Anticipated|DMG Dental Material Gesellschaft mbH||2|||f||||f||||||||||2017-10-11 01:05:11.222308|2017-10-11 01:05:11.222308
NCT01988324|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-09-14|||August 2014||2014-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||AR and ER Imaging in Metastatic Breast Cancer|Androgen Receptor and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients|Completed||Phase 2|24|Actual|University Medical Center Groningen||1|||f||||||||||||||2017-10-11 01:05:11.387261|2017-10-11 01:05:11.387261
NCT01988311|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2014-05-19|||May 2013||2013-05-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators|Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators|Completed||Phase 1|10|Anticipated|Johns Hopkins University||3|||f||||||||||||||2017-10-11 01:05:11.50156|2017-10-11 01:05:11.50156
NCT01988298|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-07-27|||October 2013||2013-10-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Nonsteroidal Antiinflammatory Drugs in Women With Postpartum Pre-eclampsia|Ibuprofen Versus Acetaminophen in Women With Severe Pre-eclampsia After Vaginal Delivery.|Completed||Phase 2/Phase 3|114|Actual|Complejo Hospitalario Dr. Arnulfo Arias Madrid||2|||f||||t||||||||||2017-10-11 01:05:11.59575|2017-10-11 01:05:11.59575
NCT01988285|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-15|||July 2011||2011-07-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Risk Factors and Biomarkers for Diagnosis and Treatment of EoE|Risk Factors and Biomarkers for Diagnosis and Treatment of EoE|Enrolling by invitation||N/A|800|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"     Esophageal, gastric, and duodenal biopsies. Blood samples.   "|No||2017-10-11 01:05:11.696688|2017-10-11 01:05:11.696688
NCT01988272|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-05-17|||June 2011||2011-06-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Observational|||Imaging Based Dosimetry for Individualized Internal Emitter Therapy|Imaging Based Dosimetry for Individualized Internal Emitter Therapy|Completed||N/A|33|Actual|University of Michigan|||1||f||||t||||||||||2017-10-11 01:05:11.7886|2017-10-11 01:05:11.7886
NCT01988259|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2015-05-21|||September 2013||2013-09-01|May 2015|2015-05-01||||December 2015|Anticipated|2015-12-01||Interventional|MISDCS||Head-neck Coordination Analysis After Minimally Invasive Surgery in the Dorsal Cervical Spine|Comparison of Open vs Minimally Invasive Dorsal Approaches for Foraminotomy and Laminoplasty in the Cervical Spine Through Performance of Head-neck-coordination Analysis|Unknown status|Recruiting|N/A|100|Anticipated|Schoen Klinik Hamburg Eilbek||4|||f||||f||||||||||2017-10-11 01:05:11.870426|2017-10-11 01:05:11.870426
NCT01988246|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-04-12|||December 2013||2013-12-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|PROMISE||Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery|Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery|Recruiting||Phase 1/Phase 2|30|Anticipated|The Cleveland Clinic||2|||f||||t||||||||Undecided||2017-10-11 01:05:11.956782|2017-10-11 01:05:11.956782
NCT01988233|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-05-01|||March 2013||2013-03-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|BAILA||BAILA: Being Active, Increasing Latinos Healthy Aging|BAILA: Being Active, Increasing Latinos Healthy Aging|Active, not recruiting||N/A|333|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-11 01:05:12.057896|2017-10-11 01:05:12.057896
NCT01988220|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-12-02|||December 2014||2014-12-01|December 2014|2014-12-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||The Effects of Lower Extremity Sensory Retraining Treatment in Individuals With Post-stroke Sensory Impairment|The Effects of Lower Extremity Sensory Retraining Treatment in Individuals With Post-stroke Sensory Impairment|Unknown status|Recruiting|N/A|60|Anticipated|University of Haifa||2|||f||||f||||||||||2017-10-11 01:05:12.16768|2017-10-11 01:05:12.16768
NCT01988207|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-11-13|||December 2013||2013-12-01|November 2013|2013-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Treating Laryngeal Hyperfunction With Flow Phonation||Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Central Arkansas||2|||f||||t||||||||||2017-10-11 01:05:12.255028|2017-10-11 01:05:12.255028
NCT01988194|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-05-30|||November 2013|Actual|2013-11-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|PRAXIS||Pragmatic Research eXamining Inpatient Symptoms|Pragmatic Randomized Controlled Trial of Adjunct Acupuncture vs Usual Care Among Hospitalized Patients|Completed||N/A|238|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:05:12.343733|2017-10-11 01:05:12.343733
NCT01988181|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-07-24|||June 2014||2014-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Adjusting Fluid Removal Based on Blood Volume in Hemodialysis: A Randomized Study|Blood Volume Monitoring Guided Ultrafiltration Biofeedback on Reduction of Intra-dialytic Hypotensive Episodes in Hemodialysis: A Randomized Cross Over Study|Completed||N/A|34|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 01:05:12.445288|2017-10-11 01:05:12.445288
NCT01988168|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-05-11|||February 2014||2014-02-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|CSCAR||Closure of Skin in ChorioAmnionitis Research Pilot Study|Closure of Skin in ChorioAmnionitis Research Pilot Study|Recruiting||N/A|60|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:05:12.558193|2017-10-11 01:05:12.558193
NCT01988155|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-02-22|||December 2013||2013-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Eccentric Exercise Versus Eccentric Exercise and Astym for Insertional Achilles Tendinopathy|Eccentric Exercise Versus Eccentric Exercise and Astym® in the Management of Insertional Achilles Tendinopathy: A Randomized Controlled Trial|Completed||N/A|16|Actual|Indiana University Health Ball Memorial Hospital Rehabiliation Services||2|||f||||f||||||||||2017-10-11 01:05:12.715942|2017-10-11 01:05:12.715942
NCT01988142|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-19|||August 2006||2006-08-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Continuous Passive Motion Training on Neuromuscular Adaptation||Completed||N/A|7|Actual|Chang Gung University||1|||f||||t||||||||||2017-10-11 01:05:12.798278|2017-10-11 01:05:12.798278
NCT01988129|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-27|2017-02-08|2015-04-29||March 2009||2009-03-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Fire Fighter Fatigue Management Program: Operation Healthy Sleep|Fire Fighter Fatigue Management Program: Operation Healthy Sleep|Completed||N/A|1189|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:05:12.880676|2017-10-11 01:05:12.880676
NCT01988116|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-08-21|||October 2013||2013-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease|Vitamin D Replacement in Chronic Kidney Disease and Its Effects on Iron Homeostasis, Serum Hepcidin, and Hemojuvelin Levels.|Completed||Early Phase 1|40|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 01:05:13.421387|2017-10-11 01:05:13.421387
NCT01988090|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-08-08|||December 2013||2013-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||High Dose Vitamin D vs Standard Dose Vitamin D Study|A Randomized, Controlled Trial of High Dose vs. Standard Dose Vitamin D for Aromatase-Inhibitor Induced Arthralgia in Breast Cancer Survivors|Recruiting||Phase 2|184|Anticipated|Baylor Breast Care Center||2|||f||||f||||||||||2017-10-11 01:05:15.352586|2017-10-11 01:05:15.352586
NCT01988077|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-05-21|||October 2013||2013-10-01|November 2013|2013-11-01|October 2018|Anticipated|2018-10-01|May 2016|Actual|2016-05-01||Interventional|||Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for Metastatic Melanoma Patients|Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for the Treatment of Metastatic Melanoma Patients|Terminated||Phase 2|2|Actual|Sheba Medical Center||1||due to toxicity of cyclophosphamide|f||||f||||||||Undecided|to be decided|2017-10-11 01:05:15.450812|2017-10-11 01:05:15.450812
NCT01988064|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-13|||October 2013||2013-10-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||Face to Face vs. Group Training Methods on Pulse Rate Taking in Patients With Cardiovascular Diseases.|Comparison of the Short-term Efficacy of Two Training Methods (Face to Face vs. Group Training) on Pulse Rate Taking in Patients With Cardiovascular Diseases, a Randomized Trial.|Unknown status|Recruiting|N/A|300|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:05:15.524815|2017-10-11 01:05:15.524815
NCT01988038|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-03-27|||November 2013||2013-11-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01|20 Years|Observational [Patient Registry]|Repository||Repository Study of Autosomal Dominant Polycystic Kidney Disease|Repository Study of Autosomal Dominant Polycystic Kidney Disease|Withdrawn||N/A|0|Actual|The Rogosin Institute|||1|No participants were enrolled.|f||||f||||||Samples With DNA|"     Blood sample for genotyping of specific PKD1 and PKD2 mutations. Buccal and/or semen sample     (optional and only if needed)   "|||2017-10-11 01:05:15.619985|2017-10-11 01:05:15.619985
NCT01988025|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-04-03|||June 2013||2013-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:05:15.689176|2017-10-11 01:05:15.689176
NCT01988012|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-01-17|2016-10-24||January 2014||2014-01-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||The full analysis set (FAS) included all enrolled participants who received at least one dose of subcutaneous tocilizumab.|A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.|An Open-label, Multicenter Study to Evaluate Disease Activity and Safety of Treatment With Actemra (Tocilizumab) Administered as Subcutaneous Injection in Adult RA Patients.|Completed||Phase 3|100|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:05:15.749288|2017-10-11 01:05:15.749288
NCT01987999|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-03-29|||February 2013||2013-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Eradication of Prostate Cancer Using an Adenosine-5'-Triphosphate (ATP) Inhibitor|Phase II Eradication of Prostate Cancer Using an Adenosine-5'-Triphosphate(ATP)Inhibitor.|Completed||Phase 2|60|Actual|Optimal Health Research||1|||f||||t||||||||||2017-10-11 01:05:16.398414|2017-10-11 01:05:16.398414
NCT01987986|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-09-07|2017-04-18|2015-03-17|October 2013||2013-10-01|September 2017|2017-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy|A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy|Completed||Phase 2|150|Actual|Endo Pharmaceuticals||4|||f||||f||||||||||2017-10-11 01:05:16.482505|2017-10-11 01:05:16.482505
NCT01987973|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2016-07-25|||February 2015||2015-02-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Allograft Reconstruction of Massive Rotator Cuff Tears vs Partial Repair Alone|Arthroscopic Repair of Chronic Two-tendon Rotator Cuff Tears by Human Dermal Allograft|Recruiting||N/A|30|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||No||2017-10-11 01:05:17.299454|2017-10-11 01:05:17.299454
NCT01987960|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-01-23|2016-10-28||December 2013||2013-12-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||The all-patients-treated set (APTS) comprises all randomized patients who took at least one dose of brexpiprazole or placebo.|Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)|Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Study of Brexpiprazole as Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)|Terminated||Phase 3|417|Actual|H. Lundbeck A/S|As the study was terminated limited efficacy and safety data were collected from the randomized patients. The data are descriptive and the primary and key secondary efficacy analyses were not done.|2||"The study was terminated due to challenges with patient eligibility; the decision to terminate   was not based on any safety concerns"|f||||f||||||||||2017-10-11 01:05:17.406121|2017-10-11 01:05:17.406121
NCT01987947|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria||Completed||Phase 2|32|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 01:05:18.157595|2017-10-11 01:05:18.157595
NCT01987934|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-13|||June 2013||2013-06-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01|2 Weeks|Observational [Patient Registry]|OSCC||Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma|Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Academy of Interdisciplinary Dental Education and Research|||2||f||||t||||||Samples Without DNA|"     Oral mucosal biopsy specimens of study participants will be collected.   "|||2017-10-11 01:05:18.276631|2017-10-11 01:05:18.276631
NCT01987921|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-09-25|||January 2014||2014-01-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|28 Days|Observational [Patient Registry]|AWARE||Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes|Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology|Completed||N/A|5237|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||Samples Without DNA|"     Urine samples will be collected from participating centers (pending local IRB approval)   "|Yes|Individual center data will be distributed per patient/location. Sites will not receive data for patients enrolled at other sites. All data will be centrally housed at Cincinnati Children's Hospital.|2017-10-11 01:05:18.405319|2017-10-11 01:05:18.405319
NCT01987908|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-02-03|2016-06-21||October 2013||2013-10-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Out of the participants who enrolled in the study, only participants who passed the screen and were randomized were entered in the Placebo Lead-in Period.|Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease|A Phase 2, Exploratory, Placebo-Controlled, Multicenter, Double-Blind Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Two Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease|Terminated||Phase 2|35|Actual|Baxalta US Inc.|PK data not determined as the assay collection method was found to be faulty rendering all samples unevaluable. Study was terminated early by the Sponsor due to unblinding between study drug and placebo groups at the subject, site and Sponsor levels.|4||"Study was terminated early by the Sponsor due to unblinding between study drug and placebo   groups at the subject, site and Sponsor levels."|f||||f||||||||||2017-10-11 01:05:18.655982|2017-10-11 01:05:18.655982
NCT01987895|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-04-19|||March 27, 2014|Actual|2014-03-27|April 2017|2017-04-01|March 24, 2017|Actual|2017-03-24|February 26, 2017|Actual|2017-02-26||Interventional|||Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea|A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)|Completed||Phase 3|632|Actual|Actelion||2|||f||||t|t|f||||||||2017-10-11 01:05:20.327548|2017-10-11 01:05:20.327548
NCT01987882|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-02-15|||June 2014||2014-06-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01|2 Years|Observational [Patient Registry]|||Cerebral Palsy Hip Outcomes Project - International Multi-centre Study|Outcomes of Hip Interventions for Children With Cerebral Palsy - An International Multi-centre Prospective Comparative Cohort Study|Recruiting||N/A|500|Anticipated|Holland Bloorview Kids Rehabilitation Hospital|||5||f||||f||||||||||2017-10-11 01:05:20.725163|2017-10-11 01:05:20.725163
NCT01987869|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-11-18|||October 2013||2013-10-01|November 2013|2013-11-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Observational|||Hiperemezis and Serotonin Elevated Serum Serotonin Levels in Hyperemesis|Relationship Between Elevated Serum Serotonin Levels in Symptomatic Patients With Hyperemezis|Unknown status|Recruiting|N/A|90|Anticipated|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||1||f||||f||||||||||2017-10-11 01:05:20.96833|2017-10-11 01:05:20.96833
NCT01987856|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-05-25|||January 2014||2014-01-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Interventional|||Idealizing Pregnancy Outcome With Single Blastocyst Transfer in a FET Cycle|Idealizing Pregnancy Outcome With Single Blastocyst Transfer in a Frozen Embryo Transfer (FET) Cycle; Array Comparative Genome Hybridization (aCGH) Euploid Screened Versus Morphology Selected Blastocyst.|Withdrawn||N/A|0|Actual|Antalya IVF||2||loss of funding|f||||f||||||||||2017-10-11 01:05:21.101582|2017-10-11 01:05:21.101582
NCT01987843|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-12-16|||September 2013||2013-09-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase IIa, Multicentre, Randomised, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate Safety, Tolerability and Clinical Efficacy of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|142|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||t||||||||||2017-10-11 01:05:21.24052|2017-10-11 01:05:21.24052
NCT01987830|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-06-27|||November 2013||2013-11-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|January 2019|Anticipated|2019-01-01||Interventional|||Bevacizumab w / Temozolomide PET & Vascular MRI For GBM|A Study to Evaluate Vascular Normalization in Patients With Recurrent Glioblastoma Treated With Bevacizumab Using [11C]Temozolomide PET and Vascular MRI|Recruiting||N/A|17|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:05:21.496954|2017-10-11 01:05:21.496954
NCT01987817|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-06-21||2016-06-16|January 2014||2014-01-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|ARC001||Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT|Phase 2 Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen Oral Immunotherapy|Completed||Phase 2|56|Actual|Aimmune Therapeutics, Inc.||2|||f||||t||||||||Undecided||2017-10-11 01:05:21.658553|2017-10-11 01:05:21.658553
NCT01987804|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2013-11-20|||January 2012||2012-01-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|OXYPEP002||Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women|A Double-blind, Placebo Controlled Single Centre Trial to Evaluate the Dose-relationship of the Effects of Vaginally Administered Oxytocin on the Vaginal Mucosal Membrane in Postmenopausal Women With Vaginal Atrophy|Completed||Phase 2|64|Actual|PepTonic Medical AB||3|||f||||f||||||||||2017-10-11 01:05:21.805647|2017-10-11 01:05:21.805647
NCT01987778|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-05-17|||November 2013|Actual|2013-11-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|August 2017|Anticipated|2017-08-01||Interventional|||Health Effects of Resistance Training on Postmenopausal Women|Health Effects of Resistance Training on Postmenopausal Women|Active, not recruiting||N/A|80|Anticipated|Ostergotland County Council, Sweden||2|||f||||f||||||||No||2017-10-11 01:05:22.033215|2017-10-11 01:05:22.033215
NCT01987765|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-03-26|2014-03-26||January 2009||2009-01-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational||The Safety Assessment Population which included all patients who completed the study, was used for the analysis of baseline characteristics.|Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea||Completed||N/A|847|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:05:22.180641|2017-10-11 01:05:22.180641
NCT01987752|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-02-25|2014-02-25||January 2009||2009-01-01|February 2014|2014-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Safety and Efficacy of Combigan® Ophthalmic Solution in Korea||Completed||N/A|732|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:05:22.404682|2017-10-11 01:05:22.404682
NCT01987739|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-02-11|||September 2009||2009-09-01|February 2016|2016-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users|A Single Center, Randomized, Double-blind, Double-dummy, Placebo- and Active-controlled, Six-way Crossover Single-dose Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Central Nervous System (CNS) Depressant Drug Users|Completed||Phase 1|42|Actual|Midnight Pharma, LLC||6|||f||||f||||||||||2017-10-11 01:05:22.62282|2017-10-11 01:05:22.62282
NCT01987726|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2017-08-07|||September 2013||2013-09-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors|Decision Impact Analysis of Foundation Medicine's Next Generation Sequencing Test in Advanced Solid Tumor Malignancies|Active, not recruiting||N/A|150|Actual|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"     Tissue, blood   "|||2017-10-11 01:05:22.757168|2017-10-11 01:05:22.757168
NCT01987713|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-05-27|||November 2013||2013-11-01|May 2014|2014-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Chronic Conditions in Childhood Obesity Subject: An Mixed Methods Research Approach|Chronic Conditions in Childhood Obesity Subject: An Mixed Methods Research Approach|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 01:05:22.88081|2017-10-11 01:05:22.88081
NCT01987700|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2015-09-21|||July 2013||2013-07-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Multi-Center Study To Examine The Use Of Flex HD® And Strattice In The Repair Of Large Abdominal Wall Hernias|A Randomized, Prospective, Double-blind, Multi-Center Study To Examine And Compare The Outcomes Associated With The Use Of Flex HD®, A Human Acellular Dermal Matrix, And Strattice™, A Porcine Acellular Dermal Matrix Allograft, When Used As A Reinforcing Material In The Repair Of Large Abdominal Wall Hernias By A Component Separation Technique|Unknown status|Recruiting|Phase 4|120|Anticipated|Musculoskeletal Transplant Foundation||4|||f||||f||||||||||2017-10-11 01:05:22.97991|2017-10-11 01:05:22.97991
NCT01987687|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-08-28|||November 2016||2016-11-01|August 2014|2014-08-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Timing of a Post-exercise Oral Glucose Tolerance Test on Glycaemic Control.|Effect of Timing of a Post-exercise Oral Glucose Tolerance Test on Glycaemic Control.|Suspended||N/A|12|Anticipated|Northumbria University||3||Lack of funding|f||||f||||||||||2017-10-11 01:05:23.095876|2017-10-11 01:05:23.095876
NCT01987674|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-05-11|||January 2014||2014-01-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PMB/T2D||Pre-meal Protein Drink Improve Glycemic Regulation|Impact of a Pre-meal Protein Drink on Metabolic Markers and Glycemic Control in Patients With Type 2 Diabetes|Terminated||Phase 1/Phase 2|35|Actual|Lund University||2||Test products expired.|f||||f||||||||||2017-10-11 01:05:23.180956|2017-10-11 01:05:23.180956
NCT01987661|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-02-24|||October 2013||2013-10-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||The Effects of Airtrapping on Sleep and Breathing in Non Invasive Ventilation (NIV) in COPD|German: Einfluss Von Airtrapping Auf Atmung Und Schlaf Bei Nichtinvasiver Beatmung (NIV) Von COPD Patienten|Active, not recruiting||N/A|15|Anticipated|Institut für Pneumologie Hagen Ambrock eV||2|||f||||f||||||||||2017-10-11 01:05:23.272793|2017-10-11 01:05:23.272793
NCT01987648|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-04-20|||November 2011||2011-11-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|eCRANIO||eCRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome|E-CRANIO Trial Study on Elective CRAniotomies: Postoperative Neurointensive Care, Imaging and Outcome|Recruiting||N/A|2000|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-11 01:05:23.365825|2017-10-11 01:05:23.365825
NCT01987635|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-12-04|||January 2014||2014-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|MEMO 3D||Assessment of Sustained Systolic-to-diastolic Flexibility of the Mitral Valve Annulus With the Sorin MEMO 3D Mitral Anuloplasty Ring|Assessment of Sustained Systolic-to-diastolic Flexibility of the Mitral Valve Annulus With the Sorin MEMO 3D Mitral Anuloplasty Ring|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:05:23.470071|2017-10-11 01:05:23.470071
NCT01987622|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-02-05|||November 2013||2013-11-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Acupuncture for Lumbar Spinal Stenosis|Acupuncture for Lumbar Spinal Stenosis: a Parallel, Randomized Controlled Pilot Study With Usual Care Comparison|Completed||N/A|50|Actual|Korean Medicine Hospital of Pusan National University||2|||f||||t||||||||||2017-10-11 01:05:23.61115|2017-10-11 01:05:23.61115
NCT01987609|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-05-09|||July 2015||2015-07-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques|Evaluation of the Effect of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques|Recruiting||Phase 2|10|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:05:23.772994|2017-10-11 01:05:23.772994
NCT01987596|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-03-28|||August 2013||2013-08-01|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer|Prospective and Randomized Study of Fixed Versus Flexible Prophylactic Administration of Granulocyte Colony-Stimulating Factor (G-CSF) in Children With Cancer|Active, not recruiting||Phase 3|23|Actual|Barbara Ann Karmanos Cancer Institute||2|||f||||t||||||||||2017-10-11 01:05:23.919573|2017-10-11 01:05:23.919573
NCT01987583|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2014-05-13|2014-05-13||November 2013||2013-11-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||The Efficacy of Wet Cupping on Blood Pressure Among Hypertension Patients|The Efficacy of Wet Cupping on Blood Pressure Among Hypertension Patients in Jeddah, 2013, A Randomised Controlled Trial|Completed||N/A|80|Actual|King Abdulaziz University||2|||f||||t||||||||||2017-10-11 01:05:24.039721|2017-10-11 01:05:24.039721
NCT01987570|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-09-07|||April 2012||2012-04-01|July 2015|2015-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Allopurinol Administration on the Prevention of Muscle Mass Loss in Subject Immobilized.|Effect of Allopurinol Administration on the Prevention of Muscle Mass Loss in Subject Immobilized.|Completed||Phase 3|53|Actual|Instituto de Investigacion Sanitaria La Fe||2|||f||||t||||||||||2017-10-11 01:05:24.304076|2017-10-11 01:05:24.304076
NCT01987557|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-06-12|2015-02-18||October 2013||2013-10-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Amplitude and Rate of Intrinsic Feedback During Treadmill Training for Parkinson's Disease|The Therapeutic Contributions of Somatosensory Feedback During Exercise in Parkinson's Disease; A Randomized, Controlled Trial.|Completed||N/A|48|Actual|Wilfrid Laurier University||3|||f||||f||||||||||2017-10-11 01:05:24.608278|2017-10-11 01:05:24.608278
NCT01987544|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-13|2016-02-24|||September 2012||2012-09-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|COPD||Effects of Ergometer Training With Telemonitoring in Patients With Chronic Obstructive Pulmonary Disease (COPD) After Exacerbation|German: Effekte Eines Telemonitorisch überwachten Ergometertrainings Bei Patienten Mit Einer COPD Nach Exazerbation: Eine Prospektiv Randomisierte Studie|Completed||N/A|53|Actual|Institut für Pneumologie Hagen Ambrock eV||2|||f||||f||||||||||2017-10-11 01:05:25.035717|2017-10-11 01:05:25.035717
NCT01987531|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-07-26|||November 2013||2013-11-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|BIPACE||Temporary Biventricular Pacing|Hemodynamic Effect of Temporary Biventricular Pacing After Mitral and/or Tricuspid Valve Surgery in Patients With Preoperative Biventricular Dysfunction|Completed||N/A|2|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 01:05:25.188404|2017-10-11 01:05:25.188404
NCT01987518|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-08-29|||January 2011||2011-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2014|Actual|2014-08-01||Observational|||French Digestive Polyposis Cohorte Family Adenomatous Polyposis With APC and MYH Gene Mutations , Cowden's Disease With PTEN Gene Mutation, Peutz Jeghers Disease With STK 11 Gene Mutation ,juvénil Polyposis With SMAD 4 Gene Mutation , Serrated and Hyperplastic Polyposis|French Digestive Polyposis Cohorte|Recruiting||N/A|350|Anticipated|Hôpital Edouard Herriot|||1||f||||f||||||Samples With DNA|"     Genetic Diagnostic   "|||2017-10-11 01:05:25.284389|2017-10-11 01:05:25.284389
NCT01987505|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-09-20|||November 18, 2013|Actual|2013-11-18|September 2017|2017-09-01|April 11, 2017|Actual|2017-04-11|April 11, 2017|Actual|2017-04-11||Interventional|||MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Mabthera/Rituxan During First-Line Treatment for Lymphoma.|OPEN LABEL, SINGLE-ARM, PHASE IIIb CLINICAL TRIAL TO EVALUATE THE SAFETY OF SWITCHING FROM INTRAVENOUS RITUXIMAB TO SUBCUTANEOUS RITUXIMAB DURING FIRST LINE TREATMENT FOR CD20+ NON-HODGKIN'S FOLLICULAR LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA.|Completed||Phase 3|140|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:05:25.424119|2017-10-11 01:05:25.424119
NCT01987492|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-05-19|||February 28, 2014|Actual|2014-02-28|May 2017|2017-05-01|December 20, 2016|Actual|2016-12-20|December 20, 2016|Actual|2016-12-20||Interventional|||A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma|A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma|Completed||Phase 2|230|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 01:05:25.625543|2017-10-11 01:05:25.625543
NCT01987479|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-05-19|2017-05-19||January 30, 2014|Actual|2014-01-30|May 2017|2017-05-01|May 26, 2016|Actual|2016-05-26|May 26, 2016|Actual|2016-05-26||Interventional|OSCAR|Full Analysis Set (FAS) population included all participants who received at least one dose of SC tocilizumab.|A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis|Multi-Center, Open Label, Single Arm Phase IIIB Study on Safety and Efficacy of Subcutaneous Tocilizumab in Monotherapy or in Combination With Methotrexate or Other Non-Biologic Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients With an Inadequate Response to Non-Biologic DMARDs - OSCAR|Completed||Phase 3|150|Actual|Hoffmann-La Roche||1|||f||||t|t|f|||t|||||2017-10-11 01:05:25.939711|2017-10-11 01:05:25.939711
NCT01987466|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2013-11-12|||October 2013||2013-10-01|November 2013|2013-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Plasma Neutrophil Gelatinase-associated Lipocalin (NGAL) as Early Biomarker for Renal Dysfunction and Good Neurologic Outcome in Out of Hospital Cardiac Arrest Patients||Unknown status|Recruiting|N/A|73|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 01:05:26.901477|2017-10-11 01:05:26.901477
NCT01987453|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-11-11|2016-11-11||July 2014||2014-07-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Safety Analysis Set: participants who received at least 1 dose of study drug|Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study|An Open-Label, Multicenter Study To Evaluate The Efficacy And Safety Of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin For 12 or 24 Weeks In Chronic Genotype 1 HCV Infected Subjects Who Participated In A Prior Gilead-Sponsored HCV Treatment Study|Completed||Phase 2|100|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|3|||f||||f||||||||||2017-10-11 01:05:27.013944|2017-10-11 01:05:27.013944
NCT01987440|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-06-12|||November 2013||2013-11-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Lubricating Gel for Pain Relief During Speculum Examination in Gynecologic Oncology Patients||Completed||N/A|100|Actual|Erzincan Military Hospital||2|||f||||||||||||||2017-10-11 01:05:28.049708|2017-10-11 01:05:28.049708
NCT01987258|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-02-26|||June 2013||2013-06-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|acute IWS||The Acute Effect of Interval-walking|The Acute Effect of Interval-walking|Completed||N/A|10|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-11 01:05:30.829855|2017-10-11 01:05:30.829855
NCT01987427|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-01-22|||October 2013||2013-10-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults|A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults|Completed||Phase 4|238|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-11 01:05:28.124191|2017-10-11 01:05:28.124191
NCT01987414|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-06-01|||August 2015||2015-08-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Forearm Rotation Orthosis for Stroke|Efficacy of a Forearm Rotation Orthosis for Persons With a Hemiparetic Arm|Recruiting||N/A|40|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||Undecided|Information gathered from outcome measures will be shared with other researchers at request. Study PI will seek approval from IRB at the University of Minnesota for means of sharing. Researchers will need to contact the study PI to obtain the information.|2017-10-11 01:05:28.241561|2017-10-11 01:05:28.241561
NCT01987388|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-05-30|||December 2012||2012-12-01|May 2017|2017-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Metabolic Flexibility as a Biomarker of Adaptation to Diet and Exercise Challenges||Completed||N/A|16|Actual|USDA Beltsville Human Nutrition Research Center||4|||f||||f||||||||||2017-10-11 01:05:28.560942|2017-10-11 01:05:28.560942
NCT01987375|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-07-12|||November 2015||2015-11-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures|Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer During Surgical Procedures|Suspended||Phase 1|1|Actual|Stanford University||1||Business decision|f||||t||||||||||2017-10-11 01:05:28.659284|2017-10-11 01:05:28.659284
NCT01987362|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-04-03|||October 16, 2013|Actual|2013-10-16|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Two Part Study of RO6870810. Dose-Escalation Study in Participants With Advanced Solid Tumors and Expansion Study in Participants With Selected Malignancies|A Two-Part, Phase I, Multicenter, Open-Label Study of RO6870810/TEN-010 Given Subcutaneously: Part A: A Dose-Escalation Study in Patients With Advanced Solid Tumors. Part B: An Expansion Cohort in Patients With Selected Malignancies|Active, not recruiting||Phase 1|120|Anticipated|Hoffmann-La Roche||2|||f||||f||||||||||2017-10-11 01:05:28.775637|2017-10-11 01:05:28.775637
NCT01987349|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-04-03|2017-01-11||September 2009||2009-09-01|April 2017|2017-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Participants between the ages of 8 - 100 years old.|T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009|Protective Mechanisms Against a Pandemic Respiratory Virus: B- Cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 1, 2009|Completed||Phase 4|72|Actual|Stanford University||7|||f||||f||||||||No||2017-10-11 01:05:28.940882|2017-10-11 01:05:28.940882
NCT01987336|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-12-10|||March 2013||2013-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||A Prospective Analysis of Biofilm in Urinary Catheters Study|A Prospective Anaylsis of Biofilm in Urinary Catheters Study|Completed||N/A|9|Actual|Southwest Regional Wound Care Center|||1||f||||f||||||Samples Without DNA|"     A 30cc urine sample would also be collected, along with the used catheter. The molecular     evaluation will be looking specifically at the biofilm accumulated on the catheter surface.     The technologies to be used are proteomics, metabolomics and metagenomics.   "|||2017-10-11 01:05:30.117603|2017-10-11 01:05:30.117603
NCT01987323|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-18|||January 2013||2013-01-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension|Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertensive Patients|Completed||Phase 1/Phase 2|6|Actual|Singapore Eye Research Institute||1|||f||||t||||||||||2017-10-11 01:05:30.195204|2017-10-11 01:05:30.195204
NCT01987310|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2017-04-25|||December 2015||2015-12-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment|Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment|Withdrawn||N/A|0|Actual|Sheba Medical Center||3||the study was stopped because of lack of interest|f||||f||||||||||2017-10-11 01:05:30.293353|2017-10-11 01:05:30.293353
NCT01987297|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-05-09|||October 2012||2012-10-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL|Combined Retinoic Acid,Arsenic Trioxide and Chemotherapy for Newly-diagnosed Acute Promyelocytic Leukemia: Chinese National Multi-center Randomized Study|Recruiting||Phase 4|680|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||No||2017-10-11 01:05:30.435694|2017-10-11 01:05:30.435694
NCT01987284|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-10-19|||October 2013||2013-10-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||SER100 in Isolated Systolic Hypertension|A Randomized, Double-blind, Placebo-controlled, Cross-over, Multi-center Study Assessing the Safety, Tolerability and Efficacy of SER100 10 mg s.c. Twice Daily for 2 Days in Patients With Isolated Systolic Hypertension Insufficiently Treated With One or More Anti-hypertensives.|Completed||Phase 2|17|Actual|Serodus ASA||2|||f||||f||||||||||2017-10-11 01:05:30.588653|2017-10-11 01:05:30.588653
NCT01987271|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-12|||August 2012||2012-08-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effects Of Noninvasive Ventilation On Functional Capacity Of Patients With Cystic Fibrosis|Effects Of Noninvasive Ventilation During The Treadmill Walking Test On Cardiorespiratory System, Walk Distance, And Thoracoabdominal Kinematics Of Patients With Cystic Fibrosis: Clinical Randomized Controlled Trial.|Completed||N/A|13|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:05:30.70261|2017-10-11 01:05:30.70261
NCT01987245|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-04-27|||January 2014||2014-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|PWMQC||Plethysmographic Waveform for Monitoring the Quality of Cardiopulmonary Resuscitation|The Application Research of Plethysmographic Waveform in Quality Control Feedback System During Cardiopulmonary Resuscitation|Completed||N/A|617|Actual|Peking Union Medical College Hospital|||1||f||||f||||||||||2017-10-11 01:05:30.92426|2017-10-11 01:05:30.92426
NCT01987232|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-07-26|2017-07-26||November 5, 2013||2013-11-05|July 2017|2017-07-01|May 4, 2017|Actual|2017-05-04|August 2016|Actual|2016-08-01||Interventional|||Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer|Phase 1b/2, Multicenter, Open-label Study of Carfilzomib, Carboplatin, and Etoposide in Subjects With Previously Untreated Extensive-stage Small-cell Lung Cancer|Completed||Phase 1/Phase 2|32|Actual|Amgen||1|||f||||f||||||||||2017-10-11 01:05:31.04002|2017-10-11 01:05:31.04002
NCT01987219|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-04-26|2016-03-14||March 2013||2013-03-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia|The Effects of Bronchodilator Therapy On Respiratory and Autonomic Function in Patients With Familial Dysautonomia|Completed||Phase 3|15|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-10-11 01:05:33.239256|2017-10-11 01:05:33.239256
NCT01987206|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-07-20|||July 2014||2014-07-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Feasibility Study of PID Versus MPC and HMS|Feasibility Study of Using a PID (Proportional-Integral-Derivative) Controller Versus an MPC (Model Predictive Control) Controller Algorithm and Health Monitoring System (HMS)|Completed||Early Phase 1|10|Actual|William Sansum Diabetes Center||2|||f||||||||||||||2017-10-11 01:05:33.811883|2017-10-11 01:05:33.811883
NCT01987193|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-07-27|||July 2012|Actual|2012-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|||Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)|Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy|Enrolling by invitation||N/A|10|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-11 01:05:33.902222|2017-10-11 01:05:33.902222
NCT01987180|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-10-05|||January 2013||2013-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|February 2014|Actual|2014-02-01||Observational|||Using Smartphones in the Neonatal Intensive Care Unit|NICU-2-HOME: Using HIT to Support Parents of NICU Graduates Transitioning Home|Completed||N/A|90|Actual|Northwestern University|||2||f||||f||||||||||2017-10-11 01:05:35.711718|2017-10-11 01:05:35.711718
NCT01987167|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-08-17|||November 2013||2013-11-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ACHTAR||Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis|Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis|Completed||Early Phase 1|25|Actual|Neuro-Ophthalmologic Associates, PC||1|||f||||t||||||||||2017-10-11 01:05:35.782958|2017-10-11 01:05:35.782958
NCT01987154|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-05-16|||February 2014||2014-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula|Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula|Completed||N/A|61|Actual|Mead Johnson Nutrition||2|||f||||f||||||||||2017-10-11 01:05:35.885307|2017-10-11 01:05:35.885307
NCT01987141|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-05-10|||October 2013||2013-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|October 2014|Actual|2014-10-01||Interventional|WATE||Gestational Weight Gain and the Electronic Medical Record|WATE Study - Gestational Weight Gain and the Electronic Medical Record|Completed||N/A|150|Actual|Loyola University||2|||f||||f||||||||||2017-10-11 01:05:35.979304|2017-10-11 01:05:35.979304
NCT01987128|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-02-26|||November 2013||2013-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Popliteal Sciatic Nerve Block: Intraneural or Extraneural?|Blocco Del Nervo Sciatico al Poplite, Intraneurale o Extraneurale? Confronto Prospettico, Randomizzato in Cieco Tra la modalità di Iniezione di Anestetico Locale Per il Blocco Eco Guidato Del Nervo Sciatico al Poplite Nella Chirurgia Dell'Alluce Valgo|Completed||Phase 4|88|Actual|ASST Gaetano Pini-CTO||2|||f||||f||||||||||2017-10-11 01:05:36.071064|2017-10-11 01:05:36.071064
NCT01987115|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-02-04|||November 2013||2013-11-01|August 2013|2013-08-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Comparison of Fascial Manipulation With Traditional Physiotherapy for the Treatment of Trigger Fingers|Comparison of Fascial Manipulation With Traditional Physiotherapy for the Treatment of Trigger Fingers.|Unknown status|Recruiting|N/A|80|Anticipated|Clalit Health Services||2|||f||||t||||||||||2017-10-11 01:05:36.162773|2017-10-11 01:05:36.162773
NCT01987102|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-08-21|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Investigation of [6R] 5,10-methylenetetrahydrofolate as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.|An Open-Label, Multicenter, Phase I/II Clinical Trial to Identify the Modufolin® Dose With Most Favorable Safety Prospect and Confirmed Ability to Mitigate High-Dose Methotrexate Induced Toxicity During Treatment of Osteosarcoma Patients|Completed||Phase 1/Phase 2|8|Actual|Isofol Medical AB||2|||f||||t||||||||||2017-10-11 01:05:36.260386|2017-10-11 01:05:36.260386
NCT01987089|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-09-07|||August 15, 2014|Actual|2014-08-15|September 2017|2017-09-01|December 1, 2019|Anticipated|2019-12-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||The Efficacy of CBT-I in Alcoholics & Its Effects on Remission & Relapse|The Efficacy of CBT-I in Alcoholics & Its Effects on Remission & Relapse|Recruiting||N/A|86|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:05:36.360172|2017-10-11 01:05:36.360172
NCT01987076|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-07-29|||October 2013||2013-10-01|July 2015|2015-07-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|DRESSCODE||Comparison Between Corticosteroid and Topical Steroids in the DRESS|DRESS - Setting of Corticosteroid Treatment.|Unknown status|Recruiting|N/A|112|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:05:36.451949|2017-10-11 01:05:36.451949
NCT01987063|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-04-18|||February 2014||2014-02-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Observational|JUMODA||National Prospective and Comparative Study on the Mode of Delivery of Twins|National Prospective and Comparative Study on the Mode of Delivery of Twins|Completed||N/A|8979|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-10-11 01:05:36.555546|2017-10-11 01:05:36.555546
NCT01987050|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-11-12|||March 2012||2012-03-01|November 2013|2013-11-01||||September 2014|Anticipated|2014-09-01||Interventional|||Intranasal Oxytocin in Schizophrenia Patients|A Double-Blind, Placebo Controlled Comparison of Two Fixed Doses of Oxytocin and Placebo Administered Intranasally in Schizophrenia Patients|Unknown status|Recruiting|Phase 3|71|Anticipated|University of California, Irvine||3|||f||||t||||||||||2017-10-11 01:05:36.735501|2017-10-11 01:05:36.735501
NCT01987024|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-07-23|||October 2013||2013-10-01|July 2014|2014-07-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|||Advantage of Detection of phIGFBP-1 to Reduce Hospitalization Time for Stable Patients With a Risk of Preterm Labour.|Advantage of Detection of phIGFBP-1 to Reduce Hospitalization Time for Stable Patients With a Risk of Preterm Labour.|Unknown status|Recruiting|N/A|420|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:05:36.959564|2017-10-11 01:05:36.959564
NCT01987011|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-07-01|||August 2013||2013-08-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|||Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers|Randomized, Double Blind, Multicenter, Phase III Study to Evaluate the Immunogenicity and Safety of 'MG1109(Egg-based, Pre-pandemic Influenza(H5N1) Vaccine)' Administered Intramuscularly in Healthy Adult Volunteers|Completed||Phase 3|420|Actual|Green Cross Corporation||2|||f||||f||||||||||2017-10-11 01:05:37.09937|2017-10-11 01:05:37.09937
NCT01986998|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-06-02|||October 2013||2013-10-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse|Multicenter, Randomized, Double-blind Clinical Trial to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse.|Completed||Phase 4|49|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-10-11 01:05:37.230536|2017-10-11 01:05:37.230536
NCT01986985|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-02-09|2015-03-12||January 2014||2014-01-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|PET/MR US|Intent to treat|Comparison of 18F FDG PET/CT TO PET MRI|Comparison of 18F FDG PET/CT TO PET MRI|Completed||N/A|58|Actual|GE Healthcare||1|||f||||f||||||||||2017-10-11 01:05:37.383448|2017-10-11 01:05:37.383448
NCT01986972|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2013-11-12|||July 2009||2009-07-01|November 2013|2013-11-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Supragingival Plaque Removal With and Without Dentifrice|Supragingival Plaque Removal With and Without Dentifrice: A Randomized Controlled Trial|Completed||Phase 2|24|Actual|Franciscan University Center||2|||f||||t||||||||||2017-10-11 01:05:37.609793|2017-10-11 01:05:37.609793
NCT01986959|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2013-11-12|||September 2011||2011-09-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Periodontal Dressing After Surgical Crown Lengthening|Periodontal Dressing After Surgical Crown Lengthening: A Randomized Clinical Trial|Completed||Phase 2|37|Actual|Franciscan University Center||2|||f||||t||||||||||2017-10-11 01:05:37.712961|2017-10-11 01:05:37.712961
NCT01986946|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-01-10|2016-09-23||October 2013||2013-10-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Epidural Analgesia Versus IV Analgesia in Lumbar Spine Fusions|A Comparison of Epidural Analgesia With Standard Care Following Lumbar Spinal Fusion: A Prospective Randomized Study|Terminated||Phase 3|17|Actual|Duke University|Enrollment was terminated when co-PI/coordinator left Duke. No surgical collaborators would enroll subjects. Low enrollment of the study significantly affected the analysis, as both study arms were expected to have 100 participants each.|2||Lack of recruitment.|f||||f||||||||||2017-10-11 01:05:37.827484|2017-10-11 01:05:37.827484
NCT01986933|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-07-04|||November 2013||2013-11-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|April 2015|Actual|2015-04-01||Interventional|||A Phase 2 Study of CIM331 for Atopic Dermatitis Patients|A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY|Completed||Phase 2|264|Actual|Chugai Pharmaceutical||5|||f||||t||||||||||2017-10-11 01:05:38.374055|2017-10-11 01:05:38.374055
NCT01986894|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-08-06|||October 2013||2013-10-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|QT/QTc||A Phase 1 QT Study in Healthy Male Subjects|A Phase 1, Double-blind, Four Period Crossover Study to Investigate the Effects of Pomalidomide (CC 4047) on the QT Interval in Healthy Male Subjects|Completed||Phase 1|72|Actual|Celgene||4|||f||||f||||||||||2017-10-11 01:05:39.119118|2017-10-11 01:05:39.119118
NCT01986881|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-04-06|||November 4, 2013|Actual|2013-11-04|April 2017|2017-04-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess Cardiovascular Outcomes Following Treatment With Ertugliflozin (MK-8835/PF-04971729) in Subjects With Type 2 Diabetes Mellitus and Established Vascular Disease, The VERTIS CV Study|Active, not recruiting||Phase 3|8000|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 01:05:39.284754|2017-10-11 01:05:39.284754
NCT01986868|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-08-14|||April 2012||2012-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Identification of Adverse Plaque Characteristics by Coronary MR Angiography|Identification of Adverse Plaque Characteristics by Coronary Magnetic Resonance Angiography|Active, not recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-11 01:05:39.882072|2017-10-11 01:05:39.882072
NCT01986855|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-10-02|2017-09-05||December 2, 2013|Actual|2013-12-02|September 2017|2017-09-01|September 28, 2016|Actual|2016-09-28|September 28, 2016|Actual|2016-09-28||Interventional||The Overall Number of Baseline Participants was the All-Participants-As-Treated population.|A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) in Subjects With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Background Antihyperglycemic Therapy|Completed||Phase 3|468|Actual|Merck Sharp & Dohme Corp.|After unblinding, analysis of retained plasma samples revealed unreported metformin use by ~17% of participants. Neither dose nor frequency of the protocol-prohibited metformin use is known. This potentially confounds glycemic analyses.|3|||f||||t|t|f||||||||2017-10-11 01:05:40.039136|2017-10-11 01:05:40.039136
NCT01986842|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-11-27|||January 2014||2014-01-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|Pro-Hab||Habitual Protein Intake and Muscle Protein Synthesis|The Impact of Habitual Dietary Protein Intake on the Anabolic Response in Elderly Men|Completed||N/A|24|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 01:05:41.275233|2017-10-11 01:05:41.275233
NCT01986829|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-08-31|||February 3, 2014|Actual|2014-02-03|August 2017|2017-08-01|May 25, 2022|Anticipated|2022-05-25|August 25, 2017|Actual|2017-08-25||Interventional|||Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy|Tumor Ablation in Metastatic Sarcoma Stable on Chemotherapy|Active, not recruiting||Phase 2|9|Actual|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||||2017-10-11 01:05:41.392708|2017-10-11 01:05:41.392708
NCT01986816|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-11-12|||April 2014||2014-04-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|ROI-LGBP||Return on Investment on Lap Gastric Bypass Regarding Quality of Life|Lap Gastric Bypass and Its Impact on Wheightloss, QoL and Economic Cost|Unknown status|Not yet recruiting|N/A|200|Anticipated|Lund University|||1||f||||t||||||||||2017-10-11 01:05:41.571309|2017-10-11 01:05:41.571309
NCT01986803|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-08-10|||December 2013||2013-12-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2015|Actual|2015-09-01||Interventional|||ABSORB STEMI: the TROFI II Study|Comparison of the ABSORBTM Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (XienceTM) in Acute ST-Elevation Myocardial Infarction|Active, not recruiting||N/A|190|Anticipated|ECRI bv||2|||f||||t||||||||||2017-10-11 01:05:41.657509|2017-10-11 01:05:41.657509
NCT01986790|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-05-02|2016-02-11||April 2012||2012-04-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Effective Communication to Improve Decision Making About Health Care Plans|Effective Communication to Improve Decision Making About Health Care Plans|Completed||N/A|343|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 01:05:41.816862|2017-10-11 01:05:41.816862
NCT01986777|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-09-15|||July 2013||2013-07-01|September 2017|2017-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|LDX||LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy|LDX in the Treatment of Executive Function Difficulties in Women After Oophorectomy|Withdrawn||N/A|0|Actual|University of Pennsylvania||2||Funding not obtained|f||||f||||||||||2017-10-11 01:05:42.474704|2017-10-11 01:05:42.474704
NCT01986764|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-03-21|||July 1, 2013|Actual|2013-07-01|March 2017|2017-03-01|July 1, 2013|Actual|2013-07-01|July 1, 2013|Actual|2013-07-01||Interventional|E2LDX||E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy|Predictors of Healthy Mood and Memory After Oophorectomy|Withdrawn||N/A|0|Actual|University of Pennsylvania||3||Funding was not obtained for this study and no participants were enrolled.|f||||f||||||||||2017-10-11 01:05:42.583916|2017-10-11 01:05:42.583916
NCT01986751|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-09-15|2016-07-20||January 2014||2014-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness of Perineural Clonidine as an Adjuvant With Ropivacaine for Popliteal Nerve Block in Patients Undergoing Foot and Ankle Surgery|Effectiveness of Perineural Clonidine as an Adjuvant With Ropivacaine for Popliteal Nerve Block in Patients Undergoing Foot and Ankle Surgery|Terminated||Phase 1/Phase 2|14|Actual|University of Alabama at Birmingham||2||failure to enroll|f||||f||||||||||2017-10-11 01:05:42.698772|2017-10-11 01:05:42.698772
NCT01986738|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-03-02|||January 2012||2012-01-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer|A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer|Completed||N/A|9|Actual|University of Michigan Cancer Center|||1||f||||t||||||||||2017-10-11 01:05:43.151451|2017-10-11 01:05:43.151451
NCT01986725|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-01-06|||September 2013||2013-09-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|WOMAN-PROII||"The Impact of the WOMAN-PRO II Program on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence"|"The Impact of the Self-management Intervention WOMAN-PRO II Program on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence: A Mixed-Methods Project"|Completed||Phase 2|45|Actual|St.Gallen University of Applied Sciences||2|||f||||t||||||||||2017-10-11 01:05:43.234747|2017-10-11 01:05:43.234747
NCT01986712|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-10-04|||December 2013||2013-12-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma|An Observational Pilot Study to Compare the Compliance With and Health Related Quality of Life During Therapy With Standard High-Dose Interferon Alfa (Intron A, HDI) Versus Pegylated Alfa-Interferon 2b (Sylatron, PEG IFN) in Patients With Surgically Resected Melanoma|Recruiting||N/A|100|Anticipated|St. Luke's Hospital and Health Network, Pennsylvania|||2||f||||t||||||||||2017-10-11 01:05:43.351114|2017-10-11 01:05:43.351114
NCT01986699|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-05-08|||March 2010||2010-03-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Laparascopic Assisted Colonoscopic Polypectomy|Randomized Controlled Trial-Laparoscopic Assisted Colonoscopic Polypectomy|Completed||N/A|34|Actual|Stony Brook University|||2||f||||f||||||||||2017-10-11 01:05:43.475367|2017-10-11 01:05:43.475367
NCT01986673|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2014-01-23|||October 2013||2013-10-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Single-Dose Relative Bioavailability Study of SST-6006, a Topical Sildenafil Cream Versus Oral Sildenafil in Healthy Male Adults||Completed||Phase 1|62|Actual|Strategic Science & Technologies, LLC||2|||f||||||||||||||2017-10-11 01:05:43.645837|2017-10-11 01:05:43.645837
NCT01986660|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2014-01-23|||October 2013||2013-10-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults||Completed||Phase 1|14|Actual|Strategic Science & Technologies, LLC||1|||f||||||||||||||2017-10-11 01:05:43.742298|2017-10-11 01:05:43.742298
NCT01986634|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-11-11|||September 2013||2013-09-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|April 2014|Anticipated|2014-04-01||Interventional|||Laser Spot Treatment of Perioral Rhytids|Efficacy of Spot Treatment of Perioral Rhytids Compared to Full Field Laser Resurfacing|Unknown status|Not yet recruiting|Phase 3|30|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-10-11 01:05:43.91837|2017-10-11 01:05:43.91837
NCT01986621|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-01-08|||April 2014||2014-04-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Observational|||Myocardial Injury or Type 4 Infarction Following Elective Coronary Artery Stenting|Identifying Patients at Higher Risk for Periprocedural Myocardial Injury or Infarction Who Might Benefit From More Potent Antiplatelet Therapy Following Elective PCI|Completed||N/A|530|Actual|University Hospital Heidelberg|||1||f||||||||||||||2017-10-11 01:05:44.007225|2017-10-11 01:05:44.007225
NCT01986608|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-09-11|||November 2013||2013-11-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects|A Single Center Open-label, Randomized, Single-dose, 3-way Crossover Study to Compare the Safety, Tolerability, and Pharmacokinetics of Lacosamide Administered as Oral Tablet or Intravenous Infusion in Healthy Japanese Subjects|Completed||Phase 1|26|Actual|UCB Pharma||3|||f||||f||||||||||2017-10-11 01:05:44.074266|2017-10-11 01:05:44.074266
NCT01986595|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-11|||August 2013||2013-08-01|November 2013|2013-11-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01|5 Years|Observational [Patient Registry]|||A Pilot Study on ALK Gene Mutations in Neuroblastoma|A Pilot Study on ALK Gene Mutations in Neuroblastoma|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     Biopsy tumor tissue(mail tumor or bone marrow) or Blood   "|||2017-10-11 01:05:44.172511|2017-10-11 01:05:44.172511
NCT01986582|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2015-09-21|||October 2013||2013-10-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|NOPAR||NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis|Stage 2, Double-blind, Randomized, Parallel Groups, One Centre Study in Patients With Allergic Rhinitis Treated With Nasal Oxymetazoline in Combination With Nasal Hydroxyl-propyl-methyl Cellulose (HPMC) or Placebo|Completed||Phase 2|40|Anticipated|Association Asthma, Bulgaria||2|||f||||t||||||||||2017-10-11 01:05:44.249283|2017-10-11 01:05:44.249283
NCT01986569|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2016-12-07|||November 2013||2013-11-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer|A Phase III, Open Label, Non-randomized, Single Center Study to Evaluate Diagnostic Accuracy and Safety of Fluorine-18 (18F) Fluoroestradiol PET/CT in the Assessment of ER Status of Recurrent or Metastatic Lesions in Patients With Breast Cancer|Completed||Phase 3|93|Actual|Asan Medical Center||1|||f||||t||||||||||2017-10-11 01:05:44.335301|2017-10-11 01:05:44.335301
NCT01986556|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2014-09-19|||November 2013||2013-11-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Lesinurad Tablet Relative Bioavailability|A Phase 1, Randomized, Open-Label, Crossover Study in Healthy Adult Male Subjects to Assess the Relative Bioavailability of Lesinurad Tablets Manufactured at Two Different Sites|Completed||Phase 1|36|Actual|Ardea Biosciences, Inc.||4|||f||||f||||||||||2017-10-11 01:05:44.406925|2017-10-11 01:05:44.406925
NCT01986543|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-12|2017-07-10|||December 2013|Actual|2013-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIFAVIRENZ||Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection|Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection|Active, not recruiting||Phase 2|105|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||3|||f||||t||||||||||2017-10-11 01:05:44.510663|2017-10-11 01:05:44.510663
NCT01986530|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2015-01-20|||November 2013||2013-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|IRISSAS||Circulating Levels of Irisin in Healthy Young Subjects|Circulating Irisin in Healthy Young Men and Women and Correlation With Lean Body Mass, Fat Mass and Adipocytokines. Circadian and Seasonal Variation and the Effect of Food Intake and Exercise|Completed||N/A|122|Actual|424 General Military Hospital|||5||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:05:44.603357|2017-10-11 01:05:44.603357
NCT01986517|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-03-19|||November 2013||2013-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Feedback and Psychotherapeutic Competencies|Impact of Feedback on the Devolpment of Psychotherapeutic Competencies: a Randomized Controlled Trial|Completed||N/A|20|Actual|Goethe University||2|||f||||f||||||||||2017-10-11 01:05:44.698773|2017-10-11 01:05:44.698773
NCT01986504|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-07-18|||June 2011||2011-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2014|Actual|2014-06-01|5 Years|Observational [Patient Registry]|||The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study|The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study|Completed||N/A|1058|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 01:05:44.925354|2017-10-11 01:05:44.925354
NCT01986491|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-11-11|||May 2009||2009-05-01|November 2013|2013-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study of Solid Formulations of JNJ-39393406 in Healthy Male Participants|An Open-Label, Single Dose, Relative Bioavailability Study of Solid Formulations in Fed and Fasted Conditions Followed by a Repeated Dose Study of a Selected Solid Formulation of JNJ-39393406 in Healthy Male Subjects|Completed||Phase 1|20|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||7|||f||||f||||||||||2017-10-11 01:05:44.992504|2017-10-11 01:05:44.992504
NCT01986478|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-03-25|||October 2013||2013-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||OCT Reference Database|Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Reference Database Study|Completed||N/A|389|Actual|Topcon Medical Systems, Inc.|||1||f||||f||||||||||2017-10-11 01:05:45.166589|2017-10-11 01:05:45.166589
NCT01986465|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-11-11|||May 2013||2013-05-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effectiveness of Steroid Injection in Treating Patients With Lateral Epicondylitis|Comparing the Effectiveness of Steroid Injection Versus Placebo and Immobilization Versus no Immobilization in Treating Patients With Lateral Epicondylitis|Completed||Phase 2/Phase 3|78|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:05:45.247965|2017-10-11 01:05:45.247965
NCT01986452|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-02-24|||December 2013||2013-12-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Telemonitoring of CPAP Therapy in Apoplexy Patients With OSA|CPAP Therapie Mit Telemonitoring Bei Obstruktiver Schlafapnoe Und Apoplexie|Recruiting||N/A|80|Anticipated|Institut für Pneumologie Hagen Ambrock eV||2|||f||||f||||||||||2017-10-11 01:05:45.350443|2017-10-11 01:05:45.350443
NCT01986439|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-04-13|||August 2007||2007-08-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Contraceptive Choice Project|The Contraceptive Choice Project|Unknown status|Active, not recruiting|N/A|9256|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||Samples Without DNA|"     vaginal swab specimens for chlamydia, gonorrhea, trichomoniasis, and bacterial vaginosis.     Blood specimens for HIV and syphilis.   "|||2017-10-11 01:05:45.446348|2017-10-11 01:05:45.446348
NCT01986426|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-03-30|||November 2013|Actual|2013-11-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab|A Phase I, Open-label, Multi-arm, Multi-centre, Multi-dose, Dose Escalation Study of LTX-315 as Monotherapy or in Combination With Either Ipilimumab or Pembrolizumab in Patients With Transdermally Accessible Tumours|Recruiting||Phase 1|80|Anticipated|Lytix Biopharma AS||4|||f||||f||||||||No||2017-10-11 01:05:45.548928|2017-10-11 01:05:45.548928
NCT01986413|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-03-23|||July 2013||2013-07-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Intelligent Volume Assured Pressure Support to Improve Sleep Quality and Respiratory Events in Patients With Non Invasive Ventilation|German: Einfluss Von Gesichertem Atemminutenvolumen Auf Schlafqualität Und Häufigkeit Respiratorischer Ereignisse Bei Patienten Mit Nicht Invasiver Beatmung (NIV)|Completed||N/A|21|Actual|Institut für Pneumologie Hagen Ambrock eV||2|||f||||f||||||||||2017-10-11 01:05:45.727607|2017-10-11 01:05:45.727607
NCT01986400|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-03-31|||July 2013||2013-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|May 2015|Actual|2015-05-01||Interventional|||Virtual Peer-to-Peer (VP2P) Support Mentoring for Juvenile Idiopathic Arthritis (JIA): A Pilot RCT|Virtual Peer-to-Peer Support Mentoring for Adolescents With Juvenile Idiopathic Arthritis: A Feasibility Pilot Randomized Controlled Trial|Completed||N/A|30|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 01:05:45.83634|2017-10-11 01:05:45.83634
NCT01986387|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-03-31|||July 2013||2013-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|May 2015|Actual|2015-05-01||Interventional|||Virtual Peer-to-Peer (VP2P) Support Mentoring for Chronic Pain: A Pilot RCT|Virtual Peer-to-Peer (VP2P) Support Mentoring for Adolescents With Chronic Pain: A Feasibility Pilot Randomized Controlled Trial|Completed||N/A|30|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 01:05:45.931544|2017-10-11 01:05:45.931544
NCT01986374|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-11-25|||June 2013||2013-06-01|November 2013|2013-11-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF|Intrauterine Injection of Human Chorionic Gonadotropin to Enhance Embryo Implantation|Unknown status|Recruiting|N/A|75|Anticipated|Servy Massey Fertility Insititute||1|||f||||f||||||||||2017-10-11 01:05:46.046462|2017-10-11 01:05:46.046462
NCT01986361|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-08-30|2017-07-20||September 2013||2013-09-01|August 2017|2017-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Randomized|Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method|A Single-Dose, Randomized, Double-Blind, Placebo-Controlled Onset-of-Action Study Utilizing the Double-Stopwatch Method|Completed||Phase 3|122|Actual|Reckitt Benckiser LLC||2|||f||||f||||||||||2017-10-11 01:05:46.176333|2017-10-11 01:05:46.176333
NCT01986348|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-05-25|||March 2014||2014-03-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|KING||A Phase 2 Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Patients With Recurrent Gliomas|A Phase 2 Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Patients With Recurrent Gliomas|Active, not recruiting||Phase 2|125|Anticipated|Karyopharm Therapeutics Inc||6|||f||||f||||||||Yes||2017-10-11 01:05:46.934036|2017-10-11 01:05:46.934036
NCT01986335|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-11|||August 2012||2012-08-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial|Phase 3 of Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial|Completed||Phase 3|600|Actual|PT Bio Farma||3|||f||||t||||||||||2017-10-11 01:05:47.078123|2017-10-11 01:05:47.078123
NCT01986322|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-11|||July 2011||2011-07-01|November 2013|2013-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine|Phase 2 Study of Immunogenicity and Safety of DPT/HB/Hib (Bio Farma) Vaccine Compared to DTP/HB (Bio Farma) Vaccine Given Simultaneously With Hib (Registered) Vaccine in Indonesian Infants|Completed||Phase 2|220|Actual|PT Bio Farma||2|||f||||t||||||||||2017-10-11 01:05:47.205652|2017-10-11 01:05:47.205652
NCT01986309|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-09-22|||March 2012||2012-03-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|LETSVN||Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery|Use of Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery, With or Without Adenoids|Completed||Phase 4|92|Actual|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||||2017-10-11 01:05:47.321406|2017-10-11 01:05:47.321406
NCT01986296|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-08-07|||January 2013||2013-01-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||ExAblate Transcranial MR Guided Focused Ultrasound in the Treatment of Medication Refractory Obsessive Compulsive Disorder|A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound Treatment of Medication-Refractory OCD|Recruiting||Phase 1/Phase 2|15|Anticipated|InSightec||1|||f||||t||||||||||2017-10-11 01:05:47.445093|2017-10-11 01:05:47.445093
NCT01986283|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-03-31|||November 2013||2013-11-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Abuse Potential Study of PF-00345439|A Randomized, Double-blind, Triple-dummy, Placebo Controlled, Single-dose, 4-way Crossover Study To Determine The Relative Abuse Potential Of Pf-00345439 (Oxycodone Extended Release Capsules) Compared To Immediate-release Oxycodone And Placebo When Administered Orally Whole And/or Chewed To Non-dependent, Recreational Opioid Users Under Fasted Conditions|Completed||Phase 1|67|Actual|Pain Therapeutics||4|||f||||f||||||||||2017-10-11 01:05:47.580526|2017-10-11 01:05:47.580526
NCT01986270|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-11|||December 1996||1996-12-01|November 2013|2013-11-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo|A Multicenter, Double-blind, Placebo Controlled, Parallel Group, Study of Two Dose Levels of Oral Eletriptan and Two Dose Levels of of Oral Sumatriptan Given for the Acute Treatment of Migraine|Completed||Phase 3|1141|Actual|Pfizer||5|||f||||t||||||||||2017-10-11 01:05:47.754246|2017-10-11 01:05:47.754246
NCT01986257|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-01-03|||September 2013||2013-09-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Interventional|||ERGT for Women Engaging in NSSI - an Effectiveness Study|Emotion Regulation Group Therapy (ERGT) for Women Engaging in Non-suicidal Self-Injury (NSSI) - an Effectiveness Study|Completed||N/A|97|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 01:05:47.869473|2017-10-11 01:05:47.869473
NCT01986244|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-07-27|||June 13, 2007|Actual|2007-06-13|July 2017|2017-07-01|July 2027|Anticipated|2027-07-01|July 2027|Anticipated|2027-07-01||Observational|TAR1600||Total Ankle Replacement for Ankle Arthritis|Total Ankle Replacement for Ankle Arthritis|Recruiting||N/A|1000|Anticipated|Duke University|||3||f||||f||||||||||2017-10-11 01:05:47.966772|2017-10-11 01:05:47.966772
NCT01986231|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-04-30|2014-09-09||January 2011||2011-01-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver|The Effect of Repeated Doses of Subcutaneous Glucagon on Hepatic Glycogen Stores in Persons With Type 1 Diabetes|Completed||N/A|12|Actual|Legacy Health System||1|||f||||t||||||||||2017-10-11 01:05:48.090838|2017-10-11 01:05:48.090838
NCT01986218|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-09-13|||November 2013||2013-11-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors|Phase I Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-986115 in Subjects With Advanced Solid Tumors|Terminated||Phase 1|36|Actual|Bristol-Myers Squibb||4||(Non-safety reason, business objectives have changed)|f||||f||||||||||2017-10-11 01:05:48.345187|2017-10-11 01:05:48.345187
NCT01986205|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-10-02|||September 6, 2017|Actual|2017-09-06|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|HYBOBI2||Hyperbaric Oxygen for Civilian Post-concussive Syndrome|A Double-blind Randomized Trial of Hyperbaric Oxygen Versus Sham in Civilian Post-concussive Syndrome|Recruiting||Phase 2|90|Anticipated|Intermountain Health Care, Inc.||3|||f||||f|t|t|f|f|f|||||2017-10-11 01:05:48.487454|2017-10-11 01:05:48.487454
NCT01986192|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-11-18|||November 2013||2013-11-01|November 2014|2014-11-01|November 2015|Anticipated|2015-11-01|February 2015|Anticipated|2015-02-01||Interventional|PRAIS||Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study|An Efficacy and Safety Study of Ribaroxaban for the Prevention of Deep Vein Thrombosis Recurrence in Patients With Acute Iliofemoral Venous Thrombosis Initially Treated With Thrombolysis|Unknown status|Recruiting|N/A|72|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:05:48.647418|2017-10-11 01:05:48.647418
NCT01986179|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-05-18|||February 2014||2014-02-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparing Remote Interpreter Modalities in the Pediatric Emergency Department|Impact of Remote Interpreter Modality on Comprehension, Communication Quality, and Consistency of Interpreter Use in the Pediatric Emergency Department|Completed||N/A|208|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-11 01:05:48.754785|2017-10-11 01:05:48.754785
NCT01986166|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-07-14|||November 2013||2013-11-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRAS|A Phase Ib, Open-Label, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of MEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors With Mutant KRAS|Completed||Phase 1|23|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-11 01:05:48.848628|2017-10-11 01:05:48.848628
NCT01986153|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-11-11|||December 2013||2013-12-01|November 2013|2013-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01|1 Day|Observational [Patient Registry]|||Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients|Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients|Completed||N/A|60|Anticipated|Radboud University|||2||f||||f||||||||||2017-10-11 01:05:48.971505|2017-10-11 01:05:48.971505
NCT01986140|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-08-03|||May 15, 2014|Actual|2014-05-15|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|February 10, 2017|Actual|2017-02-10||Interventional|SCALP||Scalp Cooling to Prevent Chemo-induced Hair Loss|Scalp Cooling for Alopecia Prevention (SCALP)|Active, not recruiting||N/A|235|Actual|Baylor Breast Care Center||2|||f||||t||||||||||2017-10-11 01:05:49.04035|2017-10-11 01:05:49.04035
NCT01986127|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-03-28|||February 2014||2014-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients|A Randomized, Double-blinded, Placebo-controlled Study on the Effects of Adalimumab Intralesional Intestinal Strictures of Crohn's Disease Patients|Recruiting||Phase 3|102|Anticipated|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 01:05:49.292175|2017-10-11 01:05:49.292175
NCT01986114|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-02-24|||November 2013||2013-11-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.|A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.|Active, not recruiting||Phase 3|405|Anticipated|Sumitomo Dainippon Pharma Co., Ltd.||1|||f||||f||||||||||2017-10-11 01:05:49.47102|2017-10-11 01:05:49.47102
NCT01986101|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-08-04|||January 2014||2014-01-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Phase III Study of SM-13496 in Patients With Bipolar I Depression.|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of SM-13496 for the Treatment of Bipolar I Depression.|Completed||Phase 3|525|Actual|Sumitomo Dainippon Pharma Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:05:49.595501|2017-10-11 01:05:49.595501
NCT01986088|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2013-11-11|||November 1996||1996-11-01|November 2013|2013-11-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study|A Multicentre, Double Blind, Double Dummy, Parallel Group, Placebo Controlled, Study of Two Dose Levels of Oral Eletriptan and Two Dose Levels Oral Sumatriptan Given for the Acute Treatment of Migraine(With and Without Aura).|Completed||Phase 3|1008|Actual|Pfizer||5|||f||||t||||||||||2017-10-11 01:05:49.728093|2017-10-11 01:05:49.728093
NCT01986075|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-04-03|||January 2014||2014-01-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||A Sequenced Behavioral and Medication Intervention for Cocaine Dependence|A Sequenced Behavioral and Medication Intervention for Cocaine Dependence|Recruiting||Phase 1/Phase 2|155|Anticipated|New York State Psychiatric Institute||3|||f||||t||||||||No||2017-10-11 01:05:49.844154|2017-10-11 01:05:49.844154
NCT01986062|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-03-18|2015-06-05||December 2013||2013-12-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting|A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom|Completed||Phase 4|97|Actual|Arbor Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:05:49.99199|2017-10-11 01:05:49.99199
NCT01986049|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-14|||February 2013||2013-02-01|November 2013|2013-11-01||||February 2014|Anticipated|2014-02-01||Interventional|TAP Block||Transversus Abdominis Plane (TAP) Block for Post Caesarian Pain|Phase 3 Study Comparing Transversus Abdominis Plane Block After Caesarian Section Usin Bupivacaine 0.5% vs. Bupivacaine 0.25% vs. Placebo (Normal Saline).|Unknown status|Recruiting|Phase 3|60|Anticipated|New York Methodist Hospital||3|||f||||t||||||||||2017-10-11 01:05:50.806191|2017-10-11 01:05:50.806191
NCT01986036|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2014-04-18|||November 2013||2013-11-01|April 2014|2014-04-01|May 2014|Anticipated|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||The Acute, Synergistic Effects of Protein and Calcium on Appetite and Energy Intake|The Acute, Synergistic Effects of Protein and Calcium on Appetite and Energy Intake|Unknown status|Active, not recruiting|N/A|20|Anticipated|Northumbria University||4|||f||||f||||||||||2017-10-11 01:05:50.917985|2017-10-11 01:05:50.917985
NCT01986023|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-08-18|||December 2013||2013-12-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Improving Medication Adherence Through SMS (Short Messaging Service) in Adult Stroke Patients: a Randomised Controlled Behaviour Intervention Trial|A Randomized Controlled SMS Intervention For Improving Medication Adherence in Adult Stroke Patients|Completed||N/A|200|Actual|Aga Khan University||2|||f||||t||||||||||2017-10-11 01:05:51.01885|2017-10-11 01:05:51.01885
NCT01986010|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-03-21|||November 25, 2013|Actual|2013-11-25|March 2017|2017-03-01|March 14, 2017|Actual|2017-03-14|April 19, 2016|Actual|2016-04-19||Interventional|||Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)|A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults|Completed||Phase 1|190|Actual|Merck Sharp & Dohme Corp.||17|||f||||f||||||||||2017-10-11 01:05:51.115672|2017-10-11 01:05:51.115672
NCT01985997|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-09-02|||January 2014||2014-01-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age|Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age|Completed||Phase 4|95000|Actual|MedImmune LLC|||1||f||||f||||||||||2017-10-11 01:05:51.256594|2017-10-11 01:05:51.256594
NCT01985984|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-03-01|||July 2012||2012-07-01|March 2017|2017-03-01|January 2023|Anticipated|2023-01-01|January 2022|Anticipated|2022-01-01|5 Years|Observational [Patient Registry]|OutcomeH&N||Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy Patients|Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy Using Multi-parameter Modelling: Disease Control, Toxicity and Quality of Life|Recruiting||N/A|1000|Anticipated|Maastricht Radiation Oncology|||1||f||||t||||||||No||2017-10-11 01:05:51.334759|2017-10-11 01:05:51.334759
NCT01985971|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-12-14|||March 2011||2011-03-01|December 2015|2015-12-01||||March 2014|Actual|2014-03-01||Interventional|||F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer|F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer|Active, not recruiting||N/A|25|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:05:51.425468|2017-10-11 01:05:51.425468
NCT01985958|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-07-31|||July 2013||2013-07-01|July 2017|2017-07-01||||September 2015|Actual|2015-09-01||Interventional|||A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas|A Pilot Study to Evaluate Radiotherapy-Induced Ant-Tumor Immunity in Metastatic Carcinoma of the Pancreas|Active, not recruiting||N/A|4|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:05:51.488699|2017-10-11 01:05:51.488699
NCT01985945|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-01-22|||March 2013||2013-03-01|January 2016|2016-01-01||||July 2015|Actual|2015-07-01||Interventional|||Yoga for Breast Cancer|A Randomized Study of the Effect of Yoga in Patients With Breast Cancer Receiving Radiation Therapy|Active, not recruiting||N/A|70|Actual|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:05:51.548408|2017-10-11 01:05:51.548408
NCT01985932|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-12-14|||July 2012||2012-07-01|December 2015|2015-12-01||||April 2014|Actual|2014-04-01||Interventional|||Functional MRI Use in Prostate Radiation Treatment Planning|A Prospective Study Evaluating Non-Endorectal Coil Functional MRI Identification of Intraprostatic Tumor During Radiation Treatment Planning|Active, not recruiting||N/A|15|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:05:51.611787|2017-10-11 01:05:51.611787
NCT01985919|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2016-04-11|||February 2010||2010-02-01|April 2016|2016-04-01||||February 2017|Anticipated|2017-02-01||Interventional|||Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples|Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples|Recruiting||N/A|150|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:05:51.686699|2017-10-11 01:05:51.686699
NCT01985906|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-05-05|||May 2014||2014-05-01|May 2014|2014-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|SEMPER||Safety and Efficacy of Multiple Overlapping Uncovered Stents for Pararenal Aortic Aneurysm Repair|Evaluation of the Safety and Efficacy of Multiple Overlapping Uncovered Stents for Endovascular Pararenal Aortic Aneurysm Repair|Recruiting||N/A|50|Anticipated|Changhai Hospital||1|||f||||t||||||||||2017-10-11 01:05:51.766093|2017-10-11 01:05:51.766093
NCT01985893|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2016-01-13|||September 2013||2013-09-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|THOR||Safety and Efficacy of Lapatinib Plus Trastuzumab or Lapatinib Plus Capecitabine in Metastatic Breast Cancer|Randomised, Open-label Phase II Study to Compare the Safety and Efficacy of Lapatinib Plus Trastuzumab or Lapatinib Plus Capecitabine in Trastuzumab-resistant HER2-overexpressing Metastatic Breast Cancer|Withdrawn||Phase 2|0|Actual|Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.||2||Due to missing patient recruitment, the financial support was stopped.|f||||f||||||||||2017-10-11 01:05:51.889845|2017-10-11 01:05:51.889845
NCT01985880|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2017-07-06|||November 2013||2013-11-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01|6 Months|Observational [Patient Registry]|||The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome|Experimental Study of Biomarker in Patient With Interstitial Cystitis/Painful Bladder|Recruiting||N/A|30|Anticipated|Asan Medical Center|||3||f||||t||||||Samples With DNA|"     bladder biopsy, urine, blood   "|||2017-10-11 01:05:52.038252|2017-10-11 01:05:52.038252
NCT01985854|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-11-09|||January 2014||2014-01-01|November 2013|2013-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery|Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery: A Pilot Study for Assessment of Recovery Parameters|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Tokyo Women's Medical University||2|||f||||f||||||||||2017-10-11 01:05:52.255819|2017-10-11 01:05:52.255819
NCT01985841|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2015-10-07|||October 2011||2011-10-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer|Phase II, Open-label Non-randomized Trial to Investigate the Efficacy of Bevacizumab in Combination With Dose Dense Sequential Chemotherapy in the Neo-adjuvant Setting for HER2 Negative Breast Cancer Patients|Terminated||Phase 2|34|Actual|Hellenic Oncology Research Group||1||Due to poor accrual|f||||f||||||||||2017-10-11 01:05:52.374125|2017-10-11 01:05:52.374125
NCT01985828|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-01-26|||March 2014||2014-03-01|January 2017|2017-01-01|December 2026|Anticipated|2026-12-01|December 2021|Anticipated|2021-12-01||Interventional|||CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer|Prospective Evaluation of CyberKnife® as Monotherapy or Boost Stereotactic Body Radiotherapy for Intermediate or High Risk Localized Prostate Cancer|Recruiting||N/A|72|Anticipated|Advocate Health Care||2|||f||||f||||||||||2017-10-11 01:05:52.512135|2017-10-11 01:05:52.512135
NCT01985815|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-11-08|||March 2008||2008-03-01|June 2013|2013-06-01||||February 2010|Actual|2010-02-01||Interventional|||Refining the Target for Deep Brain Stimulation (DBS) in Severe, Treatment Refractory Obsessive Compulsive Disorder (OCD)||Completed||Phase 1/Phase 2|6|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 01:05:52.632967|2017-10-11 01:05:52.632967
NCT01985802|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-01-31|||December 2015||2015-12-01|January 2017|2017-01-01||||June 2018|Anticipated|2018-06-01||Interventional|||Pacing in First-degree AV-block|Optimal Pacing in Patients With First-degree AV-block|Recruiting||N/A|20|Anticipated|Duke University||1|||f||||f||||||||||2017-10-11 01:05:52.733604|2017-10-11 01:05:52.733604
NCT01985789|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-04-07|||November 2013||2013-11-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Anti-histamines and Methacholine Challenges.|The Effect of Antihistamines on Methacholine Challenge Testing in Asthma Patients|Completed||Phase 4|12|Actual|University of Saskatchewan||4|||f||||f||||||||||2017-10-11 01:05:52.832591|2017-10-11 01:05:52.832591
NCT01985776|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-06-05|||June 2013||2013-06-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|ExerciseLBP||Effects of Exercise Intervention on Patients With Low Back Pain Due to Spondylolytic Spondylolisthesis.|Effects of Exercise Intervention on Patients With Low Back Pain Due to Spondylolytic Spondylolisthesis.|Unknown status|Active, not recruiting|N/A|48|Anticipated|University of Primorska||4|||f||||f||||||||||2017-10-11 01:05:52.923506|2017-10-11 01:05:52.923506
NCT01985763|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2017-01-25|||November 2013||2013-11-01|January 2017|2017-01-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|||Genistein in Treatment of Metastatic Colorectal Cancer|Genistein Combined With FOLFOX or FOLFOX-Avastin for Treatment of Metastatic Colorectal Cancer: Phase I/II Pilot Study|Completed||Phase 1/Phase 2|13|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 01:05:53.016353|2017-10-11 01:05:53.016353
NCT01985750|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-10-25|||November 2013||2013-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception|Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception|Recruiting||Early Phase 1|90|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-11 01:05:54.750773|2017-10-11 01:05:54.750773
NCT01985737|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2015-12-17|||November 2013||2013-11-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|November 2015|Actual|2015-11-01||Observational|||Catheter Biofilm Microbiome in Infected Neonatal Catheters.|BIOFILM MICROBIOME AND MICROBIAL DNA LOAD IN NEONATAL CATHETER-ASSOCIATED BLOODSTREAM INFECTIONS|Active, not recruiting||N/A|144|Actual|Baylor College of Medicine|||2||f||||f||||||Samples With DNA|"     We will collect approximately 10 drops of blood from the infant for our research study. We     will take the blood directly from the PICC tube when it is being removed. We will also take a     skin swab from around the area where the PICC tube was placed.   "|||2017-10-11 01:05:54.896574|2017-10-11 01:05:54.896574
NCT01985724|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2014-05-13|||October 2007||2007-10-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer|A Multicenter Randomized Study Comparing the Dose Dense, G-CSF-supported Sequential Administration of FE75C Followed by Docetaxel Versus Docetaxel/Cyclophosphamide Doublet as Adjuvant Chemotherapy in Women With HER-2 Negative, Axillary Lymph Node Positive Breast Cancer|Completed||Phase 3|650|Actual|Hellenic Oncology Research Group||2|||f||||||||||||||2017-10-11 01:05:54.991337|2017-10-11 01:05:54.991337
NCT01985711|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2013-11-14|||May 2014||2014-05-01|November 2013|2013-11-01|April 2017|Anticipated|2017-04-01|May 2016|Anticipated|2016-05-01||Interventional|WBCC||Web-Based Collaborative Care for Patients With Diabetes and Depression|Effects of a Web-Based Collaborative Care Management System (WBCCMS) on Psychosocial Outcomes and Biochemical Outcomes Among Patients With Diabetes and Depression|Unknown status|Not yet recruiting|N/A|300|Anticipated|Beijing Anzhen Hospital||2|||f||||f||||||||||2017-10-11 01:05:55.143836|2017-10-11 01:05:55.143836
NCT01985698|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-09|2016-10-27|||November 2013||2013-11-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|RLOAPR||A Trial of Robotic-assisted Versus Laparoscopic Versus Open Abdominoperineal Resection for Treating Low Rectal Cancer|A Single-centre, Prospective, Randomised, Controlled, Unblinded, Parallel-group Trial of Robotic-assisted Versus Laparoscopic Versus Open Abdominoperineal Resection for the Curative Treatment of Low Rectal Cancer|Recruiting||N/A|402|Anticipated|Fudan University||3|||f||||t||||||||||2017-10-11 01:05:55.324493|2017-10-11 01:05:55.324493
NCT01985685|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-11|2017-09-07|2017-09-07||October 2013||2013-10-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|TVO2_RCT||The Effect of Thiamine vs. Placebo on VO2 in Critical Illness|The Effect of Thiamine vs. Placebo on VO2 in Critical Illness|Completed||Phase 2|66|Actual|Beth Israel Deaconess Medical Center|We found differences in variability in VO2 after study drug in the subgroup of patients (35%) who were thiamine deficient.|2|||f||||t||||||||||2017-10-11 01:05:55.489675|2017-10-11 01:05:55.489675
NCT01985672|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2015-08-05|||August 2013||2013-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2014|Actual|2014-06-01||Observational|||Vitamin D Deficiency and Pregnancy Rates in Women Undergoing Frozen Embryo Transfer|Vitamin D Deficiency and Pregnancy Rates in Women Undergoing Frozen Embryo Transfer. A Prospective Cohort Study|Completed||N/A|280|Actual|Universitair Ziekenhuis Brussel|||2||f||||f||||||||||2017-10-11 01:05:55.919193|2017-10-11 01:05:55.919193
NCT01985659|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2013-11-10|||November 2013||2013-11-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|February 2014|Anticipated|2014-02-01||Observational|||Nodal Upstaging in VATS Anatomical Resections for NSCLC|Cohort Analysis of Nodal Upstaging in the Era of Increase of VATS Anatomical Resections for NSCLC|Unknown status|Active, not recruiting|N/A|900|Anticipated|University Hospital, Gasthuisberg|||3||f||||f||||||||||2017-10-11 01:05:56.168727|2017-10-11 01:05:56.168727
NCT01985646|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-10|||October 2009||2009-10-01|November 2013|2013-11-01||||November 2011|Actual|2011-11-01||Interventional|||A Trial on Conservative Treatment for Infants' Hirschsprung Disease|A Prospective, Randomized Controlled Trial of Conservative Versus Surgery Treatment of Normal and Short-segment Hirschsprung Disease for Infants|Completed||Early Phase 1|48|Actual|Tongji Hospital||2|||f||||t||||||||||2017-10-11 01:05:56.274164|2017-10-11 01:05:56.274164
NCT01985633|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-15|||January 2013||2013-01-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|MSCPRPOAK||Mesenchymal Stem Cells Enhanced With PRP Versus PRP In OA Knee|Autologous Bone Marrow Derived Mesenchymal Stem Cells Enhanced With Platelet Rich Plasma Versus Platelet Rich Plasma In Osteoarthritis Knee:A Comparative Study|Unknown status|Recruiting|Phase 1/Phase 2|24|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 01:05:56.367679|2017-10-11 01:05:56.367679
NCT01985620|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2014-06-25|||November 2013||2013-11-01|November 2013|2013-11-01||||April 2015|Anticipated|2015-04-01||Interventional|||The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.|The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate and Morbidity in Infants Born Premature.|Unknown status|Recruiting|N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 01:05:56.474576|2017-10-11 01:05:56.474576
NCT01985607|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-03-20|||February 2011||2011-02-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|ALLAR||Efficacy of a New Thickened Extensively Hydrolyzed Formula|Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Cow's Milk Hypersensitivity|Completed||N/A|72|Anticipated|United Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:05:56.592244|2017-10-11 01:05:56.592244
NCT01985594|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-10|||November 2013||2013-11-01|November 2013|2013-11-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Interventional|UTROGESTAN||Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial|STUDY ON EFFICACY OF UTROGESTAN AS TOCOLYSIS FOR PRETERM LABOR|Unknown status|Not yet recruiting|Phase 2|32|Anticipated|National University of Malaysia||2|||f||||t||||||||||2017-10-11 01:05:57.39246|2017-10-11 01:05:57.39246
NCT01985581|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2016-05-15|2016-02-20||October 2013||2013-10-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD|A Single-Center, Randomized, Double Blind, Placebo-Controlled, Crossover Evaluation of the Effect of GXR as Adjunctive Treatment With Stimulant on Executive Function and Quality of Life at Home and School in Children With ADHD|Completed||Phase 4|50|Actual|JPM van Stralen Medicine Professional|There was insufficient teacher data collected to interpret the results. Children appeared to struggle with the completion of the KINDL calling in to question the validity of the results of this questionnaire|2|||f||||t||||||||No||2017-10-11 01:05:57.526333|2017-10-11 01:05:57.526333
NCT01985568|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-09-01|||November 2013||2013-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Optimal Timing of Exercise Initiation Within a Lifestyle Weight Loss Program|Optimal Timing of Exercise Initiation Within a Lifestyle Weight Loss Program|Active, not recruiting||N/A|150|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:05:58.046143|2017-10-11 01:05:58.046143
NCT01985555|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-08-08|||May 2013||2013-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|HMPL-504||Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors|A Phase I, Open-label, Multicenter Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Volitinib in Patients With Advanced Solid Tumors|Recruiting||Phase 1|70|Anticipated|Hutchison Medipharma Limited||1|||f||||t||||||||||2017-10-11 01:05:58.147335|2017-10-11 01:05:58.147335
NCT01985542|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-14|||May 2011||2011-05-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|Birch11||The Effects of Immunotherapy in the Nose|The Molecular Biological Effects of Immunotherapy in the Nose|Completed||N/A|20|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 01:05:58.244108|2017-10-11 01:05:58.244108
NCT01985529|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-11-08|||December 2008||2008-12-01|November 2013|2013-11-01||||December 2011|Actual|2011-12-01||Interventional|||A Controlled Study of Community-based Exercise Training in Patients With Moderate COPD|A Controlled Study of Community-based Exercise Training in Patients With Moderate COPD|Completed||N/A|19|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:05:58.342744|2017-10-11 01:05:58.342744
NCT01985516|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2013-11-10|||October 2013||2013-10-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Female Urethral Catheterization - Instillation of the Lubricating Gel Into the Urethra or Pouring it on the Catheter's Tip?|Pain Level During Female Urethral Catheterization - Should we Instill the Lubrication Gel Into the Urethra or Just Lubricate the Catheter's Tip? a Prospective Randomized Study|Unknown status|Recruiting|N/A|96|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 01:05:58.455117|2017-10-11 01:05:58.455117
NCT01985503|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-11-07|||January 2015||2015-01-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|5 Years|Observational [Patient Registry]|BATFollowUp||Longitudinal Follow-up of Brown Adipose Tissue Function and Structure|Brown Adipose Tissue: Longitudinal Follow-up of Brown Adipose Tissue Structure and Associations With Obesity and Cardiovascular Risk Factors in Healthy Participants of Baseline PET Studies (BAT-Follow-Up)|Active, not recruiting||N/A|95|Anticipated|Turku University Hospital|||2||f||||f||||||Samples With DNA|"     Blood samples, fecal samples, adipose tissue biopsies and skeletal muscle biopsies.   "|||2017-10-11 01:05:58.576342|2017-10-11 01:05:58.576342
NCT01985490|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-10|2013-11-25|||November 2013||2013-11-01|November 2013|2013-11-01|May 2015|Anticipated|2015-05-01|November 2014|Anticipated|2014-11-01||Interventional|||Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane||Unknown status|Recruiting|N/A|32|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 01:05:58.676688|2017-10-11 01:05:58.676688
NCT01985477|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-09-12|||December 2013||2013-12-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma|Phase I/II Study of Lenalidomide (Revlimid), All-trans Retinoic Acid (ATRA) and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma|Terminated||Phase 1|2|Actual|M.D. Anderson Cancer Center||2||Terminated Phase I due to slow accrual without progression to Phase II.|f||||f||||||||||2017-10-11 01:05:58.787891|2017-10-11 01:05:58.787891
NCT01985464|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-08-08|||October 2013||2013-10-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|August 2018|Anticipated|2018-08-01||Interventional|||Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis|Feasibility Study of Umbilical Cord Tissue Derived Mesenchymal Stem Cells (UC-MSC) in Disease Modifying Anti-Rheumatic Drugs (DMARD) Resistant Rheumatoid Arthritis|Recruiting||Phase 1/Phase 2|20|Anticipated|Translational Biosciences||1|||f||||t||||||||||2017-10-11 01:05:58.929846|2017-10-11 01:05:58.929846
NCT01985451|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-08|||March 2013||2013-03-01|November 2013|2013-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）|Phase II Trial of Pemetrexed and Temozolomide in Treating Patients With Relapsed PCNSL|Unknown status|Active, not recruiting|Phase 2|15|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||t||||||||||2017-10-11 01:05:59.066984|2017-10-11 01:05:59.066984
NCT01985438|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-12-11|||November 2013||2013-11-01|December 2013|2013-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|PRONUS||A Trial Comparing Two Modalities of Prophylactic Nutritional Support During Treatment for Head and Neck Cancer|Prophylactic Nutritional Support During Treatment for Head and Neck Cancer: A Single-Center, Open-label, Prospective, Randomized, Controlled Trial Comparing Feeding With Percutaneous Endoscopic Gastrostomy Tubes and Nasogastric Tubes|Unknown status|Recruiting|N/A|100|Anticipated|Shaukat Khanum Memorial Cancer Hospital & Research Centre||2|||f||||f||||||||||2017-10-11 01:05:59.341514|2017-10-11 01:05:59.341514
NCT01985425|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-11-25|2016-11-25||April 2014||2014-04-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|COP-AF Pilot||Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study|Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study.|Completed||Phase 3|100|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 01:05:59.505811|2017-10-11 01:05:59.505811
NCT01985412|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-06-03|||March 2010||2010-03-01|June 2015|2015-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|GTD||Genome Transplant Dynamics: Non-invasive Sequencing-based Diagnosis of Rejection|Genome Transplant Dynamics: Non-Invasive Sequencing-Based Diagnosis of Rejection|Enrolling by invitation||N/A|430|Anticipated|Stanford University|||5||f||||f||||||Samples With DNA|"     A single whole blood specimen from both the donor and recipient of the organ prior to     transplant. Additionally, blood samples are taken post-transplant at specified timepoints and     spun down into a plasma, buffycoat layer. The plasma and buffycoat are retained while the     rest is discarded.   "|||2017-10-11 01:05:59.986863|2017-10-11 01:05:59.986863
NCT01985399|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-10-13|||December 2013||2013-12-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||"Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals (SHAC Neuro Study)"|"Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals (SHAC Neuro Study)"|Completed||N/A|100|Actual|Stanford University|||2||f||||f||||||||||2017-10-11 01:06:00.112687|2017-10-11 01:06:00.112687
NCT01985386|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-07-29|||November 2013||2013-11-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Iron Absorption From GDS Capsules II|Iron Absorption Mechanism From a Slow Release Iron Capsule Using the Gastric Delivery System (Ferrous Sulfate)|Completed||N/A|8|Actual|Swiss Federal Institute of Technology||2|||f||||f||||||||||2017-10-11 01:06:00.218929|2017-10-11 01:06:00.218929
NCT01985373|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-04-03|||December 2013||2013-12-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Nanogam||Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml|Pharmacokinetics and Safety of the Intravenous Human Immunoglobulin Product Nanogam 100 mg/ml|Completed||Phase 3|23|Actual|Sanquin||1|||f||||f||||||||||2017-10-11 01:06:00.342626|2017-10-11 01:06:00.342626
NCT01985347|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-08|||November 2013||2013-11-01|November 2013|2013-11-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|SAD||The SAD Study - SLEEP, ANXIETY & DEPRESSION Study A Prospective Cohort Study|The SAD Study - SLEEP, ANXIETY & DEPRESSION Study A Prospective Cohort Study|Unknown status|Not yet recruiting|N/A|500|Anticipated|The Queen Elizabeth Hospital||2|||f||||t||||||||||2017-10-11 01:06:00.640797|2017-10-11 01:06:00.640797
NCT01985321|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-06-23|2015-05-11||November 2013||2013-11-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional||Safety population of the modified intent to treat population|Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores|A Multicenter, Placebo-Controlled, Randomized, Double-Blind Study of the Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Episodic Treatment of Recurrent Herpes Labialis|Completed||Phase 2|469|Actual|Topical Remedy||2|||f||||||||||||||2017-10-11 01:06:02.575803|2017-10-11 01:06:02.575803
NCT01985295|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-10-08|||June 2010||2010-06-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|PASART-1||Combined Modality Treatment of Sarcomas of the Extremities|Phase I Clinical Study of a Combined Modality Treatment of Sarcomas of the Extremities With Radiotherapy (RT) and Dose-escalation of Pazopanib|Completed||Phase 1|12|Actual|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-11 01:06:03.254228|2017-10-11 01:06:03.254228
NCT01985282|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-11-08|||March 2013||2013-03-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Feasibility Clinical Study of NLA Tool|Evaluate the Feasibility of the NLA Tool, a Combined Assessment of Nutritional and Physical Functional Status, to Provide Personalized Advice for the Independence and Mobility of Elderly.|Completed||N/A|250|Actual|Nestlé|||1||f||||t||||||||||2017-10-11 01:06:03.374448|2017-10-11 01:06:03.374448
NCT01985269|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-11-08|||August 2011||2011-08-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|M-DART||Modified Directly Observed Antiretroviral Therapy|Modified Directly Observed Antiretroviral Therapy (M-DART): An Intensive, Nurse-directed, Home-centered, Treatment Strategy to Reduce Mortality and Loss to Follow-up in High-risk HIV-infected Patients Initiating Antiretroviral Therapy|Unknown status|Active, not recruiting|N/A|511|Actual|Moi University||2|||f||||t||||||||||2017-10-11 01:06:03.476878|2017-10-11 01:06:03.476878
NCT01985256|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-02-23|||October 2013||2013-10-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor|A P1 Ascending Dose Trial of the Safety and Tolerability of Toca 511, a Retroviral Replicating Vector, Administered Intravenously Prior to, and Intracranially at the Time of, Subsequent Resection for Recurrent HGG & Followed by Treatment With Extended-Release 5-FC|Active, not recruiting||Phase 1|17|Actual|Tocagen Inc.||1|||f||||t||||||||||2017-10-11 01:06:03.707775|2017-10-11 01:06:03.707775
NCT01983800|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-03-27|||July 2013||2013-07-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|VALTS||AnaConDa Long Term Sedation Study|Use of Volatile Anesthetics for Long-Term Sedation In Critically Ill Patients|Recruiting||N/A|60|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:06:23.741085|2017-10-11 01:06:23.741085
NCT01985243|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2017-03-21|||November 2013||2013-11-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Building Capacity for Sustainable Livelihoods and Health|Building Capacity for Sustainable Livelihoods and Health Through Public-private Linkages in Agriculture and Health Systems|Active, not recruiting||N/A|3000|Anticipated|McGill University||4|||f||||f||||||||||2017-10-11 01:06:03.867093|2017-10-11 01:06:03.867093
NCT01985230|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-09-21|||February 2014||2014-02-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|ReActiv8-A||ReActiv8 for Chronic Low Back Pain|Investigation of the ReActiv8 Implantable Stimulation System for Chronic Low Back Pain|Unknown status|Recruiting|N/A|96|Anticipated|Mainstay Medical||1|||f||||t||||||||||2017-10-11 01:06:04.010706|2017-10-11 01:06:04.010706
NCT01985217|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-08|||August 2009||2009-08-01|November 2013|2013-11-01|December 2013||2013-12-01|April 2012|Actual|2012-04-01||Observational|APIHA||Prevalence of Digestive Carriage of Integrons|Prevalence of Digestive Carriage of Integrons to Resistance in Two Populations in Limousin|Completed||N/A|492|Actual|University Hospital, Limoges|||1||f||||f||||||||||2017-10-11 01:06:04.206166|2017-10-11 01:06:04.206166
NCT01985204|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-07-29|||November 2013||2013-11-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Iodine Supplementation in Obesity|Assessment of the Improvement of the Cardiovascular Risk Profile in Obese Women After Correction of Iodine Deficiency|Completed||N/A|162|Actual|Swiss Federal Institute of Technology||2|||f||||f||||||||||2017-10-11 01:06:04.306867|2017-10-11 01:06:04.306867
NCT01985191|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-02-24|||November 2013||2013-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients|A Phase 1 Study of Combination Therapy With SAR405838 and Pimasertib in Patients With Advanced Cancer|Completed||Phase 1|26|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:06:04.49253|2017-10-11 01:06:04.49253
NCT01985178|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-04-14|||October 2013||2013-10-01|April 2015|2015-04-01||||August 2016|Anticipated|2016-08-01||Interventional|||Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders|Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders|Unknown status|Recruiting|Phase 1|40|Anticipated|McMaster University||1|||f||||f||||||||||2017-10-11 01:06:04.640462|2017-10-11 01:06:04.640462
NCT01985165|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-11-07|||May 2013||2013-05-01|November 2013|2013-11-01||||November 2013|Anticipated|2013-11-01||Interventional|||A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis|A Multicenter，Open-label Phase Ⅳ Trial of Imrecoxib in Treatment of Knee Osteoarthritis|Unknown status|Active, not recruiting|Phase 4|2400|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||||2017-10-11 01:06:04.731646|2017-10-11 01:06:04.731646
NCT01985152|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-07|||September 2013||2013-09-01|November 2013|2013-11-01||||December 2013|Anticipated|2013-12-01||Interventional|||A Phase Ⅰa Study of Azilsartan Trimethylethanolamine in Healthy Volunteers|A Placebo-Controlled, Phase I, Single-center Evaluation of the Single-dose Pharmacokinetics Study of Azilsartan Trimethylethanolamine|Unknown status|Recruiting|Phase 1|62|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||8|||f||||t||||||||||2017-10-11 01:06:04.864936|2017-10-11 01:06:04.864936
NCT01985139|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-02-23|||January 2014||2014-01-01|February 2016|2016-02-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|PLOBEC||Pleasure for Food and Endocannabinoids in Obesity|A New Method for the Characterisation of Pleasure for Food in Obesity and Relationships With the Endocannabinoid System|Recruiting||N/A|50|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-11 01:06:04.98902|2017-10-11 01:06:04.98902
NCT01985126|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-08-09|2016-09-30||September 27, 2013|Actual|2013-09-27|August 2017|2017-08-01|May 30, 2017|Actual|2017-05-30|January 9, 2015|Actual|2015-01-09||Interventional||All treated Analysis Set included all participants who received at least 1 dose of daratumumab.|An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD|An Open-label, Multicenter, Phase 2 Trial Investigating the Efficacy and Safety of Daratumumab in Subjects With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor and IMiD) or Are Double Refractory to a Proteasome Inhibitor and an IMiD|Completed||Phase 2|124|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 01:06:05.135476|2017-10-11 01:06:05.135476
NCT01985113|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-02-14|||May 2013||2013-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|TRCRLC||Correlation Research of Thioredoxin Reductase in Lung Cancer|Correlation Study of Blood and Tissue Thioredoxin Reductase Activity in Early Stage On-small Cell Lung Cancers|Completed||N/A|165|Actual|Hunan Province Tumor Hospital|||2||f||||f||||||Samples With DNA|"     tumor tissue and lung benign mass are obtained in surgery, and blood serum before surgery and     3-5 days after surgery, blood should be taken and centrifuged then stored at -20 degree,     tumor tissue and lung benign mass should be stored at -180 degree within 5 mins during     surgery.   "|||2017-10-11 01:06:06.474885|2017-10-11 01:06:06.474885
NCT01985100|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-09-03|||November 2013||2013-11-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|HBO||The Use of Hyperbaric Oxygen to Increase the Blood Supply in the Injured, But Still Alive Tissue, Around an Old Stroke|Hyperbaric Oxygen in the Reduction of Post Stroke Ischemic Penumbra|Withdrawn||N/A|0|Actual|St. Luke's Hospital, Chesterfield, Missouri||1||Unable to recruit any patients that fulfilled the narrow enrollment requirements|f||||f||||||||||2017-10-11 01:06:06.549316|2017-10-11 01:06:06.549316
NCT01985087|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-11-21|||September 2014||2014-09-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70|A Phase I/ II Study of Hypofractionated Radiotherapy With Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients Over 70 Years Old With Newly Diagnosed Glioblastoma|Recruiting||Phase 1/Phase 2|40|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-10-11 01:06:06.640295|2017-10-11 01:06:06.640295
NCT01985074|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-09-13|||July 2010||2010-07-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|April 2015|Actual|2015-04-01||Interventional|||A Case Management Study Targeted to Reduce Health Care Utilization for Frequent Emergency Department Visitors|A Case Management Study Targeted to Reduce Health Care Utilization for Frequent Emergency Department Visitors|Unknown status|Active, not recruiting|N/A|15000|Anticipated|Health Navigator||2|||f||||f||||||||||2017-10-11 01:06:06.738512|2017-10-11 01:06:06.738512
NCT01985061|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-06-07|||December 2013|Actual|2013-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|AAA||Evaluation of 3 Different Doses of IV Busulfan|Prospective and Multicentre Evaluation of 3 Different Doses of IV Busulfan Associated With Fludarabine and Thymoglobuline in the Conditioning of Allogeneic Stem Cell Transplantation (SCT) From a Matched Related or Unrelated Donor in Patients With Poor Prognosis Myeloid Malignancies|Recruiting||Phase 2|177|Anticipated|Institut Paoli-Calmettes||3|||f||||t||||||||||2017-10-11 01:06:06.845093|2017-10-11 01:06:06.845093
NCT01985048|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-02-12|||October 2013||2013-10-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Cardiometabolic Risk in Cardiac Rehab|Cardiometabolic Risk in the Setting of Cardiac Rehabilitation|Unknown status|Active, not recruiting|N/A|500|Anticipated|Health Diagnostic Laboratory, Inc.|||1||f||||f||||||Samples With DNA|"     Whole Blood and Serum   "|||2017-10-11 01:06:06.974492|2017-10-11 01:06:06.974492
NCT01985035|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-07-01|||October 2013||2013-10-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Influence of Obstructive Sleep Apnea on Metabolism and Weight Loss in Obese Individuals|Influence of Obstructive Sleep Apnea on Metabolism and Weight Loss in Obese Individuals|Completed||N/A|60|Actual|Federal University of São Paulo||4|||f||||f||||||||Undecided||2017-10-11 01:06:07.186974|2017-10-11 01:06:07.186974
NCT01985022|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-01-18|||May 2013||2013-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Changing Developmental Trajectories Through Early Treatment|Autism Center of Excellence: Project 3 - Changing Developmental Trajectories Through Early Treatment|Recruiting||N/A|108|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 01:06:07.302349|2017-10-11 01:06:07.302349
NCT01985009|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-07-26|||January 2014||2014-01-01|August 2016|2016-08-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|||Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.|Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease (NAFLD)Using Liver Biopsy as Reference.|Completed||N/A|450|Actual|Echosens||1|||f||||f||||||||||2017-10-11 01:06:07.420902|2017-10-11 01:06:07.420902
NCT01984996|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-06-07|||December 2013||2013-12-01|January 2016|2016-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Freedom Inguinal Hernia Repair System Study|Freedom Inguinal Hernia Repair System Study|Terminated||N/A|100|Anticipated|Insightra Medical, Inc.||1||Company was dissolved.|f||||f||||||||||2017-10-11 01:06:07.530829|2017-10-11 01:06:07.530829
NCT01984983|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2015-08-24|||December 2013||2013-12-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|June 2014|Actual|2014-06-01||Interventional|||Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers|A Phase I, Randomized, Observer-blind, Placebo Controlled Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered Intramuscularly or Intradermally by Electroporation to Healthy Adults|Completed||Phase 1|42|Actual|Ichor Medical Systems Incorporated||5|||f||||f||||||||||2017-10-11 01:06:07.639296|2017-10-11 01:06:07.639296
NCT01984970|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2014-07-10|||November 2013||2013-11-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01|3 Days|Observational [Patient Registry]|||McGrath Series 5 Videolaryngoscope for Double-lumen Tube Intubation|Evaluation McGrath Series 5 Videolaryngoscope for Double-lumen Tube Intubation|Completed||N/A|43|Actual|Huazhong University of Science and Technology|||1||f||||t||||||||||2017-10-11 01:06:07.752486|2017-10-11 01:06:07.752486
NCT01984957|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-03-20|||January 2013||2013-01-01|June 2014|2014-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TRANE||Differential Study of Muscle Transcriptome|Differential Study of Muscle Transcriptome in Patients With Neuromuscular Disease and Control Subjects|Completed||N/A|42|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:06:07.853805|2017-10-11 01:06:07.853805
NCT01984944|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2014-11-06|||October 2009||2009-10-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Characterisation of Circadian Rhythm in Autistic Spectrum Disorder|Characterisation of Circadian Rhythm in Autistic Spectrum Disorder : a Clinical, Biochemical and Genetic Study|Completed||N/A|42|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:06:07.96276|2017-10-11 01:06:07.96276
NCT01984931|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-08|||October 2013||2013-10-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting|Trimebutine Maleate (NEWBUTIN SR 300 mg Tab) as a Prophylactic Anti-emetic Drug for Patients Who Underwent Arthroscopic Rotator Cuff Repair: a Randomized Controlled Study|Unknown status|Recruiting|Phase 3|45|Anticipated|CM Chungmu Hospital||2|||f||||t||||||||||2017-10-11 01:06:08.05884|2017-10-11 01:06:08.05884
NCT01984918|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-02-04|||November 2013||2013-11-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Predictors of Colonoscopy Non-attendance and the Efficacy of a Short Message Service (SMS) Reminder to Reduce Non-attendance Rate|Predictors of Colonoscopy Non-attendance and the Efficacy of a Short Message Service (SMS) Reminder to Reduce Non-attendance Rate: A Prospective Randomized Controlled Trial (NAC Study)|Recruiting||N/A|2706|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:06:08.253797|2017-10-11 01:06:08.253797
NCT01984905|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-11-08|||October 2013||2013-10-01|November 2013|2013-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|TEDAC||Study of Prognostic Factors in Aortic Dissection Type B|Exploratory Study of Prognostic Factors in Aortic Dissection Type B: Role of Imaging (18F-FDG PET-Scan and Angioscan) and Biomarkers|Recruiting||N/A|100|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-11 01:06:08.348887|2017-10-11 01:06:08.348887
NCT01984879|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-07-11|||November 2013||2013-11-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|||Vaccination Status, Knowledge and Attitude in Korean Patients With IBD|Vaccination Status, Knowledge About Vaccination and Attitude to Vaccination in Korean Patients With Inflammatory Bowel Diseases|Completed||N/A|287|Actual|Asan Medical Center|||1||f||||t||||||||No||2017-10-11 01:06:08.556411|2017-10-11 01:06:08.556411
NCT01984866|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-04-05|||July 2013||2013-07-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||CPR Prediction After Neoadjuvant Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.|Complete Pathological Response Prediction After Neoadjuvant Treatment Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.|Recruiting||N/A|150|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||||||||Samples With DNA|"     tissue samples from breast tumors   "|||2017-10-11 01:06:08.64099|2017-10-11 01:06:08.64099
NCT01984853|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-07-30|||May 2013||2013-05-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01|18 Months|Observational [Patient Registry]|ED~Cards||Cardiology-Emergency Medicine Cardiac Biomarker Research Initiative|Cardiology-Emergency Medicine Cardiac Biomarker Research Initiative|Completed||N/A|575|Actual|Henry Ford Health System|||1||f||||t||||||Samples Without DNA|"     Approximately 6-8.5 ml of blood will be collected in each of two anticoagulant tube types:     SST and K2EDTA plasma.      The first blood collection in the ED is designated as t0 ED ECG time (+ 60 minutes).      Additional blood draws of approximately 6-8.5 mL/tube type will occur at t1 = 30 (+/- 10     minutes) after t0, t2=1 (+/-15 minutes) hour after t0, t4 = 3 (+/- 15 minutes) hours after t0     (if the patient is still in the ED/hospital).   "|||2017-10-11 01:06:08.716977|2017-10-11 01:06:08.716977
NCT01984840|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-06-16|||April 2013||2013-04-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TCN||Telemedicine for Patients Suffering From COPD (Danish Telecare North Trial)|"Effectiveness and Cost-effectiveness of Telemedicine for Chronic Obstructive Pulmonary Disease: The Danish TeleCare North Pragmatic Cluster-randomized Trial."|Completed||N/A|1225|Actual|Aalborg University||2|||f||||f||||||||||2017-10-11 01:06:08.818959|2017-10-11 01:06:08.818959
NCT01984827|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-09-26|||March 2018|Anticipated|2018-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of Glucose on QTc Interval in Type 1 Diabetes|A Crossover Study to Evaluate the Effect of Glucose on Cardiac Repolarisation Using a Glucose Clamp and a Single 400 mg Dose of Moxifloxacin as a Positive Control in Male and Female Patients With Type I Diabetes|Not yet recruiting||Phase 1|24|Anticipated|Richmond Pharmacology Limited||3|||f||||f|f|f||||||||2017-10-11 01:06:08.905941|2017-10-11 01:06:08.905941
NCT01984814|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-14|||December 2008||2008-12-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Stem Cell Therapy for Amyotrophic Lateral Sclerosis|The Effect of Autologous Bone Marrow Mononuclear Cell Transplantation on the Survival Duration in Amyotrophic Lateral Sclerosis - A Retrospective Control Study|Completed||Phase 2|57|Actual|Neurogen Brain and Spine Institute||2|||f||||t||||||||||2017-10-11 01:06:09.037503|2017-10-11 01:06:09.037503
NCT01984801|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-05-05|||October 14, 2013|Actual|2013-10-14|May 2017|2017-05-01|April 10, 2015|Actual|2015-04-10|April 10, 2015|Actual|2015-04-10||Interventional|||Study to Investigate the Irritation Potential of GSK1940029 Gel|A Single-Blind Study to Evaluate the Irritation Potential of Repeat Topical Applications of GSK1940029 Gel on the Intact Skin of Healthy Human Subjects and Acne Patients|Completed||Phase 1|54|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 01:06:09.133923|2017-10-11 01:06:09.133923
NCT01984788|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-08-14||2014-08-14|November 2013||2013-11-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|OPuS-1||Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE|A Phase 2a Double-Blind Placebo-Controlled 2-Period Crossover Study to Evaluate the Safety and Efficacy of BCX4161 as a Prophylactic Treatment to Reduce the Frequency of Attacks in Subjects With Hereditary Angioedema|Completed||Phase 2|24|Actual|BioCryst Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:06:09.288373|2017-10-11 01:06:09.288373
NCT01984775|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-06-14|||October 30, 2013|Actual|2013-10-30|June 2017|2017-06-01|July 2, 2014|Actual|2014-07-02|July 2, 2014|Actual|2014-07-02||Interventional|||A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects|An Evaluator-Blinded Study to Evaluate the Cumulative Irritation Potential of Topically-Applied GSK2894512 Cream in Healthy Subjects|Completed||Phase 1|52|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:06:09.402594|2017-10-11 01:06:09.402594
NCT01984762|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-08-11|||September 2012||2012-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|CONTROL||Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.|Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus. Randomised Controlled Trial|Recruiting||N/A|134|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-11 01:06:09.546043|2017-10-11 01:06:09.546043
NCT01984749|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-08-25|||November 2013||2013-11-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Interventional|FREED||Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy|A Multicenter, Randomized, Comparative Trial on the Effect of Febuxostat in Preventing Cerebral and Cardiorenovascular Events in Patients With Hyperuricemia|Active, not recruiting||N/A|1000|Anticipated|Freed Study Group||2|||f||||||||||||||2017-10-11 01:06:09.667586|2017-10-11 01:06:09.667586
NCT01984736|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-01-14|||June 2013||2013-06-01|January 2015|2015-01-01||||December 2014|Actual|2014-12-01||Interventional|||EVP-6124 Hepatic Impairment Study|A Multi-Center, Open-Label Phase I Study to Investigate the Effect of Different Degrees of Hepatic Impairment on the Single-Dose Pharmacokinetics of EVP-6124 in Patients With Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Completed||Phase 1|34|Actual|FORUM Pharmaceuticals Inc||1|||f||||f||||||||||2017-10-11 01:06:10.299838|2017-10-11 01:06:10.299838
NCT01984723|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-08-24|||June 2013||2013-06-01|August 2015|2015-08-01||||February 2014|Actual|2014-02-01||Interventional|||EVP-6124 Renal Impairment Study|A Multi-Center, Open-Label Phase I Study to Investigate the Effect of Different Degrees of Renal Impairment on the Single-Dose Pharmacokinetics of EVP-6124 in Patients With Renal Impairment Compared to Subjects With Normal Renal Function|Completed||Phase 1|32|Actual|FORUM Pharmaceuticals Inc||1|||f||||f||||||||||2017-10-11 01:06:10.385988|2017-10-11 01:06:10.385988
NCT01984710|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-10-26|||September 2013||2013-09-01|October 2016|2016-10-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Interventional|||DBS for TRD Medtronic Activa PC+S|"Deep Brain Stimulation for Treatment Resistant Depression: Exploration of Local Field Potentials (LFP) With the Medtronic Activa Primary Cell + Sensing (PC+S) Brain Radio System"|Recruiting||N/A|20|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 01:06:10.588301|2017-10-11 01:06:10.588301
NCT01984697|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-07-28|2016-03-23||December 12, 2013|Actual|2013-12-12|July 2017|2017-07-01|July 24, 2017|Actual|2017-07-24|June 19, 2015|Actual|2015-06-19||Interventional|||A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)|A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of a 2-dose Regimen of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, Administered in Preadolescents and Adolescents (9 to 14 Year Olds) With a Comparison to Young Women (16 to 26 Year Olds)|Completed||Phase 3|1518|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-11 01:06:10.71763|2017-10-11 01:06:10.71763
NCT01984684|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-08-29|2017-07-26|2016-11-12|May 2014|Actual|2014-05-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional||Intent-to-Treat (ITT) Population included all patients who were randomly assigned to treatment.|Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections|A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)|Completed||Phase 3|850|Actual|Melinta Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 01:06:12.423043|2017-10-11 01:06:12.423043
NCT01984671|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-11-18|||October 2013||2013-10-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Mobile Pain Coping Skills Training for Stem Cell Transplant Patients|Home-Based Tablet Computer Pain Coping Skills Following Stem Cell Transplant|Completed||N/A|72|Actual|Duke University||2|||f||||||||||||||2017-10-11 01:06:13.691072|2017-10-11 01:06:13.691072
NCT01984658|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-08-29|||October 2013||2013-10-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer Patients|A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of Administering ALECSAT to Pancreas Cancer Patients|Terminated||Phase 1|10|Actual|CytoVac A/S||1||recruitment difficulties as a new treatment for this indication available|f||||f||||||||||2017-10-11 01:06:13.791774|2017-10-11 01:06:13.791774
NCT01984645|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-02-17|||September 2012||2012-09-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|PIANO||Primary-care-provider Identification And Notification|Identifying Primary Care Providers and Notifying Them Upon Admission of Their Patients to New York-Presbyterian Hospital|Completed||N/A|7023|Actual|Columbia University||2|||f||||f||||||||No||2017-10-11 01:06:13.906192|2017-10-11 01:06:13.906192
NCT01984632|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2015-07-30|||November 2013||2013-11-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Barbed Suture in Single-port Laparoscopic Myomectomy|Single-port Laparoscopic Myomectomy Using Barbed Suture Versus Multi-port One: a Multi-center Randomized Controlled Trial|Completed||Phase 3|80|Actual|CHA University||2|||f||||f||||||||||2017-10-11 01:06:14.010851|2017-10-11 01:06:14.010851
NCT01984619|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-03-23|||September 2013||2013-09-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles|A Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles Utilizing the Iovera With Blunt Tip Cannula Smart Tip|Completed||N/A|47|Actual|MyoScience, Inc|||1||f||||||||||||||2017-10-11 01:06:14.092378|2017-10-11 01:06:14.092378
NCT01984606|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-10-24|||January 2015||2015-01-01|October 2014|2014-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes|A Phase IIIb Randomised, Double-blind, Active-controlled, Parallel Group, Efficacy and Safety Study of Once Daily Oral Administration of Empagliflozin 25 mg Compared to Sitagliptin 100 mg During 52 Weeks in Type 2 Diabetes Mellitus Patients Who Are Treatment-naïve or on Treatment With Metformin With Insufficient Glycaemic Control|Withdrawn||Phase 3|0|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:06:14.159901|2017-10-11 01:06:14.159901
NCT01984593|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-11-04|||November 2013||2013-11-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|YHIP2||Impact of Yoga on Blood Pressure, Quality of Life and Stress in Patients With Hypertension|Impact of Yoga on Blood Pressure, Quality of Life and Stress in Patients With Hypertension - A Randomized Controlled Multicenter Trial in Primary Care|Completed||N/A|190|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 01:06:14.241403|2017-10-11 01:06:14.241403
NCT01984580|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-08|||April 2011||2011-04-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01||Interventional|||Effect of Zinc on Barrett's Metaplasia|Effect of Zinc on Barrett's Metaplasia|Unknown status|Recruiting|Phase 1|120|Anticipated|Main Line Health||2|||f||||t||||||||||2017-10-11 01:06:14.328603|2017-10-11 01:06:14.328603
NCT01984567|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-08|||April 2013||2013-04-01|November 2013|2013-11-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Vitamin E or Lipoic Acid on Serum Oxyphytosterol Concentrations|The Effects of Consumption of Vitamin E or Lipoic Acid on Serum Oxyphytosterol Concentrations in Subjects With Impaired Glucose Tolerance or Type II Diabetes|Unknown status|Active, not recruiting|N/A|20|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 01:06:14.409678|2017-10-11 01:06:14.409678
NCT01984554|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-03-18|||September 2013||2013-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia|Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia|Completed||N/A|551|Actual|Luitpold Pharmaceuticals|||4||f||||f||||||||||2017-10-11 01:06:14.532744|2017-10-11 01:06:14.532744
NCT01984541|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-01-02|||March 2014||2014-03-01|May 2013|2013-05-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.|Biological Standardization of Artemisia Vulgaris Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP).|Completed||Phase 2|30|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 01:06:14.605208|2017-10-11 01:06:14.605208
NCT01984528|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-01-02|||February 2014||2014-02-01|May 2013|2013-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction.|Biological Standardization of Alternaria Alternata Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP).|Completed||Phase 2|30|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 01:06:14.775492|2017-10-11 01:06:14.775492
NCT01984515|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-11-10|2015-09-23||January 2014||2014-01-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Increasing Engagement in Evidence-Based PTSD Therapy for Primary Care Veterans|Increasing Engagement in Evidence-Based PTSD Therapy for Primary Care Veterans|Completed||N/A|59|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 01:06:14.898712|2017-10-11 01:06:14.898712
NCT01984502|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-02-23|||November 2013||2013-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer|A Phase I CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer|Recruiting||Phase 1|33|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 01:06:15.271755|2017-10-11 01:06:15.271755
NCT01984489|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2013-11-18|||June 2012||2012-06-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes|A Multicenter Randomized, Double-blind, Placebo Controlled ,Parallel Group ,Phase II Study to Access the Efficacy and Safety of SHR117887 in Combination Therapy With Metformin in Patients With Type 2 Diabetes Patients|Completed||Phase 2|120|Actual|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:06:15.377588|2017-10-11 01:06:15.377588
NCT01984476|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-03-06|||July 2013||2013-07-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury|Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury|Recruiting||N/A|110|Anticipated|James J. Peters Veterans Affairs Medical Center|||3||f||||f||||||||||2017-10-11 01:06:15.458796|2017-10-11 01:06:15.458796
NCT01984463|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-05-09|||February 2014||2014-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Impact of Epidural Morphine on Shoulder Pain Following Thoracotomy.|Impact of Epidural Morphine on the Incidence and Severity of Shoulder Pain Following Thoracotomy.|Terminated||N/A|22|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2||Increased incidence of respiratory depression in the morphine group|f||||f||||||||||2017-10-11 01:06:15.586764|2017-10-11 01:06:15.586764
NCT01984450|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-11-13|||January 2014||2014-01-01|November 2013|2013-11-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study to Compare Two Techniques for Articular Cartilage Repair:ACIC Vs. MCIC|A Study to Compare Two Articular Cartilage Repair Techniques in the Knee Joint: Autologous Collagen Induced Chondrogenesis (ACIC) Vs. Mesenchymal Cell Induced Chondrogenesis (MCIC).|Unknown status|Not yet recruiting|N/A|100|Anticipated|Shetty-Kim Research Foundation||2|||f||||t||||||||||2017-10-11 01:06:15.691692|2017-10-11 01:06:15.691692
NCT01984437|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-07-22|||November 2013||2013-11-01|July 2016|2016-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01|14 Days|Observational [Patient Registry]|ROVER||Registry of the Magellan Robotic System|The Robotic Vascular and Endovascular Registry (ROVER)|Recruiting||N/A|1000|Anticipated|Hansen Medical|||1||f||||f||||||||||2017-10-11 01:06:15.816462|2017-10-11 01:06:15.816462
NCT01984424|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-06-28||2016-09-13|December 10, 2013|Actual|2013-12-10|June 2017|2017-06-01|November 14, 2017|Anticipated|2017-11-14|November 10, 2015|Actual|2015-11-10||Interventional|||Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3|A Double-blind, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Evolocumab, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor Due to Muscle Related Side Effects|Active, not recruiting||Phase 3|511|Actual|Amgen||5|||f||||t||||||||||2017-10-11 01:06:15.943839|2017-10-11 01:06:15.943839
NCT01984411|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-11-14|||January 2013||2013-01-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Interventional|COMPACT||Comparison of Vascular Access for Radial and Femoral Completion of Diagnostic Cardiac Catheterization|Comparison of Vascular ACcess for Radial and Femoral Completion of Diagnostic Cardiac Catheterization Performed at the Clinic Patients Northern General de Barranquilla in 2013. Controlled Clinical Trial of Non-inferiority|Completed||Phase 3|220|Actual|Centro Cardiológico del Caribe, Columbia||2|||f||||f||||||||||2017-10-11 01:06:16.276171|2017-10-11 01:06:16.276171
NCT01984385|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-10-05|||December 2013||2013-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2014|Actual|2014-09-01|30 Days|Observational [Patient Registry]|||Hip Fracture Impact on Vascular Events In Noncardiac Surgery patIents: a cOhort evaluatioN (Hip VISION): Pilot Study|Hip Fracture Impact on Vascular Events In Noncardiac Surgery patIents: a cOhort evaluatioN (Hip VISION): Pilot Study|Completed||N/A|100|Actual|Population Health Research Institute|||1||f||||f||||||||||2017-10-11 01:06:16.455407|2017-10-11 01:06:16.455407
NCT01984372|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-09-14|||November 2013||2013-11-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®|A Multi-centre, Open Label, Observational, Non-interventional, Post Marketing Surveillance to Evaluate Safety and Effectiveness During Long-term Treatment With Tresiba® (Insulin Degludec) in Patients With Diabetes Mellitus Requiring Insulin Therapy Under Normal Clinical Practice Conditions|Active, not recruiting||N/A|6000|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:06:16.537675|2017-10-11 01:06:16.537675
NCT01984359|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-09-23|||May 2013||2013-05-01|September 2016|2016-09-01||||May 2017|Anticipated|2017-05-01||Interventional|||HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer|A Pilot, Single-Center Study Of Quantitative HPV Serum Or Plasma DNA As A Prognostic Marker In P16+/HPV+ Squamous Carcinomas Of The Oropharynx And Unknown Primary Head And Neck Cancers|Recruiting||N/A|80|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:06:16.640831|2017-10-11 01:06:16.640831
NCT01984333|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-10-24|||November 2013||2013-11-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|OTTM||Online Response Inhibition Training for Trichotillomania|Developing Online Response Inhibition Training for Individuals With Trichotillomania|Recruiting||N/A|50|Anticipated|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-10-11 01:06:16.991989|2017-10-11 01:06:16.991989
NCT01984320|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-08-11|||October 2013||2013-10-01|August 2017|2017-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|OHSS||Cabergoline and Coasting to Prevent OHSS|Combining Cabergoline and Coasting in Gonadotropin Releasing Hormone(GnRH)Agonist Protocol in Intracytoplasmic Sperm Injection (ICSI) to Prevent Ovarian Hyperstimulation Syndrome (OHSS): a Randomized Clinical Trial|Completed||N/A|300|Actual|Cairo University||3|||f||||f|f|f||||||||2017-10-11 01:06:17.137568|2017-10-11 01:06:17.137568
NCT01984307|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-05-12|||August 2013||2013-08-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|HELICON||A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis|A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis|Completed||N/A|100000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:06:17.600439|2017-10-11 01:06:17.600439
NCT01984294|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2015-04-30|2015-04-30||October 2013||2013-10-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional||Safety Analysis Set: participants were randomized and received at least one dose of study drug.|Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection|A Phase 2, Randomized, Open-Label Study of Sofosbuvir/Ledipasvir Fixed-Dose Combination With Ribavirin or GS-9669 250 mg or GS-9669 500 mg in Naive or Treatment-Experienced Cirrhotic Subjects With Chronic Genotype 1 HCV Infection|Completed||Phase 2|101|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-11 01:06:17.67533|2017-10-11 01:06:17.67533
NCT01984281|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2017-02-13|||November 2013||2013-11-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of a Pedometer-based Unsupervised Exercise Program Upon Lifestyle Physical Activity of Asthmatic Adults|Effects of a Pedometer-based Unsupervised Exercise Program Upon Lifestyle Physical Activity of Asthmatic Adults|Completed||N/A|37|Actual|Federal University of Juiz de Fora||2|||f||||f||||||||||2017-10-11 01:06:18.28943|2017-10-11 01:06:18.28943
NCT01984268|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2016-08-24|||June 2014||2014-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate|Adenocorticotrophic Hormone for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate|Recruiting||Phase 2|60|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 01:06:18.372326|2017-10-11 01:06:18.372326
NCT01984255|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-12-28|||April 2014||2014-04-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients|A Two-Arm, Single Center Pase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients|Terminated||Phase 1|3|Actual|University of Texas Southwestern Medical Center||2||standard of care improved combination treatment of ipilimumab plus nivolumab.|f||||t||||||||No||2017-10-11 01:06:18.487897|2017-10-11 01:06:18.487897
NCT01984229|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-08-16|2016-08-16||December 2013||2013-12-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Safety Analysis Set consisted of all participants who received at least 1 dose of study drug and had at least 1 after dosing safety assessment.|A Study of the Effects of Posaconazole on Alectinib (RO5424802) Pharmacokinetics in Healthy Volunteers|An Open-Label, Three-Period, Fixed Sequence Study to Investigate the Effect of Multiple Oral Doses of Posaconazole, a Potent Cytochrome P450 3A Inhibitor, on the Single Dose Pharmacokinetics of RO5424802 in Healthy Subjects|Completed||Phase 1|23|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:06:18.928533|2017-10-11 01:06:18.928533
NCT01984216|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-08-26|||November 2013||2013-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Billroth II Versus Roux-en-Y for the Gastrojejunostomy in the Pancreatoduodenectomy|Billroth II Versus Roux-en-Y for the Gastrojejunostomy Reconstruction in the Pancreatoduodenectomy: a Randomized Controlled Study|Completed||N/A|64|Actual|Fundacion Miguel Servet||2|||f||||f||||||||||2017-10-11 01:06:19.770441|2017-10-11 01:06:19.770441
NCT01984203|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-11-30|||November 2013||2013-11-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|RoCTEx||Rotator Cuff Tendinopathy Exercise Trial|Progressive Heavy Strength Training Compared to General Low-load Exercises in Patients With Rotator Cuff Tendinopathy: a Randomized Controlled Trial|Completed||N/A|100|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 01:06:19.84385|2017-10-11 01:06:19.84385
NCT01984190|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-09-03|||April 2011||2011-04-01|November 2013|2013-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01|3 Months|Observational [Patient Registry]|ACOR||Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty|ActiveCare+S.F.T® Outcomes Registry (ACOR)|Completed||N/A|411|Actual|Medical Compression Systems|||1||f||||f||||||||||2017-10-11 01:06:19.950506|2017-10-11 01:06:19.950506
NCT01984177|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-08-08|||June 2013||2013-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence|Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence: A [11C]-(+)-PHNO PET Investigation|Completed||N/A|17|Actual|Centre for Addiction and Mental Health|||2||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:06:20.064654|2017-10-11 01:06:20.064654
NCT01984164|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2017-10-03|||August 2014||2014-08-01|October 2017|2017-10-01|November 15, 2018|Anticipated|2018-11-15|November 15, 2018|Anticipated|2018-11-15||Interventional|CALIBREX||CAndesartan vs LIsinopril Effects on the BRain|CAndesartan vs LIsinopril Effects on the BRain and Endothelial Function in eXecutive MCI (CALIBREX)|Active, not recruiting||Phase 3|168|Actual|Emory University||2|||f||||t||||||||||2017-10-11 01:06:20.166128|2017-10-11 01:06:20.166128
NCT01984151|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-02-15|||January 2018||2018-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:06:20.262249|2017-10-11 01:06:20.262249
NCT01984138|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-08|||September 2013||2013-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|REVIVE||REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy|H- 30956 REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy|Recruiting||Phase 2|44|Anticipated|Baylor Breast Care Center||2|||f||||f||||||||||2017-10-11 01:06:20.301346|2017-10-11 01:06:20.301346
NCT01984125|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-04-28|||April 2011||2011-04-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|AIMHi||Testing the Use of Prompts to Increase Adolescent Immunization Rates|Adolescent Vaccination in the Medical Home|Completed||N/A|7040|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:06:20.396246|2017-10-11 01:06:20.396246
NCT01984112|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-10-02|||May 2011||2011-05-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Proximal Humerus Fractures: Randomized Study Between Locking Nails and Locking Plates for Neer 2 and 3 Parts|Proximal Humerus Fractures: Randomized Study Between Intramedullary Locking Nails and Locking Plates for Neer 2 and 3 Parts Displaced Fractures|Completed||N/A|72|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 01:06:20.506785|2017-10-11 01:06:20.506785
NCT01984099|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-07|||December 2011||2011-12-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||RCT on the Efficacy of Methotrexate for the Prevention of GTD|The Efficacy of Methotrexate for the Prevention of Postmolar Gestational Trophoblastic Disease Among Patients With High-Risk Hydatidiform Mole|Completed||Phase 3|99|Actual|University of the Philippines||2|||f||||t||||||||||2017-10-11 01:06:20.603724|2017-10-11 01:06:20.603724
NCT01984086|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-05-12|||October 21, 2013|Actual|2013-10-21|May 2017|2017-05-01|May 26, 2014|Actual|2014-05-26|May 26, 2014|Actual|2014-05-26||Interventional|||Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.|An Open-label, Randomised, Cross-over, Two Cohort, Single Dose Study in Healthy Volunteers to Evaluate the Unit Dose Dry Powder Inhaler (UD-DPI) for the Delivery of Salbutamol and to Compare the Pharmacokinetic Profile With the MDI and Diskus Presentations.|Completed||Phase 1|60|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:06:20.685349|2017-10-11 01:06:20.685349
NCT01984073|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-04-27|||December 2012||2012-12-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|NOFAT||Effects of Niacin On Fatty Acid Trapping|Effect of Niacin On Fatty Acid Trapping|Recruiting||Phase 1|20|Anticipated|University of Pennsylvania||3|||f||||f||||||||No||2017-10-11 01:06:20.789133|2017-10-11 01:06:20.789133
NCT01984060|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-05-10|||December 2013||2013-12-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MESH||Feasibility of an Exercise Intervention|Feasibility of an Exercise Intervention In HIV+ Older Adults|Completed||N/A|74|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 01:06:20.892871|2017-10-11 01:06:20.892871
NCT01984047|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-05-09|||January 10, 2014|Actual|2014-01-10|May 2017|2017-05-01|February 23, 2015|Actual|2015-02-23|February 23, 2015|Actual|2015-02-23||Interventional|||Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002|A Phase 1, Randomized, Double-Blind (Sponsor Open), Placebo-Controlled, Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 (Anti-CCL20 Monoclonal Antibody) in Healthy Male Volunteers|Completed||Phase 1|49|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 01:06:20.963346|2017-10-11 01:06:20.963346
NCT01984034|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-11-06|||November 2013||2013-11-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|June 2014|Actual|2014-06-01||Interventional|TEP||Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines|An Open Cluster-randomized, 18 Month Trial to Compare the Effectiveness of Educational Outreach Visits With Usual Guideline Dissemination to Improve Family Physician Prescribing|Unknown status|Active, not recruiting|N/A|200|Anticipated|Universidade Nova de Lisboa||2|||f||||f||||||||||2017-10-11 01:06:21.05385|2017-10-11 01:06:21.05385
NCT01984021|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-05-29|||December 2013||2013-12-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation of the Immediate Effect of Acupuncture on the Upper Trapezius Muscle in Patients With Nonspecific Neck Pain.|Evaluation of the Immediate Effect of Acupuncture on Pain, Cervical Range of Motion and Electromyographic Activity of the Upper Trapezius Muscle in Patients With Nonspecific Neck Pain: Randomized, Single-blinded, Sham-controlled Study.|Completed||Phase 1/Phase 2|24|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-11 01:06:21.156823|2017-10-11 01:06:21.156823
NCT01984008|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-05-31|||October 2013||2013-10-01|November 2013|2013-11-01|July 2015|Anticipated|2015-07-01|March 2014|Actual|2014-03-01||Interventional|||A Prospective, Randomized Controlled Clinical Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy||Unknown status|Active, not recruiting|Phase 3|600|Anticipated|Universal Integrated Corp.||2|||f||||||||||||||2017-10-11 01:06:21.23377|2017-10-11 01:06:21.23377
NCT01982708|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-06-11|||December 2013||2013-12-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||A Prospective Study of a Haptic Device Evaluation of the Acute Abdomen|A Prospective Study of a Haptic Device Evaluation of the Acute Abdomen|Completed||N/A|20|Actual|Michigan State University|||1||f||||f||||||||||2017-10-11 01:06:37.736927|2017-10-11 01:06:37.736927
NCT01983995|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-10-24|||November 2013||2013-11-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients|Prospective Pilot Study Evaluating the Inter-relationships Between Sleep Disturbance, Fatigue, Pain, and Daytime Activity in Breast Cancer Patients Starting Aromatase Inhibitor Therapy|Completed||N/A|49|Actual|University of Michigan|||1||f||||f||||||||||2017-10-11 01:06:21.569485|2017-10-11 01:06:21.569485
NCT01983982|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-07-25|||November 2013||2013-11-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms|Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms in Early Stage Breast Cancer|Completed||N/A|30|Actual|University of Michigan|||1||f||||f||||||||||2017-10-11 01:06:21.655329|2017-10-11 01:06:21.655329
NCT01983969|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-06-19|||November 2013|Actual|2013-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma|Azacitidine/Vorinostat/GemBuMel With Autologous Stem-Cell Transplant (SCT) in Patients With Refractory Lymphomas|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:06:21.740476|2017-10-11 01:06:21.740476
NCT01983956|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-09-27|||December 2013||2013-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|SENS||A Structured Early Palliative Care Intervention for Patients With Advanced Cancer - a Randomized Controlled Trial With a Nested Qualitative Study (SENS Trial)|A Structured Early Palliative Care Intervention for Patients With Advanced Cancer - a Randomized Controlled Trial With a Nested Qualitative Study (SENS Trial)|Recruiting||N/A|150|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 01:06:21.910507|2017-10-11 01:06:21.910507
NCT01983943|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-06-01|||August 2013||2013-08-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Olive Oil and Cardiovascular Health|Effects of Hydroxytyrosol on Vascular Health|Withdrawn||N/A|0|Actual|Mayo Clinic||2||No participants were enrolled|f||||f||||||||||2017-10-11 01:06:22.043946|2017-10-11 01:06:22.043946
NCT01983917|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-05-10|||September 2012||2012-09-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Mobile Application to Enhance Diabetic Care|Clinical Trial of Mobile Application to Enhance Diabetic Health Care|Withdrawn||N/A|0|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 01:06:22.232367|2017-10-11 01:06:22.232367
NCT01983904|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-10-26|||August 2013||2013-08-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CRIO-DBS||DBS for Treatment Resistant Depression|Therapeutic Brain Stimulation for Refractory Depression|Active, not recruiting||N/A|25|Anticipated|University of Calgary||2|||f||||f||||||||Undecided|undecided|2017-10-11 01:06:22.3079|2017-10-11 01:06:22.3079
NCT01983891|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-07-08|||April 2013||2013-04-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Improving Nutritional Outcomes Among Food Insecure Twin Cities Residents||Completed||N/A|64|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-11 01:06:22.395862|2017-10-11 01:06:22.395862
NCT01983878|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-04-19|2016-01-25||December 2013||2013-12-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|January 2015|Actual|2015-01-01||Interventional||Full Analysis Set (FAS): all enrolled participants who received at least one dose of the study drug.|A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer|A Phase 2 Study of Ramucirumab in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First Line Platinum- or Fluoropyrimidine-Containing Combination Therapy in Japanese Patients|Completed||Phase 2|36|Actual|Eli Lilly and Company||1|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 01:06:22.48391|2017-10-11 01:06:22.48391
NCT01983865|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-02-17|||November 2013||2013-11-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC)||Completed||N/A|18|Actual|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f||||||||||||||2017-10-11 01:06:23.079311|2017-10-11 01:06:23.079311
NCT01983852|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-03-21|||June 2012||2012-06-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|PELICAN||Paediatric End of Life Care Needs in Switzerland|Paediatric End of Life Care Needs in Switzerland|Completed||N/A|200|Actual|University of Basel|||1||f||||f||||||||||2017-10-11 01:06:23.152742|2017-10-11 01:06:23.152742
NCT01983839|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-03-25|2015-02-10||April 2013||2013-04-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||PK Analysis of Moxifloxacin in the Treatment of CAP|Moxifloxacin Pharmacokinetic Profile and Efficacy Evaluation in the Empiric Treatment of Community-Acquired Pneumonia|Completed||N/A|18|Actual|University of Aarhus|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 01:06:23.26382|2017-10-11 01:06:23.26382
NCT01983826|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-03-30|||November 2013||2013-11-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Dietary Nitrates and Vascular Function in Patients With Peripheral Artery Disease|Dietary Nitrates and Vascular Function in Patients With Peripheral Artery Disease|Completed||N/A|21|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 01:06:23.486242|2017-10-11 01:06:23.486242
NCT01983813|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-02-17|||March 2014||2014-03-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|November 2016|Actual|2016-11-01||Interventional|ICARE||Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care|Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care|Active, not recruiting||N/A|302|Actual|University of Iowa||2|||f||||t|f|f||||||||2017-10-11 01:06:23.604345|2017-10-11 01:06:23.604345
NCT01983787|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2015-11-06|2015-06-29||July 2013||2013-07-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Pharmacokinetics of Piperacillin, Given as Continuous Infusion to Patients With Cystic Fibrosis|Pharmacokinetics of Piperacillin, Given as Continuous Infusion to Patients With Cystic Fibrosis|Completed||Phase 4|10|Actual|University of Aarhus|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 01:06:23.856543|2017-10-11 01:06:23.856543
NCT01983774|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-04-13|||February 2008||2008-02-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations|Effect of Proton Pump Inhibitors on CF Exacerbations|Terminated||Phase 2|13|Actual|Columbia University||2||"Closed by sponsor of the study; PI has left the institution and Columbia is now the sponsor of   the record"|f||||t||||||||||2017-10-11 01:06:24.16194|2017-10-11 01:06:24.16194
NCT01983761|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-02|2013-11-14|||November 2013||2013-11-01|November 2013|2013-11-01||||March 2014|Anticipated|2014-03-01||Interventional|||Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation|A Phase I/IIa, Open-label, Non-randomized, Study of ASC-101 in Patients With Hematologic Malignancies or Myelodysplastic Syndrome (MDS) Who Are Candidates for Dual-cord Umbilical Cord Blood Transplantation (UCBT)|Unknown status|Active, not recruiting|Phase 1/Phase 2|25|Anticipated|Targazyme, Inc.||2|||f||||f||||||||||2017-10-11 01:06:24.266777|2017-10-11 01:06:24.266777
NCT01983748|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-05-04|||June 2014||2014-06-01|May 2017|2017-05-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma|A NON-COMMERCIAL, MULTICENTER, RANDOMIZED, TWO-ARMED, OPEN-LABEL PHASE III STUDY TO EVALUATE THE ADJUVANT VACCINATION WITH TUMOR RNA-LOADED AUTOLOGOUS DENDRITIC CELLS VERSUS OBSERVATION OF PATIENTS WITH RESECTED MONOSOMY 3 UVEAL MELANOMA|Recruiting||Phase 3|200|Anticipated|University Hospital Erlangen||2|||f||||t||||||||||2017-10-11 01:06:24.38447|2017-10-11 01:06:24.38447
NCT01983735|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-07|||January 2014||2014-01-01|November 2013|2013-11-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Efficacy and Safety of TELMINUVO to Stage 2 Hypertension|A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Telmisartan and S-Amlodipine(TELMINUVO TAB.) Versus S-Amlodipine Monotherapy in Patients With Stage 2 Hypertension|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||t||||||||||2017-10-11 01:06:24.544581|2017-10-11 01:06:24.544581
NCT01983722|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-08-21||||||August 2017|2017-08-01||||||||Expanded Access|||Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome|Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome|Available||N/A|||Children's Hospital Medical Center, Cincinnati|||||||||||||||||||2017-10-11 01:06:24.663313|2017-10-11 01:06:24.663313
NCT01983709|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-04-26|||October 2013||2013-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|MSC||Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer|A Phase 1 Study of Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer|Active, not recruiting||Phase 1|7|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:06:24.727449|2017-10-11 01:06:24.727449
NCT01983696|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-25|||November 2013||2013-11-01|November 2013|2013-11-01|October 2014|Anticipated|2014-10-01|March 2014|Anticipated|2014-03-01||Interventional|||The Effect of Low Oxygen Tension on the Early Development of Human Embryo in IVF/ICSI|The Effect of Low Oxygen Tension on the Early Development of Human Embryo in IVF/ICSI|Unknown status|Recruiting|N/A|100|Anticipated|Shanxi Provincial Maternity and Children's Hospital||2|||f||||t||||||||||2017-10-11 01:06:24.802795|2017-10-11 01:06:24.802795
NCT01983683|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-05-12|||December 12, 2013|Actual|2013-12-12|May 2017|2017-05-01|May 2, 2017|Actual|2017-05-02|March 9, 2017|Actual|2017-03-09||Interventional|||Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea|A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD).|Completed||Phase 3|631|Actual|Actelion||2|||f||||t|t|f||||||||2017-10-11 01:06:24.899711|2017-10-11 01:06:24.899711
NCT01983670|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-07|||July 2009||2009-07-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Investigation of the Pre-movement Facilitation of Agonist-antagonist Muscles and the Effect of the Feedforward Rehabilitation in Individuals With Hypermetria||Completed||N/A|40|Actual|Chang Gung University||4|||f||||t||||||||||2017-10-11 01:06:25.306839|2017-10-11 01:06:25.306839
NCT01983657|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-14|||January 2012||2012-01-01|November 2013|2013-11-01|October 2014|Anticipated|2014-10-01|June 2014|Anticipated|2014-06-01||Interventional|PAP||Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.|Study of Subcutaneous Injection of Low-dose Recombinant Granulocyte Macrophage-Colony Stimulating Factor (rhGM-CSF) +/- Whole Lung Lavage(WLL) in Pulmonary Alveolar Proteinosis.|Unknown status|Recruiting|Phase 2|40|Anticipated|Shanghai Pulmonary Hospital, Shanghai, China||4|||f||||t||||||||||2017-10-11 01:06:25.411176|2017-10-11 01:06:25.411176
NCT01983644|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-12-13|||September 2013||2013-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|REDIRECT||RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study|RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study: a Prospective Randomised Control Trial(REDIRECT)|Recruiting||N/A|130|Anticipated|Jinling Hospital, China||2|||f||||t||||||||Undecided||2017-10-11 01:06:25.521783|2017-10-11 01:06:25.521783
NCT01983631|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-13|||April 2011||2011-04-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Whole Body Vibration Training on Neuromuscular Property in Individuals With Ataxia||Completed||N/A|17|Actual|Chang Gung University||4|||f||||t||||||||||2017-10-11 01:06:25.633823|2017-10-11 01:06:25.633823
NCT01983618|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2015-10-14|||February 2014||2014-02-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|February 2015|Actual|2015-02-01||Interventional|||Impact of Interscalene Nerve Block on Cerebral Perfusion During Surgery in the Beachchair Position|Impact of Interscalene Nerve Block on Cerebral Perfusion During Surgery in the Beachchair Position Under General Anesthesia|Completed||N/A|25|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 01:06:25.708952|2017-10-11 01:06:25.708952
NCT01983605|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-10-07|||December 2009||2009-12-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|March 2011|Actual|2011-03-01||Interventional|PLACE II||Left Atrial Appendage Exclusion Study|Left Atrial Appendage Exclusion Study II|Completed||N/A|96|Actual|SentreHEART, Inc.||1|||f||||f||||||||||2017-10-11 01:06:25.795136|2017-10-11 01:06:25.795136
NCT01983592|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-01-26|||December 2013||2013-12-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||An N-of-1 Study of Homeopathic Treatment of Fatigue in Patients Receiving Chemotherapy|An N-of-1 Study of Homeopathic Treatment of Fatigue in Patients Receiving Chemotherapy|Completed||Phase 1/Phase 2|1|Actual|The Canadian College of Naturopathic Medicine||2|||f||||f||||||||||2017-10-11 01:06:25.857532|2017-10-11 01:06:25.857532
NCT01983579|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-11-16|||October 2013||2013-10-01|November 2015|2015-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection|A Single-center, Open Label, Prospective Study Assessing the IOP (Intraocular Pressure) Patterns Using SENSIMED Triggerfish® in Association With Anti-VEGF Injection|Terminated||Phase 4|4|Actual|Sensimed AG||3|||f||||f||||||||||2017-10-11 01:06:25.93029|2017-10-11 01:06:25.93029
NCT01983566|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-04-12|2016-01-21||November 2013||2013-11-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Treated Set (TS): included all subjects who were dispensed study medication and were documented to have taken at least 1 dose of deleobuvir or OMP.|Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects|Investigation of the Effect of Food and of Increased Gastric pH on the Relative Bioavailability of Deleobuvir Following Single Oral Administration in Healthy Caucasian and Japanese Subjects (an Open-label, Randomised, Four-way Crossover Study)|Terminated||Phase 1|16|Actual|Boehringer Ingelheim|As the study was discontinued prematurely, the results were incomplete. Due to this incomplete data the endpoint AUC(0-inf) was not evaluated,and only a limited number of the planned statistical analyses could be performed.|4|||f||||||||||||||2017-10-11 01:06:26.013988|2017-10-11 01:06:26.013988
NCT01983553|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-09-27|||November 2014||2014-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study|Long-Term Follow-Up of Hospitalized Dengue and Safety in Thai Children Who Were Included in an Efficacy Study of a Tetravalent Dengue Vaccine|Completed||N/A|3203|Actual|Sanofi|||1||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-11 01:06:26.422201|2017-10-11 01:06:26.422201
NCT01983540|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-01-04|||October 2013||2013-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination|Evaluation of Antibody Persistence at 3.5 and 4.5 Years of Age in Healthy Children After Primary Series and Booster Vaccination With Investigational (DTaP-IPV-Hep B-PRP~T) or Infanrix Hexa™ Vaccines in Latin America|Completed||Phase 3|558|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 01:06:26.496975|2017-10-11 01:06:26.496975
NCT01983527|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2013-11-13|||December 2013||2013-12-01|November 2013|2013-11-01|November 2015|Anticipated|2015-11-01|December 2014|Anticipated|2014-12-01||Interventional|CADAC||Corticosteroids and / or Arthrographic Distention in the Treatment of Adhesive Capsulitis|A Prospective Randomized 3-arm Trial Comparing Intra-articular Corticosteroid Injection vs Arthrographic Distention vs Arthrographic Distention Plus Intra-articular Corticosteroid Injection in the Treatment of Adhesive Capsulitis|Unknown status|Not yet recruiting|N/A|132|Anticipated|Imelda Hospital, Bonheiden||3|||f||||t||||||||||2017-10-11 01:06:26.598991|2017-10-11 01:06:26.598991
NCT01983514|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-04-22|||October 2013||2013-10-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults|Intranasal (Optinose Bidirectional Nose-to-brain Device) Versus Intravenous Slow Infusion of Oxytocin - a Randomized, Placebo- Controlled Double-blind, Double-dummy 4-period Cross-over Study in Healthy Adult Volunteers Evaluating Brain Functional Magnetic Resonance Imaging Changes, Cognitive Response, Heart Rate Variability, Plasma Pharmacokinetics and Saliva Concentration After Single-dose Oxytocin 8 or 24 International Units (IU) Intranasally or 1 IU as Slow Intravenous Infusion|Completed||Phase 1|19|Actual|OptiNose AS||4|||f||||f||||||||||2017-10-11 01:06:28.408386|2017-10-11 01:06:28.408386
NCT01983501|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-07-06|||February 2014||2014-02-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase 1b Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer|A Phase 1b, Open-label Study to Assess the Safety and Tolerability of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (Trastuzumab Emtansine;T-DM1)|Active, not recruiting||Phase 1|57|Actual|Cascadian Therapeutics Inc.||1|||f||||t||||||||||2017-10-11 01:06:28.53853|2017-10-11 01:06:28.53853
NCT01983488|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2017-03-21|||September 2011||2011-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Clinical Outcome in Uveitis|Clinical Outcome and Causes of Visual Loss in Uveitis|Active, not recruiting||N/A|1500|Anticipated|Moorfields Eye Hospital NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 01:06:28.669606|2017-10-11 01:06:28.669606
NCT01983475|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-10-21|||January 2015||2015-01-01|October 2015|2015-10-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Denosumab Administration After Spinal Cord Injury|The Efficacy of Denosumab to Reduce Osteoporosis After Spinal Cord Injury|Recruiting||Phase 2|24|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||t||||||||||2017-10-11 01:06:28.743901|2017-10-11 01:06:28.743901
NCT01983462|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-03-27|||October 2013||2013-10-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|VANISH||Vascular Dysfunction in Human Obesity Hypertension|Vascular Dysfunction in Human Obesity Hypertension: Integrative Role of Sympathetic and Renin-Angiotensin Systems|Recruiting||Phase 2|126|Anticipated|University of Iowa||3|||f||||t||||||||||2017-10-11 01:06:28.863166|2017-10-11 01:06:28.863166
NCT01983449|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-03-21|||November 2013||2013-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|DANCE||Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease|Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization|Active, not recruiting||Phase 4|285|Actual|Mercator MedSystems, Inc.||1|||f||||f||||||||||2017-10-11 01:06:28.975978|2017-10-11 01:06:28.975978
NCT01983436|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-08-01|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|February 16, 2019|Anticipated|2019-02-16|January 24, 2019|Anticipated|2019-01-24||Interventional|DLMOF||Impact of Manual Lymphatic Drainage on Postoperative Edema of the Face and the Neck After Orthognathic Surgery|Impact of Manual Lymphatic Drainage on Postoperative Edema of the Face and the Neck After Orthognathic Surgery.Open-label Multicenter Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|University Hospital, Tours||2|||f||||f||||||||||2017-10-11 01:06:29.141991|2017-10-11 01:06:29.141991
NCT01983423|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-04-07|||January 2013||2013-01-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|EndoBx-IVF||Effect of Endometrial Biopsy on in Vitro Fertilization Pregnancy Rates - a Multicenter Study|Effect of Endometrial Biopsy on in Vitro Fertilization Pregnancy Rates - a Randomized, Multicenter Study|Terminated||N/A|52|Actual|Pacific Centre for Reproductive Medicine||2||Suboptimal subject recruitment|f||||t||||||||||2017-10-11 01:06:29.370746|2017-10-11 01:06:29.370746
NCT01983410|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-08-07|||November 4, 2013|Actual|2013-11-04|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01|3 Years|Observational [Patient Registry]|||A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma|A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma|Recruiting||N/A|500|Anticipated|Memorial Sloan Kettering Cancer Center|||4||f||||||||||Samples With DNA|"     Blood specimens tumor tissue samples will be requested   "|||2017-10-11 01:06:29.482855|2017-10-11 01:06:29.482855
NCT01983397|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-06|||August 2012||2012-08-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Two Physical Exercise Protocols on Cognition and Physical Performances in Elderly Over 80 Years|Effects of Two Physical Exercise Protocols on Cognition and Physical Performances in Oldest Old: a Randomized Controlled Trial|Completed||N/A|69|Actual|Universidade Federal de Sao Carlos||3|||f||||t||||||||||2017-10-11 01:06:29.632516|2017-10-11 01:06:29.632516
NCT01983384|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-01-13|||August 2015||2015-08-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|ADAPT2||Anesthesia Depth And Postoperative Delirium Trial 2|THE EFFECTS OF LIGHT vs DEEP ANESTHESIA ON POSTOPERATIVE COGNITIVE OUTCOMES|Recruiting||Phase 3|202|Anticipated|University of California, San Francisco||2|||f||||t||||||||No||2017-10-11 01:06:29.737307|2017-10-11 01:06:29.737307
NCT01983371|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-05-19|||December 2013||2013-12-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer|Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer|Withdrawn||N/A|0|Actual|University of Vermont||1|||f||||f||||||||||2017-10-11 01:06:29.849133|2017-10-11 01:06:29.849133
NCT01983358|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-06-23|||November 2013||2013-11-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|JPI-289||The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers|A Phase I Clinical Study, Randomized, Double-blind, Placebo-controlled,Single Dose, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of JPI-289 in Healthy Male Subjects.|Completed||Phase 1|40|Actual|Jeil Pharmaceutical Co., Ltd.||2|||f||||t||||||||No||2017-10-11 01:06:29.948738|2017-10-11 01:06:29.948738
NCT01983345|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2016-07-31|||July 2014||2014-07-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|PRIUM||Prenatal Surgical Repair of Fetal Myelomeningocele|Prenatal Surgical Repair of Fetal Myelomeningocele|Recruiting||N/A|50|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:06:30.055791|2017-10-11 01:06:30.055791
NCT01983319|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-02-04|||January 2014||2014-01-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||tDCS Combined With Constraint Induced Movement Therapy and Role of GABA Activity in Stroke Recovery|Transcranial Direct Current Stimulation Combined With Constraint Induced Movement Therapy and Role of GABA Activity in Stroke Recovery|Completed||N/A|64|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 01:06:30.226863|2017-10-11 01:06:30.226863
NCT01983306|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-10-03|||November 2013||2013-11-01|October 2017|2017-10-01|April 2015|Actual|2015-04-01|September 2014|Actual|2014-09-01||Interventional|OIC||Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)|A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy|Completed||Phase 2|260|Anticipated|Synergy Pharmaceuticals Inc.||4|||f||||f||||||||||2017-10-11 01:06:30.324351|2017-10-11 01:06:30.324351
NCT01983293|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-08-10|||November 2013||2013-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|ENHANCE CRT||CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients|CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients (ENHANCE CRT). A Prospective, Randomized, Postmarket, Pilot Study.|Active, not recruiting||N/A|252|Actual|St. Jude Medical||2|||f||||f||||||||||2017-10-11 01:06:30.50668|2017-10-11 01:06:30.50668
NCT01983280|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-11-20|||October 2009||2009-10-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Sleep5||The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients|The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients: A Prospective Cross Over Trial|Completed||N/A|29|Actual|Shriners Hospitals for Children||1|||f||||t||||||||||2017-10-11 01:06:30.661966|2017-10-11 01:06:30.661966
NCT01983267|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-05-03|||November 2013||2013-11-01|May 2017|2017-05-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|||Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.|Cannabis-related Cognitive Impairment: Prospective Evaluation of Possible Influences in Cancer Patients During Active Oncology Treatment|Completed||N/A|100|Actual|Rambam Health Care Campus||2|||f||||f|f|f||||||No||2017-10-11 01:06:30.730577|2017-10-11 01:06:30.730577
NCT01983254|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-04-19|2017-02-17||October 2013||2013-10-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional||This includes 86 patients and 39 caregivers (coping skills training group) plus 89 patients and 47 caregivers (education program group).|Improving Psychological Distress Among Critical Illness Survivors and Their Caregivers|Improving Psychological Distress Among Critical Illness Survivors and Their Caregivers|Completed||N/A|417|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:06:30.926463|2017-10-11 01:06:30.926463
NCT01983241|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-12-01|||November 2013||2013-11-01|December 2016|2016-12-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|SPARTA||Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)|A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency|Recruiting||Phase 3|339|Anticipated|Grifols Therapeutics Inc.||3|||f||||f||||||||||2017-10-11 01:06:31.531168|2017-10-11 01:06:31.531168
NCT01983228|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-04-24|||July 1, 2016|Actual|2016-07-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|ACTION||A Proactive Walking Trial to Reduce Pain in Black Veterans|A Proactive Walking Trial to Reduce Pain in Black Veterans|Recruiting||N/A|500|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 01:06:31.794025|2017-10-11 01:06:31.794025
NCT01983215|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-01-24|||April 2013||2013-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites|EFFECTS OF PREVENA THERAPY ON REDUCTION OF GROIN SURGICAL SITE INFECTIONS IN OBESE PATIENTS UNDERGOING VASCULAR SURGERY|Enrolling by invitation||N/A|276|Actual|Ohio State University||1|||f||||f||||||||||2017-10-11 01:06:31.926686|2017-10-11 01:06:31.926686
NCT01983202|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-11-06|||January 2003||2003-01-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|January 2011|Actual|2011-01-01||Observational|||Obstetric Outcomes in Women With PCOS|Size at Birth in Newborn Children and Obstetric Outcomes in Women With PCOS|Completed||N/A|1248|Actual|Odense University Hospital|||2||f||||f||||||||||2017-10-11 01:06:32.01674|2017-10-11 01:06:32.01674
NCT01983189|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-01-12|||November 2008||2008-11-01|January 2017|2017-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism|Repetetive Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behavior in Subjects With Autism Spectrum Disorders.|Terminated||Phase 2|10|Actual|New York State Psychiatric Institute||1||Principal investigator (Dr. Sporn) left the sponsoring institution.|f||||t||||||||||2017-10-11 01:06:32.093694|2017-10-11 01:06:32.093694
NCT01983176|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2013-11-25|||October 2013||2013-10-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Retrospective Clinical Outcome of Parotid Tumor Surgery|Retrospective Clinical Outcome of Parotid Tumor Surgery|Completed||N/A|767|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:06:32.188642|2017-10-11 01:06:32.188642
NCT01983163|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-12-31|||April 2013||2013-04-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Dietary Therapy in Children With Refractory Epilepsy|Efficacy of Modified Atkins Diet Versus Ketogenic Diet in Children With Refractory Epilepsy Aged 1 Year to 18 Years: a Randomized Controlled Trial|Completed||Phase 2|30|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 01:06:32.269961|2017-10-11 01:06:32.269961
NCT01983150|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-12-01|||January 2014||2014-01-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|||A Randomized Controlled Trial to Test the Effect of a Smartphone Quit Smoking Intervention on Young Adult Smokers|Effect of a Smartphone Intervention on Quitting Smoking in a Young Adult Population of Smokers: A Randomized Controlled Trial|Completed||N/A|1601|Actual|University of Waterloo||2|||f||||t||||||||||2017-10-11 01:06:32.345208|2017-10-11 01:06:32.345208
NCT01983137|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-11-06|||April 2011||2011-04-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.|The Efficacy, With Regard to Pain Relief, of Targinact® Treatment for Patients With Severe Pain Compared to Previous Analgesic Treatment; a Non-interventional Study.|Completed||N/A|1338|Actual|Mundipharma CVA|||1||f||||f||||||||||2017-10-11 01:06:32.484433|2017-10-11 01:06:32.484433
NCT01983124|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-01-19|||February 2013||2013-02-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|April 2014|Actual|2014-04-01||Interventional|BeyPro1||Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib|A Phase II Single-arm Study for the Treatment After Recurrence of Advanced Melanoma Patients Harboring the V600BRAF Mutation and Pretreated With Vemurafenib, With the Association of Vemurafenib Plus Fotemustine.|Completed||Phase 2|31|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||1|||f||||f||||||||||2017-10-11 01:06:32.56657|2017-10-11 01:06:32.56657
NCT01983111|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-06-01|2015-09-01||October 2013||2013-10-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||* Safety set = 134|Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)|A Multicenter, Phase IV, Interventional Study to Compare the Efficacy and Safety of NORSPAN to Tramadol/Acetaminophen in Patients With Prolonged Postoperative Pain After Spinal Surgery (PASSION)|Completed||Phase 4|136|Actual|Mundipharma Korea Ltd||2|||f||||f||||||||||2017-10-11 01:06:32.662355|2017-10-11 01:06:32.662355
NCT01983098|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-05|||April 2013||2013-04-01|October 2013|2013-10-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01|1 Year|Observational [Patient Registry]|||Analysis of Circulating Tumor DNA to Monitor Metastatic Colorectal Cancer Treatment||Unknown status|Recruiting|N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Blood samples were collected from patients treated for colorectal cancer. Blood samples were     collected in EDTA tubes every two weeks before each cycles of chemotherapy. Blood samples     were processed within 2 hour after collection and were centrifuged to separate the plasma     from the peripheral-blood cells.   "|||2017-10-11 01:06:33.10504|2017-10-11 01:06:33.10504
NCT01981967|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-03-31|2016-03-31||November 2013||2013-11-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Post-licensure Safety Study of IMOJEV® in Thailand|Post-licensure, Phase IV, Safety Study of IMOJEV® in Thailand|Completed||Phase 4|10000|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 01:06:50.335818|2017-10-11 01:06:50.335818
NCT01983085|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-01-19|||September 2013||2013-09-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|ProNOx2||Nitric Oxide Generating Gel Dressing in Patients With Superficial Partial Thickness Wounds|ProNOx 2 - A Clinical Study of Superficial Partial Thickness Wound Treatment With an Oxides of Nitrogen Generating Gel Dressing|Active, not recruiting||Phase 2|160|Anticipated|Edixomed Ltd||2|||f||||t||||||||||2017-10-11 01:06:33.174112|2017-10-11 01:06:33.174112
NCT01983072|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-11-12|||April 2008||2008-04-01|November 2013|2013-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Symbiotic & Colonization|Effect of Starter Formula With Symbiotic on Microbiota Balance|Completed||Phase 2|141|Actual|Nestlé||3|||f||||f||||||||||2017-10-11 01:06:33.261359|2017-10-11 01:06:33.261359
NCT01983059|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-08-30|||March 2014||2014-03-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|SLVTS-SASL-35||Swiss Liver Venous Thrombosis Study|A Multicenter Prospective Observational Cohort Study|Recruiting||N/A|500|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||Samples With DNA|"     blood, serum, plasma, stool and urine samples   "|||2017-10-11 01:06:33.346419|2017-10-11 01:06:33.346419
NCT01983046|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2014-10-20|||September 2013||2013-09-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Rectal Short Chain Fatty Acids Combinations and Substrate and Energy Metabolism|The Effects of Rectal Administration of SCFA on Human Substrate and Energy Metabolism|Completed||N/A|12|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-11 01:06:33.559113|2017-10-11 01:06:33.559113
NCT01983033|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-05-23|||October 2013|Actual|2013-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Drop It||Training Protocol 'Drop it'. The Impact of a Training Protocol Focused on Coping With Negative Repetitive Thinking on Cognitive and Behavioural Functioning of People Suffering From GAD or Minor or Moderate Depressive Disorder or Depressive Disorder in Remission|Drop it. The Impact of a Training Protocol Focused on Coping With Negative Repetitive Thinking on Cognitive and Behavioural Functioning of People Suffering From GAD or Minor or Moderate Depressive Disorder or Depressive Disorder in Remission|Completed||N/A|80|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:06:33.645348|2017-10-11 01:06:33.645348
NCT01983020|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-04-28|2014-08-18||April 2011||2011-04-01|April 2017|2017-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery|Randomized Double Blind Comparison of Peri-Operative Standard Analgesia With Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery|Completed||Phase 3|46|Actual|Beth Israel Medical Center||4|||f||||f||||||||||2017-10-11 01:06:33.737177|2017-10-11 01:06:33.737177
NCT01983007|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-03-20|||January 2012||2012-01-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Physical Exercise on Endothelial Function in Patients With Type 2 Diabetes Mellitus|Effect of Physical Exercise on Endothelial Function in Patients With Type 2 Diabetes Mellitus|Completed||N/A|31|Actual|Universidade Federal do Ceara||2|||f||||t||||||||||2017-10-11 01:06:34.234237|2017-10-11 01:06:34.234237
NCT01982994|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-09-12|||October 2013||2013-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|July 2015|Actual|2015-07-01||Interventional|||Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients|Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients|Active, not recruiting||N/A|32|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 01:06:34.326582|2017-10-11 01:06:34.326582
NCT01982981|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2013-11-06|||March 2012||2012-03-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Instrument Design and Validation to Asses the Perception of Wellbeing Associated to Plain Water.|"Instrument Design and Validation to Evaluate the Perception of Well-being Associated to Plain Water Consumption Among Mexican Adults Residing in the City of Cuernavaca."|Completed||N/A|142|Actual|Mexican National Institute of Public Health||2|||f||||t||||||||||2017-10-11 01:06:34.450026|2017-10-11 01:06:34.450026
NCT01982968|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-10-24|||December 2013||2013-12-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|WRAP-IPF||Treatment of IPF With Laparoscopic Anti-Reflux Surgery|Weighing Risks and Benefits of Laparoscopic Anti-Reflux Surgery in Patients With Idiopathic Pulmonary Fibrosis|Active, not recruiting||Phase 2|58|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:06:34.555103|2017-10-11 01:06:34.555103
NCT01982955|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-06-08|||December 23, 2013|Actual|2013-12-23|June 2017|2017-06-01|April 16, 2018|Anticipated|2018-04-16|December 16, 2017|Anticipated|2017-12-16||Interventional|INSIGHT||Tepotinib With Gefitinib in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|A Phase Ib/II Multicenter, Randomized, Open Label Trial to Compare Tepotinib (MSC2156119J) Combined With Gefitinib Versus Chemotherapy as Second‑Line Treatment in Subjects With MET Positive, Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation and Having Acquired Resistance to Prior EGFR-Tyrosine Kinase Inhibitor (EGFR‑TKI) Therapy|Active, not recruiting||Phase 1/Phase 2|70|Actual|Merck KGaA||2|||f||||t||||||||||2017-10-11 01:06:34.680983|2017-10-11 01:06:34.680983
NCT01982942|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-08-10|||November 2013||2013-11-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis|A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis|Completed||Phase 2|255|Actual|MediciNova||2|||f||||t||||||||||2017-10-11 01:06:34.865036|2017-10-11 01:06:34.865036
NCT01982929|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-06|||November 2013||2013-11-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||An Evaluation of Post Caesarean-Section Pain Control Regimens: Non-Opioid Oral Regimen With and Without Transversus Abdominis Plane Block|An Evaluation of Post Caesarean-Section Pain Control Regimens: Non-Opioid Oral Regimen With and Without Transversus Abdominis Plane Block|Unknown status|Not yet recruiting|N/A|240|Anticipated|Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 01:06:35.134037|2017-10-11 01:06:35.134037
NCT01982734|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-10-24|||November 2012||2012-11-01|October 2016|2016-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Improved Oral Bioavailability of Curcumin Incorporated Into Micelles|Novel Strategies for the Enhancement of the Potency of Nutraceuticals With Low Oral Bioavailability and Their Application in Novel Functional Foods for Optimum Protection of the Aging Brain|Completed||Early Phase 1|23|Actual|University of Hohenheim||4|||f||||f||||||||||2017-10-11 01:06:37.495835|2017-10-11 01:06:37.495835
NCT01982916|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2014-02-18|||December 2013||2013-12-01|February 2014|2014-02-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean|A 4 Week Multicenter, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy and Safety of AGR Tablet in the Treatment of Perennial Allergic Rhinitis in Korean : a Phase III Clinical Trial Bridging Study|Unknown status|Recruiting|Phase 3|330|Anticipated|Ahn-Gook Pharmaceuticals Co.,Ltd||3|||f||||f||||||||||2017-10-11 01:06:35.270649|2017-10-11 01:06:35.270649
NCT01982903|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-05-25|||July 2015||2015-07-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01|24 Months|Observational [Patient Registry]|||Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants|Prospective Study of Urinary Connective Tissue Growth Factor and Related Pro-fibrotic Mediators as Potential Early Biomarkers of Progressive Renal Allograft Fibrosis in de Novo Kidney Recipients|Recruiting||N/A|180|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     whole blood, serum, urine, renal allograft tissue   "|||2017-10-11 01:06:35.507775|2017-10-11 01:06:35.507775
NCT01982890|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-07-11|||January 2005||2005-01-01|July 2016|2016-07-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01|5 Years|Observational [Patient Registry]|||Telomeres and T-cell Receptor Excision Circles (TRECs) From Peripheral Blood in Normal Subjects Over Time|Telomere Shortening as a Prognostic Marker in Early Inflammatory Arthritis: Establishing the Stability of Telomeres in Normal Individuals|Enrolling by invitation||N/A|200|Anticipated|Université de Sherbrooke|||1||f||||f||||||Samples With DNA|"     Genomic DNA extracted from peripheral blood   "|||2017-10-11 01:06:35.607936|2017-10-11 01:06:35.607936
NCT01982877|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-10-20|||January 2014||2014-01-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||The Four Supports Study: Family Support Intervention in Intensive Care Units|A Trial to Improve Surrogate Decision-Making for Critically Ill Older Adults|Recruiting||N/A|300|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:06:35.723313|2017-10-11 01:06:35.723313
NCT01982864|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-09-06|||October 2013||2013-10-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|DIAMS||Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.|Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.|Terminated||Phase 4|24|Actual|University Hospital, Limoges||1||Not enough patients|f||||f||||||||||2017-10-11 01:06:35.826404|2017-10-11 01:06:35.826404
NCT01982851|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-03-10|||July 2010||2010-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effects of Analgesic Techniques on Duration of Labor for Induction Patients|A Randomized Trial of the Impact of Three Labor Analgesia Techniques on Labor Duration in Nulliparous Labor Inductions|Terminated||N/A|134|Actual|Northwestern University||3||low qualified candidate enrollment|f||||f||||||||||2017-10-11 01:06:35.923629|2017-10-11 01:06:35.923629
NCT01982838|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-03-10|||July 2010||2010-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effects of Analgesic Techniques on Duration of Spontaneously Laboring Patients|A Randomized Trial of the Impact of Three Labor Analgesia Techniques on Labor Duration in Spontaneously Laboring Nulliparous Parturients|Terminated||N/A|129|Actual|Northwestern University||3||Low qualified candidate enrollment|f||||f||||||||||2017-10-11 01:06:36.026711|2017-10-11 01:06:36.026711
NCT01982825|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-12-03|||January 2013||2013-01-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Innovative Web-Based Intervention for Smoking Cessation Among College Students|Innovative Web-Based Intervention for Smoking Cessation Among College Students|Completed||Phase 1|200|Actual|Emory University||2|||f||||t||||||||||2017-10-11 01:06:36.139737|2017-10-11 01:06:36.139737
NCT01982812|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-06-20|2016-04-28||January 2014||2014-01-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LVT2||A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM|A Safety and Feasibility Study of Enteral Levetiracetam vs. Phenobarbital for Seizure Control in Pediatric Cerebral Malaria|Completed||Phase 2|44|Actual|University of Rochester||2|||f||||t||||||||Yes|After the finding have been published, the de-identified study data will be available to other researchers on request pending a review of their plans for using the data.|2017-10-11 01:06:36.232877|2017-10-11 01:06:36.232877
NCT01982799|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-11-02|||February 2014||2014-02-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|LAAEP||Local Anesthesia and Analgesics in Endodontic Pain|Local Anesthesia and Analgesics in Post-Operative Endodontic Pain|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Not enough funding|f||||f||||||||||2017-10-11 01:06:36.686011|2017-10-11 01:06:36.686011
NCT01982760|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-14|||December 2013||2013-12-01|November 2013|2013-11-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|||DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty|A Prospective Randomized Trial for the Use of DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty.|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 01:06:37.061674|2017-10-11 01:06:37.061674
NCT01982747|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-05-16|||November 2013||2013-11-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703|A Phase I, Placebo-Controlled, Double-Blind, 2-Period Crossover Study to Assess Cardiac and General Safety and Pharmacokinetics of a Single Subcutaneous Dose of 60 mg MGN1703 in Healthy Volunteers|Completed||Phase 1|14|Actual|Mologen AG||2|||f||||f||||||||||2017-10-11 01:06:37.370795|2017-10-11 01:06:37.370795
NCT01982695|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-01-31|2015-08-14||March 2009||2009-03-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|August 2012|Actual|2012-08-01||Interventional|||Cardiomyopathy in DMD: Lisinopril vs. Losartan|Compare Efficacy of the Angiotensin Converting Enzyme Inhibitor (ACEi) Lisinopril With Angiotensin II Receptor Antagonist Losartan (ARB) for the Cardiomyopathy of Duchenne Muscular Dystrophy|Completed||N/A|23|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 01:06:37.821485|2017-10-11 01:06:37.821485
NCT01982682|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-09-05|||November 4, 2013|Actual|2013-11-04|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|April 7, 2018|Anticipated|2018-04-07||Interventional|||Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor|A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor|Active, not recruiting||Phase 2|41|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 01:06:38.151469|2017-10-11 01:06:38.151469
NCT01982669|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2016-01-07|||February 2013||2013-02-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|||Spicy Diet on Salty Taste and Salt Intake|Effects of Spicy Diet on Salty Taste and Salt Intake|Completed||Phase 4|606|Actual|Third Military Medical University|||1||f||||t||||||Samples With DNA|"     Blood, Urine   "|||2017-10-11 01:06:38.296172|2017-10-11 01:06:38.296172
NCT01982656|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-03-21|||December 2013||2013-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Massage Technique for Pain, Anxiety and Delirium in SAH Patients|Effects of Massage Technique for Pain, Anxiety, and Delirium Management in ICU Patients With Subarachnoid Hemorrhage|Recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:06:38.442039|2017-10-11 01:06:38.442039
NCT01982630|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-08-24|||November 2013||2013-11-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)|A Phase Ib, Multicenter, Placebo and Active- Comparator-Controlled, Randomized, Double-Blind, Clinical Trial to Evaluate the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|87|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-10-11 01:06:38.656264|2017-10-11 01:06:38.656264
NCT01982617|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-12|||January 2003||2003-01-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI|A Randomized, Controlled Trial of Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With Severe Mental Illness|Completed||N/A|61|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:06:38.822853|2017-10-11 01:06:38.822853
NCT01982604|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-10-01|||November 2013||2013-11-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers|A Phase 1, Open-label, Randomized, Crossover Clinical Trial to Evaluate PK/PD of 30 U TI Inhalation Powders Prepared With Insulin From Two Different Suppliers|Completed||Phase 1|38|Actual|Mannkind Corporation||2|||f||||f||||||||||2017-10-11 01:06:38.915591|2017-10-11 01:06:38.915591
NCT01982591|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-06-14|||January 3, 2011|Actual|2011-01-03|June 2017|2017-06-01|March 24, 2015|Actual|2015-03-24|March 24, 2015|Actual|2015-03-24||Observational|||Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy|Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy|Completed||N/A|115|Actual|Fox Chase Cancer Center|||1||f||||t||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 01:06:39.015702|2017-10-11 01:06:39.015702
NCT01982578|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-07-31|||November 2013||2013-11-01|July 2015|2015-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|GENISTEÍNA_2||Genistein as a Possible Treatment for Alzheimer's Disease.|Effect of Activation of the Receptor PPARg/RXR as a Possible Treatment for Alzheimer's Disease. Role of Genistein.|Recruiting||N/A|50|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||t||||||||||2017-10-11 01:06:39.135757|2017-10-11 01:06:39.135757
NCT01982565|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-01-19|||June 2013||2013-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|ProNOx1||Nitric Oxide Generating Gel Dressing in Patients With Diabetic Foot Ulcers|A Clinical Pilot Study of an Oxides of Nitrogen Generating Gel Dressing System to Stimulate Healing in Diabetic Foot Ulcers|Completed||Phase 1/Phase 2|130|Actual|Edixomed Ltd||2|||f||||t||||||||||2017-10-11 01:06:39.274123|2017-10-11 01:06:39.274123
NCT01982552|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-07-20|||July 2013||2013-07-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life|An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life|Completed||N/A|147|Actual|LEO Pharma|||1||f||||f||||||||||2017-10-11 01:06:39.410888|2017-10-11 01:06:39.410888
NCT01982539|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-04-30|2015-04-30||November 2013||2013-11-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute|An Open-Label Study of the Safety and Efficacy of Zipsor® (Diclofenac Potassium) Liquid Filled Capsules in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute Pain|Completed||Phase 4|25|Actual|Depomed||1|||f||||f||||||||||2017-10-11 01:06:39.554745|2017-10-11 01:06:39.554745
NCT01982526|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-12|||May 2012||2012-05-01|May 2012|2012-05-01|May 2014|Anticipated|2014-05-01|May 2013|Actual|2013-05-01|2 Years|Observational [Patient Registry]|||Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients|Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients|Unknown status|Recruiting|N/A|50|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital|||1||f||||f||||||Samples Without DNA|"     We are collecting serum samples of pre and post operative endometroma patients and measuring     anti müllerian hormone levels.   "|||2017-10-11 01:06:39.766746|2017-10-11 01:06:39.766746
NCT01982513|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-06-03|||November 2013||2013-11-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Influence of the Method of Alleviation of Aorto-Caval Compression on the Trans-Hepatic Ultrasound-Assessed Inferior Vena Cava Diameter In Pregnant Patients|Influence of the Method of Alleviation of Aorto-Caval Compression on the Trans-Hepatic Ultrasound-Assessed Inferior Vena Cava Diameter In Pregnant Patients: An Observational Study of the Left Lateral Tilt and of the Left Uterine Displacement|Completed||N/A|30|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||1||f||||f||||||||||2017-10-11 01:06:39.838877|2017-10-11 01:06:39.838877
NCT01982500|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2017-08-08|||March 2012||2012-03-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|October 2016|Actual|2016-10-01||Observational|||Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer|A Multicentre, Observational Study of Bevacizumab (Avastin) Added to Front-line Chemotherapy in Patients With Stage IIIb, IIIC or IV Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma in Routine Clinical Practice.|Completed||N/A|200|Actual|Hellenic Oncology Research Group|||1||f||||f||||||||||2017-10-11 01:06:39.926109|2017-10-11 01:06:39.926109
NCT01982487|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-12-17|||December 2013||2013-12-01|December 2013|2013-12-01||||September 2017|Anticipated|2017-09-01||Interventional|||Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission|A Phase I/IIb Study of Recombinant ALVAC(2)-NY-ESO-1 (M)/TRICOM in Combination With INCB024360 for Patients in Remission With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen|Withdrawn||Phase 1/Phase 2|0|Actual|Roswell Park Cancer Institute||4|||f||||t||||||||||2017-10-11 01:06:40.064809|2017-10-11 01:06:40.064809
NCT01982474|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-02-05|||October 2013||2013-10-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety of Lymph Node Injection for Allergen Immunotherapy|Phase I Study of Allergen-Specific Intralymphatic Immunotherapy in the United States|Active, not recruiting||Phase 1|18|Actual|Nationwide Children's Hospital||3|||f||||t||||||||||2017-10-11 01:06:40.252288|2017-10-11 01:06:40.252288
NCT01982461|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-06|||November 2013||2013-11-01|November 2013|2013-11-01||||January 2014|Anticipated|2014-01-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.|A Randomized, Open-label, Active-controlled Study to Evaluate the Efficacy and Safety of Roty F.C. Tablets 10mg Versus Crestor 10mg F.C. Tablets in Patients With Hypercholesterolemia|Unknown status|Recruiting|N/A|40|Anticipated|Pin Siang Medical Biotechnology Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:06:40.410048|2017-10-11 01:06:40.410048
NCT01982448|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-10-02|||February 2014||2014-02-01|October 2017|2017-10-01|June 2021|Anticipated|2021-06-01|November 2017|Anticipated|2017-11-01||Interventional|||Cisplatin vs Paclitaxel for Triple Neg|A Randomized Phase II Study of Preoperative Cisplatin Versus Paclitaxel in Patients With Triple Negative Breast Cancer: Evaluating the Homologous Recombination Deficiency (HRD) Biomarker|Recruiting||Phase 2|165|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 01:06:40.565471|2017-10-11 01:06:40.565471
NCT01982435|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-07-05|2017-04-18||June 24, 2014|Actual|2014-06-24|July 2017|2017-07-01|May 26, 2016|Actual|2016-05-26|May 26, 2016|Actual|2016-05-26||Interventional|REACT||Safety and Efficacy of Ranibizumab for Diabetic Macular Edema|Safety and Efficacy of Intravitreal Ranibizumab for Diabetic Macular Edema Previously Treated With Intravitreal Bevacizumab: A Randomized Dual Arm Comparative Dosing Trial|Completed||Phase 1/Phase 2|27|Actual|The Cleveland Clinic|The relatively small sample size of eyes and short 1 year duration makes it challenging to extrapolate data to generate clinical management guidelines. The lack of a control group is an important limitation to recognize that also limits conclusions.|2|||f||||t||||||||||2017-10-11 01:06:40.874235|2017-10-11 01:06:40.874235
NCT01982422|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-06|||August 2012||2012-08-01|November 2013|2013-11-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01||Interventional|||Developmental Origins of Attention Deficit Hyperactivity Disorder|Developmental Origins of Attention Deficit Hyperactivity Disorder|Unknown status|Recruiting|N/A|40|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:06:42.056306|2017-10-11 01:06:42.056306
NCT01982409|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-03-25|||June 2013||2013-06-01|March 2014|2014-03-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children|A Study of Immune Persistence After Inoculated With One-dose Freeze-dried Live Attenuated Varicella Vaccine in Children Aged 1-6 Years|Active, not recruiting||Phase 4|350|Actual|Changchun Changsheng Life Science and Technology Co., Ltd.||1|||f||||t||||||||||2017-10-11 01:06:42.217363|2017-10-11 01:06:42.217363
NCT01982396|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-11-05|||January 2003||2003-01-01|November 2013|2013-11-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Interventional|PENTA 13||Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children|Pharmacokinetic Study of Twice Daily vs Once Daily Lamivudine and Abacavir as Part of Combination Antiretroviral Therapy in Children With HIV Infection|Completed||Phase 1|19|Actual|PENTA Foundation||2|||f||||f||||||||||2017-10-11 01:06:42.307566|2017-10-11 01:06:42.307566
NCT01982383|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-12|||November 2012||2012-11-01|October 2013|2013-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy|A Prospective Study of the Use of Micropulse 577nm Laser Treatment in Central Serous Chorioretinopathy|Unknown status|Recruiting|N/A|120|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-11 01:06:42.41554|2017-10-11 01:06:42.41554
NCT01982357|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-02-08|||July 2013||2013-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies|Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies|Recruiting||N/A|120|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-11 01:06:42.722|2017-10-11 01:06:42.722
NCT01982344|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-10-27|||October 2013||2013-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|June 2015|Actual|2015-06-01||Interventional|||A Study Comparing the Impact of Mini-exchange-room and Usual Care on Physical Activity and Quality of Life in Peritoneal Dialysis Patients||Completed||N/A|77|Actual|Peking University First Hospital||2|||f||||f||||||||||2017-10-11 01:06:42.86499|2017-10-11 01:06:42.86499
NCT01982331|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-12-22|||October 2013||2013-10-01|October 2013|2013-10-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine|Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/California/66/395 (H2N2)Influenza Vaccine|Completed||Phase 1|40|Actual|PATH||2|||f||||t||||||||||2017-10-11 01:06:42.999498|2017-10-11 01:06:42.999498
NCT01982318|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-05-24|||January 2017||2017-01-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers|A Prospective, Multi-Center, Randomized, Double Blind, Placebo-Controlled Trial Comparing Vitrogro® ECM To Placebo As An Adjunct To Standard Care In Patients With Venous Leg Ulcers|Withdrawn||Phase 2/Phase 3|0|Actual|Tissue Therapies Ltd.||2||Study discontinued. Superseded by NCT02973893 VF00102.|f|||||t|f||||||||2017-10-11 01:06:43.17155|2017-10-11 01:06:43.17155
NCT01982305|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-12|||August 2012||2012-08-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Pilot Study of a Nerve Block Simulator for the Training in Axillary Blocks|Simulator Versus Cadaver Training to Perform Ultrasound-guided Axillary Nerve Bocks|Completed||N/A|12|Actual|Fundación Universitaria de Ciencias de la Salud||2|||f||||f||||||||||2017-10-11 01:06:43.3101|2017-10-11 01:06:43.3101
NCT01982292|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-09-21|2016-09-21||May 2014||2014-05-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|RELAX-REPEAT|Full analysis set (FAS) – All patients to whom study treatment was assigned excluding patients who were mis-randomized.|Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure|Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure|Completed||Phase 2|321|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:06:43.472344|2017-10-11 01:06:43.472344
NCT01982279|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-12|||February 2011||2011-02-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|March 2011|Actual|2011-03-01||Observational|||Longitudinal Measurement of Caloric Compensation and Eating in the Absence of Hunger in French Preschool Children|One Year Change in Caloric Compensation and Eating in the Absence of Hunger in French Preschool Children|Completed||N/A|236|Actual|Centre des Sciences du Goût et de l'Alimentation|||1||f||||t||||||||||2017-10-11 01:06:44.542112|2017-10-11 01:06:44.542112
NCT01982266|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-05-16|||November 2013||2013-11-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION™ Hip Total Cartilage Replacement (TCR)™ in the Treatment of Degenerative Joint Disease of the Hip|A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION™ Hip Total Cartilage Replacement (TCR)™ in the Treatment of Degenerative Joint Disease of the Hip|Terminated||N/A|4|Actual|Biomimedica, Inc||1||Device failure|f||||t||||||||||2017-10-11 01:06:44.632058|2017-10-11 01:06:44.632058
NCT01982253|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-08-15|2015-10-21||October 2013||2013-10-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Safety analysis set included all participants who received at least 1 dose of double-blind study drug. Participants were analyzed according to the study drug they received.|Fasiglifam 25 mg BID vs 50 mg QD|A Phase 2 Randomized, Placebo-Controlled, Double-Blind Parallel-Group, Multicenter Study to Evaluate the Glycemic Effects and Safety of Fasiglifam 25 mg Twice Daily and 50 mg Once Daily on Glycemic Control in Subjects With Type 2 Diabetes|Terminated||Phase 2|10|Actual|Takeda||3||Due to potential concerns about liver safety (See Detailed Description)|f||||f||||||||||2017-10-11 01:06:44.749398|2017-10-11 01:06:44.749398
NCT01982240|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-04-26||2016-04-26|November 2013||2013-11-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||12-Week Study of Plecanatide for CIC (The CIC3 Study)|A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)|Completed||Phase 3|1394|Actual|Synergy Pharmaceuticals Inc.||3|||f||||f||||||||||2017-10-11 01:06:45.447791|2017-10-11 01:06:45.447791
NCT01982227|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-01-29|||March 2013||2013-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Monocentric Prospective Pilot Study Evaluating the Value of Indocyanine Green (ICG, Indocyanine Green) During a Surgical Resection of Cancerous Lesions Peritoneal Colorectal Origin.|Monocentric Prospective Pilot Study Evaluating the Value of Indocyanine Green (ICG, Indocyanine Green) During a Surgical Resection of Cancerous Lesions Peritoneal Colorectal Origin.|Completed||N/A|10|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 01:06:45.930508|2017-10-11 01:06:45.930508
NCT01982214|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2015-08-07|||April 2010||2010-04-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|VIBROS||Effects of Whole Body Vibration (WBV) on Musculoskeletal System of Aged Women|Effects of Whole Body Vibration (WBV) on Musculoskeletal System of Aged Women|Completed||N/A|225|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-11 01:06:46.023889|2017-10-11 01:06:46.023889
NCT01982201|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-08|2014-05-16|||November 2013||2013-11-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Antacid Interaction Study|A Phase 1, Randomized, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interaction Between Lesinurad and Calcium Carbonate and Aluminum/Magnesium Hydroxide-Containing Antacids in Healthy Adult Male Subjects|Completed||Phase 1|24|Actual|Ardea Biosciences, Inc.||2|||f||||f||||||||||2017-10-11 01:06:46.110031|2017-10-11 01:06:46.110031
NCT01982188|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-08-10|||September 2012||2012-09-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Single Incision Suburethral Sling at Time of Robotic Sacrocolpopexy|Single Incision Suburethral Sling at Time of Robotic Sacrocolpopexy|Completed||N/A|104|Actual|Atlantic Health System|||1||f||||t||||||||||2017-10-11 01:06:46.208022|2017-10-11 01:06:46.208022
NCT01982175|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-11-21|||July 2011||2011-07-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CLL004||Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia|A Multi-center, Open, Prospective, Phase II Study of Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection in Patients With Relapse and Refractory B-cell Chronic Lymphocytic Leukemia|Recruiting||Phase 2|120|Anticipated|Shanghai Zhangjiang Biotechnology Limited Company||1|||f||||f||||||||||2017-10-11 01:06:46.291484|2017-10-11 01:06:46.291484
NCT01982162|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-06-22|||April 2011||2011-04-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Observational|||Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze|Protocol for the European Multi-Centre Study Understanding Severe Asthma Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze|Completed||N/A|300|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||4||f||||f||||||||||2017-10-11 01:06:48.400022|2017-10-11 01:06:48.400022
NCT01982149|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-23|||September 2011||2011-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Incorporation of Genetic Expression of Airway Epithelium With CT Screening for Lung Cancer|Incorporation of Genetic Expression of Airway Epithelium With CT Screening for Lung Cancer|Active, not recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University|||3||f||||f|f|f||||Samples With DNA|"     Blood, urine and cells obtained for this study may be retained for future research with given     consent.   "|Undecided||2017-10-11 01:06:48.522585|2017-10-11 01:06:48.522585
NCT01982136|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-05-03|||August 2009||2009-08-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|4 Years|Observational [Patient Registry]|||Functional Outcome of Urethral Reconstructive Surgery|Prospective Long-term Single Center Cohort Study Assessing Functional Outcome of Urethral Reconstructive Surgery|Recruiting||N/A|150|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 01:06:48.637035|2017-10-11 01:06:48.637035
NCT01982123|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-09-27|||January 17, 2014|Actual|2014-01-17|September 2017|2017-09-01||||December 1, 2017|Anticipated|2017-12-01||Interventional|||SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy|Pulmonary Functional Imaging for Radiation Treatment Planning|Active, not recruiting||N/A|12|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 01:06:48.753363|2017-10-11 01:06:48.753363
NCT01982110|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-11-04|||September 2013||2013-09-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|September 2016|Actual|2016-09-01||Interventional|MBSC||A Mindfulness Based Application for Smoking Cessation|A Mindfulness Based Application for Smoking Cessation|Active, not recruiting||N/A|88|Anticipated|University of Virginia||2|||f||||t||||||||No||2017-10-11 01:06:48.901767|2017-10-11 01:06:48.901767
NCT01982097|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-08-18|||January 10, 2014|Actual|2014-01-10|August 2017|2017-08-01|August 31, 2017|Anticipated|2017-08-31|January 31, 2017|Actual|2017-01-31||Observational|SANE||Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma|"Multicenter, Prospective, Non-interventional Study Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma"|Active, not recruiting||N/A|110|Anticipated|Bayer|||1||f||||f||||||||||2017-10-11 01:06:49.030894|2017-10-11 01:06:49.030894
NCT01982084|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-11-29|||January 2014||2014-01-01|November 2016|2016-11-01||||March 2014|Actual|2014-03-01||Observational|||Group B Streptococcus: Attitudes to Immunisation in Pregnancy|Attitudes to Immunisation Against Group B Streptococcus During Pregnancy in England and Scotland|Completed||N/A|758|Actual|University of Oxford|||1||f||||f||||||||||2017-10-11 01:06:49.165495|2017-10-11 01:06:49.165495
NCT01982071|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-03-07|||September 2013||2013-09-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia|A Multi-center, Open-label, Non-comparative Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia (CFDA Commitment)|Terminated||Phase 4|59|Actual|Astellas Pharma Inc||1||Due to administrative reasons|f||||f||||||||||2017-10-11 01:06:49.263826|2017-10-11 01:06:49.263826
NCT01982058|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-08-28|||August 18, 2011|Actual|2011-08-18|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|August 7, 2017|Actual|2017-08-07||Interventional|||Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer|Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer|Active, not recruiting||N/A|483|Actual|Rutgers, The State University of New Jersey||3|||f||||t||||||||||2017-10-11 01:06:49.380528|2017-10-11 01:06:49.380528
NCT01982045|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-08-12|||October 2013||2013-10-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|AxA||RCT of AttraX® Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion|A Randomized Controlled Trial of AttraX® Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion|Active, not recruiting||N/A|100|Actual|UMC Utrecht||2|||f||||f||||||||||2017-10-11 01:06:49.63394|2017-10-11 01:06:49.63394
NCT01982032|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-05-01|||November 2013||2013-11-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|August 2017|Anticipated|2017-08-01||Interventional|ELECT||Edwards SAPIEN Periprosthetic Leakage Evaluation Versus Medtronic CoreValve in Transfemoral Aortic Valve Implantation (the ELECT Trial)||Terminated||N/A|56|Actual|UMC Utrecht||2||slow enrollmetn, study device unavailable ( CoreValve)|f||||t||||||||||2017-10-11 01:06:49.750581|2017-10-11 01:06:49.750581
NCT01982019|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-06-13|||February 2014||2014-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RFa-Ba-S||Influence of Bariatric Surgery on Serum Levels of 26RFa|Determination of Serum Levels of the Orexigenic Neuropeptide 26RFa in Obese Female Patients With or Without Diabetes. Influence of Bariatric Surgery|Recruiting||N/A|60|Anticipated|University Hospital, Rouen||3|||f||||f||||||||||2017-10-11 01:06:49.864584|2017-10-11 01:06:49.864584
NCT01982006|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-02-02|||October 9, 2013|Actual|2013-10-09|February 2017|2017-02-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|FEMCAT||Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery|Impact Médico-Economique de la Chirurgie de la cATaracte au Laser Femtoseconde|Completed||Phase 3|920|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 01:06:49.988339|2017-10-11 01:06:49.988339
NCT01981993|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-12-04|||June 2009||2009-06-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Validation of a Urinary Biomarker as Diagnostic Tool for AKI in Sepsis|Value of a Urinary Biomarker Set Obtained by a Proteomics Approach to Predict Acute Kidney Injury and Prognosis in Sepsis Patients: a Prospective Cohort Study|Unknown status|Active, not recruiting|N/A|150|Actual|University Hospital, Ghent|||1||f||||f||||||Samples Without DNA|"     urine samples for proteomic analysis   "|||2017-10-11 01:06:50.126201|2017-10-11 01:06:50.126201
NCT01981980|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-11-12|||October 2009||2009-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2011|Actual|2011-10-01||Interventional|||Comparison of the Effects of Carboxytherapy and Radiofrequency on Skin Rejuvenation|Comparison of the Effects of Carboxytherapy and Radiofrequency on Skin Rejuvenation|Completed||N/A|8|Actual|Universidade Federal do Triangulo Mineiro||2|||f||||f||||||||||2017-10-11 01:06:50.224588|2017-10-11 01:06:50.224588
NCT01981954|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-06-02||2016-06-02|September 25, 2013|Actual|2013-09-25|June 2017|2017-06-01|December 18, 2015|Actual|2015-12-18|December 18, 2015|Actual|2015-12-18||Interventional|||A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)|A Phase 3, Open-Label, Baseline-controlled, Multi-center, Sequential Dose-Titration Study to Assess the Pharmacokinetics, Long-Term Efficacy and Safety of Solifenacin Succinate Suspension in Children From 6 Months to Less Than 5 Years of Age With Neurogenic Detrusor Overactivity|Completed||Phase 3|23|Actual|Astellas Pharma Inc||1|||f||||t||||||||Undecided||2017-10-11 01:06:51.003202|2017-10-11 01:06:51.003202
NCT01981941|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2017-02-15|||May 2013||2013-05-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment|Post-marketing Clinical Study of Gabapentin Enacarbil ―Non-blinded Study in Restless Legs Syndrome (RLS) Patients With Moderate Renal Impairment―|Completed||Phase 4|19|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:06:51.142986|2017-10-11 01:06:51.142986
NCT01981928|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2014-07-09|||November 2013||2013-11-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans|A Phase 1, Randomized, Subject- and Investigator-blinded, Sponsor-unblinded, Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of ASP7962, Including a Food-effect Evaluation in Healthy Subjects|Completed||Phase 1|48|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:06:51.24647|2017-10-11 01:06:51.24647
NCT01981915|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-11-05|||January 2011||2011-01-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Optimum Insufflation Capacity in NMD|Optimum Insufflation Capacity and Peak Cough Flow Augmentation in Patients With Neuromuscular Disease|Completed||N/A|40|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-11 01:06:51.321917|2017-10-11 01:06:51.321917
NCT01981902|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-08-23|||August 2013||2013-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Non-Invasive Optical Spectroscopic Methods for Dehydration Identification in Marathon Trainees|Non-Invasive Optical Spectroscopic Methods for Dehydration Identification in Marathon Trainees|Withdrawn||N/A|0|Actual|University of California, Irvine|||1|Not a clinical trial study|f||||f||||||||||2017-10-11 01:06:51.405726|2017-10-11 01:06:51.405726
NCT01981889|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-10-31|||October 2013||2013-10-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease|Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease|Completed||Phase 4|53|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 01:06:51.504727|2017-10-11 01:06:51.504727
NCT01981876|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-02-26|||October 2010||2010-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|STEP||Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital|Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital|Completed||N/A|305|Actual|Tenwek Hospital|||1||f||||t||||||Samples With DNA|"     Blood and Urine specimens   "|||2017-10-11 01:06:51.751177|2017-10-11 01:06:51.751177
NCT01981863|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-05-23|2016-04-01||July 2013||2013-07-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Fibrinolysis Before Cardiopulmonary Bypass?|Fibrinolysis Before Cardiopulmonary Bypass?|Completed||Phase 4|40|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 01:06:51.84952|2017-10-11 01:06:51.84952
NCT01981850|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-12-07|||October 2013||2013-10-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|||A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis|A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)|Active, not recruiting||Phase 2|98|Actual|Promedior, Inc.||3|||f||||t||||||||||2017-10-11 01:06:52.229773|2017-10-11 01:06:52.229773
NCT01981837|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2016-02-04|||December 2013||2013-12-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis|A Phase 2, Open-Label Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Exploratory Clinical Activity of ALN-TTRSC in Patients With Transthyretin (TTR) Cardiac Amyloidosis|Completed||Phase 2|26|Actual|Alnylam Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:06:52.387414|2017-10-11 01:06:52.387414
NCT01981824|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-06|2013-11-06|||October 2013||2013-10-01|October 2013|2013-10-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|IUGR||Prediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio: A Case-control Study|Femur Length to Mid-thigh Circumference Ratio in Prediction of IUGR|Unknown status|Recruiting|N/A|100|Anticipated|Ain Shams Maternity Hospital|||1||f||||t||||||||||2017-10-11 01:06:52.493019|2017-10-11 01:06:52.493019
NCT01981811|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-04-27|||March 2014||2014-03-01|April 2015|2015-04-01|December 2014|Anticipated|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder|A Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole|Withdrawn||Phase 2|0|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1||"The trial was terminated because it was determined that the usability of the MIND1 System in   the intended population was necessary before conducting this trial."|f||||f||||||||||2017-10-11 01:06:52.581665|2017-10-11 01:06:52.581665
NCT01981798|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-11-05|||March 2006||2006-03-01|November 2013|2013-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|CPS||Effect of an Outpatient Intervention Program in Patients With Chronic Back or Neck Pain|The Long-term Effect of an Outpatient Intervention Program With a Behavioral Therapy Approach in Patients With Chronic Back or Neck Pain With a Focus on Psychosocial Aspects|Completed||N/A|121|Actual|Orthopedic Hospital Vienna Speising||2|||f||||t||||||||||2017-10-11 01:06:52.735368|2017-10-11 01:06:52.735368
NCT01981785|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-04-03|||December 2012||2012-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Investigation of Immune Disorders and Deficiencies|Investigation of Molecular, Genetic and Cellular Mechanisms of Human Immune Disorders and Deficiencies|Active, not recruiting||N/A|343|Actual|O & O Alpan LLC|||2||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 01:06:52.857875|2017-10-11 01:06:52.857875
NCT01981759|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-08-17|||February 2014||2014-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions|D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions|Recruiting||Phase 4|60|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 01:06:53.053204|2017-10-11 01:06:53.053204
NCT01981746|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-01-09|||November 2013||2013-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers|Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers|Completed||Phase 4|26|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:06:53.169286|2017-10-11 01:06:53.169286
NCT01981733|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-05|||March 2005||2005-03-01|November 2013|2013-11-01||||April 2012|Actual|2012-04-01||Interventional|THRIVE-1||Improving Lower Limb Blood Flow in Healthy Adult Volunteers|A Study to Determine the Effects of a Novel Method for Improving Lower Limb Blood Flow in Healthy Adult Volunteers|Completed||Early Phase 1|50|Actual|Queen Mary University of London||1|||f||||f||||||||||2017-10-11 01:06:53.265573|2017-10-11 01:06:53.265573
NCT01981720|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-01-06|||December 2013||2013-12-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Extension Study of PRX-102 for 24 Months|A Multi Center Extension Study of PRX-102 Administered by Intravenous Infusions Every 2 Weeks for 24 Months to Adult Fabry Patients|Enrolling by invitation||Phase 1/Phase 2|18|Anticipated|Protalix||3|||f||||f||||||||||2017-10-11 01:06:53.36946|2017-10-11 01:06:53.36946
NCT01981707|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-04-27|||December 2013||2013-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|PRECHOL||F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer|F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide|Terminated||Phase 2/Phase 3|12|Actual|University Hospital, Grenoble||1||enrollment default|f||||f||||||||||2017-10-11 01:06:53.481497|2017-10-11 01:06:53.481497
NCT01981694|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-03-24|||November 2013||2013-11-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751|A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Crossover, Single Oral Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Healthy Subjects|Completed||Phase 1|18|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:06:53.602954|2017-10-11 01:06:53.602954
NCT01981681|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-07-15|||November 2013||2013-11-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects|A Phase 1, Randomized, Third-Party Open, Placebo-Controlled, Multiple Dose Escalation, Parallel Group Study To Evaluate Local Tolerability, Safety And Pharmacokinetics Of Topically Applied PF-06263276 In Healthy Subjects|Completed||Phase 1|47|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 01:06:53.696899|2017-10-11 01:06:53.696899
NCT01981668|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2014-03-18||||||March 2014|2014-03-01||||September 2013|Actual|2013-09-01||Interventional|||The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation|The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation|Withdrawn||Phase 1|0|Actual|Nova Scotia Cancer Centre||1||no Canadian centre interested in conducting study in a reasonable timeframe|f||||f||||||||||2017-10-11 01:06:53.815585|2017-10-11 01:06:53.815585
NCT01981655|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-11-09|||December 2009||2009-12-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|SOLACE1||0.5M Na Lactate Solution in Acute Heart Failure (AHF)|A Phase 2, Randomised, Single-Blind, Placebo-controlled Study of Half Molar Sodium Lactate Solution in the Treatment of Subjects With Acute Heart Failure|Completed||Phase 2|41|Actual|Nepean Blue Mountains Local Health District||2|||f||||t||||||||||2017-10-11 01:06:53.897043|2017-10-11 01:06:53.897043
NCT01981642|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-03-30|||December 2011||2011-12-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Noninvasive Diagnostics in Left Ventricular Assist Device Patients|Nicht-invasive Diagnostik in Patienten Mit Herzunterstützungssystemen|Recruiting||N/A|75|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 01:06:53.990875|2017-10-11 01:06:53.990875
NCT01981629|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-10-23|||July 2012||2012-07-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||The Use of the USCOM Device in Addition to Cardiac Ultrasound in Patients Undergoing Treatment for Undifferentiated Shock|The Use of the USCOM Device in Addition to Cardiac Ultrasound in Patients Undergoing Treatment for Undifferentiated Shock|Completed||N/A|47|Actual|Minneapolis Medical Research Foundation|||1||f||||f||||||||||2017-10-11 01:06:54.082452|2017-10-11 01:06:54.082452
NCT01981616|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-06-19|2014-06-19||September 2011||2011-09-01|June 2014|2014-06-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab|A Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Single Dose Study in Healthy Subjects to Determine the Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab|Completed||Phase 1|127|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:06:54.169318|2017-10-11 01:06:54.169318
NCT01981603|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-04-05|||January 1, 2014|Actual|2014-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transplant Navigator Dissemination||Active, not recruiting||N/A|1200|Anticipated|MetroHealth Medical Center||2|||f||||f||||||||||2017-10-11 01:06:54.823346|2017-10-11 01:06:54.823346
NCT01981590|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-06-27|||August 2013||2013-08-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|MAPs||Mapping for Acute Transvenous Phrenic Nerve Stimulation Study|Mapping for Acute Transvenous Phrenic Nerve Stimulation Study (MAPS Study)|Completed||N/A|15|Actual|Medtronic BRC||1|||f||||f||||||||||2017-10-11 01:06:54.910059|2017-10-11 01:06:54.910059
NCT01966744|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-07-18|||July 2013||2013-07-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|SMART||Self-Management Assistance for Recommended Treatment (SMART) Portal|Self-Management Assistance for Recommended Treatment (SMART) Portal|Completed||N/A|87|Actual|Children's Hospital Medical Center, Cincinnati|||3||f||||f||||||||||2017-10-11 01:11:07.8018|2017-10-11 01:11:07.8018
NCT01981577|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-03-21|||April 2014||2014-04-01|March 2016|2016-03-01||||October 2016|Anticipated|2016-10-01||Observational|||Subthalamic Nucleus Connectivity in Parkinson's Disease With Ultra-high Field Magnetic Resonance Imaging|Ultra-high Field Imaging of the Cortico-striato-subthalamic Functional and Structural Connectivity to Improve Deep Brain Stimulation Surgery in Parkinson's Disease Patients|Recruiting||N/A|20|Anticipated|Maastricht University Medical Center|||2||f||||||||||||||2017-10-11 01:06:54.98672|2017-10-11 01:06:54.98672
NCT01981564|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-08-14|||April 1, 2013|Actual|2013-04-01|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Asthma Express: Bridging the Emergency to Primary Care in Underserved Children|Study of an Asthma Express Intervention to Bridge Emergency to Primary Care for High Risk Children With Asthma|Active, not recruiting||N/A|264|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 01:06:55.147301|2017-10-11 01:06:55.147301
NCT01981551|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-10-05|||October 25, 2013||2013-10-25|June 21, 2017|2017-06-21|October 12, 2019|Anticipated|2019-10-12|December 30, 2018|Anticipated|2018-12-30||Interventional|||Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis|Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis|Active, not recruiting||Phase 2|17|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:06:55.256307|2017-10-11 01:06:55.256307
NCT01981538|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-09-12|||October 22, 2013||2013-10-22|September 6, 2017|2017-09-06|August 23, 2016|Actual|2016-08-23|August 23, 2016|Actual|2016-08-23||Observational|||Web-based Patient Reported Outcome Measurement Information System (PROMIS ) to Explore Burden and Stress in Cancer Caregivers (BaSiC2)|Web-Based Patient Reported Outcome Measurement Information System to Explore Burden, and Stress in Cancer Caregivers (BaSiC2)|Completed||N/A|172|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:06:55.353958|2017-10-11 01:06:55.353958
NCT01981525|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-07|2017-06-30|||October 22, 2013||2013-10-22|April 21, 2017|2017-04-21|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|||A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome|A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome|Completed||Phase 1|26|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:06:55.456569|2017-10-11 01:06:55.456569
NCT01981499|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-05-06|||January 2014||2014-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults|A Phase 1, Placebo-Controlled, Crossover, Subject- And Investigator-Blind, Sponsor-Open Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of A Modified-Release Formulation Of PF-05180999 In Healthy Adult Subjects|Terminated||Phase 1|31|Actual|Pfizer||6||The trial was prematurely terminated on 01April2014 due to safety concerns.|f||||f||||||||||2017-10-11 01:06:55.576159|2017-10-11 01:06:55.576159
NCT01981486|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-05-22|||June 2014||2014-06-01|May 2014|2014-05-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults|A Phase I, Placebo Controlled, Randomized, Subject-And Investigator-Blind, Sponsor-Open, Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-05180999 In Healthy Adult Volunteers|Withdrawn||Phase 1|0|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:06:55.700509|2017-10-11 01:06:55.700509
NCT01981473|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-12-08|2015-09-11||January 2014||2014-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|ANTIBODY-RA|The full analysis set (FAS) composed of participants who had diagnosis of RA and who received treatment with etanercept, adalimumab, or infliximab for a minimum of 6 months and a maximum of 24 months prior to the study visit. Data was not collected or analyzed on participants who entered the study but did not complete based on not meeting criteria.|Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab|Anti-tnf Inhibitor Antibody-mediated Blockade Of Drug Efficacy In Rheumatoid Arthritis (Antibody-ra)|Completed||Phase 4|605|Actual|Pfizer|||3||f||||f||||||||||2017-10-11 01:06:55.850136|2017-10-11 01:06:55.850136
NCT01981460|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-08|||May 2013||2013-05-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||PhotoDynamic Therapy for Line Infection Prevention (PLIP): Pilot Study on Healthy Volunteers.|PhotoDynamic Therapy for Line Infection Prevention (PLIP): Pilot Study on Normal Volunteers|Completed||N/A|10|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:06:56.840676|2017-10-11 01:06:56.840676
NCT01981447|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-11-08|||April 2010||2010-04-01|November 2013|2013-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||IV Lacosamide: The Safety of Intravenous Lacosamide|IV Lacosamide: The Safety of Intravenous Lacosamide|Completed||Phase 3|40|Actual|Le Bonheur Children's Hospital||2|||f||||t||||||||||2017-10-11 01:06:56.945826|2017-10-11 01:06:56.945826
NCT01981421|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-04|||June 2013||2013-06-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic Hepatitis||Unknown status|Recruiting|N/A|60|Anticipated|Yonsei University|||1||f||||t||||||||||2017-10-11 01:06:57.702367|2017-10-11 01:06:57.702367
NCT01981408|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-01-08|||November 2013||2013-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of LY2801653 in Healthy Participants|Disposition of [^14C]-LY2801653 Following Oral Administration in Healthy Subjects|Completed||Phase 1|6|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:06:57.777907|2017-10-11 01:06:57.777907
NCT01981395|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-04-27|||January 2014||2014-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Interventional|||Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers|A Double Blind, Randomized, Placebo Controlled, Crossover Study to Investigate the Anti-hyperalgesic Efficacy of a Single Dose of Fenobam on Heat/Capsaicin Induced Cutaneous Hyperalgesia in Adult Healthy Volunteers.|Completed||Phase 1|33|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:06:57.861904|2017-10-11 01:06:57.861904
NCT01981382|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-11-10|||October 2013||2013-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Characterizing the Role of Pain Sensitivity in Acute to Persistent Low Back Pain|Characterizing Pain Sensitivity in Persistent Nonspecific Low Back Pain|Completed||N/A|220|Actual|University of Connecticut|||2||f||||t||||||Samples With DNA|"     whole blood   "|Yes|Deidentified data will be available upon completion of study and final acceptance of publications|2017-10-11 01:06:57.961343|2017-10-11 01:06:57.961343
NCT01981369|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-02-11|||January 2014|Actual|2014-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Intravenous Dexmedetomidine on Analgesic Duration of Infraclavicular Block|Effect of Intravenous Dexmedetomidine on the Analgesic Duration of Infraclavicular Block With Ropivacaine for Upper Limb Surgery: a Prospective, Randomized, Double Blind Study|Completed||N/A|100|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:06:58.039979|2017-10-11 01:06:58.039979
NCT01981356|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-04-05|2016-02-04||September 2014||2014-09-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ACT-IP|Although 18 participants were randomized to treatment condition, the consent of two participants was invalid. Thus, their data could not be utilized and is not reported other than for identification of participant flow.|Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis|Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis|Completed||Early Phase 1|18|Actual|VA Office of Research and Development|Patient recruitment was hindered by patient characteristics, and inherent difficulties in conducting research with psychiatry inpatients. These issues do not address whether ACT is a beneficial inpatient treatment for psychosis.|2|||f||||f||||||||No||2017-10-11 01:06:58.180329|2017-10-11 01:06:58.180329
NCT01981343|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-12-23|||November 2013||2013-11-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Parallel Study Evaluating the Effect of A-F Betafood® on Gallbladder and Liver Function.|A Randomized, Double Blind, Placebo Controlled Parallel Study Evaluating the Effect of A-F Betafood® on Gallbladder and Liver Function.|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-11 01:06:58.617671|2017-10-11 01:06:58.617671
NCT01981330|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-09-06|||January 2012||2012-01-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Pilot Study of Stem Cell Treatment of Patients With Vocal Fold Scarring|Pilot Study of Patients With Severe Hoarseness and Vocal Fold Scarring Treated With Mesenchymal Stem Cells With and Without Hyaluronan Gel|Active, not recruiting||Phase 1|16|Anticipated|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 01:06:58.700841|2017-10-11 01:06:58.700841
NCT01981317|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-05-01|||October 2013||2013-10-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Interventional|SC-CBT||Stepped Care Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder||Active, not recruiting||Phase 1|30|Anticipated|University of South Florida||2|||f||||||||||||||2017-10-11 01:06:58.775764|2017-10-11 01:06:58.775764
NCT01981304|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-08|||January 2014||2014-01-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|INERT||Effects of a rapamycIn-eluting carboNized Stent With a Completely biodEgradable polymeR Coating|Effects of a rapamycIn-eluting carboNized Stent With a Completely biodEgradable polymeR Coating on inflammaTory Biomarkers and Endothelial Damage|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 01:06:58.87414|2017-10-11 01:06:58.87414
NCT01981291|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-18|||October 2012||2012-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Duration of Sciatic Nerve Block After Injection of Local Anesthetic In or Around the Nerve|Duration of Subgluteal Sciatic Nerve Block After Intra- or Perineural Injection of Mepivacaine: a Randomized, Controlled Trial|Completed||Phase 4|120|Actual|University of Parma||2|||f||||f||||||||||2017-10-11 01:06:58.952557|2017-10-11 01:06:58.952557
NCT01981278|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-13|||July 2010||2010-07-01|November 2013|2013-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study to Assess Bioequivalence of a New Tapentadol Extended-Release 250-mg Tablet With Respect to a Tapentadol Extended-Release 250-mg Tablet in Healthy Participants|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess Bioequivalence of a New Tapentadol Extended-Release (TRF) 250-mg Tablet With Respect to a Tapentadol Extended-Release (PR2) 250-mg Tablet Under Fasted Conditions in Healthy Subjects|Completed||Phase 1|63|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 01:06:59.078746|2017-10-11 01:06:59.078746
NCT01981265|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-05|||February 2012||2012-02-01|November 2013|2013-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Genome-wide Study for Disease Susceptibility Gene(s) in Patients With Hand Osteoarthritis|Genome-wide Study for Disease Susceptibility Gene(s) in Patients With Hand Osteoarthritis|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 01:06:59.312912|2017-10-11 01:06:59.312912
NCT01981252|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-10-17|||October 2013||2013-10-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Peri-orbital and Peri-oral Wrinkle Reduction Trial|Evaluation of the Safety and Efficacy of the Ulthera® System for Wrinkle Reduction in the Peri-orbital and Peri-oral Regions|Terminated||N/A|90|Actual|Ulthera, Inc||1||Lack of efficacy.|f||||t||||||||||2017-10-11 01:06:59.389997|2017-10-11 01:06:59.389997
NCT01981239|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-12-01|||November 2013||2013-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Voice Analysis Using the LPC (Linear Predictive Coding)Method for the Prediction of Aspiration|Voice Analysis Using the LPC (Linear Predictive Coding)Method for the Prediction of Aspiration;Prospective, Positive-controlled, Single-blind, Single Cohort Clinical Study of Efficacy|Withdrawn||N/A|0|Actual|Ulsan University Hospital||2||no participation over the long period|f||||t||||||||||2017-10-11 01:06:59.491369|2017-10-11 01:06:59.491369
NCT01981226|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-08|||September 2010||2010-09-01|November 2013|2013-11-01||||September 2015|Anticipated|2015-09-01||Interventional|||Sonoelastographic Changes After Low Energy Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis|Sonoelastographic Changes After Low Energy Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 01:06:59.572546|2017-10-11 01:06:59.572546
NCT01981213|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-11-05|||January 2005||2005-01-01|November 2013|2013-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01|5 Days|Observational [Patient Registry]|||Attempted Suicide With Acetaminophen Among 8-18 Year-old Children / Adolescents in Denmark|Attempted Suicide With Acetaminophen Among 8-18 Year-old Children / Adolescents|Unknown status|Recruiting|N/A|500|Anticipated|Hillerod Hospital, Denmark|||1||f||||f||||||Samples Without DNA|"     The initial and maximum levels of the biochemical parameters will be registered from the     electronic biochemistry files of each patient: GLU, basic phosphatase (BP), INR, ALT, and     AST.   "|||2017-10-11 01:06:59.656995|2017-10-11 01:06:59.656995
NCT01981200|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-02-09|||October 2013||2013-10-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Feasibility of Strength Training in Patients Hospitalized Due to COPD|Feasibility of Progressive Knee Extension Strength Training Using Ankle Weight Cuffs in Patients Hospitalized With COPD in Acute Exacerbation|Completed||N/A|40|Actual|Frederikssunds Hospital, Denmark||1|||f||||t||||||||||2017-10-11 01:06:59.747565|2017-10-11 01:06:59.747565
NCT01981187|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-03-28||2016-02-11|January 2014||2014-01-01|March 2016|2016-03-01||||September 2015|Actual|2015-09-01||Interventional|SIGNATURE||LGX818 for Patients With BRAFV600 Mutated Tumors|Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 4 - LGX818 for Patients With BRAFV600 Mutated Tumors|Completed||Phase 2|12|Actual|Array BioPharma||1|||f||||f||||||||||2017-10-11 01:06:59.853861|2017-10-11 01:06:59.853861
NCT01981174|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-03-05|||November 2013||2013-11-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Pilot Study of Needle Size and Pain Perception With Botulinum Toxin A Injections|The Effect of Needle Size on Pain Perception in Patients Treated With Botulinum Toxin A Injections|Completed||N/A|20|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:06:59.970682|2017-10-11 01:06:59.970682
NCT01981161|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-02-21|||November 2013||2013-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Observational|BEST-MS||Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis|Essai de Phase IV, Multicentrique, Ouvert, Visant à Tester la différence d'efficacité du Natalizumab, Versus le Fingolimod, 2 médicaments Ayant Une AMM Pour le Traitement de la sclérose en Plaques|Recruiting||N/A|600|Anticipated|University Hospital, Toulouse|||2||f||||t||||||Samples With DNA|"     urine and blood   "|Undecided||2017-10-11 01:07:00.100991|2017-10-11 01:07:00.100991
NCT01981148|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-02-27|||February 2013||2013-02-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|FLIO Group||Measurement of Retinal Auto Fluorescence With a Fluorescence Lifetime Imaging Ophthalmoscope|Measurement of Retinal Auto Fluorescence With a Fluorescence Lifetime Imaging Ophthalmoscope|Enrolling by invitation||N/A|600|Anticipated|University Hospital Inselspital, Berne|||2||f||||t||||||||||2017-10-11 01:07:00.282881|2017-10-11 01:07:00.282881
NCT01981135|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-02-09|||September 2011||2011-09-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|March 2014|Actual|2014-03-01||Interventional|TROPICOZ||Interaction Effects of Temperature and Ozone|Interaction Effects of Temperature and Ozone|Completed||N/A|16|Actual|Environmental Protection Agency (EPA)||2|||f||||f||||||||||2017-10-11 01:07:00.381284|2017-10-11 01:07:00.381284
NCT01981122|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-04-21|||September 2013||2013-09-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer|A Randomized, Open-label, Phase 2 Study of Sipuleucel-T With Concurrent Versus Sequential Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer|Active, not recruiting||Phase 2|52|Actual|Dendreon||2|||f||||t||||||||||2017-10-11 01:07:00.484766|2017-10-11 01:07:00.484766
NCT01981109|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-01-09|||January 2012||2012-01-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|PREDICT||A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer|A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer|Recruiting||N/A|2000|Anticipated|Dendreon|||1||f||||f||||||Samples With DNA|"     Whole blood, serum   "|||2017-10-11 01:07:00.662529|2017-10-11 01:07:00.662529
NCT01981096|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-02-01|||November 2013||2013-11-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|FIT Teens||Fibromyalgia Integrative Training for Teens|Fibromyalgia Integrative Training for Teens|Completed||N/A|40|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 01:07:00.964138|2017-10-11 01:07:00.964138
NCT01981083|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-05|||November 2013||2013-11-01|November 2013|2013-11-01||||November 2014|Anticipated|2014-11-01||Interventional|||Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients|Randomized, Open Label, Controlled Clinical Trial of Egg Albumin-Based Protein Supplement Versus Renal Specific Oral Supplement in Hemodialysis Patients|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Centro Medico Lic Adolfo Lopez Mate||2|||f||||t||||||||||2017-10-11 01:07:01.060471|2017-10-11 01:07:01.060471
NCT01981070|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-06-06|||October 2013||2013-10-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Parent Supports Intervention Project|Parent Supports Intervention Project for Parents of Adults With Developmental Disabilities|Completed||N/A|50|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-11 01:07:01.199982|2017-10-11 01:07:01.199982
NCT01981057|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-05-10|2014-05-10||February 2013||2013-02-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01|6 Days|Observational [Patient Registry]|Numeta||Clinical Experience With Numeta|Clinical Experience With Numeta- Impact on Intake of Nutrients and Costs|Completed||N/A|50|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 01:07:01.349746|2017-10-11 01:07:01.349746
NCT01981031|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-05-31|||November 2013||2013-11-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional|||A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes|Phase 1 Study to Assess the Efficacy and Safety of BioChaperone® Combo and Humalog® Mix 25 in Subjects With Type 1 Diabetes|Completed||Phase 1|21|Actual|Adocia||2|||f||||f||||||||||2017-10-11 01:07:01.78819|2017-10-11 01:07:01.78819
NCT01981018|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2015-09-29|||November 2013||2013-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|MAPP||MAPP: Imagery-focused Therapy for Bipolar Disorder|Mood Action Psychology Programme (MAPP): a Case Series Investigation of Brief Imagery-focused Cognitive Therapy (imCT) for Bipolar Disorder.|Completed||N/A|15|Anticipated|Medical Research Council Cognition and Brain Sciences Unit||1|||f||||f||||||||||2017-10-11 01:07:01.874958|2017-10-11 01:07:01.874958
NCT01981005|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-11-01|||November 2013||2013-11-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of the Elimination, Pharmacokinetics, and Metabolism of RO5424802|A PHASE 1, SINGLE-CENTER, OPEN-LABEL STUDY INVESTIGATING THE EXCRETION BALANCE, PHARMACOKINETICS AND METABOLISM OF A SINGLE ORAL DOSE AND PHARMACOKINETICS OF AN INTRAVENOUS TRACER OF [14-C]-RO5424802 IN HEALTHY MALE SUBJECTS|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:07:01.979566|2017-10-11 01:07:01.979566
NCT01980992|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-04-14|2017-02-13||October 2013||2013-10-01|April 2017|2017-04-01|April 13, 2017|Actual|2017-04-13|November 2015|Actual|2015-11-01||Interventional|Wheat OIT||Oral Immunotherapy for Wheat Allergy|Oral Immunotherapy for Wheat Allergy|Completed||Phase 1/Phase 2|46|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 01:07:02.059919|2017-10-11 01:07:02.059919
NCT01980979|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-09-19|||November 2013||2013-11-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension|Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension|Withdrawn||N/A|0|Actual|University of California, Los Angeles||1||slow enrollment|f||||f||||||||||2017-10-11 01:07:02.531127|2017-10-11 01:07:02.531127
NCT01980966|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-03-07|||November 25, 2013|Actual|2013-11-25|March 2017|2017-03-01|June 19, 2014|Actual|2014-06-19|June 19, 2014|Actual|2014-06-19||Interventional|||A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model|A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study in Healthy Volunteers to Evaluate the Efficacy and Safety of MHAA4549A in an Influenza Challenge Model|Completed||Phase 2|101|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-11 01:07:02.621524|2017-10-11 01:07:02.621524
NCT01980953|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-01-31|||November 2013||2013-11-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers|A Phase 1, Open-Label Study to Evaluate the Effect of Particle Size, Formulation, and Food on the Pharmacokinetics of GDC-0032 in Healthy Subjects|Completed||Phase 1|76|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 01:07:02.704728|2017-10-11 01:07:02.704728
NCT01980940|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-04-06|2015-11-06||December 23, 2013|Actual|2013-12-23|April 2017|2017-04-01|November 26, 2014|Actual|2014-11-26|November 26, 2014|Actual|2014-11-26||Interventional|||The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)|A Study to Assess the Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Osteoarthritis Patients|Completed||Phase 1/Phase 2|70|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-10-11 01:07:02.816522|2017-10-11 01:07:02.816522
NCT01980927|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-12-10|||November 2011||2011-11-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|January 2013|Actual|2013-01-01||Interventional|||Changes in Intracranial Compliance in Migraine Subjects Following a National Upper Cervical Chiropractic Association Atlas Correction|Changes in Intracranial Compliance in Migraine Subjects Following a National Upper Cervical Chiropractic Association (NUCCA)Atlas Correction Intervention - a Pilot Study|Completed||N/A|11|Actual|University of Calgary||1|||f||||f||||||||||2017-10-11 01:07:04.101377|2017-10-11 01:07:04.101377
NCT01980914|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-04-12|||March 2015||2015-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Hypoglycemia (Low Blood Sugar) and the Heart|Impact of Hypoglycemia on Cardiac Function in Elderly Patients With Diabetes|Recruiting||N/A|20|Anticipated|University of British Columbia|||1||f||||f||||||||No||2017-10-11 01:07:04.19805|2017-10-11 01:07:04.19805
NCT01980901|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-05-01|||October 2013||2013-10-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|July 2020|Anticipated|2020-07-01||Observational|||Post-Approval Study of the Ovation™/Ovation Prime™ Abdominal Stent Graft System|A Post-Market Approved (PMA) Post-Approval Study to Evaluate the Long-Term Safety and Effectiveness of the Ovation™/Ovation Prime™ Abdominal Stent Graft System|Active, not recruiting||N/A|320|Anticipated|TriVascular, Inc.|||1||f||||t||||||||Undecided||2017-10-11 01:07:04.299847|2017-10-11 01:07:04.299847
NCT01980875|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-05-26|2017-03-30||April 21, 2015|Actual|2015-04-21|May 2017|2017-05-01|May 13, 2016|Actual|2016-05-13|May 13, 2016|Actual|2016-05-13||Interventional||Intent-to-Treat Analysis Set: participants who were randomized regardless of whether participants received any study drug(s), or received a different regimen from the regimen to which they were randomized.|Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia|A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia|Terminated||Phase 3|57|Actual|Gilead Sciences|The study was terminated in agreement with the FDA due to urgent safety measures. Complete data were not collected for any participant.|3|||f||||t|t|f||||||||2017-10-11 01:07:04.99639|2017-10-11 01:07:04.99639
NCT01980862|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2014-08-04|||August 2013||2013-08-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01|1 Day|Observational [Patient Registry]|||Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes||Completed||N/A|48|Actual|Fujirebio Diagnostics, Inc.|||1||f||||t||||||||||2017-10-11 01:07:06.211728|2017-10-11 01:07:06.211728
NCT01965665|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-09-13|2016-06-09||October 2013||2013-10-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Advancing the Standard of Care for Pin Site Care|Advancing the Standard of Care for Pin Site Care: Prospective Single Center Study Using Medihoney HCS|Completed||N/A|20|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:11:29.032685|2017-10-11 01:11:29.032685
NCT01980849|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-20|||November 2013||2013-11-01|November 2013|2013-11-01||||November 2016|Anticipated|2016-11-01||Interventional|LCAN||Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer|Phase Ⅲ Study of Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer by Nadroparin|Unknown status|Recruiting|Phase 3|272|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 01:07:06.275442|2017-10-11 01:07:06.275442
NCT01980836|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-04|||November 2013||2013-11-01|November 2013|2013-11-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine|The Effect of Tocilizumab on the Cellular Immune Response to Seasonal Influnza Vaccine in Patients With Rheumatoid Arthritis|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 01:07:06.452797|2017-10-11 01:07:06.452797
NCT01980823|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2017-08-28|||October 2013|Actual|2013-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer|"Pre-Surgical Window of Opportunity Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer"|Recruiting||Early Phase 1|40|Anticipated|Columbia University||1|||f||||t|t|f|||f|||||2017-10-11 01:07:06.55941|2017-10-11 01:07:06.55941
NCT01980810|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-06-11|||September 2013||2013-09-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|GC-A-003||First Line Chemotherapy for Advanced Cancer|Pase 2 Study of Albumin-bounded Paclitaxel Plus S-1 as First-line Chemotherapy for Locally Advanced or Metastatic Gastric or Gastro-esophageal Adenocarcinoma|Terminated||Phase 2|36|Actual|Chinese Academy of Medical Sciences||1||recruit too slowly|f||||f||||||||||2017-10-11 01:07:06.662868|2017-10-11 01:07:06.662868
NCT01980797|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-07-20|||November 2013||2013-11-01|July 2016|2016-07-01|November 2033|Anticipated|2033-11-01|November 2023|Anticipated|2023-11-01|10 Years|Observational [Patient Registry]|BAVCon||International Bicuspid Aortic Valve Consortium (BAVCon)|International Bicuspid Aortic Valve Consortium (BAVCon)|Recruiting||N/A|10000|Anticipated|Brigham and Women's Hospital|||2||f||||f||||||Samples With DNA|"     We are collecting DNA from either saliva or blood.   "|||2017-10-11 01:07:06.752555|2017-10-11 01:07:06.752555
NCT01980784|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-11-24|||June 2012||2012-06-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Posttraumatic Changes in Energy Expenditure and Body Composition in Patients With Acute Spinal Cord Injury|Posttraumatic Changes in Energy Expenditure and Body Composition in Patients With Acute Spinal Cord Injury|Completed||N/A|25|Actual|Swiss Paraplegic Centre Nottwil|||1||f||||f||||||Samples Without DNA|"     whole blood   "|||2017-10-11 01:07:06.875482|2017-10-11 01:07:06.875482
NCT01980771|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-03-29|||November 2012||2012-11-01|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Barbershop Talk: HIV Prevention for African American Heterosexual Men|Barbershop Talk: HIV Prevention for African American Heterosexual Men|Completed||N/A|880|Actual|State University of New York - Downstate Medical Center||2|||f||||f||||||||||2017-10-11 01:07:06.993025|2017-10-11 01:07:06.993025
NCT01980758|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-07-20|||May 2013||2013-05-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Pilot Study of Laparoscopic Gastric Plication in Adolescents With Severe Obesity|Pilot Study of Laparoscopic Gastric Plication in Adolescents With Severe Obesity|Recruiting||N/A|30|Anticipated|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 01:07:07.081307|2017-10-11 01:07:07.081307
NCT01980745|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-10-25|||February 2002||2002-02-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|November 2013|Actual|2013-11-01||Interventional|||CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS|DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL WITH CHLOROQUINE VERSUS PLACEBO FOR MAINTENANCE OF REMISSION OF AUTOIMMUNE HEPATITIS|Completed||Phase 4|61|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 01:07:07.171881|2017-10-11 01:07:07.171881
NCT01980732|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-08-21||||||August 2017|2017-08-01||||||||Expanded Access|||68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors|68Ga DOTA-TATE PET/CT in the Evaluation of Patients With Somatostatin Receptor Positive Tumors|No longer available||N/A|||Stanford University|||||||||||||||||||2017-10-11 01:07:07.25126|2017-10-11 01:07:07.25126
NCT01980719|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-03-25|||July 2010||2010-07-01|November 2013|2013-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|MDOF||Molecular Determinants of Persistent Cancer Related Fatigue|Molecular Determinants of Persistent Cancer Related Fatigue|Completed||N/A|30|Actual|University of Michigan|||3||f||||f||||||||||2017-10-11 01:07:07.308757|2017-10-11 01:07:07.308757
NCT01980706|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-09-28|||November 2013||2013-11-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of High Dose Baclofen for Alcohol Dependence|Efficacy and Safety of High Dose Baclofen for Alcohol Dependence|Active, not recruiting||Phase 2|120|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-11 01:07:07.372407|2017-10-11 01:07:07.372407
NCT01980693|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-03-05|||June 2013||2013-06-01|April 2013|2013-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Ultrasound Evaluation of Bone Age in Healthy Children|Cohort Study to Investigate the Relationship Between Ultrasound Apparatus Results (SonicBone's BAUS) and Skeletal Maturity Status (Bone Age) Among Healthy Children and Adolescence|Unknown status|Recruiting|N/A|300|Anticipated|Clalit Health Services||1|||f||||t||||||||||2017-10-11 01:07:07.45511|2017-10-11 01:07:07.45511
NCT01980680|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-10-03|||December 2014||2014-12-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|GnRHa trigger||The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients|The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Randomized Controlled Pilot Study in Normo-responder IVF Patients|Recruiting||Phase 4|50|Anticipated|Regionshospitalet Viborg, Skive||2|||f||||f||||||||||2017-10-11 01:07:07.537716|2017-10-11 01:07:07.537716
NCT01980667|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-01-25|||July 30, 2014||2014-07-30|January 2017|2017-01-01|January 5, 2017|Actual|2017-01-05|January 5, 2017|Actual|2017-01-05||Interventional|||Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors|Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|41|Actual|PharmaMar||1|||f||||f||||||||||2017-10-11 01:07:07.613435|2017-10-11 01:07:07.613435
NCT01980654|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-09-27|||December 2013||2013-12-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of the Bruton's Tyrosine Kinase Inhibitor in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma|A Multicenter, Open-Label, Phase 2 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma|Active, not recruiting||Phase 2|80|Anticipated|Pharmacyclics LLC.||2|||f||||f||||||||||2017-10-11 01:07:07.705305|2017-10-11 01:07:07.705305
NCT01980641|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-05-14|||September 2013||2013-09-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Effect Size of an Educational Intervention in the Home and Compliance on People Who Suffer From Stroke|Clinical Effect Size of an Educational Intervention in the Home and Compliance With a Smartphone-based Reminder on People Who Suffer From Stroke: a Protocol Study.|Recruiting||N/A|80|Anticipated|University of Malaga||4|||f||||t||||||||||2017-10-11 01:07:09.47277|2017-10-11 01:07:09.47277
NCT01980628|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-05-30|2016-12-20||December 2013||2013-12-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|July 2016|Actual|2016-07-01||Interventional|||Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma|A Multicenter, Open-Label, Phase 2 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Subjects With Relapsed/Refractory Marginal Zone Lymphoma|Active, not recruiting||Phase 2|63|Actual|Pharmacyclics LLC.|Fatal TEAEs occurred in 3 (4.8%) subjects: worsening marginal zone lymphoma in 1 subject, cerebral hemorrhage in 1 subject, and pneumonia, parainfluenza virus infection, and multiple organ dysfunction syndrome in 1 subject.|1|||f||||f||||||||||2017-10-11 01:07:09.583523|2017-10-11 01:07:09.583523
NCT01980615|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2014-04-11|||November 2013||2013-11-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers|A Phase I, Randomized, Double-Blind Within Device, Single-Dose, Four-Period, Six-Treatment, Cross-Over Study Evaluating the Safety and Pharmacokinetics of Three Doses of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI), One Dose of Glycopyrronium and Formoterol Fumarate Inhalation Aerosol (GFF MDI), and Two Doses of Symbicort® Inhalation Aerosol in Healthy Volunteers|Completed||Phase 1|84|Actual|Pearl Therapeutics, Inc.||6|||f||||t||||||||||2017-10-11 01:07:10.022194|2017-10-11 01:07:10.022194
NCT01980602|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2013-11-04|||March 2011||2011-03-01|November 2013|2013-11-01||||July 2016|Anticipated|2016-07-01||Interventional|||Effect of Exercise on Patients With Claudication Undergoing Surgery|A Randomised Controlled Trial to Analyse the Histological, Physiological and Haemorrheological Adaptations to Supervised Exercise Training in Claudicants|Unknown status|Recruiting|N/A|70|Anticipated|University of Hull||1|||f||||f||||||||||2017-10-11 01:07:10.134005|2017-10-11 01:07:10.134005
NCT01980589|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-04-28|2016-09-07||August 2013||2013-08-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CHAMPION 2||A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects|A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects|Completed||Phase 1|22|Actual|Amgen||1|||f||||f||||||||||2017-10-11 01:07:10.352462|2017-10-11 01:07:10.352462
NCT01980576|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-04-09|||December 2012||2012-12-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Qualitative Pain Measurement at Patients With Degenerative Low Back Pain|Qualitative Pain Measurement and Sensitization at Patients With Degenerative Low Back Pain With Indication for Lumbar Intervertebral Disc|Terminated||N/A|1|Actual|Northern Orthopaedic Division, Denmark|||1|Lack of patients with the right criteria for inclusion|f||||f||||||||||2017-10-11 01:07:11.599086|2017-10-11 01:07:11.599086
NCT01980563|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-11-04|||January 2011||2011-01-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Optimizing Ovarian Stimulation for IVF and ICSI|Optimizing Ovarian Stimulation for IVF and ICSI|Completed||N/A|416|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:07:11.664881|2017-10-11 01:07:11.664881
NCT01980550|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2013-11-10|||March 2004||2004-03-01|November 2013|2013-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy|Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy|Completed||Phase 4|250|Actual|National Institute on Drug Dependence, China||1|||f||||f||||||||||2017-10-11 01:07:11.741034|2017-10-11 01:07:11.741034
NCT01980537|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-11-04|||April 2008||2008-04-01|November 2013|2013-11-01||||April 2011|Actual|2011-04-01||Interventional|||Stereotaxis and Chronic Total Occlusion||Completed||N/A|40|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 01:07:11.81444|2017-10-11 01:07:11.81444
NCT01980524|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2017-02-16|2016-10-31||October 2013||2013-10-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|HYPOTESIS||The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes|HYPOglycemia Linked to Cardiac sTEatoSIS? - Identifying Mechanisms That Explain Adverse Cardiovascular Outcome Associated With Intensive Glucose Control in Patients With Diabetes (HYPOTESIS)|Completed||Phase 2/Phase 3|8|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:07:11.878227|2017-10-11 01:07:11.878227
NCT01980511|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-08-14|||March 2014||2014-03-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Observational|NeuroVISION||Detection and Neurological Impact of CerebroVascular Events In Noncardiac Surgery PatIents: A COhort EvaluatioN|Detection and Neurological Impact of CerebroVascular Events In Noncardiac Surgery PatIents: A COhort EvaluatioN|Active, not recruiting||N/A|1121|Actual|McMaster University|||1||f||||t||||||||||2017-10-11 01:07:12.108633|2017-10-11 01:07:12.108633
NCT01980498|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-10-06|||September 2014||2014-09-01|June 2014|2014-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PERFECT FAST||PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy|Multicenter Randomized Open Trial to Evaluate Efficacy of Fentanyl Pectin Nasal Spray vs Physician Choice-Usual Care in Reducing Predictable Breakthrough Pain at Swallowing in Head/Neck Cancer Patients Undergoing Radiotherapy|Withdrawn||Phase 3|0|Actual|L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.||2|||f||||||||||||||2017-10-11 01:07:12.329769|2017-10-11 01:07:12.329769
NCT01980485|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-10-08|||January 2012||2012-01-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|GQSQ||The Get Quit - Stay Quit Study|The Get Quit-Stay Quit Study: a Randomized Trial of Health Risk Feedback and Relapse Prevention for Treatment-seeking Smokers|Completed||N/A|225|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 01:07:12.506184|2017-10-11 01:07:12.506184
NCT01980472|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-02-24|||August 2013||2013-08-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|June 2015|Actual|2015-06-01||Interventional|||Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients|Phase II Trial of Geriatric Evaluation as Selection Criteria and Predictive Factor of Safety in Elderly Patients (≥ 70 Years) With Non-small Cell Lung Cancer (NSCLC)That Can be Treated With Bevacizumab, Carboplatin and Paclitaxel|Active, not recruiting||Phase 2|50|Anticipated|Grupo de Investigación y Divulgación Oncológica||1|||f||||f||||||||No||2017-10-11 01:07:12.59903|2017-10-11 01:07:12.59903
NCT01980459|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-11-29|||October 2013||2013-10-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|MagInGlu||Magnesium Treatment of Inflammation in Disorders of Glucose Homeostasis|Magnesium Treatment of Inflammation in Disorders of Glucose Homeostasis|Completed||Phase 1|47|Actual|George Washington University||1|||f||||f||||||||||2017-10-11 01:07:12.702053|2017-10-11 01:07:12.702053
NCT01980446|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-05-09|||December 2013||2013-12-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|CAPACITY||Cognitive Auditory Evoked Potential After Cardiac Arrest: Interest of Mismatch negativiTY|Cognitive Auditory Evoked Potential After Cardiac Arrest: Interest of Mismatch negativiTY: The CAPACITY Study|Recruiting||N/A|142|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:07:12.789884|2017-10-11 01:07:12.789884
NCT01980433|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-06-01|||January 2014||2014-01-01|May 2015|2015-05-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|WILSTIM||Inhibitory rTMS in Dystonic Wilson Patients|Study of Writing Improvement in Patients With Wilson Disease and Dystonia After One Session of Inhibitory Repetitive Transcranial Magnetic Stimulation|Unknown status|Recruiting|N/A|15|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:07:12.89138|2017-10-11 01:07:12.89138
NCT01980420|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-08-31|||November 2013||2013-11-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|FFSI||Prospective Study of the Impact of Sleeve Gastrectomy on Gastro-esophageal Junction Function|Prospective Study of the Impact of Sleeve Gastrectomy on Gastro-esophageal Junction Function|Completed||N/A|35|Actual|IHU Strasbourg||1|||f||||f||||||||||2017-10-11 01:07:13.032042|2017-10-11 01:07:13.032042
NCT01980407|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2015-03-04|||November 2013||2013-11-01|November 2013|2013-11-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer|A Safety and Efficacy Study of S-1, Oxaliplatin, and Leucovorin (SOL) in Patients With Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|49|Anticipated|Jilin Provincial Tumor Hospital||1|||f||||f||||||||||2017-10-11 01:07:13.156873|2017-10-11 01:07:13.156873
NCT01980394|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-02-24|||May 2004||2004-05-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Esophageal Stump Washout|Esophageal Stump Washout Reduces Free Intraluminal Tumor Cells During Resection of Carcinomas of the Esophagus and Cardia|Completed||N/A|50|Actual|Kantonsspital Liestal||1|||f||||f||||||||||2017-10-11 01:07:13.259587|2017-10-11 01:07:13.259587
NCT01980381|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-06-05|||January 2013||2013-01-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Depression and/or Anxiety - the Tree Theme Method® (TTM) as an Intervention|Treatment of Depression and/or Anxiety - a Randomized Clinical Trial of the Tree Theme Method® (TTM) as an Intervention|Active, not recruiting||N/A|121|Actual|Kronoberg County Council||2|||f||||f|f|f||||||Undecided||2017-10-11 01:07:13.337267|2017-10-11 01:07:13.337267
NCT01980368|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-09-20|||August 2013||2013-08-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Tai Chi Easy in Treating Cancer Survivors With Peripheral Sensory Neuropathy|Pilot Study of Effects of Tai Chi Easy on Cancer Survivors Experiencing Neuropathy|Recruiting||N/A|53|Anticipated|Mayo Clinic||2|||f||||||||||||||2017-10-11 01:07:13.411945|2017-10-11 01:07:13.411945
NCT01980342|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-10-31|||October 2014||2014-10-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz|Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz|Active, not recruiting||Phase 4|18|Anticipated|Johns Hopkins University||1|||f||||f||||||||No||2017-10-11 01:07:13.623787|2017-10-11 01:07:13.623787
NCT01980329|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-04-02|||January 2013||2013-01-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites|Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites|Completed||Phase 1|24|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 01:07:13.707513|2017-10-11 01:07:13.707513
NCT01980316|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-10-21|||April 2010||2010-04-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|August 2011|Actual|2011-08-01||Interventional|||Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting|Phase 4 Study of Argatroban for Preventing Restenosis After Extracranial Vertebral Artery Stenting|Completed||Phase 4|114|Actual|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 01:07:13.804538|2017-10-11 01:07:13.804538
NCT01980303|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-01-27|||November 2013||2013-11-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers|An Open-label, Single-Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|29|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-11 01:07:13.912763|2017-10-11 01:07:13.912763
NCT01980290|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-03-01|||May 2013||2013-05-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|INTEGRATE||Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C|Observational Multicenter Study in Ex-People Who INject Drugs (Ex-PWIDs) to Evaluate Efficacy, Safety, and Adherence to TElaprevir in Combination With Pegylated Interferon Alfa and Ribavirin in Genotype 1 ChRonic HepATitis C PatiEnts|Completed||N/A|50|Actual|Janssen Pharmaceutica N.V., Belgium|||1||f||||f||||||||||2017-10-11 01:07:14.180389|2017-10-11 01:07:14.180389
NCT01980277|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-09-01|||January 2014|Actual|2014-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|May 2017|Actual|2017-05-01||Interventional|TAKTIC||Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer|A Prospective, Multicentre, Uncontrolled, Phase Ib/II Study of LY2780301 in Combination With Weekly Paclitaxel in HER2-negative Metastatic or Locally Advanced Breast Cancer in Patients With and Without PI3/AKT/S6 Pathway Activation. - TAKTIC-IPC 2012-008|Recruiting||Phase 1/Phase 2|68|Anticipated|Institut Paoli-Calmettes||1|||f||||t||||||||||2017-10-11 01:07:14.326939|2017-10-11 01:07:14.326939
NCT01980264|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2013-11-11|||January 2009||2009-01-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Harmonics-based in Vivo Optical Virtual Biopsy|Harmonics-based in Vivo Optical Virtual Biopsy|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 01:07:14.446892|2017-10-11 01:07:14.446892
NCT01980251|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-08-03|||October 2013||2013-10-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01|1 Year|Observational [Patient Registry]|||Delirium, Electroencephalographic Alterations and Cortical Spreading Depression (CSD) in Critical Illness|Delirium, Electroencephalographic Alterations and Cortical Spreading Depression in Critical Illness|Completed||N/A|102|Actual|Glostrup University Hospital, Copenhagen|||1||f||||t||||||Samples With DNA|"     Blood, cerebrospinalfluid, urine   "|Undecided|Data analysis is in progress|2017-10-11 01:07:14.54303|2017-10-11 01:07:14.54303
NCT01980238|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-11-16|||January 2011||2011-01-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Defunctioning Cannula Ileostomy After Lower Anterior Resection of Rectal Cancer|Defunctioning Cannula Ileostomy After Lower Anterior Resection of Rectal Cancer.|Unknown status|Active, not recruiting|N/A|300|Anticipated|First Affiliated Hospital of Zhejiang University||2|||f||||f||||||||||2017-10-11 01:07:14.623932|2017-10-11 01:07:14.623932
NCT01980225|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-06-08|||November 2011||2011-11-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Implantation Rate of Vitrified-warmed Collapsed Blastocysts|Randomized Controlled Trial Comparing the Implantation Rate of Vitrified-warmed Blastocysts With and Without Artificial Shrinkage Before Vitrification|Completed||N/A|270|Actual|Centre for Reproductive Medicine, Belgium||2|||f||||f||||||||||2017-10-11 01:07:14.721256|2017-10-11 01:07:14.721256
NCT01980212|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-02-14|||May 2013||2013-05-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer|Serum Thioredoxin Reductase Activity Research in First-line Chemotherapy Advanced Non-small Cell Lung Cancer|Recruiting||N/A|150|Anticipated|Hunan Province Tumor Hospital|||1||f||||f||||||Samples With DNA|"     3-4 ml whole blood was obtained and then centrifuged and stored at -20 ℃   "|||2017-10-11 01:07:14.895671|2017-10-11 01:07:14.895671
NCT01980199|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-10-29|||November 2013||2013-11-01|July 2014|2014-07-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional|||Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan|Phase II Proof of Concept Trial to Determine Efficacy of Fexinidazole in Visceral Leishmaniasis Patients in Sudan|Terminated||Phase 2|14|Actual|Drugs for Neglected Diseases||1||Lack of efficacy|f||||f||||||||||2017-10-11 01:07:14.997067|2017-10-11 01:07:14.997067
NCT01980186|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-11-08|||November 2013||2013-11-01|November 2013|2013-11-01||||November 2016|Anticipated|2016-11-01||Observational|||Transcranial Ultrasonography Using Linear 2D Imaging of the Brain|Transcranial Ultrasonography Using Linear 2D Imaging of the Brain and Surrounding Tissues|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Brain Treatment Center|||2||f||||t||||||||||2017-10-11 01:07:15.113513|2017-10-11 01:07:15.113513
NCT01980173|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-09-29|||September 2014||2014-09-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|Bakri||Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care|Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care|Recruiting||N/A|66|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||||2017-10-11 01:07:15.211062|2017-10-11 01:07:15.211062
NCT01980160|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-09-30|||November 2013||2013-11-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|||Relief Band as an Adjunct to Antiemetic Therapy in Patients Who Receive Mod to Highly Emetogenic Chemotherapy|Randomized Single-Blind Study of Nometex as an Adjunct to Standard Anti-emetics in Ovarian and Advanced Endometrial and Cervical Cancer Patients Who Receive Moderately to Highly Emetogenic Chemotherapy|Withdrawn||N/A|0|Actual|Christiana Care Health Services||2||Did not receive IRB approval from our institution therefore the study was closed.|f||||||||||||||2017-10-11 01:07:15.404692|2017-10-11 01:07:15.404692
NCT01980147|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-04-25|||March 22, 2014|Actual|2014-03-22|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|SWELL||Skills for Wellness|Skills for Wellness: Cognitive-behavioural Skills Training for Psychotic-like Experiences, Basic Symptoms, Affective Lability and Anxiety in Youth|Recruiting||N/A|360|Anticipated|Nova Scotia Health Authority||2|||f||||f|f|f||||||No||2017-10-11 01:07:15.521395|2017-10-11 01:07:15.521395
NCT01980134|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-04-12|||December 2013||2013-12-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Observational|MORDIS||The MORDIS Study Clinical Investigational Plan|Multicenter, Open, Prospective Study on Modified Resect and DIScard Strategy of Small Colonic Lesions Using WavSTAT4 Optical Biopsy System: The MORDIS Study Clinical Investigational Plan|Recruiting||N/A|1200|Anticipated|SpectraScience|||1||f||||f||||||Samples With DNA|"     Samples will be sent for pathological examination and potentially used for other research     purposes.   "|||2017-10-11 01:07:15.63746|2017-10-11 01:07:15.63746
NCT01980121|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-06-18|||October 2013||2013-10-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Gastric Sonography in the Fasted Term Pregnant Patient for Elective Cesarean Delivery|Gastric Sonography in the Fasted Term Pregnant Patient for Elective Cesarean Delivery: a Prospective Descriptive Study|Completed||N/A|103|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||1||f||||f||||||||||2017-10-11 01:07:15.762048|2017-10-11 01:07:15.762048
NCT01980108|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-04-29|||October 2013||2013-10-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Quantitative Ultrasound Assessment of Gastric Volume in Pregnant Women at Term|Quantitative Ultrasound Assessment of Gastric Volume in Pregnant Women at Term|Completed||N/A|60|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||6|||f||||f||||||||||2017-10-11 01:07:15.838198|2017-10-11 01:07:15.838198
NCT01980095|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-11-13|2016-11-13||November 2013||2013-11-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|ERADICATE Hp||ERADICATE Hp - Treating Helicobacter Pylori With RHB-105|A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients|Completed||Phase 3|119|Actual|RedHill Biopharma Limited||2|||f||||f||||||||||2017-10-11 01:07:15.936307|2017-10-11 01:07:15.936307
NCT01980082|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-10-04|||January 2014||2014-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Antibiotic Prophylaxis for Revision, Clean Head and Neck Surgery|Antibiotic Prophylaxis for Revision, Clean Head and Neck Surgery|Recruiting||Phase 4|150|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 01:07:16.25206|2017-10-11 01:07:16.25206
NCT01980069|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-04-22|||November 2013||2013-11-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Double-blind, Randomized, Parallel Design Study to Compare the Effectiveness of Sugammadex Versus Neostigmine in Improving Surgical Condition in Subjects Undergoing Laryngeal Microsurgery||Completed||N/A|72|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:07:16.361321|2017-10-11 01:07:16.361321
NCT01980056|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-03-01|||October 25, 2013|Actual|2013-10-25|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|October 2018|Anticipated|2018-10-01||Interventional|||Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy|A Phase 1/2, Open-label, Dose Escalation Clinical Study of the Safety and Clinical Activity of Vosaroxin in Patients With Intermediate 2 or High-risk Myelodysplastic Syndrome (MDS) After Failure of Hypomethylating Agent-based Therapy|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Weill Medical College of Cornell University||1|||f||||f|t|f||||||No||2017-10-11 01:07:16.440543|2017-10-11 01:07:16.440543
NCT01980043|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-07-10|||May 20, 2013|Actual|2013-05-20|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Endoluminal and Needlescopic Assisted Repair of Rectal Prolapse|Endoluminal and Needlescopic Assisted Repair of Rectal Prolapse With Abdominal Fixation Under Sedation and Local Anesthesia|Recruiting||N/A|10|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 01:07:16.527132|2017-10-11 01:07:16.527132
NCT01980030|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-06-13|||November 2013||2013-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|December 2015|Actual|2015-12-01||Interventional|AGRAH003||Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell|Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:07:16.596789|2017-10-11 01:07:16.596789
NCT01980017|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-04-11|||July 2013||2013-07-01|January 2017|2017-01-01|March 15, 2017|Actual|2017-03-15|October 18, 2016|Actual|2016-10-18||Interventional|OMSC in DEP||Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs|A Prospective Cluster-Randomized Trial to Implement the Ottawa Model for Smoking Cessation in Diabetes Education Programs.|Completed||N/A|305|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-11 01:07:16.686222|2017-10-11 01:07:16.686222
NCT01980004|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-10-07|||November 2013||2013-11-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Potassium Citrate Supplementation vs. Dietary Counseling|Does Potassium Citrate Supplementation Reduce Stone Recurrence in Calcium Phosphate Stone Formers With Risk Factors?|Withdrawn||Phase 2|0|Actual|University of North Carolina, Chapel Hill||2||closure due to failure to recruit any patients that met study criteria|f||||f||||||||||2017-10-11 01:07:16.794934|2017-10-11 01:07:16.794934
NCT01979991|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-02-03|||August 2010||2010-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Model-Based Image Reconstruction for X-Ray CT in Lung Imaging|Model-Based Image Reconstruction for X-Ray CT in Lung Imaging|Completed||Phase 1|184|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 01:07:16.895203|2017-10-11 01:07:16.895203
NCT01979965|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-11-07|||November 2013||2013-11-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|May 2014|Anticipated|2014-05-01||Interventional|REIN-MR||Effect of Ranolazine on Valvular Disease in Patients With Pacemakers|Ranolazine Effects on Ischemic Mitral Regurgitation Severity in Patients With Cardiac Resynchronization Therapy|Unknown status|Enrolling by invitation|Phase 4|50|Anticipated|University Cardiology||2|||f||||t||||||||||2017-10-11 01:07:17.05583|2017-10-11 01:07:17.05583
NCT01979939|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-10-09||2015-09-23|December 2013||2013-12-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects|A Phase 3 Evaluation of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination in Non-cirrhotic Subjects With Genotype 1 Chronic Hepatitis C|Completed||Phase 3|416|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 01:07:17.515142|2017-10-11 01:07:17.515142
NCT01979926|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-05-29|||November 2013||2013-11-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis|Double-blind, A Multicenter, Randomized, Placebo-controlled, Parallel, Phase 2 Study to Comparative Evaluate the Efficacy of N02RS1 600mg/Day, 12,00mg/Day in Korean Patients With Acute and Chronic Bronchitis|Completed||Phase 2|102|Actual|PharmaKing||3|||f||||t||||||||||2017-10-11 01:07:17.756489|2017-10-11 01:07:17.756489
NCT01979913|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-04-21|||October 2013||2013-10-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|||An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More|An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More|Completed||Phase 4|16|Actual|Ordination Dr. Hommer||1|||f||||t||||||||||2017-10-11 01:07:17.833726|2017-10-11 01:07:17.833726
NCT01979900|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-12-27|||October 2013||2013-10-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis|Phase III Clinical Study of Efficacy and Safety of Mycobacterium Vaccae to Prevent Tuberculosis in High Risk Groups of Tuberculosis Infection|Unknown status|Active, not recruiting|Phase 3|10000|Anticipated|Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:07:17.913984|2017-10-11 01:07:17.913984
NCT01979887|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-08-14|||November 2013||2013-11-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction||Completed||N/A|75|Actual|Allergan|||3||f||||f||||||Samples With DNA|"     Tears   "|||2017-10-11 01:07:18.126592|2017-10-11 01:07:18.126592
NCT01979874|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-06-29|||February 2014||2014-02-01|June 2015|2015-06-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|OMEGA-PAD II||The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II|The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation II|Unknown status|Recruiting|Phase 2|70|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:07:18.215359|2017-10-11 01:07:18.215359
NCT01979861|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-07-08|||February 2014||2014-02-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding|A Prospective, Multicenter, Clinical Trial to Evaluate the Safety and Effectiveness of the AEGEA Vapor System for the Treatment of Excessive Uterine Bleeding|Active, not recruiting||Phase 3|230|Anticipated|Aegea Medical, Inc.||1|||f||||f||||||||No||2017-10-11 01:07:18.346871|2017-10-11 01:07:18.346871
NCT01979848|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-12-12|||June 2013||2013-06-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon|MRI (Magnetic Resonance Imaging) Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon|Completed||N/A|3|Actual|University of California, Irvine|||1||f||||t||||||||||2017-10-11 01:07:18.488464|2017-10-11 01:07:18.488464
NCT01979835|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2017-03-26|||February 2013||2013-02-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|GF||GyneFix-Viz*: A Study of Serosal-Anchor (SA) Distance|GYNEFIX-VIZ*: A STUDY OF SEROSAL-ANCHOR (SA) DISTANCE IN WOMEN IMMEDIATELY AND 6-8 WEEKS FOLLOWING INSERTION|Active, not recruiting||N/A|1030|Actual|Wiebe, Ellen, M.D.||1|||f||||f||||||||||2017-10-11 01:07:18.605754|2017-10-11 01:07:18.605754
NCT01979822|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-11-03|||February 2013||2013-02-01|September 2013|2013-09-01|September 2015|Anticipated|2015-09-01|April 2015|Anticipated|2015-04-01||Observational|||LenusPro Safety (LPS) Study in Patients With PH|LPS (Lenus Pro Safety) - Study in Pulmonary Hypertension (PH)|Unknown status|Recruiting|N/A|30|Anticipated|University Medicine Greifswald|||1||f||||t||||||||||2017-10-11 01:07:18.700172|2017-10-11 01:07:18.700172
NCT01979809|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-02-23|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|May 26, 2016|Actual|2016-05-26|May 26, 2016|Actual|2016-05-26||Interventional|MENU GenY||Encouraging Young Adults to Make Effective Nutrition Choices|Encouraging Young Adults to Make Effective Nutrition Choices: MENU GenY Study|Completed||N/A|1674|Actual|Henry Ford Health System||3|||f||||t||||||||||2017-10-11 01:07:18.814706|2017-10-11 01:07:18.814706
NCT01979796|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-05-07|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|SCARIS||Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.|Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning: Design of a Randomized Trial. Smoking Cessation And Reduction In Schizophrenia (The SCARIS Study)|Not yet recruiting||N/A|153|Anticipated|Universita degli Studi di Catania||3|||f||||t|f|f||||||||2017-10-11 01:07:18.92364|2017-10-11 01:07:18.92364
NCT01979783|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-07|||November 2013||2013-11-01|November 2013|2013-11-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01|1 Day|Observational [Patient Registry]|||Correlation Between Electromyography and Thickness Change of the Trunk Muscles in Subjects With Low Back Pain||Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Belgrade|||2||f||||||||||||||2017-10-11 01:07:19.008967|2017-10-11 01:07:19.008967
NCT01979770|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2013-11-02|||January 2013||2013-01-01|November 2013|2013-11-01|October 2015|Anticipated|2015-10-01|December 2013|Anticipated|2013-12-01||Observational|||Early Life Nutritional Exposures and Long-term Health and Cognitive Outcomes|Association of Early Life Nutritional Related Exposures and Long-term Health and Cognitive Development Outcomes in Adolescents in Northeast, Thailand|Unknown status|Active, not recruiting|N/A|529|Actual|Mahidol University|||1||f||||f||||||Samples With DNA|"     DNA from blood specimens   "|||2017-10-11 01:07:19.08803|2017-10-11 01:07:19.08803
NCT01979757|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-07|||April 2011||2011-04-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Outcomes After Centrifugation Versus PureGraft for Fatgrafting to the Breast|Outcomes After Centrifugation Versus PureGraft for Fatgrafting to the Breast After Breast-conserving Therapy|Completed||N/A|30|Actual|Bulovka Hospital||2|||f||||f||||||||||2017-10-11 01:07:19.170577|2017-10-11 01:07:19.170577
NCT01961427|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-11-18|||June 2013||2013-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||Dose and Response of Dietary Nitrate in Healthy and Active Men|Dose and Response of Dietary and Inorganic Nitrate in Healthy and Active Men|Completed||N/A|21|Actual|Swiss Paraplegic Centre Nottwil||7|||f||||f||||||||||2017-10-11 01:12:50.585514|2017-10-11 01:12:50.585514
NCT01979744|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-11-27|||November 2013||2013-11-01|November 2014|2014-11-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial||Unknown status|Recruiting|Phase 4|1116|Anticipated|Yonsei University||4|||f||||t||||||||||2017-10-11 01:07:19.248057|2017-10-11 01:07:19.248057
NCT01979731|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-02-23|||September 2013||2013-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|Jobrotation||Effects Job Rotation in the Prevention of Work Related Musculoskeletal Disorders|Effects Job Rotation in the Prevention of Work Related Musculoskeletal Disorders: Cluster Randomized Trial|Completed||N/A|116|Anticipated|Universidade Cidade de Sao Paulo||2|||f||||t||||||||||2017-10-11 01:07:19.342319|2017-10-11 01:07:19.342319
NCT01979718|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2016-06-15|||November 2013||2013-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Post-operative Analgesia of the Virtual Reality Using a Mirror Therapy After Total Knee Arthroplasty|The Post-operative Analgesia of the Virtual Reality Using a Mirror Therapy After Total Knee Arthroplasty: Prospective, Single-blind, Parallel Group, Randomized, Single Cohort Clinical Trial of Efficacy|Completed||N/A|60|Actual|Ulsan University Hospital||2|||f||||t||||||||Undecided||2017-10-11 01:07:19.438963|2017-10-11 01:07:19.438963
NCT01979705|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-10-05|||August 2013|Actual|2013-08-01|October 2017|2017-10-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Observational|NP||Detect Novel Pathogens and Characterize Emerging Infections|A Prospective Study to Detect Novel Pathogens and Characterize Emerging Infections|Recruiting||N/A|100|Anticipated|Singapore General Hospital|||1||f||||f|f|f||||Samples With DNA|"     1. Blood        2. Throat Swab        3. Nasal Swab        4. ETT Swab (if patient is intubated)        5. Urine        6. Stool   "|||2017-10-11 01:07:19.527972|2017-10-11 01:07:19.527972
NCT01979692|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2014-05-12|||January 2014||2014-01-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Feasibility of Confocal Laser Microscopy (CLM)in the Computed Tomography-guided Needle Biopsy of Pulmonary and Mediastinal Lesions|Feasibility of Confocal Laser Microscopy CLM in the Computed Tomography-guided Needle Biopsy of Pulmonary and Mediastinal Lesions|Unknown status|Recruiting|N/A|10|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 01:07:19.600544|2017-10-11 01:07:19.600544
NCT01979679|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-11-01|||December 2008||2008-12-01|November 2013|2013-11-01||||October 2013|Actual|2013-10-01||Interventional|||A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone|A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone|Completed||Phase 3|28|Actual|University of California, Irvine||3|||f||||t||||||||||2017-10-11 01:07:19.694991|2017-10-11 01:07:19.694991
NCT01979653|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2016-10-13|||November 2013||2013-11-01|November 2013|2013-11-01||||November 2013|Actual|2013-11-01||Interventional|||A Comparision of Midazolam-dexmedetomidine With Dexmedetomidine Alone for Hemodynamic Stability and Quality of Sedation in Elderly Patients Under Spinal Anesthesia||Withdrawn||N/A|0|Actual|Severance Hospital||2|||f||||f||||||||||2017-10-11 01:07:19.885181|2017-10-11 01:07:19.885181
NCT01979640|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2016-04-19|||August 2013||2013-08-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Adequate Additional Bronchial Cuff Volume to Achieve Blood-tight Seal After Air-tight Seal in Double Lumen Tube||Recruiting||N/A|132|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 01:07:19.986673|2017-10-11 01:07:19.986673
NCT01979627|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-01-09|||October 2013||2013-10-01|January 2017|2017-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Safety and Feasibility of Transulnar Artery Approach for Coronary Angiography or Angioplasty|Safety and Feasibility of Transulnar Artery Approach for Coronary Angiography or Angioplasty|Recruiting||N/A|1000|Anticipated|The Second Hospital of Hebei Medical University||2|||f||||||||||||||2017-10-11 01:07:20.11151|2017-10-11 01:07:20.11151
NCT01979601|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2013-12-09|||December 2010||2010-12-01|December 2013|2013-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia|A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenously Administered LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia on Stable Doses of Statin Medications|Completed||Phase 1|74|Actual|Novartis||12|||f||||||||||||||2017-10-11 01:07:20.318397|2017-10-11 01:07:20.318397
NCT01979588|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-03-30|||November 2013||2013-11-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|WGA||How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice|How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice|Completed||N/A|206703|Actual|NorthShore University HealthSystem||2|||f||||f||||||||||2017-10-11 01:07:20.436164|2017-10-11 01:07:20.436164
NCT01979575|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-10-04|||October 2013|Actual|2013-10-01|October 2017|2017-10-01|July 2015|Actual|2015-07-01|September 2014|Actual|2014-09-01||Observational|||Trendelenburg Study|An Observational Study on the Effects of Steep Trendelenburg Position and Pneumoperitoneum on Hemodynamic Changes Observed With Non-invasive Cardiac Monitors|Completed||N/A|30|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 01:07:20.538334|2017-10-11 01:07:20.538334
NCT01979562|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-05-28|||March 2014||2014-03-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01|1 Year|Observational [Patient Registry]|||Knowledge of Predicting Increased Risk for an Overuse Injury in Runners|Knowledge of Predicting Increased Risk for an Overuse Injury in Runners Related to the Mutual Length of Femur and Tibia and the Running Style|Unknown status|Recruiting|N/A|100|Anticipated|Northern Orthopaedic Division, Denmark|||1||f||||f||||||||||2017-10-11 01:07:20.606416|2017-10-11 01:07:20.606416
NCT01979549|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2014-01-20|||December 2013||2013-12-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|AEDUGESSH||Adverse Events During Upper Gastrointestinal Endoscopy|Adverse Events During Upper Gastrointestinal Endoscopy With and Without Sedation: a Multiple Center Report From Shanghai|Unknown status|Recruiting|N/A|6000|Anticipated|RenJi Hospital|||2||f||||t||||||||||2017-10-11 01:07:20.721586|2017-10-11 01:07:20.721586
NCT01979536|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-10-02|||November 8, 2013|Actual|2013-11-08|June 2017|2017-06-01||||September 30, 2020|Anticipated|2020-09-30||Interventional|||Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma|A Randomized Phase 2 Trial of Brentuximab Vedotin (SGN35, NSC# 749710), or Crizotinib (NSC#749005, Commercially Labeled) in Combination With Chemotherapy for Newly Diagnosed Patients With Anaplastic Large Cell Lymphoma (ALCL)|Suspended||Phase 2|140|Anticipated|National Cancer Institute (NCI)||2||Other - DSMC recommended supportive care guidelines update|f||||f||||||||||2017-10-11 01:07:20.856178|2017-10-11 01:07:20.856178
NCT01979523|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-09-12|||October 23, 2013|Actual|2013-10-23|September 2017|2017-09-01||||October 18, 2017|Anticipated|2017-10-18||Interventional|||Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma|A Randomized Two-Arm Phase II Study of Trametinib Alone and in Combination With GSK2141795 in Patients With Advanced Uveal Melanoma|Active, not recruiting||Phase 2|60|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 01:07:21.60627|2017-10-11 01:07:21.60627
NCT01979510|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-04-24|||November 2013||2013-11-01|April 2015|2015-04-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Safety and Efficacy Study of an Etoricoxib and Tizanidine Fixed Dose Combination in Participants With Moderate to Severe Acute Low Back Pain (MK-0663B-164)|A Phase III Randomized Clinical Trial to Evaluate the Safety and Efficacy of an Etoricoxib and Tizanidine Fixed Dose Combination in Subjects With Moderate to Severe Acute Low Back Pain|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 01:07:21.758029|2017-10-11 01:07:21.758029
NCT01979497|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-04-15|||August 2013||2013-08-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Adhesive Strips in Dermatologic Surgery: Is Cosmetic Appearance Improved?|Adhesive Strips in Dermatologic Surgery: Is Cosmetic Appearance Improved?|Completed||N/A|39|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 01:07:21.878423|2017-10-11 01:07:21.878423
NCT01979484|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-01-07|||October 2013||2013-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations|A Phase 1, Open-Label, Two-Period, Crossover Study to Evaluate the Relative Bioavailability of a New Tablet Formulation Versus the Current Capsule Formulation of PPI-668 in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Presidio Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:07:21.976429|2017-10-11 01:07:21.976429
NCT01979471|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-09-14|||January 2014||2014-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|RxEACH||The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH|The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH|Completed||N/A|723|Actual|University of Alberta||2|||f||||||||||||||2017-10-11 01:07:22.179123|2017-10-11 01:07:22.179123
NCT01979458|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2017-03-22|||November 2013||2013-11-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Photometric Stereo Endoscopy (PSE) as a Tool for Imaging the Rectum and Colon|Pilot Study to Evaluate Photometric Stereo Endoscopy (PSE) as a Tool for Imaging the Rectum and Colon|Completed||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||||2017-10-11 01:07:22.301548|2017-10-11 01:07:22.301548
NCT01979445|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2014-03-26|||November 2013||2013-11-01|October 2013|2013-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Cangrelor to Clopidogrel or Prasugrel Transition Study|A Study of the Transition From Cangrelor to Clopidogrel or Prasugrel in Patients With Coronary Artery Disease.|Completed||Phase 2|15|Actual|The Medicines Company||5|||f||||f||||||||||2017-10-11 01:07:22.393011|2017-10-11 01:07:22.393011
NCT01979432|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2015-03-08|||December 2013||2013-12-01|March 2015|2015-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|COACHES||The Cognitive and Cardiovascular Health in the Elderly Study|The Cognitive and Cardiovascular Health in the Elderly Study|Recruiting||N/A|386|Anticipated|University Hospital, Limoges||1|||f||||t||||||||||2017-10-11 01:07:22.516875|2017-10-11 01:07:22.516875
NCT01979419|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-05-06|||November 2012||2012-11-01|May 2015|2015-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01|36 Months|Observational [Patient Registry]|K-ADNI||Korea Alzheimer's Disease Neuroimaging Initiative|Korea Alzheimer's Disease Neuroimaging Initiative|Active, not recruiting||N/A|500|Anticipated|Korean Alzheimers' Disease Neuroimaing Intitiative|||5||f||||t||||||Samples With DNA|"     Blood, Serum, CSF   "|||2017-10-11 01:07:22.616941|2017-10-11 01:07:22.616941
NCT01979406|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2014-07-25|||October 2013||2013-10-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|November 2014|Anticipated|2014-11-01||Interventional|||A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines|A Phase 1 Randomized Double-Blind Positive-Controlled Ascending Dose Study to Evaluate the Safety and Immunogenicity of a Replication-Competent Adenovirus Serotype 4 Anthrax Vector Candidate Vaccines - Ad4-PA (Protective Antigen)and Ad4-PA-GPI (Glycosylphosphatidylinositol)|Unknown status|Active, not recruiting|Phase 1|120|Anticipated|PaxVax, Inc.||7|||f||||t||||||||||2017-10-11 01:07:22.7191|2017-10-11 01:07:22.7191
NCT01979393|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2016-10-11|||February 2015||2015-02-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||IRCI Gynae Sarcomas, High Grade Uterine Sarcoma|A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment|Recruiting||Phase 2|78|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 01:07:22.870353|2017-10-11 01:07:22.870353
NCT01979380|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-04|2014-08-11|||December 2013||2013-12-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects|A Randomized, Double-blind, Placebo-controlled, Ascending Single Oral Dose, Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects|Completed||Phase 1|40|Actual|Kwang Dong Pharmaceutical co., ltd.||2|||f||||f||||||||||2017-10-11 01:07:23.037313|2017-10-11 01:07:23.037313
NCT01979367|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-09-22|||March 2012||2012-03-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|January 2021|Anticipated|2021-01-01||Interventional|DTSC||Physician Clinical Trial Policy (CTP) Neurological Ischemia Lower Extremity Pain and Swelling|To Evaluate the Efficacy Treatment of Lower Extremity Pathologies Derived From Neurological Ischemia Disorders|Enrolling by invitation||N/A|1000|Anticipated|American Association of Sensory Electrodiagnostic Medicine||1|||f||||t|f|t|f|f||||||2017-10-11 01:07:23.142407|2017-10-11 01:07:23.142407
NCT01979354|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-02|2015-11-09|||February 2014||2014-02-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||0.15 mg Spinal Morphine vs. no Treatment for Morphine Requirement After VATs.|The Comparison of 0.15 Milligram Spinal Morphine vs.no Treatment for Morphine Requirement After Video-assisted Thoracoscopic Surgery. A Pilot Randomized Control Study|Recruiting||Phase 4|40|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 01:07:23.263345|2017-10-11 01:07:23.263345
NCT01979341|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-05-25|||October 2013||2013-10-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes|Dual Trigger With Gonadotropin-releasing Hormone Agonist (GnRHa) and Human Chorionic Gonadotropin (hCG) to Optimize ICSI Reproductive Outcomes|Withdrawn||N/A|0|Actual|Antalya IVF||3||treatment strategy changed|f||||f||||||||||2017-10-11 01:07:23.370673|2017-10-11 01:07:23.370673
NCT01979328|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-11-04|||March 2012||2012-03-01|October 2013|2013-10-01||||May 2012|Actual|2012-05-01||Interventional|THRIVE-III||Geko™ Plaster Cast Study, Deep Vein Thrombosis (DVT) Prophylaxis|The Efficacy of a Neuromuscular Stimulation Device (Geko™) in Promoting Blood Flow in a Plaster Cast as a Way of Offering Mechanical DVT Prophylaxis|Completed||Early Phase 1|10|Actual|University Hospital Southampton NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:07:23.498269|2017-10-11 01:07:23.498269
NCT01979315|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-04-25|||December 2015||2015-12-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01|5 Days|Observational [Patient Registry]|||Cross Correlation of Pain Hypersensitivity and Clinical Features and Electromyography in Low Back Pain Patients|Cross Correlation of Pain Hypersensitivity and Clinical and EMG Parameters|Recruiting||N/A|60|Anticipated|University of Belgrade|||2||f||||f||||||||||2017-10-11 01:07:23.599656|2017-10-11 01:07:23.599656
NCT01979302|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-07-09|||January 2009||2009-01-01|July 2014|2014-07-01||||December 2013|Actual|2013-12-01||Interventional|||Effectiveness of a Depression Care Management Initiative in Home Healthcare|Effectiveness of a Depression Care Management Initiative in Home Healthcare|Unknown status|Active, not recruiting|N/A|310|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 01:07:23.704911|2017-10-11 01:07:23.704911
NCT01979289|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-02-01|||August 2012||2012-08-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Computerized Cognitive Remediation for Geriatric Depression|Computerized Cognitive Remediation for Geriatric Depression|Recruiting||N/A|60|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 01:07:23.805575|2017-10-11 01:07:23.805575
NCT01979276|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-02-07|||November 2013|Actual|2013-11-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|Romi Poma||Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma|A Phase I/II Study of Pomalidomide (CC-4047®), Dexamethasone and Romidepsin in Patients With Relapsed or Refractory Multiple Myeloma (Romi Poma)|Completed||Phase 1/Phase 2|4|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-10-11 01:07:23.906957|2017-10-11 01:07:23.906957
NCT01979263|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-06-02|||October 2013||2013-10-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|December 2018|Anticipated|2018-12-01||Interventional|ABMT||Attention Bias Modification Treatment for Anxious Youth|Attention Bias Modification Treatment for Anxious Youth|Active, not recruiting||N/A|44|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||Yes||2017-10-11 01:07:24.015577|2017-10-11 01:07:24.015577
NCT01979250|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-08-10|||October 2013||2013-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Fuchs' Endothelial Dystrophy: Clinical Characteristics, Treatment Outcome, and Pathology|Fuchs' Endothelial Dystrophy: Clinical Characteristics, Treatment Outcome, and Pathology|Completed||N/A|81|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 01:07:24.108965|2017-10-11 01:07:24.108965
NCT01979237|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2013-11-03|||November 2013||2013-11-01|October 2013|2013-10-01||||July 2015|Anticipated|2015-07-01||Interventional|||Comparing FARES Method With SPASO Method for Reduction of Anterior Shoulder Dislocation: a Prospective Randomized Trial|Comparing FARES Method With SPASO Method for Reduction of Anterior Shoulder Dislocation: a Prospective Randomized Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 01:07:24.209541|2017-10-11 01:07:24.209541
NCT01979224|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-10-31|||February 2012||2012-02-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy of Educational Intervention for Parents of Children With Asthma|Efficacy of Educational Intervention for Parents of Children With Asthma in 4-11 Years and Their Impact on the Control Children as Measured by ACT. Randomized Controlled Clinical|Completed||N/A|42|Actual|Universidad Autonoma de San Luis Potosí||1|||f||||t||||||||||2017-10-11 01:07:24.293012|2017-10-11 01:07:24.293012
NCT01979211|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-01-04|||October 2013||2013-10-01|January 2016|2016-01-01|October 2021|Anticipated|2021-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck|Phase II Trial of Post-operative or Definitive Concurrent Radiation and Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck|Recruiting||Phase 2|40|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-10-11 01:07:24.388315|2017-10-11 01:07:24.388315
NCT01979198|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-10-31|||December 2012||2012-12-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|10 Years|Observational [Patient Registry]|||Thoracolumbar Burst Fracture Treated With Pedicle Screws: Radiographic Outcomes|Thoracolumbar Burst Fracture Treated With Pedicle Screws: Radiographic Analysis of Discs and Vertebral Body Height at Fractured and Adjacent Levels|Completed||N/A|48|Actual|Taipei Veterans General Hospital, Taiwan|||2||f||||t||||||||||2017-10-11 01:07:24.487946|2017-10-11 01:07:24.487946
NCT01978977|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2015-10-06|||July 2011||2011-07-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer|Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy Plus Bevacizumab in Women With HER2-Negative Metastatic Breast Cancer. An Observational Study.|Completed||N/A|400|Actual|Hellenic Oncology Research Group|||1||f||||f||||||||||2017-10-11 01:07:28.466585|2017-10-11 01:07:28.466585
NCT01979185|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2014-12-16|2014-12-16||November 2013||2013-11-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Safety Set: All subjects who had taken at least 1 dose of investigational product.|Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects|A Phase 1, Randomized, Open-label, Cross-over Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Simvastatin in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Shire||2|||f||||||||||||||2017-10-11 01:07:24.572324|2017-10-11 01:07:24.572324
NCT01979172|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2013-11-03|||November 2013||2013-11-01|November 2013|2013-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Comparison of Intraocular Lens Power Calculation Methods After Corneal Laser Refractive Surgery in Axial and Refractive Ammertropia|Comparison of Intraocular Lens Power Calculation Methods After Corneal Laser Refractive Surgery in Axial and Refractive Ammertropia|Unknown status|Recruiting|N/A|400|Anticipated|The National Eye Hospital, Cairo, Egypt|||1||f||||t||||||||||2017-10-11 01:07:24.888004|2017-10-11 01:07:24.888004
NCT01979159|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-09-20|||October 21, 2013|Actual|2013-10-21|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 30, 2016|Actual|2016-12-30||Interventional|AA: MoO||A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of Outcomes|A Novel Treatment for Aphasia and Apraxia of Speech: Measurement of Outcomes|Active, not recruiting||N/A|4|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-11 01:07:24.965589|2017-10-11 01:07:24.965589
NCT01979146|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-02-28|||April 2001||2001-04-01|February 2017|2017-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Cancer & Chemotherapy Symptom Management Using an Automated Telephone Reporting System|Telephone Linked Care for Cancer Symptom Management|Completed||N/A|250|Actual|University of Utah||2|||f||||t||||||||No||2017-10-11 01:07:25.235553|2017-10-11 01:07:25.235553
NCT01979133|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-03-07|2015-11-02||October 2013||2013-10-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders|A Proof of Concept Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders|Completed||Phase 3|10|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 01:07:25.340194|2017-10-11 01:07:25.340194
NCT01979120|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2013-11-03|||December 2012||2012-12-01|August 2013|2013-08-01||||August 2014|Anticipated|2014-08-01||Observational|VASA||"Validation of the ApneaScan Algorithm for the Detection of Sleep Disordered Breathing in Chronic Heart Failure"|"Validation of the ApneaScan Algorithm for the Detection of Sleep Disordered Breathing in Patients With Stable Symptomatic Chronic Heart Failure"|Unknown status|Recruiting|N/A|200|Anticipated|Medical University of Vienna|||1||f||||t||||||||||2017-10-11 01:07:25.710959|2017-10-11 01:07:25.710959
NCT01979107|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-08-11|||October 2013||2013-10-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Early Detection of and Intervention Towards Chronic Diseases Among Individuals Without Formal Education|Early Detection of and Intervention Towards Chronic Diseases Among Individuals Without Formal Education|Active, not recruiting||N/A|1047|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 01:07:25.881261|2017-10-11 01:07:25.881261
NCT01979094|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-07-16|||May 2013||2013-05-01|July 2017|2017-07-01|May 2025|Anticipated|2025-05-01|May 2025|Anticipated|2025-05-01||Observational|||Spinal Arthrodesis and Spinal Arthroplasty Database Study|General Spinal Arthrodesis and Spinal Arthroplasty Database|Recruiting||N/A|3000|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-11 01:07:26.003225|2017-10-11 01:07:26.003225
NCT01979081|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-09-13|||January 2013||2013-01-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Observational|||Detecting and Addressing Preclinical Disability|Detecting and Addressing Preclinical Disability|Active, not recruiting||N/A|148|Actual|McMaster University|||2||f||||t||||||||||2017-10-11 01:07:26.072693|2017-10-11 01:07:26.072693
NCT01979068|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-03|||March 2008||2008-03-01|November 2013|2013-11-01||||March 2011|Actual|2011-03-01||Observational|||Vascular Inflammation Stratified by Body Size Phenotype||Completed||N/A|250|Actual|Korea University|||1||f||||t||||||||||2017-10-11 01:07:26.153297|2017-10-11 01:07:26.153297
NCT01979055|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-07-05|||November 2013||2013-11-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||Achieving Better Control for Older Adults With Asthma|Use of a Self-regulation Intervention to Improve Control and Outcomes in Older Adults With Asthma|Completed||N/A|189|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 01:07:26.209559|2017-10-11 01:07:26.209559
NCT01979042|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-10-25|||October 2013||2013-10-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Urinary Markers for Unilateral Kidney Obstruction|Can Modern Urinary Markers be Used as Markers for Acute Kidney Failure Due to Stone Obstruction|Completed||N/A|53|Actual|Carmel Medical Center|||2||f||||f||||||Samples Without DNA|"     urine   "|||2017-10-11 01:07:26.286206|2017-10-11 01:07:26.286206
NCT01979029|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-04-28|2016-03-02||February 2013||2013-02-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|POTLCAORCS||Study of the Preservation of the Left Colic Artery on Rectum Cancer Surgery|Affection on Anastomotic Blood Flow and the Lymph Nodes Dissection Between Division at the Root of the Inferior Mesenteric Artery and Preserving the Left Colic Artery in Rectum Cancer Surgery|Completed||N/A|57|Actual|First Hospital of Jilin University||2|||f||||f||||||||No||2017-10-11 01:07:26.378927|2017-10-11 01:07:26.378927
NCT01979016|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-04-02||2015-04-02|December 2013||2013-12-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Study to Determine the Safety and Effectiveness of Dupilumab (REGN668/SAR231893) for Treatment of Atopic Dermatitis (AD)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis|Completed||Phase 2|54|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:07:26.696783|2017-10-11 01:07:26.696783
NCT01979003|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-06-12|||September 2014||2014-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion|A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion|Recruiting||Early Phase 1|20|Anticipated|University of Arkansas||1|||f||||f||||||||||2017-10-11 01:07:26.787744|2017-10-11 01:07:26.787744
NCT01978990|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-03|2017-03-19|||January 2018|Anticipated|2018-01-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Assessment of a Health Informatics System on Insulin-treated Diabetic Patients||Withdrawn||N/A|0|Actual|Hadassah Medical Organization|||1|financial issues|f||||f||||||||||2017-10-11 01:07:26.859087|2017-10-11 01:07:26.859087
NCT01978964|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-03-01|||November 2012||2012-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors|Maintenance Therapy With ONT-10, a Liposomal MUC1 Cancer Vaccine, in Patients Who Have Previously Received ONT-10|Completed||Phase 1|90|Anticipated|Cascadian Therapeutics Inc.||1|||f||||t||||||||||2017-10-11 01:07:28.553277|2017-10-11 01:07:28.553277
NCT01978951|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2014-03-29|||July 2011||2011-07-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|ESCORT||Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand|Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand (ESCORT Study)|Completed||N/A|443|Actual|Bhumirajanagarindra Kidney Institute, Thailand||2|||f||||t||||||||||2017-10-11 01:07:28.633179|2017-10-11 01:07:28.633179
NCT01978938|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-05-24|||December 2013||2013-12-01|May 2016|2016-05-01||||September 2015|Actual|2015-09-01||Interventional|||Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections|A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections|Active, not recruiting||Phase 3|840|Anticipated|Tetraphase Pharmaceuticals, Inc.||3|||f||||||||||||||2017-10-11 01:07:28.787023|2017-10-11 01:07:28.787023
NCT01978925|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-05-19|||November 2013||2013-11-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|AMPaRAR||Pharmaceutical Care in Emergency Department|Effectiveness Pharmaceutical Care at Discharge in the Emergency Department: a Randomized Controlled Trial|Completed||N/A|380|Actual|Hospital Moinhos de Vento||2|||f||||t||||||||||2017-10-11 01:07:28.979221|2017-10-11 01:07:28.979221
NCT01978912|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-11-29|||February 2013||2013-02-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Interventional|||A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation|Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation|Active, not recruiting||Phase 1/Phase 2|24|Actual|Teijin America, Inc.||4|||f||||t||||||||||2017-10-11 01:07:29.058577|2017-10-11 01:07:29.058577
NCT01978899|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-06-01|||November 2013||2013-11-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Healthy Living After Cancer: Weight Management Pilot Study|Healthy Living After Cancer: Weight Management Pilot Study|Completed||N/A|60|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No|There are no plans to release individual participant data.|2017-10-11 01:07:29.246807|2017-10-11 01:07:29.246807
NCT01978886|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2016-02-10|||December 2013||2013-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01|2 Years|Observational [Patient Registry]|||Prevalence of Unknown and Known Diabetes in Patients With Frozen Shoulder|Prevalence of Unknown and Known Diabetes in Patients With Frozen Shoulder|Completed||N/A|220|Actual|Sygehus Lillebaelt|||2||f||||t||||||Samples Without DNA|"     whole blood for patients not diagnosed with diabetes.   "|||2017-10-11 01:07:29.350077|2017-10-11 01:07:29.350077
NCT01978873|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-05-03|||November 2012||2012-11-01|May 2016|2016-05-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|SensiCab||Efficacy Study Evaluating Chemotherapy in Prostate Cancer|Randomized Phase III Trial Comparing Cabazitaxel Combination Hormone Therapy to Hormone Therapy Alone in Metastatic Prostate Cancer or High Risk Disease|Recruiting||Phase 3|400|Anticipated|Örebro University, Sweden||2|||f||||t||||||||Yes|All data from the main study will be made public available after the publication of the study.|2017-10-11 01:07:29.44796|2017-10-11 01:07:29.44796
NCT01978860|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-10-06|||November 2013||2013-11-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter|A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter in (CTO) Coronary Lesions|Completed||N/A|2|Actual|Nitiloop Ltd.||1|||f||||f||||||||||2017-10-11 01:07:29.583723|2017-10-11 01:07:29.583723
NCT01978847|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-12-02|||May 2013||2013-05-01|December 2016|2016-12-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Observational|||Retrospective Review of Anterior and Posterior Cervical, Thoracic, and Lumbar Instrumented Arthrodesis Surgeries|Proposal for Retrospective Review of Anterior&Posterior Cervical, Thoracic, and Lumbar Instrumented Arthrodesis Surgeries Performed at OSU.|Recruiting||N/A|3000|Anticipated|Ohio State University|||1||f||||f||||||||||2017-10-11 01:07:29.68426|2017-10-11 01:07:29.68426
NCT01978834|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-01-28|||October 2013||2013-10-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01|1 Day|Observational [Patient Registry]|||Age Dependend Diagnostic Thresholds for Osteoporosis Bindex Ultrasonometer|Age Dependend Diagnostic Thresholds for Osteoporosis Bindex Ultrasonometer|Completed||N/A|560|Actual|Bone Index Finland Ltd|||1||f||||f||||||||||2017-10-11 01:07:29.776686|2017-10-11 01:07:29.776686
NCT01978821|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-09-23|||August 2010||2010-08-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Stem Cell Therapy for Cerebral Palsy|Open Label Study of Autologous Bone Marrow Mononuclear Cells in Cerebral Palsy|Completed||Phase 1|40|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||||2017-10-11 01:07:29.860353|2017-10-11 01:07:29.860353
NCT01978808|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-11-11|||October 2013||2013-10-01|November 2013|2013-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Efficiency Study of the EUS-FNA Needles With and Without a Side Port in Pancreatic Masses|A Prospective Multi-center Randomized Study of the Difference in Diagnostic Yield Between EUS-FNA Needles With and Without a Side Port in Pancreatic Masses|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:07:29.95554|2017-10-11 01:07:29.95554
NCT01978795|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-11-06|||August 2011||2011-08-01|October 2013|2013-10-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Interactive Training in Sports Concussion Prevention and Management|The Effectiveness of a Web-Based Resource in Improving Post-Concussion Management in High Schools|Completed||Phase 2|25|Actual|Oregon Center for Applied Science, Inc.||2|||f||||f||||||||||2017-10-11 01:07:30.061144|2017-10-11 01:07:30.061144
NCT01978782|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-07-21|||January 2014||2014-01-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|RECITAL||Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).|Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).|Completed||Phase 1|24|Actual|Radboud University||3|||f||||f||||||||||2017-10-11 01:07:30.144275|2017-10-11 01:07:30.144275
NCT01978769|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2015-09-06|||November 2014||2014-11-01|July 2013|2013-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||The Effect of Physical Effort in the Decision Making Process of Preadolescents With ADHD|The Effect of Physical Effort in the Decision Making Process of Preadolescents With ADHD|Completed||N/A|60|Actual|Shaare Zedek Medical Center|||2||f||||f||||||||||2017-10-11 01:07:30.236348|2017-10-11 01:07:30.236348
NCT01978756|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2016-05-23|||March 2013||2013-03-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Outpatient Clinic for Late Outcome for Breast Carcinoma in MAASTRO Clinic.|Outpatient Clinic to Evaluate Late Outcome in Patients Curatively Treated for Breast Carcinoma in MAASTRO Clinic.|Completed||N/A|387|Actual|Maastricht Radiation Oncology|||1||f||||f||||||Samples With DNA|"     As part of the study a blood sample or saliva will be obtained, if the patient has given     written informed consent to participate in the Biobank. The purpose to determine, by means of     DNA and protein analysis, the relationship between DNA and protein profiles and a number of     endpoints, which are important for the patient such as overall survival and side effects.      For detailed information: ClinicalTrials.gov Identifier: NCT01084785   "|||2017-10-11 01:07:30.296852|2017-10-11 01:07:30.296852
NCT01978743|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2017-07-18|2017-06-08||January 2014|Actual|2014-01-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen|Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen|Completed||N/A|10|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:07:30.380723|2017-10-11 01:07:30.380723
NCT01978717|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-11-01|||September 2011||2011-09-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||General Anesthesia Combined With Epidural Anesthesia Mitigates the Surgical Stress-related Immunosuppression in Patients With Colorectal Cancer||Completed||N/A|53|Actual|Fudan University||2|||f||||t||||||||||2017-10-11 01:07:31.089087|2017-10-11 01:07:31.089087
NCT01978704|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-11-01|||February 2013||2013-02-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|GLUT||Glycaemic Load and Pre-meal Insulin Doses in Type 1 Diabetes Patients|Use of the Glycemic Load for the Adjustment of the Dose of Preprandial Insulin in Patients With Type 1 Diabetes Mellitus in Insulin Pump Therapy|Completed||N/A|9|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 01:07:31.170442|2017-10-11 01:07:31.170442
NCT01978691|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-02-01|||November 2013||2013-11-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MetSProb||The Effect of a Bifidobacterium and Polydextrose on Body Fat Mass|The Effect of Separate or Combined Supplementation of Probiotic (Bifidobacterium Lactis B420) and Polydextrose on Body Fat Mass|Completed||Phase 2|225|Actual|Danisco||4|||f||||f||||||||Undecided||2017-10-11 01:07:31.249529|2017-10-11 01:07:31.249529
NCT01978678|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-11-06|||November 2012||2012-11-01|November 2013|2013-11-01||||January 2015|Anticipated|2015-01-01|9 Months|Observational [Patient Registry]|Aperitif||Does Asthma Phenotype Have Impact on Disease Control|Does Asthma Phenotype Have Impact on Disease Control - Can Detection of Inflammation and Hyper Responsiveness Ensure Stable Disease Faster|Unknown status|Recruiting|N/A|80|Anticipated|Bispebjerg Hospital|||1||f||||t||||||||||2017-10-11 01:07:31.381263|2017-10-11 01:07:31.381263
NCT01978665|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2013-11-06|||April 2013||2013-04-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|COPDprednisone||The Effect of Prednisone and Solu-Medrol on Physical Exercise in COPD Patients and Inflammatory Response During and After Exercise|The Effect of Prednisone and Solu-Medrol on Physical Exercise in COPD Patients and the Inflammaroty Response During and After Exercis.|Unknown status|Not yet recruiting|N/A|14|Anticipated|Bispebjerg Hospital||3|||f||||t||||||||||2017-10-11 01:07:31.482968|2017-10-11 01:07:31.482968
NCT01978652|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-01-08|||December 2013||2013-12-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants.|A Two-Arm, Open-Label, Single-Dose, Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Peginterferon Beta-1a (BIIB017) in Japanese and Caucasian Adult Healthy Subjects|Completed||Phase 1|44|Actual|Biogen||2|||f||||||||||||||2017-10-11 01:07:31.591655|2017-10-11 01:07:31.591655
NCT01978639|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-05-23|||January 2014||2014-01-01|May 2017|2017-05-01||||June 2017|Anticipated|2017-06-01||Observational|||Injections of FloGraft Therapy, Autologous Stem Cells, or Platelet Rich Plasma for the Treatment of Degenerative Joint Pain|Outcomes of Single Injections of FloGraft Therapy, Autologous Stem Cells, or Platelet Rich Plasma for the Treatment of Pain in the Lumbar Facet Joints, Sacroiliac Joints, Upper Extremity Joints, and Lower Extremity Joints|Active, not recruiting||N/A|300|Anticipated|Arizona Pain Specialists|||1||f||||f||||||||No||2017-10-11 01:07:31.700771|2017-10-11 01:07:31.700771
NCT01978626|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-05-07|||March 2014||2014-03-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Enhancing Performance of Cognitive Behavioral Therapy for Insomnia With an Integrative Mobile Platform|Enhancing Performance of Cognitive Behavioral Therapy for Insomnia With an Integrative Mobile Platform|Unknown status|Recruiting|N/A|120|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:07:31.805066|2017-10-11 01:07:31.805066
NCT01978613|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2014-06-27|||November 2013||2013-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects|Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects|Completed||Phase 1|100|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-10-11 01:07:31.916203|2017-10-11 01:07:31.916203
NCT01977690|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-07-21|2016-07-16||October 2013||2013-10-01|July 2017|2017-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Clavicle Splint for Pain Reduction After Posterior Cervicothoracic Surgery|Clavicle Splint for Pain Reduction After Posterior Cervicothoracic Surgery|Completed||N/A|30|Actual|Stanford University|Small number of patients and its location at a single institution.|2|||f||||f||||||||||2017-10-11 01:07:43.575946|2017-10-11 01:07:43.575946
NCT01978600|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-03-31|2015-03-31||October 2013||2013-10-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||This analysis population includes all randomized participants.|Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension|Prospective, Randomized, Single-Center Study to Evaluate 24-hour Intraocular Pressure Control With Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination Therapy|Completed||Phase 4|89|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:07:32.041539|2017-10-11 01:07:32.041539
NCT01978587|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2014-03-15|||October 2013||2013-10-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease|A Phase 1, Open-label, Sequential Crossover Study to Evaluate the Effect of Hemodialysis on the Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease|Completed||Phase 1|6|Actual|Akros Pharma Inc.||2|||f||||f||||||||||2017-10-11 01:07:32.369691|2017-10-11 01:07:32.369691
NCT01978574|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-06|||June 2013||2013-06-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Intellectual Enrichment to Build Cognitive Reserve in MS|A Randomized Controlled Trial of Intellectual Enrichment to Build Cognitive Reserve in Multiple Sclerosis|Unknown status|Recruiting|N/A|16|Anticipated|Kessler Foundation||2|||f||||t||||||||||2017-10-11 01:07:32.468922|2017-10-11 01:07:32.468922
NCT01978561|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2015-09-10|||October 2013||2013-10-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|Thrive-IVF F/U||Follow-Up Of Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up)|Pregnancy, Delivery, And Neonatal Outcomes In Subjects With Ongoing Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up)|Completed||Phase 2|40|Actual|Nora Therapeutics, Inc.||3|||f||||t||||||||||2017-10-11 01:07:32.580846|2017-10-11 01:07:32.580846
NCT01978548|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-06-24|||December 2013||2013-12-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease|A Double-blind, Placebo-Controlled, Randomized, 4-Week, Multiple-Dose, Proof-of-Mechanism Study in Subjects With Prodromal Alzheimer's Disease Investigating the Effects of JNJ-54861911 on Aβ Processing in CSF and Plasma|Completed||Phase 1|45|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 01:07:32.663757|2017-10-11 01:07:32.663757
NCT01978535|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-09-15|||October 2013||2013-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)|A Randomized, Controlled, Double Blinded Clinical Trial of Intravenous Iron Sucrose in Adolescents With Non-anemic Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)|Recruiting||Phase 1/Phase 2|30|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:07:32.795568|2017-10-11 01:07:32.795568
NCT01978522|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-04-21|||January 2014||2014-01-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The NICOLA Questionnaire Trial (NICOLA-QT)|The NICOLA Questionnaire Trial (NICOLA-QT): Effect of Timing and Mode of Delivery on Completion and Completeness of a Self-assessment Questionnaire in a Longitudinal Study in People Over Age of 50.|Unknown status|Recruiting|N/A|8500|Anticipated|Queen's University, Belfast||1|||f||||f||||||||||2017-10-11 01:07:32.892582|2017-10-11 01:07:32.892582
NCT01978509|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-08-03|||September 2013||2013-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies|The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies|Recruiting||N/A|200|Anticipated|Mayo Clinic||3|||f||||f||||||||||2017-10-11 01:07:32.979541|2017-10-11 01:07:32.979541
NCT01978496|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-11|||July 1996||1996-07-01|November 2013|2013-11-01|December 1997|Actual|1997-12-01|December 1997|Actual|1997-12-01||Interventional|||Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine|A Multicenter Double-blind, Randomized Placebo Controlled, Parallel Group, Study of the Efficacy and Safety of Oral Eletriptan in Subjects With Acute Migraine|Completed||Phase 3|1334|Actual|Pfizer||4|||f||||t||||||||||2017-10-11 01:07:33.076278|2017-10-11 01:07:33.076278
NCT01978483|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-07-23|||November 2013||2013-11-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of RANKL Inhibition on UV-induced Immunosuppression|Effect of RANKL Inhibition on UV-induced Immunosuppression|Completed||Phase 1|31|Actual|Innovaderm Research Inc.||3|||f||||f||||||||||2017-10-11 01:07:33.156545|2017-10-11 01:07:33.156545
NCT01978470|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2016-04-11|||June 2012||2012-06-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|eTNS for DRE||External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy|External Trigeminal Nerve Stimulation for Epilepsy|Active, not recruiting||N/A|20|Anticipated|NeuroSigma, Inc.||1|||f||||t||||||||||2017-10-11 01:07:33.275953|2017-10-11 01:07:33.275953
NCT01978457|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-01-23|||October 2012||2012-10-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction|Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction|Active, not recruiting||Phase 1|24|Anticipated|Yale University||3|||f||||||||||||||2017-10-11 01:07:33.370702|2017-10-11 01:07:33.370702
NCT01978444|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-04-05|||September 2014||2014-09-01|April 2016|2016-04-01|October 2023|Anticipated|2023-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Study on Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision（D2+CME）for Advanced Gastric Cancer|Prospective Randomized Controlled Trial of Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision（D2+CME）vs. Laparoscopic D2 Lymphadenectomy for Advanced Gastric Cancer|Recruiting||N/A|167|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 01:07:33.458697|2017-10-11 01:07:33.458697
NCT01978431|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-06-26|||November 2012||2012-11-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Impulsivity and Stimulant Administration|Impulsivity and Stimulant Administration|Active, not recruiting||N/A|48|Anticipated|Yale University||2|||f||||||||||||||2017-10-11 01:07:33.560654|2017-10-11 01:07:33.560654
NCT01978418|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-12-05|||November 2013||2013-11-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|SAISTY||Inhaled Salbutamol in Elective Caesarean Section|Inhaled Salbutamol in Elective Caesarean Section|Unknown status|Recruiting|Phase 4|62|Anticipated|Helsinki University Central Hospital||2|||f||||t||||||||||2017-10-11 01:07:33.845561|2017-10-11 01:07:33.845561
NCT01978405|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-11-06|||November 2013||2013-11-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes|Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes|Unknown status|Recruiting|Phase 4|200|Anticipated|Wuhan General Hospital of Guangzhou Military Command||2|||f||||t||||||||||2017-10-11 01:07:33.972195|2017-10-11 01:07:33.972195
NCT01978392|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-01|2017-06-01|||November 2013||2013-11-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||MANAGE AT WORK: Addressing the Challenge of Chronic Physical Health Conditions in the Workplace|MANAGE AT WORK: Evaluation of a Group-based Self-management Program to Address Workplace Discomfort and Fatigue Associated With Chronic Physical Health Conditions|Completed||N/A|122|Actual|Liberty Mutual Research Institute for Safety||2|||f||||f||||||||Yes|De-identified data may be available to qualified researchers after data collection is complete|2017-10-11 01:07:34.083888|2017-10-11 01:07:34.083888
NCT01978366|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-07-05|||October 2013|Actual|2013-10-01|July 2017|2017-07-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|||Open Label Extension Study of HT-100 in Patients With DMD|An Open Label Extension Study of HT-100 in Patients With Duchenne Muscular Dystrophy Who Have Completed Protocol HALO-DMD-01|Terminated||Phase 2|17|Actual|Akashi Therapeutics||5||Dosing stopped|f||||t||||||||||2017-10-11 01:07:34.884167|2017-10-11 01:07:34.884167
NCT01978353|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-10-23|||November 2012||2012-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Memory Training in Patients With Amnestic Mild Cognitive Impairment|Episodic Memory Training for Face Name Association in Patients With Amnestic Mild Cognitive Impairment: Cognitive Measures and Functional Resonance Magnetic Imaging Outcomes|Completed||N/A|30|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 01:07:35.088404|2017-10-11 01:07:35.088404
NCT01978340|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-07-17|||November 2013||2013-11-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|February 2014|Anticipated|2014-02-01|1 Day|Observational [Patient Registry]|||Eval EarlySense Bet Lowenstein Sleeplab|Evaluation of EarlySense - a Contact-less Heart and Respiration Rate Monitor in Hospitalized Patients|Withdrawn||N/A|0|Actual|EarlySense Ltd.|||1||f||||f||||||None Retained|"     no Biospeciments will be taken.   "|||2017-10-11 01:07:35.235633|2017-10-11 01:07:35.235633
NCT01978327|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-06-07|||November 22, 2013|Actual|2013-11-22|June 2017|2017-06-01|March 3, 2014|Actual|2014-03-03|March 3, 2014|Actual|2014-03-03||Interventional|||GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers|Single-blind, Randomised, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of GSK2647544 and Its Potential Pharmacokinetic Interaction With Simvastatin in Healthy Volunteers|Terminated||Phase 1|12|Actual|GlaxoSmithKline||4||"Given the strength of CYP3A4 inhibition observed in Cohort 1, there is no rationale to   investigate higher doses of GSK2647544 in the following two cohorts"|f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:07:35.34447|2017-10-11 01:07:35.34447
NCT01978301|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-05-12|||April 15, 2014|Actual|2014-04-15|May 2017|2017-05-01|February 5, 2015|Actual|2015-02-05|February 5, 2015|Actual|2015-02-05||Interventional|||Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars|A Randomised Open Label Placebo Controlled Study to Evaluate Fractional Collagen Synthesis in Keloids and Identify Biomarkers of Keloid Biology for Potential Application in Future Clinical Trials|Terminated||Phase 1|9|Actual|GlaxoSmithKline||3||Temporary hold on recruitment during staff changes at the site|f||||f||||||||||2017-10-11 01:07:35.617708|2017-10-11 01:07:35.617708
NCT01978288|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-04-25|||January 2014||2014-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Microbial Influence on Airway Function and Inflammation|Microbial Influence on Airway Function and Inflammation|Recruiting||N/A|140|Anticipated|Indiana University|||3||f||||t||||||Samples With DNA|"     Nasal swabs, throat swabs, nasal fluid, blood, and stool specimens will be retained   "|No||2017-10-11 01:07:35.75077|2017-10-11 01:07:35.75077
NCT01978275|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2014-02-14|||April 2013||2013-04-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Stimulating Catheter for Lumbar Plexus|Are Stimulating Catheters More Efficacy for Lumbar Plexus Block Compared With Traditional Non-stimulating Ones? A Randomized, Prospective, Blinded, up and Down Study.|Completed||Phase 4|58|Actual|ASST Gaetano Pini-CTO||2|||f||||f||||||||||2017-10-11 01:07:35.867476|2017-10-11 01:07:35.867476
NCT01978262|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-07-07|||October 2013||2013-10-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Immune and Hormone Response to Influenza Vaccine|A Pilot Study of the Immune Response to Influenza Vaccination and Effect on Reproductive Hormones|Active, not recruiting||Phase 4|103|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||||2017-10-11 01:07:35.990325|2017-10-11 01:07:35.990325
NCT01978249|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-09-05|||September 2013||2013-09-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis||Terminated||Phase 3|19|Actual|Yonsei University||2||Because of the difficulties of participant enrollment.|f||||f||||||||||2017-10-11 01:07:36.119989|2017-10-11 01:07:36.119989
NCT01975103|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-05-01|||March 2013||2013-03-01|May 2017|2017-05-01||||April 2018|Anticipated|2018-04-01||Interventional|EPM||Endpoint Management Software for Photothermal Stimulation of Macular Diseases|Phase 2 Study of Endpoint Management Software for Photothermal Stimulation of Macular Diseases|Recruiting||Phase 2|20|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 01:08:47.555384|2017-10-11 01:08:47.555384
NCT01978236|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-09-23|||April 8, 2014||2014-04-08|September 2017|2017-09-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|||Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites|An Open-Label, Multicentre, Corollary Study of Pre-Operative Therapy With Dabrafenib and the Combination of Dabrafenib With Trametinib in Subjects With BRAF Mutation-Positive Metastatic Melanoma to the Brain|Completed||Phase 2|30|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:07:36.242428|2017-10-11 01:07:36.242428
NCT01978223|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-03-06|||December 2014||2014-12-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis|Case-control Study to Evaluate the Vaccine Effectiveness of RotarixTM Against Rotavirus Severe Gastroenteritis Among Hospitalised Children Aged 12 Weeks to < 5 Years, in Venezuela|Withdrawn||N/A|0|Actual|GlaxoSmithKline|||2|"As vaccine coverage rates have drastically improved in Venezuela, the study lost its objective   to show positive impact of the vaccine to stimulate higher usage"|f||||||||||Samples Without DNA|"     Stool sample   "|||2017-10-11 01:07:36.378662|2017-10-11 01:07:36.378662
NCT01978210|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-02-23|||September 2013||2013-09-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism|Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism|Completed||N/A|31|Actual|University of Rochester||2|||f||||f|f|f||||||Yes|Investigators can contact the responsible party to obtain de-identified data.|2017-10-11 01:07:36.937196|2017-10-11 01:07:36.937196
NCT01978184|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-12-23|||November 2013||2013-11-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine|Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine|Recruiting||Phase 2|60|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:07:37.069981|2017-10-11 01:07:37.069981
NCT01978158|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-05-19|||October 2013||2013-10-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α|Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α. A Pilot Proof of Principle Study|Completed||Phase 1/Phase 2|30|Actual|Radboud University||3|||f||||t||||||||||2017-10-11 01:07:37.341557|2017-10-11 01:07:37.341557
NCT01978145|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-07-18|2015-12-03||November 14, 2013|Actual|2013-11-14|July 2017|2017-07-01|April 16, 2015|Actual|2015-04-16|April 16, 2015|Actual|2015-04-16||Interventional|||A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised Multi-Centre, Double-Blind, Double-Dummy, Two Way Cross-Over, Twelve Weeks Non-inferiority Study to Evaluate The Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol 250/50 mcg Twice Daily Delivered Through a Capsule-Based Inhaler and a Multi-Dose Inhaler for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|665|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:07:37.519596|2017-10-11 01:07:37.519596
NCT01978119|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-04-25|2015-09-10||November 6, 2013|Actual|2013-11-06|April 2017|2017-04-01|January 28, 2015|Actual|2015-01-28|January 28, 2015|Actual|2015-01-28||Interventional|||A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma|A Randomised, Multi-Centre, Double-Blind, Double-Dummy, Two Way Cross-Over, Twelve Weeks Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol 250/50 mcg Twice Daily Delivered Through a Capsule-Based Inhaler and a Multi-Dose Inhaler in Adults and Adolescents With Asthma|Completed||Phase 3|124|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:07:38.286923|2017-10-11 01:07:38.286923
NCT01978106|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-06|||January 2013||2013-01-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Comparisons of the Astigmatic Power of Toric Intraocular Lens Using Three Toric Calculators: AcrySof, TECNIS, and iTrace Toric Calculator||Completed||N/A|100|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 01:07:38.994205|2017-10-11 01:07:38.994205
NCT01978067|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-02-26|||January 2013||2013-01-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|PCSD||Quality of Life and Sexual Function of Vaginal Operation in The Treatment Of Previous Cesarean Scar Defect|Safety ,Validity and Quality of (Sexual)Life of Vaginal Operation in The Treatment Of Previous Cesarean Scar Defect|Unknown status|Recruiting|N/A|60|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||||||2017-10-11 01:07:39.401679|2017-10-11 01:07:39.401679
NCT01978054|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-06-22|||September 2013||2013-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Disseminating Public Health Evidence to Support State Health Department Prevention of Cancer and Other Chronic Diseases|Disseminating Evidence-Based Interventions to Control Cancer|Active, not recruiting||N/A|960|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 01:07:39.530068|2017-10-11 01:07:39.530068
NCT01978041|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-05-26|||January 2013||2013-01-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Fluoride Bioavailability After Ingestion of Water or Foods Prepared With Fluoridated Water|Fluoride Bioavailability in Plasma and Saliva After Ingestion of Water or Foods Prepared With Fluoridated Water|Completed||Phase 1|20|Actual|University of Campinas, Brazil||6|||f||||f||||||||||2017-10-11 01:07:39.653644|2017-10-11 01:07:39.653644
NCT01978028|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-10-25|||October 2013||2013-10-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose|Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose|Recruiting||Phase 4|20|Anticipated|University of Zurich||2|||f||||f||||||||No||2017-10-11 01:07:39.806264|2017-10-11 01:07:39.806264
NCT01978015|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-10-31|||October 2011||2011-10-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Interventional|||Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG|Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With Primary Open Angle Glaucoma|Completed||Phase 4|69|Actual|University of Campinas, Brazil||4|||f||||t||||||||||2017-10-11 01:07:39.912095|2017-10-11 01:07:39.912095
NCT01978002|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-04-11|||November 2011||2011-11-01|April 2016|2016-04-01||||August 2014|Actual|2014-08-01||Observational|||Sensory Sensitivity and Urinary Symptoms in the Female Population||Completed||N/A|26|Anticipated|University of Michigan|||2||f||||f||||||||||2017-10-11 01:07:40.03752|2017-10-11 01:07:40.03752
NCT01977989|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-06|||October 2013||2013-10-01|October 2013|2013-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Vancomycin in Spine Surgery|Randomized Control Trial of Vancomycin Powder Following Posterior Instrumented Spinal Surgery for Trauma|Unknown status|Enrolling by invitation|Phase 4|140|Anticipated|University of Tennessee||2|||f||||t||||||||||2017-10-11 01:07:40.126842|2017-10-11 01:07:40.126842
NCT01977976|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-12-02|||April 2011||2011-04-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||RCT on the Effect of Endometrial Injury on Ongoing Pregnancy Rate in Subfertile Women Undergoing IVF|A Randomized Controlled Trial on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing in Vitro Fertilization Treatment|Completed||N/A|300|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 01:07:40.246061|2017-10-11 01:07:40.246061
NCT01977963|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-06|||April 2012||2012-04-01|October 2013|2013-10-01||||January 2022|Anticipated|2022-01-01||Observational|||Genetic Study of Antithyroid Drugs Associated Agranulocytosis|Genetic Study of Antithyroid Drugs Associated Agranulocytosis|Recruiting||N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:07:40.345059|2017-10-11 01:07:40.345059
NCT01977950|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-01-12|||September 2011||2011-09-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|NUTRIELD||Nutritional Risk and Nutritional Care Practices in the Hospitalized Elderly|Nutritional Status and Care of Elderly People|Completed||N/A|508|Actual|Oslo and Akershus University College of Applied Sciences|||1||f||||t||||||||||2017-10-11 01:07:40.456815|2017-10-11 01:07:40.456815
NCT01977937|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-04-30|||November 2013||2013-11-01|September 2016|2016-09-01|September 29, 2017|Anticipated|2017-09-29|June 2017|Anticipated|2017-06-01||Interventional|||Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin|Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin on Post-operative Opioid Use and Patient Satisfaction|Recruiting||Phase 4|50|Anticipated|Oregon Health and Science University||2|||f||||t||||||||Undecided||2017-10-11 01:07:40.56155|2017-10-11 01:07:40.56155
NCT01977924|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-12|||November 2013||2013-11-01|November 2013|2013-11-01||||May 2015|Anticipated|2015-05-01||Interventional|PolySAS||Impact of Polyphenols on Endothelial Function in Obstructive Sleep Apnea|Impact of Polyphenols on Endothelial Function in Obstructive Sleep Apnea: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-11 01:07:40.691186|2017-10-11 01:07:40.691186
NCT01977911|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-11-25|||August 2015||2015-08-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|RegenVOX||Clinical Trial of Stem Cell Based Tissue Engineered Laryngeal Implants|Phase I/IIa Clinical Trial of Stem Cell Based Tissue Engineered Partial Laryngeal Implants in 10 Adult Patients With End-stage Laryngeal Stenosis With 24 Months Follow-up.|Recruiting||Phase 1/Phase 2|10|Anticipated|University College, London||1|||f||||t||||||||||2017-10-11 01:07:40.7838|2017-10-11 01:07:40.7838
NCT01977898|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-01-17|||November 2011||2011-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Incidence of Headache Following an Unintentional Dural Puncture|Incidence of Post-Dural Puncture Headache Following Unintentional Dural Puncture: A Randomized Trial of Intrathecal Morphine Versus Saline|Recruiting||N/A|170|Anticipated|Northwestern University||2|||f||||f||||||||No||2017-10-11 01:07:40.895859|2017-10-11 01:07:40.895859
NCT01977885|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-09-24|||June 2013||2013-06-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|DIVAS2||Exercise-Induced Epigenetic Modifications in Obese Aging Women||Completed||N/A|21|Actual|University of Georgia||1|||f||||f||||||||||2017-10-11 01:07:41.025399|2017-10-11 01:07:41.025399
NCT01977872|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2014-12-29|||June 2012||2012-06-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||JointADventure: A Worksite Activity-Diet Intervention for Chronic Knee Pain|JointADventure: A Worksite Activity-Diet Intervention for Chronic Knee Pain|Completed||N/A|38|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 01:07:41.125681|2017-10-11 01:07:41.125681
NCT01977846|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-09-14|||August 2013||2013-08-01|October 2015|2015-10-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|ProgSTAR||A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies|Natural History of Progression of Atrophy Secondary to Stargardt Disease: Retrospective, and Prospective Longitudinal Observational Study Incl. Ancillary SMART Study- Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease|Completed||N/A|259|Actual|Foundation Fighting Blindness Clinical Research Institute|||1||f||||f||||||||||2017-10-11 01:07:41.35727|2017-10-11 01:07:41.35727
NCT01977833|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-06|||October 2013||2013-10-01|October 2013|2013-10-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|GLP-1inT2D||Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes|Effects of Meal Timing on Postprandial Glucose, Insulin and GLP-1 Responses After Breakfast Lunch and Dinner in Patients With Type 2 Diabetes|Unknown status|Recruiting|N/A|30|Anticipated|Tel Aviv University||2|||f||||f||||||||||2017-10-11 01:07:41.458513|2017-10-11 01:07:41.458513
NCT01977820|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-01-14|2015-09-21||February 2014||2014-02-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|SIGNAL|Baseline analysis population included all the subjects randomized into 24-Week study period and received least 1 dose of study drug.|Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria|A Multicenter, Double-Blind, Placebo-Controlled, Randomized, 2-Arm Phase IIa Pilot Trial Assessing the Effect of Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria|Terminated||Phase 2|2|Actual|Merck KGaA|The study was prematurely discontinued by the Sponsor due to severe enrolment difficulties as a consequence of the limited availability of treatment naïve patients with a diagnosis of phenyl ketonuria.|2||Recruitment challenges|f||||||||||||||2017-10-11 01:07:41.5756|2017-10-11 01:07:41.5756
NCT01977807|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2015-05-19|||August 2014||2014-08-01|May 2015|2015-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIK||Unknown status|Recruiting|Phase 4|100|Anticipated|Technolas Perfect Vision GmbH||2|||f||||f||||||||||2017-10-11 01:07:41.907293|2017-10-11 01:07:41.907293
NCT01977794|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-01-12|2016-07-04||March 2014||2014-03-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||MITT analysis set was defined as all randomized and treated subjects with at least 1 SBP measurement after the date of first dose of investigational medicinal product (IMP).|Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension|A Randomized, Comparative Trial of Concor AM, a Fixed Dose Combination of Bisoprolol and Amlodipine, on the Treatment of Essential Hypertensive Patients Whose Blood Pressure is Not Well Controlled by Monotherapy of Bisoprolol 5mg or Amlodipine 5mg|Completed||Phase 3|200|Actual|Merck KGaA||2|||f||||t||||||||||2017-10-11 01:07:42.022603|2017-10-11 01:07:42.022603
NCT01977781|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-05-02|2016-10-31||December 2013||2013-12-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease|Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease|Completed||Phase 1|40|Actual|Massachusetts Eye and Ear Infirmary|This study was limited by the lack of a placebo arm, which in many dry-eye trials is characterized by a topical lubricant; however, we believe that given the disease severity among patients in this trial, inclusion of a placebo was not ethical.|2|||f||||f||||||||Yes||2017-10-11 01:07:42.411705|2017-10-11 01:07:42.411705
NCT01977768|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-05-28|||March 2015|Actual|2015-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|imm03||TB Immunotherapy Trial With Heat-killed M. Vaccae|Phase III and Dose Ranging Trial of Heat-killed M. Vaccae (V7)|Enrolling by invitation||Phase 3|440|Anticipated|Lisichansk Regional Tuberculosis Dispensary||2|||f||||f||||||||||2017-10-11 01:07:42.773586|2017-10-11 01:07:42.773586
NCT01977755|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-01-14|||November 2013||2013-11-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Interventional|||Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction|A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess Clinical Efficacy and Safety of Danegaptide in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Completed||Phase 2|591|Actual|Zealand Pharma||3|||f||||t||||||||||2017-10-11 01:07:42.872198|2017-10-11 01:07:42.872198
NCT01977742|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-06|||May 2011||2011-05-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|December 2012|Actual|2012-12-01||Interventional|||Rest-exercise Transition Training to Improve Cardiac Vagal Tone|A Sudden Rest-exercise Transition Training to Improve Cardiac Vagal Tone|Completed||N/A|50|Actual|Clínica de Medicina do Exercício||2|||f||||f||||||||||2017-10-11 01:07:42.964101|2017-10-11 01:07:42.964101
NCT01977729|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-04-13|2016-03-14||October 2013||2013-10-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Sequencing CBT for Child Anxiety: CBT Plus Sertraline Versus Switch to Sertraline|Sequencing CBT for Child Anxiety: CBT Plus Sertraline Versus Switch to Sertraline|Terminated||Phase 2|1|Actual|Yale University||2||funding|f||||f||||||||||2017-10-11 01:07:43.053719|2017-10-11 01:07:43.053719
NCT01977716|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2013-11-21|||December 2013||2013-12-01|October 2013|2013-10-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Peritonitis and Loss of Residual Renal Function, Technique Failure and Mortality in Peritoneal Dialysis Patients|The Role of Peritonitis in the Loss of Residual Renal Function, Technique Failure and Mortality in Peritoneal Dialysis Patients|Unknown status|Not yet recruiting|N/A|350|Anticipated|Coordinación de Investigación en Salud, Mexico|||1||f||||t||||||||||2017-10-11 01:07:43.252113|2017-10-11 01:07:43.252113
NCT01977703|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-08-13|||October 2013||2013-10-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).|Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).|Completed||N/A|80|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 01:07:43.47187|2017-10-11 01:07:43.47187
NCT01977677|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-07-25|||November 2014||2014-11-01|July 2017|2017-07-01|November 2022|Anticipated|2022-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma|A Phase I/II Study of Local Field Irradiation and Temozolomide Followed by Continuous Infusion Plerixafor as an Upfront Therapy for Newly Diagnosed Glioblastoma GBM|Active, not recruiting||Phase 1/Phase 2|30|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 01:07:43.82187|2017-10-11 01:07:43.82187
NCT01977664|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-11-06|||March 2012||2012-03-01|October 2013|2013-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||In Vitro Maturation Induction of Oocytes From a Woman With Syndrome of Repeated Oocyte Maturation Failure in Vitro|The Factors Primarily Intrinsic to the Oocyte Are Responsible to the Oocyte Maturation Defective: a Case Report.|Completed||N/A|1|Actual|The Second Affiliated Hospital of Kunming Medical University|||1||f||||t||||||||||2017-10-11 01:07:43.953154|2017-10-11 01:07:43.953154
NCT01977651|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2017-07-24|||September 24, 2013|Actual|2013-09-24|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|February 1, 2016|Actual|2016-02-01||Interventional|UPWARD||A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide|A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Enzalutamide Who Are at Potential Increased Risk of Seizure|Active, not recruiting||Phase 4|424|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-10-11 01:07:44.067632|2017-10-11 01:07:44.067632
NCT01977638|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2016-10-16|||November 2013||2013-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase 1 Trial of CXD101 in Patients With Advanced Cancer|Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CXD101 Given Orally (Twice Daily Dosing for 5 Consecutive Days in a 21-day Period) in Patients With Advanced Malignancies Expressing the Biomarker HR23B|Recruiting||Phase 1|40|Anticipated|Oxford University Hospitals NHS Trust||1|||f||||f||||||||No||2017-10-11 01:07:44.373987|2017-10-11 01:07:44.373987
NCT01977625|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-07-31|2016-09-08||December 2011||2011-12-01|July 2017|2017-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Of the 18 participants who were recruited, they all were deemed eligible based on the criteria for the parent study NCT01324024. In addition, they must have been deemed eligible to undergo a functional brain imaging scan. Analysis of the participants presented below is indicative of the 14 participants who successfully completed all 3 scans.|LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women|Utilizing fMRI to Determine the Effects of Vyvanse® on Memory, Attention, and Brain Activity in Menopausal Women|Completed||Phase 4|18|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:07:44.490117|2017-10-11 01:07:44.490117
NCT01977612|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-07-26|2017-05-25||May 15, 2013|Actual|2013-05-15|July 2017|2017-07-01|June 30, 2016|Actual|2016-06-30|June 17, 2016|Actual|2016-06-17||Interventional|||Randomized Clinical Trial of Skin Closure With Staples Versus Suture|Randomized Controlled Phase IIB Trial Evaluating Wound Complication Rate After Skin Closure With Staples Versus Subcuticular Suture in Patients With BMI >=30|Completed||Phase 2|173|Actual|Washington University School of Medicine||2|||f||||t|f|t|f|f|f|||||2017-10-11 01:07:44.830016|2017-10-11 01:07:44.830016
NCT01977599|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-01-26|||November 2012||2012-11-01|October 2013|2013-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Are Text Message Reminders an Effective Intervention for Improving the Uptake of Breast Screening?|A Randomised Controlled Trial Investigating the Efficacy and Effectiveness of Text Message Reminders to Improve Uptake of Breast Screening by Prevalent Women Living in the London Borough of Hillingdon|Completed||N/A|2454|Actual|Imperial College Healthcare NHS Trust||2|||f||||||||||||||2017-10-11 01:07:45.611007|2017-10-11 01:07:45.611007
NCT01977586|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-11-20|||April 2014||2014-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Functional Imaging in the Assessment of mRCC Response to Sunitinib|Pilot Study to Evaluate the Feasibility of Functional MRI in Metastatic Renal Cell Carcinoma (mRCC) With Test--retest Repeatability and Early Response Assessment|Withdrawn||N/A|0|Actual|Imperial College Healthcare NHS Trust||1||Difficulty in recruiting suitable patients at centre|f||||f||||||||||2017-10-11 01:07:45.693145|2017-10-11 01:07:45.693145
NCT01977573|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-08-21|2016-01-11||October 1, 2013||2013-10-01|August 2017|2017-08-01|May 14, 2015|Actual|2015-05-14|May 1, 2015|Actual|2015-05-01||Interventional||252 participants were randomized however the Baseline measurements are provided for the Intent-to-Treat (ITT) population (235 participants), which consisted of all randomized participants who received at least one dose of study drug, had a Baseline and at least one corresponding on-treatment assessment.|A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)|A 24-week, Phase IIB, Randomized, Controlled, Parallel Group, Multi-center Study to Evaluate the Safety and Efficacy of GSK1278863 in Subjects With Anemia Associated With Chronic Kidney Diseases Who Are Not on Dialysis.|Completed||Phase 2|252|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 01:07:45.840023|2017-10-11 01:07:45.840023
NCT01977560|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-04-24|||October 2013|Actual|2013-10-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|LID||Diet and Exercise Intervention in Type 2 Diabetes|Diet and Exercise Intervention in Type 2 Diabetes|Completed||N/A|18|Actual|Washington University School of Medicine||2|||f||||t|f|f||||||||2017-10-11 01:07:50.022981|2017-10-11 01:07:50.022981
NCT01977547|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-04-19|||January 2014||2014-01-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|ABC PICU||Age of Blood in Children in Pediatric Intensive Care Units|Age of Blood in Children in Pediatric Intensive Care Units|Recruiting||Phase 3|1538|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:07:50.12113|2017-10-11 01:07:50.12113
NCT01977534|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-06-20|||January 2014||2014-01-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01|3 Years|Observational [Patient Registry]|ABSORB UK||To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels|A Post-market Registry of Patients With de Novo Lesions in Previously Untreated Vessels Treated With Absorb BVS|Active, not recruiting||N/A|1005|Actual|Abbott Vascular|||1||f||||t||||||||||2017-10-11 01:07:50.521862|2017-10-11 01:07:50.521862
NCT01977521|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-05-02|||April 2014||2014-04-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|tDCS||Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations|Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations A Sham-controlled Trial|Recruiting||N/A|62|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-11 01:07:50.717986|2017-10-11 01:07:50.717986
NCT01977508|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-05-19|||August 2013||2013-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01|1 Year|Observational [Patient Registry]|||The Vascutek Rapidax™ II Post Market Surveillance Registry|The Vascutek Rapidax™ II Post Market Surveillance Registry|Terminated||N/A|24|Actual|Vascutek Ltd.|||1||f||||f||||||||||2017-10-11 01:07:50.854737|2017-10-11 01:07:50.854737
NCT01977495|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-12-07|||December 2013||2013-12-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Take Charge of Your Diabetes|Testing Enrollment Methods on Participation in Behavioral Economic Interventions for Diabetes Care: A Randomized Controlled Pilot Study|Completed||N/A|136|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:07:50.994735|2017-10-11 01:07:50.994735
NCT01977482|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-03-27|2016-12-08|2015-06-11|November 1, 2013||2013-11-01|March 2017|2017-03-01|February 1, 2015|Actual|2015-02-01|February 1, 2015|Actual|2015-02-01||Interventional|||Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia|A Phase IIB, Randomized, Blinded, Dose-ranging, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Dose Response Relationship of GSK1278863 Over the First 4 Weeks of Treatment and Evaluate the Safety and Efficacy of GSK1278863 Over 24 Weeks in Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Switch From Recombinant Human Erythropoietin|Completed||Phase 2|216|Actual|GlaxoSmithKline||6|||f||||t||||||||||2017-10-11 01:07:51.212464|2017-10-11 01:07:51.212464
NCT01977456|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-12-16|2015-10-23||September 2013||2013-09-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|CLEAR-FDR||Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)|Phase 2 The Combined Approach to Lysis Utilizing Eptifibatide and Rt-PA in Acute Ischemic Stroke-Full Dose Regimen(CLEAR-FDR)|Completed||Phase 2|27|Actual|University of Cincinnati|Small sample size and open design. Did not include endovascular therapy patients.|1|||f||||t||||||||||2017-10-11 01:07:55.264208|2017-10-11 01:07:55.264208
NCT01977443|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-31|2016-11-01|||November 2013||2013-11-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)|Evaluation of the Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Acute Phase Adenoviral-Induced Epidemic Keratoconjunctivitis (EKC). A Randomised, Double-Masked, Placebo-Controlled, Multi-Centre Proof-of-Concept Study|Completed||Phase 2|47|Actual|Adenovir Pharma AB||2|||f||||t||||||||||2017-10-11 01:07:55.54623|2017-10-11 01:07:55.54623
NCT01977430|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-11-30|||November 2013||2013-11-01|March 2014|2014-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|RRF||Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function|Randomized Open Clinical Trial to Compare the Effectiveness of the Administration of Diuretics in Hemodialysis Patients With Residual Renal Function in Single Centre|Unknown status|Recruiting|Phase 4|36|Anticipated|Corporacion Parc Tauli||2|||f||||t||||||||||2017-10-11 01:07:55.726272|2017-10-11 01:07:55.726272
NCT01977417|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-03-27|||November 2012||2012-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|INCITE||Inflammation Inhibition in Prediabetic Humans|Inflammation Inhibition for Microvascular and Autonomic Dysfunction in Obese Prediabetic Humans|Active, not recruiting||Phase 2|21|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 01:07:55.831446|2017-10-11 01:07:55.831446
NCT01977404|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-10-30|||November 2013||2013-11-01|October 2013|2013-10-01||||December 2014|Anticipated|2014-12-01||Observational|||Nutritional Evaluation of Patients With Congestive Heart Failure|Nutritional Evaluation of Patients With Congestive Heart Failure|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||||||2017-10-11 01:07:55.967702|2017-10-11 01:07:55.967702
NCT01977391|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-06|||August 1999||1999-08-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|December 2002|Actual|2002-12-01|10 Years|Observational [Patient Registry]|||Association Between Mortality and Diabetes in Elderly Koreans: the South-West Seoul (SWS) Study||Completed||N/A|2263|Actual|Korea University|||1||f||||t||||||||||2017-10-11 01:07:56.074513|2017-10-11 01:07:56.074513
NCT01977378|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-10-30|||October 2013||2013-10-01|October 2013|2013-10-01||||September 2014|Anticipated|2014-09-01||Interventional|||A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder|A Double-Blind,Venlafaxine-Controlled Study of Efficacy and Safety of Sustained-Release Desvenlafaxine Hydrochloride in the Treatment of Major Depressive Disorder|Unknown status|Recruiting|Phase 2/Phase 3|300|Anticipated|Jiangsu Hansoh Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:07:56.168096|2017-10-11 01:07:56.168096
NCT01977365|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-05|||February 2009||2009-02-01|October 2013|2013-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|LUCOMAI||Effectiveness of Child Centered Counseling on Child Nutrition Status|Effectiveness of Child Centered Counseling on Child Nutrition Status. A Cluster Randomized Trial in Rural Burkina Faso.|Completed||N/A|2341|Actual|Institut de Recherche en Sciences de la Sante, Burkina Faso||2|||f||||t||||||||||2017-10-11 01:07:56.29635|2017-10-11 01:07:56.29635
NCT01977339|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-04-19|||May 2015||2015-05-01|April 2017|2017-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty|A Randomized, Double-Blinded, Control Trial to Evaluate the Efficacy of Single Injection Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia in Subjects Undergoing Unilateral Total Knee Arthroplasty|Withdrawn||Phase 4|0|Actual|St. Luke's-Roosevelt Hospital Center||2||New departmental administration, loss of key study faculty|f||||f||||||||||2017-10-11 01:07:56.514972|2017-10-11 01:07:56.514972
NCT01977326|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-10-27|||October 2013||2013-10-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|AFFIRM-SA||Task Sharing Counseling Intervention by Community Health Workers for Prenatal Depression in South Africa|The Effectiveness and Cost-effectiveness of a Task Sharing Counseling Intervention by Community Health Workers for Prenatal Depression in South Africa|Completed||N/A|4205|Actual|University of Cape Town||2|||f||||t||||||||||2017-10-11 01:07:56.62024|2017-10-11 01:07:56.62024
NCT01977313|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-09-24|||September 2013||2013-09-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|CAG-Libido||Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women|Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women|Completed||N/A|45|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||Samples With DNA|"     Whole blood, serum   "|||2017-10-11 01:07:56.803231|2017-10-11 01:07:56.803231
NCT01977300|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-11-19|||January 2003||2003-01-01|October 2013|2013-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode|Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode|Completed||Phase 3|159|Actual|University of British Columbia||3|||f||||t||||||||||2017-10-11 01:07:56.923901|2017-10-11 01:07:56.923901
NCT01977287|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-04-01|||June 2011||2011-06-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Walking With FES or AFO in People With MS With Foot Drop|A Pilot Study to Assess the Effects of Using FES or AFO as an Assistive Mobility for Period of 12 Weeks for People With Multiple Sclerosis With Foot Drop|Completed||N/A|18|Actual|Queen Margaret University|||2||f||||f||||||||||2017-10-11 01:07:57.057155|2017-10-11 01:07:57.057155
NCT01977274|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-06-12|||December 2013||2013-12-01|June 2017|2017-06-01|December 2028|Anticipated|2028-12-01|December 2018|Anticipated|2018-12-01||Interventional|GC-BIO||Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010|Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010|Recruiting||N/A|300|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-11 01:07:57.1796|2017-10-11 01:07:57.1796
NCT01977261|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-10-30|||January 2001||2001-01-01|October 2013|2013-10-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|HTO||High Tibial Osteotomy for Osteoarthritis of the Knee|High Tibial Osteotomy for Osteoarthritis of the Knee: a Randomised Controlled Trial|Completed||N/A|92|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 01:07:57.888728|2017-10-11 01:07:57.888728
NCT01977248|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-02-03|||October 2013||2013-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SMART||Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12|Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12|Completed||N/A|37|Actual|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-11 01:07:58.01066|2017-10-11 01:07:58.01066
NCT01977235|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-03-31|||September 2013||2013-09-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|February 2017|Anticipated|2017-02-01||Interventional|TDICC||Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer|An Open, Randomized, Parallel Control, Multiple-center Phase II Trial of Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer|Recruiting||Phase 2|110|Anticipated|Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:07:58.115849|2017-10-11 01:07:58.115849
NCT01977209|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2013-10-30|||September 2013||2013-09-01|October 2013|2013-10-01|September 2016|Anticipated|2016-09-01|February 2016|Anticipated|2016-02-01||Interventional|GTCA||Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression|A Randomized, Double Blind, Placebo-controlled Multiple-center Phase III Trial of Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression|Unknown status|Recruiting|Phase 3|204|Anticipated|Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:07:58.368016|2017-10-11 01:07:58.368016
NCT01977196|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-05|||April 2011||2011-04-01|October 2013|2013-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)|Phase 1 of DTP/Hepatitis B 10ug Hib Vaccine|Completed||Phase 1|30|Actual|PT Bio Farma||1|||f||||t||||||||||2017-10-11 01:07:58.803382|2017-10-11 01:07:58.803382
NCT01977183|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2015-07-17|||September 2013||2013-09-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Effects of MSPrebiotic on Gut Health in the Elderly|Effects of MSPrebiotic on Gut Health in the Elderly|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|St. Boniface General Hospital Research Centre||4|||f||||t||||||||||2017-10-11 01:07:58.934095|2017-10-11 01:07:58.934095
NCT01977170|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-11-05|||November 2010||2010-11-01|October 2013|2013-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety of Hib Vaccine (Bio Farma)|Phase 1 Study of Hib Vaccine (Bio Farma)|Completed||Phase 1|25|Actual|PT Bio Farma||1|||f||||t||||||||||2017-10-11 01:07:59.05918|2017-10-11 01:07:59.05918
NCT01977157|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-30|||July 2012||2012-07-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2012|Actual|2012-10-01||Observational|AlkBIS||Alcohol Detection Via Bioimpedance Mesurements|Alcohol Detection Via Bioimpedance Mesurements|Completed||N/A|12|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 01:07:59.144282|2017-10-11 01:07:59.144282
NCT01977144|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-09-27|||September 2013||2013-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|Solaire||Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency|Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency|Recruiting||N/A|400|Anticipated|Reproductive Medicine Associates of New Jersey||2|||f||||f||||||||||2017-10-11 01:07:59.228291|2017-10-11 01:07:59.228291
NCT01977131|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-20|||June 2010||2010-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis|Phase 1 Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis|Completed||Phase 1/Phase 2|10|Actual|Guangzhou Municipal Twelfth People's Hospital||1|||f||||t||||||||||2017-10-11 01:07:59.318763|2017-10-11 01:07:59.318763
NCT01977118|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-07-05|||May 2013||2013-05-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Use of Streptokinase for Enhancement of Percutaneous Drainage of Pancreatic Necrosis|Phase 2/3 Study of Use of Streptokinase for Enhancement of Percutaneous Drainage of Pancreatic Necrosis|Completed||Phase 2/Phase 3|28|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 01:07:59.380709|2017-10-11 01:07:59.380709
NCT01977105|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-02-04|||September 2013||2013-09-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Healthy Growth Abbreviated Pilot Study|Abbreviated Pilot Trial of a Peer-Based Social Media Intervention to Promote Healthy Growth During Infancy|Completed||N/A|9|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-11 01:07:59.486223|2017-10-11 01:07:59.486223
NCT01977092|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-09-22|||January 2014|Actual|2014-01-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Reducing Offenders' HIV Risk: MI Enhanced Case Management With Drug-Free Housing|Reducing Offenders' HIV Risk: MI Enhanced Case Management With Drug-Free Housing|Completed||N/A|330|Actual|Public Health Institute, California||2|||f||||t||||||||||2017-10-11 01:07:59.572627|2017-10-11 01:07:59.572627
NCT01977079|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-01-10|||December 2013||2013-12-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|MAPPRO||Procalcitonin and Threatened Premature Delivery|Procalcitonin and Threatened Premature Delivery|Terminated||N/A|131|Actual|Centre Hospitalier Departemental Vendee||2|||f||||f||||||||||2017-10-11 01:07:59.750732|2017-10-11 01:07:59.750732
NCT01977066|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-02-24|||November 2013||2013-11-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|SUPPORT||Exercise Intervention Study for Pancreatic Cancer Patients|SUPPORT - Study Supervised Progressive Resistance Training for Pancreatic Cancer Patients: a Randomized Controlled Intervention Trial|Completed||N/A|65|Actual|German Cancer Research Center||3|||f||||t||||||||||2017-10-11 01:07:59.835409|2017-10-11 01:07:59.835409
NCT01977053|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-02-02|||September 2013||2013-09-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|EMOTION||Impact of a Telephonic Monitoring During Inter-treatment Intervals on Emotional State, Quality of Life and Toxicities, on Neo Adjuvant or Adjuvant Chemotherapy-treated Patients|Impact of a Telephonic Monitoring During Neo Adjuvant or Adjuvant Chemotherapy|Recruiting||N/A|280|Anticipated|Centre Antoine Lacassagne||2|||f||||f||||||||||2017-10-11 01:07:59.937418|2017-10-11 01:07:59.937418
NCT01977040|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-03-11|||January 2014||2014-01-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|VasaPrevia||Optimal Management of Vasa Previa Study - A Retrospective Study|Optimal Management of Vasa Previa: Screening, Diagnosis and Management - A Retrospective Study.|Completed||N/A|72|Actual|Mednax Center for Research, Education and Quality|||1||f||||f||||||||Undecided|undecided|2017-10-11 01:08:00.068631|2017-10-11 01:08:00.068631
NCT01977014|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-07-05|||October 2013||2013-10-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|4 Months|Observational [Patient Registry]|||NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up|NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up|Completed||N/A|40|Actual|NordicInfu Care AB|||1||f||||t||||||||||2017-10-11 01:08:01.298125|2017-10-11 01:08:01.298125
NCT01977001|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-10-23|||November 2012||2012-11-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Use of MigraineBoxTM Head and Neck Cooling Bath for Treatment of Primary Headache in the Emergency Department|Use of MigraineBoxTM Head and Neck Cooling Bath for Treatment of Primary Headache in the Emergency Department|Completed||N/A|29|Actual|Minneapolis Medical Research Foundation|||1||f||||f||||||||||2017-10-11 01:08:01.415945|2017-10-11 01:08:01.415945
NCT01976988|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-08-21|2016-06-01||September 2013||2013-09-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery|PROSPECTIVE STUDY ON PREOPERATIVE VERSUS POSTOPERATIVE VENOUS THROMBOPROPHYLAXIS IN PATIENTS UNDERGOING MAJOR COLORECTAL SURGERY|Completed||Phase 3|410|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 01:08:01.55584|2017-10-11 01:08:01.55584
NCT01976975|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-09-13|||October 2013||2013-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Brain Mechanisms of Human Motivation|Multi Level Analysis of Positive Valence Systems Across Mood Disorders|Recruiting||N/A|192|Anticipated|Mclean Hospital|||2||f||||f||||||||Undecided||2017-10-11 01:08:02.557907|2017-10-11 01:08:02.557907
NCT01976962|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-05-27||||||May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer|Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer|Not yet recruiting||Phase 1|77|Anticipated|CancerCare Manitoba||1|||f||||t||||||||||2017-10-11 01:08:02.680737|2017-10-11 01:08:02.680737
NCT01976949|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-05-21|||July 2009||2009-07-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of a Social-networking Intervention to Reduce Cancer-related Distress|Evaluation of a Social-networking Intervention to Reduce Cancer-related Distress|Completed||N/A|347|Actual|Loma Linda University||2|||f||||f||||||||||2017-10-11 01:08:02.790821|2017-10-11 01:08:02.790821
NCT01976936|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-07-20|||February 2009|Actual|2009-02-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|NeuSTART2||Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2|A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.|Completed||Phase 2|164|Actual|Columbia University||3|||f||||t|t|f||||||||2017-10-11 01:08:02.944268|2017-10-11 01:08:02.944268
NCT01976923|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-08-29|||November 2013||2013-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy|Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy: Results of the Pan-American Collaborative Retina Study (PACORES) Group|Active, not recruiting||Phase 3|374|Anticipated|King Khaled Eye Specialist Hospital||2|||f||||||||||||||2017-10-11 01:08:03.049245|2017-10-11 01:08:03.049245
NCT01976910|ClinicalTrials.gov processed this data on October 10, 2017|2013-11-05|2013-11-05|||September 2010||2010-09-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|DM-CHOC-PEN||"Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"|A Protocol for the Safety and Tolerance of Intravenous 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer|Completed||Phase 1|23|Actual|DEKK-TEC, Inc.||1|||f||||t||||||||||2017-10-11 01:08:03.149005|2017-10-11 01:08:03.149005
NCT01976897|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-03-25|||March 2014||2014-03-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|FlessCare||Effect of the Physiological Angular Position of the Resting Knee on Pressure at the Heel/Surface Interface|Effect of the Physiological Angular Position of the Resting Knee on Pressure at the Heel/Surface Interface|Completed||N/A|65|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 01:08:03.238184|2017-10-11 01:08:03.238184
NCT01976884|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-10-30|||June 2011||2011-06-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Expression and the Clinical Significance of Neutrophil PD-L1 During Sepsis||Completed||N/A|71|Actual|Changhai Hospital|||4||f||||t||||||Samples Without DNA|"     Peripheral blood sample was collected for detection of neutrophil PD-L1, monocyte HLA-DR and     lymphocyte PD-1.   "|||2017-10-11 01:08:03.332895|2017-10-11 01:08:03.332895
NCT01976871|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-10-13|2016-06-21||August 2014||2014-08-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|SWITCH||Switching From Oral Dopamine Agonists to Rotigotine|A Method to Switch From Oral Dopamine Agonists to Rotigotine in Patients With Restless Legs Syndrome|Completed||Phase 4|21|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:08:03.409917|2017-10-11 01:08:03.409917
NCT01976858|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-30|||June 2011||2011-06-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes|A Double-Blind, Multicenter, Randomized Study Evaluating the Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Relationship in T2DMs Treated With 8 Weeks Injection of Polyethylene Glycol Loxenatide|Completed||Phase 1|50|Actual|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||f||||||||||2017-10-11 01:08:03.945006|2017-10-11 01:08:03.945006
NCT01976845|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2016-02-17|2016-01-12||November 2013||2013-11-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy of Propofol or Midazolam Compare to Placebo for Preoperative Medication|Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Propofol or Midazolam Versus Placebo for Preoperative Medication in Patients Undergoing Elective Orthopedic Surgery|Completed||Phase 4|139|Actual|Cedars-Sinai Medical Center||3|||f||||f||||||||Yes||2017-10-11 01:08:04.055098|2017-10-11 01:08:04.055098
NCT01976832|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-09-01|||July 2014||2014-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Music-with-Movement Intervention for People With Early Dementia and Their Families|Music-with-Movement Intervention for People With Early Dementia and Their Families|Completed||N/A|95|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||No||2017-10-11 01:08:04.465423|2017-10-11 01:08:04.465423
NCT01976819|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-08-10|2017-01-30||October 2013||2013-10-01|August 2017|2017-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Clinical Assessment of New Speaking Valve With Heat and Moisture Exchanger (HME) for Tracheotomized Patients|Phase 2 Clinical Feasibility Study of a New Speaking Valve With a Heat- and Moisture Exchanger (TW) for Tracheotomized Patients.|Completed||N/A|16|Actual|Atos Medical AB|small sample size;|1|||f||||f||||||||||2017-10-11 01:08:04.586187|2017-10-11 01:08:04.586187
NCT01976806|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2014-02-23|2013-12-03||June 2009||2009-06-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|DAP|Includes all subjects that completed follow-up|The Effects of DHA on Periodontitis|The Effects of Docosahexaenoic Acid on Periodontitis in Adults: A Pilot Randomized Controlled Trial|Completed||Phase 2|55|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 01:08:04.839896|2017-10-11 01:08:04.839896
NCT01976793|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-11-12|||December 2013||2013-12-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|DIANA||Retrospective Observational Study DIANA Study|Retrospective Observational Study to Estimate the Duration of Initial Antidepressant Treatment in Patients With Recurrent Depressive Disorder Who Demonstrated a Suboptimal Response to Therapy: DIANA Study|Completed||N/A|450|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:08:05.670805|2017-10-11 01:08:05.670805
NCT01976780|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-10|||June 2013||2013-06-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy|In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy in Kisumu County, Western Kenya|Completed||Phase 4|118|Actual|Global Emerging Infections Surveillance and Response System||2|||f||||f||||||||Undecided||2017-10-11 01:08:05.800949|2017-10-11 01:08:05.800949
NCT01976767|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-01-13|||April 2011||2011-04-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Observational|||Longitudinal Assessment of Adults With Severe Asthma|Protocol for the European Multi-Centre Study Understanding Severe Asthma Longitudinal Assessment of Adults With Severe Asthma|Completed||N/A|725|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||4||f||||f||||||||||2017-10-11 01:08:05.966506|2017-10-11 01:08:05.966506
NCT01976754|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-30|||September 2013||2013-09-01|October 2013|2013-10-01|July 2015|Anticipated|2015-07-01|March 2015|Anticipated|2015-03-01||Interventional|||Safety Study of Dexmedetomidine in Septic Patients|The Effective Dose of Dexmedetomidine for Moderate Sedation of Adult Intubated Septic Patients in the ICU.|Unknown status|Recruiting|N/A|40|Anticipated|First Affiliated Hospital of Zhejiang University||1|||f||||t||||||||||2017-10-11 01:08:06.10042|2017-10-11 01:08:06.10042
NCT01976715|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-07-13|||October 25, 2013||2013-10-25|July 12, 2017|2017-07-12|September 1, 2023|Anticipated|2023-09-01|August 1, 2022|Anticipated|2022-08-01||Observational|||Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy|Characterization and Management of Patients With HIV-1 Infection Who Experience Virologic Failure Despite Combination Antiretroviral Therapy|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:08:06.789282|2017-10-11 01:08:06.789282
NCT01976702|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-01-10|||October 2006||2006-10-01|October 2013|2013-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|PDA||Multi-Level HIV Prevention for Pregnant Drug Abusers|Multi-Level HIV Prevention for Pregnant Drug Abusers|Completed||N/A|250|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 01:08:06.914225|2017-10-11 01:08:06.914225
NCT01976689|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2013-11-06|||March 2012||2012-03-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Observational|||New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation|New- Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients|Completed||N/A|159|Actual|Baskent University|||2||f||||f||||||||||2017-10-11 01:08:06.99719|2017-10-11 01:08:06.99719
NCT01976676|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-06-14|||April 2011||2011-04-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Interventional|||Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion|Comparison of the Effect of Folic Acid and 5-methyltetrahydrofolate (5MTHF) on Serum Folate and Homocysteine Levels, and Abortion Rates in Women Suffering From Recurrent Abortion|Completed||Phase 2/Phase 3|220|Actual|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-11 01:08:07.100536|2017-10-11 01:08:07.100536
NCT01976663|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-04-14|2017-04-14||October 29, 2013|Actual|2013-10-29|April 2017|2017-04-01|October 26, 2015|Actual|2015-10-26|March 17, 2015|Actual|2015-03-17||Interventional||Modified Intent-to-Treat (mITT): all randomized and treated subjects|A Safety and Effectiveness Study of JUVÉDERM VOLIFT® XC Versus Control for Moderate to Severe Nasolabial Folds|A Prospective, Multicenter, Within-subject Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLIFT® XC Versus Control for the Correction of Moderate to Severe Nasolabial Folds|Completed||N/A|126|Actual|Allergan||2|||f||||t|f|t|f|||||No||2017-10-11 01:08:07.197539|2017-10-11 01:08:07.197539
NCT01976650|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-12-08|2015-12-08||March 2011||2011-03-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational||The Enrolled Population includes all 724 patients consented. The Safety Analysis Population includes 718 patients who were treated per protocol and completed a survey. The Safety Analysis Population was used for all analyses.|Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in Korea||Completed||N/A|724|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:08:07.594011|2017-10-11 01:08:07.594011
NCT01976624|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-08-28|2015-06-22||August 2009||2009-08-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational||Safety population included all participants treated for on-label indications.|Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea||Completed||N/A|756|Actual|Allergan|||1||f||||t||||||||||2017-10-11 01:08:07.924741|2017-10-11 01:08:07.924741
NCT01976611|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-04-07|||June 2012||2012-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea||Completed||N/A|402|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:08:08.203889|2017-10-11 01:08:08.203889
NCT01976598|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2015-01-15|||October 2013||2013-10-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Sub-Sensory Intraspinal Neurostimulation Therapy|Sub-Sensory Intraspinal Neurostimulation Therapy In the Treatment of Neuropathic Back and/or Leg Pain|Terminated||N/A|1|Actual|Algos Clinical Development|||1|Protocol proved too cumbersome. Consequently, only one one patient enrolled, and completed.|f||||f||||||||||2017-10-11 01:08:08.308127|2017-10-11 01:08:08.308127
NCT01976585|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-09-22|||December 2013||2013-12-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy|A Phase I/II Study of Intratumoral Injection of rhuFlt3L/CDX-301 and Poly-ICLC in Combination With Low-Dose Radiotherapy in Low-Grade B-cell Lymphomas|Recruiting||Phase 1/Phase 2|30|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 01:08:08.40843|2017-10-11 01:08:08.40843
NCT01976572|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-04-06|2015-09-28||October 2013||2013-10-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects|A Randomised, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Oral Doses of Candesartan Cilexetil in Healthy Subjects|Completed||Phase 1|18|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||f||||||||||2017-10-11 01:08:08.604411|2017-10-11 01:08:08.604411
NCT01959555|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-11-27|||March 2014||2014-03-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|PUCHS||Project to Update the Study of Congenital Haemophilia in Spain|Project to Update the Study of Congenital Haemophilia in Spain|Completed||N/A|1157|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:13:21.59223|2017-10-11 01:13:21.59223
NCT01976559|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-30|2017-08-09|||November 2013||2013-11-01|August 2017|2017-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Comparison of Continuous Noninvasive and Invasive Intracranial Pressure Measurement--Celda Infusion Subprotocol|Comparison of Continuous Noninvasive and Invasive Intracranial Pressure Measurement--Celda Infusion Subprotocol|Completed||N/A|15|Actual|LifeBridge Health||1|||f||||f||||||||||2017-10-11 01:08:09.228073|2017-10-11 01:08:09.228073
NCT01976546|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2014-10-24|||September 2013||2013-09-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Intubation With McGrath Video Laryngoscope and Boedeker Intubation Foreceps in a Population of Patients With Predictors of Difficult Airway|Intubation With McGrath Video Laryngoscope and Boedeker Intubation Foreceps in a Population of Patients With Predictors of Difficult Airway, an Observational Pilot Study|Completed||N/A|25|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 01:08:09.317466|2017-10-11 01:08:09.317466
NCT01976533|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-12-23|||October 2012||2012-10-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|December 2015|Actual|2015-12-01||Observational|||Eisenmenger Syndrome in the Nordic Countries|Eisenmenger Syndrome in the Nordic Countries: Advanced Treatment and Mortality 1977-2012|Active, not recruiting||N/A|714|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 01:08:09.396987|2017-10-11 01:08:09.396987
NCT01976520|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-06-26|||October 2013||2013-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)|NU 13H05: A Phase Ib Trial of Oncoquest-CLL Vaccine for Treatment-Naive Patients With Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|30|Actual|XEME Biopharma Inc.||1|||f||||t||||||||Undecided||2017-10-11 01:08:09.471457|2017-10-11 01:08:09.471457
NCT01976507|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-08-13|2017-08-13||October 2013|Actual|2013-10-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism|Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism in Patients Undergoing Left Atrial Catheter Ablation Procedures for Paroxysmal or Persistent (Non-permanent) Atrial Fibrillation and Left Atrial Flutter|Completed||Phase 4|101|Actual|Vanderbilt University Medical Center||1|||f||||f||||||||||2017-10-11 01:08:09.571449|2017-10-11 01:08:09.571449
NCT01976494|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-06-18|||October 2013||2013-10-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||The Efficacy and Safety of Accufuser Omnibus® (Elastomeric Infusion Pump); Comparative Clinical Trial||Completed||N/A|86|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:08:09.809466|2017-10-11 01:08:09.809466
NCT01976481|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-08-02|||November 2013||2013-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27|Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27|Completed||N/A|56|Actual|University of Zurich||2|||f||||t||||||||No||2017-10-11 01:08:09.972797|2017-10-11 01:08:09.972797
NCT01976468|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-05-10|||November 2013||2013-11-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||"Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The SCOPE-ITSCC Metastases Study"|"Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The SCOPE-ITSCC Metastases Study"|Active, not recruiting||N/A|100|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-11 01:08:10.100992|2017-10-11 01:08:10.100992
NCT01976455|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-09-21|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||The Breathe Light Study|The Breathe Light Study: Validation of Carbon Stable Isotope Ratio in Breath as an Indicator of Energy Balance and Substrate Utilization|Completed||N/A|22|Actual|USDA Grand Forks Human Nutrition Research Center|||2||f||||f||||||||||2017-10-11 01:08:10.216161|2017-10-11 01:08:10.216161
NCT01976442|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-04-10|2017-02-27||March 2011||2011-03-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia|Impact of Washed Transfusions in Adult Patients With Acute Myeloid or Lymphoid Leukemia|Completed||N/A|100|Actual|University of Rochester|This is a cohort study and thus has limits as to confounding and bias. However, it reproduces the results of a previous single center randomized trial.||1||f||||f||||||||||2017-10-11 01:08:10.318501|2017-10-11 01:08:10.318501
NCT01976429|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-11-02|||October 2013||2013-10-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Gas Supply, Demand and Middle Ear Gas Balance -- Fly/Dive Simulation|Gas Supply, Demand and Middle Ear Gas Balance -- Project 1, Specific Aim 4, Protocol 2|Recruiting||N/A|210|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:08:10.667038|2017-10-11 01:08:10.667038
NCT01976416|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-03-22|||September 2014||2014-09-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|NOHARM||Novel Use Of Hydroxyurea in an African Region With Malaria|Novel Use Of Hydroxyurea in an African Region With Malaria|Active, not recruiting||Phase 3|200|Anticipated|Indiana University||2|||f||||t||||||||No||2017-10-11 01:08:10.795148|2017-10-11 01:08:10.795148
NCT01976403|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-11-21|||January 2012||2012-01-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Intervention Study to Enhance Patients' Pain Management After Cardiac Surgery|AA Randomized Controlled Trial to Evaluate the Effect of an Intervention to Enhance Patients' Pain Management After Discharge From Cardiac Surgery|Completed||N/A|416|Actual|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-11 01:08:10.911542|2017-10-11 01:08:10.911542
NCT01976390|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2017-05-09|||February 2014||2014-02-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparing Everolimus and Sirolimus in Renal Transplant Recipients|A Prospective, Randomized, Single Center Pilot Study Comparing Patient and Graft Survival, Adverse Events and Tolerability of Zortress® (Everolimus) Versus Rapamune® (Sirolimus) in Combination With Low Dose Neoral® (Cyclosporine) Dosed by C2 Monitoring, in Deceased and Living Donor Renal Transplant Recipients Under a Thymoglobulin® (Antithymocyte Globulin) and Rapid Steroid Induction Protocol.|Active, not recruiting||N/A|60|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-11 01:08:11.015676|2017-10-11 01:08:11.015676
NCT01976377|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-12-13|||October 2013||2013-10-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Mucin Glycosylating Enzymes in Head and Neck Cancers|Expression of Mucin Glycosylating Enzymes in Head and Neck Cancers and Its Correlation With Clinico-pathological Parameters.|Recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 01:08:11.124883|2017-10-11 01:08:11.124883
NCT01976364|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-08-11|||February 17, 2014|Actual|2014-02-17|August 2017|2017-08-01|January 2, 2020|Anticipated|2020-01-02|January 2, 2020|Anticipated|2020-01-02||Interventional|OPAL BALANCE||Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis|A Long-term, Open-label Extension Study Of Tofacitinib (Cp-690,550) For The Treatment Of Psoriatic Arthritis|Active, not recruiting||Phase 3|686|Actual|Pfizer||1|||f||||t|t|f||||||||2017-10-11 01:08:11.231023|2017-10-11 01:08:11.231023
NCT01976351|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-29|||September 2009||2009-09-01|October 2013|2013-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Imaging Enhanced Endoscopy for the Screening of Barrett's Esophagus|Imaging Enhanced Endoscopy for the Screening of Barrett's Esophagus and Evaluation of Its Invasiveness in Patients With Gastroesophageal Reflux Disease|Terminated||N/A|51|Actual|National Taiwan University Hospital|||1|Insufficient research manpower|f||||f||||||Samples With DNA|"     A standardized endoscopic biopsy protocol was performed at sites with ESEM which usually     appeared as a reddish discoloration in an otherwise relatively whitish esophageal mucosa. Two     pieces of specimen were taken; one for histological confirmation and another one (preserved     as frozen tissue) for DNA analysis or immuno-histochemical staining. Biopsy from gastric     cardia was also taken for histological confirmation.   "|||2017-10-11 01:08:11.685359|2017-10-11 01:08:11.685359
NCT01976338|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-03-27|2017-03-27||November 12, 2013|Actual|2013-11-12|March 2017|2017-03-01|March 28, 2016|Actual|2016-03-28|March 28, 2016|Actual|2016-03-28||Interventional|Blossom||Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)|A Randomized Double-masked, Phase III Study Assessing Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Visual Impairment Due to Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) [Blossom]|Completed||Phase 3|283|Actual|Novartis|One patient was randomized to the ranibizumab group but received no study treatment during the study period and discontinued the study after Visit 2. Therefore, excluded from the Safety set|2|||f||||f||||||||||2017-10-11 01:08:11.792131|2017-10-11 01:08:11.792131
NCT01976325|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-04-15|||January 2014||2014-01-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|OMDA||Evaluating the Ottawa Malaria Decision Aid|Incorporation of the 'Ottawa Malaria Decision Aid' Into the Pre-travel Consultation Process: Assessment of Travelers' Knowledge, Decisional Conflict, Preparation for Decision-making and Medication Adherence Compared to Standard Care|Unknown status|Recruiting|N/A|100|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 01:08:13.318504|2017-10-11 01:08:13.318504
NCT01976312|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-04-24|2017-03-13||November 12, 2013|Actual|2013-11-12|April 2017|2017-04-01|March 14, 2016|Actual|2016-03-14|March 14, 2016|Actual|2016-03-14||Interventional|Camellia||Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)|A Randomized Double-masked, Phase III Study Assessing Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Visual Impairment Due to Macular Edema (ME) Secondary to Central Retinal Vein Occlusion (CRVO) [Camellia]|Completed||Phase 3|252|Actual|Novartis||2|||f||||f|f|f||||||||2017-10-11 01:08:13.479108|2017-10-11 01:08:13.479108
NCT01976299|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-01-09|2016-11-03||December 2013||2013-12-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|AVERT™||AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN|AVERT™ Clinical Trial|Completed||N/A|578|Actual|Osprey Medical, Inc||2|||f||||f||||||||||2017-10-11 01:08:14.521359|2017-10-11 01:08:14.521359
NCT01976286|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-02-07|||January 2015||2015-01-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma|A Pilot Study Comparing the Efficacy of Glycolic Acid Peels vs. Salicylic Acid Peels for the Treatment of Melasma: A Randomized Control Trial|Active, not recruiting||N/A|21|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:08:16.79266|2017-10-11 01:08:16.79266
NCT01976273|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-06-23|2017-05-12||October 2013||2013-10-01|June 2017|2017-06-01|January 7, 2015|Actual|2015-01-07|January 7, 2015|Actual|2015-01-07||Interventional|||A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma|A Pilot Study Comparing the Efficacy of 1064 Q-switch Laser vs. Glycolic Acid Peels for the Treatment of Melasma: A Randomized Control Trial|Completed||N/A|20|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:08:16.903641|2017-10-11 01:08:16.903641
NCT01976260|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-12-05|||October 2013||2013-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars|A Pilot, Split-Face Randomized, Evaluator Blinded Study on the Effectiveness of a Bipolar Fractional Radiofrequency System Versus 1550-nm Fractional Photothermolysis for the Treatment of Acne Scars.|Active, not recruiting||N/A|16|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:08:17.202435|2017-10-11 01:08:17.202435
NCT01976247|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-12-05|||October 2013||2013-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction|Pilot Study Comparing the Effectiveness of a Noninvasive Cryolipolysis Device vs. a High Intensity Focused Ultrasound Device for Fat Reduction: A Randomized Control Trial|Active, not recruiting||N/A|15|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-11 01:08:17.304285|2017-10-11 01:08:17.304285
NCT01976234|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-02-02|||September 2013||2013-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Stored RBC Transfusion and Immonomodulation|Infective Complication After Surgery and Transfusion of Allogenic RBC Fresh or Stored|Completed||N/A|181|Actual|Università degli Studi di Ferrara||2|||f||||t||||||||||2017-10-11 01:08:18.605091|2017-10-11 01:08:18.605091
NCT01976221|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-29|||January 2014||2014-01-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|Priority||Priority Setting and Waiting Time Decision in the Referral Process, How and by Whom?|Priority Setting and Waiting Time Decision in the Referral Process, How and by Whom? A Prospective Cluster Randomized Controlled Trial on the Effects of an Education Program in Priority Setting and Waiting Time Decision in Referrals|Unknown status|Not yet recruiting|N/A|40|Anticipated|University of Bergen||1|||f||||f||||||||||2017-10-11 01:08:18.69341|2017-10-11 01:08:18.69341
NCT01976039|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-11-04|||July 2012||2012-07-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Rhinopharyngeal Retrograde Clearance is Effective to Adequate Upper Airways Function in Adults|The Effectiveness of Rhinopharyngeal Retrograde Clearance on the Upper Airways Symptomatology and Function in Adults|Completed||N/A|24|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:08:21.293256|2017-10-11 01:08:21.293256
NCT01976208|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-12-20|||December 2010||2010-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|AA007||Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma|A Multicenter, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of Recombinant Humanized Anti-IgE Monoclonal Antibody Injection(Omalizumab) in Patients With Allergic Asthma|Completed||Phase 2/Phase 3|630|Actual|Shanghai Zhangjiang Biotechnology Limited Company||2|||f||||f||||||||||2017-10-11 01:08:18.789295|2017-10-11 01:08:18.789295
NCT01976195|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-04-18|||October 2013||2013-10-01|October 2013|2013-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP|An Open-label, Randomized Multicenter Investigation of High-dose Dexamethasone Combining Thalidomide Versus High-dose Dexamethasone Mono-therapy for Management of Newly-diagnosed Immune Thrombocytopenia|Withdrawn||Phase 2|0|Actual|Shandong University||2||No eligible patient was enrolled.|f||||t||||||||||2017-10-11 01:08:18.932653|2017-10-11 01:08:18.932653
NCT01976182|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-04-11|||September 2013||2013-09-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia|Prospective, Sequential Multiple Assignment, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia|Recruiting||Phase 2|110|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 01:08:19.069834|2017-10-11 01:08:19.069834
NCT01976169|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-06-07|||January 2014||2014-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)|Phase 1B Study of PD-0332991 in Combination With T-DM1 in the Treatment of Patients With Advanced HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Breast Cancer|Recruiting||Phase 1|17|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-11 01:08:19.600561|2017-10-11 01:08:19.600561
NCT01976156|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-01-11|||October 2013||2013-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CIDO OEA||The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity|The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity|Recruiting||N/A|168|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 01:08:19.723806|2017-10-11 01:08:19.723806
NCT01976143|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-12-20|||February 2014||2014-02-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety|A Phase 1 Study to Evaluate the Effect of Nktr-102 for Injection (Etirinotecan Pegol) on the QT/QTC Interval in Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|33|Actual|Nektar Therapeutics||1|||f||||f||||||||||2017-10-11 01:08:19.866274|2017-10-11 01:08:19.866274
NCT01976130|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-09-07|||June 2012||2012-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Mechanisms of Lung Defense and Their Relationship With Airway Infection in Chronic Obstructive Pulmonary Disease (COPD)|Mechanisms of Lung Defense and Their Relationship With Airway Infection in Chronic Obstructive Pulmonary Disease (COPD)|Active, not recruiting||N/A|45|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||f||||||||||2017-10-11 01:08:19.953568|2017-10-11 01:08:19.953568
NCT01976117|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-09-07|||June 2012||2012-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||E-nose Utility in the Diagnosis of Bacterial Infection in COPD|E-nose Utility in the Diagnosis of Bacterial Infection in Chronic Obstructive Pulmonary Disease (COPD)|Active, not recruiting||N/A|||Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||f||||||||||2017-10-11 01:08:20.074947|2017-10-11 01:08:20.074947
NCT01976104|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-06-09|||November 2013|Actual|2013-11-01|May 2017|2017-05-01|February 21, 2017|Actual|2017-02-21|January 30, 2017|Actual|2017-01-30||Interventional|||Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure|A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure|Completed||Phase 3|204|Actual|Eisai Inc.||4|||f||||t||||||||||2017-10-11 01:08:20.190194|2017-10-11 01:08:20.190194
NCT01976091|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-03-28|||February 2015||2015-02-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA|Phase I/IIa Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA|Enrolling by invitation||Phase 1/Phase 2|8|Anticipated|Nationwide Children's Hospital||3|||f||||t||||||||||2017-10-11 01:08:20.677309|2017-10-11 01:08:20.677309
NCT01976078|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-07-21|||September 2012||2012-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Interventional|||Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents|Ontogeny of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents|Active, not recruiting||Phase 1|45|Actual|Children's Hospital Los Angeles||1|||f||||f||||||||||2017-10-11 01:08:20.795194|2017-10-11 01:08:20.795194
NCT01976065|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-06-30|||September 2014||2014-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Regeneration of Pulp-Dentin Development in Teeth With Necrotic Pulps and Immature Roots|Regeneration of Pulp-Dentin Development in Teeth With Necrotic Pulps and Immature Roots|Recruiting||Phase 1|120|Anticipated|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-10-11 01:08:21.060428|2017-10-11 01:08:21.060428
NCT01976052|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-10-11|||October 2013||2013-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment||Active, not recruiting||N/A|75|Anticipated|Karolinska University Hospital|||3||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma   "|||2017-10-11 01:08:21.211953|2017-10-11 01:08:21.211953
NCT01975844|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-03-21|||July 2013||2013-07-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Interventional|||The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability|The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability|Terminated||Phase 4|48|Actual|Baystate Medical Center||1||Study has been terminated due to lack of financial support|f||||t||||||||||2017-10-11 01:08:25.596861|2017-10-11 01:08:25.596861
NCT01976026|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-11-21|||November 2013||2013-11-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|DIVERT||DIVERT: Diversion of Flow in Intracranial VErtebral and Blood Blister-like Ruptured Aneurysms Trial: A Randomized Trial Comparing Pipeline Flow Diversion and Best-Standard-Treatment|Diversion of Flow in Intracranial VErtebral and Blood Blister-like Ruptured Aneurysms Trial Trial: A Randomized Trial Comparing Pipeline Flow Diversion and Best-Standard-Treatment|Withdrawn||N/A|0|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2||Rare aneurysms. No patient enrolled at site.|f||||f||||||||||2017-10-11 01:08:21.413498|2017-10-11 01:08:21.413498
NCT01976013|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-04-04|||October 2013||2013-10-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Prediction of Major Bleeding in ELBW-infants (<1000g) by Sequential Coagulation Monitoring|Prediction of Major Bleeding in Extremely Low Birth Weight Infants (<1000g) by Sequential Coagulation Monitoring|Completed||N/A|126|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 01:08:21.539188|2017-10-11 01:08:21.539188
NCT01976000|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-03-13|||January 2012||2012-01-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Influence of CT 3D on the Learning Curve of Laparoscopic Colorectal Resection|The Impact of Preoperative Knowledge of the Colonic Vascular Anatomy on the Learning Curve for Laparoscopic Colorectal Resection|Completed||N/A|120|Actual|University of Roma La Sapienza|||2||f||||f||||||||||2017-10-11 01:08:21.652009|2017-10-11 01:08:21.652009
NCT01975987|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-07-17|||January 2014||2014-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Characteristics to Predict Successful Intubation With the Bonfils Fiberscope|Identification of Morphological Characteristics to Predict Successful Intubation With the Bonfils Fiberscope|Completed||N/A|400|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 01:08:21.740778|2017-10-11 01:08:21.740778
NCT01975974|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-04-28|2016-10-26||July 2013||2013-07-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Observational|||Technique for Successful Ultrasound-guided Peripheral Vascular Access|Technique for Successful Ultrasound-guided Peripheral Vascular Access|Completed||N/A|100|Actual|University of Iowa|||1||f||||f||||||||No|we are not planning on sharing the data|2017-10-11 01:08:21.831154|2017-10-11 01:08:21.831154
NCT01975961|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2013-10-28|||July 2013||2013-07-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin|A Randomized, Open-label, Single-dose, 2-way Cross-over Study to Compare the Safety and the Pharmacokinetic Characteristics of the Co-administration of Telmisartan and Rosuvastatin and YH16410 in Healthy Volunteers|Completed||Phase 1|185|Actual|Yuhan Corporation||2|||f||||f||||||||||2017-10-11 01:08:22.013593|2017-10-11 01:08:22.013593
NCT01975948|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-08-21|2017-02-01||November 2013|Actual|2013-11-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||It should be noted that baseline measures for the physician group are based on pre and post training completers (n=73). Patient data is based on those who completed at least one data time point (n=116).|Evaluation of a Mental Health Physician Support Program in Nova Scotia|Evaluation of a Mental Health Physician Support Program in Nova Scotia: Impact on Patient Outcomes and Stigmatization|Completed||N/A|285|Actual|Nova Scotia Health Authority|Challenges in physician sample: 75% completed pre-post OMS-HC scale Physicians experienced challenges identifying study patients leading to small number of patients.|4|||f||||t||||||||||2017-10-11 01:08:22.142273|2017-10-11 01:08:22.142273
NCT01975935|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-05-11|2017-03-28||January 2014||2014-01-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients|Clinical Protocol to Investigate the Efficacy of Amlexanox vs. Placebo for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 Diabetics|Completed||Phase 2|42|Actual|University of Michigan|Optimal drug dose is yet to be defined. The dose and the treatment duration may not have been sufficient to reveal all the positive as well as negative effects of the drug. Effects of combination with other anti-diabetics is also unknown.|2|||f||||t||||||||||2017-10-11 01:08:23.947761|2017-10-11 01:08:23.947761
NCT01975909|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-04-19|2017-03-02||September 2013||2013-09-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|TMS||Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia|Transcranial Magnetic Stimulation (TMS) in Spino-Cerebellar Ataxia|Completed||N/A|20|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 01:08:24.595974|2017-10-11 01:08:24.595974
NCT01975896|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-07-07|||September 2014||2014-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Mindfulness Training to Promote Healthy Diet and Physical Activity in Teens|Mindfulness Training to Promote Healthy Diet and Physical Activity in Teens|Completed||N/A|53|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 01:08:25.130021|2017-10-11 01:08:25.130021
NCT01975883|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-29|||July 2010||2010-07-01|October 2013|2013-10-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Observational|GLYRACH||Glycemic Instability After Spine Surgery|Glycemic Instability of Non-diabetic Patients After Spine Surgery: a Prospective Observational Cohort Study|Completed||N/A|91|Actual|Beaujon Hospital|||1||f||||f||||||||||2017-10-11 01:08:25.234695|2017-10-11 01:08:25.234695
NCT01975870|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-12-02|||September 2013||2013-09-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||A stAPP to a Healthier Lifestyle|A stAPP to a Healthier Lifestyle: a Randomized Controlled Trial|Completed||N/A|60|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 01:08:25.330541|2017-10-11 01:08:25.330541
NCT01975857|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-09-28|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Mind-Body Rehabilitative Program for Veterans With mTBI (Mild Traumatic Brain Injury)|"Evaluating a Novel Sleep-focused Mind-body Rehabilitative Program for Veterans With mTBI and Other Polytrauma Symptoms: An Randomized Controlled Trial (RCT) Study"|Active, not recruiting||N/A|88|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 01:08:25.449889|2017-10-11 01:08:25.449889
NCT01975831|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-02-14|||December 19, 2013||2013-12-19|February 2017|2017-02-01||||October 2017|Anticipated|2017-10-01||Interventional|||A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab|A Phase 1 Study to Evaluate the Safety and Tolerability of Anti-PD-L1, MEDI4736, in Combination With Tremelimumab in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|106|Actual|Ludwig Institute for Cancer Research||1|||f||||f||||||||||2017-10-11 01:08:25.702081|2017-10-11 01:08:25.702081
NCT01975818|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-03-18||2016-03-18|October 2013||2013-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|DIALOGUE4||Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934|A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan|Completed||Phase 2|201|Actual|Bayer||5|||f||||t||||||||||2017-10-11 01:08:25.853946|2017-10-11 01:08:25.853946
NCT01975805|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-28|||January 2010||2010-01-01|October 2013|2013-10-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Chlorhexidine Gluconate Versus Povidone Iodine at Cesarean Delivery: a Randomized Controlled Trial|To Determine the Difference in Positive Bacterial Cultures in Cesarean Sections With 2% Chlorhexidine- Gluconate, 70% Isopropyl Alcohol (Chloraprep) vs. Povidone-iodine 10% (Betadine) Preoperative Surgical Scrub|Completed||N/A|60|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 01:08:26.085558|2017-10-11 01:08:26.085558
NCT01975792|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-03-28|||March 2013||2013-03-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|TIPS||Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcomes|Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcome in Women at High Risk for Preterm Delivery|Completed||N/A|125|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 01:08:26.172578|2017-10-11 01:08:26.172578
NCT01975779|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-10-29|||July 2013||2013-07-01|October 2013|2013-10-01||||October 2013|Actual|2013-10-01||Interventional|||Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects|Interventional, Randomised, Double-blind, Placebocontrolled, Single- and Multiple-ascending-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|42|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-10-11 01:08:26.249156|2017-10-11 01:08:26.249156
NCT01975766|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-02-10|||January 2014||2014-01-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2016|Actual|2016-11-01||Interventional|||Ketogenic Diet Phase 1 for Head & Neck Cancer|A Phase I Trial of a Ketogenic Diet With Concurrent Chemoradiation for Head and Neck Cancer|Terminated||N/A|14|Actual|University of Iowa||1||Poor accrual|f||||t||||||||Yes|Data will be shared on clinicaltrials.gov|2017-10-11 01:08:26.338707|2017-10-11 01:08:26.338707
NCT01975753|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-06-13|||May 2014||2014-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|AEROMORPH1||First Evaluation of Morphine Hydrochloride by Nebulisation in Healthy Volunteers|First Evaluation of Morphine Hydrochloride by Nebulisation Compared to Intravenous Route in Healthy Volunteers: Preliminary Study Dose|Recruiting||Phase 1/Phase 2|72|Anticipated|University Hospital, Rouen||3|||f||||t||||||||||2017-10-11 01:08:26.448932|2017-10-11 01:08:26.448932
NCT01975740|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2013-11-04|||January 2013||2013-01-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Manual Diaphragm Release Technique Effects On Tidal Volume in Elderly|Manual Diaphragm Release Technique Effects On Tidal Volume And Upper Rib Cage Contribution During Quiet Breathing In Elderly: A Randomized Controlled Trial|Completed||N/A|18|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:08:26.575543|2017-10-11 01:08:26.575543
NCT01975727|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-06-21|||August 2012|Actual|2012-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|DexPonv||Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting|Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting - a Randomised, Placebo-controlled, Dose-finding Study|Recruiting||Phase 2|560|Anticipated|University Hospital, Geneva||4|||f||||t||||||||No||2017-10-11 01:08:26.662348|2017-10-11 01:08:26.662348
NCT01975714|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-10-28|||October 2013||2013-10-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|SPORT||Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study|Intraocular Pressure and Tolerability Study of Preservative Free Bimatoprost 0.03% Unit Dose (BUDPF) or Preservative Free Latanoprost 0.005% Unit Dose (LUDPF) (Monoprost®) in Patients With Ocular Hypertension or Glaucoma: A Randomized, Single Masked, 3 Month Cross-over, Investigator Led, European Multicentre Trial (SPORT)|Completed||Phase 4|67|Actual|Association for Innovation and Biomedical Research on Light and Image||2|||f||||f||||||||||2017-10-11 01:08:26.806464|2017-10-11 01:08:26.806464
NCT01975701|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-09-12|||December 9, 2013|Actual|2013-12-09|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||A Phase 2 Study of BGJ398 in Patients With Recurrent GBM|A Phase 2, Multicenter, Open-label Study of BGJ398 in Patients With Recurrent Resectable or Unresectable Glioblastoma|Active, not recruiting||Phase 2|24|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 01:08:27.105592|2017-10-11 01:08:27.105592
NCT01975688|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-08-10|||February 2014||2014-02-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis|An Open-label Clinical Trial to Compare the Pharmacokinetics of up to 4 Single Oromucosal Doses of 4 Sprays of Sativex® in Patients With Treatment Induced Mild, Moderate and Severe Oral Mucositis (Grade 1 - 3 RTOG Oral Mucositis) With Their Pharmacokinetic Profile Pre-treatment (When Mucositis-free)|Terminated||Phase 1|10|Actual|GW Pharmaceuticals Ltd.||4||Slow recruitment|f||||f||||||||||2017-10-11 01:08:27.214946|2017-10-11 01:08:27.214946
NCT01975675|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-06-04|2015-06-04||October 2013||2013-10-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug|Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection|A Phase 3b, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Treatment-Naïve and Treatment-Experienced Japanese Subjects With Chronic Genotype 1 HCV Infection|Completed||Phase 3|341|Actual|Gilead Sciences||4|||f||||f||||||||||2017-10-11 01:08:27.333047|2017-10-11 01:08:27.333047
NCT01975662|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-04-12|||January 2014||2014-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia|A Multi-centre Open Label Randomized Controlled Phase IIB Trial Comparing Vancomycin Versus Daptomycin for the Treatment of MRSA Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations|Terminated||Phase 2|14|Actual|Singapore General Hospital||2||slow accrual of participants|f||||t||||||||||2017-10-11 01:08:28.331327|2017-10-11 01:08:28.331327
NCT01975649|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-04-02|||June 2013||2013-06-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder|Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder|Completed||Phase 4|44|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-11 01:08:28.478352|2017-10-11 01:08:28.478352
NCT01975636|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-01-06|||June 2013||2013-06-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects|An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects|Completed||Phase 1|113|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-11 01:08:28.588153|2017-10-11 01:08:28.588153
NCT01975623|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-11-24|||September 2013||2013-09-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Pulmonary Artery Sealing Using the HARMONIC ACE+ Shears(HS) for VATS Lobectomy|Ex-Vivo Evaluation of the Effectiveness of Pulmonary Artery Sealing Using the HARMONIC ACE + Shears (HS) for VATS Lobectomy|Completed||N/A|47|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 01:08:28.680357|2017-10-11 01:08:28.680357
NCT01975610|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-07-27||2017-07-27|October 2013||2013-10-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis|A Phase 2a, 4-Week Double-Blind, Proof-of-Concept Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis|Completed||Phase 2|47|Actual|Celgene||2|||f||||f||||||||||2017-10-11 01:08:28.788349|2017-10-11 01:08:28.788349
NCT01975597|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-09-06|||August 2013||2013-08-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer|Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer|Recruiting||N/A|20|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 01:08:28.945285|2017-10-11 01:08:28.945285
NCT01975584|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-07-06|||September 2013||2013-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2017|Actual|2017-06-01||Interventional|TSST||Neuroendocrine and Immune Response to Stress in Schizophrenia|Neuroendocrine and Immune Response to Stress in Schizophrenia|Recruiting||N/A|90|Anticipated|University of Maryland||1|||f||||f||||||||||2017-10-11 01:08:29.03145|2017-10-11 01:08:29.03145
NCT01975571|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-04-13|||July 2011||2011-07-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Hybrid Cochlear Implants in Severe to Profound Adults, Children, and Adolescents|Iowa Cochlear Implant Clinical Research Center Hybrid Cochlear Implants in Severe to Profound Adults, Children, and Adolescents|Enrolling by invitation||N/A|45|Anticipated|University of Iowa||3|||f||||f||||||||||2017-10-11 01:08:29.139782|2017-10-11 01:08:29.139782
NCT01975558|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-06-07|||June 26, 2014|Actual|2014-06-26|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Radiation Metabolic Signature of Patient Undergoing Radiotherapy. A Pilot Study|The Radiation Metabolic Signature of Patient Undergoing Radiotherapy. A Pilot Study|Enrolling by invitation||N/A|30|Anticipated|University Hospital Inselspital, Berne|||3||f||||f|f|f||||Samples With DNA|"     Blood, urine, sebum, saliva.   "|||2017-10-11 01:08:29.253281|2017-10-11 01:08:29.253281
NCT01975532|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-12-04|||November 2013||2013-11-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Evaluation of Diffusion MRI as a Tool in Planning Deep Brain Stimulation (DBS)|Evaluation of MRI Based Fiber Tracking as a Tool in Deep Brain Stimulation for Movement Disorders|Completed||N/A|13|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 01:08:29.445732|2017-10-11 01:08:29.445732
NCT01975519|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-09-07|||December 2013||2013-12-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 1B Dose-escalation and Phase 2a Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma|A Phase 1B Dose-escalation and Phase 2a Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma|Active, not recruiting||Phase 1/Phase 2|111|Actual|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||||2017-10-11 01:08:29.505325|2017-10-11 01:08:29.505325
NCT01975493|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-02-02|||November 2013||2013-11-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|NAPPA||Neonatal and Paediatric Pharmacokinetics of Antimicrobials Study|Neonatal and Paediatric Pharmacokinetics of Antimicrobials Study|Active, not recruiting||N/A|428|Actual|St George's, University of London|||6||f||||f||||||Samples With DNA|"     Plasma samples and dried blood spots to be retained for retrospective analysis.   "|||2017-10-11 01:08:29.723123|2017-10-11 01:08:29.723123
NCT01975480|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-09-28|||January 2013||2013-01-01|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities|Efficacy of Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Treatment on Prefrontality in Patients With Generalized Anxiety Disorder (GAD) and Other Comorbidities|Recruiting||Phase 4|37|Anticipated|START Clinic for Mood and Anxiety Disorders||1|||f||||||||||||||2017-10-11 01:08:29.83131|2017-10-11 01:08:29.83131
NCT01975467|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-11-01|2016-11-01||October 2013||2013-10-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Post Treatment Comparison Intramedullary Nail vs. Nonoperative Treatment|CLAVICLE FRACTURE OUTCOMES: 1-3 YEAR FOLLOW UP OF DISPLACED MIDSHAFT FRACTURES TREATED WITH INTRAMEDULARY NAIL vs. NONOPERATIVE TREATMENT|Terminated||N/A|9|Actual|Sonoma Orthopedic Products, Inc.|||2|Low Enrollment|f||||f||||||||||2017-10-11 01:08:29.933712|2017-10-11 01:08:29.933712
NCT01975454|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-10-16|||April 2012||2012-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|||Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer|A Pilot Study of Teng-Long-Bu-Zhong-Tang Based Herbal Therapy in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 1/Phase 2|62|Actual|Shanghai University of Traditional Chinese Medicine||2|||f||||f||||||||Undecided||2017-10-11 01:08:30.156758|2017-10-11 01:08:30.156758
NCT01975441|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-10-11|||May 2014||2014-05-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa|Evaluate Triple-Drug Therapy With Diethylcarbamize (DEC), Albendazole (ALB) and Ivermectin (IVM) That Could Accelerate LF Elimination Outside of Africa|Active, not recruiting||Phase 2|182|Actual|University Hospitals Cleveland Medical Center||3|||f||||t||||||||||2017-10-11 01:08:30.261482|2017-10-11 01:08:30.261482
NCT01975415|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-03-12|||October 2013||2013-10-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|DigMed2||Digital Medicine in Meditation|Digital Medicine in Meditation|Completed||N/A|40|Actual|Scripps Translational Science Institute|||2||f||||f||||||||||2017-10-11 01:08:30.461162|2017-10-11 01:08:30.461162
NCT01975402|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-03-28|||November 2013||2013-11-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|August 2015|Actual|2015-08-01||Observational|R01-Aim2||Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population|Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population|Active, not recruiting||N/A|30|Anticipated|Preventice|||1||f||||f||||||||||2017-10-11 01:08:30.527163|2017-10-11 01:08:30.527163
NCT01975389|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-08-28|||October 29, 2013|Actual|2013-10-29|August 2017|2017-08-01|January 28, 2017|Actual|2017-01-28|November 1, 2016|Actual|2016-11-01||Interventional|SPIRE-2||The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects|Phase 3 Multi Center, Double Blind, Randomized, Placebo Controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (Pf-04950615), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects|Terminated||Phase 3|10564|Actual|Pfizer||2||See Detailed Description|f||||t||||||||||2017-10-11 01:08:30.987398|2017-10-11 01:08:30.987398
NCT01975376|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-08-28|||October 29, 2013|Actual|2013-10-29|August 2017|2017-08-01|January 28, 2017|Actual|2017-01-28|November 1, 2016|Actual|2016-11-01||Interventional|SPIRE-1||The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects|Phase 3 Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (Pf-04950615) In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects.|Terminated||Phase 3|16784|Actual|Pfizer||2||See Detailed Description|f||||t||||||||||2017-10-11 01:08:37.999233|2017-10-11 01:08:37.999233
NCT01975363|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-11-01|||June 2013||2013-06-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer|Nanoemulsion Curcumin for Obesity, Inflammation and Breast Cancer Prevention - a Pilot Trial|Recruiting||N/A|30|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-11 01:08:42.712508|2017-10-11 01:08:42.712508
NCT01975350|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-28|||October 2013||2013-10-01|October 2013|2013-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Pneumonia|Prospective Observation of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Tracheobronchitis/Pneumonia or Lower Respiratory Tract Colonization by Multidrug Resistant Gram-negative Bacteria|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 01:08:42.827766|2017-10-11 01:08:42.827766
NCT01975337|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-08-16|||August 2013||2013-08-01|August 2016|2016-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects|An Open-label Study to Evaluate the Pharmacokinetics and Safety of a Single Oral Dose of Alisporivir (DEB025) in Subjects With End Stage Renal Disease on Hemodialysis Compared to Matched Healthy Subjects|Completed||Phase 1|16|Actual|Debiopharm International SA||2|||f||||f||||||||||2017-10-11 01:08:42.929765|2017-10-11 01:08:42.929765
NCT01975311|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-01-09|||October 2012||2012-10-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Lower Back Treatment in People With Patellofemoral Pain Syndrome.|Effect of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity, Pain Intensity, and Functional Activity in People With Patellofemoral Pain Syndrome.|Completed||N/A|27|Actual|Texas Woman's University||2|||f||||t||||||||||2017-10-11 01:08:43.099705|2017-10-11 01:08:43.099705
NCT01975116|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-08-03|||August 2013||2013-08-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors|A Phase I Trial of p28 (NSC745104), a Non-HDM2 Mediated Peptide Inhibitor of p53 Ubiquitination in Pediatric Patients With Recurrent or Progressive CNS Tumors|Completed||Phase 1|18|Actual|Pediatric Brain Tumor Consortium||1|||f||||t||||||||||2017-10-11 01:08:47.43963|2017-10-11 01:08:47.43963
NCT01975298|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-03-03|||January 2014||2014-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|LIBRETTO||A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)|A Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Control (Rater Blinded) Study, to Evaluate The Efficacy, Safety And Tolerability Of 2 Doses Of Oral Administration Of Laquinimod (0.6 mg/Day Or 1.2 mg/Day) Compared to Interferon ß-1a Administered Intra Muscular Once Weekly in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).|Withdrawn||Phase 3|0|Actual|Teva Pharmaceutical Industries||3||Business Decision|f||||t||||||||||2017-10-11 01:08:43.164401|2017-10-11 01:08:43.164401
NCT01975285|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-04-06|2016-01-26||August 2013||2013-08-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of Popliteal Nerve Blocks With and Without Dexamethasone on the Duration of Analgesia for Foot & Ankle Surgery|Prospective Randomized Double Blind Study to Evaluate the Efficacy of Popliteal Nerve Blocks With and Without Dexamethasone on the Duration of Analgesia for Foot & Ankle Surgery.|Completed||Phase 4|60|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||Yes||2017-10-11 01:08:43.342437|2017-10-11 01:08:43.342437
NCT01975272|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-10-28|||November 2013||2013-11-01|October 2013|2013-10-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|VITAPOP||The Use of Iron Therapy for Patients With Anemia After Surgery|The Value of Iron Treatment for Postoperative Patients With Anemia: a Randomized Double Blind Controlled Trial|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-11 01:08:43.746405|2017-10-11 01:08:43.746405
NCT01975259|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-09-01|||December 2013||2013-12-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|IECF||Investigating the Incretin Effect in Cystic Fibrosis|Investigating the Incretin Effect in Cystic Fibrosis|Completed||N/A|50|Actual|Liverpool Heart and Chest Hospital NHS Foundation Trust|||2||f||||t||||||Samples Without DNA|"     Blood   "|||2017-10-11 01:08:43.884263|2017-10-11 01:08:43.884263
NCT01975246|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2016-10-06|2016-10-06|2014-07-23|November 2013||2013-11-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional||Treated Set (TS): The treated set consisted of all patients who were randomised to the double-blind period and took at least 1 dose of the randomised treatment.|Add-on to Micamlo BP Trial|An Eight-week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80 mg and Amlodipine 5 mg and Hydrochlorothiazide 12.5 mg vs. Telmisartan 80 mg and Amlodipine 5 mg in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Telmisartan 80 mg and Amlodipine 5 mg|Completed||Phase 3|309|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:08:44.030363|2017-10-11 01:08:44.030363
NCT01975233|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-18|||November 2012||2012-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|June 2015|Actual|2015-06-01||Observational|||WEB French Observatory of the WEB Aneurysm Embolization System|WEB French Observatory|Completed||N/A|62|Anticipated|Sequent Medical, Inc|||1||f||||f||||||||||2017-10-11 01:08:44.411943|2017-10-11 01:08:44.411943
NCT01975220|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2017-01-18|2017-01-18||October 2013||2013-10-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Treated Set (TS): This patient set includes all subjects who were dispensed study medication and were documented to have taken at least one dose of study drug.|Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets|Relative Bioavailability of Two Newly Developed FDC Tablet Strengths (25mg/1000mg and 12.5mg/750mg) of Empagliflozin/Metformin Extended Release Compared With the Free Combination of Empagliflozin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)|Completed||Phase 1|72|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 01:08:44.539666|2017-10-11 01:08:44.539666
NCT01975207|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-29|2015-05-20|||November 2013||2013-11-01|May 2015|2015-05-01||||June 2016|Anticipated|2016-06-01||Interventional|||Comparison Study of Family Practice Interventions for Depression in Adults||Unknown status|Active, not recruiting|N/A|4500|Anticipated|AHS Cancer Control Alberta||4|||f||||f||||||||||2017-10-11 01:08:46.757311|2017-10-11 01:08:46.757311
NCT01975194|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-11-01|||January 2012||2012-01-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|RIAA||Rosuvastatin in African Americans With Cerebrovascular Disease|Use of Rosuvastatin to Achieve Lipid Targets in African American Subjects With Cerebrovascular Disease|Terminated||Phase 4|20|Actual|Wayne State University||1||loss of research personnel|f||||f||||||||||2017-10-11 01:08:46.843892|2017-10-11 01:08:46.843892
NCT01975181|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-05-17|||September 2013||2013-09-01|May 2016|2016-05-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01|3 Years|Observational [Patient Registry]|||Cardiovascular Health Program Registry|Cardiovascular Health Program Registry|Enrolling by invitation||N/A|5000|Anticipated|Walter Reed National Military Medical Center|||1||f||||f||||||||||2017-10-11 01:08:46.932252|2017-10-11 01:08:46.932252
NCT01975168|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-11-05|||September 2013||2013-09-01|November 2013|2013-11-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||The Effect Evaluation of Laser Acupuncture in Obesity|The Effect Evaluation of Laser Acupuncture in Obesity|Unknown status|Recruiting|N/A|200|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:08:47.04046|2017-10-11 01:08:47.04046
NCT01975155|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-08-26|||June 2013||2013-06-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Observational|||Dietary Assessment and Mycotoxin Exposure in Celiac Disease|Dietary Assessment and Mycotoxin Exposure in Celiac Subjects|Unknown status|Recruiting|N/A|100|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||2||f||||||||||Samples Without DNA|"     Urine   "|||2017-10-11 01:08:47.141495|2017-10-11 01:08:47.141495
NCT01975142|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-02-23|||October 2013||2013-10-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.|Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.|Active, not recruiting||Phase 2|155|Actual|Institut Curie||1|||f||||t||||||||No||2017-10-11 01:08:47.267536|2017-10-11 01:08:47.267536
NCT01975129|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-05-27|||September 2013||2013-09-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin|A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women With Vaginal Atrophy|Completed||Phase 2|12|Actual|PepTonic Medical AB||1|||f||||f||||||||||2017-10-11 01:08:47.36482|2017-10-11 01:08:47.36482
NCT01975077|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2014-12-09|||December 2012||2012-12-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||Phase Ib Study of Fruquintinib in Patients With Metastatic Colorectal Carcinoma|"A Randomized, Open-label Phase Ib Trial of Fruquintinib 4mg Once Daily ContinuousVersus 5mg Once Daily 3wks on/1wk Off in Patients With Metastatic Colorectal Carcinoma as 3rd Therapy"|Completed||Phase 1/Phase 2|62|Actual|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-11 01:08:47.906327|2017-10-11 01:08:47.906327
NCT01975064|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-10-26|||November 2013||2013-11-01|October 2016|2016-10-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|CAN||Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia|A Randomized, Open-label Study to Compare Propofol Anesthesia With Sevoflurane Anesthesia in Terms of Overall Survival in Patients With Surgical Intervention for Either Breast-, Colon- or Rectal Cancer|Recruiting||Phase 4|8000|Anticipated|Uppsala University||2|||f||||t||||||||No||2017-10-11 01:08:48.009114|2017-10-11 01:08:48.009114
NCT01975051|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2014-11-03|||January 2013||2013-01-01|November 2012|2012-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)|A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)|Completed||Phase 4|36|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||1|||f||||t||||||||||2017-10-11 01:08:48.202661|2017-10-11 01:08:48.202661
NCT01975038|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-07-30|||October 2013||2013-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Adaption of the Skin Sun Sensitivity Scale|Adaption of the Skin Sun Sensitivity Scale for People With All Pigment Varieties|Completed||N/A|292|Actual|Northwestern University|||1||f||||f||||||||||2017-10-11 01:08:48.307098|2017-10-11 01:08:48.307098
NCT01975025|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-04-05|||June 2014||2014-06-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|Intensified HD||Hemodialysis Frequency and the Calcification Propensity of Serum|Hemodialysis Frequency and the Calcification Propensity of Serum|Completed||N/A|17|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-10-11 01:08:48.445588|2017-10-11 01:08:48.445588
NCT01975012|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-08-31|||September 2014||2014-09-01|August 2015|2015-08-01||||May 2018|Anticipated|2018-05-01||Interventional|||Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age|A Phase I/II, Open-Label Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Rilpivirine in Antiretroviral Naive HIV-1 Infected Children, < 12 Years of Age|Withdrawn||Phase 1/Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 01:08:48.527105|2017-10-11 01:08:48.527105
NCT01974999|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-01-22|||October 2013||2013-10-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study|A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study (CTOT-17)|Completed||N/A|243|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||||||2017-10-11 01:08:48.623465|2017-10-11 01:08:48.623465
NCT01974986|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-05-31|||July 2013||2013-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|||Rehydration Following Exercise-Induced Dehydration|Rehydration Following Exercise-Induced Dehydration: Beverage Formula Effects in Team Sport Athletes|Completed||N/A|26|Actual|University of Illinois at Chicago||3|||f||||f||||||||||2017-10-11 01:08:48.715256|2017-10-11 01:08:48.715256
NCT01974973|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-09-23|||August 2009||2009-08-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||Stem Cell Therapy in Autism Spectrum Disorders|Open Label Study of Autologous Bone Marrow Mononuclear Cells in Autism Spectrum Disorders|Completed||Phase 1|162|Actual|Neurogen Brain and Spine Institute||1|||f||||t||||||||No||2017-10-11 01:08:48.797896|2017-10-11 01:08:48.797896
NCT01974947|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-07-05|||July 2013||2013-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|Metasperme||Metabolic Syndrome and Male Infertility|Relationship Between Sperm Parameters and Metabolic Syndrome in a Infertile Couple Partner Man|Active, not recruiting||N/A|170|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Blood and sperm samples will be collected from all patients BLOOD :Whole blood was collected     on dry, heparin or EDTA tubes. After several soft turnings, tubes were centrifuged at 1900g     for 10min.Then plasma, serum, buffy coat or red blood cells were taken in microtubes and     frozen at -80°C.      SPERM: After liquefaction, total sperm was centrifuged at 600g for 10min. Seminal plasma was     collected directly on microtubes and stored at -80°C. After trypsinisation, spermatozoa were     fixed in Carnoy solution and stored at -20°C.      DNA was separated from buffy coat using DNA extract kit   "|||2017-10-11 01:08:48.874784|2017-10-11 01:08:48.874784
NCT01974934|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-03-18|||December 2013||2013-12-01|March 2015|2015-03-01||||April 2016|Anticipated|2016-04-01||Interventional|||Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression|A 12 Week, Open Label, Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression|Unknown status|Recruiting|Phase 4|30|Anticipated|Hotel-Dieu Grace Healthcare||1|||f||||f||||||||||2017-10-11 01:08:48.953605|2017-10-11 01:08:48.953605
NCT01974921|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-11-19|||September 2013||2013-09-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of Physiopathological Mechanisms and Results of Treatment With Bronchial Thermoplasty in Severe Asthma|Study of Physiopathological Mechanisms and Results of Treatment With Bronchial Thermoplasty in Severe Asthma|Unknown status|Recruiting|N/A|15|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||t||||||||||2017-10-11 01:08:49.046909|2017-10-11 01:08:49.046909
NCT01974908|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2013-10-28|||November 2013||2013-11-01|October 2013|2013-10-01||||November 2014|Anticipated|2014-11-01||Interventional|||Fibrillatory Factor in Ventricular Tachycardia|Using Fibrillatory Factor to Predict the Source of Ventricular Tachycardia in Man|Unknown status|Not yet recruiting|N/A|20|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:08:49.149568|2017-10-11 01:08:49.149568
NCT01973413|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-04-03|2014-06-27||July 2013||2013-07-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study|Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study|Completed||N/A|32|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 01:09:12.140193|2017-10-11 01:09:12.140193
NCT01974895|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-09-22|2015-02-26||October 2013||2013-10-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|||Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age|Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) in Children 6 to 35 Months of Age|Completed||Phase 2|316|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:08:49.273272|2017-10-11 01:08:49.273272
NCT01974882|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-28|||May 2008||2008-05-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|Ice||Minimizing Post-surgical Pain and Narcotic Administration Through Cryotherapy|Minimizing Post-surgical Pain and Narcotic Administration Through Cryotherapy|Completed||N/A|55|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:08:50.293741|2017-10-11 01:08:50.293741
NCT01974869|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-02-06|||March 2014||2014-03-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01|30 Days|Observational [Patient Registry]|||Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response|The Effect of Anti-Tumor Necrosis Factor Agents on Surgical Stress Response in Inflammatory Bowel Disease Patients Undergoing Abdominal Surgery|Completed||N/A|47|Actual|El-Hussuna, Alaa, M.D.|||2||f||||t||||||Samples With DNA|"     Blood samples   "|Yes|To be planned|2017-10-11 01:08:50.389153|2017-10-11 01:08:50.389153
NCT01974856|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-09-14|||October 2013||2013-10-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Observational|||A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay|A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies, Inc. Breast Cancer Intrinsic Subtype Test|Completed||N/A|201|Actual|NanoString Technologies, Inc.|||1||f||||f||||||Samples With DNA|"     FFPE samples from breast tumor tissue   "|||2017-10-11 01:08:50.496944|2017-10-11 01:08:50.496944
NCT01974843|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2014-02-06|||January 2011||2011-01-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01|1 Day|Observational [Patient Registry]|||Caudal Block With Tramadol and Levobupivacaine or Bupivacaine|The Assessment of Bupivacaine-tramadol and Levobupivacaine-tramadol Combinations for Preemptive Caudal Anaesthesia in Children: a Randomized, Double-blind, Prospective Study|Completed||N/A|68|Actual|Duzce University|||2||f||||f||||||||||2017-10-11 01:08:50.590715|2017-10-11 01:08:50.590715
NCT01974830|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-04-21|||October 2013||2013-10-01|April 2017|2017-04-01|October 2025|Anticipated|2025-10-01|October 2020|Anticipated|2020-10-01|5 Years|Observational [Patient Registry]|AL1TER||AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry|AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry|Recruiting||N/A|400|Anticipated|Coram Clinical Trials|||1||f||||f||||||||||2017-10-11 01:08:50.691096|2017-10-11 01:08:50.691096
NCT01974817|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-09-27|2016-09-27||May 2013||2013-05-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease|Streptococcus Pneumoniae Colonization and Immunogenicity of 13-valent Conjugate Pneumococcal Vaccine in Patients 50 Years or Older With End Stage Renal Disease on Dialysis.|Completed||Phase 4|25|Actual|Michigan State University||1|||f||||f||||||||No||2017-10-11 01:08:50.811097|2017-10-11 01:08:50.811097
NCT01974804|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-12-27|||October 2013||2013-10-01|December 2016|2016-12-01||||October 2019|Anticipated|2019-10-01||Observational|||Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis|Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis|Recruiting||N/A|36|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 01:08:51.078668|2017-10-11 01:08:51.078668
NCT01974791|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-04-06|||October 2013||2013-10-01|April 2017|2017-04-01||||October 2017|Anticipated|2017-10-01||Interventional|GET Living||GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain|GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain|Active, not recruiting||N/A|32|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 01:08:51.172439|2017-10-11 01:08:51.172439
NCT01974778|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-01-13|||March 2014||2014-03-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Role for Brown Adipose Tissue in Postprandial Thermogenesis?|A Role for Brown Adipose Tissue in Postprandial Thermogenesis?|Terminated||N/A|4|Actual|Bayside Health||2||Participant numbers too low. Could not ingest required fat.|f||||f||||||||||2017-10-11 01:08:51.261541|2017-10-11 01:08:51.261541
NCT01974765|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-06-08|||November 2013|Actual|2013-11-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies|A Phase II Trial of Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies|Recruiting||Phase 2|58|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:08:51.367706|2017-10-11 01:08:51.367706
NCT01974752|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-01-04|2016-05-09||April 2014||2014-04-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|May 2015|Actual|2015-05-01||Interventional|SUMIT||Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)|A Randomised, Double-Blind Study to Assess the Efficacy of Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Combination With Dacarbazine Compared With Placebo in Combination With Dacarbazine as First Systemic Therapy in Patients With Metastatic Uveal Melanoma (SUMIT)|Completed||Phase 3|152|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:08:51.519172|2017-10-11 01:08:51.519172
NCT01974739|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-06-22|||September 2013||2013-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Hydrochloorthiazide and Hypernatriaemie|Hypernatraemia and Diuretics in Intensive Care Patients|Completed||N/A|50|Actual|Medical Centre Leeuwarden||2|||f||||f||||||||||2017-10-11 01:08:52.233064|2017-10-11 01:08:52.233064
NCT01974726|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-11-02|||October 2013||2013-10-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Gas Supply, Demand and Middle Ear Gas Balance -- Diagnosis of Eustachian Tube Dysfunction|Gas Supply, Demand and Middle Ear Gas Balance -- Project 1, Specific Aim 4, Protocol 3|Recruiting||N/A|460|Anticipated|University of Pittsburgh||4|||f||||f||||||||||2017-10-11 01:08:52.432056|2017-10-11 01:08:52.432056
NCT01974713|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-08-31|||April 2010|Actual|2010-04-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|April 2016|Actual|2016-04-01|3 Years|Observational [Patient Registry]|AIMtoPREVENT||Inflammatory Markers and Adverse Outcomes in Chronic Kidney Disease|CAN-AIM to PREVENT: CANadian Study, Assessing Inflammatory Markers to PRedict EVents in Nephrology sTudy|Completed||N/A|2530|Actual|Institute of Kidney Lifescience Technologies|||1||f||||f||||||Samples With DNA|"     serum   "|||2017-10-11 01:08:52.575872|2017-10-11 01:08:52.575872
NCT01974700|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-03-07|2016-03-07||July 2013||2013-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Seizure Prophylaxis in Aneurysm Repair|Seizure Prophylaxis in Aneurysm Repair|Terminated||Phase 4|17|Actual|Indiana University||2||"Lack of enrollment - since the start of the study in 2013, only 17 subjects have consented. Of   those, only 8 completed the study."|f||||||||||||||2017-10-11 01:08:52.650146|2017-10-11 01:08:52.650146
NCT01974687|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-05-18|||October 31, 2013|Actual|2013-10-31|May 2017|2017-05-01|September 11, 2015|Actual|2015-09-11|September 2, 2015|Actual|2015-09-02||Interventional|||Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)|A Phase I/IIa Study Assessing Single and Multiple Doses of IDX21437 in Healthy and HCV-Infected Subjects|Completed||Phase 1/Phase 2|178|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 01:08:52.952943|2017-10-11 01:08:52.952943
NCT01974674|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-09-28|||July 2013||2013-07-01|September 2016|2016-09-01|January 2022|Anticipated|2022-01-01|December 2016|Anticipated|2016-12-01||Interventional|GRIIF||Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes|Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes|Recruiting||Phase 2|19|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:08:53.073458|2017-10-11 01:08:53.073458
NCT01974661|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-09-27|||October 2013||2013-10-01|September 2017|2017-09-01|June 28, 2017|Actual|2017-06-28|June 28, 2017|Actual|2017-06-28||Interventional|||Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma|A Phase I Open-label Study to Evaluate Safety and Immunologic Response of COMBIG-DC Administered Intra-tumorally in Patients With Hepatocellular Carcinoma|Completed||Phase 1|18|Actual|Immunicum AB||1|||f||||t||||||||||2017-10-11 01:08:53.172358|2017-10-11 01:08:53.172358
NCT01974648|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-10-25|||May 2012||2012-05-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|SC50||Propofol for Supreme LMA Insertion With and Without Remifentanil|ED 50 of Propofol for Supreme LMA Insertion With and Without Remifentanil. A Randomized Trial|Completed||Phase 4|59|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-11 01:08:53.287458|2017-10-11 01:08:53.287458
NCT01974635|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-02-23|||October 2013||2013-10-01|February 2015|2015-02-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Proprioception Testing in Persons With Sensorimotor Impairment|Proprioception Testing in Persons With Sensorimotor Impairment|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Oregon Health and Science University||1|||f||||t||||||||||2017-10-11 01:08:53.399356|2017-10-11 01:08:53.399356
NCT01974622|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-10-28|||April 2013||2013-04-01|October 2013|2013-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|ICGguidedPDT||ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study|Indocyanine Green Angiography-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities.|Unknown status|Recruiting|N/A|30|Anticipated|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-10-11 01:08:53.512064|2017-10-11 01:08:53.512064
NCT01974609|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-08-30|||March 2016||2016-03-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Narcotic vs. Non-narcotic Pain Study Protocol|A Randomized, Controlled Trial Comparing Combination Therapy of Ibuprofen + Acetaminophen Versus Hydrocodone + Acetaminophen for the Treatment of Pain After Carpal Tunnel Surgery|Recruiting||Phase 4|400|Anticipated|Horizon Health Network||2|||f||||t||||||||||2017-10-11 01:08:53.605279|2017-10-11 01:08:53.605279
NCT01974596|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-10-27|||January 2008||2008-01-01|October 2013|2013-10-01|July 2010|Actual|2010-07-01|June 2008|Actual|2008-06-01||Interventional|||Use of Probiotics in Oral Health of Patients With Dental Implants|THE EFFECT OF ORALLY ADMINISTERED PROBIOTIC LACTOBACILLUS REUTERI-CONTAINING TABLETS IN PERI-IMPLANT MUCOSITIS: A RANDOMIZED CLINICAL TRIAL|Completed||Phase 2|34|Actual|University of Valencia||1|||f||||t||||||||||2017-10-11 01:08:53.780186|2017-10-11 01:08:53.780186
NCT01974583|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-10-27|||January 2002||2002-01-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|December 2010|Actual|2010-12-01|1 Year|Observational [Patient Registry]|||Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting|Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting|Completed||N/A|192|Actual|Tang-Du Hospital|||3||f||||t||||||||||2017-10-11 01:08:53.900582|2017-10-11 01:08:53.900582
NCT01974570|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-12-23|||November 2013||2013-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects|A Randomized, Double-blind, Placebo Controlled, Parallel Study for the Assessment of Anti-hypertensive Effect and Safety of Marealis RPC (Refined Peptide Concentrate), in Healthy Subjects With Mild or Moderate Hypertension|Completed||Phase 2|144|Actual|KGK Synergize Inc.||2|||f||||f||||||||||2017-10-11 01:08:54.009821|2017-10-11 01:08:54.009821
NCT01974557|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-10-20|||October 2013||2013-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|HemReX||The Effect of Age on the Hemodynamic Response During Rest and Exercise in Healthy Humans|The Effect of Age on the Hemodynamic Response During Rest and Exercise in Healthy Humans|Completed||N/A|60|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 01:08:54.191719|2017-10-11 01:08:54.191719
NCT01974544|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2013-10-27|||May 2013||2013-05-01|October 2013|2013-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|PRODIGIES||Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines|Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines|Unknown status|Recruiting|N/A|150|Anticipated|Pontificia Universidad Catolica de Chile||3|||f||||t||||||||||2017-10-11 01:08:54.289458|2017-10-11 01:08:54.289458
NCT01974531|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-03-29|||January 2013||2013-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01|2 Years|Observational [Patient Registry]|||Psychological Distress & Stress in Parents With Preterm infants-a Prospective Study|Psychological Distress & Stress in Parents With Preterm infants-a Prospective Study on Risk and Protective Psychobiological Aspects|Recruiting||N/A|180|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||||||2017-10-11 01:08:54.447257|2017-10-11 01:08:54.447257
NCT01974518|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2014-10-29|||November 2013||2013-11-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus|A PILOT STUDY TO ASSESS THE EFFICACY OF RITUXIMAB VERSUS COMBINATION OF RITUXIMAB AND INTRAVENOUS CYCLOPHOSPHAMIDE IN THE TREATMENT OF REFRACTORY PEMPHIGUS|Unknown status|Active, not recruiting|Phase 3|20|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 01:08:54.540979|2017-10-11 01:08:54.540979
NCT01974505|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-10-28|||November 2013||2013-11-01|October 2013|2013-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Learning Curve of Optiscope by Anesthesia Providers|Learning Curve of Optiscope by Anesthesia Providers|Unknown status|Not yet recruiting|N/A|140|Anticipated|Jeju National University School of Medicine||1|||f||||||||||||||2017-10-11 01:08:54.634744|2017-10-11 01:08:54.634744
NCT01974492|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2016-06-30|||October 2013||2013-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2015|Actual|2015-04-01||Interventional|COSAVEGUL-1||Comparison of Saphenous Vein Graft Harvested From Upper Versus Lower Leg in Coronary Artery Bypass Grafting|A Comparison of Histologic and Immunohistochemical Characteristics Between the Upper and Lower Leg Saphenous Veins Used for Coronary Artery Bypass Grafting|Completed||N/A|26|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:08:54.758255|2017-10-11 01:08:54.758255
NCT01974479|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2017-08-24|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Interventional|||Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia|Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia|Suspended||Phase 1|20|Anticipated|National University Health System, Singapore||1||"Suspended for 12 months - an interim review of (CAR) CD19 research strategy for the treatment   of CD19 positive ALL."|f||||f||||||||||2017-10-11 01:08:54.853012|2017-10-11 01:08:54.853012
NCT01974466|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2013-11-18|||August 2013||2013-08-01|November 2013|2013-11-01|August 2017|Anticipated|2017-08-01|September 2016|Anticipated|2016-09-01||Interventional|||Fluid Resuscitation Goal in Early Stage of Severe Acute Pancreatitis|Fluid Resuscitation Goal in Early Stage of Severe Acute Pancreatitis|Unknown status|Recruiting|N/A|60|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-11 01:08:55.000019|2017-10-11 01:08:55.000019
NCT01974453|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2017-04-04|||August 2012||2012-08-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01|1 Day|Observational [Patient Registry]|RADIANT||RAdiation Dose In percutANeuos Coronary Procedures Through Transradial Approach (RADIANT Observational Study)|RAdiation Dose In percutANeuos Coronary Procedures Through Transradial Approach (RADIANT Observational Study)|Completed||N/A|2028|Actual|Ospedale Sandro Pertini, Roma|||3||f||||||||||||||2017-10-11 01:08:55.159812|2017-10-11 01:08:55.159812
NCT01974440|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-07-27|||January 31, 2014|Actual|2014-01-31|July 2017|2017-07-01|August 3, 2021|Anticipated|2021-08-03|November 15, 2018|Anticipated|2018-11-15||Interventional|||A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Either Bendamustine and Rituximab (BR) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects With Previously Treated Indolent Non-Hodgkin Lymphoma (iNHL)|Active, not recruiting||Phase 3|403|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 01:08:55.252252|2017-10-11 01:08:55.252252
NCT01974427|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2017-06-30|||October 22, 2013||2013-10-22|June 16, 2017|2017-06-16|April 25, 2023|Anticipated|2023-04-25|April 25, 2023|Anticipated|2023-04-25||Observational|||Functional Brain Imaging in Healthy Volunteers to Study Cognitive Functions|Functional Brain Imaging in Healthy Volunteers to Study Cognitive Functions|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:08:55.641761|2017-10-11 01:08:55.641761
NCT01974414|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2013-10-26|||September 2011||2011-09-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Cedar Honey in Oral Lichen Planus|Cedar Honey in Treatment of Oral Lichen Planus: a Randomized Clinical Trial|Completed||Phase 1/Phase 2|36|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:08:55.906334|2017-10-11 01:08:55.906334
NCT01974401|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2013-10-26|||January 2010||2010-01-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|March 2011|Actual|2011-03-01||Interventional|||Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia|Effect of Using Supragingival Irrigators Containing Chlorhexidine on Oral Health in Patients With Blood Dyscrasia|Completed||Phase 2|20|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:08:56.000502|2017-10-11 01:08:56.000502
NCT01974388|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2015-11-20|||January 2008||2008-01-01|January 2008|2008-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|LSG||Impact of Extent of Antral Resection on Outcomes of Sleeve Gastrectomy|Impact of Extent of Antral Resection on Surgical Outcomes of Sleeve Gastrectomy for Morbid Obesity (A Prospective Randomized Study)|Completed||N/A|105|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 01:08:56.113937|2017-10-11 01:08:56.113937
NCT01974375|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-27|||August 2012||2012-08-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|KOPIN||Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients|Randomized, Open Label, Non-inferiority Study of Micafungin Versus Fluconazole for the Korean Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients|Unknown status|Recruiting|Phase 3|172|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:08:56.219008|2017-10-11 01:08:56.219008
NCT01974362|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2016-12-29|||December 2016||2016-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Monolithic Zirconia Full-Mouth Implant Supported Rehabilitation Behavior|Cad/Cam Monolithic Zirconia Behavior in Full-Mouth Implant Rehabilitation - Case-control Study|Recruiting||N/A|20|Anticipated|Instituto de Implantologia|||2||f||||f||||||||||2017-10-11 01:08:56.33141|2017-10-11 01:08:56.33141
NCT01974349|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-08-12|||November 2013||2013-11-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers|A Phase I, Randomized, Open-label, Single-center, Crossover Study to Assess the Effect of Food on the Pharmacokinetics of a 75 mg Single Oral Dose of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers Aged 18 to 45 Years|Completed||Phase 1|39|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:08:56.444636|2017-10-11 01:08:56.444636
NCT01974336|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2017-02-23|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|April 2016|Actual|2016-04-01||Interventional|||The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients|The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Parenteral Nutrition-associated Cholestasis in Short Bowel Syndrome|Completed||Phase 4|30|Actual|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 01:08:56.549346|2017-10-11 01:08:56.549346
NCT01974323|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-12-13|2016-05-05|2015-09-30|November 2013||2013-11-01|December 2016|2016-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris|A Safety and Efficacy Study to Compare Dapsone Dermal Gel With Vehicle Control in Patients With Acne Vulgaris|Completed||Phase 3|2238|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:08:56.650506|2017-10-11 01:08:56.650506
NCT01974310|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2016-02-10|||October 2013||2013-10-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Postoperative Positioning After Surgery for Macular Holes|A Randomized Clinical Trial of Face-down Protocol Versus Non-face-down Protocol After Surgery for Macular Holes.|Completed||N/A|68|Actual|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-10-11 01:08:57.232546|2017-10-11 01:08:57.232546
NCT01974297|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-10-31|||July 2013||2013-07-01|October 2013|2013-10-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|AVOCADO||Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid|Comparison of the Efficacy and AtorVastatin 20mg mOnotherapy Versus Combination Atorvastatin/Fenofibric Acid 10/135mg in the Mixed hyperlipiDemia Who Were Not at Lipid gOals With Atorvastatin 10mg Monotherapy.|Unknown status|Recruiting|N/A|194|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:08:57.853055|2017-10-11 01:08:57.853055
NCT01974284|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-07-12|||March 2014||2014-03-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma|Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma|Recruiting||N/A|20|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 01:08:58.526441|2017-10-11 01:08:58.526441
NCT01974271|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-11-01|||January 2014||2014-01-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)|IMPACT OF COMORBITIES ON HEMOGLOBIN STABILITY IN CHONIC KIDNEY DISEASE PATIENTS ON DIALYSIS TREATED WITH C.E.R.A|Completed||N/A|661|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:08:58.66967|2017-10-11 01:08:58.66967
NCT01974258|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-11-01|||February 2014||2014-02-01|November 2016|2016-11-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients|A PHASE Ib, OPEN-LABEL STUDY EVALUATING THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ONARTUZUMAB IN COMBINATION WITH VEMURAFENIB AND/OR COBIMETINIB IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES|Withdrawn||Phase 1|0|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 01:08:58.955399|2017-10-11 01:08:58.955399
NCT01974245|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-12-16|2014-12-05||July 2012||2012-07-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Supplementation With Cholecalciferol in Dialysis Patients|Impact of Treatment With Cholecalciferol on Immunological Markers in Patients With Hypovitaminosis D on Dialysis|Completed||Phase 2|55|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 01:08:59.099247|2017-10-11 01:08:59.099247
NCT01974232|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-01-30|||January 2012||2012-01-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013|A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013|Completed||N/A|33|Actual|Weill Medical College of Cornell University|||2||f||||f||||||||No||2017-10-11 01:08:59.438069|2017-10-11 01:08:59.438069
NCT01974219|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-23|||April 2013||2013-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||HIV-related Accelerated Aging of the Airway Epithelium|HIV-related Accelerated Aging of the Airway Epithelium|Recruiting||N/A|330|Anticipated|Weill Medical College of Cornell University|||3||f||||f||||||Samples With DNA|"     Blood, Urine, Cells   "|Undecided||2017-10-11 01:08:59.53577|2017-10-11 01:08:59.53577
NCT01974206|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-08-23||2017-05-01|November 20, 2013|Actual|2013-11-20|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|May 13, 2016|Actual|2016-05-13||Interventional|||A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor|Active, not recruiting||Phase 2|150|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 01:08:59.706268|2017-10-11 01:08:59.706268
NCT01974193|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2015-02-10|||December 2013||2013-12-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer|Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer: a Pilot Study|Unknown status|Recruiting|Phase 3|40|Anticipated|Ewha Womans University Mokdong Hospital||2|||f||||t||||||||||2017-10-11 01:08:59.929388|2017-10-11 01:08:59.929388
NCT01974180|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-09-19|||June 2013||2013-06-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function|Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function|Terminated||N/A|48|Actual|Weill Medical College of Cornell University|||1|Closed by investigator|f||||f||||||Samples With DNA|"     Airway epithelial samples collected under IRB protocol #1204012331 will be used.   "|Undecided||2017-10-11 01:09:00.020099|2017-10-11 01:09:00.020099
NCT01974167|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2014-08-05|||December 2013||2013-12-01|May 2014|2014-05-01||||February 2018|Anticipated|2018-02-01||Interventional|e-GLORIA||Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol||Recruiting||N/A|400|Anticipated|e-GLORIA trial Protocol Review Committee||2|||f||||f||||||||||2017-10-11 01:09:00.145584|2017-10-11 01:09:00.145584
NCT01959165|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-18|||November 21, 2013|Actual|2013-11-21|August 2017|2017-08-01|April 13, 2018|Anticipated|2018-04-13|August 11, 2015|Actual|2015-08-11||Interventional|||MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients||Active, not recruiting||Phase 2|44|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 01:13:27.774118|2017-10-11 01:13:27.774118
NCT01974154|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-23|||April 2012||2012-04-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function|COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function|Recruiting||N/A|226|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||Samples With DNA|"     Lung epithelial lining fluid (ELF) obtained by bronchoalveolar lavage (BAL)   "|Undecided||2017-10-11 01:09:00.343965|2017-10-11 01:09:00.343965
NCT01974141|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2016-12-13|2016-04-07|2015-09-30|November 2013||2013-11-01|December 2016|2016-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris|A Safety and Efficacy Study to Compare Dapsone Dermal Gel With Vehicle Control in Patients With Acne Vulgaris|Completed||Phase 3|2102|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:09:00.52455|2017-10-11 01:09:00.52455
NCT01974128|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-07-19|||October 2014||2014-10-01|March 2017|2017-03-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|Acute MI||Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation by a Catheter Delivery System and/or Intravenously In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction|Withdrawn||N/A|0|Actual|Ageless Regenerative Institute||1||no participants enrolled|f||||f||||||||||2017-10-11 01:09:01.130092|2017-10-11 01:09:01.130092
NCT01974115|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2013-10-28|||December 2008||2008-12-01|October 2013|2013-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Extracorporeal Shock Wave Treatment for Cellulite|Clinical Effects of the Radial Extracorporeal Shock Wave Therapy (rESWT) Using the EMS Swiss Dolorclast and the Power+ Handpiece for Local Treatment of Cellulite|Completed||N/A|14|Actual|Concept-Clinic||1|||f||||f||||||||||2017-10-11 01:09:01.21873|2017-10-11 01:09:01.21873
NCT01974102|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2016-11-28|||October 2013||2013-10-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Family Based Mindfulness Intervention|Preventing Childhood Obesity Through a Family-Based Mindfulness Intervention|Completed||N/A|74|Actual|Yale University||2|||f||||t||||||||||2017-10-11 01:09:01.319811|2017-10-11 01:09:01.319811
NCT01974089|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-10-31|||October 2013||2013-10-01|October 2013|2013-10-01|April 2015|Anticipated|2015-04-01|October 2013|Anticipated|2013-10-01||Interventional|||Dysphagia and Pneumonia|Dysphagia in Patients With Community Acquired Pneumonia|Unknown status|Recruiting|N/A|180|Anticipated|Vendsyssel Hospital||1|||f||||f||||||||||2017-10-11 01:09:01.460202|2017-10-11 01:09:01.460202
NCT01974076|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2014-12-02|||May 2014||2014-05-01|December 2014|2014-12-01||||September 2018|Anticipated|2018-09-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) as an Adjunct to Cognitive Behaviour Therapy (CBT)|A Study of Transcranial Direct Current Stimulation (tDCS) as an Adjunct to Cognitive Behavioural Therapy (CBT) for Depression|Recruiting||N/A|135|Anticipated|The University of New South Wales||2|||f||||t||||||||||2017-10-11 01:09:01.815412|2017-10-11 01:09:01.815412
NCT01974063|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-05-23|||January 2013||2013-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Alternate Nicotine Delivery Systems and Airway Epithelial Biology|Alternate Nicotine Delivery Systems and Airway Epithelial Biology|Recruiting||N/A|125|Anticipated|Weill Medical College of Cornell University|||5||f||||t||||||Samples With DNA|"     Analysis performed will be completed per the Airway (IRB#1204012331) protocol.   "|Undecided||2017-10-11 01:09:01.962932|2017-10-11 01:09:01.962932
NCT01974037|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2016-01-07|||May 2013||2013-05-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Capsaicin on Salty Gustatory Cortices|Effects of Capsaicin on Salty Gustatory Cortices in Human|Completed||Phase 4|80|Actual|Third Military Medical University||8|||f||||t||||||||||2017-10-11 01:09:02.257732|2017-10-11 01:09:02.257732
NCT01974024|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-04-27|||October 1, 2013|Actual|2013-10-01|April 2017|2017-04-01|July 31, 2016|Actual|2016-07-31|June 30, 2016|Actual|2016-06-30||Interventional|||Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation|Antiemetic Corticosteroid Rotation From Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated With Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial|Completed||Phase 3|65|Actual|Chung-Ang University||2|||f||||f|f|f|||f|||Undecided||2017-10-11 01:09:02.431964|2017-10-11 01:09:02.431964
NCT01974011|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-09-11|||November 2013||2013-11-01|September 2017|2017-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||DPNB vs. Modified DPNB With Ventromedial Infiltration (DPNB According to Dalens' Technique)|Comparison of Dorsal Penile Nerve Block (DPNB According to Dalens' Technique) to Dorsale Penile Nerve Block With Ventromedial Infiltration|Completed||N/A|82|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 01:09:02.564968|2017-10-11 01:09:02.564968
NCT01973985|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2014-06-03|||June 2014||2014-06-01|June 2014|2014-06-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01|3 Months|Observational [Patient Registry]|||Using Ultrasound to Predict the Results of Draining Pleural Effusions|Correlation of Pleural Manometry With Real-time Thoracic Ultrasound, Symptomatic Benefit and Clinical Outcome in Patients With Pleural Effusion: a Pilot Study|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Oxford|||1||f||||f||||||||||2017-10-11 01:09:02.805983|2017-10-11 01:09:02.805983
NCT01973972|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-09-08|||December 12, 2014|Actual|2014-12-12|September 2017|2017-09-01|October 1, 2018|Anticipated|2018-10-01|July 31, 2017|Actual|2017-07-31||Interventional|Jump Start||Jump Start Shared Medical Appointments for Diabetes With Weight Management|Jump Starting Shared Medical Appointments for Diabetes With Weight Management|Active, not recruiting||N/A|308|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 01:09:02.91442|2017-10-11 01:09:02.91442
NCT01973959|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-10-25|||October 2011||2011-10-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Information Transfer During Postoperative Handovers in the Post-anaesthesia Care Unit|Quality of Postoperative Patient Handover in the Post-anaesthesia Care Unit: A Prospective Analysis|Completed||N/A|790|Actual|University of Witten/Herdecke|||1||f||||f||||||||||2017-10-11 01:09:03.046484|2017-10-11 01:09:03.046484
NCT01973946|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-02-28|||September 2007||2007-09-01|February 2017|2017-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Cancer Symptom Monitoring Telephone System With Nurse Practitioner (NP) Follow up|Telephone Linked Care: An IT Enabled Integrated System for Cancer Symptom Relief|Completed||N/A|358|Actual|University of Utah||2|||f||||t||||||||No||2017-10-11 01:09:03.115475|2017-10-11 01:09:03.115475
NCT01973933|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2013-10-27|||June 2013||2013-06-01|October 2013|2013-10-01||||August 2013|Actual|2013-08-01||Interventional|||Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction of Pyrimethamine and Metformin IR|A Open-label, Single Sequence Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Pyrimethamine and Metformin IR After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:09:03.216041|2017-10-11 01:09:03.216041
NCT01973920|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2016-03-28|||December 2013||2013-12-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study|A Single Center, Multiple-dose, Non-randomized, Dose Adjustment, Open-Label Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Tolerability of Oshadi Icp in Patients With Type 1 Diabetes Mellitus -A Phase II Clinical Study|Recruiting||Phase 2|12|Anticipated|Oshadi Drug Administration||1|||f||||||||||||||2017-10-11 01:09:03.301542|2017-10-11 01:09:03.301542
NCT01973907|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-27|2016-08-16|||January 2014||2014-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SQUEEZE||Pilot Study for the SQUEEZE Trial|Pilot Study for the SQUEEZE Trial: a Trial to Determine Whether Septic Shock Reversal is Quicker in Pediatric Patients Randomized to an Early Goal Directed Fluid-sparing Strategy vs. Usual Care (SQUEEZE)|Completed||Phase 3|53|Actual|McMaster Children's Hospital||2|||f||||f||||||||Yes|The final trial data set will be made publicly available.|2017-10-11 01:09:03.435456|2017-10-11 01:09:03.435456
NCT01973894|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2017-05-23|||January 2013||2013-01-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|MidPBPK||Midazolam Whole Body Physiologically Based Pharmacokinetic Model|Whole Body Physiologically Based Pharmacokinetic (PBPK) Model to Estimate Cerebral and Systemic Midazolam Concentrations in ICU Patients Under Sedation.|Completed||N/A|20|Actual|Università degli Studi dell'Insubria|||1||f||||t||||||Samples Without DNA|"     serum and urine   "|||2017-10-11 01:09:03.579405|2017-10-11 01:09:03.579405
NCT01973881|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-06-15|||December 2014||2014-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Quantitative MRI for Myelofibrosis|Quantitative MRI for Myelofibrosis - MRI Parameters as Biomarkers for Analyzing Extent of Disease and Measuring Response to Treatment|Recruiting||N/A|120|Anticipated|University of Michigan|||1||f||||t||||||||No||2017-10-11 01:09:03.692328|2017-10-11 01:09:03.692328
NCT01973868|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-28|2017-07-28|||November 21, 2013|Actual|2013-11-21|July 2017|2017-07-01|October 26, 2017|Anticipated|2017-10-26|August 10, 2017|Anticipated|2017-08-10||Interventional|||Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination|A Phase 1b, Multi-center, Non-randomized, Open Label, Dose Escalation Design Study of Regorafenib (BAY73-4506) in Combination With Cetuximab in Subjects With Locally Advanced or Metastatic Solid Tumors Who Are Not Candidates for Standard Therapy or in Whom Regorafenib or Cetuximab is Considered as a Standard Treatment|Active, not recruiting||Phase 1|44|Actual|Bayer||1|||f||||f|t|f||||||||2017-10-11 01:09:03.828492|2017-10-11 01:09:03.828492
NCT01973855|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-31|||January 2012||2012-01-01|October 2013|2013-10-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01||Interventional|||Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms|Syndrome of Fever Associated With Bleeding of Chinese and Western Medicine Diagnosis and Treatment of Infectious Diseases Plans and Severe Clinical Treatment Research|Unknown status|Recruiting|Phase 2|300|Anticipated|Guangzhou 8th People's Hospital||2|||f||||t||||||||||2017-10-11 01:09:03.929836|2017-10-11 01:09:03.929836
NCT01973842|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-02-11|||February 2014||2014-02-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|ATD||Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients|Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients Undergoing Ovarian Stimulation for IVF With GnRH Antagonists and Recombinant FSH.|Recruiting||Phase 2|90|Anticipated|Aristotle University Of Thessaloniki||3|||f||||t||||||||||2017-10-11 01:09:04.0605|2017-10-11 01:09:04.0605
NCT01973829|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-03-21|||November 2013||2013-11-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)|The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)|Recruiting||N/A|15000|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:09:04.255812|2017-10-11 01:09:04.255812
NCT01973816|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-06-13|||November 2014||2014-11-01|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|March 2018|Anticipated|2018-03-01||Interventional|MESURE||MEdical Versus SUrgical Treatments of Rectal Endometriosis|Randomized Trial Comparing Functional Digestive Outcomes Related to Two Types of Management of Rectal Endometriosis: Continuous Hormonal Treatment and Curative Surgery|Recruiting||Phase 3|78|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 01:09:04.48415|2017-10-11 01:09:04.48415
NCT01973803|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-10-27|||September 2013||2013-09-01|October 2013|2013-10-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Observational|||Clinical Evaluation of the Articulinx InterCarpoMetacarpal Cushion (ICMC) for Osteoarthritis of the First Metacarpal Joint||Unknown status|Enrolling by invitation|N/A|40|Anticipated|Articulinx|||1||f||||f||||||||||2017-10-11 01:09:04.675044|2017-10-11 01:09:04.675044
NCT01973790|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2017-06-27|||March 2014||2014-03-01|January 2017|2017-01-01|April 2017|Actual|2017-04-01|November 2016|Actual|2016-11-01||Interventional|||Phase III, Long-term, Open-label Safety Study of Z-338|A Phase III, Multicentre, Single-arm, Open-label Study to Evaluate the Long-term Safety of Z-338 in Subjects With Functional Dyspepsia|Completed||Phase 3|207|Actual|Zeria Pharmaceutical||1|||f||||f||||||||||2017-10-11 01:09:04.763029|2017-10-11 01:09:04.763029
NCT01973777|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-26|2017-03-26|2015-12-31||December 2013|Actual|2013-12-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2015|Actual|2015-05-01||Interventional|IUB||A Pilot Study of Early Expulsion Rates of the IUB™ SCu380A|A Pilot Study of Early Expulsion Rates of the IUB™ SCu380A Spherical Copper Intrauterine Contraceptive Device.|Active, not recruiting||N/A|51|Actual|Wiebe, Ellen, M.D.||1|||f||||f||||||||||2017-10-11 01:09:04.957784|2017-10-11 01:09:04.957784
NCT01973764|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-07-27|||November 2013||2013-11-01|July 2015|2015-07-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|In-Vent||Intraventricular Drain Insertion: Comparison of Ultrasound-guided and Landmark-based Puncture of the Ventricular System|Intraventricular Drain Insertion:Comparison of Ultrasound-guided and Landmark-based Puncture of the Ventricular System. A Prospective Randomised Clinical Trial Study.|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 01:09:05.156224|2017-10-11 01:09:05.156224
NCT01973738|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-10-18|||January 2012||2012-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Comparison Between Raloxifene and Bazedoxifene|Comparison of the Clinical Efficacy and Safety Between Raloxifene and Bazedoxifene in Postmenopausal Women.|Recruiting||N/A|300|Anticipated|Tomidahama Hospital|||1||f||||f||||||||||2017-10-11 01:09:05.41594|2017-10-11 01:09:05.41594
NCT01973725|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-11-18|||October 2013||2013-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy|PhaseⅡ Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Squamous Carcinoma After Failure of Conventional Chemotherapy|Recruiting||Phase 2|50|Anticipated|Sun Yat-sen University||1|||f||||t||||||||Yes||2017-10-11 01:09:05.51767|2017-10-11 01:09:05.51767
NCT01973712|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-17|||May 2014||2014-05-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Periprosthetic Distal Femur Fracture|Treatment of Periprosthetic Distal Femur Fractures: A Randomized Controlled Trial of Locking Plate Osteosynthesis Versus Retrograde Nailing|Recruiting||N/A|94|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:09:05.636049|2017-10-11 01:09:05.636049
NCT01973699|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-12-31|||November 2012||2012-11-01|December 2015|2015-12-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Visualization in Shoulder Arthroscopy With and Without Epinephrine|Surgeon Determined Visualization in Shoulder Arthroscopy: A Randomized, Blinded, Controlled Trial Comparing Irrigation Fluid With and Without Epinephrine|Completed||N/A|83|Actual|St. Luke's Hospital, Pennsylvania||2|||f||||t||||||||||2017-10-11 01:09:05.749498|2017-10-11 01:09:05.749498
NCT01973686|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-10-19|||October 2013||2013-10-01|October 2015|2015-10-01||||October 2015|Anticipated|2015-10-01||Interventional|||GO-ACTIWE Energy Metabolism|Active Commuting To Improve Well-being and Health in Everyday Life (ACTIWE)|Unknown status|Active, not recruiting|N/A|125|Anticipated|University of Copenhagen||3|||f||||t||||||||||2017-10-11 01:09:05.857591|2017-10-11 01:09:05.857591
NCT01973673|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-05-03|||September 2013||2013-09-01|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||Healthy Bones Study|Healthy Bones Study: An Intervention to Improve Healthy Bone Behaviours in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)|Completed||N/A|200|Actual|University Health Network, Toronto||2|||f||||f||||||||No||2017-10-11 01:09:05.97827|2017-10-11 01:09:05.97827
NCT01973660|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-02-13|||October 2013||2013-10-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|June 2016|Actual|2016-06-01||Interventional|PAMELA||PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer|PAMELA: PAM50 HER2-enriched Phenotype as a Predictor of Early Response to Neoadjuvant Lapatinib Plus Trastuzumab in Stage I to IIIA HER2-positive Breast Cancer|Active, not recruiting||Phase 2|151|Actual|SOLTI Breast Cancer Research Group||2|||f||||t||||||||||2017-10-11 01:09:07.640289|2017-10-11 01:09:07.640289
NCT01973647|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-10-24|||June 2014||2014-06-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Behavioral Therapy for Insomnia Co-existing With COPD|Efficacy and Mechanisms of a Behavioral Therapy for Insomnia Co-existing With COPD|Recruiting||N/A|140|Anticipated|University of Illinois at Chicago||4|||f||||t||||||||||2017-10-11 01:09:07.846007|2017-10-11 01:09:07.846007
NCT01973634|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2014-12-04|||December 2012||2012-12-01|December 2014|2014-12-01|March 2021|Anticipated|2021-03-01|December 2015|Anticipated|2015-12-01||Interventional|SeqB vs SIB||Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery.|Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery|Recruiting||Phase 2|170|Anticipated|University Hospital, Ghent||4|||f||||f||||||||||2017-10-11 01:09:08.027695|2017-10-11 01:09:08.027695
NCT01973621|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-12-17|||September 2012||2012-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:09:08.14698|2017-10-11 01:09:08.14698
NCT01973608|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-09-14|2016-06-30||January 2014||2014-01-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional||Safety analyst set included all subjects who signed informed consent, were enrolled into the study and received at least 1 dose of MSB0010445.|MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma|A Safety Study for MSB0010445 in Combination With Stereotactic Body Radiation in Advanced Melanoma Subjects Following Prior Treatment With Ipilimumab|Terminated||Phase 2|12|Actual|EMD Serono|The study was terminated early due to sponsor’s decision to discontinue the development of MSB0010445. The decision to discontinue development of MSB0010445 was not related to any safety or efficacy concerns.|4||"The study is terminated prematurely as the sponsor decided to discontinue program of NHS-IL2   [MSB0010445]"|f||||||||||||||2017-10-11 01:09:08.217728|2017-10-11 01:09:08.217728
NCT01973595|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-04-26|2015-11-12||December 2013||2013-12-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Data from parents and children were analyzed separately. All parents and children received both treatments arms.|Almonds: Digestive Health and Immune Function of Adults and Children|Almonds: Digestive Health and Immune Function of Adults and Children: a Randomized Crossover Study|Completed||N/A|58|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:09:09.515012|2017-10-11 01:09:09.515012
NCT01973582|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2013-10-25|||July 2011||2011-07-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Observational|||Hepatitis B Seroepidemiology Among Young Adults|A Retrospective Cohort Study of Hepatitis B Seroepidemiology Among Young Adults|Unknown status|Recruiting|N/A|6000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples Without DNA|"     Serum, blood cells   "|||2017-10-11 01:09:09.940913|2017-10-11 01:09:09.940913
NCT01973556|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2013-10-25|||July 2010||2010-07-01|October 2013|2013-10-01||||June 2012|Actual|2012-06-01||Interventional|||Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) Demonstration Project|Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) Demonstration Project|Completed||N/A|75|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:09:10.131677|2017-10-11 01:09:10.131677
NCT01973543|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-06-26|||October 2013|Actual|2013-10-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|AADC||Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease|An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Into the Putamen of Subjects With Parkinson's Disease With Fluctuating Responses to Levodopa|Active, not recruiting||Phase 1|15|Actual|Voyager Therapeutics||3|||f||||t||||||||Undecided||2017-10-11 01:09:10.200559|2017-10-11 01:09:10.200559
NCT01973530|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2014-09-08|||October 2014||2014-10-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|February 2015|Anticipated|2015-02-01||Interventional|||Comparison of Femoral Nerve Catheter and Adductor Canal Block With Steroid Adjuvant in Total Knee Replacement (TKR)|Comparison of the Analgesic Efficacy of Continuous Femoral Nerve Block and Adductor Canal Block With Steroid Adjuvant in Patients Undergoing Total Knee Arthroplasty|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Queen Elizabeth Hospital, Hong Kong||2|||f||||t||||||||||2017-10-11 01:09:10.301096|2017-10-11 01:09:10.301096
NCT01973517|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-10-03|||April 2014||2014-04-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases|7T MRI Ferumoxytol-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases|Suspended||N/A|15|Anticipated|Stanford University|||1|Logistical factors affecting recruitment|f||||f||||||||||2017-10-11 01:09:10.408025|2017-10-11 01:09:10.408025
NCT01973504|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-10-25|||December 2013||2013-12-01|October 2013|2013-10-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Phase 2c Dose Comparison Study of MP4OX in Trauma|A Multi-center, Multinational, Randomized, Double-blind, Controlled, Dose Comparison Study to Evaluate Safety and Efficacy of MP4OX Plus Standard Treatment, in Severely Injured Trauma Subjects With Lactic Acidosis Due to Hemorrhagic Shock|Withdrawn||Phase 2|0|Actual|Sangart||3||Sangart ceased operations|f||||t||||||||||2017-10-11 01:09:10.518973|2017-10-11 01:09:10.518973
NCT01973491|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-06-05|2017-03-01||February 28, 2014|Actual|2014-02-28|June 2017|2017-06-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Interventional||The Safety (SAF) Analysis Set included all subjects who received at least 1 dose of investigational medicinal product (IMP).|ATX-MS-1467 in Multiple Sclerosis|An Open-label, One-arm, Proof of Concept Trial to Evaluate the Safety of ATX-MS-1467 (MSC2358825A) and Its Effect on Immune Tolerance in Subjects With Relapsing Multiple Sclerosis|Completed||Phase 2|37|Actual|Merck KGaA||1|||f||||t||||||||||2017-10-11 01:09:10.728805|2017-10-11 01:09:10.728805
NCT01973478|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-21|||May 2014||2014-05-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|March 2018|Anticipated|2018-03-01||Interventional|STHYM||Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression|Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression|Active, not recruiting||Phase 3|40|Anticipated|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 01:09:11.415789|2017-10-11 01:09:11.415789
NCT01973465|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-10-25|||September 2013||2013-09-01|October 2013|2013-10-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis|Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis|Unknown status|Recruiting|N/A|10|Anticipated|OSF Healthcare System||1|||f||||f||||||||||2017-10-11 01:09:11.546444|2017-10-11 01:09:11.546444
NCT01973452|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-02-07|||October 2013|Actual|2013-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery|A Double-Masked Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery|Active, not recruiting||Phase 3|332|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:09:11.637042|2017-10-11 01:09:11.637042
NCT01973439|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2014-02-03|2013-12-04||July 2006||2006-07-01|February 2014|2014-02-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|PENTA15||PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months|PENTA15: Plasma Pharmacokinetic Study of Once Versus Twice Daily Abacavir as Part of Combination Antiretroviral Therapy in Children With HIV-1 Infection Aged 3 Months to <36 Months|Completed||Phase 1|23|Actual|PENTA Foundation||1|||f||||f||||||||||2017-10-11 01:09:11.741346|2017-10-11 01:09:11.741346
NCT01973426|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-04-27|||October 2013||2013-10-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|January 2014|Actual|2014-01-01||Observational|IOTA||Evaluating Human-Machine Interfaces in a Robotic Thumb Orthosis|Development and Evaluation of a Human-Machine Interface for Grasp Assistance Using a Robotic Thumb Orthosis in Children With Hemiplegic Cerebral Palsy and Hemiplegic Stroke|Active, not recruiting||N/A|12|Actual|Wyss Institute at Harvard University|||1||f||||f||||||||||2017-10-11 01:09:12.044534|2017-10-11 01:09:12.044534
NCT01973400|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-05-01|||June 2011||2011-06-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|September 2015|Actual|2015-09-01||Interventional|VENUS||Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus|A Clinical Study on the Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus|Completed||Phase 3|300|Actual|University of Science Malaysia||2|||f||||t|f|f||||||||2017-10-11 01:09:12.610098|2017-10-11 01:09:12.610098
NCT01973387|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-05-04|2016-11-29||October 28, 2013|Actual|2013-10-28|May 2017|2017-05-01|June 1, 2017|Anticipated|2017-06-01|December 1, 2015|Actual|2015-12-01||Interventional||Intent-to-Treat (ITT) analysis set is defined as all participants randomized into the study.|A Study of PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/Lymphoma|A Randomized, Multicenter, Open-Label, Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor PCI-32765 (Ibrutinib) Versus Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Active, not recruiting||Phase 3|160|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 01:09:12.744117|2017-10-11 01:09:12.744117
NCT01973374|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-02-19|||January 2013||2013-01-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|Sugar Text||Sugar Text: A Randomized Controlled Trial of a Text Message Intervention for Women With Diabetes in Pregnancy|Sugar Text: A Randomized Controlled Trial of a Text Message Intervention for Women With Diabetes in Pregnancy|Completed||N/A|30|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:09:13.646829|2017-10-11 01:09:13.646829
NCT01973348|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-07-25|2017-04-25||November 2013||2013-11-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Comparison of AmblyzTM Glasses and Patching for Amblyopia|Comparison of AmblyzTM Glasses and Patching for Amblyopia|Terminated||N/A|45|Actual|Indiana University|"Sample size is limited; some patients did not come for followup visit.
Compliance with treatment is only estimated with calendar log and many patients did not bring back report."|4||funding and personnel are lack.|f||||t||||||||||2017-10-11 01:09:13.846563|2017-10-11 01:09:13.846563
NCT01973335|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-10-27|||November 2013||2013-11-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|DIURESIS-CHF||Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure|Diamox/Aldactone to Increase the URinary Excretion of Sodium: an Investigational Study in Congestive Heart Failure|Recruiting||Phase 4|80|Anticipated|Hasselt University||4|||f||||t||||||||||2017-10-11 01:09:14.409053|2017-10-11 01:09:14.409053
NCT01973322|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-09-28|||July 2013||2013-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ABSIDE||"Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized Proof-of-principle Phase II Study"|"Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized Proof-of-principle Phase II Study"|Recruiting||Phase 2|24|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||4|||f||||t||||||||||2017-10-11 01:09:14.603718|2017-10-11 01:09:14.603718
NCT01973309|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-09-13|||September 2013||2013-09-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|June 2017|Actual|2017-06-01||Interventional|||A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer|A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer|Active, not recruiting||Phase 1|37|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 01:09:14.774884|2017-10-11 01:09:14.774884
NCT01973296|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-01-22|||November 2013||2013-11-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Implementing an Emergency Department to Home Care Transition Intervention|Implementing an Emergency Department to Home Care Transition Intervention|Completed||N/A|62|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 01:09:14.894473|2017-10-11 01:09:14.894473
NCT01973283|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2016-12-27|||September 2011||2011-09-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults|Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults|Recruiting||Phase 4|60|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 01:09:14.987055|2017-10-11 01:09:14.987055
NCT01973270|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-10-04|||December 2013||2013-12-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|COTES||Community-Based Cognitive Training in Early Schizophrenia|Community-Based Cognitive Training in Early Schizophrenia|Recruiting||N/A|125|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 01:09:15.133477|2017-10-11 01:09:15.133477
NCT01973257|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-31|||August 2007||2007-08-01|October 2013|2013-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Perfusion and Diffusion Mechanism of Intervertebral Disc-Significance With Age, Degeneration, Posture and Stress Loading.|Perfusion and Diffusion Mechanism of Intervertebral Disc-Significance With Age, Degeneration, Posture and Stress Loading.|Completed||N/A|50|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 01:09:15.233777|2017-10-11 01:09:15.233777
NCT01973244|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-03-25|||December 2013||2013-12-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency|A Randomised, Open-labelled, Active-controlled, Multinational, Dose-escalation Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (NNC0195-0092) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency|Completed||Phase 1|32|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:09:15.32808|2017-10-11 01:09:15.32808
NCT01973231|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-12-15|2015-11-18||October 2013||2013-10-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|LIRA-LIXI™||Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes|Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes|Completed||Phase 4|404|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:09:15.49871|2017-10-11 01:09:15.49871
NCT01973218|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-10-05|2015-02-20||November 2013||2013-11-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.|A Phase 3, Randomized, Observer-blind, Multicenter Study to Evaluate the Immunogenicity and Safety of Novartis rMenB+OMV NZ Vaccine in Healthy Subjects Aged 11 to 17 Years in Korea|Completed||Phase 3|264|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:09:16.2182|2017-10-11 01:09:16.2182
NCT01973205|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-06-09|2015-05-20||October 2013||2013-10-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine|A Multi-center, Randomized, Double-blind, Parallel-group, Single-dose, Placebo-controlled Study Comparing the Efficacy and Safety of a Combination of Acetaminophen and Aspirin vs Placebo in the Acute Treatment of Migraine|Completed||Phase 3|900|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:09:17.165984|2017-10-11 01:09:17.165984
NCT01973192|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-04-03|||May 2013||2013-05-01|April 2017|2017-04-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Observational|Early CF||Viral Pathogenesis of Early Cystic Fibrosis Lung Disease|Viral Pathogenesis of Early Cystic Fibrosis Lung Disease|Completed||N/A|65|Actual|Indiana University|||1||f||||t|f|f||||Samples With DNA|"     Blood Urea, Bronchopulmonary Lavage samples, Nasal swabs and Oral swabs, Stool samples   "|||2017-10-11 01:09:17.695272|2017-10-11 01:09:17.695272
NCT01973179|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-07-25|||July 2015||2015-07-01|July 2017|2017-07-01|August 2023|Anticipated|2023-08-01|August 2022|Anticipated|2022-08-01||Observational|ReKo||Re-irradiation of Recurrent Head and Neck Cancer|Observational Study to Re-irradiation for Recurrent Head and Neck Cancer|Recruiting||N/A|50|Anticipated|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 01:09:17.782287|2017-10-11 01:09:17.782287
NCT01973166|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2014-07-24|||September 2013||2013-09-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Interventional|||Study of Picosecond and Nanosecond Q-switched Lasers for Tattoo Removal|Randomized, Split-tattoo Study Comparing Safety and Efficacy of Picosecond and Nanosecond Q-switched Nd:YAG Lasers for Tattoo Removal|Completed||N/A|44|Actual|Cutera Inc.||2|||f||||f||||||||||2017-10-11 01:09:17.89241|2017-10-11 01:09:17.89241
NCT01973153|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2014-01-30|||January 2012||2012-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Added Value of Telephone Follow Up and Home Visits in Helping Children to Grow Up Healthy|The Added Value of Telephone Follow Up and Home Visits in Helping Children to Grow Up Healthy|Completed||N/A|81|Actual|Connecticut Children's Medical Center||3|||f||||f||||||||||2017-10-11 01:09:17.990821|2017-10-11 01:09:17.990821
NCT01973140|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-09-26|||November 2013||2013-11-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Tolvaptan in Healthy Adults|Variation in the Aquaretic Efficacy of Tolvaptan in Healthy Adults|Completed||Phase 4|17|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 01:09:18.087275|2017-10-11 01:09:18.087275
NCT01973127|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-25|||May 2014||2014-05-01|October 2013|2013-10-01|December 2016|Anticipated|2016-12-01|April 2015|Anticipated|2015-04-01||Interventional|MAGENTA||Transcranial Magnetic Stimulation in the Treatment of Addiction|Repetitive Transcranial Magnetic Stimulation (rTMS) in Alcohol Dependent Patients: a Mechanistic Study.|Unknown status|Not yet recruiting|N/A|30|Anticipated|IrisZorg||2|||f||||f||||||||||2017-10-11 01:09:18.203782|2017-10-11 01:09:18.203782
NCT01973114|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-03-22|||October 2013||2013-10-01|March 2016|2016-03-01||||May 2016|Anticipated|2016-05-01||Interventional|||Latanoprost for the Treatment of Menière's Disease|A Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Determine the Efficacy, the Duration of Action, and Safety of Latanoprost in Patients With Menière's Disease|Active, not recruiting||Phase 2|100|Actual|Synphora AB||4|||f||||||||||||||2017-10-11 01:09:18.360368|2017-10-11 01:09:18.360368
NCT01973101|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-07-14|||June 2012||2012-06-01|July 2014|2014-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|CIRCE||Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.|Phase II, Prospective, Randomized, Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.|Unknown status|Recruiting|Phase 2|120|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||||||||||||2017-10-11 01:09:18.497708|2017-10-11 01:09:18.497708
NCT01973088|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2013-12-08|||November 2013||2013-11-01|September 2013|2013-09-01||||June 2015|Anticipated|2015-06-01||Observational|||Screening and Identification of Human Urate Transporter hURAT1 MicroRNA||Unknown status|Active, not recruiting|N/A|80|Anticipated|Southwest Hospital, China|||3||f||||||||||||||2017-10-11 01:09:18.611553|2017-10-11 01:09:18.611553
NCT01973075|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2017-08-09|||November 2013||2013-11-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|April 2016|Actual|2016-04-01|6 Months|Observational [Patient Registry]|POI||Genetic Etiology in Premature Ovarian Insufficiency|Genetic Etiology in Premature Ovarian Insufficiency|Completed||N/A|100|Actual|Sisli Etfal Training & Research Hospital|||2||f||||f||||||Samples With DNA|"     4ml whole blood sample   "|||2017-10-11 01:09:18.684878|2017-10-11 01:09:18.684878
NCT01973062|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-06-16|||March 2014||2014-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma|Phase II Study of Radioimmunotherapy With Zevalin (Ibritumomab Tiuxetan) Therapy for Patients With Refractory or Relapsed Primary Central Nervous System Lymphoma (PCNSL)|Terminated||Phase 2|1|Actual|Case Comprehensive Cancer Center||1||Funding Unavailable|f||||t||||||||||2017-10-11 01:09:18.794343|2017-10-11 01:09:18.794343
NCT01972867|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-02-10|||November 2013||2013-11-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Pilot Study of NanoKnife for Ablation of Prostate Cancer in Low Risk Patients|A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in a Low Risk Patient Population|Withdrawn||N/A|0|Actual|Angiodynamics, Inc.||1|||f||||f||||||||||2017-10-11 01:09:20.714374|2017-10-11 01:09:20.714374
NCT01973049|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2015-09-23||2015-09-23|December 2013||2013-12-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis|A Phase 3 Evaluation of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination in Subjects With Genotype 1 Chronic Hepatitis C and Compensated Cirrhosis|Completed||Phase 3|202|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 01:09:18.907885|2017-10-11 01:09:18.907885
NCT01973036|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-03-06|||March 2014|Actual|2014-03-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|FOLCROM||FOLCROM Trial: Foley Catheter in Rupture of Membranes|Foley Catheter Versus Oxytocin for Labor Induction in Women With Term and Near Term Premature Rupture of Membranes: A Randomized Clinical Trial (FOLCROM Trial)|Completed||N/A|201|Actual|Geisinger Clinic||2|||f||||t||||||||No||2017-10-11 01:09:19.160016|2017-10-11 01:09:19.160016
NCT01973023|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-03-01|||July 2013||2013-07-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Observational|||Stroke's Gait Pattern Modifications of Induced by Repeated BTI|Improvement of Chronic Stroke Patients Gait Pattern Following Repetitive Multifocal Botulinum Toxin Injection Sessions in Paretic Lower Limb: an Observational Study.|Completed||N/A|25|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-11 01:09:19.390606|2017-10-11 01:09:19.390606
NCT01973010|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-09-07|||June 2013||2013-06-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Massage Therapy for Chronic Low Back Pain|Phase 1 Study of Massage Therapy for Chronic Low Back Pain|Completed||Phase 2/Phase 3|150|Actual|Chengdu University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 01:09:19.505479|2017-10-11 01:09:19.505479
NCT01972997|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-11-16|||July 2013||2013-07-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||SENSIMED Triggerfish Sensor Sizes|A Single-center, Randomized, Double-blinded, Prospective Study to Assess the Changes in the 24-hour IOP (Intraocular Pressure) Pattern in Relation to SENSIMED Triggerfish® Sensor Sizes in Healthy Subjects|Completed||Phase 4|14|Actual|Sensimed AG||1|||f||||||||||||||2017-10-11 01:09:19.61427|2017-10-11 01:09:19.61427
NCT01972984|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-02-02|||October 2012||2012-10-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|NEO ER 11-05||Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients|The NEO (NEOADJUVANT ENDOCRINE OUTCOMES) TRIAL: Neoadjuvant Endocrine Therapy for Primary Breast Cancer: Investigation of Clinical and Translational Outcomes|Completed||Phase 2|20|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-11 01:09:19.70155|2017-10-11 01:09:19.70155
NCT01972971|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2013-10-24|||February 2012||2012-02-01|October 2013|2013-10-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||To Establish a Novel Prototype of Clinical Pharmacy Services by Warfarin Consultation in a Pharmacist Clinic|To Establish a Novel Prototype of Clinical Pharmacy Services by Warfarin Consultation in a Pharmacist Clinic|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 01:09:19.800916|2017-10-11 01:09:19.800916
NCT01972958|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-24|||March 2010||2010-03-01|October 2013|2013-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Community Health Programs by Nurses for Older Adults|Effects of Community Health Programs by Nurses for Older Adults|Completed||N/A|220|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:09:19.900849|2017-10-11 01:09:19.900849
NCT01972945|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-07-14|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|VAST||Vaginoscopy Against Standard Treatment (VAST): a Randomised Controlled Trial|Vaginoscopy Against Standard Treatment (VAST): a Randomised Controlled Trial|Recruiting||N/A|1600|Anticipated|Birmingham Women's NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:09:19.986439|2017-10-11 01:09:19.986439
NCT01972932|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-08-04|||November 2013||2013-11-01|June 2014|2014-06-01|August 2017|Anticipated|2017-08-01|November 2014|Actual|2014-11-01||Interventional|||Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea|Protocol CHUM 2014-5056: A Randomized, Double Blinded Placebo Controlled Study to Evaluate the Efficacy of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea in Hospitalized Patients|Terminated||Phase 4|60|Actual|Bio-K Plus International Inc.||2||Recruitment problems|f||||f||||||||||2017-10-11 01:09:20.205047|2017-10-11 01:09:20.205047
NCT01972919|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-07-06|||March 2016||2016-03-01|July 2017|2017-07-01|December 2023|Anticipated|2023-12-01|December 2020|Anticipated|2020-12-01||Interventional|||MR Guided Dose Escalated RT + Concurrent Chemotherapy in Unresectable Pancreatic Cancer|MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-metastatic Pancreatic Cancer|Recruiting||Phase 2|23|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 01:09:20.317578|2017-10-11 01:09:20.317578
NCT01972906|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-11-25|||February 2012||2012-02-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Moxibustion for Primary Dysmenorrhea|Traditional Chinese Moxibustion for Primary Dysmenorrhea|Completed||Early Phase 1|152|Actual|Chengdu University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 01:09:20.432634|2017-10-11 01:09:20.432634
NCT01972893|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-10-25|||February 2011||2011-02-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|ZYD1||A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, a Selective Glucagon-like Peptide (GLP) 1 Agonist, Following Subcutaneous Administration in Healthy Volunteers.|Completed||Phase 1|56|Actual|Cadila Healthcare Limited||2|||f||||t||||||||||2017-10-11 01:09:20.547607|2017-10-11 01:09:20.547607
NCT01972880|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2014-02-06|||September 2013||2013-09-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Compare the Oral Absorption of ASP1941 Among Two Types of Tablets|ASP1941 Pharmacokinetic Study - Verification of Bioequivalence Between ASP1941 New Tablets and ASP1941 Conventional Tablets -|Completed||Phase 1|32|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:09:20.632326|2017-10-11 01:09:20.632326
NCT01972854|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-06-20||2016-06-27|November 2013||2013-11-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|March 2016|Actual|2016-03-01||Interventional|||Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus|A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus|Terminated||Phase 3|92|Actual|Avedro, Inc.||2|||f||||f||||||||No||2017-10-11 01:09:20.810014|2017-10-11 01:09:20.810014
NCT01972841|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-25|2017-09-28||2016-10-14|November 5, 2013|Actual|2013-11-05|September 2017|2017-09-01|October 22, 2015|Actual|2015-10-22|October 22, 2015|Actual|2015-10-22||Interventional|SYNERGY||This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder|A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder|Completed||Phase 3|3527|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-10-11 01:09:20.990089|2017-10-11 01:09:20.990089
NCT01972828|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-10-30|||July 2007||2007-07-01|October 2013|2013-10-01||||August 2013|Actual|2013-08-01||Interventional|EHOSS-1||Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1|Effect of Haemodynamic Optimization Using Preload Dependence Indexes and Pulmonary Thermodilution on Cardiovascular Failure Duration During Septic Shock: a Randomized Study|Completed||N/A|61|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 01:09:22.393056|2017-10-11 01:09:22.393056
NCT01972815|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-29|||October 2012||2012-10-01|October 2013|2013-10-01||||October 2012|Actual|2012-10-01||Observational|||Reproducibility and Reliability of Epstein-Barr Virus (EBV) DNA/RNA Measures in Nasopharyngeal Swabs|Reproducibility and Reliability of Epstein-Barr Virus (EBV) DNA/RNA Measures in Nasopharyngeal Swabs|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:09:22.505881|2017-10-11 01:09:22.505881
NCT01972802|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-29|||January 2011||2011-01-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|InterCHANGE||International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) Study|International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) Study|Unknown status|Recruiting|N/A|900|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     BLOOD 20ML, Fresh (biopsy)samples, Oral scrape   "|||2017-10-11 01:09:22.579233|2017-10-11 01:09:22.579233
NCT01972789|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-07-22|||October 31, 2013|Actual|2013-10-31|July 2017|2017-07-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|FLUID||Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Primarily Intra-retinal Fluid) Treatment.|"A Phase IV, Randomised, Controlled, Single Masked Study Investigating the Efficacy and Safety of Ranibizumab Inject and Extend Using an Intensive Retinal Fluid Retreatment Regimen Compared to a Relaxed Retinal Fluid Retreatment Regimen in Patients With Wet Age-related Macular Degeneration (AMD)"|Completed||Phase 4|346|Actual|Novartis||2|||f||||t|f|f||||||||2017-10-11 01:09:22.654399|2017-10-11 01:09:22.654399
NCT01972776|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-02-24|2016-01-22||November 2013||2013-11-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076.|A Two Part, Double Blind, Placebo Controlled, Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Multiple Doses of QBM076 in Patients With COPD|Terminated||Phase 2|48|Actual|Novartis|Part 2 was terminated after 21 patients were enrolled. Three of the 21 patients experienced moderate to severe (up to 17-fold) asymptomatic and reversible elevation of liver transaminase levels after 3 weeks of treatment with QBM076 150 mg bid.|6||Part 1 was completed. Part 2 was terminated for safety reasons.|f||||t||||||||||2017-10-11 01:09:22.817377|2017-10-11 01:09:22.817377
NCT01972763|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-11-14|||October 2013||2013-10-01|November 2014|2014-11-01||||September 2015|Anticipated|2015-09-01||Interventional|RESCUE||Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.||Unknown status|Recruiting|Phase 1/Phase 2|8|Anticipated|Northern California Retina Vitreous Associates||2|||f||||||||||||||2017-10-11 01:09:23.902867|2017-10-11 01:09:23.902867
NCT01972750|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-04-18|||October 2013||2013-10-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|TKI258||Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma|The Multi-targeted Tyrosine Kinase Inhibitor Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma|Active, not recruiting||Phase 1|12|Actual|University Hospital, Bonn||1|||f||||t||||||||||2017-10-11 01:09:24.027144|2017-10-11 01:09:24.027144
NCT01972737|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-04-04|||October 2013||2013-10-01|April 2017|2017-04-01|January 13, 2016|Actual|2016-01-13|June 3, 2014|Actual|2014-06-03||Interventional|||Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer|A Phase I Study of Guanylyl Cyclase C (GCC)-Encoding Replication-Deficient Human Type 5 Recombinant Adenovirus Vaccine (Ad5-hGCC-PADRE) in Stage I and II Colon Cancer Patients|Completed||Phase 1|10|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 01:09:24.114741|2017-10-11 01:09:24.114741
NCT01972711|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-02-22|||March 2014||2014-03-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics|A Randomized, Double-blind, Placebo-controlled, Single-dose, Study of the Effects of SEP 363856 and Amisulpride on BOLD-fMRI Signal in Healthy Male and Female Volunteers With High or Low Schizotype Characteristics.|Completed||Phase 1|105|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 01:09:24.326551|2017-10-11 01:09:24.326551
NCT01948440|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-27|2013-09-20|||July 2010||2010-07-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||ASI-MV Solutions: A Tailored Program for Substance Abusers in Early Recovery|ASI-MV Solutions: A Tailored Program for Substance Abusers in Early Recovery|Completed||Phase 2|39|Actual|Inflexxion, Inc.||2|||f||||t||||||||||2017-10-11 01:16:34.265348|2017-10-11 01:16:34.265348
NCT01972698|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-12-05|||November 2014||2014-11-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Focused Cardiac and Lung Ultrasound in Anesthesia/Critical Care - The Role of Self-directed Simulation-assisted Training Compared to a Traditional Supervised Approach|Focused Cardiac and Lung Ultrasound in Anesthesia/Critical Care - The Role of Self-directed Simulation-assisted Training Compared to a Traditional Supervised Approach|Recruiting||N/A|30|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:09:24.429936|2017-10-11 01:09:24.429936
NCT01972685|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-02-28|||June 2013||2013-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD)|Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD)|Recruiting||N/A|20|Anticipated|Duke University||1|||f||||f||||||||||2017-10-11 01:09:24.568521|2017-10-11 01:09:24.568521
NCT01972672|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-01-27|||October 2013||2013-10-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma|An Open-label,Single-arm Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|50|Anticipated|Beijing Shenogen Biomedical Co., Ltd||1|||f||||f||||||||||2017-10-11 01:09:26.407901|2017-10-11 01:09:26.407901
NCT01972659|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2014-01-10|2014-01-10||October 2012||2012-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients|Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients|Completed||Phase 4|80|Actual|Kocaeli University||2|||f||||t||||||||||2017-10-11 01:09:26.530814|2017-10-11 01:09:26.530814
NCT01972646|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-24|||June 2010||2010-06-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Predictors of Failure of Empiric Outpatient Antibiotic Therapy in Emergency Department Patients With Uncomplicated Cellulitis.|Predictors of Failure of Empiric Outpatient Antibiotic Therapy in Emergency Department Patients With Uncomplicated Cellulitis.|Completed||N/A|500|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-11 01:09:26.757516|2017-10-11 01:09:26.757516
NCT01972633|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-10-24|||June 2010||2010-06-01|October 2013|2013-10-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|||Endoluminale Obliteration Der Stammvene Mit Dem 1470nm Laser Versus VNUS Closure Fast|Endovenous Treatment of the Saphenous Vein With Biolitec 1470nm Laser Versus Vnus Closure Fast|Unknown status|Recruiting|Phase 1/Phase 2|140|Anticipated|Ludwig Boltzmann Institute for Operative Laparoscopy||2|||f||||f||||||||||2017-10-11 01:09:26.824407|2017-10-11 01:09:26.824407
NCT01972620|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-10-24|||February 2010||2010-02-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|LapChole||RCT: Multi-modal Analgesia for Laparoscopic Cholecystectomy|Prospective Randomized Controlled Trial (PRCT) Comparing Standard Analgesia With Multi-modal Targeted Operative and Port-Site Local Anesthesia for Post-Operative Pain Management in Elective Laparoscopic Cholecystectomy (LapChole)|Completed||N/A|63|Actual|Klinicki Centar Vojvodine||2|||f||||t||||||||||2017-10-11 01:09:26.91476|2017-10-11 01:09:26.91476
NCT01972607|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-04-07|||March 2012||2012-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of Aerobic Exercise Training for Migraine Prevention.|The Effect of Aerobic Exercise Training for Migraine Prevention.|Completed||N/A|60|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 01:09:27.020718|2017-10-11 01:09:27.020718
NCT01972594|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-03-12|||January 2014||2014-01-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Pedometer Based Intervention After Total Hip Replacement-A Pilot Study|A 12 Week Pedometer Based Walking Intervention to Enhance Physical Activity Performance Following Total Hip Replacement-A Pilot Study|Completed||N/A|20|Actual|Glasgow Caledonian University||2|||f||||t||||||||||2017-10-11 01:09:27.091814|2017-10-11 01:09:27.091814
NCT01972581|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-02-17|||October 2013||2013-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Neurocognitive Visual Reaction Training|Neurocognitive Visual Reaction Training|Completed||N/A|21|Actual|High Point University||2|||f||||f||||||||||2017-10-11 01:09:27.163011|2017-10-11 01:09:27.163011
NCT01972555|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-08-03|||October 2013||2013-10-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|CMILE||Cardiac Function After Minimally Invasive Aortic Valve Implantation|Single-center Randomized Controlled Trial of Cardiac Function After Minimally Invasive Aortic Valve Implantation (CMILE)|Completed||N/A|40|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 01:09:27.764415|2017-10-11 01:09:27.764415
NCT01972542|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-10-23|||June 2013||2013-06-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular Risk|The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular Risk in Healthy People, Impaired Glucose Tolerance and Type 2 Diabetes|Completed||N/A|80|Actual|Seoul National University Bundang Hospital||3|||f||||t||||||||||2017-10-11 01:09:27.876825|2017-10-11 01:09:27.876825
NCT01972529|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-06-01|||February 2014|Actual|2014-02-01|May 2017|2017-05-01|February 27, 2017|Actual|2017-02-27|January 26, 2017|Actual|2017-01-26||Interventional|||Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure|A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure|Completed||Phase 3|231|Actual|Eisai Inc.||4|||f||||t||||||||||2017-10-11 01:09:27.998445|2017-10-11 01:09:27.998445
NCT01972139|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-04-24||2014-09-15|October 2013||2013-10-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|July 2014|Actual|2014-07-01||Interventional|HTN-4||Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4|Renal Denervation Using the SYMPLICITY Renal Denervation System in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4|Completed||N/A|44|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-10-11 01:09:34.145091|2017-10-11 01:09:34.145091
NCT01972516|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-05-04|2016-06-13||November 2013||2013-11-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|||Tivozanib As Maintenance Therapy In GYN|A Phase II Study of Tivozanib as Maintenance Therapy, Post-Chemotherapy, in Patients With Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Terminated||Phase 2|4|Actual|Dana-Farber Cancer Institute|Terminated early due to low accrual.|2||due to slow accrual|f||||t||||||||||2017-10-11 01:09:28.389016|2017-10-11 01:09:28.389016
NCT01972503|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-12-10|||June 2008||2008-06-01|December 2013|2013-12-01|September 2015|Anticipated|2015-09-01|September 2013|Actual|2013-09-01||Interventional|||Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer|A Prospective,Randomized Control Trial of Intraoperative Intraportal Chemotherapy (5-FU and Oxaliplatin) Combined With Adjuvant Chemotherapy to Prevent Liver Metastasis in Patients Receiving Curative Colorectal Cancer Resection.|Unknown status|Recruiting|Phase 4|300|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 01:09:29.029193|2017-10-11 01:09:29.029193
NCT01972490|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-12-09|||June 2011||2011-06-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|December 2014|Actual|2014-12-01||Interventional|ACCMCC||Avastin in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer|Study of Avastin in Combination With Chemotherapy for the First Treatment of Metastatic Colorectal Cancer|Unknown status|Recruiting|Phase 4|150|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 01:09:29.119463|2017-10-11 01:09:29.119463
NCT01972477|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-08-03|||July 2016||2016-07-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||DLBS1449 in Diabetic Patients With Low HDL|The Effect of DLBS1449 in Diabetic Patients With Low HDL-Cholesterol - Double Blind Comparative Study With Placebo|Withdrawn||Phase 2/Phase 3|0|Actual|Dexa Medica Group||3|||f||||t||||||||||2017-10-11 01:09:29.221453|2017-10-11 01:09:29.221453
NCT01972451|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-04-13|||November 2014||2014-11-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CONSCOP||Feasibility of Reduction in Right Sided Bowel Cancer Through Contrast Enhanced Colonoscopy|A Feasibility Randomised Controlled Trial (RCT) of Contrast Enhanced vs Non-enhanced Colonscopy in Index Bowel Cancer Screening to Reduce Bowel Cancer Mortality|Active, not recruiting||Phase 2|1320|Anticipated|Cardiff University||2|||f||||t||||||||||2017-10-11 01:09:29.426767|2017-10-11 01:09:29.426767
NCT01972438|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-10-26|2016-05-24||November 2013||2013-11-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Interventional|GVHD ASED||A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients|A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients|Terminated||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)||2||Investigational product unavailable due to manufacturing issues|f||||t||||||||No||2017-10-11 01:09:29.536317|2017-10-11 01:09:29.536317
NCT01972425|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-03-27|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|VAPRapid-2||Biomarker-based Exclusion of VAP for Improved Antibiotic Stewardship|A Randomised Controlled Trial of Biomarker-based Exclusion of VAP to Improve Antibiotic Stewardship|Completed||N/A|211|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 01:09:30.533593|2017-10-11 01:09:30.533593
NCT01972399|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-04-01|||January 2016||2016-01-01|April 2015|2015-04-01||||April 2017|Anticipated|2017-04-01||Interventional|||Laser Therapy Treatment of Peri-implantitis.|Influence of Laser Therapy Upon Surgical Treatment of Peri-implantitis Lesions.|Withdrawn||Phase 3|0|Actual|University of Michigan||2||Withdrawn from IRB at PI's request|f||||f||||||||||2017-10-11 01:09:30.783726|2017-10-11 01:09:30.783726
NCT01972386|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-10-31|||September 2013||2013-09-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||EBUS/Spectrum Analysis|Spectrum Image Analysis of Lymph Nodes During Endobronchial Ultrasound-Guided (EBUS) Transbronchial Needle Aspiration (TBNA) in Patients With Lung Cancer|Recruiting||N/A|300|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 01:09:30.863867|2017-10-11 01:09:30.863867
NCT01972373|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-10-26|||October 2013||2013-10-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|RAPIDO-TRACT||Visualization of Rectal Cancer During Endoscopy, Using a Fluorescent Tracer|Visualization of a VEGF-targeted Optical Fluorescent Imaging Tracer in Rectal Cancer During Flexible NIR Fluorescence Endoscopy|Recruiting||Phase 1|30|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 01:09:31.05843|2017-10-11 01:09:31.05843
NCT01972360|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-03-23|||October 2012||2012-10-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Observational|MITNECB5||Non-isotope Based Imaging Modalities vs Technetium-99m Single-Photon Emission Computed Tomography(99mTcSPECT)|Non-isotope Based Imaging Modalities vs 99mTcSPECT to Detect Myocardial Ischemia in Patients at High Risk for Ischemic Cardiovascular Events|Recruiting||N/A|450|Anticipated|Montreal Heart Institute|||3||f||||f||||||||Undecided||2017-10-11 01:09:31.198156|2017-10-11 01:09:31.198156
NCT01972347|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-08-28|||October 2014||2014-10-01|August 2017|2017-08-01|May 2022|Anticipated|2022-05-01|May 4, 2017|Actual|2017-05-04||Interventional|||Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma|An Open Label, Single Centre, Phase II Pilot Study of Neoadjuvant Dabrafenib + Trametinib in Patients With Resectable American Joint Committee on Cancer (AJCC) Stage IIIB-C BRAF V600 Mutation Positive Melanoma|Active, not recruiting||Phase 2|35|Actual|Melanoma Institute Australia||1|||f||||t||||||||||2017-10-11 01:09:31.307313|2017-10-11 01:09:31.307313
NCT01972334|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-08-30|||October 2013||2013-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Stool Transplant in Pediatric Patients With Recurring C. Difficile Infection|A Randomized, Placebo-controlled Pilot Trial to Administer Fecal Microbial Therapy (Stool Transplant) or Placebo in Children Ages 8 to 18 With Recurrent C. Difficile Infection|Completed||Phase 2|9|Actual|MemorialCare Health System||2|||f||||f||||||||Undecided||2017-10-11 01:09:31.433964|2017-10-11 01:09:31.433964
NCT01972321|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-01-07|||April 2013||2013-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|inSCALE||ICCM of Common Childhood Diseases: Mozambique and Uganda|Integrated Community Case Management of Common Childhood Diseases: Mozambique and Uganda|Completed||N/A|2289|Actual|Malaria Consortium||3|||f||||t||||||||||2017-10-11 01:09:31.546388|2017-10-11 01:09:31.546388
NCT01972308|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-04-04|||November 2013||2013-11-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|HAP2||A Patient Advocate to Improve Real-world Asthma Management for Inner City Adults|A Patient Advocate to Improve Real-world Asthma Management for Inner City Adults|Active, not recruiting||N/A|312|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:09:31.695042|2017-10-11 01:09:31.695042
NCT01972295|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-06-22|||January 13, 2014|Actual|2014-01-13|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01|2 Years|Observational [Patient Registry]|WASP||Registry on WATCHMAN Outcomes in Real-Life Utilization WASP Registry|Registry on WATCHMAN Outcomes in Real-Life Utilization WASP Registry|Active, not recruiting||N/A|201|Actual|Boston Scientific Corporation|||1||f||||f||||||||Undecided||2017-10-11 01:09:31.806809|2017-10-11 01:09:31.806809
NCT01972269|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-06-03|||October 2013||2013-10-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Determination of the Effective Volume of 0.125% Bupivacaine-fentanyl 5mcg/mL in Labour Epidurals|Determination of the Effective Volume of the 0.125% Bupivacaine-fentanyl 5mcg/mL Mixture Used for Epidural Analgesia in Labor|Completed||N/A|80|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||14|||f||||f||||||||||2017-10-11 01:09:32.175415|2017-10-11 01:09:32.175415
NCT01972256|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-06-03|||April 2013||2013-04-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||A Study Comparing Fusion Rates of Two Lumbar Fusion Procedures|Prospective Multicenter Clinical Evaluation of Fusion|Completed||N/A|60|Anticipated|Baxano Surgical, Inc.|||2||f||||f||||||||||2017-10-11 01:09:32.326774|2017-10-11 01:09:32.326774
NCT01972243|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-29|||September 2013||2013-09-01|October 2013|2013-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model|Identification of Patients at Low Risk of Recurrent Venous Thromboembolism After Stopping Anticoagulant Treatment: A Prospective Multicenter Cohort Study (Validation of the Vienna Prediction Model)|Unknown status|Recruiting|N/A|500|Anticipated|Medical University of Vienna|||1||f||||||||||||||2017-10-11 01:09:32.418975|2017-10-11 01:09:32.418975
NCT01972230|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-04-06|||January 2013||2013-01-01|April 2016|2016-04-01||||April 2015|Actual|2015-04-01||Interventional|||Sevoflurane Protective Effect on Ischemia Reperfusion Injury in Microvascular Surgery||Completed||N/A|128|Actual|Regina Elena Cancer Institute||2|||f||||t||||||||||2017-10-11 01:09:32.501155|2017-10-11 01:09:32.501155
NCT01972204|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-24|||September 2013||2013-09-01|October 2013|2013-10-01||||March 2015|Anticipated|2015-03-01||Interventional|||Intensive Instruction on the Use of Aricept|A Study About the Impact of Intensive Instruction on the Use of Aricept and the Reasons for Discontinuation in Patients With Alzheimer's Disease|Unknown status|Recruiting|N/A|150|Anticipated|Mirai Iryo Research Center, Inc.||2|||f||||||||||||||2017-10-11 01:09:32.818271|2017-10-11 01:09:32.818271
NCT01972191|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-10-23|||October 2012||2012-10-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Comparison of Three Corneal Horizontal Marking Techniques Using iTrace™||Completed||N/A|156|Actual|Yonsei University|||3||f||||f||||||||||2017-10-11 01:09:32.911741|2017-10-11 01:09:32.911741
NCT01972178|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-10-07||2015-09-21|November 2013||2013-11-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia|Terminated||Phase 2|113|Actual|Pronova BioPharma||2|||f||||t||||||||||2017-10-11 01:09:32.980568|2017-10-11 01:09:32.980568
NCT01972165|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-23|||November 2011||2011-11-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparison of Subjective Outcomes and Changes of Ultrasonographic Morphology of Median Nerves of Mini-open and Endoscopic Carpal Tunnel Release in Patients With Idiopathic Carpal Tunnel Syndrome||Completed||N/A|67|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:09:33.148189|2017-10-11 01:09:33.148189
NCT01972152|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-01-04|2015-11-20||October 2013||2013-10-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||The study involved a 3-way cross-over design with 30 total randomized subjects, so the baseline characteristics are the same for all 3 arms.|Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia|A RANDOMIZED, PHASE 2, DOUBLE-BLIND, 3-WAY CROSSOVER STUDY WITH G-PEN™ (GLUCAGON INJECTION) TO EVALUATE SAFETY, TOLERABILITY AND COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS TO LILLY GLUCAGON™ (GLUCAGON FOR INJECTION [rDNA ORIGIN]) IN HEALTHY VOLUNTEERS|Completed||Phase 2|30|Actual|Xeris Pharmaceuticals||3|||f||||f||||||||||2017-10-11 01:09:33.262666|2017-10-11 01:09:33.262666
NCT01972126|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-01-11|||September 2013||2013-09-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|MAGNITUDE||MAGNetic QRS-Fragmentation in Patients With Myocardial InfarcTion and Moderately RedUceD Ejection Fraction|MAGNetic QRS-Fragmentation in Patients With Myocardial InfarcTion and Moderately RedUceD Ejection Fraction|Terminated||N/A|9|Actual|Medtronic Bakken Research Center|||1|Manufacturer of the MFI QRS Fragmentation Systems used in the study, has filed for insolvency|f||||f||||||||||2017-10-11 01:09:34.256503|2017-10-11 01:09:34.256503
NCT01972113|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-09-28|||September 2013||2013-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)|Vitamin K and Glucose Metabolism in Children at Risk for Diabetes|Recruiting||Phase 1/Phase 2|60|Anticipated|Augusta University||3|||f||||t||||||||||2017-10-11 01:09:34.33924|2017-10-11 01:09:34.33924
NCT01972100|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-29|||April 2013||2013-04-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Use of Low-level Laser Therapy (808nm) to Muscle Fatigue Resistance|Use of Low-level Laser Therapy (808nm) to Muscle Fatigue Resistance: a Randomized Double-blind Crossover Trial|Completed||N/A|7|Actual|Universidade Federal de Sao Carlos||2|||f||||||||||||||2017-10-11 01:09:34.478205|2017-10-11 01:09:34.478205
NCT01972087|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-11-07|||September 2013||2013-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|STAT911||Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest|Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest|Completed||N/A|157|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 01:09:34.598486|2017-10-11 01:09:34.598486
NCT01972074|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2017-09-06|||November 2014||2014-11-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder|Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder|Recruiting||Phase 3|90|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 01:09:34.687243|2017-10-11 01:09:34.687243
NCT01972061|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-05-01|||March 2014||2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FootStim||Foot/Hand Neuromodulation for Overactive Bladder (OAB)|Foot/Hand Neuromodulation for Overactive Bladder (OAB)|Enrolling by invitation||N/A|80|Anticipated|University of Pittsburgh||4|||f||||f||||||||No||2017-10-11 01:09:34.828367|2017-10-11 01:09:34.828367
NCT01972048|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2016-01-04|||January 2014||2014-01-01|January 2016|2016-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening|Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening: Intervention Phase|Recruiting||N/A|149|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:09:34.947965|2017-10-11 01:09:34.947965
NCT01972035|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-09-15|||August 2014||2014-08-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation|ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation|Recruiting||Phase 2|160|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 01:09:35.053004|2017-10-11 01:09:35.053004
NCT01972022|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-07-02|||November 2013||2013-11-01|March 2015|2015-03-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|TRANSFORM||TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography|A Prospective Optical Coherence Tomography (OCT) Study on Coronary Vessel Wall Response to Stent Eluting Everolimus From a Biodegradable Polymer (EES SYNERGY™) Compared With Stent Eluting Zotarolimus From a Durable Polymer (ZES, RESOLUTE Integrity™).|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||t||||||||||2017-10-11 01:09:35.176263|2017-10-11 01:09:35.176263
NCT01972009|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2013-10-31|||October 2013||2013-10-01|October 2013|2013-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|||Wave Intensity Analysis in the Pulmonary Artery|Systematic Assessment of Pulmonary Artery Haemodynamics Using Wave Intensity Analysis|Unknown status|Not yet recruiting|N/A|36|Anticipated|Imperial College London|||2||f||||t||||||||||2017-10-11 01:09:35.276747|2017-10-11 01:09:35.276747
NCT01971996|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-07-01|||November 2013||2013-11-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Measuring the Effect of External Pressure on the Regional Cerebral Oxygen Saturation Monitored by Near-infrared Spectroscopy(NIRS) Technology|Measuring the Cerebral Oxygen Saturation With NIRS Sensor Placed on the Forehead of Patients in the Prone Position. How Does the External Pressure Affect the Measurement.|Completed||N/A|60|Actual|Glostrup University Hospital, Copenhagen|||1||f||||t||||||||||2017-10-11 01:09:35.395766|2017-10-11 01:09:35.395766
NCT01971983|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2014-03-15|||February 2013||2013-02-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Effect of Two Osteopathic Techniques on Thickness of Paravertebral Muscles of the Lumbar Spine|Effect of Two Osteopathic Techniques on Thickness of Paravertebral Muscles of the Lumbar Spine: Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|60|Anticipated|Federal University of Health Science of Porto Alegre||3|||f||||f||||||||||2017-10-11 01:09:35.485412|2017-10-11 01:09:35.485412
NCT01971970|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-24|2015-09-04|||October 2013||2013-10-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Observational|||Biomarkers of Anti-TNF Treatment in IBD|Biomarkers Predicting the Effect of Anti-TNF Treatment in Pediatric and Adult Inflammatory Bowel Disease|Unknown status|Recruiting|N/A|60|Anticipated|Erasmus Medical Center|||2||f||||f||||||Samples With DNA|"     whole blood, gastrointestinal tract biopsies,buccal epithelium   "|||2017-10-11 01:09:35.601518|2017-10-11 01:09:35.601518
NCT01971957|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-10-29|||April 2013||2013-04-01|October 2013|2013-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01|5 Years|Observational [Patient Registry]|SLS||Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers|Sjogren-Larsson Syndrome: A Longitudinal Study of Natural History, Clinical Variation and Evaluation of Biochemical Markers|Unknown status|Recruiting|N/A|50|Anticipated|University of Nebraska|||1||f||||t||||||Samples Without DNA|"     Blood, urine, skin   "|||2017-10-11 01:09:35.786801|2017-10-11 01:09:35.786801
NCT01971372|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-06-08|||September 2013||2013-09-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Post-Operative Pain Management With NSAIDS|Comparing Methods of NSAID Delivery for Postoperative Pain|Completed||N/A|120|Actual|University of Oklahoma|||1||f||||f||||||||||2017-10-11 01:09:45.345759|2017-10-11 01:09:45.345759
NCT01971944|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-04-13|||December 2010||2010-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure|The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure|Recruiting||N/A|87|Anticipated|University of North Carolina, Chapel Hill|||3||f||||f||||||||||2017-10-11 01:09:35.892017|2017-10-11 01:09:35.892017
NCT01971931|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-05-10|||June 2013||2013-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||Prospective Evaluation of Biomarkers Variability in Knee Prosthetic Surgery|Prospective Evaluation of Biomarkers Variability in Knee Prosthetic Surgery|Active, not recruiting||N/A|40|Actual|University of Milan|||1||f||||f||||||Samples With DNA|"     Serum, tibial bone biopsy.   "|No||2017-10-11 01:09:36.068049|2017-10-11 01:09:36.068049
NCT01971918|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-06-13|||May 2014||2014-05-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|STRADA||Comparative Analysis of Two Therapeutic Strategies in Patients With Spondyloarthritis Treated With Anti-tnf Biologics|"Comparative Analysis of Two Therapeutic Strategies: Early Switch Versus Therapeutic Intensification in Patients With Spondyloarthritis Treated With Anti-tnf Biologics, in Case of Secondary Treatment Failure Suspicion."|Terminated||Phase 4|8|Actual|University Hospital, Rouen||2||lack of recruitment|f||||f||||||||||2017-10-11 01:09:36.235654|2017-10-11 01:09:36.235654
NCT01971905|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2017-02-05|||February 2014||2014-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Perfusion Scanning's for Kidney Tumors|Perfusion Scanning's for Kidney Tumors|Recruiting||N/A|100|Anticipated|University Hospital Roskilde|||1||f||||t||||||||||2017-10-11 01:09:36.37816|2017-10-11 01:09:36.37816
NCT01971892|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-12-02|||May 2013||2013-05-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|NIVAS||Non Invasive Ventilation in Abdominal Postoperative Period|Non Invasive Ventilation After Abdominal Surgery in Postoperative Acute Respiratory Failure: a Multicenter Randomized Controlled Trial.|Unknown status|Active, not recruiting|N/A|300|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 01:09:36.528602|2017-10-11 01:09:36.528602
NCT01971879|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-23|||October 2013||2013-10-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|PARADIS||Protection of Arteritic Patients by Remote Preconditioning|Protection of Arteritic Patients by Remote Preconditioning|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-11 01:09:36.690688|2017-10-11 01:09:36.690688
NCT01971866|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-01-26|||October 2013||2013-10-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|DS02||Camera Based System to Monitor Patient Movement During Radiation Treatment|Improving Safety and Accuracy of Proton Therapy by Use of Camera-Based Patient Localization System|Terminated||N/A|1|Actual|University of Florida|||1|Slow enrollment, feasibility issues|f||||t||||||||||2017-10-11 01:09:36.871599|2017-10-11 01:09:36.871599
NCT01971853|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-03-23|||October 2013||2013-10-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|Analgesia||Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry|Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry?|Terminated||N/A|35|Actual|University of Colorado, Denver||2||Insufficient number of participants recruited|f||||f||||||||||2017-10-11 01:09:36.969052|2017-10-11 01:09:36.969052
NCT01971840|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-12-22|||September 2013||2013-09-01|October 2013|2013-10-01|June 2015|Anticipated|2015-06-01|October 2013|Actual|2013-10-01||Interventional|MOVI-KIDS||Effectiveness of a Physical Activity Intervention on Preventing Obesity During the Adiposity Rebound Period.|Effectiveness of an Intervention of Physical Activity Promotion in Schoolchildren on Preventing Obesity During the Adiposity Rebound Period: a Cross-over Randomized Cluster Trial.|Unknown status|Enrolling by invitation|N/A|1600|Anticipated|University of Castilla-La Mancha||2|||f||||t||||||||||2017-10-11 01:09:37.114467|2017-10-11 01:09:37.114467
NCT01971827|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-12-22|||September 2013||2013-09-01|October 2013|2013-10-01|June 2015|Anticipated|2015-06-01|October 2013|Actual|2013-10-01||Interventional|MOVI-KIDS||Effectiveness of a Physical Activity Intervention to Prevent Obesity and Improve Academic Performance|Effectiveness of Physical Activity Intervention to Prevent Obesity and Improve Academic Performance in Children With and Without Attention Deficit Hyperactivity Disorder (ADHD) Risk|Unknown status|Enrolling by invitation|N/A|1600|Anticipated|University of Castilla-La Mancha||2|||f||||t||||||||||2017-10-11 01:09:37.26518|2017-10-11 01:09:37.26518
NCT01971814|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-05-27|||November 2013||2013-11-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|EaSiFx||Early Serum Infliximab Levels in Severe Ulcerative Colitis.|Early Serum Infliximab Levels in Severe Ulcerative Colitis|Completed||Phase 1|11|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:09:37.379751|2017-10-11 01:09:37.379751
NCT01971801|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-03-08|||January 2014||2014-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Vitamin D Supplementation in Older Adults With Urinary Incontinence|Vitamin D Supplementation in Older Adults With Urinary Incontinence|Recruiting||N/A|69|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 01:09:37.518202|2017-10-11 01:09:37.518202
NCT01971788|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-23|||June 2013||2013-06-01|October 2013|2013-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||The MATRIX OCT Substudy||Unknown status|Recruiting|N/A|160|Anticipated|S.M. Misericordia Hospital||2|||f||||||||||||||2017-10-11 01:09:37.6711|2017-10-11 01:09:37.6711
NCT01971775|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2013-10-23|||August 2011||2011-08-01|October 2013|2013-10-01||||May 2013|Actual|2013-05-01||Interventional|||Clinical Study for Energy Based Devices in Open Gastrectomy for Gastric Cancer|Clinical Study for Energy Based Devices in Open Gastrectomy for Gastric Cancer: Conventional Monopolar Electrosurgery vs. Ultrasonically Activated Shear(UAS)|Completed||Phase 3|56|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 01:09:37.791165|2017-10-11 01:09:37.791165
NCT01971762|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2014-12-04|||April 2011||2011-04-01|November 2013|2013-11-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Observational|||Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology|Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology|Completed||N/A|600|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||||||2017-10-11 01:09:37.905359|2017-10-11 01:09:37.905359
NCT01971749|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-08-04|||May 2013||2013-05-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01|2 Years|Observational [Patient Registry]|RETRATO||Register of Treatment of Unprotected Left Main Coronary Artery Stenosis in Andalucía|Multicenter, Prospective, Observational Study of of Treatment of Unprotected Left Main Coronary Artery Stenosis in Andalucía|Unknown status|Recruiting|N/A|315|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud|||1||f||||f||||||||||2017-10-11 01:09:38.058498|2017-10-11 01:09:38.058498
NCT01971736|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-10-23|||September 2012||2012-09-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening|Randomized-controlled Split-face Treatment of Facial Rhytids and Laxity in Asians Using Long-pulse 1064nm Laser|Completed||N/A|22|Actual|Phramongkutklao College of Medicine and Hospital|||1||f||||f||||||||||2017-10-11 01:09:38.170904|2017-10-11 01:09:38.170904
NCT01971723|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-02-01|2015-01-05||June 2013||2013-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Multi-ingredient Supplement for Strength and Power|The Impact of T+ Supplementation on Anabolic Hormone Profile and Performance in Power Athletes|Completed||N/A|32|Actual|Florida State University|Unable to standardize individual ingredients in T+ supplement. Volume of lifts not tested was not analyzed for statistical significance. Neuromuscular adaptations were not tested. Length of study may have affected body composition measures.|2|||f||||f||||||||||2017-10-11 01:09:38.277919|2017-10-11 01:09:38.277919
NCT01971710|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-01-13|||April 2013||2013-04-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|ACCLAIM||Advancing Community Level Action for Improving MCH/PMTCT|Advancing Community Level Action for Improving MCH/PMTCT (ACCLAIM): A Multi-Country Randomized Trial to Evaluate the Effectiveness of Selected Community-Level Interventions on Key MCH/PMTCT Outcomes|Completed||N/A|187335|Actual|Elizabeth Glaser Pediatric AIDS Foundation||3|||f||||f||||||||No|The dataset may be available in 2018. Enquiries may be made with the organization.|2017-10-11 01:09:39.6074|2017-10-11 01:09:39.6074
NCT01971697|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-10-15|||September 2013||2013-09-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Observational|||Socio-Economic Survey in Uganda|Short Term Socio-economic Impact Due to Blunt Orthopedics Trauma on the Victims in Uganda|Completed||N/A|30|Actual|Duke University|||1||f||||f||||||||||2017-10-11 01:09:39.745394|2017-10-11 01:09:39.745394
NCT01971684|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-06-13|||August 2013||2013-08-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|ICON1||ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP|ICON1: Physician Treatment Decisions and Patient-Reported Outcomes in Pediatric Refractory Immune Thrombocytopenia|Completed||N/A|120|Actual|Boston Children’s Hospital|||1||f||||t||||||||No||2017-10-11 01:09:39.847486|2017-10-11 01:09:39.847486
NCT01971671|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2013-10-23|||August 2011||2011-08-01|October 2013|2013-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|MING||Evaluation of the Nutrients Composition of Breast Milk of Chinese Lactating Mothers and Their Nutrition Intake|Evaluation of the Nutrients Composition of Breast Milk of Chinese Lactating Mothers and Nutrition Intake of Chinese Pregnant and Lactating Mothers, Infants and Young Children|Completed||N/A|560|Actual|Nestlé|||1||f||||f||||||Samples Without DNA|"     breask milk sample.   "|||2017-10-11 01:09:40.146338|2017-10-11 01:09:40.146338
NCT01971658|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-10-06|||October 2013||2013-10-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|IFM2013-04||Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)|"A PHASE III STUDY OF VELCADE (BORTEZOMIB) THALIDOMIDE DEXAMETHASONE (VTD) VERSUS VELCADE (BORTEZOMIB) CYCLOPHOSPHAMIDE DEXAMETHASONE (VCD) AS AN INDUCTION TREATMENT PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA."|Completed||Phase 3|358|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 01:09:40.263328|2017-10-11 01:09:40.263328
NCT01971645|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-02-01|||July 2014||2014-07-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Decadron as Adjuvant in Femoral Nerve Blocks in Knee Arthroscopy|Dexamethasone as an Adjuvant to Ropivacaine for Femoral Nerve Blocks in Children Undergoing Knee Arthroscopy|Completed||Phase 3|77|Actual|Nationwide Children's Hospital||3|||f||||t||||||||||2017-10-11 01:09:40.54683|2017-10-11 01:09:40.54683
NCT01971632|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-02-21|||January 2005||2005-01-01|October 2013|2013-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain||Completed||Phase 3|463|Actual|Mundipharma Research GmbH & Co KG||2|||f||||||||||||||2017-10-11 01:09:40.659332|2017-10-11 01:09:40.659332
NCT01971619|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-28|||August 2013||2013-08-01|October 2013|2013-10-01|August 2015|Anticipated|2015-08-01|October 2013|Actual|2013-10-01||Observational|||Association of Vitamin D, Parathyroid Hormone and Fibroblast Growth Factor-23 With Infarction-related Arrhythmia in Patients With Acute Myocardial Infarction||Unknown status|Recruiting|N/A|510|Anticipated|Yonsei University|||1||f||||f||||||Samples With DNA|"     plasma blood sample (5ml)   "|||2017-10-11 01:09:40.742505|2017-10-11 01:09:40.742505
NCT01971606|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-31|||October 2007||2007-10-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|June 2012|Actual|2012-06-01||Interventional|||Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study||Completed||Phase 4|234|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:09:40.854203|2017-10-11 01:09:40.854203
NCT01971593|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-02-16|||August 2013||2013-08-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease|Eplerenone to Prevent Myocardial Fibrosis in Congenital Heart Disease|Terminated||Phase 4|27|Actual|Washington University School of Medicine||2||Investigator left institution|f||||t||||||||||2017-10-11 01:09:40.972064|2017-10-11 01:09:40.972064
NCT01971580|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-06-01|||August 2012||2012-08-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effects of Ambrisentan on Exercise Capacity in Fontan Patients|The Effects of Ambrisentan on Exercise Capacity in Fontan Patients|Completed||Phase 4|28|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:09:41.073008|2017-10-11 01:09:41.073008
NCT01971567|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-04-17|||October 2013|Actual|2013-10-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|February 2017|Actual|2017-02-01||Interventional|||High-resolution, Relational, Resonance-based, Electroencephalic Mirroring (HIRREM) to Relieve Insomnia|High-resolution, Relational, Resonance-based, Electroencephalic Mirroring (HIRREM) to Relieve Insomnia: A Randomized, Placebo-Controlled Clinical Trial|Active, not recruiting||N/A|122|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 01:09:41.167217|2017-10-11 01:09:41.167217
NCT01971554|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-08-16|2016-10-14||October 14, 2013|Actual|2013-10-14|August 2017|2017-08-01|April 26, 2014|Actual|2014-04-26|April 26, 2014|Actual|2014-04-26||Interventional|||Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)|A Multiple Dose Clinical Trial to Study the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Type 2 Diabetes Mellitus Patients|Completed||Phase 1|63|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 01:09:41.316499|2017-10-11 01:09:41.316499
NCT01971541|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2014-07-01|||April 2014||2014-04-01|July 2014|2014-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|GROW||Groups for Regaining Our Wellbeing (GROW)|A Non-inferiority Trial of MBSR and CPT for PTSD|Withdrawn||Phase 2/Phase 3|0|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 01:09:42.391032|2017-10-11 01:09:42.391032
NCT01971528|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2014-04-23|||February 2012||2012-02-01|April 2014|2014-04-01||||January 2015|Anticipated|2015-01-01||Interventional|||Central and Peripheral Fatigue in Individuals With Parkinson's Disease - Evaluation and Training||Unknown status|Recruiting|N/A|90|Anticipated|Chang Gung University||6|||f||||t||||||||||2017-10-11 01:09:42.574143|2017-10-11 01:09:42.574143
NCT01971515|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-09-27|||December 13, 2013|Actual|2013-12-13|September 2017|2017-09-01|January 3, 2019|Anticipated|2019-01-03|January 3, 2019|Anticipated|2019-01-03||Interventional|||First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies|A Phase I, First-in-Human, Dose Escalation Trial of MSC2363318A, a Dual p70S6K/Akt Inhibitor, in Subjects With Advanced Malignancies|Recruiting||Phase 1|129|Anticipated|EMD Serono||3|||f|||||t|f||||||||2017-10-11 01:09:42.763228|2017-10-11 01:09:42.763228
NCT01971502|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-10-24|||October 2013||2013-10-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of BI 1060469 in Healthy Male Volunteers (Single-blind, Placebo-controlled, Randomised, Partly Fixed-sequence, Parallel Group Design) and Effect of Food on the Bioavailability of BI 1060469 (Open-label, Randomised, Two-way Cross-over)|Completed||Phase 1|68|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:09:43.06002|2017-10-11 01:09:43.06002
NCT01971489|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-08-11|||September 2015||2015-09-01|August 2015|2015-08-01||||August 2016|Anticipated|2016-08-01||Interventional|||Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors|A Phase I Study of the PI3-Kinase Inhibitor BKM120 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|Roswell Park Cancer Institute||1|||f||||f||||||||||2017-10-11 01:09:43.231869|2017-10-11 01:09:43.231869
NCT01971476|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-02-06|||October 2013||2013-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|June 2015|Actual|2015-06-01||Interventional|||Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known|Open, Non-controlled, Dose Escalating Phase I Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, Tolerability and Toxicity of Volasertib in Paediatric Patients From 2 Years to Less Than 18 Years of Age With Acute Leukaemia or Advanced Solid Tumour, for Whom no Effective Treatment is Known|Completed||Phase 1|22|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 01:09:43.427529|2017-10-11 01:09:43.427529
NCT01971463|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-10-27|||October 2013||2013-10-01|October 2016|2016-10-01||||September 2016|Actual|2016-09-01||Interventional|BOSS||Bolus of Saline in Stroke|Optical Measurement of Cerebral Blood Flow Response After Ischemic Stroke|Completed||Phase 2|81|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 01:09:43.545715|2017-10-11 01:09:43.545715
NCT01971450|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-09-22|||December 15, 2013|Actual|2013-12-15|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|June 28, 2017|Actual|2017-06-28||Observational|IVENT||Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension|Prospective Multicentre Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension|Active, not recruiting||N/A|59|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:09:43.649788|2017-10-11 01:09:43.649788
NCT01971437|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-03-20|||October 2013||2013-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Cystoscopy and Cystodistension; Therapeutic and Aetiological Aspect in Overactive Bladder|A Randomised Study of Cystoscopy and Cystodistension Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome.|Completed||N/A|70|Actual|Medway NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:09:43.761889|2017-10-11 01:09:43.761889
NCT01971424|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-23|||January 2012||2012-01-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|Magnesium||Assessment of Physical Performance After Oral Supplementation of Magnesium in a Sample of Old Women in Good Health||Completed||N/A|100|Actual|University of Padova||2|||f||||f||||||||||2017-10-11 01:09:44.095473|2017-10-11 01:09:44.095473
NCT01971411|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-10-23|||March 2006||2006-03-01|October 2013|2013-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Vitamin D Deficiency in Elderly African American Women in Central Texas|Vitamin D Deficiency in Elderly African American Women in Central Texas|Completed||N/A|60||McLennan County Medical Education and Research Foundation|||1||f||||t||||||||||2017-10-11 01:09:44.232001|2017-10-11 01:09:44.232001
NCT01971398|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-23|||April 2007||2007-04-01|October 2013|2013-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Development of Education Materials for Prevention of FAS in Russia|Development of Education Materials for Prevention of Fetal Alcohol Syndrome (FAS) in Russia|Completed||N/A|422|Actual|University of Oklahoma||3|||f||||f||||||||||2017-10-11 01:09:44.442369|2017-10-11 01:09:44.442369
NCT01971385|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-05-05|2017-03-23||October 2013||2013-10-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Squarex||Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis|A Clinical Trial to Test the Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis|Completed||Phase 1|54|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:09:44.616059|2017-10-11 01:09:44.616059
NCT01971359|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-05-18|||September 2013||2013-09-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|MISPACE||Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study|Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study|Completed||N/A|2|Actual|OSF Healthcare System|||1||f||||t||||||||||2017-10-11 01:09:45.418795|2017-10-11 01:09:45.418795
NCT01971346|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-05-31|||March 13, 2014|Actual|2014-03-13|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||The Immunological Basis for Treatment Resistance to Anti-TNF Treatments|The Immunological Basis for Treatment Resistance to Anti-TNF Treatments|Recruiting||Phase 4|50|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-11 01:09:45.506202|2017-10-11 01:09:45.506202
NCT01971333|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-29|||October 2013||2013-10-01|October 2013|2013-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|||Dynamic Preload Parameters During Liver Transplantation|The Validity of Dynamic Preload Parameters During Liver Transplantation|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:09:45.632435|2017-10-11 01:09:45.632435
NCT01971320|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-08-16|||June 2014||2014-06-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|TENSDEG||Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia|Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia|Terminated||Phase 3|2|Actual|University Hospital, Rouen||2||lack of recruitment|f||||f||||||||||2017-10-11 01:09:45.75226|2017-10-11 01:09:45.75226
NCT01971307|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2015-12-21|||December 2013||2013-12-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SGE-PsyScan||Supporting Primary Care in Diagnosis and Choice of Treatment for Patients With Psychosocial Symptoms: SGEPsyScan.|Supporting Primary Care in Diagnosis and Choice of Treatment for Patients With Psychosocial Symptoms: SGEPsyScan.|Completed||N/A|336|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 01:09:45.859742|2017-10-11 01:09:45.859742
NCT01971294|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-23|||October 2013||2013-10-01|October 2013|2013-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Lower Urinary Tract Symptoms in Systemic Sclerosis|Lower Urinary Tract Symptoms in Patients Suffering From Systemic Sclerosis: a Multi-centric Longitudinal Study|Unknown status|Enrolling by invitation|N/A|480|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 01:09:45.968429|2017-10-11 01:09:45.968429
NCT01971281|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-09-12|||November 2013||2013-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)|A Phase II Study of TTFields (150 kHz) Concomitant With Gemcitabine and TTFields Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma|Active, not recruiting||Phase 1/Phase 2|40|Actual|NovoCure Ltd.||2|||f||||f||||||||||2017-10-11 01:09:46.068437|2017-10-11 01:09:46.068437
NCT01971268|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-23|||January 2014||2014-01-01|October 2013|2013-10-01|January 2015|Anticipated|2015-01-01|August 2014|Anticipated|2014-08-01||Observational|||Compare the Success Rate of T3 Dental Implant (Biomet 3I) With or Without Platform-switch Concept|Marginal Bone Behavior of Dental Implants to Different Rehabilitation Protocols|Unknown status|Not yet recruiting|N/A|50|Anticipated|Instituto de Implantologia|||2||f||||f||||||||||2017-10-11 01:09:46.221403|2017-10-11 01:09:46.221403
NCT01971255|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-03-13|2016-10-20||September 2013||2013-09-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People|Evaluation of Anti-Hemagglutinin Antibodies as a Correlate of Protection in an H1N1 Influenza Healthy Human Challenge Model|Completed||Phase 1/Phase 2|74|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||Yes|Data will be shared through the NIH data repository BTRIS - Biomedical Translational Research Information System|2017-10-11 01:09:46.372208|2017-10-11 01:09:46.372208
NCT01971242|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-11-16|||June 2014||2014-06-01|March 2015|2015-03-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|EXENATIDE-PD||Trial of Exenatide for Parkinson's Disease|A Randomised, Double Blind, Placebo Controlled, Single Centre, 60 Week Trial of Exenatide Once Weekly for the Treatment of Moderate Severity Parkinson's Disease|Completed||Phase 2|60|Actual|University College, London||2|||f||||t||||||||No|No plans to share individual participant data (IPD)|2017-10-11 01:09:47.028072|2017-10-11 01:09:47.028072
NCT01971229|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2014-11-18|||December 2013||2013-12-01|November 2014|2014-11-01|July 2015|Anticipated|2015-07-01|October 2014|Actual|2014-10-01||Interventional|||Gastric Emptying and Insulin Response to Test Drink|Assessment of Insulin Response Following Ingestion of a Carbohydrate/Whey Protein Drink. A Cross-over Randomized Double Blind Study.|Unknown status|Active, not recruiting|N/A|20|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-11 01:09:47.153173|2017-10-11 01:09:47.153173
NCT01971216|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2014-12-02|||December 2013||2013-12-01|December 2014|2014-12-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|MOMS||Mother-infant Signalling During Breastfeeding|Mother-infant Signalling During Breastfeeding: A Randomised Trial Investigating the Effects of a Relaxation Intervention in Breastfeeding Mothers on Breast Milk Production, Breast Milk Cortisol and Infant Behaviour and Growth.|Unknown status|Recruiting|N/A|100|Anticipated|University College, London||2|||f||||f||||||||||2017-10-11 01:09:47.26372|2017-10-11 01:09:47.26372
NCT01971190|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-06-24|||October 2013||2013-10-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy|Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy|Completed||Phase 2|43|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 01:09:47.521794|2017-10-11 01:09:47.521794
NCT01971177|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2014-03-13|||October 2013||2013-10-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Addressing of Efficacy and Safety of Femtosecond-laser Assisted Versus Manual Lens Fragmentation Procedure|A Multi-centre, Multi-surgeon, Randomized, Controlled, Prospective, Post-Market-Clinical-Follow-Up Study to Investigate the Impact of Cataract Grade on the Efficacy and Safety of Femtosecond-laser Assisted Lens Fragmentation Procedure|Completed||Phase 4|136|Actual|Technolas Perfect Vision GmbH||2|||f||||f||||||||||2017-10-11 01:09:47.669163|2017-10-11 01:09:47.669163
NCT01971164|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2014-07-11|||May 2013||2013-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease|Randomized, Single-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTZ-951 Administered Once Daily for 15 Days in Anemic Subjects With End-stage Renal Disease|Completed||Phase 1|29|Actual|Akros Pharma Inc.||4|||f||||f||||||||||2017-10-11 01:09:47.778006|2017-10-11 01:09:47.778006
NCT01971151|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-23|||February 2012||2012-02-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Exposure Therapy and Safety-seeking Behavior in Chronic Low Back Pain|An Investigation Into the Effectiveness of Treatment of Chronic Low Back Pain|Unknown status|Active, not recruiting|N/A|6|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 01:09:47.963077|2017-10-11 01:09:47.963077
NCT01971138|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-10-23|||March 2013||2013-03-01|October 2013|2013-10-01||||April 2013|Actual|2013-04-01||Observational|||Review of Surgical Site Infection Registration Routine at Surgery Departments in Sweden and Validation of One of the Used Routines||Completed||N/A|||Halmstad County Hospital|||1||f||||f||||||||||2017-10-11 01:09:48.08569|2017-10-11 01:09:48.08569
NCT01971125|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-02-03|||July 2006||2006-07-01|October 2013|2013-10-01|November 2010|Actual|2010-11-01|March 2009|Actual|2009-03-01||Observational|DYDA||Left Ventricular DYsfunction in DiAbetes|Left Ventricular DYsfunction in DiAbetes|Completed||N/A|970|Actual|Heart Care Foundation|||1||f||||f||||||Samples Without DNA|"     whole blood   "|||2017-10-11 01:09:48.214726|2017-10-11 01:09:48.214726
NCT01971112|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-23|||October 2013||2013-10-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Nutritional Intervention and Respiratory Infections in Older Subjects|Effect of Supplementation With Multivitamins and Minerals on the Incidence of Respiratory Infections in Older People in Ecuador: a Randomised Controlled Trial.|Unknown status|Recruiting|N/A|320|Anticipated|Corporacion Ecuatoriana de Biotecnologia||2|||f||||t||||||||||2017-10-11 01:09:48.361199|2017-10-11 01:09:48.361199
NCT01971099|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-01-13|||May 2013||2013-05-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder|Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder|Completed||Phase 4|44|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-11 01:09:48.49814|2017-10-11 01:09:48.49814
NCT01971086|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-03-13|2015-03-13||October 2013||2013-10-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||Patients from the Treated Set (TS) which includes all patients who were documented to have taken at least one dose of the investigational treatment.|Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary|Treatment With Rhinospray Plus of Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary|Completed||N/A|300|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 01:09:48.612829|2017-10-11 01:09:48.612829
NCT01971073|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-12|2015-07-21|||January 2015||2015-01-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in Schizophrenia|Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in Schizophrenia|Unknown status|Recruiting|N/A|30|Anticipated|Bar-Ilan University, Israel||2|||f||||f||||||||||2017-10-11 01:09:50.577411|2017-10-11 01:09:50.577411
NCT01971060|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-01-24|||August 2013||2013-08-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|VLocmyo||a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy.|A Case Study to Evaluate Adhesion Risk in Fertility Patients' Post Laparoscopic Myomectomy Utilizing Vloc Suture.|Withdrawn||N/A|0|Actual|The Advanced Gynecologic Surgery Institute||1||lack of funding|f||||t||||||||||2017-10-11 01:09:50.756485|2017-10-11 01:09:50.756485
NCT01971047|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-03-13|||October 2013||2013-10-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery|The Safety and Efficacy of Correcting Preoperative Hyperglycemia in Ambulatory Surgical Patients With Diabetes: A Randomized Controlled Clinical Trial|Withdrawn||Phase 4|0|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:09:50.8342|2017-10-11 01:09:50.8342
NCT01971034|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2014-05-14|||June 2011||2011-06-01|May 2014|2014-05-01||||June 2012|Actual|2012-06-01||Interventional|||Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.|A Prospective Study to Evaluate the Combination of Metformin With Paclitaxel in the Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.|Completed||Phase 2|41|Anticipated|Instituto do Cancer do Estado de São Paulo||1|||f||||||||||||||2017-10-11 01:09:50.945345|2017-10-11 01:09:50.945345
NCT01971021|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-04-02|||April 2013|Actual|2013-04-01|April 2017|2017-04-01||||February 6, 2017|Actual|2017-02-06|12 Months|Observational [Patient Registry]|||Vascular Access in Cancer Patients - PICC vs PORT in a Randomized Controlled Trial.|Vascular Access in Cancer Patients - PICC vs PORT in a Randomized Controlled Trial.|Completed||N/A|400|Actual|Linkoeping University|||1||f||||t||||||||||2017-10-11 01:09:51.030692|2017-10-11 01:09:51.030692
NCT01971008|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-08-12|||May 2013||2013-05-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|ABOHP||Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)|Abdominal Binders for the Treatment of Orthostatic Hypotension in Parkinson's Disease: an Investigator-initiated Randomized, Placebo-controlled, Cross-over Study|Completed||Phase 2|14|Anticipated|Medical University Innsbruck||2|||f||||t||||||||||2017-10-11 01:09:51.107732|2017-10-11 01:09:51.107732
NCT01970826|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2013-10-22|||January 2014||2014-01-01|October 2013|2013-10-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|||Compare Sterilized Clean vs Sterilized Aseptic Dental Implant Surgery|Sterilized Aseptic Versus Sterilized Clean Field for Dental Implant Placement - Randomized Clinical Control Trial for Non-inferiority Comparison|Unknown status|Not yet recruiting|N/A|80|Anticipated|Instituto de Implantologia||6|||f||||f||||||||||2017-10-11 01:09:55.942019|2017-10-11 01:09:55.942019
NCT01970995|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-02-08|2016-12-14||August 2013||2013-08-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional||"Study population = all randomized subjects who had at least one post randomization product use experience and at least one valid biomarker of exposure measurement.
160 randomized subjects: 78 in mTHS 2.2, 42 in mCC and 40 in SA arms
155 completed, subjects who withdrew: 2 in mTHS 2.2, 1 in mCC and 2 in SA arms"|Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting|A Randomized, Controlled, Multi-center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Smokers Switching to THS 2.2 Menthol or Smoking Abstinence Compared to Smoking Menthol Conventional Cigarettes, for 90 Days|Completed||N/A|160|Actual|Philip Morris Products S.A.||3|||f||||f||||||||No||2017-10-11 01:09:51.210856|2017-10-11 01:09:51.210856
NCT01970982|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-08-19|2016-01-26||July 2013||2013-07-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional||"The study population consisted of all the randomized subjects who had at least 1 post randomization product use experience (THS 2.2 or CC arms), and 1 valid biomarker of exposure (BoExp) measurement.
160 randomized subjects: 80 in THS 2.2, 40 in CC and 40 in SA
158 completers: 2 subjects (SA arm) voluntarily withdrew on Day 1 and Day 3"|Reduced Exposure Study in Smokers Using the Tobacco Heating System 2.2 (THS 2.2) for 5 Days in a Confinement Setting|A Controlled, 3-arm Parallel Group Study to Demonstrate Reduction in Exposure to Smoke Constituents in Healthy Smokers Switching to THS 2.2 or to Smoking Abstinence, Compared to Conventional Cigarettes for 5 Days in Confinement|Completed||N/A|166|Actual|Philip Morris Products S.A.||3|||f||||f||||||||No||2017-10-11 01:09:51.686539|2017-10-11 01:09:51.686539
NCT01970969|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-05-01|||September 2013||2013-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|GIRAFFE||THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring|This Study Will Investigate the Association Between a Set of Single Nucleotide Polymorphisms (SNPs) and Atrial Fibrillation in Patients at High Risk of Developing Atrial Fibrillation. The SNPs Investigated Will Have Been Previously Shown to be Associated With the Atrial Fibrillation.|Active, not recruiting||N/A|928|Actual|Scripps Translational Science Institute|||1||f||||t||||||None Retained|"     A blood sample (in a 4 ml EDTA tube) for genotyping and a serum sample (in two 10ml red top     tubes) will be obtained from each patient.   "|||2017-10-11 01:09:52.326073|2017-10-11 01:09:52.326073
NCT01970930|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-12-21|||August 2012||2012-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients|Treatment Strategies for Myeloproliferative Neoplasms by Targeting the Tumor Suppressor P53|Recruiting||N/A|400|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||Samples Without DNA|"     CD34+ cells isolated from the peripheral blood Splenic CD34+ cells   "|||2017-10-11 01:09:52.495218|2017-10-11 01:09:52.495218
NCT01970917|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-11-26|||October 2013||2013-10-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects|Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects|Completed||Phase 4|16|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:09:52.583073|2017-10-11 01:09:52.583073
NCT01970904|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-04-18|||October 2013||2013-10-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients|A Multicenter, Open-label, Randomized, 3-arm, Phase II Profiling Trial of Pharmacokinetics, Pharmacodynamics and Safety of DEB025/Alisporivir in Combination With Ribavirin Therapy in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients|Completed||N/A|147|Actual|Debiopharm International SA||3|||f||||t||||||||||2017-10-11 01:09:52.671683|2017-10-11 01:09:52.671683
NCT01970891|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2013-10-22|||October 2013||2013-10-01|October 2013|2013-10-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||Electrical Stimulation for the Relief of Freezing of Gait (FOG) in Parkinson's Patients|Electrical Stimulation for the Relief of Freezing of Gait (FOG)|Unknown status|Recruiting|N/A|15|Anticipated|National University of Ireland, Galway, Ireland||1|||f||||t||||||||||2017-10-11 01:09:52.833145|2017-10-11 01:09:52.833145
NCT01970878|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-02-07|2016-05-21|2014-07-15|November 2013||2013-11-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Baseline population includes all subjects enrolled into active treatment arms for the lead-in Studies PT003006 & PT003007|Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)|A 28-Week, Multi-Center, Randomized, Double Blind, Parallel-Group, Active-Controlled Safety Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® as an Active Control|Completed||Phase 3|892|Actual|Pearl Therapeutics, Inc.||4|||f||||t||||||||||2017-10-11 01:09:52.985548|2017-10-11 01:09:52.985548
NCT01970865|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-09-28|||January 2014|Actual|2014-01-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|March 2017|Actual|2017-03-01||Interventional|||A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations|Phase 1/2 Study Of Pf-06463922 (an Alk/ros1 Tyrosine Kinase Inhibitor) In Patients With Advanced Non-small Cell Lung Cancer Harboring Specific Molecular Alterations|Recruiting||Phase 2|340|Anticipated|Pfizer||2|||t||||f||||||||||2017-10-11 01:09:55.34696|2017-10-11 01:09:55.34696
NCT01970852|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-01-05|||March 2014||2014-03-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Addressing Hospital Patient Information Needs Using Information Technology|Addressing Hospital Patient Information Needs Using a Personal Health Record Portal|Recruiting||N/A|426|Anticipated|Columbia University||3|||f||||f||||||||||2017-10-11 01:09:55.728159|2017-10-11 01:09:55.728159
NCT01970839|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-03-20|||November 2014||2014-11-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Tourniquet on Sensory Nerve Conduction Threshold (sNCT) and OxyNeuroGram (ONG) Index- A Volunteer Study|Effect of Tourniquet on Sensory Nerve Conduction Threshold (sNCT) and OxyNeuroGram (ONG) Index- A Volunteer Study|Completed||N/A|10|Actual|Duke University||1|||f||||f|f|f||||||Undecided||2017-10-11 01:09:55.831204|2017-10-11 01:09:55.831204
NCT01970813|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-09-06|||October 2012||2012-10-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy of Acupuncture and Bee Venom Acupuncture on Patients With Idiopathic Parkinson's Disease|Efficacy of Acupuncture and Bee Venom Acupuncture on Patients With Idiopathic Parkinson's Disease|Completed||N/A|74|Actual|Kyunghee University Medical Center||3|||f||||t||||||||||2017-10-11 01:09:56.089947|2017-10-11 01:09:56.089947
NCT01970800|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-25|||January 2013||2013-01-01|October 2013|2013-10-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature|The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature|Unknown status|Not yet recruiting|Phase 2/Phase 3|35|Anticipated|Maimonides Medical Center||1|||f||||t||||||||||2017-10-11 01:09:56.185548|2017-10-11 01:09:56.185548
NCT01970787|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-12-12|2016-04-26||March 2013||2013-03-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|AIN|HIV-negative subjects with AIN containing HSIL located within half of the anorectal circumference, which is defined as no more than two contiguous quadrants and in the study referred to as the eligible treatment zone (ETZ).|A Trial of Radiofrequency Ablation for Anal Intraepithelial Neoplasia Using the HALO Ablation System|A Trial of Radiofrequency Ablation for Anal Intraepithelial Neoplasia Using the HALO Ablation System|Completed||N/A|22|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-11 01:09:56.283667|2017-10-11 01:09:56.283667
NCT01970774|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-04-17|||November 2013||2013-11-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Medication Therapy Management With Pharmacogenetic Testing|Assessing Feasibility and Utility of Enhancing Medication Therapy Management With Pharmacist-Delivered Pharmacogenetic Testing|Completed||N/A|30|Actual|Duke University||1|||f||||t||||||||||2017-10-11 01:09:56.539706|2017-10-11 01:09:56.539706
NCT01970761|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-10-23|||February 2008||2008-02-01|December 2012|2012-12-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Observational|||Autologous Fat Graft Alleviate Scar Pain|Alleviation of Neuropathic Scar Pain With Autologous Fat Graft|Completed||N/A|36|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||t||||||||||2017-10-11 01:09:56.617382|2017-10-11 01:09:56.617382
NCT01970748|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-22|||August 2009||2009-08-01|October 2013|2013-10-01||||December 2013|Anticipated|2013-12-01||Interventional|P-HCC||Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices|Endoscopic Treatment Versus Propranolol for Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices|Unknown status|Recruiting|Phase 4|200|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 01:09:56.68529|2017-10-11 01:09:56.68529
NCT01970735|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2013-12-10|||October 2013||2013-10-01|October 2013|2013-10-01||||October 2016|Anticipated|2016-10-01||Interventional|||Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2|Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 01:09:56.792156|2017-10-11 01:09:56.792156
NCT01970722|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-08-18|||May 2014||2014-05-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer|Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Optional Postoperative Normothermic Intraperitoneal (IP) Chemotherapy to Treat Primary or Recurrent Carcinoma of Ovarian, Fallopian Tube, Uterine, or Peritoneal Origin|Recruiting||N/A|50|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:09:56.869205|2017-10-11 01:09:56.869205
NCT01970709|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-03-18|||November 2013||2013-11-01|March 2015|2015-03-01||||November 2015|Anticipated|2015-11-01|60 Days|Observational [Patient Registry]|DART||Diagnosing Adverse Drug Reactions Registry|DART Registry: Diagnosing Adverse Drug Reactions Registry|Unknown status|Active, not recruiting|N/A|250000|Anticipated|Renaissance RX|||1||f||||f||||||Samples With DNA|"     Buccal swab   "|||2017-10-11 01:09:57.018402|2017-10-11 01:09:57.018402
NCT01970696|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-11-01|||December 2011||2011-12-01|November 2016|2016-11-01||||December 2020|Anticipated|2020-12-01|10 Years|Observational [Patient Registry]|OTST||International Ovarian & Testicular Stromal Tumor Registry|International Ovarian & Testicular Stromal Tumor Registry|Recruiting||N/A|200|Anticipated|Children's Hospitals and Clinics of Minnesota|||3||f||||f||||||Samples With DNA|"     1) whole blood for DNA extraction and lymphoblastoid cell line generation, 2) stained and     unstained slides and snap frozen tumor tissue (if available), and 3) paraffin blocks.   "|||2017-10-11 01:09:57.374853|2017-10-11 01:09:57.374853
NCT01970683|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-07-23|||August 2014||2014-08-01|July 2017|2017-07-01|February 28, 2017|Actual|2017-02-28|February 2017|Actual|2017-02-01||Interventional|PROGRESS||Probiotics and Recovery From Surgery|Effect of Perioperative Probiotics on Clinical Outcomes of Patients Undergoing Major Abdominal Operation in Community Settings.|Terminated||Phase 3|140|Actual|Catholic Health Initiatives||2||organizational problems|f||||f||||||||||2017-10-11 01:09:57.482091|2017-10-11 01:09:57.482091
NCT01970670|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-07-07|||April 2015||2015-04-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Observational|||Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer|Contrast-Enhanced Digital Mammography (CEDM) vs Contrast-Enhanced Breast MRI (CE-MRI) in Patients With Known Breast Cancer|Recruiting||Phase 2|50|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 01:09:57.556073|2017-10-11 01:09:57.556073
NCT01970657|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-06-21|||May 2014||2014-05-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247|An Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 in Subjects Who Participated in Study 802-247-09-032(EU)|Completed||N/A|221|Actual|Healthpoint|||2||f||||t|t|f||||None Retained|"     The treatment assignment codes and randomization schedule for the prior trial will be     maintained for this observational study. The treatment assignments will not be made known to     the Investigators until the present follow-up study has been completed by all consenting     subjects thus keeping treating physician and subjects blind to treatment.   "|Yes|Publication submitted to Journal of Vascular Surgery in May 2017|2017-10-11 01:09:57.628014|2017-10-11 01:09:57.628014
NCT01970644|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-05-27|||April 2014||2014-04-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases|Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases|Terminated||N/A|3|Actual|CancerCare Manitoba|||1|Poor accrual. Investigator decision.|f||||t||||||||No||2017-10-11 01:09:57.785465|2017-10-11 01:09:57.785465
NCT01970618|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-11-19|||October 2013||2013-10-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients|A Randomised, Double Blind, Placebo-controlled, Three Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treatment With Single and Repeat Doses of Inhaled RV1162 in Healthy Subjects and Subjects With Chronic Obstructive Pulmonary Disease.|Completed||Phase 1|78|Actual|Respivert Ltd||3|||f||||f||||||||||2017-10-11 01:09:58.034271|2017-10-11 01:09:58.034271
NCT01970605|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-02-21|||October 2013||2013-10-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Silver Graft All Comers Registry|Silver Graft All Comers Registry is to Assess the Long Term Clinical Benefit of Silver Graft in an Unselected Patient Population|Recruiting||N/A|500|Anticipated|B. Braun Melsungen AG|||1||f||||t||||||||||2017-10-11 01:09:58.15821|2017-10-11 01:09:58.15821
NCT01970592|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-10-04|||October 1, 2013|Actual|2013-10-01|October 2017|2017-10-01|March 30, 2018|Anticipated|2018-03-30|September 29, 2017|Actual|2017-09-29||Interventional|||Power Training Post-stroke|Skeletal Muscle Plasticity As An Indicator of Functional Performance Post-Stroke|Active, not recruiting||Phase 1/Phase 2|56|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-11 01:09:58.265903|2017-10-11 01:09:58.265903
NCT01970579|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-07-26|||October 2013||2013-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|ConSeQuent||Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter|Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter|Active, not recruiting||Phase 3|150|Anticipated|B. Braun Melsungen AG||2|||f||||t||||||||||2017-10-11 01:09:58.347041|2017-10-11 01:09:58.347041
NCT01970566|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-01-14|||November 2013||2013-11-01|January 2014|2014-01-01|November 2017|Anticipated|2017-11-01|August 2015|Anticipated|2015-08-01||Interventional|||Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity|Effect of Intense-Exercise/Moderate-Calorie vs Topiramate-Phentermine on Obesity|Withdrawn||N/A|0|Actual|VA Office of Research and Development||3||The project was not announced to the field and it was not funded.|f||||t||||||||||2017-10-11 01:09:58.464723|2017-10-11 01:09:58.464723
NCT01970553|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-03-31|||May 2011||2011-05-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors|Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM01183 in Combination With Gemcitabine in Non-heavily Pretreated Patients With Selected Advanced Solid Tumors|Completed||Phase 1|47|Actual|PharmaMar||1|||f||||f||||||||||2017-10-11 01:09:58.615299|2017-10-11 01:09:58.615299
NCT01970540|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-08-22|||May 25, 2011|Actual|2011-05-25|January 2017|2017-01-01|August 9, 2017|Actual|2017-08-09|August 9, 2017|Actual|2017-08-09||Interventional|||Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors|Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM01183 in Combination With Doxorubicin in Non-heavily Pretreated Patients With Selected Advanced Solid Tumors|Completed||Phase 1|122|Actual|PharmaMar||1|||f||||f||||||||||2017-10-11 01:09:58.755634|2017-10-11 01:09:58.755634
NCT01970527|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-08-07|||March 2014||2014-03-01|August 2017|2017-08-01||||March 15, 2018|Anticipated|2018-03-15||Interventional|||Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma|RADVAX: A Stratified Phase II Dose Escalation Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Metastatic Melanoma|Recruiting||Phase 2|40|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 01:09:59.481262|2017-10-11 01:09:59.481262
NCT01970514|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-01-13|||April 2012||2012-04-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Safety Study of ARO Spinal System as an Adjunct to Lumbar Decompression|Temporary Axial Rotation Stabilization for Lumbar Disc Prolapse Surgery With the ARO® Spinal System: A Non-randomized Prospective Analysis of Clinical Efficacy, Safety and Cost Effectiveness|Unknown status|Active, not recruiting|Early Phase 1|20|Anticipated|ARO Medical||1|||f||||f||||||||||2017-10-11 01:09:59.623388|2017-10-11 01:09:59.623388
NCT01970501|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2017-09-05|||April 2014||2014-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GENETIC-AF||Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure|GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure|Active, not recruiting||Phase 2|250|Anticipated|ARCA Biopharma, Inc.||2|||f||||t||||||||||2017-10-11 01:09:59.737867|2017-10-11 01:09:59.737867
NCT01970488|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-10-20|2016-10-20|2015-05-19|October 2013||2013-10-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis|A Phase 3, Multicenter, Randomized, Double-blind Study Evaluating the Efficacy and Safety of ABP 501 Compared With Adalimumab in Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 3|350|Actual|Amgen||2|||f||||t||||||||||2017-10-11 01:10:00.150151|2017-10-11 01:10:00.150151
NCT01970475|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-10-20|2016-10-20|2015-04-15|October 2013||2013-10-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||The full analysis set (all randomized participants)|Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis|A Randomized, Double-blind, Phase 3 Study of ABP 501 Efficacy and Safety Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|526|Actual|Amgen||2|||f||||t||||||||||2017-10-11 01:10:01.764135|2017-10-11 01:10:01.764135
NCT01970462|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-09-26|||January 2014||2014-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery|Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery|Terminated||Phase 4|8|Actual|Ohio State University||2||Recruitment|f||||f||||||||||2017-10-11 01:10:02.764889|2017-10-11 01:10:02.764889
NCT01970254|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-01-10|||June 2013||2013-06-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Observational|||Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy|Widespread Versus Selective Screening for Hepatitis B Infection Prior to Chemotherapy|Recruiting||N/A|3441|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 01:10:04.83264|2017-10-11 01:10:04.83264
NCT01970449|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-11-04||||||November 2014|2014-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults|A Phase 1 Randomized, Double-blind, Placebo Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of DNA Prime and NYVAC Boost With 3 Different HIV-1 Envelope Inserts (Nat-B Env, CON-S Env, and Mosaic Env) in Healthy, HIV-1-uninfected Adults|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-11 01:10:02.939931|2017-10-11 01:10:02.939931
NCT01970436|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-08-10|||May 2014||2014-05-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Personalized Prenatal Care for Low-Risk Pregnancies Using Telemedicine|Personalized Prenatal Care for Low-Risk Pregnancies Using Remote Patient Monitoring|Active, not recruiting||N/A|200|Actual|University of Utah||2|||f||||f||||||||No||2017-10-11 01:10:03.057993|2017-10-11 01:10:03.057993
NCT01970423|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-09-29|||January 2014||2014-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Sleep Apnea and CRT Upgrading|Central Sleep Apnea and New-onset Cardiac Resynchronization in Patients With Conventional Pacemaker or ICD Therapy: a Multicenter, Randomized Clinical Trial|Recruiting||N/A|80|Anticipated|Medical University Innsbruck||2|||f||||f||||||||||2017-10-11 01:10:03.148366|2017-10-11 01:10:03.148366
NCT01970410|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-08-28|||October 2013||2013-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide|Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?|Active, not recruiting||Phase 4|70|Anticipated|Multiple Sclerosis Center of Northeastern New York||1|||f||||t||||||||||2017-10-11 01:10:03.277082|2017-10-11 01:10:03.277082
NCT01970397|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2015-08-05|2015-08-05||October 2013||2013-10-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Intent-to-treat population included all randomized participants who received study treatment.|JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines|A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of JUVEDERM® Ultra XC Injectable Gel Versus Belotero Balance® for Perioral Lines|Completed||N/A|138|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:10:03.400193|2017-10-11 01:10:03.400193
NCT01970384|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-10-12|||June 2012||2012-06-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Transcranial Direct Current Stimulation for Dysphagia Therapy in Acute Stroke Patients|Transcranial Direct Current Stimulation for Dysphagia Therapy in Acute Stroke Patients|Completed||N/A|60|Actual|University Hospital Muenster||2|||f||||t||||||||||2017-10-11 01:10:03.766425|2017-10-11 01:10:03.766425
NCT01970371|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-23|2016-10-03|||September 2014||2014-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|CARE||A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)|A Phase 3, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)|Completed||Phase 3|69|Actual|Achaogen, Inc.||3|||f||||t||||||||||2017-10-11 01:10:03.871678|2017-10-11 01:10:03.871678
NCT01970358|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-09-08|||January 2014||2014-01-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|January 2017|Anticipated|2017-01-01||Interventional|||A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma|A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma|Recruiting||Phase 1|20|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:10:04.030853|2017-10-11 01:10:04.030853
NCT01970345|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-01-10|||May 2014||2014-05-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder|A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder|Recruiting||Phase 2|10|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 01:10:04.160878|2017-10-11 01:10:04.160878
NCT01970332|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-09-22|||September 2010||2010-09-01|September 2017|2017-09-01|May 30, 2016|Actual|2016-05-30|May 30, 2016|Actual|2016-05-30||Interventional|||Mechanisms That Produce the Leg Dysfunction of Claudication (Leg Pain and Limping During Walking) and Treatment Strategies for the Care of Patients With Claudication|Mitochondrial Dysfunction, Oxidative Damage and Inflammation in Claudication|Completed||N/A|220|Actual|University of Nebraska||3|||f||||f||||||||||2017-10-11 01:10:04.291629|2017-10-11 01:10:04.291629
NCT01970319|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-09-20|||October 2013||2013-10-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Observational|MRHD||Mechanisms and Reversibility of Heart Failure Associated With Diabetes||Completed||N/A|110|Actual|University of Leeds|||2||f||||t||||||Samples Without DNA|"     Frozen serum   "|||2017-10-11 01:10:04.387135|2017-10-11 01:10:04.387135
NCT01970306|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-09-22|||October 18, 2013|Actual|2013-10-18|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material|A Prospective Phase II Trial to Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material|Recruiting||Phase 2|86|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:10:04.475836|2017-10-11 01:10:04.475836
NCT01970293|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-07-19|||October 2013||2013-10-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||AA Linkage for Alcohol Abusing Women Leaving Jail|AA Linkage for Alcohol Abusing Women Leaving Jail|Recruiting||N/A|400|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-11 01:10:04.582986|2017-10-11 01:10:04.582986
NCT01970280|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-25|||September 2013||2013-09-01|October 2013|2013-10-01|January 2015|Anticipated|2015-01-01|November 2014|Anticipated|2014-11-01||Interventional|||Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.||Unknown status|Recruiting|Phase 4|26|Anticipated|Meir Hospital, Kfar Saba, Israel||2|||f||||||||||||||2017-10-11 01:10:04.672293|2017-10-11 01:10:04.672293
NCT01970267|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-04-20|||October 2013||2013-10-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Clear Vision Study|Randomized Trial of Laser Ablation for Highly Symptomatic Floaters|Completed||N/A|35|Actual|University of British Columbia||2|||f||||f||||||||No||2017-10-11 01:10:04.756749|2017-10-11 01:10:04.756749
NCT01970228|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-08-02|||October 2012|Actual|2012-10-01|August 2017|2017-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|Propeli||Imaging of Joint Replacement Complications by PET/CT|Prospective Intra-individual Comparison of 18F-FDG and 68Ga-citrate PET/CT in Symptomatic Total Hip Arthroplasty Patients|Completed||N/A|12|Actual|Turku University Hospital||3|||f||||f||||||||||2017-10-11 01:10:05.073589|2017-10-11 01:10:05.073589
NCT01970215|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2014-08-20|||August 2013||2013-08-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TULIP||TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)|A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of TA-8995 in Patients With Mild Dyslipidaemia, Alone and In Combination With Statin Therapy|Completed||Phase 2|364|Actual|Xention Ltd||9|||f||||t||||||||||2017-10-11 01:10:05.183133|2017-10-11 01:10:05.183133
NCT01970202|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2013-10-22|||November 2013||2013-11-01|October 2013|2013-10-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity|Comparing the Efficacy of Two Frequently Used Doses of Enoxaparin for VTE Prophylaxis After Bariatric Surgery|Unknown status|Not yet recruiting|Phase 4|55|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||||2017-10-11 01:10:05.343542|2017-10-11 01:10:05.343542
NCT01970189|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-10-26|||January 2011||2011-01-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01|24 Months|Observational [Patient Registry]|||The International ITP Registry|A Multi-centre, Prospective Disease Registry for Adults Diagnosed With Primary Immune Thrombocytopenia (ITP) in International Countries|Recruiting||N/A|500|Anticipated|South Eastern Sydney Local Health District|||1||f||||f||||||||||2017-10-11 01:10:05.522688|2017-10-11 01:10:05.522688
NCT01970176|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-08-25|||November 2013||2013-11-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|Aim2||Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)|Define in Preclinical Systolic Dysfunction (PSD) With Renal Dysfunction, the Cardiorenal and Humoral Actions of Chronic Type V Phosphodiesterase (PDEV) Inhibition|Recruiting||Phase 1/Phase 2|45|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 01:10:05.790876|2017-10-11 01:10:05.790876
NCT01970163|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-09-06|||October 2013||2013-10-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||DermACELL in Subjects With Chronic Wounds of the Lower Extremities|A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities|Completed||Phase 4|202|Actual|LifeNet Health||3|||f||||f||||||||||2017-10-11 01:10:05.919209|2017-10-11 01:10:05.919209
NCT01970150|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-09-06|||February 2014||2014-02-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||The Effect of Repeated Transcranial Magnetic Stimulation on Off-line Resting Electroencephalographic Signal in Alzheimer's Disease|To Investigate the Effect of Application of Repeated Trans-cranial Magnetic Stimulation (rTMS) Applied on the Left Prefrontal Cortex on Electroencephalography Signal Recorded From Brain Regions Involved in Cognitive Function in Patients With Alzheimer's Disease (AD)|Terminated||N/A|5|Actual|Lawson Health Research Institute||1||"1. New data from a published trial requires substantial change in study protocol      2. no funding available to carry the study further"|f||||f||||||||||2017-10-11 01:10:06.064735|2017-10-11 01:10:06.064735
NCT01970137|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-04-15||||||April 2016|2016-04-01||||October 2014|Actual|2014-10-01||Interventional|||A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)||Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 01:10:06.332673|2017-10-11 01:10:06.332673
NCT01970124|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-04-15||||||April 2016|2016-04-01||||May 2015|Actual|2015-05-01||Interventional|||A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)||Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 01:10:06.408445|2017-10-11 01:10:06.408445
NCT01970111|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-04-15||||||April 2016|2016-04-01||||July 2015|Actual|2015-07-01||Interventional|||An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)||Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 01:10:06.496796|2017-10-11 01:10:06.496796
NCT01970098|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-04-15||||||April 2016|2016-04-01||||January 2015|Actual|2015-01-01||Interventional|||A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)||Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 01:10:06.587392|2017-10-11 01:10:06.587392
NCT01970072|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-22|||October 2013||2013-10-01|October 2013|2013-10-01||||October 2013|Anticipated|2013-10-01||Interventional|||A Phase Ⅰa Study of Remimazolam Tosylate in Healthy Volunteers|A Placebo- and Midazolam-Controlled, Phase Ia, Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam Tosylate|Unknown status|Recruiting|Phase 1|64|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||11|||f||||t||||||||||2017-10-11 01:10:06.666351|2017-10-11 01:10:06.666351
NCT01970059|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-22|||October 2013||2013-10-01|October 2013|2013-10-01||||October 2013|Anticipated|2013-10-01||Interventional|||A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension|Efficacy and Safety Comparison of Extended-Release Carvedilol Sulfate and Sustained-release Metoprolol Succinate in Patients With Hypertension|Unknown status|Recruiting|Phase 3|302|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:10:06.780267|2017-10-11 01:10:06.780267
NCT01970046|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-22|||April 2013||2013-04-01|October 2013|2013-10-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes|A Multicenter Randomized, Double-blind, Placebo Controlled ,Parallel Group ,Phase III Study to Access the Efficacy and Safety of SP2086 in Combination Therapy With Metformin in Patients With Type 2 Diabetes Patients|Unknown status|Recruiting|Phase 3|360|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:10:06.889571|2017-10-11 01:10:06.889571
NCT01970033|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-22|||December 2012||2012-12-01|October 2013|2013-10-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes|A Multicenter Randomized, Double-blind, Placebo Controlled ,Parallel Group ,Phase III Study to Access the Efficacy and Safety of SP2086 Treated Type 2 Diabetes Patients|Unknown status|Recruiting|Phase 3|450|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:10:06.993238|2017-10-11 01:10:06.993238
NCT01970020|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-22|||October 2012||2012-10-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study to Investigate the Absorption, Metabolism, and Excretion of JNJ-38518168 After a Single Oral Dose in Healthy Male Participants.|An Open-Label Study to Investigate the Absorption, Metabolism, and Excretion of JNJ-38518168 in Healthy Subjects Following a Single Oral Dose Administration of 14C-JNJ-38518168|Completed||Phase 1|6|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 01:10:07.135525|2017-10-11 01:10:07.135525
NCT01970007|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-02-13|||October 2013||2013-10-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|||VIVO Clinical Study|Evaluation of the Zilver® Vena™ Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction|Active, not recruiting||N/A|243|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 01:10:07.335587|2017-10-11 01:10:07.335587
NCT01969994|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-22|||December 2009||2009-12-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Absorption, Metabolism, and Excretion of (-)-[2-14C]Epicatechin in Humans|A Single-Center, Open-Label Study to Evaluate the Absorption, Metabolism, and Excretion of (-)-[2-14C]Epicatechin Following Oral Intake|Completed||N/A|12|Actual|The Institutes for Pharmaceutical Discovery, LLC||1|||f||||t||||||||||2017-10-11 01:10:07.535978|2017-10-11 01:10:07.535978
NCT01969981|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-09-11|||October 2013||2013-10-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|SHERLOCK 3CG||A Study to Assess Placement and Confirmation of Peripheral Inserted Central Catheters Tip Position Using a New Electrocardiographic Method|An Observational, Prospective, Single-center Study of Placement and Confirmation of Peripheral Inserted Central Catheters Tip Position Using a New Electrocardiographic Method|Completed||N/A|571|Actual|Centre Leon Berard|||1||f||||f||||||||||2017-10-11 01:10:07.689596|2017-10-11 01:10:07.689596
NCT01969968|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-09-29|||December 2013||2013-12-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|December 2016|Anticipated|2016-12-01||Interventional|POLOB||Lipophilic Organic Polluants and Morbid Obesity|Lipophilic Organic Polluants and Morbid Obesity: Kinetic of the Release and Impact on the Metabolic Syndrome Before and After Bariatric Surgery|Recruiting||N/A|250|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 01:10:07.830006|2017-10-11 01:10:07.830006
NCT01969955|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-04-24|||September 2013||2013-09-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer|A Phase II Trial of Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer After Failure of Platinum Doublet (Except Pemetrexed) Therapy|Unknown status|Recruiting|Phase 2|50|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 01:10:07.970109|2017-10-11 01:10:07.970109
NCT01969942|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-05-08|||April 2013||2013-04-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ASCT||A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma|A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma|Withdrawn||Phase 1|0|Actual|University of Louisville||2||No subjects meeting study inclusion were enrolled.|f||||f||||||||||2017-10-11 01:10:08.097712|2017-10-11 01:10:08.097712
NCT01969929|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-05-29|||October 2013||2013-10-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|20Gvs23G||Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy|Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Cologne||2|||f||||t||||||||||2017-10-11 01:10:08.225423|2017-10-11 01:10:08.225423
NCT01969916|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-05-11|||June 2014||2014-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Stress CT Perfusion in Patients With Chest Pain|Comprehensive Evaluation of Patients With Chest Pain Using Cardiac Computed Tomography: Value of Adding Regadenoson Stress Perfusion Imaging to Noninvasive Coronary Angiography|Recruiting||N/A|300|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 01:10:08.329844|2017-10-11 01:10:08.329844
NCT01969903|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-12-07|||November 2014||2014-11-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study of Use of Dexmedetomidine for Regional Anesthesia|Effect of Dexmedetomidine Added to Lidocaine for Infra- and Supraclavicular Brachial Plexus Block|Withdrawn||Phase 2|0|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-10-11 01:10:08.464364|2017-10-11 01:10:08.464364
NCT01969890|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-02-24|||October 2013||2013-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|STEM-AMI||STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial|Phase III Study on STem cElls Mobilization in Acute Myocardial Infarction|Suspended||Phase 3|1530|Anticipated|Heart Care Foundation||2||Upon DSMC suggestion due to a too low enrollment rate.|f||||t||||||||||2017-10-11 01:10:08.577539|2017-10-11 01:10:08.577539
NCT01969877|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-03-06|||November 2013||2013-11-01|September 2016|2016-09-01|November 2024|Anticipated|2024-11-01|November 2024|Anticipated|2024-11-01||Interventional|ARTSCANIII||A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.|A Randomized Multicenter Phase III Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.|Recruiting||Phase 3|618|Anticipated|Lund University Hospital||4|||f||||f||||||||||2017-10-11 01:10:08.809011|2017-10-11 01:10:08.809011
NCT01969864|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-05-09|||October 2013||2013-10-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||University Student Intervention to Increase Organ Donation|College and University Student Intervention to Increase Consent for Organ Donation|Unknown status|Recruiting|N/A|1200|Anticipated|Case Western Reserve University||3|||f||||f||||||||||2017-10-11 01:10:08.97777|2017-10-11 01:10:08.97777
NCT01969851|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-08-03|||February 2014|Actual|2014-02-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.|A MULTI-CENTER, OPEN-LABEL, EXPLORATORY STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN SUBJECTS ≥1 MONTH TO <18 YEARS WITH EPILEPSY SYNDROMES ASSOCIATED WITH GENERALIZED SEIZURES.|Recruiting||Phase 2|50|Anticipated|UCB Pharma||1|||f||||f||||||||||2017-10-11 01:10:09.127745|2017-10-11 01:10:09.127745
NCT01969838|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-08-23||2017-01-05|December 6, 2013|Actual|2013-12-06|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|September 12, 2016|Actual|2016-09-12||Interventional|Simplify 1||Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis|A Phase 3, Randomized, Double-blind Active-controlled Study Evaluating Momelotinib vs. Ruxolitinib in Subjects With Primary Myelofibrosis (PMF) or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)|Active, not recruiting||Phase 3|432|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-11 01:10:09.359494|2017-10-11 01:10:09.359494
NCT01969825|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2013-10-22|||December 2005||2005-12-01|October 2013|2013-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||The Role of Massage in Increasing Total Motile Sperm Count of IUI|The Role of Massage in Increasing Total Motile Sperm Count of Intrauterine Insemination|Completed||Phase 4|40|Actual|Carolinas Healthcare System||2|||f||||f||||||||||2017-10-11 01:10:09.814955|2017-10-11 01:10:09.814955
NCT01969812|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-02-15|||January 2014||2014-01-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Tolerability and Satisfaction With Evie|Patient Satisfaction and Tolerability With the Evie® Slow-Release Insemination Device: Pilot Study|Completed||Phase 4|20|Actual|Carolinas Healthcare System||2|||f||||f||||||||||2017-10-11 01:10:09.916881|2017-10-11 01:10:09.916881
NCT01969799|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-06-04|2016-07-08||December 2013||2013-12-01|March 2016|2016-03-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|IASIS||Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia|A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)|Completed||Phase 2|143|Actual|Cardeas Pharma||2|||f||||t||||||||Undecided||2017-10-11 01:10:10.026411|2017-10-11 01:10:10.026411
NCT01969786|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-06-09|||February 2014||2014-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VIEW||Village Integrated Eye Workers Trial|Village Integrated Eye Workers Trial|Recruiting||N/A|216000|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:10:10.898669|2017-10-11 01:10:10.898669
NCT01969773|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-02-16|||December 2012|Actual|2012-12-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment|Intravesical Botulinum Toxin A Injection in Treatment of Interstitial Cystitis Refractory to Conventional Treatment - A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 2|60|Actual|Buddhist Tzu Chi General Hospital||2|||f||||f|t|f|||t|||No|IPD was not planned to share|2017-10-11 01:10:11.009338|2017-10-11 01:10:11.009338
NCT01969760|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-01-26|||October 2013||2013-10-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|HFDC||Pilot-Testing a Family-Based Intervention to Improve Child Outcomes and Increase Family Activity|Pilot-Testing a Family-Based Intervention to Improve Child Outcomes and Increase Family Activity|Completed||N/A|18|Actual|Georgetown University||2|||f||||f||||||||||2017-10-11 01:10:11.133433|2017-10-11 01:10:11.133433
NCT01969747|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2015-04-06|2015-03-23||November 2013||2013-11-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Full analysis set (FAS): all patients randomised, treated with at least one dose of study drug, had a baseline UGE (g/24 h) and a UGE (g/24 h) on Day 1 or Day 7.|Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days|A 28-day Randomised, Placebo-controlled, Double-blind Parallel Group Phase IIa Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Once Daily Oral Doses of 2.5 mg, 10 mg, and 25 mg Empagliflozin as Adjunctive to Insulin in Patients With Type 1 Diabetes Mellitus (EASE-2)|Completed||Phase 2|75|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 01:10:11.225842|2017-10-11 01:10:11.225842
NCT01969734|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-05-19|||March 2014||2014-03-01|May 2017|2017-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|REMODEL||Endobronchial Valves in Moderate COPD|Response to Endobronchial Valves in Moderate Obstructive Airways Disease and Exercise Limitation - The REMODEL Trial|Completed||N/A|7|Actual|Sherwood Forest Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:10:11.65976|2017-10-11 01:10:11.65976
NCT01969721|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2016-01-14|2016-01-14||October 2013||2013-10-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional||Treated Set: All randomised patients who received any dose of the trial medication.|Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients|Randomized, Double-blind, Double-dummy, Active-controlled, 4 Period Complete Cross-over Study to Compare the Effect on Lung Function of 6 Weeks Once Daily Treatment With Orally Inhaled Tiotropium+Olodaterol Fixed Dose Combination Delivered by the Respimat® Inhaler vs. 6 Weeks Twice Daily Treatment With Fluticasone Propionate+Salmeterol Fixed Dose Combination Delivered by the Accuhaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|229|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 01:10:13.486008|2017-10-11 01:10:13.486008
NCT01969708|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-05-15|||September 2014||2014-09-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|November 2016|Actual|2016-11-01||Interventional|SCORE2||Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)|Study of COmparative Treatments for REtinal Vein Occlusion 2 [SCORE2]: a Multicenter, Prospective, Randomized Non-inferiority Trial of Eyes With Macular Edema Secondary to Central Retinal Vein Occlusion, Comparing Intravitreal Bevacizumab Every 4 Weeks With Intravitreal Aflibercept Every 4 Weeks.|Active, not recruiting||Phase 3|362|Actual|The EMMES Corporation||2|||f||||t||||||||Yes|SCORE2 will follow specific plans for sharing of research data. After analysis, the final data set can be provided after appropriate procedures are implemented to preserve the anonymity of the records, specifically where PHI (protected health information) is required. Upon request, anonymized data will be shared under confidentiality agreements with researchers interested in the project.|2017-10-11 01:10:14.362471|2017-10-11 01:10:14.362471
NCT01969695|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-07-21|||December 31, 2013||2013-12-31|July 2017|2017-07-01|July 16, 2018|Anticipated|2018-07-16|July 16, 2018|Anticipated|2018-07-16||Interventional|||An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma|An Extension Study of Venetoclax in Subjects With Advanced Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1|12|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-11 01:10:14.615772|2017-10-11 01:10:14.615772
NCT01948063|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-03-11|2016-03-01||October 2012||2012-10-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Ubiquinol (Reduced COQ10) for Patients With Sepsis|Ubiquinol (Reduced COQ10) for Patients With Sepsis|Completed||Phase 2|38|Actual|Beth Israel Deaconess Medical Center||2|||f||||t|f|f||||||No||2017-10-11 01:16:40.515695|2017-10-11 01:16:40.515695
NCT01969682|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-05-22|||April 2014||2014-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199|A Phase 1 Study to Assess the Effect of Rifampin on the Pharmacokinetics of ABT-199|Withdrawn||Phase 1|0|Actual|AbbVie||1||This study will be conducted in healthy volunteer subjects.|f||||f||||||||||2017-10-11 01:10:14.726799|2017-10-11 01:10:14.726799
NCT01969669|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2014-10-14|||December 2013||2013-12-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199|A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-199|Completed||Phase 1|12|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 01:10:14.834661|2017-10-11 01:10:14.834661
NCT01969656|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-07-25||||||July 2017|2017-07-01||||June 2004|Actual|2004-06-01||Interventional|||Safety Study of an Oral Vitamin D Analog in Postmenopausal Women|A Phase 1B, Double-Blind, Placebo-Controlled, Calcitriol Active-Controlled, Daily-Dose, Escalating-Dose, Safety and Tolerance Study of 2MD Soft Gel Capsules in Normal Healthy Postmenopausal Women|Completed||Phase 1|||Deltanoid Pharmaceuticals||7|||||||||||||||||2017-10-11 01:10:14.97024|2017-10-11 01:10:14.97024
NCT01969643|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-09-28|||September 2013||2013-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Safety Study of SGN-LIV1A in Breast Cancer Patients|A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of SGN-LIV1A in Patients With Metastatic Breast Cancer|Recruiting||Phase 1|216|Anticipated|Seattle Genetics, Inc.||3|||f||||f||||||||||2017-10-11 01:10:15.084271|2017-10-11 01:10:15.084271
NCT01969630|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-10-21|||October 2013||2013-10-01|October 2013|2013-10-01||||October 2015|Anticipated|2015-10-01||Interventional|||Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions||Unknown status|Recruiting|Phase 4|250|Anticipated|Ospedale San Donato||2|||f||||f||||||||||2017-10-11 01:10:15.324904|2017-10-11 01:10:15.324904
NCT01969617|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-11-10|||November 2013||2013-11-01|November 2014|2014-11-01||||October 2014|Actual|2014-10-01||Interventional|||Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge|Interventional, Randomized, Double-blind, Cross-over, Placebo-controlled Study to Investigate the Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge|Completed||Phase 1|22|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 01:10:15.43271|2017-10-11 01:10:15.43271
NCT01969604|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-06-02|||April 2013||2013-04-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Reduction of Daily Sitting Time in Patients With Rheumatoid Arthritis|Reduction of Daily Sitting Time in Patients With Rheumatoid Arthritis. A Randomized Controlled Trial.|Completed||N/A|150|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-11 01:10:15.526031|2017-10-11 01:10:15.526031
NCT01969578|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-08-11|||February 2015||2015-02-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Androgen Deprivation Therapy in Advanced Salivary Gland Cancer|A Randomized Phase II Study to Evaluate the Efficacy and Safety of Chemotherapy (CT) vs Androgen Deprivation Therapy (ADT) in Patients With Recurrent and/or Metastatic, Androgen Receptor (AR) Expressing, Salivary Gland Cancer (SGCs)|Recruiting||Phase 2|152|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 01:10:15.732578|2017-10-11 01:10:15.732578
NCT01969565|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-10-06|2015-10-06||August 2013||2013-08-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma|An Open-label, Single-arm, Phase 1b/ 2 Study of Carfilzomib in Combination With Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma|Terminated||Phase 2|1|Actual|Emory University|One patient consented but withdrew prior to beginning treatment.|1||Logistical reasons|f||||t||||||||||2017-10-11 01:10:16.056105|2017-10-11 01:10:16.056105
NCT01969552|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2014-09-01|||July 2013||2013-07-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|IIFHT||Interrelations Between FT3, FT4 and Pituitary TSH|Interrelations Between FT3, FT4 and Pituitary TSH and Implications For Thyroid Hormone Treatment (IIFHT-Study)|Completed||N/A|1912|Actual|Klinikum Lüdenscheid|||1||f||||f||||||||||2017-10-11 01:10:16.286268|2017-10-11 01:10:16.286268
NCT01969539|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-01-19|2015-11-19||October 2013||2013-10-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||Treated set which included all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Ventilator Adapters for Combivent Respimat|Open Label, Non-randomised, 1-day Trial to Characterize the Performance of Two Adapter Devices Designed to Permit Use of the Respimat® Inhaler Device With Patients Requiring Mechanical Ventilation.|Terminated||Phase 4|11|Actual|Boehringer Ingelheim|The study was closed early based on the results of an interim pharmacokinetic analysis, prior to enrollment of any patient in cohort 2, therefore only the Trudell adapter was assessed (in cohort 1)|2|||f||||||||||||||2017-10-11 01:10:16.369326|2017-10-11 01:10:16.369326
NCT01969526|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-03-02|||January 2013||2013-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Effectiveness of a Multifactorial Intervention on Frailty|Effectiveness of a Multifactorial Intervention to Modify Frailty Parameters in Elderly Population|Active, not recruiting||N/A|352|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 01:10:16.564645|2017-10-11 01:10:16.564645
NCT01969513|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-01-23|||November 2012|Actual|2012-11-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effectiveness of the Epley Manoeuvre Performed in Primary Care to Treat Benign Paroxysmal Positional Vertigo|Effectiveness of the Epley Manoeuvre Performed in Primary Care to Treat Posterior Canal Benign Paroxysmal Positional Vertigo|Completed||N/A|153|Actual|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-10-11 01:10:16.651793|2017-10-11 01:10:16.651793
NCT01969500|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-02-06|||September 2014||2014-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Development of a Mobile System for Self-management of Schizophrenia (SOS)|Development of a Mobile System for Self-management of Schizophrenia (SOS)|Completed||N/A|50|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 01:10:16.761004|2017-10-11 01:10:16.761004
NCT01969487|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2015-08-31|||December 2012||2012-12-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Preoperative Simulator Warmup on Intraoperative Robotic Surgical Skills|Effect of Preoperative Warmup on a Simulator by Trainee Surgeons on Intraoperative Robotic Surgical Skill and Postoperative Patient Outcomes|Completed||N/A|66|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:10:16.857653|2017-10-11 01:10:16.857653
NCT01969474|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-12-25|||December 2013||2013-12-01|December 2016|2016-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effectiveness of Cannabis in the Treatment of Tinnitus Patients|Phase 1 Study to Study the Efficacy and Safety of Cannabis in the Treatment of Tinnitus|Withdrawn||Phase 1|0|Actual|Wolfson Medical Center||2|||f||||f||||||||||2017-10-11 01:10:16.944506|2017-10-11 01:10:16.944506
NCT01969461|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-01-06|||July 2014||2014-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth|Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth|Recruiting||N/A|400|Anticipated|Wayne State University||2|||f||||t||||||||No||2017-10-11 01:10:17.036671|2017-10-11 01:10:17.036671
NCT01969448|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-06-15|||March 2013||2013-03-01|June 2017|2017-06-01|April 17, 2017|Actual|2017-04-17|April 17, 2017|Actual|2017-04-17||Interventional|NASSM||Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction|A Prospective Randomized Trial to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction|Completed||N/A|83|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 01:10:17.171555|2017-10-11 01:10:17.171555
NCT01969435|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-06-22|2016-09-21||March 19, 2014|Actual|2014-03-19|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|September 30, 2015|Actual|2015-09-30||Interventional|||Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma|A Phase II Study of Melphalan HCl for Injection (Propylene Glycol-free), Combined With Carmustine, Etoposide, and Cytarabine (BEAM Regimen) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation|Completed||Phase 2|50|Actual|Washington University School of Medicine||1|||f||||t|t|f||||||No||2017-10-11 01:10:17.346168|2017-10-11 01:10:17.346168
NCT01969422|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-12-02|||November 2013||2013-11-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Online Question-answering and Conventional Consultation With a Dermatologist|Online Question-answering and Conventional Consultation With a Dermatologist|Completed||Phase 4|100|Actual|University of Zurich|||1||f||||t||||||||||2017-10-11 01:10:17.963394|2017-10-11 01:10:17.963394
NCT01969409|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-12-08|||January 2014||2014-01-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|ART-IPF||Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis|Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis (ART-IPF)|Recruiting||Phase 2|58|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 01:10:18.075149|2017-10-11 01:10:18.075149
NCT01969396|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-12-22|||October 2013||2013-10-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology|Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology|Terminated||N/A|2|Actual|Cook Group Incorporated||2||Enrollment considerations and current status of the clinical study|f||||||||||||||2017-10-11 01:10:18.212929|2017-10-11 01:10:18.212929
NCT01969383|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-21|||April 2013||2013-04-01|October 2013|2013-10-01|October 2013|Anticipated|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Comparative Analysis Between Electrical Muscle Activity In Water And Soil|COMPARATIVE ANALYSIS BETWEEN THE ELECTRICAL ACTIVITY WITH AND WITHOUT MUSCULAR STRENGTH IN WATER AND SOIL|Unknown status|Recruiting|N/A|1|Anticipated|Universidade do Vale do Paraíba||1|||f||||f||||||||||2017-10-11 01:10:18.323415|2017-10-11 01:10:18.323415
NCT01969370|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-05-02|||August 2012||2012-08-01|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|NCGENES||NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing|NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing|Completed||N/A|645|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||Yes|"Raw genotype calls from whole exome sequencing are shared with the database of Genotypes and Phenotypes (dbGaP). Other participant demographic variables include: age of onset, birthplace, sex, race, education level, age.
Data is uploaded in batches to the dbGaP website. Currently, the data for 403 participants who have consented for release of their data is available on the dbGaP website.
To access data, users must request authorized access by submitting a Data Use Agreement certified by their institution. This is reviewed by the DbGaP Data Access Committee for approval prior to accessing study data.
All data that is submitted to dbGaP, including individual participant data, is anonymous."|2017-10-11 01:10:18.408122|2017-10-11 01:10:18.408122
NCT01969357|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-21|||June 2011||2011-06-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||A Study of the Effectiveness and Safety of SP2086 to Treat Type 2 Diabetes|A Multicenter Randomized, Double-blind, Placebo and Positive Controlled ,Parallel Group ,Phase II Study to Access the Efficacy and Safety of SP2086 Treated Type 2 Diabetes Patients|Completed||Phase 2|200|Actual|Jiangsu HengRui Medicine Co., Ltd.||5|||f||||f||||||||||2017-10-11 01:10:18.511276|2017-10-11 01:10:18.511276
NCT01969344|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-01-17|||November 2010||2010-11-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|SPIROMICS||Study of COPD Subgroups and Biomarkers|Subpopulations and Intermediate Markers in COPD Study|Active, not recruiting||N/A|3200|Anticipated|University of North Carolina, Chapel Hill|||4||f||||t||||||Samples With DNA|"     Whole blood, serum, plasma, urine, lung biopsies, lung bronchial wash and lavage fluid, oral     rinse and tongue scrapping, and sputum   "|||2017-10-11 01:10:18.614105|2017-10-11 01:10:18.614105
NCT01968785|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2014-08-08|||August 2013||2013-08-01|August 2014|2014-08-01||||December 2015|Anticipated|2015-12-01||Interventional|||Renal Denervation in Patients With Uncontrolled Blood Pressure|RENAL ARTERY IRRADIATION FOR SYMPATHETIC RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION|Unknown status|Recruiting|N/A|20|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-11 01:10:35.290768|2017-10-11 01:10:35.290768
NCT01969331|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-21|||December 2008||2008-12-01|October 2013|2013-10-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Efficacy and Safety of Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori|An Interventional, Prospective, Multi-center, Double-blind, Placebo Controlled Postmarketing Study to Evaluate Efficacy and Safety of Normia® Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori|Completed||Phase 4|804|Actual|University Hospital Rijeka||2|||f||||f||||||||||2017-10-11 01:10:18.86989|2017-10-11 01:10:18.86989
NCT01969318|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-21|||March 2012||2012-03-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes|A Multicenter Randomized, Double-blind, Placebo Controlled ,Parallel Group ,Phase II Study to Access the Efficacy and Safety of SP2086 in Combination Therapy With Metformin in Patients With Type 2 Diabetes Patients|Completed||Phase 2|120|Actual|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:10:18.999654|2017-10-11 01:10:18.999654
NCT01969305|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-06|2016-05-24|||January 2014||2014-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|September 2015|Actual|2015-09-01||Interventional|||Youth Drug Abuse Prevention in Kazakhstan|A Computerized Family-Based Youth HIV and Drug Abuse Prevention in Kazakhstan|Completed||N/A|181|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 01:10:19.149158|2017-10-11 01:10:19.149158
NCT01969292|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-08-17|||September 2013||2013-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Colometer - A Real Time Quality Improvement Feedback System for Screening Colonoscopy|Colometer - A Real Time Quality Improvement Feedback System for Screening Colonoscopy|Terminated||N/A|79|Actual|University of Calgary||3||Stage 1 Complete; Stage 2 and 3 not pursued|f||||f||||||||||2017-10-11 01:10:19.267312|2017-10-11 01:10:19.267312
NCT01969279|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2016-10-18|||October 2000||2000-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|||Radiographic Influences of Bisphosphonate Treatment on Femur|Radiographic Influences of Long-term Bisphosphonate Treatment on Femur|Recruiting||N/A|100|Anticipated|Tomidahama Hospital|||1||f||||f||||||||||2017-10-11 01:10:19.370599|2017-10-11 01:10:19.370599
NCT01969266|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-02-12|||October 2013||2013-10-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With Food|Open-Label, 2-Period, Sequential Design, Exploratory Pharmacokinetic Study In Healthy Subjects to Assess the Pharmacokinetics and Safety of a Supra-Therapeutic Dose of Ibrutinib Capsule and Solution Formulations Administered With Food|Completed||Phase 1|8|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 01:10:19.480668|2017-10-11 01:10:19.480668
NCT01969253|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-10-13|||May 2012||2012-05-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||A Prospective Observational Study of Lymphedema in Breast Cancer With Axillary Lymph Node Dissection|A Prospective Observational Study of Lymphedema in Breast Cancer With Axillary Lymph Node Dissection (ALND)|Completed||N/A|400|Actual|National Cancer Center, Korea|||1||f||||t||||||||||2017-10-11 01:10:19.592303|2017-10-11 01:10:19.592303
NCT01969227|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-03-21|||January 2014||2014-01-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures|The Effects of Subanesthetic Ketamine on Respiratory Stimulation and Transpulmonary Pressures in Mechanically Ventilated Critically Ill Patients|Recruiting||N/A|15|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:10:19.788831|2017-10-11 01:10:19.788831
NCT01969201|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-03-06|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|June 2016|Actual|2016-06-01||Interventional|FAST||FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)|Randomised Clinical Trial Comparing Highly Purified FSH Formulation (Fostimon®) and Recombinant FSH (Gonal-F®) in GnRH-antagonist Controlled Ovarian Hyperstimulation Cycles.|Active, not recruiting||Phase 4|712|Actual|IBSA Institut Biochimique SA||2|||f||||f|f|f||||||No||2017-10-11 01:10:19.979478|2017-10-11 01:10:19.979478
NCT01969188|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-06-12|||January 2013||2013-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement|A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement|Recruiting||N/A|70|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-11 01:10:20.259517|2017-10-11 01:10:20.259517
NCT01969175|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-11-08|||October 2013||2013-10-01|November 2013|2013-11-01||||July 2014|Anticipated|2014-07-01||Interventional|||Effect of a Low-glycemic-load and Milk-free Diet on Acne Severity||Unknown status|Recruiting|N/A|60|Anticipated|Hospital Parc Taulí, Sabadell||2|||f||||t||||||||||2017-10-11 01:10:20.357158|2017-10-11 01:10:20.357158
NCT01969162|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2014-11-17|2014-11-17||September 2013||2013-09-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Tear Collection in Adult Volunteers||Completed||N/A|35|Actual|Allergan|||1||f||||f||||||Samples With DNA|"     Tears   "|||2017-10-11 01:10:20.465018|2017-10-11 01:10:20.465018
NCT01969149|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-10-05|||January 2015||2015-01-01|March 2016|2016-03-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|ExSTRESS||Exenatide for Stress Hyperglycemia|Intravenous Exenatide (Byetta®) Versus Insulin for Perioperative Glycemic Control in Cardiac Surgery: the Open-labeled Randomized Phase II/III ExStress Study|Completed||Phase 2/Phase 3|110|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-11 01:10:20.675607|2017-10-11 01:10:20.675607
NCT01969136|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-05-02|||October 2013||2013-10-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease|A Randomized, Double-blind, Placebo-controlled, Parallel-Group, 26-Week, Phase 3 Study of 2 Doses of EVP-6124 or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication|Terminated||Phase 3|403|Actual|FORUM Pharmaceuticals Inc||3||Study has been suspended due to clinical hold.|f||||||||||||||2017-10-11 01:10:20.798964|2017-10-11 01:10:20.798964
NCT01969123|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-05-02|||October 2013||2013-10-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease|A Randomized, Double-blind, Placebo-controlled, Parallel-Group, 26-Week, Phase 3 Study of 2 Doses of EVP-6124 or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication|Terminated||Phase 3|474|Actual|FORUM Pharmaceuticals Inc||3||Study has been suspended due to clinical hold.|f||||||||||||||2017-10-11 01:10:21.095632|2017-10-11 01:10:21.095632
NCT01969110|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2013-10-24|||January 2013||2013-01-01|October 2013|2013-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy|Additional Effects of Perioperative Immunonutrition on Th1/Th2 Differentiation in Patients Undergoing Pancreaticoduodenectomy|Unknown status|Recruiting|Phase 4|60|Anticipated|Chiba University||2|||f||||t||||||||||2017-10-11 01:10:21.345864|2017-10-11 01:10:21.345864
NCT01969097|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-03-16|||May 2012||2012-05-01|March 2016|2016-03-01||||December 2015|Actual|2015-12-01||Interventional|||Efficacy Basics of Bihemispheric Motorcortex Stimulation After Stroke|Efficacy Basics of Bihemispheric Motorcortex Stimulation After Stroke|Completed||N/A|50|Anticipated|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 01:10:21.432814|2017-10-11 01:10:21.432814
NCT01969084|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-11-17|2016-09-20||October 2013||2013-10-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Effect of Linagliptin on Mitochondrial and Endothelial Function||Completed||Phase 4|45|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 01:10:21.539678|2017-10-11 01:10:21.539678
NCT01969071|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-10-23|||July 2009||2009-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|||The Effects of Levosimendan During Mitral Valve Surgery|The Effects of Levosimendan on Renal Function in Patients With Low Ejection Fraction Undergoing Mitral Valve Surgery.|Completed||Phase 4|140|Actual|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital||2|||f||||t||||||||||2017-10-11 01:10:21.960382|2017-10-11 01:10:21.960382
NCT01969058|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-09-01|2017-08-04||July 2014||2014-07-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional||All enrolled participants|Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery|A Prospective Randomized Controlled Study to Evaluate the Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery on Suppressive Antiretroviral Therapy (ART)|Completed||Phase 2|76|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 01:10:22.236658|2017-10-11 01:10:22.236658
NCT01969045|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-02-17|||February 2014||2014-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|EnkAtomizer||Effect of the EnkFiberoptic Atomizer Set on Usage of Anaesthetics During the Bronchoscopy|Effect of the EnkFiberoptic Atomizer Set on Usage of Anaesthetics During the Bronchoscopy|Completed||Phase 4|30|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 01:10:23.290474|2017-10-11 01:10:23.290474
NCT01969032|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2014-11-04|||August 2011||2011-08-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer|Phase 2 Study of Two Consequent Chemotherapy Regimens as Induction Preoperative Therapy for Patients With Locally Advanced Triple Negative Breast Cancer|Completed||Phase 2|41|Actual|Russian Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 01:10:23.415809|2017-10-11 01:10:23.415809
NCT01969019|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-10-21|||January 2010||2010-01-01|October 2013|2013-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy|A Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy|Unknown status|Recruiting|Phase 4|70|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-11 01:10:23.518447|2017-10-11 01:10:23.518447
NCT01969006|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2014-12-16|||January 2014||2014-01-01|October 2013|2013-10-01||||January 2015|Anticipated|2015-01-01||Interventional|||Ilioinguinal Block in Laparoscopic Inguinal Hernia Repair|Effect of Ilioinguinal Blockage on Postoperative Pain After Laparoscopic Inguinal Herna Repair|Withdrawn||Phase 2|0|Actual|Randers Regional Hospital||2||Another study has been planned, so we did not initiate this one.|f||||f||||||||||2017-10-11 01:10:23.631314|2017-10-11 01:10:23.631314
NCT01968980|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-05-31|2017-04-07||October 23, 2013|Actual|2013-10-23|May 2017|2017-05-01|April 15, 2016|Actual|2016-04-15|April 15, 2016|Actual|2016-04-15||Interventional|SPIRE-FH|Full analysis set (FAS) included all participants who were randomized.|A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia|A 52 Week, Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|370|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 01:10:23.984426|2017-10-11 01:10:23.984426
NCT01968772|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-12-23|||October 2013||2013-10-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia|Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia - A Pilot Study|Completed||N/A|40|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:10:35.38818|2017-10-11 01:10:35.38818
NCT01968967|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-07-21|2017-06-22||October 29, 2013|Actual|2013-10-29|July 2017|2017-07-01|July 5, 2016|Actual|2016-07-05|July 5, 2016|Actual|2016-07-05||Interventional|SPIRE-LDL|Full analysis set (FAS) included all participants who were randomized.|Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events|A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Long-term Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events|Completed||Phase 3|2139|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 01:10:26.132534|2017-10-11 01:10:26.132534
NCT01968954|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-04-06|2017-04-06||October 2013||2013-10-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SPIRE-HR|Full analysis set (FAS) included all participants who were randomized.|Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events|A Phase 3 Double-blind,Randomized, Placebo-controlled,Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events|Completed||Phase 3|711|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 01:10:29.435471|2017-10-11 01:10:29.435471
NCT01968941|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-07-26|||February 2014||2014-02-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|LUSTRE||Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients|A Randomized Trial of Medically-Inoperable Stage 1 Non-small Cell Lung Cancer Patients Comparing Stereotactic Body Radiotherapy Versus Conventional Radiotherapy|Recruiting||Phase 3|324|Anticipated|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-10-11 01:10:33.606737|2017-10-11 01:10:33.606737
NCT01968928|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2013-10-24|||January 2014||2014-01-01|October 2013|2013-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|1 Day|Observational [Patient Registry]|||The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma|The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma|Unknown status|Not yet recruiting|N/A|25|Anticipated|National Taiwan University Hospital|||3||f||||f||||||None Retained|"     Tissue samples of tumors as well as normal-appearing mucosa collected in the tissue bank are     to be used to examine the cellular and molecular events involved. Comparisons will be made to     differentiate cellular changes between tumors and the normal counterparts.   "|||2017-10-11 01:10:33.778931|2017-10-11 01:10:33.778931
NCT01968915|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-01-20|||November 2013||2013-11-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors|A Phase I Study of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors|Completed||Phase 1|9|Actual|Novartis||1|||f||||||||||||||2017-10-11 01:10:33.867868|2017-10-11 01:10:33.867868
NCT01968902|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-03-21|||November 2013||2013-11-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|January 27, 2016|Actual|2016-01-27||Interventional|||Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients|A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Incobotulinumtoxin Type A for the Functional Improvement of Lower Extremity Spasticity in Patients With Multiple Sclerosis|Completed||Phase 4|27|Actual|Multiple Sclerosis Center of Northeastern New York||2|||f||||f||||||||||2017-10-11 01:10:34.07288|2017-10-11 01:10:34.07288
NCT01968889|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-12-02|||May 2013||2013-05-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||ICU Acquired Neuromyopathy and Diaphragm Function|Diaphragm Function in Patients Acquired Weakness and Neuromyopathy in ICU: Impact on Weaning and Outcome (DIAPH-WEAK ICU)|Completed||N/A|60|Actual|University Hospital, Montpellier|||1||f||||t||||||||||2017-10-11 01:10:34.198807|2017-10-11 01:10:34.198807
NCT01968876|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-11-22|||October 2013||2013-10-01|November 2016|2016-11-01||||October 2017|Anticipated|2017-10-01||Interventional|||Is a Smartphone Application Effective as an Oral Medication Adherence Aid|Is a Smartphone Application Effective as an Oral Medication Adherence Aid|Recruiting||Early Phase 1|228|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-10-11 01:10:34.318394|2017-10-11 01:10:34.318394
NCT01968863|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-07-08|||November 2013||2013-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues|Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues|Terminated||N/A|13|Actual|University of Arkansas|||1|Investigator Non Compliance|f||||f||||||||||2017-10-11 01:10:34.434199|2017-10-11 01:10:34.434199
NCT01968850|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-04-15|||May 2014||2014-05-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|BATARI||Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial|Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial|Recruiting||Phase 2|30|Anticipated|St. Michael's Hospital, Toronto||3|||f||||t||||||||||2017-10-11 01:10:34.510492|2017-10-11 01:10:34.510492
NCT01968837|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-04-12|||May 2014||2014-05-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|KCCP||The Kilimanjaro Cervical Screening Project|The Kilimanjaro Cervical Screening Project|Completed||N/A|1072|Actual|Queen's University||1|||f||||f||||||||||2017-10-11 01:10:34.630565|2017-10-11 01:10:34.630565
NCT01968824|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-01-19|||January 2013||2013-01-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Brachial Plexus Block in Post-Op Pain Control After Distal Upper Extremity Fracture: A Prospective Randomized Study|Efficacy of Brachial Plexus Block in Post-Operative Pain Control After Distal Upper Extremity Fracture: A Prospective Randomized Study|Completed||N/A|99|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 01:10:34.741104|2017-10-11 01:10:34.741104
NCT01968811|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-04-06|2015-06-10||November 2013||2013-11-01|May 2014|2014-05-01||||March 2014|Actual|2014-03-01||Interventional|||Post Market Clinical Follow Up Study of Avance Foam Abdominal Dressing Kit in Open Abdomen|A Multi-Centre, Post CE Mark, Open Clinical Investigation to Evaluate an Abdominal NPWT (Negative Pressure Wound Therapy) System (Avance® Pump and Avance® Foam Abdominal Dressing Kit) in Subjects With Open Abdominal Wounds|Completed||N/A|10|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 01:10:34.824741|2017-10-11 01:10:34.824741
NCT01968798|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-07-20|||September 2013||2013-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|ACES||ASPREE Cancer Endpoints Study|ASPREE Cancer Endpoints Study|Enrolling by invitation||Phase 4|14500|Anticipated|Minneapolis Medical Research Foundation||2|||f||||t||||||||||2017-10-11 01:10:35.091656|2017-10-11 01:10:35.091656
NCT01968759|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-10-09|||October 2013||2013-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ANSWER||Sevelamer in Proteinuric CKD|A Prospective, Randomized, Multicenter, Open, Blinded Endpoint (PROBE), Clinical Trial to Assess the Renal and Humoral Effects of Sevelamer Carbonate in Patients With Chronic Kidney Disease and Residual Proteinuria Despite Best Available Treatment|Completed||Phase 2|53|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-11 01:10:35.493978|2017-10-11 01:10:35.493978
NCT01968746|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2016-07-06|||August 2012||2012-08-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Observational|AVERT||The AVERT Sepsis Investigation|The AVERT Sepsis Investigation: Assessment of Variability in Early Resuscitation and Treatment of Sepsis|Completed||N/A|100|Actual|Christiana Care Health Services|||1||f||||f||||||||||2017-10-11 01:10:35.576817|2017-10-11 01:10:35.576817
NCT01968733|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-03-01||2015-11-03|November 2013||2013-11-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|SOLITAIRE-IV||Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia|A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients With Community-Acquired Bacterial Pneumonia|Completed||Phase 3|863|Actual|Cempra Inc||2|||f||||t||||||||||2017-10-11 01:10:35.78909|2017-10-11 01:10:35.78909
NCT01968720|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-07-27||2015-07-27|October 2013||2013-10-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia|A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia|Completed||Phase 2|16|Actual|Catabasis Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:10:36.512458|2017-10-11 01:10:36.512458
NCT01968707|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-05-13||2015-03-25|October 2013||2013-10-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||In-vivo Efficacy Study of Patient Pre-operative Preps|Assessment of the Antimicrobial Efficacy of 3M CHG/IPA Preoperative Skin Preparation Against Resident Human Skin Flora on the Abdominal and Inguinal Regions|Completed||Phase 3|510|Actual|3M||4|||f||||||||||||||2017-10-11 01:10:36.627504|2017-10-11 01:10:36.627504
NCT01968694|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2017-05-11|2017-05-11||December 2010||2010-12-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effects of Intravenous Lidocaine on Endometriosis Pain|Effects of Intravenous Lidocaine on Endometriosis Pain|Completed||N/A|20|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:10:36.743581|2017-10-11 01:10:36.743581
NCT01968681|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-02-22|||September 2013||2013-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Treatment of Nevus Flammeus With Alexandrite Laser|Treatment of Nevus Flammeus With Alexandrite Laser|Completed||N/A|19|Actual|Bispebjerg Hospital||1|||f||||f||||||||||2017-10-11 01:10:37.142347|2017-10-11 01:10:37.142347
NCT01968668|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-01-08|||October 2013||2013-10-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)|A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy|Completed||Phase 2|96|Actual|Bayer||8|||f||||t||||||||||2017-10-11 01:10:37.21911|2017-10-11 01:10:37.21911
NCT01968655|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-06-26||||||October 2013|2013-10-01||||||||Expanded Access|||Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies|Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies|No longer available||N/A|||Baxalta US Inc.|||||||||||||||||||2017-10-11 01:10:37.362927|2017-10-11 01:10:37.362927
NCT01968642|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2014-02-10|||November 2013||2013-11-01|February 2014|2014-02-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Education and Feedback Intervention to Reduce Inappropriate Transthoracic Echocardiograms|Educational Intervention to Reduce Outpatient Inappropriate Transthoracic Echocardiograms Ordered by Attending Physicians|Unknown status|Recruiting|N/A|150|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 01:10:37.464942|2017-10-11 01:10:37.464942
NCT01968629|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2015-09-22|||December 2013||2013-12-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||24hr Imaging Of HCC After EOVIST|Pilot Study of Delayed, 24 Hour Imaging of Hepatocellular Carcinoma Following the Administration of the Hepatobiliary MRI Contrast Agent Gadolinium Ethoxybenzyl Dimeglumine (Eovist)|Withdrawn||Early Phase 1|0|Actual|Massachusetts General Hospital||1||No eligible subject enrolled|f||||t||||||||||2017-10-11 01:10:37.575827|2017-10-11 01:10:37.575827
NCT01968616|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2017-03-08|||September 2013||2013-09-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Ranibizumab Treatment for Retinal Vein Occlusion|Predictive Factors of 2-year Visual Outcome in Retinal Vein Occlusion Following Intravitreal Ranibizumab Treatment|Recruiting||N/A|100|Anticipated|Kyoto University, Graduate School of Medicine||1|||f||||f||||||||||2017-10-11 01:10:37.653789|2017-10-11 01:10:37.653789
NCT01968603|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-20|2013-10-20|||July 2013||2013-07-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Weight Gain in Surgically Treated Adult-onset Craniopharyngioma|Weight Gain in Surgically Treated Adult-onset Craniopharyngioma|Completed||N/A|120|Actual|Huashan Hospital|||1||f||||f||||||||||2017-10-11 01:10:37.76591|2017-10-11 01:10:37.76591
NCT01968590|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-08-16|||August 16, 2017|Actual|2017-08-16|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|VitDBoneNF1||Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)|A Phase II Trial on the Effect of Low-Dose Versus High-Dose Vitamin D Supplementation on Bone Mass in Adults With Neurofibromatosis Type 1 (NF1)|Recruiting||Phase 2|320|Anticipated|University of Utah||2|||f||||f|t|f||||||||2017-10-11 01:10:37.838638|2017-10-11 01:10:37.838638
NCT01968564|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2017-03-17|||June 2013||2013-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Oral Curcumin Supplementation in Middle-Aged and Older Adults Improves Vascular Function|Clinical Translation of Curcumin Therapy to Treat Arterial Aging|Active, not recruiting||N/A|118|Actual|University of Colorado, Boulder||3|||f||||t||||||||||2017-10-11 01:10:38.144415|2017-10-11 01:10:38.144415
NCT01968551|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-07-07|2016-07-20|2015-04-16|September 3, 2013|Actual|2013-09-03|July 2017|2017-07-01|July 9, 2016|Actual|2016-07-09|July 21, 2015|Actual|2015-07-21||Interventional||"Safety analysis set included:
Cohort 1: participants who (1) were enrolled into Cohort 1 and (2) received at least 1 dose of study drug during the OL Phase or the Extension Phase
Cohort 2: participants who (1) were randomized into Cohort 2 and (2) received at least 1 dose of study drug during the OL Phase or the Extension Phase"|Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults|A Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults|Completed||Phase 3|158|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-11 01:10:38.254935|2017-10-11 01:10:38.254935
NCT01968538|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-09-20|||January 2009||2009-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Prostate Metabolomic Study|A Pilot Study to Establish a Standardized Protocol for Omic Analysis of Patients With Clinically Localized Prostate Cancer Receiving Radiation Therapy|Enrolling by invitation||N/A|400|Anticipated|Georgetown University|||2||f||||f||||||Samples With DNA|"     Specimen:For future Research Optional Destruction if requested identifiable Urine yes no yes     no Sputum yes no yes no Blood yes no yes no   "|||2017-10-11 01:10:39.649359|2017-10-11 01:10:39.649359
NCT01968525|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-12|2013-10-18|||April 2013||2013-04-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology Patients|The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology Patients|Completed||N/A|45|Actual|Fudan University||3|||f||||t||||||||||2017-10-11 01:10:39.753068|2017-10-11 01:10:39.753068
NCT01968512|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2014-04-30|||October 2013||2013-10-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|NAADHD||Neurobiological Aspects of the Attention Deficit Hyperactivity Disorder|Neurobiological Aspects of the Attention Deficit Hyperactivity Disorder: Contribution of the Transcranial Direct Current Stimulation in Control Inhibitory.|Completed||N/A|60|Actual|Federal University of Bahia||2|||f||||f||||||||||2017-10-11 01:10:39.872|2017-10-11 01:10:39.872
NCT01968486|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-10-25|||June 2012||2012-06-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia|Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia: 48 Weeks Study Results|Completed||Phase 1|60|Actual|"University of Campania Luigi Vanvitelli"||3|||f||||t||||||||||2017-10-11 01:10:40.106714|2017-10-11 01:10:40.106714
NCT01968473|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-10-19|||September 2013||2013-09-01|October 2013|2013-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Comfort and Tolerance of Surface Neuro Muscular Electrical Stimulation in Parkinson's Disease.|An Evaluation of Comfort and Tolerance of Surface Neuro Muscular Electrical Stimulation (NMES), When Applied to Parkinson's Disease Patients for Both Sensory and Motor Activation.|Unknown status|Recruiting|N/A|10|Anticipated|National University of Ireland, Galway, Ireland||1|||f||||t||||||||||2017-10-11 01:10:40.230323|2017-10-11 01:10:40.230323
NCT01968460|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-04-30|||December 2013||2013-12-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease|A Phase 2B, Twelve-week Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study, To Determine the Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease|Unknown status|Active, not recruiting|Phase 2/Phase 3|150|Anticipated|Pharma Two B Ltd.||3|||||||t||||||||||2017-10-11 01:10:40.336135|2017-10-11 01:10:40.336135
NCT01968434|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-10-05|2015-05-14||December 2013||2013-12-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|URTI|Enrolled patients had a minimum cough intensity both day and night, according to questionnaire, had not received any cough medicine the day before enrollment and fulfilled all inclusion criteria.|Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.|Randomized, Single Blind, Multicenter Study to Evaluate the Efficacy and Tolerability of Syr. Grintuss Pediatric and Syr. Mucolit in Cough Due to Upper Respiratory Tract Infection in Children|Completed||Phase 4|150|Actual|Clalit Health Services||2|||f||||f||||||||||2017-10-11 01:10:40.62348|2017-10-11 01:10:40.62348
NCT01968421|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-01-31|||March 1, 2015|Actual|2015-03-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Prevention of OM-85 on Bronchiectasis Exacerbation|To Investigate the PRevention of OM-85 on Bronchiectasis Exacerbation (iPROBE): a Multicenter, Randomised, Double-dummy, Placebo-controlled Clinical Trial in Chinese Patients|Recruiting||Phase 3|244|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f|f|f||||||||2017-10-11 01:10:41.071906|2017-10-11 01:10:41.071906
NCT01968408|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2015-06-17|||September 2012||2012-09-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children|Effectiveness of Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children: a Randomized, Double-blind Placebo Controlled Trial|Completed||Phase 3|184|Actual|Medical University of Warsaw||2|||f||||t||||||||||2017-10-11 01:10:41.192645|2017-10-11 01:10:41.192645
NCT01968395|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-10-23|||September 2013||2013-09-01|October 2013|2013-10-01|August 2015|Anticipated|2015-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure|Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure|Unknown status|Recruiting|Phase 4|20|Anticipated|Erasme University Hospital||1|||f||||t||||||||||2017-10-11 01:10:41.300432|2017-10-11 01:10:41.300432
NCT01968382|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-08-11|||December 2014||2014-12-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|TREAT||Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis|A Multicenter Randomized, Double-Blind, Placebo-controlled, Dosing, Safety and Efficacy Study of IMM 124-E (Hyperimmune Bovine Colostrum) for Patients With Severe Alcoholic Hepatitis|Recruiting||Phase 2|66|Anticipated|Virginia Commonwealth University||3|||f||||t|t|f||||||||2017-10-11 01:10:41.412569|2017-10-11 01:10:41.412569
NCT01968369|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-05-01|||October 2013||2013-10-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|VRPM||Effects of Tomato Sauce on Endothelial Dysfunction Induced by a High Fat Meal in Healthy Subjects|Effects of Tomato Sauce on Endothelial Dysfunction Induced by a High Fat Meal in Healthy Subjects|Active, not recruiting||N/A|16|Anticipated|Universita di Verona||2|||f||||f||||||||||2017-10-11 01:10:41.55642|2017-10-11 01:10:41.55642
NCT01968356|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-21|2015-05-13||2015-03-25|October 2013||2013-10-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||In-vivo Efficacy Study of Patient Preoperative Preps|Assessment of the Antimicrobial Efficacy of 3M CHG/IPA Preoperative Skin Preparation Against Resident Human Skin Flora on the Abdominal and Inguinal Regions|Terminated||Phase 3|419|Actual|3M||4||Study discontinued due to data quality issues.|f||||||||||||||2017-10-11 01:10:41.742346|2017-10-11 01:10:41.742346
NCT01968343|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-08-18|||January 2008||2008-01-01|October 2013|2013-10-01||||December 2010|Actual|2010-12-01||Interventional|||Trichotillomania: Group Cognitive-Behavioral Therapy|Group Treatment for Trichotillomania: Cognitive-Behavioral Therapy Versus Supportive Therapy|Completed||Phase 2|44|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-11 01:10:41.834389|2017-10-11 01:10:41.834389
NCT01968330|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-05-19|||May 2014||2014-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Postpartum Weight Loss and Sleep Amongst Obese Women|Postpartum Weight Loss in Obese Women Using a Sleep Intervention in a Group Prenatal Care Setting|Completed||N/A|53|Actual|University of South Florida||2|||f||||t||||||||||2017-10-11 01:10:41.916427|2017-10-11 01:10:41.916427
NCT01968317|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-07-04|||October 2013||2013-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma|Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma|Recruiting||Phase 2|150|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 01:10:42.007864|2017-10-11 01:10:42.007864
NCT01968304|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2016-07-25|||September 2013||2013-09-01|November 2015|2015-11-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|CANFER||Prospective Evaluation of Iron Status in Cancer Patients Beginning Chemotherapy|Prospective Evaluation of Iron Status in Cancer Patients Beginning Chemotherapy|Completed||N/A|480|Actual|Centre Antoine Lacassagne||1|||f||||t||||||||||2017-10-11 01:10:42.202421|2017-10-11 01:10:42.202421
NCT01968291|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-22|||June 2012||2012-06-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Use of Teach Back to Improve Comprehension of Discharge Instructions for Emergency Patients With Limited Health Literacy|The Impact of Teach-back on Comprehension of Discharge Instructions Among Emergency Patients With Limited Health Literacy: A Randomized, Controlled Study|Completed||N/A|254|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 01:10:42.301008|2017-10-11 01:10:42.301008
NCT01968278|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-10-20|||January 2013||2013-01-01|October 2013|2013-10-01||||November 2014|Anticipated|2014-11-01||Interventional|||Use of Baked Milk in Oral Immunotherapy for Severe IgE-mediated Cow's Milk Protein Allergic Patients||Unknown status|Recruiting|N/A|50|Anticipated|Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-10-11 01:10:42.382817|2017-10-11 01:10:42.382817
NCT01968265|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-05-11|||October 2013||2013-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes|A Randomized, Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability and Efficacy of ISIS 426115 (an Antisense Glucocorticoid Receptor Antagonist) Administered Subcutaneously Once Weekly for 6 Weeks to Patients With Type 2 Diabetes Mellitus Being Treated With Metformin|Completed||Phase 2|38|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:10:42.49418|2017-10-11 01:10:42.49418
NCT01968252|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-11-30|||May 2014||2014-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Observational|||Speckle-tracking Tricuspid Annular Plane Systolic Excursion|Validation of Speckle-tracking Echocardiography Measurements of Tricuspid Annular Plane Systolic Excursion During Transesophageal Echocardiography|Completed||N/A|112|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 01:10:42.667383|2017-10-11 01:10:42.667383
NCT01968239|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-18|||October 2013||2013-10-01|October 2013|2013-10-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Interventional|RabOCT||Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT|A Randomized, Controlled Interventional Phase 2b (Proof of Concept) Study of the Efficacy, Safety, and Tolerability of Repeated Intravitreal Administration of Ranibizumab Guided by Morphological Changes Documented by Optical Coherence Tomography (OCT) in Subjects With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)|Unknown status|Recruiting|Phase 2|24|Anticipated|University of Leipzig||2|||f||||t||||||||||2017-10-11 01:10:42.792237|2017-10-11 01:10:42.792237
NCT01967537|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-10-05|||August 20, 2013||2013-08-20|January 17, 2017|2017-01-17|December 3, 2022|Anticipated|2022-12-03|January 1, 2021|Anticipated|2021-01-01||Interventional|||Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors|Evaluation of (68)Gallium- DOTATATE PET/CT for Detecting Primary and Metastatic Neuroendocrine Tumors|Recruiting||Phase 2|390|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:10:55.704287|2017-10-11 01:10:55.704287
NCT01968226|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-08-14|2017-07-13||November 2013|Actual|2013-11-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TRACER|Due to trial termination, no subject analysis was completed|TRACER RGD-K5 Carotid Plaque Imaging Study|An Exploratory, Phase II, Open Label, Single-Center, Non-Randomized Study Of [F-18] RGD-K5 Positron Emission Tomography (PET) In Participants With Carotid Artery Stenosis|Terminated||Phase 2|3|Actual|The Cleveland Clinic||1||Investigator left instititution|f||||f|t|f||||||||2017-10-11 01:10:42.94102|2017-10-11 01:10:42.94102
NCT01968213|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-05-17|||January 2014||2014-01-01|May 2017|2017-05-01||||April 2017|Actual|2017-04-01||Interventional|ARIEL3||A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous and Endometrioid Ovarian Cancer (ARIEL3)|Active, not recruiting||Phase 3|540|Anticipated|Clovis Oncology, Inc.||2|||f||||t||||||||||2017-10-11 01:10:43.249314|2017-10-11 01:10:43.249314
NCT01968200|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-08-09|||December 2012||2012-12-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|ICOS-ONE||Prevention of Anthracycline-induced Cardiotoxicity|ICOS-ONE - Prevention of Anthracycline-induced Cardiotoxicity: a Multicentre Randomized Trial Comparing Two Therapeutic Strategies.|Active, not recruiting||Phase 3|268|Anticipated|European Institute of Oncology||2|||f||||f||||||||||2017-10-11 01:10:43.562547|2017-10-11 01:10:43.562547
NCT01968187|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-07-06||2015-07-06|January 2014||2014-01-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome||Completed||Phase 2|38|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:10:43.648993|2017-10-11 01:10:43.648993
NCT01968174|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2014-08-11|||June 2014||2014-06-01|August 2014|2014-08-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01|3 Months|Observational [Patient Registry]|||Astigmatic Changes Secondary to Eyelid Surgeries|Astigmatic Corneal Changes Secondary to Eyelid Surgery|Unknown status|Recruiting|N/A|30|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-11 01:10:43.750488|2017-10-11 01:10:43.750488
NCT01968161|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2014-01-08|||October 2013||2013-10-01|January 2014|2014-01-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|||Investigator Initiated Study - Asenapine Early Psychosis|An Open-label Switch Study to Asenapine in the Early Stage of Psychosis|Unknown status|Not yet recruiting|Phase 4|12|Anticipated|Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec||1|||f||||f||||||||||2017-10-11 01:10:43.890973|2017-10-11 01:10:43.890973
NCT01968148|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2015-03-17|||November 2013||2013-11-01|March 2015|2015-03-01||||October 2015|Anticipated|2015-10-01||Observational|||Mechanisms of Ultra-acute Hyperglycemia After Successful Resuscitation From Out-of-hospital Cardiac Arrest||Unknown status|Recruiting|N/A|40|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 01:10:44.000342|2017-10-11 01:10:44.000342
NCT01968135|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-04-01|2015-12-22||October 2013||2013-10-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study|Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study|Completed||Phase 2|32|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:10:44.144734|2017-10-11 01:10:44.144734
NCT01968122|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2017-04-25|||September 2013||2013-09-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01|1 Year|Observational [Patient Registry]|||Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China|Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China-a Prospective Multicenter Registry Study|Completed||N/A|300|Actual|Beijing Tiantan Hospital|||1||f||||f||||||||||2017-10-11 01:10:44.785213|2017-10-11 01:10:44.785213
NCT01968096|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-10-18|||August 2013||2013-08-01|October 2013|2013-10-01||||July 2015|Anticipated|2015-07-01||Interventional|||The Reversal of Neuromuscular Adaptation in Human With Spinal Cord Injury II||Unknown status|Recruiting|N/A|52|Anticipated|Chang Gung University||6|||f||||t||||||||||2017-10-11 01:10:45.177493|2017-10-11 01:10:45.177493
NCT01968083|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-01-30|||September 2013||2013-09-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children|A Phase I Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV cps2, Lot RSV#005A, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age|Completed||Phase 1|51|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 01:10:45.269955|2017-10-11 01:10:45.269955
NCT01968057|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-05-15|2017-03-10||October 2013||2013-10-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All enrolled participants|A Study of Baricitinib and Ciclosporin in Healthy Participants|A Study to Investigate the Effect of Ciclosporin on the Pharmacokinetics of Baricitinib (LY3009104) in Healthy Subjects|Completed||Phase 1|18|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:10:45.49641|2017-10-11 01:10:45.49641
NCT01968044|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-03-21|||October 2013||2013-10-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|GUARD||A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)|A Multicenter,Randomized, Placebo-controlled, Parallel Group, Double-blind, Phase IIIb Study to Evaluate the Safety and Efficacy After 12 Weeks Administration of Gemigliptin and Placebo in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment With an Additional 40 Weeks, Double-blind,Active-controlled, Double-dummy,Long-term Extension Study|Completed||Phase 3|132|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-11 01:10:45.873593|2017-10-11 01:10:45.873593
NCT01968031|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-12-09||2016-12-09|October 2013||2013-10-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|KW-6002||A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease|A Phase 3, 12-week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study to Evaluate the Efficacy of Oral Istradefylline 20 and 40 mg/Day as Treatment for Subjects With Moderate to Severe Parkinson's Disease|Completed||Phase 3|613|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||3|||f||||f||||||||||2017-10-11 01:10:45.981121|2017-10-11 01:10:45.981121
NCT01968018|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-18|||July 2004||2004-07-01|October 2013|2013-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain|A Study of Safety and Efficacy of Ultracet in Patients With Chronic Cancer Pain|Completed||Phase 4|35|Actual|Janssen-Cilag Ltd.,Thailand||1|||f||||f||||||||||2017-10-11 01:10:46.554941|2017-10-11 01:10:46.554941
NCT01968005|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2014-05-06|||November 2013||2013-11-01|December 2013|2013-12-01||||May 2014|Actual|2014-05-01||Interventional|||Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain|A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the Treatment of Acute Low Back Pain|Completed||Phase 3|232|Actual|MEDRx USA, Inc.||2|||f||||f||||||||||2017-10-11 01:10:46.694889|2017-10-11 01:10:46.694889
NCT01967992|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-10-12|||October 2013||2013-10-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Examining the Effects of Diet on Health With an Online Program|Examining the Effects of Diet on Health With an Online Program|Completed||Phase 2|25|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:10:46.844229|2017-10-11 01:10:46.844229
NCT01967979|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-11-01|||October 2013||2013-10-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects|A Single-Center, Open-Label, One-Sequence, 2-Period, Within-Subject Study in 2 Cohorts to Investigate the Effect of Multiple Doses of Itraconazole (Cohort 1) and Fluoxetine (Cohort 2) on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects|Completed||Phase 1|28|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:10:47.027607|2017-10-11 01:10:47.027607
NCT01967966|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-11-01|||November 2013||2013-11-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers|A PHASE 1 STUDY TO INVESTIGATE THE ABSOLUTE BIOAVAILABILITY OF GDC-0032 AND THE ABSORPTION, METABOLISM, AND EXCRETION OF [14C]-GDC-0032 IN HEALTHY MALE SUBJECTS|Completed||Phase 1|15|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 01:10:47.151748|2017-10-11 01:10:47.151748
NCT01967953|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-22|||January 2011||2011-01-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|EVLP_MI||Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation|Ex-Vivo Lung Perfusion to Improve Donor Lung Function and Increase the Number of Organs Available for Transplantation|Completed||Phase 1|7|Actual|Policlinico Hospital||2|||f||||t||||||||||2017-10-11 01:10:47.287158|2017-10-11 01:10:47.287158
NCT01967940|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-08-14|2017-05-09||October 25, 2013|Actual|2013-10-25|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|May 9, 2016|Actual|2016-05-09||Interventional||Full Analysis Set: participants who enrolled into Part 1 of the study and received at least one dose of study drug in Part 1.|Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults|A Phase 3, Two Part Study to Evaluate the Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults|Completed||Phase 3|55|Actual|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-11 01:10:47.41554|2017-10-11 01:10:47.41554
NCT01967927|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-07-10|||December 2013||2013-12-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy|Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy|Active, not recruiting||Early Phase 1|6|Anticipated|University of Arkansas||1|||f||||t||||||||||2017-10-11 01:10:48.293295|2017-10-11 01:10:48.293295
NCT01967914|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-06-15|||October 2013||2013-10-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||PVI for Prediction of Spinal Induced Hypotension|Can Plethysmography Variability Index (PVI) Predict Spinal Induced Hypotension in Women Undergoing Cesarean Delivery?|Completed||N/A|38|Actual|Duke University|||1||f||||t||||||||||2017-10-11 01:10:48.408892|2017-10-11 01:10:48.408892
NCT01967901|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-05-17|||March 2014||2014-03-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Impact of Multidisciplinary Self-care Management of Diabetic Nephropathy on Quality of Life, Self-care Behavior, Glycemic Control, and Renal Function.|Impact of a Multidisciplinary Self-care Management Program on Quality of Life, Self-care Behavior, Adherence to the Anti-hypertensive Treatment, Glycemic Control, and Renal Function in Adults Living With Diabetic Kidney Disease|Completed||N/A|36|Actual|University of Applied Sciences of Western Switzerland||4|||f||||t||||||||||2017-10-11 01:10:48.518098|2017-10-11 01:10:48.518098
NCT01967888|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-01-23|||February 2014||2014-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation|A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Assignment Study to Assess the Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation|Active, not recruiting||Phase 2/Phase 3|100|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||t||||||||Undecided||2017-10-11 01:10:48.643745|2017-10-11 01:10:48.643745
NCT01967875|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-10-18|||July 2013||2013-07-01|October 2013|2013-10-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|||A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer|A Prospective, Multi-Center, Randomized Control Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer|Unknown status|Recruiting|Phase 2|180|Anticipated|China Medical University, China||3|||f||||f||||||||||2017-10-11 01:10:48.815564|2017-10-11 01:10:48.815564
NCT01967862|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-08-21|||December 2013||2013-12-01|August 2017|2017-08-01|August 18, 2018|Anticipated|2018-08-18|August 18, 2018|Anticipated|2018-08-18||Interventional|||Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer|F18 NaF PET/CT and Whole Body and Axial MRI for the Detection of Metastases in Patients With Biochemical Recurrence of Prostate Cancer|Active, not recruiting||Phase 2|56|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:10:48.9751|2017-10-11 01:10:48.9751
NCT01967849|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-04-25|||September 1999||1999-09-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Prevalence of Carbohydrate Intolerance in Lean and Overweight/Obese Children|Prevalence of Carbohydrate Intolerance in Lean and Overweight/Obese Children|Recruiting||N/A|2000|Anticipated|Yale University||2|||f||||f||||||||No||2017-10-11 01:10:49.139254|2017-10-11 01:10:49.139254
NCT01967836|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-02-24|2016-10-10||October 2013||2013-10-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||"Subjects who present to ambulatory oncology or outpatient clinic sites with the presence of a centrally placed IV catheter for infusion therapy who meet were approached for consent
19 Oncology subjects who met criteria were approached with 9 declines to participate 1 ambulatory care subject was approached and accepted participation"|Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients|Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients|Completed||N/A|11|Actual|Wheaton Franciscan Healthcare||1|||f||||f||||||||No||2017-10-11 01:10:49.282427|2017-10-11 01:10:49.282427
NCT01967823|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-10-03|||September 25, 2013||2013-09-25|September 19, 2017|2017-09-19|July 28, 2028|Anticipated|2028-07-28|July 5, 2027|Anticipated|2027-07-05||Interventional|||T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer|Phase II Study of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 Murine TCR-Gene Engineered Lymphocytes|Recruiting||Phase 2|43|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:10:49.68151|2017-10-11 01:10:49.68151
NCT01967810|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-09-20||2017-09-15|October 2013||2013-10-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||ANG1005 in Patients With Recurrent High-Grade Glioma|A Phase II, Open-Label, Multi-Center Study of ANG1005 in Patients With Recurrent High-Grade Glioma|Completed||Phase 2|73|Actual|Angiochem Inc||3|||f||||t||||||||||2017-10-11 01:10:49.835953|2017-10-11 01:10:49.835953
NCT01967797|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-03-15|||September 2013||2013-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|5AsT||"Implementation and Validation of the 5As Framework of Obesity Management in Primary Care. 5AsT"|"Implementation and Validation of the 5As Framework of Obesity Management in Primary Care. 5AsT"|Active, not recruiting||N/A|255|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 01:10:50.053908|2017-10-11 01:10:50.053908
NCT01967784|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-12-14|2015-12-14||October 2013||2013-10-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan|Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan|Completed||Phase 3|100|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:10:50.18271|2017-10-11 01:10:50.18271
NCT01967771|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2014-01-23|||October 2013||2013-10-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects|A Phase I, Open Label, Randomized, Three Period, Fixed Sequence Crossover Study to Evaluate the Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (200901)|Completed||Phase 1|16|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-10-11 01:10:50.529224|2017-10-11 01:10:50.529224
NCT01967758|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-09-22|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I Study of Safety and Immunogenicity of ADU-623|Phase I Study of Safety and Immunogenicity of ADU-623, a Live-attenuated Listeria Monocytogenes Strain (ΔactA/ΔinlB) Expressing the EGFRvIII-NY-ESO-1 Vaccine, in Patients With Treated and Recurrent WHO Grade III/IV Astrocytomas|Active, not recruiting||Phase 1|11|Actual|Providence Health & Services||3|||f||||f||||||||||2017-10-11 01:10:50.625254|2017-10-11 01:10:50.625254
NCT01967745|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2014-10-22|||January 2007||2007-01-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|December 2009|Actual|2009-12-01||Observational|||Laparoscopic Versus Open Appendectomy|Laparoscopic vs. Open Surgical Procedure in Management of Acute Appendicitis|Completed||N/A|100|Actual|Varazdin General Hospital|||2||f||||f||||||||||2017-10-11 01:10:50.728676|2017-10-11 01:10:50.728676
NCT01967732|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-07-01|2016-01-26||November 2013||2013-11-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional||"PK population: all randomized subjects who completed at least 1 of the single-use days, with at least 1 derived PK parameter. No subjects were excluded due to major protocol deviations impacting the evaluation of the results.
62 randomized: 44 in Group 1, 18 in Group 2
60 completers: 42 in Group 1 (2 discontinued), 18 in Group 2"|Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)|A Single-center, Open-label, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of Tobacco Heating System 2.2 (THS 2.2) Following Single Use in Smoking, Healthy Subjects Compared to Conventional Cigarettes and Nicotine Nasal Spray.|Completed||N/A|62|Actual|Philip Morris Products S.A.||4|||f||||f||||||||No||2017-10-11 01:10:50.819126|2017-10-11 01:10:50.819126
NCT01967550|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-06-02|2015-04-28||October 2013||2013-10-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)|A 4-week, Randomized, Double-blind, Multi-center, Vehicle-controlled, Parallel Group Study to Assess the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel for the Relief of Signs and Symptoms in Patients With Knee Osteoarthritis|Completed||Phase 3|304|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:10:55.192602|2017-10-11 01:10:55.192602
NCT01967719|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-12-14|2016-02-05||October 2013||2013-10-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional||"PK population: all randomized subjects who completed at least 1 of the single-use days, with at least 1 derived PK parameter.
62 randomized subjects : 44 in Group 1, 18 in Group 2.
PK population = 58 => 41 in Group 1 (2 withdrawn + 1 excluded due to major protocol deviation), 17 in Group 2 (1 withdrawn)."|Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol)|A Single-center, Open-label, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol) Following Single Use in Smoking, Healthy Subjects Compared to Menthol Conventional Cigarettes and Nicotine Nasal Spray|Completed||N/A|64|Actual|Philip Morris Products S.A.||4|||f||||f||||||||No||2017-10-11 01:10:52.814166|2017-10-11 01:10:52.814166
NCT01967706|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-08-04|2015-06-10||August 2013||2013-08-01|August 2017|2017-08-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional||"PK population: all randomized subjects who completed at least 1 of the single-use days, with at least 1 derived PK parameter. Subjects with major protocol deviations impacting the evaluation of the results were excluded.
62 randomized subjects : 44 in Group 1, 18 in Group 2.
61 completers: 43 in Group 1 (1 withdrawn subject), 18 in Group 2."|Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).|A Single-center, Open-label, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol) Following Single Use in Smoking, Healthy Subjects Compared to Menthol Conventional Cigarettes and Nicotine Gum.|Completed||N/A|73|Actual|Philip Morris Products S.A.||4|||f||||f||||||||||2017-10-11 01:10:53.215514|2017-10-11 01:10:53.215514
NCT01967693|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-05-13|||March 2008||2008-03-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2012|Actual|2012-08-01||Observational|||Characterization of Laryngeal Contact Granulomas: Retrospective Analysis of Symptoms, Promotive Factors and Therapy|Characterization of Laryngeal Contact Granulomas: Retrospective Analysis of Symptoms, Promotive Factors and Therapy|Completed||N/A|42|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 01:10:53.674393|2017-10-11 01:10:53.674393
NCT01967667|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-03-16|||April 2014||2014-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Biological Evaluation of Dietary Supplement Liposomal Glutathione|Biological Evaluation of Dietary Supplement Liposomal Glutathione|Suspended||N/A|25|Anticipated|University of Maryland||2||lack of funding|f||||t||||||||No||2017-10-11 01:10:54.108324|2017-10-11 01:10:54.108324
NCT01967654|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-08-03|||January 2014||2014-01-01|August 2015|2015-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Implementing Tobacco Use Guidelines in Community Health Centers in Vietnam||Withdrawn||N/A|0|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 01:10:54.253078|2017-10-11 01:10:54.253078
NCT01967628|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-11-08|||June 2007||2007-06-01|November 2013|2013-11-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|||Human Lung Responses to Respiratory Pathogens|Human Lung Responses to Respiratory Pathogens|Completed||Phase 1/Phase 2|105|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 01:10:54.498886|2017-10-11 01:10:54.498886
NCT01967615|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-10-29|||January 2015||2015-01-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|May 2015|Actual|2015-05-01||Observational|P2BiTO||P2Y12 Inhibitors Utilization in Bifurcation and Chronic Total Occlusion PCI|P2Y12 Inhibitors Utilization in Bifurcation and Chronic Total Occlusion PCI With Biologically Active Stents (P2BiTO) Registry|Enrolling by invitation||N/A|3150|Anticipated|G. d'Annunzio University|||1||f||||f||||||||||2017-10-11 01:10:54.616734|2017-10-11 01:10:54.616734
NCT01967602|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-10-22|||October 2011||2011-10-01|October 2013|2013-10-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|ARDS||Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support|Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support|Unknown status|Recruiting|N/A|70|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     Plasma, Cell, BALF, Urine   "|||2017-10-11 01:10:54.721005|2017-10-11 01:10:54.721005
NCT01967589|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2014-06-19|||October 2013||2013-10-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects|Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects|Completed||Phase 1|82|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 01:10:54.838174|2017-10-11 01:10:54.838174
NCT01967576|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-19|2017-10-05|||October 15, 2013||2013-10-15|June 20, 2017|2017-06-20|December 1, 2018|Anticipated|2018-12-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma|Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma|Active, not recruiting||Phase 2|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:10:54.959821|2017-10-11 01:10:54.959821
NCT01967563|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-22|2017-06-30|||September 24, 2013||2013-09-24|May 10, 2017|2017-05-10|February 23, 2015|Actual|2015-02-23|February 23, 2015|Actual|2015-02-23||Observational|||Study of the Effect of a Very-Low-Carbohydrate Diet on Energy Expenditure|Effect of a Eucaloric Ketogenic Diet on Energy Expenditure: A Pilot Study|Completed||N/A|5|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:10:55.084732|2017-10-11 01:10:55.084732
NCT01967524|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-12-14|||September 2013||2013-09-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|MYOTOX||Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain|Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain|Completed||Phase 3|80|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 01:10:55.807141|2017-10-11 01:10:55.807141
NCT01967511|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-06-06|||October 2013||2013-10-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|DEFINE||Defining the Basis of Fibromuscular Dysplasia (FMD)|Defining the Basis of Fibromuscular Dysplasia: The Define-FMD Study|Recruiting||N/A|600|Anticipated|Icahn School of Medicine at Mount Sinai|||4||f||||f||||||Samples With DNA|"     Fibroblasts and other cell lines generated under this protocol and all blood-derived     specimens (plasma, serum, DNA) will be kept indefinitely in a secure clinical database or     bio-repository (as appropriate).   "|Yes||2017-10-11 01:10:55.903891|2017-10-11 01:10:55.903891
NCT01967498|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-17|||November 2013||2013-11-01|October 2013|2013-10-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|COME||Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study|Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study|Unknown status|Not yet recruiting|N/A|52|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 01:10:55.993582|2017-10-11 01:10:55.993582
NCT01967485|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-02-22|||January 2014||2014-01-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Text Messaging Adherence to Stimulant Medication|Text Messaging Adherence to Stimulant Medication|Completed||N/A|35|Actual|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-11 01:10:56.063489|2017-10-11 01:10:56.063489
NCT01967472|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-09-09|||September 2013||2013-09-01|October 2013|2013-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Adherence to Antimalarial Drugs in Sierra Leone|Adherence to Artemisinin-Based Combination Therapy (ACT) for the Treatment of Malaria in Sierra Leone|Completed||N/A|792|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 01:10:56.154382|2017-10-11 01:10:56.154382
NCT01967459|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-10-04|||October 2013||2013-10-01|October 2017|2017-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|DOSFEM||Effects Vitamin D Suppletion on Postprandial Leukocyte Activation|Effects of High and Low Dose Vitamin D Suppletion on Postprandial Leukocyte Activation, Oxidative Stress and Vascular Function in Healthy Overweight and Obese Females|Completed||N/A|24|Actual|Sint Franciscus Gasthuis||2|||f||||f||||||||||2017-10-11 01:10:56.239893|2017-10-11 01:10:56.239893
NCT01967446|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-12-08|||March 2012||2012-03-01|August 2012|2012-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Predictors of Post Operative Morbidity in Older Women With Pelvic Organ Prolapse|Predictors of Post Operative Morbidity in Older Women With Pelvic Organ Prolapse|Completed||N/A|132|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 01:10:56.344537|2017-10-11 01:10:56.344537
NCT01967433|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-04-07|||December 2013||2013-12-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids|Use of Diphenhydramine as an Adjunctive Sedative for Colonoscopy in Patients Chronically on Opioids|Active, not recruiting||Phase 4|150|Anticipated|University of Oklahoma||2|||f||||t||||||||||2017-10-11 01:10:56.630946|2017-10-11 01:10:56.630946
NCT01967420|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-07-01|||August 2013||2013-08-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|July 2015|Actual|2015-07-01||Interventional|||Cognitive Remediation for First Episode of Psychosis Patients|Using Computerised Training to Improve Cognition and Functioning in the First Episode of Psychosis|Active, not recruiting||N/A|40|Actual|University of Manchester||2|||f||||||||||||||2017-10-11 01:10:56.779718|2017-10-11 01:10:56.779718
NCT01967407|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2014-11-18|||October 2013||2013-10-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|IRENE||IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.|Prospective, Monocentric, Clinical Phase-I/II Study of the Effectiveness of the Percutaneous Irreversible Electroporation (IRE) of Locally Confined Kidney Tumors (Renal Cell Carcinomas).|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|University of Magdeburg||1|||f||||t||||||||||2017-10-11 01:10:56.921928|2017-10-11 01:10:56.921928
NCT01967394|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-12-25|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Social Media, Teen Moms and PPD|Social Media, Teen Moms, and Postpartum Depression|Completed||N/A|287|Actual|University of Louisville||2|||f||||t||||||||||2017-10-11 01:10:57.122336|2017-10-11 01:10:57.122336
NCT01967381|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-10-02|||October 2013||2013-10-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse|Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse|Recruiting||Early Phase 1|28|Anticipated|University of Kentucky||4|||f||||t||||||||||2017-10-11 01:10:57.283702|2017-10-11 01:10:57.283702
NCT01967368|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-10-17|||October 2013||2013-10-01|October 2013|2013-10-01|June 2015|Anticipated|2015-06-01|May 2014|Anticipated|2014-05-01||Interventional|||Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults|Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults|Unknown status|Recruiting|Phase 4|100|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:10:57.38639|2017-10-11 01:10:57.38639
NCT01967355|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-06-01|||April 2013||2013-04-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis|Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis|Unknown status|Recruiting|N/A|15|Anticipated|University Hospital Freiburg||1|||f||||f||||||||||2017-10-11 01:10:57.511098|2017-10-11 01:10:57.511098
NCT01967342|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-05-26|2017-01-13||September 12, 2013|Actual|2013-09-12|March 2017|2017-03-01|December 2016|Actual|2016-12-01|February 2016|Actual|2016-02-01||Interventional|LAMP||"Literacy-Adapted Psychosocial Treatments for Chronic Pain --- Learning About Mastering/My Pain"|Reducing Disparities With Literacy-Adapted Psychosocial Treatments for Chronic Pain: A Comparative Trial|Completed||N/A|290|Actual|University of Alabama, Tuscaloosa||3|||f||||t||||||||Yes|The complete data set may be obtained by request from the PI. The dataset will be available in November.|2017-10-11 01:10:57.624721|2017-10-11 01:10:57.624721
NCT01967329|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-05-01|||November 2008||2008-11-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||CANHelp Working Group Treatment Trials|Canadian North Helicobacter Pylori (CANHelp) Working Group Treatment Trials|Enrolling by invitation||Phase 4|500|Anticipated|University of Alberta||7|||f||||f||||||||Yes|No plan to make individual participant data (IPD) available|2017-10-11 01:10:58.617061|2017-10-11 01:10:58.617061
NCT01967303|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-10-17|||January 2008||2008-01-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Restless Legs Syndrome in Stroke Patients|Restless Legs Syndrome in Stroke Patients|Completed||N/A|447|Actual|Rambam Health Care Campus|||2||f||||f||||||||||2017-10-11 01:10:58.746099|2017-10-11 01:10:58.746099
NCT01967290|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2013-11-27|||May 2013||2013-05-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|SWORD-IT||Stroke Wearable Operative Rehabilitation Device Impact Trial|Phase II Study of the Impact of the SWORD Device on Rehabilitation Tasks Performance in the Early Post Stroke Period|Completed||N/A|44|Actual|Centro Hospitalar de Entre o Douro e Vouga||2|||f||||f||||||||||2017-10-11 01:10:58.828301|2017-10-11 01:10:58.828301
NCT01967277|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2015-05-05|2015-05-05||March 2014||2014-03-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy|A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy|Completed||N/A|44|Actual|Capillus, LLC||2|||f||||t||||||||||2017-10-11 01:10:58.958409|2017-10-11 01:10:58.958409
NCT01967264|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-17|||July 2013||2013-07-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults|A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety Profile and Pharmacokinetic Parameters of Udenafil 150 mg in Healthy Mexican Subjects.|Completed||Phase 1|83|Actual|Takeda||4|||f||||f||||||||||2017-10-11 01:10:59.861332|2017-10-11 01:10:59.861332
NCT01967251|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-03-03|||September 2015||2015-09-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction|A Randomized, Triple Blind, Placebo-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Dose Response of Udenafil for 12 Weeks in Mexican Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction|Withdrawn||Phase 2|0|Actual|Takeda||4|||f||||f||||||||||2017-10-11 01:11:00.014875|2017-10-11 01:11:00.014875
NCT01967238|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-11-11|||March 2013||2013-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||An Open Label Study of IgG Fc Glycan Composition in Human Immunity|An Open Label Study of IgG Fc Glycan Composition in Human Immunity|Recruiting||N/A|140|Anticipated|Rockefeller University||3|||f||||f||||||||No||2017-10-11 01:11:00.142184|2017-10-11 01:11:00.142184
NCT01967212|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2013-10-17|||December 2012||2012-12-01|October 2013|2013-10-01||||December 2013|Anticipated|2013-12-01||Interventional|||Swallowing Training Combined With Game-based Biofeedback in Post-stroke Dysphagia|Swallowing Training Combined With Game-based Biofeedback in Post-stroke Dysphagia|Unknown status|Active, not recruiting|N/A|30|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:11:00.626048|2017-10-11 01:11:00.626048
NCT01967199|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-02-23|||April 18, 2013|Actual|2013-04-18|February 2017|2017-02-01|February 14, 2017|Actual|2017-02-14|February 14, 2017|Actual|2017-02-14||Interventional|RESTORE||Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis|Treatment of Drug-Eluting Stent REstenosis Using Drug-Eluting STents vs. Drug-COated Balloon for Preventing REcurrent In-Stent Restenosis|Terminated||Phase 4|175|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:11:00.731695|2017-10-11 01:11:00.731695
NCT01967186|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-10-05|||April 2007||2007-04-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation|Open Multi-Center Randomized Study to Compare Safety and Efficacy of Islet Transplantation Using The Intraportal or Intramuscular Site in Simultaneous Islet and Kidney Transplantation|Unknown status|Active, not recruiting|N/A|36|Anticipated|The Nordic Network For Clinical Islet Transplantation||4|||f||||t||||||||||2017-10-11 01:11:00.885154|2017-10-11 01:11:00.885154
NCT01967173|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-07-25|||February 2014||2014-02-01|July 2017|2017-07-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|BARD||Best African American Response to Asthma Drugs|Best African American Response to Asthma Drugs|Completed||Phase 3|574|Actual|Milton S. Hershey Medical Center||8|||f||||t||||||||||2017-10-11 01:11:00.986123|2017-10-11 01:11:00.986123
NCT01967160|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2017-06-30|||October 1, 2011|Actual|2011-10-01|June 2017|2017-06-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Observational|||Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid|A Non-interventional Pharmacovigilance Study of Osteonecrosis of the Jaw and Infection Leading to Hospitalization Among Patients With Cancer Treated With XGEVA™ or Zoledronic Acid in Sweden, Denmark, and Norway|Active, not recruiting||N/A|2560|Actual|Amgen|||3||f||||||||||||||2017-10-11 01:11:01.235641|2017-10-11 01:11:01.235641
NCT01967147|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-02-23|2016-01-27||February 2014||2014-02-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||This analysis population includes all randomized subjects.|Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects|Evaluation of Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects With Lipid Deficiency|Completed||N/A|279|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:11:01.339548|2017-10-11 01:11:01.339548
NCT01967134|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-18|2016-04-25|||November 2011||2011-11-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis|Phase I Open Label Dose-Escalation Study to Evaluate the Safety and Immunogenicity of H56:IC31 (AERAS-456) in HIV-negative Adults With and Without Latent Tuberculosis Infection|Completed||Phase 1|25|Actual|Aeras||3|||f||||t||||||||||2017-10-11 01:11:01.871172|2017-10-11 01:11:01.871172
NCT01967121|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2014-08-28|2014-04-23||October 2013||2013-10-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Participants first had their leg girth measured with a measuring tape. Pain measurement was taken using a syringe with spring in place of algometer six and 12 inches above the popliteal fossa for tenderness. After completing the visual analog scale, participants completed the induction DOMS protocol.|Compex Use With Delayed Onset Muscle Soreness: A Comparison to Other Methods|Compex Use With Delayed Onset Muscle Soreness: A Comparison to Other Methods|Completed||N/A|75|Actual|Michigan State University||3|||f||||f||||||||||2017-10-11 01:11:02.051496|2017-10-11 01:11:02.051496
NCT01967108|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-05-06|||December 2013||2013-12-01|February 2014|2014-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Post Extubation Chest Physiotherapy in ICU|The Effect of Post Extubation Chest Physiotherapy on Respiratory Complications and Weaning Failure in Critically Ill Patients|Completed||N/A|65|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 01:11:02.436489|2017-10-11 01:11:02.436489
NCT01967095|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-05-09|||October 15, 2013||2013-10-15|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer|A Phase 1 Trial of Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer|Active, not recruiting||Phase 1|53|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:11:02.551471|2017-10-11 01:11:02.551471
NCT01967082|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-06-12|||October 16, 2013|Actual|2013-10-16|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||APPSPIRE: Expanding the Reach of an Innovative Tobacco Control Program for Youth|APPSPIRE: Expanding the Reach of an Innovative Tobacco Control Program for Youth|Active, not recruiting||N/A|30|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-10-11 01:11:02.69104|2017-10-11 01:11:02.69104
NCT01967069|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-01-23|2016-08-15|2015-08-10|November 2013||2013-11-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis||Completed||Phase 3|277|Actual|Promius Pharma, LLC||2|||f||||f||||||||||2017-10-11 01:11:02.812966|2017-10-11 01:11:02.812966
NCT01967056|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-10-17|||June 2013||2013-06-01|October 2013|2013-10-01|October 2014|Anticipated|2014-10-01|June 2014|Anticipated|2014-06-01||Observational|||Predictors of Respiratory Failure Following Extubation in the SICU|Predictors of Respiratory Failure Following Extubation in Teh Surgical Intensive Care Unit (SICU)|Unknown status|Recruiting|N/A|750|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 01:11:03.211791|2017-10-11 01:11:03.211791
NCT01967043|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-12-15|||October 2013||2013-10-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies|A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies|Completed||Phase 1|34|Anticipated|Kinex Pharmaceuticals Inc||2|||f||||t||||||||No||2017-10-11 01:11:03.313311|2017-10-11 01:11:03.313311
NCT01967030|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-07-27|||May 2008||2008-05-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|SWIFT||SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy|SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy|Active, not recruiting||N/A|1035|Actual|Kaiser Permanente|||1||f||||f||||||Samples With DNA|"     We collected fasting and 2-hour plasma specimens during each Oral Glucose Tolerance Test     (OGTT). The EDTA treated plasma specimens and buffy coats are stored in cryovials at -70     degrees Centrigrade in low temperature freezers.   "|||2017-10-11 01:11:03.399848|2017-10-11 01:11:03.399848
NCT01967017|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-06-09|||June 2014|Actual|2014-06-01|June 2017|2017-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study of Local Anesthesia as a Method to Decrease IUD Insertion Related Pain|Paracervical Block With Lidocaine as a Modality to Decrease IUD Insertion Related Pain|Withdrawn||Phase 4|0|Actual|Johns Hopkins University||2||Funding was denied.|f||||f||||||||||2017-10-11 01:11:03.492047|2017-10-11 01:11:03.492047
NCT01967004|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-03-04|||August 2013||2013-08-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|RFIDIBT||Enhancing Upper Limb Prostheses With Radio Frequency Identification|Validation of a Control Method for Upper Limb Myoelectric Prostheses Using Radio Frequency Identification (RFID)|Unknown status|Active, not recruiting|N/A|10|Anticipated|Infinite Biomedical Technologies||1|||f||||||||||||||2017-10-11 01:11:03.594194|2017-10-11 01:11:03.594194
NCT01966991|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-12-21|||June 2014||2014-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Observational|DNAFirst||Prenatal Screening for Down Syndrome With DNAFirst|DNAFirst: Primary Screening for Down Syndrome by Maternal Plasma DNA|Completed||N/A|100|Actual|Women and Infants Hospital of Rhode Island|||1||f||||f||||||||||2017-10-11 01:11:03.689473|2017-10-11 01:11:03.689473
NCT01966978|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-05-03|||November 2014||2014-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SIMPLE||The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study|The Effect of Simple Insulin Detemir Titration, Metformin Plus Liraglutide Compared to Simple Insulin Detemir Titration Plus Insulin Aspart and Metformin for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study: A 26 Week, Randomized, Open Label, Parallel-group, Intention to Treat Study|Recruiting||Phase 4|100|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 01:11:03.798567|2017-10-11 01:11:03.798567
NCT01966965|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-22|||July 2014||2014-07-01|October 2013|2013-10-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|ESPX||Efficacy and Safety Study for PIOLIN® Shampoo|Phase 3 Efficacy and Safety Study for PIOLIN® Shampoo to Treat Pediculosis|Unknown status|Not yet recruiting|Phase 3|212|Anticipated|Phytopharm Consulting Brazil||2|||f||||f||||||||||2017-10-11 01:11:03.966138|2017-10-11 01:11:03.966138
NCT01966952|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-02-08|||September 2013||2013-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|RSRA||Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension|Centre of Excellence for Treatment of Resistant Hypertension: Establishment and Critical Evaluation of Efficacy, Mechanisms and Safety of Renal Sympathetic Radioablation.|Terminated||N/A|4|Actual|Ottawa Hospital Research Institute|||1|"Simplicity HTN 3 trial did meet safety endpoint, but did not meet efficacy endpoint and   withdrew support for their catheter in 2014."|f||||t||||||||||2017-10-11 01:11:04.066159|2017-10-11 01:11:04.066159
NCT01966939|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2013-10-17|||June 2012||2012-06-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Influences of Types of Skull Surgery on Temporomandibular Joint Performance|Influences of Types of Skull Surgery on Temporomandibular Joint Performance|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 01:11:04.151995|2017-10-11 01:11:04.151995
NCT01966926|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-04-07|2013-10-22||October 2009||2009-10-01|April 2015|2015-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Self-Weighing Instruction Feasibility Study|Self-Weighing Instruction Feasibility Study|Completed||N/A|30|Actual|University of Minnesota - Clinical and Translational Science Institute|Small sample size; Absence of instructions that would mimic a weight loss program.|2|||f||||f||||||||||2017-10-11 01:11:04.288307|2017-10-11 01:11:04.288307
NCT01966913|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-06-23|||April 2012||2012-04-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|TAXIFIII||Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors|Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors - A Phase I-II Sequential Chemotherapy Protocol of Bevacizumab (Avastin) Plus High-dose ICE (Ifosfamide - Carboplatin - Etoposide) Intensification|Recruiting||Phase 1/Phase 2|30|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:11:04.867201|2017-10-11 01:11:04.867201
NCT01966900|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-02-16|||October 2013||2013-10-01|October 2013|2013-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Safety and Immunogenicity of a Potential HIV Vaccine|A Phase 1 Open-Labelled Trial to Evaluate the Safety and Immunogenicity of CN54gp140 in HIV-Uninfected, Healthy Volunteers|Completed||Phase 1|14|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 01:11:04.963012|2017-10-11 01:11:04.963012
NCT01966887|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-08-28|||December 2013||2013-12-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|AGENT-HF||AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure|Phase 2 Study of SERCA2a Gene Transfer in Patients With Severe Heart Failure|Terminated||Phase 2|10|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:11:05.078884|2017-10-11 01:11:05.078884
NCT01966874|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-10-17|||August 2011||2011-08-01|October 2013|2013-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation|Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation|Completed||Phase 2/Phase 3|1001|Actual|Gynuity Health Projects|||1||f||||t||||||||||2017-10-11 01:11:05.402872|2017-10-11 01:11:05.402872
NCT01966861|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-03-02|||March 2016||2016-03-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|WEANLUS-BR||Weaning From Mechanical Ventilation Guided by Lung Ultrasound (Brazilian WEANLUS)|Weaning From Mechanical Ventilation Guided by Lung Ultrasound (Brazilian WEANLUS)|Enrolling by invitation||Phase 3|300|Anticipated|D'Or Institute for Research and Education||2|||f||||t||||||||||2017-10-11 01:11:05.509197|2017-10-11 01:11:05.509197
NCT01966848|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-11-03|||November 2013||2013-11-01|November 2015|2015-11-01|November 2024|Anticipated|2024-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties. A Trial Evaluating Early Component Migration by RSA and Patient Reported Outcome.|Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties. A Randomized Controlled Trial Evaluating Early Component Migration by RSA and Patient Reported Outcome.|Active, not recruiting||N/A|60|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 01:11:05.618803|2017-10-11 01:11:05.618803
NCT01966835|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2014-07-17|||May 2013||2013-05-01|July 2014|2014-07-01||||December 2014|Anticipated|2014-12-01||Interventional|JR||Effect of Moderate to High Intensity Aerobic Interval Training on Polysomnographic Measured Sleep in Patients With Rheumatoid Arthritis|Effect of Moderate to High Intensity Aerobic Interval Training on Polysomnographic Measured Sleep in Patients With Rheumatoid Arthritis. A Randomized Controlled Trial|Unknown status|Recruiting|N/A|44|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-11 01:11:05.719241|2017-10-11 01:11:05.719241
NCT01966822|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-11-27|||January 2014||2014-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density|MULTICENTRE STUDY TO ASSESS CHANGES IN BONE MINERAL DENSITY OF THE SWITCH FROM PROTEASE INHIBITORS TO DOLUTEGRAVIR IN HIV-1-INFECTED SUBJECTS WITH LOW BONE MINERAL DENSITY|Completed||Phase 3|75|Actual|Fundacio Lluita Contra la SIDA||2|||f||||f||||||||||2017-10-11 01:11:05.822129|2017-10-11 01:11:05.822129
NCT01966809|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-10-10|||June 2015||2015-06-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas|A Phase II Study of Photodynamic Therapy (PDT) With Photofrin® (IND 104,613) For Recurrent High Grade Gliomas in Adults|Recruiting||Phase 2|30|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 01:11:05.948457|2017-10-11 01:11:05.948457
NCT01966783|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-01-20|||September 2013||2013-09-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis|Randomized, Double-blind, Multicentre Study to Compare the Efficacy and Safety of Budesonide Versus Mesalazine Suppository Versus a Combination Therapy of Budesonide/Mesalazine Suppositories in Patients With Acute Ulcerative Proctitis|Completed||Phase 2|320|Anticipated|Dr. Falk Pharma GmbH||4|||f||||f||||||||||2017-10-11 01:11:06.168375|2017-10-11 01:11:06.168375
NCT01966770|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-02-25|2015-01-14||October 2013||2013-10-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||All particpants wore Day 1 followed by Day 2 lenses|Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses|Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses|Completed||N/A|20|Actual|Coopervision, Inc.||6|||f||||f||||||||||2017-10-11 01:11:06.318748|2017-10-11 01:11:06.318748
NCT01966757|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-07-25|||July 2013||2013-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Neuronal Ceroid Lipofuscinosis and Associated Sleep Abnormalities|Neuronal Ceroid Lipofuscinosis and Associated Sleep Abnormalities|Completed||N/A|57|Actual|Nationwide Children's Hospital|||1||f||||f||||||||No||2017-10-11 01:11:07.687135|2017-10-11 01:11:07.687135
NCT01966731|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-03-30|||June 2014||2014-06-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|REACH||Realizing Effectiveness Across Continents With Hydroxyurea (REACH)|Realizing Effectiveness Across Continents With Hydroxyurea (REACH): A Phase I/II Pilot Study Of Hydroxyurea For Children With Sickle Cell Anemia|Active, not recruiting||Phase 1/Phase 2|636|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 01:11:07.923414|2017-10-11 01:11:07.923414
NCT01966718|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-07-11|2015-12-03||October 2013||2013-10-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||Rheumatoid arthritis patients who have failed at least three biologics with different methods of action|Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.|Repository Corticotropin Injection As Adjunctive Therapy In Patients With Rheumatoid Arthritis Who Have Failed At Least Three Biologic Therapies With Different Modes Of Action|Completed||Phase 4|8|Actual|Arthritis Treatment Center, Maryland|Small sample size (8 patients); Open label, Sampling bias cannot be excluded;Single group study; no standardization of concomitant therapy|1|||f||||f||||||||||2017-10-11 01:11:08.070839|2017-10-11 01:11:08.070839
NCT01966705|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-11-04|||October 2013||2013-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Cognitive Behavior Therapy for Health Anxiety: A Comparison of Three Forms of Self-help|Self-help Based Cognitive Behavior Therapy for Health Anxiety Delivered Via the Internet or in Book Form - the Effect of Administration Strategy and Therapist Contact: a Randomized Controlled Trial|Completed||N/A|132|Anticipated|Karolinska Institutet||4|||f||||t||||||||||2017-10-11 01:11:08.364251|2017-10-11 01:11:08.364251
NCT01966692|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-06-23|||November 2016|Actual|2016-11-01|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Sensitivity of Pharmacokinetics to Differences in Aerodynamic Particle Size Distribution|Evaluation of the Sensitivity of Pharmacokinetics to Differences in the Aerodynamic Particle Size Distribution of Three Different Formulations of Fluticasone Propionate Dry Powder Inhalers|Recruiting||Phase 1|60|Anticipated|University of Florida||4|||f||||f|t|f||||||Yes|Sharing of subject's de-identified data.|2017-10-11 01:11:08.49019|2017-10-11 01:11:08.49019
NCT01966679|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-10-21|||October 2013||2013-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|FAST-AS||Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial|Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial|Completed||Phase 2|40|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 01:11:08.639721|2017-10-11 01:11:08.639721
NCT01966666|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-12-05|||November 2013||2013-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|||A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI-287 in Patients With Mild to Moderate Alzheimer's Disease|Active, not recruiting||Phase 1|33|Anticipated|University of California, San Francisco||4|||f||||t||||||||||2017-10-11 01:11:08.735754|2017-10-11 01:11:08.735754
NCT01966653|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-01|||October 2013|Actual|2013-10-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|AIDA-WP2||Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women|Randomised Clinical Trial Comparing Fosfomycin vs. Nitrofurantoin for Treatment of Uncomplicated Lower Urinary Tract Infection in Female Adults at Increased Risk of Antibiotic-resistant Bacterial Infection|Active, not recruiting||Phase 4|600|Anticipated|University Hospital, Geneva||2|||f||||t||||||||||2017-10-11 01:11:08.84103|2017-10-11 01:11:08.84103
NCT01966640|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-11-18|||September 2013||2013-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TAB-TPO||Basophil Activation Test (BAT) Sensitivity in Child Food Allergy|Basophil Activation Test (BAT) Sensitivity in Child Food Allergy|Recruiting||Phase 4|140|Anticipated|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 01:11:08.949262|2017-10-11 01:11:08.949262
NCT01966627|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-04-25|||July 2011||2011-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Genetics of Fatty Liver Disease in Children|Genetics of Fatty Liver Disease in Childhood Obesity.|Recruiting||N/A|1000|Anticipated|Yale University|||1||f||||f||||||Samples With DNA|"     Serum   "|No||2017-10-11 01:11:09.055849|2017-10-11 01:11:09.055849
NCT01966614|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-04-26|||October 2013||2013-10-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PLUS-1||Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH|Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of a Single Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (The PLUS 1 Trial)|Completed||Phase 3|479|Actual|Sophiris Bio Corp||2|||f||||t||||||||||2017-10-11 01:11:09.194042|2017-10-11 01:11:09.194042
NCT01966601|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-09-09|||December 2013||2013-12-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|BLAST-AHF||A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure|A Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure|Unknown status|Recruiting|Phase 2|620|Anticipated|Trevena Inc.||4|||f||||t||||||||||2017-10-11 01:11:09.474369|2017-10-11 01:11:09.474369
NCT01966588|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-05-30|||June 2013||2013-06-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01|3 Months|Observational [Patient Registry]|AEGIS||Adverse Events and Genomics in Schizophrenia|Genomic Biomarkers of Adverse Events Arising From Antipsychotic Drug Therapy|Recruiting||N/A|100|Anticipated|University of British Columbia|||2||f||||f||||||Samples With DNA|"     We will be collecting and retaining whole blood samples for genomic testing.   "|||2017-10-11 01:11:10.001912|2017-10-11 01:11:10.001912
NCT01966575|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2014-11-04|||October 2013||2013-10-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene Citrate|Effect of Progestin-Induced Endometrial Shedding on Ovulation Induction Cycles With Clomiphene Citrate: A Randomized Study|Withdrawn||Phase 4|0|Actual|University of British Columbia||2||Recent findings suggest that letrozole may be a superior Clomiphene Citrate.|f||||f||||||||||2017-10-11 01:11:10.179882|2017-10-11 01:11:10.179882
NCT01966562|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-16|||November 2011||2011-11-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|October 2012|Actual|2012-10-01||Interventional|PAHA||PAHA Study: Psychological Active and Healthy Ageing|Psychological Well Being, Proactive Attitude and Happiness Effects of Whole-body Vibration vs. Multi-component Training in Aged Women: a Randomized Controlled-trial Study Protocol|Completed||N/A|69|Actual|University of Bergamo||3|||f||||f||||||||||2017-10-11 01:11:10.338667|2017-10-11 01:11:10.338667
NCT01966549|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-06-06||2016-06-06|November 2013||2013-11-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Randomized, Placebo Controlled Double-Blind, Multi-Center, Phase II Study to Assess the Efficacy and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 2|187|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 01:11:10.445834|2017-10-11 01:11:10.445834
NCT01966536|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-09-11|||November 2013||2013-11-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|March 2014|Anticipated|2014-03-01||Interventional|||CD133 Transplantation to Generate Oocytes in Poor Ovarian Reserve|CD133+ Autologue Transplantation to Promote Ovarian Follicles Development in Women With Poor Ovarian Reserve.|Withdrawn||N/A|0|Actual|Hospital Universitario La Fe||1||Due to fundamental changes in procedures design no patients have been enrolled|f||||f||||||||||2017-10-11 01:11:10.753199|2017-10-11 01:11:10.753199
NCT01966523|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-08-19|||October 2013||2013-10-01|September 2015|2015-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia|A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia|Completed||Phase 2|62|Actual|Hebrew Rehabilitation Center, Boston||2|||f||||t||||||||||2017-10-11 01:11:10.861302|2017-10-11 01:11:10.861302
NCT01966510|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-04-15|||March 2013||2013-03-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|March 2015|Actual|2015-03-01||Interventional|LYMPHCORD||Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies|A Prospective Phase II Study to Evaluate Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies.|Active, not recruiting||Phase 2|19|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:11:10.958182|2017-10-11 01:11:10.958182
NCT01966497|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-04-20|||November 2012||2012-11-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|ALFA1200||Observational Study of Patients Older Than 60 Years With Acute Myeloblastic Leukemia|Observational Study of Patients Older Than 60 Years and With Acute Myeloblastic Leukemia Who Are Administered Standard Chemotherapy Based on Idarubicine-cytarabine|Withdrawn||N/A|0|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 01:11:11.049185|2017-10-11 01:11:11.049185
NCT01966484|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2014-07-29|||October 2013||2013-10-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Interventional|||Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy||Completed||N/A|100|Anticipated|Dr. Horst Schmidt Klinik GmbH||2|||f||||f||||||||||2017-10-11 01:11:11.13782|2017-10-11 01:11:11.13782
NCT01966471|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-08-22|||January 31, 2014|Actual|2014-01-31|August 2017|2017-08-01|January 31, 2024|Anticipated|2024-01-31|January 31, 2024|Anticipated|2024-01-31||Interventional|||A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer|A Randomized, Multicenter, Open-Label, Phase III Trial Comparing Trastuzumab Plus Pertuzumab Plus a Taxane Following Anthracyclines Versus Trastuzumab Emtansine Plus Pertuzumab Following Anthracyclines as Adjuvant Therapy in Patients With Operable HER2-Positive Primary Breast Cancer|Active, not recruiting||Phase 3|1846|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:11:11.316092|2017-10-11 01:11:11.316092
NCT01966458|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-09-08|||October 2013||2013-10-01|September 2015|2015-09-01||||August 2016|Anticipated|2016-08-01||Interventional|||A Clinical Trial to Evaluate the HeartWare® Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL)|A Prospective, Randomized, Controlled, Unblinded, Multi-Center Clinical Trial to Evaluate the HeartWare® Ventricular Assist Device System for Destination Therapy of Advanced Heart Failure|Unknown status|Active, not recruiting|N/A|465|Anticipated|HeartWare, Inc.||2|||f||||t||||||||||2017-10-11 01:11:12.204523|2017-10-11 01:11:12.204523
NCT01966445|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-08-03|||November 26, 2013|Actual|2013-11-26|August 2017|2017-08-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Interventional|||Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors|A Phase I, First Time in Human, Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Anti-Her3 Monoclonal Antibody GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors|Active, not recruiting||Phase 1|155|Anticipated|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:11:12.412741|2017-10-11 01:11:12.412741
NCT01966432|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-08-24|2017-06-02||August 2013|Actual|2013-08-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SBIRT-PC||Screening, Brief Intervention, and Referral to Treatment in Primary Care|"Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC): An add-on Project to Duke University Southeastern Diabetes Initiative"|Completed||N/A|134|Actual|Duke University|This pilot study is not randomized, and it is not designed for hypothesis testing. Any conclusions arising from these data must be regarded as exploratory and preliminary, and need to be validated by independent data.|1|||f||||t|f|f||||||||2017-10-11 01:11:12.535216|2017-10-11 01:11:12.535216
NCT01966419|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-02-16|||November 2013||2013-11-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|STOP-HE||Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)|Multicenter, Randomized Phase 2B Study Evaluating Efficacy, Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Cirrhotic Patients With Associated Hyperammonemia and an Episode of Hepatic Encephalopathy STOP-HE Study|Completed||Phase 2|231|Actual|Ocera Therapeutics||2|||f||||t||||||||||2017-10-11 01:11:13.333568|2017-10-11 01:11:13.333568
NCT01966406|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2013-10-21|||September 2013||2013-09-01|October 2013|2013-10-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Is Nasogastric Tube Necessary After Pancreaticoduodenectomy?|Is Nasogastric Tube Necessary After Pancreaticoduodenectomy? A Prospective Randomized Multicenter Trial|Unknown status|Recruiting|N/A|90|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:11:15.610192|2017-10-11 01:11:15.610192
NCT01966393|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-05-01|||April 2014||2014-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes|An Open-label, Randomized, Three-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Conventional Insulin Pump Therapy in Regulating Glucose Levels During 60 Hours in Free-living Conditions in Patients With Type 1 Diabetes|Completed||Phase 2|23|Actual|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-11 01:11:15.738996|2017-10-11 01:11:15.738996
NCT01966380|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-12-22|2015-01-14||September 2013||2013-09-01|December 2015|2015-12-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia|An Open Randomised, Prospective, Crossover, Proof of Concept (Design Validation) Clinical Investigation to Caompare the Performance and Safety of Wound Dressing(Leia) Compared to and Hydroactive Surgical Dressing on Low to Highly Exuding Wounds|Terminated||Phase 2|6|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-11 01:11:15.917944|2017-10-11 01:11:15.917944
NCT01966367|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-07-13|||March 2013||2013-03-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation|CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease|Recruiting||Early Phase 1|25|Anticipated|Columbia University||1|||f||||t|t|f||||||||2017-10-11 01:11:16.246363|2017-10-11 01:11:16.246363
NCT01966354|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-06-30|2016-05-19||March 2012||2012-03-01|June 2016|2016-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|OISO-1||Comparison of Three Techniques for Ultrasound-guided Internal Jugular Cannulation|Comparison of Three Techniques for Ultrasound-guided Internal Jugular Cannulation: Long Axis, In-plane Needle v. Short Axis, Out-of-plane Needle v. Oblique Axis, In-plane Needle|Completed||N/A|220|Actual|Fundacion Miguel Servet|Results may be only extrapolative to experienced cannulators|3|||f||||t||||||||||2017-10-11 01:11:16.410934|2017-10-11 01:11:16.410934
NCT01966341|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-05-14|||April 2014||2014-04-01|May 2014|2014-05-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|CAPP||Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease|A Randomized Controlled Trial Comparing a Collaborative Cognitive Behavioral Therapy / Hypnotherapy Program to Standard Medical Management in the Treatment of Pediatric Functional Gastrointestinal Disease|Unknown status|Recruiting|N/A|20|Anticipated|Seton Healthcare Family||2|||f||||f||||||||||2017-10-11 01:11:18.415702|2017-10-11 01:11:18.415702
NCT01966328|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-03-29|||October 2013||2013-10-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment|A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment|Completed||Phase 1|21|Actual|Ophthalmic Consultants of Boston||2|||f||||f||||||||||2017-10-11 01:11:18.575565|2017-10-11 01:11:18.575565
NCT01966315|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2016-02-10|||October 2013||2013-10-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Observational|||The Comparison of Dexmedetomidine and Midazolam for the Sleep in Intensive Care Unit|The Comparison of Dexmedetomidine and Midazolam for the Sleep of Mechanical Ventilated Intensive Care Unit Patients|Recruiting||N/A|30|Anticipated|Seoul National University Hospital|||2||f||||t||||||||||2017-10-11 01:11:18.693509|2017-10-11 01:11:18.693509
NCT01966302|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-09-07|||November 2013||2013-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)|Compassionate Use of Beraprost Sodium 314d Modified Release (BPS-314d-MR) for Three Patients With Pulmonary Arterial Hypertension (PAH).|Active, not recruiting||Phase 2|3|Anticipated|Los Angeles Biomedical Research Institute||1|||f||||f||||||||||2017-10-11 01:11:18.801973|2017-10-11 01:11:18.801973
NCT01966289|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-07-07|||December 2013|Actual|2013-12-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)|A Pilot Study of SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) as Maintenance Therapy|Recruiting||Phase 1|32|Anticipated|Sidney Kimmel Comprehensive Cancer Center||4|||f||||t||||||||||2017-10-11 01:11:18.892224|2017-10-11 01:11:18.892224
NCT01966263|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-05-01|||November 2013||2013-11-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional|||Fast Track Total Knee Arthroplasty: Local Infiltration Analgesia vs Femoral Nerve Block|Fast-track Rehabilitation Protocol for Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Local Infiltration Analgesia With Femoral Nerve Block|Completed||Phase 4|80|Actual|Sint Maartenskliniek||2|||f||||f||||||||No||2017-10-11 01:11:19.160047|2017-10-11 01:11:19.160047
NCT01966250|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2015-03-30|||October 2013||2013-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Electroacupuncture as a Complement to Usual Care for Patients With Non-acute Pain After Back Surgery|Electroacupuncture as a Complement to Usual Care for Patients With Non-acute Pain After Back Surgery: a Study Protocol for a Pilot Randomized Controlled Trial|Completed||N/A|40|Actual|Korean Medicine Hospital of Pusan National University||2|||f||||||||||||||2017-10-11 01:11:19.286287|2017-10-11 01:11:19.286287
NCT01966237|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-02-02|||September 2013||2013-09-01|February 2015|2015-02-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|MIL-PK||Milrinone Pharmacokinetics and Acute Kidney Injury|USE OF ACUTE KIDNEY INJURY BIOMARKERS TO PREDICT IMPAIRED MILRINONE PHARMACOKINETICS IN CHILDREN FOLLOWING CARDIAC SURGERY|Unknown status|Active, not recruiting|N/A|74|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||||||2017-10-11 01:11:19.529197|2017-10-11 01:11:19.529197
NCT01966224|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-04-29|||September 2013||2013-09-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects|A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated CryJ2-DNA-LAMP Vaccinated Subjects and the Safety of a Booster Vaccination|Completed||Phase 1|17|Actual|Immunomic Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 01:11:19.618893|2017-10-11 01:11:19.618893
NCT01966211|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2015-02-02|||October 2013||2013-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:11:19.708379|2017-10-11 01:11:19.708379
NCT01966198|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-12|2014-04-14|||October 2013||2013-10-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Estimation of Autonomic Nervous System Modulation by Pulse Plethysmographic Analysis||Completed||N/A|10|Actual|ASST Fatebenefratelli Sacco||1|||f||||f||||||||||2017-10-11 01:11:19.756248|2017-10-11 01:11:19.756248
NCT01966185|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2015-05-04|||October 2013||2013-10-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Establishing Learning Curves in Virtual Simulation Training of Mastoidectomy|Establishing Learning Curves in Virtual Simulation Training of Mastoidectomy|Completed||N/A|43|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:11:19.851282|2017-10-11 01:11:19.851282
NCT01966172|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-10-16|||March 2007||2007-03-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery|Multimodal Opiate-sparing Analgesia Versus Traditional Opiate Based Analgesia After Cardiac Surgery, a Randomized Controlled Trial|Completed||Phase 4|180|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:11:19.946972|2017-10-11 01:11:19.946972
NCT01966159|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2017-05-16|2015-12-11||October 2013||2013-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|July 2014|Actual|2014-07-01||Interventional|EVOLVE-CHINA||The EVOLVE China Clinical Trial|EVOLVE China: A Prospective, Multicenter Trial to Assess the Safety and Effectiveness of the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System) for the Treatment of Atherosclerotic Lesion(s)|Active, not recruiting||N/A|412|Actual|Boston Scientific Corporation||2|||f||||f||||||||No||2017-10-11 01:11:20.096442|2017-10-11 01:11:20.096442
NCT01966146|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-12-01|||May 2013||2013-05-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|3D_TTE_TAVI||Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI|Quantitative Analysis of Catheter-based Interventional Therapies for Treating Valve Insufficiency by Using 3D Echocardiography.|Completed||N/A|200|Anticipated|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 01:11:20.709218|2017-10-11 01:11:20.709218
NCT01966133|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-01-06|||August 2011||2011-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||TACE as an Adjuvant Therapy After Hepatectomy for HCC|Randomised Controlled Trial on Adjuvant Transarterial Chemoembolisation After Curative Hepatectomy for Hepatocellular Carcinoma|Active, not recruiting||Phase 3|280|Actual|Fudan University||2|||f||||t||||||||||2017-10-11 01:11:20.78388|2017-10-11 01:11:20.78388
NCT01966120|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-17|2016-10-26|2016-06-10||October 2013||2013-10-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)|A Randomized, Double-blind, Phase III, Multi-center Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) Versus Placebo in the Field-directed Treatment of Mild to Moderate Actinic Keratosis With Photodynamic Therapy (PDT) When Using the BF-RhodoLED® Lamp|Completed||Phase 3|87|Actual|Biofrontera Bioscience GmbH||2|||f||||f||||||||No||2017-10-11 01:11:20.902631|2017-10-11 01:11:20.902631
NCT01966107|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-09-25|||October 16, 2013|Actual|2013-10-16|September 2017|2017-09-01|December 19, 2017|Anticipated|2017-12-19|December 19, 2017|Anticipated|2017-12-19||Interventional|ASCENT COPD||Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.|Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD (ASCENT COPD)|Active, not recruiting||Phase 4|3635|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 01:11:21.632168|2017-10-11 01:11:21.632168
NCT01966094|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-07-25|||October 2013||2013-10-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Observational|HAND2||Observational Study of HIV-associated Neurocognitive Disorder|Observational Study of HIV-associated Neurocognitive Disorder|Recruiting||N/A|46|Anticipated|Emory University|||2||f||||t||||||Samples Without DNA|"     Blood (plasma) samples and cerebrospinal fluid (CSF)   "|||2017-10-11 01:11:22.938923|2017-10-11 01:11:22.938923
NCT01966081|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-16||||||October 2013|2013-10-01||||November 2014|Anticipated|2014-11-01||Interventional|AGARIC||AGARIC Case Control Study|Consumption of Fatty Acids, Metabolism of Adipose Tissue and Risk of Colorectal Cancer: AGARIC Case Control Study|Unknown status|Recruiting|N/A|576|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-11 01:11:23.045494|2017-10-11 01:11:23.045494
NCT01966068|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-08-30|2016-07-13||October 2013||2013-10-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Baseline analysis population included every family of children with asthma who logged onto the MyAsthma portal at least once.|Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3|Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3|Completed||N/A|294|Actual|Children's Hospital of Philadelphia|Enrollment occurred in practices across 11 states, yet more than half of practices were within a single health system thus affecting generalizability. This study also includes a relatively short follow-up period.|1|||f||||f||||||||Undecided||2017-10-11 01:11:23.165422|2017-10-11 01:11:23.165422
NCT01966055|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-02-20|||December 2013||2013-12-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents|A Phase 1, Open-label, Multi-center Study to Determine the PK and Safety of Solithromycin as Add-on Therapy in Adolescents With Suspected or Confirmed Bacterial Infection|Completed||Phase 1|13|Actual|Cempra Inc||1|||f||||t||||||||||2017-10-11 01:11:23.737155|2017-10-11 01:11:23.737155
NCT01966042|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2014-05-05|2013-12-27||July 2005||2005-07-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|November 2011|Actual|2011-11-01||Interventional|ReACT|One patient died from cardiogenic shock due to anterior myocardial infarction after 5 months of follow-up. One patient, after 47.3 months of ReACT's procedure, migrated to CCSAC 4 and met inclusion criteria again. This patient was submitted to a new ReACT's procedure.|Study Protocol of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina|Phase II Study of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina in Patients With Normal or Slightly Reduced Left Ventricular Function.|Completed||Phase 2|13|Actual|CellPraxis Bioengenharia Ltda.|Due to ethical aspects and the inability to justify the use of a surgical intramyocardial placebo in this population, this was non-randomized, open study.|1|||f||||t||||||||||2017-10-11 01:11:23.850702|2017-10-11 01:11:23.850702
NCT01966029|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-01-27|||July 2013||2013-07-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|MOR-AUS||BMN 110 Phase 3B in Australian Patients|A Multicenter Open-Label, Phase 3B Study to Evaluate the Efficacy and Safety of BMN 110 in Australian Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)|Unknown status|Active, not recruiting|Phase 3|13|Actual|BioMarin Pharmaceutical||1|||f||||t||||||||||2017-10-11 01:11:24.142347|2017-10-11 01:11:24.142347
NCT01966016|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2013-10-16|||January 2013||2013-01-01|October 2013|2013-10-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety of Multisite Cardiac Resynchronization Therapy|Efficacy and Safety of Multisite Cardiac Resynchronization Therapy - a Prospective Single Center Study in Selected Patient Population|Unknown status|Recruiting|N/A|100|Anticipated|Barzilai Medical Center||2|||f||||f||||||||||2017-10-11 01:11:24.253723|2017-10-11 01:11:24.253723
NCT01965990|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-10-18|||April 2010||2010-04-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|NEP||VLCD by Enteral Route for Weight Loss|A 2-week Course of Enteral Treatment With a Very Low-calorie Protein-based Formula for the Management of Severe Obesity|Completed||N/A|364|Actual|San Giuseppe Moscati Hospital|||1||f||||t||||||||||2017-10-11 01:11:24.462889|2017-10-11 01:11:24.462889
NCT01965977|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-04-08|||July 2013||2013-07-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|Borma||Bortezomib Maintenance in High Risk DLBCL|Open-label, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients With High Risk Diffuse Large B Cell Lymphoma|Recruiting||Phase 2|53|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 01:11:24.562992|2017-10-11 01:11:24.562992
NCT01965964|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-12-14|||May 2013||2013-05-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Translation of the Sydney Swallow Questionnaire and Validation of the German Version|Sydney Swallow Questionnaire: Translation of a Questionnaire Relating to the Function of Swallowing and Validation of the German Version|Completed||N/A|30|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 01:11:24.825376|2017-10-11 01:11:24.825376
NCT01965951|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-06-13|||July 2013||2013-07-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|RESPONSE||Remediation of Spatial Neglect Trial|RESPONSE: Remediation of Spatial Neglect Trial|Completed||N/A|96|Actual|Posit Science Corporation||2|||f||||t||||||||||2017-10-11 01:11:24.916826|2017-10-11 01:11:24.916826
NCT01965938|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-11-05|2015-06-04||September 2012||2012-09-01|October 2016|2016-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope|RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope: A Comparison of the Ease of Use During Intubation on Difficult Airways|Completed||N/A|41|Actual|Vanderbilt University||2|||f||||t||||||||Undecided||2017-10-11 01:11:25.040634|2017-10-11 01:11:25.040634
NCT01965925|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-08-19|||January 2014||2014-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil|Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil|Recruiting||Phase 4|48|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 01:11:25.567158|2017-10-11 01:11:25.567158
NCT01965912|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-05-10|||October 2013||2013-10-01|May 2016|2016-05-01|December 2022|Anticipated|2022-12-01|November 2022|Anticipated|2022-11-01||Interventional|KOGNITO||Kuvan®'s Effect on the Cognition of Children With Phenylketonuria|A Phase 4 Open-Label, Single-Cohort Study of the Long-Term Neurocognitive Outcomes in 4 to 5 Year-Old Children With Phenylketonuria Treated With Sapropterin Dihydrochloride (Kuvan®) for 7 Years|Active, not recruiting||Phase 4|34|Actual|BioMarin Pharmaceutical||1|||f||||||||||||||2017-10-11 01:11:25.701341|2017-10-11 01:11:25.701341
NCT01965899|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-08-02|2016-06-08||September 2013||2013-09-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|July 2014|Actual|2014-07-01||Interventional|||Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System|Reveal LINQ Usability Study|Completed||N/A|151|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-10-11 01:11:25.836465|2017-10-11 01:11:25.836465
NCT01965886|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-01-05|||October 2013||2013-10-01|October 2013|2013-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ValgusKnee||Medial vs Lateral Approach for Total Knee Replacement on Valgus Knee: a Randomized Clinical Trial|Medial vs Lateral Approach for Total Knee Replacement on Valgus Knee: Prospective and Randomized Clinical Trial|Recruiting||N/A|126|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 01:11:26.354706|2017-10-11 01:11:26.354706
NCT01965873|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-03-30|||May 2007||2007-05-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Enteral Nutrition in Acute Pancreatitis|Enteral Nutrition for Treatment of Acute Pancreatitis - a Prospective, Randomized Clinical Trial|Completed||Phase 4|214|Actual|University Hospital Rijeka||2|||f||||f||||||||||2017-10-11 01:11:26.458913|2017-10-11 01:11:26.458913
NCT01965132|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-03-02|||January 1, 2013|Actual|2013-01-01|March 2017|2017-03-01|June 30, 2023|Anticipated|2023-06-30|December 31, 2022|Anticipated|2022-12-31|5 Years|Observational [Patient Registry]|KOBIO||Korean College of Rheumatology Biologics Registry|Korean College of Rheumatology Biologics Registry|Recruiting||N/A|3500|Anticipated|Seoul National University Hospital|||1||f||||t|t|f|||f|||No||2017-10-11 01:11:45.91956|2017-10-11 01:11:45.91956
NCT01965860|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2014-12-04|||August 2014||2014-08-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|PROSPECT||Transferability and Cost-effectiveness of a Proficiency-based Stepwise Endovascular Curricular Training Program (PROSPECT)|The Study of Transferability and Cost-effectiveness of a Proficiency-based Stepwise Endovascular Curricular Training Program (PROSPECT) in Surgical Trainees|Unknown status|Recruiting|N/A|60|Anticipated|University Ghent||2|||f||||f||||||||||2017-10-11 01:11:26.545123|2017-10-11 01:11:26.545123
NCT01965847|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-06-24|||November 2013||2013-11-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Morning Versus Evening Dosing of Antihypertensive Medications: A Pilot Study to Assess Feasibility and Efficacy|Evening Dosing of Antihypertensive Medications in Chronic Kidney Disease Patients - A Pilot Study|Active, not recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:11:26.625061|2017-10-11 01:11:26.625061
NCT01965834|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-05-12|2017-03-17||November 19, 2012|Actual|2012-11-19|May 2017|2017-05-01|July 1, 2016|Actual|2016-07-01|March 21, 2016|Actual|2016-03-21||Interventional|||Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma|Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma|Terminated||Phase 2|6|Actual|University of Miami||1||Lack of adequate accrual.|f||||t|t|f||||||No||2017-10-11 01:11:26.712472|2017-10-11 01:11:26.712472
NCT01965821|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-03-23|||October 2013||2013-10-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|RCPBALSTAT||Impact of Mallinckrodt Electronic Device on Continuous Control of Tracheal Cuff Pressure|Impact of Mallinckrodt Electronic Device on Continuous Control of Tracheal Cuff Pressure|Completed||N/A|18|Actual|University Hospital, Lille||2|||f||||f||||||||No||2017-10-11 01:11:27.040091|2017-10-11 01:11:27.040091
NCT01965808|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-12-03|||October 2013||2013-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||A Study of LY2157299 in Healthy Participants|Effect of Food on the Pharmacokinetics of LY2157299 Monohydrate in Healthy Subjects|Completed||Phase 1|16|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:11:27.12759|2017-10-11 01:11:27.12759
NCT01965795|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-01-15|||October 2013||2013-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|WCFC||Whole Coffee Fruit Concentrate Pilot Study 1|Effects of Whole Coffee Fruit Concentrate On Cognition and Mood In Healthy Adults: A Pilot Clinical Study|Completed||N/A|39|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:11:27.228903|2017-10-11 01:11:27.228903
NCT01965769|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-10-15|||March 2011||2011-03-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Effects Of Not Measuring Gastric Residual Content On Feeding Tolerance In Premature Infants iNFANTS|Effects Of Not Measuring Gastric Residuals Prior To Enteral Bolus Feeding On Gastrointestinal Function And Feeding Tolerance In Very Low Birth Weight Infants|Completed||N/A|61|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:11:27.469845|2017-10-11 01:11:27.469845
NCT01965756|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-08-21|2017-06-06||January 2013||2013-01-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|December 22, 2015|Actual|2015-12-22||Interventional|||Effect of Insulin Sensitizer Metformin on AD Biomarkers|A Phase II Trial to Study the Effect of Metformin on AD Biomarkers: A Randomized Placebo Controlled Crossover Pilot Study of Metformin Effects on Cognitive, Physiological and Biochemical Biomarkers of MCI and Dementia Due to AD|Completed||Phase 2|20|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:11:27.651329|2017-10-11 01:11:27.651329
NCT01965743|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2014-09-09|||April 2014||2014-04-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot of Social Network Intrauterine Contraceptive (IUC) Intervention|The Woman-to-Woman Dissemination Project: Harnessing the Power of Social Networks to Increase IUC Use|Completed||N/A|53|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:11:28.279716|2017-10-11 01:11:28.279716
NCT01965730|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-08-18|||January 2013||2013-01-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|EACA||Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery|The Effect of Standard vs Aggressive Dosing Regimens for Epsilon-aminocaproic Acid on a Quantifiable Parameter of Fibrinolysis as Measured by Thromboelastography|Completed||Early Phase 1|8|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:11:28.375898|2017-10-11 01:11:28.375898
NCT01965717|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-02-24|||July 2012||2012-07-01|February 2015|2015-02-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Observational|BIOLEAK||Multicentre Trial Of Serum Levels Of MMP-9 As A Biomarker Of Endoleak||Recruiting||N/A|150|Anticipated|University of Belgrade|||1||f||||f||||||Samples With DNA|"     Venous blood will be drawn via an antecubital vein puncture and collected in Heparin buffered     vacutainer for plasma. Exactly 30 min after collection, blood will be centrifuged (15 min,     1000 g, 4C) and multiple aliquots will be stored at exactly 1 h after collection at < - 20 C.   "|||2017-10-11 01:11:28.506981|2017-10-11 01:11:28.506981
NCT01965704|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-01-24|||December 2013||2013-12-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|AIM2NAS||Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women|AIM 2- Prevention of Neonatal Abstinence Syndrome|Recruiting||Phase 2|90|Anticipated|Stanford University||2|||f||||t||||||||No|We will not share any individual participant data with other researchers.|2017-10-11 01:11:28.654455|2017-10-11 01:11:28.654455
NCT01965691|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-05-24|||October 2013||2013-10-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Protein Requirements in Children With Phenylketonuria (PKU)|Application of Stable Isotopes to Determine Protein Requirements in Children With Phenylketonuria (PKU)|Completed||N/A|4|Actual|University of British Columbia||1|||f||||t||||||||||2017-10-11 01:11:28.830408|2017-10-11 01:11:28.830408
NCT01965678|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-10-17|||September 2010||2010-09-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|ESoQoLiO||Epidemiological Study of Quality of Life in Osteopathy||Completed||N/A|1000|Actual|European Institute for Evidence Based Osteopathic Medicine||1|||f||||t||||||||||2017-10-11 01:11:28.923442|2017-10-11 01:11:28.923442
NCT01965652|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-04-19|2017-04-19||September 24, 2013|Actual|2013-09-24|May 2016|2016-05-01|January 12, 2016|Actual|2016-01-12|January 12, 2016|Actual|2016-01-12||Interventional||The safety population included all participants who received at least 1 dose of study drug. Five participants (2 in the naldemedine group and 3 in the placebo group) were excluded due to double enrollment at different sites. One participant in the placebo arm received naldemedine in error and is included in the naldemedine arm for safety analyses.|Long Term Safety of Naldemedine|A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy|Completed||Phase 3|1246|Actual|Shionogi Inc.||2|||f||||t||||||||||2017-10-11 01:11:29.623275|2017-10-11 01:11:29.623275
NCT01965639|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-06-16|||April 2013||2013-04-01|April 2015|2015-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SEDI||Southeastern Diabetes Initiative Clinical Intervention|A Clinical Intervention to Serve High-Risk Patients in the Southeastern Diabetes Initiative and Durham Diabetes Coalition|Completed||N/A|648|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:11:32.053904|2017-10-11 01:11:32.053904
NCT01965626|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-07-22|||October 2016||2016-10-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multicenter Randomized Open-label Study of Oseltamivir Combined With High-dose Dexamethasone Versus High-dose Dexamethasone in the Management of Immune Thrombocytopenia With High Platelet Desialylation Level|A Multicenter Randomized Open-label Study of Oseltamivir Combined With High-dose Dexamethasone Versus High-dose Dexamethasone in the Management of Immune Thrombocytopenia With High Platelet Desialylation Level|Not yet recruiting||Phase 2|240|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-11 01:11:32.176066|2017-10-11 01:11:32.176066
NCT01965613|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-01-23|||January 2014||2014-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum|A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum|Completed||Phase 2|10|Actual|XBiotech, Inc.||1|||f||||f||||||||||2017-10-11 01:11:32.314029|2017-10-11 01:11:32.314029
NCT01965600|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-06-21|2016-06-21||March 2014||2014-03-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|POM|All 23 participants who were randomized to study treatment and who received at least 1 dose of study drug were included in the baseline analysis.|A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model|A Phase 1, Randomized, Double Blind, Placebo Controlled, Multiple Dose, 2 Way Crossover Study To Evaluate The Safety And Pharmacodynamic Effects Of Pf 06282999 Using An Endotoxin (Lipopolysaccharide) Induced Inflammatory Response Model In Healthy Adult Subjects|Terminated||Phase 1|23|Actual|Pfizer|Due to early study termination, PK, PD, or biomarker changes assessments were incomplete and there was only safety data from partial enrollment. As such, it was not possible to have meaningful interpretation and/or comparison of these data.|2|||f||||f||||||||||2017-10-11 01:11:32.419977|2017-10-11 01:11:32.419977
NCT01965587|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-10-17|||December 2013||2013-12-01|October 2013|2013-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||RCT Novasure Versus Novasure + Mirena IUS in the Treatment of Menorrhagia|RCT Novasure Versus Novasure + Mirena IUS in the Treatment of Menorrhagia. A Pilot Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Walsall Healthcare NHS Trust||2|||f||||f||||||||||2017-10-11 01:11:33.392209|2017-10-11 01:11:33.392209
NCT01965574|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2017-01-30|||October 2013|Actual|2013-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|PRD-ARDS-PP||Preload Dependence During Prone Position In ARDS Patients|Evaluation of Performance Diagnosis of Hemodynamic Parameters of Preload Dependence in ARDS Patients During Prone Position|Completed||N/A|33|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 01:11:33.495024|2017-10-11 01:11:33.495024
NCT01965561|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-05-10|2015-09-01||October 2013||2013-10-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Healthy human volunteers|Performance of Junctional Tourniquets in Normal Human Volunteers|Performance of Junctional Tourniquets in Normal Human Volunteers|Completed||Phase 4|10|Actual|United States Army Institute of Surgical Research||4|||f||||f||||||||||2017-10-11 01:11:33.631562|2017-10-11 01:11:33.631562
NCT01965548|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-01-08|||September 2014||2014-09-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Treatment of Splenic Trauma: a Retrospective Cohort Study|Treatment of Splenic Trauma: a Retrospective Cohort Study|Completed||N/A|109|Actual|University Hospital of North Norway|||1||f||||f||||||||||2017-10-11 01:11:33.912771|2017-10-11 01:11:33.912771
NCT01965535|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-06-03|2015-08-27||October 2013||2013-10-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug|Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks With Ribavirin or for 24 Weeks Without Ribavirin in Treatment-Experienced Cirrhotic Subjects With Chronic Genotype 1 HCV Infection|Completed||Phase 2|155|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||t||||||||||2017-10-11 01:11:34.01446|2017-10-11 01:11:34.01446
NCT01965522|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-06-14|||October 2013||2013-10-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|August 2016|Actual|2016-08-01||Interventional|MELO-D||Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer|Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer|Completed||Phase 2|100|Actual|Juravinski Cancer Center||4|||f||||t||||||||||2017-10-11 01:11:34.779743|2017-10-11 01:11:34.779743
NCT01965509|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-10-15|||May 2012||2012-05-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes|A Double-Blind, Multicenter, Randomized Study Evaluating the Safety, and Pharmacokinetic/Pharmacodynamic Relationship in T2DMs Treated With 12 Weeks Injection of Polyethylene Glycol Loxenatide Add to Metformin|Completed||Phase 2|120|Actual|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:11:34.895772|2017-10-11 01:11:34.895772
NCT01965119|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-05-16|||November 2013||2013-11-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|JAK2||Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma|Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma|Active, not recruiting||Phase 2|20|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 01:11:46.190811|2017-10-11 01:11:46.190811
NCT01965496|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-10-15|||March 2012||2012-03-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes|A Double-Blind, Multicenter, Randomized Study Evaluating the Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Relationship in T2DMs Treated With 14 Weeks Injection of Polyethylene Glycol Loxenatide|Completed||Phase 1|64|Actual|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:11:35.012749|2017-10-11 01:11:35.012749
NCT01965483|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2013-11-07|||November 2013||2013-11-01|November 2013|2013-11-01||||December 2014|Anticipated|2014-12-01||Interventional|||Phase 2 Study of Adjuvant Radiotherapy in Breast Cancer Using a Once a Week Hypofractionated Regimen|Weekly Hypofractionated Radiotherapy in Breast Cancer: a Phase 2 Clinical Trial|Unknown status|Recruiting|Phase 2|40|Anticipated|Instituto do Cancer do Ceara||1|||f||||f||||||||||2017-10-11 01:11:35.189022|2017-10-11 01:11:35.189022
NCT01965470|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-07-25|||October 2013||2013-10-01|July 2016|2016-07-01||||October 2018|Anticipated|2018-10-01||Interventional|BCPP||Botswana Combination Prevention Project|Botswana Combination Prevention Project: -Evaluation Protocol (Protocol #1): Research Design and Impact Evaluation -Closed Clinical Cohort Protocol (Protocol #3) Implementation, Monitoring and Evaluation of Combination HIV Prevention Interventions in Rural and Peri-Urban Communities in Botswana|Enrolling by invitation||Phase 4|||Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 01:11:35.322298|2017-10-11 01:11:35.322298
NCT01965457|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-07-27|||September 2013||2013-09-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Assessment of Adenoidal Obstruction in Children : Clinical Signs Versus Flexible Nasal Endoscopy and Roentgenographic Findings|Assessment of Adenoidal Obstruction in Children : Clinical Signs Versus Flexible Nasal Endoscopy and Roentgenographic Findings|Recruiting||N/A|36|Anticipated|Carmel Medical Center|||1||f||||t||||||||||2017-10-11 01:11:35.425633|2017-10-11 01:11:35.425633
NCT01965444|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2013-12-23|||September 2013||2013-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||A Test of the Investigational SEM Scanner|An Investigational, Non-significant Risk Study to Collect Data Needed to Analyze Readings Given by the SEM Scanner Point of Care 200 Series (SEM POC 200) and Its Ability to Detect Sub Epidermal Moisture.|Completed||N/A|50|Actual|Bruin Biometrics, LLC|||1||f||||f||||||||||2017-10-11 01:11:35.520418|2017-10-11 01:11:35.520418
NCT01965431|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2016-03-15|2016-01-21||October 2013||2013-10-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Treated Set: All subjects who received at least 1 dose of investigational treatment|Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.|Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Female and Male Subjects. Randomised, Placebo Controlled, Single-blind, Three-period Crossover Phase-I-study With Moxifloxacin as Positive Control|Completed||Phase 1|48|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 01:11:35.598765|2017-10-11 01:11:35.598765
NCT01965418|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-16|2015-08-14|||September 2013||2013-09-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|||A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial||Unknown status|Recruiting|Phase 4|1000|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||||2017-10-11 01:11:36.006284|2017-10-11 01:11:36.006284
NCT01965405|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-04-20|||August 2013||2013-08-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Smoking Cessation for People Living With HIV/AIDS|Behavioral Smoking Cessation Treatment for People Living With HIV/AIDS|Recruiting||N/A|400|Anticipated|Wayne State University||6|||f||||t||||||||||2017-10-11 01:11:36.110937|2017-10-11 01:11:36.110937
NCT01965392|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-15|||March 2009||2009-03-01|October 2013|2013-10-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Efficiency of an Educational Program for Informal Caregivers of Hospitalized, Dependent Patients: Cluster Randomised Trial||Completed||N/A|151|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||1|||f||||t||||||||||2017-10-11 01:11:36.272433|2017-10-11 01:11:36.272433
NCT01965379|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-03-09|||January 2012||2012-01-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Restriction of Foods Containing Phosphorus Additives|Effect of Restriction of Foods Containing Phosphorus Additives on the Phosphatemia of Patients With End-stage Renal Disease.|Completed||N/A|140|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t||||||||||2017-10-11 01:11:36.382866|2017-10-11 01:11:36.382866
NCT01965366|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-06-27|||October 2013||2013-10-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Interventional|Dex||Dexamethasone Plus Virtual Reality Exposure Therapy for PTSD|A Pilot Study of the Effects of Dexamethasone Administration on Virtual Reality Exposure Therapy for PTSD|Completed||Phase 4|28|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:11:36.484888|2017-10-11 01:11:36.484888
NCT01965353|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-09-01|||October 2013||2013-10-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|December 2017|Anticipated|2017-12-01||Interventional|PanRVD||A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma|A Phase I Open Label Study Of Panobinostat In Combination With Lenalidomide, Bortezomib, And Dexamethasone In Patients With Relapsed And Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1|21|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:11:36.571606|2017-10-11 01:11:36.571606
NCT01965340|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2016-11-10|||October 2013||2013-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Impact of Therapeutic Drug Monitoring on Anti-Infective Agents Amongst Severely Burned Patients Requiring ICU Admission||Completed||N/A|39|Actual|University of Lausanne Hospitals||2|||f||||t||||||||||2017-10-11 01:11:36.687639|2017-10-11 01:11:36.687639
NCT01965327|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-04-29|2015-04-15||August 2013||2013-08-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Interferon Gamma-1b in Friedreich Ataxia (FRDA)|Open-label Pilot Study of Interferon Gamma-1b (Actimmune™) for the Treatment of Friedreich Ataxia (FRDA)|Completed||Phase 2|12|Actual|Children's Hospital of Philadelphia|This study was performed in a small population of children with Friedreich ataxia (n=12) and without a placebo arm.|1|||f||||t||||||||||2017-10-11 01:11:36.768172|2017-10-11 01:11:36.768172
NCT01965314|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-02-01|||July 2010||2010-07-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Trial to Determine the Effect of Simulation Based Training on Initial Performance of Ultrasound Guided Axillary Brachial Plexus Blockade in a Clinical Setting|Randomised Control Trial to Determine the Effect of Simulation Based Training on Initial Performance of Ultrasound Guided Axillary Brachial Plexus Blockade in a Clinical Setting|Terminated||N/A|10|Actual|Cork University Hospital||2||"1. The simulator lacked the fidelity required to meet training needs of the novices, 2.   Recruitment of novice anesthetists more difficult than anticipated"|f||||f||||||||||2017-10-11 01:11:37.047572|2017-10-11 01:11:37.047572
NCT01965301|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2015-01-20|||October 2014||2014-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375|Double-blind, Placebo Controlled, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375 After Single Oral Administrations Ranging From 0.5 mg to 100 mg in Healthy Male Subjects (Part 1) Followed by the Assessment of the Effect of 3 Single Different BP1.5375 Oral Doses on Polysomnography in Comparison to 50 mg Diphenhydramine and Placebo in Healthy Male Subjects (Part 2).|Terminated||Phase 1|48|Actual|Bioprojet||3|||f||||t||||||||||2017-10-11 01:11:37.145445|2017-10-11 01:11:37.145445
NCT01965288|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2014-11-06|2014-10-10||September 2013||2013-09-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional||The subject sample consisted of sixty (60) habitual toric contact lens wearers.|Clinical Performance of Biofinity Toric Versus Air Optix for Astigmatism|A Single-Center Study Comparing the Clinical Performance of Biofinity Toric Versus Air Optix for Astigmatism Over 1 Month of Daily Wear.|Completed||Phase 4|60|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 01:11:37.546907|2017-10-11 01:11:37.546907
NCT01965275|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-03|||October 2013||2013-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs|An Open,Multi Center Trial to Evaluate the Efficacy and Safety of High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced Non-Small Cell Lung Cancer Patients After Failure of Standard Dose EGFR-TKIs|Recruiting||Phase 2|20|Anticipated|Anhui Medical University||1|||f||||t||||||||Undecided||2017-10-11 01:11:42.749025|2017-10-11 01:11:42.749025
NCT01965262|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-02-07|2016-02-24||April 2014||2014-04-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|||A Clinical Assessment of the Hemacopolymer Daily Disposable Limbal Ring Soft Contact Lens|A Clinical Assessment of the Hemacopolymer Daily Disposable Limbal Ring Soft Contact Lens|Completed||N/A|30|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 01:11:42.92421|2017-10-11 01:11:42.92421
NCT01965249|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-01-25|||February 2014|Actual|2014-02-01|January 2017|2017-01-01|December 2024|Anticipated|2024-12-01|July 2019|Anticipated|2019-07-01||Interventional|ESTOIH||Effect of Stitch Technique on the Occurrence of Incisional Hernia After Abdominal Wall Closure|Short Stitch Versus Long Stitch Suture Technique Using Monomax® for Abdominal Wall Closure After Primary Median Laparotomy. A Randomized, Controlled, Double-blinded, Multicenter, International Trial|Recruiting||Phase 4|468|Anticipated|Aesculap AG||2|||f||||f||||||||||2017-10-11 01:11:44.137824|2017-10-11 01:11:44.137824
NCT01965236|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-05-31|||May 2013||2013-05-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Influence of Sodium Intake on Left Ventricular-arterial Coupling|Influence of Sodium Intake on Left Ventricular-arterial Coupling in Hypertension: Biomechanical Assessment and Modelisation of Left Ventricular Function With Arterial Pressure|Terminated||N/A|12|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 01:11:44.296578|2017-10-11 01:11:44.296578
NCT01965223|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2017-07-10|||December 2014||2014-12-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|February 2019|Anticipated|2019-02-01||Interventional|SAFRON II||A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II)|Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomised Phase II Trial|Recruiting||Phase 2|84|Anticipated|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-10-11 01:11:44.38631|2017-10-11 01:11:44.38631
NCT01965210|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-10-21|||March 2013||2013-03-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of Dietary Fibre and Plant Protein on Appetite and Metabolic Function|The Combined Effect of Dietary Fibre and Plant Protein on Appetite and Metabolic Function After Short-Term Consumption|Completed||N/A|22|Actual|Swedish University of Agricultural Sciences||6|||f||||f||||||||||2017-10-11 01:11:44.555255|2017-10-11 01:11:44.555255
NCT01965184|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2014-07-07|||October 2013||2013-10-01|July 2014|2014-07-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|RDoC-CBT||Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents|Using CBT to Examine Circuitry of Frustrative Non-reward in Aggressive Children|Unknown status|Recruiting|N/A|80|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 01:11:44.700148|2017-10-11 01:11:44.700148
NCT01965171|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-05-15|||October 18, 2013|Actual|2013-10-18|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Transfusional Iron Overload Among Leukemia Survivors|Transfusional Iron Overload Among Leukemia Survivors|Completed||N/A|24|Actual|St. Jude Children's Research Hospital|||1||f||||f|f|f||||||||2017-10-11 01:11:44.865656|2017-10-11 01:11:44.865656
NCT01965158|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-04-19|2017-04-19||August 29, 2013|Actual|2013-08-29|April 2016|2016-04-01|January 22, 2015|Actual|2015-01-22|January 22, 2015|Actual|2015-01-22||Interventional||The intent-to-treat population included all randomized participants; one participant was excluded from each arm due to enrollment at 2 different sites simultaneously.|Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy|Completed||Phase 3|547|Actual|Shionogi Inc.||2|||f||||t||||||||||2017-10-11 01:11:44.97221|2017-10-11 01:11:44.97221
NCT01965145|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-10-05|||November 2012||2012-11-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|EYEGUARD™-B||Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)|A Randomized, Double-masked, Placebo-controlled Study of the Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis|Terminated||Phase 3|84|Actual|Servier||2|||f||||t||||||||||2017-10-11 01:11:45.830713|2017-10-11 01:11:45.830713
NCT01965106|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-04-06||2017-04-06|December 2013||2013-12-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)|Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)|Completed||Phase 2|46|Actual|Quark Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:11:46.297547|2017-10-11 01:11:46.297547
NCT01965093|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-10-15|||November 2012||2012-11-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01|1 Year|Observational [Patient Registry]|||Growth and Intelligence Outcome in Children Who Developed Perioperative Desaturation|Possible Effect of Peri-operative Desaturation on Growth and Intelligence Outcome in Children Undergone General Anesthesia at a Tertiary Care Hospital in Southern Thailand|Completed||N/A|104|Actual|Prince of Songkla University|||2||f||||t||||||||||2017-10-11 01:11:46.41021|2017-10-11 01:11:46.41021
NCT01965080|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2013-10-15|||March 2004||2004-03-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Exemestane in Advanced and Recurrent Endometrial Carcinoma|Phase 2 Study of Exemestane in Advanced and Recurrent Endometrial Carcinoma|Completed||Phase 2|52|Actual|Nordic Society for Gynaecologic Oncology||1|||f||||f||||||||||2017-10-11 01:11:46.495762|2017-10-11 01:11:46.495762
NCT01965067|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2014-07-25|2014-06-16||October 2013||2013-10-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Influence of Mild Hypothermia on Reversal of Rocuronium With Sugammadex|A Randomized, Parallel-group, Safety-assessor-blinded Phase IV Study to Estimate the Influence of Mild Hypothermia on Reversal of Rocuronium-induced Neuromuscular Block With Sugammadex|Completed||Phase 4|60|Actual|MSD Korea Ltd.||2|||f||||t||||||||||2017-10-11 01:11:46.599462|2017-10-11 01:11:46.599462
NCT01965054|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-10-15|||December 2012||2012-12-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of Pregnancy|The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of Pregnancy|Withdrawn||N/A|0|Actual|Icahn School of Medicine at Mount Sinai||2||Logistics unresolved at the IRB at Elmhurst Hospital|f||||f||||||||||2017-10-11 01:11:47.043953|2017-10-11 01:11:47.043953
NCT01965041|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2014-12-30|||October 2013||2013-10-01|December 2014|2014-12-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|AVA||Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy|Use Of Intravitreal Aflibercept Injections In The Treatment Of Adult-Onset Vitelliform Detachments Associated With Pattern Dystrophy|Withdrawn||N/A|0|Actual|Manhattan Eye, Ear & Throat Hospital||1||No patients enrolled.|f||||t||||||||||2017-10-11 01:11:47.134432|2017-10-11 01:11:47.134432
NCT01965028|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-03-04|||October 2013||2013-10-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|tRNS-tin||Daily Bi-temporal Transcranial Random Noise Stimulation in Tinnitus|Effectiveness of Daily Bi-temporal Transcranial Random Noise Stimulation in Patients With Chronic Tinnitus|Completed||N/A|30|Actual|University of Regensburg||1|||f||||||||||||||2017-10-11 01:11:47.229676|2017-10-11 01:11:47.229676
NCT01965015|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-12|2016-11-01|||March 2014||2014-03-01|November 2016|2016-11-01|April 2021|Anticipated|2021-04-01|April 2016|Actual|2016-04-01||Interventional|VW-SP-1||The V-Wave Shunt: FIM Safety and Feasibility Study|The V-Wave Shunt For 'Left Atrial Decompression' In Patients With Advanced Chronic Heart Failure: FIM Safety and Feasibility Study|Active, not recruiting||Phase 1|16|Actual|V-Wave Ltd||1|||f||||f||||||||||2017-10-11 01:11:47.339538|2017-10-11 01:11:47.339538
NCT01965002|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-07-08|||May 2014||2014-05-01|July 2017|2017-07-01|March 24, 2015|Actual|2015-03-24|March 24, 2015|Actual|2015-03-24||Interventional|||Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors|A Feasibility Study to Evaluate the Safety and Effectiveness of ExAblate Magnetic Resonance Imaging Guided High Intensity Focused Ultrasound Treatment of Soft Tissue Tumors of the Extremities|Terminated||N/A|5|Actual|Stanford University||1||Accrual factor|f||||f||||||||||2017-10-11 01:11:47.451835|2017-10-11 01:11:47.451835
NCT01964989|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-10-14||2016-10-14|November 2013||2013-11-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|October 2015|Actual|2015-10-01||Interventional|||Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.|A Phase III, Stratified, Randomized, Observer Blind, Controlled, Multicenter Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to < 72 Months of Age.|Completed||Phase 3|10647|Actual|Seqirus||2|||f||||t||||||||||2017-10-11 01:11:47.589262|2017-10-11 01:11:47.589262
NCT01964976|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-02-27|2016-08-31||July 2011||2011-07-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational||The safety analysis set was defined as all participants who completed the study and had safety data available.|Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides|Nesina Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides|Completed||N/A|1096|Actual|Takeda|||1||f||||f||||||||||2017-10-11 01:11:48.121425|2017-10-11 01:11:48.121425
NCT01964963|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-07-30|||August 3, 2011|Actual|2011-08-03|July 2017|2017-07-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Observational|||Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus|Nesina Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus|Completed||N/A|19192|Actual|Takeda|||1||f||||f||||||||||2017-10-11 01:11:49.968213|2017-10-11 01:11:49.968213
NCT01964950|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-02-27|2016-08-23||July 2011||2011-07-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational||The safety analysis set was defined as all participants who completed the study and had safety data available.|Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea|Nesina Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea|Completed||N/A|1101|Actual|Takeda|||1||f||||f||||||||||2017-10-11 01:11:50.11815|2017-10-11 01:11:50.11815
NCT01964937|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-11-19||||||November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults|A Phase 1b Clinical Trial to Evaluate the Safety and Immunogenicity of Different Combinations of DNAHIV-PT123, NYVAC-HIV-PT1 and NYVAC-HIV-PT4, and AIDSVAX® B/E in Healthy, HIV Uninfected Adult Participants|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-10-11 01:11:52.162732|2017-10-11 01:11:52.162732
NCT01964924|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-09-15|||October 2, 2013|Actual|2013-10-02|September 2017|2017-09-01||||June 1, 2017|Actual|2017-06-01||Interventional|||Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer|A Single Arm, Phase II Study of Single Agent Trametinib Followed by Trametinib in Combination With GSK2141795 in Patients With Advanced Triple Negative Breast Cancer|Active, not recruiting||Phase 2|41|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:11:52.338117|2017-10-11 01:11:52.338117
NCT01964911|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-05-03|||February 2014||2014-02-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|ANGIOCATH||To Assess Analgesia Provided by Continuous Sciatic Nerve Block in Patients With Hypertensive Leg Ulcer|Monocentric Prospective Study, in Order to Assess Analgesia Provided by Continuous Sciatic Nerve Block, in Patients With Hypertensive Leg Ulcer.|Recruiting||Phase 4|30|Anticipated|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 01:11:52.530306|2017-10-11 01:11:52.530306
NCT01964898|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-01-10|2016-10-05||October 2013||2013-10-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PACES||Post Acute Coronary Event Smoking Study|Integrated Smoking Cessation and Mood Management for Cardiac Patients|Completed||N/A|65|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 01:11:52.666033|2017-10-11 01:11:52.666033
NCT01964885|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-02-10|||October 2013||2013-10-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections|Clinical Trial to Explore Benefit and Tolerability of IQP-AS-105 (Xaludicin®) in Subjects With Increased Susceptibility to Upper Respiratory Tract Infections|Terminated||Phase 3|140|Actual|InQpharm Group||2||No significant results during interim analysis|f||||f||||||||||2017-10-11 01:11:53.189077|2017-10-11 01:11:53.189077
NCT01964872|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2014-09-11|||November 2013||2013-11-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants|A Double Blind, Placebo-Controlled, Randomized, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Subjects|Completed||Phase 1|84|Actual|Janssen Cilag N.V./S.A.||2|||f||||f||||||||||2017-10-11 01:11:53.306416|2017-10-11 01:11:53.306416
NCT01964859|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-08-28|||December 2014||2014-12-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Feasibility Study for Fibroblast Autologous Skin Grafts|Feasibility Study for Fibroblast Autologous Skin Grafts: Biopsy of Skin Fibroblasts, Expansion in Cell Therapy Core, Topical Injection of Fibroblasts, and Subsequent Removal of Graft for Laboratory Studies.|Recruiting||Phase 1|20|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:11:53.438236|2017-10-11 01:11:53.438236
NCT01964846|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-09-21|||October 2013||2013-10-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Antioxidant Intake on Cardiovascular Risk|The Effect of Resveratrol and Curcumin on Postprandial Inflammation in Men and Postmenopausal Women|Completed||N/A|22|Actual|Laval University||2|||f||||f||||||||||2017-10-11 01:11:53.556462|2017-10-11 01:11:53.556462
NCT01964833|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-08-07|||October 2013||2013-10-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PDTDMT2||PDT and Periodontal Treatment in DMT2 Patients|Combination of Photodynamic Therapy and Periodontal Treatment in Patients With Type 2 Diabetes Mellitus: Randomized, Double-blind Clinical Trial|Completed||N/A|44|Actual|University of Nove de Julho||2|||f||||f||||||||||2017-10-11 01:11:53.657645|2017-10-11 01:11:53.657645
NCT01964820|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-05-22|||July 2014||2014-07-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|MARIGOLD||Online Positive Emotion Skills Intervention for Symptoms of Depression|Online Positive Emotion Skills Intervention for Symptoms of Depression - Pilot Feasibility Trial|Active, not recruiting||N/A|200|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:11:53.76707|2017-10-11 01:11:53.76707
NCT01964807|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2015-05-29|||November 2013||2013-11-01|May 2015|2015-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Cardiovascular Assessment of the Effects of Tobacco and Nicotine Delivery Products|Cardiovascular Assessment of the Effects of Tobacco and Nicotine Delivery Products|Recruiting||N/A|90|Anticipated|University of California, San Francisco||4|||f||||f||||||||||2017-10-11 01:11:53.910715|2017-10-11 01:11:53.910715
NCT01964794|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-10-06|||May 2012||2012-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling|Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling|Completed||N/A|60|Actual|University of Arkansas|||1||f||||||||||Samples With DNA|"     Blood specimens to identify coumadin genetic and metabolic biomarkers.   "|||2017-10-11 01:11:54.066103|2017-10-11 01:11:54.066103
NCT01964781|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-03-06|||August 2013|Actual|2013-08-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Topical Administration of Common Drugs on Postoperative Bleeding and Pain|The Effect of Topical Administration of Tranexamic Acid, Adrenaline and Bupivacain on Postoperative Bleeding and Pain in Patients Undergoing Breast Surgery. A Four-armed Placebo-controlled Double Blinded Randomized Study|Completed||Phase 4|30|Actual|St. Olavs Hospital||6|||f||||t|f|f||||||No||2017-10-11 01:11:54.295679|2017-10-11 01:11:54.295679
NCT01964768|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-14|||December 2010||2010-12-01|October 2013|2013-10-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Interventional|||Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing|Determination of Sensitivity and Specificity of Three Solutions of Allergen Extract (5 Grasses, Birch Pollens and Dermatophagoides Pteronyssinus Mites) for Diagnosis by Skin Prick Testing|Completed||Phase 3|324|Actual|Stallergenes Greer|||||f||||f||||||||||2017-10-11 01:11:54.431261|2017-10-11 01:11:54.431261
NCT01964755|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-09-20|||April 21, 2009|Actual|2009-04-21|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|March 8, 2017|Actual|2017-03-08||Interventional|||Phase II of Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma|Phase II Study of Chemotherapy (Doxorubicin, Methotrexate and Leucovorin) in Combination With Antiviral-Based Therapy (Zidovudine + Hydroxyurea) for AIDS, Immunocompromised, or Immunocompetent Patients With Relapsed or CNS Positive Epstein Barr Virus Associated Lymphoma|Active, not recruiting||Phase 2|6|Actual|University of Miami||1|||f||||t|t|f|||f|||||2017-10-11 01:11:54.533565|2017-10-11 01:11:54.533565
NCT01964742|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2015-08-06|||October 2013||2013-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients|Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients|Completed||N/A|68|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:11:54.772529|2017-10-11 01:11:54.772529
NCT01964729|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-10-17|||August 2013||2013-08-01|October 2013|2013-10-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Interventional|||rTMS Effects in the Neuromodulation and Pain Threshold of Chronic Myofascial Pain Patients|Effect of Transcranial Magnetic Stimulation in the Cortical, Subcortical Neuromodulation and in Pain Threshold of Chronic Myofascial Pain Patients|Unknown status|Recruiting|Phase 2|24|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 01:11:54.889698|2017-10-11 01:11:54.889698
NCT01964716|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-02-27|2015-02-27||January 2014||2014-01-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Safety population included all participants who received at least 1 dose of investigational product.|13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.|A Phase 3, Randomized, Open-label Trial To Evaluate The Safety, Tolerability And Immunogenicity Of 13-valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials Given With Routine Pediatric Vaccinations In Healthy Infants|Completed||Phase 3|500|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 01:11:55.152787|2017-10-11 01:11:55.152787
NCT01964703|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2013-10-14|||April 2013||2013-04-01|October 2013|2013-10-01||||October 2013|Actual|2013-10-01||Interventional|||Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes|Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes; A Proof-of-concept, Randomized, Double-blind, Parallel-group Placebo-controlled Study|Completed||Phase 4|29|Actual|Korea University Anam Hospital||3|||f||||t||||||||||2017-10-11 01:11:58.043958|2017-10-11 01:11:58.043958
NCT01964690|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2014-04-26|||December 2013||2013-12-01|January 2014|2014-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Lactate Use as Triage Tool in Sepsis : Veinous, Capillary or Arterial?|Lactate and Sepsis : What Dosage Use as Triage Tool in Emergency Department for Patients With Suspected Infection.|Completed||N/A|103|Actual|Hopital Saint Roch|||1||f||||t||||||||||2017-10-11 01:11:58.113678|2017-10-11 01:11:58.113678
NCT01964677|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-08-18|||January 2014||2014-01-01|August 2017|2017-08-01|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Interventional|||MR-HIFU for Bone Metastases|Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases - a Multicenter Study|Completed||N/A|12|Actual|Institute of Cancer Research, United Kingdom||1|||f||||t||||||||||2017-10-11 01:11:58.195427|2017-10-11 01:11:58.195427
NCT01964664|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-04-11|||January 2013||2013-01-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|MSPi||Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments|Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments|Completed||N/A|8|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:11:58.349526|2017-10-11 01:11:58.349526
NCT01964651|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2014-12-02|||October 2013||2013-10-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42165279 in Healthy Young and Elderly Participants|A Double-Blind, Placebo-Controlled, Randomized, Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42165279 in Healthy Young and Elderly Subjects|Completed||Phase 1|40|Actual|Janssen Research & Development, LLC||4|||f||||||||||||||2017-10-11 01:11:58.496803|2017-10-11 01:11:58.496803
NCT01964638|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-14|||June 2012||2012-06-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.|Comparative Analysis of Software-based MRI-Ultrasound Image Fusion Against Cognitive Targeting of Multi-Parametric MRI Findings With Prostate Biopsy|Completed||N/A|126|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 01:11:58.635232|2017-10-11 01:11:58.635232
NCT01964625|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-01|2013-10-14|||November 2010||2010-11-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD)|Assessment of Positron Emission Tomography - Computed Tomography (PET-CT) Scanning as a Potential Biomarker to Assess Disease Activity in Chronic Graft Versus Host Disease (GvHD): A Pilot Study|Terminated||N/A|1|Actual|University of Rochester||1||Terminated due to lack of enrollment|f||||t||||||||||2017-10-11 01:11:58.763225|2017-10-11 01:11:58.763225
NCT01964612|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-14|||July 2012||2012-07-01|October 2013|2013-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Illness Crisis Adapting in Early or Middle Phase of Patient With Chronic Disease: Study of Meta-cognition Model|Illness Crisis Adapting in Early or Middle Phase of Patient With Chronic Disease: Study of Meta-cognition Model|Unknown status|Recruiting|N/A|460|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 01:11:58.913236|2017-10-11 01:11:58.913236
NCT01964599|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-01-25|||January 2014||2014-01-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Potato Fiber and Gastrointestinal Function: Phase 3|Potato Fiber and Gastrointestinal Function: Phase 3 (Grant #94521)|Completed||N/A|90|Actual|University of Florida||3|||f||||f||||||||||2017-10-11 01:11:59.062391|2017-10-11 01:11:59.062391
NCT01964586|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-10-15|||March 2013||2013-03-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Preincisional Infiltrated Dexmedetomidine and Lidocaine Plus Adrenaline for Nasal Sephoplasty Surgery.|Phase 4 Study of Comparison of Preincisional Infiltrated Dexmedetomidine and Lidocaine Plus Adrenaline for Surgical Conditions and Postoperative Analgesic Consumption in Nasal Sephoplasty Surgery.|Completed||Phase 4|60|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 01:11:59.235183|2017-10-11 01:11:59.235183
NCT01964573|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2014-10-17|||December 2006||2006-12-01|October 2013|2013-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects|A Single-site, Randomized, Double-blind, Placebo-controlled, Repeated-dose Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in 2 Different Dosages (2 mg / 24 Hours [10 cm2], 4 mg / 24 Hours [20 cm2]) in Healthy Korean Subjects|Completed||Phase 1|48|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 01:11:59.340005|2017-10-11 01:11:59.340005
NCT01964560|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-09-27|||March 2014||2014-03-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|March 2021|Anticipated|2021-03-01||Interventional|||Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children With Partial Onset Seizures|A Multicenter, Open-label, Long-term Extension Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Pediatric Subjects With Epilepsy With Partial-Onset Seizures|Enrolling by invitation||Phase 3|500|Anticipated|UCB Pharma||1|||f||||f||||||||||2017-10-11 01:11:59.572543|2017-10-11 01:11:59.572543
NCT01964547|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2014-04-02|2013-10-29||January 2012||2012-01-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients|A Multicentre, Double-blind, Randomised, Parallel Group, Placebo-controlled Study of the Effect of Long-term Treatment With Sativex on Cognitive Function and Mood of Patients With Spasticity Due to Multiple Sclerosis|Completed||Phase 4|121|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-10-11 01:12:00.613183|2017-10-11 01:12:00.613183
NCT01964534|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-01-30|||December 12, 2013|Actual|2013-12-12|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|AFUGEM||Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer|Randomized Phase II Study of Weekly ABI-007 Plus Gemcitabine or Simplified LV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer|Active, not recruiting||Phase 2|114|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2|||f||||f||||||||||2017-10-11 01:12:01.627783|2017-10-11 01:12:01.627783
NCT01964508|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2013-10-14|||September 2013||2013-09-01|October 2013|2013-10-01||||December 2015|Anticipated|2015-12-01|1 Year|Observational [Patient Registry]|||microRNA in Thyroid Cancer|The Use of a microRNA Panel to Identify Thyroid Malignancy in FNA Leftover Cells and the Effect of These microRNAs on Target Genes.|Unknown status|Recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"     FNA samples, CDNA, RNA   "|||2017-10-11 01:12:02.26368|2017-10-11 01:12:02.26368
NCT01964495|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-01-23|||December 5, 2013|Actual|2013-12-05|January 2017|2017-01-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|REDUCE||Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)|Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)|Completed||N/A|468|Actual|Medical Center Alkmaar||3|||f||||t||||||||||2017-10-11 01:12:02.403443|2017-10-11 01:12:02.403443
NCT01964482|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-11-23|||October 2013||2013-10-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||In-hospital and Post-discharge Training of Older Medical Patients|In-hospital and Post-discharge Training of Older Medical Patients|Active, not recruiting||N/A|54|Anticipated|Copenhagen University Hospital, Hvidovre||2|||f||||t||||||||||2017-10-11 01:12:02.516739|2017-10-11 01:12:02.516739
NCT01964469|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-01-15|||February 2013||2013-02-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|June 2014|Actual|2014-06-01||Interventional|ASMA||Consumer Access to Personal Health Information for Asthma Self-Management|Consumer Access to Personal Health Information for Asthma Self-Management Phase 2 (Pilot Implementation)|Unknown status|Active, not recruiting|N/A|400|Anticipated|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-11 01:12:02.611804|2017-10-11 01:12:02.611804
NCT01964456|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-02-27|||November 2013||2013-11-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|Narcisse||"Self-consciousness and the Inter-subjective Body"|"Narcisse & Echo : Self-consciousness and the Inter-subjective Body"|Completed||N/A|39|Actual|Centre Hospitalier St Anne||2|||f||||t||||||||||2017-10-11 01:12:02.743828|2017-10-11 01:12:02.743828
NCT01964443|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-12-14|||September 2013||2013-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|EPIDEPSO||Clinical Assessment and Psychosocial Impact of Psoriasis|EPidemiological Study In Patients With Recently DiagnosEd PSOriasis: Clinical Assessment and Psychosocial Impact of This Disease|Completed||Phase 4|719|Actual|Janssen Pharmaceutica N.V., Belgium|||1||f||||f||||||||||2017-10-11 01:12:02.888506|2017-10-11 01:12:02.888506
NCT01964430|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-08-31|||March 1, 2014|Actual|2014-03-01|August 2017|2017-08-01|October 1, 2020|Anticipated|2020-10-01|April 1, 2019|Anticipated|2019-04-01||Interventional|apact||"Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the Apact Study)"|A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma|Active, not recruiting||Phase 3|866|Actual|Celgene||2|||f||||t||||||||||2017-10-11 01:12:03.228041|2017-10-11 01:12:03.228041
NCT01964417|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-01-09|||September 2013||2013-09-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CSBPM||The Comparative Study Between Bowel Preparation Method|The Comparative Study Between Bowel Preparation Method: 4L-split Dose of PEG Solution, Low-volume PEG Plus Ascorbic Acid Focusing on the Bowel Cleansing Efficacy, Patients' Affinity to Preparation Solution and Mucosal Injury|Completed||Phase 3|319|Actual|Inje University||2|||f||||f||||||||||2017-10-11 01:12:03.819946|2017-10-11 01:12:03.819946
NCT01964404|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-04-18|||July 2014||2014-07-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|March 2020|Anticipated|2020-03-01||Interventional|||Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?|Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?|Recruiting||Phase 1|240|Anticipated|Dartmouth-Hitchcock Medical Center||3|||f||||t||||||||||2017-10-11 01:12:03.966958|2017-10-11 01:12:03.966958
NCT01964391|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-23|||February 21, 2014|Actual|2014-02-21|August 2017|2017-08-01|December 5, 2018|Anticipated|2018-12-05|December 5, 2018|Anticipated|2018-12-05||Interventional|||A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer|An Open-Label, Multinational, Multicenter, Phase IIIb Study With Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction|Active, not recruiting||Phase 3|174|Actual|Hoffmann-La Roche||1|||f||||f||||||||||2017-10-11 01:12:04.137499|2017-10-11 01:12:04.137499
NCT01964378|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-11-05|||November 2013||2013-11-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CORAL||CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer|Efficacy, Safety, and Tolerability of Oral Cebranopadol Versus Morphine Sulfate PR in Subjects With Chronic Moderate to Severe Pain Related to Cancer.|Terminated||Phase 3|200|Actual|Grünenthal GmbH||2||low accrual that made the study no longer feasible/ decision not related to safety and efficacy|f||||t||||||||||2017-10-11 01:12:04.320418|2017-10-11 01:12:04.320418
NCT01964365|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2014-02-12|||September 2013||2013-09-01|October 2013|2013-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers|An Open-label, Randomized, 6-Sequence, 3-Period Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Rosuvastatin and Fenofibric Acid in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Daewoong Pharmaceutical Co. LTD.||3|||f||||f||||||||||2017-10-11 01:12:04.549785|2017-10-11 01:12:04.549785
NCT01964352|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2015-10-23|2015-10-23||November 2013||2013-11-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)|A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|813|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 01:12:04.69557|2017-10-11 01:12:04.69557
NCT01964339|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2013-10-14|||October 2013||2013-10-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|||Obesity Hypoventilation Syndrome Prevalence Study|Obesity Hypoventilation Syndrome Prevalence Study|Unknown status|Recruiting|N/A|200|Anticipated|Philips Respironics|||2||f||||f||||||||||2017-10-11 01:12:05.859299|2017-10-11 01:12:05.859299
NCT01964326|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-04-18|2015-12-18||October 2013||2013-10-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Users/Safety set included all participants reported taking at least 1 dose of study medication or had at least 1 dosing record available or responded 'yes' to the question 'have you started taking Lipitor OTC' in any phone interview, or contacted the study site in any other manner and indicated the use of study product.|Actual Use Trial of Atorvastatin Calcium 10 mg|A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg|Completed||Phase 3|1311|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:12:06.156781|2017-10-11 01:12:06.156781
NCT01964313|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-06-20|||July 2012||2012-07-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Acute Coronary Syndrome Genetic Study|Comprehensive Intervention and Outcome Research Programs for Acute Coronary Syndrome|Recruiting||N/A|3422|Anticipated|Peking University First Hospital|||1||f||||f||||||Samples With DNA|"     4ml of vein blood are to be retained for genetic analysis.   "|||2017-10-11 01:12:07.173742|2017-10-11 01:12:07.173742
NCT01964300|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2017-07-10|||September 2013||2013-09-01|July 2017|2017-07-01||||January 2019|Anticipated|2019-01-01||Interventional|||Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery|Phase II Study of Peginterferon Alfa-2b (Sylatron) for Pediatric Patients With Unresectable or Recurrent Craniopharyngioma|Recruiting||Phase 2|52|Anticipated|Pediatric Brain Tumor Consortium||1|||f||||t||||||||||2017-10-11 01:12:07.268838|2017-10-11 01:12:07.268838
NCT01964287|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-08-16|||August 2013||2013-08-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|GABRINOX||First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.|Phase I-II Trial of Gemcitabine Plus Nab-paclitaxel (GemBrax) Followed by Folfirinox as First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.|Recruiting||Phase 1/Phase 2|60|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-11 01:12:07.448536|2017-10-11 01:12:07.448536
NCT01964274|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-08-09|||October 2013||2013-10-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|July 2016|Actual|2016-07-01||Observational|CESARO||Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients|Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients|Active, not recruiting||N/A|815|Actual|Charite University, Berlin, Germany|||1||f||||||||||||||2017-10-11 01:12:07.583791|2017-10-11 01:12:07.583791
NCT01964261|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2017-04-14|||November 2013||2013-11-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|||Providing Closed Loop Cortical Control of Extracorporeal Devices to Patients With Quadriplegia|A Feasibility Study of the Ability of the Neural Prosthetic System 2 to Provide Direct Closed Loop Cortical Control of Extracorporeal Devices Through the Use of Intracortical Microstimulation in Patients With Quadriplegia|Recruiting||N/A|2|Anticipated|California Institute of Technology||1|||f||||t||||||||||2017-10-11 01:12:07.72572|2017-10-11 01:12:07.72572
NCT01964248|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-10-15|||December 2012||2012-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|GAEL||Local Anesthesia Before Arterial Puncture for Blood Gas Analysis|Evaluation of Local Anesthesia Before Arterial Puncture for Blood Gas Analysis Randomized, Control Placebo Study|Completed||Phase 3|136|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 01:12:07.873766|2017-10-11 01:12:07.873766
NCT01964235|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2016-08-30|||December 2016||2016-12-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma|A Randomized Phase II, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of INC280 in Adult Patients With Advanced Hepatocellular Carcinoma After Progression or Intolerance to Sorafenib Treatment|Withdrawn||Phase 2|0|Actual|Novartis||2||Study was cancelled by Sponsor.|f||||t||||||||||2017-10-11 01:12:07.974229|2017-10-11 01:12:07.974229
NCT01964222|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-11-02|2015-09-25||May 2014||2014-05-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation|A Mixed Methods Study to Reduce Disparities in Cancer Clinical Trials by Adapting a Health Literacy Intervention for Informed Consent and Comparing it to Usual Care in a Randomized Experiment|Completed||N/A|201|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:12:08.122702|2017-10-11 01:12:08.122702
NCT01964209|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-02-02|||May 2014||2014-05-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Initial Validation of the Vanderbilt ADHD Measure for Adolescent Patients in the ICISS Project|Initial Validation of the Vanderbilt Attention Deficit Hyperactive Disoder (ADHD) Measure for Adolescent Patients in the Integrated Clinical Information Sharing System (ICISS) Project|Recruiting||N/A|400|Anticipated|Boston Children’s Hospital|||1||f||||t||||||||Undecided||2017-10-11 01:12:08.720732|2017-10-11 01:12:08.720732
NCT01964196|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-01-04|||August 2013||2013-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-|ASP1517 Phase 2 Clinical Trial -A Multi-center, Randomized, Parallel Groups, Placebo-controlled, Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-|Completed||Phase 2|107|Actual|Astellas Pharma Inc||4|||f||||f||||||||Undecided||2017-10-11 01:12:08.846498|2017-10-11 01:12:08.846498
NCT01964183|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2013-10-15|||June 2013||2013-06-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine|Post-Marketing Study of Mirabegron - A Pharmacokinetic Study to Assess Drug-Drug Interaction Between Mirabegron and Tolterodine -|Completed||Phase 4|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:12:08.961674|2017-10-11 01:12:08.961674
NCT01964170|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-15|2016-09-07|||August 2013||2013-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer|ASP3550 Phase III Study - An Open-Label, Active-Controlled, Parallel-Arm Study, Comparing ASP3550 With Goserelin Acetate in Patients With Prostate Cancer -|Completed||Phase 3|234|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:12:09.082777|2017-10-11 01:12:09.082777
NCT01964157|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-03-23|||September 1, 2013|Actual|2013-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement||Recruiting||Phase 2|32|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 01:12:09.232602|2017-10-11 01:12:09.232602
NCT01964144|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2014-11-26|||January 2013||2013-01-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer||Completed||Phase 2|40|Actual|Yonsei University||1|||f||||t||||||||||2017-10-11 01:12:09.348649|2017-10-11 01:12:09.348649
NCT01964131|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-14|2013-12-30|||October 2013||2013-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects|An Open Label, Randomised, Single Center, 2 Way Crossover Study to Assess Bioequivalence Between a Commercial HPMC Capsule of D961H 20 mg and a Pellets Based Sachet Formulation of D961H 20 mg by Pharmacodynamics (Intragastric pH) After Once-daily Repeated Oral Administration in Japanese Healthy Male Subjects|Completed||Phase 1|34|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:12:09.436633|2017-10-11 01:12:09.436633
NCT01964118|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-08-10|||July 2013||2013-07-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|IF||Can Intermittent Fasting Mimic the Metabolic and Cardiovascular and Anti-aging Effects of Calorie Restriction?|Can Intermittent Fasting Mimic the Metabolic and Cardiovascular and Anti-aging Effects of Calorie Restriction?|Completed||N/A|50|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 01:12:09.558656|2017-10-11 01:12:09.558656
NCT01964092|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-05-12|||May 2013||2013-05-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect Evaluation of Individual Placement and Support (IPS)|Effect Evaluation of Individual Placement and Support (IPS)|Active, not recruiting||N/A|800|Anticipated|Uni Research||2|||f||||t||||||||||2017-10-11 01:12:09.767423|2017-10-11 01:12:09.767423
NCT01964079|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-11|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|||Comparision of Blood Pressure Variability Between Amlodipine and Losartan|The COMPAriSon of Systolic Blood Pressure Variability and Central Blood Pressure of Calcium Channel Blocker (Amlodipine) in Comparison With Angiotensin Receptor Blocker (Losartan) in Patients With Essential Hypertension|Completed||Phase 4|144|Actual|Wonju Severance Christian Hospital||2|||f||||t||||||||||2017-10-11 01:12:10.067987|2017-10-11 01:12:10.067987
NCT01964066|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-10-13|||January 2008||2008-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional|||Study of Effectiveness of Thoracic Epidural Analgesia for the Prevention of Acute Pancreatitis After ERCP Procedures|Effectiveness of Thoracic Epidural Analgesia for the Prevention of Post-ERCP Pancreatitis|Completed||Phase 1|491|Actual|Volgograd State Medical University||2|||f||||t||||||||||2017-10-11 01:12:10.217318|2017-10-11 01:12:10.217318
NCT01964053|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-05-21|||October 2013||2013-10-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PATCH||Self-management Adherence in Heart Failure Patients|Promoting Self-management Through Adherence Among Heart Failure Patients|Completed||Phase 2/Phase 3|98|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-10-11 01:12:10.305927|2017-10-11 01:12:10.305927
NCT01964040|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2013-10-14|||August 2013||2013-08-01|October 2013|2013-10-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Perineural Dexmedetomidine and Femoral Nerve Block|Perineural Dexmedetomidine as an Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block.|Unknown status|Active, not recruiting|Phase 4|45|Anticipated|Cairo University||3|||f||||t||||||||||2017-10-11 01:12:10.421439|2017-10-11 01:12:10.421439
NCT01964027|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2013-10-14|||October 2013||2013-10-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|SIEG||The Study of Irinotecan Plus Epirubicin as the Second-line Chemoregime for Advanced Gastric Cancer|The Study of Irinotecan Plus Epirubicin as the Second-line Chemoregime for Advanced Gastric Cancer|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Anhui Medical University||1|||f||||t||||||||||2017-10-11 01:12:10.547557|2017-10-11 01:12:10.547557
NCT01964014|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2016-07-19|||October 2013||2013-10-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CISECON||Once-a-day Immunosuppression(CISECON_a_day)|Clinical Investigation for Safety and Efficacy, Patient Reported Outcomes of the Conversion to ONce-a-day Immunosuppression After Kidney Transplantation|Completed||Phase 4|160|Actual|Ajou University School of Medicine||1|||f||||t||||||||||2017-10-11 01:12:10.712884|2017-10-11 01:12:10.712884
NCT01964001|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-06-14|||January 2014||2014-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer||Completed||Phase 2/Phase 3|71|Actual|Taichung Veterans General Hospital||2|||f||||f||||||||||2017-10-11 01:12:10.847921|2017-10-11 01:12:10.847921
NCT01963988|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-12-14|||June 2012||2012-06-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients|Pilot Study for Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients|Active, not recruiting||N/A|118|Anticipated|Samsung Medical Center|||2||f||||f||||||||||2017-10-11 01:12:10.977358|2017-10-11 01:12:10.977358
NCT01963962|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-08-04|||July 2013||2013-07-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|COLIEC||Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception|A Prospective Trial of the Copper T380 IUD or Oral Levonorgestrel and the Levonorgestrel IUD Initiated With Emergency Contraception|Completed||N/A|188|Actual|University of Utah|||2||f||||t||||||Samples Without DNA|"     Urine to test for progesterone and/or pregnandiol   "|||2017-10-11 01:12:11.078444|2017-10-11 01:12:11.078444
NCT01963949|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2014-05-15|||October 2013||2013-10-01|May 2014|2014-05-01||||November 2018|Anticipated|2018-11-01|5 Years|Observational [Patient Registry]|||Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events|Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events|Withdrawn||N/A|0|Actual|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples Without DNA|"     To collect tumor tissue from patients with liver masses suspicious for primary liver cancer.   "|||2017-10-11 01:12:11.189272|2017-10-11 01:12:11.189272
NCT01963936|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-10-15|||July 2012||2012-07-01|October 2013|2013-10-01||||December 2013|Anticipated|2013-12-01||Interventional|||Supreme-LMA for Neonatal Resuscitation: a Prospective, Randomized Single-center Study|NEWBORN VENTILATION IN THE DELIVERY ROOM: CAN IT BE IMPROVED WITH A LARYNGEAL MASK AIRWAY? A Prospective, Randomized Single-center Study|Unknown status|Recruiting|Phase 3|142|Anticipated|University of Padova||2|||f||||t||||||||||2017-10-11 01:12:11.280737|2017-10-11 01:12:11.280737
NCT01963923|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-12-19|||October 2013||2013-10-01|October 2013|2013-10-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Effectiveness of a Preoperative Pulmonary Rehabilitation Program in Patients Awaiting Lung Resection|Effectiveness of a Preoperative Pulmonary Rehabilitation Program in Exercise Tolerance and Quality of Life in Patients Awaiting Lung Resection by Video-assisted Thoracic Surgery|Unknown status|Recruiting|N/A|22|Anticipated|Universidade da Coruña||2|||f||||f||||||||||2017-10-11 01:12:11.370719|2017-10-11 01:12:11.370719
NCT01963910|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-02-28|||December 2013||2013-12-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|LipTRP||Double-blind Trial of Mannitol Cream to Block the Effect of Capsaicin Cream|Double-blind Trial of Mannitol Cream to Block the Effect of Capsaicin Cream|Completed||N/A|25|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:12:11.499042|2017-10-11 01:12:11.499042
NCT01963897|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-12|2017-09-22|||August 2013||2013-08-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01|3 Years|Observational [Patient Registry]|||Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.|Duchenne Muscular Dystrophy in Norway. Genotype/Phenotype in Patients Younger Than 18 Years, With a Main Focus on Growth, Puberty, Bone Health and Quality of Life.|Completed||N/A|73|Actual|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 01:12:11.583517|2017-10-11 01:12:11.583517
NCT01963884|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-12|2013-10-12|||January 2014||2014-01-01|October 2013|2013-10-01|August 2016|Anticipated|2016-08-01|January 2016|Anticipated|2016-01-01||Observational|||Relate Tooth Alveolar Extraction Socket Anatomy to Alveolar Remodeling Rate|Study of Tooth Alveolar Extraction Socket Anatomy and Its Relation to Alveolar Post-extraction Changes|Unknown status|Not yet recruiting|N/A|45|Anticipated|Instituto de Implantologia|||3||f||||f||||||||||2017-10-11 01:12:11.642651|2017-10-11 01:12:11.642651
NCT01963871|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2014-05-22|||August 2013||2013-08-01|May 2014|2014-05-01||||May 2014|Actual|2014-05-01||Interventional|||The Effect of Yoga in Chronic Low Back Pain|The Effect of Yoga in Chronic Low Back Pain|Completed||N/A|10|Anticipated|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 01:12:11.764644|2017-10-11 01:12:11.764644
NCT01963858|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-12|2016-09-20|||October 2013||2013-10-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Functional Relaxation on Patients Undergoing Colonoscopy|Effect of Functional Relaxation on Patients Undergoing Colonoscopy: A Prospective Randomized Controlled Trial|Completed||N/A|120|Actual|The Catholic University of Korea||2|||f||||t||||||||No||2017-10-11 01:12:11.835316|2017-10-11 01:12:11.835316
NCT01963845|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-10-06|2016-08-01||January 2014||2014-01-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease|Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease|Completed||Phase 2|50|Actual|University of California, San Diego||2|||f||||||||||||||2017-10-11 01:12:11.922642|2017-10-11 01:12:11.922642
NCT01963832|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2015-01-09|||November 2016||2016-11-01|December 2014|2014-12-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Interventional|||RCT of a Neuroplasticity Agent and CI Therapy for Severe Arm Paresis After Stroke|RCT of a Neuroplasticity Agent and CI Therapy for Severe Arm Paresis After Stroke|Withdrawn||Phase 2|0|Actual|University of Alabama at Birmingham||4||not funded|f||||t||||||||||2017-10-11 01:12:14.094135|2017-10-11 01:12:14.094135
NCT01963819|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-01-29|||January 2014||2014-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Therapeutic Endometrial Biopsy||Recruiting||N/A|250|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 01:12:14.197225|2017-10-11 01:12:14.197225
NCT01963806|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-11-16|||September 2013||2013-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder|Guided and Unguided CBT for Social Anxiety Disorder and/or Panic Disorder Via the Internet and a Smartphone Application|Completed||N/A|150|Anticipated|Stockholm University||3|||f||||f||||||||||2017-10-11 01:12:14.307235|2017-10-11 01:12:14.307235
NCT01963793|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2014-10-06|||October 2013||2013-10-01|February 2014|2014-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|iTAPP||Topical Aprepitant in Prurigo Patients|Topical Aprepitant in Prurigo Patients An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo|Completed||Phase 2|20|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 01:12:14.402362|2017-10-11 01:12:14.402362
NCT01963780|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-03-28|||November 2013||2013-11-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|EXPANDLung||International EXPAND Lung Pivotal Trial|International Trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System (OCS™) Lung For Recruiting, Preserving and Assessing Expanded Criteria Donor Lungs for Transplantation (EXPAND Trial)|Recruiting||Phase 3|75|Anticipated|TransMedics||1|||f||||f||||||||||2017-10-11 01:12:14.493495|2017-10-11 01:12:14.493495
NCT01963767|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2014-06-02|2014-05-02||May 2011||2011-05-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Description is limited to persons who completed the entire study. The eight subjects who did not complete the study are excluded from this table.|Nutraceutical Effects on Long-Term Memory|Phase II Study of a Nutraceutical on the Cognitive Performance of Older Adults.|Completed||Phase 2|139|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 01:12:14.621876|2017-10-11 01:12:14.621876
NCT01963754|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-12|2017-04-29|||April 1, 2017|Actual|2017-04-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Compare Subperiosteal and Loco-Regional Anesthesia in Posterior Mandible Dental Implant Installation|Compare Articaine 1:100.000, 4% Epinephrine, Subperiosteal With Loco-regional Anesthesia for Placing Dental Implants in Posterior Mandible - Double-Blinded Randomized Clinical Trial|Recruiting||Phase 4|88|Anticipated|Instituto de Implantologia||2|||f||||t|f|f||||||No||2017-10-11 01:12:15.039977|2017-10-11 01:12:15.039977
NCT01963741|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-07-08|||November 2012||2012-11-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis|Leukotriene D4 Nasal Provocation Test: Rationale, Methodology, Diagnostic Value and Its Impact on Airway Inflammation in Allergic Rhinitis With or Without Asthma|Completed||N/A|60|Actual|Guangzhou Institute of Respiratory Disease||2|||f||||f||||||||||2017-10-11 01:12:15.181494|2017-10-11 01:12:15.181494
NCT01963715|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-09-30|||October 2013||2013-10-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors|A Phase 1, Multi-center, Open-label Study of IMGN289 Administered Intravenously in Adult Patients With EGFR-positive Solid Tumors|Terminated||Phase 1|20|Actual|ImmunoGen, Inc.||1|||f||||f||||||||||2017-10-11 01:12:15.497274|2017-10-11 01:12:15.497274
NCT01963702|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-12|||August 2012||2012-08-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC|Phase II Trial of Exploring the Predictive Factors of Docetaxol Plus Capecitabine(TX) Regimen and Oxaliplatin Plus Capecitabine (XELOX) Regimen in the First Line Treatment of Patients With Metastatic Gastric Cancer (MGC)|Unknown status|Recruiting|Phase 2|120|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 01:12:15.644761|2017-10-11 01:12:15.644761
NCT01963689|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2013-10-13|||June 2012||2012-06-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Aromatherapy for Anxiety and Self-esteem: Clinical Trial|Aromatherapy for Anxiety and Self-esteem: Clinical Trial|Completed||N/A|34|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 01:12:15.774849|2017-10-11 01:12:15.774849
NCT01963676|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2016-01-25|2015-12-10||January 2014||2014-01-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Based on our randomized block design model, a block size of 10 (subjects, 20 total), 2 levels of (within-factors) TREATMENT and TIME each and a residual standard deviation of 14 (Brunelin et al., 2012), the power of our study is estimated to be 0.85 at the significant level alpha=0.05 and the difference of percentage change in 5 days of 15.|Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia|Clinical Trial to Assess Transcranial Current Stimulation as a Treatment for Medication Refractory Auditory Hallucinations in Schizophrenia|Completed||N/A|26|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:12:15.896588|2017-10-11 01:12:15.896588
NCT01963663|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2013-10-15|||November 2012||2012-11-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients|Comparison of Metformin and Pioglitazone Effects on Serum YKL-40 Concentrations in Patients With Newly Diagnosed Type 2 Diabetes|Completed||N/A|84|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:12:16.349225|2017-10-11 01:12:16.349225
NCT01963650|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-04-19|||December 2013||2013-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Natural History Study of Children With Metachromatic Leukodystrophy|Natural History Study of Children With Metachromatic Leukodystrophy|Terminated||N/A|1|Actual|Shire|||1|Enrollment issues|f||||f||||||Samples With DNA|"     Sample for genotype testing is collected and any remaining sample is retained for follow up     or repeat testing. The sample is not retained for unspecified additional testing.   "|||2017-10-11 01:12:16.491148|2017-10-11 01:12:16.491148
NCT01963637|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-11-18|||September 2012||2012-09-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|VOLUSCAN||Gastric Volumetry by Gastric Tomodensitometry With Gas|Evolution of Gastric Volume Measured by Gastric Tomodensitometry With Gas After Gastric Bypass Surgery or Sleeve Gastrectomy. Research for a Correlation With Weight Evolution : Pilot Study.|Completed||N/A|46|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 01:12:16.673118|2017-10-11 01:12:16.673118
NCT01963624|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2016-04-18|||November 2013||2013-11-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Combined Elastography and Color Doppler Ultrasonography for Breast Screening With Ultrasound|Multicenter Prospective Study to Evaluate the Value of Combined Elastography and Color Doppler Ultrasonography for Breast Screening With Ultrasound|Completed||N/A|1241|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 01:12:16.787933|2017-10-11 01:12:16.787933
NCT01963611|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-04-05|2016-04-05||October 2013||2013-10-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Safety Analysis Set (SAF) includes all randomized subjects who had received at least 1 dose of investigational medicinal product (IMP).|Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)|A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis|Terminated||Phase 2|255|Actual|EMD Serono|Based on Sponsor decision to discontinue the clinical development program of plovamer acetate therapy for multiple sclerosis the trial was prematurely terminated|5||Study was terminated based on sponsor discretion.|f||||t||||||||||2017-10-11 01:12:16.977482|2017-10-11 01:12:16.977482
NCT01963598|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-02-29||2016-02-29|November 2013||2013-11-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia|A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Safety and Efficacy of 3-month Subcutaneous REGN1033 Treatment in Patients With Sarcopenia|Completed||Phase 2|253|Actual|Regeneron Pharmaceuticals||4|||f||||f||||||||||2017-10-11 01:12:19.482935|2017-10-11 01:12:19.482935
NCT01963585|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2013-10-13|||July 2011||2011-07-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|September 2012|Actual|2012-09-01||Observational|||Evaluating the Capacity of High-sensitivity Serum CRP Levels to Predict Bronchial Hyper Responsiveness in School Age Children|Evaluating the Capacity of High-sensitivity Serum CRP Levels to Predict Bronchial Hyper Responsiveness in School Age Children|Completed||N/A|131|Actual|Rambam Health Care Campus|||2||f||||||||||||||2017-10-11 01:12:19.653828|2017-10-11 01:12:19.653828
NCT01963572|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2013-10-13|||August 2013||2013-08-01|October 2013|2013-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast Cancer|A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast Cancer|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital||2|||f||||||||||||||2017-10-11 01:12:19.715987|2017-10-11 01:12:19.715987
NCT01963559|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-11-21|||April 2012||2012-04-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|M2P2||Cutaneous Microcirculation and Diabetic Foot|Cutaneous Microcirculation and Diabetic Foot|Completed||N/A|80|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:12:19.814727|2017-10-11 01:12:19.814727
NCT01963546|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-09-17|||March 2014||2014-03-01|January 2014|2014-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Effects of Different Types of Anesthesia on Stress Response in Laparoscopic Gastric Bypass for Type 2 Diabetes Mellitus|Effects of Different Types of Anesthesia on Stress Response in Laparoscopic Gastric Bypass for Type 2 Diabetes Mellitus and the Effect of Dexmedetomidine on the Stress Response in Patients With Diabetic Undergoing Gastric-bypass Surgery|Unknown status|Recruiting|N/A|80|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||4|||f||||t||||||||||2017-10-11 01:12:19.921188|2017-10-11 01:12:19.921188
NCT01963533|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-16|||August 2012||2012-08-01|October 2013|2013-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||The Roles of Age, Comorbidity, and Telomere Length in Lung Cancer Treatment and Prognosis|The Roles of Age, Comorbidity, and Telomere Length in Lung Cancer Treatment and Prognosis|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     peripheral blood   "|||2017-10-11 01:12:20.188727|2017-10-11 01:12:20.188727
NCT01963520|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-09-18|||November 2002||2002-11-01|September 2017|2017-09-01|March 2012|Actual|2012-03-01|March 2010|Actual|2010-03-01||Observational|PHIPS||Prosthetic Hip Infections: Prospective Study|Prospective Study of Patients Treated for Prosthetic Hip Infection and Followed for at Least 2 Years|Completed||N/A|347|Actual|Groupe Hospitalier Diaconesses Croix Saint-Simon|||1||f||||f||||||||||2017-10-11 01:12:20.294295|2017-10-11 01:12:20.294295
NCT01963507|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-11|||April 2010||2010-04-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme|Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme|Completed||N/A|136|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 01:12:20.403853|2017-10-11 01:12:20.403853
NCT01963494|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-01-05|||March 2013||2013-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|February 2015|Actual|2015-02-01||Interventional|DiM||Days in Motion: A Planning Intervention Study With Couples to Enhance Daily Physical Activity|Days in Motion: A Planning Intervention Study With Couples to Enhance Daily Physical Activity (DiM)|Completed||N/A|346|Actual|Freie Universität Berlin||3|||f||||f||||||||||2017-10-11 01:12:20.50012|2017-10-11 01:12:20.50012
NCT01963468|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-10-21|||October 2013||2013-10-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Maximizing Language Development in Children With Hearing Loss|Pre-Implantation Communication Treatment for Children With Hearing Loss|Active, not recruiting||N/A|30|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 01:12:20.749788|2017-10-11 01:12:20.749788
NCT01963455|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-05-05|||January 2013||2013-01-01|January 2013|2013-01-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Autologous Muscle Derived Stem Cells Transplantation in Urine Incontinency|The Effect Evaluation of Autologous Muscle Derived Stem Cells Injection Into the Paraurethral Tissues for Treatment of Urinary Incontinency|Completed||Phase 1|10|Anticipated|Royan Institute||1|||f||||t||||||||||2017-10-11 01:12:20.855766|2017-10-11 01:12:20.855766
NCT01963442|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-08-11|||November 2013||2013-11-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|PTC||Short Duration Treatment of Non-severe Community Acquired Pneumonia|A Non-Inferiority, Multicentered, Controlled, Randomized, Double Blinded Study Investigating the Antibiotic Treatment Duration (3-day Versus 8-day) for Subjects Admitted to Emergency Services With Acute Non-severe Community Acquired Pneumonia (CAP)|Recruiting||Phase 2|310|Anticipated|Versailles Hospital||2|||f||||t||||||||||2017-10-11 01:12:20.97181|2017-10-11 01:12:20.97181
NCT01963429|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2015-03-22|||October 2013||2013-10-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC|A Randomized Phase III Study of the Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation in Patients With Recurrent/Residual Small Hepatocellular Carcinoma (APROH Study)|Recruiting||Phase 3|144|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 01:12:21.148814|2017-10-11 01:12:21.148814
NCT01963416|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-11|||June 2012||2012-06-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Fruit Consumption on Risk Factors of Chronic Disease|A Randomized Controlled, Crossover in Design, Double Blind Clinical Trial Investigating the Effects of Whole Versus Processed Fruit Consumption on Risk Factors for Chronic Disease and Performance Indicators.|Completed||N/A|34|Actual|University of Reading||4|||f||||t||||||||||2017-10-11 01:12:21.253232|2017-10-11 01:12:21.253232
NCT01963403|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-04-04|2016-12-19||December 2013||2013-12-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|ROBI||Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive|Relief of Bleeding on the Implant: Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With a Combined Oral Contraceptive: A Placebo-Controlled Randomized Trial|Terminated||Phase 4|26|Actual|University of California, Davis||2||Futility of recruitment|f||||f||||||||No||2017-10-11 01:12:21.364002|2017-10-11 01:12:21.364002
NCT01963390|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-13|2016-09-14|||July 2012||2012-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Metabolomics During Testosterone Therapy|Testosterone Therapy and Its Effects on Metabolic Function|Active, not recruiting||N/A|60|Actual|Men's Health Boston|||1||f||||f||||||Samples Without DNA|"     Serum samples obtained for metabolomics   "|||2017-10-11 01:12:22.003753|2017-10-11 01:12:22.003753
NCT01963377|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-11|||January 2013||2013-01-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Toward the Development of a Bronchoscope With a Dedicated O2 Channel ?|Evaluation of Feasibility of Dedicated Extra O2-channel in a Bronchoscope.|Completed||N/A|8|Actual|Centre Hospitalier Universitaire Saint Pierre||2|||f||||f||||||||||2017-10-11 01:12:22.125565|2017-10-11 01:12:22.125565
NCT01963364|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-01-16|||October 2013||2013-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PERFECT||Pilot Study of the Effect of Fructans on Fermentation in the Colon & Transit|A Pilot Study Using Magnetic Resonance Imaging to Measure the Effect of Dietary Supplementation With Fructans on Whole Gut Transit Time, Colonic Gas Volume, and Volume Change in Response to a Fructan Challenge|Completed||N/A|16|Actual|University of Nottingham||1|||f||||f||||||||||2017-10-11 01:12:22.21623|2017-10-11 01:12:22.21623
NCT01963351|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-12-05|||January 2012||2012-01-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01|24 Months|Observational [Patient Registry]|||Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC|Open-label Study of Bevacizumab (AVASTIN®) in Combination With Platinum-containing Chemotherapy as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer|Completed||N/A|150|Actual|University of Athens|||1||f||||t||||||||||2017-10-11 01:12:22.388018|2017-10-11 01:12:22.388018
NCT01963338|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-03-15|||April 2012||2012-04-01|March 2016|2016-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination|A Randomized Controlled Study to Assess the Acceptability and Usability of New Delivery Device for Intradermal Vaccination in Healthy Volunteers|Completed||N/A|102|Actual|Universiteit Antwerpen||2|||f||||f||||||||||2017-10-11 01:12:22.552806|2017-10-11 01:12:22.552806
NCT01963325|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-11-22|||August 2013||2013-08-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||S-1 in Combination With Abraxane in Treating Cholangiocarcinoma|Phase II Study of Abraxane Plus S-1 as Second-line Treatment for Cholangiocarcinoma|Terminated||Phase 2|2|Actual|Sun Yat-sen University||1||the toxicity was unacceptable, the efficacy was unsatisfied.|f||||t||||||||||2017-10-11 01:12:22.823782|2017-10-11 01:12:22.823782
NCT01963312|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-05-04|||March 2014||2014-03-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|April 2018|Anticipated|2018-04-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.|A Randomised Clinical Trial to Compare Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate Compared Versus the Transurethral Resection of the Prostate to Treat the Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.|Active, not recruiting||N/A|81|Actual|Fundacion Miguel Servet||2|||f||||||||||||||2017-10-11 01:12:22.950449|2017-10-11 01:12:22.950449
NCT01963299|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-11|||August 2013||2013-08-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|CRAPO||Clonidine - Ropivacaine in Peribulbar Anesthesia|Prospective Randomised Double-blind Study to Compare Ropivacaine 10mg/mL Alone Versus Ropivacaine 10mg/mL Associated With Clonidine 1µg/kg for Peribulbar Anesthesia in Posterior Eye Surgery|Completed||Phase 2|60|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-11 01:12:23.075139|2017-10-11 01:12:23.075139
NCT01963286|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-10-21|||August 2013||2013-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ReduceIT||Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT Discriminators|Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT Discriminators|Completed||N/A|735|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 01:12:23.173434|2017-10-11 01:12:23.173434
NCT01963273|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-15|||September 2013||2013-09-01|October 2013|2013-10-01||||December 2015|Anticipated|2015-12-01||Interventional|||Video Assisted Ablation of Pilonidal Sinus|Video Assisted Ablation of Pilonidal Sinus. Evaluation of Safety and Efficacy of a New Minimally Invasive Technique|Unknown status|Active, not recruiting|N/A|200|Anticipated|Federico II University||1|||f||||||||||||||2017-10-11 01:12:23.297563|2017-10-11 01:12:23.297563
NCT01963260|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-01-31|2017-01-31||October 2013||2013-10-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Baseline characteristics are presented for all participants that enrolled in the study according to the actual treatment administered (i.e., as treated). 2 participants that completed Part 2 MK-8723 10 mg/kg were re-enrolled in Part 2 MK-8723 100 mg/kg and dosed per protocol procedure.|Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)|A Two-Part, Single Rising Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of MK-8723 in Healthy Adults and Patients With Immune Thrombocytopenia Purpura|Completed||Phase 1|50|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-10-11 01:12:23.407497|2017-10-11 01:12:23.407497
NCT01963247|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-04-08|||October 2013||2013-10-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|||An Investigator Initiated Study to Evaluate the Effectiveness of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion|Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth Athletes|Completed||N/A|145|Actual|ElMindA Ltd|||2||f||||f||||||||||2017-10-11 01:12:24.996586|2017-10-11 01:12:24.996586
NCT01963234|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-10-26|||March 2014||2014-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|Seva||Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)|Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)|Recruiting||N/A|300|Anticipated|University of Wisconsin, Madison|||1||f||||t||||||||||2017-10-11 01:12:25.235183|2017-10-11 01:12:25.235183
NCT01963221|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2013-10-13|||January 2010||2010-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|August 2011|Actual|2011-08-01||Interventional|FICTEP||Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly Patients|RELATIONSHIP BETWEEN THORACIC AORTIC STRUCTURE ASSESSED BY PET/CT SCAN AND ARTERIAL STIFFNESS IN ELDERLY PATIENTS: FICTEP STUDY|Completed||N/A|30|Actual|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-11 01:12:25.337329|2017-10-11 01:12:25.337329
NCT01963208|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-04-28|||October 2013||2013-10-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|May 2016|Actual|2016-05-01||Interventional|||Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension|A Multicenter, Double Blind, Randomized, Placebo-Controlled Trial to Determine the Efficacy and Safety of Ganaxolone as Adjunctive Therapy for Adults With Drug-Resistant Partial-Onset Seizures Followed by Long-term Open-Label Treatment|Completed||Phase 3|405|Actual|Marinus Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:12:25.487457|2017-10-11 01:12:25.487457
NCT01963195|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-05-03|||February 2014||2014-02-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy|An Open, Single Center Trial to Evaluate the Efficacy and Safety of Dose Escalation of Icotinib in Advanced NSCLC Patients After TKI Therapy|Recruiting||Phase 2|30|Anticipated|Anhui Medical University||1|||f||||t||||||||||2017-10-11 01:12:25.792034|2017-10-11 01:12:25.792034
NCT01963182|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-12-13|||October 2013||2013-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|IriGen||Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer|Phase II Study: Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer|Recruiting||Phase 2|47|Anticipated|Centre Jean Perrin||1|||f||||f||||||||||2017-10-11 01:12:25.944294|2017-10-11 01:12:25.944294
NCT01963156|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-01-07|||November 2013||2013-11-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|SyNCMed||Synchronization to Improve Non-Adherence to Cardiovascular Medications|Synchronization to Improve Non-Adherence to Cardiovascular Medications (SyNCMed)|Terminated||N/A|3675|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-10-11 01:12:26.174219|2017-10-11 01:12:26.174219
NCT01963143|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-02-10|2017-02-10||February 2014||2014-02-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|GMX07||Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases|A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases|Completed||Phase 3|48|Actual|Bio Products Laboratory||3|||f||||t||||||||||2017-10-11 01:12:26.279006|2017-10-11 01:12:26.279006
NCT01963130|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-11|||July 2012||2012-07-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study|Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study|Completed||N/A|97|Actual|Bezmialem Vakif University|||2||f||||f||||||||||2017-10-11 01:12:26.981869|2017-10-11 01:12:26.981869
NCT01963117|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2015-05-18|||October 2013||2013-10-01|August 2014|2014-08-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|||Effectiveness of the Combined Whole Liver Irradiation (WLI) and Hyperthermia for Gastrointestinal Tract Cancer Liver Metastasis|Effectiveness of the Combined Whole Liver Irradiation (WLI) and Hyperthermia for Unresectable Chemoresistant Multiple Liver Metastasis From Gastrointestinal Tract Cancer: Prospective Phase II Trial|Terminated||Phase 2|11|Actual|Samsung Medical Center||1||Poor accrual|f||||f||||||||||2017-10-11 01:12:27.079736|2017-10-11 01:12:27.079736
NCT01963104|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-09-20|||September 2013||2013-09-01|September 2017|2017-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||Community-Based Kiosks for Hearing Screening and Education|Community-Based Kiosks for Hearing Screening and Education|Enrolling by invitation||N/A|2400|Anticipated|Portland VA Medical Center||10|||f||||f||||||||||2017-10-11 01:12:27.304042|2017-10-11 01:12:27.304042
NCT01963091|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2013-12-18|2013-12-18||July 2011||2011-07-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals|Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals|Completed||Phase 2|33|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:12:27.446739|2017-10-11 01:12:27.446739
NCT01963078|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-02-05|||April 2013||2013-04-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Sex/Gender Differences in Risk and Resilience to PTSD; Implication of Oxytocin|Sex/Gender Differences in Risk and Resilience to PTSD; Implication of Oxytocin|Completed||Phase 2|38|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 01:12:27.828428|2017-10-11 01:12:27.828428
NCT01963065|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-09-22|||March 2015||2015-03-01|September 2017|2017-09-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01||Observational|||NICU-HEALTH (Hospital Exposures and Long-Term Health)|Chemical Exposures and Infant Outcomes in the Neonatal Intensive Care Unit|Recruiting||N/A|150|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||Samples With DNA|"     Samples with DNA - samples retained, with potential for extraction of DNA from at least one     fo the types of samples retained (e.g., frozen tissue, whole blood)   "|||2017-10-11 01:12:27.998149|2017-10-11 01:12:27.998149
NCT01963052|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-06-09|||November 14, 2013|Actual|2013-11-14|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer|A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer|Active, not recruiting||Phase 1|93|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 01:12:28.151323|2017-10-11 01:12:28.151323
NCT01963039|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-01-12|||May 2013||2013-05-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|VERTOSV||A Trial of Vertebroplasty for Painful Chronic Osteoporotic Vertebral Fractures (Vertos V)|A Randomised Sham Controlled Trial of Vertebroplasty for Painful Chronic Osteoporotic Vertebral Fractures|Enrolling by invitation||N/A|180|Actual|Elisabeth-TweeSteden Ziekenhuis||2|||f||||t||||||||No||2017-10-11 01:12:28.402219|2017-10-11 01:12:28.402219
NCT01963026|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2015-12-28|||November 2013||2013-11-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Linking Brain to Behaviour Research in SCI|Plasticity, Motor Learning and Functional Recovery Induced by Client-centred Task-oriented Training of the Upper Extremity in Tetraplegia|Completed||N/A|5|Actual|Adelante, Centre of Expertise in Rehabilitation and Audiology||1|||f||||f||||||||||2017-10-11 01:12:28.509301|2017-10-11 01:12:28.509301
NCT01963013|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2013-10-17|||June 2012||2012-06-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||Non-returning Catheter Valve for Reducing CAUTI|A Pilot Study of Non-returning Catheter Valve for Reducing Catheter-associated Urinary Tract Infection in Critically-ill Patients|Completed||N/A|100|Actual|Khon Kaen University||2|||f||||t||||||||||2017-10-11 01:12:28.626447|2017-10-11 01:12:28.626447
NCT01963000|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-15|||January 2007||2007-01-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Standardized Emergency Care for Community Acquired Pneumonia (CAP)|Reduction of Mortality in Community-Acquired Pneumonia After Implementing Standardized Care Bundles in the Emergency Department|Completed||N/A|2819|Actual|Klinikum Nürnberg|||1||f||||f||||||||||2017-10-11 01:12:28.723498|2017-10-11 01:12:28.723498
NCT01962987|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-11|||March 2013||2013-03-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis|A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Diclofenac Sodium Gel 3% (Actavis) to Solaraze ® (Diclofenac Sodium) Gel 3% (Fougera Pharms) in the Treatment of Actinic Keratosis|Completed||Phase 3|585|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-11 01:12:28.814888|2017-10-11 01:12:28.814888
NCT01962974|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-03-01|2016-12-14||October 2013||2013-10-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|REGAIN||A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)|A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)|Terminated||Phase 3|7|Actual|Janssen Biotech, Inc.|The primary limitation for this study was the very low enrolment, ie, 7 participants which led to the early termination of the study.|1||Cancelled due to low enrollment|f||||f||||||||||2017-10-11 01:12:28.995937|2017-10-11 01:12:28.995937
NCT01962961|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2016-01-11|2015-11-04||October 2013||2013-10-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults|A Randomized, Placebo-Controlled Pilot Trial Assessing Two Doses of N-Acetylcysteine on Changes in Oxidative Stress and Endothelial Function in HIV-infected Older Adults Receiving Stable Antiretroviral Therapy|Completed||Phase 1/Phase 2|24|Actual|Indiana University||3|||f||||t||||||||||2017-10-11 01:12:29.345572|2017-10-11 01:12:29.345572
NCT01962948|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2017-06-14|||October 9, 2013|Actual|2013-10-09|June 2017|2017-06-01|July 7, 2019|Anticipated|2019-07-07|July 7, 2015|Actual|2015-07-07||Interventional|||Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase I/II Trial of Weekly Paclitaxel In Combination With Ganetespib In Patients With Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Active, not recruiting||Phase 1/Phase 2|12|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 01:12:30.427173|2017-10-11 01:12:30.427173
NCT01962935|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-11|2015-06-24|||November 2013||2013-11-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069|A Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4721 After Once Daily Administration of Multiple Ascending Doses for 10 Days, and an Open-label Comparison With the Pharmacodynamics of AZD5069 Given Twice Daily for 3 Days|Completed||Phase 1|84|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 01:12:30.532834|2017-10-11 01:12:30.532834
NCT01962740|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-06-27|||September 2013||2013-09-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|STRUT-OCT||Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)|Serial Evaluation of Drug-Eluting Stents Using OCT|Terminated||N/A|3|Actual|North Texas Veterans Healthcare System||3||Lack of eligible patients|f||||t||||||||No||2017-10-11 01:12:33.161712|2017-10-11 01:12:33.161712
NCT01962922|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-07-05|2016-02-23||November 2013||2013-11-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.|Prospective, Rand, Open-label, Single-center, 2 Sequence, 3 Period Crossover Study to Compare the Steady State PK of Once-Daily-Extended Release LCP-Tacro to Generic Tacrolimus Capsules Twice Daily in Stable A A Renal Transplant pt.|Completed||Phase 3|50|Actual|Veloxis Pharmaceuticals||2|||f||||f||||||||No||2017-10-11 01:12:30.680074|2017-10-11 01:12:30.680074
NCT01962909|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-03-16|||November 2013||2013-11-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer|A Phase 0, Open Label Study to Evaluate the Biodistribution and Pharmacokinetics of a Single Intravenous Bolus Dose of PTP-01 in Subjects With Resectable Pancreatic Ductal Adenocarcinoma|Terminated||Early Phase 1|3|Actual|University of Virginia||1||From preliminary imaging data, the study was stopped due to futility.|f||||t||||||||||2017-10-11 01:12:31.333347|2017-10-11 01:12:31.333347
NCT01962896|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01||||January 2019|Anticipated|2019-01-01||Interventional|||A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors|A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors|Recruiting||Phase 2|11|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 01:12:31.475041|2017-10-11 01:12:31.475041
NCT01962883|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2015-02-02|||August 2013||2013-08-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|PCS||Effects of Osteopathic Treatment on Vestibular Disturbed Active Post Concussed Individual|The Effects of Osteopathic Treatment on Balance and Dizziness of the Vestibular Disturbed Active Post Concussed Individual.|Completed||N/A|6|Actual|Collège d'Études Ostéopathiques||2|||f||||f||||||||||2017-10-11 01:12:31.645194|2017-10-11 01:12:31.645194
NCT01962870|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-04-24|||October 2013||2013-10-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Role of Vasopressin in the Social Deficits of Autism|Randomized Placebo-controlled Trial of Vasopressin Treatment for Social Deficits in Children With Autism|Recruiting||Phase 2|50|Anticipated|Stanford University||2|||f||||t||||||||Yes||2017-10-11 01:12:31.832905|2017-10-11 01:12:31.832905
NCT01962857|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-06-02|||October 2013||2013-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of 4 Weeks of Shuttle Run Training on Insulin Sensitivity in Sedentary Men|Effect of 4 Weeks of Shuttle Run Training on Insulin Sensitivity in Sedentary Men|Suspended||N/A|30|Anticipated|University of Glasgow||2||No member of staff available for active recruitment at the moment|f||||f||||||||||2017-10-11 01:12:32.004646|2017-10-11 01:12:32.004646
NCT01962844|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-10|||January 2012||2012-01-01|October 2013|2013-10-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|HCCO||Coconut Oil in Cardiovascular Disease|The Effect of Extra Virgin Coconut Oil Treatment Nutritional Associated With Data Anthropometric and Lipid Profile in Patients With Chronic Heart Disease|Unknown status|Active, not recruiting|N/A|116|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-11 01:12:32.131603|2017-10-11 01:12:32.131603
NCT01962831|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-10-12|||October 2013||2013-10-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Randomized Controlled Trial: Induction of Labour of Obese Women With Dinoprostone or Single Balloon Catheter|Randomized Controlled Trial: Single Balloon Catheter Versus Dinoprostone Vaginal Insert for Induction of Labour of Women With a BMI Equal to or Greater Than 30|Completed||N/A|41|Actual|Regina Qu'Appelle Health Region||2|||f||||t||||||||||2017-10-11 01:12:32.269332|2017-10-11 01:12:32.269332
NCT01962818|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-09-30|||January 2014||2014-01-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance.|High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths in Neonates Compared With Standard High Frequency Oscillatory Ventilation - Effects on Lung Volume Monitored by Electric Tomography Impedance|Active, not recruiting||N/A|16|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:12:32.406667|2017-10-11 01:12:32.406667
NCT01962805|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2014-01-23|||October 2013||2013-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of Two Formulations of Proellex for Vaginal Administration|A Double-Blind, Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Vaginal Administration|Completed||Phase 1|8|Actual|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 01:12:32.534375|2017-10-11 01:12:32.534375
NCT01962792|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-09-28|||December 2013|Actual|2013-12-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Study of the Bruton's Tyrosine Kinase Inhibitor in Combination With Carfilzomib (Kyprolis™) in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma|A Multicenter Phase 1/2b Study of the Bruton's Tyrosine Kinase Inhibitor, Ibrutinib (PCI-32765), in Combination With Carfilzomib (Kyprolis™) in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|127|Anticipated|Pharmacyclics LLC.||3|||f||||t||||||||||2017-10-11 01:12:32.637026|2017-10-11 01:12:32.637026
NCT01962779|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-05-05|||July 2013||2013-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SARA||Sleep, Aging and Risk for Alzheimer's Disease|Sleep, Aging and Risk for Alzheimer's Disease (SARA) Study|Recruiting||N/A|45|Anticipated|New York University School of Medicine||2|||f||||t|f|t|f|f|f|||||2017-10-11 01:12:32.841815|2017-10-11 01:12:32.841815
NCT01962766|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-12-08|||October 2013||2013-10-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Myofunctionnal Therapy on Nasal Breathing and Orthodontic Corrections Stability|Myofunctionnal Therapy on Nasal Breathing and Orthodontic Corrections Stability|Completed||N/A|70|Anticipated|Université de Montréal||2|||f||||f||||||||||2017-10-11 01:12:32.962608|2017-10-11 01:12:32.962608
NCT01962753|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-02-13|||May 2012||2012-05-01|October 2013|2013-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ASAP||Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)|Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)|Recruiting||N/A|150|Anticipated|University Hospital, Tours||1|||f||||t||||||||||2017-10-11 01:12:33.051724|2017-10-11 01:12:33.051724
NCT01962727|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-10-10|||March 2012||2012-03-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Scapular Dyskinesis: a Reliability and Validity Study of Comprehensive Classification Test|Scapular Dyskinesis: a Reliability and Validity Study of Comprehensive Classification Test|Completed||N/A|60|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 01:12:33.251705|2017-10-11 01:12:33.251705
NCT01962714|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-31|||December 1, 2014|Actual|2014-12-01|May 2017|2017-05-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||Loving-Kindness Meditation for PTSD|A Trial of Loving-Kindness Meditation and Cognitive Processing Therapy for PTSD|Recruiting||N/A|170|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Yes|A de-identified, anonymized dataset will be created and shared.|2017-10-11 01:12:33.3386|2017-10-11 01:12:33.3386
NCT01962701|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-05-09|||January 2013||2013-01-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|CopOCT||Fetal Copeptin After Oxytocin Challenge Test|Fetal Copeptin After Oxytocin Challenge Test|Completed||N/A|140|Actual|University of Zurich|||2||f||||f||||||Samples Without DNA|"     EDTA plasma of arterial umbilical cord blood   "|Undecided||2017-10-11 01:12:33.493641|2017-10-11 01:12:33.493641
NCT01962675|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-11-13|2015-11-13||July 2013||2013-07-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SLT|Study was to be PhD student dissertation. PI left institution. Months later PhD student withdrew without notice. Data were stored on computers and not accessible to PI. Computers were replaced by new lab director.|Skilled Motor Training and tDCS to Improve Leg Function After Spinal Cord Injury|Skilled Motor Training and tDCS to Improve Leg Function After Spinal Cord Injury|Terminated||N/A|15|Actual|University of Miami||2||PI left study institution, declined to continue study at new institution|f||||f||||||||||2017-10-11 01:12:33.728327|2017-10-11 01:12:33.728327
NCT01962662|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-10-10|||January 2012||2012-01-01|October 2013|2013-10-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Intervention Study of EMG Biofeedback Assisted Force Control to Treat Stroke Movement Disorder|Effects of Force Level Control Training Using EMG Biofeedback on Transcranial Magnetic Stimulation-Induced Excitability to Anterial Tibialis and Motor Functions After Stroke|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-11 01:12:34.649877|2017-10-11 01:12:34.649877
NCT01962649|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-10|||October 2013||2013-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:12:34.762049|2017-10-11 01:12:34.762049
NCT01962636|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-10-04|||December 2016||2016-12-01|September 2017|2017-09-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases|Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for the Treatment of Hematological Diseases|Recruiting||N/A|200|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-10-11 01:12:34.821329|2017-10-11 01:12:34.821329
NCT01962623|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-22|||August 2013||2013-08-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Interpersonal Psychotherapy for Youth With Severe Mood Dysregulation|Interpersonal Psychotherapy for Youth With Severe Mood Dysregulation- Randomized Trial|Completed||N/A|31|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 01:12:34.984867|2017-10-11 01:12:34.984867
NCT01962610|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-11-04|||June 2011||2011-06-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Improving Pain Management for Older Adults in the Emergency Department (ED)|Improving Management of Acute Pain for Older Adults in the ED Setting|Completed||N/A|4693|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 01:12:35.111816|2017-10-11 01:12:35.111816
NCT01962597|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-04-18|||October 2013||2013-10-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|THESIS||Trial of Hemodialysis Based Exercise for Strength Improvement Study|Comparison of Aerobic Exercise, Strength Training, or Its Combination in Hemodialysis Patients: a Randomized Controlled Trial|Active, not recruiting||N/A|60|Anticipated|St. Joseph's Healthcare Hamilton||3|||f||||f||||||||||2017-10-11 01:12:35.212937|2017-10-11 01:12:35.212937
NCT01962584|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2015-12-09|||September 2013||2013-09-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||CMR in Patients With Myocarditis|Value of CMR Including T1 Mapping in Patients With Acute Myocarditis|Completed||N/A|66|Actual|University Hospital, Bonn|||2||f||||f||||||||||2017-10-11 01:12:35.313283|2017-10-11 01:12:35.313283
NCT01962545|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2017-08-15|||October 2013||2013-10-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|OAC-ALONE||Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study|Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study|Active, not recruiting||Phase 4|692|Actual|Kyoto University, Graduate School of Medicine||2|||f||||t||||||||||2017-10-11 01:12:35.736826|2017-10-11 01:12:35.736826
NCT01962532|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-05-20|||August 2013||2013-08-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma|A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects With Advanced or Refractory Solid Tumors or Lymphoma|Completed||Phase 1|19|Actual|Janssen Research & Development, LLC||3|||f||||f||||||||||2017-10-11 01:12:35.844328|2017-10-11 01:12:35.844328
NCT01962519|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-10|||January 2012||2012-01-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Early Oral Feeding After Total Gastrectomy for Cancer|A Randomized Clinical Trial of Early Oral Feeding as a Component of Accelerated Recovery Protocol After Total Gastrectomy for Cancer|Unknown status|Recruiting|N/A|112|Anticipated|Jagiellonian University||2|||f||||f||||||||||2017-10-11 01:12:35.981751|2017-10-11 01:12:35.981751
NCT01962506|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-10|||December 2012||2012-12-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|COPACS||Diagnostic Utility of Copeptin in Addition to High-sensitivity Cardiac Troponin for the Early Diagnosis of NSTE-ACS|Diagnostic Utility of Copeptin in Addition to High-sensitivity Cardiac Troponin for the Early Diagnosis of Non-ST-Elevation Acute Coronary Syndromes - The COPACS Study|Unknown status|Recruiting|N/A|180|Anticipated|G. d'Annunzio University|||1||f||||||||||||||2017-10-11 01:12:36.085828|2017-10-11 01:12:36.085828
NCT01962493|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-02-12|2014-07-17||September 2013||2013-09-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||An Efficacy Study of Stain Control of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Tooth Staining|A Study to Evaluate the Effect of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Digluconate Tooth Staining|Completed||Phase 4|160|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 01:12:36.179301|2017-10-11 01:12:36.179301
NCT01962480|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-11-21|||November 2013||2013-11-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|August 2016|Actual|2016-08-01||Interventional|CLOSE-GAP||The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain|The Clinical Effects of Intracorporally Closure of the Hernia Defect in Laparoscopic Umbilical or Epigastric Hernia Repair|Enrolling by invitation||N/A|80|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||No||2017-10-11 01:12:37.337663|2017-10-11 01:12:37.337663
NCT01962467|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-12|||October 11, 2013|Actual|2013-10-11|May 2017|2017-05-01|February 27, 2014|Actual|2014-02-27|February 27, 2014|Actual|2014-02-27||Interventional|||A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine|A Relative Bioavailability Study to Compare the Pharmacokinetics of a Fixed Dose Combination of Fluticasone Furoate and Levocabastine With Levocabastine and Fluticasone Furoate Alone|Completed||Phase 1|30|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:12:37.487244|2017-10-11 01:12:37.487244
NCT01962454|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-05|||May 5, 2014|Actual|2014-05-05|May 2017|2017-05-01|March 20, 2015|Actual|2015-03-20|March 20, 2015|Actual|2015-03-20||Interventional|||A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers|A Pilot Study in Healthy Male Volunteers to Evaluate a Skeletal-Muscle Microbiopsy Technique for Suitability of Use With Dynamic Proteomic Measurement|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:12:37.594644|2017-10-11 01:12:37.594644
NCT01962441|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-24|2016-01-07||September 24, 2013|Actual|2013-09-24|May 2017|2017-05-01|July 7, 2016|Actual|2016-07-07|January 7, 2015|Actual|2015-01-07||Interventional||Safety Analysis Set: participants with genotype 2 or 3 HCV infection who were randomized and received at least 1 dose of study drug.|SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection|A Phase 3B Randomized, Open-Label, Multi-Center Trial Assessing Sofosbuvir + Ribavirin for 16 or 24 Weeks and Sofosbuvir + Pegylated Interferon + Ribavirin for 12 Weeks in Subjects With Genotype 2 or 3 Chronic HCV Infection.|Completed||Phase 3|601|Actual|Gilead Sciences||4|||f||||f|t|f||||||||2017-10-11 01:12:37.754812|2017-10-11 01:12:37.754812
NCT01962428|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-09-21|2016-09-21||June 2014||2014-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI|Randomized Trial of Different Loading Dose of Ticagrelor for Antiplatelet Effect in Patients With Non -ST-segment Elevation ACS Undergoing Percutaneous Coronary Intervention|Completed||Phase 4|250|Actual|General Hospital of Chinese Armed Police Forces||2|||f||||t||||||||||2017-10-11 01:12:39.734574|2017-10-11 01:12:39.734574
NCT01962415|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-06-02|||June 26, 2012|Actual|2012-06-26|June 2017|2017-06-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|HSCT+RIC||Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT|A Phase II Study of Reduced Intensity Conditioning in Patients ≤35 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation Transplantation|Recruiting||Phase 2|30|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 01:12:40.030304|2017-10-11 01:12:40.030304
NCT01962402|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-01-29|||January 2014||2014-01-01|January 2014|2014-01-01||||July 2015|Anticipated|2015-07-01||Interventional|||Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study|Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study|Unknown status|Recruiting|Phase 4|15|Anticipated|Southern California Institute for Research and Education||1|||f||||t||||||||||2017-10-11 01:12:40.182986|2017-10-11 01:12:40.182986
NCT01962389|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-12-04|||January 2014||2014-01-01|December 2014|2014-12-01||||April 2014|Anticipated|2014-04-01||Interventional|||First in Human Study of Winsor Laser Catheter: A Prospective Registry to Evaluate The Safety and Performance of the Winsor Laser Catheter in the Treatment of In-Stent Restenosis|First in Human Study of Winsor Laser Catheter|Withdrawn||Phase 1|0|Actual|Spectranetics Corporation||1|||f||||f||||||||||2017-10-11 01:12:40.302306|2017-10-11 01:12:40.302306
NCT01962376|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-10|||February 2013||2013-02-01|October 2013|2013-10-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Interventional|||Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis|Phase IV Multi-Institutional Randomized Trial of Capecitabine Plus Oxaliplatin With Bevacizumab in Patients With Potentially Resectable Gastric Cancer With Liver Metastasis|Unknown status|Recruiting|Phase 4|60|Anticipated|Hebei Medical University||2|||f||||f||||||||||2017-10-11 01:12:40.388725|2017-10-11 01:12:40.388725
NCT01962363|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-06-28|||October 2013||2013-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||EPI-743 in Friedreich's Ataxia Point Mutations|A Phase 2A Clinical Trial of EPI-743 (Vincerinone™) on Visual Function in Friedreich's Ataxia Patients With Point Mutations|Completed||Phase 2|4|Actual|University of South Florida||1|||f||||f||||||||||2017-10-11 01:12:40.505228|2017-10-11 01:12:40.505228
NCT01962350|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-11-20|||February 2014||2014-02-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|rTMSH1Coil||Treatment of Bipolar Depression With H1-Coil Deep Brain rTMS: Clinical-Cognitive and Safety Evaluation|Evaluation Clinical, Cognitive and Safety in the Treatment of Bipolar Depression With H1-Coil Deep Transcranial Magnetic Stimulation|Completed||N/A|50|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:12:40.624795|2017-10-11 01:12:40.624795
NCT01962337|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-09-13|||October 2013||2013-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects|A Phase 1, Randomized, Double Blind, Placebo Controlled, Single and Multiple Ascending Dose Study of FPA008 in Healthy Volunteers and Subjects With Rheumatoid Arthritis|Terminated||Phase 1|66|Actual|Five Prime Therapeutics, Inc.||4||We have discontinued development of FPA008 in RA|f||||f||||||||||2017-10-11 01:12:40.838587|2017-10-11 01:12:40.838587
NCT01962324|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-10-26|||March 2015||2015-03-01|October 2016|2016-10-01|November 2022|Anticipated|2022-11-01|November 2020|Anticipated|2020-11-01||Interventional|PARAPLY-1||Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer|Phase 2 Study of High Risk Prostatae Cancer Treated With Dose-escalated Simultaneous Integrated Boost to Prostate and Lymph Node GTV|Recruiting||Phase 2|86|Anticipated|Umeå University||1|||f||||f||||||||||2017-10-11 01:12:40.948594|2017-10-11 01:12:40.948594
NCT01962311|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-05-11|||February 2013||2013-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Interventional|METABALS||Evaluation of Metabolomic Analysis in Early Diagnosis of ALS|Evaluation of Metabolomic Analysis in Early Diagnosis of ALS|Active, not recruiting||N/A|400|Anticipated|University Hospital, Tours||1|||f||||t||||||||No||2017-10-11 01:12:41.047288|2017-10-11 01:12:41.047288
NCT01962298|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2014-12-31|||October 2013||2013-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SUDIA||Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex|Sugammadex and the Diaphragm: Recovery of Diaphragmatic Function and Neuromuscular Blockade. A Double-blind Randomized Controlled Trial|Completed||Phase 3|75|Actual|University Hospital, Antwerp||5|||f||||t||||||||||2017-10-11 01:12:41.165957|2017-10-11 01:12:41.165957
NCT01962272|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-11|||January 2010||2010-01-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||The Effect of Nutritional Counseling for Cancer Patients|Randomised Trial of the Effects of Individual Nutritional Counseling in Cancer Patients|Completed||Phase 4|61|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 01:12:41.401305|2017-10-11 01:12:41.401305
NCT01962259|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2015-10-19|||October 2013||2013-10-01|October 2015|2015-10-01||||October 2015|Anticipated|2015-10-01||Interventional|GO-ACTIWE||Active Commuting To Improve Well-being and Health in Everyday Life|Active Commuting To Improve Well-being and Health in Everyday Life|Unknown status|Active, not recruiting|N/A|175|Anticipated|University of Copenhagen||4|||f||||t||||||||||2017-10-11 01:12:41.495418|2017-10-11 01:12:41.495418
NCT01962246|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-22|2016-08-27|||February 2012||2012-02-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|A-C||Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction|Phase II Multi-Institutional Randomized Trial of Capecitabine Plus Oxaliplatin With Concurrent Radiotherapy in Patients With Potentially Resectable Adenocarcinoma of Gastroesophageal Cancer|Recruiting||Phase 2/Phase 3|450|Anticipated|Hebei Medical University||2|||f||||f||||||||||2017-10-11 01:12:41.599792|2017-10-11 01:12:41.599792
NCT01962233|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2013-10-10|||September 2013||2013-09-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Hypoxic Ischemic Encephalopathy|Safety and Efficacy Investigation of Patients With Hypoxic Ischemic Encephalopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells|Unknown status|Recruiting|Phase 1|10|Anticipated|Hebei Medical University||1|||f||||t||||||||||2017-10-11 01:12:41.721939|2017-10-11 01:12:41.721939
NCT01962220|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-12-19|||March 2013||2013-03-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MIR4HEALTH||Mother Infant Retention for Health: MIR4Health|Mother Infant Retention for Health: Evaluation of a Multicomponent Strategy to Link and Retain Newly Identified HIV-infected Pregnant Women and Their Infants Throughout the Antenatal and Post-partum Period|Completed||N/A|680|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:12:41.830665|2017-10-11 01:12:41.830665
NCT01962194|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-10-10|||December 2013||2013-12-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Mapping and Stimulating the Limbic Areas of the Subthalamic Nucleus|Mapping and Stimulating the Limbic Areas of the Subthalamic Nucleus|Unknown status|Not yet recruiting|N/A|10|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 01:12:42.075954|2017-10-11 01:12:42.075954
NCT01962181|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-10-10|||October 2013||2013-10-01|September 2013|2013-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment|Identifying Characteristic Signature of Brain Activity of Electroencephalogram Records in Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 01:12:42.154|2017-10-11 01:12:42.154
NCT01962168|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-04-07|||December 2013||2013-12-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Evolution® Biliary Stent System Clinical Study|Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System|Completed||N/A|113|Actual|Cook Group Incorporated|||1||f||||||||||||||2017-10-11 01:12:42.255587|2017-10-11 01:12:42.255587
NCT01962155|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2016-09-08|||August 2013||2013-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01|6 Months|Observational [Patient Registry]|HBV||Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters|Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus|Completed||N/A|1841|Actual|Peking University First Hospital|||1||f||||t||||||Samples Without DNA|"     liver biopsy samples and blood samples   "|||2017-10-11 01:12:42.402706|2017-10-11 01:12:42.402706
NCT01962142|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-08-07|||September 2012||2012-09-01|August 2015|2015-08-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Assessment of Activity Limitation in Asthma Patients|Subjective and Objective Assessment of Activity Limitation in Asthma Patients|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire Saint Pierre|||1||f||||||||||||||2017-10-11 01:12:42.595757|2017-10-11 01:12:42.595757
NCT01962129|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-10|||June 2011||2011-06-01|October 2013|2013-10-01||||June 2014|Anticipated|2014-06-01||Observational|OFD1||Clinical and Molecular Characterisation of Orofaciodigital Syndromes and Other Clinical Phenotypes Secondary to Mutations in the OFD1 Gene|Clinical and Molecular Characterisation of Orofaciodigital Syndromes and Other Clinical Phenotypes Secondary to Mutations in the OFD1 Gene|Unknown status|Recruiting|N/A|133|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||f||||||||||2017-10-11 01:12:42.698807|2017-10-11 01:12:42.698807
NCT01962116|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-10-10|||June 2013||2013-06-01|October 2013|2013-10-01||||February 2015|Anticipated|2015-02-01||Interventional|VERROUREA||Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU|Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU = Multicentre, Controlled, Randomised Superiority Trial|Unknown status|Recruiting|Phase 4|386|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-11 01:12:42.800409|2017-10-11 01:12:42.800409
NCT01962103|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-08-29|||December 4, 2013|Actual|2013-12-04|August 2017|2017-08-01|February 10, 2020|Anticipated|2020-02-10|December 14, 2018|Anticipated|2018-12-14||Interventional|||To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors|A Phase 1/2, Multicenter, Open-label, Dose-finding Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent or Refractory Solid Tumors.|Recruiting||Phase 1/Phase 2|134|Anticipated|Celgene||1|||f||||f||||||||||2017-10-11 01:12:42.89606|2017-10-11 01:12:42.89606
NCT01962090|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-02-19|||October 2013||2013-10-01|September 2013|2013-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain in Dentistry Students|A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain in Dentistry Students: a Randomized Controlled Trial.|Unknown status|Recruiting|N/A|50|Anticipated|A.T. Still University of Health Sciences||2|||f||||f||||||||||2017-10-11 01:12:43.066853|2017-10-11 01:12:43.066853
NCT01962077|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-12-18|||October 2013||2013-10-01|August 2016|2016-08-01||||October 2018|Anticipated|2018-10-01||Interventional|||Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.|Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth|Active, not recruiting||N/A|60|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-10-11 01:12:43.196095|2017-10-11 01:12:43.196095
NCT01962064|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-10-10|||June 2013||2013-06-01|October 2013|2013-10-01|November 2014|Anticipated|2014-11-01|July 2014|Anticipated|2014-07-01||Interventional|COSIMAGE||Social Cognition in Ageing and in Frontotemporal Lobar Degeneration|Social Cognition in Ageing and in Frontotemporal Lobar Degeneration (Frontotemporal Dementia and Semantic Dementia): a Cognitive and Neuroimaging Study|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Caen||4|||f||||t||||||||||2017-10-11 01:12:43.270517|2017-10-11 01:12:43.270517
NCT01962051|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-09-19|||October 2013||2013-10-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|ACP LA||AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational|AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational|Withdrawn||N/A|0|Actual|St. Jude Medical|||1|St. Jude Medical business decision|f||||t||||||||No|No data collected as study stopped before sites activated|2017-10-11 01:12:43.396235|2017-10-11 01:12:43.396235
NCT01962038|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-04-03|||May 2013||2013-05-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|||A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment|A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment|Active, not recruiting||N/A|100|Anticipated|Palo Alto Veterans Institute for Research||2|||f||||f||||||||||2017-10-11 01:12:43.477583|2017-10-11 01:12:43.477583
NCT01962025|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-01-20|||October 2013||2013-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis|Vanguard Multi-Centre Feasibility Trial to Determine if Buttonhole Versus Step Ladder Cannulation for High Dose Hemodialysis is Associated With Reduced Overall Cost|Active, not recruiting||N/A|49|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 01:12:43.58955|2017-10-11 01:12:43.58955
NCT01962012|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-09-27|||October 2013||2013-10-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|June 2014|Actual|2014-06-01||Interventional|||Effect of AcceleDent® Aura on Orthodontic Tooth Movement With Aligners|Effect of AcceleDent® Aura on Orthodontic Tooth Movement With Aligners|Completed||Phase 4|46|Actual|OrthoAccel Technologies Inc.||2|||f||||f||||||||||2017-10-11 01:12:43.699391|2017-10-11 01:12:43.699391
NCT01961817|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-04-07|||July 2013||2013-07-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Airway Management Via the Retromolar Route Access|Airway Management Via the Retromolar Route Access - a Clinical Study|Completed||N/A|100|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 01:12:46.144551|2017-10-11 01:12:46.144551
NCT01961999|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2013-10-09|||July 2011||2011-07-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Early Versus Late Renal Replacement Therapy After Cardiac Surgery|"Early and Late Timing Indication for Starting Renal Replacement Therapy in Acute Renal Failure After Cardiac Surgery: a Prospective, Controlled, Interventional, Single-center Trial"|Completed||N/A|1800|Actual|Ospedali Riuniti Ancona||2|||f||||f||||||||||2017-10-11 01:12:43.802198|2017-10-11 01:12:43.802198
NCT01961986|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-05-04|||July 2010|Actual|2010-07-01|May 2017|2017-05-01|May 4, 2022|Anticipated|2022-05-04|May 4, 2017|Actual|2017-05-04||Interventional|||Rotator Cuff Sparing Total Arthroplasty|Rotator Cuff Sparing Total Arthroplasty - A Prospective, Randomized Clinical Trial|Active, not recruiting||N/A|120|Actual|New York University School of Medicine||2|||f||||f|f|f||||||||2017-10-11 01:12:43.924128|2017-10-11 01:12:43.924128
NCT01961973|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-10|||January 2014||2014-01-01|October 2013|2013-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|Cultured||A Study to Compare Two Techniques for Articular Cartilage Repair: Cultured Chondrocytes Vs. Cultured BMAC|Trial to Compare the Efficacy of Two Surgical Techniques for Articular Cartilage Repair in the Knee: The Use of Cultured Chondrocytes Vs. the Use of Cultured Bone Marrow Aspirate Cells.|Unknown status|Not yet recruiting|N/A|100|Anticipated|Shetty-Kim Research Foundation||2|||f||||t||||||||||2017-10-11 01:12:44.049254|2017-10-11 01:12:44.049254
NCT01961960|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-09-27|||October 2013||2013-10-01|September 2017|2017-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Evaluate Intramuscular ASP7374|Phase 3 Study of ASP7374 －Open-label Study of Intramuscular ASP7374 in Adults ≥61 Years of Age－|Completed||Phase 3|55|Actual|UMN Pharma Inc.||1|||f||||f||||||||||2017-10-11 01:12:44.193278|2017-10-11 01:12:44.193278
NCT01961947|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-09-27|||October 2013||2013-10-01|September 2017|2017-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study of ASP7374, Cell-culture-derived Influenza Vaccine|Phase 3 Study of ASP7374 －Approved Egg-derived Vaccine Controlled, Double-blind, Parallel Group Study in Adults ≥20 and <65 Years of Age－|Completed||Phase 3|900|Actual|UMN Pharma Inc.||2|||f||||f||||||||||2017-10-11 01:12:44.313633|2017-10-11 01:12:44.313633
NCT01961934|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-09-27|||May 2014||2014-05-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2016|Anticipated|2016-05-01||Interventional|||C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression|Carbon-11-Sodium Acetate Positron Emission Tomography/Computed Tomography (PET/CT) Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression|Withdrawn||Phase 2/Phase 3|0|Actual|Phoenix Molecular Imaging||1||Awaiting funding|f||||f||||||||||2017-10-11 01:12:44.700071|2017-10-11 01:12:44.700071
NCT01961921|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-07-13||2017-06-02|October 2013||2013-10-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||The Study of an Investigational Drug, ALN-TTR02 (Patisiran), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)|A Phase 2, Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety, Clinical Activity, and Pharmacokinetics of ALN-TTR02 in Patients With Familial Amyloidotic Polyneuropathy Who Have Previously Received ALN-TTR02|Completed||Phase 2|27|Actual|Alnylam Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:12:44.797985|2017-10-11 01:12:44.797985
NCT01961908|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2014-02-06|||December 2013||2013-12-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Open-Label Extension Study to ZPE-202|A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis|Withdrawn||Phase 2|0|Actual|Repros Therapeutics Inc.||1|||f||||t||||||||||2017-10-11 01:12:44.920054|2017-10-11 01:12:44.920054
NCT01961895|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-11|||May 2010||2010-05-01|October 2013|2013-10-01||||May 2012|Actual|2012-05-01||Interventional|||Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture|Evaluation of the Effect of Perioperative Continuous Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture.|Completed||Phase 4|31|Actual|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||||2017-10-11 01:12:45.060374|2017-10-11 01:12:45.060374
NCT01961882|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-02-22|||October 2013||2013-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia|Active, not recruiting||Phase 2|||Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:12:45.189732|2017-10-11 01:12:45.189732
NCT01961869|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-03-14|||July 2013||2013-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Black Raspberry Confection in Preventing Oral Cancer in Healthy Volunteers|Phytochemical Release Rate From Black Raspberry Confections Alters Gene Expression and Chemical Profiles Relevant to Inhibition of Oral Carcinogenesis|Active, not recruiting||Phase 1|60|Anticipated|Ohio State University Comprehensive Cancer Center||6|||f||||t||||||||||2017-10-11 01:12:45.371415|2017-10-11 01:12:45.371415
NCT01961856|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-08-19|||September 2013||2013-09-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor.|Platelet Reactivity After Ticagrelor Loading Dose Versus Clopidogrel Loading Dose and Reloading With Ticagrelor, in Patients With ST-elevation Myocardial Infarction (STEMI) Undergoing Primary Percutaneous Coronary Intervention (PCI).|Completed||Phase 3|74|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 01:12:45.530773|2017-10-11 01:12:45.530773
NCT01961843|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-03-16|||October 2013||2013-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Abiraterone Acetate for Castrate Resistant Prostate Cancer|Investigator-Initiated, Pilot Translational Study of Circulating Tumor Cells to Identify Predictive Factors of Response to Abiraterone Acetate in Men With Castration-Resistant Prostate Cancer|Active, not recruiting||N/A|40|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-11 01:12:45.653453|2017-10-11 01:12:45.653453
NCT01961830|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-06-10|||September 2013||2013-09-01|June 2014|2014-06-01||||December 2013|Actual|2013-12-01||Interventional|||Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers|An Open-label, Single Dose Study to Assess Intrapulmonary Pharmacokinetics of ME1100 Inhalation Solution Administered to Healthy Volunteers|Completed||Phase 1|42|Actual|Meiji Seika Pharma Co., Ltd.||1|||f||||f||||||||||2017-10-11 01:12:45.965926|2017-10-11 01:12:45.965926
NCT01961804|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-12-23|||March 2014||2014-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|PREVACT||PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma|Phase 3 Study Comparing Preventive Reversal of Vitamine K Antagonist Versus Reversion Only in Case of Intracranial Bleeding in Patients Receiving Vitamine K Antagonist Treatment|Recruiting||Phase 3|400|Anticipated|University Hospital, Angers||2|||f||||||||||||||2017-10-11 01:12:46.393061|2017-10-11 01:12:46.393061
NCT01961791|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-09|||January 2000||2000-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2011|Actual|2011-12-01||Observational|||Lymph Node Staging System With a Novel Concept for Gastric Cancer: a Hybrid Type of Topographic and Numeric Ones||Completed||N/A|6025|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 01:12:46.766058|2017-10-11 01:12:46.766058
NCT01961778|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-04-10|||November 2013||2013-11-01|April 2017|2017-04-01|February 2020|Anticipated|2020-02-01|November 2019|Anticipated|2019-11-01||Interventional|||Comparison of Radiofrequency Ablation and Cryotherapy for the Treatment of Barrett's Esophagus With High-Grade Dysplasia and/or Early Adenocarcinoma|Prospective Randomized Trial Comparing Radiofrequency Ablation (Barrx™) and Cryotherapy (TruFreeze™) for the Treatment of Barrett's Esophagus With High-Grade Dysplasia and/or Early Adenocarcinoma|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:12:46.899793|2017-10-11 01:12:46.899793
NCT01961765|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-07-18|||November 2013|Actual|2013-11-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Interventional|||Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML).|Completed||Phase 1|18|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:12:47.033038|2017-10-11 01:12:47.033038
NCT01961752|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-10|||July 2012||2012-07-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Efficacy of Topical Bupivacaine and Triamcinolone Acetonide Injection in the Relief of Pain After Endoscopic Submucosal Dissection for Gastric Neoplasia: A Randomized Double-blind, Placebo-controlled Trial||Completed||N/A|111|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 01:12:47.194922|2017-10-11 01:12:47.194922
NCT01961739|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-10|||October 2013||2013-10-01|October 2013|2013-10-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|H1-5||Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids|Double Blinded Randomized Clinical Trial of the Efficacy of Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids|Unknown status|Recruiting|Phase 2/Phase 3|138|Anticipated|University Hospital Dubrava||2|||f||||t||||||||||2017-10-11 01:12:47.320478|2017-10-11 01:12:47.320478
NCT01961726|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-10-22|||October 2013||2013-10-01|October 2014|2014-10-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|RETRO-HF||Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure|A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure|Unknown status|Active, not recruiting|Phase 1/Phase 2|72|Anticipated|Juventas Therapeutics, Inc.||3|||f||||t||||||||||2017-10-11 01:12:47.498296|2017-10-11 01:12:47.498296
NCT01961713|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-30|2017-03-16|||April 2010||2010-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Observational|||Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy|Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital|||1||f||||t||||||Samples With DNA|"     Blood samples   "|No||2017-10-11 01:12:47.671418|2017-10-11 01:12:47.671418
NCT01961700|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-10-05|||December 2014||2014-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||In-hospital Physiotherapy for Patients Undergoing Thoracic Surgery - a Randomized Controlled Trial|In-hospital Physiotherapy for Patients Undergoing Thoracic Surgery - a Randomized Controlled Trial|Recruiting||N/A|106|Anticipated|Region Örebro County||2|||f||||f||||||||No||2017-10-11 01:12:47.777067|2017-10-11 01:12:47.777067
NCT01961687|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-11-08|||September 2013||2013-09-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.|A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.|Active, not recruiting||N/A|120|Anticipated|C. R. Bard||1|||f||||f||||||||Undecided||2017-10-11 01:12:47.878362|2017-10-11 01:12:47.878362
NCT01961674|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-02-01|||November 2013||2013-11-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Studying the Effect of Capsinoids on Brown Fat Using Infrared Thermal Imaging.|Infrared Thermal Imaging for Assessing the Effect of Capsinoids on Brown Adipose Tissue Activity.|Completed||N/A|40|Actual|Clinical Nutrition Research Centre, Singapore||2|||f||||f||||||||||2017-10-11 01:12:48.027877|2017-10-11 01:12:48.027877
NCT01961661|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-11|||September 2009||2009-09-01|October 2013|2013-10-01||||December 2009|Actual|2009-12-01||Interventional|||Probiotics on Intestinal Inflammation in Cystic Fibrosis|Effect of Probiotics on Intestinal Inflammation and Microflora in Cystic Fibrosis: a Pilot Study|Completed||Phase 3|22|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 01:12:48.137886|2017-10-11 01:12:48.137886
NCT01961648|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-06-26|||August 2013||2013-08-01|September 2013|2013-09-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|||Respiratory Drive on Obstructive Apnea|Effect of Increasing Respiratory Drive on Severity of Obstructive Apnea|Terminated||N/A|13|Actual|University of Manitoba||2||Investigators were not able to continue recruiting and enrolling.|f||||t||||||||||2017-10-11 01:12:48.256679|2017-10-11 01:12:48.256679
NCT01961635|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2017-04-29|||January 2016||2016-01-01|April 2017|2017-04-01|March 23, 2017|Actual|2017-03-23|March 23, 2017|Actual|2017-03-23||Interventional|||Healing of Bone/Soft Tissue to Different Abutment Biomaterials and the Impact on Marginal Bone Loss|Healing Response if Peri-implant Tissues to Different Abutment Materials - Double-blinded Randomized Clinical Trial|Completed||N/A|60|Actual|Instituto de Implantologia||3|||f||||f||||||||Undecided||2017-10-11 01:12:48.394233|2017-10-11 01:12:48.394233
NCT01961622|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2015-06-04|||April 2014||2014-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|AP@home04||Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions|An Open-label, Multi-centre, Randomised, Two-period, Crossover Study to Assess the Efficacy, Safety and Utility of 12 Week Day and Night Automated Closed-loop Glucose Control Under Free Living Conditions Compared to Conventional Insulin Pump Therapy Combined With Continuous Glucose Monitoring in Adults With Type 1 Diabetes With Sub-optimal Glucose Control|Completed||N/A|33|Actual|University of Cambridge||2|||f||||t||||||||||2017-10-11 01:12:48.581151|2017-10-11 01:12:48.581151
NCT01961609|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-02-08|||October 2013||2013-10-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SIGNATURE||Secukinumab in TNF-IR Psoriasis Patients.|Secukinumab In Patients With Moderate to Severe Active, Chronic Plaque Psoriasis Who Have Failed on TNFα antaGoNists: A Clinical Trial EvalUating Treatment REsults|Completed||Phase 3|230|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:12:48.708015|2017-10-11 01:12:48.708015
NCT01961596|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-07-19|||October 2013||2013-10-01|July 2016|2016-07-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||"The Influence of a Cooling Ice Spray  Application on the Time to Stability After a Forward Jump?"|"Does Have a Short-term Cooling Ice Spray Application at the Lateral Ankle an Influence on the Time to Stability After a Forward Jump?"|Completed||N/A|22|Actual|Balgrist University Hospital||2|||f||||f||||||||No||2017-10-11 01:12:48.887439|2017-10-11 01:12:48.887439
NCT01961583|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-02-27|||September 2013||2013-09-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||[18F]Fluciclatide PET Imaging of Pazopanib Response|Evaluation of [18F]FluciclatidePositron Emission Tomography For the Prediction of Response to Pazopanib In Patients With Metastatic Renal Cell Carcinoma: An Exploratory Study|Terminated||Phase 2|12|Actual|Asan Medical Center||1||Termination of [18F]Fluciclatide production|f||||f||||||||||2017-10-11 01:12:48.972203|2017-10-11 01:12:48.972203
NCT01961570|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-18|||October 2013||2013-10-01|October 2013|2013-10-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01||Observational|||Clinical Evaluation of the Articulinx InterCarpoMetacarpal Cushion (ICMC)for Osteoarthritis of the First CarpoMetacarpal Joint|Clinical Evaluation of the Articulinx InterCarpoMetacarpal Cushion (ICMC) for Osteoarthritis of the First CarpoMetacarpal Joint: A New Study of the ICMC in a Clinical Setting|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Articulinx|||1||f||||f||||||||||2017-10-11 01:12:49.081381|2017-10-11 01:12:49.081381
NCT01961557|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-10-05|||September 24, 2013||2013-09-24|June 15, 2017|2017-06-15|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Observational|||Evaluating a New Knee-Ankle-Foot Brace to Improve Crouch Gait in People With Cerebral Palsy|Evaluating an Extension Assist Knee Ankle Foot Orthosis to Improve Crouch Gait in Cerebral Palsy|Recruiting||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:12:49.369748|2017-10-11 01:12:49.369748
NCT01961544|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-08-16|2016-08-16||June 2013||2013-06-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|ESKIMO||Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer|Phase IV Clinical Trial to Evaluate Safety of Eribulin in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 4|101|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 01:12:49.470478|2017-10-11 01:12:49.470478
NCT01961531|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-05-23|||July 2014||2014-07-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB)|BrUOG 291: FIVE FRACTION PARTIAL BREAST IRRADIATION USING NON-INVASIVE IMAGE-GUIDED BREAST BRACHYTHERAPY (NIBB)|Active, not recruiting||Phase 2|40|Actual|Brown University||1|||f||||t||||||||||2017-10-11 01:12:49.892757|2017-10-11 01:12:49.892757
NCT01961518|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-08-10|||October 2013||2013-10-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Observational|||Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome|Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome Type A and Maroteaux-Lamy Syndrome|Completed||N/A|17|Actual|Greenwood Genetic Center|||1||f||||f||||||Samples With DNA|"     Consent will be requested for specimen storage (DNA and urine) to allow use of the specimens     for future research related or unrelated to the participant's condition.   "|||2017-10-11 01:12:49.966275|2017-10-11 01:12:49.966275
NCT01961492|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2014-12-02|||October 2013||2013-10-01|December 2014|2014-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fecal Microbiota Transplantation in Patients With Ulcerative Colitis|Single Fecal Microbiota Transplantation Via Colonoscope as an Adjunct Therapy in the Treatment of Ulcerative Colitis|Recruiting||Phase 1|40|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-11 01:12:50.132491|2017-10-11 01:12:50.132491
NCT01961479|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-09-19|||July 2013||2013-07-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|July 2017|Actual|2017-07-01||Interventional|praemensis||Treatment of Premenstrual Syndrome - Internet-based Self-help|Development and Evaluation of an Internet-based Cognitive Behaviour Therapy for Women With Premenstrual Syndrome (PMS)|Active, not recruiting||N/A|130|Anticipated|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-10-11 01:12:50.212239|2017-10-11 01:12:50.212239
NCT01961466|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2013-10-10||||||October 2013|2013-10-01||||December 2013|Anticipated|2013-12-01||Observational|DPP||Diabetes and Psychological Profile|Prospective Study on the Influence of Psychosocial Variables (Stress, Type A Behaviour Pattern, Quality of Life of the Diabetic) on Glycemic Balance in Patients With Type 1 and 2 Diabetes.|Unknown status|Recruiting|N/A|600|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||f||||||||||2017-10-11 01:12:50.318588|2017-10-11 01:12:50.318588
NCT01961453|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-08-09|||August 2013||2013-08-01|October 2014|2014-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|ISMN||Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function|Targeting Wave Reflections to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function in Hypertension|Withdrawn||Phase 2|0|Actual|Corporal Michael J. Crescenz VA Medical Center||2||Funding|f||||f||||||||||2017-10-11 01:12:50.404478|2017-10-11 01:12:50.404478
NCT01961440|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-09|||October 2013||2013-10-01|September 2013|2013-09-01||||December 2014|Anticipated|2014-12-01||Observational|||Prognosis Scoring System for Acute-on-Chronic Liver Failure||Unknown status|Not yet recruiting|N/A|1000|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||1||f||||||||||||||2017-10-11 01:12:50.525099|2017-10-11 01:12:50.525099
NCT01961414|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-10-29|||October 2013||2013-10-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|RANGE||Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910|Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)|Unknown status|Active, not recruiting|Phase 4|45|Anticipated|Palmetto Retina Center, LLC||1|||f||||f||||||||||2017-10-11 01:12:50.686669|2017-10-11 01:12:50.686669
NCT01961401|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-11-11|||January 2013||2013-01-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|GDMakutt||Acute Effects of Moderate Versus High Intensity Exercise on Insulin Sensitivity in Gestational Diabetes Mellitus|Acute Effects of Moderate Versus High Intensity Exercise on Insulin Sensitivity in Pregnant Women With and Without Gestational Diabetes Mellitus|Recruiting||N/A|24|Anticipated|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 01:12:50.763991|2017-10-11 01:12:50.763991
NCT01961388|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-06-14|||August 2015||2015-08-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|STARCH AM||Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy|Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy|Withdrawn||N/A|0|Actual|Bayer|||2||f||||f||||||||||2017-10-11 01:12:50.86996|2017-10-11 01:12:50.86996
NCT01961375|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2017-09-19|||November 30, 2015|Actual|2015-11-30|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|October 30, 2017|Anticipated|2017-10-30||Observational|MIDAS||MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study|MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study.|Recruiting||N/A|600|Anticipated|Bayer|||1||f||||f||||||||||2017-10-11 01:12:50.983831|2017-10-11 01:12:50.983831
NCT01961362|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-05-02|||October 2013||2013-10-01|April 2015|2015-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Supplemental Oxygen in Pulmonary Fibrosis|Observing the Effects of Supplemental Oxygen on Patients With Pulmonary Fibrosis|Completed||N/A|360|Actual|National Jewish Health|||3||f||||t||||||||||2017-10-11 01:12:52.756041|2017-10-11 01:12:52.756041
NCT01961349|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2015-10-27|2015-03-24||October 2013||2013-10-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Kagami_SDS||Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy|A Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III Confirmatory Study to Assess Efficacy and Safety of the Moderate Sedation of ICI35,868 With and Without EES0000645/A on Gastrointestinal Endoscopy|Completed||Phase 3|279|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 01:12:52.838961|2017-10-11 01:12:52.838961
NCT01961336|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-10|2016-06-27|||October 2013||2013-10-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF|The Effect of Transdermal Testosterone Pretreatment in Poor Responders Undergoing Ovarian Stimulation for In-vitro Fertilization (IVF)|Completed||Phase 3|50|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-11 01:12:53.17811|2017-10-11 01:12:53.17811
NCT01961323|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-06-22|||March 2012||2012-03-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart|Effects of Nebivolol on Left Ventricular and Left Atrial Morphodynamics in Adults With Hypertension and Isolated Diastolic Dysfunction|Completed||Phase 4|70|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 01:12:53.27376|2017-10-11 01:12:53.27376
NCT01961310|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-01-31|||March 8, 2016|Actual|2016-03-08|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|MICROPOLY||Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis|Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 01:12:53.410715|2017-10-11 01:12:53.410715
NCT01961284|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-09-20|||October 2013||2013-10-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Zygomatic Versus Conventional Dental Implants in Augmented Maxillae|Zygomatic Versus Conventional Dental Implants in Augmented Maxillae: a Pragmatic Multicentre Randomised Clinical Trial.|Withdrawn||N/A|0|Actual|NHS Lothian||2||Sponsor company decision to terminate study|f||||||||||||||2017-10-11 01:12:53.628405|2017-10-11 01:12:53.628405
NCT01961271|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-08-17|2016-03-29||June 2013||2013-06-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain|Multicentre Study To Evaluate Efficacy And Safety Of Buprenorphine Transdermal Patch (Norspan) In Chronic Non-Malignant Pain Of Moderate To Severe Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint / Muscle Pain, When Opioid Is Needed For Analgesia|Completed||Phase 4|114|Actual|Mundipharma Pte Ltd.||1|||f||||f||||||||||2017-10-11 01:12:53.880804|2017-10-11 01:12:53.880804
NCT01961258|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-04-12|||June 2015||2015-06-01|October 2013|2013-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01|30 Days|Observational [Patient Registry]|||"SEVERE ASTHMA in the COMMUNITY"|"SEVERE ASTHMA in the COMMUNITY: How Severe it Really is and to What Extent Its Management Has Been Exhausted"|Unknown status|Not yet recruiting|N/A|250|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 01:12:54.32469|2017-10-11 01:12:54.32469
NCT01961245|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-03-01|||December 2013|Actual|2013-12-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Nocturnal Non-invasive Ventilation on Energy Expenditure in Patients With Severe Chronic Obstructive Pulmonary Disease||Recruiting||N/A|85|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||||||||||||2017-10-11 01:12:54.398117|2017-10-11 01:12:54.398117
NCT01961232|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-01-27|||August 2013|Actual|2013-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Trans-pulmonary Biomarkers in Pulmonary Hypertension|Examination of Trans-pulmonary Biomarkers in Pulmonary Hypertension: a Potential Step Towards Personalized Therapy|Active, not recruiting||N/A|100|Anticipated|Vanderbilt University Medical Center|||4||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:12:54.505965|2017-10-11 01:12:54.505965
NCT01961219|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-11-17|||November 2013||2013-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Manipulation Under Anesthesia Versus Arthroscopic Capsular Release in the Treatment of Adhesive Capsulitis|Manipulation Under Anesthesia Versus Arthroscopic Capsular Release in the Treatment of Adhesive Capsulitis: A Comparison.|Recruiting||N/A|50|Anticipated|University of Missouri, Kansas City||2|||f||||f||||||||||2017-10-11 01:12:54.59557|2017-10-11 01:12:54.59557
NCT01961206|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-11-19|||October 2013||2013-10-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Observational|||Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis|Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase (ESBL)Producing Escherichia Coli or Klebsiella Pneumoniae in China: Prevalence, Risk Factors and Prognosis|Completed||N/A|960|Actual|Sir Run Run Shaw Hospital|||2||f||||f||||||Samples With DNA|"     bacterial strains   "|||2017-10-11 01:12:54.736444|2017-10-11 01:12:54.736444
NCT01961193|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2013-10-10|||May 2015||2015-05-01|October 2013|2013-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|COMLENPLSTAN||A Comparison Between Bandage Contact Lens, Punctal Plugs and Standard Measures in Preventing Corneal Injuries|A Comparison Between Bandage Contact Lens, Punctal Plugs and Standard Measures in Preventing Corneal Injuries Related to Exposure in Patients Admitted to the General Intensive Care Unit.|Unknown status|Not yet recruiting|N/A|105|Anticipated|Rabin Medical Center||3|||f||||t||||||||||2017-10-11 01:12:54.832638|2017-10-11 01:12:54.832638
NCT01961180|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-05-06|||June 2013||2013-06-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS|The Effect of Cipralex in Polycystic Ovary Syndrome|Completed||Phase 4|42|Actual|Odense University Hospital||2|||f||||t||||||||Yes||2017-10-11 01:12:54.980334|2017-10-11 01:12:54.980334
NCT01961154|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-08-31|||October 2012||2012-10-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Stepping Down of Asthma Medication in Controlled Asthma|Stepping Down of Asthma Medication in Controlled Asthma|Completed||N/A|56|Actual|Kuopio University Hospital||1|||f||||f||||||||||2017-10-11 01:12:55.189672|2017-10-11 01:12:55.189672
NCT01961141|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2015-08-12|||November 2014||2014-11-01|May 2013|2013-05-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|||Evaluation of Lung Doppler Signals in Patients Presenting to EMD|Evaluation of Lung Doppler Signals in Patients With Acute Cardiovascular or Pulmonary Conditions Presenting to the Emergency Medicine Department by a Modified Ultrasound Doppler TCD Device.|Withdrawn||N/A|0|Actual|Echosense Ltd.|||1|review the study concept|f||||f||||||||||2017-10-11 01:12:55.289661|2017-10-11 01:12:55.289661
NCT01961128|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2014-04-28|||October 2011||2011-10-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||RPFNA Assessment of Exercise Effect in Breast Cancer|Pilot Feasibility Study of the Use of Random Periareolar Fine Needle Aspiration Exercise Induced Changes in Breast Tissue|Completed||N/A|2|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-11 01:12:55.366162|2017-10-11 01:12:55.366162
NCT01961115|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-10-04|||September 13, 2013|Actual|2013-09-13|October 2017|2017-10-01|March 20, 2018|Anticipated|2018-03-20|October 31, 2016|Actual|2016-10-31||Interventional|||Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma|A Phase II Pilot Trial of an Indoleamine 2,3, Dioxygenase-1 (IDO1) Inhibitor (INCB024360) Plus a Multipeptide Melanoma Vaccine (MELITAC 12.1) in Patients With Advanced Melanoma|Active, not recruiting||Phase 2|12|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-10-11 01:12:55.436042|2017-10-11 01:12:55.436042
NCT01961102|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-08-07|||May 2013||2013-05-01|December 2015|2015-12-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Observational|||OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer|Pilot-study of OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer|Completed||N/A|300|Actual|Krankenhaus Barmherzige Schwestern Linz|||1||f||||t||||||||||2017-10-11 01:12:55.528943|2017-10-11 01:12:55.528943
NCT01961076|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-03-20|||November 2013||2013-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Overnight Feeding Study in Glycogen Storage Disease Type 1|New Approaches for Over-night Feeding in Glycogen Storage Disease Type 1 (GSD 1)|Completed||N/A|5|Actual|University of Zurich||3|||f||||||||||||||2017-10-11 01:12:55.706854|2017-10-11 01:12:55.706854
NCT01961063|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-09-07|||June 11, 2014|Actual|2014-06-11|September 2017|2017-09-01|June 2031|Anticipated|2031-06-01|June 2031|Anticipated|2031-06-01||Interventional|||Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma|Safety and Feasibility of Gene Transfer After Frontline Chemotherapy for Non-Hodgkin Lymphoma in AIDS Patients Using Peripheral Blood Stem/Progenitor Cells Treated With a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs|Active, not recruiting||N/A|3|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:12:55.917762|2017-10-11 01:12:55.917762
NCT01961050|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-02-18|||September 2007||2007-09-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Preventing FAS/ARND in Russian Children|Preventing FAS/ARND in Russian Children|Completed||N/A|767|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-11 01:12:56.02384|2017-10-11 01:12:56.02384
NCT01961037|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-12-22|||February 2014||2014-02-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Translation of an Evidence-Based Fall-Prevention Program Into Rural West Virginia Churches|Translation of an Evidence-Based Fall-Prevention Program Into Rural West Virginia Churches|Completed||N/A|236|Actual|West Virginia University||1|||f||||f||||||||||2017-10-11 01:12:56.147081|2017-10-11 01:12:56.147081
NCT01961024|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-05-01|||January 2014||2014-01-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Postprandial VLDL-TG Metabolism|Postprandial VLDL-TG Metabolism|Completed||N/A|21|Actual|University of Aarhus|||2||f||||t||||||Samples With DNA|"     specimen of muscle specimen of adipose tissue   "|||2017-10-11 01:12:56.272837|2017-10-11 01:12:56.272837
NCT01961011|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-09|||June 2012||2012-06-01|October 2013|2013-10-01|March 2014|Anticipated|2014-03-01|July 2013|Actual|2013-07-01||Observational|||Bilateral vs Unilateral CTR|Simultaneous Bilateral Versus Unilateral Carpal Tunnel Release: A Prospective Comparison of Early Pain and Limitations in Activities of Daily Living|Unknown status|Enrolling by invitation|N/A|120|Actual|Washington University School of Medicine|||2||f||||t||||||||||2017-10-11 01:12:56.338942|2017-10-11 01:12:56.338942
NCT01960998|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-09-28|||August 11, 2014|Actual|2014-08-11|September 2017|2017-09-01|September 30, 2018|Anticipated|2018-09-30|June 18, 2018|Anticipated|2018-06-18||Interventional|ProsTel||Perioperative Post-Prostatectomy Incontinence Home Telehealth Program|Perioperative Post-Prostatectomy Incontinence Home Telehealth Program|Active, not recruiting||N/A|244|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:12:56.446799|2017-10-11 01:12:56.446799
NCT01960985|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2015-06-29|||August 2006||2006-08-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|December 2008|Actual|2008-12-01||Interventional|||Balance Training in Parkinson's Disease Using Cues|Efficiency of Motor Training Program Associated With Extrenal Cues on the Balance of Patients With Parkinson's Disease.|Completed||Phase 3|42|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 01:12:56.607871|2017-10-11 01:12:56.607871
NCT01960972|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-08-24|||March 2014|Actual|2014-03-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2017|Actual|2017-03-01||Interventional|||Launching a Salt Substitute to Reduce Blood Pressure at the Population Level in Peru|Launching a Salt Substitute to Reduce Blood Pressure at the Population Level - Peru|Completed||N/A|2376|Actual|Universidad Peruana Cayetano Heredia||1|||f||||f||||||||||2017-10-11 01:12:56.749492|2017-10-11 01:12:56.749492
NCT01960946|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-06-06|||October 2013||2013-10-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Galectin-3 Blockade in Patients With High Blood Pressure|Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension|Recruiting||N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-11 01:12:56.850495|2017-10-11 01:12:56.850495
NCT01960933|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-10-17|||May 2011||2011-05-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2015|Actual|2015-02-01||Interventional|PRIMULTI||Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization|Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization (DANAMI-3-PRIMULTI) A Randomised Comparison of the Clinical Outcome After Complete Revascularisation Versus Treatment of the Infarct-related Artery Only During Primary Percutaneous Coronary Intervention|Active, not recruiting||N/A|650|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:12:56.975206|2017-10-11 01:12:56.975206
NCT01960920|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2015-08-24|||February 2013||2013-02-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Air Pollution Exposure Reduction by Filter Mask on Heart Failure|Effects of Air Pollution Exposure Reduction by Filter Mask on Heart Failure: a Prospective Randomized Double-blind Controlled Trial|Completed||N/A|45|Actual|InCor Heart Institute||2|||f||||f||||||||||2017-10-11 01:12:57.108179|2017-10-11 01:12:57.108179
NCT01960907|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-09-29|2016-07-26||October 2013||2013-10-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|CHROMED||Clinical Trials for Elderly Patients With Multiple Disease|Clinical Trials for Elderly Patients With Multiple Disease|Completed||N/A|312|Actual|Restech Srl||2|||f||||f||||||||||2017-10-11 01:12:57.261639|2017-10-11 01:12:57.261639
NCT01960894|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-10|||September 2013||2013-09-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|NIPVA||Non-invasive Pressure-Volume Analysis (NIPVA): Extending Comprehensive Left Ventricular Pump Function Assessment to More Patients and Settings|Non-invasive Pressure-Volume Analysis (NIPVA): Extending Comprehensive Left Ventricular Pump Function Assessment to More Patients and Settings|Unknown status|Recruiting|N/A|60|Anticipated|Imperial College London|||1||f||||f||||||||||2017-10-11 01:12:57.777143|2017-10-11 01:12:57.777143
NCT01960868|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2013-10-09|||October 2013||2013-10-01|October 2013|2013-10-01|April 2015|Anticipated|2015-04-01|October 2014|Anticipated|2014-10-01||Interventional|||Early Rehabilitation Program is Feasible and Safe in ICU in Liver Transplanted Patients|Early Rehabilitation Program is Feasible and Safe in ICU in Liver Transplanted Patients|Unknown status|Active, not recruiting|N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-10-11 01:12:58.128562|2017-10-11 01:12:58.128562
NCT01960855|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-06-30||2016-06-30|October 2013||2013-10-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 Given With Methotrexate (MTX) in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Anti-TNF Biologic Therapy|Completed||Phase 2|276|Actual|AbbVie||5|||f||||f||||||||||2017-10-11 01:12:58.233065|2017-10-11 01:12:58.233065
NCT01960478|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-10-10|||October 2013||2013-10-01|October 2013|2013-10-01||||March 2016|Anticipated|2016-03-01||Interventional|||Predictive Value of Copeptin in the Diagnosis of Acute Ischemic Stroke|Predictive Value of Copeptin in the Diagnosis of Acute Ischemic Stroke|Unknown status|Not yet recruiting|N/A|150|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 01:13:06.770145|2017-10-11 01:13:06.770145
NCT01960842|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-04-11|2016-03-03||October 2013||2013-10-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Safety Analysis Set: All subjects who had undergone the N-J placement procedure.|A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications|An Open-Label, Single-Arm, Baseline-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medication|Completed||Phase 3|31|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 01:12:58.796193|2017-10-11 01:12:58.796193
NCT01960829|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-04-30|||September 2013||2013-09-01|April 2015|2015-04-01||||May 2015|Anticipated|2015-05-01||Interventional|||Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study|A Single-armed, Open-labeled and Single-centered Phase II Trial of Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study|Unknown status|Recruiting|Phase 2|60|Anticipated|Beijing Cancer Hospital||1|||f||||f||||||||||2017-10-11 01:12:59.918178|2017-10-11 01:12:59.918178
NCT01960816|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-08-18|2016-07-12||September 2013||2013-09-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||InFlux System for Nasal Breathing Improvement|Pilot Study of Aerin Medical's InFlux System for Improvement in Nasal Breathing|Completed||N/A|33|Actual|Aerin Medical||1|||f||||f||||||||No||2017-10-11 01:13:00.032424|2017-10-11 01:13:00.032424
NCT01960803|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-11-06|||May 2013||2013-05-01|November 2016|2016-11-01|July 2023|Anticipated|2023-07-01|July 2022|Anticipated|2022-07-01||Interventional|||Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)|Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT) As A Single, Full Dose Partial Breast Irradiation For Early Stage, Node Negative, Invasive Breast Cancer|Recruiting||N/A|100|Anticipated|Advocate Health Care||1|||f||||f||||||||No||2017-10-11 01:13:01.264428|2017-10-11 01:13:01.264428
NCT01960790|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-05-30|||May 25, 2013||2013-05-25|May 2017|2017-05-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Observational|||Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)|Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)|Completed||N/A|473|Actual|AbbVie|||1||f||||||||||||||2017-10-11 01:13:01.480116|2017-10-11 01:13:01.480116
NCT01960777|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-03-07|||March 2014||2014-03-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ONLAP||Chronic Pain After Inguinal Hernia Repair, the ONSTEP Technique Versus the Laparoscopic Approach|Chronic Pain After Inguinal Hernia Repair, ONSTEP vs. Laparoscopic Approach, A Randomised Observer Blinded Multicenter Study|Recruiting||N/A|188|Anticipated|Herlev Hospital||2|||f||||f||||||||||2017-10-11 01:13:02.685147|2017-10-11 01:13:02.685147
NCT01960764|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-05-19|||August 2015||2015-08-01|May 2014|2014-05-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Interventional|||Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival|Phase 1 Study of Whether Host Preconditioning Modifies Short-term Transplant Survival|Unknown status|Not yet recruiting|Phase 1|14|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:13:02.792439|2017-10-11 01:13:02.792439
NCT01960751|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-10-08|||October 2013||2013-10-01|October 2013|2013-10-01|March 2015|Anticipated|2015-03-01|October 2014|Anticipated|2014-10-01||Interventional|CogRad||Long Term Neurocognitive Effects of Low-dose Radiation in the Brain: Study of 150 Patients in the French Hemangioma Cohort|Etude Des séquelles Neurocognitives à Long Terme Des Faibles Doses de Radiation Chez 150 Patients traités Par radiothérapie Dans l'Enfance Pour un hémangiome cutané à l'Institut Gustave Roussy (IGR) Entre 1941 et 1973|Unknown status|Not yet recruiting|N/A|150|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 01:13:02.894095|2017-10-11 01:13:02.894095
NCT01960738|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-09|||June 2012||2012-06-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|Checklists||Common Recreational Diving Practices: A Randomized Control Trial Using Pre-Dive Checklist|A Group Randomized Trial to Evaluate the Efficacy of Using Pre-dive Checklist to Prevent the Incidence of Recreational Scuba Diving Mishaps|Completed||N/A|1116|Actual|Divers Alert Network||2|||f||||||||||||||2017-10-11 01:13:03.063804|2017-10-11 01:13:03.063804
NCT01960725|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-03-10|2016-11-08||February 2014||2014-02-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)|An Open-label, Pilot Study to Compare the Safety and Immunogenicity of an Alternate Dosing Schedule (2-5 Weeks, 2 Months, and 4 Months) for Pentavalent Rotavirus Vaccine (RotaTeq) to the Standard Recommended Schedule (2, 4, and 6 Months)|Completed||Phase 4|66|Actual|Duke University||2|||f||||f||||||||No||2017-10-11 01:13:03.212673|2017-10-11 01:13:03.212673
NCT01960712|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-02-17|||November 2008||2008-11-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|||The Role of Transpapillary Stenting in the Treatment of Bile Leakage After Liver Transection.|The Role of Transpapillary Stenting in the Treatment of Bile Leakage After Liver Transection.|Enrolling by invitation||Phase 2|40|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 01:13:03.928429|2017-10-11 01:13:03.928429
NCT01960699|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-02-08|||October 2013||2013-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01|3 Years|Observational [Patient Registry]|||Proteomic Profiling to Reveal Novel Prognostic Markers for Neurological Outcome Following Resuscitation|Proteomic Profiling to Reveal Novel Prognostic Markers for Neurological Outcome Following Resuscitation|Active, not recruiting||N/A|100|Anticipated|Medical University of Vienna|||2||f||||f||||||Samples Without DNA|"     Plasma samples stored at -80°C   "|||2017-10-11 01:13:04.023188|2017-10-11 01:13:04.023188
NCT01960686|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-04-27||2015-10-15|October 2013||2013-10-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||RSV F Dose-Ranging Study in Women|A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age|Completed||Phase 2|720|Actual|Novavax||8|||f||||t||||||||||2017-10-11 01:13:04.136296|2017-10-11 01:13:04.136296
NCT01960491|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-07-19|||May 2014||2014-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|January 2017|Actual|2017-01-01||Interventional|||FIH Study With CBSO|Prospective Single Center Pilot Clinical Study to Evaluate the Safety and Effectiveness of an Intracardiac Septal Closure Device With Biodegradable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)|Active, not recruiting||N/A|15|Actual|Carag AG||1|||f||||f||||||||||2017-10-11 01:13:06.681584|2017-10-11 01:13:06.681584
NCT01960673|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-11-11|||September 2013||2013-09-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||The Influence of Head and Neck Position About Oropharyngeal Leak Pressure and Sealing Between the Laryngeal Mask and Vocal Cord Using Different Types of Supraglottic Airway Device|The Influence of Head and Neck Position About Oropharyngeal Leak Pressure and Sealing Between the Laryngeal Mask and Vocal Cord Using Different Types of Supraglottic Airway Device|Completed||Phase 1/Phase 2|120|Actual|National Taiwan University Hospital||4|||f||||f||||||||||2017-10-11 01:13:04.354754|2017-10-11 01:13:04.354754
NCT01960660|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-12-10|||May 2012||2012-05-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Marketing-oriented Study to Evaluate the Comparative Bioavailability of Omega-3 Fatty Acids From Four Different Natural Health Products|A Marketing-oriented Study to Evaluate the Comparative Bioavailability of Omega-3 Fatty Acids From Four Different Natural Health Products|Completed||N/A|35|Actual|Nordic Pharma, USA||4|||f||||f||||||||||2017-10-11 01:13:04.502438|2017-10-11 01:13:04.502438
NCT01960647|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-10-09|||May 2011||2011-05-01|October 2013|2013-10-01||||September 2014|Anticipated|2014-09-01||Interventional|||FREERIDE STUDY, Freeway Paclitaxel Coated Balloon Catheter to Treat Peripheral Artery Disease|Phase III FREERIDE STUDY Freeway Randomized Angioplasty Study|Unknown status|Recruiting|Phase 3|280|Anticipated|Eurocor GmbH||2|||f||||f||||||||||2017-10-11 01:13:04.645142|2017-10-11 01:13:04.645142
NCT01960634|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-05-04|||April 2013||2013-04-01|April 2015|2015-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|BRAFV600||Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma|Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma|Completed||N/A|58|Actual|Grupo Español Multidisciplinar de Melanoma|||1||f||||t||||||Samples With DNA|"     Serum and Plasma   "|||2017-10-11 01:13:04.824842|2017-10-11 01:13:04.824842
NCT01960621|ClinicalTrials.gov processed this data on October 10, 2017|2008-05-08|2015-08-26|||August 2016||2016-08-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Cyclodextrin on Sensory Nerve Activity: A Novel Anti-tussive Therapy|The Effect of Cyclodextrin on Sensory Nerve Activity and the Cough Relex in Man: A Novel Anti−Tussive Therapy|Terminated||Phase 4|18|Actual|Imperial College London||1||"Study has not been able to start due to difficulty in obtaining an intravenous formulation of   cyclodextrin (intravenous 2HPBCD) suitable for man"|f||||||||||||||2017-10-11 01:13:04.930729|2017-10-11 01:13:04.930729
NCT01960608|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2016-03-29|||January 2015||2015-01-01|March 2016|2016-03-01||||January 2015|Actual|2015-01-01||Observational|||The Analysis of Correlation About the Spot Urine Sodium and the Blood Pressure in General Population According to the Income Level||Completed||N/A|7000|Actual|Inje University|||7||f||||||||||||||2017-10-11 01:13:05.009276|2017-10-11 01:13:05.009276
NCT01960595|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2013-10-09|||August 2013||2013-08-01|May 2013|2013-05-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Interventional|||Post-operative Pain Management In Patients Undergoing Hullax Valgus Surgery|Comparison of the Efficacy and Cost Analysis of Regional Anesthesia and Intravenous Fentanyl for Postoperative Pain Management in Patients Undergoing Hullax Valgus Surgery|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||t||||||||||2017-10-11 01:13:05.100877|2017-10-11 01:13:05.100877
NCT01960582|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-03-31|||April 2013||2013-04-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|November 2015|Anticipated|2015-11-01||Interventional|FORMASEvid||Evaluation of Housing Adaptations and Mobility Devices|Housing Adaptations and Mobility Devices - Evaluation of a New Practice Strategy|Unknown status|Recruiting|N/A|340|Anticipated|Lund University||2|||f||||f||||||||||2017-10-11 01:13:05.178965|2017-10-11 01:13:05.178965
NCT01960556|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-09|||December 2010||2010-12-01|October 2013|2013-10-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|CA-BSI||Simulation-Based Central Venous Line Maintenance Bundle Education|Simulation-Based Pediatric Intensive Care Unit Central Venous Line Maintenance Bundle Education|Completed||N/A|80|Actual|Children's Healthcare of Atlanta|||2||f||||f||||||||||2017-10-11 01:13:05.401186|2017-10-11 01:13:05.401186
NCT01960543|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2015-02-03|||October 2013||2013-10-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Bupivacaine and Levobupivacaine on Cerebral Oxygenation During Intrathecal Anesthesia in Elderly Patients|Comparison of the Effects of Bupivacaine or Levobupivacaine on Cerebral Oxygenation During Intrathecal Anesthesia in Elderly Patients Who Underwent Hip Fracture Repair|Completed||Phase 4|58|Actual|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-11 01:13:05.483991|2017-10-11 01:13:05.483991
NCT01960530|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2017-04-12|2016-04-14||October 2013||2013-10-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||Healthy volunteers|An Investigational Study of Hydrocortisone|An Open Label, Partially Randomised, Single Dose, Crossover Study to Evaluate the PK, Oral Bioavailability and Relationship to Metabolic Parameters of Hydrocortisone and Infacort® in Healthy Adult Male Volunteers.|Completed||Phase 1|14|Actual|Diurnal Limited||5|||f||||f||||||||No||2017-10-11 01:13:05.818657|2017-10-11 01:13:05.818657
NCT01960517|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-01-22|||January 2014||2014-01-01|October 2013|2013-10-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|ACS1||Feasibility Assessment of ACS Catheter|A Feasibility Assessment of a New Urinary Catheter: The Alternative Catheter System ACS)|Withdrawn||Phase 2/Phase 3|0|Actual|Alternative Urological Catheter Systems Ltd.||1||Sponsor decision not to proceed with study|f||||f||||||||||2017-10-11 01:13:06.40023|2017-10-11 01:13:06.40023
NCT01960504|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2017-02-02|||October 2013|Actual|2013-10-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|August 2015|Actual|2015-08-01||Interventional|BIOSOLVE-II||First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II)|BIOTRONIK - Safety and Clinical PerFormance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects With de NOvo Lesions in NatiVE Coronary Arteries: BIOSOLVE-II|Active, not recruiting||N/A|121|Anticipated|Biotronik AG||1|||f||||t||||||||||2017-10-11 01:13:06.493092|2017-10-11 01:13:06.493092
NCT01960465|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-09-07|||January 5, 2015|Actual|2015-01-05|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|June 30, 2018|Anticipated|2018-06-30||Interventional|RACE||Race And CPAP Effectiveness|Targeted Treatment of Obstructive Sleep Apnea to Reduce Cardiovascular Disparity|Recruiting||N/A|220|Anticipated|VA Office of Research and Development||2|||f||||t|f|t|f|f|f|||||2017-10-11 01:13:06.855937|2017-10-11 01:13:06.855937
NCT01960452|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-05-01|||October 2013||2013-10-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||A High Density EEG Comparison of Sleep Patterns in Insomnia|A High Density EEG Comparison of Sleep, Sleep Initiation, and Arousal Patterns in Insomnia Patients and Normal Controls|Recruiting||N/A|40|Anticipated|University of Wisconsin, Madison|||2||f||||f||||||||||2017-10-11 01:13:06.962911|2017-10-11 01:13:06.962911
NCT01960439|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-12-01|||July 2013||2013-07-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Responsiveness of Endoscopic Evaluation in UC|Responsiveness of Endoscopic Evaluation of Ulcerative Colitis Using a Central Reader Based Image Management System|Completed||N/A|194|Actual|University of Western Ontario, Canada|||1||f||||f||||||||||2017-10-11 01:13:07.068728|2017-10-11 01:13:07.068728
NCT01960426|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-05-12|||April 2014||2014-04-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Test-NoTest||Evaluation of Health Costs and Resource Utilization|A Randomized Evaluation of Health Costs and Resource Utilization Comparing Testing-Based Therapy to Empiric Dose Intensification for the Management of Inflammatory Bowel Disease.|Terminated||Phase 4|51|Actual|University of Western Ontario, Canada||2||recruitment issues|f||||f||||||||Undecided||2017-10-11 01:13:07.174127|2017-10-11 01:13:07.174127
NCT01960413|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-14|||November 2013||2013-11-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia|Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia (Also Known as the Montelukast Trial in Sickle Cell Anemia)|Recruiting||Phase 2|63|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 01:13:07.319512|2017-10-11 01:13:07.319512
NCT01960400|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-12-13|2015-10-28||April 2013||2013-04-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Investigation of the Efficacy of tDCS in the Treatment of Complex Regional Pain Syndrome (CRPS) Type 1|Investigation of the Efficacy of Transcranial Direct Current Stimulation (tDCS) Added to the Graded Motor Imagery (GMI) in the Treatment of Complex Regional Pain Syndrome (CRPS) Type 1|Completed||N/A|22|Actual|Université de Sherbrooke||2|||f||||t||||||||||2017-10-11 01:13:07.493301|2017-10-11 01:13:07.493301
NCT01960387|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-06-21|2016-04-26||October 2013||2013-10-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|UPCI 13-066|Patients with newly diagnosed AML based on the WHO classification, who have persistent disease after their first course treatment with an anthracycline and cytarabine.|Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia|A Phase II Study of Clofarabine and Cytarabine for Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Persistent Disease After Treatment With an Anthracycline and Cytarabine|Terminated||Phase 2|2|Actual|University of Pittsburgh|Results data is not available for Overall Survival, Relapse-free Survival, or assessment of potential predictive factors for response to treatment, due to early termination leading to small numbers of subjects analyzed.|1||lack of accrual|f||||t||||||||||2017-10-11 01:13:08.129452|2017-10-11 01:13:08.129452
NCT01960374|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2014-05-30|||October 2013||2013-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK|A Phase I, Single-centre, Open-label, Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Selumetinib Given Orally in Japanese and Non-Japanese Asian Healthy Male Volunteers|Completed||Phase 1|117|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:13:08.397761|2017-10-11 01:13:08.397761
NCT01960361|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2016-06-28|||January 2015||2015-01-01|December 2015|2015-12-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|ICE||A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant|A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant System Over 24 Months, for Patients With Tooth Loss Requiring up to 4 Implants, in Staged Loading Protocol|Active, not recruiting||Phase 4|35|Anticipated|Alpha - Bio Tec Ltd.||1|||f||||t||||||||||2017-10-11 01:13:08.565504|2017-10-11 01:13:08.565504
NCT01960348|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-09|2017-09-15|||November 2013||2013-11-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis|APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran (ALN-TTR02) in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP)|Completed||Phase 3|225|Actual|Alnylam Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:13:08.656975|2017-10-11 01:13:08.656975
NCT01960335|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2013-10-09|||January 2011||2011-01-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|January 2012|Actual|2012-01-01||Interventional|P+RISE||Whey Protein Intake With and Without Exercise on Visceral Fat: The P+RISE Study|Whey Protein With and Without Exercise Training Enhances Total and Regional Body Composition, Insulin, Leptin, and Blood Pressure in Overweight and Obese Adults - The P+RISE Study|Completed||N/A|79|Actual|Skidmore College||3|||f||||f||||||||||2017-10-11 01:13:08.88849|2017-10-11 01:13:08.88849
NCT01960322|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-06-30|||August 2014||2014-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|I-AM||Improving Medication-taking After Liver Transplant|Intervention After MALT (I-AM): Feasibility of Improving Adherence Among Pediatric and Adult Cardiac Transplant Patients Using a Telemetric Intervention|Completed||Phase 1|7|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 01:13:08.994233|2017-10-11 01:13:08.994233
NCT01960309|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-12-02|||September 2012||2012-09-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|AMI-NCS||Minimal Invasive Imaging of Coronary Artery Disease in Patients With Asymptomatic Myocardial Injury After Major Non-cardiac Surgery.|Minimal Invasive Imaging of Coronary Artery Disease in Patients With Asymptomatic Myocardial Injury After Major Non-cardiac Surgery.|Unknown status|Recruiting|N/A|70|Anticipated|UMC Utrecht||6|||f||||t||||||||||2017-10-11 01:13:09.089258|2017-10-11 01:13:09.089258
NCT01959750|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-10-09|||April 2009||2009-04-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2009|Actual|2009-12-01||Interventional|||Psychological Intervention on Burnout in ICU Caregivers|Psychological Intervention on Burnout in ICU Caregivers: a Randomised Controlled Study|Completed||N/A|166|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 01:13:19.019855|2017-10-11 01:13:19.019855
NCT01960296|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-04-28|2017-03-17||January 2012||2012-01-01|April 2017|2017-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Does Continued Use of Clopidogrel Into Surgery Cause Increased Perioperative Bleeding?|Evaluation of Clopidogrel Use in Peri-Operative General Surgery Patients: A Prospective Study|Completed||Phase 2|48|Actual|Icahn School of Medicine at Mount Sinai|The major limitation of the study is its low sample size, making it underpowered to draw unequivocal conclusions.|2|||f||||t||||||||||2017-10-11 01:13:09.207554|2017-10-11 01:13:09.207554
NCT01960283|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-09-19|||November 2011|Actual|2011-11-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|MUCIS||Methotrexate in the Treatment of Chronic Idiopathic Urticaria|Randomized Clinical Trial Evaluating the Efficacy of Methotrexate in Addition to Anti-H1 Versus Placebo and Anti-H1 in the Treatment of Severe Chronic Idiopathic Urticaria|Completed||Phase 3|83|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 01:13:09.840701|2017-10-11 01:13:09.840701
NCT01960270|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-08-21|||October 2013||2013-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|NEUROBIL||Secondary Bilateral Sacral Nerve Stimulation in Overactive Bladder Patients|Secondary Bilateral or Controlateral Sacral Nerve Stimulation in Overactive Bladder Patients With Unilateral Stimulation Failure - Multicenter Study|Recruiting||Phase 3|34|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 01:13:09.956031|2017-10-11 01:13:09.956031
NCT01960257|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-29|||October 25, 2013|Actual|2013-10-25|August 2017|2017-08-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis|A Pilot Clinical Trial Characterizing Use of Ingestion Sensor Enabled Rifamate in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis|Completed||Phase 4|78|Actual|mHealth UCSD||2|||f||||f||||||||||2017-10-11 01:13:10.148119|2017-10-11 01:13:10.148119
NCT01960244|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-08-01|||October 2013||2013-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01|3 Years|Observational [Patient Registry]|CASCADE-FH||Study of Awareness and Detection of Familial Hypercholesterolemia|CASCADE FH Registry (CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia Registry)|Recruiting||N/A|5000|Anticipated|The Familial Hypercholesterolemia Foundation|||1||f||||f||||||||||2017-10-11 01:13:10.241978|2017-10-11 01:13:10.241978
NCT01960231|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-06-18|||October 2013||2013-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Effect of ß-cell Specific Glucokinase Mutation on Glucose Homeostasis and Insulin Secretion in a MODY-2 Family||Recruiting||N/A|30|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 01:13:10.326076|2017-10-11 01:13:10.326076
NCT01960218|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2014-04-03|||October 2013||2013-10-01|April 2014|2014-04-01|January 2015|Anticipated|2015-01-01|July 2014|Anticipated|2014-07-01||Observational|||Gas Exchange for Predicting Hospital Heart Failure Readmissions|Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study|Unknown status|Recruiting|N/A|120|Anticipated|Shape Medical Systems, Inc.|||1||f||||f||||||||||2017-10-11 01:13:10.511101|2017-10-11 01:13:10.511101
NCT01960205|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-09-23|||August 2013||2013-08-01|September 2014|2014-09-01||||December 2014|Anticipated|2014-12-01||Interventional|||Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity|Effect of Saxagliptin on Body Fat , Glucose and Beta Cell Function in Patients With Newly Diagnosed Pre-Diabetes Mellitus and Obesity|Unknown status|Recruiting|Phase 4|80|Anticipated|Shandong Provincial Hospital||4|||f||||t||||||||||2017-10-11 01:13:10.64955|2017-10-11 01:13:10.64955
NCT01960192|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-07-19|||June 2012||2012-06-01|July 2015|2015-07-01|June 2020|Anticipated|2020-06-01|June 2016|Anticipated|2016-06-01||Interventional|FVD||Treatment of Primary CNS Lymphoma|The Prospective Study of FVD Program and HD-MTX-Ara-C Program Contrast in the Treatment of PCNSL Lymphoma.|Recruiting||Phase 4|50|Anticipated|Zhengzhou University||2|||f||||f||||||||||2017-10-11 01:13:10.815195|2017-10-11 01:13:10.815195
NCT01960179|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-04-08|||November 2013||2013-11-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes|An Open-label, Multicenter 24-Week And 52-Week Study Assessing The Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes|Completed||Phase 3|361|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:13:10.972321|2017-10-11 01:13:10.972321
NCT01960166|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-09|||June 2013||2013-06-01|October 2013|2013-10-01|June 2016|Anticipated|2016-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Active vs Passive Distraction on Procedural Pain in the Pediatric Emergency Department|Impact of Active vs Passive Distraction on Procedural Pain/Distress in the Pediatric Emergency|Unknown status|Recruiting|N/A|80|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 01:13:11.14253|2017-10-11 01:13:11.14253
NCT01960153|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-09-09|||October 2013||2013-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|PITCH-ER||Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage|Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage (PITCH-ER)|Withdrawn||Phase 3|0|Actual|Massachusetts General Hospital||2||Award was ended by NIH for parent study|f||||t||||||||||2017-10-11 01:13:11.254404|2017-10-11 01:13:11.254404
NCT01960140|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-05-15|2017-03-10||October 2013||2013-10-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All enrolled participants.|A Study of Baricitinib and Simvastatin in Healthy Participants|Effects of Multiple Baricitinib (LY3009104) Doses on the Pharmacokinetics of a Cytochrome P450 3A Substrate, Simvastatin, in Healthy Subjects|Completed||Phase 1|40|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:13:11.381605|2017-10-11 01:13:11.381605
NCT01960127|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-09|||October 2013||2013-10-01|October 2013|2013-10-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||Effects of Aerobic Training on Exercise Capacity in Patients With Advanced Cirrhosis 2|Effects of Aerobic Training on Exercise Capacity in Patients With Advanced Cirrhosis 2|Unknown status|Recruiting|N/A|20|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 01:13:11.70312|2017-10-11 01:13:11.70312
NCT01960114|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-06-11|2015-05-28|2015-03-23|October 2013||2013-10-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study of Long-Acting Acetaminophen in Postoperative Dental Pain|A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Efficacy, Safety, and Pharmacokinetics Study of Extended-Release (ER) Acetaminophen in Postoperative Dental Pain|Completed||Phase 2|403|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 01:13:11.847205|2017-10-11 01:13:11.847205
NCT01960101|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-12-02|||October 2013||2013-10-01|December 2015|2015-12-01||||March 2015|Anticipated|2015-03-01||Interventional|LactoXeros||Development of a Milk Product Substitution for Patients Suffering From Xerostomia Caused by Medication|Development of a Milk Product Substitution for Patients Suffering From Xerostomia Caused by Psychotropic Drugs and Comparison of Its Efficiency With the Use of Aequasyal (Oxidized Glycerol Triester)Spray.|Withdrawn||N/A|0|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-11 01:13:12.267893|2017-10-11 01:13:12.267893
NCT01960088|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-04-14|||July 2015||2015-07-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|AVIP||Adolescent Vaccination in Pharmacies|Building Evidence to Expand Adolescent Vaccination in Pharmacies|Recruiting||N/A|1704|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||None Retained|"     N=1200 anticipated in national study N=100 anticipated in pharmacy demonstration project   "|||2017-10-11 01:13:12.43795|2017-10-11 01:13:12.43795
NCT01960075|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-05-01|||October 2015||2015-10-01|May 2017|2017-05-01||||December 2019|Anticipated|2019-12-01||Interventional|ESETT||Established Status Epilepticus Treatment Trial|A Multicenter, Randomized, Blinded, Comparative Effectiveness Study of Fosphenytoin, Valproic Acid, or Levetiracetam in the Emergency Department Treatment of Patients With Benzodiazepine-refractory Status Epilepticus.|Recruiting||Phase 3|795|Anticipated|University of Virginia||3|||f||||t||||||||||2017-10-11 01:13:12.589149|2017-10-11 01:13:12.589149
NCT01960062|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-03-18|||October 2011||2011-10-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Impact of Web-based Care Management for Poorly Controlled Type 2 Diabetes Mellitus: a Randomized, Controlled Trial|Impact of Web-based Care Management for Poorly Controlled Type 2 Diabetes Mellitus: a Randomized, Controlled Trial|Withdrawn||N/A|0|Actual|Kaiser Permanente||2||no potential participants met the inclusion criteria|f||||f||||||||||2017-10-11 01:13:12.900389|2017-10-11 01:13:12.900389
NCT01960049|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-07-28|||October 2013||2013-10-01|May 2016|2016-05-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Novel Technique of Analgesia Following Open Liver Resection|Multicentre Evaluation of a Novel Technique of Analgesia Following Open Liver Resection: Medial Open Transversus Abdominis Plane (MOTAP) Catheters|Completed||Phase 4|150|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:13:13.005842|2017-10-11 01:13:13.005842
NCT01960036|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Body-oriented Therapy for Women in SUD Treatment|Body-oriented Therapy for Womens Substance Use Disorder Treatment|Active, not recruiting||N/A|219|Actual|University of Washington||3|||f||||f||||||||||2017-10-11 01:13:13.117821|2017-10-11 01:13:13.117821
NCT01960023|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-05-05|||October 2013||2013-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer|"A Phase I/II Dose-Escalation Study Evaluating the Combination of Neratinib and Cetuximab in Patients With Quadruple Wild-Type (KRAS/NRAS/BRAF/PIK3CA Wild-Type) Metastatic Colorectal Cancer Resistant to Cetuximab"|Active, not recruiting||Phase 1/Phase 2|22|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-10-11 01:13:13.260647|2017-10-11 01:13:13.260647
NCT01960010|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2014-08-25|||October 2013||2013-10-01|May 2014|2014-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye|A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye|Completed||Phase 3|403|Actual|Mimetogen Pharmaceuticals USA, Inc.||2|||f||||t||||||||||2017-10-11 01:13:13.457798|2017-10-11 01:13:13.457798
NCT01959997|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-09-21|||September 2013||2013-09-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI|Randomized Comparison of Redo Pulmonary Vein Isolation With vs. Without Renal Denervation for Recurrent Atrial Fibrillation After Initial Pulmonary Vein Isolation|Unknown status|Recruiting|Phase 2|60|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 01:13:13.583355|2017-10-11 01:13:13.583355
NCT01959984|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2013-10-09|||January 2013||2013-01-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||"Study on the Comparison BetweenStandard Noodles and Traditional Carbohydrates in the Diagnosis of Diabetes Mellitus."|"Study on the Comparison BetweenStandard Noodles and Traditional Carbohydrates in the Diagnosis of Diabetes Mellitus."|Unknown status|Active, not recruiting|N/A|240|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 01:13:13.724847|2017-10-11 01:13:13.724847
NCT01959971|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-04-28|||December 2013||2013-12-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol|A Phase 1 Study of the Effects of Subcutaneous Doses of Alirocumab on Lipid and Lipoprotein Metabolism in Adults With Mildly Elevated LDL-Cholesterol|Completed||Phase 1|20|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:13:13.807871|2017-10-11 01:13:13.807871
NCT01959958|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-05-09|||October 2013||2013-10-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease|Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease|Completed||N/A|250|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 01:13:13.92112|2017-10-11 01:13:13.92112
NCT01959945|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-08-02|2016-06-17||November 2013||2013-11-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)|Evaluation of the Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Quadrivalent Recombinant Influenza Vaccine,Seasonal Formulation) Administered Intramuscularly to Healthy Children and Adolescents Age 6-17 Years|Completed||Phase 3|219|Actual|Protein Sciences Corporation|The numbers of subjects available for analysis in Cohort B (age 6-8 years) was fewer than anticipated due to early termination of enrollment.|4|||f||||t||||||||||2017-10-11 01:13:14.026083|2017-10-11 01:13:14.026083
NCT01959932|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-08-19|2016-01-26||June 2013||2013-06-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional||"The study population consisted of all the randomized subjects who had at least 1 post randomization product use experience (THS 2.2 or CC arms), and 1 valid biomarker of exposure (BoExp) measurement.
160 randomized subjects: 80 in THS 2.2, 41 in CC and 39 in SA
159 completers: 1 subject (THS 2.2 arm) voluntarily withdrew on Day 3"|Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.|A Randomized, Controlled, Open-label, 3-arm Parallel Group, Single-center Study to Demonstrate Reductions in Exposure to Selected Smoke Constituents in Smoking, Healthy Subjects Switching to the Tobacco Heating System 2.2 (THS 2.2) or Smoking Abstinence, Compared to Continuing to Use Conventional Cigarettes, for 5 Days in Confinement.|Completed||N/A|169|Actual|Philip Morris Products S.A.||3|||f||||f||||||||No||2017-10-11 01:13:14.642449|2017-10-11 01:13:14.642449
NCT01959919|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-02-21|||January 2014||2014-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO|Non Interventional Longitudinal Study To Assess The Acceptability And The Satisfaction Of Patients With Haemophilia A Treated Both On Demand And On Prophylaxis With A New Factor Viii Delivery System Fusengo|Completed||N/A|87|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:13:16.977773|2017-10-11 01:13:16.977773
NCT01959906|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-09|||July 2013||2013-07-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Observational|||Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer.|Prognostic Value of a Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer.|Unknown status|Active, not recruiting|N/A|923|Actual|University Hospital, Gasthuisberg|||3||f||||f||||||||||2017-10-11 01:13:17.092834|2017-10-11 01:13:17.092834
NCT01959893|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-10-09|||December 2013||2013-12-01|October 2013|2013-10-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Observational|||Computerized Cognitive Testing in Patients Suffering From Fibromyalgia|Computerized Cognitive Testing in Patients Suffering From Fibromyalgia|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 01:13:17.18444|2017-10-11 01:13:17.18444
NCT01959880|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-09-23|2016-04-20||August 2013||2013-08-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||All subjects who signed informed consent and were implanted with MemoryGel breast implants.|CPG Styles Study: A Study of the Safety of the Contour Profile Gel Breast Implants (CPG Styles Study)|CPG Styles Study: A Study of the Safety of the Contour Profile Gel Breast Implants in Subjects Who Are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction or Revision|Completed||Phase 3|1891|Actual|Mentor Worldwide, LLC||4|||f||||f||||||||||2017-10-11 01:13:17.291157|2017-10-11 01:13:17.291157
NCT01959867|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-01-06|||January 2017||2017-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy|Clinical Study Comparing Two-Stage Breast Reconstruction Following Mastectomy With and Without the Use of SurgiMend® PRS Fetal Bovine Collagen Matrix in Patients With Pre-Mastectomy Radiation Therapy|Withdrawn||N/A|0|Actual|Integra LifeSciences Corporation||2|||f||||f||||||||||2017-10-11 01:13:17.965601|2017-10-11 01:13:17.965601
NCT01959854|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-10-15|||September 2013||2013-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye|Evaluation of Xanthan Gum Eye Drops in Patients With Dry Eye|Completed||N/A|30|Actual|SIFI SpA||2|||f||||f||||||||||2017-10-11 01:13:18.066059|2017-10-11 01:13:18.066059
NCT01959841|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-03-15|||August 2013||2013-08-01|March 2016|2016-03-01||||July 2015|Actual|2015-07-01||Interventional|||Phase III Study of ASP2151 in Herpes Zoster Patients|Phase III Study of ASP2151 in Herpes Zoster Patients― A Double-blind, Valaciclovir-controlled Study|Completed||Phase 3|750|Anticipated|Maruho Co., Ltd.||3|||f||||||||||||||2017-10-11 01:13:18.209515|2017-10-11 01:13:18.209515
NCT01959828|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-09-08|||September 2013||2013-09-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery|Examination of Safety and Effectiveness of IK-3001 (Nitric Oxide for Inhalation) in Japanese Subjects With Pulmonary Hypertension Associated With Cardiac Surgery - Multi-Center, Open-Label, Clinical Study|Completed||Phase 3|18|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-11 01:13:18.340145|2017-10-11 01:13:18.340145
NCT01959815|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-09-17|||October 2013||2013-10-01|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Novel Screening Strategies for Scleroderma PAH||Recruiting||N/A|200|Anticipated|University of Michigan|||4||f||||t|||||||"     Blood samples will be drawn at rest and during exercise.   "|||2017-10-11 01:13:18.499416|2017-10-11 01:13:18.499416
NCT01959802|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-08|||April 2008||2008-04-01|October 2013|2013-10-01|March 2012|Actual|2012-03-01|April 2008|Actual|2008-04-01||Interventional|||Foveal Cone Outer Segment Tips Line Defect in Macular Pseudohole|Correlation Between Foveal Cone Outer Segment Tips Line Defect and Visual Acuity After Surgery for Macular Pseudohole|Completed||N/A|22|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 01:13:18.618178|2017-10-11 01:13:18.618178
NCT01959776|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-08|||July 2009||2009-07-01|October 2013|2013-10-01|March 2012|Actual|2012-03-01|July 2009|Actual|2009-07-01||Interventional|||Asymmetrical Recovery of Cone Outer Segment Tips and Foveal Displacement After Macular Hole Surgery|Asymmetrical Recovery of Cone Outer Segment Tips and Foveal Displacement After Macular Hole Surgery|Completed||N/A|35|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 01:13:18.796051|2017-10-11 01:13:18.796051
NCT01959763|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-04-11|||February 2013||2013-02-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|PrevMetSyn||Prevention of the Metabolic Syndrome by New Lifestyle Intervention Methods|Prevention of the Metabolic Syndrome by a Lifestyle Intervention - an Application of the New Intervention Methods in the Primary Health Care.|Active, not recruiting||N/A|574|Actual|University of Oulu||3|||f||||f||||||||||2017-10-11 01:13:18.885922|2017-10-11 01:13:18.885922
NCT01959737|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-05-11|||February 2012||2012-02-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|deisy||Delivery Room Skin-to-skin Study|Influence of Early SSC of Mothers and Their VLBW Infants on Maternal Sensitivity and Responsiveness, Attachment Patterns and Reactivity of HPA Axis. Molecular Characterization of SSC Influence on Stress Signaling Pathways.|Completed||N/A|88|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-11 01:13:19.124471|2017-10-11 01:13:19.124471
NCT01959724|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-08|||April 2007||2007-04-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional|||Macular Detachment Associated With Intrachoroidal Cavitation|Macular Detachment Associated With Intrachoroidal Cavitation|Completed||N/A|69|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 01:13:19.216007|2017-10-11 01:13:19.216007
NCT01959711|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2013-10-08|||January 2006||2006-01-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|June 2008|Actual|2008-06-01||Interventional|||Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy|Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Transperitoneal Laparoscopic Adrenalectomy With a Five-year Follow-up|Completed||Phase 4|65|Actual|Jagiellonian University||2|||f||||t||||||||||2017-10-11 01:13:19.307113|2017-10-11 01:13:19.307113
NCT01959698|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-07-08|||April 17, 2014|Actual|2014-04-17|July 2017|2017-07-01|July 15, 2020|Anticipated|2020-07-15|July 15, 2019|Anticipated|2019-07-15||Interventional|||Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma|Phase I/II Study of Carfilzomib Plus Rituximab Plus Ifosfamide Plus Carboplatin Plus Etoposide (C-R-ICE) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Recruiting||Phase 1/Phase 2|73|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 01:13:19.424838|2017-10-11 01:13:19.424838
NCT01959685|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-07-23|2014-06-26||October 2013||2013-10-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Safety population|A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal|A Dose Escalating Study To Determine the Tolerability and Pharmacokinetics of a Single Dose of Androxal in Healthy Volunteers|Completed||Phase 1|9|Actual|Repros Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 01:13:19.589306|2017-10-11 01:13:19.589306
NCT01959672|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-02-28|||September 2013||2013-09-01|February 2017|2017-02-01||||December 2018|Anticipated|2018-12-01||Interventional|||Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer|A Phase II Study of Neoadjuvant Chemotherapy With and Without Immunotherapy to CA125 (Oregovomab) Followed by Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir in Patients With Locally Advanced Pancreatic Cancer|Recruiting||Phase 2|66|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-11 01:13:19.768122|2017-10-11 01:13:19.768122
NCT01959659|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-11-01|||May 2013||2013-05-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness||Completed||N/A|1431|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:13:19.938032|2017-10-11 01:13:19.938032
NCT01959646|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-02-25|||January 2014||2014-01-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|EAGESIS II||The Effect of AGE on the Immune System|The Effect of Aged Garlic Extract Supplementation on the Immune System|Completed||N/A|91|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:13:20.345568|2017-10-11 01:13:20.345568
NCT01959633|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-01-18|||March 2014||2014-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VEMUPLINT||Study of the Combination Vemurafenib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation|Phase I-II Study of the Combination Vemurafenib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation|Recruiting||Phase 1/Phase 2|48|Anticipated|Fondazione Melanoma Onlus||1|||f||||t||||||||||2017-10-11 01:13:20.442317|2017-10-11 01:13:20.442317
NCT01959620|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2017-07-19|||October 2013||2013-10-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Optimal Dose of Early Intervention to Prevent PTSD|Optimal Dose of Early Intervention to Prevent PTSD|Completed||N/A|95|Actual|Emory University||3|||f||||t||||||||||2017-10-11 01:13:20.571916|2017-10-11 01:13:20.571916
NCT01959607|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-04|2015-04-24||July 2013||2013-07-01|August 2017|2017-08-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional||"PK population: all randomized subjects who completed at least 1 of the single-use days, with at least 1 derived PK parameter. Subjects with major protocol deviations impacting the evaluation of the results were excluded.
62 randomized subjects: 44 in Group 1, 18 in Group 2.
60 completers: 42 in Group 1 (2 withdrawn subjects), 18 in Group 2."|Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)|A Single-center, Open-label, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of THS 2.2 Following Single Use in Healthy Smokers Compared to Conventional Cigarettes and Nicotine Gum|Completed||N/A|65|Actual|Philip Morris Products S.A.||4|||f||||f||||||||||2017-10-11 01:13:20.677353|2017-10-11 01:13:20.677353
NCT01959594|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-03-27|||November 2013||2013-11-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers|Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Dose Escalation, Parallel Group Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Repeat Doses Of PF-06412562 In Healthy Subjects|Completed||Phase 1|40|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 01:13:21.092926|2017-10-11 01:13:21.092926
NCT01959581|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-06-06|2017-02-06||May 2014||2014-05-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Movement Enhancing Device for Children|An Innovative Device for Intervention in Infants With Nervous System Injury|Completed||N/A|30|Actual|University of Delaware||1|||f||||f||||||||No||2017-10-11 01:13:21.203455|2017-10-11 01:13:21.203455
NCT01959568|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2014-05-27|||March 2010||2010-03-01|May 2014|2014-05-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery.|Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery: Randomised Clinical Trial of Safety|Recruiting||N/A|290|Anticipated|The S.N. Fyodorov Eye Microsurgery State Institution||2|||f||||t||||||||||2017-10-11 01:13:21.463142|2017-10-11 01:13:21.463142
NCT01959542|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-07-26|||December 2013||2013-12-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Early Changes In Multiparametric MRI In Prostate Cancer|Early Changes in Multiparametric MRI in Response to Neoadjuvant Androgen Deprivation and External Beam Radiation Therapy for Prostate Cancer|Completed||N/A|15|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:13:21.692046|2017-10-11 01:13:21.692046
NCT01959529|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-09-18|||October 29, 2013|Actual|2013-10-29|September 2017|2017-09-01|October 16, 2016|Actual|2016-10-16|October 16, 2016|Actual|2016-10-16||Interventional|DEVOTE||A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events|A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events|Completed||Phase 3|7637|Actual|Novo Nordisk A/S||2|||f||||t||||||||||2017-10-11 01:13:21.834014|2017-10-11 01:13:21.834014
NCT01959516|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2016-03-29|2015-10-21||February 2014||2014-02-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||The intention-to-treat (ITT) population consisted of all randomized patients who received at least one dose of the study treatment and had at least one post-dose value of FEV1|Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD|Multicenter, Randomized, Blinded, Two-period Cross-over Study to Assess the Effect of Glycopyrronium (44 Micrograms QD) Versus Tiotropium (18 Micrograms QD) on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD|Completed||Phase 4|124|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:13:22.958806|2017-10-11 01:13:22.958806
NCT01959503|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-04-06|2016-06-27||November 2013||2013-11-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All participants who were randomized and treated|Progel Vascular Sealant|A Prospective, Randomized Study to Compare Progel Vascular Sealant to Gelfoam Plus as an Adjunct for the Control of Bleeding in Subjects Undergoing Thoracic Aortic Surgery|Completed||N/A|158|Actual|C. R. Bard||2|||f||||f||||||||||2017-10-11 01:13:23.379242|2017-10-11 01:13:23.379242
NCT01959490|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-08-03|||September 24, 2013|Actual|2013-09-24|August 2017|2017-08-01|March 29, 2017|Actual|2017-03-29|November 11, 2016|Actual|2016-11-11||Interventional|||Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer|Next Generation Sequencing to Evaluate Breast Cancer Subtypes and Genomic Predictors of Response to Therapy in the Preoperative Setting for Stage II-III Breast Cancer|Completed||Phase 2|16|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:13:24.131416|2017-10-11 01:13:24.131416
NCT01959477|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-08-12|||March 2014||2014-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|||Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant|Personalized Monitoring of Intravenous Busulfan Dosing for Patients With Lymphoma Undergoing Autologous Stem Cell Transplantation.|Completed||Early Phase 1|33|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:13:24.280501|2017-10-11 01:13:24.280501
NCT01959451|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-06-28|||September 2013||2013-09-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|May 2016|Actual|2016-05-01||Interventional|TROPICAL-ACS||Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial|Platelet Function Guided Prasugrel Therapy in ACS Patients Undergoing PCI|Completed||Phase 4|2600|Actual|Klinikum der Universitaet Muenchen||2|||f||||t||||||||||2017-10-11 01:13:24.542757|2017-10-11 01:13:24.542757
NCT01959438|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-08|||February 2007||2007-02-01|October 2013|2013-10-01|June 2018|Anticipated|2018-06-01|October 2016|Anticipated|2016-10-01||Interventional|SECAR||Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma|Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma. A Phase I and Phase II Study.|Recruiting||Phase 1/Phase 2|32|Anticipated|Karolinska University Hospital||1|||f||||t||||||||||2017-10-11 01:13:24.807592|2017-10-11 01:13:24.807592
NCT01959425|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-06-27|||August 1, 2013|Actual|2013-08-01|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|December 31, 2019|Anticipated|2019-12-31||Interventional|OAT||Oral Anticoagulation Therapy Pilot Study|Safety of Oral Anticoagulation Therapy Withdrawal After Successful Cardiac Ablation in Patients With Atrial Fibrillation and Associated High Risk Factors for Embolic Events (OAT Pilot Study)|Recruiting||Phase 4|100|Anticipated|Biosense Webster, Inc.||2|||f||||t|t|f||||||||2017-10-11 01:13:24.922398|2017-10-11 01:13:24.922398
NCT01959412|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-04-20|2015-03-16||November 2013||2013-11-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|QAB149||Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma|A Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Five Different Doses of Inhaled Indacaterol (QAB149) Delivered Via the Single Dose Dry Powder Inhaler (SDDPI) in Patients With Persistent Asthma|Completed||Phase 2|91|Actual|Novartis||6|||f||||f||||||||||2017-10-11 01:13:25.099979|2017-10-11 01:13:25.099979
NCT01959399|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-08|||May 2013||2013-05-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin|A Phase 1, Open-Label, Single-Sequence Drug Interaction Study to Evaluate the Effect of Multiple-Dose ASP015K on the Pharmacokinetics of Rosuvastatin in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:13:25.678235|2017-10-11 01:13:25.678235
NCT01959386|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-16|||November 7, 2013|Actual|2013-11-07|August 2017|2017-08-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|HerSCin||A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast Cancer|Clinical Practice Surveillance of the Use of Herceptin® Subcutaneous in Patients With HER2-Positive Early Breast Cancer (HerSCin)|Active, not recruiting||N/A|1006|Actual|Hoffmann-La Roche|||1||f||||f|t|f||||||||2017-10-11 01:13:25.758459|2017-10-11 01:13:25.758459
NCT01959373|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-08-21|||October 2013||2013-10-01|August 2015|2015-08-01||||July 2014|Actual|2014-07-01||Interventional|||Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis|Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis|Suspended||N/A|30|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:13:25.851017|2017-10-11 01:13:25.851017
NCT01959360|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-10-03|||August 2011|Actual|2011-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|||Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Strength, Functionality and Post Operative Complications|Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Strength, Functionality and Post Operative Complications|Active, not recruiting||N/A|60|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 01:13:25.95551|2017-10-11 01:13:25.95551
NCT01959347|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-02-08|||October 2013||2013-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ESTEEM||Combined Treatment for Mixed Incontinence|Effects of Surgical Treatment Enhanced With Exercise for Mixed Urinary Incontinence (ESTEEM)|Active, not recruiting||Phase 3|480|Actual|NICHD Pelvic Floor Disorders Network||2|||f||||t||||||||No||2017-10-11 01:13:26.067282|2017-10-11 01:13:26.067282
NCT01959334|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2016-04-26||2015-07-07|September 2013||2013-09-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluate the Immunogenicity of a Novel Glucagon Formulation|A Single Center, Randomized, Parallel Safety Study To Evaluate The Immunogenicity Of A Novel Glucagon Formulation Compared To Commercially Available Glucagon Administered By Intramuscular Injection In Adults With Type 1 OR Type 2 Diabetes|Completed||Phase 3|75|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:13:26.215187|2017-10-11 01:13:26.215187
NCT01959321|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-05-02|||October 2012||2012-10-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|December 2020|Anticipated|2020-12-01||Observational|HCV||An Observational Study of Hepatitis C Virus in Pregnancy|An Observational Study of Hepatitis C Virus in Pregnancy|Recruiting||N/A|1250|Anticipated|The George Washington University Biostatistics Center|||2||f||||f||||||Samples With DNA|"     maternal serum maternal plasma infant serum infant plasma   "|Yes|The dataset will be shared per NIH policy after the completion and publication of the main analyses. Requests for datasets can be sent to mfmudatasets@bsc.gwu.edu.|2017-10-11 01:13:26.327468|2017-10-11 01:13:26.327468
NCT01959308|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-08|||June 2013||2013-06-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|AIM||Adherence to Immunosuppressive Therapy Liver Transplant Recipients|Adherence to Immunosuppressive Therapy in Adult and Adolescent Liver Transplant Recipients: A Questionnaire Survey|Unknown status|Recruiting|N/A|100|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 01:13:26.496735|2017-10-11 01:13:26.496735
NCT01959295|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-03-15|||August 2013||2013-08-01|March 2016|2016-03-01||||April 2015|Actual|2015-04-01||Interventional|||Phase III Study of ASP2151 in Herpes Simplex Patients|Phase III Study of ASP2151 in Herpes Simplex Patients ― A Double-blind, Placebo-controlled Study ―|Completed||Phase 3|453|Anticipated|Maruho Co., Ltd.||2|||f||||||||||||||2017-10-11 01:13:26.580744|2017-10-11 01:13:26.580744
NCT01959282|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-06-06||2016-04-14|November 2013||2013-11-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis|A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis|Completed||Phase 2|219|Actual|Janssen Research & Development, LLC||5|||f||||t||||||||||2017-10-11 01:13:26.67702|2017-10-11 01:13:26.67702
NCT01959269|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2017-08-30|||October 31, 2013|Actual|2013-10-31|August 2017|2017-08-01|July 7, 2017|Actual|2017-07-07|March 31, 2017|Actual|2017-03-31||Observational|RECORA||Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy|RECORA- Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy.|Completed||N/A|483|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:13:26.968997|2017-10-11 01:13:26.968997
NCT01959256|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-01-21|||December 2013||2013-12-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VIVID||Visual Perceptual Learning for the Treatment of Visual Field Defect|Visual Perceptual Learning for the Treatment of Visual Field Defect|Recruiting||N/A|40|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:13:27.063946|2017-10-11 01:13:27.063946
NCT01959243|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-07-24|||February 2014||2014-02-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Subjects.|A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% in a Population of Pediatric, Adult, and Geriatric Subjects.|Completed||Phase 3|507|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 01:13:27.145705|2017-10-11 01:13:27.145705
NCT01959230|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2014-07-24|||November 2013||2013-11-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects With Ocular Redness.|Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Used Four Times Daily in a Population of Adult and Geriatric Subjects With Ocular Redness|Completed||Phase 3|60|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 01:13:27.242083|2017-10-11 01:13:27.242083
NCT01959217|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-10-08|||January 2013||2013-01-01|October 2013|2013-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Targeting PM to Improve HIV Adherence in Adolescents at Risk for Substance Abuse|Targeting Prospective Memory to Improve HIV Adherence in Adolescents at Risk for Substance Abuse|Unknown status|Recruiting|Phase 1/Phase 2|194|Anticipated|Wayne State University||2|||f||||t||||||||||2017-10-11 01:13:27.327329|2017-10-11 01:13:27.327329
NCT01959204|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-11-21|||October 2013||2013-10-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects|A Phase IV Study to Evaluate the Pharmacokinetics and Safety of Oxycodone Oral Solution in Pediatric and Adolescent Subjects|Recruiting||Phase 4|120|Anticipated|VistaPharm, Inc.||1|||f||||f||||||||||2017-10-11 01:13:27.432304|2017-10-11 01:13:27.432304
NCT01959191|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-07|||January 2008||2008-01-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Clinical Significance of Platelet Reactivity on Clopidogrel During Off-pump Coronary Artery Bypass||Completed||N/A|859|Actual|Yonsei University|||2||f||||t||||||None Retained|"     Whole blood   "|||2017-10-11 01:13:27.655077|2017-10-11 01:13:27.655077
NCT01959178|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2013-10-08|||June 2013||2013-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:13:27.729128|2017-10-11 01:13:27.729128
NCT01959152|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-08|2015-05-20|||October 2013||2013-10-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode|Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode|Terminated||N/A|1|Actual|Advanced Bionics||1|||f||||f||||||||||2017-10-11 01:13:27.996664|2017-10-11 01:13:27.996664
NCT01959139|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-05-23|||January 2014||2014-01-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|April 2019|Anticipated|2019-04-01||Interventional|||S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer|S1313, A Phase IB/II Randomized Study of Modified FOLFIRINOX + Pegylated Recombinant Human Hyaluronidase (PEGPH20) Versus Modified FOLFIRINOX Alone in Patients With Good Performance Status Metastatic Pancreatic Adenocarcinoma|Active, not recruiting||Phase 1/Phase 2|172|Anticipated|Southwest Oncology Group||3|||f||||t||||||||||2017-10-11 01:13:28.1257|2017-10-11 01:13:28.1257
NCT01959126|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-11-04|||May 2013||2013-05-01|November 2013|2013-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|HEART||Health Enhancement And Resilience Training|The Effect of a Stress Reduction Program Using Mindfulness Techniques on Markers of Cellular Stress and Aging|Unknown status|Enrolling by invitation|N/A|100|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 01:13:28.547104|2017-10-11 01:13:28.547104
NCT01959113|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-03-30|||January 2015||2015-01-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Validation of the Short-term Antimicrobial Action of Transplanted Bacteria|Phase 1 Study of the Short-term Antimicrobial Action of Transplanted Bacteria in Adult Patients With Atopic Dermatitis|Active, not recruiting||Phase 1|14|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:13:28.639017|2017-10-11 01:13:28.639017
NCT01959100|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-06-01|||February 2014||2014-02-01|December 2016|2016-12-01|August 2020|Anticipated|2020-08-01|April 2017|Actual|2017-04-01||Interventional|ALLOZITHRO||Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation|Evaluation of the Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation|Active, not recruiting||Phase 3|480|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:13:28.776734|2017-10-11 01:13:28.776734
NCT01959087|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-08-18|||January 2014||2014-01-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|TRUE||Single Port Colic Laparoscopic Surgery|Single Port Colic Laparoscopic Surgery - THE TRUE TRIAL|Recruiting||Phase 3|128|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:13:28.924076|2017-10-11 01:13:28.924076
NCT01959074|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-12-08|||May 2014||2014-05-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Naftopidil for the Double-J Stent Discomfort|The Effect of Naftopidil for the Double-J Stent Discomfort: Multicenter, Randomized, Double-blind, Placebo Controlled Study|Completed||Phase 3|100|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:13:29.050954|2017-10-11 01:13:29.050954
NCT01959061|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-03-09|||September 2013|Actual|2013-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TACE||Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases|Raltitrexed and Oxaliplatin and Lipiodol Transcatheter Arterial Chemoembolization for Advanced Colorectal Cancer|Recruiting||Phase 4|320|Anticipated|Nanjing Chia-tai Tianqing Pharmaceutical||1|||f||||t||||||||Undecided||2017-10-11 01:13:29.164853|2017-10-11 01:13:29.164853
NCT01959048|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-02-22|||November 2013||2013-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis|Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis|Recruiting||N/A|10|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 01:13:29.27217|2017-10-11 01:13:29.27217
NCT01959035|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-02-08|2016-02-17||October 2013||2013-10-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Demographic data is based on all patients who received at least one dose of IMP in Study 14724B.|Aripiprazole Once-monthly in Patients With Schizophrenia|Interventional, Open-label, Flexible-dose Extension Study of Aripiprazole Once-monthly in Patients With Schizophrenia|Completed||Phase 3|88|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 01:13:29.396925|2017-10-11 01:13:29.396925
NCT01959022|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-10-19|||October 2013||2013-10-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD|A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD|Completed||Phase 4|15|Actual|San Francisco Veterans Affairs Medical Center||1|||f||||f||||||||||2017-10-11 01:13:29.968214|2017-10-11 01:13:29.968214
NCT01959009|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-09-30|||August 2014||2014-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Blood Oxygenation and Stability of Oxygenation|Does High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths Improve Oxygenation Compared to High Frequency Oscillatory Ventilation Without Sigh Breaths in Neonates?|Active, not recruiting||N/A|16|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:13:30.089601|2017-10-11 01:13:30.089601
NCT01958983|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2013-10-06|||June 2013||2013-06-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Music Therapy to Promote Emotion and Cognition for Dementia|The Effect of Music Therapy on Emotion and Cognition for Individuals With Mild to Moderate Dementia|Unknown status|Recruiting|N/A|30|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:13:30.30582|2017-10-11 01:13:30.30582
NCT01946932|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-12-04|||June 2011||2011-06-01|August 2013|2013-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Cognitive Impairment Following Cardiac Arrest and Target Temperature Management|Cognitive Impairment Following Cardiac Arrest and Target Temperature Management|Completed||N/A|287|Actual|Region Skane||2|||f||||t||||||||||2017-10-11 01:16:57.802232|2017-10-11 01:16:57.802232
NCT01958970|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-03-31|||January 2014||2014-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|||Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting|A Randomized, Double-blind, Pilot Study of PINTA 745, an Anti-myostatin Peptibody, in Patients With End Stage Renal Disease Who Require Maintenance Hemodialysis and Have Protein Energy Wasting|Completed||Phase 1/Phase 2|51|Actual|Pinta Biotherapeutics||2|||f||||f||||||||||2017-10-11 01:13:30.456446|2017-10-11 01:13:30.456446
NCT01958957|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2014-12-23|||June 2013||2013-06-01|May 2013|2013-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.|A Multicenter Safety Clinical Trial of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke With Syndrome of Intermingled Phlegm and Blood Stasis.|Completed||Phase 4|6300|Actual|Jiangsu Kanion Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-11 01:13:30.56195|2017-10-11 01:13:30.56195
NCT01958944|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2016-06-02|||December 2013||2013-12-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis|Phase II Prospective, Open Labeled, Multi-Center, Evaluation of the Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Cystic Fibrosis|Completed||Phase 1/Phase 2|9|Actual|Advanced Inhalation Therapies Ltd||1|||f||||f||||||||||2017-10-11 01:13:30.815411|2017-10-11 01:13:30.815411
NCT01958931|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-08|||September 2007||2007-09-01|October 2013|2013-10-01|January 2011|Actual|2011-01-01|November 2008|Actual|2008-11-01||Observational|||Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer||Completed||N/A|55|Actual|Fresh Medical Laboratories|||1||f||||t||||||||||2017-10-11 01:13:30.916797|2017-10-11 01:13:30.916797
NCT01958918|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-07-31|||October 23, 2013|Actual|2013-10-23|July 2017|2017-07-01|May 29, 2017|Actual|2017-05-29|May 29, 2017|Actual|2017-05-29||Interventional|SALT||Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD|A 12-month, Phase IV, Randomized, Open Label, Multicenter Study to Compare Efficacy of 0.5 mg Ranibizumab Pro re Nata (PRN) Versus 2 mg Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability Till Month 6 of Treatment and Explore Functional Outcomes up to Month 12 in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD)|Completed||Phase 4|712|Actual|Novartis||2|||f||||f|f|f||||||||2017-10-11 01:13:30.994455|2017-10-11 01:13:30.994455
NCT01958905|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-12-17|||November 2013||2013-11-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|MAL-NUT||Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children|Efficacy and Bio-availability of Artemether-Lumefantrine Fixed Combination in Severely Malnourished Children Compared to Non-severely Malnourished Children|Completed||N/A|399|Actual|Epicentre||1|||f||||t||||||||||2017-10-11 01:13:31.302195|2017-10-11 01:13:31.302195
NCT01958892|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2013-10-08||||||October 2013|2013-10-01||||October 2012|Actual|2012-10-01||Observational|||To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate||Completed||N/A|||Singapore General Hospital|||2||f||||||||||||||2017-10-11 01:13:31.395556|2017-10-11 01:13:31.395556
NCT01958879|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2014-10-04|||September 2012||2012-09-01|October 2013|2013-10-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy of Arthrocentesis by Injection of Ringer With or Without Corticosteroid in Treatment of Internal Derangement|Treatment of Temporomandibular Disorder|Completed||Phase 2|60|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:13:31.465227|2017-10-11 01:13:31.465227
NCT01958866|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-03-10|||October 2013||2013-10-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study of Efficacy and Safety of Tinospora Crispa-extract Product Compared With the Acetaminophen||Completed||Phase 2/Phase 3|96|Actual|Chulalongkorn University||3|||f||||t||||||||||2017-10-11 01:13:31.621003|2017-10-11 01:13:31.621003
NCT01958853|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2015-09-02||2015-07-27|August 2013||2013-08-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|PERRFECT||Prospective Evaluation of Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE) to Reduce Fibromyalgia Effects - Extension Study|An Open Label Extension Trial for Patients With Fibromyalgia Who Complete Study NPT-201 (NCT01825954) and Who Experience Inadequate Pain Reduction|Completed||N/A|23|Actual|Cerephex Corporation||1|||f||||f||||||||||2017-10-11 01:13:31.760138|2017-10-11 01:13:31.760138
NCT01958840|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-11-30|||August 2013||2013-08-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluating Behavioral Activation Efficacy in Depressed Spanish-Speaking Latinos||Completed||N/A|46|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 01:13:31.919335|2017-10-11 01:13:31.919335
NCT01958827|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-03-11|2016-03-11||September 2013||2013-09-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease|A Multicenter Open-label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Investigate Efficacy, Safety and Pharmacokinetics After Dose Escalation in Japanese Subjects With Crohn's Disease|Completed||Phase 3|28|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 01:13:32.066355|2017-10-11 01:13:32.066355
NCT01958814|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-05-13|||February 2012||2012-02-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|BANNISTER||Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.|Controlled Randomized Double-blind Study Comparing Salbutamol and Placebo Via Aerosol in Chronic Obstructive Respiratory Insufficiency in Exacerbartion Treated With Noninvasive Ventilation|Completed||Phase 2|43|Actual|University Hospital, Tours||2|||f||||f||||||||No||2017-10-11 01:13:33.095798|2017-10-11 01:13:33.095798
NCT01958801|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-04-06|||September 2013||2013-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Clinical Efficacy of Supraclavicular Block for Arthroscopic Shoulder Surgery|Comparison Between Ultrasound-guided Supraclavicular and Interscalene Brachial Plexus Blocks in the Patients Undergoing Arthroscopic Shoulder Surgery|Completed||N/A|104|Actual|Daegu Catholic University Medical Center||2|||f||||f||||||||||2017-10-11 01:13:33.218273|2017-10-11 01:13:33.218273
NCT01958398|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2015-08-31|||February 2013||2013-02-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Brief Alcohol Interventions With Mobile Phone Applications for University Students: A Randomized Controlled Trial|Brief Alcohol Interventions With Mobile Phone Applications for University Students: A Randomized Controlled Trial|Completed||N/A|4408|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 01:13:41.035007|2017-10-11 01:13:41.035007
NCT01958788|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-01-26|2015-12-19||September 2013||2013-09-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder|Challenging Uncertainty: Behavioural Experiments in the Treatment of Generalized Anxiety Disorder|Completed||N/A|7|Actual|Concordia University|Small sample size due to clinical case replication series design. This reduced statistical power and types of statistical analyses that could be conducted. Participants were homogeneous in ethnicity and language, which may limit generalizability.|1|||f||||t||||||||No||2017-10-11 01:13:33.334941|2017-10-11 01:13:33.334941
NCT01958775|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-03-06|||March 2012||2012-03-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2|Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like|Completed||Phase 3|12|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:13:33.807104|2017-10-11 01:13:33.807104
NCT01958762|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-04-25|||October 2013||2013-10-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|IDECAB||Screening for Cancers in the Oral CAvity|Screening for Cancers in the Oral CAvity Targeting Tobacco Users in Somme, France|Recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:13:33.926202|2017-10-11 01:13:33.926202
NCT01958749|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-08||||||September 2013|2013-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||Fat Graft Myringoplasty With and Without Platelet Rich Plasma (PRP) for Treating Smaller Tympanic Membrane Perforations|Efficacy of Fat Graft Myringoplasty Versus Fat Plus Platelet Rich Plasma (PRP) Myringoplasty in Closing Smaller Tympanic Membrane Perforations in an Outpatient Setting: a Randomized Study|Unknown status|Not yet recruiting|N/A|92|Anticipated|Nova Scotia Health Authority||2|||f||||||||||||||2017-10-11 01:13:34.065161|2017-10-11 01:13:34.065161
NCT01958736|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-10-17|||February 2014||2014-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Ballistic Strength Training in Stroke: A Pilot Study|Ballistic Strength Training in Stroke: A Phase II Randomized, Controlled, Assessor Blinded Pilot Study|Completed||N/A|31|Actual|Bayside Health||2|||f||||f||||||||||2017-10-11 01:13:34.162133|2017-10-11 01:13:34.162133
NCT01958723|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-04-10|||November 2013||2013-11-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Problem Specific Templates for Electronic Hospital Documentation|Problem Specific Templates for Electronic Hospital Documentation|Completed||N/A|10|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 01:13:34.260561|2017-10-11 01:13:34.260561
NCT01958710|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-07|||October 2013||2013-10-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Observational|||Outcome After Treatment of Pulmonary Aspergilloma|Outcome After Surgical Treatment or Bronchial Embolisation in Aspergilloma of the Lung: a Single Center Experience.|Unknown status|Active, not recruiting|N/A|100|Anticipated|University Hospital, Gasthuisberg|||2||f||||f||||||||||2017-10-11 01:13:34.417972|2017-10-11 01:13:34.417972
NCT01958697|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-07|||July 2013||2013-07-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|October 2013|Anticipated|2013-10-01||Observational|||Age and Gender Corrected Body Mass Index|Age and Gender Corrected Body Mass Index: When Preoperative Weight Loss and Underweight Are Becomming Clinically Significant in Esophagectomy for Cancer.|Unknown status|Active, not recruiting|N/A|650|Anticipated|University Hospital, Gasthuisberg|||2||f||||f||||||||||2017-10-11 01:13:34.497718|2017-10-11 01:13:34.497718
NCT01958684|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-10-15|||October 2013||2013-10-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|POST||Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion|A Non-interventional Study to Observe the Bleeding Pattern of LNG-IUS Inserted Immediately After Surgical Abortion Compared With Copper IUD|Completed||N/A|512|Actual|Bayer|||2||f||||f||||||||||2017-10-11 01:13:34.574118|2017-10-11 01:13:34.574118
NCT01958671|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-09-01|2017-07-14||October 9, 2013|Actual|2013-10-09|July 2017|2017-07-01|July 28, 2016|Actual|2016-07-28|July 28, 2016|Actual|2016-07-28||Interventional|||A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)|A Phase 3, Randomized, Double-blind, Placebo-controlled, 26-week Multicenter Study With a 26-Week Extension to Evaluate the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise|Completed||Phase 3|461|Actual|Merck Sharp & Dohme Corp.||3|||f||||t|t|f||||||||2017-10-11 01:13:34.719406|2017-10-11 01:13:34.719406
NCT01958645|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-01-05|2015-10-22||November 2013||2013-11-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses.|A Phase I, Single-blind, Randomised, Placebo-controlled, Single Centre Study to Investigate the Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses in Healthy Male Subjects|Completed||Phase 1|157|Actual|AstraZeneca|Limitations: few subjects, high variability of coagulation variables|2|||f||||f||||||||||2017-10-11 01:13:35.704737|2017-10-11 01:13:35.704737
NCT01958632|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-05|2013-10-05|||February 2012||2012-02-01|October 2013|2013-10-01||||June 2013|Actual|2013-06-01||Observational|||Muscle-in-vein Conduits for Digital Nerve Reconstruction|Evaluation of Sensory Recovery After Reconstruction of Digital Nerves of the Hand Using Muscle-in-vein Conduits in Comparison to Nerve Suture or Nerve Transplantation|Completed||N/A|77|Actual|BG Trauma Center Tuebingen|||3||f||||f||||||||||2017-10-11 01:13:38.112495|2017-10-11 01:13:38.112495
NCT01958619|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-04-21|2015-04-08||October 2013||2013-10-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||All subjects who received at least one single dose of OZ439 or Piperaquine|Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers|Open Label Pharmacokinetic Study of OZ439 and Piperaquine Following Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in the Fasted State in Healthy Volunteers|Completed||Phase 1|55|Actual|Medicines for Malaria Venture||4|||f||||f||||||||||2017-10-11 01:13:38.213459|2017-10-11 01:13:38.213459
NCT01958606|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-04-08|2017-02-12||October 2013||2013-10-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|HIT||High Intensity Interval Training in Chronic Stroke|High Intensity Interval Training in Chronic Stroke|Completed||N/A|18|Actual|University of Cincinnati||2|||f||||t||||||||||2017-10-11 01:13:38.727028|2017-10-11 01:13:38.727028
NCT01958593|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-08-08|||September 2013||2013-09-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|October 2016|Actual|2016-10-01||Interventional|||Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD|A Randomized, Double-Blind, Controlled Phase 2 Pilot Study of Manualized 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in 12 Subjects With Treatment-Resistant Posttraumatic Stress Disorder (PTSD) - Canada|Completed||Phase 2|12|Anticipated|Multidisciplinary Association for Psychedelic Studies||2|||f||||f||||||||||2017-10-11 01:13:39.372034|2017-10-11 01:13:39.372034
NCT01958580|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-01-16|||June 2013||2013-06-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery|A Pilot Safety and Toxicity Trial of Adjuvant Chemotherapy With Gemcitabine and Docetaxel and Radiation Therapy for Completely Resected Uterine Leiomyosarcoma|Unknown status|Recruiting|N/A|18|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 01:13:39.546284|2017-10-11 01:13:39.546284
NCT01958567|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-08-29|||July 2012||2012-07-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis|Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis|Completed||N/A|32|Actual|The Eye Center and The Eye Foundation for Research in Ophthalmology||2|||f||||f||||||||||2017-10-11 01:13:39.682088|2017-10-11 01:13:39.682088
NCT01958554|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2015-09-27|||October 2013||2013-10-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Impact of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence|Randomised Controlled Trial of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence|Completed||Phase 2|120|Actual|Macmillan Research Group UK||2|||f||||t||||||||||2017-10-11 01:13:39.796633|2017-10-11 01:13:39.796633
NCT01958541|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-11-21|||March 2013||2013-03-01|November 2016|2016-11-01||||January 2017|Anticipated|2017-01-01||Interventional|||A Brief Behavioral Sleep Intervention for Depression Among Military Veterans|A Brief Behavioral Sleep Intervention for Depression Among Military Veterans|Recruiting||N/A|120|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 01:13:39.88359|2017-10-11 01:13:39.88359
NCT01958528|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-07-31|||October 2013||2013-10-01|July 2017|2017-07-01||||October 2017|Anticipated|2017-10-01||Observational|||A Prospective Study Of Circulating Multiple Myeloma Cells As A Biomarker Of Progression In Myeloma Precursor States (MGUS And SMM)|A Prospective Study Of Circulating Multiple Myeloma Cells As A Biomarker Of Progression In Myeloma Precursor States (MGUS And SMM)|Active, not recruiting||N/A|100|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-11 01:13:39.993308|2017-10-11 01:13:39.993308
NCT01958515|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2016-01-14|||March 2016||2016-03-01|January 2016|2016-01-01||||March 2019|Anticipated|2019-03-01||Observational|||Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation|Evaluation of Immunologic Responses in HPV-Associated Oropharyngeal Carcinoma Patients Receiving Chemoradiation Therapy|Not yet recruiting||N/A|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 01:13:40.073603|2017-10-11 01:13:40.073603
NCT01958502|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-10-08|||July 2013||2013-07-01|October 2013|2013-10-01|November 2014|Anticipated|2014-11-01|July 2014|Anticipated|2014-07-01||Interventional|||Evaluation the Treatment of Nonunion of Long Bone Fracture of Lower Extremities (Femur and Tibia) Using Mononuclear Stem Cells From the Iliac Wing Within a 3-D Tissue Engineered Scaffold||Unknown status|Recruiting|Phase 2|18|Anticipated|Emdadi Kamyab Hospital||1|||f||||t||||||||||2017-10-11 01:13:40.176535|2017-10-11 01:13:40.176535
NCT01958489|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2014-01-29|||October 2013||2013-10-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Evacetrapib in Japanese and Non-Japanese Participants|Effect of Evacetrapib on the Pharmacokinetics of Pravastatin in Healthy Japanese and Non-Japanese Subjects|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:13:40.268468|2017-10-11 01:13:40.268468
NCT01958476|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-09-14|||September 2013||2013-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|||Improving Outcomes in Neonatal Abstinence Syndrome|Improving Outcomes in Neonatal Abstinence Syndrome|Active, not recruiting||Phase 3|184|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-10-11 01:13:40.347698|2017-10-11 01:13:40.347698
NCT01958463|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2013-10-08|||November 2013||2013-11-01|October 2013|2013-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Transplantation of Fecal Microbiota for Clostridium Difficile Infection|Transplantation of Fecal Microbiota for Clostridium Difficile Infection|Unknown status|Not yet recruiting|Phase 3|10|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 01:13:40.486784|2017-10-11 01:13:40.486784
NCT01958450|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2013-10-09|||July 2012||2012-07-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of the Efficacy of Fractional Er:YAG Laser for Acne Scar|Comparitive Study of Efficacy and Safety Between Fractional Er:YAG Laser and Bipolar Radiofrequency Treatment for Acne Scar|Completed||N/A|27|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:13:40.57059|2017-10-11 01:13:40.57059
NCT01958437|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-05-26|||October 1, 2013|Actual|2013-10-01|May 2017|2017-05-01|October 1, 2018|Anticipated|2018-10-01|February 1, 2017|Actual|2017-02-01||Interventional|||Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation|Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation|Active, not recruiting||Phase 1|40|Anticipated|VA Office of Research and Development||2|||f||||f|f|t|t|f|f|||No||2017-10-11 01:13:40.652099|2017-10-11 01:13:40.652099
NCT01958424|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2016-05-10|||April 2014||2014-04-01|October 2013|2013-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||In Vitro Fertilization Outcomes in Metabolic Syndrome|The Influence of Metabolic Syndrome on in Vitro Fertilization Treatment Outcome|Completed||N/A|30|Actual|Meir Medical Center|||2||f||||f||||||Samples Without DNA|"     whole blood   "|No||2017-10-11 01:13:40.746689|2017-10-11 01:13:40.746689
NCT01958411|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2013-10-07|||December 2008||2008-12-01|October 2013|2013-10-01||||March 2011|Actual|2011-03-01||Observational|||Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)||Completed||N/A|340|Actual|Korea University|||1||f||||t||||||||||2017-10-11 01:13:40.826221|2017-10-11 01:13:40.826221
NCT01957176|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-05-16|||October 15, 2013|Actual|2013-10-15|May 2017|2017-05-01|January 1, 2024|Anticipated|2024-01-01|January 1, 2024|Anticipated|2024-01-01||Interventional|||A Rollover Study to Provide Continued Treatment With Eltrombopag|Study 200170: A Rollover Study to Provide Continued Treatment With Eltrombopag|Recruiting||Phase 4|100|Anticipated|Novartis||3|||f||||f|t|f||||||Undecided||2017-10-11 01:14:00.959895|2017-10-11 01:14:00.959895
NCT01958385|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-03-31|||December 1, 2013|Actual|2013-12-01|March 2017|2017-03-01|August 1, 2016|Actual|2016-08-01|May 1, 2015|Actual|2015-05-01||Interventional|||The USGI Medical ESSENTIAL Study for Weight Loss|A RANDOMIZED, SUBJECT AND EVALUATOR-BLINDED, PARALLEL-GROUP, MULTICENTER CLINICAL TRIAL USING AN ENDOSCOPIC SUTURING DEVICE (G-CATH EZ™ SUTURE ANCHOR DELIVERY CATHETER) FOR PRIMARY WEIGHT LOSS|Completed||N/A|377|Actual|USGI Medical||2|||f||||f|f|t|f|f||||No||2017-10-11 01:13:41.134328|2017-10-11 01:13:41.134328
NCT01958372|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-07|2017-05-23|||August 2014||2014-08-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer|Phase I Study of Thoracic Radiotherapy and Concurrent Chemotherapy With Soy Isoflavones in Stage III NSCLC (Non-Small Cell Lung Cancer) Patients|Active, not recruiting||Phase 1|24|Anticipated|Barbara Ann Karmanos Cancer Institute||2|||f||||||||||||||2017-10-11 01:13:41.26006|2017-10-11 01:13:41.26006
NCT01958359|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2014-11-02|||February 2011||2011-02-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Screening and Brief Intervention Via IVR for Problematic Use of Alcohol: A Randomized Controlled Trial|Screening and Brief Intervention Via IVR for Problematic Use of Alcohol: A Randomized Controlled Trial|Completed||N/A|260|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 01:13:41.377309|2017-10-11 01:13:41.377309
NCT01958346|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-08-02|2015-12-02||June 2012||2012-06-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||New Maneuver to Facilitate Fiberoptic Intubation for Difficult Airway|New Maneuver to Facilitate Fiberoptic Intubation for Difficult Airway: A Prospective, Randomized Study|Completed||N/A|78|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 01:13:41.475859|2017-10-11 01:13:41.475859
NCT01958333|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2017-01-30|||June 2013||2013-06-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Muscular and Metabolic Adaptations to Exercise to Benefit High-Risk Workforce|The Effects of Medium-Term Exercise Program on Health-Related Physical Fitness and Biochemical Outcomes in High-Risk Employees|Completed||N/A|2114|Actual|Center for Health, Exercise and Sport Sciences, Serbia||3|||f||||f||||||||No||2017-10-11 01:13:41.860056|2017-10-11 01:13:41.860056
NCT01958320|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-10-26|||December 2013||2013-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PDA:TOLERATE||Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus|Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial|Recruiting||Phase 2|200|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:13:41.963134|2017-10-11 01:13:41.963134
NCT01958307|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-09-19|||September 2013||2013-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|GeLiS||Healthy Living in Pregnancy|Healthy Living in Pregnancy|Active, not recruiting||N/A|2500|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-11 01:13:42.128055|2017-10-11 01:13:42.128055
NCT01958294|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2015-11-16|||August 2011||2011-08-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|LOTUS||The MICHI NEUROPROTECTION SYSTEM: Evaluation of Performance in Carotid Artery Stent Procedures (The LOTUS Study)|The MICHI NEUROPROTECTION SYSTEM: Evaluation of Performance in Carotid Artery Stent Procedures (The LOTUS Study)|Completed||N/A|12|Actual|Silk Road Medical||1|||f||||t||||||||||2017-10-11 01:13:42.222702|2017-10-11 01:13:42.222702
NCT01958281|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-06|2017-08-15|||October 7, 2013|Actual|2013-10-07|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|July 18, 2017|Actual|2017-07-18||Interventional|||Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency|A Phase 2b, Open-Label Study of 200 mg or 400 mg Sofosbuvir+RBV for 24 Weeks in Genotype 1 or 3 and Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) Tablet for 12 Weeks in Genotype 1 or 4 HCV Infected Subjects With Renal Insufficiency|Active, not recruiting||Phase 2|38|Actual|Gilead Sciences||3|||f||||f|t|f||||||||2017-10-11 01:13:42.312578|2017-10-11 01:13:42.312578
NCT01958268|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-01-04|||August 2013||2013-08-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Observational|||Dysphagia Handicap Index: A Structured Translation From English to German|Dysphagia Handicap Index: A Structured Translation From English to German of a Quality of Life Questionnaire Relating to Swallowing|Completed||N/A|130|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 01:13:42.437273|2017-10-11 01:13:42.437273
NCT01958255|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2013-10-08|||May 2012||2012-05-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|June 2013|Actual|2013-06-01||Interventional|CBTCP||Community Based Tobacco Cessation Programme Mumbai|Community Based Tobacco Cessation Programme|Unknown status|Active, not recruiting|N/A|333|Actual|Tata Memorial Hospital||1|||f||||t||||||||||2017-10-11 01:13:42.5091|2017-10-11 01:13:42.5091
NCT01958242|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-11-23|||January 2014||2014-01-01|August 2012|2012-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of Blood Harvesting and Administration at End of CPB on Coagulation Profile|The Effect of Preoperative Blood Harvesting and Its Re-administration at the End of Cardio-pulmonary Bypass on the Coagulation Profile in the Pediatric Population Undergoing Open Heart Surgery.|Withdrawn||N/A|0|Actual|Rabin Medical Center||1||Technical problems.|f||||f||||||||||2017-10-11 01:13:42.584178|2017-10-11 01:13:42.584178
NCT01958229|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2013-10-08|||December 2009||2009-12-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|March 2012|Actual|2012-03-01||Observational|||Efficacy Study of Telbivudine in Chronic Hepatitis B Patients|A Multicenter Open-label, Observational Study of Telbivudine Treatment Outcome in Patients With Chronic B Virus Infection|Completed||N/A|23|Actual|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     10 c.c whole blood   "|||2017-10-11 01:13:42.667684|2017-10-11 01:13:42.667684
NCT01958216|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-10-08|||September 2013||2013-09-01|September 2013|2013-09-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|in vivoTICE||in Vivo TICE (TransIntestinal Cholesterol Excretion)|In Vivo TICE (TransIntestinal Cholesterol Excretion) Measurement in Bile Duct Diverted Patients|Unknown status|Recruiting|N/A|5|Anticipated|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 01:13:42.746013|2017-10-11 01:13:42.746013
NCT01958203|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2013-10-08|||January 2013||2013-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|VTE||Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.|Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.|Completed||N/A|386|Actual|Ministry of Health, United Arab Emirates|||1||f||||||||||||||2017-10-11 01:13:42.835057|2017-10-11 01:13:42.835057
NCT01958190|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-08-09|||January 2011||2011-01-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus|A Multicenter Randomized in Primary Livertransplantation Comparing Longterm Renal Function in Recipients Treated With Tacrolimus Alone and Recipients Treated With a Combination Tacrolimus and Sirolimus|Recruiting||Phase 2/Phase 3|196|Anticipated|Foundation for Liver Research||2|||f||||f||||||||Undecided||2017-10-11 01:13:42.902583|2017-10-11 01:13:42.902583
NCT01958177|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia|Clinical Study to Evaluate the Safety and Efficacy of Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) in Cerebellar Ataxia .It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Chaitanya Hospital, Pune||1|||f||||f||||||||||2017-10-11 01:13:43.020796|2017-10-11 01:13:43.020796
NCT01958164|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2015-04-16|2015-04-16||September 2013||2013-09-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||All randomised patients|Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion|A Multicenter, Open-label, Randomised, Clinical Trial to Compare the Efficacy and Safety of Actilyse 2 mg/ 2 ml Versus Saline Solution in Restoring Function of an Occluded Central Venous Access Device|Completed||Phase 3|16|Actual|Boehringer Ingelheim|The study was stopped prematurely due to slow recruitment of patients.|2|||f||||||||||||||2017-10-11 01:13:43.144418|2017-10-11 01:13:43.144418
NCT01958151|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-10-08|||January 2013||2013-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01|1 Day|Observational [Patient Registry]|||Pre-procedural Anxiety and Sedation.|Does Pre-procedural Anxiety Affect the Consumption of Sedatives During Colonoscopy?|Completed||N/A|75|Actual|Ankara University|||1||f||||f||||||||||2017-10-11 01:13:43.551681|2017-10-11 01:13:43.551681
NCT01958138|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-10-08|||April 2012||2012-04-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Isoflurane Versus Propofol for Removal of LMA in Children|Isoflurane Versus Small Dose Propofol With Isoflurane for Removal of Laryngeal Mask Airway in Anesthetized Children|Unknown status|Enrolling by invitation|Phase 2/Phase 3|50|Actual|Aga Khan University||2|||f||||t||||||||||2017-10-11 01:13:43.65283|2017-10-11 01:13:43.65283
NCT01958125|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-02-04|||August 2013||2013-08-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||A Randomized Multicentre Study for the Acute Relief of Episodic and Chronic Cluster Headache.|A Randomized, Multicentre, Double-blind, Parallel, Sham-controlled Study of GammaCore®, a Non-invasive Neurostimulator Device for the Acute Relief of Episodic and Chronic Cluster Headache.|Completed||N/A|120|Actual|ElectroCore LLC||2|||f||||f||||||||||2017-10-11 01:13:43.776069|2017-10-11 01:13:43.776069
NCT01958112|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-08-16|||October 2013||2013-10-01|August 2017|2017-08-01|March 2020|Anticipated|2020-03-01|December 2017|Anticipated|2017-12-01||Interventional|||GSK1120212+GSK2141795 for Cervical Cancer|A Single Arm, Single Stage Phase II Trial of GSK1120212 and GSK2141795 in Persistent or Recurrent Cervical Cancer|Terminated||Phase 2|14|Actual|Dana-Farber Cancer Institute||1||Drug supply|f||||t||||||||||2017-10-11 01:13:44.031597|2017-10-11 01:13:44.031597
NCT01958099|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2013-10-07|||August 2010||2010-08-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2011|Actual|2011-12-01||Interventional|||Teaching Injury Prevention|Behavior Change by Families in a Pediatric Emergency Department After Receiving Injury Prevention Information From a Safety Specialist Compared to a Computerized Kiosk|Completed||N/A|359|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 01:13:44.134004|2017-10-11 01:13:44.134004
NCT01958086|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-04-14|||October 2013||2013-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Brain Implant for Neural Control of a Computer|Feasibility Study for Use of a Brain Implant for Neural Control of a Computer|Recruiting||N/A|2|Anticipated|California Institute of Technology||1|||f||||t||||||||||2017-10-11 01:13:44.233854|2017-10-11 01:13:44.233854
NCT01958073|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-02-08|||October 2013||2013-10-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|VESPR||Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women||Active, not recruiting||Phase 4|35|Actual|University of California, San Diego||3|||f||||t||||||||||2017-10-11 01:13:44.374294|2017-10-11 01:13:44.374294
NCT01958060|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2015-07-02|2015-07-02||October 2013||2013-10-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Treated set (TS):This subject set included all subjects who were dispensed study medication and were documented to have received 1 dose of trial medication.|Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous and Subcutaneous Doses of BI 1034020 in Healthy Male Volunteers (Partially Randomised, Single-blind, Placebo-controlled Within Dose Groups, Clinical Phase I Study)|Terminated||Phase 1|35|Actual|Boehringer Ingelheim|Due to a drug-related Serious Adverse event in the first subject of 100 mg BI 1034020 single iv dose group, the trial was prematurely terminated. No further iv dosing was performed and no planned sc dosing scheme was performed in this trial.|2|||f||||||||||||||2017-10-11 01:13:44.539801|2017-10-11 01:13:44.539801
NCT01958047|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2013-10-04|||July 2012||2012-07-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability|A Phase 1 Open-label Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single Dose of ASP3652 in Caucasian, Japanese, Black/African and Chinese Healthy Male and Female Subjects|Completed||Phase 1|64|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:13:45.44501|2017-10-11 01:13:45.44501
NCT01958034|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2016-10-09|||February 2014||2014-02-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|BEAR SMART||Bilberry as a Dietary Supplement After Myocardial Infarction (The BEAR SMART Trial)|Bilberry as a Dietary Supplement After Myocardial Infarction (The BEAR SMART Trial)|Completed||Phase 4|50|Actual|Region Örebro County||2|||f||||f||||||||||2017-10-11 01:13:45.560058|2017-10-11 01:13:45.560058
NCT01958021|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-05-24|2017-04-04||December 17, 2013|Actual|2013-12-17|May 2017|2017-05-01|September 29, 2020|Anticipated|2020-09-29|January 29, 2016|Actual|2016-01-29||Interventional|MONALEESA-2|The Full Analysis Set (FAS-population) consisted of all randomized patients.|Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)|A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease|Active, not recruiting||Phase 3|668|Actual|Novartis|Four patients who were randomized to the placebo plus letrozole arm did not receive study treatment and so are not part of the Safety Set.|2|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent expert panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data is currently available according to the process described on www.clinicalstudydatarequest.com."|2017-10-11 01:13:45.69478|2017-10-11 01:13:45.69478
NCT01958008|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2016-11-23|2016-11-23||September 2013||2013-09-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Treated set: All patients who received at least 1 dose of study drug were included in the Treated Set (TS).|BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis|Randomized, Placebo-controlled, Double-blind Within Dose Groups, Multiple Rising-dose Study to Evaluate Safety, Tolerability, and PK of Oral BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With COPD Associated With Chronic Bronchitis|Completed||Phase 1|84|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 01:13:47.417749|2017-10-11 01:13:47.417749
NCT01957995|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-04-08|||November 8, 2013|Actual|2013-11-08|April 2017|2017-04-01|July 14, 2016|Actual|2016-07-14|May 29, 2014|Actual|2014-05-29||Interventional|||Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors|An Open Label, Randomized Study to Evaluate Safety and Pharmacokinetics of Intravenous Infusion of Nanosomal Docetaxel Lipid Suspension for Injection in Patients With Advanced Solid Tumors|Completed||Phase 1|13|Actual|University of Southern California||4|||f||||t||||||||||2017-10-11 01:13:47.990078|2017-10-11 01:13:47.990078
NCT01957982|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2014-06-18|||November 2013||2013-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:13:48.073392|2017-10-11 01:13:48.073392
NCT01957969|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-07-03|||September 2013||2013-09-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01|15 Months|Observational [Patient Registry]|||French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence|French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence|Active, not recruiting||N/A|286|Anticipated|Medtronic International Trading Sarl|||2||f||||f||||||||||2017-10-11 01:13:48.115878|2017-10-11 01:13:48.115878
NCT01957956|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-03-17|||November 2013||2013-11-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma|Pilot Clinical Trial of Allogeneic Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccination in Newly Diagnosed Glioblastoma|Active, not recruiting||N/A|21|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:13:48.233445|2017-10-11 01:13:48.233445
NCT01957943|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-03-24|||May 2014||2014-05-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|OTLT||Omega 3 Lipid Emulsions and Liver Transplantation|Impact of Pre-treatment of Living-donor Liver Transplant Recipients With Omega 3 Enriched Lipid Emulsions on Graft and Patient Outcome. A Prospective, Randomized, Multi-central Trial.|Recruiting||N/A|114|Anticipated|Mansoura University||3|||f||||f||||||||||2017-10-11 01:13:48.330955|2017-10-11 01:13:48.330955
NCT01957930|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2015-11-16|2015-11-16||January 1984||1984-01-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|December 2011|Actual|2011-12-01||Observational|||Intensive Insulin Treatment and Ischemic Foot Ulcer|Intensified Insulin Treatment and Skin Microcirculation; Its Relation to Ischemic Foot Ulcer in Patients With Type 1 Diabetes Mellitus: A Long-term Follow-up Study|Completed||N/A|72|Actual|Karolinska Institutet|||2||f||||f||||||||||2017-10-11 01:13:48.44361|2017-10-11 01:13:48.44361
NCT01957917|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-10-09|||December 2013||2013-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania|Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania|Completed||N/A|800|Actual|University of California, Berkeley||3|||f||||f||||||||||2017-10-11 01:13:48.732069|2017-10-11 01:13:48.732069
NCT01957904|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-11-16|||June 2013||2013-06-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||ArterX Safety and Efficacy Study for Cardiac Indications|Prospective, Multi-Center, Open-Label, Post-Market ArterX® Safety and Efficacy Study Protocol for Cardiac Indications|Completed||N/A|44|Actual|Tenaxis Medical, Inc.||1|||f||||f||||||||||2017-10-11 01:13:48.838894|2017-10-11 01:13:48.838894
NCT01957891|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-03-06|||September 2013||2013-09-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Hypoxia at Multiple Wavelengths of Light|Effect of Induced Hypoxia at Multiple Wavelengths|Completed||N/A|26|Actual|Nonin Medical, Inc|||1||f||||f||||||||||2017-10-11 01:13:48.916123|2017-10-11 01:13:48.916123
NCT01957878|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-12-01|||December 2013||2013-12-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|RHEIA-VAC||Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL|A Double-blind, Randomised, Placebo-controlled, Phase II Study to Evaluate ProCervix Efficacy to Clear HPV 16 and HPV 18 Infection in Women With Normal Cytology or ASCUS/LSIL|Completed||Phase 2|239|Actual|Genticel||2|||f||||t||||||||||2017-10-11 01:13:48.990867|2017-10-11 01:13:48.990867
NCT01957865|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-03-23|2016-04-05||September 2013||2013-09-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Real-Time Antiretroviral Therapy Adherence Intervention in Uganda|Development of a Real-Time Antiretroviral Therapy Adherence Intervention in Uganda|Completed||N/A|63|Actual|Massachusetts General Hospital||3|||f||||t||||||||Yes|De-identified data will be available at the end of the study upon request.|2017-10-11 01:13:49.164665|2017-10-11 01:13:49.164665
NCT01957852|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-02-24|||January 2008||2008-01-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|||FloSeal in CRS and HIPEC|Can FloSeal Reduce the Risk of Intra-abdominal Bleeding After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Performed for the Treatment of Peritoneal Carcinomatosis ?|Completed||N/A|86|Actual|Maisonneuve-Rosemont Hospital|||2||f||||f||||||||||2017-10-11 01:13:49.484579|2017-10-11 01:13:49.484579
NCT01957839|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-10-07|||March 2010||2010-03-01|October 2013|2013-10-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Color Doppler Analysıs Of Uterin And Intraovarian Blood Flow Before And After Treatment Wıth Cabergoline In Hyperprolactinemic Patients||Completed||Phase 4|48|Actual|Istanbul Bakirkoy Maternity and Children Diseases Hospital||2|||f||||f||||||||||2017-10-11 01:13:49.567553|2017-10-11 01:13:49.567553
NCT01957826|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2016-11-17|||March 2013||2013-03-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy|Phase I/II Randomized Clinical Trial to Assess the Safety and Feasibility of Transendocardial Injection of Bone Marrow Autologous Mesenchymal Stem Cells in Patients With Idiopathic Dilated Cardiomyopathy.|Recruiting||Phase 1/Phase 2|70|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||||||||||||2017-10-11 01:13:49.640291|2017-10-11 01:13:49.640291
NCT01957813|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-09-19|||June 20, 2013|Actual|2013-06-20|September 2017|2017-09-01|May 30, 2014|Actual|2014-05-30|May 30, 2014|Actual|2014-05-30||Interventional|||Evaluation of a Peer Education Program to Promote Family Planning Among Female Sex Workers in Kenya|Development and Evaluation of an Intervention to Increase Family Planning Use Among Female Sex Workers in Kenya|Completed||N/A|719|Actual|FHI 360||2|||f||||f|f|f||||||||2017-10-11 01:13:49.751302|2017-10-11 01:13:49.751302
NCT01957800|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-08-31|||October 2013||2013-10-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Weight Loss and Healthy Diet Through Mobile Phone-enabled Social Interactions|Enhancing the Sustainability of Weight Loss and Healthy Diet Through Mobile Phone-enabled Social Interactions|Completed||N/A|102|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 01:13:49.847666|2017-10-11 01:13:49.847666
NCT01957787|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-07-11|||March 2014|Actual|2014-03-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|SOLSTICE||Study of Cryoablation for Metastatic Lung Tumors|Multi-center Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation|Active, not recruiting||N/A|134|Actual|Galil Medical||1|||f||||t||||||||||2017-10-11 01:13:49.956109|2017-10-11 01:13:49.956109
NCT01957774|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-02-03|||October 2013||2013-10-01|December 2013|2013-12-01||||November 2014|Actual|2014-11-01||Interventional|||THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA|Double-blind, Placebo-controlled, Escalating Single-dose, Phase 2a Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of THR-18 in Subjects With Acute Ischemic Stroke and Treated With tPA|Completed||Phase 2|30|Actual|D-Pharm Ltd.||2|||f||||f||||||||||2017-10-11 01:13:50.117469|2017-10-11 01:13:50.117469
NCT01957761|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-01-26|2016-01-26||October 2012||2012-10-01|October 2013|2013-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Molecular Epidemiology of Clostridium Difficile Infections in Children|Molecular Epidemiologic Survey and Risk Factor Assessment of Clostridium Difficile Infections in Children: A Focus on Recurrent and Community-associated Infections|Completed||N/A|132|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||||||2017-10-11 01:13:50.2101|2017-10-11 01:13:50.2101
NCT01957748|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-02-24|||October 2013|Actual|2013-10-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|April 2016|Actual|2016-04-01||Interventional|||CCTG 594: Engagement and Retention in Care for HIV+|CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group|Active, not recruiting||N/A|300|Anticipated|California Collaborative Treatment Group||2|||f||||f||||||||||2017-10-11 01:13:50.377989|2017-10-11 01:13:50.377989
NCT01957722|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-11-23|||January 2014||2014-01-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|July 2018|Anticipated|2018-07-01||Interventional|N3D||NOVOCART®3D for Treatment of Articular Cartilage of the Knee|A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects|Recruiting||Phase 3|233|Anticipated|Aesculap Biologics, LLC||2|||f||||t||||||||No||2017-10-11 01:13:50.580938|2017-10-11 01:13:50.580938
NCT01957709|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-10-02|||September 25, 2013|Actual|2013-09-25|October 2017|2017-10-01||||October 1, 2018|Anticipated|2018-10-01||Interventional|||Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma|A Pilot Study to Test Whether Systemic Interferon Gamma Increases Tumor Class I MHC Expression in Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma|Recruiting||N/A|12|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 01:13:50.85777|2017-10-11 01:13:50.85777
NCT01957566|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-05-10|||January 2014||2014-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Utility of Pretracheal Stethoscope in Detecting Respiratory Abnormalities in Sedated Children|The Utility of Amplified Pretracheal Stethoscope in Detecting Ventilatory Abnormalities During Propofol Sedation of Non Intubated Children: a Validation Study|Recruiting||N/A|105|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 01:13:53.311411|2017-10-11 01:13:53.311411
NCT01957553|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2014-09-01|2014-08-18||September 2013||2013-09-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Baseline data are summarized with the subjects included in the ITT population. Two subjects where exposed to a product but did not register any endpoint data. These subjects are only found in the safety population.|Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click 2-piece|Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click in 130 Subjects With an Ileostomy.|Completed||N/A|130|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 01:13:53.407282|2017-10-11 01:13:53.407282
NCT01957696|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-10-09|||September 2013||2013-09-01|October 2013|2013-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01|5 Years|Observational [Patient Registry]|PTx||The Norwegian Pancreas Transplantation (PTx) Study|A Prospective, Observational Study in Pancreatic Allograft Recipients: The Effect of Risk Factors, Immunosuppressive Level and the Benefits of Scheduled Biopsies - on Surgical Complications, Rejections and Graft Survival|Recruiting||Phase 4|80|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Blood samples will be obtained at the time of Tx and later scheduled time points to:        -  Study of immune cell activation (CD25, FOXP3, CD4, CD3, CD8, CD45RO, perforin, granzyme          A/B, etc) and cytokines (IL-2, IL-12 etc)        -  Compare biomarkers in serum, indicative of acute rejection; RNA microarray on a series          of genes related to rejection, quantitative PCR on selected genes)      Scheduled biopsies will be taken according to our present routine protocol at 3 wks, 6 wks     and 12 mts post-Tx, as well as indication biopsies; simultaneosly from these four     transplant/organ sources:      Pancreas-Tx (P); Kidney-Tx (K); Duodenal segment of pancreas-Tx (tD; Native Duodenum     (control)      Histological and molecular evaluations will involve:        -  Rejection histology scores        -  Immunoshistochemistry on immunologic markers (CD25, FOXP3, CD4, CD3, CD8, CD45RO,          perforin, granzyme A/B, etc)        -  DNA/RNA analyses on immunologic markers: PCR, RNA microarray   "|||2017-10-11 01:13:50.967217|2017-10-11 01:13:50.967217
NCT01957683|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2014-01-21||||||January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|CESIS||Canadian eCLIPs™ Safety and Feasibility Study Protocol|A Multi-center Pilot Study Evaluating the Safety and Feasibility of the eCLIPs™ Family of Products for the Treatment of Unruptured Bifurcation Intracranial Aneurysms|Unknown status|Not yet recruiting|Phase 1|30|Anticipated|Evasc Medical Systems Corp.||1|||f||||t||||||||||2017-10-11 01:13:51.079629|2017-10-11 01:13:51.079629
NCT01957670|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-03-06|||February 2014||2014-02-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients|Pilot, Open-label, Single-Arm Study Designed to Clinically Evaluate Various Lacrima Medical Device Prototypes in Adult Patients With Dry Eye Syndrome|Withdrawn||N/A|0|Actual|Lacrima Medical LTD||1||Sponsor decision due to change the clinical indication to Chronic Insomnia|f||||f||||||||||2017-10-11 01:13:51.198083|2017-10-11 01:13:51.198083
NCT01957657|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2016-03-16|2016-01-21||October 2013||2013-10-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Treated Set, (TS) included all enrolled subjects, who had taken at least one dose of trial medication.|Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients|Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function in a Single Center, Open-label, Parallel-group, Phase I Trial|Terminated||Phase 1|4|Actual|Boehringer Ingelheim|The sponsor decided to stop the development of Hepatitis C treatments and terminated the trial prematurely on 27 Dec 2013. Due to the small sample size the pharmacokinetic endpoints were not determined.|4|||f||||||||||||||2017-10-11 01:13:51.279335|2017-10-11 01:13:51.279335
NCT01957644|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2017-01-10|||November 2013||2013-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML|An Open Label Phase I Dose Escalation Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics and Efficacy of Intravenous Volasertib in Combination With Subcutaneous Azacitidine in Patients With Previously Untreated High-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Not Candidates for Haematopoetic Stem Cell Transplant|Terminated||Phase 1|16|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 01:13:51.587355|2017-10-11 01:13:51.587355
NCT01957631|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-09-05|||June 2013||2013-06-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis|Steroid Injections vs. Platelet Rich Plasma Injections in Patients With Plantar Fasciitis: A Comparison of Clinical and Ultrasound Findings|Recruiting||Phase 2/Phase 3|60|Anticipated|King Hamad University Hospital, Bahrain||2|||f||||t||||||||||2017-10-11 01:13:51.733681|2017-10-11 01:13:51.733681
NCT01957618|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2013-10-01|||October 2011||2011-10-01|October 2013|2013-10-01|December 2021|Anticipated|2021-12-01|January 2012|Actual|2012-01-01||Observational|CTEAM||The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy|The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy|Enrolling by invitation||N/A|1500|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 01:13:51.853219|2017-10-11 01:13:51.853219
NCT01957605|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2015-09-29|||December 2013||2013-12-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Mean Systemic Pressure Measurement During Prone Position Surgery|Study of Hemodynamic Variations During Prone Position Surgery: Measurement of Mean Systemic Pressure and Venous Return Resistance|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 01:13:51.933283|2017-10-11 01:13:51.933283
NCT01957592|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2014-10-01|||October 2014||2014-10-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|DiabCare Asia||A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka|A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka|Withdrawn||N/A|0|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:13:52.014019|2017-10-11 01:13:52.014019
NCT01957579|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2017-05-08|2017-02-27||May 25, 2011|Actual|2011-05-25|May 2017|2017-05-01|September 15, 2015|Actual|2015-09-15|September 15, 2015|Actual|2015-09-15||Interventional||All patients who received at least 1 dose of MEDI-551.|A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies|A Phase 1, Dose-escalation Study of MEDI-551, a Humanized Monoclonal Antibody Directed Against CD19, in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies|Completed||Phase 1|32|Actual|AstraZeneca||1|||f||||t||||||||||2017-10-11 01:13:52.143539|2017-10-11 01:13:52.143539
NCT01957371|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2014-12-08|||September 2013||2013-09-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|||Mindful Yoga Therapy for Veterans With PTSD and Pain|Mindful Yoga Therapy as an Adjunctive Treatment for Veterans With PTSD and Pain|Withdrawn||N/A|0|Actual|VA Connecticut Healthcare System||1||Recruitment difficulty|f||||f||||||||||2017-10-11 01:13:57.520448|2017-10-11 01:13:57.520448
NCT01957540|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-01-08|||June 2014||2014-06-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease|Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease|Completed||Phase 4|22|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 01:13:53.679771|2017-10-11 01:13:53.679771
NCT01957527|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-08-19|||June 2014||2014-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Offset of Ticagrelor's Effect on Endothelial Function as Assessed With Peripheral Arterial Tonometry (EndoPAT Assay)|Offset of Ticagrelor's Effect on Endothelial Function as Assessed With Peripheral Arterial Tonometry (EndoPAT Assay)|Completed||Phase 4|30|Actual|University of Patras|||1||f||||f||||||||||2017-10-11 01:13:53.761475|2017-10-11 01:13:53.761475
NCT01957514|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-06-19|||October 28, 2013|Actual|2013-10-28|June 2017|2017-06-01||||November 1, 2018|Anticipated|2018-11-01||Observational|ITOMIC||Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer Therapy|Intensive Trial of OMics in Cancer (ITOMIC) - Intensive Longitudinal Monitoring in Subjects With Triple-Negative Breast Cancer|Recruiting||N/A|120|Anticipated|University of Washington|||1||f||||t||||||Samples With DNA|"     Tissue, blood, buccal mucosa, saliva, urine   "|||2017-10-11 01:13:53.845125|2017-10-11 01:13:53.845125
NCT01957501|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-04-06|||July 2013||2013-07-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Observational|||Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel|Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel|Terminated||N/A|75|Actual|University of Utah|||3|Funding has been terminated for this study.|f||||f||||||||||2017-10-11 01:13:54.000178|2017-10-11 01:13:54.000178
NCT01957488|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-08-18|2014-09-11||July 2013||2013-07-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Of the183 randomised subjects 4 subjects were not exposed to a product and were only included in the safety population (N =179). Of the 179 subjects 5 subjects were not included in the ITT population as no endpoint data was recorded for these subjects. The ITT population consisted of 174 subjects. Baseline data is only summerized for ITT subjects.|Investigating the Safety and Performance of Two New 1-piece Ostomy Products Compared With SenSura 1-piece|Investigating the Safety and Performance of Two New 1-piece Ostomy Products in 180 Subjects With Ileostomy|Completed||N/A|183|Actual|Coloplast A/S||3|||f||||f||||||||||2017-10-11 01:13:54.120714|2017-10-11 01:13:54.120714
NCT01957475|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-08-10|2014-07-21||April 2013||2013-04-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Investigation of Two Newly Developed 2-piece Convex Baseplates in Subjects With Ileostomy|Investigation of Two Newly Developed 2-piece Convex Baseplates in Subjects With Ileostomy|Completed||N/A|20|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 01:13:54.579465|2017-10-11 01:13:54.579465
NCT01957462|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-08-18|2014-07-21||April 2013||2013-04-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Investigation of Two Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy and Colostomy|Investigation of Two Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy and Colostomy|Completed||N/A|31|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 01:13:54.826818|2017-10-11 01:13:54.826818
NCT01957449|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-06-02|||December 2013||2013-12-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Propranolol in Severely Burned Children|Safety and Efficacy of Propranolol in Severely Burned Children|Recruiting||Phase 2/Phase 3|160|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||No||2017-10-11 01:13:55.098734|2017-10-11 01:13:55.098734
NCT01957436|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-10-18|||October 2013||2013-10-01|October 2016|2016-10-01|October 2023|Anticipated|2023-10-01|May 2017|Anticipated|2017-05-01||Interventional|PEACE1||A Phase III of ADT +/- Docetaxel +/- Local RT +/- Abiraterone Acetate in Metastatic Hormone-naïve Prostate Cancer.|A Prospective Randomised Phase III Study of Androgen Deprivation Therapy (+/- Docetaxel) With or Without Local Radiotherapy With or Without Abiraterone Acetate and Prednisone in Patient With Metastatic Hormone-naïve Prostate Cancer.|Recruiting||Phase 3|916|Anticipated|UNICANCER||4|||f||||t||||||||Undecided||2017-10-11 01:13:55.235573|2017-10-11 01:13:55.235573
NCT01957423|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2013-09-30|||March 2012||2012-03-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.|Immune Response Regulation and Nutritional Status of Crohn's Disease Patients Under Anti-TNF-alpha and Azathioprine Therapy.|Completed||N/A|41|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 01:13:55.845545|2017-10-11 01:13:55.845545
NCT01957410|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-12-05|2016-09-21||February 2014||2014-02-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Baseline analysis population included all participants who were received at least one dose of study drug.|A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder|An Open-Label and Double-Blind Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Subjects With Major Depressive Disorder|Terminated||Phase 2|13|Actual|Janssen Research & Development, LLC|Study was planned as open label treatment phase (Cohort 1) and double blind treatment phase (Cohort 2). However, study was terminated after completion of Cohort 1.|2||"Clinical Team decision to terminate the study after the results from Cohort 1 did not support   conducting Cohort 2."|f||||f||||||||||2017-10-11 01:13:55.983696|2017-10-11 01:13:55.983696
NCT01957397|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-01|2016-08-23|2014-02-26||October 2012||2012-10-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy|Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy|Completed||N/A|26|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 01:13:56.317395|2017-10-11 01:13:56.317395
NCT01957384|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-02-26|2013-11-21||February 2012||2012-02-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Two subjects were screening failiures and did not test any test product, but did contribute with baseline data. These subjects are not inclæuded in the participant flow (as the did not test products) but contributed with baseline data.|Investigation of the Performance and Safety of New 1-piece Open Ostomy Appliances Compared to Standard Care|An Open-labelled, Randomized, Controlled, Comparative, Single Country (Denmark), Explorative, Cross-over Study Investigating the Performance and Safety of New 1-piece Open Ostomy Appliances Compared to Standard Care 1-piece Open Ostomy Appliances in 25 Subjects With Ileostomy|Completed||N/A|25|Actual|Coloplast A/S||3|||f||||f||||||||||2017-10-11 01:13:56.654396|2017-10-11 01:13:56.654396
NCT01957345|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-07-24|||February 2013||2013-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluation of a New Approach of the Diagnosis of Constitutional Functional Disorders of Platelets|Multicentre Evaluation of a New Laboratory Approach for the Diagnosis of Constitutional Functional Disorders of Platelets|Recruiting||N/A|160|Anticipated|University Hospital, Toulouse||3|||f||||f||||||||||2017-10-11 01:13:57.819168|2017-10-11 01:13:57.819168
NCT01957332|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-06-01|||August 2013||2013-08-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|IMPACT-MBC||IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer|Towards Patient Tailored Cancer Treatment Supported by Molecular Imaging IMPACT: IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer|Recruiting||Phase 1/Phase 2|200|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 01:13:57.997852|2017-10-11 01:13:57.997852
NCT01957319|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-09-30|||February 2010||2010-02-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Silybin Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin Reduces Depression and Increases Work Ability|Silybin Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin Reduces Depression and Increases Work Ability|Completed||Phase 3|72|Actual|University of Catania||2|||f||||t||||||||||2017-10-11 01:13:58.169071|2017-10-11 01:13:58.169071
NCT01957306|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-06-12|||November 2013||2013-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy of Dr. Tagliaferri's Menopause Formula|A Phase 2, Open Label Clinical Trial Assessing Safety and Efficacy of Dr. Tagliaferri's Menopause Formula for Hot Flushes and Menopausal Symptoms in Postmenopausal Women|Completed||Phase 2|30|Anticipated|Herba Buena, Inc||1|||f||||f||||||||||2017-10-11 01:13:58.279329|2017-10-11 01:13:58.279329
NCT01957293|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-12-15|||October 2013||2013-10-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|Salmon-Basel||Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects|Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects|Completed||Phase 2|40|Actual|University of Basel||2|||f||||t||||||||||2017-10-11 01:13:58.371415|2017-10-11 01:13:58.371415
NCT01957280|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-05-13|||June 2013||2013-06-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|||Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287)|Phase 1, Open-label Study Assessing the Pharmacokinetics, Immunogenicity and Safety/Tolerability of Process 2 Patritumab in Patients With Advanced, Refractory Solid Tumors|Completed||Phase 1|17|Actual|Daiichi Sankyo, Inc.||1|||f||||t||||||||||2017-10-11 01:13:58.464295|2017-10-11 01:13:58.464295
NCT01957267|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-04-21|||September 2013||2013-09-01|April 2015|2015-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|FSOCT||Functional and Structural Imaging for Glaucoma|Longitudinal Observational Study Using Functional and Structural Optical Coherence Tomography to Diagnose and Guide Treatment of Glaucoma|Recruiting||N/A|150|Anticipated|Oregon Health and Science University|||3||f||||t||||||||||2017-10-11 01:13:58.597807|2017-10-11 01:13:58.597807
NCT01957254|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2014-12-01|||January 2013||2013-01-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Investigate the Activity of Endotoxin in Severe Sepsis|Investigate the Activity of Endotoxin in Patients With Severe Sepsis and Septic Shock|Terminated||N/A|2|Actual|National Taiwan University Hospital|||1|The quality of Limulus Amebocyte Lysate (LAL) test was poor.|f||||f||||||||||2017-10-11 01:13:58.709741|2017-10-11 01:13:58.709741
NCT01957241|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-04-15|||August 2011||2011-08-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||PLA for HCC and Esophageal ca Serum|Serum Biomarker Study for the Prognosis of Patients With Hepatocellular Carcinoma and Esophageal Cancer Undergoing Radiotherapy Using Multiplex Proximity Ligation Assay|Unknown status|Recruiting|N/A|164|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     We have collected the serum samples of patients before, during, and after RT with consent of     two completed clinical trials and one active trial.   "|||2017-10-11 01:13:58.79384|2017-10-11 01:13:58.79384
NCT01957228|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-08-31|||October 2013||2013-10-01|August 2015|2015-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Causative Diagnosis on Prosthetic Joint Infections: Establishment of a Comprehensive Diagnostic Strategy|Causative Diagnosis on Prosthetic Joint Infections: Establishment of a Comprehensive Diagnostic Strategy|Recruiting||N/A|480|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:13:58.876075|2017-10-11 01:13:58.876075
NCT01957215|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2015-05-21|2015-03-26||October 2013||2013-10-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief|A Clinical Study to Assess the Efficacy of Pain Relief of Topical Indomethacin Patch Over Placebo in Ankle Sprain Patients|Completed||Phase 4|270|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:13:59.002219|2017-10-11 01:13:59.002219
NCT01957202|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-11-18|2014-10-02||October 2013||2013-10-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)|A Randomised, Double-blind, Placebo-controlled, 3 Way, Incomplete Block Cross Over Study in Subjects With Allergic Rhinitis to Assess the Effect of Once Daily Single and Repeat Doses of Intranasal Fluticasone Furoate/Levocabastine Fixed Dose Combination (FDC) Relative to Levocabastine and Fluticasone Furoate Alone on the Onset and Magnitude of Symptoms of Rhinitis in an Allergen Challenge Chamber|Completed||Phase 2|71|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:13:59.688782|2017-10-11 01:13:59.688782
NCT01957189|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2017-05-12|||October 25, 2013|Actual|2013-10-25|May 2017|2017-05-01|January 22, 2014|Actual|2014-01-22|January 22, 2014|Actual|2014-01-22||Interventional|||This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples|An Open Label, Single Sequence, Three Period, Drug-Drug Interaction Study To Examine The Pharmacokinetics Of Dutasteride And Tamsulosin And Their Interactions In Chinese Male Healthy Volunteers|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:14:00.864376|2017-10-11 01:14:00.864376
NCT01957163|ClinicalTrials.gov processed this data on October 10, 2017|2013-10-04|2016-11-18|2014-11-20||October 2013||2013-10-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 1|Completed||Phase 3|619|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:14:02.865051|2017-10-11 01:14:02.865051
NCT01957137|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-03-27|2016-10-12||September 2013||2013-09-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Baseline descriptions provided were based on 24 subjects who first finished their randomized sequences who were included in the primary analysis.|InterStim® Sacral Nerve Modulation Cycling Study|InterStim® Sacral Nerve Modulation Cycling Study|Completed||N/A|30|Actual|MedtronicNeuro||5|||f||||f||||||||||2017-10-11 01:14:03.91783|2017-10-11 01:14:03.91783
NCT01957124|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-09-07|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Treatment of the Hypertensive Leg Ulcers by PRF Application|Treatment of the Hypertensive Leg Ulcers by PRF Application|Terminated||Phase 4|10|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 01:14:04.490294|2017-10-11 01:14:04.490294
NCT01957111|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-11-14|2016-09-23||October 2013||2013-10-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Metabolomics of Insomnia-Related Hyperarousal|Metabolomics of Insomnia-Related Hyperarousal|Completed||N/A|32|Actual|University of Pennsylvania|||2||f||||f||||||||||2017-10-11 01:14:04.622384|2017-10-11 01:14:04.622384
NCT01957098|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-10-07|||October 2006||2006-10-01|October 2013|2013-10-01|May 2007|Actual|2007-05-01|January 2007|Actual|2007-01-01||Interventional|M192||The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man|The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man|Completed||N/A|14|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-11 01:14:05.054974|2017-10-11 01:14:05.054974
NCT01957072|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-03-10|||February 2014||2014-02-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PIN-CF||Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis|Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis|Completed||N/A|17|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:14:05.284828|2017-10-11 01:14:05.284828
NCT01957059|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-10-27|||June 2013||2013-06-01|June 2015|2015-06-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)|A Phase I/II, Open-label, Dose Escalating With 48 Week Treatment Study to Assess the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of BMN053 (Previously Known as PRO053) in Subjects With Duchenne Muscular Dystrophy.|Terminated||Phase 1/Phase 2|9|Actual|BioMarin Pharmaceutical||4|||f||||t||||||||||2017-10-11 01:14:05.408634|2017-10-11 01:14:05.408634
NCT01957046|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-05-03|||October 2013||2013-10-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|August 2014|Actual|2014-08-01||Interventional|||A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC).|A Single-arm, Open-label, Multicentre, Non-randomised, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy for the Reversal of Opioid-induced Constipation in Subjects Suffering From Malignant or Non-malignant Pain That Requires Around-the-clock Opioid Therapy|Completed||Phase 4|117|Actual|Mundipharma Research GmbH & Co KG||1|||f||||f||||||||||2017-10-11 01:14:05.54249|2017-10-11 01:14:05.54249
NCT01957033|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2016-09-12|||October 2013||2013-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2015|Actual|2015-08-01||Interventional|||Responses of People With Neck Pain Being Treated With Varying Doses of Manual Therapy: A Pilot Study|Clinical and Biological Responses of People With Neck Pain Being Treated With Varying Doses of Manual Therapy: A Pilot Study|Completed||N/A|10|Actual|McMaster University||9|||f||||f||||||||||2017-10-11 01:14:05.648918|2017-10-11 01:14:05.648918
NCT01957020|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-10-13|||June 2008||2008-06-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|||Stereotactic Directional Vacuum-Assisted Breast Biopsy|The Diagnostic Accuracy of Stereotactic Directional Vacuum-Assisted Breast Biopsy|Completed||N/A|130|Actual|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 01:14:05.799662|2017-10-11 01:14:05.799662
NCT01957007|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-07-25|||September 2013||2013-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC|A Phase 1b Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer|Completed||Phase 1|34|Anticipated|OncoMed Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:14:05.849693|2017-10-11 01:14:05.849693
NCT01956994|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-10-03|||October 2013|Actual|2013-10-01|October 2017|2017-10-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effect of Whey Protein Supplementation on Vascular and Cognitive Function in Older Adults|The Effect of Whey Protein Supplementation on Cerebrovascular and Cognitive Function in Older Adults|Completed||N/A|99|Actual|Syracuse University||2|||f||||t||||||||||2017-10-11 01:14:06.06026|2017-10-11 01:14:06.06026
NCT01956981|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-28|2013-10-07|||January 2012||2012-01-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||Controlled Hypotension During Functional Endoscopic Sinus Surgery|Comparison Between Magnesium Sulfate and Dexmedetomidine in Controlled Hypotension During Functional Endoscopic Sinus Surgery: A Double-blind, Randomized Clinical Trial|Completed||Phase 4|60|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 01:14:06.155655|2017-10-11 01:14:06.155655
NCT01956968|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2014-04-24|||October 2013||2013-10-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Flexibility, Range of Motion and Strength Among Patients With Differing Response to the Scapular and Humeral Assistance Tests||Unknown status|Recruiting|N/A|130|Anticipated|Meir Medical Center|||1||f||||||||||||||2017-10-11 01:14:06.24195|2017-10-11 01:14:06.24195
NCT01956955|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2013-10-07|||January 2011||2011-01-01|October 2013|2013-10-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism||Unknown status|Recruiting|Phase 4|150|Anticipated|Ataturk University||2|||f||||f||||||||||2017-10-11 01:14:06.331682|2017-10-11 01:14:06.331682
NCT01956942|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-11-06|||August 2013||2013-08-01|September 2013|2013-09-01|August 2015|Anticipated|2015-08-01|August 2014|Anticipated|2014-08-01||Interventional|MLT versus SLT||Micropulse Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty for Treatment of Open Angle Glaucoma|Phase IV Study of Micropulse Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty for Treatment of Open Angle Glaucoma|Unknown status|Recruiting|Phase 4|84|Anticipated|George Washington University||2|||f||||f||||||||||2017-10-11 01:14:06.445044|2017-10-11 01:14:06.445044
NCT01956929|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-08-31|||October 2013||2013-10-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.|Metformin's Effect on Glucagon-induced Endogenous Glucose Production, Protein Metabolism and Resting Energy Expenditure in Insulin Resistant Individuals.|Completed||Phase 1|12|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:14:06.552731|2017-10-11 01:14:06.552731
NCT01956916|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2015-09-22|||October 2010||2010-10-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Probiotics in Cystic Fibrosis|Effects of LGG Administration in Children With Cystic Fibrosis: A Randomized Controlled Trial|Completed||Phase 3|110|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 01:14:06.66572|2017-10-11 01:14:06.66572
NCT01956903|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-09-30|||January 2010||2010-01-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|CSM/EICH2010||Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.|Phase 1/2 Study of Treatment of Refractory Acute Graft-Versus-Host Disease After First Line Therapy by Sequential Infusion of Expanded In-Vitro Allogenic Mesenchymal Stem Cell|Completed||Phase 1/Phase 2|15|Actual|Grupo Espanol de trasplantes hematopoyeticos y terapia celular||1|||f||||f||||||||||2017-10-11 01:14:06.800808|2017-10-11 01:14:06.800808
NCT01956890|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2013-10-13|||June 2011||2011-06-01|October 2013|2013-10-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||18F-FLT Positron Emission Tomography and Magnetic Resonance Imaging of the Breast|Integrative Diagnosis of 18F-FLT Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate the Suspicious Findings on Mammography and Breast Ultrasound: a Pilot Study|Unknown status|Recruiting|Phase 4|80|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 01:14:06.89788|2017-10-11 01:14:06.89788
NCT01956877|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-08-04|||November 2013||2013-11-01|August 2014|2014-08-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Assessment of Normal Values of Esophagogastric Junction (EGJ) Distensibility in Healthy Volunteers|Assessment of Normal Values of Esophagogastric Junction (EGJ) Distensibility in Healthy Volunteers|Unknown status|Recruiting|N/A|15|Anticipated|Maastricht University Medical Center|||1||f||||||||||||||2017-10-11 01:14:07.004981|2017-10-11 01:14:07.004981
NCT01956864|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-08-11|||September 2013||2013-09-01|August 2014|2014-08-01||||September 2014|Anticipated|2014-09-01||Interventional|||Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer|A Phase I Study of High-Dose Oral Vitamin D for the Prevention of Hepatocellular Carcinoma in Subjects With Cirrhosis|Suspended||Phase 1|24|Anticipated|Johns Hopkins University||6|||f||||f||||||||||2017-10-11 01:14:07.069726|2017-10-11 01:14:07.069726
NCT01956851|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-10-24|||September 2013||2013-09-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus|Hospital Based Pilot Study: Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus|Completed||N/A|55|Actual|Ganga Care Hospital, Nagpur|||3||f||||f||||||||||2017-10-11 01:14:07.156358|2017-10-11 01:14:07.156358
NCT01956838|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2014-10-13|||September 2013||2013-09-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Bitter, Umami and Sweet Tastants on Food Intake|The Effect of Bitter, Umami and Sweet Tastants on Food Intake|Completed||N/A|15|Actual|Maastricht University Medical Center||5|||f||||f||||||||||2017-10-11 01:14:07.241947|2017-10-11 01:14:07.241947
NCT01956825|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-10-07|||January 2014||2014-01-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver|THE EFFECT OF DUAL TREATMENT WITH L-CARNITINE AND MAGNESIUM ON Patients With Non Alcoholic Fatty Liver Disease|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-11 01:14:07.339703|2017-10-11 01:14:07.339703
NCT01956812|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-03-15|||January 2014||2014-01-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|PANCRIT®-1||Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer|An International, Multi-Center, Double-Blind, Randomized, Phase III Trial of 90Y-Clivatuzumab Tetraxetan Plus Low-Dose Gemcitabine Versus Placebo Plus Low-Dose Gemcitabine in Patients With Metastatic (Stage IV) Pancreatic Adenocarcinoma Who Received at Least Two Prior Treatments (PANCRIT-1)|Terminated||Phase 3|334|Actual|Immunomedics, Inc.||2||"The DSMB conducted an interim analysis on overall survival, which showed that the treatment arm   did not demonstrate a sufficient improvement in OS vs. placebo."|f||||t||||||||||2017-10-11 01:14:07.478584|2017-10-11 01:14:07.478584
NCT01956604|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2015-10-21|||April 2014||2014-04-01|October 2015|2015-10-01||||May 2017|Anticipated|2017-05-01||Interventional|LUCID||The Oslo Study of Clonidine in Elderly Patients With Delirium||Unknown status|Recruiting|Phase 2|100|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 01:14:09.572042|2017-10-11 01:14:09.572042
NCT01956799|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-08-10|||May 2013||2013-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BIOFER12||Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy|Identification of Mechanisms in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy|Recruiting||N/A|100|Anticipated|Fondazione Italiana Sindromi Mielodisplastiche Onlus|||1||f||||f||||||Samples With DNA|"     Peripheral blood and bone marrow   "|||2017-10-11 01:14:07.759916|2017-10-11 01:14:07.759916
NCT01956786|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-09-30|||September 2013||2013-09-01|July 2013|2013-07-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine|Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension, Hyperhomocysteinemia and Angiotension-Converting Enzyme Inhibitor Intolerance|Unknown status|Recruiting|Phase 2/Phase 3|540|Anticipated|Shenzhen Ausa Pharmed Co.,Ltd||3|||f||||t||||||||||2017-10-11 01:14:07.933076|2017-10-11 01:14:07.933076
NCT01956773|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-04-11|||April 11, 2014|Actual|2014-04-11|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Family Health History in Diverse Care Settings|Family Health History in Diverse Care Settings|Active, not recruiting||N/A|7000|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 01:14:08.053318|2017-10-11 01:14:08.053318
NCT01956760|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-01-09|||September 2012||2012-09-01|January 2014|2014-01-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Effects of Acupuncture and Intradermal Acupuncture on Insomnia|A Randomized Controlled Clinical Trial to Evaluate Effectiveness of Acupuncture on Insomnia|Unknown status|Enrolling by invitation|N/A|38|Actual|Kyunghee University||2|||f||||t||||||||||2017-10-11 01:14:08.154891|2017-10-11 01:14:08.154891
NCT01956747|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-03-17|||July 2013||2013-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|OptiMal||Optimization of Systemic Treatment Strategies in Elderly Patients With Advanced Solid Malignancies|Optimization of Systemic Treatment Strategies in Elderly Patients With Advanced Solid Malignancies|Recruiting||N/A|100|Anticipated|VU University Medical Center|||1||f||||t||||||||||2017-10-11 01:14:08.267893|2017-10-11 01:14:08.267893
NCT01956734|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-11-12|||September 2013||2013-09-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|December 2015|Anticipated|2015-12-01||Interventional|D24GBM||Virus DNX2401 and Temozolomide in Recurrent Glioblastoma|Phase I Trial of Combination of DNX-2401 (Formerly Named Delta-24-RGD) Oncolytic Adenovirus With a Short Course of Temozolomide for Treatment of Glioblastoma at First Recurrent|Active, not recruiting||Phase 1|31|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||t||||||||||2017-10-11 01:14:08.353414|2017-10-11 01:14:08.353414
NCT01956721|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-11-30|||September 2013||2013-09-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|June 2016|Actual|2016-06-01||Interventional|CALCICARD2||Impact of Heart Failure on Calcium Homeostasis and Mitochondrial Function in Human Skeletal Muscle|Evaluation of Calcium Homeostasis and Mitochondrial Function in Skeletal Muscle in Subjects With Heart Failure|Terminated||N/A|21|Actual|University Hospital, Montpellier||3||Difficulty of inclusion|f||||f||||||||||2017-10-11 01:14:08.464198|2017-10-11 01:14:08.464198
NCT01956708|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2014-12-02|||September 2013||2013-09-01|December 2014|2014-12-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Transfer of Cardioprotection During RIPC||Unknown status|Recruiting|Phase 2/Phase 3|332|Anticipated|University Hospital, Essen||2|||f||||t||||||||||2017-10-11 01:14:08.665048|2017-10-11 01:14:08.665048
NCT01956695|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-08-23|||September 2013||2013-09-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|REVRI||Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma|Phase II Study Evaluating the Efficacy of Lenalidomide in Association With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma (PCNSL)|Active, not recruiting||Phase 2|45|Anticipated|Institut Curie||1|||f||||t||||||||||2017-10-11 01:14:08.768936|2017-10-11 01:14:08.768936
NCT01956682|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-03-31|||October 2014||2014-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying|Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying|Completed||Phase 4|132|Actual|University of Bari||2|||f||||t||||||||||2017-10-11 01:14:08.908487|2017-10-11 01:14:08.908487
NCT01956669|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-07-10|||October 9, 2014|Actual|2014-10-09|July 2017|2017-07-01|February 3, 2019|Anticipated|2019-02-03|February 3, 2019|Anticipated|2019-02-03||Interventional|||Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors|A Phase II Study of Pazopanib GW786034, NSC# 737754 in Children, Adolescents and Young Adults With Refractory Solid Tumors|Recruiting||Phase 2|154|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-11 01:14:09.018984|2017-10-11 01:14:09.018984
NCT01956643|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-05-18|||October 2013||2013-10-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Sham Feeding on Postoperative Ileus After Elective Liver Transplantation|Effect of Sham Feeding on Postoperative Ileus After Elective Liver Transplantation|Completed||Phase 4|70|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:14:09.31568|2017-10-11 01:14:09.31568
NCT01956630|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-02-18|||September 2013||2013-09-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCT|Clinical Study of Genetically Modified Dendritic Cells Combining to Cytokine-Induced Killer Cells for Patients With Relapse Acute Leukemia After Allo-HSCT|Active, not recruiting||Phase 1/Phase 2|25|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-11 01:14:09.398275|2017-10-11 01:14:09.398275
NCT01956617|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-06-19|||October 2013||2013-10-01|June 2014|2014-06-01||||May 2014|Actual|2014-05-01||Interventional|||"The Mininimum Effective Anaesthetic Volume of Local Anaesthetic in Ultrasound-guided Shamrock Lumbar Plexus Block"|"The Mininimum Effective Anaesthetic Volume of Local Anaesthetic in Ultrasound-guided Shamrock Lumbar Plexus Block"|Completed||N/A|30|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 01:14:09.479661|2017-10-11 01:14:09.479661
NCT01956591|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-10-07|||September 2007||2007-09-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis|Retrospective Evaluation of Long Term Use of Oxybutynin in the Pharmacological Treatment of Primary Hyperhidrosis|Completed||N/A|1100|Actual|Hospital Israelita Albert Einstein|||5||f||||f||||||||||2017-10-11 01:14:09.686658|2017-10-11 01:14:09.686658
NCT01956578|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2013-10-07|||September 2013||2013-09-01|September 2013|2013-09-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||REVEAL for Respiration Detection|REVEAL for Respiration Detection|Unknown status|Enrolling by invitation|N/A|15|Anticipated|Medtronic BRC||1|||f||||f||||||||||2017-10-11 01:14:09.823025|2017-10-11 01:14:09.823025
NCT01956565|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-04-13|||June 2014||2014-06-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Feasibility of Inspiratory Muscle Training in People With COPD Who Decline Pulmonary Rehabilitation|Feasibility of Inspiratory Muscle Training in People With Chronic Obstructive Pulmonary Disease (COPD) Who Decline Pulmonary Rehabilitation|Completed||N/A|10|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:14:09.937815|2017-10-11 01:14:09.937815
NCT01956552|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-07-11|||November 2009||2009-11-01|November 2013|2013-11-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)|Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting|Terminated||N/A|130|Actual|Institut Curie||1|||f||||f||||||||||2017-10-11 01:14:10.047998|2017-10-11 01:14:10.047998
NCT01956539|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-02-12|||February 2014||2014-02-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|12 Months|Observational [Patient Registry]|FRESH||FREnch Survey on Heart Failure|FREnch Survey on Heart Failure|Unknown status|Recruiting|N/A|4000|Anticipated|French Cardiology Society|||1||f||||f||||||||||2017-10-11 01:14:10.181923|2017-10-11 01:14:10.181923
NCT01956526|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-10-07|||August 2013||2013-08-01|October 2013|2013-10-01|September 2017|Anticipated|2017-09-01|September 2015|Anticipated|2015-09-01||Interventional|||CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction||Unknown status|Recruiting|N/A|12|Anticipated|CorAssist Cadiovascular Ltd.||3|||f||||||||||||||2017-10-11 01:14:10.29185|2017-10-11 01:14:10.29185
NCT01956513|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2013-10-07|||March 2012||2012-03-01|October 2013|2013-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|ADC||Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer|Etude ADC Apport de l'IRM Dans l'évaluation du Coefficient de Diffusion Apparent et prédiction de la réponse à la chimiothérapie néoadjuvante Dans le Cancer du Sein|Withdrawn||N/A|0|Actual|Centre Jean Perrin||1||We have finally no financial support and any patients have been included.|f||||f||||||||||2017-10-11 01:14:10.407861|2017-10-11 01:14:10.407861
NCT01956500|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2013-10-07|||April 2013||2013-04-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Instaflex and Joint Pain in Community Adults|Influence of Instaflex Joint Support Supplement on Joint Pain, Stiffness, Function, and Inflammation: a Randomized, Placebo-controlled Community Trial|Completed||N/A|110|Actual|Appalachian State University||2|||f||||f||||||||||2017-10-11 01:14:10.485118|2017-10-11 01:14:10.485118
NCT01956487|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-06-09|||April 11, 2012|Actual|2012-04-11|June 2017|2017-06-01|June 27, 2012|Actual|2012-06-27|June 27, 2012|Actual|2012-06-27||Interventional|||Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites|A Phase 1, Open-Label, Crossover Study to Demonstrate the Bioequivalence of RYTHMOL SR® (Propafenone Hydrochloride) Manufactured at Two Different Sites|Completed||Phase 1|38|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:14:10.62893|2017-10-11 01:14:10.62893
NCT01956474|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-02-01|||January 2013||2013-01-01|August 2015|2015-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas|Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas|Recruiting||Phase 4|1500|Anticipated|Cxlusa||1|||f||||f||||||||||2017-10-11 01:14:10.757895|2017-10-11 01:14:10.757895
NCT01956461|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2016-10-18|||September 2010||2010-09-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|November 2016|Anticipated|2016-11-01|4 Years|Observational [Patient Registry]|||Effects of Teriparatide Therapy for Japanese||Recruiting||N/A|500|Anticipated|Tomidahama Hospital|||1||f||||f||||||||||2017-10-11 01:14:10.896986|2017-10-11 01:14:10.896986
NCT01956448|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-10-06|||March 2011||2011-03-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|SO VI||SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®|Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity® Coronary Stents in Non-selected Patients With Ischemic Heart Disease The SORT OUT VI Study*|Completed||N/A|2800|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 01:14:10.987991|2017-10-11 01:14:10.987991
NCT01956422|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2014-07-10|||August 2013||2013-08-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Continuous Positive Airway Pressure (CPAP) for Preventing Respiratory Failure After Laparoscopic Radical Prostatectomy||Completed||N/A|48|Actual|ASST Fatebenefratelli Sacco||2|||f||||f||||||||||2017-10-11 01:14:11.204212|2017-10-11 01:14:11.204212
NCT01956409|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-02-03|||September 2012||2012-09-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis|Use of Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis, Prediction of Clinical Outcome and Monitoring of Treatment Response to Neoadjuvant Chemotherapy|Active, not recruiting||Phase 4|80|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 01:14:11.292262|2017-10-11 01:14:11.292262
NCT01956032|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-01-25|2015-11-06||September 2013||2013-09-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources|Levodopa Carbidopa Intestinal Gel Home Titration Using Telemedicine: Evaluation of Use of Resources|Completed||N/A|15|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 01:14:15.674517|2017-10-11 01:14:15.674517
NCT01956396|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-10-06|||October 2011||2011-10-01|October 2013|2013-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|ZW-01||Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe|Phase I of Study of Safety and Efficacy of the PrePex Device for MC Programs in Zimbabwe|Completed||Phase 1|53|Actual|Ministry of Health and Child Welfare, Zimbabwe||1|||f||||t||||||||||2017-10-11 01:14:11.404015|2017-10-11 01:14:11.404015
NCT01956383|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-10-06|||April 2012||2012-04-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses|Phase III of Study of Safety and Efficacy of the PrePex Device for MC Programs in Zimbabwe (Nurses Study)|Completed||Phase 3|603|Actual|Ministry of Health and Child Welfare, Zimbabwe||1|||f||||t||||||||||2017-10-11 01:14:11.521564|2017-10-11 01:14:11.521564
NCT01956370|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-10-06|||November 2011||2011-11-01|October 2013|2013-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting|Phase II - Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult Male Circumcision Programs in Zimbabwe (Comparative Study)|Completed||Phase 2|240|Actual|Ministry of Health and Child Welfare, Zimbabwe||2|||f||||t||||||||||2017-10-11 01:14:11.6336|2017-10-11 01:14:11.6336
NCT01956357|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2014-11-04|||August 2012||2012-08-01|May 2014|2014-05-01||||December 2012|Actual|2012-12-01||Interventional|||Chronic Effects of Two Aerobic-training Models Performed in Water and on Dry Land in Patients With Type 2 Diabetes Mellitus (T2DM).||Completed||N/A|35|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||||||||||||2017-10-11 01:14:11.74997|2017-10-11 01:14:11.74997
NCT01956344|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-03-25|||July 2013||2013-07-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Neural Mechanisms of CBT Response in Hoarding Disorder|Neural Mechanisms of CBT Response in Hoarding Disorder|Recruiting||N/A|120|Anticipated|Hartford Hospital||3|||f||||t||||||||Yes|We will upload de-identified study data to an online database to be shared with colleagues upon request.|2017-10-11 01:14:11.882658|2017-10-11 01:14:11.882658
NCT01956331|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2013-10-06|||March 2009||2009-03-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|OPERAGE||Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer|Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer - A Prospective Observational Study in Elderly Patients With Non-small Cells Lung Cancer|Completed||N/A|302|Actual|Groupe Francais De Pneumo-Cancerologie|||1||f||||f||||||||||2017-10-11 01:14:12.025203|2017-10-11 01:14:12.025203
NCT01956318|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2013-10-06|||July 2010||2010-07-01|October 2013|2013-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Crenobalneotherapy in the Treatment of Chronic Venous Insufficiency|Crenobalneotherapy in the Treatment of Chronic Venous Insufficiency. A Randomized Clinical Trial.|Completed||Phase 3|99|Actual|Centre de Recherche Rhumatologique et Thermal||2|||f||||f||||||||||2017-10-11 01:14:12.149054|2017-10-11 01:14:12.149054
NCT01956305|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-11-20|||September 2013||2013-09-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study|A Single Blind, (Subject and Investigator Blinded, Sponsor Unblinded), Two-Period, Placebo-Controlled, Randomized, Sequential, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS 7309 In Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|48|Actual|Daiichi Sankyo, Inc.||7|||f||||f||||||||||2017-10-11 01:14:12.382016|2017-10-11 01:14:12.382016
NCT01956292|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2013-10-05|||October 2013||2013-10-01|October 2013|2013-10-01|June 2015|Anticipated|2015-06-01|October 2014|Anticipated|2014-10-01||Observational|BP-MONICH||Continuous Monitoring of Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage|Observational Study of Continous Monitoring of Arterial Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage|Unknown status|Not yet recruiting|N/A|100|Anticipated|Azienda Ospedaliera Sant'Anna|||1||f||||f||||||||||2017-10-11 01:14:12.495809|2017-10-11 01:14:12.495809
NCT01956279|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-05-19|||October 1, 2013|Actual|2013-10-01|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)|Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)|Recruiting||Phase 2|140|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||Undecided||2017-10-11 01:14:12.585775|2017-10-11 01:14:12.585775
NCT01956266|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-06-23|||October 1, 2013|Actual|2013-10-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Emotional Prosody Treatment in Parkinson's|Treatment of Emotional Prosodic Disorders in Parkinson's Disease|Completed||Phase 1/Phase 2|10|Actual|VA Office of Research and Development||2|||f||||f|f|f|||f|||Yes|A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset.|2017-10-11 01:14:12.72966|2017-10-11 01:14:12.72966
NCT01956253|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-03-10|||July 2013||2013-07-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Expanded Access|||Single Subject Neratinib in Bladder Cancer (NRR)|Single Subject Neratinib in Bladder Cancer|No longer available||N/A|||UNC Lineberger Comprehensive Cancer Center||||||t|||||||||||||2017-10-11 01:14:12.84555|2017-10-11 01:14:12.84555
NCT01956240|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2015-05-17|2015-01-18||June 2013||2013-06-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional|PMISP||Effects of a Pectoralis Minor Muscle Stretching Protocol|Phase 4 Effects of a Stretching Protocol for the Pectoralis Minor Muscle on This Resting Length and on the 3D Kinematics of the Scapula During Arm Flexion in Asymptomatic Subjects and Patients With Impingement Syndrome|Completed||Phase 4|97|Actual|Universidade Federal de Sao Carlos|"Participants may not have maximally elongated muscle;
Linear measurements such as that used to quantify muscle length cannot represent real structural changes;
Only chronic pain was evaluated."|2|||f||||f||||||||||2017-10-11 01:14:12.955671|2017-10-11 01:14:12.955671
NCT01956227|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-11-23|||April 2013||2013-04-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|FARMS-2||Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior|Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior|Completed||Phase 1/Phase 2|37|Actual|University of Illinois at Urbana-Champaign||4|||f||||f||||||||||2017-10-11 01:14:13.39082|2017-10-11 01:14:13.39082
NCT01956214|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-09-19|||December 2012||2012-12-01|August 2014|2014-08-01|November 2016|Actual|2016-11-01|December 2015|Actual|2015-12-01||Interventional|||Functional Electrical Stimulation (FES) Exercise Training in Hemodialysis Patients|Efficacy of Functional Electrical Stimulation Exercise Training in Hemodialysis Patients|Terminated||N/A|9|Actual|University of Illinois at Urbana-Champaign||2||Lack of recruitment|f||||f||||||||||2017-10-11 01:14:13.526925|2017-10-11 01:14:13.526925
NCT01956201|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-02-02|||December 2013||2013-12-01|February 2015|2015-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin|Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin in Mixed Hypercholesterolemic Patient: Multi Center, Randomized, Double-blind, Parallel-group, Therapeutic Confirmatory Study.|Unknown status|Recruiting|Phase 3|476|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 01:14:13.631632|2017-10-11 01:14:13.631632
NCT01956188|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-09-25|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|||Omega 3 in LES and APS|Efficacy of EPA and DHA Supplementation in Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome|Active, not recruiting||N/A|22|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:14:13.880807|2017-10-11 01:14:13.880807
NCT01956175|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-02-19|||June 2013||2013-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Electrical Pharyngeal Stimulation for Dysphagia Therapy in Tracheostomized Stroke Patients|A Single-centre, Double Blind, Randomised Controlled Clinical Trial to Evaluate the Effect of Electrical Pharyngeal Stimulation as a Treatment for Stroke-related Dysphagia in Tracheostomized Stroke Patients|Completed||N/A|30|Actual|University Hospital Muenster||2|||f||||t||||||||||2017-10-11 01:14:13.978485|2017-10-11 01:14:13.978485
NCT01956162|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-05-31|||October 2013||2013-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|ORTHODIAB||"Evaluation of a New Device Orthèse Diabète in the Healing of Foot Ulcers in Diabetic Patients"|"Evaluation of a New Customized Removable Device With Rocker Sole for Plantar Off-Loading Orthèse Diabète in the Healing of Foot Ulcers in Diabetic Patients"|Completed||N/A|118|Actual|Proteor Group||2|||f||||t||||||||Undecided||2017-10-11 01:14:14.123212|2017-10-11 01:14:14.123212
NCT01956149|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-03-06|||September 2013||2013-09-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer|Multicentre, Phase II Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Adenocarcinoma of the Oesophagogastric Junction and Stomach|Active, not recruiting||Phase 2|65|Actual|Krankenhaus Nordwest||1|||f||||t||||||||||2017-10-11 01:14:14.259113|2017-10-11 01:14:14.259113
NCT01956136|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2015-08-18|||March 2014||2014-03-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MUBI||Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury|Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury|Recruiting||N/A|60|Anticipated|Helsinki University||2|||f||||t||||||||||2017-10-11 01:14:14.359983|2017-10-11 01:14:14.359983
NCT01956123|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-02-06||2016-05-02|October 2013||2013-10-01|February 2017|2017-02-01|January 3, 2017|Actual|2017-01-03|May 2015|Actual|2015-05-01||Interventional|ESTHER-2||Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2|A Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Evaluating the Immunogenicity of FE 999049 in Repeated Cycles of Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme|Completed||Phase 3|513|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:14:14.479365|2017-10-11 01:14:14.479365
NCT01956110|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-02-06||2016-05-02|October 2013||2013-10-01|February 2017|2017-02-01|January 3, 2017|Actual|2017-01-03|May 2015|Actual|2015-05-01||Interventional|ESTHER-1||Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1|A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme|Completed||Phase 3|1329|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:14:14.593169|2017-10-11 01:14:14.593169
NCT01956097|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-05-25|2015-04-09||March 2012||2012-03-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effects of HX106 on Improvement in Cognitive-Bio-Markers of Memory Function|Effects of HX106 on Improvement in Cognitive-Bio-Markers of Memory Function in Healthy Adults With Subjective Memory Complaints: An 8-Week Prospective Randomized Double-Blind Placebo-Controlled Trial With Multimodal Neuroimaging and Neurocognitive Assessments|Completed||N/A|75|Actual|Ewha Womans University||3|||f||||t||||||||||2017-10-11 01:14:14.731932|2017-10-11 01:14:14.731932
NCT01956084|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-12-19|||November 2013||2013-11-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|ALCI2||Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma|ADMINISTRATION OF LMP-SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO PATIENTS WITH RELAPSED EBV-POSITIVE LYMPHOMA|Recruiting||Phase 1|24|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-11 01:14:15.252242|2017-10-11 01:14:15.252242
NCT01956071|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-01-15|||January 2014||2014-01-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|WAPD||Workers' Acceptability of a Prototype Integrated and Interactive Pedal Desk|Workers' Acceptability of a Prototype Integrated and Interactive Pedal Desk|Completed||N/A|44|Actual|Pennington Biomedical Research Center|||1||f||||f|||||||"     No biospecimens will be retained   "|||2017-10-11 01:14:15.354404|2017-10-11 01:14:15.354404
NCT01956058|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-06-19|||September 2013|Actual|2013-09-01|June 2017|2017-06-01|September 2020|Anticipated|2020-09-01|September 2015|Actual|2015-09-01||Interventional|CAPRICUR||Brachytherapy for Recurrent Prostate Cancer|Recurrent Prostate Cancer After Irradiation Treated With Brachytherapy Remedial: Phase 2 Study|Active, not recruiting||Phase 2|30|Actual|Centre Georges Francois Leclerc||1|||f||||t||||||||||2017-10-11 01:14:15.418114|2017-10-11 01:14:15.418114
NCT01956045|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-07-03|||April 2012||2012-04-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|Capacity||Critically Ill Patient's Capacity|Critically Ill Patient's Capacity|Completed||N/A|215|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 01:14:15.522726|2017-10-11 01:14:15.522726
NCT01945060|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-05-10|||September 2013||2013-09-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator|Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator|Completed||N/A|18|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 01:17:31.545049|2017-10-11 01:17:31.545049
NCT01956019|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-04-25|||February 2014|Actual|2014-02-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study|Feasibility Study to Compare Early Response Assessment and Planning Volumes With Contrast-enhanced Computed Tomography (CT), MRI Including Diffusion Weighted MRI (DWI) and Dynamic-contrast Enhanced (DCE) MRI in Patients With Limb Sarcoma Undergoing Pre-operative Radiotherapy|Completed||N/A|15|Actual|The Christie NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:14:17.509442|2017-10-11 01:14:17.509442
NCT01956006|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-01-29|||October 2013||2013-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure|Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure|Active, not recruiting||Phase 1/Phase 2|26|Actual|The Alfred||1|||f||||f||||||||No||2017-10-11 01:14:17.589802|2017-10-11 01:14:17.589802
NCT01955993|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-09-30|||September 2011||2011-09-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|January 2012|Actual|2012-01-01||Observational|||Fentanyl Metabolism in Obese Adolescents|The Pharmacokinetics of Intravenous Fentanyl in Adolescent Patients With Higher BMI Percentiles.|Completed||N/A|12|Actual|Children's Research Institute|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:14:17.677637|2017-10-11 01:14:17.677637
NCT01955980|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-04-10|||April 2015||2015-04-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis|A Pilot Study to Investigate the Potential of Buparid/PARI SINUS Versus Budes® Nasal Spray to Avoid or Postpone Sinus Surgery in Adult Patients With Chronic Rhinosinusitis|Recruiting||Phase 3|20|Anticipated|Pari Pharma GmbH||2|||f||||f||||||||||2017-10-11 01:14:17.814102|2017-10-11 01:14:17.814102
NCT01955967|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2013-10-07|||April 2006||2006-04-01|September 2013|2013-09-01||||September 2011|Actual|2011-09-01||Interventional|||The Effect of Intravenous Lidocaine on Trigeminal Neuralgia||Completed||N/A|20|Actual|Pain Relief & Palliative Care Center, Athens, Greece||1|||f||||||||||||||2017-10-11 01:14:17.941918|2017-10-11 01:14:17.941918
NCT01955941|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-04-25|||October 2013||2013-10-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Vascular Response to Brachytherapy Using Functional OCT|Characterization of Vascular Response to Brachytherapy Using Functional Optical Coherence Tomography|Recruiting||N/A|100|Anticipated|OHSU Knight Cancer Institute|||2||f||||f||||||||Undecided||2017-10-11 01:14:18.137284|2017-10-11 01:14:18.137284
NCT01955928|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2014-12-29|||October 2013||2013-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Internet-delivered CBT for Insomnia: Role of Sleep-related Cognitions|Internet-delivered CBT for Insomnia: Role of Sleep-related Cognitions|Completed||Phase 3|100|Anticipated|VU University of Amsterdam||2|||f||||||||||||||2017-10-11 01:14:18.226697|2017-10-11 01:14:18.226697
NCT01955915|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-04-25|||October 2013||2013-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|April 2015|Actual|2015-04-01||Observational|||Blood Vessel Patterns in Small Choroidal Tumors|Characterization of Small Choroidal Tumors Using Functional Optical Coherence Tomography|Active, not recruiting||N/A|15|Actual|OHSU Knight Cancer Institute|||1||f||||f||||||||Undecided||2017-10-11 01:14:18.314936|2017-10-11 01:14:18.314936
NCT01955902|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2013-11-08|||August 2013||2013-08-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Using mHealth to Aid Opioid Addicts|Using mHealth to Aid Opioid Medication Adherence Focus Groups|Completed||N/A|11|Actual|Care Team Solutions|||1||f||||f||||||||||2017-10-11 01:14:18.408352|2017-10-11 01:14:18.408352
NCT01955889|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-07-18|||October 2013||2013-10-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Mobile Health Technology to Promote Physical Activity in Persons With Parkinson Disease|Mobile Health Technology to Promote Physical Activity in Persons With Parkinson Disease|Completed||N/A|60|Actual|Boston University Charles River Campus||2|||f||||f||||||||||2017-10-11 01:14:18.515394|2017-10-11 01:14:18.515394
NCT01955876|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-12-07|||October 2013||2013-10-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Observational|||Fosrenol Post-marketing Surveillance in Japan|Drug Use Investigation of Fosrenol for Hyperphosphatemia With Chronic Kidney Disease Not on Dialysis|Completed||N/A|343|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:14:18.655196|2017-10-11 01:14:18.655196
NCT01955863|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-01-13|||March 2011||2011-03-01|January 2016|2016-01-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|ORP-SAC||Outpatient Radical Prostatectomy - Surgical and Anesthetic Considerations|Outpatient Radical Prostatectomy - Surgical and Anesthetic Considerations - Open Label Randomized Pilot Study|Completed||N/A|45|Actual|Barretos Cancer Hospital||3|||f||||f||||||||||2017-10-11 01:14:18.765684|2017-10-11 01:14:18.765684
NCT01955850|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2014-12-29|||October 2013||2013-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|||Online or Face-to-face Treatment for Insomnia?|Online or Face-to-face Treatment for Insomnia? A Wait-list Controlled Trial|Completed||Phase 3|90|Actual|VU University of Amsterdam||3|||f||||||||||||||2017-10-11 01:14:18.869129|2017-10-11 01:14:18.869129
NCT01955837|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-02-05|||September 2013||2013-09-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|TERRA||Study of TAS-102 in Patients With Metastatic Colorectal Cancer in Asia|Randomized, Double-Blind, Phase III Study of TAS-102 Versus Placebo in Asian Patients With Metastatic Colorectal Cancer Refractory or Intolerable to Standard Chemotherapies|Active, not recruiting||Phase 3|400|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 01:14:18.98626|2017-10-11 01:14:18.98626
NCT01955824|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2014-12-26|||May 2014||2014-05-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy|"A RCT ON CLINICAL EFFICACY OF 1% vs. 2% LIGNOCAINE IN COUGH SUPPRESSION AND PAIN RELIEF IN PATIENTS UNDERGOING FLEXIBLE BRONCHOSCOPY"|Completed||Phase 2/Phase 3|500|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 01:14:19.077126|2017-10-11 01:14:19.077126
NCT01955811|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2016-03-22|||December 2012||2012-12-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|FiT2012||Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion|Bicentric Clinical Trial With in Vitro Experiments to Assess the Effect of Fibrinogen (FGTW) on Coagulation in Thrombocytopenia|Completed||Phase 4|130|Actual|Medical University Innsbruck||1|||f||||f||||||||||2017-10-11 01:14:19.226846|2017-10-11 01:14:19.226846
NCT01955798|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-04-13|||January 2015||2015-01-01|April 2015|2015-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Direct Trocar Entry Versus Veress Needle Entry in Laparoscopic Gynecological Surgery|Direct Trocar Entry Versus Veress Needle Entry in Laparoscopic Gynecological Surgery , a Randomized Study|Suspended||N/A|300|Anticipated|Institut Universitari Dexeus||2|||f||||f||||||||||2017-10-11 01:14:19.346428|2017-10-11 01:14:19.346428
NCT01955785|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-07-28|||September 2013||2013-09-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Respiratory Treatment of Patients With Moderate and Severe Traumatic Brain Injury|Respiratory Treatment of Patients With Moderate and Severe Traumatic Brain Injury: A Randomised Comparison of Pressure Controlled Ventilation and Pressure Regulated Volume Controlled Ventilation|Completed||N/A|11|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 01:14:19.450783|2017-10-11 01:14:19.450783
NCT01955772|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-07-28|||November 2013||2013-11-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|NEPHA||Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.||Recruiting||Phase 3|240|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:14:19.535565|2017-10-11 01:14:19.535565
NCT01955759|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2013-12-15|||December 2013||2013-12-01|December 2013|2013-12-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Atrial Fibrillation and By-pass Surgery|Pharmacologic Prophylaxis for Atrial Fibrillation Following Coronary By-Pass Surgery|Unknown status|Not yet recruiting|Early Phase 1|260|Anticipated|Heart Center BH Tuzla||3|||f||||||||||||||2017-10-11 01:14:19.632143|2017-10-11 01:14:19.632143
NCT01955746|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-06-10|||September 2013||2013-09-01|September 2013|2013-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|PATT||PST Linkage Based Analysis in the Family of More Than Two Members With Type 1 Diabetes in Taiwan|Parent-sibling Tracing (PST) Linkage Based Analysis in the Family of More Than Two Members With Type 1 Diabetes in Taiwan for Novel HLA and Non-HLA Candidate Risk Alleles Detection|Completed||N/A|20|Actual|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-11 01:14:19.723074|2017-10-11 01:14:19.723074
NCT01955733|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2017-03-02|||May 2013||2013-05-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis|Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis: an Open-label Extension Trial|Completed||Phase 3|90|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 01:14:19.788335|2017-10-11 01:14:19.788335
NCT01955720|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-01-13|2015-11-13||September 2013||2013-09-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional||Treated Set|Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran|Randomised, Double-blind, Placebo-controlled, Two-way Cross-over Phase Ib Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655075 and to Establish the Efficacy of BI 655075 in Reversal of Dabigatran Anticoagulant Activity in Volunteers|Completed||Phase 1|46|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 01:14:19.954954|2017-10-11 01:14:19.954954
NCT01955707|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-05-24|2016-02-04|2015-08-27|January 2014||2014-01-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|ACTION||Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke|A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke|Completed||Phase 2|161|Actual|Biogen||2|||f||||t||||||||||2017-10-11 01:14:22.389172|2017-10-11 01:14:22.389172
NCT01955694|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2016-10-14|||November 2013||2013-11-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|ARTS-HF Japan||Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone|A Randomized, Double-blind, Double-dummy, Multi-center Study to Assess Safety and Efficacy of BAY94-8862 in Japanese Subjects With Emergency Presentation at the Hospital Because of Worsening Chronic Heart Failure With Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone Versus Eplerenone|Completed||Phase 2|72|Actual|Bayer||6|||f||||t||||||||||2017-10-11 01:14:23.709506|2017-10-11 01:14:23.709506
NCT01955681|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2015-11-03|||December 2013||2013-12-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|SEQUENCE||A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.|A Retrospective, Non-interventional Study to Evaluate EGFR-Tyrosine Kinase Inhibitor Retreatment in Patients With Locally Advanced or Metastatic EGFR Mutated NSCLC Who Previously Treated With EGFR-TKI as First-line Therapy and Chemotherapy as Second-line Therapy - SEQUENCE Study|Completed||N/A|200|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:14:23.87505|2017-10-11 01:14:23.87505
NCT01955668|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-30|2014-06-18|||November 2013||2013-11-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||AZD6738 First Time in Patient Multiple Ascending Dose Study|A Two-part Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Anti-tumour Activity of Multiple Ascending Doses of AZD6738 in Patients With Relapsed/Refractory B Cell Malignancies With Expansion to Patients With Prospectively Identified 11q-deleted or ATM-deficient, Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL)|Completed||Phase 1|2|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 01:14:23.982375|2017-10-11 01:14:23.982375
NCT01955655|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2013-10-06|||December 2005||2005-12-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|RCSCPSQ||Recurrent Crying Spells in Cerebral Palsy|Recurrent Crying Spells in Cerebral Palsy With Spastic Quadriparesis - A Crossover Study|Completed||Phase 4|70|Actual|Sathbhavana Brain Clinic||2|||f||||t||||||||||2017-10-11 01:14:24.076204|2017-10-11 01:14:24.076204
NCT01955642|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-12-30|||September 2013||2013-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|AAPIX||Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke|Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke : Role of Platelet alpha2-adrenergic Receptors|Completed||N/A|91|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"     Blood DNA   "|||2017-10-11 01:14:24.167037|2017-10-11 01:14:24.167037
NCT01955629|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-03-18|2016-03-18||December 2013||2013-12-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|AMOR||Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient|A Single-Arm, Open Label Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient|Terminated||Phase 1/Phase 2|4|Actual|Sanofi|The study enrollment was prematurely halted due to safety reasons.|1||The study enrollment was prematurely halted due to safety reasons.|f||||f||||||||||2017-10-11 01:14:24.277457|2017-10-11 01:14:24.277457
NCT01955616|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-09-21||2015-12-02|September 2013||2013-09-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|MOVE-PD||A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation|A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy|Terminated||Phase 2|18|Actual|Motus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 01:14:24.722384|2017-10-11 01:14:24.722384
NCT01955603|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-10-14|||September 2013||2013-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis|A Randomised, Placebo-controlled, Double-blind Within Cohort, Dose Escalation, Multiple-dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered Subcutaneously to Subjects With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 1|24|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 01:14:24.915431|2017-10-11 01:14:24.915431
NCT01955590|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-09-12|||November 2012||2012-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|||A Randomized Controlled Trial of Metacognitive Therapy and EMDR for Posttraumatic Stress Disorder|A Randomized Controlled Trial of Metacognitive Therapy and Eye Movement Desensitization and Reprocessing for Posttraumatic Stress Disorder|Active, not recruiting||N/A|96|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 01:14:25.059206|2017-10-11 01:14:25.059206
NCT01955577|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-04-09|||April 2015||2015-04-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Vitamin D Supplement for Patients With Tibial Fracture|Vitamin D Supplement for Patients With Tibial Fracture Treated With an External Ring Fixator. A Prospective Randomized Double-blind Study.|Unknown status|Not yet recruiting|Phase 1|130|Anticipated|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 01:14:25.166771|2017-10-11 01:14:25.166771
NCT01955564|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-04-06|2016-05-24||June 2013||2013-06-01|April 2017|2017-04-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional||9 healthy volunteers were assigned per cohort, within which 6 subjects received NW-3509A and 3 subjects received placebo by randomised selection.|A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.|A Phase I, Prospective, Randomized, Double-blind, Placebo-controlled, Sequential-cohort, Escalating, Single-dose Study Designed to Determine the Maximum Tolerated Oral Dose of NW-3509A in Healthy, Male Volunteers.|Completed||Phase 1|54|Actual|Newron||6|||f||||t||||||||||2017-10-11 01:14:25.306319|2017-10-11 01:14:25.306319
NCT01955551|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-28|2015-12-01|||September 2013||2013-09-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Motivational Interviewing to Increase Parent Engagement in Preventive Parenting Programming|A Randomized Controlled Trial Evaluating the Use of Motivational Interviewing to Increase Engagement by Low-income Parents in Preventive Parenting-skills Programming|Completed||Phase 2|112|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 01:14:26.307491|2017-10-11 01:14:26.307491
NCT01955538|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-04-27|||September 2013||2013-09-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PTF4||The Effect of BAT Versus Mixed Physical Activity as add-on Treatment for Traumatised Refugees.|Treatment of Traumatised Refugees: the Effect of Basic Body Awareness Therapy Versus Mixed Physical Activity as add-on Treatment. A Randomised Controlled Trial.|Completed||Phase 3|338|Actual|Mental Health Services in the Capital Region, Denmark||3|||f||||t||||||||||2017-10-11 01:14:26.416036|2017-10-11 01:14:26.416036
NCT01955525|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-28|2013-10-04|||November 2013||2013-11-01|September 2013|2013-09-01|November 2023|Anticipated|2023-11-01|November 2023|Anticipated|2023-11-01|10 Years|Observational [Patient Registry]|EMMACE-3X||Long-term Follow-up of Health Related Quality of Life in Patients With Acute Coronary Syndrome|Long-term Follow-up of Health Related Quality of Life in Patients Hospitalised With Acute Coronary Syndrome: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE)-3X|Not yet recruiting||N/A|3500|Anticipated|University of Leeds|||1||f||||t||||||||||2017-10-11 01:14:26.54071|2017-10-11 01:14:26.54071
NCT01955512|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2013-09-27|||May 2013||2013-05-01|September 2013|2013-09-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Effect of Clopidogrel on Allergen Challenge in Asthma|Effect of Clopidogrel on Allergen Challenge in Asthma|Unknown status|Recruiting|Phase 2|24|Anticipated|University of Southampton||2|||f||||f||||||||||2017-10-11 01:14:26.638159|2017-10-11 01:14:26.638159
NCT01955486|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2016-11-02|||October 2013||2013-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Gas Supply, Demand and Middle Ear Gas Balance -- Preliminary Protocol|Gas Supply, Demand and Middle Ear Gas Balance -- Project 1, Specific Aim 4, Protocol 1|Recruiting||N/A|10|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 01:14:26.87013|2017-10-11 01:14:26.87013
NCT01955473|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-07-19|2016-11-01||October 31, 2013|Actual|2013-10-31|July 2017|2017-07-01|October 31, 2015|Actual|2015-10-31|October 31, 2015|Actual|2015-10-31||Interventional||Safety analysis set consisted of all subjects (from Parts A and B) who received at least 1 administration of Sym004.|Japanese Phase 1 Trial of Sym004 in Solid Tumors|A Japanese Phase I Open-label Dose-escalation Trial of Sym004 Administered as Monotherapy in Japanese Subjects With Advanced Solid Tumors|Completed||Phase 1|51|Actual|Merck KGaA||1|||f||||f||||||||||2017-10-11 01:14:27.054707|2017-10-11 01:14:27.054707
NCT01955460|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-09-11|||October 2014|Actual|2014-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study of Lymphodepletion Plus Adoptive Cell Transfer With TGF-beta Resistant (DNRII) and NGFR Transduced T-Cells Followed by High Dose Interleukin-2 in Participants With Metastatic Melanoma|A Pilot Study of Lymphodepletion Plus Adoptive Cell Transfer With TGF-beta Resistant (DNRII) and NGFR Transduced T-Cells Followed by High Dose Interleukin-2 in Participants With Metastatic Melanoma|Recruiting||Phase 1|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:14:30.187494|2017-10-11 01:14:30.187494
NCT01955447|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2014-01-20|||November 2013||2013-11-01|November 2013|2013-11-01||||January 2014|Actual|2014-01-01||Interventional|||Post-prandial Glucose in Healthy Subjects|Effect of Different Levels of Plant-based Ingredients on Post-prandial Glucose in Healthy Subjects|Completed||N/A|84|Actual|Unilever R&D||4|||f||||f||||||||||2017-10-11 01:14:30.371332|2017-10-11 01:14:30.371332
NCT01955421|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-07-01|||July 2013||2013-07-01|July 2015|2015-07-01||||June 2016|Anticipated|2016-06-01||Interventional|NSCLC EGFR TKI||Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc|A Randomized, Open-label Phase II Trial of Erlotinib 100mg Daily Versus Gefitinib 250mg Daily in Patients With Advanced Non-small Cell Lung Cancer Who Harbor EGFR Mutations.|Unknown status|Recruiting|Phase 2|224|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:14:30.645723|2017-10-11 01:14:30.645723
NCT01955408|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-10-04|||September 30, 2013|Actual|2013-09-30|October 2017|2017-10-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|12 Weeks|Observational [Patient Registry]|OABSYNERGO||Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment|Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment for Bladder Cancer|Completed||N/A|35|Actual|Meir Medical Center|||1||f||||f||||||||||2017-10-11 01:14:30.749599|2017-10-11 01:14:30.749599
NCT01955395|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-03-15|||October 2013||2013-10-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma|Genomic and Psychosocial Effects of the Relaxation Response Resiliency Program (3RP) on Patients With MGUS and Smoldering Multiple Myeloma|Completed||N/A|93|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 01:14:30.842073|2017-10-11 01:14:30.842073
NCT01955369|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-28|2016-04-13|2015-04-06||October 2009||2009-10-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2012|Actual|2012-09-01|3 Years|Observational [Patient Registry]|||Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate|Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate|Completed||N/A|200|Actual|Klinikum Ludwigshafen|||1||f||||t||||||||||2017-10-11 01:14:31.057809|2017-10-11 01:14:31.057809
NCT01955356|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-28|2017-04-28|||October 2013||2013-10-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Embryo Implantation After Induced Endometrial Injury|Evaluation of Induced Endometrial Injury in the Subsequent IVF Cycle.|Recruiting||N/A|600|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||t||||||||||2017-10-11 01:14:31.238781|2017-10-11 01:14:31.238781
NCT01955343|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-06-22|||September 2012||2012-09-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Observational|IRLC||Immune Response in Lung Cancer|Immune Response in Lung Cancer|Completed||N/A|100|Actual|Lithuanian University of Health Sciences|||2||f||||f||||||Samples With DNA|"     Blood serum and lung biopsy   "|||2017-10-11 01:14:31.32996|2017-10-11 01:14:31.32996
NCT01955330|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2013-09-27|||September 2013||2013-09-01|September 2013|2013-09-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Observational|||Long Term Follow-up Hybrid Revascularization|Long Term Follow-up of Robotic Hybrid Surgical Revascularization With CT Angiography|Unknown status|Recruiting|N/A|50|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-11 01:14:31.391836|2017-10-11 01:14:31.391836
NCT01955317|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2017-08-31|||October 2013|Actual|2013-10-01|August 2016|2016-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Waterless Hand Cleansing With Chlorhexidine During the Perinatal Period|Waterless Hand Cleansing With Chlorhexidine During the Perinatal Period|Completed||N/A|300|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-11 01:14:31.47726|2017-10-11 01:14:31.47726
NCT01955304|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-28|2013-09-28|||June 2012||2012-06-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Food Effect Study of Single Dose of Fruquintinib (HMPL-013) in Healthy Subjects|A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Fruquintinib (HMPL-013) in Healthy Subjects|Completed||Phase 1|20|Actual|Hutchison Medipharma Limited||2|||f||||t||||||||||2017-10-11 01:14:31.560281|2017-10-11 01:14:31.560281
NCT01955291|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2016-08-31|||January 2008||2008-01-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|RFVE||Reinforced Feedback in Virtual Environment|The Role of Virtual Therapy by Means of Reinforced Feedback in Virtual Environment on Upper Limb Function in Post-stroke Patients.|Completed||N/A|136|Actual|IRCCS San Camillo, Venezia, Italy||2|||f||||t||||||||||2017-10-11 01:14:31.637377|2017-10-11 01:14:31.637377
NCT01955278|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-09-16|||March 2013||2013-03-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|RPMPPH||Role of Prosthetic Mesh in Preventing Parastomal Hernias|Prospective Randomized Study of the Role of Prosthetic Mesh in Preventing Parastomal Hernias in Patients With Definitive End Colostomy|Unknown status|Recruiting|Phase 3|60|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||t||||||||||2017-10-11 01:14:31.855649|2017-10-11 01:14:31.855649
NCT01955265|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2016-02-18|||September 2013||2013-09-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|July 2014|Actual|2014-07-01||Interventional|||Promoting Adolescent Development Through Sports in Hong Kong|Promoting Adolescent Development Through Sports in Hong Kong: A Randomised Controlled Trial|Completed||N/A|719|Actual|The University of Hong Kong||2|||f||||f||||||||Undecided||2017-10-11 01:14:31.999264|2017-10-11 01:14:31.999264
NCT01955252|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-08-25|||March 2013||2013-03-01|January 2017|2017-01-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|YESA-13||Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea|Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea|Completed||Phase 3|16000|Actual|Lihir Medical Centre||1|||f||||f||||||||||2017-10-11 01:14:32.11457|2017-10-11 01:14:32.11457
NCT01955239|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-06-21|||September 2013||2013-09-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|SCS-IMRT||Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy|Prevention of Radiation-induced Parotid Gland Dysfunction by Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy(SCS-IMRT)|Completed||N/A|106|Actual|University Medical Center Groningen||2|||f||||t||||||||No||2017-10-11 01:14:32.24081|2017-10-11 01:14:32.24081
NCT01955226|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-05-11|||February 2014||2014-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||CHG Dressings in Children With Central Lines|Unit Based Comparison of Non- Versus Chlorhexidine-Impregnated Central Line Dressings|Terminated||N/A|16|Actual|Yale University||2||Poor enrollment|f||||t||||||||||2017-10-11 01:14:32.337694|2017-10-11 01:14:32.337694
NCT01955213|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-03-29|||July 2012||2012-07-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|RILAX||Methylnaltrexone for Opioid Induced Constipation|Clinical Evaluation of the Efficacy of Methylnaltrexone in Resolving Constipation Induced by Different Opioid Subtypes, Combined With Laboratory Analysis of Immunomodulatory and Antiangiogenic Effects of Methylnaltrexone|Terminated||N/A|7|Actual|VU University Medical Center|||3||f||||f||||||Samples Without DNA|"     From patients who also give informed consent for the second part of the study 50 ml of     heparinized blood will be drawn before the first administration of methylnaltrexone (day 0),     after 24 hours (day 1), at day 14 and approximately day 42 for immuno- and angiogenic     measurements (see flow chart below).      From this blood sample the size, phenotype and function of various leukocyte subsets, serum     cytokine levels, VEGF levels, thrombocyte levels and circulating endothelial cell levels will     be determined by means of fluorescence-activated cell sorting (FACS) or enzyme-linked     immunosorbent assay (ELISA).   "|||2017-10-11 01:14:32.441535|2017-10-11 01:14:32.441535
NCT01955200|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-28|2016-03-16|||October 2013||2013-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|OPTIMAL||Optimal Anti-platelet Treatment for Patients With Clopidogrel Low Response|Optimal Anti-Platelet Treatment for Patients With Stent IMplantation And Clopidogrel Low Response: OPTIMAL Study|Recruiting||Phase 4|1350|Anticipated|The First Affiliated Hospital with Nanjing Medical University||5|||f||||f||||||||||2017-10-11 01:14:32.545083|2017-10-11 01:14:32.545083
NCT01955187|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-08-18|||January 2014||2014-01-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|STARMEN||Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy|European Multicenter and Open-Label Controlled Randomized Trial to Evaluate the Efficacy of Sequential Treatment With Tacrolimus-Rituximab Versus Steroids Plus Cyclophosphamide in Patients With Primary Membranous Nephropathy (The STARMEN Study)|Recruiting||Phase 3|106|Anticipated|Hospital Universitario 12 de Octubre||2|||f||||t||||||||||2017-10-11 01:14:32.687096|2017-10-11 01:14:32.687096
NCT01955174|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-05-29|||August 2013|Actual|2013-08-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|May 2017|Anticipated|2017-05-01||Interventional|TIBOH||Botulinum Toxin Injection in Hypercontractile Esophagus|Endoscopic Injection of Botulinum Toxin in Patients With Hypercontractile Esophageal Motility Disorders: a Prospective, Randomized, Double-blind, Controlled Study|Active, not recruiting||Phase 2|24|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:14:32.834173|2017-10-11 01:14:32.834173
NCT01955161|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-08-22|2017-07-11||October 2013||2013-10-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|STARSHINE|A total of 933 patients were randomized into the study but 3 patients were not treated (did not receive IMP). The baseline analysis population only consist of patients who have been treated.|Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil|Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil|Completed||Phase 3|933|Actual|H. Lundbeck A/S||3|||f||||t||||||||||2017-10-11 01:14:32.991054|2017-10-11 01:14:32.991054
NCT01955148|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-08-24|||October 2013||2013-10-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Observational|||fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth|Prospective Phase III Evaluation Of Fetal Fibronectin In A High Risk Asymptomatic Population For The Prediction Of Spontaneous Preterm Birth|Unknown status|Recruiting|N/A|1210|Anticipated|Hologic, Inc.|||4||f||||f||||||Samples Without DNA|"     cervicovaginal fluid   "|||2017-10-11 01:14:35.073724|2017-10-11 01:14:35.073724
NCT01955135|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-27|||September 2010||2010-09-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Anesthesia for Retinopathy of Prematurity|DECREASING THE NEED FOR MECHANICAL VENTILATION AFTER RETINOPATHY OF PREMATURITY SURGERY: Sedation vs General Anesthesia|Completed||Phase 4|60|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 01:14:35.309569|2017-10-11 01:14:35.309569
NCT01955122|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-01-15|2016-01-20||July 2013||2013-07-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Polyp Detection With the EndoRings™: A Randomized Tandem Colonoscopy Study|Polyp Detection With the EndoRings™: A Randomized Tandem Colonoscopy Study|Completed||N/A|126|Actual|EndoAid||2|||f||||t||||||||No||2017-10-11 01:14:35.430408|2017-10-11 01:14:35.430408
NCT01955109|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-10-04|||September 2013||2013-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|OLFUS-VIPES||Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children|Open-label Follow-up Study of the VIPES Study to Evaluate Long-term Efficacy and Safety of the Viaskin Peanut|Completed||Phase 2|171|Actual|DBV Technologies||1|||f||||t||||||||||2017-10-11 01:14:35.880285|2017-10-11 01:14:35.880285
NCT01955083|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-29|2014-07-28|2013-10-06||August 2010||2010-08-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Analysis of Snore Sound Following Minimal Invasive Surgery in Sleep-disordered Breathing Patients|Analysis of Snore Sound Following Minimal Invasive Surgery in Sleep-disordered Breathing Patients|Completed||N/A|30|Actual|Chang Gung Memorial Hospital|The major limitations to this study were unbalanced randomization in Total-Imax despite insignificant differences in other baseline parameters between the two groups and the small sample size of the study limited the subgroup analysis.|2|||f||||t||||||||||2017-10-11 01:14:36.124347|2017-10-11 01:14:36.124347
NCT01955070|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-27|||May 2011||2011-05-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Use of a Multimedia Presentation for Informed Consent|Use of a Multimedia Presentation to Enhance the Informed Consent for Ketamine Sedation in a Pediatric Emergency Department|Completed||N/A|184|Actual|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-11 01:14:37.06083|2017-10-11 01:14:37.06083
NCT01955057|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-06-08|||December 2013||2013-12-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Study of Psychopathological Characteristics of Patient Smoking in Thoracic Oncology|Study of Psychopathological Characteristics of Patient Smoking in Thoracic Oncology|Completed||N/A|50|Actual|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 01:14:37.173704|2017-10-11 01:14:37.173704
NCT01955044|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-02-07|2016-02-26||September 2013||2013-09-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Interventional|||PUFA Supplementation in Premature Infants|Early DHA Supplementation in Extremely Low Birth Weight Infants|Completed||N/A|30|Actual|NorthShore University HealthSystem Research Institute||3|||f||||t||||||||||2017-10-11 01:14:37.265699|2017-10-11 01:14:37.265699
NCT01955031|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-08-21|||November 2013||2013-11-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|May 2016|Actual|2016-05-01||Interventional|EDUC@DOM||Effectiveness and Cost-effectiveness of a Telemonitoring Program for Diabetic People at Home|Effectiveness and Cost-effectiveness Analysis of a Telemonitoring Program on Lifestyle for People With Type 2 Diabetes at Home. Study Based on a Health Network in Diabetology.|Active, not recruiting||N/A|282|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-11 01:14:37.65151|2017-10-11 01:14:37.65151
NCT01955018|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-10-04|||September 2012||2012-09-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Comparison of the Ultra-low-dose Veo Algorithm With the Gold Standard Filtered Back Projection for Detecting Pulmonary Asbestos-related Conditions|Comparison of the Ultra-low-dose Veo Algorithm With the Gold Standard Filtered Back Projection for Detecting Pulmonary Asbestos-related Conditions|Completed||Phase 4|90|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:14:37.799703|2017-10-11 01:14:37.799703
NCT01955005|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-01-08|2015-10-14||October 2013||2013-10-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Veterans with a diagnosis of at least one chronic health condition taking 5 or more medications who have both a VA and a non-VA provider.|Use of the My HealtheVet for Health Information Sharing|Pilot of My HealtheVet Training to Improve Co-Managed Care for Veterans|Completed||N/A|60|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 01:14:37.895965|2017-10-11 01:14:37.895965
NCT01954992|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-02-23|||September 2013||2013-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer|A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Fluorouracil (5-FU) in Patients With Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine|Recruiting||Phase 3|480|Anticipated|Eleison Pharmaceuticals LLC.||2|||f||||t||||||||||2017-10-11 01:14:38.314009|2017-10-11 01:14:38.314009
NCT01954979|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-06-30|||October 2013||2013-10-01|June 2017|2017-06-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)|A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)|Recruiting||Phase 1|22|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:14:38.731238|2017-10-11 01:14:38.731238
NCT01954966|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-08-15|||November 2010||2010-11-01|August 2017|2017-08-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Progesterone and Brain Imaging Study|Multimodal Imaging of Progesterone/Neurosteroid Effects in Nicotine Addiction|Recruiting||Phase 4|150|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:14:38.863892|2017-10-11 01:14:38.863892
NCT01954953|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-02-03|||September 2013||2013-09-01|September 2013|2013-09-01||||January 2016|Anticipated|2016-01-01||Observational|EURUSH||Clinical and Genetic Examination of Usher Syndrome Patients' Cohort in Europe|European Research Projects on Rare Diseases Driven by Young Investigators|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts|||1||f||||t||||||||||2017-10-11 01:14:38.987288|2017-10-11 01:14:38.987288
NCT01954940|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-02-21|||March 2013||2013-03-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy|THE EFFECT OF WHOLE BODY VIBRATION THERAPY UPON MUSCLE STRENGTH & FUNCTION IN AMBULATORY BOYS WITH DUCHENNE MUSCULAR DYSTROPHY|Active, not recruiting||N/A|4|Actual|Children's Hospital of Eastern Ontario||2|||f||||f||||||||||2017-10-11 01:14:39.097813|2017-10-11 01:14:39.097813
NCT01954927|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-09-14|||October 7, 2013|Actual|2013-10-07|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Pain Management in Children and Young Adults With Sickle Cell Disease|Pain Management of Vaso-Occlusive Crisis in Children and Young Adults With Sickle Cell Disease|Recruiting||Phase 2|190|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|t|f||||||||2017-10-11 01:14:39.190291|2017-10-11 01:14:39.190291
NCT01954914|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2016-09-16|||December 2013||2013-12-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|MOBIL1||Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers|Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers|Completed||Phase 2|39|Actual|Technische Universität Dresden||1|||f||||f||||||||No||2017-10-11 01:14:39.311382|2017-10-11 01:14:39.311382
NCT01954901|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-11-05|||October 2013||2013-10-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers|Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers: a Double-blind, Randomized,Controlled Clinical Trial.|Terminated||Phase 3|2|Actual|David Grant U.S. Air Force Medical Center||2||Failure to enroll subjects due to change in referral policy.|f||||t||||||||||2017-10-11 01:14:39.408339|2017-10-11 01:14:39.408339
NCT01954888|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-10-30|||September 2013||2013-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Impact of the Ultrasound-guided Approach on the Efficiency and Safety of the Stellate Ganglion Block in Chronic Pain|Impact of the Ultrasound-guided Approach on the Efficiency and Safety of the Stellate Ganglion Block in Chronic Pain|Recruiting||N/A|60|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||t||||||||No||2017-10-11 01:14:39.579853|2017-10-11 01:14:39.579853
NCT01954875|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2013-09-27|||December 2009||2009-12-01|September 2013|2013-09-01||||December 2013|Anticipated|2013-12-01||Observational|||Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases|Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases|Unknown status|Recruiting|N/A|300|Anticipated|Carolinas Healthcare System|||3||f||||f||||||Samples With DNA|"     blood, feces   "|||2017-10-11 01:14:39.709462|2017-10-11 01:14:39.709462
NCT01954862|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2014-07-30|||October 2013||2013-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Comparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided Colonoscopy|Comparison of Methods for Luminal Distention for on Demand Sedation Colonoscopy: Air Insufflation, Carbon Dioxide and Water-aided Colonoscopy. A Randomized Controlled Trial.|Completed||N/A|624|Actual|Presidio Ospedaliero Santa Barbara||6|||f||||f||||||||||2017-10-11 01:14:39.804315|2017-10-11 01:14:39.804315
NCT01954849|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-08-17|||August 2014||2014-08-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Assessment of a Probiotic to Treat Gingivitis in Pediatric Patients|Assessment of Therapeutic Potential of a Novel Dental Probiotic in Pediatric Patients Affected by Gingivitis|Completed||Phase 2|60|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:14:39.945295|2017-10-11 01:14:39.945295
NCT01954836|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2016-12-12|||October 2013||2013-10-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|FIT||Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial|Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial|Completed||N/A|50|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||No||2017-10-11 01:14:40.056225|2017-10-11 01:14:40.056225
NCT01954823|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2015-08-02|||September 2015||2015-09-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Use of an Electronic Diary by People With Multiple Sclerosis|Randomized Controlled Trial for the Evaluation of the Use of an Electronic Diary by People With Multiple Sclerosis|Unknown status|Not yet recruiting|N/A|100|Anticipated|Carmel Medical Center||2|||f||||t||||||||||2017-10-11 01:14:40.170855|2017-10-11 01:14:40.170855
NCT01954810|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2013-10-06|||October 2013||2013-10-01|October 2013|2013-10-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children|Assessment of Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With a Single Dose of JE-CV|Unknown status|Not yet recruiting|Phase 4|88|Anticipated|Khon Kaen University||1|||f||||f||||||||||2017-10-11 01:14:40.303658|2017-10-11 01:14:40.303658
NCT01954797|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-07-20|||October 2013||2013-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|November 2016|Actual|2016-11-01||Observational|BAPTISe||Biomarkers and Perfusion - Training-Induced Changes After Stroke|Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe): Protocol of an Observational Study Accompanying a Randomized Controlled Trial|Active, not recruiting||N/A|100|Actual|Charite University, Berlin, Germany|||2||f||||t||||||Samples With DNA|"     Patients will receive blood draws (whole blood) for blood biomarker analyses.   "|||2017-10-11 01:14:40.430607|2017-10-11 01:14:40.430607
NCT01954784|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2017-02-16|||October 7, 2013|Actual|2013-10-07|February 2017|2017-02-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|||Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma|A Study of Low-dose Lenalidomide After Non-myeloablative Allogeneic Stem Cell Transplant With Bortezomib as GVHD Prophylaxis in High Risk Multiple Myeloma|Terminated||Phase 1|8|Actual|Case Comprehensive Cancer Center||1||Funding unavailable|f||||t||||||||||2017-10-11 01:14:40.548179|2017-10-11 01:14:40.548179
NCT01954771|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-06-27|2016-08-31||June 2013||2013-06-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CAD|A Prospective, Randomized, Controlled Study on Self-monitoring of Blood Glucose (SMBG) Protocols in Predicting Glucose Levels in Senior Patients With Type 2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD)|Completed||N/A|89|Actual|Beijing Anzhen Hospital|This clinical trial population may not be representative of all patients. Because patients missed clinic visits in three months by reason of vacation tour, or complained about frequent blood samplings, 14.6% of all did not follow the study protocol.|3|||f||||t||||||||No||2017-10-11 01:14:40.7045|2017-10-11 01:14:40.7045
NCT01954758|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-03-06|||October 2013||2013-10-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer|Clinical Study, International, Multicentre, Prospective, Randomised, Interventional and Controlled, Comparing Fresh Embryo Transfer (ET) Versus Elective Delayed Embryo Transfer (DET) and Personalised Embryo Transfer (pET) Guided by the ERA (Endometrial Receptivity Array) Test as a Diagnostic Tool in Patients Treated by IVF/ICSI (in Vitro Fertilisation; Intra-cytoplasmic Sperm Injection)|Recruiting||N/A|546|Anticipated|Igenomix||4|||f||||t||||||||||2017-10-11 01:14:41.65438|2017-10-11 01:14:41.65438
NCT01954745|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-12-12|2016-12-12||September 2013||2013-09-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma|A Phase II Study of Cabozantinib (XL-184) Monotherapy in Patients With Advanced Cholangiocarcinoma After Progression on First or Second Line Systemic Therapy|Completed||Phase 2|19|Actual|Massachusetts General Hospital|After 12 patients failed to be progression-free at 16 weeks, the study was terminated as it was determined that the criterion for proceeding to stage 2 could not be met. (i.e. 9 of 20 patients needed to be progression free at 4 months.)|1|||f||||t||||||||No||2017-10-11 01:14:41.914609|2017-10-11 01:14:41.914609
NCT01954732|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-07-14|||January 2014||2014-01-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery|A Pharmacodynamic Study of Metformin in Patients With Resectable Pancreatic Cancer|Withdrawn||Phase 1|0|Actual|Case Comprehensive Cancer Center||3||Slow accrual|f||||t||||||||||2017-10-11 01:14:42.254692|2017-10-11 01:14:42.254692
NCT01954719|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2013-10-04|||November 2012||2012-11-01|September 2013|2013-09-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Is Routine Cervical Dilatation Necessary During Elective Caesarean Section? A Randomised Controlled Trial|Is Routine Cervical Dilatation Necessary During Elective Caesarean Section? A Randomised Controlled Trial|Unknown status|Recruiting|N/A|200|Anticipated|Bakirkoy Dr. Sadi Konuk Research and Training Hospital||2|||f||||f||||||||||2017-10-11 01:14:42.331697|2017-10-11 01:14:42.331697
NCT01954706|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2015-11-25|||November 2013||2013-11-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|BCS2||Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients|Pilot Trial of Aerobic and Resistance Exercise Training for the Primary Prevention of Musculoskeletal Side Effects From Aromatase Inhibitors in Postmenopausal Breast Cancer Patients|Terminated||N/A|5|Actual|Baltimore VA Medical Center||2||The study was stopped due to recruitment difficulties|f||||t||||||||||2017-10-11 01:14:42.433679|2017-10-11 01:14:42.433679
NCT01954693|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-01-30|||June 2012||2012-06-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Interventional|TRON||A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis|TRON: A Randomised, Double Blind, Placebo-controlled Study of RAD001 (Everolimus) in the Treatment of Neurocognitive Problems in Tuberous Sclerosis|Recruiting||Phase 2|48|Anticipated|Cardiff University||2|||f||||t||||||||||2017-10-11 01:14:42.532378|2017-10-11 01:14:42.532378
NCT01954680|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-07-18|||August 2013||2013-08-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|COGFLEX||Retrain Your Brain in Children/Adolescents With Bipolar Disorder: A Pilot Study|COGFLEX: Pilot Translational Intervention of Pediatric Bipolar Disorder|Recruiting||Phase 1|40|Anticipated|Bradley Hospital||2|||f||||t||||||||||2017-10-11 01:14:42.654508|2017-10-11 01:14:42.654508
NCT01954667|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2013-09-29|||January 2012||2012-01-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01|6 Weeks|Observational [Patient Registry]|||Anthropometric Measures and Severity of Gastroesophageal Reflux Disease||Completed||N/A|80|Actual|Ain Shams University|||3||f||||f||||||||||2017-10-11 01:14:42.745245|2017-10-11 01:14:42.745245
NCT01954654|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-29|2013-10-06|||October 2013||2013-10-01|October 2013|2013-10-01||||April 2015|Anticipated|2015-04-01||Interventional|||Effectiveness of Accelerated Intervention With Compression Sleeve in Mild and Moderate Breast Cancer-related Lymphedema|Effectiveness of Accelerated Intervention With Custom-made Compression Sleeve in Women With Mild and Moderate Arm Lymphedema Secondary to Breast Cancer Treatment|Unknown status|Recruiting|N/A|84|Anticipated|Aarhus University Hospital||2|||f||||||||||||||2017-10-11 01:14:42.822024|2017-10-11 01:14:42.822024
NCT01954641|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-06-16|||April 2013||2013-04-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|ACCURE||Accountability for Cancer Care Through Undoing Racism and Equity|Accountability for Cancer Care Through Undoing Racism and Equity|Active, not recruiting||N/A|300|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-11 01:14:42.911173|2017-10-11 01:14:42.911173
NCT01954628|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-05-08|2017-05-08||October 2013||2013-10-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|FLAGSHIP|Safety set.|Efficacy and Safety of AQX-1125 in Unstable COPD|The FLAGSHIP Study: A 12-week Phase II Study to Evaluate the Efficacy and Safety of AQX-1125 Following Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD) by Targeting the SHIP1 Pathway|Completed||Phase 2|400|Actual|Aquinox Pharmaceuticals (Canada) Inc.|"Secondary objective of The frequency and severity of AEs and changes in physical exam, vital signs, ophthalmic exam, laboratory tests, weight, ECG, and con meds was monitored throughout the study, clinically significant events were reported as AEs."|2|||f||||f||||||||No||2017-10-11 01:14:43.030127|2017-10-11 01:14:43.030127
NCT01954615|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2013-10-09|||October 2011||2011-10-01|October 2013|2013-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Single-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male Subjects|A Single-center, Double-blind, Randomized, Placebo-controlled, Single-ascending Oral Dose and Food Interaction Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male Subjects|Completed||Phase 1|49|Actual|Actelion||7|||f||||f||||||||||2017-10-11 01:14:43.935887|2017-10-11 01:14:43.935887
NCT01954589|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-27|2013-10-09|||November 2011||2011-11-01|October 2013|2013-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206|Double-blind, Placebo- and Active-controlled, Randomized, Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206 in Healthy Male Subjects|Completed||Phase 1|56|Actual|Actelion||7|||f||||f||||||||||2017-10-11 01:14:44.145609|2017-10-11 01:14:44.145609
NCT01943708|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-10|2014-08-06|||September 2010||2010-09-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Novel Auto-continuous Positive Airway Pressure (CPAP) Validation|A Study to Validate a Novel Auto Continuous Positive Airway Pressure Therapy|Completed||Phase 3|74|Actual|Fisher and Paykel Healthcare||2|||f||||f||||||||||2017-10-11 01:17:53.810066|2017-10-11 01:17:53.810066
NCT01954563|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-01-27|||October 2013||2013-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector Immunity|A Phase I Trial Evaluating Mucosal Administration of a Candidate TB Vaccine, MVA85A, as a Way to Induce Potent Local Cellular Immune Responses and Avoid Anti-vector Immunity|Completed||Phase 1|37|Actual|University of Oxford||3|||f||||t||||||||||2017-10-11 01:14:44.38383|2017-10-11 01:14:44.38383
NCT01954550|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-11-09|||March 2014||2014-03-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|FIT-AD||Effects of Aerobic Exercise for Treating Alzheimer's Disease|Aerobic Exercise in Alzheimer's Disease: Cognition and Hippocampal Volume Effects|Recruiting||N/A|90|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||Undecided||2017-10-11 01:14:44.465835|2017-10-11 01:14:44.465835
NCT01954537|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2013-09-26|||July 2013||2013-07-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Comparing Risk of Heat Illness Based on Peak Core Temps During Preseason Football Camp Across 3 Different Age Levels|"Using Peak Core Temperature in Hot Preseason American Football Practice to Compare and Contrast Risk of Heat Illness at High School, College, and Professional Levels."|Completed||N/A|22|Actual|University of Minnesota - Clinical and Translational Science Institute|||3||f||||f||||||||||2017-10-11 01:14:44.725326|2017-10-11 01:14:44.725326
NCT01954524|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-09-25|||May 2014||2014-05-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis|A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis|Terminated||Phase 1|2|Actual|University of Maryland||1||The study is closed due to lack of funding to support the study.|f||||t||||||||||2017-10-11 01:14:44.831555|2017-10-11 01:14:44.831555
NCT01954511|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-01-29|||July 2012||2012-07-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Manual Therapy and Exercises Applied to Cervical Spine in Patients With Temporomandibular Disorders|Effects of Manual Therapy and Exercises Applied to Cervical Spine in Patients With Temporomandibular Disorders: Pilot Study|Completed||N/A|12|Actual|Universidade Federal de Sao Carlos||1|||f||||f||||||||||2017-10-11 01:14:44.955456|2017-10-11 01:14:44.955456
NCT01954498|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-11-22|||May 2014||2014-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Walnuts on Sperm Parameters and Male Fertility|Effect of Walnuts on Sperm Parameters and Male Fertility|Recruiting||Phase 2/Phase 3|140|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:14:45.107544|2017-10-11 01:14:45.107544
NCT01954485|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2013-09-26|||January 2013||2013-01-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2013|Actual|2013-09-01||Interventional|||Adhesion of Connective Tissue Around Laser-treated Abutments for Dental Implants - Clinical Trial in Humans|Histological Differences in the Adhesion of Connective Tissue Around Laser-treated Abutments and Standard Abutments for Dental Implants - Clinical Trial in Humans|Unknown status|Recruiting|Phase 4|||University of Barcelona||2|||f||||f||||||||||2017-10-11 01:14:45.285353|2017-10-11 01:14:45.285353
NCT01954472|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-04-25||||||April 2017|2017-04-01|October 7, 2014|Actual|2014-10-07|October 7, 2014|Actual|2014-10-07||Interventional|EDP8||Enhanced Multicenter Dietary Portfolio Study|The Effect of an Enhanced Dietary Portfolio Plus Exercise on Cardiovascular Risk in High Risk Individuals.|Withdrawn||N/A|0|Actual|St. Michael's Hospital, Toronto||2||"This study was combined with another CIHR funded study (NCT02078635). Both studies involve the   same dietary portfolio and the same study population."|f||||f||||||||||2017-10-11 01:14:45.444537|2017-10-11 01:14:45.444537
NCT01954459|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-09-30|||September 2013||2013-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?|Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?|Terminated||Early Phase 1|11|Actual|Yale University||2||unable to complete due to lack of funding|f||||f||||||||||2017-10-11 01:14:45.591524|2017-10-11 01:14:45.591524
NCT01954446|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-09-26|||April 2013||2013-04-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Novel Non-interfering Arterial Blood Pressure Monitoring Device|A Novel Non-interfering Arterial Blood Pressure Monitoring Device|Withdrawn||N/A|0|Actual|Sense A/S||2||The investigational devices need alterations before validation|f||||f||||||||||2017-10-11 01:14:45.681277|2017-10-11 01:14:45.681277
NCT01954433|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-03-20|||November 2013||2013-11-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Observational|||Costs and Consequences of Three Common Orthopedic Procedures on the Upper Extremity|Costs and Consequences of Three Common Orthopedic Procedures on the Upper Extremity - Health Economic Investigation (Cost-effectiveness and Cost-utility Analyses) With Before and After Surgery Comparison|Recruiting||N/A|450|Anticipated|Schulthess Klinik|||6||f||||t||||||||||2017-10-11 01:14:45.770308|2017-10-11 01:14:45.770308
NCT01954420|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-02-02|||December 2013||2013-12-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer|A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer|Completed||N/A|188|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 01:14:45.952918|2017-10-11 01:14:45.952918
NCT01954407|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-06-13|||September 2013|Actual|2013-09-01|June 2017|2017-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Young Adults' Responses to Anti-smoking Messages|Young Adults' Anti-smoking Message Ratings and Ideas About Smoking Survey|Completed||N/A|2200|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-11 01:14:46.122309|2017-10-11 01:14:46.122309
NCT01953510|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-08-20|||September 30, 2013|Actual|2013-09-30|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|January 27, 2016|Actual|2016-01-27||Interventional|||Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam|Evaluation of Different Infant Vaccination Schedules Incorporating Pneumococcal Vaccination|Active, not recruiting||Phase 2/Phase 3|1400|Actual|Murdoch Childrens Research Institute||7|||f||||f||||||||||2017-10-11 01:15:04.594506|2017-10-11 01:15:04.594506
NCT01954394|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-12-14|||December 2013||2013-12-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|ODYSSEY OLE||Open Label Study of Long Term Safety Evaluation of Alirocumab|Open-Label Extension Study of EFC12492, R727-CL-1112, EFC12732 and LTS11717 Studies to Assess the Long-Term Safety and Efficacy of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia|Active, not recruiting||Phase 3|1000|Anticipated|Sanofi||1|||f||||t||||||||||2017-10-11 01:14:46.268792|2017-10-11 01:14:46.268792
NCT01954381|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-07-21|||October 2011||2011-10-01|September 2014|2014-09-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|||Impact of Adalimumab Therapy on Brachial Endothelial Function and Large Artery Stiffness in Patients With Rheumatoid Arthritis|Impact of Adalimumab Therapy on Brachial Endothelial Function and Large Artery Stiffness in Patients With Rheumatoid Arthritis|Completed||Phase 3|60|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:14:46.842977|2017-10-11 01:14:46.842977
NCT01954368|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-11-30|||January 2014||2014-01-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|InSPEED||Intranasal Sufentanil Pain-management at Entrance of Emergency Department : Influence on Pain-relief Delay|Acute Severe Traumatic Pain in the ED : Can we Improve Time to Pain-relief With a Single Dose of Intranasal Sufentanil Given at Triage ? A Randomized Double-blinded Placebo Controlled Study (InSPEED Study)|Completed||Phase 4|144|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 01:14:46.94568|2017-10-11 01:14:46.94568
NCT01954355|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-11-23|||September 2013||2013-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2015|Actual|2015-10-01||Interventional|||LDE225 and Paclitaxel in Solid Tumors|LDE225 in Combination With Paclitaxel in Patients With Advanced Solid Tumors - A Multicenter Phase I Trial|Completed||Phase 1|30|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||No||2017-10-11 01:14:47.028139|2017-10-11 01:14:47.028139
NCT01954342|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-08-04|||December 2014||2014-12-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|July 2017|Actual|2017-07-01||Observational|MomEE||Determinants of Gestational Weight Gain in Obese Pregnant Women|MomEE: Determinants of Gestational Weight Gain in Obese Pregnant Women|Active, not recruiting||N/A|75|Anticipated|Pennington Biomedical Research Center|||1||f||||f||||||Samples Without DNA|"     Placenta, Cord Blood, fasting Urine, fasting Maternal plasma and serum (during pregnancy and     postpartum).   "|||2017-10-11 01:14:47.119956|2017-10-11 01:14:47.119956
NCT01954329|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-06-12|||September 2013||2013-09-01|June 2015|2015-06-01||||March 2016|Anticipated|2016-03-01||Observational|MIND-TIA||Markers in the Diagnosis of TIA|Markers in the Diagnosis of TIA|Unknown status|Recruiting|N/A|350|Anticipated|UMC Utrecht|||1||f||||t||||||Samples With DNA|"     Serum, RNA and DNA material.   "|||2017-10-11 01:14:47.195997|2017-10-11 01:14:47.195997
NCT01954316|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-06-16|||March 2014||2014-03-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of CFI-400945 Fumarate in Patients With Advanced Cancer|An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-400945 Fumarate Administered Orally to Patients With Advanced Cancer|Recruiting||Phase 1|48|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:14:47.275384|2017-10-11 01:14:47.275384
NCT01954303|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-05-09|||October 2013||2013-10-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Observational|||HsTnT in Stable Coronary Artery Disease|Elevated High-sensitivity Cardiac Troponin T Levels in Patients With Stable Coronary Artery Disease|Completed||N/A|965|Actual|University Hospital Heidelberg|||2||f||||f||||||||||2017-10-11 01:14:47.378704|2017-10-11 01:14:47.378704
NCT01954290|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-12-13|||September 2015||2015-09-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study of Stroke Related Edema Treatments|Treatment of Brain Edema and Herniation Secondary to Ischemic or Hemorrhagic Stroke|Withdrawn||Phase 2|0|Actual|University of Florida||2||Investigator is leaving the institution.|f||||f||||||||||2017-10-11 01:14:47.446282|2017-10-11 01:14:47.446282
NCT01954277|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-11-15|||October 2010||2010-10-01|September 2013|2013-09-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Immune-Pineal Axis Function in Chronic Tension-Type Headache|Immune-Pineal Axis Function in Chronic Tension-Type Headache: Noradrenergic Modulation and the Effect of Electroacupuncture|Completed||Phase 2/Phase 3|34|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 01:14:47.528528|2017-10-11 01:14:47.528528
NCT01954238|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-12-18|||August 2013||2013-08-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers|A Phase I, Randomized, Double-blind, Placebo-controlled, Single and Multiple Sequential Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered GCC-4401C in Healthy Males|Completed||Phase 1|46|Actual|Green Cross Corporation||3|||f||||t||||||||||2017-10-11 01:14:49.567331|2017-10-11 01:14:49.567331
NCT01954225|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-26|||February 2006||2006-02-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|April 2006|Actual|2006-04-01||Interventional|Bhagandara||Role of Udumbara Sutra in the Management of Fistula in Ano a Rare Case Study|Role of Udumbara Sutra in the Management of Fistula in Ano a Rare Case Study|Completed||N/A|1|Actual|Government Ayurved College and Hospital||1|||f||||f||||||||||2017-10-11 01:14:51.291013|2017-10-11 01:14:51.291013
NCT01954212|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-02-27|||October 2013||2013-10-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Interventional|SOCLE II||Stroke Oral healthCare pLan Evaluation|A Multi-centred, Stepped Wedge, Cluster Randomised Controlled Trial to Compare the Clinical and Cost Effectiveness of a Complex Oral Health Care Intervention and Standard Oral Health Care in Stroke Care Settings: a Phase II Pilot Trial.|Completed||Phase 2|437|Actual|Glasgow Caledonian University||2|||f||||t||||||||||2017-10-11 01:14:51.399339|2017-10-11 01:14:51.399339
NCT01954199|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-06-01|||March 2015||2015-03-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain|The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain|Completed||N/A|60|Actual|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||||2017-10-11 01:14:51.493074|2017-10-11 01:14:51.493074
NCT01954186|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-22|2013-09-26|||January 2010||2010-01-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||When and How to Administer Oxytocin for Active Management of Third Stage of Labour|When and How to Administer Oxytocin for Active Management of Third Stage of Labour|Completed||N/A|600|Actual|Etlik Zubeyde Hanim Womens' Health and Teaching Hospital||2|||f||||f||||||||||2017-10-11 01:14:51.580126|2017-10-11 01:14:51.580126
NCT01954173|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-03-20|||July 2013||2013-07-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Adjuvant Radiation for High Risk Bladder Cancer|Phase II Study of Adjuvant 3D-Conformal Radiotherapy in High Risk Bladder Cancer|Recruiting||N/A|41|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 01:14:51.666054|2017-10-11 01:14:51.666054
NCT01954160|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-12-30|2015-12-30||December 2013||2013-12-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PRESERVE|All patients were required to have suitable anatomy per renal ultrasound. One randomized subject did not have suitable anatomy to proceed to renal denervaton.|Study of Renal Denervation in Patients With Heart Failure|Promotion of Renal Sodium Excretion by Renal Sympathetic Denervation in Congestive Heart Failure|Terminated||Phase 2|5|Actual|Duke University|Data Safety Monitoring Board (DSMB) terminated trial based upon noted lack of efficacy in manufacturers pivotal trials. Endpoint data not collected or analyzed.|2||DSMB decision based upon noted lack of efficacy in manufacturers pivotal trials.|f||||t||||||||||2017-10-11 01:14:51.782278|2017-10-11 01:14:51.782278
NCT01954147|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-02-19|||October 2013||2013-10-01|February 2014|2014-02-01|October 2015|Anticipated|2015-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus|Umbilical Cord Mesenchymal Stem Cell Infusion With Liraglutide in Type 2 Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 1/Phase 2|100|Anticipated|Diabetes Care Center of Nanjing Military Command||4|||f||||t||||||||||2017-10-11 01:14:53.62983|2017-10-11 01:14:53.62983
NCT01954134|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2013-09-26|||December 2010||2010-12-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||P53 in Differentiated Thyroid Cancer|P53 Antibody; Is it an Indicator of Dedifferentiated Thyroid Cancer?|Completed||N/A|199|Actual|Cumhuriyet University|||1||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:14:53.749215|2017-10-11 01:14:53.749215
NCT01954121|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-07-06|2016-03-18||September 2013||2013-09-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||The Baseline Characteristics refers to the Safety Set (SS) which consists of all subjects who were randomized and received at least 1 dose of trial medication.|Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures|An Open-label, Randomized, Parallel-group, Active-controlled Study Comparing the Efficacy and Safety of Levetiracetam to Carbamazepine Used as Monotherapy in Subjects Newly or Recently Diagnosed as Epilepsy and Partial-onset Seizures|Completed||Phase 3|436|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 01:14:53.878361|2017-10-11 01:14:53.878361
NCT01954108|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-11-06|||December 2013||2013-12-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Hyaluronan in the Treatment of Painful Achilles Tendinopathy.|Hyaluronan in the Treatment of Painful Achilles Tendinopathy.|Completed||N/A|62|Actual|TRB Chemedica AG||2|||f||||f||||||||||2017-10-11 01:14:54.57208|2017-10-11 01:14:54.57208
NCT01954095|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-12-01|||August 2013||2013-08-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|||The Impact of Vaginal and IM Progestins on the Cervix|Determining the Pharmacodynamic Impact of Vaginal and IM Progestins on the Cervix|Completed||N/A|89|Actual|University of Pittsburgh|||4||f||||t||||||Samples With DNA|"     Blood for DNA extraction, hormone, and metabolomic analyses      Cervicovaginal fluid for proteome, cytokines, and matrix metalloproteins (MMPs)   "|||2017-10-11 01:14:54.691673|2017-10-11 01:14:54.691673
NCT01954082|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-09-22|||April 2014||2014-04-01|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|December 31, 2016|Actual|2016-12-31||Interventional|INS-3||Inositol to Reduce Retinopathy of Prematurity|INS-3: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Myo-Inositol 5% Injection to Increase Survival Without Severe Retinopathy of Prematurity (Reduce-ROP) in Extremely Premature Infants|Terminated||Phase 3|638|Actual|NICHD Neonatal Research Network||2||Study terminated due to safety concerns; participant follow up will continue until March 2018|f||||t|t|f||||||||2017-10-11 01:14:54.797141|2017-10-11 01:14:54.797141
NCT01954069|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-01-14|||November 2013||2013-11-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service|Simplifying Menstrual Regulation (MR): Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service Provision in Pakistan|Completed||N/A|280|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-10-11 01:14:54.972369|2017-10-11 01:14:54.972369
NCT01954056|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-12-08|||July 2014||2014-07-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|||Hydrocortisone for Term Hypotension|Hydrocortisone Treatment of Cardiovascular Insufficiency in Term and Late Preterm Infants: A Randomized Controlled Trial|Active, not recruiting||Phase 3|646|Anticipated|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-10-11 01:14:55.119313|2017-10-11 01:14:55.119313
NCT01953692|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-09-08|||November 22, 2013|Actual|2013-11-22|August 2017|2017-08-01|June 29, 2018|Anticipated|2018-06-29|October 11, 2017|Anticipated|2017-10-11||Interventional|||A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)|A Phase Ib Multi-Cohort Trial of MK-3475 (Pembrolizumab) in Subjects With Hematologic Malignancies|Active, not recruiting||Phase 1|222|Anticipated|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-10-11 01:14:58.567585|2017-10-11 01:14:58.567585
NCT01954043|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-07-20|||December 20, 2013|Actual|2013-12-20|July 2017|2017-07-01|May 31, 2016|Actual|2016-05-31|March 31, 2016|Actual|2016-03-31||Interventional|||A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors|An Open-label Study to Evaluate the Effects of a Potent CYP3A4 Inducer and the Effects of a pH Elevating Agent on the Repeat Dose Pharmacokinetics of Dabrafenib (GSK2118436) in Subjects With BRAF V600 Mutation Positive Tumors|Completed||Phase 1|23|Actual|GlaxoSmithKline||1|||f||||f|t|f||||||||2017-10-11 01:14:55.292173|2017-10-11 01:14:55.292173
NCT01954030|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-02-17|||October 2013||2013-10-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure|A Phase 1/2 Trial of Carboxyamidotriazole Orotate (CTO) Alone or in Combination With Bevacizumab for Adult Patients With Recurrent Malignant Glioma Post-Bevacizumab Failure|Terminated||Phase 1|17|Actual|Duke University||3||Study terminated early due to funding reasons prior to completing Phase 1|f||||f||||||||||2017-10-11 01:14:55.421688|2017-10-11 01:14:55.421688
NCT01954017|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-03-21|||December 2013||2013-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||STP206 for the Prevention of NEC|A Phase Ib/IIa Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates|Recruiting||Phase 1/Phase 2|400|Anticipated|Leadiant Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 01:14:55.562699|2017-10-11 01:14:55.562699
NCT01954004|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-05-29|||April 2013||2013-04-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01|4 Months|Observational [Patient Registry]|||Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients|An Open Registry to Measure the Impact of Adding Genomic Testing (Prolaris®) on the Treatment Decision Following Biopsy in Newly Diagnosed Prostate Cancer Patients|Completed||N/A|1270|Actual|Myriad Genetic Laboratories, Inc.|||1||f||||f||||||||||2017-10-11 01:14:55.716284|2017-10-11 01:14:55.716284
NCT01953991|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-05-12|||May 2014||2014-05-01|October 2016|2016-10-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||OHQoL With Removable Partial Dentures; a Pilot Study|A Pilot Study Investigating Oral Health Related Quality of Life Improvements in Removable Partial Denture Treatments for the Replacement of Missing Teeth|Active, not recruiting||N/A|25|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:14:55.789377|2017-10-11 01:14:55.789377
NCT01953978|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-10-26|||December 2012||2012-12-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery|The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen as Adjuvant, Postoperative Pain After Herniated Disc Surgery|Completed||Phase 4|160|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:14:55.86941|2017-10-11 01:14:55.86941
NCT01953952|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-03-18|||December 2013||2013-12-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer|Randomized Phase II Trial of Transoral Endoscopic Head And Neck Surgery Followed by Risk-Based IMRT and Weekly Cisplatin Versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer|Withdrawn||Phase 2|0|Actual|Radiation Therapy Oncology Group||2||Slow accrual|f||||||||||||||2017-10-11 01:14:55.984482|2017-10-11 01:14:55.984482
NCT01953939|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-03-17|||September 2013||2013-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Outcome Measures for Lower Limb Amputees - A Repeatability Study|PhD Research Project: Clinimetric Properties of Outcome Measures of Physical Function Used With Lower Limb Amputees, Study 2|Completed||N/A|14|Actual|Queen Margaret University||1|||f||||f||||||||||2017-10-11 01:14:56.118214|2017-10-11 01:14:56.118214
NCT01953926|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-08-09|||September 30, 2013|Actual|2013-09-30|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||An Open-label, Phase 2 Study of Neratinib in Patients With Solid Tumors With Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification|An Open-label, Multicenter, Multinational, Phase 2 Study Exploring the Efficacy and Safety of Neratinib Therapy in Patients With Solid Tumors With Activating HER2, HER3 or EGFR Mutations or With EGFR Gene Amplification.|Recruiting||Phase 2|292|Anticipated|Puma Biotechnology, Inc.||3|||f||||f|t|f||||||||2017-10-11 01:14:56.268027|2017-10-11 01:14:56.268027
NCT01953913|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-10-03|||September 30, 2013|Actual|2013-09-30|October 2017|2017-10-01|July 6, 2018|Anticipated|2018-07-06|July 6, 2018|Anticipated|2018-07-06||Interventional|||Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation|An Open Label, Multicentre, Single Arm Trial to Assess the Safety of Afatinib for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)|Recruiting||Phase 3|550|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 01:14:56.515079|2017-10-11 01:14:56.515079
NCT01953900|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-08-14|||April 2014||2014-04-01|August 2017|2017-08-01|April 2033|Anticipated|2033-04-01|April 2018|Anticipated|2018-04-01||Interventional|||iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma/VEGAS|Vaccination to Enhance the Anti-Tumor Activity of GD2 Chimeric Antigen Receptor-Expressing, VZV-Specific T Cells in Subjects With Advanced Sarcomas (VEGAS)|Active, not recruiting||Phase 1|26|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 01:14:56.665378|2017-10-11 01:14:56.665378
NCT01953887|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-05-28|||March 2010||2010-03-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and Tamsulosin|An Open-label, Randomized, Three-period Crossover, Single Dose Study to Compare the Pharmacokinetics of the Final EC905 Formulation to Marketed Solifenacin (Vesicare®) and Tamsulosin OCAS (Omnic OCAS®)|Completed||Phase 1|30|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 01:14:56.773475|2017-10-11 01:14:56.773475
NCT01953861|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-05-28|||April 2010||2010-04-01|May 2014|2014-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Study to Evaluate Whether Food Has an Effect on the Uptake of Solifenacin and Tamsulosin When Administered in a Combination Tablet|An Open-label, Single Dose, Randomized, Three-way Cross-over Study to Evaluate the Effect of Food on the Pharmacokinetics of Solifenacin and Tamsulosin Administered as Combination Tablet EC905 in Young, Healthy Male Subjects|Completed||Phase 1|52|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 01:14:57.032328|2017-10-11 01:14:57.032328
NCT01953848|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-05-28|||April 2010||2010-04-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)|An Open-label, Randomized, Two-way Crossover, Multiple Dose Study to Evaluate the Steady State Pharmacokinetics of the Two Final Combination Tablet Formulations (EC905; Tamsulosin HCl/ Solifenacin Succinate; 0.4 mg/6 mg and 0.4 mg/9 mg) in Healthy Male Volunteers Over 45 Years of Age|Completed||Phase 1|27|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:14:57.1745|2017-10-11 01:14:57.1745
NCT01953835|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-05-12|||October 4, 2013|Actual|2013-10-04|May 2017|2017-05-01|March 10, 2014|Actual|2014-03-10|March 10, 2014|Actual|2014-03-10||Interventional|||A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184|A Two-part Healthy Volunteer Study to Investigate Both the Interaction of GSK2586184 With Rosuvastatin and Simvastatin and to Compare the Pharmacokinetics of Two Different Formulations of GSK2586184|Completed||Phase 1|37|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:14:57.308134|2017-10-11 01:14:57.308134
NCT01953822|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-12-23|||October 2013||2013-10-01|December 2016|2016-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom|An Observational Cohort Study to Assess the Risk of Autoimmune Diseases in Adolescent and Young Adult Women Aged 9 to 25 Years Exposed to Cervarix® in the United Kingdom|Completed||N/A|1053|Actual|GlaxoSmithKline|||4||f||||||||||||||2017-10-11 01:14:57.419773|2017-10-11 01:14:57.419773
NCT01953809|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-01-26|||August 2014||2014-08-01|January 2015|2015-01-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women|A Phase 1, Randomized, Single Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women of Childbearing Age Who Are of Non-Childbearing Potential Due to Surgical Sterilization or IUD Placement (PDF112163)|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||4||"Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen   that changed the risk: benefit profile and led to a termination"|f||||f||||||||||2017-10-11 01:14:57.514162|2017-10-11 01:14:57.514162
NCT01953770|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2016-08-10|||February 2008||2008-02-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|January 2015|Actual|2015-01-01||Interventional|ALL-MB 2008||Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008|Moscow-Berlin 2008 Multicenter Randomised Study for Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents|Active, not recruiting||N/A|3000|Anticipated|Federal Research Institute of Pediatric Hematology, Oncology and Immunology||9|||f||||t||||||||||2017-10-11 01:14:57.817504|2017-10-11 01:14:57.817504
NCT01953757|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-04-24|||September 2013||2013-09-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)|A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2)|Completed||N/A|20|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-10-11 01:14:58.010918|2017-10-11 01:14:58.010918
NCT01953744|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2015-12-01|||February 2014||2014-02-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus|Phase 3 Randomized Trial Comparing Fluconazole to Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis Caused by L. Braziliensis and L. Guyanensis|Terminated||Phase 3|53|Actual|Hospital Universitário Professor Edgard Santos||2||Low cure rate in the study (fluconazole) group|f||||t||||||||||2017-10-11 01:14:58.124596|2017-10-11 01:14:58.124596
NCT01953731|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-01-16|||October 2013||2013-10-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)|A Phase 1, Open-Label Fixed-Sequence 2-Period Study To Investigate The Effect Of Multiple Doses Of Rifampin On Palbociclib (PD-0332991) Pharmacokinetics In Healthy Volunteers|Completed||Phase 1|15|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:14:58.250391|2017-10-11 01:14:58.250391
NCT01953718|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2013-10-09|||July 2013||2013-07-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||A Retrospective Study of the Effects of Different Parameters on Motor Symptoms of PD in Bilateral STN Stimulation|A Retrospective Study of the Effects of Different Parameters on Motor Symptoms of PD in Bilateral STN Stimulation|Completed||N/A|27|Actual|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||||||||||||2017-10-11 01:14:58.383717|2017-10-11 01:14:58.383717
NCT01953705|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-12-02|||May 2014||2014-05-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||n-3 PUFA for Vascular Cognitive Aging|Omega 3 PUFA for the Vascular Component of Age-related Cognitive Decline|Active, not recruiting||Phase 2|150|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 01:14:58.459112|2017-10-11 01:14:58.459112
NCT01953679|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-02-19|||March 2014||2014-03-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|CCN013||Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days|A Phase IIb Randomized, Double Blind, Comparative Study to Assess the Efficacy, Safety, Tolerability and Inhibition of Ovulation of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days|Completed||Phase 2|180|Actual|Health Decisions||2|||f||||t||||||||||2017-10-11 01:14:58.694637|2017-10-11 01:14:58.694637
NCT01953666|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-07-18|||September 2013||2013-09-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|September 2015|Actual|2015-09-01||Observational|Smartwrite||Evaluation of the Efficiency of Word Prediction Software to Text Input Speed for Tetraplegia|Phase 1 Evaluation of the Influence of Settings of Word Prediction Software (Phase 1)and the Efficiency of Rehabilitation Programm (Phase 2)to Text Input Speed for People With Spinal Cord Injury|Completed||N/A|42|Actual|Centre d'Investigation Clinique et Technologique 805|||3||f||||f||||||||||2017-10-11 01:14:58.880349|2017-10-11 01:14:58.880349
NCT01953653|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-19|2017-02-27|||February 2013||2013-02-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Feasibility of Using a Structured Daily Diary|Feasibility of Using a Structured Daily Diary to Assess Mood, Stressful Events, Support, Substance Use, and Sexual Behavior in HIV-Positive Young Men Who Have Sex With Men|Completed||N/A|67|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:14:59.07836|2017-10-11 01:14:59.07836
NCT01953640|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2017-04-06|||May 2013||2013-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PROMOTE||Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy|PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)|Active, not recruiting||N/A|92|Actual|Mayo Clinic|||1||f||||t|f|f||||Samples With DNA|"     Samples with DNA and RNA will be retained.   "|No||2017-10-11 01:14:59.184471|2017-10-11 01:14:59.184471
NCT01953627|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2014-07-23|||October 2012||2012-10-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Laparoscopic Gynecologic Surgery With Robotic Assistance System Kymerax® : Pilot Study|Laparoscopic Gynecologic Surgery With Robotic Assistance System Kymerax® : Pilot Study|Unknown status|Recruiting|N/A|150|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:14:59.348099|2017-10-11 01:14:59.348099
NCT01953614|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-04-19|||June 2013||2013-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Chiropractic Adjustments on Brain Function Using Quantitative Encephalography|Effects of Chiropractic Adjustments on Brain Function Using Quantitative Encephalography|Completed||N/A|30|Actual|Life University||3|||f||||||||||||||2017-10-11 01:14:59.451762|2017-10-11 01:14:59.451762
NCT01953601|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-04-11|||November 5, 2013|Actual|2013-11-05|April 2017|2017-04-01|March 16, 2021|Anticipated|2021-03-16|February 5, 2019|Anticipated|2019-02-05||Interventional|APECS||Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)|A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects With Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD)|Active, not recruiting||Phase 3|1350|Anticipated|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 01:14:59.53518|2017-10-11 01:14:59.53518
NCT01953588|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-09-29|||December 2013||2013-12-01|September 2017|2017-09-01||||April 2020|Anticipated|2020-04-01||Interventional|||Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery|Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study|Recruiting||Phase 3|1455|Anticipated|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 01:15:00.076328|2017-10-11 01:15:00.076328
NCT01953562|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-08-08|||October 2013||2013-10-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Positioning and the Spontaneous Breathing Test in Neonates|Evaluation of the Influence of Positioning and Time Duration on the Spontaneous Breathing Test in Neonates|Withdrawn||N/A|0|Actual|Christiana Care Health Services|||1|This protocol was closed and will be redesigned and submitted as a new protocol.|f||||f||||||||||2017-10-11 01:15:04.116089|2017-10-11 01:15:04.116089
NCT01953549|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-09-05|||October 2013||2013-10-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|July 6, 2017|Actual|2017-07-06||Interventional|||Physical Fitness Training in Subacute Stroke (PHYS-Stroke)|Physical Fitness Training in Subacute Stroke (PHYS-Stroke)|Active, not recruiting||Phase 3|215|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:15:04.179058|2017-10-11 01:15:04.179058
NCT01953536|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2014-12-18|||April 2014||2014-04-01|December 2014|2014-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)|A Phase IIa Open Label, Randomized Clinical Trial to Study the Safety and Efficacy of Vintafolide and the Combination of Vintafolide and Paclitaxel Compared to Paclitaxel in Subjects With Advanced Triple Negative Breast Cancer Using Etarfolatide (EC20) Subject Selection|Withdrawn||Phase 2|0|Actual|Endocyte||3|||f||||f||||||||||2017-10-11 01:15:04.277048|2017-10-11 01:15:04.277048
NCT01953523|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2016-06-14|||March 2012||2012-03-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions|Clinical Intervention Study: Adverse Events and Clinical Outcomes for the Deployment of Adipose Derived SVF (Rich in Adult Stem Cells and Growth Factors)for Select Orthopedic, Neurologic, Urologic, and Cardio-Pulmonary Conditions.|Recruiting||N/A|3000|Anticipated|Cell Surgical Network Inc.||1|||f||||t||||||||Yes|Finishing 1000 patient safety paper for peer review and publication.|2017-10-11 01:15:04.359718|2017-10-11 01:15:04.359718
NCT01941472|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-31|2017-03-03|2016-10-29||September 2013||2013-09-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Transcutaneous pO2, Transcutaneous pCO2 and Central Venous SO2 Variations to Define Fluid Responsiveness||Completed||N/A|40|Actual|Peking Union Medical College Hospital||1|||f||||t||||||||||2017-10-11 01:18:29.572162|2017-10-11 01:18:29.572162
NCT01953497|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-03-06|||May 23, 2013|Actual|2013-05-23|March 2017|2017-03-01|July 2014|Actual|2014-07-01|December 24, 2013|Actual|2013-12-24||Interventional|||Phase 1 Study of URC102 in Healthy Subjects|A Phase I, Placebo-controlled, Randomized, Double Blind, Single or Multiple Dose Study of URC102 in Healthy Male Volunteers of Korean and Caucasian to Assess Safety, Pharmacokinetics and Pharmacodynamics|Completed||Phase 1|81|Actual|JW Pharmaceutical||2|||f||||f||||||||||2017-10-11 01:15:04.7755|2017-10-11 01:15:04.7755
NCT01953484|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-10-14|||July 2013||2013-07-01|October 2013|2013-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||Changes in Spontaneous Ventilation in Response to Changes in Extracorporeal Carbon Dioxide Removal|Changes in Spontaneous Ventilation in Response to Changes in Extracorporeal Carbon Dioxide Removal|Unknown status|Recruiting|N/A|30|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||3|||f||||||||||||||2017-10-11 01:15:04.871576|2017-10-11 01:15:04.871576
NCT01953471|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-11-02|||April 2011||2011-04-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|||Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)|Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen by the Assessment of the Relationship Between the Symptom Scores and Global Rating of Change Questionnaires on the Quality of Life and Well-being.|Completed||N/A|959|Actual|Hopital Foch|||1||f||||||||||||||2017-10-11 01:15:04.96476|2017-10-11 01:15:04.96476
NCT01953458|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-10-04|||August 6, 2012|Actual|2012-08-06|October 2017|2017-10-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|HEPATHER||Therapeutic Option for Hepatitis B and C: a French Cohort|Therapeutic Option for Hepatitis B and C: a French Cohort|Recruiting||N/A|25000|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||t||||||Samples With DNA|"     whole blood, serum, plasma and urine   "|||2017-10-11 01:15:05.060495|2017-10-11 01:15:05.060495
NCT01953445|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-12-05|||August 2014||2014-08-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer|Neoadjuvant Phase II Trial of Paclitaxel in Combination With BKM120 in Endocrine Resistant Clinical Stage II or III Estrogen Receptor-Positive and HER2 Negative Breast Cancer|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||1||The study sponsor found the trial to be not viable.|f||||f||||||||||2017-10-11 01:15:05.172812|2017-10-11 01:15:05.172812
NCT01953432|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-03-31|||April 1, 2014|Actual|2014-04-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse|Pharmacogenetic Trial of Noradrenergic Medication for Treatment of Cocaine Abuse|Recruiting||Phase 2|100|Anticipated|VA Office of Research and Development||2|||f||||t||||||||No||2017-10-11 01:15:05.28239|2017-10-11 01:15:05.28239
NCT01953419|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2016-07-26|||September 2010||2010-09-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy|Pemetrexed for Previously Treated Patients With Metastatic Gastric Cancer: a Prospective Phase II Study|Completed||Phase 2|34|Actual|Sun Yat-sen University||1|||f||||t||||||||No||2017-10-11 01:15:05.476691|2017-10-11 01:15:05.476691
NCT01953406|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2016-04-26|||November 2015||2015-11-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma|Phase II Study Evaluating the Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma Who Had Progressive Disease With Sorafenib|Withdrawn||Phase 2|0|Actual|Seoul National University Hospital||1||No participants were enrolled. Therefore, we stop this study, prematurely.|f||||f||||||||||2017-10-11 01:15:05.604054|2017-10-11 01:15:05.604054
NCT01953393|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2013-09-24|||April 2006||2006-04-01|September 2013|2013-09-01|October 2006|Actual|2006-10-01|May 2006|Actual|2006-05-01||Interventional|||The Acute Effects of Low-dose TNF-α on Glucose Metabolism and β-cell Function in Humans|The Acute Effects of Low-dose TNF-α on Glucose Metabolism and β-cell Function in Humans|Completed||N/A|||Rigshospitalet, Denmark|||||f||||f||||||||||2017-10-11 01:15:05.760339|2017-10-11 01:15:05.760339
NCT01953380|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-04-11|||October 2013||2013-10-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ISICA-13||Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy|Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy|Completed||N/A|400|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 01:15:05.864557|2017-10-11 01:15:05.864557
NCT01953367|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-04-24|||September 2013||2013-09-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects|Bioequivalence and Safety Study of Vantobra and TOBI Nebulizer Solutions in Healthy Subjects|Completed||Phase 1|72|Actual|Pari Pharma GmbH||2|||f||||f||||||||||2017-10-11 01:15:05.971631|2017-10-11 01:15:05.971631
NCT01953354|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-02-09|2016-12-16||November 2013||2013-11-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||The Randomized population included all subjects who were randomized to receive either TSO 7500 or placebo.|Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis|A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota|Terminated||Phase 2|16|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Recruitment was slower than anticipated. The study was ultimately terminated when the manufacturer decided to discontinue study product production.|2||MFR's business decision to d/c TSO production -unrelated to any safety concern.|f||||t||||||||||2017-10-11 01:15:06.092145|2017-10-11 01:15:06.092145
NCT01953341|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2014-12-08|||October 2013||2013-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines|A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 333 in Healthy Subjects and Subjects With Migraines.|Completed||Phase 1|74|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:15:06.978162|2017-10-11 01:15:06.978162
NCT01953328|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-26|2015-11-19|2015-09-23|2015-04-09|October 2013||2013-10-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|AMG145|Full analysis set (all randomized participants who reveid at least 1 dose of blinded investigational product).|Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) on LDL-C in Combination With Statin Therapy in Japanese Subjects With High Cardiovascular Risk and With Hyperlipidemia or Mixed Dyslipidemia|Completed||Phase 3|409|Actual|Amgen||8|||f||||t||||||||||2017-10-11 01:15:07.339155|2017-10-11 01:15:07.339155
NCT01953315|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-04-17|||January 2014||2014-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Muscle Progenitor Cell Therapy for Urinary Incontinence|A Phase 1 Pilot Safety and Feasibility Study of Muscle Progenitor Cell (MPC) Therapy for Urinary Incontinence|Active, not recruiting||Phase 1/Phase 2|10|Actual|Wake Forest University Health Sciences||1|||f||||t||||||||Undecided||2017-10-11 01:15:13.129054|2017-10-11 01:15:13.129054
NCT01953302|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-04-17|||May 2010||2010-05-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||"Modified Open Intraperitoneal Mesh Technique of Incisional Ventral Hernia Repair"|"Modified Open Intraperitoneal Mesh Technique of Incisional Ventral Hernia Repair"|Completed||N/A|124|Actual|Varazdin General Hospital||1|||f||||f||||||||||2017-10-11 01:15:13.235172|2017-10-11 01:15:13.235172
NCT01953289|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-07-03|||July 2012||2012-07-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|IFFSA||Importance of Peritoneal Free Fluid Cultures in Acute Appendicitis|Importance of Peritoneal Free Fluid Cultures in Both Perforated and Non-perforated Appendicitis|Withdrawn||N/A|0|Actual|Universitaire Ziekenhuizen Leuven|||1|Sub investigator is working no longer in the hospital. No participants were enrolled.|f||||f||||||||||2017-10-11 01:15:13.328822|2017-10-11 01:15:13.328822
NCT01953276|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-08-23|||January 2013||2013-01-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|May 2015|Actual|2015-05-01||Observational|ASAP Cath||Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain|Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain (ASAP CATH) Study|Active, not recruiting||N/A|382|Anticipated|Wake Forest University Health Sciences|||1||f||||f||||||Samples With DNA|"     Whole blood samples are obtained from patients and processed so that the plasma is extracted     and frozen for future research.   "|||2017-10-11 01:15:13.438019|2017-10-11 01:15:13.438019
NCT01953263|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-04-17|||January 2016||2016-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Muscle Fiber Fragment Treatment for Urinary Incontinence|A Phase 1 Study of Human Muscle Fiber Fragment (MFF) Treatment for Urinary Incontinence|Recruiting||Phase 1/Phase 2|10|Anticipated|Wake Forest University Health Sciences||1|||f||||t||||||||No||2017-10-11 01:15:13.683307|2017-10-11 01:15:13.683307
NCT01953250|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-09-25|||June 2012||2012-06-01|April 2012|2012-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Functional Outcome in Patients That Underwent Laparoscopic Sigmoid and/or Rectum Resection|To Assess the Functional Outcome in Patients That Underwent Laparoscopic Sigmoid and/or Rectum Resection|Completed||N/A|143|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:15:13.789688|2017-10-11 01:15:13.789688
NCT01953237|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-10-25|2016-10-25||September 2013||2013-09-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications|MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications|Completed||N/A|31|Actual|University of Maryland||2|||f||||f||||||||||2017-10-11 01:15:13.881867|2017-10-11 01:15:13.881867
NCT01953224|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-06-02|||September 2014||2014-09-01|May 2016|2016-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||STEP AND GO: A Study of Technology-based Exercise Promotion|STEP AND GO: A Study of Technology-based Exercise Promotion and Gaming Outcomes|Completed||N/A|50|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-11 01:15:14.191897|2017-10-11 01:15:14.191897
NCT01953198|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-09-25|||December 2012||2012-12-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|HiReach 2013||High Altitude Medical Research Expedition Himlung 2013 - a Study of Human Adaption to Hypoxia|High Altitude Medical Research Expedition Himlung 2013 - an Observational Cohort Study of Human Adaption to Hypobaric Hypoxia|Completed||N/A|40|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||Samples With DNA|"     serum urine   "|||2017-10-11 01:15:14.452652|2017-10-11 01:15:14.452652
NCT01953185|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-09-27|||January 2011||2011-01-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Interventional|||MANUAL DIAPHRAGM RELEASE TECHNIQUE INCREASES TIDAL VOLUME IN ELDERLY|MANUAL DIAPHRAGM RELEASE TECHNIQUE INCREASES TIDAL VOLUME AND UPPER RIB CAGE CONTRIBUTION DURING QUIET BREATHING IN ELDERLY: A RANDOMIZED CONTROLLED TRIAL|Completed||N/A|17|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:15:14.567949|2017-10-11 01:15:14.567949
NCT01953172|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2015-03-10|||October 2013||2013-10-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Health Status and Quality of Life in the Elderly|Exploratory, Double-blind, Randomized, Placebo Controlled Study of AMP-886 in the Elderly|Terminated||N/A|12|Actual|Unilever R&D||2||Recruitment problems|f||||f||||||||||2017-10-11 01:15:14.669219|2017-10-11 01:15:14.669219
NCT01953159|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-09-08|||August 29, 2013|Actual|2013-08-29|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Observational|||Assessment of Paclitaxel-Induced Neuropathy|Validation of a Polygenic Neurotoxicity Risk Score in Patients With Unusually Severe Paclitaxel-Induced Neuropathy|Active, not recruiting||N/A|43|Actual|University of Chicago|||2||f||||f||||||Samples With DNA|"     Whole blood, DNA,Peripheral Blood Mononuclear Cells (PBMC)   "|||2017-10-11 01:15:14.810956|2017-10-11 01:15:14.810956
NCT01953146|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-09-25|||September 2012||2012-09-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|PCOS||The Influence of Polycystic Ovairan Syndrome on Embryonic Developmental Timing|Timing of Development in Embryos Derived From Women With Polycystic Ovairan Syndrome and Controls|Completed||N/A|240|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 01:15:14.91555|2017-10-11 01:15:14.91555
NCT01953133|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-10-21|||April 2012||2012-04-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Couples in Context: An RCT of a Couples-based HIV Prevention Intervention|Randomized Controlled Trial of a Couples-based Intervention to Increase Testing for HIV Among Heterosexual Couples in Vulindlela, KwaZulu-Natal, South Africa|Unknown status|Active, not recruiting|N/A|700|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:15:15.078732|2017-10-11 01:15:15.078732
NCT01953120|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-12-22|||October 2013||2013-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)|Mechanisms of Belatacept (Nulojix) Effect on Alloimmunity and Antiviral Response After Kidney Transplantation - (BMS Study# IM 103-309)|Active, not recruiting||Phase 4|21|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 01:15:15.200817|2017-10-11 01:15:15.200817
NCT01953107|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-04-24|||November 2013||2013-11-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|January 2017|Actual|2017-01-01||Interventional|||Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.|A Randomized Controlled Trial of Pre-Operative Treatment With Ferrous Fumarate 300 mg Once Daily Versus Placebo in Newly Diagnoses Gynecologic Oncology Patients Who Are Primary Surgical Candidates.|Recruiting||Phase 4|200|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 01:15:15.294389|2017-10-11 01:15:15.294389
NCT01953081|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-05-16|2016-12-20||January 2014||2014-01-01|May 2017|2017-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance|A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance|Completed||Phase 1/Phase 2|13|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||No||2017-10-11 01:15:15.563851|2017-10-11 01:15:15.563851
NCT01953068|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2016-10-12|||January 2014||2014-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures|Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures|Recruiting||N/A|40|Anticipated|Tampere University Hospital|||1||f||||f||||||||||2017-10-11 01:15:16.148965|2017-10-11 01:15:16.148965
NCT01953055|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-04-24|||November 2013||2013-11-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|SATURN||SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)|Phase II Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 01:15:16.24258|2017-10-11 01:15:16.24258
NCT01953042|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-05-24|||September 2013||2013-09-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders|A Randomized Trial Testing the Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders|Suspended||N/A|100|Anticipated|Sunnybrook Health Sciences Centre||2||Lack of dedicated resources at this time. Potential to reopen later.|f||||t||||||||No||2017-10-11 01:15:16.415803|2017-10-11 01:15:16.415803
NCT01953029|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-09-25|||December 2013||2013-12-01|September 2013|2013-09-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Observational|||Mechanisms of Myocardial Infarction in Women With Non Obstructive Coronary Artery Disease|Mechanisms of Myocardial Infarction in Women With Non Obstructive Coronary Artery Disease|Not yet recruiting||N/A|80|Anticipated|Rambam Health Care Campus|||1||f||||t||||||||||2017-10-11 01:15:16.627106|2017-10-11 01:15:16.627106
NCT01953016|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2017-09-02|||September 20, 2013||2013-09-20|September 1, 2017|2017-09-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Observational|||Participation in a Research Registry for Immune Disorders|NIH Participation to USIDNET Registry|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:15:16.756488|2017-10-11 01:15:16.756488
NCT01953003|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-09-27|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer|A Multicenter, Randomised, Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously|Completed||Phase 3|131|Actual|Pierre Fabre Medicament||2|||f||||f||||||||||2017-10-11 01:15:16.878083|2017-10-11 01:15:16.878083
NCT01952990|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2015-05-15||2015-05-15|September 2013||2013-09-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety and Pharmacokinetics of Kovacaine Nasal Spray in Pediatric Subjects|A Single-Center, Study Evaluating The Pharmacokinetics Of Tetracaine, Para-Butylaminobenzoic Acid, And Oxymetazoline After Intranasal Administration Of Kovacaine Mist To Healthy Pediatric Subjects|Completed||Phase 2|18|Actual|St. Renatus, LLC||1|||f||||f||||||||||2017-10-11 01:15:17.014444|2017-10-11 01:15:17.014444
NCT01952977|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-09-27|||June 2010||2010-06-01|September 2013|2013-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|MCT||Effect of Medium Chain Triglyceride Consumption on Appetite||Completed||N/A|17|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||f||||||||||2017-10-11 01:15:17.128301|2017-10-11 01:15:17.128301
NCT01952951|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-09-12|||June 2014||2014-06-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2017|Actual|2017-09-01||Interventional|PREPARE||Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer|A Randomized Phase II Trial of Preoperative Chemoradiation (Preop CRT) Followed by CapOx (Capecitabine Plus Oxaliplatin) Versus Preop CRT Alone for Locally Advanced Rectal Cancer (LARC)|Active, not recruiting||Phase 2|110|Actual|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 01:15:17.351405|2017-10-11 01:15:17.351405
NCT01952938|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-09-27|||July 2012||2012-07-01|September 2013|2013-09-01||||July 2014|Anticipated|2014-07-01|1 Year|Observational [Patient Registry]|||Outcome EnduRo Versus LINK SL Rotating Hinge Knee||Unknown status|Recruiting|N/A|50|Anticipated|Orthopaedische Klinik Koenig-Ludwig-Haus|||2||f||||t||||||||||2017-10-11 01:15:17.493167|2017-10-11 01:15:17.493167
NCT01952925|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-09-27|||January 2014||2014-01-01|September 2013|2013-09-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Combined Afib Ablation and RA Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension|Combined Atrial Fibrillation Ablation and Renal Artery Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension|Not yet recruiting||N/A|40|Anticipated|Oregon Health and Science University||1|||f||||||||||||||2017-10-11 01:15:17.575024|2017-10-11 01:15:17.575024
NCT01952912|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-09-27|||January 2004||2004-01-01|December 2003|2003-12-01|June 2013|Actual|2013-06-01|June 2007|Actual|2007-06-01||Interventional|||Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates|Comparison of Plasmakinetic Enucleation of the Prostate With Open Prostatectomy for the Treatment of Benign Prostatic Hypertrophy Patients With Large Prostate|Completed||N/A|160|Actual|Fuzhou General Hospital||2|||f||||t||||||||||2017-10-11 01:15:17.653946|2017-10-11 01:15:17.653946
NCT01952899|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2013-09-30|||April 2012||2012-04-01|September 2013|2013-09-01|April 2016|Anticipated|2016-04-01|May 2015|Anticipated|2015-05-01|4 Weeks|Observational [Patient Registry]|iDECePTIvE||The ICU DElirium in Clinical PracTice Implementation Evaluation Study Screening and Treatment|Improvement of Care for ICU Patients With Delirium by Early Screening and Treatment|Unknown status|Recruiting|N/A|1500|Anticipated|Erasmus Medical Center|||6||f||||f||||||||||2017-10-11 01:15:17.737208|2017-10-11 01:15:17.737208
NCT01952886|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-25|2014-09-19||||||September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients|Phase II Randomized Cross-over Study to Evaluate Patient Satisfaction, Efficacy and Compliance of Granisetron Patch vs. Ondansetron in Malignant Glioma Patients Receiving Standard Radiotherapy (RT) and Concomitant Temozolomide (TMZ)|Withdrawn||Phase 2|0|Actual|Duke University||2||Lack of approval and funding from company|f||||t||||||||||2017-10-11 01:15:17.846367|2017-10-11 01:15:17.846367
NCT01952873|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2014-07-11|||December 2014||2014-12-01|July 2014|2014-07-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|INFLATION/DE||Rapid Inflation/Deflation Compared With Prolonged High-Pressure Balloon Inflation|Rapid Inflation/Deflation Compared With Prolonged High-Pressure Balloon Inflation on the Results of Stent Deployment|Unknown status|Not yet recruiting|N/A|40|Anticipated|Central Arkansas Veterans Healthcare System||2|||f||||f||||||||||2017-10-11 01:15:17.965581|2017-10-11 01:15:17.965581
NCT01952860|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-09-19|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Hatha Yoga in Lung Cancer Couples|A Feasibility Study of Hatha Yoga in Couples Coping With Lung Cancer|Active, not recruiting||N/A|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:15:18.078336|2017-10-11 01:15:18.078336
NCT01952834|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-12-15|2015-09-21||June 2013||2013-06-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Probiotic Supplementation on Endothelial Function|Effect of Probiotic Supplementation on Endothelial Function in Men With Coronary Artery Disease|Completed||Phase 4|21|Actual|Medical College of Wisconsin||1|||f||||f||||||||||2017-10-11 01:15:18.296452|2017-10-11 01:15:18.296452
NCT01952821|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2015-05-21|||September 2013||2013-09-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Observational|||Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck|The Validity and Reliability of the Six-Minute Walk Test, Ten-Meter Walk Test, 30 Second Chair Stand, Linear Analog Scale of Function, and the Modified Brief Fatigue Inventory in Patients With Cancer of the Head and Neck|Completed||N/A|66|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 01:15:18.577309|2017-10-11 01:15:18.577309
NCT01952808|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-03-21|||September 2013||2013-09-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|August 2014|Actual|2014-08-01||Interventional|||Healthy Immigrant Families: Working Together To Move More and To Eat Well|Healthy Immigrant Families: Working Together To Move More and To Eat Well|Completed||N/A|151|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:15:18.691126|2017-10-11 01:15:18.691126
NCT01952795|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-08-21|||November 2013||2013-11-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Hypocaloric Diet and Exercise in Obese Women Who Are Subjected to IVF Cycle|Effect of Hypocaloric Diet and Exercise in Obese Women Who Are Subjected to IVF Cycle|Completed||N/A|41|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 01:15:18.79516|2017-10-11 01:15:18.79516
NCT01952782|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-06-16|||January 2014||2014-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Neuropeptides in Human Reproduction|Neuropeptides in Human Reproduction|Recruiting||Phase 1|128|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:15:18.880511|2017-10-11 01:15:18.880511
NCT01952769|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2016-09-11|||February 2014||2014-02-01|October 2015|2015-10-01|April 2019|Anticipated|2019-04-01|November 2018|Anticipated|2018-11-01||Interventional|||Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma|A Phase I/ II Clinical Trial of MDV9300 (Pidilizumab) in Diffuse Intrinsic Pontine Glioma|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 01:15:19.005191|2017-10-11 01:15:19.005191
NCT01952756|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2014-07-16|||January 2012||2012-01-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)|Cilostazol Enhances the Number and Functions of Circulating Endothelial Progenitor Cells and Collateral Formation Assessed by Dual-energy 128-row CT Angiography Mediated Through Multiple Mechanisms in Patients With Mild-to-moderate PAOD|Completed||Phase 4|44|Actual|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-11 01:15:19.122353|2017-10-11 01:15:19.122353
NCT01952743|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-03-21|||September 2013||2013-09-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|||Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation|Concomitant Renal Denervation Therapy in Hypertensive Patients Undergoing Atrial Fibrillation Ablation - A Feasibility Study|Terminated||N/A|3|Actual|Mayo Clinic||2||Lack of efficacy with renal denervation in multicenter trials|f||||f||||||||||2017-10-11 01:15:19.274805|2017-10-11 01:15:19.274805
NCT01952730|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-11-17|||July 2013||2013-07-01|November 2016|2016-11-01|July 2030|Anticipated|2030-07-01|July 2018|Anticipated|2018-07-01||Interventional|||GVAX for Colorectal Cancer|A Pilot Safety Study of Vaccination With Autologous, Lethally Irradiated Colorectal Cancer Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Stimulating Factor|Suspended||Phase 1|15|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:15:19.392582|2017-10-11 01:15:19.392582
NCT01952717|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-03-10|||June 2012||2012-06-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||PMA Required Pivotal Multi-reader Multi-case Reader Study|A Multi-Reader Multi-Case Clinical Trial To Evaluate Diagnostic Accuracy of 3D Koning Breast CT Compared to 2D Diagnostic Mammography|Completed||N/A|236|Actual|Koning Corporation|||1||f||||t||||||||||2017-10-11 01:15:19.490821|2017-10-11 01:15:19.490821
NCT01952704|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2013-09-30|||October 2013||2013-10-01|September 2013|2013-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Aerobic Exercise to Improve Memory in TBI|A Randomized Controlled Trial of Aerobic Exercise to Improve Memory in TBI|Unknown status|Not yet recruiting|N/A|24|Anticipated|Kessler Foundation||2|||f||||t||||||||||2017-10-11 01:15:19.577437|2017-10-11 01:15:19.577437
NCT01952691|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-02-18|2015-03-25||March 2011||2011-03-01|April 2015|2015-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Initial Effects of Kinesiotaping in Non Surgical Treatment of Hallux Valgus|Initial Effects of Kinesiotaping in Conservative Treatment of Hallux Valgus|Completed||N/A|22|Actual|Hacettepe University||1|||f||||f||||||||||2017-10-11 01:15:19.652563|2017-10-11 01:15:19.652563
NCT01952665|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-05-31|2015-02-09||October 2013||2013-10-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear|A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear|Completed||N/A|63|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 01:15:20.187293|2017-10-11 01:15:20.187293
NCT01952652|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2013-09-26|||January 2013||2013-01-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Naproxen Codeine in Arthroscopic Surgery|Comparison of Post-operative Analgesic Effects of Naproxen Sodium and Naproxen Sodium-codeine Phosphate Administered Preemptively for Arthroscopic Meniscus Surgery|Completed||Phase 4|61|Actual|Baskent University||2|||f||||t||||||||||2017-10-11 01:15:22.521252|2017-10-11 01:15:22.521252
NCT01952639|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-11-26|||January 2014||2014-01-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Postprandial Muscle Protein Synthesis Following Wheat Protein Ingestion in Vivo in Humans|Postprandial Muscle Protein Synthesis Following Wheat Protein Ingestion in Vivo in Humans|Completed||N/A|60|Actual|Maastricht University Medical Center||5|||f||||f||||||||||2017-10-11 01:15:22.618153|2017-10-11 01:15:22.618153
NCT01952626|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-04-07|||April 2013||2013-04-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron|Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron|Completed||N/A|80|Actual|Kyungpook National University||2|||f||||t||||||||||2017-10-11 01:15:22.753327|2017-10-11 01:15:22.753327
NCT01952613|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-08-16|||April 2013||2013-04-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Interventional|||Effect of FES Interventions on Gait Dynamics in Stroke Population|Identification of Responders to the FES Interventions in Stroke Population|Completed||N/A|10|Actual|Kessler Foundation||1|||f||||t||||||||||2017-10-11 01:15:22.88513|2017-10-11 01:15:22.88513
NCT01952600|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-08-10|2016-06-24||June 2013||2013-06-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Observational|EPOCH-RRT||Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)|Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)|Completed||N/A|215|Actual|Arbor Research Collaborative for Health|||3||f||||f||||||||||2017-10-11 01:15:22.99498|2017-10-11 01:15:22.99498
NCT01952587|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-06-30|||November 2013||2013-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|X LIBRIS||X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study|Frequency and Functional Impact of the c.32A>T Genetic Polymorphism of TLR7 in Women Infected With HIV-1 : the ANRS EP53 Study|Completed||N/A|90|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||f||||||||||2017-10-11 01:15:23.436177|2017-10-11 01:15:23.436177
NCT01952574|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-06-01||2015-04-30|August 6, 2013|Actual|2013-08-06|June 2017|2017-06-01|November 11, 2019|Anticipated|2019-11-11|September 25, 2014|Actual|2014-09-25||Interventional|||A Phase 2 Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention|Active, not recruiting||Phase 2|483|Actual|Amgen||5|||f||||f||||||||||2017-10-11 01:15:23.509656|2017-10-11 01:15:23.509656
NCT01952561|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-08-25|||November 2013||2013-11-01|September 2013|2013-09-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Expanded Use PK of Dapivirine Vaginal Ring|An Open-label, Parallel-group Pharmacokinetic Trial in Healthy HIV-negative Women to Characterize the Release Profile of Dapivirine Delivered by a Silicone Matrix Ring (Ring 004), Containing 25 mg of Dapivirine, Over Various Ring Use Periods|Completed||Phase 1|40|Actual|International Partnership for Microbicides, Inc.||5|||f||||f||||||||||2017-10-11 01:15:23.857837|2017-10-11 01:15:23.857837
NCT01952548|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2013-12-30|||May 2013||2013-05-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Interventional|||Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers||Completed||Phase 1|||Kowa Research Institute, Inc.||14|||||||||||||||||2017-10-11 01:15:23.941966|2017-10-11 01:15:23.941966
NCT01952535|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-22|2014-02-18|||September 2013||2013-09-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Study of Administrating Single Ascending Dose of HMS5552 in Healthy Adult Volunteers|Completed||Phase 1|60|Actual|Hua Medicine Limited||6|||f||||t||||||||||2017-10-11 01:15:24.045062|2017-10-11 01:15:24.045062
NCT01952522|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2015-05-04|||May 2013||2013-05-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|ANANTA||Effects of a Walking Intervention With Additional Weights on the Unaffected Leg in People After Stroke|Comparison of Two Rehabilitation Programs to Improve Walking in Community-dwelling People After Stroke|Unknown status|Recruiting|Phase 2|100|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:15:24.174119|2017-10-11 01:15:24.174119
NCT01952509|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-11-01|||October 2013||2013-10-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis|Multinational, Multicenter, Non Interventional Study, in Patients With Rheumatoid Arthritis (RA) Treated With Tocilizumab.|Completed||N/A|169|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:15:24.274997|2017-10-11 01:15:24.274997
NCT01952496|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-02-15|||February 2014||2014-02-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Load Experienced While Using a Stander in Children With Cerebral Palsy|Load Experienced While Using a Stander in Children With Cerebral Palsy|Completed||N/A|3|Actual|Gillette Children's Specialty Healthcare||1|||f||||t||||||||||2017-10-11 01:15:24.39474|2017-10-11 01:15:24.39474
NCT01952483|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-01-31|||August 2012||2012-08-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|3 Months|Observational [Patient Registry]|||Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients|Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients|Active, not recruiting||N/A|108|Actual|American University of Beirut Medical Center|||2||f||||f||||||Samples Without DNA|"     We will focus on proliferation and cytokine production to myelin basic protein (MBP) and     myelin oligodendrocyte glycoprotein (MOG) peptides and on the percentage of Th1 (IFN gamma     producing cells) and Th17 (IL-17 producing cells) during in vitro polarization assays   "|No||2017-10-11 01:15:24.505077|2017-10-11 01:15:24.505077
NCT01952470|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-31|2017-01-23|||October 2013||2013-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Preliminary Study of Dornase Alpha to Treat Chest Infections Post Lung Transplant.|Investigating the Role of Nebulised Mucolytic Therapy During Lower Respiratory Tract Infections Post Lung Transplantation.|Recruiting||Phase 2|32|Anticipated|The Alfred||2|||f||||f||||||||||2017-10-11 01:15:24.621904|2017-10-11 01:15:24.621904
NCT01952457|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-01-11|||August 2014||2014-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ZILVERPASS||The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions||Recruiting||Phase 4|220|Anticipated|Flanders Medical Research Program||2|||f||||||||||||||2017-10-11 01:15:24.764998|2017-10-11 01:15:24.764998
NCT01952444|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2014-09-30|||October 2013||2013-10-01|April 2014|2014-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Open-Label, Randomized, Parallel Group Study to Assess the Safety, Tolerability and PK of ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers|An Open-Label, Randomized, Parallel Group Study to Assess the Safety, Tolerability and Pharmacokinetics of ETI-204 Alone and in the Presence of Ciprofloxacin in Adult Volunteers|Completed||Phase 1|39|Actual|Elusys Therapeutics||2|||f||||||||||||||2017-10-11 01:15:24.881571|2017-10-11 01:15:24.881571
NCT01952431|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-11-09|||April 2013||2013-04-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Measurement and Evaluation of Total Lung Capacity (TLC) in the Field of Pulmonary Functional Testing (PFT)|Measurement and Evaluation of Total Lung Capacity (TLC) in the Field of Pulmonary Functional Testing (PFT)|Completed||N/A|100|Actual|PulmOne Advanced Medical Devices, Ltd.||2|||f||||t||||||||||2017-10-11 01:15:24.977258|2017-10-11 01:15:24.977258
NCT01952418|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-04-21|2017-03-03||October 2013|Actual|2013-10-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional||patients who had endoscopy performed in the study|Effect of Video Monitor Size on Adenoma Detection Rate|Effect of Video Monitor Size on Adenoma Detection Rate|Completed||N/A|1805|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:15:25.135293|2017-10-11 01:15:25.135293
NCT01952405|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-03-02|||May 18, 2013|Actual|2013-05-18|March 2017|2017-03-01|February 24, 2017|Actual|2017-02-24|February 24, 2017|Actual|2017-02-24||Interventional|||Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder|Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder: a Controlled Trial in Taiwan|Completed||N/A|60|Actual|Mackay Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:15:25.453313|2017-10-11 01:15:25.453313
NCT01952392|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-02-23|||October 2013||2013-10-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|AReMIS||Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome|Study on the Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome|Completed||N/A|4992|Actual|AstraZeneca|||2||f||||||||||||||2017-10-11 01:15:25.548365|2017-10-11 01:15:25.548365
NCT01952379|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-11-22|||July 2013||2013-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Inflammation in Melasma: Study of Its Infiltrate and the Expression of Acute and Chronic Mediators|Inflammation in Melasma: Study of Its Infiltrate and the Expression of Acute and Chronic Mediators|Completed||N/A|20|Actual|Universidad Autonoma de San Luis Potosí|||1||f||||f||||||Samples With DNA|"     3 mm Skin punch biopsies   "|||2017-10-11 01:15:25.635247|2017-10-11 01:15:25.635247
NCT01952366|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-08-02|2016-04-18||December 2009||2009-12-01|February 2012|2012-02-01|April 2016|Actual|2016-04-01|January 2013|Actual|2013-01-01||Observational|PRODE||Prognosis of Depression in the Elderly (PRODE). A Multicentre, Longitudinal Study of Elderly Depressed Patients.|Prognosis of Depression in the Elderly (PRODE)|Completed||N/A|169|Actual|Sykehuset Innlandet HF|The study's recruitment is finished. Analyses are ongoing from the one-year and three-year follow-up||1||f||||f||||||Samples With DNA|"     Apolipoprotein E polymorphism   "|||2017-10-11 01:15:25.750383|2017-10-11 01:15:25.750383
NCT01952353|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2013-09-24|||February 2006||2006-02-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion|Efficacy of Preoperative Transarterial Chemoembolization for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Prospective Non-Randomized Comparative Study|Completed||Phase 4|330|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:15:25.98574|2017-10-11 01:15:25.98574
NCT01952340|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-10-27|||July 2014||2014-07-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Efficacy of Dietary Flaxseed for the Reduction of Blood Pressure in Newly Diagnosed Hypertensive Individuals|A Phase II/III, Randomized, Double-Blinded, Controlled Clinical Trial to Investigate the Efficacy of Dietary Flaxseed for the Reduction of Blood Pressure in Newly Diagnosed Hypertensive Individuals|Recruiting||Phase 2/Phase 3|100|Anticipated|St. Boniface General Hospital Research Centre||2|||f||||t||||||||||2017-10-11 01:15:26.098054|2017-10-11 01:15:26.098054
NCT01952327|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-06-12|||May 2014||2014-05-01|June 2017|2017-06-01|December 13, 2016|Actual|2016-12-13|December 13, 2016|Actual|2016-12-13||Interventional|ADEPT||Investigation Into the Automated Drainage of Recurrent Effusions From the Pleural Space in Thoracic Malignancy.|Investigation Into the Automated Drainage of Recurrent Effusions From the Pleural Space in Thoracic Malignancy.|Terminated||N/A|2|Actual|Sequana Medical AG||1|||f||||f||||||||||2017-10-11 01:15:26.195205|2017-10-11 01:15:26.195205
NCT01952314|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-12-08|||May 2014||2014-05-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Medical Expulsive Therapy for Ureter Stone Using Naftopidil|Medical Expulsive Therapy for Ureter Stone Using Naftopidil: Multicenter, Randomized, Double-blind, Placebo Controlled Study|Completed||Phase 3|150|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:15:26.276869|2017-10-11 01:15:26.276869
NCT01952301|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-05-24|2014-01-28||November 2010||2010-11-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation|A Randomized, Controlled Clinical Trial to Evaluate a Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation|Completed||N/A|30|Actual|Perio Health Professionals, PLLC||2|||f||||f||||||||||2017-10-11 01:15:26.404834|2017-10-11 01:15:26.404834
NCT01952288|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-08-28|||September 16, 2013|Actual|2013-09-16|August 2017|2017-08-01|April 1, 2018|Anticipated|2018-04-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Simvastatin for mTBI-II|Simvastatin: Proof-of-Concept for Prevention of Neurodegeneration in Mild TBI|Suspended||Phase 4|120|Anticipated|VA Office of Research and Development||2||Study revisions pending IRB approval|f||||t|t|f|||f|||||2017-10-11 01:15:26.681297|2017-10-11 01:15:26.681297
NCT01952275|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-09-26|||January 2014||2014-01-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|NEUTROGENE||Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases|Assessment of the Enrichment of Rare Coding Genetic Variants in Patients Affected by Neutrophil-Mediated Inflammatory Dermatoses|Recruiting||N/A|600|Anticipated|University of Zurich|||1||f||||f||||||Samples With DNA|"     Saliva or Blood Serum Histology FFPE   "|||2017-10-11 01:15:26.803642|2017-10-11 01:15:26.803642
NCT01952262|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-03-08|||August 2013||2013-08-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Ultrasound of the Diaphragm in ICU Patients|Ultrasound Evaluation of Diaphragmatic Dysfunction in Critically Ill Patients. An Observational Study.|Recruiting||N/A|100|Anticipated|Università Vita-Salute San Raffaele|||1||f||||||||||||||2017-10-11 01:15:26.933184|2017-10-11 01:15:26.933184
NCT01952249|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-09-16|||August 2013||2013-08-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SIERRA||A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian|SIERRA: A PhaSe 1b/2 Study of DemcIzumab Plus PaclitaxEl in Subjects With Platinum Resistant OvaRian, PrimAry Peritoneal or Fallopian Tube Cancer|Completed||Phase 1/Phase 2|20|Actual|OncoMed Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:15:27.114755|2017-10-11 01:15:27.114755
NCT01952236|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-08-17|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|October 2017|Anticipated|2017-10-01||Interventional|MobileQuit||Web and Mobile Smoking Cessation|Web and Mobile Smoking Cessation Interventions|Active, not recruiting||N/A|1266|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-10-11 01:15:27.235136|2017-10-11 01:15:27.235136
NCT01952223|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-04-26|||September 2013||2013-09-01|April 2016|2016-04-01|September 2026|Anticipated|2026-09-01|September 2019|Anticipated|2019-09-01||Interventional|PEACE2||A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse|A Randomized Phase III, Factorial Design, of Cabazitaxel and Pelvic Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse|Recruiting||Phase 3|1048|Anticipated|UNICANCER||4|||f||||t||||||||Yes||2017-10-11 01:15:27.354978|2017-10-11 01:15:27.354978
NCT01944501|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-12|||March 2012||2012-03-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Neuromodulation Techniques in the Treatment of Chronic Tinnitus With Hearing Loss|Neuromodulation Techniques in the Treatment of Chronic Tinnitus With Hearing Loss|Completed||N/A|36|Actual|University of Brasilia||4|||f||||f||||||||||2017-10-11 01:17:44.680289|2017-10-11 01:17:44.680289
NCT01952210|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-04-22|||June 2012||2012-06-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient|The Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient Receiving Neoadjuvant Chemoradiation.|Completed||N/A|56|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:15:27.506819|2017-10-11 01:15:27.506819
NCT01952197|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2014-09-03|||June 2013||2013-06-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|EP-PCEH||Passive Leg Raise (PLR) During Cardiopulmonary Resuscitation (CPR)|Passive Leg Raise (PLR) During Cardiopulmonary Resuscitation (CPR): a Randomised Study of Survival in Out-of-hospital Cardiac Arrest (OHCA)|Unknown status|Recruiting|N/A|3130|Anticipated|University Rovira i Virgili||1|||f||||t||||||||||2017-10-11 01:15:27.615568|2017-10-11 01:15:27.615568
NCT01952184|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-12-02|||September 2013||2013-09-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.|Oocyte Survival After Vitrification in an Open or Closed Commercial Device: Study on Sibling Donor Oocytes.|Completed||N/A|48|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 01:15:27.746315|2017-10-11 01:15:27.746315
NCT01952171|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-07-11|||September 17, 2013||2013-09-17|June 26, 2017|2017-06-26|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Observational|||The Genetic Basis of Congenital Heart Disease in Africa|The International Genetic Basis of Congenital Heart Disease Study|Recruiting||N/A|2500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:15:27.853319|2017-10-11 01:15:27.853319
NCT01952158|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-08-22|||September 13, 2013||2013-09-13|January 13, 2017|2017-01-13|January 13, 2017|Actual|2017-01-13|September 13, 2013|Actual|2013-09-13||Observational|||Point Prevalence Study of Multidrug-Resistant Organism Carriage by Healthcare Personnel|Point Prevalence Study of Multidrug-Resistant Organism Carriage by Healthcare Personnel|Completed||N/A|800|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:15:27.970608|2017-10-11 01:15:27.970608
NCT01952145|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-07-12|2016-11-23|2016-10-04|September 20, 2013|Actual|2013-09-20|July 2017|2017-07-01|November 4, 2014|Actual|2014-11-04|November 4, 2014|Actual|2014-11-04||Interventional|DUAL™ V|Full analysis set (FAS) was used for baseline measurements. FAS included all randomised subjects.|A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus|A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)|Completed||Phase 3|557|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:15:28.099517|2017-10-11 01:15:28.099517
NCT01952132|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-08-13|||September 2013||2013-09-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects|Phase 2 Randomized, Double-blind, Placebo-controlled, Sequential Dose Escalation Cohort Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects|Completed||Phase 2|40|Actual|Omeros Corporation||4|||f||||f||||||||||2017-10-11 01:15:28.992229|2017-10-11 01:15:28.992229
NCT01952119|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2013-09-24|||October 2011||2011-10-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care System|Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care Delivery System|Completed||N/A|182|Actual|Kaiser Permanente||2|||f||||||||||||||2017-10-11 01:15:29.126298|2017-10-11 01:15:29.126298
NCT01952106|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2014-12-04|||October 2013||2013-10-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effects of Distraction on Pain and Distress During Venepuncture in Children|Effects of Distraction on Pain and Distress During Venepuncture in Children|Completed||N/A|60|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 01:15:29.302674|2017-10-11 01:15:29.302674
NCT01952093|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-08-20|||May 2013||2013-05-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Effects of Early Intervention for Preterm Children at School Age|Effects of Early Intervention for Preterm Children at School Age|Unknown status|Recruiting|N/A|240|Anticipated|National Taiwan University Hospital||4|||f||||f||||||||||2017-10-11 01:15:29.41048|2017-10-11 01:15:29.41048
NCT01952080|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2015-11-10|2015-08-12||November 2013||2013-11-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome|A 12-Week Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects Aged 1 Year Through 17 Years, With Short Bowel Syndrome Who Are Dependent on Parenteral Support|Completed||Phase 3|42|Actual|Shire||2|||f||||t||||||||||2017-10-11 01:15:29.574732|2017-10-11 01:15:29.574732
NCT01952067|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-01-19|||March 2013||2013-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Two Cementing Techniques of the Femoral Component in a Hip Prosthesis|Comparison of Two Cementing Techniques of the Femoral Component in a Hip Prosthesis. A Randomized Single-blind Trial|Active, not recruiting||N/A|50|Anticipated|Norwegian University of Science and Technology||2|||f||||t|f|f||||||||2017-10-11 01:15:31.05502|2017-10-11 01:15:31.05502
NCT01952054|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-08-03|||February 9, 2015|Actual|2015-02-09|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Denosumab for Breast Cancer With Bone Mets|Phase II Study of Denosumab to Define the Role of Bone Related Biomarkers in Breast Cancer Bone Metastasis|Recruiting||Phase 2|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:15:31.148301|2017-10-11 01:15:31.148301
NCT01952041|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-02-06|||March 2015||2015-03-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia|A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia|Active, not recruiting||N/A|150|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 01:15:31.240729|2017-10-11 01:15:31.240729
NCT01952028|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-10-05|||November 2013||2013-11-01|October 2015|2015-10-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|||LAMA2-related Muscular Dystrophy Brain Study|A LAMA2-related Muscular Dystrophy Study: Brain Magnetic Resonance Imaging (MRI)and Brain Electrophysiology Evaluation|Withdrawn||N/A|0|Actual|Cure CMD|||1||f||||f||||||||||2017-10-11 01:15:31.325219|2017-10-11 01:15:31.325219
NCT01952002|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-09-24|||October 2012||2012-10-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01|1 Day|Observational [Patient Registry]|||Clinical Safety for the Inspiratory Muscle Training|CLINICAL SAFETY FOR THE INSPIRATORY MUSCLE TRAINING IN CARDIOPULMONARY REHABILITATION PROGRAM|Completed||N/A|21|Actual|Clínica de Medicina do Exercício|||1||f||||f||||||||||2017-10-11 01:15:31.53201|2017-10-11 01:15:31.53201
NCT01951989|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-09-24|||November 2012||2012-11-01|September 2013|2013-09-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Interventional|CIMI||Intra-monocyte Imiglucerase Kinetics in Gaucher Disease|Study of Intra-monocytic Imiglucerase Kinetic and Its Correlation With Clinical and Biological Gaucher Disease|Unknown status|Recruiting|Phase 2|60|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 01:15:31.605265|2017-10-11 01:15:31.605265
NCT01951976|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-07-01|||September 2013||2013-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2015|Actual|2015-03-01||Interventional|||Yoga for Aromatase Inhibitor-associated Joint Pain|Evaluating Yoga for Aromatase Inhibitor-associated Joint Pain in Women With Breast Cancer: A Pilot Study|Completed||N/A|16|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 01:15:31.733958|2017-10-11 01:15:31.733958
NCT01951950|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-08-28|2014-08-18||September 2013||2013-09-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Nicardipine vs Esmolol Craniotomy Emergence|Nicardipine Versus Esmolol for Management of Emergence Hypertension After Craniotomy|Completed||Phase 1|40|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 01:15:31.959679|2017-10-11 01:15:31.959679
NCT01951937|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-09-15|||September 2014|Actual|2014-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2015|Actual|2015-11-01||Interventional|FINS||Herring and Mackerel Intervention and Learning Abilities|Herring and Mackerel Intervention and Learning Abilities in German Youths|Active, not recruiting||N/A|200|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 01:15:32.263045|2017-10-11 01:15:32.263045
NCT01951924|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-07-18|||December 2013||2013-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|LIME||LIME Study (LFB IVIg MMN Efficacy Study)|A European, Randomised, Double-blind, Active Comparator Controlled, Cross-over, Efficacy and Safety Study of a New 10% Ready To-use Liquid Human Intravenous Immunoglobulin (I10E) Versus Kiovig® in Patients With Multifocal Motor Neuropathy|Completed||Phase 3|23|Actual|Laboratoire français de Fractionnement et de Biotechnologies||2|||f||||f||||||||||2017-10-11 01:15:32.384826|2017-10-11 01:15:32.384826
NCT01951911|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-07-06|||September 2013|Actual|2013-09-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|KETA-1||Effectiveness of Ketamine in Malignant Neuropathic Pain Relief|Low-dose Ketamine as Adjuvant Treatment to Morphine in Neuropathic Cancer Pain|Withdrawn||Phase 3|0|Actual|Haukeland University Hospital||2||Poor patient recruitment. Vast majority of the patients have exclusions criteria|f||||t||||||||||2017-10-11 01:15:32.544027|2017-10-11 01:15:32.544027
NCT01951898|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-09-24|||June 2012||2012-06-01|September 2013|2013-09-01|May 2015|Anticipated|2015-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Effects of Montelukast on Airway Regulatory T Cells in Asthma|Effects of Montelukast on Airway Foxp3+ and CTLA4+CD25highCD4+ T Cells in Asthmatics|Unknown status|Recruiting|Phase 2/Phase 3|15|Anticipated|Kurume University||2|||f||||||||||||||2017-10-11 01:15:32.660496|2017-10-11 01:15:32.660496
NCT01951885|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-09-29|||May 2014||2014-05-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention|Tacrolimus, Mini-dose Methotrexate and Mycophenolate Mofetil Versus Tacrolimus and Methotrexate for the Prevention of Acute Graft-versus-Host-Disease|Recruiting||Phase 3|100|Anticipated|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:15:32.7978|2017-10-11 01:15:32.7978
NCT01951872|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-08-15|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Treatment for Caffeine Dependence|Treatment for Caffeine Dependence|Completed||N/A|82|Actual|Johns Hopkins University||2|||f||||f|f|f||||||||2017-10-11 01:15:34.686681|2017-10-11 01:15:34.686681
NCT01951859|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-07-22|||August 2013||2013-08-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Interventional|||Effects of a Homeopathic Anti-inflammatory Topical Cream on Ulcers and Neuropathy in the Diabetic Foot|A Double Blind Placebo Controlled Pilot Study to Evaluate the Effects of a Homeopathic Anti-inflammatory Topical Cream on the Healing of Wounds That Develop Into Ulcers and Neuropathy in the Diabetic Foot.|Unknown status|Recruiting|N/A|15|Anticipated|Calvary Hospital, Bronx, NY||2|||f||||f||||||||||2017-10-11 01:15:34.85579|2017-10-11 01:15:34.85579
NCT01951846|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-09-24|||November 2002||2002-11-01|September 2013|2013-09-01||||November 2004|Actual|2004-11-01||Interventional|||To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours|An Open Label Dose Escalation Study of BIBF 1120 Administered Orally for Four Weeks in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit|Completed||Phase 1|61|Actual|Boehringer Ingelheim||1|||||||||||||||||2017-10-11 01:15:34.970947|2017-10-11 01:15:34.970947
NCT01951833|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-01-14|||January 2013||2013-01-01|November 2013|2013-11-01|May 2017|Anticipated|2017-05-01|May 2015|Anticipated|2015-05-01||Observational|||Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis|Does Lung Clearance Index (LCI) Predict the Future Lung Disease Course in Patients With Cystic Fibrosis|Withdrawn||N/A|0|Actual|University Hospital St Luc, Brussels|||2||f||||t||||||||||2017-10-11 01:15:35.062118|2017-10-11 01:15:35.062118
NCT01951820|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-06-12|2016-04-09||August 2013||2013-08-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Comparison of Two Topical Anesthetics: Benzocaine Versus Pliaglis|Comparison of Efficacy of Two Topical Anesthetics: Benzocaine Versus Pliaglis for Control of Pain Associated With Dental Needle Insertion in the Palate, A Double Blind Study|Completed||Phase 4|64|Actual|University of Michigan||2|||f||||f||||||||No||2017-10-11 01:15:35.189694|2017-10-11 01:15:35.189694
NCT01951807|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-09-21|||June 2010||2010-06-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Psychological Interventions for Gynecologic Cancer|Psychological Interventions for Gynecologic Cancer|Active, not recruiting||N/A|375|Actual|Rutgers, The State University of New Jersey||3|||f||||t||||||||||2017-10-11 01:15:35.495369|2017-10-11 01:15:35.495369
NCT01951794|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-04-17|||June 2014|Actual|2014-06-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Validation of a Community Survey Methodology for Measuring PMTCT Program Impact|CIDRZ 1225 - Validation of a Community Survey Methodology for Measuring PMTCT Program Impact|Completed||N/A|827|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples Without DNA|"     We will collect Dried Blood Specimens (DBS) from both mother and infant and link them using     pre-printed bar codes. For a mother who refuses real-time testing, but agrees to collection     of this maternal DBS specimen, she will be provided a card with a unique study-generated     identification number that can be used pick-up results at the community's designated health     facility. For those who agreed to on-site HIV testing, we will retain the DBS specimens for     quality assurance purposes. As part of the informed consent process, participants will also     be asked whether leftover specimens may be used for future use, pending local and     international ethical approvals for specified substudies.   "|||2017-10-11 01:15:35.633899|2017-10-11 01:15:35.633899
NCT01951781|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-01-08|||June 2013||2013-06-01|September 2013|2013-09-01|November 2015|Anticipated|2015-11-01|June 2014|Actual|2014-06-01||Interventional|NEOCD64||Neutrophil CD64 for Early Diagnosis of Nosocomial Infection in Preterm Newborns|Rapid Quantitative Neutrophil CD64 Measurement for Early Diagnosis of Nosocomial Infection in Preterm Newborns|Unknown status|Recruiting|N/A|153|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 01:15:35.737695|2017-10-11 01:15:35.737695
NCT01951768|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2013-09-30|||September 2013||2013-09-01|September 2013|2013-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Efficacy and Safety of Garamycin® Sponge (Gentamicin-Collagen Sponge) in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection|A Randomized, Controlled Study to Investigate the Efficacy and Safety of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection|Unknown status|Recruiting|Phase 4|144|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 01:15:35.867117|2017-10-11 01:15:35.867117
NCT01951755|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-12-05|||January 2012||2012-01-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01|24 Months|Observational [Patient Registry]|||Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)|An Observational Study for Safety and Efficacy of Erlotinib Beyond 1st Line in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer|Completed||N/A|150|Actual|University of Athens|||1||f||||t||||||||||2017-10-11 01:15:36.087029|2017-10-11 01:15:36.087029
NCT01951742|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-22|2014-05-20||2014-05-20|September 2013||2013-09-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Dose Finding Study In Subjects With Crow's Feet|Dose Finding Study of Botulinum Neurotoxin Type A In Subjects With Crow's Feet (Lateral Canthal Lines)|Completed||Phase 2|145|Actual|Anterios Inc.||6|||f||||f||||||||||2017-10-11 01:15:36.177128|2017-10-11 01:15:36.177128
NCT01951729|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-05-17|||March 13, 2013|Actual|2013-03-13|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|August 10, 2015|Actual|2015-08-10||Interventional|||The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion|The Effects of GIP and/or Xenin-25, With and Without Atropine, on Insulin Secretion in Humans With Pre-diabetes|Active, not recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 01:15:36.300012|2017-10-11 01:15:36.300012
NCT01951716|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-05-17|||January 2013||2013-01-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy|Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy|Active, not recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 01:15:36.479707|2017-10-11 01:15:36.479707
NCT01951703|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-04-29|2015-07-06||September 2013||2013-09-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||This includes all randomized subjects|Senofilcon A Investigational Manufacturing Process|Clinical Investigation of Senofilcon A Manufactured Using an Alternate Hydration Process|Completed||N/A|136|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 01:15:36.65415|2017-10-11 01:15:36.65415
NCT01951690|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-04-12||2017-04-12|September 2013||2013-09-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer|Phase II Study of VS-6063, A Focal Adhesion Kinase (FAK) Inhibitor, in Patients With KRAS Mutant Non-Small Cell Lung Cancer|Completed||Phase 2|55|Actual|Verastem, Inc.||1|||f||||f|t|f||||||||2017-10-11 01:15:37.080274|2017-10-11 01:15:37.080274
NCT01951677|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-12-15|||July 2013||2013-07-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine|Phase 1 Randomized, Controlled, Double-blind Study to Compare the Safety and Effectiveness of Hepatitis B Vaccines in Individuals With Renal Impairment, Diabetes Mellitus or Age Greater Than 40 Years|Recruiting||Phase 1|240|Anticipated|Vaxine Pty Ltd||12|||f||||t||||||||No|Currently no plan|2017-10-11 01:15:37.198564|2017-10-11 01:15:37.198564
NCT01951664|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-04-26|||August 2013||2013-08-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors|Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors|Completed||N/A|40|Actual|Vanderbilt-Ingram Cancer Center||2|||f||||f||||||||||2017-10-11 01:15:37.34401|2017-10-11 01:15:37.34401
NCT01951651|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-04-14|2016-02-19||April 2010||2010-04-01|April 2016|2016-04-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Exenatide on Liver and Heart Fat and Inflammation|Effect of Exenatide Treatment on Myocardial Fat Content, Left Ventricular Function, and Vascular Inflammation in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|24|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 01:15:37.46138|2017-10-11 01:15:37.46138
NCT01951638|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2015-10-09||2015-09-23|November 2013||2013-11-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)|A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)|Completed||Phase 2|477|Actual|Bayer||5|||f||||t||||||||||2017-10-11 01:15:37.781606|2017-10-11 01:15:37.781606
NCT01951625|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-10-14||2015-08-28|November 2013||2013-11-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)|A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure With Reduced Ejection Fraction (HFrEF)|Completed||Phase 2|456|Actual|Bayer||5|||f||||t||||||||||2017-10-11 01:15:38.556037|2017-10-11 01:15:38.556037
NCT01951612|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2016-07-18|||November 2011||2011-11-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Cognitive Changes and Rehabilitation in People With Transient Ischemic Attack, Stroke, or Stroke Risk Factors|Cognitive Changes and Rehabilitation in People With Transient Ischemic Attack, Stroke, or Stroke Risk Factors|Recruiting||N/A|40|Anticipated|Baycrest||2|||f||||||||||||||2017-10-11 01:15:39.414008|2017-10-11 01:15:39.414008
NCT01951599|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-03-30|||October 9, 2013|Actual|2013-10-09|March 2017|2017-03-01|June 4, 2014|Actual|2014-06-04|June 4, 2014|Actual|2014-06-04||Interventional|||To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.|A Phase I, Open-label, Single-center, Sequential Design Study in Healthy Volunteers to Determine the Relative Bioavailability of Different Oral Formulations of AZD9291 and the Effect of Food|Completed||Phase 1|35|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 01:15:39.52458|2017-10-11 01:15:39.52458
NCT01951586|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-07-27|2017-07-27||December 31, 2013|Actual|2013-12-31|July 2017|2017-07-01|September 26, 2018|Anticipated|2018-09-26|July 29, 2016|Actual|2016-07-29||Interventional|||Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer|A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|226|Actual|Amgen||2|||f||||f|t|f||||||||2017-10-11 01:15:39.79361|2017-10-11 01:15:39.79361
NCT01951573|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2014-11-24|2014-11-24||October 2013||2013-10-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||This analysis population includes all subjects/eyes exposed to any Investigational Product (IP) evaluated in this study.|Evaluation of a New Daily Disposable Multifocal Contact Lens Design|Delefilcon A Multifocal Plus Power Lens Design Evaluation|Completed||N/A|36|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:15:41.714918|2017-10-11 01:15:41.714918
NCT01951560|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-12-16|||September 2013||2013-09-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1)|A Phase 1, Single Ascending Dose, Double Blind, Placebo Controlled Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1) or Trauma Patients(Part 2)|Completed||Phase 1|59|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 01:15:42.094279|2017-10-11 01:15:42.094279
NCT01951547|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-09-23|||January 2010||2010-01-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Periodontal Disease and Diabetes Mellitus Interrelationship Among Adult Malaysians|The Effect of Non-surgical Periodontal Therapy on Host Response and Microbiological Profile of Type 2 Diabetics With Periodontal Disease.|Completed||N/A|40|Actual|University of Malaya||2|||f||||t||||||||||2017-10-11 01:15:42.1994|2017-10-11 01:15:42.1994
NCT01951534|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-01-20|||January 2011||2011-01-01|January 2017|2017-01-01|June 7, 2016|Actual|2016-06-07|June 30, 2015|Actual|2015-06-30||Interventional|BRDA||Decisional Aid Intervention for Women Considering Breast Reconstruction|Decisional Aid Intervention for Women Considering Breast Reconstruction|Completed||N/A|56|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-11 01:15:42.305421|2017-10-11 01:15:42.305421
NCT01951521|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-03-29|||September 2014||2014-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|RECTAL BOOST||RECTAL BOOST Study|RandomizEd Controlled Trial for Pre-operAtive Dose-escaLation BOOST in Locally Advanced Rectal Cancer|Recruiting||N/A|120|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-11 01:15:42.393735|2017-10-11 01:15:42.393735
NCT01951508|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-01-20|||October 2013||2013-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study|Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study|Completed||Early Phase 1|24|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 01:15:42.504033|2017-10-11 01:15:42.504033
NCT01951482|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-11-16|||June 2013||2013-06-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Pemetrexed/Cisplatin With or Without Bevacizumab in Brain Metastases From Non Squamous Non-small Cell Lung Cancer|Multicenter Phase II Study of Pemetrexed/Cisplatin With or Without Bevacizumab in Patients With Brain Metastases From Non Squamous Non-small Cell Lung Cancer Harboring EGFR Wild Type|Recruiting||Phase 2|108|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:15:42.619575|2017-10-11 01:15:42.619575
NCT01951274|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2015-05-20|||October 2013||2013-10-01|June 2013|2013-06-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||VPD-737 for Treatment of Chronic Pruritus|A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus|Completed||Phase 2|257|Actual|Menlo Therapeutics Inc.||4|||f||||f||||||||||2017-10-11 01:15:45.720088|2017-10-11 01:15:45.720088
NCT01951469|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-11-16|||June 2013||2013-06-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Gefitinib With or Without Pemetrexed/Cisplatin in Brain Metastases From Non-small Cell Lung Cancer|Multicenter Phase II Study of Gefitinib Mono-therapy or Gefitinib Combined With Pemetrexed/Cisplatin in Patients With Brain Metastases From Non-small Cell Lung Cancer Harboring EGFR Mutation|Recruiting||Phase 2|160|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:15:42.77434|2017-10-11 01:15:42.77434
NCT01951456|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-04-25|||November 2013||2013-11-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Resistance Training as an Aid to Smoking Cessation Treatment|Resistance Training as an Aid to Smoking Cessation Treatment|Recruiting||N/A|206|Anticipated|Teachers College, Columbia University||2|||f||||f||||||||||2017-10-11 01:15:42.895017|2017-10-11 01:15:42.895017
NCT01951443|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2014-04-25|||August 2013||2013-08-01|March 2014|2014-03-01||||February 2014|Actual|2014-02-01||Interventional|KRAB||Korean Red Ginseng Rg3 Extract on Arterial Stiffness and Blood Pressure|Acute Effect of Rg3-enriched Korean Red Ginseng (Steamed Panax Ginseng C.A. Meyer) Standardized Extract on Arterial Stiffness and Aortic and Brachial Blood Pressure in Healthy Individuals|Completed||Phase 1|24|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:15:42.982049|2017-10-11 01:15:42.982049
NCT01951430|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-02-16|||March 2014||2014-03-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients|Observational Prospective Multicenter Study to Evaluate the Infective Risk in Myelodysplastic Syndrome Patients: Antimicrobial Prophylaxis and Granulocyte Growth Factors.|Recruiting||N/A|1000|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||No||2017-10-11 01:15:43.068946|2017-10-11 01:15:43.068946
NCT01951417|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-02-17|2014-07-08||October 2013||2013-10-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris|Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foaming Wash Regimen in Patients With Mild to Moderate Acne Vulgaris|Completed||Phase 4|81|Actual|Galderma Laboratories, L.P.|"Open label study with small sample size
Short study duration"|1|||f||||f||||||||||2017-10-11 01:15:43.425855|2017-10-11 01:15:43.425855
NCT01951404|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-11-03|||September 2013||2013-09-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|Altered||Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study|Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study|Completed||Phase 4|80|Actual|University of Dundee||2|||f||||t||||||||||2017-10-11 01:15:44.056466|2017-10-11 01:15:44.056466
NCT01951391|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-05-17|||September 2013||2013-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Surfactants on the Skin Microbiome|Effect of Surfactants on the Skin Microbiome|Completed||N/A|20|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 01:15:44.187369|2017-10-11 01:15:44.187369
NCT01951378|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-10-12|||September 2013||2013-09-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Comparison of Nebulizers in ED in Pediatric Asthma Patients|Comparison of a Breath Enhanced High Density Jet Nebulizer With a Standard Jet Nebulizer for the Treatment of Children With a Moderate to Severe Asthma Exacerbation in the Emergency Department|Completed||Phase 4|242|Actual|Seton Healthcare Family||2|||f||||t||||||||No||2017-10-11 01:15:44.270857|2017-10-11 01:15:44.270857
NCT01951365|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-09-23|||June 1998||1998-06-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|February 2012|Actual|2012-02-01||Observational|||Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma|Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma: A Longitudinal Study of Natural History|Completed||N/A|56|Actual|Seoul National University Hospital|||2||f||||f||||||None Retained|"     The investigators analyzed MR images only   "|||2017-10-11 01:15:44.36348|2017-10-11 01:15:44.36348
NCT01951352|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-05-17|||September 2013||2013-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Surfactants on the Innate Immune System|Effects of Surfactants on the Innate Immune System|Completed||N/A|10|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 01:15:44.441148|2017-10-11 01:15:44.441148
NCT01951339|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-08-29|||October 2013||2013-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes|Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes|Recruiting||N/A|28|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:15:44.538254|2017-10-11 01:15:44.538254
NCT01951326|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-09-01|||September 2013||2013-09-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|MAPUS||Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease|A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease|Recruiting||Phase 3|410|Anticipated|RedHill Biopharma Limited||2|||f||||t||||||||||2017-10-11 01:15:44.705183|2017-10-11 01:15:44.705183
NCT01951313|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-06-17|||January 2014||2014-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Egg Consumption on Carotenoid Absorption From Co-consumed, Non-Egg Food|EffectEffects of Egg Consumption on Carotenoid Absorption From Co-consumed, Non-Egg Food|Completed||N/A|17|Actual|Purdue University||1|||f||||f||||||||||2017-10-11 01:15:45.418174|2017-10-11 01:15:45.418174
NCT01951300|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-11-03|||September 2013||2013-09-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SITRAT||68Ga-Citrate PET of Healthy Volunteers|68Ga-Citrate Positron Emission Tomography (PET) of Healthy Volunteers|Completed||N/A|6|Actual|Turku University Hospital||1|||f||||f||||||||||2017-10-11 01:15:45.506248|2017-10-11 01:15:45.506248
NCT01951287|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-02-04|||August 2013||2013-08-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|S37||Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overwt/Obese Adults|Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overweight/Obese Adults With Normal or Impaired Glucose Tolerance or Type 2 Diabetes|Completed||N/A|54|Actual|Purdue University||6|||f||||f||||||||||2017-10-11 01:15:45.596541|2017-10-11 01:15:45.596541
NCT01951261|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-09-26|||March 2012||2012-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Early Assisted Discharge for COPD Exacerbations With Telemonitoring.|Early Assisted Discharge With Generic Community Nursing and Pulmonary Physicians vs Telemonitoring at Home for Chronic Obstructive Pulmonary Disease Exacerbations|Recruiting||N/A|116|Anticipated|Puerta de Hierro University Hospital||2|||f||||t||||||||||2017-10-11 01:15:45.873373|2017-10-11 01:15:45.873373
NCT01951248|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-10-08|||December 2013||2013-12-01|October 2014|2014-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|NOSI||Central and Peripheral 24-h Blood Pressure Before and After 3 Month of CPAP Treatment in Obstructive Sleep Apnea|Central and Peripheral 24-h Blood Pressure Measurements in Patients With Chronic Renal Failure and Obstructive Sleep Apnea Before and After Treatment With CPAP|Unknown status|Active, not recruiting|N/A|30|Anticipated|Regional Hospital Holstebro||1|||f||||f||||||||||2017-10-11 01:15:46.009081|2017-10-11 01:15:46.009081
NCT01951235|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-07-24||2015-07-02|January 2013||2013-01-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes|A Dose-ranging, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes Mellitus.|Completed||Phase 2|315|Actual|Poxel SA||5|||f||||f||||||||||2017-10-11 01:15:46.108262|2017-10-11 01:15:46.108262
NCT01951222|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-09-16|||September 2013||2013-09-01|September 2013|2013-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Bronchodilator Properties and Safety in Asthma|Bronchodilator Properties and Safety of a Repeated Dose of V0162 in Asthma.|Completed||Phase 2|59|Actual|Pierre Fabre Medicament||3|||f||||f||||||||||2017-10-11 01:15:46.341864|2017-10-11 01:15:46.341864
NCT01951209|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-09-20|||August 2016||2016-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis|Prospective Pilot Study of the Effect of Rifaximin on B-Cell Dysregulation in Cirrhosis Due to Chronic Hepatitis C Infection|Recruiting||N/A|18|Anticipated|Corporal Michael J. Crescenz VA Medical Center||2|||f||||f||||||||Yes|Deidentified primary data will be made available for verification|2017-10-11 01:15:46.49323|2017-10-11 01:15:46.49323
NCT01951196|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-10-08|||October 2013||2013-10-01|October 2014|2014-10-01|October 2017|Anticipated|2017-10-01|December 2015|Anticipated|2015-12-01||Observational|NOSA||Nocturnal Blood Pressure - Central and Peripheral 24-h Blood Pressure in Chronic Kidney Disease.|Nocturnal Blood Pressure in Chronic Kidney Disease, Obstructive Sleep Apnea and Healthy Subjects - Central and Peripheral 24-h Blood Pressure.|Unknown status|Active, not recruiting|N/A|225|Anticipated|Regional Hospital Holstebro|||2||f||||f||||||Samples Without DNA|"     Whole blood, serum, urine   "|||2017-10-11 01:15:46.648773|2017-10-11 01:15:46.648773
NCT01951183|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin|A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 2A STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE-DAILY RO6811135 IN TYPE 2 DIABETIC PATIENTS INADEQUATELY CONTROLLED WITH METFORMIN|Withdrawn||Phase 2|0|Actual|Hoffmann-La Roche||2||Cancelled due to Sponsor's decision|f||||||||||||||2017-10-11 01:15:46.733478|2017-10-11 01:15:46.733478
NCT01951170|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-08-01|2016-08-01||November 2013||2013-11-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Full Analysis Set (FAS) included all enrolled participants who received at least one dose of subcutaneous tocilizumab.|An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis|An Open-Label Study to Evaluate Non-Progression Of Structural Joint Damage Of Subcutaneous Tocilizumab In Patients With Moderate To Severe Active Rheumatoid Arthritis (Ac-Cute)|Completed||Phase 3|52|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:15:46.8607|2017-10-11 01:15:46.8607
NCT01951157|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-12-14|||October 2013||2013-10-01|May 2016|2016-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients|A Randomized-Controlled Three-arm Phase II Study of Lurbinectedin (PM01183) Alone or In Combination With Gemcitabine and a Control Arm With Docetaxel as Second-Line Treatment in Unresectable Non-Small Cell Lung Cancer (NSCLC) Patients|Completed||Phase 2|69|Actual|PharmaMar||3|||f||||f||||||||||2017-10-11 01:15:47.422398|2017-10-11 01:15:47.422398
NCT01951144|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2014-08-15|||October 2013||2013-10-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865|A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Crossover Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06372865 in Healthy Male and Female Subjects|Completed||Phase 1|45|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 01:15:47.55002|2017-10-11 01:15:47.55002
NCT01951131|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2014-06-23|||September 2013||2013-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:15:47.669586|2017-10-11 01:15:47.669586
NCT01951118|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-12-27|||October 2013||2013-10-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly|Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly|Recruiting||Phase 4|170|Anticipated|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-11 01:15:47.710823|2017-10-11 01:15:47.710823
NCT01951092|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-04-11|2014-10-08||February 2013||2013-02-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||mHealth Intervention Supporting HIV Treatment Adherence and Retention|mHealth Intervention Supporting HIV Treatment Adherence and Retention|Completed||N/A|32|Actual|The Miriam Hospital||1|||f||||t||||||||||2017-10-11 01:15:47.982953|2017-10-11 01:15:47.982953
NCT01951079|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-09-23|||November 2013||2013-11-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy|The Safety and Outcome of Intra-amniotic DIGOXIN Injection for Feticide Prior to Second Trimester Abortion|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|Meir Medical Center||1|||f||||t||||||||||2017-10-11 01:15:48.212741|2017-10-11 01:15:48.212741
NCT01951066|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-08-23|2016-05-10||October 2013||2013-10-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|DMEO||Diabetic Macular Edema Treated With Ozurdex (DMEO)|Diabetic Macular Edema Treated With Ozurdex (DMEO)|Completed||Phase 2|20|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:15:48.312392|2017-10-11 01:15:48.312392
NCT01951053|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-23|||January 2010||2010-01-01|September 2013|2013-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of JNJ-404118413 in Healthy Male Patients|A Blinded, Placebo- and Comparator-Controlled Three-way Crossover Study to Investigate the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of JNJ-40411813 in Healthy Male Subjects|Completed||Phase 1|18|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||6|||f||||f||||||||||2017-10-11 01:15:48.656423|2017-10-11 01:15:48.656423
NCT01951040|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2013-09-23|||February 2011||2011-02-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Observational|||Effect of Synthetic Oxytocin Administered During Labor on Breastfeedings|Effect of Oxytocin Administered During Labor on the Onset and Duration of Breastfeeding: A Retrospective Cohort Study.|Completed||N/A|346|Actual|Hospital Materno-Infantil de Málaga|||2||f||||f||||||||||2017-10-11 01:15:48.822382|2017-10-11 01:15:48.822382
NCT01951027|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-01-27|||September 2013||2013-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|GX-G3||Phase I Study GX-G3 in Healthy Subjects|A Dose-block Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase I Study to Investigate the Safety, Tolerability, and PK/PD of GX-G3 After Single SC Administration in Healthy Male Subjects|Completed||Phase 1|53|Actual|Genexine, Inc.||4|||f||||f||||||||||2017-10-11 01:15:48.918969|2017-10-11 01:15:48.918969
NCT01951014|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-11-13|||September 2013||2013-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Text for Prenatal Health Study|Text for Prenatal Health Study|Completed||N/A|30|Actual|Cornell University||2|||f||||f||||||||||2017-10-11 01:15:49.056308|2017-10-11 01:15:49.056308
NCT01951001|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-04-30|||July 2013||2013-07-01|April 2014|2014-04-01|October 2014|Anticipated|2014-10-01|June 2014|Anticipated|2014-06-01||Interventional|||Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome|Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome|Unknown status|Recruiting|Phase 4|240|Anticipated|Gyeongsang National University Hospital||3|||f||||t||||||||||2017-10-11 01:15:49.137251|2017-10-11 01:15:49.137251
NCT01950988|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-25|||July 2013||2013-07-01|September 2013|2013-09-01||||July 2015|Anticipated|2015-07-01||Interventional|BROSCYL||Effectiveness of a Novel Concept for a Manual Toothbrush Broscyl®|Effectiveness and Satisfaction-adaptability of a Novel Concept for a Manual Toothbrush Broscyl®: Randomised Clinical Trial in Children, Adults and Elderly People|Unknown status|Recruiting|N/A|234|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f||||f||||||||||2017-10-11 01:15:49.235707|2017-10-11 01:15:49.235707
NCT01950975|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-23||||||September 2013|2013-09-01||||February 2014|Anticipated|2014-02-01||Interventional|MOSAÏQUE||Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism.|Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism. National Multicentre Descriptive Study.|Unknown status|Recruiting|N/A|240|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-11 01:15:49.329582|2017-10-11 01:15:49.329582
NCT01950962|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-23|||October 2010||2010-10-01|September 2013|2013-09-01||||April 2014|Anticipated|2014-04-01||Interventional|TOXIB||Role Of Phospholipid Transfer Proteins (Pltp) On Endotoxemia Caused By Buccal Inflammation|ROLE OF PHOSPHOLIPID TRANSFER PROTEINS (PLTP) ON ENDOTOXEMIA CAUSED BY BUCCAL INFLAMMATION|Unknown status|Recruiting|N/A|240|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f||||f||||||||||2017-10-11 01:15:49.410704|2017-10-11 01:15:49.410704
NCT01950949|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-09-17|||July 2012||2012-07-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|March 2014|Actual|2014-03-01||Interventional|||The Correlational Study of PPV in Various VT in Mechanically Ventilated Patients|The Correlational Study of Pulse Pressure Variation in Various Tidal Volume in Mechanically Ventilated Patients Under General Anaesthesia|Completed||N/A|69|Actual|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:15:49.48252|2017-10-11 01:15:49.48252
NCT01950936|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-09-25|||November 2012||2012-11-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ProToCOLD||Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD)|Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease|Completed||Phase 2/Phase 3|120|Actual|Danish Procalcitonin Study Group||2|||f||||f||||||||||2017-10-11 01:15:49.544247|2017-10-11 01:15:49.544247
NCT01950923|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-24|2017-05-25|||September 2013||2013-09-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer|Sildenafil Prior to Robotic Partial Nephrectomy to Improve Postoperative Renal Function: A Randomized, Placebo-Controlled Pilot Study|Completed||Phase 2|30|Actual|Wake Forest University Health Sciences||2|||f||||f|t|f||||||||2017-10-11 01:15:49.635479|2017-10-11 01:15:49.635479
NCT01950910|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2014-07-02|||June 2007||2007-06-01|July 2014|2014-07-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|WBC||Establishment of a Tissue Bank (Blood, CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND)|Establishment of a Tissue Bank (Blood, CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND).|Unknown status|Recruiting|N/A|1000|Anticipated|Carolinas Healthcare System|||2||f||||t||||||Samples Without DNA|"     blood samples (serum and protein/RNA/DNA from blood cells) and CSF   "|||2017-10-11 01:15:49.741529|2017-10-11 01:15:49.741529
NCT01950897|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2014-07-02|||September 2005||2005-09-01|July 2014|2014-07-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|||Establishment of Phenotypic Profiles of Muscular Dystrophies for Understanding Disease Progression, Diagnosis and Development of New Therapies||Unknown status|Recruiting|N/A|250|Anticipated|Carolinas Healthcare System|||2||f||||f||||||Samples With DNA|"     skeletal muscle tissue   "|||2017-10-11 01:15:49.843807|2017-10-11 01:15:49.843807
NCT01950884|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2013-09-23|||October 2013||2013-10-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis|A Randomised Controlled Trial of Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis|Unknown status|Enrolling by invitation|Phase 4|45|Anticipated|University of Palermo||2|||f||||t||||||||||2017-10-11 01:15:50.112467|2017-10-11 01:15:50.112467
NCT01950871|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-01-02|||October 2013||2013-10-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|PHSTT-01||Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning|Diagnostic Performance of Prostate HistoScanningTM (PHS) in Men at Risk of Prostate Cancer Scheduled for an Initial Prostate Biopsy|Terminated||Phase 4|80|Actual|Advanced Medical Diagnostics s.a.||1||Sponsor is bankrupt|f||||f||||||||||2017-10-11 01:15:50.239782|2017-10-11 01:15:50.239782
NCT01950858|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-09-19|||May 2012||2012-05-01|September 2013|2013-09-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|||Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee|Safety and Efficacy of Hyper Baric Oxygen Therapy (HBOT) in Patients Presenting With Spontaneous Osteonecrosis of the Knee|Unknown status|Recruiting|Phase 1|40|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 01:15:50.433161|2017-10-11 01:15:50.433161
NCT01950845|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-07-06|||February 2014||2014-02-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CL vs CP||Automated Versus Manual Fluid Management for High Risk Abdominal Surgical Patient. A Prospective, Randomized Trial|Per Operative Fluid Optimisation Comparison of an Automated Closed-Loop System Versus Current Practice in High Risk Abdominal Surgical Patient. A Prospective, Randomized Clinical Trial.|Completed||N/A|46|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:15:50.539371|2017-10-11 01:15:50.539371
NCT01950832|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-09-19|||March 2013||2013-03-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01|1 Month|Observational [Patient Registry]|||Eye Evaluation in Patients With PCOS|Evaluation of the Macula, Retinal Nerve Fiber Layer and Choroid Thickness in Women With Polycystic Ovary Syndrome By Using Spectral-domain Optical Coherence Tomography.|Completed||N/A|124|Actual|Kayseri Education and Research Hospital|||2||f||||f||||||||||2017-10-11 01:15:50.624912|2017-10-11 01:15:50.624912
NCT01950819|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-08-21|||December 3, 2013|Actual|2013-12-03|August 2017|2017-08-01|January 29, 2018|Anticipated|2018-01-29|February 1, 2017|Actual|2017-02-01||Interventional|TRANSFORM||Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)|A 24 Month, Multicenter, Randomized, Open-label Safety and Efficacy Study of Concentration-controlled Everolimus With Reduced Calcineurin Inhibitor vs Mycophenolate With Standard Calcineurin Inhibitor in de Novo Renal Transplantation|Active, not recruiting||Phase 4|2037|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:15:50.764789|2017-10-11 01:15:50.764789
NCT01950806|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-04-24|||January 2014||2014-01-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes|The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes: A Controlled Feeding Trial in Overweight/Obese Adults With Central Adiposity|Completed||N/A|28|Actual|Tufts University||2|||f||||||||||||||2017-10-11 01:15:51.720691|2017-10-11 01:15:51.720691
NCT01950793|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-11-02|||November 2012||2012-11-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||A Comparison Between Sonoguided Injection Corticosteroid and Hyaluronic Acid Injection in Treatment of Trigger Finger|Steroid Versus Hyaluronic Acid Ultrasound-guided Injection for Trigger Finger: A Comparative Study of Outcomes|Completed||N/A|36|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 01:15:51.875676|2017-10-11 01:15:51.875676
NCT01950767|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-11-28|||December 2011||2011-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:15:52.09653|2017-10-11 01:15:52.09653
NCT01950754|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-09-24||||||September 2013|2013-09-01||||October 2014|Anticipated|2014-10-01||Interventional|DOUBLE TACHE||Study of the Effect of a Cognitive Task on Static Balance in Depressive Elderly Subjects According to the Double Task Principle|Study of the Effect of a Cognitive Task on Static Balance in Depressive Elderly Subjects According to the Double Task Principle|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-11 01:15:52.140431|2017-10-11 01:15:52.140431
NCT01950741|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-03-29|2015-10-20||September 2013||2013-09-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|VAULT||Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy|An Single Arm, Single Dose Study to Evaluate the Effect of Intravitreal Injection of VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy|Completed||Phase 4|48|Actual|Pusan National University Hospital|Conjunctival hemorrhage is assessed based on medical records, and the incidence might be underestimated.|1|||f||||f||||||||No||2017-10-11 01:15:52.236877|2017-10-11 01:15:52.236877
NCT01950728|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2013-09-25|||October 2013||2013-10-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Effects of Different Electrical Currents on Pressure Pain Threshold and Sensory Comfort.|Investigation of the Effects of Transcutaneous Electrical Nerve Stimulation, Aussie Current and Interferential Current on Pressure Pain Threshold and Sensory Comfort in Healthy Humans.|Unknown status|Not yet recruiting|N/A|80|Anticipated|Paulista University||4|||f||||f||||||||||2017-10-11 01:15:52.524689|2017-10-11 01:15:52.524689
NCT01950715|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-04-28|||September 2013||2013-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Multimodal Stimulation Before and After Sacral Nerve Stimulation for Irritable Bowel Syndrome|Evaluation of the Gastro-colic Response in IBS Patients Treated With Sacral Nerve Stimulation|Recruiting||N/A|24|Anticipated|University of Aarhus||1|||f||||t||||||||Undecided||2017-10-11 01:15:52.621288|2017-10-11 01:15:52.621288
NCT01950702|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2014-10-22|||September 2013||2013-09-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Laryngoscope Asssited Lightwand Intubation|Laryngoscope Assisted Lightwand Can Provide More Successful Intubation Than Lightwand Alone in Patients With Cervical Spine Injury : A Prospective Randomized Study|Unknown status|Recruiting|N/A|168|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:15:52.77405|2017-10-11 01:15:52.77405
NCT01950689|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-08-08|||May 2014||2014-05-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|November 2019|Anticipated|2019-11-01||Interventional|NIMRAD||NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)|A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)|Recruiting||Phase 3|470|Anticipated|The Christie NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:15:52.913371|2017-10-11 01:15:52.913371
NCT01950676|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-22|2016-01-07|||March 2013||2013-03-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Feasibility of Using a Smart Phone Application for Self-titration of Insulin on Glycemic Control in Patients With T2DM|Feasibility of Using a Smart Phone Application for Self-titration of Insulin on Glycemic Control in Patients With Type 2 Diabetes|Completed||N/A|66|Actual|National University, Singapore||2|||f||||f||||||||||2017-10-11 01:15:53.11797|2017-10-11 01:15:53.11797
NCT01950663|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-05-08|2017-03-28||September 2013||2013-09-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||RETeval Study for Diabetic Retinopathy|RETeval Calibration / Validation Study - Diabetic Retinopathy|Completed||N/A|468|Actual|Inoveon Corporation||1|||f||||f||||||||No||2017-10-11 01:15:53.224038|2017-10-11 01:15:53.224038
NCT01950650|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-04-25|||March 2010||2010-03-01|April 2017|2017-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus|GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus|Completed||N/A|1800|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-10-11 01:15:53.475965|2017-10-11 01:15:53.475965
NCT01950637|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-01-12|||January 2012||2012-01-01|January 2017|2017-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus|GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus|Completed||N/A|4000|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-10-11 01:15:53.593822|2017-10-11 01:15:53.593822
NCT01950624|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-06-30|||September 5, 2013||2013-09-05|May 9, 2017|2017-05-09|August 16, 2018|Anticipated|2018-08-16|August 16, 2018|Anticipated|2018-08-16||Observational|||DS-Connect {TM}: The Down Syndrome Registry|DS-Connect [TM]: The Down Syndrome Registry|Suspended||N/A|100000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:15:53.711769|2017-10-11 01:15:53.711769
NCT01950611|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-22|2013-09-24|||May 2013||2013-05-01|September 2013|2013-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PIAPL||Proteasome Inhibition in Acute Promyelocytic Leukemia|Phase II Study to Evaluate the Role of Bortezomib in the Management of Relapsed Acute Promyelocytic Leukemia|Recruiting||Phase 2|30|Anticipated|Christian Medical College, Vellore, India||1|||f||||t||||||||||2017-10-11 01:15:53.947455|2017-10-11 01:15:53.947455
NCT01950598|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-22|||September 2013||2013-09-01|September 2013|2013-09-01|January 2020|Anticipated|2020-01-01|November 2019|Anticipated|2019-11-01||Interventional|||Frozen Versus Fresh Corneal Carriers for the Boston KPro Type I Donor Carriers|Boston Keratoprosthesis Type 1 Surgery: Use of Frozen Versus Fresh Corneal Donor Carriers|Enrolling by invitation||Phase 4|37|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 01:15:54.047474|2017-10-11 01:15:54.047474
NCT01950585|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-06-30|||September 6, 2013||2013-09-06|October 23, 2014|2014-10-23|October 23, 2014|Actual|2014-10-23|October 23, 2014|Actual|2014-10-23||Interventional|||Hydroxyurea in Pulmonary Arterial Hypertension|Hydroxyurea in Pulmonary Arterial Hypertension|Withdrawn||Early Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:15:54.142078|2017-10-11 01:15:54.142078
NCT01950572|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-06-30|||September 5, 2013||2013-09-05|April 5, 2017|2017-04-05|July 11, 2034|Anticipated|2034-07-11|July 25, 2033|Anticipated|2033-07-25||Observational|||Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma|Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma and Other Mesothelin Expressing Cancers|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:15:54.217577|2017-10-11 01:15:54.217577
NCT01950559|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-09-01|||September 2013||2013-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|Monsanto||Evaluation of Potential Allergenicity of New Soybean Varieties|Evaluation of Potential Allergenicity of New Soybean Varieties|Recruiting||N/A|30|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"     Subjects may opt to have extra blood drawn. Ths sample will be de-identified and sent to the     sponsor, Monsanto, for future study that is yet to be determined.   "|||2017-10-11 01:15:54.300604|2017-10-11 01:15:54.300604
NCT01950546|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-06-08|||September 2014||2014-09-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|NSFCT||Nanosilver Fluoride to Prevent Dental Biofilms Growth|Nanosilver Fluoride: a Microbiological and Clinical Trial|Completed||Phase 1|30|Actual|University of Pernambuco||1|||f||||t||||||||||2017-10-11 01:15:54.390765|2017-10-11 01:15:54.390765
NCT01950533|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-03-27|||September 2013||2013-09-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Observational|IMMULITE 2000||The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy|The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy|Active, not recruiting||N/A|102|Actual|National Jewish Health|||3||f||||f||||||||||2017-10-11 01:15:54.497595|2017-10-11 01:15:54.497595
NCT01950520|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-10-03|||September 5, 2013||2013-09-05|September 26, 2017|2017-09-26|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Observational|||Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate|The Mechanism of Human Non-Shivering Thermogenesis and Basal Metabolic Rate|Recruiting||N/A|134|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:15:54.616558|2017-10-11 01:15:54.616558
NCT01950507|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-09-21|||August 31, 2013||2013-08-31|September 15, 2017|2017-09-15|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease|Evaluation of Serum Concentrations of Budesonide in Patients Treated for Gastrointestinal Graft-Versus-Host Disease and the Potential Interaction With Fluconazole or Voriconazole|Recruiting||Phase 1|21|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:15:54.717387|2017-10-11 01:15:54.717387
NCT01950494|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-01-03|||September 2013||2013-09-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|FiteBac||FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults|A One Month, Randomized, Two-center, Parallel-group, Double-blind,Placebo-controlled Study to Evaluate the Efficacy and Safety of FiteBac Hand Sanitizer TID vs Emollient Therapy in the Management of Hand Dermatitis in Adults|Completed||N/A|22|Actual|National Jewish Health||2|||f||||f||||||||||2017-10-11 01:15:54.81327|2017-10-11 01:15:54.81327
NCT01950481|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-12-12|||January 2014||2014-01-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Effect of Hepatic Impairment on LDK378 Pharmacokinetics|A Phase I, Open Label, Multi-center, Single Dose Study to Evaluate the Pharmacokinetics of LDK378 in Subjects With Hepatic Impairment Compared to Subjects With Normal Hepatic Function|Completed||Phase 1|36|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:15:54.911415|2017-10-11 01:15:54.911415
NCT01950468|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-09-12|||April 2017|Anticipated|2017-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes|Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes|Withdrawn||Phase 3|0|Actual|Navidea Biopharmaceuticals||2||The entire drug development program for this molecule was sold to another company.|f||||f|t|f||||||||2017-10-11 01:15:54.997403|2017-10-11 01:15:54.997403
NCT01950455|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-09-12|||November 2013||2013-11-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes|Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes|Terminated||Phase 3|13|Actual|Navidea Biopharmaceuticals||1||The entire drug development program for this molecule was sold to another company.|f||||f||||||||||2017-10-11 01:15:55.13178|2017-10-11 01:15:55.13178
NCT01950442|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-08-31|||October 2013||2013-10-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|June 2017|Actual|2017-06-01||Interventional|CT0046||Balloon Dilation to Permit Complete Endoscopic Ultrasound Staging in Esophageal Cancer|Balloon Dilation of Malignant Strictures to Permit Complete Endoscopic Ultrasound Staging in Esophageal Cancer|Completed||N/A|41|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 01:15:55.243229|2017-10-11 01:15:55.243229
NCT01950429|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-08-08|||August 27, 2013||2013-08-27|August 4, 2017|2017-08-04|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Observational|||Evaluation of Sickle Cell Liver Disease|Evaluation of Sickle Cell Liver Disease|Recruiting||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:15:55.342379|2017-10-11 01:15:55.342379
NCT01950416|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2015-08-19|||March 2013||2013-03-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis|Pharmacodynamic Assessment of Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Exhibiting High Platelet Reactivity Post Fibrinolysis|Completed||Phase 4|56|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 01:15:55.465803|2017-10-11 01:15:55.465803
NCT01950403|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-08-28|||September 2013||2013-09-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers|Phase I, Randomized, Placebo-Controlled Trial of Linaclotide to Demonstrate Colorectal Bioactivity in Healthy Volunteers|Active, not recruiting||Phase 1|18|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 01:15:55.590367|2017-10-11 01:15:55.590367
NCT01950377|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-08-01|||August 20, 2013||2013-08-20|July 28, 2017|2017-07-28|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Observational|||Imaging and Genetic Investigation of Learning and Decision Making|Imaging and Genetic Investigation of Learning and Decision Making|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:15:58.859446|2017-10-11 01:15:58.859446
NCT01950364|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-03-30|2015-10-30||November 2013||2013-11-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional||Safety population included all participants who received at least 1 dose of study drug.|A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma|A Phase 1 Study to Estimate MMAE Metabolites in Human Plasma and Urine in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma or Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Receiving Brentuximab Vedotin|Completed||Phase 1|20|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:15:59.201206|2017-10-11 01:15:59.201206
NCT01950351|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-06-28|||October 2013|Actual|2013-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Hypofractionated Proton Beam Therapy for Localized Prostate Cancer|Phase II Trial of Hypofractionated Proton Beam Therapy in Men With Localized Prostate Adenocarcinoma|Recruiting||Phase 2|200|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:16:02.692566|2017-10-11 01:16:02.692566
NCT01950338|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2013-10-28|||January 2013||2013-01-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Deep Dry Needling for the Management of Post-stroke Spasticity|CHANGES IN SPASTICITY, WIDESPREAD PRESSURE PAIN SENSITIVITY, AND BAROPODOMETRY AFTER DRY NEEDLING IN STROKE PATIENTS|Completed||N/A|34|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 01:16:02.799121|2017-10-11 01:16:02.799121
NCT01950325|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-06-30|||August 22, 2013||2013-08-22|August 20, 2015|2015-08-20|August 20, 2015|Actual|2015-08-20|August 20, 2015|Actual|2015-08-20||Interventional|||VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...|VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected Adults|Completed||Phase 1|27|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-11 01:16:02.88716|2017-10-11 01:16:02.88716
NCT01950312|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-02-02|||August 2013||2013-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease|An Open-label Study of the Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease|Completed||Phase 2|10|Anticipated|XOMA (US) LLC||1|||f||||t||||||||||2017-10-11 01:16:02.984686|2017-10-11 01:16:02.984686
NCT01950299|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-08-08|||July 1, 2014|Actual|2014-07-01|August 2017|2017-08-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|VCU-ART3||Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)|Interleukin-1 Blockade With Anakinra in Patients With ST-segment Elevation Myocardial Infarction - the Virginia Commonwealth University Anakinra Remodeling Trial 3|Recruiting||Phase 2/Phase 3|99|Anticipated|Virginia Commonwealth University||3|||f||||t|t|f||||||||2017-10-11 01:16:03.085891|2017-10-11 01:16:03.085891
NCT01950273|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-01-06|||September 2013||2013-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Lymphoma|A Randomized, Double-blind, Parallel-arm, Phase I Study to Evaluate the Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab (MabThera) Induction Immunotherapy as a First-line Treatment in Patients With Low Tumor Burden Follicular Lymphoma|Completed||Phase 1|||Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:16:03.329601|2017-10-11 01:16:03.329601
NCT01950260|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-05-13|||September 2013||2013-09-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Early Levothyroxine Post Radioactive Iodine|Prevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves' Disease|Active, not recruiting||Phase 2/Phase 3|60|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:16:03.694752|2017-10-11 01:16:03.694752
NCT01950247|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-09-07|||August 15, 2013|Actual|2013-08-15|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 20, 2016|Actual|2016-10-20||Interventional|||Trial to Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron and to Compare Safety, Effect on Quality of Life, and Resource Utilization of Injectafer vs Intravenous Standard of Care for the Treatment of IDA in an Infusion Center Setting|A Multi-Center, Randomized, Open Label Trial to Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron and Compare the Safety, Effect on Quality of Life, and Resource Utilization of Injectafer vs. Intravenous Iron Standard of Care for the Treatment of Iron Deficiency Anemia (IDA) in an Infusion Center Setting|Active, not recruiting||Phase 4|1000|Anticipated|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:16:03.811404|2017-10-11 01:16:03.811404
NCT01950234|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-12-07|||October 2013||2013-10-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||ACTH in Progressive Forms of MS|Treatment of Progressive Forms of Multiple Sclerosis With Pulsed ACTH (Acthar Gel)|Recruiting||Phase 2|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 01:16:03.918175|2017-10-11 01:16:03.918175
NCT01950221|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-06-14|||October 2011||2011-10-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Pomegranate Extract and Memory|12-Month, Double-blind, Placebo-Controlled Study of Pomegranate Extract|Completed||Phase 2|212|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:16:04.042417|2017-10-11 01:16:04.042417
NCT01950208|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-09-20|||August 2012||2012-08-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Observational|MKQ||The Munich Knee Questionnaire - Development and Validation|The Munich Knee Questionnaire (MKQ) - Development and Validation of a New Patient-reported Outcome Measurement Tool in Knee Surgery|Completed||N/A|105|Actual|Technische Universität München|||1||f||||f||||||||||2017-10-11 01:16:04.134635|2017-10-11 01:16:04.134635
NCT01950195|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-11-10|||September 2013||2013-09-01|November 2016|2016-11-01||||September 2016|Actual|2016-09-01||Interventional|||SRS (Stereotactic Radiosurgery) Plus Ipilimumab|A Pilot Study of Stereotactic Radiosurgery Combined With Ipilimumab in Patients With Newly Diagnosed Melanoma Metastases in the Brain and Spine|Terminated||Phase 1|4|Actual|Sidney Kimmel Comprehensive Cancer Center||2||Local IRB required us to submit amendment as a separate study.|f||||t||||||||||2017-10-11 01:16:04.235984|2017-10-11 01:16:04.235984
NCT01950182|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-12-19|||September 2013||2013-09-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SYSUCC-002||Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer|A Multicentre, Randomized Study of Trastuzumab Combined With Chemotherapy or Endocrine Therapy as the First Line Treatment for Patients With Metastatic Luminal B2 Breast Cancer Subtype|Recruiting||Phase 3|392|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Yes||2017-10-11 01:16:04.362914|2017-10-11 01:16:04.362914
NCT01950169|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2014-09-10|||December 2004||2004-12-01|September 2014|2014-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effects of Bisphosphonates and Nutritional Supplementation After a Hip Fracture|Effects of Bisphosphonates and Nutritional Supplementation After a Hip Fracture|Completed||N/A|79|Actual|Karolinska Institutet||3|||f||||t||||||||||2017-10-11 01:16:04.483848|2017-10-11 01:16:04.483848
NCT01949961|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-03-01|||January 2016|Actual|2016-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|NOR-SASS||The Norwegian Sonothrombolysis in Acute Stroke Study|Randomised Trial of Contrast-enhanced Sonothrombolysis in Acute Ischaemic Stroke|Recruiting||Phase 3|180|Anticipated|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 01:16:06.656514|2017-10-11 01:16:06.656514
NCT01950156|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-09-24|||September 2011||2011-09-01|September 2013|2013-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer|Phase I/II Study Using Epitope Peptide Restricted to HLA-A*24 (URLC10,CDCA1,KIF20A) in Patients With Disease Controlled Advanced Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 1/Phase 2|6|Anticipated|Shiga University||1|||f||||t||||||||||2017-10-11 01:16:04.630826|2017-10-11 01:16:04.630826
NCT01950143|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2017-08-16|||August 2013||2013-08-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|ESCAPE||Effect of Sulforaphane on Prostate CAncer PrEvention|A Human Dietary Intervention Study to Investigate the Effect of Sulforaphane on Prostate Cancer Interception|Active, not recruiting||N/A|78|Anticipated|Quadram Institute||3|||f||||f||||||||||2017-10-11 01:16:04.756771|2017-10-11 01:16:04.756771
NCT01950130|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-02-17|||June 2015||2015-06-01|February 2015|2015-02-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Prophylactic IABP in High-risk Patients Undergoing CABG|Prophylactic Preoperative Inatraaortic Balloon Pump (IABP) in High-risk Patients Undergoing Coronary Artery Bypass Surgery (CABG)|Not yet recruiting||N/A|200|Anticipated|University of Giessen||2|||f||||t||||||||||2017-10-11 01:16:04.894194|2017-10-11 01:16:04.894194
NCT01950117|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2014-11-02|||September 2013||2013-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Complete Removal of Neoplastic Large Colorectal Polyps: a Prospective Randomized Comparison of Endoscopic Mucosal Resection or Conventional Polypectomy||Completed||N/A|60|Actual|Showa Inan General Hospital||2|||f||||f||||||||||2017-10-11 01:16:05.017054|2017-10-11 01:16:05.017054
NCT01950104|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2016-08-04||||||August 2015|2015-08-01||||August 2016|Actual|2016-08-01||Interventional|VINCI||Day 3 Embryo Biopsy Versus Blastocyst Biopsy in PGS Cases|Comparative Study Between Day 3 Embryo Biopsy and Blastocyst Biopsy in Preimplantation Genetic Screening Cases|Withdrawn||N/A|0|Actual|IVI Sevilla||2||No started, lack of funding|f||||f||||||||||2017-10-11 01:16:05.110296|2017-10-11 01:16:05.110296
NCT01950091|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2013-10-21|||January 2013||2013-01-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|BackPain2||Internet App to Self-Manage Occasional Low Back Pain|Randomized Controlled Trial of Internet App to Self-Manage Occasional Low Back Pain|Completed||N/A|606|Actual|Oregon Center for Applied Science, Inc.||3|||f||||f||||||||||2017-10-11 01:16:05.214246|2017-10-11 01:16:05.214246
NCT01950078|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-23|2015-02-12|2015-01-30||August 2013||2013-08-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|||The Possible Correlations Between the Genes Related to Pain Sensation and the Pain Sensitivity in the General Population|The Possible Correlations Between the Genes Related to Pain Sensation and the Pain Sensitivity in the General Population|Completed||N/A|1533|Actual|Huazhong University of Science and Technology|||2||f||||t||||||Samples With DNA|"     Heparin anti-coagulated blood (5 ml) was collected from the periphery venous of subjects and     all blood samples were stored at -80℃. Genomic DNA was extracted from the blood samples using     a guanidinium isothiocyanate method.   "|||2017-10-11 01:16:05.31276|2017-10-11 01:16:05.31276
NCT01950065|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-03-23|||September 2013||2013-09-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles||Completed||N/A|85|Actual|MyoScience, Inc||2|||f||||||||||||||2017-10-11 01:16:05.58822|2017-10-11 01:16:05.58822
NCT01950052|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-06-08|||November 2012||2012-11-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Pre-operative Diet: Effect of Wound Healing After Bariatric Surgery|Randomised Controlled Trial to Study the Effects of Preoperative Very Low Calorie Diet on Wound Healing in Morbidly Obese Patients Undergoing Bariatric Surgery|Active, not recruiting||N/A|20|Actual|King's College Hospital NHS Trust||2|||f||||f||||||||Undecided||2017-10-11 01:16:05.686282|2017-10-11 01:16:05.686282
NCT01950039|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-01-05|||January 2014||2014-01-01|January 2017|2017-01-01||||October 2017|Anticipated|2017-10-01||Interventional|||Metabolic Effects of Betaine Supplementation|Bedside to Bench and Back: Cardiometabolic Effects of Betaine Supplementation|Active, not recruiting||Phase 2|30|Anticipated|Joslin Diabetes Center||2|||f||||f||||||||||2017-10-11 01:16:05.79191|2017-10-11 01:16:05.79191
NCT01950026|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-09-21|||January 2013||2013-01-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Temperature Skin Check After Cryotherapy Application|Temperature Skin Check in Different Ethnic Groups After Cryotherapy Application|Completed||Phase 3|24|Actual|Paulista University||4|||f||||f||||||||||2017-10-11 01:16:05.920734|2017-10-11 01:16:05.920734
NCT01950013|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-03-06|||July 2013||2013-07-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|Training||At-home Auditory Training Clinical Trial|At-home Auditory Training Clinical Trial|Completed||N/A|63|Actual|Indiana University||3|||f||||t||||||||||2017-10-11 01:16:06.024752|2017-10-11 01:16:06.024752
NCT01950000|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-27|||March 2011||2011-03-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Treatment of Procedural Pain Associated With Turning in Patients With Mechanical Ventilation|Efficacy and Safety of Opioid Analgesics as a Preventive Treatment of Procedural Pain Associated With Turning Among Critically Ill Patients Under Mechanical Ventilation. A Controlled Clinical Trial Comparing Placebo and Fentanyl|Completed||Phase 4|75|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 01:16:06.153556|2017-10-11 01:16:06.153556
NCT01949987|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-09-09|||October 2013||2013-10-01|September 2016|2016-09-01||||October 2014|Actual|2014-10-01||Interventional|||Does Oral Intake Decreases Postoperative Pain Score in Children|The Effect of Oral Intake on Pain Score in Children Undergoing Herniorrhaphy|Completed||N/A|80|Actual|Ibaraki Children's Hospital||2|||f||||t||||||||||2017-10-11 01:16:06.45522|2017-10-11 01:16:06.45522
NCT01949974|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2014-05-27|||June 2013||2013-06-01|August 2013|2013-08-01|June 2016|Anticipated|2016-06-01|June 2014|Anticipated|2014-06-01||Interventional|PAI||Integral Attention Program With or Without Palliative Chemotherapy in Advanced Cancer Patients|Integral Attention Program With or Without Palliative Chemotherapy in Advanced Cancer Patients: A Randomized Multicenter Clinical Trial|Withdrawn||Phase 4|0|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2||Dificulties in the recruitment of patients.|f||||f||||||||||2017-10-11 01:16:06.546453|2017-10-11 01:16:06.546453
NCT01949779|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-01-13|||November 2013||2013-11-01|October 2014|2014-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01|1 Day|Observational [Patient Registry]|||TransForm™ Occlusion Balloon Catheter Registry||Completed||N/A|81|Actual|Stryker Neurovascular|||1||f||||f||||||||||2017-10-11 01:16:08.68579|2017-10-11 01:16:08.68579
NCT01949948|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2017-05-05|||September 2012|Actual|2012-09-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|NOR-TEST||Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke|Randomised Trial of Tenecteplase vs. Alteplase for Recanalisation in Acute Ischemic Stroke|Completed||Phase 3|1050|Actual|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 01:16:06.817784|2017-10-11 01:16:06.817784
NCT01949935|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2013-09-20|||March 2009||2009-03-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MIR-CABG||Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting|MIR-CABG: A Randomized, Double-blind, Placebo-controlled, Single-Center Study to Evaluate the Impact of Mupirocin on Infection Rate Post Coronary Artery Bypass Grafting|Completed||Phase 3|974|Actual|Horizon Health Network||2|||f||||t||||||||||2017-10-11 01:16:06.964016|2017-10-11 01:16:06.964016
NCT01949922|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2016-02-18|||April 2013||2013-04-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Treatment of Fecal Incontinence by Injection of Autologous Muscle Fibers Into the Anal Sphincter|Treatment of Fecal Incontinence by Injection of Autologous Muscle Fibers Into the Anal Sphincter - a Pilot Study.|Recruiting||N/A|15|Anticipated|Herlev Hospital||1|||f||||f||||||||||2017-10-11 01:16:07.063099|2017-10-11 01:16:07.063099
NCT01949909|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-07-22|||March 2014||2014-03-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|P27A||Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ib|Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A With Alhydrogel® Or GLA-SE As Adjuvant: A Staggered, Antigen And Adjuvant Dose-Finding, Randomized, Multi-Centre Phase Ia/Ib Trial|Completed||Phase 1|56|Actual|Centre Hospitalier Universitaire Vaudois||3|||f||||t||||||||||2017-10-11 01:16:07.188925|2017-10-11 01:16:07.188925
NCT01949896|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-21|2016-03-10|||September 2013||2013-09-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Impact of Feeding on Pro-Inflammatory Cytokine Response in Neonates Receiving a RBC Transfusion|Impact of Feeding on Pro-Inflammatory Cytokine Response in Neonates Receiving a RBC Transfusion|Terminated||N/A|12|Actual|Christiana Care Health Services||2||Study is being closed due to insufficient patient population for enrollment.|f||||f||||||||||2017-10-11 01:16:07.375806|2017-10-11 01:16:07.375806
NCT01949883|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-11-22|||September 2013||2013-09-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma|A Phase 1 Study of CPI-0610, a Small Molecule Inhibitor of BET (Bromodomain and Extra-terminal) Proteins, in Patients With Progressive Lymphoma|Recruiting||Phase 1|102|Anticipated|Constellation Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:16:07.477548|2017-10-11 01:16:07.477548
NCT01949870|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-05-05|2015-08-19||October 2013||2013-10-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study|A Phase I, Open-Label, Multi-Center Study to Assess the Safety and Tolerability of Selumetinib (AZD6244, ARRY-142886) in Combination With Cisplatin/Gemcitabine in Japanese Patients With Inoperable Locally Advanced or Metastatic Biliary Tract Cancer (BTC)|Terminated||Phase 1|6|Actual|AstraZeneca|Dose escalation stopped after the first cohort due to changes in the drug development strategy. As such, a non-tolerated dose was not determined and the maximum tolerated dose could not be confirmed.|1||change in the development strategy|f||||f||||||||||2017-10-11 01:16:07.624473|2017-10-11 01:16:07.624473
NCT01949857|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-07-28|||September 2013||2013-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|HAV||The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines|Phase 4 Clinical Trial to Assess the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) and Live Attenuated HAV Vaccine|Completed||Phase 4|35000|Actual|Chinese Academy of Medical Sciences||4|||f||||t||||||||||2017-10-11 01:16:07.89723|2017-10-11 01:16:07.89723
NCT01949844|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-07-24|||May 2012||2012-05-01|July 2017|2017-07-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies|Artifact-Free High-resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies|Active, not recruiting||N/A|44|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-11 01:16:08.027307|2017-10-11 01:16:08.027307
NCT01949831|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2014-02-28|||October 2013||2013-10-01|February 2014|2014-02-01||||February 2014|Actual|2014-02-01||Interventional|||The Effect of Systematic Assessment of Functional Ability, Development of Rehabilitation Plan and Follow-up at Home for Elderly Medical Patients|The Effect of Systematic Assessment of Functional Ability, Development of Rehabilitation Plan and Follow-up at Home for Elderly Medical Patients|Terminated||N/A|52|Actual|Aarhus University Hospital||2||"Due to inclusion problems (not recruting enough participants) recruiting participants has   halted prematurely and will not resume."|f||||f||||||||||2017-10-11 01:16:08.147826|2017-10-11 01:16:08.147826
NCT01949818|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-12-28|||September 2012||2012-09-01|December 2015|2015-12-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Treatment of Diffuse Large B Cell Lymphoma|A Randomized, Controlled Mutiple-center Clinical Research on the Treatment With Yangzhengxiaoji Capsule Combination Chemotherapy for III/IV Diffuse Large B Cell Lymphoma|Recruiting||Phase 4|120|Anticipated|Zhengzhou University||2|||f||||t||||||||||2017-10-11 01:16:08.249883|2017-10-11 01:16:08.249883
NCT01949805|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-11-24|||September 2013||2013-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PROUD-PV||Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera|A Randomized, Open-label, Multicenter, Controlled, Parallel Arm, Phase III Study Assessing the Efficacy and Safety of AOP2014 vs. Hydroxyurea in Patients With Polycythemia Vera|Completed||Phase 3|257|Actual|AOP Orphan Pharmaceuticals AG||2|||f||||t||||||||No||2017-10-11 01:16:08.363871|2017-10-11 01:16:08.363871
NCT01949792|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2014-11-13|||September 2013||2013-09-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors|An Open-label Single- and Multiple-dose Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa Following i.v. Administration of One Dose of 270 Microg/kg and Three Doses of 90 Microg/kg in Patients With Haemophilia A or B With or Without Inhibitors|Completed||Phase 1|6|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:16:08.594934|2017-10-11 01:16:08.594934
NCT01949753|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-08-02|||September 2013||2013-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|P-EX||Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder|Influence of Pregnenolone on Distress and Autonomic Parameters During Cognitive-behavioral Exposure Therapy in Patients With Obsessive-compulsive Disorder|Recruiting||Phase 2|60|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 01:16:08.833392|2017-10-11 01:16:08.833392
NCT01949740|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-09-01|||June 2013||2013-06-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer|Patient Preferences in Head and Neck Cancer Treatment Decisions - a Pilot Study of the Durability of Patient Priorities|Terminated||N/A|37|Actual|University of Chicago|||1|Poor accrual|f||||f||||||||||2017-10-11 01:16:08.958079|2017-10-11 01:16:08.958079
NCT01949727|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-09-05|||October 2013||2013-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||Examining Vascular Outcomes in COPD Inpatients (AIM 1) Examining Early Rehabilitation on Discharged COPD Patients (AIM 2)|COPD Hospitalization:Examining Pulmonary and Cardiovascular Outcomes in Chronic Obstructive Pulmonary Disease Inpatients (AIM 1). COPD Rehabilitation:Examining the Impact of Early Pulmonary Rehabilitation on Discharged COPD Patients (AIM 2)|Recruiting||N/A|100|Anticipated|University of Alberta|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 01:16:09.078828|2017-10-11 01:16:09.078828
NCT01949714|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-10-26|||August 2013||2013-08-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue|Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue|Recruiting||N/A|15|Anticipated|University of Aarhus|||2||f||||t||||||Samples With DNA|"     Blood and adipose tissue samples   "|||2017-10-11 01:16:09.218451|2017-10-11 01:16:09.218451
NCT01949701|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2013-09-20|||August 2011||2011-08-01|September 2013|2013-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer|Phase I/II Study Using Epitope Peptide Restricted to HLA-A*24 (URLC10) in Patients With Disease Controlled Advanced Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 1/Phase 2|6|Anticipated|Shiga University||1|||f||||t||||||||||2017-10-11 01:16:09.313997|2017-10-11 01:16:09.313997
NCT01949688|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2013-09-20|||June 2010||2010-06-01|September 2013|2013-09-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors|Phase I/II Study Using Epitope Peptide Restricted to HLA-A*24 or HLA-A*02 in Patients With Advanced Solid Tumors That Are Refractory to Standard Therapy|Unknown status|Recruiting|Phase 1/Phase 2|26|Anticipated|Shiga University||2|||f||||t||||||||||2017-10-11 01:16:09.403976|2017-10-11 01:16:09.403976
NCT01949675|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-09-03|||March 2014||2014-03-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines|Safety and Immunogenicity of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines|Completed||Phase 4|336|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 01:16:09.486171|2017-10-11 01:16:09.486171
NCT01949662|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-03-28|||January 2014|Actual|2014-01-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer|A Preliminary Double-Blind Randomized Controlled Trial of Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer Admitted to a Palliative Care Unit|Active, not recruiting||Phase 2|93|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:16:09.595492|2017-10-11 01:16:09.595492
NCT01949623|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-08-14|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|June 2017|Actual|2017-06-01||Observational|BIRP||Biomarkers In Retinitis Pigmentosa (BIRP)|Biomarkers In Retinitis Pigmentosa (BIRP)|Completed||N/A|100|Actual|Johns Hopkins University|||2||f||||f||||||Samples Without DNA|"     Anterior Chamber fluid from the eye   "|||2017-10-11 01:16:09.897189|2017-10-11 01:16:09.897189
NCT01949610|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2013-10-04|||January 2010||2010-01-01|October 2013|2013-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male Participants|Absorption, Metabolism, and Excretion of 14C-JNJ26489112 After a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|10|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 01:16:09.97993|2017-10-11 01:16:09.97993
NCT01949597|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-04-26|||December 2016||2016-12-01|April 2016|2016-04-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Recurrences After Surgery for Deep Endometriosis Depending on the Involvement of the Surgical Margins in the Specimen|Recurrences After Surgery for Deep Endometriosis Depending on the Involvement of the Surgical Margins in the Specimen|Not yet recruiting||N/A|120|Anticipated|Institut Universitari Dexeus|||1||f||||f||||||Samples With DNA|"     tissue   "|||2017-10-11 01:16:10.075079|2017-10-11 01:16:10.075079
NCT01949584|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-03-23|||August 2013||2013-08-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|SNORE||Study of Nasal Airflow Pressure Optimization to Resolve Excessive Snoring|Study of Nasal Airflow Pressure Optimization to Resolve Excessive Snoring|Completed||N/A|26|Actual|inSleep Technologies, LLC||1|||f||||t||||||||||2017-10-11 01:16:10.167707|2017-10-11 01:16:10.167707
NCT01931709|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-05-16|2017-03-24||November 2011||2011-11-01|May 2017|2017-05-01||||February 2016|Actual|2016-02-01||Interventional|||FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer|Quantitative Dynamic PET and MRI and Breast Cancer Therapy|Active, not recruiting||N/A|35|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 01:21:22.700793|2017-10-11 01:21:22.700793
NCT01949558|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-09-15|||December 2012||2012-12-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|LIV||Randomized Controlled Trial of Lifestyle Intervention Postpartum in Primary Health Care|From Efficacy to Effectiveness: Randomized Controlled Trial of Lifestyle Intervention Postpartum Among Overweight and Obese Women Within Primary Health Care in the Vastra Gotaland Region|Completed||N/A|110|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 01:16:10.324533|2017-10-11 01:16:10.324533
NCT01949545|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-04-28|2016-08-25||October 2013||2013-10-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment|An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment|Completed||Phase 1|46|Actual|Amgen||4|||f||||f||||||||||2017-10-11 01:16:10.673928|2017-10-11 01:16:10.673928
NCT01949532|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-04-28|2016-03-31||January 2014||2014-01-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|April 2015|Actual|2015-04-01||Interventional|||Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease|An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Relapsed Multiple Myeloma and End-stage Renal Disease|Completed||Phase 1|26|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:16:13.595582|2017-10-11 01:16:13.595582
NCT01949519|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-10-18|||November 2013||2013-11-01|October 2016|2016-10-01||||June 2015|Actual|2015-06-01||Interventional|||Docetaxel and Lycopene in Metastatic Prostate Cancer|A Phase I Study of Docetaxel Plus Synthetic Lycopene in Metastatic Prostate Cancer Patients With Biochemical or Clinical Relapse|Active, not recruiting||Phase 1|24|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 01:16:15.441667|2017-10-11 01:16:15.441667
NCT01949506|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-03-01|||September 2013||2013-09-01|March 2017|2017-03-01|October 2025|Anticipated|2025-10-01|October 2020|Anticipated|2020-10-01||Interventional|||(SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas|Pilot Study Evaluating Stereotactic Body Radiation Therapy (SBRT) and Adaptive Radiation Therapy (ART) for Pulmonary Metastases From Soft Tissue Sarcomas|Recruiting||N/A|20|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||Undecided||2017-10-11 01:16:15.550245|2017-10-11 01:16:15.550245
NCT01949493|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-12-08|||October 2013||2013-10-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MT-CTS||Non-surgical Treatment of Carpal Tunnel Syndrome by Means of Mechanical Traction|Study of the Effectiveness of Mechanical Traction as a Non-Surgical Treatment for Carpal Tunnel Syndrome Compared to Care as Usual: a Randomized Controlled Trial|Completed||N/A|181|Actual|University of Tilburg||2|||f||||f||||||||No||2017-10-11 01:16:15.648429|2017-10-11 01:16:15.648429
NCT01949467|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-05-29|||February 10, 2014|Actual|2014-02-10|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|April 10, 2019|Anticipated|2019-04-10||Interventional|||Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.|Prospective, Comparative (5 Groups), Non-randomized, Multicenter, Physiopathological Study, Evaluating Pharmacokinetic Characteristics of Serum Hepcidin Level in Response to Iron Oral Intake in Order to Evaluate Their Interest to Discriminate Patients With Dysmetabolic Hepatosiderosis or Ferroportin Disease.|Recruiting||Phase 2|100|Anticipated|Rennes University Hospital||5|||f||||f||||||||||2017-10-11 01:16:15.868057|2017-10-11 01:16:15.868057
NCT01949454|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-04-20|||November 2013||2013-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Fluorometholone as Ancillary Therapy for TT Surgery|Fluorometholone 0.1% as Perioperative Adjunct Therapy for Lid-rotation Surgery in Trachomatous Entropion and Trichiasis, Dose-varying Study|Completed||N/A|154|Actual|University of Pennsylvania||6|||f||||t||||||||||2017-10-11 01:16:15.992679|2017-10-11 01:16:15.992679
NCT01949441|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2014-06-10|||September 2013||2013-09-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||ToleroMune House Dust Mite (HDM) Tolerability Study|A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Parallel-Group Study to Assess the Tolerability of ToleroMune House Dust Mite in Subjects With Controlled Asthma and House Dust Mite-Induced Rhinoconjunctivitis|Completed||Phase 2|30|Actual|Circassia Limited||2|||f||||f||||||||||2017-10-11 01:16:17.836091|2017-10-11 01:16:17.836091
NCT01949428|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2014-05-14|||September 2013||2013-09-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||House Dust Mite Observational Study|A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis|Completed||N/A|100|Actual|Circassia Limited|||1||f||||f||||||||||2017-10-11 01:16:17.921867|2017-10-11 01:16:17.921867
NCT01949415|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2014-05-20|||September 2013||2013-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||An Optional Investigation of Biomarkers of Efficacy|An Optional Investigation of Biomarkers of Efficacy in TH002 Clinical Study Subjects.|Completed||N/A|105|Anticipated|Circassia Limited|||1||f||||f||||||||||2017-10-11 01:16:17.983305|2017-10-11 01:16:17.983305
NCT01949402|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-05-15|||February 2014||2014-02-01|May 2017|2017-05-01|July 31, 2016|Actual|2016-07-31|July 31, 2016|Actual|2016-07-31|1 Day|Observational [Patient Registry]|||A New Way of Looking at Your Lungs|Thoracic Ultrasonography in the Assessment of Extravascular Lung Water & Respiratory Failure|Completed||N/A|86|Actual|University of Oxford|||4||f||||f||||||||||2017-10-11 01:16:18.041044|2017-10-11 01:16:18.041044
NCT01949389|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2015-12-11|2014-12-15||October 2012||2012-10-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Veterans recieving care at the VA Connecticut out patient Substance Use Disorders Clinic|Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders|Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders|Completed||N/A|51|Actual|VA Connecticut Healthcare System||1|||f||||f||||||||||2017-10-11 01:16:18.138676|2017-10-11 01:16:18.138676
NCT01949376|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-03-27|||June 2013||2013-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|HippoPCI||Mild Cognitive Impairment in Breast Cancer Patients|Hippocampal Predictors of Cognitive Impairment (HippoPCI) in Breast Cancer Patients|Recruiting||N/A|120|Anticipated|Northwestern University|||5||f||||f|f|f||||||No||2017-10-11 01:16:18.298683|2017-10-11 01:16:18.298683
NCT01949363|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-03-26|||December 2013||2013-12-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study|The Pharmacokinetics of Extended Duration High-Dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study|Completed||Phase 1|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 01:16:18.423368|2017-10-11 01:16:18.423368
NCT01949350|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2015-10-07|||February 2014||2014-02-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Hypohydration and Cardiorespiratory Function|Clinical Observational Study of the Effect of Hypohydration Upon Cardiorespiratory Function|Completed||N/A|26|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||3|||f||||f||||||||||2017-10-11 01:16:18.523984|2017-10-11 01:16:18.523984
NCT01949337|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-03-06|||January 2014||2014-01-01|March 2017|2017-03-01||||December 2019|Anticipated|2019-12-01||Interventional|||Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer|Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer|Active, not recruiting||Phase 3|1311|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 01:16:18.933119|2017-10-11 01:16:18.933119
NCT01949324|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-06-26|||April 2014||2014-04-01|June 2017|2017-06-01|May 22, 2017|Actual|2017-05-22|April 14, 2017|Actual|2017-04-14||Interventional|||A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel|A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)|Completed||Phase 2|67|Actual|Neurotech Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:16:20.633398|2017-10-11 01:16:20.633398
NCT01949311|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2017-02-07|||October 2013||2013-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis|An Open-label Study of Dupilumab in Patients With Atopic Dermatitis Who Participated in Previous Dupilumab Clinical Trials|Enrolling by invitation||Phase 3|2000|Anticipated|Regeneron Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:16:20.85092|2017-10-11 01:16:20.85092
NCT01949298|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-12-01|||July 2010||2010-07-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|January 2014|Actual|2014-01-01||Interventional|||Immediate vs Delayed Loading of Two Implants Supporting a Mandibular Over Denture|Immediate vs Delayed Loading of Two Implants Supporting a Locator Retained Mandibular Overdenture - A Randomized Controlled Study|Completed||N/A|36|Actual|UConn Health||2|||f||||f||||||||||2017-10-11 01:16:21.836834|2017-10-11 01:16:21.836834
NCT01949285|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-01-20|||June 2015||2015-06-01|April 2016|2016-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Transcutaneous Electrical Spinal Cord Stimulation for Lower Limbs|A Theranostic Tool to Assess and Enable Spared Spinal Motor Function After SCI|Completed||N/A|10|Actual|NeuroEnabling Technologies, Inc.||2|||f||||f||||||||||2017-10-11 01:16:21.939216|2017-10-11 01:16:21.939216
NCT01949272|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-06-24|||September 2013||2013-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|OPERA||Optimization of PEEP for Alveolar Recruitment in ARDS|Optimization of PEEP for Alveolar Recruitment in ARDS|Completed||N/A|22|Actual|Hopital of Melun|||1||f||||t||||||||||2017-10-11 01:16:22.052785|2017-10-11 01:16:22.052785
NCT01949259|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-09-29|||September 2013||2013-09-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Rapid Learning for Lung Cancer|Rapid Learning in Practice: A Lung Cancer Survival Decision Support System in Routine Patient Care Data|Completed||N/A|10000|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-11 01:16:22.145142|2017-10-11 01:16:22.145142
NCT01949246|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-01-29|||September 2007||2007-09-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|BIOCRT||Biomarkers to Predict CRT Response in Patients With HF (BIOCRT)|Analysis of Circulating Biomarkers in Predicting Response to Cardiac Resynchronization Therapy (CRT) With Biventricular Pacing in Patients With Congestive Heart Failure (BIOCRT)|Unknown status|Recruiting|N/A|496|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 01:16:22.258028|2017-10-11 01:16:22.258028
NCT01949233|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2015-06-08|||October 2013||2013-10-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|October 2015|Anticipated|2015-10-01||Interventional|||The Oxford Marfan Trial|A Randomised, Double-blind, Placebo-controlled Pilot Trial of Irbesartan, Doxycycline and a Combination on Markers of Vascular Dysfunction in the Marfan Syndrome, Using Cardiovascular Magnetic Resonance Imaging|Recruiting||Phase 2|56|Anticipated|University of Oxford||4|||f||||f||||||||||2017-10-11 01:16:22.360046|2017-10-11 01:16:22.360046
NCT01949220|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-08-23|||March 2014||2014-03-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Willebrand International Non-interventional Global Surveillance|International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.|Recruiting||N/A|80|Anticipated|Laboratoire français de Fractionnement et de Biotechnologies|||1||f||||f||||||||||2017-10-11 01:16:22.484299|2017-10-11 01:16:22.484299
NCT01949207|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-05-16|||July 2014||2014-07-01|May 2014|2014-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||RCT - Does Treating Incompetent Perforators Reduce Recurrence?|Randomised Controlled Study to Determine Whether Treating Incompetent Perforating Veins at the Time of Endothermal Varicose Vein Surgery for Truncal Reflux Reduces Recurrence After Varicose Vein Treatments.|Not yet recruiting||N/A|190|Anticipated|The Whiteley Clinic||2|||f||||t||||||||||2017-10-11 01:16:22.640389|2017-10-11 01:16:22.640389
NCT01949194|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-08-16|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers|A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients With Metastatic Colorectal Cancer Who Have Failed First-line Therapy|Recruiting||Phase 2|52|Anticipated|Jewish General Hospital||1|||f||||f||||||||||2017-10-11 01:16:22.745839|2017-10-11 01:16:22.745839
NCT01949181|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-05-02|||August 2011||2011-08-01|May 2016|2016-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Métaux/Poumons||Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease|Relationship Between Blood, Hair and Lung Metals/Metalloids Concentration (Cadmium, Iron, Copper, Nickel, Chrome, Arsenic, Vanadium, Beryllium, and Zinc) and Lung Cancer or Chronic Obstructive Pulmonary Disease.|Completed||N/A|251|Actual|Hopital Foch||1|||f||||||||||||||2017-10-11 01:16:22.901218|2017-10-11 01:16:22.901218
NCT01949168|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-19|||September 2013||2013-09-01|September 2013|2013-09-01||||September 2015|Anticipated|2015-09-01||Interventional|HCV-6||A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV|Phase 2a Study of Boceprevir for the Treatment of Genotype 6 Hepatitis C|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|St Vincent's Hospital Melbourne||3|||f||||f||||||||||2017-10-11 01:16:22.989771|2017-10-11 01:16:22.989771
NCT01949155|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-09-23|2016-01-27|2015-08-17|November 2013||2013-11-01|September 2016|2016-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||The reporting group includes all randomized participants.|OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement|Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, P3 Study of OTO-201 Given as a Single IT Injection For Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement|Completed||Phase 3|266|Actual|Otonomy, Inc.||2|||f||||f||||||||||2017-10-11 01:16:23.254262|2017-10-11 01:16:23.254262
NCT01949142|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2016-05-09|2016-01-27|2015-08-17|November 2013||2013-11-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional||The reporting group includes all randomized participants.|OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement|Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, P3 Study of OTO-201 Given as a Single IT Injection For Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement|Completed||Phase 3|266|Actual|Otonomy, Inc.||2|||f||||f||||||||||2017-10-11 01:16:23.668689|2017-10-11 01:16:23.668689
NCT01949129|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-02-15|||April 2013||2013-04-01|February 2016|2016-02-01|April 2023|Anticipated|2023-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia|Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia|Recruiting||Phase 2/Phase 3|1000|Anticipated|St. Anna Kinderkrebsforschung||3|||f||||t||||||||||2017-10-11 01:16:24.029513|2017-10-11 01:16:24.029513
NCT01949116|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-04-27|||December 2013||2013-12-01|April 2017|2017-04-01|December 8, 2016|Actual|2016-12-08|December 8, 2016|Actual|2016-12-08||Interventional|||Evaluating Safety and Effectiveness of Low-Dose Methotrexate at Reducing Inflammation in HIV-Infected Adults Taking Antiretroviral Medications|Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection|Completed||Phase 2|176|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 01:16:24.728415|2017-10-11 01:16:24.728415
NCT01949103|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2014-09-03|||October 2013||2013-10-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||TD-1607 MAD Study in Healthy Subjects|A Randomized, Double−Blind, Placebo−Controlled, Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TD−1607, a Glycopeptide−Cephalosporin Heterodimer Antibiotic, in Healthy Subjects|Completed||Phase 1|48|Actual|Theravance Biopharma Antibiotics, Inc.||6|||f||||f||||||||||2017-10-11 01:16:24.878941|2017-10-11 01:16:24.878941
NCT01949077|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-06-10|||December 2011||2011-12-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.|Evaluation of Serum Chemokines for Patients Undergoing Treatment With Boceprevir.|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples Without DNA|"     Serum and tissue collected through the UNC Liver Center serum and tissue bank.   "|||2017-10-11 01:16:25.117919|2017-10-11 01:16:25.117919
NCT01949064|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2014-12-02|||July 2011||2011-07-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Use of Electromyography With Bio-Feedback for the Treatment of Craniomandibular Disorders|Anwendung Von Elektromyographie Mit Gleichzeitigem Bio-Feedback Zur Behandlung Von Craniomandibulären Dysfunktionen Und/Oder Bruxismus.|Completed||Phase 2|44|Actual|Heidelberg University||2|||f||||t||||||||||2017-10-11 01:16:25.203496|2017-10-11 01:16:25.203496
NCT01949051|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-05-09|2014-09-18||October 1, 2013|Actual|2013-10-01|May 2017|2017-05-01|February 4, 2014|Actual|2014-02-04|February 4, 2014|Actual|2014-02-04||Interventional|||A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis|A Randomized, Double-blind, Placebo Controlled, 3 Way Cross Over Study in Subjects With Allergic Rhinitis to Assess the Effect of Intranasal Repeat Doses of Levocabastine When Administered Once Daily or Twice Daily on the Symptoms of Rhinitis in an Allergen Challenge Chamber|Completed||Phase 2|78|Actual|GlaxoSmithKline||1|||f||||f|f|f||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:16:25.31644|2017-10-11 01:16:25.31644
NCT01949038|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-10-16|||September 2011||2011-09-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy|Comparison Between Sublingual and Oral Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy|Completed||Phase 2/Phase 3|220|Actual|Isfahan University of Medical Sciences||4|||f||||f||||||||||2017-10-11 01:16:25.778156|2017-10-11 01:16:25.778156
NCT01949025|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-04-24|||October 2013||2013-10-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|September 2015|Actual|2015-09-01||Interventional|ALARM||Prevention of Serious Adverse Events in Acute Care Hospitals by Afferent Limb and Response Method Intervention - the ALARM Intervention Study.|Prevention of Serious Adverse Events in Acute Care Hospitals by Afferent Limb and Response Method Intervention - the ALARM Intervention Study.|Completed||N/A|69656|Actual|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-11 01:16:25.862082|2017-10-11 01:16:25.862082
NCT01949012|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-06-01|||October 2013||2013-10-01|May 2015|2015-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Capnography Monitoring During Intravenous Conscious Sedation Sedation With Midazolam for Oral Surgery|A Randomised Control Trial to Determine Whether Intervention Based on a Microstream Capnography-based Ventilation Monitoring System Will Decrease Hypoxaemaia During Intravenous Sedation With Midazolam.|Completed||N/A|190|Actual|University College Cork||2|||f||||t||||||||||2017-10-11 01:16:25.971872|2017-10-11 01:16:25.971872
NCT01948999|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-12-19|||December 2013||2013-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Electroconvulsive Therapy for Treatment Refractory Schizophrenia - A Randomized, Double-blinded, Sham-controlled Study|Electroconvulsive Therapy for Treatment Refractory Schizophrenia - A Randomized, Double-blinded, Sham-controlled Study|Terminated||N/A|3|Actual|University of Aarhus||2||Missing ressources. The study official has left and will not be replaced|f||||f||||||||No||2017-10-11 01:16:26.14047|2017-10-11 01:16:26.14047
NCT01948986|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-20|2015-10-30|||October 2013||2013-10-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)|A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|36|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-11 01:16:26.295201|2017-10-11 01:16:26.295201
NCT01948973|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-04-28|||September 2013||2013-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Subsensory Sacral Nerve Stimulation for Irritable Bowel Syndrome|A Randomised, Controlled Crossover Study of Subsensory Sacral Nerve Stimulation for Irritable Bowel Syndrome|Recruiting||N/A|24|Anticipated|University of Aarhus||2|||f||||t||||||||Undecided||2017-10-11 01:16:26.385729|2017-10-11 01:16:26.385729
NCT01948960|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-09-28|||August 2013||2013-08-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|October 1, 2017|Anticipated|2017-10-01||Interventional|INPRES||Influence of Exceptional Patient Characteristics on Everolimus Exposure|Influence of Exceptional Patient Characteristics on Everolimus Exposure|Recruiting||Phase 4|50|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 01:16:26.496392|2017-10-11 01:16:26.496392
NCT01948947|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-10-05|||May 2014||2014-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Improving Functions in MTBI Patients With Headache by rTMS|Improving Functions in MTBI Patients With Headache by rTMS|Completed||N/A|52|Anticipated|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 01:16:26.61966|2017-10-11 01:16:26.61966
NCT01948934|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-03-24|||June 2012||2012-06-01|March 2017|2017-03-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds|Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds|Completed||Phase 1|6|Actual|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||1|||f||||t||||||||||2017-10-11 01:16:26.71947|2017-10-11 01:16:26.71947
NCT01948921|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-03-16|||September 2013||2013-09-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Meperidine for Patients Expected to Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy.|Meperidine as the Single Sedative Agent for Patients Expected to Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy.|Completed||N/A|110|Actual|Dalin Tzu Chi General Hospital||2|||f||||t||||||||||2017-10-11 01:16:26.826743|2017-10-11 01:16:26.826743
NCT01948908|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2016-04-04|2016-03-05||June 2013||2013-06-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Volumes of Administration for Intranasal Midazolam|Optimal Volumes of Administration for Intranasal Midazolam in Children|Completed||Phase 2|99|Actual|Columbia University||3|||f||||t||||||||||2017-10-11 01:16:26.943069|2017-10-11 01:16:26.943069
NCT01948895|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-11-06|||August 2012||2012-08-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Desvenlafaxine Monotherapy in Dysthymia|An 8-week Open-Label Flexible-Dose Study Of Desvenlafaxine as Monotherapy In The Treatment Of Dysthymia|Completed||N/A|30|Actual|Centre for Addiction and Mental Health||1|||f||||t||||||||||2017-10-11 01:16:27.562493|2017-10-11 01:16:27.562493
NCT01948882|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-10-11|||September 2013||2013-09-01|October 2016|2016-10-01|December 2024|Anticipated|2024-12-01|September 2015|Actual|2015-09-01||Interventional|||Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women|A Multi-Center, Multi-National Clinical Study to Evaluate the Safety and Effectiveness of the Essure® (Model ESS505) Device to Prevent Pregnancy in Women Who Are Seeking Permanent Contraception|Active, not recruiting||N/A|612|Actual|Bayer||1|||f||||t||||||||||2017-10-11 01:16:27.716444|2017-10-11 01:16:27.716444
NCT01948869|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2014-08-06|||October 2013||2013-10-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|Phoenix II||Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis|An Investigator-blinded, Randomized, Monocentre, 3-arm, Pilot Trial to Compare the Efficacy and Safety of Two Topical Medical Devices in Patients With Mild to Moderate Atopic Dermatitis in an Intra-individual Comparison With Untreated Skin|Completed||N/A|35|Actual|Bayer||3|||f||||f||||||||||2017-10-11 01:16:27.885222|2017-10-11 01:16:27.885222
NCT01948856|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-02-02|||September 2013||2013-09-01|February 2017|2017-02-01|December 13, 2016|Actual|2016-12-13|October 17, 2016|Actual|2016-10-17||Interventional|||CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study||Completed||Phase 3|1003|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 01:16:28.012188|2017-10-11 01:16:28.012188
NCT01948843|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-04-13|||April 2014||2014-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast Cancer|Phase 1 Trial of ADI-PEG 20 Plus Doxorubicin in Patients With HER2 Negative Metastatic Breast Cancer or Advanced Solid Tumor|Completed||Phase 1|15|Actual|Polaris Group||1|||f||||f||||||||||2017-10-11 01:16:28.166679|2017-10-11 01:16:28.166679
NCT01948830|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-03-16|2016-10-19||December 17, 2013|Actual|2013-12-17|March 2017|2017-03-01|November 19, 2015|Actual|2015-11-19|November 19, 2015|Actual|2015-11-19||Interventional|TREND||Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD|A 12-month, Phase 3b, Randomized, Visual Acuity Assessor-masked, Multicenter Study Assessing the Efficacy and Safety of Ranibizumab 0.5mg in Treat and Extend Regimen Compared to Monthly Regimen, in Patients With Neovascular Age-related Macular Degeneration|Completed||Phase 3|650|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:16:28.302712|2017-10-11 01:16:28.302712
NCT01948817|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2017-04-19|||February 2014||2014-02-01|January 2014|2014-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses|A Prospective Single Arm Study to Assess the Efficacy and Safety of Deferasirox 20 mg/kg BID in Transfusion Dependent Thalassemia Patients Inadequately Responding to Current Treatment With Doses > 35mg/kg QD (Once a Day).|Withdrawn||Phase 2|0|Actual|Novartis||1|||f||||f||||||||||2017-10-11 01:16:30.218956|2017-10-11 01:16:30.218956
NCT01948804|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2014-01-14|||January 2014||2014-01-01|January 2014|2014-01-01||||March 2014|Anticipated|2014-03-01||Interventional|||The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization.|The Comparison of Effect of Four Different Treatment Protocols: Antagonist/Letrozole Protocol, Microdose Flare-up Protocol, Antagonist/Clomiphene Protocol, Antagonist on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization; a Prospective Randomized-controlled Study.|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Yeditepe University Hospital||1|||f||||t||||||||||2017-10-11 01:16:30.374077|2017-10-11 01:16:30.374077
NCT01948791|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-19|2016-12-20|2016-09-27||August 2014||2014-08-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|INSTINCT|Subjects who received at least one treatment, and had at least one post-baseline assessment on primary efficacy variables.|16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients|16 Weeks Interventional Study on Titration and Dose/Efficacy Assessment of Exelon (Rivastigmine) in Chinese Alzheimer's Disease Patients (INSTINCT)|Completed||Phase 4|222|Actual|Novartis|Of the total recruited subjects, 181 subjects received at least one drug treatment and there were post-baseline safety assessment. They were incorporated into the safety population.|1|||f||||f||||||||||2017-10-11 01:16:30.458805|2017-10-11 01:16:30.458805
NCT01948778|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2015-02-24|||August 2013||2013-08-01|February 2015|2015-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||The Effects of a Polyethyleneimine-coated Membrane (oXiris™) for Hemofiltration Versus Polymyxin B- Immobilized Fibre Column (Toraymyxin™) for Hemoperfusion on Endotoxin Activity and Inflammatory Conditions in Septic Shock- A Randomized Controlled Pilot Study (ENDoX-study)|The Effects of a Polyethyleneimine-coated Membrane (oXiris™) for Hemofiltration Versus Polymyxin B- Immobilized Fibre Column (Toraymyxin™) for Hemoperfusion on Endotoxin Activity and Inflammatory Conditions in Septic Shock- A Randomized Controlled Pilot Study|Unknown status|Recruiting|N/A|30|Anticipated|University of Zurich||3|||f||||||||||||||2017-10-11 01:16:30.770391|2017-10-11 01:16:30.770391
NCT01948765|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-04-16|||June 2013||2013-06-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Xenon as an Adjuvant to Propofol Anaesthesia in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery.|Xenon as an Adjuvant to Propofol Anaesthesia in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery:a Randomised Controlled Trial|Completed||Phase 2|50|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 01:16:30.85121|2017-10-11 01:16:30.85121
NCT01948752|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-09-18|||November 2010||2010-11-01|September 2013|2013-09-01||||June 2011|Actual|2011-06-01||Interventional|||Clinical Trial of Menu Labeling||Completed||N/A|661|Actual|University of Waterloo||4|||f||||f||||||||||2017-10-11 01:16:30.949983|2017-10-11 01:16:30.949983
NCT01948739|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-05-08|||September 2013||2013-09-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Brain Machine Interface Control of an Robotic Exoskeleton in Training Upper Extremity Functions in Stroke|NRI:BMI Control of a Therapeutic Exoskeleton|Recruiting||N/A|30|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f||||||||||2017-10-11 01:16:31.048155|2017-10-11 01:16:31.048155
NCT01948726|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-12-09|||December 2013||2013-12-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer|Multicenter Phase-II-Trial of Evaluation of Acute Toxicity in Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer|Completed||Phase 2|150|Actual|University of Schleswig-Holstein||1|||f||||f||||||||||2017-10-11 01:16:31.191043|2017-10-11 01:16:31.191043
NCT01948713|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-04-04|||January 7, 2013|Actual|2013-01-07|March 2017|2017-03-01|January 8, 2015|Actual|2015-01-08|September 18, 2014|Actual|2014-09-18||Interventional|||Effect of Pelvic Floor and Hip Muscle Strengthening in the Treatment of Stress Urinary Incontinence|Effect of Pelvic Floor and Hip Muscle Strengthening in the Treatment of Stress Urinary Incontinence: Randomized Blind Clinical Trial|Completed||N/A|43|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||No||2017-10-11 01:16:31.310758|2017-10-11 01:16:31.310758
NCT01948700|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-12-11|||October 2009||2009-10-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|AMICA||Assessing the Fit of Motivational Interviewing by Cultures With Adolescents|AMICA: Assessing the Fit of Motivational Interviewing by Cultures With Adolescents|Completed||N/A|506|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-11 01:16:31.405121|2017-10-11 01:16:31.405121
NCT01948687|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-18|||August 2013||2013-08-01|September 2013|2013-09-01|November 2014|Anticipated|2014-11-01|March 2014|Anticipated|2014-03-01||Observational|RT-ELASTO||Real Time Elastography in Liver Fibrosis|The Role of Real Time Elastography in the Noninvasive Assessment of Liver Fibrosis in Chronic Viral Hepatitis|Unknown status|Recruiting|N/A|500|Anticipated|University of Medicine and Pharmacy Craiova|||3||f||||t||||||||||2017-10-11 01:16:31.503337|2017-10-11 01:16:31.503337
NCT01948674|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-08-22|||October 2013||2013-10-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Cognitive Stimulation in Adolescents|Cognitive Training in Adolescents During Treatment for Substance Use Disorders|Completed||Phase 2|87|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:16:31.621138|2017-10-11 01:16:31.621138
NCT01948661|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-10-02|||March 2014||2014-03-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|MIRACOL||Anthocyanin Extract and Phospholipid Curcumin in Colorectal Adenoma|Randomized Window of Opportunity Trial of Anthocyanin Extract and Phospholipid Curcumin in Subjects With Colorectal Adenoma|Recruiting||N/A|100|Anticipated|Ente Ospedaliero Ospedali Galliera||2|||f||||t||||||||||2017-10-11 01:16:31.740835|2017-10-11 01:16:31.740835
NCT01948648|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-08-30|||October 2016||2016-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Fish Oil and Colesevelam|Effects of Fish Oil, Colesevelam and Combination Therapy on Sterol Metabolism in Sitosterolemia|Not yet recruiting||N/A|16|Anticipated|University of Manitoba||3|||f||||t||||||||||2017-10-11 01:16:31.893478|2017-10-11 01:16:31.893478
NCT01948635|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-31|2015-12-01|||April 2014||2014-04-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|BestCuff||Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care Units|Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care Units|Completed||Phase 4|326|Actual|University Hospital, Lille||2|||f||||f||||||||||2017-10-11 01:16:32.051147|2017-10-11 01:16:32.051147
NCT01948622|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-18|||January 2012||2012-01-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|||Anxiety Control by Erythrina Mulungu|Anxiety Control by Using Erythrina Mulungu in Mandibular Third Molars Extraction|Completed||Phase 1/Phase 2|30|Actual|Universidade Federal de Sergipe||2|||f||||f||||||||||2017-10-11 01:16:32.230919|2017-10-11 01:16:32.230919
NCT01948609|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-01-12|||July 2014||2014-07-01|January 2017|2017-01-01||||July 2018|Anticipated|2018-07-01||Observational|PROSper||Prospective Research of Outcomes After Salpingo-oophorectomy|Prospective Research of Outcomes After Salpingo-oophorectomy|Active, not recruiting||N/A|100|Anticipated|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     whole blood; serum; EDTA Plasma   "|||2017-10-11 01:16:32.376732|2017-10-11 01:16:32.376732
NCT01948596|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-04-19|||October 2013||2013-10-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO): Open Trial|The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO) : Open Trial|Completed||Phase 2|13|Actual|Tokyo Medical University||1|||f||||t||||||||||2017-10-11 01:16:32.485435|2017-10-11 01:16:32.485435
NCT01948583|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-19|||May 2013||2013-05-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|GYNOMUNAL®||Humectant Activity of a New Formulation of Gynomunal® Vaginalgel|Humectant Activity of a New Formulation of Gynomunal® Vaginalgel: Crossover Test Use Versus Previous Formula|Completed||Phase 4|28|Actual|Derming SRL||2|||f||||t||||||||||2017-10-11 01:16:32.672419|2017-10-11 01:16:32.672419
NCT01948570|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-08-31|||March 2013||2013-03-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01|2 Months|Observational [Patient Registry]|ANTI-ACNE||Clinical Study for the Evaluation of P-3075 Cream on Acne Treatment|Clinical Study for the Evaluation of P-3075 Cream on Acne Treatment|Completed||N/A|40|Actual|Derming SRL|||2||f||||t||||||||||2017-10-11 01:16:32.796065|2017-10-11 01:16:32.796065
NCT01948544|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2015-11-24|||September 2013||2013-09-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease|A Study to Evaluate Improvement in the Quality of Life and Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|27|Actual|StratiHealth|||1||f||||t||||||||||2017-10-11 01:16:33.111556|2017-10-11 01:16:33.111556
NCT01948531|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-09-19|||December 2012||2012-12-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|E2912||"Clinical Trial on a Topical Antiage Face Gel"|"Clinical and Instrumental Evaluation of a Topical Antiage Formulation for the Face"|Completed||Phase 4|33|Actual|Derming SRL||1|||f||||t||||||||||2017-10-11 01:16:33.225147|2017-10-11 01:16:33.225147
NCT01948518|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2014-09-24|2014-01-28||June 2009||2009-06-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease|The Effect of Sildenafil on Diffusion Capacity Measurements in Patients With Pulmonary Hypertension and Parenchymal Lung Disease|Completed||N/A|15|Actual|The Cleveland Clinic||1|||f||||t||||||||||2017-10-11 01:16:33.3461|2017-10-11 01:16:33.3461
NCT01948505|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-12-08|||August 2013||2013-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit||Completed||Phase 4|210|Actual|University of Utah||2|||f||||||||||||||2017-10-11 01:16:33.645074|2017-10-11 01:16:33.645074
NCT01948492|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-04-27|||March 2012||2012-03-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Determination of Protein Requirement in Elderly Male Subjects >75 Yrs Old||Completed||N/A|6|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 01:16:33.768679|2017-10-11 01:16:33.768679
NCT01948479|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2013-09-25|||January 2014||2014-01-01|September 2013|2013-09-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Insole Optimisation for Ulcer Prevention: a Feasibility Trial|Prevention of Foot Ulcer Recurrence in People With Diabetes Using an In-shoe Pressure Measurement Technology: A Randomised Control Trial Feasibility Study|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of Plymouth||2|||f||||f||||||||||2017-10-11 01:16:33.874545|2017-10-11 01:16:33.874545
NCT01948466|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-11-15|||January 2014||2014-01-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|PSA||Nutritional PSA's on Fruit and Vegetable Consumption|Using Media to Improve Fruit and Vegetable Consumption in Elementary School Lunch Programs|Completed||N/A|750|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:16:34.002017|2017-10-11 01:16:34.002017
NCT01948453|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-14|2015-05-27|||August 2013||2013-08-01|September 2013|2013-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Garlic Tablet Some Indicators Related to Atherosclerosis|Effect of Garlic Tablet on Carotid Intima Media Thickness and Flow-mediated Dilation in Patients Undergoing Angioplasty|Completed||N/A|56|Actual|Shahid Beheshti University||2|||f||||t||||||||||2017-10-11 01:16:34.134211|2017-10-11 01:16:34.134211
NCT01948427|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-11-10|||September 2013||2013-09-01|November 2016|2016-11-01|September 2026|Anticipated|2026-09-01|September 2026|Anticipated|2026-09-01|10 Years|Observational [Patient Registry]|THRIVE||Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)|Long-Term Registry of Patients With Urea Cycle Disorders (UCDs)|Recruiting||N/A|500|Anticipated|Horizon Pharma Ireland, Ltd., Dublin Ireland|||1||f||||f||||||||||2017-10-11 01:16:34.383652|2017-10-11 01:16:34.383652
NCT01948414|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2016-08-26|||July 2013||2013-07-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|P300||Cognitive Processes Study in Obese Women With and Without Eating Disorders|Cognitive Processes Study in Obese Women With and Without Eating Disorders : Research of Electro-physiological Similarity With Addiction|Completed||N/A|108|Actual|Hospices Civils de Lyon||3|||f||||t||||||||||2017-10-11 01:16:34.499714|2017-10-11 01:16:34.499714
NCT01948401|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-11-01|||July 2013||2013-07-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma|A STUDY TO MEASURE SERUM PERIOSTIN, ASTHMA-RELATED BIOMARKERS AND RESPONSE TO PREDNISOLONE IN ADULT AND ADOLESCENT PATIENTS WITH SEVERE ORAL CORTICOSTEROID-DEPENDENT ASTHMA|Completed||Phase 2|54|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 01:16:34.659438|2017-10-11 01:16:34.659438
NCT01948388|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-08-08|||September 2013||2013-09-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients|Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging|Active, not recruiting||Phase 4|20|Actual|Gaylis, Norman B., M.D.||2|||f||||t||||||||||2017-10-11 01:16:34.832008|2017-10-11 01:16:34.832008
NCT01948375|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2014-06-05|2014-05-05||August 2013||2013-08-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Crossover Study on the Blinding Effect of a New Pragmatic Placebo Needle|Effect of Blinding With a New Pragmatic Placebo Needle: a Crossover Study|Completed||N/A|60|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 01:16:34.997969|2017-10-11 01:16:34.997969
NCT01948362|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2013-09-18|||November 2012||2012-11-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Sulforadex in Healthy Volunteers SAD|A Randomised, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of Sulforadex® in Healthy Male Subjects|Completed||Phase 1|29|Actual|Evgen Pharma||2|||f||||t||||||||||2017-10-11 01:16:36.030866|2017-10-11 01:16:36.030866
NCT01948349|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-11-30|||October 2012||2012-10-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient|Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient|Completed||N/A|40|Anticipated|UConn Health||4|||f||||t||||||||||2017-10-11 01:16:36.219122|2017-10-11 01:16:36.219122
NCT01948336|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-14|2013-09-18|||April 2012||2012-04-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients|Phase 4 THE EFFECTS OF DEXMEDETOMIDINE ON EARLY STAGE RENAL FUNCTIONS IN PEDIATRIC PATIENTS UNDERGOING CARDIAC ANGIOGRAPHY USING NON- IONIC CONTRAST MEDIA: A DOUBLE- BLIND, RANDOMIZED CLINICAL TRIAL|Completed||Phase 4|60|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 01:16:36.475106|2017-10-11 01:16:36.475106
NCT01948323|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-08-13|||September 2013||2013-09-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|PROTECT-AFRI||Pregnancy-Related Obesity Prevention Through Education & Communication Technology in AFRICA:The PROTECT-AFRICA STUDY|Pregnancy-Related Obesity Prevention Through Education & Communication Technology in AFRICA:The PROTECT-AFRICA STUDY|Unknown status|Recruiting|N/A|1200|Anticipated|University of Cape Town||2|||f||||t||||||||||2017-10-11 01:16:36.622306|2017-10-11 01:16:36.622306
NCT01948297|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-09-22|||August 2013||2013-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations|A Phase I, Gene Alteration-based, Open Label, Multicenter Study of Oral Debio 1347 (CH5183284) in Patients With Advanced Solid Malignancies, Whose Tumours Have an Alteration of the FGFR 1, 2 or 3 Genes|Recruiting||Phase 1|112|Anticipated|Debiopharm International SA||2|||f||||f||||||||||2017-10-11 01:16:36.960574|2017-10-11 01:16:36.960574
NCT01948284|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-09-20|||August 2013||2013-08-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Comparing Maximal and Half-maximal Suction Pressure Applied During Water Exchange in Colonoscopy|A Randomized, Controlled Trial Comparing Maximal and Half-maximal Suction Pressure Applied During Water Exchange in Colonoscopy|Unknown status|Recruiting|N/A|74|Anticipated|Dalin Tzu Chi General Hospital||2|||f||||t||||||||||2017-10-11 01:16:37.124506|2017-10-11 01:16:37.124506
NCT01948271|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-09-14|||July 2013||2013-07-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis|An Open-label Pilot Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis|Terminated||Phase 1|3|Actual|Tufts Medical Center||1||lack of efficacy|f||||f||||||||No||2017-10-11 01:16:37.26112|2017-10-11 01:16:37.26112
NCT01948245|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-04-05|||October 2013||2013-10-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml.|A Double Blinded, Randomized, Controlled Investigation of Taurolidine-citrate/Heparin Catheter Lock Solution Versus Heparin in Patients on Home Parenteral Nutrition With Previously Proven High Risk of Catheter Related Blood Stream Infections.|Active, not recruiting||Phase 4|42|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:16:37.47607|2017-10-11 01:16:37.47607
NCT01948232|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-10-02|||September 2013||2013-09-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pilot Study of Perindopril in Childhood Cancer Survivors|A Phase II Open Label Pilot Study of the Angiotensin-converting Enzyme Inhibitor, Perindopril, in Pediatric Cancer Survivors With Evidence of Early Cardiac Remodelling or Dysfunction.|Withdrawn||Phase 2|0|Actual|The Hospital for Sick Children||1||no participants enrolled|f||||t||||||||||2017-10-11 01:16:37.635165|2017-10-11 01:16:37.635165
NCT01948219|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-03-15|||October 2014||2014-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||ENTegral Clinical Trial|An Evaluation of the ENTegral Artificial Larynx (AL) in Patients Indicated for Total Laryngectomy|Active, not recruiting||N/A|15|Anticipated|ProTiP Medical||1|||f||||f||||||||||2017-10-11 01:16:37.770912|2017-10-11 01:16:37.770912
NCT01948206|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-12-11|||October 2013||2013-10-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Study of Paced QRS Duration as a Marker of Sudden Cardiac Death|Assessment of Prolonged Paced QRS Duration as a Marker of Sudden Cardiac Death in Subjects With Implantable Cardioverter-defibrillators|Terminated||N/A|100|Actual|Pocono Medical Center|||2|Ran out of funds|f||||f||||||||No||2017-10-11 01:16:37.932042|2017-10-11 01:16:37.932042
NCT01948193|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-09-29|2015-08-26||February 2014||2014-02-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth|Immunogenicity and Safety of Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T Combined Vaccine Given at 6, 10 and 14 Weeks of Age in Infants From India Who Previously Received a Dose of Hepatitis B Vaccine at Birth|Completed||Phase 3|177|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:16:38.132347|2017-10-11 01:16:38.132347
NCT01948180|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-08-07|||September 2014||2014-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|CITADEL||Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma|A Phase 2 Single Arm Study to Investigate the Efficacy of Autologous EBV-specific T-cells for the Treatment of Patients With Aggressive EBV Positive Extranodal NK/T-cell Lymphoma (ENKTCL)|Recruiting||Phase 2|35|Anticipated|Cell Medica Ltd||1|||f||||t||||||||||2017-10-11 01:16:38.819018|2017-10-11 01:16:38.819018
NCT01948167|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-09-29|||September 2013||2013-09-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Bending Adolescent Depression Trajectories Through Personalized Prevention|Bending Adolescent Depression Trajectories Through Personalized Prevention|Active, not recruiting||N/A|205|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 01:16:39.013829|2017-10-11 01:16:39.013829
NCT01948154|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-10-10|||February 2013||2013-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01|3 Years|Observational [Patient Registry]|||The Relationship of Speech Function and Quality of Life in Children With Cerebral Palsy: A Longitudinal Study|The Relationship of Speech Function and Quality of Life in Children With Cerebral Palsy: A Longitudinal Study|Recruiting||N/A|300|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||||||2017-10-11 01:16:39.135503|2017-10-11 01:16:39.135503
NCT01948141|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-05-10|2016-06-22||January 30, 2014|Actual|2014-01-30|May 2017|2017-05-01|August 16, 2016|Actual|2016-08-16|August 16, 2016|Actual|2016-08-16||Interventional||All treated and eligible patients|Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens|FGFR1 Amplification as A Predictor of Efficacy in A Biomarker-Driven Phase II Study of BIBF 1120 in Advanced Squamous Cell Lung Cancer Patients Who Have Failed Up to Two Prior Chemotherapeutic Regimens|Completed||Phase 2|6|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 01:16:39.226962|2017-10-11 01:16:39.226962
NCT01948128|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-02-02|||October 2013||2013-10-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|OTT 12-06||Effects of Vitamin D in Patients With Breast Cancer|A Phase 2 Randomized, Double-blind, Window of Opportunity Trial Evaluating Clinical and Correlative Effects of Vitamin D in Patients With Breast Cancer. The ICARUS Trial|Completed||Phase 2|83|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 01:16:39.582197|2017-10-11 01:16:39.582197
NCT01948115|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2015-12-17|||November 2013||2013-11-01|November 2015|2015-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MEOREV||Evaluation of the Efficacy and Safety of an Equimolar Mixture of Oxygen and Nitrous Oxide in External Cephalic Version (ECV)|Prospective Randomized Controlled Trial to Evaluate the Efficacy and Safety of an Equimolar Mixture of Oxygen and Nitrous Oxide in External Cephalic Version (ECV) in Singleton Pregnancy in Breech Presentation at Term|Completed||Phase 3|150|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 01:16:39.670802|2017-10-11 01:16:39.670802
NCT01948102|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2014-07-02|||July 2008||2008-07-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples|Identification of Diagnostic and Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples|Unknown status|Recruiting|N/A|100|Anticipated|Carolinas Healthcare System|||2||f||||t||||||Samples With DNA|"     skin and adipose tissue   "|||2017-10-11 01:16:39.762376|2017-10-11 01:16:39.762376
NCT01948089|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-09-17|||September 2013||2013-09-01|August 2013|2013-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Exploring the Long-term Effects of Cognitive Exercise on Cognition After Stroke||Terminated||N/A|2|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 01:16:39.864836|2017-10-11 01:16:39.864836
NCT01948076|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-02-27|2013-10-22||September 2012||2012-09-01|February 2015|2015-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination|Use of a Pocket-sized Ultrasound Device as an Aid to the Physical Examination for Internal Medicine Residents|Completed||N/A|40|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:16:39.989539|2017-10-11 01:16:39.989539
NCT01948050|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-06-13|2014-02-24||January 2009||2009-01-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients|Pilot Study on Safety and Efficacy of the Non-invasive Transcranial Stimulation (tDCS) to Relieve Neuropathic Pain in Cancer Patients|Completed||N/A|24|Actual|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-11 01:16:40.851341|2017-10-11 01:16:40.851341
NCT01948037|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2013-09-18|||January 2012||2012-01-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effectiveness Study of Hydrotherapy Against Pain and Other Symptoms in Diabetes-induced LEAD|Hydrotherapy for the Treatment of Symptomatic Lower Extremity Arterial Disease in Diabetes Type 2 Patients:A Randomized Controlled Trial|Unknown status|Recruiting|N/A|70|Anticipated|Nanjing Jinling Hospital||2|||f||||f||||||||||2017-10-11 01:16:41.188548|2017-10-11 01:16:41.188548
NCT01948024|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2014-02-21|||July 2013||2013-07-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|ASN||Bio-equivalence Study Between SAPHRIS and Asenapine|An Open-label, Randomized, Two Treatment, Multi-site, Multiple Dose, Steady State, Three-way, Reference-replicated Crossover, Pharmacokinetic Study to Determine the In-vivo Bioequivalence Between Asenapine 10 mg Sublingual Tablet and SAPHRIS® (Asenapine) 10 mg Sublingual Tablet|Completed||Phase 1|57|Actual|bioRASI, LLC||2|||f||||f||||||||||2017-10-11 01:16:41.283852|2017-10-11 01:16:41.283852
NCT01948011|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2014-02-24|||September 2013||2013-09-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Racecadotril Suspension Linearity Study & Comparative Bioavailability Versus Granules|Study of the Racecadotril Linearity After Single Administrations of 10, 30 and 60 mg of a New Racecadotril Formulation (Suspension) by Oral Route and Evaluation of the Comparative Bioavailability of This New Formulation Versus the Sachet Formulation (Granules) After a 60 mg Single Oral Administration in Healthy Male Volunteers|Completed||Phase 1|53|Actual|Bioprojet||4|||f||||f||||||||||2017-10-11 01:16:43.195547|2017-10-11 01:16:43.195547
NCT01947972|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-07-12|||October 2013||2013-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Individualized Maternal Milk Fortification for Feeding the Preterm Infants|Individualized Maternal Milk Fortification for Feeding the Preterm Infants|Completed||N/A|60|Actual|Aristotle University Of Thessaloniki||1|||f||||f||||||||||2017-10-11 01:16:43.522247|2017-10-11 01:16:43.522247
NCT01947946|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-11-23|2015-07-21||November 2013||2013-11-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||The number of participants for analysis will be from the full analysis set. The full analysis set consists of all patients randomized and receiving any investigational product, irrespective of their protocol adherence and continued participation in the study.|Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma|A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma|Terminated||Phase 3|13|Actual|AstraZeneca||3||Study terminated due to sponsor decision|f||||f||||||||||2017-10-11 01:16:43.694417|2017-10-11 01:16:43.694417
NCT01947933|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-05-25|||October 2013||2013-10-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Safety Study of Mirikizumab (LY3074828)|A Phase I, Randomized, Placebo-Controlled Study of LY3074828, an Anti-IL-23 Humanized Antibody|Completed||Phase 1|45|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 01:16:44.182493|2017-10-11 01:16:44.182493
NCT01947920|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-12-15|||August 2013||2013-08-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics Following Multiple Ascending Doses of Tramadol Hydrochloride in Healthy Male and Female Subjects|Completed||Phase 1|30|Actual|Janssen Scientific Affairs, LLC||3|||f||||f||||||||||2017-10-11 01:16:44.28039|2017-10-11 01:16:44.28039
NCT01947907|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-11-28|2016-10-03||July 2013||2013-07-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)|A Multicenter, Phase 2, Randomized, Open Label, Active-controlled, Parallel-group Study Investigating the Safety, Tolerability, and Efficacy of Different Dose Levels of ACP-001 Administered Once Weekly Versus Standard Daily rhGH Replacement Therapy in Pre-pubertal Children With Growth Hormone Deficiency (GHD)|Completed||Phase 2|53|Actual|Ascendis Pharma A/S||4|||f||||t||||||||||2017-10-11 01:16:44.423582|2017-10-11 01:16:44.423582
NCT01947894|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-08-03|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients|Swegho - A Prospective Non Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Ghd Patients In Sweden|Active, not recruiting||N/A|372|Actual|Pfizer|||1||f||||f|t|f||||||||2017-10-11 01:16:45.815683|2017-10-11 01:16:45.815683
NCT01947881|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-03-09|||January 2014||2014-01-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Observational|CHARTRES||Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)|Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)|Completed||N/A|71|Actual|Association for Innovation and Biomedical Research on Light and Image|||1||f||||f||||||||||2017-10-11 01:16:45.932466|2017-10-11 01:16:45.932466
NCT01947868|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-09-22|||November 2013||2013-11-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor|A Prospective, Non-interventional Evaluation of Symptoms Improvement of First-Line Therapy of EGFR Tyrosine Kinase Inhibitor in Advanced NSCLC Patients With Positive EGFR Mutation - the SMILE Study|Completed||N/A|346|Actual|AstraZeneca|||1||f||||f||||||None Retained|"     no biospecimen collected   "|||2017-10-11 01:16:46.024683|2017-10-11 01:16:46.024683
NCT01947855|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2014-12-16|2014-12-16||September 2013||2013-09-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Full analysis set: all patients treated with at least 1 dose of randomised study drug, and with a baseline AUC1-4h for plasma glucose.|Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus|A Randomised, Double-blind, Placebo-controlled, Parallel Group, 4-week Study to Evaluate the Efficacy of Empagliflozin (10 mg and 25 mg Administered Orally Once Daily) in Postprandial Glucose and 24-hour Glucose Variability in Japanese Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control|Completed||Phase 3|60|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 01:16:46.222102|2017-10-11 01:16:46.222102
NCT01947842|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2013-09-20|||January 2014||2014-01-01|September 2013|2013-09-01||||December 2014|Anticipated|2014-12-01||Interventional|||Effect of a Smartphone Application on Oral Contraceptive Adherence in College Females|Effect of a Smartphone Application on Oral Contraceptive Adherence in College Females: a Randomized-controlled Trial.|Unknown status|Not yet recruiting|N/A|300|Anticipated|Belmont University||2|||f||||f||||||||||2017-10-11 01:16:46.595368|2017-10-11 01:16:46.595368
NCT01947829|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2016-11-22|||October 2013||2013-10-01|November 2016|2016-11-01||||December 2014|Actual|2014-12-01||Observational|IVP||Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)|Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)|Completed||N/A|120|Actual|B.Braun Avitum AG|||1||f||||f||||||||||2017-10-11 01:16:46.691932|2017-10-11 01:16:46.691932
NCT01947816|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-07-24|||August 9, 2013||2013-08-09|July 2017|2017-07-01|March 31, 2018|Anticipated|2018-03-31|July 28, 2017|Anticipated|2017-07-28||Observational|||Special Investigation in Patients With Ulcerative Colitis|Special Investigation in Patients With Ulcerative Colitis|Active, not recruiting||N/A|1500|Anticipated|AbbVie|||1||f||||||||||||||2017-10-11 01:16:46.83615|2017-10-11 01:16:46.83615
NCT01947803|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-03-11|||September 2013||2013-09-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia|Safety and Effectiveness of Paliperidone Palmitate in 25-week Treatment on Chinese Patients With Schizophrenia: an Open-label, Single-arm, Multicenter Prospective Study|Completed||Phase 4|353|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||||||||||2017-10-11 01:16:47.910516|2017-10-11 01:16:47.910516
NCT01947790|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-08-17|||September 2013||2013-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease|Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease|Completed||Phase 4|120|Actual|Wuhan General Hospital of Guangzhou Military Command||2|||f||||t||||||||||2017-10-11 01:16:48.046134|2017-10-11 01:16:48.046134
NCT01947777|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-07-28|||October 2013||2013-10-01|July 2017|2017-07-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|DDI||Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145|A Phase 1, Open-Label, Single-Sequence, 2-Period Study to Evaluate the Effect of Rifampin (a CYP3A Inducer) on the Pharmacokinetics of IPI-145 in Healthy Subjects|Completed||Phase 1|14|Actual|Verastem, Inc.||1|||f||||f||||||||||2017-10-11 01:16:48.133549|2017-10-11 01:16:48.133549
NCT01947764|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-03-06|||August 2012||2012-08-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|HADITHI||Patient-Centered Disclosure Intervention for HIV-Infected Children|Patient-Centered Disclosure Intervention for HIV-Infected Children|Completed||N/A|330|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 01:16:48.216697|2017-10-11 01:16:48.216697
NCT01947751|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2013-09-19|||March 2013||2013-03-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|||Catheter Early Withdrawal or Maintenance in Sepsis or Septic Shock|Comparison Between Catheter Early Withdrawal or Maintenance in Sepsis or Septic Shock With Undefined Origin|Unknown status|Recruiting|N/A|100|Anticipated|Hospital Nossa Senhora da Conceicao||2|||f||||f||||||||||2017-10-11 01:16:48.289372|2017-10-11 01:16:48.289372
NCT01947738|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-12-27|||March 2013||2013-03-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1)|A Two-Part, Double-Blind, Randomized, Placebo-Controlled, Sequential, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of VBY-891 in Healthy Subjects|Completed||Phase 1|89|Actual|Virobay Inc.||2|||f||||t||||||||||2017-10-11 01:16:48.383007|2017-10-11 01:16:48.383007
NCT01947725|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-03-30|||January 2014||2014-01-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Behavioral Activation for Smoking Cessation in Veterans With PTSD|Behavioral Activation for Smoking Cessation in Veterans With PTSD|Recruiting||N/A|120|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 01:16:48.464353|2017-10-11 01:16:48.464353
NCT01947712|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-17|||October 2010||2010-10-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Effect of Polyphenols on Peripheral Vascular Disease.|Effect of Dark Chocolate on Endothelial Function and Oxidative Stress in Patients With Peripheral Vascular Disease.|Completed||Phase 1/Phase 2|20|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 01:16:48.585359|2017-10-11 01:16:48.585359
NCT01947699|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-05-10|||September 2013||2013-09-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide||Withdrawn||Phase 4|0|Actual|University of Pittsburgh||3||PI decided to withdrawal study before recruitment started|f||||f||||||||||2017-10-11 01:16:48.708931|2017-10-11 01:16:48.708931
NCT01947686|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-11-17|||February 2013||2013-02-01|November 2015|2015-11-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Observational|||Survivorship and Outcomes of Robotically Assisted Patellofemoral UKA|Survivorship and Outcomes of Robotically Assisted Patellofemoral UKA|Enrolling by invitation||N/A|40|Anticipated|St. Helena Hospital Coon Joint Replacement Institute|||1||f||||f||||||||||2017-10-11 01:16:48.79419|2017-10-11 01:16:48.79419
NCT01947673|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-09-27|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|MID-H||Mechanisms of Intradialytic Hypertension|Sympathetic Regulation in Intradialytic Hypertension|Recruiting||N/A|100|Anticipated|Emory University||2|||f||||f||||||||||2017-10-11 01:16:48.883945|2017-10-11 01:16:48.883945
NCT01947660|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-09-17|||October 2013||2013-10-01|September 2013|2013-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|ACOSM||Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery|Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery|Unknown status|Not yet recruiting|N/A|260|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 01:16:48.977335|2017-10-11 01:16:48.977335
NCT01947647|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-09-18|||November 17, 2014|Actual|2014-11-17|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|December 29, 2017|Anticipated|2017-12-29||Interventional|TBT-RCT||Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders|Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders|Recruiting||N/A|96|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:16:49.200992|2017-10-11 01:16:49.200992
NCT01947634|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2015-03-02|||September 2013||2013-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Sleepiness and Sleep-disordered Breathing in Fabry Disease. A Prospective Cohort Study.|Cross-sectional Study on the Incidence of Sleepiness and Sleep-disordered Breathing in Patients With Fabry Disease|Completed||N/A|52|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 01:16:49.309912|2017-10-11 01:16:49.309912
NCT01947621|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-05-20|||January 2011||2011-01-01|May 2014|2014-05-01|December 2020|Anticipated|2020-12-01|October 2014|Anticipated|2014-10-01||Observational|InterTAK||International Takotsubo Registry (InterTAK Registry)|International Multicenter Registry on Takotsubo Cardiomyopathy|Recruiting||N/A|4000|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 01:16:49.415483|2017-10-11 01:16:49.415483
NCT01947608|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-08-02||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC|An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity|Available||N/A|||Novartis||||||||t|||||||||||2017-10-11 01:16:49.52579|2017-10-11 01:16:49.52579
NCT01947595|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-08-22|||March 2012||2012-03-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|PLIS||Individualized Lifestyle Intervention in Subjects With Prediabetes|Prediabetes Lifestyle Intervention Study|Completed||N/A|1145|Actual|University Hospital Tuebingen||4|||f||||||||||||||2017-10-11 01:16:49.761558|2017-10-11 01:16:49.761558
NCT01947582|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-02-04|2015-05-13||October 2013||2013-10-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS)|The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS)|Completed||N/A|2|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 01:16:49.968033|2017-10-11 01:16:49.968033
NCT01947569|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2013-10-22|||October 2013||2013-10-01|October 2013|2013-10-01||||November 2014|Anticipated|2014-11-01||Interventional|||Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy|Autologous Co-stimulation-impaired Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy: A Sequential Open Label Phase IB Safety Assessment/ Randomized, Double-blind Phase IIA Efficacy Trial to Maintain and Improve Functional Beta Cell Mass in New Onset Disease T1DM Patients|Unknown status|Not yet recruiting|Phase 1/Phase 2|90|Anticipated|DiaVacs, Inc.||3|||f||||t||||||||||2017-10-11 01:16:50.313602|2017-10-11 01:16:50.313602
NCT01947556|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2014-11-25|||March 2014||2014-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Insulin by Jet-injection for Hyperglycemia in Diabetes|The Effect of Rapid-acting Insulin Injected by Needle-free Jet-injection in the Management of Hyperglycemia in Patients With Diabetes|Completed||N/A|20|Actual|University Medical Center Nijmegen||2|||f||||f||||||||||2017-10-11 01:16:50.441855|2017-10-11 01:16:50.441855
NCT01947543|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-10-09|||January 2017||2017-01-01|October 2016|2016-10-01||||May 2018|Anticipated|2018-05-01||Observational|||Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study|Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study|Not yet recruiting||N/A|160|Anticipated|Region Örebro County|||2||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:16:50.541277|2017-10-11 01:16:50.541277
NCT01947530|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-10-31|||September 2013||2013-09-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Study Using Combined Virtual 4-D Electromagnetic (EM) Tip-Tracked Devices & EBUS in Diagnosis of Lung Nodules|Pilot Study Using Combined Virtual 4-D EM Tip-Tracked Devices and Endobronchial Ultrasound (EBUS)in the Diagnosis of Peripheral Pulmonary Nodules|Recruiting||N/A|20|Anticipated|University Health Network, Toronto||2|||f||||||||||||||2017-10-11 01:16:50.618356|2017-10-11 01:16:50.618356
NCT01947517|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-03-30|2015-10-01||September 2013||2013-09-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Observational|||The Retention Rate Between Brand A and Brand B Punctal Plugs|The Retention Rate Between Superflex Punctal Plugs, and Parasol Punctal Occluders|Completed||N/A|52|Actual|Queen's University|||2||f||||f||||||||No||2017-10-11 01:16:50.701397|2017-10-11 01:16:50.701397
NCT01947504|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-03-21|||January 2016||2016-01-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Early Intervention Following Mild TBI|Acute and Brief Intervention Following Mild Traumatic Brain Injury: A Randomized Controlled Clinical Trial|Recruiting||N/A|60|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 01:16:51.03899|2017-10-11 01:16:51.03899
NCT01947491|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-12-01|2016-08-15|2016-02-08|November 2013||2013-11-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis||Completed||Phase 3|394|Actual|Promius Pharma, LLC||4|||f||||f||||||||||2017-10-11 01:16:51.148886|2017-10-11 01:16:51.148886
NCT01947478|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-01-10|||September 2013||2013-09-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|MDT-2113 SFA||MDT-2113 Drug-Eluting Balloon vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery|Randomized Trial of MDT-2113 Drug-Eluting Balloon (DEB) vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery|Active, not recruiting||Phase 2|100|Anticipated|Medtronic Endovascular||2|||f||||t||||||||||2017-10-11 01:16:51.763384|2017-10-11 01:16:51.763384
NCT01947465|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-02-24|||October 2013||2013-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|||Immunogenicity and Safety of Vaccinations in Immunocompromised Persons|A Prospective Cohort Study in 6 Swiss Rheumatology Centres and 4 Travel Clinics on the Immunogenicity and Safety of Tetanus and Hepatitis A Vaccine in Patients With Rheumatoid Arthritis, Axial Spondyloarthritis and Vasculitis and Healthy Controls|Completed||N/A|645|Actual|University of Zurich|||4||f||||f||||||Samples Without DNA|"     Sera from participants will be kept in a biobank for further measurements of antibody     responses after vaccination.   "|||2017-10-11 01:16:51.861084|2017-10-11 01:16:51.861084
NCT01947452|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-08-30|||June 2012||2012-06-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||The Effects of Summer Employment on Disadvantaged Youth: Experimental Evidence|The Effects of Summer Employment on Disadvantaged Youth: Experimental Evidence|Active, not recruiting||Phase 1/Phase 2|1634|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 01:16:52.013|2017-10-11 01:16:52.013
NCT01947439|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-01-30|||March 2013||2013-03-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Comparison of the Biolimus A9-eluting Stent With the Zotarolimus -Eluting Stent in Multi-vessel PCI|Phase 4, Prospective,Multicenter Study of Randomized Comparison of the Biolimus A9-eluting Stent With the Zotarolimus-eluting Stent in Multi-vessel PCI|Recruiting||Phase 4|932|Anticipated|Keimyung University Dongsan Medical Center||2|||f||||f||||||||||2017-10-11 01:16:52.12979|2017-10-11 01:16:52.12979
NCT01947426|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-17|||April 2008||2008-04-01|September 2013|2013-09-01|April 2011|Actual|2011-04-01|April 2010|Actual|2010-04-01||Interventional|||Effect of Mother DHA Supplementation on Term Newborn.|Effect of Maternal Supplementation With DHA During Pregnancy and Lactation on the Development of the Term Newborn|Completed||Phase 2/Phase 3|120|Actual|Universidad de Granada||2|||f||||t||||||||||2017-10-11 01:16:52.266004|2017-10-11 01:16:52.266004
NCT01947413|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-09-07|||December 2012||2012-12-01|September 2016|2016-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||New Protocols in the Treatment of Upper Limb Dysfunctions of Patients With Stroke.|New Protocols in the Treatment of Upper Limb Dysfunctions of Patients With Stroke: An Evidence of Clinical and Kinematic Studies.|Completed||N/A|80|Actual|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-11 01:16:52.375825|2017-10-11 01:16:52.375825
NCT01947400|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-04-10|||December 2013||2013-12-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|AIDET||Effect of AIDET on Physician-Patient Communication|Does Use of the AIDET (Acknowledge, Introduce, Duration, Explanation, Thank) Method for Physician-patient Communication Improve Patient Satisfaction in a Real World Setting as Measured by Modified HCAHPS (Hospital Consumer Assessment of Health Plans Survey) Scores?|Terminated||N/A|26|Actual|University of Florida|||1|The data that was critical to the study was not able to be obtained.|f||||f||||||||||2017-10-11 01:16:52.482548|2017-10-11 01:16:52.482548
NCT01947387|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2016-12-01|||August 2013||2013-08-01|December 2016|2016-12-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Observational|||Retrospective Study Evaluating Outcomes for Integra® Skin Sheet Products in Lower Extremity Complex Wounds|A Retrospective, Multi-Center Study Evaluating the Outcomes for Integra® Skin Sheet Bilayer or Single Layer Products Used in Complex Lower Extremity Soft Tissue Reconstruction|Completed||N/A|320|Actual|Integra LifeSciences Corporation|||9||f||||f||||||||||2017-10-11 01:16:52.559053|2017-10-11 01:16:52.559053
NCT01947374|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2017-04-11|||January 2010||2010-01-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Arthroscopic Autologous Chondrocyte Implantation Versus Microfractures|Matrix-encapsulated Arthroscopic Autologous Chondrocyte Implantation Versus Microfractures for Articular Cartilage Regeneration. Randomised Clinical Trial.|Completed||Phase 3|48|Actual|Instituto Nacional de Rehabilitacion||2|||f||||t||||||||||2017-10-11 01:16:52.888328|2017-10-11 01:16:52.888328
NCT01947361|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-17|||January 2012||2012-01-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)|Heterogeneity in Association of Heart Rate and Initial Presentation of Cardiovascular Diseases Using Linked Electronic Health Records|Unknown status|Active, not recruiting|N/A|1961286|Actual|University College, London|||1||f||||t||||||||||2017-10-11 01:16:53.018171|2017-10-11 01:16:53.018171
NCT01947348|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-09-02|||September 2012||2012-09-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Safety and Clinical Effectiveness of A3 SVF in Osteoarthritis|Safety and Clinical Effectiveness of A3 SVF in Osteoarthritis|Unknown status|Recruiting|N/A|30|Anticipated|Institute of Regenerative and Cellular Medicine||1|||f||||t||||||||||2017-10-11 01:16:53.129601|2017-10-11 01:16:53.129601
NCT01947335|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-05-06|2016-05-06||November 2012||2012-11-01|May 2016|2016-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|MOZART||IVUS Guidance to Reduce Contrast in Coronary Angioplasty|Minimizing cOntrast utiliZAtion With IVUS Guidance in coRonary angioplasTy: The MOZART Study|Completed||Phase 4|83|Actual|InCor Heart Institute|Patients were enrolled according to somewhat restricted criteria, which excluded patients with recent catheterization, using nephrotoxic agents, or with unstable or unknown renal function.|2|||f||||f||||||||||2017-10-11 01:16:53.233767|2017-10-11 01:16:53.233767
NCT01947322|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-08-28|||May 2011|Actual|2011-05-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|NK||Haploidentical NK-cell Infusion in Acute Myeloid Leukemia|Haploidentical NK-cell Infusion in Bad Prognosis AML Patients: Evaluation of Feasibility and Antitumoral Effect|Completed||Phase 1/Phase 2|10|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:16:53.528658|2017-10-11 01:16:53.528658
NCT01947309|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2017-01-10|||November 2013||2013-11-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Observational|||Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)|A Non-interventional, Observational Post-marketing Registry of Multiple Myeloma Adult Patients Treated With Revlimid (Lenalidomide) in China|Terminated||N/A|176|Actual|Celgene|||1|Business Decision|f||||f||||||||||2017-10-11 01:16:53.619916|2017-10-11 01:16:53.619916
NCT01947296|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-02-20|||October 2013|Actual|2013-10-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Observational|CHIMORAL||Impact of a Coordinated Regional Organization to Secure Patient's Care Treated by Oral Antineoplastic Agents|Evaluation of the Impact of a Coordinated Regional Organization to Secure Patient's Care Treated by Oral Antineoplastic Agents|Completed||N/A|284|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||Undecided||2017-10-11 01:16:53.753391|2017-10-11 01:16:53.753391
NCT01947270|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-09-27|||January 2013|Actual|2013-01-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|OPMED||"Multidisciplinary Program Optimization of Drug Prescription : Impact on the Quality of Drug Prescription in Hospitalized Elderly Patients"|"OPMED STUDY: Multidisciplinary Program Optimization of Drug Prescription : Impact on the Quality of Drug Prescription in Hospitalized Elderly Patients"|Completed||N/A|3055|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-11 01:16:54.11415|2017-10-11 01:16:54.11415
NCT01947257|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-08-29|||September 2013||2013-09-01|August 2014|2014-08-01|January 2015|Anticipated|2015-01-01|July 2014|Actual|2014-07-01||Interventional|||Is There a Correlation Between the Pulmonary Artery Pressure and the Acceleration of the Flow in the Pulmonary Artery Evaluated by Transesophageal Echocardiography (TOE) ?|Is There a Correlation Between the Pulmonary Artery Pressure and the Acceleration of the Flow in the Pulmonary Artery Evaluated by Transesophageal Echocardiography (TOE) ?|Unknown status|Active, not recruiting|N/A|50|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:16:54.215717|2017-10-11 01:16:54.215717
NCT01947244|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-11-02|||November 2011||2011-11-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Doula Home Visiting Randomized Trial|Illinois Maternal, Infant, and Early Childhood Home Visiting (MIECHV): Doula Randomized Controlled Trial|Active, not recruiting||N/A|300|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 01:16:54.31061|2017-10-11 01:16:54.31061
NCT01947231|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-01-29|||September 2013|Actual|2013-09-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||GPR vs Manual PT for Chronic Neck Pain|Randomized Controlled Trial of Global Postural Re-education vs. Standard Manual Physical Therapy for Non-specific Chronic Neck Pain With Cross-over|Completed||N/A|100|Actual|University of Bologna||2|||f||||f||||||||||2017-10-11 01:16:54.455233|2017-10-11 01:16:54.455233
NCT01947218|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-08-20|||July 2014||2014-07-01|August 2015|2015-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||EFFECT OF SMOKING ON MUCUS HYPERSECRETION MECHANISMS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE|EFFECT OF SMOKING ON MUCUS HYPERSECRETION MECHANISMS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE|Recruiting||N/A|70|Anticipated|Assistance Publique Hopitaux De Marseille||4|||f||||||||||||||2017-10-11 01:16:54.584719|2017-10-11 01:16:54.584719
NCT01947205|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-09-19|||November 2012||2012-11-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Pain and Suction Curettage||Completed||N/A|111|Actual|Kayseri Education and Research Hospital||5|||f||||f||||||||||2017-10-11 01:16:54.731793|2017-10-11 01:16:54.731793
NCT01947192|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2016-02-23|||November 2011||2011-11-01|February 2016|2016-02-01||||November 2012|Actual|2012-11-01||Interventional|||Chlorhexidine as Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions|Chlorhexidine as Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions and Failure-prognostic Variables: A Randomized Controlled Trial|Completed||N/A|50|Actual|Federal University of Pelotas||2|||f||||||||||||||2017-10-11 01:16:54.856567|2017-10-11 01:16:54.856567
NCT01947179|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-25|||September 2011||2011-09-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|CAST||Cognitive Anxiety Sensitivity Treatment for Suicide|Development and Evaluation of a Brief, Suicide Prevention Intervention Reducing Anxiety Sensitivity|Completed||N/A|108|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 01:16:54.981209|2017-10-11 01:16:54.981209
NCT01947166|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-11-28|||December 2013||2013-12-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Pancreatic Resection, Malnutrition and Readmission|Pancreatic Resection, Malnutrition, and Readmission: Assessment and Prevention|Completed||N/A|38|Actual|Duke University|||||f||||t||||||||||2017-10-11 01:16:55.087772|2017-10-11 01:16:55.087772
NCT01947153|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-18|2015-02-24|2015-01-27||November 2013||2013-11-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Treated set (TS): includes all subjects who had been dispensed study medication and were documented to have taken at least 1 dose of study medication.|Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.|Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto® (Two Fixed Dose Combination Tablets of Linagliptin 2.5 mg and Metformin 500 mg) Compared With the Free Combination of Linagliptin 5 mg and Metformin 1000 mg Tablets Under Fasting Conditions.|Completed||Phase 1|36|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:16:55.194557|2017-10-11 01:16:55.194557
NCT01947140|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-02-14|||September 9, 2013|Actual|2013-09-09|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|PDX+Romi||Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies|Phase I/IIA Study of the Novel Antifolate Agent Pralatrexate in Combination With the Histone Deacetylase Inhibitor Romidepsin for the Treatment of Patients With Relapsed and Refractory Lymphoid Malignancies and Multiple Myeloma|Recruiting||Phase 1/Phase 2|93|Anticipated|Columbia University||3|||f||||t|t|f||||||Undecided||2017-10-11 01:16:55.688197|2017-10-11 01:16:55.688197
NCT01946945|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-09-08|||September 2013||2013-09-01|September 2014|2014-09-01||||December 2014|Anticipated|2014-12-01||Interventional|||Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis|Comparison of Standard ART Practice vs. Trophectoderm Biopsy, Whole Chromosome Analysis by Next Generation Sequencing, and Replacement of a Single Euploid Embryo|Unknown status|Recruiting|Phase 2|240|Anticipated|Reprogenetics||2|||f||||t||||||||||2017-10-11 01:16:57.688153|2017-10-11 01:16:57.688153
NCT01947127|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-10-21|2015-04-21||March 2013||2013-03-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01|1 Month|Observational [Patient Registry]|||Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department|Can Venous Lactate Predict the Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients Without Hemodynamic Shock in Emergency Department?|Completed||N/A|458|Actual|Chulalongkorn University|1. This was an observational study that did not evaluate the aggressiveness of the treatment strategies. 2. The study was done in a single, urban, university hospital. 3. The staging of co-morbidity (e.g. cancers) was not well-categorized.||2||f||||t||||||Samples Without DNA|"     Venous blood lactate obtained by standard venipuncture together with other essential blood     works before giving antibiotics or intravenous fluid, if required. Lactate level is measured     by Epoc® point-of-care blood analyzer (Epocal Inc., Ottawa, ON, Canada) within 5 minutes     after obtaining the venous sample without any preservative.   "|No||2017-10-11 01:16:55.881874|2017-10-11 01:16:55.881874
NCT01947114|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-17|||November 2005||2005-11-01|September 2013|2013-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Remifentanil Use in Pediatric Rigid Bronchoscopy|Remifentanil-based Total Intravenous Anesthesia for Pediatric Rigid Bronchoscopy: Comparison of Propofol and Ketamine As Adjuvant|Completed||Phase 4|40|Actual|Bezmialem Vakif University||2|||f||||f||||||||||2017-10-11 01:16:56.36111|2017-10-11 01:16:56.36111
NCT01947101|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-06-12|||February 2014||2014-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|December 2014|Actual|2014-12-01||Interventional|FMT||Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children|A Phase I Study of Fecal Microbiota Transplantation (FMT) in Immunomodulator Dependent Pediatric Ulcerative Colitis (UC)|Completed||Phase 1|6|Actual|Baylor College of Medicine||1|||f||||t||||||||No||2017-10-11 01:16:56.491413|2017-10-11 01:16:56.491413
NCT01947088|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-01-07|||September 2013||2013-09-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Music Therapy on Cognitive Recovery|I. The Effect of Music Therapy on Cognitive Recovery From Pediatric Epilepsy Surgery|Withdrawn||N/A|0|Actual|Seton Healthcare Family||2||Principal Investigator left facility|f||||f||||||||||2017-10-11 01:16:56.609838|2017-10-11 01:16:56.609838
NCT01947075|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2014-08-20|||July 2013||2013-07-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01|30 Days|Observational [Patient Registry]|||Etiologies of Fever Among Adults in Dar es Salaam|Etiologies of Acute Febrile Illness Among Adults Attending an Outpatient Department in Dar es Salaam|Completed||N/A|538|Actual|Swiss Tropical & Public Health Institute|||2||f||||f||||||Samples With DNA|"     Whole blood Serum Sputa Urine   "|||2017-10-11 01:16:56.697414|2017-10-11 01:16:56.697414
NCT01947062|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-17|||October 2013||2013-10-01|September 2013|2013-09-01|October 2014|Anticipated|2014-10-01|June 2014|Anticipated|2014-06-01||Interventional|||Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma|Evaluation of the Benefits of Oral Metronomic Cyclophosphamide in Combination With Standard Cisplatin-etoposide Based Chemotherapy for Squamous Cell Lung Carcinoma|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Swami Rama Cancer Hospital and Research Institute||2|||f||||f||||||||||2017-10-11 01:16:56.799436|2017-10-11 01:16:56.799436
NCT01947049|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-09-15|||July 2013||2013-07-01|September 2017|2017-09-01|June 30, 2014|Actual|2014-06-30|June 30, 2014|Actual|2014-06-30||Interventional|||Influenza Diagnosis, Treatment and Surveillance With Xpert Flu|Influenza Diagnosis, Treatment and Surveillance With Xpert Flu|Completed||N/A|2011|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:16:56.927344|2017-10-11 01:16:56.927344
NCT01947036|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|SRA01||T and B Cell Responses in Autoimmune Diseases|T and B Cell Responses Across Autoimmune Diseases|Terminated||N/A|68|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||6|Lack of enrollment.|f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:16:57.021725|2017-10-11 01:16:57.021725
NCT01947023|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-09-29|||August 29, 2013|Actual|2013-08-29|September 2017|2017-09-01||||December 31, 2019|Anticipated|2019-12-31||Interventional|||Dabrafenib and Lapatinib Ditosylate in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery|A Phase 1 Study of Dabrafenib in Combination With Lapatinib in BRAF Mutant Thyroid Cancer|Recruiting||Phase 1|18|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:16:57.125831|2017-10-11 01:16:57.125831
NCT01947010|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-02-06|||July 2013||2013-07-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PneuVAC||Pneumococcal Vaccination of Crohn Patients|Pneumococcal Vaccination of Crohn Patients - A Randomized, Non-blinded Phase 4 Clinical Trial With the Purpose of Investigating the Immune Response Against Two Different Pneumococcal Vaccines in Patients With Crohn's Disease|Completed||Phase 4|151|Actual|Statens Serum Institut||3|||f||||f||||||||||2017-10-11 01:16:57.22966|2017-10-11 01:16:57.22966
NCT01946997|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-09-19|||July 2006||2006-07-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Observational|||Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography|Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography|Completed||N/A|200|Actual|Johns Hopkins University|||2||f||||f||||||||||2017-10-11 01:16:57.31932|2017-10-11 01:16:57.31932
NCT01946984|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-19|||June 2012||2012-06-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis|Intramuscular Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial, In Post ERCP Pancreatitis.|Completed||Phase 1|182|Actual|Specialized Arab Hospital||2|||f||||t||||||||||2017-10-11 01:16:57.388259|2017-10-11 01:16:57.388259
NCT01946971|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-11-17|||September 2013||2013-09-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)|Lansoprazole in Preterm Infants With Gastroesophageal Reflux|Completed||Phase 1/Phase 2|12|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:16:57.500553|2017-10-11 01:16:57.500553
NCT01946958|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-17|||July 2011||2011-07-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Triple P With Pediatric Residents|Randomized Control Study of the Impact of Primary Care Triple P on Pediatric Residents and Their Patients|Completed||N/A|155|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-11 01:16:57.607238|2017-10-11 01:16:57.607238
NCT01946919|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-11-30|||October 2012||2012-10-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01|14 Days|Observational [Patient Registry]|PACER||Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study|Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study|Unknown status|Recruiting|N/A|18000|Anticipated|Peking University Third Hospital|||1||f||||t||||||||||2017-10-11 01:16:57.94944|2017-10-11 01:16:57.94944
NCT01946906|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2015-04-23|||October 2013||2013-10-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Rifaximin Study in CVID|Effects of Rifaximin, by Modulation of the Gut Microbiota, on Markers of Systemic Inflammation in Patients With Common Variable Immunodeficiency - An Exploratory Open-label Randomized Controlled Trial|Completed||Phase 4|40|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:16:58.547443|2017-10-11 01:16:58.547443
NCT01946893|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2015-07-09|||September 2013||2013-09-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Mindfulness Meditation for Cognition and Mood|Mindfulness Meditation for Cognition and Mood: A Pilot Study Evaluating Feasibility and Collecting Preliminary Data|Completed||N/A|21|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:16:58.633005|2017-10-11 01:16:58.633005
NCT01946880|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-02-03|||November 2013||2013-11-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ALE06||Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)|An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)|Recruiting||Phase 2|120|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 01:16:58.729755|2017-10-11 01:16:58.729755
NCT01946867|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-03-24|||August 2013||2013-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx|PhI Study of NBTXR3 With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx|Recruiting||Phase 1|48|Anticipated|Nanobiotix||2|||f||||t||||||||||2017-10-11 01:16:59.066556|2017-10-11 01:16:59.066556
NCT01946854|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-10-07|||July 2013||2013-07-01|October 2016|2016-10-01||||July 2018|Anticipated|2018-07-01||Interventional|||Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei|A Randomized Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei|Recruiting||N/A|30|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 01:16:59.235651|2017-10-11 01:16:59.235651
NCT01946841|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2015-04-16|||August 2013||2013-08-01|September 2013|2013-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|AL-EN-PHED||Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life|Effets de la Nutrition entérale spécifique RealDiet®Renal (NES) Chez Des Patients Insuffisants rénaux hémodialysés dénutris : efficacité, tolérance, qualité de Vie.|Withdrawn||Phase 2|0|Actual|Lactalis||1||No Patient recruitment|f||||t||||||||||2017-10-11 01:16:59.342358|2017-10-11 01:16:59.342358
NCT01946828|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2013-09-16|||October 2013||2013-10-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|TP 7601-CL||Evaluation of the FIM - a Non Invasive Device for Temporarily and Quick Pupil Dilation (Mydriasis)|Evaluation of the FIM - a Non Invasive Device for Temporarily and Quick Pupil Dilation (Mydriasis)|Unknown status|Not yet recruiting|N/A|70|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 01:16:59.440219|2017-10-11 01:16:59.440219
NCT01946815|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-01-30|||September 2013||2013-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|FORTE||Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease|Phase 3 Study of Effect of ATorvastatin on Fractional Flow Reserve in Coronary Artery Disease|Active, not recruiting||Phase 3|119|Anticipated|Keimyung University Dongsan Medical Center||1|||f||||f||||||||||2017-10-11 01:16:59.562969|2017-10-11 01:16:59.562969
NCT01946789|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-01-23|||April 2014||2014-04-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors|A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803, a Novel Recombinant IL-15 Complex in Patients With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer|Recruiting||Phase 1|20|Anticipated|Altor BioScience||1|||f||||t||||||||Undecided||2017-10-11 01:16:59.822555|2017-10-11 01:16:59.822555
NCT01946776|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-12-23|||June 2013||2013-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CARELINK||Cardiac Arrhythmias in Epilepsy: the CARELINK-study|Cardiac Arrhythmias in Refractory Epilepsy: Identifying Prevalence and LINKage Between Seizures and Arrhythmias|Completed||N/A|49|Actual|Stichting Epilepsie Instellingen Nederland||1|||f||||f||||||||||2017-10-11 01:16:59.962647|2017-10-11 01:16:59.962647
NCT01946763|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-09-19|||June 2013||2013-06-01|September 2013|2013-09-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Interventional|||Does Pre-operative Patients' Education Facilitates Emergence of Anesthesia Following Bariatric Surgery?|Does Pre-operative Patients' Education Facilitates Emergence of Anesthesia Following Bariatric Surgery?|Unknown status|Recruiting|N/A|80|Anticipated|Procare Riaya Hospital||2|||f||||f||||||||||2017-10-11 01:17:00.13051|2017-10-11 01:17:00.13051
NCT01946750|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-08-17|||December 2012|Actual|2012-12-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2016|Actual|2016-06-01||Interventional|SERODIFF||Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections||Completed||N/A|240|Actual|Versailles Hospital||2|||f||||t||||||||||2017-10-11 01:17:00.28091|2017-10-11 01:17:00.28091
NCT01944488|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-12|||September 2013||2013-09-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||LH Response to GnRH Test in Prepubescent Girls Under 6 Years|LH Response to GnRH Test in Prepubescent Girls Under 6 Years|Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-10-11 01:17:44.8121|2017-10-11 01:17:44.8121
NCT01946737|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-16|||April 2011||2011-04-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||High Definition CT Coronary Angiography Accuracy Trial|Diagnostic Performance of 64 Slice High Definition Computed Tomographic Coronary Angiography in Patients With High Risk of Significant Coronary Artery Disease.|Completed||N/A|302|Actual|Plymouth Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 01:17:00.502664|2017-10-11 01:17:00.502664
NCT01946724|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-03-28|||August 2013||2013-08-01|April 2014|2014-04-01||||December 2016|Anticipated|2016-12-01||Observational|Perspective||In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program|A Single Center, Observational Study to Evaluate Procedural, In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program|Unknown status|Recruiting|N/A|500|Anticipated|Piedmont Healthcare|||1||f||||f||||||||||2017-10-11 01:17:00.582523|2017-10-11 01:17:00.582523
NCT01946711|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-04-10|||April 2014||2014-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi|A Pilot Study to Investigate the Efficacy and Safety of Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis (CRS) With Polyposis Nasi in Adult Patients|Recruiting||Phase 3|20|Anticipated|Pari Pharma GmbH||2|||f||||f||||||||||2017-10-11 01:17:00.689475|2017-10-11 01:17:00.689475
NCT01946698|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2013-09-19|||June 2013||2013-06-01|September 2013|2013-09-01|September 2030|Anticipated|2030-09-01|December 2016|Anticipated|2016-12-01|4 Months|Observational [Patient Registry]|||Endometriosis, Food Consumption and Fertility|A Study on the Differences in Inflammatory Markers Between Women With Endometriosis and Women Without in Relation to Fertility and Food Consumption.|Recruiting||N/A|60|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Blood samples for inflammatory markers, hormones and genetic testing. Follicular fluid for     inflammatory markers. Cells from the uterus for testing of different additives and what     characterize cells from women with endometriosis compared to controls.   "|||2017-10-11 01:17:00.84613|2017-10-11 01:17:00.84613
NCT01946685|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-03-30|||November 2012||2012-11-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|November 2015|Anticipated|2015-11-01||Interventional|||A Randomized Clinical Trial of Mifepristone in PTSD|Novel Therapeutics in PTSD: A Randomized Clinical Trial of Mifepristone|Unknown status|Recruiting|Phase 2|136|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||t||||||||||2017-10-11 01:17:00.927224|2017-10-11 01:17:00.927224
NCT01946672|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-02-02|||July 2013||2013-07-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|SENTIJAMBE||Lower-Limb Drainage Mapping in Pelvic Lymphadenectomy for Gynaecological Cancer|Individualisation du Drainage Lymphatique Des Membres inférieurs Lors du Curage Pelvien Pour Cancer gynécologique|Active, not recruiting||Phase 4|55|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:17:01.023092|2017-10-11 01:17:01.023092
NCT01946659|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-09-09|||September 2009||2009-09-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MetSO||Promoting Adherence to Sleep Apnea Treatment Among Blacks With Metabolic Syndrome|Promoting Adherence to Sleep Apnea Treatment Through Health Education Among Blacks With Metabolic Syndrome|Completed||N/A|344|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 01:17:01.105204|2017-10-11 01:17:01.105204
NCT01946646|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-01-15|||October 2013||2013-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SR-GS||Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer|A Phase I Study of TS-1 With Concurrent Radiotherapy Followed by Gemcitabine and TS-1 in Metastatic Pancreatic Cancer (SR-GS Study)|Terminated||Phase 1|10|Actual|National Taiwan University Hospital||1||slow recruitment|f||||f||||||||||2017-10-11 01:17:01.221385|2017-10-11 01:17:01.221385
NCT01946633|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-10-28|||October 2013||2013-10-01|October 2013|2013-10-01||||September 2014|Anticipated|2014-09-01||Interventional|||Remote-controlled Capsule Endoscopy: a Feasibility Study|Remote-controlled Capsule Endoscopy: a Feasibility Study|Unknown status|Recruiting|N/A|80|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||||2017-10-11 01:17:01.292649|2017-10-11 01:17:01.292649
NCT01946620|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-08-30|||October 2013||2013-10-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD|A Randomised, Double-blind, Double Dummy, Parallel Group Study Comparing Fluticasone Propionate / Formoterol Fumarate (Flutiform®) 250/10 µg (2 Puffs BID) and Flutiform® 125/5 µg (2 Puffs BID) Versus Formoterol Fumarate Dihydrate (Atimos®) 12 µg (1 Puff BID) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|1767|Actual|Mundipharma Research Limited||3|||f||||f||||||||||2017-10-11 01:17:01.367231|2017-10-11 01:17:01.367231
NCT01946607|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2013-09-16|||July 2009||2009-07-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Antidepressants, Emotions and Personality|Antidepressants, Emotions and Personality: Comparing the Neuropsychological Effects of the Antidepressant Citalopram in Healthy Volunteers With High and Low Neuroticism|Completed||N/A|42|Actual|Medical Research Council Cognition and Brain Sciences Unit||2|||f||||f||||||||||2017-10-11 01:17:01.49932|2017-10-11 01:17:01.49932
NCT01946594|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-01-19|||October 2013||2013-10-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV|Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Rates of Fever After 2013-2014 Inactivated Influenza Vaccine (IIV) in Young Children|Completed||Phase 4|41|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:17:01.586519|2017-10-11 01:17:01.586519
NCT01946581|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-16|||May 2013||2013-05-01|September 2013|2013-09-01||||May 2014|Anticipated|2014-05-01||Observational|||Retrospective Patient Satisfaction Survey in Subjects With Tecnis Intra Ocular Lenses and Cataracts Surgery|Retrospective Patient Satisfaction Survey in Subjects With Tecnis Intra Ocular Lenses Cataracts Surgery|Unknown status|Recruiting|N/A|200|Anticipated|MDbackline, LLC|||1||f||||f||||||||||2017-10-11 01:17:01.702035|2017-10-11 01:17:01.702035
NCT01946399|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-12-21|||September 2013||2013-09-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF|Dexamethasone Intravitreal Implant for Retinal Vein Occlusion Associated Macular Edema After Treatment Failure With Anti-VEGF Medications|Terminated||N/A|10|Actual|Retina Research Institute, LLC||1||enrollment not met|f||||f||||||||||2017-10-11 01:17:08.768181|2017-10-11 01:17:08.768181
NCT01946568|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-06-22|||June 2013||2013-06-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.|A Phase 1, Open Label, Single Dose Study To Investigate The Pharmacokinetics, Safety and Tolerability Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment For Bacterial Infections|Completed||Phase 1|36|Anticipated|Durata Therapeutics Inc., an affiliate of Allergan plc||1|||f||||f||||||||||2017-10-11 01:17:02.388417|2017-10-11 01:17:02.388417
NCT01946555|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-04-13|||September 2013||2013-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|RER||Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain|Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain|Completed||N/A|150|Actual|Mario Negri Institute for Pharmacological Research|||1||f||||f||||||||||2017-10-11 01:17:02.491374|2017-10-11 01:17:02.491374
NCT01946542|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-11-10|2015-09-28||February 2014||2014-02-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure|Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure|Terminated||Phase 1/Phase 2|2|Actual|Duke University|The study was terminated due to low enrollment.|2||Low enrollment|f||||f||||||||||2017-10-11 01:17:02.607403|2017-10-11 01:17:02.607403
NCT01946529|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-04-11|2016-06-30||November 2013||2013-11-01|August 2016|2016-08-01|July 2026|Anticipated|2026-07-01|August 2015|Actual|2015-08-01||Interventional|||Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors|Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors|Active, not recruiting||Phase 2|24|Actual|St. Jude Children's Research Hospital|Interim analysis to evaluate efficacy of the therapy determined that the window therapy did not meet the anticipated response, and trial accrual was stopped. Some patients continue on therapy.|2|||f||||t|t|f||||||||2017-10-11 01:17:02.893597|2017-10-11 01:17:02.893597
NCT01946516|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-07-17|||August 29, 2013|Actual|2013-08-29|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|January 2018|Anticipated|2018-01-01||Observational|||S1204, Viral Screening in Newly Diagnosed Cancer Patients|A Sero-Epidemiologic Survey and Cost Effectiveness Study of Screening for Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Among Newly Diagnosed Cancer Patients|Active, not recruiting||N/A|2863|Actual|Southwest Oncology Group|||1||f||||t||||||Samples With DNA|"     Specimen submission is optional.   "|||2017-10-11 01:17:03.726486|2017-10-11 01:17:03.726486
NCT01946503|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-03-02|||April 2013||2013-04-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Infant & Toddler Short Gut Feeding Outcomes Study|Infant & Toddler Short Gut Feeding Outcomes Study|Recruiting||N/A|40|Anticipated|Children's Hospital Los Angeles|||1||f||||f||||||||No||2017-10-11 01:17:03.902177|2017-10-11 01:17:03.902177
NCT01946490|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-09-29|||December 2015||2015-12-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Time Trends in Waiting Times of NSCLC Patients.|Time Trends in Diagnostic Delay and Waiting Times of Four Patient Cohorts, Diagnosed With Non-small Cell Lung Cancer, Treated With High Dose Radiotherapy.|Withdrawn||N/A|0|Actual|Maastricht Radiation Oncology|||4|Not subsidized, will not start in the near future|f||||f||||||||||2017-10-11 01:17:03.983768|2017-10-11 01:17:03.983768
NCT01946477|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-09-28|||May 29, 2014|Actual|2014-05-29|September 2017|2017-09-01|February 28, 2023|Anticipated|2023-02-28|December 31, 2018|Anticipated|2018-12-31||Interventional|POM MM 014||Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting|A Phase 2, Multicenter, Multi-cohort, Open-label Study of Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide Based Therapy in the First or Second Line Setting.|Recruiting||Phase 2|156|Anticipated|Celgene||2|||f||||f||||||||||2017-10-11 01:17:04.067349|2017-10-11 01:17:04.067349
NCT01946464|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-12-23|||September 2012||2012-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Novel Technique for Face Mask Ventilation|Novel Technique for Face Mask Ventilation|Terminated||N/A|30|Actual|Rutgers, The State University of New Jersey|||2||f||||f||||||||No||2017-10-11 01:17:06.241257|2017-10-11 01:17:06.241257
NCT01946451|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-09-18|||June 2012||2012-06-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|September 2013|Actual|2013-09-01||Observational|||Gene Expression in Patients With Epiretinal Membranes|Gene Expression and Their Correlations in Patients With Idiopathic and Secondary Epiretinal Membranes in Proliferative Diabetic Retinopathy|Unknown status|Active, not recruiting|N/A|||Medical University of Silesia|||2||f||||f||||||||||2017-10-11 01:17:06.315835|2017-10-11 01:17:06.315835
NCT01946438|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-09-17|2014-09-17||September 2013||2013-09-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|||Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults|Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines, 2013-2014 Formulations|Completed||Phase 4|208|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 01:17:06.397818|2017-10-11 01:17:06.397818
NCT01946425|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-09-17|2014-09-17||September 2013||2013-09-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine|Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine (2013-2014 Formulation)|Completed||Phase 4|60|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:17:07.280673|2017-10-11 01:17:07.280673
NCT01946412|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-12-06|2016-12-06||December 2013||2013-12-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation|A Phase 3, 2-Arm, Roll-Over Study to Evaluate the Long-term Safety and Pharmacodynamics of Ivacaftor Treatment in Pediatric Subjects With Cystic Fibrosis and a CFTR Gating Mutation|Completed||Phase 3|33|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||t||||||||||2017-10-11 01:17:07.925206|2017-10-11 01:17:07.925206
NCT01946373|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-09-26|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma|A Phase I Study to Evaluate Safety, Feasibility and Immunologic Response of Adoptive T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Metastatic Melanoma|Recruiting||Phase 1|10|Anticipated|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 01:17:08.930156|2017-10-11 01:17:08.930156
NCT01946360|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-09-26|||April 2014||2014-04-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).||Completed||N/A|24|Actual|Institute of Liver and Biliary Sciences, India||1|||f||||f||||||||||2017-10-11 01:17:09.03114|2017-10-11 01:17:09.03114
NCT01946347|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-03-03|||September 2013||2013-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|EndoPat||Endothelial Function in Patients With Type 2 Diabetes Versus Healthy Subjects|Effect of Hyperinsulinemia and Postprandial Metabolic Changes on Endothelial Function in Patients With Type 2 Diabetes Versus Healthy Subjects|Completed||N/A|60|Actual|Institute for Clinical and Experimental Medicine||2|||f||||t||||||||||2017-10-11 01:17:09.201388|2017-10-11 01:17:09.201388
NCT01946334|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2014-08-29|||June 2013||2013-06-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Does Body Position Influence Pressure Recording by High-resolution Manometry ?|Does Body Position Influence Pressure Recording by High-resolution Manometry ?|Completed||N/A|40|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:17:09.278242|2017-10-11 01:17:09.278242
NCT01946321|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-03-17|||September 2013||2013-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Outcome Measures for Lower Limb Amputees - A Rehabilitation Study|PhD Research Project: Clinimetric Properties of Outcome Measures of Physical Function Used With Lower Limb Amputees, Study 1|Completed||N/A|30|Actual|Queen Margaret University||1|||f||||f||||||||||2017-10-11 01:17:09.342912|2017-10-11 01:17:09.342912
NCT01946308|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2013-09-18|||September 2011||2011-09-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Sleep Organization in Premature Infants With Feeding Difficulties|Sleep Organization in Premature Infants With Feeding Difficulties|Completed||N/A|25|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 01:17:09.430495|2017-10-11 01:17:09.430495
NCT01946295|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-04-13|||March 2014||2014-03-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Famotidine in Schizophrenia|Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia|Unknown status|Recruiting|Phase 2/Phase 3|140|Anticipated|Helsinki University||2|||f||||f||||||||||2017-10-11 01:17:09.522468|2017-10-11 01:17:09.522468
NCT01946282|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-06-21|||November 2013|Actual|2013-11-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|April 2017|Actual|2017-04-01||Interventional|||Evidence-Based Colorectal Cancer Screening for the Uninsured|Evidence-Based Colorectal Cancer Screening for the Uninsured|Active, not recruiting||N/A|15152|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-11 01:17:09.644993|2017-10-11 01:17:09.644993
NCT01946269|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-09-18|||September 2013||2013-09-01|September 2013|2013-09-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|GRICS II||Goal-Directed Therapy in Cancer Surgery|Goal-directed Resuscitation in High-risk Patients Undergoing Major Cancer Surgery: a Controlled and Randomized Study|Unknown status|Recruiting|Phase 3|128|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:17:09.735434|2017-10-11 01:17:09.735434
NCT01946256|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-03-26|||October 2013||2013-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Treatment of Antenatal Chlamydia Infection|Erythromycin Versus Amoxicillin for Treatment of Antenatal Chlamydia Trachomatis Infection: A Randomized Controlled Trial|Completed||Phase 2|220|Actual|Obafemi Awolowo University Teaching Hospital||2|||f||||f||||||||||2017-10-11 01:17:09.843689|2017-10-11 01:17:09.843689
NCT01946243|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2015-06-01|2015-04-27||August 2013||2013-08-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Feasibility of Florbetapir Quantitation|The Feasibility and Reliability of Utilizing Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Qualitative Interpretation of Amyvid Brain Scans|Completed||Phase 4|96|Actual|Avid Radiopharmaceuticals|No conclusions can be drawn regarding the relative performance of software packages (different readers) or on impact of additional qualitative practice on quantitative interpretation results (Vis Q always after Qualitative).|1|||f||||f||||||||||2017-10-11 01:17:09.961852|2017-10-11 01:17:09.961852
NCT01946230|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-04-25|||June 2014||2014-06-01|April 2014|2014-04-01||||August 2014|Anticipated|2014-08-01|6 Years|Observational [Patient Registry]|p62/SQSTM1||The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma|The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma|Unknown status|Not yet recruiting|N/A|2000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:17:10.50422|2017-10-11 01:17:10.50422
NCT01946217|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-08-16|||September 2013||2013-09-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials|Improving Participation in AMC Clinical Trials (IMPACTS)|Completed||N/A|82|Actual|AIDS Malignancy Consortium|||1||f||||f||||||||No||2017-10-11 01:17:10.597637|2017-10-11 01:17:10.597637
NCT01946204|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-09-25|||October 14, 2013|Actual|2013-10-14|September 2017|2017-09-01|August 29, 2019|Anticipated|2019-08-29|May 19, 2017|Actual|2017-05-19||Interventional|SPARTAN||A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 3|1200|Actual|Aragon Pharmaceuticals, Inc.||2|||f||||t||f||||||||2017-10-11 01:17:10.808823|2017-10-11 01:17:10.808823
NCT01946191|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-08-23|||October 2013||2013-10-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Interventional|MAINTAIN-PC||Computer-Based Weight Maintenance in Primary Care|Maintaining Activity and Nutrition Through Technology-Assisted Innovation in Primary Care|Active, not recruiting||N/A|194|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:17:11.878151|2017-10-11 01:17:11.878151
NCT01946178|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-04-28|2016-02-24||January 2011||2011-01-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Baseline characteristics are reported for the entire study population (all treated patients).|Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids|Clinical Study of a Focused Ultrasound Device for Treating Uterine Fibroids and Menorrhagia|Completed||N/A|73|Actual|Mirabilis Medica, Inc.||1|||f||||f||||||||||2017-10-11 01:17:11.968488|2017-10-11 01:17:11.968488
NCT01946165|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-08-08|||October 31, 2013|Actual|2013-10-31|August 2017|2017-08-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|||Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide|A Pre-Operative Study to Assess the Effects of Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide for Six Months for Prostate Cancer Patients at High-Risk for Recurrence|Completed||Phase 2|69|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:17:12.217292|2017-10-11 01:17:12.217292
NCT01946152|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-09-22|||March 5, 2014|Actual|2014-03-05|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Study of Pomalidomide and Dexamethasone With Growth Factor Support in Patients With Relapsed/Refractory Multiple Myeloma|A Phase I/II Study of Pomalidomide and Dexamethasone With Growth Factor Support in Patients With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|21|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:17:12.324079|2017-10-11 01:17:12.324079
NCT01946139|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-06-14|||December 2013||2013-12-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV|Screening HIV-Infected Women for Anal Cancer Precursors|Active, not recruiting||N/A|276|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-10-11 01:17:12.451983|2017-10-11 01:17:12.451983
NCT01946126|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2016-02-15|2015-10-29||March 2014||2014-03-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache||Completed||N/A|459|Actual|Allergan|||2||f||||f||||||||||2017-10-11 01:17:12.615018|2017-10-11 01:17:12.615018
NCT01946113|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-08-19|||September 2013||2013-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Mineral-Homeostasis in Continuous Renal Replacement Therapy|Phosphate, Magnesium and Calcium-Homeostasis in Patients With Acute Renal Failure and Continuous Renal Replacement Therapy|Completed||N/A|200|Actual|Heinrich-Heine University, Duesseldorf|||2||f||||f||||||||||2017-10-11 01:17:12.900542|2017-10-11 01:17:12.900542
NCT01946100|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-12-19|||October 2013||2013-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Treatment of Multifocal Lung Adenocarcinoma|A Clinical Pathway for the Treatment of Multifocal Lung Adenocarcinoma Using Genome Sequencing|Recruiting||N/A|100|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:17:12.964388|2017-10-11 01:17:12.964388
NCT01946087|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-11-19|||June 2013||2013-06-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Remote Ischemic Preconditioning Induces Myocardial RISK Signaling Pathway in Patients Undergoing Valvular Heart Surgery||Completed||Phase 4|79|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:17:13.080299|2017-10-11 01:17:13.080299
NCT01946074|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-17|2017-07-11|||August 27, 2013||2013-08-27|July 2017|2017-07-01|February 13, 2018|Anticipated|2018-02-13|February 13, 2018|Anticipated|2018-02-13||Interventional|||Study of ABT-165 in Subjects With Advanced Solid Tumors|A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABT-165, a Dual Variable Domain Immunoglobulin in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|90|Anticipated|AbbVie||3|||f||||f||||||||||2017-10-11 01:17:13.153603|2017-10-11 01:17:13.153603
NCT01946061|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-08-18|||May 2015||2015-05-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer||Terminated||Phase 2|3|Actual|Yonsei University||1||This study was stopped because of difficulties of supplying the drug.|f||||t||||||||||2017-10-11 01:17:13.261578|2017-10-11 01:17:13.261578
NCT01946048|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-10-05|||October 2013||2013-10-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy|Safety and Efficacy Investigation of Patients With Ischemic Cardiomyopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells|Unknown status|Not yet recruiting|Phase 1|10|Anticipated|Hebei Medical University||1|||f||||t||||||||||2017-10-11 01:17:13.335751|2017-10-11 01:17:13.335751
NCT01946035|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-12-11|||September 2013||2013-09-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MAN01||Alpha-Blockers in Allergic Rhinitis (MAN 01)|A Proof of Concept Study in Allergic Rhinitis, to Evaluate the Differential Effects Between Single and Chronic Dosing of Doxazosin on Nasal Airway Calibre|Completed||Phase 4|17|Actual|University of Dundee||2|||f||||f||||||||||2017-10-11 01:17:13.435901|2017-10-11 01:17:13.435901
NCT01946022|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-11-06|||September 2013||2013-09-01|November 2013|2013-11-01||||October 2014|Anticipated|2014-10-01||Interventional|||Evaluation of Granulosa Cells Function After IVF Protocols|In Vitro Evaluation of Luteinized Granulosa Cells After Being Submitted to in Vitro Fertilization Protocols With Gonadotropin-Releasing Hormone (GnRH) Agonist and GnRH Antagonist|Unknown status|Recruiting|N/A|28|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||||||||||||2017-10-11 01:17:13.558802|2017-10-11 01:17:13.558802
NCT01946009|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-06-28|||September 2013||2013-09-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|CIDAN12||A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients|A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients|Completed||N/A|20|Actual|Fundacion SEIMC-GESIDA||1|||f||||f||||||||||2017-10-11 01:17:13.683868|2017-10-11 01:17:13.683868
NCT01945983|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-03-31|||September 2013||2013-09-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CENSER||Early Use of Norepinephrine in Septic Shock Resuscitation|The Comparison Between Early Norepinephrine Use and Standard Treatment During Severe Sepsis and Septic Shock Resuscitation.|Recruiting||N/A|300|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-11 01:17:14.021523|2017-10-11 01:17:14.021523
NCT01945970|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2017-02-17|2016-12-23||September 2013||2013-09-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|Heraclitus|Cross over study where all subjects recieved all treatments|Effect of Black Tea on Vascular Function|Randomized Double Blind Placebo Controlled Crossover Study to Assess the Effect of Black Tea on Flow-Mediated Dilation in Healthy, Non-tea Drinking Males|Completed||N/A|30|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-11 01:17:14.181297|2017-10-11 01:17:14.181297
NCT01945957|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-04-21|||September 2014||2014-09-01|August 2016|2016-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Brain Imaging of Intranasal Oxytocin Treatment in Autism|Brain Imaging and Eye-tracking in Response to Intranasal Oxytocin Treatment in Children and Adolescents With Autism|Completed||Phase 1|33|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:17:15.073264|2017-10-11 01:17:15.073264
NCT01945944|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-05-19|2015-07-27||October 2013||2013-10-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Nebulized Hypertonic Saline for Mechanically Ventilated Children|Nebulized Hypertonic Saline for Mechanically Ventilated Children|Completed||Phase 1/Phase 2|18|Actual|University Hospitals Cleveland Medical Center|As shown above, baseline lung function (as measured by PEEP) was worse in the treatment (HTS) group.|2|||f||||t||||||||No||2017-10-11 01:17:15.191895|2017-10-11 01:17:15.191895
NCT01945931|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2015-10-06|||September 2013||2013-09-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Evaluation of a Smartphone Application to Reduce Adverse Pregnancy Outcomes in Ethiopia|Evaluation of a Smartphone Application to Reduce Adverse Pregnancy Outcomes in Ethiopia: A Cluster-randomised Controlled Trial|Completed||N/A|3601|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 01:17:15.699243|2017-10-11 01:17:15.699243
NCT01945918|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-01-09|||October 2013||2013-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparing Strategies for Translating Self-management Support Into Primary Care|Comparing Strategies for Translating Self-management Support Into Primary Care|Active, not recruiting||N/A|1080|Anticipated|University of Colorado, Denver||3|||f||||t||||||||||2017-10-11 01:17:15.797353|2017-10-11 01:17:15.797353
NCT01945905|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-08-10|||December 2009||2009-12-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|DOTS||Cost-effectiveness of Two Forms of DOTS in a Demonstration Area of the DOTS Strategy in Colombia|Cost-effectiveness of Two Forms of Delivery of Directly Observed Treatment in a Demonstration Area of the DOTS Strategy in Colombia|Completed||N/A|264|Actual|Fundación FES||2|||f||||t||||||||||2017-10-11 01:17:15.898882|2017-10-11 01:17:15.898882
NCT01945892|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-09-18|||November 2011||2011-11-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome|Ozurdex as an Treatment Option for Macula Edema Due to Irvine Gass Syndrome|Completed||N/A|23|Actual|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||||2017-10-11 01:17:16.008958|2017-10-11 01:17:16.008958
NCT01945879|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-16|||January 2003||2003-01-01|September 2013|2013-09-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer|Pilot Study of Intensified Chemotherapy and Simultaneous Treatment With Heparin in Out-patients With Pancreatic Cancer.|Completed||Phase 1/Phase 2|19|Actual|CONKO-Studiengruppe||1|||f||||t||||||||||2017-10-11 01:17:16.09124|2017-10-11 01:17:16.09124
NCT01945866|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-07-11|||February 2014|Actual|2014-02-01|July 2017|2017-07-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Interventional|||Phase II Combination Steroid and Anti-VEGF for Persistent DME|Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy|Completed||Phase 2|129|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-11 01:17:16.196396|2017-10-11 01:17:16.196396
NCT01945853|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-08-31|||July 2013||2013-07-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)|Imaging Myelin Injury in Amyotrophic Lateral Sclerosis (ALS)|Withdrawn||N/A|0|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 01:17:16.396578|2017-10-11 01:17:16.396578
NCT01945840|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-09-16|||October 2013||2013-10-01|September 2013|2013-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Gut Hormones and Roux en Y Gastric Bypass|Do Gut Hormones Mediate the Beneficial Effects of Roux-en-Y Bypass?|Not yet recruiting||N/A|136|Anticipated|Imperial College London||5|||f||||t||||||||||2017-10-11 01:17:16.481253|2017-10-11 01:17:16.481253
NCT01945827|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-07-02|||January 2014||2014-01-01|July 2014|2014-07-01||||December 2014|Anticipated|2014-12-01|12 Months|Observational [Patient Registry]|||Evaluation of DeltaMaxx® Microcoil System in Intracranial Aneurysms||Withdrawn||N/A|0|Actual|Codman & Shurtleff|||1||f||||f||||||||||2017-10-11 01:17:16.576304|2017-10-11 01:17:16.576304
NCT01945814|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-05-01|||February 2014||2014-02-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|August 2018|Anticipated|2018-08-01||Interventional|||Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)|Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) Targeting CMV (IE1 and pp65), EBV (LMP2, EBNA1), and Adv (Hexon and Penton)|Recruiting||Phase 1|28|Anticipated|Children's Research Institute||2|||f||||t|t|||||||||2017-10-11 01:17:16.645189|2017-10-11 01:17:16.645189
NCT01945801|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-08-19|||October 2013||2013-10-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|DESALT||Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea|The Effect of Sodium-Restricted Diet and Diuretic in the Severe Sleep Apnea: a Randomized Controlled Trial - DESALT Study|Completed||Phase 4|54|Actual|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||||2017-10-11 01:17:16.744601|2017-10-11 01:17:16.744601
NCT01945788|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2014-01-21|||June 2013||2013-06-01|September 2013|2013-09-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|||Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo|Comparación de la Eficacia y Seguridad clínicas de Osteofortil Respecto de Forteo|Unknown status|Active, not recruiting|Phase 4|110|Anticipated|Bio Sidus SA||2|||f||||f||||||||||2017-10-11 01:17:16.864141|2017-10-11 01:17:16.864141
NCT01945775|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-09-08|||October 14, 2013|Actual|2013-10-14|September 2017|2017-09-01|December 27, 2019|Anticipated|2019-12-27|September 15, 2017|Anticipated|2017-09-15||Interventional|EMBRACA||A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)|A Phase 3, Open-label, Randomized Parallel,2-arm,Multi-center Study Of Talazoparib(Bmn 673) Versus Physician's Choice In Germline Brca Mutation Subjects With Locally Advanced And/or Metastatic Breast Cancer, Who Have Received Prior Chemotherapy Regimens For Metastatic Disease|Active, not recruiting||Phase 3|442|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:17:17.014645|2017-10-11 01:17:17.014645
NCT01945762|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-02-28|||February 2014||2014-02-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|Caprelsa104||Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer|European, Observational, Prospective Study to Evaluate the Benefit/Risk of Vandetanib in RET Mutation Negative and Positive Patients With Symptomatic, Aggressive, Sporadic, Unresectable, Locally Advanced/Metastatic Medullary Thyroid Cancer|Recruiting||N/A|80|Anticipated|Sanofi|||2||f||||f||||||||||2017-10-11 01:17:18.061546|2017-10-11 01:17:18.061546
NCT01945749|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2014-05-05|||October 2012||2012-10-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Exercise and Steroid in Knee Osteoarthritis|Combined Intra Articular Corticosteroid and Physiotherapeutic Exercise in Patients With Osteoarthritis of the Knee: A Random-ised Clinical Trial|Completed||N/A|100|Actual|Frederiksberg University Hospital||2|||f||||t||||||||||2017-10-11 01:17:18.277548|2017-10-11 01:17:18.277548
NCT01945736|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-03-04|||January 2014||2014-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|MTH01||Pharmacokinetics of Multiple Dose Methadone in Children Treated for Opiate Withdrawal|Pharmacokinetics of Multiple Dose Methadone in Children|Completed||Phase 1|26|Actual|Duke University|||3||f||||t||||||Samples With DNA|"     The Study team is interested in learning more about how genetic differences in proteins known     as cytochrome P450 enzymes effect the breakdown of methadone. The study team will gather     leftover blood collected from the infant or child while the infant/child was in this study     and send it to a laboratory to test for genetics. There will be no extra blood draws for this     part of the study.      The samples for genetic testing will be given a code number and will not be labeled with the     infant or child's name or initials, or any other information that could identify the infant     or child. Any remaining blood will be destroyed after the genetic laboratory testing is     complete.   "|||2017-10-11 01:17:18.394326|2017-10-11 01:17:18.394326
NCT01945723|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-09-17|||September 2013||2013-09-01|September 2013|2013-09-01|October 2015|Anticipated|2015-10-01|December 2014|Anticipated|2014-12-01||Observational|||Tissue Characterization From Various Parts of the Gastrointestinal Tract in Healthy Volunteers|Tissue Characterization From Various Parts of the Gastrointestinal Tract in Healthy Volunteers|Unknown status|Recruiting|N/A|10|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"     Tissue, liquid and stool samples from Gastrointestinal tract.   "|||2017-10-11 01:17:18.500481|2017-10-11 01:17:18.500481
NCT01945710|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-08-09|||December 2012||2012-12-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|October 2015|Actual|2015-10-01||Interventional|||An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid Tumors|An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid Tumors|Completed||Phase 1|71|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 01:17:18.592814|2017-10-11 01:17:18.592814
NCT01945697|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2014-04-14|||December 2012||2012-12-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Observational|||Validation of DNA Methylation Biomarkers for Oral Cancer Detection|Validation of DNA Methylation Biomarkers for Oral Cancer Detection|Unknown status|Recruiting|N/A|160|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples With DNA|"     Cells from oral mouthwash   "|||2017-10-11 01:17:18.696656|2017-10-11 01:17:18.696656
NCT01945684|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-03-01|||September 2013||2013-09-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity||Completed||Phase 3|197|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||No||2017-10-11 01:17:18.779605|2017-10-11 01:17:18.779605
NCT01945671|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-09-17|||November 2013||2013-11-01|August 2013|2013-08-01|May 2015|Anticipated|2015-05-01|January 2015|Anticipated|2015-01-01||Observational|||The Influence of Obesity on Oocyte, Cumulus and Granulosa Functioning|The Influence of Obesity on Oocyte Functioning and Fertilization, Cumulus and Granulosa Functioning and Metabolic Factors.|Unknown status|Not yet recruiting|N/A|80|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||Samples Without DNA|"     1. triglycerides, free fatty acid, cholesterol (HDl, LDL), insulin, glucose, lactate, IGF-1,     Leptin E2, Progessterone, IL-1, Il-6 and TNF-2. α.blood free fluid from the leading follicle     will be collected in a container for further evaluation of metabolic markers including     triglycerides, free fatty acid, cholesterol (HDl, LDL), insulin, glucose, lactate, IGF-1,     Leptin E2, Progessterone, IL-1, Il-6 and TNF-α , ROS.      3. Cumulus cells 4. Oocytes diameter 5. GV oocytes, M1 and M2 that fail to fertilize 6.     GDF-9, BMP-15, BMP-6, TNF-α, SMAD family will be analyzed by western blott as marker for     oocytes quality.   "|||2017-10-11 01:17:18.916874|2017-10-11 01:17:18.916874
NCT01945658|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-09-15|||November 2013||2013-11-01|August 2013|2013-08-01|May 2015|Anticipated|2015-05-01|January 2015|Anticipated|2015-01-01||Observational|||The Impact of In-Vitro Fertilization (IVF) ON Vitamin D|Evaluate the Influence of Different Levels of Vitamin D on IVF -ICSI Cycles. We Will Evaluate as Well the Influence of Increased Estradiol Level in IVF-ICSI Cycles on Peripheral Vitamin D.|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||Samples Without DNA|"     blood for vitamin-D   "|||2017-10-11 01:17:19.003795|2017-10-11 01:17:19.003795
NCT01945645|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-14|2013-09-14|||September 2006||2006-09-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Ready to Act - Health Education in People With Hyperglycaemia|Ready to Act. A Health Education Programme for People With Screen-detected Hyperglycaemia|Completed||N/A|509|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 01:17:19.099202|2017-10-11 01:17:19.099202
NCT01945632|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-09-17|||January 2011||2011-01-01|September 2013|2013-09-01||||January 2013|Actual|2013-01-01||Interventional|||Effect of Root Planing on Surface Topography.||Completed||N/A|19|Actual|Universidad de Granada||4|||f||||t||||||||||2017-10-11 01:17:19.227717|2017-10-11 01:17:19.227717
NCT01945619|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2016-01-19||||||January 2016|2016-01-01||||||||Expanded Access|EAP CHALLAH||Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)|Expanded Access Protocol: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection With Adenovirus, CMV and EBV After HSCT|No longer available||N/A|||Baylor College of Medicine|||||||||||||||||||2017-10-11 01:17:19.33603|2017-10-11 01:17:19.33603
NCT01945606|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2015-06-12|||November 2013||2013-11-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||Study to Assess the Safety of BAY1067197 in Stable Heart Failure Patients on Standard Therapy Including ß-blocker|A Single Blind, Placebo Controlled Pilot Study to Explore the Safety and Tolerability of a Single Oral Dose of 30 mg BAY1067197 in Patients With Chronic Heart Failure on the Background of Preexisting Beta-blocker Therapy|Completed||Phase 2|11|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:17:19.442082|2017-10-11 01:17:19.442082
NCT01945593|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-03-06|||October 2013||2013-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase 3b Continuation Study of the Safety and Efficacy of Prophylactic BAX 855 in PTPs With Severe Hemophilia A|A Phase 3b Continuation Study of the Safety and Efficacy of PEGylated Recombinant Factor VIII (PEG-rFVIII; BAX 855) in Prophylaxis of Bleeding in Previously Treated Patients With Severe Hemophilia A|Active, not recruiting||Phase 3|250|Anticipated|Baxalta US Inc.||1|||f||||f||||||||||2017-10-11 01:17:19.574789|2017-10-11 01:17:19.574789
NCT01945580|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2017-04-12|||February 2014||2014-02-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|36 Months|Observational [Patient Registry]|Xenform||Xenform Postmarket Surveillance Study|A Prospective, Non-Randomized, Parallel Cohort, Multi-Center Study of Xenform vs. Native Tissue for the Treatment of Women With Anterior/Apical Pelvic Organ Prolapse|Active, not recruiting||N/A|372|Actual|Boston Scientific Corporation|||2||f||||f||||||||||2017-10-11 01:17:20.009782|2017-10-11 01:17:20.009782
NCT01945567|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-14|2014-12-30|||August 2012||2012-08-01|December 2014|2014-12-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|||Randomised Crossover Trial of Deep Brain Stimulation of Differential Posterior Subthalamic Area Regions in Parkinson's Disease and Tremor|Randomised Crossover Trial of Deep Brain Stimulation of Differential Posterior Subthalamic Area Regions in Parkinson's Disease and Tremor|Recruiting||Phase 2|50|Anticipated|The University of Western Australia||3|||f||||f||||||||||2017-10-11 01:17:20.200782|2017-10-11 01:17:20.200782
NCT01945554|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-12-06|||July 2013||2013-07-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|InfStu||The Value of Short-term Pain Relief for the Prediction of Long-term Outcome After Cervical or Lumbar Nerve Root Infiltration|The Value of Short-term Pain Relief for the Prediction of Long-term Outcome After Cervical or Lumbar Nerve Root Infiltration|Active, not recruiting||N/A|250|Anticipated|Cantonal Hospital of St. Gallen||2|||f||||t||||||||||2017-10-11 01:17:20.320038|2017-10-11 01:17:20.320038
NCT01945541|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-31|2016-03-21|||August 2013||2013-08-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|BCM||Body Composition Monitoring(BCM) for Determination of the Fluid Status in Patients Undergoing General Anesthesia|Body Composition Monitoring for Determination of the Fluid Status in Patients Undergoing General Anesthesia|Recruiting||N/A|100|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 01:17:20.450387|2017-10-11 01:17:20.450387
NCT01945528|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2017-09-25|||April 2014||2014-04-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|B-PRPtendon||Platelet Rich Plasma (PRP) in Chronic Epicondylitis|Pilot Randomized Controlled Trial to Evaluate Safety and Efficacy of Percutaneous Needle Tenotomy With Platelet Rich Plasma (Leukocyte Depleted)in Epicondylitis|Active, not recruiting||Phase 3|86|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 01:17:20.603382|2017-10-11 01:17:20.603382
NCT01945515|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2016-12-18|||September 2013||2013-09-01|December 2016|2016-12-01||||December 2016|Actual|2016-12-01||Interventional|||Robotic-assisted Gait Training Combined With Transcranial Direct Current Stimulation to Maximize Gait Recovery After Stroke|Robotic-assisted Gait Training Combined With Transcranial Direct Current Stimulation to Maximize Gait Recovery After Stroke: A Double-blind, Randomized, Controlled Trial|Completed||N/A|21|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 01:17:20.700365|2017-10-11 01:17:20.700365
NCT01945502|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-16|2013-09-16|||September 2013||2013-09-01|September 2013|2013-09-01||||December 2013|Anticipated|2013-12-01||Observational|||Nasopharyngeal Packing and Rhinologic Surgery.|The Effectiveness of Three Different Nasopharyngeal Packing on the Prevention of Postoperative Nausea- Vomiting and Postoperative Throat Pain in Rhinologic Surgery.|Unknown status|Recruiting|N/A|120|Anticipated|Ankara University|||4||f||||f||||||||||2017-10-11 01:17:20.813218|2017-10-11 01:17:20.813218
NCT01945476|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-10-05|||September 2013||2013-09-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Midazolam Premedication Before Induction on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast Surgery Due to Breast Cancer||Completed||N/A|82|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:17:21.216154|2017-10-11 01:17:21.216154
NCT01945463|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-09-15|||October 2013||2013-10-01|September 2013|2013-09-01||||October 2014|Anticipated|2014-10-01||Observational|||The Effect of Breast Augmentation on the Quality of Echocardiography Test||Unknown status|Not yet recruiting|N/A|50|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 01:17:21.356995|2017-10-11 01:17:21.356995
NCT01945450|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2013-11-26|||January 2014||2014-01-01|August 2013|2013-08-01||||September 2016|Anticipated|2016-09-01||Interventional|||Prophylactic Antibiotics for Manual Removal of Retained Placenta in Vaginal Birth: a Randomized Controlled Trial|Prophylactic Antibiotics for Manual Removal of Retained Placenta in Vaginal Birth|Unknown status|Not yet recruiting|N/A|300|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 01:17:21.439695|2017-10-11 01:17:21.439695
NCT01945437|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2013-09-13|||January 2014||2014-01-01|September 2013|2013-09-01||||December 2014|Anticipated|2014-12-01||Interventional|||Magnesium and TKA Pain||Unknown status|Not yet recruiting|N/A|60|Anticipated|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-11 01:17:21.541598|2017-10-11 01:17:21.541598
NCT01945424|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-06-28|||November 5, 2016|Actual|2016-11-05|June 2017|2017-06-01|November 3, 2022|Anticipated|2022-11-03|November 3, 2022|Anticipated|2022-11-03|15 Months|Observational [Patient Registry]|||Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry|Sanofi Pasteur Quadrivalent Influenza Vaccine Pregnancy Registry Protocol|Active, not recruiting||N/A|500|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 01:17:21.625039|2017-10-11 01:17:21.625039
NCT01945411|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-07-30|||September 2013||2013-09-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Assessment of Facial Measurements, the Length of Mouth Corner-mandible Angle and Incisors-mandible Angle, for Determining the Proper Sizes of Oropharyngeal Airway||Completed||N/A|113|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:17:21.746226|2017-10-11 01:17:21.746226
NCT01945398|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-15|2015-12-02|||June 2013||2013-06-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||IMT in Ventilatory Muscle Metaboreflex in COPD|Effect of Inspiratory Muscle Training in the Ventilatory Muscle Metaboreflex in Chronic Obstructive Pulmonary Disease Patients.|Completed||N/A|13|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 01:17:21.853798|2017-10-11 01:17:21.853798
NCT01945385|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2014-07-25|||June 2013||2013-06-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|LARC IUD||Impact of Video Intervention on Postabortal Uptake of Long Acting Reversible Contraception (LARC)||Completed||N/A|193|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 01:17:21.999862|2017-10-11 01:17:21.999862
NCT01945372|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2014-03-26|||October 2013||2013-10-01|September 2013|2013-09-01|August 2017|Anticipated|2017-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Neurofeedback Treatment of Affective Instability in Premenstrual Dysphoric Disorder(PMDD)|Self-modulation of Prefrontal Alpha Asymmetry:Novel Neurofeedback Treatment of Affective Instability in Premenstrual Dysphoric Disorder(PMDD)|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-11 01:17:22.102276|2017-10-11 01:17:22.102276
NCT01945359|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2015-10-14|||September 2013||2013-09-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Observational|IIT6||Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design|A Pilot Study to Assess Disease State Stability, Efficacy, and Tolerability in a Natalizumab to Dimethyl Fumarate Crossover Design|Completed||N/A|30|Actual|Rocky Mountain MS Research Group, LLC|||1||f||||f||||||Samples Without DNA|"     Serum Samples   "|||2017-10-11 01:17:22.201965|2017-10-11 01:17:22.201965
NCT01945346|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2015-08-25|||September 2013||2013-09-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||An Exploratory Study of PRX167700 in Patients With Knee Osteoarthritis|A Double-Blind, Randomised, Exploratory Study to Investigate the Safety, Efficacy and Pharmacokinetics of PRX167700 in Subjects With Knee Osteoarthritis.|Completed||Phase 2|74|Actual|Proximagen Limited||2|||f||||f||||||||||2017-10-11 01:17:22.299406|2017-10-11 01:17:22.299406
NCT01945333|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-06-06|||September 2013||2013-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Personalized and Scalable Cognitive Remediation Approaches|Personalized and Scalable Cognitive Remediation Approaches|Active, not recruiting||N/A|122|Actual|New York State Psychiatric Institute||4|||f||||f||||||||||2017-10-11 01:17:22.438854|2017-10-11 01:17:22.438854
NCT01945320|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-04-11|||March 2012||2012-03-01|April 2014|2014-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Effects Nutrition Status and Body Composition on HD Patients' Outcome|The Effects Nutrition Status and Body Composition on HD Patients' Outcome|Unknown status|Recruiting|N/A|250|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 01:17:22.59295|2017-10-11 01:17:22.59295
NCT01945307|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-05-23|||October 2013||2013-10-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Observational|C2||Complement 2: Blood Donations to Develop Vaccines Against Infectious Diseases|Sourcing Human Blood Products to Support the Development of New Vaccines Against Infectious Diseases|Recruiting||N/A|400|Anticipated|University of Oxford|||1||f||||f||||||Samples Without DNA|"     Serum only, no DNA or other blood components are stored.   "|||2017-10-11 01:17:22.706181|2017-10-11 01:17:22.706181
NCT01945294|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-02-23|2016-07-27||October 2013||2013-10-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional||The total number of participants in Arm 3 (i.e., n=50) includes participants who completed the BOC + PR lead-in and were allocated at Week 12 based on having detectable HCV RNA (n=29), as well as participants who began the BOC + PR lead-in but discontinued prior to Week 12 (n=21).|Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)|A Phase 3 Clinical Trial to Study Short Duration Versus Standard Response-Guided Therapy With MK-3034 (SCH 503034)/Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Subjects With Chronic HCV Genotype 1 in Asia|Completed||Phase 3|257|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:17:22.831965|2017-10-11 01:17:22.831965
NCT01945268|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-08-03|||April 2015||2015-04-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IVVE:Pilot||Influenza Vaccine To Prevent Adverse Vascular Events:Pilot|A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events: A Pilot Study|Completed||Phase 4|107|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 01:17:23.729603|2017-10-11 01:17:23.729603
NCT01945047|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-12-13|||May 2013||2013-05-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|||Action of Ketamine in Treatment-Resistant Depression|Phase 2 Optimization of the Antidepressant Action of Ketamine in Treatment-Resistant Depression and Investigations on Its Mechanism of Action|Recruiting||Phase 2/Phase 3|63|Anticipated|University of Ottawa||2|||f||||t||||||||Undecided||2017-10-11 01:17:31.755992|2017-10-11 01:17:31.755992
NCT01945255|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-04-11|||March 2012||2012-03-01|April 2014|2014-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Relationship Between Aortic Pulse Wave and Peripheral Artery Occlusion Disease in Hemodialysis Patients|The Relationship Between Aortic Pulse Wave and Peripheral Artery Occlusion Disease in Hemodialysis Patients|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 01:17:23.924142|2017-10-11 01:17:23.924142
NCT01945242|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-09-23|2016-06-13||March 2011||2011-03-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational||The safety analysis set was defined as all participants who were enrolled and completed the study.|"Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"|"Nesina Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"|Completed||N/A|1374|Actual|Takeda|||1||f||||f||||||||||2017-10-11 01:17:24.039657|2017-10-11 01:17:24.039657
NCT01945229|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-08-29|||February 2014||2014-02-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|TAMBOURINE||Thumb-ECG Ambulant Screening for Atrial Fibrillation in Patients Treated for Hyperthyroidism (TAMBOURINE)|Thumb-ECG Ambulant Screening for Atrial Fibrillation in Patients Treated for Hyperthyroidism (TAMBOURINE)|Recruiting||N/A|423|Anticipated|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 01:17:26.127917|2017-10-11 01:17:26.127917
NCT01945203|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-15|||December 2011||2011-12-01|September 2013|2013-09-01||||July 2013|Actual|2013-07-01||Observational|||The Relationship Between Aortic Pulse Wave, Aortic Calcification and Peripheral Artery Occlusion Disease in Peritoneal Dialysis Patients|The Relationship Between Aortic Pulse Wave, Aortic Calcification and Peripheral Artery Occlusion Disease in Peritoneal Dialysis Patients|Completed||N/A|174|Actual|National Taiwan University Hospital|||1||f||||t||||||Samples Without DNA|"     Plasma, 8ml/patient   "|||2017-10-11 01:17:26.292347|2017-10-11 01:17:26.292347
NCT01945190|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-10-15|||September 2013||2013-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Acupuncture for Inflammatory Pain and Central Sensitization - A Pilot Study|Acupuncture for Inflammatory Pain and Central Sensitization - A Pilot Study|Completed||N/A|15|Actual|University of Vermont||2|||f||||f||||||||||2017-10-11 01:17:26.359717|2017-10-11 01:17:26.359717
NCT01945177|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-08-24|||January 2012||2012-01-01|September 2013|2013-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||RCT: WLE vs. NBI in Upper Gastrointestinal Endoscopy|A Randomized Comparison Between White Light Endoscopy (WLE) and Bright Narrow Band Imaging (B-NBI) in Subjects Undergoing Upper Gastrointestinal Endoscopy|Completed||N/A|600|Actual|Changi General Hospital||2|||f||||t||||||||||2017-10-11 01:17:26.457535|2017-10-11 01:17:26.457535
NCT01945164|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2014-10-17|||April 2010||2010-04-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Expanded Access|||XL999 Administered Intravenously to a Subject With Advanced Malignancies|Single Patient Treatment Study for the Use of XL999 Administered Intravenously to a Subject With Advanced Malignancies Previously Enrolled in Study XL999-900|No longer available||N/A|||The University of Texas Health Science Center at San Antonio|||||||||t||||||||||2017-10-11 01:17:28.112806|2017-10-11 01:17:28.112806
NCT01945151|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-09-13|||June 2013||2013-06-01|September 2013|2013-09-01|November 2013|Anticipated|2013-11-01|September 2013|Anticipated|2013-09-01||Interventional|EENM||Analysis of the Electrical Muscle Activity and Resistance to Movement in Spastic Hemiparetic Patients.|Analysis of the Electrical Muscle Activity and Resistance to Movement After Pplication Neuromuscular Electrical Stimulation (EENM) in Patients With Hemiparesis Spastic.|Unknown status|Recruiting|N/A|15|Anticipated|Universidade do Vale do Paraíba||1|||f||||f||||||||||2017-10-11 01:17:28.195208|2017-10-11 01:17:28.195208
NCT01945138|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-06-30|2015-06-15||February 2014||2014-02-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Closed Loop Insulin Pump Therapy After Islet Auto-Transplantation|Efficacy and Feasibility of Fully Automated Closed Loop Insulin Pump Therapy After Islet Auto-Transplantation|Completed||N/A|14|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 01:17:28.294211|2017-10-11 01:17:28.294211
NCT01945125|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-12-09|||October 2011||2011-10-01|November 2013|2013-11-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Effects of THW and rhTSH in Glomerular Filtration Rate During RIT|Effects of Thyroid Hormone Withdrawal and Recombinant Human Thyroid Stimulating Hormone in Glomerular Filtration Rate During Radioiodine Therapy|Completed||N/A|28|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 01:17:29.010291|2017-10-11 01:17:29.010291
NCT01945112|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-04-07|2016-07-23||February 2014||2014-02-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)|Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)|Completed||N/A|128|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 01:17:29.096184|2017-10-11 01:17:29.096184
NCT01945099|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-01-24|||September 2013||2013-09-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy|Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy|Completed||Early Phase 1|13|Actual|Yale University||3|||f||||f||||||||No||2017-10-11 01:17:29.549851|2017-10-11 01:17:29.549851
NCT01945086|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-02-11|2015-12-15||September 2013||2013-09-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of Ustekinumab in Adult Japanese Subjects With Severe Atopic Dermatitis|Completed||Phase 2|79|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-10-11 01:17:29.711068|2017-10-11 01:17:29.711068
NCT01945073|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-11-30|||August 2013||2013-08-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|KNOW-IT||Improving Disease Knowledge in Adolescents With Sickle Cell Disease|An Educational Intervention to Improve Disease Knowledge Among Adolescents With Sickle Cell Disease|Completed||N/A|150|Actual|The University of The West Indies||3|||f||||f||||||||||2017-10-11 01:17:31.465707|2017-10-11 01:17:31.465707
NCT01945034|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-04-19|2015-08-19||November 2013||2013-11-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||The full analysis set included all randomized participants who dosed with the study medication and provided a baseline assessment.|5% Topical Ibuprofen (IBU) for Ankle Sprain|Placebo-controlled, Double-blind Evaluation Of The Efficacy And Safety Of Ibuprofen 5% Topical Gel For The Treatment Of Ankle Sprain|Completed||Phase 3|304|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 01:17:32.022157|2017-10-11 01:17:32.022157
NCT01945021|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-08-02|2016-07-28||September 2013|Actual|2013-09-01|August 2017|2017-08-01|December 28, 2018|Anticipated|2018-12-28|July 2015|Actual|2015-07-01||Interventional||The Safety Population (n=127) contains all enrolled patients who received at least one dose of study medication.|Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC|Phase II, Open Label, Single Arm Study of the Efficacy and Safety of Crizotinib in East Asian Patients With Advanced ALK-Negative NSCLC Harboring a Translocation or Inversion Involving the c-ROS Oncogene (ROS1) Locus|Active, not recruiting||Phase 2|129|Actual|Pfizer||1|||f||||||||||||||2017-10-11 01:17:35.735967|2017-10-11 01:17:35.735967
NCT01945008|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2015-03-24|||April 2014||2014-04-01|March 2015|2015-03-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|||Observational Study in HCV Chronic Infection|Prospective Multicentric Observational Study in HCV Chronic Infected Patients.|Recruiting||N/A|10000|Anticipated|Istituto Superiore di Sanità|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 01:17:36.428925|2017-10-11 01:17:36.428925
NCT01944995|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2014-08-27|||September 2013||2013-09-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|||Work of Breathing in Nasal CPAP Versus High Flow Nasal Prong in Infants With Severe Acute Bronchiolitis|Work of Breathing in Nasal CPAP Versus High Flow Nasal Prong in Infants With Severe Acute Bronchiolitis|Unknown status|Recruiting|N/A|18|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:17:36.641121|2017-10-11 01:17:36.641121
NCT01944982|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-12-19|||July 2013||2013-07-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|HNJ-NKAES-2012||Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma|Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma.|Terminated||Phase 1/Phase 2|7|Actual|Hospital Infantil Universitario Niño Jesús, Madrid, Spain||1||"The low recruitment rate makes it very difficult to complete the study within a reasonable   period of time."|f||||t||||||||||2017-10-11 01:17:37.148571|2017-10-11 01:17:37.148571
NCT01944969|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-02-04|2015-08-17||October 2013||2013-10-01|February 2016|2016-02-01||||May 2014|Actual|2014-05-01||Interventional|||Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder|Interventional, Open-label, Long-term Extension Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder|Terminated||Phase 3|26|Actual|H. Lundbeck A/S|Because the study was terminated, few efficacy data were collected. These data have not been reported in accordance with the ICH E3 regarding abbreviated clinical study reports. Furthermore, no firm conclusions can be drawn regarding safety.|1||"The study was terminated because the lead-in study (14571A) in elderly was terminated; see   Detailed Description."|f||||f||||||||||2017-10-11 01:17:37.243238|2017-10-11 01:17:37.243238
NCT01944956|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2013-09-15|||June 2011||2011-06-01|March 2011|2011-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Swallowing Sound in Preterm Infant Evaluation of Feeding Maturation|Swallow Maturation in Preterm and Term Infants|Completed||N/A|94|Actual|Baskent University|||1||f||||t||||||||||2017-10-11 01:17:37.624816|2017-10-11 01:17:37.624816
NCT01944943|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-03-08|||February 2013||2013-02-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|VISMOLY||Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia|Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia|Terminated||Phase 2|31|Actual|The Lymphoma Academic Research Organisation||1||lack of efficacy|f||||t||||||||||2017-10-11 01:17:37.701224|2017-10-11 01:17:37.701224
NCT01944930|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-07-14|||January 2013||2013-01-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases||Completed||Phase 1|20|Actual|Lahey Clinic||2|||f||||||||||||||2017-10-11 01:17:37.873009|2017-10-11 01:17:37.873009
NCT01944917|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-09-15|||August 2013||2013-08-01|September 2013|2013-09-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01|1 Day|Observational [Patient Registry]|||Effects of Pulsed Electromagnetic Field on Autonomic Function in Patients With Chronic Musculoskeletal Pain|Pilot Study to Investigate Autonomic Function in Patients With Chronic Musculoskeletal Pain.|Unknown status|Recruiting|N/A|40|Anticipated|Aerotel Ltd|||1||f||||f||||||||||2017-10-11 01:17:37.971291|2017-10-11 01:17:37.971291
NCT01944904|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-02-27|||September 2013||2013-09-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|XOS2||Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels|Study of the Effect of Prebiotic Xylooligosaccharide (XOS) on Microbita and Blood Glucose|Completed||N/A|18|Actual|University of California, Los Angeles||2|||f||||f||||||||No|No plan to share IPD with other researchers.|2017-10-11 01:17:38.074274|2017-10-11 01:17:38.074274
NCT01944891|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-09-13|||January 2010||2010-01-01|September 2013|2013-09-01||||June 2010|Actual|2010-06-01||Observational|ZANE||Diet and Nutritional Status of Adolescent Girls in Zambézia, Mozambique|Estudo do Estado Nutricional e da Dieta em Raparigas Adolescentes na Zambézia|Completed||N/A|551|Actual|Helsinki University|||1||f||||f||||||Samples With DNA|"     Blood, urine, buccal cells   "|||2017-10-11 01:17:38.187476|2017-10-11 01:17:38.187476
NCT01944878|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2014-07-22|2014-01-23||May 2013||2013-05-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational||A total of 127 patients with chronic hepatitis and 328 patients with liver cirrhosis were enrolled.|The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient|Retrospective Observational Study of Impact of Portal Hypertension for the Peptic Ulcer in Liver Cirrhosis and Chronic Hepatitis|Completed||N/A|455|Actual|Chuncheon Sacred Heart Hospital|||2||f||||f||||||||||2017-10-11 01:17:38.284698|2017-10-11 01:17:38.284698
NCT01944865|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-31|2013-09-13|||October 2010||2010-10-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Interval Training and Performance in Mountain Bikers|Effect of Intermittent Versus Interval Training on Mountain Bike Cross-country Performance: a Parallel-group Randomized Trial|Completed||N/A|16|Actual|Universidade Gama Filho||2|||f||||f||||||||||2017-10-11 01:17:38.586892|2017-10-11 01:17:38.586892
NCT01944852|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-06-28|||March 2013|Actual|2013-03-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|February 2018|Anticipated|2018-02-01||Interventional|DIDo||Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD.|Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental Peritoneal Dialysis Therapy: the DIDo Study|Recruiting||Phase 4|160|Anticipated|Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 01:17:38.663629|2017-10-11 01:17:38.663629
NCT01944839|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-08-23|||August 2013||2013-08-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy|A Phase 3 Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista® (Anti PDGF-B Pegylated Aptamer) Administered in Combination With Lucentis® Compared to Lucentis® Monotherapy in Subjects With Subfoveal Neovascular Age-related Macular Degeneration.|Terminated||Phase 3|619|Actual|Ophthotech Corporation||2|||f||||t||||||||||2017-10-11 01:17:38.779215|2017-10-11 01:17:38.779215
NCT01944826|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2013-09-13|||February 2011||2011-02-01|September 2013|2013-09-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01|5 Years|Observational [Patient Registry]|TTAC||The TAKO-TSUBO And Cancer Registry|A Prospective, Multicenter, Observational Registry to Evaluate the Prevalence and Incidence of Cancer and Long-term Prognosis in Patients With Tako-Tsubo (Stress-induced) Cardiomyopathy.|Unknown status|Recruiting|N/A|800|Anticipated|Deutsches Herzzentrum Muenchen|||1||f||||f||||||Samples Without DNA|"     Laboratory parameters and biomarkers:        -  Faecal occult blood test        -  Complete blood count including erythrocyte sedimentation rate        -  Serum protein electrophoresis        -  Prostate-specific antigen (PSA) testing in men   "|||2017-10-11 01:17:39.37465|2017-10-11 01:17:39.37465
NCT01944813|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2014-12-19|||November 2013||2013-11-01|September 2013|2013-09-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Advance Care Planning: A Way to Improve End-of-life Care Life Care|Advance Care Planning: A Way to Improve End-of-life Care|Unknown status|Recruiting|N/A|360|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 01:17:39.507738|2017-10-11 01:17:39.507738
NCT01944800|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2017-03-10|||September 2013||2013-09-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|ISAR-REACT 5||Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome|Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5|Recruiting||Phase 4|4000|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 01:17:39.659801|2017-10-11 01:17:39.659801
NCT01944787|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-17|||September 2013||2013-09-01|September 2013|2013-09-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Hydration and Rate of Cesarean Delivery Among Nulliparous|Intrapartum Hydration and Rate of Cesarean Delivery Among Nulliparous at > 37 Weeks: A Multicenter Randomized|Not yet recruiting||N/A|670|Anticipated|Chauhan, Suneet P., M.D.||2|||f||||f||||||||||2017-10-11 01:17:39.888087|2017-10-11 01:17:39.888087
NCT01944774|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-02-01|2015-01-08||March 2013||2013-03-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||mITT population: Subjects who were screened and randomized, received at least one complete dose of the drug (Nemonoxacin or Moxifloxacin), met the minimal disease criteria (inclusion criteria 4, 5 and 7), and was evaluated at least once for clinical efficacy .|Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride|A Multi-Center, Randomized, Double-Blind, Parallel Comparative, Phase II Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Versus Moxifloxacin in Treating Adult Patients With Community-Acquired Pneumonia (CAP)|Completed||Phase 2|207|Actual|TaiGen Biotechnology Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:17:40.191159|2017-10-11 01:17:40.191159
NCT01944761|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2015-11-16|||July 2013||2013-07-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Neuro-protective Effects of Exercise in Children With Brain Tumors|The Neuro-protective Effects of Exercise in Children With Brain Tumors|Completed||N/A|28|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 01:17:42.063428|2017-10-11 01:17:42.063428
NCT01944748|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-04-05|||July 2011||2011-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Interventional|||Family Mediation Program For At-Risk Youth|Family Mediation Program For At-Risk Youth|Completed||N/A|111|Actual|RAND||2|||f||||t||||||||||2017-10-11 01:17:42.163379|2017-10-11 01:17:42.163379
NCT01944735|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-03-04|||September 2013||2013-09-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTX-4430 When Administered Orally to Cystic Fibrosis Patients for Fifteen Days|Completed||Phase 1|17|Actual|Celtaxsys, Inc.||2|||f||||t||||||||||2017-10-11 01:17:42.244769|2017-10-11 01:17:42.244769
NCT01944722|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-02-24||2017-02-14|August 2013||2013-08-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Clinical Evaluation of the HPV Assay on the BD Viper LT System With Cervical Specimens|Clinical Evaluation of the HPV Assay on the BD Viper LT System With Cervical Specimens.|Completed||N/A|33858|Actual|Becton, Dickinson and Company||2|||f||||f||||||||||2017-10-11 01:17:42.33786|2017-10-11 01:17:42.33786
NCT01944709|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2013-09-13|||August 2006||2006-08-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|December 2007|Actual|2007-12-01||Interventional|||Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma|Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma|Terminated||Phase 1/Phase 2|2|Actual|Cantonal Hospital of St. Gallen||1||Progressive Disease|f||||f||||||||||2017-10-11 01:17:42.666292|2017-10-11 01:17:42.666292
NCT01944696|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-06-15|||March 2014||2014-03-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?|Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?|Recruiting||N/A|210|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 01:17:42.739022|2017-10-11 01:17:42.739022
NCT01944683|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-07-12|||September 2013||2013-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure|Phase 1b Study of Pharmacokinetic Interaction, Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure|Completed||Phase 1|22|Actual|Acorda Therapeutics||2|||f||||f||||||||||2017-10-11 01:17:42.872194|2017-10-11 01:17:42.872194
NCT01944670|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-02-16|2017-02-16||August 2013||2013-08-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional||Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E)|Multi-Center Trial to Evaluate an Internal Joint Stabilizer - Elbow|"Multi-Center Trial to Evaluate an Internal Joint Stabilizer - Elbow (IJS-E)"|Completed||N/A|26|Actual|Skeletal Dynamics, LLC|Two patients were lost to follow-up prior to IJS-E implant removal (explant).|1|||f||||t||||||||||2017-10-11 01:17:43.004453|2017-10-11 01:17:43.004453
NCT01944657|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-04-24|||September 2013||2013-09-01|April 2017|2017-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study|Supplemental TMS vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study|Withdrawn||N/A|0|Actual|Sheppard Pratt Health System||2||unable to enroll subjects|f||||f||||||||||2017-10-11 01:17:43.207777|2017-10-11 01:17:43.207777
NCT01944644|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-12|||August 2013||2013-08-01|September 2013|2013-09-01||||August 2015|Anticipated|2015-08-01||Interventional|||Low Field Magnetic Stimulation for Treatment Resistant Depression|The Effect of Low Field Magnetic Stimulation on Resting State Networks in Major Depressive Disorder|Unknown status|Recruiting|N/A|60|Anticipated|Weill Medical College of Cornell University||2|||f||||||||||||||2017-10-11 01:17:43.306932|2017-10-11 01:17:43.306932
NCT01944631|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2015-04-02|2015-02-27||September 2013||2013-09-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Treated set which included all randomised patients who used at least one dose of trial treatment.|Iota-Carrageenan Nasal Spray in Common Cold|Efficacy and Safety of Iota-Carrageenan Nasal Spray 1.2 g/l (0.12 Percent) (Bisolviral) Versus Placebo Nasal Spray in the Early Treatment of Common Cold|Completed||Phase 4|200|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:17:43.403013|2017-10-11 01:17:43.403013
NCT01944618|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-09-12|||October 2013||2013-10-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|forREAL||forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)|forREAL: FORXIGA (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) PRESCRIPTION EVENT MONITORING PROGRAM|Terminated||N/A|5000|Anticipated|AstraZeneca|||1|"Participant Data obtained to 30Sep2015:    Baseline data: 447 6 month data: 253 Program terminated: recruitment target not met. No   analysis will be provided."|f||||f||||||||||2017-10-11 01:17:43.862447|2017-10-11 01:17:43.862447
NCT01944605|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-10-05|||September 2013||2013-09-01|October 2017|2017-10-01|March 30, 2014|Actual|2014-03-30|March 30, 2014|Actual|2014-03-30||Observational|TICA||Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest|Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest|Completed||N/A|40|Actual|Virginia Commonwealth University|||1||f||||f||||||Samples Without DNA|"     Blood plasma Blood serum Whole blood Stool Expired Gas   "|||2017-10-11 01:17:43.97546|2017-10-11 01:17:43.97546
NCT01944592|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2015-02-03|||September 2013||2013-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TARGET||Teaching Associates Randomised to Evaluate the Effectiveness of Gynaecological Pelvic Examination Versus Traditional Teaching Using Manikins|Gynaecology Teaching Associates Versus Teaching on Manikins: a Randomised Controlled Trial|Completed||N/A|492|Actual|Birmingham Women's NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:17:44.054411|2017-10-11 01:17:44.054411
NCT01944579|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-07-21|||September 2013||2013-09-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria||Completed||N/A|46|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 01:17:44.152135|2017-10-11 01:17:44.152135
NCT01944566|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-12-04|||October 2013||2013-10-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Microbial Community Transplantation on the Armpit.|Microbial Community Transplantation on the Armpit in Order to Reduce the Malodour Generation on Armpit.|Unknown status|Enrolling by invitation|N/A|20|Anticipated|University Ghent||1|||f||||f||||||||||2017-10-11 01:17:44.231573|2017-10-11 01:17:44.231573
NCT01944553|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-02-26|||September 2013||2013-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ARASS||Robotic-assisted Pedicule Screw Placement|A Prospective Study on the Feasibility of Pedicle Screw Placement in the Lumbar Level With a New Robotic-assisted System|Completed||N/A|10|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 01:17:44.309097|2017-10-11 01:17:44.309097
NCT01944540|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2013-09-16|||August 2013||2013-08-01|September 2013|2013-09-01||||March 2014|Anticipated|2014-03-01||Interventional|||Brief Title : Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm|Comparison of Coventional Endoscopic Submucosal Dissection and Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm|Unknown status|Recruiting|N/A|70|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 01:17:44.387164|2017-10-11 01:17:44.387164
NCT01944527|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-13|2016-02-01|||October 2013||2013-10-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|December 2015|Actual|2015-12-01||Observational|ANRSCO23CUPILT||Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection|Cohort of Liver Transplanted Patients With Hepatitis C Virus Recurrence and Treated With Direct-acting Antiviral Agents|Active, not recruiting||N/A|699|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||t||||||Samples With DNA|"     Serum and plasma   "|||2017-10-11 01:17:44.504289|2017-10-11 01:17:44.504289
NCT01944514|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-19|||January 2010||2010-01-01|September 2013|2013-09-01||||November 2012|Actual|2012-11-01||Observational|ICD-IRS||Implantable Cardioverter Defibrillators - Improving Risk Stratification|Improving Risk Stratification of Patients for Implantable Cardioverter Defibrillators Through Electrophysiological Tests, Cardiac Magnetic Resonance Imaging, Autonomic Function Tests, RNA Analysis and Plasma Biomarkers.|Completed||N/A|92|Actual|University Hospitals, Leicester|||3||f||||t||||||Samples Without DNA|"     Fresh frozen plasma   "|||2017-10-11 01:17:44.583313|2017-10-11 01:17:44.583313
NCT01944475|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-12|||September 2013||2013-09-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01|1 Day|Observational [Patient Registry]|||Follow-up of Girls With Premature Thelarche and Precocious Puberty|Follow-up of Girls With Premature Thelarche and Precocious Puberty: a Clinical and Paraclinical Study of Girls With Thelarche and Healthy Controls|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Aarhus|||1||f||||t||||||Samples With DNA|"     GnRH test, p-estrogen, p-testosterone , p-SHBG, p- androstenedione, p-dihydroandrostendion,     p-inhibin B, p-thyroid parameters, ultrasound examination of the genitalia interna and a     blood sample for studies of polymorphism in the estrogen receptor gene and aromatase enzyme     gene.   "|||2017-10-11 01:17:45.011065|2017-10-11 01:17:45.011065
NCT01944436|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-04-12|||September 2006||2006-09-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease|Lewy Body Spectrum Disorders: Investigating Neuropsychiatric Benefit and Adverse Effects in Response to Cholinesterase Inhibitors Using Genetics and Brain SPECT|Completed||N/A|57|Actual|Sunnybrook Health Sciences Centre|||2||f||||f||||||Samples With DNA|"     Functional and tag SNPs in the following genes will be assessed:      acetylcholinesterase (ACHE); butyrylcholinesterase (BCHE); M1 muscarinic receptor (CHRM1);     alpha7-nicotinic receptor (CHRNA7); Apolipoprotein E (ApoE); Cytochrome P450 2D6 (protein:     CYP2D6 /gene: CYP2D6); CYP3A4; all genes related to blood pressure disregulation, white     matter changes found on neuroimaging, and genes related to Lewy Body Spectrum disorders in     general.   "|||2017-10-11 01:17:45.492296|2017-10-11 01:17:45.492296
NCT01944423|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-09-05|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|DCS/PSRT||Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine|Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine|Recruiting||Early Phase 1|80|Anticipated|University of Texas at Austin||2|||f||||f||||||||||2017-10-11 01:17:45.613359|2017-10-11 01:17:45.613359
NCT01944410|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2014-10-05|||January 2013||2013-01-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|TBC||Use of PRP in Treatment of Mandibular Traumatic Bone Cyst|Efficacy of Platelet-rich Plasma in Treatment of Mandibular Traumatic Bone Cyst|Completed||Phase 1|12|Anticipated|Shiraz University of Medical Sciences||1|||f||||t||||||||||2017-10-11 01:17:45.72039|2017-10-11 01:17:45.72039
NCT01944397|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-12|||December 2011||2011-12-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||A CALIBER Study: Risk Factors for Stroke, Heart Failure, and Myocardial Infarction in Atrial Fibrillation|Risk Factors for the Development of Stroke, Heart Failure, and Myocardial Infarction in Patients Diagnosed With Atrial Fibrillation: a CALIBER Study|Unknown status|Active, not recruiting|N/A|125000|Anticipated|University College, London|||1||f||||t||||||||||2017-10-11 01:17:45.844984|2017-10-11 01:17:45.844984
NCT01944384|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-12|||August 2010||2010-08-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Impacts of Aldosterone Blockade on Myocardial Remodeling in Hypertensive Patients With Diastolic Failing Heart|Impacts of Aldosterone Blockade on Myocardial Remodeling in Hypertensive Patients With Diastolic Failing Heart|Completed||Phase 4|40|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:17:45.940667|2017-10-11 01:17:45.940667
NCT01944371|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-10-27|||August 2013||2013-08-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study|Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study|Completed||Phase 1/Phase 2|30|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 01:17:46.353538|2017-10-11 01:17:46.353538
NCT01944358|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2013-09-12|||January 2007||2007-01-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Observational|||Comparisons of Serologic Response of Early Syphilis|Comparisons of Treatment Response to Standard Treatment With Penicillin Between HIV-infected and HIV-uninfected Patients With Syphilis|Completed||N/A|1128|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 01:17:46.451707|2017-10-11 01:17:46.451707
NCT01944345|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-04-14|2016-01-06||June 2013||2013-06-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01|1 Year|Observational [Patient Registry]|||Patient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion Device|VariLift Lumbar and Cervical Patient Registry|Completed||N/A|69|Actual|Wenzel Spine|||1||f||||f||||||||No|Data will not be shared|2017-10-11 01:17:46.534585|2017-10-11 01:17:46.534585
NCT01944332|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-01-11|||September 2007||2007-09-01|January 2017|2017-01-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Gamete Treatment to Correct Fertilization Failure|Gamete Treatment to Correct Fertilization Failure|Recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-10-11 01:17:46.777461|2017-10-11 01:17:46.777461
NCT01944319|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-01-28|2015-10-18||July 2013||2013-07-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Meropenem Dosage Strategy Based on PPK Model|Clinical Evaluation of a Meropenem Dosage Strategy Based on a Population Pharmacokinetic-pharmacodynamic Model in Lower Respiratory Tract Infection Patients|Completed||Phase 4|79|Actual|Peking University Third Hospital||2|||f||||t||||||||No||2017-10-11 01:17:46.887666|2017-10-11 01:17:46.887666
NCT01943903|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-03-21|||September 2013||2013-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PLATFORM||The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)|Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts|Completed||N/A|584|Actual|HeartFlow, Inc.|||2||f||||t||||||||||2017-10-11 01:17:50.845453|2017-10-11 01:17:50.845453
NCT01944306|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-04-15|||August 2013||2013-08-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|April 2015|Actual|2015-04-01||Observational|||Obesity and Oral Contraceptive Failure|Prenatal Growth Programs Oral Contraceptive Metabolism and Effectiveness|Terminated||N/A|40|Anticipated|Oregon Health and Science University|||4|"Due to lack of funds, the study has been terminated upon recruiting less than desired number of   subjects"|f||||f||||||Samples With DNA|"     Blood, Plasma, and Urine will be collected for the analaysis of drug levels and genotyping of     various genes that could explain pharmacokinetics of oral contraceptives.   "|||2017-10-11 01:17:47.243044|2017-10-11 01:17:47.243044
NCT01944293|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2017-02-06|||September 2013||2013-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ketamine for Suicidality in Bipolar Depression|Ketamine vs. Midazolam in Bipolar Depression|Active, not recruiting||Phase 1/Phase 2|16|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 01:17:47.362457|2017-10-11 01:17:47.362457
NCT01944280|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2015-10-02|||September 2013||2013-09-01|October 2015|2015-10-01||||December 2013|Actual|2013-12-01||Interventional|||Investigating the Effectiveness of Intradialytic Massage on Cramping in Dialysis Patients|Investigating the Effectiveness of Intradialytic Massage on Cramping in Dialysis Patients|Completed||N/A|32|Actual|MetroHealth Medical Center||2|||f||||f||||||||||2017-10-11 01:17:47.571126|2017-10-11 01:17:47.571126
NCT01944267|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-10-18|||October 2013||2013-10-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2014|Actual|2014-05-01||Interventional|||Procedures for Improving the Mucosa Around Implants|Apically Positioned Flap, Free Gingival Graft and Apically Positioned Flap With Collagen Matrix Around Dental Implants|Completed||N/A|30|Actual|Tufts University School of Dental Medicine||3|||f||||f||||||||||2017-10-11 01:17:47.657594|2017-10-11 01:17:47.657594
NCT01944254|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2016-07-28|||September 2013||2013-09-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|TEMP2||The Precision of Pulmonary Artery Cardiac Output-measurements in Spontaneously Breathing Patients|Comparison of the Precision of Cardiac Output-measures at Random to Respiration, Synchronised With Expiration and Instructed Slow Exhalation, Obtained by Pulmonal Artery Catheter Thermodilution Technique With Cold Injection|Completed||N/A|18|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 01:17:47.760563|2017-10-11 01:17:47.760563
NCT01944241|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2013-09-12|||October 2012||2012-10-01|September 2013|2013-09-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Observational|c-SAFE||Cervical Surgery and the Fertility Effect (c-SAFE)|Cervical Surgery and the Fertility Effect|Unknown status|Enrolling by invitation|N/A|1500|Anticipated|Merrion Fertility Clinic|||2||f||||f||||||||||2017-10-11 01:17:47.881745|2017-10-11 01:17:47.881745
NCT01944228|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-10-29|||August 2013||2013-08-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|NoSIRS||Effects of Transvenous Vagus Nerve Stimulation on Immune Response: a Pilot Study|Effects of Transvenous Vagus Nerve Stimulation on Immune Response: a Pilot Study|Completed||Phase 1|22|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||t||||||||||2017-10-11 01:17:47.987581|2017-10-11 01:17:47.987581
NCT01944215|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-04-17|||September 2013||2013-09-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue|Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue|Completed||Phase 1|154|Actual|Mayo Clinic||4|||f||||f||||||||||2017-10-11 01:17:48.113587|2017-10-11 01:17:48.113587
NCT01944202|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-12|||August 2012||2012-08-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Educational Intervention to Reduce Outpatient Inappropriate Transthoracic Echocardiograms|Reducing Outpatient Inappropriate Transthoracic Echocardiograms With An Educational Intervention: A Randomized Control Trial|Completed||N/A|112|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 01:17:48.240708|2017-10-11 01:17:48.240708
NCT01944189|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-05-27|||September 2013||2013-09-01|May 2014|2014-05-01|March 2015|Anticipated|2015-03-01|September 2014|Anticipated|2014-09-01||Interventional|||Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics and Population Pharmacokinetics|Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics of Lumefantrine and Population Pharmacokinetics of Lumefantrine Among Ugandan Children|Unknown status|Recruiting|Phase 4|70|Anticipated|Makerere University||2|||f||||f||||||||||2017-10-11 01:17:48.318604|2017-10-11 01:17:48.318604
NCT01944176|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-03-15|||September 2013||2013-09-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients|The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokines in COPD Patients|Completed||Phase 3|24|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 01:17:48.42451|2017-10-11 01:17:48.42451
NCT01944163|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-11-23|||September 2014||2014-09-01|November 2015|2015-11-01|November 2017|Anticipated|2017-11-01|March 2016|Anticipated|2016-03-01||Interventional|IMPACT||The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain|The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain - a Cluster Randomized Trial|Active, not recruiting||N/A|850|Anticipated|Maasstad Hospital||2|||f||||t||||||||||2017-10-11 01:17:48.512741|2017-10-11 01:17:48.512741
NCT01944150|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-08-02|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|HYPTENS||Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis|Interest of the Association of Two Complementary Techniques, Hypnosis and Transcutaneous Electrical Nerve Stimulation in the Treatment of Chronic Non-cancer Pain, Nociceptive and / or Neuropathic Pain: Randomized Trial|Completed||N/A|72|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:17:48.63973|2017-10-11 01:17:48.63973
NCT01944137|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2015-04-08|||September 2013||2013-09-01|March 2015|2015-03-01||||November 2014|Actual|2014-11-01||Interventional|IMPACT||Improving Care After Chemotherapy|Improving Care After Chemotherapy|Unknown status|Active, not recruiting|N/A|120|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:17:48.75792|2017-10-11 01:17:48.75792
NCT01944124|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-10-21|||November 2009||2009-11-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Exercise and Technology to Reduce Risk in a Rural Population With Metabolic Syndrome|A Lifestyle Intervention Supported by Mobile Health Technologies to Improve the Cardiometabolic Risk Profile of Individuals at Risk for Cardiovascular Disease and Type 2 Diabetes.|Completed||N/A|149|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:17:48.870841|2017-10-11 01:17:48.870841
NCT01944111|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-16|||September 2013||2013-09-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Plicated Laparoscopic Adjustable Gastric Banding Study|Prospective Clinical Trial of Plicated Laparoscopic Adjustable Gastric Banding|Unknown status|Enrolling by invitation|Phase 1|100|Anticipated|Tenet Healthcare Corporation||1|||f||||f||||||||||2017-10-11 01:17:48.993307|2017-10-11 01:17:48.993307
NCT01944085|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-12|||October 2008||2008-10-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Percutaneous Pin Removal in Children - is Analgesia Necessary?|Percutaneous Pin Removal in the Outpatient Clinic - do Children Require Analgesia? A Randomized Controlled Trial|Completed||N/A|240|Actual|KK Women's and Children's Hospital||3|||f||||t||||||||||2017-10-11 01:17:49.210594|2017-10-11 01:17:49.210594
NCT01944072|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-12|||September 2009||2009-09-01|September 2013|2013-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Pulmonary Rehabilitation in COPD: Effects of Two Aerobic Exercise Intensity in Patient-centered Outcomes|Pulmonary Rehabilitation in COPD: Effects of Two Aerobic Exercise Intensity in Patient-centered Outcomes - a Randomized Controlled Trial|Completed||N/A|34|Actual|Universidade Nova de Lisboa||2|||f||||f||||||||||2017-10-11 01:17:49.315502|2017-10-11 01:17:49.315502
NCT01944059|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-05-04|2016-05-03||November 2013||2013-11-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||Theramine® in the Prevention of Migraine Headache|The Role of Theramine® in the Prevention of Migraine Headache: A Pilot Study|Terminated||Phase 4|31|Actual|Targeted Medical Pharma||2||Funding Discontinued|f||||t||||||||Undecided||2017-10-11 01:17:49.406666|2017-10-11 01:17:49.406666
NCT01944046|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-01-03|||August 2014||2014-08-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SOARS-B||Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors|Phase II Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors|Active, not recruiting||Phase 2|290|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:17:49.750728|2017-10-11 01:17:49.750728
NCT01944033|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-06-18|||July 2013||2013-07-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Interventional|||β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation|β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation|Recruiting||Phase 3|110|Anticipated|University of Monastir||2|||f||||f||||||||Yes||2017-10-11 01:17:49.965349|2017-10-11 01:17:49.965349
NCT01944020|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-01-30|||May 2015||2015-05-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effects of CPAP on Diet, Physical Activity, and Cardiovascular Risk|Effects of CPAP on Diet, Physical Activity, and Cardiovascular Risk|Recruiting||N/A|25|Anticipated|Columbia University||1|||f||||t||||||||||2017-10-11 01:17:50.080296|2017-10-11 01:17:50.080296
NCT01944007|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-16|||December 2007||2007-12-01|September 2013|2013-09-01||||March 2008|Actual|2008-03-01||Interventional|||Evaluation of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers|Open-label Phase 1 Multiple Dose Escalation Trial to Assess the Safety, Tolerability, and Efficacy of Capsules Containing Cross-linked Polyelectrolyte (CLP) Given to Normal Healthy Volunteers|Completed||Phase 1|25|Actual|Sorbent Therapeutics||4|||f||||f||||||||||2017-10-11 01:17:50.165787|2017-10-11 01:17:50.165787
NCT01943994|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-12-07|||September 2008||2008-09-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study|Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study|Recruiting||N/A|75|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:17:50.237522|2017-10-11 01:17:50.237522
NCT01943981|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-12|||September 2013||2013-09-01|September 2013|2013-09-01||||February 2015|Anticipated|2015-02-01|2 Years|Observational [Patient Registry]|AF-CPX||Exercise Performance in Patients With Atrial Fibrillation|Exercise Performance in Patients With Atrial Fibrillation: Usefulness of Cardiopulmonary Exercise Test|Unknown status|Not yet recruiting|N/A|50|Anticipated|Incheon St.Mary's Hospital|||1||f||||f||||||||||2017-10-11 01:17:50.326716|2017-10-11 01:17:50.326716
NCT01943968|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2013-09-12|||December 2013||2013-12-01|September 2013|2013-09-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis||Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 01:17:50.40912|2017-10-11 01:17:50.40912
NCT01943955|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-12|||May 2011||2011-05-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Home-based Computer Gaming in Vestibular Rehabilitation|Home-based Computer Gaming in Vestibular Rehabilitation: Effects on Gaze and Balance Impairment|Completed||N/A|10|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 01:17:50.486848|2017-10-11 01:17:50.486848
NCT01943942|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-13|||May 16, 2010|Actual|2010-05-16|June 2017|2017-06-01|May 26, 2010|Actual|2010-05-26|May 26, 2010|Actual|2010-05-26||Interventional|||Bioequivalence Study of Montelukast 10 mg Tablets|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparations Containing Montelukast 10 mg (Product of GlaxoSmithKline México, S.A. de C.V. vs. Singulair, Merck Sharp & Dohme de México, S.A. de C.V.)in Fasting Healthy Volunteers|Completed||Phase 1|32|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:17:50.569721|2017-10-11 01:17:50.569721
NCT01943929|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-09-12|||November 2012||2012-11-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Observational|||Correlation Between Headaches and Septum and Nasal Mucosa Contact|Correlation Between Headaches and Septum and Nasal Mucosa Contact|Unknown status|Recruiting|N/A|2000|Anticipated|Hospital Israelita Albert Einstein|||1||f||||f||||||||||2017-10-11 01:17:50.643147|2017-10-11 01:17:50.643147
NCT01943916|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-08-16|||July 2013||2013-07-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Observational|||The PIONEER-01 Pivotal Study of the Imagio Breast Imaging System|A Pivotal Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists|Completed||N/A|2105|Actual|Seno Medical Instruments Inc.|||1||f||||f||||||||||2017-10-11 01:17:50.740137|2017-10-11 01:17:50.740137
NCT01943890|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2013-09-16|||February 2010||2010-02-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||High Volumes of Hypertonic Saline and Chest Physiotherapy in CF Patients|Establishment and Implementation of Nebulised High Volumes of Hypertonic Saline in Cystic Fibrosis Patients|Completed||N/A|8|Actual|Haukeland University Hospital||1|||f||||f||||||||||2017-10-11 01:17:51.169185|2017-10-11 01:17:51.169185
NCT01943877|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-09-16|||December 2012||2012-12-01|September 2013|2013-09-01|October 2013|Anticipated|2013-10-01|August 2013|Actual|2013-08-01||Interventional|PROPOLIS||Propolis In The Treatment Of Periodontitis|Propolis In The Treatment Of Chronic Periodontitis - A Clinicomicrobiologic Study|Unknown status|Active, not recruiting|N/A|20|Actual|Rajarajeswari Dental College & Hospital||2|||f||||t||||||||||2017-10-11 01:17:51.252988|2017-10-11 01:17:51.252988
NCT01943864|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-05-03|2015-03-02||September 19, 2013||2013-09-19|May 2017|2017-05-01|February 1, 2016|Actual|2016-02-01|July 1, 2014|Actual|2014-07-01||Interventional|||A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers|A Phase IIa Study of the MEK Inhibitor GSK1120212 Monotherapy in the Treatment of Gemcitabine Refractory Locally Advanced, Recurrent or Metastatic Biliary Tract Cancers|Completed||Phase 2|20|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 01:17:51.385565|2017-10-11 01:17:51.385565
NCT01943851|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-09-18|||May 14, 2014||2014-05-14|September 2017|2017-09-01|February 24, 2020|Anticipated|2020-02-24|February 26, 2018|Anticipated|2018-02-26||Interventional|||A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies|A Phase I/II Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies|Recruiting||Phase 1|180|Anticipated|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 01:17:52.675117|2017-10-11 01:17:52.675117
NCT01943838|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-04-21|||October 2013||2013-10-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma|A Phase 1 Dose-escalation Study of the Safety and Pharmacokinetics of a Tablet Formulation of SAR245408 Polymorph E Administered Once Daily to Subjects With Solid Tumors or Lymphoma|Completed||Phase 1|18|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:17:52.85945|2017-10-11 01:17:52.85945
NCT01943825|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-04-28||2017-04-28|September 2013||2013-09-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine|Exploration of Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity Following Various Administration Schedules With CYD Tetravalent Dengue Vaccine|Completed||Phase 2|90|Actual|Sanofi||4|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-11 01:17:52.955801|2017-10-11 01:17:52.955801
NCT01943812|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-10-03|||December 2013||2013-12-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation|Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation|Recruiting||Phase 4|722|Anticipated|Regionshospitalet Viborg, Skive||2|||f||||f||||||||||2017-10-11 01:17:53.066908|2017-10-11 01:17:53.066908
NCT01943799|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2015-03-05||2015-01-16|September 2013||2013-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B|A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B|Completed||Phase 2|178|Actual|Gilead Sciences||4|||f||||t||||||||||2017-10-11 01:17:53.204512|2017-10-11 01:17:53.204512
NCT01943786|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-03-13|||April 2013||2013-04-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Observational|BEAMING||RAS Switch in Patients With Metastatic RAS Native Colorectal Tumors Treated With 1st Line FOLFIRI-Cetuximab|Prospective, Non-Interventional Study of K-ras Status Switch in K-ras Native Patients With Metastatic Colorectal Tumors Treated With FOLFIRI-Cetuximab as First-line Treatment|Unknown status|Active, not recruiting|N/A|40|Anticipated|Grupo Hospital de Madrid|||1||f||||f||||||Samples With DNA|"     Tissue and whole blood   "|||2017-10-11 01:17:53.326023|2017-10-11 01:17:53.326023
NCT01943773|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-07-15|||March 2013||2013-03-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Functional Prehabilitation and Major Elective Surgery|Functional Prehabilitation and Major Elective Surgery|Completed||N/A|16|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:17:53.402048|2017-10-11 01:17:53.402048
NCT01943760|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-16|||September 2012||2012-09-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Tamadol Wound Infiltration in Children Under Inguinal Hernioplasty|Evaluation of the Analgesic Effect of Tramadol Wound Infiltration in Children Under Inguinal Hernioplasty. A Double-blind, Randomized Study.|Completed||Phase 4|40|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 01:17:53.508468|2017-10-11 01:17:53.508468
NCT01943747|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-08-19|||November 2013||2013-11-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Observational|IMPRESS||International Multicentre Prevalence Study on Sepsis|Surviving Sepsis Campaign. International Multicentre Prevalence Study on Sepsis.|Completed||N/A|1000|Anticipated|European Society of Intensive Care Medicine|||1||f||||f||||||||||2017-10-11 01:17:53.591469|2017-10-11 01:17:53.591469
NCT01943734|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-16|||March 2010||2010-03-01|September 2013|2013-09-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||The Influence of Health Information in Stretch Break Program Participant's Lifestyle|The Influence of Health Information in Stretch Break Program Participant's Lifestyle: a Quantitative and Qualitative Study|Completed||N/A|14|Actual|Federal University of Paraíba||1|||f||||t||||||||||2017-10-11 01:17:53.676929|2017-10-11 01:17:53.676929
NCT01943721|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2014-12-15|||October 2013||2013-10-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension|A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension|Completed||Phase 1|14|Actual|ForSight Vision5, Inc.||1|||f||||f||||||||||2017-10-11 01:17:53.741425|2017-10-11 01:17:53.741425
NCT01943695|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-09-21|||January 2013||2013-01-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer|Optimal Timing Trial: Randomized Trial of Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer|Recruiting||N/A|160|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||f||||||||||2017-10-11 01:17:53.879438|2017-10-11 01:17:53.879438
NCT01943682|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-02-28|||September 2013||2013-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma|A Phase I/Pilot Study of CPX-351 for Children, Adolescents and Young Adults With Recurrent or Refractory Hematologic Malignancies|Recruiting||Phase 1|30|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 01:17:54.018252|2017-10-11 01:17:54.018252
NCT01943669|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-09-16|||June 2013||2013-06-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Exoskeletons for Spinal Cord Injury: A Feasibility Study|An Open, Longitudinal, Prospective, Non-randomized, Self-Controlled Feasibility Study to Investigate the Effect of the ReWalk™ Device on Mobility Outcomes in Patients With Chronic Spinal Cord Injury.|Unknown status|Recruiting|Phase 4|10|Anticipated|Buckinghamshire Healthcare NHS Trust||1|||f||||f||||||||||2017-10-11 01:17:54.293884|2017-10-11 01:17:54.293884
NCT01943656|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-09-12|||August 2013||2013-08-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Eyegaze Systems for Spinal Cord Injury: A Feasibility Study|A Longitudinal Clinical Feasibility Study to Evaluate the Psychological and Functional Effects of Using the Tobii™ Eyegaze System by Inpatients With Tetraplegia|Unknown status|Not yet recruiting|Phase 4|12|Anticipated|Buckinghamshire Healthcare NHS Trust||1|||f||||f||||||||||2017-10-11 01:17:54.41296|2017-10-11 01:17:54.41296
NCT01943643|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-03-05|||September 2013||2013-09-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Multislice CT Angiography of Coronary Bifurcations and Outcomes After Intervention|The Influence of Coronary Bifurcation Lesion Plaque Characteristics Assessed by Multislice CT Angiography On Side Branch Compromise After Provisional Stenting|Recruiting||N/A|100|Anticipated|Clinical Hospital Center Zemun||1|||f||||f||||||||||2017-10-11 01:17:54.525905|2017-10-11 01:17:54.525905
NCT01943630|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-10-31|||January 2015||2015-01-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts|A Phase II, Multicenter, Randomized, Double Blind, Vehicle Controlled Study Evaluating the Efficacy and Tolerability of AS101 15% Gel for External Genital Warts.|Recruiting||Phase 2|60|Anticipated|BioMAS Ltd||2|||f||||f||||||||||2017-10-11 01:17:54.623238|2017-10-11 01:17:54.623238
NCT01943617|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-01-12|||June 2013||2013-06-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis|Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis|Recruiting||Phase 4|600|Anticipated|Beijing Friendship Hospital||2|||f||||t||||||||||2017-10-11 01:17:54.762686|2017-10-11 01:17:54.762686
NCT01943604|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-04-28|||January 2012||2012-01-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effects of Breakfast on Neuropsychological Functioning|The Effects of Breakfast on Neuropsychological Functioning in Children Ages 8-10 From Low to Middle Income Families|Completed||N/A|195|Actual|Baylor College of Medicine||1|||f||||f||||||||||2017-10-11 01:17:54.967201|2017-10-11 01:17:54.967201
NCT01943591|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-08-01|||November 13, 2013||2013-11-13|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|DELTA||DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial|DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial|Active, not recruiting||N/A|210|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 01:17:55.10466|2017-10-11 01:17:55.10466
NCT01943578|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2014-11-04|||September 2013||2013-09-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Value of Physical Capacity Tests in Lung Cancer|Prospective Observational Cohort Study of the Value of the Six Minute Walk Test and Handgrip Strength in Lung Cancer Patients Undergoing Chemotherapy|Completed||N/A|80|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 01:17:55.221171|2017-10-11 01:17:55.221171
NCT01943565|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-05-22|2017-05-22||December 2014|Actual|2014-12-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study|Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study|Terminated||Phase 4|29|Actual|Brigham and Women's Hospital||3||Research question answered by another group of researchers (Sviggum et al)|f||||f||||||||||2017-10-11 01:17:55.316912|2017-10-11 01:17:55.316912
NCT01943552|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2016-09-16|2016-07-26||October 2013||2013-10-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional||Treated set (TS): All patients who were dispensed study medication and were documented to have taken at least one dose of study medication.|Ipratropium Bromide in Peri-Operative COPD|Peri-operative Intervention With Nebulized Ipratropium Bromide in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial.|Completed||Phase 4|192|Actual|Boehringer Ingelheim|192 patients were entered in this trial. It was planned to treat 96 with Ipratropium bromide and 96 with Placebo. Out of these, one patient was randomised to the placebo group, but received nebulized ipratropium bromide.|2|||f||||||||||||||2017-10-11 01:17:55.8334|2017-10-11 01:17:55.8334
NCT01943526|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2017-08-30|||November 30, 2011|Actual|2011-11-30|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|iTOP||Ireland Natalizumab (TYSABRI) Observational Program|Ireland Natalizumab (TYSABRI®) Observational Program (iTOP)|Active, not recruiting||N/A|191|Actual|Biogen|||1||f||||f||||||||||2017-10-11 01:17:57.961964|2017-10-11 01:17:57.961964
NCT01943513|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-08-29|||October 2013||2013-10-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Intravenous BIIB023 (Anti-TWEAK) on Lower Limb Muscle Mass and Strength During and After Knee-Joint Immobilization in Healthy Male Volunteers|Completed||Phase 1|34|Actual|Biogen||2|||f||||f||||||||||2017-10-11 01:17:58.045584|2017-10-11 01:17:58.045584
NCT01943500|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-02-13|||September 30, 2013|Actual|2013-09-30|February 2017|2017-02-01|August 26, 2016|Actual|2016-08-26|January 28, 2014|Actual|2014-01-28||Observational|||Collection of Blood Specimens for Circulating Tumor Cell Analysis|Collection of Blood Specimens for Circulating Tumor Cell Analysis|Completed||N/A|14|Actual|Viatar LLC|||1||f||||f||||||||No||2017-10-11 01:17:58.137858|2017-10-11 01:17:58.137858
NCT01943487|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-05-29|||August 2009||2009-08-01|May 2014|2014-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet|A Phase 1, Open-label, One-sequence Study to Assess the Effect of Verapamil on the Steady State Pharmacokinetics of Solifenacin and Tamsulosin Administered as a Combination Tablet EC905 in Healthy Male Subjects.|Completed||Phase 1|36|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:17:58.239993|2017-10-11 01:17:58.239993
NCT01943474|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-01-18|2014-11-30||April 2013||2013-04-01|January 2017|2017-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use|The AccuCath Intravenous Catheter System With Retractable Coiled Tip Guidewire and Conventional Peripheral Intravenous Catheters: A Prospective, Randomized, Controlled Comparison by General Hospital Nursing Staff|Completed||N/A|248|Actual|C. R. Bard||2|||f||||f||||||||No||2017-10-11 01:17:58.37824|2017-10-11 01:17:58.37824
NCT01943461|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-09-21|||September 2, 2013|Actual|2013-09-02|September 2017|2017-09-01|December 28, 2018|Anticipated|2018-12-28|January 7, 2015|Actual|2015-01-07||Interventional|||Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN)|A Phase I Trial to Investigate the Tolerability, Safety, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Japanese Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion Part in Asian Subjects With Gastric Cancer|Active, not recruiting||Phase 1|57|Actual|Merck KGaA||1|||f||||f||||||||||2017-10-11 01:17:59.098893|2017-10-11 01:17:59.098893
NCT01943448|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-12|2014-04-13|||August 2013||2013-08-01|April 2014|2014-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01|2 Years|Observational [Patient Registry]|||Macular Hemorrhage in Myopic Eyes|Macular Hemorrhage in Myopic Eyes|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:17:59.232407|2017-10-11 01:17:59.232407
NCT01943435|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2017-05-24|2017-02-09||October 2013||2013-10-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study Comparing 3 Different Treatments for Arthritis of the Lower Back (Lumbar Spinal Stenosis)|A Comparison of Non-Surgical Treatment Methods for Patients With Lumbar Spinal Stenosis|Completed||N/A|240|Actual|University of Pittsburgh|"We realize in retrospect that our original choice of the term usual medical care may have been confusing, because there is great variation in the medical management of patients with stenosis. We suggest that medical care is a better term."|3|||f||||f||||||||Yes|De-identified data may be shared with other researchers at the discretion and approval of the PI.|2017-10-11 01:17:59.368469|2017-10-11 01:17:59.368469
NCT01943422|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-06-22|||September 2013||2013-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|12-107||Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma|Dose-seeking and Efficacy Study of the Combination of the BRAF Inhibitor Vemurafenib and High-dose Interferon Alfa-2b for Therapy of Advanced Melanoma|Active, not recruiting||Phase 1|7|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 01:18:00.28159|2017-10-11 01:18:00.28159
NCT01943409|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-05-10|||July 2013||2013-07-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|September 2016|Anticipated|2016-09-01||Interventional|||Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils|Parenteral Nutrition in Hospitalized Patients: Comparison of Two Commercially Available Lipid Emulsions|Recruiting||Phase 4|350|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:18:01.228288|2017-10-11 01:18:01.228288
NCT01943396|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-05-30|||September 2013||2013-09-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|May 2016|Actual|2016-05-01||Interventional|TARHF||Treatment of AMD With Rheohemapheresis /RHF/|Rationalization of the Systemic Treatment of Age-related Macular Degeneration With Rheohemapheresis (RHF)|Active, not recruiting||Phase 4|36|Anticipated|University Hospital Hradec Kralove||2|||f||||f||||||||||2017-10-11 01:18:01.374202|2017-10-11 01:18:01.374202
NCT01943383|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-06-09|||August 2013||2013-08-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|PEAR-iPSC||Pharmacogenomic Evaluation of Antihypertensive Responses in Induced Pluripotent Stem (iPS) Cells Study|PHARMACOGENOMIC EVALUATION OF ANTIHYPERTENSIVE RESPONSES IN INDUCED PLURIPOTENT STEM (IPS) CELLS STUDY (PEAR-IPSC) (PEAR-iPSC)|Enrolling by invitation||N/A|50|Anticipated|University of Florida|||1||f||||f||||||Samples With DNA|"     Induced Pluripotent Stem Cells (iPS cells)   "|||2017-10-11 01:18:01.480006|2017-10-11 01:18:01.480006
NCT01943370|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-16|||October 2013||2013-10-01|September 2013|2013-09-01||||January 2014|Anticipated|2014-01-01||Interventional|||Early Saline Irrigation to Decrease Post-operative Endoscopic Debridement|Early Saline Irrigation to Decrease Post-operative Endoscopic Debridement|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 01:18:01.583953|2017-10-11 01:18:01.583953
NCT01943357|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-04-24|||September 2013||2013-09-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|March 2016|Actual|2016-03-01||Interventional|||Improving Self Management Skills of Older Adults With Diabetes|Improving the Self Management Skills of Older Adults With Diabetes|Completed||N/A|1000|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 01:18:01.675671|2017-10-11 01:18:01.675671
NCT01943344|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-05-25|2016-05-25||July 2013||2013-07-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|July 2014|Actual|2014-07-01||Interventional|FRONTIER-I||Safety and Performance Study of Large Hole Vascular Closure Device|Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER I Study|Completed||N/A|12|Actual|Vivasure Medical Limited||1|||f||||t||||||||||2017-10-11 01:18:02.682989|2017-10-11 01:18:02.682989
NCT01943331|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2016-02-14|||March 2013||2013-03-01|April 2013|2013-04-01||||March 2018|Anticipated|2018-03-01||Observational|||Epidemiological Investigation of CRBSI, VAP, CAUTI in Chinese ICU|Colonization and Infection in Critically Ill Patients: a Multicenter, Prospective, Observational Study in Intensive Care Units (ICUs) in China|Recruiting||N/A|1000|Anticipated|Southeast University, China|||1||f||||t||||||||||2017-10-11 01:18:02.955785|2017-10-11 01:18:02.955785
NCT01943318|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-11-24|||January 2013||2013-01-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01|20 Years|Observational [Patient Registry]|||Boramae Hospital Liver Cirrhosis Patient Cohort Study|Prospective Cohort Study to Evaluate Long-term Outcomes in Patients With Liver Cirrhosis of Boramae Hospital|Recruiting||N/A|500|Anticipated|Seoul National University Boramae Hospital|||7||f||||f||||||Samples With DNA|"     At enrollement, 20 ml of blood will be collected for freezing and storage of serum and     plasma, and constitution of a DNA library   "|Undecided||2017-10-11 01:18:03.055077|2017-10-11 01:18:03.055077
NCT01943305|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-04-19|||October 2013||2013-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans|An Open-label Phase 2a Clinical Trial to Test the Effect of Yellow Fever Vaccination in a Background of Japanese Encephalitis Antibodies.|Completed||Phase 2|84|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-10-11 01:18:03.336367|2017-10-11 01:18:03.336367
NCT01943292|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-01-26|2015-06-09||September 2, 2013|Actual|2013-09-02|January 2016|2016-01-01|June 9, 2014|Actual|2014-06-09|June 9, 2014|Actual|2014-06-09||Interventional|||Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies|A Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of VS-6063, a Focal Adhesion Kinase Inhibitor, in Japanese Subjects With Non-Hematologic Malignancies|Completed||Phase 1|9|Actual|Verastem, Inc.|There were no limitations of the trial.|1|||f||||t||||||||||2017-10-11 01:18:03.442314|2017-10-11 01:18:03.442314
NCT01943279|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2014-12-08|||July 2011||2011-07-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|||Comparison of Telephone Follow-up With In-person Follow-up After Medical Abortion|A Comparison of Remote Follow-up After Medical Abortion Using Telephone and Serum Pregnancy Testing With Standard In-person Follow-up|Completed||N/A|139|Actual|Women's College Hospital||2|||f||||f||||||||||2017-10-11 01:18:04.028101|2017-10-11 01:18:04.028101
NCT01943266|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2014-05-13|||March 2012||2012-03-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Determination of Protein Requirement in Elderly Male Subjects 65-75 Yrs Old.|Use of Indicator Amino Acid Oxidation Technique to Determine Protein Requirement of Elderly Male Subjects 65-75 Yrs Old.|Completed||Early Phase 1|13|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 01:18:04.164831|2017-10-11 01:18:04.164831
NCT01943253|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-11|||May 2011||2011-05-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer|Water-jet Assisted Endoscopic Submucosal Dissection (ESD) in Comparison to Conventional ESD Technique for Treatment of Early Gastric Cancer|Completed||N/A|117|Actual|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-11 01:18:04.235784|2017-10-11 01:18:04.235784
NCT01943240|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-10-25|||March 2014||2014-03-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Pectoral Nerve Blockade in Mastectomy|Improvement of Analgesia With Addition of Pectoral Nerve Block to Thoracic Paravertebral Blocks in Unilateral Total Simple Mastectomy|Withdrawn||Phase 4|0|Actual|University of New Mexico||2||Insufficient population of eligible patients; none enrolled|f||||f||||||||||2017-10-11 01:18:04.333916|2017-10-11 01:18:04.333916
NCT01943214|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2013-09-16|||July 2013||2013-07-01|September 2013|2013-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|||Prospective Cohort Study of the Body Constitution Among Type II Diabetes Mellitus Patients|Prospective Cohort Study of the Body Constitution Among Type II Diabetes Mellitus Patients|Unknown status|Recruiting|N/A|1000|Anticipated|Taichung Veterans General Hospital|||1||f||||t||||||||||2017-10-11 01:18:04.544355|2017-10-11 01:18:04.544355
NCT01943201|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-11-21|||January 2010||2010-01-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Low Friction Bed Sheet|Does a Low Friction Bed Sheet Optimize the Skin, Resistance and Physiology and Reduce the Risk for Pressure Ulcer?|Completed||N/A|20|Actual|Swiss Paraplegic Centre Nottwil||2|||f||||f||||||||||2017-10-11 01:18:04.620926|2017-10-11 01:18:04.620926
NCT01943188|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-03-13|||May 2014||2014-05-01|March 2017|2017-03-01||||March 2016|Actual|2016-03-01||Interventional|||Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer|Pilot Study of Local Tumor Irradiation With Autologous T-Cell Infusion for Metastatic Renal Cell Carcinoma|Terminated||Phase 1|2|Actual|Stanford University||1|||f||||||||||||||2017-10-11 01:18:04.718498|2017-10-11 01:18:04.718498
NCT01943175|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-12-04|||September 2013||2013-09-01|December 2013|2013-12-01||||June 2016|Anticipated|2016-06-01||Observational|||Stem Cell Research on Subjects at Genetic High Risk for Schizophrenia|Stem Cell-based Approaches to Neuronal Characteristics and Endophenotype of Schizophrenia in Genetic High Risk Subjects|Unknown status|Recruiting|N/A|30|Anticipated|Seoul National University Hospital|||2||f||||t||||||Samples With DNA|"     5-10mL of adipose cells in tumescent solution      5-10mL of venous blood   "|||2017-10-11 01:18:04.827514|2017-10-11 01:18:04.827514
NCT01943162|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-12-05|||August 2012||2012-08-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|||Enhanced Cognitive Rehabilitation to Treat Comorbid TBI and PTSD|Enhanced Cognitive Rehabilitation to Treat Comorbid TBI and PTSD|Active, not recruiting||N/A|108|Actual|San Diego Veterans Healthcare System||2|||f||||f||||||||||2017-10-11 01:18:04.918918|2017-10-11 01:18:04.918918
NCT01943149|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-10-26|||January 2014||2014-01-01|October 2015|2015-10-01||||January 2024|Anticipated|2024-01-01||Observational|||E-MAX 2nd Gen Vit E Poly On BIOLOX Delta Ceramic Heads|E-MAX 2nd Generation Vitamin E Polyethylene On BIOLOX Delta Ceramic Heads|Active, not recruiting||N/A|50|Anticipated|Renovis Surgical Technologies, Inc.|||1||f||||f||||||||||2017-10-11 01:18:05.005709|2017-10-11 01:18:05.005709
NCT01943136|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-12-18|||August 2013||2013-08-01|December 2013|2013-12-01||||June 2015|Anticipated|2015-06-01||Interventional|||The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial||Unknown status|Recruiting|Phase 1|128|Anticipated|Philippine Dermatological Society||2|||f||||||||||||||2017-10-11 01:18:05.100699|2017-10-11 01:18:05.100699
NCT01943123|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-11|||February 2011||2011-02-01|September 2013|2013-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Probiotic Drink on Number of Salivary Mutans Streptococci in School Going Children|Effect of Commercially Available Probiotic Drink on Number of Salivary Mutans Streptococci in School Going Children Aged 12-14 Years in Bangalore City (India): Randomized Controlled Trial|Completed||N/A|60|Actual|The Oxford Dental College, Hospital and Research Center, Bangalore, India||2|||f||||t||||||||||2017-10-11 01:18:05.219218|2017-10-11 01:18:05.219218
NCT01943110|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-02-03|2015-04-28||July 2013||2013-07-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Healthy adults aged 18-55 years.|Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.|A Clinical Trial to Evaluate the Performance and Safety of Two Intradermal Delivery Devices.|Completed||N/A|30|Actual|PATH||1|||f||||f||||||||||2017-10-11 01:18:05.307666|2017-10-11 01:18:05.307666
NCT01943097|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2014-04-11|||June 2007||2007-06-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01|3 Months|Observational [Patient Registry]|||Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma|The Evaluation of the 6-[18F]Fluoro-levo-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma|Unknown status|Active, not recruiting|N/A|160|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 01:18:05.6113|2017-10-11 01:18:05.6113
NCT01943084|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-03-18|||September 2013||2013-09-01|January 2015|2015-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects|A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects|Completed||Phase 1|32|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:18:05.663711|2017-10-11 01:18:05.663711
NCT01943071|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-10-03|||August 2013||2013-08-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ECOD||Effects and Costs of a Day Care Centre Program Designed for People With Dementia|Effects and Costs of a Day Care Centre Program Designed for People With Dementia - a 24 Month Controlled Study|Active, not recruiting||N/A|261|Actual|Norwegian Centre for Ageing and Health||2|||f||||t||||||||||2017-10-11 01:18:05.751475|2017-10-11 01:18:05.751475
NCT01943058|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2014-09-09|||March 2014||2014-03-01|September 2014|2014-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer|A Phase II Head-to-Head Comparison of Fertility-Sparing Approaches to Treat Complex Atypical Hyperplasia of the Edometrium: Megestrol Versus Levonorgestrel-Releasing Intrauterine System (LNG-IUS)|Withdrawn||Phase 2|0|Actual|University of Southern California||2||Lack of funding|f||||t||||||||||2017-10-11 01:18:05.840356|2017-10-11 01:18:05.840356
NCT01943045|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-11-14|||September 2013||2013-09-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Phase 2 Study of NGM282 in Patients With Type 2 Diabetes|A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Activity of NGM282 Administered for 28 Days to Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|81|Actual|NGM Biopharmaceuticals, Inc||4|||f||||f||||||||||2017-10-11 01:18:05.930445|2017-10-11 01:18:05.930445
NCT01943032|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-19|||April 2011||2011-04-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|April 2011|Actual|2011-04-01|1 Year|Observational [Patient Registry]|||Discordant Hormonal Status of Breast Cancer.|Discordant Hormonal Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.|Completed||N/A|105|Actual|National Cancer Institute, Thailand|||2||f||||f||||||Samples With DNA|"     Paraffin embedded tissue blocks of primary breast tumor and axillary lymph nodes.   "|||2017-10-11 01:18:06.152848|2017-10-11 01:18:06.152848
NCT01943019|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-09-23|||August 2013||2013-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Linagliptin in Schizophrenia Patients|A Pilot Study to Assess the Efficacy of Linagliptin as an Adjunct in Schizophrenia Patients|Suspended||Phase 1|5|Anticipated|Monash University||1||Inability to obtain patients|f||||f||||||||||2017-10-11 01:18:06.225987|2017-10-11 01:18:06.225987
NCT01943006|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-09-14|||May 2015||2015-05-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis|Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment of Superficial Infusion Thrombophlebitis|Recruiting||Phase 3|144|Anticipated|Medinova AG||2|||f||||f||||||||||2017-10-11 01:18:06.302092|2017-10-11 01:18:06.302092
NCT01942993|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-03-15|||September 2013||2013-09-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma|The Effect of BRAF Inhibition With Vemurafenib On The Innate and Adaptive Immune Systems in Patients With Unresectable Stage III or Stage IV Melanoma Expressing a V600 BRAF Mutation|Terminated||Phase 2|3|Actual|Icahn School of Medicine at Mount Sinai||1||standard of care has changed|f||||t||||||||||2017-10-11 01:18:06.448394|2017-10-11 01:18:06.448394
NCT01942980|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-06-20|||March 2013||2013-03-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2016|Actual|2016-03-01||Interventional|||Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer|Double-blind Randomized Multicenter Phase III Study Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer.|Suspended||Phase 3|88|Anticipated|Institut Paoli-Calmettes||2|||f||||f||||||||||2017-10-11 01:18:06.568952|2017-10-11 01:18:06.568952
NCT01942967|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2015-08-03|||August 2013||2013-08-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Impact of Different Modes of Noninvasive Ventilation on Regional Oximetry and Hemodynamics in Premature Newborn|Impact of Different Modes of Noninvasive Ventilation (NCPAP Versus TrPA) on Regional Cerebral and Splanchnic Oximetry as Measured by Near Infrared Spectroscopy (NIRS) and Hemodynamics Using Echocardiography in Premature Newborns|Completed||N/A|10|Actual|University of Manitoba|||1||f||||f||||||||||2017-10-11 01:18:06.689877|2017-10-11 01:18:06.689877
NCT01942954|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-09-10|||October 2012||2012-10-01|September 2013|2013-09-01||||March 2013|Actual|2013-03-01||Interventional|||Health Mobile Cognitive Stimulation in Alcoholics|Executive Functioning in Alcoholics Following a Mobile Health Cognitive Stimulation Approach: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|54|Actual|Universidade Lusófona de Humanidades e Tecnologias||2|||f||||t||||||||||2017-10-11 01:18:06.791869|2017-10-11 01:18:06.791869
NCT01942941|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-05-29|||June 2013||2013-06-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|CCLINS||Peripheral Vascular Disease and Nerve Stimulation|Prospective Observational Series to Establish the Haemodynamic Efficacy and Tolerability of gekoTM Device in Patients With Lower Limb Vascular Disease|Completed||Phase 4|80|Anticipated|University of Hull||1|||f||||t||||||||||2017-10-11 01:18:06.878263|2017-10-11 01:18:06.878263
NCT01942928|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-02-19|||June 2014||2014-06-01|February 2015|2015-02-01||||December 2016|Anticipated|2016-12-01||Interventional|||Cranial Osteopathy in Infantile Colic|Cranial Osteopathic Manipulative Therapy in Addition to Usual Care in Excessively Crying Infants, Sometimes Called Colic|Unknown status|Recruiting|N/A|60|Anticipated|European School of Osteopathy||2|||f||||t||||||||||2017-10-11 01:18:06.993254|2017-10-11 01:18:06.993254
NCT01942915|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-11-14|||January 2012||2012-01-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Umbilical Cord Blood Mononuclear Cells Therapy in Liver Cirrhosis|Safety and Efficacy Investigation of Patients With Liver Cirrhosis by Transplantation of Umbilical Cord Blood Mononuclear Cells|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|Hebei Medical University||1|||f||||t||||||||||2017-10-11 01:18:07.092771|2017-10-11 01:18:07.092771
NCT01942902|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-11-05|||July 2013||2013-07-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Comparative Study to Evaluate the Accuracy and Safety of the GlySure Continuous Intravascular Glucose Monitoring System Versus Intermittent Blood Glucose Monitoring|A Comparative Study to Evaluate the Accuracy and Safety of the GlySure Continuous Intravascular Glucose Monitoring System Versus Intermittent Blood Glucose Monitoring Using the Yellow Springs Blood Glucose Analyser for Conformité Européenne (CE) Marking Purposes in a Total of Thirty Patients Admitted to The Surgical Intensive Care Unit (SICU)|Completed||N/A|38|Actual|GlySure||1|||f||||f||||||||||2017-10-11 01:18:07.22117|2017-10-11 01:18:07.22117
NCT01942889|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-05-21|||April 2012||2012-04-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|AREB-1||Antioxidants and Pulmonary Rehabilitation in COPD Patients|Antioxidants Supplementation Associated With Pulmonary Rehabilitation is it Effective on Muscle Dysfunction and Signaling Pathways Involved in the Myopathy of COPD?|Completed||Phase 3|64|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 01:18:07.318298|2017-10-11 01:18:07.318298
NCT01942876|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-11-16|||January 2011||2011-01-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|QUIT||Preventing Drug Use in Low Income Clinic Populations|Preventing Drug Use in Low Income Clinic Populations|Completed||Phase 2/Phase 3|411|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:18:07.438671|2017-10-11 01:18:07.438671
NCT01942863|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-03-24|||December 2013||2013-12-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Water Exchange Method on Single-balloon Enteroscopy|Effect of Water Exchange Method on Intubation Depth and Diagnostic Yield in Patients Undergoing Single-balloon Enteroscopy: a Prospective, Randomized, Controlled, Patient-blind Trial.|Completed||N/A|110|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 01:18:07.5535|2017-10-11 01:18:07.5535
NCT01942850|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2014-12-30|||August 2013||2013-08-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||International Ataxia Rating Scale in Younger Patients|APPLICABILITY OF THE INTERNATIONAL ATAXIA RATING SCALE (ICARS) IN YOUNGER PATIENTS AND DEVELOPMENT OF GLOBAL RATING INSTRUMENTS FOR PATIENTS WITH ATAXIA TELANGIECTASIA (AT)|Completed||N/A|63|Actual|Erydel|||1||f||||f||||||||||2017-10-11 01:18:07.674368|2017-10-11 01:18:07.674368
NCT01942837|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-06-28|||September 2013||2013-09-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Trial of Enzalutamide for CRPC With Correlative Assessment of Androgen Receptor Signaling|Phase II Trial of Enzalutamide for Castrate-resistant Prostate Cancer (CRPC) With Correlative Assessment of Androgen Receptor (AR) Signaling and Whole-exome and Transcriptome Sequencing|Active, not recruiting||Phase 2|66|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 01:18:07.76777|2017-10-11 01:18:07.76777
NCT01942824|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2014-06-22|||September 2013||2013-09-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Adult Influenza Vaccination Text Message Reminders|Adult Influenza Vaccination Text Message Reminders|Completed||N/A|7250|Actual|Columbia University||2|||f||||||||||||||2017-10-11 01:18:07.899879|2017-10-11 01:18:07.899879
NCT01942811|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-01-08|||February 2013||2013-02-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|BiN-QUIT||BiNational Quit Using Drugs Intervention Trial|US-Mexico Binational Quit Using Drugs Intervention Trial (QUIT)|Completed||N/A|134|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 01:18:07.992128|2017-10-11 01:18:07.992128
NCT01942798|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-11-02|||April 2014||2014-04-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|WiiNWalk||Study of WiiFit to Enhance Walking in Older Adult Amputees|Evaluation of the WiiFit to Enhance Walking in Older Adults With Lower Limb Amputation|Recruiting||N/A|72|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:18:08.087595|2017-10-11 01:18:08.087595
NCT01942785|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-02-16|2015-12-02||October 2013||2013-10-01|February 2016|2016-02-01||||July 2014|Actual|2014-07-01||Interventional||The all-patients-treated set (APTS) comprises all patients who took at least one dose of brexpiprazole.|Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy|Interventional, Open-label, Flexible-dose, Exploratory Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy|Completed||Phase 3|55|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 01:18:08.33167|2017-10-11 01:18:08.33167
NCT01942772|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-11|||January 2013||2013-01-01|March 2013|2013-03-01||||February 2013|Actual|2013-02-01||Interventional|||A Powered Ankle Foot Rehabilitation Orthosis|Design of A Powered Ankle Foot Orthoses for Ankle Rehabilitation|Unknown status|Active, not recruiting|N/A|2|Anticipated|Beijing Institute of Technology||1|||f||||||||||||||2017-10-11 01:18:09.035512|2017-10-11 01:18:09.035512
NCT01942759|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2014-06-08|||September 2013||2013-09-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer|The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Detection of Primary Tumor and Axillary Metastasis for Breast Cancer: SUVMax Against to ADC|Completed||N/A|43|Actual|Bagcilar Training and Research Hospital|||6||f||||f||||||||||2017-10-11 01:18:09.110571|2017-10-11 01:18:09.110571
NCT01942746|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-09-11|||July 2005||2005-07-01|September 2013|2013-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Blueberry Effects on Dark Vision and Glare Recovery|Placebo-controlled Cross-over Studies Examining Blueberries Effects on Dark Vision and Recovery After Photo-bleaching|Completed||N/A|72|Actual|Atlantic Food and Horticulture Research Center||4|||f||||f||||||||||2017-10-11 01:18:09.206579|2017-10-11 01:18:09.206579
NCT01942733|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-02-02|2015-11-16||September 2013||2013-09-01|February 2016|2016-02-01||||August 2014|Actual|2014-08-01||Interventional||The all-patients-treated set (APTS) comprises all patients who took at least one dose of brexpiprazole.|Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder|Interventional, Open-label, Flexible-dose, Exploratory Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder|Completed||Phase 3|44|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 01:18:09.345407|2017-10-11 01:18:09.345407
NCT01942720|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-04-30|2016-12-22||August 2013||2013-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects|Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects|Completed||N/A|74|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-11 01:18:10.171068|2017-10-11 01:18:10.171068
NCT01942707|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-04-21|2015-04-01||March 2013||2013-03-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Scarpa´s Fascia in the Formation of Seroma Post Abdominoplasty After Bariatric Surgery|Study of Scarpa´s Fascia in the Formation of Seroma Post Abdominoplasty After Bariatric Surgery|Active, not recruiting||N/A|46|Actual|Federal University of São Paulo||2|||f||||f||||||||No||2017-10-11 01:18:10.605901|2017-10-11 01:18:10.605901
NCT01942694|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-03-10|||October 2013||2013-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|D2d||Vitamin D and Type 2 Diabetes Study|Vitamin D and Type 2 Diabetes Study|Active, not recruiting||N/A|2382|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-10-11 01:18:11.01129|2017-10-11 01:18:11.01129
NCT01942681|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-07-14|||September 2013||2013-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|FRESH||Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride|Multi-institution Study on Efficacy and Safety of Propiverine Hydrochloride for Female Patients With Urge and Stress Urinary Incontinence|Completed||N/A|62|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||f||||||||||2017-10-11 01:18:11.187011|2017-10-11 01:18:11.187011
NCT01942668|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-08-08||2017-02-08|September 2013||2013-09-01|August 2017|2017-08-01|October 28, 2016|Actual|2016-10-28|October 28, 2016|Actual|2016-10-28||Interventional|REPLENISH||A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms|A Phase 3 Study Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms in Postmenopausal Women With an Intact Uterus|Completed||Phase 3|1847|Actual|TherapeuticsMD||5|||f||||f||||||||||2017-10-11 01:18:11.308735|2017-10-11 01:18:11.308735
NCT01942655|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-02-13|||June 1, 2014|Actual|2014-06-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|INTESTIPAX||IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection|ANRS RF002 Intestipax : Interleukin-23 (IL-23)/Interleukin-12 (IL-12) Imbalance and T Lymphocyte Polarization in HIV Infection|Recruiting||N/A|45|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-11 01:18:11.656763|2017-10-11 01:18:11.656763
NCT01942642|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-13|||November 2012||2012-11-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery||Completed||N/A|48|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:18:11.744348|2017-10-11 01:18:11.744348
NCT01942629|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2013-09-10|||October 2013||2013-10-01|September 2013|2013-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Observational|||Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas|Prognostic Value of Quantitative p63 Immunostaining in Adenocarcinoma of Lung, Breast, and Pancreas|Unknown status|Not yet recruiting|N/A|300|Anticipated|Rambam Health Care Campus|||3||f||||t||||||||||2017-10-11 01:18:11.798741|2017-10-11 01:18:11.798741
NCT01942616|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-09-10|||July 2009||2009-07-01|September 2013|2013-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||The Development of a Domestic Violence Perpetrator Collusion Measurement Tool|Media, Public Health, and Colluding With Murder: The Development of a Domestic Violence Perpetrator Collusion Measurement Tool.|Completed||N/A|72|Actual|Yale University||3|||f||||f||||||||||2017-10-11 01:18:11.867528|2017-10-11 01:18:11.867528
NCT01942603|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2017-07-26|||July 2009||2009-07-01|July 2017|2017-07-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01|5 Years|Observational [Patient Registry]|Minitub||Minimal SN Tumor Burden|Minitub: Prospective Registry of Sentinel Node (SN) Positive Melanoma Patients With Minimal SN Tumor Burden Who Undergo Completion Lymph Node Dissection (CLND) or Nodal Observation|Recruiting||N/A|260|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||2||f||||t||||||||||2017-10-11 01:18:11.94998|2017-10-11 01:18:11.94998
NCT01942577|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-11-02|||September 2013||2013-09-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Microbiome Survey of Preterm Infants|Comprehensive Microbiome Survey of Preterm Infants|Withdrawn||N/A|0|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:18:12.191861|2017-10-11 01:18:12.191861
NCT01942564|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-09-20|||August 2013||2013-08-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|HIPP||The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study|The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study|Completed||N/A|40|Actual|Ohio State University|||2||f||||f||||||||||2017-10-11 01:18:12.280243|2017-10-11 01:18:12.280243
NCT01942551|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-01-22|||September 2013||2013-09-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride||Completed||Phase 1|47|Actual|Dongkook Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:18:12.371946|2017-10-11 01:18:12.371946
NCT01942538|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2015-08-05|||September 2013||2013-09-01|July 2015|2015-07-01|February 2017|Anticipated|2017-02-01|August 2016|Anticipated|2016-08-01||Interventional|||Efficiency of Repetitive Transcranial Magnetic Stimulation (rTMS) Sessions After a Successful 3 Week-treatment in Fibromyalgia|Study of the Effectiveness of Maintenance rTMS Sessions for 6 Months Versus Placebo in Subjects With Fibromyalgia Responders to 3 Week-rTMS Treatment|Unknown status|Recruiting|N/A|78|Anticipated|Centre Hospitalier Esquirol||5|||f||||f||||||||||2017-10-11 01:18:12.451079|2017-10-11 01:18:12.451079
NCT01942525|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-24|2013-09-13|||June 2010||2010-06-01|September 2013|2013-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants|Intrauterine Growth Restriction Has an Impact on Amplitude-integrated EEG in Preterm Infants|Unknown status|Active, not recruiting|N/A|156|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 01:18:12.549913|2017-10-11 01:18:12.549913
NCT01942512|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-11|2016-12-27|||November 2013||2013-11-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Observational|ARETA||Risk Factors for Intracranial Aneurysm Recanalization After Endovascular Treatment.|Evaluation of Risk Factors Associated With Intracranial Aneurysm Recanalization After Endovascular Treatment|Active, not recruiting||N/A|1275|Anticipated|CHU de Reims|||1||f||||f||||||||||2017-10-11 01:18:12.632784|2017-10-11 01:18:12.632784
NCT01942499|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-05-09|||November 2012||2012-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Community-Based Maintenance Exercise Program for COPD|A Randomized Controlled Trial of a Post-rehabilitation Community-based Exercise Program for Individuals With COPD|Recruiting||N/A|100|Anticipated|West Park Healthcare Centre||2|||f||||f||||||||||2017-10-11 01:18:12.741845|2017-10-11 01:18:12.741845
NCT01942486|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-05-02|||January 2014||2014-01-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Child and Adolescent Patients With Migraine|Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Child and Adolescent Patients With Migraine|Recruiting||N/A|50|Anticipated|University of Utah||1|||f||||f||||||||No||2017-10-11 01:18:12.854967|2017-10-11 01:18:12.854967
NCT01942473|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-11-25|||August 2012||2012-08-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|FiO2-Contr||Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants|Effects of Automated Adjustment of Inspired Oxygen on Fluctuations of Regional Cerebral and Arterial Oxygenation in Preterm Infants With Frequent Desaturations|Completed||N/A|17|Actual|University of Ulm||2|||f||||f||||||||||2017-10-11 01:18:12.930125|2017-10-11 01:18:12.930125
NCT01942460|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-04-10|||September 2013||2013-09-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients|Use of FERAHEME® (Ferumoxytol) for Severe Chronic Kidney Disease and Peritoneal Dialysis|Completed||Phase 4|15|Actual|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||||2017-10-11 01:18:13.009167|2017-10-11 01:18:13.009167
NCT01942447|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-10-10|||October 2013||2013-10-01|October 2013|2013-10-01|May 2015|Anticipated|2015-05-01|December 2014|Anticipated|2014-12-01||Interventional|TOCSIN||Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis||Unknown status|Not yet recruiting|N/A|30|Anticipated|University Hospital Tuebingen||2|||f||||||||||||||2017-10-11 01:18:13.086556|2017-10-11 01:18:13.086556
NCT01942434|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-04-17|||January 2010||2010-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2011|Actual|2011-11-01||Observational|||Fatty Acid Levels and Memory in Breastfed Children|The Influence of FADS2 rs 174575 on Breastmilk Fatty Acid Levels and the Recognition Memory Abilities of 6-month Old Breastfed Infants and Follow-up|Active, not recruiting||N/A|202|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     saliva, blood   "|||2017-10-11 01:18:13.285972|2017-10-11 01:18:13.285972
NCT01942421|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-09-10|||January 2008||2008-01-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation|Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation.|Unknown status|Active, not recruiting|Phase 2/Phase 3|20|Anticipated|Mahidol University||1|||f||||t||||||||||2017-10-11 01:18:13.385582|2017-10-11 01:18:13.385582
NCT01942408|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-03-02|||November 2013||2013-11-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PRESSURE||The Effect of Early Repeat Atrial Fibrillation (AF) Ablation on AF Recurrence|Pulmonary Vein Re-isolation as a Routine Strategy: a Success Rate Evaluation|Completed||N/A|80|Actual|Liverpool Heart and Chest Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:18:13.481867|2017-10-11 01:18:13.481867
NCT01942395|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-06-02|||March 2013||2013-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2)|Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2)|Recruiting||N/A|25|Anticipated|University of Michigan||3|||f||||f||||||||||2017-10-11 01:18:13.585043|2017-10-11 01:18:13.585043
NCT01942382|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-10|||April 2009||2009-04-01|September 2013|2013-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia|Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Subjects With Schizophrenia|Completed||Phase 1|76|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-10-11 01:18:13.729952|2017-10-11 01:18:13.729952
NCT01942187|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-03-20|||August 2013||2013-08-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults|A Comparison of Medication Augmentation and Problem Solving Therapy|Withdrawn||Phase 4|0|Actual|New York State Psychiatric Institute||2||No participants enrolled.|f||||f||||||||||2017-10-11 01:18:15.526992|2017-10-11 01:18:15.526992
NCT01942369|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-05-04|||September 2013||2013-09-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|DIE-NIS||A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months|A Multi-centre, Prospective, Non-interventional Study to Describe the Efficacy of a Continuous up to 24-week Treatment of Diphereline 3.75mg Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months.|Active, not recruiting||N/A|400|Anticipated|Ipsen|||1||f||||f||||||||||2017-10-11 01:18:13.838509|2017-10-11 01:18:13.838509
NCT01942356|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-01-26|||September 2013||2013-09-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor|Evaluation of Closed-loop Titration of the Intravenous Anesthetic Propofol, Sufentanil and Ketamine Guided by BIS Monitor|Completed||N/A|4|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||f||||||||||2017-10-11 01:18:13.963454|2017-10-11 01:18:13.963454
NCT01942343|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-09-07|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Akathisia in Post Operative Outpatients Surgery|Etude de l'Effet du dropéridol et de l'Ondansetron Sur l'Incidence de l'Akathisie Post opératoire en Chirurgie Ambulatoire|Completed||Phase 3|300|Actual|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-10-11 01:18:14.11374|2017-10-11 01:18:14.11374
NCT01942330|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-12-02|||August 2013||2013-08-01|December 2015|2015-12-01||||August 2016|Anticipated|2016-08-01||Interventional|TVC||Pain and Infection After Transvaginal Colectomy|Prospective Evaluation of a Laparoscopic-Assisted Transvaginal Approach for Colonic Resection|Recruiting||N/A|110|Anticipated|University of South Florida||2|||f||||t||||||||||2017-10-11 01:18:14.211152|2017-10-11 01:18:14.211152
NCT01942317|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-10|||October 2013||2013-10-01|September 2013|2013-09-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|||The Role of Balneotherapy in Obese Patients With Knee Osteoarthritis||Unknown status|Not yet recruiting|N/A|74|Anticipated|University of Padua||2|||f||||||||||||||2017-10-11 01:18:14.334259|2017-10-11 01:18:14.334259
NCT01942304|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-05-01|||October 2013||2013-10-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Prospective Evaluation of Anorganic Bovine Bone Mineral Versus Calcium Phosphosilicate Alloplastic Bone Putty in Direct Sinus Augmentation: a Spilt-mouth Study|Prospective Evaluation of Anorganic Bovine Bone Mineral Versus Calcium Phosphosilicate Alloplastic Bone Putty in Direct Sinus Augmentation: a Spilt-mouth Study|Active, not recruiting||N/A|12|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:18:14.440005|2017-10-11 01:18:14.440005
NCT01942291|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-10|||March 2012||2012-03-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Short-term Effect of Extended-release Niacin on Endothelial Function.|Short-term Effect of Extended-release Niacin With and Without the Addition of Laropiprant on Endothelial Function|Completed||Phase 4|18|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-11 01:18:14.550429|2017-10-11 01:18:14.550429
NCT01942278|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-04-12|||January 2011|Actual|2011-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|BHOMA||Better Health Outcomes Through Mentoring and Assessment (BHOMA)|CIDRZ 1229- Better Health Outcomes Through Mentoring and Assessment (BHOMA)|Completed||N/A|207517|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:18:14.649706|2017-10-11 01:18:14.649706
NCT01942265|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-07-03||2017-07-03|September 2013||2013-09-01|September 2014|2014-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||H7N9 Mix and Match With AS03 and MF59 in Healthy Adults|A Phase II Randomized, Double-Blinded, Controlled Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Influenza A/H7N9 Virus Vaccine Administered at Different Dosages Given With and Without AS03 and MF59 Adjuvants|Completed||Phase 2|980|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||10|||f||||||||||||||2017-10-11 01:18:14.751287|2017-10-11 01:18:14.751287
NCT01942252|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-10|||August 2013||2013-08-01|September 2013|2013-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||COMPLICATIONS RELATED CARBOXYHEMOGLOBIN LEVELS IN SECOND HAND SMOKING PEDIATRIC TONSILLECTOMY PATIENTS|COMPLICATIONS OF SECOND HAND SMOKING IN PEDIATRIC TONSILLECTOMY PATIENTS|Unknown status|Recruiting|Phase 4|100|Anticipated|Mustafa Kemal University|||1||f||||t||||||||||2017-10-11 01:18:14.911212|2017-10-11 01:18:14.911212
NCT01942239|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-12|||December 2008||2008-12-01|December 2008|2008-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Real-time Continuous Glucose Monitoring in Very Low Birth Weight Neonates|Real-time Continuous Glucose Monitoring Reduces Duration of Hypoglycemia Episodes in Very Low Birth Weight Neonates|Completed||N/A|48|Actual|University Hospital, Tours||2|||f||||f||||||||||2017-10-11 01:18:15.085682|2017-10-11 01:18:15.085682
NCT01942226|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-12-06|||August 2013||2013-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|||Investigation on Medical Management of Dry Eye Patients||Completed||N/A|466|Actual|National Cheng Kung University|||1||f||||f||||||||||2017-10-11 01:18:15.182086|2017-10-11 01:18:15.182086
NCT01942213|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-05-31|||December 2013||2013-12-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.|Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients|Completed||N/A|136|Actual|NJ Retina|||2||f||||f||||||||||2017-10-11 01:18:15.302404|2017-10-11 01:18:15.302404
NCT01942200|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-11-21|||September 2013||2013-09-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer|Open, Multicenter Observational Study of Oxaliplatin Utilized in Combination Therapy for Adjuvant Treatment of Colon Carcinoma of Stage III After Complete Removal of the Primary Tumor and for Treatment of Metastasizing Colorectal Carcinoma.|Recruiting||N/A|350|Anticipated|Onkovis GmbH|||1||f||||f||||||||||2017-10-11 01:18:15.411639|2017-10-11 01:18:15.411639
NCT01942174|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-04-26|||September 2013||2013-09-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|April 2017|Anticipated|2017-04-01||Interventional|VACIMRA||VACcination In Methotrexate Treated Rheumatoid Arthritis Patients|Lead Time of the Methotrexate Establishment and Vaccinal Protection Against the Pneumococcal Agent in Patients Affected With Rheumatoid Polyarthritis|Recruiting||Phase 3|276|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 01:18:15.689414|2017-10-11 01:18:15.689414
NCT01942161|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-04-11|2016-12-27||August 2010||2010-08-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia|A Multicenter, Double-blind, Randomized, Dose-comparison Study of Three Different Doses of Aripiprazole (2 mg/Day, 6-12 mg/Day, 24-30 mg/Day) Orally Administered Over 6 Weeks in Pediatric Patients (Aged 13-17 Years) With Schizophrenia|Completed||Phase 2/Phase 3|106|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:18:15.911584|2017-10-11 01:18:15.911584
NCT01942148|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-04-11|2016-12-27||August 2010||2010-08-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia|A Multicenter, Open-label, Long-term Safety Study of Aripiprazole (Initial Dose 2 mg/Day, Maintenance Dose 6-24 mg/Day, Maximum Dose 30 mg/Day) Orally Administered Over 52 Weeks in Patients Who Complete a Short-term Treatment Study of Aripiprazole in Pediatric Patients (Aged 13-17 Years) With Schizophrenia (031-09-003 Study)|Completed||Phase 3|68|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 01:18:16.51005|2017-10-11 01:18:16.51005
NCT01942135|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-09-08|2015-12-03||September 26, 2013|Actual|2013-09-26|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|December 5, 2014|Actual|2014-12-05||Interventional|||Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)|Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Trial Of Fulvestrant (Faslodex (Registered)). With Or Without Pd-0332991 (Palbociclib) +/- Goserelin In Women With Hormone Receptor-positive, Her2-negative Metastatic Breast Cancer Whose Disease Progressed After Prior Endocrine Therapy|Active, not recruiting||Phase 3|521|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 01:18:16.863919|2017-10-11 01:18:16.863919
NCT01942122|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-09-25|||October 2015||2015-10-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis|Role of DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis|Recruiting||Phase 2/Phase 3|60|Anticipated|Dexa Medica Group||3|||f||||t||||||||||2017-10-11 01:18:20.310844|2017-10-11 01:18:20.310844
NCT01942109|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-24|2017-06-07|||September 2013||2013-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|TORNADO||The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure|The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure - Prospective, Randomized, Open, Blinded Endpoint Trial|Recruiting||Phase 4|100|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 01:18:20.452245|2017-10-11 01:18:20.452245
NCT01942096|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-06-20|||December 2011||2011-12-01|June 2016|2016-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Study of Airway Inflammation in Relation to Exercise in Elite Athletes|Study of Airway Inflammation in Relation to Exercise in Elite Athletes|Completed||N/A|66|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||Samples With DNA|"     induced sputum sample nasal fluid venous blood (serum)   "|Yes|Overall results are presented in a closed session for participants and parents. Confidential individual data are afterwards discussed with the respective parents and participants.|2017-10-11 01:18:20.58281|2017-10-11 01:18:20.58281
NCT01942083|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-05-07|||May 29, 2013|Actual|2013-05-29|May 2017|2017-05-01|July 11, 2016|Actual|2016-07-11|June 1, 2016|Actual|2016-06-01||Interventional|||A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)||Terminated||Phase 1|33|Actual|Korea Otsuka Pharmaceutical Co., Ltd.||1||Company decision|f||||f||||||||||2017-10-11 01:18:20.669365|2017-10-11 01:18:20.669365
NCT01942070|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-10-30|||September 2013||2013-09-01|October 2013|2013-10-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|ISAR-Absorb MI||A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction|Intracoronary Scaffold Assessment a Randomised Evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction|Unknown status|Recruiting|Phase 4|260|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 01:18:20.762442|2017-10-11 01:18:20.762442
NCT01942057|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2015-07-16|||December 2013||2013-12-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|Falcon||Myopia Prevalence in Canadian School Children - a Pilot Study|Myopia Prevalence in Canadian School Children - a Pilot Study|Completed||N/A|173|Actual|University of Waterloo|||3||f||||f||||||||||2017-10-11 01:18:20.886341|2017-10-11 01:18:20.886341
NCT01942044|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2013-09-10|||February 2013||2013-02-01|September 2013|2013-09-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)|Impact of Stent Platform on Shear Stress Distribution and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)|Unknown status|Recruiting|Phase 4|30|Anticipated|Kobe University||3|||f||||f||||||||||2017-10-11 01:18:20.955723|2017-10-11 01:18:20.955723
NCT01942031|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-08-15|||October 2013||2013-10-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2015|Actual|2015-12-01||Interventional|||Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke)|An Interventional Study of How Collegial Feed Back to Primary Care Physicians on Detection of Diagnosis and Dispensation of Prescribed Secondary Preventive Drugs Affect Stroke Prevention.|Enrolling by invitation||N/A|204|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:18:21.059014|2017-10-11 01:18:21.059014
NCT01942018|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-05-11|||July 2015||2015-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Per Oral Endoscopic Myotomy (POEM) for Esophagogastric Junction Outflow Obstruction (EGOO)|Per Oral Endoscopic Myotomy (POEM) for Esophagogastric Junction Outflow Obstruction (EGOO)|Recruiting||Phase 2|15|Anticipated|Johns Hopkins University||1|||f||||t||||||||Undecided||2017-10-11 01:18:21.181881|2017-10-11 01:18:21.181881
NCT01942005|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-12-03|||January 2010||2010-01-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|EBVER/TMC||EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients|EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients,Especially Patients After Organ Transplantation and Patients With HIV Infection|Completed||N/A|144|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples With DNA|"     Blutsample   "|||2017-10-11 01:18:21.309638|2017-10-11 01:18:21.309638
NCT01941992|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-09-16|||December 2012||2012-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ROSAM||Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients|Role of SAMITAL® in Prevention and Treatment of Oral Mucositis in Patients Treated With Chemo-radiation (CT/RT)for Head-and-neck Squamous Cell Carcinomas. A Double-blind, Phase 2 Placebo Controlled, Randomized Trial.|Active, not recruiting||Phase 2|120|Actual|Istituto Oncologico Veneto IRCCS||2|||f||||||||||||||2017-10-11 01:18:21.390376|2017-10-11 01:18:21.390376
NCT01941979|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-10-29|||September 2011||2011-09-01|October 2014|2014-10-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment.|A Phase III, Randomized Study of Adjuvant Chemotherapy for Patients With Rectal Adenocarcinoma Who Achieved Suboptimal Response After Neoadjuvant Chemo-radiotherapy.|Unknown status|Recruiting|Phase 3|309|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||||||||||||2017-10-11 01:18:21.51026|2017-10-11 01:18:21.51026
NCT01941966|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-03-26|||November 2010||2010-11-01|March 2014|2014-03-01||||November 2013|Actual|2013-11-01||Interventional|||A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.|A Phase II Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.|Completed||Phase 2|51|Anticipated|Instituto do Cancer do Estado de São Paulo||1|||f||||||||||||||2017-10-11 01:18:21.636812|2017-10-11 01:18:21.636812
NCT01941953|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-04-06|||November 2012||2012-11-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Metformin and 5-fluorouracil for Refractory Colorectal Cancer.|Phase II Study of Metformin and 5-fluorouracil in Patients With Advanced Colorectal Cancer Previously Treated With Oxaliplatin and Irinotecan Based Chemotherapy.|Completed||Phase 2|50|Actual|Instituto do Cancer do Estado de São Paulo||1|||f||||f||||||||||2017-10-11 01:18:21.749246|2017-10-11 01:18:21.749246
NCT01941940|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-06-12|2016-10-21||September 5, 2013|Actual|2013-09-05|June 2017|2017-06-01|July 5, 2016|Actual|2016-07-05|September 9, 2015|Actual|2015-09-09||Interventional||Full Analysis Set (FAS) included all recruited participants who received at least one dose of SC tocilizumab.|A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants|A National, Open-Label, Single-Arm, Phase IIIb Study to Evaluate the Efficacy of Weekly Tocilizumab Subcutaneous, Administered as Monotherapy or in Combination With Methotrexate and/or Other DMARDs in Rheumatoid Arthritis (RA) Patients|Completed||Phase 3|227|Actual|Hoffmann-La Roche||1|||f|||||f|f||||||||2017-10-11 01:18:21.890316|2017-10-11 01:18:21.890316
NCT01941927|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2015-02-17|||September 2013||2013-09-01|February 2015|2015-02-01|May 2016|Anticipated|2016-05-01|December 2014|Actual|2014-12-01||Interventional|||Trametinib With GSK2141795 in BRAF Wild-type Melanoma|Phase II Clinical Trial of the MEK Inhibitor Trametinib With the AKT Inhibitor GSK2141795 in BRAF Wild-type Melanoma|Unknown status|Active, not recruiting|Phase 2|20|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:18:23.456173|2017-10-11 01:18:23.456173
NCT01941914|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-08-28|||August 2013||2013-08-01|August 2015|2015-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Calcium Electroporation for the Treatment of Keloids|Calcium Electroporation for the Treatment of Keloids|Recruiting||Phase 1|8|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-10-11 01:18:23.550921|2017-10-11 01:18:23.550921
NCT01941901|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-08-28|||September 2013||2013-09-01|August 2015|2015-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Calcium Electroporation for Treatment of Cutaneous Metastases|Calcium Electroporation for Treatment of Cutaneous Metastases|Recruiting||Phase 2|15|Anticipated|Herlev Hospital||2|||f||||t||||||||||2017-10-11 01:18:23.672974|2017-10-11 01:18:23.672974
NCT01941888|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-10|||May 2012||2012-05-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|PropTCI/2012||Propofol TCI Administered by Gastroenterologists During Endoscopy: a Randomized Double Blind Controlled Study|Phase IV Study of Propofol TCI (Target Controlled Infusion)Administered by Gastroenterologists During Endoscopy in Moderate Sedation: a Randomized Double Blind Controlled Study|Completed||Phase 4|140|Actual|Ospedale San Raffaele||2|||f||||t||||||||||2017-10-11 01:18:23.778274|2017-10-11 01:18:23.778274
NCT01941875|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-12-31|||July 2014||2014-07-01|July 2013|2013-07-01|January 2016|Anticipated|2016-01-01|September 2015|Anticipated|2015-09-01||Interventional|||Luteal Phase Progesterone in IUI and Gonadotropin Cycles|The Effect of Luteal Phase Support on Pregnancy Rate in Intrauterine Insemination Cycles Following Ovarian Stimulation With Gonadotropins|Unknown status|Recruiting|Phase 3|300|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 01:18:23.853109|2017-10-11 01:18:23.853109
NCT01941862|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2017-07-12|||November 2013||2013-11-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|DARTS||Depression and Anxiety Reduction Treatment for Suicide|Development and Evaluation of a Brief, Suicide Prevention Intervention Targeting Anxiety and Mood Vulnerabilities|Active, not recruiting||N/A|300|Actual|Florida State University||4|||f||||f||||||||||2017-10-11 01:18:23.937499|2017-10-11 01:18:23.937499
NCT01941849|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-12-18|||October 2014||2014-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|VIBRaNT||Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma|A Phase I Trial of Vandetanib Combined With 131I-mIBG Radiotherapy in Patients With Neuroendocrine Tumours, Advanced Phaeochromocytoma and Paraganglioma|Withdrawn||Phase 1|0|Actual|University College, London||1||Poor patient accrual|f||||t||||||||||2017-10-11 01:18:24.0221|2017-10-11 01:18:24.0221
NCT01940393|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2014-02-16|||August 2013||2013-08-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria|Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria|Completed||Phase 4|150|Actual|Grupo de Alergología Clínica y Experimental||5|||f||||t||||||||||2017-10-11 01:18:47.722367|2017-10-11 01:18:47.722367
NCT01941836|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-08-27||2015-08-13|September 2013||2013-09-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients|A Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients With or Without Statin Intolerance|Completed||Phase 2|349|Actual|Esperion Therapeutics||5|||f||||f||||||||||2017-10-11 01:18:24.13772|2017-10-11 01:18:24.13772
NCT01941823|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-10-20|||December 2014||2014-12-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Observational|||Carnitine, Aclycarnitine, Myocardial Function, and CRRT|Pilot Study: Effect of Carnitine Supplementation on Acylcarnitine Profile and Myocardial Function in Children and Young Adults Receiving Continuous Renal Replacement Therapy|Recruiting||Phase 4|30|Anticipated|Children's Research Institute|||3||f||||f||||||||No||2017-10-11 01:18:24.480544|2017-10-11 01:18:24.480544
NCT01941810|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-05-25|||February 2014||2014-02-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy|A Pilot Study of Bovine Lactoferrin in Cancer Patients Reporting Taste Disturbances While Receiving Chemotherapy|Completed||N/A|14|Actual|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 01:18:24.561101|2017-10-11 01:18:24.561101
NCT01941797|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-04-24|||September 2012||2012-09-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Experimental Peri-implant Mucositis in Humans|Experimental Peri-implant Mucositis in Humans|Completed||N/A|18|Actual|UConn Health||2|||f||||f||||||||||2017-10-11 01:18:24.65745|2017-10-11 01:18:24.65745
NCT01941784|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-05-25|||November 25, 2013|Actual|2013-11-25|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy|Taking Health Realization Into Valued Eating and Exercise (THRIVE): A Feasibility Study of an Intervention to Prevent Weight Gain for Breast Cancer Survivors During Chemotherapy|Active, not recruiting||N/A|28|Anticipated|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 01:18:24.734458|2017-10-11 01:18:24.734458
NCT01941771|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-10-27|||June 2012||2012-06-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|XeNa||Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer|Randomized Phase II Trial of Capecitabine Plus Oral Vinorelbine Day 1 and 8 vs Metronomic Capecitabine Plus Oral Vinorelbine as Treatment of Metastatic Breast Cancer.|Completed||Phase 2|110|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 01:18:24.848458|2017-10-11 01:18:24.848458
NCT01941758|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-05-25|||November 2013||2013-11-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors|A Pilot Single Arm Study of High-Dose Influenza Vaccine Immunogenicity in Patients With Central Nervous System Tumors|Completed||Phase 1|28|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 01:18:24.950744|2017-10-11 01:18:24.950744
NCT01941719|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-09-09|||September 2009||2009-09-01|January 2013|2013-01-01||||January 2013|Actual|2013-01-01||Interventional|DFE||Enhancing Diabetic Foot Education by Viewing Personal Plantar Pressures|Enhancing Diabetic Foot Education by Viewing Personal Plantar Pressures|Suspended||N/A|101|Actual|Temple University||2||Analysis of 99 subjects showed no significant benefits of the novel diabetic foot education.|f||||f||||||||||2017-10-11 01:18:25.244514|2017-10-11 01:18:25.244514
NCT01941706|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-02-11|||October 2009||2009-10-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT|Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT|Completed||N/A|130|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:18:25.354332|2017-10-11 01:18:25.354332
NCT01941693|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-09|||March 2007||2007-03-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|December 2010|Actual|2010-12-01||Interventional|||A Randomized Controlled Trial of Structured Stepped-care Intervention for Psychiatric Comorbidity|Novel Treatments for Alcohol Dependence: A Randomized Controlled Trial of Structured Stepped-care Intervention for Psychiatric Comorbidity|Completed||N/A|86|Actual|South West Sydney Local Health District||2|||f||||f||||||||||2017-10-11 01:18:25.470642|2017-10-11 01:18:25.470642
NCT01941680|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-04-25|||October 31, 2013|Actual|2013-10-31|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|ATLL-HR-01||High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant|Observational Prospective Study, Evaluating the Standard of Care as Recommend by International Consensus With Zidovudine-Pegylated Interferon +/-Polychemotherapy in High Risk Adult-T-cell Lymphoma/Leukaemia (T-cell Lymphoma/Leukaemia) Followed by Allogeneic Transplant Among Eligible Patients Younger Than 65 Years Old|Recruiting||N/A|20|Anticipated|University Hospital Center of Martinique|||3||f||||f||||||||||2017-10-11 01:18:25.570694|2017-10-11 01:18:25.570694
NCT01941667|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-09-29|||July 2012||2012-07-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|November 2016|Actual|2016-11-01||Interventional|||Transitional Telehealth Home Care: REACH|Transitional Telehealth Home Care: REACH|Completed||N/A|218|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 01:18:25.657508|2017-10-11 01:18:25.657508
NCT01941485|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-11-07|2015-02-01||October 2013||2013-10-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|January 2014|Actual|2014-01-01||Interventional||This analysis population includes all enrolled subjects who underwent LASIK surgery (59).|WaveLight® Refractive Flap Accuracy Study|A Prospective, Global, Multi-Center Study to Evaluate Longitudinal Flap Accuracy on Subjects Undergoing Myopic Refractive Surgery Using the WaveLight® Refractive Suite|Completed||N/A|60|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 01:18:28.262689|2017-10-11 01:18:28.262689
NCT01941654|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-07-06|||September 2013||2013-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||ATOM_local Ablative Therapy|A Single-arm Phase II Study to Determine the Efficacy of Preemptive Local Ablative Therapy to Residual Metabolic Active Oligo-metastases in Those EGFR Mutation Positive Non-small Cell Lung Cancer Patients Who Have Achieved a Good Partial Response With First-line EGFR TKI (ATOM)|Recruiting||Phase 2|34|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 01:18:25.74548|2017-10-11 01:18:25.74548
NCT01941641|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-07-20|||October 2013||2013-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Colon Neoadjuvant FOLFOXIRI Study|A Phase II Study of Neoadjuvant FOLFOXIRI Followed by Concurrent Capecitabine and Radiotherapy for High Risk Rectal Cancer|Recruiting||Phase 2|40|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 01:18:25.835866|2017-10-11 01:18:25.835866
NCT01941628|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-01-29|||February 2013||2013-02-01|January 2014|2014-01-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||Comparison of Surgical Conditions in Cesarean Section Under General Anesthesia With Deep Neuromuscular Blockade Versus Succinylcholine|A Double-blind, Randomized, Parallel Design Study to Compare Surgical Conditions for Fetus Delivery and Suture of the Uterus and Abdominal Wall in Cesarean Section Under General Anesthesia With Deep Neuromuscular Blockade Versus Succinylcholine|Unknown status|Recruiting|Phase 4|45|Anticipated|Charles University, Czech Republic||2|||f||||t||||||||||2017-10-11 01:18:25.936957|2017-10-11 01:18:25.936957
NCT01941615|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-03-16|2016-01-21||November 2013||2013-11-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel|An Open-label, Two-period, Fixed-sequence, Phase I Trial to Evaluate the Effect of Multiple Doses of BI 207127 + Faldaprevir on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Premenopausal Female Subjects|Terminated||Phase 1|18|Actual|Boehringer Ingelheim|This trial was prematurely discontinued during the run-in period. During the run-in period, subjects were to receive Microgynon® once daily for 21 to 49 days. The investigational products Deleobuvir + faldaprevir were not administered.|1|||f||||||||||||||2017-10-11 01:18:26.049186|2017-10-11 01:18:26.049186
NCT01941602|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-09-28|||August 2013|Actual|2013-08-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery|A Comparative Study of Prophylactic Enoxaparin Routinely Administered Preoperative for Prevention of Venous Thromboembolism in Meningioma Surgery - an Acceptable Risk-benefit Ratio?|Completed||N/A|979|Actual|St. Olavs Hospital|||2||f||||f|f|f||||||||2017-10-11 01:18:26.287908|2017-10-11 01:18:26.287908
NCT01941589|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-04-09|||September 2013||2013-09-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis|Combination Corticosteroids + 5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis.|Recruiting||Phase 4|160|Anticipated|Sheba Medical Center||4|||f||||f||||||||No||2017-10-11 01:18:26.402944|2017-10-11 01:18:26.402944
NCT01941576|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-04-20|||September 2013||2013-09-01|January 2016|2016-01-01||||September 2016|Anticipated|2016-09-01||Interventional|||Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot|Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot|Recruiting||Phase 2/Phase 3|100|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 01:18:26.581381|2017-10-11 01:18:26.581381
NCT01941563|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-03-13|||September 2013||2013-09-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|November 2015|Actual|2015-11-01||Interventional|||A Study of SI-6603 in Patients With Lumbar Disc Herniation||Active, not recruiting||Phase 3|360|Anticipated|Seikagaku Corporation||2|||f||||t||||||||||2017-10-11 01:18:26.710275|2017-10-11 01:18:26.710275
NCT01941550|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-09-12|||July 2013||2013-07-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CLUBNET||Neoadjuvant Chemotherapy With Cabazitaxel|Neoadjuvant Chemotherapy With Cabazitaxel in High Risk Prostate Cancer Patients Prior to Radical Prostatectomy|Terminated||Phase 2|11|Actual|RWTH Aachen University||1||Investigator left the site. Site closed.|f||||t||||||||||2017-10-11 01:18:26.915498|2017-10-11 01:18:26.915498
NCT01941537|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-06-06|||October 2013||2013-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis|A Randomized Placebo-controlled Study to Determine the Safety, Tolerability, Pharmacodynamics and Clinical Efficacy of ILV-094 (an IL-22 Antibody) Administered Intravenously to Subjects With Atopic Dermatitis (AD)|Active, not recruiting||Phase 2|60|Anticipated|Rockefeller University||2|||f||||t||||||||Undecided||2017-10-11 01:18:27.004332|2017-10-11 01:18:27.004332
NCT01941524|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-10-18|||September 2013||2013-09-01|October 2013|2013-10-01|August 2014|Anticipated|2014-08-01|December 2013|Anticipated|2013-12-01||Interventional|||Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations|Assessment of the Cerebral Tissue Oxygenation and the Bioelectrical Brain Activity of Preterm Newborns During Administration of Two Different Surfactant|Unknown status|Recruiting|Phase 4|24|Anticipated|Poznan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:18:27.085128|2017-10-11 01:18:27.085128
NCT01941511|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-09-04|||August 2013||2013-08-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Evaluate the Effect of IV Doses of GMI-1070 on Qtc Intervals in Healthy African-American Adult Subjects|A Phase 1, Randomized, 3-way, Crossover Single Dose, Placebo, and Active Controlled Study to Evaluate the Effect of Intravenous Doses of GMI-1070 on Qtc Intervals in Healthy African-American Adult Subjects|Completed||Phase 1|48|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:18:27.172209|2017-10-11 01:18:27.172209
NCT01941498|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-10-02|2015-02-01||September 2013||2013-09-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Interventional||This analysis population includes all enrolled participants.|WaveLight® Refractive Myopic Study|A Prospective, Global, Multi-Center Study for the Evaluation of Outcomes on Subjects Undergoing Myopic Treatments Using the WaveLight® Refractive Suite|Completed||N/A|104|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 01:18:27.272209|2017-10-11 01:18:27.272209
NCT01941446|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-10|||March 2013||2013-03-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization|A Randomized, Placebo- and Positive Controlled, Three-Way, Crossover Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization in Healthy Male and Female Subjects: A Thorough QT/QTc Study|Completed||Phase 1|54|Actual|Tetraphase Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 01:18:29.847951|2017-10-11 01:18:29.847951
NCT01941433|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2015-03-31|||September 2013||2013-09-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|January 2015|Actual|2015-01-01||Interventional|AHJ||Arthritis Health Journal Proof of Concept Study|Proof of Concept Study of the Arthritis Health Journal, a Patient Passport for Rheumatoid Arthritis|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:18:29.934132|2017-10-11 01:18:29.934132
NCT01941407|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-03-15|||November 2013||2013-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|August 2014|Actual|2014-08-01||Interventional|ESMERALDA||First Line Metastatic Breast Cancer Treatment (ESMERALDA)|A PHASE II TRIAL EVALUATING THE COMBINATION OF ERIBULIN (HALAVEN®) + BEVACIZUMAB (AVASTIN®) AS A FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC HER2- BREAST CANCER|Completed||Phase 2|61|Actual|ARCAGY/ GINECO GROUP||1|||f||||t||||||||||2017-10-11 01:18:30.130813|2017-10-11 01:18:30.130813
NCT01941394|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-09-12|||October 2007||2007-10-01|September 2013|2013-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation|Pilot Study for Safety and Effectiveness Assessment of Bone Marrow Mesenchymal Stem Cell Infusion for Acute Graft-versus-host Disease Prophylaxis and Treatment After Allogenic Bone Marrow Transplantation|Unknown status|Recruiting|Phase 2|70|Anticipated|National Research Center for Hematology, Russia||2|||f||||f||||||||||2017-10-11 01:18:30.291194|2017-10-11 01:18:30.291194
NCT01941381|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-10-25|||October 2013||2013-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|October 2017|Anticipated|2017-10-01||Observational|||Does Tympanometry Predict Antibiotic Usage in Acute Otitis Media?|Does Tympanometry Predict Antibiotic Usage in Acute Otitis Media?|Recruiting||N/A|137|Anticipated|University of Alberta|||2||f||||f||||||||||2017-10-11 01:18:30.407032|2017-10-11 01:18:30.407032
NCT01941368|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-03-14|||September 2013||2013-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of β-Hydroxy-β-methylbutyrate Free Acid and High-Intensity Interval Training|The Effects of β-Hydroxy-β-methylbutyrate Free Acid Gel and High-Intensity Interval Training on Quadriceps Muscle Architecture and Quality, Neuromuscular Economy, and Metabolic Performance in Recreationally Trained Individuals|Completed||N/A|40|Actual|Metabolic Technologies Inc.||3|||f||||f||||||||||2017-10-11 01:18:30.504444|2017-10-11 01:18:30.504444
NCT01941355|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-11-04|||September 2013||2013-09-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|SheppHeart||Trial of Rehabilitation in Phase 1 After Coronary Artery Bypass Grafting|SheppHeartCABG Shaping Outcomes by Exercise Training and Psycho-education in Phase 1 for Coronary Artery Bypass Grafting Patients|Completed||N/A|60|Actual|Rigshospitalet, Denmark||4|||f||||t||||||||||2017-10-11 01:18:30.583879|2017-10-11 01:18:30.583879
NCT01941342|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2014-01-13|||January 2014||2014-01-01|January 2014|2014-01-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy|Evaluation of Preoperative Biliary Drainage on Outcome of Pancreatoduodenectomy: A Multicenter Randomized Controlled Study|Unknown status|Not yet recruiting|Phase 2|274|Anticipated|Southwest Hospital, China||4|||f||||t||||||||||2017-10-11 01:18:30.668192|2017-10-11 01:18:30.668192
NCT01941329|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2017-09-13|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|April 2016|Actual|2016-04-01||Interventional|PROTEUS||Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.|Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. (PROTEUS)|Active, not recruiting||Phase 2/Phase 3|94|Anticipated|Association for Innovation and Biomedical Research on Light and Image||2|||f||||f||||||||||2017-10-11 01:18:30.785203|2017-10-11 01:18:30.785203
NCT01941316|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-05-05|||November 2013||2013-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients|Phase 1b/II Trial of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies (Phase Ib) and Small Cell Lung Cancer Patients (Phase II) Who Have Progressed on Prior Platinum-based Chemotherapy|Recruiting||Phase 1/Phase 2|112|Anticipated|Cancer Research and Biostatistics Clinical Trials Consortium||1|||f||||f||||||||No||2017-10-11 01:18:30.894533|2017-10-11 01:18:30.894533
NCT01941303|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-03-21|||August 2014||2014-08-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease|Radical Re-irradiation of Recurrent NSCLC - Analysis of Outcome and Toxicity.|Completed||N/A|34|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-11 01:18:31.040497|2017-10-11 01:18:31.040497
NCT01941290|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-09-26|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||BIOFLOW III Asia Registry Orsiro Stent System|Biotronik-Safety and Performance Registry for an All-comers Diabetic Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice-III Asia|Completed||N/A|387|Actual|BIOTRONIK Asia Pacific Pte Ltd|||1||f||||f||||||||||2017-10-11 01:18:31.228745|2017-10-11 01:18:31.228745
NCT01941277|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-07-14|||August 2014||2014-08-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|EFFORT||Effect of Exercise on Insulin Resistance|Effect of Exercise on Insulin Resistance|Terminated||N/A|3|Actual|Alere San Diego||2||funding withdrawn|f||||f||||||||||2017-10-11 01:18:31.395078|2017-10-11 01:18:31.395078
NCT01941264|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2016-10-03|||October 2013||2013-10-01|November 2015|2015-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|COSMIC||Community-based Screening and Treatment of Malaria in Pregnancy: a Cluster-randomized Trial|Community-based Scheduled Screening and Treatment of Malaria in Pregnancy for Improved Maternal and Infant Health: a Cluster-randomized Trial in The Gambia, Burkina Faso and Benin|Completed||N/A|4265|Actual|Royal Tropical Institute||2|||f||||t||||||||||2017-10-11 01:18:31.50438|2017-10-11 01:18:31.50438
NCT01941251|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-03-28|||March 2013||2013-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Interventional|nTMS_NS||Navigated αTMS in Treatment-resistant Schizophrenia|Navigated Alpha Frequency Transcranial Magnetic Stimulation (αTMS) in Treatment-resistant Schizophrenia|Active, not recruiting||N/A|50|Actual|Niuvanniemi Hospital||2|||f||||f||||||||||2017-10-11 01:18:31.668349|2017-10-11 01:18:31.668349
NCT01941238|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-04-05|||July 2013||2013-07-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|September 2013|Actual|2013-09-01||Observational|||Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi Dose Injection|Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi-dose Insulin Injection|Completed||N/A|142|Actual|King Abdullah International Medical Research Center|||2||f||||||||||||||2017-10-11 01:18:31.810809|2017-10-11 01:18:31.810809
NCT01941225|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-12-15|||September 2013||2013-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients|Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients|Completed||Phase 2|24|Actual|Louisiana State University Health Sciences Center in New Orleans||2|||f||||f||||||||||2017-10-11 01:18:31.905848|2017-10-11 01:18:31.905848
NCT01941212|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-10|2013-09-15|||September 2013||2013-09-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Effect of Music Therapy Intervention on Pain After Gynecological Surgery|Effect of Music Therapy Intervention on Pain After Gynecological Surgery|Unknown status|Not yet recruiting|N/A|75|Anticipated|Rambam Health Care Campus||3|||f||||f||||||||||2017-10-11 01:18:32.022172|2017-10-11 01:18:32.022172
NCT01941199|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-11-25|||July 2013||2013-07-01|November 2013|2013-11-01||||November 2013|Actual|2013-11-01||Interventional|||Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects|A Randomized, Open-label, Multiple Dosing, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 5 mg and Metformin IR 1000 mg After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Dong-A ST Co., Ltd.||6|||f||||||||||||||2017-10-11 01:18:32.116031|2017-10-11 01:18:32.116031
NCT01941186|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-08-30|2016-07-13||December 2013||2013-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional||64 parent-child dyads were enrolled, randomized and included in the final analysis. 1 parent-child dyad who completed the intervention could not be contacted for follow-up to determine early intervention (EI) disposition within 1 year of enrollment. Intervention phase data was complete and is in the final analysis.|A Family Centered Intervention to Promote Optimal Child Development|A Family Centered Intervention to Promote Optimal Child Development at the Interface of the Health System and Community|Completed||N/A|64|Actual|Children's Hospital of Philadelphia|Given that the study recruited a convenience sample from one primary care network, findings may not be generalizable to all settings. Also worth noting, EI services differ by state and some of the information is not applicable in all states.|2|||f||||f||||||||No||2017-10-11 01:18:32.246154|2017-10-11 01:18:32.246154
NCT01941173|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-07-17|||January 2014||2014-01-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Interventional|||Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy|A Prospective Study of Short Infusion of Ziv-Aflibercept in Combination With FOLFIRI in Patients With Metastatic Colorectal Cancer|Withdrawn||N/A|0|Actual|City of Hope Medical Center||1||Lack of accrual|f||||t||||||||||2017-10-11 01:18:33.631169|2017-10-11 01:18:33.631169
NCT01941160|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-05-12|||August 2013||2013-08-01|March 2014|2014-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment|A Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Effect of a Probiotic Product, Lacidofil® STRONG, in Healthy Adults Taking Antibiotic Treatment|Completed||Phase 1/Phase 2|160|Actual|KGK Synergize Inc.||2|||f||||||||||||||2017-10-11 01:18:33.747759|2017-10-11 01:18:33.747759
NCT01941147|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-09|||August 2013||2013-08-01|September 2013|2013-09-01||||September 2014|Anticipated|2014-09-01||Interventional|||Extremely Low Frequency Magnetic Fields in Acute Ischemic Stroke|An Open Label, One Arm, Dose Escalation Study to Evaluate the Safety of Extremely Low Frequency Magnetic Fields in Acute Ischemic Stroke.|Unknown status|Recruiting|N/A|9|Anticipated|Campus Bio-Medico University||1|||f||||f||||||||||2017-10-11 01:18:33.839879|2017-10-11 01:18:33.839879
NCT01941134|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-03-01|||April 2013||2013-04-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Changes in Oral Contraceptive Hormones After Gastric Bypass Surgery|Impact of Gastric Bypass Surgery on the Pharmacokinetics of Oral Contraceptive Hormones|Recruiting||Phase 4|16|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 01:18:33.947586|2017-10-11 01:18:33.947586
NCT01941121|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-02-24|||July 2013||2013-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|February 2016|Actual|2016-02-01||Interventional|||CCTG 593: Testing and Linkage to Care|CCTG 593: Testing and Linkage to Care, A Multicenter Demonstration Project of the California Collaborative Treatment Group|Active, not recruiting||N/A|600|Anticipated|California Collaborative Treatment Group||1|||f||||f||||||||||2017-10-11 01:18:34.043768|2017-10-11 01:18:34.043768
NCT01941108|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-06-01|||September 2013||2013-09-01|April 2015|2015-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|mP2P||Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care|Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care: The mPeer2Peer Study|Completed||N/A|39|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 01:18:34.165934|2017-10-11 01:18:34.165934
NCT01941082|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration|A Multiple-Center, Non-Randomized, Open-Label, Single- and Multiple-Ascending-Dose, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6867461 Following Intravitreal Administration in Patients With Wet Age-Related Macular Degeneration|Completed||Phase 1|24|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:18:34.398727|2017-10-11 01:18:34.398727
NCT01941069|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-10-21|||January 2013||2013-01-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|Project Access||School Climate and Children's Behavioral Health|Targeting School Climate and Children's Behavioral Health in Urban Schools|Recruiting||N/A|379|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 01:18:34.499918|2017-10-11 01:18:34.499918
NCT01941056|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-07-31|||January 5, 2014|Actual|2014-01-05|July 2017|2017-07-01|July 28, 2017|Actual|2017-07-28|July 28, 2017|Actual|2017-07-28||Interventional|||Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus|Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia|Completed||Phase 1|24|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:18:34.602224|2017-10-11 01:18:34.602224
NCT01941043|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-09-25||2017-09-18|November 2013||2013-11-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment|A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment|Completed||Phase 2|1357|Actual|Cerecor Inc||3|||f||||f||||||||||2017-10-11 01:18:34.712356|2017-10-11 01:18:34.712356
NCT01941030|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-08-04|||March 2013||2013-03-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CLARITY I||Complete Lesion Assessment With ffR and IVUS TechnologY|Complete Lesion Assessment With ffR and IVUS TechnologY (CLARITY I)|Completed||N/A|51|Actual|Cardiovascular Systems Inc||2|||f||||f||||||||||2017-10-11 01:18:34.868766|2017-10-11 01:18:34.868766
NCT01941017|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-09-09|||April 2009||2009-04-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Observational|||Evaluation of the Ovarian Reserve in Infertile Patients With Endometriosis|Evaluation of the Ovarian Reserve in Infertile Patients With Endometriosis|Completed||N/A|40|Actual|Ain Shams University|||2||f||||f||||||||||2017-10-11 01:18:34.97133|2017-10-11 01:18:34.97133
NCT01941004|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-04-20|||June 2014||2014-06-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Safety and Efficacy of Fingolimod in MS Patients in China|A 12 Month Study, With a 6-month, Double-blind, Randomized, Placebo-controlled, Multi-center Parallel- Groups, Treatment Phase Evaluating Efficacy and Safety of Fingolimod 0.5 mg and a 6-month, Open-label, Treatment Phase, in Chinese Patients With Relapsing-remitting Multiple Sclerosis|Withdrawn||Phase 3|0|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:18:35.071563|2017-10-11 01:18:35.071563
NCT01940991|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-12-27||2013-12-27|August 2013||2013-08-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines||Completed||Phase 2|82|Actual|Revance Therapeutics, Inc.||2|||f||||||||||||||2017-10-11 01:18:35.167956|2017-10-11 01:18:35.167956
NCT01940978|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-04-08|||March 2014||2014-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study of Combination Therapy in Children With ADHD|A Double-Blind Placebo-Controlled Study of Combination Therapy in Children With ADHD|Completed||Phase 4|99|Actual|Sears, Douglas, M.D.||3|||f||||t||||||||||2017-10-11 01:18:35.250605|2017-10-11 01:18:35.250605
NCT01940965|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-08-03|||September 2013||2013-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes|An Open-Label, Multicenter 52-Week Study Assessing the Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes|Completed||Phase 3|294|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 01:18:35.354458|2017-10-11 01:18:35.354458
NCT01940952|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-09|||September 2013||2013-09-01|September 2013|2013-09-01||||August 2015|Anticipated|2015-08-01||Interventional|||Zydena on Cognitive Function of Alzheimer's Disease Patients|Efficacy of Zydena (Udenafil) on Cognitive Function of Alzheimer's Disease Patients: A Randomized, Double Blind, Placebo-controlled Multicenter Study|Unknown status|Not yet recruiting|Phase 3|210|Anticipated|Samsung Medical Center||3|||f||||f||||||||||2017-10-11 01:18:35.48342|2017-10-11 01:18:35.48342
NCT01940185|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-02-13|||June 2012||2012-06-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||A Post-Approval Study of the LINX® Reflux Management System|A Post-Approval Study of the LINX® Reflux Management System|Active, not recruiting||N/A|200|Anticipated|Torax Medical Incorporated|||1||f||||f||||||||||2017-10-11 01:18:50.490091|2017-10-11 01:18:50.490091
NCT01940926|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-04-05|||February 2012||2012-02-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|GRGDRA||68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis|Diagnostic Performance and Evaluation Efficacy of 68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis|Recruiting||Early Phase 1|50|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-11 01:18:35.643564|2017-10-11 01:18:35.643564
NCT01940913|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-05-08|||October 2013||2013-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders.||Completed||Phase 2|400|Anticipated|Probi AB||2|||f||||||||||||||2017-10-11 01:18:35.733376|2017-10-11 01:18:35.733376
NCT01940900|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-08-23|||August 2013||2013-08-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy|A Phase 3 Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista® (Anti PDGF-B Pegylated Aptamer) Administered in Combination With Lucentis® Compared to Lucentis® Monotherapy in Subjects With Subfoveal Neovascular Age-related Macular Degeneration.|Terminated||Phase 3|627|Actual|Ophthotech Corporation||2|||f||||t||||||||||2017-10-11 01:18:35.914146|2017-10-11 01:18:35.914146
NCT01940887|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-08-23|||May 2014||2014-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy|A Phase 3 Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista® (Anti PDGF-B Pegylated Aptamer) Administered in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy in Subjects With Subfoveal Neovascular Age-related Macular Degeneration.|Terminated||Phase 3|645|Actual|Ophthotech Corporation||2|||f||||t||||||||||2017-10-11 01:18:36.327398|2017-10-11 01:18:36.327398
NCT01940874|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-10-08|||February 2011||2011-02-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|Co-HLM||Cerebral Oxymetry at Elective Coronary and Valve Surgery.|Cerebral Oxymetry at Elective Coronary and Valve Surgery: An Observational Study Using Norepinephrine to Maintain Arterial Blood Pressure on Cardio Pulmonary Bypass.|Completed||N/A|54|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 01:18:36.935169|2017-10-11 01:18:36.935169
NCT01940861|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-11-21|||November 2014||2014-11-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|1 Day|Observational [Patient Registry]|||Cerebral Oxymetry in Traumatic Brain Injury|Cerebral Oxymetry in Traumatic Brain Injury|Unknown status|Recruiting|N/A|15|Anticipated|Oslo University Hospital|||1||f||||t||||||||||2017-10-11 01:18:37.071844|2017-10-11 01:18:37.071844
NCT01940848|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-09-28|||October 11, 2013|Actual|2013-10-11|September 2017|2017-09-01|October 13, 2017|Anticipated|2017-10-13|July 5, 2017|Actual|2017-07-05||Interventional|||Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo|A Double-blind, Randomised, Placebo-controlled Study on the Efficacy of Iberogast® (STW5) in Patients With Irritable Bowel Syndrome|Active, not recruiting||Phase 3|243|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:18:37.173496|2017-10-11 01:18:37.173496
NCT01940835|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-09-26|||September 2013||2013-09-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes|Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes|Recruiting||N/A|40|Anticipated|Mayo Clinic|||2||f||||f||||||Samples With DNA|"     Serum, DNA, RNA extraction, brush biopsies from duodenal mucosa, biopsies of small intestine,     stool samples   "|||2017-10-11 01:18:37.366113|2017-10-11 01:18:37.366113
NCT01940822|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-11-29|||July 2013||2013-07-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Cardiovascular Effects of Energy Drinks in Healthy Adults|Cardiovascular Effects of Energy Drinks in Healthy Adults|Recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 01:18:37.482994|2017-10-11 01:18:37.482994
NCT01940809|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-09-12|||August 28, 2013|Actual|2013-08-28|September 2017|2017-09-01||||January 19, 2018|Anticipated|2018-01-19||Interventional|||Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery|A Sequential Safety and Biomarker Study of BRAF-MEK Inhibition on the Immune Response in the Context of Combined CTLA-4 Blockade and PD-1 Blockade for BRAF Mutant Melanoma|Recruiting||Phase 1|40|Anticipated|National Cancer Institute (NCI)||8|||f||||f||||||||||2017-10-11 01:18:37.596721|2017-10-11 01:18:37.596721
NCT01940796|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-03-21|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)|Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)|Terminated||Phase 1|18|Actual|Massachusetts General Hospital||1||Toxicity|f||||f||||||||No||2017-10-11 01:18:37.770812|2017-10-11 01:18:37.770812
NCT01940783|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-11|||September 2013||2013-09-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|ABMS1||Assessment of the AB HiFocusTM Mid Scala Electrode Movement Using Cone Beam Imaging Following Cochlea Implantation|Assessment of the AB HiFocusTM Mid Scala Electrode Movement Using Cone Beam Imaging Following Cochlea Implantation|Unknown status|Recruiting|N/A|14|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-11 01:18:37.866907|2017-10-11 01:18:37.866907
NCT01940770|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-08-24|||October 18, 2013|Actual|2013-10-18|August 2017|2017-08-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Observational|||Specific Clinical Experience Investigation for Long-term Use of Bydureon|Specific Clinical Experience Investigation for Long-term Use of Bydureon Subcutaneous Injection 2 mg and Bydureon Subcutaneous Injection 2 mg PEN|Active, not recruiting||N/A|1137|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:18:37.967543|2017-10-11 01:18:37.967543
NCT01940757|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-05-30|||January 2015|Actual|2015-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae|An Experimental Infection Study of Dermally-applied Infectious Necator Americanus Hookworm Larvae in Hookworm-naïve Adults|Recruiting||Phase 1|30|Anticipated|Baylor College of Medicine||3|||f||||t||||||||||2017-10-11 01:18:38.146305|2017-10-11 01:18:38.146305
NCT01940744|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-11-08|||October 2013||2013-10-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Prescriptive Mobilization Versus a Pragmatic Mobilization|The Investigation of a Prescriptively Prescribed Non-Thrust Manipulation Versus a Pragmatically Prescribed Non-Thrust Manipulation for Treatment of Individuals With Low Back Pain: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|46|Anticipated|Walsh University||2|||f||||f||||||||||2017-10-11 01:18:38.260747|2017-10-11 01:18:38.260747
NCT01940731|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-09|||October 2013||2013-10-01|September 2013|2013-09-01||||March 2014|Anticipated|2014-03-01||Interventional|||Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults|A Prospective, Open, Non-controlled, Multi-center Study of Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults.|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||t||||||||||2017-10-11 01:18:38.408446|2017-10-11 01:18:38.408446
NCT01940718|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-01-18|||March 2014||2014-03-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Androgen Regulation of Priapism in Sickle Cell Disease|Androgen Regulation of Priapism in Sickle Cell Disease|Withdrawn||Early Phase 1|0|Actual|Johns Hopkins University||1||Funding could not be secured|f||||f||||||||||2017-10-11 01:18:38.512147|2017-10-11 01:18:38.512147
NCT01940692|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-02-04|||July 2014||2014-07-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Topical and Intravenous Administration of TXA Are Equally Effective in DAA THA|TOPICAL AND INTRAVENOUS ADMINISTRATION OF TRANEXAMIC ACID ARE EQUALLY EFFECTIVE IN DIRECT ANTERIOR TOTAL HIP ARTHROPLASTY - A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL|Completed||Phase 2|120|Actual|Ziekenhuis Oost-Limburg||2|||f||||t||||||||||2017-10-11 01:18:38.792493|2017-10-11 01:18:38.792493
NCT01940679|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-03-03|||September 2013||2013-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bioavailability of Encapsulated Omega-3 Fatty Acids|Bioavailability of Encapsulated Omega-3 Fatty Acids|Completed||N/A|14|Anticipated|United States Army Research Institute of Environmental Medicine||4|||f||||f||||||||||2017-10-11 01:18:38.874965|2017-10-11 01:18:38.874965
NCT01940653|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2014-05-20|||November 2012||2012-11-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|PROFETA-3||Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone|Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone|Unknown status|Recruiting|Phase 4|300|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||t||||||||||2017-10-11 01:18:39.02826|2017-10-11 01:18:39.02826
NCT01940640|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-11-30|||January 2012||2012-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Mother DHA Supplementation on Premature Newborn.|Multidisciplinary Study of the Effect of the Mother suplementación During the Lactation With High Doses of DHA on Diverse Aspects Related to the Development of the Premature Newborn in the First Year of Life.|Completed||Phase 2/Phase 3|40|Actual|Universidad de Granada||2|||f||||t||||||||||2017-10-11 01:18:39.11421|2017-10-11 01:18:39.11421
NCT01940627|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-11|||April 2013||2013-04-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Influence of a Short Term Supplementation With Ubiquinol on Diverse Aspects Related to the Physical Activity|Influence of a Short Term Supplementation With Ubiquinol on Diverse Aspects Related to the Physical Activity (Muscle Function, Oxidative Stress and Inflammatory Signaling)|Completed||Phase 2/Phase 3|100|Actual|Universidad de Granada||2|||f||||t||||||||||2017-10-11 01:18:39.188716|2017-10-11 01:18:39.188716
NCT01940614|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-01-09|||January 2015||2015-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Use of Copeptin in Diabetes Insipidus|Use of Copeptin in the Differential Diagnosis of Diabetes insipidus-a Prospective International Study|Recruiting||N/A|140|Anticipated|University Hospital, Basel, Switzerland|||1||f||||t||||||||||2017-10-11 01:18:39.272883|2017-10-11 01:18:39.272883
NCT01940601|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-01-13|||September 2014||2014-09-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors|An Open Label, Randomized, Active Controlled, Dose Finding Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim at Doses of 300 µg/kg and 670 µg/kg in Pediatric Patients Diagnosed With Solid Tumors Receiving Chemotherapy|Withdrawn||Phase 2|0|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-10-11 01:18:39.353324|2017-10-11 01:18:39.353324
NCT01940588|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-01-05|||March 2012||2012-03-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence|Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence|Completed||Early Phase 1|30|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-10-11 01:18:39.442208|2017-10-11 01:18:39.442208
NCT01940575|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2014-04-06|||July 2013||2013-07-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy and Safety Study of SkinPlus-Hyal® to Nasolabial Fold|Clinical Trial to Evaluate the Safety and Efficacy of SkinPlus-Hyal® as Tissue Restorative Biomaterials in the Improvement of Bilateral Nasolabial Fold Wrinkles|Completed||N/A|123|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:18:39.504419|2017-10-11 01:18:39.504419
NCT01940562|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2015-06-15|||October 2013||2013-10-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation|Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation|Unknown status|Recruiting|Phase 2|20|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 01:18:41.401186|2017-10-11 01:18:41.401186
NCT01940549|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-09-08|||October 2013||2013-10-01|September 2013|2013-09-01||||August 2016|Anticipated|2016-08-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy for Posttraumatic Stress Disorder|Transcranial Direct Current Stimulation (tDCS) Enhancement of Trauma-focused Therapy for Posttraumatic Stress Disorder|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 01:18:41.513138|2017-10-11 01:18:41.513138
NCT01940536|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-03-24|||December 2015||2015-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures|The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures: A Prospective, Double-Blind, Randomized Controlled Trial|Withdrawn||Phase 4|0|Actual|Hospital for Special Surgery, New York||2||Possible change in study protocol|f||||t||||||||||2017-10-11 01:18:41.614113|2017-10-11 01:18:41.614113
NCT01940523|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-05-16|2017-03-27||May 2013|Actual|2013-05-01|May 2017|2017-05-01|May 16, 2017|Actual|2017-05-16|December 28, 2015|Actual|2015-12-28||Interventional|||Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical|Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical|Completed||Phase 4|640|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 01:18:41.715842|2017-10-11 01:18:41.715842
NCT01940510|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2016-11-01|2016-08-25||October 2013||2013-10-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Safety analysis set included all participants who received at least one dose of the study treatment and had at least 1 postdose safety assessment.|A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802|An Open-Label, Three-Period, Fixed Sequence Study to Investigate the Effect of Multiple Oral Doses of Rifampin, a Potent Cytochrome P450 3A Inducer, on the Single Dose Pharmacokinetics of RO5424802 in Healthy Subjects|Completed||Phase 1|24|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:18:42.00544|2017-10-11 01:18:42.00544
NCT01940497|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-06-26|2017-05-12||November 16, 2013|Actual|2013-11-16|June 2017|2017-06-01|April 30, 2018|Anticipated|2018-04-30|April 5, 2016|Actual|2016-04-05||Interventional|SCHEARLY|Intent-to-treat (ITT) population included all enrolled participants.|A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer|National Phase IIIb Prospective Two-Cohort Non-Randomized, Multi-centre, Open Label Study to Assess the Safety of Subcutaneous Trastuzumab and Molecular Biomarkers in Patients With Early and Locally Advanced HER2-Positive Breast Cancer|Active, not recruiting||Phase 3|240|Actual|Hoffmann-La Roche||2|||f|||||t|f|||t|||||2017-10-11 01:18:43.911755|2017-10-11 01:18:43.911755
NCT01940484|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-06-13|2016-03-21||August 31, 2009|Actual|2009-08-31|May 2017|2017-05-01|July 31, 2012|Actual|2012-07-31|July 31, 2012|Actual|2012-07-31||Observational||Included all enrolled participants.|An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis|An Observational, Non-Interventional Cohort Study to Observe the Efficacy and Use of MIRCERA in the Treatment of Chronic Renal Anaemia in Patients With Chronic Kidney Disease Stage V on Haemodialysis|Completed||N/A|98|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:18:45.215718|2017-10-11 01:18:45.215718
NCT01940471|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-09-13|2016-12-09|2016-08-23|August 2013|Actual|2013-08-01|September 2017|2017-09-01|November 2023|Anticipated|2023-11-01|November 2015|Actual|2015-11-01||Interventional||Safety Analysis Set: participants who received at least 1 dose of study drug|Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis B|Active, not recruiting||Phase 3|875|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 01:18:45.846326|2017-10-11 01:18:45.846326
NCT01940458|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2015-07-15|||September 2013||2013-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:18:47.295604|2017-10-11 01:18:47.295604
NCT01940445|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-08|2017-01-25|||September 2013||2013-09-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Impact of Synergistic Sequential Treatment (SST)|Impact of Synergistic Sequential Treatment (SST) of Fractional Non-ablative and Q-Switched Lasers on Skin Texture|Completed||N/A|17|Actual|Lumenis Ltd.||2|||f||||f||||||||||2017-10-11 01:18:47.346302|2017-10-11 01:18:47.346302
NCT01940432|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-07-18|||March 2014||2014-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Efficacy of Electroacupuncture for Treatment of Simple Female Stress Urinary Incontinence: Comparison With Pelvic Floor Muscle Training-a Multicenter Randomized Controlled Trial|The Efficacy of Electroacupuncture for Treatment of Simple Female Stress Urinary Incontinence: Comparison With Pelvic Floor Muscle Training-a Multicenter Randomized Controlled Trial|Recruiting||N/A|320|Anticipated|Shaanxi Hospital of Traditional Chinese Medicine||2|||f||||t||||||||Yes||2017-10-11 01:18:47.427181|2017-10-11 01:18:47.427181
NCT01940419|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2015-10-21|||April 2013||2013-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Interventional|PeTraH||Testing of the Drug Tranexamic Acids as Prophylaxis of Bleeding in Benign Surgical Removal of the Uterus|Peroperative Tranexamic Acid as Prophylaxis of Haemorrhage in Benign Hysterectomy - a Randomized, Placebo-controlled Trial|Completed||Phase 4|332|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-10-11 01:18:47.540593|2017-10-11 01:18:47.540593
NCT01940406|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-10-08|||October 2013||2013-10-01|October 2016|2016-10-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||The Essential Tremor (ET) and Parkinson Disease (PD) Tremor Acute Stimulation Study|The ET and PD Tremor Study - Rainbow Medical Acute Stimulation Evaluation for Tremor Reduction|Withdrawn||N/A|0|Actual|Rainbow Medical||1||Internal desicions|f||||t||||||||||2017-10-11 01:18:47.642652|2017-10-11 01:18:47.642652
NCT01940380|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-03-20|||September 2013|Actual|2013-09-01|March 2017|2017-03-01|December 9, 2016|Actual|2016-12-09|December 1, 2013|Actual|2013-12-01||Observational|||The Study of LTBP1 of Postmenopausal Women Osteoporosis Molecular Mechanism of Kidney Yang Deficiency Syndrome|The Study of LTBP1 of Postmenopausal Women Osteoporosis Molecular Mechanism of Kidney Yang Deficiency Syndrome|Completed||N/A|25|Anticipated|Fujian Academy of Traditional Chinese Medicine|||1||f||||t||||||||||2017-10-11 01:18:47.826796|2017-10-11 01:18:47.826796
NCT01940367|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-04-27|||October 2013||2013-10-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments|Percutaneous Tibial Nerve Stimulation vs. Transcutaneous Electrical Nerve Stimulation for Overactive Bladder: A Randomized Trial|Enrolling by invitation||N/A|114|Anticipated|Walter Reed National Military Medical Center||2|||f||||t||||||||||2017-10-11 01:18:47.885534|2017-10-11 01:18:47.885534
NCT01940341|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-09-13|2016-12-09|2016-08-23|September 2013|Actual|2013-09-01|September 2017|2017-09-01|January 2024|Anticipated|2024-01-01|September 2015|Actual|2015-09-01||Interventional||Safety Analysis Set: participants who received at least 1 dose of study drugs.|Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B|Active, not recruiting||Phase 3|426|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 01:18:48.246437|2017-10-11 01:18:48.246437
NCT01940328|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-02-07|||October 2013||2013-10-01|August 2013|2013-08-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01|3 Days|Observational [Patient Registry]|||Measurements of Doppler Signals Noninvasively From the Lung in Congestive Heart Failure|Evaluation of Lung Doppler Signals in Congestive Heart Failure(CHF)|Completed||N/A|50|Actual|Echosense Ltd.|||3||f||||f||||||||||2017-10-11 01:18:49.434022|2017-10-11 01:18:49.434022
NCT01940315|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-08-04|||October 2020||2020-10-01|November 2013|2013-11-01|September 2023|Anticipated|2023-09-01|March 2023|Anticipated|2023-03-01||Interventional|rBV A/B||Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B|A Phase 3, Double Blind, Placebo Controlled, Randomized, Multicenter Clinical Trial to Demonstrate the Safety, Lot Consistency and Clinical Benefit of Recombinant Botulinum Vaccine A/B (rBV A/B)|Suspended||Phase 3|6174|Anticipated|DynPort Vaccine Company LLC, A CSC Company||2||programmatic decision|f||||t||||||||||2017-10-11 01:18:49.546794|2017-10-11 01:18:49.546794
NCT01940302|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2014-05-08|||June 2013||2013-06-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes|Metabolic Control Before and After Supplementation With LEHEL in Patients With Type 2 Diabetes|Completed||Early Phase 1|71|Actual|Shaoguan University||2|||f||||t||||||||||2017-10-11 01:18:49.644289|2017-10-11 01:18:49.644289
NCT01940289|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2013-09-17|||January 2014||2014-01-01|September 2013|2013-09-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Validation of Algometry for Use in the Human Foot|Validation of Algometry for Use in the Human Foot|Unknown status|Not yet recruiting|N/A|544|Anticipated|Dundee Podiatry Clinic||2|||f||||t||||||||||2017-10-11 01:18:49.746298|2017-10-11 01:18:49.746298
NCT01940276|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-09|2017-08-08|||October 2013|Actual|2013-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer|A Phase II Open-label, Parallel Group Study of Abiraterone Acetate Plus Prednisone in African American and Caucasian Men With Metastatic Castrate-resistant Prostate Cancer|Active, not recruiting||Phase 2|100|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:18:49.857714|2017-10-11 01:18:49.857714
NCT01940263|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2014-07-31|||June 2013||2013-06-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Purified Anthocyanin and Nonalcoholic Fatty Liver Disease|Effects of Purified Anthocyanin on Oxidative and Inflammatory Markers in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Trial|Completed||Early Phase 1|63|Actual|Shaoguan University||2|||f||||t||||||||||2017-10-11 01:18:49.98649|2017-10-11 01:18:49.98649
NCT01940250|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-03-06|||April 21, 2014|Actual|2014-04-21|November 2014|2014-11-01|December 28, 2016|Actual|2016-12-28|June 30, 2016|Actual|2016-06-30||Interventional|||Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam|A Randomized, Placebo-controlled, Double-blind Trial of Intravenous Magnesium Sulfate for the Management of Severe Hand, Foot and Mouth Disease With Autonomic Nervous System Dysregulation in Vietnamese Children.|Completed||Phase 2|26|Actual|Oxford University Clinical Research Unit, Vietnam||2|||f||||t||||||||||2017-10-11 01:18:50.100749|2017-10-11 01:18:50.100749
NCT01940237|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-05-18|||April 2012||2012-04-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer||Terminated||N/A|4|Actual|New York State Psychiatric Institute||1||Low recruitment|f||||t||||||||||2017-10-11 01:18:50.20399|2017-10-11 01:18:50.20399
NCT01940224|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-09-06|||July 2013||2013-07-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of Preoperative Use of Pregabalin on Postoperative Analgesia After Laparoscopic Colorectal Surgery|Effectiveness of Preemptive Use of Pregabalin on Pain Intensity and Postoperative Morphine Consumption After Laparoscopic Colorectal Surgery|Recruiting||N/A|140|Anticipated|Larissa University Hospital||2|||f||||t||||||||||2017-10-11 01:18:50.280505|2017-10-11 01:18:50.280505
NCT01940211|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-11-17|||September 2013||2013-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:18:50.376421|2017-10-11 01:18:50.376421
NCT01940198|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-01|2013-09-08|||April 2010||2010-04-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|August 2011|Actual|2011-08-01||Observational|REfLecT||Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia|Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia|Completed||N/A|117|Actual|Holdsworth House Medical Practice|||1||f||||f||||||||||2017-10-11 01:18:50.419143|2017-10-11 01:18:50.419143
NCT01940172|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-01-13|||November 2013||2013-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer|A Phase 1b, Open-label, Non-randomized Multicenter Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer|Completed||Phase 1|27|Actual|TetraLogic Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:18:50.60419|2017-10-11 01:18:50.60419
NCT01940159|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2014-07-03|||August 2013||2013-08-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia|A Randomized Single-Blind, Placebo-Controlled, Ascending Single Oral Dose Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia.|Completed||Phase 1|48|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 01:18:50.843891|2017-10-11 01:18:50.843891
NCT01940146|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-03-10|2015-11-19||October 2014||2014-10-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis|Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis|Completed||Phase 2|222|Actual|Sun Pharma Advanced Research Company Limited||4|||f||||f||||||||||2017-10-11 01:18:50.934543|2017-10-11 01:18:50.934543
NCT01940133|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-04-10|||January 2014||2014-01-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309|Phase I Study of Oral PQR309 in Patients With Advanced Solid Tumors|Completed||Phase 1|28|Actual|PIQUR Therapeutics AG||1|||f||||t||||||||||2017-10-11 01:18:51.260741|2017-10-11 01:18:51.260741
NCT01940120|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-04-25|2013-12-10|2013-09-18|February 2007||2007-02-01|April 2017|2017-04-01|February 2013|Actual|2013-02-01|March 2008|Actual|2008-03-01||Interventional|HRR||EVEREST II Pivotal Study High Risk Registry (HRR)|A Study of the Evalve® Cardiovascular Valve Repair (MitraClip®) System Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II) EVEREST II High Risk Registry|Completed||N/A|78|Actual|Evalve||1|||f||||t||||||||||2017-10-11 01:18:51.431081|2017-10-11 01:18:51.431081
NCT01940107|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-10|||August 2010||2010-08-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Domiciliary Physiotherapy in Women Undergoing Treatment for Breast Cancer Radiation|Domiciliary Physiotherapy in Women Undergoing Treatment for Breast Cancer Radiation|Completed||N/A|36|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-11 01:18:53.580277|2017-10-11 01:18:53.580277
NCT01940094|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-02-21|||February 2014||2014-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|TAPIR||The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach|The Assessment of Prednisone In Remission Trial (TAPIR) - Centers of Excellence Approach|Recruiting||Phase 3|60|Anticipated|University of Pennsylvania||2|||f||||t||||||||No||2017-10-11 01:18:53.681468|2017-10-11 01:18:53.681468
NCT01940081|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-12-29|||October 2011||2011-10-01|December 2016|2016-12-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|||The Leiden Nonischemic Cardiomyopathy Study|The Leiden Nonischemic Cardiomyopathy Study|Recruiting||N/A|220|Anticipated|Leiden University Medical Center|||3||f||||f||||||Samples With DNA|"     Per patient:      Blood samples (40 mL) Ventricular biopsies   "|||2017-10-11 01:18:53.856488|2017-10-11 01:18:53.856488
NCT01940068|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-03-20|||March 2011||2011-03-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates|A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates|Completed||N/A|86|Actual|United Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:18:53.972905|2017-10-11 01:18:53.972905
NCT01940055|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-01-06|||December 2013||2013-12-01|December 2013|2013-12-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of a Novel Dual-Task Exercise Program for Balance, Mobility and Cognition in Community Dwelling Older Adults|A Phase II, Pilot-Randomized Clinical Trial to Study the Effect of a Novel Dual-Task Exercise Program for Balance, Mobility and Cognition in Community Dwelling Older Adults|Completed||Phase 2|30|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 01:18:54.164509|2017-10-11 01:18:54.164509
NCT01940042|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2016-07-13|||October 2013||2013-10-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||the Effect of Simple Clinical Maneuver on Shoulder and Abdominal Pain a Laparascopic Gynecological Surgery:a Prospective Randomised Trial||Completed||N/A|110|Actual|Istanbul Bakirkoy Maternity and Children Diseases Hospital||2|||f||||||||||||||2017-10-11 01:18:54.259289|2017-10-11 01:18:54.259289
NCT01940029|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-09-06|||June 2011||2011-06-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Pharmacokinetic Study in Neurosurgical ICU Patients —Using Vancomycin as an Example|Pharmacokinetic Study in Neurosurgical ICU Patients —Using Vancomycin as an Example|Completed||N/A|16|Actual|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Urine, Cerebrospinal fluid   "|||2017-10-11 01:18:54.332072|2017-10-11 01:18:54.332072
NCT01940016|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2017-09-13|||April 2007||2007-04-01|September 2017|2017-09-01||||November 2009|Actual|2009-11-01||Interventional|BePHIT||Communication & Peer Support Effects on Physical Activity in Overweight Postmenopausal Women|A Feasibility Study on the Effects of Tailored Communication and Health Coach Support on Physical Activity in Overweight Postmenopausal Women: BePHIT|Active, not recruiting||N/A|71|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:18:54.396214|2017-10-11 01:18:54.396214
NCT01940003|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-10-06|||September 2013||2013-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of an Aquatic Physical Exercise Program on Glycaemic Control and Perinatal Outcomes of Gestational Diabetes: Study Protocol for a Randomized Controlled Trial|Effects of an Aquatic Physical Exercise Program on Glycemic Control and Perinatal Outcomes of Gestational Diabetes - a Randomized Clinical Trial|Recruiting||N/A|72|Anticipated|Professor Fernando Figueira Integral Medicine Institute||2|||f||||t||||||||||2017-10-11 01:18:54.485918|2017-10-11 01:18:54.485918
NCT01939990|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-01-11|||January 2012||2012-01-01|January 2016|2016-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety Study of Nebivolol for COPD Patients|Nebivolol in Chronic Obstructive Pulmonary Disease|Withdrawn||Phase 2/Phase 3|0|Actual|University of Chicago||2||Funding was discontinued.|f||||f||||||||||2017-10-11 01:18:54.587871|2017-10-11 01:18:54.587871
NCT01939964|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2013-09-07|||November 2013||2013-11-01|September 2013|2013-09-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||Study to Determine Effectiveness of Activation Mist on Facial Skin Wrinkles|A Double-Blind, Randomized, Placebo-controlled Study to Compare the Efficacy and Safety of Rena ™ Activation Mist on Facial Skin Wrinkles.|Unknown status|Not yet recruiting|N/A|60|Anticipated|California Allergy and Asthma Medical Group, Inc.||2|||f||||f||||||||||2017-10-11 01:18:54.815644|2017-10-11 01:18:54.815644
NCT01939951|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-07|2013-09-07|||January 2014||2014-01-01|September 2013|2013-09-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.|A Double-Blind, Randomized, Parallel Group, Placebo-controlled Study to Compare the Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo on Patients With Mild to Moderate Persistent Asthma.|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|California Allergy and Asthma Medical Group, Inc.||2|||f||||f||||||||||2017-10-11 01:18:54.908202|2017-10-11 01:18:54.908202
NCT01939938|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-05-17|2017-02-14||June 2013||2013-06-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Mask_MRI||Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment|Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With Positive Airway Pressure Treatment|Completed||N/A|10|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-10-11 01:18:55.008839|2017-10-11 01:18:55.008839
NCT01939925|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-06|||May 2009||2009-05-01|September 2013|2013-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|PLSRCT||Communicating Evidence From Systematic Reviews to the Public|Communicating Evidence From Systematic Reviews to the Public: A Randomised Controlled Trial|Completed||N/A|193|Actual|Norwegian Knowledge Centre for the Health Services||2|||f||||f||||||||||2017-10-11 01:18:55.250279|2017-10-11 01:18:55.250279
NCT01939912|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-10-14|||August 2013||2013-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Study on Reflex Response During Temporary Stimulation and Inhibition of Chemoreceptors of Carotid Bodies - a Pilot Study|Study on Reflex Response During Temporary Stimulation and Inhibition of Chemoreceptors of Carotid Bodies - a Pilot Study|Completed||N/A|10|Actual|Noblewell||1|||f||||t||||||||||2017-10-11 01:18:55.355295|2017-10-11 01:18:55.355295
NCT01939899|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-03-28||2016-11-29|October 31, 2013|Actual|2013-10-31|March 2017|2017-03-01|March 23, 2017|Actual|2017-03-23|June 1, 2016|Actual|2016-06-01||Interventional|||Phase 2 Study of Oral IXAZOMIB in Adult Patients With Relapsed and/or Refractory Follicular Lymphoma|An Open-label, Multicenter, Phase 2 Study of Oral IXAZOMIB (MLN9708) in Adult Patients With Relapsed and/or Refractory Follicular Lymphoma|Completed||Phase 2|29|Actual|Takeda||1|||f||||f||||||||||2017-10-11 01:18:55.4503|2017-10-11 01:18:55.4503
NCT01939886|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-11-27|||April 2013||2013-04-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|TRANSACT2||Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)|Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)|Completed||Phase 3|219|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 01:18:55.586985|2017-10-11 01:18:55.586985
NCT01939873|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-09-10|||September 2012||2012-09-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect Of Kristeller Maneuver On Maternal And Neonatal Outcome|A Prospective, Randomized, Controlled Trial|Completed||N/A|285|Actual|Kayseri Education and Research Hospital||2|||f||||f||||||||||2017-10-11 01:18:55.712548|2017-10-11 01:18:55.712548
NCT01939860|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-05-29|||December 2013||2013-12-01|February 2014|2014-02-01||||December 2014|Actual|2014-12-01||Interventional|||A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment||Completed||N/A|56|Anticipated|University of Warwick||2|||f||||f||||||||||2017-10-11 01:18:55.803734|2017-10-11 01:18:55.803734
NCT01939847|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-05-02|||September 2013||2013-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins|IMAGE Study: Individualized Molecular Analyses Guide Efforts in Breast Cancer - Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins|Active, not recruiting||N/A|96|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 01:18:55.882754|2017-10-11 01:18:55.882754
NCT01939834|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-03-30|||December 2013||2013-12-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes|Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes|Terminated||N/A|6|Actual|University of Virginia||2||Subjects preferred the 5 night overnight system in terms of ease of use.|f||||f||||||||||2017-10-11 01:18:55.983125|2017-10-11 01:18:55.983125
NCT01939821|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-01-25|||September 2013||2013-09-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|PEI||A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes|A Pilot Study to Evaluate Feasibility of Educational Programs With Regard to Good Fecal Incontinence Care in Nursing Homes|Completed||N/A|60|Actual|Norwegian University of Science and Technology||3|||f||||t||||||||||2017-10-11 01:18:56.09371|2017-10-11 01:18:56.09371
NCT01939808|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-11-24|||May 2015||2015-05-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Flexor Tendon Injury Rehabilitation Regime Study|Comparison of the Effect of Splinting the Wrist in Extension Versus Neutral Positioning During Rehabilitation Following Zone I/II Flexor Tendon Repair|Recruiting||N/A|72|Anticipated|St Helens & Knowsley Teaching Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 01:18:56.208541|2017-10-11 01:18:56.208541
NCT01939795|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-10-24|||January 2009||2009-01-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Physical Training Combined Cardiac Resynchronization Therapy in Heart Failure Patients|Effect of Physical Training Combined Cardiac Resynchronization Therapy in Heart Failure Patients|Completed||N/A|40|Actual|University of Sao Paulo General Hospital||3|||f||||f||||||||||2017-10-11 01:18:56.301679|2017-10-11 01:18:56.301679
NCT01939782|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-04-20|||February 2015||2015-02-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|MCG-T2D||Metabolic Clock Genes During Fasting and After Food Intake in Type 2 Diabetics|Metabolic Clock Gene Expression in Peripheral Blood Cells During Fasting and After Food Intake in the Breakfast in Type 2 Diabetic Patients|Unknown status|Recruiting|N/A|30|Anticipated|Tel Aviv University||2|||f||||t||||||||||2017-10-11 01:18:56.397975|2017-10-11 01:18:56.397975
NCT01939769|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-08-29|||August 31, 2013||2013-08-31|August 28, 2017|2017-08-28|August 28, 2017|Actual|2017-08-28|May 21, 2015|Actual|2015-05-21||Interventional|||Effects of Exercise on Memory in Healthy and Brain-Injured Individuals|Acute Effects of Exercise on Memory in Healthy and Brain-Injured Individuals|Terminated||Phase 1|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:18:56.515882|2017-10-11 01:18:56.515882
NCT01939756|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-09-05|||January 2012||2012-01-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Baobab||Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms|Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms: a Phase I-II Study|Completed||Phase 1/Phase 2|50|Actual|University of Rome Tor Vergata||1|||f||||t||||||||||2017-10-11 01:18:56.644887|2017-10-11 01:18:56.644887
NCT01939743|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-09-07|||October 2011||2011-10-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy of Diclofenac Suppository for Pain Control in Ultrasound Guided Biopsy of Prostate|Diclofenac Suppository As a Preemptive Analgesia in Ultrasound Guided Biopsy of Prostate: Randomized Controlled Trial|Completed||Phase 2|100|Actual|Aga Khan University||2|||f||||t||||||||||2017-10-11 01:18:56.729494|2017-10-11 01:18:56.729494
NCT01939730|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-11-03|||August 1999||1999-08-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|December 2006|Actual|2006-12-01||Interventional|||Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma|Rituximab (IDEC-C2B8) Plus GM-CSF in Patients With Follicular B-Cell Lymphoma|Completed||Phase 2|42|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:18:56.856981|2017-10-11 01:18:56.856981
NCT01939717|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2016-05-30|||August 2013||2013-08-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Randomized Controlled Pilot Trial Comparing Irish Set Dancing to Usual Care for People With Parkinson's Disease|A Randomized Controlled Pilot Trial Comparing Irish Set Dancing to Usual Care for People With Parkinson's Disease|Completed||N/A|90|Actual|University of Limerick||2|||f||||f||||||||||2017-10-11 01:18:56.995291|2017-10-11 01:18:56.995291
NCT01939704|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-10-27|||October 2013||2013-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|September 2015|Actual|2015-09-01||Interventional|CCLiP@SFGH||Community to Clinic Linkage Program at SFGH|Community to Clinic Linkage Program at SFGH|Active, not recruiting||N/A|2250|Anticipated|University of California, San Francisco||4|||f||||f||||||||||2017-10-11 01:18:57.588358|2017-10-11 01:18:57.588358
NCT01939691|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-04-24|||December 2017|Anticipated|2017-12-01|April 2017|2017-04-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Topical Treatment for Uveitic Macular Edema|First-line Topical Treatments for Uveitic Macular Edema Trial|Not yet recruiting||Phase 4|96|Anticipated|University of California, San Francisco||3|||f||||t|t|f||||||No||2017-10-11 01:18:57.727875|2017-10-11 01:18:57.727875
NCT01939678|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-04-10|||September 2013||2013-09-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease|Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease|Recruiting||N/A|90|Anticipated|Region Örebro County|||1||f||||f||||||Samples With DNA|"     Bloodsamples and Aortic valve samples   "|||2017-10-11 01:18:57.872367|2017-10-11 01:18:57.872367
NCT01939665|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-04-28|||September 2013||2013-09-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|PANFIRE||PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma|PANFIRE - Pilot-study: Non-thermal Ablation Using Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma - a Phase I Clinical Trial|Recruiting||Phase 1/Phase 2|40|Anticipated|VU University Medical Center||1|||f||||t||||||||||2017-10-11 01:18:57.95525|2017-10-11 01:18:57.95525
NCT01939652|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-09-05|||February 2009||2009-02-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Restrictive Versus Standard Fluid Regime in Elective Minilaparotomy Abdominal Aortic Aneurysm Repair|Restrictive Versus Standard Fluid Regime in Elective Minilaparotomy Abdominal Aortic Aneurysm Repair|Completed||Early Phase 1|60|Actual|University Clinical Center Tuzla||2|||f||||t||||||||||2017-10-11 01:18:58.090944|2017-10-11 01:18:58.090944
NCT01939639|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-05|||March 2013||2013-03-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||The Influence of Oxytocin on the Processing of Social Contact||Completed||Phase 1|40|Actual|University Hospital, Bonn||2|||f||||f||||||||||2017-10-11 01:18:58.217087|2017-10-11 01:18:58.217087
NCT01939626|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-10-28|||August 2013||2013-08-01|October 2013|2013-10-01|November 2014|Anticipated|2014-11-01|February 2014|Anticipated|2014-02-01||Interventional|||Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse Imaging|Comparison of Human Embryonic Development Using Sequential and Single Media in IVF Monitored by Time-lapse Imaging.|Unknown status|Recruiting|N/A|150|Anticipated|Vitrolife||1|||f||||f||||||||||2017-10-11 01:18:58.324992|2017-10-11 01:18:58.324992
NCT01939613|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-09-05|||July 2010||2010-07-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01|2 Days|Observational [Patient Registry]|||Colloid Improves Organs Function in Resuscitation of Extensive Burn Patients|Colloid Improves Organ Function by Reducing the Elevation of Intra-abdominal Pressure in Resuscitation of Critical Burn Patients|Completed||N/A|47|Actual|Tang-Du Hospital|||2||f||||t||||||||||2017-10-11 01:18:58.441524|2017-10-11 01:18:58.441524
NCT01939600|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2014-11-17|||September 2013||2013-09-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional|||Digestibility of Selected Resistant Starches in Humans|Digestibility of Selected Resistant Starches in Humans|Completed||N/A|3|Actual|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-11 01:18:58.583889|2017-10-11 01:18:58.583889
NCT01939236|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-10-08|||May 2010||2010-05-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Traditional Chinese Medicine for Treatment of Chronic Heart Failure|Traditional Chinese Medicine for Treatment of Chronic Heart Failure: A Multicenter Randomized Double-blind Placebo-controlled Clinical Trial|Completed||Phase 2|220|Actual|Beijing University of Chinese Medicine||2|||f||||f||||||||||2017-10-11 01:19:08.159009|2017-10-11 01:19:08.159009
NCT01939587|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-03-07|||December 2013||2013-12-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study to Assess the Efficacy of a Single PBF-680 Oral Administration to Attenuate Adenosine 5'-Monophosphate Challenge-induced Airway Hyperresponsiveness in Mild-to-moderate Asthmatics|"A Single-centre, Randomised, Double-blind, Placebo-controlled, 3-way Multiple Dose, Cross-over, Proof-of-concept Study to Assess the Efficacy of a Single PBF-680 Oral Administration to Attenuate Adenosine 5'-Monophosphate (AMP) Challenge-induced Airway Hyperresponsiveness in Mild-to-moderate Asthmatics"|Completed||Phase 2|21|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||3|||f||||f||||||||||2017-10-11 01:18:58.71882|2017-10-11 01:18:58.71882
NCT01939574|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2016-01-20|||August 2013||2013-08-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma|An Open-label, Single Arm Study to Explore Whether Potential Image Biomarkers Correlate With Efficacy of Bevacizumab Combined With Conventional Therapy in Newly Diagnosed Glioblastoma|Active, not recruiting||N/A|20|Actual|Shandong Cancer Hospital and Institute||1|||f||||t||||||||Undecided||2017-10-11 01:18:58.838915|2017-10-11 01:18:58.838915
NCT01939561|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-04-22|||November 2013||2013-11-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Lamotrigine as Treatment of Myotonia|Lamotrigine as Treatment of Myotonia - a Phase 3 Randomized Controlled Trial Study|Completed||Phase 3|27|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:18:58.969724|2017-10-11 01:18:58.969724
NCT01939548|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-07-12|2015-10-16||October 2013||2013-10-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||All participants who received study treatment were included in the baseline characteristics summary.|An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia|A 12-week , Randomized, Phase 2, Double-blind, Parallel-group Study Of Two Dose Levels Of Pf-02545920 Compared To Placebo In The Adjunctive Treatment Of Outpatients With Sub-optimally Controlled Symptoms Of Schizophrenia|Terminated||Phase 2|240|Actual|Pfizer|The study was terminated prematurely as a pre-planned interim analysis indicated the study was unlikely to meet the pre-specified efficacy criteria. The decision was not based on any safety concerns.|3||"A pre-planned interim analysis indicated the trial was unlikely to meet the pre-specified   efficacy criteria. The decision was not based on any safety concerns."|f||||t||||||||||2017-10-11 01:18:59.137338|2017-10-11 01:18:59.137338
NCT01939535|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-06-11|||September 2013||2013-09-01|October 2012|2012-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|IDEAL||Preoperative Staging of Endometriosis With MRI|Prospective Evaluation of the Value of Magnetic Resonance Imaging as a One-stop-shop for Preoperative Stratification of Patients With Complexe Endometriosis - Imaging Deep Endometriosis Assessment Versus Laparoscopy.|Unknown status|Recruiting|N/A|70|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:19:01.324038|2017-10-11 01:19:01.324038
NCT01939522|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-05-08|||August 2013||2013-08-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|April 2016|Actual|2016-04-01||Interventional|T1DM||Protection Against Pneumococcal Infection in Children With T1DM|An Open Label Single-arm Trial of the Immunogenicity and Reactogenicity of a 13-valent Pneumococcal Conjugate Vaccine (Prevenar13®) Given to Children With Type 1 Diabetes Mellitus Who Have Not Previously Received a Primary Schedule of Immunisation With Pneumococcal Conjugate Vaccines in Infancy.|Completed||Phase 4|50|Actual|University of Oxford||1|||f||||t||||||||||2017-10-11 01:19:01.417255|2017-10-11 01:19:01.417255
NCT01939509|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-12-04|||February 2012||2012-02-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|CHAB||Hemodynamic Changes of Patients Receiving Atenolol/Bisoprolol|Comparison of the Hemodynamic Changes in Patients Under Treatment With Bisoprolol Versus Atenolol|Completed||Phase 4|80|Anticipated|Hospital Italiano de Buenos Aires||1|||f||||f||||||||||2017-10-11 01:19:01.521093|2017-10-11 01:19:01.521093
NCT01939496|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-03-02|2016-03-08||October 2013||2013-10-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||The full analysis set included all randomized participants who took at least 1 dose of double blind study medication.|Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Blood Pressure Reduction With Ambulatory Blood Pressure Monitoring (ABPM), Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Hypertension and Type 2 Diabetes Mellitus|Completed||Phase 4|171|Actual|Janssen Scientific Affairs, LLC||3|||f||||f||||||||||2017-10-11 01:19:01.662233|2017-10-11 01:19:01.662233
NCT01939483|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2014-10-07|||December 2012||2012-12-01|October 2014|2014-10-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases|A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases|Withdrawn||N/A|0|Actual|University of California, Irvine||1||Slow accrual|f||||t||||||||||2017-10-11 01:19:03.438309|2017-10-11 01:19:03.438309
NCT01939470|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-05-23|||October 2007||2007-10-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|March 2011|Actual|2011-03-01||Observational|||Oklahoma Native American Women's Osteoporosis Screening Study|Oklahoma Native American Women's Osteoporosis Screening Study|Active, not recruiting||N/A|301|Actual|Oklahoma State University|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:19:03.53256|2017-10-11 01:19:03.53256
NCT01939457|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-09-06|||September 2011||2011-09-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||400mcg Sublingual Misoprostol as First Line Treatment|Introduction of 400mcg Sublingual Misoprostol as First Line Treatment in 11 Health Posts in Three Districts in Senegal|Completed||N/A|641|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-10-11 01:19:03.614174|2017-10-11 01:19:03.614174
NCT01939444|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-01-02|||August 2013||2013-08-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||A Pilot Study of the Bioavailability of Nasal Naloxone|A Pilot Study of the Bioavailability of Nasal Naloxone|Completed||Phase 2|5|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-10-11 01:19:03.71427|2017-10-11 01:19:03.71427
NCT01939431|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-10-05|||August 20, 2013||2013-08-20|February 16, 2017|2017-02-16|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Observational|||Genetic and Other Aspects of Podoconiosis|Investigation of the Pathogenesis of Podoconiosis Using RNA-seq and Immunopathologic Approaches|Not yet recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:19:05.774394|2017-10-11 01:19:05.774394
NCT01939418|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-10-01|||August 2013|Actual|2013-08-01|October 2017|2017-10-01|July 30, 2017|Actual|2017-07-30|July 30, 2016|Actual|2016-07-30||Interventional|||Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer|A Phase Ib Trial of Gemcitabine and Cisplatin With RAD001 in Patients With Metastatic Triple Negative Breast Cancer Proceeding to an Open Label Randomized Phase II Trial Comparing Gemcitabine/Cisplatin With or Without RAD001.|Terminated||Phase 1/Phase 2|23|Actual|National Cancer Center, Korea||1||slow recruitment|f||||f||||||||||2017-10-11 01:19:05.877535|2017-10-11 01:19:05.877535
NCT01939405|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-08-31|2017-03-21||October 2013||2013-10-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|CUBES||Children's Use of the Built Environment for Physical Activity|Use of the Built Environment to Promote Physical Activity in Children.|Completed||N/A|60|Actual|Massachusetts General Hospital|Small sample size, single office setting, short term (4 months) follow-up, multi-component intervention including financial incentives and text messages.|2|||f||||f||||||||||2017-10-11 01:19:05.980868|2017-10-11 01:19:05.980868
NCT01939392|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-08-14|||September 2013||2013-09-01|August 2015|2015-08-01|September 2018|Anticipated|2018-09-01|September 2015|Anticipated|2015-09-01||Interventional|RAPID II||Rapid Renal Sympathetic Denervation for Resistant Hypertension II|Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot Renal Denervation System II|Withdrawn||Phase 2/Phase 3|0|Actual|Medtronic Endovascular||2|||f||||t||||||||||2017-10-11 01:19:06.366454|2017-10-11 01:19:06.366454
NCT01939379|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-09-05|||September 2013||2013-09-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Adductor Canal Nerve Block Following Total Knee Arthroplasty|Adductor Canal Nerve Block Following Total Knee Arthroplasty: A Randomized, Prospective Study Comparing High vs. Low Volume Bolus of 0.33% Ropivacaine|Active, not recruiting||N/A|15|Actual|Loma Linda University||2|||f||||f||||||||||2017-10-11 01:19:06.457822|2017-10-11 01:19:06.457822
NCT01939366|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-01-30|||September 2013||2013-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves|Efficacy, Safety and Tolerability of Multiple Doses of Oral Cebranopadol in Subjects With Moderate to Severe Chronic Pain Due to Diabetic Peripheral Neuropathy.|Completed||Phase 2|699|Actual|Grünenthal GmbH||5|||f||||f||||||||||2017-10-11 01:19:06.551295|2017-10-11 01:19:06.551295
NCT01939353|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2015-10-12||2015-09-22|September 2013||2013-09-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||An Exploratory, Single-Blind Pilot Study Of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 SR in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder|An Exploratory, Single-Blind Pilot Study Of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 SR in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder|Completed||Phase 2|41|Actual|Euthymics BioScience, Inc.||2|||f||||f||||||||||2017-10-11 01:19:06.94637|2017-10-11 01:19:06.94637
NCT01939340|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2013-09-11|||April 2010||2010-04-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|September 2012|Actual|2012-09-01||Observational|||Prevalence of Cachexia in Patients Undergoing Chemotherapy|Prevalence and Impact of Cachexia in Cancer Patients Undergoing Chemotherapy|Completed||N/A|285|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 01:19:07.04723|2017-10-11 01:19:07.04723
NCT01939327|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-10-13|||September 2013||2013-09-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|September 2016|Actual|2016-09-01||Interventional|R2||Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma|A Phase II Single-arm, Open-label Study to Evaluate the Safety and Efficacy of Combination Lenalidomide (Revlimid®) With Rituximab in Subjets With Relapsed or Refractory Diffuse Large b Cell Non-Hodgkin's Lymphoma.|Recruiting||Phase 2|38|Anticipated|Institut Paoli-Calmettes||1|||f||||t||||||||||2017-10-11 01:19:07.114014|2017-10-11 01:19:07.114014
NCT01939314|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-07-06|2015-04-15||October 2012||2012-10-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Sphenopalatine Nerve Block for Headache Tx360|A Prospective, Randomized, Double-Blind Study Comparing the Efficacy of Sphenopalatine Nerve Block by Localized Mucosal Application of an Anesthetic vs Placebo for the Emergency Department Management|Completed||Phase 3|93|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 01:19:07.222094|2017-10-11 01:19:07.222094
NCT01939301|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-03-30|||October 2013||2013-10-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|October 2017|Anticipated|2017-10-01||Interventional|||Nitric Oxide to Treat Pulmonary Embolism|Randomized Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism|Active, not recruiting||Phase 2|78|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 01:19:07.568976|2017-10-11 01:19:07.568976
NCT01939275|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-06-14|||September 25, 2014|Actual|2014-09-25|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer|64Cu-DOTA-trastuzumab Positron Emission Tomography in Patients With Gastric Cancer|Recruiting||N/A|22|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:19:07.730012|2017-10-11 01:19:07.730012
NCT01939262|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-19|||December 2010||2010-12-01|September 2013|2013-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||The Impact of Dietary Restriction of Animal Protein and Fat on Osteoarthritis|The Impact of Dietary Restriction of Animal Protein and Fat on Subjective Complaints of Osteoarthritis|Completed||N/A|40|Actual|Essentia Health||2|||f||||f||||||||||2017-10-11 01:19:07.835659|2017-10-11 01:19:07.835659
NCT01939249|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2017-06-23|||September 2013||2013-09-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|March 23, 2016|Actual|2016-03-23||Interventional|BIOFLOW-IV||Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent|BIOTRONIK-A Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two de Novo Coronary Artery Lesions - IV|Active, not recruiting||N/A|585|Anticipated|Biotronik AG||2|||f||||f||||||||||2017-10-11 01:19:07.931084|2017-10-11 01:19:07.931084
NCT01938885|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-17|||October 2011||2011-10-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Hepatic Pseudoaneurysms After Trauma|Hepatic Pseudoaneurysms After Conservatively Managed Liver Injuries|Completed||N/A|238|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 01:19:14.460463|2017-10-11 01:19:14.460463
NCT01939210|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-06|2016-01-11|||February 2010||2010-02-01|January 2016|2016-01-01||||June 2015|Actual|2015-06-01||Interventional|||Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy|Influence of Meditation-Based Breathing Training on Target Motion Management and Distress During Radiation for Abdominal and Lung Malignancies|Active, not recruiting||N/A|17|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||||||||||||2017-10-11 01:19:08.771411|2017-10-11 01:19:08.771411
NCT01939184|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-06-01||2015-06-01|August 2013||2013-08-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia|A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)|Completed||Phase 2|796|Actual|Warner Chilcott||5|||f||||f||||||||||2017-10-11 01:19:09.213279|2017-10-11 01:19:09.213279
NCT01939171|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-05|||June 2010||2010-06-01|September 2013|2013-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Thymoglobulin in Cadaver Donor|Conditioning of the Cadaver Donor by Thymoglobulin Administered to Reduce the Pro-inflammatory State After Brain Death.|Completed||Phase 2|20|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-11 01:19:09.526161|2017-10-11 01:19:09.526161
NCT01939158|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-09-14|||October 2, 2013|Actual|2013-10-02|September 2017|2017-09-01|February 12, 2020|Anticipated|2020-02-12|February 12, 2020|Anticipated|2020-02-12||Interventional|||Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine|A Phase III, Randomised, Open, Controlled, Multicentre, Primary Vaccination Study To Evaluate The Immunogenicity And Persistence Of 1 And 2 Doses Of Meningococcal Conjugate Vaccine MenACWY-TT In Toddlers (After 1 Month And Up To 5 Years) And To Demonstrate Non-inferiority Of Co-administration Of MenACWY-TT And 13-valent Pneumococcal Conjugate Vaccine Prevenar 13(Registered) Versus Separate Administration Of The 2 Vaccines|Active, not recruiting||Phase 3|804|Actual|Pfizer||4|||f|||||f|f||||||||2017-10-11 01:19:09.635953|2017-10-11 01:19:09.635953
NCT01939145|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-11-08|2016-01-07||September 2013||2013-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2014|Actual|2014-07-01||Interventional|||Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation|A Prospective Randomized Trial Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation|Completed||Phase 4|100|Actual|Georgetown University||2|||f||||f||||||||No|Data collected has not been approved for use beyond the scope of this trial and will not be made available.|2017-10-11 01:19:09.870003|2017-10-11 01:19:09.870003
NCT01939132|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-09|||July 2013||2013-07-01|September 2013|2013-09-01|November 2014|Anticipated|2014-11-01|July 2014|Anticipated|2014-07-01||Interventional|||Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis|Title of Study: A Single-Site, Investigator Initiated Open-Label Trial of H.P. Acthar Gel (Repository Corticotropin Injection) an Adrenocorticotropic Hormone (ACTH) Analogue in Subjects With Moderately to Severely Active Psoriatic Arthritis (PsA)|Unknown status|Recruiting|Phase 4|10|Anticipated|Fiechtner, Justus J., M.D., P.C.||1|||f||||f||||||||||2017-10-11 01:19:10.245008|2017-10-11 01:19:10.245008
NCT01939119|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-05|||January 2013||2013-01-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||Body-fluid Balance and Drinking Habits in Patients With Retinal Vascular Occlusion|Examination of the Body-fluid Balance in Patients With Retinal Vascular Occlusion Before and During Hemodilution and the Influence of Drinking Habits on the Degree of Body Hydration|Unknown status|Recruiting|N/A|30|Anticipated|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 01:19:10.457206|2017-10-11 01:19:10.457206
NCT01939093|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-09-05|||March 2010||2010-03-01|September 2013|2013-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|MAP||Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis|Therapeutic Effect Between Quetiapine and Haloperidol on the Treatment of Methamphetamine - Induced Psychosis|Completed||Phase 4|80|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-11 01:19:10.642541|2017-10-11 01:19:10.642541
NCT01939080|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-08-17|||April 2013||2013-04-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|June 2017|Anticipated|2017-06-01||Interventional|ACT||Variation of Aortic Compliance Related to Exercise Training With or Without Supervised Sessions|Exercise Training in Patients With Cardiovascular Risk: Predictability of Aortic Compliance Normalization|Recruiting||N/A|308|Anticipated|University Hospital Center of Martinique||2|||f||||f||||||||||2017-10-11 01:19:10.75522|2017-10-11 01:19:10.75522
NCT01922557|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-08-12|||January 2011||2011-01-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|January 2011|Actual|2011-01-01||Observational|||Thoracic Fluid Content and Acute Lung Injury|The Association of Thoracic Fluid Content and Acute Lung Injury in Liver Transplantation|Completed||N/A|22|Actual|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 01:23:52.998236|2017-10-11 01:23:52.998236
NCT01939067|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2015-09-14|||March 2014||2014-03-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP|Pulmonary Mechanics in Preterm Infants Treated With Heated Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure.|Withdrawn||Phase 1|0|Actual|Children's Hospital of Philadelphia||2||Application for regulatory approval withdrawn|f||||f||||||||||2017-10-11 01:19:10.844485|2017-10-11 01:19:10.844485
NCT01939054|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-06-03|||September 2013||2013-09-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients|A Randomized, Controlled, Open-Label, Multicenter, Phase 2 Study of Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine as First-Line Treatment in Patients With Recurrent/Metastatic Triple Negative Breast Cancer|Unknown status|Recruiting|Phase 2|90|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:19:10.938101|2017-10-11 01:19:10.938101
NCT01939041|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-05-17|||August 1, 2013|Actual|2013-08-01|June 2016|2016-06-01|February 20, 2017|Actual|2017-02-20|February 20, 2017|Actual|2017-02-20||Interventional|||Efficacy of Unilateral Versus Bilateral Approach to Robot-Assisted Rehabilitation in Patients With Subacute Stroke|Efficacy of Unilateral Versus Bilateral Approach to Robot-Assisted Rehabilitation on Motor Control/Performance, Daily Functions, and Physiological Responses in Patients With Subacute Stroke|Withdrawn||N/A|0|Actual|Chang Gung Memorial Hospital||3||Difficult to recruit participant|f||||f||||||||||2017-10-11 01:19:11.071389|2017-10-11 01:19:11.071389
NCT01939028|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-10-17|||July 2013||2013-07-01|October 2016|2016-10-01||||October 2016|Actual|2016-10-01||Interventional|||Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery|Sentinel Lymph Node Mapping for Endometrial Cancer|Terminated||N/A|39|Actual|Case Comprehensive Cancer Center||1||Slow Accrual|f||||t||||||||||2017-10-11 01:19:11.184603|2017-10-11 01:19:11.184603
NCT01939015|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2013-12-27|||February 2013||2013-02-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|RCTs||Three Dimensional Versus Standard Miniplate In Fixation Of Mandibular Angle Fracture- A Prospective Randomized Controlled Clinical Trial|3D Vs Standard Miniplate in Fixation of the MAFs|Completed||N/A|20|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-11 01:19:11.291972|2017-10-11 01:19:11.291972
NCT01939002|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-11-30|2016-10-06||November 2013||2013-11-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|ALLOW||Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)|An Open-Label, Two-Arm Randomized Study to Characterize Flu-Like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Current Interferon Beta Therapies to BIIB017|Completed||Phase 3|251|Actual|Biogen||2|||f||||f||||||||||2017-10-11 01:19:11.438524|2017-10-11 01:19:11.438524
NCT01938989|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-01-14|2015-01-14||September 2013||2013-09-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||This analysis population includes all randomized participants.|Effect of Blue Light Filtration on Visual Performance|Effect of Blue Light Filtration on Visual Performance|Completed||N/A|158|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:19:13.495755|2017-10-11 01:19:13.495755
NCT01938976|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-05|||October 2012||2012-10-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|TAJPlus||Efficacy of School-Based, Peer-Led Asthma and Smoking Prevention Program on CO1 Levels and Smoking Behavior Among Early Adolescents in Jordan|Efficacy of School-Based, Peer-Led Asthma and Smoking Prevention Program on CO1 Levels, Nicotine Dependence, and Smoking Behavior Among Early Adolescents in Jordan|Completed||Phase 2|815|Actual|University of Technology, Sydney||2|||f||||t||||||||||2017-10-11 01:19:13.674457|2017-10-11 01:19:13.674457
NCT01938963|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-01-28|||January 2014||2014-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|COACH||Chinese Older Adults-Collaboration in Health (COACH)Study|The Depression/Hypertension in Chinese Older Adults-Collaboration in Health|Recruiting||N/A|2400|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 01:19:13.790489|2017-10-11 01:19:13.790489
NCT01938950|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-06-27|||October 2013||2013-10-01|June 2017|2017-06-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|RCT:RCT||Resistance and Cardiorespiratory Time-matched Exercise in Youth: A Randomized Clinical Trial (RCT:RCT)|Resistance and Cardiorespiratory Time-matched Exercise in Youth: A Randomized Clinical Trial (RCT:RCT)|Terminated||N/A|118|Actual|University of Pittsburgh||3||PI is leaving the institution|f||||||||||||||2017-10-11 01:19:13.952689|2017-10-11 01:19:13.952689
NCT01938937|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-02-25|||March 2012||2012-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Effect of Acute Transcranial Bright Light on Anxiety Symptoms|The Effect of Acute Transcranial Bright Light on Anxiety Symptoms|Completed||N/A|60|Anticipated|University of Oulu||2|||f||||||||||||||2017-10-11 01:19:14.051039|2017-10-11 01:19:14.051039
NCT01938924|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-12-18|||September 2013||2013-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SRANS||Surgical Revascularisation and Nerve Stimulation Trial|A Randomised Control Trial to Establish if Use of the gekoTM (Trademark) Post Infra-inguinal Surgical Vein Revascularisation Increases Flow Through the Graft|Withdrawn||Phase 4|0|Actual|University of Hull||2||No funding|f||||t||||||||||2017-10-11 01:19:14.140743|2017-10-11 01:19:14.140743
NCT01938911|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-11-14|||November 2014||2014-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension|The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension|Suspended||N/A|160|Anticipated|University Hospital Inselspital, Berne||8||not enough study personnel|f||||t||||||||||2017-10-11 01:19:14.25291|2017-10-11 01:19:14.25291
NCT01938898|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2015-04-21|||January 2014||2014-01-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|NICOLA-RT||The NICOLA Recruitment Trial (NICOLA-RT)|The NICOLA Recruitment Trial (NICOLA-RT): the Effect of Invitation Letters on Overall Recruitment in a Longitudinal Cohort Study in People Over Age of 50.|Unknown status|Recruiting|N/A|13000|Anticipated|Queen's University, Belfast||1|||f||||f||||||||||2017-10-11 01:19:14.369075|2017-10-11 01:19:14.369075
NCT01938872|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-05|||September 2013||2013-09-01|September 2013|2013-09-01||||September 2015|Anticipated|2015-09-01|12 Months|Observational [Patient Registry]|||Evaluating the Effectiveness of Paclitaxel-eluting Balloons for Below-the-knee Angioplasty in Patients With Critical Limb Ischemia||Unknown status|Recruiting|N/A|100|Anticipated|Ospedale San Donato|||1||f||||f||||||||||2017-10-11 01:19:14.559484|2017-10-11 01:19:14.559484
NCT01938859|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-10-03|||June 2012|Actual|2012-06-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|AGTs-BD||Algorithm Guided Treatment Strategies for Bipolar Depression|Algorithm Guided Treatment Strategies for Bipolar Depression|Active, not recruiting||Phase 4|360|Anticipated|Shanghai Mental Health Center||3|||f||||f||||||||||2017-10-11 01:19:14.704761|2017-10-11 01:19:14.704761
NCT01938846|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-06-22|||September 5, 2013|Actual|2013-09-05|June 2017|2017-06-01|April 27, 2017|Actual|2017-04-27|July 30, 2016|Actual|2016-07-30||Interventional|||BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors|An Open Label Phase I Dose Finding Study of BI 860585 Administered Orally in a Continuous Dosing Schedule as Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumours|Completed||Phase 1|90|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 01:19:14.818074|2017-10-11 01:19:14.818074
NCT01938833|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-09-05|2017-09-05||April 2014|Actual|2014-04-01|September 2017|2017-09-01|December 8, 2016|Actual|2016-12-08|August 18, 2016|Actual|2016-08-18||Interventional|||Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer|A Phase I/II Study of Romidepsin in Combination With Abraxane in Patients With Metastatic Inflammatory Breast Cancer|Terminated||Phase 1/Phase 2|9|Actual|Thomas Jefferson University||1||Closed by Sponsor|f||||t||||||||||2017-10-11 01:19:14.931039|2017-10-11 01:19:14.931039
NCT01938820|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-01-12|||June 2013||2013-06-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Optimized Treatment and Regression of HBV-induced Early Cirrhosis|Optimized Treatment and Regression of HBV-induced Early Cirrhosis|Recruiting||Phase 4|200|Anticipated|Beijing Friendship Hospital||2|||f||||t||||||||||2017-10-11 01:19:15.355488|2017-10-11 01:19:15.355488
NCT01938807|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-10-24|||October 2013||2013-10-01|October 2014|2014-10-01||||June 2015|Anticipated|2015-06-01||Interventional|||Audio Health Engagement Analysis in Diabetes: The AHEAD Study|Audio Health Engagement Analysis in Diabetes: The AHEAD Study|Unknown status|Active, not recruiting|Phase 1|60|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:19:15.5559|2017-10-11 01:19:15.5559
NCT01938794|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-09-21|||September 2013||2013-09-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Observational|||A New Approach to Measuring Energy Expenditure in Humans|Improvements to the Doubly Labeled Water Technique to Measure Total Daily Energy Expenditure|Completed||N/A|72|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 01:19:15.636|2017-10-11 01:19:15.636
NCT01938781|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-01-12|||June 2013||2013-06-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Optimized Treatment and Regression of HBV-induced Liver Fibrosis|Optimized Treatment and Regression of HBV-induced Liver Fibrosis|Recruiting||Phase 4|400|Anticipated|Beijing Friendship Hospital||2|||f||||t||||||||||2017-10-11 01:19:15.705559|2017-10-11 01:19:15.705559
NCT01938768|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2015-11-30|||November 2013||2013-11-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Effects of an Early Prehospital Administration of Tranexamic Acid on Hyperfibrinolysis in Multiple Trauma||Completed||N/A|110|Actual|University of Göttingen|||2||f||||f||||||Samples Without DNA|"     blood samples   "|||2017-10-11 01:19:15.926699|2017-10-11 01:19:15.926699
NCT01938755|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-04-03|||June 2013||2013-06-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Hyperbaric Levobupivacaine for Spinal Anaesthesia||Completed||Phase 4|73|Actual|T.C. ORDU ÜNİVERSİTESİ||3|||f||||||||||||||2017-10-11 01:19:16.011609|2017-10-11 01:19:16.011609
NCT01938742|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-12-08||2015-03-26|September 2013||2013-09-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||H7N9 Mix and Match With MF59 in Healthy Adults|A Phase II Randomized, Double-Blinded, Controlled Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Influenza A/H7N9 Virus Vaccine Administered at Different Dosages Given With and Without MF59 Adjuvant|Completed||Phase 2|700|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-10-11 01:19:16.089369|2017-10-11 01:19:16.089369
NCT01938729|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-09-08|||September 2013||2013-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma|Phase I Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma|Active, not recruiting||Phase 1|8|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:19:16.21167|2017-10-11 01:19:16.21167
NCT01938716|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-09-21|||March 2012|Actual|2012-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy|Tissue Pharmacokinetics of Intraoperative Gemcitabine in Adenocarcinoma of the Pancreas After Preoperative Chemoradiation Therapy|Active, not recruiting||N/A|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:19:16.435214|2017-10-11 01:19:16.435214
NCT01938690|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-02-24|||February 2013||2013-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of Transcranial Magnetic Stimulation on Recovery of Upper Limb Among Stroke Survivors|Effect of Transcranial Magnetic Stimulation on Motor Recovery of Upper Limb Among Stroke Survivors: Pilot Study|Active, not recruiting||N/A|12|Anticipated|Kessler Foundation||2|||f||||t||||||||||2017-10-11 01:19:16.524028|2017-10-11 01:19:16.524028
NCT01938677|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-08-29|||April 2013||2013-04-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study|Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study|Recruiting||N/A|80|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:19:16.591722|2017-10-11 01:19:16.591722
NCT01938664|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-01-25|||January 2013||2013-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||A Pilot Study of Candesartan as a Treatment for Cocaine Dependence|Pilot Study of Candesartan: An Angiotensin Receptor Blocker as a Treatment for Cocaine Dependence|Active, not recruiting||Phase 2|41|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 01:19:16.682888|2017-10-11 01:19:16.682888
NCT01938651|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-08-02|||January 2013||2013-01-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer|Ultra-High Field (7 Tesla) MRI/MRS Evaluation of Breast Cancer|Terminated||N/A|3|Actual|Vanderbilt-Ingram Cancer Center||1||funding ceased|f||||t||||||||||2017-10-11 01:19:16.775964|2017-10-11 01:19:16.775964
NCT01938638|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-02-20|||September 2013||2013-09-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer|An Open-label Phase I Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY1143572 Given in a Once-daily or an Intermittent Dosing Schedule in Subjects With Advanced Malignancies|Completed||Phase 1|80|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:19:16.877883|2017-10-11 01:19:16.877883
NCT01938625|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-06-30||2016-04-05|December 2013||2013-12-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation|Phase 2, Open-Label Study to Investigate the Pharmacokinetics, Efficacy, Safety, and Tolerability of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052) and Ribavirin (RBV) in Subjects With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation|Completed||Phase 2|35|Actual|Janssen R&D Ireland||2|||f||||f||||||||||2017-10-11 01:19:16.999994|2017-10-11 01:19:16.999994
NCT01938612|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-09-29|||September 12, 2013|Actual|2013-09-12|September 2017|2017-09-01|March 20, 2018|Anticipated|2018-03-20|March 20, 2018|Anticipated|2018-03-20||Interventional|||A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours|A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|268|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 01:19:17.133463|2017-10-11 01:19:17.133463
NCT01938599|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-11-30||2014-07-09|August 2013||2013-08-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis|A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis|Completed||Phase 2|92|Actual|AmDerma||2|||f||||f||||||||||2017-10-11 01:19:17.304261|2017-10-11 01:19:17.304261
NCT01938586|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-04-14|||November 2013||2013-11-01|September 2013|2013-09-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Observational|||Comparison of Traditional Superficial Cutaneous Sutures Versus Steri-Strip Coaptive Film in Layered Dermatologic Closures|Comparison of Traditional Superficial Cutaneous Sutures Versus Steri-Strip Coaptive Film in Layered Dermatologic Closures on the Back - a Prospective, Randomized, Split-scar Study|Completed||N/A|10|Actual|Henry Ford Health System|||1||f||||||||||||||2017-10-11 01:19:17.40206|2017-10-11 01:19:17.40206
NCT01938560|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-09-29|||February 2013||2013-02-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||REMS Retigabine Study|REMS Prescriber and Pharmacist Understanding of the Risk of Urinary Retention With POTIGA™|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 01:19:17.64291|2017-10-11 01:19:17.64291
NCT01938547|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-05-12|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PIONEER||Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER)|Open Label Study to Assess the Efficacy, Safety and Dosing of Clevidipine in Pediatric Patients Undergoing Surgery|Suspended||Phase 4|100|Anticipated|Chiesi USA||1|||f||||t|t|f||||||||2017-10-11 01:19:17.716941|2017-10-11 01:19:17.716941
NCT01938534|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-12-31|||September 2013||2013-09-01|December 2013|2013-12-01||||December 2014|Anticipated|2014-12-01||Interventional|||Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use||Unknown status|Recruiting|Phase 4|440|Anticipated|Ajou University School of Medicine||2|||f||||||||||||||2017-10-11 01:19:17.824643|2017-10-11 01:19:17.824643
NCT01938521|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2015-06-02|||September 2013||2013-09-01|June 2015|2015-06-01|November 2015|Anticipated|2015-11-01|February 2014|Actual|2014-02-01||Interventional|RGC-T2D||Effects of Red Grape Cells (RGC) Powder in Type 2 Diabetics|Effects of Red Grape Cells (RGC) Powder on Glycemic and Lipid Control in Patients With Type 2 Diabetes ¬ A Double-blind, Randomized, Placebo Controlled Study|Unknown status|Active, not recruiting|Early Phase 1|40|Anticipated|Tel Aviv University||2|||f||||t||||||||||2017-10-11 01:19:17.912918|2017-10-11 01:19:17.912918
NCT01938508|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-11-14|||May 2013||2013-05-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Minocycline Bioequivalence Study|Bioequivalence Study Between Two Medications for the Oral Administration of 100 mg of Minocycline in Oral Solids in Healthy Volunteers.|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:19:18.001064|2017-10-11 01:19:18.001064
NCT01938495|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-12-22|||August 2013||2013-08-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|DPS in ALS||Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)|Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)|Active, not recruiting||Phase 2|52|Actual|Barrow Neurological Institute||2|||f||||t||||||||||2017-10-11 01:19:18.090831|2017-10-11 01:19:18.090831
NCT01920867|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-09-26|||August 2013||2013-08-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|SCOTS||Stem Cell Ophthalmology Treatment Study|Bone Marrow Derived Stem Cell Ophthalmology Treatment Study|Enrolling by invitation||N/A|300|Anticipated|Retina Associates of South Florida||3|||f||||t||||||||||2017-10-11 01:24:24.007817|2017-10-11 01:24:24.007817
NCT01938482|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-05-05|||October 31, 2013|Actual|2013-10-31|May 2017|2017-05-01|February 17, 2015|Actual|2015-02-17|February 17, 2015|Actual|2015-02-17||Interventional|||Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029|A Randomized, Single-Blind, Dose-Rising Study to Evaluate the Safety, Tolerability and Preliminary Pharmacokinetics of Single and 14 Day Repeat Topical Applications of GSK1940029 Gel on the Intact Skin of Healthy Human Subjects|Completed||Phase 1|55|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:19:18.233913|2017-10-11 01:19:18.233913
NCT01938469|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-12-28|||September 2010||2010-09-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery|Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery|Completed||N/A|33|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||f||||||||||2017-10-11 01:19:18.328479|2017-10-11 01:19:18.328479
NCT01938456|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-07-24|||October 2013||2013-10-01|July 2014|2014-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer|An Open-Label, Phase Ib Study to Assess the Safety and Tolerability of GSK1120212 in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||1||This study was Cancelled Before Active|f||||f||||||||||2017-10-11 01:19:18.413056|2017-10-11 01:19:18.413056
NCT01938443|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2017-04-27|||November 18, 2013|Actual|2013-11-18|April 2017|2017-04-01|June 23, 2016|Actual|2016-06-23|June 23, 2016|Actual|2016-06-23||Interventional|||A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors|A Phase 1b, Multi-center, Open-label, Dose Escalation Study of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors|Completed||Phase 1|34|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:19:18.507459|2017-10-11 01:19:18.507459
NCT01938430|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-03-16|2016-03-16|2015-11-04|September 2013||2013-09-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional||Safety Analysis Set: participants who were enrolled and received at least one dose of study drug|Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant|A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected With Chronic HCV Who Have Advanced Liver Disease or Are Post-Liver Transplant|Completed||Phase 2|339|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|14|||f||||t||||||||||2017-10-11 01:19:18.74056|2017-10-11 01:19:18.74056
NCT01938417|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-10|||October 2006||2006-10-01|September 2013|2013-09-01||||March 2008|Actual|2008-03-01||Observational|||Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute||Completed||N/A|12|Actual|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 01:19:27.999994|2017-10-11 01:19:27.999994
NCT01938404|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-09-21|||June 6, 2017|Actual|2017-06-06|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Octaplas Adult TTP Trial|Post-Marketing Requirement Study to Evaluate the Safety and Efficacy of Octaplas™ in Patients With Thrombotic Thrombocytopenic Purpura With Special Emphasis on Monitoring the Occurrence of Thromboembolic Events|Recruiting||N/A|200|Anticipated|Octapharma|||2||f||||t|t|||||||||2017-10-11 01:19:28.070249|2017-10-11 01:19:28.070249
NCT01938391|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-07-21|2017-03-28||January 2013||2013-01-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TRUTH|Subjects with symptomatic peripheral artery disease|Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal|Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal (TRUTH Study)|Completed||N/A|25|Actual|Cardiovascular Systems Inc|TRUTH was a single center, non-randomized trial that enrolled a small number of subjects (25).|1|||f||||f||||||||||2017-10-11 01:19:28.166853|2017-10-11 01:19:28.166853
NCT01938378|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-08-30|||April 2015||2015-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|Octaplas||Octaplas Pediatric Plasma Exchange Trial|An Open-label, Multicenter, Post-Marketing Requirement Study to Investigate the Safety and Tolerability of Octaplas™ in the Management of Pediatric Patients Who Require Therapeutic Plasma Exchange|Recruiting||Phase 4|40|Anticipated|Octapharma||1|||f||||t||||||||||2017-10-11 01:19:30.443924|2017-10-11 01:19:30.443924
NCT01938365|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-11-11|||January 2012||2012-01-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Observational|||Genetics of Type 1 Diabetes in Chinese Adolescents and Youth|A Prospective Cohort Study of Clinical Characteristics and Genetic Susceptibility of Type 1 Diabetes in Chinese Adolescents and Youth|Unknown status|Recruiting|N/A|500|Anticipated|Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||Samples With DNA|"     Whole blood,fasting serum and stool   "|||2017-10-11 01:19:30.553156|2017-10-11 01:19:30.553156
NCT01938352|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2014-03-03|||September 2013||2013-09-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge|Randomised, Double-Blind, Placebo-Controlled, Phase IIa Study in Healthy Volunteers to Evaluate the Protective Efficacy and Safety of CR8020 in an Influenza Challenge Model|Completed||Phase 2|22|Actual|Crucell Holland BV||2|||f||||f||||||||||2017-10-11 01:19:30.639359|2017-10-11 01:19:30.639359
NCT01938339|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-12-03|||May 2012||2012-05-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|April 2014|Anticipated|2014-04-01||Interventional|||Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer|Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer|Unknown status|Recruiting|N/A|60|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 01:19:30.725209|2017-10-11 01:19:30.725209
NCT01938326|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2017-08-31|||August 1, 2017|Actual|2017-08-01|August 2017|2017-08-01|August 2021|Anticipated|2021-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Pure Single Incision Laparoscopic Distal Gastrectomy (SIDG) Versus Totally Laparoscopic Distal Gastrectomy (TLDG)|Prospective Randomized Controlled Study of Acute Inflammatory Reaction and Morbidity After Pure Single Incision Laparoscopic Distal Gastrectomy (SIDG) and Totally Laparoscopic Distal Gastrectomy (TLDG) for Early Gastric Cancer.|Recruiting||N/A|86|Anticipated|Seoul National University Bundang Hospital||2|||f||||t|f|f||||||||2017-10-11 01:19:30.847281|2017-10-11 01:19:30.847281
NCT01938313|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2017-01-04|||August 2012||2012-08-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|August 2014|Actual|2014-08-01||Interventional|ERAS||Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy|Comparison of ERAS (Early Recovery After Surgery) Protocol With Conventional Protocol After Laparoscopic Gastrectomy: A Prospective Randomized Controlled Trial (Phase II Study))|Completed||Phase 2|100|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||No||2017-10-11 01:19:30.958192|2017-10-11 01:19:30.958192
NCT01938300|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2015-11-17|||June 2011||2011-06-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Magnesium and Rotational Thromboelastometry (ROTEM) in Colorectal Cancer Surgery||Completed||N/A|44|Actual|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-11 01:19:31.061697|2017-10-11 01:19:31.061697
NCT01938287|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-11-16|||July 2013||2013-07-01|November 2015|2015-11-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||SENSIMED Triggerfish in Closed Eyes|A Prospective, Open Label Study to Assess the 24-hour Intraocular Pressure Pattern Recorded With SENSIMED Triggerfish® in Healthy Subjects With Closed Eye|Completed||Phase 4|6|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 01:19:31.167517|2017-10-11 01:19:31.167517
NCT01938274|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-05-24|||December 1, 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LEAP||Leisure Expectations About Physical Activity Study|Establishing Appropriate Activity Expectations After Total Joint Replacement|Not yet recruiting||N/A|60|Anticipated|West Virginia University||2|||f||||f|f|f||||||No||2017-10-11 01:19:31.341114|2017-10-11 01:19:31.341114
NCT01938261|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-05-27|||August 2013||2013-08-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|PreParaS||The Preterm Infants' Paracetamol Study|The Preterm Infants' Paracetamol Study|Completed||Phase 2|48|Actual|University of Oulu||2|||f||||t||||||||||2017-10-11 01:19:31.445506|2017-10-11 01:19:31.445506
NCT01938248|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-05-24|||May 2015|Actual|2015-05-01|May 2017|2017-05-01|April 2021|Anticipated|2021-04-01|December 2020|Anticipated|2020-12-01||Interventional|ARTESiA||Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation|Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation|Recruiting||Phase 4|4000|Anticipated|Population Health Research Institute||2|||f||||t||||||||||2017-10-11 01:19:31.702632|2017-10-11 01:19:31.702632
NCT01938235|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-08-03|||February 2014||2014-02-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|EMPRES||Exenatide for Myocardial Protection During Reperfusion Study|Exenatide for Myocardial Protection During Reperfusion Study: A Double-blind, Placebo-controlled Trial|Recruiting||Phase 2|198|Anticipated|University Health Network, Toronto||2|||f||||t||||||||Undecided||2017-10-11 01:19:32.198057|2017-10-11 01:19:32.198057
NCT01938222|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-02-21|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Observational|Short-Stitch||Short Stitch Monomax®|A Prospective, Controlled Monocentric Study Evaluating the 6:1 Suture Technique Using Suture Material Monomax® for Abdominal Wall Closure After Primary Abdominal Incision|Recruiting||N/A|351|Anticipated|Diakonie-Klinikum Schwäbisch Hall gGmbH|||1||f||||f||||||||||2017-10-11 01:19:32.456564|2017-10-11 01:19:32.456564
NCT01938209|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-09|||September 2011||2011-09-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Comparison of Seated Thoracic Manipulation and Targeted Supine Thoracic Manipulation on Cervical Flexion Motion and Pain|A Randomized Control Trial of the Immediate Effects of Seated Thoracic Manipulation and Targeted Supine Thoracic Manipulation on Cervical Spine Flexion Range of Motion and Pain|Completed||N/A|39|Actual|Chatham University||2|||f||||t||||||||||2017-10-11 01:19:32.565032|2017-10-11 01:19:32.565032
NCT01938196|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-11-11||||||November 2014|2014-11-01||||January 2014|Actual|2014-01-01||Interventional|||A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation||Completed||Phase 2|||Kissei Pharmaceutical Co., Ltd.||5|||f||||||||||||||2017-10-11 01:19:32.650217|2017-10-11 01:19:32.650217
NCT01938183|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-09-04|||November 2006||2006-11-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|March 2010|Actual|2010-03-01||Interventional|||Full-mouth Periodontal Debridement and Metronidazole Gel in Patients With Chronic Periodontitis|Full-mouth Periodontal Debridement With or Without Adjunctive Metronidazole Gel in Smoking Patients With Chronic Periodontitis|Completed||Phase 2|30|Actual|University of Campinas, Brazil||3|||f||||t||||||||||2017-10-11 01:19:32.73202|2017-10-11 01:19:32.73202
NCT01938170|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-04-19|2016-04-19||September 2014||2014-09-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|||Home Administration of FluMist by Parents/Caregivers|A Pilot Study to Assess the Acceptability, Tolerability, and Feasibility of Home Intranasal Administration of FluMist® by a Trained Primary Caregiver to Healthy Family Members 2 Through 17 Years of Age|Completed||N/A|41|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 01:19:32.854222|2017-10-11 01:19:32.854222
NCT01938157|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-05-16|||August 2013||2013-08-01|April 2016|2016-04-01|March 9, 2017|Actual|2017-03-09|January 2016|Actual|2016-01-01||Interventional|||Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study|Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study|Completed||N/A|55|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 01:19:33.062567|2017-10-11 01:19:33.062567
NCT01938144|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-10-13|||April 2016||2016-04-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America|Three-day Clinical Evaluation Of The Efficacy And Safety Of Two Ibuprofen Combination Products For The Symptomatic Treatment Of The Common Cold And Flu: A Multicenter Study|Withdrawn||Phase 3|0|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:19:33.170824|2017-10-11 01:19:33.170824
NCT01938131|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-09|||August 2012||2012-08-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Study of Effectiveness of rMV (Repeated Muscle Vibration) in Knee Osteoarthritis|Effectiveness of Treatment With rMV (Repeated Muscle Vibration) in Patients Affected by Knee Osteoarthritis: a Prospective Randomized Clinical Trial|Completed||N/A|60|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 01:19:33.371355|2017-10-11 01:19:33.371355
NCT01919398|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-06-09|||August 2013||2013-08-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|May 2016|Actual|2016-05-01||Interventional|||A Study of LY2940680 in Japanese Participants With Advanced Cancers|A Phase 1 Study of LY2940680 in Japanese Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|12|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:24:50.19882|2017-10-11 01:24:50.19882
NCT01938118|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-04-17|||October 2013|Actual|2013-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mothers and Others: Family-based Obesity Prevention for Infants and Toddlers|Mothers and Others: Family-based Obesity Prevention for Infants and Toddlers|Active, not recruiting||N/A|430|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:19:33.473082|2017-10-11 01:19:33.473082
NCT01938105|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-24|||July 2013||2013-07-01|September 2013|2013-09-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer|Preoperative Concurrent Chemoradiotherapy Combined With Nimotuzumab Injection for Locally Advanced Cervical Cancer: a Phase II Study|Unknown status|Recruiting|Phase 2|40|Anticipated|People's Hospital of Guangxi||1|||f||||t||||||||||2017-10-11 01:19:33.746854|2017-10-11 01:19:33.746854
NCT01938092|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-07-25|||September 2013|Actual|2013-09-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Vaginal Diazepam for the Treatment of Female Pelvic Pain|Intravaginal Diazepam for the Treatment of Pelvic Pain Among Women With Pelvic Floor Hypertonic Disorder: a Double Blind, Randomized, Placebo Controlled Trial|Completed||Phase 2|50|Actual|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-11 01:19:33.877892|2017-10-11 01:19:33.877892
NCT01938079|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2016-08-05|2016-08-05||September 2013||2013-09-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||Pharmacokinetic Alterations During ECMO|Pharmacokinetic Alterations During ECMO (Ketamine and Extracorporeal Membrane Oxygenation)|Completed||N/A|20|Actual|Columbia University||2|||f||||t||||||||No||2017-10-11 01:19:34.035876|2017-10-11 01:19:34.035876
NCT01938066|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-03-21|2015-03-25||July 2013||2013-07-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Procellera and Negative Pressure Therapy for Acute Wounds|Clinical Outcomes for Patients With Acute Surgical Wounds Treated With Procellera and Negative Pressure Therapy Versus Standard of Care, Negative Pressure Therapy Only|Completed||N/A|30|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 01:19:34.330402|2017-10-11 01:19:34.330402
NCT01938053|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-05|2013-09-05|||April 2011||2011-04-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Improving Sexually Transmitted Infection (STI) Results Notification and Partner Services|Improving Sexually Transmitted Infection (STI) Results Notification and Partner Services|Unknown status|Active, not recruiting|N/A|609|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 01:19:34.784239|2017-10-11 01:19:34.784239
NCT01938040|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-10-28|2015-09-23||May 2013||2013-05-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effect IV Ibuprofen and Inflammatory Responses|Randomized, Double Blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes|Completed||Phase 4|60|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||No||2017-10-11 01:19:34.921035|2017-10-11 01:19:34.921035
NCT01938027|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-03-25|||September 2013||2013-09-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision|A Pilot Study for the Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision|Completed||N/A|12|Actual|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-11 01:19:35.789283|2017-10-11 01:19:35.789283
NCT01938014|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2015-08-10|||January 2009||2009-01-01|August 2015|2015-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children|Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children|Unknown status|Recruiting|N/A|150|Anticipated|University of Chicago|||1||f||||t||||||None Retained|"     None collected; this is data-collection only, via a telephone-interview of children's     care-givers.   "|||2017-10-11 01:19:35.898664|2017-10-11 01:19:35.898664
NCT01937988|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-07-29|||May 2013||2013-05-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Patient Support During Surgical Abortion|Patient Support During Surgical Abortion|Completed||N/A|220|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 01:19:36.749243|2017-10-11 01:19:36.749243
NCT01937975|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-03-01|2016-02-03||September 2013||2013-09-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050)|An Open-Label Study to Investigate the Pharmacokinetics of MK-5172 and MK-8742 in Subjects With Renal Insufficiency|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:19:36.884844|2017-10-11 01:19:36.884844
NCT01937949|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-03-29|||August 2013||2013-08-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|IDE#1||Complex Aortic Aneurysm Repair With Fenestrated Stent Grafts|Clinical Outcomes and Quality of Life Measures in Patients Treated for Complex Abdominal Aortic Aneurysms With Fenestrated Stent Grafts.|Recruiting||N/A|200|Anticipated|Mayo Clinic||1|||f||||t|f|f||||||||2017-10-11 01:19:37.881952|2017-10-11 01:19:37.881952
NCT01937936|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-10-26|||September 2013||2013-09-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Heart Failure Caregiver Study|Stress and Health in Family Caregivers of Persons With Heart Failure|Completed||N/A|50|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:19:37.993098|2017-10-11 01:19:37.993098
NCT01937546|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2015-07-23|||January 2013||2013-01-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||The Effect of Primary Delivery of the Anterior Compared With the Posterior Shoulder on Perineal Trauma: a Randomized Controlled Trial|The Effect of Primary Delivery of the Anterior Compared With the Posterior Shoulder on Perineal Trauma: a Randomized Controlled Trial|Completed||N/A|650|Actual|Holbaek Sygehus||2|||f||||t||||||||||2017-10-11 01:19:46.014095|2017-10-11 01:19:46.014095
NCT01937923|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-10-28|||August 2013||2013-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|PRE-CELL||A Pre-Cellular Therapy Observational Study in Early Huntington's Disease|A Pre-Cellular Therapy Observational Study in Early Huntington's Disease|Completed||N/A|29|Actual|University of California, Davis|||1||f||||f||||||Samples Without DNA|"     Safety labs: Complete blood count, comprehensive metabolic panel, international normalized     ration, partial thromboplastic time, thyroid stimulating hormone, urinalysis, HIV screen.      Biomarkers: Brain-derived neurotrophic factor (BDNF) in cerebrospinal fluid (CSF) and Plasma,     BDNF related and Huntington's Disease (HD) specific gene transcription markers in CSF and     blood, Small molecule markers of HD in CSF and plasma   "|No||2017-10-11 01:19:38.117005|2017-10-11 01:19:38.117005
NCT01937910|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-01-09|||September 2014||2014-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|Myelin||Neuroplastic Change in Myelin of the Brain|Structural and Functional Correlates of Neuroplastic Change Associated With Stroke|Recruiting||N/A|88|Anticipated|University of British Columbia||2|||f||||f||||||||Undecided||2017-10-11 01:19:38.197627|2017-10-11 01:19:38.197627
NCT01937897|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2014-02-03|||July 2013||2013-07-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Unilateral Massage as a Potential Treatment for Depression|Unilateral Massage as a Potential Treatment for Depression|Completed||N/A|12|Actual|University of Arizona||3|||f||||f||||||||||2017-10-11 01:19:38.319821|2017-10-11 01:19:38.319821
NCT01937884|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2016-06-30|||August 2013||2013-08-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SuPPeR||Supplemental Parenteral Nutrition in Pediatric Respiratory Failure|Supplemental Parenteral Nutrition in Pediatric Respiratory Failure|Recruiting||Phase 2|80|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-11 01:19:38.421687|2017-10-11 01:19:38.421687
NCT01937871|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-05-25|2016-12-14||September 2013||2013-09-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||All randomized participants.|A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multicenter Study to Evaluate the Efficacy and Safety of Tadalafil Once-Daily Dosing for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia and Erectile Dysfunction|Completed||Phase 3|909|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 01:19:38.589668|2017-10-11 01:19:38.589668
NCT01937858|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-04-05|||July 2012||2012-07-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Observational|||The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure|The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure|Unknown status|Recruiting|N/A|80|Anticipated|King Abdullah International Medical Research Center|||3||f||||f||||||||||2017-10-11 01:19:40.279674|2017-10-11 01:19:40.279674
NCT01937845|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-03-01|||August 2006||2006-08-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Observational|||Evaluating the Health Outcomes of the Joslin Why WAIT? Program|Evaluating the Health Outcomes of the Joslin Why WAIT? Program (Weight Achievement & Intensive Treatment Program)|Active, not recruiting||N/A|110|Actual|Joslin Diabetes Center|||1||f||||f|f|f||||||No||2017-10-11 01:19:40.397122|2017-10-11 01:19:40.397122
NCT01937832|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-04|||October 2013||2013-10-01|September 2013|2013-09-01||||October 2015|Anticipated|2015-10-01||Interventional|||A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia|A Phase III Study to Evaluate the Efficacy and Safety of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia|Unknown status|Not yet recruiting|Phase 3|540|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-11 01:19:40.609722|2017-10-11 01:19:40.609722
NCT01937819|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-04|||September 2013||2013-09-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|BPBUSA||Patients Judging Bowel Preparation by Using SMARTPHONE Application|Patients Judging Dose Adjustment of Bowel Preparation Solution for Bowel Preparation by Using SMARTPHONE Application: A Pilot Study|Unknown status|Not yet recruiting|N/A|60|Anticipated|Inje University||2|||f||||f||||||||||2017-10-11 01:19:40.726694|2017-10-11 01:19:40.726694
NCT01937806|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-03-12|||October 2013||2013-10-01|March 2014|2014-03-01|January 2016|Anticipated|2016-01-01|July 2015|Anticipated|2015-07-01||Interventional|||Phase 3 Study of Besifovir|A Phase Ⅲ, Multi-center, Randomized, Double-blinded, Parallel Study to Assess the Antiviral Activity and Safety of Besifovir 150 mg Compared to Tenofovir 300 mg in Chronic Hepatitis B Patients for 48 Weeks|Unknown status|Recruiting|Phase 3|188|Anticipated|IlDong Pharmaceutical Co Ltd||2|||f||||f||||||||||2017-10-11 01:19:40.852307|2017-10-11 01:19:40.852307
NCT01937793|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-04-16|||January 2013||2013-01-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy|Swallowing Exercises for Patients With Nasopharyngeal Cancer After Radiation Therapy|Completed||N/A|16|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:19:41.139952|2017-10-11 01:19:41.139952
NCT01937780|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-09-04|||August 2013||2013-08-01|September 2013|2013-09-01||||September 2021|Anticipated|2021-09-01||Observational|ANCARAD||Anal Cancer Radiotherapy Study|Anal Cancer Radiotherapy - Prospective Study of Treatment Outcome, Patient-Reported Outcomes, Utility of Imaging and Biomarkers, and Cancer Survivorship|Recruiting||N/A|75|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Tissue and blood specimens   "|||2017-10-11 01:19:41.255189|2017-10-11 01:19:41.255189
NCT01937767|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2014-02-11|||August 2013||2013-08-01|February 2014|2014-02-01||||February 2014|Actual|2014-02-01||Interventional|||Remimazolam Phase II Cardiac Anesthesia Study|A Randomized, Single-blind Phase II Study Evaluating the Efficacy, Safety and Pharmacokinetics of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the PACU/ICU|Completed||Phase 2|90|Actual|Paion UK Ltd.||3|||f||||f||||||||||2017-10-11 01:19:41.371346|2017-10-11 01:19:41.371346
NCT01937754|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-04|||January 2013||2013-01-01|September 2013|2013-09-01||||September 2013|Anticipated|2013-09-01||Interventional|||Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults|Study of the Effects of an Oral Nitric Oxide Supplement on Functional Capacity and Blood Pressure in Healthy Adults With Prehypertension|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|Neogenis Laboratories||2|||f||||||||||||||2017-10-11 01:19:41.490071|2017-10-11 01:19:41.490071
NCT01937728|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-12-28|||March 2010||2010-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)|A Randomized, Multicenter, Open Label Study Evaluating the Efficacy and Safety of Tailored Regimens With Peginterferon Alfa-2a Plus Ribavirin According Viral Kinetics for Genotype 1 Chronic Hepatitis C Patients|Completed||Phase 4|542|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||6|||f||||t||||||||||2017-10-11 01:19:41.578877|2017-10-11 01:19:41.578877
NCT01937715|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-07-08|2016-07-08|2015-12-15|February 2014||2014-02-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||The baseline analysis population included all participants who received at least 1 dose of study treatment.|A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer|An Open-Label, Multi-Center, Randomized Phase 1b/2 Study Of PF-05212384 Plus 5-Fluorouracil-Leucovorin-Irinotecan (FOLFIRI) Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer|Terminated||Phase 1/Phase 2|18|Actual|Pfizer|As this study was terminated due to Pfizer portfolio prioritization prior to the Phase 2 portion, there are no efficacy evaluations for Phase 2.|2||"B2151007 was prematurely discontinued due to Pfizer's change in prioritization for the   portfolio and is not due to any safety concerns or regulatory interaction"|f||||f||||||||||2017-10-11 01:19:41.753521|2017-10-11 01:19:41.753521
NCT01937702|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-12-29|||April 2014||2014-04-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain|A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain|Completed||Phase 1|80|Actual|Profil Institut für Stoffwechselforschung GmbH||1|||f||||f||||||||||2017-10-11 01:19:44.548219|2017-10-11 01:19:44.548219
NCT01937689|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-06-07|||January 2013||2013-01-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer|A Phase I Study of Pyrotinib in Patients With HER2 Positive Advanced Breast Cancer|Active, not recruiting||Phase 1|40|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||||2017-10-11 01:19:44.614285|2017-10-11 01:19:44.614285
NCT01937676|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-09-03|||September 2013||2013-09-01|September 2016|2016-09-01||||April 2014|Actual|2014-04-01||Observational|||LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting|LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting|Completed||N/A|1250|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 01:19:44.678863|2017-10-11 01:19:44.678863
NCT01937663|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-11-11||||||November 2014|2014-11-01||||January 2014|Actual|2014-01-01||Interventional|||A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation||Completed||Phase 2|||Kissei Pharmaceutical Co., Ltd.||4|||f||||||||||||||2017-10-11 01:19:44.734059|2017-10-11 01:19:44.734059
NCT01937637|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-07-20|||July 2013||2013-07-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Improving Management of Breathlessness in Patients With Lung Cancer|Improving Management of Breathlessness in Patients With Lung Cancer|Completed||N/A|32|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:19:44.86422|2017-10-11 01:19:44.86422
NCT01937611|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2013-09-07|||March 2013||2013-03-01|September 2013|2013-09-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Intramuscular Dexmedetomidine as Premedication|Comparison of Dexmedetomidine and Midazolam as Intramuscular Premedication for Suspension Laryngoscopy|Unknown status|Recruiting|Phase 4|40|Anticipated|Guangzhou First People's Hospital||2|||f||||t||||||||||2017-10-11 01:19:45.016075|2017-10-11 01:19:45.016075
NCT01937598|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-12-07|2015-07-02||August 2013||2013-08-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|April 2014|Actual|2014-04-01||Interventional|||Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D|Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin|Completed||Phase 3|16|Actual|Diabeteszentrum Bad Lauterberg im Harz|Results may not be interpretable for combinations of other DPP-4 Inhibitors than sitagliptin in combination with other (especially short-acting) GLP-1 receptor agonists|2|||f||||f||||||||Undecided||2017-10-11 01:19:45.129419|2017-10-11 01:19:45.129419
NCT01937585|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-09-07|||August 2010||2010-08-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men|Evaluation of a Culturally Targeted, Personalized Mail-Home Brochure Directed to Partners of At-Risk Men to Facilitate Prostate Cancer Risk Assessment|Completed||N/A|231|Actual|Fox Chase Cancer Center||2|||f||||t||||||||||2017-10-11 01:19:45.658497|2017-10-11 01:19:45.658497
NCT01937572|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-04-06|||November 2011||2011-11-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Visionaire: A Prospective Study|Visionaire Versus Conventional Knee Arthroplasty: A Prospective Study|Recruiting||N/A|168|Anticipated|The Hawkins Foundation||2|||f||||t||||||||||2017-10-11 01:19:45.764996|2017-10-11 01:19:45.764996
NCT01937559|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-04-06|||April 2013||2013-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Topical Tranexamic Acid (TXA) in Joint Arthroplasty|Topical Application of Tranexamic Acid in Joint Arthroplasty|Recruiting||Phase 4|180|Anticipated|The Hawkins Foundation||2|||f||||t||||||||||2017-10-11 01:19:45.891693|2017-10-11 01:19:45.891693
NCT01937182|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-02-23|||September 2013|Actual|2013-09-01|December 2016|2016-12-01|December 19, 2016|Actual|2016-12-19|December 19, 2016|Actual|2016-12-19||Interventional|TALOS||The Efficacy of Citalopram Treatment in Acute Stroke|The Efficacy of Citalopram Treatment in Acute Stroke|Completed||Phase 2|642|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 01:19:51.588374|2017-10-11 01:19:51.588374
NCT01937533|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-09-14|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Observational|||Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer|Diffusion-weighted MRI at 3T Using an Endovaginal Coil: Evaluating the Prognostic Value of the Apparent Diffusion Coefficient Distribution in Stage 1 Cervical Tumours|Recruiting||N/A|225|Anticipated|Institute of Cancer Research, United Kingdom|||1||f||||f||||||||||2017-10-11 01:19:46.110579|2017-10-11 01:19:46.110579
NCT01937520|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-03-15|2015-12-02||July 2013||2013-07-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|July 2014|Actual|2014-07-01||Interventional||patients undergoing thyroid or parathyroid surgery under general anesthesia|Acupuncture for Reduction of Inflammation|Acupuncture for Reduction of Inflammation in Thyroid and Parathyroid Surgery: Randomized, Prospective Double Blind Pilot Clinical Trial|Completed||N/A|20|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||No|data is in results section|2017-10-11 01:19:46.212439|2017-10-11 01:19:46.212439
NCT01937494|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-02-20|||May 2013||2013-05-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Bronchial Hyperreactivity During Histamine Passive Exposure|Are Technicians Showing Bronchial Hyperreactivity Able to Safely Perform Bronchial Provocation Tests?|Completed||N/A|13|Actual|Centre Hospitalier Universitaire Saint Pierre||1|||f||||f||||||||||2017-10-11 01:19:47.033026|2017-10-11 01:19:47.033026
NCT01937481|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-02-13|||September 2010||2010-09-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Colorado LEAP Study: A Socioecological Approach to Obesity Prevention in Early Childhood|A Longitudinal Study to Assess if the Effectiveness of a Preschool Nutrition and Physical Activity Program is Sustained in Elementary School|Active, not recruiting||N/A|230|Anticipated|Colorado State University||2|||f||||f||||||||No||2017-10-11 01:19:47.117857|2017-10-11 01:19:47.117857
NCT01937468|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-07-06|||November 2013||2013-11-01|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease|A Phase I Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease|Recruiting||Phase 1|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:19:47.232904|2017-10-11 01:19:47.232904
NCT01937455|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-09-20|||September 2014||2014-09-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.|Safety and Immunogenicity Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.|Recruiting||Phase 1|24|Anticipated|International AIDS Vaccine Initiative||4|||f||||t||||||||||2017-10-11 01:19:47.337959|2017-10-11 01:19:47.337959
NCT01937442|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-05-02|||November 2013||2013-11-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma|A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of Thalidomide Following Multiple Oral Dosing in Subjects With Multiple Myeloma|Completed||Phase 1|7|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 01:19:47.450586|2017-10-11 01:19:47.450586
NCT01937429|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-06|||January 2013||2013-01-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|GRAND BLEU||Effectiveness of Instillation of Blue Water (Indigo Carmin®) for Colonoscopy|GRAND BLEU Study: Does the Colonoscopy With Instillation of Blue Water (Indigo Carmin® Dilute) Enable an Improved Rate of Adenoma Detection for Colonoscopy With Insufflation of Air?|Unknown status|Recruiting|Phase 3|1000|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:19:47.54759|2017-10-11 01:19:47.54759
NCT01937416|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-12-03|||January 2012||2012-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|September 2013|Actual|2013-09-01||Interventional|||Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia|Safety and Efficacy Investigation of Patients With Diabetic Lower Limb Ischemia by Transplantation of Autologous Bone Marrow Mononuclear Cells|Unknown status|Recruiting|Phase 1|10|Anticipated|Hebei Medical University||1|||f||||t||||||||||2017-10-11 01:19:47.644752|2017-10-11 01:19:47.644752
NCT01937403|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-05-04|||October 2009||2009-10-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Observational|||Sport Cord Test Following ACL Reconstruction|The Use of the Sport Cord Test as a Measure of Physical Performance Following Anterior Cruciate Ligament Reconstruction|Unknown status|Recruiting|N/A|200|Anticipated|The Hawkins Foundation|||1||f||||t||||||||||2017-10-11 01:19:47.727433|2017-10-11 01:19:47.727433
NCT01937390|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-06-09|||November 6, 2011|Actual|2011-11-06|June 2017|2017-06-01|October 22, 2016|Actual|2016-10-22|October 22, 2016|Actual|2016-10-22||Observational|||Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD)|Post-Marketing Observational Study of the Impact of Adherence to Treatment With Once-Daily Administered Long-Acting Bronchodilators (LABAs / LAMAs) on Patients Health Related Quality of Life in COPD Patients|Completed||N/A|645|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 01:19:47.810011|2017-10-11 01:19:47.810011
NCT01937377|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-08-25|||September 2, 2013|Actual|2013-09-02|August 2017|2017-08-01|January 14, 2020|Anticipated|2020-01-14|January 14, 2020|Anticipated|2020-01-14||Observational|||GLORIA-AF Registry Program (Phase II/III)|GLORIA-AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III-India and Switzerland)|Active, not recruiting||N/A|200|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 01:19:48.277319|2017-10-11 01:19:48.277319
NCT01937364|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-03-27|2016-11-12||November 2013||2013-11-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|BACLOFEN III||Preventing Alcohol Withdrawal With Oral Baclofen|Preventing Alcohol Withdrawal With Oral Baclofen: A Randomized, Placebo Controlled Trial|Terminated||Phase 2|17|Actual|Essentia Health||2||The enrollment in the study was too limited for meaningful data analysis.|f||||f||||||||No||2017-10-11 01:19:48.366587|2017-10-11 01:19:48.366587
NCT01937351|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2017-04-05|2017-04-05||July 2014|Actual|2014-07-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|VISION|The study consisted of Roll-In Cohort and a Primary Analysis Cohort. Up to 2 Roll-In subjects could be treated at each study site prior to initiation of enrollment in the Primary Analysis Cohort.Roll-In subjects were designed to provide the Investigator an opportunity to gain experience with the Pantheris System for learning curve purposes.|Evaluation of the Pantheris Atherectomy System|Evaluation of the Pantheris Optical Coherence Tomography Imaging Atherectomy System for Use in the Peripheral Vasculature|Active, not recruiting||N/A|162|Actual|Avinger, Inc.||1|||f||||t|f|t|f|f||||No||2017-10-11 01:19:48.751792|2017-10-11 01:19:48.751792
NCT01937338|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-05-06|||October 2013||2013-10-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge|A Double Blind, Randomised, Placebo-controlled, 2-period, Cross-over Study in Healthy Volunteers to Investigate the Effects of a Single Dose of Inhaled AZD7624 on White Blood Cells and Inflammatory Markers in Induced Sputum and Blood After Oral Inhalation of 45,000 Endotoxin Units Lipopolysaccharide (LPS)|Completed||Phase 1|60|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:19:49.421032|2017-10-11 01:19:49.421032
NCT01937325|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-07-21|||February 2014||2014-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||CPET in CF Patients With One G551D Mutation Taking VX770|Airway Infection, Inflammatory Markers and Exercise Capacity in Patients With Cystic Fibrosis and at Least One G551D Mutation Taking VX770 (Ivacaftor)|Active, not recruiting||Phase 4|20|Actual|The Alfred||2|||f||||f||||||||No||2017-10-11 01:19:49.515931|2017-10-11 01:19:49.515931
NCT01937312|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-07-06|2015-05-22||October 2013||2013-10-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||This analysis population includes all subjects who received study medication and completed at least 1 scheduled on-therapy visit (intent-to-treat).|Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue|Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue|Completed||Phase 4|282|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:19:49.604291|2017-10-11 01:19:49.604291
NCT01937299|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2015-04-29|2015-04-29||October 2013||2013-10-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||This analysis population includes all subjects who received study medication and completed at least 1 scheduled on-therapy study visit (intent-to-treat).|Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®|Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination As Adjunctive Therapy to Travoprost|Completed||Phase 4|307|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:19:49.984545|2017-10-11 01:19:49.984545
NCT01937286|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2013-09-04|||January 2002||2002-01-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Observational|||Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits|Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits|Completed||N/A|590|Actual|Ain Shams University|||1||f||||f||||||||||2017-10-11 01:19:50.328809|2017-10-11 01:19:50.328809
NCT01937273|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-04|||June 2013||2013-06-01|September 2013|2013-09-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01|8 Weeks|Observational [Patient Registry]|PANSOCRP||The Nutritional Status of Chemo-radiotherapy Patients|Prospective Analysis of the Nutritional Status of Chemo-radiotherapy Patients|Unknown status|Recruiting|N/A|50|Anticipated|Charles Darwin University|||1||f||||f||||||||||2017-10-11 01:19:50.403129|2017-10-11 01:19:50.403129
NCT01937260|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-04-07|2016-11-08||September 2013||2013-09-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects|An Open-label Study to Evaluate the Effect of Brodalumab on the Pharmacokinetics of Midazolam and Assess Single-Dose Brodalumab Pharmacokinetics in Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 1|31|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 01:19:50.488609|2017-10-11 01:19:50.488609
NCT01937247|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-01-13|||January 2016||2016-01-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Redesigned Process in the Operating Room|Redesigned Process in the Operating Room: Monitoring and Evaluating Success of Reducing Non Operative Time|Not yet recruiting||Phase 2|60|Anticipated|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-11 01:19:50.937459|2017-10-11 01:19:50.937459
NCT01937234|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2017-03-09|||July 2013||2013-07-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Use of an Antiemetic to Shorten the Length of Labor in Nulliparous Women|Use of an Antiemetic to Shorten the Length of Labor in Nulliparous Women, Exploring a Potential Role of an Old Drug|Completed||Phase 4|250|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 01:19:51.044127|2017-10-11 01:19:51.044127
NCT01937221|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-11-22|||September 2013||2013-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease|Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease|Active, not recruiting||N/A|60|Anticipated|Duke University|||3||f||||f||||||||||2017-10-11 01:19:51.1378|2017-10-11 01:19:51.1378
NCT01937208|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-09-03|||August 2013||2013-08-01|September 2013|2013-09-01|July 2017|Anticipated|2017-07-01|August 2015|Anticipated|2015-08-01||Interventional|||Comparable Study of Different Radiation Dose in Esophageal Carcinoma|A Prospective, Randomised Phase 3 Study of High-dose Versus Standard-dose Radiation of Inoperable Esophageal Carcinoma Treated With Concurrent Chemoradiation|Unknown status|Recruiting|Phase 3|300|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-11 01:19:51.222571|2017-10-11 01:19:51.222571
NCT01937195|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-03-09|2015-05-16||April 2013||2013-04-01|March 2017|2017-03-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional||Inpatients requiring IV therapy during hospital admission of > 24 hours.|AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)|A Prospective, Randomized, Controlled, Multicenter Comparison Between the AccuCath™ Intravenous Catheter System With Retractable Coiled Tip Guidewire and Conventional Peripheral Intravenous Catheters With a Vascular Access Team|Completed||N/A|95|Actual|C. R. Bard||1|||f||||f||||||||No||2017-10-11 01:19:51.32112|2017-10-11 01:19:51.32112
NCT01937169|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-12-17|||January 2014||2014-01-01|December 2013|2013-12-01||||January 2016|Anticipated|2016-01-01||Interventional|||Targeting Dopamine Therapy in RLS||Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||||2017-10-11 01:19:51.760029|2017-10-11 01:19:51.760029
NCT01937156|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2014-04-11|||August 2013||2013-08-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting|A Randomized, Active-control, Double-blind, Double-dummy, Parallel-group, Multi-center Study to Assess the Efficacy and Safety of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Moderately or Highly Emetogenic (ME or HE) Multi-day Chemotherapy|Completed||Phase 3|313|Actual|Solasia Pharma K.K.||2|||f||||f||||||||||2017-10-11 01:19:51.844633|2017-10-11 01:19:51.844633
NCT01937143|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-09-19|||October 2013||2013-10-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|August 2017|Anticipated|2017-08-01||Interventional|IIAP||A Hospital-based Postnatal Parent Education Intervention About Infant Immunizations|Immunizing Infants Against Pain: a Hospital-based Postnatal Parent Education Intervention About Infant Immunizations|Active, not recruiting||Phase 3|3420|Anticipated|University of Toronto||3|||f||||f||||||||||2017-10-11 01:19:51.914215|2017-10-11 01:19:51.914215
NCT01937130|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2016-03-28|2016-02-26||September 2013||2013-09-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional||Subjects with acute-on-Chronic liver failure (ACLF)|Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF|A Placebo-Controlled, Multicenter, Double-Blind, Randomized, Pharmacokinetic and Pharmacodynamic Trial of IDN-6556 in Subjects With Acute-on-Chronic Liver Failure|Terminated||Phase 2|23|Actual|Conatus Pharmaceuticals Inc.|Study was terminated early.|4||Data needs met|f||||t||||||||||2017-10-11 01:19:52.009012|2017-10-11 01:19:52.009012
NCT01937117|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-09-27|||January 2014||2014-01-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|August 15, 2017|Actual|2017-08-15||Interventional|||Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer|A Phase 2 Clinical Trial Assessing the Correlation of Early Changes in Standardized Uptake Value (SUV) on Positron Emission Tomography (PET) With Pathological Complete Response (pCR) to Pertuzumab and Trastuzumab in Patients With Primary Operable HER2-Positive Breast Cancer|Active, not recruiting||Phase 2|88|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:19:53.29509|2017-10-11 01:19:53.29509
NCT01937104|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-04|2014-10-28|||September 2013||2013-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ONSD||ONSD According to the Position During Laparoscopy|Comparison of Optic Nerve Sheath Diameter According to Position During Laparoscopy|Completed||N/A|60|Anticipated|Chosun University Hospital||2|||f||||t||||||||||2017-10-11 01:19:53.420766|2017-10-11 01:19:53.420766
NCT01937091|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-02-10|||August 2013||2013-08-01|April 2014|2014-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Determining the Barriers and Motivations to Clinical Trial Participation|Determining the Barriers and Motivations to Clinical Trial Participation|Completed||N/A|48|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-11 01:19:53.541968|2017-10-11 01:19:53.541968
NCT01937078|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2014-05-01|||April 2011||2011-04-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Famotidine for Levodopa-induced Dyskinesia in PD|An 'N-of-1' Study of the Histamine H@ Antagonist, Famotidine in Levodopa-induced Dyskinesia in Parkinson's Disease|Completed||Phase 2|7|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 01:19:53.619345|2017-10-11 01:19:53.619345
NCT01937065|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-09-03|||January 2012||2012-01-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|IP4||Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study||Unknown status|Active, not recruiting|N/A|1937360|Actual|University College, London|||1||f||||t||||||||||2017-10-11 01:19:53.703905|2017-10-11 01:19:53.703905
NCT01937052|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-05-02|||February 2012||2012-02-01|May 2017|2017-05-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database|Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database|Active, not recruiting||N/A|1000|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||Samples With DNA|"     Blood (for example: serum, plasma, and whole blood) and saliva samples   "|||2017-10-11 01:19:53.801829|2017-10-11 01:19:53.801829
NCT01937039|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-05-02|||April 2009||2009-04-01|May 2017|2017-05-01|January 2030|Anticipated|2030-01-01|January 2030|Anticipated|2030-01-01||Observational|||Johns Hopkins Breast Cancer Program Longitudinal Repository|Johns Hopkins Breast Cancer Program Longitudinal Repository|Recruiting||N/A|1000|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||3||f||||f||||||Samples With DNA|"     Blood for example: whole blood, serum, plasma, urine, and tissue samples   "|||2017-10-11 01:19:53.877321|2017-10-11 01:19:53.877321
NCT01937026|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-05-15|2017-03-10||September 2013||2013-09-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||All enrolled participants.|A Study of Baricitinib and Probenecid in Healthy Participants|A Study to Investigate the Potential Impact of Organic Anion Transporter 3 Inhibition by Probenecid on the Pharmacokinetics of Baricitinib (LY3009104) in Healthy Subjects|Completed||Phase 1|18|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:19:53.96776|2017-10-11 01:19:53.96776
NCT01937013|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-03-09|||September 2013||2013-09-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|IEMO||Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia|Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia|Recruiting||Phase 2|72|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||Undecided||2017-10-11 01:19:54.428064|2017-10-11 01:19:54.428064
NCT01937000|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-12-17|||August 2013||2013-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:19:54.554896|2017-10-11 01:19:54.554896
NCT01936064|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2016-10-29|||October 2016||2016-10-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients|A Prospective Phase II Randomized, Blinded Study to Demonstrate the Effectiveness of Jobelyn for the Treatment of Breast Cancer Patients.|Recruiting||Phase 1/Phase 2|60|Anticipated|Lagos State University||2|||f||||t||||||||||2017-10-11 01:19:54.605096|2017-10-11 01:19:54.605096
NCT01936896|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-01-15|2015-12-10||December 2013||2013-12-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|VCU-Alpha1RT||Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction|Alpha-1 Anti-Trypsin (AAT) to Quench the Acute Inflammatory Response in ST-segment Elevation Acute Myocardial Infarction|Completed||Phase 1/Phase 2|10|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-10-11 01:19:56.272415|2017-10-11 01:19:56.272415
NCT01936051|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-02|||February 2012||2012-02-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||Modeling Between Plasma Concentration and Serotonin Transporter Occupancy Induced by Escitalopram in Obsessive-compulsive Disorder(OCD) Patients|Modeling Between Plasma Concentration and Serotonin Transporter Occupancy Induced by Escitalopram in Obsessive-compulsive Disorder(OCD) Patients|Unknown status|Recruiting|N/A|12|Anticipated|Seoul National University Hospital|||1||f||||f||||||Samples With DNA|"     blood sample   "|||2017-10-11 01:19:54.74739|2017-10-11 01:19:54.74739
NCT01936038|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-24|2013-09-01|||June 2013||2013-06-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Upper Airway Toning for Improve the Compliance of CPAP|Effectiveness of Upper Airway Toning as Adjuvant Treatment in the Former Period of Adaptation of the Continuous Positive Airway Pressure|Unknown status|Recruiting|Phase 1|110|Anticipated|Fisiolistic||2|||f||||t||||||||||2017-10-11 01:19:54.846679|2017-10-11 01:19:54.846679
NCT01936025|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-11-03|||October 2013||2013-10-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|DXM2||A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test|A Phase IIa, Dose-finding, Double-blind, Placebo-controlled, Double-dummy, Randomized, Eightfold Cross-over Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test|Completed||Phase 2|34|Actual|Profil Institut für Stoffwechselforschung GmbH||8|||f||||f||||||||||2017-10-11 01:19:54.969643|2017-10-11 01:19:54.969643
NCT01936012|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2013-09-01|||February 2013||2013-02-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition|Bioequivalence Study of 10 mg Lisinopril Tablets (Lisinopril 10 mg) Produced by PT Dexa Medica in Comparison With The Innovator Tablets (Zestril® 10 mg, PT Boehringer Ingelheim Indonesia, Indonesia, Under License From Astra Zeneca UK Ltd.)|Completed||N/A|34|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 01:19:55.086783|2017-10-11 01:19:55.086783
NCT01935999|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-09-05|||June 2013||2013-06-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||One Piece Closed Pouch in Subjects With a Colostomy|A Single Center Study to Assess the Safety and Performance of a One Piece Closed Pouch in Subjects With a Colostomy|Completed||Phase 2|11|Actual|ConvaTec Inc.||1|||f||||f||||||||||2017-10-11 01:19:55.184421|2017-10-11 01:19:55.184421
NCT01935986|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-11-30|||August 2013||2013-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children|The Effect of a Probiotic on Protection Against Upper Respiratory Tract Infections in Children|Terminated||Phase 2|131|Actual|Probi AB||2||Due to bankruptcy of the CRO company|f||||||||||||||2017-10-11 01:19:55.281059|2017-10-11 01:19:55.281059
NCT01935973|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-09-11|||September 30, 2013|Actual|2013-09-30|September 2017|2017-09-01||||February 1, 2017|Actual|2017-02-01||Interventional|||Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Randomized Phase I Study With a Safety Lead-In to Assess the Antitumor Efficacy of the MEK Inhibitor Trametinib Alone or in Combination With GSK2141795, an AKT Inhibitor, in Patients With Recurrent or Persistent Endometrial Cancer NCT #01935973|Active, not recruiting||Phase 1|26|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 01:19:55.387443|2017-10-11 01:19:55.387443
NCT01936987|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-12-17|||August 2013||2013-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:19:55.571779|2017-10-11 01:19:55.571779
NCT01936961|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-06-23|||June 2013||2013-06-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|I-CREST||Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors|A Pilot Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors (I-CREST)|Withdrawn||N/A|0|Actual|Western Regional Medical Center||1||No patients enrolled|f||||f||||||||||2017-10-11 01:19:55.765428|2017-10-11 01:19:55.765428
NCT01936948|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-03-01|||April 2013||2013-04-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.|Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.|Recruiting||N/A|1020|Anticipated|White River Junction Veterans Affairs Medical Center||4|||f||||t||||||||||2017-10-11 01:19:55.858546|2017-10-11 01:19:55.858546
NCT01936935|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-03|||September 2012||2012-09-01|September 2013|2013-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Clinical Trial to Assess the Effects of Dairy on Insulin Sensitivity and β-Cell Function|A Randomized, Controlled, Crossover Trial to Assess the Effects of Dairy Intake on Insulin Sensitivity and β-Cell Function in Men and Women at Risk for Diabetes Who Are Habitual Consumers of High Sugar Beverages|Unknown status|Active, not recruiting|N/A|44|Anticipated|Provident Clinical Research||2|||f||||f||||||||||2017-10-11 01:19:55.962305|2017-10-11 01:19:55.962305
NCT01936922|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-08-13|||September 2013||2013-09-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Testing Whether Brief Use of a Virtual Reality Device Improves Gait|Testing Whether Brief Use of a Wearable Virtual Reality Device Improves Gait, Balance, and Confidence After Falls|Completed||Phase 1|24|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 01:19:56.078159|2017-10-11 01:19:56.078159
NCT01936883|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-08-04|||January 2014||2014-01-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Interventional|BrachyQOL||Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy|IMPROVING QUALITY OF LIFE AFTER OPTIMAL RADIOTHERAPY FOR INTERMEDIATE AND HIGH RISK PROSTATE CANCER: A Randomized Comparison of HDR Versus LDR BRACHYTHERAPY BOOST|Recruiting||N/A|200|Anticipated|British Columbia Cancer Agency||2|||f||||t||||||||||2017-10-11 01:19:56.441331|2017-10-11 01:19:56.441331
NCT01936870|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-02-22|2017-02-22||October 2013||2013-10-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational||A total of 2492 participants completed this study. Of the 2492 participants, 189 participants were excluded from the baseline analysis due to following reasons: no visit after treatment (176 participants), protocol violation (12 participants), and no drug administration (1 participant).|Drug Use Investigation for Toviaz|Drug Use Investigation For Toviaz|Completed||N/A|2521|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:19:56.556803|2017-10-11 01:19:56.556803
NCT01936857|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-06-02|||July 2015|Actual|2015-07-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO)|Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial (BRAVO)|Recruiting||Phase 4|450|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 01:19:56.847795|2017-10-11 01:19:56.847795
NCT01936844|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-03-31|2016-01-15||February 2014||2014-02-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF)|Interleukin-1 Blockade in Acute Decompensated Heart Failure|Completed||Phase 2/Phase 3|30|Actual|Virginia Commonwealth University||2|||f||||t||||||||No|Data may be available upon request|2017-10-11 01:19:56.939803|2017-10-11 01:19:56.939803
NCT01936831|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-02-28|||July 2014||2014-07-01|February 2017|2017-02-01|July 14, 2018|Anticipated|2018-07-14|June 30, 2018|Anticipated|2018-06-30||Interventional|||High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)|The Early Bactericidal Activity of High-Dose or Standard-Dose Isoniazid Among Adult Participants With Isoniazid-Resistant or Drug-Sensitive Tuberculosis|Recruiting||Phase 2|198|Anticipated|AIDS Clinical Trials Group||3|||f||||t||||||||||2017-10-11 01:19:57.385263|2017-10-11 01:19:57.385263
NCT01936818|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-10-21|||August 2013||2013-08-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen||Completed||N/A|21|Actual|ORA, Inc.|||1||f||||f||||||||||2017-10-11 01:19:57.483586|2017-10-11 01:19:57.483586
NCT01936805|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-09-02|||January 2008||2008-01-01|September 2013|2013-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|ROLOCO||ROsuvastatin LOading and Clinical Outcomes Trial||Completed||Phase 3|299|Actual|Yuksek Ihtisas Hospital||2|||f||||t||||||||||2017-10-11 01:19:57.539449|2017-10-11 01:19:57.539449
NCT01936792|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2015-04-17|||August 2013||2013-08-01|March 2015|2015-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01|3 Months|Observational [Patient Registry]|||Pathology in the Brain After mTBI - A Multimodal MRI Study|Pathology in the Brain After mTBI - A Multimodal MRI Study|Completed||N/A|60|Actual|University of Aarhus|||2||f||||t||||||||||2017-10-11 01:19:57.60845|2017-10-11 01:19:57.60845
NCT01936779|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-01-04|||September 2013||2013-09-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Understanding the Role of Dietary Fatty Acids on Liver Fat Metabolism in Humans|Investigating Intra-hepatic Fatty Acid Partitioning and Its Regulation in Man. Studies to Understand the Role of Dietary Nutrients in Liver Fat Metabolism in Relation to Obesity in Man.|Completed||N/A|40|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 01:19:57.69071|2017-10-11 01:19:57.69071
NCT01936766|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-08-15|||June 2013||2013-06-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|14 Days|Observational [Patient Registry]|DRIPICCO||Optimal Fluid Management in Adult Severe Malaria|Optimal Fluid Management in Adult Severe Malaria - Development of Renal Impairment and Pulmonary Edema in Complicated Malaria Under Conventional Fluid Strategy|Unknown status|Recruiting|N/A|120|Anticipated|University of Oxford|||1||f||||f||||||||||2017-10-11 01:19:57.776949|2017-10-11 01:19:57.776949
NCT01936753|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-03-22|||September 2012|Actual|2012-09-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|November 2016|Actual|2016-11-01||Interventional|MoMent||The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria|The Impact of Mentor Mother Programmes on PMTCT Service Uptake and Retention at Primary Healthcare Facilities in Nigeria|Active, not recruiting||N/A|497|Actual|Institute of Human Virology, Nigeria||2|||f||||t|f|f||||||No||2017-10-11 01:19:57.865102|2017-10-11 01:19:57.865102
NCT01936740|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-05|||June 2012||2012-06-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|October 2012|Actual|2012-10-01||Interventional|||Comparison of Two Phacoemulsification-methods: HF EasyTip 2.2mm vs. HF EasyTip 2.8mm|Comparison of Two Phacoemulsification-methods: HF EasyTip 2.2mm vs. HF EasyTip 2.8mm|Completed||N/A|50|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 01:19:57.947715|2017-10-11 01:19:57.947715
NCT01936727|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-05|||December 2011||2011-12-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Comparison of Two Phacoemulsification-methods: EasyTip 2.2mm vs. Infusion Assisted EasyTip 2.2mm|Comparison of Two Phacoemulsification-methods: EasyTip 2.2mm vs. Infusion Assisted EasyTip 2.2mm|Completed||N/A|50|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 01:19:58.019187|2017-10-11 01:19:58.019187
NCT01936714|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-04-09|||February 2013||2013-02-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of Two Phacoemulsification-methods: Low Fluidic EasyTip 2.2mm vs. High Fluidic EasyTip 2.2mm|Comparison of Two Phacoemulsification-methods: Low Fluidic EasyTip 2.2mm vs. High Fluidic EasyTip 2.2mm|Completed||N/A|50|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 01:19:58.091555|2017-10-11 01:19:58.091555
NCT01936701|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-05|||March 2011||2011-03-01|September 2013|2013-09-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Interventional|||Comparison of the Effect of Hydrophobic Acrylic and Silicone 3-piece IOLs on Posterior Capsule Opacification|Comparison of the Effect of Hydrophobic Acrylic and Silicone 3-piece IOLs on Posterior Capsule Opacification|Completed||N/A|50|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 01:19:58.163076|2017-10-11 01:19:58.163076
NCT01936506|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-03|||July 2010||2010-07-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Cognitive Training for Depression|Cognitive Training for Depression|Completed||Phase 1/Phase 2|21|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 01:20:02.053479|2017-10-11 01:20:02.053479
NCT01936688|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-07-02|||September 2013||2013-09-01|July 2015|2015-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)|A 28-Week, Phase 3, Randomized, Active Comparator and Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222 / MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis (Protocol No. MK-3222-012)|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-10-11 01:19:58.227472|2017-10-11 01:19:58.227472
NCT01936675|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-05-02|||July 2013||2013-07-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|MI-GENES||Myocardial Infarction Genes (MI-GENES) Study|Myocardial Infarction Genes (MI-GENES) Study - Using Genomic Data to Refine Risk Assessment for Heart Attack|Completed||N/A|216|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 01:19:58.330421|2017-10-11 01:19:58.330421
NCT01936662|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-04-25|2013-09-17||August 2011||2011-08-01|April 2016|2016-04-01|February 2013|Actual|2013-02-01|July 2012|Actual|2012-07-01||Interventional|||Endotracheal Tube Versus Laryngeal Mask Airway for Esophagogastroduodenoscopy|Endotracheal Intubation vs. Laryngeal Mask Airway for Esophagogastroduodenoscopy in Children|Completed||N/A|84|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 01:19:58.42889|2017-10-11 01:19:58.42889
NCT01936649|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-10-14|2015-01-14||August 2013||2013-08-01|October 2016|2016-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Safety population defined as all enrolled participants who received at least 1 administration of AdreView (Iobenguane I 123 Injection).|Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.|A Phase 4, Open-label Test-retest Study to Assess the Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView (Iobenguane I 123 Injection)|Completed||Phase 4|63|Actual|GE Healthcare||1|||f||||f||||||||||2017-10-11 01:19:58.662595|2017-10-11 01:19:58.662595
NCT01936636|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-11-03|||October 2013||2013-10-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01|4 Weeks|Observational [Patient Registry]|RELIEF||Observational Registry Study of Quality of Life When Treating BTcP With Abstral|Rapid Evaluation of Lifestyle, Independence, and Elimination of Breakthrough Cancer Pain With Freedom From Oral Discomfort Through the Use of Abstral® (Fentanyl) Sublingual Tablets|Completed||N/A|164|Actual|Galena Biopharma, Inc.|||1||f||||f||||||||||2017-10-11 01:19:58.867113|2017-10-11 01:19:58.867113
NCT01936623|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-04-19|2017-01-13||August 2013||2013-08-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Computerized Brief Intervention vs. Delayed Computerized Brief Intervention||Completed||N/A|80|Actual|Friends Research Institute, Inc.||2|||f||||f||||||||No||2017-10-11 01:20:00.695204|2017-10-11 01:20:00.695204
NCT01936610|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2013-09-05|||June 2010||2010-06-01|May 2010|2010-05-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||the Effect of Instructional Method on Decision Making||Completed||Phase 2/Phase 3|67|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:20:01.063812|2017-10-11 01:20:01.063812
NCT01936597|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2014-06-18|||September 2013||2013-09-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|TeleMacc||Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage|Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage During Training in Non-hospital Cardiac Cases.|Completed||N/A|210|Actual|University Hospital, Rouen||3|||f||||f||||||||||2017-10-11 01:20:01.144933|2017-10-11 01:20:01.144933
NCT01936584|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-09-17|||September 2013||2013-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|LIQUOR||Validation of Quality of Life Assessment After Laparoscopic TAPP and TEP Surgery of Inguinal Hernias Using EuraHS of Life Score and Carolinas Comfort Scale™|Validation of Quality of Life Assessment After Laparoscopic TAPP and TEP Surgery of Inguinal Hernias Using EuraHS of Life Score and Carolinas Comfort Scale™|Completed||N/A|101|Actual|University Hospital, Ghent|||2||f||||f||||||||||2017-10-11 01:20:01.232147|2017-10-11 01:20:01.232147
NCT01936571|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2014-04-10|||September 2013||2013-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Observational|||Usefulness of Blood Biomarkers for Overall Survival in NSCLC|Use of Blood Biomarkers to Predict Overall Survival for Non-Small-cell Lung Cancer (NSCLC) Patients Treated With (Chemo)Radiotherapy.|Completed||N/A|250|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-11 01:20:01.342994|2017-10-11 01:20:01.342994
NCT01936558|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-01-14|||January 2013||2013-01-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01|6 Months|Observational [Patient Registry]|||The Origin of Phantom Limb Sensation and Phantom Limb Pain in Amputees|The Origin of Phantom Limb Sensation and Phantom Limb Pain in Amputees|Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 01:20:01.43588|2017-10-11 01:20:01.43588
NCT01936545|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-07-22|||May 2011||2011-05-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Anesthetic Methods and Liver Transplantation|The Impact of Different Anesthetic Methods on Ischemia Reperfusion Injury Following Liver Transplantation|Unknown status|Recruiting|N/A|144|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:20:01.641038|2017-10-11 01:20:01.641038
NCT01936532|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-03-27|||November 12, 2014|Actual|2014-11-12|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|January 2019|Anticipated|2019-01-01||Interventional|IFM2013-06||Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)|Phase II Trial Studying the Efficacy of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone as Induction Prior to, and as Consolidation After High-dose Therapy With Peripheral Stem Cell Transplantation Followed by MLN9708 Maintenance in the Initial Management of Multiple Myeloma in Patients Younger Than 66 Years|Active, not recruiting||Phase 2|42|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 01:20:01.783001|2017-10-11 01:20:01.783001
NCT01936519|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-09-05|||August 2013||2013-08-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.|A Randomized Prospective Trial of Conversion to Everolimus Therapy From Calcineurin Inhibitor Based Maintenance Immunosuppression in Association With Mycophenolic Acid in Liver Transplantation: Examination of Impact on Long Term Renal Function.|Recruiting||N/A|24|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 01:20:01.92824|2017-10-11 01:20:01.92824
NCT01936493|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-03-23|||August 2009||2009-08-01|March 2017|2017-03-01|May 26, 2015|Actual|2015-05-26|May 2015|Actual|2015-05-01||Observational|||Biologic Predictors of Leiomyoma Treatment Outcomes|Biologic Predictors of Leiomyoma Treatment Outcomes|Completed||N/A|38|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Serum aliquots and genomic DNA samples will be collected, processed and stored in the     Biospecimen Accessioning Processing (BAP) lab at Mayo Clinic in Rochester, MN.   "|No||2017-10-11 01:20:02.149463|2017-10-11 01:20:02.149463
NCT01936480|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-06-15|||October 2013||2013-10-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|MOXIGEN||Genetics of QT Response to Moxifloxacin|Genetics of QT Response to Moxifloxacin|Enrolling by invitation||Phase 4|160|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:20:02.23992|2017-10-11 01:20:02.23992
NCT01936467|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-03-02|2016-08-20||January 2013||2013-01-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions|Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided|Completed||Phase 3|121|Actual|Johns Hopkins University|The endosonographers were not blinded to the procedure technique. A small possibility that cytotechnicians may have witnessed the technique. Cellularity of the specimens were not quantified. A 6 months follow-up may not detect all false negatives|2|||f||||t||||||||||2017-10-11 01:20:02.358268|2017-10-11 01:20:02.358268
NCT01936454|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-02-16|||July 2013||2013-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Observational|||Contraceptive Effectiveness of Sino-implant (II) in China|A Study to Evaluate the Contraceptive Effectiveness During the Third, Fourth and Fifth Year of Sino-implant (II) Use and the Pharmacokinetics Over Five Years of Use in Chinese Women|Completed||N/A|538|Actual|FHI 360|||4||f||||f||||||||Undecided||2017-10-11 01:20:03.463604|2017-10-11 01:20:03.463604
NCT01936441|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2015-10-21|||November 2013||2013-11-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MsFLASH-04||MsFLASH-04: Pilot Trial: Telephone Behavioral Therapy for Menopause-related Sleep Disturbance|Menopausal Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH) 04: A Pilot Trial of Telephone-Based Cognitive-Behavioral Therapy for Midlife Women With Menopause-related Sleep Disturbance|Completed||N/A|106|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-11 01:20:03.569735|2017-10-11 01:20:03.569735
NCT01936428|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-09-29|||January 2013||2013-01-01|September 2015|2015-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Prospective Study of the Perception of Palliative Care by Relatives of Patients Treated in Oncology|Prospective Study of the Perception of Palliative Care by Relatives of Patients Treated in Oncology|Completed||N/A|20|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 01:20:03.65959|2017-10-11 01:20:03.65959
NCT01936415|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-09-03|||May 2010||2010-05-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Importance of Different Implant Surfaces of the Tibial Component for Migration and Adaptive Bone Remodeling in Uncemented Total Knee Arthroplasty (Vanguard Versus Regenerex)|The Importance of Different Implant Surfaces of the Tibial Component for Migration and Adaptive Bone Remodeling in Uncemented Total Knee Arthroplasty (Vanguard Versus Regenerex)|Completed||Phase 4|60|Actual|Hillerod Hospital, Denmark||2|||f||||f||||||||||2017-10-11 01:20:03.71665|2017-10-11 01:20:03.71665
NCT01936402|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-03|||February 2013||2013-02-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||Instruction to Compress Chest Approximately 6-7cm for Healthcare Provider in Hospital|Novel Instruction to Perform Chest Compression Approximately 6-7cm for Healthcare Provider Improves Chest Compression Depth During Cardiopulmonary Resuscitation in Hospital.|Completed||N/A|66|Actual|Hanyang University||2|||f||||f||||||||||2017-10-11 01:20:03.785829|2017-10-11 01:20:03.785829
NCT01936389|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-04-23|2014-10-10||September 2013||2013-09-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ROCK||A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma|A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma|Completed||Phase 2|10|Actual|Glaucoma Associates of New York||2|||f||||||||||||||2017-10-11 01:20:03.856237|2017-10-11 01:20:03.856237
NCT01936376|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-01-23|||September 2012||2012-09-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers|A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers|Unknown status|Recruiting|N/A|150|Anticipated|Foundation for the National Institutes of Health|||2||f||||f||||||Samples Without DNA|"     urine and blood   "|||2017-10-11 01:20:04.120059|2017-10-11 01:20:04.120059
NCT01936363|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-09-25|2016-05-31||September 30, 2013|Actual|2013-09-30|September 2017|2017-09-01|November 30, 2019|Anticipated|2019-11-30|May 31, 2015|Actual|2015-05-31||Interventional||Intent-To Treat (ITT) analysis set included all subject who were randomized.|Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer|Phase II Randomized Double Blind Placebo Controlled Trial of Combination of Pimasertib With SAR245409 or of Pimasertib With SAR245409 Placebo in Subjects With Previously Treated Unresectable Low Grade Ovarian Cancer|Active, not recruiting||Phase 2|65|Actual|EMD Serono|An interim analysis for futility was introduced by IDMC recommendation and new subject enrollment was permanently discontinued as it would be futile to continue the trial as planned. Few participants who were enrolled are still ongoing treatment.|2|||f||||t||||||||||2017-10-11 01:20:04.347455|2017-10-11 01:20:04.347455
NCT01936350|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-11-06|||September 2013||2013-09-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Sildenafil Impact on Ventricular Function in Patients With Heart Failure|Sildenafil Impact on Ventricular Function in Patients With Heart Failure: Randomized Clinical Trial|Completed||Phase 2/Phase 3|24|Actual|Hospital Ana Nery||2|||f||||t||||||||||2017-10-11 01:20:05.372642|2017-10-11 01:20:05.372642
NCT01936142|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-07-06|||September 2013||2013-09-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||The Use of Renal Guard System in Patients Undergoing CRT Implantation|The Effect of Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During CRT Implantation|Withdrawn||N/A|0|Actual|Tel-Aviv Sourasky Medical Center||2||No suitable patient found|f||||f||||||||No||2017-10-11 01:20:09.300866|2017-10-11 01:20:09.300866
NCT01936337|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-08-11|||August 2013||2013-08-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients|A Multi-center, Double-blinded, Randomized, Placebo-controlled, Phase II Study to Evaluate the Safety, Tolerability and Efficacy of a Topical Application of DLX105 Onto Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris|Completed||Phase 2|59|Actual|Delenex Therapeutics AG||2|||f||||f||||||||||2017-10-11 01:20:05.474763|2017-10-11 01:20:05.474763
NCT01936324|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-01-19|||August 2013||2013-08-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel|A Study of the Safety, Tolerability and Preliminary Efficacy of DRM01B Topical Gel in Healthy Volunteers and Subjects With Acne Vulgaris|Completed||Phase 1/Phase 2|108|Actual|Dermira, Inc.||2|||f||||f||||||||||2017-10-11 01:20:05.55408|2017-10-11 01:20:05.55408
NCT01936311|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2014-09-18|||June 2013||2013-06-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Study of Screening Self-management Goals on Short Term Behavior Change|Study of Screening for Patients Self-selected Health Goal and Treatment Modality Prior to Primary Care Visit and the Effect on Short-term Behavior Change|Completed||N/A|167|Actual|Denver Health and Hospital Authority||2|||f||||f||||||||||2017-10-11 01:20:05.656748|2017-10-11 01:20:05.656748
NCT01936298|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-10-25|||September 2013||2013-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Robot-assisted Rehabilitation of Hand by Paralysis of the Upper Limb After Stroke|Robot-assisted Rehabilitation of Hand by Paralysis of the Upper Limb After Stroke|Completed||N/A|35|Anticipated|Habilita, Ospedale di Sarnico||2|||f||||t||||||||||2017-10-11 01:20:05.731957|2017-10-11 01:20:05.731957
NCT01936285|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-04-22|||July 2013||2013-07-01|April 2015|2015-04-01||||April 2015|Anticipated|2015-04-01||Interventional|||Colchicine in ST-elevation Myocardial Infarction|Study of Anti-inflammatory Treatment With Colchicine in the Acute Phase of ST-elevation Myocardial Infarction to Reduce Infarct Size|Unknown status|Recruiting|Phase 4|150|Anticipated|G.Gennimatas General Hospital||2|||f||||t||||||||||2017-10-11 01:20:05.831653|2017-10-11 01:20:05.831653
NCT01936272|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-03-15|||April 2013||2013-04-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|||Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants|Neurocognitive Outcomes and Changes in Brain and Cerebral Spinal Fluid (CSF) Volume After Treatment of Post-Infectious Hydrocephalus (PIH) in Ugandan Infants by Shunting Versus ETV/CPC|Active, not recruiting||Phase 3|100|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||No|IPD will not be shared with researchers outside of the study team.|2017-10-11 01:20:05.917662|2017-10-11 01:20:05.917662
NCT01936259|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-05-24|||August 2013||2013-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:20:05.987104|2017-10-11 01:20:05.987104
NCT01936246|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-07-05|||August 2012||2012-08-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|March 2014|Actual|2014-03-01||Interventional|||Protein Supplementation in Infants With Brain Injury|Protein Supplementation in Infants With Brain Injury|Completed||N/A|24|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 01:20:06.027457|2017-10-11 01:20:06.027457
NCT01936233|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2013-09-05|||August 2013||2013-08-01|August 2013|2013-08-01||||October 2015|Anticipated|2015-10-01||Interventional|||Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery||Unknown status|Recruiting|Phase 3|112|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 01:20:06.107153|2017-10-11 01:20:06.107153
NCT01936220|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2013-09-05|||September 1997||1997-09-01|September 2013|2013-09-01|February 2016|Anticipated|2016-02-01|February 2007|Actual|2007-02-01||Interventional|||Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial|Relapse Prevention in First Episode of Schizophrenia and Related Psychotic Disorders: a 5 Year Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||t||||||||||2017-10-11 01:20:06.191557|2017-10-11 01:20:06.191557
NCT01936207|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2014-12-10|||November 2014||2014-11-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Intensive Care - GLObal Study on Severe Acute Respiratory Infection|A Multi-centre, International 14-day Inception Cohort Study of Severe Acute Respiratory Infections on the Intensive Care Unit|Completed||N/A|800|Actual|European Society of Intensive Care Medicine|||1||f||||f||||||||||2017-10-11 01:20:06.292439|2017-10-11 01:20:06.292439
NCT01936194|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-09-15|||September 2013||2013-09-01|September 2016|2016-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis|The Effects of Polyunsaturated Fatty Acids on Allergic/Atopic Dermatitis|Withdrawn||N/A|0|Actual|Mead Johnson Nutrition||3||Investigators don't want to conduct this study as time is limited.|f||||f||||||||||2017-10-11 01:20:06.375569|2017-10-11 01:20:06.375569
NCT01936181|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-08-16|2016-07-13||August 2013||2013-08-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy|A Randomised, Double-blind, Parallel Group, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity of SB2 Compared to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 3|584|Actual|Samsung Bioepis Co., Ltd.||4|||f||||t||||||||||2017-10-11 01:20:06.546357|2017-10-11 01:20:06.546357
NCT01936168|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-02-22|||October 2012||2012-10-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|MARADONA||MOCA Versus RFA in the Treatment of Primary Great Saphenous Varicose Veins|Mechanochemical Endovenous Ablation (MOCA) Versus RADiofrequeNcy Ablation (RFA) in the Treatment of Primary Great Saphenous Varicose Veins: a Multicentre Randomized Trial|Active, not recruiting||N/A|460|Anticipated|Rijnstate Hospital||2|||f||||f||||||||Yes||2017-10-11 01:20:09.070862|2017-10-11 01:20:09.070862
NCT01936155|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-04-14|||August 2015||2015-08-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Does NMES Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels?|Does Neuromuscular Electrical Stimulation (NMES) Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels?|Unknown status|Not yet recruiting|N/A|30|Anticipated|National University of Ireland, Galway, Ireland||1|||f||||f||||||||||2017-10-11 01:20:09.181461|2017-10-11 01:20:09.181461
NCT01936129|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-09-04|||September 2010||2010-09-01|September 2013|2013-09-01||||October 2013|Anticipated|2013-10-01||Interventional|||Investigating the Neuroprotective Effect of Cop-1 (Copaxone) in Acute Primary Angle Closure|Investigating the Neuroprotective Effect of Cop-1 in Acute Primary Angle Closure|Unknown status|Recruiting|Phase 3|196|Anticipated|Singapore Eye Research Institute||2|||f||||t||||||||||2017-10-11 01:20:09.390445|2017-10-11 01:20:09.390445
NCT01936116|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2014-05-04|||May 2012||2012-05-01|February 2012|2012-02-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Optimal Balloon Catheter Placement During Sonohysterography|Pain Perception and Side Effects During Sonohysterography With Balloon Catheters: a Randomized Comparative Study of Cervical With Uterine Catheter Placement|Completed||Phase 4|300|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 01:20:09.492677|2017-10-11 01:20:09.492677
NCT01936103|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-09-02|||April 2012||2012-04-01|August 2013|2013-08-01|July 2014|Anticipated|2014-07-01|May 2014|Anticipated|2014-05-01||Interventional|||Effects of Intensive Statin Treatment on Left Ventricular Function|Effects of Intensive Statin Therapy on Left Ventricular Function for Patients With the First Acute Anterior Myocardial Infarction After Directly to Percutaneous Coronary Intervention.|Unknown status|Recruiting|Phase 4|120|Anticipated|Shenyang Northern Hospital||2|||f||||f||||||||||2017-10-11 01:20:09.595655|2017-10-11 01:20:09.595655
NCT01936090|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2017-02-13|||August 2013|Actual|2013-08-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma|Phase I/II Bortezomib, Melphalan and Low Dose TBI Conditioning for Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|11|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:20:09.707395|2017-10-11 01:20:09.707395
NCT01936077|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-28|2013-09-02|||June 2010||2010-06-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|OPTOMALH||Severe LH Suppressed Patients After Administration of a GnRH Antagonist|To Define the Individual Need of Exogenous LH During Ovarian Stimulation for Severe LH Suppressed Patients After Administration of a GnRH Antagonist|Completed||Phase 4|50|Actual|Assuta Hospital Systems||1|||f||||f||||||||||2017-10-11 01:20:09.828174|2017-10-11 01:20:09.828174
NCT01935960|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-12-22|||August 2013||2013-08-01|December 2016|2016-12-01||||October 2016|Actual|2016-10-01||Interventional|||Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers|A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 01:20:09.916508|2017-10-11 01:20:09.916508
NCT01935947|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2017-06-13|||May 2013||2013-05-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer|A Randomized Phase II Trial of Cytotoxic Chemotherapy With or Without Epigenetic Priming in Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|10|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-10-11 01:20:10.028506|2017-10-11 01:20:10.028506
NCT01935921|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-03|2016-10-12|||April 2013||2013-04-01|October 2016|2016-10-01||||October 2016|Anticipated|2016-10-01||Interventional|||Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer|A Phase Ib Trial of Concurrent Cetuximab (ERBITUX®) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOY®) in Locally Advanced Head and Neck Cancer|Active, not recruiting||Phase 1|18|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 01:20:10.51041|2017-10-11 01:20:10.51041
NCT01935908|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2013-09-01|||January 2014||2014-01-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|SPLASH - Pilot||Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study|Pilot Study of Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage|Unknown status|Not yet recruiting|Phase 4|36|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-10-11 01:20:10.630304|2017-10-11 01:20:10.630304
NCT01935895|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2013-09-01|||September 2010||2010-09-01|September 2013|2013-09-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Observational|||Exercise and Blood Pressure Reactivity|Combined Exercise Circuit Session Acutely Attenuates Stress-Induced Blood Pressure Reactivity in Healthy Adults|Completed||N/A|20|Actual|Universidade Federal do vale do São Francisco|||1||f||||t||||||||||2017-10-11 01:20:10.778711|2017-10-11 01:20:10.778711
NCT01935882|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-09-01|||September 2013||2013-09-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|LOPRIM||Low Dose Primaquine for Clearance of Gametocytes|A Double Blind Randomized Controlled Trial to Assess the Efficacy and Safety of Low Dose Primaquine for Clearance of Gametocytes in Asymptomatic Individuals Infected With P. Falciparum in Burkina Faso|Completed||Phase 2/Phase 3|360|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-10-11 01:20:10.856807|2017-10-11 01:20:10.856807
NCT01935869|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-07-17|||August 2013||2013-08-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100|Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100|Completed||Phase 1|224|Actual|LEO Pharma||3|||f||||f||||||||||2017-10-11 01:20:10.944577|2017-10-11 01:20:10.944577
NCT01935856|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2017-02-28|||August 2013||2013-08-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis|A Dose Escalation, Single and Multiple Dose, Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis|Completed||Phase 1/Phase 2|20|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-11 01:20:11.040593|2017-10-11 01:20:11.040593
NCT01935843|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2016-01-26|||September 2013||2013-09-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|CART-HER-2||Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors|Clinical Study of Chimeric HER-2 Antigen Receptor-modified T Cells in Chemotherapy Refractory HER-2 Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|10|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:20:11.131508|2017-10-11 01:20:11.131508
NCT01935830|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-06-07|||August 2013||2013-08-01|June 2017|2017-06-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||LAAM-HAART PET Imaging|Efavirenz and Ritonavir Influence on Human Brain Levo-acetylmethadol (LAAM) Disposition Assessed Using PET Imaging|Completed||Early Phase 1|10|Actual|Washington University School of Medicine||1|||f||||t|t|f||||||No||2017-10-11 01:20:11.255063|2017-10-11 01:20:11.255063
NCT01935817|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2013-09-04|||June 2010||2010-06-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV||Completed||Phase 3|64|Actual|University of Catania||2|||f||||||||||||||2017-10-11 01:20:11.365886|2017-10-11 01:20:11.365886
NCT01935804|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-06-16|||January 2009||2009-01-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Pioglitazone||Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes|Phase 1 Study of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes|Completed||Phase 2|440|Anticipated|King Abdulaziz University||2|||f||||t||||||||||2017-10-11 01:20:11.470833|2017-10-11 01:20:11.470833
NCT01935791|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-11-10|||July 2013||2013-07-01|February 2016|2016-02-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Investigating Brown Adipose Tissue Activation in Humans|Investigating Brown Adipose Tissue Activation in Humans|Active, not recruiting||N/A|25|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 01:20:11.586207|2017-10-11 01:20:11.586207
NCT01935778|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2017-07-13|||September 2013||2013-09-01|July 2017|2017-07-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV|A Phase 3, Open-Label, Randomized Study to Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxaliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer Patients at Stage IIIB and IV (M0) (Based on AJCC Ed. 6) Who Received Radical Resection|Recruiting||Phase 3|286|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 01:20:11.676838|2017-10-11 01:20:11.676838
NCT01935765|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2015-05-28|||September 2013||2013-09-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|DIASOM||Sleep Apnea in Type 1 Diabetes|Sleep Apnea in Type 1 Diabetes : Prevalence, Role of Glycemic Control and Autonomic Neuropathy|Unknown status|Recruiting|Early Phase 1|145|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:20:11.781049|2017-10-11 01:20:11.781049
NCT01935752|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-02|2016-10-17|||November 2011||2011-11-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|MeDyA||Pathophysiological Mechanisms of Fibromuscular Dysplasia|Pathophysiological Mechanisms of Fibromuscular Dysplasia|Completed||N/A|150|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 01:20:11.904848|2017-10-11 01:20:11.904848
NCT01935739|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-09-14|||June 2010||2010-06-01|September 2013|2013-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01|1 Year|Observational [Patient Registry]|||Discordant HER2/Neu Status of Breast Cancer.|Discordant HER2/Neu Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.|Completed||N/A|105|Actual|National Cancer Institute, Thailand|||2||f||||f||||||Samples With DNA|"     Paraffin embedded tissue blocks of primary breast tumor and axillary lymph nodes   "|||2017-10-11 01:20:11.99102|2017-10-11 01:20:11.99102
NCT01935726|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-31|2014-11-17|||August 2013||2013-08-01|August 2013|2013-08-01|January 2040|Anticipated|2040-01-01|January 2040|Anticipated|2040-01-01|20 Years|Observational [Patient Registry]|||Pulmonary Fibrosis Contact Registry|Pulmonary Fibrosis Contact Registry|Recruiting||N/A|50000|Anticipated|National Jewish Health|||1||f||||t||||||||||2017-10-11 01:20:12.058161|2017-10-11 01:20:12.058161
NCT01935713|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-05-03|||April 2012||2012-04-01|May 2017|2017-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|EZI||Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure|Novel Methods to Reduce Children's Secondhand Smoke Exposure I|Completed||N/A|89|Actual|University of Oklahoma||3|||f||||f||||||||||2017-10-11 01:20:12.135596|2017-10-11 01:20:12.135596
NCT01935700|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-24|2016-09-03|||August 2013||2013-08-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma|Evaluation the Potential of Colchicine for the Palliative Management of Hepatocellular Carcinoma Patients With Distant Metastasis or Large Vessel Invasion|Recruiting||Phase 2|60|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||||2017-10-11 01:20:12.211658|2017-10-11 01:20:12.211658
NCT01935687|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-03-17|||December 2012||2012-12-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|April 2014|Actual|2014-04-01||Interventional|FRM||Clinical Evaluation of Instrumented Wheel as Biomedical Device Quantifying the Displacement Efficiency|Clinical Evaluation of Instrumented Wheel of Wheelchair as Biomedical Device Quantifying the Displacement Efficiency|Completed||N/A|62|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:20:12.309181|2017-10-11 01:20:12.309181
NCT01935674|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2014-10-07|||September 2013||2013-09-01|September 2013|2013-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|SOS||Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels|Rosuvastatin Versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults|Completed||Phase 4|21|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 01:20:12.392523|2017-10-11 01:20:12.392523
NCT01935661|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-08-09|||September 2013||2013-09-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients.|A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients in EMEK MEDICAL CENTER Compare to Healthy Controls.|Enrolling by invitation||N/A|120|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-11 01:20:12.499187|2017-10-11 01:20:12.499187
NCT01935635|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2017-04-26|||January 2015||2015-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB|A Clinical Trial on Hepatitis B Vaccine Activated-DCs Combined With Peg-interferon or Nucleotide Analogs in Chronic Hepatitis B|Recruiting||Phase 1/Phase 2|450|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||6|||f||||t||||||||Undecided||2017-10-11 01:20:12.976852|2017-10-11 01:20:12.976852
NCT01935622|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-08-19|2014-06-20||July 2012||2012-07-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DOXY-HF|(No data analysis conducted. Insufficient enrollment)|Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy|Phase II Study of Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy|Terminated||Phase 2|10|Actual|Virginia Commonwealth University|(No data analysis conducted. Insufficient enrollment)|3||End of funding|f||||f||||||||||2017-10-11 01:20:13.129527|2017-10-11 01:20:13.129527
NCT01935609|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-07-19|||March 2013||2013-03-01|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Evaluation of a Skill-Building, Supportive, and Educational Intervention for Couples|Evaluation of a Skill-Building, Supportive, and Educational Intervention for Couples (a Research Project Within the Traumatic Brain Injury Model System Grant)|Recruiting||N/A|240|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 01:20:13.478987|2017-10-11 01:20:13.478987
NCT01935596|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-05-13|||May 2013||2013-05-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|ROPI-LEVO||Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%|Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%|Completed||Phase 4|50|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-11 01:20:13.60753|2017-10-11 01:20:13.60753
NCT01935583|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-10-05|||January 2013||2013-01-01|October 2017|2017-10-01|September 30, 2017|Actual|2017-09-30|October 2016|Actual|2016-10-01||Interventional|||Intervention to Promote Survivor Resilience and Adjustment: Efficacy Evaluation|Intervention to Promote Survivor Resilience and Adjustment: Efficacy Evaluation (a Research Project Within the Traumatic Brain Injury Model System Grant)|Completed||N/A|164|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 01:20:13.691921|2017-10-11 01:20:13.691921
NCT01935570|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-07-03|||September 2013||2013-09-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|BioChronoMag||Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg.|Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg.|Completed||Phase 1|17|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 01:20:13.787394|2017-10-11 01:20:13.787394
NCT01935557|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2016-04-13|||December 2012||2012-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|COHERE||Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation|Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation|Completed||Phase 3|296|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-11 01:20:13.894968|2017-10-11 01:20:13.894968
NCT01935544|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-12-03|||September 2013||2013-09-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effectiveness of Two Techniques in Injection Site Spotting for Botulinum Toxin Injections: Echography or Electro Stimulation.|Effectiveness of Two Techniques in Injection Site Spotting for Botulinum Toxin Injections: Echography or Electro Stimulation.|Recruiting||N/A|30|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:20:13.979958|2017-10-11 01:20:13.979958
NCT01935531|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-03-30|||June 2013||2013-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Effects of Topical Diclofenac on Tumor Metabolism|Prospective, Controlled and Monocentric Study to Evaluate the Effects of Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel on Tumor Metabolism in the Treatment of Actinic Keratoses in Immunocompetent and Immunocompromised Patients|Completed||Phase 4|38|Actual|University Hospital Regensburg||1|||f||||t||||||||||2017-10-11 01:20:14.20774|2017-10-11 01:20:14.20774
NCT01935518|ClinicalTrials.gov processed this data on October 10, 2017|2013-09-01|2013-09-05|||September 2013||2013-09-01|September 2013|2013-09-01|May 2015|Anticipated|2015-05-01|March 2015|Anticipated|2015-03-01||Interventional|||A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)|A Historical Placebo Controlled Screening Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)|Unknown status|Recruiting|Phase 2|10|Anticipated|Peking University Third Hospital||1|||f||||f||||||||||2017-10-11 01:20:14.33781|2017-10-11 01:20:14.33781
NCT01935505|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-09-04|||October 2008||2008-10-01|September 2013|2013-09-01|December 2018|Anticipated|2018-12-01|September 2013|Anticipated|2013-09-01||Observational|||Study on the Model of Smoking Cessation Intervention and Service Ability Improvement|Study on the Model of Smoking Cessation Intervention and Service Ability Improvement in General Hospital|Enrolling by invitation||N/A|2000|Anticipated|Chinese PLA General Hospital|||4||f||||t||||||||||2017-10-11 01:20:14.466409|2017-10-11 01:20:14.466409
NCT01935492|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-26|2017-05-18|||November 2010||2010-11-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|June 2017|Anticipated|2017-06-01||Interventional|Stop&Go||8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer|8 Continuous vs 8 Intermittent Cycles in First and Second Line Treatment of Patients With HER2/Neu Negative, Incurable, Metastatic or Unresectable Locally Advanced Breast Cancer.|Active, not recruiting||Phase 3|420|Anticipated|Borstkanker Onderzoek Groep||2|||f||||t||||||||Undecided||2017-10-11 01:20:14.577524|2017-10-11 01:20:14.577524
NCT01935479|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-02-13|||August 2013||2013-08-01|September 2013|2013-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase I Study of AK159 in Healthy Postmenopausal Women||Completed||Phase 1|170|Anticipated|Asahi Kasei Pharma Corporation||11|||f||||||||||||||2017-10-11 01:20:14.724137|2017-10-11 01:20:14.724137
NCT01935466|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-04-04|||July 2013||2013-07-01|April 2017|2017-04-01|July 2021|Anticipated|2021-07-01|December 2020|Anticipated|2020-12-01||Observational|PROBE-PIO||"Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy PROBE"|"Pioglitazone and Risk of Bladder Cancer in Patients With Type 2 Diabetes MellitusPROBE-PIOStudy"|Recruiting||N/A|6107|Anticipated|Postgraduate Institute of Medical Education and Research|||2||f||||f||||||||||2017-10-11 01:20:14.897251|2017-10-11 01:20:14.897251
NCT01935440|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-03-07|||November 1, 2012|Actual|2012-11-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|P&T||A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives|A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives|Recruiting||N/A|1000|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||Undecided||2017-10-11 01:20:15.141135|2017-10-11 01:20:15.141135
NCT01935427|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-03-04|||September 2013||2013-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume|Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume|Completed||N/A|42|Actual|Flashback Technologies|||1||f||||t||||||||||2017-10-11 01:20:15.256854|2017-10-11 01:20:15.256854
NCT01935414|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-04-12|||August 2013||2013-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study|A Multicentre Randomised Controlled Trial Comparing the Incidence of Asymptomatic and Symptomatic Deep Vein Thrombosis Between the gekoTM Device and Thromboembolism Deterrent Stockings in Patients Recovering From Total Hip Replacement Surgery|Recruiting||N/A|40|Anticipated|Firstkind Ltd||2|||f||||f||||||||||2017-10-11 01:20:15.354729|2017-10-11 01:20:15.354729
NCT01935401|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2014-10-06|||June 2011||2011-06-01|October 2014|2014-10-01||||September 2014|Actual|2014-09-01||Observational|||Self-regulatory Control and Eating: A Neuroimaging Study of Bulimia Nervosa|Self-regulatory Control and Eating: A Neuroimaging Study of Bulimia Nervosa|Completed||N/A|47|Actual|Drexel University|||2||f||||f||||||||||2017-10-11 01:20:15.479163|2017-10-11 01:20:15.479163
NCT01935388|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-10-06|||June 2013||2013-06-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Common Canister Protocol for Inhaler Administration in Mechanically Ventilated Patients|Common Canister Protocol for Metered Dose Inhaler Administration in Mechanically Ventilated Patients|Completed||Phase 4|354|Actual|Barnes-Jewish Hospital||2|||f||||f||||||||||2017-10-11 01:20:15.591905|2017-10-11 01:20:15.591905
NCT01935375|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-24|2015-08-05|||July 2010||2010-07-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Multidisciplinary Model of Nurse Midwife|Multidisciplinary Model of Nurse Midwife Psychotherapy for Postpartum Depression|Completed||N/A|61|Actual|Drexel University||2|||f||||f||||||||||2017-10-11 01:20:15.714592|2017-10-11 01:20:15.714592
NCT01935362|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-03-31|||June 2013||2013-06-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Impact of Oranges on Cardiovascular Health|Bioavailability of Flavanones Compounds and Their Impact on Cardiovascular Health|Completed||Phase 1/Phase 2|25|Actual|University of Leeds||2|||f||||t||||||||||2017-10-11 01:20:15.845817|2017-10-11 01:20:15.845817
NCT01935349|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-09-05|||September 2010||2010-09-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|September 2016|Actual|2016-09-01||Observational|QoC PEP||Evaluation of Quality of Care - Patient Empowerment Programme, HA|Evaluation of Quality of Care - Patient Empowerment Programme, HA|Completed||N/A|2496|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 01:20:15.948771|2017-10-11 01:20:15.948771
NCT01935336|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-08-18|||May 21, 2014|Actual|2014-05-21|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers|A Phase II Study of Ponatinib in Cohorts of Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers|Recruiting||Phase 2|110|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 01:20:16.095463|2017-10-11 01:20:16.095463
NCT01935323|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-01-08|||February 2013||2013-02-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|HIIT-MAX||High Intensity Interval Versus Continuous Moderate Intensity Training: Maximizing the Benefits of Exercise in Overweight Adolescents|High Intensity Interval Versus Continuous Moderate Intensity Training: Maximizing the Benefits of Exercise in Overweight Adolescents.|Completed||N/A|30|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 01:20:16.23885|2017-10-11 01:20:16.23885
NCT01935310|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-30|||July 2010||2010-07-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|November 2010|Actual|2010-11-01||Interventional|||Photoaging Treatment With Imiquimod|Clinical and Histological Analysis of Photoaging Treatment With Imiquimod Cream 5%|Completed||N/A|17|Actual|CES University||1|||f||||t||||||||||2017-10-11 01:20:16.34704|2017-10-11 01:20:16.34704
NCT01935297|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2015-01-22|||June 2013||2013-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SPORT:TAVI||Exercise Training After Transcatheter Aortic Valve Implantation|Safety, Applicability and Outcome of Regular Exercise Training After Transcatheter Aortic Valve Implantation|Completed||N/A|30|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-11 01:20:16.466387|2017-10-11 01:20:16.466387
NCT01935271|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-11-08|||January 2013||2013-01-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Nutritional Supplementation and Muscle Health: A Pilot Study on Immune Function|Nutritional Supplementation and Muscle Health: A Pilot Study on Immune Function|Completed||N/A|12|Actual|Central Arkansas Veterans Healthcare System||2|||f||||f||||||||||2017-10-11 01:20:16.631638|2017-10-11 01:20:16.631638
NCT01935258|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-09-03|||April 2013||2013-04-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|PsySom||Psychosomatic Therapy, Feasibility and Cost Analysis|Psychosomatic Therapy, Feasibility and Cost Analysis, a Pilot Randomised Trial|Completed||N/A|42|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 01:20:16.725587|2017-10-11 01:20:16.725587
NCT01935245|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-01-08|||April 2013||2013-04-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|ECCTEG||Platelet Function in Minimal Extracorporeal Circulation in CABG|Platelet Function in Minimal Extracorporeal Circulation Versus Conventional Extracorporeal Circulation in Coronary Artery Bypass Grafting|Completed||N/A|40|Actual|Catharina Ziekenhuis Eindhoven||2|||f||||f||||||||||2017-10-11 01:20:16.836717|2017-10-11 01:20:16.836717
NCT01935232|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-05-16|||August 2013|Actual|2013-08-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|1 Day|Observational [Patient Registry]|||Bindex Ultrasonometer for Osteoporosis Diagnostics|Validation of Bindex Bone Ultrasonometer for Osteoporosis Diagnostics|Terminated||N/A|135|Actual|Bone Index Finland Ltd|||2|Institution not able to carry out research as of 2015|f||||f||||||||||2017-10-11 01:20:16.958169|2017-10-11 01:20:16.958169
NCT01935219|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-07-11|||August 2013||2013-08-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Improving Performance in Drivers With Mild Cognitive Impairment|Improving Performance in Drivers With Mild Cognitive Impairment: An RCT of Cognitive Training|Recruiting||N/A|128|Anticipated|Baycrest||3|||f||||f||||||||||2017-10-11 01:20:17.036103|2017-10-11 01:20:17.036103
NCT01935206|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-02-24|||June 2013||2013-06-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effect of High Dose Naloxone on Secondary Hyperalgesia|Effect of a High-dose Naloxone Infusion on Secondary Hyperalgesia After a First-degree Burn|Completed||Phase 1|15|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:20:17.162562|2017-10-11 01:20:17.162562
NCT01935180|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-04-17|2017-03-04||December 2010||2010-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|May 2012|Actual|2012-05-01||Interventional|CAP||Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)|Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)|Active, not recruiting||N/A|1148|Actual|White River Junction Veterans Affairs Medical Center||2|||f||||t||||||||||2017-10-11 01:20:17.344671|2017-10-11 01:20:17.344671
NCT01935167|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-02-16|||October 2013||2013-10-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|August 2014|Actual|2014-08-01||Interventional|||To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy|A Phase Ⅱ, Prospective, 24 Weeks, Double-blind, Placebo-controlled, Randomized, Multi-center Clinical Trial for the Evaluation of the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy|Completed||Phase 2|158|Actual|Dong Wha Pharmaceutical Co. Ltd.||3|||f||||f||||||||No||2017-10-11 01:20:17.983139|2017-10-11 01:20:17.983139
NCT01935154|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-11-04|||August 2012||2012-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy Study of Vx001 Vaccine in NSCLC Patients|Phase II Study of Vx001 Vaccine in HLA-A*0201 Positive Patients With TERT Positive Stage IV or Recurrent Stage I-III NSCLC|Active, not recruiting||Phase 2|221|Actual|Vaxon Biotech||2|||f||||f||||||||||2017-10-11 01:20:18.090831|2017-10-11 01:20:18.090831
NCT01935141|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-11-06|||January 2016||2016-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli|Efficacy Of Low(30 Ml) Versus Full Dose (100 Ml)Contrast CT Pulmonary Angiography Performed On 64 Multi-Detector CT In Detecting Emboli|Withdrawn||N/A|0|Actual|VA Greater Los Angeles Healthcare System||2||Staffing difficulties to run project.|f||||t||||||||||2017-10-11 01:20:18.314241|2017-10-11 01:20:18.314241
NCT01935128|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-03-10|||July 2013||2013-07-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction|A 24-month, Single Center, Pilot, Open Label, Controlled Trial to Evaluate the Efficacy and Safety of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Reduced Dose Tacrolimus/Everolimus in Adult Renal Transplant Recipients Following Campath® Induction and Steroid Avoidance|Recruiting||Phase 4|50|Anticipated|University of Toledo Health Science Campus||1|||f||||f||||||||||2017-10-11 01:20:18.423006|2017-10-11 01:20:18.423006
NCT01935115|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-09-12|||September 2013||2013-09-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy|A Prospective Randomized Double Blinded Control Trial Using Ketamine or Propofol Anesthesia for Electroconvulsive Therapy: Improving Treatment-Resistant Depression|Completed||Phase 4|27|Actual|University of Saskatchewan||2|||f||||t||||||||||2017-10-11 01:20:18.552322|2017-10-11 01:20:18.552322
NCT01935102|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2014-12-01|||December 2012||2012-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|BEVAGENE||Polymorphism Interaction to Predict Bevacizumab Efficacy|Polymorphism Interaction to Predict Bevacizumab Efficacy in Advanced Breast Cancer Patients: an Exploratory Retrospective Analysis|Completed||N/A|169|Actual|University of Pisa|||2||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:20:18.764231|2017-10-11 01:20:18.764231
NCT01935089|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-10-31|||November 2013||2013-11-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV|Pilot Study: Single Arm, Multi-site, Open-label Study to Assess the Effectiveness of Peg-IFN-a2b in Decreasing the Levels of Cell-associated Integrated Viral DNA in HIV Chronic Infection|Active, not recruiting||Phase 2|25|Anticipated|The Wistar Institute||1|||f||||t||||||||||2017-10-11 01:20:18.869352|2017-10-11 01:20:18.869352
NCT01935076|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-05-23|||January 2013||2013-01-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|MIFO||miRNA in Fetal Overgrowth|Placental miRNA (microRNA) Profile in Fetal Overgrowth Related to Maternal Obesity Study|Completed||N/A|82|Actual|University of Pennsylvania|||4||f||||f||||||Samples Without DNA|"     A small placental sample will be obtained after delivery in addition to cord blood     collection.   "|||2017-10-11 01:20:18.98465|2017-10-11 01:20:18.98465
NCT01935063|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-06-21|||November 2013||2013-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|CBCT-RCT||Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia|A Comparison of Cognitive-behavioral Couple Therapy and Lidocaine in the Treatment of Provoked Vestibulodynia: A Randomized Clinical Trial|Recruiting||Phase 4|224|Anticipated|Université de Montréal||2|||f||||f||||||||No||2017-10-11 01:20:19.102779|2017-10-11 01:20:19.102779
NCT01935050|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-10-28|||April 2013||2013-04-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Guided Self-Help for Depression in Parkinson's Disease|A Guided Cognitive-Behavioral Self-Help Treatment for Depression in Parkinson's Disease|Completed||N/A|34|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-11 01:20:19.307347|2017-10-11 01:20:19.307347
NCT01935024|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-11-04|||August 2013||2013-08-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Benefits of Exercise in Alzheimer's Disease|Assessing the Benefits of an Outpatient Aerobic Activity Program in Patients With Alzheimer's Disease|Recruiting||N/A|60|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 01:20:19.431781|2017-10-11 01:20:19.431781
NCT01935011|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-04-27|||August 2013||2013-08-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||DBS Frequency on Swallowing Function in Parkinson's Disease|Effects of the Stimulation Frequency of STN DBS on Swallowing Function in Patients With Parkinson's Disease|Completed||N/A|7|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 01:20:19.553819|2017-10-11 01:20:19.553819
NCT01934998|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-04-27|||July 2013||2013-07-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Parkinsonism in Spinocerebellar Ataxia Type 6|Characterization of the Parkinsonism and Other Non-ataxia Spectrum and Striatal Dopaminergic Degeneration in Spinocerebellar Ataxia Type 6|Completed||N/A|20|Actual|University of Chicago|||2||f||||f||||||||||2017-10-11 01:20:19.673376|2017-10-11 01:20:19.673376
NCT01934985|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-06-04|||March 2012||2012-03-01|June 2015|2015-06-01||||September 2015|Anticipated|2015-09-01||Observational|SPECT||Dynamic Cardiac SPECT Imaging|Dynamic Cardiac SPECT Imaging|Unknown status|Recruiting|N/A|160|Anticipated|University of California, San Francisco|||4||f||||f||||||||||2017-10-11 01:20:19.770264|2017-10-11 01:20:19.770264
NCT01934972|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-04-24|||March 2013|Actual|2013-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|DCS||A Randomized Controlled Trial of Cognitive Remediation and D-cycloserine for Individuals With Bipolar Disorder|A Randomized Controlled Trial of Cognitive Remediation and D-cycloserine for Individuals With Bipolar Disorder|Completed||Phase 3|30|Actual|University of Arizona||2|||f||||t||||||||||2017-10-11 01:20:19.860484|2017-10-11 01:20:19.860484
NCT01934959|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-29|||January 2008||2008-01-01|August 2013|2013-08-01||||January 2010|Actual|2010-01-01||Interventional|||A Trial on Probiotics in Preventing Hirschsprung's Disease Associated Entercolitis|A Prospective Multicenter Randomized Controlled Trial on Probiotics in Preventing Hirschsprung's Disease Associated Entercolitis|Completed||Early Phase 1|60|Actual|Tongji Hospital||1|||f||||t||||||||||2017-10-11 01:20:19.972544|2017-10-11 01:20:19.972544
NCT01934946|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2013-09-04|||September 2013||2013-09-01|September 2013|2013-09-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Rehabilitation Care for Hip Fracture|Effectiveness of Post Acute Rehabilitation Care for Hip Fracture|Unknown status|Recruiting|N/A|150|Anticipated|Taipei City Hospital||2|||f||||t||||||||||2017-10-11 01:20:20.061054|2017-10-11 01:20:20.061054
NCT01934933|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2016-09-12|||August 2013||2013-08-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Delaying Ossification and Improving Inflammation of Celebrex Plus/or Enbrel Treatment on Active Ankylosing Spondylitis|An Open Clinical Trial to Assess Efficacy for Delaying Ossification and Improving Inflammation of Celebrex Plus/or Enbrel Treatment on Active Ankylosing Spondylitis|Active, not recruiting||Phase 4|150|Actual|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 01:20:20.183984|2017-10-11 01:20:20.183984
NCT01934920|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-08-05|||August 2016||2016-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Identifying Patients With Unrecognized Treatable Diabetic Macular Edema|Identifying Patients With Unrecognized Treatable Diabetic Macular Edema|Recruiting||N/A|500|Anticipated|Elman Retina Group|||1||f||||f||||||||||2017-10-11 01:20:20.304235|2017-10-11 01:20:20.304235
NCT01934894|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-06-01|2017-02-01||May 2014|Actual|2014-05-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|February 2016|Actual|2016-02-01||Interventional||Includes participants that received at least one dose of study treatment.|Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases|Phase II Study With Lead-in Safety Cohort of Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases|Terminated||Phase 2|11|Actual|SCRI Development Innovations, LLC|Early termination of study resulted in small number of subjects analyzed.|1||Study was terminated due to lack of significant signal of efficacy|f||||f||||||||||2017-10-11 01:20:20.508578|2017-10-11 01:20:20.508578
NCT01934881|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-08-08|||September 2013||2013-09-01|August 2016|2016-08-01||||August 2018|Anticipated|2018-08-01||Interventional|||Voltage Adjustment Only Versus Combined Parameters Adjustment in PD Patients Treated With Bilateral STN DBS||Recruiting||N/A|150|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||||||||||||2017-10-11 01:20:20.972853|2017-10-11 01:20:20.972853
NCT01934868|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-08-15|||November 2013||2013-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prolotherapy Versus Epidural Steroid Injections (ESI) for Lumbar Pain Radiating to the Leg|A Comparison of the Long Term Outcomes of Prolotherapy Versus Interlaminar Epidural Steroid Injections (ESI) for Lumbar Pain Radiating to the Leg|Recruiting||Early Phase 1|160|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 01:20:21.060569|2017-10-11 01:20:21.060569
NCT01934855|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2015-10-09|||October 2013||2013-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Tumor Motion Management in Radiotherapy Using 4D-MRI|Evaluation of Tumor Motion Management Strategies in Radiotherapy Using 4D-MRI|Completed||N/A|32|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-11 01:20:21.163287|2017-10-11 01:20:21.163287
NCT01934842|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2014-11-24|||September 2013||2013-09-01|August 2013|2013-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate|A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick Using the SAFE-T-FILL Capillary Blood Collection System|Withdrawn||N/A|0|Actual|Seventh Sense Biosystems||2|||f||||f||||||||||2017-10-11 01:20:21.223697|2017-10-11 01:20:21.223697
NCT01934829|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2013-08-30|||July 2009||2009-07-01|August 2013|2013-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Urea Cream Treatment Sorafenib-Associated HSFR in HCC|Randomized Controlled Phase II Study of the Prophylactic Effect of Urea-Based Cream on Sorafenib-Associated Hand-Foot Skin Reactions in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 2|871|Actual|Chinese Anti-Cancer Association||2|||f||||f||||||||||2017-10-11 01:20:21.282157|2017-10-11 01:20:21.282157
NCT01934816|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-02-16|||June 2013|Actual|2013-06-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|January 2015|Actual|2015-01-01||Interventional|||Incretin and KATP Channels|Effects of KATP Channel Blockers on GLP-1 and Its Analogues' Mediated Microvascular Function|Terminated||N/A|2|Actual|Royal Devon and Exeter NHS Foundation Trust||3||Technical Issues with intervention|f||||t||||||||||2017-10-11 01:20:21.562161|2017-10-11 01:20:21.562161
NCT01934803|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-09-07|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|February 2017|Actual|2017-02-01||Interventional|ZINC||Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort|Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort|Active, not recruiting||N/A|250|Anticipated|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-11 01:20:21.639406|2017-10-11 01:20:21.639406
NCT01934790|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-04-13|2016-06-01||December 22, 2013|Actual|2013-12-22|April 2017|2017-04-01|April 12, 2017|Actual|2017-04-12|June 4, 2015|Actual|2015-06-04||Interventional|||Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases|A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks|Completed||Phase 1/Phase 2|45|Actual|Bayer||1|||f||||t||||||||||2017-10-11 01:20:21.749883|2017-10-11 01:20:21.749883
NCT01934777|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-01-13|||October 2013||2013-10-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis|Study of Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis|Completed||Phase 3|60|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||t||||||||||2017-10-11 01:20:22.400811|2017-10-11 01:20:22.400811
NCT01934764|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-03|||September 2013||2013-09-01|August 2013|2013-08-01||||September 2014|Anticipated|2014-09-01||Observational|||Identification of Correlations Between Reaction to Biotine and Autoimmune Diseases||Unknown status|Not yet recruiting|N/A|60|Anticipated|Ziv Hospital|||1||f||||||||||||||2017-10-11 01:20:22.49788|2017-10-11 01:20:22.49788
NCT01934751|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2014-12-10|||September 2013||2013-09-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|H-SOAP||Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction|Randomized Controlled Trial on the Effectiveness of Immediate Versus Delayed Access to Hospital-based Addiction Services|Unknown status|Recruiting|N/A|124|Anticipated|Women's College Hospital||2|||f||||f||||||||||2017-10-11 01:20:22.583876|2017-10-11 01:20:22.583876
NCT01934738|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2014-03-09|||October 2013||2013-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)|A Phase 1, Double Blind (3rd Party Open) Randomized, Placebo Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Doses of PF-06273340 in Healthy Subjects|Completed||Phase 1|52|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 01:20:22.714936|2017-10-11 01:20:22.714936
NCT01934725|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-11-22|||November 2013||2013-11-01|November 2016|2016-11-01|December 2028|Anticipated|2028-12-01|December 2028|Anticipated|2028-12-01||Observational|SECRETO||Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome|Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome (SECRETO)|Recruiting||N/A|1200|Anticipated|SECRETO Study Consortium|||2||f||||t||||||Samples With DNA|"     Patients at baseline:      4 x 2.7 mL sodium citrate tube, aliquoted in 10 x 300 µL cryovials; 1 x 5 mL PPACK sodium     citrate tube, aliquoted in 5 x 300 µL cryovials; 1 x 8 mL serum tube, aliquoted in 5 x 300 µL     cryovials; 1 x 9 mL EDTA tube #1, aliquoted in 10 x 300 µL cryovials; 1 x 9 mL EDTA tube #2,     full blood for DNA extraction.      Patients at 3-month visit (fasting): 4 x 2.7 mL sodium citrate tube, aliquoted in 10 x 300 µL     cryovials; 1 x 5 mL PPACK sodium citrate tube, aliquoted in 5 x 300 µL cryovials; 1 x 8 mL     serum tube, aliquoted in 5 x 300 µL cryovials; 1 x 9 mL EDTA tube, aliquoted in 10 x 300 µL     cryovials.      Control subjects:      4 x 2.7 mL sodium citrate tube, aliquoted in 10 x 300 µL cryovials; 1 x 5 mL PPACK sodium     citrate tube, aliquoted in 5 x 300 µL cryovials; 1 x 8 mL serum tube, aliquoted in 5 x 300 µL     cryovials; 1 x 9 mL EDTA tube #1, aliquoted in 10 x 300 µL cryovials; 1 x 9 mL EDTA tube #2,     full blood for DNA extraction.   "|Undecided||2017-10-11 01:20:22.826641|2017-10-11 01:20:22.826641
NCT01934712|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2017-06-08|||August 30, 2013|Actual|2013-08-30|June 2017|2017-06-01|January 28, 2014|Actual|2014-01-28|January 28, 2014|Actual|2014-01-28||Interventional|||A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes|Completed||Phase 1|50|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:20:24.88374|2017-10-11 01:20:24.88374
NCT01934699|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-09-22|||June 2011||2011-06-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods|Intraprocedural Determination of Myocardial Vitality Using Speckle Tracking Echocardiography Compared to Two-time MRI Diagnostics|Unknown status|Active, not recruiting|N/A|130|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 01:20:24.992169|2017-10-11 01:20:24.992169
NCT01934686|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2014-05-26|||September 2013||2013-09-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|DiabCare Asia||A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia|A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia|Completed||N/A|1862|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:20:25.089455|2017-10-11 01:20:25.089455
NCT01933789|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-01-07|||September 2013||2013-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ICSI||Improving Communication About Serious Illness|Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients|Completed||N/A|792|Actual|University of Washington||2|||f||||t||||||||No||2017-10-11 01:20:39.020367|2017-10-11 01:20:39.020367
NCT01934673|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2014-11-28|||September 2013||2013-09-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|DiabCare Asia||A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia|A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia|Completed||N/A|1668|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:20:25.174347|2017-10-11 01:20:25.174347
NCT01934660|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-06-30|||August 23, 2013||2013-08-23|May 31, 2017|2017-05-31|July 15, 2029|Anticipated|2029-07-15|July 15, 2029|Anticipated|2029-07-15||Observational|||Links Between Inflammation and Cardiometabolic Diseases|Inflammatory Characterization of Known or Possible Cardiovascular Diseases|Recruiting||N/A|270|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:20:25.261848|2017-10-11 01:20:25.261848
NCT01934647|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-01-22|||November 2013||2013-11-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)|A Non-randomized, Single-Panel, Open-Label Trial to Study the Safety, Tolerability and Pharmacodynamics of MK-8892 Acute Dosing in Subjects With Moderate to Severe Pulmonary Arterial Hypertension|Terminated||Phase 1|20|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 01:20:25.356727|2017-10-11 01:20:25.356727
NCT01934634|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-11-07|||March 2014||2014-03-01|November 2015|2015-11-01||||March 2016|Anticipated|2016-03-01||Interventional|||Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer|Phase I Trial of the Proapoptotic Agonist, LCL161, and Gemcitabine Plus Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer|Active, not recruiting||Phase 1|24|Anticipated|US Oncology Research||1|||f||||f||||||||||2017-10-11 01:20:25.431201|2017-10-11 01:20:25.431201
NCT01934621|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-08-14|||November 2013||2013-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|ADAPTS||Adapting Daily Activity Performance Through Strategy Training|Closing the Gap: Early Intervention for Cognitive Disability After Stroke|Recruiting||N/A|120|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:20:25.538984|2017-10-11 01:20:25.538984
NCT01934608|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-12-21|||September 2013||2013-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Effect of Synching Prescription Refills on Adherence|A Randomized Controlled Trial to Test a Synchronized Prescription Refill Program to Improve Medication Adherence|Completed||N/A|691|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:20:25.638532|2017-10-11 01:20:25.638532
NCT01934595|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-06-06|||September 2013||2013-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Optimal Protein Supplementation for Critically Ill Patients|Optimal Protein Supplementation for Critically Ill Patients|Withdrawn||N/A|0|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-11 01:20:25.721447|2017-10-11 01:20:25.721447
NCT01934582|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-09-06|2016-07-14||August 2013||2013-08-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Pharmacokinetic Substudy of the TDE-PH-304 Protocol|A Pharmacokinetic Substudy of Subjects Transitioning From Twice Daily to Three Times Daily Dosing of UT-15C SR (Treprostinil Diethanolamine) in the TDE-PH-304 Protocol|Completed||Phase 3|13|Actual|United Therapeutics||1|||f||||f||||||||||2017-10-11 01:20:25.893157|2017-10-11 01:20:25.893157
NCT01934569|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2014-01-15|||September 2013||2013-09-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Drug-Drug Interaction Study With PF-05089771|Evaluation Of The Effect Of PF-05089771 On The Metabolism Of Multiple Cytochrome P450 And OATP1B1 Transporter Substrates|Completed||Phase 1|17|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:20:26.442604|2017-10-11 01:20:26.442604
NCT01934556|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-04-03|||November 2013||2013-11-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2017|Actual|2017-04-01||Interventional|TREX-DME||A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema|A Phase I/II, Open Label, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of Intravitreal Injections of 0.3 mg Ranibizumab Given Monthly Compared to a TReat and EXtend Protocol in Patients With Diabetic Macular Edema|Active, not recruiting||Phase 1/Phase 2|150|Anticipated|Palmetto Retina Center, LLC||3|||f||||f||||||||||2017-10-11 01:20:26.532066|2017-10-11 01:20:26.532066
NCT01934543|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2016-09-07|||January 2014||2014-01-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|September 2015|Actual|2015-09-01||Interventional|PUFA||Effects of Polyunsaturated Fatty Acids on Intestinal Lipid Metabolism in Insulin-resistant Men|Differential Effects of Saturated and Polyunsaturated Fatty Acids on Chylomicron Secretion and Expression of Key Genes and Proteins That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With Insulin-resistance|Completed||N/A|30|Actual|Laval University||2|||f||||f||||||||||2017-10-11 01:20:26.651569|2017-10-11 01:20:26.651569
NCT01934530|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-02-09|||August 2009||2009-08-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||A Randomized Control Trial Testing Connective Tissue Grafts vs. Allograft on Dental Implants|Implant Associated Soft Tissue Defects in the Anterior Maxilla: A Randomized Control Trial Between Subepithelial Connective Tissue Graft and Acellular Dermal Matrix Allograft|Completed||N/A|13|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 01:20:26.737358|2017-10-11 01:20:26.737358
NCT01934517|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-01-17|2015-06-01||August 2013||2013-08-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|May 2014|Actual|2014-05-01||Observational|||Validity of Digital Models Obtained With iTero® and Lava Digital® in Comparison With Plaster Models.|Validity, Reliability and Reproducibility of Digital Models Obtained With iTero® (AlignTech) and Lava Digital® (3M) in Comparison With Plaster Models.|Completed||N/A|25|Actual|Université de Montréal|||1||f||||f||||||||||2017-10-11 01:20:26.836879|2017-10-11 01:20:26.836879
NCT01934504|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-04-13|2016-04-13||December 2013||2013-12-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|AAV|The baseline analysis population is defined as all participants who have undergone the Week 0 blood sample collection|Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)|Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)|Terminated||N/A|33|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Study termination due to slow enrollment, resulting in no outcome analyses.||4|Slow accrual|f||||t||||||Samples With DNA|"     -  peripheral blood mononuclear cells (PBMCs)        -  whole blood RNA        -  serum   "|||2017-10-11 01:20:27.084602|2017-10-11 01:20:27.084602
NCT01934478|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-10-11|||August 2013||2013-08-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer|Study on Human Epidermal Growth Factor 2 (Her2) Expression Changes in Human Breast Cancer After Radiotherapy|Unknown status|Recruiting|N/A|30|Anticipated|Qingdao Central Hospital|||1||f||||f||||||||||2017-10-11 01:20:27.909226|2017-10-11 01:20:27.909226
NCT01934465|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-30|2014-10-23|||February 2010||2010-02-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment|Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) Retrospectively and Prospectively as First Line Treatment for Patients With Advanced or Metastatic Non Small Cell Lung Cancer. Assessment of Toxicity, Compliance and Survival of Patients.|Completed||N/A|300|Actual|Hellenic Oncology Research Group|||1||f||||f||||||||||2017-10-11 01:20:27.987928|2017-10-11 01:20:27.987928
NCT01934452|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-09-28|||May 21, 2015|Actual|2015-05-21|September 2017|2017-09-01|April 15, 2020|Anticipated|2020-04-15|April 15, 2020|Anticipated|2020-04-15||Observational|APERCU||Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients|ANALYSE PROSPECTIVE DES REMISSIONS COMPLETES OBSERVEES SOUS SUNITINIB CHEZ DES PATIENTS ATTEINTS D'UN CANCER DU REIN METASTATIQUE (mRCC)|Recruiting||N/A|120|Anticipated|Pfizer|||2||f||||t||||||Samples Without DNA|"     whole blood and serum   "|||2017-10-11 01:20:28.090534|2017-10-11 01:20:28.090534
NCT01934439|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-02-23|||August 2013||2013-08-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|AMES||AMES Treatment of the Proximal Arm in Chronic Stroke|AMES Rehabilitation of the Proximal Arm in Severely Impaired Stroke Patients|Unknown status|Recruiting|Phase 1|10|Anticipated|Oregon Health and Science University||1|||f||||t||||||||||2017-10-11 01:20:28.205303|2017-10-11 01:20:28.205303
NCT01934426|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2014-04-22|||April 2013||2013-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Observational|||Identification of Admission High Risk Elderly|Identification of Admission High Risk Elderly From Multiple Cohorts: a Pilot Study|Completed||N/A|760|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:20:28.466742|2017-10-11 01:20:28.466742
NCT01934413|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-02-13|||September 2013||2013-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TPC||Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study|Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study|Completed||N/A|17|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:20:28.54665|2017-10-11 01:20:28.54665
NCT01934400|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2014-04-22|||April 2013||2013-04-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Observational|||Osteoporosis and Fall Prevention Education|Osteoporosis and Fall Prevention Education With High Risk Population Telephone Follow up Study|Completed||N/A|127|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:20:28.627998|2017-10-11 01:20:28.627998
NCT01934387|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-04-22|||March 2013||2013-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|||Geriatric Health Exam Osteoporosis Screening|Increasing Osteoporosis Awareness With Fracture Risk Assessments and Management Among Geriatric Health Examination Recipients at National Taiwan University Hospital|Completed||N/A|1319|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:20:28.704884|2017-10-11 01:20:28.704884
NCT01934374|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-29|||March 2009||2009-03-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Long-Term Effects of Task-Oriented Lower Extremity Strengthening Training|Long-Term Effects of Task-Oriented Lower Extremity Strengthening Training on Functional Connectivity of the Brain, Motor Functions, Physical Activity Level, and Quality of Life in Patients With Subacute Stroke|Completed||N/A|120|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:20:28.771598|2017-10-11 01:20:28.771598
NCT01934361|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-05-26|||February 28, 2014|Actual|2014-02-28|May 2017|2017-05-01|July 7, 2016|Actual|2016-07-07|July 7, 2016|Actual|2016-07-07||Interventional|||Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme|Phase Ib/II Multicenter Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 1/Phase 2|35|Actual|Novartis||5|||f||||f|t|f||||||No||2017-10-11 01:20:28.862067|2017-10-11 01:20:28.862067
NCT01934348|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-04-10|||June 2012||2012-06-01|August 2013|2013-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Psychological First Aid for Victims of Crime|Psychological First Aid for Victims of Crime|Completed||Phase 1/Phase 2|200|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:20:29.005096|2017-10-11 01:20:29.005096
NCT01934335|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-08-10|||October 2013||2013-10-01|August 2017|2017-08-01||||July 2018|Anticipated|2018-07-01||Interventional|||Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Effect of Vandetanib on Cellular Markers of Proliferation and Apoptosis in Invasive Breast Cancer|Recruiting||Phase 2|100|Anticipated|University of Iowa||2|||f||||t||||||||||2017-10-11 01:20:29.087873|2017-10-11 01:20:29.087873
NCT01934322|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-05-26|||June 2012||2012-06-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Case Management for Frequent Users of the Emergency Department|Case Management for Frequent Users of the Emergency Department: A Randomized Controlled Trial|Completed||N/A|250|Actual|University of Lausanne||2|||f||||f||||||||||2017-10-11 01:20:29.167179|2017-10-11 01:20:29.167179
NCT01934309|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-08-21|||September 2013||2013-09-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|TBTech||Do Clinical Decision-support Reminders for Medical Providers Improve the Do Clinical Decision-support Reminders for Medical Providers Improve the Prevalence of IPT Initiation Among HIV Positive Adults in Western Kenya?|Do Clinical Decision-support Reminders for Medical Providers Improve the Prevalence of IPT Initiation Among HIV Positive Adults in Western Kenya?|Completed||N/A|1000|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 01:20:29.243887|2017-10-11 01:20:29.243887
NCT01934296|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-05-19|||November 2013||2013-11-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|Activa PC+S||Chronic Effects of DBS in Parkinson's Disease and Dystonia|Chronic Effects of Deep Brain Stimulation on Cortical Local Field Potentials in Parkinson's Disease and Dystonia|Recruiting||Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:20:29.322771|2017-10-11 01:20:29.322771
NCT01934283|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-08-29|||October 2013||2013-10-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Intrabdominal Pressure in Small Bowel Obstruction as a Possible Predictor for the Need of Operation|Intrabdominal Pressure in Small Bowel Obstruction as a Possible Predictor for the Need of Operation|Unknown status|Not yet recruiting|N/A|125|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 01:20:29.405879|2017-10-11 01:20:29.405879
NCT01934270|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-09-20|||May 2014||2014-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Growth Hormone Secretion Following the Anaerobic Exercise|Growth Hormone Secretion Following the Anaerobic Exercise|Recruiting||N/A|40|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 01:20:29.492651|2017-10-11 01:20:29.492651
NCT01934257|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-29|||June 1994||1994-06-01|August 2013|2013-08-01|June 1996|Actual|1996-06-01|June 1996|Actual|1996-06-01||Interventional|||The Evaluation of Infant Formulas Fed to Infants With Common Feeding Problems|The Evaluation of Infant Formulas Fed to Infants With Common Feeding Problems|Completed||N/A|296|Actual|Mead Johnson Nutrition||3|||f||||f||||||||||2017-10-11 01:20:29.601977|2017-10-11 01:20:29.601977
NCT01934244|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-05-03|||November 2013||2013-11-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Observational|PANEL||Post Approval NovaSure Essure Labeling Study|Evaluation of the Safety of NovaSure in the Presence of Essure Following the Essure Confirmation Test (ECT) Post-Approval Study|Enrolling by invitation||N/A|318|Anticipated|Hologic, Inc.|||3||f||||f||||||||||2017-10-11 01:20:29.718693|2017-10-11 01:20:29.718693
NCT01934231|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-06-10|2014-05-29||August 30, 2013|Actual|2013-08-30|June 2017|2017-06-01|November 7, 2013|Actual|2013-11-07|November 7, 2013|Actual|2013-11-07||Interventional|||Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis|A Multicenter, Open-Label Study To Assess The Efficacy And Safety Of Potassium Clavulanate/Amoxicillin (CVA/AMPC 1:14 Combination) In The Treatment Of Children With Acute Bacterial Rhinosinusitis|Completed||Phase 3|27|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:20:29.842969|2017-10-11 01:20:29.842969
NCT01934218|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-06-02|2017-02-01||August 2013||2013-08-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Gel-One Treatment in Knee Osteoarthritis|A Multi-Center, Randomized, Double-Blind, Phosphate Buffered Saline-Controlled Study to Evaluate Effectiveness and Safety of a Single Intra-Articular Injection of Gel-One® for the Treatment of Osteoarthritis of the Knee With Open-Label Safety Extension|Completed||N/A|814|Actual|Seikagaku Corporation||2|||f||||f||||||||||2017-10-11 01:20:30.356264|2017-10-11 01:20:30.356264
NCT01934205|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-05-12|||September 25, 2013|Actual|2013-09-25|May 2017|2017-05-01|December 21, 2013|Actual|2013-12-21|December 21, 2013|Actual|2013-12-21||Interventional|||To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944|An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666)|Completed||Phase 1|22|Actual|GlaxoSmithKline||12|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:20:31.076855|2017-10-11 01:20:31.076855
NCT01934179|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-09-08|||October 2013||2013-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy|Pilot Study Assessing the Correlation Between Telomere Length and Chemotherapy- Related Toxicity Among Early Stage and Metastatic Colorectal Patients Over the Age of 70|Active, not recruiting||N/A|6|Actual|Fox Chase Cancer Center|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:20:31.358337|2017-10-11 01:20:31.358337
NCT01934166|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-11-07|||July 2013||2013-07-01|November 2016|2016-11-01||||August 2014|Actual|2014-08-01||Interventional|||Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects|An Interventional, Single-site, Open-label, Four-group, Single-dose Study Investigating the Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment (Mild, Moderate, or Severe) and in Healthy Subjects|Completed||Phase 1|32|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 01:20:31.456515|2017-10-11 01:20:31.456515
NCT01934153|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-05-12|||September 2, 2013|Actual|2013-09-02|May 2017|2017-05-01|February 19, 2014|Actual|2014-02-19|February 19, 2014|Actual|2014-02-19||Interventional|||Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects|Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects|Completed||Phase 1|18|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:20:31.558858|2017-10-11 01:20:31.558858
NCT01934140|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-09-29|||April 29, 2014|Actual|2014-04-29|September 2017|2017-09-01|September 29, 2018|Anticipated|2018-09-29|April 5, 2018|Anticipated|2018-04-05||Interventional|||Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination|A Phase Iiib, Open, Multi-center Study To Evaluate The Long-term Antibody Persistence At 6, 7, 8, 9 And 10 Years After The Administration Of One Dose Of Meningococcal Conjugate Vaccine Menacwy-tt Versus One Dose Of Meningococcal Polysaccharide Vaccine Mencevax(Registered) Acwy, And To Evaluate The Safety And Immunogenicity Of A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Primary Vaccination Of 11-55 Year Old Subjects With Menacwy-tt Or Mencevax (Registered) Acwy.|Recruiting||Phase 3|336|Anticipated|Pfizer||2|||f|||||f|f||||||||2017-10-11 01:20:31.665263|2017-10-11 01:20:31.665263
NCT01933776|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-02-04|2014-03-17||August 2013||2013-08-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China|Clinical Safety Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China|Completed||Phase 1|40|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:20:39.169915|2017-10-11 01:20:39.169915
NCT01934127|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-05-04|||August 26, 2013|Actual|2013-08-26|May 2017|2017-05-01|October 20, 2014|Actual|2014-10-20|November 1, 2013|Actual|2013-11-01||Interventional|||Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age|An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK2789869A and GSK2789868A Administered in Adults 21 to 64 Years of Age|Completed||Phase 1|427|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:20:31.78977|2017-10-11 01:20:31.78977
NCT01934114|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-04-26|||August 2010||2010-08-01|January 2015|2015-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo|NIR (Near Infrared Spectral Tomography)Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo.|Terminated||N/A|8|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||t||||||||||2017-10-11 01:20:31.948819|2017-10-11 01:20:31.948819
NCT01934101|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-05-12|||August 12, 2013|Actual|2013-08-12|May 2017|2017-05-01|May 28, 2014|Actual|2014-05-28|May 28, 2014|Actual|2014-05-28||Interventional|||Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers|A Phase 1 Double-blind, Randomised, Placebo-controlled, Dose Escalating Study to Assess the Safety and Tolerability of Single and Multiple Oral Doses of CHR-5154 and the Effect of the Fasted and Fed State on Pharmacokinetics of CHR-5154 and CHR-5426 in Healthy Male Volunteers|Terminated||Phase 1|64|Actual|GlaxoSmithKline||2||"Following the emergence of an unexpected pharmacodynamic effect, the sponsor has decided to   conclude the study early without fully achieving its objective"|f||||t||||||||||2017-10-11 01:20:32.016924|2017-10-11 01:20:32.016924
NCT01934088|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-09-28|||January 2014||2014-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy|Nurse Administered Propofol Sedation vs. Standard Therapy for Colonoscopy in Patients With IBD. A Randomised Controlled Study on Satisfaction and Adherence to Treatment Program.|Completed||Phase 4|130|Actual|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 01:20:32.09236|2017-10-11 01:20:32.09236
NCT01934075|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2016-08-08|||September 2013||2013-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Development of Mental Health Treatment for Obstetric Fistula Patients in Tanzania|Development of Mental Health Treatment for Obstetric Fistula Patients in Tanzania|Completed||N/A|60|Actual|Duke University||2|||f||||f||||||||Yes|Data will be made available upon request.|2017-10-11 01:20:32.193169|2017-10-11 01:20:32.193169
NCT01934062|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2015-05-14|||August 2013||2013-08-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Observational|||Induction Hypotension in Pediatric Population||Completed||N/A|200|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 01:20:32.281573|2017-10-11 01:20:32.281573
NCT01934049|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-09-07|||September 2013||2013-09-01|September 2013|2013-09-01|June 2014|Anticipated|2014-06-01|February 2014|Anticipated|2014-02-01||Interventional|||Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty|The Effect of Dexmedetomidine on Postoperative Recovery in Elderly Patients With Femoral Neck Fracture Undergoing Hip Hemi-arthroplasty|Unknown status|Recruiting|Phase 4|80|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 01:20:32.351509|2017-10-11 01:20:32.351509
NCT01934036|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2014-02-24|||August 2013||2013-08-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women|Efficacy and Safety of Obex®, a Nutritional Supplement, in Overweight or Obese Women|Completed||Phase 2/Phase 3|92|Actual|Catalysis SL||2|||f||||t||||||||||2017-10-11 01:20:32.451152|2017-10-11 01:20:32.451152
NCT01934023|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-08-24|||September 2013||2013-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|VAR-PAS||Effects of Varenicline on Plasticity in Schizophrenia|Effects of Varenicline on Cortical Neuroplasticity and Working Memory in Patients With Schizophrenia and Healthy Controls|Completed||Phase 2|24|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 01:20:32.545937|2017-10-11 01:20:32.545937
NCT01934010|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-01-26|||June 2014||2014-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|AMPACT1||AM-101 in the Treatment of Post-Acute Tinnitus 1|AM-101 in the Post-Acute Treatment of Peripheral Tinnitus 1 (AMPACT1) - an Open-Label Extension to the TACTT2 Study|Completed||Phase 3|260|Actual|Auris Medical, Inc.||1|||f||||f||||||||||2017-10-11 01:20:32.643836|2017-10-11 01:20:32.643836
NCT01933997|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2014-01-13|||August 2013||2013-08-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers|A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered as Repeated Doses to Healthy Volunteers|Completed||Phase 1|16|Actual|Alcobra Ltd.||1|||f||||f||||||||||2017-10-11 01:20:32.717944|2017-10-11 01:20:32.717944
NCT01933984|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-09|||August 2013||2013-08-01|September 2013|2013-09-01||||August 2016|Anticipated|2016-08-01||Interventional|||Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients|Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated Chronic Obstructive Pulmonary Disease Patients|Unknown status|Recruiting|N/A|100|Anticipated|Changhua Christian Hospital||2|||f||||t||||||||||2017-10-11 01:20:32.797908|2017-10-11 01:20:32.797908
NCT01933971|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-09-06|||June 2007||2007-06-01|September 2013|2013-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the Test Injectable Formulation BK0023 vs. Neupogen®|Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the BK0023 Injectable Formulation vs. Neupogen®|Completed||Phase 1|102|Actual|Bio-ker S.r.l.||3|||f||||f||||||||||2017-10-11 01:20:32.951954|2017-10-11 01:20:32.951954
NCT01933958|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-09-19|||September 4, 2013|Actual|2013-09-04|September 2017|2017-09-01|June 25, 2021|Anticipated|2021-06-25|June 25, 2021|Anticipated|2021-06-25||Observational|||Regorafenib Post-marketing Surveillance in Japan|Drug Use Investigation of Regorafenib/ STIVARGA for Gastrointestinal Stromal Tumor Progressed After Cancer Chemotherapy|Recruiting||N/A|135|Anticipated|Bayer|||1||f||||f||||||||||2017-10-11 01:20:33.067363|2017-10-11 01:20:33.067363
NCT01933945|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-08-15|||June 26, 2013|Actual|2013-06-26|August 2017|2017-08-01|October 22, 2017|Anticipated|2017-10-22|July 22, 2017|Actual|2017-07-22||Observational|OPTIMIS||Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib|OPTIMIS - Outcomes of HCC Patients Treated With TACE Followed or Not Followed by Sorafenib and the Influence of Timing to Initiate Sorafenib|Active, not recruiting||N/A|1701|Actual|Bayer|||2||f||||f||||||||||2017-10-11 01:20:33.150671|2017-10-11 01:20:33.150671
NCT01933932|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-08-28|2017-02-27||September 25, 2013|Actual|2013-09-25|June 2017|2017-06-01|December 29, 2017|Anticipated|2017-12-29|June 7, 2016|Actual|2016-06-07||Interventional|SELECT-1||Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC|A Phase III, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy and Safety of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Combination With Docetaxel, in Patients Receiving Second Line Treatment for KRAS Mutation-Positive Locally Advanced or Metastatic Non Small Cell Lung Cancer (Stage IIIB - IV) (SELECT 1)|Active, not recruiting||Phase 3|510|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 01:20:33.405146|2017-10-11 01:20:33.405146
NCT01933906|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2017-05-23|||August 2013||2013-08-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response|Phase 1 Study to Evaluate the Feasibility and Efficacy of the Addition of P1101 (PEG-Proline-Interferon Alpha-2b) to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response (MR 4.5 or BCR-ABL Transcripts Not Detectable)|Recruiting||Phase 1|12|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||||2017-10-11 01:20:36.673265|2017-10-11 01:20:36.673265
NCT01933893|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-29|2013-08-29|||October 2013||2013-10-01|August 2013|2013-08-01||||May 2014|Anticipated|2014-05-01|1 Year|Observational [Patient Registry]|||Follicular Versus Luteal Pipelle in Repeated Implantation Failure Patients||Unknown status|Not yet recruiting|N/A|100|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-10-11 01:20:36.806768|2017-10-11 01:20:36.806768
NCT01933880|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-09-16|2013-11-25||December 2009||2009-12-01|September 2014|2014-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||Full Analysis Set (FAS) includes all of the subjects who received at least one study drug therapy and at least one efficacy evaluation. FAS for normal group included all participants who received baseline assessment scale evaluation and had at least one endpoint assessment scale evaluation.|A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants|An Open, Self-Controlled, Prospective Study of Concerta on Cognitive Functions, Efficacy and Tolerance in the Pediatric Patients With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 4|194|Actual|Xian-Janssen Pharmaceutical Ltd.||2|||f||||f||||||||||2017-10-11 01:20:36.933987|2017-10-11 01:20:36.933987
NCT01933867|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-11-16|||September 2013||2013-09-01|June 2014|2014-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Water-aided Colonoscopy in Inflammatory Bowel Disease Patients|Water-aided Colonoscopy in Patients With Inflammatory Bowel Disease - a Single-center, Single-blinded Randomized Trial|Completed||N/A|92|Actual|Vitkovice Hospital||2|||f||||f||||||||||2017-10-11 01:20:38.297932|2017-10-11 01:20:38.297932
NCT01933854|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-08-28|||February 2013||2013-02-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|September 2013|Anticipated|2013-09-01|2 Days|Observational [Patient Registry]|iuemcp||Urinary Incontinence in Women From Amapa|ASSESSMENT OF URINARY INCONTINENCE IN WOMEN AT AMAPA STATE: COMPARISON BETWEEN URBAN AND RIVERSIDE POPULATIONS|Unknown status|Active, not recruiting|N/A|380|Anticipated|University of Sao Paulo General Hospital|||2||f||||f||||||None Retained|"     Urban group: women aged 20 years or over, who are not pregnant and are looking for a health     facility to perform womb cancer prevention exam in Macapa, the capital city of the Amapa     State.      Riverside Group: Women aged 20 years or over, who are not pregnant and are looking for a     health facility to perform womb cancer prevention exam on the Bailique Island.   "|||2017-10-11 01:20:38.398868|2017-10-11 01:20:38.398868
NCT01933841|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-07-05|||August 2013||2013-08-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery|The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery|Recruiting||N/A|400|Anticipated|Vanderbilt University Medical Center|||4||f||||t||||||||||2017-10-11 01:20:38.49602|2017-10-11 01:20:38.49602
NCT01933828|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-11-07|||June 2013||2013-06-01|August 2013|2013-08-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|SCOPE||Treatment of Early Stage Lung Cancer by VATS Versus OPEN Lobectomy|thoracoSCopic Versus OPen Lobectomy for Early Stage Lung Cancer: a Randomized Prospective Trial|Unknown status|Recruiting|N/A|176|Anticipated|Radboud University||3|||f||||t||||||||||2017-10-11 01:20:38.628933|2017-10-11 01:20:38.628933
NCT01933815|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-02-09|||August 2013||2013-08-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma|Phase 1/2 Dose-Escalation Study of TPI 287 in Combination With Bevacizumab Followed by Randomized Study of the Maximum Tolerated Dose of TPI 287 in Combination With Bevacizumab Versus Bevacizumab Alone in Adults With Recurrent Glioblastoma|Recruiting||Phase 1/Phase 2|92|Anticipated|Cortice Biosciences, Inc.||2|||f||||f||||||||||2017-10-11 01:20:38.742143|2017-10-11 01:20:38.742143
NCT01933750|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-04-04|||February 2013||2013-02-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Trial of the PresView Implant for the Improvement of Near Vision in Presbyopic Patients|A Prospective, Multicenter, Controlled Clinical Study of the PresVIEW Scleral Implant for the Improvement of Near Visual Acuity in Presbyopic Patients|Completed||N/A|20|Actual|Refocus Ocular Europe, B.V.||2|||f||||t||||||||||2017-10-11 01:20:39.666466|2017-10-11 01:20:39.666466
NCT01933737|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-30|||January 2012||2012-01-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Interventional|||Kinesio Taping Effect on Postural Balance in Elderly|Kinesio Taping Effect on Postural Balance in Elderly|Terminated||N/A|61|Actual|University of Franca||2||The collected data was finished|f||||f||||||||||2017-10-11 01:20:39.748434|2017-10-11 01:20:39.748434
NCT01933724|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-08-03|||February 2014||2014-02-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TAPIR||The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach|The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach|Recruiting||Phase 3|60|Anticipated|University of South Florida||2|||f||||t|t|f||||||||2017-10-11 01:20:39.846536|2017-10-11 01:20:39.846536
NCT01933711|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-05-11|||July 2002||2002-07-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma|Rituximab Maintenance Therapy Versus Observation in Aggressive CD20+ Lymphoma and Mantle Cell Lymphoma - a Prospective Randomized Phase III Trial|Active, not recruiting||Phase 3|328|Anticipated|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-11 01:20:40.016791|2017-10-11 01:20:40.016791
NCT01933698|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-28|||February 2005||2005-02-01|August 2013|2013-08-01|July 2005|Actual|2005-07-01|May 2005|Actual|2005-05-01||Interventional|||Bioequivalence of Two Commercial Amoxicillin Suspensions|Bioequivalence Study of Two Commercial Amoxicillin Suspension Formulations in Healthy Human Volunteers|Completed||Phase 4|25|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-11 01:20:40.139122|2017-10-11 01:20:40.139122
NCT01933672|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-08-03|2016-06-17||October 2013||2013-10-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||All participants who were randomized to 1 of the 6 treatment sequences (ABC, ACB, BAC, BCA, CAB, and CBA) of PF split dose (150+100 mg) (Treatment A), PF once daily (300 mg) (Treatment B) and sitagliptin 100 mg QD (Treatment C).|Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes|A Phase 1b, Randomized, Double-blind, Active Comparator Controlled, 3-period, Cross-over Study To Characterize The Pharmacodynamics And Tolerability Of Two Dosing Regimens Of Pf-04937319 In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin|Completed||Phase 1|33|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:20:40.43702|2017-10-11 01:20:40.43702
NCT01933659|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-05-12|||September 2013||2013-09-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Anti-H. Pylori Effect of Deep See Water|Anti-bacterial Effects of Ingesting Deep Sea Water in Subjects With H. Pylori Infection|Completed||Phase 3|54|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:20:42.082795|2017-10-11 01:20:42.082795
NCT01933646|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-01-06|||September 2013||2013-09-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China|Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China: Incidence, Case Fatality Rate and Serotype Distribution|Completed||N/A|10|Actual|Novartis|||1||f||||f||||||||||2017-10-11 01:20:42.19422|2017-10-11 01:20:42.19422
NCT01933633|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-12-09|||September 2013||2013-09-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Interventional|FertilEX||Improved Fertility After Exercise in Overweight/Obese Women|Study of Pregnancy Rate After Exercise Training Prior to Assisted Fertilisation in Overweight/Obese Women|Recruiting||N/A|140|Anticipated|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 01:20:42.305143|2017-10-11 01:20:42.305143
NCT01933620|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-07-11|||August 22, 2013||2013-08-22|June 27, 2017|2017-06-27|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Observational|||Study of the Human Microbiome in Clinical Center Patients|Studies of the Human Microbiome in Clinical Center Patients|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:20:42.449764|2017-10-11 01:20:42.449764
NCT01933607|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-04-14|||May 2014||2014-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TOPS||Post-market Study of the TOPS™ System|A Study to Evaluate the Safety and Effectiveness of the TOPS System|Recruiting||N/A|10|Anticipated|Premia Spine||1|||f||||f||||||||Undecided|May publish if enough enrollment|2017-10-11 01:20:42.56912|2017-10-11 01:20:42.56912
NCT01933594|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-09-11|||February 2014||2014-02-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load|A Phase I/II Study of Romidepsin in HIV-Infected Adults With Suppressed Viremia on Antiretroviral Therapy to Assess Safety, Tolerability, and Activation of HIV-1 Expression|Recruiting||Phase 1/Phase 2|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||t||||||||||2017-10-11 01:20:42.708151|2017-10-11 01:20:42.708151
NCT01933581|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-04-05|||October 2012|Actual|2012-10-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|ICON1||A Study to Improve Cardiovascular Outcomes in High Risk PatieNts With Acute Coronary Syndrome|ICON1: A Study to Improve Cardiovascular Outcomes in High Risk PatieNts With Acute Coronary Syndrome|Completed||N/A|300|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f||||||Samples With DNA|"     PBMCs   "|||2017-10-11 01:20:42.921229|2017-10-11 01:20:42.921229
NCT01933204|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-09-02|||September 2013||2013-09-01|August 2013|2013-08-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Acupuncture for Relieving Perimenopausal Symptoms|Acupuncture for Relieving Perimenopausal Symptoms: a Randomised Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|220|Anticipated|Chengdu University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 01:20:49.61619|2017-10-11 01:20:49.61619
NCT01933568|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-04-04|||February 2013||2013-02-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|N12HYB||Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.|Combined Stereotactic Radiotherapy and Conventional Fractionation in Stage II and III Non Small Cell Lung Cancer (NSCLC) With Peripheral Tumors Smaller Than 5 cm|Completed||Phase 1|15|Actual|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-11 01:20:43.015697|2017-10-11 01:20:43.015697
NCT01933555|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-08-28|||January 2013||2013-01-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Impact of Women's Empowerment Program for Abused Pregnant Women|Impact of Women's Empowerment Program for Abused Pregnant Women: A Randomized Controlled Trial|Completed||Phase 2|76|Actual|Macmillan Research Group UK||2|||f||||t||||||||||2017-10-11 01:20:43.13412|2017-10-11 01:20:43.13412
NCT01933542|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-09-16|||August 2013||2013-08-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery|The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery|Completed||Phase 4|110|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:20:43.207116|2017-10-11 01:20:43.207116
NCT01933529|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-09-02|||October 2013||2013-10-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|June 2014|Actual|2014-06-01||Interventional|||ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)|Effects of ARA 290, a Non-hematopoietic Erythropoietin Analogue, on Glucose Tolerance, Insulin Secretion, Insulin Sensitivity and Long-term Glucose Control in Individuals With Prediabetes and/or Drug-naive Type 2 Diabetes; a Phase II Study.|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:20:43.307631|2017-10-11 01:20:43.307631
NCT01933503|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-12-04|||October 2013||2013-10-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)|An Open Label, Randomized, Single Dose and Multiple Dose Trial to Assess the Pharmacokinetics of Obeticholic Acid (OCA)|Completed||Phase 1|24|Actual|Intercept Pharmaceuticals||3|||f||||t||||||||||2017-10-11 01:20:43.50554|2017-10-11 01:20:43.50554
NCT01933490|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-11-16|||August 2013||2013-08-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Post-Gastric Bypass Hypoglycemia|Prevention of Hypoglycemia in Patients With Post-Gastric Bypass Hyperinsulinemic Hypoglycemia|Completed||N/A|10|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-11 01:20:43.602321|2017-10-11 01:20:43.602321
NCT01933477|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-07-05|||March 2013||2013-03-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|July 2016|Actual|2016-07-01||Interventional|MCH-ART||Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study|Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study|Active, not recruiting||N/A|1554|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-11 01:20:43.695481|2017-10-11 01:20:43.695481
NCT01933464|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-28|||August 2013||2013-08-01|August 2013|2013-08-01||||February 2014|Anticipated|2014-02-01||Interventional|||An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema|An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:20:43.799895|2017-10-11 01:20:43.799895
NCT01933451|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-08-28|||March 2013||2013-03-01|March 2013|2013-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|PPV||Outcome Study of Restrictive vs. Liberal Intraoperative Fluid Management Guided by PPV in Esophagectomy|Postoperative Lung Function, Kidney Function, Inflammatory Response and Short-term Outcome After Esophagectomy and Reconstruction: Intraoperative Fluid Management Controlled With Lower and Higher Pulse Pressure Variation|Terminated||N/A|7|Actual|National Taiwan University Hospital||2||The grant for this study was not allowed.|f||||t||||||||||2017-10-11 01:20:43.908281|2017-10-11 01:20:43.908281
NCT01933438|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-07-24|||June 2013||2013-06-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Sup-ER Protocol RCT|Does Early Supination and External Rotation Repositioning in Children With Birth Related Brachial Plexus Injury Have Benefit? A Randomized Controlled Trial of the Sup-ER Protocol.|Terminated||N/A|2|Actual|University of British Columbia||2||"The study ended early after encountering logistics challenges and difficulties with site   recruitment."|f||||f||||||||||2017-10-11 01:20:44.00814|2017-10-11 01:20:44.00814
NCT01933425|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-03-27|2015-02-24||August 2013||2013-08-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Females|Optimizing Surgical Conditions During Gynecologic Laparoscopic Surgery With Deep Neuromuscular Blockade|Optimizing Surgical Conditions: Intraabdominal Distance During Gynecologic Laparoscopic Surgery With and Without Muscle Relaxation (The Measurement Study)|Completed||Phase 4|14|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 01:20:44.247395|2017-10-11 01:20:44.247395
NCT01933412|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-08-30|||March 2012||2012-03-01|August 2013|2013-08-01||||August 2013|Anticipated|2013-08-01||Interventional|||Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients|Efficacy and Safety of Sci B Vac vs. Engerix in Dialysis Patients|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 01:20:44.578661|2017-10-11 01:20:44.578661
NCT01933399|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-04-13|2015-02-20||September 2007||2007-09-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|LSO LBP||Comparison of Extensible and Inextensible Lumbosacral Orthoses for Lower Back Pain|Comparison of Inextensible and Extensible Lumbosacral Orthoses for the Management of Episodes of Lower Back Pain|Completed||N/A|98|Actual|Medical University of South Carolina||3|||f||||f||||||||||2017-10-11 01:20:44.683105|2017-10-11 01:20:44.683105
NCT01933191|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-02-06|||August 2011||2011-08-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Exercise Treatment of Dental Anxiety|A Randomised Placebo Controlled Cross-over Trial on Exercise Treatment of Dental Anxiety|Completed||N/A|30|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 01:20:49.747719|2017-10-11 01:20:49.747719
NCT01933386|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-10-25|||September 2013||2013-09-01|October 2013|2013-10-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||"Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance (SoundBite)"|"Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance (SoundBite)"|Unknown status|Not yet recruiting|Phase 4|15|Anticipated|Sonitus Medical Inc||2|||f||||f||||||||||2017-10-11 01:20:45.217557|2017-10-11 01:20:45.217557
NCT01933373|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-08-30|||May 2007||2007-05-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||A Prospective Study Comparing Two Reconstructive Operation Techniques After Myotomy of Achalasia|A Prospective Randomized Trial Comparing Two Reconstructive Operation Techniques After Myotomy of Achalasia. Comparing Toupet Versus DOR.|Completed||N/A|25|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 01:20:45.313952|2017-10-11 01:20:45.313952
NCT01933360|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2014-08-13|||August 2013||2013-08-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Misoprostol for Cervical Priming Prior to Vacuum Aspiration|Sublingual Versus Vaginal Misoprostol for Cervical Dilatation 1 or 3 Hours Prior to Surgical Abortion|Completed||Phase 2|184|Actual|Karolinska Institutet||4|||f||||t||||||||||2017-10-11 01:20:45.403602|2017-10-11 01:20:45.403602
NCT01933347|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-02-23|||April 7, 2014|Actual|2014-04-07|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|October 10, 2016|Actual|2016-10-10||Interventional|||Third-line Treatment of Gefitinib in NSCLC Patients|Third-line Treatment of Gefitinib in NSCLC Patients Who Had Received First-line Gefitinib With EGFR 19del/L858R Mutation and Tumor Progression After the Second-line Chemotherapy: a Single-arm, Prospective and Multi-center Study|Active, not recruiting||Phase 2|46|Actual|Guangdong Association of Clinical Trials||1|||f||||t||||||||No||2017-10-11 01:20:45.507407|2017-10-11 01:20:45.507407
NCT01933334|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-07-06|2015-08-25||October 2013||2013-10-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|LOTUSS|Safety population included all randomized participants who provided written informed consent and received at least one dose of study medication.|Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)|The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)|Completed||Phase 2|63|Actual|Genentech, Inc.||2|||f||||t||||||||||2017-10-11 01:20:45.612133|2017-10-11 01:20:45.612133
NCT01933321|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-04-01|||September 2012||2012-09-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)|Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2/Phase 3|14|Actual|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||f||||||||||2017-10-11 01:20:48.327941|2017-10-11 01:20:48.327941
NCT01933308|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-02-28|||March 2010||2010-03-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|OPTION||Optimization of Pulmonary Rehabilitation Programmes: the OPTION Study|Optimization of Pulmonary Rehabilitation Programmes: the OPTION Study|Unknown status|Recruiting|N/A|120|Anticipated|Hopital du Sacre-Coeur de Montreal||3|||f||||t||||||||||2017-10-11 01:20:48.417406|2017-10-11 01:20:48.417406
NCT01933295|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-08-08|||March 2014||2014-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes|Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes|Recruiting||N/A|150|Anticipated|Henry Ford Health System||3|||f||||f||||||||||2017-10-11 01:20:48.581521|2017-10-11 01:20:48.581521
NCT01933282|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-12-21|||January 2013||2013-01-01|December 2013|2013-12-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|MTN||MESA Treatment for NK/T Cell Lymphoma|Phase II Study of MESA Chemotherapy in Patients With Natural Killer/T Cell Lymphoma|Unknown status|Recruiting|Phase 2|100|Anticipated|Fourth Military Medical University||1|||f||||t||||||||||2017-10-11 01:20:48.699255|2017-10-11 01:20:48.699255
NCT01933269|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-04-03|||May 2015||2015-05-01|April 2017|2017-04-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||FACBC for Head and Neck Cancers|Initial Evaluation of Anti-1-amino-F-18 Flurocyclobutane-1carboxylic Acid (Anti-18F-FACBC) in the Assessment of Head and Neck Cancer: A Pilot Study.|Suspended||Early Phase 1|10|Anticipated|Emory University||1||Change in Principal Investigator. Revising the study|f||||t||||||||||2017-10-11 01:20:48.814931|2017-10-11 01:20:48.814931
NCT01933256|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-11-14|||August 2013||2013-08-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin|A Randomized, Double-blind, Placebo-controlled Study of the Effect of 49 Days of Treatment With Repeated Subcutaneous Doses of HIP2B to Assess Safety, Tolerability and Measures of Islet β-cell Function in Subjects With Type 2 Diabetes Mellitus Treated With Metformin|Completed||Phase 1|32|Actual|CureDM||3|||f||||f||||||||||2017-10-11 01:20:48.923495|2017-10-11 01:20:48.923495
NCT01933230|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-01-06|2015-02-02||June 2013||2013-06-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|CCSICH||Trial of Cooling for Patients With Excel Cryo Cooling System in Intracerebral Hemorrhage (ICH)|Trial of Cooling for Patients With Excel Cryo Cooling System in Intracerebral Hemorrhage (ICH)|Terminated||Phase 1|2|Actual|The Cleveland Clinic||1||Closed due to issues encountered with meeting enrollment goals at our site.|f||||f||||||||No||2017-10-11 01:20:49.214398|2017-10-11 01:20:49.214398
NCT01933217|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-11-16|||November 2013||2013-11-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2016|Actual|2016-08-01||Interventional|||Methylphenidate for Attention Problems After Pediatric TBI|Efficacy of Methylphenidate for Management of Long-Term Attention Problems After Pediatric Traumatic Brain Injury (TBI)|Active, not recruiting||Phase 4|26|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 01:20:49.518015|2017-10-11 01:20:49.518015
NCT01933178|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-06-09|||September 2013||2013-09-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Reproducibility of Anterior Segment Optical Coherence Tomography (AS-OCT) for Imaging Conjunctivochalasis|Inter and Intra Examiner Reproducibility of Anterior Segment Optical Coherence Tomography (AS-OCT) for Imaging Conjunctivochalasis|Completed||N/A|20|Actual|Singapore National Eye Centre||1|||f||||f||||||||||2017-10-11 01:20:49.867413|2017-10-11 01:20:49.867413
NCT01933165|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-06-09|||September 2013||2013-09-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Reproducibility of LipiView Ocular Surface Interferometer (LipiView) for Measuring Tear Lipid Layer Thickness|Inter and Intra Examiner Reproducibility of LipiView Ocular Surface Interferometer (LipiView) for Measuring Tear Lipid Layer Thickness|Completed||N/A|20|Actual|Singapore National Eye Centre||1|||f||||f||||||||||2017-10-11 01:20:49.968347|2017-10-11 01:20:49.968347
NCT01933152|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2014-09-30|||August 2012||2012-08-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|REVIEW||Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration|Review Study: A Retrospective Noninterventional Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration|Completed||N/A|137|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:20:50.064713|2017-10-11 01:20:50.064713
NCT01933139|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-08-26|||November 2013||2013-11-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Informed Consent for Hysterectomy: Effectiveness of Audio-visual Presentations on Patient Comprehension|Informed Consent for Hysterectomy: Effectiveness of Audio-visual Presentations on Patient Comprehension|Completed||N/A|120|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-10-11 01:20:50.177705|2017-10-11 01:20:50.177705
NCT01933126|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2014-02-18|||August 2013||2013-08-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Intrauterine Injection of HCG and Implantation Rate|The Effect of HCG Injection to the Uterine Cavity on Pregnancy Rate in Women Undergoing IVF Treatment|Unknown status|Recruiting|N/A|100|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 01:20:50.271661|2017-10-11 01:20:50.271661
NCT01933100|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-08-30|||July 2012||2012-07-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Brown Rice Based-meal or Polished Rice Based-meal or Wheat Based-meal on Functional Constipation in Young Korean Women|Comparison of Brown Rice Based-meal or Polished Rice Based-meal or Wheat Based-meal on Functional Constipation in Young Korean Women: A Opened, Clinical Trial|Completed||N/A|39|Actual|Chonbuk National University Hospital||3|||f||||t||||||||||2017-10-11 01:20:50.465586|2017-10-11 01:20:50.465586
NCT01933087|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-04-27|||October 2013||2013-10-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|HAND||Hand Hygiene Intervention Study|A Stepped Wedge Cluster Randomised Controlled Trial to Evaluate the Impact of a Multimodal Hand Hygiene Intervention at Sappasithiprasong Hospital, Ubon Ratchathani|Active, not recruiting||N/A|58|Actual|University of Oxford||2|||f||||f||||||||Undecided||2017-10-11 01:20:50.555943|2017-10-11 01:20:50.555943
NCT01933074|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-12-08|||January 2013||2013-01-01|January 2013|2013-01-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Observational|||Clinical and Biochemical Evidence of Neurogenic Inflammation in Women With Urinary Urgency|Clinical and Biochemical Evidence of Neurogenic Inflammation in Women With Urinary Urgency|Completed||N/A|137|Actual|University of Pennsylvania|||1||f||||f||||||Samples Without DNA|"     First morning urine specimens are collected from each subject after completing questionnaires     - one week from initial visit or at follow-up visit.   "|||2017-10-11 01:20:50.631065|2017-10-11 01:20:50.631065
NCT01933061|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2014-02-03|||January 2014||2014-01-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma|A Randomized, Open Label, Multi-center Phase 2 Study of Nab-Paclitaxel Versus Epigenetic Modifying Therapy of CC-4386 With Nab-Paclitaxel in Subjects With Chemotherapy naïve Metastatic Melanoma|Withdrawn||Phase 2|0|Actual|Celgene||2||"Strategic decision not to proceed with the opening of this study. There are no concerns over   the safety or quality of the investigational products involved."|f||||f||||||||||2017-10-11 01:20:50.697003|2017-10-11 01:20:50.697003
NCT01933048|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-08-10|2016-03-28||September 2012||2012-09-01|August 2017|2017-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|SNIF||Self-Administered Nasal Influenza Feasibility Study|Self-Administered Nasal Influenza Vaccine: Immunogenicity and Feasibility of Group Administration|Completed||Phase 4|1077|Actual|Uniformed Services University of the Health Sciences|Subjects were not followed for clinical outcomes during the influenza season.|2|||f||||t||||||||||2017-10-11 01:20:50.795847|2017-10-11 01:20:50.795847
NCT01933035|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2016-05-16|||October 2013||2013-10-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|12 Months|Observational [Patient Registry]|||Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.|Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.|Completed||N/A|50|Actual|Beth Israel Medical Center|||3||f||||f||||||Samples Without DNA|"     Study subjects will have the following collected: Lavender tri-potassium EDTA tubes filled     according to the manufacturer's specifications [approximately 4ML of venous blood], labeled,     and promptly dispatched to the laboratory.The sample will be gently inverted several times     prior to analysis on the ADVIA 120 taking care not to overly agitate the sample. Moreover,     the specimen shall be inspected for clot formation prior to being assayed. The full blood     count shall be obtained and in the configuration sub-menu the extended platelet parameter     option shall be selected and thus actuated. A print out will be generated including the MPC,     MPM, platelet component distribution width, platelet mass distribution width, and large     platelet count in addition to the standard platelet count and mean platelet volume [MPV].   "|||2017-10-11 01:20:51.387982|2017-10-11 01:20:51.387982
NCT01933022|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-03-07|||August 2014||2014-08-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|EFFECT||A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease|An Exploratory, Open Label, Single-arm Study to Evaluate the Effect of Eligard® 6-month on Biomarkers of Disease in Patients With Metastatic Prostate Cancer|Terminated||Phase 4|1|Actual|Astellas Pharma Inc||1||Termination due to high current screen rate failure and unreliable PSA mRNA assay.|f||||f||||||||||2017-10-11 01:20:51.473676|2017-10-11 01:20:51.473676
NCT01933009|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2013-08-28|||August 2013||2013-08-01|August 2013|2013-08-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01|1 Year|Observational [Patient Registry]|||The Effect of GnRH Administration During Luteal Support in Frozen-thawed Transfer Cycles||Unknown status|Recruiting|N/A|100|Anticipated|Assaf-Harofeh Medical Center|||1||f||||||||||||||2017-10-11 01:20:51.567966|2017-10-11 01:20:51.567966
NCT01932996|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-06-08|||January 2015||2015-01-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Enhancing Smoking Cessation in the Homeless Population|Enhancing Smoking Cessation in the Homeless Population|Recruiting||Phase 4|450|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:20:51.767836|2017-10-11 01:20:51.767836
NCT01932983|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-10-26|||April 2012||2012-04-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01|1 Day|Observational [Patient Registry]|||"Clinical Application of Train of Four Testing in the Intraoperative Monitoring Setting"|Clinical Application of Train of Four Testing in the Intraoperative Monitoring Setting|Completed||N/A|150|Actual|New York University School of Medicine|||1||f||||t||||||||||2017-10-11 01:20:52.004079|2017-10-11 01:20:52.004079
NCT01932970|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-04-12|2017-02-16|2015-02-17|August 2013||2013-08-01|April 2017|2017-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional||Full analysis set includes iall participants who enrolled into the study and had at least one dose of etelcalcetide and at least one post-baseline serum corrected calcium value.|Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide|A Multicenter, Multiple-dose, Single-arm Study to Switch Hemodialysis Subjects With Secondary Hyperparathyroidism From Oral Cinacalcet HCl to Intravenous AMG 416|Completed||Phase 3|158|Actual|Amgen||1|||f||||f||||||||||2017-10-11 01:20:52.133884|2017-10-11 01:20:52.133884
NCT01932957|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27|||May 2012||2012-05-01|August 2013|2013-08-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||Laparascopy Versus Laparatomy in the Management of Ruptured Ectopic Pregnancy|A RANDOMISED TRIAL COMPARING LAPARASCOPY VERSUS LAPAROTOMY IN THE MANAGEMENT OF WOMEN DIAGNOSED WITH ECTOPIC PREGNANCY|Unknown status|Recruiting|Phase 4|140|Anticipated|University of Pretoria||2|||f||||t||||||||||2017-10-11 01:20:52.617326|2017-10-11 01:20:52.617326
NCT01932944|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2017-01-23|||August 2013||2013-08-01|January 2017|2017-01-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Observational|ACS||Accuracy Characterization Study|Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System Compared to Venous and Capillary Glucose|Completed||N/A|30|Actual|Abbott Diabetes Care|||1||f||||f||||||||||2017-10-11 01:20:52.752285|2017-10-11 01:20:52.752285
NCT01932931|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-28|2015-01-13|||October 2013||2013-10-01|January 2015|2015-01-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|||Vitamin D, SSRIs and the Musculoskeletal System|Depression - Can Vitamin D Alleviate Symptoms of Depression Not Cured by Antidepressants as Well as Alleviate Negative Skeletal Effects Caused by Antidepressants?|Unknown status|Recruiting|N/A|150|Anticipated|Aalborg University||2|||f||||f||||||||||2017-10-11 01:20:52.859706|2017-10-11 01:20:52.859706
NCT01932918|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-07-21|||January 2011||2011-01-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Antinociceptive Modalities on Ischemia Reperfusion Injury|The Interaction of Nociceptive Stimulation and Various Antinociceptive Modalities on Ischemia Reperfusion Injury|Completed||Phase 4|142|Actual|National Taiwan University Hospital|||4||f||||f||||||Samples Without DNA|"     plasma   "|||2017-10-11 01:20:53.020007|2017-10-11 01:20:53.020007
NCT01932905|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-05-08|||March 2011|Actual|2011-03-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|December 2013|Actual|2013-12-01||Interventional|DRTMS||Deep rTMS in Central Neuropathic Pain Syndromes|Deep rTMS in Central Neuropathic Pain Syndromes|Completed||N/A|120|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 01:20:53.17801|2017-10-11 01:20:53.17801
NCT01932892|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2014-06-19|||May 2013||2013-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Quantifying Prosthetic Socket Interface Movement|Quantifying Prosthetic Socket Interface Movement|Completed||N/A|10|Actual|University of South Florida|||1||f||||t||||||||||2017-10-11 01:20:53.285228|2017-10-11 01:20:53.285228
NCT01932879|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-12-05|||July 2013||2013-07-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Blackberry Polyphenol Intake and Fuel Management||Completed||N/A|35|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 01:20:53.394423|2017-10-11 01:20:53.394423
NCT01932866|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-27|||June 2010||2010-06-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|IDEA||Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence|Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence (IDEA Trial)|Completed||N/A|223|Actual|Wilford Hall Medical Center||2|||f||||f||||||||||2017-10-11 01:20:53.494425|2017-10-11 01:20:53.494425
NCT01932853|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-07-12|||October 2013||2013-10-01|October 2015|2015-10-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Observational|||Association Between Dose Dialysis by Kt and Mortality|Evaluation of the Association of Dialysis Dose Obtained by Kt and Mortality in Hemodialysis Patients|Completed||N/A|6129|Actual|NephroCare Spain|||1||f||||f||||||||||2017-10-11 01:20:53.612315|2017-10-11 01:20:53.612315
NCT01932840|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27|||September 2011||2011-09-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Attitudes and Understanding of Plant Sterol Claims on Food Labels||Completed||N/A|1017|Actual|University of Toronto|||1||f||||f||||||||||2017-10-11 01:20:53.705169|2017-10-11 01:20:53.705169
NCT01932827|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27|||September 2011||2011-09-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Attidutes and Understanding of Oat Fibre Claims on Food Labels||Completed||N/A|1002|Actual|University of Toronto|||1||f||||||||||||||2017-10-11 01:20:53.793949|2017-10-11 01:20:53.793949
NCT01932814|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27|||September 2012||2012-09-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|REAMICHOC||Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful?|Retrospective Analysis of Aminoglycoside-associated Acute Renal Injury in Septic Critically Ill Patients|Completed||N/A|317|Actual|Université Victor Segalen Bordeaux 2|||2||f||||f||||||||||2017-10-11 01:20:53.867174|2017-10-11 01:20:53.867174
NCT01932801|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-10-26|||August 2013||2013-08-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|HaRP||Harm Reduction With Pharmacotherapy (HaRP)|Harm Reduction With Pharmacotherapy for Homeless Adults With Alcohol Dependence|Recruiting||Phase 2|300|Anticipated|University of Washington||4|||f||||t||||||||||2017-10-11 01:20:53.94952|2017-10-11 01:20:53.94952
NCT01932788|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-04-08|||January 2013||2013-01-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Preventing Health Disparities During Pregnancy Through Vitamin D Supplementation|Preventing Health Disparities During Pregnancy Through Vitamin D Supplementation|Active, not recruiting||Phase 3|410|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 01:20:54.05624|2017-10-11 01:20:54.05624
NCT01932775|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-01-20|||May 2013||2013-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards|An Open, Single-centre, Non-controlled Study of Efficacy, Safety and Usability of the GlucoTab System for Glycaemic Management in Non-critically Ill Patients With Type 2 Diabetes at General Wards|Completed||Phase 3|99|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-11 01:20:54.161027|2017-10-11 01:20:54.161027
NCT01932762|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-03-01|2016-02-03||October 2013||2013-10-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047)|A Phase II Clinical Trial to Evaluate the Efficacy and Safety of a Combination Regimen of MK-5172 With/Without MK-8742 and/or Ribavirin (RBV) in Treatment-naive Subjects With Chronic Hepatitis C Genotype 2, 4, 5 and 6 Infection|Completed||Phase 2|98|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:20:54.268902|2017-10-11 01:20:54.268902
NCT01932749|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2014-04-03|||August 2013||2013-08-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||The Study of Effectiveness Repetitive Transcranial Magnetic Stimulation in Bipolar Depression|The Comparison of Effectiveness of Bilateral rTMS Versus Unilateral TMS in Patients With Bipolar Depression: a Study Randomized and Single Blind|Completed||N/A|30|Actual|University of Tehran||2|||f||||t||||||||||2017-10-11 01:20:55.365112|2017-10-11 01:20:55.365112
NCT01932736|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-06-17|||August 2013||2013-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2014|Actual|2014-04-01||Interventional|||Functional Manifestations of Pressure Changes in the Middle Ear System|Functional Manifestations of Pressure Changes in the Middle Ear System: An fMRI Study|Completed||N/A|5|Actual|University of Pittsburgh||1|||f||||f||||||||No||2017-10-11 01:20:55.447608|2017-10-11 01:20:55.447608
NCT01932723|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-08-27|||January 2011||2011-01-01|August 2013|2013-08-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|LBP||Effect of Functional Lumbar Stabilization Exercises in Women With Menstrual Low Back Pain|Effect of Functional Lumbar Stabilization Exercises on Pain, Disability and Kinesiophobia in Women With Menstrual Low Back Pain|Completed||N/A|30|Actual|University of Social Welfare and Rehabilitation Science||1|||f||||t||||||||||2017-10-11 01:20:55.546035|2017-10-11 01:20:55.546035
NCT01932710|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-11-04|||September 2013||2013-09-01|November 2016|2016-11-01||||September 2018|Anticipated|2018-09-01||Interventional|||A Feasibility Study of Prophylactic White Blood Cell Transfusions|A Feasibility Study of White Blood Cell Transfusion for the Prevention of Infection in Acute Myelogenous Leukemia Patients Undergoing Front-Line or First Salvage Induction Therapy|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:20:55.635141|2017-10-11 01:20:55.635141
NCT01932697|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-12-20|||September 2013||2013-09-01|June 2016|2016-06-01||||October 2017|Anticipated|2017-10-01||Interventional|||Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer|Phase II Evaluation of Adjuvant Hyperfractionated Radiation and Docetaxel for HPV Associated Oropharynx Cancer|Suspended||Phase 2|81|Anticipated|Mayo Clinic||1||pending an IRB modification to increase overall accrual to 81|f||||t||||||||||2017-10-11 01:20:55.730568|2017-10-11 01:20:55.730568
NCT01932684|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-08-29|||June 2012||2012-06-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Effects Of Breath And Stacking-Spirometry Incentive in Patients With Parkinson's Disease|EFFECTS OF BREATH AND STACKING-SPIROMETRY INCENTIVE PACKAGES IN THE RIB CAGE IN PATIENTS WITH PARKINSON'S DISEASE|Completed||N/A|15|Actual|Universidade Federal de Pernambuco||3|||f||||t||||||||||2017-10-11 01:20:55.881924|2017-10-11 01:20:55.881924
NCT01932671|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2013-08-27|||August 2012||2012-08-01|August 2013|2013-08-01||||September 2016|Anticipated|2016-09-01||Observational|SMART-ORACLE||The SMART-ORACLE Study|Optimising Risk Assessment With CT-angiography or Calcium Score in Patients at High Risk for a Cardiovascular Event|Unknown status|Enrolling by invitation|N/A|1500|Anticipated|UMC Utrecht|||1||f||||t||||||||||2017-10-11 01:20:55.990917|2017-10-11 01:20:55.990917
NCT01932658|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-04-13|||February 2014||2014-02-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|HSCT||Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment|Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment|Withdrawn||Early Phase 1|0|Actual|University of California, Los Angeles||1||patients insurance would not cover the cost of the study procedures|f||||f||||||||||2017-10-11 01:20:56.079512|2017-10-11 01:20:56.079512
NCT01932463|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2013-08-29|||May 2011||2011-05-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) for Treatment of Tremor|A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Tremor|Completed||N/A|6|Actual|InSightec||1|||f||||f||||||||||2017-10-11 01:20:58.507323|2017-10-11 01:20:58.507323
NCT01913210|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-03-02|||April 2013||2013-04-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|May 2013|Actual|2013-05-01||Observational|||Effect of Ginseng on Blood Pressure|Effect of Ginseng on Blood Pressure: A Systematic Review and Meta-Analysis of Controlled Trials|Completed||N/A|500|Anticipated|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-11 01:26:15.468176|2017-10-11 01:26:15.468176
NCT01932645|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-04-06|||December 2013||2013-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Etiology Study of Prostatitis|Modern Genetic Methods to Test EPS Samples in Prostatitis Patients|Recruiting||N/A|24|Anticipated|University of British Columbia|||2||f||||f||||||Samples With DNA|"     Patients will have a digital rectal exam (DRE) performed and have their Expressed Prostatic     Secretions (EPS) sampled as well as the first void after the DRE (other wise called the VB3     sample). Patients will also have their maximum urinary flow rate tested by voiding into a     special machine. This will be done at the urology clinic, 6th floor Diamond Building.      These biological samples will be tested for bacterial DNA rather than the traditional     microbiological culturing techniques. Identification of these bacterial DNA will then be     assessed between the groups to determine if prostatitis patients, in fact, do have more     bacteria than normal controls.   "|No||2017-10-11 01:20:56.182228|2017-10-11 01:20:56.182228
NCT01932632|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-05-04|||September 2013||2013-09-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|WiseMed||Medication Minimization for Long-term Care Residents|The Effect of Medication Minimization on Mortality and Hospitalization in Long-Term Care Residents: The WiseMed RCT|Withdrawn||N/A|0|Actual|University of British Columbia||2||unable to recruit|f||||t||||||||||2017-10-11 01:20:56.27632|2017-10-11 01:20:56.27632
NCT01932606|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-02-15|2016-01-15||August 2013||2013-08-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction|Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction|Completed||Phase 2|28|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:20:56.477448|2017-10-11 01:20:56.477448
NCT01932593|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-04-16|||January 2014||2014-01-01|April 2014|2014-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|SIAMMS-II||Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis|Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis (SIAMMS-II)|Unknown status|Recruiting|Phase 1|6|Anticipated|North Bristol NHS Trust||1|||f||||f||||||||||2017-10-11 01:20:57.486085|2017-10-11 01:20:57.486085
NCT01932580|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-10-25|||August 2013||2013-08-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma|Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma|Completed||Phase 2|10|Actual|McGill University||1|||f||||f||||||||||2017-10-11 01:20:57.609573|2017-10-11 01:20:57.609573
NCT01932567|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-07-23|||August 2013||2013-08-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Interventional|||Electrical Impedance Tomography (EIT) and Physiotherapy|Effect of Physiotherapy Evaluated by Electrical Impedance Tomography|Unknown status|Recruiting|N/A|30|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f||||||||||||||2017-10-11 01:20:57.742885|2017-10-11 01:20:57.742885
NCT01932554|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-03-24|||November 2013||2013-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis|Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis|Withdrawn||Phase 2|0|Actual|St. Louis University||2||Insufficient recruitment|f||||t||||||||||2017-10-11 01:20:57.868722|2017-10-11 01:20:57.868722
NCT01932541|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-06-28|||January 2017||2017-01-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old|Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old With Bipolar I, Bipolar II and Bipolar Spectrum Disorder|Suspended||Phase 4|40|Anticipated|Massachusetts General Hospital||1||On hold due to competing departmental studies|f||||f||||||||||2017-10-11 01:20:57.992348|2017-10-11 01:20:57.992348
NCT01932528|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-10-22|||August 2013||2013-08-01|October 2013|2013-10-01||||September 2013|Actual|2013-09-01||Interventional|LX1606-104||An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males|A Phase 1, Open-label, Non-randomised, Single-dose Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate (LX1606) in Healthy Male Subjects|Completed||Phase 1|8|Actual|Lexicon Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:20:58.072368|2017-10-11 01:20:58.072368
NCT01932515|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-06-25|||November 2013||2013-11-01|June 2014|2014-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|DIADS||Diagnostic Instruments for Autism in Deaf Children Study|Diagnostic Instruments for Autism in Deaf Children Study|Unknown status|Active, not recruiting|N/A|325|Anticipated|Leeds and York Partnership NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 01:20:58.142874|2017-10-11 01:20:58.142874
NCT01932502|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-03-01|||February 2013||2013-02-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy|Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy: Efficacy, Tolerability, Dosing Equivalence, and Retention Rate|Active, not recruiting||Phase 4|21|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||1|||f||||t||||||||||2017-10-11 01:20:58.210333|2017-10-11 01:20:58.210333
NCT01932489|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-05-19|||December 2013||2013-12-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PRECISION-F||The Jules Bordet Institute Molecular Profiling Program Feasibility Trial|THE JULES BORDET INSTITUTE PROGRAM FOR MOLECULAR PROFILING OF METASTATIC LESIONS: FEASIBILITY. PRECISION - Feasibility.|Completed||N/A|35|Actual|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 01:20:58.315309|2017-10-11 01:20:58.315309
NCT01932476|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-04-13|||August 2013|Actual|2013-08-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes|Randomized Double-Masked Gluten Challenge to Evaluate Markers of Autoimmunity in Patients With Type-1 Diabetes and Celiac Disease After Oral Gluten Challenge|Completed||N/A|7|Actual|Joslin Diabetes Center||4|||f||||f||||||||||2017-10-11 01:20:58.415524|2017-10-11 01:20:58.415524
NCT01932450|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2014-09-23|||August 2013||2013-08-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|RAFALE||Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control|A Randomized, Open-label Study Investigating the Effect of Bilateral Renal Artery Sympathetic Denervation by Catheter-based Radiofrequency Ablation on Blood Pressure and Disease Progression in Autosomal Dominant Polycystic Kidney Disease|Unknown status|Recruiting|Phase 2|100|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||||2017-10-11 01:20:58.586399|2017-10-11 01:20:58.586399
NCT01932437|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-09-30|||July 2013||2013-07-01|April 2014|2014-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety, Tolerability, and PK of Single IM Doses of ETI-204 in Adult Volunteers|A Randomized, Double-Blind, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single Intramuscular Doses of ETI-204 in Adult Volunteers|Completed||Phase 1|36|Actual|Elusys Therapeutics||2|||f||||f||||||||||2017-10-11 01:20:58.86127|2017-10-11 01:20:58.86127
NCT01932424|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-29|||January 2013||2013-01-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Blood Propofol Concentrations in Children During Spinal Surgery|Comparison of Measured Versus Predicted Blood Propofol Concentrations During Total Intravenous Anaesthesia in Children Undergoing Spinal Surgery|Completed||Phase 4|20|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 01:20:58.974141|2017-10-11 01:20:58.974141
NCT01932411|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-06-26|||July 2013||2013-07-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Factors Affect Outcomes in Cardiovascular Surgery|Factors That Affect the Outcomes of Cardiothoracic and Vascular Surgery|Recruiting||N/A|5000|Anticipated|University of California, Davis|||1||f||||f||||||||||2017-10-11 01:20:59.084984|2017-10-11 01:20:59.084984
NCT01932398|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-01-19|||November 2011||2011-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|SHARK||A Study on the Inter-Hemispheric Alpha Ratio in Kids With ADHD (SHARK)|Posterior Alpha Oscillations as an Index for the Attentional Bias in Children With Attentional Deficit Hyperactivity Disorder|Completed||N/A|60|Actual|Radboud University|||2||f||||f||||||||||2017-10-11 01:20:59.184248|2017-10-11 01:20:59.184248
NCT01932385|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-10-11|||August 2013||2013-08-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma|Phase 2 Study of Sorafenib in the Management of Liver Function Impaired Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2/Phase 3|90|Anticipated|Qingdao Central Hospital||2|||f||||f||||||||||2017-10-11 01:20:59.255024|2017-10-11 01:20:59.255024
NCT01932372|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-09-25|||July 26, 2013|Actual|2013-07-26|September 2017|2017-09-01|January 26, 2021|Anticipated|2021-01-26|January 26, 2021|Anticipated|2021-01-26||Observational|||Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis|Tofacitinib Special Investigation Of Xeljanz Tablets 5mg. (Regulatory Post Marketing Commitment Plan)|Active, not recruiting||N/A|6000|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 01:20:59.341708|2017-10-11 01:20:59.341708
NCT01932359|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-04-10|||October 2013||2013-10-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01||Interventional|RAVNAS||Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study|Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study (RAVNAS)|Completed||N/A|105|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:20:59.427267|2017-10-11 01:20:59.427267
NCT01932346|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-02-21|||August 2013||2013-08-01|February 2014|2014-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Using Near Infra-red Spectroscopy to Measure Tissue Perfusion in Patients Receiving Coronary Artery Bypass Graft Surgery|Using Non-invasive Near Infra-red Spectroscopy to Measure the Regional Tissue Perfusion in Patients Receiving Off-pump Coronary Artery Bypass Graft Surgery|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:20:59.504389|2017-10-11 01:20:59.504389
NCT01932333|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27|||May 2010||2010-05-01|August 2013|2013-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-40411813 in Male and Female Elderly Patients|A Double-Blind, Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-40411813 in Male and Female Elderly Subjects|Completed||Phase 1|36|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 01:20:59.583504|2017-10-11 01:20:59.583504
NCT01932320|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-09-05|||February 2010||2010-02-01|September 2013|2013-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Evaluate the Relative Bioavailability, Food Effect and Effect of Ketoconazole on the Rate and Extent of Absorption of Solid Dosage Formulation(s) of JNJ-40411813|An Open Label Study to Investigate the Relative Bioavailability, Food Effect and Effect of Ketoconazole on the Rate and Extent of Absorption of Solid Dosage Formulation(s) of JNJ-40411813|Completed||Phase 1|36|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-10-11 01:20:59.689973|2017-10-11 01:20:59.689973
NCT01932307|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-09-29|||December 2015||2015-12-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Cervical Spine Health of Surgeons|Cervical Spine Health of Surgeons|Withdrawn||N/A|0|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 01:20:59.80223|2017-10-11 01:20:59.80223
NCT01932294|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-01-25|||April 2013||2013-04-01|January 2017|2017-01-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20|2 Years|Observational [Patient Registry]|Medamacs||Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support|Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support|Completed||N/A|161|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||||Yes|Individual participant data (IPD) is not available. De-identified datasets may be available upon approval.|2017-10-11 01:20:59.891199|2017-10-11 01:20:59.891199
NCT01932281|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-07-13|||May 2014||2014-05-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes|SierraSil as an Ergogenic Aid to Performance in Athletes|Completed||N/A|10|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:20:59.994245|2017-10-11 01:20:59.994245
NCT01932255|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-05-12|||October 2013||2013-10-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Observational|||CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap|CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap|Withdrawn||N/A|0|Actual|St. Olavs Hospital|||2|inadequate data|f||||f||||||||||2017-10-11 01:21:00.180463|2017-10-11 01:21:00.180463
NCT01932242|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-09-30|||July 2013||2013-07-01|November 2013|2013-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety, Tolerability and PK of Repeat Administration of IV ETI-204|A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Repeat Administration of Intravenous ETI-204 in Adult Volunteers|Completed||Phase 1|60|Actual|Elusys Therapeutics||2|||f||||f||||||||||2017-10-11 01:21:00.268975|2017-10-11 01:21:00.268975
NCT01932229|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-29|||February 2013||2013-02-01|August 2013|2013-08-01||||January 2015|Anticipated|2015-01-01||Interventional|||An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib|An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib|Unknown status|Recruiting|Phase 2|20|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 01:21:00.38386|2017-10-11 01:21:00.38386
NCT01932203|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-09-23|||July 2013||2013-07-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|Challenge||Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease|A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease|Active, not recruiting||Phase 4|255|Actual|Inha University Hospital||2|||f||||t||||||||||2017-10-11 01:21:00.601739|2017-10-11 01:21:00.601739
NCT01932190|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-06-23|||September 2013||2013-09-01|August 2013|2013-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|AKIKI||Artificial Kidney Initiation in Kidney Injury|Artificial Kidney Initiation in Kidney Injury, a Multicenter Randomised Trial|Completed||N/A|620|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-11 01:21:00.776866|2017-10-11 01:21:00.776866
NCT01932177|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-08-27|||April 2013||2013-04-01|April 2013|2013-04-01|October 2015|Anticipated|2015-10-01|May 2013|Actual|2013-05-01||Interventional|EVESOR||EVESOR: a Phase 1 Trial of Everolimus and Sorafenib|EVESOR: a Phase 1 Trial of Everolimus and Sorafenib to Assess the Impact of Doses and Administration Sequences on Pharmacokinetic and Pharmacodynamic Effects of the Combination|Unknown status|Recruiting|Phase 1|60|Anticipated|Hospices Civils de Lyon||4|||f||||t||||||||||2017-10-11 01:21:00.896654|2017-10-11 01:21:00.896654
NCT01932164|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-08-15|2015-03-18||May 2013|Actual|2013-05-01|August 2017|2017-08-01|December 16, 2015|Actual|2015-12-16|December 16, 2015|Actual|2015-12-16||Interventional|||Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients|Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients|Completed||N/A|5|Actual|Hospital Sirio-Libanes||1|||f||||t||||||||||2017-10-11 01:21:01.013477|2017-10-11 01:21:01.013477
NCT01932151|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-09-04|||December 2012||2012-12-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis|Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome Associated With Sepsis|Completed||N/A|18|Actual|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-11 01:21:01.230115|2017-10-11 01:21:01.230115
NCT01932138|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-02-26|||January 2013||2013-01-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|FS||Trial to Improve Access to PMTCT Services and Reduce HIV Transmission From Mother to Child|Evaluation of Interventions to Achieve Universal Access to PMTCT Services and Reduce Mother-to-Child Transmission of HIV in Dar es Salaam, Tanzania|Completed||N/A|190530|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 01:21:01.370364|2017-10-11 01:21:01.370364
NCT01932125|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2016-11-01|||February 2018||2018-02-01|November 2016|2016-11-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||An Observational Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer|An Indian Multicentric Open Label Prospective Post Marketing Surveillance Study of Bevacizumab in the Front Line Management of Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer in Real-life Clinical Practice|Not yet recruiting||N/A|100|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:21:01.46752|2017-10-11 01:21:01.46752
NCT01932112|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-04-24|2015-05-23||November 2012||2012-11-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|APPLE||Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial)|Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial)|Completed||Phase 3|378|Actual|Seoul St. Mary's Hospital||1|||f||||f||||||||||2017-10-11 01:21:01.552604|2017-10-11 01:21:01.552604
NCT01932099|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-10-27||2016-02-10|August 2013||2013-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2014|Actual|2014-06-01||Interventional|SALUS||TranScatheter Aortic Valve RepLacement System US Feasibility Trial|The Direct Flow Medical TranScatheter Aortic Valve RepLacement System US Feasibility Trial|Active, not recruiting||Phase 2|30|Actual|Direct Flow Medical, Inc.||1|||f||||f||||||||Undecided||2017-10-11 01:21:01.777112|2017-10-11 01:21:01.777112
NCT01932086|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-30|||March 2011||2011-03-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|April 2011|Actual|2011-04-01||Interventional|||Effects of White Rice, Brown Rice, and Black Rice on Postprandial Glucose and Lipid Profiles in Healthy Korean Adults|A Randomized, Crossover Clinical Trial|Completed||N/A|15|Actual|Chonbuk National University Hospital||5|||f||||t||||||||||2017-10-11 01:21:01.895277|2017-10-11 01:21:01.895277
NCT01932073|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-12-03|||August 2013||2013-08-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|DERMIS||Laser Therapy for the Management of Radiation Dermatitis|Low-Level Laser Therapy for the Management of Radiation Dermatitis: A Pilot Study in Breast Cancer Patients|Completed||N/A|79|Actual|Hasselt University||2|||f||||f||||||||||2017-10-11 01:21:02.005735|2017-10-11 01:21:02.005735
NCT01932060|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-12-07|2016-02-03||August 2013||2013-08-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.|Effects of Different Oxytocin Infusions on Blood Loss and Postpartum Hemoglobin Values in Patients Undergoing Elective Cesarean Delivery|Completed||Phase 3|51|Actual|Stanford University||2|||f||||f||||||||Undecided||2017-10-11 01:21:02.12167|2017-10-11 01:21:02.12167
NCT01932047|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27|||April 2010||2010-04-01|August 2013|2013-08-01|April 2015|Anticipated|2015-04-01|August 2013|Actual|2013-08-01|10 Years|Observational [Patient Registry]|||Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment|Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment - Establishment of Personalized Cell Library|Unknown status|Enrolling by invitation|N/A|1523|Anticipated|Samsung Medical Center|||1||f||||f||||||Samples With DNA|"     -  The problem with the existing pre-clinical testing technology             1. Efficacy evaluation using existing cell lines             2. Existing preclinical animal models (The tumors produced by the cancer cells               subcutaneously injected into immunodeficient mice)        -  The solution plan             1. The development of patient-specific personalized cell library             2. The development of stereotactic(orthotopic) personalized animal models with the               patient-derived cell lines derived from patients   "|||2017-10-11 01:21:02.40339|2017-10-11 01:21:02.40339
NCT01932034|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-08-24|||September 2012||2012-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|June 2016|Actual|2016-06-01||Interventional|||Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software|Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Multiple-Model Bayesian Adaptive Control|Active, not recruiting||Phase 2|263|Actual|Children's Hospital Los Angeles||3|||f||||f||||||||Undecided|Individual data requests will be evaluated on a case-by-case basis.|2017-10-11 01:21:02.482023|2017-10-11 01:21:02.482023
NCT01932021|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-04-08|||April 2013||2013-04-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|April 2014|Anticipated|2014-04-01||Interventional|Angiolipo||Treatment of Hypertensive Leg Ulcer by Adipose Tissue Grafting|Treatment of Hypertensive Leg Ulcer by Adipose Tissue Grafting|Unknown status|Recruiting|N/A|10|Anticipated|University Hospital, Caen||1|||f||||t||||||||||2017-10-11 01:21:02.569498|2017-10-11 01:21:02.569498
NCT01932008|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-29|||May 2012||2012-05-01|April 2012|2012-04-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Evaluation of the Bone Mineral Density and Muscle Mass in Patients Post Coronary Artery Bypass Graft Surgery With Chronic Kidney Disease||Completed||N/A|60|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 01:21:02.667133|2017-10-11 01:21:02.667133
NCT01931995|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-06-11|||February 2013||2013-02-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigation of Brain Network Dynamics in Depression|Investigation of Cortico-limbic Networks and Their Dynamics in Major Depressive Disorder|Active, not recruiting||N/A|40|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:21:02.734464|2017-10-11 01:21:02.734464
NCT01931982|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-06-24|||May 2013||2013-05-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|EGOFIP||Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.|Effect of GLP-1 on Microvascular Myocardial Function in Patients With Type 2|Completed||Phase 4|20|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 01:21:02.827135|2017-10-11 01:21:02.827135
NCT01931969|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2013-08-29|||December 2012||2012-12-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Observational|||Central Landmark vs USG for IJV Catheterization|Comparison of Internal Jugular Vein Catheterization Entry Points Determined by Ultrasonography Versus the Central Landmark Guided Method|Unknown status|Active, not recruiting|N/A|30|Anticipated|Ankara University|||1||f||||t||||||||||2017-10-11 01:21:02.91747|2017-10-11 01:21:02.91747
NCT01931956|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-05-18|2016-11-17||November 2008||2008-11-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2015|Actual|2015-02-01||Interventional|REALISM||Real World Expanded Multicenter Study of the MitraClip® System (REALISM)|A Continued Access Registry of the Evalve® MitraClip® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)|Active, not recruiting||N/A|66|Actual|Evalve||4|||f||||f|f|t|f|||||||2017-10-11 01:21:03.009216|2017-10-11 01:21:03.009216
NCT01931943|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-08-27|||April 2013||2013-04-01|August 2013|2013-08-01||||December 2013|Anticipated|2013-12-01||Interventional|||A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer|A Phase Ib Study to Evaluate the Tolerability and Pharmacokinetics of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer|Unknown status|Recruiting|Phase 1|24|Anticipated|Qilu Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 01:21:05.165835|2017-10-11 01:21:05.165835
NCT01931930|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2013-08-29|||July 2012||2012-07-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Perilla Extract on Improvement on Gastrointestinal Discomfort|Effect of Perilla Extract on Improvement of Intestinal Discomfort and Bowel Function in Healthy Volunteers With Gastrointestinal Discomfort|Completed||N/A|47|Actual|Amino Up Chemicals Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:21:05.313375|2017-10-11 01:21:05.313375
NCT01931917|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-05-21|||August 2013||2013-08-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Incredible Years Parents and Babies Program in Denmark|A Randomised Controlled Pilot Trial of The Incredible Years Parents and Babies Program in Denmark|Unknown status|Recruiting|N/A|120|Anticipated|The Danish National Centre For Social Research||2|||f||||f||||||||||2017-10-11 01:21:05.460048|2017-10-11 01:21:05.460048
NCT01931904|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-04-21|||February 2014||2014-02-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|IOP||Eye Pressure Lowering Surgery|OBSERVATIONAL STUDY OF OCULAR BLOOD FLOW PRE- AND POST- TRABECULECTOMY SURGERY USING FUNCTIONAL AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY|Unknown status|Recruiting|N/A|40|Anticipated|Oregon Health and Science University|||2||f||||f||||||||||2017-10-11 01:21:05.605718|2017-10-11 01:21:05.605718
NCT01931891|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2013-08-28|||July 2013||2013-07-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|February 2014|Anticipated|2014-02-01||Observational|||Extracellular Matrix Remodeling of the Umbilical Cord and Placenta in Preeclampsia||Unknown status|Recruiting|N/A|20|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||1||f||||f||||||Samples With DNA|"     umbilical cord placenta   "|||2017-10-11 01:21:05.716269|2017-10-11 01:21:05.716269
NCT01931878|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-02-23|2015-09-04||September 2012||2012-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Cross over study. total 24 enrolled , 21 completed. The twenty one who competed the study had both saline and incobotulinum toxin injection ( crossover).|Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.|Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.|Completed||Phase 2|24|Actual|Yale University|Relatively small number of participants. crossover not parallel design|2|||f||||f||||||||||2017-10-11 01:21:05.844366|2017-10-11 01:21:05.844366
NCT01931865|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-12-30|2015-08-31||September 2012||2012-09-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation|IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation|Terminated||Phase 2|12|Actual|Yale University|Open study, small number of patients|1||lost the recruiting source- no recruitment for the past 18months, PI moving|f||||f||||||||||2017-10-11 01:21:06.153489|2017-10-11 01:21:06.153489
NCT01931852|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-03-29|||September 2013|Actual|2013-09-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|CMR-IMPACT||Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin|Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin|Recruiting||N/A|312|Anticipated|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 01:21:06.371553|2017-10-11 01:21:06.371553
NCT01931839|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-04-03|2017-04-03||October 2013||2013-10-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Safety Set (study 105) included all participants who were exposed to any amount of study drug.|A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis|A Phase 3, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation|Completed||Phase 3|1164|Actual|Vertex Pharmaceuticals Incorporated|Analysis using baseline values of the current study 105 (NCT01931839) was not performed for Part B Treatment Cohort.|7|||f||||t||||||||||2017-10-11 01:21:07.045407|2017-10-11 01:21:07.045407
NCT01931826|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2013-08-26|||January 2003||2003-01-01|August 2013|2013-08-01|March 2009|Actual|2009-03-01|March 2005|Actual|2005-03-01||Interventional|||Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery|Treatment of Schistosomal Portal Hypertension: Assessment of Efficacy of Endoscopic Therapy Alone or in the Combined With Surgical Procedure|Completed||N/A|54|Actual|Universidade Estadual de Ciências da Saúde de Alagoas||2|||f||||f||||||||||2017-10-11 01:21:21.768297|2017-10-11 01:21:21.768297
NCT01931813|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27||||||August 2013|2013-08-01||||September 2012|Actual|2012-09-01||Observational|METHORIVAC||METHORIVAC - Vaccinal Pharmacoepidemiologic|Pharmacoepidemiological Methodology to Evaluate the Vaccination Risk in Young Infants|Completed||N/A|500|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||f||||||||||2017-10-11 01:21:21.876464|2017-10-11 01:21:21.876464
NCT01931800|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27|||December 2005||2005-12-01|August 2013|2013-08-01||||June 2014|Anticipated|2014-06-01||Observational|Hyalo strepto||Identification and Quantification of Immune Response Induced by Hyaluronidase and Other Factors of Virulence of Invasive Human Infections of Streptococcus Pneumoniae|Identification and Quantification of Immune Response Induced by Hyaluronidase and Other Factors of Virulence of Invasive Human Infections of Streptococcus Pneumoniae|Unknown status|Recruiting|N/A|165|Anticipated|Centre Hospitalier Universitaire Dijon|||3||f||||f||||||||||2017-10-11 01:21:21.950008|2017-10-11 01:21:21.950008
NCT01931787|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-07-31|||October 2013|Actual|2013-10-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer|A Pilot Clinical Trial of CPI-613 in Patients With Relapsed or Refractory Small Cell Lung Carcinoma (SCLC)|Completed||Phase 1|15|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 01:21:22.031598|2017-10-11 01:21:22.031598
NCT01931774|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2013-08-27|||April 2013||2013-04-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Is Acne a Skin Disease Affecting the Brain Functions? Neurocognition in Patients With Acne Vulgaris|Is Acne a Skin Disease Affecting the Brain Functions? Neurocognition in Patients With Acne Vulgaris|Completed||N/A|66|Actual|Bezmialem Vakif University|||2||f||||f||||||||||2017-10-11 01:21:22.117174|2017-10-11 01:21:22.117174
NCT01931761|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2015-06-29|||October 2013||2013-10-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers|A Phase I, Single-centre, Non-randomised, Open-label, Pharmacokinetic and Mass Balance Study of Orally Administered [14C]-Selumetinib in Healthy Male Volunteers|Completed||Phase 1|6|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 01:21:22.191203|2017-10-11 01:21:22.191203
NCT01931748|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2014-05-07|||April 2013||2013-04-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|UNCNT||A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome|Study of Non-inferiority UNCNT Versus MELSMON in Female With Menopausal Syndrome: Randomized Confirmatory Clinical Trial|Completed||Phase 3|104|Actual|Unimed Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:21:22.399284|2017-10-11 01:21:22.399284
NCT01931735|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-09-13|||October 1, 2013|Actual|2013-10-01|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|April 1, 2017|Actual|2017-04-01||Interventional|||Prospective Trial of Arthroscopic Meniscectomy for Degenerative Meniscus Tears|Prospective Trial of Arthroscopic Meniscectomy for Degenerative Meniscus Tears|Active, not recruiting||N/A|82|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 01:21:22.479401|2017-10-11 01:21:22.479401
NCT01931722|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-01-09|||January 2016||2016-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Exercise and Branched Chain Amino Acids (BCAA)Requirements in Older Men|Can Branched Chained Amino Acid Supplementation Combined With Strength-Training Minimize Sarcopenia in Older Men?|Suspended||N/A|6|Actual|University of Western Ontario, Canada||2||not able to find enough participants for this study|f||||t||||||||||2017-10-11 01:21:22.587917|2017-10-11 01:21:22.587917
NCT01931696|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-04-14|||July 2013||2013-07-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma|Clinical Assessment of Acupuncture for the Treatment of Asthma: A Randomized, Multicenter, Double-blind, Parallel-group Controlled Trial|Completed||N/A|200|Actual|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 01:21:23.00402|2017-10-11 01:21:23.00402
NCT01931683|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2014-10-13|||October 2013||2013-10-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)|Effect-site Concentration of Remifentanil for Smooth Removal of the LMA From Propofol Anesthesia|Completed||Phase 4|27|Actual|Ajou University School of Medicine||1|||f||||t||||||||||2017-10-11 01:21:23.120905|2017-10-11 01:21:23.120905
NCT01931670|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-27|2017-03-18||2016-12-22|September 2013||2013-09-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|January 2016|Actual|2016-01-01||Interventional|||A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain|Completed||Phase 3|818|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 01:21:23.248507|2017-10-11 01:21:23.248507
NCT01931657|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2016-02-24|||August 2013||2013-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MiMi||Pretreatment With Mifepristone Prior to Mirena Insertion|Pre-treatment With Mifepristone in Patients With Mirena for Optimizing Bleeding Pattern in Pre-menopausal Women|Completed||Phase 2|60|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 01:21:24.228569|2017-10-11 01:21:24.228569
NCT01931644|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-03-16|||July 2013||2013-07-01|March 2016|2016-03-01|December 2040|Anticipated|2040-12-01|August 2020|Anticipated|2020-08-01||Observational|||Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)|A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives|Recruiting||N/A|20000|Anticipated|Sanguine Biosciences|||2||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid,     tumor tissue, urine   "|||2017-10-11 01:21:24.326433|2017-10-11 01:21:24.326433
NCT01931631|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-04-11|||January 2014||2014-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|WCCR-DIAB2||Plant-Based Dietary Intervention in Type 2 Diabetes-2|A Practice-Based, Nutrition Intervention in Type 2 Diabetes|Suspended||N/A|60|Anticipated|Physicians Committee for Responsible Medicine||2||Erroneously duplicated study|f||||t||||||||Undecided|This study has been suspended|2017-10-11 01:21:24.440293|2017-10-11 01:21:24.440293
NCT01931618|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-09-07|||April 2011||2011-04-01|September 2017|2017-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Testing the Efficacy of an Online Alcohol Intervention in a Workplace Setting|"Digital Therapy: Evaluation of the Fully Automated Alcohol Intervention Balance."|Completed||N/A|85|Actual|University of Oslo||2|||f||||f||||||||||2017-10-11 01:21:24.547553|2017-10-11 01:21:24.547553
NCT01931605|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-07-29|||May 2014||2014-05-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Prost-EMBOL||Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment.|Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment.|Terminated||Phase 3|2|Actual|University Hospital, Rouen||1||"Enrolling participants has halted prematurely and will not resume due to the Departure of the   principal investigator"|f||||t||||||||||2017-10-11 01:21:24.646001|2017-10-11 01:21:24.646001
NCT01931592|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-05-03|||January 2014||2014-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|CLEAR||Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E|Controling Intestinal Colonization of High Risk Patients With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae (ESBL-E) - A Randomized Trial (CLEAR)|Terminated||Phase 2/Phase 3|29|Actual|University of Cologne||2||One of the study drugs was no longer available on a worldwide level.|f||||f||||||||||2017-10-11 01:21:24.747795|2017-10-11 01:21:24.747795
NCT01931579|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-08-16|||May 2012||2012-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|NODIVEM||Assessment of Probe Based Confocal Laser Endo-microscopy for In-vivo Diagnosis of Peripheral Lung Nodules and Masses.|"Assessment of Probe Based Confocal Laser Endo-microscopy for In-vivo Diagnosis of Peripheral Lung Nodules and Masses. NODIVEM Study"|Completed||N/A|120|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 01:21:24.889743|2017-10-11 01:21:24.889743
NCT01931566|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-01-31|||August 2013||2013-08-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|TOMMORROW||Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset|A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment Due to Alzheimer's Disease (MCI Due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD-4833 SR 0.8 mg QD) to Delay the Onset of MCI Due to AD in Cognitively Normal Subjects|Active, not recruiting||Phase 3|3494|Actual|Takeda||2|||f||||t||||||||||2017-10-11 01:21:24.994169|2017-10-11 01:21:24.994169
NCT01931553|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-05-14|||September 2013||2013-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine|Back to Bedside: A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine|Completed||N/A|1200|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:21:25.235678|2017-10-11 01:21:25.235678
NCT01931540|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-03-21|||June 2012||2012-06-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|April 2014|Actual|2014-04-01||Interventional|DORIAN||Developmental ORIgins of Healthy and Unhealthy AgeiNg: the Role of Maternal Obesity|Developmental ORIgins of Healthy and Unhealthy AgeiNg: the Role of Maternal Obesity|Completed||N/A|48|Actual|Turku University Hospital||3|||f||||f||||||||||2017-10-11 01:21:25.314537|2017-10-11 01:21:25.314537
NCT01928459|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-08-17|||October 2013||2013-10-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Phase 1b Trial of BGJ398/BYL719 in Solid Tumors|A Phase Ib, Open-label Study of Oral BGJ398 in Combination With Oral BYL719 in Adult Patients With Select Advanced Solid Tumors|Completed||Phase 1|62|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:22:20.506693|2017-10-11 01:22:20.506693
NCT01931527|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-04-28|2015-04-28||July 2006||2006-07-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|June 2008|Actual|2008-06-01||Interventional||Obese subjects with low uric acid (<5mg/dL)|Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status|Effect of Plasma Uric Acid on Insulin Sensitivity, Endothelial Function and Inflammation|Completed||N/A|31|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 01:21:25.401838|2017-10-11 01:21:25.401838
NCT01931514|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-26||||||August 2013|2013-08-01||||February 2008|Actual|2008-02-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable 5mg Tablet Under Fed Conditions|An Open Label, Randomized, Two-Period, Two-Treatment, Crossover, Single-Dose Bioequivalence Study of Montelukast Sodium Chewable Tablets 5mg [Test Formulation, Torrent Pharmaceutical Limited., India] Versus Singulair® (Montelukast Sodium) Chewable Tablets 5mg [Reference Formulation, Merck & Co., Inc. USA] in Healthy Human Volunteers Under Fed Conditions.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 01:21:25.790233|2017-10-11 01:21:25.790233
NCT01931501|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-26||||||August 2013|2013-08-01||||February 2008|Actual|2008-02-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable Tablets 5mg Under Fasted Conditions|An Open Label, Randomized, Two-Period, Two-Treatment, Crossover, Single-Dose Bioequivalence Study of Montelukast Sodium Chewable Tablets 5mg [Test Formulation, Torrent Pharmaceutical Limited., India] Versus Singulair® (Montelukast Sodium) Chewable Tablets 5mg [Reference Formulation, Merck & Co., Inc. USA] in Healthy Human Volunteers Under Fasting Conditions.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 01:21:25.877881|2017-10-11 01:21:25.877881
NCT01931488|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-28|||August 2013||2013-08-01|August 2013|2013-08-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|||124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.|The Feasibility of Novel 124I-MIBG Tracer in Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors. Comparison With 123I-MIBG.|Unknown status|Recruiting|Phase 2|40|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 01:21:25.961474|2017-10-11 01:21:25.961474
NCT01931475|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-04-14|2016-02-29||September 2013||2013-09-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional||All randomized participants.|A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China|Effect of Duloxetine 60mg Once Daily in Patients With Chronic Pain Due to Osteoarthritis in China|Completed||Phase 3|407|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:21:26.114071|2017-10-11 01:21:26.114071
NCT01931462|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-06-19|||August 2014||2014-08-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Microwave Coagulation in Partial Nephrectomy Protocol|A Single Arm Phase 1 Study of Microwave Coagulation Using 2450-MHz Antennae and CO2 Cooling in Partial Nephrectomy for T1 Renal Tumors|Terminated||N/A|2|Actual|University of Wisconsin, Madison||1||Slow enrollment|f||||t||||||||||2017-10-11 01:21:28.085856|2017-10-11 01:21:28.085856
NCT01931449|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-26|||January 2014||2014-01-01|August 2013|2013-08-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|||Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy|Evaluation of a Modified Procedure of Digestive Tract Reconstruction Following Pancreatoduodenectomy: A Multicenter Randomized Controlled Study|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 01:21:28.176473|2017-10-11 01:21:28.176473
NCT01931436|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-26|||August 2013||2013-08-01|August 2013|2013-08-01||||September 2013|Anticipated|2013-09-01||Interventional|||Pharmacokinetics Study of Qing'E Pill|A Single-site, Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics of the Main Components of Qing'E Pill (a Chinese Medicine Formula) Into the Blood in Chinese Menopausal Women|Unknown status|Recruiting|Phase 1|24|Anticipated|Shanghai University of Traditional Chinese Medicine||1|||f||||t||||||||||2017-10-11 01:21:28.287225|2017-10-11 01:21:28.287225
NCT01931423|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2014-03-07|||November 2013||2013-11-01|November 2013|2013-11-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||The Influence of Placental Drainage of Management of the Third Stage of Labor:a Randomized Controlled Study||Completed||N/A|485|Actual|Istanbul Bakirkoy Maternity and Children Diseases Hospital||2|||f||||||||||||||2017-10-11 01:21:28.387102|2017-10-11 01:21:28.387102
NCT01931397|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-03-16|2016-09-21||July 2013||2013-07-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|DBS|Descriptive|DBS for Home Monitoring in Children With Kidney Transplantation|Novel Use of Dried Blood Spots (DBS)for Home Monitoring in Children With Kidney|Completed||N/A|30|Actual|Oregon Health and Science University|This is a pilot study to assess the feasibility of doing home dried blood spot sampling.||1||f||||f||||||||||2017-10-11 01:21:28.589039|2017-10-11 01:21:28.589039
NCT01931384|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-12-10|||July 2012||2012-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of Human Chorionic Gonadotrophin as Luteal Phase Support in Frozen Embryo Transfer|A Randomized Controlled Comparison of Human Chorionic Gonadotrophin as Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles|Completed||N/A|450|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:21:28.884383|2017-10-11 01:21:28.884383
NCT01931371|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-22|||May 2007||2007-05-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|AFPERAF||Anal Fistula Plug Versus Endorectal Advancement Flap|An Outcome and Cost Analysis of Anal Fistula Plug Versus Endorectal Advancement Flap in Complex Anal Fistulae|Unknown status|Active, not recruiting|N/A|71|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 01:21:29.00635|2017-10-11 01:21:29.00635
NCT01931345|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-10-24|||July 2013||2013-07-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||The SPOT Project : Motivational Interviewing in Conjunction With Rapid HIV Testing|The SPOT Project: Effect of Counseling Based on Motivational Interviewing Offered in Conjunction With Rapid HIV Testing on the Occurrence of Unprotected Anal Sex and Its Determinants Among Men Who Have Sex With Men (MSM) in Montreal|Completed||N/A|900|Actual|Universite du Quebec a Montreal||2|||f||||t||||||||||2017-10-11 01:21:29.36982|2017-10-11 01:21:29.36982
NCT01931332|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-26|||February 2010||2010-02-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Intrathecal Diamorphine Versus Femoral Nerve Block in Primary Total Knee Arthroplasty|Randomised, Observer Blinded, Controlled Trial of Intrathecal Diamorphine Versus Femoral Nerve Block for Post-operative Analgesia Following Primary Total Knee Arthroplasty|Completed||N/A|120|Actual|Royal Devon and Exeter NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:21:29.450366|2017-10-11 01:21:29.450366
NCT01931306|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-08-24||||||August 2017|2017-08-01||||||||Expanded Access|||Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)|An Open Label Expanded Access Program of Afatinib (BIBW 2992) in Treatment-naive or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)|Approved for marketing||N/A|||Boehringer Ingelheim|||||f|||t|||||||||||2017-10-11 01:21:29.660608|2017-10-11 01:21:29.660608
NCT01931293|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-01-28|||April 2013||2013-04-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome|HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome|Recruiting||N/A|750|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 01:21:29.750985|2017-10-11 01:21:29.750985
NCT01931280|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-08-10|||September 2013||2013-09-01|September 2014|2014-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|GooD MomS||A Transgenerational e-Intervention for Gestational Diabetics and Their Offspring|A Transgenerational e-Intervention for Gestational Diabetics and Their Offspring: A Pilot Trial|Completed||N/A|50|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 01:21:29.842698|2017-10-11 01:21:29.842698
NCT01931267|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-04-11|||September 2012||2012-09-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||An Coach-based Intervention Study of an Extended Discharge Planning Program on Patients With COPD|An Intervention Study of an Extended Discharge Planning and Disease Management Program on Patients With COPD|Unknown status|Recruiting|N/A|154|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:21:29.947765|2017-10-11 01:21:29.947765
NCT01931254|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2014-12-03|||October 2013||2013-10-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Observational|OPPORTUNITY||Assess a Diagnostic Tool to Distinguish Between Bacterial and Viral Infection|Prospective, Blinded Validation Study to Assess Accuracy of a Diagnostics for Distinguishing Between Bacterial and Viral Etiology in Pediatric Patients With Lower Respiratory Tract Infections and Fever Without Source|Unknown status|Recruiting|N/A|830|Anticipated|UMC Utrecht|||1||f||||f||||||Samples Without DNA|"     One blood sample and one nasal swab will be collected per patient   "|||2017-10-11 01:21:30.10197|2017-10-11 01:21:30.10197
NCT01931241|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-11-18|||June 2013||2013-06-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Safety Study of Bile Acid to Treat Hypercholesteremia|Phase I Randomized Placebo Controlled Double Blind SAD and MAD Study of Oral AHRO-001 to Assess Safety, Tolerability &PK in Volunteers w/Mild/Moderate Hypercholesteremia|Unknown status|Active, not recruiting|Phase 1|110|Anticipated|AtheroNova Inc.||5|||f||||f||||||||||2017-10-11 01:21:30.320024|2017-10-11 01:21:30.320024
NCT01931228|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-07-30|||May 2012||2012-05-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|February 2015|Actual|2015-02-01||Interventional|NEUROMIE||Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy|Contribution of Mechanical Insufflation-Exsufflation in Preventing Respiratory Failure Post Extubation in Patient With Critical Care Neuromyopathy|Unknown status|Recruiting|N/A|240|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 01:21:30.457063|2017-10-11 01:21:30.457063
NCT01931202|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-09-22|||August 2013||2013-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Mechanisms of Antidepressant Non-Response in Late-Life Depression|Mechanisms of Antidepressant Non-Response in Late-Life Depression|Recruiting||N/A|130|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-10-11 01:21:30.727193|2017-10-11 01:21:30.727193
NCT01931189|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2014-06-27|||August 2013||2013-08-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Pharmacokinetics Study of NI-071|A Clinical Pharmacokinetics Study of NI-071|Completed||Phase 1|96|Actual|Nichi-Iko Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:21:30.860816|2017-10-11 01:21:30.860816
NCT01931176|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-12-14|||June 2013||2013-06-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults|A Phase 1 Evaluation of the Safety and Immunogenicity of rDEN2Δ30-7169, a Live Attenuated Monovalent Dengue Virus Vaccine|Completed||Phase 1|14|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 01:21:30.956864|2017-10-11 01:21:30.956864
NCT01931163|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-09-12|||July 2013||2013-07-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|NECTAR||NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer|Neoadjuvant Phase II Study Of Everolimus Plus Cisplatin In Triple Negative Breast Cancer Patients With Residual Disease After Standard Chemotherapy|Recruiting||Phase 2|32|Anticipated|The Methodist Hospital System||1|||f||||f||||||||||2017-10-11 01:21:31.099471|2017-10-11 01:21:31.099471
NCT01931150|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-11-18|2016-01-19||August 2013||2013-08-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT|A Phase III Randomized Double-blind Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT|Completed||Phase 3|11|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:21:31.23242|2017-10-11 01:21:31.23242
NCT01931137|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2014-01-03|||August 2013||2013-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects|A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects|Completed||Phase 1|45|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 01:21:31.499335|2017-10-11 01:21:31.499335
NCT01931124|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-09-01|||August 2012|Actual|2012-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||High Intensity and Moderate Training and Maximal Oxygen Uptake and Activity Levels|Effect of High Intensity and Moderate Training on Maximal Oxygen Uptake and Activity Levels in an Elderly Norwegian Population|Active, not recruiting||N/A|1600|Anticipated|Norwegian University of Science and Technology||2|||f||||t|f|f||||||||2017-10-11 01:21:31.589501|2017-10-11 01:21:31.589501
NCT01931111|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-09-18|||August 2012|Actual|2012-08-01|September 2017|2017-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Cardiovascular Risk Factors, Maximal Oxygen Uptake and Sedentariness: an Observational Study|Correlation Between Cardiovascular Risk Factors, Sedentary Behaviors and Maximal Oxygen Uptake in an Elderly Norwegian Population|Completed||N/A|874|Actual|Norwegian University of Science and Technology|||1||f||||t|f|f||||||||2017-10-11 01:21:31.66887|2017-10-11 01:21:31.66887
NCT01931098|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-08-05|||December 10, 2015||2015-12-10|November 30, 2016|2016-11-30|September 1, 2020|Anticipated|2020-09-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab|A Phase II Trial of Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A)Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab|Not yet recruiting||Phase 2|66|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:21:31.751887|2017-10-11 01:21:31.751887
NCT01931085|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-08-18||||||August 2016|2016-08-01||||||||Expanded Access|||Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)|"Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)"|Available||N/A|||University of Colorado, Denver|||||||||||||||||||2017-10-11 01:21:31.88312|2017-10-11 01:21:31.88312
NCT01931072|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-03-07|||August 2012|Actual|2012-08-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Exercise-induced Changes in DNA-methylation|The Effect of Exercise on Maximal Aerobic Capacity, DNA-methylation and Gene Expression in Healthy Elderly Men|Completed||N/A|37|Actual|Norwegian University of Science and Technology||3|||f||||t|f|f||||||No||2017-10-11 01:21:31.948499|2017-10-11 01:21:31.948499
NCT01931046|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2015-12-28|||October 2013||2013-10-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of a Recombinant Adenovirus to Treat Localized Prostate Cancer|A Phase 1 / 2a Study of In-situ REIC/Dkk-3 Therapy in Subjects With Localized Prostate Cancer (MTG-REIC-PC003)|Recruiting||Phase 1/Phase 2|30|Anticipated|Momotaro-Gene Inc.||2|||f||||f||||||||||2017-10-11 01:21:32.613086|2017-10-11 01:21:32.613086
NCT01931033|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-06-21|||October 2013||2013-10-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders|An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:21:32.735543|2017-10-11 01:21:32.735543
NCT01931020|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-06-24|||July 2013||2013-07-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Analgesic Effect of Oral 25% Glucose Versus Oral 24% Sucrose for Pain Relief During Heel Lance in Preterm Neonates|Double Blind Randomised Controlled Trial to Compare the Efficacy of Oral 25% Glucose With Oral 24% Sucrose for Pain Relief During Heel Lance in Preterm Neonates|Completed||N/A|94|Actual|Lady Hardinge Medical College||2|||f||||t||||||||Undecided||2017-10-11 01:21:32.858402|2017-10-11 01:21:32.858402
NCT01931007|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-05-03|||August 2013||2013-08-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|BMAC||Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis|Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis, A Randomized Placebo Controlled Pilot Study|Completed||Phase 1|25|Actual|Mayo Clinic||2|||f||||t|t|f||||||Undecided||2017-10-11 01:21:32.945839|2017-10-11 01:21:32.945839
NCT01930994|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-10-11|||September 2013||2013-09-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Kenya Sino-implant (II) PK Study|A Pharmacokinetic Study to Compare Sino-implant (II) During Four Years of Use to Jadelle During Five Years of Use by Kenyan Women|Withdrawn||N/A|0|Actual|FHI 360|||6|Insufficient numbers of Sino-implant users available for study participation.|f||||f||||||||||2017-10-11 01:21:33.042866|2017-10-11 01:21:33.042866
NCT01930981|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-02-01|||October 2012||2012-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life|Prospective Assessment of Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life|Active, not recruiting||N/A|300|Anticipated|Fred Hutchinson Cancer Research Center|||1||f||||f||||||||||2017-10-11 01:21:33.12926|2017-10-11 01:21:33.12926
NCT01930968|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-02-24|||January 2018|Anticipated|2018-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Definity for Ultrasound of Intraocular Tumors|Use of Definity® Contrast Agent for Ultrasound of Intraocular Tumors|Not yet recruiting||N/A|10|Anticipated|Emory University|||1||f||||t|f|f||||||Yes|Once research is completed, results of the study will be published in a specialty journal|2017-10-11 01:21:33.208475|2017-10-11 01:21:33.208475
NCT01930955|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-02-10|||August 2011||2011-08-01|August 2013|2013-08-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Non-antibiotic Prescribing for Acute Upper Respiratory Tract Infection|Non-antibiotic Prescribing for Acute Upper Respiratory Tract Infection：a Randomized-control Trial|Unknown status|Recruiting|N/A|150|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:21:33.297584|2017-10-11 01:21:33.297584
NCT01930942|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-01-04|||January 2006||2006-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal Carcinoma|Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal Carcinoma|Recruiting||Phase 2|150|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 01:21:33.385994|2017-10-11 01:21:33.385994
NCT01930929|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-12-03|||November 2013||2013-11-01|August 2013|2013-08-01|July 2016|Anticipated|2016-07-01|August 2015|Anticipated|2015-08-01||Observational|||Prevalence of Complications After Bariatric Surgery - an Epidemiologic Survey|Prevalence of Medical and Nutritional Complications After Bariatric Surgery (Gastric Bypass) Based on an Epidemiologic Survey|Unknown status|Recruiting|N/A|5000|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-11 01:21:33.470321|2017-10-11 01:21:33.470321
NCT01930916|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-04-08|||October 2012||2012-10-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|AGINR||Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients|Accuracy of a Portable International Normalized Ratio Monitor in a Population Aged 75 Years Old and Over|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Caen||1|||f||||t||||||||||2017-10-11 01:21:33.676952|2017-10-11 01:21:33.676952
NCT01930903|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-04-29|||September 2013||2013-09-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PaneLux PTCA||PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon|Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon|Unknown status|Active, not recruiting|N/A|500|Anticipated|Biotronik France|||||f||||f||||||||||2017-10-11 01:21:33.840007|2017-10-11 01:21:33.840007
NCT01930890|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-11-22|2016-11-22||November 2013||2013-11-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis|A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis|Terminated||Phase 2|87|Actual|Biogen|Study was terminated based on the pre-specified, blinded futility analysis of Study 211LE201 (NCT01499355), which did not demonstrate sufficient efficacy to warrant continuation of the studies. Study was not terminated based on safety considerations.|2||"Results from pre-specified criteria in study NCT01499355 (211LE201) did not demonstrate   sufficient efficacy to warrant continuation of the study"|f||||t||||||||||2017-10-11 01:21:33.949115|2017-10-11 01:21:33.949115
NCT01930877|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2015-09-29|||August 2013||2013-08-01|September 2015|2015-09-01||||April 2014|Actual|2014-04-01||Interventional|||Effect of Perioperative Intravenous Lidocaine on Postoperative Quality of Recovery in Patients Undergoing Spine Surgery|The Effect of Perioperative Lidocaine on Postoperative Quality of Recovery in Patients Undergoing Spine Surgery: A Randomized, Double - Blinded, Placebo Controlled Study|Withdrawn||Phase 2|0|Actual|Baylor College of Medicine||2||Withdrawn by PI|f||||f||||||||||2017-10-11 01:21:35.065186|2017-10-11 01:21:35.065186
NCT01930864|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2017-06-21|||September 1, 2015|Actual|2015-09-01|June 2017|2017-06-01|December 1, 2020|Anticipated|2020-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||Metformin Plus Irinotecan for Refractory Colorectal Cancer|Phase II Trial of Metformin Combined to Irinotecan for Refractory Metastatic or Recurrent Colorectal Cancer|Recruiting||Phase 2|41|Anticipated|Barretos Cancer Hospital||1|||f||||f||||||||Yes|Upon data collection, the info will be put on a online database|2017-10-11 01:21:35.135712|2017-10-11 01:21:35.135712
NCT01930851|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-12-03|||February 2014||2014-02-01|August 2013|2013-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Complications After Bariatric Surgery Based, a Questionnaire Survey|Prevalence of Medical and Nutritional Complications After Bariatric Surgery (Gastric Bypass) Based on a Questionnaire Survey|Completed||N/A|1429|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 01:21:35.257321|2017-10-11 01:21:35.257321
NCT01930838|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2014-12-03|||August 2015||2015-08-01|September 2013|2013-09-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01|1 Month|Observational [Patient Registry]|||Complications After Bariatric Surgery - a Clinical Trial|Prevalence of Medical and Nutritional Complications After Bariatric Surgery (Gastric Bypass) Based on a Clinical Trial|Unknown status|Not yet recruiting|N/A|400|Anticipated|University of Aarhus|||2||f||||f||||||Samples With DNA|"     Whole blood Urine   "|||2017-10-11 01:21:35.329292|2017-10-11 01:21:35.329292
NCT01930812|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-12-28|||April 2014||2014-04-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||18F-NaF PET Imaging for Bone Scintigraphy|18F- Sodium Fluoride PET Imaging as a Replacement for Bone Scintigraphy|Recruiting||Phase 3|286|Anticipated|British Columbia Cancer Agency||1|||f||||t||||||||||2017-10-11 01:21:35.4275|2017-10-11 01:21:35.4275
NCT01930799|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-26|2016-04-21|2016-03-07||August 2013||2013-08-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns||Completed||Phase 4|120|Actual|Allergan||1|||f||||f||||||||||2017-10-11 01:21:35.567716|2017-10-11 01:21:35.567716
NCT01930773|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-08-29|||March 2013||2013-03-01|August 2013|2013-08-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|ONSIDE TEST||Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)|Optimal P2Y12-receptor treatmeNt Guided by bedSIDe Genetic or Pharmacodynamic TESTing to Prevent Periprocedural Myonecrosis During Elective Percutaneous Coronary Intervention.|Unknown status|Recruiting|Phase 3|150|Anticipated|Medical University of Warsaw||3|||f||||f||||||||||2017-10-11 01:21:36.146918|2017-10-11 01:21:36.146918
NCT01930760|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-08-25|||January 2010||2010-01-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|SPEAK IM OK||Supporting Physicians With Education And Know-how in Identifying and Motivating Overweight Kids|Supporting Physicians With Education And Know-how in Identifying and Motivating Overweight Kids: SPEAK IM OK|Completed||N/A|20|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 01:21:36.280567|2017-10-11 01:21:36.280567
NCT01930734|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-08-29|||October 2013||2013-10-01|August 2013|2013-08-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|DoBHF||Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients|Randomized-Controlled-Double Blind Trial of Low Dose Dobutamine in Advanced Heart Failure Patients in a Day-Care Clinic|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 01:21:36.446695|2017-10-11 01:21:36.446695
NCT01930721|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2013-08-28|||March 2012||2012-03-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|IAME||Comparison of Incision Angle of Mediolateral Episiotomy at 40 and 60 Degrees|Comparison of Incision Angle of Mediolateral Episiotomy at 40 and 60 Degrees|Unknown status|Recruiting|Phase 2|330|Anticipated|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-11 01:21:36.528812|2017-10-11 01:21:36.528812
NCT01930708|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-08-25|||October 31, 2013|Actual|2013-10-31|August 2017|2017-08-01|April 8, 2019|Anticipated|2019-04-08|March 31, 2016|Actual|2016-03-31||Interventional|PROTEC||A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes|A Multicenter, Open-Label Study Evaluating the Effectiveness of Oral Tecfidera™ (Dimethyl Fumarate) on MS Disease Activity and Patient-Reported Outcomes in Subjects With Relapsing-Remitting Multiple Sclerosis in the Real-World Setting|Active, not recruiting||Phase 4|1114|Actual|Biogen||1|||f||||f||||||||||2017-10-11 01:21:36.628254|2017-10-11 01:21:36.628254
NCT01930695|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2015-01-09|||August 2013||2013-08-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|Pre-CRAFT||Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T|Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T|Completed||N/A|18|Actual|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 01:21:37.057811|2017-10-11 01:21:37.057811
NCT01930682|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-08-28|||January 13, 2014|Actual|2014-01-13|August 2013|2013-08-01|September 12, 2016|Actual|2016-09-12|September 2016|Actual|2016-09-01||Interventional|EARLY-MYO||EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction|EARLY Routine Catheterization or Rescue Angioplasty After Alteplase Fibrinolysis vs. Primary Angioplasty in Acute ST-elevation MYOcardial Infarction: An Open, Prospective, Randomized, Multicentre Trial|Completed||Phase 4|344|Actual|RenJi Hospital||2|||f||||t||||||||||2017-10-11 01:21:37.165218|2017-10-11 01:21:37.165218
NCT01930669|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2014-11-03|||August 2013||2013-08-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Transplanted-like Heart in Critical Ill Patients||Completed||N/A|150|Actual|ASST Fatebenefratelli Sacco||1|||f||||f||||||||||2017-10-11 01:21:37.284719|2017-10-11 01:21:37.284719
NCT01930656|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-04-22|||March 2013||2013-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|||Mobile Device to Help FRAX® Screening|The Effectiveness of Using Mobile Device and the World Health Organization Fracture Risk Assessment Tool (FRAX®) to Assist Osteoporosis Assessment and Management|Completed||N/A|225|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:21:37.415374|2017-10-11 01:21:37.415374
NCT01930643|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2016-11-04|||August 2013||2013-08-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Electric Muscle Stimulation for Patients With Chronic Respiratory Failure|Effect of Electric Muscle Stimulation on Patients With Chronic Respiratory Failure|Suspended||N/A|100|Anticipated|Mackay Memorial Hospital||2||slow recruitment and change of faculty|f||||f||||||||No||2017-10-11 01:21:37.530292|2017-10-11 01:21:37.530292
NCT01930630|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-22|||October 2013||2013-10-01|August 2013|2013-08-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|ESI||ESI With EUS to Differentiate T3 and T4 ESCC|Extraesophageal Saline Injection Combined With EUS to Differentiate Between T3 and T4 Stage Esophageal Squamous Cell Carcinoma — A PhaseⅠTrial|Unknown status|Not yet recruiting|Phase 1|10|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 01:21:37.648182|2017-10-11 01:21:37.648182
NCT01930617|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-06-24|||June 2014||2014-06-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Irrigation of Chronic Subdural Hematomas - is More Better?|Irrigation of Chronic Subdural Hematomas - is More Better? A Population Based Study Between Different Treatment Policies|Completed||N/A|1258|Actual|St. Olavs Hospital|||3||f||||f||||||||||2017-10-11 01:21:37.777762|2017-10-11 01:21:37.777762
NCT01930604|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2016-08-16|||September 2013||2013-09-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis|Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis, a Randomized, Double Blind, Placebo Controlled Study|Recruiting||Phase 2|588|Anticipated|Hidrosis Clinic, Stockholm, Sweden||10|||f||||t||||||||||2017-10-11 01:21:37.902217|2017-10-11 01:21:37.902217
NCT01930591|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-11-21|||May 2014||2014-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|SETFAST||Ticagrelor for PCI Post Thrombolysis|The Safety and Efficacy of Ticagrelor for Coronary Stenting Post Thrombolysis (SETFAST) Trial.|Completed||Phase 3|140|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||No||2017-10-11 01:21:38.043059|2017-10-11 01:21:38.043059
NCT01930578|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-09-12|||May 2008||2008-05-01|September 2013|2013-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Bioimpedance Spectroscopy in Humans During Acute Fluid Volume Expansion With Different Crystalloid Solutions|Bioimpedance Spectroscopy in Humans During Acute Fluid Volume Expansion With Different Crystalloid Solutions|Completed||Phase 1|15|Actual|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-11 01:21:38.186368|2017-10-11 01:21:38.186368
NCT01930565|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-22|||January 2013||2013-01-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effectiveness and Safety of New Botanical Component-LFCO- Compared With Existing TTO in Clinical Study|Comparison of Clinical and Histological Effects Between Lactobacillus Fermented Chamaecypris Obtusa and Tea Tree Oil for the Treatment of Mild to Moderate Acne: an 8-week Double Blind, Randomized Controlled, Split-face Study|Completed||N/A|34|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:21:38.314348|2017-10-11 01:21:38.314348
NCT01930552|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-01-06|||September 2013||2013-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies|A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Aflibercept in Combination With FOLFIRI Administrated Every 2 Weeks in Chinese Patients With Advanced Solid Malignancies|Completed||Phase 1|20|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:21:38.444552|2017-10-11 01:21:38.444552
NCT01930539|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-10-25|||October 2013||2013-10-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Vitamin D Deficiency in Intestinal Rehabilitation Clinic Patients With a Portable Ultraviolet B Lamp|Treatment of Vitamin D Deficiency in Intestinal Rehabilitation Clinic Patients With a Portable Ultraviolet B Lamp|Recruiting||N/A|70|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-10-11 01:21:38.547962|2017-10-11 01:21:38.547962
NCT01930526|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-01-04|||July 2011||2011-07-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|November 2012|Actual|2012-11-01||Interventional|||Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation|Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation|Completed||N/A|22|Actual|West Park Healthcare Centre||1|||f||||f||||||||||2017-10-11 01:21:38.673576|2017-10-11 01:21:38.673576
NCT01930513|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-01-04|||November 2010||2010-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2012|Actual|2012-01-01||Observational|||Exercise Capacity and Daily Physical Activity in Obese Subjects With Treated Obstructive Sleep Apnea|Exercise Capacity and Daily Physical Activity in Obese Subjects With Treated Obstructive Sleep Apnea|Completed||N/A|16|Actual|West Park Healthcare Centre|||1||f||||f||||||||||2017-10-11 01:21:38.76653|2017-10-11 01:21:38.76653
NCT01930500|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-01-20|||November 2012||2012-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|November 2015|Actual|2015-11-01||Interventional|||The Effectiveness of Neuropsychological Rehabilitation in Young Dyslexic Adults|The Effectiveness of Neuropsychological Rehabilitation in Young Dyslexic Adults - a Single Blind, Randomized, Controlled Study|Active, not recruiting||N/A|120|Actual|Rehabilitation Foundation, Finland||3|||f||||f||||||||||2017-10-11 01:21:38.862069|2017-10-11 01:21:38.862069
NCT01930487|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-10-13|2016-05-31||August 2013||2013-08-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional||patients who completed both periods of the crossover study|The Effects of an Antioxidant Formulation on Ocular Blood Flow|The Effects of an Antioxidant Formulation on Intraocular Pressure, Ocular Perfusion Pressure, Retrobulbar, Retinal Capillary and Choroidal Blood Flow|Completed||N/A|47|Actual|ScienceBased Health||2|||f||||f||||||||||2017-10-11 01:21:39.014101|2017-10-11 01:21:39.014101
NCT01930474|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-12-03|||July 2013||2013-07-01|December 2013|2013-12-01||||December 2018|Anticipated|2018-12-01||Observational|||Analysis of Plasma Tumor DNA in Lung Cancer Patients|Analysis of Mechanism of Resistance to Chemotherapy by Sequencing of Plasma DNA|Recruiting||N/A|200|Anticipated|Seoul National University Hospital|||1||f||||||||||||||2017-10-11 01:21:40.848538|2017-10-11 01:21:40.848538
NCT01930461|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-12-17|||September 2013||2013-09-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma|A Dose Ranging Study Investigating the Efficacy and Safety of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adults With House Dust Mite-associated Allergic Asthma|Completed||Phase 2|386|Actual|Stallergenes Greer||4|||f||||t||||||||||2017-10-11 01:21:40.965254|2017-10-11 01:21:40.965254
NCT01930448|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-09-09|||September 2008||2008-09-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1|Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1|Withdrawn||N/A|0|Actual|St. Luke's-Roosevelt Hospital Center|||2|PI relocated to another Institution|f||||f||||||||||2017-10-11 01:21:41.087736|2017-10-11 01:21:41.087736
NCT01930435|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-07-11|2015-12-01||July 2013||2013-07-01|July 2017|2017-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer Patients|A Phase II Study Monitoring Quality of Life and Correlative Biomarkers of Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy Utilizing a Personalized Sterile Humidification Device|Completed||N/A|20|Actual|University of California, San Francisco|The primary endpoint was based on results from a prior MDASI validation study in a similar population. However, patients enrolled in this study reported a much higher level of symptoms than was recorded in this MDASI validation study.|1|||f||||t||||||||||2017-10-11 01:21:41.380223|2017-10-11 01:21:41.380223
NCT01930422|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2014-02-21|||July 2013||2013-07-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|TABELEC||Effect of Transcranial Direct Current Stimulation (tDCS) on Tobacco Consumption|Effect of Transcranial Direct Current Stimulation (tDCS) on Tobacco Consumption.|Completed||N/A|34|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 01:21:41.696578|2017-10-11 01:21:41.696578
NCT01930409|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-05-27|||November 2013||2013-11-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|B2F||Back to the Future: Bridging the Hospital to Home Continuum After Hip Fracture|A Feasibility Study Investigating Telephone Supported Discharge From Acute Care to the Community After Hip Fracture|Completed||N/A|30|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 01:21:41.884007|2017-10-11 01:21:41.884007
NCT01930396|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-10-12|||September 2013||2013-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|HEMO-TIN||Use of Tinzaparin for Anticoagulation in Hemodialysis|Intermittent HEMOdialysis Anticoagulation With TINzaparin Versus Unfractionated Heparin: A Pilot Multicentre Randomized Controlled Trial (HEMO-TIN Trial)|Completed||Phase 4|191|Actual|St. Joseph's Healthcare Hamilton||2|||f||||t||||||||||2017-10-11 01:21:42.007362|2017-10-11 01:21:42.007362
NCT01930383|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-11-13|||October 2013||2013-10-01|November 2013|2013-11-01||||August 2015|Anticipated|2015-08-01||Observational|CTCs for HCC||Circulating Tumor Cells for Hepatocellular Carcinoma|Circulating Tumor Cells (CTCs) as Biomarkers of Prognosis and Predictors of Efficacy of Drug Therapy for Patients With Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||3||f||||f||||||Samples With DNA|"     The blood samples will be separated to blood cells and plasma. Blood cells will be used for     isolation and enumeration of CTCs. Plasma will be used to extract DNA to measure molecular     aberration (gene mutations related to hepatocarcinogenesis or response of HCC cells to     molecular targeted therapy).   "|||2017-10-11 01:21:42.123089|2017-10-11 01:21:42.123089
NCT01930370|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-05-27|||March 2010||2010-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Varied Dialysate Bicarbonate Levels on Phosphate and Potassium Removal|Effect of Varied Dialysate Bicarbonate Levels on Phosphate and Potassium Removal: A Pilot Study|Completed||Phase 4|12|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 01:21:42.221829|2017-10-11 01:21:42.221829
NCT01930357|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-04-24||2014-11-17|September 2013||2013-09-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|||Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen|Immunogenicity and Safety of the Purified Vero Rabies Vaccine - Serum Free (VRVg) in Comparison With the Human Diploid Cell Vaccine, Imovax® Rabies in a Pre-exposure Prophylaxis Regimen in Healthy Children and Adolescents Aged 2 to 17 Years|Completed||Phase 2|342|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:21:42.329702|2017-10-11 01:21:42.329702
NCT01930344|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-12-02|||May 2013||2013-05-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Investigating Three-Dimensional Versus Two-Dimensional Imaging in Laparoscopic Cholecystectomies|Does Three-Dimensional Laparoscopy Provide Significant Advantages for Patients and Surgeons? A Randomised Controlled Trial Investigating Operating Time and Surgical Errors With 3D vs 2D Visual Systems in Laparoscopic Cholecystectomies.|Completed||N/A|114|Actual|Royal Surrey County Hospital||2|||f||||t||||||||||2017-10-11 01:21:42.447237|2017-10-11 01:21:42.447237
NCT01930331|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-08-23|||September 2013||2013-09-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO|Safety, Tolerability, Pharmacokinetics and Efficacy, Phase Iv, Open Label Study of Fixed Arco® and Eurartesim® Therapies in Adults and Children With Uncomplicated P. Falciparum Malaria in Tanzania|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Ifakara Health Institute||2|||f||||t||||||||||2017-10-11 01:21:42.537688|2017-10-11 01:21:42.537688
NCT01930318|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2014-11-07|||August 2013||2013-08-01|November 2014|2014-11-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic Surgery|Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance, Tramadol PCA and Early Postoperative Enteral Nutrition in Patients After Gastrointestinal Laparoscopic Surgery|Unknown status|Recruiting|Phase 4|164|Anticipated|Jinling Hospital, China||4|||f||||t||||||||||2017-10-11 01:21:42.673565|2017-10-11 01:21:42.673565
NCT01930305|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-07-10|||June 2012||2012-06-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|||Effects of Heating Transfusion on Brain Function|Effects of Heating Transfusion on Brain Function of Surgical Patients|Completed||N/A|100|Anticipated|General Hospital of Ningxia Medical University|||1||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:21:42.777232|2017-10-11 01:21:42.777232
NCT01930292|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-03-23|||April 2013||2013-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies|A Phase I Study to Evaluate the Safety and Determine the Maximum Tolerated Dose (MTD) of Debio 1143 Combined With Carboplatin and Paclitaxel in Patients With Squamous Non-Small Cell Lung Cancer (NSCLC), Platinum-refractory Ovarian Cancer, and Basal-like/Claudin Low Triple Negative Breast Cancer (TNBC)|Terminated||Phase 1|31|Actual|Debiopharm International SA||4||Part B was cancelled based on business decision|f||||f||||||||||2017-10-11 01:21:42.853735|2017-10-11 01:21:42.853735
NCT01930279|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-08-27|||September 2013||2013-09-01|August 2013|2013-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||Effect of Partial Sleep Deprivation on Immunological System in Peripheral Blood|Effect of Sleep Deprivation on Expression of T Cell Markers in Peripheral Blood of Medical Residents|Unknown status|Not yet recruiting|N/A|50|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-10-11 01:21:43.012115|2017-10-11 01:21:43.012115
NCT01930266|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-25|2013-08-27|||August 2013||2013-08-01|August 2013|2013-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Young Adults With Life Threatening Cow's Milk Allergy: Risks of Decrease Bone Mineralization and Methods of Calcium Supplementation||Unknown status|Recruiting|N/A|150|Anticipated|Assaf-Harofeh Medical Center||3|||f||||t||||||||||2017-10-11 01:21:43.0983|2017-10-11 01:21:43.0983
NCT01930253|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2013-08-23|||July 2012||2012-07-01|August 2013|2013-08-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Use of Bortezomib to Treat Refractory Autoimmune Cytopenia(s) in Allogeneic Stem Cell Transplantation|Use of Bortezomib to Treat Refractory Autoimmune Cytopenia(s) in Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|Phase 1|5|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 01:21:43.18537|2017-10-11 01:21:43.18537
NCT01930240|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-07-25|||November 2007||2007-11-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|Cortria-002||The Safety of a Hypolipidemic Agent in Healthy Normal Volunteers|A Randomized Placebo Controlled Double Blind Two Period Cross-Over Study to Assess the Safety and Pharmacokinetics and Pharmacodynamics of Oral Dosages of TRIA-662 (A Hypolipidemic Agent) in Healthy Volunteers|Completed||Phase 1|20|Actual|Cortria Corporation||3|||f||||f||||||||No||2017-10-11 01:21:43.272885|2017-10-11 01:21:43.272885
NCT01930227|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-24|2014-12-07|||September 2013||2013-09-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|THSAP||Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hypotension After Spinal Anesthesia in Parturients|Effect of Transcutaneous Electrical Acupoint Stimulation(TEAS) on the Incidence of Hypotension After Spinal Anesthesia in Patients Undergoing Cesarean Section: a Prospective, Randomized Controlled Trial|Completed||N/A|150|Actual|Xijing Hospital||3|||f||||t||||||||||2017-10-11 01:21:43.351648|2017-10-11 01:21:43.351648
NCT01930214|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-08-29|||September 26, 2013|Actual|2013-09-26|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|December 30, 2016|Actual|2016-12-30||Observational|MACE||Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)|Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)|Completed||N/A|350|Actual|Cardiovascular Systems Inc|||3||f||||f||||||||||2017-10-11 01:21:43.460346|2017-10-11 01:21:43.460346
NCT01930201|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-10-28|||June 2013||2013-06-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Caudal Epidural Block for Postoperative Analgesia in Adolescents Following Major Hip Surgery.||Completed||N/A|32|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 01:21:43.74084|2017-10-11 01:21:43.74084
NCT01930188|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-04-18||2016-11-10|December 2, 2013|Actual|2013-12-02|April 2017|2017-04-01|October 12, 2015|Actual|2015-10-12|October 12, 2015|Actual|2015-10-12||Interventional|SUSTAIN™ 2||Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes|Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes (SUSTAIN™ 2 - vs. DPP-4 Inhibitor)|Completed||Phase 3|1231|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 01:21:43.835016|2017-10-11 01:21:43.835016
NCT01930175|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-09-13|||December 18, 2013|Actual|2013-12-18|September 2017|2017-09-01|February 13, 2018|Anticipated|2018-02-13|February 13, 2018|Anticipated|2018-02-13||Interventional|||Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris|A Randomized, Partial-blind, Placebo-controlled Trial Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of VAY736 in the Treatment of Patients With Pemphigus Vulgaris|Active, not recruiting||Phase 2|16|Actual|Novartis||3|||f||||t|t|f||||||||2017-10-11 01:21:44.198937|2017-10-11 01:21:44.198937
NCT01930162|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-08-31|2017-07-12||October 7, 2014|Actual|2014-10-07|August 2017|2017-08-01|August 29, 2016|Actual|2016-08-29|August 29, 2016|Actual|2016-08-29||Interventional|UCBT|Safety Analysis Set: The Safety analysis included all enrolled patients who were transplanted with HSC835 (any patient with a date for HSC835 transplant).|Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant|A Single-arm, Open-label Study to Evaluate the Safety and Tolerability of Infusing HSC835 in Patients With Hematological Malignancies Undergoing UCB Transplantation Using a Non-myeloablative Conditioning Regimen|Completed||Phase 2|9|Actual|Novartis||1|||f||||t|t|f||||||||2017-10-11 01:21:44.28681|2017-10-11 01:21:44.28681
NCT01930149|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-09-26|||December 2013||2013-12-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Promoting Cholesterol Screening|Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening|Completed||N/A|480|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:21:44.601503|2017-10-11 01:21:44.601503
NCT01930136|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-07-06|||May 2013||2013-05-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|May 2018|Anticipated|2018-05-01||Interventional|CRESO2||Effects of Caloric Restriction in Obesity and Type 2 Diabetes|LONG-TERM EFFECTS OF CALORIC RESTRICTION ON METABOLIC, RENAL AND RETINAL HEALTH IN SUBJECTS AFFECTED BY OBESITY AND TYPE 2 DIABETES|Active, not recruiting||N/A|100|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-11 01:21:44.672908|2017-10-11 01:21:44.672908
NCT01930123|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-07-06|||October 2013||2013-10-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Impact of Fructose on Metabolism, Energy Homeostasis and MR Biomarkers in NAFLD||Recruiting||Phase 1|100|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 01:21:44.749271|2017-10-11 01:21:44.749271
NCT01930110|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-05-01|||April 2014||2014-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Closed-loop Control of Glucose Levels (Artificial Pancreas) During Exercise in Adults With Type 1 Diabetes|An Open-label, Randomized, Cross-over Study to Compare the Efficacy of Single-hormone Closed-loop Strategy and Dual-hormone Closed-loop Strategy at Regulating Glucose Levels During Continuous Exercise and Interval Exercise in Adults With Type-1 Diabetes|Completed||Phase 2|15|Actual|Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||||2017-10-11 01:21:46.520971|2017-10-11 01:21:46.520971
NCT01930097|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-04-08|||August 2013||2013-08-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes|An Open-label, Randomized, Three-way, Cross-over Study to Compare the Efficacy of Closed-loop Operation Combined With Meal-and-carbohydrate-announcement Closed-loop Operation Combined With Meal-announcement, and Conventional Pump Therapy in Regulating Glucose Levels in Adults With Type 1 Diabetes|Completed||Phase 2|12|Actual|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-11 01:21:46.604356|2017-10-11 01:21:46.604356
NCT01930084|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-02-06|||April 2013|Actual|2013-04-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|E4H||ENGAGE4HEALTH: A Combination Intervention Strategy for Linkage and Retention in Mozambique|ENGAGE4HEALTH: A Combination Strategy for Linkage and Retention in HIV Care Among Adults in Mozambique|Completed||N/A|2004|Actual|Columbia University||3|||f||||f|f|f||||||No||2017-10-11 01:21:46.704087|2017-10-11 01:21:46.704087
NCT01930071|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-04-11|||November 2013||2013-11-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PQB4FP1||PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass|PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass|Completed||N/A|4|Actual|PQ Bypass, Inc.||1|||f||||f||||||||||2017-10-11 01:21:46.803815|2017-10-11 01:21:46.803815
NCT01930058|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-03-10|2015-11-11||October 2013||2013-10-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003)|A Multiple Dose Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MK-8876 in Hepatitis C Patients|Completed||Phase 1|9|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 01:21:46.886659|2017-10-11 01:21:46.886659
NCT01930045|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-02-14|2014-10-29||October 2013||2013-10-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)|A Study to Evaluate the Effect of Staggered Dosing of a Magnesium/Aluminum Antacid on Raltegravir Pharmacokinetics in HIV-Infected Subjects on a Raltegravir-Containing Regimen|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:21:47.291661|2017-10-11 01:21:47.291661
NCT01930032|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-03-06|||August 2013||2013-08-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Pathogenic Mechanisms in C Diff Infection and Colitis|Pathogenic Mechanisms in Clostridium Difficile Infection and Colitis|Completed||N/A|24|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||Samples With DNA|"     Colonic biopsy samples   "|||2017-10-11 01:21:48.064224|2017-10-11 01:21:48.064224
NCT01930019|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2013-08-27|||June 2009||2009-06-01|August 2013|2013-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Influence of Induction Anesthetic Agents on Serum Cortisol Concentration in Morbidly Obese Patients.|The Influence of Induction Agents of General Anesthesia (Etomidate and Thiopental) on Serum Cortisol Concentration in Morbidly Obese Patients. A Randomized Controlled Trial.|Completed||N/A|82|Actual|Military Institute of Medicine, Poland||4|||f||||f||||||||||2017-10-11 01:21:48.153069|2017-10-11 01:21:48.153069
NCT01930006|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2015-01-06|||August 2013||2013-08-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety Study of Two Oral Formulations of MGCD265 Administered in Healthy Subjects in the Fasting State|Phase 1 Single Dose 2-Way Crossover Comparative Bioavailability Study Of Two Oral Formulations Of MGCD265 In Healthy Male And Female Subjects - Fasting State|Completed||Phase 1|14|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 01:21:48.278585|2017-10-11 01:21:48.278585
NCT01929993|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2015-06-30|2015-05-24||January 2008||2008-01-01|June 2015|2015-06-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins|Large Loop Excision of Transformation Zone Cone Versus Straight Wire Excision of Transformation Zone : Histopathological Analysis of Excision Margins|Completed||Phase 3|164|Actual|Oswaldo Cruz Foundation||2|||f||||f||||||||||2017-10-11 01:21:48.408793|2017-10-11 01:21:48.408793
NCT01929980|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-10-18|2016-10-18||July 2012||2012-07-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Bortezomib||Bortezomib to Treat Significant Complication of HSCT|Use of Bortezomib to Treat Refractory Autoimmune Cytopenia(s) in Allogeneic Stem Cell Transplantation|Completed||Phase 2|4|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 01:21:48.718719|2017-10-11 01:21:48.718719
NCT01929967|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-06-26|||August 2013||2013-08-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Defining Immunodeficiency in Heterotaxy Syndrome: Pilot Study Data|Defining Immunodeficiency in Heterotaxy Syndrome: Pilot Study Data|Completed||N/A|10|Actual|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-11 01:21:48.9071|2017-10-11 01:21:48.9071
NCT01929954|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-09-23|||July 2013||2013-07-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety Study of Gintuit™ in Subjects Requiring Socket Grafting|Phase 1/2, Randomized, Controlled Assessment of the Safety Of Gintuit™ Versus Bio-Gide® in Subjects Requiring Socket Grafting|Terminated||Phase 1/Phase 2|5|Actual|Organogenesis||2||Changes in corporate business environment|f||||f||||||||||2017-10-11 01:21:49.006934|2017-10-11 01:21:49.006934
NCT01929941|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-02-03|||September 2013||2013-09-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies|A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB047986 in Subjects With Advanced Malignancies|Terminated||Phase 1|5|Actual|Incyte Corporation||2||Business decision.|f||||f||||||||||2017-10-11 01:21:49.149378|2017-10-11 01:21:49.149378
NCT01929928|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-02-11|||January 2013||2013-01-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Observational|SCUD||Evaluation of Efficacy and Accuracy of a Cordless Ultrasonic Dissection System|Sonicision Cordless Ultrasonic Dissection System in General Surgery: A Prospective Post-market Observational Study to Evaluate the Efficacy and Accuracy of a Cordless Ultrasonic Dissection System|Completed||N/A|110|Actual|Carolinas Healthcare System|||1||f||||t||||||||||2017-10-11 01:21:49.28648|2017-10-11 01:21:49.28648
NCT01929915|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-07-14|||August 2012||2012-08-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Analgesia and Pancreatic Cancer Surgery|Perioperative Epidural Analgesia for Short-term and Long-term Outcomes of Pancreatic Cancer Surgery- Randomised Trial|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:21:49.370328|2017-10-11 01:21:49.370328
NCT01929902|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-04-30|||July 2013||2013-07-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Observational|||Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery|Laparoscopic Aquamantys Device in General Surgery: A Prospective Observational Study to Evaluate the Efficacy and Accuracy|Completed||N/A|20|Actual|Carolinas Healthcare System|||1||f||||t||||||||||2017-10-11 01:21:49.486726|2017-10-11 01:21:49.486726
NCT01929889|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-07-06|2015-05-19||April 2012||2012-04-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|||Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia|An Exploratory Study to Assess the Effects of Fanapt® on Social Cognitive Performance|Terminated||Phase 4|19|Actual|Northwestern University|The most common reason for early termination was disagreement between the subjects’ self-reported diagnosis and the diagnosis obtained by the research psychiatrist.|1||Low recruitment|f||||f||||||||||2017-10-11 01:21:49.575054|2017-10-11 01:21:49.575054
NCT01929876|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-06-22|2016-06-22||July 2013||2013-07-01|June 2016|2016-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Safety population consisted of all participants who received at least 1 dose of cobimetinib and had at least 1 postdose safety assessment.|A Study to Evaluate Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Participants|A Phase 1, Open-Label Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Subjects|Completed||Phase 1|16|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 01:21:49.888411|2017-10-11 01:21:49.888411
NCT01929863|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-07-14|2017-06-08|2014-04-24|August 1, 2013||2013-08-01|June 2017|2017-06-01|November 21, 2013|Actual|2013-11-21|November 1, 2013|Actual|2013-11-01||Interventional|||Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin|A Randomized, Double-blind (Sponsor Unblinded), Placebo Controlled, Repeat Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin|Completed||Phase 2|16|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:21:50.275293|2017-10-11 01:21:50.275293
NCT01929850|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2015-05-06||||||May 2015|2015-05-01||||October 2018|Anticipated|2018-10-01||Interventional|||Laparoscopic Sleeve Gastrectomy Plus Weight Watchers vs. Weight Watchers Alone in Underserved Minority Women|Bariatric Surgery Plus Weight Watchers vs. Weight Watchers in Underserved Minorities: Randomized Controlled Cross-over Trial|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||2||Scientific/feasibility approval required prior to IRB review|f||||f||||||||||2017-10-11 01:21:51.241774|2017-10-11 01:21:51.241774
NCT01929837|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-08-30|||September 2013||2013-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Tinnitus rTMS 2013|Treatment of Tinnitus With Transcranial Magnetic Stimulation|Completed||N/A|80|Actual|Turku University Hospital||4|||f||||f||||||||||2017-10-11 01:21:51.331184|2017-10-11 01:21:51.331184
NCT01929824|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-09-12|||August 2013||2013-08-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||Nasal Nitric Oxide Levels in EoE|A Pilot Study: Nasal Nitric Oxide Levels in Eosinophilic Esophagitis.|Active, not recruiting||N/A|50|Anticipated|Mayo Clinic|||1||f||||f||||||||Undecided||2017-10-11 01:21:51.444184|2017-10-11 01:21:51.444184
NCT01929811|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2017-09-20|||October 2013|Actual|2013-10-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|December 2019|Anticipated|2019-12-01||Interventional|NeoMET||NeoMET Study in Neoadjuvant Treatment of Breast Cancer|Neoadjuvant Treatment of TEC Versus TEC Plus Metformin in Breast Cancer：A Prospective, Randomized Trial|Recruiting||Phase 2|200|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 01:21:51.523767|2017-10-11 01:21:51.523767
NCT01929798|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2015-10-20|||November 2013||2013-11-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|DP3||Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin|Randomized Crossover Feasibility Study of Artificial Pancreas Device (AP) Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS) With and Without Basal and Insulin-to-Carbohydrate Bolus Initialization|Completed||Early Phase 1|36|Actual|William Sansum Diabetes Center||2|||f||||f||||||||||2017-10-11 01:21:51.657377|2017-10-11 01:21:51.657377
NCT01929785|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-01-12|||December 2009||2009-12-01|January 2016|2016-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||BIIR Gene to Manage Heart Allograft Patients|Application of In-House Developed Nanomedicine Technology for Diagnosis and Management of Post-Transplant Heart Allograft Patients|Completed||N/A|56|Actual|Baylor Research Institute|||2||f||||t||||||Samples With DNA|"     To create new means to detect rejection at the earliest stages, to help prevent progression     through earlier treatment, to discover new avenues targets for treatment of heart graft     rejection, and to reduce the cost of post-transplant health care   "|||2017-10-11 01:21:51.75034|2017-10-11 01:21:51.75034
NCT01929772|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-09-22|||September 2012||2012-09-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|GLASS||German Lactat Clearance in Severe Sepsis|German Lactat Clearance in Severe Sepsis|Completed||N/A|300|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 01:21:51.826661|2017-10-11 01:21:51.826661
NCT01929759|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-07-26|2017-03-27||January 2014|Actual|2014-01-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen|Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen|Completed||N/A|10|Actual|Massachusetts General Hospital|One participant did not have repeat fMRI because the pre-switch fMRI was not done correctly. The patient did not fully understand the tasks to be performed, therefore no repeat follow up fMRI was done without the comparator study.|1|||f||||f||||||||||2017-10-11 01:21:51.906193|2017-10-11 01:21:51.906193
NCT01929746|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-05-01|||October 2013||2013-10-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Daclizumab Japanese PK Study|A Single-Dose, Single-Blind, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BIIB019, Daclizumab High Yield Process (DAC HYP), in Japanese and Caucasian Adult Healthy Volunteers|Completed||Phase 1|56|Actual|Biogen||2|||f||||||||||||||2017-10-11 01:21:52.339504|2017-10-11 01:21:52.339504
NCT01929733|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-21|||January 1998||1998-01-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Long Term Results of 450 Percutaneous Closures of PDA in a Single Center|Long Term Results of 450 Percutaneous Closures of PDA in a Single Center|Completed||N/A|450|Actual|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 01:21:52.427912|2017-10-11 01:21:52.427912
NCT01929720|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-04-04|||August 2011|Actual|2011-08-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|FOCUS||Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors|Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors|Completed||N/A|33|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:21:52.53716|2017-10-11 01:21:52.53716
NCT01929694|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-10-02|||September 2013||2013-09-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Effect of Consuming a guaraná and Vitamin/Mineral Complex Pre-exercise on Affect, Exertion, Metabolism and Cognition|The Effect of Consuming a Guaraná and Vitamin and Mineral Complex Before a Morning Exercise Session on Affect, Exertion and Substrate Metabolism During Exercise and Cognitive Performance During the Post-exercise Recovery Period|Completed||Phase 4|40|Actual|Northumbria University||2|||f||||f||||||||||2017-10-11 01:21:52.810889|2017-10-11 01:21:52.810889
NCT01929681|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-08-28|2017-04-11||July 2013||2013-07-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|LFMS|Three enrolled subjects did not complete.|Multiple Treatment Study Using Low Field Magnetic Stimulation for Bipolar Depression|Low Field Magnetic Stimulation in Mood Disorders: Three Daily Visits|Completed||N/A|53|Actual|Mclean Hospital|Study was designed for 72 subjects but only 50 subjects were completed due to lack of funds.|2|||f||||f||||||||||2017-10-11 01:21:52.904887|2017-10-11 01:21:52.904887
NCT01929668|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2016-04-27|||August 2013||2013-08-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|2SCANI||Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients|Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Patients With Inactive Ulcerative Colitis; Randomized, Single Blind, Multicenter Study|Completed||N/A|114|Actual|Kyungpook National University||2|||f||||f||||||||||2017-10-11 01:21:53.350798|2017-10-11 01:21:53.350798
NCT01929655|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-06-08|||September 30, 2013|Actual|2013-09-30|June 2017|2017-06-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|||Japanese BAY88-8223 Monotherapy Phase II Study|A Single-arm, Open-label, Multicenter, Phase II Study of BAY88-8223 in the Treatment of Japanese Patients With Symptomatic Castration-resistant Prostate Cancer (CRPC) With Bone Metastases|Completed||Phase 2|49|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-11 01:21:53.456232|2017-10-11 01:21:53.456232
NCT01929642|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-09-06|||July 2013||2013-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|RAPT||Rapalogues for Autism Phenotype in TSC: A Feasibility Study|Rapalogues for Autism Phenotype in TSC: A Feasibility Study|Completed||Phase 2|3|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||t||||||||||2017-10-11 01:21:53.623118|2017-10-11 01:21:53.623118
NCT01929629|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-04-14|||September 2013||2013-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914|A Phase I, Randomized, Placebo-controlled, Single-center Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD0914 After a Single Oral Administration and to Assess the Effect of Food in Healthy Adult Volunteers|Completed||Phase 1|100|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:21:53.752467|2017-10-11 01:21:53.752467
NCT01929616|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2017-03-07|||August 2013||2013-08-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|RegARd-C||Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)|Regorafenib Assessment in Refractory Advanced Colorectal Cancer|Active, not recruiting||Phase 2|124|Anticipated|Jules Bordet Institute||1|||f||||t||||||||||2017-10-11 01:21:53.847046|2017-10-11 01:21:53.847046
NCT01929603|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2017-01-13|||December 2013||2013-12-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|May 2014|Actual|2014-05-01||Interventional|||Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours|A Non-randomised, Open-label, Sequential, Multicentre, Two-part, Phase I Study to Assess the Effect of Rifampicin, a CYP Inducer, on the Pharmacokinetics of Olaparib Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours|Completed||Phase 1|32|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 01:21:53.958753|2017-10-11 01:21:53.958753
NCT01929590|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-21|||October 2011||2011-10-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Low-volume Polyethylene Glycol Bowel Preparation for Colonoscopy|Efficacy and Tolerability of Low-volume Polyethylene Glycol (2 L) vs. Single- (4 L) vs. Split-dose (2L + 2L) of Polyethylene Glycol Bowel Preparation for Colonoscopy: a Randomized Clinical Trial.|Completed||Phase 3|180|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||3|||f||||t||||||||||2017-10-11 01:21:54.085743|2017-10-11 01:21:54.085743
NCT01929577|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2013-09-13|||May 2013||2013-05-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects|A Phase 1, Single-Dose, Open-Label, 3-Period, Randomized Crossover Study to Assess the Relative Bioavailability Between Two ASP015K Tablet Formulations and the Food Effect on a New Tablet Formulation in Healthy Adult Subjects|Completed||Phase 1|36|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 01:21:54.204786|2017-10-11 01:21:54.204786
NCT01929564|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2014-07-28|||July 2012||2012-07-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|BASH||Broccoli and Vascular Health Study|Broccoli and Vascular Health Study|Completed||N/A|95|Actual|Quadram Institute||2|||f||||f||||||||||2017-10-11 01:21:54.298502|2017-10-11 01:21:54.298502
NCT01929551|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-23|2014-09-03|||August 2013||2013-08-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Glycemic Index of Mango and Pear in Different Solid Products and Drinks|Comparison of the Glycemic Index of a Drink Made of Natural Concentrated Mango Puree With Natural Concentrated Pear Juice With That of Other Five Products Based on Mango and Pear in Different Solid Products and Drinks|Completed||N/A|38|Actual|Instituto Tecnologico y de Estudios Superiores de Monterey||7|||f||||f||||||||||2017-10-11 01:21:54.397763|2017-10-11 01:21:54.397763
NCT01929538|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-01-13|||August 2013||2013-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Covered Metal Stent for Benign Biliary Stricture Caused by Chronic Pancreatitis|Covered Self-expandable Metal Stent, 6 Versus 12 Months, for Benign Biliary Stricture Caused by Chronic Pancreatitis: a Prospective Randomized Study|Recruiting||N/A|30|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 01:21:54.547484|2017-10-11 01:21:54.547484
NCT01929525|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-22|||August 2013||2013-08-01|August 2013|2013-08-01|March 2014|Anticipated|2014-03-01|January 2014|Anticipated|2014-01-01||Observational|||Effectiveness of Silver Nitrate Solution in the Treatment of Anal Fistula|Effectiveness of Silver Nitrate Solution in the Treatment of Anal Fistula: A Novel Strategy for Managing Anal Fistula|Unknown status|Recruiting|N/A|70|Anticipated|Marmara University|||1||f||||t||||||||||2017-10-11 01:21:54.707983|2017-10-11 01:21:54.707983
NCT01929512|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-29|||June 2013||2013-06-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg|An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 750/20 mg and Coadministration of Metformin SR 750 mg and Rosuvastatin 20 mg in Healthy Volunteers|Completed||Phase 1|72|Actual|Hanmi Pharmaceutical Company Limited||4|||f||||f||||||||||2017-10-11 01:21:54.805555|2017-10-11 01:21:54.805555
NCT01929499|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-27|||September 2013||2013-09-01|August 2013|2013-08-01|August 2019|Anticipated|2019-08-01|August 2016|Anticipated|2016-08-01||Interventional|CIKCC||Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer|Efficacy of Adjuvant Immunotherapy With Cytokine-induced Killer Cells in Patients With Stage II/III Colon Cancer|Not yet recruiting||Phase 2|210|Anticipated|Guangdong Provincial Hospital of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-11 01:21:54.92181|2017-10-11 01:21:54.92181
NCT01929486|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-02-16|||February 2013||2013-02-01|February 2016|2016-02-01||||June 2016|Anticipated|2016-06-01||Interventional|||Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.|Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.|Active, not recruiting||Phase 1|58|Anticipated|Aichi Medical University||3|||f||||||||||||||2017-10-11 01:21:55.056185|2017-10-11 01:21:55.056185
NCT01929473|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2016-06-02|2016-06-02||September 2013||2013-09-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Seroepidemiological Study of Pertussis and Other Infectious Diseases|Seroepidemiological Study of Pertussis and Other Infectious Diseases|Completed||N/A|3830|Actual|Gifu Prefecture Medical Association|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:21:55.142288|2017-10-11 01:21:55.142288
NCT01929460|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-01-13|2015-10-07||January 2014||2014-01-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration|A Prospective, Placebo-controlled Trial on the Use of Antibiotics for Pancreatic Cyst Aspiration: a Pilot Study|Completed||N/A|26|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 01:21:55.318035|2017-10-11 01:21:55.318035
NCT01929447|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-09-18|||October 2013||2013-10-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Observational|||Evaluation of WP200 With the Unified Probe (WP200U)|A Prospective, Comparative Study to Evaluate the Watch-PAT200 (WP200) With the Unified Probe (WP200U) Compared to the Currently Used Configuration of WP200 With the Nonin Oximetry Module|Completed||N/A|75|Actual|Itamar-Medical, Israel|||1||f||||f||||||||||2017-10-11 01:21:55.789891|2017-10-11 01:21:55.789891
NCT01929434|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-07-17|||October 2013||2013-10-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|CP||Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis|Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Children With Cerebral Paralysis|Unknown status|Recruiting|Phase 3|300|Anticipated|General Hospital of Chinese Armed Police Forces||3|||f||||t||||||||||2017-10-11 01:21:55.879375|2017-10-11 01:21:55.879375
NCT01929421|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-21|||December 2009||2009-12-01|August 2013|2013-08-01||||July 2013|Actual|2013-07-01||Interventional|||A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.||Completed||Phase 2|36|Actual|Gachon University Gil Medical Center||1|||f||||||||||||||2017-10-11 01:21:56.01927|2017-10-11 01:21:56.01927
NCT01929408|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-02-01|||July 2013||2013-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients|Feasibility and Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) Compared to Conventional Therapy for Older and Medically Infirm Patients Diagnosed With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes: A Prospective Observational Study|Recruiting||N/A|1000|Anticipated|Fred Hutchinson Cancer Research Center|||1||f||||f||||||||||2017-10-11 01:21:56.111545|2017-10-11 01:21:56.111545
NCT01929395|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-03-25|||September 2009||2009-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery|A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery|Recruiting||N/A|136|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 01:21:56.451945|2017-10-11 01:21:56.451945
NCT01929369|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-02-19|||August 2013||2013-08-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Pilot Study of IVUS Imaging During Endovascular Interventions of Failing Hemodialysis Access Grafts|Pilot Study of IVUS Imaging During Endovascular Interventions of Failing Hemodialysis Access Grafts|Completed||N/A|100|Actual|Volcano Corporation|||2||f||||f||||||||||2017-10-11 01:21:56.649352|2017-10-11 01:21:56.649352
NCT01929356|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2013-08-27|||October 2013||2013-10-01|August 2013|2013-08-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia|The Influence of Chest Physiotherapy on Lung Function Parameters in Primary Ciliary Dyskinesia|Unknown status|Not yet recruiting|N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 01:21:56.729678|2017-10-11 01:21:56.729678
NCT01929343|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-05-29|||January 2014||2014-01-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|LIDO||Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving|Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving|Recruiting||Phase 2|66|Anticipated|University of Texas Southwestern Medical Center||3|||f||||t||||||||||2017-10-11 01:21:56.853542|2017-10-11 01:21:56.853542
NCT01929330|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-05-05|||September 23, 2013|Actual|2013-09-23|May 2017|2017-05-01|January 9, 2014|Actual|2014-01-09|January 9, 2014|Actual|2014-01-09||Interventional|||Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers|An Evaluation of the Bioequivalence of Five 0.1 mg GI198745/Dutasteride Soft Gelatin Capsules Compared to One 0.5 mg GI198745/Dutasteride Gelatin Capsules in Healthy Male Volunteers|Completed||Phase 1|36|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:21:57.003877|2017-10-11 01:21:57.003877
NCT01912248|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-01-26|||July 2013||2013-07-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Acute Effect of Strength Training on Blood Pressure in Cardiac Patients|Acute Effect of Strength Training on Blood Pressure in Cardiac Patients|Completed||N/A|36|Actual|Bispebjerg Hospital|||3||f||||t||||||||||2017-10-11 01:26:28.024222|2017-10-11 01:26:28.024222
NCT01929317|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-02-18|2015-04-09||August 2013||2013-08-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.|A Study ROP116991, Clinical Evaluation of 18 to 24mg/Day Ropinirole CR for Parkinson's Disease.|Completed||Phase 3|81|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:21:57.26481|2017-10-11 01:21:57.26481
NCT01929304|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-01-10|||August 2013||2013-08-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|DIVAs 2||DIVAs Perception: Difficult IV Access - Assessment of Patient Understanding|Assessment of Patient Understanding and Preference of Rescue Venous Access When Shown a Narrated Video Vignette Versus Traditional Paper Information Sheet|Completed||N/A|1180|Actual|University of Pennsylvania|||2||f||||t||||||||||2017-10-11 01:21:59.645949|2017-10-11 01:21:59.645949
NCT01929291|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-08-04|||September 2013||2013-09-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea|Assessment of Safety of GlaxoSmithKline (GSK) Biologicals' Combined Reduced Antigen Content Diphtheria-tetanus Toxoids and Acellular Pertussis Vaccine (dTPa), Boostrix When Administered According to the Approved Prescribing Information in Korea|Completed||N/A|690|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 01:21:59.713225|2017-10-11 01:21:59.713225
NCT01929278|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-07-13|||December 8, 2008|Actual|2008-12-08|July 2017|2017-07-01|December 19, 2008|Actual|2008-12-19|December 19, 2008|Actual|2008-12-19||Interventional|||W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers|A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers|Completed||Phase 1|37|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 01:21:59.802935|2017-10-11 01:21:59.802935
NCT01929252|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-22|||August 2011||2011-08-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||Postoperative Analgesic Effect Of Dexmedetomidine Administration in Wound Infiltration for Total Abdominal Hysterectomy|Phase 4 Study of Postoperative Analgesic Effect Of Dexmedetomidine Administration in Wound Infiltration For Total Abdominal Hysterectomy|Completed||Phase 4|50|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 01:22:00.049693|2017-10-11 01:22:00.049693
NCT01929239|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-06-16|||March 2006||2006-03-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning|Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Prostate Cancer After Non-Myeloablative Conditioning|Suspended||Phase 1/Phase 2|12|Anticipated|Roger Williams Medical Center||1||Funding|f||||t||||||||Undecided||2017-10-11 01:22:00.141406|2017-10-11 01:22:00.141406
NCT01929226|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-04-10|||July 2013||2013-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|AH104||A Study to Assess the Safety, Tolerability and PK of a Single IV Dose of ETI-204 in Adult Volunteers|Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers|Completed||Phase 1|280|Actual|Elusys Therapeutics||2|||f||||f||||||||||2017-10-11 01:22:00.228088|2017-10-11 01:22:00.228088
NCT01929213|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2014-01-07|||August 2013||2013-08-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration|A Randomized, Open-label, Multiple Dose, Three-treatment, Three-period, Six-sequence Williams Design to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration in Healthy Volunteers|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:22:00.319544|2017-10-11 01:22:00.319544
NCT01929200|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2015-05-21|||August 2013||2013-08-01|May 2015|2015-05-01|August 2017|Anticipated|2017-08-01|December 2015|Anticipated|2015-12-01||Interventional|||Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation|Randomized, Open-label, Multicenter Study of Icotinib as Adjuvant Therapy in Treating Stage II-IIIA Non-small-cell Lung Cancer Patients With Positive EGFR Mutation|Unknown status|Recruiting|Phase 2|120|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 01:22:00.400574|2017-10-11 01:22:00.400574
NCT01929187|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2013-08-22|||February 2013||2013-02-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Interventional|||A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis|A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis|Unknown status|Recruiting|N/A|72|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:22:00.634042|2017-10-11 01:22:00.634042
NCT01929174|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-04-05|||August 2013||2013-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Observational|||Diffuse Myocardial Fibrosis in Fontan Patients|Heart Failure and Fibrosis in Adult Congenital Heart Patients With a Single Ventricle and Prior Fontan Operation.|Active, not recruiting||N/A|18|Actual|Oregon Health and Science University|||2||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 01:22:00.779705|2017-10-11 01:22:00.779705
NCT01929161|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-07-14|||September 2013||2013-09-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of Wellness Behaviors as a Function of Oxytocin vs Placebo|Affective and Genomic Mediators of Sustained Behavior Change: A Randomized, Dual-blind, Placebo-controlled Experimental Design That Will Examine Wellness Behavior as a Function of Oxytocin vs. Placebo.|Completed||Phase 1|239|Actual|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-10-11 01:22:00.872092|2017-10-11 01:22:00.872092
NCT01929148|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-11-17|||August 2013||2013-08-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prophylactic Bilateral Salpingectomy and Laparoscopic Myomectomy|Is Prophylactic Bilateral Salpingectomy Added to Laparoscopic Myomectomy as New Preventive Strategy for Ovarian Cancer a Safe Procedure?|Recruiting||N/A|154|Anticipated|University Magna Graecia||2|||f||||t||||||||||2017-10-11 01:22:01.027996|2017-10-11 01:22:01.027996
NCT01929135|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2014-07-25|2014-05-23||May 2013||2013-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Short-term Effect of 2% Atorvastatin Dentifrice in Periodontal Status.|Short-term Effect of 2% Atorvastatin Dentifrice as an Adjunct to Periodontal Therapy: A Randomized Double-blind Clinical Trial.|Completed||Phase 2|38|Actual|Universidad Los Andes, Chile||2|||f||||t||||||||||2017-10-11 01:22:01.162148|2017-10-11 01:22:01.162148
NCT01929122|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-07-18|||August 2010||2010-08-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|BENEFIT||Beans/Bran Enriching Nutritional Eating For Intestinal Health Trial|BENEFIT: Beans/Bran Enriching Nutritional Eating For Intestinal Health Trial|Completed||N/A|29|Actual|Colorado State University||3|||f||||f||||||||||2017-10-11 01:22:01.717026|2017-10-11 01:22:01.717026
NCT01929109|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2014-10-09|||August 2013||2013-08-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of LY2409021 in Participants With Different Levels of Kidney Function|Pharmacokinetics of LY2409021 Following Administration to Subjects With Varying Degrees of Renal Function|Completed||Phase 1|60|Anticipated|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 01:22:01.865207|2017-10-11 01:22:01.865207
NCT01929096|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-07-01|||August 2013||2013-08-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Compound Edaravone Injection for Acute Ischemic Stroke|Compound Edaravone Injection for Acute Ischemic Stroke, a Multi-center, Randomized, Double-blind, Multi-dose, Parallel, and Controlled Phase II Trial|Completed||Phase 2|400|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-11 01:22:01.96213|2017-10-11 01:22:01.96213
NCT01929083|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-10-29|2015-08-27||April 2013||2013-04-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Includes n=15 subjects included in the final analysis. Includes subjects randomized to receive progesterone first and patients randomized to receive placebo first|Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening|Influence of Progesterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes|Completed||Phase 2|19|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 01:22:02.152931|2017-10-11 01:22:02.152931
NCT01929070|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-03-07|||February 2013||2013-02-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007|A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007 in Healthy Male Volunteers|Completed||Phase 1|12|Actual|Hanmi Pharmaceutical Company Limited||4|||f||||t||||||||||2017-10-11 01:22:02.791791|2017-10-11 01:22:02.791791
NCT01929057|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2014-06-19|||August 2013||2013-08-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris|Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris|Completed||N/A|34|Actual|University of California, San Diego|||2||f||||f||||||||||2017-10-11 01:22:02.879057|2017-10-11 01:22:02.879057
NCT01929044|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-02-10|2016-02-10||August 2013||2013-08-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Treated Set (TS): All randomised patients who received at least one dose of study medication constituted the treated set. One patient was randomized to 654-II but incorrectly treated with Buscopan® so in the disposition table and efficacy analysis, number of patients are 152 and 143 while for demographic and AE analysis, they are 153 and 142.|Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain|A Randomized, Double-blind, Independent 3rd Party Unblind, Active-controlled, Parallel-group, Multi-center Trial, in Contrast With Anisodamine (654-II), 10mg, to Evaluate the Efficacy and Safety of Buscopan® Solution for Injection, 20mg (Intramuscularly) for the Treatment of Acute Gastric or Intestinal Spasm-like Pain|Completed||Phase 3|299|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:22:02.983681|2017-10-11 01:22:02.983681
NCT01929031|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2016-09-27|2015-02-18||August 2013||2013-08-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||All treated patients|Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain|A Single-centre, Double-blind, Randomised, Two-stage, Parallel-group Study to Assess the Efficacy and Safety of the Fixed Dose Combination of Ibuprofen 400 mg and Caffeine 100 mg Versus Ibuprofen 400 mg, Caffeine 100 mg and Placebo in Patients With Postoperative Dental Pain|Completed||Phase 3|562|Actual|Boehringer Ingelheim||6|||f||||f||||||||||2017-10-11 01:22:03.949381|2017-10-11 01:22:03.949381
NCT01929018|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-08-25|||September 2013||2013-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|||Collaborative-care Rehabilitation After Dysvascular Amputation|Collaborative-care Rehabilitation to Improve Functional Outcomes After Dysvascular Amputation|Active, not recruiting||N/A|44|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:22:04.587316|2017-10-11 01:22:04.587316
NCT01929005|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2017-01-24|||November 2012|Actual|2012-11-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|CCP||Comprehensive Care Physician: Integrated Inpatient and Outpatient Care for Patients at High Risk of Hospitalization|Integrated Inpatient/Outpatient Care for Patients at High Risk of Hospitalization|Recruiting||N/A|2000|Anticipated|University of Chicago||2|||f||||f|f|f||||||No||2017-10-11 01:22:04.687932|2017-10-11 01:22:04.687932
NCT01928992|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-11-18|||March 2013||2013-03-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|3DM||Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital Mammography|A Multi-reader, Multi-case, Controlled Clinical Trial to Evaluate the Fuji Film 3D Digital Mammography System Used in Conjunction With 2D Digital Mammography in the Detection of Breast Cancer / A Pilot Study|Completed||N/A|100|Actual|Fujifilm Medical Systems USA, Inc.|||2||f||||f||||||||||2017-10-11 01:22:04.806414|2017-10-11 01:22:04.806414
NCT01928446|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-07-24|||July 8, 2015|Actual|2015-07-08|July 2017|2017-07-01|August 30, 2019|Anticipated|2019-08-30|May 31, 2019|Anticipated|2019-05-31||Interventional|Li+||Lithium for Suicidal Behavior in Mood Disorders|CSP #590 - Lithium for Suicidal Behavior in Mood Disorders|Recruiting||Phase 2/Phase 3|1862|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||t|||||2017-10-11 01:22:20.671106|2017-10-11 01:22:20.671106
NCT01928979|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2014-12-21|||May 2013||2013-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|CLOT-AF||Retrospective Registry Providing Baseline Data on the Outcome of Left Atrial (LA) or LA Appendage (LAA) Thrombus in Patients With Nonvalvular Atrial Fibrillation (AF) or Atrial Flutter After Standard of Care (SoC) Anticoagulant Therapy|Retrospective Registry Providing Baseline Data on the Outcome of Left Atrial (LA) or LA Appendage (LAA) Thrombus in Patients With Nonvalvular Atrial Fibrillation (AF) or Atrial Flutter After Standard of Care (SoC) Anticoagulant Therapy|Completed||N/A|160|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:22:04.923373|2017-10-11 01:22:04.923373
NCT01928966|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-05-24|||August 2013||2013-08-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|PSS1||Effect of Pumpkin Seeds on the Dietary Fatty Acid Intake and Blood Pressure in Women|Effect of Pumpkin Seeds on the Dietary Fatty Acid Intake and Blood Pressure in Women|Withdrawn||N/A|0|Actual|Texas Woman's University||2||Advisor left the university and student moved to a clinical track|f||||t||||||||No|The study was stopped before data collection began - no data to share.|2017-10-11 01:22:05.036344|2017-10-11 01:22:05.036344
NCT01928953|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2015-07-07|||October 2012||2012-10-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Longitudinal Study of Patients With Opioid-Induced Constipation|Longitudinal Study of Patients With Opioid-Induced Constipation|Completed||N/A|520|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:22:05.13103|2017-10-11 01:22:05.13103
NCT01928940|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-07-20|2015-04-23||August 15, 2013||2013-08-15|July 2017|2017-07-01|July 4, 2016|Actual|2016-07-04|September 18, 2014|Actual|2014-09-18||Interventional|||Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part)|A Japanese Open-label Phase I/II Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of GSK2118436 and GSK1120212 Combination Therapy in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) and BRAF V600E/K Mutation Positive Cutaneous Melanoma (Phase II Part).|Completed||Phase 2|12|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 01:22:07.055422|2017-10-11 01:22:07.055422
NCT01928927|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-22|2017-08-08|2017-03-01||January 2014|Actual|2014-01-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|TRAFIC|All Step 2 randomized participants with data available for specific measures.|Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)|Effects of Telmisartan on Fibrotic and Inflammatory Contributors to End-Organ Disease in HIV-Infected Patients Well Controlled on Antiretroviral Therapy|Completed||Phase 2|58|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 01:22:09.198006|2017-10-11 01:22:09.198006
NCT01928914|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-06-09|||July 26, 2011|Actual|2011-07-26|June 2017|2017-06-01|June 4, 2012|Actual|2012-06-04|June 4, 2012|Actual|2012-06-04||Interventional|||Tafenoquine Thorough QTc Study in Healthy Subjects|A Randomized, Placebo-Controlled Study to Evaluate the Effect of Tafenoquine (SB252263) on the Electrocardiogram (ECG) With Focus on Cardiac Repolarization (QTc Duration) in Healthy Subjects|Completed||Phase 1|260|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:22:11.415876|2017-10-11 01:22:11.415876
NCT01928901|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2014-06-30|||August 2013||2013-08-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)|Randomized, Placebo-controlled, Double-blind, Cross-over Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)|Completed||Phase 2|56|Actual|Bionorica SE||4|||f||||f||||||||||2017-10-11 01:22:11.531371|2017-10-11 01:22:11.531371
NCT01928888|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-12-23|||May 2003||2003-05-01|December 2014|2014-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes|A Randomized, Double-blind, Three-fold Cross-over, Multi-center Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid (1000 mg Hydrotalcite), a Single Dose of Oral Famotidine 10 mg, and a Single Dose of Placebo in Patients With Acute Heartburn Episodes.|Completed||Phase 4|559|Actual|Bayer||6|||f||||f||||||||||2017-10-11 01:22:11.616899|2017-10-11 01:22:11.616899
NCT01928875|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-04-28|||December 2013||2013-12-01|April 2017|2017-04-01||||February 1, 2017|Actual|2017-02-01||Interventional|||Comparison of Adequacy of Anesthesia Monitoring With Standard Clinical Practice During Routine General Anesthesia|Comparison of Adequacy of Anesthesia Monitoring With Standard Clinical Practice During Routine General Anesthesia|Completed||N/A|496|Actual|GE Healthcare||2|||f||||f||||||||||2017-10-11 01:22:11.713997|2017-10-11 01:22:11.713997
NCT01928862|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-04-21|||June 3, 2014|Actual|2014-06-03|April 2017|2017-04-01|March 16, 2017|Actual|2017-03-16|February 15, 2017|Actual|2017-02-15||Interventional|Prepopik PREA||Efficacy and Safety of Prepopik™ in Children for Overall Colon Cleansing in Preparation for Colonoscopy|A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik™ Versus Polyethylene Glycol Preparation (Local Standard of Care) in Children Aged 9 Years to 16 Years|Completed||Phase 1/Phase 2|78|Actual|Ferring Pharmaceuticals||5|||f||||f||||||||||2017-10-11 01:22:11.80156|2017-10-11 01:22:11.80156
NCT01928849|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-07-25|||December 2013||2013-12-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Valproic Acid for the Prevention of Post-Amputation Pain|Regional Anesthesia and Valproate Sodium for the Prevention of Chronic Post-Amputation Pain|Recruiting||Phase 2|224|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 01:22:11.913686|2017-10-11 01:22:11.913686
NCT01928836|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-05-24|||October 2012||2012-10-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01|1 Year|Observational [Patient Registry]|LCBP||Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China|Multicenter Study for Risk Stratification of Patients Presenting With Symptoms Related to Lung Cancer Using the Lung Cancer Biomarker Panel (LCBP) in China|Completed||N/A|764|Actual|Chinese Alliance Against Lung Cancer|||2||f||||f||||||Samples Without DNA|"     10mL blood sample of the patient will be tested for cancer biomarkers, biochemical detection     and cardiovascular disease biomarkers, etc.   "|||2017-10-11 01:22:12.158782|2017-10-11 01:22:12.158782
NCT01928823|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2014-05-16|||November 2011||2011-11-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Exposure-DCS||Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia|Augmentation of Exposure Therapy With D-Cycloserine in Patients With Agoraphobia With or Without Panic Disorder|Completed||Phase 2|73|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:22:12.27205|2017-10-11 01:22:12.27205
NCT01928810|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-02-06|||March 2011||2011-03-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia|The Influence of Physical Activity (Prior to In-vivo Exposure) on the Effect of Cognitive Behavioural Therapy in Patients With Panic Disorder and Agoraphobia|Completed||N/A|78|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 01:22:12.374684|2017-10-11 01:22:12.374684
NCT01928797|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-08-27|2017-01-07||November 1, 2013||2013-11-01|August 2017|2017-08-01|December 31, 2014|Actual|2014-12-31|December 31, 2014|Actual|2014-12-31||Interventional|||Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.|To Determine if the Cardiac Output Monitoring During Cesarean Delivery Under Spinal Anesthesia Will Change Our Clinical Practice of Using Vasopressors|Completed||N/A|60|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:22:12.46387|2017-10-11 01:22:12.46387
NCT01928784|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-22|||June 2013||2013-06-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Radial Extracorporeal Shock Wave Therapy on Chronic Low Back Pain: a Prospective Controlled Study|Radial Extracorporeal Shock Wave Therapy on Chronic Low Back Pain: a Prospective Controlled Study|Unknown status|Recruiting|N/A|26|Anticipated|Beijing Jishuitan Hospital||2|||f||||t||||||||||2017-10-11 01:22:12.810014|2017-10-11 01:22:12.810014
NCT01928771|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-03-23|2016-09-28||September 19, 2013||2013-09-19|March 2017|2017-03-01|April 5, 2016|Actual|2016-04-05|April 5, 2016|Actual|2016-04-05||Interventional|||Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma|A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma|Completed||Phase 3|2681|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 01:22:12.990994|2017-10-11 01:22:12.990994
NCT01928758|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-07-03|||September 2015||2015-09-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders|Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders|Recruiting||N/A|280|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 01:22:15.654994|2017-10-11 01:22:15.654994
NCT01928745|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-05-19|||September 2013||2013-09-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Experimental Determination of Atot en Ka in the Critically Ill|Experimental Determination of Atot en Ka in the Critically Ill|Completed||N/A|30|Actual|VU University Medical Center|||2||f||||f||||||Samples With DNA|"     24 mL of blood will be drawn   "|||2017-10-11 01:22:15.752136|2017-10-11 01:22:15.752136
NCT01928732|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-06-01|||October 31, 2014|Actual|2014-10-31|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|CERV-PTSD||Comparative Effectiveness Research in Veterans With PTSD|CSP #591 - CERV-PTSD: Comparative Effectiveness Research in Veterans With PTSD|Recruiting||N/A|900|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-11 01:22:15.842902|2017-10-11 01:22:15.842902
NCT01928719|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-06-29|||September 2015||2015-09-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status|Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status|Active, not recruiting||N/A|400|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 01:22:15.984447|2017-10-11 01:22:15.984447
NCT01928706|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-21|||March 2009||2009-03-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|OHRQoL||Quality of Life After Denture Relining|Oral Health Related Quality of Life of Edentulous Patients After Relining Mandibular Dentures With Soft and Hard Denture Liners.|Completed||N/A|44|Actual|Fundação de Amparo à Pesquisa do Estado de São Paulo||2|||f||||t||||||||||2017-10-11 01:22:16.07484|2017-10-11 01:22:16.07484
NCT01928693|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-08-11|2015-08-11||July 2013||2013-07-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Eye02||A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.|A Single-site, Single Masked, Prospective Comparison of Three Fluoroquinolone Topical Therapies (Besifloxacin 0.6% or Gatifloxacin 0.5% or Moxifloxacin 0.5%) in the Treatment of Infectious Corneal Ulcers.|Terminated||Phase 2|2|Actual|Cornea Consultants Of Nashville|The study was terminated due to slow enrollment.|3||study terminated due to slow accrual|f||||f||||||||||2017-10-11 01:22:16.172967|2017-10-11 01:22:16.172967
NCT01928680|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-02-04|2015-02-04||November 2012||2012-11-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|October 2015|Anticipated|2015-10-01||Interventional|||Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer|Phase II Study of Capecitabine and Cisplatin in Anthracycline and Taxanes-pretreated Metastatic Triple Negative Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 2|33|Actual|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 01:22:16.800134|2017-10-11 01:22:16.800134
NCT01928667|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-07-18|||July 2014||2014-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Observational|||Case-Control Study to Identify Risk Factors for Microscopic Colitis|Risk Factors for Microscopic Colitis: A Dutch Case-Control Study|Completed||N/A|487|Actual|Maastricht University Medical Center|||2||f||||t||||||Samples With DNA|"     saliva samples   "|||2017-10-11 01:22:16.985774|2017-10-11 01:22:16.985774
NCT01928654|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2014-03-18|||July 2013||2013-07-01|March 2014|2014-03-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|||Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular Edema|Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular Edema|Unknown status|Recruiting|N/A|32|Anticipated|Luigi Sacco University Hospital||2|||f||||f||||||||||2017-10-11 01:22:17.062566|2017-10-11 01:22:17.062566
NCT01928641|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2013-08-26|||August 2013||2013-08-01|August 2013|2013-08-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Observational|COSSO||Certainty Of Stroke Symptom Onset Study|Observational Study on the Certainty of Stroke Symptom Onset|Unknown status|Not yet recruiting|N/A|100|Anticipated|Asan Medical Center|||1||f||||t||||||||||2017-10-11 01:22:17.168476|2017-10-11 01:22:17.168476
NCT01928264|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-10-14|||August 2013||2013-08-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|PhysActIV||Physical Activity in Insurance Medicine: Effects on Patients With Psychiatric Disorders|Physical Activity in Insurance Medicine: Effects on Psycho(-Physio-)Logical Functions, Capacity / Participation Skills, and the Ability to Work in Psychiatric Disorders|Terminated||N/A|13|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 01:22:25.154989|2017-10-11 01:22:25.154989
NCT01928628|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-27|||May 2012||2012-05-01|August 2013|2013-08-01||||April 2013|Actual|2013-04-01||Interventional|||Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients|A Randomized, Multicenter, Parallel Design Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients Who Are Not Adequately Controlled on Lercanidipine 10mg Monotherapy.|Completed||Phase 3|449|Actual|LG Life Sciences||3|||f||||f||||||||||2017-10-11 01:22:17.262692|2017-10-11 01:22:17.262692
NCT01928615|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2014-09-25|2014-07-31||September 2013||2013-09-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|LISAH|Full analysis set: All participants who were enrolled in the study.|A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer|LISAH: An Open-label, Randomised Phase II Study Assessing Quality of Life Associated With Subcutaneous Trastuzumab Injected Into the Thigh or Upper Arm in Patients With HER2-positive Early Breast Cancer|Terminated||Phase 2|2|Actual|Hoffmann-La Roche||2||Problems with drug supply|f||||||||||||||2017-10-11 01:22:17.365973|2017-10-11 01:22:17.365973
NCT01928602|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-01-23|||November 2013||2013-11-01|January 2014|2014-01-01|August 2015|Anticipated|2015-08-01|January 2015|Anticipated|2015-01-01||Interventional|CATChES||Computerised Therapy in Chronic Stroke|Does Inner Speech Improve Access to Overt Speech in Aphasia Following Stroke? An fMRI Study Utilising Computerised Rehabilitation Software.|Unknown status|Not yet recruiting|N/A|40|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:22:17.753817|2017-10-11 01:22:17.753817
NCT01928589|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-09-21|||September 2013||2013-09-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|PBI 3||Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer|Randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women With Early Stage Breast Cancer (PBI 3.0)|Recruiting||Phase 1/Phase 2|108|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 01:22:17.875203|2017-10-11 01:22:17.875203
NCT01928576|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-10-05|||August 2013||2013-08-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|NA_00084192||Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.|A Randomized Phase II Study of Epigenetic Therapy With Azacitidine and Entinostat With Concurrent Nivolumab Versus Nivolumab Alone in Subjects With Recurrent Metastatic Non-Small Cell Lung Cancer.|Recruiting||Phase 2|120|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:22:18.044905|2017-10-11 01:22:18.044905
NCT01928563|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2013-08-21|||September 2013||2013-09-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine|A Randomized, Open-label, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine in Healthy Male Subjects|Unknown status|Not yet recruiting|Phase 1|24|Anticipated|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:22:18.181131|2017-10-11 01:22:18.181131
NCT01928550|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2015-04-21|||August 2013||2013-08-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|PRP||Diabetes PRP and OCT|Pilot Study OCT of Retinal Blood Flow in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation|Unknown status|Active, not recruiting|N/A|28|Anticipated|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 01:22:18.286824|2017-10-11 01:22:18.286824
NCT01928524|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-02-07|||September 2013||2013-09-01|February 2017|2017-02-01|December 17, 2015|Actual|2015-12-17|June 5, 2015|Actual|2015-06-05||Interventional|DOS||Chemotherapy for Patients With Cancer of the Stomach|Phase I Trial With Docetaxel, Oxaliplatin and S1 as First-line Treatment for Patients With Non-resectable Adenocarcinoma of the Esophagus or Gastric|Completed||Phase 1|34|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 01:22:18.584419|2017-10-11 01:22:18.584419
NCT01928511|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-03-23|||January 2014||2014-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SWAP||Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy|SWITCH OR ADD PEGYLATED-INTERFERON IN CHRONIC HEPATITIS B PATIENTS ON LONG TERM NUCLEOS(T)IDE THERAPY (SWAP TRIAL)|Recruiting||Phase 4|255|Anticipated|National University Health System, Singapore||3|||f||||f||||||||||2017-10-11 01:22:18.705963|2017-10-11 01:22:18.705963
NCT01928498|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-09-06|||October 2013||2013-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|DEB||Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis|Evaluation of Drug Eluting Balloon for the Prevention of Hemodialysis Access Restenosis: A Prospective Randomized Trial (DEB Study)|Recruiting||N/A|140|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 01:22:18.845967|2017-10-11 01:22:18.845967
NCT01928485|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-03-02|||August 30, 2013|Actual|2013-08-30|March 2017|2017-03-01|November 7, 2016|Actual|2016-11-07|October 5, 2016|Actual|2016-10-05||Interventional|||Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer|Randomized Study of Sunphenon Decaffeinated Capsules in Men With Low-Risk Prostate Cancer on Active Surveillance|Terminated||Phase 2|6|Actual|Case Comprehensive Cancer Center||2||Slow Accrual|f||||t||||||||||2017-10-11 01:22:18.997294|2017-10-11 01:22:18.997294
NCT01928472|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2015-05-05|2015-05-05||August 2013||2013-08-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years|Phase I Multi-center, Observer-Blind, Randomized Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated A/H7N9 Monovalent Subunit Influenza Virus Vaccine (H7N9c) in Adults 18 to <65 Years|Completed||Phase 1|402|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:22:19.140866|2017-10-11 01:22:19.140866
NCT01928433|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-04-06|2016-12-20||December 2012||2012-12-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|June 2014|Actual|2014-06-01||Interventional||Subjects that received at least one dose of study medication (safety set).|Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis|A Multi-Dose, Double-Blind, Double-Dummy, Active- Control, Randomized Clinical (Phase II) Study of Two Dosing Regimens of Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis Requiring Hospitalisation.|Completed||Phase 2|225|Actual|MerLion Pharmaceuticals GmbH||3|||f||||t||||||||No||2017-10-11 01:22:21.145825|2017-10-11 01:22:21.145825
NCT01928420|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-10-14||2016-10-07|April 2007||2007-04-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease|A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease|Completed||Phase 2|30|Actual|Humanetics Corporation||2|||f||||t||||||||Undecided||2017-10-11 01:22:21.894515|2017-10-11 01:22:21.894515
NCT01928407|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-08-20|||March 2011||2011-03-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|DATA||Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts|A Phase IV, Prospective, Multicenter , Randomized Open Label, 48 Weeks Study to Evaluate the Antiretroviral Efficacy and Safety of Atazanavir or Darunavir,Each in Combination With a Fixed Dose of Tenofovir Emtricitabine in HIV-1-infected Treatment-naïve Subjects With CD4counts Below 200 µL.|Unknown status|Recruiting|Phase 4|120|Anticipated|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba||2|||f||||t||||||||||2017-10-11 01:22:22.002923|2017-10-11 01:22:22.002923
NCT01928394|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2017-09-14|||October 7, 2013|Actual|2013-10-07|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors|A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab in Subjects With Advanced or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|1150|Anticipated|Bristol-Myers Squibb||6|||f||||f|t|f||||||||2017-10-11 01:22:22.535817|2017-10-11 01:22:22.535817
NCT01928381|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-08-09|2016-05-12||November 2013||2013-11-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Started Part 1|Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability|A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate the Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With Painful Diabetic Neuropathy and Good Pain Reporting Ability|Completed||Phase 2|150|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 01:22:22.920588|2017-10-11 01:22:22.920588
NCT01928368|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-21|2016-12-13|||August 2013||2013-08-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.|A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma|Completed||Phase 1|70|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:22:24.125418|2017-10-11 01:22:24.125418
NCT01928355|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-29|||September 2013||2013-09-01|August 2013|2013-08-01||||August 2014|Anticipated|2014-08-01||Observational|||Cognitive Dysfunction in People Who Are Obese But Metabolically Healthy||Unknown status|Not yet recruiting|N/A|60|Anticipated|Ziv Hospital|||2||f||||||||||||||2017-10-11 01:22:24.241108|2017-10-11 01:22:24.241108
NCT01928342|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-08-19|||March 2012||2012-03-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia|The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia: a Randomized, Double-blinded, Placebo-controlled, Multi-center Clinical Trial|Unknown status|Recruiting|Phase 2/Phase 3|320|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-10-11 01:22:24.3059|2017-10-11 01:22:24.3059
NCT01928329|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-12-14|||September 2013||2013-09-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes|A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes|Recruiting||Phase 2|120|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 01:22:24.426043|2017-10-11 01:22:24.426043
NCT01928316|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-22|||June 2009||2009-06-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers|Bioequivalence Study of Home-made and Imported Mizolastine Tablets in Healthy Volunteers|Completed||Phase 1|24|Actual|Xian-Janssen Pharmaceutical Ltd.||2|||f||||f||||||||||2017-10-11 01:22:24.552772|2017-10-11 01:22:24.552772
NCT01928303|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2014-09-12|||March 2013||2013-03-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|AFTSLabs||Predicting Oxycodone Dose From Oral Fluid Drug Levels|Predicting Oxycodone Dose From Oral Fluid Drug Levels For Chronic Pain Management Patients|Completed||N/A|55|Actual|Weill Medical College of Cornell University|||2||f||||f||||||Samples Without DNA|"     Once received into the laboratory at AFTS labs, oral fluid, blood and urine specimens will be     aliquoted for analysis, and any remaining sample will be transferred to long term storage at     -20 - 0°C.   "|||2017-10-11 01:22:24.671529|2017-10-11 01:22:24.671529
NCT01928290|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-10-03|||November 8, 2013|Actual|2013-11-08|October 2017|2017-10-01|February 28, 2021|Anticipated|2021-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|FOLFIRINOX||Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer|Phase II Study of FOLFIRINOX Chemotherapy for Treatment of Advanced Gastric, Gastro-esophageal Junction, and Esophageal Tumors|Recruiting||Phase 2|65|Anticipated|Washington University School of Medicine||2|||f||||t|t|f||||||||2017-10-11 01:22:24.756309|2017-10-11 01:22:24.756309
NCT01928277|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-12-11|||September 2012||2012-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Weaning From Mechanical Ventilation: Spontaneous Breathing Trial and the Assessment of Work of Breathing|Weaning From Mechanical Ventilation: Spontaneous Breathing Trial and the Assessment of Work of Breathing|Completed||N/A|100|Actual|University of Tromso|||1||f||||f||||||||||2017-10-11 01:22:24.9002|2017-10-11 01:22:24.9002
NCT01928251|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-06-26|||June 2013||2013-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|||Promoting Smoking Cessation in the Community Via Quit to Win Contest 2013|Promoting Smoking Cessation in the Community Via Quit to Win Contest 2013: A Prospective Study and a Randomized Controlled Trial|Completed||N/A|1143|Actual|The University of Hong Kong||3|||f||||t||||||||||2017-10-11 01:22:25.294154|2017-10-11 01:22:25.294154
NCT01928238|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-06-24|||August 2012||2012-08-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|NAVA-VNI||Physiologic Effects of Noninvasive Neurally Adjusted Ventilatory Assist (NAVA) Versus Noninvasive Pressure Support Ventilation in Patients at Risk for Respiratory Distress Needed Preventive Used of Noninvasive Ventilation After Extubation.|Physiologic Effects of Noninvasive Neurally Adjusted Ventilatory Assist (NAVA) Versus Noninvasive Pressure Support Ventilation in Patients at Risk for Respiratory Distress Needed Preventive Used of Noninvasive Ventilation After Extubation.|Completed||N/A|13|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 01:22:25.385444|2017-10-11 01:22:25.385444
NCT01928225|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-05-12|||September 2014||2014-09-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL|A Randomized, Placebo-controlled Trial of Pre-treatment HPV Vaccination on Outcomes to LEEP Treatment of Cervical High Grade Squamous Intraepithelial Lesions in HIV-infected Women.|Enrolling by invitation||Phase 2|180|Anticipated|University of Witwatersrand, South Africa||2|||f||||t||||||||Undecided||2017-10-11 01:22:25.486243|2017-10-11 01:22:25.486243
NCT01928212|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-07-16|||August 2013||2013-08-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Observational|||Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysis|Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysis|Completed||N/A|500|Actual|Wenzhou Medical University|||2||f||||||||||||||2017-10-11 01:22:25.590748|2017-10-11 01:22:25.590748
NCT01928199|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-10-31|||September 2013||2013-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant|A Single Center, Randomized, Double-blind Controlled Trial of Sitagliptin Versus Placebo to Reduce the Incidence and Severity of New-onset Diabetes After Kidney Transplant|Recruiting||Phase 2|50|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:22:25.673316|2017-10-11 01:22:25.673316
NCT01928186|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-08-25|2017-04-14||September 2011||2011-09-01|August 2017|2017-08-01|July 20, 2015|Actual|2015-07-20|July 20, 2015|Actual|2015-07-20||Interventional|||FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer|Imaging Early Response of ER+, HER2- Breast Cancer to Aromatase Inhibitor (AI) +/- Ovarian Suppression (OS) Therapy With [18F]Fluorothymidine (FLT) PET|Completed||N/A|28|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 01:22:25.806846|2017-10-11 01:22:25.806846
NCT01928173|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-08-20|||February 2013||2013-02-01|August 2013|2013-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Self-Help Video for Insomnia in College Students|Self-Help Video for Insomnia in College Students|Suspended||N/A|50|Anticipated|University of Alabama, Tuscaloosa||2||Summer vacation|f||||f||||||||||2017-10-11 01:22:26.213949|2017-10-11 01:22:26.213949
NCT01928160|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-07-09|||June 2014||2014-06-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib|A Randomized Open-Label Phase II Trial of Pemetrexed and a Platinum (Carboplatin or Cisplatin) With or Without Erlotinib in Patients With Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations and Acquired Resistance to First-Line EGFR TKIs, Erlotinib or Gefitinib|Withdrawn||Phase 2|0|Actual|Vanderbilt-Ingram Cancer Center||2||study not accruing|f||||t||||||||||2017-10-11 01:22:26.32933|2017-10-11 01:22:26.32933
NCT01928147|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-11-24|||August 2013||2013-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients|A Phase Ia and Ib Dose-Ranging Study to Assess the Safety, Pharmacokinetics, and Antiviral Efficacy of PPI-383 in Healthy Adults and Hepatitis C Patients|Completed||Phase 1|114|Actual|Presidio Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 01:22:26.483512|2017-10-11 01:22:26.483512
NCT01928134|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-22|||April 2011||2011-04-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||The Efficacy of Vitamin K2 n Human Osteoporosis, Blood-vessel Calcification and Sclerosis|The Efficacy of Vitamin K2 on Human Osteoporosis, Blood-vessel Calcification and Sclerosis|Completed||N/A|60|Actual|Changhua Christian Hospital||2|||f||||f||||||||||2017-10-11 01:22:26.577293|2017-10-11 01:22:26.577293
NCT01928121|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-23|||September 2013||2013-09-01|August 2013|2013-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Effectiveness of an Interdisciplinary, Nurse-coordinated Atrial Fibrillation Expert Program for Primary Care Patients|Effectiveness of an Interdisciplinary, Nurse-coordinated Atrial Fibrillation Expert Program for Primary Care Patients - A Clustered Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|450|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 01:22:26.675974|2017-10-11 01:22:26.675974
NCT01928108|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-03-24|||July 2013||2013-07-01|March 2017|2017-03-01|March 16, 2017|Actual|2017-03-16|March 1, 2017|Actual|2017-03-01||Observational|||Fluid Intake Application to Reduce Kidney Stone Risks|Do Different Methods of Educating Patients Regarding Fluid Intake Reduce Kidney Stone Risks?|Completed||N/A|10|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-11 01:22:26.782351|2017-10-11 01:22:26.782351
NCT01928095|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-04-11|||October 2013||2013-10-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||RNA Cloning and Visualization in Human Atherosclerosis|RNA Cloning and Visualization in Human Atherosclerosis|Completed||N/A|22|Actual|University of Virginia|||1||f||||f|f|f||||Samples Without DNA|"     discarded artherosclerotic tissue obtained during carotid endarterectomy   "|||2017-10-11 01:22:26.885183|2017-10-11 01:22:26.885183
NCT01928069|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-20||||||August 2013|2013-08-01||||December 2009|Actual|2009-12-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium 10mg Tablet Under Fed Conditions|An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Montelukast Sodium 10mg Tablet (Test, Torrent Pharmaceuticals Ltd., India) Versus Singulair® (Montelukast Sodium) 10 mg Tablet (Reference, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed Condition.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 01:22:27.06612|2017-10-11 01:22:27.06612
NCT01928056|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-20||||||August 2013|2013-08-01||||December 2009|Actual|2009-12-01||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium 10mg Tablet Under Fasted Conditions|An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Montelukast Sodium 10 mg Tablet (Test, Torrent Pharmaceuticals Ltd., India) Versus Singulair® (Montelukast Sodium) 10 mg Tablet (Reference, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 01:22:29.185092|2017-10-11 01:22:29.185092
NCT01928043|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-10-03|||September 2013||2013-09-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations|Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations|Recruiting||Phase 2|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 01:22:29.316952|2017-10-11 01:22:29.316952
NCT01928030|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-02-13|2016-12-13||December 2013||2013-12-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer|Pilot Phase 1-2 Investigational Study to Assess the Efficacy and Safety of Recombinant Hyaluronidase (rHUPH20) in the Treatment of Secondary Lymphedema Resulting From Local Management of Malignancy|Terminated||Phase 1/Phase 2|3|Actual|Stanford University||1||Low accrual|f||||t||||||||Undecided||2017-10-11 01:22:29.442513|2017-10-11 01:22:29.442513
NCT01928017|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2014-12-02|||June 2013||2013-06-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With Thrombocytopenia|Monitoring of Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With Thrombocytopenia|Completed||N/A|13|Actual|University of Bergen|||1||f||||f||||||Samples Without DNA|"     Plasma specimens are kept frozen.   "|||2017-10-11 01:22:29.725485|2017-10-11 01:22:29.725485
NCT01928004|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2016-07-12|||September 2007||2007-09-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|April 2012|Actual|2012-04-01||Interventional|||Mandibular Implants in Elderly Patients|Implant-supported Mandibular Overdentures in Very Old Adults - a Randomized Controlled Trial|Active, not recruiting||N/A|45|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 01:22:29.838057|2017-10-11 01:22:29.838057
NCT01927991|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2015-04-27|||September 2012||2012-09-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||Internet-based Self-help for Tinnitus: The Role of Support|Internet-based Self-help for Tinnitus: The Role of Support|Completed||N/A|112|Actual|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-10-11 01:22:29.971657|2017-10-11 01:22:29.971657
NCT01927978|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-04-13|||October 2012||2012-10-01|April 2014|2014-04-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||"Using PET Response Criteria in Solid Tumors (PERCIST) in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer"|"Using PET Response Criteria in Solid Tumors (PERCIST) in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer"|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:22:30.116924|2017-10-11 01:22:30.116924
NCT01927965|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-03-02|||August 2013||2013-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Study of Minnelide™ in Patients With Advanced GI Tumors|A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Given Daily for 21 Days Followed by 7 Days Off Schedule in Patients With Advanced GI Tumors.|Completed||Phase 1|45|Actual|Minneamrita Therapeutics LLC||1|||f||||f||||||||||2017-10-11 01:22:30.303335|2017-10-11 01:22:30.303335
NCT01927952|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-12-03|||September 2013||2013-09-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes|A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes|Withdrawn||Phase 4|0|Actual|Milton S. Hershey Medical Center||3||Study withdrawn from IRB approval process by PI|f||||f||||||||||2017-10-11 01:22:30.469345|2017-10-11 01:22:30.469345
NCT01927939|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2014-04-13|||October 2012||2012-10-01|April 2014|2014-04-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.|The Effectiveness of 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:22:30.816078|2017-10-11 01:22:30.816078
NCT01927926|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-19|||May 2008||2008-05-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||The Effects of Consuming Whey Protein Polydextrose Snacks on Appetite and Energy Intake|The Effects of Consuming Between- Meal, High Protein Polydextrose Containing Snack Bars on Subjective Satiety, Energy Intake and Metabolic Responses.|Completed||N/A|10|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-11 01:22:30.950564|2017-10-11 01:22:30.950564
NCT01927913|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-05-06|||July 2014||2014-07-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Treatment of Iron Overload Requiring Chelation Therapy|A 48-week, Open-label, 2-arm, Parallel-group, Randomized Exploratory Study to Assess Liver Iron Concentration Measured by FerriScan® (R2) Magnetic Resonance Imaging in B-thalassemia Subjects Administered SPD602 (SSP-004184AQ) or Exjade® (Deferasirox) for Treatment of Chronic Transfusional Iron Overload|Withdrawn||Phase 2|0|Actual|Shire||2||This study was withdrawn until the evaluation of the nonclinical rat findings is complete.|f||||t||||||||||2017-10-11 01:22:31.083199|2017-10-11 01:22:31.083199
NCT01927536|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-09-05|||July 2013||2013-07-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Evaluating Color Perception Under LED Red/Green and Green Dominant Light|Evaluating Color Perception Under LED Red/Green and Green Dominant Light|Recruiting||N/A|200|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 01:22:35.736055|2017-10-11 01:22:35.736055
NCT01927900|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-03-17|||May 2014||2014-05-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|HMO-VOL||The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers|THE EFFECTS OF HUMAN-MILK-OLIGOSACCHARIDES ON THE FAECAL MICROBIOTA AND ON GASTROINTESTINAL SYMPTOMS IN HEALTHY VOLUNTEERS A PARALLEL, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED DOSE FINDING STUDY|Completed||N/A|100|Actual|Glycom A/S||10|||f||||f||||||||||2017-10-11 01:22:31.243344|2017-10-11 01:22:31.243344
NCT01927887|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-05-08|2017-01-24||July 2012|Actual|2012-07-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Interventional|||Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study|Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study|Completed||N/A|12|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-11 01:22:31.378639|2017-10-11 01:22:31.378639
NCT01927874|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-02-02|||January 2013||2013-01-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Subarachnoid or Infiltration for Hemorrhoidectomy|Comparative Study of the Analgesic Effect of Subarachnoid or Infiltration for Hemorrhoidectomy|Completed||N/A|40|Actual|Federal University of São Paulo||2|||f||||f||||||||No||2017-10-11 01:22:31.626893|2017-10-11 01:22:31.626893
NCT01927861|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-08-08|||August 19, 2013|Actual|2013-08-19|August 2017|2017-08-01|July 6, 2018|Anticipated|2018-07-06|June 26, 2018|Anticipated|2018-06-26||Interventional|||Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome|A 52-week, Multi-centre, Randomised, Double-blind, Parallel-group, no Treatment Controlled (Open-label) Trial Investigating the Efficacy and Safety of Two Doses of NN-220 in Short Stature With Noonan Syndrome|Active, not recruiting||Phase 3|51|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:22:31.743767|2017-10-11 01:22:31.743767
NCT01927848|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-01-14|||September 2013||2013-09-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Improving Gait in Persons With Knee Related Mobility Limitations by Rosenoids® Food Supplement: a Randomized Double-blind Placebo-controlled Trial||Completed||Phase 4|100|Actual|Frederiksberg University Hospital||2|||f||||f||||||||||2017-10-11 01:22:31.896287|2017-10-11 01:22:31.896287
NCT01927835|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-09-22||||||September 2016|2016-09-01||||January 2017|Anticipated|2017-01-01||Interventional|||Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Homologous and Heterologous Prime-Boost Regimens Comprising DNA-HIV-PT123, NYVAC-HIV-PT1 and NYVAC-HIV-PT4, and AIDSVAX B/E in Healthy, HIV-Uninfected US and South African Adults|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-11 01:22:31.97608|2017-10-11 01:22:31.97608
NCT01927822|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2015-07-04|||August 2013||2013-08-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Factors Influencing the Abortion Interval of Second-trimester Termination of Pregnancy Using Misoprostol||Completed||N/A|101|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 01:22:32.095809|2017-10-11 01:22:32.095809
NCT01927809|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-04-06|||April 2013||2013-04-01|April 2017|2017-04-01|August 2021|Anticipated|2021-08-01|December 2020|Anticipated|2020-12-01||Observational|||Genetic Mosaicism in Hirschsprung's Disease|Genetics of Hirschsprung's Disease - Can Genetic Mosaicism Due to Early Somatic Mutations, Explain Disease Development?|Recruiting||N/A|90|Anticipated|Erasmus Medical Center|||1||f||||f||||||Samples With DNA|"     Blood samples, skin tissue, colon tissue   "|||2017-10-11 01:22:32.167326|2017-10-11 01:22:32.167326
NCT01927783|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-10-04|||July 31, 2013||2013-07-31|May 16, 2017|2017-05-16|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention|Cardiovascular Health and Needs Assessment in Washington D.C. - Development of a Community-Based Behavioral Weight Loss Intervention|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:22:32.24527|2017-10-11 01:22:32.24527
NCT01927770|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-08-11|||July 27, 2013||2013-07-27|August 7, 2017|2017-08-07|March 10, 2018|Anticipated|2018-03-10|March 10, 2018|Anticipated|2018-03-10||Observational|||A Study of Consent Forms for Whole Exome and Whole Genome Sequencing|Randomized Trial of Consent Interventions for NIH Whole Exome and Whole Genome Sequencing Studies|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:22:32.326199|2017-10-11 01:22:32.326199
NCT01927757|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-07-29|2016-05-30||May 2013||2013-05-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ROCkIES|Full analysis set, which included all participants enrolled who received at least 1 dose of etanercept. Three additional participants were excluded from the FAS due to GCP violations.|Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab|A Single Arm Trial to Evaluate the Efficacy of Etanercept in Moderate to Severe Rheumatoid Arthritis Patients Who Failed to Respond or Lost a Satisfactory Response to Treatment With Adalimumab When Used as Their First Biologic Agent|Terminated||Phase 4|90|Actual|Amgen||1||Business decision due to slow enrollment|f||||f||||||||||2017-10-11 01:22:32.425254|2017-10-11 01:22:32.425254
NCT01927744|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-08-15|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection|Randomized, Placebo-Controlled, Phase 2 Study Of Induction Chemotherapy With Cisplatin/Carboplatin, And Docetaxel With Or Without Erlotinib In Patients With Head And Neck Squamous Cell Carcinomas Amenable For Surgical Resection|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:22:33.155206|2017-10-11 01:22:33.155206
NCT01927731|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-07-11|||October 2013|Actual|2013-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Eltrombopag in Cord Blood or Haploidentical Bone Marrow Transplantation|Safety and Efficacy of Eltrombopag in Patients Undergoing Cord Blood or Haploidentical Bone Marrow Transplantation|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 01:22:33.303052|2017-10-11 01:22:33.303052
NCT01927133|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-08-21|||January 1997||1997-01-01|August 2013|2013-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|FIBROFRANCE||LIVER FIBROSIS PREVALENCE IN FRANCE||Recruiting||N/A|10000|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Serum, liver biopsy   "|||2017-10-11 01:22:41.62477|2017-10-11 01:22:41.62477
NCT01927718|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-11-23|||January 2014||2014-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)|A Pilot Study of Thalidomide to Overcome Lenalidomide Resistance in Patients Suffering Biochemical Progression on Maintenance Therapy After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma|Terminated||N/A|10|Actual|M.D. Anderson Cancer Center||1||Poor Response Rate|f||||f||||||||||2017-10-11 01:22:33.415317|2017-10-11 01:22:33.415317
NCT01927705|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-10-05|||September 2013||2013-09-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)|Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis|Completed||Phase 1/Phase 2|34|Actual|Kang Stem Biotech Co., Ltd.||1|||f||||t||||||||||2017-10-11 01:22:33.559213|2017-10-11 01:22:33.559213
NCT01927692|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-07-15|||July 2013||2013-07-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|TPE||Therapeutic Plasma Exchange in MG|Exploratory Study Of Immunological Profiles In Myasthenia Gravis Subjects That Receive Therapeutic Plasma Exchange|Completed||N/A|11|Actual|Duke University|||1||f||||f||||||||||2017-10-11 01:22:33.694864|2017-10-11 01:22:33.694864
NCT01927679|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-03-03|||August 2013||2013-08-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Vitamin E Prevention of Visible Light Pigmentation|Effect of Vitamin E in the Prevention of Visible Light Induced Pigmentation|Completed||N/A|10|Actual|Innovaderm Research Inc.||2|||f||||f||||||||||2017-10-11 01:22:33.819448|2017-10-11 01:22:33.819448
NCT01927666|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2016-09-02|||December 2012||2012-12-01|November 2015|2015-11-01|August 2016|Actual|2016-08-01|December 2014|Actual|2014-12-01||Interventional|ENGAGE||The Conversion of ENcapsulated GlucorAphanin, Gut Microbiota Phylogeny and gEnotype Study (ENGAGE)|A Human Intervention Trial Investigating the Conversion of Encapsulated Glucoraphanin to Isothiocyanates; and the Potential Link Between the Extent of the Conversion to an Individual's Gut Microbiota Phylogeny and Genotype.|Completed||N/A|57|Actual|Quadram Institute||1|||f||||f||||||||||2017-10-11 01:22:33.949292|2017-10-11 01:22:33.949292
NCT01927653|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-07-19|||January 2011||2011-01-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|||Imaging the Neural Network Connectivity on Patients With Mild Cognitive Impairment|Imaging the Neural Network Connectivity on Patients With Mild Cognitive Impairment|Completed||N/A|108|Actual|Chang Gung Memorial Hospital|||3||f||||t||||||||||2017-10-11 01:22:34.083107|2017-10-11 01:22:34.083107
NCT01927640|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-21|||May 2013||2013-05-01|August 2013|2013-08-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|||Dexmedetomidine for Reversal of Cocaine's Effects on the Heart|Phase 2B Study of Dexmedetomidine for the Reversal of Cocaine's Effects on Myocardial Perfusion|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 01:22:34.728735|2017-10-11 01:22:34.728735
NCT01927627|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-06-09|||November 11, 2013|Actual|2013-11-11|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 29, 2017|Actual|2017-03-29||Interventional|||Enzalutamide in Patients With High-risk Prostate Cancer|A Phase 2 Study of Enzalutamide in Patients With High-risk Prostate Cancer Who Have Undergone Local Definitive Therapy With Radical Prostatectomy|Active, not recruiting||Phase 2|42|Actual|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-11 01:22:34.841927|2017-10-11 01:22:34.841927
NCT01927614|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-02-02|||September 2014||2014-09-01|August 2013|2013-08-01|September 2023|Anticipated|2023-09-01|September 2015|Anticipated|2015-09-01||Observational|||Advanced Cardiac Imaging in Cardiac Allograft Vasculopathy|Advanced Cardiac Imaging in Cardiac Allograft Vasculopathy|Recruiting||N/A|40|Anticipated|Nova Scotia Health Authority|||3||f||||f||||||||||2017-10-11 01:22:34.950715|2017-10-11 01:22:34.950715
NCT01927601|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2016-10-24|||August 2013||2013-08-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Observational|TAVR-Neuro||Assessment of Neurologic Injury Subsequent to Transcatheter Aortic Valve Replacement: A Feasibility Study|Assessment of Neurologic Injury Subsequent to Transcatheter Aortic Valve Replacement: A Feasibility Study|Withdrawn||N/A|0|Actual|University of Michigan|||1|Lack of funding|f||||f||||||||No||2017-10-11 01:22:35.126693|2017-10-11 01:22:35.126693
NCT01927588|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-20|||August 2013||2013-08-01|August 2013|2013-08-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients|An Exploratory Evaluation of Early Use of Everolimus (EVE) on Tacrolimus (TAC)-Based Immunosuppressive Regiment vs. Mycophenolate Sodium (MPS) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients.|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Fundação Pró Rim||2|||f||||t||||||||||2017-10-11 01:22:35.224489|2017-10-11 01:22:35.224489
NCT01927575|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-05-02|2016-09-09||September 2013||2013-09-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|TOMO|1 patient was enrolled in this study, and they underwent Standard X-Ray and CT as well as Tomosynthesis.|Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury|Pilot Study Comparing Diagnostic Imagining Versus FujiFilm's Digital Radiographic AcSellerate CsI System With Tomosynthesis|Terminated||N/A|1|Actual|Fujifilm Medical Systems USA, Inc.||3||Sponsor decision to close trial|f||||f||||||||No||2017-10-11 01:22:35.329943|2017-10-11 01:22:35.329943
NCT01927562|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-07-12|||August 2013||2013-08-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|May 2018|Anticipated|2018-05-01||Interventional|||Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes|Evaluation of the Fractyl Duodenal Remodeling System for the Treatment of Type 2 Diabetes|Active, not recruiting||N/A|57|Actual|Fractyl Laboratories, Inc.||1|||f||||f||||||||||2017-10-11 01:22:35.543111|2017-10-11 01:22:35.543111
NCT01927549|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-10-06|||April 2013||2013-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|CULPRIT-SHOCK||Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock|Prospective Randomized Multicenter Study Comparing Immediate Multivessel Revascularization by PCI Versus Culprit Lesion PCI With Staged Non-culprit Lesion Revascularization in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock|Recruiting||Phase 4|706|Anticipated|University of Luebeck||2|||f||||t||||||||||2017-10-11 01:22:35.620423|2017-10-11 01:22:35.620423
NCT01927523|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-07-07|||August 2013||2013-08-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Improving Life Chances of Disadvantaged Youth: Testing Best-Practice Academic vs. Non-Academic Supports|Improving Life Chances of Disadvantaged Youth: Testing Best-Practice Academic vs. Non-Academic Supports Through a Large-Scale Randomized Control Trial in Chicago|Active, not recruiting||N/A|5344|Anticipated|University of Chicago||4|||f||||t||||||||||2017-10-11 01:22:35.844323|2017-10-11 01:22:35.844323
NCT01927510|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2015-06-15|||August 2013||2013-08-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|TEAM-RCT||TEAM: A Trial of Early Activity and Mobility in ICU|Pilot Randomised Controlled Trial of Early Mobilisation in Critically Ill Patients to Improve Functional Recovery and Quality of Life.|Completed||Phase 1/Phase 2|50|Actual|Australian and New Zealand Intensive Care Research Centre||2|||f||||t||||||||||2017-10-11 01:22:35.971559|2017-10-11 01:22:35.971559
NCT01927484|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-08-19|||January 2013||2013-01-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Knee Osteoarthritis AND Methotrexate Use||Unknown status|Active, not recruiting|Phase 2|144|Actual|Faculty of Medicine, University of Alexandria||2|||f||||t||||||||||2017-10-11 01:22:36.871043|2017-10-11 01:22:36.871043
NCT01927471|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-09-26|||September 2011||2011-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome|Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome|Recruiting||N/A|300|Anticipated|Cornell University|||2||f||||f||||||None Retained|"     Blood serum, subcutaneous fat   "|||2017-10-11 01:22:36.977584|2017-10-11 01:22:36.977584
NCT01927458|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-02-04|||March 2013||2013-03-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Transcranial Direct Current Stimulation Aided Rehabilitation of Gait in Subacute Stroke||Terminated||N/A|6|Actual|University of Aarhus||1||Slow recruitment rate|f||||f||||||||||2017-10-11 01:22:37.134723|2017-10-11 01:22:37.134723
NCT01927445|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-10-03|||August 2014||2014-08-01|October 2017|2017-10-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Improving Stroke Prevention Therapy for Patients With Atrial Fibrillation in Primary Care|Improving Stroke Prevention Therapy for Patients With Atrial Fibrillation in Primary Care: Protocol for a Pragmatic, Cluster-randomized Trial|Completed||N/A|5000|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 01:22:37.239877|2017-10-11 01:22:37.239877
NCT01927432|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-09-26|||September 2011||2011-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea|Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea|Recruiting||N/A|60|Anticipated|Cornell University|||2||f||||f||||||Samples With DNA|"     Blood serum, subcutaneous fat   "|||2017-10-11 01:22:37.345107|2017-10-11 01:22:37.345107
NCT01927419|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-10-03|2015-11-03|2015-07-03|August 21, 2013|Actual|2013-08-21|October 2017|2017-10-01|February 6, 2019|Anticipated|2019-02-06|July 24, 2014|Actual|2014-07-24||Interventional|CheckMate 069|All randomized participants|Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma|Phase 2, Randomized, Double Blinded, Study of Nivolumab (BMS-936558) in Combination With Ipilimumab vs Ipilimumab Alone in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma|Active, not recruiting||Phase 2|179|Actual|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-11 01:22:37.523951|2017-10-11 01:22:37.523951
NCT01927406|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-08-19|||August 2013||2013-08-01|August 2013|2013-08-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.|The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 01:22:39.055972|2017-10-11 01:22:39.055972
NCT01927393|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2014-12-18|||December 2014||2014-12-01|December 2014|2014-12-01||||October 2017|Anticipated|2017-10-01||Interventional|||Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer|Integration of Palliative Care Planning in Pancreatic and Ovarian Cancers|Withdrawn||N/A|0|Actual|City of Hope Medical Center||2||Study was not funded|f||||t||||||||||2017-10-11 01:22:39.200313|2017-10-11 01:22:39.200313
NCT01927380|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-11-03|||August 2013||2013-08-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Autonomic Nervous System Modulation During Laparoscopic Prostatectomy||Completed||N/A|37|Actual|ASST Fatebenefratelli Sacco|||1||f||||f||||||||||2017-10-11 01:22:39.347401|2017-10-11 01:22:39.347401
NCT01927367|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-09-27|||September 2013||2013-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|IMPACT-AF||Integrated Management Program Advancing Community Treatment of Atrial Fibrillation|Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF)|Active, not recruiting||N/A|1145|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 01:22:39.470768|2017-10-11 01:22:39.470768
NCT01927354|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-09-13|||December 2012||2012-12-01|September 2013|2013-09-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.|Observational Study on the Investigation of the Molecular Mechanism and Clinical Significance of the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     tissue   "|||2017-10-11 01:22:39.576238|2017-10-11 01:22:39.576238
NCT01927341|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-04-03||2016-02-11|November 2013||2013-11-01|April 2017|2017-04-01||||October 2015|Actual|2015-10-01||Interventional|||Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors|A Phase Ib/II, Open-label, Multi-center, Dose Escalation Study of MEK162 in Combination With Panitumumab in Adult Patients With Mutant RAS or Wild-type RAS Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|90|Anticipated|Array BioPharma||5|||f||||||||||||||2017-10-11 01:22:39.685193|2017-10-11 01:22:39.685193
NCT01927328|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-10-27|||August 2013||2013-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|IRON||Iron Replacement in Oesophagogastric Neoplasia|An Pilot Study to Assess the Efficacy of Intravenous Iron Isomaltoside 1000 (Monofer®) in the Management of Anaemia Associated With the Palliative Management of Oesophagogastric Adenocarcinoma|Recruiting||Phase 4|40|Anticipated|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 01:22:39.809113|2017-10-11 01:22:39.809113
NCT01927315|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-12-25|||August 2013||2013-08-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes|Effects of Fenofibrate on Endothelial Progenitor Cell Levels in Diabetic Patients With Retinopathy. A Randomized Controlled Trial.|Unknown status|Recruiting|Phase 4|38|Anticipated|University of Padova||2|||f||||f||||||||||2017-10-11 01:22:39.928044|2017-10-11 01:22:39.928044
NCT01927302|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-08-31|||April 2013||2013-04-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery|The Center for the Neurobiology of Language Recovery (CNLR)|Active, not recruiting||N/A|83|Actual|Northwestern University||3|||f||||f||||||||||2017-10-11 01:22:40.062774|2017-10-11 01:22:40.062774
NCT01927289|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-21|||March 2013||2013-03-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||DBRCT on the Effect of Grip Strength in Brachial Plexus vs Distal Forearm Nerve Blocks|A Double-blind Randomized Controlled Trial Between Ultrasound-guided Brachial Plexus and Distal Peripheral Nerve Blocks for Hand Surgery|Completed||Phase 4|14|Actual|University of New Mexico||2|||f||||f||||||||||2017-10-11 01:22:40.172801|2017-10-11 01:22:40.172801
NCT01927276|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-05-15|||September 1, 2013||2013-09-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive|Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive|Completed||N/A|26|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 01:22:40.264245|2017-10-11 01:22:40.264245
NCT01927263|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-04-06|||July 2013||2013-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis|A Phase 3 Clinical Study of NI-071 in Patients With Rheumatoid Arthritis ―A Double-blind, Active Drug-controlled Study and Long-term Study―|Completed||Phase 3|242|Actual|Nichi-Iko Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:22:40.340833|2017-10-11 01:22:40.340833
NCT01927250|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2013-08-19|||February 2007||2007-02-01|August 2013|2013-08-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|MDWP||Influence of Multi-dimensional Wellness Program on Quality of Life|Influence of Multi-dimensional Wellness Program (Diet, Art and Biofield Therapy) on Quality of Life in Japanese Population|Completed||N/A|12166|Actual|MOA Health Science Foundation||1|||f||||f||||||||||2017-10-11 01:22:40.425669|2017-10-11 01:22:40.425669
NCT01927237|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-02-24|||September 2013||2013-09-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide|The Pulmonary Vascular Consequences of Divergent Strategies for Low Tidal Volume Ventilation: Hypercapnia or High Respiratory Rate?|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-10-11 01:22:40.656594|2017-10-11 01:22:40.656594
NCT01927224|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-10-14|||November 2013||2013-11-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients|Open Label, Randomized, Single Dose Cross-over Study to Assess Bioequivalence Between Single 120 mg Nifurtimox Tablet and Four 30 mg Nifurtimox Tablets Administered Orally, Following High Calorie/High Fat Meal to Adult Male and Female Patients Suffering From Chronic Chagas' Disease and to Determine the Pharmacokinetics of Nifurtimox Tablets Administered Orally, in a Form of Aqueous Slurry|Completed||Phase 1|37|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:22:40.772755|2017-10-11 01:22:40.772755
NCT01927211|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-12-28|||July 2013||2013-07-01|December 2015|2015-12-01||||June 2016|Anticipated|2016-06-01||Interventional|||Prospective Study on Cesarean Wound Outcomes|A Prospective Randomized Study Assessing Post Operative Wound Infections Along With Cosmetic Outcomes Using Silver Plated Dressings Compared to Conventional Dressings on Cesarean Section Incisions|Recruiting||N/A|660|Anticipated|Argentum Medical LLC||2|||f||||f||||||||||2017-10-11 01:22:40.924077|2017-10-11 01:22:40.924077
NCT01927198|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2015-06-04||2015-06-04|August 2013||2013-08-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||RDEA3170 Monotherapy in Subjects With Gout|A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of RDEA3170 Monotherapy in Subjects With Gout|Completed||Phase 2|172|Actual|Ardea Biosciences, Inc.||4|||f||||f||||||||||2017-10-11 01:22:41.070205|2017-10-11 01:22:41.070205
NCT01927185|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2017-01-24|||June 2013||2013-06-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation|Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation|Completed||N/A|190|Actual|Azienda Ospedaliero-Universitaria di Parma||2|||f||||f||||||||Undecided||2017-10-11 01:22:41.270677|2017-10-11 01:22:41.270677
NCT01927172|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-19|||September 2013||2013-09-01|August 2013|2013-08-01||||August 2014|Anticipated|2014-08-01||Interventional|||AirSonea Wheeze Detection Study|AirSonea Wheeze Detection Study - Multipart Clinical Performance Assessment to Determine Agreement on Wheeze Detection Between AirSonea™ Versus Physician Auscultation and an Expert Panel.|Unknown status|Not yet recruiting|N/A|85|Anticipated|iSonea||1|||f||||||||||||||2017-10-11 01:22:41.376281|2017-10-11 01:22:41.376281
NCT01927159|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-09-14|||September 2013||2013-09-01|September 2017|2017-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers|A Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of the ID93 + GLA-SE Vaccine in BCG-Vaccinated Healthy Adults|Completed||Phase 1|66|Actual|IDRI||5|||f||||t||||||||||2017-10-11 01:22:41.435141|2017-10-11 01:22:41.435141
NCT01927146|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-21|||July 2013||2013-07-01|August 2013|2013-08-01||||December 2013|Anticipated|2013-12-01||Observational|||Lauren Classifications and HER2 Status in Gastric Cancer Patients|Retrospective Study of Lauren Classifications and HER2 Status in Chinese Patients With Resectable Gastric Adenocarcinoma|Unknown status|Active, not recruiting|N/A|800|Actual|Sun Yat-sen University|||1||f||||f||||||||||2017-10-11 01:22:41.532559|2017-10-11 01:22:41.532559
NCT01927120|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-06-01|2017-04-18||March 25, 2014|Actual|2014-03-25|March 2017|2017-03-01|March 9, 2017|Actual|2017-03-09|August 25, 2016|Actual|2016-08-25||Interventional||All participants.|In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis|In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis With IL-2, Sirolimus, and Tacrolimus Following Allogeneic Hematopoietic Cell Transplantation|Completed||Phase 2|20|Actual|H. Lee Moffitt Cancer Center and Research Institute|Strategies to overcome interference from soluble IL-2 receptor and STAT3-mediated acute GVHD are needed.|1|||f||||f|t|f|||f|||||2017-10-11 01:22:41.711446|2017-10-11 01:22:41.711446
NCT01927107|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-07-25|||April 2012||2012-04-01|July 2017|2017-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|Prob-esity||Effects of Probiotics in Obese Children|Effects of Probiotics Mixture to Standard Diet Therapy in Obese Children|Completed||N/A|120|Actual|Eskisehir Osmangazi University||2|||f||||f||||||||||2017-10-11 01:22:42.209335|2017-10-11 01:22:42.209335
NCT01927094|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-02-12|||June 2012||2012-06-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|PROBAGE||Effects of Probiotics and/or Prebiotics on the Duration of Diarrhea and Hospitalization in Children|The Effect of a Probiotic and/or Prebiotic on the Duration of Diarrhea and Length of Hospital Stay in Children With Acute Diarrhea: Prospective, Double Blind, Randomized Controlled Trial|Completed||Phase 4|1280|Actual|Eskisehir Osmangazi University||2|||f||||f||||||||||2017-10-11 01:22:42.289886|2017-10-11 01:22:42.289886
NCT01927081|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-06-28|||September 2014||2014-09-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Self-management Interventions for Advanced Breast Cancer|Self-management Interventions for Pain in Advanced Breast Cancer|Active, not recruiting||N/A|65|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 01:22:42.374602|2017-10-11 01:22:42.374602
NCT01927068|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-07-19|||July 2013||2013-07-01|July 2017|2017-07-01||||November 2018|Anticipated|2018-11-01||Interventional|ILLUMENATE||Global Study of a Drug-coated Balloon to Treat Obstructive SFA and/or Popliteal Lesions|ILLUMENATE GLOBAL and ISR: Prospective, Single-Arm, Global Multi-Center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions With a Novel Paclitaxel-Coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis|Recruiting||N/A|501|Anticipated|Spectranetics Corporation||1|||f||||t||||||||||2017-10-11 01:22:42.484768|2017-10-11 01:22:42.484768
NCT01927055|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-12-04|2015-11-02||November 2013||2013-11-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy|A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy|Terminated||Phase 3|61|Actual|Chelsea Therapeutics|The study was prematurely terminated; the limited sample size precludes meaningful conclusions on the efficacy or safety of droxidopa in this study.|2||Due to potential competition with a post-marketing study requested by FDA|f||||f||||||||||2017-10-11 01:22:42.707006|2017-10-11 01:22:42.707006
NCT01927042|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-07-18|||April 2014||2014-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|ECHO||Effectiveness of the ECHOs Approach for Patients With Eating Disorders and Their Carers|Effectiveness of the Expert Carers Helping Others (ECHOs) Approach for Patients With Eating Disorders and Their Carers|Recruiting||N/A|60|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 01:22:43.414429|2017-10-11 01:22:43.414429
NCT01927029|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-20|||August 2013||2013-08-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Preterm Delivery Prevention in Twins With Progesterone|Prevención de Parto Prematuro en Gemelares: Ensayo Aleatorio Con Progesterona Vaginal.|Unknown status|Active, not recruiting|Phase 4|213|Actual|Universidad del Desarrollo||2|||f||||f||||||||||2017-10-11 01:22:43.521168|2017-10-11 01:22:43.521168
NCT01927016|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-03-31|||July 2012||2012-07-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|FREGAT I||Outcomes After Esophageal Cancer Surgery|Factors Linked to Outcomes After Esophageal Cancer Surgery: a Multicenter National Study|Completed||N/A|2944|Actual|University Hospital, Lille|||1||f||||t||||||||||2017-10-11 01:22:43.609343|2017-10-11 01:22:43.609343
NCT01927003|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-19|||April 2009||2009-04-01|April 2010|2010-04-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||Direct and Reversed Dorsal Digito-metacarpal Flaps: A Review of 24 Cases||Completed||N/A|24|Actual|The Second Hospital of Tangshan||1|||f||||||||||||||2017-10-11 01:22:43.712179|2017-10-11 01:22:43.712179
NCT01926990|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-11-16|||August 2014||2014-08-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|||Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma|Developing Non-Invasive Early Therapeutic Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma|Recruiting||N/A|15|Anticipated|Stanford University|||1||f||||||||||||||2017-10-11 01:22:43.818394|2017-10-11 01:22:43.818394
NCT01926977|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-02-03|2015-12-29||September 2013||2013-09-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration|Evaluation of Post Injection Inflammation and Pain After Ranibizumab vs Aflibercept Intravitreal Injections|Completed||Phase 1/Phase 2|100|Actual|Sierra Eye Associates|Small sample size. Non-randomized choice of medications.|2|||f||||f||||||||||2017-10-11 01:22:43.948744|2017-10-11 01:22:43.948744
NCT01926964|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-09-28|||September 2013||2013-09-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01|3 Weeks|Observational [Patient Registry]|||Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer|Impact of Recurrence Score® on Recommendations for Adjuvant Treatment in Patients With ER-positive Breast Cancer|Completed||N/A|229|Actual|Swiss Group for Clinical Cancer Research|||1||f||||f||||||||||2017-10-11 01:22:44.48492|2017-10-11 01:22:44.48492
NCT01926951|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-10-27|||September 2013||2013-09-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Renal Denervation Using Externally Focused Therapeutic Ultrasound|A Feasibility Study: An Evaluation of Renal Denervation Using Externally Focused Therapeutic Ultrasound With External Targeting and Tracking on Patients With Refractory Hypertension|Completed||N/A|27|Actual|Kona Medical Inc.||1|||f||||t||||||||||2017-10-11 01:22:44.606365|2017-10-11 01:22:44.606365
NCT01926938|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-20|||May 2003||2003-05-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Endothelial Function in Young Hispanic Adults at Risk for Type 2 Diabetes||Completed||N/A|44|Actual|Joslin Diabetes Center|||2||f||||t||||||||||2017-10-11 01:22:44.709809|2017-10-11 01:22:44.709809
NCT01926925|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-20|||May 2001||2001-05-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|May 2010|Actual|2010-05-01||Observational|||Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes|Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes|Completed||N/A|38|Actual|Joslin Diabetes Center|||2||f||||f||||||Samples Without DNA|"     plasma samples   "|||2017-10-11 01:22:44.841948|2017-10-11 01:22:44.841948
NCT01926912|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-08-21|||May 2013||2013-05-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|HOSPIPalm||A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting|HOSPItal Use of Paliperidone Palmitate - A Prospective Non-Interventional Study|Completed||Phase 4|371|Actual|Janssen-Cilag International NV|||1||f||||f||||||||||2017-10-11 01:22:45.046644|2017-10-11 01:22:45.046644
NCT01926899|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-02-28|||August 2013||2013-08-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients|A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease (aGVHD) Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant (Allo HSCT) Patients|Recruiting||Phase 1|20|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-11 01:22:45.365641|2017-10-11 01:22:45.365641
NCT01926873|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2016-11-01|||August 2013||2013-08-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||A Screening Study To Assess The Cognition Status in Healthy Volunteers|MULTI-CENTER COGNITION ASSESSMENT IN HEALTHY SUBJECTS TO COLLECT REFERENCE DATA FOR COMPARISON TO PATIENTS WITH DEPRESSION|Completed||N/A|240|Actual|Hoffmann-La Roche|||1||f||||||||||Samples With DNA|"     Blood Samples   "|||2017-10-11 01:22:45.698736|2017-10-11 01:22:45.698736
NCT01926860|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-20|||September 2013||2013-09-01|August 2013|2013-08-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|PCV13+HepA||PCV13 + Hepatitis A Vaccine for Adults|Immune Response to Pneumococcal Conjugate Vaccine in Adults Receiving Hepatitis A Vaccine at the Same Time|Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Helsinki University Central Hospital||3|||f||||t||||||||||2017-10-11 01:22:45.823697|2017-10-11 01:22:45.823697
NCT01926847|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-06-13|||October 2013||2013-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DIGIT||Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator|Single Dose, Double-blind, Placebo-controlled, Single Center, Randomized Cross-over Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetic Properties of BAY63-2521 After Oral Dosing in 20 Patients With Raynaud's Phenomenon (RP)|Completed||Phase 2|23|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:22:45.988319|2017-10-11 01:22:45.988319
NCT01926834|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-19|||August 2013||2013-08-01|August 2013|2013-08-01|March 2014|Anticipated|2014-03-01|August 2013|Anticipated|2013-08-01||Interventional|||The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels|The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Guangzhou University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-11 01:22:46.156509|2017-10-11 01:22:46.156509
NCT01926821|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-05-27|||May 2013||2013-05-01|May 2017|2017-05-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer During Radiation or Chemoradiation Therapy|The Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer|Recruiting||Phase 1|200|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:22:46.303378|2017-10-11 01:22:46.303378
NCT01926808|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-01-28|||June 2013||2013-06-01|January 2016|2016-01-01||||December 2015|Actual|2015-12-01||Observational|||Vitamin D Serum Concentrations & Supplementation in Children With Cerebral Palsy|Vitamin D Serum Concentrations and Vitamin D Supplementation in Children and Young Adults With Cerebral Palsy|Completed||N/A|115|Actual|Akron Children's Hospital|||1||f||||f||||||||||2017-10-11 01:22:46.427413|2017-10-11 01:22:46.427413
NCT01926795|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2015-04-06|||June 2013||2013-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Interventional|||Immobilization Versus Observation in Children With Toddler's Fractures: a Prospective Randomized Controlled Trial|Immobilization Versus Observation in Children With Toddler's Fractures: a Prospective Randomized Controlled Trial|Completed||N/A|21|Actual|Greenville Health System||3|||f||||f||||||||||2017-10-11 01:22:46.513709|2017-10-11 01:22:46.513709
NCT01926782|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-01-30|2017-01-30|2015-01-24|September 2013||2013-09-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|September 2014|Actual|2014-09-01||Interventional||All randomized population regardless of concomitant statin therapy.|Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab in Patients With Primary Hypercholesterolemia|Completed||Phase 3|803|Actual|Regeneron Pharmaceuticals||3|||f||||t||||||||||2017-10-11 01:22:46.730264|2017-10-11 01:22:46.730264
NCT01926769|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-19|||February 2012||2012-02-01|August 2013|2013-08-01||||January 2015|Anticipated|2015-01-01||Interventional|||A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer||Unknown status|Recruiting|Phase 2|48|Anticipated|Gachon University Gil Medical Center||1|||f||||||||||||||2017-10-11 01:22:51.333091|2017-10-11 01:22:51.333091
NCT01926756|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-20|||July 2013||2013-07-01|August 2013|2013-08-01||||June 2014|Anticipated|2014-06-01||Interventional|||Does Straight Catheterization in Short Gynecologic Procedures Cause Bacteriuria?|Intraoperative One-Time Catheterization in Short Gynecologic Procedures and Its Potential Effect on Symptomatic and Asymptomatic Bacteriuria|Unknown status|Recruiting|N/A|200|Anticipated|Abington Memorial Hospital||2|||f||||||||||||||2017-10-11 01:22:51.411311|2017-10-11 01:22:51.411311
NCT01926743|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2014-07-13|||August 2013||2013-08-01|July 2014|2014-07-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Identification of Complete Lymph Node Removal by Application of Near Infrared Fluorescence Imaging in Laparoscopic and Robotic Gastrectomy||Unknown status|Recruiting|N/A|30|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 01:22:51.490954|2017-10-11 01:22:51.490954
NCT01926730|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2017-02-13|||November 2013|Actual|2013-11-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|FACES||Food and Crohn's Exacerbation Study (FACES)|Food and Crohn's Exacerbation Study (FACES)|Completed||N/A|216|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:22:51.579141|2017-10-11 01:22:51.579141
NCT01926717|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-03-06|||December 2010||2010-12-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Comparative Clinical Research on Single Roux-en-Y and Traditional Roux-en-Y of Pancreaticojejunostomy-choledochojejunostomy For Treatment of Obstruction of Pancreatic Duct and Bile Duct||Recruiting||N/A|100|Anticipated|The First Affiliated Hospital of Guangzhou Medical University|||2||f||||t||||||||||2017-10-11 01:22:51.646143|2017-10-11 01:22:51.646143
NCT01926704|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-02-18|||October 2013||2013-10-01|February 2014|2014-02-01||||October 2013|Actual|2013-10-01||Observational|||MTF Image Modifications|A Pilotstudy Investigating the Impact of Image Modifications on Subjective Image Quality|Completed||N/A|30|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-11 01:22:51.71556|2017-10-11 01:22:51.71556
NCT01926691|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2013-08-20|||April 2008||2008-04-01|August 2013|2013-08-01||||April 2018|Anticipated|2018-04-01|10 Years|Observational [Patient Registry]|TABASCO||Predictors for Poststroke Outcomes: Tel Aviv Brain Acute Stroke Cohort Acute Stroke Cohort (TABASCO)|Predictors for Poststroke Outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) Study|Recruiting||N/A|534|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||Samples With DNA|"     whole blood, serum, white cells, saliva   "|||2017-10-11 01:22:51.776253|2017-10-11 01:22:51.776253
NCT01926678|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-07-08|||November 2013||2013-11-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy of Swedish Massage Therapy on Cancer-related Fatigue in Cancer Survivors|Efficacy of Swedish Massage Therapy on Cancer-related Fatigue in Cancer|Completed||Phase 2|66|Actual|Emory University||3|||f||||t||||||||||2017-10-11 01:22:51.857997|2017-10-11 01:22:51.857997
NCT01926665|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-09-18|||June 17, 2014|Actual|2014-06-17|September 2017|2017-09-01|September 17, 2017|Actual|2017-09-17|September 17, 2017|Actual|2017-09-17||Interventional|||Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)|Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Patients With Mantle Cell (MCL), T-cell (TCL), and Diffuse B-Cell Lymphoma (DLBCL)|Completed||Phase 1|2|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:22:51.931742|2017-10-11 01:22:51.931742
NCT01926652|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-18|2013-08-20|||July 2013||2013-07-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg|An Open-label, Multiple-dosing, Two-arm, One-sequence, Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Amlodipine 10mg and Candesartan 32mg in Healthy Male Volunteers|Completed||Phase 1|34|Actual|Shin Poong Pharmaceutical Co. Ltd.||2|||f||||t||||||||||2017-10-11 01:22:52.018919|2017-10-11 01:22:52.018919
NCT01926639|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2014-10-22|||October 2009||2009-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Lymvac-1||Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma|Radiotherapy Combined With Intratumoral Injections of Dendritic Cells and Rituximab - a Phase II Cancer Vaccine Trial for Patients With Untreated and Relapsed Indolent Non-Hodgkin`s Lymphoma|Completed||Phase 2|14|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 01:22:52.22748|2017-10-11 01:22:52.22748
NCT01926626|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-08-17|2015-06-08||September 2013||2013-09-01|August 2017|2017-08-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|RIMA||Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers|Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers|Completed||Phase 2|76|Actual|Duke University||1|||f||||t||||||||||2017-10-11 01:22:52.332987|2017-10-11 01:22:52.332987
NCT01926613|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-20|||April 2006||2006-04-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2009|Actual|2009-10-01||Interventional|TSW||Thinking Skills for Work in Severe Mental Illness|Cognitive Rehabilitation and Supported Employment for Severe Mental Illness|Completed||N/A|110|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-11 01:22:52.796919|2017-10-11 01:22:52.796919
NCT01926600|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2013-08-20|||August 2013||2013-08-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Observational|||Sublingual Administration of PPI|Sublingual Administration is More Fast Than Oral or IV Administration in PPI Dosing With Respect to Intragastric pH and Therapeutic Effectiveness: a Prospective, Randomized, Controlled Trial|Unknown status|Recruiting|N/A|60|Anticipated|The Catholic University of Korea|||3||f||||f||||||||||2017-10-11 01:22:52.908091|2017-10-11 01:22:52.908091
NCT01926574|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-04-19|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|June 2015|Actual|2015-06-01||Interventional|||Evaluation of Return to Work Rehabilitation|Evaluation of Inpatient-return- To-work, Multicomponent, Rehabilitation Programs for Persons Temporary Out of Work With Musculoskeletal-, Unspecific-, and/or Common Mental Health Disorders; Randomized Controlled Trial|Active, not recruiting||N/A|300|Anticipated|Norwegian University of Science and Technology||4|||f||||f|f|f||||||||2017-10-11 01:22:53.145363|2017-10-11 01:22:53.145363
NCT01926561|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-10-07|||August 2011||2011-08-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Predictive Factors for Hypotensive Bradycardic Events During Arthroscopic Shoulder Surgery|Predicting the Occurence of Hypotensive Bradycardic Events in the Patients Undergoing Arthroscopic Shoulder Surgery in the Sitting Position Under Interscalene Brachial Plexus Block|Completed||N/A|68|Actual|Daegu Catholic University Medical Center|||1||f||||f||||||||||2017-10-11 01:22:53.255118|2017-10-11 01:22:53.255118
NCT01926548|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-20|||February 2012||2012-02-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers|Open-label, Randomized, Single-dose, 2-way Crossover Study to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers|Completed||Phase 1|28|Actual|CJ HealthCare Corporation||2|||f||||||||||||||2017-10-11 01:22:53.353364|2017-10-11 01:22:53.353364
NCT01926535|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-22|||November 2011||2011-11-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|AMBUK||Amniotic Membrane Graft In Syntomathic Bullous Keratopathy|Comparative Analysis of Human Amniotic Membrane Graft Versus Contact Lenses in Syntomathic Bullous Keratopathy|Completed||Phase 2|20|Actual|Universidad de Valparaiso||2|||f||||t||||||||||2017-10-11 01:22:53.453391|2017-10-11 01:22:53.453391
NCT01926522|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2014-03-21|||September 2013||2013-09-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic Patients|Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic|Completed||N/A|36|Anticipated|Habilita, Ospedale di Sarnico||2|||f||||t||||||||||2017-10-11 01:22:53.581491|2017-10-11 01:22:53.581491
NCT01926509|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2016-04-22|||November 2013||2013-11-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)|A 28-Day Multiple-Dose Titration Study to Assess the Effects of MK-8892 on Safety, Tolerability and Pharmacokinetics in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 1|23|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 01:22:53.706275|2017-10-11 01:22:53.706275
NCT01926496|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-19|2017-09-22|||September 2013||2013-09-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%|A Phase 4 Trial Comparing the Cumulative Incidence of SCC After Treatment With Ingenol Mebutate and Imiquimod for Multiple Actinic Keratoses on Face and Scalp. A Multi-centre, Randomised, Two-arm, Open Label, Active-controlled, Parallel Group, 36-month Trial|Active, not recruiting||Phase 4|579|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 01:22:53.794143|2017-10-11 01:22:53.794143
NCT01926483|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-08-16|||March 2013||2013-03-01|July 2012|2012-07-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|ZTOG-1202||Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection|A Prospective, Phase II Trial of a Trimodality Regimen for Stage III (N2) Non-small-cell Lung Cancer Using Concurrent Chemoradiotherapy as Induction Treatment Followed by Subsequent Resection|Unknown status|Recruiting|Phase 2|75|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-11 01:22:54.074276|2017-10-11 01:22:54.074276
NCT01926470|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-07-24|||July 2013||2013-07-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||The Incidence of the Intravascular Injection During S1 Transforaminal Epidural Steroid Injection in Two Approaches: Anteroposterior Versus Oblique||Completed||N/A|201|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:22:54.160835|2017-10-11 01:22:54.160835
NCT01926457|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2016-10-19|||July 2013||2013-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|||Treating Prediabetes in the First Trimester|Treating Prediabetes in the First Trimester: A Randomized Controlled Trial|Terminated||N/A|202|Actual|University of California, San Diego||2||Poor Enrollment|f||||t||||||||||2017-10-11 01:22:54.249814|2017-10-11 01:22:54.249814
NCT01926444|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-08-08|||July 2013||2013-07-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy|A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Proof-of-Concept Study of GIC-1001 for the Management of Visceral Pain in Subjects Undergoing Sedation-Free, Full Colonoscopy|Completed||Phase 2|308|Actual|gicare Pharma Inc.||4|||f||||t||||||||||2017-10-11 01:22:54.372252|2017-10-11 01:22:54.372252
NCT01926431|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-20|2013-08-20|||September 2009||2009-09-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effects of Intense Exercise on Neural Responses to Food.|The Effects of High Intensity Exercise on Neural Responses to Images of Food|Completed||N/A|16|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-11 01:22:54.505998|2017-10-11 01:22:54.505998
NCT01926418|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2013-08-19|||November 2013||2013-11-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Using Implementation Intentions to Increase Safe Sex Practices in MSM|Using Implementation Intentions to Increase Safe Sex Practices Among and Australian Sample of Men Who Have Sex With Men|Unknown status|Not yet recruiting|N/A|180|Anticipated|University of Sydney||3|||f||||t||||||||||2017-10-11 01:22:54.584996|2017-10-11 01:22:54.584996
NCT01926405|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-06-26|||January 2013||2013-01-01|June 2014|2014-06-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|Amylase||Amylase and Hypersomnia|Evaluation of Excessive Diurnal Sleepiness by the Expression and Activity of Salivary Amylase in Children With Hypersomnia.|Unknown status|Recruiting|N/A|80|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:22:54.674409|2017-10-11 01:22:54.674409
NCT01926392|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2013-08-20|||April 2011||2011-04-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns|A Prospective Randomized Trial Comparing Silver Sulfadiazine Cream to a Water-Soluble Poly-Antimicrobial Gel in Partial Thickness Burn Wounds|Completed||Phase 4|8|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 01:22:54.772679|2017-10-11 01:22:54.772679
NCT01926379|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-05-17|||July 2013||2013-07-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|February 2016|Actual|2016-02-01||Interventional|ENRICH||ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)|A Combination Intervention Package for Isoniazid Preventive Therapy in Ethiopia|Active, not recruiting||N/A|338|Actual|Columbia University||2|||f||||f||||||||Undecided||2017-10-11 01:22:54.856144|2017-10-11 01:22:54.856144
NCT01926366|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-04-03|||September 2013||2013-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|AZD6423||AZD6423 SAD/MAD Study in Healthy Volunteers|A Randomized, Double-Blind, Third-Party-Unblinded, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of AZD6423 in Healthy Volunteers|Completed||Phase 1|175|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:22:54.970923|2017-10-11 01:22:54.970923
NCT01926353|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2015-04-05|||July 2013||2013-07-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Polyacrylate Polyalcohol Copolymer for Vesicoureteral Reflux|Tissue Bulking Agent -Polyacrylate Polyalcohol Copolymer for Endoscopic Correction of Vesicoureteral Reflux in Children: A Comparative Study|Completed||N/A|25|Actual|St. Luke's Medical Center, Philippines|||3||f||||t||||||||||2017-10-11 01:22:55.073745|2017-10-11 01:22:55.073745
NCT01926340|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-08-04|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|FEP||Early Medication Discontinuation and Long-term Clinical Outcome in FEP|The Impact of Early Medication Discontinuation on Long-term Clinical Outcome in First Episode Psychosis|Completed||N/A|178|Actual|The University of Hong Kong|||2||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:22:55.148316|2017-10-11 01:22:55.148316
NCT01926327|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2014-04-24|||January 2013||2013-01-01|September 2012|2012-09-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of Platelet-rich Plasma in Patients With Osteoarthritis of the Knee|The Effects of Intraarticular Injection of Platelet-rich Plasma in Patients With Osteoarthritis of the Knee (in a Clinical Trial Phase III)|Completed||Phase 3|150|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 01:22:55.235972|2017-10-11 01:22:55.235972
NCT01926314|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2013-08-19|||August 2013||2013-08-01|August 2013|2013-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Postpartum Pelvic Floor Rehabilitation in Prevention and Treatment of Pelvic Floor Dysfunction|The Effect of Postpartum Pelvic Floor Rehabilitation in Prevention and Treatment of Pelvic Floor Dysfunction- a Multiple Centers Cooperation Research.|Recruiting||N/A|1000|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 01:22:55.341293|2017-10-11 01:22:55.341293
NCT01926301|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2013-08-17|||August 2013||2013-08-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|SepsAR2||Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy|Cerebrovascular Autoregulation in Patients With Severe Sepsis and Septic Shock, Influence of Renal Replacement Therapy|Unknown status|Recruiting|N/A|47|Anticipated|Johannes Gutenberg University Mainz|||2||f||||f||||||Samples Without DNA|"     Serum and whole blood   "|||2017-10-11 01:22:55.484369|2017-10-11 01:22:55.484369
NCT01926288|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-19|||October 2008||2008-10-01|August 2013|2013-08-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B|Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B|Unknown status|Active, not recruiting|Phase 4|287|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-11 01:22:55.584882|2017-10-11 01:22:55.584882
NCT01926275|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-18|||July 2013||2013-07-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||NPPV Added Inspiratory Muscle Training in Severe COPD|Noninvasive Positive Pressure Ventilation Added Inspiratory Muscle Training in Severe Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|80|Anticipated|Guangzhou Institute of Respiratory Disease||4|||f||||t||||||||||2017-10-11 01:22:55.744108|2017-10-11 01:22:55.744108
NCT01926262|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-12-01|||November 2013||2013-11-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Exercise as Treatment of Neck Pain Among Helicopter Pilots and Crew Members|Physical Exercise Against Neck and Shoulder Pain in Danish Military Helicopter Pilots and Crewmembers - A Clinical Randomized, Controlled Trail|Completed||Phase 2|69|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 01:22:55.851495|2017-10-11 01:22:55.851495
NCT01926249|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-04-05|||April 2011|Actual|2011-04-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|MEMENTO||A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders|A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders|Active, not recruiting||N/A|2300|Anticipated|University Hospital, Bordeaux|||1||f||||f||||||Samples With DNA|"     -  Blood sampling        -  Lumbar puncture (samples without DNA)   "|||2017-10-11 01:22:55.933648|2017-10-11 01:22:55.933648
NCT01926236|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-17|2017-07-27|||February 2014||2014-02-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|ABC06||Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers|A Phase III, Randomised, Multicentre Open-label Study of Active Symptom Control (ASC) Alone or ASC With Oxaliplatin/ 5F-U Chemotherapy for Patients With Locally Advanced/ Metastatic Biliary Tract Cancers Previously Treated With Cisplatin/ Gemcitabine Chemotherapy.|Recruiting||Phase 3|162|Anticipated|The Christie NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:22:56.11778|2017-10-11 01:22:56.11778
NCT01926223|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-16|||February 2008||2008-02-01|August 2013|2013-08-01||||December 2011|Actual|2011-12-01||Interventional|MHFE2||Massachusetts Healthy Families Evaluation-2||Completed||N/A|||Tufts University||2|||f||||||||||||||2017-10-11 01:22:56.28639|2017-10-11 01:22:56.28639
NCT01926210|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-20|||September 2013||2013-09-01|August 2013|2013-08-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|POR||Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders|The Comparison of Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders: a Prospective Randomized Study.|Unknown status|Not yet recruiting|Phase 4|500|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:22:56.354937|2017-10-11 01:22:56.354937
NCT01926197|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-08-11|||August 2013||2013-08-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase III FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer|A Randomized Phase III Study Evaluating Modified FOLFIRINOX (mFFX) With or Without Stereotactic Body Radiotherapy (SBRT) in the Treatment of Locally Advanced Pancreatic Cancer|Recruiting||Phase 3|172|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 01:22:56.460653|2017-10-11 01:22:56.460653
NCT01926184|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-09-28|||January 2013|Actual|2013-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ARTEMIS||RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users|Randomized Controlled Trial of an Integrative Intervention for Non-Treatment-Seeking Meth Users|Active, not recruiting||N/A|230|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:22:56.719003|2017-10-11 01:22:56.719003
NCT01926171|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-07-14|||June 2013||2013-06-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases|A Single Center, Open Label, Multicenter Study to Determine the Safety and Efficacy of Icotinib in Combination With Whole Brain Radiation Therapy For NSCLC Patients With Brain Metastases|Unknown status|Recruiting|Phase 4|80|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 01:22:56.819561|2017-10-11 01:22:56.819561
NCT01926158|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2014-01-07|||December 2013||2013-12-01|January 2014|2014-01-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Interventional|ProliaHip||Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women|Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women: a Randomized, Double-blind, Placebo-controlled Study|Unknown status|Recruiting|Phase 4|68|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-11 01:22:56.91945|2017-10-11 01:22:56.91945
NCT01926145|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-06-09|||April 2013||2013-04-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|DenHeart||DenHeart - Self-reported Health and Quality of Life at Hospital Discharge From a Heart Centre in Denmark|DenHeart - Self-reported Health and Quality of Life at Hospital Discharge From a Heart Centre in Denmark|Completed||N/A|16712|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 01:22:57.025745|2017-10-11 01:22:57.025745
NCT01926132|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-08-19|||August 2013||2013-08-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||High-dose Ascorbic Acid Intravenous Injection Decreases Mitochondrial DNA Damage in Chronic Fatigue Patients: Randomized-controlled Study||Unknown status|Recruiting|Phase 4|60|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:22:57.114792|2017-10-11 01:22:57.114792
NCT01926119|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-03-30|2015-11-17||July 2013||2013-07-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||TMS for CRPS - Pilot Study||Completed||N/A|4|Actual|Stanford University||1|||f||||||||||||||2017-10-11 01:22:57.204928|2017-10-11 01:22:57.204928
NCT01926106|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-02-10|||July 2012||2012-07-01|August 2013|2013-08-01|July 2016|Anticipated|2016-07-01|July 2014|Actual|2014-07-01||Interventional|twins||Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome|Nasal Intermittent Positive-Pressure Ventilation vs Nasal Continuous Positive Airway Pressure for Twin Infants With Respiratory Distress Syndrome|Unknown status|Recruiting|N/A|64|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:22:57.471942|2017-10-11 01:22:57.471942
NCT01926093|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-01-08|||June 2012||2012-06-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Low Dose Lung CT Scan for Quantitative Analysis in ARDS Patients||Completed||N/A|51|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-10-11 01:22:57.579063|2017-10-11 01:22:57.579063
NCT01926080|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-08-16|||January 2008||2008-01-01|August 2013|2013-08-01||||February 2011|Actual|2011-02-01||Interventional|||Impact of a Neonatal-Bereavement-Support DVD on Grief|End-of-Life Care in the NICU: Does Bereavement Support Make a Difference?|Completed||N/A|107|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:22:57.661145|2017-10-11 01:22:57.661145
NCT01926067|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-02-27|||June 2012||2012-06-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Monitoring of Cardiac Function With 3-axis Accelerometers|Monitoring of Cardiac Function With 3-axis Accelerometers During Weaning of Cardiopulmonary by Pass After Heart Surgery|Completed||N/A|20|Actual|Oslo University Hospital|||1||f||||t||||||||||2017-10-11 01:22:57.752488|2017-10-11 01:22:57.752488
NCT01926054|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-01-17|||July 2013||2013-07-01|January 2017|2017-01-01||||February 2018|Anticipated|2018-02-01||Interventional|||ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis|An Open Label Randomized Phase IV Study of the Safety and Efficacy of ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis|Recruiting||Phase 4|25|Anticipated|Ohio State University||2|||f||||t||||||||||2017-10-11 01:22:57.830404|2017-10-11 01:22:57.830404
NCT01926041|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-01-26|||August 2013||2013-08-01|January 2016|2016-01-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||The Effectiveness of Smoking Cessation Clinics Combined With Coach-assisted Lifestyle Change in Prediabetic Smokers|The Effectiveness of Smoking Cessation Clinics Combined With Coach-assisted Lifestyle Change in Prediabetic Smokers|Recruiting||N/A|446|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:22:57.936008|2017-10-11 01:22:57.936008
NCT01926028|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-09-21|||July 2013||2013-07-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis|Phase 1b/2a, Multi-center, Double-blind, Randomized, Placebo-controlled Study of a Single Dose of NDV-3A or NDV-3 Vaccine to Evaluate Safety, Tolerability, Immunogenicity and Efficacy in Preventing Recurrent Vulvovaginal Candidiasis|Completed||Phase 1/Phase 2|188|Actual|NovaDigm Therapeutics, Inc.||3|||f||||t||||||||Yes|Presentations at scientific meetings and publication|2017-10-11 01:22:58.053976|2017-10-11 01:22:58.053976
NCT01926015|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-05-02|2015-03-27||September 19, 2013|Actual|2013-09-19|May 2017|2017-05-01|June 6, 2014|Actual|2014-06-06|June 6, 2014|Actual|2014-06-06||Interventional|||Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)|Post-marketing, Randomized, Open-label Study to Assess the Immunogenicity and Safety of Concomitant Administration of V260 and Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Japanese Healthy Infants|Completed||Phase 4|192|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:22:58.217752|2017-10-11 01:22:58.217752
NCT01926002|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-07-15|||September 2013||2013-09-01|July 2015|2015-07-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)|A Multicenter Randomized Clinical Trial to Study the Effects of Single Doses of MK-8351 on the Early Asthmatic Response to a Lung Allergen Challenge|Withdrawn||Phase 1|0|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 01:22:58.882182|2017-10-11 01:22:58.882182
NCT01925820|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2014-12-03|||January 2013||2013-01-01|December 2014|2014-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B|Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B|Recruiting||Phase 4|540|Anticipated|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-11 01:23:00.340335|2017-10-11 01:23:00.340335
NCT01925989|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2016-02-08|||November 2013||2013-11-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of How LY2605541 and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics|Evaluation of the Effects of LY2605541 on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus|Completed||Phase 1|32|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 01:22:58.976931|2017-10-11 01:22:58.976931
NCT01925976|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-16|||August 2011||2011-08-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Individualized Dietetic Intervention-eating Habits in Obese Hispanic Children of Low Socioeconomic Status|Individualized Tailor-made Dietetic Intervention Program at Schools Enhances Eating Behaviors and Dietary Habits in Obese Hispanic Children of Low Socioeconomic Status|Completed||N/A|105|Actual|Instituto Tecnologico y de Estudios Superiores de Monterey||1|||f||||f||||||||||2017-10-11 01:22:59.074809|2017-10-11 01:22:59.074809
NCT01925963|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2016-12-19|||October 2013||2013-10-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|NORMAL||Normative Datasets for Assessments Planned for Mild Traumatic Brain Injury (NORMAL)|Development of Normative Datasets for Assessments Planned for Use in Patients With Mild Traumatic Brain Injury (NORMAL)|Active, not recruiting||N/A|75|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||Samples With DNA|"     Serum and plasma will be collected and frozen for future analyses. Future work may examine     DNA, chronic neuro-response biomarkers, plasma- and leukocyte-based markers of TBI using a     number of modern molecular techniques to examine the expression profiles of genes, proteins,     and other macromolecules and to correlate these profiles to clinical outcomes, and genotypes.   "|||2017-10-11 01:22:59.196944|2017-10-11 01:22:59.196944
NCT01925950|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-05-18|||December 2013||2013-12-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of orBec® (Oral Beclomethasone 17,21-Dipropionate) Administered as Monotherapy in the Treatment of Upper Gastrointestinal (GI) Symptoms Caused by GVHD in Patients With Chronic GI GVHD|Terminated||Phase 2|2|Actual|Soligenix||2||The study was stopped due to patient enrollment challenges.|f||||f||||||||||2017-10-11 01:22:59.291125|2017-10-11 01:22:59.291125
NCT01925924|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-05-10|||February 2009||2009-02-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|December 2013|Actual|2013-12-01||Interventional|||RMGI v Composite for Orthodontic Bonding|Resin-modified Glass Ionomer or Composite for Orthodontic Bonding? - a Multi-centre, Randomised, Single Blinded Clinical Trial|Active, not recruiting||N/A|210|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||Undecided|May share if suitably anonymised|2017-10-11 01:22:59.485312|2017-10-11 01:22:59.485312
NCT01925911|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-07-28|||August 2013||2013-08-01|July 2017|2017-07-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|DDI||Phase 1 Study in Healthy Subjects to Evaluate the Effect of IPI-145 on the Pharmacokinetics of Midazolam|A Phase 1, Open-Label, Single-Sequence, 2-Period Study to Evaluate the Effect of IPI-145 on Single-Dose Pharmacokinetics of Midazolam (a CYP3A Substrate) in Healthy Subjects|Completed||Phase 1|14|Actual|Verastem, Inc.||1|||f||||f||||||||||2017-10-11 01:22:59.577484|2017-10-11 01:22:59.577484
NCT01925898|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-01-20|||August 2013||2013-08-01|August 2013|2013-08-01|July 2014|Anticipated|2014-07-01|February 2014|Anticipated|2014-02-01||Interventional|||A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.|A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.|Unknown status|Recruiting|Phase 4|60|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 01:22:59.647055|2017-10-11 01:22:59.647055
NCT01925885|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-04-04|||September 2013||2013-09-01|April 2017|2017-04-01|December 23, 2015|Actual|2015-12-23|December 23, 2015|Actual|2015-12-23||Interventional|FIRMAT-PAF||Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)|Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)|Terminated||N/A|1|Actual|Indiana University||2||"•Terminated: recruiting or enrolling participants has halted prematurely and will not resume;   participants are no longer being examined or treated"|f||||t||||||||||2017-10-11 01:22:59.732804|2017-10-11 01:22:59.732804
NCT01925872|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2015-01-27|||May 2013||2013-05-01|August 2013|2013-08-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|ORETCR||Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance|The Optimal Regimen of Medical Treatment in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance|Unknown status|Enrolling by invitation|N/A|2000|Anticipated|Beijing Tiantan Hospital|||1||f||||f||||||Samples With DNA|"     whole blood were retained to extract DNA for genetic sequencing.   "|||2017-10-11 01:22:59.836645|2017-10-11 01:22:59.836645
NCT01925859|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-05-29|||June 2013||2013-06-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|EryDex||EryDex Pharmacokinetics in Healthy Volunteers|Pharmacokinetics Study to Measure Plasma Concentrations of Dexamethasone Following EryDex (Dexamethasone Sodium Phosphate Encapsulated in Autologous Erythrocytes) Infusion in Healthy Volunteers|Completed||Phase 1|18|Actual|Erydel||1|||f||||f||||||||||2017-10-11 01:22:59.890938|2017-10-11 01:22:59.890938
NCT01925846|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2014-04-14|||January 2013||2013-01-01|April 2014|2014-04-01|July 2015|Anticipated|2015-07-01|January 2015|Anticipated|2015-01-01||Observational|||Pseudomonal Type Three Secretion System and Contact Lens Associated Microbial Keratitis|Association of Type Three Secretion System (T3SS) of Pseudomonas Aeruginosa With Pathogenesis of Contact Lens-Associated Microbial Keratitis (CLMK)|Unknown status|Recruiting|N/A|180|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:22:59.961244|2017-10-11 01:22:59.961244
NCT01925833|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2013-08-16|||September 2013||2013-09-01|August 2013|2013-08-01||||August 2015|Anticipated|2015-08-01||Interventional|||Adenoma Detection by Polypectomy During Both Insertion and Withdrawal|Comparison of Adenoma Detection by Polypectomy During Both Insertion and Withdrawal Versus Only Withdrawal of Colonoscopy: a Randomized, Controlled Trial|Unknown status|Not yet recruiting|N/A|1600|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-10-11 01:23:00.12317|2017-10-11 01:23:00.12317
NCT01925807|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-08-10|||February 2014||2014-02-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|BRAVA||Building Resilience and Attachment in Vulnerable Adolescents|Brief Group Intervention for Adolescents With Mild to Moderate Suicidal Ideation and Their Caregivers: Preliminary Investigation for a Novel Treatment Approach|Completed||N/A|76|Actual|Children's Hospital of Eastern Ontario||1|||f||||f||||||||||2017-10-11 01:23:01.102311|2017-10-11 01:23:01.102311
NCT01925781|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2015-12-10|2015-12-10||August 2013||2013-08-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||e-Cigarettes Versus NRT Gum for Smoking Cessation|e-Cigarettes Versus Nicotine Replacement Therapy for Smoking Cessation|Terminated||Phase 4|10|Actual|Creighton University||2||IND required|f||||f||||||||||2017-10-11 01:23:01.493525|2017-10-11 01:23:01.493525
NCT01925768|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-04-04|2016-02-25||September 4, 2013|Actual|2013-09-04|April 2017|2017-04-01|November 17, 2016|Actual|2016-11-17|February 25, 2015|Actual|2015-02-25||Interventional||Full analysis set consisting of all participants who were randomized as specified in the protocol.|Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis|A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis|Completed||Phase 3|219|Actual|Celgene||2|||f||||t||||||||||2017-10-11 01:23:01.887535|2017-10-11 01:23:01.887535
NCT01925755|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-01-19|||July 2013||2013-07-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Observational|NEURO-XAR||Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients|Prospective Multicenter Observational Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients|Completed||N/A|209|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:23:02.641726|2017-10-11 01:23:02.641726
NCT01925742|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2017-01-30|||November 2013||2013-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|PEGASUS||Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood|PEGASUS: PErsonalized Genomics for Prenatal Aneuploidy Screening USing Maternal Blood|Active, not recruiting||N/A|3819|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 01:23:02.750869|2017-10-11 01:23:02.750869
NCT01925729|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-08-23|||October 2013||2013-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||TransMEM Gas Exchange -- Project 1, Aim 2|Middle Ear Pressure Regulation in Health and Disease -- Gas Supply, Demand and Middle Ear Gas Balance -- Specific Aim 2|Recruiting||N/A|120|Anticipated|University of Pittsburgh||4|||f||||f||||||||||2017-10-11 01:23:02.88079|2017-10-11 01:23:02.88079
NCT01925716|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-19|||March 2013||2013-03-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effects of The Effects of Dietary Oils on Fasting Lipoprotein Lipids|A Randomized Double Blind Controlled Crossover Trial to Assess the Effects of Dietary Oils on Fasting Lipoprotein Lipids|Completed||N/A|57|Actual|ACH Food Companies, Inc.||2|||f||||f||||||||||2017-10-11 01:23:02.992631|2017-10-11 01:23:02.992631
NCT01925703|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-08-12|2015-06-09||April 2011||2011-04-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure|Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure|Completed||Phase 4|13|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 01:23:03.077905|2017-10-11 01:23:03.077905
NCT01925690|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2015-11-30|||February 2013||2013-02-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|MIMS||Development of a Motivational Intervention to Improve Treatment Adherence in MS|Development of a Motivational Intervention to Improve Treatment Adherence in MS|Completed||N/A|80|Actual|University of Missouri, Kansas City||2|||f||||f||||||||||2017-10-11 01:23:03.967912|2017-10-11 01:23:03.967912
NCT01925677|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-08-16|||January 2015||2015-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Robotic Single Port Donor Nephrectomy|Use of the Intuitive Surgical da Vinci® Single-Site™ With Instruments and Accessories for Single-Port Laparoscopic Nephrectomies|Completed||N/A|3|Actual|University of Maryland||1|||f||||f||||||||||2017-10-11 01:23:04.085156|2017-10-11 01:23:04.085156
NCT01925664|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-09-04|||January 2001||2001-01-01|September 2013|2013-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Doula Support for Young Mothers: A Randomized Trial|Doula Support for Young Mothers: A Randomized Trial|Completed||N/A|248|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 01:23:04.214894|2017-10-11 01:23:04.214894
NCT01925651|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-01-24|||August 2013||2013-08-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Clinical Trial of The Use of Bolus in Post Mastectomy Irradiation in Breast Cancer|Randomized Clinical Trial of the Impact of the Use of Bolus in the Treatment of Post Mastectomy Radiotherapy for Breast Cancer|Completed||Phase 2/Phase 3|54|Anticipated|AC Camargo Cancer Center||4|||f||||f||||||||||2017-10-11 01:23:04.342793|2017-10-11 01:23:04.342793
NCT01925638|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-16|2014-01-07|||September 2013||2013-09-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Ketoconazole on the Pharmacokinetics of Refametinib|An Open-label Study in Healthy Male Subjects to Assess the Effect of a Strong CYP3A4 Inhibitor, Ketoconazole, on the Pharmacokinetics of Refametinib|Completed||Phase 1|18|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:23:04.454995|2017-10-11 01:23:04.454995
NCT01925625|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-12-03|||August 2013||2013-08-01|December 2014|2014-12-01|August 2018|Anticipated|2018-08-01|August 2016|Anticipated|2016-08-01||Interventional|ECLS||Early Cancer Detection Test - Lung Cancer Scotland|Detection in Blood of Autoantibodies to Tumour Antigens as a Case-finding Method in Lung Cancer Using the EarlyCDT-Lung Test|Recruiting||N/A|10000|Anticipated|University of Dundee||2|||f||||t||||||||||2017-10-11 01:23:04.563257|2017-10-11 01:23:04.563257
NCT01925053|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-02-26|||July 2013||2013-07-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Flintstone Foods 1|A Pilot Study on Gastric Layering and Emptying Induced by a Palaeolithic Inspired Meal|Completed||N/A|4|Actual|Quadram Institute||2|||f||||t||||||||||2017-10-11 01:23:16.753345|2017-10-11 01:23:16.753345
NCT01925612|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-05-31|||August 2013||2013-08-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)|A Phase 2 Study of Brentuximab Vedotin in Combination With Standard of Care Treatment (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone [RCHOP]) or RCHP ( Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone) as Front-line Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)|Terminated||Phase 2|87|Actual|Seattle Genetics, Inc.||5||"Sponsor decision based on portfolio prioritization and changing treatment landscape in   frontline DLBCL"|f||||f||||||||||2017-10-11 01:23:04.680012|2017-10-11 01:23:04.680012
NCT01925599|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2016-08-04|||July 2013||2013-07-01|August 2016|2016-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma|Identification of Germline BAP1 Mutation In Subjects With Choroidal Nevi or Uveal Melanoma|Recruiting||N/A|100|Anticipated|Greater Houston Retina Research|||1||f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 01:23:04.942571|2017-10-11 01:23:04.942571
NCT01925586|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2016-09-09|||August 2013||2013-08-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|ALCOVE||Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)|Atypical Lesions of the Breast: Close Observation vs. Excision|Active, not recruiting||N/A|9|Actual|Yale University|||1||f||||f||||||||||2017-10-11 01:23:05.05033|2017-10-11 01:23:05.05033
NCT01925573|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-07-17|||May 2014||2014-05-01|July 2017|2017-07-01|December 2026|Anticipated|2026-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)|Proposed Pilot Study of Combined Optune+ Bevacizumab, and Hypofractionated Stereotactic Irradiation for Bevacizumab-Naive Recurrent Glioblastoma|Recruiting||N/A|27|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-11 01:23:05.113719|2017-10-11 01:23:05.113719
NCT01925560|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-05-13|||January 2013||2013-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Tolerance and Utilization of Agave Inulin in Healthy Adults|Tolerance and Utilization of Agave Inulin in Healthy Adults|Completed||N/A|30|Actual|University of Illinois at Urbana-Champaign||3|||f||||f||||||||||2017-10-11 01:23:05.212306|2017-10-11 01:23:05.212306
NCT01925547|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-10-24|||July 2013||2013-07-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Micellar Curcumin and Metabolic Syndrome Biomarkers|Effect of Micellar Curcumin on Inflammation and Lipid Metabolism Markers|Completed||Phase 2|42|Actual|University of Hohenheim||2|||f||||f||||||||||2017-10-11 01:23:05.304075|2017-10-11 01:23:05.304075
NCT01925534|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-01-19|||November 2013|Actual|2013-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|May 2015|Actual|2015-05-01||Interventional|OPTINIV||Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation|Pilot Study of Optiflow as a NIV Rest Therapy|Completed||N/A|54|Actual|Tufts Medical Center||2|||f||||f||||||||||2017-10-11 01:23:05.413574|2017-10-11 01:23:05.413574
NCT01925521|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-11-05|||August 2013||2013-08-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|OPS-2071Ph1||OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.|A phase1,Randomized,Double-blind,Placebo-controlled,Two-part,Sequential Ascending Single and Multiple Dose Study to Investigate the Safety, Tolerability and the PK and PD Profile of OPS-2071 in Healthy Male Korean Subjects|Completed||Phase 1|96|Actual|Korea Otsuka Pharmaceutical Co., Ltd.||4|||f||||t||||||||||2017-10-11 01:23:05.52558|2017-10-11 01:23:05.52558
NCT01925508|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-05-10|||July 2012||2012-07-01|May 2016|2016-05-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Observational|||Evaluation of a Physical Therapy Protocol on Quality of Life Musculoskeletal Pain and Anxiety in Women With Preeclampsia|Evaluation of a Physical Therapy Protocol on Quality of Life, Musculoskeletal Pain and Anxiety in Women With Preeclampsia|Completed||N/A|60|Actual|University of Sao Paulo|||1||f||||f||||||||||2017-10-11 01:23:05.629078|2017-10-11 01:23:05.629078
NCT01925495|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-11-02|||November 2016||2016-11-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3|Middle Ear Pressure Regulation in Health and Disease/Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3|Recruiting||N/A|10|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 01:23:05.696883|2017-10-11 01:23:05.696883
NCT01925482|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-11-02|||September 2013||2013-09-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Trans-Middle-Ear Mucosal Gas Exchange Project 1, Specific Aim 1|Middle Ear Pressure Regulation in Health and Disease: Gas Supply, Demand and Middle-Ear Gas Balance -- Specific Aim 1|Recruiting||N/A|20|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:23:05.969397|2017-10-11 01:23:05.969397
NCT01925469|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-03-17|2013-12-17||December 2011||2011-12-01|March 2017|2017-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram|A Randomized Controlled Trial of Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram|Completed||Phase 4|30|Actual|University of Pennsylvania|Standard deviations were wider than anticipated.|2|||f||||t||||||||||2017-10-11 01:23:06.09977|2017-10-11 01:23:06.09977
NCT01925456|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2014-12-08|||May 2011||2011-05-01|June 2011|2011-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PfizerOABLUT||Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder|Validation of Instruments for Pragmatic Clinical Trials for Overatcive Bladder|Completed||Phase 1|75|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:23:06.795695|2017-10-11 01:23:06.795695
NCT01925443|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-08|2015-12-02|||December 2015||2015-12-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Low Power Laser Therapy on Muscle Performance Isokinetic Pre-exercise in Individuals With Diabetes Mellitus Type II||Suspended||N/A|60|Anticipated|University of Nove de Julho||3||technical problems with equipment from the main outcome|f||||t||||||||||2017-10-11 01:23:06.919726|2017-10-11 01:23:06.919726
NCT01925430|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-05-01|||November 2013||2013-11-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||The Evaluation of a New Sleep Algorithm|The Evaluation of a New Sleep/Wake State Algorithm|Completed||N/A|36|Actual|ResMed|||2||f||||t||||||||||2017-10-11 01:23:07.03569|2017-10-11 01:23:07.03569
NCT01925417|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-04-24|2015-05-28||August 2013||2013-08-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|PUNCH CD||Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea|A Phase 2 Open-label Clinical Trial Demonstrating the Safety of RBX2660 Microbiota Suspension for the Treatment of Recurrent Clostridium Difficile-associated Diarrhea (CDAD): the PUNCH CD Study|Completed||Phase 2|34|Actual|Rebiotix Inc.|Small sample size (n=34) limits extrapolation of results to a larger population.|1|||f||||f||||||||||2017-10-11 01:23:07.153709|2017-10-11 01:23:07.153709
NCT01925404|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-04-12|||June 2013||2013-06-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|October 2015|Actual|2015-10-01||Interventional|||Promoting Physical Activity In High Poverty Neighborhoods|Promoting Physical Activity In High Poverty Neighborhoods|Active, not recruiting||N/A|5943|Actual|RAND||4|||f||||t||||||||Yes|May be available upon request as appropriate. We have response data from park users and residents living within one mile of enrolled parks. Interested researchers should contact the PI|2017-10-11 01:23:07.53871|2017-10-11 01:23:07.53871
NCT01925391|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-06-13|||January 2013||2013-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|IOP||The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops|The Measurement of Intraocular Pressure in Nonglaucomatous Children Under Nitrous Oxide/02/Topical Anesthesia and Sevoflurane/Nitrous Oxide/Topical Anesthesia|Completed||Early Phase 1|75|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 01:23:07.703976|2017-10-11 01:23:07.703976
NCT01925378|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-02-22|||July 2012||2012-07-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia|A PHASE II SINGLE-ARM INTERVENTION TRIAL OF NELFINAVIR IN PATIENTS WITH GRADE 2/3 or 3 CERVICAL INTRAEPITHELIAL NEOPLASIA|Recruiting||Phase 2|10|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||f||||||||||2017-10-11 01:23:07.846815|2017-10-11 01:23:07.846815
NCT01925365|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-15|||May 2009||2009-05-01|August 2013|2013-08-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Health Benefits of Whole Grain Oats in Population at Risk of Cardio-metabolic Disease|Hypocholesterolaemic and Prebiotic Effects of a Whole-grain Oat-based Breakfast Cereal in a Cardio-metabolic 'at Risk' Population|Completed||N/A|30|Actual|University of Reading||2|||f||||t||||||||||2017-10-11 01:23:07.966855|2017-10-11 01:23:07.966855
NCT01925352|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-19|||November 2012||2012-11-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease|Phase 2 Study of Adenovirus Hepatocyte Growth Factor for Treatment of Ischemic Heart Disease|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|The First Affiliated Hospital with Nanjing Medical University||1|||f||||t||||||||||2017-10-11 01:23:08.056987|2017-10-11 01:23:08.056987
NCT01925339|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-05-22|||December 2015||2015-12-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Esthetic Outcomes of Immediately Placed Implants Receiving Immediate Provisionalization and Delayed Restoration||Active, not recruiting||N/A|40|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 01:23:08.172739|2017-10-11 01:23:08.172739
NCT01925313|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-15|||December 2012||2012-12-01|December 2012|2012-12-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers|A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers|Completed||Phase 1|30|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 01:23:08.252835|2017-10-11 01:23:08.252835
NCT01925300|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2016-12-28|||July 2013||2013-07-01|December 2016|2016-12-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin|A Randomized, Open-label, Repeated-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Bisoprolol and Rosuvastatin in Healthy Adult Volunteers|Withdrawn||Phase 1|0|Actual|CJ HealthCare Corporation||3|||f||||f||||||||||2017-10-11 01:23:08.341167|2017-10-11 01:23:08.341167
NCT01925287|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-10-24|||October 2011||2011-10-01|October 2016|2016-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Oral Bioavailability of Curcumin From Micronized Powder and Liquid Micelles in Healthy Young Women and Men|Novel Strategies for the Enhancement of the Potency of Nutraceuticals With Low Oral Bioavailability and Their Application in Novel Functional Foods for Optimum Protection of the Aging Brain|Completed||Early Phase 1|23|Actual|University of Hohenheim||3|||f||||f||||||||||2017-10-11 01:23:08.428663|2017-10-11 01:23:08.428663
NCT01925274|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-04-28|2017-01-09||November 2013||2013-11-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||The baseline analysis population included all enrolled participants who received the study drug.|A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer|A Randomized Phase 2 Study Of Pf-05212384 Plus Irinotecan Versus Cetuximab Plus Irinotecan In Patients With Kras And Nras Wild Type Metastatic Colorectal Cancer|Terminated||Phase 2|19|Actual|Pfizer|This study was terminated by sponsor due to strategic reasons and not due to any safety or efficacy concerns with treatment of PF-05212384.|2||"Enrollment to the study was terminated on 11Nvo2014 due to slow recruitment. There were no   safety or efficacy issues that contributed to this decision."|f||||f||||||||||2017-10-11 01:23:08.616993|2017-10-11 01:23:08.616993
NCT01925261|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-04-19|||January 2014||2014-01-01|May 2015|2015-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees|A Randomized, Double-blind, Placebo-controlled, Multi-dose Phase 2 Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees|Completed||Phase 2|120|Anticipated|OrthoTrophix, Inc||5|||f||||t||||||||||2017-10-11 01:23:10.419588|2017-10-11 01:23:10.419588
NCT01925248|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-05-24|||July 2013||2013-07-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Can Whey Protein Improve Glycemic Control in Type 2 Diabetes?|Can Whey Protein Improve Glycemic Control in Type 2 Diabetes?|Completed||N/A|32|Actual|University of California, Davis||2|||f||||t||||||||No||2017-10-11 01:23:12.550369|2017-10-11 01:23:12.550369
NCT01925235|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-16|||March 2010||2010-03-01|August 2013|2013-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|RenPRO-TAVI||Analysis of Remote-ischemic Preconditioning Effects on Kidney Function|Remote Ischemic Preconditioning Effects on Kidney Function in Patients Receiving Transcatheter Aortic Valve Implantation|Completed||N/A|18|Actual|University of Cologne|||2||f||||t||||||||||2017-10-11 01:23:12.651584|2017-10-11 01:23:12.651584
NCT01925222|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-03-29|||August 2013||2013-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage|Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage: a FinIP Effectiveness Trial Satellite Study During PCV National Vaccination Programme|Completed||N/A|3900|Actual|National Institute for Health and Welfare, Finland|||5||f||||f||||||Samples Without DNA|"     Nasopharyngeal and oropharyngeal swabs   "|||2017-10-11 01:23:12.733699|2017-10-11 01:23:12.733699
NCT01925209|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-08-07|2017-01-05||September 26, 2013|Actual|2013-09-26|August 2017|2017-08-01|January 6, 2016|Actual|2016-01-06|January 6, 2016|Actual|2016-01-06||Interventional|RESILIENT|The Full Analysis Set (FAS), which included all randomized participants who had received at least one dose of study drug and had at least one post-baseline efficacy assessment, was analyzed.|Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients|A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group, Dose-finding, Pivotal, Phase 2b/3 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravenous BYM338 at 52 Weeks on Physical Function, Muscle Strength, and Mobility and Additional Long Term Safety up to 2 Years in Patients With Sporadic Inclusion Body Myositis|Completed||Phase 2/Phase 3|251|Actual|Novartis||4|||f||||t||||||||||2017-10-11 01:23:12.847419|2017-10-11 01:23:12.847419
NCT01925196|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-08-28|||August 12, 2013||2013-08-12|August 4, 2017|2017-08-04|September 10, 2018|Anticipated|2018-09-10|September 10, 2018|Anticipated|2018-09-10||Observational|||Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation|Natural History and Biomarkers of C9ORF72 Amyotrophic Lateral Sclerosis and Frontotemporal Dementia|Recruiting||N/A|62|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:23:14.61387|2017-10-11 01:23:14.61387
NCT01925183|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-02-08|2016-12-18||August 2013||2013-08-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|HIVCOBOC-RGT||Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C|Response-guided Triple-therapy Using Boceprevir in Combination With PEGIFN/RBV in HIV/HCV-coinfected Patients|Completed||Phase 4|6|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:23:14.701809|2017-10-11 01:23:14.701809
NCT01925170|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2014-07-30|2014-05-29||April 2009||2009-04-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts|Evaluation of Low-dose Molecular Breast Imaging as a Screening Tool in Women With Mammographically Dense Breasts and Increased Risk of Breast Cancer|Completed||N/A|1638|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:23:15.05889|2017-10-11 01:23:15.05889
NCT01925157|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2015-09-30|||August 2013||2013-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)|A Single-Dose, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3090106 in Healthy Subjects and Subjects With Rheumatoid Arthritis|Completed||Phase 1|43|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 01:23:15.668191|2017-10-11 01:23:15.668191
NCT01925144|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-05-15|2017-03-10||October 2013||2013-10-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||All enrolled participants.|A Study of Baricitinib and Omeprazole in Healthy Participants|Evaluation of the Impact of Increased Gastric pH Following Omeprazole Administration on the Absorption of Baricitinib in Healthy Subjects|Completed||Phase 1|30|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:23:15.772509|2017-10-11 01:23:15.772509
NCT01925131|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-07-12|||April 2014||2014-04-01|July 2017|2017-07-01|January 2023|Anticipated|2023-01-01|January 2022|Anticipated|2022-01-01||Interventional|||S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia|S1312, A Phase I Study of Inotuzumab Ozogamicin (NSC-772518) in Combination With CVP (Cyclophosphamide, Vincristine, Prednisone) for Patients With Relapsed/Refractory CD22-Positive Acute Leukemia (Including B-ALL, Mixed Phenotypic Leukemia, and Burkitt's Leukemia)|Recruiting||Phase 1|38|Anticipated|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 01:23:16.087168|2017-10-11 01:23:16.087168
NCT01925118|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-04-22|||August 2013||2013-08-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2|Phase II Study of Irradiated Donor Lymphocyte Infusion Plus High-dose Interleukin-2 in Patients With Metastatic Malignant Melanoma and Renal Cell Carcinoma|Terminated||Phase 2|9|Actual|Seoul National University Hospital||1||Ineffectiveness|f||||f||||||||||2017-10-11 01:23:16.23405|2017-10-11 01:23:16.23405
NCT01925105|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-09-14|||August 2013||2013-08-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Comprehensive Geriatric Assessment - Can it Improve Quality of Life|Comprehensive Geriatric Assessment - Can it Improve Quality of Life|Unknown status|Active, not recruiting|N/A|220|Anticipated|Örebro County Council||2|||f||||f||||||||||2017-10-11 01:23:16.326219|2017-10-11 01:23:16.326219
NCT01925092|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-07-31|||August 2013||2013-08-01|July 2014|2014-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Mifepristone in Children With Refractory Cushing's Disease|An Open-label Study of the Safety, Pharmacokinetics and Pharmacodynamics of Mifepristone in Children With Refractory Cushing's Disease|Withdrawn||Phase 3|0|Actual|Corcept Therapeutics||1||Lack of enrollment|f||||t||||||||||2017-10-11 01:23:16.418009|2017-10-11 01:23:16.418009
NCT01925079|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-18|||August 2013||2013-08-01|August 2013|2013-08-01|June 2015|Anticipated|2015-06-01|February 2015|Anticipated|2015-02-01||Interventional|||Intensive Education on Lipid Management|A Randomized and Controlled Study About the Impact of Intensive Education on Lipid Management in Patients With Acute Coronary Syndrome in China|Unknown status|Not yet recruiting|N/A|2568|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-11 01:23:16.519254|2017-10-11 01:23:16.519254
NCT01925066|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-03-02|||August 2013||2013-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation|Optimal Two-Stage Phase 2 Study of Efficacy and Pharmacokinetics of Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation|Recruiting||Phase 2|86|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 01:23:16.648002|2017-10-11 01:23:16.648002
NCT01925040|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-15|||June 2013||2013-06-01|August 2013|2013-08-01||||June 2016|Anticipated|2016-06-01||Interventional|||Comparison of 2 Different Resin Based Filling Materials in Posterior Teeth - a Multicenter Study|Clinical Investigation of a New Nanohybrid Resin Composite Venus Pearl in Class 2 Cavities- a Multi-center Study|Unknown status|Recruiting|N/A|180|Anticipated|Heraeus Kulzer GmbH||2|||f||||f||||||||||2017-10-11 01:23:16.854539|2017-10-11 01:23:16.854539
NCT01925001|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-10-25|||October 2013||2013-10-01|October 2013|2013-10-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis|A Phase 2 Multi-center, Randomized, Double-blind, Comparator-Controlled Dose Finding Study to Evaluate MP4CO for the Acute Treatment of Vaso-occlusive Crises in Subjects With Sickle Cell Disease|Withdrawn||Phase 2|0|Actual|Sangart||2||Sangart ceased operations|f||||t||||||||||2017-10-11 01:23:17.364769|2017-10-11 01:23:17.364769
NCT01924988|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-07-20|||August 2013||2013-08-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Prostate Embolization for Benign Prostatic Hyperplasia|Prostate Embolization for Benign Prostatic Hyperplasia|Completed||Phase 1/Phase 2|20|Actual|Georgetown University||1|||f||||f||||||||||2017-10-11 01:23:17.502592|2017-10-11 01:23:17.502592
NCT01924975|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-03-31|2016-03-31||July 2013||2013-07-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Saphenous Vein Cannulation in Infants and Small Children|Ultrasound-image Guided Versus Traditional Landmark Technique for Saphenous Vein Cannulation in Infants and Small Children|Completed||N/A|102|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 01:23:17.647646|2017-10-11 01:23:17.647646
NCT01924962|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2013-08-19|||August 2011||2011-08-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|REVASC||Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries|A Randomized Comparison of Recanalisation With Implantation of Cypher Sirolimus Eluting Coronary Stents and Medical Therapy|Unknown status|Recruiting|N/A|300|Anticipated|Heart Center Bad Krozingen||2|||f||||f||||||||||2017-10-11 01:23:17.931627|2017-10-11 01:23:17.931627
NCT01924949|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-05-13|2015-05-13||July 2013||2013-07-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional||Safety Analysis Set: participants who were enrolled and received at least 1 dose of study drug|Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV Infection|An Open-Label Study of Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks in Subjects With Nosocomial Genotype 1 HCV Infection|Completed||Phase 2|5|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 01:23:18.05279|2017-10-11 01:23:18.05279
NCT01924936|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-03-12|||July 2012||2012-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NMN_SSIP||Now Matters Now: An Online Suicide Prevention Program|Pilot Study of Online Interventions for Population-based Suicide|Completed||N/A|460|Anticipated|Kaiser Permanente||3|||f||||f||||||||||2017-10-11 01:23:18.54457|2017-10-11 01:23:18.54457
NCT01924923|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-03-25|||June 2013||2013-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||New Biopsy Technique for Uveal Melanoma|New Biopsy Technique for Uveal Melanoma|Completed||N/A|1|Actual|Greater Houston Retina Research|||1||f||||f||||||Samples Without DNA|"     The eye will be enucleated and histopathologic sections of the sclera will be examined for     extra scleral extension of cells. After the tissues are examined, they will be stored in the     ocular histopathology lab for 10 years.   "|||2017-10-11 01:23:18.660561|2017-10-11 01:23:18.660561
NCT01924910|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-07-11|||October 2012||2012-10-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|December 2013|Actual|2013-12-01||Interventional|||A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Status in Healthy Adults|A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Concentrations in Healthy Adults: A Pilot Study|Completed||Phase 4|28|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:23:18.76375|2017-10-11 01:23:18.76375
NCT01924897|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-16||||||August 2013|2013-08-01||||August 2016|Anticipated|2016-08-01||Interventional|||Preop CPET Testing and Exercise Training in Colorectal Patients|An Investigation Into the Role of Cardiopulmonary Exercise Testing and Pre-operative Exercise Training in Patients Undergoing Major Surgery for Colorectal Cancer|Unknown status|Not yet recruiting|N/A|90|Anticipated|University of East Anglia||2|||f||||t||||||||||2017-10-11 01:23:18.887879|2017-10-11 01:23:18.887879
NCT01924884|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-16|||July 2013||2013-07-01|August 2013|2013-08-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Observational|||Surgical Site Infection Rate After Intra-Abdominal Surgery Using Negative Pressure Wound Therapy at Initial Closure|Surgical Site Infection (SSI) Rate After Intra-Abdominal Surgery Using Negative Pressure Wound Therapy (NPWT) at Initial Closure|Unknown status|Enrolling by invitation|N/A|400|Anticipated|Johns Hopkins University|||4||f||||f||||||||||2017-10-11 01:23:19.033643|2017-10-11 01:23:19.033643
NCT01924871|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-04-04|2014-04-04||July 2013||2013-07-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Comparison of Deep Extubation During Emergence Using Desflurane or Desflurane With Remifentanil in Patients Undergoing General Anesthesia||Completed||Phase 4|62|Actual|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||2|||f||||||||||||||2017-10-11 01:23:19.133954|2017-10-11 01:23:19.133954
NCT01924507|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-15|||August 2013||2013-08-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Bedside Sleep Medicine|Intensive Cared Bedside Sleep Medicine|Unknown status|Recruiting|N/A|400|Anticipated|Associação Fundo de Incentivo à Pesquisa||2|||f||||f||||||||||2017-10-11 01:23:24.105759|2017-10-11 01:23:24.105759
NCT01924858|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-15|2017-05-05|||August 19, 2013|Actual|2013-08-19|May 2017|2017-05-01|March 3, 2014|Actual|2014-03-03|March 3, 2014|Actual|2014-03-03||Interventional|||A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.|An Open Label Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F-GSK2647544 in Healthy Subjects|Terminated||Phase 1|4|Actual|GlaxoSmithKline||1||Study objectives met so study concluded earlier than planned hence we terminated the study.|f||||f||||||||||2017-10-11 01:23:19.415937|2017-10-11 01:23:19.415937
NCT01924832|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-02-12|||August 2013||2013-08-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||BG00012 Regional Absorption Study|Study to Investigate the Pharmacokinetics, Safety, and Tolerability of BG00012 (Dimethyl Fumarate) When Delivered to Different Regions of the Gastrointestinal Tract in Healthy Subjects|Completed||Phase 1|32|Actual|Biogen||2|||f||||f||||||||||2017-10-11 01:23:19.664336|2017-10-11 01:23:19.664336
NCT01924819|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-07-12|||September 2009||2009-09-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TOPGEAR||Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma|A Randomised Phase II/III Trial of Preoperative Chemoradiotherapy Versus Preoperative Chemotherapy for Resectable Gastric Cancer|Recruiting||Phase 2/Phase 3|752|Anticipated|Australasian Gastro-Intestinal Trials Group||2|||f||||t||||||||||2017-10-11 01:23:19.781377|2017-10-11 01:23:19.781377
NCT01924806|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-10-06|||December 2013||2013-12-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|WoundWand||A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention|A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention|Terminated||N/A|11|Actual|Smith & Nephew, Inc.||2||Lower than anticipated accrual rate and desire to reassess overall study strategy|f||||f||||||||||2017-10-11 01:23:19.971738|2017-10-11 01:23:19.971738
NCT01924793|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-07-18|||August 2013||2013-08-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|PIV||An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection|An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection|Completed||Phase 2|23|Actual|Ansun Biopharma, Inc.||2|||f||||t||||||||||2017-10-11 01:23:20.112349|2017-10-11 01:23:20.112349
NCT01924780|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-09-06|||August 2013||2013-08-01|September 2013|2013-09-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||NEMOS in Normal Volunteer and JIA Study|Evaluation of the Anti-inflammatory Potential of NEMOS® Transcutaneous Vagus Nerve Stimulation Device in Patients With Juvenile Idiopathic Arthritis|Unknown status|Enrolling by invitation|N/A|12|Anticipated|Astrid Lindgren Children´s Hospital||3|||f||||t||||||||||2017-10-11 01:23:20.239954|2017-10-11 01:23:20.239954
NCT01924767|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2014-07-03|2014-05-16||July 2007||2007-07-01|July 2014|2014-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional||Treated set includes all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 4 Multiple Rising Oral Doses (2.5 mg to 100 mg) of BI 10773 Tablets in Male and Female Type 2 Diabetic Patients|Completed||Phase 1|48|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 01:23:20.382777|2017-10-11 01:23:20.382777
NCT01924754|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2014-04-08|||January 2014||2014-01-01|April 2014|2014-04-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Observational|GINI||Gardasil Immunogenicity With Needle-Free Injection|Gardasil Immunogenicity With Needle-Free Injection|Unknown status|Recruiting|N/A|150|Anticipated|University of California, San Francisco|||3||f||||f||||||||||2017-10-11 01:23:21.926667|2017-10-11 01:23:21.926667
NCT01924741|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2014-07-30|||August 2013||2013-08-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01|5 Years|Observational [Patient Registry]|ALPPSREG||Registry of Major Liver Resections Including ALPPS and Other Liver Resections in Two Stages|International Registry to Assess Outcomes of Major Liver Resections Requiring Two Interventions Including the New Operation Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS)|Unknown status|Enrolling by invitation|N/A|500|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-11 01:23:21.993978|2017-10-11 01:23:21.993978
NCT01924728|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-02-19|||September 2013||2013-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy of Magnetic Stimulation for Stress Urinary Incontinence|A Randomized, Double-blind, Placebo Controlled Clinical Trial to Investigate the Effects of Transpelvic Magnetic Stimulation (Using QRS®-1010 PelviCenter) in Patients With Stress Urinary Incontinence.|Completed||N/A|120|Actual|QRS Asia Sdn Bhd||2|||f||||t||||||||||2017-10-11 01:23:22.154787|2017-10-11 01:23:22.154787
NCT01924715|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-08-15|||January 2008||2008-01-01|July 2013|2013-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|CEISTDP||Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study|Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study|Completed||N/A|1082|Actual|Nova Scotia Health Authority|||2||f||||f||||||||||2017-10-11 01:23:22.245745|2017-10-11 01:23:22.245745
NCT01924702|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-02-03|||January 2011||2011-01-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation (CATS)|Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation (CATS)|Unknown status|Recruiting|Phase 2|24|Anticipated|Charité Neurocure AG Flöel||2|||f||||t||||||||||2017-10-11 01:23:22.330978|2017-10-11 01:23:22.330978
NCT01924494|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-08-15|||April 2012||2012-04-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Gastro Intestinal Tele Endoscopy Project|Gastrointestinal Tele-Endoscopy Project: Synchronous Tele-Endoscopy - A Clinical Feasibility Study of Implementation of EndoAlpha Platform in Gastrointestinal Endoscopy.|Completed||N/A|100|Actual|Bispebjerg Hospital|||1||f||||t||||||||||2017-10-11 01:23:24.211977|2017-10-11 01:23:24.211977
NCT01924689|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-06-21|||October 2013||2013-10-01|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies|Phase I Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores in Patients With Treatment-refractory Solid Tumor Malignancies|Active, not recruiting||Phase 1|24|Actual|BioMed Valley Discoveries, Inc||1|||f||||t||||||||||2017-10-11 01:23:22.432488|2017-10-11 01:23:22.432488
NCT01924676|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-08-28|||August 2013||2013-08-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers|An Open-label, Single-dose, Randomized, Three-way Crossover Study to Estimate the Effects of Food on Oxycodone Pharmacokinetics Following Oral 40 Mg Doses of PF-00345439 Formulation K and to Estimate Its Relative Bioavailability of Oxycodone Compared to PF-003454390 Formulation X in the Fasted State in Healthy Volunteers|Completed||Phase 1|18|Actual|Pain Therapeutics||3|||f||||f||||||||||2017-10-11 01:23:22.541421|2017-10-11 01:23:22.541421
NCT01924663|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-12-05|||September 2013||2013-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MyDAKI-01||Viral Illness in Pediatric Critical Care: Incidence Timing & Severity of Associated Heart Dysfunction & Acute Kidney Injury|Viral Illness in the Pediatric Critical Care Setting: the Incidence, Timing and Severity of Associated Myocardial Dysfunction and Acute Kidney Injury.|Recruiting||N/A|60|Anticipated|University of Saskatchewan|||1||f||||f||||||||||2017-10-11 01:23:22.648569|2017-10-11 01:23:22.648569
NCT01924650|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-12-19|||March 2014||2014-03-01|December 2013|2013-12-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804|A Randomized, Open Label, Single Dose, 6 Treatment, 4-way Crossover Study in Healthy Subjects to Assess the Pharmacokinetics of Three Different Particle Sizes of PH-797804 Tablet With and Without the Solubilizing Agent Sodium Lauryl Sulphate (SLS)|Withdrawn||Phase 1|0|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 01:23:22.732207|2017-10-11 01:23:22.732207
NCT01924637|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-01-16|||August 2013||2013-08-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes|Completed||Phase 1|36|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:23:22.814399|2017-10-11 01:23:22.814399
NCT01924624|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2013-08-15|||July 2013||2013-07-01|July 2013|2013-07-01|December 2019|Anticipated|2019-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma|Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma.: a Randomized Controlled Trial|Recruiting||N/A|140|Anticipated|The First Affiliated Hospital of Xiamen University||2|||f||||f||||||||||2017-10-11 01:23:22.920946|2017-10-11 01:23:22.920946
NCT01924611|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-15|||September 2004||2004-09-01|August 2013|2013-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Two Years Survival Rate of Class II ART Restorations in Primary Molars Using Two Ways to Avoid Saliva Contamination|Two Years Survival Rate of Class II ART Restorations in Primary Molars Using Either Rubber Dam or Cotton Rolls.|Completed||N/A|232|Actual|Federal University of Paraíba||2|||f||||f||||||||||2017-10-11 01:23:23.034515|2017-10-11 01:23:23.034515
NCT01924598|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-10-26|||July 2013||2013-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Pilot Study of Deep Brain Stimulation for Severe Anorexia Nervosa|Hungry for Reward : A Pilot Investigation of the Ethics, Practice and Neural Basis of Deep Brain Stimulation to the Nucleus Accumbens in Severe Intractible Anorexia Nervosa.|Recruiting||N/A|6|Anticipated|University of Oxford||1|||f||||t||||||||||2017-10-11 01:23:23.142133|2017-10-11 01:23:23.142133
NCT01924585|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-03-25|||December 2012||2012-12-01|August 2012|2012-08-01|July 2015|Anticipated|2015-07-01|December 2014|Actual|2014-12-01||Observational|SAGE||Surgery in Persons of Older Age|Prospective Observational Study of Patients Aged >=60 Years Undergoing Major Gastrointestinal Surgery With 1 Year Follow-up|Unknown status|Recruiting|N/A|200|Anticipated|Imperial College London|||1||f||||t||||||Samples Without DNA|"     Preoperative serum and urine sample.   "|||2017-10-11 01:23:23.247131|2017-10-11 01:23:23.247131
NCT01924572|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2013-08-14|||July 2010||2010-07-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|||Placental Transfusion in Term Infants: A Pilot Study|Placental Transfusion in Term Infants Placed Skin-to-Skin: A Pilot Controlled Trial|Completed||N/A|32|Actual|University of Rhode Island||4|||f||||f||||||||||2017-10-11 01:23:23.372922|2017-10-11 01:23:23.372922
NCT01924559|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-03-31|2015-10-06||August 2013||2013-08-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Prospectively enrolled EM residents, including PGY 1s through 4s; each resident was observed performing all six arms of the study.|Comparison of Airway Intubation Devices When Using a Biohazard Suit|Comparison of Airway Intubation Devices When Using a Biohazard Suit: A Feasibility Study|Completed||N/A|37|Actual|Lehigh Valley Hospital|Limitations described in associated reference|6|||f||||f||||||||No||2017-10-11 01:23:23.479956|2017-10-11 01:23:23.479956
NCT01924546|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2014-08-20|||August 2013||2013-08-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study of Dehydration and Cognition in Pupils in Zambia|Cognitive Effects of Drinking Water and Improving Hydration Status Among Schoolchildren in Zambia|Completed||N/A|292|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:23:23.740837|2017-10-11 01:23:23.740837
NCT01924520|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-02-14|||November 2010||2010-11-01|February 2017|2017-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Oral Multiple-dose Study in Patients With Major Depressive Disorder|Phase I Study of FK949E - Phase I Oral Multiple-dose Study in Patients With Major Depressive Disorder|Completed||Phase 1|32|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 01:23:24.008524|2017-10-11 01:23:24.008524
NCT01924455|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-08-07|||April 2014||2014-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||HBV-HIV Coinfection Research Network|HBV-HIV Coinfection Research Network|Recruiting||N/A|250|Anticipated|Virginia Commonwealth University|||1||f||||t||||||Samples With DNA|"     Serum at baseline and every 6 months for 4 years. Liver biopsy at baseline and year 4   "|||2017-10-11 01:23:24.466233|2017-10-11 01:23:24.466233
NCT01924416|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-11-17|||September 2012||2012-09-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|LCIS-R01||Lung Cancer Information Study (LCIS-R01)|A Decision Aid With Health-Related Quality of Life (HRQL) Assessment to Reduce Costs in the Treatment of Non-Small Cell Lung Cancer (NSCLC)|Recruiting||N/A|196|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 01:23:24.714976|2017-10-11 01:23:24.714976
NCT01924403|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-02-13|||August 2013||2013-08-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Perfusion Assessment of Wound Closure Techniques in Primary Total Knee Arthroplasty|Assessment of Wound Closure Techniques in Primary Total Knee Arthroplasty Using SPY Intra-operative Angiography|Completed||N/A|45|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 01:23:24.79222|2017-10-11 01:23:24.79222
NCT01924390|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-10-01|2014-10-01||November 2012||2012-11-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft|Histological Comparison of Healing Following Tooth Extraction With Ridge Preservation Using Mineralized Freeze Dried Bone Allograft Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft|Completed||N/A|44|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 01:23:24.85814|2017-10-11 01:23:24.85814
NCT01924377|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-12-03|||May 2013||2013-05-01|August 2013|2013-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|CENTRA-AF||Characterization and Elimination of Mother Rotors|Characterization and Elimination of Mother Rotors - A Mechanism-targeted Approach for Catheter Ablation of Atrial Fibrillation|Unknown status|Recruiting|N/A|234|Anticipated|Maria Cecilia Hospital||2|||f||||t||||||||||2017-10-11 01:23:25.296858|2017-10-11 01:23:25.296858
NCT01924351|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-06-07|||February 2015||2015-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)|A Phase II Study of Stereotactic Radiosurgery Plus HER-2 Directed Therapy in HER2-positive Breast Cancer With Brain Metastasis|Withdrawn||Phase 2|0|Actual|University of Maryland||1|||f||||t||||||||||2017-10-11 01:23:25.483912|2017-10-11 01:23:25.483912
NCT01924338|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-08-20|||September 2013||2013-09-01|August 2014|2014-08-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Validation of a Method to Measure Soft Tissue Thickness Using Near Infrared Laser Light|Validierung Der Bestimmung Der Gewebedicke Mit Hilfe Von Licht im Infrarotbereich|Unknown status|Recruiting|N/A|25|Anticipated|University of Luebeck||4|||f||||f||||||||||2017-10-11 01:23:25.566445|2017-10-11 01:23:25.566445
NCT01924325|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-13|||January 2014||2014-01-01|August 2013|2013-08-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|ADANCE||Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events|Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in High-risk Patients With Acute Non-disabling Cerebrovascular Events (ADANCE): Rationale, Objectives, and Design|Unknown status|Not yet recruiting|Phase 2/Phase 3|10000|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 01:23:25.673079|2017-10-11 01:23:25.673079
NCT01924312|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-03-08|||May 2013|Actual|2013-05-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|MCI/CVD||Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease|Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease|Active, not recruiting||N/A|80|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 01:23:25.804561|2017-10-11 01:23:25.804561
NCT01924299|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2017-05-15|2017-03-10||August 2013||2013-08-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||All enrolled participants.|A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants|The Effect of Ketoconazole or Fluconazole on the Pharmacokinetics of Baricitinib in Healthy Subjects|Completed||Phase 1|36|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:23:25.916283|2017-10-11 01:23:25.916283
NCT01924286|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2016-12-15|||August 2013||2013-08-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2016|Actual|2016-04-01||Interventional|Pred-ART||Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone|Preventing Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone|Active, not recruiting||Phase 3|240|Actual|University of Cape Town||2|||f||||t||||||||||2017-10-11 01:23:26.717275|2017-10-11 01:23:26.717275
NCT01924273|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-02-08|||June 2013||2013-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Novel Treatment for Port Wine Stain Birthmarks|Novel Treatment for Port Wine Stain Birthmarks|Recruiting||Phase 1|24|Anticipated|University of California, Irvine||1|||f||||t||||||||||2017-10-11 01:23:26.868234|2017-10-11 01:23:26.868234
NCT01924260|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-04-27|||August 2013||2013-08-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer|Phase I Study of the Combination of MLN8237 and Gemcitabine in Advanced Solid Tumors With Emphasis on Pancreatic Cancer|Active, not recruiting||Phase 1|26|Actual|University of California, Davis||1|||f||||t|t|f||||||||2017-10-11 01:23:26.984498|2017-10-11 01:23:26.984498
NCT01924247|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-06-15|||November 2013|Actual|2013-11-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Study to Validate the Effects of an Outpatient Secondary Prevention Program for Stroke Victims|Prospective Randomized Study to Validate the Effects of an Outpatient Secondary Prevention Program for Stroke Victims With Minor or no Residual Deficits|Recruiting||N/A|100|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 01:23:27.095555|2017-10-11 01:23:27.095555
NCT01924234|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-12-02|||August 2013||2013-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers|Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers|Completed||Phase 4|18|Actual|Region Örebro County||2|||f||||t||||||||||2017-10-11 01:23:27.231325|2017-10-11 01:23:27.231325
NCT01924221|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2015-09-01|||December 2011||2011-12-01|September 2015|2015-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|RER-CRT||Reverse Electrical Remodeling of Native Conduction in Cardiac Resynchronization Therapy|Study of Reverse Electrical Remodeling of Native Conduction in Cardiac Resynchronization Therapy|Active, not recruiting||N/A|70|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 01:23:27.357975|2017-10-11 01:23:27.357975
NCT01924208|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-10|2016-04-20|||October 2013||2013-10-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|Tons2||Tonsillar Cytokine Expression After Allergen and/or Virus Intervention|T Cell and Interferon Expression in Tonsils After Sublingual Immunotherapy and/or Nasal Live Attenuated Influenza Vaccine|Recruiting||Phase 3|180|Anticipated|Turku University Hospital||4|||f||||t||||||||||2017-10-11 01:23:27.450253|2017-10-11 01:23:27.450253
NCT01924195|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-10-27|||August 2013||2013-08-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）|A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Study of Anlotinib(AL3818) as Third Line Treatment in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）|Completed||Phase 2|117|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-11 01:23:27.615103|2017-10-11 01:23:27.615103
NCT01924182|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-02-09|2015-12-21||October 2013||2013-10-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|CONVERT-TDD||Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects|Post-market Study Evaluating a Treatment Conversion to Low Dose Intrathecal Morphine From Conventional Medical Management for Maintenance of Pain Control and Improvement of Opioid-related Side Effects. (CONVERT Targeted Drug Delivery [TDD])|Terminated||Phase 4|7|Actual|MedtronicNeuro|Due to the small sample size (only 1 IT Group and 0 CMM Group participants completed the primary outcome assessment), statistical tests cannot be performed and conclusions cannot be made on any of the original study objectives.|2||Amendment changes were significant enough to warrant a new study.|f||||f||||||||No||2017-10-11 01:23:27.770276|2017-10-11 01:23:27.770276
NCT01924169|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-02-22|||November 24, 2014|Actual|2014-11-24|February 2017|2017-02-01||||November 2018|Anticipated|2018-11-01||Interventional|||Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)|A Study of Immune-adjuvant Effect of Lenalidomide in Patients With Chronic Lymphocytic Leukemia and Hypogammaglobulinemia and Impaired Response to Vaccinations - RV-CL-CLL-PI-002544|Terminated||Phase 2|3|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f||||||||||2017-10-11 01:23:28.064297|2017-10-11 01:23:28.064297
NCT01924156|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-14|2016-02-18|||July 2013||2013-07-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma|Safety and Therapeutic Efficacy of DC Vaccine Combined With Cytokine-induced Killer Cells in Patients With Renal Cell Carcinoma: a Phase I/II Study|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-11 01:23:28.173555|2017-10-11 01:23:28.173555
NCT01924143|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2015-05-11|||October 2013||2013-10-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||TD-9855 Mass Balance Study|An Open-Label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD-9855 Following a Single Oral Dose Containing Approximately 100 µCi [14C]-Labeled TD-9855 (20 mg) in Healthy Subjects|Completed||Phase 1|6|Actual|Theravance Biopharma R & D, Inc.||1|||f||||f||||||||||2017-10-11 01:23:28.245288|2017-10-11 01:23:28.245288
NCT01924130|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-08-29|||July 2012||2012-07-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|SBPI||School Breakfast Policy Initiative Study|Increasing Breakfast Consumption and Decreasing Childhood Obesity Among Low-income, Ethnically Diverse Youth.|Completed||N/A|2000|Anticipated|Temple University||2|||f||||f||||||||||2017-10-11 01:23:28.338206|2017-10-11 01:23:28.338206
NCT01924117|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-15|||February 2011||2011-02-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Interventional|HPV||Genotypification and Predisposing Factors in Human Papilloma Virus Infection|Genotypification and Predisposing Factors in Human Papilloma Virus Infection and Its Association With the Carbohydrate Antigen (CA-125) Tumoral Marker|Completed||N/A|129|Actual|Materno-Perinatal Hospital of the State of Mexico||1|||f||||f||||||||||2017-10-11 01:23:28.416826|2017-10-11 01:23:28.416826
NCT01924104|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-15|||August 2013||2013-08-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|||Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.|Effects of Low Dose Aspirin and Low Molecular Weight Heparin Cotreatment, Alone and/or in Combination on Implantation and Clinical Pregnancy Rates in Repeated Implantation Failures in IVF Cycle.|Unknown status|Recruiting|Phase 3|400|Anticipated|Jeevan Jyoti Hospital||4|||f||||t||||||||||2017-10-11 01:23:28.483235|2017-10-11 01:23:28.483235
NCT01924091|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-09-05|||September 2013||2013-09-01|September 2017|2017-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||PK/PD of Single Dose Dapivirine Vaginal Film|Comparison of the Pharmacokinetics and Pharmacodynamics of Single Dose Dapivirine Vaginal Gel and Film Formulation|Completed||Phase 1|60|Actual|International Partnership for Microbicides, Inc.||2|||f||||f||||||||||2017-10-11 01:23:28.583231|2017-10-11 01:23:28.583231
NCT01924078|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-08-14|||October 2010||2010-10-01|August 2013|2013-08-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer|Capecitabine Metronomic Chemotherapy Combined With Aromatase Inhibitors in Postmenopausal Hormone-receptor-positive Breast Cancer|Unknown status|Recruiting|Phase 2|100|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-11 01:23:28.650143|2017-10-11 01:23:28.650143
NCT01924065|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-01-18|||August 2013||2013-08-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|August 2016|Actual|2016-08-01||Interventional|AFTER-CV||Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation|Does Cardioversion of Atrial Fibrillation Increase the Risk of Stroke and Silent Cerebrovascular Thromboembolism? Comparison of the Two Cardioversion Methods|Active, not recruiting||Phase 3|108|Actual|Suleyman Demirel University||2|||f||||f||||||||||2017-10-11 01:23:28.738228|2017-10-11 01:23:28.738228
NCT01924052|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-10|2013-08-14|||June 2013||2013-06-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load|CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load|Completed||N/A|40|Actual|Danish Headache Center||2|||f||||f||||||||||2017-10-11 01:23:28.981374|2017-10-11 01:23:28.981374
NCT01924039|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-12-16|||June 2013||2013-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Brief Motivational Enhancement Therapy for Concurrent Disorders|Brief Motivational Enhancement Therapy for Individuals With Psychotic Disorders and Concurrent Substance Use Disorders|Terminated||N/A|8|Actual|Centre for Addiction and Mental Health||2||Not enough study participants|f||||f||||||||||2017-10-11 01:23:29.070097|2017-10-11 01:23:29.070097
NCT01924026|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-02-13|||September 2013||2013-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study|Neuropsychological and Quality of Life Outcomes in Untreated Adults With Mild Hyperphenylalaninemia (MHP)/Phenylketonuria (PKU) With Phenylalanine Levels Between 360 and 600 µmol/L Caused by Phenylalanine Hydroxylase (PAH) Deficiency.|Completed||N/A|10|Actual|The Hospital for Sick Children|||2||f||||f||||||||Yes|in progress- to be decided.|2017-10-11 01:23:29.162708|2017-10-11 01:23:29.162708
NCT01924013|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-04-18|||March 2014||2014-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Interventional|MDIG||Maternal Vitamin D for Infant Growth (MDIG) Trial|Randomized Placebo-controlled Trial of Maternal Vitamin D Supplementation During Pregnancy and Lactation to Improve Infant Linear Growth in Dhaka, Bangladesh.|Active, not recruiting||Phase 3|1300|Actual|The Hospital for Sick Children||5|||f||||t||||||||||2017-10-11 01:23:29.247872|2017-10-11 01:23:29.247872
NCT01924000|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-04-20|||December 2013||2013-12-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Minoxidil 1% for Eyebrow Enhancement|Minoxidil 1% for Eyebrow Enhancement: A Randomized , Double-blind , Placebo-controlled , Split-face Comparative Study|Completed||Phase 4|40|Actual|Mae Fah Luang University Hospital||2|||f||||f||||||||||2017-10-11 01:23:29.34995|2017-10-11 01:23:29.34995
NCT01923987|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-04-21|||August 2012||2012-08-01|April 2016|2016-04-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis|Multicenter Phase II Study of Short Course Radiotherapy Followed by Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis|Recruiting||Phase 2|39|Anticipated|Korea Cancer Center Hospital||1|||f||||f||||||||No||2017-10-11 01:23:29.4387|2017-10-11 01:23:29.4387
NCT01923974|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-10-21|||August 2013||2013-08-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||The Analgesic Effects of Melatonin|The Analgesic Effects of Melatonin: A Randomized, Placebo-controlled, Double-blinded Study on Healthy Volunteers|Completed||Phase 2/Phase 3|36|Anticipated|Herlev Hospital||3|||f||||t||||||||||2017-10-11 01:23:29.566004|2017-10-11 01:23:29.566004
NCT01923948|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-03-30|||May 2013||2013-05-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Preoperative Pain Control in Liver Surgery Patients|A Randomized Placebo-Controlled Study of Whether Pre-operative Pregabalin 150 mg Will Improve Pain Control in Patients With Hepatocellular Carcinoma Undergoing Partial Hepatectomy|Completed||N/A|40|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 01:23:29.755712|2017-10-11 01:23:29.755712
NCT01923935|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-08-15|||January 2013||2013-01-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|January 2014|Anticipated|2014-01-01||Interventional|||Busulfan and Melphalan Conditioning in Multiple Myeloma|A Phase 2, Open-label, Prospective, Multicenter Study to Evaluate the Efficacy of Intravenous Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|105|Anticipated|Chonnam National University Hospital||1|||f||||t||||||||||2017-10-11 01:23:29.866449|2017-10-11 01:23:29.866449
NCT01923922|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-01-26|||September 2013||2013-09-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||CT Perfusion in the Prognostication of Cerebral High Grade Glioma|CT Perfusion in the Prognostication of Cerebral High Grade Glioma|Recruiting||N/A|100|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||No||2017-10-11 01:23:30.048818|2017-10-11 01:23:30.048818
NCT01923909|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-03-01|||April 2013||2013-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intraarticular Platelet-rich Plasma Injections Versus Intraarticular Corticosteroid Injections in Primary Knee Osteoarthritis|Comparison of Intraarticular Platelet-rich Plasma Injections With Intraarticular Corticosteroid Injections in the Treatment of Primary Knee Osteoarthritis : A Randomized Control Trial|Recruiting||Phase 4|100|Anticipated|King Hamad University Hospital, Bahrain||2|||f||||t||||||||||2017-10-11 01:23:30.178788|2017-10-11 01:23:30.178788
NCT01923896|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-10-17|2014-10-17||March 2013||2013-03-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional||Sixteen subjects (10 male subjects, 6 female subjects) were randomly assigned to DCS or placebo (Table 1). There were no significant group differences on demographic or clinical measures at baseline. Participants were enrolled beginning in April 2013 through July 2013, with final follow-up visits completed September 2013.|D-cycloserine and Treatment of Feeding Disorders|Use of D-cycloserine to Facilitate Extinction of Food Aversion in Pediatric Populations|Completed||Phase 1/Phase 2|16|Actual|Emory University|The sample size was small and analyses were underpowered to detect group differences.|2|||f||||f||||||||||2017-10-11 01:23:30.321109|2017-10-11 01:23:30.321109
NCT01923883|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-15|||June 2013||2013-06-01|August 2013|2013-08-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Comparison of EUS-Guided Fine Needle Aspiration Technique|Comparison of EUS-guided Fine Needle Aspiration Technique: Negative-pressure Suction With Syringe vs. Capillary Sampling With Stylet Slow-pull Technique|Unknown status|Recruiting|N/A|51|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 01:23:30.651921|2017-10-11 01:23:30.651921
NCT01923870|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-01-23|||August 2013||2013-08-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function|An Open Label Study to Evaluate the Pharmacokinetics and Safety Profile of Androxal in Male Subjects With Impaired Hepatic Function|Completed||Phase 1|19|Actual|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 01:23:30.750107|2017-10-11 01:23:30.750107
NCT01923857|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-08-07|||August 2013||2013-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function|A Single-Dose, Open-Label Study to Evaluate the Pharmacokinetics and Safety Profile of Androxal in Male Subjects With Impaired Renal Function|Completed||Phase 1|26|Actual|Repros Therapeutics Inc.||4|||f||||f||||||||||2017-10-11 01:23:30.842002|2017-10-11 01:23:30.842002
NCT01923844|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-15|||March 2012||2012-03-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effects of Bolus Surfactant Therapy on Peripheral Perfusion Index and Tissue Carbon Monoxide|Effects of Bolus Surfactant Therapy on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants With Severe Respiratory Distress Syndrome|Completed||Phase 4|48|Actual|Ege University||3|||f||||f||||||||||2017-10-11 01:23:33.031125|2017-10-11 01:23:33.031125
NCT01923831|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-03-11|||August 2013||2013-08-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Comparison of the Effect of Magnesium Sulfate and Dexamethasone on Postoperative Sore Throat After Spinal Surgery in Prone Position With Tracheal Intubation: a Double-blind, Randomized, Noninferiority Clinical Trial||Completed||N/A|146|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:23:33.123603|2017-10-11 01:23:33.123603
NCT01923818|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-08-13|||September 2013||2013-09-01|August 2013|2013-08-01|April 2016|Anticipated|2016-04-01|September 2015|Anticipated|2015-09-01||Interventional|TRACE||Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events|Randomized,Double-blind Trial Comparing the Effects of a Rivaroxaban Regimen During the First 30 Days,Versus Aspirin for the Acute Treatment of TIA or Minor Stroke|Unknown status|Not yet recruiting|Phase 2/Phase 3|3700|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 01:23:33.230225|2017-10-11 01:23:33.230225
NCT01923805|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-05-05|2017-01-18||April 2013||2013-04-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Vitagel Revision Total Knee Arthroplasty|A Prospective Randomized Evaluation of a Collagen/Thrombin Autologous Platelet Hemostatic Agent During Revision Knee Arthroplasty|Terminated||N/A|8|Actual|The Cleveland Clinic||2||Difficulty enrolling patients|f||||f||||||||No|Study terminated early|2017-10-11 01:23:33.401292|2017-10-11 01:23:33.401292
NCT01923792|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-05-14|||September 2013||2013-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||ToleroMune House Dust Mite Follow on Study|An Optional Follow-Up Study to Evaluate the Continued Efficacy of ToleroMune HDM in House Dust Mite Allergic Subjects Following Challenge With House Dust Mite Allergen in an Environmental Exposure Chamber|Completed||N/A|105|Actual|Circassia Limited|||3||f||||f||||||||||2017-10-11 01:23:33.665107|2017-10-11 01:23:33.665107
NCT01923779|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-11-25|||May 2013||2013-05-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|||ToleroMune Grass Follow on Study|An Optional Follow-Up Study to Evaluate the Continued Efficacy of ToleroMune Grass in Grass Allergic Subjects Following Challenge With Grass Allergen in an Environmental Exposure Unit|Completed||N/A|163|Anticipated|Circassia Limited|||1||f||||f||||||||||2017-10-11 01:23:33.772575|2017-10-11 01:23:33.772575
NCT01923766|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-10-25|||September 2013||2013-09-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Cytotoxic T Cells to Prevent Virus Infections|Adoptive Transfer of Cord Blood T Cells to Prevent and Treat CMV, EBV and Adenovirus Infections After Transplantation|Recruiting||Phase 1|18|Anticipated|Children's Research Institute||1|||f||||t||||||||||2017-10-11 01:23:33.863707|2017-10-11 01:23:33.863707
NCT01923753|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-06-02|||September 2013||2013-09-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Short-term Comparative Study of Aerosure for Airway Clearance in Patients With Cystic Fibrosis|A Short-term Comparative Study of Aerosure for Airway Clearance in Patients With Cystic Fibrosis|Terminated||Phase 2|6|Actual|Actegy Ltd.||3||Unable to recruit sufficient patients within reasonable timeframe|f||||t||||||||||2017-10-11 01:23:33.965945|2017-10-11 01:23:33.965945
NCT01923740|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-08-16|||July 2013||2013-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|May 2015|Actual|2015-05-01||Interventional|ABSORB CHINA||A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)|A Clinical Evaluation of Absorb™ BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects With de Novo Native Coronary Artery Lesions in Chinese Population|Active, not recruiting||N/A|480|Actual|Abbott Vascular||2|||f||||t||||||||||2017-10-11 01:23:34.072315|2017-10-11 01:23:34.072315
NCT01923727|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-08-02|||August 2013||2013-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|IAB2M||Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer|A Phase I/IIA Study of PET Imaging With 89Zr-Df-IAb2M in Patients With Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|38|Actual|ImaginAb, Inc.||1|||f||||f||||||||Yes||2017-10-11 01:23:34.385076|2017-10-11 01:23:34.385076
NCT01923714|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-13|||August 2011||2011-08-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Impact of a Tolerability Switch to Dorzolamide/Timolol Preservative-free Fixed Combination on Ocular Surface Symptoms|Impact of a Tolerability Switch to Dorzolamide/Timolol Preservative-free Fixed Combination on Ocular Surface Symptoms in Belgian Glaucoma Patients|Completed||N/A|103|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:23:34.490816|2017-10-11 01:23:34.490816
NCT01923701|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-08-13|||October 2012||2012-10-01|August 2013|2013-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk|Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk|Unknown status|Recruiting|N/A|24|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 01:23:34.607792|2017-10-11 01:23:34.607792
NCT01923688|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2014-06-19|||August 2011||2011-08-01|June 2014|2014-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Preventing Hypoglycemia|Prevention of Hypoglycemia and Insulin Errors in Barnes-Jewish Hospital Inpatients|Completed||N/A|390|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 01:23:34.803332|2017-10-11 01:23:34.803332
NCT01923675|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-13|||September 2013||2013-09-01|August 2013|2013-08-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Myopia:the Role of Cone Opsin Mutations & Glasses That Control Axial Elongation|Myopia:the Role of Cone Opsin Mutations & Glasses That Control Axial Elongation|Not yet recruiting||N/A|240|Anticipated|University of Washington||4|||f||||f||||||||||2017-10-11 01:23:34.988553|2017-10-11 01:23:34.988553
NCT01923662|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-05-30|||April 11, 2013|Actual|2013-04-11|May 2017|2017-05-01|April 10, 2019|Anticipated|2019-04-10|April 10, 2019|Anticipated|2019-04-10||Interventional|||A Neuroprosthesis for Prolonged Standing After SCI Using Multi-Contact Peripheral Nerve Electrodes|Exploiting Selective Recruitment to Prolong Standing After SCI|Recruiting||N/A|10|Anticipated|VA Office of Research and Development||1|||f||||f|f|t|f|f|f|||Undecided||2017-10-11 01:23:35.226996|2017-10-11 01:23:35.226996
NCT01923649|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-08-21|||April 2008||2008-04-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||SOMATULINE Autogel 90 mg IN DUMPING SYNDROME|SOMATULINE Autogel 90 mg IN DUMPING SYNDROME|Unknown status|Recruiting|Phase 2|25|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 01:23:35.436594|2017-10-11 01:23:35.436594
NCT01923636|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-12-23|||September 2013||2013-09-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|CYMEPEDIA||Prognostic Value of Neonatal Markers (Clinical, Imaging and Biological) for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus (CMV) in Utero|Evaluation of the Prognostic Value of Clinical, Imaging, Immunological and Virological Markers in the Neonatal Period for the Development of Neurosensorial Sequelae at 1 Year in Children Infected by Cytomegalovirus in Utero.|Recruiting||N/A|250|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:23:35.618733|2017-10-11 01:23:35.618733
NCT01923623|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-04-02|||July 1, 2013|Actual|2013-07-01|April 2017|2017-04-01|July 31, 2013|Actual|2013-07-31|July 1, 2013|Actual|2013-07-01||Interventional|||The Effect of Nerve Blockades in Addition to General Anesthesia in Surgical Fixation of Ankle Fractures.|The Effect of Combined Popliteal and Saphenous Block in Addition to General Anesthesia in Surgical Fixation of Ankle Fractures: a Prospective Randomized Study|Withdrawn||Phase 4|0|Actual|Herlev Hospital||2||Study was redesigned and taken over by a ph.D-student|f||||f||||||||||2017-10-11 01:23:35.754579|2017-10-11 01:23:35.754579
NCT01923610|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-03-20|||September 2013|Actual|2013-09-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B|Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B|Completed||Phase 1|24|Actual|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-11 01:23:35.84605|2017-10-11 01:23:35.84605
NCT01923597|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-08-02|||November 2013||2013-11-01|August 2013|2013-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.|A Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Green Tea on Albuminuria in Patients With Diabetic Nephropathy and Use of Maximum Dose of ACE-I and / or Angiotensin II Receptor Blocker.|Completed||Phase 2|50|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-11 01:23:35.95761|2017-10-11 01:23:35.95761
NCT01923584|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-09-16|||September 2013||2013-09-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease|A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease|Completed||Phase 2|15|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 01:23:36.080467|2017-10-11 01:23:36.080467
NCT01923571|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-06-24|||April 2013||2013-04-01|June 2014|2014-06-01||||June 2014|Actual|2014-06-01||Observational|||Blood Glucose Concentration & Craniotomy|Blood Glucose Concentration During Craniotomy: Epidemiology and Relationship With Postoperative Infections|Unknown status|Recruiting|N/A|53|Anticipated|University of Roma La Sapienza|||2||f||||t||||||||||2017-10-11 01:23:36.192822|2017-10-11 01:23:36.192822
NCT01923558|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-13|||October 2010||2010-10-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition|Single Dose Crossover Comparative Bioavailability Study of Donepezil 23 mg Tablets in Healthy Male and Female Volunteers / Fasting State|Completed||Phase 1|76|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 01:23:36.312055|2017-10-11 01:23:36.312055
NCT01923545|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-09-29|||July 2010||2010-07-01|September 2014|2014-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|PEG-G-CSF||Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia|Multi-Center, Randomized, Open, Phase II Study to Evaluate Efficacy and Safety in Chemotherapy-induced Neutropenia of Once-per-cycle DA-3031(PEG-G-CSF) and Daily G-CSF in Patients With Malignancies Receiving Myelosuppressive Chemotherapy|Completed||Phase 2|61|Actual|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:23:36.424398|2017-10-11 01:23:36.424398
NCT01923519|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-13|||August 2013||2013-08-01|July 2013|2013-07-01||||February 2015|Anticipated|2015-02-01||Interventional|GENEBRO||Study of Genic Expression Profiles of the Epithelium of the Nose and Bronchi in Healthy and Allergic Subjects|Study of Genic Expression Profiles of the Epithelium of the Nose and Bronchi in Healthy and Allergic Subjects|Unknown status|Not yet recruiting|N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 01:23:36.571314|2017-10-11 01:23:36.571314
NCT01923506|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-08-16|||October 17, 2013|Actual|2013-10-17|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery|Stereotactic Body Radiation Therapy to the Prostate Fossa: Phase I Dose Escalation Study|Recruiting||Phase 1|28|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:23:36.673764|2017-10-11 01:23:36.673764
NCT01923493|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-02-06|||August 2013||2013-08-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|tuina||Tuina for Patients With Chronic Neck Pain|Chronic Neck Pain: a Randomized Controlled Trial in Patients With Chronic Neck Pain Comparing Tuina vs. no Intervention Waiting List|Completed||N/A|92|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 01:23:36.799335|2017-10-11 01:23:36.799335
NCT01923480|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-03-23|2016-02-19||July 2013||2013-07-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Dosing Study of Amino Acids in Seriously Ill Patients|Determination of the Optimal Infusion Rate of Amino Acids in Seriously Ill Patients|Terminated||Phase 4|16|Actual|Baxter Healthcare Corporation||3|||f||||f||||||||||2017-10-11 01:23:37.273026|2017-10-11 01:23:37.273026
NCT01923467|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-05-29|2015-05-29||August 2013||2013-08-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Smoker recruited from an online survey panel.|Project Quit: Positive vs. Negative Offers of an Online Stop Smoking Program|Project Quit: Positive vs. Negative Offers of an Online Stop Smoking Program|Completed||N/A|767|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 01:23:41.333819|2017-10-11 01:23:41.333819
NCT01923454|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-04|2013-08-14|||December 2005||2005-12-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Immediate Anterior Chamber Paracentesis With A 30-Gauge Needle for Acute Primary Angle - Closure|Immediate Anterior Chamber Paracentesis With A 30-Gauge Needle for Acute Primary Angle - Closure|Completed||N/A|15|Actual|Siriraj Hospital||1|||f||||t||||||||||2017-10-11 01:23:41.671513|2017-10-11 01:23:41.671513
NCT01923441|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-04-08|||August 2013||2013-08-01|August 2013|2013-08-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Observational|||Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth and Adolescents Athletes.|Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth and Adolescents Athletes.|Completed||N/A|18|Actual|ElMindA Ltd|||2||f||||f||||||||||2017-10-11 01:23:41.780661|2017-10-11 01:23:41.780661
NCT01923428|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2015-02-24|||August 2013||2013-08-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of AZD1722 for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)|Completed||Phase 2/Phase 3|371|Actual|Ardelyx||4|||f||||f||||||||||2017-10-11 01:23:41.883986|2017-10-11 01:23:41.883986
NCT01923415|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-09-11|||April 2013||2013-04-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||A Non-drug Study Profiling Cutaneous Lupus|Cross-Sectional Study in Subjects With Active Cutaneous Lupus Erythematosus|Completed||Early Phase 1|29|Actual|Janssen Research & Development, LLC|||3||f||||f||||||Samples With DNA|"     Blood from participants with discoid lupus erythematosus (DLE), subacute cutaneous lupus     erythematosus (SCLE), and active systemic lupus erythematosus (SLE) with cutaneous     involvement.   "|||2017-10-11 01:23:42.006195|2017-10-11 01:23:42.006195
NCT01923402|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-02-17|||June 2010||2010-06-01|February 2016|2016-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Development of Biomarkers of Effect From Chronic Tobacco Usage|Development of Biomarkers of Effect From Chronic Tobacco Usage: A Clinical Study Examining Metabolic Profiling, Inflammation, and Oxidative Stress|Completed||N/A|120|Actual|R.J. Reynolds Tobacco Company|||3||f||||f||||||Samples With DNA|"     Blood, urine, buccal cells, and saliva   "|No||2017-10-11 01:23:42.107169|2017-10-11 01:23:42.107169
NCT01923389|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-09-08|2014-09-08||September 2013||2013-09-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All participants who received at least 1 dose of study medication (PF-05231023 or placebo).|Multiple Dose Study Of PF-05231023 In Obese Adult Subjects|A Phase 1, Placebo-Controlled, Randomized Trial To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenous Doses Of PF-05231023 In Obese Adult Subjects|Terminated||Phase 1|4|Actual|Pfizer||2||"The study was terminated on December 19th, 2013 due to a business decision by the Sponsor. No   safety concerns have been observed in this study."|f||||f||||||||||2017-10-11 01:23:42.220825|2017-10-11 01:23:42.220825
NCT01923376|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-05-09|||February 2013||2013-02-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|HELP||Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)|Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)|Withdrawn||N/A|0|Actual|New York Methodist Hospital||2||Not enough staff to collect data|f||||t||||||||||2017-10-11 01:23:42.653702|2017-10-11 01:23:42.653702
NCT01923363|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-09-13|||January 2014||2014-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||PK/PD of High Dose Pip/Tazo in Obese Patients|Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin/Tazobactam in Obese Patients|Completed||N/A|28|Actual|Loma Linda University||2|||f||||t||||||||No||2017-10-11 01:23:42.787131|2017-10-11 01:23:42.787131
NCT01923350|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-14|||December 2011||2011-12-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|ADAPT||Avoiding Diabetes After Pregnancy Trial|Increasing Adoption of Early Intervention to Prevent Diabetes After Gestational Diabetes Mellitus|Completed||N/A|140|Actual|Social & Scientific Systems Inc.||4|||f||||f||||||||||2017-10-11 01:23:42.917751|2017-10-11 01:23:42.917751
NCT01922778|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-07-19|||September 2013||2013-09-01|July 2017|2017-07-01|March 31, 2016|Actual|2016-03-31|March 31, 2016|Actual|2016-03-31||Interventional|||Screening for Endometrial Abnormalities in Overweight and Obese Women|Screening for Endometrial Abnormalities in Overweight and Obese Women|Completed||N/A|303|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||t||||||||||2017-10-11 01:23:49.695174|2017-10-11 01:23:49.695174
NCT01923337|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-09-13|||August 2013||2013-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer|Phase I Study of the Combination of Irinotecan and MLN8237 in Advanced Solid Tumors With Emphasis on Colorectal Cancer|Active, not recruiting||Phase 1|42|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-11 01:23:43.03786|2017-10-11 01:23:43.03786
NCT01923324|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-13|||July 2005||2005-07-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|STC||Standard Telephone Consultation for Pain|Physician to Physician Telephone Consultation for Chronic Pain Patients: a Pragmatic Randomized Trial|Completed||N/A|80|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 01:23:43.15957|2017-10-11 01:23:43.15957
NCT01923311|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-07-20|||August 26, 2013|Actual|2013-08-26|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants|A Phase 2/3 Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered With a Background-Regimen (BR) Containing a Ritonavir-Boosted Protease Inhibitor (PI/r) in HIV-1 Infected, Antiretroviral Treatment-Experienced Pediatric Subjects|Active, not recruiting||Phase 2/Phase 3|31|Actual|Gilead Sciences||4|||f||||t|t|f||||||||2017-10-11 01:23:43.248729|2017-10-11 01:23:43.248729
NCT01923298|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-02-03|||August 9, 2013||2013-08-09|February 2017|2017-02-01|June 30, 2017|Anticipated|2017-06-30|November 30, 2016|Actual|2016-11-30||Interventional|||Estradiol Levels in Patients Treated With Estring|A Single-arm Phase II Trial to Evaluate Serum Estradiol Levels in Patients With Breast Cancer Treated With Vaginal Estrogen, Estring|Active, not recruiting||Phase 2|10|Actual|University of Arizona||1|||f||||t||||||||||2017-10-11 01:23:43.377115|2017-10-11 01:23:43.377115
NCT01923285|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2016-10-17|||August 2013||2013-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ACCURATE||A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain|A Prospective, Randomized, Multi-Center, Controlled Clinical Trial to Assess the Safety and Efficacy of the Spinal Modulation™ AXIUM™ Neurostimulator System in the Treatment of Chronic Pain (ACCURATE Trial)|Completed||N/A|152|Actual|St. Jude Medical||2|||f||||f||||||||||2017-10-11 01:23:43.46568|2017-10-11 01:23:43.46568
NCT01923272|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2013-08-14|||October 2012||2012-10-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore Device for the Relief of EIB|Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore Device for the Relief of Exercised Induced Bronchoconstriction|Withdrawn||N/A|0|Actual|ElectroCore LLC||2||Similar study being conducted, Sponsor decided to not duplicate study|f||||f||||||||||2017-10-11 01:23:43.584888|2017-10-11 01:23:43.584888
NCT01923259|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-13|||October 2010||2010-10-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition|Single Dose Crossover Comparative Bioavailability Study of Donepezil 23 mg Tablets in Healthy Male and Female Volunteers / Fed State|Completed||Phase 1|94|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 01:23:43.651201|2017-10-11 01:23:43.651201
NCT01923246|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2013-08-13|||September 2011||2011-09-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Development of IVR and WEB Alcohol Interventions|Development of IVR and WEB Alcohol Interventions|Completed||N/A|1672|Actual|Region Skane||5|||f||||f||||||||||2017-10-11 01:23:43.932389|2017-10-11 01:23:43.932389
NCT01923233|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-12-07|||November 2013||2013-11-01|December 2015|2015-12-01|June 2015|Anticipated|2015-06-01|November 2014|Anticipated|2014-11-01||Interventional|||In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer|Phase I Feasibility Study of ALLOSTIM(TM) in Combination With Radiofrequency Ablation in Patients With Refractory Hepatocellular Carcinoma|Withdrawn||Phase 1/Phase 2|0|Actual|Immunovative Therapies, Ltd.||1||change to ITL-022-HCC-BKK-VAX+S|f||||t||||||||||2017-10-11 01:23:44.032881|2017-10-11 01:23:44.032881
NCT01923220|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-12|||September 2013||2013-09-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|ARD||Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis|An Open-Label, Randomized Study to Evaluate the Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis In Breast Cancer Patients Undergoing Radiation Therapy.|Unknown status|Not yet recruiting|Early Phase 1|90|Anticipated|HealOr||2|||f||||f||||||||||2017-10-11 01:23:44.166158|2017-10-11 01:23:44.166158
NCT01923207|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-04-29|||August 2013||2013-08-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects|A Phase 1, Double-Blind, Single Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 (Recombinant Fully Human Antibody Inhibitor of Plasma Kallikrein) in Healthy Subjects|Completed||Phase 1|32|Actual|Shire||2|||f||||f||||||||||2017-10-11 01:23:44.290311|2017-10-11 01:23:44.290311
NCT01923194|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-08-20|||October 2013||2013-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|Compass||Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females|A Randomized, Assessor-blinded, Parallel Group, Multi-center, Non-inferiority Study Investigating the Efficacy and Safety of Highly Purified Urofollitropin for Injection Compared to Recombinant Human Follitropin Alfa for Injection for Ovulation Induction Using a Low-dose, Step-up Protocol in Chinese Females With WHO Group II Anovulatory Infertility Failing to Conceive on Clomiphene Citrate|Completed||Phase 3|215|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:23:44.391385|2017-10-11 01:23:44.391385
NCT01923181|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-03-30||2017-03-30|December 2, 2013|Actual|2013-12-02|March 2017|2017-03-01|December 11, 2014|Actual|2014-12-11|December 11, 2014|Actual|2014-12-11||Interventional|||Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes|Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes|Completed||Phase 2|632|Actual|Novo Nordisk A/S||9|||f||||f||||||||||2017-10-11 01:23:44.536505|2017-10-11 01:23:44.536505
NCT01922765|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-02-09|||August 2013||2013-08-01|February 2014|2014-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Concomitant Therapy of H. Pylori|Evaluation of the Efficacy of Concomitant Therapy for Eradication of Helicobacter Pylori|Unknown status|Recruiting|Phase 4|540|Anticipated|The Catholic University of Korea||4|||f||||f||||||||||2017-10-11 01:23:49.828391|2017-10-11 01:23:49.828391
NCT01923168|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2017-07-27|||March 11, 2014|Actual|2014-03-11|July 2017|2017-07-01|July 8, 2017|Actual|2017-07-08|July 8, 2017|Actual|2017-07-08||Interventional|||Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women|A Phase II Randomized, Double-blind Placebo Controlled, Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women With Hormone Receptor-positive HER2-negative Breast Cancer|Completed||Phase 2|340|Actual|Novartis||3|||f||||t|t|f||||||||2017-10-11 01:23:44.953807|2017-10-11 01:23:44.953807
NCT01923155|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-14|||March 2012||2012-03-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety & Effectiveness of Nurse Performed Colonoscopies Under Supervision|Safety & Effectiveness of Nurse Performed Colonoscopies Under Supervision: A Randomized Controlled Study in Asia (NE Study)|Completed||N/A|731|Actual|Chinese University of Hong Kong||2|||f||||||||||||||2017-10-11 01:23:45.223105|2017-10-11 01:23:45.223105
NCT01923142|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-01-26|||January 2014||2014-01-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo|Double Blind Within-Subject Controlled Study of Autologous Hair Follicle Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo|Terminated||Phase 2|4|Actual|Centro Studi Gised||2|||f||||f||||||||||2017-10-11 01:23:45.30483|2017-10-11 01:23:45.30483
NCT01923129|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-01-30|||November 2012||2012-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery|Prospective Study Investigating Optimal Duration of Indwelling Urinary Catheter Following Infraperitoneal Colorectal Surgery and Role of Postoperative Alpha Blockade|Recruiting||N/A|142|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-11 01:23:45.416531|2017-10-11 01:23:45.416531
NCT01923116|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-08-05|||August 2013||2013-08-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|VACCAIN-T||Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia|Therapeutic Vaccination Against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men|Recruiting||Phase 1/Phase 2|45|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-11 01:23:45.523081|2017-10-11 01:23:45.523081
NCT01923103|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-12-02|||May 2012||2012-05-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|DD||Natural Disease Progress of Dupuytren Disease|Natural Disease Progress of Dupuytren Disease|Active, not recruiting||N/A|261|Actual|University Medical Center Groningen|||1||f||||f||||||Samples With DNA|"     whole blood   "|Undecided||2017-10-11 01:23:45.628548|2017-10-11 01:23:45.628548
NCT01923090|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-08-13|||August 2012||2012-08-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|FIND-IT||Finasteride, Dutasteride and Insulin Action|An Open Label Study of 5α-reductase Inhibition on the Regulation of Insulin Action and Metabolic Phenotype in Healthy Volunteers.|Unknown status|Recruiting|Phase 2|12|Anticipated|University of Birmingham||2|||f||||f||||||||||2017-10-11 01:23:45.715549|2017-10-11 01:23:45.715549
NCT01923077|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-08-14|||April 2010||2010-04-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|INTENSIFY||Intensive Statin Therapy in Patients With AMI|Early Intensive Treatment With Statins Improves Left Ventricular Function in Patients With Acute Myocardial Infarction.|Unknown status|Active, not recruiting|Phase 2|140|Actual|Svendborg Hospital||2|||f||||t||||||||||2017-10-11 01:23:45.812061|2017-10-11 01:23:45.812061
NCT01923051|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-04-02|||August 2013||2013-08-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Czech Multicentre Research Database of Chronic Obstructive Pulmonary Disease (COPD)|Czech Multicentre Research Database of Chronic Obstructive Pulmonary Disease (COPD): Registry of the Czech Pneumological Society (CPPS) at the Czech Medical Association (CzMA)|Recruiting||N/A|1000|Anticipated|Masaryk University|||1||f||||f||||||Samples With DNA|"     In the following centres, we will be collecting samples with DNA (blood samples): University     Hospital Olomouc, University Hospital Hradec Kralove, University Hospital Motol, University     Hospital Brno.   "|Undecided||2017-10-11 01:23:46.013247|2017-10-11 01:23:46.013247
NCT01923038|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-01-17|||November 2012||2012-11-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Evaluation of Ventilatory Strategies During Laparoscopic Surgery|Re-expansion of Atelectasis During Laparoscopic Surgery. Recruitment Maneuver vs Positive End-expiratory Pressure: a Randomized Study|Completed||N/A|45|Actual|Maria Vittoria Hospital||3|||f||||t||||||||||2017-10-11 01:23:46.16884|2017-10-11 01:23:46.16884
NCT01923025|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-11-01|||August 2013||2013-08-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A PET Study With RO5545965 in Healthy Male Volunteers|A Single Centre, Open Label Study to Characterize the PK-PDE10A Enzyme Occupancy Relationship of RO5545965 After a Single Dose in Healthy Male Volunteers Using [11C]IMA107 Positron Emission Tomography|Completed||Phase 1|9|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:23:46.278473|2017-10-11 01:23:46.278473
NCT01923012|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-13|2014-05-24|||September 2013||2013-09-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|SCAVIT-K2||Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis|Phase 2 Study Randomized Placebo Controlled With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis|Unknown status|Not yet recruiting|Phase 2|200|Anticipated|Azienda Ospedaliera Sant'Anna||1|||f||||f||||||||||2017-10-11 01:23:46.364129|2017-10-11 01:23:46.364129
NCT01922999|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-01-23|||December 2012||2012-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders|A Randomized, Prospective, Double Blind, Placebo-Controlled Trial of Two Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders|Recruiting||Phase 2/Phase 3|53|Anticipated|Southeast Renal Research Institute||2|||f||||f||||||||||2017-10-11 01:23:46.451376|2017-10-11 01:23:46.451376
NCT01922986|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-04-26|2016-08-04||September 2013||2013-09-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Four people with acute stroke were enrolled. All four completed the study|Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke|Real vs Sham rTMS Combined With Conventional Therapy in Acute Stroke|Completed||N/A|4|Actual|University of Minnesota - Clinical and Translational Science Institute|Enrollment of subjects was insufficient.|2|||f||||t||||||||No||2017-10-11 01:23:46.571963|2017-10-11 01:23:46.571963
NCT01922973|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-12|||May 2003||2003-05-01|August 2013|2013-08-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Effect of Fasting on Ghrelin and Growth Hormone in Healthy Young and Older Adults|Effect of Fasting on Ghrelin and Growth Hormone in Healthy Young and Older Adults|Completed||N/A|21|Actual|University of Virginia|||1||f||||f||||||||||2017-10-11 01:23:47.030112|2017-10-11 01:23:47.030112
NCT01922960|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-01-27|||April 2012||2012-04-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Microcirculatory Assessment in Patients With Trauma and Severe Burns|Microcirculatory Assessment in Patients With Trauma and Severe Burns|Active, not recruiting||N/A|200|Anticipated|University of South Alabama||1|||f||||f||||||||||2017-10-11 01:23:47.095042|2017-10-11 01:23:47.095042
NCT01922947|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-06-09|||August 2012||2012-08-01|June 2017|2017-06-01|November 30, 2014|Actual|2014-11-30|November 30, 2014|Actual|2014-11-30||Interventional|||Motivational Interviewing Integrated With Social Network Counseling for Teens|Motivational Interviewing Integrated With Social Network Counseling for Teens|Completed||N/A|120|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 01:23:47.194744|2017-10-11 01:23:47.194744
NCT01922934|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-07-20|2017-02-01||January 2014||2014-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|Toolbox||A Toolbox Approach to Obesity Treatment in Primary Care|A Toolbox Approach to Obesity Treatment in Primary Care|Completed||Phase 4|4730|Actual|Denver Health and Hospital Authority||2|||f||||f||||||||||2017-10-11 01:23:47.281687|2017-10-11 01:23:47.281687
NCT01922921|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-09-27|||February 5, 2014||2014-02-05|September 2017|2017-09-01||||March 31, 2018|Anticipated|2018-03-31||Interventional|||Vaccine Therapy With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy|Phase I/II Randomized Study of Combination Immunotherapy With or Without Polysaccharide Krestin (PSK®) Concurrently With a HER2 ICD Peptide-Based Vaccine in Patients With Stage IV Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy|Active, not recruiting||Phase 1/Phase 2|31|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 01:23:48.057833|2017-10-11 01:23:48.057833
NCT01922908|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-10-24|||December 2016||2016-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SAMCIS||Mesenchymal Stromal Cells for Ischemic Stroke|SAfety of Mesenchymal Stromal Cells for Ischemic Stroke|Not yet recruiting||Phase 1/Phase 2|48|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 01:23:48.192282|2017-10-11 01:23:48.192282
NCT01922895|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-05-10|||October 2013||2013-10-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|NTAH-Mod||Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis|Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis|Recruiting||N/A|130|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-11 01:23:48.305739|2017-10-11 01:23:48.305739
NCT01922882|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-08-22|||May 2013||2013-05-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Amagugu||Maternal HIV Disclosure to School Children: RCT of Family-based Intervention|Maternal HIV Disclosure to School Children: RCT of Family-based Intervention (Amagugu)|Completed||N/A|465|Actual|University of KwaZulu||2|||f||||t||||||||||2017-10-11 01:23:48.455898|2017-10-11 01:23:48.455898
NCT01922869|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-08-12|||July 2013||2013-07-01|August 2013|2013-08-01|September 2014|Anticipated|2014-09-01|May 2014|Anticipated|2014-05-01||Interventional|COB||An Acute Human Intervention With Flavonoid to Investigate Absorption, Metabolism and Excretion|An Acute Flavonoid Intervention Study to Examine Influences of Genotype and Phenotype on Flavonoid Absorption, Metabolism and Excretion|Unknown status|Recruiting|N/A|240|Anticipated|University of East Anglia||1|||f||||f||||||||||2017-10-11 01:23:48.642095|2017-10-11 01:23:48.642095
NCT01922856|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-07-05|||September 19, 2013|Actual|2013-09-19|July 2017|2017-07-01|July 14, 2016|Actual|2016-07-14|February 6, 2016|Actual|2016-02-06||Interventional|||Challenge Study of an ETEC Vaccine|A Phase 2b Controlled Efficacy Study of Intradermally Delivered ETEC Fimbrial Tip Adhesin Vaccine Against Experimental Challenge With ETEC H10407 in Healthy Adult Volunteers|Completed||Phase 2|56|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||f||||||||||2017-10-11 01:23:48.791167|2017-10-11 01:23:48.791167
NCT01922843|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-08-15||2017-08-14|September 2013||2013-09-01|August 2017|2017-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|2MD-7H-2B||A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis|A Phase 2B, Double-blind, Randomized, Placebo-controlled, Proof-of-concept Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis|Completed||Phase 2|62|Actual|Deltanoid Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:23:48.956021|2017-10-11 01:23:48.956021
NCT01922830|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-03-24|||October 2013||2013-10-01|March 2014|2014-03-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Probiotics and Microbiota in Bariatric Surgery|Probiotics and Microbiota in Bariatric Surgery|Unknown status|Recruiting|Phase 3|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 01:23:49.123639|2017-10-11 01:23:49.123639
NCT01922817|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-05-04|||September 2012||2012-09-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||DPP4inhibitors in Type 1 Diabetes|A Dipeptidyl Peptidase 4 (DPP-4) Inhibitor in Type 1 Diabetes|Completed||Phase 3|14|Actual|University of Dundee||2|||f||||t||||||||||2017-10-11 01:23:49.265146|2017-10-11 01:23:49.265146
NCT01922804|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-10-27|||July 2013||2013-07-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|K2vita||Investigations of the Effect of MK-7 on Bone and Glucose Metabolism and Arterial Calcification|Investigations of the Effect of MK-7 on Bone and Glucose Metabolism and Arterial Calcification|Active, not recruiting||N/A|150|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:23:49.394231|2017-10-11 01:23:49.394231
NCT01922791|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-08-08|||October 2013|Actual|2013-10-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Nutrition and Pregnancy Intervention Study|Placebo-controlled Intervention Study for Maternal and Child Health|Active, not recruiting||N/A|440|Anticipated|Turku University Hospital||4|||f||||f||||||||||2017-10-11 01:23:49.531091|2017-10-11 01:23:49.531091
NCT01922752|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-12-08|||July 2013||2013-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors|An Open-Label Study to Determine the Maximum Tolerated Dose of Oral CEP-37440 Administered as a Single Agent in Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|32|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-11 01:23:49.988|2017-10-11 01:23:49.988
NCT01922739|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-04-28|2017-02-19|2015-07-29|July 2013||2013-07-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Enrolled participants|Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets|A 6-Month, Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 15 to 90 mg Every 12 Hours for Relief of Moderate to Severe Pain in Patients With Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time|Completed||Phase 3|182|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-11 01:23:50.154516|2017-10-11 01:23:50.154516
NCT01922726|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-09-12|||July 2013|Actual|2013-07-01|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Registry of Sleep Apnea Monitoring and Atrial Fibrillation in Pacemaker Patients (RESPIRE)|Registry of Sleep Apnea Monitoring and Atrial Fibrillation in Pacemaker Patients|Active, not recruiting||N/A|1257|Actual|LivaNova|||1||f||||f||||||||||2017-10-11 01:23:51.414538|2017-10-11 01:23:51.414538
NCT01922713|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-01-22|||October 2013||2013-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Daily Consumption of Orange Maize on Breast Milk Retinol in Lactating Zambian Women|Effect of Daily Consumption of β-carotene Biofortified Maize on Milk Retinol Concentration in Lactating Zambian Women|Completed||N/A|149|Actual|University of California, Davis||3|||f||||f||||||||||2017-10-11 01:23:51.626382|2017-10-11 01:23:51.626382
NCT01922700|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-07-18|||April 2013||2013-04-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Effects of Pepper Gas Exposure in Non-combatant Bystanders.|Pepper Gas Exposure Study|Completed||N/A|298|Actual|Sheri Kashmir Institute of Medical Sciences|||1||f||||f||||||||||2017-10-11 01:23:51.759824|2017-10-11 01:23:51.759824
NCT01922687|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-08-12|||April 2011||2011-04-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|March 2014|Anticipated|2014-03-01||Interventional|||Amlodipine Plus/Minus Atorvastatin for Protection of Arteries|Amlodipine Plus/Minus Atorvastatin for Protection of Arteries|Unknown status|Recruiting|Phase 4|109|Anticipated|Shanghai Institute of Hypertension||2|||f||||t||||||||||2017-10-11 01:23:51.861915|2017-10-11 01:23:51.861915
NCT01922674|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-13|||January 1999||1999-01-01|August 2013|2013-08-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair|Inguinal Hernia Management: Watchful Waiting vs. Tension-Free Open Repair|Completed||N/A|720|Actual|Creighton University||2|||f||||t||||||||||2017-10-11 01:23:51.98775|2017-10-11 01:23:51.98775
NCT01922661|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-06-09|||August 2013||2013-08-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects||Completed||Phase 1|24|Actual|Regeneron Pharmaceuticals||3|||f||||f||||||||||2017-10-11 01:23:52.085933|2017-10-11 01:23:52.085933
NCT01922648|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-11-19|||June 2013||2013-06-01|November 2015|2015-11-01||||April 2015|Actual|2015-04-01||Observational|||RSV Observational Study 2|Analysis of the Immune Response to Respiratory Syncytial Virus (RSV) Exposure in a Paediatric Population|Completed||N/A|35|Actual|University of Oxford|||3||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 01:23:52.22567|2017-10-11 01:23:52.22567
NCT01922635|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-01-12|||July 2013||2013-07-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|LYMPHOQOL||Validation of Metrological Properties of Lymphoqol|Validation of Metrological Properties of Questionnaire of Quality of Life LYMPHOQOL|Recruiting||N/A|170|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 01:23:52.325236|2017-10-11 01:23:52.325236
NCT01922622|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-02-02|||July 2013||2013-07-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Minimum Effective Intrathecal Dose of Local Anaesthetic With Fentanyl for Fractured Neck of Femur(Dose Finding Study).|Determination of the Initial Minimum Effective Dose of 0.5% Bupivacaine With 20mcg of Fentanyl Via a Spinal Catheter for Operative Fixation of Fractured Neck of Femur.|Completed||N/A|33|Actual|Cork University Hospital|||2||f||||t||||||||||2017-10-11 01:23:52.435867|2017-10-11 01:23:52.435867
NCT01922609|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2013-08-11|||May 2013||2013-05-01|August 2013|2013-08-01||||August 2015|Anticipated|2015-08-01||Observational|||Prediction of Carotid Occlusion Intolerance by Transcranial Doppler Evaluation in Patients Undergoing Carotid Artery Stenting With Proximal Flow Arrest Protection System.|Prediction of Carotid Occlusion Intolerance by Transcranial Doppler Evaluation in Patients Undergoing Carotid Artery Stenting With Proximal Flow Arrest Protection System.|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Motol|||2||f||||f||||||||||2017-10-11 01:23:52.56001|2017-10-11 01:23:52.56001
NCT01922596|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2014-01-09|||January 2013||2013-01-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Adductor Canal Blockade vs Femoral Nerve Blockade on Muscle Strength, Mobility and Pain After TKA|Effect of Adductor Canal Blockade vs Femoral Nerve Blockade on Muscle Strength, Mobility and Pain in Patients With Severe Pain After Total Knee Arthroplasty|Completed||Phase 4|50|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-11 01:23:52.654643|2017-10-11 01:23:52.654643
NCT01922583|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-09-10|||January 2014|Actual|2014-01-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|NSCLC||AUY922 in Patient With Stage IV NSCLC|A Multi-center Phase II Study of AUY922 in Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) With Driver Molecular Alterations Other Than Sensitive EGFR Mutation, Who Have Progressed After One Line of Systemic Therapy|Completed||Phase 2|31|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 01:23:52.776897|2017-10-11 01:23:52.776897
NCT01922570|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-08-11|||January 2012||2012-01-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Economics of Diarrhoea in Intensive Care Unit|Economic Investigation of Diarrhoea During Nutritional Support in Intensive Care Unit Patients|Completed||N/A|305|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-10-11 01:23:52.881891|2017-10-11 01:23:52.881891
NCT01922544|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2013-08-13|||August 2013||2013-08-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||EP-Catheter Guided CS-Lead Implantation|Conventional Versus EP-Catheter Guided Implantation of Coronary Sinus Lead in Patients Undergoing Cardiac Resynchronization Therapy|Completed||N/A|120|Actual|University of Cologne|||2||f||||t||||||||||2017-10-11 01:23:53.076571|2017-10-11 01:23:53.076571
NCT01922531|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-13|||September 2010||2010-09-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Defining Axonal Injury in Children With Mild Traumatic Brain Injury|Defining Axonal Injury in Children With Mild Traumatic Brain Injury|Completed||N/A|59|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples With DNA|"     Whole blood and serum   "|||2017-10-11 01:23:53.149249|2017-10-11 01:23:53.149249
NCT01922518|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-04-24|||March 2013||2013-03-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|RVpacing||Impact of Right Ventricular Pacing Determined by Electrocardiography|Impact of Right Ventricular Pacing Determined by Electrocardiography; Prospective Randomized Trial|Recruiting||Phase 3|264|Anticipated|Seoul St. Mary's Hospital||2|||f||||f||||||||No||2017-10-11 01:23:53.226862|2017-10-11 01:23:53.226862
NCT01922505|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2013-08-11|||January 2003||2003-01-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01|4 Weeks|Observational [Patient Registry]|||Eradication Rates of Helicobacter Pylori and Its Affecting Factors|The Trend of Eradication Rates of First-line Triple Therapy for Helicobacter Pylori and Clinical Factors That Affect the Eradication in Korean: Single Center Experience for Recent Ten Years|Completed||Phase 4|2500|Actual|Seoul National University Bundang Hospital|||1||f||||f||||||||||2017-10-11 01:23:53.338812|2017-10-11 01:23:53.338812
NCT01922492|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2015-11-17|||May 2008||2008-05-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug.|Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug in Partially Pancreatectomized Patients Due to Benign Pancreatic Neoplasm.|Active, not recruiting||N/A|28|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:23:53.446519|2017-10-11 01:23:53.446519
NCT01922479|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2017-04-11|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|PRACTICEASIAHF||Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure|Pilot RAndomized Controlled Trial of FerrIC CarboxymaltosE in ASIAns With Heart Failure (the PRACTICE-ASIA-HF) Study|Completed||Phase 4|50|Actual|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-11 01:23:53.554744|2017-10-11 01:23:53.554744
NCT01922466|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-11-20|||July 2013||2013-07-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia|Clinical Research on the Efficacy and Safety of East-West Collaborative Treatment Using NSAIDs and BV on Chronic Cervical Pain; A Randomized, Controlled, Parallel, Pilot Study|Completed||Phase 2|60|Anticipated|Kyunghee University Medical Center||3|||f||||f||||||||||2017-10-11 01:23:55.426282|2017-10-11 01:23:55.426282
NCT01922453|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-11|2013-08-11|||September 2013||2013-09-01|August 2013|2013-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|RITMO||Music and Sounds for ECV|Use of Music and Sounds for the External Cephalic Version of Breech Fetuses Near Term.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 01:23:55.541229|2017-10-11 01:23:55.541229
NCT01922440|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-05-24|||July 1, 2013||2013-07-01|May 2017|2017-05-01|June 1, 2032|Anticipated|2032-06-01|June 1, 2030|Anticipated|2030-06-01|17 Years|Observational [Patient Registry]|PARADIGHM||PARADIGHM A Natural History Registry for Patients With Chronic Hypoparathyroidism|PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Natural History Registry for Patients With Chronic Hypoparathyroidism|Recruiting||N/A|900|Anticipated|Shire|||1||f||||t||||||||||2017-10-11 01:23:55.643809|2017-10-11 01:23:55.643809
NCT01922427|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2015-04-08||||||January 2015|2015-01-01||||October 2014|Actual|2014-10-01||Interventional|||Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery|Study of RNS60 on Post-operative Pain and Function in Patients Undergoing Knee Anterior Cruciate Reconstruction Surgery|Withdrawn||Phase 2|0|Actual|Revalesio Corporation|||||f||||||||||||||2017-10-11 01:23:55.936208|2017-10-11 01:23:55.936208
NCT01922414|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-08-10|||August 2011||2011-08-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Laser Versus Ultrasonic Lithotripsy in Percutaneous Nephrolithotomy for Staghorn Stones|Laser Versus Ultrasonic Lithotripsy in Percutaneous Nephrolithotomy for Staghorn Stones|Completed||N/A|70|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 01:23:55.990828|2017-10-11 01:23:55.990828
NCT01922401|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-08-30|||September 2013||2013-09-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Inverse Ratio Ventilation on Bariatric Operation|Effects of a Changes in Inspiratory to Expiratory Ratio on Respiratory Mechanics and Oxygenation During Laparosopic Bariatric Surgery|Completed||N/A|30|Actual|Gachon University Gil Medical Center||1|||f||||t||||||||||2017-10-11 01:23:56.079252|2017-10-11 01:23:56.079252
NCT01922388|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-08-08|||August 2013||2013-08-01|August 2016|2016-08-01||||December 2020|Anticipated|2020-12-01||Interventional|||Early Versus Late Introduction of STN DBS in PD Patients With Motor Complications|Early Versus Late Introduction of STN DBS in PD Patients With Motor Complications: A Prospective, Comparative Multicentre Clinical Study|Recruiting||N/A|200|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-11 01:23:56.281449|2017-10-11 01:23:56.281449
NCT01922375|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-08-11|||December 2011||2011-12-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia|A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Design Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia|Completed||Phase 4|411|Actual|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:23:56.402875|2017-10-11 01:23:56.402875
NCT01922362|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-12|||December 2012||2012-12-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Negative Pressure Drainage System Split-thickness Skin Graft Recipient Sites|"The Use of Negative Pressure Drainage System for Caring Split-thickness Skin Graft Recipient Sites"|Unknown status|Recruiting|N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 01:23:56.499498|2017-10-11 01:23:56.499498
NCT01922349|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2016-11-23|2016-11-23||August 2013||2013-08-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||The treated set (TS) included all subjects who were dispensed trial medication and were documented to have taken at least 1 dose of the investigational treatment.|Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 113608 in Healthy Male Asian and Caucasian Volunteers (Randomised, Double-blind, Placebo-controlled Within Dose Groups)|Completed||Phase 1|98|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-11 01:23:56.644486|2017-10-11 01:23:56.644486
NCT01922336|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-07-10|||July 2013||2013-07-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects|A Randomised, Single-blind, Three-arm, Parallel Group, Single-dose Study to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Three Formulations of Infliximab (SB2, EU Sourced Remicade® and US Sourced Remicade®) in Healthy Subjects|Completed||Phase 1|159|Actual|Samsung Bioepis Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:23:58.927849|2017-10-11 01:23:58.927849
NCT01922323|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-03-27|||August 2013||2013-08-01|March 2017|2017-03-01|September 26, 2016|Actual|2016-09-26|September 26, 2016|Actual|2016-09-26||Observational|||Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors|Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors|Completed||N/A|20|Actual|Baylor Research Institute|||1||f||||f||||||Samples Without DNA|"     Each subject will provide samples of urine and blood at specific timepoints as outlined in     the protocol   "|||2017-10-11 01:23:59.040004|2017-10-11 01:23:59.040004
NCT01922310|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-10|2017-10-03|||May 1, 2013|Actual|2013-05-01|October 2017|2017-10-01|December 21, 2016|Actual|2016-12-21|July 8, 2016|Actual|2016-07-08||Interventional|COMFORT||Communication Regarding Organ and Tissue Donation in Intensive Care|Communication With Families Regarding Organ and Tissue Donation After Death in Intensive Care Study|Completed||N/A|417|Actual|NSW Organ and Tissue Donation Service||1|||f||||t||||||||||2017-10-11 01:23:59.130818|2017-10-11 01:23:59.130818
NCT01922297|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-10|2015-08-21|||January 2010||2010-01-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Day Treatment||Juvenile Offender HIV Prevention and Drug Abuse Services|Juvenile Offender HIV Prevention and Drug Abuse Services|Completed||N/A|121|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 01:23:59.250419|2017-10-11 01:23:59.250419
NCT01922284|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-09-26|||June 2013||2013-06-01|August 2013|2013-08-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|UKHVCSpoke003||Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses|A Phase I Clinical Trial Investigating Immunisation Strategies Using DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses|Completed||Phase 1|40|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 01:23:59.384481|2017-10-11 01:23:59.384481
NCT01922271|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2014-12-19|2014-12-19||August 2013||2013-08-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|FAST||Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Multicenter, 2-period Single-dose Cross-over Study to Assess the Early Bronchodilation of Glycopyrronium Bromide (44 μg o.d.) Compared to Tiotropium (18 µg. o.d.) in Patients With Moderate to Severe COPD (FAST Study)|Completed||Phase 4|152|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:23:59.700499|2017-10-11 01:23:59.700499
NCT01922258|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-07-25|||September 2013|Actual|2013-09-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type|A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Flexible Dosing of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type|Completed||Phase 3|270|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-10-11 01:24:00.434256|2017-10-11 01:24:00.434256
NCT01922245|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-08-17|||July 2013||2013-07-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||tDCS and Aphasia Treatment|tDCS and Aphasia Treatment|Unknown status|Recruiting|N/A|20|Anticipated|Hunter College of City University of New York||1|||f||||t||||||||||2017-10-11 01:24:00.742569|2017-10-11 01:24:00.742569
NCT01922232|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2014-10-01|||August 2013||2013-08-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01|1 Year|Observational [Patient Registry]|||MRI and Bladder Cancer Chemotherapy|Pilot Study of Role of MRI in Neoadjuvant Chemotherapy for Bladder Cancer|Withdrawn||N/A|0|Actual|New York University School of Medicine|||1||f||||t||||||||||2017-10-11 01:24:00.877559|2017-10-11 01:24:00.877559
NCT01922219|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2017-09-18|2016-12-22||December 2009||2009-12-01|September 2017|2017-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression|Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression|Completed||N/A|37|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 01:24:00.982658|2017-10-11 01:24:00.982658
NCT01922206|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-08-10|||March 2013||2013-03-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|August 2016|Actual|2016-08-01||Interventional|TRACK II||Maternal HIV: Trial to Assist Disclosure to Children|2/2-Maternal HIV: Multisite Trial to Assist Disclosure to Children|Active, not recruiting||N/A|362|Actual|Georgia State University||2|||f||||t||||||||||2017-10-11 01:24:01.314413|2017-10-11 01:24:01.314413
NCT01922193|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2015-06-15|||October 2013||2013-10-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program|A Randomized, Assessor-blinded, Parallel Group, Multi-center, Non-inferiority Study Investigating the Efficacy and Safety of Highly Purified Urofollitropin for Injection Compared to Recombinant Human Follitropin Alfa for Injection in Controlled Ovarian Stimulation in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program|Completed||Phase 3|263|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:24:01.406832|2017-10-11 01:24:01.406832
NCT01922180|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-08-13|||July 2007||2007-07-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Chronic Obstructive Pulmonary Disease: CT Features of Severe Exacerbation|Chronic Obstructive Pulmonary Disease: CT Features of Severe Exacerbation|Completed||N/A|44|Actual|Erasme University Hospital|||1||f||||f||||||||||2017-10-11 01:24:01.539897|2017-10-11 01:24:01.539897
NCT01922167|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-09-05|||November 2013||2013-11-01|September 2017|2017-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Resistance Exercise Training and Amino Acid Leucine Supplementation in Frail Elderly Women|The Impact of Exercise Training and Leucine Supplementation in Frail Elderly Women With an Exploration Into Mechanistic Explanations|Recruiting||N/A|24|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 01:24:01.772982|2017-10-11 01:24:01.772982
NCT01922154|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-04|2013-08-13|||February 2009||2009-02-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma|Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma|Completed||Phase 4|15|Actual|Siriraj Hospital||1|||f||||t||||||||||2017-10-11 01:24:01.928973|2017-10-11 01:24:01.928973
NCT01922141|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-04-14|||May 2015||2015-05-01|April 2015|2015-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ASSESS||Aliskiren Study of Safety and Efficacy in Senior Hypertensives|A Randomized, Double-blind, Parallel Group, Active-controlled Study to Compare the Systolic Blood Pressure Lowering Efficacy of Aliskiren, Ramipril and a Combination of Aliskiren and Amlodipine, With an Initial 8-week Evaluation, Followed by a 2-3 Year Follow-up to Compare Long-term Safety of an Aliskiren-based Regimen to a Ramipril-based Regimen in Hypertensive Patients ≥ 65 Years of Age|Withdrawn||Phase 4|0|Actual|Novartis||3|||f||||t||||||||||2017-10-11 01:24:02.066965|2017-10-11 01:24:02.066965
NCT01922128|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-04-17|||September 2013||2013-09-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration|A Phase 1 Randomized, Double-masked, Vehicle-controlled, Dose Escalation Study of the Ocular Safety and Tolerability of MC-1101 in Medically Stable Individuals|Completed||Phase 1|20|Actual|MacuCLEAR, Inc.||2|||f||||t||||||||||2017-10-11 01:24:02.210199|2017-10-11 01:24:02.210199
NCT01922115|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-02-17|2016-03-07||June 2013||2013-06-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ACE||The Effect of Anticholinergics on Cognitive Function in the Elderly|The Effect of Anticholinergics on Cognitive Function in the Elderly: a Randomized Controlled Trial|Completed||Phase 4|59|Actual|University of North Carolina, Chapel Hill||2|||f||||f|t|f||||||||2017-10-11 01:24:02.31692|2017-10-11 01:24:02.31692
NCT01922089|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-09-16|2015-07-16||November 2013||2013-11-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|TITRATION||Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients|A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens|Completed||Phase 2|498|Actual|Novartis||2|||f||||||||||||||2017-10-11 01:24:03.107558|2017-10-11 01:24:03.107558
NCT01922063|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2013-08-13|||July 1996||1996-07-01|August 2013|2013-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Physiotherapy Following Disc Surgery: Long Term Follow-up of a RCT|Long Term Follow-up of Comprehensive Physiotherapy Following Disc Herniation Operation: Results of a Randomized Clinical Trial|Completed||Phase 3|120|Actual|Medical University of Vienna||3|||f||||f||||||||||2017-10-11 01:24:04.689691|2017-10-11 01:24:04.689691
NCT01922050|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-12|2015-10-20||2015-10-20|October 2013||2013-10-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis|Safety and Efficacy of Escalating Doses of Two LEO 43204 Formulations Applied Once Daily for Two Consecutive Days on Full Face or Approximately 250 cm2 (40 in2) on the Chest in Subjects With Actinic Keratosis|Completed||Phase 1/Phase 2|324|Actual|LEO Pharma||8|||f||||f||||||||||2017-10-11 01:24:04.785239|2017-10-11 01:24:04.785239
NCT01922037|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-01-11|||June 2013||2013-06-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)|A Prospective Observational Study To Evaluate Predictors of Clinical Response To Omalizumab|Completed||Phase 4|806|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:24:04.973232|2017-10-11 01:24:04.973232
NCT01921634|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-12-19|||August 2013||2013-08-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Endometriosis and the Appendix - Incidence and Pathologic Analysis|Endometriosis and the Appendix: Is Incidence Related to Method of Pathologic Analysis?|Active, not recruiting||N/A|100|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 01:24:12.082269|2017-10-11 01:24:12.082269
NCT01922011|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-06-02|2017-06-02||September 13, 2013|Actual|2013-09-13|June 2017|2017-06-01|December 20, 2016|Actual|2016-12-20|June 14, 2016|Actual|2016-06-14||Interventional|||Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)|A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daptomycin Versus Active Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis Due to Gram-Positive Organisms|Completed||Phase 3|149|Actual|Cubist Pharmaceuticals LLC||2|||f||||t|t|f||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:24:05.928293|2017-10-11 01:24:05.928293
NCT01921998|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2015-02-03|||October 2013||2013-10-01|February 2015|2015-02-01||||November 2015|Anticipated|2015-11-01||Observational|BioACT||Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy|Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy|Suspended||N/A|50|Anticipated|The Christie NHS Foundation Trust|||1|Trial has been suspended due to lack of resource and staff|f||||f||||||Samples With DNA|"     Blood samples will be collected to analyse for biomarkers CK18 and FLT 3 Ligand.   "|||2017-10-11 01:24:06.785184|2017-10-11 01:24:06.785184
NCT01921972|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-12|||November 2004||2004-11-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|AD-Combi||The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease|"Competence Network - Dementia (BMBF) Pharmacological and Psychosocial Treatment (Modul E.2) Part II: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease"|Completed||Phase 4|232|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:24:07.004729|2017-10-11 01:24:07.004729
NCT01921959|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2015-12-19|||August 2013||2013-08-01|December 2015|2015-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Fit Moms in Partners, Children, and Other Members|Effects of Postpartum Weight Loss Intervention on Partner and Offspring Weight|Active, not recruiting||N/A|300|Actual|California Polytechnic State University-San Luis Obispo|||2||f||||t||||||||||2017-10-11 01:24:07.128483|2017-10-11 01:24:07.128483
NCT01921946|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-10-20|||August 2013||2013-08-01|August 2013|2013-08-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin|A Phase Ⅰ Study to Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin in Healthy Male Volunteers|Completed||Phase 1|50|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-10-11 01:24:07.237354|2017-10-11 01:24:07.237354
NCT01921933|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-01-11|||February 2014||2014-02-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|OPEN||The Optiflow Patency and Maturation Study|"The OPEN Study Optiflow PatEncy and MaturatioN"|Completed||N/A|51|Actual|Bioconnect Systems, Inc||1|||f||||t||||||||||2017-10-11 01:24:07.367408|2017-10-11 01:24:07.367408
NCT01921920|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-11-21|||August 2013||2013-08-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Prilosec Bioequivalence Study in Healthy Volunteers|An Open-label, Randomized, Single-center, 4-way Crossover, Single Dose Bioequivalence Study Comparing Omeprazole 20 and 40-mg Aqueous Solvent Based Capsules Manufactured by AstraZeneca With Omeprazole 20 and 40-mg Organic-solvent Based Capsules Manufactured by Merck|Completed||Phase 1|54|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 01:24:07.487575|2017-10-11 01:24:07.487575
NCT01921907|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-03-09|||July 2013||2013-07-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Evaluation of a Topical Treatment for Actinic Keratosis|Phase 2 Double-blind, Randomized, Placebo-controlled, Parallel Group, Multi-center Study|Completed||Phase 2|52|Actual|Assuta Hospital Systems||2|||f||||||||||||||2017-10-11 01:24:07.600295|2017-10-11 01:24:07.600295
NCT01921894|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-02-02|2016-02-15||August 2013||2013-08-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SAVED-P||Vitamin D and Severe Asthma Exacerbations|A Phase I Trial for Children With Vitamin D Insufficiency and High Risk of Severe Asthma Exacerbations|Completed||Phase 1|48|Actual|University of Pittsburgh||3|||f||||f||||||||No||2017-10-11 01:24:07.694407|2017-10-11 01:24:07.694407
NCT01921881|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2015-02-12|||September 2013||2013-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Does the Natural Medicinal Plant St John's Wort Affect the Glucose Tolerance in Healthy Individuals||Completed||Phase 1|10|Actual|University of Southern Denmark||1|||f||||f||||||||||2017-10-11 01:24:08.102381|2017-10-11 01:24:08.102381
NCT01921868|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-04-11|||August 2013||2013-08-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia|An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia|Recruiting||N/A|20|Anticipated|University of South Florida||1|||f||||f||||||||||2017-10-11 01:24:08.177896|2017-10-11 01:24:08.177896
NCT01921855|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-08-20|||January 2009||2009-01-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|MATCHBOX||Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors|A Phase I, Randomized, Double-blind, Placebo Controlled, Single Dose Escalation Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors|Completed||Phase 1|16|Actual|Bayer||4|||f||||t||||||||||2017-10-11 01:24:08.299953|2017-10-11 01:24:08.299953
NCT01921842|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-09|||January 2008||2008-01-01|August 2013|2013-08-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|CCWS||Child Care Wellness Study on Nutrition and Physical Activity|Promoting Nutrition and Physical Activity in Child Care Centers|Completed||N/A|18|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 01:24:08.430133|2017-10-11 01:24:08.430133
NCT01921829|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-07-18|2017-04-12||November 2013||2013-11-01|July 2017|2017-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ProDiuS||Protocolized Diuretic Strategy in Cardiorenal Failure|Effect of Protocolized Diuretic Strategy on Clinical Outcomes and Health-related Quality of Life in Cardiorenal Failure: A Randomized Trial|Terminated||Phase 4|19|Actual|University of Pittsburgh|Early termination leading to small numbers of subjects analyzed|2||Due to futility due to lower than expected recruitment|f||||t||||||||||2017-10-11 01:24:08.584431|2017-10-11 01:24:08.584431
NCT01921816|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-12-02|||May 2012||2012-05-01|December 2014|2014-12-01||||August 2013|Actual|2013-08-01||Interventional|||A Study on the Efficacy and Safety of Continuous Renal Replacement Therapy (CVVHDF) Using a Commercial Citrate-containing Replacement Fluid (Prismocitrate 18/0)||Completed||N/A|35|Anticipated|The University of Hong Kong||1|||f||||||||||||||2017-10-11 01:24:10.410375|2017-10-11 01:24:10.410375
NCT01921803|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-12-04|||August 2013||2013-08-01|December 2014|2014-12-01|July 2017|Anticipated|2017-07-01|July 2015|Anticipated|2015-07-01||Interventional|Hypofraction||Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer|Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer: Randomised Trial Comparing Toxicity Between 2 Different Hypofractionated Schedules|Unknown status|Recruiting|Phase 2|346|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:24:10.503883|2017-10-11 01:24:10.503883
NCT01921790|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2013-08-20|||August 2013||2013-08-01|August 2013|2013-08-01|August 2020|Anticipated|2020-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma|An Open-Label, Uncontrolled, Single Centered Phase Ⅱ Study of Avastin Combined With Gemcitabine, Oxaliplatin, Pegaspargase and Dexamethasone (Avastin+ GemAOD) As First-Line Treatment in Patients With Untreated NK/T Cell Lymphoma|Recruiting||Phase 2|30|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 01:24:10.603841|2017-10-11 01:24:10.603841
NCT01921777|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2014-01-20|||January 2010||2010-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Traumeel®S Tablets on Recovery and Inflammatory Immune Response After Repeated Bouts of Exercise||Completed||Phase 1|95|Actual|University of Giessen||2|||f||||f||||||||||2017-10-11 01:24:10.715677|2017-10-11 01:24:10.715677
NCT01921764|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-10|2014-01-26|||September 2013||2013-09-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|IRMA||Implementation of Physical Exercise at the Workplace (IRMA08) - Healthcare Workers|Implementation of Physical Exercise at the Workplace (IRMA08) - Healthcare Workers|Completed||N/A|200|Actual|National Research Centre for the Working Environment, Denmark||2|||f||||f||||||||||2017-10-11 01:24:10.801971|2017-10-11 01:24:10.801971
NCT01921738|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-10|||May 2012||2012-05-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Azithromycin in the Treatment of Chronic Periodontitis|The Effects of Systemic and Locally Azithromycin Adjunct to Scaling and Root Planning on Clinical and Microbiological Periodontal Indices in Moderate to Severe Chronic Periodontitis|Completed||Phase 2|80|Actual|Isfahan University of Medical Sciences||4|||f||||t||||||||||2017-10-11 01:24:11.154548|2017-10-11 01:24:11.154548
NCT01921725|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-08-09|||May 2013||2013-05-01|August 2013|2013-08-01||||August 2013|Actual|2013-08-01||Interventional|||The Clinical Application and Efficacy Verification of an Innovative Carbon Fiber Dressing|The Clinical Application and Efficacy Verification of an Innovative Carbon Fiber Dressing|Completed||N/A|60|Actual|Bio-medical Carbon Technology Co., Ltd.||1|||f||||||||||||||2017-10-11 01:24:11.28471|2017-10-11 01:24:11.28471
NCT01921712|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2014-03-17|||July 2013||2013-07-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients|A Phase I, 2-Part, Single-dose, Placebo and Active-Controlled, Dose-ranging, Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|38|Actual|Pulmatrix Inc.||5|||f||||f||||||||||2017-10-11 01:24:11.383126|2017-10-11 01:24:11.383126
NCT01921699|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-09|||August 2013||2013-08-01|August 2013|2013-08-01||||September 2013|Anticipated|2013-09-01||Interventional|||Macrophages Effect on Chemoresistance|Impact of Macrophages on De-Novo Chemoresistance of Adenocarcinoma Cells|Unknown status|Not yet recruiting|N/A|2|Anticipated|Rambam Health Care Campus||1|||f||||||||||||||2017-10-11 01:24:11.497255|2017-10-11 01:24:11.497255
NCT01921686|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-07-17|||March 2013||2013-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2014|Actual|2014-09-01||Observational|||Morphological Markers of Gastroesophageal Reflux Disease (GERD)|Dilation of Intercellular Spaces as Morphological Markers of Gastroesophageal Reflux Disease (GERD)In Children|Active, not recruiting||N/A|54|Actual|Baylor College of Medicine|||3||f||||f||||||Samples Without DNA|"     Three esophageal biopsy samples   "|||2017-10-11 01:24:11.586449|2017-10-11 01:24:11.586449
NCT01921673|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-10|2017-07-13|||August 2013|Actual|2013-08-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Dovitinib Plus Docetaxel in Gastric Cancer|A Phase I-II Trial of Dovitinib Plus Docetaxel as Second-line Chemotherapy in Patients With Metastatic or Unresectable Gastric Cancer After Failure of First-line Chemotherapy|Completed||Phase 1/Phase 2|14|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 01:24:11.697266|2017-10-11 01:24:11.697266
NCT01921660|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-06-27|||September 2015||2015-09-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|DDRAMATIC-SVT||Dipole Density Mapping in Right (and Left) SVT|Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia|Completed||N/A|12|Actual|Acutus Medical||1|||f||||f||f||||||Undecided||2017-10-11 01:24:11.841655|2017-10-11 01:24:11.841655
NCT01921647|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-12-02|||July 2013||2013-07-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|YH4808-108||The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects|The Exploration for Pharmacodynamics and Pharmacokinetic Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects|Completed||Phase 1|95|Actual|Yuhan Corporation||4|||f||||f||||||||||2017-10-11 01:24:11.971545|2017-10-11 01:24:11.971545
NCT01921621|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-03-27|||August 2013||2013-08-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Proficiency Based Training in Surgery - Employing An Arthroscopic Bankart Repair|The Copernicus Initiative - The Study of Proficiency Based Training in Arthroscopic Surgery|Completed||N/A|44|Actual|Arthroscopy Association of North America||3|||f||||t||||||||||2017-10-11 01:24:12.164668|2017-10-11 01:24:12.164668
NCT01921608|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2013-08-12|||January 2013||2013-01-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|RMC-07||Safety Study of the PrePex Device for Non-Surgical Adult Male Circumcision During Phased in National Implementation in an Effort to Prevent the Spread of HIV|One-Arm, Open Label, Prospective Safety Study of the PrePex Device for Non-Surgical Adult Male Circumcision During Phased in National Implementation in an Effort to Prevent the Spread of HIV.|Completed||N/A|1001|Actual|Ministry of Health, Rwanda||1|||f||||f||||||||||2017-10-11 01:24:12.28332|2017-10-11 01:24:12.28332
NCT01921595|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-07-24|||August 2013||2013-08-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Impact of Balanced Slat Colloid HES 130/0.42 on Coagulation Profiles in Patients Undergoing Spinal Cord Tumor Surgery||Unknown status|Recruiting|N/A|70|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:24:12.388098|2017-10-11 01:24:12.388098
NCT01921582|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-02-03|||August 2013||2013-08-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder|A Randomized Comparison of Osmotic Release Oral System Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Obese Patients With Binge Eating Disorder|Completed||Phase 2|51|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-11 01:24:12.494158|2017-10-11 01:24:12.494158
NCT01921569|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-09-23|||June 2013||2013-06-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis|Micronized Dehydrated Human Amniotic Membrane (dHACM) Suspension in the Treatment of Lateral Epicondylitis.|Terminated||N/A|5|Actual|MiMedx Group, Inc.||2||Study closed by sponsor|f||||||||||||||2017-10-11 01:24:12.628172|2017-10-11 01:24:12.628172
NCT01921556|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-06-17|||September 2013||2013-09-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|CAROL||The Improving Care in Chronic Obstructive Lung Disease Study A Cluster Randomized Trial|The Improving Care in Chronic Obstructive Lung Disease Study: CAROL Improving Processes of Care and Quality of Life of COPD Patients in Primary Care: A Cluster Randomized Trial|Active, not recruiting||N/A|216|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 01:24:12.746232|2017-10-11 01:24:12.746232
NCT01921543|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-07-15|||January 2005||2005-01-01|June 2013|2013-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|DBSTRD||Deep Brain Stimulation in Treatment Refractory Depression|Electrical Stimulation of the Internal Capsule/Grey Matter and Inferior Thalamic Peduncle for Treatment-refractory Major Depressive Disorder|Terminated||Phase 1/Phase 2|7|Actual|Universitaire Ziekenhuizen Leuven||4||Patient inclusion was very tedious and slower than expected. (7 patients in 5 years)|f||||f||||||||||2017-10-11 01:24:12.852257|2017-10-11 01:24:12.852257
NCT01921530|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-03-07|||December 2013||2013-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interbody vs Instrumented Posterolateral Fusion Following Decompression for Lumbar Spinal Stenosis With Degenerative Spondylolisthesis|Interbody Fusion and Decompression Versus Instrumented Posterolateral Fusion and Decompression for Lumbar Spinal Stenosis With Degenerative Spondylolisthesis|Recruiting||Phase 4|178|Anticipated|The London Spine Centre||2|||f||||||||||||||2017-10-11 01:24:12.998253|2017-10-11 01:24:12.998253
NCT01921517|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-03-16|||September 2012||2012-09-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|LMMS||Micromechanical Modeling Using Low Magnitude Mechanical Stimulation|Osteoporosis Treatment Response Assessed by Micromechanical Modeling of MRI Data|Recruiting||N/A|64|Anticipated|University of Pennsylvania||2|||f||||f||||||||No||2017-10-11 01:24:13.132953|2017-10-11 01:24:13.132953
NCT01921504|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-09|||August 2013||2013-08-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled Trial|Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled Trial|Unknown status|Recruiting|N/A|76|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-11 01:24:13.258775|2017-10-11 01:24:13.258775
NCT01921491|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2015-12-11|||August 2013||2013-08-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||DHACM vs Other Commercially Available Treatments|DHACM vs Other Commercially Available Treatments|Completed||N/A|105|Actual|MiMedx Group, Inc.||3|||f||||f||||||||||2017-10-11 01:24:13.433474|2017-10-11 01:24:13.433474
NCT01921478|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2013-08-09|||August 2010||2010-08-01|August 2013|2013-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis|Retrospective, Multi-center, Observational Study of Daily Practice Patterns and Outcomes of the Management of Rheumatoid Arthritis Patients Without Documented Erosions Treated With RoACTEMRA in Belgium|Completed||N/A|77|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:24:13.550957|2017-10-11 01:24:13.550957
NCT01921465|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-08-16|||October 2013||2013-10-01|February 2014|2014-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01|4 Months|Observational [Patient Registry]|||Outpatient Care for Multiparas After Elective Cesarean Section: an Observational Study||Completed||N/A|20|Actual|Herning Hospital|||1||f||||f||||||||||2017-10-11 01:24:13.68241|2017-10-11 01:24:13.68241
NCT01921452|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2014-11-20|2014-11-20||October 2013||2013-10-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Full analysis set (FAS) included all enrolled participants.|Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit|A Single-center Interventional Study to Verify Clinical Utility of the Quantitative and the Qualitative POC TSH Test Kits Compared With the Third Generation TSH Test Kit|Completed||Phase 4|283|Actual|Merck KGaA||1|||f||||f||||||||||2017-10-11 01:24:13.771998|2017-10-11 01:24:13.771998
NCT01921439|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-04-07|||July 2013||2013-07-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|OCAST||OCAST Cessation Study|Matching Brief Smoking Interventions to Stage of Change|Completed||N/A|152|Actual|University of Oklahoma||2|||f||||f||||||||||2017-10-11 01:24:13.961724|2017-10-11 01:24:13.961724
NCT01921426|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-09-21|||August 2013||2013-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2015|Actual|2015-07-01||Interventional|||A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck|A Phase 1 Dose Escalation Study of GC4419 in Combination With Radiation and Chemotherapy for Squamous Cell Cancers of the Head and Neck.|Completed||Phase 1|30|Anticipated|Galera Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 01:24:14.068078|2017-10-11 01:24:14.068078
NCT01921413|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-04-21|||July 2013||2013-07-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)|Clinical Validation of Fyodor Urine Malaria Test (UMT)|Completed||N/A|1893|Actual|Fyodor Biotechnologies Inc|||1||f||||t||||||Samples Without DNA|"     Urine   "|||2017-10-11 01:24:14.290838|2017-10-11 01:24:14.290838
NCT01921400|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-05-25|||January 2013||2013-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Pathogenesis of Hepatitis C Virus Vertical Transmission|The Pathogenesis of Hepatitis C Virus Vertical Transmission|Recruiting||N/A|50|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"     Our planned protocol will be to secure whole placental organs after delivery for study     patients. Tissue preparation will include a combination of segments preserved in nucleic acid     preservative (TriZol or equivalent) and flash freeze of sections to preserve cellular     anatomy.   "|||2017-10-11 01:24:14.41024|2017-10-11 01:24:14.41024
NCT01921387|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-08-23|||October 9, 2013|Actual|2013-10-09|August 2017|2017-08-01|May 23, 2022|Anticipated|2022-05-23|May 23, 2018|Anticipated|2018-05-23||Interventional|||Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies|A Phase I/II Study Evaluating Escalating Doses of 90Y-BC8-DOTA (Anti-CD45) Antibody Followed by BEAM Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Lymphoid Malignancies|Active, not recruiting||Phase 1/Phase 2|21|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 01:24:14.498926|2017-10-11 01:24:14.498926
NCT01921374|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-02-02|||August 2013||2013-08-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|August 2013|Actual|2013-08-01||Interventional|DMDK||Mother-caregivers of Children With Duchenne Muscular Dystrophy|Profile of Mother-caregivers of Children With Duchenne Muscular Dystrophy|Completed||N/A|60|Actual|Federal University of São Paulo||5|||f||||t||||||||||2017-10-11 01:24:14.653589|2017-10-11 01:24:14.653589
NCT01921361|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2013-08-12|||January 2011||2011-01-01|August 2013|2013-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||The Effects of Dexmedetomidine on Peroperative Shivering Incidence Under Spinal Anesthesia|The Effects of Dexmedetomidine on Peroperative Shivering Incidence Under Spinal Anesthesia|Completed||Phase 4|120|Actual|TC Erciyes University||3|||f||||t||||||||||2017-10-11 01:24:14.78983|2017-10-11 01:24:14.78983
NCT01921348|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-05-23|2017-03-06||August 2013||2013-08-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis|Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis|Terminated||N/A|18|Actual|University of Mississippi Medical Center|The target number of participants needed to achieve target power and statistically reliable results was not met.|2||Target enrollment not met within specific time period.|f||||f||||||||||2017-10-11 01:24:14.996242|2017-10-11 01:24:14.996242
NCT01921335|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-10-02|||August 2013||2013-08-01|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|September 2018|Anticipated|2018-09-01||Interventional|||ARRY-380 + Trastuzuamab for Breast w/ Brain Mets|Phase I Dose-escalation Trial of ARRY-380 in Combination With Trastuzumab in Participants With Brain Metastases From HER2+ Breast Cancer|Active, not recruiting||Phase 1|41|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 01:24:15.436718|2017-10-11 01:24:15.436718
NCT01921322|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-06-06|2017-05-12||April 2013||2013-04-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Amoung the study completers, four met the target range on or before the first day and one subjects blinded CGM data was lost due to removal of the devices battery. The five subjects were excluded from the final analysis.|Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy|Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy for Hospitalized Patients in China With Type 2 Diabetes; Time to Target|Completed||N/A|118|Actual|Medtronic Diabetes||2|||f||||f|f|t|f|f|t|||No||2017-10-11 01:24:15.58453|2017-10-11 01:24:15.58453
NCT01921309|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-01-05|||December 2012||2012-12-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Trinity™ BIOLOX Delta™ CoC THR Multi-center Study|Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System|Active, not recruiting||Phase 3|342|Actual|Corin||2|||f||||t||||||||||2017-10-11 01:24:16.098208|2017-10-11 01:24:16.098208
NCT01921296|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-03-21|2014-11-12||August 2013||2013-08-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional|||Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients|UMCC 2013.051: Prospective Pilot Study Evaluating the Use of Cyclobenzaprine for Treatment of Sleep Disturbance, Fatigue, and Musculoskeletal Symptoms in Aromatase Inhibitor-treated Breast Cancer Patients|Terminated||Phase 2|2|Actual|University of Michigan Cancer Center|The study was closed early for futility. The primary endpoint was not analyzed.|1||Accrual terminated early because of poor accrual|f||||t||||||||||2017-10-11 01:24:16.28157|2017-10-11 01:24:16.28157
NCT01921283|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-08-08|||September 2011||2011-09-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring||Completed||N/A|180|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:24:16.678728|2017-10-11 01:24:16.678728
NCT01921257|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-03-22||2017-03-21|August 2013||2013-08-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Paediatric Safety Study in Cat-PAD|A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects|Completed||Phase 2|16|Actual|Circassia Limited||1|||f||||f||||||||||2017-10-11 01:24:16.964362|2017-10-11 01:24:16.964362
NCT01921244|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-02-04|||August 2013||2013-08-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Shared Decision Making to Improve Care and Outcomes for Children With Autism|Shared Decision Making to Improve Care and Outcomes for Children With Autism|Completed||N/A|142|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 01:24:17.071534|2017-10-11 01:24:17.071534
NCT01921231|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-08-09|||May 2007||2007-05-01|August 2013|2013-08-01|December 2007|Actual|2007-12-01|May 2007|Actual|2007-05-01||Interventional|BUPIPRILO-07||Selective Subarachnoid Anesthesia. Comparison of Hyperbaric Bupivacaine and Hyperbaric Prilocaine|Selective Subarachnoid Anesthesia. Comparison of Hyperbaric Bupivacaine and Hyperbaric Prilocaine in Knee Arthroscopy and Inguinal Hernia Repair in Ambulatory Surgery|Completed||Phase 4|119|Actual|Consorci Hospitalari de Vic||2|||f||||t||||||||||2017-10-11 01:24:17.228852|2017-10-11 01:24:17.228852
NCT01921218|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2016-12-13|||August 2013||2013-08-01|December 2016|2016-12-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|IM103-133||Belatacept Therapy for the Failing Renal Allograft|Belatacept Therapy for the Failing Renal Allograft|Recruiting||Phase 3|72|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 01:24:17.348117|2017-10-11 01:24:17.348117
NCT01921205|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-03-02|||August 29, 2013|Actual|2013-08-29|March 2017|2017-03-01|January 24, 2017|Actual|2017-01-24|January 24, 2017|Actual|2017-01-24||Interventional|||Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures|A Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy ≥4 Years to <17 Years of Age With Partial Onset Seizures|Completed||Phase 3|404|Actual|UCB Pharma||2|||f||||t||||||||||2017-10-11 01:24:17.538153|2017-10-11 01:24:17.538153
NCT01921192|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-08|||September 2012||2012-09-01|August 2013|2013-08-01||||July 2014|Anticipated|2014-07-01||Interventional|||Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy||Unknown status|Recruiting|Phase 4|160|Anticipated|University of Catania||2|||f||||||||||||||2017-10-11 01:24:17.961403|2017-10-11 01:24:17.961403
NCT01921179|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-07-12|||July 31, 2013|Actual|2013-07-31|July 2017|2017-07-01|June 29, 2018|Anticipated|2018-06-29|December 15, 2017|Anticipated|2017-12-15||Interventional|||Rehabilitation of Executive Functioning in Veterans With PTSD and Mild TBI|Rehabilitation of Executive Functioning in Veterans With PTSD and Mild TBI|Recruiting||N/A|54|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:24:18.054051|2017-10-11 01:24:18.054051
NCT01921153|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-05-03|||August 2013||2013-08-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||An Environmental Intervention to Encourage Healthy Food Choices|Encouraging Healthy Food Choices With an Environmental Intervention in Military Dining Facilities|Completed||N/A|39|Actual|United States Army Research Institute of Environmental Medicine||2|||f||||f||||||||Undecided||2017-10-11 01:24:18.401538|2017-10-11 01:24:18.401538
NCT01921140|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-04-26|||September 24, 2013|Actual|2013-09-24|April 2017|2017-04-01|December 29, 2017|Anticipated|2017-12-29|April 8, 2014|Actual|2014-04-08||Interventional|||To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours|A Randomised, Open-label, Three-part, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of Olaparib and to Provide Data on the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|80|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:24:18.482248|2017-10-11 01:24:18.482248
NCT01921127|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-02-02|||August 2013||2013-08-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients|A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol (BFC) vs. Fluticasone/Salmeterol (FSC) Combination in Patients With COPD.|Completed||N/A|3000|Anticipated|AstraZeneca|||2||f||||||||||||||2017-10-11 01:24:18.614015|2017-10-11 01:24:18.614015
NCT01921114|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-08-15|||October 2013||2013-10-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PROOF||The PROOF Study: The PICC Related Obstruction Of Flow Study|A Randomized Prospective Multicenter Evaluation to Investigate the Incidence of Catheter Related Venous Thrombosis in Patients Undergoing Intravenous Therapy With the BioFlo™ Peripherally Inserted Central Catheter (PICC) or Bard® Dual-Lumen PowerPICC SOLO2®|Terminated||N/A|57|Actual|Angiodynamics, Inc.||2||Low enrollment|f||||f||||||||||2017-10-11 01:24:18.704011|2017-10-11 01:24:18.704011
NCT01921101|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-08-01|2014-04-15||July 2009||2009-07-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|INTACT|gender, race/ethnicity, age, diagnosis, admission height and weight, body mass index, ICU admission Acute Physiology and Chronic Health Evaluation II score, Sequential Organ Failure Assessment scores|Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT)|Intensive Nutrition in ARDS: A Clinical Trail (INTACT)|Terminated||N/A|78|Actual|University of Illinois at Chicago||2||greater mortality in intervention group|f||||t||||||||||2017-10-11 01:24:18.802592|2017-10-11 01:24:18.802592
NCT01921088|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-03-24|||August 2013||2013-08-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Regulation of Psychophysiological Functions|Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Regulation of Psychophysiological Functions|Active, not recruiting||N/A|31|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 01:24:19.244436|2017-10-11 01:24:19.244436
NCT01921075|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-08|||January 2010||2010-01-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Physiologic Plasticity of Intramyocardial Lipid Storage|Patterns and Plasticity of Orthotopic and Ectopic Fat Deposition and Associations With Insulin Sensitivity: A Magnetic-resonance-imaging and -Spectroscopy Study in Lean and Obese Individuals: Methodological Part|Completed||N/A|9|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-11 01:24:19.347552|2017-10-11 01:24:19.347552
NCT01921062|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-12-02|||July 2011||2011-07-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|MIDRF||Motor Imagery in Rehabilitation After a Distal Radius Fracture|Kinesthetic Motor Imagery Training During Immobilization to Improve Wrist Functional Outcome After a Distal Radius Fracture in Women of 45-75 Years of Age|Recruiting||N/A|52|Anticipated|University Medical Center Groningen||2|||f||||f||||||||Undecided||2017-10-11 01:24:19.436443|2017-10-11 01:24:19.436443
NCT01921049|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2014-12-07|||September 2013||2013-09-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Systemic Inflammatory Response Syndrome (SIRS) in Patients Undergoing Major Procedures in Oral and Maxillofacial Surgery|Systemic Inflammatory Response Syndrome (SIRS) in Patients Undergoing Major Procedures in Oral and Maxillofacial Surgery|Completed||N/A|27|Actual|University of Cologne|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 01:24:19.528045|2017-10-11 01:24:19.528045
NCT01921036|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2015-01-22|||February 2011||2011-02-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|DOPPELHERZ||The Effects of Combined Exercise Training on Exercise Capacity in Cardiac Rehabilitation|Individuell Dosiertes Kraft-ausdauer-training in Ambulanten Herzgruppen - Einfluss Auf Koerperliche Belastbarkeit Von Herzpatienten.|Completed||N/A|70|Actual|Technische Universität München||2|||f||||t||||||||||2017-10-11 01:24:19.591759|2017-10-11 01:24:19.591759
NCT01921023|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-11-17|||September 2014||2014-09-01|February 2014|2014-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Comparison of Performance of a Conventional Blood Gas Analyser With the Proxima System|An Open, Non-randomised, Study to Provide a Comparison of Data From a Conventional Blood Gas Analyser With Those Obtained From the CE Marked Proxima System|Completed||N/A|21|Actual|Sphere Medical Ltd.|||1||f||||f||||||||||2017-10-11 01:24:19.677031|2017-10-11 01:24:19.677031
NCT01921010|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-09|2017-03-23|||June 2003||2003-06-01|March 2017|2017-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Benefit of Elevation of HDL-C in Women|Benefit of Elevation of HDL-cholesterol/Triglyceride Lowering on Cardiovascular Outcomes in Women|Completed||Phase 4|43|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||Yes||2017-10-11 01:24:19.734817|2017-10-11 01:24:19.734817
NCT01920997|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-09-01|||August 2013||2013-08-01|September 2013|2013-09-01||||October 2013|Anticipated|2013-10-01||Observational|||Qing'E Formula Therapy on Menopausal Symptoms (Healthy Volunteers Recruitment for Control Study)||Unknown status|Recruiting|N/A|50|Anticipated|Shanghai University of Traditional Chinese Medicine|||1||f||||||||||||||2017-10-11 01:24:21.811007|2017-10-11 01:24:21.811007
NCT01920984|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-12|||January 2005||2005-01-01|January 2004|2004-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|VL||Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy|Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy|Completed||N/A|100|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:24:21.884758|2017-10-11 01:24:21.884758
NCT01920971|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-08|||August 2013||2013-08-01|August 2013|2013-08-01|July 2014|Anticipated|2014-07-01|April 2014|Anticipated|2014-04-01||Interventional|||Therapeutic Effects of Monochromatic Infrared Energy Therapy on Patients With Chronic Low Back Pain|Therapeutic Effects of Monochromatic Infrared Energy Therapy on Patients With Chronic Low Back Pain: A Double-Blind, Randomized, Placebo-Controlled Study|Unknown status|Recruiting|Phase 4|70|Anticipated|Taipei Medical University||2|||f||||t||||||||||2017-10-11 01:24:21.98403|2017-10-11 01:24:21.98403
NCT01920958|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-10-26|2015-05-07||September 2012||2012-09-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|SEAL|ITT population consisted of all patients who received patient information and who consented to the collection, transmission and evaluation of their data and who underwent lymph node resection with TachoSil®.|Use of Tachosil® for Lymph Sealing During Surgery|Use of Tachosil® for Lymph Sealing During Surgery. A Non-Interventional Study|Completed||N/A|233|Actual|Takeda|||1||f||||f||||||||||2017-10-11 01:24:22.130334|2017-10-11 01:24:22.130334
NCT01920945|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-10-24|||September 2014||2014-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study|OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study|Terminated||Phase 2|6|Actual|St. Luke's-Roosevelt Hospital Center||1||Difficult enrollment|f||||t||||||||||2017-10-11 01:24:22.502365|2017-10-11 01:24:22.502365
NCT01920932|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-08-29|||August 12, 2013|Actual|2013-08-12|August 2017|2017-08-01|April 30, 2025|Anticipated|2025-04-30|August 31, 2021|Anticipated|2021-08-31||Interventional|||Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma|Adcetris Substituting Vincristine in the OEPA/COPDac Regimen [Treatment Group 3 (TG3) of Euro-Net C1] With Low Dose Tailored-Field Radiation Therapy for Unfavorable Risk Pediatric Hodgkin Lymphoma|Recruiting||Phase 2|77|Anticipated|St. Jude Children's Research Hospital||1|||f||||t|t|f||||||||2017-10-11 01:24:22.607726|2017-10-11 01:24:22.607726
NCT01920919|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-11-18|||June 2013||2013-06-01|November 2014|2014-11-01||||August 2016|Anticipated|2016-08-01||Interventional|DEXSAR||Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis||Unknown status|Recruiting|Phase 3|76|Anticipated|St. Antonius Hospital||2|||f||||||||||||||2017-10-11 01:24:22.916181|2017-10-11 01:24:22.916181
NCT01920906|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-05-05|||January 2014||2014-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Comparative Analysis of Small and Large Plaque Psoriasis|Comparative Analysis of Small and Large Plaque Psoriasis|Completed||N/A|13|Actual|Rockefeller University||1|||f||||f||||||||||2017-10-11 01:24:23.020908|2017-10-11 01:24:23.020908
NCT01920893|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-06-07|2017-04-27|2015-11-03|August 2013||2013-08-01|June 2017|2017-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||Baseline population included all randomized participants.|An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis|A Randomized, Double-Blind, Phase 2, Placebo Controlled, 2 Arm Study To Evaluate Dupilumab In Patients With Bilateral Nasal Polyposis And Chronic Symptoms Of Sinusitis|Completed||Phase 2|60|Actual|Sanofi|Limitations of the trial such as small numbers of participants analysed or technical problems leading to unreliable data.|2|||f||||t||||||||||2017-10-11 01:24:23.121389|2017-10-11 01:24:23.121389
NCT01920880|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-11-14|||June 2013||2013-06-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Observational|||Nociceptive Processing in Acute Cutaneous Nerve Entrapment Syndrome|Nociceptive Processing in Acute Cutaneous Nerve Entrapment Syndrome: a Quantitative Sensory Testing Analysis.|Completed||N/A|50|Actual|Radboud University|||2||f||||f||||||||||2017-10-11 01:24:23.915894|2017-10-11 01:24:23.915894
NCT01920854|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-01-12|2014-12-11||June 2013||2013-06-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.|A Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study of Intravenously Administered SFP in Healthy Volunteers|Completed||Phase 1|48|Actual|Rockwell Medical Technologies, Inc.||2|||f||||f||||||||||2017-10-11 01:24:24.206827|2017-10-11 01:24:24.206827
NCT01920841|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-12-17|||June 2013||2013-06-01|December 2015|2015-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ThighCream||A Blinded Comparison Trial of Two Topical Creams to Reduce Thigh Girth and to Smooth Thigh Skin in Women|A Blinded Comparison Trial of Two Topical Creams to Reduce Thigh Girth and to Smooth Thigh Skin in Women.|Withdrawn||N/A|0|Actual|Pennington Biomedical Research Center||2||Study Design changed and will be resubmitted as a new study|f||||f||||||||||2017-10-11 01:24:28.091389|2017-10-11 01:24:28.091389
NCT01920828|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-09|||August 2013||2013-08-01|August 2013|2013-08-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Observational|||Gait Analysis in MPS IVA|Gait Analysis in Patients With MPS IVA Treated With Enzyme Replacement Therapy|Unknown status|Recruiting|N/A|10|Anticipated|Oregon Health and Science University|||1||f||||t||||||||||2017-10-11 01:24:28.170689|2017-10-11 01:24:28.170689
NCT01920815|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-04-05|||July 2013|Actual|2013-07-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|June 2016|Actual|2016-06-01|24 Months|Observational [Patient Registry]|||Bicuspid Valve Aortopathy Feasibility Study|Bicuspid Valve Aortopathy: Feasibility of a Comparative Effectiveness Study|Active, not recruiting||N/A|500|Anticipated|Oregon Health and Science University|||3||f||||t||||||||No||2017-10-11 01:24:28.249183|2017-10-11 01:24:28.249183
NCT01920802|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-01-30|2016-09-22||November 2012||2012-11-01|January 2017|2017-01-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo|Quantitative Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking the Antipsychotic Medications Fanapt (Iloperidone) or Zyprexa (Olanzapine) or Placebo|Completed||Phase 4|31|Actual|New York State Psychiatric Institute||3|||f||||f||||||||||2017-10-11 01:24:28.370003|2017-10-11 01:24:28.370003
NCT01920789|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2014-12-08|||January 2007||2007-01-01|December 2014|2014-12-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|SPACE||Stereotactic Precision And Conventional Radiotherapy Evaluation|A Multicenter Randomized Phase II Study of Stereotactic Hypofractionated Radiotherapy With Body Frame Versus Conventionally Fractionated Radiotherapy for Stage I Medically Inoperable Non-small Cell Lung Cancer|Unknown status|Active, not recruiting|N/A|102|Actual|Swedish Lung Cancer Study Group||2|||f||||f||||||||||2017-10-11 01:24:29.194398|2017-10-11 01:24:29.194398
NCT01920776|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-08-09|||July 2013||2013-07-01|August 2013|2013-08-01||||July 2014|Anticipated|2014-07-01||Interventional|||Focused Ultrasound in Septic Shock Patients||Unknown status|Recruiting|N/A|100|Anticipated|Peking Union Medical College Hospital||1|||f||||||||||||||2017-10-11 01:24:29.294703|2017-10-11 01:24:29.294703
NCT01920763|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-04-02|||July 2013||2013-07-01|August 2013|2013-08-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Observational|MiSPACE||Observational Study of Safety and Outcomes After Minimally Invasive Surgery for Intracerebral Hemorrhage|Clinical Outcomes Following Parafascicular Surgical Evaluation of Intracerebral Hemorrhage: A Pilot Study|Withdrawn||N/A|0|Actual|Ottawa Hospital Research Institute|||1|Lack of recruitment.|f||||f||||||||||2017-10-11 01:24:29.387412|2017-10-11 01:24:29.387412
NCT01920750|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-07-24|||January 1989||1989-01-01|August 2013|2013-08-01|February 1999|Actual|1999-02-01|February 1999|Actual|1999-02-01||Interventional|||Leprosy Skin Test Antigens Phase 1|Phase I Study to Evaluate New Leprosy Skin Test Antigens: MLSA-LAM and MLCwA|Completed||Phase 1|10|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||||||||||||||||2017-10-11 01:24:29.524922|2017-10-11 01:24:29.524922
NCT01920737|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-09-06|||August 2013||2013-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||"A Novel Pediatric-Inspired Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia"|"A Novel Pediatric-Inspired Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia"|Recruiting||Phase 2|39|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:24:29.644962|2017-10-11 01:24:29.644962
NCT01920724|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2013-08-08|||November 2010||2010-11-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Body Composition in Preschool Children|Body Composition and Dietary Intake in Preschool Children Aged 3-5 Years in Daycare Centers|Completed||N/A|137|Actual|Mahidol University|||1||f||||f||||||Samples Without DNA|"     Urine samples   "|||2017-10-11 01:24:29.817149|2017-10-11 01:24:29.817149
NCT01920698|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-09-21|||November 2013||2013-11-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|MITRA-FR||Multicentre Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral Regurgitation|Multicentre Randomized Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral Regurgitation.|Unknown status|Recruiting|Phase 3|288|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:24:32.389168|2017-10-11 01:24:32.389168
NCT01920685|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-03-16|||January 2014||2014-01-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|CITADEL||Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial|Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial|Completed||N/A|25|Actual|King's College London||2|||f||||f||||||||||2017-10-11 01:24:32.6496|2017-10-11 01:24:32.6496
NCT01920672|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-08|||September 2013||2013-09-01|August 2013|2013-08-01||||June 2015|Anticipated|2015-06-01||Interventional|||Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD|Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of Alzheimer's Disease (AD)|Unknown status|Not yet recruiting|Phase 1/Phase 2|54|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 01:24:32.756832|2017-10-11 01:24:32.756832
NCT01920659|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-12-02|||April 2012||2012-04-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|METAPREDICT||METAPREDICT: Developing Predictors of the Health Benefits of Exercise for Individuals|Developing Predictors of the Health Benefits of Exercise for Individuals|Completed||N/A|188|Actual|Loughborough University||3|||f||||f||||||||||2017-10-11 01:24:32.843509|2017-10-11 01:24:32.843509
NCT01920646|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-09|||February 2012||2012-02-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|ALV||Effect of African Leafy Vegetables on Nutritional Status of South African School Children.|The Effect of African Leafy Vegetables on Nutritional Status (Including Iron, Zinc and Vitamin A Status) of School Children Residing in Semi-rural Farm Community in the North West Province of South Africa|Completed||N/A|171|Actual|North-West University, South Africa||2|||f||||||||||||||2017-10-11 01:24:32.943199|2017-10-11 01:24:32.943199
NCT01920633|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-07-17|||October 31, 2013|Actual|2013-10-31|July 2017|2017-07-01|January 31, 2015|Actual|2015-01-31|January 31, 2015|Actual|2015-01-31||Observational|||A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)|A Screening Protocol to Assess Adult and Adolescent Individuals With Down Syndrome for Eligibility to Participate in an Upcoming Study to Evaluate the Efficacy, Safety and Tolerability of RG1662 (Study BP27832)|Completed||N/A|135|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:24:33.017923|2017-10-11 01:24:33.017923
NCT01920620|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-01-19|||January 2011||2011-01-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Inpatient Obesity Intervention With Phone Follow-up|Inpatient Obesity: Can Weight Loss Intervention During Hospitalization Lead to Sustained Weight Loss at Six Months Following Discharge?|Completed||N/A|176|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 01:24:33.263237|2017-10-11 01:24:33.263237
NCT01920607|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-06-23|||November 2013||2013-11-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|December 2016|Actual|2016-12-01||Interventional|MOS STIC||Medical and Economic Evaluation of a Magnetic Anal Sphincter for Patients With Severe Anal Incontinence|Medical and Economic Evaluation of a Magnetic Anal Sphincter for Patients With Severe Anal Incontinence|Suspended||N/A|71|Actual|Nantes University Hospital||2||recruitment difficulties|f||||f||||||||||2017-10-11 01:24:33.353218|2017-10-11 01:24:33.353218
NCT01920581|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-09|||February 2012||2012-02-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Observational|||Use of Benzodiazepines and Z Drugs in the Elderly|Assessment of Problematic Use of Benzodiazepines and Z Drugs in the Elderly in France: a Public Health Issue|Unknown status|Recruiting|N/A|1100|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 01:24:33.582077|2017-10-11 01:24:33.582077
NCT01920568|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-11-29|2016-05-16||August 2013||2013-08-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors|DCA114273: A Study Comparing Denosumab With Zoledronic Acid in Subjects of Asian Ancestry With Bone Metastases From Solid Tumors|Completed||Phase 3|487|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:24:33.710546|2017-10-11 01:24:33.710546
NCT01920555|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2017-03-16|||December 2014||2014-12-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)|Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)|Completed||Phase 2|99|Actual|Massachusetts General Hospital||5|||f||||t||||||||||2017-10-11 01:24:35.42816|2017-10-11 01:24:35.42816
NCT01920542|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-11-08|||September 2013||2013-09-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Dexmedetomidine on Pediatric Heart Operation|Renal Effects of Dexmedetomidine During Pediatric Cardiac Surgery: a Randomized Placebo-controlled Study|Completed||N/A|30|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||Undecided||2017-10-11 01:24:35.585325|2017-10-11 01:24:35.585325
NCT01920529|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-08-08|||August 2011||2011-08-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|AECA||Aerobic Exercise in Children With Moderate and Severe Asthma|Effectiveness of a Physical Training Program on Inflammatory Response, Functional Capacity and Quality Life in Children With Moderate and Severe Asthma.|Completed||N/A|50|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||f||||||||||2017-10-11 01:24:35.697952|2017-10-11 01:24:35.697952
NCT01920516|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-08-02|||July 2013||2013-07-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|June 2019|Anticipated|2019-06-01||Observational|ILI||Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment|Prospective Observational Study on Isolated Limb Perfusion of Melphalan in Treating Patients With Metastasis or Recidivism of Limb Melanoma or Sarcoma That Are Not Operable|Recruiting||N/A|40|Anticipated|International Group of Endovascular Oncology|||1||f||||t||||||||||2017-10-11 01:24:35.829929|2017-10-11 01:24:35.829929
NCT01920503|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-08-02|||July 2013||2013-07-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|July 2019|Anticipated|2019-07-01|12 Months|Observational [Patient Registry]|CHOLANGIO||International Registry on Cholangiocarcinoma Treatment|International Registry on Cholangiocarcinoma Treatment|Recruiting||N/A|40|Anticipated|International Group of Endovascular Oncology|||1||f||||t||||||||||2017-10-11 01:24:35.981845|2017-10-11 01:24:35.981845
NCT01920490|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-07-21|||May 2013||2013-05-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|GUIMRINFB1||Blame Rebalance fMRI Feedback Proof-of-concept|Rebalancing Blame Using fMRI Neurofeedback: a Double-blind Controlled Clinical Proof-of-concept Trial in Remitted Major Depressive Disorder|Completed||N/A|32|Actual|D'Or Institute for Research and Education||2|||f||||f||||||||||2017-10-11 01:24:36.114648|2017-10-11 01:24:36.114648
NCT01920477|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-05-23|||August 13, 2013|Actual|2013-08-13|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris|OPV116910: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Ofatumumab Injection for Subcutaneous Use in Subjects With Pemphigus Vulgaris|Active, not recruiting||Phase 3|35|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:24:36.247178|2017-10-11 01:24:36.247178
NCT01920464|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-09-11|||April 2013||2013-04-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|flixovate HAS||Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians|Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians|Completed||N/A|160|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 01:24:36.419098|2017-10-11 01:24:36.419098
NCT01920451|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-08-04|||August 2013||2013-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Blood Pressure, Heart Rate Variability & Sleep in Veterans With PTSD|Is Reduced Blood Pressure a Consequence of Improved Sleep in Veterans With PTSD?|Terminated||N/A|19|Actual|Durham VA Medical Center||2||PI started new position.|f||||f||||||||||2017-10-11 01:24:36.473978|2017-10-11 01:24:36.473978
NCT01920438|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-09|||December 2011||2011-12-01|August 2013|2013-08-01|August 2017|Anticipated|2017-08-01|August 2014|Anticipated|2014-08-01||Interventional|PEG Vs RIG||Outcome Study of Endoscopically Inserted Gastrostomy (PEG)Versus Radiologically-guided Insertion of Gastrostomy (RIG)in Children|PEG Vs RIG: Percutaneous Endoscopic Gastrostomy Versus Radiologically Inserted Gastrostomy in Children|Unknown status|Recruiting|N/A|200|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:24:36.557574|2017-10-11 01:24:36.557574
NCT01920425|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-01-08|||July 2013||2013-07-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Kinesia HomeView - Home Diary Comparison|Kinesia HomeView - Home Diary Comparison|Completed||N/A|2|Actual|Great Lakes NeuroTechnologies Inc.||2|||f||||||||||||||2017-10-11 01:24:36.649607|2017-10-11 01:24:36.649607
NCT01920412|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-10-15|||October 2012||2012-10-01|August 2013|2013-08-01|September 2014|Anticipated|2014-09-01|October 2013|Anticipated|2013-10-01||Interventional|||Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder|A Prospective, Non-randomized, Multicenter, Open-label, Non-comparative, First-in-Man Study to Evaluate the Feasibility and Safety of LAmbre Left Atrial Appendage Occluder|Unknown status|Recruiting|Early Phase 1|20|Anticipated|Lifetech Scientific (Shenzhen) Co., Ltd.||1|||f||||t||||||||||2017-10-11 01:24:36.740009|2017-10-11 01:24:36.740009
NCT01920399|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-09-01|||October 2013||2013-10-01|September 2017|2017-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects|A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Ceftazidime-Avibactam Administered as Single and Repeated Intravenous Doses in Healthy Chinese Subjects|Completed||Phase 1|42|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:24:36.998144|2017-10-11 01:24:36.998144
NCT01920386|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-10-11|||June 2013||2013-06-01|October 2016|2016-10-01||||September 2013|Actual|2013-09-01||Interventional|||Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patients After Teeth Extraction Surgery|A Randomized, Double-blind, Active-controlled, Parallel, Multicenter Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patients After Teeth Extraction Surgery|Completed||Phase 3|240|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 01:24:37.107707|2017-10-11 01:24:37.107707
NCT01920373|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2015-03-10|||November 2013||2013-11-01|March 2015|2015-03-01||||November 2013|Actual|2013-11-01||Interventional|||Platelet-Rich Plasma vs Corticosteroid Injection as Treatment for Degenerative Pathology of the Temporomandibular Joint|Platelet-Rich Plasma Versus Corticosteroid Injection as Treatment for Degenerative Pathology of the Temporomandibular Joint|Withdrawn||Phase 1|0|Actual|Kaiser Permanente||2||The study was cancelled.|f||||t||||||||||2017-10-11 01:24:37.173866|2017-10-11 01:24:37.173866
NCT01920360|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-08-10|||February 2011||2011-02-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Evaluation Study of the Effects of Sulphurous Water in the Treatment of Knee Osteoarthritis.|Study of the Effects of Immersion Baths in Sulphurous Water in Patients With Knee Osteoarthritis: Randomized Controlled Clinical Trial.|Completed||N/A|140|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-10-11 01:24:37.26275|2017-10-11 01:24:37.26275
NCT01920347|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-02-16|||May 2013||2013-05-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|NPI-ON-ICU||The Neurological Pupil Index (NPi) on Intensive Care Unit (ICU) Trial|Prospective Pilot Trial to Evaluate the NeurOptics Pupillometer and Clinical Examination of the Pupillary Reflex After Cardiac Arrest|Completed||N/A|100|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 01:24:37.360242|2017-10-11 01:24:37.360242
NCT01920334|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-08|||July 2013||2013-07-01|August 2013|2013-08-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Interventional|||Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients|Effects of Zolpidem CR in Sleep and Clinical Outcomes of Patients in Cardiac Intensive Care Unit|Unknown status|Recruiting|Phase 4|100|Anticipated|Associação Fundo de Incentivo à Pesquisa||2|||f||||f||||||||||2017-10-11 01:24:37.440202|2017-10-11 01:24:37.440202
NCT01920321|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-08-08|||February 2013||2013-02-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|BTSA||Bronchoscopic Thermal Saline Ablation (BTSA) of Emphysematous Lung. A New Emphysema Therapy|Lung Volume Reduction in COPD Patients With an Inhomogeneous Severe Emphysema Located in the Upper Lobes, by Injecting Warm Saline Through the Bronchoscope Channel|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Assaf-Harofeh Medical Center||1|||f||||t||||||||||2017-10-11 01:24:37.553662|2017-10-11 01:24:37.553662
NCT01920308|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2016-11-09|||August 2013||2013-08-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|April 2014|Actual|2014-04-01||Observational|REALITY||A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY)|A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY)|Completed||N/A|30|Actual|C. R. Bard|||1||f||||f||||||||||2017-10-11 01:24:37.641597|2017-10-11 01:24:37.641597
NCT01920295|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-08-07|||January 2011||2011-01-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|C-frost||Safety and Efficacy of Cryoballoon Ablation of Atrial Fibrillation as First-line Therapy||Completed||N/A|60|Actual|Yuksek Ihtisas Hospital||4|||f||||t||||||||||2017-10-11 01:24:37.714143|2017-10-11 01:24:37.714143
NCT01912235|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-08-07|||September 2007||2007-09-01|August 2013|2013-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Arginine Synthesis in Healthy Adult Humans|Arginine Synthesis in Healthy Adult Humans: Does Proline or Glutamate Provide the 5-Carbon Chain?|Completed||N/A|6|Actual|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-11 01:26:28.139917|2017-10-11 01:26:28.139917
NCT01920282|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-03-18|2015-12-16||January 2010||2010-01-01|March 2016|2016-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Nebivolol, Lifestyle Modification and Arterial Stiffness|Effect of Nebivolol and Lifestyle Modification on Large Artery Stiffness in Middle-Aged and Older Hypertensive Adults|Completed||Phase 4|45|Actual|Virginia Polytechnic Institute and State University||3|||f||||t||||||||||2017-10-11 01:24:37.807757|2017-10-11 01:24:37.807757
NCT01920269|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-08|||January 1994||1994-01-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|December 2004|Actual|2004-12-01||Interventional|EMDA/MMC||Intravesical Adjuvant Electromotive Mitomycin-C|Intravesical Adjuvant Electromotive Mitomycin-C in Patients With pTa-pT1 and G1-G2 Non-muscle Invasive Bladder Cancer: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|331|Actual|University of Rome Tor Vergata||3|||f||||t||||||||||2017-10-11 01:24:38.312856|2017-10-11 01:24:38.312856
NCT01920256|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-04-05|||August 2013||2013-08-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|March 2016|Actual|2016-03-01||Interventional|||Provider-Initiated Regular Remote Interventions for Optimal Type 2 Diabetes Care|Provider-Initiated Regular Remote Interventions for Optimal Type 2 Diabetes Care|Active, not recruiting||N/A|60|Anticipated|University of Michigan||2|||f||||t||||||||No|Experimental group patients informed of A1C results.|2017-10-11 01:24:38.419894|2017-10-11 01:24:38.419894
NCT01920243|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-03-10|||October 28, 2013|Actual|2013-10-28|March 2017|2017-03-01|February 21, 2017|Actual|2017-02-21|February 21, 2017|Actual|2017-02-21||Interventional|||Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)|Applying Health Mechanics to Enhance Bowel and Bladder Health for Persons With SCI|Completed||N/A|63|Actual|University of Michigan||4|||f||||t||||||||||2017-10-11 01:24:38.512487|2017-10-11 01:24:38.512487
NCT01920230|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-12-01|||March 2013||2013-03-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|Muupu||The Effectiveness of Mindfulness Practices in the Recovery of Burnout|The Effectiveness of Mindfulness Practices in the Recovery of Burnout|Active, not recruiting||N/A|200|Anticipated|University of Jyvaskyla||2|||f||||f||||||||||2017-10-11 01:24:38.621437|2017-10-11 01:24:38.621437
NCT01920217|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2013-08-08|||January 2013||2013-01-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|January 2015|Anticipated|2015-01-01|28 Days|Observational [Patient Registry]|||Identification Sepsis Related Single Nucleotide Polymorphism (SNP) by Whole Exome Sequencing|Identification Sepsis Related SNP by Whole Exome Sequencing: a Prospective Observational Study|Unknown status|Recruiting|N/A|1000|Anticipated|Chinese PLA General Hospital|||2||f||||t||||||Samples With DNA|"     whole blood sample   "|||2017-10-11 01:24:38.736987|2017-10-11 01:24:38.736987
NCT01920204|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2015-01-15|||August 2013||2013-08-01|January 2015|2015-01-01|May 2015|Anticipated|2015-05-01|March 2015|Anticipated|2015-03-01||Interventional|||Midostaurin in Indolent Systemic Mastocytosis|Phase II Single Arm Open Pilot Study to Demonstrate the Efficacy of Midostaurin in Symptom Improvement and Decrease of Mast Cell Burden in Patients With Indolent or Smoldering Systemic Mastocytosis.|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 01:24:38.827192|2017-10-11 01:24:38.827192
NCT01920191|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-04-19|||August 2013||2013-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma|Phase I/II Study of Intradermal IMA950 Peptide-based Vaccine Adjuvanted With Intra Muscular Poly-ICLC in Combination With Temozolomide in Newly Diagnosed HLA-A2 Glioblastoma Patients|Completed||Phase 1/Phase 2|19|Actual|University Hospital, Geneva||1|||f||||t||||||||||2017-10-11 01:24:38.939503|2017-10-11 01:24:38.939503
NCT01920178|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-04-18|2016-07-15||April 2013||2013-04-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis|A Placebo Controlled, Randomized, Prospective Study to Evaluate the Efficacy and Safety of PinPointe FootLaser in Patients Who Have Failed Oral Terbinafine Treatment for Onychomycosis|Terminated||N/A|7|Actual|Cambridge Health Alliance|Withdrawal of financial support by Nuvolase, Inc in June, 2014 with very small enrollment of only 7 subjects ( 40 originally anticipated) led to loss of vital Primary and Secondary Outcome Measures with no reliable or interpretable data produced.|2||"Financial support of the Study withdrawn by Nuvolase, Inc ( PinPointe FootLaser) due to delayed   start of the Study and inadequate subjects enrolled"|f||||f||||||||No||2017-10-11 01:24:39.055116|2017-10-11 01:24:39.055116
NCT01920165|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-09|||January 2001||2001-01-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Smoking Ban and Paediatric Hospital Admissions for Respiratory Tract Infections in England|Smoke-free Legislation in England and Hospital Admissions for Respiratory Tract Infections Among Children|Completed||N/A|1660652|Actual|University of Edinburgh|||1||f||||f||||||||||2017-10-11 01:24:39.364465|2017-10-11 01:24:39.364465
NCT01920152|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-08-18|||August 2013||2013-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Platelet Rich Plasma vs Hyaluronic-Acid in Hip OA (Osteoarthritis)|A Randomized Clinical Trial Evaluating Platelet Rich Plasma Versus Hyaluronic-Acid in the Short-term Treatment of Symptomatic OA (Osteoarthritis) of the Hip|Enrolling by invitation||N/A|80|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 01:24:39.479224|2017-10-11 01:24:39.479224
NCT01920139|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-08-06|||December 2008||2008-12-01|August 2013|2013-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy|Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy in Patients Suspected of Having Breast Cancer.|Completed||N/A|105|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 01:24:39.588173|2017-10-11 01:24:39.588173
NCT01920126|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-06-20|||August 2013||2013-08-01|June 2016|2016-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Sodium Bicarbonate on Postoperative Renal Function in Infective Endocarditis Patients Undergoing Open Heart Surgery||Recruiting||Phase 4|70|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 01:24:39.668759|2017-10-11 01:24:39.668759
NCT01920113|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-01-07|||October 2012||2012-10-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil||Completed||N/A|60|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:24:39.76009|2017-10-11 01:24:39.76009
NCT01920100|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-10-18|||April 2009||2009-04-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2015|Actual|2015-01-01||Observational|REDIC||Resource Use and Disease Course in Dementia (REDIC)|Resource Use and Disease Course in Dementia (REDIC)|Active, not recruiting||N/A|2800|Anticipated|Sykehuset Innlandet HF|||4||f||||f||||||Samples With DNA|"     DNA samples are collected by mouth swabs from persons recruited from nursing homes.   "|Yes|On request|2017-10-11 01:24:39.855687|2017-10-11 01:24:39.855687
NCT01920087|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-08|2014-03-12|||March 2014||2014-03-01|March 2014|2014-03-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Interventional|AFP||Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain|Phase II Double Blind, Randomized, Placebo Controlled, Safety and Efficacy Study of ATNC05 in Patients With Atypical Facial Pain With an Open-Label Extension Phase for Nonresponders|Withdrawn||Phase 2/Phase 3|0|Actual|Allodynic Therapeutics, LLC||2|||f||||f||||||||||2017-10-11 01:24:39.963978|2017-10-11 01:24:39.963978
NCT01920074|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2015-05-01|||June 2013||2013-06-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure|A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure|Withdrawn||Phase 4|0|Actual|Forest Laboratories||1||"Study stopped due to study enrollment challenges that impacted the feasibility of conducting   the study."|f||||f||||||||||2017-10-11 01:24:40.099519|2017-10-11 01:24:40.099519
NCT01920061|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-09-28|||September 10, 2013|Actual|2013-09-10|September 2017|2017-09-01|December 18, 2019|Anticipated|2019-12-18|December 18, 2019|Anticipated|2019-12-18||Interventional|||A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)|A Phase 1b Open-label Three-arm Multi-center Study To Assess The Safety And Tolerability Of Pf-05212384 (pi3k/Mtor Inhibitor) In Combination With Other Anti-tumor Agents|Recruiting||Phase 1|124|Anticipated|Pfizer||5|||f||||f||||||||||2017-10-11 01:24:40.217375|2017-10-11 01:24:40.217375
NCT01920048|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2016-07-20|||August 2013||2013-08-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|REVIVED-BCIS2||Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure|REVascularisation for Ischaemic VEntricular Dysfunction (REVIVED): a Randomized Comparison of Percutaneous Coronary Intervention (With Optimal Medical Therapy) Versus Optimal Medical Therapy Alone for Treatment of Heart Failure Secondary to Coronary Disease|Recruiting||N/A|700|Anticipated|King's College London||2|||f||||t||||||||||2017-10-11 01:24:40.445785|2017-10-11 01:24:40.445785
NCT01920035|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-11-03|||May 2013||2013-05-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|October 2014|Actual|2014-10-01||Interventional|UroCool||Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence|A Randomized, Controlled Study of the Use of Localized Endorectal Cooling Using the UroCool System During Robotic-Assisted Radical Prostatectomy (RARP) to Minimize Trauma and to Provide Earlier Return to Continence|Unknown status|Active, not recruiting|N/A|200|Actual|Philips Healthcare||2|||f||||t||||||||||2017-10-11 01:24:40.637519|2017-10-11 01:24:40.637519
NCT01920022|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-02-24|||October 2013||2013-10-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Quickstart of Nexplanon® at Medical Abortion|Early Versus Delayed Insertion of Nexplanon® at Medical Abortion - a Randomized Controlled Equivalence Trial.|Completed||Phase 4|551|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 01:24:40.728184|2017-10-11 01:24:40.728184
NCT01920009|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-04-30|||September 2013||2013-09-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|Pharmacycare||Impact of Motivational Interviews Within Pharmacy Care Upon Adherence to Cardiovascular Medicines|Feasibility and Potential Impact of Community Pharmacy Care Including Motivational Interviews on Adherence to Secondary Prevention Medication in Patients With Coronary Heart Diseases|Completed||N/A|200|Anticipated|University College, London||2|||f||||f||||||||||2017-10-11 01:24:40.840162|2017-10-11 01:24:40.840162
NCT01919996|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-07-06|2016-03-28||December 2013||2013-12-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional||The safety population included all enrolled participants that took at least one dose of study medication.|PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients|Ocular Effects Of Azithromycin Oral Solution In Pediatric Patients With Pharyngitis/Tonsillitis|Terminated||Phase 2|8|Actual|Pfizer|The study was terminated after the FDA released the Sponsor from the PMC. The FDA deemed the study as impracticable, given the azithromycin dose studied in the PMC was not used and the available data did not identify a signal for ocular toxicity.|1||See Termination Statement in the Detailed Description below|f||||f||||||||||2017-10-11 01:24:40.969096|2017-10-11 01:24:40.969096
NCT01919983|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-07|||March 2012||2012-03-01|August 2013|2013-08-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|||Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death|Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death|Unknown status|Recruiting|N/A|100|Anticipated|Johns Hopkins University|||1||f||||t||||||Samples With DNA|"     Blood Sample   "|||2017-10-11 01:24:41.532955|2017-10-11 01:24:41.532955
NCT01919970|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-05-02|||August 2013||2013-08-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety|Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety|Active, not recruiting||N/A|50|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-11 01:24:41.662942|2017-10-11 01:24:41.662942
NCT01919957|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-02-05|||October 2013||2013-10-01|February 2015|2015-02-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|MemO-Epi||Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies|Etude de la mémoire Avant et après Chirurgie d'Une épilepsie Partielle pharmacorésistante : Bases Neurobiologiques, Applications Cliniques|Recruiting||N/A|120|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 01:24:41.787231|2017-10-11 01:24:41.787231
NCT01919944|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-06-01|||August 2013||2013-08-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P|A Randomized, Double-Blind, Placebo-Controlled, Four-Way Crossover Study on Itch Control by VLY-686 Administration in Healthy Volunteers After Intradermal Injections of Substance P|Completed||Phase 1|12|Actual|Vanda Pharmaceuticals||4|||f||||f||||||||||2017-10-11 01:24:41.911025|2017-10-11 01:24:41.911025
NCT01919931|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-12-06|||March 2013||2013-03-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Observational|||Immunological Interaction Between the Host and Candida Albicans Biofilm|Immunological and Molecular Interaction Between the Host and Candida Albicans Biofilm|Completed||N/A|237|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||||||||None Retained|"     Samples to be retained: whole blood, Plasma and White cells.   "|||2017-10-11 01:24:42.031582|2017-10-11 01:24:42.031582
NCT01919918|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-01-03|||September 2013||2013-09-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Muscle Afferent Feedback Effects in Patients With Heart Failure|Muscle Afferent Feedback Effects in Patients With Heart Failure: The Development of Central Fatigue|Recruiting||Phase 1|144|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-11 01:24:42.118999|2017-10-11 01:24:42.118999
NCT01919905|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2013-08-06|||January 2012||2012-01-01|August 2013|2013-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Mozzarella Cheese Vitamin D and Bioavailability|Fortification of Mozzarella Cheese With Vitamin D3: Effect of High Temperature Cooking and Bioavailability of Vitamin D3|Completed||N/A|100|Actual|University of Toronto||2|||f||||t||||||||||2017-10-11 01:24:42.231027|2017-10-11 01:24:42.231027
NCT01919892|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-08-06|||September 2010||2010-09-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium|Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium in Bipolar Disorder: Identification of Cellular and Molecular Targets Clinically Relevant|Completed||Phase 4|30|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 01:24:42.347816|2017-10-11 01:24:42.347816
NCT01919879|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-06-16|||October 2012||2012-10-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|November 2015|Actual|2015-11-01||Interventional|||Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal Cancer|A Multicentric Randomized Phase II Trial Evaluating Dual Targeting of EGFR Using the Combination of Cetuximab and Afatinib Versus Cetuximab Alone in Patients With Chemotherapy Refractory wtKRAS Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|75|Actual|UNICANCER||2|||f||||t||||||||||2017-10-11 01:24:42.448221|2017-10-11 01:24:42.448221
NCT01919866|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-10-07|||March 2004||2004-03-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells|Haploidentical Stem Cell Transplantation With CD3/CD19 Depleted Stem Cells in Pediatric Patients With Refractory Hematological and Oncological Diseases|Unknown status|Recruiting|Phase 1/Phase 2|120|Anticipated|University Children’s Hospital Tuebingen||1|||f||||t||||||||||2017-10-11 01:24:42.545149|2017-10-11 01:24:42.545149
NCT01919853|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-12-31|||September 2012||2012-09-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response|Treatment for Breast and Colorectal Cancer Survivors With Persistent Cancer-Related Fatigue: A Randomized Controlled Trial|Completed||Phase 2|107|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 01:24:42.811869|2017-10-11 01:24:42.811869
NCT01919840|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2013-08-08|||February 2010||2010-02-01|August 2013|2013-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ROTEM-2010||Blood Products Transfusion in Cardiac Surgery After the Implementation of a Coagulation Monitoring System at Patient Bedside: Thromboelastometry Versus Standard Transfusion Protocol|Indicación de transfusión de Hemoderivados en el Postoperatorio de cirugía Cardiaca Tras la implantación de un Sistema de monitorización de la coagulación a la Cabecera Del Paciente: Tromboelastometría Versus Protocolo Habitual de transfusión|Terminated||Phase 4|49|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2||Low recruitment after the expected time to finish the study|f||||f||||||||||2017-10-11 01:24:42.957917|2017-10-11 01:24:42.957917
NCT01919827|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-01-05|||March 2013||2013-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CMM/FPI||Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis|Treatment of Idiopathic Pulmonary Fibrosis With Bone Marrow Derived Mesenchymal Stem Cells|Active, not recruiting||Phase 1|17|Actual|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||t||||||||||2017-10-11 01:24:43.080781|2017-10-11 01:24:43.080781
NCT01919814|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-12-17|||July 2013||2013-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Pizza||A Short-Term Appetite Suppression Trial Using Appethyl™: The Pizza|A Short-Term Appetite Suppression Trial Using Appethyl™: The Pizza|Completed||N/A|60|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 01:24:43.223779|2017-10-11 01:24:43.223779
NCT01919801|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-07-07|2016-08-16||December 2013||2013-12-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Intent-to-treat (ITT) population included all randomized participants.|Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema|Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study Evaluating the Safety & Efficacy of Icatibant as a Treatment for Angiotensin-Converting Enzyme Inhibitor (ACE-I)-Induced Angioedema in Adults|Completed||Phase 3|118|Actual|Shire||2|||f||||t||||||||||2017-10-11 01:24:43.343938|2017-10-11 01:24:43.343938
NCT01919788|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-02-23|||August 2013||2013-08-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose|Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose|Completed||N/A|9|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 01:24:44.153498|2017-10-11 01:24:44.153498
NCT01919775|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-07|||December 2007||2007-12-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01|6 Years|Observational [Patient Registry]|||Amnesia After Surgery for Anterior Communicating Aneurysm： High Resolution Magnetic Resonance (MR) Imaging Findings|Basal Forebrain Amnesia After Surgery for Anterior Communicating Aneurysm： High Resolution 3-dimensional (3D) Magnetic Resonance (MR) Imaging Findings|Completed||N/A|14|Actual|Tohoku University|||1||f||||f||||||||||2017-10-11 01:24:44.273713|2017-10-11 01:24:44.273713
NCT01919762|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2015-09-25|||August 2013||2013-08-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|DIREBT||Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)|Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)-Part I (Prospective Collection and Freezing of Whole Blood Specimens)|Completed||N/A|156|Actual|T2 Biosystems|||2||f||||f||||||Samples With DNA|"     Whole blood specimens, in addition to bacterial isoaltes   "|||2017-10-11 01:24:44.407033|2017-10-11 01:24:44.407033
NCT01919749|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-11-17|||August 2013||2013-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|SO2||A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer|A Pilot Study Utilizing Proteomic and Genomic Profiling by Reverse Phase Protein Microarray (RPMA), IHC Analysis, RNA Seq, and Exome Sequencing of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer|Completed||N/A|25|Actual|Translational Drug Development||1|||f||||f||||||||||2017-10-11 01:24:44.520259|2017-10-11 01:24:44.520259
NCT01919736|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-07-12|||September 2013||2013-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Loaded and Unloaded Magnetic Resonance (MR) Imaging of Meniscus-Cartilage-Trabecular Bone in Osteoarthritis|Loaded and Unloaded Magnetic Resonance (MR) Imaging of Meniscus-Cartilage-Trabecular Bone in Osteoarthritis|Active, not recruiting||N/A|30|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:24:44.63178|2017-10-11 01:24:44.63178
NCT01919723|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-01-09|2016-09-27||February 2014||2014-02-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion|Pharmacodynamic Effects of Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion in Patients Undergoing Percutaneous Coronary Intervention|Completed||Phase 2|70|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 01:24:44.733825|2017-10-11 01:24:44.733825
NCT01919710|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-06-02|||October 2012||2012-10-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia|Phase 1 Study of rHSA/GCSF in Neutropenia After Chemotherapy of Cancer Patients|Completed||Phase 1|29|Actual|Tianjin SinoBiotech Ltd.||1|||f||||t||||||||||2017-10-11 01:24:45.131438|2017-10-11 01:24:45.131438
NCT01919697|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-08-11||2016-08-11|August 2013||2013-08-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)|An Open-Label Extension (OLE), Long-term Safety and Tolerability Study of Plecanatide in Patients With Chronic Idiopathic Constipation (CIC)|Completed||Phase 3|2370|Actual|Synergy Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-11 01:24:45.261782|2017-10-11 01:24:45.261782
NCT01919684|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-09-22|||November 2013||2013-11-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus|Double-blind, Placebo-controlled, Randomized, Ascending Single Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LGD-6972 in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|56|Actual|Ligand Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:24:45.881422|2017-10-11 01:24:45.881422
NCT01919671|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-01-03|||March 2014||2014-03-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|||Tongxinluo Capsule in Ischemic Stroke Patients（TISS)|A Randomized, Double-blind, Placebo Controlled Evaluation, Multicenter Clinical Study of Tongxinluo Capsule in Ischemic Stroke Patients|Completed||Phase 4|2007|Actual|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||No||2017-10-11 01:24:45.95766|2017-10-11 01:24:45.95766
NCT01919658|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-11-03|||July 2013||2013-07-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Femoral vs Saphenous Nerve Blocks on Function After ACL Repair|Effects of Femoral Versus Saphenous Nerve Blocks on Knee Extensor Strength, Pain, and Patient-Perceived Physical Function Following ACL Reconstruction|Recruiting||N/A|20|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 01:24:46.046889|2017-10-11 01:24:46.046889
NCT01919645|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2016-08-31|||July 2012||2012-07-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SRA||Effectiveness and Safety of Physical Exercises in the Improvement of the Sleep Quality. Regarding Rheumatoid Arthritis|Effectiveness and Safety of Physical Exercises in the Improvement of the Sleep Quality in Women With Rheumatoid Arthritis: A Randomized Clinical Trial Study|Completed||N/A|43|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 01:24:46.125819|2017-10-11 01:24:46.125819
NCT01919632|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2015-05-11|||October 2009||2009-10-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MOVING||MOVING - MOtiVation, INtervention and Vascular chanGe|MOVING - Einfluß Eines Lebensstilprogramms Auf Gefaeßzustand, Metabolisches Risikoprofil Und Leistungsfaehigkeit (MOVING - Influence of a Lifestyle Intervention Program on Vascular Condition, Metabolic Risk Profile and Physical Performance)|Completed||N/A|330|Anticipated|Technische Universität München||1|||f||||f||||||||||2017-10-11 01:24:46.197811|2017-10-11 01:24:46.197811
NCT01919619|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-04-21|||November 2013|Actual|2013-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Lenalidomide and Ipilimumab Post Allo or Auto Stem Cell Transplantation (SCT)|A Pilot Study of Lenalidomide Alternating With Ipilimumab Post Allogeneic and Autologous Stem Cell Transplantation|Recruiting||Early Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:24:46.289098|2017-10-11 01:24:46.289098
NCT01919606|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-04-07|2014-04-15||August 2012||2012-08-01|April 2016|2016-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||EXPAREL Administered Into the TAP for Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy|Evaluation of the Safety and Efficacy of EXPAREL(R) (Bupivacaine Liposome Injectable Suspension) When Administered Into the Transversus Abdominis Plane (TAP) for Prolonged Postoperative Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy|Terminated||Phase 4|1|Actual|Pacira Pharmaceuticals, Inc||2||Lack of enrollment|f||||f||||||||||2017-10-11 01:24:46.398873|2017-10-11 01:24:46.398873
NCT01919593|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-09|||January 2012||2012-01-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of 2% Chlorhexidine Gluconate in 70% Alcohol Compare 10% Povidone Iodine in Blood Culture in Children|The Efficacy of 2% Chlorhexidine Gluconate in 70% Alcohol Compared With 10% Povidone Iodine in Reducing Blood Culture Contamination in Pediatric Patients|Completed||Phase 4|1269|Actual|Thammasat University||2|||f||||f||||||||||2017-10-11 01:24:46.6299|2017-10-11 01:24:46.6299
NCT01918657|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-22|2014-09-08|||February 2014||2014-02-01|September 2014|2014-09-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Walnut Oral Immunotherapy for Tree Nut Allergy|Walnut Oral Immunotherapy for Tree Nut Allergy-CHOP|Withdrawn||N/A|0|Actual|Children's Hospital of Philadelphia||2||Unable to get an IND from the FDA for the walnut powder|f||||t||||||||||2017-10-11 01:24:58.117657|2017-10-11 01:24:58.117657
NCT01919580|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-04-14|||December 2012||2012-12-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|April 2014|Actual|2014-04-01||Observational|||Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor.|Observational Study on the Carcinogenesis of Gα12 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using Ga12 Inhibitor.|Unknown status|Recruiting|N/A|255|Anticipated|National Taiwan University Hospital|||3||f||||t||||||Samples With DNA|"     tissue, serum, saliva   "|||2017-10-11 01:24:48.492041|2017-10-11 01:24:48.492041
NCT01919567|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-12-08|||November 2011||2011-11-01|November 2013|2013-11-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.|Observational Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using SOX-9 Inhibitor.|Unknown status|Recruiting|N/A|255|Anticipated|National Taiwan University Hospital|||3||f||||t||||||Samples With DNA|"     tissue, serum, saliva   "|||2017-10-11 01:24:48.578895|2017-10-11 01:24:48.578895
NCT01919554|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-01-03|||July 2013||2013-07-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents|Investigation of the Safety and Tolerability of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents With House Dust Mite-associated Allergic Rhinitis|Completed||Phase 1|37|Actual|Stallergenes Greer||2|||f||||f||||||||||2017-10-11 01:24:48.704968|2017-10-11 01:24:48.704968
NCT01919541|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-09-21|||December 2016||2016-12-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Mechanistic Prehabilitation|Understanding How Exercise and Nutrition Enhance Preoperative Functional Capacity: a Mechanistic Study|Unknown status|Not yet recruiting|N/A|12|Anticipated|McGill University Health Center||1|||f||||t||||||||||2017-10-11 01:24:48.800352|2017-10-11 01:24:48.800352
NCT01919528|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-04|2016-05-08|||December 2012||2012-12-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Ultrasound-guided Catheterization of the Axillary Vein|Real-time Ultrasound-guided Catheterization of the Axillary Vein in the Intensive Care Unit|Completed||N/A|202|Actual|Publiczny Samodzielny Zaklad Opieki Zdrowotnej Wojewodzkie Centrum Medyczne||1|||f||||f||||||||||2017-10-11 01:24:48.892973|2017-10-11 01:24:48.892973
NCT01919515|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-10-07|||April 2013||2013-04-01|October 2014|2014-10-01||||June 2017|Anticipated|2017-06-01||Interventional|||Trial of a New NuSmile ZR Esthetic Primary Molar Crown|Randomized Controlled Clinical Trial of a New NuSmile ZR Esthetic Primary Molar Crown|Unknown status|Active, not recruiting|N/A|50|Anticipated|NuSmile, Ltd.||1|||f||||f||||||||||2017-10-11 01:24:48.965543|2017-10-11 01:24:48.965543
NCT01919502|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2014-05-12|||October 2013||2013-10-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility Treatment|Feasibility and Acceptability of Using a Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility Treatment|Completed||N/A|51|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-10-11 01:24:49.049914|2017-10-11 01:24:49.049914
NCT01919476|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-08-04|||September 2011||2011-09-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women|Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women|Completed||N/A|18|Actual|Children's Hospital & Research Center Oakland||2|||f||||f||||||||No||2017-10-11 01:24:49.245965|2017-10-11 01:24:49.245965
NCT01919463|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2015-03-02|||March 2015||2015-03-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|August 2015|Anticipated|2015-08-01||Interventional|SINOCOLO2013||Intubation Techniques on Colonoscopy Quality (SINOCOLO2013)|Intubation Techniques on Colonoscopy Quality: A Single Center Randomized Control Clinical Trial|Unknown status|Recruiting|N/A|300|Anticipated|Changhai Hospital||3|||f||||f||||||||||2017-10-11 01:24:49.373942|2017-10-11 01:24:49.373942
NCT01919450|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-02-07|2016-10-25||July 2013||2013-07-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation|Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation|Completed||Phase 4|80|Actual|Cardiovascular Imaging Technologies||4|||f||||f||||||||||2017-10-11 01:24:49.546673|2017-10-11 01:24:49.546673
NCT01919437|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-08-07|||April 2012||2012-04-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|October 2012|Actual|2012-10-01||Interventional|5I||Comparison of Methamphetamine-Dependent and Healthy Volunteers Using a Web-Enabled Cognitive Neuropsychological Evaluation System|Comparison of Methamphetamine-Dependent and Healthy Volunteers Using a Web-Enabled Cognitive Neuropsychological Evaluation System|Unknown status|Active, not recruiting|N/A|32|Actual|California Pacific Medical Center Research Institute||1|||f||||t||||||||||2017-10-11 01:24:49.890226|2017-10-11 01:24:49.890226
NCT01919424|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-04-14|||April 2011||2011-04-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Comparison of the Methacholine PC20 Between the Trudell Aeroeclipse* II Ban Nebulizer and the Wright Nebulizer|Comparison of the Methacholine PC20 Between the Trudell Aeroeclipse* II Ban Nebulizer and the Wright Nebulizer|Completed||N/A|46|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 01:24:49.96347|2017-10-11 01:24:49.96347
NCT01919411|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-04-03|||February 2013||2013-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial|Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial|Recruiting||Phase 4|140|Anticipated|Massachusetts Eye and Ear Infirmary||2|||f||||f||||||||Undecided||2017-10-11 01:24:50.072819|2017-10-11 01:24:50.072819
NCT01919385|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2013-09-17|||July 2013||2013-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia|Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting|Completed||Phase 1|12|Anticipated|Animas Corporation||1|||f||||f||||||||||2017-10-11 01:24:50.286764|2017-10-11 01:24:50.286764
NCT01919372|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-09|||January 2014||2014-01-01|August 2013|2013-08-01||||June 2015|Anticipated|2015-06-01||Interventional|PREDIRCAM 2||Individualized Telemedical Assistance for Lifestyle Modification in the Treatment of Obesity and Cardiometabolic Risk Prevention|Intensificación y monitorización telemática Personalizada de la modificación Del Estilo de Vida en el Tratamiento de la Obesidad y la prevención Del Riesgo cardiometabólico|Unknown status|Not yet recruiting|N/A|222|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 01:24:50.387194|2017-10-11 01:24:50.387194
NCT01919359|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-07|||July 2013||2013-07-01|August 2013|2013-08-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Interventional|||A Study of Nutritional Supplementation in Altering Ecchymosis, Erythema and Health Outcomes Associated With Aesthetic Procedures|A Double-blinded, Randomized Placebo Controlled Study to Assess the Efficacy of Nutritional Supplementation in Altering Ecchymosis, Erythema and Health Outcomes Associated With Aesthetic Procedures|Unknown status|Recruiting|N/A|120|Anticipated|DeNova Research||2|||f||||f||||||||||2017-10-11 01:24:50.470138|2017-10-11 01:24:50.470138
NCT01919346|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-08-11|||August 2013||2013-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation|Eculizumab for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplantation|Active, not recruiting||Phase 2|48|Anticipated|Heeger, Peter, M.D.||2|||f||||t||||||||||2017-10-11 01:24:50.585227|2017-10-11 01:24:50.585227
NCT01919320|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-03-27|||December 2013||2013-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|C2 PAS||SynCardia Companion 2 Driver System Post Approval Study Protocol With INTERMACS™-Based Data Collection|SynCardia Companion 2 Driver System Post Approval Study Protocol With INTERMACS™-Based Data Collection|Enrolling by invitation||N/A|500|Anticipated|SynCardia Systems. LLC|||3||f||||t||||||||||2017-10-11 01:24:50.761806|2017-10-11 01:24:50.761806
NCT01919294|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-04-25|||July 2013||2013-07-01|April 2017|2017-04-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|TEREPINS||Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)|Pilot Open Study of Testosterone Replacement in Non-alcoholic Steatohepatitis|Completed||Phase 2|3|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 01:24:50.906906|2017-10-11 01:24:50.906906
NCT01919281|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-09-28|||July 2013||2013-07-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|January 2014|Actual|2014-01-01||Interventional|||High Intensity Interval Training or Strength Training in Women With Polycystic Ovary Syndrome|High Intensity Interval Training or Strength Training in Women With Polycystic Ovary Syndrome. A Randomized Controlled Trial|Completed||N/A|31|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 01:24:50.999029|2017-10-11 01:24:50.999029
NCT01919268|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2015-06-15|||October 2013||2013-10-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Addition of the Interferential Current to the Pilates Method in the Treatment of Chronic Nonspecific Low Back Pain|Effectiveness of the Addition of the Interferential Current to the Pilates Method in the Treatment of Patients With Chronic Nonspecific Low Back Pain: a Randomized Controlled Trial|Completed||N/A|148|Actual|Universidade Cidade de Sao Paulo||2|||f||||t||||||||||2017-10-11 01:24:51.086804|2017-10-11 01:24:51.086804
NCT01919255|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2015-03-25|||August 2013||2013-08-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of PICOLIGHT Plus COOLPREP, PICOLIGHT Plus CLICOLON for Bowel Preparation|Evaluation of PICOLIGHT Plus COOLPREP, PICOLIGHT Plus CLICOLON for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)|Completed||Phase 2|236|Actual|National Cancer Center, Korea||4|||f||||f||||||||||2017-10-11 01:24:51.163218|2017-10-11 01:24:51.163218
NCT01919242|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-10-03|||January 2013||2013-01-01|October 2016|2016-10-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Observational|||Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study||Recruiting||N/A|10000|Anticipated|Yonsei University|||2||f||||t||||||||||2017-10-11 01:24:51.250907|2017-10-11 01:24:51.250907
NCT01919229|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-11-30|2015-09-10||October 2013||2013-10-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MONALEESA-1|The full analysis set (FAS) comprised of all randomized patients. Patients were analyzed according to the treatment they had been assigned to during the randomization procedure.|A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)|A Randomized Pre-surgical Pharmacodynamics Study to Assess the Biological Activity of LEE011 Plus Letrozole Versus Single Agent Letrozole in Primary Breast Cancer|Terminated||Phase 2|14|Actual|Novartis||3||Due to low recruitment, it was decided to terminate the study.|f||||f||||||||||2017-10-11 01:24:51.478249|2017-10-11 01:24:51.478249
NCT01917929|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-05-26|||August 2013||2013-08-01|May 2017|2017-05-01|December 2027|Anticipated|2027-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Secur-Fit Advanced Outcomes Study|A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Secur-Fit Advanced Hip Stem|Recruiting||N/A|326|Anticipated|Stryker Orthopaedics||1|||f||||f||||||||||2017-10-11 01:25:11.771519|2017-10-11 01:25:11.771519
NCT01919203|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2015-07-14|||August 2013||2013-08-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Children|the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Pediatric Patients|Completed||N/A|50|Actual|Yeungnam University College of Medicine||1|||f||||t||||||||||2017-10-11 01:24:52.182867|2017-10-11 01:24:52.182867
NCT01919177|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-04-27|||January 2013||2013-01-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Inorganic Nitrates (Beetroot Juice) on Arterial Hemodynamics and Exercise Capacity|Effect of Inorganic Nitrates on Arterial Hemodynamics and Exercise Capacity|Completed||Phase 2|17|Actual|Corporal Michael J. Crescenz VA Medical Center||2|||f||||f||||||||||2017-10-11 01:24:52.41136|2017-10-11 01:24:52.41136
NCT01919164|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-09-15|||July 31, 2013|Actual|2013-07-31|September 2017|2017-09-01|May 20, 2019|Anticipated|2019-05-20|May 5, 2016|Actual|2016-05-05||Interventional|FORWARD||A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin (AS902330) in Patients With Osteoarthritis of the Knee|A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel-group Trial to Investigate the Efficacy and Safety of Different Intra Articular (i.a.) Dosages of Sprifermin in Subjects With Primary Osteoarthritis of the Knee|Active, not recruiting||Phase 2|549|Actual|EMD Serono||5|||f||||t||||||||||2017-10-11 01:24:52.533806|2017-10-11 01:24:52.533806
NCT01919151|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2013-08-08|||June 2008||2008-06-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Observational|||Micrometastasis in Gastrointestinal Cancer|The Process of Metastasis in Colorectal Cancer Tumour Biology and Prognostic Factors in Pancreatic Cancer|Unknown status|Recruiting|N/A|500|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Blood and bone marrow cells fixated to slides or to cartridge. Some fresh frozen tumor     samples   "|||2017-10-11 01:24:52.729676|2017-10-11 01:24:52.729676
NCT01919138|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-06-22|||July 2013||2013-07-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|||Outcomes of Severe Sepsis Patients in Surgical Intensive Care Units|Outcomes of Severe Sepsis Patients in Surgical Intensive Care Units of National Taiwan University Hospital: Retrospective Review|Completed||N/A|762|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:24:52.828404|2017-10-11 01:24:52.828404
NCT01919125|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-01-25|||August 2013||2013-08-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)|A Phase I, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of IDX719 in Subjects With Normal and Impaired Hepatic Function|Completed||Phase 1|36|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 01:24:52.926273|2017-10-11 01:24:52.926273
NCT01919112|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-02-24|||September 2013||2013-09-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|FEASt||Fostering Eating After Stroke With Transcranial Direct Current Stimulation|Non-invasive Brain Stimulation for Swallowing Recovery After a Dysphagic Stroke|Recruiting||N/A|99|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||t||||||||||2017-10-11 01:24:53.042187|2017-10-11 01:24:53.042187
NCT01919099|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-08-25|||July 23, 2013||2013-07-23|August 24, 2017|2017-08-24|August 24, 2017|Actual|2017-08-24|August 24, 2017|Actual|2017-08-24||Observational|||Study of the Complications Associated With Certain Stem Cell Transplants|Natural History Study of the Complications Associated With Allogeneic Hematopoietic Stem Cell Transplantations|Completed||N/A|100|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:24:53.173043|2017-10-11 01:24:53.173043
NCT01919086|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2017-03-29|||August 2013|Actual|2013-08-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma|Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma|Active, not recruiting||Phase 2|30|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:24:53.281427|2017-10-11 01:24:53.281427
NCT01919073|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-05-04|||December 2012||2012-12-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers|Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers|Active, not recruiting||N/A|29|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 01:24:53.419408|2017-10-11 01:24:53.419408
NCT01919060|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-07|||January 2007||2007-01-01|January 2007|2007-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Acute Non-mechanical Lower Digestive Tract Disorders Should Distinguish Whether Colonic Lesions or Not in Critically Ill Patients||Completed||N/A|69|Actual|Nanjing PLA General Hospital|||2||f||||t||||||||||2017-10-11 01:24:53.531012|2017-10-11 01:24:53.531012
NCT01919047|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2015-10-02|||April 2012||2012-04-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Drug Use-Results Survey of Betanis Tablets in Japan|Drug Use-Results Survey of Betanis Tablets 25 and 50 mg|Completed||N/A|10711|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:24:53.604466|2017-10-11 01:24:53.604466
NCT01919034|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-08-06|||April 2012||2012-04-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||Evaluating the Relationship of Morphine Consumption and Pain-related Molecules in Hepatic Surgical Patients|Evaluating the Relationship of Morphine Consumption and Pain-related Molecules in Hepatic Surgical Patients|Unknown status|Recruiting|N/A|40|Anticipated|National Cheng-Kung University Hospital|||1||f||||t||||||Samples Without DNA|"     blood will be sampling (15cc/time), iver tissue (10mm3)   "|||2017-10-11 01:24:53.732849|2017-10-11 01:24:53.732849
NCT01919021|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-04-08|||April 2011||2011-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Assessment of Gastro-Intestinal Function to a Mixed Meal by Non-invasive Imaging|Pilot Study: Assessment of Gastric Motor and Sensory Function to a Mixed Liquid and Solid Test Meal by Gamma Scintigraphy, Magnetic Resonance Imaging and a Nutrient Drink Test in Health and Patients With Disorders of Gastric Function|Completed||N/A|72|Anticipated|Nottingham University Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 01:24:53.827569|2017-10-11 01:24:53.827569
NCT01919008|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-02-14|||March 2012||2012-03-01|February 2017|2017-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder|Phase I Study of FK949E - Comparison of Pharmacokinetics Between FK949E 50 mg Tablets and FK949E 150 mg Tablets in Patients With Major Depressive Disorder|Completed||Phase 1|16|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:24:53.945942|2017-10-11 01:24:53.945942
NCT01918995|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-28|||May 2013||2013-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects|A Phase 1, Randomized, Double-blind, Dose Escalation, Parallel Group, Placebo-controlled, Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects|Completed||Phase 1|36|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 01:24:54.057547|2017-10-11 01:24:54.057547
NCT01918982|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-07|||October 2013||2013-10-01|August 2013|2013-08-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Observational|ANOPEC3||Circulating Endothelial Progenitor Cells and Aortic Aneurysm|Interest of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in the Follow-up of Aortic Aneurysm|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hopital Jean Minjoz|||1||f||||f||||||||||2017-10-11 01:24:54.171648|2017-10-11 01:24:54.171648
NCT01918969|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-07|||October 2013||2013-10-01|August 2013|2013-08-01|March 2014|Anticipated|2014-03-01|January 2014|Anticipated|2014-01-01||Observational|ANOPEC2||Reference Values of Circulating Endothelial Progenitor Cells|Determination of Reference Values of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in a Blood Donnor Population|Unknown status|Not yet recruiting|N/A|120|Anticipated|Hopital Jean Minjoz|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 01:24:54.257419|2017-10-11 01:24:54.257419
NCT01918956|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2014-04-10|||September 2013||2013-09-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||PURETHAL Birch RUSH Study|A Prospective, Randomized, Open, Multi-centre Study to Assess Safety of PURETHAL Birch Given With a Rush Up-dosing Regimen to Patients With Allergic Rhinitis/Rhinoconjunctivitis|Completed||Phase 4|120|Anticipated|HAL Allergy||2|||f||||f||||||||||2017-10-11 01:24:54.351025|2017-10-11 01:24:54.351025
NCT01918943|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-06|||August 2012||2012-08-01|August 2013|2013-08-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Evaluation of Aspen Spinous Process Fixation System and PLIF Technique for the Treatment of Low Back Pain|Evaluation of Aspen Spinous Process Fixation System and PLIF Technique for the Treatment of Low Back Pain in the Presence of Lumbar Instability and Degenerative Disk Disease|Unknown status|Recruiting|N/A|50|Anticipated|American British Cowdray Medical Center|||1||f||||f||||||||||2017-10-11 01:24:54.607205|2017-10-11 01:24:54.607205
NCT01918930|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-12-21|||July 2013||2013-07-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Tissue Procurement Substudy for Participants in Study CP-MGA271-01|A Tissue Procurement and Examination Substudy of Study CP-MGA271-01 (NCT01391143)|Terminated||Phase 1|6|Actual|MacroGenics||1||Unable to accrue as planned for optional biopsies|f||||f||||||||No||2017-10-11 01:24:54.717388|2017-10-11 01:24:54.717388
NCT01918917|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-07|||July 2011||2011-07-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Adding Intra-articular Dexmedetomidine to Levobupivacaine for Postoperative Analgesia in Arthroscopic Knee Surgery|Phase 4 Study of Intra-articular Dexmedetomidine Adding to Levobupivacaine for Postoperative Analgesia in Arthroscopic Knee Surgery|Completed||Phase 4|60|Actual|TC Erciyes University||2|||f||||t||||||||||2017-10-11 01:24:54.813807|2017-10-11 01:24:54.813807
NCT01918904|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-11-15|||September 2013||2013-09-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|STS-CALC||A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis|A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis (STS-CALC)|Withdrawn||Phase 2|0|Actual|Loyola University||2||PI decided not to proceed with this project. No participants were enrolled.|f||||f||||||||||2017-10-11 01:24:54.920321|2017-10-11 01:24:54.920321
NCT01918891|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-10-03|||September 2012||2012-09-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|June 2017|Anticipated|2017-06-01||Interventional|CSDS||Center for Stroke Disparities Solution - Community Transitions Intervention|Center for Stroke Disparities Solution (CSDS) Project II: Community Transitions Intervention (CTI)|Recruiting||N/A|495|Anticipated|Visiting Nurse Service of New York||3|||f||||t||||||||||2017-10-11 01:24:55.057347|2017-10-11 01:24:55.057347
NCT01918878|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-01-12|||October 2013||2013-10-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.|A 7-month, Multicenter Study to Evaluate the Efficacy of Intravitreal Injections of Aflibercept (EYLEA) 2mg /0.05 ml as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration (NVAMD).|Unknown status|Active, not recruiting|Phase 4|48|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 01:24:55.17909|2017-10-11 01:24:55.17909
NCT01918865|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-02-27|||August 2013||2013-08-01|September 2014|2014-09-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes|A Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of ISIS 404173 Administered Once Weekly to Obese Patients With Type 2 Diabetes Mellitus Being Treated With Metformin or Metformin Plus Sulfonylurea|Completed||Phase 2|92|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:24:55.277212|2017-10-11 01:24:55.277212
NCT01918852|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-01-31|||December 2013||2013-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|SALTO||S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.|S1 Versus Capecitabine in the First Line Treatment of Metastatic Colorectal Cancer Patients, the SALTO Randomised Phase III Study of the Dutch Colorectal Cancer Group. A Safety Evaluation of Oral Fluoropyrimidines|Active, not recruiting||Phase 3|161|Actual|Dutch Colorectal Cancer Group||2|||f||||t||||||||Undecided||2017-10-11 01:24:55.420785|2017-10-11 01:24:55.420785
NCT01918839|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-08-01|||February 2014||2014-02-01|January 2014|2014-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy and Safety of Injection With VINCI Plus Hyaluronic Acid Filler|Clinical Study to Evaluate the Efficacy and Safety of Injection With VINCI Plus as Compared to Restylane-L in Correction of Nasolabial Fold|Completed||N/A|46|Anticipated|D.med||2|||f||||t||||||||||2017-10-11 01:24:55.625278|2017-10-11 01:24:55.625278
NCT01918826|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-08-07|||June 2012||2012-06-01|July 2012|2012-07-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs|Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs|Unknown status|Recruiting|N/A|40|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 01:24:55.757946|2017-10-11 01:24:55.757946
NCT01918800|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-08-17|2016-11-15||March 28, 2013|Actual|2013-03-28|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|December 30, 2015|Actual|2015-12-30||Interventional|||A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis|A Randomized Trial of a Formal Group Program for Fatigue in Multiple Sclerosis|Active, not recruiting||N/A|218|Actual|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 01:24:56.043855|2017-10-11 01:24:56.043855
NCT01918787|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-07|||April 2012||2012-04-01|April 2012|2012-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||rTMS for Adults With Autistic Spectrum Disorder|Examine the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) Over the Symptoms of Autism Spectrum Disorder|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-10-11 01:24:57.098699|2017-10-11 01:24:57.098699
NCT01918774|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-05-10|||February 1, 2016|Actual|2016-02-01|May 2017|2017-05-01|September 30, 2018|Anticipated|2018-09-30|January 1, 2018|Anticipated|2018-01-01||Interventional|||Cognitive Behavior Therapy for Work Success in Veterans With Mental Illness: A Pre-post Efficacy Study|Cognitive Behavioral Therapy to Enhance Competitive Work Outcomes|Active, not recruiting||N/A|55|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||No||2017-10-11 01:24:57.204305|2017-10-11 01:24:57.204305
NCT01918761|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-02-17|||August 2013||2013-08-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)|Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC): a Phase I Trial to Identify a Dose of Dacomitinib in Combination With Pemetrexed That is Safe and Tolerated as Determined by the Incidence of DLT|Recruiting||Phase 1|6|Anticipated|Central European Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 01:24:57.332695|2017-10-11 01:24:57.332695
NCT01918748|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-04|2013-08-06|||July 2013||2013-07-01|August 2013|2013-08-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke Patients|Effect of a Training Regime Featuring the I-TRAVLE System on Arm Function and Skill Performance in Persons With Multiple Sclerosis and Chronic Stroke Patients: a Single Arm Trial|Unknown status|Recruiting|N/A|30|Anticipated|Hasselt University||1|||f||||t||||||||||2017-10-11 01:24:57.433894|2017-10-11 01:24:57.433894
NCT01918735|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2014-09-02|||August 2013||2013-08-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects|A Randomised, Double-Blind, Placebo-Controlled, Dose Escalation, Safety, Tolerability and Pharmacokinetics Study of Single Ascending and Multiple Doses of GWP42006 in Healthy Volunteers|Completed||Phase 1|66|Actual|GW Research Ltd||10|||f||||t||||||||||2017-10-11 01:24:57.532562|2017-10-11 01:24:57.532562
NCT01918722|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-03-10|||October 2013||2013-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy|Clinical Re-evaluation of Removing Blood Stasis Therapy of Herbal Medicine in Treating Acute Cerebral Hemorrhage Safety|Enrolling by invitation||Phase 4|360|Anticipated|Guangzhou University of Traditional Chinese Medicine||3|||f||||t||||||||Yes|The study has recruited 278 subjects by so far|2017-10-11 01:24:57.637811|2017-10-11 01:24:57.637811
NCT01918709|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-08-06|||September 2011||2011-09-01|August 2013|2013-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers|A Randomized, Open Label, Multiple Dose, Cross-over, Phase I Trial to Evaluate a Pharmacokinetic Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers|Completed||Phase 1|30|Actual|LG Life Sciences||3|||f||||f||||||||||2017-10-11 01:24:57.756754|2017-10-11 01:24:57.756754
NCT01918696|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-12-21|||October 2013||2013-10-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Controlled Evaluation of a Computerized Anger-reduction Treatment for Suicide Prevention|Controlled Evaluation of a Computerized Anger-reduction Treatment for Suicide Prevention|Completed||N/A|120|Actual|Florida State University||3|||f||||f||||||||||2017-10-11 01:24:57.856705|2017-10-11 01:24:57.856705
NCT01918683|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-07|2016-09-23|||July 2013||2013-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients|A Pilot Trial of Transarterial Chemoembolization With or Without Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation|Recruiting||Early Phase 1|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:24:57.933987|2017-10-11 01:24:57.933987
NCT01918670|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-08-06|||November 2010||2010-11-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|July 2013|Actual|2013-07-01|18 Months|Observational [Patient Registry]|FrenchAF||A French Multi-centric Atrial Fibrillation Catheter Ablation Survey|A French Multi-centric Atrial Fibrillation Catheter Ablation Survey|Unknown status|Active, not recruiting|N/A|||Clinique Pasteur|||6||f||||f||||||||||2017-10-11 01:24:58.01899|2017-10-11 01:24:58.01899
NCT01916096|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-08-01|||February 2012||2012-02-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Lancet Blood Volume Comparison Study|Lancet Blood Volume Comparison Study|Completed||N/A|180|Actual|Facet Technologies|||6||f||||f||||||||||2017-10-11 01:25:34.760788|2017-10-11 01:25:34.760788
NCT01918644|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-04-03|||August 2013||2013-08-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Stereotactic Body Radiation Therapy and Capecitabine Before Surgery in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery|A Phase Ia-Ib Dose-escalation Study Evaluating Safety and Efficacy of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) With Concomitant Capecitabine Chemotherapy for Resectable Carcinoma of Exocrine Pancreas.|Recruiting||Phase 1|36|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 01:24:58.32528|2017-10-11 01:24:58.32528
NCT01918631|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-07-18|||August 2013||2013-08-01|July 2017|2017-07-01|January 31, 2017|Actual|2017-01-31|January 2017|Actual|2017-01-01||Interventional|||A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir||Completed||N/A|36|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 01:24:58.440957|2017-10-11 01:24:58.440957
NCT01918618|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-08-06|||April 2013||2013-04-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Observational|||Renal Effects of Levosimendan in Cardiac Surgery Patients||Completed||N/A|92|Actual|Charite University, Berlin, Germany|||2||f||||||||||||||2017-10-11 01:24:58.536576|2017-10-11 01:24:58.536576
NCT01918605|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-11-30|||June 2013||2013-06-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Protection of Rectum From High Radiation Doses Using a Spacer|Protection of Rectum From High Radiation Doses During Prostate Cancer Low-dose Brachytherapy Using Diluted or Non-diluted DuraSeal as a Spacer|Enrolling by invitation||N/A|20|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-11 01:24:58.614534|2017-10-11 01:24:58.614534
NCT01918592|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-11-05|||August 2013||2013-08-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|March 2016|Anticipated|2016-03-01||Interventional|ACEBIB||PET/MRI and Biomarkers in Bladder Cancer|PET/MRI and Biomarkers in Clinical Staging of Bladder Cancer and in the Estimation of Neoadjuvant Chemotherapy Response Prior to Radical Cystectomy|Recruiting||N/A|50|Anticipated|Turku University Hospital||1|||f||||f||||||||||2017-10-11 01:24:58.712547|2017-10-11 01:24:58.712547
NCT01918579|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2016-11-13|||March 2014||2014-03-01|June 2014|2014-06-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|CRP||C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting|Efficacy of Point-of-care (POC) C-reactive Protein Testing to Reduce Inappropriate Use of Antibiotics for Acute Respiratory Infections (ARIs) in the Primary Health Care Setting of Hanoi - a Randomized Controlled Trial|Completed||N/A|2037|Actual|Oxford University Clinical Research Unit, Vietnam||2|||f||||t||||||||||2017-10-11 01:24:58.811504|2017-10-11 01:24:58.811504
NCT01918566|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-08-05|||March 2012||2012-03-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity|The Role of Endogenous GLP-1 in Regulating Glucose Stimulated Brain Activity|Completed||N/A|12|Actual|University Hospital, Basel, Switzerland||6|||f||||f||||||||||2017-10-11 01:24:58.899988|2017-10-11 01:24:58.899988
NCT01918553|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-09-05|||July 9, 2015|Actual|2015-07-09|September 2017|2017-09-01|July 2024|Anticipated|2024-07-01|July 2024|Anticipated|2024-07-01||Interventional|ECLAIR||Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors|Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors|Active, not recruiting||N/A|516|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-11 01:24:59.022998|2017-10-11 01:24:59.022998
NCT01918540|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2014-11-25|||February 2003||2003-02-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|February 2004|Actual|2004-02-01||Interventional|||Importance of Hollow or Solid Centralizer for Polished, Collarless and Tapered Stems in Total Hip Arthroplasty|Comparing Hollow and Solid Centralizer Designs When Using a Polished, Collarless, Tapered Hip Prosthesis Stem (MS30). A Prospective, Randomized, Multicenter Study Evaluated by RadioStereometric Analysis (RSA).|Completed||N/A|60|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 01:24:59.150315|2017-10-11 01:24:59.150315
NCT01918527|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-08-03|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer|Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer|Recruiting||Phase 3|250|Anticipated|Vejle Hospital||2|||f||||t||||||||||2017-10-11 01:24:59.238248|2017-10-11 01:24:59.238248
NCT01918514|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-06||||||August 2013|2013-08-01||||||||Expanded Access|||The Effect of Adding Magnesium Sulfate to Standard Epidural and Interscalene Block in Treatment of Patients With Chronic Pain|The Effect of Adding Magnesium Sulfate to Standard Epidural and Interscalene Block in Treatment of Patients With Chronic Pain|Available||N/A|||State University of New York - Upstate Medical University|||||f||||||||||||||2017-10-11 01:24:59.386029|2017-10-11 01:24:59.386029
NCT01918501|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-12-02|||August 2013||2013-08-01|August 2013|2013-08-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients|Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients|Unknown status|Recruiting|N/A|120|Anticipated|Ziv Hospital||1|||f||||f||||||||||2017-10-11 01:24:59.486755|2017-10-11 01:24:59.486755
NCT01918475|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2015-02-11|||July 2013||2013-07-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Analgesic Effect of Oxytocin Receptor Modulation|Analgesic Effect of Oxytocin Receptor Modulation in Healthy Volunteers|Completed||N/A|25|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 01:24:59.755203|2017-10-11 01:24:59.755203
NCT01918462|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-02-24|||April 2013||2013-04-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|AHIL||Protective Immune Mechanisms in Alcoholic Hepatitis|Protective Immune Mechanisms in Alcoholic Hepatitis|Recruiting||N/A|60|Anticipated|University of Aarhus|||2||f||||t||||||Samples With DNA|"     Whole blood, serum, plasma, PBMC's, hepatic leukocytes   "|||2017-10-11 01:24:59.847663|2017-10-11 01:24:59.847663
NCT01918449|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-11-24|||January 2013||2013-01-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Follow-up of Patients With Obstructive Sleep Apnea in Primary Care.|Follow-up of Patients With the Apnea-hypopnea Syndrome in Primary Care and Sleep Disorders Units. Equivalence Randomized Comparative Study on Compliance and Clinical Response.|Completed||N/A|210|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||f||||||||||2017-10-11 01:24:59.937128|2017-10-11 01:24:59.937128
NCT01918436|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-06|||October 2012||2012-10-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|TEAMS||RCT, Proof of Concept Study of TEAMS (Training Executive, Attention and Motor Skills) Intervention Program|TEAMS (Training Executive, Attention, and Motor Skills): - Intervention Program for Preschoolers With ADHD (Attention Deficit Hyperactivity Disorder). A Rct. Proof-of-Concept Study.|Unknown status|Recruiting|N/A|160|Anticipated|Holbaek Sygehus||2|||f||||t||||||||||2017-10-11 01:25:00.036942|2017-10-11 01:25:00.036942
NCT01918423|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-05|||February 2011||2011-02-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|LiPO||Lifestyle in Pregnancy and Offspring - Comparison Between Children Born to Obese Women and Children Born to Normal Weight Women|The Effects of Lifestyle Intervention During Pregnancy in Obese Women on Offspring Adiposity and Metabolic Risk Factors- Comparison With Offspring of Normal Weight Women Not Participating in a Lifestyle Intervention Programme.|Completed||N/A|258|Actual|Odense University Hospital|||3||f||||f||||||Samples Without DNA|"     We have created a biobank of bloodsamples   "|||2017-10-11 01:25:00.164383|2017-10-11 01:25:00.164383
NCT01918410|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2015-05-18|||February 2014||2014-02-01|June 2014|2014-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Contact Lens With Alginic Acid in Dry Eye Patients|To Evaluate Effect of Contact Lens With Alginic Acid (7 Days) in Patients With Dry Eye|Completed||N/A|30|Actual|Singapore National Eye Centre||2|||f||||f||||||||||2017-10-11 01:25:00.265077|2017-10-11 01:25:00.265077
NCT01918397|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-07-27|||January 2015||2015-01-01|July 2017|2017-07-01|July 11, 2017|Actual|2017-07-11|July 11, 2017|Actual|2017-07-11||Interventional|Opti-Q||Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB|Prospective, Randomized, Blinded Phase II Pharmacokinetic/Pharmacodynamic Study of the Efficacy and Tolerability of Levofloxacin in Combination With Optimized Background Regimen for the Treatment of MDR-TB|Completed||Phase 2|111|Actual|Boston University||4|||f||||t|t|f||||||||2017-10-11 01:25:00.382585|2017-10-11 01:25:00.382585
NCT01918384|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-09-02|||August 2013||2013-08-01|September 2015|2015-09-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|NORTH POLE DMD||Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy|Phase II Study of Nonsense Readthrough Compound NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy Patients (NORTH POLE DMD Study)|Unknown status|Active, not recruiting|Phase 2|21|Anticipated|Kobe University||2|||f||||t||||||||||2017-10-11 01:25:00.488545|2017-10-11 01:25:00.488545
NCT01918371|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-04-20|2015-11-25||August 2013||2013-08-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational||All participants with data available.|A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema||Completed||N/A|323|Actual|Allergan|||2||f||||f||||||||||2017-10-11 01:25:00.653687|2017-10-11 01:25:00.653687
NCT01918358|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-06|||December 2012||2012-12-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg|A Randomized, Open-label, Single Dose Crossover Study to Compare the Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg in Healthy Male Volunteers|Completed||Phase 1|60|Actual|LG Life Sciences||3|||f||||f||||||||||2017-10-11 01:25:02.117949|2017-10-11 01:25:02.117949
NCT01918345|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-10-31|||July 2014||2014-07-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|ADAPT-M||Avoiding Diabetes After Pregnancy Trial in Moms|Avoiding Diabetes After Pregnancy Trial in Moms (ADAPT-M): Pilot and Feasibility Study|Active, not recruiting||N/A|225|Actual|Women's College Hospital||4|||f||||t||||||||||2017-10-11 01:25:02.228848|2017-10-11 01:25:02.228848
NCT01918332|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2014-12-08|2014-04-24||April 2012||2012-04-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Full Analysis Set|Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia|A Multicenter, Randomized, Factorial, Double-blinded, Double-dummy Phase Ⅲ Trial to Evaluate the Efficacy and Safety of the Coadministration of Valsartan 160mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone in Patients With Hypertension and Hyperlipidemia|Completed||Phase 3|168|Actual|LG Life Sciences|Withdrawal(discontinuation) leading to smaller number of per-protocol set than full analysis set. The violation of protocol was the criterion of subjects' withdrawal.|4|||f||||f||||||||||2017-10-11 01:25:02.335297|2017-10-11 01:25:02.335297
NCT01918319|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-05|||February 2011||2011-02-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|LiPO||Lifestyle in Pregnancy and Offspring|The Effect of Lifestyle Intervention in Pregnancy - Follow-up on the Offspring in Early Childhood.|Completed||N/A|157|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 01:25:02.88799|2017-10-11 01:25:02.88799
NCT01918306|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-05-22|2016-09-30||September 2013||2013-09-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional||One participant that is listed in Cisplatin and GDC-0941 arm is a Crossover patient from the Cisplatin only arm.|GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer|A Phase Ib/II Trial of GDC-0941 (a PI3K Inhibitor) in Combination With Cisplatin in Patients With Androgen Receptor Negative Triple Negative Metastatic Breast Cancer|Terminated||Phase 1/Phase 2|11|Actual|Vanderbilt-Ingram Cancer Center||5||company stopped production of study drug due to excessive toxicities, lack of efficacy|f||||t||||||||||2017-10-11 01:25:03.128758|2017-10-11 01:25:03.128758
NCT01918293|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2013-11-26|||September 2012||2012-09-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult|Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma) in Adult|Completed||N/A|60|Actual|Inje University||2|||f||||f||||||||||2017-10-11 01:25:04.688128|2017-10-11 01:25:04.688128
NCT01918280|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-05-29|||September 2010||2010-09-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|FERTIPRESERVE||Fertility Preservation in Cases of Klinefelter Syndrome.|Fertility Preservation in Cases of Spermatogenesis Failure : Prospective Study for Klinefelter Syndrome With Non-mosaic Karyotype (47, XXY, Homogeneous)|Recruiting||N/A|120|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:25:04.906995|2017-10-11 01:25:04.906995
NCT01918267|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2017-09-27|||April 10, 2012|Actual|2012-04-10|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)||Active, not recruiting||N/A|226|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:25:05.094279|2017-10-11 01:25:05.094279
NCT01918254|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-09-11|||August 6, 2013|Actual|2013-08-06|September 2017|2017-09-01|October 7, 2016|Actual|2016-10-07|October 7, 2016|Actual|2016-10-07||Interventional|||A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein|Phase IB, Open-Label, Multicenter, Dose-Escalation Study Followed by an Extension Phase to Evaluate the Safety, Pharmacokinetics and Activity of RO5479599, a Glycoengineered Antibody Against HER3, Administered in Combination With Pertuzumab and Paclitaxel in Patients With Metastatic Breast Cancer Expressing HER3 & HER2 Protein|Completed||Phase 1|66|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 01:25:05.259726|2017-10-11 01:25:05.259726
NCT01918241|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2015-11-09|||July 2013||2013-07-01|November 2015|2015-11-01||||January 2016|Anticipated|2016-01-01||Interventional|PEG-rhG-CSF||Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia|Saftey and Efficacy Phase II Study of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia|Recruiting||Phase 2|200|Anticipated|Hangzhou Jiuyuan Gene Engineering Co. Ltd.,||4|||f||||f||||||||||2017-10-11 01:25:05.488244|2017-10-11 01:25:05.488244
NCT01918228|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-08-22|||February 2013||2013-02-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|September 2014|Actual|2014-09-01||Interventional|VRRPF||Effect of Reassuring Information on Danish Workers Who Experience Low Back Pain in the Following Year.|Effect of an Educational Based Intervention on Danish Workers With Low Back Pain. A Randomized Controlled Single Blinded Study.|Completed||N/A|505|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-11 01:25:05.635579|2017-10-11 01:25:05.635579
NCT01918215|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-11-29|||June 2015||2015-06-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|CMR_GUIDE||Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.|Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction|Recruiting||N/A|1055|Anticipated|Flinders University||2|||f||||t||||||||||2017-10-11 01:25:05.743221|2017-10-11 01:25:05.743221
NCT01918202|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2014-11-06|||March 2014||2014-03-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|PET||A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers|A Phase 1, Open-label Adaptive Design Study To Evaluate Pde10 Enzyme Occupancy As Measured By Positron Emission Tomography (Pet) Following Single Oral Dose Administration Of Pf-02545920 In Healthy Male Subjects|Completed||Phase 1|9|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 01:25:05.979756|2017-10-11 01:25:05.979756
NCT01918189|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-09-21|||July 1, 2014|Actual|2014-07-01|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||Internet-based Behavioral Pain Management|Development of an Internet-based Behavioral Pain Management Intervention|Recruiting||N/A|70|Anticipated|VA Office of Research and Development||1|||f||||f|f|f|||f|||||2017-10-11 01:25:06.086681|2017-10-11 01:25:06.086681
NCT01918176|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-10-06|||September 2013||2013-09-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)|A Phase 1, Open-Label Fixed-Sequence 2-Period Crossover Study Of Palbociclib In Healthy Subjects To Investigate The Potential Effect Of Antacid Treatment On The Pharmacokinetics Of A Single Oral Dose Administered Under Fasted Conditions|Completed||Phase 1|26|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:25:06.205775|2017-10-11 01:25:06.205775
NCT01918163|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2013-08-06|||September 2013||2013-09-01|July 2013|2013-07-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|Pomegranate||Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.|Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.|Unknown status|Not yet recruiting|Phase 3|55|Anticipated|Hillel Yaffe Medical Center||2|||f||||f||||||||||2017-10-11 01:25:06.326954|2017-10-11 01:25:06.326954
NCT01918150|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-01-07|||March 2011||2011-03-01|January 2014|2014-01-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|EVIDENCE II||Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII|A French, Multicentric, Randomized, Simple Blind, Superiority Study Comparing the Efficiency and the Safety at 24 Months of the Stent Titan2 Versus Bare Metal Stent in Cobalt-Chrome in All Comers Patients Among Which 40 % Present an ACS.|Unknown status|Active, not recruiting|Phase 4|1350|Anticipated|Hexacath, France||2|||f||||t||||||||||2017-10-11 01:25:06.484175|2017-10-11 01:25:06.484175
NCT01918137|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-06|||August 2013||2013-08-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||The Effect of a Deep-fried Chocolate Bar or Porridge on Cerebral Blood Flow|A Randomised Trial of Effect of Deep-fried Chocolate Bar and Porridge Upon Cerebrovascular Reactivity in Healthy Adult Volunteers|Unknown status|Not yet recruiting|N/A|24|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 01:25:06.660608|2017-10-11 01:25:06.660608
NCT01918124|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-08-06|||January 2008||2008-01-01|August 2013|2013-08-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|EC-0701||A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer|A Phase II Clinical Trial of Adjuvant Postoperative Irradiation Combined With Paclitaxel/Carboplatin(TP) or Cisplatin/Doxorubicin/Cyclophosphamide (CAP) Chemotherapy for Patients With High-risk Endometrial Cancer|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-11 01:25:06.745242|2017-10-11 01:25:06.745242
NCT01918111|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-07-24|||September 2013||2013-09-01|July 2014|2014-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT Trial From RENEWAL RDN Registry)||Unknown status|Recruiting|Phase 4|52|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:25:06.84457|2017-10-11 01:25:06.84457
NCT01918098|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-07-31|||September 2013||2013-09-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Targin for Non-cancer Pain|A Randomized, Double-blind, Double-dummy, Parallel-group, Multicenter Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Moderate to Severe Non-malignant Pain Taking Oxycodone Equivalent of ≥10 mg/Day and ≤50 mg/Day as Oxycodone/Naloxone Prolonged-release (OXN) Compared to Subjects Taking Oxycodone Prolonged-release (OXY) Tablets Alone.|Recruiting||Phase 3|230|Anticipated|Mundipharma (China) Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 01:25:06.932081|2017-10-11 01:25:06.932081
NCT01918085|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-06|2014-01-28|2013-11-21||April 2012||2012-04-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Human Skin Test Model in Colostomists|Open, Prospective, Single Centre, Randomized, Controlled, Cross-over. Clinical Study Investigating the Correlation in Peel Force of Standard Hydrocolloid Adhesive and a Standard Strata Adhesive From Peristomal Skin and Pre-stripped Abdominal Skin in Colostomists|Completed||N/A|22|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 01:25:07.228454|2017-10-11 01:25:07.228454
NCT01918072|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-05-30|||March 1, 2013|Actual|2013-03-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|June 30, 2017|Anticipated|2017-06-30||Observational|WH CREATE P4||Controlled Trial of Tele-Support and Education for Womens Health Care in CBOCs|Controlled Trial of Tele-Support and Education for Womens Health Care in CBOCs|Recruiting||N/A|100|Anticipated|VA Office of Research and Development|||2||f||||f|f|f|||f|None Retained|"     Not applicable - none   "|No||2017-10-11 01:25:07.464465|2017-10-11 01:25:07.464465
NCT01918059|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-12-02|||August 2013||2013-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Cosmetic Outcome Study of Lid Laceration Repair With Suture Versus Tissue Adhesive|Prospective, Randomized, Controlled Trial of Tissue Adhesive (Octyl-2-Cyanoacrylate) vs. Traditional Suture in Traumatic Lid Laceration Repair|Terminated||Phase 4|4|Actual|The University of Texas Health Science Center, Houston||3||Recruitment difficulties|f||||f||||||||||2017-10-11 01:25:07.587297|2017-10-11 01:25:07.587297
NCT01918046|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-08-06|||July 2013||2013-07-01|August 2013|2013-08-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Observational|||MIOX for Early Detection of Acute Kidney Injury After Cardiac Surgery|MIOX for Early Detection of Acute Kidney Injury After Cardiac Surgery|Unknown status|Recruiting|N/A|100|Anticipated|Barnes-Jewish Hospital|||1||f||||f||||||Samples Without DNA|"     Only for analysis of biomarker   "|||2017-10-11 01:25:07.692718|2017-10-11 01:25:07.692718
NCT01918033|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-03-10|2014-07-24||August 2013||2013-08-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)|A Phase III, Multi-Center, Randomized, Parallel-Group, Placebo-Controlled and Double- Blind Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Perennial Allergic Rhinitis|Completed||Phase 3|608|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:25:07.79744|2017-10-11 01:25:07.79744
NCT01918020|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2014-09-02|||September 2012||2012-09-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|SNAP-Ed||Impact Study of Minnesota SNAP-Ed Health and Nutrition Education Programs|Impact Study of Minnesota SNAP-Ed Health and Nutrition Education Programs|Completed||N/A|796|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:25:10.874535|2017-10-11 01:25:10.874535
NCT01918007|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-08-31|||June 2013||2013-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study|Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study|Completed||N/A|186|Actual|Chania General Hospital ”St. George”||2|||f||||f||||||||||2017-10-11 01:25:10.953982|2017-10-11 01:25:10.953982
NCT01917994|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-02-06|||August 2013|Actual|2013-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Connect4Care||Text Messaging Intervention to Improve Retention in Care and Virologic Suppression in an Urban HIV-Infected Population|Seek Test Treat Retain Strategies Leveraging Mobile Health Technologies|Completed||N/A|230|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:25:11.189203|2017-10-11 01:25:11.189203
NCT01917981|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-04-24|||September 2013||2013-09-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Testing the Accuracy of a Personal Heart Rhythm Monitor to Detect Prolonged Paroxysmal Atrial Fibrillation|Testing the Accuracy of an Intermittent Personal Heart Rhythm Monitor (PHRM) to Detect Prolonged Paroxysmal Atrial Fibrillation (PAF) Against Implantable Devices.|Withdrawn||Phase 3|0|Actual|University of Surrey||1||Failure to recruit.|f||||t||||||||||2017-10-11 01:25:11.295949|2017-10-11 01:25:11.295949
NCT01917968|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-04-12|||October 2013||2013-10-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|Uphold LITE||Multi-center Study of Uphold LITE Versus Native Tissue for the Treatment of Women With Anterior/Apical Pelvic Organ Prolapse|A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of Uphold LITE Versus Native Tissue for the Treatment of Women With Anterior/Apical Pelvic Organ Prolapse|Active, not recruiting||N/A|289|Anticipated|Boston Scientific Corporation|||2||f||||f||||||||||2017-10-11 01:25:11.408377|2017-10-11 01:25:11.408377
NCT01917955|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-11-07|||January 2012||2012-01-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|CaMriSS||Cardiac MRI in Ischemic Stroke Study|Cardiac MRI in Ischemic Stroke Study|Completed||N/A|103|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 01:25:11.587584|2017-10-11 01:25:11.587584
NCT01917942|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-07-10|||June 2008||2008-06-01|July 2017|2017-07-01|August 2013|Actual|2013-08-01|November 2011|Actual|2011-11-01||Interventional|RadioHum||Radiotherapy With Humidification in Head And Neck Cancer|A Randomised Phase III Trial of Radiotherapy With Humidification in Head And Neck Cancer|Completed||Phase 3|210|Anticipated|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||t||||||||||2017-10-11 01:25:11.679119|2017-10-11 01:25:11.679119
NCT01917916|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-08-06|||August 2013||2013-08-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Single Rising Doses of BI 655064 in Healthy Chinese and Japanese Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 655064 (Buffer Solution for Injection) in Healthy Chinese and Japanese Male Volunteers (Randomised, Double-blind, Placebocontrolled Within Dose Groups, Clinical Phase I Study)|Completed||Phase 1|64|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-11 01:25:11.897594|2017-10-11 01:25:11.897594
NCT01917903|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-11-09|||April 2013||2013-04-01|November 2016|2016-11-01||||April 2020|Anticipated|2020-04-01||Interventional|||Walking While Talking: The Effect of Doing Two Things at Once in Individuals With Neurological Injury or Disease|Walking While Talking: The Effects of Dual Task on Gait and Cognition in Individuals With Neurological Injury or Disease.|Enrolling by invitation||N/A|100|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-10-11 01:25:12.003443|2017-10-11 01:25:12.003443
NCT01917890|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2015-11-16|||March 2011||2011-03-01|November 2015|2015-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer|Radiation Therapy With or Without Curcumin Supplement in Treating Patients With Prostate Cancer|Completed||N/A|40|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:25:12.094077|2017-10-11 01:25:12.094077
NCT01917877|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-10-11|||August 2013||2013-08-01|October 2015|2015-10-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab|Phase II Study of Bevasizumab in the Management of Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis|Unknown status|Recruiting|Phase 2|30|Anticipated|Qingdao Central Hospital||2|||f||||t||||||||||2017-10-11 01:25:12.202924|2017-10-11 01:25:12.202924
NCT01917864|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-06-13|||July 2013||2013-07-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||iPad Application to Treat Prosodic Deficits in Students With Communication Disorders|Handheld Technology for Speech Development in Students With Autism Spectrum Disorders|Completed||N/A|200|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 01:25:12.320287|2017-10-11 01:25:12.320287
NCT01917851|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2013-08-06|||April 2011||2011-04-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01|1 Day|Observational [Patient Registry]|||Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients|Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients.|Unknown status|Active, not recruiting|N/A|300|Actual|OrSense, Ltd.|||1||f||||t||||||||||2017-10-11 01:25:12.417906|2017-10-11 01:25:12.417906
NCT01917838|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-11-01|||November 2015||2015-11-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|MHealth||Mobile Health Solutions for Behavioral Skill Implementation Through Homework|Mobile Health Solutions for Behavioral Skill Implementation Through Homework|Recruiting||N/A|96|Anticipated|NYU Silver School of Social Work||1|||f||||f||||||||||2017-10-11 01:25:12.473566|2017-10-11 01:25:12.473566
NCT01917825|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-04-19||2017-04-19|July 2013||2013-07-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy|An Open-Label, Sequential, Dose Escalation Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy|Completed||Phase 2|54|Actual|Medtronic Spinal and Biologics||1|||f||||t|t|f||||||||2017-10-11 01:25:12.560287|2017-10-11 01:25:12.560287
NCT01917812|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-02-17|2015-11-03||January 2014||2014-01-01|February 2017|2017-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|mActive||mActive: A Blinded, Randomized mHealth Activity Trial|mActive: A Blinded, Randomized mHealth Trial of Digital Activity Tracking and Smart Texting to Promote Physical Activity|Completed||N/A|48|Actual|Johns Hopkins University|Given its limited size and scope, mActive may be categorized as a pilot trial. As such, it is most appropriately interpreted as exploratory evidence to guide a definitive pivotal trial in the future.|3|||f||||f||||||||||2017-10-11 01:25:12.654893|2017-10-11 01:25:12.654893
NCT01917799|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2013-08-06|||January 2009||2009-01-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Aspirin, Heparin and Miscarriage|Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage|Unknown status|Recruiting|Phase 4|150|Anticipated|University of Khartoum||2|||f||||f||||||||||2017-10-11 01:25:13.166486|2017-10-11 01:25:13.166486
NCT01917786|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-01-07|||July 2013||2013-07-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Effect of Dexmedetomidine on QT Interval in Pediatric Patients Under General Anesthesia||Completed||N/A|50|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 01:25:13.262112|2017-10-11 01:25:13.262112
NCT01917773|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-12-17|2015-11-12||August 2013||2013-08-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Octreotide on the Colonic Motility in Pediatric Patients|Effect of Octreotide on the Colonic Motility in Pediatric Patients|Completed||Phase 4|13|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 01:25:13.339175|2017-10-11 01:25:13.339175
NCT01917760|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-06|2015-10-30|||July 2013||2013-07-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Observational|GABA-PK||Pharmacokinetics Study of Gamma-aminobutyric Acid|The Pharmacokinetics of Gamma-aminobutyric Acid in Healthy Volunteers.|Completed||Phase 1|12|Actual|Huashan Hospital|||1||f||||t||||||Samples Without DNA|"     This is an open-labeled, 3-phase, self-control study. In phase 1, blood is sampled from     volunteers who will take placebo to obtain the baseline value. In phase 2, volunteers will     take a single oral dose of 2000 mg GABA. There are at least 7 days between the two phases. In     phase 3, volunteers will take a repeated oral dose of 2000 mg GABA (thrice daily for seven     days). There are at least 5-7 days between phase 3 and phase 3. In each phase, individuals     will be observed for 24 hours to obtain the complete concentration time curve. 4 ml of blood     will be sampled at the following time-point for predose and 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4,     6, 8, 10, 12 and 24 hour postdose.   "|||2017-10-11 01:25:13.636068|2017-10-11 01:25:13.636068
NCT01917747|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators|Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators|Recruiting||N/A|346|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 01:25:13.723051|2017-10-11 01:25:13.723051
NCT01917734|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2013-08-06|||January 2010||2010-01-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|December 2011|Actual|2011-12-01||Observational|||Integrated Program for Children With Severe Acute Malnutrition in Madhya Pradesh, India|Evaluation of the Effectiveness of an Integrated Program for the Management of Severe Acute Malnutrition in Children in Madhya Pradesh, India|Completed||N/A|2740|Actual|UNICEF|||1||f||||t||||||||||2017-10-11 01:25:13.833905|2017-10-11 01:25:13.833905
NCT01917721|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-05-14|||October 2013||2013-10-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease|Phase 2 Study to Assess the Efficacy and Safety of Doxycycline in Preventing Coronary Artery Aneurysm Formation and Progression|Recruiting||Phase 2|50|Anticipated|Hawaii Pacific Health||2|||f||||f||||||||No||2017-10-11 01:25:13.92225|2017-10-11 01:25:13.92225
NCT01917708|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-07-19|||January 2014||2014-01-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||BMT Abatacept for Non-Malignant Diseases|Abatacept for Post-Transplant Immune Suppression in Children and Adolescents Receiving Allogeneic Hematopoietic Stem Cell Transplants for Non-Malignant Diseases|Recruiting||Phase 1|20|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 01:25:14.047091|2017-10-11 01:25:14.047091
NCT01917695|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2015-08-11|||August 2013||2013-08-01|August 2015|2015-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study on Early Stage Bulky Cervical Cancers|Randomised Phase III Clinical Trial on Concurent Chemoradiation vs. Neoadjuvant Chemoradiation and Surgery vs. Neoadjuvant Chemotherapy and Surgery in Early Stage Bulky Cervical Cancers (FIGO Stages IB2, IIA2 and IIB)|Recruiting||Phase 3|180|Anticipated|Government Royapettah Hospital||3|||f||||t||||||||||2017-10-11 01:25:14.169882|2017-10-11 01:25:14.169882
NCT01917682|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-06-09|||August 2013|Actual|2013-08-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|3 Days|Observational [Patient Registry]|PRECISION||Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions|A Post-Market Registry for the Evaluation of the CorPath 200 System Effectiveness in Percutaneous Coronary Interventions|Completed||N/A|754|Actual|Corindus Inc.|||1||f||||f||||||||No||2017-10-11 01:25:14.289604|2017-10-11 01:25:14.289604
NCT01917669|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-10-24|||October 2013||2013-10-01|October 2016|2016-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||A Pilot Feasibility Study of Fibroblast Calcium and Glucoregulation in Health and Disease|A Pilot Feasibility Study of Fibroblast Calcium and Glucoregulation in Health|Withdrawn||N/A|0|Actual|University of Kentucky|||4|Funding was never available to conduct the proposed series of experiments.|f||||f||||||Samples Without DNA|"     Serum and tissue (skin biopsy)   "|||2017-10-11 01:25:14.452|2017-10-11 01:25:14.452
NCT01917656|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-07-25|2015-09-02||January 9, 2014|Actual|2014-01-09|July 2017|2017-07-01|September 4, 2014|Actual|2014-09-04|September 1, 2014|Actual|2014-09-01||Interventional|LIRA-Ramadan™|Safety analysis set|Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes|Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes|Completed||Phase 4|343|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:25:14.557148|2017-10-11 01:25:14.557148
NCT01917643|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-02-02|||August 2013||2013-08-01|February 2016|2016-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients|A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol (BFC) and Tiotropium Bromide Among COPD Patients|Completed||N/A|2396|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 01:25:15.227164|2017-10-11 01:25:15.227164
NCT01917630|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-12-16|||August 2013||2013-08-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet|Unknown status|Active, not recruiting|Phase 2|500|Anticipated|Alvine Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 01:25:15.330112|2017-10-11 01:25:15.330112
NCT01917604|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-03-03|||January 2015||2015-01-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|January 2020|Anticipated|2020-01-01||Interventional|||Open Versus Closed Surgical Exposure of Impacted Canine Teeth|Open Versus Closed Surgical Exposure of Impacted Canine Teeth-A Randomised Controlled Trial|Recruiting||N/A|160|Anticipated|Jamia Millia Islamia||2|||f||||t||||||||||2017-10-11 01:25:15.996064|2017-10-11 01:25:15.996064
NCT01917591|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-02-28|||January 2013||2013-01-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study|Healing of Punch Graft Wounds With Two Biologic Exracellular Matrices; a Non-inferiority Study|Completed||N/A|81|Actual|Kerecis Ltd.||2|||f||||t||||||||||2017-10-11 01:25:16.138087|2017-10-11 01:25:16.138087
NCT01917578|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-04|2013-08-04|||August 2008||2008-08-01|August 2013|2013-08-01|July 2014|Anticipated|2014-07-01|March 2014|Anticipated|2014-03-01||Interventional|BCSMANC||Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction|Phase III Trail of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction|Unknown status|Recruiting|Phase 3|4|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||t||||||||||2017-10-11 01:25:16.25705|2017-10-11 01:25:16.25705
NCT01917565|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-05|||August 2013||2013-08-01|August 2013|2013-08-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Observational|||The Use of Airtraq Laryngoscope Versus Macintosh Laryngoscope and Fiberoptic Bronchoscope by Experienced Anesthesiologists||Unknown status|Not yet recruiting|N/A|90|Anticipated|Marmara University|||3||f||||||||||||||2017-10-11 01:25:16.452204|2017-10-11 01:25:16.452204
NCT01917552|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-07-13|||November 2013||2013-11-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|August 2021|Anticipated|2021-08-01||Interventional|||Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer|Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer|Recruiting||Phase 3|870|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 01:25:16.571397|2017-10-11 01:25:16.571397
NCT01917539|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2015-06-17|||June 2013||2013-06-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome|Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome|Withdrawn||N/A|0|Actual|University of Miami||2||Trouble enrolling patients|f||||f||||||||||2017-10-11 01:25:16.737603|2017-10-11 01:25:16.737603
NCT01917526|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2016-11-07|2016-09-19||April 2013||2013-04-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional||Patients aged between 18-70 years who were scheduled for elective surgery under general anesthesia and had American Society of Anesthesiologists (ASA) physical status 1-3.|The Performance of Two Oxygen Delivery Devices Used After General Anesthesia.|The Performance Comparison of Two Oxygen Delivery Devices [Nasal Cannula and Mask] Used After General Anesthesia.|Completed||N/A|500|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 01:25:16.832601|2017-10-11 01:25:16.832601
NCT01917513|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-10-25|||May 2014||2014-05-01|October 2016|2016-10-01||||October 2016|Actual|2016-10-01||Interventional|||Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy|Prospective Randomized Trial to Compare the Clinical Efficiency (Adenoma Detection Rate) of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy|Completed||N/A|1000|Actual|Smart Medical Systems Ltd.||2|||f||||f||||||||||2017-10-11 01:25:17.149265|2017-10-11 01:25:17.149265
NCT01917500|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-08-05|||August 2013||2013-08-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||Feasibility Study of Non-invasive and Continuous Measurement of Blood Pressure and Cardiac Output: Comparison to Non-invasive and Non-continuous Measurements|Feasibility Study of Non-invasive and Continuous Measurement of Blood Pressure and Cardiac Output: Comparison to Non-invasive and Non-continuous Measurements|Unknown status|Not yet recruiting|N/A|10|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 01:25:17.282347|2017-10-11 01:25:17.282347
NCT01917487|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-09-09|||November 2011||2011-11-01|September 2013|2013-09-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Observational|||A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode|A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode|Unknown status|Active, not recruiting|N/A|150|Anticipated|OrSense, Ltd.|||1||f||||f||||||||||2017-10-11 01:25:17.372631|2017-10-11 01:25:17.372631
NCT01917474|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-11-21|||July 2013||2013-07-01|November 2014|2014-11-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Effects of Changes in Dietary Intake and Headache's Attacks|Effects of Changes in Dietary Intake and Headache's Attacks|Unknown status|Recruiting|N/A|150|Anticipated|Federico II University||2|||f||||t||||||||||2017-10-11 01:25:17.460368|2017-10-11 01:25:17.460368
NCT01917461|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-03-06|||September 2010||2010-09-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Observational|CURIOSITY||Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections|Observational, Prospective Study to Evaluate Biomarkers as Indicators of Bacterial or Viral Infection During Acute Infectious Diseases|Completed||N/A|1001|Actual|MeMed Diagnostics Ltd.|||1||f||||f||||||Samples Without DNA|"     Blood samples Nasopharyngeal samples   "|No||2017-10-11 01:25:17.58993|2017-10-11 01:25:17.58993
NCT01917448|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-04-06|||February 2014||2014-02-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Low-dose Spinal Morphine for Post-Thoracotomy Pain After Video-Assisted Thoracoscopic Surgery|Low-dose Spinal Morphine for Post-Thoracotomy Pain After Video-Assisted Thoracoscopic Surgery: A Prospective Randomized Double-Blind Controlled Trial|Completed||Phase 4|36|Actual|Mahidol University||2|||f||||t||||||||Undecided||2017-10-11 01:25:17.687524|2017-10-11 01:25:17.687524
NCT01917435|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-08-04|||January 2013||2013-01-01|August 2013|2013-08-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Video-stylet for Nasotracheal Intubation in Limited Mouth Opening Patient|Nasotracheal Intubation Assisted by a Video-stylet in Limited Mouth Opening Patient|Unknown status|Recruiting|N/A|80|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:25:17.790578|2017-10-11 01:25:17.790578
NCT01917422|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2013-08-04|||July 2012||2012-07-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Clinical Specimens Testing Program of Dengue Antigen Detection Reagents|Clinical Specimens Testing Program of Dengue Antigen Detection Reagents|Completed||N/A|195|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||Samples With DNA|"     no biospecimens are to be retained   "|||2017-10-11 01:25:17.902233|2017-10-11 01:25:17.902233
NCT01917409|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-08-04|||December 2012||2012-12-01|July 2013|2013-07-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Video-stylet for Nasotracheal Intubation|Comparison of Conventional Laryngoscopy and Video-stylet to Assist Nasotracheal Intubation for Patients Undergoing Oro-Maxillo-facial Surgery|Unknown status|Recruiting|N/A|100|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:25:17.976001|2017-10-11 01:25:17.976001
NCT01917396|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-04|2015-02-19|||August 2013||2013-08-01|January 2015|2015-01-01|October 2014|Anticipated|2014-10-01|December 2013|Anticipated|2013-12-01||Expanded Access|||Influence of Preoperative Enema Application on Return of Gastrointestinal Function After Elective Cesarean Section: A Randomized Controlled Study||Approved for marketing||N/A|||Istanbul Bakirkoy Maternity and Children Diseases Hospital|||||f||||t||||||||||2017-10-11 01:25:18.091523|2017-10-11 01:25:18.091523
NCT01917383|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-08-15||2015-03-23|August 2013||2013-08-01|August 2017|2017-08-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma|A Phase II Multi-center, Randomized Study to Evaluate the Monocular Addition of Trabodenoson (INO-8875) Ophthalmic Formulation to Latanoprost Ophthalmic Solution Therapy in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma|Completed||Phase 2|101|Actual|Inotek Pharmaceuticals Corporation||2|||f||||f||||||||||2017-10-11 01:25:18.176971|2017-10-11 01:25:18.176971
NCT01917370|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-05|||October 2012||2012-10-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|icc||VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway|VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF|Unknown status|Active, not recruiting|N/A|20|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||f||||||Samples Without DNA|"     Cut tissue into small pieces (~2 mm2)and wash in drops of saline (1x PBS). Place pieces     individually into LN2 in Styrofoam cup. Transfer pieces into LN2-cooled 1.5 mL cryovial. Pour     out excess LN2 from vial, then seal and keep in LN2 until freezer storage.   "|||2017-10-11 01:25:18.289226|2017-10-11 01:25:18.289226
NCT01917357|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2014-07-12|||September 2013||2013-09-01|February 2014|2014-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject|A Phase III, Open-label, Randomized Parallel-group Study on the Immunogenicity and Safety of Quinvaxem® DTwP-HepB-Hib) in Uniject™ With Quinvaxem® Monodose Vials in Healthy Infants at 6, 10 and 14 Weeks of Age|Completed||Phase 3|400|Actual|Crucell Holland BV||2|||f||||f||||||||||2017-10-11 01:25:18.426107|2017-10-11 01:25:18.426107
NCT01917344|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2015-06-02|2015-05-08||August 2013||2013-08-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Adults (ages 18 and older) with phenylketonuria (PKU)|The Brain, Neurological Features and Neuropsychological Functioning in Adults With Phenylketonuria: A Pilot Study|The Brain, Neurological Features and Neuropsychological Functioning in Adults With Phenylketonuria: A Pilot Study|Completed||N/A|10|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-11 01:25:18.573648|2017-10-11 01:25:18.573648
NCT01917331|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2017-02-21|||March 2014||2014-03-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD|A Phase 3 Randomised Double Blind Randomised Parallel Multinational Trial Comparing a Fixed Combination of Beclometasone+Formoterol+Glycopyrrolate to Foster® in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|1368|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||t||||||||No||2017-10-11 01:25:18.821368|2017-10-11 01:25:18.821368
NCT01917305|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2013-08-06|||February 2007||2007-02-01|August 2013|2013-08-01||||March 2010|Actual|2010-03-01||Interventional|||Influence of Platform-switching on Bone Level Alterations: a 3 Year Randomized Clinical Trial (RCT).|Influence of Platform-switching on Bone Level Alterations: a 3 Year RCT.|Completed||N/A|25|Actual|University Hospital, Bonn||2|||f||||||||||||||2017-10-11 01:25:19.075336|2017-10-11 01:25:19.075336
NCT01917292|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-04-15|||December 2012||2012-12-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Impact of Periodontal Intervention on Vascular Dysfunction|Periodontal Intervention Improves Vascular Function Among Chinese Prehypertensive Adults With Periodontitis|Completed||Phase 3|123|Actual|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 01:25:19.183138|2017-10-11 01:25:19.183138
NCT01917279|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-11-21|||October 2013||2013-10-01|November 2013|2013-11-01|September 2018|Anticipated|2018-09-01|July 2016|Anticipated|2016-07-01||Interventional|CAMELLIA||Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC|A Randomized Phase III Study of Metronomic vs. Intermittent Capecitabine Maintenance Therapy Following First-line Capecitabine and Docetaxel Therapy in HER2-negative Metastatic Breast Cancer|Recruiting||Phase 3|928|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:25:19.307843|2017-10-11 01:25:19.307843
NCT01917266|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-07-13|||July 2013|Actual|2013-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide|Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide|Completed||N/A|40|Anticipated|St. Jude Medical|||2||f||||t||||||||||2017-10-11 01:25:19.468782|2017-10-11 01:25:19.468782
NCT01917253|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-05|||September 2013||2013-09-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|Long&short||Standard Length Catheters vs Long Catheters in Peripheral Vein Cannulation.|Standard Length Catheters vs Long Catheters in Peripheral Vein Cannulation. A Randomized Controlled Clinical Trial to Test the Complications.|Unknown status|Recruiting|N/A|220|Anticipated|ASL TO2 Torino||2|||f||||t||||||||||2017-10-11 01:25:19.546733|2017-10-11 01:25:19.546733
NCT01917240|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-06-21|||July 2013||2013-07-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|SuMMIT||Sequential vs. Monophasic Media Impact Trial (SuMMIT)|Evaluation of the Impact of Monophasic vs. Sequential Media on the Reproductive Potential of Embryos Undergoing in Vitro Fertilization (IVF)|Completed||Phase 4|200|Actual|Reproductive Medicine Associates of New Jersey||2|||f||||f||||||||||2017-10-11 01:25:19.670563|2017-10-11 01:25:19.670563
NCT01917227|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2014-06-06|||July 2013||2013-07-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|EGVD||Evaluation of Group Health Teaching With Video in Diabetic Patients|Evaluation of Group Health Teaching With Video in Diabetic Patients|Completed||N/A|80|Actual|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-10-11 01:25:19.770662|2017-10-11 01:25:19.770662
NCT01917214|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-03-13|2015-03-13||August 2013||2013-08-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||Analysis population included participants diagnosed with metastatic renal cell carcinoma (mRCC) during the time period between 1 January 2006 and 31 December 2011.|A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival|Patterns Of Care Among Australian Cohort Of Patients With Advanced Rrc Receiving Sutent|Completed||N/A|212|Actual|Pfizer|Due to retrospective nature of this study, PFS could not be determined as restaging scans are not done on a consistent and regular basis in clinical practice. Time to treatment failure was used as a surrogate for PFS.||1||f||||f||||||||||2017-10-11 01:25:19.880254|2017-10-11 01:25:19.880254
NCT01917201|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2014-10-26|||March 2012||2012-03-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|ORENBURG||Optimal dRug Eluting steNts Implantation Guided By Intravascular Ultrasound and Optical coheRence tomoGraphy ORENBURG|Prospective, Single-center, Randomized Trial, Intended to Compare of Intravascular Ultrasound and Optical Coherence Tomography Guided Implantation of Different Drug-eluting Stents and Implantation Without Using of Intravascular Visualization|Unknown status|Recruiting|N/A|1000|Anticipated|The Orenburg Regional Clinical Hospital||2|||f||||f||||||||||2017-10-11 01:25:20.475995|2017-10-11 01:25:20.475995
NCT01917175|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-05|2013-08-05|||June 1997||1997-06-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|PRECO-CI||Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire|"Research Platform  Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire "|Unknown status|Recruiting|N/A|564|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f||||||Samples With DNA|"     Plasma and whole blood for PBMC preparation   "|||2017-10-11 01:25:20.687398|2017-10-11 01:25:20.687398
NCT01917162|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-04|2013-11-06|||September 2013||2013-09-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses (Study 2)|Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses|Completed||N/A|86|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:25:20.792075|2017-10-11 01:25:20.792075
NCT01917149|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-05-16|||March 2005||2005-03-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy|Efficacy and Safety Study of Supramaximal Titrated Inhibition of RAAS in Idiopathic Dilated Cardiomyopathy|Completed||Phase 4|480|Actual|Xijing Hospital||5|||f||||t||||||||||2017-10-11 01:25:20.893968|2017-10-11 01:25:20.893968
NCT01917136|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2017-06-22|||August 2013|Actual|2013-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension|Evaluation of Regional Myocardial Perfusion, Glucose Utilization and Oxidative Metabolism in Patients With Pulmonary Hypertension Using Combined [11C]Acetate and [18F]Fluorodeoxyglucose (FDG) PET/CT and Cardiovascular MRI|Active, not recruiting||Phase 2|36|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:25:21.010778|2017-10-11 01:25:21.010778
NCT01917123|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2013-08-03|||August 2013||2013-08-01|July 2013|2013-07-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease|Phase 0 Study of The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease According to Their Smoking History|Unknown status|Not yet recruiting|Early Phase 1|20|Anticipated|Masih Daneshvari Hospital||2|||f||||f||||||||||2017-10-11 01:25:21.096863|2017-10-11 01:25:21.096863
NCT01917110|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-01-12|||September 2013||2013-09-01|January 2017|2017-01-01|January 2017|Anticipated|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy and Safety of MiSight ® Contact Lenses in Reducing the Progression of Childhood Myopia.|Efficacy and Safety of MiSight ® Contact Lenses in Reducing the Progression of Childhood Myopia, Not Pathological, Aged 8-12 Years Randomized Clinical Trial.|Active, not recruiting||Phase 4|80|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 01:25:21.206927|2017-10-11 01:25:21.206927
NCT01917097|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-10-26|||August 2013||2013-08-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Bradycardia Following Intraoperative Administration of Dexmedetomidine||Completed||N/A|921|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 01:25:21.297962|2017-10-11 01:25:21.297962
NCT01917084|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-03-17|||June 2013||2013-06-01|December 2013|2013-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|TEAM 4 Growth||Training in Exercise Activities and Motion for Growth|Training in Exercise Activities and Motion for Growth (A Study Conducted by the Pediatric Heart Network)|Completed||N/A|20|Actual|New England Research Institutes||1|||f||||t||||||||||2017-10-11 01:25:21.414127|2017-10-11 01:25:21.414127
NCT01917071|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-07-27|||August 2013||2013-08-01|August 2013|2013-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of Directional Specific Thoracic Spine Mobilization on Cervical Spine Pain|The Effect of Directional Specific Thoracic Spine Mobilization on Cervial Spine Pain.|Completed||N/A|60|Anticipated|Chatham University||1|||f||||t||||||||||2017-10-11 01:25:21.523951|2017-10-11 01:25:21.523951
NCT01917058|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-07-23|||August 2013||2013-08-01|July 2014|2014-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata|A Randomized Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata|Withdrawn||Phase 2|0|Actual|Columbia University||2||Unfortunately we did not receive funding and therefore were not able to begin the trial.|f||||t||||||||||2017-10-11 01:25:21.607474|2017-10-11 01:25:21.607474
NCT01917045|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-08-03|||January 2012||2012-01-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Different Lipid Soluble Opioids for Gynecologic Laparoscopic Surgery Postoperative Patient-controlled Analgesia|Different Lipid Soluble Opioids for Gynecologic Laparoscopic Surgery Postoperative Patient-controlled Analgesia --- a Double Blind Randomized Study|Completed||N/A|180|Actual|Peking University First Hospital||2|||f||||f||||||||||2017-10-11 01:25:21.721165|2017-10-11 01:25:21.721165
NCT01917032|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-05|||September 2013||2013-09-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Effect of Home-fortification With Sprinkles in Hematologic and Nutritional Status in Preschool Children in Medellín|Effect of Home-fortification With Micronutrient Powder Sprinkles in Hematologic and Nutritional Status in Preschool Children in Medellín: a Randomized Clinical Trial.|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|CES University||2|||f||||f||||||||||2017-10-11 01:25:21.895641|2017-10-11 01:25:21.895641
NCT01911299|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2014-07-30|||May 2013||2013-05-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders|Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders|Completed||Phase 2|55|Actual|San Diego State University||2|||f||||t||||||||||2017-10-11 01:26:43.291961|2017-10-11 01:26:43.291961
NCT01917019|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-03-17|||August 2013||2013-08-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|October 2015|Actual|2015-10-01||Interventional|MOTION - JAPAN||A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis|A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Subjects With Multiple Sclerosis Followed by an Open-Label Safety Extension|Completed||Phase 3|101|Actual|Biogen||4|||f||||||||||||||2017-10-11 01:25:22.049034|2017-10-11 01:25:22.049034
NCT01917006|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-09-18|||August 27, 2013|Actual|2013-08-27|September 2017|2017-09-01|August 15, 2017|Actual|2017-08-15|August 15, 2017|Actual|2017-08-15||Interventional|||A Safety and Efficacy Study of BOTOX® in Premature Ejaculation|An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation|Terminated||Phase 2|59|Actual|Allergan||7|||f||||t|t|f||||||||2017-10-11 01:25:22.208232|2017-10-11 01:25:22.208232
NCT01916993|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-01-14|||August 2013||2013-08-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild,Moderate, or Severe Hepatic Insufficiency|A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild, Moderate, or Severe Hepatic Insufficiency|Completed||Phase 1|24|Actual|Neurocrine Biosciences||4|||f||||f||||||||||2017-10-11 01:25:22.363814|2017-10-11 01:25:22.363814
NCT01916980|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-08-05|2014-11-12||August 2013||2013-08-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)|A Phase III, Multicenter, Open-Label Long-Term Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Eczema/Dermatitis and Dermal Pruritus.|Completed||Phase 3|94|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 01:25:22.476309|2017-10-11 01:25:22.476309
NCT01916967|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2015-08-04|2014-10-24||August 2013||2013-08-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)|A Phase III Multicentre, Parallel-group, Randomized, Placebo-controlled, Double-blind Clinical Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Chronic Urticaria.|Completed||Phase 3|239|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 01:25:22.998138|2017-10-11 01:25:22.998138
NCT01916954|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2014-03-24|||July 2013||2013-07-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Interventional|ALN5P||Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancy|Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Pregnant Women in the Democratic Republic of Congo|Completed||Phase 3|96|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 01:25:23.709266|2017-10-11 01:25:23.709266
NCT01916928|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-02-01|2014-12-31||May 2013||2013-05-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Observational||Analysis of cell free fetal DNA in 50 non-viable pregnancies.|The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage|The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage|Completed||N/A|50|Actual|Medstar Health Research Institute|||1||f||||f||||||Samples With DNA|"     Blood collection will consist of two ten milliliters samples of whole blood in the cffDNA     STRECK tube. Plasma will be retained for analysis of circulating cell free fetal DNA.   "|||2017-10-11 01:25:23.879586|2017-10-11 01:25:23.879586
NCT01916915|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-06-28|||July 2013||2013-07-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Usage of Tramadol With Levobupivacaine for Pain Treatment After Cesarean Section|The Effect of Addition of Tramadol to Levobupivacaine in Continuous Wound Infusion for Postoperative Pain Treatment in Cesarean Section|Completed||Phase 4|65|Actual|Ufuk University||3|||f||||f||||||||No||2017-10-11 01:25:24.017722|2017-10-11 01:25:24.017722
NCT01916902|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-05-23|||February 2014||2014-02-01|May 2014|2014-05-01||||February 2015|Anticipated|2015-02-01||Interventional|||Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study|Effect of Pretreatment With Ticagrelor on Residual Thrombus After Percutaneous Coronary Intervention (PCI) in Patients Presenting With Acute Coronary Syndrome in Comparison With Delayed Treatment at the Time of PCI: an Optical Coherence Tomography Study|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||2||Despite a large number of patients screened, very few met eligibility guidelines.|f||||||||||||||2017-10-11 01:25:24.09261|2017-10-11 01:25:24.09261
NCT01916889|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-05-10|||September 2013||2013-09-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional|RACY||"4-question RACY Delirium Screening Tool Validation Study"|"Validation Study of the 4-question RACYDelirium Screening Tool in General Medical In-patients From a Developing Country Setting"|Completed||N/A|1093|Actual|University of Cape Town||1|||f||||f||||||||||2017-10-11 01:25:24.170085|2017-10-11 01:25:24.170085
NCT01916876|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2014-12-02|||March 2015||2015-03-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|RECALL-CT||Impact of Medical Follow-up Discharge Package|A Randomised Controlled Trial of an Integrated Post-discharge Transitional Care Package for General Medical In-patients in Cape Town, South Africa|Withdrawn||N/A|0|Actual|University of Cape Town||2||Funding shortage|f||||f||||||||||2017-10-11 01:25:24.252161|2017-10-11 01:25:24.252161
NCT01916863|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-10-28|||August 2013||2013-08-01|October 2013|2013-10-01||||October 2013|Actual|2013-10-01||Interventional|||Study to Evaluate the Effect of Single Doses of LX4211 and Canagliflozin on Intestinal Glucose Absorption in Healthy Adult Subjects|A Phase 1, Single-center, Partially Double-blind, Randomized, Single-dose, 3-Period Crossover Study to Assess the Pharmacodynamic Effects of LX4211 and INVOKANA™ (Canagliflozin) in Healthy Subjects Using Stable Isotope Tracer Methods|Completed||Phase 1|25|Actual|Lexicon Pharmaceuticals||3|||f||||||||||||||2017-10-11 01:25:24.327293|2017-10-11 01:25:24.327293
NCT01911286|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-10-10|||July 2013||2013-07-01|October 2016|2016-10-01||||December 2015|Actual|2015-12-01|1 Day|Observational [Patient Registry]|APNEE REA||Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain in Potentiel Organ Donors.||Completed||N/A|208|Actual|Poitiers University Hospital|||2||f||||||||||||||2017-10-11 01:26:43.392234|2017-10-11 01:26:43.392234
NCT01916850|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-10-28|||August 2013||2013-08-01|October 2013|2013-10-01||||October 2013|Actual|2013-10-01||Interventional|||Study to Determine the Safety, Tolerability and Pharmacokinetics Following Multiple Doses of LX4211 in Healthy Subjects|A Phase 1b, Single-center, Double-blind, Randomized, Placebo-controlled Study on the Safety, Tolerability, and Pharmacokinetic Effects of Multiple Doses of LX4211 400 mg qd and LX4211 800 mg qd in Healthy Subjects|Completed||Phase 1|25|Actual|Lexicon Pharmaceuticals||3|||f||||||||||||||2017-10-11 01:25:24.412591|2017-10-11 01:25:24.412591
NCT01916837|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-08-02|||February 2010||2010-02-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer|Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer|Completed||N/A|180|Actual|Jules Bordet Institute|||1||f||||f||||||Samples Without DNA|"     This study includes the collection of fresh-frozen tumor biopsies at the time of breast     cancer surgery.   "|||2017-10-11 01:25:24.647662|2017-10-11 01:25:24.647662
NCT01916811|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2013-08-05|||January 2013||2013-01-01|August 2013|2013-08-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Load Quantitative MRI Study of Incipient LBP Patients.|Load Quantitative MRI Study of Incipient LBP Patients.|Unknown status|Recruiting|N/A|60|Anticipated|Central South University|||1||f||||t||||||||||2017-10-11 01:25:24.870982|2017-10-11 01:25:24.870982
NCT01916798|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-03|2014-12-25|||May 2013||2013-05-01|December 2014|2014-12-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Interventional|||Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI)|Intravenous Intralipid Therapy Among Women Aged 35-40 Years With Positive Peripheral Blood Natural Killer Cells Undergoing in Vitro Fertilization-Embryo Transfer: A Randomized Controlled Trial.|Unknown status|Recruiting|Phase 3|200|Anticipated|Cairo University||2|||f||||f||||||||||2017-10-11 01:25:24.970899|2017-10-11 01:25:24.970899
NCT01916785|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-08-19|||May 2009||2009-05-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|OPTIM-DASA||OPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy)|A PROSPECTIVE RANDOMIZED PHASE II STUDY EVALUATING THE OPTIMIZATION OF THE RESIDUAL PLASMATIC LEVEL OF DASATINIB (SPRYCEL®) IN PATIENTS NEWLY DIAGNOSED WITH CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML).|Completed||Phase 2|289|Actual|Versailles Hospital||3|||f||||t||||||||||2017-10-11 01:25:25.104376|2017-10-11 01:25:25.104376
NCT01916772|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-01-06|||July 2013||2013-07-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Natural History of Cherubism Observational Study|Natural Hisotry of Cherubism Observational Study|Completed||N/A|33|Actual|The Cleveland Clinic|||1||f||||f||||||Samples With DNA|"     We may take blood or skin samples.   "|No|There is no plan to share IPD.|2017-10-11 01:25:25.334716|2017-10-11 01:25:25.334716
NCT01916759|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-04-22|||June 2013||2013-06-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda|Systems Biological Responses to Influenza Vaccination in an HIV-infected and HIV-uninfected Adult Population in Kampala, Uganda|Completed||N/A|63|Actual|Emory University||3|||f||||f||||||||||2017-10-11 01:25:25.444259|2017-10-11 01:25:25.444259
NCT01916746|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-08-02|||January 2013||2013-01-01|January 2013|2013-01-01||||December 2015|Anticipated|2015-12-01||Interventional|CSP||Treatment of Caesarean Scar Pregnancy|Safety and Effectiveness of Transvaginal Resection of Pregnancy Tissue in the Treatment of Caesarean Scar Pregnancy|Unknown status|Recruiting|N/A|150|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||||2017-10-11 01:25:25.572914|2017-10-11 01:25:25.572914
NCT01916733|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-10-24|||January 2013||2013-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study|A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Patients After Vascular Surgery|Completed||N/A|89|Actual|University of Vermont Medical Center|||2||f||||f||||||||||2017-10-11 01:25:25.690002|2017-10-11 01:25:25.690002
NCT01916720|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-12-02|||January 2003||2003-01-01|December 2016|2016-12-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy|A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Effect of the Lp-PLA2 Inhibitor SB-480848 (40, 80mg od) on Carotid Plaque Composition in Patients With Carotid Artery Disease and Planned Carotid Endarterectomy, Stratified for Statin Use and Gender, After 14+/-4 Days Treatment|Completed||Phase 2|103|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:25:25.797939|2017-10-11 01:25:25.797939
NCT01916707|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-04-04|||July 2013||2013-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|WeBET||Weight Based Enoxaparin in Trauma Patients|Weight Based Enoxaparin for Venous Thromboembolism Prophylaxis in Trauma Patients|Active, not recruiting||Phase 4|1200|Anticipated|Intermountain Health Care, Inc.||2|||f||||t||||||||||2017-10-11 01:25:25.904392|2017-10-11 01:25:25.904392
NCT01916694|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-05-19|||September 2013||2013-09-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|TREAT-GDM||Trial of Remote Evaluation and Treatment of Gestational Diabetes Mellitus|A Randomised Pilot Trial to Compare Remote Blood Glucose Monitoring With Standard Clinical Care in the Gestational Diabetic Population|Completed||N/A|203|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 01:25:26.011363|2017-10-11 01:25:26.011363
NCT01916681|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-04-10|2016-10-05||May 2013||2013-05-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|FORMOMI||Foley OR MisO for the Management of Induction|Foley OR MisO for the Management of Induction (FOR MOMI) Trial|Completed||N/A|491|Actual|University of Pennsylvania||4|||f||||t||||||||No||2017-10-11 01:25:26.152449|2017-10-11 01:25:26.152449
NCT01916668|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2014-05-06|||April 2013||2013-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||A Cross-sectional Study on Intradialytic Hypertension at Four Haemodialysis Units in the Western Cape|A Cross-sectional Study on Intradialytic Hypertension at Four Haemodialysis Units in the Western Cape, South Africa|Completed||N/A|200|Actual|University of Stellenbosch|||1||f||||f||||||||||2017-10-11 01:25:26.960115|2017-10-11 01:25:26.960115
NCT01916655|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-07-12|||August 3, 2015|Actual|2015-08-03|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Improving the Frequency and Quality of Sleep Apnea Care Management|Improving the Frequency and Quality of Sleep Apnea Care Management|Recruiting||N/A|360|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||||2017-10-11 01:25:27.03014|2017-10-11 01:25:27.03014
NCT01916642|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-08-01|||April 2013||2013-04-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||A Dose-response Study of Lidocaine and Etomidate|Can Intravenous Lidocaine Decrease the Minimal Inducing Dose of Etomidate?: A Randomized Placebo-controlled Dose-response Study.|Completed||Phase 1|100|Actual|West China Hospital||5|||f||||f||||||||||2017-10-11 01:25:27.141321|2017-10-11 01:25:27.141321
NCT01916629|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-02-12|2015-12-11||August 2013||2013-08-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Photocil (Topical) for the Treatment of Psoriasis Vulgaris|Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Psoriasis Vulgaris|Completed||N/A|12|Actual|Applied Biology, Inc.||2|||f||||f||||||||||2017-10-11 01:25:27.252489|2017-10-11 01:25:27.252489
NCT01916616|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-09-13|||August 2013||2013-08-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||A Multidisciplinary Approach to Vocal Cord Dysfunction: A Novel Pilot Study|A Multidisciplinary Approach to Vocal Cord Dysfunction: A Novel Pilot Study|Unknown status|Recruiting|N/A|20|Anticipated|CAMC Health System||1|||f||||f||||||||||2017-10-11 01:25:27.474056|2017-10-11 01:25:27.474056
NCT01916603|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-08-01|||September 2013||2013-09-01|July 2013|2013-07-01|March 2017|Anticipated|2017-03-01|September 2013|Anticipated|2013-09-01||Interventional|||Diet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and Development|Effectiveness of a Normative Intervention (Diet, Physical Activity and Breastfeeding) on Maternal Nutrition and Offspring Growth and Development: Nutrition in the First 1000 Days Key to Healthy Growth and Long-term Health.|Unknown status|Not yet recruiting|N/A|2400|Anticipated|University of Chile||2|||f||||t||||||||||2017-10-11 01:25:27.54394|2017-10-11 01:25:27.54394
NCT01916590|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-06-17|2016-03-07||July 2011||2011-07-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effectiveness of Continuous Femoral Nerve Block Versus Single Shot Femoral Nerve Block for Pain Control|Effectiveness of Continuous Femoral Nerve Block Versus Single Shot Femoral Nerve Block for Pain Control After Anterior Cruciate Ligament Reconstruction With Patellar Tendon Graft or Allograft|Terminated||N/A|7|Actual|University of Colorado, Denver|Serious and Other (Not Including Serious) Adverse Events were not monitored/collected for the 7 enrolled participants.|2||lack of patients|f||||f||||||||||2017-10-11 01:25:27.643835|2017-10-11 01:25:27.643835
NCT01916577|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-05-23|||August 2013||2013-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation|Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation|Recruiting||Phase 1|20|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:25:27.852676|2017-10-11 01:25:27.852676
NCT01916564|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-08-01|||August 2012||2012-08-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Split-dose Versus Same-day Reduced-volume PEG-ELS Plus Bisacodyl for Morning Colonoscopy|Efficacy and Tolerability of Split-dose Versus Same-day Administration of Reduced-volume PEG-ELS Plus Bisacodyl for Morning Colonoscopy: a Randomised Trial|Completed||N/A|303|Actual|University of Malaya||2|||f||||f||||||||||2017-10-11 01:25:27.996056|2017-10-11 01:25:27.996056
NCT01916538|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-12-13|||June 2013||2013-06-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|ANGI||Anorexia Nervosa Genetics Initiative|Anorexia Nervosa Genetics Initiative|Completed||N/A|22445|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"     The blood sample participants provide will be used to identify biological characteristics and     other biological markers. Some analyses will include genetic analyses which are measured     using DNA and can look at places in DNA, and others can analyze most of the genome. Other     analyses measure a large number of proteins. Still others assess the messenger substance     (called RNA) that transfers information from DNA to protein. Investigators plan to store the     blood specimens and data indefinitely.      Investigators will be collecting DNA to permit immediate and future genetic analyses and     analyses of immune, endocrine, and proteins. All blood will be biobanked indefinitely to     allow for assays that may become available in the future analyses.   "|||2017-10-11 01:25:28.071835|2017-10-11 01:25:28.071835
NCT01916525|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-08-01|||February 2011||2011-02-01|August 2013|2013-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|EFEX-CARE||Effectiveness of Exercise Cardiac Rehabilitation|Effectiveness of Exercise-based Rehabilitation Program for Patients After Acute Coronary Syndrome|Unknown status|Recruiting|N/A|300|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-11 01:25:28.144421|2017-10-11 01:25:28.144421
NCT01916512|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-04-14|||February 2012||2012-02-01|August 2013|2013-08-01||||March 2016|Anticipated|2016-03-01||Observational|INFINITY||Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia|Investigation of Relationship Between Cholesteryl Ester Transfer Protein Deficiency and Carotid/Coronary Atherosclerosis in Patients With Hyperalphalipoproteinemia|Unknown status|Recruiting|N/A|1500|Anticipated|Osaka University|||1||f||||f||||||Samples Without DNA|"     serum and plasma   "|||2017-10-11 01:25:28.237192|2017-10-11 01:25:28.237192
NCT01916499|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-05-23|||May 2012|Actual|2012-05-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|April 2015|Actual|2015-04-01||Observational|||MRI Study After Arterial Switch Operation in Patients With Transposition of the Great Arteries|MRI Study After Arterial Switch Operation in Patients With Transposition of the Great Arteries|Completed||N/A|70|Actual|Oslo University Hospital|||2||f||||f||||||||Undecided||2017-10-11 01:25:28.341643|2017-10-11 01:25:28.341643
NCT01916486|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-05-01|||November 2013||2013-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Vitality||Vitality: Promoting Cognitive Function in Older Adults With Chronic Stroke|Complex Mental and Social Activities to Promote Cognitive Function in Older Adults With Chronic Stroke: A Randomized Controlled Trial|Recruiting||N/A|119|Anticipated|University of British Columbia||3|||f||||t||||||||||2017-10-11 01:25:28.420168|2017-10-11 01:25:28.420168
NCT01916473|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-08-01|||April 2010||2010-04-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Epidural Versus Continuous Wound Ropivacaine Infusion Analgesia|Epidural Versus Continuous Wound Ropivacaine Infusion: Effect on Acute and Chronic Pain After Myomectomy or Total Abdominal Hysterectomy. A Randomized Controlled Trial|Completed||N/A|80|Actual|University of Athens||2|||f||||f||||||||||2017-10-11 01:25:28.512882|2017-10-11 01:25:28.512882
NCT01916447|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-10-05|||September 2013|Actual|2013-09-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.|A Phase 1, Open-label, Non-randomized, Dose-escalating Safety, Tolerability, and Pharmacokinetic Study of TAS-102 in Combination With CPT-11 and Bevacizumab in Patients With Advanced Gastrointestinal Tumors|Completed||Phase 1|65|Anticipated|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-10-11 01:25:28.663519|2017-10-11 01:25:28.663519
NCT01916434|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-03-24|||March 2013||2013-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|FISHDISH||Farmed Fish Human Intervention Study|FIsh for a Sustainable Healthy Diet In Scottish Households Study|Completed||N/A|51|Actual|University of Aberdeen||3|||f||||f||||||||||2017-10-11 01:25:30.427347|2017-10-11 01:25:30.427347
NCT01916421|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2017-05-15|||September 2012||2012-09-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Cellularity Yield of Three Different 22-gauge FNA Needles|The Cellularity Yield of Three Different 22-gauge Endoscopic Ultrasound Fine Needle Aspiration Needles|Completed||N/A|107|Actual|Texas Tech University Health Sciences Center, El Paso||3|||f||||t||||||||No||2017-10-11 01:25:30.528762|2017-10-11 01:25:30.528762
NCT01916408|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-06-29|||August 2013||2013-08-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Interventional|Enzy-MagIC||The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon|The Effects of Oral Proteolytic and Hydrolytic Enzymes and Flavonoids on Inflammatory Markers and Coagulation After Marathon Running|Completed||Phase 1|160|Actual|Technische Universität München||2|||f||||t||||||||||2017-10-11 01:25:30.616645|2017-10-11 01:25:30.616645
NCT01916395|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-02|||December 2009||2009-12-01|December 2009|2009-12-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Observational|||Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache|Comparison of Treximet and Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache.|Completed||N/A|30|Actual|Westside Family Medical Center, P.C.|||1||f||||t||||||||||2017-10-11 01:25:30.753075|2017-10-11 01:25:30.753075
NCT01916382|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-01-12|||April 2014||2014-04-01|August 2013|2013-08-01|April 2018|Anticipated|2018-04-01|February 2016|Anticipated|2016-02-01||Interventional|SONIA 2||Suitability of Nitisinone in Alkaptonuria 2|An International, Multicentre, Randomised, Evaluator-blind, No-treatment Controlled, Parallel-group Study to Assess the Efficacy and Safety of Once Daily Nitisinone in Patients With Alkaptonuria After 12 Months of Treatment, Followed by an Additional 36 Month Treatment Period.|Active, not recruiting||Phase 3|140|Anticipated|University of Liverpool||2|||f||||t||||||||||2017-10-11 01:25:30.85466|2017-10-11 01:25:30.85466
NCT01916369|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-04-23|||April 2014||2014-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia|A Phase I Ascending Dose Safety Study Of Intramuscular CTX0E03 In Patients With Lower Limb Ischaemia|Active, not recruiting||Phase 1|5|Actual|ReNeuron Limited||1|||f||||t||||||||||2017-10-11 01:25:30.973341|2017-10-11 01:25:30.973341
NCT01916356|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2014-12-01|||August 2013||2013-08-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Improving Knowledge About Infertility; an Online Educational Tool|Improving Knowledge About Infertility Etiologies, Risk Factors, Treatments and Fertility Myths; an Online Educational Tool|Completed||N/A|72|Actual|Queen's University||1|||f||||f||||||||||2017-10-11 01:25:31.090524|2017-10-11 01:25:31.090524
NCT01916343|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-05-23|||July 2013||2013-07-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Laparoscopic Gynecology Curriculum for Residents|Design of a Comprehensive Evidence-Based Laparoscopy Curriculum for Gynecology Residents|Completed||N/A|27|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:25:31.183155|2017-10-11 01:25:31.183155
NCT01916330|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2014-11-20|||December 2012||2012-12-01|August 2013|2013-08-01||||December 2015|Anticipated|2015-12-01||Observational|||Development of Pharmacokinetics Model in Pregnancy Women and Fetus||Unknown status|Recruiting|N/A|120|Anticipated|Seoul National University Hospital|||1||f||||||||||||||2017-10-11 01:25:31.259829|2017-10-11 01:25:31.259829
NCT01916317|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-10-18|||December 2011||2011-12-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer|Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer|Recruiting||Phase 3|1600|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:25:31.341969|2017-10-11 01:25:31.341969
NCT01916304|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-06-22|2015-06-22||July 2013||2013-07-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation|A Multicentre, Open-label Switch Study to Investigate the Necessity of Dose Adjustment After Switching From L-Thyroxine Christiaens® to the New Levothyroxine Sodium Test Formulation in (Near) Total Thyroidectomised Patients.|Completed||Phase 2|101|Actual|Takeda||1|||f||||f||||||||||2017-10-11 01:25:31.618793|2017-10-11 01:25:31.618793
NCT01916291|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-09-01|||July 2013||2013-07-01|August 2013|2013-08-01||||October 2015|Anticipated|2015-10-01||Interventional|||Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38||Unknown status|Recruiting|Phase 2|194|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 01:25:31.940777|2017-10-11 01:25:31.940777
NCT01915628|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-09-06|||May 2013||2013-05-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01|2 Years|Observational [Patient Registry]|||e-BioMatrix Canada Registry|A Canadian Pre-market Registry of the BioMatrix Flex™ Drug Eluting Stents.|Unknown status|Recruiting|N/A|533|Anticipated|Biosensors Europe SA|||1||f||||f||||||||||2017-10-11 01:25:42.352474|2017-10-11 01:25:42.352474
NCT01916278|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-09-23|||September 2013||2013-09-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Efficacy Study of Lip Injections With Emervel Lips Lidocaine and Juvéderm Volbella With Lidocaine|A Randomized, Evaluator-blinded, Comparative Study of the Safety and Efficacy of Lip Injections With Emervel Lips Lidocaine and Juvéderm Volbella With Lidocaine|Completed||N/A|||Q-Med AB||2|||f||||f||||||||||2017-10-11 01:25:32.038969|2017-10-11 01:25:32.038969
NCT01916265|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-02-04|||August 2013||2013-08-01|August 2013|2013-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages|A Randomised, Single Center, Three-period Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages at Four Different Blood Glucose Concentrations|Completed||Phase 1|6|Anticipated|Profil Institut für Stoffwechselforschung GmbH||3|||f||||||||||||||2017-10-11 01:25:32.137347|2017-10-11 01:25:32.137347
NCT01916252|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-09-26|||September 2013||2013-09-01|December 2016|2016-12-01|November 16, 2016|Actual|2016-11-16|November 16, 2016|Actual|2016-11-16||Interventional|GEM2012MENOS65||Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old|A Randomized, National, Open-label, Multicenter, Phase III Trial Studying Induction Therapy With Bortezomib/Lenalidomide/Dexamethasone (VRD-GEM), Followed by High-dose Chemotherapy With Melphalan-200 (MEL-200) Versus Busulfan-melphalan (BUMEL), and Consolidation With VRD-GEM in Patients Under 65 Years Old With Newly-diagnosed, Symptomatic Multiple Myeloma|Completed||Phase 3|460|Anticipated|PETHEMA Foundation||2|||f||||t||||||||||2017-10-11 01:25:32.252457|2017-10-11 01:25:32.252457
NCT01916239|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2015-04-13|||June 2012||2012-06-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|POMEcolon||Pomegranate Extract Supplementation in Colorectal Cancer Patients|Phase I-II Study of Pomegranate Extract Formulations in Colorectal Cancer Patients: Metabolic and Gene Expression Profiling in Tumoral and Normal Colon Tissues|Completed||Phase 1/Phase 2|60|Anticipated|National Research Council, Spain||3|||f||||f||||||||||2017-10-11 01:25:32.523967|2017-10-11 01:25:32.523967
NCT01916226|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-02-17|2014-08-14||August 2013||2013-08-01|February 2017|2017-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis|Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment With Fluticasone Propionate Nasal Spray Versus Cetirizine in Adult Subjects With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 4|682|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:25:32.62882|2017-10-11 01:25:32.62882
NCT01916213|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-10-13|||March 2013||2013-03-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Valve of Hyaluronic Binding Selection (PICSI) in Improving IVF Outcome||Completed||N/A|30|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||t||||||||||2017-10-11 01:25:33.703575|2017-10-11 01:25:33.703575
NCT01916200|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2014-07-14|||January 2014||2014-01-01|July 2014|2014-07-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients|Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients: An Open-label, Randomized, add-on Study|Withdrawn||Phase 4|0|Actual|GlaxoSmithKline||2||This study was Cancelled Before Active|f||||f||||||||||2017-10-11 01:25:33.790758|2017-10-11 01:25:33.790758
NCT01916187|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-02-07|||July 2013||2013-07-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma|A Pilot Study of Imetelstat Given Intravenously on Day 1 and 8 of a 21 Day Schedule Alone and With Standard 13-Cis-Retinoic Acid in Children With Recurrent and/or Refractory Neuroblastoma|Withdrawn||Phase 1|0|Actual|Canadian Cancer Trials Group||1||"drug company withdrww support following a re-examination of the benefit-risk assessment for the   investigational use of imetelstat in this population"|f||||f||||||||||2017-10-11 01:25:33.901064|2017-10-11 01:25:33.901064
NCT01916174|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-11-07|||August 2013||2013-08-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects|A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects|Completed||Phase 1|50|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:25:33.989721|2017-10-11 01:25:33.989721
NCT01916161|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-03-21|||October 2013||2013-10-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients|The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients|Completed||N/A|307|Actual|National Health Service, United Kingdom|||1||f||||f||||||||||2017-10-11 01:25:34.130166|2017-10-11 01:25:34.130166
NCT01916148|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-01-31||||||January 2017|2017-01-01||||||||Expanded Access|||18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia|Expanded Access Use of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia|Available||N/A|||Children's Hospital of Philadelphia|||||||||||||||||||2017-10-11 01:25:34.226232|2017-10-11 01:25:34.226232
NCT01916135|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-06-21|||July 2013||2013-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative||Active, not recruiting||Phase 1|11|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:25:34.320939|2017-10-11 01:25:34.320939
NCT01916109|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-01-14|2016-01-14||August 2013||2013-08-01|January 2016|2016-01-01||||July 2015|Actual|2015-07-01||Interventional|||Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer|Phase II Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer|Terminated||Phase 2|4|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-11 01:25:34.546366|2017-10-11 01:25:34.546366
NCT01914991|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2014-05-05|||June 2011||2011-06-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|September 2011|Actual|2011-09-01||Interventional|StaDinOrt||Combined Static and Dynamic Orthotic Treatment of the PIP Joint|Treatment of the PIP Joint Flexion Contracture: Combined Static and Dynamic Orthotic Intervention Compared With Traditional Combine Therapy. A Randomized Controlled Trial|Completed||Phase 4|62|Actual|University of Malaga||2|||f||||t||||||||||2017-10-11 01:25:34.832786|2017-10-11 01:25:34.832786
NCT01914978|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-07-28|||July 2013||2013-07-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluating the Effectiveness of a Handbook for Parents of Children Newly Diagnosed With Food Allergy|Living Confidently With Food Allergy: Evaluating the Effectiveness of a Handbook for the Newly Diagnosed|Completed||N/A|180|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 01:25:34.913009|2017-10-11 01:25:34.913009
NCT01914965|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-09-08|||June 2012||2012-06-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Action-HD||Apathy Cure Through Bupropion in Huntington's Disease|A Randomized, Double-blind, Placebo-controlled Prospective Crossover Trial Investigating the Efficacy and Safety of the Treatment With Bupropion in Patients With Apathy in Huntington's Disease|Completed||Phase 2|40|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:25:34.996141|2017-10-11 01:25:34.996141
NCT01914952|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-09-15|||May 2013||2013-05-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses|Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses|Completed||N/A|11|Actual|Metabolic Technologies Inc.||5|||f||||f||||||||||2017-10-11 01:25:35.144435|2017-10-11 01:25:35.144435
NCT01914939|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-08-27|||April 2014||2014-04-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder|A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder|Recruiting||Phase 2|100|Anticipated|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-11 01:25:35.273204|2017-10-11 01:25:35.273204
NCT01914926|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-05-01|2013-10-23||June 2009||2009-06-01|May 2014|2014-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|DiME||Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter|DiME Study: Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Response: A Prospective Randomized and Double-Blinded Non-Inferiority Trial of Safety and Efficacy|Completed||Phase 4|54|Actual|Maimonides Medical Center||2|||f||||f||||||||||2017-10-11 01:25:35.411903|2017-10-11 01:25:35.411903
NCT01914913|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa|An Open Labeled Clinical Study to Evaluate the Safety and Efficacy OF Autologous Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) in Retinitis Pigmentosa. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:25:35.705817|2017-10-11 01:25:35.705817
NCT01916083|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2017-09-19|||December 2017||2017-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:25:35.794215|2017-10-11 01:25:35.794215
NCT01916070|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-02|||July 2011||2011-07-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01|6 Months|Observational [Patient Registry]|||Syncope Patient Evaluation in the Emergency Department|Syncope Patient Evaluation in the Emergency Department (SPEED)|Completed||N/A|397|Actual|Klinikum Nürnberg|||2||f||||f||||||||||2017-10-11 01:25:35.842303|2017-10-11 01:25:35.842303
NCT01916057|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-07-31|||November 19, 2013|Actual|2013-11-19|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|CANHPARI||Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis|Multicenter Prospective Pilot Study Investigating Pathophysiology, Diagnostic and Therapeutic Strategies of Hepatosplenic Candidiasis|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f|f|f||||||||2017-10-11 01:25:35.925001|2017-10-11 01:25:35.925001
NCT01916044|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2017-06-13|||July 11, 2013||2013-07-11|June 2017|2017-06-01|November 11, 2019|Anticipated|2019-11-11|May 11, 2019|Anticipated|2019-05-11||Interventional|||Ultrasound Measure of the Thickness of the Lower Segment in Women Having a History of Caesarian|Evaluation of the Efficiency of the Ultrasound Measure of the Thickness of the Lower Segment Associated With a Rule of Decision to Reduce the Foetal and Maternal Morbidity and Mortality in the Care of the Deliveries of the Women Having a History of Caesarian: a Pragmatic Randomized Trial : Lustrial|Recruiting||N/A|2942|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-11 01:25:36.032555|2017-10-11 01:25:36.032555
NCT01916031|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-08-01||||||August 2013|2013-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Appropriate Care of URI (ACURI): Early Head Start||Completed||N/A|||Columbia University||2|||f||||f||||||||||2017-10-11 01:25:36.138832|2017-10-11 01:25:36.138832
NCT01916018|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-08-25|||May 2013||2013-05-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|HYPOTYGEN||Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis.|Phenotype and Genotype Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. The Use of Genetic Analysis in the Early Care of Children With Thyroid Dysgenesis|Active, not recruiting||N/A|558|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:25:36.362248|2017-10-11 01:25:36.362248
NCT01916005|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-08-21|||May 2013||2013-05-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|August 2016|Anticipated|2016-08-01||Interventional|||Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis|Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis|Unknown status|Recruiting|N/A|174|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:25:36.454218|2017-10-11 01:25:36.454218
NCT01915823|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-06-09|2015-03-22||July 2013||2013-07-01|June 2015|2015-06-01||||February 2014|Actual|2014-02-01||Interventional|||Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)|Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis|Completed||Phase 3|348|Actual|Meda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:25:39.661287|2017-10-11 01:25:39.661287
NCT01915992|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-08-29|||February 2013||2013-02-01|August 2014|2014-08-01|January 2015|Anticipated|2015-01-01|August 2014|Anticipated|2014-08-01||Interventional|||Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies|Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies|Unknown status|Recruiting|N/A|15|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:25:36.541719|2017-10-11 01:25:36.541719
NCT01915979|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-05-04|||February 2014||2014-02-01|May 2015|2015-05-01||||May 2015|Anticipated|2015-05-01||Interventional|||Effect of Plasma Rich in Growth Factors in Rotator Cuff Tendinopathy|Role of Biological Therapy in Rotator Cuff Tendinopathy. Effectiveness of Plasma Rich in Growth Factors Regarding Functional Capacity and Pain Compared With the Conventional Treatment Using Steroids|Unknown status|Recruiting|Phase 3|84|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias||2|||f||||f||||||||||2017-10-11 01:25:36.641487|2017-10-11 01:25:36.641487
NCT01915966|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-02-10|||April 2013||2013-04-01|February 2014|2014-02-01||||January 2014|Actual|2014-01-01||Interventional|||Efficacy Study of a Ginger and Cardamom Gelatin for Xerostomy in Terminally Ill Patients|Randomized Clinical Trial of a Ginger and Cardamom Gelatin Compared to a Camomile and Lemon Juice Infusion in Control of Xerostomy in Terminally Ill Patients|Completed||N/A|32|Actual|Fundacio Salut i Envelliment UAB||2|||f||||f||||||||||2017-10-11 01:25:36.782308|2017-10-11 01:25:36.782308
NCT01915953|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-08-04|||February 2011||2011-02-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP|A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP|Unknown status|Active, not recruiting|N/A|500|Anticipated|OrSense, Ltd.|||1||f||||f||||||||||2017-10-11 01:25:36.87851|2017-10-11 01:25:36.87851
NCT01915940|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-08-08||2015-12-01|October 2013||2013-10-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension|A Phase 2, Multicenter, Randomized, Subject- and Examiner-masked, Controlled Clinical Trial Designed to Evaluate the Safety and Effectiveness of the Bimatoprost Ocular Insert as Compared to Topical Timolol Solution (0.5%) in Patients With Glaucoma or Ocular Hypertension|Completed||Phase 2|169|Actual|ForSight Vision5, Inc.||2|||f||||f||||||||||2017-10-11 01:25:36.961501|2017-10-11 01:25:36.961501
NCT01915927|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-09-15|||July 2013|Actual|2013-07-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|November 2017|Anticipated|2017-11-01||Interventional|MSC-AFP||Stem Cell Fistula Plug in Perianal Crohn's Disease|A Phase 1 Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease.|Active, not recruiting||Phase 1|20|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:25:37.114174|2017-10-11 01:25:37.114174
NCT01915914|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-11-19|2015-10-12||December 2013||2013-12-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis|A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic Dermatitis|Completed||Phase 4|107|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 01:25:37.260549|2017-10-11 01:25:37.260549
NCT01915901|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2014-02-28|||August 2013||2013-08-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily|A Multicenter, Double Blind, Placebo-Controlled Study of Pepto-Bismol® (Bismuth Subsalicylate) on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral TECFIDERA™ (Dimethyl Fumarate) Delayed-Release Capsules Twice Daily|Completed||Phase 1|175|Actual|Biogen||2|||f||||||||||||||2017-10-11 01:25:38.643408|2017-10-11 01:25:38.643408
NCT01915888|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-11-13|||August 2013||2013-08-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination|Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination|Completed||N/A|1|Actual|GlaxoSmithKline|||4||f||||||||||||||2017-10-11 01:25:38.764543|2017-10-11 01:25:38.764543
NCT01915875|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-01-29|||February 2012||2012-02-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Interventional|MUCO SOPHRO||Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis|Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis|Completed||N/A|30|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:25:38.875262|2017-10-11 01:25:38.875262
NCT01915862|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-05-18|||August 2013||2013-08-01|May 2015|2015-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01|3 Months|Observational [Patient Registry]|PREVISE||Blood Pressure Variability in Acute Ischemic Stroke|Comparison of Blood Pressure Variability Indices and Ambulatory Arterial Stiffness Index as Prognostic Indicators in the Medium Term Outcome of Acute Ischemic Stroke|Unknown status|Recruiting|N/A|300|Anticipated|Aristotle University Of Thessaloniki|||1||f||||t||||||||||2017-10-11 01:25:38.967091|2017-10-11 01:25:38.967091
NCT01915849|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-01-22|2015-01-22||July 2013||2013-07-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Safety analysis set: all patients that received study drug and with no protocol deviations with relevant impact on safety.|Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus|A Randomized, Double-blinded, Placebo-controlled, Crossover Trial to Assess the Effect of Orally Administered LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|14|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:25:39.063876|2017-10-11 01:25:39.063876
NCT01915836|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2014-12-10|||March 2011||2011-03-01|December 2014|2014-12-01||||December 2014|Actual|2014-12-01||Interventional|||Quit IT: Development of a Web-based, 3D Coping Skills Game to Increase Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization|Quit IT: Development of a Web-based, 3D Coping Skills Game to Increase Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization|Completed||N/A|20|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:25:39.578196|2017-10-11 01:25:39.578196
NCT01915810|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-10-14|||January 2014||2014-01-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||Move To Quit - Using Physical Activity to Facilitate Smoking Cessation Among African American Adults|Using Physical Activity to Facilitate Smoking Cessation Among African American Adults|Active, not recruiting||N/A|45|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 01:25:39.986386|2017-10-11 01:25:39.986386
NCT01915797|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-08-25|||June 2013||2013-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|October 2016|Anticipated|2016-10-01||Observational|TED||Tumor and Development (TED)|Identification of Patients/Families With a Paediatric Tumor and One or More Developmental Abnormalities - Characterization of New Tumor Predisposition Syndromes and Study Their Molecular Basis|Recruiting||N/A|500|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 01:25:40.200312|2017-10-11 01:25:40.200312
NCT01915784|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-05-28|||July 2013||2013-07-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD|Study Evaluating Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients|Completed||Phase 3|128|Actual|Almirall, S.A.||2|||f||||||||||||||2017-10-11 01:25:40.290472|2017-10-11 01:25:40.290472
NCT01915758|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-07-13|||November 21, 2008|Actual|2008-11-21|July 2017|2017-07-01|February 20, 2009|Actual|2009-02-20|February 20, 2009|Actual|2009-02-20||Interventional|||W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers|A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers|Completed||Phase 1|64|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:25:40.475765|2017-10-11 01:25:40.475765
NCT01915745|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-07-05|||February 2014||2014-02-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|Ostéo-SMS||Study of Current Practice Evaluating the Efficacy of a Mobile Short Message Service (SMS) on Post-fracture Management.|Evaluation of the Efficacy of a Mobile Phone Short Message Service on Post-fracture Management for Patients Who Consult to the Emergency Department|Completed||N/A|97|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:25:40.589008|2017-10-11 01:25:40.589008
NCT01915732|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-01-16|2014-11-20||April 2013||2013-04-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris|A Multicentre, Randomized, Assessor-blind, Comparator-Controlled, Parallel-Group Clinical Trial to Establish the Efficacy and Safety of Duac™(1% Clindamycin as Clindamycin Phosphate and 5% Benzoyl Peroxide) Once Daily Gel Compared With Clindamycin Phosphate Gel (1% Clindamycin as Clindamycin Phosphate) Twice Daily in the Treatment of Mild to Moderate Acne Vulgaris.|Completed||Phase 3|1018|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:25:40.722092|2017-10-11 01:25:40.722092
NCT01915719|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-04-15|||August 2013||2013-08-01|November 2015|2015-11-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|IVNICTUS||Early Non Invasive Ventilation in Immuno-compromized Patients With Acute Respiratory Failure.|Early Non Invasive Ventilation in Immuno-compromized Patients With Acute Respiratory Failure. A Prospective Randomized Clinical Trial.|Completed||N/A|374|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:25:41.600791|2017-10-11 01:25:41.600791
NCT01915706|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-03-07|||September 2013||2013-09-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants|The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants|Recruiting||N/A|50|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 01:25:41.698117|2017-10-11 01:25:41.698117
NCT01915693|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-04-15|||October 2013||2013-10-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ROCS||ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study|Palliative Radiotherapy in Addition to Self-expanding Metal Stent for Improving Dysphagia and Survival in Advanced Oesophageal Cancer: ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study.|Recruiting||Phase 3|496|Anticipated|Velindre NHS Trust||2|||f||||t||||||||Undecided||2017-10-11 01:25:41.81219|2017-10-11 01:25:41.81219
NCT01915680|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-12-23|||June 2013||2013-06-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|||Intraocular Pressure Fluctuation in Patients With Glaucoma and in Healthy Patients During Standard Yoga Positions|Intraocular Pressure Fluctuation in Patients With Glaucoma and in Healthy Patients During Standard Yoga Positions|Completed||N/A|20|Actual|Glaucoma Associates of New York|||2||f||||f||||||||||2017-10-11 01:25:41.991127|2017-10-11 01:25:41.991127
NCT01915667|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-09-16|||July 2013||2013-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Oral Bioavailability of Two Solid Formulations of GLPG0634|Bioavailability Study Comparing Two Solid Oral Formulations of GLPG0634 in Healthy Male Subjects|Completed||Phase 1|12|Actual|Galapagos NV||3|||f||||f||||||||||2017-10-11 01:25:42.08635|2017-10-11 01:25:42.08635
NCT01915654|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2016-07-21|||January 2013||2013-01-01|August 2013|2013-08-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Observational|CGRCard||Impact of RBC Transfusion Less Than 14 Days on Morbidity and Mortality in Cardiac Surgical Patients|Impact de la Transfusion de Culots Globulaires de Moins de 14 Jours Sur la Morbi-mortalité Chez Des Patients en Chirurgie Cardiaque|Terminated||N/A|459|Actual|Centre Hospitalier Universitaire de Besancon|||2|Retrospective study from December 2007 to May 2010|f||||f||||||||||2017-10-11 01:25:42.173907|2017-10-11 01:25:42.173907
NCT01915641|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2016-11-20|||April 2013||2013-04-01|April 2013|2013-04-01||||November 2016|Actual|2016-11-01||Interventional|||CPAP Improves the Walking Capacity in Patients With COPD and OSA|CPAP Improves the Walking Capacity in Patients With COPD and OSA|Completed||N/A|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:25:42.257845|2017-10-11 01:25:42.257845
NCT01915615|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-04-11|||April 2014||2014-04-01|April 2017|2017-04-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01|5 Years|Observational [Patient Registry]|HCMR||HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy|HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy|Active, not recruiting||N/A|2750|Anticipated|University of Virginia|||1||f||||t||||||Samples With DNA|"     Blood samples for genetic analysis and biomarkers will be obtained and retained.   "|||2017-10-11 01:25:42.464958|2017-10-11 01:25:42.464958
NCT01915602|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-05-12|||September 27, 2013|Actual|2013-09-27|May 2017|2017-05-01|February 8, 2017|Actual|2017-02-08|July 29, 2015|Actual|2015-07-29||Interventional|||Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)|A Prospective, Single-arm, Multicenter, Uncontrolled, Open-label Phase II Trial of Refametinib (BAY86-9766) in Combination With Sorafenib as First Line Treatment in Patients With RAS Mutant Hepatocellular Carcinoma (HCC)|Completed||Phase 2|14|Actual|Bayer||1|||f||||f|t|f||||||||2017-10-11 01:25:42.660282|2017-10-11 01:25:42.660282
NCT01915589|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-06-13|||September 16, 2013|Actual|2013-09-16|June 2017|2017-06-01|October 8, 2014|Actual|2014-10-08|October 8, 2014|Actual|2014-10-08||Interventional|||Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)|A Prospective, Single-arm, Multicenter, Uncontrolled, Open-label Phase II Trial of Refametinib (BAY86-9766) in Patients With RAS Mutant Hepatocellular Carcinoma (HCC)|Completed||Phase 2|16|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:25:43.065184|2017-10-11 01:25:43.065184
NCT01915576|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-12-26|||September 2013||2013-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in Patients|A Phase I, Multi-center, Non-randomized, Open-label, Dose Escalation Design Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY 1125976 in Subjects With Advanced Solid Tumors|Completed||Phase 1|79|Actual|Bayer||3|||f||||f||||||||||2017-10-11 01:25:43.25165|2017-10-11 01:25:43.25165
NCT01915563|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-01-29|||September 2013||2013-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Rest After Spontaneous Breathing Trial for Prevention of Post-extubation Failure|Phase 2 Study of 60-min Rest After Successful Spontaneous Breathing Trial Before Extubation as a Tool for Reduction Post-extubation Failure.|Completed||Phase 2|450|Actual|Althaia Xarxa Assistencial Universitària de Manresa||2|||f||||f||||||||||2017-10-11 01:25:43.347816|2017-10-11 01:25:43.347816
NCT01915550|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-02|2013-08-02|||April 2012||2012-04-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy|The Role of Adding Metformin in Insulin-Resistant Diabetic Pregnant Women - a Randomized Controlled Trial|Completed||Phase 3|90|Actual|Ain Shams University||2|||f||||||||||||||2017-10-11 01:25:43.528371|2017-10-11 01:25:43.528371
NCT01915537|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-08-01|||August 2013||2013-08-01|July 2013|2013-07-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|INNOVATION||Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients|A Prospective Cohort Study to Observe the Difference of Efficacy Between Infliximab With Methotrexate and Classic DMARDs in the Severe Rheumatoid Arthritis Patients With Poor Prognosis|Not yet recruiting||N/A|170|Anticipated|Zhang, Xiao, M.D.||2|||f||||t||||||||||2017-10-11 01:25:43.640973|2017-10-11 01:25:43.640973
NCT01915524|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-08-04|||April 2013||2013-04-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)|An Exploratory, Open-label Phase Ib Study of RNActive®-Derived Cancer Vaccine and Local Radiation as Consolidation and Maintenance Treatment in Patients With Stage IV NSCLC and a Response or Stable Disease After First-line Chemotherapy or Therapy With an EGFR Tyrosine Kinase Inhibitor|Terminated||Phase 1|26|Actual|CureVac AG||1||Slow recruitment in stratum 3: enrolled only 2 instead of 8 pts. within predicted time|f||||t||||||||||2017-10-11 01:25:43.801545|2017-10-11 01:25:43.801545
NCT01915511|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-04-06|||June 2014||2014-06-01|April 2017|2017-04-01|September 2021|Anticipated|2021-09-01|August 2021|Anticipated|2021-08-01|3 Years|Observational [Patient Registry]|IPF-PRO||Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry|Prospective Outcomes Registry of Subjects With Idiopathic Pulmonary Fibrosis|Recruiting||N/A|1500|Anticipated|Duke University|||1||f||||f||||||Samples With DNA|"     Whole blood for DNA collected at enrollment. Plasma, serum, and RNA samples collected at     enrollment and approximate 6-month intervals throughout study follow-up.   "|||2017-10-11 01:25:43.940903|2017-10-11 01:25:43.940903
NCT01915498|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-07-21|||August 27, 2013|Actual|2013-08-27|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation|A Phase 1/2, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation|Active, not recruiting||Phase 1/Phase 2|357|Actual|Celgene||1|||f||||f||||||||||2017-10-11 01:25:44.205511|2017-10-11 01:25:44.205511
NCT01915485|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2016-09-02|||August 2013||2013-08-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|||Radiolabeled Molecules for Medullary Thyroid Cancer|The Use of Lu177 in the Treatment of Progressive and Unresectable Metastatic Medullary Thyroid Cancer|Recruiting||Phase 4|20|Anticipated|Instituto Nacional de Cancer, Brazil||1|||f||||t||||||||||2017-10-11 01:25:44.423872|2017-10-11 01:25:44.423872
NCT01915472|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2013-08-01|||September 2013||2013-09-01|August 2013|2013-08-01||||August 2015|Anticipated|2015-08-01||Interventional|||A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer|A Phase II Study of IMMU 130 (hMN-14-SN38 Antibody Drug Conjugate) in Patients With Metastatic Colorectal Cancer|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|Immunomedics, Inc.||1|||f||||f||||||||||2017-10-11 01:25:44.526392|2017-10-11 01:25:44.526392
NCT01915459|ClinicalTrials.gov processed this data on October 10, 2017|2013-08-01|2015-04-30|||June 2013||2013-06-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity|A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity|Completed||Phase 3|186|Actual|Hugel||2|||f||||t||||||||||2017-10-11 01:25:44.644006|2017-10-11 01:25:44.644006
NCT01915251|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-07-13|||July 26, 2013||2013-07-26|July 12, 2017|2017-07-12|January 1, 2099|Anticipated|2099-01-01|January 1, 2099|Anticipated|2099-01-01||Observational|||Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women|Microbiomic and Immunologic Profiling of Women With Antibiotic Induced Vaginal Candidiasis|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:25:46.525868|2017-10-11 01:25:46.525868
NCT01915446|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-12-17|||July 2013||2013-07-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|KISMED||Kidney and Intestinal Markers for Early Detection of Organ Injury After Endovascular Aortic Repair|Kidney and Intestinal Markers for Early Detection of Organ Injury After Endovascular Aortic Repair - The KISMED Study|Completed||N/A|20|Actual|University Hospital Regensburg|||1||f||||f||||||Samples Without DNA|"     Plasma Urine   "|||2017-10-11 01:25:44.772833|2017-10-11 01:25:44.772833
NCT01915433|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-03-29|||July 2013||2013-07-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|February 2014|Actual|2014-02-01||Interventional|||Wahls Paleo Diet and Progressive Multiple Sclerosis|Wahls Paleo Diet and Progressive Multiple Sclerosis|Completed||N/A|15|Actual|University of Iowa||3|||f||||f||||||||No||2017-10-11 01:25:44.904892|2017-10-11 01:25:44.904892
NCT01915420|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-02-05|||August 2013||2013-08-01|February 2015|2015-02-01|August 2017|Anticipated|2017-08-01|August 2015|Anticipated|2015-08-01|3 Years|Observational [Patient Registry]|ASSURE ROT||The ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary Lesions|Postmarketing Surveillance Registry to Monitor Everolimus-eluting Bioresorbable Vascular Scaffold Following Rotational Atherectomy for the Treatment of Complex Coronary Lesions - The ASSURE ROT Registry|Unknown status|Recruiting|N/A|42|Anticipated|Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.|||1||f||||t||||||||||2017-10-11 01:25:45.037153|2017-10-11 01:25:45.037153
NCT01915407|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-08-01|||April 2013||2013-04-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction|AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction|Completed||N/A|150|Actual|Aggredyne, Inc.|||1||f||||f||||||||||2017-10-11 01:25:45.190364|2017-10-11 01:25:45.190364
NCT01915394|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-01-13|||September 2013||2013-09-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|TurkNICU-RSV||Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)|Management of Hospitalized Respiratory Syncytial Virus (RSV) Infected Patients in the Neonatal Intensive Care Unit (NICU) and Control of Epidemics; TurkNICU-RSV Study: A Multicentric, Prospective Trial|Completed||N/A|250|Actual|Ankara University|||1||f||||f||||||||||2017-10-11 01:25:45.264026|2017-10-11 01:25:45.264026
NCT01915381|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-03-30|||March 2013||2013-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2014|Actual|2014-07-01||Interventional|APPCOID||Improving Adherence Healthy Lifestyle With a Smartphone Application Based on Adults With Intellectual Disabilities|Improving Adherence Healthy Lifestyle on a Smartphone Based on Complementation Adults With Intellectual Disabilities|Active, not recruiting||N/A|40|Actual|University of Malaga||2|||f||||t||||||||||2017-10-11 01:25:45.342843|2017-10-11 01:25:45.342843
NCT01915368|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-08-15|||September 2013||2013-09-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Determining Optimal Post-Stroke Exercise (DOSE)|Determining Optimal Post-Stroke Exercise (DOSE)|Recruiting||N/A|75|Anticipated|University of British Columbia||3|||f||||t||||||||||2017-10-11 01:25:45.432411|2017-10-11 01:25:45.432411
NCT01915355|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-08-17|||July 2013||2013-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Pulsed Dye Laser Treatment of Onychomycosis|Pulsed Dye Laser Treatment of Onychomycosis|Completed||N/A|11|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 01:25:45.612596|2017-10-11 01:25:45.612596
NCT01915342|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2014-10-08|||August 2013||2013-08-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|||Developing Optimal Focal Muscle Vibration for Improving Spasticity|Optimization of Physical Focal Stimulation Parameters for Improving Spasticity and Identification of Neurophysiological Mechanism|Completed||N/A|17|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 01:25:45.701207|2017-10-11 01:25:45.701207
NCT01915329|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-07-31|||February 2012||2012-02-01|June 2013|2013-06-01||||February 2014|Anticipated|2014-02-01||Interventional|||Effects of Repetitive Electric Sensory Stimulation (RSS) as Intervention in Complex-regional-pain-syndrome Type I (CRPS)|Effects of Repetitive Electric Sensory Stimulation on Sensorimotor Performance and Pain Intensity in Complex Regional Pain Syndrome Type I|Unknown status|Recruiting|N/A|50|Anticipated|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-11 01:25:45.778052|2017-10-11 01:25:45.778052
NCT01915316|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2015-10-27|||February 2014||2014-02-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy|Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy|Completed||N/A|30|Actual|ProSight|||1||f||||f||||||||||2017-10-11 01:25:45.867336|2017-10-11 01:25:45.867336
NCT01915303|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-06-30|||March 6, 2014|Actual|2014-03-06|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease|A Phase II Trial to Assess the Efficacy and Safety of Pasireotide s.c. Alone or in Combination With Cabergoline in Patients With Cushing's Disease|Active, not recruiting||Phase 2|70|Actual|Novartis||1|||f||||f||||||||||2017-10-11 01:25:46.051817|2017-10-11 01:25:46.051817
NCT01915290|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-08-12|||August 2012||2012-08-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|Gen100sub2||Physical Activity and Its Correlation to Maximal Oxygen Uptake in an Elderly Population|Self Reported Physical Activity vs Objectively Measured Physical Activity and Its Correlation to Maximal Oxygen Uptake in an Elderly Population: an Observational Study|Completed||N/A|1237|Actual|Norwegian University of Science and Technology|||1||f||||t||||||||||2017-10-11 01:25:46.231232|2017-10-11 01:25:46.231232
NCT01915277|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-04-04|||March 2014||2014-03-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics|A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics|Recruiting||Phase 1|106|Anticipated|New England Research Institutes||10|||f||||t||||||||||2017-10-11 01:25:46.304647|2017-10-11 01:25:46.304647
NCT01915264|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-04-22|||August 2015||2015-08-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|GLORY||GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice|Glucobay M - Evaluation of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice|Withdrawn||N/A|0|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:25:46.445021|2017-10-11 01:25:46.445021
NCT01915238|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-08-29|||July 16, 2013||2013-07-16|June 20, 2014|2014-06-20|June 20, 2014|Actual|2014-06-20|June 20, 2014|Actual|2014-06-20||Observational|||Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study|Age-Related Eye Disease Study 2 (AREDS2) Ancillary Spectral Domain Optical Coherence Tomography (A2A_SDOCT) Extension Study|Completed||N/A|52|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:25:46.621267|2017-10-11 01:25:46.621267
NCT01915225|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-10-04|||July 11, 2013||2013-07-11|April 25, 2017|2017-04-25|June 30, 2024|Anticipated|2024-06-30|June 30, 2023|Anticipated|2023-06-30||Observational|||Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer|Tumor, Normal Tissue and Specimens From Patients Undergoing Evaluation or Surgical Resection of Solid Tumors|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:25:46.699775|2017-10-11 01:25:46.699775
NCT01915212|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-07-13|||July 23, 2013||2013-07-23|July 12, 2017|2017-07-12|March 6, 2017|Actual|2017-03-06|March 6, 2017|Actual|2017-03-06||Interventional|||Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection|Phase I Study of the Safety of Replication-Defective Herpes Simplex Virus-2 Vaccine, HSV529, in Adults Aged 18 to 40 Years With or Without HSV Infection|Completed||Phase 1|69|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 01:25:46.792555|2017-10-11 01:25:46.792555
NCT01915199|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-01-15|||October 2000||2000-10-01|January 2014|2014-01-01||||December 2002|Actual|2002-12-01||Interventional|||Effects of a Comprehensive Intervention on Blood Pressure Control in a Primary Care Setting|Effects of a Comprehensive Intervention on Blood Pressure Control in a Primary Care Setting|Completed||N/A|144|Actual|National Institute for Health and Welfare, Finland||2|||f||||f||||||||||2017-10-11 01:25:46.902267|2017-10-11 01:25:46.902267
NCT01915186|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2013-12-19|||October 2010||2010-10-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|||Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF|A Randomized Controlled Trial on the Effect of Dehydroepiandrosterone (DHEA) Supplementation on Ovarian Reserve Markers, Response to a Standard Low Dose FSH Stimulation and IVF Cycle Outcomes in Patients With Normal and Poor Ovarian Reserve|Completed||N/A|104|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 01:25:46.996034|2017-10-11 01:25:46.996034
NCT01915173|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-02-24|2015-10-29||June 2013||2013-06-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Response to Supplement and Placebo in GERD|Response to Supplement and Placebo in GERD|Completed||N/A|24|Actual|Beth Israel Deaconess Medical Center|Small, pilot study.|4|||f||||t||||||||||2017-10-11 01:25:47.101394|2017-10-11 01:25:47.101394
NCT01915160|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-09-29|||November 2013||2013-11-01|August 2012|2012-08-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||Technology-Based Tools to Enhance Quality of Care in Mental Health Treatment|Technology-Based Tools to Enhance Quality of Care in Mental Health Treatment|Completed||N/A|20|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 01:25:47.853673|2017-10-11 01:25:47.853673
NCT01915147|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-12-11|||July 2013||2013-07-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects||Completed||Phase 2|108|Actual|Mundipharma Research GmbH & Co KG||2|||f||||||||||||||2017-10-11 01:25:47.94953|2017-10-11 01:25:47.94953
NCT01915134|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2014-12-30|||August 2013||2013-08-01|July 2013|2013-07-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma|A Prospective,Randomized,Controlled,Multicenter,Phase III Study of Stage Ⅲ Study of Gemcitabine Plus Cisplatin With or Without Endostatin to the Metastatic Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 3|362|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-11 01:25:49.712667|2017-10-11 01:25:49.712667
NCT01915121|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-08-03|||September 2013||2013-09-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|||An Educational Intervention for Patients With Bladder Cancer|An Educational Intervention for Patients With Bladder Cancer 121193-MRSG-11-103-01-CPPB American Cancer Society|Completed||N/A|43|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 01:25:49.841234|2017-10-11 01:25:49.841234
NCT01915108|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-08-21|2014-07-13||July 2012||2012-07-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Optimal Effect-site Concentration of Remifentanil for Inhibiting Response to Laryngeal Mask Airway (LMA) Removal|Optimal Effect-site Concentration of Remifentanil for Inhibiting Response to Laryngeal Mask Airway (LMA) Removal During Emergence From Sevoflurane-remifentanil Anesthesia|Completed||N/A|128|Actual|Yeungnam University College of Medicine||4|||f||||t||||||||||2017-10-11 01:25:49.98239|2017-10-11 01:25:49.98239
NCT01915095|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-05-09|||February 11, 2015|Actual|2015-02-11|May 2017|2017-05-01|February 2021|Anticipated|2021-02-01|January 2020|Anticipated|2020-01-01||Interventional|||Improving Motor Function After Spinal Cord Injury|Enhancement of Hand Motor Function After Cervical Spinal Cord Injury|Recruiting||N/A|500|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||Undecided||2017-10-11 01:25:50.454588|2017-10-11 01:25:50.454588
NCT01915082|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-11-10|||September 2013||2013-09-01|September 2013|2013-09-01||||October 2015|Actual|2015-10-01||Interventional|AZI003||Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation|A Prospective, Randomized, Placebo-controlled Trial of Pre-transplant and Prompt Post-transplant Treatment With Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation|Completed||Phase 4|70|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 01:25:50.616223|2017-10-11 01:25:50.616223
NCT01915056|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-02-18|||July 2013||2013-07-01|October 2015|2015-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Geriatric Assessment Intervention for Older Cancer Patients Receiving Chemotherapy|A Pilot Study of a Geriatric Assessment Intervention for Older Cancer Patients Receiving Chemotherapy|Completed||N/A|80|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 01:25:50.912721|2017-10-11 01:25:50.912721
NCT01915043|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-03-30|||January 2013||2013-01-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|APPCOMCAN||Improving Adherence Healthy Lifestyle With a Smartphone Application Based After Surgery in Cancer Patients|Improving Adherence Healthy Lifestyle With a Smartphone Application Based After Surgery in Cancer Patients|Enrolling by invitation||N/A|100|Anticipated|University of Malaga||2|||f||||t||||||||||2017-10-11 01:25:51.017845|2017-10-11 01:25:51.017845
NCT01915030|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-07-30|||June 2012||2012-06-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Protect - The Impact of a High Protein Diet on Preservation of Muscle Mass|Protect The Impact of a High Protein Diet on the Preservation of Muscle Mass During Caloric Restriction in Middle Age and Elderly People|Completed||N/A|61|Actual|Wageningen University||2|||f||||f||||||||||2017-10-11 01:25:51.247014|2017-10-11 01:25:51.247014
NCT01915017|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-08-01|||April 2008||2008-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Mcog||Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia|Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia|Completed||N/A|178|Actual|The University of Texas Health Science Center at San Antonio||4|||f||||t||||||||||2017-10-11 01:25:51.344091|2017-10-11 01:25:51.344091
NCT01915004|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-08-28|||November 2014||2014-11-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Effectiveness of a Bladder Training Video for Management of Lower Urinary Tract Symptoms.|Bladder Training Video Versus Individual Urotherapy for Children With Non-neurogenic Lower Urinary Tract Dysfunction.|Active, not recruiting||N/A|150|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 01:25:51.445709|2017-10-11 01:25:51.445709
NCT01914900|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-07-31|||June 2012||2012-06-01|July 2013|2013-07-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|||Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer|Phase II Study of Preoperative TPF Chemotherapy in Locally Advanced Resectable Oral Cavity Squamous Cell Cancer in Order to Improve the Rate of Pathological Complete Response|Unknown status|Recruiting|Phase 2|14|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t||||||||||2017-10-11 01:25:51.558159|2017-10-11 01:25:51.558159
NCT01914887|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-07-31|||June 2013||2013-06-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|ALOASCU||Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis|A Phase I/IIa Clinical Trial to Evaluate Safety and Efficacy of Adipose Tissue-derived Mesenchymal Stem Cells (ASC) on Induction to Remission in Ulcerative Colitis|Unknown status|Recruiting|Phase 1/Phase 2|8|Anticipated|Instituto de Investigación Hospital Universitario La Paz||1|||f||||f||||||||||2017-10-11 01:25:51.668308|2017-10-11 01:25:51.668308
NCT01914874|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2015-06-29|||July 2013||2013-07-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy of a Mindfulness Meditation Program for Social Anxiety Disorder|Efficacy of an Enhanced Mindfulness-based Intervention for Social Anxiety Disorder: A Pilot Feasibility Randomized Controlled Trial|Completed||N/A|39|Actual|Hopital Montfort||2|||f||||f||||||||||2017-10-11 01:25:51.79983|2017-10-11 01:25:51.79983
NCT01914861|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2013-07-31|||July 2013||2013-07-01|July 2013|2013-07-01||||December 2013|Anticipated|2013-12-01||Observational|||Cortisol Diurnal Variation and the Risk for Developing Post Traumatic Stress Disorder||Unknown status|Not yet recruiting|N/A|60|Anticipated|Sheba Medical Center|||1||f||||||||||Samples Without DNA|"     Plasma cortisol levels plasma neuropeptide y   "|||2017-10-11 01:25:51.922531|2017-10-11 01:25:51.922531
NCT01914848|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-06-03|||July 2013||2013-07-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|MAPS||Multiprofessional Advance Care Planning and Shared Decision Making for End of Life Care|Multiprofessional Advance Care Planning and Shared Decision-making for End of Life Care MAPS Trial|Completed||N/A|115|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 01:25:52.037436|2017-10-11 01:25:52.037436
NCT01914835|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-05-24|||April 2011||2011-04-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|||Neuropsychological Rehabilitation on Cocaine/Crack Dependents|The Impact of Neuropsychological Rehabilitation on Cocaine/Crack Dependents: a Placebo-controlled Study Using Cognitive Tests and Functional Magnetic Resonance Imaging.|Enrolling by invitation||N/A|56|Anticipated|University of Sao Paulo General Hospital||1|||f||||f||||||||||2017-10-11 01:25:52.177539|2017-10-11 01:25:52.177539
NCT01914822|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-09-11|||July 2013||2013-07-01|September 2017|2017-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Effect Methylphenidate Hydrochloride on Pain and Auditory Sensitivity in Healthy Subjects|The Effect of Ritalin (Methylphenidate Hydrochloride) on Pain and Auditory Sensitivity: an Exploratory Double-blind Randomized Controlled Trial on Healthy Subjects|Completed||Phase 2|41|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 01:25:52.325305|2017-10-11 01:25:52.325305
NCT01914809|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-07-06|||January 2011||2011-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Micro Array Analysis in Preeclampsia|Micro Array Analysis in Preeclampsia|Recruiting||N/A|40|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:25:52.470056|2017-10-11 01:25:52.470056
NCT01914796|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-05-22|||August 2013||2013-08-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562|A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Crossover, Single Oral Dose Escalation Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-06412562 In Healthy Subjects|Completed||Phase 1|39|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:25:52.612022|2017-10-11 01:25:52.612022
NCT01914783|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-07-31|||July 2013||2013-07-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|Particles||Experimental Exposure to Air Pollutants and Sympathetic Nerve Activity in Human Subjects|Experimental Exposure to Air Pollutants and Sympathetic Nerve Activity in Human Subjects|Unknown status|Recruiting|N/A|30|Anticipated|Hannover Medical School||3|||f||||f||||||||||2017-10-11 01:25:52.708728|2017-10-11 01:25:52.708728
NCT01914770|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2013-09-12|||July 2009||2009-07-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76|Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76|Completed||N/A|1016|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 01:25:52.832659|2017-10-11 01:25:52.832659
NCT01914757|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-11-30|2016-09-08||August 2013||2013-08-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist|A Multicentre, Randomized, Double-blind, Parallel Group, Placebocontrolled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Asthmatic Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist (CALIMA)|Completed||Phase 3|2508|Actual|AstraZeneca||3|||f||||t||||||||||2017-10-11 01:25:53.057106|2017-10-11 01:25:53.057106
NCT01914744|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-02|2013-07-31|||February 2013||2013-02-01|July 2013|2013-07-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL|Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Virus Reactivation in Patients With Non-Hodgkin Lymphoma on CHOP/R-CHOP: a Randomized Phase II Study|Unknown status|Recruiting|Phase 2|82|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 01:25:55.712047|2017-10-11 01:25:55.712047
NCT01914731|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-07-15|||August 2013||2013-08-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum|Fecal Microbiota Transplant (FMT) for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum|Completed||Phase 1|20|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:25:55.844313|2017-10-11 01:25:55.844313
NCT01914718|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-02|2014-08-19|||February 2013||2013-02-01|August 2014|2014-08-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Dose-adjusted EPOCH-R in MYC Positive DLBCL|Dose-adjusted EPOCH-R in Patients With Diffuse Large B-cell Lymphoma: a Phase II Study|Terminated||Phase 2|26|Anticipated|Fudan University||1||Poor accrual of eligible patients|f||||f||||||||||2017-10-11 01:25:55.97658|2017-10-11 01:25:55.97658
NCT01914705|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-08-07|||February 2012||2012-02-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Landmark vs. Ultrasound Guided SCVC in the ED|Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement in the Emergency Department|Terminated||N/A|11|Actual|Maimonides Medical Center||2||Too few patients who met enrollment criteria.|f||||f||||||||||2017-10-11 01:25:56.076362|2017-10-11 01:25:56.076362
NCT01914692|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-07-31|||January 2013||2013-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection|Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection —a Prospective Randomized Controlled Study|Completed||Phase 4|2|Actual|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 01:25:56.307036|2017-10-11 01:25:56.307036
NCT01914679|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-03-07|2017-01-04||July 2013||2013-07-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|PERRFECT-UM||A Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - University of Michigan|A Phase 2 Clinical Trial Evaluating Use of the NeuroPoint Medical Device as a Treatment for Fibromyalgia.|Terminated||N/A|17|Actual|University of Michigan|This mechanistic study wasn’t powered to show statistically significant clinical improvement, even as originally planned. Sponsor terminated study early when they realized the devices were not delivering enough current to be of therapeutic benefit.|1||Sponsor terminated the study|f||||f||||||||||2017-10-11 01:25:56.388232|2017-10-11 01:25:56.388232
NCT01914666|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-12-18|2015-12-18||September 2013||2013-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Full Analysis Set (FAS) is defined as all randomized participants who received at least 1 dose of study drug, had at least 1 post-dose BPI Pain Severity (average pain) scores. 1 Naïve group participant (pt) received at least 1 dose of study drug but had no post-dose data, was not included in FAS.|An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain|Phase 3 Clinical Study of Duloxetine Hydrochloride in Patients With CLBP - Open Label Long Term Extension Study|Completed||Phase 3|151|Actual|Eli Lilly and Company|FAS:all randomized pts who received at least 1 dose of study drug and had at least 1 post-dose BPI pain severity (average pain) score. 1 Naïve group pt received at least 1 dose of study drug but had no post-dose data and not included in FAS.|1|||f||||f||||||||||2017-10-11 01:25:56.742313|2017-10-11 01:25:56.742313
NCT01914640|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-07-31|||March 2003||2003-03-01|July 2013|2013-07-01|September 2005|Actual|2005-09-01|September 2004|Actual|2004-09-01||Observational|||The Sex Specific Waist Circumference Cut Off Points to Predict Overweight or Obesity|The Cross Sectional Study to Investigate the Waist Circumference Cut Off Points for the Prediction of Overweight and Obesity of the Turkish Adult Population|Completed||N/A|4310|Actual|TC Erciyes University|||1||f||||f||||||||||2017-10-11 01:25:58.191462|2017-10-11 01:25:58.191462
NCT01914627|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-11-04|||August 2013||2013-08-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis|A Single-centre Randomised, Active-controlled, Observer-blinded, Parallel Group Trial to Evaluate the Efficacy and Safety of a Topical Dimeticone Formulation (Loion®) Compared to 10% Salicylic Acid in the Removal of Scaling in Patients With Chronic Psoriasis Capitis|Completed||Phase 2|90|Actual|G. Pohl-Boskamp GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 01:25:58.257859|2017-10-11 01:25:58.257859
NCT01914614|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-05-26|||November 2013||2013-11-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||A Pilot Study of Working Women and Breast Cancer|A Pilot Study of Working Women and Breast Cancer|Completed||N/A|22|Actual|University of Kentucky|||2||f||||f||||||||||2017-10-11 01:25:58.360463|2017-10-11 01:25:58.360463
NCT01914601|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2016-08-06|||January 2014||2014-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||King Vision and Cervical Spines Movement|Does King Vision® Videolaryngoscope Reduce Cervical Spine Motion During Endotracheal Intubation? A Cross-over Study.|Completed||Phase 2|29|Actual|Dammam University||2|||f||||t||||||||||2017-10-11 01:25:58.44174|2017-10-11 01:25:58.44174
NCT01914588|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-07-31|||June 2012||2012-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||Multiparametric Telemonitoring In Elderly People With Chronic Heart Failure|Effectiveness of a Multiparametric Telemonitoring System on Prevention of Hospital Admissions and Mortality In Elderly People With Chronic Heart Failure|Completed||N/A|100|Actual|Campus Bio-Medico University||2|||f||||t||||||||||2017-10-11 01:25:58.563842|2017-10-11 01:25:58.563842
NCT01914575|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-03-06|||May 2015|Anticipated|2015-05-01|March 2017|2017-03-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|DDRAMATIC-SVT||Dipole Density Mapping of Right and Left Atrial Supraventricular Tachycardia|Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia|Withdrawn||N/A|0|Actual|Acutus Medical||1||Site never got up and running due to institutional issues|f||||f||f||||||No||2017-10-11 01:25:58.649236|2017-10-11 01:25:58.649236
NCT01914562|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-08-07|||August 2013||2013-08-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)|An Open Label Trial to Assess the Effects of Food on the Pharmacokinetic Parameters of Obeticholic Acid (OCA)|Completed||Phase 1|32|Actual|Intercept Pharmaceuticals||4|||f||||t||||||||||2017-10-11 01:25:58.726596|2017-10-11 01:25:58.726596
NCT01914549|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-03-06|||April 2015||2015-04-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|DDRAMATIC-SVT||Dipole Density Mapping of Supraventricular Tachycardia|Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia|Completed||N/A|2|Actual|Acutus Medical||1|||f||||f||f||||||Undecided||2017-10-11 01:25:58.823246|2017-10-11 01:25:58.823246
NCT01914536|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2013-08-29|||July 2013||2013-07-01|August 2013|2013-08-01|July 2017|Anticipated|2017-07-01|July 2014|Anticipated|2014-07-01||Observational|POMPE 2013||A Natural History Study of Adult Onset Pompe Disease Using Muscle MRI|A Natural History Study of Adult Onset Pompe Disease Using Muscle MRI|Unknown status|Recruiting|N/A|30|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||Samples With DNA|"     Blood an urine samples will be obtained   "|||2017-10-11 01:25:58.900046|2017-10-11 01:25:58.900046
NCT01914523|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2015-05-12|||September 2013||2013-09-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of the Macintosh, King Vision®, Glidescope® and AirTraq® Laryngoscopes in Routine Airway Management|Comparison of the Macintosh, King Vision®, Glidescope® and AirTraq® Laryngoscopes in Routine Airway Management|Completed||Phase 1/Phase 2|86|Actual|Dammam University||4|||f||||t||||||||||2017-10-11 01:25:59.005912|2017-10-11 01:25:59.005912
NCT01914510|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-08-05|||September 2013||2013-09-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Study of ENMD-2076 in Ovarian Clear Cell Cancers|Phase II Study of Oral ENMD-2076 Administered to Patients With Ovarian Clear Cell Carcinomas|Recruiting||Phase 2|36|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:25:59.108289|2017-10-11 01:25:59.108289
NCT01914497|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2015-01-13|||October 2014||2014-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:25:59.230357|2017-10-11 01:25:59.230357
NCT01914484|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2016-03-04|||August 2013||2013-08-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia|A PHASE I/II, MULTI-CENTRE, TRIAL OF RUXOLITINIB THERAPY IN COMBINATION WITH NILOTINIB IN PATIENTS WITH PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKEMIA OR ACUTE LYMPHOBLASTIC LEUKEMIA WHO HAVE FAILED TYROSINE KINASE INHIBITOR THERAPY|Recruiting||Phase 1/Phase 2|32|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:25:59.273185|2017-10-11 01:25:59.273185
NCT01914471|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-08-01|||September 2008||2008-09-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|June 2012|Actual|2012-06-01||Interventional|SNaX||A Randomized Controlled Trial of Students for Nutrition and eXercise|A Community-Academic Partnership to Address Disparities in Obesity Among Youth|Completed||N/A|2997|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 01:25:59.385211|2017-10-11 01:25:59.385211
NCT01914458|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2013-07-31|||February 2013||2013-02-01|July 2013|2013-07-01||||January 2018|Anticipated|2018-01-01||Interventional|IDEALCAP||Image Discovering Early Lung Cancer Project|Low-Dose Computed Tomography for Lung Cancer Screening in High Risk Asymptomatic Patients: the Taiwan Study|Recruiting||Phase 2|600|Anticipated|Cathay General Hospital||1|||f||||t||||||||||2017-10-11 01:25:59.473454|2017-10-11 01:25:59.473454
NCT01914445|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2013-07-31|||August 2013||2013-08-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine||Unknown status|Not yet recruiting|N/A|10|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 01:25:59.572546|2017-10-11 01:25:59.572546
NCT01914432|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-07-07|||November 2013||2013-11-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia|A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Investigate the Safety and Efficacy Between YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia|Completed||Phase 3|210|Actual|Yuhan Corporation||4|||f||||f||||||||||2017-10-11 01:25:59.66852|2017-10-11 01:25:59.66852
NCT01914419|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-03-10|||April 2014||2014-04-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage|Administration of Oxytocin Via Intramuscular Injection and Intravenous Bolus or Intravenous Infusion in the Third Stage of Labor for Prevention of Postpartum Hemorrhage|Completed||N/A|4983|Actual|Gynuity Health Projects||3|||f||||f||||||||||2017-10-11 01:25:59.773175|2017-10-11 01:25:59.773175
NCT01914406|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-01-26|||January 2011||2011-01-01|January 2015|2015-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||High-intensity Interval Training Versus Moderate Continuous Training in Heart Transplant Recipients.|High-intensity Interval Training Versus Moderate Continuous Training in Heart Transplant Recipients With Impaired Chronotropic Response: A Randomized Controlled Crossover Trial.|Completed||N/A|20|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 01:25:59.870909|2017-10-11 01:25:59.870909
NCT01914393|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-10-02|||September 2013||2013-09-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Pediatric Open-Label Extension Study|A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects|Active, not recruiting||Phase 3|702|Anticipated|Sunovion||1|||f||||t||||||||||2017-10-11 01:26:00.131|2017-10-11 01:26:00.131
NCT01914380|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-07-20|||July 29, 2013|Actual|2013-07-29|July 2017|2017-07-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|PERSEUS||Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration|PERSEUS - A Prospective Non-interventional Study to Assess the Effectiveness of Aflibercept (Eylea®) in Routine Clinical Practice in Patients With Wet Age-related Macular Degeneration|Completed||N/A|988|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:26:00.413442|2017-10-11 01:26:00.413442
NCT01914367|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-06-02|||September 2013||2013-09-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|HPVXneutra001||Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)|Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)|Unknown status|Recruiting|Phase 4|12|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:26:00.512159|2017-10-11 01:26:00.512159
NCT01914354|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-10-26|||February 2012||2012-02-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Observational|NKG2D||Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population|"Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity: An Untargeted T Cell Population (# 859869783)."|Completed||N/A|90|Actual|The Cleveland Clinic|||1||f||||f||||||Samples Without DNA|"     blood/serum   "|||2017-10-11 01:26:00.619992|2017-10-11 01:26:00.619992
NCT01914341|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2014-01-22|||July 2013||2013-07-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Short Term Effects of Live Music in Newborn Infants|Short-term Effects of Live Pentatonic Music on Physiological Parameters in Newborns Infants|Completed||N/A|20|Actual|ARCIM Institute Academic Research in Complementary and Integrative Medicine||2|||f||||||||||||||2017-10-11 01:26:00.680366|2017-10-11 01:26:00.680366
NCT01914328|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-11-01|||June 2013||2013-06-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Observational|PPC||Postoperative Pulmonary Complications in Major Abdominal Surgery|Postoperative Pulmonary Complications in Major Abdominal Surgery: Prospective Observational Multicentric Study|Recruiting||N/A|1500|Anticipated|Azienda Ospedaliera S. Maria della Misericordia|||1||f||||t||||||||||2017-10-11 01:26:00.786208|2017-10-11 01:26:00.786208
NCT01914315|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-11-17|||October 2013||2013-10-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Rehabilitation Program in Heart Failure With Preserved Ejection Fraction|Multi-Disciplinary Rehabilitation Program in Recently Hospitalized Patients With Preserved Ejection Fraction Heart Failure|Unknown status|Recruiting|N/A|1100|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 01:26:01.063657|2017-10-11 01:26:01.063657
NCT01914302|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2013-08-01|||July 2013||2013-07-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||The Characterization of Blood Volumes of Commercially Available Lancing Devices|Lancing Device Blood Volume Study|Completed||N/A|64|Actual|Facet Technologies|||8||f||||f||||||||||2017-10-11 01:26:01.191445|2017-10-11 01:26:01.191445
NCT01914289|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2016-03-30|||January 2011||2011-01-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|April 2015|Actual|2015-04-01||Interventional|||Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients|Comparison of Resection and Radiotherapy in the Prognosis of Intrahepatic Cholangiocarcinoma Patients|Recruiting||N/A|200|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 01:26:01.319453|2017-10-11 01:26:01.319453
NCT01914276|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-06-22|||October 2013||2013-10-01|June 2017|2017-06-01||||June 2017|Actual|2017-06-01||Observational|||Lymphedema in Endometrial Cancer|A Pilot Study of Postoperative Lower-extremity Lymphedema and Quality of Life Among Women Undergoing Endometrial Cancer Staging Surgery|Completed||N/A|100|Actual|Duke University|||1||f||||||||||||||2017-10-11 01:26:01.436203|2017-10-11 01:26:01.436203
NCT01914263|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-04-15|||March 2014||2014-03-01|July 2014|2014-07-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection|Phase 1 Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection|Unknown status|Recruiting|Phase 1|40|Anticipated|Alliancells-PuRui Biocience Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:26:01.525535|2017-10-11 01:26:01.525535
NCT01914250|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-12-25|||January 2013||2013-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pain Associated With Neonatal Frenotomy||Completed||N/A|40|Anticipated|Rambam Health Care Campus||1|||f||||||||||||||2017-10-11 01:26:01.653483|2017-10-11 01:26:01.653483
NCT01914237|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-08-01|||April 2013||2013-04-01|August 2013|2013-08-01|April 2017|Anticipated|2017-04-01|April 2015|Anticipated|2015-04-01||Interventional|||A Multi-center Trial of Single-Branched Stent Graft System to Treat Aortic Dissection|A Multi-center Trial of Castor Single-Branched Stent Graft System for Endovascular Repair of Aortic Dissection.|Unknown status|Recruiting|N/A|70|Anticipated|Changhai Hospital||1|||f||||f||||||||||2017-10-11 01:26:01.730744|2017-10-11 01:26:01.730744
NCT01914224|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2014-05-20|||March 2013||2013-03-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Combined Dietary Education of Low Sodium and High Potassium Consumption|Research for the Effectiveness of Combined Dietary Education of Low Sodium and High Potassium Consumption|Unknown status|Recruiting|N/A|200|Anticipated|DongGuk University||2|||f||||f||||||||||2017-10-11 01:26:01.848345|2017-10-11 01:26:01.848345
NCT01914211|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-01-31|||July 2013||2013-07-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates||Withdrawn||N/A|0|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 01:26:01.980862|2017-10-11 01:26:01.980862
NCT01914198|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-02-01|||August 2013||2013-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Revisiting Parental Survey for Screening for Obstructive Sleep Apnea in Patients Undergoing Polysomnography||Enrolling by invitation||N/A|300|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 01:26:02.102654|2017-10-11 01:26:02.102654
NCT01914185|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2013-07-31|||January 2008||2008-01-01|July 2013|2013-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|APPLE Schools||Alberta Project Promoting Active Living and Healthy Eating in Schools|The Effectiveness of a Comprehensive School Health Intervention in Improving Healthy Eating and Physical Activity and Preventing Childhood Obesity|Completed||N/A|8663|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 01:26:02.187582|2017-10-11 01:26:02.187582
NCT01914172|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-31|2017-09-27|||July 2013||2013-07-01|September 2017|2017-09-01|September 27, 2017|Actual|2017-09-27|March 2014|Actual|2014-03-01||Observational|||Health Needs of Patients With Kallmann Syndrome|Factors Affecting Health Promoting Behavior in Rare Disease Patients: A Mixed Methods Study of Men With Congenital Hypogonadotropic Hypogonadism (CHH)|Completed||N/A|249|Actual|Centre Hospitalier Universitaire Vaudois|||3||f||||f||||||||||2017-10-11 01:26:02.277145|2017-10-11 01:26:02.277145
NCT01914159|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2016-05-12|||February 2013||2013-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|RIP||Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study||Completed||Phase 2|25|Actual|University Hospital, Bonn||1|||f||||t||||||||||2017-10-11 01:26:02.377268|2017-10-11 01:26:02.377268
NCT01914146|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-06-27|||April 2015||2015-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Insulin Therapy and Falls Due to Orthostatic Hypotension|Insulin Therapy and Falls Due to Orthostatic Hypotension (Pilot Study)|Recruiting||N/A|45|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-11 01:26:02.474391|2017-10-11 01:26:02.474391
NCT01914133|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-04-12|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PPH||Acarbose and Older Adults With Postprandial Hypotension|Acarbose and Older Adults With Postprandial Hypotension|Recruiting||Phase 2|240|Anticipated|University of British Columbia||3|||f||||t|f|f||||||No||2017-10-11 01:26:02.588938|2017-10-11 01:26:02.588938
NCT01914120|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2015-08-26|||November 2012||2012-11-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||the Quality of Life Assessment of Lung Cancer Patients in China|A Multicenter, Observational, Phase III Clinical Study: the Quality of Life Assessment of Lung Cancer Patients in China.|Unknown status|Recruiting|N/A|3000|Anticipated|Sun Yat-sen University|||1||f||||t||||||||||2017-10-11 01:26:02.695545|2017-10-11 01:26:02.695545
NCT01914107|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-08-26|||March 2012||2012-03-01|August 2015|2015-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Real-time Cancer Pain Assessment and Intervention|A Randomized, Controlled Clinical Study: Assess and Intervene Cancer Pain of Advanced Malignant Tumor Patients in Real-Time, Using the Real-time Cancer Pain Assessment and Intervention System Based on Cloud Computing Concept.|Recruiting||Phase 2/Phase 3|200|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 01:26:02.793998|2017-10-11 01:26:02.793998
NCT01914094|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-07-30|||February 2011||2011-02-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Pre-habilitation Program for Elective Coronary Artery Bypass Graft Surgery Patients|Pre-habilitation Program for Elective Coronary Artery Bypass Graft Surgery Patients|Completed||N/A|17|Actual|St. Boniface General Hospital Research Centre||2|||f||||f||||||||||2017-10-11 01:26:02.912309|2017-10-11 01:26:02.912309
NCT01914081|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-04-19|||January 2015||2015-01-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|February 2018|Anticipated|2018-02-01||Interventional|||Resveratrol: a Potential Anti-remodeling Agent in Heart Failure, From Bench to Bedside|Resveratrol: a Potential Anti-remodeling Agent in Heart Failure, From Bench to Bedside|Recruiting||Phase 3|40|Anticipated|St. Boniface General Hospital Research Centre||2|||f||||t||||||||No||2017-10-11 01:26:03.00276|2017-10-11 01:26:03.00276
NCT01914068|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-10-14|||August 2013||2013-08-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|SRETP||The Effects of a 9 Week Exercise Programme on Fitness and Quality of Life in Rectal Cancer Patients After Chemoradiotherapy and Before Surgery|A Pilot Study to Investigate Improvements in Physical Fitness and Quality of Life Resulting From a 9 Week Structured Responsive Endurance Training Programme (SRETP) Following Neoadjuvant Chemoradiotherapy Prior to Elective Rectal Cancer Surgery|Completed||N/A|34|Actual|University Hospital Southampton NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:26:03.112766|2017-10-11 01:26:03.112766
NCT01914055|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-10-21|||July 2013||2013-07-01|October 2013|2013-10-01||||July 2015|Anticipated|2015-07-01||Interventional|TOBIAS||Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study.||Unknown status|Recruiting|Phase 4|20|Anticipated|Ospedale San Donato||2|||f||||f||||||||||2017-10-11 01:26:03.193477|2017-10-11 01:26:03.193477
NCT01914042|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-09-11|||July 2013||2013-07-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|||Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica|Prediction of Inter-individual Differences in the Response to Morphine by Psychophysical Assessment of Pain Enhancing and Inhibiting Mechanisms in Patients With Chronic Neuropathic Pain|Recruiting||Phase 2|150|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 01:26:03.27783|2017-10-11 01:26:03.27783
NCT01914029|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-08-26|||August 2013||2013-08-01|August 2013|2013-08-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01||Observational|||Immunological Mechanisms of Allergy Immunotherapy|Immunological Mechanisms of Allergy Immunotherapy|Unknown status|Recruiting|N/A|70|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 01:26:03.376413|2017-10-11 01:26:03.376413
NCT01914016|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-09-27|||September 2013||2013-09-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop|Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop:Feasibility of Instrumented Gait Analysis in Clinical Practice.|Completed||N/A|15|Actual|Queen Margaret University||1|||f||||f||||||||||2017-10-11 01:26:03.448165|2017-10-11 01:26:03.448165
NCT01914003|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-08-16|2016-07-07||May 2013||2013-05-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Observational|CSID GPS||Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)|A Multi-Center Study of the Prevalence of Known Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Variants and Functional Sucrase Activity by 13C-Sucrose Breath Test in Children With Chronic Diarrhea or Chronic Abdominal Pain|Completed||N/A|53|Actual|QOL Medical, LLC|||2||f||||f||||||||||2017-10-11 01:26:03.533723|2017-10-11 01:26:03.533723
NCT01913990|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-01-27|||September 2011||2011-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|ER11-02||Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.|A Randomized, Phase IV Trial of Individualized Care Versus Standard Care, in the Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients. The EPIC Study|Active, not recruiting||Phase 4|323|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 01:26:03.926579|2017-10-11 01:26:03.926579
NCT01913977|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-06-02|||June 2013||2013-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System|Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System.|Unknown status|Recruiting|N/A|5|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 01:26:04.047156|2017-10-11 01:26:04.047156
NCT01913964|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-07-31|||October 1997||1997-10-01|July 2013|2013-07-01|October 1997|Actual|1997-10-01|October 1997|Actual|1997-10-01||Interventional|||Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin||Completed||Phase 4|||University of Catania||2|||f||||t||||||||||2017-10-11 01:26:04.229707|2017-10-11 01:26:04.229707
NCT01913951|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-07-17|||November 22, 2013|Actual|2013-11-22|July 2017|2017-07-01|December 31, 2021|Anticipated|2021-12-31|December 5, 2016|Actual|2016-12-05||Interventional|||Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes|A Phase I Study of Vosaroxin Plus Azacitidine for Patients With Myelodysplastic Syndrome|Active, not recruiting||Phase 1|35|Actual|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-11 01:26:04.845287|2017-10-11 01:26:04.845287
NCT01913938|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-10-24|||July 2013||2013-07-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|HCIAP||Hemophagocytosis in Critically Ill Adult Patients|Hemophagocytosis in Critically Ill Adult Patients With Cytopenias|Recruiting||N/A|40|Anticipated|University of Ulm|||1||f||||f||||||Samples With DNA|"     whole blood, serum, white cells, bone marrow   "|||2017-10-11 01:26:04.999182|2017-10-11 01:26:04.999182
NCT01913925|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-07-30|||July 2009||2009-07-01|July 2013|2013-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effect of Tyrosine Supplementation on Cognitive Performance and Mood During Military Stress|Effect of Tyrosine Supplementation on Cognitive Performance and Mood During Military Stress|Completed||N/A|80|Actual|United States Army Research Institute of Environmental Medicine||2|||f||||f||||||||||2017-10-11 01:26:05.186809|2017-10-11 01:26:05.186809
NCT01913912|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-12-04|||January 2015||2015-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ERESA||Event Rate and Effects of Stimulants in ADHD|Can Changing the Rate at Which Information is Presented Alter the Effects of Stimulants on ADHD Information Processing. Testing a Prediction of the State Regulation Deficit Model.|Unknown status|Not yet recruiting|Phase 3|25|Anticipated|University Ghent||2|||f||||f||||||||||2017-10-11 01:26:05.330847|2017-10-11 01:26:05.330847
NCT01913899|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-07-30|||April 2013||2013-04-01|April 2012|2012-04-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|PPSS||Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain|Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain|Unknown status|Recruiting|N/A|70|Anticipated|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-11 01:26:05.553178|2017-10-11 01:26:05.553178
NCT01913886|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-05-30|||January 2010||2010-01-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|September 2013|Actual|2013-09-01||Interventional|||Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy|Autologous Grafting of Mesenchymal Stem Cells in Severe Refractory Ischemic Cardiomyopathy|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Pontifícia Universidade Católica do Paraná||1|||f||||f||||||||||2017-10-11 01:26:05.692313|2017-10-11 01:26:05.692313
NCT01913873|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-03-17|||January 2014||2014-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||High-sensitivity Troponin in Cardiac Surgery|High-sensitivity Cardiac Troponin and CK-MB Concentrations in Patients Undergoing Cardiac Surgery|Completed||Phase 4|400|Actual|Onze Lieve Vrouw Hospital||1|||f||||f||||||||||2017-10-11 01:26:05.848147|2017-10-11 01:26:05.848147
NCT01913860|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2014-12-04|||September 2013||2013-09-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|SIMPle||Supporting the Improvement and Management of Prescribing for Urinary Tract Infections (SIMPle)|Supporting the Improvement and Management of Prescribing for Urinary Tract Infections (SIMPle): Protocol for a Randomised Complex Intervention|Completed||N/A|2577|Actual|National University of Ireland, Galway, Ireland||3|||f||||t||||||||||2017-10-11 01:26:06.008368|2017-10-11 01:26:06.008368
NCT01913847|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-09-26|||September 2013||2013-09-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension|Phase III Study to Evaluate Efficacy and Safety of HGP1207 in Patients With Pulmonary Hypertension Associated With Systolic Heart Failure|Recruiting||Phase 3|144|Anticipated|Hanmi Pharmaceutical Company Limited||2|||f||||t||||||||No||2017-10-11 01:26:06.19355|2017-10-11 01:26:06.19355
NCT01913808|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-04-04|||January 2011||2011-01-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|February 2012|Actual|2012-02-01||Interventional|||Comparing Intravenous and Oral Iron in Postoperative Anemia|Efficacy of Intravenous Ferric Carboxymaltose in the Improvement of Anemia in Patients With Postoperative Knee Prosthesis|Completed||Phase 4|122|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 01:26:06.629976|2017-10-11 01:26:06.629976
NCT01913795|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-09-15|2015-07-29||May 2013||2013-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Environmental Intervention to Reduce Allergens in Urban Schools and Childhood Asthma|Environmental Intervention to Reduce Allergens in Urban Schools and Childhood Asthma|Completed||N/A|29|Actual|Boston Children’s Hospital||4|||f||||f||||||||||2017-10-11 01:26:06.819028|2017-10-11 01:26:06.819028
NCT01913782|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-08-05|||October 2012||2012-10-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Observational|||The Impact of Epidural Steroid Analgesia on Functional MRI for Patients With LBP|The Impact of Epidural Steroid Analgesia on Functional MRI for Patients With Low Back Pain|Unknown status|Recruiting|N/A|60|Anticipated|National Cheng-Kung University Hospital|||1||f||||t||||||None Retained|"     fMRI image   "|||2017-10-11 01:26:07.248106|2017-10-11 01:26:07.248106
NCT01913769|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-07-30|||July 2013||2013-07-01|July 2013|2013-07-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01||Observational|||Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan|Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan: Correlation Between Radiotherapy Dose Distribution, Myocardial Perfusion, Cardiac Function, Serum Biomarkers and Clinical Prognosis.|Unknown status|Active, not recruiting|N/A|100|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||Samples Without DNA|"     Venous blood sampling   "|||2017-10-11 01:26:07.333367|2017-10-11 01:26:07.333367
NCT01913756|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-11-17|||April 2013||2013-04-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Dairy Products and Metabolic Syndrome||Completed||N/A|153|Actual|Norwegian University of Life Sciences||3|||f||||||||||||||2017-10-11 01:26:07.424179|2017-10-11 01:26:07.424179
NCT01913743|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-07-30|||July 2013||2013-07-01|July 2013|2013-07-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|MINDSETS||The Effects of Mindsets on the Brain's Response to Food Cues|The Effects of Mindsets on the Brain's Response to Food Cues|Unknown status|Recruiting|N/A|35|Anticipated|The Miriam Hospital|||1||f||||f||||||||||2017-10-11 01:26:07.538064|2017-10-11 01:26:07.538064
NCT01913730|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-05-09|||November 2013||2013-11-01|May 2016|2016-05-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Maintenance Therapy With Subcutaneous Bortezomib|A PHASE II MULTI-CENTRE, RANDOMIZED, OPEN LABEL STUDY OF MAINTENANCE THERAPY WITH SUBCUTANEOUS BORTEZOMIB TWICE MONTHLY ASSOCIATED WITH DEXAMETHASONE, IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA PATIENTS AFTER SALVAGE WITH BORTEZOMIB-BASED THERAPY|Recruiting||Phase 2|216|Anticipated|Stichting Hemato-Oncologie voor Volwassenen Nederland||3|||f||||f||||||||||2017-10-11 01:26:07.613888|2017-10-11 01:26:07.613888
NCT01913717|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-08-09|||January 2014||2014-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion|Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion|Active, not recruiting||N/A|65|Anticipated|European Institute of Oncology||1|||f||||f||||||||||2017-10-11 01:26:07.719024|2017-10-11 01:26:07.719024
NCT01913704|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-08-01|||October 2012||2012-10-01|August 2013|2013-08-01|October 2014|Anticipated|2014-10-01|May 2014|Anticipated|2014-05-01||Interventional|||Pilot Study Comparing NatroxTM Topical Oxygen Therapy to A Placebo in the Management of Non-Healing Leg Ulcers|A Randomised Controlled Double Blind Pilot Study Comparing NatroxTM Topical Oxygen Therapy to A Placebo in the Management of Non-Healing Leg Ulcers in Conjunction With Standard Best Practice|Unknown status|Recruiting|N/A|50|Anticipated|Inotec AMD Limited||2|||f||||f||||||||||2017-10-11 01:26:07.812313|2017-10-11 01:26:07.812313
NCT01913691|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2017-10-05|||July 9, 2013||2013-07-09|February 3, 2014|2014-02-03|February 3, 2014|Actual|2014-02-03|February 3, 2014|Actual|2014-02-03||Interventional|||Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma|Phase II Open-Label Trial of Ipilimumab for Metastatic Merkel Cell Carcinoma|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:26:07.914188|2017-10-11 01:26:07.914188
NCT01913678|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-04-19|||July 2013||2013-07-01|April 2017|2017-04-01|July 3, 2014|Actual|2014-07-03|July 3, 2014|Actual|2014-07-03||Interventional|FIAF||The Effect of Dairy Fat and Inulin on Fasting Induced Adipose Factor (FIAF) Blood Concentrations|The Effect of Dairy Fat and Inulin on Fasting Induced Adipose Factor (FIAF) Blood Concentrations|Completed||N/A|21|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 01:26:07.995124|2017-10-11 01:26:07.995124
NCT01913665|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-08-05|||September 2013||2013-09-01|August 2013|2013-08-01||||December 2014|Anticipated|2014-12-01||Interventional|||The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation|The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation|Unknown status|Not yet recruiting|N/A|200|Anticipated|Eskisehir Osmangazi University||4|||f||||f||||||||||2017-10-11 01:26:08.133079|2017-10-11 01:26:08.133079
NCT01913652|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-04-27|||October 2014||2014-10-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Ph II Cabazitaxel DD Liposarcoma|Phase II Trial of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma|Recruiting||Phase 2|100|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 01:26:08.217007|2017-10-11 01:26:08.217007
NCT01913639|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-04-19|||July 2013||2013-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer|Phase II Study of FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer|Active, not recruiting||Phase 2|36|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:26:08.359574|2017-10-11 01:26:08.359574
NCT01913626|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-07-30|||June 2013||2013-06-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Assessing the Efficiency of Cognitive Group Therapy for Patient With Subjective Memory Complains Using the WebNeuro System From Brain Resource(BRC)||Unknown status|Enrolling by invitation|N/A|10|Anticipated|Meir Medical Center||1|||f||||||||||||||2017-10-11 01:26:08.492228|2017-10-11 01:26:08.492228
NCT01913613|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-09-13|||September 2013||2013-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|December 2015|Actual|2015-12-01||Interventional|REDUCE LAP-HF||REDUCE LAP-HF TRIAL|REDUCE LAP-HF TRIAL: A Study to Evaluate the DC Devices, Inc. IASD™ System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure|Active, not recruiting||N/A|100|Anticipated|Corvia Medical||1|||f||||t||||||||||2017-10-11 01:26:08.570877|2017-10-11 01:26:08.570877
NCT01913600|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-04-19|||July 2013|Actual|2013-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2016|Actual|2016-12-01||Interventional|RI-US XL||Resolute Integrity US Extended Length Sub-Study(RI-US XL)|Resolute Integrity US A Postapproval Study of the Medtronic Resolute™ Integrity Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2 mm|Active, not recruiting||N/A|56|Actual|Medtronic Vascular||1|||f||||f||||||||||2017-10-11 01:26:08.683849|2017-10-11 01:26:08.683849
NCT01913587|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-02-02|||March 2013||2013-03-01|February 2014|2014-02-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Efficacy Study of Acupuncture on Spinal Compression Fracture|Efficacy and Safety of Acupuncture on Spinal Compression Fracture in Patients Treated With Nerve Block|Unknown status|Recruiting|N/A|14|Anticipated|Daegu Catholic University Medical Center||2|||f||||f||||||||||2017-10-11 01:26:08.768602|2017-10-11 01:26:08.768602
NCT01913574|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2014-01-28|||March 2013||2013-03-01|January 2014|2014-01-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Efficacy Study of Acupuncture to Treat the Upper Abdominal Pain of Cancer Patients|Pilot Study of Acupuncture to Alleviate the Upper Abdominal Pain of Cancer Patients Treated With Neurolytic Celiac Plexus Block|Unknown status|Recruiting|Phase 2|14|Anticipated|Daegu Catholic University Medical Center||2|||f||||f||||||||||2017-10-11 01:26:10.473915|2017-10-11 01:26:10.473915
NCT01913561|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-08-22|||September 2013||2013-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|June 2017|Actual|2017-06-01||Interventional|||The Use of Master Caution Garment for Continuous Monitoring for Arrhythmia Detection|The Use of Master Caution Garment for Continuous Monitoring for Arrhythmia Detection Compared To Standard Gel-Electrode-Based ECG|Terminated||N/A|16|Actual|HealthWatch Ltd.||1||"the study design was not good. the use of garment and telemetry device simultaneously impact   the ECG recording quality."|f||||f||||||||||2017-10-11 01:26:10.608598|2017-10-11 01:26:10.608598
NCT01913548|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-07-30|||March 2010||2010-03-01|July 2013|2013-07-01|October 2013|Anticipated|2013-10-01|July 2013|Actual|2013-07-01||Observational|MCSIO||Multi-Center Study of Iron Overload: Survey Study (MCSIO)|Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies SURVEY STUDY|Unknown status|Active, not recruiting|N/A|100|Anticipated|Children's Hospital & Research Center Oakland|||3||f||||f||||||||||2017-10-11 01:26:10.701489|2017-10-11 01:26:10.701489
NCT01913535|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-05-31|2017-04-17||September 12, 2013|Actual|2013-09-12|May 2017|2017-05-01|January 22, 2016|Actual|2016-01-22|January 22, 2016|Actual|2016-01-22||Interventional|RAPID KOR|Only 8 participants were randomized because the study terminated early due to slow enrollment.|Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression|Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of CERC-501, a Kappa-Selective Opioid Receptor Antagonist, Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)|Terminated||Phase 2|8|Actual|Massachusetts General Hospital||5||slow enrollment|f||||t||||||||||2017-10-11 01:26:10.819209|2017-10-11 01:26:10.819209
NCT01913522|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-06-23|||September 2014|Actual|2014-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|CIRCA-DOSE||Cryoballoon vs. Irrigated Radiofrequency Catheter Ablation: Double Short vs. Standard Exposure Duration|Cryoballoon vs. Irrigated Radiofrequency Catheter Ablation: The Effect of Double Short vs. Standard Exposure Cryoablation Duration During Pulmonary Vein Isolation.|Active, not recruiting||N/A|348|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-11 01:26:11.661854|2017-10-11 01:26:11.661854
NCT01913509|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-02-17|||December 2013||2013-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of Post-Stroke Pain and Fatigue: Clinical Evaluation and Treatment Effect|A Study of Post-Stroke Pain and Fatigue: Clinical Evaluation and Treatment Effect|Recruiting||N/A|80|Anticipated|Chang Gung University||2|||f||||f||||||||No||2017-10-11 01:26:11.869584|2017-10-11 01:26:11.869584
NCT01913496|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-03-12|||April 2013||2013-04-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Development of Web Application and Evaluation Its Impact on Healthy Lifestyle|Development of Internet Web Application and Evaluation of Its Impact as a Tool in Promoting Healthy Lifestyle Indicators in Adults|Completed||N/A|99|Actual|Hebrew University of Jerusalem||2|||f||||t||||||||||2017-10-11 01:26:11.979519|2017-10-11 01:26:11.979519
NCT01913483|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-04-21|2017-02-17||September 24, 2013|Actual|2013-09-24|April 2017|2017-04-01|March 16, 2016|Actual|2016-03-16|March 16, 2016|Actual|2016-03-16||Interventional|ENDOMAX|mITT Population: Participants who were randomized into the trial, received at least one dose of study drug, and underwent the index PEI procedure.|ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial|ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial|Terminated||Phase 3|732|Actual|The Medicines Company||2|||f||||t|t|f||||||No||2017-10-11 01:26:12.103331|2017-10-11 01:26:12.103331
NCT01913470|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-04-06|2016-12-30||July 2013||2013-07-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||The baseline analysis population includes all participants who consented to participate in the study and met eligibility criteria.|Study of Losartan in the Treatment of NAFLD in Children|A Pilot Study of Losartan in the Treatment of Pediatric NAFLD|Completed||Phase 2|12|Actual|Emory University||2|||f||||t||||||||||2017-10-11 01:26:12.980584|2017-10-11 01:26:12.980584
NCT01913457|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-07-27|||July 2013||2013-07-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01|1 Day|Observational [Patient Registry]|||Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult Patients|Evaluation of Lung Doppler Signals in Pediatric and Adult Patients|Recruiting||N/A|200|Anticipated|Echosense Ltd.|||3||f||||t||||||||||2017-10-11 01:26:13.472059|2017-10-11 01:26:13.472059
NCT01913444|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-01-10|||July 2013||2013-07-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO|Pharmacokinetics of Recombinant Antithrombin III in Neonates Undergoing Extracorporeal Membrane Oxygenation|Withdrawn||Phase 4|0|Actual|Children's Hospital Los Angeles||1||Unable to enroll patients into study.|f||||t||||||||||2017-10-11 01:26:13.571476|2017-10-11 01:26:13.571476
NCT01913431|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2017-08-30|||September 12, 2013|Actual|2013-09-12|August 2017|2017-08-01|November 6, 2015|Actual|2015-11-06|November 6, 2015|Actual|2015-11-06||Interventional|||Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B|A Multicenter, Double-blind, Active-controlled, Randomized, Parallel Group Study to Demonstrate the Comparison and Evaluation of Baracle Tab.® and Baraclude Tab.® for HBeAG Chronic Hepatitis B|Completed||Phase 4|118|Actual|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:26:13.654582|2017-10-11 01:26:13.654582
NCT01913418|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-28|2014-03-16|||July 2013||2013-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone Maintenance|Clinical Efficacy and Serum Proteomic Profiling of Traditional Chinese Medicine, Suan-Zao-Ren Tang, for Sleep Disturbance During Methadone Maintenance: Study Protocol for a Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 2|90|Actual|China Medical University, Taiwan||2|||f||||t||||||||||2017-10-11 01:26:13.745106|2017-10-11 01:26:13.745106
NCT01913392|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2016-09-12|||July 2013||2013-07-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate|Prospective, Clinical Study of the Effect of Bariatric Surgery, Laparoscopic Sleeve Gastrectomy, on the Pharmacokinetics of Immunosuppressive Drugs in the Morbidly Obese, Kidney Transplant Candidate|Recruiting||Phase 4|10|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||||2017-10-11 01:26:14.123791|2017-10-11 01:26:14.123791
NCT01913379|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-07-30|||August 2011||2011-08-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole|A Phase I Randomized, Open-label, 3-arm Parallel-design Study to Determine the Effect of Multiple-dose Gemfibrozil or Itraconazole on the Pharmacokinetics, Safety and Tolerability of Single-dose MDV3100 (ASP9785) in Healthy Male Subjects|Completed||Phase 1|41|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 01:26:14.230112|2017-10-11 01:26:14.230112
NCT01913366|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-06-09|||August 2013||2013-08-01|June 2015|2015-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SPARROW||Senior Peer Alliance for Rural Research On Wellness|Case Management and Problem Solving Therapy for Depressed Older Adults|Recruiting||N/A|160|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:26:14.343441|2017-10-11 01:26:14.343441
NCT01913353|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-07-20|||March 2015|Actual|2015-03-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®|A Randomized, Open-label Phase III Non-inferiority Trial to Compare Indicators of Efficacy for MVA-BN® Smallpox Vaccine to ACAM2000® in 18-42 Year Old Healthy Vaccinia-naïve Subjects|Active, not recruiting||Phase 3|440|Anticipated|Bavarian Nordic||2|||f||||t||||||||||2017-10-11 01:26:14.440465|2017-10-11 01:26:14.440465
NCT01913314|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-11-19|||August 2013||2013-08-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study of ^14C-LY2835219 in Healthy Participants|Disposition of [^14C]-LY2835219 Following Oral Administration in Healthy Subjects|Completed||Phase 1|8|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:26:14.761894|2017-10-11 01:26:14.761894
NCT01913288|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-07-31|||May 2013||2013-05-01|July 2013|2013-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Mother's Voice and Heartbeat Sounds on Preterm Newborns|Exposure to Biological Maternal Sounds in Extremely Preterm Infants: Effects on Short- and Long-term Outcomes|Recruiting||N/A|150|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:26:14.92134|2017-10-11 01:26:14.92134
NCT01913275|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2013-07-30|||March 2006||2006-03-01|July 2013|2013-07-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy|Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy|Unknown status|Recruiting|N/A|134|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 01:26:15.038814|2017-10-11 01:26:15.038814
NCT01913262|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2013-07-31|||March 2013||2013-03-01|July 2013|2013-07-01||||March 2015|Anticipated|2015-03-01|4 Months|Observational [Patient Registry]|||IFH Depression Registry 2013||Unknown status|Active, not recruiting|N/A|1000|Anticipated|The Institute for Family Health|||1||f||||||||||||||2017-10-11 01:26:15.145864|2017-10-11 01:26:15.145864
NCT01913249|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-04-18|||September 2013||2013-09-01|September 2013|2013-09-01||||July 2017|Anticipated|2017-07-01||Interventional|||Effect of Short Term Versus Long Term Treatment With Seton Prior to LIFT Surgery for Complex Anal Fistula|Effect of Short Term Versus Long Term Treatment With Seton Prior to LIFT Surgery for Complex Anal Fistula, a Randomized Controlled Trial.|Suspended||N/A|100|Anticipated|Sykehuset Innlandet HF||2||Unable to get MRI of patients within reasonable time on a local hospital.|f||||f||||||||||2017-10-11 01:26:15.226503|2017-10-11 01:26:15.226503
NCT01913236|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-08-02|||September 2013||2013-09-01|July 2013|2013-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TICD||Tailored Implementation Intervention for Managing Depressed Elderly Patients in Primary Care|A Pragmatic Cluster Randomised Trial of a Tailored Intervention for Implementing Recommendations for Managing Depressed Elderly Patients in Primary Care: Protocol|Completed||N/A|80|Actual|Sykehuset Innlandet HF||2|||f||||f||||||||||2017-10-11 01:26:15.313813|2017-10-11 01:26:15.313813
NCT01913223|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-08-26|||June 2012||2012-06-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|NESTIS||Endoscopic Sub-mucosal Dissection With the Nestis® Jet Injector System With a Bi-functional Catheter: First Prospective Trial|Endoscopic Sub-mucosal Dissection With the Nestis® Jet Injector System With a Bi-functional Catheter: First Prospective Trial.|Completed||N/A|17|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 01:26:15.397798|2017-10-11 01:26:15.397798
NCT01913197|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-01-05|||August 2013||2013-08-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy|Phase I/II Evaluation Magnetic Resonance Imaging (MRI)-Guided Differential-Dose Prostate Brachytherapy|Terminated||Phase 1/Phase 2|2|Actual|St. Luke's-Roosevelt Hospital Center||1||low enrollment|f||||t||||||||||2017-10-11 01:26:15.544818|2017-10-11 01:26:15.544818
NCT01913184|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-07-30|||April 2012||2012-04-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Lung Bioavailability With Continuous or Discontinuous Nebulization|EFFECT OF DRUG TARGETING NEBULIZATION ON LUNG DELIVERY|Completed||N/A|6|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-11 01:26:15.621832|2017-10-11 01:26:15.621832
NCT01913171|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-07-30|||November 2011||2011-11-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Hula Hooping as Compared to Walking on Adipose Tissue Distribution, Metabolic Parameters and Adipose Tissue Gene Expression|Effect of Hula Hooping as Compared to Walking on Adipose Tissue Distribution, Metabolic Parameters and Adipose Tissue Gene Expression|Completed||N/A|53|Actual|Helsinki University||2|||f||||f||||||||||2017-10-11 01:26:15.695129|2017-10-11 01:26:15.695129
NCT01913158|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-11-02||2016-09-09|October 2013||2013-10-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids|A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate Safety and Efficacy of Anucort HC TM (Hydrocortisone Acetate) 25mg Rectal Suppositories in the Treatment of Symptomatic Internal Hemorrhoids|Completed||Phase 2|150|Actual|G & W Laboratories Inc.||2|||f||||f||||||||No||2017-10-11 01:26:15.765084|2017-10-11 01:26:15.765084
NCT01913145|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-04-18|||May 2012||2012-05-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Comparison Study of Lay Person Finger Stick Versus Blood Draw|Usability and HbA1c Method Comparison Study Using Lay Person Micro-Blood Specimens|Completed||Phase 1|128|Actual|Home Access Health Corporation||1|||f||||t||||||||||2017-10-11 01:26:15.867268|2017-10-11 01:26:15.867268
NCT01913132|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-03-15|||November 2013||2013-11-01|March 2016|2016-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||PICO Above Incisions After Vascular Surgery|PICO Versus Standard Dressing Above Groin Incisions After Vascular Surgery - a Prospective Randomized Trial|Recruiting||N/A|160|Anticipated|Skane University Hospital||2|||f||||||||||||||2017-10-11 01:26:15.950183|2017-10-11 01:26:15.950183
NCT01913119|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-29|||July 2013||2013-07-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Ro-ENKTL||A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma|A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell|Completed||Early Phase 1|16|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 01:26:16.034387|2017-10-11 01:26:16.034387
NCT01913106|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-06-29|||June 2007||2007-06-01|June 2016|2016-06-01|December 2028|Anticipated|2028-12-01|December 2018|Anticipated|2018-12-01||Interventional|||HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer|Phase I-II Study HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer With or Without Metastatic Disease|Recruiting||Phase 1/Phase 2|25|Anticipated|The Methodist Hospital System||1|||f||||t||||||||No||2017-10-11 01:26:16.148159|2017-10-11 01:26:16.148159
NCT01913093|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-04-24|||July 2013||2013-07-01|April 2017|2017-04-01||||July 2018|Anticipated|2018-07-01||Observational|N-PhenoGENICS||N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors|N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors|Recruiting||N/A|500|Anticipated|The Hospital for Sick Children|||2||f||||||||||Samples With DNA|"     DNA samples obtained via blood, saliva and buccal sample collection.   "|||2017-10-11 01:26:16.271488|2017-10-11 01:26:16.271488
NCT01913080|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2017-01-31|||September 2013||2013-09-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Health Log: A Randomized Clinical Trial|The Use of a Health Management Tool in a Clinic Setting to Improve Self-Efficacy in Rheumatoid Arthritis Patients: a Randomized Clinical Trial.|Completed||N/A|67|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:26:16.378268|2017-10-11 01:26:16.378268
NCT01913067|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-07-23|||September 2013||2013-09-01|July 2014|2014-07-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Interventional|CRANIAL||Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC|A Phase II Evaluating Cabazitaxel in Patients With Brain Metastasis Secondary to Breast and Non-small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Jules Bordet Institute||1||Scientific rationale is deemed obsolete. Funders lost interest in the trial.|f||||f||||||||||2017-10-11 01:26:16.489112|2017-10-11 01:26:16.489112
NCT01913054|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-12-13|||August 2013||2013-08-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Combined Use of Etomidate and Propofol in Painless Gastroscopy.|Combined Use of Etomidate and Propofol in Painless Gastroscopy, a Multiple Center, Double Blinded, Randomized,Controled Study.|Unknown status|Recruiting|Phase 4|2450|Anticipated|Jiangsu Nhwa Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 01:26:16.605089|2017-10-11 01:26:16.605089
NCT01913041|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2014-07-02|2014-05-16||August 2013||2013-08-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Observational||39 patients were eliminated for the reasons operation cancelled temporarily or volate the eligible criteria, so 830 participants for analysis was determined in the end.|An Epidemiology Survey on the Incidence of Perioperative Hypothermia|An Epidemiology Survey on the Incidence of Perioperative Hypothermia of Patients Undergo Elective Operation With General Anaesthesia in Beijing Area|Completed||N/A|869|Actual|Peking Union Medical College Hospital|In this study some information can hardly be completely collected such as wound infection incidence within 30 days postoperation, so further intervention study is needed to explore the relationship between hyperthermia and the potential complication.||1||f||||t||||||||||2017-10-11 01:26:16.898365|2017-10-11 01:26:16.898365
NCT01913028|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-30|2014-02-11|||August 2013||2013-08-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI9929 After Single Administration in Healthy Male Japanese Subjects|A Phase 1, Single Centre, Single-blind, Randomized, Placebo-controlled Parallel-group Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI9929 After Administration of Single Ascending Doses in Healthy Male Japanese Subjects|Completed||Phase 1|64|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:26:17.083789|2017-10-11 01:26:17.083789
NCT01913015|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-04-26|||July 2013||2013-07-01|April 2017|2017-04-01||||June 2014|Actual|2014-06-01||Interventional|||Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer|An Open-Label, Phase I, Randomized Pharmacokinetic Study of Dietary Effects on Abiraterone Acetate Drug Levels in Patients With Metastatic Castration-Resistant Prostate Cancer (DEAL)|Terminated||Phase 1|3|Actual|OHSU Knight Cancer Institute||2||"After enrollment of the first 3 subjects, an interim assessment was conducted. Comparing DBS   sampling to plasma PK levels yielded unconvincing results."|f||||t||||||||||2017-10-11 01:26:17.197393|2017-10-11 01:26:17.197393
NCT01913002|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-10-28|||July 2013||2013-07-01|October 2013|2013-10-01||||October 2013|Actual|2013-10-01||Interventional|||Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects|Randomized, Double-blind, Placebo-controlled, Positive-controlled, 4-period, 4-way Crossover Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 800 mg and 2000 mg Compared With Placebo and Open-label Moxifloxacin in Healthy Subjects: A Thorough QT Study|Completed||Phase 1|63|Actual|Lexicon Pharmaceuticals||4|||f||||f||||||||||2017-10-11 01:26:17.310184|2017-10-11 01:26:17.310184
NCT01912989|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-09-23|||January 2013||2013-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|NOURISH+MI||Motivational Interviewing in NOURISH for Parents of Overweight Children|Motivational Interviewing in NOURISH for Parents of Overweight Children|Completed||N/A|64|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 01:26:17.400961|2017-10-11 01:26:17.400961
NCT01912976|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-30|||March 2011||2011-03-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease|A Randomized, Intra-individual, Prospective Study Comparing Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Ablative Fractional Laser Treatment in Asian Patients With Lower Extremity Bowen's Disease|Completed||Phase 1|21|Actual|Dong-A University||2|||f||||f||||||||||2017-10-11 01:26:17.480933|2017-10-11 01:26:17.480933
NCT01912963|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-09-19|||August 2013||2013-08-01|September 2017|2017-09-01|March 2020|Anticipated|2020-03-01|May 2017|Actual|2017-05-01||Interventional|||Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer|A Phase II Study of Eribulin Mesylate in Combination With Trastuzumab and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer|Active, not recruiting||Phase 2|32|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:26:17.609497|2017-10-11 01:26:17.609497
NCT01912950|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-09-09|||December 2013||2013-12-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair|Randomized, Controlled, Open-Label Pilot Study of a Novel IPL for Removal of Unwanted Fine Hair|Completed||Phase 4|10|Actual|Cutera Inc.||2|||f||||f||||||||||2017-10-11 01:26:17.721047|2017-10-11 01:26:17.721047
NCT01912937|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-10-12|||June 2013||2013-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|PK||Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries:|ProspectIve, SingLe-Arm, MuLti-Center, Pharmacokinetic Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon|Active, not recruiting||Phase 2/Phase 3|25|Anticipated|Spectranetics Corporation||1|||f||||t||||||||||2017-10-11 01:26:17.828306|2017-10-11 01:26:17.828306
NCT01912924|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-03|2013-07-29|||August 2011||2011-08-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Prospective Trial for the Effectiveness of the Use of Spinal Cord Stimulation (SCS) in Failed Knee Surgery|"A Prospective Single Centre Open Label Trial to Assess the Effectiveness of the Use of Spinal Cord Stimulation in Subjects With Chronic Knee Pain Failed Knee Surgery"|Withdrawn||N/A|0|Actual|Coastal Orthopedics & Sports Medicine||1||Difficult enrollment, no subjects identified to enroll|f||||f||||||||||2017-10-11 01:26:17.921452|2017-10-11 01:26:17.921452
NCT01912911|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2014-08-06|||June 2013||2013-06-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|iTransmit||Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure||Completed||N/A|60|Actual|The Cleveland Clinic|||1||f||||f||||||||||2017-10-11 01:26:18.02187|2017-10-11 01:26:18.02187
NCT01912898|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-30|||March 2013||2013-03-01|February 2013|2013-02-01||||March 2013|Actual|2013-03-01||Observational|||Development of Non-invasive Method for Quantifying Vitamin D Levels in the Body Using Spectroscopy||Unknown status|Recruiting|N/A|40|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 01:26:18.092785|2017-10-11 01:26:18.092785
NCT01912885|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-07-29|||March 2012||2012-03-01|June 2013|2013-06-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Interventional|||Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome|Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome: Randomized Blind Clinical Trial|Unknown status|Recruiting|N/A|145|Anticipated|University of Sao Paulo General Hospital||5|||f||||f||||||||||2017-10-11 01:26:18.182139|2017-10-11 01:26:18.182139
NCT01912872|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-09-27|||November 2013||2013-11-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|MEXIC||Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma|Multicentric, Open-label, Randomized, Parallel--group Study to Evaluate the Efficacy and Safety of Omalizumab in a 12- Month Period, in Patients With Severe IgE-mediated Asthma Inadequately Controlled With High Doses of Corticosteroids.|Recruiting||Phase 4|138|Anticipated|Novartis||2|||f||||t||||||||||2017-10-11 01:26:18.284874|2017-10-11 01:26:18.284874
NCT01912859|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-09-03|||July 2013||2013-07-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Next Steps: a Community-led Solution to Address Childhood Obesity|Next Steps: a Community-led Solution to Sustaining Healthy Behaviors in Families Addressing Childhood Obesity|Completed||N/A|48|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:26:18.427484|2017-10-11 01:26:18.427484
NCT01912846|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-07-19|||January 2013|Actual|2013-01-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||An Interactive Advance Care Planning Intervention to Facilitate a Good Death for Cancer Patients|An Interactive Advance Care Planning Intervention to Facilitate a Good Death for Cancer Patients|Recruiting||N/A|462|Anticipated|Chang Gung University||2|||f||||f||||||||||2017-10-11 01:26:18.522057|2017-10-11 01:26:18.522057
NCT01912833|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2014-12-05|||August 2013||2013-08-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|SEPAH||Study of Exposure to Stress, Postpartum Mood, Adverse Life Events, and Hormonal Function Among Latinas (SEPAH Latina)|Assessing the Association Between Stressful Life Events, Hormonal Dysregulation, and Postpartum Depression Among Lactating Latina Mothers: A Pilot Study|Completed||N/A|34|Actual|University of North Carolina, Chapel Hill|||1||f||||||||||Samples With DNA|"     oxytocin, cortisol, and adrenocorticotropic hormone (ACTH)   "|||2017-10-11 01:26:18.643665|2017-10-11 01:26:18.643665
NCT01912820|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-09-12|||January 1, 2014|Actual|2014-01-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2016|Actual|2016-01-31||Interventional|||Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery|A Phase I Randomized, Double-Blind, Placebo-Controlled Two-Arm Study of Quercetin and Green Tea to Enhance the Bioavailability of Green Tea Polyphenols in Men Scheduled for Prostatectomy|Active, not recruiting||Phase 1|31|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:26:18.718506|2017-10-11 01:26:18.718506
NCT01912807|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-03-22|||December 2013||2013-12-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|DEXPO||Postoperative Vomiting in Children - Is Dextrose an Effective Prophylactic Anti-emetic?|Postoperative Vomiting in Children - Is Dextrose an Effective Prophylactic Anti-emetic? A Non-Inferiority, Randomized Control Trial|Completed||N/A|300|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 01:26:18.836955|2017-10-11 01:26:18.836955
NCT01912781|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-06-10|2015-05-26||November 2013||2013-11-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||This analysis population includes all randomized subjects.|Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Gas Permeable Contact Lens Wearers|Clinical Evaluation of the Safety and Efficacy of FID 120947A Compared to a Marketed Lens Care Solution in Gas Permeable Contact Lens Wearers|Completed||N/A|112|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:26:19.059806|2017-10-11 01:26:19.059806
NCT01912768|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-06-10|2015-05-26||December 2013||2013-12-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||This analysis population includes all randomized participants.|Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Soft Contact Lens Wearers|Clinical Evaluation of the Safety and Efficacy of FID 120947A Compared to a Marketed Lens Care Solution|Completed||N/A|362|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:26:20.113836|2017-10-11 01:26:20.113836
NCT01912755|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-29|||February 2010||2010-02-01|July 2013|2013-07-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Interventional|||Anesthetic Efficacy of Articaine and Lidocaine in Lower Molars With Irreversible Pulpits|Anesthetic Efficacy of 4% Articaine (Mandibular Infiltration) and 2% Lidocaine (Alveolar Nerve Block), Associated With 1:100.000 Epinephrine, in Lower Molars With Irreversible Pulpits|Completed||Phase 4|50|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 01:26:21.205186|2017-10-11 01:26:21.205186
NCT01912742|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-09-19|||August 2013|Actual|2013-08-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|FVS||Effect of Speed of Weight Loss on Compensatory Mechanisms Activated During Weight Reduction|Effect of Speed of Weight Loss on Compensatory Mechanisms Activated During Weight Reduction|Completed||N/A|35|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 01:26:21.409641|2017-10-11 01:26:21.409641
NCT01912716|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-09-02|||July 2013||2013-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis|Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients: Searching for the Optimal Dose. A Prospective, Randomized Trial|Recruiting||Phase 2/Phase 3|1036|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 01:26:21.629599|2017-10-11 01:26:21.629599
NCT01912703|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-07-30|||December 2013||2013-12-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||The Long-term Neurodevelopmental Outcome After Intraventricular Hemorrhage (IVH)-Grades I-II in Preterm Infants at Ages 1-7 Years||Unknown status|Not yet recruiting|N/A|700|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-10-11 01:26:21.813845|2017-10-11 01:26:21.813845
NCT01912690|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-09-20|||July 2013||2013-07-01|August 2015|2015-08-01||||January 2015|Actual|2015-01-01||Interventional|||The Influence of Different Training Regimens on Electrical Stability Following Myocardial Infarction||Completed||N/A|60|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||||2017-10-11 01:26:21.904485|2017-10-11 01:26:21.904485
NCT01912677|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-07-07|||April 2015|Actual|2015-04-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy|Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy|Recruiting||Phase 4|894|Anticipated|Gynuity Health Projects||3|||f||||t||||||||||2017-10-11 01:26:21.987896|2017-10-11 01:26:21.987896
NCT01912651|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-05-08|||July 2013||2013-07-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery|The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery|Recruiting||Phase 4|300|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-11 01:26:22.11707|2017-10-11 01:26:22.11707
NCT01912638|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-09-20|||July 2012||2012-07-01|July 2015|2015-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma|Comparative Study of the Efficacy and Safety of Ologen Collagen Implant Versus Cohesive Viscoelastic in Trabeculectomy Performed for Steroid Induced Glaucoma|Completed||Phase 1/Phase 2|17|Actual|National Centre of Ophthalmology named after academician Zarifa Aliyeva||2|||f||||t||||||||||2017-10-11 01:26:22.207574|2017-10-11 01:26:22.207574
NCT01912625|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-09-12|||October 28, 2013|Actual|2013-10-28|September 2017|2017-09-01||||July 27, 2018|Anticipated|2018-07-27||Interventional|||Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery|A Phase 1 Study of Trametinib in Combination With Chemoradiation for KRAS Mutant Non-small Cell Lung Cancer|Recruiting||Phase 1|30|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:26:22.359472|2017-10-11 01:26:22.359472
NCT01912612|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-09-25|||August 2013|Actual|2013-08-01|September 2017|2017-09-01|March 2023|Anticipated|2023-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Mechanistic Study of Duloxetine Versus Placebo in Breast Cancer Patients With Chronic Pain|A Study to Identify Predictors of Response to Duloxetine in Breast Cancer Patients With Chronic Pain|Recruiting||Phase 2|132|Anticipated|University of Utah||1|||f||||t|t|f|||f|||||2017-10-11 01:26:22.611209|2017-10-11 01:26:22.611209
NCT01912599|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-05-10|2016-03-09||July 2013||2013-07-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||N/A Pilot Study|Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma|Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma|Completed||N/A|36|Actual|University of North Carolina, Chapel Hill|The limitation is that the contact lens expresses the IOP values in a unit that is not convertible to mmHg. Therefore, we do not know exactly what the cutoff of normal IOP with the lens is.|2|||f||||f||||||||No||2017-10-11 01:26:22.725354|2017-10-11 01:26:22.725354
NCT01912586|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2015-06-17|||May 2013||2013-05-01|February 2014|2014-02-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer|A Non-randomised Controlled Trial of Early Intervention to Preserve Erectile Function After Laparoscopic Resection for Rectal Cancer|Completed||Phase 4|90|Actual|Nanfang Hospital of Southern Medical University||3|||f||||f||||||||||2017-10-11 01:26:23.260796|2017-10-11 01:26:23.260796
NCT01912573|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2013-07-29|||September 2013||2013-09-01|July 2013|2013-07-01|March 2015|Anticipated|2015-03-01|September 2014|Anticipated|2014-09-01||Interventional|||Nasal Naloxone for Narcotic Overdose|Nasal Naloxone for Narcotic Overdose|Unknown status|Not yet recruiting|Phase 4|236|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-10-11 01:26:23.381765|2017-10-11 01:26:23.381765
NCT01912560|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-07-26||2015-02-24|July 2013||2013-07-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PATHWAYS I||Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia|A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Safety, Efficacy and Pharmacodynamics of CAT-2003 Alone and In Combination With A Statin in Patients With Hyperlipidemia (PATHWAYS I)|Completed||Phase 2|99|Actual|Catabasis Pharmaceuticals||4|||f||||f||||||||||2017-10-11 01:26:23.524862|2017-10-11 01:26:23.524862
NCT01912547|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-27|2015-01-28|||September 2013||2013-09-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Thromboelastography During Surgery for Malignant Pleural Mesothelioma|Thromboelastography During Surgery for Malignant Pleural Mesothelioma|Unknown status|Recruiting|Early Phase 1|100|Anticipated|Brigham and Women's Hospital|||1||f||||t||||||||||2017-10-11 01:26:23.657502|2017-10-11 01:26:23.657502
NCT01912534|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-05-16|||April 2014||2014-04-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|VANISH||Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM|Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM|Recruiting||Phase 2|150|Anticipated|New England Research Institutes||2|||f||||t||||||||||2017-10-11 01:26:23.782993|2017-10-11 01:26:23.782993
NCT01912521|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-07-29|||November 2011||2011-11-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|MIHNIS||Mfangano Island Healthy Networks Impact Study|Mfangano Island Healthy Networks Impact Study|Completed||N/A|883|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:26:24.04154|2017-10-11 01:26:24.04154
NCT01912508|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2014-08-12|||August 2013||2013-08-01|August 2014|2014-08-01||||August 2014|Anticipated|2014-08-01||Observational|||Preterm Labor Prediction by Cervical Contour in Ultrasound||Unknown status|Recruiting|N/A|200|Anticipated|Meir Medical Center|||2||f||||||||||||||2017-10-11 01:26:24.17394|2017-10-11 01:26:24.17394
NCT01912495|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-03-02|2015-12-07||August 2013||2013-08-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|DAHHS||Dutch Acute HCV in HIV Study (DAHHS)|Efficacy of 12 Week Boceprevir in Addition to Standard of Care Therapy Consisting of Peginterferon-alpha-2b and Ribavirin for the Treatment of Acute HCV Genotype 1 in HIV Co-infected Patients. A Proof of Concept Feasibility Clinical Trial.|Completed||Phase 2|65|Actual|Erasmus Medical Center||1|||f||||f||||||||||2017-10-11 01:26:24.267458|2017-10-11 01:26:24.267458
NCT01912482|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-01-03|||July 2015||2015-07-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|RMS||Cardiorespiratory Training and Ventilatory Muscle Strength|Chronic Effect of Cardiorespiratory Training on Ventilatory Muscle Strength in Elderly Women: Controlled Trial, Randomized and Double Blind.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Universidade Gama Filho||3|||f||||t||||||||||2017-10-11 01:26:24.609916|2017-10-11 01:26:24.609916
NCT01912469|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-09-12|||April 2010||2010-04-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effects of Traumeel®S Tablets on Exercise Induced Muscle Damage and Muscle Soreness||Completed||Phase 1|96|Actual|University of Giessen||2|||f||||f||||||||||2017-10-11 01:26:24.714453|2017-10-11 01:26:24.714453
NCT01912456|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-07-27||2016-10-12|January 2014||2014-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema|A Double-blind, Randomized, Placebo-controlled, Cross-over Study to Evaluate the Clinical Efficacy and Safety of Subcutaneous Administration of Human Plasma-derived C1-esterase Inhibitor in the Prophylactic Treatment of Hereditary Angioedema|Completed||Phase 3|90|Actual|CSL Behring||4|||f||||||||||||||2017-10-11 01:26:24.830273|2017-10-11 01:26:24.830273
NCT01912443|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2014-04-25|||August 2013||2013-08-01|April 2014|2014-04-01||||August 2017|Anticipated|2017-08-01||Observational|||Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer||Unknown status|Recruiting|N/A|600|Anticipated|Sun Yat-sen University|||1||f||||f||||||||||2017-10-11 01:26:25.079074|2017-10-11 01:26:25.079074
NCT01912027|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-10-09|||January 2013||2013-01-01|October 2013|2013-10-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|||Open Latarjet Techniques Versus Arthroscopic Latarjet Techniques on Anterior Shoulder Instability: The Comparison of Clinical and Radiographic Outcomes||Unknown status|Recruiting|N/A|30|Anticipated|Beijing Jishuitan Hospital||2|||f||||||||||||||2017-10-11 01:26:32.492223|2017-10-11 01:26:32.492223
NCT01912430|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-07-30|||July 2012||2012-07-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Retrospective Data Analysis of VitalCare Targeted Population Management on Scott and White Chronically Ill Beneficiaries|Retrospective Data Analysis of the Impact of Vital Care Targeted Population Management Upon a Matched Cohort of Scott and White Health Plan Beneficiaries|Completed||N/A|17559|Actual|Scott & White Health Plan||2|||f||||f||||||||||2017-10-11 01:26:25.264033|2017-10-11 01:26:25.264033
NCT01912417|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-09-04|||August 2010||2010-08-01|September 2013|2013-09-01|January 2014|Anticipated|2014-01-01|February 2012|Actual|2012-02-01||Interventional|||Aerobic Exercise During Hemodialysis|Aerobic Exercise Increases Phosphate Removal During Hemodialysis|Unknown status|Active, not recruiting|N/A|28|Actual|Universidade Católica de Pelotas||2|||f||||f||||||||||2017-10-11 01:26:25.355263|2017-10-11 01:26:25.355263
NCT01912404|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2016-09-16|2016-07-29||July 2013||2013-07-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|AH|Study in patients with alcoholic hepatitis who were contraindicated to receive corticosteroid therapy.|Study of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Steroid Therapy|A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Corticosteroid Therapy|Terminated||Phase 2|5|Actual|Conatus Pharmaceuticals Inc.|Since the study was stopped early, no conclusions regarding efficacy can be made.|2||Due to concern for high systemic drug levels that could exceed levels in toxicology studies.|f||||t||||||||No|Study was terminated early with insufficient subjects for meaningful analysis.|2017-10-11 01:26:25.440693|2017-10-11 01:26:25.440693
NCT01912391|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2015-10-06|||October 2012||2012-10-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder|A Phase III Randomized Double-blind, 12 Week, Placebo Controlled Trial of Transdermal Selegiline in Borderline Personality Disorder (BPD) to Evaluate Efficacy and Safety|Completed||Phase 3|30|Actual|Mood and Anxiety Research, Inc||2|||f||||f||||||||||2017-10-11 01:26:25.953374|2017-10-11 01:26:25.953374
NCT01912378|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-05-14|||August 2013||2013-08-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|TAO||Triadic Interactions of Families With Autism and Oxytocin|Phase 1 Study of Intranasal Oxytocin on Parents' Behavioral and Physiological Responses to Children With Autism|Withdrawn||Phase 1|0|Actual|University of California, San Francisco||2||unable to launch the study due to lack of participation with Autism Clinic|f||||f||||||||||2017-10-11 01:26:26.062753|2017-10-11 01:26:26.062753
NCT01912365|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-05-31|||August 2013||2013-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Splinting Versus Casting for Type I Supracondylar Fractures|Splinting Versus Above Elbow Casting for Type I Supracondylar Fractures of the Humerus in Children: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|University of British Columbia|||2||f||||f||||||||||2017-10-11 01:26:26.185373|2017-10-11 01:26:26.185373
NCT01912352|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-11-26|2014-11-20||May 2010||2010-05-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder|Gene-environment Interactions and Brain Functional Connectivity Associated With Norepinephrine System Genes in Attention Deficit Hyperactivity Disorder|Completed||N/A|83|Actual|Seoul National University||1|||f||||t||||||||||2017-10-11 01:26:26.304592|2017-10-11 01:26:26.304592
NCT01912339|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-04-04|2016-11-29||July 2013||2013-07-01|April 2017|2017-04-01|October 17, 2016|Actual|2016-10-17|March 2015|Actual|2015-03-01||Interventional|REZUM||Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate)|Minimally Invasive Prostatic Vapor Ablation - Multicenter, Controlled Study for the Treatment of BPH (Rezūm II)|Completed||N/A|197|Actual|NxThera Inc|"All adverse events reported, including those not related to the Rezum procedure. Events related to the procedure are summarized in McVary 2016 (see Publications automatically indexed to this study)."|2|||f||||t||||||||No||2017-10-11 01:26:26.54857|2017-10-11 01:26:26.54857
NCT01912326|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2014-12-17|||July 2002||2002-07-01|December 2014|2014-12-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|PAFOS||Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation|Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation|Completed||N/A|249|Actual|St. Jude Medical||2|||f||||f||||||||||2017-10-11 01:26:27.241676|2017-10-11 01:26:27.241676
NCT01912313|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-02-07|||August 2013||2013-08-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)|Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)|Recruiting||N/A|99999999|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-11 01:26:27.36043|2017-10-11 01:26:27.36043
NCT01912300|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-30|||July 2013||2013-07-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|July 2013|Actual|2013-07-01||Interventional|||Nutritional Adaptations to Physical or Sedentary Activities in Youth|Nutritional Adaptation to Contemporary Sedentary Behaviors and Physical Exercise in Youth: Effect of Weight Status|Withdrawn||N/A|0|Actual|Université Blaise Pascal, Clermont-Ferrand||2|||f||||f||||||||||2017-10-11 01:26:27.452121|2017-10-11 01:26:27.452121
NCT01912287|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-01-11|||December 2013||2013-12-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||GATE: Generalized Anxiety - A Treatment Evaluation|GATE: Generalized Anxiety - A Treatment Evaluation|Recruiting||N/A|230|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||No||2017-10-11 01:26:27.548337|2017-10-11 01:26:27.548337
NCT01912274|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-02-23|||October 2013||2013-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)|A Phase II Open-Label, Single-arm, Two-Stage, Multicenter Trial of Pracinostat in Combination With Azacitidine in Elderly (Age 65 Years or Older) Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 2|50|Anticipated|Helsinn Healthcare SA||1|||f||||t||||||||||2017-10-11 01:26:27.724248|2017-10-11 01:26:27.724248
NCT01912261|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-29|2017-02-23|||December 2014||2014-12-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|||Effects of Oral Iron on Postoperative Fatigue Upon Coronary Artery Bypass Graft Patients|Phase III Randomized Double Blind Placebo-Controlled Study To Assess The Effects Of FeraMax When Administered Orally Once A Day On Postoperative Fatigue Levels In Patients Following Elective Coronary Artery Bypass Graft Surgery (CABG)|Recruiting||Phase 3|300|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||No||2017-10-11 01:26:27.893438|2017-10-11 01:26:27.893438
NCT01912222|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-05-03|2016-02-24||August 2013||2013-08-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||The safety analysis population was defined as participants who received at least 1 dose of ixazomib.|Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction|A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) in Patients With Advanced Solid Tumors or Hematologic Malignancies With Varying Degrees of Liver Dysfunction|Completed||Phase 1|48|Actual|Millennium Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 01:26:28.258293|2017-10-11 01:26:28.258293
NCT01912209|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-02-19|||August 2013||2013-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|BEHHS||A Web-based Approach to Treating Cardiovascular Disease Risk in Employees With Metabolic Syndrome|Baptist Employee Healthy Heart Study (BEHHS) - A Novel Web-based Approach to Reduce Cardiovascular Disease Risk in a Diverse Employee Population With Metabolic Syndrome Via Diet and Lifestyle Change|Completed||N/A|182|Actual|Baptist Health South Florida||2|||f||||f||||||||||2017-10-11 01:26:29.553836|2017-10-11 01:26:29.553836
NCT01912196|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-03-17|||October 2013||2013-10-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)|A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy|Completed||Phase 2|376|Actual|MSI Methylation Sciences, Inc.||2|||f||||t||||||||||2017-10-11 01:26:29.640296|2017-10-11 01:26:29.640296
NCT01912183|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-04-06|||July 2014||2014-07-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Family-centred E-health in Pediatric Weight Management: A Pilot Study|Family-centred E-health in Pediatric Weight Management: A Pilot Study|Completed||N/A|60|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 01:26:29.822775|2017-10-11 01:26:29.822775
NCT01912170|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-27|2013-07-27|||August 2013||2013-08-01|July 2013|2013-07-01||||February 2014|Anticipated|2014-02-01||Interventional|||Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Gestational Diabetic Patients||Unknown status|Not yet recruiting|N/A|75|Anticipated|Zhejiang University||3|||f||||||||||||||2017-10-11 01:26:29.937032|2017-10-11 01:26:29.937032
NCT01912157|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-04-18|||July 2013||2013-07-01|April 2017|2017-04-01|December 1, 2018|Anticipated|2018-12-01|April 1, 2017|Actual|2017-04-01||Interventional|GUGKS||Couples Coping With Multiple Chronic Medical Conditions|Couples Coping With Multimorbidity: Does Solitary Expressive Writing Foster Psycho-social Adaptation?|Active, not recruiting||N/A|22|Actual|University of Zurich||2|||f||||f|f|f||||||||2017-10-11 01:26:30.032427|2017-10-11 01:26:30.032427
NCT01912144|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-08-19|||September 2012||2012-09-01|August 2013|2013-08-01||||October 2013|Anticipated|2013-10-01||Interventional|||Absorption of Phenolic Acids From Coffee in Humans|Bioavailability of Coffee Phenolic Acids and Cardiovascular Health in Healthy Humans.|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Leeds||1|||f||||f||||||||||2017-10-11 01:26:30.102966|2017-10-11 01:26:30.102966
NCT01912131|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-03-01|||July 2013|Actual|2013-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients|Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients|Active, not recruiting||N/A|178|Actual|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-11 01:26:30.176759|2017-10-11 01:26:30.176759
NCT01912118|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-04-02|||July 2013||2013-07-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||The Medasense Study|Measurement of Nociceptive Index During General Anesthesia in ASA 1‐3 Patients Undergoing Elective Surgery Using the Nociception Level (NoL) Index|Completed||N/A|96|Actual|Leiden University Medical Center||8|||f||||t||||||||||2017-10-11 01:26:30.303628|2017-10-11 01:26:30.303628
NCT01912105|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-08-24|||April 2013||2013-04-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Evaluation of a Closed Suction System to Remove Secretions From the Endotracheal Tube|Evaluation of a Closed Suction System to Remove Secretions From the Endotracheal Tube: a Randomized Trial|Completed||Phase 2|40|Actual|Azienda Ospedaliera San Gerardo di Monza||2|||f||||f||||||||||2017-10-11 01:26:30.418564|2017-10-11 01:26:30.418564
NCT01912092|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-07-30|||April 2013||2013-04-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Askina Calgitrol Paste Diabetic Foot Ulcers|A NON-CONTROLLED PROSPECTIVE COHORT STUDY OF THE USE OF ASKINA® CALGITROL® PASTE + STANDARD OF CARE ON MILDLY INFECTED, NON-ISCHAEMIC DIABETIC FOOT ULCERS|Completed||N/A|22|Actual|BBraun Medical SAS||1|||f||||||||||||||2017-10-11 01:26:30.507228|2017-10-11 01:26:30.507228
NCT01912066|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-09-29|||September 2012||2012-09-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601|A Phase IV Clinical Trial to Evaluate the Preventive Effectiveness of NSAID-Associated Gastroduodenal Injury (Multi-center, Double-blind, Active-controlled, Stratified Randomized, Parallel Group)|Completed||Phase 4|520|Actual|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:26:32.212914|2017-10-11 01:26:32.212914
NCT01912053|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-12-02|||September 2013||2013-09-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Interventional|MispheC||Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma|An Open-label, Multicenter, Phase II Trial, to Evaluate the Efficacy of Intra-hepatic Administration of Yttrium 90-labelled Microspheres (Therasphere®, Nordion) in Association With Intravenous Chemotherapy With Gemcitabine and Cisplatin for the Treatment of Intra-hepatic Cholangiocarcinoma, First Line.|Active, not recruiting||Phase 2|41|Anticipated|Center Eugene Marquis||1|||f||||t||||||||||2017-10-11 01:26:32.319525|2017-10-11 01:26:32.319525
NCT01912040|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-29|||July 2006||2006-07-01|July 2013|2013-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Study Of the Safety of Locally Manufactured 123I-metaiodobenzylguanidine(MIBG) in Routine Clinical Use|A Prospective, Open Label, Single Arm Cohort Study to Assess the Frequency of Adverse Reactions of Locally Manufactured 123I-metaiodobenzylguanidine in Routine Clinical Use|Recruiting||N/A|1000|Anticipated|Nova Scotia Health Authority|||1||f||||f||||||||||2017-10-11 01:26:32.411924|2017-10-11 01:26:32.411924
NCT01912014|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-07-29|||January 2007||2007-01-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|||Psychosocial Wellbeing Following Stroke|Psychosocial Wellbeing Following Stroke: Developing and Testing a Psychosocial Nursing Intervention for Primary Care|Completed||Phase 1/Phase 2|25|Actual|University of Oslo||1|||f||||t||||||||||2017-10-11 01:26:32.566829|2017-10-11 01:26:32.566829
NCT01912001|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-05-10|||September 2013||2013-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|Virtual Ward||Virtual Ward for Home Dialysis|Virtual Ward for Home Dialysis - A Novel Model to Address Transitions of Care|Completed||N/A|215|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 01:26:32.641398|2017-10-11 01:26:32.641398
NCT01911988|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-10-19|||June 2013||2013-06-01|October 2016|2016-10-01||||December 2020|Anticipated|2020-12-01||Observational|PICC-1||Study of Association Between Peripheral Immune Cells and Recurrence in Stage II/III Colorectal Cancer|Study of Association Between Peripheral Immune Cells and Recurrence in Stage II/III Colorectal Cancer|Active, not recruiting||N/A|1|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|||1||f||||t||||||||||2017-10-11 01:26:32.751827|2017-10-11 01:26:32.751827
NCT01911975|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2016-08-26|||September 2014||2014-09-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy|Efficacy, Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy: a Randomized, Double-blind, Placebo Controlled, Crossover Trial|Active, not recruiting||Phase 3|25|Actual|Academisch Ziekenhuis Maastricht||2|||f||||t||||||||||2017-10-11 01:26:32.827366|2017-10-11 01:26:32.827366
NCT01911962|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-27|||January 2011||2011-01-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Observational|||A Prospective Randomized Controlled Study of Natural Orifice Medium-low Rectal Endometriosis Resection|A Prospective Randomized Controlled Study of Natural Orifice Medium-low Rectal Endometriosis Resection|Completed||N/A|1|Actual|First Affiliated Hospital, Sun Yat-Sen University|||2||f||||f||||||||||2017-10-11 01:26:32.928369|2017-10-11 01:26:32.928369
NCT01911949|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-01-20|||June 2013||2013-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||USFIB at the Inguinal Ligament for Total Hip Arthroplasty|An Ultrasound Guided Fascia Iliaca Block Placed at the Level of the Inguinal Ligament for Analgesia After Hip Arthroplasty|Suspended||N/A|24|Anticipated|McMaster University||2||Difficulty recruiting patients. Need more funding.|f||||f||||||||||2017-10-11 01:26:33.13285|2017-10-11 01:26:33.13285
NCT01911936|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2015-05-15|||September 2013||2013-09-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors|A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors|Completed||Phase 1|12|Actual|Novartis||1|||f||||t||||||||||2017-10-11 01:26:33.236927|2017-10-11 01:26:33.236927
NCT01911923|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2014-08-25|||August 2013||2013-08-01|August 2014|2014-08-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Ventilation Strategy Reduces Postoperative Atelectasis|Reduction in Postoperative Atelectasis by Continuous Positive Airway Pressure and Low Oxygen Concentration After Endotracheal Extubation.|Withdrawn||N/A|0|Actual|Landstinget Västmanland||2|||f||||t||||||||||2017-10-11 01:26:33.319908|2017-10-11 01:26:33.319908
NCT01911910|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-07-27|||June 2013||2013-06-01|July 2017|2017-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|HAPPYLondon||Heart Attack Prevention Programme for You (HAPPY) London|Heart Attack Prevention Programme for You (HAPPY) London|Completed||N/A|402|Actual|Queen Mary University of London||2|||f||||f||||||||||2017-10-11 01:26:33.396533|2017-10-11 01:26:33.396533
NCT01911897|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-08-14|||June 2013||2013-06-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|August 2016|Actual|2016-08-01||Interventional|CALM-FIM_EUR||Controlling and Lowering Blood Pressure With The MOBIUSHD™ (CALM-FIM_EUR)|CALM-FIM_EUR - Controlling and Lowering Blood Pressure With the MobiusHD - A Prospective Multicenter Safety Study|Active, not recruiting||N/A|30|Actual|Vascular Dynamics, Inc.||1|||f||||t||||||||||2017-10-11 01:26:33.501219|2017-10-11 01:26:33.501219
NCT01911884|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-07-02|||October 2012||2012-10-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|April 2015|Actual|2015-04-01||Interventional|MRKH||Assessment of Quality of Global and Sexual Life and Impact of Surgical and Non Surgical Vaginal Aplasia in Patients With a Rokitansky Syndrome|Assessment of Quality of Global and Sexual Life and Impact of Surgical and Non Surgical Vaginal Aplasia in Patients With a Rokitansky Syndrome|Unknown status|Active, not recruiting|N/A|138|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:26:33.621184|2017-10-11 01:26:33.621184
NCT01911871|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-04-09|||March 2012||2012-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Observational|SUFEMYO||Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations|Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations|Completed||N/A|110|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||||||2017-10-11 01:26:33.718104|2017-10-11 01:26:33.718104
NCT01911858|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-08-21|||April 2013||2013-04-01|August 2014|2014-08-01||||December 2013|Anticipated|2013-12-01||Interventional|||Askina Calgitrol Paste Burns|Non-controlled Prospective Cohort Study of the Use of Askina® Calgitrol® Paste on III Degree Burns in Adults|Withdrawn||Phase 3|0|Actual|BBraun Medical SAS||1|||f||||f||||||||||2017-10-11 01:26:33.813717|2017-10-11 01:26:33.813717
NCT01911845|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-09-16|2014-12-23||April 2013||2013-04-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional||All participants who received at least 1 dose of study drug.|An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine|An Open-label, Single-Arm, Phase 2 Study to Evaluate the Combination of ABT-450/r/ABT-267 and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Hepatitis C Virus (HCV) Infection Taking Methadone or Buprenorphine|Completed||Phase 2|38|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 01:26:33.899468|2017-10-11 01:26:33.899468
NCT01911832|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-09-10|||March 2012||2012-03-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers|Impact of Widths After Gastric Tube Reconstruction on Quality of Life for Patients With Esophagogastric Cancers|Recruiting||Phase 3|60|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-11 01:26:34.387501|2017-10-11 01:26:34.387501
NCT01911806|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2014-08-23|||March 2013||2013-03-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Effectiveness of Back Care Pillow in Addition to Physical Therapy in Chronic Non-specific Low Back Pain Treatment||Completed||Phase 2/Phase 3|52|Actual|Khon Kaen University||2|||f||||t||||||||||2017-10-11 01:26:34.628453|2017-10-11 01:26:34.628453
NCT01911793|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-05-26|2017-02-13||July 2013||2013-07-01|May 2017|2017-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Data were not collected and no data was analyzed study was terminated due to issues with study enrollment and study administrative coverage.|Stoma Tube Decompression and Postoperative Ileus After Major Colorectal Surgery|Stoma Tube Decompression and Postoperative Ileus After Major Colorectal Surgery|Terminated||N/A|6|Actual|Cedars-Sinai Medical Center|"Study only accrued 6 patients. Due to poor enrollment and issues with administrative coverage for study it was decided to terminate the study.
NO data analysis has been done and will not be done in the future. This study was closed with the IRB."|2||Not enough staff resource to complete study.|f||||f||||||||||2017-10-11 01:26:34.74194|2017-10-11 01:26:34.74194
NCT01911780|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-02-26|2016-01-22|2014-06-25|July 2013||2013-07-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Treated set (TS) was defined as a collection of patients i) randomised to the double-blind period; ii) taking at least 1 dose of either T80/A5/H12.5 mg or T80/H12.5 mg during the double-blind period.|Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine|An Eight-week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80 mg and Amlodipine 5 mg and Hydrochlorothiazide 12.5 mg vs. Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg, Followed by a 52 Weeks Extension Study to Assess Long Term Safety of Telmisartan 80 mg and Amlodipine 5 mg and Hydrochlorothiazide 12.5 mg|Completed||Phase 3|132|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:26:35.289519|2017-10-11 01:26:35.289519
NCT01911767|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-08-18|||October 30, 2013|Actual|2013-10-30|August 2017|2017-08-01|June 15, 2028|Anticipated|2028-06-15|June 15, 2028|Anticipated|2028-06-15|52 Weeks|Observational [Patient Registry]|||Biogen Multiple Sclerosis Pregnancy Exposure Registry|Biogen Idec Multiple Sclerosis Pregnancy Exposure Registry|Recruiting||N/A|750|Anticipated|Biogen|||3||f||||t||||||||||2017-10-11 01:26:35.881358|2017-10-11 01:26:35.881358
NCT01911754|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-10-07|||August 2013||2013-08-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|||Japanese Pediatric H5N1 Vaccine Study|An Open-Label Phase 3 Study to Assess Immunogenicity and Safety of a Vero Cell-Derived Whole Virus H5N1 Influenza Vaccine in a Japanese Pediatric Population Aged 6 Months to 17 Years|Completed||Phase 3|60|Actual|Nanotherapeutics, Inc.||1|||f||||t||||||||||2017-10-11 01:26:36.01377|2017-10-11 01:26:36.01377
NCT01911741|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-07-26|||November 2012||2012-11-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects|A Phase I, Single-center, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and Tablet Formulations of Enzalutamide Following a Single 160 mg Dose Under Fasted Conditions in Healthy Male Subjects|Completed||Phase 1|55|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 01:26:36.12901|2017-10-11 01:26:36.12901
NCT01911728|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-06-22|||July 25, 2011|Actual|2011-07-25|June 2017|2017-06-01|February 21, 2012|Actual|2012-02-21|February 21, 2012|Actual|2012-02-21||Interventional|||Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates|A Phase I Open-label Study to Evaluate the Effect of Multiple Doses of MDV3100 (ASP9785) on the Pharmacokinetics of Substrates for CYP2C8, CYP2C9, CYP2C19, and CYP3A4 in Patients With Castration-resistant Prostate Cancer|Completed||Phase 1|14|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:26:36.22107|2017-10-11 01:26:36.22107
NCT01911715|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-07-26|||April 2011||2011-04-01|July 2013|2013-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study to Explore the Routes of Elimination of MDV3100|A Phase I Open-label Study to Investigate the Mass Balance and Biotransformation of a Single Oral 160 mg (100 µCi) Dose of 14C-MDV3100 (ASP9785) in Healthy Male Subjects|Completed||Phase 1|6|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:26:36.326052|2017-10-11 01:26:36.326052
NCT01911702|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-07-26|||January 2010||2010-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||Different Fluidic Strategy in Patients With Acute Abdomen : The Sure Volume|MANAGEMENT OF THE PATIENT WITH ACUTE ABDOMEN SUBMITTED TO URGENT ABDOMINAL SURGERY: a Pilot Randomized Multicentre Study|Completed||Phase 2|99|Actual|Azienda Ospedaliera - Universitaria di Modena||2|||f||||t||||||||||2017-10-11 01:26:36.429341|2017-10-11 01:26:36.429341
NCT01911689|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-08-19|2015-03-30||August 2013||2013-08-01|November 2014|2014-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Magnetic Resonance Imaging Study of Acute Pancreatitis||Completed||N/A|168|Actual|Afﬁliated Hospital of North Sichuan Medical College|Some diseases, such as chronic anemia, diabetes, etc., may lead to iron deposition in pancreas and may lead to change the T2* value.||2||f||||t||||||||||2017-10-11 01:26:36.530233|2017-10-11 01:26:36.530233
NCT01911676|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-06-22|||August 2013||2013-08-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|NCATS||Translational Neuroscience Optimization of GlyT1 Inhibitor|Translational Neuroscience Optimization of GlyT1 Inhibitor|Recruiting||Phase 2|90|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 01:26:36.93526|2017-10-11 01:26:36.93526
NCT01911663|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-07-26|||November 2011||2011-11-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||The Effect of Korean Red Ginseng Supplementation on Glucose Control|The Effect of Korean Red Ginseng Supplementation on Glucose Control in Subjects With Impaired Fasting Glucose, Impaired Glucose Tolerance or Newly-diagnosed Type 2 Diabetes Mellitus|Completed||Phase 4|60|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:26:37.052598|2017-10-11 01:26:37.052598
NCT01910012|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-08-17|||June 2012||2012-06-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||PH 2 ADI-PEG 20 Acute Myeloid Leukemia|Phase 2 Study of ADI-PEG 20 in Acute Myeloid Leukemia|Active, not recruiting||Phase 2|43|Actual|Polaris Group||1|||f||||f||||||||||2017-10-11 01:27:06.161374|2017-10-11 01:27:06.161374
NCT01911650|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-08-15|||June 2013||2013-06-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|April 2018|Anticipated|2018-04-01||Interventional|||A Pilot Study: Treatment of Achilles Tendinopathy With Platelet-Rich Plasma Therapy|A Pilot Study Correlating Novel Ultrasound Elastography Techniques to Standard Clinical Outcomes in the Treatment of Achilles Tendinopathy With Platelet-Rich Plasma Therapy|Recruiting||N/A|20|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 01:26:37.132315|2017-10-11 01:26:37.132315
NCT01911637|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-12-27|||May 2013||2013-05-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)|A Double-Blind, Randomized, Placebo-Controlled, Sequential, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of VBY-036 in Healthy Subjects|Completed||Phase 1|48|Actual|Virobay Inc.||2|||f||||t||||||||||2017-10-11 01:26:37.232824|2017-10-11 01:26:37.232824
NCT01911624|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-07-11|||January 2013||2013-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia|Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia. A Prospective Randomized Controlled Academic Single-centre Feasibility Study.|Completed||Phase 2|94|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||Undecided||2017-10-11 01:26:37.326493|2017-10-11 01:26:37.326493
NCT01911611|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-11-01|||August 2013||2013-08-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study of RO6870868 in Healthy Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacodynamics and the Effect of Food on the Pharmacokinetics of RO6870868|Completed||Phase 1|60|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:26:37.416563|2017-10-11 01:26:37.416563
NCT01911598|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-07-04|||September 19, 2013|Actual|2013-09-19|July 2017|2017-07-01|June 22, 2017|Actual|2017-06-22|June 22, 2017|Actual|2017-06-22||Interventional|||A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)|A Phase 1b Open-Label Study of the Safety and Pharmacokinetics of MEHD7945A in Combination With Either Cisplatin and 5-FU or Paclitaxel and Carboplatin in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|24|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 01:26:37.488505|2017-10-11 01:26:37.488505
NCT01911585|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-08-02|||July 2013||2013-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure|Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure|Recruiting||N/A|60|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:26:37.603824|2017-10-11 01:26:37.603824
NCT01911572|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-05-16|||December 2013||2013-12-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Observational|||Genetic Susceptibility to Severe Streptococcal Infections|Genetic Susceptibility to Invasive Streptococcal Disease|Recruiting||N/A|200|Anticipated|University of Oxford|||2||f||||f||||||Samples With DNA|"     Primarily we will collect saliva from which DNA will be isolated. Secondly, from a subset of     individuals, we will request follow-up blood samples from which we will extract RNA and     separate leukocytes for studies of function.   "|||2017-10-11 01:26:37.703869|2017-10-11 01:26:37.703869
NCT01911559|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-05-16|||January 2013||2013-01-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|CP||Effectiveness of Standing Frame on Constipation in Children With Cerebral Palsy|Effectiveness of Standing Frame on Constipation in Children With Cerebral Palsy: a Single Subject Study|Completed||N/A|1|Actual|University of Modena and Reggio Emilia|||1||f||||f||||||||||2017-10-11 01:26:37.802256|2017-10-11 01:26:37.802256
NCT01911533|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-06-02|||August 2013||2013-08-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Veno-venous Extracorporeal CO2 Removal in ARDS-patients to Treat Respiratory Acidosis|Veno-venous Extracorporeal CO2 Removal in ARDS-patients to Treat Respiratory Acidosis.|Unknown status|Recruiting|N/A|10|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 01:26:37.962118|2017-10-11 01:26:37.962118
NCT01911520|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-26|||January 2011||2011-01-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|BRIDION||Dose Finding Study for Effective Reversal of a Deep Rocuronium-induced Neuromuscular Block With Sugammadex in Morbidly Obese Patients|Dose Finding Study for Effective Reversal of a Deep Rocuronium-induced Neuromuscular Block With Sugammadex in Morbidly Obese Patients.|Completed||Phase 2|40|Actual|University Hospital, Ghent||8|||f||||f||||||||||2017-10-11 01:26:38.194093|2017-10-11 01:26:38.194093
NCT01911507|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-10-02|||July 2013||2013-07-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer|Phase I Study of INC280 Plus Erlotinib in Patients With C-Met Expressing Non-Small Cell Lung Cancer|Recruiting||Phase 1|44|Anticipated|University of California, Davis||1|||f||||t|t|f||||||||2017-10-11 01:26:38.314772|2017-10-11 01:26:38.314772
NCT01911494|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-05-02|||September 2013||2013-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CLIP||Community Level Interventions for Pre-eclampsia|The CLIP (Community Level Interventions for Pre-eclampsia) Cluster Randomized Controlled Trial|Active, not recruiting||N/A|87500|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 01:26:38.44205|2017-10-11 01:26:38.44205
NCT01911481|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-12-09|||October 2011||2011-10-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Maternal Oral Hydration and External Cephalic Version|Maternal Oral Hydration and External Cephalic Version: a Single Blind Randomised Controlled Trial|Completed||N/A|164|Actual|University of Milano Bicocca||2|||f||||t||||||||||2017-10-11 01:26:38.603242|2017-10-11 01:26:38.603242
NCT01911468|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2013-07-26|||November 2011||2011-11-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|||Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin|Short-term Combined Treatment With Liraglutide and Metformin Leads to Significant Weight Loss in Obese Women With Polycystic Ovary Syndrome and Previous Poor Response to Metformin|Completed||Phase 4|36|Actual|University Medical Centre Ljubljana||3|||f||||f||||||||||2017-10-11 01:26:38.70548|2017-10-11 01:26:38.70548
NCT01911455|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-07-18|||June 2013||2013-06-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of Acamprosate in Fragile x Syndrome|Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome|Recruiting||Phase 2/Phase 3|48|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 01:26:38.803707|2017-10-11 01:26:38.803707
NCT01911442|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-01-27|2015-11-08||August 2013||2013-08-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||The disposition table for the overall study used all subjects randomized. The baseline characteristics summary used safety population. 1 subject in placebo group did not take any study medication, and was removed from the safety population.|Lurasidone Pediatric Autism Study|A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder|Completed||Phase 3|150|Actual|Sunovion||3|||f||||t||||||||||2017-10-11 01:26:38.962356|2017-10-11 01:26:38.962356
NCT01911429|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-03-22|2016-12-01||August 2013||2013-08-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||two subjects from the lurasidone 80mg (originally 106) group transferred to the lurasidone 40 mg (originally 108) group|Pediatric Schizophrenia Efficacy and Safety Study|A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia|Completed||Phase 3|327|Actual|Sunovion||3|||f||||t||||||||||2017-10-11 01:26:40.092932|2017-10-11 01:26:40.092932
NCT01911416|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-06-07|||January 2014||2014-01-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer|A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer|Withdrawn||N/A|0|Actual|University of Utah||1||No accrual|f||||t||||||||||2017-10-11 01:26:41.368912|2017-10-11 01:26:41.368912
NCT01911403|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2015-02-26|2015-02-26||December 2010||2010-12-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|AGIR||AGIR Study: Angio-Seal in Interventional Radiology|Efficacy Superiority of Angio-Seal™ vs. Manual Compression in Interventional Radiology|Terminated||Phase 4|123|Actual|St. Jude Medical|This study has been early terminated on 15 May 2014 due to low enrollment rate and the publication of other larger studies about closure device versus manual compression.This lead to small number of subjects analyzed.|2||Low enrollment rate.|f||||f||||||||||2017-10-11 01:26:41.459435|2017-10-11 01:26:41.459435
NCT01911390|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-05-12|2016-12-30||July 2013|Actual|2013-07-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional||Children aged 8-13 years old at risk for CVD due to abnormal lipids were recruited. Elevated cholesterol levels were defined as total cholesterol ≥180mg/dL and HDL <60mg/dL; LDL ≥100mg/dL and HDL <60mg/dL; or non-HDL >100mg/dL and HDL <60mg/dL.|Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children|Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children Involved in the Healthy Hearts Program|Completed||N/A|41|Actual|Poudre Valley Health System||4|||f||||f||||||||No||2017-10-11 01:26:41.991604|2017-10-11 01:26:41.991604
NCT01911377|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-10-01|||October 2013||2013-10-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MS|The Efficacy of Botulinum Toxin Type A in the Treatment of Allodynic-Type Neuropathic Pain in People With Spinal Cord Injury or Multiple Sclerosis|Terminated||Phase 2|12|Actual|University of Manitoba||2||"12 SCI volunteers completed the study. As the data analysis was negative, the decision was made   not to proceed with MS recruitment."|f||||f||||||||||2017-10-11 01:26:42.36678|2017-10-11 01:26:42.36678
NCT01911364|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2016-04-05|||January 2014||2014-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease|A 52-wk Randomized Double Blind Parallel Trial: Combination of Beclometasone+Formoterol+Glycopyrrolate vs Tiotropium and vs Combination of Beclometasone+Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|3686|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||t||||||||Undecided||2017-10-11 01:26:42.466693|2017-10-11 01:26:42.466693
NCT01911351|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-03-11|2015-11-02||July 2013||2013-07-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Nitrous Oxide Use in Minor Procedures|High Concentration Continuous Flow Nitrous Oxide Use for Procedural-induced Pain or Anxiety During Pediatric Minor Procedures|Completed||N/A|82|Actual|New York City Health and Hospitals Corporation||2|||f||||t||||||||||2017-10-11 01:26:42.574378|2017-10-11 01:26:42.574378
NCT01911338|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-12-03|||February 2012||2012-02-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Inertial Sensors Used to Learn Manipulation|EFFECT OF REAL-TIME FEEDBACK THROUGH INERTIAL SENSORS IN LEARNING POSTEROANTERIOR THORACIC MANIPULATION|Completed||N/A|64|Actual|University of Malaga||2|||f||||t||||||||||2017-10-11 01:26:42.949068|2017-10-11 01:26:42.949068
NCT01911325|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-02-03|||October 2013||2013-10-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients|A Phase Ib/II Study of Docetaxel With or Without Buparlisib as Second Line Therapy for Patients With Advanced or Metastatic Squamous Non-small Cell Lung Cancer|Terminated||Phase 1/Phase 2|27|Actual|Novartis||3||Review of safety and preliminary efficacy data showed marginal anti-tumor activity.|f||||t||||||||||2017-10-11 01:26:43.035079|2017-10-11 01:26:43.035079
NCT01911312|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-26|||July 2013||2013-07-01|July 2013|2013-07-01||||September 2013|Anticipated|2013-09-01||Interventional|||Evaluation of Thermal-Aided Muscle Stimulation||Unknown status|Recruiting|N/A|20|Anticipated|Niveus Medical, Inc.||2|||f||||||||||||||2017-10-11 01:26:43.201098|2017-10-11 01:26:43.201098
NCT01911273|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2015-10-06|2015-06-09||October 2013||2013-10-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer|A Phase 2, Randomized, Double Blind Study To Evaluate The Efficacy, Safety, Pharmacodynamics And Pharmacokinetics Of The Anti-alk-1 Monoclonal Antibody Pf-03446962 In Combination With Best Supportive Care Vs. Placebo Plus Best Supportive Care In Adult Patients With Advanced Hepatocellular Carcinoma Following Failure Of Sorafenib|Terminated||Phase 2|3|Actual|Pfizer|This study was prematurely terminated due to a Sponsor decision not to pursue the clinical development of PF-03446962 as monotherapy in second-line hepatocellular carcinoma.|2||See termination reason in detailed description.|f||||t||||||||||2017-10-11 01:26:43.531537|2017-10-11 01:26:43.531537
NCT01911260|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-11-04|2013-08-15||September 2000||2000-09-01|November 2013|2013-11-01|March 2001|Actual|2001-03-01|December 2000|Actual|2000-12-01||Interventional|APZinc||Weekly Zinc Chelate Supplementation on Children's Growth|Effect of Weekly Zinc Chelate Supplementation on Schoolchildren's Growth: a Randomized Double-blind Controlled Trial|Completed||Phase 2/Phase 3|199|Actual|Federal University of São Paulo|The sample loss is a factor that hinders the adoption of results as definitive. Even if they remained similar according to biodemographic variables, we cannot guarantee the maintenance of group equality defined in randomization.|4|||f||||f||||||||||2017-10-11 01:26:43.995968|2017-10-11 01:26:43.995968
NCT01911247|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-25|||May 2011||2011-05-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer|Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer|Completed||Early Phase 1|28|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 01:26:44.524914|2017-10-11 01:26:44.524914
NCT01911234|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-01-13|||September 2013||2013-09-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs' TNF-Kinoid in Adult Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 2|143|Actual|Neovacs||2|||f||||t||||||||||2017-10-11 01:26:44.623353|2017-10-11 01:26:44.623353
NCT01911221|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2017-05-08|2014-10-16||August 2013||2013-08-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Subjects received two doses of rMenB+OMV NZ at 0 month and 2 month schedule.|A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive.|A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive.|Completed||Phase 3|13|Actual|Novartis||1|||f||||f||||||||||2017-10-11 01:26:44.817168|2017-10-11 01:26:44.817168
NCT01911208|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-05-02|||November 2011||2011-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|RECRUIT||A Randomized Recruitment Intervention Trial|A Randomized Recruitment Intervention Trial|Active, not recruiting||N/A|60|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||Undecided||2017-10-11 01:26:45.251996|2017-10-11 01:26:45.251996
NCT01911195|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2017-04-05|||July 2013|Actual|2013-07-01|April 2017|2017-04-01|February 9, 2015|Actual|2015-02-09|February 9, 2015|Actual|2015-02-09||Interventional|RCC||Reconstructing Consciousness and Cognition|Reconstructing Consciousness and Cognition|Completed||N/A|60|Actual|University of Michigan||2|||f||||t|f|f||||||||2017-10-11 01:26:45.327715|2017-10-11 01:26:45.327715
NCT01911182|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-02-18|||October 2011||2011-10-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|||Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea|A Prospective, Controlled Trial of Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea of Prematurity|Terminated||Phase 2/Phase 3|7|Actual|University of Manitoba||2||Low recruitment rate|f||||f||||||||||2017-10-11 01:26:45.411056|2017-10-11 01:26:45.411056
NCT01911156|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-05-27|||July 2013||2013-07-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|Stop||Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues|Sustained Off-treatment Response After HBeAg Loss in HBeAg-Pos Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues|Unknown status|Recruiting|Phase 4|66|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 01:26:45.589488|2017-10-11 01:26:45.589488
NCT01911143|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-03-06|||September 2013||2013-09-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|PATHFINDER||A Retrospective, Blinded Validation of a Host-response Based Diagnostics|A Retrospective, Blinded Validation Study to Assess the Accuracy of a Host-response Based Diagnostics for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients With an Acute Febrile Disease|Completed||N/A|600|Actual|MeMed Diagnostics Ltd.|||1||f||||f||||||Samples Without DNA|"     Serum samples   "|No||2017-10-11 01:26:45.921876|2017-10-11 01:26:45.921876
NCT01911130|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-03-22|||July 2013|Actual|2013-07-01|September 2015|2015-09-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Observational|||Longitudinal Study of Outcomes Measures in ALS Trials|Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials|Completed||N/A|100|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 01:26:46.028672|2017-10-11 01:26:46.028672
NCT01911117|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-26|2013-07-30|||June 2012||2012-06-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Observational|||Evaluating the Correction of Non-invasive Estimated Continuous Cardiac Output in Cardiac Surgical Patients|Evaluating the Correction of Non-invasive Estimated Continuous Cardiac Output in Cardiac Surgical Patients|Unknown status|Recruiting|N/A|52|Anticipated|National Cheng-Kung University Hospital|||1||f||||t||||||||||2017-10-11 01:26:46.155762|2017-10-11 01:26:46.155762
NCT01911104|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-04-24|||August 2013|Actual|2013-08-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|January 2017|Actual|2017-01-01||Interventional|RESIST||Exercise Resistance in Type 2 Diabetes|Investigating the Underlying Mechanisms of Exercise Resistance in Individuals With Type 2 Diabetes|Active, not recruiting||N/A|33|Actual|Translational Research Institute for Metabolism and Diabetes, Florida||2|||f||||f||||||||||2017-10-11 01:26:46.277287|2017-10-11 01:26:46.277287
NCT01911078|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-07-19|||September 2014||2014-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study)|Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study)|Completed||N/A|20|Actual|St. Jude Medical||2|||f||||t||||||||||2017-10-11 01:26:46.556099|2017-10-11 01:26:46.556099
NCT01911065|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-04-03|2017-01-11||September 2010||2010-09-01|April 2017|2017-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020|T Cell Responses to Varicella Zoster Virus After Vaccination and Viral Escape|Completed||Phase 4|54|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 01:26:46.643248|2017-10-11 01:26:46.643248
NCT01911052|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-07-16|||July 2013||2013-07-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Impact of Telephone and Short Message System Based Education on Bowel Preparation for Colonoscopy|The Impact of Telephone and Short Message System Based Education on Bowel Preparation for Colonoscopy in Health Screened Population|Completed||Phase 3|390|Actual|Keimyung University Dongsan Medical Center||3|||f||||f||||||||||2017-10-11 01:26:47.060409|2017-10-11 01:26:47.060409
NCT01911039|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-03-30|||July 2013||2013-07-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD|A Phase 1 Safety and Tolerability Study of Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic Graft Versus Host Disease|Unknown status|Recruiting|Phase 1|20|Anticipated|Stanford University||1|||f||||f||||||||||2017-10-11 01:26:47.149586|2017-10-11 01:26:47.149586
NCT01911026|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-12-25|||July 2013||2013-07-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Impact of Nurse Education on the Quality of Inpatient Bowel Preparation for Colonoscopy|The Impact of Nurse Education on the Quality of Inpatient Bowel Preparation for Colonoscopy; Randomized Single Blinded Study|Completed||Phase 3|205|Actual|Keimyung University Dongsan Medical Center||2|||f||||f||||||||||2017-10-11 01:26:47.258399|2017-10-11 01:26:47.258399
NCT01911013|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2016-10-19|||September 2013||2013-09-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of Korean Society of Spine Surgery on the Outcomes of Anterior Cervical Discectomy and Fusion|A Study of Korean Society of Spine Surgery on the Outcomes of Anterior Cervical Discectomy and Fusion|Recruiting||Phase 4|500|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:26:47.350759|2017-10-11 01:26:47.350759
NCT01911000|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-08-19|||September 2013||2013-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis|Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis: Prospective Phase II Trial|Completed||Phase 2|69|Actual|Samsung Medical Center||1|||f||||||||||||||2017-10-11 01:26:47.712858|2017-10-11 01:26:47.712858
NCT01910987|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-02-16|||April 2013||2013-04-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|OPTIMRETREAT||Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib|A Randomized, Controlled Phase 3 Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib (Velcade) in Patients With Multiple Myeloma in First or Second Relapse.|Completed||Phase 3|80|Actual|Janssen-Cilag International NV||2|||f||||t||||||||||2017-10-11 01:26:47.836676|2017-10-11 01:26:47.836676
NCT01910974|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-08-29|||July 2012||2012-07-01|July 2012|2012-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Multicentric Study an Endoscopic Treatment of Digestive Neoplasia by Submucosal Dissection Evaluation of a New Water Jet System|TRESTIS: Multicentric Study With a Curative Endoscopic Treatment of Superficial Neoplasia of a Digestive Tract by Endoscopic Submucosal Dissection: Evaluation of a New Water Jet System Injecting Glycerol Mix|Completed||N/A|80|Actual|Hôpital Edouard Herriot||1|||f||||t||||||||||2017-10-11 01:26:48.068971|2017-10-11 01:26:48.068971
NCT01910961|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-07-26|||August 2013||2013-08-01|July 2013|2013-07-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Impact of Limb Remote Ischemic Preconditioning on Mortality and Quality of Life During Abdominal Aortic Aneurysm Repair|Impact of Limb Remote Ischemic Preconditioning on Mortality, Hospitalization Costs and Quality of Life During Elective Abdominal Aortic Aneurysm Repair: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|360|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 01:26:48.148532|2017-10-11 01:26:48.148532
NCT01910935|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2014-06-04|||July 2013||2013-07-01|February 2014|2014-02-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Effectiveness of Physical Activity Prescription Among Hypertensive Patients of Primary Health Care.|Effectiveness of Physical Activity Prescription Among Hypertensive Patients of Primary Health Care.|Completed||N/A|224|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||||2017-10-11 01:26:48.287209|2017-10-11 01:26:48.287209
NCT01910922|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2013-07-26|||September 2010||2010-09-01|July 2013|2013-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|WP23_HabEat||Effect of Learning on Vegetable Acceptance by Toddlers|Learning Mechanisms of Food Preferences in 2-3 y. o. Toddlers in Nurseries|Completed||N/A|160|Actual|Centre des Sciences du Goût et de l'Alimentation|||3||f||||t||||||||||2017-10-11 01:26:48.368885|2017-10-11 01:26:48.368885
NCT01910909|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-08-19|||August 2013||2013-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|SBRT for HCC||Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma|Effectiveness and Safety of the Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prospective Phase II Trial|Recruiting||Phase 2|60|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-10-11 01:26:48.446282|2017-10-11 01:26:48.446282
NCT01910896|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-09-08|||October 2013||2013-10-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Effectiveness and Safety Study of Overnight Intensive Patch in Scars|A Prospective, Intra-individual Randomized, Observer-blind, Controlled Investigation to Investigate the Effectiveness and Safety of Overnight Intensive Patch (OIP) Over 12 to 24 Weeks in Post Dermatological Surgery Scars|Completed||N/A|125|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-10-11 01:26:48.534086|2017-10-11 01:26:48.534086
NCT01910883|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-25|||September 2010||2010-09-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects|Finafloxacin - A Double-blind, Placebo-controlled, Randomised, Dose-escalating, Crossover Study to Determine the Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects|Completed||Phase 1|58|Actual|MerLion Pharmaceuticals GmbH||6|||f||||f||||||||||2017-10-11 01:26:48.636958|2017-10-11 01:26:48.636958
NCT01910870|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-10-10|||July 2013||2013-07-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes||Terminated||Phase 2|4|Actual|Centre Jean Perrin||1||Because of difficulties in recruiting|f||||t||||||||||2017-10-11 01:26:48.754013|2017-10-11 01:26:48.754013
NCT01910857|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-08-24|||January 2012||2012-01-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Improving Hypertension Control||Completed||N/A|60|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 01:26:48.857728|2017-10-11 01:26:48.857728
NCT01910844|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-10-10|||July 2013||2013-07-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|META2||Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes||Terminated||Phase 2|3|Actual|Centre Jean Perrin||1||Because of difficulties in recruting|f||||t||||||||||2017-10-11 01:26:48.940267|2017-10-11 01:26:48.940267
NCT01910831|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-03-30|2015-02-03||July 2013||2013-07-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CCCR28-2013|20 Subjects were enrolled into the study. 40 arms were analyzed.|Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms and Hands|Randomized, Double-Blind, Contralateral, Controlled Study to Assess the Efficacy of DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Mature Skin of the Forearms and Hands|Completed||Phase 4|20|Actual|The Center for Clinical and Cosmetic Research||2|||f||||t||||||||||2017-10-11 01:26:49.038795|2017-10-11 01:26:49.038795
NCT01910818|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-01-07|||November 2013||2013-11-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Pilot Study of the Effect of Laser on Reversing Chronic Radiation Injury|Understanding and Reversing Chronic Radiation Dermatitis - A Pilot Study|Recruiting||N/A|22|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-11 01:26:49.340098|2017-10-11 01:26:49.340098
NCT01910805|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-01-08|||August 2014||2014-08-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|LIFe||Recent GDM Lifestyle Intervention|Lifestyle Intervention for African-American Women: A Pilot Study for Women With a Recent History of Gestational Diabetes (The LIFe Study)|Completed||N/A|15|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 01:26:49.461833|2017-10-11 01:26:49.461833
NCT01910792|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-06-12|2017-04-06||March 2011||2011-03-01|June 2017|2017-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery|Ultraviolet Light and Vitamin D in Subjects With Fat Malabsorption or After Gastric Bypass Surgery|Completed||N/A|19|Actual|Boston University||2|||f||||f|f|t|f|||||Undecided||2017-10-11 01:26:49.587254|2017-10-11 01:26:49.587254
NCT01910779|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-07-29|||May 2013||2013-05-01|July 2013|2013-07-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|OPTIMA||Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic Shocks|Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic Shocks (OPTIMA Trial).|Unknown status|Recruiting|N/A|154|Anticipated|Maria Vittoria Hospital||2|||f||||t||||||||||2017-10-11 01:26:49.896052|2017-10-11 01:26:49.896052
NCT01910766|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-29|||January 2010||2010-01-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in Polycystic Ovary Syndrome|Combined Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in CC-resistant Patients With Polycystic Ovary Syndrome|Completed||N/A|110|Actual|Mansoura University||2|||f||||f||||||||||2017-10-11 01:26:49.991166|2017-10-11 01:26:49.991166
NCT01910753|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-09-06|||May 2013||2013-05-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|APANVADS||Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer Population|Feasibility Study: Physical Activity Program Associated Wtih Nutrition Therapeutic Education in Head and Neck Cancer Population Treating by Chemotherapy With or Without Radiotherapy.|Terminated||N/A|10|Actual|University Hospital, Limoges||1||Not enough patients|f||||f||||||||||2017-10-11 01:26:50.080364|2017-10-11 01:26:50.080364
NCT01910740|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-05-31|||January 2014||2014-01-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MOVE||Mobility in Older People|Optimising Rehabilitation Outcomes in Frail Older Adults: Effects of Increasing the Amount of Physical Activity|Completed||N/A|198|Actual|La Trobe University||2|||f||||t||||||||||2017-10-11 01:26:50.154472|2017-10-11 01:26:50.154472
NCT01910727|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-03-16|||December 2011||2011-12-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth|Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth|Completed||N/A|506|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||No||2017-10-11 01:26:50.232249|2017-10-11 01:26:50.232249
NCT01910714|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-04-15|||September 2010||2010-09-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth|Adapting and Evaluating an Evidence-Based Intervention to Prevent HIV/AIDS Risk Among Apache Youth|Completed||N/A|267|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 01:26:50.336137|2017-10-11 01:26:50.336137
NCT01910701|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-03-16|||January 2013||2013-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Extension Study of the Family Spirit Program|Extension Study of the Family Spirit Program|Active, not recruiting||N/A|92|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||No||2017-10-11 01:26:50.42438|2017-10-11 01:26:50.42438
NCT01910688|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-06-02|2016-04-27||July 2013||2013-07-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Patient who had undergone RGB at least 1 year prior to enrollment, achieved > 40% EBWL after surgery, and then regained > 25% of the lost weight.|Use of Radiofrequency Ablation for RGB Salvage|Use of Endoscopically Delivered Radiofrequency Ablation for the Treatment of Ptients Who Have Undergone Roux-en-Y Gastric Bypass and Have Failed to Achieve/ Maintain Satisfactory Excess Body Weight Loss|Completed||N/A|25|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-11 01:26:50.505729|2017-10-11 01:26:50.505729
NCT01910675|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2014-01-02|||July 2013||2013-07-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||PCC and Fibrinogen Compared With FFP in PPH|Use of Prothrombin Complex Concentrate and Fibrinogen Compared With Fresh Frozen Plasma (and Fibrinogen if Needed) in the Treatment of Postpartum Haemorrhage|Unknown status|Recruiting|Phase 4|40|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 01:26:50.97202|2017-10-11 01:26:50.97202
NCT01910662|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-05-12|||February 22, 2013|Actual|2013-02-22|May 2017|2017-05-01|November 26, 2013|Actual|2013-11-26|November 26, 2013|Actual|2013-11-26||Interventional|||Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)|Characterisation of the T-cell Response in Delayed Type Hypersensitivity Reactions to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) in Healthy Volunteers|Completed||Phase 1|24|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 01:26:51.1102|2017-10-11 01:26:51.1102
NCT01910649|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-11-04|||March 2008||2008-03-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration|A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess the Effect, Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for Intravenous Dosing as an Alternative Route of Administration|Terminated||Phase 2|12|Actual|BioMarin Pharmaceutical||1||"Regulatory approval was not obtained for drisapersen, hence BioMarin is stopping the   development of all exon skipping oligonucleotides in DMD."|f||||t||||||||||2017-10-11 01:26:51.263537|2017-10-11 01:26:51.263537
NCT01910636|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-03-13|2015-03-13||February 2013||2013-02-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional||Safety Analysis Set: participants who were enrolled and received at least 1 dose of study drug|Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection|A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Treatment-Naïve and Treatment-Experienced Japanese Subjects With Chronic Genotype 2 HCV Infection|Completed||Phase 3|153|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 01:26:51.394597|2017-10-11 01:26:51.394597
NCT01910623|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-10-01|||February 2013||2013-02-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|QOL-APL0512||Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia|Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia: a Follow-up Observational Study of Patients Enrolled in the GIMEMA AIDA 0493 and AIDA 200|Completed||N/A|||Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||||2017-10-11 01:26:51.964937|2017-10-11 01:26:51.964937
NCT01910610|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-09-12|||July 2013||2013-07-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|STRATEGIC-1||Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer|Multi-Line Therapy Trial in Unresectable Wild-Type RAS Metastatic Colorectal Cancer. A GERCOR Randomized Open-label Phase III Study.|Recruiting||Phase 3|474|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2|||f||||t||||||||||2017-10-11 01:26:52.199419|2017-10-11 01:26:52.199419
NCT01910597|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-10-19|||August 2013||2013-08-01|October 2015|2015-10-01||||June 2016|Anticipated|2016-06-01||Interventional|||Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors||Unknown status|Recruiting|Phase 1|10|Anticipated|Prince of Songkla University||1|||f||||f||||||||||2017-10-11 01:26:52.647757|2017-10-11 01:26:52.647757
NCT01910584|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2013-07-25|||November 2012||2012-11-01|September 2012|2012-09-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Quality of Life and Sexual Function of the Novasure Endometrial Ablation in Menorrhagia|Prospective Study of the Influence on Quality of Life and Sexual Function of the Novasure Endometrial Ablation in the Treatment of Menorrhagia|Unknown status|Recruiting|N/A|100|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||||||2017-10-11 01:26:52.740818|2017-10-11 01:26:52.740818
NCT01910571|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-11-24|||August 2013||2013-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects.|Completed||Phase 1|100|Actual|Piramal Enterprises Limited||2|||f||||f||||||||||2017-10-11 01:26:52.836119|2017-10-11 01:26:52.836119
NCT01910558|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-04-25|||October 2013||2013-10-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|FAT ABSORBER||The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion|The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion|Withdrawn||N/A|0|Actual|Pennington Biomedical Research Center||3||Cancelled by Sponsor|f||||t||||||||||2017-10-11 01:26:52.922005|2017-10-11 01:26:52.922005
NCT01910545|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-05-31|||August 23, 2013||2013-08-23|May 2017|2017-05-01|May 4, 2016|Actual|2016-05-04|April 11, 2016|Actual|2016-04-11||Interventional|||Phase 1 Study of OTS167 in Patients With Solid Tumors|PhaseI, Single-Center, Cohort Dose Escalation Trial to Determine the Safety, Tolerance, and Preliminary Antineoplastic Activity of OTS167, a MELK Inhibitor, in Patients With Refractory Locally Advanced or Metastatic Solid Tumor Malignancies|Completed||Phase 1|32|Actual|OncoTherapy Science, Inc.||1|||f||||f||||||||No||2017-10-11 01:26:53.008866|2017-10-11 01:26:53.008866
NCT01910532|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-07-25|||April 2010||2010-04-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy|The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy|Withdrawn||Phase 4|0|Actual|Ohio State University||1||Sponsor discontinued the research|f||||t||||||||||2017-10-11 01:26:53.076443|2017-10-11 01:26:53.076443
NCT01910506|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-01-08|||August 2013||2013-08-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||RDEA3170 AME Study|A Phase 1 Absorption, Metabolism and Excretion Study of [14C]RDEA3170 Orally Administered to Healthy Adult Male Subjects|Completed||Phase 1|8|Actual|Ardea Biosciences, Inc.||1|||f||||f||||||||||2017-10-11 01:26:53.238051|2017-10-11 01:26:53.238051
NCT01910493|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-07-25|||November 2011||2011-11-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|SMSaude||Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique|Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique: A Randomized Control Trial|Completed||N/A|1352|Actual|Absolute Return for Kids||4|||f||||f||||||||||2017-10-11 01:26:53.302433|2017-10-11 01:26:53.302433
NCT01910480|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-09-03|||July 2013||2013-07-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects|A Phase 1, Open-Label Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects|Completed||Phase 1|24|Actual|Neurocrine Biosciences||1|||f||||f||||||||||2017-10-11 01:26:53.389508|2017-10-11 01:26:53.389508
NCT01910467|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-01-16|||November 2013||2013-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|AHIP||Avoiding Hypotension in Preterm Neonates|Avoiding Hypotension in Preterm Neonates (AHIP) - A Randomised Controlled Study on Near Infrared Spectroscopy Monitoring of Peripheral-muscle and Cerebral Oxygenation With Defined Interventions Versus Routine Monitoring and Treatment in Preterm Neonates|Completed||N/A|98|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 01:26:53.473537|2017-10-11 01:26:53.473537
NCT01910454|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-04-27|||August 2012||2012-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|COSTAR||Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke|Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke|Completed||Phase 1|47|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 01:26:53.555198|2017-10-11 01:26:53.555198
NCT01910441|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-09-22|2015-09-22||July 2013||2013-07-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|VARIABLE||Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients|A Comparative Study to Assess the Effect of Vildagliptin Versus Glimepiride on Glucose Variability in Type 2 Diabetic Patients Uncontrolled on Metformin Alone|Terminated||Phase 4|95|Actual|Novartis||2||"The study was terminated due to the unavailability of Continuous Glucose Monitoring sensors   (CGMS) which were required to assess the primary end-point."|f||||f||||||||||2017-10-11 01:26:53.643664|2017-10-11 01:26:53.643664
NCT01910428|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-04-10|||October 2013|Actual|2013-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL|A Phase I Study of L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) in Combination With the CALGB Regimen During Induction and Consolidation Phases in the Treatment of Adult Patients With Acute Lymphoblastic Leukemia and Lymphoma|Recruiting||Phase 1|24|Anticipated|ERYtech Pharma||1|||f||||t||||||||Undecided||2017-10-11 01:26:53.891698|2017-10-11 01:26:53.891698
NCT01910415|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2014-08-08|||June 2013||2013-06-01|February 2014|2014-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Phase 1, QT/QTC Interval Study in Healthy Subjects|A Phase 1, Randomized, Placebo and Active Controlled, Double-Blind, Parallel, Electrocardiogram Study to Evaluate the Effect of Lumacaftor in Combination With Ivacaftor on the QT/QTc Interval in Healthy Subjects|Completed||Phase 1|200|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-11 01:26:53.997646|2017-10-11 01:26:53.997646
NCT01910402|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-06-05|2016-07-25||August 1, 2013||2013-08-01|June 2017|2017-06-01|December 31, 2020|Anticipated|2020-12-31|September 22, 2015|Actual|2015-09-22||Interventional|||A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)|A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve Women|Active, not recruiting||Phase 3|499|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 01:26:54.163446|2017-10-11 01:26:54.163446
NCT01909999|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-07-26|||March 2010||2010-03-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Release of Osteogenic Markers in Immediately and Non-loaded Dental Implants|Release of Osteogenic Markers in Immediately and Non-loaded Dental Implants|Completed||N/A|40|Actual|Paulista University||2|||f||||f||||||||||2017-10-11 01:27:06.286679|2017-10-11 01:27:06.286679
NCT01910389|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-04-16|2015-04-16||November 2013||2013-11-01|January 2014|2014-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PITCH-HF||Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure|Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure|Terminated||Phase 3|23|Actual|New England Research Institutes|Early termination leading to small numbers of subjects. Outcome measure data not obtained.|2||terminated by funding agency|f||||t||||||||||2017-10-11 01:26:59.163208|2017-10-11 01:26:59.163208
NCT01910376|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-07-14|||October 2014||2014-10-01|July 2016|2016-07-01||||June 2017|Anticipated|2017-06-01|2 Years|Observational [Patient Registry]|||Cancer in Nursing Home Residents|Cancer in Elderly Nursing Home Residents in Belgium: Prospective Cohort Study Including Translational Research to Develop Better Prognostic Tools to Help With Treatment Decisions in the Elderly|Recruiting||N/A|825|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||3||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-11 01:26:59.988543|2017-10-11 01:26:59.988543
NCT01910363|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-01-09|||July 2013||2013-07-01|January 2014|2014-01-01||||January 2014|Anticipated|2014-01-01||Interventional|A2NTX||Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke|Comparison of Clinical Efficacy of Botulinum Neurotoxin Type A1 and A2 for Post-Stroke Lower Limb Spasticity: Phase 2/3|Unknown status|Active, not recruiting|Phase 2/Phase 3|30|Anticipated|University of Tokushima||2|||f||||f||||||||||2017-10-11 01:27:00.092457|2017-10-11 01:27:00.092457
NCT01910350|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-09-23|||July 2010||2010-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|KinKeeper||Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening|Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening|Completed||N/A|516|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 01:27:00.187666|2017-10-11 01:27:00.187666
NCT01910337|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2013-07-26|||June 2011||2011-06-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Observational|||Evaluation of Heart Rate Variability in Third Lower Molars Surgeries|Evaluation of Heart Rate Variability in Third Lower Molars Surgeries|Completed||N/A|33|Actual|University of Sao Paulo|||3||f||||f||||||||||2017-10-11 01:27:00.276912|2017-10-11 01:27:00.276912
NCT01910324|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-05-21|||April 2006||2006-04-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|September 2008|Actual|2008-09-01||Interventional|DTC||Juvenile Detention to Community Life|Facilitating Adolescent Offenders' Reintegration From Juvenile Detention to Community Life (DTC)|Completed||N/A|154|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 01:27:00.354018|2017-10-11 01:27:00.354018
NCT01910311|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-05-15|2017-03-10||August 2013||2013-08-01|May 2017|2017-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||All enrolled participants.|A Study of Baricitinib and Rifampicin in Healthy Participants|The Effect of CYP3A Induction by Rifampicin on the Pharmacokinetics of Baricitinib in Healthy Subjects|Completed||Phase 1|18|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:27:00.465927|2017-10-11 01:27:00.465927
NCT01910298|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-03-13|||July 2013||2013-07-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|August 2016|Actual|2016-08-01||Interventional|ESSBR||Efficacy of Single Stage Breast Reconstruction|A Prospective, Multicenter, Controlled Study of Implant-based Breast Reconstruction, Measuring the Safety, Efficacy and Outcomes, of Immediate Single Stage Breast Reconstruction With Strattice™ Reconstructive Tissue Matrix Versus Immediate Two Stage Breast Reconstruction Without Strattice™ TM .|Terminated||N/A|127|Actual|LifeCell||2||The study is being terminated due to no enrollment in over one year in the control arm|f||||t||||||||||2017-10-11 01:27:00.799683|2017-10-11 01:27:00.799683
NCT01910285|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-05-06|||June 2013||2013-06-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|REMIDENT||Remifentanil Versus Sufentanil for Intubation Condition Without Myorelaxant|Comparison of Intubation Conditions After Induction With Propofol Associated With a Dose of Remifentanil or Sufentanil in Surgical Tooth Extraction.|Completed||Phase 4|70|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 01:27:00.934332|2017-10-11 01:27:00.934332
NCT01910272|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-26|||January 2013||2013-01-01|July 2013|2013-07-01||||July 2013|Actual|2013-07-01||Observational|BRAIN||Brain Radiation Exposure and Attenuation During Invasive Cardiology Procedures|Brain Radiation Exposure and Attenuation During Invasive Cardiology Procedures.|Completed||N/A|11|Actual|University of California, San Diego|||1||f||||f||||||||||2017-10-11 01:27:01.03458|2017-10-11 01:27:01.03458
NCT01910259|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-07-12|||December 2014||2014-12-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MS-SMART||MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial|A Multi-arm Phase IIB Randomised, Double Blind Placebo-controlled Clinical Trial Comparing the Efficacy of Three Neuroprotective Drugs in Secondary Progressive Multiple Sclerosis.|Active, not recruiting||Phase 2|445|Actual|University College, London||4|||f||||t||||||||||2017-10-11 01:27:01.180055|2017-10-11 01:27:01.180055
NCT01910246|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-03-04|||April 2015||2015-04-01|March 2015|2015-03-01||||June 2016|Anticipated|2016-06-01||Interventional|||Cardiovascular Effects of Metformin on Obesity|Cardiovascular Effects of Metformin on Obesity With Subclinical Myocardial Dysfunction|Unknown status|Not yet recruiting|Phase 4|24|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 01:27:01.324706|2017-10-11 01:27:01.324706
NCT01910233|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-03-31|||May 2013||2013-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01|6 Months|Observational [Patient Registry]|||Registry of Patients With Acute Dyspnea in the Emergency Department|Prospective Registry for Quality Assurance of Medical Care of Patients With Acute Dyspnea in the Emergency Department|Completed||N/A|947|Actual|Klinikum Nürnberg|||1||f||||f||||||||||2017-10-11 01:27:01.508943|2017-10-11 01:27:01.508943
NCT01910220|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2014-11-07|||August 2013||2013-08-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)||Completed||Phase 1|125|Actual|Regeneron Pharmaceuticals||4|||f||||f||||||||||2017-10-11 01:27:01.587603|2017-10-11 01:27:01.587603
NCT01910194|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-01-21|||December 2013||2013-12-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying|A Bicentric Open-label, Randomized, Two-parallel-group Study Investigating the Impact of Combined Lantus Insulin Glargine) and Lyxumia(Lixisenatide) on Insulin Secretion and Gastric Emptying in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled on Diet and Oral Antidiabetic Medication|Completed||Phase 2|39|Actual|Profil Institut für Stoffwechselforschung GmbH||2|||f||||f||||||||||2017-10-11 01:27:01.674459|2017-10-11 01:27:01.674459
NCT01910181|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-08-30|2016-04-15||August 17, 2013|Actual|2013-08-17|August 2017|2017-08-01|July 3, 2018|Anticipated|2018-07-03|October 22, 2013|Actual|2013-10-22||Interventional||Safety Population: All participants who received at least one dose of study medication.|A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma|A Phase I Open-Label, Multicenter, Multiple-Dose Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Vemurafenib in Chinese Patients With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma|Active, not recruiting||Phase 1|46|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:27:01.808933|2017-10-11 01:27:01.808933
NCT01910168|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-11-01|||August 2013||2013-08-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||A Study to Collect Blood Samples From Patients With Spinal Muscular Atrophy for Biomarker Analysis|A Single Center Study to Collect Samples From SMA Patients for Biomarker Analysis|Completed||N/A|36|Actual|Hoffmann-La Roche|||1||f||||||||||Samples With DNA|"     Blood Samples   "|||2017-10-11 01:27:02.356252|2017-10-11 01:27:02.356252
NCT01910155|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-10-14|||July 2013||2013-07-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa|A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspension (Par) Compared to CIPRODEX® (Ciprofloxacin 0.3%/Dexamethasone 0.1%) Sterile Otic Suspension (Alcon) in the Treatment of Adults With Acute Bacterial Otitis Externa|Terminated||Phase 3|455|Actual|Par Pharmaceutical, Inc.||3||"FDA's draft guidance (March 2015) provided option of in-vitro or in-vivo studies for   bioequivalence. Small study size resulted in negative culture rates."|f||||f||||||||||2017-10-11 01:27:02.457935|2017-10-11 01:27:02.457935
NCT01910142|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-09|2013-07-26|||November 2008||2008-11-01|July 2013|2013-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effect of Nutrition on Bone Metabolism as Assessed by 41Ca|The Effect of Nutritional Intervention on Bone Metabolism as Assessed by 41Ca and Modeling; Proof of Concept|Completed||N/A|12|Actual|TNO||2|||f||||f||||||||||2017-10-11 01:27:02.659978|2017-10-11 01:27:02.659978
NCT01910129|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-10-21|||July 2013||2013-07-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy|A Randomized, Multi-center, Double-blind, Parallel, Crossover Study of a Non-invasive Neurostimulation to the Vagus Nerve With the gammaCore Device for the Reduction in Frequency of Seizures Associated With Epilepsy.|Terminated||N/A|13|Actual|ElectroCore LLC||2||Slow enrollment|f||||f||||||||||2017-10-11 01:27:02.747975|2017-10-11 01:27:02.747975
NCT01910116|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-11-16|2015-02-28||September 2013||2013-09-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||1 patients in the Shinbaro group (n=110) and 3 in the placebo group (n=110) did not receive the allocated intervention as they withdrew immediately after randomization. Also, information on 1 patient in the placebo group was not complete leading to drop out.|Efficacy of Shinabro in Hand Osteoarthritis|Treatment Efficacy of 'Shinbaro Capsule' in the Treatment of Hand Osteoarthritis: Randomized, Double-blinded, Placebo-controlled, Multicenter Investigator Initiated Trial.|Completed||Phase 2/Phase 3|220|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:27:02.881935|2017-10-11 01:27:02.881935
NCT01910103|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-05-18|||June 2013||2013-06-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Observational|||Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense Breasts|Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense Breasts|Completed||N/A|825|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 01:27:04.391794|2017-10-11 01:27:04.391794
NCT01910090|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2013-07-24|||December 2012||2012-12-01|December 2012|2012-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions|Comparative, Randomized, Two-period, Two-treatment, Two-sequence, Single Dose, Open-label, Crossover Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET (One Tablet) of (Sanovel İlaç San. ve Tic. A.Ş., İstanbul / Türkiye) Versus ANTADYS® Flurbiprofen 100 mg Comprimé Pelliculé (One Film-coated Tablet) of (LaboratoireThẻramex 6, Avenue Albert II- BP.59 98007 MONACO Cedex) and PEPCID® (Famotidine) 20 mg Tablets, USP (One Tablet) of (Marathon Pharmaceuticals, LLC USA) in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|36|Actual|Pharmaceutical Research Unit, Jordan||2|||f||||||||||||||2017-10-11 01:27:04.482489|2017-10-11 01:27:04.482489
NCT01910077|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2014-07-21|||August 2013||2013-08-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg|An Open Label, Randomized, Single Dose, Crossover Pivotal Bioequivalence Study of Tacrobell Capsule 1mg Versus Prograf Capsule 1mg in Healthy Subjects|Completed||N/A|50|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 01:27:05.170808|2017-10-11 01:27:05.170808
NCT01910064|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-02-27|2016-09-15||May 2013||2013-05-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Long Term Study of GK530G in Subjects With Acne Vulgaris|A Long Term Study of GK530G in Subjects With Acne Vulgaris|Completed||Phase 3|436|Actual|Galderma R&D||1|||f||||f||||||||||2017-10-11 01:27:05.315306|2017-10-11 01:27:05.315306
NCT01910051|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-09-08|||September 2013||2013-09-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Explorative Assessment of Biomarkers in Overweight and Obese Subjects|Explorative Assessment of Biomarkers Indicative of Insulin Resistance and Prediabetes in Overweight and Obese Subjects|Recruiting||N/A|600|Anticipated|Profil Institut für Stoffwechselforschung GmbH|||2||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 01:27:05.817777|2017-10-11 01:27:05.817777
NCT01910038|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-12-03|||November 2013||2013-11-01|September 2013|2013-09-01||||May 2015|Anticipated|2015-05-01||Interventional|HORTOCI||Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Horton's Disease: Proof of Concept Study.||Unknown status|Recruiting|Phase 2|20|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 01:27:05.933916|2017-10-11 01:27:05.933916
NCT01910025|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-04-13|||July 2012||2012-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy|Phase 2 Study of ADI PEG 20 in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy|Completed||Phase 2|18|Actual|Polaris Group||1|||f||||f||||||||||2017-10-11 01:27:06.054282|2017-10-11 01:27:06.054282
NCT01909986|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-04-14|||October 2013||2013-10-01|July 2013|2013-07-01||||February 2014|Actual|2014-02-01||Interventional|||A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053|An Open Label, Single-dose Study to Evaluate the Pharmacokinetics, Metabolism and Excretion Balance of [14C]-ONO-4053 in Healthy Adult Male Subjects|Completed||Phase 1|8|Actual|Ono Pharmaceutical Co. Ltd||1|||f||||f||||||||||2017-10-11 01:27:06.458784|2017-10-11 01:27:06.458784
NCT01909973|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-08-02|||April 2012||2012-04-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Medlink RCT||Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment||Completed||N/A|15|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:27:06.556104|2017-10-11 01:27:06.556104
NCT01909960|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-11-10|||June 2012||2012-06-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|HydroFlux||Flow MRI in Normal Pressure Hydrocephalus|Benefit of Flow Magnetic Resonance Imaging in the Management of Normal Pressure Hydrocephalus|Recruiting||N/A|184|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-11 01:27:06.662254|2017-10-11 01:27:06.662254
NCT01909947|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-02-06|||September 2013|Actual|2013-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|||Prediction of Extubation Readiness in Extreme Preterm Infants by the Automated Analysis of CardioRespiratory Behavior|Prediction of Extubation Readiness in Extreme Preterm Infants by the Automated Analysis of CardioRespiratory Behavior: the APEX Study|Recruiting||N/A|250|Anticipated|McGill University Health Center|||1||f||||f||||||||||2017-10-11 01:27:06.813116|2017-10-11 01:27:06.813116
NCT01909934|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-07-20||2017-02-08|October 1, 2013|Actual|2013-10-01|July 2017|2017-07-01|April 23, 2020|Anticipated|2020-04-23|October 1, 2015|Actual|2015-10-01||Interventional|||Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma|A Phase 4, Open-label, Single-Arm Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma|Active, not recruiting||Phase 4|45|Actual|Takeda||1|||f||||f||||||||||2017-10-11 01:27:06.960054|2017-10-11 01:27:06.960054
NCT01909921|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-05-16|||January 2009||2009-01-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|December 2012|Actual|2012-12-01||Observational|||Retrospective Medical Record Review of Mind Body Depression Group Participants|Retrospective Medical Record Review of Mind Body Depression Group Participants|Completed||N/A|156|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 01:27:07.158936|2017-10-11 01:27:07.158936
NCT01909908|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2016-09-28|||February 2013||2013-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||ECM and Blood Components for Wound Healing|Treatment of Chronic Wounds Using Extracellular Matrix-Based Devices and the Patient's Own Blood Components|Terminated||N/A|2|Actual|Cook Group Incorporated||3||Slow enrollment|f||||||||||||||2017-10-11 01:27:07.226226|2017-10-11 01:27:07.226226
NCT01909895|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2017-07-15|||August 2013||2013-08-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|PUME||Study of the Effects of Negative Emotions on Endothelial Function|Translational Research of Negative Emotions and Acute Endothelial Dysfunction|Completed||N/A|280|Actual|Columbia University||4|||f||||f|f|f||||||||2017-10-11 01:27:07.319921|2017-10-11 01:27:07.319921
NCT01909882|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-07-25|||August 2007||2007-08-01|August 2012|2012-08-01|May 2013|Actual|2013-05-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Family Member's Massage Therapy on the Vital Signs and Glasgow Coma Scale Score|The Effect of Family Members' Massage Therapy on Vital Signs and Glasgow Coma Scale Score of Patients Hospitalized in Intensive Care Unit: A Triple-blinded Randomized Controlled Clinical Trial Study|Completed||N/A|180|Actual|Baqiyatallah Medical Sciences University||1|||f||||t||||||||||2017-10-11 01:27:07.436704|2017-10-11 01:27:07.436704
NCT01909869|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-07-24|||January 2013||2013-01-01|July 2013|2013-07-01|March 2018|Anticipated|2018-03-01|September 2013|Anticipated|2013-09-01||Interventional|CREDIT||A Pilot First In Man Study of EXCEL-Ⅱto Treat the Patients With de Novo Coronary Artery Lesions|A PILOT First-In-Man Study to Evaluate Safety and Efficacy of the EXCEL-Ⅱ With Cobalt Chromium Alloys Sirolimus Eluting Biodegradable Polymer Stent in the Treatment of Patients With de Novo Coronary Artery Lesions(CREDIT-I)|Recruiting||Phase 1|45|Anticipated|JW Medical Systems Ltd||1|||f||||t||||||||||2017-10-11 01:27:07.52211|2017-10-11 01:27:07.52211
NCT01909856|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-12-02|||October 2011||2011-10-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy|The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy|Completed||Phase 2|92|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:27:07.634464|2017-10-11 01:27:07.634464
NCT01909843|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2014-01-02|||August 2013||2013-08-01|January 2014|2014-01-01||||December 2013|Actual|2013-12-01||Interventional|||ALX-0171 Safety Study in Adults With Hyperresponsive Airways|A Phase I, Single-centre, Open Label Study to Evaluate the Potential Occurrence, Reversibility and Prevention of Bronchoconstriction as Individual Response to Escalating Doses Followed by Repeated Doses of ALX-0171, Administered by Oral Inhalation to Adults With Hyperresponsive Airways|Completed||Phase 1|24|Actual|Ablynx||1|||f||||||||||||||2017-10-11 01:27:07.74312|2017-10-11 01:27:07.74312
NCT01909830|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-06-18|||July 2012||2012-07-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients|A Phase II Study to Evaluate Activity and Toxicity of Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients|Completed||Phase 2|18|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-11 01:27:07.833688|2017-10-11 01:27:07.833688
NCT01909817|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-07-24|||July 2013||2013-07-01|July 2013|2013-07-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||A Novel Method for Enhancement of Standard Rest Electrocardiograms (ECG) Provides New Parameters for Early Detection of Coronary Artery Disease (CAD)||Unknown status|Active, not recruiting|N/A|300|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 01:27:07.930139|2017-10-11 01:27:07.930139
NCT01909609|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-08-11|||July 2013|Actual|2013-07-01|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|June 16, 2017|Actual|2017-06-16||Interventional|||Parents' Knowledge and Perception of Benefits and Risks Regarding Neonatal Circumcision||Active, not recruiting||N/A|680|Anticipated|University of Michigan||2|||f||||||||||||||2017-10-11 01:27:13.605003|2017-10-11 01:27:13.605003
NCT01909804|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-07-27|2016-07-27|2015-01-16|June 2013||2013-06-01|July 2016|2016-07-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug.|Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection|A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Experienced Subjects With Chronic HCV Infection|Completed||Phase 2|323|Actual|Gilead Sciences||12|||f||||f||||||||||2017-10-11 01:27:08.048794|2017-10-11 01:27:08.048794
NCT01909791|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-12-09|||October 2013||2013-10-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|Protocol V||Treatment for CI-DME in Eyes With Very Good VA Study|Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity|Recruiting||Phase 3|702|Anticipated|Jaeb Center for Health Research||3|||f||||t||||||||||2017-10-11 01:27:10.337907|2017-10-11 01:27:10.337907
NCT01909778|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-25|2015-08-03|2015-07-03||June 2008||2008-06-01|August 2015|2015-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||While a number of 12 entered patients with non-HCV liver cirrhosis was planned, only a total of 2 patients were enrolled in 1 centre in Germany.|Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis|An Open Label Single Dose Phase I Trial of 120 mg and 240 mg BI 201335 Soft Gel Capsules to Study Pharmacokinetic Properties and Safety in Patients With Compensated Liver Cirrhosis in Historical Comparison With 1220.2|Completed||Phase 1|2|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 01:27:11.031492|2017-10-11 01:27:11.031492
NCT01909765|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-07-26|||July 2013||2013-07-01|July 2013|2013-07-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Two Different Surgical Techniques on Postoperative Circumcision Pain|Comparison of Two Different Circumcision Surgical Technique on Postoperative Pain|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||2|||f||||f||||||||||2017-10-11 01:27:11.527024|2017-10-11 01:27:11.527024
NCT01909752|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-07-03|||July 2013||2013-07-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|November 2016|Actual|2016-11-01||Interventional|||Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer|Randomized Phase II Trial of Cyclophosphamide With Allogeneic Non-Small Cell Lung Cancer (NSCLC) DRibble Vaccine Alone or With Granulocyte-Macrophage Colony-Stimulating Factor or Imiquimod for Adjuvant Treatment of Definitively-Treated Stage IIIA or IIIB NSCLC|Completed||Phase 2|12|Actual|UbiVac||3|||f||||f||||||||||2017-10-11 01:27:11.647428|2017-10-11 01:27:11.647428
NCT01909739|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2014-02-04|||July 2013||2013-07-01|February 2014|2014-02-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||The Effects of Statin on Postoperative Renal Function in Valvular Heart Surgery: a Randomized, Placebo-controlled Study||Unknown status|Recruiting|N/A|200|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:27:11.786692|2017-10-11 01:27:11.786692
NCT01909726|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-07-30|||June 2012||2012-06-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||The Art of Waiting: Evaluation of an Interactive Media Experience in a Children's Hospital Clinic Waiting Space|The Art of Waiting: Evaluation of an Interactive Media Experience in a Children's Hospital Clinic Waiting Space|Completed||N/A|310|Actual|Holland Bloorview Kids Rehabilitation Hospital|||3||f||||f||||||||||2017-10-11 01:27:11.886974|2017-10-11 01:27:11.886974
NCT01909713|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2014-02-05|2013-12-17||May 2013||2013-05-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.|Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.|Completed||Phase 4|35|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:27:12.035927|2017-10-11 01:27:12.035927
NCT01909700|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-05-04|||July 2011||2011-07-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Single Incision Pelvic Floor Mesh Implants|Single Incision Pelvic Floor Mesh Implants|Completed||Phase 2/Phase 3|157|Actual|Western Galilee Hospital-Nahariya||1|||f||||t||||||||||2017-10-11 01:27:12.828732|2017-10-11 01:27:12.828732
NCT01909687|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-06-26|||July 2013||2013-07-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Assessment of Blood Glucose Monitoring Systems|Leistungsbewertung Von Blutzuckermesssystemen im Methodenvergleich|Completed||N/A|163|Actual|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm|||||f||||f||||||||||2017-10-11 01:27:12.916395|2017-10-11 01:27:12.916395
NCT01909674|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-04-06|2017-02-16||September 2011|Actual|2011-09-01|April 2017|2017-04-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of OSA With CPAP|Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure (CPAP): A Randomized Cross-over Study|Completed||N/A|21|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 01:27:13.028287|2017-10-11 01:27:13.028287
NCT01909661|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-04-16|||March 2013||2013-03-01|July 2013|2013-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|JUNGLO||Tolerance of Infants With Cow's Milk Protein Allergy to Extensively Hydrolyzed Rice Protein or Casein Infant Formulas|Tolerancia a 2 fórmulas de Leche Infantil Altamente Hidrolizadas en Base a proteínas de Arroz y a caseína en niños Con Alergia a Las proteínas de Leche de Vaca|Completed||Phase 2|114|Actual|Lactalis||2|||f||||t||||||||||2017-10-11 01:27:13.302458|2017-10-11 01:27:13.302458
NCT01909635|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-07-13|||July 2014|Anticipated|2014-07-01|July 2017|2017-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Assessment of Thoughts and Feelings Occurring During and After a Meal|Assessment of Thoughts and Feelings Occurring During and After a Meal|Withdrawn||N/A|0|Actual|University of Tennessee||2||Decision was made not to start the study before it was initiated.|f||||f||||||||||2017-10-11 01:27:13.457537|2017-10-11 01:27:13.457537
NCT01909622|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-10-25|||June 2013||2013-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2013|Actual|2013-10-01||Interventional|||Trial of Vitamin D Fortified Milk|A Randomized Trial of Milk Fortified With Vitamin D in Colombia|Completed||Phase 3|80|Actual|University of Michigan||2|||f||||||||||||||2017-10-11 01:27:13.537208|2017-10-11 01:27:13.537208
NCT01909596|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-23|||May 2011||2011-05-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Lateral Wedge Insoles With Arch Support in Knee Osteoarthritis|Does it Exist a Relationship Between Inclination Angle of Foot Orthoses and Varus Angle of the Knee in the Relief of the Knee Osteoarthritis Symptoms?|Completed||N/A|24|Actual|Laval University||1|||f||||t||||||||||2017-10-11 01:27:13.668726|2017-10-11 01:27:13.668726
NCT01909583|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-06-11|||June 2013||2013-06-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Pediatric Cardiac Surgery Pre-operative Counselling Study|Pediatric Cardiac Surgery Pre-operative Counselling Study|Completed||N/A|50|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 01:27:13.766503|2017-10-11 01:27:13.766503
NCT01909570|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2015-04-07|2015-02-03||January 2010||2010-01-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|eSET|Women aged under 38 years, with BMI between 19–29 kg/m2, FSH <15mUI/mL on the third day and first cycle of IVF/ICSI or second cycle after a prior attempt with a positive pregnancy test result. The infertile period must be less of five years, without previous uterine surgery, uterine malformations, neither repeated spontaneous abortions.|eSET Plus Single Embryo Cryotransfer vs Double Embryo Transfer|Randomized Clinical Trial Comparing Elective Single Embryo Transfer Plus Single Embryo Cryotransfer vs Double Embryo Transfer|Completed||N/A|194|Actual|University Hospital Virgen de las Nieves|"Our study could have been complemented by improved embryo selection, using a time-lapse system.
Another limitation of our study is that after devitrification, blastocyst culture was not performed."|2|||f||||f||||||||||2017-10-11 01:27:13.848981|2017-10-11 01:27:13.848981
NCT01909557|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-07-25|||January 2010||2010-01-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.|Effect of Supplementation of Antioxidant Substances and Probiotics in HCV Correlated Liver Disease Treated With Interferon and Ribavirin. Studies on Biochemical and Virological Response and on Quality of Life.|Completed||Phase 3|62|Actual|University of Catania||2|||f||||t||||||||||2017-10-11 01:27:14.247252|2017-10-11 01:27:14.247252
NCT01909544|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-02-06|||September 2011||2011-09-01|February 2014|2014-02-01||||July 2014|Anticipated|2014-07-01||Interventional|||Muscle Metabolism and Oxygenation During Localized Fatigue-exercise in COPD|Muscle Oxygenation and Metabolism in Response to a Localized Fatigue-inducing Exercise in Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|20|Anticipated|Laval University||2|||f||||f||||||||||2017-10-11 01:27:14.330059|2017-10-11 01:27:14.330059
NCT01909531|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-03-01|||April 2013||2013-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Deep Brain Stimulation (DBS) Data Base Study|Deep Brain Stimulation (DBS) Data Base Study|Enrolling by invitation||N/A|500|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix|||1||f||||f||||||||||2017-10-11 01:27:14.424452|2017-10-11 01:27:14.424452
NCT01909518|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-07-24|||July 2013||2013-07-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Detection of Early Esophageal Squamous Neoplasia|Detection of Early Esophageal Squamous Neoplasia by Using Virtual Chromoendoscopy and Probe-based Confocal Laser Endomicroscopy|Unknown status|Recruiting|N/A|200|Anticipated|Shandong University|||1||f||||t||||||Samples With DNA|"     endoscopic biopsies will be taken at suspicious lesions   "|||2017-10-11 01:27:14.487878|2017-10-11 01:27:14.487878
NCT01909505|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-07-24|||June 2013||2013-06-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Observational|||Comparison of Salivary and Serum Free Testosterone in Normal and Hypogonadal Men|Comparison of Salivary Testosterone With Serum Free Testosterone Done by Equilibrium Dialysis.|Unknown status|Recruiting|N/A|60|Anticipated|Saliva Biomarkers, Inc.|||2||f||||f||||||||||2017-10-11 01:27:14.554032|2017-10-11 01:27:14.554032
NCT01909492|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-09-26|||July 2013||2013-07-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Relaxin in Multiple Sclerosis (MS)|Measurement of Relaxin in the Serum and Cerebrospinal Fluid of Subjects With and Without the Relapsing Form of Multiple Sclerosis|Recruiting||N/A|30|Anticipated|Providence Health & Services|||3||f||||f||||||Samples Without DNA|"     Patients will provide blood and cerebrospinal fluid for use in this research.   "|No||2017-10-11 01:27:14.627436|2017-10-11 01:27:14.627436
NCT01909479|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-09-20|||June 2013||2013-06-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||A Phase 3, Multicenter Study Designed To Evaluate The Efficacy And Safety Of A Long Acting Hgh Product (Mod-4023) In Adult Subjects With Growth Hormone Deficiency|A PHASE 3, MULTICENTER STUDY DESIGNED TO EVALUATE THE EFFICACY AND SAFETY OF A LONG ACTING HGH PRODUCT (MOD-4023) IN ADULT SUBJECTS WITH GROWTH HORMONE DEFICIENCY|Active, not recruiting||Phase 3|189|Anticipated|Opko Biologics||2|||f||||t||||||||||2017-10-11 01:27:14.749048|2017-10-11 01:27:14.749048
NCT01909466|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2015-06-03|2015-03-19||July 2013||2013-07-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia|An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia|Completed||Phase 1|141|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-10-11 01:27:14.836505|2017-10-11 01:27:14.836505
NCT01909453|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-02-17|||September 2013||2013-09-01|February 2017|2017-02-01|March 31, 2018|Anticipated|2018-03-31|September 2016|Actual|2016-09-01||Interventional|COLUMBUS||Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma|A 2-part Phase III Randomized, Open Label, Multicenter Study of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma|Active, not recruiting||Phase 3|921|Actual|Array BioPharma||4|||f||||t||||||||||2017-10-11 01:27:17.35023|2017-10-11 01:27:17.35023
NCT01909440|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-04-29|||July 8, 2013|Actual|2013-07-08|April 2017|2017-04-01|July 8, 2019|Anticipated|2019-07-08|July 8, 2018|Anticipated|2018-07-08||Interventional|||Resistance Training and Protein Supplementation for Prostate Cancer Survivors|Exercise and Protein Supplementation for Prostate Cancer Survivors Receiving Androgen Deprivation Therapy|Active, not recruiting||N/A|41|Actual|University of Southern California||4|||f||||t||||||||||2017-10-11 01:27:18.101065|2017-10-11 01:27:18.101065
NCT01909245|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-12-07|||October 2013||2013-10-01|December 2016|2016-12-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|TCD||Islet Cell Transplant for Type 1 Diabetes|Islet Transplantation Using a T-Cell Depleting Immunosuppression Induction Regimen|Recruiting||Phase 2|30|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:27:20.221008|2017-10-11 01:27:20.221008
NCT01909427|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-02-03||2015-12-18|June 2013||2013-06-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy|A Randomized, Placebo-controlled Double-blind, Multicenter, Phase 2 Dose Ranging Study To Assess The Efficacy And Safety of CNTO 6785 In Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 2|257|Actual|Janssen Research & Development, LLC||5|||f||||t||||||||||2017-10-11 01:27:18.209885|2017-10-11 01:27:18.209885
NCT01909414|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-08-19||||||August 2013|2013-08-01||||November 2014|Anticipated|2014-11-01||Interventional|||Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications|A Phase 1 Study of the Safety and Immunogenicity of DNA/MVA Immunizations With Co-Expressed GM-CSF in HIV-1 Infected Young Adults With Suppressed Viremia on HAART|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 01:27:18.417937|2017-10-11 01:27:18.417937
NCT01909401|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-07-23|||June 2013||2013-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation|Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation|Completed||Early Phase 1|1|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 01:27:18.517566|2017-10-11 01:27:18.517566
NCT01909388|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-23|||June 2013||2013-06-01|July 2013|2013-07-01|July 2016|Anticipated|2016-07-01|May 2014|Anticipated|2014-05-01||Interventional|BRAPROST||Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy|Phase II Study of Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion Real Time High Dose Rate (HDR) Brachytherapy in Patients With Intermediate and High Risk Prostate Cancer|Unknown status|Recruiting|Phase 2|15|Anticipated|Hospital de Cruces||1|||f||||t||||||||||2017-10-11 01:27:18.60571|2017-10-11 01:27:18.60571
NCT01909375|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-01-27|||August 2011||2011-08-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01|5 Years|Observational [Patient Registry]|AJRR||American Joint Replacement Registry|American Joint Replacement Registry|Enrolling by invitation||N/A|500000|Anticipated|American Joint Replacement Registry|||1||f||||f||||||||Yes|AJRR provides participating hospitals their data back in the form of dashboards and reports available on our registry platform. AJRR also releases an Annual Report every November which includes aggregate, de-identified data.|2017-10-11 01:27:18.692051|2017-10-11 01:27:18.692051
NCT01909362|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2014-02-25|||July 2013||2013-07-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)|Feasibility Study of Biomarker Analysis for Patients With Metastatic Colorectal Cancer|Completed||N/A|52|Actual|US Oncology Research|||2||f||||f||||||Samples With DNA|"     Tumor tissue (biopsy or surgery) retrieved within 4 weeks from the date of signing the ICF     and tested as outlined in the protocol:      - FFPE specimen (blocks or cut slides) currently in storage at a pathology lab. Such tissue     may be archival and stored, for no more than 5 years, being obtained at the time for a     standard of care diagnostic or research biopsy.   "|||2017-10-11 01:27:18.752346|2017-10-11 01:27:18.752346
NCT01909349|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-04-17|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|September 2015|Actual|2015-09-01||Interventional|RENATA||Web-based Aftercare Intervention for Cardiac Patients|Rehabiliation-Aftercare for an Optimal Transfer Into Autonomous Daily Life (RENATA) - an eHealth Intervention Study|Completed||N/A|1000|Actual|Jacobs University Bremen gGmbH||2|||f||||f||||||||||2017-10-11 01:27:18.824401|2017-10-11 01:27:18.824401
NCT01909336|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2016-10-21|2016-08-29||July 2013||2013-07-01|October 2016|2016-10-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia|Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia.|Completed||Phase 3|161|Actual|Instituto Tecnologico y de Estudios Superiores de Monterey||3|||f||||t||||||||||2017-10-11 01:27:19.067306|2017-10-11 01:27:19.067306
NCT01909323|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-07-25|||September 2011||2011-09-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Digestive Tolerance of Maltitol and FOS|Digestive Tolerance and Postprandial Glycaemic and Insulinaemic Responses Evaluation of Different Maltitol/FOS Mixtures in Healthy Adults|Completed||N/A|36|Actual|Syral||6|||f||||||||||||||2017-10-11 01:27:19.564763|2017-10-11 01:27:19.564763
NCT01909310|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-03-21|||September 2013||2013-09-01|March 2017|2017-03-01|April 1, 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|||Head Positions to Open the Airway IV|Head Positions to Open the Upper Airway IV|Completed||N/A|80|Actual|Medical University Innsbruck||2|||f||||f||||||||||2017-10-11 01:27:19.657839|2017-10-11 01:27:19.657839
NCT01909297|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-07-25|||May 2013||2013-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Comparison of the I-gel, Supreme and Proseal LMA in Paralyzed Patients|Comparison of the I-gel, Supreme and Proseal LMA in Paralyzed Patients Undergoing Gynaecological Laparoscopic Surgery With Oropharyngeal Leak Pressure|Completed||N/A|35|Actual|Inonu University||3|||f||||f||||||||||2017-10-11 01:27:19.73706|2017-10-11 01:27:19.73706
NCT01909284|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-02-02|||March 2013||2013-03-01|February 2014|2014-02-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Efficacy Study of Acupuncture to Treat Spinal Pain|Pilot Study of Efficacy and Safety of Acupuncture on Patient With Spinal Pain Due to Spondylolithesis|Unknown status|Recruiting|N/A|14|Anticipated|Daegu Catholic University Medical Center||2|||f||||f||||||||||2017-10-11 01:27:19.842188|2017-10-11 01:27:19.842188
NCT01909271|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-01-28|||July 2013||2013-07-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|TASHE||Tailored Approaches to Stroke Health Education|Tailored Approaches to Stroke Health Education|Enrolling by invitation||N/A|266|Anticipated|Columbia University||2|||f||||t|f|f||||||Undecided||2017-10-11 01:27:19.963009|2017-10-11 01:27:19.963009
NCT01909258|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-05-19|||January 2015||2015-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|CRESPEOS||Pelvic Area Extension Measurements for Four Types of Lumbopelvic Balance Using Three Different Methods|Comparison and Reproducibility of Pelvic Area Extension Measurements for Four Types of Lumbopelvic Balance Using Three Different Methods: Clinical Observation Versus Photography Versus the EOS Imaging System|Completed||N/A|120|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 01:27:20.108542|2017-10-11 01:27:20.108542
NCT01909232|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-07-25||2015-06-23|July 2013||2013-07-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||A Clinical Trial for the Treatment of Depression With Repetitive Transcranial Magnetic Stimulation (rTMS)|A Prospective, Double-Blind, Randomized, Parallel-Group, Sham-Controlled Feasibility Trial of Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depressive Disorder|Completed||N/A|92|Actual|Cervel Neurotech, Inc.||2|||f||||t||||||||||2017-10-11 01:27:20.350351|2017-10-11 01:27:20.350351
NCT01909219|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-07-25|||January 2012||2012-01-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|June 2012|Actual|2012-06-01||Interventional|MAGIC-P||PMC Split Preparation for Colon Cleansing|A Randomized Controlled Trial Comparing Efficacy and Acceptability of Split and Standard Dose Sodium Picosulphate/Magnesium Citrate for Bowel Cleansing Prior to Colonoscopy: the MAGIC-P Multicenter Study|Completed||Phase 4|862|Actual|Luigi Sacco University Hospital||2|||f||||t||||||||||2017-10-11 01:27:20.469841|2017-10-11 01:27:20.469841
NCT01909193|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-02-22|||January 2011||2011-01-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||CBT vs. ABM vs. for Social Anxiety|Cognitive Behavior Therapy vs. Attention Bias Modification Treatment for Social Anxiety|Completed||N/A|69|Actual|Hebrew University of Jerusalem||2|||f||||f||||||||||2017-10-11 01:27:20.570675|2017-10-11 01:27:20.570675
NCT01909180|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-03-22|2015-03-12||May 2013||2013-05-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Clinical Evaluation for General Electric (GE) CT System|Clinical Evaluation for GE CT System|Completed||N/A|49|Actual|GE Healthcare||3|||f||||f||||||||||2017-10-11 01:27:20.653053|2017-10-11 01:27:20.653053
NCT01909167|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-03-05|||December 2014||2014-12-01|January 2014|2014-01-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|OnCBTDep||Keeping Well:Online Cognitive Behavioral Therapy (CBT) for Pregnant Women With Depressive Symptoms|A Randomized Controlled Trial of Internet Based Cognitive Behavioural Therapy (CBT) Versus Treatment as Usual (TAU) for Pregnant Women With Symptoms of Depression|Unknown status|Not yet recruiting|N/A|120|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 01:27:20.812727|2017-10-11 01:27:20.812727
NCT01909141|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-09-30|2015-02-03||August 2013||2013-08-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS|Combined Letrozole-metformin-pioglitazone Versus Combined Clomiphene Citrate-metformin-pioglitazone in Clomiphene Citrate-resistant Women With Polycystic Ovary Syndrome|Completed||Early Phase 1|100|Actual|Cairo University||2|||f||||||||||||||2017-10-11 01:27:21.019869|2017-10-11 01:27:21.019869
NCT01909128|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2015-03-18|||February 2013||2013-02-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms||Completed||Phase 3|405|Actual|Federico II University||3|||f||||f||||||||||2017-10-11 01:27:21.536486|2017-10-11 01:27:21.536486
NCT01909115|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2017-07-08|||September 2014|Actual|2014-09-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|April 2020|Anticipated|2020-04-01||Interventional|||Randomized Study of Two Vitamin D Dosing Strategies in Children With Chronic Kidney Disease|Randomized Study of Two Vitamin D Dosing Strategies in Children With Chronic Kidney Disease|Active, not recruiting||Phase 3|80|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 01:27:21.772141|2017-10-11 01:27:21.772141
NCT01909102|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-09-23|||January 2014||2014-01-01|September 2013|2013-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|ACTonHEART||The ACTonHEART Study: Design of a Randomized Controlled Clinical Trial of Acceptance and Commitment Therapy for Cardiac Patients|The ACTonHEART Study: a Randomized Controlled Clinical Trial of Acceptance and Commitment Therapy in Cardiac Patients|Unknown status|Not yet recruiting|N/A|160|Anticipated|Istituto Auxologico Italiano||2|||f||||f||||||||||2017-10-11 01:27:21.870507|2017-10-11 01:27:21.870507
NCT01909089|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-12-04|||June 2013||2013-06-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Determination of the Minimum Local Analgesic Dose of Spinal Chloroprocaine in Labour|Determination of the Minimum Local Analgesic Dose of Spinal Chloroprocaine in Labour.|Unknown status|Recruiting|Phase 4|40|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 01:27:22.001193|2017-10-11 01:27:22.001193
NCT01909076|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-03-02|||January 2014||2014-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|TOPCARE||Transforming Opioid Prescribing in Primary Care|Implementing Opioid Risk Reduction Strategies Into Primary Care Practice|Completed||N/A|53|Actual|Boston Medical Center||2|||f||||t||||||||||2017-10-11 01:27:22.099581|2017-10-11 01:27:22.099581
NCT01909063|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-02-27|||January 2005||2005-01-01|February 2017|2017-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Randomized Controlled Trial Testing The Effect Of A Multi-Nutrient Fortified Juice|A Randomized Controlled Trial Testing the Effect of a Multi-nutrient Fortified Juice|Completed||N/A|180|Actual|Boston University||3|||f||||f||||||||||2017-10-11 01:27:22.200548|2017-10-11 01:27:22.200548
NCT01909050|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-03-23|||February 2013||2013-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Immune Response in Celiac Disease on In-vitro Gluten Challenge|An In-vitro Gluten Challenge on the Immunologic Response in Celiac Disease.|Enrolling by invitation||N/A|40|Anticipated|Beth Israel Deaconess Medical Center|||5||f||||f||||||Samples With DNA|"     Duodenal biopsy samples   "|||2017-10-11 01:27:22.294971|2017-10-11 01:27:22.294971
NCT01909037|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-06-22|||March 2012||2012-03-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Exploratory Non Comparative Study to Evaluate the Efficacy of Highly Bioavailable Curcumin (Flexofytol) in Patients With Knee Osteoarthritis|Exploratory Non Comparative Study to Evaluate the Efficacy of Highly Bioavailable Curcumin (Flexofytol) in Patients With Knee Osteoarthritis|Completed||Early Phase 1|22|Actual|Tilman S.A.||1|||f||||||||||||||2017-10-11 01:27:22.380831|2017-10-11 01:27:22.380831
NCT01909024|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-05-16|||July 2013||2013-07-01|May 2014|2014-05-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Pelvic Embolisation to Reduce Recurrent Varicose Veins - Recurrent|A Randomised Controlled Trial Investigating The Use Of Pelvic Vein Embolisation To Reduce Recurrent Varicose Veins Of The Legs In Women With Recurrent Varicose Veins And Associated Pelvic Venous Reflux.|Not yet recruiting||N/A|270|Anticipated|The Whiteley Clinic||2|||f||||t||||||||||2017-10-11 01:27:22.464682|2017-10-11 01:27:22.464682
NCT01909011|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-11-19|2015-02-12||January 2013||2013-01-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Single Blind Study of Cranial Electrical Stimulation in Bipolar II Disorder|A Single Blind, Randomized, Sham Controlled Study of Cranial Electrical Stimulation in Bipolar II Disorder|Completed||N/A|16|Actual|Beth Israel Medical Center|"A small sample size.
A possible self-selection bias due to extensive time commitment required from the study participants."|2|||f||||f||||||||||2017-10-11 01:27:22.587522|2017-10-11 01:27:22.587522
NCT01908998|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-04-17|||July 2013||2013-07-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Influence of Supportive Sandals on Y-Balance Performance on Healthy Young Individuals|Influence of Supportive Sandals on Y-Balance Performance on Healthy Young Individuals|Completed||N/A|40|Actual|Temple University||1|||f||||f||||||||||2017-10-11 01:27:22.962027|2017-10-11 01:27:22.962027
NCT01908985|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2015-06-15||||||July 2013|2013-07-01||||||||Expanded Access|||Ocular Fluorophotometry for Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).|Ocular Fluorophotometry to Assess the Aqueous Humor Production for Patients With Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).|Available||N/A|||EyeTechCare|||||f||||||||||||||2017-10-11 01:27:23.048468|2017-10-11 01:27:23.048468
NCT01908972|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-02-15|||June 2013||2013-06-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma|The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma|Completed||Phase 4|34|Actual|Seoul National University Hospital||2|||f||||t||||||||Yes||2017-10-11 01:27:23.111353|2017-10-11 01:27:23.111353
NCT01908959|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-24|||February 2010||2010-02-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Madres Para la Salud (Mothers for Health)|Madres Para la Salud (Mothers for Health)|Completed||N/A|177|Actual|Arizona State University||2|||f||||f||||||||||2017-10-11 01:27:23.232168|2017-10-11 01:27:23.232168
NCT01908933|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-11-13|||September 2013||2013-09-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema|Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema|Withdrawn||Phase 3|0|Actual|Aeris Therapeutics||1|||f||||t||||||||||2017-10-11 01:27:23.438872|2017-10-11 01:27:23.438872
NCT01908920|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-09-08|||May 2013||2013-05-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects||Completed||N/A|60|Actual|European Institute for Evidence Based Osteopathic Medicine||3|||f||||t||||||||||2017-10-11 01:27:23.528001|2017-10-11 01:27:23.528001
NCT01908894|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2013-07-24|||February 2012||2012-02-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Injection Site Toleration|A Double-blind Study of the Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Safety and Injection Site Toleration|Completed||Phase 1|12|Actual|Biodel||3|||f||||||||||||||2017-10-11 01:27:23.738049|2017-10-11 01:27:23.738049
NCT01908881|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-11-03|||April 2013||2013-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||An Intervention for Enhancing Early Attachment in Primary Health Care|Impact of a Group Intervention for Promoting Maternal Sensitivity in Primary Health Care Dyads at Psychosocial Risk. A Randomized Clinical Trial.|Completed||N/A|181|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 01:27:23.826289|2017-10-11 01:27:23.826289
NCT01908868|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-12-26|||November 2011||2011-11-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Trial of EBUS-TBNA Versus Conventional TBNA in Diagnosis of Sarcoidosis||Completed||N/A|130|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 01:27:23.921873|2017-10-11 01:27:23.921873
NCT01908855|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-08-09|||October 2013||2013-10-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|October 2016|Actual|2016-10-01||Interventional|ENCERT||Cognitive-Behavioral Therapy Enriched With Emotion Regulation Training for Multiple Somatoform Symptoms|Enriching Cognitive-Behavioral Therapy With Emotion Regulation Training in Patients With Chronic Multiple Somatoform Symptoms (ENCERT): A Randomized Controlled Trial|Completed||N/A|255|Actual|Philipps University Marburg Medical Center||2|||f||||t||||||||||2017-10-11 01:27:24.012851|2017-10-11 01:27:24.012851
NCT01908842|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-04-03|2015-04-08||August 2013||2013-08-01|April 2017|2017-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|ISTART||Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults|Induction, STabilization, Adherence, and Retention Trial (ISTART) - A Randomized, Non-inferiority, Multicenter Study to Assess Early Treatment Efficacy of OX219 Versus SUBOXONE Film and to Explore Switching Between Treatments|Completed||Phase 3|759|Actual|Orexo AB||2|||f||||f||||||||||2017-10-11 01:27:24.168224|2017-10-11 01:27:24.168224
NCT01908803|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2015-10-16|2015-08-24||December 2013||2013-12-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||This analysis population includes all randomized and treated subjects.|Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes|Proof of Concept of Single Application of AL-60371/AL-817 Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes Compared to CIPRODEX® (BID for 7 Days)|Terminated||Phase 2|84|Actual|Alcon Research||2||Management decision|f||||f||||||||||2017-10-11 01:27:30.539748|2017-10-11 01:27:30.539748
NCT01908790|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-09-25|||July 2013||2013-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Correlation of Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous Catheter|Correlation of Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter vs Venous Oxygen Saturation From Blood Samples From the Jugular Vein vs Central Venous Oxygen Saturation vs Mixed Venous Oxygen Saturation, Measured by a CO-Oximeter.|Completed||N/A|17|Actual|Mespere Lifesciences Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:27:30.881811|2017-10-11 01:27:30.881811
NCT01908777|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-05-19|||July 16, 2013||2013-07-16|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma|A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma|Recruiting||Phase 2|33|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-10-11 01:27:30.96405|2017-10-11 01:27:30.96405
NCT01908764|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-24|2016-03-04|||November 2014||2014-11-01|October 2014|2014-10-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery|An Open-Label, Single Dose, Pharmacokinetic Study of AL-60371 Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery|Withdrawn||Phase 1|0|Actual|Alcon Research||2||Management Decision|f||||f||||||||||2017-10-11 01:27:31.120954|2017-10-11 01:27:31.120954
NCT01908751|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-09-05|||September 2014||2014-09-01|September 2017|2017-09-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2023|Anticipated|2023-03-31||Interventional|FAITH-2||Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)|Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2): A Multi-Centre 2x2 Factorial Randomized Trial Comparing Sliding Hip Screws Versus Cancellous Screws AND Vitamin D Versus Placebo on Patient Important Outcomes and Quality of Life in the Treatment of Young Adult (18-60) Femoral Neck Fractures|Recruiting||Phase 3|898|Anticipated|McMaster University||4|||f||||t||||||||||2017-10-11 01:27:31.218771|2017-10-11 01:27:31.218771
NCT01908738|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-02-20||2017-02-20|September 2013|Actual|2013-09-01|March 2014|2014-03-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|||Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy|Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy Under Oral Analgesic Drugs; A Randomized Controlled Trial|Completed||N/A|120|Actual|Mahidol University||3|||f||||t||||||||||2017-10-11 01:27:31.412458|2017-10-11 01:27:31.412458
NCT01908725|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-09-01|||June 2013||2013-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|rhLAMAN-09||Lamazym Aftercare Study|A Single-center, Un-controlled, Open-labeled Trial of the Long-term Safety of Lamazym Aftercare Treatment of Subjects With Alpha-Mannosidosis Whom Previously Participated in Lamazym Trials|Active, not recruiting||Phase 3|5|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-11 01:27:31.499209|2017-10-11 01:27:31.499209
NCT01908712|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-09-01|||August 2013||2013-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|rhLAMAN-07||Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients|A Single-center, Un-controlled, Open-labeled Trial of the Long-term Safety of Lamazym Aftercare Treatment of Subjects With Alpha-Mannosidosis Whom Previously Participated in Lamazym Trials|Active, not recruiting||Phase 3|7|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-11 01:27:31.59297|2017-10-11 01:27:31.59297
NCT01908699|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-09-20|||May 2013||2013-05-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|March 2018|Anticipated|2018-03-01||Interventional|BEAT||Beraprost-314d Added-on to Tyvaso® (BEAT)|A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension|Active, not recruiting||Phase 3|240|Anticipated|Lung Biotechnology PBC||2|||f||||t||||||||||2017-10-11 01:27:33.234131|2017-10-11 01:27:33.234131
NCT01908686|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-07-25|||May 2012||2012-05-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PRT||Pivotal Response Treatment for Children With Autism Spectrum Disorders||Recruiting||N/A|60|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 01:27:33.440264|2017-10-11 01:27:33.440264
NCT01908296|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-02-14|||July 2011||2011-07-01|February 2017|2017-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers|Phase I Study of FK949E - A Study of Drug-drug Interactions Between FK949E and Fluvoxamine in Healthy Male Adults|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:27:38.587458|2017-10-11 01:27:38.587458
NCT01908673|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-02-25|||August 2013||2013-08-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Automatic Self Transcending Meditation (ASTM) Versus Heart Rate Variability (HRV) Biofeedback in Patients With Late Life Depression (LLD): a Longitudinal Pilot Feasibility Study|Automatic Self Transcending Meditation (ASTM) Versus Heart Rate Variability (HRV) Biofeedback in Patients With Late Life Depression (LLD): a Randomized Controlled Longitudinal Pilot Feasibility Study|Completed||N/A|8|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:27:33.529157|2017-10-11 01:27:33.529157
NCT01908660|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-11-10|||January 2007||2007-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01|1 Year|Observational [Patient Registry]|||Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions|Hepatic Safety of Currently Used Antiretroviral Regimens in HIV-infected Patients With Chronic Hepatitis B and/or Hepatitis C Under Real Life Conditions: The HEPAVIR HEPATIC SAFETY Cohort.|Completed||N/A|192|Actual|Valme University Hospital|||1||f||||f||||||||||2017-10-11 01:27:33.608268|2017-10-11 01:27:33.608268
NCT01908647|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-04-24|||April 2014||2014-04-01|April 2014|2014-04-01||||July 2015|Anticipated|2015-07-01||Interventional|||Using Real-Time Functional Brain Imaging to Enhance Recovery From TBI|Using Real-Time Functional Brain Imaging to Enhance Recovery From TBI|Unknown status|Recruiting|N/A|150|Anticipated|Van Boven, Robert W., M.D.||4|||f||||f||||||||||2017-10-11 01:27:33.706697|2017-10-11 01:27:33.706697
NCT01908634|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-02-06|||July 2013||2013-07-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|FRT||Matrix on Fruit Constituent Bioavailability|A Pilot Study to Test the Effects of Matrix on Fruit Constituent Bioavailability and Influence on Chronic Disease Risk Factors.|Active, not recruiting||N/A|10|Anticipated|Institute for Food Safety and Health, United States||4|||f||||f||||||||Undecided||2017-10-11 01:27:33.978563|2017-10-11 01:27:33.978563
NCT01908621|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-23|||March 2013||2013-03-01|July 2013|2013-07-01||||December 2013|Anticipated|2013-12-01||Interventional|||Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.|Safety and Efficacy of Stem Cell Mobilization Using G-CSF (Filgrastim) Alone Compared to Intermediate-dose Cytosine Arabinoside Plus G-CSF in Multiple Myeloma Patients.|Unknown status|Recruiting|Phase 3|90|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||t||||||||||2017-10-11 01:27:34.108892|2017-10-11 01:27:34.108892
NCT01908595|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-08-14||2015-08-14|August 2013||2013-08-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis|An Open-label, Multi-center, Long-term Study to Evaluate the Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis|Completed||Phase 3|480|Actual|Maruho North America Inc.||1|||f||||f||||||||||2017-10-11 01:27:34.757328|2017-10-11 01:27:34.757328
NCT01908582|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-10-30|||July 2013||2013-07-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of Evacetrapib and Rifampin in Healthy Participants|Effect of Rifampin on the Pharmacokinetics of Evacetrapib in Healthy Subjects|Completed||Phase 1|26|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:27:34.918337|2017-10-11 01:27:34.918337
NCT01908569|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-08-04|||July 2013||2013-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Application of MACS and Time-lapse Technology in Good-prognosis Patients|Application of MACS (Magnetic-activated Cell Sorting) and Time-lapse Technology (Embryoscope) in Assisted Reproduction Patients With Good Prognosis|Recruiting||N/A|200|Anticipated|IVI Sevilla||2|||f||||f||||||||||2017-10-11 01:27:35.034038|2017-10-11 01:27:35.034038
NCT01908556|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-24|||February 2009||2009-02-01|February 2009|2009-02-01||||December 2015|Anticipated|2015-12-01||Interventional|PreFace||Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)|Open Labeled, Propective, Multicentric Phase IV Study to Examine the Influence of Pharmacogenetic Markers on the Efficacy and Side Effects in Postmenopausal, Steroid Hormone Positive Breast Cancer Patients, Who Are Treated With Letrozol.|Unknown status|Active, not recruiting|Phase 4|3545|Actual|Institut fuer Frauengesundheit||1|||f||||t||||||||||2017-10-11 01:27:35.181876|2017-10-11 01:27:35.181876
NCT01908543|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-05-28|||July 2013||2013-07-01|July 2013|2013-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Iron Deficiency and Hereditary Haemorrhagic Telangiectasia|Iron Deficiency and Hereditary Haemorrhagic Telangiectasia|Unknown status|Recruiting|N/A|100|Anticipated|Imperial College London||1|||f||||f||||||||||2017-10-11 01:27:35.298087|2017-10-11 01:27:35.298087
NCT01908530|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-09-08|||November 2013||2013-11-01|August 2015|2015-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Clinical Assessment of a Novel Microprobe Array Continuous Glucose Monitor for Type 1 Diabetes|Clinical Assessment of a Novel Microprobe Array Continuous Glucose Monitor for Type 1 Diabetes|Recruiting||N/A|36|Anticipated|Imperial College London||1|||f||||f||||||||||2017-10-11 01:27:35.423976|2017-10-11 01:27:35.423976
NCT01908504|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-06-01|||January 2012||2012-01-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Adaptive Pet Study|F Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Delivery of Adaptive Radiation Therapy|Enrolling by invitation||N/A|320|Anticipated|Duke University||1|||f||||f||||||||||2017-10-11 01:27:35.63973|2017-10-11 01:27:35.63973
NCT01908491|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-11-13|||October 2012||2012-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Comparison of IV PCA and Wound Infusion After Repair of Pectus Excavatum|Comparison of the Effects of Opioid-Based Intravenous Patient Controlled Analgesia and Continuous Ropivacaine Infusion Through Wound Catheters After Repair of Pectus Excavatum|Completed||Phase 4|80|Actual|The Catholic University of Korea||2|||f||||f||||||||||2017-10-11 01:27:35.714757|2017-10-11 01:27:35.714757
NCT01908101|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-04-18|||January 8, 2014|Actual|2014-01-08|April 2017|2017-04-01||||February 2018|Anticipated|2018-02-01||Interventional|||Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer|Phase II Trial of Metronomic Eribulin (Halaven) in Pretreated Metastatic Breast Cancer (MBC)|Recruiting||Phase 2|60|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 01:27:41.537976|2017-10-11 01:27:41.537976
NCT01908478|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-02-17|||July 2013||2013-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|VelGemRad||A Phase I Study of Veliparib (ABT-888) in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Locally Advanced, Unresectable Pancreatic Cancer|A Phase I Study of Veliparib (ABT-888) in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Locally Advanced, Unresectable Pancreatic Cancer|Active, not recruiting||Phase 1|34|Actual|Cedars-Sinai Medical Center||1|||f||||f|t|f||||||||2017-10-11 01:27:35.798704|2017-10-11 01:27:35.798704
NCT01908465|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-02-07|||November 2013||2013-11-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial|Peripheral Histamine 1 Receptor Blockade in IBS|Recruiting||Phase 4|200|Anticipated|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 01:27:35.902147|2017-10-11 01:27:35.902147
NCT01908452|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-07-23|||July 2011||2011-07-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Pyridoxal Kinase Activity in Tardive Dyskinesia|Pyridoxal Kinase Activity in Schizophrenia Patients Without Versus With Tardive Dyskinesia Treated With Vitamin B6|Withdrawn||Phase 3|0|Actual|Beersheva Mental Health Center||2||Not funded|f||||||||||||||2017-10-11 01:27:36.079398|2017-10-11 01:27:36.079398
NCT01908439|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-09-02|||August 2013||2013-08-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Simple Method to Determine the Reflex Latency During WBV|A Simple Method to Determine the Reflex Latency During Whole Body Vibration|Completed||N/A|5|Actual|Bagcilar Training and Research Hospital||1|||f||||f||||||||||2017-10-11 01:27:36.250233|2017-10-11 01:27:36.250233
NCT01908426|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-08-04|||August 2013||2013-08-01|August 2016|2016-08-01||||October 2016|Anticipated|2016-10-01||Interventional|CELESTIAL||Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib|A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib|Recruiting||Phase 3|760|Anticipated|Exelixis||2|||f||||t||||||||||2017-10-11 01:27:36.446101|2017-10-11 01:27:36.446101
NCT01908413|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-11-30|||July 2013||2013-07-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|||Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma|A Phase I Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral CUDC-427, an Antagonist of Inhibitors of Apoptosis (IAP) Proteins, When Administered in Subjects With Advanced and Refractory Solid Tumors or Lymphoma|Terminated||Phase 1|23|Actual|Curis, Inc.||1|||f||||f||||||||||2017-10-11 01:27:37.456274|2017-10-11 01:27:37.456274
NCT01908400|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Safety and Efficacy of BMMNCin Patients With Mental Retardation|An Open Labeled Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) in Patients With Mental Retardation. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:27:37.549886|2017-10-11 01:27:37.549886
NCT01908387|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-07-24|||July 2013||2013-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms|A Phase 1, Multicenter, Open-label, Dose-escalation Study of Oral Azacitidine (CC-486) in Japanese Subjects With Hematological Neoplasms|Terminated||Phase 1|2|Actual|Celgene||1||Due to Slow Accrual study was terminated.|f||||t||||||||||2017-10-11 01:27:37.649406|2017-10-11 01:27:37.649406
NCT01908374|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-23|||July 2013||2013-07-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Bioavailability of EPA and DHA From Two Dietary Supplements|A Randomized, Controlled, Crossover Study to Evaluate the Acute and Subchronic Bioavailability of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) From Two Dietary Supplements in Men and Women With Mildly Elevated Triglycerides|Unknown status|Recruiting|N/A|32|Anticipated|Arctic Nutrition AS||2|||f||||f||||||||||2017-10-11 01:27:37.807337|2017-10-11 01:27:37.807337
NCT01908361|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-08-06|||January 2014||2014-01-01|August 2014|2014-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Hybrid Approach to Unilateral vs. Bilateral Upper Limb Rehabilitation in Subacute and Chronic Stroke|Hybrid Approach to Unilateral vs. Bilateral Upper Limb Rehabilitation in Subacute and Chronic Stroke|Withdrawn||N/A|0|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation||3|||f||||f||||||||||2017-10-11 01:27:37.959826|2017-10-11 01:27:37.959826
NCT01908348|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-03-08|||July 18, 2013|Actual|2013-07-18|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 1, 2014|Actual|2014-12-01||Interventional|||Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus|Pilot Study: Dose Dependent Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||N/A|24|Anticipated|Boston University||1|||f||||f|f|f||||||No||2017-10-11 01:27:38.093004|2017-10-11 01:27:38.093004
NCT01908335|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-10-16|||October 2012||2012-10-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|August 2013|Actual|2013-08-01||Interventional|||A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C|Phase Ⅱ, Multi-center, Randomized, Open-label, Parallel-group, Active Controlled Study for the Efficacy and Safety of Pegylated Recombinant Consensus Interferon Variant Solution for Injection in the Treatment of Chronic Hepatitis C|Completed||Phase 2|212|Actual|Beijing Kawin Technology Share-Holding Co., Ltd.||4|||f||||f||||||||||2017-10-11 01:27:38.179085|2017-10-11 01:27:38.179085
NCT01908322|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-11-10|||August 2013||2013-08-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Observational|SORINT||Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety|SORINT - SORafenib for Treatment of Patients With INTermediate Stage Hepatocellular Carcinoma|Completed||N/A|19|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:27:38.408567|2017-10-11 01:27:38.408567
NCT01908309|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2015-06-22|||April 2013||2013-04-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|DrKILDARE||Contrast-inDuced nephRotoxicity as Assessed by the KIdney Load-to-DAmage RElationship|Contrast-inDuced nephRotoxicity as Assessed by the Cystatin-modified KIdney Load-to-DAmage RElationship|Completed||Early Phase 1|150|Actual|Azienda Sanitaria Locale 9, Grosseto||2|||f||||f||||||||||2017-10-11 01:27:38.497184|2017-10-11 01:27:38.497184
NCT01908283|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-12-29|||March 2014||2014-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|PCV13inSIBDCS||Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease|Influence of Immunosuppressive Treatment on Immunological Response to Pneumococcal Conjugated Vaccine (PCV13) in Patients With Inflammatory Bowel Disease|Completed||Phase 4|300|Actual|University Hospital, Geneva||2|||f||||t||||||||||2017-10-11 01:27:38.684404|2017-10-11 01:27:38.684404
NCT01908270|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-07-30|||August 2013||2013-08-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer|Randomized Controlled Trial of Yoga for Menopausal Symptoms in Women With Breast Cancer|Completed||N/A|40|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-11 01:27:38.778347|2017-10-11 01:27:38.778347
NCT01908257|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-01-08|||July 2013||2013-07-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Lesinurad Interaction Study With Ranitidine|A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Effects of Ranitidine on the Pharmacokinetics of Lesinurad in Healthy Adult Male Subjects|Completed||Phase 1|16|Actual|Ardea Biosciences, Inc.||2|||f||||f||||||||||2017-10-11 01:27:38.874842|2017-10-11 01:27:38.874842
NCT01908244|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-10-22|||July 2013||2013-07-01|July 2013|2013-07-01||||October 2013|Actual|2013-10-01||Interventional|MTN05||Short-term Effects of Live Music in Preterm Infants|Short-term Effects of Live Pentatonic Music on Physiological Parameters in Preterm Infants - A Randomized Controlled Trial With Crossover Design|Completed||N/A|21|Actual|ARCIM Institute Academic Research in Complementary and Integrative Medicine||2|||f||||||||||||||2017-10-11 01:27:38.991642|2017-10-11 01:27:38.991642
NCT01908231|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2014-02-15|||December 2012||2012-12-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Observational|TELOS||Prognostic Value of Plasma Lactate Levels Among Patients With Acute Pulmonary Embolism|Prognostic Value of Plasma Lactate Levels Among Patients With Acute Pulmonary Embolism: the Thrombo-Embolism Lactate Outcome Study|Completed||N/A|330|Anticipated|Azienda Ospedaliero-Universitaria Careggi|||1||f||||f||||||||||2017-10-11 01:27:39.273729|2017-10-11 01:27:39.273729
NCT01908218|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-22|||February 2009||2009-02-01|July 2013|2013-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||The Reliability and Validity of the Upper Lip Bite Test to Predict Difficult Laryngoscopy in Korean||Completed||N/A|344|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:27:39.367718|2017-10-11 01:27:39.367718
NCT01908205|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-03-17|||September 2013||2013-09-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|OXY-R||Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)|Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism|Completed||Phase 2|60|Actual|Anagnostou, Evdokia, M.D.||2|||f||||t||||||||No||2017-10-11 01:27:39.445859|2017-10-11 01:27:39.445859
NCT01908192|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-04-25|||June 2014||2014-06-01|April 2017|2017-04-01|June 30, 2019|Anticipated|2019-06-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®|An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents|Recruiting||Phase 2/Phase 3|126|Anticipated|SyneuRx International (Taiwan) Corp||2|||f||||t||||||||||2017-10-11 01:27:39.572922|2017-10-11 01:27:39.572922
NCT01908179|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-24|||January 2013||2013-01-01|July 2013|2013-07-01||||July 2015|Anticipated|2015-07-01|12 Months|Observational [Patient Registry]|||Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS)||Unknown status|Recruiting|N/A|100|Anticipated|Swedish Medical Center|||1||f||||f||||||||||2017-10-11 01:27:39.806929|2017-10-11 01:27:39.806929
NCT01908166|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-06-06|||January 2014||2014-01-01|June 2017|2017-06-01|November 1, 2016|Actual|2016-11-01|November 1, 2016|Actual|2016-11-01||Interventional|||Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions|US Elastography for Characterizing Focal Lesions in the Liver and Kidney|Completed||N/A|61|Actual|Stanford University||1|||f||||||||||||||2017-10-11 01:27:39.885594|2017-10-11 01:27:39.885594
NCT01908153|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-01-04|||September 2013||2013-09-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Taste Reward Processing in Pediatric Obesity|Taste Reward Processing in Pediatric Obesity|Completed||N/A|30|Actual|Stanford University|||2||f||||f||||||||||2017-10-11 01:27:39.966605|2017-10-11 01:27:39.966605
NCT01908140|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2016-02-08|2015-08-06||September 2013||2013-09-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Patients with more than 1 treatment were analysed in the Safety population with the actual treatment assigned; for this reason, the Overall Number of Baseline Participants in the safety population is different than the randomised population.|Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Double-dummy, Active-controlled Study Evaluating the Efficacy, Safety and Tolerability of Twice-daily Aclidinium Bromide/Formoterol Fumarate Compared With Twice-daily Salmeterol/Fluticasone Propionate for 24 Weeks Treatment in Symptomatic Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|933|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:27:40.120013|2017-10-11 01:27:40.120013
NCT01908127|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-12-17|2013-07-28||September 2010||2010-09-01|December 2013|2013-12-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy of Film Modelling in Paediatric Dentistry|The Effect of Filmed Modelling on the Anxious and Cooperative Behaviour of 4-6 Years Old Children During Dental Treatment|Completed||N/A|50|Actual|Zahedan University of Medical Sciences|providing a quiet environment and patient sampling were the most important limitations.|2|||f||||t||||||||||2017-10-11 01:27:41.175209|2017-10-11 01:27:41.175209
NCT01908114|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-01-24|||July 2013||2013-07-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2014|Actual|2014-06-01||Interventional|||To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan|To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan|Active, not recruiting||Phase 4|60000|Anticipated|Aga Khan University||3|||f||||t||||||||||2017-10-11 01:27:41.451007|2017-10-11 01:27:41.451007
NCT01895595|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-03|||January 2007||2007-01-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Guided Imagery Intervention for Obese Latino Adolescents|Guided Imagery Intervention for Obese Latino Adolescents|Completed||N/A|51|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 01:30:50.005571|2017-10-11 01:30:50.005571
NCT01908088|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-24|||July 2010||2010-07-01|February 2010|2010-02-01|July 2013|Actual|2013-07-01|September 2012|Actual|2012-09-01||Interventional|||Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis Bullosa|Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane for Mitten Hand Deformity in Patients With Epidermolysis Bullosa|Completed||Phase 1|6|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 01:27:41.664338|2017-10-11 01:27:41.664338
NCT01908075|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-24|||January 2011||2011-01-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|REACH||Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management|REACH Fostair vs Seretide - Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management|Completed||N/A|194723|Actual|Research in Real-Life Ltd|||2||f||||||||||||||2017-10-11 01:27:41.755142|2017-10-11 01:27:41.755142
NCT01908049|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-11-11|||August 2012||2012-08-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|July 2013|Actual|2013-07-01||Interventional|||Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection.|Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection.|Active, not recruiting||Phase 2|44|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 01:27:41.943049|2017-10-11 01:27:41.943049
NCT01908036|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-07-24|||July 2013||2013-07-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Observational|||Use of a Monitor in ME/CFS||Unknown status|Recruiting|N/A|50|Anticipated|New York CFS Association|||1||f||||t||||||||||2017-10-11 01:27:42.017805|2017-10-11 01:27:42.017805
NCT01908023|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2017-04-26|||May 2013|Actual|2013-05-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Exercise and Radiotherapy, a Good Combination?|Exercise and Radiotherapy, a Good Combination? A Pilot Study of Group Exercise for Patients With Breast Cancer|Completed||N/A|15|Actual|Norwegian University of Science and Technology||1|||f||||f|f|f||||||||2017-10-11 01:27:42.217733|2017-10-11 01:27:42.217733
NCT01908010|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-23|2013-12-09|||July 2013||2013-07-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors|A Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors|Completed||Phase 1|20|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 01:27:42.319687|2017-10-11 01:27:42.319687
NCT01907997|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-06-05|||July 2013||2013-07-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy||Completed||N/A|90|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:27:42.441543|2017-10-11 01:27:42.441543
NCT01907984|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-07-22|||December 2012||2012-12-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Diclofenac Administered Before Skull Operations Reduces the Severity of Headache After the Intervention|Preoperatively Administered Single Dose Diclofenac Reduces the Intensity of Acute Postcraniotomy Headache and Decreases Postoperative Analgesic Requirements- a Randomized, Controlled Trial|Completed||Phase 4|200|Actual|University of Debrecen||2|||f||||f||||||||||2017-10-11 01:27:42.526109|2017-10-11 01:27:42.526109
NCT01907971|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-05-26|||August 2013||2013-08-01|March 2014|2014-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||Assessment of Left and Right Ventricular Function in Patients With Ebstein Anomaly With Different Echocardiographic Methods|Left Ventricular Function in Ebstein Anomaly: Assessment by 3D Echocardiography and Speckle Tracking. Assessment and Validation of the Right Ventricle by VentriPoint Method.|Completed||N/A|18|Actual|University Children's Hospital, Zurich|||1||f||||t||||||||||2017-10-11 01:27:42.647968|2017-10-11 01:27:42.647968
NCT01907958|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-07-24|||April 2013||2013-04-01|July 2013|2013-07-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01|3 Months|Observational [Patient Registry]|CLINPRADIA||Management of Albuminuria in Hypertensive Diabetics|A Multicentre Study to Evaluate the Management of Microalbuminuria in Hypertensive Patients With Type 2 Diabetes: Improving Clinical Practice|Unknown status|Recruiting|N/A|280|Anticipated|Medpharmgene, Inc.|||1||f||||f||||||Samples With DNA|"     urine whole blood   "|||2017-10-11 01:27:42.732343|2017-10-11 01:27:42.732343
NCT01907945|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-07-30|||October 2012||2012-10-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|HNWT||Healthy Networks Water Treatment Study|Healthy Networks Water Treatment Study|Completed||N/A|150|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:27:42.818502|2017-10-11 01:27:42.818502
NCT01907932|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-04-12|||November 2013|Actual|2013-11-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Estimation of Spleen by Residents With VScan|Estimation of Spleen Size by Medical Residents With Hand Carried Ultrasound|Completed||N/A|29|Actual|University of British Columbia||1|||f||||f|f|f||||||No||2017-10-11 01:27:42.909186|2017-10-11 01:27:42.909186
NCT01907919|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-24|||July 2011||2011-07-01|July 2013|2013-07-01||||August 2012|Actual|2012-08-01|12 Months|Observational [Patient Registry]|Laser in DPC||Pilot Study,Diode Laser 808 nm Supported Direct Pulp Capping in Permanent Teeth|Diode Laser-Assisted Direct Pulp Capping In Permanent Teeth|Completed||N/A|10|Actual|Yazdanfar, Iraj, M.D.|||2||f||||||||||||||2017-10-11 01:27:43.008948|2017-10-11 01:27:43.008948
NCT01907906|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-07-28|2015-05-22||June 2013||2013-06-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|IMPROVEII|Adults ≥ 18 yrs; eligible WB donors with normal health status and vital signs by AABB criteria; negative infectious disease and direct/indirect antiglobulin test (DAT/IAAT), and did not meet any exclusion criteria.|Inactivation of Whole Blood With Mirasol|Inactivation of Whole Blood With Mirasol : Performance in Red Blood Cells in Healthy Volunteers|Completed||Phase 1|29|Actual|Terumo BCTbio||2|||f||||f||||||||||2017-10-11 01:27:43.111637|2017-10-11 01:27:43.111637
NCT01907893|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-04-15|||July 2013||2013-07-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2014|Actual|2014-12-01||Interventional|TCCS||Improving Activity and Quality of Life Following Orthopaedic Trauma: The Trauma Collaborative Care Study (TCCS)|Improving Activity and Quality of Life Following Orthopaedic Trauma: The Trauma Collaborative Care Study (TCCS)|Completed||N/A|900|Actual|Major Extremity Trauma Research Consortium||2|||f||||f||||||||||2017-10-11 01:27:44.241376|2017-10-11 01:27:44.241376
NCT01907880|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-07-05|||August 2012||2012-08-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|ER11-03||The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer|A Randomized, Double-blind, Placebo-controlled, Phase IV Trial Evaluating the Palliative Benefit of Either Continuing Pamidronate or Switching to Second-line Zoledronic Acid in Breast Cancer Patients With High-risk Bone Metastases.|Completed||Phase 4|74|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 01:27:44.347315|2017-10-11 01:27:44.347315
NCT01907867|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-02-17|||January 2012||2012-01-01|February 2017|2017-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin|An Open-Label Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin After Single and Multiple Doses Administered Orally in Healthy Volunteers|Completed||Phase 1|18|Actual|MerLion Pharmaceuticals GmbH||3|||f||||f||||||||||2017-10-11 01:27:44.436792|2017-10-11 01:27:44.436792
NCT01907854|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-12-15|2016-05-23||December 2013||2013-12-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LIRA-SWITCH™|Demographics and baseline characteristics of all exposed subjects are summarised in continuous variables. There were missing baseline values for fasting plasma glucose in 2 subjects in the liraglutide arm and 1 subject in the sitagliptin arm.|Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin|Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin|Completed||Phase 4|407|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:27:44.540725|2017-10-11 01:27:44.540725
NCT01907841|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-03-05|||July 2013||2013-07-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Effect of Ischemic Pre-Conditioning on the Rate of Recovery Following Exercise-Induced Muscle Damage|The Effect of Ischemic Pre-Conditioning on the Rate of Recovery Following Exercise-Induced Muscle Damage: a Randomized Control Trial|Completed||N/A|24|Anticipated|St Mary's University College||2|||f||||f||||||||||2017-10-11 01:27:45.210228|2017-10-11 01:27:45.210228
NCT01907828|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-03-15|||July 2013||2013-07-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|RDN+AF||A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence|A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence|Active, not recruiting||N/A|61|Actual|St. Jude Medical||2|||f||||f||||||||No||2017-10-11 01:27:45.283825|2017-10-11 01:27:45.283825
NCT01907802|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-09-28|||August 23, 2013|Actual|2013-08-23|May 2017|2017-05-01||||July 31, 2019|Anticipated|2019-07-31||Interventional|||Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction|A Phase 1 and Pharmacokinetic Study of Dabrafenib (GSK2118436B) in Patients With BRAFV600X Mutations and Renal or Hepatic Dysfunction|Active, not recruiting||Phase 1|122|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:27:45.460583|2017-10-11 01:27:45.460583
NCT01907789|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-08-18|||August 2013|Actual|2013-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Prophylactic Salpingectomy With Delayed Oophorectomy|Prophylactic Salpingectomy With Delayed Oophorectomy, Risk-Reducing Salpingo-Oophorectomy, and Ovarian Cancer Screening Among BRCA Mutation Carriers: A Proof-of-Concept Study|Active, not recruiting||N/A|80|Anticipated|M.D. Anderson Cancer Center|||3||f||||f|f|f||||Samples With DNA|"     Blood (about 2 tablespoons) drawn to measure CA125 and HE4 levels.   "|||2017-10-11 01:27:45.710171|2017-10-11 01:27:45.710171
NCT01907776|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-06-10|||July 2013||2013-07-01|June 2014|2014-06-01||||December 2013|Actual|2013-12-01||Interventional|||Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ME1100 Inhalation Solution (Arbekacin Inhalation Solution) Administered to Healthy Volunteers|Completed||Phase 1|56|Actual|Meiji Seika Pharma Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:27:45.825726|2017-10-11 01:27:45.825726
NCT01907763|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-01-26|||January 2013||2013-01-01|January 2016|2016-01-01||||October 2015|Actual|2015-10-01||Interventional|||Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients|A 12-week, Multi-center, Randomized, Double Blinded, Parallel Group, Placebo-controlled Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients|Terminated||Phase 3|194|Actual|SK Chemicals Co.,Ltd.||3|||f||||t||||||||||2017-10-11 01:27:45.915773|2017-10-11 01:27:45.915773
NCT01907750|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2016-02-28|||January 2009||2009-01-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT|Transcystic Versus Transanastomotic Biliary Drainage Tubes in Living Donor Liver Transplantation. A Prospective Randomized Trial.|Recruiting||Phase 3|180|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 01:27:46.028171|2017-10-11 01:27:46.028171
NCT01907737|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2016-12-16|||July 2013||2013-07-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Combined Brain and Peripheral Nerve Stimulation for Stroke|Combined Brain and Peripheral Nerve Stimulation to Enhance Beneficial Effects of Functional Electrical Stimulation on Hand Motor Function After Stroke|Completed||N/A|22|Actual|University of Sao Paulo General Hospital||4|||f||||t||||||||||2017-10-11 01:27:46.12879|2017-10-11 01:27:46.12879
NCT01891825|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2014-06-25|||September 2014||2014-09-01|June 2014|2014-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|PAAT||Persistent Atrial Fibrillation Ablation Trial|Persistent Atrial Fibrillation Ablation Trial|Suspended||N/A|50|Anticipated|Eastbourne General Hospital||2||Internal protocol review|f||||t||||||||||2017-10-11 01:31:52.776994|2017-10-11 01:31:52.776994
NCT01907724|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-01-25|||May 2013||2013-05-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)|A Phase I, Randomized, Multiple-Dose Study to Evaluate the Pharmacokinetic Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Subjects|Completed||Phase 1|34|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 01:27:46.24181|2017-10-11 01:27:46.24181
NCT01907711|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-08-28|||February 2013||2013-02-01|August 2013|2013-08-01|October 2014|Anticipated|2014-10-01|January 2014|Anticipated|2014-01-01||Interventional|AV/AS||Clinical Trial to Evaluate the Effectiveness of Acupuncture as a Treatment in Patients Diagnosed With CFS.|Clinical Trial, Randomized, Controlled, Parallel, to Evaluate the Effectiveness of Acupuncture as a Treatment in Patients Diagnosed With Chronic Fatigue Syndrome.|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Hospital Vall d'Hebron||2|||f||||t||||||||||2017-10-11 01:27:46.346597|2017-10-11 01:27:46.346597
NCT01907698|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2013-07-22|||April 2009||2009-04-01|July 2013|2013-07-01||||June 2011|Actual|2011-06-01||Observational|||Effect of Vaginal Intercourse on Spontaneous Labour at Term|Effect of Vaginal Intercourse on Spontaneous Labour at Term- A Randomized Trial|Completed||N/A|123|Actual|Hospital de Santa Maria, Portugal|||2||f||||t||||||||||2017-10-11 01:27:46.50295|2017-10-11 01:27:46.50295
NCT01907685|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-07-22|||June 2006||2006-06-01|July 2013|2013-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors|An Open Label, Dose Escalation, Safety and Pharmacokinetic Phase 1 Study With AVE8062 Administered as a 30 Minutes Intravenous Infusion Followed by Docetaxel Administered as an 1 Hour Intravenous Infusion 24 Hours-Apart Every 3 Weeks in Patients With Advanced Solid Tumors|Completed||Phase 1|58|Actual|Sanofi||1|||f||||||||||||||2017-10-11 01:27:46.578968|2017-10-11 01:27:46.578968
NCT01907672|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-02|2013-07-22|||August 2011||2011-08-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|GhanaCommRDT||The Role of Rapid Diagnostic Tests for Malaria for Targeting of ACTs at Community Level|The Role of Rapid Diagnostic Tests for Malaria for Targeting of ACTs at Community Level: a Cluster Randomized Trial|Completed||Phase 4|4748|Actual|Ghana Health Services||2|||f||||f||||||||||2017-10-11 01:27:46.655906|2017-10-11 01:27:46.655906
NCT01907659|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-06-30|||October 2013||2013-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections|Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections|Completed||N/A|300|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 01:27:46.767776|2017-10-11 01:27:46.767776
NCT01907646|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2013-07-24|||April 2009||2009-04-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|November 2011|Actual|2011-11-01||Interventional|||Role of Bladder Training During Post-operative Hospital Stay After Radical Hysterectomy in Patients|Role of Bladder Training During Post-operative Hospital Stay After Radical Hysterectomy in Patients: a Randomized Trial|Completed||Phase 2|111|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 01:27:46.862985|2017-10-11 01:27:46.862985
NCT01907633|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-05-18|||December 2011||2011-12-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||An Observational Study to Assess the Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide|Post-Authorization Safety Study: Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide|Completed||Phase 4|15000|Actual|Janssen Research & Development, LLC|||1||f||||f||||||||||2017-10-11 01:27:46.945608|2017-10-11 01:27:46.945608
NCT01907620|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-22|||November 2010||2010-11-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Circulating Oxidative Stress and Gestational Hypertension. Study of the Evolution of Free-radical Markers of Oxidative Stress From Before to After Childbirth in Two Groups of Women: Normal Pregnancy and Pre-eclampsia.||Completed||N/A|120|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 01:27:47.06246|2017-10-11 01:27:47.06246
NCT01907607|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-09-29|||August 2013||2013-08-01|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|CYCLIGIST||Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib|Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Phase 2 Study|Active, not recruiting||Phase 2|63|Anticipated|Institut Bergonié||1|||f||||t||||||||||2017-10-11 01:27:47.162147|2017-10-11 01:27:47.162147
NCT01907594|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-22|||August 2013||2013-08-01|July 2013|2013-07-01||||July 2014|Anticipated|2014-07-01||Interventional|||Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers|Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|New York State Psychiatric Institute||2|||f||||||||||||||2017-10-11 01:27:47.272681|2017-10-11 01:27:47.272681
NCT01907581|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-22|||June 2013||2013-06-01|July 2013|2013-07-01||||April 2015|Anticipated|2015-04-01||Interventional|IVOIRE||Impact of Socio-economic Vulnerability on Initial Severity and Prognosis in Patients Admitted to an ICU.|Impact of Socio-economic Vulnerability on Initial Severity and Prognosis in Patients Admitted to an ICU. Prospective, Multi-centre Cohort Study|Unknown status|Recruiting|N/A|1400|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 01:27:47.365998|2017-10-11 01:27:47.365998
NCT01907568|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-10-25|||June 2013||2013-06-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|UH-1||Understanding Hallucinations (Part I)|Understanding Hallucinations (Part I) - Phenomenology and Cognition|Recruiting||N/A|700|Anticipated|UMC Utrecht|||11||f||||t||||||||||2017-10-11 01:27:47.448052|2017-10-11 01:27:47.448052
NCT01907555|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-22|||May 2013||2013-05-01|July 2013|2013-07-01||||May 2015|Anticipated|2015-05-01|1 Day|Observational [Patient Registry]|||Clinical, Molecular and Physiopathological Study of Cohen Syndrome and Cohen-like Syndromes||Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire Dijon|||3||f||||f||||||||||2017-10-11 01:27:47.562498|2017-10-11 01:27:47.562498
NCT01907542|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-07-22|||June 2013||2013-06-01|July 2013|2013-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Trial Comparing Stapled Versus Monocryl Sutured Skin Closure for Elective Open Colectomy|A Randomized Controlled Trial Comparing Stapled Versus Monocryl Sutured Skin Closure for Elective Open Colectomy.|Unknown status|Recruiting|N/A|144|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-11 01:27:47.62746|2017-10-11 01:27:47.62746
NCT01907529|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-08-29|||August 2018||2018-08-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|August 2020|Anticipated|2020-08-01||Interventional|TENDENCY||A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer|A Trail of Neoadjuvant Endostar in Combination With Docetaxel, Epirubicin and Cyclophosphamide in Patients With Stage III Breast Cancer (TENDENCY)|Not yet recruiting||Phase 2/Phase 3|300|Anticipated|Hebei Medical University Fourth Hospital||2|||f||||f||||||||||2017-10-11 01:27:47.713062|2017-10-11 01:27:47.713062
NCT01907516|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-05-29|2013-09-23||February 2009||2009-02-01|May 2015|2015-05-01|June 2011|Actual|2011-06-01|August 2010|Actual|2010-08-01||Interventional|||Managing Diabetes in Pregnancy Using Cell Phone/Internet Technology|Managing Diabetes in Pregnancy Using Cell Phone/Internet Technology|Completed||N/A|100|Actual|Hawaii Pacific Health|Selection bias towards English speaking, educated, and technology savvy women, a 25% drop out rate, a high rate of glucose reporting compliance in the control system, and technical problems when Confidant first started which were quickly resolved.|2|||f||||f||||||||||2017-10-11 01:27:47.803046|2017-10-11 01:27:47.803046
NCT01907503|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-24|||February 2008||2008-02-01|July 2013|2013-07-01||||December 2013|Anticipated|2013-12-01||Interventional|||Adaptation of Locomotor Activity in Patients Suffering From Hip OA - Analysis of This Adaptation as a Prognostic Criterion for Future Disease Progression||Unknown status|Recruiting|N/A|200|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-11 01:27:48.123155|2017-10-11 01:27:48.123155
NCT01907490|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-03-27|2015-01-12||March 2013||2013-03-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation|A Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically Under Maximal Use Conditions for the Treatment of Head Lice Infestation.|Completed||Phase 2|38|Actual|Hatchtech Pty Ltd||1|||f||||f||||||||No||2017-10-11 01:27:48.204349|2017-10-11 01:27:48.204349
NCT01907477|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-22|||August 2008||2008-08-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Identification of Serum and/or Plasma Biomarkers for the Diagnosis Prognosis and/or Prediction of Invasive Mycosis in Neutropenic Patients||Completed||N/A|500|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 01:27:48.384427|2017-10-11 01:27:48.384427
NCT01907464|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-12-02|||September 2011||2011-09-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Bone Loss in Patients With Anorexia Nervosa|Physiopathology of Bone Loss in Young Patient With Anorexia Nervosa|Unknown status|Recruiting|N/A|320|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 01:27:48.458007|2017-10-11 01:27:48.458007
NCT01907451|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-24|||May 2010||2010-05-01|July 2013|2013-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|letswalk||Long-Term Effects Of An Early Individualised Retraining Programme On Walking Ability In Patients Following Hemiplegic Stroke||Terminated||N/A|14|Actual|Centre Hospitalier Universitaire Dijon|||2||f||||||||||||||2017-10-11 01:27:48.564708|2017-10-11 01:27:48.564708
NCT01907438|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-07-24|||September 2013||2013-09-01|July 2013|2013-07-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01|7 Days|Observational [Patient Registry]|||Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast Cells|Identification of the Transformation Potential of Normal Estrogen Exposed BRCA1 (Breast Cancer Susceptibility Gene 1) and BRCA2 (Breast Cancer Susceptibility Gene 2) Heterozygous Epithelial Breast Cells Due to Irradiation|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hadassah Medical Organization|||3||f||||t||||||||||2017-10-11 01:27:48.621071|2017-10-11 01:27:48.621071
NCT01907425|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-22|||July 2013||2013-07-01|July 2013|2013-07-01||||March 2017|Anticipated|2017-03-01||Interventional|compass||Prenatal Molecular Characterisation by CGH+SNP-ARRAY of Supernumerary Marker Chromosomes and de Novo Apparently Balanced Reciprocal Translocations||Unknown status|Recruiting|N/A|225|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 01:27:48.702013|2017-10-11 01:27:48.702013
NCT01907412|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2016-08-08|||June 2008||2008-06-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|FF2||Trial of Transition to Parenthood Program for Couples|Trial of Transition to Parenthood Program for Couples|Active, not recruiting||N/A|1200|Actual|Feinberg, Mark, Ph.D.||2|||f||||f||||||||||2017-10-11 01:27:48.777965|2017-10-11 01:27:48.777965
NCT01907399|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-24|||September 2010||2010-09-01|July 2013|2013-07-01||||September 2013|Anticipated|2013-09-01||Interventional|IMMUNOBEDIA||Study of Immune Response in Obesity and Type 2 Diabetes||Unknown status|Recruiting|N/A|150|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f||||||||||||||2017-10-11 01:27:48.843792|2017-10-11 01:27:48.843792
NCT01907386|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-08-02|||January 2014||2014-01-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|AAA-Elasto||Abdominal Aortic Aneurysm Follow-up After Endovascular Repair by Non-invasive Vascular Elastography|Abdominal Aortic Aneurysm Follow-up After Endovascular Repair by Non-invasive Vascular Elastography|Recruiting||N/A|45|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 01:27:48.95133|2017-10-11 01:27:48.95133
NCT01907373|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-07-24|||August 2009||2009-08-01|July 2013|2013-07-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers|Effect of Probenecid on Pharmacokinetics, and Tolerability of Olmesartan in Healthy Chinese Volunteers|Completed||Phase 4|12|Actual|Central South University||2|||f||||t||||||||||2017-10-11 01:27:49.042729|2017-10-11 01:27:49.042729
NCT01907360|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-09-25||2017-09-07|August 2013||2013-08-01|September 2017|2017-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Phase I/II Single Center, Open-Label Study Examining Image Result for Pharmacokinetics of 2 Modified-Release Formulations of MPH in Adolescent/Pediatric With ADHD|Phase I/II Single Center/Treatment Open-Label Adaptive Trial Examining the PK of up to Two Separate HLD200 Modified Release Formulations of Methylphenidate in Adolescent and Pediatric Subjects With Attention-Deficit Hyperactivity Disorder|Completed||Phase 1/Phase 2|36|Actual|Ironshore Pharmaceuticals and Development, Inc||2|||f||||t||||||||||2017-10-11 01:27:49.127461|2017-10-11 01:27:49.127461
NCT01907347|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2013-07-18|||March 2013||2013-03-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|April 2014|Anticipated|2014-04-01||Observational|PAP||Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) Patients|PHASE ANGLE PROJECT|Unknown status|Recruiting|N/A|1000|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 01:27:49.207072|2017-10-11 01:27:49.207072
NCT01907334|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-10-06|2014-09-17||August 2013||2013-08-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional||All randomized participants were analyzed according to protocol.|Dose-Response of Salmeterol in Children|Dose-response of Salmeterol Delivered by Advair Diskus in Children: Bioassay by Methacholine Challenge Using Oscillometry as the Endpoint|Completed||Phase 4|10|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:27:49.348481|2017-10-11 01:27:49.348481
NCT01907321|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-12-05|2016-04-18||January 2011||2011-01-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Fourteen adults between the ages of 50 and 80 years, with a history of ischemic stroke within the previous 2 years.|Cough and Swallow Rehab Following Stroke|Cough and Swallow Rehabilitation Following Stroke|Completed||Phase 1/Phase 2|14|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:27:49.540241|2017-10-11 01:27:49.540241
NCT01907308|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-04-25|||February 2014||2014-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma|A Phase II Single-arm Study of AMG 386 in Combination With Docetaxel for Advanced Urothelial Carcinoma After Failure of a Platinum-containing Regimen|Withdrawn||Phase 2|0|Actual|University of Colorado, Denver||1||Sponsor's decision to terminate the study|f||||t||||||||||2017-10-11 01:27:49.759682|2017-10-11 01:27:49.759682
NCT01907295|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-10-26|||February 2014||2014-02-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01|5 Years|Observational [Patient Registry]|NAIAD||National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension|National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension|Recruiting||N/A|3600|Anticipated|University of Cambridge|||2||f||||t||||||Samples With DNA|"     All subjects will have a sample of blood taken for next generation genetic sequencing (up to     their entire genome). Samples will be sequenced to identify novel genetic mutations     associated with PAH. This blood sample will be taken once during the study   "|No|Consent for sharing of non identifiable study data for regulatory authorities and NHS trusts where it is relevant to taking part in this research.|2017-10-11 01:27:49.861712|2017-10-11 01:27:49.861712
NCT01907282|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-07-18|||January 2010||2010-01-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis|Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis|Completed||N/A|129|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:27:49.99255|2017-10-11 01:27:49.99255
NCT01907269|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-11-09|||August 2013||2013-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2015|Actual|2015-10-01||Interventional|APROPOS||A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care|Activating Patients to Reduce OsteoPOrosiS|Completed||N/A|2684|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 01:27:50.141673|2017-10-11 01:27:50.141673
NCT01907256|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-01-17|||December 2012||2012-12-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Comparing the Aesthetic Results of Two Common Incisions in External Rhinoplasty|Comparing the Aesthetic Results of Two Common Incisions in External Rhinoplasty A Randomized Trial|Completed||Phase 3|56|Anticipated|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:27:50.352258|2017-10-11 01:27:50.352258
NCT01907243|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-07-23|||May 2011||2011-05-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|||The Role of Spreader Flaps in Preventing of Nasal Obstruction|The Role of Spreader Flaps in Preventing of Nasal Obstruction in Primary Rhinoplasty: A Randomized-controlled Trial.|Completed||Phase 3|67|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:27:50.454176|2017-10-11 01:27:50.454176
NCT01907230|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2016-03-31|||July 2013||2013-07-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients|Propylactic Use of Entecavir for Biological Agents Associated Hepatitis B Virus Reactivation in Inflammatory Arthritis Patients: a Randomized Controlled Trial|Recruiting||Phase 4|220|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-11 01:27:50.545962|2017-10-11 01:27:50.545962
NCT01907204|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-01-24|||July 2013||2013-07-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional|||Evaluation of Inhaled Treatment in Sinusitis|Evaluation of Inhaled Corticosteroid Treatment in Sinusitis|Completed||Phase 2/Phase 3|50|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||3|||f||||f||||||||||2017-10-11 01:27:50.795138|2017-10-11 01:27:50.795138
NCT01907191|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-03-07|||July 2013||2013-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy|Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.|Recruiting||N/A|36|Anticipated|Saint Francis Care||2|||f||||t||||||||||2017-10-11 01:27:50.89728|2017-10-11 01:27:50.89728
NCT01907178|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-04-26|||July 2014||2014-07-01|April 2017|2017-04-01|June 16, 2015|Actual|2015-06-16|June 16, 2015|Actual|2015-06-16||Observational|||Postoperative Pain Management in Hospital and Following Discharge From Hospital.|Assessment of Postoperative Pain Management in Patients Undergoing Total Knee Arthroplasty Immediately After Surgery and Following Discharge From Hospital.|Completed||N/A|200|Actual|Saint Francis Care|||1||f||||f||||||||||2017-10-11 01:27:51.012232|2017-10-11 01:27:51.012232
NCT01907165|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-03-14|||October 10, 2013|Actual|2013-10-10|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|November 10, 2016|Actual|2016-11-10||Interventional|||Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide|A Pharmacodynamic Study of Proteasome Inhibition by Disulfiram in Patients With Glioblastoma|Active, not recruiting||Early Phase 1|21|Actual|Washington University School of Medicine||2|||f||||t|t|f|||f|||No||2017-10-11 01:27:51.097279|2017-10-11 01:27:51.097279
NCT01907152|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2014-05-15|||September 2013||2013-09-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Increase Protein Intake in Elderly|Increase Protein Intake in Elderly|Completed||N/A|106|Actual|Wageningen University and Research Centre||2|||f||||f||||||||||2017-10-11 01:27:51.204551|2017-10-11 01:27:51.204551
NCT01907139|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-02-01|||August 2013||2013-08-01|January 2016|2016-01-01|July 31, 2016|Actual|2016-07-31|July 31, 2016|Actual|2016-07-31||Interventional|||Comparative Efficacy Research of Robot-Assisted Therapy With and Without Constraint-Induced Therapy in Stroke Rehabilitation|Comparative Efficacy Research of Robot-Assisted Therapy With and Without Constraint-Induced Therapy in Stroke Rehabilitation: Does the Combined Therapy Improve Outcomes Compared With Monotherapy?|Completed||N/A|46|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation||4|||f||||f||||||||||2017-10-11 01:27:51.297366|2017-10-11 01:27:51.297366
NCT01907126|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-01-12|||September 2011||2011-09-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence|HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence|Completed||Phase 2|42|Actual|Brown University||2|||f||||t||||||||||2017-10-11 01:27:51.447765|2017-10-11 01:27:51.447765
NCT01907113|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-07-11|2014-05-16||July 2009||2009-07-01|July 2014|2014-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||The treated set included all patients who were dispensed study medication and were documented to have at least one dose of investigational treatment.|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment|Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single 50 mg Dose of BI 10773 in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Type 2 Diabetes and Normal Renal Function in a Monocentric, Open-label, Parallel-group, Phase 1 Trial|Completed||Phase 1|40|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 01:27:51.59188|2017-10-11 01:27:51.59188
NCT01907100|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-10-03|||September 19, 2013|Actual|2013-09-19|October 2017|2017-10-01|October 30, 2019|Anticipated|2019-10-30|October 30, 2019|Anticipated|2019-10-30||Interventional|||Nintedanib (BIBF 1120) in Mesothelioma|LUME-Meso: Double Blind, Randomised, Multicentre, Phase II/III Study of Nintedanib in Combination With Pemetrexed / Cisplatin Followed by Continuing Nintedanib Monotherapy Versus Placebo in Combination With Pemetrexed / Cisplatin Followed by Continuing Placebo Monotherapy for the Treatment of Patients With Unresectable Malignant Pleural Mesothelioma|Recruiting||Phase 3|537|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:27:52.809961|2017-10-11 01:27:52.809961
NCT01907087|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-04-25|||September 2013||2013-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease|A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease|Completed||Phase 1/Phase 2|24|Actual|BioMarin Pharmaceutical||1|||f||||t||||||||||2017-10-11 01:27:53.170162|2017-10-11 01:27:53.170162
NCT01907074|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2017-02-14|||July 2011||2011-07-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Quantitative Liver Function Tests Using Cholates|Quantitative Liver Function Tests Using Cholates|Recruiting||N/A|200|Anticipated|Baylor Research Institute|||1||f||||t||||||||No||2017-10-11 01:27:53.270245|2017-10-11 01:27:53.270245
NCT01907061|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-01-12|||July 2007||2007-07-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Acute Renal Failure Post Liver Transplantation|Acute Renal Failure Post Liver Transplantation: The Role of Cytokines and Oxidative Stress|Completed||N/A|30|Actual|Baylor Research Institute||3|||f||||t||||||||||2017-10-11 01:27:53.337246|2017-10-11 01:27:53.337246
NCT01907048|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-09-29|||September 15, 2014|Actual|2014-09-15|September 2017|2017-09-01|March 15, 2019|Anticipated|2019-03-15|December 15, 2018|Anticipated|2018-12-15||Observational|||Patient and Physician Knowledge of Key Safety Messages|Xarelto (Rivaroxaban) - Risk Minimisation Plan Evaluation: Patient and Physician Knowledge of Key Safety Messages|Recruiting||N/A|500|Anticipated|Bayer|||2||f||||f||||||||||2017-10-11 01:27:53.426963|2017-10-11 01:27:53.426963
NCT01907035|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2013-07-23|||August 2012||2012-08-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|September 2013|Anticipated|2013-09-01||Interventional|PSICCAPAD||Anxiety-depressive Disorder in Primary Care and Cognitive-behavioral Treatment|Improving Anxiety-depressive Disorder in Primary Care Applying a Cognitive-behavioral Treatment, Applied by Psychologists.|Unknown status|Recruiting|Phase 3|246|Anticipated|Basque Health Service||2|||f||||t||||||||||2017-10-11 01:27:53.5113|2017-10-11 01:27:53.5113
NCT01907022|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2015-03-11|||July 2013||2013-07-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|RELAX||Combined rTMS and Relaxation in Chronic Tinnitus|Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) in Combination With Relaxation Therapy in Patients With Chronic Tinnitus|Completed||N/A|42|Actual|University of Regensburg||1|||f||||f||||||||||2017-10-11 01:27:53.592873|2017-10-11 01:27:53.592873
NCT01907009|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-22|2015-09-07|||January 2013||2013-01-01|July 2013|2013-07-01|September 2017|Anticipated|2017-09-01|January 2016|Anticipated|2016-01-01||Interventional|MEL-CAP||A PHASEII STUDY EVALUATING INTRAVENOUS MELPHALAN WITH AUTOLOGOUS WHOLE BLOOD STEM CELL TRANSPLANTATION (PBSCT)OVER THREE CYCLES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (MEL-CAP).|A PHASEII STUDY EVALUATING INTRAVENOUS MELPHALAN WITH AUTOLOGOUS WHOLE BLOOD STEM CELL TRANSPLANTATION (PBSCT)OVER THREE CYCLES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (MEL-CAP).|Unknown status|Recruiting|Phase 2/Phase 3|39|Anticipated|Barts & The London NHS Trust||1|||f||||t||||||||||2017-10-11 01:27:53.670803|2017-10-11 01:27:53.670803
NCT01906996|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-02-26|||July 2013||2013-07-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Proximal Row Carpectomy Versus Four Corner Fusion|Comparison of Subjective, Radiological and Functional Results After Proximal Row Carpectomy and Four Corner Fusion|Completed||N/A|114|Anticipated|Schulthess Klinik|||2||f||||f||||||||||2017-10-11 01:27:53.755016|2017-10-11 01:27:53.755016
NCT01906983|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2015-08-25|||July 2013||2013-07-01|August 2015|2015-08-01||||August 2015|Anticipated|2015-08-01|3 Months|Observational [Patient Registry]|||Evaluation of Portal Venous System Thrombosis After Blunt Splenic Trauma Utilizing Doppler Ultrasound|Evaluation of Portal Venous System Thrombosis After Blunt Splenic Trauma Utilizing Doppler Ultrasound|Unknown status|Recruiting|N/A|80|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 01:27:53.834227|2017-10-11 01:27:53.834227
NCT01906177|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-03-20|||July 2012||2012-07-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||A Prospective Munti-center Study on VANGUARD™ PS Total Knee Replacement System|A Prospective Munti-center Study on VANGUARD™ PS Total Knee Replacement System|Active, not recruiting||N/A|100|Anticipated|Zimmer Biomet|||1||f||||f||||||||Yes||2017-10-11 01:28:04.369312|2017-10-11 01:28:04.369312
NCT01906970|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-05-03|||June 19, 2013|Actual|2013-06-19|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Experimental Study 2|Clinical Experimental Study 2, to Further Investigate the Measurement Accuracy, Glucose Control Quality, Safety, Handling and Functionality of ClampArt® and Its Influence on Pharmacodynamic Parameters in Glucose Clamps|Active, not recruiting||N/A|70|Anticipated|Profil Institut für Stoffwechselforschung GmbH||1|||f||||f||||||||||2017-10-11 01:27:55.608748|2017-10-11 01:27:55.608748
NCT01906957|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2015-08-24|||September 2013||2013-09-01|August 2015|2015-08-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|COGNEX-2||Cognition and Exercise Training|Cerebral Oxygenation, Cardiac Output,Cognitive Function, and Exercise Training in Patients With Metabolic Syndrome, Coronary Heart Disease and Chronic Heart Failure.|Recruiting||N/A|160|Anticipated|Montreal Heart Institute||4|||f||||t||||||||||2017-10-11 01:27:55.672991|2017-10-11 01:27:55.672991
NCT01906944|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-11-08|||January 2012||2012-01-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain|Ultrasound Guided Transversus Abdominis Plane Block vs. Trigger Point Injection for Abdominal Wall Pain: A Randomized Comparative Trial|Recruiting||Phase 2|60|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:27:55.779073|2017-10-11 01:27:55.779073
NCT01906931|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-06-23|||August 2013||2013-08-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Ambulatory Oxygen for ILD|Effective Delivery of Ambulatory Oxygen in Interstitial Lung Disease - a Crossover Trial.|Completed||Phase 2|10|Anticipated|The Alfred||2|||f||||f||||||||||2017-10-11 01:27:55.90244|2017-10-11 01:27:55.90244
NCT01906918|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2013-11-27|||August 2013||2013-08-01|November 2013|2013-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Application of Remote Ischemic Preconditioning in Patients Undergoing Open Heart Surgeries|Evaluation of Remote Preconditioning on Heart Resistance to Ischemia and Reperfusion Injury|Unknown status|Recruiting|N/A|120|Anticipated|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 01:27:55.99811|2017-10-11 01:27:55.99811
NCT01906905|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-12-02|||June 2013||2013-06-01|December 2014|2014-12-01||||July 2018|Anticipated|2018-07-01||Interventional|||A Comparative Trial of TMS Approaches to Treating Depression|A Comparative Trial of TMS Approaches to Treating Depression|Recruiting||Phase 4|||The University of New South Wales||3|||f||||f||||||||||2017-10-11 01:27:56.110222|2017-10-11 01:27:56.110222
NCT01906892|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2015-11-25|||November 2013||2013-11-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Creative Practice as Mutual Recovery|Creative Practice as Mutual Recovery: Connecting Communities for Mental Health and Wellbeing|Completed||N/A|150|Actual|Royal College of Music||8|||f||||t||||||||||2017-10-11 01:27:56.212845|2017-10-11 01:27:56.212845
NCT01906879|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2017-06-09|||June 2013||2013-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection|Comparison of the Efficacy of Clarithromycin-based Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial|Recruiting||Phase 4|1620|Anticipated|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-11 01:27:56.333693|2017-10-11 01:27:56.333693
NCT01906866|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-07-11|||October 2013||2013-10-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities|A Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Circadin® to Alleviate Sleep Disturbances in Children With Neurodevelopmental Disabilities|Active, not recruiting||Phase 3|125|Actual|Neurim Pharmaceuticals Ltd.||2|||f||||t||||||||||2017-10-11 01:27:56.530333|2017-10-11 01:27:56.530333
NCT01906853|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2016-09-13|||July 2013||2013-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|MIS BAIR||Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction|A Randomised, Controlled Trial to Determine if BCG Immunisation at Birth Reduces Allergy and Infection in Infants|Active, not recruiting||Phase 3|1438|Anticipated|Murdoch Childrens Research Institute||2|||f||||f||||||||||2017-10-11 01:27:56.868386|2017-10-11 01:27:56.868386
NCT01906840|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2013-07-23|||April 2011||2011-04-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Role of Turmeric on Oxidative Modulation in ESRD Patients|Evaluate the Effects of Turmeric on Oxidative Stress Markers in HD Patients|Completed||Phase 1/Phase 2|48|Actual|Shiraz University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:27:56.996459|2017-10-11 01:27:56.996459
NCT01906827|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2014-03-16|||July 2013||2013-07-01|July 2013|2013-07-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Observational|||P-wave Duration and Dispersion in Intrahepatic Cholestasis of Pregnancy||Unknown status|Recruiting|N/A|90|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||1||f||||f||||||||||2017-10-11 01:27:57.095403|2017-10-11 01:27:57.095403
NCT01906814|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2015-12-09|||January 2013||2013-01-01|December 2015|2015-12-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation|Three Cycles Versus Six Cycles of Adjuvant Chemotherapy for the Patients With High-risk Retinoblastoma After Enucleation: Prospective Randomized Control Study|Recruiting||Phase 3|156|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:27:57.215877|2017-10-11 01:27:57.215877
NCT01906801|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2017-05-25|||July 2013||2013-07-01|May 2017|2017-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Clinical Efficacy of Glucosamine Plus Diacerein Versus Mono-therapy of Glucosamine||Completed||Phase 4|148|Actual|Ramathibodi Hospital||2|||f||||t||||||||||2017-10-11 01:27:57.331446|2017-10-11 01:27:57.331446
NCT01906788|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2013-07-23|||May 2013||2013-05-01|July 2013|2013-07-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy|THE OPTIMAL TIMING OF PRIMAQUINE TO PREVENT MALARIA TRANSMISSION AFTER ARTEMISININ-COMBINATION THERAPY|Unknown status|Recruiting|Phase 4|250|Anticipated|Kilimanjaro Clinical Research Institute||3|||f||||t||||||||||2017-10-11 01:27:57.443093|2017-10-11 01:27:57.443093
NCT01906775|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2013-07-23|||June 2003||2003-06-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|September 2012|Actual|2012-09-01||Observational|||Sub-threshold Pacing to Prevent Pacemaker-induced Ventricular Tachycardia|Sub-threshold Ventricular Back-up Pacing to Prevent Pacemaker-induced Ventricular Tachycardia|Completed||N/A|550|Actual|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-11 01:27:57.558073|2017-10-11 01:27:57.558073
NCT01906762|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2013-07-20|||July 2012||2012-07-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||Comparing the Analgesic Effect of Intravenous Acetaminophen and Morphine on Patients With Renal Colic Pain Reffering to the Emergency Department: A Randomized Controlled Trial|Comparing the Effect of Intravenous Morphine and Injectable Acetaminophen on Renal Colic Patients Presenting to the Emergency Department: A Randomized Controlled Trial|Completed||Phase 2|124|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:27:57.646072|2017-10-11 01:27:57.646072
NCT01906749|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2013-07-23|||June 2013||2013-06-01|July 2013|2013-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|COACS||Colchicine for Acute Coronary Syndromes|Colchicine for Acute Coronary Syndromes. A Multicenter Double Blind Randomized Trial.|Unknown status|Recruiting|Phase 4|500|Anticipated|Maria Vittoria Hospital||2|||f||||t||||||||||2017-10-11 01:27:57.73237|2017-10-11 01:27:57.73237
NCT01906736|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2015-07-15|||July 2013||2013-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:27:57.844078|2017-10-11 01:27:57.844078
NCT01906723|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2016-01-04|||August 2013||2013-08-01|July 2013|2013-07-01||||August 2014|Actual|2014-08-01||Interventional|||Evaluation of the Effectiveness of a Novel Gait Trainer in Increasing the Functionality of Motor Impaired Patients: Pilot Study|Evaluation of the Effectiveness of a Novel Gait Trainer in Increasing the Functionality of Motor Impaired Patients: Pilot Study|Completed||N/A|4|Actual|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 01:27:57.889578|2017-10-11 01:27:57.889578
NCT01906710|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-21|||January 2013||2013-01-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|PITH||the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes|The Effect of Patient Centered Medication Reconciliation, Medication Review and Discharge Counseling With Information Transfer in Hospitalized Patients on Clinical and Economic Parameters: a Multicentre, Before-after Study.|Unknown status|Recruiting|N/A|1200|Anticipated|Dutch Society of Outpatient Pharmacies||2|||f||||f||||||||||2017-10-11 01:27:57.963431|2017-10-11 01:27:57.963431
NCT01906697|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-23|||May 2011||2011-05-01|July 2013|2013-07-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||The Effect of RF Turbinoplasty in Polypoid Change of Middle Turbinates|The Effect of RF Turbinoplasty Versus Two Other Methods in Management of Polypoid Change of Middle Turbinates: A Randomized Trial.|Unknown status|Active, not recruiting|Phase 3|90|Anticipated|Tehran University of Medical Sciences||3|||f||||f||||||||||2017-10-11 01:27:58.088044|2017-10-11 01:27:58.088044
NCT01906684|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-31|||August 2013||2013-08-01|July 2013|2013-07-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Comprehensive Analysis of Relapse in Multiple Sclerosis|Comprehensive Analysis of Relapse in Multiple Sclerosis|Unknown status|Not yet recruiting|N/A|20|Anticipated|Tanner Foundation for Multiple Sclerosis||1|||f||||f||||||||||2017-10-11 01:27:58.169054|2017-10-11 01:27:58.169054
NCT01906671|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-05-10|||June 2013|Actual|2013-06-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid|Plasma Kinetics of Tablet and Liquid Formulations of 6-mercaptopurine in Childhood Acute Lymphoblastic Leukemia.|Recruiting||Phase 4|16|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||Undecided||2017-10-11 01:27:58.253948|2017-10-11 01:27:58.253948
NCT01906658|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-11-08|2016-11-08||July 2013||2013-07-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis|A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis|Completed||Phase 2|43|Actual|Mallinckrodt||4|||f||||f||||||||||2017-10-11 01:27:58.372848|2017-10-11 01:27:58.372848
NCT01906645|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-19|||November 2010||2010-11-01|July 2013|2013-07-01||||March 2012|Actual|2012-03-01||Interventional|||Care Transitions Innovation (C-TraIn)|Care Transitions Innovation (C-TraIn): Study of a Multi-component Transitional Care Intervention for Uninsured and Low-income Publicly Insured Adults|Completed||N/A|382|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:27:59.130772|2017-10-11 01:27:59.130772
NCT01906632|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-21|2017-02-03|||May 2013||2013-05-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy||Recruiting||N/A|50|Anticipated|Capital Medical University||1|||f||||f||||||||||2017-10-11 01:27:59.216267|2017-10-11 01:27:59.216267
NCT01906619|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2013-07-23|||July 2011||2011-07-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Observational|||Respiratory Physiology in Children With Febrile Seizures.|Investigation of the Respiratory Physiology of Children With and Without Febrile Seizures During Febrile Illness.|Unknown status|Recruiting|N/A|100|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 01:27:59.327589|2017-10-11 01:27:59.327589
NCT01906606|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-03-17|||January 2013||2013-01-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Effectiveness of Parenting Programs on Child Development and Maternal Well-being in Rural Uganda|Effectiveness of Parenting Programs on Child Development and Maternal Well-being in Rural Uganda|Completed||N/A|360|Actual|McGill University||2|||f||||f||||||||||2017-10-11 01:27:59.471768|2017-10-11 01:27:59.471768
NCT01906593|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2013-07-20|||June 2013||2013-06-01|March 2013|2013-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01|1 Year|Observational [Patient Registry]|||A Post-marketing Safety Study of Beijing Tiantan Biological's Influenza Virus Vaccine in Elderly|A Post-marketing Study to Monitor the Safety of Beijing Tiantan Biological's Influenza Virus Vaccine Administered in Chinese Subjects Aged 60 Years or Older|Completed||N/A|536812|Actual|Centers for Disease Control and Prevention, China|||2||f||||t||||||||||2017-10-11 01:27:59.560651|2017-10-11 01:27:59.560651
NCT01906580|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-08-14|||July 2011||2011-07-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B|Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Hepatitis B e Antigen-positive Patients With Chronic Hepatitis B|Unknown status|Recruiting|Phase 4|105|Anticipated|Beijing 302 Hospital||3|||f||||t||||||||||2017-10-11 01:27:59.642001|2017-10-11 01:27:59.642001
NCT01906567|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2013-08-04|||July 2013||2013-07-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01|6 Months|Observational [Patient Registry]|||İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels?||Unknown status|Recruiting|N/A|90|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||3||f||||f||||||None Retained|"     maternal whole blood maternal hair umbilical whole blood   "|||2017-10-11 01:27:59.775178|2017-10-11 01:27:59.775178
NCT01906554|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-07-20|||October 2012||2012-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||Plasma and Urine TMAO Formation and Changes to Oxidized LDL After Ingestion of Different Amounts of Egg|Determining Whether or Not Egg Ingestion Increases Concentrations of Trimethylamine N-oxide (TMAO) in Plasma and Urine and Activates LDL Oxidation in Humans|Completed||N/A|6|Actual|University of North Carolina, Chapel Hill||1|||f||||||||||||||2017-10-11 01:27:59.872793|2017-10-11 01:27:59.872793
NCT01906541|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-08-01|||July 2013||2013-07-01|August 2013|2013-08-01|December 2019|Anticipated|2019-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Gene Therapy for X-CGD|A Phase I/II Gene Therapy Trial for X-CGD With a SIN Gammaretroviral Vector|Recruiting||Phase 1/Phase 2|5|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||t||||||||||2017-10-11 01:27:59.963082|2017-10-11 01:27:59.963082
NCT01906528|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-04-09|||March 2013||2013-03-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium|The Pharmacodynamics of Mivacurium in Males and Females: A Study in Human Volunteers|Completed||Phase 1|20|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 01:28:00.078605|2017-10-11 01:28:00.078605
NCT01906515|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2014-01-24|2013-09-24||February 2012||2012-02-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Impact of SpHb Monitoring on Transfusion|Continuous and Noninvasive Hemoglobin Monitoring Reduces Red Blood Cell Transfusion During Neurosurgery: A Prospective Cohort Study|Completed||N/A|106|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 01:28:00.184255|2017-10-11 01:28:00.184255
NCT01906502|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-08-25|||July 2013||2013-07-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||24-hour IOP Pattern With SENSIMED Triggerfish® in a Healthy Population|A Prospective, Open Label Study to Assess the 24-hour IOP Pattern Recorded With SENSIMED Triggerfish® in a Healthy Population|Completed||N/A|115|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 01:28:01.002866|2017-10-11 01:28:01.002866
NCT01906489|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-20|2016-03-29||2014-11-12|July 2013||2013-07-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||20-Week Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia|Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Assess the Pharmacodynamic Response, Safety, and Tolerability to 20 Weeks of Oral Dosing of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), GFR Categories G3a-G5 (Stages 3, 4, AND 5) (Pre-Dialysis)|Completed||Phase 2|210|Actual|Akebia Therapeutics||2|||f||||f||||||||||2017-10-11 01:28:01.140855|2017-10-11 01:28:01.140855
NCT01906476|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-09-14|||February 2015||2015-02-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Stepped Telemental Health Care Intervention for Depression|Stepped Telemental Health Care Intervention for Depression|Active, not recruiting||N/A|312|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:28:01.390216|2017-10-11 01:28:01.390216
NCT01906463|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-17|||July 2011||2011-07-01|July 2013|2013-07-01||||December 2014|Anticipated|2014-12-01||Observational|INDIA||Social and Prognostic Inequalities in Patients Hospitalised for Cerebrovascular Accident (CVA) in Four Contrasting French Departments|Social and Prognostic Inequalities in Patients Hospitalised for Cerebrovascular Accident (CVA) in Four Contrasting French Departments: Côte d'Or, Martinique, Guadeloupe and French Guyana Analysis of Their Impact on Vascular Risk Factors and the Management of CVA|Unknown status|Recruiting|N/A|1500|Anticipated|Centre Hospitalier Universitaire Dijon|||1||f||||f||||||||||2017-10-11 01:28:01.489711|2017-10-11 01:28:01.489711
NCT01906450|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-07-19|||May 2013||2013-05-01|July 2013|2013-07-01|January 2014|Anticipated|2014-01-01|September 2013|Anticipated|2013-09-01||Interventional|||STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.|STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.|Unknown status|Active, not recruiting|N/A|75|Actual|Universidad del Valle, Colombia||3|||f||||||||||||||2017-10-11 01:28:01.567765|2017-10-11 01:28:01.567765
NCT01906437|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-03-21|||March 2013||2013-03-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Cardiac Fibrosis by CMR in Patients With Cancer|Non-invasive Detection of Cardiac Fibrosis After Administration of Doxorubicin-based Chemotherapy in Patients With Lymphoma Using Cardiac Magnetic Resonance|Completed||N/A|10|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:28:01.651434|2017-10-11 01:28:01.651434
NCT01906424|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-01-20|||April 2016||2016-04-01|April 2016|2016-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Restoring Arm and Hand Function With Non-invasive Spinal Stimulation|Restoring Arm and Hand Function With Non-invasive Spinal Stimulation|Completed||N/A|7|Actual|NeuroEnabling Technologies, Inc.||3|||f||||t||||||||||2017-10-11 01:28:01.747903|2017-10-11 01:28:01.747903
NCT01906411|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-05-28||||||May 2015|2015-05-01||||March 2014|Actual|2014-03-01||Observational|||Dopaminergic Function and Food Reward||Completed||N/A|36|Actual|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-11 01:28:01.838998|2017-10-11 01:28:01.838998
NCT01906398|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-03-22|||January 2013||2013-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KD||Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy|Evaluation of the Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy: a Pilot Study.|Active, not recruiting||Phase 2|30|Anticipated|Mid-Atlantic Epilepsy and Sleep Center, LLC||1|||f||||f||||||||Undecided||2017-10-11 01:28:01.909498|2017-10-11 01:28:01.909498
NCT01906372|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-08-02|2017-01-17||September 2013||2013-09-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|September 2015|Actual|2015-09-01||Interventional||A total of 12 participants were enrolled however only 11 participants were assessed for baseline characteristics due to one subject withdrawing after screening and never received study drug.|Acthar in Treatment of Refractory Dermatomyositis and Polymyositis|Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis|Completed||Phase 2|12|Actual|University of Pittsburgh|Small pilot open label single arm trial. Larger double blinded placebo controlled randomized trials are required.|1|||f||||f||||||||||2017-10-11 01:28:02.162963|2017-10-11 01:28:02.162963
NCT01906359|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2015-10-09|||September 2012||2012-09-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers|The Acute Effects of Triacylglycerol Structure of Dietary Fats on Gut Hormones and Haemostatic Markers in Subjects With Type 2 Diabetes Mellitus|Completed||N/A|23|Actual|Malaysia Palm Oil Board||3|||f||||f||||||||||2017-10-11 01:28:02.646845|2017-10-11 01:28:02.646845
NCT01906346|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-03-07|||January 2014||2014-01-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Impact of a Non-Drug Choice on Cocaine Reinforcement|Impact of a Non-Drug Choice on Cocaine Reinforcement|Completed||Early Phase 1|8|Actual|University of Kentucky||3|||f||||f||||||||||2017-10-11 01:28:02.77664|2017-10-11 01:28:02.77664
NCT01906333|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2015-05-27|||May 2013||2013-05-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Elevated FFA and Skeletal Muscle Lipid Content|Effects of Acute Elevation of Circulating Fatty Acids on Skeletal Muscle Lipid Accumulation and Metabolism in Healthy Lean Young Men|Completed||N/A|12|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 01:28:02.895505|2017-10-11 01:28:02.895505
NCT01906320|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-19|||January 2009||2009-01-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effects of a High Intensity Resistance Training in Muscular Strength, Agility, and Body Composition of Anorexia Nervosa Restricting Type Patients||Completed||N/A|36|Actual|Universidad Europea de Madrid||2|||f||||t||||||||||2017-10-11 01:28:02.989175|2017-10-11 01:28:02.989175
NCT01906307|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-03-01|||March 2014||2014-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome|A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome|Terminated||Phase 1|6|Actual|La Jolla Pharmaceutical Company||1||Corporate decision|f||||f||||||||||2017-10-11 01:28:03.085088|2017-10-11 01:28:03.085088
NCT01906294|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-04-08|||August 2013||2013-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|10 Years|Observational [Patient Registry]|||IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus|Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus|Terminated||N/A|2104|Actual|IMS HEALTH GmbH & Co. OHG|||1|Representativeness and results about treatment and health condition available|f||||f||||||||||2017-10-11 01:28:03.224495|2017-10-11 01:28:03.224495
NCT01906281|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2013-11-07|||July 2013||2013-07-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|||Influence of Adipocytokines in Osteoarthritis|Adipocytokines Influence on Clinical and Ultrasonographic Inflammatory Activity in Patients With Knee Osteoarthritis|Unknown status|Recruiting|N/A|105|Anticipated|Hospital Parc Taulí, Sabadell|||2||f||||t||||||Samples With DNA|"     First we analyze the blood and articular fluid adipocytokines. If we can define a subset of     patients characterized by a pattern of adipocytokines, genetic analysis will be performed     later.   "|||2017-10-11 01:28:03.337152|2017-10-11 01:28:03.337152
NCT01906268|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-07-17|||July 2013||2013-07-01|July 2014|2014-07-01||||December 2014|Anticipated|2014-12-01||Interventional|||Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants|Attentional Bias Modification Treatment (ABMT) as Adjuvant Therapy for Anxiety Disorder Patients Resistent to Antidepressants: A Randomized Clinical Trial|Unknown status|Recruiting|N/A|60|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||||||||||||2017-10-11 01:28:03.485202|2017-10-11 01:28:03.485202
NCT01906255|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-09-29|||October 7, 2013|Actual|2013-10-07|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada® for PrEP: A Case Control Study|Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada® for PrEP: A Case Control Study|Recruiting||N/A|7000|Anticipated|Gilead Sciences|||1||f||||f||||||||||2017-10-11 01:28:03.657687|2017-10-11 01:28:03.657687
NCT01906242|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-02-23|||April 2013||2013-04-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Hygiene Protocol of Complete Dentures|Hygiene Protocols for Cleaning Complete Dentures|Completed||N/A|40|Anticipated|Federal University of Pelotas||4|||f||||f||||||||||2017-10-11 01:28:03.75619|2017-10-11 01:28:03.75619
NCT01906229|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-02-23|||July 2013||2013-07-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Observational|||Lung and Systemic Inflammation in the Critically Ill Patient|Acute Pulmonary and Systemic Inflammation in Mechanically Ventilated Intensive Care Patients|Recruiting||N/A|18|Anticipated|Rigshospitalet, Denmark|||3||f||||t||||||||||2017-10-11 01:28:03.871027|2017-10-11 01:28:03.871027
NCT01906216|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-08-21|||September 2013||2013-09-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|SELECT||Sorafenib Chemoembolization Evaluation Controlled Trial|Sorafenib With or Without Transarterial Chemoembolization (TACE) in Advanced Hepatocellular Carcinoma : A Multicenter, Randomized, Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|246|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-11 01:28:03.95002|2017-10-11 01:28:03.95002
NCT01906203|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-11-25|||May 2013||2013-05-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|IMPETRAIL||Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance|Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance|Completed||N/A|200|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 01:28:04.110791|2017-10-11 01:28:04.110791
NCT01906190|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-19|||August 2011||2011-08-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||Persistence of Immune Response After Vaccination With Influenza Vaccine|Persistence Study of Immune Response After Vaccination With Influenza Vaccine in Healthy Population|Completed||N/A|207|Actual|Centers for Disease Control and Prevention, China||1|||f||||t||||||||||2017-10-11 01:28:04.22745|2017-10-11 01:28:04.22745
NCT01906164|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-05-13|||May 2013||2013-05-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-Part Study of Orally Administered ALS-008176 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosing, Multiple Ascending Dosing and Food-effect in Healthy Volunteers|Completed||Phase 1|101|Actual|Alios Biopharma Inc.||2|||f||||f||||||||||2017-10-11 01:28:04.503782|2017-10-11 01:28:04.503782
NCT01906151|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2014-05-12|||January 2014||2014-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||IOP Pattern in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After LPI|A Prospective, Open Label Study Assessing the 24-hour Intraocular Pressure Pattern Monitored by SENSIMED Triggerfish® in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After Laser Peripheral Iridotomy|Withdrawn||N/A|0|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 01:28:04.651523|2017-10-11 01:28:04.651523
NCT01906138|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2014-08-25|||July 2013||2013-07-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||An Open Label Study Assessing the 24-hour Intraocular Pressure Pattern in PAC and PACG Patients, Before and After Laser Peripheral Iridotomy|A Prospective, Open Label Study Assessing the 24-hour Intraocular Pressure Pattern Monitored by SENSIMED Triggerfish® in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After Laser Peripheral Iridotomy|Completed||N/A|27|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 01:28:04.781119|2017-10-11 01:28:04.781119
NCT01906125|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-01-17|||September 2013||2013-09-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product|A Phase 1, Open-Label 3 Sequence 3 Period Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Establish The Bioequivalence Of The Phase 1/2 And Phase 3 Formulation To Palbociclib ICH Formulation Under Fasted Conditions|Completed||Phase 1|73|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:28:05.424548|2017-10-11 01:28:05.424548
NCT01906112|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-02-26|||August 2013||2013-08-01|February 2015|2015-02-01|August 2019|Anticipated|2019-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.|Role of Surgery for the Primary in Patients With Breast Cancer Stage IV - A Prospective Randomized Multicenter Controlled Trial|Withdrawn||Phase 3|0|Actual|National Cancer Institute, Thailand||2||Low accrual and no further funding.|f||||t||||||||||2017-10-11 01:28:05.555514|2017-10-11 01:28:05.555514
NCT01906099|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-18|||September 2012||2012-09-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Legume Intake on Cardiovascular Risk Factors Among Adults at Risk for Diabetes||Completed||N/A|26|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:28:05.692813|2017-10-11 01:28:05.692813
NCT01906086|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2014-05-16|||September 2012||2012-09-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among Adults|Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among First Degree Relatives of Diabetic Patients|Completed||N/A|26|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:28:05.798651|2017-10-11 01:28:05.798651
NCT01906073|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-01-04|||January 2017||2017-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Interventional|NFCP-2||Nasal Fentanyl for Chronic Cancer Pain|An Open Label, Cross-over, Randomized Controlled Multicenter Phase III Study Comparing Standard Oral SR-morphine by the Clock Medications With Self-controlled Nasal Fentanyl for Chronic Cancer Pain Requiring Opioids|Recruiting||Phase 3|108|Anticipated|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-10-11 01:28:05.886082|2017-10-11 01:28:05.886082
NCT01906060|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-06-28|||July 2013||2013-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Blind Intubation Through The Self-Pressurised Disposable Air-Q Laryngeal Intubation Mask: An International Multicentre Trial||Completed||Phase 4|1000|Actual|University of Zurich||1|||f||||||||||||||2017-10-11 01:28:06.033915|2017-10-11 01:28:06.033915
NCT01906047|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-07-18|||June 2006||2006-06-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01|6 Years|Observational [Patient Registry]|||Impact of Chronic Air Pollution on Non-cystic Fibrosis Bronchiectasis|Impact of Chronic Air Pollution on Non-cystic Fibrosis Bronchiectasis|Completed||N/A|189|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:28:06.165168|2017-10-11 01:28:06.165168
NCT01906034|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-03-19|||September 2013||2013-09-01|March 2017|2017-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of a Fall Preventive Exercise Program on Intrinsic Fall Risk Factors in Healthy Older Adults.|Effects of a Fall Preventive Exercise Program on Intrinsic Fall Risk Factors in Healthy Older Adults.|Completed||N/A|66|Actual|University of Potsdam||3|||f||||f||||||||||2017-10-11 01:28:06.247981|2017-10-11 01:28:06.247981
NCT01906021|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-06-30|||July 16, 2013||2013-07-16|January 23, 2017|2017-01-23|August 5, 2015|Actual|2015-08-05|August 1, 2015|Actual|2015-08-01||Interventional|||Study of New Software Used During Ablations|Prospective Pilot Observational Study Examining Cone Beam CT and CT Thermometry During Ablations|Completed||Phase 2|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:28:06.339043|2017-10-11 01:28:06.339043
NCT01906008|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-03-31|||November 2013|Actual|2013-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients|Phase II, Randomized, Placebo-Controlled Study of Minocycline for Reducing Symptom Burden in Patients With Colorectal Cancer|Active, not recruiting||Phase 2|122|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:28:06.437209|2017-10-11 01:28:06.437209
NCT01905995|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-07-22|||July 2013||2013-07-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|||Basal Ganglia Local Field Potentials in Gait and Speech|Recording of Gait and Speech Related Neurophysiological Parameters With an Implantable Bi-directional Deep Brain Stimulation System in Parkinson's Disease|Unknown status|Recruiting|N/A|10|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||||2017-10-11 01:28:06.566897|2017-10-11 01:28:06.566897
NCT01905982|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-10-07|||January 2016||2016-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2|The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea, Activity and Parasympathetic Activities in Patients With COPD III-IV|Recruiting||N/A|44|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 01:28:06.654575|2017-10-11 01:28:06.654575
NCT01905969|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2015-03-24|||October 2012||2012-10-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2014|Actual|2014-03-01||Observational|NJBMR||Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy|Retrospective Validation for Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy With S-1|Unknown status|Active, not recruiting|N/A|500|Anticipated|Iwate Medical University|||2||f||||f||||||Samples With DNA|"     Archived paraffin blocks   "|||2017-10-11 01:28:06.768636|2017-10-11 01:28:06.768636
NCT01905956|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-02-10|2016-01-04||July 2013||2013-07-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety and Efficacy of IQP- AK-102 in Reducing Body Weight|Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate Safety and Efficacy of IQP- AK-102 in Reducing Body Weight in Overweight and Obese Subjects|Completed||Phase 3|119|Actual|InQpharm Group||2|||f||||f||||||||No||2017-10-11 01:28:06.849074|2017-10-11 01:28:06.849074
NCT01905930|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-05-19|||April 2013||2013-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Post-Approval Clinical Trial of the PCM® Cervical Disc|A Prospective, Randomized, Multi-Center, Post-Approval Clinical Trial Evaluating the Long-Term (7 Year) Safety and Effectiveness of the PCM® Cervical Disc|Completed||Phase 3|494|Actual|NuVasive||2|||f||||f||||||||||2017-10-11 01:28:08.163003|2017-10-11 01:28:08.163003
NCT01905917|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-09-12|||November 2013||2013-11-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|March 2017|Actual|2017-03-01||Interventional|STARS||The Singapore Tele-technology Aided Rehabilitation in Stroke (STARS) Study|The Singapore Tele-technology Aided Rehabilitation in Stroke (STARS) Study: A Randomized Controlled Trial|Completed||N/A|124|Actual|National University, Singapore||2|||f||||f||||||||||2017-10-11 01:28:08.299797|2017-10-11 01:28:08.299797
NCT01905904|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-07-22|||March 2013||2013-03-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Sevoflurane in Electroconvulsive Therapy|The Comparision of Different Doses of Sevoflurane for Induction of General Anesthesia in Electroconvulsive Therapy|Completed||Phase 4|25|Actual|Inonu University||2|||f||||f||||||||||2017-10-11 01:28:08.408346|2017-10-11 01:28:08.408346
NCT01905891|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-11-17|||July 2013||2013-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Nanocytology Test to Evaluate Skin Cancer in High Risk Patients|Nanocytology Evaluation of Epidermal Cells to Assess Risk of Squamous Cell Carcinoma and Field Cancerization in High Risk Patients|Completed||N/A|7|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:28:08.499531|2017-10-11 01:28:08.499531
NCT01905878|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-05-11|||June 2013|Actual|2013-06-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Biological Half Life of DLBS1033 in Healthy Volunteers|Biological Half Life of DLBS1033 in Healthy Volunteers|Completed||Phase 1/Phase 2|14|Actual|Indonesia University||2|||f||||t||||||||||2017-10-11 01:28:08.593425|2017-10-11 01:28:08.593425
NCT01905865|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-06-30|||June 12, 2013||2013-06-12|January 9, 2017|2017-01-09|June 12, 2013|Actual|2013-06-12|June 12, 2013|Actual|2013-06-12||Observational|||The Role of Uncertainty in Coping: The Experience of Parents of Children With Undiagnosed Medical Conditions|The Role of Uncertainty in Coping Efficacy: The Experience of Parents of Children With Undiagnosed Medical Conditions|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:28:08.670529|2017-10-11 01:28:08.670529
NCT01905852|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-06-30|||June 27, 2013||2013-06-27|April 8, 2014|2014-04-08|December 31, 2016|Anticipated|2016-12-31|December 31, 2016|Anticipated|2016-12-31||Observational|||Use of Cardiac-MRI to Predict Results for People With Severe Aortic Stenosis|Utilization of Cardiac Magnetic Resonance Imaging to Predict Clinical Outcomes of Patients With Severe Aortic Stenosis|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:28:08.751056|2017-10-11 01:28:08.751056
NCT01905839|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-06-30|||June 18, 2013||2013-06-18|April 15, 2015|2015-04-15|April 15, 2015|Actual|2015-04-15|April 15, 2015|Actual|2015-04-15||Observational|||A Study of Movement Disorders Using the QMAT At-Home Testing Device|A Longitudinal Study Assessing the Pathophysiology of Movement Disorders Utilizing the QMAT at Home Testing Device|Terminated||N/A|3|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:28:08.842374|2017-10-11 01:28:08.842374
NCT01905826|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-07-13|||June 3, 2013||2013-06-03|July 12, 2017|2017-07-12|January 1, 2040|Anticipated|2040-01-01|March 1, 2028|Anticipated|2028-03-01||Observational|||Natural History Study of GATA2 Deficiency and Related Disorders|The Natural History of GATA2 Deficiency and Related Disorders|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:28:08.923127|2017-10-11 01:28:08.923127
NCT01905813|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-04-18|||June 2013||2013-06-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies|A Phase 1, Open-label, Dose Escalation, Safety and Tolerability Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies|Active, not recruiting||Phase 1|121|Actual|Incyte Corporation||2|||f||||f||||||||||2017-10-11 01:28:09.024862|2017-10-11 01:28:09.024862
NCT01905800|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-08-08|||August 2013||2013-08-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||BPPV Treatment in Biaxial Rotational Chair|Randomized Multicenter Study of Benign Paroxysmal Positional Vertigo Treatment in Biaxial Rotational Chair|Completed||N/A|170|Actual|Haukeland University Hospital||4|||f||||t||||||||||2017-10-11 01:28:09.122209|2017-10-11 01:28:09.122209
NCT01905787|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-08-08|||January 2012||2012-01-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study|Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study. Clinical and Genetic Characteristics of Sickle Cell Anemia (SCA) Patients in Three Different Communities.|Recruiting||N/A|300|Anticipated|HaEmek Medical Center, Israel|||4||f||||f||||||||||2017-10-11 01:28:09.216455|2017-10-11 01:28:09.216455
NCT01905774|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-08-30|||March 2011||2011-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Observational|||Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox|Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox|Completed||N/A|36|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-11 01:28:09.318813|2017-10-11 01:28:09.318813
NCT01905761|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-11-23|||February 2013||2013-02-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||UMP Lifestyle Medicine Program|UMP Lifestyle Medicine Program|Active, not recruiting||N/A|300|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 01:28:09.405119|2017-10-11 01:28:09.405119
NCT01905748|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-08-08|||August 2011||2011-08-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine|Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine, Laboratory Investigations in Steady State and During Migraine Attack|Enrolling by invitation||N/A|15|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-11 01:28:09.470989|2017-10-11 01:28:09.470989
NCT01905735|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-08-01|||August 2013||2013-08-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|||A Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis|A Multicentric,Double-blind,Placebo Controlled,Phase-2 Study to Assess the Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis .|Unknown status|Recruiting|Phase 2|60|Anticipated|Healthcare Homoeo Charitable Society||2|||f||||t||||||||||2017-10-11 01:28:09.553269|2017-10-11 01:28:09.553269
NCT01905722|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-07-31|||December 10, 2013|Actual|2013-12-10|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Development of Novel Therapies for NIDDM|Development of Novel Therapies for NIDDM: Technology Development for Mitochondrial Substrate Oxidation at 3 Tesla and 7 Tesla|Active, not recruiting||N/A|130|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 01:28:09.671456|2017-10-11 01:28:09.671456
NCT01905709|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-12-15|||July 2013||2013-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Fecal Microbiota Transplantation for C Diff Infection|Fecal Microbiota Transplantation for the Treatment of Recurrent or Refractory Clostridium Difficile Infection (CDI)|Recruiting||N/A|100|Anticipated|Englewood Hospital and Medical Center||1|||f||||f||||||||||2017-10-11 01:28:09.756672|2017-10-11 01:28:09.756672
NCT01905696|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-12-28|||March 2013||2013-03-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Role of S-nitrosohemoglobin in Regulating Systemic Blood Flow During Hypoxia and Normoxia|The Role of S-nitrosohemoglobin in Regulating Systemic Blood Flow Under Hypoxic and Normoxic Conditions|Terminated||Early Phase 1|10|Actual|Duke University||1||Lack of funding|f||||f||||||||||2017-10-11 01:28:09.87487|2017-10-11 01:28:09.87487
NCT01905670|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-09-27|||July 2013||2013-07-01|September 2016|2016-09-01|February 2020|Anticipated|2020-02-01|August 2015|Actual|2015-08-01||Interventional|SELECT-LV||Safety and Performance of Electrodes Implanted in the Left Ventricle|Multicenter, Prospective Evaluation of Safety and Performance of the WiCS-LV System in Patients Indicated for Cardiac Resynchronization Therapy|Active, not recruiting||N/A|39|Actual|EBR Systems, Inc.||1|||f||||t||||||||||2017-10-11 01:28:10.239246|2017-10-11 01:28:10.239246
NCT01905657|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-09-06|2016-09-15||August 9, 2013|Actual|2013-08-09|September 2017|2017-09-01|March 29, 2019|Anticipated|2019-03-29|September 30, 2015|Actual|2015-09-30||Interventional||The Intent-To-Treat population consisted of all participants who were randomized. Participants were included in the treatment group to which they were randomized. Data from one participant in the Pembrolizumab 2 mg/kg group were excluded from efficacy analyses due to Good Clinical Practice (GCP) non-compliance.|Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)|A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) Versus Docetaxel in Previously Treated Subjects With Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2/Phase 3|1034|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 01:28:10.378525|2017-10-11 01:28:10.378525
NCT01905644|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2017-06-16|||March 7, 2014|Actual|2014-03-07|June 2017|2017-06-01|April 15, 2017|Actual|2017-04-15|November 24, 2016|Actual|2016-11-24||Interventional|OASIS 2||Verifying Post-delivery Anal Sphincter Integrity Using Perineal Ultrasound: Impact on Immediate Care|Verifying Anal Sphincter Integrity in the Delivery Room Using a Specific Perineal Ultrasound: Impact on Immediate Care and Postpartum Anal Incontinence Rates in Mothers Undergoing Vaginal Birth|Completed||N/A|276|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 01:28:12.980692|2017-10-11 01:28:12.980692
NCT01905631|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2013-09-20|||July 2013||2013-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:28:13.069689|2017-10-11 01:28:13.069689
NCT01905618|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-06-01|||July 2009||2009-07-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|MSQuit||Tobacco Treatment Medical Education in 10 Medical Schools|RCT for Smoking Cessation in 10 Medical Schools|Completed||N/A|10|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 01:28:13.110922|2017-10-11 01:28:13.110922
NCT01905605|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-03-03|||September 2013|Anticipated|2013-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Phosphatidylcholine Supplementation in Infants|Phosphatidylcholine Supplementation in Infants With Diminished Sensory Gating|Withdrawn||Phase 1/Phase 2|0|Actual|University of Colorado, Denver||2||Funding not secured. IRB approval has been withdrawn as of January 2017.|f||||t||||||||||2017-10-11 01:28:13.241453|2017-10-11 01:28:13.241453
NCT01905592|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-08-24|||October 2013||2013-10-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|BRAVO||A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients|A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients|Active, not recruiting||Phase 3|306|Anticipated|Tesaro, Inc.||2|||f||||t||||||||||2017-10-11 01:28:13.339419|2017-10-11 01:28:13.339419
NCT01905579|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-08-29|||March 2013||2013-03-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Correlation Between Aqueous Protein Level and Clinical Grading of Flare and Flaremetry.|Correlation Between Aqueous Protein Level and Clinical Grading of Flare and Flaremetry.|Completed||N/A|20|Actual|The Eye Center and The Eye Foundation for Research in Ophthalmology||2|||f||||f||||||||||2017-10-11 01:28:13.650884|2017-10-11 01:28:13.650884
NCT01905566|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-19|2016-02-25|||September 2013||2013-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation|Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation: Serial FDG PET/CT Imaging Study of Carotid Artery and Ascending Aorta|Completed||Phase 4|50|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:28:13.73681|2017-10-11 01:28:13.73681
NCT01905553|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-12-16|2014-12-16||August 2013||2013-08-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||The Safety Set consists of all subjects who have taken at least 1 dose of investigational product and have at least 1 post-dose safety assessment.|The Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects|A Phase 1, Open-label, Randomized, 2-period, Crossover, Exploratory Study to Investigate the Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects|Completed||Phase 1|9|Actual|Shire||2|||f||||f||||||||||2017-10-11 01:28:13.830756|2017-10-11 01:28:13.830756
NCT01905540|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-12-16|2014-12-16||August 2013||2013-08-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Safety Set: All enrolled subjects who had taken at least 1 dose of investigational product and had at least 1 post-dose safety assessment (defined as treatment emergent adverse events [TEAEs], physical examination findings, clinical laboratory test results, vital sign measurements, and 12-lead ECG readings).|A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt)|A Phase 1, Open-label, Randomized, 3-Period, Relative Bioavailability Study Comparing the Pharmacokinetics of SSP-004184AQ (Magnesium Salt) to SSP-004184SS (Disodium Salt) Each Administered as a Single Dose and as Two Doses of SSP-004184 (Free Acid) in Healthy Adult Subjects|Completed||Phase 1|28|Actual|Shire||4|||f||||f||||||||||2017-10-11 01:28:14.191825|2017-10-11 01:28:14.191825
NCT01905527|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-01-30|||July 2013||2013-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Adherence Trial With MS LifeLines ® Services|A Prospective, Parallel Group, Phase IV Study of Three Levels of MS LifeLines ® Support Services Provided to Patients Prescribed Rebif ® for Newly Diagnosed or First-switch Relapsing Remitting Multiple Sclerosis (RRMS)|Terminated||N/A|306|Actual|EMD Serono|||3|The study was terminated as per the Sponsor's decision.|f||||f||||||||||2017-10-11 01:28:16.498708|2017-10-11 01:28:16.498708
NCT01905514|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-04-25|||September 2013||2013-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|PRIMA||ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients|ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients|Enrolling by invitation||N/A|140|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 01:28:16.612276|2017-10-11 01:28:16.612276
NCT01905501|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-04-06|||February 2013||2013-02-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial|Sevoflurane Protective Effect on Ischemia-reperfusion Injury in Patients Undergoing Reconstructive Plastic Surgery With Microsurgical Flap. Multicenter, Randomized Controlled Trial.|Completed||N/A|132|Actual|Regina Elena Cancer Institute||2|||f||||||||||||||2017-10-11 01:28:16.696803|2017-10-11 01:28:16.696803
NCT01905488|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-07-18|||May 2009||2009-05-01|July 2013|2013-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted Prostatectomy||Completed||N/A|50|Actual|Yonsei University|||3||f||||f||||||||||2017-10-11 01:28:16.772485|2017-10-11 01:28:16.772485
NCT01905475|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-06-09|||July 2013||2013-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Interventional|CATCH-AMI||CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)|CXCR4 AnTagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI). A Phase IIa, Double-Blind, Placebo-Controlled, Randomised, Multi-centre Study of POL6326, a CXCR4 Antagonist, in Patients With Large Reperfused ST Elevation Myocardial Infarction|Completed||Phase 2|120|Actual|Polyphor Ltd.||2|||f||||t||||||||||2017-10-11 01:28:16.836332|2017-10-11 01:28:16.836332
NCT01905462|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-09-26|||November 2012||2012-11-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK|Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix in the United Kingdom|Completed||N/A|1046|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 01:28:16.956424|2017-10-11 01:28:16.956424
NCT01905449|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-07-11|||May 2013||2013-05-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Ultrasound Biofeedback for Speech Sound Disorders|Biofeedback and Speech Disorders|Completed||Phase 1|35|Actual|Yale University||2|||f||||f||||||||||2017-10-11 01:28:17.038134|2017-10-11 01:28:17.038134
NCT01891812|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2017-07-14|||June 2013||2013-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Nitrous Oxide Analgesia Vaso-occlusive Crisis|Nitrous Oxide for Analgesia in Sickle Cell Vaso-occlusive Crisis|Recruiting||Phase 2|12|Anticipated|Columbia University||1|||f||||t||||||||||2017-10-11 01:31:52.866167|2017-10-11 01:31:52.866167
NCT01905436|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-05-24|||March 2012||2012-03-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|April 2017|Actual|2017-04-01||Observational|DOLF-LIBERIA||Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia|Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia|Active, not recruiting||N/A|15600|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples Without DNA|"     Study procedures include collection of finger prick blood that will be tested for     microfilaremia and for serology testing (antigenemia and antibody testing). Investigators     will also collect skin snips (small superficial skin biopsies) to detect Onchocerca     microfilariae, and stool samples to detect parasitic worm eggs indicative of STH infections.      All assays will be performed in Liberia (filarial serology tests, MF smears, stool     examinations).   "|||2017-10-11 01:28:17.105202|2017-10-11 01:28:17.105202
NCT01905410|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-12-24|||July 2013||2013-07-01|July 2013|2013-07-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|P1_VVZ149IV||Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection|A Randomized, Double-blind, Single and Multiple Ascending Dose Escalation, Placebo-controlled Clinical Trial to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection in Healthy Male Volunteers|Completed||Phase 1|66|Actual|Vivozon, Inc.||4|||f||||f||||||||||2017-10-11 01:28:17.408145|2017-10-11 01:28:17.408145
NCT01905384|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-10-02|||April 2013||2013-04-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Covered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction|Randomized Controlled Trial Comparing Covered Versus Uncovered Metal Stents for Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction|Enrolling by invitation||N/A|96|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 01:28:17.564801|2017-10-11 01:28:17.564801
NCT01905371|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2013-07-18|||April 2001||2001-04-01|July 2013|2013-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Amphetamine-Enhanced Stroke Recovery|Amphetamine-Enhanced Stroke Recovery|Completed||Phase 2|99|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:28:17.643312|2017-10-11 01:28:17.643312
NCT01905358|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-03-15|||July 2013||2013-07-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|5 Years|Observational [Patient Registry]|KUCE||The Knee Usual Care Evaluation Study|Title: The Study of Intra-articular Interventions of Platelet Rich Plasma or Hyaluronic Acid Compounds vs. Usual Care (Exercise/Diet/Supplements) in the Medical Management of Knee OA- Effects on Pain and Function; Effects on Articular Cartilage; Effects on Time to Partial or Total Knee Arthroplasty: The Knee Usual Care Evaluation (KUCE) Study|Terminated||N/A|1000|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-11 01:28:17.743513|2017-10-11 01:28:17.743513
NCT01905345|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-08-04|||August 2013||2013-08-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|December 2015|Actual|2015-12-01||Interventional|||Influence of Consecutive Strength- and Endurance Regimes on the Myonuclear Domain and Satellite Cell in the M. Vastus Lateralis of Old Healthy Men||Completed||N/A|30|Actual|University of Zurich||3|||f||||||||||||||2017-10-11 01:28:17.83255|2017-10-11 01:28:17.83255
NCT01905332|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2015-04-30|||July 2013||2013-07-01|April 2015|2015-04-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Preschool Literacy Screening: Validating a 5 Question Survey Using the GRTR-R and the Efficacy of Literacy-promoting Interventions|Preschool Literacy Screening: Validating a 5 Question Survey Using the GRTR-R and Evaluation of the Efficacy of Literacy-promoting Interventions.|Withdrawn||N/A|0|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 01:28:17.915937|2017-10-11 01:28:17.915937
NCT01905319|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-07-18|||January 1998||1998-01-01|July 2013|2013-07-01|December 2002|Actual|2002-12-01|December 2000|Actual|2000-12-01||Observational|||Juvenile Idiopathic Arthritis in Children in Estonia.|Juvenile Idiopathic Arthritis in Children in Estonia - an Epidemiological and Clinical Investigation.|Completed||N/A|162|Actual|University of Tartu|||1||f||||f||||||Samples Without DNA|"     Sera and plasma.   "|||2017-10-11 01:28:18.00012|2017-10-11 01:28:18.00012
NCT01905306|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-07-18|||January 2013||2013-01-01|July 2013|2013-07-01||||July 2016|Anticipated|2016-07-01||Interventional|||Randomized Controlled Trial of Full-Arch Rehabilitation|Clinical Evaluation of Immediate Loading Full Arch Rehabilitation Made With Methodology for Computer Guided Implant Planning With Software Polyvalent vs Free Hand Implants Placement|Unknown status|Active, not recruiting|N/A|20|Actual|University of Siena||2|||f||||f||||||||||2017-10-11 01:28:18.073067|2017-10-11 01:28:18.073067
NCT01905293|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-07-18|||May 2011||2011-05-01|June 2013|2013-06-01||||March 2012|Actual|2012-03-01||Interventional|||Individual Differences in Children's Susceptibility to Overeating|Individual Differences in Children's Susceptibility to Overeating|Completed||N/A|50|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-11 01:28:18.166241|2017-10-11 01:28:18.166241
NCT01905280|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-12-06|||September 2013||2013-09-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Ridge Preservation Comparing 2 Membranes|Ridge Preservation Comparing the Clinical and Histologic Healing of a PTFE Non-resorbable Membrane Versus an Acellular Dermal Matrix Allograft Plus a Facial Overaly Bovine Xenograft.|Completed||N/A|24|Actual|University of Louisville||2|||f||||f||||||||||2017-10-11 01:28:18.247036|2017-10-11 01:28:18.247036
NCT01905254|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-05-04|2014-12-07||August 2007||2007-08-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|August 2010|Actual|2010-08-01||Interventional||Data analysis was performed on 34 patients (female: 28 (82%); male: 6 (18 %). Indications for liver biopsy and Transient elastography were: 19 patients for follow-up of AIH while receiving immunosuppression and 15 patients for staging and grading of AIH before starting with an immunosuppressive therapy in.|Transient Elastography in Autoimmune Hepatitis|Prospective Comparison of Transient Elastography and Mini-laparoscopic Guided Liver Biopsy in Autoimmune Hepatitis|Completed||N/A|34|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-10-11 01:28:18.407485|2017-10-11 01:28:18.407485
NCT01905241|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-09-21|||July 2013||2013-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:28:18.584382|2017-10-11 01:28:18.584382
NCT01905228|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-03-17|||July 2013||2013-07-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|September 2017|Anticipated|2017-09-01||Interventional|||A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm|A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm|Recruiting||Phase 1|84|Anticipated|Incuron||1|||f||||f||||||||||2017-10-11 01:28:18.622581|2017-10-11 01:28:18.622581
NCT01905215|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-05-24|||July 22, 2013|Actual|2013-07-22|May 2017|2017-05-01|March 16, 2015|Actual|2015-03-16|April 9, 2014|Actual|2014-04-09||Interventional|||Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines|An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Men|Completed||Phase 1|128|Actual|GlaxoSmithKline||8|||f||||||||||||||2017-10-11 01:28:18.711541|2017-10-11 01:28:18.711541
NCT01905202|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-08-01|||April 2013||2013-04-01|August 2014|2014-08-01||||April 2015|Anticipated|2015-04-01||Interventional|||The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus|Phase 1 Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus|Unknown status|Enrolling by invitation|Phase 1|13|Anticipated|Effexus Pharmaceutical||1|||f||||t||||||||||2017-10-11 01:28:18.819115|2017-10-11 01:28:18.819115
NCT01905189|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2014-04-08|||July 2013||2013-07-01|April 2014|2014-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|RETRIEVE||Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension|Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension|Unknown status|Recruiting|N/A|15|Anticipated|University Hospital, Caen||1|||f||||t||||||||||2017-10-11 01:28:18.901595|2017-10-11 01:28:18.901595
NCT01905176|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-07-22|||April 2010||2010-04-01|July 2013|2013-07-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|MEETTinCY||Management of Patients With HF by Using Educational or Educational & Telephone or Telephone Interventions and Support in Cyprus|The Effectiveness of Multiple Nursing Interventions, for Promoting Heart Failure Self-care, on Patients' Quality of Life and Heart Failure Outcomes: A Randomized Control Trial.|Unknown status|Recruiting|N/A|300|Anticipated|Cyprus University of Technology||4|||f||||f||||||||||2017-10-11 01:28:19.130575|2017-10-11 01:28:19.130575
NCT01905163|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-07-18|||August 2013||2013-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|August 2016|Actual|2016-08-01||Interventional|CILOVE||Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients|Prospective Study Assessing the Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinomatosis of Ovarian Origin, Tubal or Primary Peritoneal, in Chemosensitive Patients Treated by Neoadjuvant Chemotherapy.|Completed||Phase 2|47|Actual|Centre Jean Perrin||1|||f||||f||||||||||2017-10-11 01:28:19.244763|2017-10-11 01:28:19.244763
NCT01905150|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2017-01-30|||July 2014||2014-07-01|January 2016|2016-01-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer|Ph 2 Trial of G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan & Oxaliplatin), Followed by G-FLIP-DM (G-FLIP + Low Doses Docetaxel & MitomycinC), When Used in Combination With Vitamin C, in Patients With Advanced Pancreatic Cancer|Recruiting||Phase 2|30|Anticipated|Bruckner Oncology||2|||f||||f||||||||||2017-10-11 01:28:19.366144|2017-10-11 01:28:19.366144
NCT01905124|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2015-12-16|||January 2017||2017-01-01|December 2015|2015-12-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety &Efficacy of CF101 to Subjects With Uveitis|A Phase 2, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Daily CF101 Administered Orally to Subjects With Active, Sight-Threatening, Noninfectious Intermediate or Posterior Uveitis|Not yet recruiting||Phase 2|45|Anticipated|Can-Fite BioPharma||2|||f||||f||||||||||2017-10-11 01:28:19.604752|2017-10-11 01:28:19.604752
NCT01905111|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-09-03|||July 2013||2013-07-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer|An Open-label Phase I Dose Finding Study of BI 853520 Administered Orally in a Continuous Dosing Schedule in Japanese and Taiwanese Patients With Various Advanced or Metastatic Solid Tumours|Completed||Phase 1|21|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 01:28:19.700594|2017-10-11 01:28:19.700594
NCT01905098|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2015-04-16|||July 2013||2013-07-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|||Complementary and Alternative Medicine Sauna Detoxification Study: Phase I|Complementary and Alternative Medicine Sauna Detoxification Study: A Phase I Randomized 2-Arm Study to Determine the Impact of Hyperthermia Intervention Protocol on Serum Polychlorinated Biphenyls (PCBs) in Healthy Human Adults.|Terminated||Phase 1|1|Actual|Bastyr University||2|||f||||t||||||||||2017-10-11 01:28:19.791723|2017-10-11 01:28:19.791723
NCT01905085|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-09-08|||November 2011||2011-11-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Energy Expenditure Methodology Infant|Energy Expenditure Methodology Infant|Completed||N/A|30|Actual|Arkansas Children's Hospital Research Institute|||1||f||||t||||||||||2017-10-11 01:28:19.896021|2017-10-11 01:28:19.896021
NCT01905072|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-01-25|||October 2012||2012-10-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Preventing Childhood Obesity Through Early Guidance|Preventing Childhood Obesity Through Early Feeding and Parenting Guidance|Active, not recruiting||N/A|177|Actual|Arizona State University||2|||f||||t||||||||Yes|We will make our data available through our website. All data will be de-identified and will not be able to be altered but can be downloaded (with permission from PI) for secondary analysis.|2017-10-11 01:28:19.951354|2017-10-11 01:28:19.951354
NCT01905059|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-07-19|||February 2014||2014-02-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|April 2016|Actual|2016-04-01||Interventional|MOBIDIP||Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa|Multicenter, International, Prospective, Phase III, Randomized, Superiority Trial Comparing Two Maintenance Strategies With Mono or Bi-therapy of Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment Over a Period of 96 Weeks in Africa (Dakar, Bobo Dioulasso, Yaounde)|Completed||Phase 3|265|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-11 01:28:20.047176|2017-10-11 01:28:20.047176
NCT01905046|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-08-15|||August 2013||2013-08-01|August 2017|2017-08-01||||February 2019|Anticipated|2019-02-01||Interventional|||Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer|Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention Versus Placebo Control in Premenopausal Women|Recruiting||Phase 3|128|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 01:28:20.192914|2017-10-11 01:28:20.192914
NCT01905033|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-04-28|||January 2011||2011-01-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|1 Year|Observational [Patient Registry]|MARS||Molecular Diagnosis and Risk Stratification of Sepsis|Molecular Diagnosis and Risk Stratification of Sepsis|Recruiting||N/A|7500|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     Whole blood, plasma, RNA, DNA.   "|||2017-10-11 01:28:20.397519|2017-10-11 01:28:20.397519
NCT01905020|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-10-18|||July 2013||2013-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 Diabetes|An Open-label, Randomized, Three-way, Multicenter Study to Compare the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Conventional Insulin Pump Therapy in Regulating Overnight Glucose Levels at Home in Adolescents and Adults With Type 1 Diabetes|Completed||Phase 2|28|Actual|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-11 01:28:20.486776|2017-10-11 01:28:20.486776
NCT01905007|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2013-07-17|||December 2010||2010-12-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|TNT-ICD||Study of Defibrillation Testing In Patients Undergoing Initial ICD Implantation|"Test-No Test Implantable Cardioverter Defibrillator Pilot Study (TNT-ICD)"|Unknown status|Recruiting|Phase 4|100|Anticipated|The Cooper Health System||2|||f||||t||||||||||2017-10-11 01:28:20.612601|2017-10-11 01:28:20.612601
NCT01904994|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-07-28|||August 2013||2013-08-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|May 2016|Actual|2016-05-01||Interventional|L4H||Link4Health: A Combination Strategy for Linkage and Retention, Swaziland|LINK4HEALTH: A Combination Approach to Linkage and Retention for HIV (Human Immunodeficiency Virus) Infected Individuals in Swaziland|Active, not recruiting||N/A|2201|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:28:20.737443|2017-10-11 01:28:20.737443
NCT01904981|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-07-24|||January 2013||2013-01-01|July 2014|2014-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial)||Unknown status|Recruiting|Phase 4|400|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 01:28:20.879762|2017-10-11 01:28:20.879762
NCT01904968|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-17|||December 2011||2011-12-01|July 2013|2013-07-01||||December 2015|Anticipated|2015-12-01||Observational|||Impact of Methylation Alterations in Colon Cancer: Epidemiology and Prognosis||Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 01:28:20.953749|2017-10-11 01:28:20.953749
NCT01904955|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-12-10|||September 2010||2010-09-01|July 2013|2013-07-01||||February 2013|Actual|2013-02-01|1 Day|Observational [Patient Registry]|||Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort||Completed||N/A|598|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 01:28:21.015908|2017-10-11 01:28:21.015908
NCT01904942|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-17|||October 2008||2008-10-01|July 2013|2013-07-01||||June 2010|Actual|2010-06-01||Observational|CIRCE ProSpec||Study of Hepatocellular Carcinoma in Cirrhotic Patients|Study of Hepatocellular Carcinoma in Cirrhotic Patients|Completed||N/A|600|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 01:28:21.075858|2017-10-11 01:28:21.075858
NCT01904929|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-17|||June 2013||2013-06-01|July 2013|2013-07-01||||June 2015|Anticipated|2015-06-01||Interventional|TML 400 m||The 400m-walk-test for Stable Coronary Patients|Evaluation of the Psychometric Properties of the 400m-walk-test at a Self-selected Speed (400m WT) for Stable Coronary Patients|Unknown status|Recruiting|N/A|65|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||f||||||||||2017-10-11 01:28:21.128086|2017-10-11 01:28:21.128086
NCT01904916|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-02-23|||January 2014||2014-01-01|February 2014|2014-02-01||||August 2021|Anticipated|2021-08-01||Interventional|||CPCT-05 Biopsy Protocol Patient Selection|Protocol to Obtain Tumor Biopsies From Patients With Locally Advanced (Incurable) or Metastatic Cancer to Improve Selection for Clinical Trials. (CPCT - 05 Biopsy Protocol Patient Selection)|Recruiting||N/A|200|Anticipated|UMC Utrecht||1|||f||||t||||||||||2017-10-11 01:28:21.20606|2017-10-11 01:28:21.20606
NCT01904903|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-12-07|||August 2013||2013-08-01|December 2015|2015-12-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|SAFE-HEaRt||Cardiac Safety Study in Patients With HER2 + Breast Cancer|SAFE-HEaRt: A Pilot Study Assessing the Cardiac SAFEty of HER2 Targeted Therapy in Patients With HER2 Positive Breast Cancer and Reduced Left Ventricular Function|Recruiting||Phase 2|30|Anticipated|Washington Hospital Center||1|||f||||t||||||||||2017-10-11 01:28:21.300976|2017-10-11 01:28:21.300976
NCT01904890|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-12-29|||March 2012||2012-03-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|AANCARTLHW||AANCART Research Project on Lay Health Workers and Asian Americans|Asian American Network for Cancer Awareness, Research, and Training (AANCART): The National Center for Reducing Asian American Cancer Health Disparities Research Project on Lay Health Workers and Asian Americans|Completed||N/A|994|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:28:21.409532|2017-10-11 01:28:21.409532
NCT01904877|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-04-03|||March 2013|Actual|2013-03-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|May 2015|Actual|2015-05-01|1 Year|Observational [Patient Registry]|MP3||Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men —Test, Link and Care (TLC)|Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men —Test, Link and Care (TLC) Version 1.0 Dated 10/15/12|Completed||N/A|3760|Actual|Vanderbilt University Medical Center|||2||f||||f||||||Samples With DNA|"     HIV RNA will be extracted from plasma and the HIV PR and RT genes will be amplified by a     one-step RT-PCR using TaKaRa One Step RNA PCR Kit . The quality of sequences will be     evaluated using Sequence Scanner v1.0, and the sequences will be cleaned and assembled by     Sequencher (Gene Codes Corporation, Ann Arbor, MI,USA).   "|||2017-10-11 01:28:21.505112|2017-10-11 01:28:21.505112
NCT01904864|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-08-15|2017-08-15||July 2013||2013-07-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|BESTIRON||Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia|A Single-center, Double-blinded, Randomized, 12 Week, Superiority Study in Infants and Young Children to Compare the Efficacy of NovaFerrum® Versus Ferrous Sulfate in the Treatment of Nutritional Iron Deficiency Anemia.|Completed||Phase 4|80|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 01:28:21.596293|2017-10-11 01:28:21.596293
NCT01904851|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-05-10|||January 2013||2013-01-01|May 2016|2016-05-01|January 2033|Anticipated|2033-01-01|January 2033|Anticipated|2033-01-01|12 Months|Observational [Patient Registry]|XLPAD||Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes|Multi-Center Registry Comparing Stent and Non-Stent Based Interventional Outcomes for Patients With Peripheral Arterial Disease|Recruiting||N/A|14000|Anticipated|University of Texas Southwestern Medical Center|||2||f||||t||||||||||2017-10-11 01:28:22.146139|2017-10-11 01:28:22.146139
NCT01904838|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-11-30|||September 2012||2012-09-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|September 2013|Actual|2013-09-01||Observational|HEAL2||The Healing Context in CAM: Instrument Development and Initial Validation - Calibration Study|The Healing Context in Complementary and Alternative Medicine (CAM): Instrument Development and Initial Validation - Calibration Study|Completed||N/A|1650|Actual|University of Pittsburgh|||2||f||||t||||||||||2017-10-11 01:28:22.351996|2017-10-11 01:28:22.351996
NCT01904825|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-19|||September 2006||2006-09-01|July 2013|2013-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01|1 Day|Observational [Patient Registry]|||Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation||Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 01:28:22.4251|2017-10-11 01:28:22.4251
NCT01904812|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-17|||December 2011||2011-12-01|July 2013|2013-07-01||||January 2015|Anticipated|2015-01-01||Interventional|EQUAL||Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus||Unknown status|Active, not recruiting|N/A|356|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 01:28:22.490235|2017-10-11 01:28:22.490235
NCT01904799|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2015-07-15|||December 2014||2014-12-01|January 2015|2015-01-01||||June 2017|Anticipated|2017-06-01||Interventional|Casper||Cognitive Assessment for Stroke Patients: Reproductibility and Validity Study||Unknown status|Recruiting|N/A|290|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||f||||||||||2017-10-11 01:28:22.572632|2017-10-11 01:28:22.572632
NCT01904786|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-07-01|||April 2014||2014-04-01|January 2015|2015-01-01|November 2018|Anticipated|2018-11-01|December 2017|Anticipated|2017-12-01||Interventional|||Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy|Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy|Withdrawn||Phase 1|0|Actual|St. Louis University||2||Lack of enrollment of suitable candidates|f||||t||||||||||2017-10-11 01:28:22.656515|2017-10-11 01:28:22.656515
NCT01904773|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-09-22|2016-02-15||August 2013||2013-08-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||All patients enrolled in Part 1 of the study, 23 of whom continued into Part 2|Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder|A 6-month, Multicenter, Randomized, Safety, Tolerability, Pharmacokinetic, and Preliminary Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder|Completed||Phase 2|29|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 01:28:22.795189|2017-10-11 01:28:22.795189
NCT01904760|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-11-05|2014-11-05||June 2013||2013-06-01|November 2014|2014-11-01||||November 2013|Actual|2013-11-01||Interventional|||Dexmedetomidine to Prevent Agitation After Free Flap Surgery|The Effect of Dexmedetomidine on Agitation and Delirium in Patients After Free Flap Reconstructive Surgery|Completed||Phase 4|80|Actual|Peking University||2|||f||||t||||||||||2017-10-11 01:28:24.276253|2017-10-11 01:28:24.276253
NCT01904747|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-12-16|||July 2013||2013-07-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Characterization Of The Effect Of Food On Palbociclib (PD-0332991) Absorption|A Phase 1, Open-Label 4 Sequence 4 Period Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Estimate The Effect Of Food On The Bioavailability Of Palbociclib|Completed||Phase 1|28|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:28:24.556277|2017-10-11 01:28:24.556277
NCT01904734|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-10-20|||October 2012||2012-10-01|October 2015|2015-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Clomid in Men With Low Testosterone With and Without Prior Treatment|A Comparison of Clomiphene Citrate Responses in Men With Hypothalamic Hypogonadism naïve to, and Previously Treated With, Testosterone|Unknown status|Recruiting|Phase 2|64|Anticipated|Phoenix VA Health Care System||2|||f||||f||||||||||2017-10-11 01:28:24.664233|2017-10-11 01:28:24.664233
NCT01904721|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-18|2016-02-23|2015-11-04||August 2013||2013-08-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|||A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)||Completed||Phase 2|244|Actual|Allergan||7|||f||||t||||||||||2017-10-11 01:28:24.797739|2017-10-11 01:28:24.797739
NCT01904708|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-10-15|||May 2013||2013-05-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Moderate Intensity Exercise and Phenylketonuria|The Effects of an Acute Bout of Moderate Intensity Exercise on Plasma Amino Acids in Subjects With Phenylketonuria|Terminated||N/A|2|Actual|Oregon Health and Science University||2||Current design not able to measure the outcomes anticipated.|f||||f||||||||||2017-10-11 01:28:25.850816|2017-10-11 01:28:25.850816
NCT01904695|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2016-09-04|||August 2013||2013-08-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study|Causal Inference Research of Resistant Hypertension Treatment With Recipe of Removing Both Phlegm and Blood Stasis in a Real World Study|Completed||Early Phase 1|192|Actual|China Academy of Chinese Medical Sciences||2|||f||||t||||||||No||2017-10-11 01:28:25.956503|2017-10-11 01:28:25.956503
NCT01904669|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-10-26|||July 2013||2013-07-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|PEEPS||Internet-based Study of Fertility and Early Pregnancy (PEEPS)|Prospective Evaluation of the Elements of Pregnancy Study|Completed||N/A|161|Actual|Ohio State University|||1||f||||f||||||||||2017-10-11 01:28:26.201483|2017-10-11 01:28:26.201483
NCT01904656|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-05-08|||September 2009||2009-09-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||CBPR Strategies to Increase Colorectal Cancer Screening in Ohio Appalachia|Community-Based Participatory Research(CBPR)Strategies in Increasing Colorectal Cancer(CRC)Screening in Participants in Ohio Appalachia|Active, not recruiting||N/A|4320|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-11 01:28:26.294124|2017-10-11 01:28:26.294124
NCT01904643|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-06-12|||February 2014||2014-02-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase I Study of Lenalidomide Therapy Prior to Re-induction Chemotherapy With Mitoxantrone, Etoposide, and Cytarabine (MEC) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|30|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 01:28:26.381891|2017-10-11 01:28:26.381891
NCT01904630|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-07-13|||December 2012||2012-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Sequencing to Identify Gene Variants in Familial Colorectal Cancer|Exom-sekvensering for å Identifisere høyrisiko Genvarianter i en Familie Predisponert for Colorectal Cancer|Completed||N/A|14|Actual|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"     Blood samples for DNA sequencing   "|||2017-10-11 01:28:26.488404|2017-10-11 01:28:26.488404
NCT01904617|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2015-01-07|||April 2013||2013-04-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas|A Randomized Controlled Trial on the Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas|Completed||N/A|300|Actual|MemorialCare Health System||3|||f||||f||||||||||2017-10-11 01:28:26.557038|2017-10-11 01:28:26.557038
NCT01904604|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-02-02|2016-07-15||September 2013||2013-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|August 2015|Actual|2015-08-01||Interventional||All randomized subjects who received study treatment. Note that 1 subject in the 100 µg Peanut Patch group who never received treatment was not included.|Peanut Epicutaneous Phase II Immunotherapy Clinical Trial|Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)|Active, not recruiting||Phase 2|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||Yes|The plan is to share data in ImmPort [https://immport.niaid.nih.gov/ ], a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 01:28:26.655366|2017-10-11 01:28:26.655366
NCT01904591|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-09-12|||October 2013||2013-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Effects of Anti-oxidants on Clinical Outcomes and Radiological Features of Chronic Spinal Cord Injury: A Pilot Study|The Effects of Anti-oxidants on Clinical Outcomes and Radiological Features of Chronic Spinal Cord Injury: A Pilot Study|Completed||N/A|4|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 01:28:27.529718|2017-10-11 01:28:27.529718
NCT01904578|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-07|2013-07-21|||February 2010||2010-02-01|February 2010|2010-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||The Efficacy of Acupressure on Sleep Quality in Menopausal Women|The Effect of Acupressure on Sleep Quality in Menopausal Women|Completed||Phase 2/Phase 3|120|Actual|Mashhad University of Medical Sciences||3|||f||||t||||||||||2017-10-11 01:28:27.623012|2017-10-11 01:28:27.623012
NCT01904565|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-08-31|||February 2014||2014-02-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|HYPROSAR||Hyperthermia and Proton Therapy in Unresectable Soft Tissue Sarcoma|A Phase I/II Study of Concurrent Hyperthermia and Proton Beam Radiotherapy in Primary and Recurrent Unresectable Soft Tissue Sarcoma|Recruiting||Phase 1/Phase 2|26|Anticipated|Kantonsspital Aarau||1|||f||||t||||||||||2017-10-11 01:28:27.687038|2017-10-11 01:28:27.687038
NCT01904552|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-07-17|||September 2012||2012-09-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ERCLMDs||Accuracy of ERCLMDs in Teeth With Apical Periodontitis|Influence of Apical Periodontitis on the Accuracy of Three Electronic Root Canal Length Measurement Devices: An In Vivo Study|Completed||Phase 1|32|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:28:27.793251|2017-10-11 01:28:27.793251
NCT01904539|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-10-23|||June 2013||2013-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Hepatic Impairment Trial of Obeticholic Acid|An Open-Label, Single-Dose Trial to Assess the Effects of Hepatic Impairment on the Pharmacokinetics of Obeticholic Acid (OCA)|Completed||Phase 1|32|Actual|Intercept Pharmaceuticals||4|||f||||t||||||||||2017-10-11 01:28:27.886682|2017-10-11 01:28:27.886682
NCT01904526|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-11-22|||July 2013||2013-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||PK/PD Comparison of Guanfacine ER and IR|Pharmacokinetic/Dynamic (PK/PD) Comparison of Guanfacine Extended Release (ER) and Immediate Release (IR) in Smokers|Active, not recruiting||Phase 2|8|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 01:28:28.0025|2017-10-11 01:28:28.0025
NCT01904513|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-12-16|||December 2012||2012-12-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|December 2012|Actual|2012-12-01||Interventional|PDTX||Investigating the Effects of Probiotic Yogurt on Reducing the Levels of Environmental Toxins Among School Children in Mwanza, Tanzania|Investigating the Effects of Probiotic Yogurt on Reducing the Levels of Environmental Toxins Among School Children in Mwanza, Tanzania|Completed||N/A|44|Actual|Western University, Canada||2|||f||||f||||||||||2017-10-11 01:28:28.097855|2017-10-11 01:28:28.097855
NCT01904500|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-08-15|||August 2013||2013-08-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Peri-operative Cefazolin Prophylaxis at Time of Cesarean Delivery in the Obese Gravida|Peri-operative Cefazolin Prophylaxis at Time of Cesarean Delivery in the Obese Gravida|Completed||Phase 1|26|Anticipated|University of Pittsburgh||2|||f||||||||||||||2017-10-11 01:28:28.191533|2017-10-11 01:28:28.191533
NCT01904487|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-08-25|||April 19, 2011||2011-04-19|August 2017|2017-08-01|October 1, 2013|Actual|2013-10-01|October 1, 2013|Actual|2013-10-01||Interventional|||Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence|Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence|Completed||Phase 1|11|Actual|University of Pittsburgh||1|||f||||f|t|f||||||||2017-10-11 01:28:28.33323|2017-10-11 01:28:28.33323
NCT01904474|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-11-16|||April 2013||2013-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||E-therapeutic Program for Obese Adolescents|Internet Based Intervention Program for Obese Adolescents and Their Families(NEXT.STEP)|Completed||N/A|116|Actual|Hospital de Santa Maria, Portugal||2|||f||||||||||||||2017-10-11 01:28:28.466985|2017-10-11 01:28:28.466985
NCT01904461|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-07-04|||October 2014||2014-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|HemORL||HemORL: Monocentric, Prospective, Comparative Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children|Monocentric, Prospective, Comparative and Randomised Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children|Recruiting||N/A|74|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 01:28:28.60988|2017-10-11 01:28:28.60988
NCT01904448|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-04-18|||September 2012||2012-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Auditory Brainstem Implantation in Young Children|An Early Feasibility Study of the Safety and Efficacy of the Nucleus 24 Auditory Brainstem Implant in Children With Cochlear or Cochlear Nerve Disorders Not Resulting From Neurofibromatosis Type II|Suspended||N/A|5|Actual|University of North Carolina, Chapel Hill||1||Primary surgeon has left UNC|f||||t|f|t|f|||||||2017-10-11 01:28:28.728006|2017-10-11 01:28:28.728006
NCT01904422|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2015-12-15|||March 2013||2013-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|FONIS12I2106||Periodontal Treatment in Non-controlled Type 2 Diabetes Mellitus Patients. Clinical Trial|Evaluation of the Effectiveness of Intensive Periodontal Treatment as Compared to Conventional Periodontal Treatment on the Level of Glycosylated Hemoglobin in Patients With Decompensated Type 2 Diabetes Mellitus: Randomized Clinical Trial|Completed||N/A|87|Actual|Universidad Los Andes, Chile||2|||f||||t||||||||||2017-10-11 01:28:28.816971|2017-10-11 01:28:28.816971
NCT01904409|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-03-02|||June 2013||2013-06-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis|A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early Decompensated Liver Cirrhosis|Completed||Phase 2|420|Actual|Valeant Pharmaceuticals International, Inc.||6|||f||||t||||||||||2017-10-11 01:28:29.031328|2017-10-11 01:28:29.031328
NCT01904396|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-07-17|||August 2013||2013-08-01|July 2013|2013-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|C001||Identification of Carnitine-Responsive Cardiomyopathy|Identification of Carnitine-responsive Cardiomyopathy and Myopathy in Adult Patients With Dilated and/or Hypertrophic Cardiomyopathy and Limb Girdle Weakness.|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 01:28:29.48317|2017-10-11 01:28:29.48317
NCT01904383|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-08-25|||July 2013||2013-07-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|||PMS of Trazenta on the Long-term Use as Add-on Therapy|Post Marketing Surveillance on Long Term Drug Use of Trazenta® Tablets as add-on Therapy in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||N/A|3640|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 01:28:29.647638|2017-10-11 01:28:29.647638
NCT01904357|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-07-20|||March 2013||2013-03-01|July 2017|2017-07-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Pediatric Cefazolin PK Study|USP and Dextrose Injection USP in the DUPLEX® Drug Delivery System in Pediatric Subjects of 10-12 Years (Inclusive) Scheduled for Surgery|Completed||Phase 1|12|Actual|B. Braun Medical Inc.||2|||f||||t||||||||||2017-10-11 01:28:31.588138|2017-10-11 01:28:31.588138
NCT01904344|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-05-27|||June 2013||2013-06-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NXT_SLEEP||Clinical Validation of New Breathing Sensors in Patients With Respiratory Insufficiency|NXT_SLEEP: the Development of a Next Generation Sleep Monitoring Platform|Completed||N/A|28|Actual|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-11 01:28:31.674829|2017-10-11 01:28:31.674829
NCT01904331|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2015-12-02|||June 2013||2013-06-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|January 2016|Anticipated|2016-01-01|1 Day|Observational [Patient Registry]|BLOC||Breast Cancer Long-term Outcome of Cardiac Dysfunction|Study of the Cardiovascular and Psychosocial Effects of the Treatment of Breast Cancer With Chemotherapy and/or Radiotherapy|Recruiting||N/A|700|Anticipated|University Medical Center Groningen|||2||f||||f||||||Samples With DNA|"     EDTA-plasma, Heparin-Lithium plasma, Serum, Frozen whole blood   "|||2017-10-11 01:28:31.885701|2017-10-11 01:28:31.885701
NCT01904318|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-02-11|||July 2013||2013-07-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|PDF inhibitor||A Phase I Study of IDP-73152 Mesylate in Health Male Volunteer|A Dose Block-randomized, Doubled, Placebo-controlled, Single Dose, Dose-escalation Clinical Phase I Study to Evaluate the Safety, Pharmacokinetics and Food|Completed||Phase 1|56|Actual|IlDong Pharmaceutical Co Ltd||7|||f||||f||||||||||2017-10-11 01:28:31.99285|2017-10-11 01:28:31.99285
NCT01904305|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-07-17|||January 2011||2011-01-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Observational|||Clinician Ability to Predict the Presence of Nosocomial Pneumonia Based on Bronchoscopic Findings|Clinician Ability to Predict the Presence of Nosocomial Pneumonia Based on Macroscopic Examination of Bronchoscopic Findings in Critically Ill Surgical Patients|Completed||N/A|30|Actual|University of Cincinnati|||1||f||||f||||||Samples Without DNA|"     Standard lavage specimens collected as part of standard of care and submitted for laboratory     evaluation   "|||2017-10-11 01:28:32.127635|2017-10-11 01:28:32.127635
NCT01904292|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-10-04|||August 15, 2013|Actual|2013-08-15|October 2017|2017-10-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Interventional|||A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis|A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Systemic Juvenile Idiopathic Arthritis|Completed||Phase 1|52|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:28:32.258168|2017-10-11 01:28:32.258168
NCT01904279|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-05-16|2017-01-24||July 2013||2013-07-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|JIGSAW 117|Safety population included all participants who received at least one dose of treatment and who had at least one post-dose safety assessment.|A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)|A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Polyarticular Juvenile Idiopathic Arthritis|Completed||Phase 1|52|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:28:32.490031|2017-10-11 01:28:32.490031
NCT01904266|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-11-24|||May 2013||2013-05-01|November 2015|2015-11-01||||March 2016|Anticipated|2016-03-01||Interventional|||Paravertebral Blocks for Breast Cancer Surgery|Combined General Anesthesia Plus Paravertebral Block Versus General Anesthesia Plus Opioid Analgesia for Breast Cancer Surgery: A Prospective Randomized Trial|Recruiting||N/A|60|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 01:28:33.54338|2017-10-11 01:28:33.54338
NCT01904253|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-07-11|||July 2013||2013-07-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy|An Open-Label, Randomized, Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin in Patients Requiring Second-Line Chemotherapy for Small Cell Lung Cancer That is Refractory or Sensitive to First-Line Platinum-Based Chemotherapy|Terminated||Phase 2|18|Actual|Taiho Oncology, Inc.||2||"The preliminary data does not suggest any safety signal, but an ad hoc interim analysis showed   an imbalance of PFS between the two arms"|f||||f||||||||||2017-10-11 01:28:33.665098|2017-10-11 01:28:33.665098
NCT01904240|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-11-11|||July 2013||2013-07-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Evaluation of a Biomarker Related to the GI Tract for the Diagnosis of Parkinson's Disease|Lipopolysaccharide Binding Protein as a Potential Biomarker of Parkinson's Disease|Completed||N/A|200|Actual|Rush University Medical Center|||2||f||||f||||||||||2017-10-11 01:28:33.805302|2017-10-11 01:28:33.805302
NCT01904227|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-11-09|||February 2012||2012-02-01|November 2014|2014-11-01|April 2015|Anticipated|2015-04-01|August 2014|Actual|2014-08-01||Interventional|REDBT||Intensified, Inpatient Adaptation of Dialectical Behavior Therapy (DBT)|A Randomized Controlled Study of the Efficacy of an Intensified, Inpatient Adaptation of Dialectical Behavior Therapy (DBT) for a Population of Borderline Patients (Young Adults/Adults: 18 - 40), Compared With Standard Outpatient DBT.|Unknown status|Active, not recruiting|N/A|150|Anticipated|Rivierduinen, Centre for Personality disorders Jelgersma||2|||f||||t||||||||||2017-10-11 01:28:33.878987|2017-10-11 01:28:33.878987
NCT01904214|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-06-02|||July 2013||2013-07-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function||Completed||Phase 1|16|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:28:33.992725|2017-10-11 01:28:33.992725
NCT01904201|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-07-07|||July 2013||2013-07-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|QFM||Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People|QuantiFERON® Monitor Test to Evaluate Immune Function in HIV Infected and Uninfected Control Study Subjects|Terminated||N/A|57|Actual|QIAGEN Gaithersburg, Inc|||1||f||||t||||||Samples With DNA|"     A portion of the study blood sample collected for the HIVVR test will be banked for future     HIV research using the HIVVR test. Specifically, this future research will involve the HIVVR     test for additional cell associated markers relating to HIV pathogenesis including (for     example) other markers of activation and senescence, apoptosis (programmed cell death) and     chemokine receptors (for HIV tropism).   "|||2017-10-11 01:28:34.092716|2017-10-11 01:28:34.092716
NCT01904188|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-08-29|||June 2015||2015-06-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Clinical Microbial Species and Antibiotic Resistance Identification in Patients Presenting to the Emergency Department With Three of Four Systemic Inflammatory Response Syndrome (SIRS) Criteria - is Rapid Identification Possible and Accurate?|Clinical Microbial Species and Antibiotic Resistance Identification in Patients Presenting to the Emergency Department With Three of Four Systemic Inflammatory Response Syndrome (SIRS) Criteria - is Rapid Identification Possible and Accurate?|Recruiting||N/A|300|Anticipated|Michigan State University|||1||f||||f||||||None Retained|"     No specimens will be retained after analysis by study investigators. Prior to being sent to     the laboratory they will be retained in frozen state until there is a large enough quantity     to batch run specimens.   "|||2017-10-11 01:28:34.185233|2017-10-11 01:28:34.185233
NCT01904175|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-05-03|||August 2013||2013-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|1 Year|Observational [Patient Registry]|||Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant|Registry Study of T Cell Depleted Allogeneic Non-Myeloablative Stem Cell Transplant Recipients|Completed||N/A|48|Actual|Duke University|||1||f||||f||||||||||2017-10-11 01:28:34.313517|2017-10-11 01:28:34.313517
NCT01904162|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-17|||February 2010||2010-02-01|July 2013|2013-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Effect of Age and Gender on the PK and Tolerability of Finafloxacin|Determination of the Effect of Age and Gender on the Pharmacokinetics and Tolerability of a Single Dose of Finafloxacin-HCL in Healthy Volunteers|Completed||Phase 1|40|Actual|MerLion Pharmaceuticals GmbH||4|||f||||f||||||||||2017-10-11 01:28:34.394879|2017-10-11 01:28:34.394879
NCT01904149|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-03-04|2015-02-09||May 2013||2013-05-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|DAVID lap|Intention-to-treat (ITT) population (which includes all patients randomized).|Oral Treatment for Gynaecological Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride|A Randomized, Double-blind, Placebo and Active-controlled, Parallel-group Study to Evaluate the Analgesic Efficacy and Safety of Dexketoprofen Trometamol and Tramadol Hydrochloride Oral Fixed Combination on Moderate to Severe Acute Pain Following Abdominal Hysterectomy|Completed||Phase 3|606|Actual|Menarini Group||6|||f||||f||||||||||2017-10-11 01:28:34.498097|2017-10-11 01:28:34.498097
NCT01904136|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-06-07|||April 2014|Actual|2014-04-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||NK Cells to Prevent Disease Relapse for Patients High Risk Myeloid Malignancies|A Phase I/II Clinical Trial of Natural Killer (NK) Cells Administration to Prevent Disease Relapse for Patient With High-Risk Myeloid Malignancies Undergoing Haploidentical Stem-Cell Transplantation|Recruiting||Phase 1/Phase 2|45|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:28:35.660464|2017-10-11 01:28:35.660464
NCT01904123|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-10-04|||March 2018|Anticipated|2018-03-01|October 2017|2017-10-01|March 2022|Anticipated|2022-03-01|March 2021|Anticipated|2021-03-01||Interventional|||A Phase I Trial of WP1066 in Patients With Recurrent Malignant Glioma and Brain Metastasis From Melanoma|A Phase I Trial of WP1066 in Patients With Recurrent Malignant Glioma and Brain Metastasis From Melanoma|Not yet recruiting||Phase 1|33|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:28:35.799659|2017-10-11 01:28:35.799659
NCT01904110|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2013-07-17|||December 2012||2012-12-01|July 2013|2013-07-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women|For 12months, the Multi Center, Randomized, Open-label Comparative Clinical Study to Evaluate the Efficacy and the Safety of Monthly(RisenexM Group) Versus Weekly Oral Risedronate(Risenexsplus Group) With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women(Phase IV)|Unknown status|Recruiting|Phase 4|176|Anticipated|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:28:35.922437|2017-10-11 01:28:35.922437
NCT01904097|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-17|||March 2013||2013-03-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Functional Neuroimaging in Fibromyalgia Patients Receiving tDCS|Study of the Brain With Optic Functional Neuroimaging in Patients With Chronic Pain Using Transcranial Direct Current Stimulation|Unknown status|Recruiting|Phase 2|34|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 01:28:36.028409|2017-10-11 01:28:36.028409
NCT01904084|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-06-07|||August 2013||2013-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Interventional|||Volar Locked Plating vs Bridging External Fixation in Distal Radius Fracture|A Randomized, Prospective Comparison of Volar Locked Plating Versus Hoffman II Bridging External Fixation in Patients With Dislocated Distal Radius Fractures, AO/OTA Type A.|Active, not recruiting||N/A|160|Actual|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 01:28:36.145864|2017-10-11 01:28:36.145864
NCT01904071|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-05-15|2013-12-26||October 2008||2008-10-01|May 2014|2014-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Ultrasound Guided Pain Control Versus Standard Treatment in Emergency Department HIP Fracture Patients|Ultrasound Guided Femoral (3 in 1) Nerve Block Versus Ultrasound Guided Fascia Iliacus Compartment Block Versus Standard Treatment for Pain Control in Patients With Hip Fractures in the Emergency Department|Completed||Phase 4|64|Actual|Maimonides Medical Center||3|||f||||f||||||||||2017-10-11 01:28:36.23565|2017-10-11 01:28:36.23565
NCT01904058|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-05-24|2016-04-01||August 2013||2013-08-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|CLARITY||Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate LUM001, an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTi) in Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primary Biliary Cirrhosis|Completed||Phase 2|66|Actual|Shire||2|||f||||t||||||||||2017-10-11 01:28:36.929735|2017-10-11 01:28:36.929735
NCT01904045|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-03-16|||May 2013||2013-05-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Observational|Pelicon||PEL-1235_REN-0176-I|A Multicentre, Prospective, Non-Interventional Study to Assess the Intra-patient Variability of Tacrolimus Once and Twice Daily After Kidney Transplantation|Recruiting||N/A|176|Anticipated|Technische Universität München|||1||f||||||||||||||2017-10-11 01:28:38.307864|2017-10-11 01:28:38.307864
NCT01904032|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-06-19|||September 2013||2013-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sunshine 2 Study for Women With Diabetes|Vitamin D Supplement to Women With Type 2 Diabetes|Recruiting||Phase 2|180|Anticipated|Loyola University||2|||f||||t||||||||||2017-10-11 01:28:38.389037|2017-10-11 01:28:38.389037
NCT01904019|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-09-19|||April 2013||2013-04-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Observational|||Comparison of ARPE Prosthesis With the Literature|Trapezia-metacarpal Arthroplasty: Comparison of ARPE Prosthesis With the Literature|Active, not recruiting||N/A|100|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-11 01:28:38.513525|2017-10-11 01:28:38.513525
NCT01904006|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-08-01|||April 30, 2013|Actual|2013-04-30|March 2017|2017-03-01|October 2016|Actual|2016-10-01|November 17, 2015|Actual|2015-11-17||Interventional|AGRUPADO||Impact of Human Embryo Culture System on Live Birth|Improvement of Live Birth Rate With a New Standardized Human Embryo Culture System: a Prospective, Randomized, Controlled Trial|Completed||N/A|182|Actual|IVI Sevilla||2|||f||||f|f|f||||||||2017-10-11 01:28:38.584986|2017-10-11 01:28:38.584986
NCT01903629|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-07-19|||November 2011||2011-11-01|July 2015|2015-07-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Comparative Study of the Magnetic-controlled Capsule Endoscopy Versus Standard Gastroscopy|A Double-center Self-controlled Comparative Study of the Magnetic-controlled Capsule Endoscopy Versus Standard Gastroscopy for Gastric Diseases|Completed||Phase 1/Phase 2|70|Actual|Changhai Hospital||1|||f||||t||||||||||2017-10-11 01:28:45.493926|2017-10-11 01:28:45.493926
NCT01903993|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-07-28|2016-11-16|2016-06-15|August 6, 2013|Actual|2013-08-06|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|November 19, 2015|Actual|2015-11-19||Interventional||Intent to treat (ITT) population for efficacy analyses included all randomized participants, regardless of whether they received any study drug. In the efficacy analyses, the ITT population, participants were grouped according to the treatment arm to which they were assigned.|"A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - POPLAR"|A Phase II, Open-label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of MPDL3280A (Anti−PD-L1 Antibody) Compared With Docetaxel in Patients With Non−Small Cell Lung Cancer After Platinum Failure|Active, not recruiting||Phase 2|287|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:28:38.699551|2017-10-11 01:28:38.699551
NCT01903980|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-17|||June 2013||2013-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01|2 Years|Observational [Patient Registry]|epipericardial||Epipericardial Fat Necrosis: A Misdiagnosed Condition|Epipericardial Fat Necrosis: A Misdiagnosed Condition|Completed||N/A|10|Actual|Hospital Sirio-Libanes|||1||f||||t||||||||||2017-10-11 01:28:39.732225|2017-10-11 01:28:39.732225
NCT01903967|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-01-20|||September 2013||2013-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|PITUIGENE||Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)|Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)|Completed||N/A|213|Actual|Hospices Civils de Lyon|||2||f||||f||||||Samples With DNA|"     Pituitary tumour DNA may be extracted from frozen or paraffin-embedded tumours.   "|||2017-10-11 01:28:39.841507|2017-10-11 01:28:39.841507
NCT01903954|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-11-01||2016-07-07|January 2011||2011-01-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of ANA598 Administered With Pegylated Interferon and Ribavirin in Genotype 1 Patients With Chronic Hepatitis C Infection|Completed||Phase 2|283|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:28:39.917597|2017-10-11 01:28:39.917597
NCT01903941|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2013-07-17|||December 2006||2006-12-01|July 2013|2013-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Anti-inflammatory Effect of Aerobic Exercise in Individual With Increased Cardiovascular Risk|Anti-inflammatory Effect of Aerobic Exercise in Individual With Increased Cardiovascular Risk|Completed||Phase 2|68|Actual|Escola Bahiana de Medicina e Saude Publica||2|||f||||t||||||||||2017-10-11 01:28:40.000233|2017-10-11 01:28:40.000233
NCT01903928|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-02-05|||May 2013||2013-05-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell Transplant|An Open Phase 2 Trial to Evaluate Safety of a Cytomegalovirus (CMV) Therapeutic Vaccine, ASP0113, in Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)|Completed||Phase 2|9|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-10-11 01:28:40.105077|2017-10-11 01:28:40.105077
NCT01903915|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-17|||July 2012||2012-07-01|July 2013|2013-07-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Observational|||Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia|Resting-state Magnetic Resonance Imaging of Brain in Patients With Schizophrenia Compared With Healthy Controls to Prove the Association Between Social Cognition Dysfunction and Abnormality of Brain Function|Unknown status|Recruiting|N/A|100|Anticipated|Asan Medical Center|||2||f||||t||||||||||2017-10-11 01:28:40.191251|2017-10-11 01:28:40.191251
NCT01903902|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-18|||June 2013||2013-06-01|July 2013|2013-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries|The Efficacy and Safety of Paclitaxel-eluting SeQuent Please Drug-Eluting Balloon for Treatment of lesiOns in Native smalL coronarY Arteries (DEB-ONLY)|Unknown status|Recruiting|Phase 4|1000|Anticipated|Gachon University Gil Medical Center||1|||f||||t||||||||||2017-10-11 01:28:40.268698|2017-10-11 01:28:40.268698
NCT01903889|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-01-08|||January 2013||2013-01-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Male Engagement in PMTCT Services|Promoting Constructive Male Engagement to Increase Use of Prevention of Mother to Child Transmission (PMTCT) Services|Completed||N/A|3806|Actual|FHI 360||2|||f||||f||||||||||2017-10-11 01:28:40.455948|2017-10-11 01:28:40.455948
NCT01903876|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-07-22|2014-04-29||February 2010||2010-02-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|RealConsent||A Web-based Bystander Education Program|Preventing Violence Against Women: A Web-based Approach|Completed||N/A|743|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:28:40.589285|2017-10-11 01:28:40.589285
NCT01903863|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-05-25|2017-03-27||July 2013||2013-07-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|February 18, 2016|Actual|2016-02-18||Interventional|||The Effect of Prophylactic FFP Administration on ECMO Circuit Longevity|Prospective, Randomized Pilot Study of Prophylactic Fresh Frozen Plasma Administration During Neonatal-Pediatric Extracorporeal Membrane Oxygenation.|Completed||N/A|31|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:28:41.262425|2017-10-11 01:28:41.262425
NCT01903850|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-02-01|||July 2013||2013-07-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|TAO||TruFreeze™ Airway Obstruction: TAO STUDY|"A PROSPECTIVE, MULTI-CENTER PILOT STUDY OF THE truFREEZE™ SYSTEM TO ASSESS THE EFFICACY AND SAFETY OF CRYO SPRAY ABLATION IN THE TREATMENT OF AIRWAY OBSTRUCTIONS (TruFreeze AIRWAY OBSTRUCTION - TAO STUDY)"|Withdrawn||Phase 4|0|Actual|CSA Medical, Inc.||1||Withdrawn for business reasons|f||||t||||||||No||2017-10-11 01:28:41.728256|2017-10-11 01:28:41.728256
NCT01903837|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2015-04-07||2015-04-07|June 2013||2013-06-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||A Study of ALKS 3831 in Adults With Schizophrenia|A Phase 2, Randomized, Multicenter, Safety, Tolerability, and Dose-Ranging Study of Samidorphan, a Component of ALKS 3831, in Adults With Schizophrenia Treated With Olanzapine|Completed||Phase 2|309|Actual|Alkermes, Inc.||4|||f||||t||||||||||2017-10-11 01:28:41.838996|2017-10-11 01:28:41.838996
NCT01902485|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-03-03|||July 2013||2013-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Quickstart||Study of Immediate Start of Progestin Contraceptives in Medical Abortion|Immediate Initiation of Progestin Contraceptives in First Trimester Medical Abortion: A Randomized Controlled Trial|Completed||Phase 4|937|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 01:29:01.735714|2017-10-11 01:29:01.735714
NCT01903824|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-04-02|||August 2013||2013-08-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects|A Double-Blind, Placebo- and Positive-Controlled, Randomized, Partial 6-way Crossover Study to Investigate the Pharmacodynamics and Pharmacokinetics of CEP-26401 (5, 25, and 125 μg) Following Single-Dose Administration to Healthy Subjects|Completed||Phase 1|40|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 01:28:42.05205|2017-10-11 01:28:42.05205
NCT01903811|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-02-23|||October 2013||2013-10-01|February 2017|2017-02-01||||February 2018|Anticipated|2018-02-01||Interventional|||S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma|A Phase II Randomized Study Comparing Two Doses of Carfilzomib (NSC-756640) With Dexamethasone for Multiple Myeloma Patients With Relapsed or Refractory Disease|Active, not recruiting||Phase 2|143|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 01:28:42.203484|2017-10-11 01:28:42.203484
NCT01903798|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-04-15|||December 2014||2014-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis|A Phase II, Multicenter, Randomized, Open-label Study to Investigate the Safety and Efficacy of Mycophenolate Mofetil and Rilonacept (Anti-interleukin-1) in Patients With Alcoholic Hepatitis|Completed||Phase 2|5|Actual|Southern California Institute for Research and Education||4|||f||||t||||||||||2017-10-11 01:28:43.581462|2017-10-11 01:28:43.581462
NCT01903785|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-10-31|||May 2013||2013-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|December 2014|Actual|2014-12-01||Interventional|||Salbutamol, Pharmacogenetics and Breathing Mechanics|The Pharmacogenetic Effects of Inhaled Salbutamol on Breathing Mechanics and Cycling Performance|Completed||Phase 4|94|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:28:43.71856|2017-10-11 01:28:43.71856
NCT01903772|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-03-01|||April 2013||2013-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|IMTCO||Effects of Inspiratory Muscle Training in Chronic Obstructive Pulmonary Disease (COPD)||Completed||N/A|72|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||t||||||||||2017-10-11 01:28:43.829194|2017-10-11 01:28:43.829194
NCT01903759|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-18|||September 2007||2007-09-01|July 2013|2013-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Kinetics of Inflammation Markers in Maternal Plasma: Study of the Correlation With the Diagnosis of Chorioamnionitis in Women Hospitalized for Spontaneous Rupture of the Fetal Membranes|Kinetics of Inflammation Markers in Maternal Plasma (Interleukins, Matrix Metalloproteinases -MMP): Study of the Correlation With the Diagnosis of Chorioamnionitis in Women Hospitalized for Spontaneous Rupture of the Fetal Membranes (SPROM) Before 34 Weeks of Amenorrhea (WA) With no Modification in the Usual Therapy.|Terminated||N/A|97|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||f||||||||||2017-10-11 01:28:43.922747|2017-10-11 01:28:43.922747
NCT01903746|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-17|||October 2010||2010-10-01|July 2013|2013-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Epidemiology of Septic Shock in Medical or Polyvalent ICU in the North-East Region of France||Terminated||N/A|1495|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 01:28:44.031695|2017-10-11 01:28:44.031695
NCT01903733|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-09-28|||August 28, 2013|Actual|2013-08-28|September 2017|2017-09-01|April 3, 2020|Anticipated|2020-04-03|April 3, 2020|Anticipated|2020-04-03||Interventional|||Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008|An Open-label Bosutinib Treatment Extension Study For Subjects With Chronic Myeloid Leukemia (Cml) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008|Recruiting||N/A|300|Anticipated|Pfizer|||||t||||f||||||||||2017-10-11 01:28:44.103661|2017-10-11 01:28:44.103661
NCT01903707|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-12-04|||May 2013||2013-05-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||Cognitive Remediation in Schizophrenia|Cognitive Remediation in Schizophrenia: Effects on Brain Structure, Brain Function and Social Outcome.|Unknown status|Recruiting|N/A|80|Anticipated|University of Dublin, Trinity College||2|||f||||f||||||||||2017-10-11 01:28:44.834143|2017-10-11 01:28:44.834143
NCT01903694|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2014-05-12|||March 2010||2010-03-01|July 2013|2013-07-01||||November 2013|Actual|2013-11-01||Interventional|||Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma||Completed||Phase 3|474|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 01:28:44.925722|2017-10-11 01:28:44.925722
NCT01903681|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-04-03|||March 2013||2013-03-01|June 2013|2013-06-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances|Open Label, Single Ascending Dose, Cross-over Study to Assess the Pharmacokinetics of Circadin® (Prolonged-Release Melatonin) Mini Tablets in Children With Neurodevelopmental Disorders and Sleep Disturbances|Completed||Phase 1|16|Actual|Neurim Pharmaceuticals Ltd.||2|||f||||t||||||||||2017-10-11 01:28:45.003312|2017-10-11 01:28:45.003312
NCT01903668|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-17|||April 2012||2012-04-01|July 2013|2013-07-01||||April 2014|Anticipated|2014-04-01||Observational|||Determination of the Nature of the Endogenous Ligand of TREM-1 and Its Use as a New Diagnostic Biomarker in Sepsis||Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 01:28:45.101981|2017-10-11 01:28:45.101981
NCT01903655|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-18|||April 2010||2010-04-01|July 2013|2013-07-01||||April 2014|Anticipated|2014-04-01||Interventional|||Study of the Telomere-telomerase System and the Expression of Candidate Genes in the Leukocytes of Patients With Depressive Disorder: Search for Peripheral Markers of Somatic Stress||Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f||||||||||||||2017-10-11 01:28:45.281277|2017-10-11 01:28:45.281277
NCT01903642|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2013-07-17|||March 2010||2010-03-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Interventional|Proteome||Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.||Terminated||N/A|97|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 01:28:45.406481|2017-10-11 01:28:45.406481
NCT01903616|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-07-23|||July 2009||2009-07-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|December 2017|Anticipated|2017-12-01||Observational|||A Longitudinal Study of Movement and Participation in Life Activities of Young Children With Cerebral Palsy in Taiwan|A Longitudinal Study of Movement and Participation in Life Activities of Young Children With Cerebral Palsy in Taiwan|Recruiting||N/A|200|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||||||2017-10-11 01:28:45.60486|2017-10-11 01:28:45.60486
NCT01903603|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-09-07|||August 2012||2012-08-01|September 2016|2016-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||A Longitudinal Study of Movement and Participation in Patients With Cerebral Palsy|A Longitudinal Study of Movement and Participation in Patients With Cerebral Palsy: a Combined Brain Imaging and Kinematic Analysis|Completed||N/A|80|Actual|Chang Gung Memorial Hospital|||2||f||||t||||||||||2017-10-11 01:28:45.680252|2017-10-11 01:28:45.680252
NCT01903590|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2014-06-28|||June 2013||2013-06-01|March 2014|2014-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||TVT Versus TOT in Urinary Stress Incontinence With No Intrinsic Sphincter Deficiency|PROSPECTIVE RANDOMIZED STUDY COMPARING TVT AND TOT IN FEMALE STRESS URINARY INCONTINENCE WITH NO INTRINSIC SPHINCTER DEFICIENCY|Completed||N/A|100|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-11 01:28:45.749382|2017-10-11 01:28:45.749382
NCT01903577|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-16|||September 2012||2012-09-01|July 2013|2013-07-01||||December 2013|Anticipated|2013-12-01||Interventional|||Comparative Ergonomic Analysis of Robotic Versus Laparoscopic Surgery|Comparative Ergonomic Analysis of Robotic Versus Laparoscopic Surgery|Unknown status|Recruiting|N/A|42|Anticipated|Washington University School of Medicine||3|||f||||f||||||||||2017-10-11 01:28:45.826263|2017-10-11 01:28:45.826263
NCT01903551|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2016-10-24|||May 2013||2013-05-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Interventional|||Loco-regional Analgesia for Post-operative Pain Management in Cardiac Surgery|Phase 3 Study of Post-operative Pain Management With Loco-regional Analgesia in Minithoracotomy for Cardiac Surgery. A Randomized Controlled Trial|Completed||Phase 3|56|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-10-11 01:28:46.036002|2017-10-11 01:28:46.036002
NCT01903538|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2013-07-16|||July 2011||2011-07-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Interference With Cognitive Control by Transcranial Direct Current Stimulation||Completed||N/A|28|Actual|University Hospital Tuebingen||2|||f||||||||||||||2017-10-11 01:28:46.10644|2017-10-11 01:28:46.10644
NCT01903525|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-05-09|||September 2013||2013-09-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||DHA For The Treatment of Pediatric Concussion Related to Sports Injury|Docosahexaenoic Acid (DHA) For The Treatment of Pediatric Concussion Related to Sports Injury|Recruiting||Phase 1|40|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||No||2017-10-11 01:28:46.175478|2017-10-11 01:28:46.175478
NCT01903512|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-07-16|||November 2010||2010-11-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Observational|||Arthrocentesis and Temporomandibular Joint Disorders a Conservative Alternative to Surgical Treatments||Completed||N/A|30|Actual|Università degli Studi di Sassari|||1||f||||f||||||||||2017-10-11 01:28:46.442092|2017-10-11 01:28:46.442092
NCT01903499|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-04-08|||March 2013||2013-03-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Satiety Effects of Beef Compared to Beans|Satiety Effects of Beef Compared to Beans|Completed||N/A|28|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:28:46.555416|2017-10-11 01:28:46.555416
NCT01903486|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-09-12|||March 2013||2013-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Assessing the Efficacy of Steroid Treatment of Achalasia|A Pilot Study Assessing the Efficacy of Steroids in the Treatment of Achalasia|Enrolling by invitation||Phase 4|10|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:28:46.664863|2017-10-11 01:28:46.664863
NCT01903473|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-16|||July 2013||2013-07-01|July 2013|2013-07-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)|Donor Regulatory T Cells (Treg) Infusion (DTI) in Patients With Steroid-refractory Chronic Graft-versus-host Disease (GVHD)|Unknown status|Recruiting|Phase 2|35|Anticipated|University Hospital of Liege||2|||f||||f||||||||||2017-10-11 01:28:46.766818|2017-10-11 01:28:46.766818
NCT01903460|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2015-11-02|2015-11-02||August 2013||2013-08-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|IMAGO|All randomized participants|Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille Syndrome|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LUM001, an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Paediatric Patients With Alagille Syndrome|Completed||Phase 2|20|Actual|Shire||2|||f||||t||||||||||2017-10-11 01:28:46.930819|2017-10-11 01:28:46.930819
NCT01903447|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-05-30|||September 2013||2013-09-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment|Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment|Recruiting||Phase 4|200|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-11 01:28:47.903871|2017-10-11 01:28:47.903871
NCT01903434|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-01-08|||July 2013||2013-07-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study of Evacetrapib (LY2484595) in Healthy Participants|A Bioequivalence Study in Healthy Subjects Administered Evacetrapib Tablets of Varying Tablet Solid Fractions|Completed||Phase 1|60|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:28:47.991479|2017-10-11 01:28:47.991479
NCT01903421|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-03-27|||March 2014||2014-03-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Inhalational Anesthesia and Precipitation of Dementia: is There a Link?|Inhalational Anesthesia and Precipitation of Dementia: is There a Link? A Prospective, Multicenter, Randomized, Controlled Clinical Trial Comparing Two Different Anesthetic Techniques in Elderly Patients|Recruiting||N/A|500|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:28:48.071137|2017-10-11 01:28:48.071137
NCT01903408|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-05-01|||May 2009||2009-05-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|July 2018|Anticipated|2018-07-01||Interventional|PLATIN||Radiotherapy of the Prostate and the Pelvic Lymph Nodes After Neoadjuvant Antihormonal Treatment|Prostate and Whole Pelvis Irradiation With Integrated-boost Intensity-modulated Radiotherapy (IMRT) After Neoadjuvant Antihormonal Treatment - a Phase II Trial|Recruiting||Phase 2|200|Anticipated|Heidelberg University||5|||f||||f||||||||||2017-10-11 01:28:48.191198|2017-10-11 01:28:48.191198
NCT01903395|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-10-24|||March 2012||2012-03-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|FAMKOL||Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer|Nurse-led Colon Cancer Risk Counseling for First-degree Relatives to Enhance Use of Colonoscopy|Completed||N/A|313|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-10-11 01:28:48.292202|2017-10-11 01:28:48.292202
NCT01903382|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-11-07|||January 2006||2006-01-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Circadian, Weekly and Seasonal Variability of Postoperative Mortality and Morbidity (Zirkadianest)|The Association Between Circadian, Weekly, and Seasonal Effects and Time of Surgery on Postoperative Morbidity and Mortality of Patients (Zirkadianest)|Completed||N/A|247506|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 01:28:48.445124|2017-10-11 01:28:48.445124
NCT01903369|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-07-16|||January 2014||2014-01-01|July 2013|2013-07-01|January 2015|Anticipated|2015-01-01|June 2014|Anticipated|2014-06-01||Observational|||Comparison of Intraneural and Extraneural Young's Modulus Using Shear Wave Elastography|Comparison of Intraneural and Extraneural Young's Modulus Using Shear Wave Elastography in Patients Undergoing Regional Anaesthesia|Unknown status|Not yet recruiting|N/A|48|Anticipated|University of Dundee|||1||f||||f||||||||||2017-10-11 01:28:48.525036|2017-10-11 01:28:48.525036
NCT01903356|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-08-25|||July 11, 2013|Actual|2013-07-11|August 2017|2017-08-01|June 10, 2017|Actual|2017-06-10|May 30, 2017|Actual|2017-05-30||Observational|||A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea|A Regulatory Requirement Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta Duo® (Linagliptin/Metformin HCl, 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/1000 mg, b.i.d) in Korean Patients With Type 2 Diabetes Mellitus|Completed||N/A|724|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 01:28:48.770753|2017-10-11 01:28:48.770753
NCT01903343|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-10-28|||December 2013||2013-12-01|October 2013|2013-10-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Repeatability and Reproducibility of the Measurement of Young's Modulus Using Shear Wave Elastography in Volunteers|Repeatability and Reproducibility of the Measurement of Young's Modulus Using Shear Wave Elastography in Volunteers|Unknown status|Not yet recruiting|N/A|8|Anticipated|University of Dundee|||1||f||||f||||||||||2017-10-11 01:28:48.85624|2017-10-11 01:28:48.85624
NCT01903330|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-12-28|||March 2014||2014-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme|A Randomized, Double-blinded, Placebo-controlled Study of (ERC1671/GM-CSF/Cyclophosphamide)+Bevacizumab vs. (Placebo Injection/Placebo Pill) +Bevacizumab in the Treatment of Recurrent/Progressive, Bevacizumab naïve Glioblastoma Multiforme and Glioasarcoma Patients (WHO Grade IV Malignant Gliomas, GBM)|Recruiting||Phase 2|84|Anticipated|University of California, Irvine||2|||f||||t||||||||No||2017-10-11 01:28:48.941499|2017-10-11 01:28:48.941499
NCT01903317|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-10-07|||June 2013||2013-06-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Evaluation of Vitamin D Levels in Psoriasis Patients|Evaluation of Vitamin D Levels in Psoriasis Patients|Withdrawn||N/A|0|Actual|University of California, Irvine|||3|No subjects enrolled|f||||f||||||Samples Without DNA|"     For all Vitamin D level testing in this protocol, the Vitamin D 25-hydroxy level will be     drawn, which involves 0.5mL of blood per draw.   "|||2017-10-11 01:28:49.06897|2017-10-11 01:28:49.06897
NCT01903304|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2015-11-04|||May 2011||2011-05-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|OOS||Immunological Impact of High Olive Oil Consumption|Immunological Impact of High Olive Oil Consumption|Completed||N/A|41|Actual|Tufts University||2|||f||||f||||||||||2017-10-11 01:28:49.147804|2017-10-11 01:28:49.147804
NCT01903291|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2016-07-22|||August 2013||2013-08-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|RESPOND||Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS|A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate|Completed||N/A|333|Actual|Biogen|||1||f||||f||||||||||2017-10-11 01:28:49.242474|2017-10-11 01:28:49.242474
NCT01903278|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2015-09-24|||June 2013||2013-06-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C|Multi-center, Randomized, Open-label, Parallel-group, Active Controlled Study for the Efficacy and Safety of Pegylated Recombinant Consensus Interferon Variant Solution for Injection in the Treatment of Chronic Hepatitis C|Completed||Phase 3|719|Actual|Beijing Kawin Technology Share-Holding Co., Ltd.||4|||f||||f||||||||||2017-10-11 01:28:49.459863|2017-10-11 01:28:49.459863
NCT01903265|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-10-31|2016-07-15||September 2013||2013-09-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|BESTFIT||BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)|A Phase 2b, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients With Fibromyalgia|Completed||Phase 2/Phase 3|205|Actual|Tonix Pharmaceuticals, Inc.||2|||f||||f||||||||Undecided||2017-10-11 01:28:49.63992|2017-10-11 01:28:49.63992
NCT01901926|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-07-15|||December 2012||2012-12-01|July 2013|2013-07-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||Periodontal Treatment and Glycemic Control|Impact of Non Surgical Periodontal Treatment on Glycemic Control in Type II Diabetics|Unknown status|Active, not recruiting|N/A|184|Actual|Pakistan Institute of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:29:09.359606|2017-10-11 01:29:09.359606
NCT01903239|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-02-04|||November 2011||2011-11-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas|Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas|Active, not recruiting||N/A|179|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 01:28:50.055686|2017-10-11 01:28:50.055686
NCT01903226|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-10-04|||January 2013||2013-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Intervention Study to Assess the Effects of Moderate and High Intensity Aerobic Training on Physical Capacity and Activity Level in Persons With Incomplete Spinal Cord Injury|High Intensity Aerobic Training in Persons With Incomplete Spinal Cord Injury|Active, not recruiting||N/A|30|Actual|Sunnaas Rehabilitation Hospital||3|||f||||t||||||||||2017-10-11 01:28:50.124507|2017-10-11 01:28:50.124507
NCT01903213|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-10-02|||March 1, 2013|Actual|2013-03-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis|Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis|Recruiting||N/A|100|Anticipated|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:28:52.32803|2017-10-11 01:28:52.32803
NCT01903200|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-17|2017-02-14|||February 2010||2010-02-01|February 2017|2017-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder|Phase I Study of FK949E - Multiple Dose Study of Elderly Adult Patients With Major Depressive Disorder|Completed||Phase 1|16|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:28:52.443971|2017-10-11 01:28:52.443971
NCT01903187|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-05-24|2015-10-15||October 2013||2013-10-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|June 2014|Actual|2014-06-01||Interventional|EnligHTN-IV|All subjects enrolled.|EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension|Multi-center, Randomized, Single-blind, Sham Controlled Clinical Investigation of Renal Denervation for Uncontrolled Hypertension|Terminated||N/A|4|Actual|St. Jude Medical|Enrollment ended early due to a sponsor decision unrelated to safety. The 2 treatment group subjects are being followed up through 3 years. The 2 sham group subjects were exited after their 1 month visit. Due to these reasons, data is limited.|2||"There were no safety or effectiveness concerns. There were concerns about completing enrollment   due to a competitive device's potential approval."|f||||t||||||||No||2017-10-11 01:28:52.566461|2017-10-11 01:28:52.566461
NCT01903174|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2014-03-21|||June 2012||2012-06-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|ASPIRE||Study of AeroForm Tissue Expander for Breast Reconstruction|AeroForm Patient Controlled Tissue Expansion for Breast Reconstruction|Completed||N/A|21|Actual|AirXpanders, Inc.||1|||f||||t||||||||||2017-10-11 01:28:53.628165|2017-10-11 01:28:53.628165
NCT01903161|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-06-07|||May 2013||2013-05-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|RIPC||Effect of Delayed Remote Ischemic Preconditioning on Myocardial Injury|Effect of Delayed Remote Ischemic Preconditioning on Myocardial Injury in Patients Undergoing Cardiac Valve Replacement Surgery|Completed||N/A|160|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:28:53.715592|2017-10-11 01:28:53.715592
NCT01903148|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-11-08|2013-08-22||October 2011||2011-10-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|ACERCA||Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations|ANEMIA MANAGEMENT IN CHRONIC KIDNEY DISEASE NOT ON DIALYSIS PATIENTS AFTER THE ERBP WORKING GROUP RECOMMENDATIONS|Completed||N/A|455|Actual|Fundación Senefro|||1||f||||f||||||||||2017-10-11 01:28:53.844996|2017-10-11 01:28:53.844996
NCT01903135|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-01-31|||September 2013||2013-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|BIO-OHS||Prevalence of Obesity Hypoventilation Syndrome|Prevalence of Obesity Hypoventilation Syndrome in Subjects With Obesity Referred to Clinical (Medical Analysis) Laboratories for Regular Follow-up|Completed||N/A|1004|Actual|AGIR à Dom||3|||f||||f||||||||Undecided||2017-10-11 01:28:54.321459|2017-10-11 01:28:54.321459
NCT01903122|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-16|||February 2009||2009-02-01|July 2013|2013-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions|Completed||Early Phase 1|26|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 01:28:54.455784|2017-10-11 01:28:54.455784
NCT01903109|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-11-26|||February 2009||2009-02-01|November 2013|2013-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions|Completed||Early Phase 1|27|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 01:28:54.54689|2017-10-11 01:28:54.54689
NCT01903096|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-04-03|||March 2014||2014-03-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|PsychPC||Treating Emotional Disorders in Primary Care With Psychological Techniques|A Pilot Study to Treat Emotional Disorders in Primary Care With Evidence-based Psychological Techniques: A Randomized Controlled Trial|Recruiting||N/A|1126|Anticipated|Psicofundación: Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicolo||2|||f||||f||||||||||2017-10-11 01:28:54.653702|2017-10-11 01:28:54.653702
NCT01903083|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-04-03|||July 2013||2013-07-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CRIT||Chemoimmunotherapy and Radiation in Pancreatic Cancer|Phase I Trial of Chemoimmunotherapy and Hypofractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.|Active, not recruiting||Phase 1|10|Actual|Providence Health & Services||1|||f||||f||||||||No||2017-10-11 01:28:54.819362|2017-10-11 01:28:54.819362
NCT01903070|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-03-01|||July 11, 2013|Actual|2013-07-11|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment|EFFECTS OF LINAGLIPTIN ON ACTIVE GLP-1 CONCENTRATIONS IN SUBJECTS WITH RENAL IMPAIRMENT|Completed||Phase 4|99|Actual|Profil Institut für Stoffwechselforschung GmbH||2|||f||||f||||||||||2017-10-11 01:28:54.960203|2017-10-11 01:28:54.960203
NCT01903057|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-05-21|||February 2014||2014-02-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|March 2014|Anticipated|2014-03-01||Interventional|AZIVAL2||Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis|AZIVAL 2: A Double-blind Cluster-randomized Placebo-controlled Study on the Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults With Azithromycin, Ivermectin and Albendazole|Withdrawn||Phase 4|0|Actual|Emory University||2||"As of November 2013, the security situation in rural Northern Mozambique is no longer suitable   for this clinical trial."|f||||t||||||||||2017-10-11 01:28:55.072509|2017-10-11 01:28:55.072509
NCT01903044|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-06-26|||September 2013||2013-09-01|July 2013|2013-07-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating|Multicentric Study of the Autologous Bone Marrow-derived Mononuclear Cells Injection for Treatment of the Patients With Critical Lower Extremity Ischemia|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|Pontifícia Universidade Católica do Paraná||1|||f||||f||||||||||2017-10-11 01:28:55.261071|2017-10-11 01:28:55.261071
NCT01903018|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-09-03|||July 2012||2012-07-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00|A Multicenter, Phase II/III Study to Assess Radiation Induced Mucositis in Subjects With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Administered Cisplatin and Radiation With or Without P276-00|Completed||Phase 2|73|Actual|Piramal Enterprises Limited||1|||f||||f||||||||||2017-10-11 01:28:55.643158|2017-10-11 01:28:55.643158
NCT01903005|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-09-28|2015-08-17||July 2013||2013-07-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Safety population|Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence|A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219|Completed||Phase 4|668|Actual|Orexo AB||1|||f||||f||||||||||2017-10-11 01:28:55.960587|2017-10-11 01:28:55.960587
NCT01902992|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-03-20|||March 2012||2012-03-01|March 2017|2017-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|INSIDE||Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Intraseasonal Specific Short-term Immunotherapy With Depigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract (Depiquick® Birch) in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma|Completed||Phase 3|202|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:28:56.775895|2017-10-11 01:28:56.775895
NCT01902979|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2013-09-09|||September 2013||2013-09-01|September 2013|2013-09-01||||September 2015|Anticipated|2015-09-01||Interventional|SSPANLI||The Spinal Stenosis Pedometer and Nutrition e-Health Lifestyle Intervention (SSPANLI) Trial|The Spinal Stenosis Pedometer and Nutrition e-Health Lifestyle Intervention (SSPANLI) Randomized Trial|Unknown status|Recruiting|N/A|88|Anticipated|Mount Royal University||2|||f||||f||||||||||2017-10-11 01:28:57.402553|2017-10-11 01:28:57.402553
NCT01902966|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-02-06|||September 2013||2013-09-01|February 2017|2017-02-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)|Effect of a Beta Adrenergic Blockade Combined With Relaxation/Guided Imagery Audio Intervention on Symptom Distress in Women With Advanced, Recurrent Incurable Cervical Cancer - Feasibility Study|Active, not recruiting||N/A|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:28:57.49866|2017-10-11 01:28:57.49866
NCT01902953|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-08-12|||March 2013||2013-03-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)|Prospective, Open-Label, Ex Vivo Comparison Study of Lymphoseek® and Vital Blue Dye (VBD) as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC) Patients' Excised Colon w/ Abdominal Lymphatic Bed|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|Maimonides Medical Center||1|||f||||f||||||||||2017-10-11 01:28:57.631996|2017-10-11 01:28:57.631996
NCT01902940|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-08-31|||June 2013||2013-06-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Natural History in CCFDN and IBM Syndromes|Retrospective Cohort Study Assessing the Natural Course in Congenital Cataract Facial Dysmorphism Neuropathy Syndrome (CCFDN) and Sporadic and Hereditary Inclusion Body Myopathies (IBM)|Completed||N/A|350|Actual|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||||2017-10-11 01:28:57.741872|2017-10-11 01:28:57.741872
NCT01902927|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-16|||July 2013||2013-07-01|July 2013|2013-07-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|DVD||Modulation of Dyspnea Perception During Exercise in COPD Patients Using Attentional Distraction|Modulation of Dyspnea Perception During Exercise in COPD Patients Using Attentional Distraction : a Pilot Study|Unknown status|Not yet recruiting|N/A|10|Anticipated|Laval University||1|||f||||||||||||||2017-10-11 01:28:57.838072|2017-10-11 01:28:57.838072
NCT01902901|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-08-22|||January 2014||2014-01-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|January 2017|Actual|2017-01-01||Interventional|NextGen||Clinical Implementation of Carrier Status Using Next Generation Sequencing|Clinical Implementation of Carrier Status Using Next Generation Sequencing|Active, not recruiting||N/A|384|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 01:28:58.061655|2017-10-11 01:28:58.061655
NCT01901913|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-04-15|||October 2013||2013-10-01|November 2014|2014-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals Management|MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals Management|Completed||N/A|26|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 01:29:09.454211|2017-10-11 01:29:09.454211
NCT01902888|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2015-06-17|2015-05-19||July 2013||2013-07-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|PAA 12-01||Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm|Retrospective Evaluation of the GORE® VIABAHN® Endoprosthesis for a Popliteal Artery Aneurysm Indication|Terminated||N/A|3|Actual|W.L.Gore & Associates|Early termination of study. No subject analysis done||1|Closed due to internal and external factors.|f||||f||||||||||2017-10-11 01:28:58.156652|2017-10-11 01:28:58.156652
NCT01902875|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2013-07-16|||June 2013||2013-06-01|July 2013|2013-07-01||||December 2014|Anticipated|2014-12-01||Observational|||Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy|Preconditioning Chemotherapy Combined With Cytokine Induced Killer Cell Immunotherapy in Advanced Non Small Cell Lung Cancer|Unknown status|Recruiting|N/A|100|Anticipated|Jinling Hospital, China|||2||f||||t||||||||||2017-10-11 01:28:58.327316|2017-10-11 01:28:58.327316
NCT01902862|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2014-03-31|||February 2006||2006-02-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular Lymphoma|Pilot Study With Bortezomib in Combination With Rituximab Standard Therapy in Patients With Relapsed or Refractory Follicular Lymphoma and at Least 2 Previous Therapies|Terminated||Phase 2|7|Actual|Janssen-Cilag G.m.b.H||1||Recruitment too slow|f||||f||||||||||2017-10-11 01:28:58.418344|2017-10-11 01:28:58.418344
NCT01902849|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2014-03-09|||February 2012||2012-02-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01|1 Day|Observational [Patient Registry]|T-IL-Co-ReCa||Anesthetic Technique on Immune Response in Colorectal Cancer|The Influence of Anesthetic Technique on Interleukin Plasma Level in Colorectal Cancer Surgery - TIVA vs Inhalation Anesthesia|Completed||N/A|70|Actual|Iuliu Hatieganu University of Medicine and Pharmacy|||2||f||||f||||||Samples Without DNA|"     The collected blood samples are centrifuged at 2500 rpm / min for 10 minutes and the     resulting plasma is stored at -70 °   "|||2017-10-11 01:28:58.528965|2017-10-11 01:28:58.528965
NCT01902836|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-07-26|||August 2011||2011-08-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic Dermatitis|Efficacy of Human Dialyzed Leukocytes Extracts in Paediatrics Patients With Moderate Atopic Dermatitis.|Completed||Phase 2|58|Actual|National Polytechnic Institute, Mexico||2|||f||||t||||||||||2017-10-11 01:28:58.630104|2017-10-11 01:28:58.630104
NCT01902823|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-11-03|||November 2011||2011-11-01|November 2015|2015-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Cancer Nurse Navigators on Patient Outcomes|Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes|Terminated||Phase 2/Phase 3|16|Actual|University of Wisconsin, Madison||2||Clinicians were not offering the study to eligible potential subjects.|f||||f||||||||||2017-10-11 01:28:58.725478|2017-10-11 01:28:58.725478
NCT01902810|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-05-31|||July 2013||2013-07-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Protective Effects of Propranolol in Adults|Protective Effects of Propranolol in Adults Following Major Burn Injury: A Safety and Efficacy Trial|Recruiting||Phase 2/Phase 3|250|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 01:28:58.814272|2017-10-11 01:28:58.814272
NCT01902797|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-04-27|||July 2013||2013-07-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Malaria Survey in the Tak Province Refugee Camps|Malaria Survey in the Tak Province Refugee Camps|Completed||N/A|908|Actual|University of Oxford||1|||f||||f||||||||||2017-10-11 01:28:58.963659|2017-10-11 01:28:58.963659
NCT01902784|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-06-13|||June 2013||2013-06-01|June 2017|2017-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Surrogate Project (Surrogate Storytelling)|Surrogate Project - Aim 2: Pilot Randomized Controlled Trial|Completed||Phase 1/Phase 2|115|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:28:59.209926|2017-10-11 01:28:59.209926
NCT01902771|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2017-03-08|||September 3, 2013|Actual|2013-09-03|March 2017|2017-03-01|January 26, 2017|Actual|2017-01-26|October 24, 2016|Actual|2016-10-24||Interventional|||Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors|A Phase I Study of Dendritic Cell Vaccine Therapy With In Situ Maturation for Pediatric Brain Tumors|Terminated||Phase 1|1|Actual|University of Miami||1||Lack of Accrual|f||||t|t|f||||||||2017-10-11 01:28:59.318303|2017-10-11 01:28:59.318303
NCT01902758|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-01-28|2015-12-16||August 2013||2013-08-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Drug Combination on Exercise Performance at High Altitude|Enhancing Physical Performance and Mitigating Acute Mountain Sickness Via Pharmaceutical Intervention While at Altitude|Completed||Phase 2/Phase 3|28|Actual|University of Montana||2|||f||||f||||||||||2017-10-11 01:28:59.426961|2017-10-11 01:28:59.426961
NCT01902745|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-02-02|||November 2013||2013-11-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|FRD||Fatigue Reduction Diet|Fatigue Reduction Diet in Breast Cancer Survivors|Completed||N/A|30|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 01:28:59.709792|2017-10-11 01:28:59.709792
NCT01902732|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-07-15|||June 2013||2013-06-01|July 2013|2013-07-01||||December 2014|Anticipated|2014-12-01||Interventional|||Endoscopic Lung Volume Reduction After Catheter-based CV Measurement in Patients With Heterogeneous Emphysema and Complete Interlobar Fissures|Bronchoscopic Volume Reduction With Valve Implants After Analysis of Interlobar Fissure Integrity and Measurement of Collateral Ventilation in Patients With Severe, Heterogeneous Emphysema|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Heidelberg University||1|||f||||||||||||||2017-10-11 01:28:59.810198|2017-10-11 01:28:59.810198
NCT01902719|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-09-01|||September 2013||2013-09-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|ACT||Achieving Blood Pressure Control Together Study|Family and Community Intervention to Address Hypertension Disparities|Completed||N/A|159|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 01:28:59.920339|2017-10-11 01:28:59.920339
NCT01902693|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2015-09-08|||October 2013||2013-10-01|February 2015|2015-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Prospective HIV Chemotherapy Cohort Study|Prospective Observational Study of HIV Positive Individuals on Suppressive HAART With Malignancy Undergoing Chemotherapy|Completed||N/A|17|Actual|Imperial College London|||1||f||||f||||||Samples With DNA|"     Blood Cerebrospinal fluid   "|||2017-10-11 01:29:00.00748|2017-10-11 01:29:00.00748
NCT01902680|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2015-05-26|||August 2013||2013-08-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|CURIEFOCALE||Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.|Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.|Unknown status|Recruiting|Phase 2|17|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||||2017-10-11 01:29:00.105589|2017-10-11 01:29:00.105589
NCT01902667|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-09-14|||July 2013|Actual|2013-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Observational|PIRS||Preoperative Imaging in Retroperitoneal Sarcoma|Preoperative Imaging in Retroperitoneal Sarcoma|Active, not recruiting||N/A|32|Actual|Institute of Cancer Research, United Kingdom|||2||f||||f||||||||||2017-10-11 01:29:00.212456|2017-10-11 01:29:00.212456
NCT01902654|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-02-09|||September 2013||2013-09-01|November 2013|2013-11-01||||February 2014|Anticipated|2014-02-01||Observational|||Osteoarthritis Cardiovascular Risk Factors|Prevalence of Cardiovascular Risk Factors Between Patients With Knee or Hand Osteoarthritis|Unknown status|Recruiting|N/A|490|Anticipated|Hospital Parc Taulí, Sabadell|||3||f||||t||||||||||2017-10-11 01:29:00.319542|2017-10-11 01:29:00.319542
NCT01902641|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-16|||October 2011||2011-10-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Muscle Relaxation for Short Procedures|Comparing Intubating Conditions and Patient Satisfaction Using Succinylcholine or Low-dose Rocuronium for Rigid Bronchoscopy: A Randomized Study|Completed||N/A|105|Actual|Dr. Horst Schmidt Klinik GmbH||3|||f||||f||||||||||2017-10-11 01:29:00.443446|2017-10-11 01:29:00.443446
NCT01902628|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-11-01|||July 2013||2013-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Stages 3 & 4 Not on Dialysis|An Observational, Prospective Study to Evaluate the Hemoglobin Levels in Non-dialysis Chronic Kidney Disease Subjects With Renal Anaemia, Treated With MIRCERA® (Methoxy-polyethylene-glycol-epoetin Beta) (OPTIMA).|Completed||N/A|437|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:29:00.611794|2017-10-11 01:29:00.611794
NCT01902615|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-16|2016-11-01|||January 2001||2001-01-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection|Multicenter, Observational, Retrospective Study to Assess the Therapeutic Effectiveness of a Strategy of Induction With Enfuvirtide Within an Optimized Regimen of Antiretroviral Drugs (ARV) in Patients Infected With HIV-1 in Routine Clinical Practice|Completed||N/A|58|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:29:00.738329|2017-10-11 01:29:00.738329
NCT01902602|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-08-12|||August 2013||2013-08-01|August 2013|2013-08-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Observational|HAB||Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia|Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia|Unknown status|Not yet recruiting|N/A|100|Anticipated|Herrmann Apparatebau GmbH|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 01:29:00.830264|2017-10-11 01:29:00.830264
NCT01902589|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-08-30|||December 2010||2010-12-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Observational|||Resistance of Helicobacter Pylori to Antibiotics in Children|Resistance of Helicobacter Pylori to Antibiotics in Children|Completed||N/A|115|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-11 01:29:00.924802|2017-10-11 01:29:00.924802
NCT01902563|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-05-16||||||May 2014|2014-05-01||||||||Expanded Access|||Osteopathic Approach Into Neonatology Ward: the NE-O Model|Osteopathic Approach Into Neonatology Ward: the NE-O Model|Available||N/A|||European Institute for Evidence Based Osteopathic Medicine|||||f||||||||||||||2017-10-11 01:29:01.123381|2017-10-11 01:29:01.123381
NCT01902550|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-10-31|||July 2013||2013-07-01|October 2016|2016-10-01|May 2014|Anticipated|2014-05-01|October 2013|Anticipated|2013-10-01||Interventional|||A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants|A Randomized, Double-Blind, 2-Period Crossover Study to Evaluate the Effect of Single Dose JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Subjects|Withdrawn||Phase 1|0|Actual|Janssen Research & Development, LLC||2||Trial was stopped because study not required for development.|f||||f||||||||||2017-10-11 01:29:01.198236|2017-10-11 01:29:01.198236
NCT01902537|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-07-15|||August 2012||2012-08-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||An Observational Study to Evaluate the Quality of Life in Korean Female Participants With Chronic Constipation|Health Related Quality of Life in Female Patients With Chronic Constipation|Completed||Phase 4|150|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 01:29:01.324166|2017-10-11 01:29:01.324166
NCT01902524|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-08-27|||October 2005||2005-10-01|August 2014|2014-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain|Evaluation in Efficacy and Safety of Fentanyl-TTS (Durogesic® D-Trans) for Treatment of Chronic Pain|Completed||Phase 4|65|Actual|Janssen Korea, Ltd., Korea||1|||f||||f||||||||||2017-10-11 01:29:01.430846|2017-10-11 01:29:01.430846
NCT01902511|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-11-21|||July 2013||2013-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.||Completed||N/A|60|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 01:29:01.530817|2017-10-11 01:29:01.530817
NCT01902498|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-03-18|||July 2013||2013-07-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B|Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B|Completed||Phase 2|70|Actual|Hamilton Health Sciences Corporation||3|||f||||f||||||||||2017-10-11 01:29:01.62805|2017-10-11 01:29:01.62805
NCT01902472|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-09-29|||September 2, 2013|Actual|2013-09-02|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)|A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)|Recruiting||N/A|150|Anticipated|Gilead Sciences|||1||f||||f||||||||||2017-10-11 01:29:01.873239|2017-10-11 01:29:01.873239
NCT01902446|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-06-07|||July 2013||2013-07-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|P-VAPP||Prehospital Ventilator-Associated Pneumonia Prevention Trial|A Pilot Study of Prehospital Oral Chlorhexidine Gluconate to Prevent Early Ventilator Associated Pneumonia in Intubated Trauma Patients|Completed||N/A|70|Actual|University of Iowa|||2||f||||t||||||||||2017-10-11 01:29:02.05553|2017-10-11 01:29:02.05553
NCT01902433|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-01-21|||August 2013||2013-08-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Astym® Compared Eccentric Exercise for Chronic Mid-substance Achilles Tendinopathy|Astym® Treatment Compared With Eccentric Exercise in the Management of Chronic Mid-substance Achilles Tendinopathy: A Multisite a Randomized Controlled Trial|Terminated||N/A|50|Anticipated|University of Indianapolis||2||We were unable to recruit participants to the study|f||||f||||||||Undecided|Only two participants were recruited to the study at the closure of the study|2017-10-11 01:29:02.146217|2017-10-11 01:29:02.146217
NCT01902420|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-18|||November 2012||2012-11-01|July 2013|2013-07-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|AIP||Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly|Investigation of Prevalence and Clinical Effects of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations With DNA Sequence Analysis in Acromegaly Patients in Turkey|Unknown status|Recruiting|N/A|80|Anticipated|TC Erciyes University|||2||f||||f||||||Samples With DNA|"     DNA samples   "|||2017-10-11 01:29:02.263311|2017-10-11 01:29:02.263311
NCT01902407|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-06-30|||March 2011||2011-03-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|DYMOSA||Computer Models of Airways in Children and Young Adults With Sleep Apnea and Down Syndrome|Dynamic Computational Modeling of Obstructive Sleep Apnea in Down Syndrome|Recruiting||N/A|73|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 01:29:02.363198|2017-10-11 01:29:02.363198
NCT01902394|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-05-19|||June 2012||2012-06-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Addition of Whole Grains to the Diets of Adults: A Study of Digestive Health and Natural Defenses|The Addition of Whole Grains to the Diets of Adults: A Study of Digestive Health and Natural Defenses|Completed||N/A|108|Actual|Tufts University||3|||f||||f||||||||||2017-10-11 01:29:02.444339|2017-10-11 01:29:02.444339
NCT01902381|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-07-28|||August 2013|Actual|2013-08-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy|A Pilot Study of CPI-613 in Patients With Myelodysplastic Syndrome Who Have Failed Previous Therapy|Recruiting||Phase 2|20|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 01:29:02.553793|2017-10-11 01:29:02.553793
NCT01902368|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-03-23|||September 2013||2013-09-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Celiac Disease Screening|A Prospective Trial of Celiac Disease Screening|Terminated||N/A|14|Actual|Beth Israel Deaconess Medical Center||2||No funding was obtained.|f||||f||||||||||2017-10-11 01:29:02.641214|2017-10-11 01:29:02.641214
NCT01902355|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-07-02|||July 2013||2013-07-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Comparison of Two Needle Insertion Techniques on Success Rate and Complications During Central Venous Catheterization|Comparison of Two Needle Insertion Techniques on Success Rate and Complications During Central Venous Catheterization: Seldinger vs. Modified Seldinger Technique|Completed||N/A|272|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:29:02.728053|2017-10-11 01:29:02.728053
NCT01902342|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-05-15|||July 2013||2013-07-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CES1||A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir|A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Pharmacokinetic Characteristics of Oseltamivir in Healthy Korean Volunteers|Completed||Phase 1|20|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:29:02.811286|2017-10-11 01:29:02.811286
NCT01902329|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-08-03|||July 2013||2013-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|March 18, 2016|Actual|2016-03-18||Interventional|||A Safety Study of SGN-CD33A in AML Patients|A Phase 1 Trial of SGN-CD33A in Patients With CD33-positive Acute Myeloid Leukemia|Active, not recruiting||Phase 1|195|Actual|Seattle Genetics, Inc.||2|||f||||f||||||||||2017-10-11 01:29:03.005402|2017-10-11 01:29:03.005402
NCT01902316|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-07-17|||January 2009||2009-01-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Clinical Verification of Peptide Biomarkers for Type 2 Diabetes Mellitus|Clinical Verification for Early Diagnosis of Type 2 Diabetes Mellitus by Standard-Free, Label-Free LC-MS/MS Quantification of Glycated Peptides|Completed||N/A|389|Actual|Beijing Institute of Technology|||1||f||||t||||||||||2017-10-11 01:29:03.136946|2017-10-11 01:29:03.136946
NCT01902303|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-03-27|2016-02-14||July 2013||2013-07-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional||Demographics based on number of subjects who were randomization and subsequently assigned investigational product|Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores|Evaluation of Cold Sore Treatments on UV Induced Cold Sores|Completed||Phase 2|303|Actual|Beech Tree Labs, Inc.||2|||f||||f||||||||No||2017-10-11 01:29:03.207016|2017-10-11 01:29:03.207016
NCT01901900|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-08-03|||September 2013||2013-09-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|REASSURE-E||Safety and Efficacy of Extended Treatment With Secukinumab in Anti-TNF Inadequate Responders in RA.|A Three Year Extension Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Subjects With Active Rheumatoid Arthritis|Completed||Phase 3|196|Actual|Novartis||1|||f||||t||||||||||2017-10-11 01:29:09.561219|2017-10-11 01:29:09.561219
NCT01902290|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-03-14||2016-03-14|May 2013||2013-05-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility|Terminated||Phase 2|421|Actual|Amgen||2||"The decision to stop the study was due to a lack of observed efficacy in a pre-specified   interim analysis. The decision was not related to safety concerns."|f||||f||||||||||2017-10-11 01:29:03.536422|2017-10-11 01:29:03.536422
NCT01902277|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2013-07-17|||June 2012||2012-06-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||ICU Delirium: a One-week Snapshot of Burden Across the Eastern UK Region|ICU Delirium: a One-week Snapshot of Burden Across the Eastern UK Region|Completed||N/A|225|Actual|Papworth Hospital NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 01:29:03.970936|2017-10-11 01:29:03.970936
NCT01902264|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-04-28|||August 2013||2013-08-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception|Prospective, Open-label, Single-center Clinical Study to Investigate the Red Blood Cell and Plasma Folate Concentrations During a 24-week Treatment Period With the Combination of Drospirenone 3 mg Plus Ethinyl Estradiol 0.02 mg Plus Levomefolate Calcium 0.451 mg in Mexican Women Seeking Contraception|Completed||Phase 3|34|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:29:04.059374|2017-10-11 01:29:04.059374
NCT01902251|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-09-08|||November 2012||2012-11-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients|A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer|Completed||Phase 1|27|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:29:04.158792|2017-10-11 01:29:04.158792
NCT01902238|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-11-29|||July 2013||2013-07-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|EUS||EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study|EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Feasibility and Long Term Outcome|Active, not recruiting||N/A|34|Actual|Asan Medical Center||1|||f||||t||||||||No||2017-10-11 01:29:04.275883|2017-10-11 01:29:04.275883
NCT01902225|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-07-02|||April 2014||2014-04-01|July 2014|2014-07-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma|A Multicenter Phase I Dose-finding and Preliminary Efficacy Study of the Histone Deacetylase Inhibitor Romidepsin (Istodax®) in Combination With Doxorubicin HCl Liposomal (Doxil®) for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma|Unknown status|Recruiting|Phase 1|24|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:29:04.389307|2017-10-11 01:29:04.389307
NCT01902212|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-03-02|||June 2013||2013-06-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Evaluation of an Oral Nutrition Supplement|Evaluation of an Oral Nutrition Supplement|Completed||N/A|25|Actual|Abbott Nutrition||1|||f||||f||||||||||2017-10-11 01:29:04.53011|2017-10-11 01:29:04.53011
NCT01902199|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-09-29|||October 2014||2014-10-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Tobacco Retraining of Automatic Approach to Treat Individuals With Tobacco Dependence and Severe Concurrent Disorders.|Studying a Novel Intervention, the Tobacco Retraining of Automatic Approach (TRAA), to Treat Individuals With Tobacco Dependence and Severe Concurrent Disorders|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:29:04.617802|2017-10-11 01:29:04.617802
NCT01902186|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-05-10|||September 2014||2014-09-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RALBAT||Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir|Switching HIV-positive Women on Tenofovir/Emtricitabine Plus Boosted Atazanavir to RALtegravir Plus Boosted ATazanavir: A Pilot Randomized Clinical Trial Investigating 48-weeks Changes in Bone Mineral Density|Recruiting||Phase 4|66|Anticipated|University of Turin, Italy||2|||f||||f||||||||||2017-10-11 01:29:04.70602|2017-10-11 01:29:04.70602
NCT01902173|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-06-30|||July 19, 2013|Actual|2013-07-19|May 2017|2017-05-01||||June 30, 2017|Anticipated|2017-06-30||Interventional|||Akt Inhibitor GSK2141795, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer|Phase I/II Study of the Safety and Efficacy of the AKT Inhibitor GSK2141795 in Combination With Dabrafenib and Trametinib in Patients With BRAF Mutant Cancer|Suspended||Phase 1/Phase 2|97|Anticipated|National Cancer Institute (NCI)||1||Temporarily stopped for assessment. Contact ctsucontact@westat.com for specifics|f||||f||||||||||2017-10-11 01:29:04.898836|2017-10-11 01:29:04.898836
NCT01902160|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-11-06|||September 2013||2013-09-01|November 2015|2015-11-01||||May 2015|Actual|2015-05-01||Interventional|||Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma|A Phase 1 Study of Brentuximab Vedotin in Combination With Temsirolimus in Relapsed and Refractory Hodgkin Lymphoma|Completed||Phase 1|3|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:29:05.126344|2017-10-11 01:29:05.126344
NCT01902147|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-09-21|||November 2013||2013-11-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Postoperative Quality Recovery Scale (PQRS)|Measuring Recovery in Patients Undergoing Major Abdominal, Thoracic, and Arthroplasty Surgery Using an Enhanced Recovery Program.|Completed||N/A|200|Anticipated|McGill University Health Center|||1||f||||f||||||||||2017-10-11 01:29:06.146312|2017-10-11 01:29:06.146312
NCT01902134|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2016-02-04|2015-02-06||April 2013||2013-04-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|DAVID-art|Intention-to-treat (ITT) population (which includes all patients randomized).|Oral Treatment for Orthopaedic Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride|A Randomized, Double-blind, Placebo and Active-controlled, Parallel-group Study to Evaluate the Analgesic Efficacy and Safety of Dexketoprofen Trometamol and Tramadol Hydrochloride Oral Fixed Combination on Moderate to Severe Acute Pain After Elective Unilateral Total Hip Arthroplasty|Completed||Phase 3|641|Actual|Menarini Group||6|||f||||f||||||||||2017-10-11 01:29:06.30069|2017-10-11 01:29:06.30069
NCT01902121|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2014-12-11|||August 2013||2013-08-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|November 2013|Actual|2013-11-01||Interventional|||Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge|A Phase 1, Open-label, Randomized, Crossover Clinical Trial in Healthy Normal Volunteers to Evaluate the Bioequivalence of 30 U TI Inhalation Powder Delivered by Gen2 Inhaler Using One 30 U Cartridge Versus a Combination of 10 U and 20 U Cartridges|Completed||Phase 1|40|Actual|Mannkind Corporation||2|||f||||f||||||||||2017-10-11 01:29:07.73083|2017-10-11 01:29:07.73083
NCT01902108|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2015-12-06|||January 2013||2013-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Added Value of Local Clonidine for Spine Postoperative Pain Control, in Addition to Bupivacaine|Randomized Double-blind Trial Comparing the Post-operative Analgesic Efficacy of Local Wound Infiltration With Bupivacaine Alone to Bupivacaine With Clonidine in Posterior Spine Surgeries|Completed||Phase 4|225|Actual|St Joseph University, Beirut, Lebanon||2|||f||||f||||||||||2017-10-11 01:29:07.818941|2017-10-11 01:29:07.818941
NCT01902082|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2013-07-14|||November 2012||2012-11-01|July 2013|2013-07-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome|Phase I Study of Allogeneic Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome|Unknown status|Recruiting|Phase 1|20|Anticipated|Shaoxing Second Hospital||2|||f||||f||||||||||2017-10-11 01:29:07.971558|2017-10-11 01:29:07.971558
NCT01902069|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2015-07-14|||July 2013||2013-07-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Gut-brain Axis in Food Reward and Alcohol Consumption|The Gut-brain Axis in Food Reward and Alcohol Consumption|Completed||N/A|29|Actual|Yale University||2|||f||||t||||||||||2017-10-11 01:29:08.074351|2017-10-11 01:29:08.074351
NCT01902056|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2013-07-15|||November 2012||2012-11-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Implant Placement and Simultaneous Soft Tissue Grafting With Single or Double Layers of Acellular Dermal Matrix|Implant Placement and Simultaneous Soft Tissue Grafting With Single or Double Layers of Acellular Dermal Matrix: A Randomized, Controlled Clinical Tria.|Completed||N/A|26|Actual|University of Louisville||2|||f||||f||||||||||2017-10-11 01:29:08.171402|2017-10-11 01:29:08.171402
NCT01902043|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-12-11|||September 2011||2011-09-01|December 2014|2014-12-01||||December 2015|Anticipated|2015-12-01||Observational|CoDiab-VD||CoDiab-VD: a Population-based Cohort on Quality of Care of Patients With Diabetes in the Canton of Vaud (Switzerland)|CoDiab-VD: a Population-based Cohort on Quality of Care of Patients With Diabetes in the Canton of Vaud (Switzerland)|Unknown status|Active, not recruiting|N/A|519|Actual|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 01:29:08.251265|2017-10-11 01:29:08.251265
NCT01902030|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-05-05|||January 2014||2014-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Evaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised Patients|Diagnostic Study of Performance of an Aspergillus Specific Polymerase Chain Reaction in Tissue and Pleural Effusion Samples of Immunocompromised Patients for the Diagnosis of Invasive Aspergillosis|Enrolling by invitation||N/A|100|Anticipated|Heidelberg University|||2||f||||f||||||Samples With DNA|"     Fungal DNA, no human DNA   "|||2017-10-11 01:29:08.318303|2017-10-11 01:29:08.318303
NCT01902017|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-04-07|||June 2013||2013-06-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|Ketotifen||Investigations of Mechanisms and Treatment in Post-traumatic Joint Contractures|Randomized, Double Blind, Placebo Controlled Trial of Ketotifen in Patients With Elbow Fractures or Dislocations|Active, not recruiting||Phase 2|152|Actual|University of Calgary||4|||f||||f||||||||||2017-10-11 01:29:08.535147|2017-10-11 01:29:08.535147
NCT01902004|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2016-05-10|||October 2013||2013-10-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Brain Aging and Treatment Response in Geriatric Depression|Treatment of Geriatric Depression With Mild Cognitive Impairment: A Double-blind Placebo-Controlled Trial of Namenda (Memantine) Augmentation of Lexapro (Escitalopram) in Depressed Patients at Least 60 Years of Age|Recruiting||Phase 3|134|Anticipated|University of California, Los Angeles||2|||f||||t||||||||No||2017-10-11 01:29:08.663051|2017-10-11 01:29:08.663051
NCT01901991|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2017-08-09|||January 2014||2014-01-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Localization of Nonpalpable Breast Lesions|A Randomized Study of Localization of Nonpalpable Breast Lesions - RSL vs WGL|Completed||N/A|410|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:29:08.812051|2017-10-11 01:29:08.812051
NCT01901978|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-15|2017-03-06|||May 2011||2011-05-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|July 2014|Actual|2014-07-01||Interventional|||Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents|Study to Investigate Benefits of Weight Loss in Yound Adults and Adolescents|Active, not recruiting||N/A|40|Anticipated|Yale University||1|||f||||f||||||||Yes|IPD will not be shared with other researchers. Only group data that is used in data analysis for manuscripts will be shared and that is de-identified.|2017-10-11 01:29:08.938951|2017-10-11 01:29:08.938951
NCT01901965|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-04-27|||May 2013||2013-05-01|April 2015|2015-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||Contralateral Strength-training After Anterior Cruciate Ligament (ACL) Reconstruction|Could Contralateral Quadriceps Strength Training Attenuate the Strength Loss in the ACL-operated Knee?|Unknown status|Recruiting|N/A|36|Anticipated|Schulthess Klinik||3|||f||||||||||||||2017-10-11 01:29:09.058129|2017-10-11 01:29:09.058129
NCT01901952|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-05-08|||March 2012||2012-03-01|May 2017|2017-05-01|December 2, 2015|Actual|2015-12-02|November 25, 2015|Actual|2015-11-25||Interventional|LIFE||Lifestyle Improvement Through Food and Exercise (LIFE)Study|Lifestyle Improvement Through Food and Exercise (LIFE) Study|Completed||N/A|211|Actual|Rush University Medical Center||2|||f||||t||||||||||2017-10-11 01:29:09.162349|2017-10-11 01:29:09.162349
NCT01901939|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-04-18|||February 2014||2014-02-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly|Role of Exercise in Reversal of Hospitalization-associated Disability in Elderly|Withdrawn||N/A|0|Actual|Palo Alto Veterans Institute for Research||1||not funded|f||||f|f|f||||||No||2017-10-11 01:29:09.260937|2017-10-11 01:29:09.260937
NCT01901887|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-06-06|||March 2014||2014-03-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|August 2016|Anticipated|2016-08-01||Interventional|BRAVO||The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study|The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study: A Double Blind, Placebo-Controlled Trial of Omega-3 Fatty Acid Supplementation Among Military Veterans|Active, not recruiting||N/A|300|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 01:29:09.867802|2017-10-11 01:29:09.867802
NCT01901874|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-08-03|||July 2013||2013-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:29:10.001843|2017-10-11 01:29:10.001843
NCT01901861|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2015-12-14|||July 2013||2013-07-01|March 2015|2015-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes|Effect of a Single Dose of the DPP-4 Inhibitor on Islet Function After Igestion of a Standardized Mixed Meal in Subjects With Type 2 Diabetes|Completed||N/A|12|Actual|Lund University||2|||f||||t||||||||||2017-10-11 01:29:10.0637|2017-10-11 01:29:10.0637
NCT01901848|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-10-05|||December 11, 2013|Actual|2013-12-11|October 2017|2017-10-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||CPT and Smoking Cessation|Combined Smoking Cessation and Cognitive Processing Therapy for PTSD|Active, not recruiting||Phase 2/Phase 3|50|Anticipated|VA Office of Research and Development||2|||f||||f|t|f|||t|||||2017-10-11 01:29:10.16276|2017-10-11 01:29:10.16276
NCT01901835|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-03-13|||February 12, 2014||2014-02-12|March 2017|2017-03-01|February 8, 2017|Actual|2017-02-08|May 24, 2016|Actual|2016-05-24||Interventional|||Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy|The Effects of a Media Diversion on Quality of Life in Patients Receiving Chemotherapy for Recurrent Gynecologic Cancers|Completed||N/A|67|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 01:29:10.28441|2017-10-11 01:29:10.28441
NCT01901822|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-12-06|||September 2013||2013-09-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Root Coverage Comparing Suturing Techniques|Root Coverage With Acellular Dermal Matrix Using the Coronally Positioned Tunnel Technique Comparing Two Different Suturing Techniques.|Completed||N/A|16|Actual|University of Louisville||2|||f||||f||||||||||2017-10-11 01:29:10.38371|2017-10-11 01:29:10.38371
NCT01901809|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-03-07|||August 2013||2013-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|ROPA-DOP||Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction|Randomized Evaluation of HFpEF Patients With Acute Heart Failure and Dopamine (ROPA-DOP) Trial|Active, not recruiting||Phase 4|120|Anticipated|Johns Hopkins University||4|||f||||t||||||||||2017-10-11 01:29:10.486335|2017-10-11 01:29:10.486335
NCT01901796|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Integrated Maternal Psychosocial Assessment to Care Trial (IMPACT) Full Trial|Integrated Maternal Psychosocial Assessment to Care Trial (IMPACT): Intervening Early to Improve Maternal and Family Well-being.|Recruiting||N/A|54|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 01:29:10.60532|2017-10-11 01:29:10.60532
NCT01901783|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-12-06|||September 2013||2013-09-01|December 2016|2016-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Ridge Augmentation Without Primary Closure|Ridge Augmentation Comparing the Clinical and Histologic Healing of a Cancellous Block Allograft Plus a Barrier Membrane With and Without Primary Closure|Completed||N/A|18|Actual|University of Louisville||2|||f||||f||||||||||2017-10-11 01:29:10.729659|2017-10-11 01:29:10.729659
NCT01901770|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2017-05-08|||January 2012||2012-01-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|October 31, 2017|Anticipated|2017-10-31||Interventional|PARENT||The Parents in Appalachia Receive Education Needed for Teen Project|The Ohio State University Center for Population Health and Health Disparities Community Awareness, Resources and Education (CARE II): Project 4 The PARENT (Parents in Appalachia Receive Education Needed for Teens) Project|Active, not recruiting||N/A|624|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-11 01:29:10.838785|2017-10-11 01:29:10.838785
NCT01901757|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2013-08-12|||June 2013||2013-06-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers|An Open-label, Randomized, Single-dose, 2-way Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of HCP1201 Tablet in Healthy Volunteers|Completed||Phase 1|12|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 01:29:10.95488|2017-10-11 01:29:10.95488
NCT01901744|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-16|||January 2009||2009-01-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|July 2011|Actual|2011-07-01||Interventional|||Contrast Sensitivity Assessment in Pediatric Cataract Surgery With IOL Implantation|Contrast Sensitivity Assessment in Pediatric Cataract Surgery With IOL Implantation: A Comparison of Preoperative and Early Postoperative Outcomes|Completed||N/A|25|Actual|Iladevi Cataract and IOL Research Center||1|||f||||t||||||||||2017-10-11 01:29:11.060463|2017-10-11 01:29:11.060463
NCT01901731|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-01-24|||March 2014||2014-03-01|January 2014|2014-01-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Interventional|||Pelvic Embolisation to Reduce Recurrent Varicose Veins - Primary|A Randomised Controlled Trial Investigating The Use Of Pelvic Vein Embolisation To Reduce Recurrent Varicose Veins Of The Legs In Women With Primary Varicose Veins And Associated Pelvic Venous Reflux.|Not yet recruiting||N/A|270|Anticipated|The Whiteley Clinic||2|||f||||t||||||||||2017-10-11 01:29:11.150851|2017-10-11 01:29:11.150851
NCT01901718|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2014-09-02|||April 2013||2013-04-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|||An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.|An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray Compared to Actiq® for the Management of Breakthrough Pain in Chronic Pain Patients.|Terminated||N/A|4|Actual|International Clinical Research Institute|||1|Enrollment was more challenging than anticipated.|f||||f||||||||||2017-10-11 01:29:11.28153|2017-10-11 01:29:11.28153
NCT01901705|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-02-02|||February 2013||2013-02-01|February 2017|2017-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis|A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis|Completed||Phase 2|24|Actual|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 01:29:11.405534|2017-10-11 01:29:11.405534
NCT01901692|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-14|2017-09-15|||July 29, 2013|Actual|2013-07-29|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|January 20, 2017|Actual|2017-01-20||Interventional|START||Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion|Randomized Trial Comparing Sorafenib and Transarterial Chemoembolization Plus External Beam Radiotherapy in Patients With Hepatocellular Carcinoma Showing Macroscopic Vascular Invasion|Completed||Phase 2/Phase 3|90|Actual|Asan Medical Center||2|||f||||f|f|f||||||||2017-10-11 01:29:11.519948|2017-10-11 01:29:11.519948
NCT01901679|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-11-04|||July 2013||2013-07-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women|A Pilot Study: Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women|Completed||Early Phase 1|10|Actual|Rockefeller University||1|||f||||f||||||||||2017-10-11 01:29:11.62032|2017-10-11 01:29:11.62032
NCT01901666|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2013-07-12|||January 2013||2013-01-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission|ASSESSMENT OF GH-IGF1 AXIS AND TO STUDY RESPONSE TO GH THERAPY IN CHILDREN WITH CML IN REMISSION HAVING GH DEFICIENCY|Unknown status|Recruiting|Phase 4|20|Anticipated|Postgraduate Institute of Medical Education and Research||1|||f||||t||||||||||2017-10-11 01:29:11.726536|2017-10-11 01:29:11.726536
NCT01901653|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-04-24|||July 2013||2013-07-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||SC16LD6.5 in Recurrent Small Cell Lung Cancer|Phase I/II Open Label Dose Escalation Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of SC16LD6.5 as a Single Agent in Patients With Recurrent Small Cell Lung Cancer|Completed||Phase 1/Phase 2|75|Anticipated|Stemcentrx||1|||f||||f||||||||||2017-10-11 01:29:11.822706|2017-10-11 01:29:11.822706
NCT01901640|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-07-15|||November 2011||2011-11-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction|Phase 3 Study to Evaluate Longterm Safety of Once-a-Day Dosing of Udenafil in the Treatment of Erectile Dysfunction|Completed||Phase 3|302|Actual|Dong-A ST Co., Ltd.||1|||f||||f||||||||||2017-10-11 01:29:11.966176|2017-10-11 01:29:11.966176
NCT01901627|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-07-12|||April 2013||2013-04-01|July 2013|2013-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis|A Multicenter Registry to Evaluate the Clinical Outcome of Chinese Adult Patients With Active Ankylosing Spondylitis Treated With Adalimumab in the Real World Practice|Unknown status|Recruiting|N/A|400|Anticipated|Peking Union Medical College Hospital|||1||f||||f||||||||||2017-10-11 01:29:12.035215|2017-10-11 01:29:12.035215
NCT01901614|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-04-21|||August 2013||2013-08-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||OCT-guided LALAK for KCN|RANDOMIZED CLINICAL TRIAL OF OCT-GUIDED LASER-ASSISTED LAMELLAR ANTERIOR KERATOPLASTY IN ADULTS FOR KERATOCONUS|Unknown status|Recruiting|N/A|94|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:29:12.141972|2017-10-11 01:29:12.141972
NCT01901601|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-04-21|||July 2013||2013-07-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||LALAK for Opacities|Randomized Clinical Trial of OCT-Guided Laser-Assisted Lamellar Anterior Keratoplasty in Adults for Stromal Opacities|Unknown status|Recruiting|N/A|40|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:29:12.245005|2017-10-11 01:29:12.245005
NCT01901588|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-06-08|2016-02-08||March 2012||2012-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery|Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery|Completed||Phase 4|63|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 01:29:12.365978|2017-10-11 01:29:12.365978
NCT01901575|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-05-09|2014-12-11||July 2011||2011-07-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|IVPCA||Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia|Remifentanil IV PCA for Ablation of Idiopathic Ventricular Tachycardia|Completed||N/A|16|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-11 01:29:12.773584|2017-10-11 01:29:12.773584
NCT01901562|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-13|2017-02-12|||September 2013||2013-09-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge|Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge|Recruiting||Phase 1/Phase 2|30|Anticipated|Montefiore Medical Center||1|||f||||f||||||||||2017-10-11 01:29:14.662434|2017-10-11 01:29:14.662434
NCT01901549|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-09-21|||June 2013||2013-06-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|June 2015|Actual|2015-06-01||Interventional|ACSRD||Renal Denervation in Patients After Acute Coronary Syndrome|Renal Denervation in Patients After Acute Coronary Syndrome|Unknown status|Recruiting|Phase 2|80|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 01:29:14.751454|2017-10-11 01:29:14.751454
NCT01901536|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-07-16|||December 2002||2002-12-01|July 2013|2013-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|FF1||Family Foundations Coparenting Pilot Trial|Promotion of Coparenting During Family Formation Period|Completed||N/A|497|Actual|Feinberg, Mark, Ph.D.||2|||f||||f||||||||||2017-10-11 01:29:14.859924|2017-10-11 01:29:14.859924
NCT01901523|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-05-16|||June 2014||2014-06-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Coordinated Assessment of Notifications of Trials Containing Overt Published Errors|Phase II Study of Response of Medical Journal Editorial Boards to Notification of Serious Discrepancies in Published Clinical Trials in Human Patients.|Unknown status|Not yet recruiting|N/A|15|Anticipated|Imperial College London||1|||f||||t||||||||||2017-10-11 01:29:14.939055|2017-10-11 01:29:14.939055
NCT01901510|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-03-02|||May 2013||2013-05-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep|Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep|Completed||Phase 1|21|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:29:15.055555|2017-10-11 01:29:15.055555
NCT01901497|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-01-29|||July 2013||2013-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Interventional|NIV-NEBU||Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers.|Comparison of Pharmacokinetics of Amikacin Administered by Three Vibrating Mesh Nebulizers in Healthy Volunteers|Completed||N/A|7|Actual|University Hospital St Luc, Brussels||3|||f||||f||||||||||2017-10-11 01:29:15.162437|2017-10-11 01:29:15.162437
NCT01901484|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-09-16|||December 2012||2012-12-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Schistosoma Mansoni Morbidity in Children Aged 1-5 Years|Intestinal Schistosomiasis in Children Aged 1-5 Years,Morbidity Assessment and the Effect of Praziquantel on Morbidity; Along Lake Victoria Shorelines.|Completed||Phase 2|800|Anticipated|Makerere University||2|||f||||f||||||||||2017-10-11 01:29:15.268646|2017-10-11 01:29:15.268646
NCT01901471|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-03-15|||September 2015||2015-09-01|March 2016|2016-03-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|CLOTILDE||Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock|Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock|Withdrawn||Phase 2|0|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:29:15.375446|2017-10-11 01:29:15.375446
NCT01901458|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-03-18|||March 2014||2014-03-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|optiMaL||Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®|Prospective Randomized Trial Comparing Efficiency of Peripheral Blood Progenitor Cell Collection in Allogeneic Donors Using the Spectra Optia® IDL Set in Comparison With the Spectra Optia® MNC Collection Set|Completed||N/A|50|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 01:29:15.488794|2017-10-11 01:29:15.488794
NCT01901445|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2013-07-13|||May 2013||2013-05-01|July 2013|2013-07-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Quality of Life in Children and Adolescents With Chronic Functional Constipation: Educational Action Effects|Quality of Life in Children and Adolescents With Chronic Functional Constipation: Educational Action Effects|Unknown status|Recruiting|N/A|11|Anticipated|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:29:15.754956|2017-10-11 01:29:15.754956
NCT01901432|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-09-28|||October 2013||2013-10-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|September 2017|Actual|2017-09-01||Interventional|||A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera|A Two-part Study Top Assess the Safety and Preliminary Efficacy of Givinostat in Patients With JAK2V617F Positive Polycythemia Vera|Active, not recruiting||Phase 1/Phase 2|48|Actual|Italfarmaco||1|||f||||f||||||||||2017-10-11 01:29:15.865327|2017-10-11 01:29:15.865327
NCT01901419|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-13|||July 2013||2013-07-01|July 2013|2013-07-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Nitroglycerin Infusion During Cardiac Surgery|Nitroglycerin Infusion During Rewarming in Cardiac Surgery and Its Effects on Tissue Perfusion and Coagulation|Unknown status|Recruiting|N/A|80|Anticipated|Tri-Service General Hospital||2|||f||||t||||||||||2017-10-11 01:29:16.064147|2017-10-11 01:29:16.064147
NCT01901406|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-08-11|||July 2013||2013-07-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Change of Retinally-Induced Aniseikonia in Patients With Epiretinal Membrane After Vitrectomy||Completed||N/A|24|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:29:16.27768|2017-10-11 01:29:16.27768
NCT01901393|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-02-12|2016-01-18||July 2013||2013-07-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||The Intent-to-Treat population consisted of all subjects who were enrolled and received at least a partial dose of investigational medicinal product.|Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery|A Multicenter, Prospective, Randomized, Double-blind Study to Determine the Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery|Completed||Phase 4|100|Actual|Cumberland Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:29:16.43516|2017-10-11 01:29:16.43516
NCT01901380|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-07-27|||February 2013||2013-02-01|July 2017|2017-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Cow's Milk Allergy and Functional Gastrointestinal Disorders|Effect of Lactobacillus GG on the Appearance of Functional Gastrointestinal Disorders in Children With Cow's Milk Allergy|Completed||N/A|220|Actual|Federico II University|||2||f||||f||||||||||2017-10-11 01:29:16.983511|2017-10-11 01:29:16.983511
NCT01901367|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-03-27|||May 2013||2013-05-01|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2014|Actual|2014-09-30||Interventional|||ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients|ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients|Active, not recruiting||N/A|33|Actual|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-10-11 01:29:17.071478|2017-10-11 01:29:17.071478
NCT01901354|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-09-26|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ALIVE||Acute Lung Injury Ventilator Evaluation (ALIVE)|Acute Lung Injury Ventilator Evaluation (ALIVE) Trial: Biomarkers of Lung Injury With Low Tidal Volume Ventilation Compared With Airway Pressure Release Ventilation in Trauma Patients|Terminated||N/A|4|Actual|University of Wisconsin, Madison||2||Lead Investigator no longer at Institution|f||||t||||||||||2017-10-11 01:29:17.17887|2017-10-11 01:29:17.17887
NCT01901341|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-10-16|2015-04-19||July 2013||2013-07-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional||All participants randomized to treatment who received ≥ 1 dose of double-blind study medication.|The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain|Terminated||Phase 3|44|Actual|Cubist Pharmaceuticals LLC|Due to difficulties with enrollment, the study was terminated early.|2||Due to difficulties with enrollment, the study was terminated early.|f||||t||||||||||2017-10-11 01:29:17.289516|2017-10-11 01:29:17.289516
NCT01901146|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-04-06||2017-04-06|April 29, 2013|Actual|2013-04-29|April 2017|2017-04-01|January 27, 2017|Actual|2017-01-27|May 5, 2016|Actual|2016-05-05||Interventional|Lilac||Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer|A Randomized, Double-Blind, Phase 3 Study Evaluating the Efficacy and Safety of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer|Completed||Phase 3|827|Actual|Amgen||2|||f||||t||||||||||2017-10-11 01:29:21.540906|2017-10-11 01:29:21.540906
NCT01901328|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-01-05|2015-04-19||August 2013||2013-08-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional||All participants randomized to treatment who received ≥ 1 dose of double-blind study medication.|Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain|Terminated||Phase 3|49|Actual|Cubist Pharmaceuticals LLC|Due to difficulties with enrollment, this study was terminated early.|2||Sponsor decision due to lack of enrollment.|f||||t||||||||||2017-10-11 01:29:18.053959|2017-10-11 01:29:18.053959
NCT01901315|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-05-21|||March 2012||2012-03-01|July 2013|2013-07-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Psychiatric Care Via Videoconferencing|New Information and Communication Technologies in the Delivery of Mental Health Treatment: Psychiatric Care Via Videoconferencing|Completed||N/A|107|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 01:29:18.587897|2017-10-11 01:29:18.587897
NCT01901302|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-01-05|2015-04-19||July 2013||2013-07-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional||All participants randomized to treatment who received ≥ 1 dose of double-blind study medication.|Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain|Terminated||Phase 3|61|Actual|Cubist Pharmaceuticals LLC|Due to difficulties with enrollment, this study was terminated early.|2||Sponsor decision due to lack of enrollment.|f||||t||||||||||2017-10-11 01:29:18.750862|2017-10-11 01:29:18.750862
NCT01901289|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-02-13|||August 2013||2013-08-01|February 2017|2017-02-01|October 2021|Anticipated|2021-10-01|October 21, 2016|Actual|2016-10-21||Interventional|||Zilver® PTX® V Clinical Study|Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study|Active, not recruiting||N/A|200|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 01:29:19.336395|2017-10-11 01:29:19.336395
NCT01901263|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-11-30|||October 2012||2012-10-01|July 2015|2015-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|3 Years|Observational [Patient Registry]|||Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units|Initial and Long-term Evaluation of Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units|Completed||N/A|306|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 01:29:19.510069|2017-10-11 01:29:19.510069
NCT01901250|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-07-22|2014-07-22||August 2007||2007-08-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Xylitol for Caries Prevention in Inner-City Children|Xylitol for Caries Prevention in Inner-City Children|Completed||N/A|562|Actual|Case Western Reserve University|Nearly half the children moved out of the school district by the time of the exit examination, which made the power of the analysis insufficient to detect the difference between two groups.|2|||f||||t||||||||||2017-10-11 01:29:19.606972|2017-10-11 01:29:19.606972
NCT01901237|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-07-11|||September 2013||2013-09-01|July 2017|2017-07-01|June 13, 2017|Actual|2017-06-13|June 13, 2017|Actual|2017-06-13||Interventional|||Yoga for Adolescent and Young Adult Non-Curative Cancer Patients|Impact of Yoga on Quality of Life for Adolescent and Young Adult Non-Curative Cancer Patients: A Pilot Study|Completed||N/A|5|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 01:29:19.946094|2017-10-11 01:29:19.946094
NCT01901224|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2015-01-26|||July 2013||2013-07-01|January 2015|2015-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease||Unknown status|Recruiting|Phase 4|72|Anticipated|Brigham and Women's Hospital||2|||f||||||||||||||2017-10-11 01:29:20.066849|2017-10-11 01:29:20.066849
NCT01901211|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-01-31|2017-01-31||September 2013|Actual|2013-09-01|January 2016|2016-01-01|April 5, 2014|Actual|2014-04-05|April 5, 2014|Actual|2014-04-05||Interventional|||Physical and Social Benefits of Multi-Player Interactive Computer Play Games in Youth With Cerebral Palsy|CP Fit 'n' Fun Project: Physical and Social Benefits of Multi-Player Interactive Computer Play Games in Youth With Cerebral Palsy|Completed||N/A|11|Actual|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||f||||||||||2017-10-11 01:29:20.340387|2017-10-11 01:29:20.340387
NCT01901198|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-11-14|||April 2013||2013-04-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase I Study in Chinese Healthy Volunteers|A Phase 1 Study to Evaluate the Pharmacokinetic and Pharmacodynamic Profile, Safety, and Tolerability of Escalating Single Dose Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein in Healthy Volunteers|Completed||Phase 1|34|Actual|Beijing Bio-Fortune Ltd.||2|||f||||f||||||||||2017-10-11 01:29:20.728505|2017-10-11 01:29:20.728505
NCT01901185|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-11-14|2014-11-05||June 2013||2013-06-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept|A Single-arm, Multicenter Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Electromechanical Autoinjector to Self-inject Etanercept|Completed||Phase 3|77|Actual|Amgen||1|||f||||f||||||||||2017-10-11 01:29:20.844915|2017-10-11 01:29:20.844915
NCT01901172|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-08-17|||August 2013||2013-08-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors||Completed||Phase 1|61|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 01:29:21.226772|2017-10-11 01:29:21.226772
NCT01901159|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-11-01|||June 2013||2013-06-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study of RO4995819 to Assess Bioavailability and Safety in Healthy Volunteers|A Randomized, Single Dose, Open-label, Two Parts, Two and Three Period Cross-over Study to Investigate the Relative Bioavailability of Two Tablet Formulations and the Effect of Fasting Following Oral Administration of RO4995819 in Healthy Subjects|Completed||Phase 1|52|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:29:21.41248|2017-10-11 01:29:21.41248
NCT01901133|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-09-12|||October 2011||2011-10-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group|A Phase I, Non-randomized, Open-label, Single-dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of MDV3100 in Male Subjects With Mild or Moderate Hepatic Impairment and Normal Hepatic Function|Completed||Phase 1|33|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:29:22.047894|2017-10-11 01:29:22.047894
NCT01901120|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-10-30|||October 2012||2012-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Long-Term Specified Drug Use-results Survey of Betanis Tablets|Long-Term Specified Drug Use-results Survey of Betanis Tablets|Completed||N/A|1263|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:29:22.175234|2017-10-11 01:29:22.175234
NCT01901107|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-01-26|||January 2013||2013-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients|Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphataemia Receiving Hemodialysis|Completed||N/A|1078|Actual|Astellas Pharma Inc|||1||f||||f||||||||Undecided||2017-10-11 01:29:22.307953|2017-10-11 01:29:22.307953
NCT01901094|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-09-29|||February 2014||2014-02-01|September 2017|2017-09-01||||January 2024|Anticipated|2024-01-01||Interventional|||Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy|A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy|Recruiting||Phase 3|2918|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 01:29:22.912769|2017-10-11 01:29:22.912769
NCT01901081|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-02-27|||May 2013|Actual|2013-05-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|IMES||Feasibility of Implantable Myoelectric Sensors to Control Upper Limb Prostheses|A Feasibility Study to Assess Safety and Functionality of Implantable Myoelectric Sensors for Upper Extremity Prosthetic Control in Transradial Amputees|Completed||N/A|3|Actual|The Alfred E. Mann Foundation for Scientific Research||1|||f||||f||||||||||2017-10-11 01:29:31.477754|2017-10-11 01:29:31.477754
NCT01901068|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2016-02-09|||February 2013||2013-02-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Observational|MULTIMAC||MonoMax for Abdominal Wall Closure|A Multicentre, International, Prospective Post-market Clinical Follow-up to Evaluate MonoMax for Abdominal Wall Closure|Completed||N/A|200|Actual|Aesculap AG|||1||f||||f||||||||No||2017-10-11 01:29:31.564697|2017-10-11 01:29:31.564697
NCT01901055|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-11-04|||July 2013||2013-07-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|DOTT||Diabetes-Obstructive Sleep Apnea Treatment Trial|The Effect of Treatment of Obstructive Sleep Apnea on Diabetes Self Management and Glycemic Control|Recruiting||N/A|210|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 01:29:31.64557|2017-10-11 01:29:31.64557
NCT01901042|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2013-07-13|||January 2012||2012-01-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms|Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms. A Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 2/Phase 3|20|Actual|Federal University of Mato Grosso do Sul||2|||f||||t||||||||||2017-10-11 01:29:31.738075|2017-10-11 01:29:31.738075
NCT01901029|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2013-08-09|||July 2013||2013-07-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|August 2013|Actual|2013-08-01||Observational|||Male Reproductive Health of Floating Population: a Large-Scale Survey in Dongguan|Prevalence of Reproductive Health Problems and Their Social, Psychological and Physical Association Among Men in Floating Population: a Large-Scale Cross-Sectional Study in Dongguan City|Unknown status|Recruiting|N/A|3100|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||2||f||||t||||||||||2017-10-11 01:29:31.817528|2017-10-11 01:29:31.817528
NCT01901016|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-16|||June 2013||2013-06-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Relaxation, Depressive Symptoms, Quality of Life, Immunological and Virological Status in People Living With HIV: a Pilot Study|Pilot Study to Determine the Feasibility, Acceptability and Preliminary Effects of Relaxation as a Nursing Intervention for Depressive Symptoms, Quality of Life, Immune Status and Viral Load in People Living With HIV|Unknown status|Recruiting|N/A|90|Anticipated|Université de Montréal||3|||f||||f||||||||||2017-10-11 01:29:31.922556|2017-10-11 01:29:31.922556
NCT01901003|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-04-20|||November 2012||2012-11-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PremedX||Sedative Premedication: Efficacy On Patient Experience|SEDATIVE PREMEDICATION: EFFICACY ON PATIENT EXPERIENCE|Completed||Phase 3|1200|Actual|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-11 01:29:32.162554|2017-10-11 01:29:32.162554
NCT01900990|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-26|2013-07-13|||July 2009||2009-07-01|July 2013|2013-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Noninvasive Positive Pressure Ventilation for Difficult Weaning in Tracheotomy Patients|A Randomized Controlled Trial of Noninvasive Positive Pressure Ventilation for Weaning From Mechanical Ventilation in Tracheotomy Patients|Completed||N/A|32|Actual|Chongqing Medical University||2|||f||||t||||||||||2017-10-11 01:29:32.24387|2017-10-11 01:29:32.24387
NCT01900977|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-08-15|||September 2013||2013-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PopART||Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART)|Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART): A Cluster-randomized Trial of the Impact of a Combination Prevention Package on Population-level HIV Incidence in Zambia and South Africa|Recruiting||N/A|52500|Anticipated|HIV Prevention Trials Network||3|||f||||t||||||||||2017-10-11 01:29:32.32948|2017-10-11 01:29:32.32948
NCT01900964|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-12-06|||October 2012||2012-10-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Ridge Preservation Comparing a PTFE Nonresorbable Membrane to a Collagen Membrane|Ridge Preservation Comparing the Clinical and Histologic Healing of a PTFE Non-resorbable vs. a Collagen Membrane With an Intrasocket Mineralized Cancellous Allograft Plus a Facial Overlay Bovine Xenograft.|Completed||N/A|30|Actual|University of Louisville||2|||f||||f||||||||||2017-10-11 01:29:32.45654|2017-10-11 01:29:32.45654
NCT01900951|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-01-24|||January 2013||2013-01-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Interventional|||Temozolomide as Maintenance Therapy in Small Cell Lung Cancer|Phase 2 Study of Temozolomide as Maintenance Therapy After Initial Induction Chemotherapy in Small Cell Lung Cancer|Active, not recruiting||Phase 2|60|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:29:32.542273|2017-10-11 01:29:32.542273
NCT01900938|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-07-16|||September 2013||2013-09-01|July 2013|2013-07-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP|Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During Endoscopic Retrograde Cholangiopancreatography: a Prospective Randomized Controlled Study|Unknown status|Not yet recruiting|N/A|210|Anticipated|Hanyang University||2|||f||||t||||||||||2017-10-11 01:29:32.628017|2017-10-11 01:29:32.628017
NCT01900925|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2016-04-29|||September 2013||2013-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|HiLoBaS||Does Prescriptive Treatment of the Hips Improve Outcomes in Patients With Low Back Pain? A Randomized Controlled Trial|Does Prescriptive Treatment of the Hips Improve Outcomes in Patients With Low Back Pain? A Randomized Controlled Trial|Completed||Phase 2/Phase 3|90|Actual|Regis University||2|||f||||f||||||||||2017-10-11 01:29:32.736951|2017-10-11 01:29:32.736951
NCT01900912|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-02-17|||January 2011||2011-01-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|CLTS||Evaluating the Impact of Community Led Total Sanitation Programs in Mali|Evaluating the Impact of Community Led Total Sanitation in Mali. A Randomized Controlled Trial|Completed||N/A|39246|Actual|Universidad Nacional de La Plata||2|||f||||f||||||||||2017-10-11 01:29:32.842257|2017-10-11 01:29:32.842257
NCT01900899|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-09-21|||July 16, 2013|Actual|2013-07-16|September 2017|2017-09-01|November 14, 2017|Anticipated|2017-11-14|November 14, 2017|Anticipated|2017-11-14||Interventional|||Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children|A Phase III, Open, Multi-centre, Controlled Study To Evaluate The Long-term Antibody Persistence At 2, 3, 4, 5 And 6 Years After A Booster Dose Of Meningococcal Serogroup A, C, W-135, Y- Tetanus Toxoid Conjugate Vaccine (MENACWY-TT) Or Meningitec (Registered) Administered In Healthy 5-year-old Children In Study MENACWY-TT-048 Ext: 039 Y2, 3, 4, 5 (112036), Who Were Primed With The Same Vaccine In Study MENACWY-TT-039 (109670) At 12 Through 23 Months Of Age.|Active, not recruiting||Phase 3|193|Actual|Pfizer||2|||f||||f|f|f||||||||2017-10-11 01:29:32.949539|2017-10-11 01:29:32.949539
NCT01900886|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-12|||December 2010||2010-12-01|December 2010|2010-12-01|December 2013|Anticipated|2013-12-01|June 2013|Actual|2013-06-01||Observational|Perseo||Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C|"Prospective Observational Study to Assess Personality Disorders in Prison Populations for Hepatitis C Treatment. "|Unknown status|Active, not recruiting|N/A|263|Anticipated|Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:29:33.073982|2017-10-11 01:29:33.073982
NCT01900873|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-02-02|||July 2013||2013-07-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|IMTCOCOPD||Effects of Inspiratory Muscle Training on Dyspnea Perception During Exercise in Patients With COPD|Effects of Inspiratory Muscle Training on Dyspnea Perception During Exercise in Patients With COPD|Completed||N/A|20|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 01:29:33.192752|2017-10-11 01:29:33.192752
NCT01900860|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-04-04|||August 2013||2013-08-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose-dependent Effects of Vitamin D on Bone Health|Randomized Double-blind Study Investigating Dose-dependent Longitudinal Effects of Vitamin D Supplementation on Bone Health|Active, not recruiting||N/A|300|Anticipated|University of Calgary||3|||f||||t||||||||Undecided||2017-10-11 01:29:33.415848|2017-10-11 01:29:33.415848
NCT01900847|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-12|||June 2013||2013-06-01|July 2013|2013-07-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency Department|Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency Department|Unknown status|Recruiting|N/A|112|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-11 01:29:33.539798|2017-10-11 01:29:33.539798
NCT01900834|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-10-07|||July 2013||2013-07-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period|An Observational Study Evaluating Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period|Completed||Early Phase 1|61|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"     Monthly venous blood samples within the first half year and thereafter bi-monthly the rest of     the year. A subgroup of the subjects will also be invited for a visit within a week after the     former visit to assess the variation of the biomarkers within a week. The blood samples will     be assayed for peripheral blood mononuclear cells (PBMC) specificity, phenotype and function     as well as for islet autoantibodies (presence and precise titers), for autoantibody isotypes     and diabetes risk parameters. Finally C-peptide levels and residual beta cell function will     be measured three times during the study after a mix meal tolerance test (MMTT) in subjects     with T1D.   "|||2017-10-11 01:29:33.657826|2017-10-11 01:29:33.657826
NCT01900821|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-02-17|||July 2009||2009-07-01|February 2014|2014-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|1 Year|Observational [Patient Registry]|||National Mammography Database||Recruiting||N/A|8000000|Anticipated|American College of Radiology|||1||f||||t||||||||||2017-10-11 01:29:33.788462|2017-10-11 01:29:33.788462
NCT01900808|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-01-15|||March 2012||2012-03-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Observational|||Improvement of Transient Elastography Applicability and Diagnostic Accuracy to Identify Significant Fibrosis by Experienced Operators Using the M and XL Probe.|Improvement of Transient Elastography Applicability and Diagnostic Accuracy to Identify Significant Fibrosis by Experienced Operators Using the M and XL Probe.|Completed||N/A|868|Actual|Parc de Salut Mar|||1||f||||f||||||||||2017-10-11 01:29:33.870962|2017-10-11 01:29:33.870962
NCT01900626|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2015-10-01|||July 2013||2013-07-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Single vs Double Epidural Catheter Analgesia for Scoliosis Surgery|Single Versus Double Epidural Catheter Technique for Postoperative Analgesia Following Scoliosis Surgery|Terminated||N/A|2|Actual|University of Wisconsin, Madison||2||Study was unable to meet patient enrollment goals. PI chose to terminate the study early.|f||||f||||||||||2017-10-11 01:29:36.05749|2017-10-11 01:29:36.05749
NCT01900795|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-12-03|||July 2013||2013-07-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction|A Phase 2a, Single-Center, Randomized, Double-Blind, Double- Dummy, Placebo- and Active-Controlled Analgesic Study of an Oral Dose of V117957 4.5 mg for the Treatment of Postsurgical Pain Due to Third Molar Extraction|Terminated||Phase 2|114|Actual|Purdue Pharma LP||3||Terminated early due to administrative reasons not related to safety.|f||||t||||||||||2017-10-11 01:29:33.956786|2017-10-11 01:29:33.956786
NCT01900782|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-08-14|||October 2013||2013-10-01|August 2013|2013-08-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.|A Randomized, Double-blind, Double-dummy, Multicenter Study of Subcutaneous Secukinumab to Demonstrate Efficacy After Twelve Weeks of Treatment, Compared to Placebo and Etanercept, and to Assess the Safety, Tolerability and Long-term Efficacy up to One Year in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis.|Withdrawn||Phase 3|0|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:29:34.075349|2017-10-11 01:29:34.075349
NCT01900756|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-05-04|||September 2014||2014-09-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|THRIVES||Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke|Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke|Active, not recruiting||N/A|400|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:29:34.31429|2017-10-11 01:29:34.31429
NCT01900743|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-07-28|||June 2013||2013-06-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|REGO-SARC||Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma|Activity and Safety of Regorafenib in Patients With Metastatic Soft Tissue Sarcoma Previously Treated With Anthracycline-based Chemotherapy : a Multinational, Randomized, Phase II, Placebo-controlled Trial|Active, not recruiting||Phase 2|196|Anticipated|Centre Oscar Lambret||2|||f||||t||||||||No||2017-10-11 01:29:34.417942|2017-10-11 01:29:34.417942
NCT01900730|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-03-28|||July 31, 2014|Actual|2014-07-31|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter|Randomized Phase II Double Blind Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter|Active, not recruiting||Phase 2|3|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:29:34.572595|2017-10-11 01:29:34.572595
NCT01900717|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-05-12|||April 2011||2011-04-01|July 2013|2013-07-01||||July 2013|Actual|2013-07-01||Interventional|Prodige20||Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma (Prodige20)|Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma|Completed||Phase 2|102|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 01:29:34.696528|2017-10-11 01:29:34.696528
NCT01900704|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2015-11-23||2015-11-23|August 2013||2013-08-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|DB4||Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4|A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Investigate the Efficacy and Safety of SER120 Nasal Spray Formulation in Patients With Nocturia|Completed||Phase 3|891|Actual|Serenity Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 01:29:34.805882|2017-10-11 01:29:34.805882
NCT01900691|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-09-26|||September 2013||2013-09-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|CLARITY||Removal of the Evolution® Esophageal Stent - Fully Covered|Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered|Recruiting||N/A|130|Anticipated|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 01:29:34.93105|2017-10-11 01:29:34.93105
NCT01900678|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-06-26|||June 2013||2013-06-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation System|VLIC-USA: A Single-Center Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation System|Completed||N/A|7|Actual|VytronUS, Inc.||1|||f||||t||||||||||2017-10-11 01:29:35.093709|2017-10-11 01:29:35.093709
NCT01900665|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-03-07||2016-12-21|July 2013||2013-07-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|EXPEDITION 3||Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo|Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo|Terminated||Phase 3|2121|Actual|Eli Lilly and Company||2||Solanezumab did not meet the study's primary endpoint.|f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 01:29:35.207995|2017-10-11 01:29:35.207995
NCT01900652|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-04-25||2015-05-08|August 2013||2013-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2015|Actual|2015-02-01||Interventional|Chime||A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) Participants|A Randomized, Open-Label Phase 2 Study Evaluating LY2875358 Plus Erlotinib and LY2875358 Monotherapy in MET Diagnostic Positive NSCLC Patients With Acquired Resistance to Erlotinib|Completed||Phase 2|89|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:29:35.781344|2017-10-11 01:29:35.781344
NCT01900639|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-02-19|||July 2013||2013-07-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Aspirin AM or PM: Effect on Circadian Rhythm of Platelet Reactivity|Effect of Aspirin Intake on Awakening Versus at Bedtime on Circadian Rhythm of Platelet Reactivity in Healthy Subjects|Completed||Phase 4|14|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-11 01:29:35.972271|2017-10-11 01:29:35.972271
NCT01900613|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-07-17|||April 2011|Actual|2011-04-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Niños Sanos, Familia Sana - A Multi-Intervention Program to Prevent Childhood Obesity in Mexican-Heritage Children in Rural California|Niños Sanos, Familia Sana (Healthy Children/Healthy Family): A Multi-Intervention Program to Prevent Childhood Obesity in Mexican-Heritage Children in Rural California|Completed||N/A|800|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 01:29:36.224229|2017-10-11 01:29:36.224229
NCT01900600|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-06|2017-09-14|||April 2013||2013-04-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)|Substudy of the the CANTOS Trial (Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated Hs-CRP; CACZ885M2301)|Active, not recruiting||N/A|16|Actual|Virginia Commonwealth University||4|||f||||f||||||||||2017-10-11 01:29:36.329241|2017-10-11 01:29:36.329241
NCT01900587|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2013-10-31|||July 2010||2010-07-01|October 2013|2013-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess Bio-equivalence of a New Tapentadol Extended-Release (TRF) 50-mg Tablet With Respect to a Tapentadol Extended-Release (PR2) 50-mg Tablet Under Fasted Conditions in Healthy Subjects|Completed||Phase 1|64|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 01:29:36.456552|2017-10-11 01:29:36.456552
NCT01900574|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-07-11|||August 9, 2013|Actual|2013-08-09|July 2017|2017-07-01|August 8, 2023|Anticipated|2023-08-08|February 18, 2015|Actual|2015-02-18||Interventional|||A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis|A Phase 1b Open-Label Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis|Active, not recruiting||Phase 1|35|Actual|Janssen Research & Development, LLC||1|||f||||t|t|||||||||2017-10-11 01:29:36.561695|2017-10-11 01:29:36.561695
NCT01900548|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-04-05|||January 2014||2014-01-01|July 2013|2013-07-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Intake of Whey Protein in Elderly Osteopenic Patients. Implications for Metabolism and Physical Function.|Effect of Intake of Protein High in Ketogenic Amino Acids (e.g. Leucine) in Elderly Osteopenic Patients. Implications for Muscle, Bone , Metabolism, and Physical Function.|Completed||N/A|57|Actual|University of Aarhus||3|||f||||f||||||||No||2017-10-11 01:29:36.841424|2017-10-11 01:29:36.841424
NCT01900522|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2015-02-17|||July 2013||2013-07-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia|A Phase 1, Randomized, Placebo- Controlled, Double-Blind Safety, Tolerability, Pharmacokinetic, and Exploratory Pharmacodynamic Study in Healthy Subjects and Subjects With Stable Schizophrenia After Multiple Doses of ITI-214|Terminated||Phase 1|76|Anticipated|Takeda||2||Business Decision; No Safety or Efficacy Concerns|f||||f||||||||||2017-10-11 01:29:37.032851|2017-10-11 01:29:37.032851
NCT01900509|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-03-21|||August 2013||2013-08-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies|A Phase I Trial of Bendamustine in Combination With Clofarabine and Etoposide in Pediatric Patients With Relapsed or Refractory Hematologic Malignancies|Completed||Phase 1|16|Actual|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-11 01:29:37.156508|2017-10-11 01:29:37.156508
NCT01900496|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-05-17|||April 2014||2014-04-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma|Pilot Study of Rituximab and Brentuximab Vedotin With Deferred BMT for Relapsed Classical Hodgkin Lymphoma|Recruiting||Early Phase 1|25|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:29:37.293147|2017-10-11 01:29:37.293147
NCT01900483|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-11-09||||||November 2015|2015-11-01||||August 2014|Actual|2014-08-01||Observational|||Brain Functions in Patients Before and After Bariatric Surgery||Completed||N/A|24|Actual|University Hospital Tuebingen|||2||f||||||||||||||2017-10-11 01:29:37.409527|2017-10-11 01:29:37.409527
NCT01900470|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-05-02|||July 2013||2013-07-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|May 2015|Actual|2015-05-01||Interventional|||Effectiveness of Patient-centered Community Health Worker Support to Help Patients Control Chronic Disease|Community Health Worker Support to Help Patients Control Chronic Disease|Completed||N/A|302|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:29:37.487556|2017-10-11 01:29:37.487556
NCT01900457|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2015-04-20|||June 2012||2012-06-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy Volunteers|Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy Volunteers|Completed||N/A|208|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 01:29:37.579736|2017-10-11 01:29:37.579736
NCT01900444|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2015-01-09|||July 2013||2013-07-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|||Study of a Booster Dose of IMOJEV® Vaccine One Year After Primary Immunization in Healthy Children in South Korea|Immunogenicity and Safety Exploration of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) Given One Year After Primary Immunization in Healthy Children in South Korea|Completed||Phase 3|119|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:29:37.658338|2017-10-11 01:29:37.658338
NCT01900431|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-05-23|2017-05-23|2016-03-07|October 2013||2013-10-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|July 2015|Actual|2015-07-01||Interventional|SARILNIUSATURN||Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis|A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)|Completed||Phase 2|58|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 01:29:37.774183|2017-10-11 01:29:37.774183
NCT01900418|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-08-05|||August 2013||2013-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|October 2015|Actual|2015-10-01||Interventional|||Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy|Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy|Completed||N/A|78|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 01:29:38.463657|2017-10-11 01:29:38.463657
NCT01900405|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-11|||April 2013||2013-04-01|July 2013|2013-07-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Observational|||Intranasal Dexmedetomidine Sedation for Pediatric CT Imaging|Intranasal Dexmedetomidine Sedation for Pediatric Computerized Tomography Imaging|Unknown status|Recruiting|N/A|60|Anticipated|University of Sao Paulo|||1||f||||f||||||||||2017-10-11 01:29:38.679981|2017-10-11 01:29:38.679981
NCT01900392|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-03-28|||September 2013||2013-09-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|||Financial Incentives for Maintenance of Weight Loss|A Randomized Trial of Financial Incentives for Maintenance of Weight Loss|Completed||N/A|191|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-10-11 01:29:38.771634|2017-10-11 01:29:38.771634
NCT01900379|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-02-02|||July 2013|Actual|2013-07-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|PAC-IC-SAOS||PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular Function|Impact of the Obstructive Sleep Apnea Syndrome Treatment and Ventricular Function in Heart Failure Patients Undergoing Coronary Artery Bypass Surgery or Other Coronary Reperfusion|Completed||N/A|17|Actual|University Hospital, Grenoble||3|||f||||t||||||||||2017-10-11 01:29:38.867102|2017-10-11 01:29:38.867102
NCT01900366|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-09-16|||August 2013||2013-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Pilot Study for Noninvasive Spectroscopic Detection of Adipose Tissue Inflammation in Obesity|Pilot Study for Noninvasive Spectroscopic Detection of Adipose Tissue Inflammation in Obesity|Completed||N/A|14|Actual|Rockefeller University|||2||f||||f||||||Samples Without DNA|"     Adipose tissue   "|||2017-10-11 01:29:38.964404|2017-10-11 01:29:38.964404
NCT01900340|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2013-07-11|||November 2011||2011-11-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans|Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans|Completed||Phase 1|12|Actual|University Hospital, Basel, Switzerland||4|||f||||t||||||||||2017-10-11 01:29:39.12983|2017-10-11 01:29:39.12983
NCT01900327|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-01-30|||February 2014||2014-02-01|January 2015|2015-01-01|December 2020|Anticipated|2020-12-01|February 2020|Anticipated|2020-02-01||Interventional|NEOPA||Neoadjuvant Treatment in Resectable Pancreatic Cancer|Sequential Neoadjuvant Chemoradiotherapy (CRT) Followed by Curative Surgery vs. Primary Surgery Alone for Resectable, Non-metastasized Pancreatic Adenocarcinoma|Recruiting||Phase 3|410|Anticipated|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-11 01:29:39.227082|2017-10-11 01:29:39.227082
NCT01900314|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-04-20|2017-01-09||September 2013||2013-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional||Baseline data for completers only, since this is the group entered into the analysis.|Imaging Biomarkers for TMS Treatment of Depression|Imaging Biomarkers for TMS Treatment of Depression|Completed||N/A|40|Actual|University of Michigan|Small size, not powered for group differences. Primary measure was not clinical, but brain changes (primary measures for this report have only focused on clinical changes as neural changes cannot be entered into this reporting format|2|||f||||f||||||||||2017-10-11 01:29:39.508394|2017-10-11 01:29:39.508394
NCT01900301|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-11-01|||August 2013||2013-08-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Generalization of Extinction Learning|Cholinergic Decontextualization of Exposure Therapy for Anxiety|Recruiting||Phase 1|100|Anticipated|University of California, Los Angeles||4|||f||||t||||||||||2017-10-11 01:29:39.844576|2017-10-11 01:29:39.844576
NCT01900288|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-01-26|||August 2012||2012-08-01|January 2017|2017-01-01|December 23, 2016|Actual|2016-12-23|December 2015|Actual|2015-12-01||Interventional|||Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research|Mobile Technologies Assisting Patients & Family Caregivers in Healthy Living|Completed||N/A|121|Actual|University of Kansas Medical Center||2|||f||||t|f|f||||||||2017-10-11 01:29:39.964852|2017-10-11 01:29:39.964852
NCT01900275|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2014-11-21|||July 2013||2013-07-01|November 2014|2014-11-01||||November 2014|Actual|2014-11-01||Observational|||Urinary Heparanase Activity as a Predictor of Acute Kidney Injury in Critically Ill Adults|Urinary Heparanase Activity as a Predictor of Acute Kidney Injury in Critically Ill Adults|Completed||N/A|57|Actual|Denver Health and Hospital Authority|||1||f||||f||||||Samples Without DNA|"     Urine will be collected, centrifuged, and frozen   "|||2017-10-11 01:29:40.102874|2017-10-11 01:29:40.102874
NCT01900262|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-08-13|||February 2014||2014-02-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||Exercise Interventions, Running Biomechanics and Injury in Novice Runners|The Effects of Isolated Strengthening and Functional Training on Strength, Running Mechanics, Postural Control and Injury Prevention in Novice Runners|Unknown status|Active, not recruiting|N/A|120|Anticipated|University of Calgary||3|||f||||f||||||||||2017-10-11 01:29:40.182907|2017-10-11 01:29:40.182907
NCT01900249|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-08-09|2016-06-06||July 2013||2013-07-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|DROPS||To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca|A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca|Completed||Phase 2|204|Actual|Rigel Pharmaceuticals||3|||f||||f||||||||No||2017-10-11 01:29:40.287057|2017-10-11 01:29:40.287057
NCT01900236|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-07-19|||December 2013||2013-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 30, 2017|Actual|2017-06-30||Interventional|iENGAGE||Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV|Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV|Active, not recruiting||N/A|371|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 01:29:40.993716|2017-10-11 01:29:40.993716
NCT01900223|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-01-13|||June 2013||2013-06-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Chronic Pain After Shoulder Arthroplasty|Chronic Pain After Shoulder Arthroplasty: Epidemiology and Risk Factors.|Completed||N/A|786|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 01:29:41.095986|2017-10-11 01:29:41.095986
NCT01900210|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-11|||August 2008||2008-08-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|DRR||Sustainable HIV Risk Reduction Strategies for CJ Systems|Sustainable Disease Risk Reduction Strategies for CJ Systems|Completed||N/A|1396|Actual|Texas Christian University||2|||f||||f||||||||||2017-10-11 01:29:41.158756|2017-10-11 01:29:41.158756
NCT01900197|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-03-01|||August 2013||2013-08-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01|1 Year|Observational [Patient Registry]|||Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)|A Non-intervention Trial of the Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)|Completed||N/A|391|Actual|Pharmacosmos A/S|||1||f||||f||||||||||2017-10-11 01:29:41.230002|2017-10-11 01:29:41.230002
NCT01900184|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-07-11|||December 2012||2012-12-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects|Part 1: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Ascending Single Dose and Food Influence Study of QGC001 Administered Orally To Healthy Adult Subjects, Part 2: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Ascending Multiple Dose Study of QGC001 Administered Orally To Healthy Adult Subjects.|Completed||Phase 1|69|Actual|Quantum Genomics SA||4|||f||||t||||||||||2017-10-11 01:29:41.304722|2017-10-11 01:29:41.304722
NCT01900171|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-11|||February 2012||2012-02-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo|A Phase I, Double-blind, Placebo-controlled, Ascending Single-dose, Safety, Tolerability and Pharmacokinetic Study of QGC001 in Healthy Male Subjects.|Completed||Phase 1|56|Actual|Quantum Genomics SA||9|||f||||t||||||||||2017-10-11 01:29:41.41695|2017-10-11 01:29:41.41695
NCT01900158|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-10-12|||May 2013||2013-05-01|October 2016|2016-10-01||||August 2019|Anticipated|2019-08-01||Interventional|||A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas|A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability and Efficacy of PCI of Gemcitabine Followed by Gemcitabine/Cisplatin Chemotherapy in Patients With Inoperable Cholangiocarcinomas|Recruiting||Phase 1/Phase 2|55|Anticipated|PCI Biotech AS||2|||f||||t||||||||No||2017-10-11 01:29:41.534051|2017-10-11 01:29:41.534051
NCT01900132|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-06-30|||June 18, 2013||2013-06-18|March 16, 2017|2017-03-16|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Electrical Impedance Myography: Exploratory Studies in Healthy People and People With Neuromuscular Disorders|Electrical Impedance Myography: Exploratory Studies in Normal Subjects and Patients With Neuromuscular Disorders|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:29:41.68725|2017-10-11 01:29:41.68725
NCT01900119|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-06-30|||June 18, 2013||2013-06-18|January 27, 2017|2017-01-27|July 5, 2016|Actual|2016-07-05|July 5, 2016|Actual|2016-07-05||Observational|||A Description of Bacteria in the Mouths of Patients With Severe Aplastic Anemia|A Description of the Oral Microbiome of Patients With Severe Aplastic Anemia|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:29:41.76716|2017-10-11 01:29:41.76716
NCT01900106|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2016-10-25|||July 2013||2013-07-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)|A Prospective, Open-label Trial of Two Abacavir/Lamivudine Based Regimen (ABC/3TC + Darunavir/Ritonavir or ABC/3TC + Raltegravir) in Late Presenter naïve Patients (With CD4 Count <200 Cells/µL - Advanced HIV Disease)|Recruiting||Phase 3|350|Anticipated|University of Modena and Reggio Emilia||2|||f||||f||||||||No||2017-10-11 01:29:41.852574|2017-10-11 01:29:41.852574
NCT01900093|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-09-01|||July 2013||2013-07-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses|An Open-Label Prospective Proof-Of-Concept Trial to Evaluate the Response to Acthar Gel Therapy in Patients With Multiple Sclerosis (MS) Relapses Who Have Failed To Make an Adequate Recovery After Treatment With High-Dose Intravenous Methylprednisolone|Recruiting||N/A|10|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-11 01:29:41.960017|2017-10-11 01:29:41.960017
NCT01900080|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-10-10|||August 2013||2013-08-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|June 2016|Actual|2016-06-01||Interventional|||Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care|Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care|Active, not recruiting||N/A|814|Actual|Brigham and Women's Hospital||4|||f||||t||||||||Yes|Study data will be posted after publication.|2017-10-11 01:29:42.173914|2017-10-11 01:29:42.173914
NCT01900067|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-04-21|2014-12-10||November 2012||2012-11-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Study to Evaluate Safety and Efficacy of Blanket Used to Prevent Anesthesia Induced Hypothermia|An Open-Label, Multicenter, Randomised, Controlled Study to Evaluate the Efficacy and Safety of the BARRIER® EasyWarm Active Self-Warming Blanket Used for Continuous Active Warming to Prevent General Anaesthesia Induced Hypothermia During the Perioperative Surgical Period|Completed||N/A|271|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-11 01:29:42.270248|2017-10-11 01:29:42.270248
NCT01900041|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-12-11|||April 2012||2012-04-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss|Multicenter, Randomised, Open Label, Comparative Clinical Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss (Including AGA Ludwig's Type 1-2)|Completed||Phase 2|74|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-10-11 01:29:42.706896|2017-10-11 01:29:42.706896
NCT01900028|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-10-14|||October 2013||2013-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|April 2014|Actual|2014-04-01||Interventional|||To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours|A Non-randomised, Open-label, Sequential, Three-part, Phase I Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib Following Oral Dosing of a Tablet Formulation, and to Provide Data on the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours|Completed||Phase 1|85|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 01:29:42.882321|2017-10-11 01:29:42.882321
NCT01900015|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2017-07-24|||February 3, 2014|Actual|2014-02-03|July 2017|2017-07-01|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|STERAL||Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection|Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among HIV/HCV-Coinfected Patients Receiving Two Nucleoside Analogs Plus Efavirenz: The Steral Study|Completed||Phase 4|45|Actual|Andaluz Health Service||2|||f||||t||||||||||2017-10-11 01:29:43.024003|2017-10-11 01:29:43.024003
NCT01900002|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-04-13|||September 13, 2013|Actual|2013-09-13|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC)|A Phase II Study of Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma, BCLC Stage C|Active, not recruiting||Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:29:43.165834|2017-10-11 01:29:43.165834
NCT01899989|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-08-08|||July 5, 2013||2013-07-05|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer|Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer|Recruiting||Phase 1|26|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:29:43.285109|2017-10-11 01:29:43.285109
NCT01899976|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-01-17|||August 2013||2013-08-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||X-MAS Biliary Study With Covered Biliary Stent|A Non-Randomized, Multi-Center, Prospective, Single Arm Clinical Study of the X-SUIT NIR® Covered Biliary Metallic Stent for Palliation of Malignant Strictures in the Biliary Tree Via Endoscopic Approach|Active, not recruiting||Phase 3|68|Actual|Medinol Ltd.||1|||f||||f||||||||||2017-10-11 01:29:43.416827|2017-10-11 01:29:43.416827
NCT01899963|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-03-14|||November 2013||2013-11-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|||Time to Treatment Utilizing a Tele-Retinal Referral System for Wet Age Related Macular Degeneration and Diabetic Macular Edema: A Pilot Study|Time to Treatment Utilizing a Tele-Retinal Referral System for Wet Age Related Macular Degeneration and Diabetic Macular Edema: A Pilot Study|Recruiting||N/A|165|Anticipated|McMaster University|||2||f||||f||||||||||2017-10-11 01:29:43.53568|2017-10-11 01:29:43.53568
NCT01899950|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-01-04|||March 2011||2011-03-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|NPC||Longitudinal Study of Cognition With Niemann-Pick Disease, Type C|Longitudinal Study of Cognition With Niemann-Pick Disease, Type C|Completed||N/A|70|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 01:29:43.650864|2017-10-11 01:29:43.650864
NCT01899937|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-07-11|||June 2013||2013-06-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Effect of Different Methodologies on Variability of Brachial Artery Flow Mediated Dilation|Effect of Different Methodologies on Reliability of Flow Mediated Dilation as Measurement Tool: Meta-regression Analysis to Determine Minimum Quality Standards|Unknown status|Active, not recruiting|N/A|15000|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-11 01:29:43.764936|2017-10-11 01:29:43.764936
NCT01899924|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-03-08|||July 2013||2013-07-01|March 2015|2015-03-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|PEC||Cognitive Assessment by the Mean of Event Related Potentials|Cognitive Assessment of Patients With Brain Injuries by the Mean of Event|Recruiting||N/A|320|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-10-11 01:29:43.886951|2017-10-11 01:29:43.886951
NCT01899911|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2015-08-14|2015-04-20||March 2013||2013-03-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Clinical Study of Peripheral Capillary Oxygen Saturation (SpO2): Vital Signs Patch (VSP)|Pulse Oximeter Response TO Multiple Levels Of Stable Hypoxia|Completed||N/A|12|Actual|LifeWatch Services, Inc.|Not applicable for this trial.|1|||f||||f||||||||||2017-10-11 01:29:44.035218|2017-10-11 01:29:44.035218
NCT01899898|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-07-11|||April 2013||2013-04-01|July 2013|2013-07-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|SMAD||Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy|Phase 2/3 Study of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy|Unknown status|Active, not recruiting|Phase 2/Phase 3|70|Anticipated|Lady Hardinge Medical College||2|||f||||t||||||||||2017-10-11 01:29:44.256007|2017-10-11 01:29:44.256007
NCT01899885|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-06-11|||June 2013||2013-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|AHA||Acute High-risk Abdominal Surgery Study - an Optimized Perioperative Course|Acute High-risk Abdominal Surgery Study - an Optimized Perioperative Course|Completed||N/A|1200|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 01:29:44.370655|2017-10-11 01:29:44.370655
NCT01899872|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-11|||December 2011||2011-12-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|EAEEFD||Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes.|Acute Effects of Aerobic and Resistance Exercise on Endothelial Function in Patients With Type 1 Diabetes.|Unknown status|Recruiting|N/A|15|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||t||||||||||2017-10-11 01:29:44.471372|2017-10-11 01:29:44.471372
NCT01899859|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-02-19|||July 2013||2013-07-01|June 2014|2014-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis|A Multi-Center, Partially Blinded, Maximum Tolerated Multiple Dose Escalation, Phase 1 Clinical Trial to Evaluate the Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH)With Advanced Hepatic Fibrosis|Completed||Phase 1|31|Actual|Galectin Therapeutics Inc.||3|||f||||t||||||||||2017-10-11 01:29:44.567605|2017-10-11 01:29:44.567605
NCT01899846|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-08-14|||July 2013||2013-07-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood|A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery|Completed||Phase 1|30|Actual|Lumara Health, Inc.||3|||f||||f||||||||||2017-10-11 01:29:44.683921|2017-10-11 01:29:44.683921
NCT01899833|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-05-05|||April 3, 2017|Actual|2017-04-03|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)|A Prospective, Open-label, Multicenter Study With Blinded Over-reading Characterizing the Efficacy and Safety of 99mTc-EC-DG in the Evaluation of Coronary Artery Disease (CAD)|Recruiting||Phase 2|60|Anticipated|Cell>Point LLC||1|||f||||t|t|f||||||No||2017-10-11 01:29:44.82911|2017-10-11 01:29:44.82911
NCT01899820|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-10-07|||April 2013||2013-04-01|October 2013|2013-10-01|July 2015|Anticipated|2015-07-01|June 2014|Anticipated|2014-06-01||Interventional|EAPHLNP||Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya|Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya|Unknown status|Active, not recruiting|Phase 3|2100|Anticipated|KEMRI-Wellcome Trust Collaborative Research Program||2|||f||||t||||||||||2017-10-11 01:29:44.953328|2017-10-11 01:29:44.953328
NCT01899807|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-03-30|||June 2013||2013-06-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Bone Reconstruction of the Skull Using a Metal Ceramic Implant After Previously Failed Reconstruction|Cranial Reconstruction With Patient-specific Titanium Mesh/Mosaic-designed Calcium Phosphate-implant - A Multi Center Center, Single Arm, Non-comparative Prospective Case Series|Unknown status|Active, not recruiting|N/A|11|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 01:29:45.098253|2017-10-11 01:29:45.098253
NCT01899794|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-11|||October 2007||2007-10-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy of a Combined Surgical and Pharmacological Therapy to Treat Mixed Urinary Incontinence.|Efficacy of a Combined Surgical and Pharmacological Therapy to Treat Mixed Urinary Incontinence|Completed||Phase 4|66|Actual|Jewish General Hospital||2|||f||||t||||||||||2017-10-11 01:29:45.17542|2017-10-11 01:29:45.17542
NCT01899781|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2013-07-12|||August 2013||2013-08-01|July 2013|2013-07-01||||January 2015|Anticipated|2015-01-01||Interventional|||Prophylactic Antibiotic Treatment for Hand Lacerations Involving Flexor and/or Extensor Tendon|Prophylactic Antibiotic Treatment for Hand Lacerations Involving Flexor and/or Extensor Tendon|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-10-11 01:29:45.264356|2017-10-11 01:29:45.264356
NCT01899768|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-02-20|2016-12-15||November 2013||2013-11-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||GSK2339345 Hypertussive Challenge Study|A Randomised, Double-Blind (Sponsor-Unblind), Placebo Controlled, Cross-Over Study to Investigate the Efficacy, Effect on Cough Reflex Sensitivity, Safety, Tolerability and Pharmacokinetics of Inhaled GSK2339345 in Patients With Chronic Idiopathic Cough Using an Aqueous Droplet Inhaler|Completed||Phase 2|16|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:29:45.422768|2017-10-11 01:29:45.422768
NCT01899755|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-05-10|||July 10, 2013|Actual|2013-07-10|May 2017|2017-05-01|April 3, 2014|Actual|2014-04-03|April 3, 2014|Actual|2014-04-03||Interventional|||A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.|A Study to Evaluate the Pharmacokinetics, Safety and Tolerability, Immunogenicity, and Pharmacodynamics of GSK2800528 in Healthy Subjects.|Completed||Phase 1|45|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:29:48.902113|2017-10-11 01:29:48.902113
NCT01899742|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-07-18|2016-01-11||September 15, 2014|Actual|2014-09-15|July 2017|2017-07-01|July 22, 2015|Actual|2015-07-22|July 22, 2015|Actual|2015-07-22||Interventional|||The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium|DB2116960: A Randomized, Double-Dummy, Parallel Group, Multicenter Trial Comparing the Efficacy and Safety of UMEC/VI (a Fixed Combination of Umeclidinium and Vilanterol) With Tiotropium In Subjects With COPD Who Continue To Have Symptoms on Tiotropium|Completed||Phase 3|497|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:29:49.012492|2017-10-11 01:29:49.012492
NCT01899729|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-10-16|||May 2013||2013-05-01|July 2013|2013-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|8400-201||A 12-week Dose-Ranging Trial in Patients With Moderate to Sever Plaque Psoriasis|A Randomized, Double-Blind, Placebo-Controlled, 12-week Dose-Ranging Trial of IMO-8400 in Patients With Moderate to Sever Plaque Psoriasis|Completed||Phase 2|45|Actual|Idera Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 01:29:49.576329|2017-10-11 01:29:49.576329
NCT01899716|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-12-27|||January 2008||2008-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Exercise and Severe Depression: Clinical and Biological Analysis|Exercise and Severe Depression: Clinical and Biological Analysis|Completed||N/A|50|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||||||||||||2017-10-11 01:29:49.663702|2017-10-11 01:29:49.663702
NCT01899521|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-05-31|||May 1, 2013|Actual|2013-05-01|May 2017|2017-05-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|ExZACTO||Examination of Zinc, S-adenosylmethionine, and Combination Therapy Versus Placebo in Alcoholics|Alcohol Abuse, Oxidative Stress, and Zinc Deficiency in Lung Disease|Recruiting||N/A|100|Anticipated|VA Office of Research and Development||4|||f||||t|f|f|||f|||Undecided||2017-10-11 01:29:53.440324|2017-10-11 01:29:53.440324
NCT01899690|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-02-22|||June 2016|Anticipated|2016-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Antibiotics and Tissue Expanders in Breast Reconstruction|Impact of Prophylactic Perioperative Antibiotic Administration on Surgical Site Infections Following Implant-based Breast Reconstruction.|Withdrawn||Phase 4|0|Actual|Emory University||2||The study was withdrawn prior to IRB approval.|f||||f||||||||||2017-10-11 01:29:49.902849|2017-10-11 01:29:49.902849
NCT01899677|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2014-08-05|2014-07-13||July 2013||2013-07-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Very low birth weight neonates|The Efficacy of Symbiotic on Cytokines|The Efficacy of Symbiotic Preparation on Cytokines Which Act on Necrotising Enterocolitis Pathogenesis in Very Low Birth Weight Infants|Completed||Phase 3|70|Actual|Zeynep Kamil Maternity and Pediatric Research and Training Hospital||2|||f||||t||||||||||2017-10-11 01:29:50.01683|2017-10-11 01:29:50.01683
NCT01899664|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-05-12|||June 2012||2012-06-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Upper Extremity Surgery in Spinal Cord Injury|Study of the Surgical Treatment of Cervical Spinal Cord Injuries With Nerve Transfers to Restore Upper Extremity and Hand Function|Recruiting||N/A|50|Anticipated|Washington University School of Medicine||1|||f||||f||||||||No||2017-10-11 01:29:50.495585|2017-10-11 01:29:50.495585
NCT01899651|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-01-19|||May 2014||2014-05-01|November 2014|2014-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|DQNIH||Detection and Quantification of Neonatal Intraventricular Hemorrhage|Detection and Quantification of Neonatal Intraventricular Hemorrhage|Completed||N/A|14|Actual|Electrical Geodesics, Inc.|||1||f||||f||||||||||2017-10-11 01:29:50.596221|2017-10-11 01:29:50.596221
NCT01899638|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-06-06|||May 20, 2013|Actual|2013-05-20|June 2017|2017-06-01|July 25, 2013|Actual|2013-07-25|July 25, 2013|Actual|2013-07-25||Interventional|||Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study.|A Randomized, Open Label, 3 Crossover, Balanced Incomplete Block Study To Evaluate The Pharmacokinetics Of Umeclidinium Bromide and Vilanterol Trifenatate as Monotherapies and Concurrently in Healthy Chinese Subjects.|Completed||Phase 1|20|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:29:50.664494|2017-10-11 01:29:50.664494
NCT01899625|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-06|2016-02-25|||September 2012||2012-09-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|LiveWellRVA||Motivational Interviewing for Weight Loss With Young Adults|Using Motivational Interviewing to Improve Weight Loss Outcomes With Young Adults|Completed||N/A|51|Actual|Virginia Commonwealth University||2|||f||||f||||||||No||2017-10-11 01:29:50.771938|2017-10-11 01:29:50.771938
NCT01899612|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-10|||August 2010||2010-08-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal Inflammation|Vaginal Cytokines in Postmenopausal Women With Symptoms of Vulvovaginal Irritation|Completed||N/A|16|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||Samples Without DNA|"     vaginal lavage, serum   "|||2017-10-11 01:29:50.86133|2017-10-11 01:29:50.86133
NCT01899599|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-07-13|||September 2013||2013-09-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|June 16, 2017|Actual|2017-06-16||Interventional|||PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer|A Double-blind, Placebo-controlled, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of Maintenance Therapy With PankoMab-GEX™ After Chemotherapy in Patients With Recurrent Epithelial Ovarian Carcinoma|Active, not recruiting||Phase 2|216|Actual|Glycotope GmbH||2|||f||||t||||||||||2017-10-11 01:29:50.937251|2017-10-11 01:29:50.937251
NCT01899586|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-02-28|||September 2009||2009-09-01|February 2014|2014-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|FIT||Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly|Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly|Completed||N/A|108|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:29:52.947573|2017-10-11 01:29:52.947573
NCT01899573|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-06-07|||October 2013||2013-10-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|LVRESTORESA||Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function|A Study of Percutaneous Left Ventricular Reshaping of Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve LV Function Using the Accucinch® System|Completed||N/A|8|Actual|Ancora Heart, Inc.||1|||f||||f||||||||||2017-10-11 01:29:53.03683|2017-10-11 01:29:53.03683
NCT01899560|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-05-11|||March 2013||2013-03-01|May 2017|2017-05-01|November 27, 2014|Actual|2014-11-27|June 2013|Actual|2013-06-01||Interventional|ELASTANCE||ELASTANCE: Prospective Physiological Study of Lung Elastance in Recruitment and Derecruitment in Early Onset Mechanically Ventilated ARDS Patients|Prospective Physiological Study of Lung Elastance in Recruitment and Derecruitment in Early Onset Mechanically Ventilated Acute Respiratory Distress Syndrome (ARDS)Patients|Completed||Phase 3|12|Actual|Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer||1|||f||||||||||||||2017-10-11 01:29:53.126874|2017-10-11 01:29:53.126874
NCT01899547|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-02-09|||August 2013||2013-08-01|February 2016|2016-02-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|LASRE||Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum|Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum : A Prospective, Multi-Center, Randomized, Open-Label, Parallel Group, Non-Inferiority Clinical Trial|Recruiting||Phase 3|1150|Anticipated|Fujian Medical University||2|||f||||t||||||||||2017-10-11 01:29:53.217984|2017-10-11 01:29:53.217984
NCT01899534|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-10-24|||July 2013||2013-07-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Mental Health E-screening in Pregnant and Postpartum Women|Mental Health E-screening in Pregnant and Postpartum Women|Completed||N/A|566|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 01:29:53.347471|2017-10-11 01:29:53.347471
NCT01899508|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-01-31|||January 2015|Actual|2015-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|VROA||Virtual Reality for Osteoarthritis Knee Pain Pilot|Virtual Reality for Osteoarthritis Knee Pain Pilot|Suspended||N/A|30|Anticipated|Duke University||1||The study has been suspended, due to technically difficulties.|f||||f||||||||||2017-10-11 01:29:53.59751|2017-10-11 01:29:53.59751
NCT01899495|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-10-14|||January 2005||2005-01-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Blood Pressure Response to Sodium in the Diet|D1 and AT1 Receptor Interaction in Human Hypertension: Sodium Sensitivity of Blood Pressure|Recruiting||N/A|400|Anticipated|University of Virginia||1|||f||||f||||||||Undecided||2017-10-11 01:29:53.820085|2017-10-11 01:29:53.820085
NCT01899482|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-03-23|||July 2013||2013-07-01|July 2013|2013-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|MLDCVI||Manual Lymphatic Drainage in Chronic Venous Insufficiency: a Randomized Controlled Trial|Manual Lymphatic Drainage in Chronic Venous Insufficiency: a Randomized Controlled Trial|Completed||N/A|41|Actual|Technical University of Lisbon||2|||f||||t||||||||Yes|http://www.archives-pmr.org/article/S0003-9993(14)01127-7/abstract|2017-10-11 01:29:53.934742|2017-10-11 01:29:53.934742
NCT01899469|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-05-20|||March 2012||2012-03-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|LUMCRO||Efficiency of Physiotherapy Treatments for Low Back Pain in Women.|Efficiency of Physiotherapy Treatments for Low Back Pain in Women.|Completed||N/A|96|Actual|University Rovira i Virgili||3|||f||||t||||||||||2017-10-11 01:29:54.034731|2017-10-11 01:29:54.034731
NCT01899456|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-11-03|||July 2013||2013-07-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|ISAR-denerve||Impact of Sympathetic Renal Denervation- a Study in Patients After Renal Transplantation|A Randomized Safety and Efficacy Study Investigating the Effects of Catheter-based Renal Denervation in Patients After Renal Transplantation|Completed||N/A|18|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-11 01:29:54.124084|2017-10-11 01:29:54.124084
NCT01899443|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-03-21|||August 2013||2013-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Improving Services and Outcomes for Joint Replacement Patients|Improving Services and Outcomes for Joint Replacement Patients|Completed||N/A|1900|Actual|South West Sydney Local Health District|||1||f||||f||||||||||2017-10-11 01:29:54.204965|2017-10-11 01:29:54.204965
NCT01899430|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2013-07-10|||November 2011||2011-11-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|||Polycystic Ovary Syndrome and Liraglutide|Short-term Liraglutide Treatment in Obese Women With Polycystic Ovary Syndrome|Completed||Phase 4|32|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-11 01:29:54.343599|2017-10-11 01:29:54.343599
NCT01899417|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-06-18|||July 2013||2013-07-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Costs and Benefits of ConforMIS iTotal® Knee Replacement System Versus Standard Total Knee|Analysis of Procedure-related Costs and Proposed Benefits of the ConforMIS iTotal® Cruciate Retaining Knee Replacement System Versus Standard Total Knee|Completed||N/A|235|Actual|ConforMIS, Inc.|||2||f||||t||||||||||2017-10-11 01:29:54.453087|2017-10-11 01:29:54.453087
NCT01899404|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-12-28|||October 2012||2012-10-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|December 2016|Actual|2016-12-01||Interventional|||MRI FDG PET Imaging Cervix|A Pilot Prospective Study of the Utility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI), Diffusion Weighted MRI (DWI)and Positron Emission Tomography (PET) Imaging With 18F-Fluorodeoxyglucose (18FDG) in Brachytherapy for Cervix Cancer|Recruiting||N/A|30|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:29:54.564162|2017-10-11 01:29:54.564162
NCT01899391|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-07-10|||August 2009||2009-08-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Periperal Blood Lymphocytes During Prostate RT|A Pilot Study of Gamma H2AX DNA Repair Foci Kinetics in Peripheral Blood Lymphocytes During Prostate Cancer Radiotherapy|Withdrawn||N/A|0|Actual|University Health Network, Toronto|||1|Recuritment Challenges|f||||f||||||||||2017-10-11 01:29:54.667447|2017-10-11 01:29:54.667447
NCT01899378|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-10-13|||October 2013||2013-10-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety and Efficacy of Probiotics in Bangladeshi Infants|Safety and Efficacy of Probiotics in Bangladeshi Infants|Completed||Phase 1|160|Actual|Stanford University||4|||f||||t||||||||||2017-10-11 01:29:54.738252|2017-10-11 01:29:54.738252
NCT01899352|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-10|||January 2014||2014-01-01|July 2013|2013-07-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Procedures, Complications and Follow-up of Tracheostomy in Intensive Care Units.|Procedures, Complications and Follow-up of Tracheostomy in Intensive Care Units - a Prospective Study by Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI)|Unknown status|Not yet recruiting|N/A|1000|Anticipated|University of Genova||1|||f||||f||||||||||2017-10-11 01:29:55.103893|2017-10-11 01:29:55.103893
NCT01899339|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-12|||May 2013||2013-05-01|July 2013|2013-07-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|SPEAR||Long Term Study Looking at the Effects of Treating Submassive Pulmonary Embolism With Ultra-sound Accelerated Thrombolysis|Submassive Pulmonary Embolism Treatment With Ultrasound-Accelerated Thrombolysis|Unknown status|Recruiting|N/A|25|Anticipated|Spectrum Health Hospitals|||1||f||||f||||||||||2017-10-11 01:29:55.234272|2017-10-11 01:29:55.234272
NCT01899326|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2016-01-11|||December 2012||2012-12-01|January 2016|2016-01-01||||March 2015|Actual|2015-03-01||Interventional|||Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant|Pilot Clinical Study of GCSF in Combination With Desipramine for Autologous Stem Cell Mobilization in Multiple Myeloma|Active, not recruiting||N/A|9|Actual|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 01:29:55.319474|2017-10-11 01:29:55.319474
NCT01898195|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-07-19|2016-08-05||March 2013||2013-03-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|HIV||Improving Adherence to Smoking Cessation Medication Among PLWHA|Improving Adherence to Smoking Cessation Medication Among PLWHA|Completed||N/A|158|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-10-11 01:30:11.357374|2017-10-11 01:30:11.357374
NCT01899313|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-05-12|||May 2014||2014-05-01|May 2014|2014-05-01||||January 2015|Anticipated|2015-01-01||Interventional|||A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence|A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence|Unknown status|Recruiting|N/A|50|Anticipated|California Pacific Medical Center Research Institute||2|||f||||f||||||||||2017-10-11 01:29:55.417833|2017-10-11 01:29:55.417833
NCT01899287|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-11-30|||July 2012||2012-07-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PREVEX||A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema|A Randomised Clinical Trial on the Effect of Group Education on Skin-protective Behaviour Versus Treatment as Usual Among Individuals With Newly Notified Occupational Hand Eczema|Completed||N/A|770|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 01:29:55.733024|2017-10-11 01:29:55.733024
NCT01899274|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-04-18|||July 2013||2013-07-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Assessment of an iPhone Application on Glycemic Control in Type 1 Diabetes|Assessment of an Electronic Self-Management Tool on Glycemic Control in Teens With Type 1 Diabetes|Completed||N/A|92|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 01:29:55.81714|2017-10-11 01:29:55.81714
NCT01899261|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2017-06-27|||October 7, 2010|Actual|2010-10-07|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 9, 2016|Actual|2016-05-09||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|A Pilot Study of Stereotactic Liver Irradiation for Hepatocellular Carcinoma|Active, not recruiting||N/A|20|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||||||||||||2017-10-11 01:29:55.907974|2017-10-11 01:29:55.907974
NCT01899248|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-05-13|||December 2012||2012-12-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||The Effect of Inhalation Agent on the QTc Interval During Liver Transplantation: Sub Study (NCT01886664)||Completed||N/A|52|Actual|Seoul National University Hospital|||2||f||||||||||||||2017-10-11 01:29:55.998793|2017-10-11 01:29:55.998793
NCT01899235|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-11|2014-03-15|||May 2011||2011-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|EXPEL||The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study|The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study|Terminated||Phase 4|||Aalborg Universitetshospital||2||Slow recruitment|f||||f||||||||||2017-10-11 01:29:56.086049|2017-10-11 01:29:56.086049
NCT01899222|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-12|2016-11-04|||April 2015||2015-04-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||Assessment of Prototype Hand-Held Fundus Camera|Assessment of Prototype Hand-Held Fundus Camera|Recruiting||N/A|10|Anticipated|University of Rochester||1|||f||||f||||||||||2017-10-11 01:29:56.167838|2017-10-11 01:29:56.167838
NCT01899209|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-06-26|||August 2013||2013-08-01|June 2014|2014-06-01||||August 2015|Anticipated|2015-08-01||Interventional|PRO-REST||Surgical Treatment of Obstructed Defecation Syndrome|Obstructed Defecation Caused by Rectal Intussusception and Rectocele:STARR Versus Laparoscopic Ventral Rectopexy|Unknown status|Recruiting|N/A|40|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||||2017-10-11 01:29:56.260843|2017-10-11 01:29:56.260843
NCT01899196|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-07-05|||July 2013||2013-07-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ANRS EP 52||Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients|EPICARDIAL ADIPOSE TISSUE AND CORONARY RISK IN HIV-INFECTED PATIENTS|Completed||N/A|24|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-11 01:29:56.373573|2017-10-11 01:29:56.373573
NCT01899183|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-07-10|||January 1995||1995-01-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Observational|CCGERD||Surgery in Chronic Cough GERD Related|Effectiveness of Anti-reflux Surgery for the Cure of Chronic Cough Associated With Gastro-oesophageal Reflux Disease|Completed||N/A|67|Actual|University of Bologna|||1||f||||f||||||||||2017-10-11 01:29:56.49007|2017-10-11 01:29:56.49007
NCT01899170|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-08-22|||April 2014||2014-04-01|July 2013|2013-07-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|DBSforPain||Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain|Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain|Suspended||Phase 2|20|Anticipated|University of Aarhus||3||Device for multi coil TMS no longer supported|f||||t||||||||||2017-10-11 01:29:56.599427|2017-10-11 01:29:56.599427
NCT01899157|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-07-10|||August 2009||2009-08-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Observational|TNT-HIV 001||Nutritional Status Among naïve HIV Infected Patients and HIV Infected Patients Receiving Highly Active Antiretroviral Therapy|Nutritional Status Among naïve HIV-infected Patients and HIV-infected Patients Receiving Highly Active Antiretroviral Therapy|Completed||N/A|580|Actual|Thai Red Cross AIDS Research Centre|||1||f||||f||||||||||2017-10-11 01:29:56.753178|2017-10-11 01:29:56.753178
NCT01899144|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-02-05|2016-01-06|2015-03-19|July 2013||2013-07-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Randomized participants|Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients|A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma|Completed||Phase 2|61|Actual|Teva Pharmaceutical Industries||5|||f||||f||||||||||2017-10-11 01:29:56.872236|2017-10-11 01:29:56.872236
NCT01899131|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-03-26|||October 2013||2013-10-01|June 2013|2013-06-01|June 2016|Anticipated|2016-06-01|June 2014|Anticipated|2014-06-01||Interventional|||A Prospective Clinical and Radiographic Assessment on New Platform-switched Laser Lok Implants|A Prospective Clinical and Radiographic Assessment on New Platform-switched Laser Lok Implants|Unknown status|Not yet recruiting|N/A|10|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 01:29:57.526897|2017-10-11 01:29:57.526897
NCT01899118|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-12|||April 2013||2013-04-01|July 2013|2013-07-01||||April 2016|Anticipated|2016-04-01||Interventional|||Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer|A Multicenter Phase II Trial of Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer|Unknown status|Recruiting|Phase 2|50|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-11 01:29:57.605539|2017-10-11 01:29:57.605539
NCT01899105|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-04-02|||July 2013||2013-07-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor|A Phase 1, Randomized, Single-Dose, Open-Label Crossover Study to Investigate the Effect of Food on the Relative Bioavailability of 2 Fixed-Dose Combinations of Lumacaftor and Ivacaftor Tablet Formulations in Healthy Adult Subjects|Completed||Phase 1|28|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-11 01:29:57.706039|2017-10-11 01:29:57.706039
NCT01899092|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-11-28|||January 2014||2014-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C|A Phase I,II Open-Label Dose Escalation Study to Evaluate the Safety and Efficacy of Single Doses of TT-034 for Subjects With Chronic Hepatitis C (CHC) Infection|Completed||Phase 1/Phase 2|9|Actual|Tacere Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 01:29:57.775906|2017-10-11 01:29:57.775906
NCT01899079|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-03-17|||June 2013||2013-06-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Observational|||A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay|Prospective Observational Study to Evaluate the Impact of the Determination of the Intrinsic Subtypes of Breast Cancer by PAM50 NanoString Technology in the Use of Adjuvant Chemotherapy in Women With Breast Cancer, HR+ and Node -.|Completed||N/A|217|Actual|NanoString Technologies, Inc.|||1||f||||f||||||Samples With DNA|"     FFPE breast tumor tissue samples   "|||2017-10-11 01:29:57.871591|2017-10-11 01:29:57.871591
NCT01899066|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-05-10|||July 2013||2013-07-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy Study of Lucentis in the Treatment of Retinoblastoma|Lucentis in the Treatment of Retinoblastoma - A Phase II, Single Center, Randomized Study to Evaluate the Efficacy of Ranibizumab in Subjects With Retinoblastoma|Unknown status|Recruiting|Phase 2|20|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:29:57.957688|2017-10-11 01:29:57.957688
NCT01899053|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-11-08|||July 2013||2013-07-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||Phase 1b Study of MLN0128 in Combination With MLN1117 in Adult Patients With Advanced Nonhematologic Malignancies|A Multicenter, Open-label, Phase 1b Study of MLN0128 (an Oral mTORC1/2 Inhibitor) in Combination With MLN1117 (an Oral PI3Kα Inhibitor) in Adult Patients With Advanced Nonhematologic Malignancies|Active, not recruiting||Phase 1|152|Anticipated|Takeda||3|||f||||f||||||||||2017-10-11 01:29:58.083481|2017-10-11 01:29:58.083481
NCT01899040|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2016-10-15|||August 2013||2013-08-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache|A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache|Completed||N/A|81|Actual|Scion NeuroStim||2|||f||||f||||||||||2017-10-11 01:29:58.172476|2017-10-11 01:29:58.172476
NCT01899027|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-12|||January 2014||2014-01-01|July 2013|2013-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|ARTEMISIA||Rosuvastatin for Preventing Complications in Renal Ablation|Adjunctive Rosuvastatin Treatment for prEventing coMplIcationS In Renal Ablation|Not yet recruiting||Phase 4|112|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 01:29:58.389413|2017-10-11 01:29:58.389413
NCT01899014|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-04-09|||July 2013||2013-07-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ParisK||18F-choline PET-CT and MRI of Carotid Plaques|Plaque at Risk (ParisK): Molecular Imaging of Plaque Vulnerability Using 18F-choline PET-CT and MRI in Patients With Carotid Artery Atherosclerosis|Unknown status|Active, not recruiting|Phase 3|10|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-11 01:29:58.493312|2017-10-11 01:29:58.493312
NCT01899001|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-11-22|||July 2013||2013-07-01|November 2016|2016-11-01||||August 2016|Actual|2016-08-01||Interventional|MANI-PCOS||Mood and Nutrition Interventions in Polycystic Ovary Syndrome|Improving Psychological Health and Cardiovascular Disease Risk in Women With PCOS|Completed||N/A|40|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:29:58.589362|2017-10-11 01:29:58.589362
NCT01898975|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-05-26|||June 2013||2013-06-01|May 2016|2016-05-01|May 2014|Anticipated|2014-05-01|January 2014|Anticipated|2014-01-01||Observational|||A Gray Zone Approach to Stroke Volume Variation Derived From NICOM|Evaluation of Stroke Volume Variation Derived From NICOM as a Predictor of Fluid Responsiveness in Neurosurgical Patients: A Gray Zone Approach|Withdrawn||N/A|0|Actual|Samsung Medical Center|||1|The investigators decided not to proceed this study because of some internal matters.|f||||t||||||||||2017-10-11 01:29:58.709869|2017-10-11 01:29:58.709869
NCT01898962|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-10|||December 2005||2005-12-01|July 2013|2013-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Definitive Therapy for Oligometastatic Solid Malignancies|A Prospective Investigation of Definitive Targeted Therapy for Solid Malignancies With Oligometastases|Recruiting||Phase 2|110|Anticipated|Rocky Mountain Cancer Centers||1|||f||||f||||||||||2017-10-11 01:29:58.797786|2017-10-11 01:29:58.797786
NCT01898949|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2016-01-06|||November 2010||2010-11-01|January 2016|2016-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|BAT&DIT||Stimulation of Diet-Induced Thermogenesis by Cold-Exposure|BAT&DIT: Stimulation of Diet-Induced Thermogenesis by Cold-Exposure|Completed||N/A|9|Actual|Pennington Biomedical Research Center||1|||f||||f||||||||||2017-10-11 01:29:58.920847|2017-10-11 01:29:58.920847
NCT01891617|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-06-10|||November 2010||2010-11-01|June 2016|2016-06-01|March 2013|Actual|2013-03-01|July 2012|Actual|2012-07-01||Interventional|XFG||Exercise Effects on Insulin, Gut Peptides, and Appetite|The Exercise Effects on Appetite and Gut Peptides While on High-fat Diet|Completed||N/A|16|Actual|University of Michigan||4|||f||||f||||||||||2017-10-11 01:31:59.450004|2017-10-11 01:31:59.450004
NCT01898923|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-01-25|||September 2012||2012-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|WH-1||Evaluate the Efficacy and Safety of WH-1 Ointment for the Treatment of Chronic Diabetic Foot Ulcers|Randomized Controlled Study to Evaluate the Efficacy and Safety of WH-1 Ointment for the Treatment of Chronic Diabetic Foot Ulcers|Recruiting||Phase 3|236|Anticipated|Oneness Biotech Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:29:59.167435|2017-10-11 01:29:59.167435
NCT01898910|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-07-12|||June 2012||2012-06-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation|Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation. A Randomized Comparison|Completed||Phase 2|80|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 01:29:59.409148|2017-10-11 01:29:59.409148
NCT01898897|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-15|||March 2010||2010-03-01|July 2013|2013-07-01|May 2015|Anticipated|2015-05-01|January 2015|Anticipated|2015-01-01||Interventional|ROBOTNGAL||Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions|Combined Anesthesia Considerations in Uro-Genital Robot Assisted Laparoscopic Surgeries: Acute Kidney Injury|Unknown status|Recruiting|N/A|60|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy||2|||f||||t||||||||||2017-10-11 01:29:59.533589|2017-10-11 01:29:59.533589
NCT01898884|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-08-12|2016-06-16||July 2013||2013-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||The intent-to-treat (ITT) set consisted of all participants who were randomly assigned to an investigational product treatment group. The baseline data for 14 participants who were randomised directly to multiple dose groups, was not summarised and not reported.|Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia|A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia|Completed||Phase 1|46|Actual|Shire||2|||f||||f||||||||||2017-10-11 01:29:59.73397|2017-10-11 01:29:59.73397
NCT01898871|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-10|||February 2012||2012-02-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Effectiveness of Nutritional Products to Treat Moderate Acute Malnutrition|Using Indigenous Foods to Reduce Malnutrition in Children|Completed||Phase 2|81|Actual|Centre for Food and Nutrition Research, Yaounde||2|||f||||t||||||||||2017-10-11 01:30:02.255696|2017-10-11 01:30:02.255696
NCT01898858|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2014-10-14|||September 2013||2013-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|H2PAP||Effects of O2 and/or CO2 Inhalation on Rest and Exercise Pulmonary Hemodynamic|Effects of O2 and/or CO2 Inhalation on Rest and Exercise Pulmonary Hemodynamic|Completed||N/A|8|Actual|University Hospital, Strasbourg, France|||3||f||||f||||||||||2017-10-11 01:30:02.340929|2017-10-11 01:30:02.340929
NCT01898845|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-02-26|||May 2013||2013-05-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Phase I Study of LEE011 in Asian Patients|A Phase I Study of LEE011 in Asian Patients With Advanced Solid Tumors|Completed||Phase 1|17|Actual|Novartis||1|||f||||t||||||||||2017-10-11 01:30:02.440061|2017-10-11 01:30:02.440061
NCT01898832|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-03-16|||July 2013||2013-07-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01|12 Months|Observational [Patient Registry]|||Il-17 Levels in Intrahepatic Cholestasis of Pregnancy|to Investigate the Maternal Serum IL-17 Levels in Pregnant Women With Intrahepatic Cholestasis of Pregnancy|Unknown status|Recruiting|N/A|30|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||1||f||||f||||||None Retained|"     maternal venous ad umbilical cordon blood   "|||2017-10-11 01:30:02.509421|2017-10-11 01:30:02.509421
NCT01898819|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-01-23|||July 2013||2013-07-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Dexmedetomidine in Intraocular Pressure During Robot-Assisted Laparoscopic Radical Prostatectomy||Completed||N/A|70|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:30:02.612146|2017-10-11 01:30:02.612146
NCT01898806|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-07-28|||September 2011|Actual|2011-09-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Intralesional Steroids in the Treatment of Alopecia Areata|A Phase 4 Multicenter, Randomized, Placebo Controlled Trial of 3 Doses of Intralesional Triamcinolone (KENALOG®) In the Treatment of Mild to Moderate Patch Type Alopecia Areata|Recruiting||Phase 4|68|Anticipated|Columbia University||4|||f||||f|t|f|||f|||||2017-10-11 01:30:02.685563|2017-10-11 01:30:02.685563
NCT01898793|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-09-14|||August 11, 2014|Actual|2014-08-11|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)|A Phase 1/2 Study of Cytokine-Induced Memory-Like NK Cells in Patients With AML or MDS|Recruiting||Phase 1/Phase 2|48|Anticipated|Washington University School of Medicine||4|||f||||t|t|f||||||||2017-10-11 01:30:02.961598|2017-10-11 01:30:02.961598
NCT01898780|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-12|||June 2013||2013-06-01|July 2013|2013-07-01||||June 2017|Anticipated|2017-06-01||Interventional|||Horizontal Mattress vs. Interrupted Suture in Surgical Techniques of Pancreaticojejunostomy||Unknown status|Enrolling by invitation|Phase 3|190|Anticipated|Wakayama Medical University||2|||f||||t||||||||||2017-10-11 01:30:03.132561|2017-10-11 01:30:03.132561
NCT01898767|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-06-28|||December 17, 2013|Actual|2013-12-17|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses|Production of Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses: An In Vitro Model System to Study the Mechanisms of Asthma Exacerbation Resolution|Recruiting||N/A|30|Anticipated|University of Wisconsin, Madison|||1||f||||t||||||Samples With DNA|"     whole blood, serum, plasma, DNA, RNA, bronchoalveolar lavage, bronchial brushings   "|Yes||2017-10-11 01:30:03.224343|2017-10-11 01:30:03.224343
NCT01898754|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-05-02|||May 2013|Actual|2013-05-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|OLA||Oligonucleotide Ligation Assay (OLA) Resistance Study|Drug-resistance Testing in Kenya to Improve ART Suppression of HIV Replication|Active, not recruiting||N/A|1000|Anticipated|University of Washington||2|||f||||t||||||||No||2017-10-11 01:30:03.315117|2017-10-11 01:30:03.315117
NCT01898741|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-02-01|||July 2013||2013-07-01|February 2015|2015-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer|Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|UMC Utrecht||1|||f||||t||||||||||2017-10-11 01:30:03.410233|2017-10-11 01:30:03.410233
NCT01898728|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2013-07-10|||December 2012||2012-12-01|July 2013|2013-07-01||||July 2013|Anticipated|2013-07-01||Interventional|||Comparison of the Effectiveness of Povidone-iodine in Reducing Conjunctival Bacterial Load Prior to Cataract Surgery in Patients Treated With a Lidocaine Gel Dilating Formulation Versus Eye Drops: A Randomized Controlled Trial|Comparison of the Effectiveness of Povidone-iodine in Reducing Conjunctival Bacterial Load Prior to Cataract Surgery in Patients Treated With a Lidocaine Gel Dilating Formulation Versus Eye Drops: A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|104|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 01:30:03.501316|2017-10-11 01:30:03.501316
NCT01898715|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-02-06|||July 2013||2013-07-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|February 2019|Anticipated|2019-02-01||Interventional|||Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma|Phase 1 Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma|Recruiting||Phase 1|78|Anticipated|Millendo Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 01:30:03.584283|2017-10-11 01:30:03.584283
NCT01898702|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2013-07-21|||May 2013||2013-05-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Interventional|EPPD-ICS||Clinical Trial on Diabetes Expert Patients Programme|Expert Patients Programme Effectiveness on Diabetes Control. A Controlled Clinical Trial|Unknown status|Recruiting|N/A|500|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 01:30:03.701768|2017-10-11 01:30:03.701768
NCT01898689|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-11-04|||July 2013||2013-07-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks|Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks|Completed||Phase 4|26|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:30:03.826776|2017-10-11 01:30:03.826776
NCT01898676|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-07-09|||July 2013||2013-07-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|Epilepsy||A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets|An Open Label, Randomized, Four-period, Two-sequence, Fully Replicated, Single-dose, Crossover Study of the Relative Bioavailability of Two Formulations of Extended-release Divalproex Sodium Tablets in Fed Patients With Stable Epilepsy.|Unknown status|Recruiting|Phase 1|16|Anticipated|Vince & Associates Clinical Research, Inc.||2|||f||||f||||||||||2017-10-11 01:30:03.933162|2017-10-11 01:30:03.933162
NCT01898663|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-02-18|||June 2013||2013-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With High-risk Soft Tissue Sarcoma|Safety and Therapeutic Efficacy of DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With High-risk Soft Tissue Sarcoma: a Phase Ⅰ/Ⅱ Study|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-11 01:30:04.030081|2017-10-11 01:30:04.030081
NCT01898650|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-05-12|||December 2012||2012-12-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||MRI for Non-invasive Evaluation of Brain Stress|MRI for Non-invasive Evaluation of Brain Stress|Recruiting||N/A|20|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 01:30:04.128716|2017-10-11 01:30:04.128716
NCT01898637|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-04-01|||June 2013||2013-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1|A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1|Enrolling by invitation||N/A|120|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:30:04.216809|2017-10-11 01:30:04.216809
NCT01898624|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-10-02|||December 4, 2012|Actual|2012-12-04|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Specified Drug Use-results Survey of Betanis Tablets|Specified Drug Use-results Survey of Betanis Tablets in OAB Patients With Coexisting Glaucoma|Recruiting||N/A|300|Anticipated|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:30:04.312039|2017-10-11 01:30:04.312039
NCT01898598|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-03-27|2017-03-27||January 23, 2014|Actual|2014-01-23|March 2017|2017-03-01|January 26, 2016|Actual|2016-01-26|January 26, 2016|Actual|2016-01-26||Interventional||The Intent-to-treat (ITT) population included all randomized participants who received at least one dose of study treatment.|A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma|A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Oral Vismodegib for the Treatment of Basal Cell Carcinoma Preceding Excision by Mohs Micrographic Surgery|Terminated||Phase 2|18|Actual|Hoffmann-La Roche|The study was discontinued early by the Sponsor and due to a small sample size, no conclusions can be drawn.|2|||f||||||||||||||2017-10-11 01:30:04.526679|2017-10-11 01:30:04.526679
NCT01898585|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-09-26|||October 17, 2013|Actual|2013-10-17|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma|An Open-Label, Single-Arm, Multicenter Study To Assess The Safety Of Vemurafenib In Patients With Braf V600 Mutation Positive Metastatic Melanoma In South Africa.|Active, not recruiting||Phase 4|60|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:30:05.017329|2017-10-11 01:30:05.017329
NCT01898572|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-06-24|||January 2012||2012-01-01|June 2014|2014-06-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Observational|DIABIMCAP||Carotid Atherosclerosis In Newly Diagnosed Type 2 Individuals|Carotid Intimae-media Thickness (CIMT) and Carotid Plaque (CP) Presence as Risk Markers of Cardiovascular Disease at the Time of Type 2 Diabetes Diagnosis|Unknown status|Active, not recruiting|N/A|200|Anticipated|Hospital Clinic of Barcelona|||2||f||||f||||||Samples With DNA|"     Whole blood, serum, urine   "|||2017-10-11 01:30:05.155153|2017-10-11 01:30:05.155153
NCT01898559|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-10-05|||December 2012||2012-12-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|October 2014|Actual|2014-10-01||Interventional|||Nicotine Metabolism and Little Cigars|Nicotine Metabolism and Little Cigars|Completed||N/A|197|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:30:05.263044|2017-10-11 01:30:05.263044
NCT01898546|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-09|||October 2011||2011-10-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|POSTRE||Ischemic Postconditioning on Microvascular Obstruction in Reperfused Myocardial Infarction|Effect of Ischemic Postconditioning on Microvascular Obstruction in Reperfused Myocardial Infarction. Results of a Randomized Study in Patients|Completed||N/A|243|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||||2017-10-11 01:30:05.368158|2017-10-11 01:30:05.368158
NCT01898533|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-07-07|||September 2013||2013-09-01|July 2017|2017-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|BOLD||Feasibility of Blood Oxygenation Level-Dependent Contrast (BOLD) Breast MRI Induced by Breath- Holding|A Pilot Study of the Feasibility of Blood Oxygenation Level-Dependent Contrast ( BOLD) Breast MRI Induced by Breath- Holding|Completed||N/A|11|Actual|Duke University|||1||f||||f||||||||||2017-10-11 01:30:05.470229|2017-10-11 01:30:05.470229
NCT01898520|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-05-16|||December 2013|Actual|2013-12-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|September 2016|Actual|2016-09-01||Interventional|||A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years|The Efficacy, Safety and Tolerability of Sativex as an Adjunctive Treatment to Existing Anti-spasticity Medications in Children Aged 8 to 18 Years With Spasticity Due to Cerebral Palsy or Traumatic Central Nervous System Injury Who Have Not Responded Adequately to Their Existing Anti-spasticity Medications: a Parallel Group Randomised, Double-blind, Placebo-controlled Study Followed by a 24-week Open Label Extension Phase|Completed||Phase 3|72|Actual|GW Research Ltd||2|||f||||t||||||||||2017-10-11 01:30:05.556601|2017-10-11 01:30:05.556601
NCT01898507|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-06-21|||September 2013|Actual|2013-09-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|November 2015|Actual|2015-11-01||Interventional|||Nicotine Metabolism and Low Nicotine Cigarettes|Nicotine Metabolism and Low Nicotine Cigarettes|Active, not recruiting||N/A|207|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 01:30:05.736439|2017-10-11 01:30:05.736439
NCT01898494|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2017-07-07|||August 2013||2013-08-01|July 2017|2017-07-01|February 2023|Anticipated|2023-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer|Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer|Active, not recruiting||Phase 2|511|Actual|Eastern Cooperative Oncology Group||4|||f||||t||||||||||2017-10-11 01:30:05.873505|2017-10-11 01:30:05.873505
NCT01898481|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-02-05|||August 2013||2013-08-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Triadic Expectations: Decision Making in the Context of Cancer Treatment|Triadic Expectations: Decision Making in the Context of Cancer Treatment|Completed||N/A|38|Actual|Duke University|||1||f||||f||||||||||2017-10-11 01:30:06.705324|2017-10-11 01:30:06.705324
NCT01898468|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-12-02|||June 2013||2013-06-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Post-Thoracotomy Closure Study|Post-Thoracotomy Pain Syndrome: A Randomized, Double Blind, Study Comparing Closure Techniques|Recruiting||N/A|90|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:30:06.801258|2017-10-11 01:30:06.801258
NCT01898455|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2014-12-03|||August 2013||2013-08-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|COOLHEAD||Intranasal Cooling for Cluster Headache and Migraine|IntraNasal Evaporative Cooling for the Symptomatic Relief of Migraine and Cluster Headache|Completed||N/A|15|Actual|Cumbria Partnership NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:30:06.887165|2017-10-11 01:30:06.887165
NCT01898442|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-05-26|2015-05-26||September 2013||2013-09-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||The primary population was used for analysis of baseline characteristics and primary and secondary endpoints. The primary population was defined as patients who received the randomized loading dose of study medication and had at least 75% of valid data, which needed to include the primary endpoint time point.|High Ticagrelor Loading Dose in STEMI|Pharmacodynamic Profiles of Ticagrelor in Patients With ST Elevation Myocardial Infarction: A Randomized Comparison of Different Loading Dosage Regimens|Completed||Phase 2|52|Actual|University of Florida|The study was not powered to assess safety or efficacy, which would require larger clinical studies. Although laboratory personnel were blinded to treatment assignment, the study had an open-label design.|3|||f||||t||||||||||2017-10-11 01:30:07.023828|2017-10-11 01:30:07.023828
NCT01898429|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-01-17|||July 2013||2013-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD)|Deep Brain Stimulation for Treatment-Resistant Depression|Completed||N/A|5|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 01:30:07.750584|2017-10-11 01:30:07.750584
NCT01898416|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-10-30|||June 2013||2013-06-01|October 2013|2013-10-01|December 2026|Anticipated|2026-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors|A PHASE 2, SINGLE CENTRE, SINGLE ARM STUDY TO DETERMINE THE EFFICACY AND SAFETY OF 5- ALA POHOTODYNAMIC THERAPY AS ADJUVANT THERAPY AFTER SURGICAL DISSECTION IN PATIENTS WITH DESMOID TUMORS.|Recruiting||Phase 2|140|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 01:30:07.856664|2017-10-11 01:30:07.856664
NCT01898403|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-04-19|2017-02-24||June 2013||2013-06-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|June 2014|Actual|2014-06-01||Interventional|||Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma|Testing the Efficacy of Indocyanine Green Imaging (ICG-SPY) in the Identification of Sentinel Lymph Nodes (SLN) in Patients With Malignant Melanoma|Completed||N/A|50|Actual|Stanford University||1|||f||||t||||||||No||2017-10-11 01:30:07.975929|2017-10-11 01:30:07.975929
NCT01898390|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-05-01|||May 2012||2012-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TRANSEURO||TRANSEURO Open Label Transplant Study in Parkinson's Disease|An Open Label Study to Assess the Safety and Efficacy of Neural Allo-Transplantation With Fetal Ventral Mesencephalic Tissue in Patients With Parkinson's Disease|Enrolling by invitation||Phase 1|40|Anticipated|University of Cambridge||2|||f||||t||||||||||2017-10-11 01:30:08.341155|2017-10-11 01:30:08.341155
NCT01898013|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-04-20|||September 2013||2013-09-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans|Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans|Recruiting||Phase 2|90|Anticipated|Durham VA Medical Center||2|||f||||f||||||||||2017-10-11 01:30:15.390105|2017-10-11 01:30:15.390105
NCT01898377|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-04-28|||August 2013||2013-08-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children|Open-label, Multicenter Phase II Study of Combination Therapy of Imatinib Mesylate and Mycophenolate Mofetil in Children With Steroid-Refractory Sclerotic/Fibrotic Type Chronic Graft-versus-host Disease|Recruiting||Phase 2|28|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:30:08.456907|2017-10-11 01:30:08.456907
NCT01898364|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-03-10|||July 2013||2013-07-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.|An Open-label, Multicenter, Multinational, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Repeated Biweekly Infusions of neoGAA in naïve and Alglucosidase Alfa Treated Late-onset Pompe Disease Patients.|Completed||Phase 1|24|Actual|Sanofi||6|||f||||t||||||||||2017-10-11 01:30:08.560891|2017-10-11 01:30:08.560891
NCT01898351|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-11-11|||March 2013||2013-03-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Health Impacts of Sustainable Ingredient Selection in the Food and Drink Industry - ALTERNATIVE PROTEIN STUDY|Health Impacts of Sustainable Ingredient Selection in the Food and Drink Industry - ALTERNATIVE PROTEIN STUDY|Completed||N/A|10|Actual|University of Aberdeen||1|||f||||f||||||||||2017-10-11 01:30:08.723939|2017-10-11 01:30:08.723939
NCT01898338|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-07-06|||December 2013||2013-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia|Randomized Multicenter Study to Assess Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin Monotherapy for Treatment of Methicillin Resistant Staphylococcus Aureus Bacteremia in Hospitalized Patients|Recruiting||Phase 3|206|Anticipated|Spanish Network for Research in Infectious Diseases||2|||f||||t||||||||||2017-10-11 01:30:08.845571|2017-10-11 01:30:08.845571
NCT01898325|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-07-09|||August 2013||2013-08-01|July 2013|2013-07-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan|Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan|Unknown status|Not yet recruiting|N/A|40|Anticipated|Rambam Health Care Campus||4|||f||||t||||||||||2017-10-11 01:30:09.060871|2017-10-11 01:30:09.060871
NCT01898312|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-03-02|||September 2013||2013-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||BRCA1/2 and Effect of Mifepristone on the Breast|The Effect of a Progesterone Receptor Modulator on Breast Tissue in Women With BRCA-1 and -2 Mutations - a Placebo Controlled RCT.|Recruiting||Phase 2|45|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:30:09.182276|2017-10-11 01:30:09.182276
NCT01898299|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-09-14|||May 2013||2013-05-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||TDCS for Auditory Hallucinations in Schizophrenia|tDCS for Auditory Hallucinations in Schizophrenia|Recruiting||N/A|100|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 01:30:09.306394|2017-10-11 01:30:09.306394
NCT01898286|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2016-04-19|2015-11-16||October 2013||2013-10-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|DIA-AID 2||Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®|Open-Label Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277® in Subjects Who Have Completed Study 1001 (NCT01103284)|Terminated||Phase 3|38|Actual|Andromeda Biotech Ltd.|The objectives of this study were to evaluate the safety and tolerability of long term treatment with DiaPep277. The study was terminated by the Sponsor on 08Sep14; hence many of the protocol-specified objectives could not be adequately assessed|1||A corporate decision to suspend development of DiaPep277®|f||||t||||||||||2017-10-11 01:30:09.418581|2017-10-11 01:30:09.418581
NCT01898260|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-10|2015-05-08|||August 2013||2013-08-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses|Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses|Completed||N/A|89|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:30:09.800152|2017-10-11 01:30:09.800152
NCT01898247|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-07-13|||December 2012||2012-12-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Use of Simulation-Based Mastery Learning for Thoracentesis to Improve Outcomes|Use of Simulation-Based Mastery Learning for Resident Thoracentesis Training to Improve Patient Outcomes|Completed||N/A|1000|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 01:30:09.889426|2017-10-11 01:30:09.889426
NCT01898234|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-09|||October 2012||2012-10-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Dialysis Membranes and Hemodynamic Tolerance|Assessment of Subjective and Hemodynamic Tolerance of Different High- and Low-flux Dialysis Membranes in Patients Undergoing Chronic Intermittent Hemodialysis: a Randomized Controlled Trial|Completed||N/A|25|Actual|Ospedale Regionale di Locarno||4|||f||||||||||||||2017-10-11 01:30:09.97414|2017-10-11 01:30:09.97414
NCT01898221|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-09-29|||October 2013||2013-10-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|VOM-R01||Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation|Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation|Recruiting||Phase 2/Phase 3|350|Anticipated|The Methodist Hospital System||2|||f||||t||||||||||2017-10-11 01:30:10.204144|2017-10-11 01:30:10.204144
NCT01898208|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-02-17|2015-12-02||August 2013||2013-08-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Randomized subjects were excluded if they had a positive blood culture in the prior week, had not provided the state research authorization, previously enrolled in the study, died or transitioned to comfort care within 24 hours of enrollment, or had a negative Gram stain. Only non-excluded subjects were included in the baseline characteristics.|Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures|Rapid Identification and Susceptibility Testing of Pathogens Growing in Blood Culture Bottles - A Quality Improvement Theragnostic Stewardship Project|Completed||N/A|743|Actual|Mayo Clinic||3|||f||||f||||||||No||2017-10-11 01:30:10.403125|2017-10-11 01:30:10.403125
NCT01898182|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-09-12|||November 2013||2013-11-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety of Kinetin 0.1% for Treatment of Skin Photoaging|A Single Arm, Phase IV, Open-Label, Split-Face Trial to Evaluate the Efficacy and Safety of Kinetin, N6-furfuryladenine, 0.1% for Treatment of Cutaneous Photoaging|Completed||Phase 4|132|Actual|Makati Medical Center||1|||f||||t||||||||||2017-10-11 01:30:11.731531|2017-10-11 01:30:11.731531
NCT01898169|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-10|||April 2013||2013-04-01|July 2013|2013-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Evaluation of Short-term Safety and Use Patterns of an Electronic Nicotine Delivery System|Evaluation of Plasma Nicotine, Carbon Monoxide, Heart Rate, Craving and Withdrawal After Acute Use of the NJOY King E-Cigarette in the Clinic, Following a One-Week Actual Use Pilot Study|Unknown status|Active, not recruiting|N/A|33|Actual|LA Clinical Trials||1|||f||||f||||||||||2017-10-11 01:30:11.831592|2017-10-11 01:30:11.831592
NCT01898156|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-12-13|||July 2013||2013-07-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer|Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Subjects With Previously Treated Advanced/Recurrent Lung Cancer or Mesothelioma|Terminated||Phase 1/Phase 2|37|Actual|Kyowa Hakko Kirin Korea Co., Ltd.||1||lack of efficacy|f||||f||||||||||2017-10-11 01:30:11.923747|2017-10-11 01:30:11.923747
NCT01898143|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-02-23|||June 2013||2013-06-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease|Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Interstitial Lung Disease (ILD)|Completed||N/A|10|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 01:30:12.003361|2017-10-11 01:30:12.003361
NCT01898130|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-04-24|||October 2013|Actual|2013-10-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy|A Phase II Trial of Bevacizumab in Patients With Recurrent Solid Tumor Brain Metastases Who Have Failed Whole Brain Radiation Therapy|Active, not recruiting||Phase 2|27|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 01:30:12.080825|2017-10-11 01:30:12.080825
NCT01898117|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-04-13|||July 2013||2013-07-01|April 2017|2017-04-01|December 2029|Anticipated|2029-12-01|December 2019|Anticipated|2019-12-01||Interventional|Triple-B||Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Bevacizumab as First-line Treatment in Advanced Triple Negative Breast Cancer|Biomarker Discovery Randomized Phase IIb Trial With Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Bevacizumab as First-line Treatment in Advanced Triple Negative Breast Cancer|Recruiting||Phase 2|304|Anticipated|The Netherlands Cancer Institute||4|||f||||t||||||||||2017-10-11 01:30:13.91725|2017-10-11 01:30:13.91725
NCT01898104|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-03-28|||May 2012||2012-05-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|V-shoRT-R3||Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer|Phase 1/2 Study of Valproic Acid and Short-course Radiotherapy Plus Capecitabine as preoperatIve Treatment in Low-moderate Risk Rectal Cancer|Recruiting||Phase 1/Phase 2|152|Anticipated|National Cancer Institute, Naples||4|||f||||f||||||||||2017-10-11 01:30:14.184106|2017-10-11 01:30:14.184106
NCT01898091|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-01-13|2016-11-18||July 2013||2013-07-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|OM||Herbal Mouthrinse for Oral Mucositis Study|Randomized Controlled Double-blinded Clinical Trial of an Herbal Mouthrinse for Radiotherapy Induced Mucositis in Cancer Patients|Completed||Phase 2|50|Actual|Medical University of South Carolina||2|||f||||t||||||||Yes|After publication of the results of the primary and secondary endpoints of the trial, we will offer our collected experience to other interested clinicians/scientists. Our first priority is that any data sets that are used be subject of a confidentiality agreement. Any clinical data that is shared will be stripped of any subject personal information (de-indentified data). Our intent, if the trial results are promising is to share the findings through the HCC Clinical Trial Network. If our intervention is useful we are open to further investigation though clinical trial and other cooperative groups. Dr. Susan Reed, as PI, will participate in all sharing activities.|2017-10-11 01:30:14.335655|2017-10-11 01:30:14.335655
NCT01898078|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-01-31|||July 2013||2013-07-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|October 2014|Actual|2014-10-01||Interventional|||Food Effect Study of Alisertib (MLN8237) in Patients With Advanced Solid Tumors or Lymphomas|An Open-Label, Phase 1, Two-Way, Cross-Over Study of the Effect of the Food on the Pharmacokinetics of MLN8237 (Alisertib) in Patients With Advanced Solid Tumors or Lymphomas|Active, not recruiting||Phase 1|25|Anticipated|Takeda||1|||f||||f||||||||||2017-10-11 01:30:14.715311|2017-10-11 01:30:14.715311
NCT01898065|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-11-06|||June 2012||2012-06-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|HYPOXProstat||Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate Cancer|Evaluation of Hypoxia by PET With 18-FluoroMisonidazole During Radiation Therapy of Prostate Cancer|Completed||Phase 2|20|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||f||||||||||2017-10-11 01:30:14.807287|2017-10-11 01:30:14.807287
NCT01898052|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-03-31|||October 2012||2012-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|TKA||The Efficacy of Periarticular Single Drug Compared With Multimodal Drug Injection in Controlling Pain After TKA|A Comparative Study on the Efficacy of Periarticular Single Anesthetic Drug Compared With Multimodal Drug Injection in Controlling Pain After Total Knee Arthroplasty: A Double Blinded Randomized Controlled Trial|Completed||Phase 4|60|Anticipated|Thammasat University||2|||f||||t||||||||||2017-10-11 01:30:14.899307|2017-10-11 01:30:14.899307
NCT01898039|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-07-10|||May 2013||2013-05-01|June 2013|2013-06-01||||April 2016|Anticipated|2016-04-01||Interventional|||Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients|Allogeneic Vaccine Modified to Express HLA A2/4-1BB Ligand for High Risk or Low Residual Disease Melanoma Patients - Phase I/II Study.|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 01:30:15.122482|2017-10-11 01:30:15.122482
NCT01898026|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-02-04|||July 2013||2013-07-01|February 2014|2014-02-01|January 2015|Anticipated|2015-01-01|July 2014|Anticipated|2014-07-01||Interventional|||Soluble Fibre Enriched CHO Food Study|Development of Palatable Soluble Fibre Containing Carbohydrate Foods and Its Effects on Postprandial Blood Glucose Response in Healthy Individuals|Unknown status|Active, not recruiting|N/A|35|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:30:15.267061|2017-10-11 01:30:15.267061
NCT01898000|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-07-10|||January 2013||2013-01-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||"Triphala - A New Herbal Mouthwash in Gingivitis"|"Triphala - A New Herbal Mouthwash in Gingivitis: A Randomized Controlled Clinical Trial"|Completed||N/A|90|Actual|Government Dental College and Research Institute, Bangalore|||||f||||||||||||||2017-10-11 01:30:15.528935|2017-10-11 01:30:15.528935
NCT01897987|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-04-18|||January 2014||2014-01-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial|Follow-up Safety and Efficacy Evaluation on Subjects Who Completed the Initial Stage of PNEUMOSTEM® Phase-II Clinical Trial|Recruiting||Phase 2|70|Anticipated|Medipost Co Ltd.||2|||f||||t||||||||||2017-10-11 01:30:15.634685|2017-10-11 01:30:15.634685
NCT01897974|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-08-26|||June 2013||2013-06-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Revisiting Survey Investigating Why Patients Are Not Receiving Home Anti-convulsant Medication Prior to Surgery/or Procedure Involving General Anesthesia||Completed||N/A|300|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 01:30:15.803285|2017-10-11 01:30:15.803285
NCT01897961|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-07-10|||March 2012||2012-03-01|July 2012|2012-07-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|PRAM-KT||Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation|Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 01:30:15.872603|2017-10-11 01:30:15.872603
NCT01897948|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-04-04|||July 2013||2013-07-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Effects of Feeding Different Levels of Docosahexaenoic Acid to Pre-School Children|The Effects of Feeding Different Levels of Docosahexaenoic Acid to Pre-School Children|Terminated||N/A|18|Actual|Mead Johnson Nutrition||3||Non-compliance|f||||f||||||||||2017-10-11 01:30:15.953849|2017-10-11 01:30:15.953849
NCT01897935|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-04-30|||June 2013||2013-06-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Flare Photometry in Uveitis Patients||Completed||N/A|100|Actual|ChromoLogic, LLC|||1||f||||f||||||||||2017-10-11 01:30:16.038467|2017-10-11 01:30:16.038467
NCT01897922|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-09-24|||July 2013||2013-07-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants|The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants|Completed||N/A|348|Actual|Mead Johnson Nutrition||2|||f||||f||||||||||2017-10-11 01:30:16.108666|2017-10-11 01:30:16.108666
NCT01897909|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-02-13|||November 2011||2011-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|HHECO||The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana|The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana|Active, not recruiting||N/A|1100|Anticipated|Bernhard Nocht Institute for Tropical Medicine|||3||f||||f||||||Samples With DNA|"     Blood sample, stool sample   "|||2017-10-11 01:30:16.255026|2017-10-11 01:30:16.255026
NCT01897896|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-12-01|||November 2013||2013-11-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|ARC-HD||Alternatives for Reducing Chorea in HD|An Open Label, Long Term Safety Study of SD-809 ER in Patients With Chorea Associated With Huntington Disease|Active, not recruiting||Phase 3|238|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 01:30:16.3625|2017-10-11 01:30:16.3625
NCT01897883|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-07-29|||July 2013||2013-07-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Dyslipidemia Management in Chinese Post Stroke Patients|Dyslipidemia Management in Chinese Post Stroke Patients|Completed||N/A|5000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:30:16.544989|2017-10-11 01:30:16.544989
NCT01897870|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-02-22|||November 2013||2013-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|HomeCoMe||The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge.|The Effect of a Home-based Community Pharmacist-led Medication Management Program (HomeCoMe-program) Complementary to an In-hospital Medication Reconciliation Program on Drug-related Problems Post-discharge: A Prospective Cohort Study.|Completed||N/A|150|Actual|Zorggroep Almere||1|||f||||f||||||||||2017-10-11 01:30:16.848937|2017-10-11 01:30:16.848937
NCT01897857|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-04-06|||July 2013||2013-07-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Influence of DM on Artery Blood Flow and Complications After Radial Artery Cannulation||Completed||N/A|80|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:30:16.987746|2017-10-11 01:30:16.987746
NCT01897844|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-04-08|||May 2013||2013-05-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|14 days MAD||A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers|A Two-part Phase I Study in Male Healthy Volunteers to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Repeated Incremental Doses of ITF2984. Part A is Double-Blind, Randomized, Subcutaneous Administration. Part B is Open Label, Continuous Infusion.|Completed||Phase 1|36|Actual|Italfarmaco||3|||f||||f||||||||||2017-10-11 01:30:17.081331|2017-10-11 01:30:17.081331
NCT01897831|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-07-09|||August 2011||2011-08-01|September 2012|2012-09-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|PIP-SBT||Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection|A Open Multi-center Clinical Study on Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection|Unknown status|Enrolling by invitation|Phase 4|2000|Anticipated|Xiangbei Welman Pharmaceutical Co., Ltd||1|||f||||t||||||||||2017-10-11 01:30:17.211319|2017-10-11 01:30:17.211319
NCT01897818|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-09|||July 2013||2013-07-01|May 2013|2013-05-01||||July 2015|Anticipated|2015-07-01||Interventional|||Communication by Brain - Computer Interface in Amyotrophic Lateral Sclerosis:Feasibility Study||Unknown status|Recruiting|N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||||||||||||2017-10-11 01:30:17.327146|2017-10-11 01:30:17.327146
NCT01897805|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-12-17|||July 2011||2011-07-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||A Trial to Evaluate Efficacy of Heart-protecting Musk Pill|A Randomized, Double-blind, Multi-centered, Placebo-controlled Trial to Examine Effects of Heart-protecting Musk Pill on Clinical Outcome in Patients With Chronic Stable Coronary Artery Disease|Unknown status|Active, not recruiting|Phase 4|2700|Anticipated|Shanghai Hutchison Pharmaceuticals Limited||2|||f||||f||||||||||2017-10-11 01:30:17.47828|2017-10-11 01:30:17.47828
NCT01897792|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-02-08|2015-10-27||May 2013||2013-05-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma|Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma|Terminated||Phase 2|11|Actual|University of Alabama at Birmingham|Study terminated--inability to recruit patient that met inclusion criteria.|2||Inability to recruit patients that meet inclusion criteria.|f||||t||||||||||2017-10-11 01:30:17.855856|2017-10-11 01:30:17.855856
NCT01897779|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-04-27|||July 2013||2013-07-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous RPX2014 and RPX7009 Alone and in Combination in Healthy Adult Subjects|Completed||Phase 1|94|Actual|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||4|||f||||f||||||||||2017-10-11 01:30:18.466837|2017-10-11 01:30:18.466837
NCT01897766|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-04-17|||September 2013|Actual|2013-09-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age (SGA)|Special Investigation For Genotropin(Sga Long Follow-up)|Completed||N/A|488|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:30:18.569109|2017-10-11 01:30:18.569109
NCT01897753|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-01-17|||March 2012||2012-03-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|GH-RAST||Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age|Retrospective Study Of The Influence Of Age At Start Of Growth Hormone (Gh) Treatment On Height Gain In Children Born Small for Gestational Age (SGA)|Completed||Phase 4|264|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:30:18.6597|2017-10-11 01:30:18.6597
NCT01897740|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-08-14||||||August 2017|2017-08-01||||||||Expanded Access|||Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil|A Local, Single-centre, Extension, Open Label Access Study, To Provide Sildenafil Therapy For Subjects Who Completed A1481156 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil, Prior To Reimbursement And Availability For Subjects In Russian Federation|Available||N/A|||Pfizer|||||f|t|||||||||||||2017-10-11 01:30:18.781434|2017-10-11 01:30:18.781434
NCT01897727|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-12-13|2013-09-03||January 2009||2009-01-01|December 2013|2013-12-01||||April 2012|Actual|2012-04-01||Interventional|||Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment|Randomized Controlled Trial of Spironolactone Versus Standard of Care Blood Pressure Treatment on the Severity of Obstructive Sleep Apnea in Patients With Resistant Hypertension|Completed||N/A|41|Actual|University of Alabama at Birmingham|"Unanticipated enrollment challenges led to small numbers of participants analyzed.
Open-label study design may have prevented a placebo effect.
An outlier in AHI was present in the control group."|2|||f||||f||||||||||2017-10-11 01:30:18.885842|2017-10-11 01:30:18.885842
NCT01897714|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-08-17|||July 2013||2013-07-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients|An Open-Label Phase I/IIa Study of the Safety and Efficacy of Melphalan-flufenamide (Melflufen) and Dexamethasone Combination for Patients With Relapsed and/or Relapsed-Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|75|Actual|Oncopeptides AB||1|||f||||t||||||||||2017-10-11 01:30:19.169797|2017-10-11 01:30:19.169797
NCT01897701|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-10-10|||July 2013||2013-07-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1|A Phase 1 Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/2013 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Adjuvant 1|Completed||Phase 1|280|Actual|Novavax||7|||f||||f||||||||||2017-10-11 01:30:19.298798|2017-10-11 01:30:19.298798
NCT01897688|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-12-01|||June 2012||2012-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients|A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients|Recruiting||Phase 3|20|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-11 01:30:19.409741|2017-10-11 01:30:19.409741
NCT01897675|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-08-01|||August 2013|Actual|2013-08-01|August 2017|2017-08-01|March 1, 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Interventional|LoopDrainage||A Comparison of Techniques for Treating Skin Abscesses|Is Loop Drainage of a Cutaneous Abscess in the Emergency Department as Effective as Incision and Drainage With Packing?|Active, not recruiting||N/A|233|Actual|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-11 01:30:19.500278|2017-10-11 01:30:19.500278
NCT01897662|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-11|||April 2012||2012-04-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ROQ_NUTRIMETAB||Effect of Nutriose Supplementation on Satiety, Weight Loss and Adiposity in Overweight Subjects|Study of the Consumption of Nutriose on Satiety, Weight Loss and Fat Mass Reducing in Overweight Subjects|Completed||Phase 1|76|Actual|Nealth Sarl||2|||f||||f||||||||||2017-10-11 01:30:19.752685|2017-10-11 01:30:19.752685
NCT01897649|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-09|||June 2012||2012-06-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|ROQ_NUTRIFLORE||Effect of 15g Daily Consumption of NUTRIOSE on Healthy Volunteers Microbiota.|Effect of 15g Daily Consumption of NUTRIOSE During 2 and 4 Weeks on Healthy Volunteers Microbiota and Digestive Tolerance.|Completed||Phase 1|60|Actual|Nealth Sarl||2|||f||||f||||||||||2017-10-11 01:30:19.85733|2017-10-11 01:30:19.85733
NCT01897636|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-09|||December 2013||2013-12-01|June 2013|2013-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|DC||Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer||Unknown status|Not yet recruiting|N/A|30|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||t||||||||||2017-10-11 01:30:19.979444|2017-10-11 01:30:19.979444
NCT01897623|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-12-15|||July 2013||2013-07-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CAD-AAA||Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease|Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease|Completed||N/A|||North Karelia Central Hospital||1|||f||||f||||||||||2017-10-11 01:30:20.123586|2017-10-11 01:30:20.123586
NCT01897610|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-09-25|||December 2013||2013-12-01|March 2016|2016-03-01|July 4, 2017|Actual|2017-07-04|July 2017|Actual|2017-07-01||Interventional|||Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC|Randomized, Open-label and Multi-center Clinical Trial to Evaluate the Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced Hepatocellular Carcinoma|Completed||Phase 2|40|Actual|Green Cross Cell Corporation||2|||f||||f||||||||||2017-10-11 01:30:20.212403|2017-10-11 01:30:20.212403
NCT01897597|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-09-04|||July 2013||2013-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions|An Open-label, Single Dose, Randomised, Crossover Trial in Healthy Male Subjects to Investigate the Relative Bioavailability of Tablet and Oral Solution of Two Doses of BI 144807 and Relative Bioavailability of BI 144807 When Administered as Tablet Under Fed and Fasted Conditions|Completed||Phase 1|31|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-11 01:30:20.372131|2017-10-11 01:30:20.372131
NCT01897584|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-08-30|||July 2013||2013-07-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect Inverse Ratio Ventilation on Arterial Oxygenation and Respiratory Mechanics During lapaLAR|Effect of Inverse Ratioventilation on Laparoscopic Low Anterior Resection|Completed||N/A|30|Actual|Gachon University Gil Medical Center||1|||f||||t||||||||||2017-10-11 01:30:20.509673|2017-10-11 01:30:20.509673
NCT01897571|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-03-28|||June 2013||2013-06-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|November 2019|Anticipated|2019-11-01||Interventional|||Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Adv. Solid Tumors or With B-cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With DLBCL|An Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Advanced Solid Tumors or With B-cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With Diffuse Large B Cell Lymphoma|Recruiting||Phase 1/Phase 2|420|Anticipated|Epizyme, Inc.||2|||f||||t||||||||||2017-10-11 01:30:20.648672|2017-10-11 01:30:20.648672
NCT01897558|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-02-12|||April 2013||2013-04-01|September 2014|2014-09-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|PACMAN||Myocardial Micro-damage in Relation to Active and Passive Fixation Pacemaker Electrodes|Effect of Passive Versus Active Fixation Leads on the Magnitude of Troponin Release After Pacemaker Implantation (PACMAN Trial)|Completed||N/A|290|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||||2017-10-11 01:30:20.849087|2017-10-11 01:30:20.849087
NCT01897545|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-10-08|||April 2012||2012-04-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Combined Treatment of Arterial Hypertension and Atrial Fibrillation|The Role of Renal Denervation in Improving Outcomes of Catheter Ablation in Patients With Atrial Fibrillation and Arterial Hypertension|Completed||Phase 2|60|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 01:30:20.949967|2017-10-11 01:30:20.949967
NCT01897532|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-08-02|||July 10, 2013|Actual|2013-07-10|August 2017|2017-08-01|December 11, 2017|Anticipated|2017-12-11|December 11, 2017|Anticipated|2017-12-11||Interventional|||Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)|CARMELINA: A Multicenter, International, Randomized, Parallel Group, Double-blind, Placebo-controlled, Cardiovascular Safety and Renal Microvascular Outcome Study With Linagliptin, 5 mg Once Daily in Patients With Type 2 Diabetes Mellitus at High Vascular Risk|Active, not recruiting||Phase 4|7003|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:30:21.074011|2017-10-11 01:30:21.074011
NCT01897519|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-06-05|||May 2013||2013-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery|A Phase 2b, Randomized, Double-Blind, Placebo Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Major Surgery|Terminated||Phase 2|56|Actual|AbbVie||4||"Topline results from study M13-796 showed an overall lack of efficacy. There were no safety   concerns."|f||||t||||||||||2017-10-11 01:30:22.195326|2017-10-11 01:30:22.195326
NCT01897506|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-04-12|||June 2013||2013-06-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Observational|||Assessing Risk of Food Insecurity Within Households of Children With Food Allergy|Assessing Risk of Food Insecurity Within Households of Children With Food Allergy|Enrolling by invitation||N/A|650|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-10-11 01:30:22.34321|2017-10-11 01:30:22.34321
NCT01897493|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-09-19|||July 2013||2013-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of Evacetrapib and Digoxin in Healthy Participants|Effect of Evacetrapib on the Pharmacokinetics of Digoxin in Healthy Subjects|Completed||Phase 1|20|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:30:22.42079|2017-10-11 01:30:22.42079
NCT01897480|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-08-13||2016-08-13|August 2013||2013-08-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|March 2016|Actual|2016-03-01||Interventional|Balise||A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations|A Randomized, Controlled Phase 2 Study Evaluating LY2875358 Plus Erlotinib Versus Erlotinib as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations Who Have Disease Control After an 8-Week Lead-In Treatment With Erlotinib|Active, not recruiting||Phase 2|150|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:30:22.522164|2017-10-11 01:30:22.522164
NCT01897467|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-01-06|||August 2013||2013-08-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Effect of a Wii Fit Intervention on Components of Fall Risk in Middle-aged Women|Effect of a Wii Fit Intervention on Balance, Muscular Fitness, and Bone Health in Middle-aged Women|Completed||N/A|24|Actual|Arizona State University||2|||f||||f||||||||||2017-10-11 01:30:22.726931|2017-10-11 01:30:22.726931
NCT01897454|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-03-11|||November 2012||2012-11-01|March 2016|2016-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Combination Chemotherapy, Gemcitabine Hydrochloride, and Radiation Therapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer|A Phase II Trial of Preoperative FOLFIRINOX Followed by Gemcitabine Based Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Adenocarcinoma|Recruiting||Phase 2|50|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 01:30:22.830449|2017-10-11 01:30:22.830449
NCT01897441|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2016-01-13|||June 2013||2013-06-01|January 2016|2016-01-01||||January 2016|Anticipated|2016-01-01||Interventional|||Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer|Prospective Tissue Collection in Breast Cancer Patients Receiving Preoperative Systemic Therapy|Recruiting||N/A|132|Anticipated|Albert Einstein College of Medicine, Inc.||3|||f||||t||||||||||2017-10-11 01:30:23.067012|2017-10-11 01:30:23.067012
NCT01897428|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2013-07-11|||April 2011||2011-04-01|March 2011|2011-03-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg|Clinical Trial to Evaluate Pharmacokinetic Characteristics of Belion in Healthy Subjects|Completed||Phase 1|26|Actual|Korea University Anam Hospital||2|||f||||f||||||||||2017-10-11 01:30:23.259672|2017-10-11 01:30:23.259672
NCT01897415|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2017-09-16|||July 2013||2013-07-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Interventional|||Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer|Phase I Clinical Trial of Autologous Mesothelin Re-directed T Cells in Patients With Chemotherapy Refractory Metastatic Pancreatic Cancer|Completed||Phase 1|16|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:30:23.345868|2017-10-11 01:30:23.345868
NCT01897402|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2015-04-16|2015-03-26||July 2013||2013-07-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional||Population contains all randomized subjects. Two randomized subjects could not be vaccinated. Three subjects, one female and 3 males received incorrect vaccine. They are listed according to randomized treatment in the baseline population, but were analyzed according to the actual vaccine received in the safety population (secondary outcomes).|Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine|A Phase 2 Double Blind Study to Evaluate Safety and Immunogenicity of Meningococcal Meningitis Serogroups A, C, Y & W-135 Polysaccharide Diphtheria Toxoid Conjugate Vaccine (NmVac4-A/C/Y/W-135-DT™) Compared With a Licensed Vaccine|Completed||Phase 2|525|Actual|JN-International Medical Corporation|Three subjects, 1 female and 2 males, received incorrect vaccine. They are listed according to randomized treatment in the baseline population, but were analyzed according to the actual vaccine received in the safety population (outcomes 2 and 3).|2|||f||||f||||||||||2017-10-11 01:30:23.446547|2017-10-11 01:30:23.446547
NCT01897389|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-09|2014-11-27|||July 2013||2013-07-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Participants|A Single-Dose, Open-Label, Randomized, 4-Period, 5-Treatment Crossover Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Subjects|Completed||Phase 1|32|Actual|Janssen Research & Development, LLC||8|||f||||f||||||||||2017-10-11 01:30:23.887143|2017-10-11 01:30:23.887143
NCT01897376|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-06-28|||July 2013||2013-07-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|C-SIT||Cesarean Skin Incision Trial|The Comparative Effectiveness of Pfannenstiel Versus Vertical Skin Incision in Preventing Wound Complications After Cesarean Delivery in Morbidly Obese Women: a Randomized Clinical Trial.|Completed||N/A|228|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 01:30:23.993012|2017-10-11 01:30:23.993012
NCT01897363|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-09-24|||July 2013||2013-07-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|||Hypoglycemia in Prader-Willi Syndrome|Hypoglycemia in Prader-Willi Syndrome: A Prospective Study|Completed||N/A|2|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 01:30:24.072451|2017-10-11 01:30:24.072451
NCT01897350|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-10-20|||July 2013||2013-07-01|October 2014|2014-10-01||||December 2013|Actual|2013-12-01||Observational|||Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial||Completed||N/A|30|Actual|University of Bristol|||1||f||||||||||||||2017-10-11 01:30:24.144426|2017-10-11 01:30:24.144426
NCT01897337|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-08|||June 2012||2012-06-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting|The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting|Completed||Phase 4|125|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:30:24.346562|2017-10-11 01:30:24.346562
NCT01897324|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-10-19|||July 2013||2013-07-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||IVF/ICSI Protocols in Poor Responders With Growth Hormone|Which is the Best IVF/ICSI Protocol to be Used in Poor Responders Receiving Growth Hormone as an Adjuvant Treatment ? A Prospective Randomized Study|Completed||Phase 4|287|Actual|Woman's Health University Hospital, Egypt||4|||f||||t||||||||||2017-10-11 01:30:24.425704|2017-10-11 01:30:24.425704
NCT01897311|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-04-20|||August 2011||2011-08-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Modulation of TENS in Pain After Cesarean Section|Hypoalgesic Effect of TENS Modulation in Post-Cesarean Pain: A Clinical Trial Controlled and Randomized.|Completed||N/A|34|Actual|Universidade Federal do Piauí||3|||f||||f||||||||||2017-10-11 01:30:24.505754|2017-10-11 01:30:24.505754
NCT01897298|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-04-29|||July 2013||2013-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Urban Training for COPD Patients|Effectiveness of an Intervention of Urban Training in Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomised Controlled Trial|Completed||N/A|412|Actual|Centre for Research in Environmental Epidemiology, Spain||2|||f||||t||||||||||2017-10-11 01:30:24.593709|2017-10-11 01:30:24.593709
NCT01897285|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-05-16|2014-03-18||May 2013||2013-05-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Ten male (50%) and ten female (50%) healthy volunteers were enrolled into the study with a mean age of 37.1 years.|A Single Centre, Randomised, Comparative, Blinded Wear Test of Two Adhesives on the AQUACEL® Foam Adhesive Dressing|A Single Centre, Randomised, Comparative, Blinded Wear Test of Two Adhesives on the AQUACEL® Foam Adhesive Dressing|Completed||N/A|20|Actual|ConvaTec Inc.|Many dressings detached from the skin when the volunteers were at home/away from the clinic and prior to returning for the assessments. It was therefore not possible for the Investigator to give a rating for several parameters on several volunteers.|1|||f||||f||||||||||2017-10-11 01:30:24.710936|2017-10-11 01:30:24.710936
NCT01896206|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-02-25|2015-02-03||June 2013||2013-06-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||CNAP Accuracy in the Bariatric Surgery Population||Completed||N/A|21|Actual|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-11 01:30:41.706909|2017-10-11 01:30:41.706909
NCT01897272|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-04-14|||September 2012||2012-09-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|6 Months|Observational [Patient Registry]|||Post-Operative Splinting After Short-Incision Carpal Tunnel Release: a Prospective Study|Post-Operative Splinting After Short-Incision Carpal Tunnel Release: a Prospective, Randomized Study|Recruiting||N/A|40|Anticipated|Christine M. Kleinert Institute for Hand and Microsurgery|||2||f||||t||||||||||2017-10-11 01:30:25.063941|2017-10-11 01:30:25.063941
NCT01897259|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-04-14|||March 2012||2012-03-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Conservative Methods for the Treatment of Lateral Epicondylitis: A Randomized, Prospective Study|Comparison of Conservative Methods for the Treatment of Lateral Epicondylitis: A Randomized, Prospective Study|Recruiting||Phase 2|200|Anticipated|Christine M. Kleinert Institute for Hand and Microsurgery||4|||f||||f||||||||||2017-10-11 01:30:25.24955|2017-10-11 01:30:25.24955
NCT01897246|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2013-07-09|||September 2010||2010-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Computer Assisted Planning of Corrective Osteotomy for Distal Radius Malunion|Computer Assisted Planning of Corrective Osteotomy for Distal Radius Malunion|Completed||Phase 2|10|Anticipated|Christine M. Kleinert Institute for Hand and Microsurgery||2|||f||||f||||||||||2017-10-11 01:30:25.376909|2017-10-11 01:30:25.376909
NCT01897233|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-05-23|2016-10-07||July 2013||2013-07-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||The Safety Set included all participants who received at least 1 dose of study drug.|Study of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|A Phase 3, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation|Completed||Phase 3|62|Actual|Vertex Pharmaceuticals Incorporated|Due to limited sampling and instances of missing data, C4h was reported instead of Cmax as an approximation of maximum concentration. Sparse PK sampling scheme was optimized around parent compounds which limited the estimation of AUC for metabolites.|1|||f||||f||||||||||2017-10-11 01:30:25.506043|2017-10-11 01:30:25.506043
NCT01897220|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-07-10|||December 2011||2011-12-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01|1 Week|Observational [Patient Registry]|PRAGUE-14||Perioperative Ischemia Versus Perioperative Bleeding During Non-cardiac Surgery in Cardiac Patients|Perioperative Ischemia Versus Perioperative Bleeding During Non-cardiac Surgery in Cardiac Patients : PRAGUE 14 Study|Completed||N/A|1200|Actual|Charles University, Czech Republic|||1||f||||f||||||||||2017-10-11 01:30:26.643562|2017-10-11 01:30:26.643562
NCT01897194|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-12-09|||July 2013||2013-07-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Using EEG to Study Coma in the Neurocritical Care Unit|A Wireless EEG Patch Device for Continuous Electrographic Monitoring and Study of Coma in the Neurocritical Care Unit|Completed||N/A|1|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 01:30:26.852916|2017-10-11 01:30:26.852916
NCT01897181|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2016-02-14|||July 2013||2013-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CAPHA||Central Auditory Processing and the Use of Hearing Aids|Evaluation of the Central Auditory Processing in Patients (Elder Than 45 Years Old) With Bilateral Sensorineural Hearing Loss and the Change of the Central Auditory Processing Ability by the Use of Hearing Aids (CAPHA)|Completed||N/A|27|Actual|Asan Medical Center||2|||f||||f||||||||Undecided|Data is being analyzed.|2017-10-11 01:30:26.919454|2017-10-11 01:30:26.919454
NCT01897168|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-06-28|||June 2013||2013-06-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Bone Mineral Content in Healthy Children|Bone Mineral Content in Healthy Children|Recruiting||N/A|150|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||Samples Without DNA|"     Serum and urine may be collected from study participants.   "|||2017-10-11 01:30:27.016785|2017-10-11 01:30:27.016785
NCT01897155|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-19|2013-07-08|||January 2010||2010-01-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Acute Arterial Hypertension on Morphine's Requirements and Postsurgical Pain.|Effect of Acute Arterial Hypertension on Morphine's Requirements and Postsurgical Pain.|Completed||Phase 4|50|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 01:30:27.117866|2017-10-11 01:30:27.117866
NCT01897142|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-04-21|||September 2013||2013-09-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers|A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo-controlled, Single Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Subjects|Completed||Phase 1|49|Actual|Pfizer||6|||f||||t||||||||||2017-10-11 01:30:27.206894|2017-10-11 01:30:27.206894
NCT01897129|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-08|||November 2011||2011-11-01|July 2013|2013-07-01|November 2015|Anticipated|2015-11-01|November 2014|Anticipated|2014-11-01||Observational|HPVandPregn||Human Papillomavirus and Pregnancy|Human Papillomavirus and Pregnancy|Unknown status|Recruiting|N/A|546|Anticipated|Odense University Hospital|||6||f||||t||||||Samples With DNA|"     Biospecimen will be kept in a biobank for a period of 10 years after the end of this project.     The biospecimens will be blood samples, cells collected from the ectocervix, vaginal     microbioma, placental biopsies from prenatal diagnostics or miscarriages.   "|||2017-10-11 01:30:27.382221|2017-10-11 01:30:27.382221
NCT01897116|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-07-28|||June 2013||2013-06-01|July 2017|2017-07-01||||January 2016|Actual|2016-01-01||Interventional|||A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma|A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma|Active, not recruiting||Phase 1|7|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:30:27.507347|2017-10-11 01:30:27.507347
NCT01889758|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-02-19|||June 2013||2013-06-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PK||Pharmacokinetic Studies of Tacrolimus in Transplant Patients|Pharmacokinetic Studies of Tacrolimus in Transplant Patients|Completed||Phase 4|78|Actual|University of Cincinnati||3|||f||||f||||||||||2017-10-11 01:32:28.102689|2017-10-11 01:32:28.102689
NCT01897103|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-01-23|||June 2013||2013-06-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Observational|PIVOTAL||Platelet Activity in Vascular Surgery for Thrombosis and Bleeding|Platelet Activity in Vascular Surgery|Recruiting||N/A|200|Anticipated|New York University School of Medicine|||1||f||||f||||||Samples With DNA|"     serum, plasma, platelet RNA   "|||2017-10-11 01:30:27.585253|2017-10-11 01:30:27.585253
NCT01897090|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-04-04|||January 2013||2013-01-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease|"The Relationship of a Crohn's Disease Diet in Reducing Symptoms of Crohn's Disease, Improving Quality of Life, and Decreasing Related Health Care Costs."|Withdrawn||N/A|0|Actual|Johns Hopkins University||2||Unable to recruit|f||||f||||||||||2017-10-11 01:30:27.701944|2017-10-11 01:30:27.701944
NCT01897077|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-03-21|||November 2012|Actual|2012-11-01|March 2017|2017-03-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy|The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy|Suspended||Phase 1/Phase 2|15|Anticipated|Johns Hopkins University||2||Study product manufacturing suspended|f||||t||||||||||2017-10-11 01:30:27.803349|2017-10-11 01:30:27.803349
NCT01897064|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-08-14|||April 2012||2012-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.|The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.|Completed||N/A|41|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 01:30:27.899544|2017-10-11 01:30:27.899544
NCT01897051|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-04-19|||July 2013||2013-07-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|RECOVER||Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients|Hemodynamic Response of Rifaximin and Non-selective β-blocker Combination Therapy Versus Non-selective β-blocker Monotherapy in Cirrhotic Patients With Esophageal Varices|Unknown status|Recruiting|Phase 2/Phase 3|140|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:30:27.991242|2017-10-11 01:30:27.991242
NCT01897038|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-11-01|||September 2013||2013-09-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma|A Phase Ib, Open-Label Study Evaluating The Safety, Tolerability, and Pharmacokinetics of Onartuzumab Given as a Single Agent and in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)|Completed||Phase 1|9|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:30:28.113749|2017-10-11 01:30:28.113749
NCT01897025|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-02-11|2015-07-28||January 2011||2011-01-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||subjects aged 21 to 70 years who had their first-ever subcortical stroke at least 9 months , with moderate to severe impairment of upper extremity function (subscore of the Fugl-Meyer Motor Assessment [FMMA], 11-45), were recruited.|Combined Transcranial Direct Current Stimulation and Motor Imagery-based Robotic Arm Training for Stroke Rehabilitation|Combined Transcranial Direct Current Stimulation and Motor Imagery-based Robotic Arm Training for Stroke Rehabilitation - a Feasibility Study|Completed||Phase 2|42|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 01:30:28.266926|2017-10-11 01:30:28.266926
NCT01897012|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-07-25|||July 17, 2013|Actual|2013-07-17|July 2017|2017-07-01||||July 31, 2017|Anticipated|2017-07-31||Interventional|||Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas|A Phase 1 Trial of MLN8237 Plus Romidepsin for Relapsed/Refractory Aggressive B-Cell and T-Cell Lymphomas|Recruiting||Phase 1|42|Anticipated|National Cancer Institute (NCI)||1|||f||||f|t|f||||||||2017-10-11 01:30:28.520478|2017-10-11 01:30:28.520478
NCT01896986|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-03-28|2016-11-22||March 2012||2012-03-01|March 2017|2017-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational||Group A:PRD - Children/adolescent females 12-26 years with a PRD such as JIA (Juvenile Idiopathic Arthritis) or SLE (Systemic Lupus Erythematosus) Group B: IBD (Inflammatory Bowel Disease) Children/adolescent females 12-26 years diagnosed with IBD.|HPV Vaccination in Special Risk Groups: 5 Year Follow-up|HPV Immunisation Protecting Special Risk Group Patients From Cervical Cancer: 5 Year Follow-up Post-vaccination|Terminated||N/A|37|Actual|Murdoch Childrens Research Institute|Study serum samples being misplaced so sample testing could not be done. As such we had no choice but to close this study. This was communicated to the enrolled participants and the RCH ethics department.||2|recruitment problems|f||||f||||||||||2017-10-11 01:30:29.041324|2017-10-11 01:30:29.041324
NCT01896973|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-02-22|||July 2013||2013-07-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)|Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)|Active, not recruiting||N/A|35|Anticipated|HistoSonics, Inc.||1|||f||||t||||||||||2017-10-11 01:30:29.253454|2017-10-11 01:30:29.253454
NCT01896960|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-06-20|||July 2013||2013-07-01|June 2014|2014-06-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|ET-50-Fent||ET50 With Fentanyl for Post Caesarean Section Spinal Hypotension|The Time Required to Remain Sitting After Spinal Anesthesia With Fentanyl for 50% of Patients to Not Experience Hypotension.|Unknown status|Recruiting|Phase 2|40|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 01:30:29.338574|2017-10-11 01:30:29.338574
NCT01896947|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-10|||September 2013||2013-09-01|July 2013|2013-07-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||3T MRI Versus MR Arthrogram in SLAP Lesions|Three Tesla Magnetic Resonance Imaging Compared to Magnetic Resonance Arthrogram in Diagnosing Superior Labrum Anterior Posterior (SLAP) Lesions|Unknown status|Not yet recruiting|N/A|30|Anticipated|Henry Ford Health System|||1||f||||t||||||||||2017-10-11 01:30:29.42446|2017-10-11 01:30:29.42446
NCT01896934|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-06-21|2017-05-16||July 2013||2013-07-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression|Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression (R21)|Completed||Phase 4|31|Actual|Vanderbilt University Medical Center|Limitations include a small sample that reflects this is a pharmacoimaging study using MRI to examine imaging findings related to antidepressant treatment outcomes.|1|||f||||f||||||||||2017-10-11 01:30:29.51198|2017-10-11 01:30:29.51198
NCT01896921|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-08-19|||September 2013||2013-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Switch to Maraviroc + Integrase Inhibitor|Switch to Maraviroc and Integrase Strand Transfer Inhibitor Combination Therapy (a Triple Class-Sparing Regimen) for the Treatment of HIV-1-Infected Patients on Suppressive Antiretroviral Regimens|Recruiting||Phase 3|30|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-11 01:30:29.920298|2017-10-11 01:30:29.920298
NCT01896908|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-08-01|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|July 31, 2016|Actual|2016-07-31|July 31, 2016|Actual|2016-07-31||Interventional|||Effect of Dietary Sodium Restriction in the Management of Patients With Heart Failure and Diastolic Dysfunction|Effect of Dietary Sodium Restriction in the Management of Patients With Heart Failure and Preserved Ejection Fraction: a Randomized Clinical Trial|Completed||N/A|74|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 01:30:30.045546|2017-10-11 01:30:30.045546
NCT01896895|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-03-30||2017-03-30|November 2013||2013-11-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid|Prospective, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of Two Different Doses of NT 201 in Botulinum Toxin Treatment-naïve Subjects With Blepharospasm|Completed||Phase 3|61|Actual|Merz Pharmaceuticals GmbH||3|||f||||f||||||||||2017-10-11 01:30:30.15282|2017-10-11 01:30:30.15282
NCT01896882|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-08|||March 2012||2012-03-01|February 2012|2012-02-01|August 2014|Anticipated|2014-08-01|March 2014|Anticipated|2014-03-01||Interventional|||Dietary Sodium Restriction in Hemodialysis Patients|Effects of Dietary Sodium Restriction in Hemodialysis Patients: Randomized Clinical Trial|Unknown status|Enrolling by invitation|N/A|112|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 01:30:30.292471|2017-10-11 01:30:30.292471
NCT01896869|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-07-18|||November 2013||2013-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|November 2018|Anticipated|2018-11-01||Interventional|||A Phase 2, Multicenter Study of FOLFIRINOX Followed by Ipilimumab With Allogenic GM-CSF Transfected Pancreatic Tumor Vaccine in the Treatment of Metastatic Pancreatic Cancer|A Phase 2, Multicenter Study of FOLFIRINOX Followed by Ipilimumab in Combination With Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine (GVAX) in the Treatment of Metastatic Pancreatic Cancer|Suspended||Phase 2|92|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2||On hold during during interim analysis|f||||t||||||||||2017-10-11 01:30:30.408287|2017-10-11 01:30:30.408287
NCT01896856|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-12-28|||September 2013||2013-09-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase I Study of SGI-110 With Irinotecan Followed by Randomized Phase II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Previously Treated Metastatic Colorectal Cancer|A Phase I Study of SGI-110 Combined With Irinotecan Followed by a Randomized Phase II Study of SGI-110 Combined With Irinotecan Versus Regorafenib or TAS-102 in Previously Treated Metastatic Colorectal Cancer Patients|Recruiting||Phase 1/Phase 2|108|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 01:30:30.527061|2017-10-11 01:30:30.527061
NCT01896843|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-06-30|||June 27, 2013||2013-06-27|January 11, 2017|2017-01-11|June 16, 2016|Actual|2016-06-16|June 16, 2016|Actual|2016-06-16||Interventional|||Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in Brain|Evaluation of [11C]FPEB, [18C]FPEB, and [11C]SP203 To Image mGluR5 Receptors In Brain|Completed||Phase 1|19|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:30:30.645871|2017-10-11 01:30:30.645871
NCT01896830|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-10-15||2015-10-15|July 2013||2013-07-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|October 2013|Actual|2013-10-01||Interventional|||Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan|Safety and Immunogenicity of a Clostridium Difficile Toxoid Vaccine Administered to Healthy Adult Subjects Aged 40 to 75 Years in Japan|Completed||Phase 1/Phase 2|102|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:30:30.746136|2017-10-11 01:30:30.746136
NCT01896791|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-07-13|||July 2013||2013-07-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|July 2016|Actual|2016-07-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) in Vasomotor Symptoms of Menopause|Transcranial Direct Current Stimulation (tDCS) in Vasomotor Symptoms of Menopause: Blind Sham Controlled Randomized Clinical Trial|Recruiting||N/A|30|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-11 01:30:30.877726|2017-10-11 01:30:30.877726
NCT01896778|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-09-27|||October 4, 2013|Actual|2013-10-04|September 2017|2017-09-01|April 11, 2019|Anticipated|2019-04-11|April 11, 2018|Anticipated|2018-04-11||Interventional|||Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer|Body Warming to Alter [Thermo] Regulation and the Microenvironment [B-WARM] Therapy: A Pilot Study|Recruiting||N/A|20|Anticipated|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-11 01:30:31.017715|2017-10-11 01:30:31.017715
NCT01896765|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2017-08-09|||October 2013||2013-10-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|April 2017|Actual|2017-04-01||Interventional|IPP||Intensive Prevention Program After Myocardial Infarction|Intensive Longterm Prevention Program After Myocardial Infarction in Northwest Germany|Completed||N/A|300|Actual|Herzzentrum Bremen||2|||f||||t||||||||||2017-10-11 01:30:31.149782|2017-10-11 01:30:31.149782
NCT01896752|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-14|||March 2011||2011-03-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL|Pharmacokinetics: Renal and Hepatic Clearance Following High-Dose Methotrexate in Children With Acute Lymphoblastic Leukemia|Completed||N/A|43|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     whole blood for RFC allele determination; serum for determination of concentration of MTX,     clearances, and other pharmacokinetic parameters; urine for determination of concentration of     MTX and clearances, and other pharmacokinetic parameters   "|||2017-10-11 01:30:31.27602|2017-10-11 01:30:31.27602
NCT01896739|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-08|||August 2009||2009-08-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants|A Multicentre, Comparative, Open-label, Randomized, Phase III Study to Assess the Immunogenicity and Safety of EutravacTMinj (DTaP-HB Combined Vaccine) Administered at 2,4, 6 Months of Age Compared With DTaP Vaccine at 2, 4, 6 Months of Age Combined Administered Monovalent Hepatitis B Vaccine Administered at Birth, 1, 6 Months of Age in Healthy Infants.|Completed||Phase 3|289|Actual|LG Life Sciences||4|||f||||f||||||||||2017-10-11 01:30:31.379747|2017-10-11 01:30:31.379747
NCT01896726|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-05-15|2017-03-10||July 2013||2013-07-01|May 2017|2017-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||All enrolled participants.|A Study of Baricitinib and Birth Control Pills in Healthy Females|The Effects of Multiple Doses of Baricitinib on the Pharmacokinetics of a Single Dose of an Oral Contraceptive in Healthy Female Subjects|Completed||Phase 1|20|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:30:31.532811|2017-10-11 01:30:31.532811
NCT01896713|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-07-08|||April 2010||2010-04-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer|To Determine if MultiSpectral 3 Tesla MRI Can Provide Added Value in the Detection of Significant Cancers in Patients o n Active Surveillance for Prostate Cancer|Completed||N/A|81|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 01:30:31.976313|2017-10-11 01:30:31.976313
NCT01896687|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-06-09|2014-08-18||March 2013||2013-03-01|June 2017|2017-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Trial of Scrambler Therapy or Sham Treatment for Low Back Pain|A Pilot Randomized Trial of Scrambler Therapy or Sham Treatment for Persistent Nonspecific Low Back Pain|Completed||N/A|30|Actual|Virginia Commonwealth University||2|||f||||t||||||||No||2017-10-11 01:30:32.21313|2017-10-11 01:30:32.21313
NCT01896674|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-10|||May 2012||2012-05-01|July 2013|2013-07-01||||January 2013|Actual|2013-01-01||Observational|||Knowledge-based Iterative Model Reconstruction at Low-kilovoltage (kV) Cardiac Computed Tomography (CT)|Value of Knowledge-based Iterative Model Reconstruction at Low-kilovoltage Cardiac 256-slice CT: A Comparison of Filtered Back Projection-, Hybrid-, and Iterative Model Reconstruction|Completed||N/A|21|Actual|Kumamoto University|||1||f||||f||||||||||2017-10-11 01:30:32.517074|2017-10-11 01:30:32.517074
NCT01896661|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-07-13|||December 2014||2014-12-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Antihypertensive Agents Over Sleep Apnea|The Effect of Antihypertensive Agents Over Sleep Apnea: a Randomized Controlled Trial|Completed||Phase 3|53|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-11 01:30:32.592178|2017-10-11 01:30:32.592178
NCT01896648|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-07-06|||June 2013||2013-06-01|July 2013|2013-07-01|June 2016|Anticipated|2016-06-01|December 2014|Anticipated|2014-12-01||Observational|||Sexual Dysfunction in Type 2 Diabetic Women|Sexual Dysfunction in Type 2 Diabetic Women: Study on Prevalence and on Risk|Unknown status|Recruiting|N/A|306|Anticipated|University of Pavia|||1||f||||f||||||Samples Without DNA|"     The following parameters will be assessed:      Blood: ematology, glycated hemoglobin, fasting plasma glucose, fasting plasma insulin, total     cholesterol, HDL cholesterol, triglycerides, LDL cholesterol, creatinine, urea,     transaminases, electrolytes, homocysteine, high sensitivity C-reactive protein (hs-CRP),     metalloproteinase-2 (MMP-2), metalloproteinase-9 (MMP-9), soluble adhesion molecules     (sICAM-1, sVCAM-1), sE-selectin, lipoprotein (a) [Lp (a)], Plasminogen Activator Inhibitor-1     (PAI-1).      Urine: complete urinalysis, 24-hour microalbuminuria   "|||2017-10-11 01:30:32.682982|2017-10-11 01:30:32.682982
NCT01896635|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-06|2016-10-24|||November 2013||2013-11-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|November 2015|Actual|2015-11-01||Interventional|FOCUS||Faecal Microbiota Transplantation in Ulcerative Colitis|Faecal Microbiota Transplantation for Chronic Active Ulcerative Colitis - A Randomised Double Blind Controlled Study of Efficacy & Safety|Completed||Phase 2|81|Actual|The University of New South Wales||2|||f||||||||||||||2017-10-11 01:30:32.761526|2017-10-11 01:30:32.761526
NCT01896622|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-06|2017-06-30|||June 18, 2013||2013-06-18|January 17, 2017|2017-01-17|January 17, 2017|Actual|2017-01-17|January 17, 2017|Actual|2017-01-17||Interventional|||The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers|The Influence of Cobicistat or Ritonavir on Dabigatran Pharmacokinetics and Pharmacodynamics in Healthy Volunteers|Completed||Phase 1|40|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:30:32.862386|2017-10-11 01:30:32.862386
NCT01896609|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-07-10|||June 2013||2013-06-01|July 2013|2013-07-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|Quadritherapy||Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population|A Single Center, Prospective Phase IV, Open-Label, Randomized Trial Comparing the Efficacy , Tolerability, and Safety of Quadritherapy Regimen (Reiferon Retard® + Ribavirin + Nitazoxanide + Alfacalcidol ( Bon-One ®) ) Versus Triple Therapy Regimen (Reiferon Retard® + Ribavirin + Nitazoxanide) Versus the Standard of Care Regimen(Reiferon Retard® + Ribavirin) in the Treatment of Naïve Chronic Hepatitis- C Among the Egyptian Population. Effectiveness Will be Evaluated Based on Sustained Viral Response (SVR)|Unknown status|Recruiting|Phase 4|300|Anticipated|MinaPharm Pharmaceuticals||3|||f||||t||||||||||2017-10-11 01:30:32.95966|2017-10-11 01:30:32.95966
NCT01896596|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-04-04|||July 2013|Actual|2013-07-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|Infanrix||Hepatitis B Vaccination in Infants|A Phase IV Study to Evaluate the Primary and Booster Immune Responses of UK Infants Receiving a Licensed 6-in-1 DTaP/IPV/Hib/HBV Vaccine (Infanrix-HexaTM) With a 13-valent Pneumococcal Conjugate Vaccine and Incorporating a Randomisation Study of a Single Dose of 3 Different Meningococcal Group C Conjugate Vaccines at 3 Months of Age|Completed||Phase 4|300|Actual|Public Health England||3|||f||||f||||||||No||2017-10-11 01:30:33.219211|2017-10-11 01:30:33.219211
NCT01895998|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-12-02|||August 2013||2013-08-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease|Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease|Completed||Phase 1|5|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:30:44.920896|2017-10-11 01:30:44.920896
NCT01896583|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-12-22|||November 2013||2013-11-01|February 2014|2014-02-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Efficacy, Safety and Tolerability, of ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)|Completed||Phase 2|64|Actual|Seldar Pharma, Inc.||2|||f||||||||||||||2017-10-11 01:30:33.357786|2017-10-11 01:30:33.357786
NCT01896570|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-06|2013-07-10|||June 2009||2009-06-01|July 2013|2013-07-01||||March 2013|Actual|2013-03-01||Observational|||Role of Subsequent Atrial Tachycardia in Mechanisms of Persistent AF|The Prognostic Role of Subsequent Atrial Tachycardias Occurring After Atrial Fibrillation Termination: A Prospective Randomized Trial|Completed||N/A|110|Actual|Johannes Gutenberg University Mainz|||2||f||||f||||||||||2017-10-11 01:30:33.480362|2017-10-11 01:30:33.480362
NCT01896557|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-05-12|2015-05-28||October 2011||2011-10-01|October 2011|2011-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Ranitidin Versus Omeprazole in Patients Taking Clopidogrel|Possible Drug Interaction Between Clopidogrel and Ranitidin or Omeprazole in Patients With Stable Coronary Heart Disease: a Comparative Study|Completed||Phase 4|92|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 01:30:33.575007|2017-10-11 01:30:33.575007
NCT01896544|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-05-05|2016-02-05||January 2014||2014-01-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|CSI||Cholecalciferol Supplementation for Sepsis in the ICU|The Effect of Cholecalciferol Supplementation on Vitamin D Status in Sepsis|Completed||Phase 3|30|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 01:30:33.875104|2017-10-11 01:30:33.875104
NCT01896531|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-11-09||2016-07-15|August 2013||2013-08-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||A Study of GDC-0068 in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer|A Randomized, Phase II, Placebo-Controlled Study of GDC-0068, an Inhibitor to Akt, in Combination With Fluoropyrimidine Plus Oxaliplatin in Patients With Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 2|153|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 01:30:34.48677|2017-10-11 01:30:34.48677
NCT01896518|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-04-10|||November 2012|Actual|2012-11-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|March 2017|Actual|2017-03-01||Interventional|EZII||Novel Methods to Reduce Children's Secondhand Smoke Exposure II|Novel Methods to Reduce Children's Secondhand Smoke Exposure II|Active, not recruiting||N/A|74|Actual|University of Oklahoma||3|||f||||f||||||||||2017-10-11 01:30:34.712542|2017-10-11 01:30:34.712542
NCT01896505|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-05-25|||July 2013||2013-07-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma|An Open-Label Phase IB Trial To Evaluate the Effects of Food and Formulation on Pharmacokinetics of the Oral Selective Inhibitor of Nuclear Export/SINE Compound KPT-330 in Patients With Soft-Tissue or Bone Sarcoma|Completed||Phase 1|54|Actual|Karyopharm Therapeutics Inc||6|||f||||f||||||||Yes||2017-10-11 01:30:34.813482|2017-10-11 01:30:34.813482
NCT01896492|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-22|2013-07-05|||January 2011||2011-01-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|NACIPCOS||Clomiphene Plus N-acetyl Cysteine for Induction of Ovulation in Newly Diagnosed Pcos.|Clomiphene Citrate Plus N-acetyl Cysteine Versus Clomiphene Citrate for Induction of Ovulation in Women With Newly Diagnosed Polycystic Ovary Syndrome: a Randomized Double-blind Controlled Trial|Completed||Phase 4|200|Actual|Woman's Health University Hospital, Egypt||3|||f||||t||||||||||2017-10-11 01:30:34.940375|2017-10-11 01:30:34.940375
NCT01896479|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-05-08|||December 2014||2014-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|EXAMINER||A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer|A Randomized, Double-blind Study To Evaluate the Efficacy and Safety of Cabozantinib (XL184) at 60 mg/Day Compared to a 140 mg/Day in Progressive, Metastatic Medullary Thyroid Cancer Patients|Recruiting||Phase 4|188|Anticipated|Exelixis||2|||f||||t||||||||||2017-10-11 01:30:36.843746|2017-10-11 01:30:36.843746
NCT01896466|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-03-03|||September 2013||2013-09-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Enhanced Gait and Balance Training|Influence of Neuromodulation on Gait and Balance|Completed||N/A|39|Actual|University of Wisconsin, Madison||6|||f||||t||||||||||2017-10-11 01:30:37.077769|2017-10-11 01:30:37.077769
NCT01896453|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-12-03|||June 2013||2013-06-01|October 2013|2013-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Brain and Peripheral Electrical Stimulation in Chronic Low Back Pain: a Factorial Design|Treatment of Chronic Non-specific Low Back Pain With Brain and Peripheral Electrical Stimulation: a Factorial, Randomized Controlled Trial|Completed||Phase 2/Phase 3|92|Actual|University of Sao Paulo General Hospital||4|||f||||t||||||||||2017-10-11 01:30:37.172579|2017-10-11 01:30:37.172579
NCT01896440|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-10-04|||October 2013||2013-10-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Heart Safety Study of Ondansetron in Children Receiving Chemotherapy|The Effects of Ondansetron on Myocardial Repolarization in Children Receiving Chemotherapy|Withdrawn||Phase 4|0|Actual|University of Oklahoma||2||FDA did not approve|f||||t||||||||||2017-10-11 01:30:37.269702|2017-10-11 01:30:37.269702
NCT01896427|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2013-07-06|||April 2013||2013-04-01|July 2013|2013-07-01||||April 2014|Anticipated|2014-04-01||Interventional|||Comparing Pain and Swelling After Surgical Extraction of Mandibular Third Molar in Dexamethasone Injection and Without Corticosteroid Methods||Unknown status|Recruiting|Phase 4|75|Anticipated|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:30:37.35531|2017-10-11 01:30:37.35531
NCT01896414|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-07-06|||July 2014||2014-07-01|July 2017|2017-07-01|May 30, 2016|Actual|2016-05-30|May 30, 2016|Actual|2016-05-30||Interventional|||Metabolic Actions of Omega-3 Fatty Acids|Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome|Completed||N/A|40|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 01:30:37.464507|2017-10-11 01:30:37.464507
NCT01896401|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-06|2016-02-22|||February 2012||2012-02-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|VCD||InSeal Vascular Closure Device Clinical Study Protocol|InSeal Vascular Closure Device Clinical Study Protocol|Terminated||N/A|33|Actual|InSeal Medical Ltd.||1||Initiated a new study with improved device|f||||f||||||||||2017-10-11 01:30:37.584033|2017-10-11 01:30:37.584033
NCT01896388|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-08-10|||June 2013||2013-06-01|August 2016|2016-08-01||||June 2020|Anticipated|2020-06-01||Interventional|||Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial|Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial|Recruiting||Phase 1/Phase 2|40|Anticipated|Chiba University||2|||f||||t||||||||||2017-10-11 01:30:37.656683|2017-10-11 01:30:37.656683
NCT01896375|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-10|||December 2012||2012-12-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|GPMBan||Gutkha Pan Masala Ban Impact Study in Mumbai|Impact of 'Gutkha and Pan Masala Ban' in the State of Maharashtra on Users and Vendors|Completed||N/A|73|Actual|Tata Memorial Hospital|||1||f||||t||||||||||2017-10-11 01:30:37.855088|2017-10-11 01:30:37.855088
NCT01896362|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-08|||May 2010||2010-05-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|October 2010|Actual|2010-10-01||Observational|||The Healthcare Professionals and the Leishmaniasis|Leishmaniasis: the Healthcare Professionals' Knowledge in Endemic Area|Completed||N/A|228|Actual|Centro de Pesquisas René Rachou|||1||f||||f||||||||||2017-10-11 01:30:37.94945|2017-10-11 01:30:37.94945
NCT01896349|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-10|||April 2013||2013-04-01|July 2013|2013-07-01|November 2014|Anticipated|2014-11-01|August 2014|Anticipated|2014-08-01||Interventional|||Interpersonal Psychotherapy for Treatment Resistant Depression|Efficacy of Interpersonal Psychotherapy in Treatment Resistant Depression|Unknown status|Recruiting|N/A|74|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 01:30:38.024368|2017-10-11 01:30:38.024368
NCT01896336|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-09-23|||February 2013||2013-02-01|September 2013|2013-09-01|March 2014|Anticipated|2014-03-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia|National Study, Phase IV, Single-center, Double-blind, Randomized, Parallel, Controlled by 10 mg Oral Zolpidem, in Evaluating the Efficacy and Safety of Zolpidem 5 mg Sublingual in the Induction and Maintenance of Sleep in Patients With Primary Insomnia|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|EMS||2|||f||||t||||||||||2017-10-11 01:30:38.244651|2017-10-11 01:30:38.244651
NCT01896323|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-04-03|||July 2013||2013-07-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||CC-223 and Ketoconazole Drug-Drug Interaction Study|An Open-Label, Two-Period, Fixed-Sequence Study to Evaluate the Effect of Multiple Doses of Ketoconazole on the Single Dose Pharmacokinetics of CC-223 in Healthy Adult Male Subjects|Completed||Phase 1|14|Actual|Celgene||2|||f||||f||||||||||2017-10-11 01:30:38.352108|2017-10-11 01:30:38.352108
NCT01896310|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-05-09|||June 2013||2013-06-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy|New Classification of Gastric Pit Patterns and Vessel Architecture Using Probe-based Confocal Laser Endomicroscopy|Completed||N/A|272|Actual|Shandong University|||1||f||||t||||||Samples With DNA|"     endoscopic biopsies will be taken at suspicious lesions   "|||2017-10-11 01:30:38.440933|2017-10-11 01:30:38.440933
NCT01896297|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2016-10-07|2016-10-07||July 2013||2013-07-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||Treated set (TS) which included all enrolled patients who were eligible to enter the trial, who were dispensed trial medication and were documented to have taken at least one dose of trial drug.|Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function|A Prospective, Open Label Study to Evaluate the Pharmacokinetics of Dabigatran in Non-valvular Atrial Fibrillation (NVAF) Patients With Severely Impaired Renal Function on Dabigatran Etexilate 75 mg BID Therapy|Completed||Phase 4|63|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 01:30:38.534578|2017-10-11 01:30:38.534578
NCT01896284|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-10|||July 2013||2013-07-01|July 2013|2013-07-01|March 2015|Anticipated|2015-03-01|March 2014|Anticipated|2014-03-01||Interventional|MACBETH||Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor|Phase IV Study to Evaluate the Efficacy of Aflibercept in Subjects With Neovascular Age-related Macular Degeneration (wAMD), Without Optimal Response to Repeated Monthly Intravitreal Injections of Anti Vascular Endothelial Growth Factor (Anti VEGF-A) Therapy.|Unknown status|Not yet recruiting|Phase 4|43|Anticipated|Barcelona Macula Foundation||1|||f||||f||||||||||2017-10-11 01:30:38.783957|2017-10-11 01:30:38.783957
NCT01896271|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2015-03-19|||September 2013||2013-09-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|August 2016|Anticipated|2016-08-01||Interventional|||High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer|A Phase II Trial of High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy (SABR) for Patients With Metastatic Clear Cell Renal Cell Cancer (mRCC)|Recruiting||Phase 2|26|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 01:30:38.894126|2017-10-11 01:30:38.894126
NCT01896258|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-08|||September 2012||2012-09-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Observational|||A Nationwide Survey of Korean Emergency Department Triage Systems and Scales|A Nationwide Survey of Korean Emergency Department Triage Systems and Scales; a First Step Towards Korean Triage and Acuity Scale(KTAS)|Completed||N/A|136|Actual|Hanyang University|||2||f||||||||||||||2017-10-11 01:30:38.990915|2017-10-11 01:30:38.990915
NCT01896245|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2014-10-03|||July 2013||2013-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|SEVODosage||Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant)|Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant)|Completed||N/A|90|Actual|University of Rostock||3|||f||||f||||||||||2017-10-11 01:30:39.053583|2017-10-11 01:30:39.053583
NCT01896232|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2017-02-07|2017-02-07|2015-10-07|August 2013||2013-08-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Full Analysis Set (FAS), defined as all randomized participants.|Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet|A Multicenter, Multiple-dose, Two-arm, Active-controlled, Double-blind, Double-dummy Study to Compare the Therapeutic Efficacy and Safety of Oral Doses of Cinacalcet HCl With Intravenous Doses of AMG 416 in Hemodialysis Subjects With Secondary Hyperparathyroidism|Completed||Phase 3|683|Actual|Amgen||2|||f||||t||||||||||2017-10-11 01:30:39.215863|2017-10-11 01:30:39.215863
NCT01896219|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2016-03-29|||September 2013||2013-09-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||CTNAV II : Multicentric Evaluation of IMACTIS-CT Navigation System|Multicentric Evaluation of IMACTIS-CT Navigation System|Recruiting||N/A|464|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 01:30:41.577724|2017-10-11 01:30:41.577724
NCT01896193|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-05-07|2015-04-07||June 2013||2013-06-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug|Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection|A Phase 3b, Multicenter, Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naïve Adults With Genotype 1 and 3 Chronic HCV Infection.|Completed||Phase 3|127|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 01:30:41.883444|2017-10-11 01:30:41.883444
NCT01896180|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2014-09-29|||July 2013||2013-07-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost|A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost|Completed||Phase 2|63|Actual|Alleanza Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:30:42.617606|2017-10-11 01:30:42.617606
NCT01896167|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-02-11|||April 2013||2013-04-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia|Study of Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries by Hypoxia in a Humane Experimental Migraine Model|Completed||N/A|34|Actual|Danish Headache Center||2|||f||||f||||||||||2017-10-11 01:30:42.73055|2017-10-11 01:30:42.73055
NCT01896154|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-11-16|||August 2012||2012-08-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|August 2013|Actual|2013-08-01||Interventional|Fib-P-2012||Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity|A Randomized, Controlled Clinical Study on the Effect of Non-digestible Polysaccharides (NPS) on the Immune Response to Influenza Vaccination in Elderly|Completed||Phase 1/Phase 2|239|Actual|Clinical Research Center Kiel GmbH||6|||f||||f||||||||||2017-10-11 01:30:42.844086|2017-10-11 01:30:42.844086
NCT01896141|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2015-03-19|||July 2013||2013-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:30:42.981984|2017-10-11 01:30:42.981984
NCT01896128|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-07-25|||January 2008||2008-01-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke|Use of a Wakefulness-Promoting Agent (Armodafinil) Combined With Neuro-rehabilitation to Improve Neurological Recovery and to Reduce the Incidence of Disability in Patients Who Suffered a Stroke|Completed||Phase 2|19|Actual|Burke Rehabilitation Hospital||2|||f||||f||||||||||2017-10-11 01:30:43.042265|2017-10-11 01:30:43.042265
NCT01896115|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-12-22|2016-09-15||June 2013||2013-06-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CUSTOM-DBS||CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation|Current Steering to Optimize Deep Brain Stimulation|Completed||N/A|40|Actual|Boston Scientific Corporation||4|||f||||f||||||||||2017-10-11 01:30:43.165469|2017-10-11 01:30:43.165469
NCT01896089|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-08-31|||December 2013||2013-12-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01|24 Months|Observational [Patient Registry]|||Regional Kidney Paired Donor Exchange in Sensitized Patients|Prospective, Multicenter, Observational Registry Study to Determine if Enrollment in a Regional Kidney Paired Donor Exchange Program Improves the Overall Rate of Kidney Transplantation in Sensitized Patients, and Sensitized Patients Undergoing Desensitization Treatments.|Recruiting||N/A|100|Anticipated|BiologicTx, LLC|||1||f||||t||||||||||2017-10-11 01:30:43.780003|2017-10-11 01:30:43.780003
NCT01896076|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2014-07-24|||June 2013||2013-06-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Observational|||The Caudal Space in Children: Ultrasound Evaluation||Completed||N/A|300|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:30:43.881115|2017-10-11 01:30:43.881115
NCT01896063|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-08-17|||September 2011||2011-09-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional|||Sedative and Hypnotic Effects Induced by EA|EA Induces Sedative and Hypnotic Effects by Detecting BIS Value and MRI.|Completed||Phase 1|45|Actual|Xijing Hospital||1|||f||||t||||||||||2017-10-11 01:30:43.99217|2017-10-11 01:30:43.99217
NCT01896050|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2016-05-25|2016-03-03||September 2009||2009-09-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|LOGRIBMET||Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer|A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Third-generation Aromatase Inhibitors and Tamoxifen|Completed||N/A|115|Actual|University of Michigan Cancer Center|||2||f||||f||||||Samples With DNA|"     Whole blood is being collected at baseline for DNA extraction. Serum is being collected at     baseline and after 3, 6, and 12 months.   "|||2017-10-11 01:30:44.095515|2017-10-11 01:30:44.095515
NCT01896037|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-05-03|||July 2013|Actual|2013-07-01|May 2017|2017-05-01|March 28, 2017|Actual|2017-03-28|January 28, 2017|Actual|2017-01-28||Interventional|||Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels|Omega-3 Supplementation to Increase HDL-c Levels in Those With Tetraplegia|Completed||Phase 4|21|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 01:30:44.587146|2017-10-11 01:30:44.587146
NCT01896024|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2014-12-01|||June 2010||2010-06-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Interventional|MOTR||Effects of Motive-Oriented Therapeutic Relationship in the Early-Phase Treatment of Borderline Personality Disorder||Completed||N/A|85|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-11 01:30:44.695908|2017-10-11 01:30:44.695908
NCT01896011|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2016-10-27|||July 2013||2013-07-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures|Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures: a Randomized Controlled Trial|Recruiting||Phase 3|60|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:30:44.788854|2017-10-11 01:30:44.788854
NCT01895985|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-11-26|||July 2013||2013-07-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|KRONUS||Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers|A Single-Center, Open-Label Study Evaluating the Efficacy of Latanoprostene Bunod Ophthalmic Solution 0.024%, in Lowering Intraocular Pressure Over a 24-Hour Period in Japanese Healthy Male Volunteers|Completed||Phase 1|24|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 01:30:45.00026|2017-10-11 01:30:45.00026
NCT01895972|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-08-21|||July 2013||2013-07-01|August 2014|2014-08-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|JUPITER||A Study Evaluating the Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024%, in Japanese Subjects With Open-Angle Glaucoma or Ocular Hypertension|A Single-Arm, Multicenter, Open-Label Study Evaluating the Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024%, in Japanese Subjects With Open-Angle Glaucoma or Ocular Hypertension|Unknown status|Active, not recruiting|Phase 3|130|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 01:30:45.080698|2017-10-11 01:30:45.080698
NCT01895959|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-05-12|||August 2013||2013-08-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|||To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection|Quantifications of Biochemical Changes of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection Using Novel MRI (Magnetic Resonance Imaging) and NMR (Nuclear Magnetic Resonance) Techniques|Completed||Phase 4|12|Actual|University of California, San Francisco||1|||f||||f|f|t|f|||||||2017-10-11 01:30:45.158034|2017-10-11 01:30:45.158034
NCT01895946|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-04-19|2016-01-18||December 2013||2013-12-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|OAK||Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability|A Phase I, Open-Label, Multicentre Study to Compare Two Dosage Formulations of AZD5363 and to Establish the Effect of Food on the Pharmacokinetic Exposure, Safety and Tolerability of AZD5363 in Patients With Advanced Solid Malignancies|Completed||Phase 1|33|Actual|AstraZeneca|Small numbers of patients in the first (fasted) and second (fed) treatment periods overall make interpretation difficult.|2|||f||||f||||||||||2017-10-11 01:30:45.262908|2017-10-11 01:30:45.262908
NCT01895933|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-08|2013-07-21|||March 2012||2012-03-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel|The Aim of This Study is to Evaluate the Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel Made by D Med|Completed||Phase 1|33|Actual|D.med||2|||f||||t||||||||||2017-10-11 01:30:46.00957|2017-10-11 01:30:46.00957
NCT01895920|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-02-13|||January 2013|Actual|2013-01-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TRANSBioHIV||Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?||Completed||N/A|6|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-11 01:30:46.098785|2017-10-11 01:30:46.098785
NCT01895894|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2017-07-04|||September 2013|Actual|2013-09-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome|A Prospective, Randomized, Open-label Study Evaluating the Efficacy of Mycophenolate Mofetil in the Prevention of Relapse of Steroid Dependent Nephrotic Syndrome in Children|Completed||Phase 4|34|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:30:46.268285|2017-10-11 01:30:46.268285
NCT01895881|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-04-04|||April 2013||2013-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|EPPA||Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial|Estrogen Therapy as Prevention in the Progression of Aneurysm|Recruiting||Phase 2|26|Anticipated|Rush University Medical Center||2|||f||||f||||||||Undecided||2017-10-11 01:30:46.37577|2017-10-11 01:30:46.37577
NCT01895868|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-07|2014-04-04|||July 2013||2013-07-01|April 2014|2014-04-01||||April 2014|Actual|2014-04-01||Interventional|||Long-terms Effects of Simulation-based Ultrasound Training: A Randomized Trial||Completed||N/A|26|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:30:46.613295|2017-10-11 01:30:46.613295
NCT01895855|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2014-12-07|||September 2013||2013-09-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera|A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial of a Single Dose Live Oral Cholera Vaccine, PXVX0200 CVD 103-HgR, in Preventing Cholera Following Challenge With Vibrio Cholerae 10 Days or 3 Months After Vaccination|Completed||Phase 3|210|Actual|PaxVax, Inc.||2|||f||||t||||||||||2017-10-11 01:30:46.716971|2017-10-11 01:30:46.716971
NCT01895842|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-02-06|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)|Phase I Study of Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)|Active, not recruiting||Phase 1|31|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:30:46.801137|2017-10-11 01:30:46.801137
NCT01895829|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-05-15|||September 2013|Actual|2013-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI|Pilot Feasibility Study of Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI for Primary and Nodal Tumor Imaging in Locally Advanced Head and Neck Squamous Cell Carcinomas|Active, not recruiting||Early Phase 1|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:30:46.902697|2017-10-11 01:30:46.902697
NCT01895816|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-07-11|||June 2012||2012-06-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|(ZO2C5)||Herbal Tonic Fertile Supplement(ZO2C5)|Phase 3 of Study on Effects of New Herbal Mixture on Men Infertility|Completed||Phase 3|1|Actual|Islamic Azad University of Tabriz||1|||f||||t||||||||||2017-10-11 01:30:47.005734|2017-10-11 01:30:47.005734
NCT01895803|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-07|||July 2013||2013-07-01|June 2013|2013-06-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Observational|||The Factors That Inhibit Women Who Smoke to do Pap Smear Test|To Find Factors That Inhibit Women Who Smoke to do Pap Smear Test|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 01:30:47.104503|2017-10-11 01:30:47.104503
NCT01895790|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-03-02|||July 2014||2014-07-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer|Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients: A Prospective Pilot Study|Withdrawn||Phase 1/Phase 2|0|Actual|Johns Hopkins University||1||We could not find any candidate eligible for recruitment|f||||t||||||||||2017-10-11 01:30:47.191395|2017-10-11 01:30:47.191395
NCT01895777|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-10-03|||September 25, 2013|Actual|2013-09-25|October 2017|2017-10-01|June 29, 2018|Anticipated|2018-06-29|June 29, 2018|Anticipated|2018-06-29||Interventional|||Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)|Open-label, Randomized, Parallel-group, Active-controlled, Multi-centre Non-inferiority Study of Dabigatran Etexilate Versus Standard of Care for Venous Thromboembolism Treatment in Children From Birth to Less Than 18 Years of Age|Recruiting||Phase 3|180|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:30:47.319095|2017-10-11 01:30:47.319095
NCT01895764|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-09-28|||March 2013||2013-03-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|COMARIS||Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)|Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)|Completed||Phase 4|110|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 01:30:47.616275|2017-10-11 01:30:47.616275
NCT01895751|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-07-19|||April 2012||2012-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CABG-ACS||Conservative Non-Invasive Versus Routine Invasive Management in Coronary Artery Bypass Surgery Patients With Non ST Elevation Elevation Acute Coronary Syndrome|A Clinical Trial of Conservative Versus Routine Invasive Management in Patients With Prior Coronary Artery Bypass Surgery in Patients With a Non-ST Elevation Acute Coronary Syndrome: a Pilot Trial and Registry.|Completed||Phase 4|60|Actual|NHS National Waiting Times Centre Board||2|||f||||t||||||||||2017-10-11 01:30:47.727393|2017-10-11 01:30:47.727393
NCT01895738|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-06-01|||November 2013||2013-11-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||WrapAround Care for Youth Injured by Violence|WrapAround Care for Youth Injured by Violence: A Pilot Randomized Control Trial|Completed||N/A|133|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-11 01:30:47.839089|2017-10-11 01:30:47.839089
NCT01895725|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-09-27|||June 2013||2013-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin|Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin|Recruiting||N/A|600|Anticipated|Medical University Innsbruck|||1||f||||f||||||Samples With DNA|"     Plasma samples   "|||2017-10-11 01:30:47.936379|2017-10-11 01:30:47.936379
NCT01895712|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-09-26|||August 2013|Actual|2013-08-01|September 2017|2017-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||BIOFLOW-III Israel Satellite Registry|Safety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Canada|Completed||N/A|120|Actual|BIOTRONIK Israel|||1||f||||f||||||||||2017-10-11 01:30:48.035535|2017-10-11 01:30:48.035535
NCT01895699|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-08-11|||July 2013||2013-07-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Contrast Agent on Endothelial Function in Healthy Men|The Effect of Contrast Agent on Endothelial Function in Healthy Men|Completed||Phase 4|60|Actual|Wuhan General Hospital of Guangzhou Military Command||3|||f||||t||||||||||2017-10-11 01:30:48.162062|2017-10-11 01:30:48.162062
NCT01895686|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-11-02|||November 2011||2011-11-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Observational|ASOCT||Comparison of Gonioscopy With Cirrus and Visante|Comparison of Visante and Cirrus Optical Coherent Tomography for Assessment of the Anterior Segment|Completed||N/A|54|Actual|Wills Eye|||3||f||||f||||||||Yes|A manuscript has been published in the Journal of Glaucoma.|2017-10-11 01:30:48.259129|2017-10-11 01:30:48.259129
NCT01895673|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-12-14|||June 2013||2013-06-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||PET-MRI After Radiofrequency Ablation (RFA) or Microwave Ablation (MWA)|The Use of PET-MRI in the Follow-up of RFA and MWA Treated Colorectal Liver Metastases|Completed||N/A|20|Actual|VU University Medical Center|||1||f||||t||||||||||2017-10-11 01:30:48.389915|2017-10-11 01:30:48.389915
NCT01895660|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-11-02|||April 2013||2013-04-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|CHAMP||Children With Hemiparesis Arm and Hand Movement Project (CHAMP Study)|A Multisite Trial of Pediatric Constraint-Induced Movement Therapy|Recruiting||Phase 2|135|Anticipated|Virginia Polytechnic Institute and State University||5|||f||||f||||||||||2017-10-11 01:30:48.513534|2017-10-11 01:30:48.513534
NCT01895634|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-02-04|2016-01-06||May 2013||2013-05-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)|Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)|Completed||N/A|49|Actual|Johnson & Johnson K.K. Medical Company||1|||f||||f||||||||||2017-10-11 01:30:48.727476|2017-10-11 01:30:48.727476
NCT01895621|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-06-23|||March 2013||2013-03-01|January 2015|2015-01-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial.|The Association of Alpha Lipoic Acid to the Median Nerve Decompression in the Carpal Tunnel Syndrome: a Randomized Controlled Trial.|Completed||Phase 4|64|Actual|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-11 01:30:49.066668|2017-10-11 01:30:49.066668
NCT01895582|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-02-27|||July 17, 2013|Actual|2013-07-17|February 2017|2017-02-01|March 17, 2019|Anticipated|2019-03-17|March 17, 2019|Anticipated|2019-03-17||Observational|IGRage||Performance of IGRAs for TB Infection Diagnosis in Elderly|Mycobacterium Tuberculosis Infection Diagnosis in Patients Above 75 Years Old/ Performance of Interferon Gamma Releasing Assays (IGRA)|Recruiting||N/A|160|Anticipated|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 01:30:50.139769|2017-10-11 01:30:50.139769
NCT01895569|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2013-07-03|||June 2013||2013-06-01|July 2013|2013-07-01|June 2016|Anticipated|2016-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Triple Therapy in Type 2 Diabetic Patients|Effects on Glycemic Variability and Glyco-metabolic Control of Metformin, Pioglitazone and Sitagliptin in Type 2 Diabetic Patients|Unknown status|Recruiting|Phase 4|64|Anticipated|University of Pavia||1|||f||||f||||||||||2017-10-11 01:30:50.28601|2017-10-11 01:30:50.28601
NCT01895556|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2013-07-03|||August 2008||2008-08-01|July 2013|2013-07-01||||December 2009|Actual|2009-12-01||Interventional|||Information About HIV Transmission and Circumcision on Subsequent Sexual Behavior, and the Demand for Circumcision|A Study of the Effect of Information About the Relationship Between HIV Transmission and Circumcision on Subsequent Sexual Behavior, and the Demand for Circumcision Among Circumcised and Uncircumcised Men in Malawi, Africa.|Completed||N/A|1200|Actual|University of Michigan||2|||f||||||||||||||2017-10-11 01:30:50.428074|2017-10-11 01:30:50.428074
NCT01895543|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-04-29|2015-10-08||September 2013||2013-09-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation|A Multicenter, Open-label, Safety and Tolerability Extension Trial of 5 mg and 10 mg Elobixibat Daily in the Treatment of Chronic Idiopathic Constipation|Completed||Phase 3|411|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:30:50.551433|2017-10-11 01:30:50.551433
NCT01895530|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2013-07-05|||July 2010||2010-07-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|August 2011|Actual|2011-08-01||Interventional|||Impact of Probiotics in Modulation of Intestinal Microbiota|Impact of Probiotics in Modulation of Intestinal Microbiota of Patients Undergoing a Resection Colonic|Completed||N/A|33|Actual|Federal University of Minas Gerais||2|||f||||t||||||||||2017-10-11 01:30:51.641011|2017-10-11 01:30:51.641011
NCT01895517|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-08-02|||June 2013||2013-06-01|August 2016|2016-08-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）|Randomized Controlled Trial to Evaluate the Efficacy of Concurrent Liquid-based Cytology ( LBC) and HPV DNA Testing Versus LBC Alone for the Primary Cervical Cancer Screening|Active, not recruiting||Phase 4|18471|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||f||||||||||2017-10-11 01:30:51.768983|2017-10-11 01:30:51.768983
NCT01895504|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-03-02|||April 2013||2013-04-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||ColoAssist vs. MEI|ColoAssist vs. Magnetic Guided Colonoscopy - a Randomized Controlled Trial|Completed||N/A|475|Actual|Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-11 01:30:51.885651|2017-10-11 01:30:51.885651
NCT01895491|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2015-01-20|||March 2011||2011-03-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|VM206RY||Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer|An Open-Label, Uncontrolled, Single Center, Phase I Trial to Assess the Safety of VM206RY in Subjects With Expression of Her2 in Breast Cancer|Completed||Phase 1|9|Actual|Reyon Pharmaceutical Co., Ltd.||3|||f||||t||||||||||2017-10-11 01:30:52.023295|2017-10-11 01:30:52.023295
NCT01895478|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-09|||April 2011||2011-04-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Adaptation of the Pediatric Asthma Control & Communication Instrument (PACCI) in a Pediatric Emergency Department||Completed||N/A|77|Actual|Rhode Island Hospital||2|||f||||f||||||||||2017-10-11 01:30:52.131669|2017-10-11 01:30:52.131669
NCT01895465|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-07-22|||August 2013||2013-08-01|July 2013|2013-07-01|July 2015|Anticipated|2015-07-01|August 2014|Anticipated|2014-08-01||Interventional|0244-12-RMC||Improvement in Urine Collection Methods in Children|Improvement in Urine Collection Methods in Children|Unknown status|Not yet recruiting|N/A|150|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 01:30:52.234799|2017-10-11 01:30:52.234799
NCT01895452|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-07-25|2017-06-22||July 2013||2013-07-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional||Safety population includes all subjects who received at least 1 dose of ALKS 9072 in the current study.|An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)|A Phase 3, Multicenter Extension of Study ALK9072-003EXT to Assess the Long-term Safety and Durability of Effect of ALKS 9072 in Subjects With Stable Schizophrenia|Completed||Phase 3|291|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-10-11 01:30:52.36122|2017-10-11 01:30:52.36122
NCT01895439|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-05-01|||October 2012||2012-10-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis|Phase II Study: Use of Autologus Mesenchymal Stem Cells in Multiple Sclerosis Patients Who do Not Respond to Conventional Treatment|Completed||Phase 1/Phase 2|13|Actual|University of Jordan||1|||f||||f||||||||||2017-10-11 01:30:53.279183|2017-10-11 01:30:53.279183
NCT01895426|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2017-03-21|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Observational|ArcadiusXPLPMS||ArcadiusXP L Post Market Clinical Follow-Up|Clinical Follow-up of the ArcadiusXP L Stand Alone Intervertebral Body Fusion Device|Completed||N/A|32|Actual|Aesculap AG|||1||f||||f||||||||||2017-10-11 01:30:53.385499|2017-10-11 01:30:53.385499
NCT01895413|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-10|||September 2012||2012-09-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair|Autologous Bone Marrow-derived Mesenchymal Stem Cells Used in the Treatment of Articular Cartilage Injury|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Pontifícia Universidade Católica do Paraná||1|||f||||f||||||||||2017-10-11 01:30:53.472025|2017-10-11 01:30:53.472025
NCT01895400|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-05|2016-02-14|||July 2013||2013-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|REREV||Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy|A Single-center, Prospective, Randomized, Parallel Group, Placebo-controlled Exploratory Study on the Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy|Terminated||Phase 3|26|Actual|Asan Medical Center||2||Participant enrollment is much delayed. The whole design needs to be revised.|f||||f||||||||Undecided|This study is decided to be terminated. Among 26 participants, 15 finished medication according to the protocol. I am not sure that these data can be analyzed because data is still unblinded.|2017-10-11 01:30:53.5963|2017-10-11 01:30:53.5963
NCT01895387|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-07-04|||January 2012||2012-01-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes|Replacing With Whole Grains and Legumes Reduces Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activities in Plasma and Peripheral Blood Mononuclear Cells in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes|Completed||N/A|100|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:30:53.707788|2017-10-11 01:30:53.707788
NCT01895374|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-07-03|||July 2012||2012-07-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Clinical Efficacy of Bovine Freeze-dried Amniotic Membrane on Wound Healing in Laser Treatment|A Comparison of the Effects of Bovine Freeze-dried Amniotic Membrane and Hydrocolloid on Epithelialization After Laser Treatments|Completed||N/A|51|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:30:53.797225|2017-10-11 01:30:53.797225
NCT01895361|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-09-28|||July 2013||2013-07-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SUSTAIN||Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises|A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Sickle Cell-Related Pain Crises|Completed||Phase 2|198|Actual|Reprixys Pharmaceutical Corporation||3|||f||||t||||||||||2017-10-11 01:30:53.917579|2017-10-11 01:30:53.917579
NCT01895348|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-08-16|||July 2012||2012-07-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Comparison of Surgical Outcome Following Drug-induced Sleep Endoscopic Diagnosis Using Propofol or Dexmedetomidine for Sedation : A Prospective Randomized Trial||Completed||Phase 4|60|Actual|Yonsei University||3|||f||||||||||||||2017-10-11 01:30:54.220933|2017-10-11 01:30:54.220933
NCT01895335|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-10-10|2016-10-10||June 2013||2013-06-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|TERI-PRO|Baseline population included all treated participants.|Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients|A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients|Completed||Phase 4|1001|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:30:54.339743|2017-10-11 01:30:54.339743
NCT01895322|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-11-30|2015-08-21||July 2013||2013-07-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis|A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis|Completed||Phase 2|20|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 01:30:57.046715|2017-10-11 01:30:57.046715
NCT01895309|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-07-10|2016-07-13||June 2013||2013-06-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|April 2014|Actual|2014-04-01||Interventional|||A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy|A Randomised, Double-blind, Parallel Group, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity of SB4 Compared to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 3|596|Actual|Samsung Bioepis Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:30:57.423116|2017-10-11 01:30:57.423116
NCT01895296|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-04|||September 2008||2008-09-01|July 2013|2013-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|CSOM230BBE01T||Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome|Exploratory Randomized, Placebo-controlled Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome|Completed||Phase 2|9|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 01:30:58.725584|2017-10-11 01:30:58.725584
NCT01895283|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-04-04|||September 2013||2013-09-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Aerobic Exercise, on Fitness and Functional Muscle Strength, in Patients With Muscular Dystrophy|The Effect of a Bike Ergometer Training Program in Patients With Bethlem Myopathy|Completed||N/A|7|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 01:30:58.814019|2017-10-11 01:30:58.814019
NCT01895270|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-05-02|2017-05-02||October 2013||2013-10-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||These numbers refer to those that actually started the clinical trial proper.|Improving Buprenorphine Detoxification Outcomes With Isradipine|Improving Buprenorphine Detoxification Outcomes With Isradipine|Completed||Phase 1/Phase 2|28|Actual|University of Arkansas|Results are limited by the high dropout rate. Because opioid dependent individuals tend to have relatively low pressure, the feasibility of using an immediate-formulation of a calcium channel blocker is unclear.|2|||f||||f||||||||||2017-10-11 01:30:58.908056|2017-10-11 01:30:58.908056
NCT01895257|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-07-06|||August 2013||2013-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer|A Randomised Phase III Trial Comparing Hepatic Arterial Injection of Yttrium-90 Resin Microspheres (SIR-spheres) Plus Systemic Maintenance Therapy Versus Systemic Maintenance Therapy Alone for Patients With Unresectable Liver Metastases From Colorectal Cancer Which Are Controlled After Induction Systemic Therapy|Recruiting||Phase 3|162|Anticipated|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-11 01:30:59.50608|2017-10-11 01:30:59.50608
NCT01895244|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-10-24|||September 2012||2012-09-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|AST-MOMA||Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis|Highdose Chemotherapy and Transplantation of 34+ Selected Stem Cell for Progressive Systemic Sclerosis - Modification According to Manifestation|Recruiting||Phase 2|44|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-11 01:30:59.647971|2017-10-11 01:30:59.647971
NCT01895231|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-03-01|||June 2013||2013-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors|A Randomized, Prospective, Double-Blind, Comparative Placebo-Controlled Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-Deficient Blood Donors|Recruiting||Phase 3|100|Anticipated|Pharmacosmos A/S||2|||f||||f||||||||||2017-10-11 01:30:59.742861|2017-10-11 01:30:59.742861
NCT01895218|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-04-28|||June 2013||2013-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PP-01||Treatment of Women After Postpartum Haemorrhage|A, Randomized Comparative, Open-Label Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by High Single Dose In-fusions or Standard Medical Care in Women After Postpartum Haemorrhage|Completed||Phase 3|200|Actual|Pharmacosmos A/S||2|||f||||f||||||||||2017-10-11 01:30:59.85555|2017-10-11 01:30:59.85555
NCT01895205|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-08-18|||June 2013||2013-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|PP-02||Treatment of Women After Severe Postpartum Haemorrhage|A Randomized Comparative, Open-Label Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by High Single Dose In-fusions or Red Blood Cell Transfusion in Women With Severe Postpartum Iron Deficiency Anaemia|Completed||Phase 3|13|Actual|Pharmacosmos A/S||2|||f||||f||||||||||2017-10-11 01:30:59.959323|2017-10-11 01:30:59.959323
NCT01895192|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-07-04|||October 2011||2011-10-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|FERTIFORT||Sperm Morphology by High Magnification in Fertility Men|Assessment of Sperm Morphology by High Magnification (x6000) With Interference Contrast Microscopy in Fertile Men.|Completed||N/A|54|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-11 01:31:00.08811|2017-10-11 01:31:00.08811
NCT01895179|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-08-15|||July 2013||2013-07-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TIMED EATING||Comparison of Time-Restricted Feeding Versus Grazing|Time-Restricted Feeding to Improve Glucose Tolerance and Vascular Condition|Completed||N/A|8|Actual|Pennington Biomedical Research Center||2|||f||||||||||||||2017-10-11 01:31:00.187301|2017-10-11 01:31:00.187301
NCT01895166|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-07-30|||July 2013||2013-07-01|July 2013|2013-07-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||EBUS-GS-TBLB With or Without Fluoroscopy for the Diagnosis of PPLs|Diagnostic Value of Endobronchial Ultrasound(EBUS) With a Guide Sheath(GS) for Peripheral Pulmonary Lesions(PPLs) Without Fluoroscopy: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|100|Anticipated|Shanghai Chest Hospital||2|||f||||t||||||||||2017-10-11 01:31:00.278806|2017-10-11 01:31:00.278806
NCT01895153|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-02-12|||April 2012||2012-04-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome|The Efficacy of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy in Patients With Bladder Pain Syndrome|Unknown status|Recruiting|Phase 4|72|Anticipated|Samsung Medical Center|||3||f||||f||||||||||2017-10-11 01:31:00.382663|2017-10-11 01:31:00.382663
NCT01895140|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-10-10|||October 2013||2013-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PaCE||A Study of Renal Denervation in Patients With Treatment Resistant Hypertension|A Pragmatic Randomized Clinical Evaluation of Renal Denervation for Treatment Resistant Hypertension|Terminated||N/A|8|Actual|Sunnybrook Health Sciences Centre||2||Manufacturer updated device technology.|f||||t||||||||||2017-10-11 01:31:00.483731|2017-10-11 01:31:00.483731
NCT01895127|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-08-24|2017-07-17||November 2013||2013-11-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation|Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation.|Terminated||Phase 2|11|Actual|Brigham and Women's Hospital||2||Lack of efficacy|f||||t||||||||||2017-10-11 01:31:00.595156|2017-10-11 01:31:00.595156
NCT01895114|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-07-27|||December 2010||2010-12-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Assessment of Renal Function in Cirrhotic Patients|Assessment of Renal Function in Cirrhotic Patients -A Comparison of Cystatin C and Creatinine Based Calculations to 125I-iothalamate|Unknown status|Recruiting|N/A|200|Anticipated|Baylor Research Institute|||1||f||||t||||||||||2017-10-11 01:31:01.030786|2017-10-11 01:31:01.030786
NCT01895101|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-05-01|2015-03-30||October 2013||2013-10-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients|The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients: a Randomized Placebo-controlled Trial|Completed||Phase 4|750|Actual|Amphia Hospital||3|||f||||t||||||||||2017-10-11 01:31:01.132812|2017-10-11 01:31:01.132812
NCT01895088|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-07-06|2017-04-03||May 2011||2011-05-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|||A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A|A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A|Completed||N/A|271|Actual|AcuFocus, Inc.||1|||f||||t||||||||||2017-10-11 01:31:01.638722|2017-10-11 01:31:01.638722
NCT01895075|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-04-24|||January 1, 2018|Anticipated|2018-01-01|April 2017|2017-04-01|September 1, 2019|Anticipated|2019-09-01|July 1, 2019|Anticipated|2019-07-01||Interventional|||Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study|Evaluation of the Effectiveness of Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study|Not yet recruiting||Phase 2|50|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t|f|f|||f|||No||2017-10-11 01:31:01.944305|2017-10-11 01:31:01.944305
NCT01895062|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2014-07-11|2014-03-04||March 2013||2013-03-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||The number of participants in the cNEP group was estimated from the number required to show a 50% decrease in the primary endpoint compared to the no intervention group.|Effectiveness of Continuous Negative External Pressure in Preventing Upper Airway Impairment During Routine Colonoscopy|Effectiveness and Safety of Continuous Negative External Pressure (cNEP) in Preventing Sedation-Related Respiratory Impairment in Adults Undergoing Colonoscopy|Completed||Phase 1/Phase 2|54|Actual|5i Sciences, Inc.||2|||f||||f||||||||||2017-10-11 01:31:02.190597|2017-10-11 01:31:02.190597
NCT01895049|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-08-11|||August 2013||2013-08-01|August 2017|2017-08-01|March 7, 2017|Actual|2017-03-07|March 2016|Actual|2016-03-01||Interventional|||Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria||Completed||Phase 4|171|Actual|Hospital do Rim e Hipertensão||2|||f||||||||||||||2017-10-11 01:31:02.494191|2017-10-11 01:31:02.494191
NCT01895036|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-08-07|2017-08-07||February 2011||2011-02-01|August 2017|2017-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Nalrexone Facilitated Discontinuation of Buprenorphine||Completed||Phase 1/Phase 2|6|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 01:31:02.596174|2017-10-11 01:31:02.596174
NCT01895023|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-01-02|||September 2013||2013-09-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Dexmedetomidine Premedication on Emergence Agitation After Strabismus Surgery in Children|Dexmedetomidine Versus Midazolam Premedication on Emergence Agitation After Strabismus Surgery in Children|Completed||Phase 4|156|Actual|Fujian Provincial Hospital||3|||f||||f||||||||||2017-10-11 01:31:02.793266|2017-10-11 01:31:02.793266
NCT01895010|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-07-09|||June 2013||2013-06-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE|Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE|Unknown status|Recruiting|Phase 2|74|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 01:31:02.88796|2017-10-11 01:31:02.88796
NCT01894997|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-09-02|||January 2014||2014-01-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Blood Flow in the Lower Limb|A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Lower Limb Haemodynamics|Completed||N/A|30|Actual|National University of Ireland, Galway, Ireland||1|||f||||f||||||||||2017-10-11 01:31:02.998341|2017-10-11 01:31:02.998341
NCT01894984|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2014-04-22|2013-09-05||January 2007||2007-01-01|April 2014|2014-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational||"N (number of participants analyzed) signifies the participants evaluable for this measure."|An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia|Clinical Observation of the Efficacy and Safety of Risperidone Long-Acting Injection (Risperdal Consta) in the Treatment of Schizophrenia in China|Terminated||Phase 4|640|Actual|Xian-Janssen Pharmaceutical Ltd.|||2|The study was terminated because of high dropout rate.|f||||f||||||||||2017-10-11 01:31:03.10572|2017-10-11 01:31:03.10572
NCT01894971|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-04-09|||November 2012||2012-11-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Ligasure® to Destroy Cornual Portion of Fallopian Tube|The Effect of Thermal Damage of Ligasure® to Destroy Cornual Portion of Fallopian Tube Tissue|Completed||Phase 3|40|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 01:31:03.570291|2017-10-11 01:31:03.570291
NCT01894958|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-03-27|||January 2014||2014-01-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome|A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome|Completed||Phase 2|72|Actual|Neuren Pharmaceuticals Limited||2|||f||||t||||||||||2017-10-11 01:31:03.673181|2017-10-11 01:31:03.673181
NCT01894945|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-07-09|||March 2012||2012-03-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|February 2014|Anticipated|2014-02-01||Observational|||Dual Time Point PET in Lymphoma||Unknown status|Recruiting|N/A|30|Anticipated|Odense University Hospital|||1||f||||f||||||||||2017-10-11 01:31:03.823786|2017-10-11 01:31:03.823786
NCT01894932|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-08-12|||April 2011||2011-04-01|July 2013|2013-07-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Interventional|||MBCGT and Psycho-physiological Stress Regulation Group for Depression and Psycho-physiological Stress Patient|Mindfulness-based Cognitive Group Therapy (MBCGT) and Psycho-physiological Stress Regulation Group for Depression and Psycho-physiological Stress Patient: An Outcome Study|Unknown status|Enrolling by invitation|N/A|150|Anticipated|National Taiwan University Hospital||6|||f||||f||||||||||2017-10-11 01:31:03.905138|2017-10-11 01:31:03.905138
NCT01894906|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-01-28|2014-12-16||July 2013||2013-07-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||No prospective calculations of statistical power were made. The sample size of 12 subjects (N = 6 for each of 2 dialysis membrane groups) was selected to provide information on safety and to provide preliminary data for assessing the variance of iron delivery under different, pre-specified dialysis conditions.|Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients|A Controlled, Randomized Study to Assess the Quantitative Mass Transfer of Iron From SFP-containing Hemodialysate Under Varying Conditions of Blood and Dialysate Flow Rates, Dialyzer Membrane Types and Dialysate Bicarbonate Concentrations in CKD-HD Patients.|Completed||Phase 1/Phase 2|12|Actual|Rockwell Medical Technologies, Inc.|Total iron, TBI, NTBI, and UIBC could not be measured because the ferrozine assay for total iron and transferrin-bound iron was unreliable due to the presence of heparin in the samples, which caused the formation of fibrin strands.|2|||f||||f||||||||||2017-10-11 01:31:04.219285|2017-10-11 01:31:04.219285
NCT01894893|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-01-04|||December 2012||2012-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Atlas of Human Milk Nutrients|Atlas of Human Milk Nutrients|Completed||N/A|370|Actual|Nestlé|||1||f||||f||||||Samples With DNA|"     1. Mother milk        2. Umbilical cord blood        3. Mother blood        4. Adipose tissue   "|||2017-10-11 01:31:05.117482|2017-10-11 01:31:05.117482
NCT01894880|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-04-21|||July 2013||2013-07-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|SSC||Pilot Study: Sectio Bonding/Early Skin-to-skin Contact (SSC) After Caesarean Section|Pilot Study: Sectio Bonding/Early Skin-to-skin Contact (SSC) After Caesarean Section|Completed||N/A|35|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 01:31:05.223502|2017-10-11 01:31:05.223502
NCT01894867|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-07-11|||August 2013||2013-08-01|June 2013|2013-06-01||||April 2014|Anticipated|2014-04-01||Interventional|||Magnesium in Liver Cirrhosis|Magnesium Deficiency in Cirrhotic Patients|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Meir Medical Center||2|||f||||||||||||||2017-10-11 01:31:05.307231|2017-10-11 01:31:05.307231
NCT01894646|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-08-16|||February 2013||2013-02-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA|PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA|Recruiting||N/A|60|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 01:31:07.935986|2017-10-11 01:31:07.935986
NCT01894854|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-05-27|||October 2012||2012-10-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|July 2013|Actual|2013-07-01||Interventional|||RSA Study of Furlong Evolution With and Without Collar|Evaluation of the Furlong Evolution Uncemented Hip Prosthesis With Special Emphasize on the Use of Collared Design or Not. A Prospective, Randomized Study Evaluated by RadioStereometric Analysis (RSA) and DXA.|Active, not recruiting||N/A|50|Anticipated|Region Skane||2|||f||||f||||||||No||2017-10-11 01:31:05.415751|2017-10-11 01:31:05.415751
NCT01894841|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-06-08|||February 24, 2014|Actual|2014-02-24|June 2017|2017-06-01|March 30, 2018|Anticipated|2018-03-30|August 31, 2017|Anticipated|2017-08-31||Interventional|CLASP-VA||Veterans Coping Long-term With Active Suicide|Veterans Coping Long-Term With Suicide|Recruiting||N/A|300|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 01:31:05.498736|2017-10-11 01:31:05.498736
NCT01894828|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-07-09|||April 2011||2011-04-01|July 2013|2013-07-01||||August 2013|Anticipated|2013-08-01||Interventional|||Nutritional Supplementation in Patients With no Signs of Malnutrition|The Effect of Nutritional Supplementation in Cancer Patients With no Clinical Signs of Malnutrition|Unknown status|Recruiting|Phase 4|200|Anticipated|MedSource Polska||2|||f||||t||||||||||2017-10-11 01:31:05.585809|2017-10-11 01:31:05.585809
NCT01894815|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-12-01|||October 2013||2013-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|ELECT-TDCS||Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial|Escitalopram and Transcranial Direct Current Stimulation in Major Depressive Disorder: a Double-blind, Placebo-controlled, Randomized, Non-inferiority Trial|Completed||Phase 3|245|Actual|University of Sao Paulo||3|||f||||t||||||||No||2017-10-11 01:31:05.704638|2017-10-11 01:31:05.704638
NCT01894802|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-07-24|||December 2013||2013-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|CRS-BMI||Cortical Recording and Stimulating Array Brain-Machine Interface|A Sensorimotor Microelectrode Brain-Machine Interface for Individuals With Tetraplegia|Recruiting||N/A|5|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 01:31:05.988665|2017-10-11 01:31:05.988665
NCT01894789|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-04-21|||March 2013||2013-03-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PATH||Ticagrelor vs Clopidogrel Effect on MFR in CAD Population|ComPArison of the Effect of Ticagrelor Versus Clopidogrel on Myocardial Blood Flow (MBF) and Reserve (MBFR) Measured With Positron Emission TomograpHy (PET) in Patients With Coronary Artery Disease (CAD): The PATH Study|Completed||Phase 2/Phase 3|36|Actual|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 01:31:06.115114|2017-10-11 01:31:06.115114
NCT01894776|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-03-02|||June 2013||2013-06-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|December 2013|Actual|2013-12-01||Interventional|RIFAMARA||A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc|A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc|Completed||Phase 1|15|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-11 01:31:06.237438|2017-10-11 01:31:06.237438
NCT01894763|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-04|||September 2003||2003-09-01|July 2013|2013-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia|Randomized, Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia|Completed||Phase 1|100|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:31:06.842583|2017-10-11 01:31:06.842583
NCT01894750|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-04-14|||June 2010||2010-06-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Building Skill in Heart Failure Self-care: A Community Based Intervention|Building Skill in Heart Failure Self-Care: A Community Based Intervention|Completed||Phase 1/Phase 2|75|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 01:31:06.982581|2017-10-11 01:31:06.982581
NCT01894737|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-08-28|||October 2013||2013-10-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|CML||The Effect of Creatine on Muscle Loss|The Effect of Creatine Supplementation on Muscle Loss During Immobilisation|Completed||N/A|30|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 01:31:07.092922|2017-10-11 01:31:07.092922
NCT01894724|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2015-04-15|||February 2014||2014-02-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Targeted Hypothermia During Cardiac Surgery|Targeted Cerebral Hypothermia During Cardiac Surgery: A Feasibility Trial|Completed||Phase 1|5|Actual|NeuroSave Inc.||1|||f||||f||||||||||2017-10-11 01:31:07.189905|2017-10-11 01:31:07.189905
NCT01894711|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-09|||May 2010||2010-05-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Observational|||Real World Efficiency of Trastuzumab in Early Breast Cancer|Real-world Use and (Cost)-Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer|Completed||N/A|2684|Actual|Maastricht University Medical Center|||1||f||||t||||||||||2017-10-11 01:31:07.284517|2017-10-11 01:31:07.284517
NCT01894698|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-02-22|||August 2013||2013-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:31:07.371673|2017-10-11 01:31:07.371673
NCT01894685|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-12-06|||July 2012||2012-07-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Mesalazine Effects in Sporadic Colorectal Adenoma Patients|Chemopreventive Effects of Mesalazine in Patients at High Risk of Recurrent (Nonfamilial) Colorectal Adenomas|Completed||Phase 2|74|Actual|UMC Utrecht||2|||f||||t||||||||||2017-10-11 01:31:07.424307|2017-10-11 01:31:07.424307
NCT01894672|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-07-21|2017-03-14||July 2013||2013-07-01|May 2017|2017-05-01|March 17, 2016|Actual|2016-03-17|March 17, 2016|Actual|2016-03-17||Interventional|||BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation|A Phase 2 Trial of the BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation|Completed||Phase 2|7|Actual|Memorial Sloan Kettering Cancer Center|The protocol was stopped after 7 participants were accrued due to intolerable toxicities.|1|||f||||||||||||||2017-10-11 01:31:07.546035|2017-10-11 01:31:07.546035
NCT01894659|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-07-06|||February 2014||2014-02-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Oral Sucrose Versus Glucose for Procedural Pain in Premature Neonates|Oral Sucrose Versus Glucose for Procedural Pain in Premature Neonates|Recruiting||N/A|93|Anticipated|Loma Linda University||3|||f||||t||||||||||2017-10-11 01:31:07.837654|2017-10-11 01:31:07.837654
NCT01894633|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2017-03-02|||May 2011||2011-05-01|March 2017|2017-03-01|January 2013|Actual|2013-01-01|April 2012|Actual|2012-04-01||Interventional|CLQ||Study of Whole-brain Irradiation With Chloroquine for Brain Metastases|Phase II Randomized, Double Blind, Placebo Controlled Study of Whole-brain Irradiation With Concomitant Daily-dose Chloroquine for Brain Metastases.|Terminated||Phase 2|73|Actual|Instituto Nacional de Cancerologia de Mexico||2||terminated|f||||f||||||||||2017-10-11 01:31:08.025519|2017-10-11 01:31:08.025519
NCT01894607|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-03-15|2016-02-17||October 2013||2013-10-01|March 2016|2016-03-01||||December 2014|Actual|2014-12-01||Interventional|||Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy|Feasibility Study of Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy|Completed||N/A|11|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:31:08.263694|2017-10-11 01:31:08.263694
NCT01894594|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-06-14|||June 2013||2013-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease|Alkali Therapy in Subjects With Sickle Cell Disease (SCD) - Evaluation of Efficacy, Safety, and Beneficial Effects|Recruiting||Phase 1|15|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||f||||||||No||2017-10-11 01:31:08.474333|2017-10-11 01:31:08.474333
NCT01894581|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-12-08|2016-06-02||July 2014||2014-07-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women|Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women|Completed||N/A|39|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:31:08.626844|2017-10-11 01:31:08.626844
NCT01894568|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-09-03||2015-09-03|July 2013||2013-07-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study Comparing LY2605541 With Insulin Glargine as Basal Insulin Treatment|A Phase 3, Open Label, Randomized, Parallel, 26 Week Treatment Study Comparing LY2605541 With Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti Hyperglycemia Medications in Asian Insulin Naïve Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|392|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:31:08.934789|2017-10-11 01:31:08.934789
NCT01894555|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-11-10|2016-08-01||January 2013||2013-01-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PARes-II||Pharmacogenomics of Antiplatelet Response - II (PARes-II)|Pharmacogenomics of Antiplatelet Response - II|Completed||Phase 4|33|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:31:09.10896|2017-10-11 01:31:09.10896
NCT01894542|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-10-25|||August 2013||2013-08-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|FISK4||A Study of the Effects of Intake of Two Cod Protein Fractions on Glucose Homeostasis and Inflammation in Overweight and Obese Adults|An 8 Week Study to Compare the Effects of Water Soluble and Non-water Soluble Cod Proteins on Glucose Homeostasis and Inflammatory Markers in Overweight and Obese Adults|Active, not recruiting||N/A|100|Anticipated|University of Bergen||4|||f||||f||||||||||2017-10-11 01:31:09.320546|2017-10-11 01:31:09.320546
NCT01894529|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2015-04-28|||January 2010||2010-01-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Immunological Biomarkers in Patients With Acute Ischemic Stroke|Clinical Implications of a Panel of Immunological Biomarkers in Patients With Acute Ischemic Stroke|Completed||N/A|132|Actual|Hospital Clinic of Barcelona|||2||f||||f||||||Samples Without DNA|"     Whole blood, serum and plasma.   "|||2017-10-11 01:31:09.417722|2017-10-11 01:31:09.417722
NCT01894516|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-04-18||2016-04-18|July 2013||2013-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Patients (DARWIN2)|Randomized, Double-blind, Placebo-controlled, Multicenter, Phase IIb Dose Finding Study of GLPG0634 Administered for 24 Weeks as Monotherapy to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate (MTX) Alone|Completed||Phase 2|287|Actual|Galapagos NV||4|||f||||t||||||||||2017-10-11 01:31:09.548132|2017-10-11 01:31:09.548132
NCT01894503|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-03-13||2015-03-19|June 2013||2013-06-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|S8PK||Safety and Performance of the Steroid-Releasing S8 Sinus Implant|A Clinical Evaluation of the Safety and Performance of the Steroid-Releasing S8 Sinus Implant When Used in Post-Sinus Surgery Patients With Recurrent Sinus Polyps|Completed||Phase 2|5|Actual|Intersect ENT||1|||f||||t||||||||No|No plan|2017-10-11 01:31:09.853752|2017-10-11 01:31:09.853752
NCT01894490|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2013-07-09|||January 2008||2008-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|||Randomized Clinical Trial: Nasoenteric Catheter or Jejunostomy|Randomized Clinical Trial: Nasoenteric Catheter or Jejunostomy as a Route For Nutrition After Major Upper Gastrointestinal Operations|Completed||N/A|50|Actual|Federal University of Minas Gerais|||2||f||||f||||||||||2017-10-11 01:31:09.956561|2017-10-11 01:31:09.956561
NCT01894477|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-10-03|||November 2013||2013-11-01|October 2017|2017-10-01|January 2022|Anticipated|2022-01-01|January 9, 2017|Actual|2017-01-09||Interventional|||Treosulfan, Fludarabine Phosphate, and Total Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia|A Randomized Phase II Study of Treosulfan, Fludarabine and Low-Dose TBI as Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 2|102|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-11 01:31:10.051236|2017-10-11 01:31:10.051236
NCT01894464|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-03-07|||August 2013||2013-08-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Interventional|ETPP||The Early Truancy Prevention Project|The Early Truancy Prevention Project|Completed||N/A|20|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:31:10.228052|2017-10-11 01:31:10.228052
NCT01894295|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-07-09|||June 2012||2012-06-01|July 2013|2013-07-01|September 2013|Anticipated|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Assessment Vitamin D Analogues Intake Pathways on the Proteins Which Involved in Metabolic Rate in Obese Subjects||Unknown status|Recruiting|N/A|96|Anticipated|Tehran University of Medical Sciences||2|||f||||||||||||||2017-10-11 01:31:11.922119|2017-10-11 01:31:11.922119
NCT01894451|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-08-01|||June 2015||2015-06-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy|Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy|Recruiting||Early Phase 1|10|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:31:10.334452|2017-10-11 01:31:10.334452
NCT01894438|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-08-02|||April 2013||2013-04-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease|Effect of a Mediterranean Lifestyle Intervention on Biochemical and Clinical Characteristics of Patients With Non-alcoholic Fatty Liver Disease.|Completed||N/A|63|Actual|Harokopio University||3|||f||||f||||||||||2017-10-11 01:31:10.447465|2017-10-11 01:31:10.447465
NCT01894425|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-01-30|||May 2014||2014-05-01|April 2016|2016-04-01|December 2016|Actual|2016-12-01|October 23, 2016|Actual|2016-10-23||Observational|PAPILLO-PMA||Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation|Study of the Role of Infection by Human Papillomavirus (HPV) in the Success Rate of Pregnancies Achieved Via Medically Assisted Procreation|Completed||N/A|700|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||Samples With DNA|"     Samples collected (semen and cervical smears) will be sent to the Virology Laboratory of the     Hôpital St-Eloi, CHU Montpellier, for analysis. After analysis, the remains of viral DNA will     be banked for future studies on the Papilloma Virus.   "|No||2017-10-11 01:31:10.53118|2017-10-11 01:31:10.53118
NCT01894412|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-07-12|||July 2013||2013-07-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers|A Randomized, Double-blind, Single-dosing, Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 25 mg With Those of Enbrel® Injection 25 mg After Subcutaneous Injection in Healthy Male Volunteers|Completed||Phase 1|48|Actual|Hanwha Chemical||2|||f||||f||||||||||2017-10-11 01:31:10.615685|2017-10-11 01:31:10.615685
NCT01894399|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-12-14|||September 2013||2013-09-01|December 2016|2016-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects|Phase I Study to Assess the Safety, Tolerability, Pharmacokinetic Characteristics of HM61713 Tablet in Healthy Korean, Japanese and Caucasian|Completed||Phase 1|59|Actual|Hanmi Pharmaceutical Company Limited||7|||f||||f||||||||||2017-10-11 01:31:10.697238|2017-10-11 01:31:10.697238
NCT01894386|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-05-12|||July 15, 2013|Actual|2013-07-15|May 2017|2017-05-01|September 26, 2013|Actual|2013-09-26|September 26, 2013|Actual|2013-09-26||Interventional|||Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses|An Open Label, Randomised, Four-Period Crossover, Single Dose Study in Healthy Volunteers to Evaluate the Pharmacokinetics of FF/UMEC/VI Combination Administered at Dose Levels 100/62.5/25 mcg and 100/125/25 mcg and in Comparison With FF/VI (100/25 mcg) and UMEC/VI (62.5/25 mcg).|Completed||Phase 1|48|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:31:11.041403|2017-10-11 01:31:11.041403
NCT01894373|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-07-03|||June 2013||2013-06-01|June 2013|2013-06-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis|Autologous Cytokine Induced Killer Cells as Adjuvant Adoptive Immunotherapy in Patients With Psoriasis|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:31:11.217858|2017-10-11 01:31:11.217858
NCT01894360|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-05-12|||October 14, 2013|Actual|2013-10-14|May 2017|2017-05-01|May 13, 2014|Actual|2014-05-13|May 13, 2014|Actual|2014-05-13||Interventional|||A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects|A Randomized, Parallel-Group, Open-Label Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Administered Subcutaneously to Healthy Subjects by Prefilled Syringe or Autoinjector|Completed||Phase 1|81|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:31:11.371386|2017-10-11 01:31:11.371386
NCT01894347|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-08-02|||September 2013||2013-09-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Observational|LOKALE||Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP)|Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP)|Completed||N/A|9|Actual|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"     Blood, tracheal aspirates   "|||2017-10-11 01:31:11.488978|2017-10-11 01:31:11.488978
NCT01894334|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-08|2014-01-23|||April 2013||2013-04-01|January 2014|2014-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Mechanism and Early Intervention Research on ALI During Emergence Surgery of Acute Stanford A Aortic Dissection|Mechanism and Early Intervention Research on Acute Lung Injury During Emergence Surgery of Acute Stanford A Aortic Dissection|Unknown status|Active, not recruiting|N/A|220|Anticipated|Beijing Anzhen Hospital||4|||f||||t||||||||||2017-10-11 01:31:11.590599|2017-10-11 01:31:11.590599
NCT01894321|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2013-07-03|||January 2007||2007-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy.|The Percutaneous Cholecystostomy is Appropriate as the Ultimate Treatment of Acute Cholecystitis in Critically Ill Patients: a Cross-sectional Study at Single Center.|Completed||N/A|82|Actual|Cheju Halla General Hospital|||1||f||||f||||||||||2017-10-11 01:31:11.681595|2017-10-11 01:31:11.681595
NCT01894308|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-10-18|||July 2013||2013-07-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|PARC-T-D||A Dose Ranging Study to Examine Testagen® TDS-Testosterone 5%|A Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine Testagen® TDS-Testosterone 5% in Adult Male Subjects|Enrolling by invitation||Phase 2|48|Anticipated|Transdermal Delivery Solutions Corp||2|||f||||t||||||||No||2017-10-11 01:31:11.793468|2017-10-11 01:31:11.793468
NCT01894282|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-06-14|||July 2013||2013-07-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Mind Body Intervention for Chronic Lower Back Pain|Mind Body Intervention for Chronic Lower Back Pain: A Pilot Study|Active, not recruiting||Phase 3|30|Anticipated|Canandaigua VA Medical Center||2|||f||||f||||||||Undecided||2017-10-11 01:31:12.066764|2017-10-11 01:31:12.066764
NCT01894269|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2013-07-20|||July 2013||2013-07-01|July 2013|2013-07-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication|Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related Hepatocellular Carcinoma With Low HBV DNA Replication: Effectiveness and Safety. A Prospective and Randomized Clinical Trial|Unknown status|Recruiting|Phase 4|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:31:12.190549|2017-10-11 01:31:12.190549
NCT01894256|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2016-08-19|2016-03-18||November 2013||2013-11-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|March 2015|Actual|2015-03-01||Interventional|||Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function|An Open-label, Non-randomised, Multicentre, Comparative, Phase I Study of the Pharmacokinetics, Safety and Tolerability of Olaparib Following a Single Oral 300 mg Dose to Patients With Advanced Solid Tumours and Normal Renal Function or Renal Impairment|Completed||Phase 1|56|Actual|AstraZeneca|Data are presented for Part A and Part B.|3|||f||||f||||||||||2017-10-11 01:31:12.40528|2017-10-11 01:31:12.40528
NCT01894243|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-04|2017-04-13|||March 13, 2014|Actual|2014-03-13|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|December 1, 2016|Actual|2016-12-01||Interventional|||Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment|An Open-label, Non-randomised, Multicentre, Comparative, Phase I Study to Determine the Pharmacokinetics, Safety and Tolerability of Olaparib Following a Single Oral 300 mg Dose to Patients With Advanced Solid Tumours and Normal Hepatic Function or Mild or Moderate Hepatic Impairment|Completed||Phase 1|53|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 01:31:13.91377|2017-10-11 01:31:13.91377
NCT01894230|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-06-21|2017-04-24||July 2013||2013-07-01|June 2017|2017-06-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Interventional|||Genetically Guided Statin Therapy|Genetically Guided Statin Therapy to Improve Medication Adherence|Completed||N/A|167|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:31:14.089232|2017-10-11 01:31:14.089232
NCT01894217|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2015-01-06|||May 2011||2011-05-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|December 2012|Actual|2012-12-01||Interventional|||Statin Therapy to Improve Medication Adherence|Pilot Study: Statin Therapy to Improve Medication Adherence|Completed||Phase 1|63|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:31:14.973576|2017-10-11 01:31:14.973576
NCT01894204|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-06-22|||June 27, 2013|Actual|2013-06-27|June 2017|2017-06-01|December 27, 2018|Anticipated|2018-12-27|December 27, 2017|Anticipated|2017-12-27||Interventional|PADIS-HTP||Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism.|"Frequency and Risk Factors of the Lung High Blood Pressure Post-embolique in the Fall of a First Episode of Idiopathic Pulmonary Embolism. Study  PADIS HTP "|Recruiting||N/A|374|Anticipated|University Hospital, Brest||1|||f||||t||||||||||2017-10-11 01:31:15.121044|2017-10-11 01:31:15.121044
NCT01894191|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2016-06-27|||May 2013||2013-05-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparing the Adenoma Detection Rate With Air Insufflation, Water Immersion and Water Exchange|A Randomized, Controlled Trial Comparing the Adenoma Detection Rate With Air Insufflation, Water Immersion and Water Exchange During Colonoscopy|Completed||N/A|651|Actual|Dalin Tzu Chi General Hospital||3|||f||||t||||||||||2017-10-11 01:31:15.304254|2017-10-11 01:31:15.304254
NCT01894178|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-10-24|||July 2013||2013-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study Examining Parker-Flex Endotracheal Tube for Obese Patients|STUDY EVALUATING THE PARKER-FLEX ENDOTRACHEAL TUBE FOR FIBEROPTIC INTUBATION ON OBESE PATIENTS|Completed||N/A|60|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 01:31:15.439318|2017-10-11 01:31:15.439318
NCT01894165|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-11-05|||June 2013||2013-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers|A Phase 1, Randomized, Blinded, Placebo-Controlled, Single-Dose, Sequential-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ALXN1101 in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Alexion Pharma GmbH||2|||f||||f||||||||||2017-10-11 01:31:15.53119|2017-10-11 01:31:15.53119
NCT01894139|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-08-15|||November 2013||2013-11-01|August 2017|2017-08-01|December 2025|Anticipated|2025-12-01|December 2017|Anticipated|2017-12-01||Interventional|||An Optimized Programming of Healthy Children (APPROACH)|An Optimized Programming of Healthy Children (APPROACH) - The Most Favourable Dietary Protein:Carbohydrate Ratio During Pregnancy in the Context of New Nordic Diet|Active, not recruiting||N/A|390|Anticipated|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 01:31:15.765641|2017-10-11 01:31:15.765641
NCT01894126|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-11-07|||July 2013||2013-07-01|November 2016|2016-11-01||||July 2015|Actual|2015-07-01||Interventional|Mobile WACh||Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya|Mobile Phone One Way Short Message Service (SMS) Versus SMS Dialogue for Women's and Child Health (Mobile WACh) in Kenya: A Randomized Control Trial|Completed||N/A|300|Actual|University of Washington||3|||f||||f||||||||||2017-10-11 01:31:17.713016|2017-10-11 01:31:17.713016
NCT01894113|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-05-02|||January 2012||2012-01-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|TRABIS||Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease.|Prospective, Randomised Multicenter Study Comparing Transbronchial Forceps Biopsy With Cryobiopsy in Interstitial Lung Disease|Completed||N/A|382|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-11 01:31:17.808703|2017-10-11 01:31:17.808703
NCT01894100|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-05-16|2016-09-02||July 2013||2013-07-01|May 2017|2017-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Shoe Lifts for Leg Length Inequality in Adults With Knee or Hip Symptoms|Defining and Correcting Limb Length Inequality in Adults With Knee or Hip Symptoms|Completed||N/A|46|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:31:17.90079|2017-10-11 01:31:17.90079
NCT01894074|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-12-03|||July 2013||2013-07-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effects of an Intensive Lifestyle Intervention on Reproductive Outcomes|The Effects of an Intensive Lifestyle Intervention on Reproductive Outcomes in Obese, Subfertile Women|Completed||N/A|14|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 01:31:18.379458|2017-10-11 01:31:18.379458
NCT01894061|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-08-07|||June 2013||2013-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma|A Prospective Phase II Trial of NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma|Recruiting||Phase 2|40|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-11 01:31:18.480909|2017-10-11 01:31:18.480909
NCT01894048|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-06-08|||January 2014||2014-01-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|ANDA3||Targeted Small Airways Therapy in Persistent Asthma|Targeted Small Airways Therapy in Persistent Asthma|Recruiting||Phase 4|30|Anticipated|University of Dundee||1|||f||||f||||||||||2017-10-11 01:31:18.600792|2017-10-11 01:31:18.600792
NCT01894035|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-05-03|||September 23, 2013|Actual|2013-09-23|May 2017|2017-05-01|April 13, 2017|Actual|2017-04-13|July 21, 2016|Actual|2016-07-21||Observational|COMPHI||Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation|Study to Assess the Compliance of Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost.|Completed||N/A|13|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:31:18.834268|2017-10-11 01:31:18.834268
NCT01894022|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-03|2017-08-09|2016-07-15||January 23, 2014|Actual|2014-01-23|August 2017|2017-08-01|November 18, 2015|Actual|2015-11-18|November 18, 2015|Actual|2015-11-18||Interventional|AMBER II|Participant characteristics at the start of the extension study.|A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|Terminated||Phase 3|19|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-10-11 01:31:19.003751|2017-10-11 01:31:19.003751
NCT01894009|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-07-02|||September 2009||2009-09-01|July 2013|2013-07-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|PPGP||Foot Manipulation for Pregnancy Related Pelvic Girdle Pain|Effect of Foot Manipulation for Relief of Pregnancy Related Pelvic Girdle Pain. A Randomised Clinical Trial in Primary Care|Completed||N/A|97|Actual|Vastra Gotaland Region||2|||f||||f||||||||||2017-10-11 01:31:21.142148|2017-10-11 01:31:21.142148
NCT01893996|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-05-01|||July 2013||2013-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease|Adalimumab to Mitigate Cardiovascular Risk in RA Patients With Well-Controlled Joint Disease|Active, not recruiting||Phase 4|60|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:31:21.232273|2017-10-11 01:31:21.232273
NCT01893983|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-06-20|||October 1, 2015|Actual|2015-10-01|June 2017|2017-06-01|September 30, 2018|Anticipated|2018-09-30|May 31, 2018|Anticipated|2018-05-31||Interventional|COACH||Motivational Coaching to Enhance Mental Health Engagement in Rural Veterans|Motivational Coaching to Enhance Mental Health Engagement in Rural Veterans|Recruiting||N/A|1000|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-11 01:31:21.329965|2017-10-11 01:31:21.329965
NCT01893970|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-04-25|||April 2013||2013-04-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|SWIFT||SWIFT Study in the ED|Social Work Intervention for Adults With Mild Traumatic Brain Injury: SWIFT Pilot Study|Recruiting||N/A|80|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 01:31:21.45282|2017-10-11 01:31:21.45282
NCT01893957|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-07-15|||August 2012||2012-08-01|July 2013|2013-07-01|September 2013|Anticipated|2013-09-01|July 2013|Anticipated|2013-07-01||Interventional|||Effects of Electrical Stimulation on Blood Circulation and Sensibility Tactil in Lymphadenectomy|Evaluation of the Effects of High Voltage Electrical Stimulation in the Floe Blood and Tactile Sensitivity of Women Undergoing Axillary Lymphadenectomy|Unknown status|Recruiting|N/A|30|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:31:21.564527|2017-10-11 01:31:21.564527
NCT01893944|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2014-02-14|||January 2013||2013-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Applicability of Video Games and Vibrational Therapy in Reducing Pain Secondary to Breast Cancer|Applicability of Video Games and Vibrational Therapy in Reducing Pain Secondary to Breast Cancer|Completed||N/A|60|Anticipated|Universidade do Vale do Paraíba||3|||f||||t||||||||||2017-10-11 01:31:21.66807|2017-10-11 01:31:21.66807
NCT01893931|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-07-08|||August 2013||2013-08-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Use of a Brief Phone Call After ED Discharge|Discharge Planning for Older Adults in the Emergency Department: Use of a Brief Phone Call After Discharge to Decrease Return Visits to the Emergency Department and Re-admissions to the Hospital|Completed||N/A|2003|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||No||2017-10-11 01:31:21.760478|2017-10-11 01:31:21.760478
NCT01893749|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-10-31|||February 2012||2012-02-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CATCH-IT||Primary Care Internet Based Depression Prevention for Adolescents (CATCH-IT) Also Known as Promoting AdolescenT Health|Primary Care Internet Based Depression Prevention for Adolescents (Promoting AdolescenT Health-PATH)|Completed||N/A|1142|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-11 01:31:23.634544|2017-10-11 01:31:23.634544
NCT01893918|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-07-02|||March 2011||2011-03-01|July 2013|2013-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01|3 Years|Observational [Patient Registry]|||Assessment of Severity and Prognosis in Elderly Patients With COPD and Complex Chronic Comorbidities|Assessment of Severity and Prognosis in Elderly Patients With Chronic Obstructive Pulmonary Disease (COPD) and Complex Chronic Comorbidities|Unknown status|Recruiting|N/A|100|Anticipated|University of Modena and Reggio Emilia|||1||f||||t||||||Samples Without DNA|"     Blood sampling for complete blood count, fasting glucose, bilirubin, creatinine, blood urea,     uric acid, electrolytes (magnesium, sodium, potassium, chloride), total cholesterol,     cholesterol high-density lipoprotein (HDL), triglycerides, serum glutamic oxaloacetic     transaminase, serum glutamic pyruvic transaminase, gamma-glutamyl transpeptidase, creatine     phosphokinase, hemoglobin A1c, serum insulin. Urine sampling for microalbuminuria and urine     creatinine. Measurement of arterial blood gas. Blood sampling for biomarkers (NT-proBNP,     high-sensitive C-Reactive Protein, IL-1β, IL-6).   "|||2017-10-11 01:31:21.859387|2017-10-11 01:31:21.859387
NCT01893905|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-04-25|2016-12-22||June 2013||2013-06-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis|Phase III Clinical Trial to Evaluate the Efficacy and Safety of Chondroitin Sulfate and Glucosamine Sulfate in Combination Versus Placebo in Patients With Osteoarthritis of the Knee|Completed||Phase 3|158|Actual|Tedec-Meiji Farma, S.A.||2|||f||||f||||||||No||2017-10-11 01:31:21.961856|2017-10-11 01:31:21.961856
NCT01893892|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-08-03|||March 2014||2014-03-01|August 2017|2017-08-01|March 15, 2017|Actual|2017-03-15|March 15, 2017|Actual|2017-03-15||Interventional|||Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms|Double-blind, Randomized, Placebo-controlled Two-period Crossover Study to Assess the Effect of Levocarnitine on Vismodegib-associated Muscle Spasms|Completed||N/A|12|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 01:31:22.346346|2017-10-11 01:31:22.346346
NCT01893879|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-04-13|2016-12-09||April 2014||2014-04-01|April 2017|2017-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PCTTPL||Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema|Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema in High Risk Patients|Terminated||N/A|14|Actual|Stanford University||2||insufficient enrollment|f||||t||||||||Undecided||2017-10-11 01:31:22.459329|2017-10-11 01:31:22.459329
NCT01893866|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-12-11|||August 2013||2013-08-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects|An Open-Label, Randomized, Phase 1, Single-Dose Crossover, Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects|Completed||Phase 1|17|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:31:22.688971|2017-10-11 01:31:22.688971
NCT01893853|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-09-10|||October 2012||2012-10-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|APEX||Fluid Balance During Exercise in the Heat With Water, Flavored Placebo, or a Carbohydrate-electrolyte Beverage Intake (The APEX Study)|Fluid Balance During Exercise in the Heat With Water, Flavored Placebo, or a Carbohydrate-electrolyte Beverage Intake (The APEX Study)|Completed||N/A|24|Actual|Pennington Biomedical Research Center||3|||f||||f||||||||||2017-10-11 01:31:22.766471|2017-10-11 01:31:22.766471
NCT01893840|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-10-30|||August 2013||2013-08-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg|Effect on Blood Flow Using the FlowOx™ Device in Patients With Reduced Peripheral Circulation in the Lower Leg|Unknown status|Active, not recruiting|N/A|20|Anticipated|Otivio AS||1|||f||||f||||||||||2017-10-11 01:31:22.86712|2017-10-11 01:31:22.86712
NCT01893827|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-11-10|||June 2014||2014-06-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|X-ON||Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care|Randomized, Open-label Clinical Trial of Extended-Release vs. Oral Naltrexone for Alcohol Treatment in Primary Care.|Recruiting||Phase 4|234|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 01:31:22.937551|2017-10-11 01:31:22.937551
NCT01893814|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-09-21|||April 2013||2013-04-01|September 2016|2016-09-01||||January 2014|Actual|2014-01-01||Interventional|||Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort||Terminated||Phase 2|5|Actual|Probi AB||2||Poor recruitment|f||||f||||||||||2017-10-11 01:31:23.043343|2017-10-11 01:31:23.043343
NCT01893801|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-02-27|||May 2013||2013-05-01|February 2014|2014-02-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01||Interventional|||Nab-Paclitaxel+Cisplatin+Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)|A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)|Unknown status|Recruiting|Phase 1/Phase 2|25|Anticipated|Pancreatic Cancer Research Team||1|||f||||t||||||||||2017-10-11 01:31:23.119129|2017-10-11 01:31:23.119129
NCT01893788|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-07-18|||April 2013||2013-04-01|July 2013|2013-07-01||||March 2016|Anticipated|2016-03-01||Interventional|EARTH||Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy||Unknown status|Recruiting|Phase 4|100|Anticipated|Nagoya University||2|||f||||t||||||||||2017-10-11 01:31:23.246312|2017-10-11 01:31:23.246312
NCT01893775|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||June 11, 2013||2013-06-11|June 16, 2017|2017-06-16|June 3, 2021|Anticipated|2021-06-03|June 3, 2020|Anticipated|2020-06-03||Interventional|||Antibody Treatment for Advanced Celiac Disease|Phase I Study of the Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward IL-2/IL-15R Beta (CD122) That Blocks IL-15 Action In Patients With Refractory Celiac Disease|Recruiting||Phase 1|12|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:31:23.341876|2017-10-11 01:31:23.341876
NCT01893762|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-06-30|||May 2013||2013-05-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|INCREASE||Innate Immune Response to (An)Aerobic Exercise in Rowing Athletes|Innate Immune Response to Anaerobe and Aerobe Exercise in Rowing Athletes|Completed||N/A|16|Actual|UMC Utrecht||1|||f||||f||||||||||2017-10-11 01:31:23.429948|2017-10-11 01:31:23.429948
NCT01889368|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-06-26|||November 2012|Actual|2012-11-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of a Grape Seed Extract (GSE) on Insulin Resistance|Effect of a Grape Seed Extract (GSE) on Insulin Resistance|Completed||N/A|19|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 01:32:31.710555|2017-10-11 01:32:31.710555
NCT01893736|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-03-12|||September 2010||2010-09-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|April 2012|Actual|2012-04-01||Interventional|||Professional Breastfeeding Support Intervention|A Randomized Controlled Trial of a Professional Breastfeeding Support Intervention to Increase the Exclusivity and Duration of Breastfeeding|Completed||N/A|722|Actual|The University of Hong Kong||3|||f||||f||||||||||2017-10-11 01:31:23.765009|2017-10-11 01:31:23.765009
NCT01893723|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-11-03|||June 2012||2012-06-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|AIVOC-ANI||Analgesia Nociception Index Guided Remifentanil Administration During Propofol Anesthesia for Laparoscopic Surgery|Analgesia Nociception Index Guided Remifentanil Administration During Propofol Anesthesia for Laparoscopic Surgery : Multicenter Randomized Clinical Trial|Terminated||N/A|37|Actual|University Hospital, Lille||2||Changes of usual clinical practices|f||||f||||||||||2017-10-11 01:31:23.869067|2017-10-11 01:31:23.869067
NCT01893710|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-11-09|||February 2011||2011-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|3 Years|Observational [Patient Registry]|||International Pediatric Peritoneal Biopsy Study|International Pediatric Peritoneal Biopsy Study in Children on PD and Healthy Controls|Recruiting||N/A|400|Anticipated|Heidelberg University|||1||f||||f||||||Samples With DNA|"     Parietal ond omental peritoneal membrane specimen will be collected in all groups   "|||2017-10-11 01:31:23.969894|2017-10-11 01:31:23.969894
NCT01893697|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-05-27|||April 2013||2013-04-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||The Influence of Posture on Airway Diameter, Resistance and Airflow Distribution in Healthy Subjects|The Influence of Posture on Airway Diameter, Resistance and Airflow Distribution in Healthy Subjects|Completed||N/A|5|Actual|University Hospital, Antwerp|||1||f||||f||||||||||2017-10-11 01:31:24.191225|2017-10-11 01:31:24.191225
NCT01893684|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-09-05|||January 1, 2013|Actual|2013-01-01|September 2017|2017-09-01|July 1, 2015|Actual|2015-07-01|December 31, 2014|Actual|2014-12-31||Interventional|ugaDIVAS||Dietary Intervention and Varying Physical Activity in Seniors|Effects of a Higher Protein Weight Loss Diet and Exercise on Body Composition, Physical Function, and Fatigue in Overweight Older Women|Completed||N/A|81|Actual|University of Georgia||3|||f||||f||||||||||2017-10-11 01:31:24.26705|2017-10-11 01:31:24.26705
NCT01893671|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-04-21|||January 2011||2011-01-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Corneal Power, Astigmatism, and Aberration Changes After LASIK|Observational Study of Corneal Power, Astigmatism, and Aberration Changes After LASIK|Unknown status|Recruiting|N/A|50|Anticipated|Oregon Health and Science University|||1||f||||||||||||||2017-10-11 01:31:24.368997|2017-10-11 01:31:24.368997
NCT01893632|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2013-07-24|||July 2013||2013-07-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Gabapentin Treatment of Benzodiazepine Dependence|Gabapentin Treatment of Benzodiazepine Dependence|Unknown status|Recruiting|Phase 2|50|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 01:31:24.781201|2017-10-11 01:31:24.781201
NCT01893619|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-24|||June 2013||2013-06-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|immunoprop||Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome|Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome|Unknown status|Recruiting|N/A|100|Anticipated|New York CFS Association|||1||f||||t||||||||||2017-10-11 01:31:24.910675|2017-10-11 01:31:24.910675
NCT01893606|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-07-23|||April 2013||2013-04-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|||Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment|Multicenter Randomized Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for Irritable Bowel Syndrome With Diarrhea (IBS-D) Treatment|Unknown status|Recruiting|Phase 2/Phase 3|180|Anticipated|Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:31:25.013654|2017-10-11 01:31:25.013654
NCT01893593|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-08-13|||November 2011||2011-11-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|December 2012|Actual|2012-12-01||Interventional|||Young Hearts, Strong Starts|A Cluster Randomized Trial of the Implementation of the NHLBI Expert Panel Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents|Completed||Phase 4|32|Actual|RTI International||2|||f||||f||||||||||2017-10-11 01:31:25.163051|2017-10-11 01:31:25.163051
NCT01893580|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-05-05|||May 2012||2012-05-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|PROLUCA||Perioperative Rehabilitation in Operation for Lung Cancer|Perioperative Rehabilitation in Operation for Lung Cancer|Terminated||N/A|40|Actual|Rigshospitalet, Denmark||4||Due to low recruiment rate, the study design is chanced to a feasibility study|f||||t||||||||||2017-10-11 01:31:25.295305|2017-10-11 01:31:25.295305
NCT01893567|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-09-03|2014-06-11||July 2013||2013-07-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%|Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%|Completed||Phase 4|28|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:31:25.466466|2017-10-11 01:31:25.466466
NCT01893554|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-01-31|||June 2013||2013-06-01|January 2017|2017-01-01||||May 2017|Anticipated|2017-05-01||Interventional|||Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children|A Phase I Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV ΔNS2 Δ1313 I1314L, Lot RSV#006A, Delivered as Nose Drops to RSV-Seropositive Children 12 to 59 Months of Age and RSV-Seronegative Infants and Children 6 to 24 Months of Age|Recruiting||Phase 1|75|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-11 01:31:25.704559|2017-10-11 01:31:25.704559
NCT01893541|ClinicalTrials.gov processed this data on October 10, 2017|2009-08-04|2013-07-08|||June 2008||2008-06-01|July 2013|2013-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?|PROPRANOLOL ASSOCIATED WITH ENDOSCOPIC BAND LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES FOR PRIMARY PROPHYLAXIS OF VARICEAL BLEEDING?: A RANDOMIZED CONTROLLED TRIAL|Completed||Phase 4|100|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 01:31:25.839981|2017-10-11 01:31:25.839981
NCT01893528|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2014-11-07|||June 2013||2013-06-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers||Completed||Phase 1|49|Actual|Regeneron Pharmaceuticals||3|||f||||f||||||||||2017-10-11 01:31:25.965369|2017-10-11 01:31:25.965369
NCT01893515|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-10-07||2015-09-21|July 2013||2013-07-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects|A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 Once Daily Versus Placebo in Statin-Naïve or Statin-Stable Hypertriglyceridemic Subjects|Completed||Phase 2|87|Actual|Pronova BioPharma||2|||f||||t||||||||||2017-10-11 01:31:26.085284|2017-10-11 01:31:26.085284
NCT01893502|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-04-06|||June 2013||2013-06-01|April 2017|2017-04-01|March 18, 2016|Actual|2016-03-18|March 18, 2016|Actual|2016-03-18||Interventional|||Duration of Follow-Up Counselling on Smoking Cessation Outcomes|Smoke Free Randomized Controlled Trial|Completed||N/A|11|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 01:31:26.281847|2017-10-11 01:31:26.281847
NCT01893489|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-08-23|||September 2012||2012-09-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Visualization of Carotid Atherosclerosis by 68Ga-MSA|Phase I Study to Evaluated the Safety of Noninvasive Molecular Imaging for the Detection of Inflammation in Carotid Atherosclerotic Lesions by Using Ga-68-NOTA-MSA in Healthy Volunteers and Patients With Coronary Artery Disease|Completed||Phase 1|12|Actual|Korea University||2|||f||||f||||||||||2017-10-11 01:31:26.373789|2017-10-11 01:31:26.373789
NCT01893476|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-10-29|||September 2013||2013-09-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|TICD-COPD||A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management|Tailored Implementation for Chronic Diseases.|Completed||N/A|540|Actual|Medical Universtity of Lodz||2|||f||||f||||||||||2017-10-11 01:31:26.504366|2017-10-11 01:31:26.504366
NCT01893463|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-12-18|||August 2013||2013-08-01|December 2013|2013-12-01||||December 2013|Anticipated|2013-12-01||Observational|||Prospective Evaluation of the iTClamp50 to Provide Temporary Wound Closure|Prospective Study to Evaluate the Safety and Effectiveness of the iTClamp50 to Provide Temporary Wound Closure|Withdrawn||N/A|0|Actual|Innovative Trauma Care Inc.|||1||f||||f||||||||||2017-10-11 01:31:26.601393|2017-10-11 01:31:26.601393
NCT01893450|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2013-07-02|||June 2008||2008-06-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment|Comparison of the Effect of Bromocriptine and Pentoxifylline in Mild to Moderate Autoimmune Ophthalmopathy. A Randomized, Controlled, Single Blind, Clinical Trial.|Terminated||N/A|31|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||3||Efficacy demonstrated on a preliminary analysis|f||||f||||||||||2017-10-11 01:31:26.710129|2017-10-11 01:31:26.710129
NCT01893437|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-11-01|||July 2013||2013-07-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study of RO6799477 in Healthy Volunteers|A Single-center, Randomized, Double-blind, Placebo-controlled, Single Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6799477 Following Oral Administration of Single Ascending Doses in Healthy Volunteers.|Completed||Phase 1|27|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:31:26.826262|2017-10-11 01:31:26.826262
NCT01893424|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2016-03-23|||August 2013||2013-08-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)|Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoid Combination (Δ9 -Tetrahydrocannabinol (THC) and Cannabidiol (CBD) In 1:1 Ratio)|Completed||Phase 1|12|Actual|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 01:31:26.89994|2017-10-11 01:31:26.89994
NCT01893411|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-08-02|2017-01-25|2016-07-26|June 2013||2013-06-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Interventional||A total of 338 participants were screened and 311 participants were randomised and treated with high dose (156 participants), mid dose (77 participants) and low dose (78 participants).|Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy|Prospective, Multicenter, Randomized, Double-blind, Parallel-group, Dose-response Study of Three Doses Xeomin® (incobotulinumtoxinA, NT 201) for the Treatment of Lower Limb Spasticity in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy|Completed||Phase 3|311|Actual|Merz Pharmaceuticals GmbH||3|||f||||t||||||||||2017-10-11 01:31:27.023123|2017-10-11 01:31:27.023123
NCT01893398|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-07-02|||January 2010||2010-01-01|June 2013|2013-06-01||||December 2012|Actual|2012-12-01||Interventional|||Multistimulation Group Therapy for Alzheimer's Disease|Multistimulation Group Therapy in Mild to Moderate Alzheimer's Disease|Completed||N/A|60|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||||||||||||2017-10-11 01:31:28.914132|2017-10-11 01:31:28.914132
NCT01893385|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-12-22|||June 2013||2013-06-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Vitamin D Supplementation and the Immune Response|Impact of Vitamin D Supplementation on Immune Functions: Study in Subjects Aged Over 65 Years Vaccinated Against Influenza|Terminated||Phase 2|37|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:31:29.041829|2017-10-11 01:31:29.041829
NCT01893372|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-11-04|||October 2013||2013-10-01|November 2016|2016-11-01||||October 2019|Anticipated|2019-10-01||Interventional|||Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)|Phase II Study of Eltrombopag With or Without Continuation of Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)|Active, not recruiting||Phase 2|46|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 01:31:29.1657|2017-10-11 01:31:29.1657
NCT01892579|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-02-06|||November 2013||2013-11-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|TAP||Reducing Agitation in People With Dementia: the Customized Activity Trial|Reducing Agitation in People With Dementia: the Customized Activity Trial|Active, not recruiting||Phase 3|250|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-11 01:31:38.228706|2017-10-11 01:31:38.228706
NCT01893359|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-06-20|2016-07-18||August 2013||2013-08-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism|A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of LASIK With Cross-linking Performed With the KXL System and Photrexa ZD™ (Riboflavin Ophthalmic Solution) Compared to LASIK Alone for Hyperopia and Hyperopic Astigmatism|Terminated||Phase 1/Phase 2|2|Actual|Avedro, Inc.||3|||f||||f||||||||||2017-10-11 01:31:29.288757|2017-10-11 01:31:29.288757
NCT01893346|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-09-01|2015-04-09||July 2013||2013-07-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Baseline characteristics are shown for safety analysis set. The safety analysis set included all patients who received any amount of IV study dose of CAZ AVI.|Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections|A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection|Completed||Phase 1|35|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 01:31:29.702827|2017-10-11 01:31:29.702827
NCT01893333|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-05-27|||March 2013||2013-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|NSRHCXCA||The Efficacy and Safety of Nerve-sparing Radical Hysterectomy in Cervical Cancer|The Efficacy and Safety of Nerve-sparing Radical Hysterectomy in Cervical Cancer|Recruiting||N/A|146|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:31:30.497031|2017-10-11 01:31:30.497031
NCT01893320|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-02-03|||July 18, 2013|Actual|2013-07-18|February 2017|2017-02-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome|A Phase I/II Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome|Active, not recruiting||Phase 1/Phase 2|68|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:31:30.608633|2017-10-11 01:31:30.608633
NCT01893307|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-09-18|||August 2013|Actual|2013-08-01|September 2017|2017-09-01|August 2023|Anticipated|2023-08-01|August 2023|Anticipated|2023-08-01||Interventional|||Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck|Phase II/III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck|Recruiting||Phase 2/Phase 3|360|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 01:31:30.714051|2017-10-11 01:31:30.714051
NCT01893294|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-03-21|||April 2013|Actual|2013-04-01|October 2015|2015-10-01|October 30, 2015|Actual|2015-10-30|October 30, 2015|Actual|2015-10-30||Interventional|||Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer|Phase I Trial of Intra-tumoral Gemcitabine Therapy for Locally Advanced Pancreatic Carcinoma|Completed||Phase 1|1|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:31:30.840174|2017-10-11 01:31:30.840174
NCT01893281|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-10-21|2014-10-21||July 2013||2013-07-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||All enrolled participants who received at least 1 dose of study drug.|The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel|The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel|Completed||Phase 4|78|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:31:30.957062|2017-10-11 01:31:30.957062
NCT01893268|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-10-02|||July 25, 2013|Actual|2013-07-25|October 2017|2017-10-01|October 6, 2017|Anticipated|2017-10-06|December 31, 2015|Actual|2015-12-31||Observational|||An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice|Therapeutic Strategies Including Avastin as 1st Line Therapy in Elderly Patients Suffering From Advanced (IIIB/IV Stage) Non-squamous Non-small Cell Lung Cancer, in Routine Clinical Practice.|Active, not recruiting||N/A|279|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:31:31.7678|2017-10-11 01:31:31.7678
NCT01893255|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-11-01|||September 2012||2012-09-01|November 2016|2016-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)|A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Who Are Treated With Tocilizumab|Withdrawn||N/A|0|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:31:32.017806|2017-10-11 01:31:32.017806
NCT01893242|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)|A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE POTENTIAL OF ALEGLITAZAR TO REDUCE THE RISK OF END STAGE RENAL DISEASE AND CARDIOVASCULAR MORTALITY IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE (ALERENAL STUDY)|Withdrawn||Phase 3|0|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:31:32.114097|2017-10-11 01:31:32.114097
NCT01893229|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-03-14|||September 2013||2013-09-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania|Comparative Efficacy and Acceptability of Lithium, Valproate, Oxcarbazepine, Quetiapine, Olanzapine, and Ziprasidone in Bipolar I Disorder, Manic or Mixed Phase|Unknown status|Recruiting|Phase 4|120|Anticipated|Guangzhou Psychiatric Hospital||6|||f||||t||||||||||2017-10-11 01:31:32.199102|2017-10-11 01:31:32.199102
NCT01893216|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-05|||April 2013||2013-04-01|July 2013|2013-07-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Observational|||Risk Factors of Psychiatric Disorders and Sexual Dysfunction in Infertile Men|Study of Possible Interactions Between Psychiatric Disorders and Sexual Dysfunction in Infertile Men|Unknown status|Recruiting|N/A|1500|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||2||f||||t||||||||||2017-10-11 01:31:32.332823|2017-10-11 01:31:32.332823
NCT01893203|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-05-29|2015-12-23||August 2013||2013-08-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|2013-002108-15|14 patients were recruited. One withdrew because of conditions not related to the study. This patient was not included in the analysis.|Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)|Treatment of AKs With Daylight-PDT: Comparing Two Photosensitizers (BF-200 ALA and MAL)|Completed||Phase 4|14|Actual|Joint Authority for Päijät-Häme Social and Health Care||1|||f||||t||||||||||2017-10-11 01:31:32.424459|2017-10-11 01:31:32.424459
NCT01893190|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-01-19|||September 2013||2013-09-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|NEWTON||Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage|NEWTON TRIAL - Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After subarachNoid Hemorrhage: Phase I/IIa Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability, and Pharmacokinectic Study Comparing EG-1962 and Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage|Completed||Phase 1/Phase 2|73|Actual|Edge Therapeutics Inc||2|||f||||t||||||||||2017-10-11 01:31:32.676238|2017-10-11 01:31:32.676238
NCT01893177|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-08-29|||July 2013||2013-07-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)|Open, Non-randomized Trial to Assess the Immunogenicity and Safety of the 2013/2014-season Virosomal Subunit Influenza Vaccine in Elderly and Young Subjects According to EMA Regulations|Completed||Phase 3|110|Actual|Crucell Holland BV||2|||f||||f||||||||||2017-10-11 01:31:32.815198|2017-10-11 01:31:32.815198
NCT01893164|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2013-07-05|||July 2013||2013-07-01|July 2013|2013-07-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Interventional|||Comparison of Different Surgical Treatments for Different Scales of Cubital Tunnel Syndrome|Comparison of Simple Decompression Versus Anterior Subcutaneous and Intramuscular Transposition of the Ulnar Nerve for Moderate and Severe Cubital Tunnel Syndrome ：A Randomized Double-blind Control Trial|Unknown status|Recruiting|N/A|144|Anticipated|Jilin University||2|||f||||t||||||||||2017-10-11 01:31:32.905168|2017-10-11 01:31:32.905168
NCT01893151|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-10-21|||July 2012||2012-07-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI|A Randomized, Double-blind Study to Evaluate the Efficacy of Iguratimod Versus Placebo in Patients With Rheumatoid Arthritis on Magnetic Resonance Imaging (MRI)|Unknown status|Recruiting|Phase 4|200|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:31:33.013544|2017-10-11 01:31:33.013544
NCT01893138|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-09-08|||October 2013||2013-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Autologous Muscle Derived Cells for Female Urinary Sphincter Repair|A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence|Active, not recruiting||Phase 3|310|Anticipated|Cook Group Incorporated||3|||f||||||||||||||2017-10-11 01:31:33.119313|2017-10-11 01:31:33.119313
NCT01893125|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-10-29|||August 2013||2013-08-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy|A Randomised Three Week Double-blind Crossover Study to Compare the Efficacy and Safety of CNV2197944 75 mg Tid Versus Placebo in the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy|Completed||Phase 2|126|Actual|Convergence Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:31:33.477364|2017-10-11 01:31:33.477364
NCT01893112|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-05-03|||June 2013||2013-06-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|November 2016|Actual|2016-11-01||Interventional|||Reducing HIV Stigma for African American Women|Reducing HIV Stigma to Improve Health Outcomes for African-American Women|Completed||N/A|240|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 01:31:33.56426|2017-10-11 01:31:33.56426
NCT01893099|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2017-08-22|||June 2013||2013-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma|Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma|Active, not recruiting||Phase 1|24|Anticipated|Centre Hospitalier Universitaire Vaudois||4|||f||||f||||||||||2017-10-11 01:31:33.65222|2017-10-11 01:31:33.65222
NCT01893086|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-01-26|||June 2013||2013-06-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy|Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy: a Multi-center, Randomized Controlled Trial|Completed||Phase 3|68|Actual|CHA University||2|||f||||f||||||||||2017-10-11 01:31:33.754133|2017-10-11 01:31:33.754133
NCT01893073|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2014-03-25|||June 2013||2013-06-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Interventional|MW-LBP||Mindful Walking in Low Back Pain|Effectiveness of a a Mindful Walking Program in Patients With Chronic Low Back Pain - a Randomized Controlled Trial|Completed||N/A|48|Actual|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 01:31:33.831416|2017-10-11 01:31:33.831416
NCT01893060|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-08-01|||July 2013||2013-07-01|August 2013|2013-08-01|July 2014|Anticipated|2014-07-01|May 2014|Anticipated|2014-05-01||Interventional|||Umbilical Cord Care for the Prevention of Colonization|Umbilical Cord Care for the Prevention of Colonization|Unknown status|Recruiting|N/A|100|Anticipated|University of Virginia||4|||f||||f||||||||||2017-10-11 01:31:33.921313|2017-10-11 01:31:33.921313
NCT01893047|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-10-04|||July 2013||2013-07-01|October 2017|2017-10-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Effect of Music on Breastmilk|Effect of Quiet or Listening to Music While Breastfeeding on the Production and Lipid and Sodium Content of the Milk|Completed||N/A|32|Actual|University of Rochester||3|||f||||f||||||||||2017-10-11 01:31:34.037484|2017-10-11 01:31:34.037484
NCT01893034|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-12-02|||July 2013||2013-07-01|December 2013|2013-12-01|July 2017|Anticipated|2017-07-01|April 2015|Anticipated|2015-04-01||Interventional|FAIT||Trial for Femoroacetabular Impingement Treatment|A Randomised Controlled Trial of Surgical Versus Non-surgical Treatment of Femoroacetabular Impingement|Unknown status|Recruiting|N/A|120|Anticipated|University of Oxford||2|||f||||||||||||||2017-10-11 01:31:34.113911|2017-10-11 01:31:34.113911
NCT01893021|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-02-03|||May 2013||2013-05-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Family Planning Knowledge, Attitudes, and Practices of Postpartum Malawian Women|Family Planning Knowledge, Attitudes, and Practices of HIV+ and HIV- Postpartum Malawian Women|Completed||N/A|634|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 01:31:34.206433|2017-10-11 01:31:34.206433
NCT01893008|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-05-10|||September 2013||2013-09-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PREPARE||Preoperative Inspiratory Muscle Training in Esophageal Resection|Preoperative Inspiratory Muscle Training to Prevent Postoperative Pneumonia in Patients Undergoing Esophageal Resection|Completed||N/A|245|Actual|UMC Utrecht||2|||f||||f||||||||||2017-10-11 01:31:34.289996|2017-10-11 01:31:34.289996
NCT01892995|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-02-13|||June 2015||2015-06-01|February 2015|2015-02-01||||December 2017|Anticipated|2017-12-01||Interventional|LDK-SI||Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial|Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial|Not yet recruiting||N/A|53|Anticipated|Brooke Army Medical Center||3|||f||||f||||||||||2017-10-11 01:31:34.47421|2017-10-11 01:31:34.47421
NCT01892982|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2016-10-07|||June 2013||2013-06-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Improving Preterm Outcomes by Safeguarding Maternal Mental Health|Improving Preterm Outcomes by Safeguarding Maternal Mental Health|Recruiting||N/A|325|Anticipated|Boston Medical Center||2|||f||||t||||||||||2017-10-11 01:31:34.573717|2017-10-11 01:31:34.573717
NCT01892969|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-10-24|||October 2012||2012-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Observational|CAF-PINT||Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)|Coagulation and Fibrinolysis in a Pediatric Insulin Titration Trial|Active, not recruiting||N/A|800|Anticipated|University of California, San Francisco|||1||f||||t||||||Samples With DNA|"     Blood Samples   "|||2017-10-11 01:31:34.70194|2017-10-11 01:31:34.70194
NCT01892956|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2014-03-26|||April 2013||2013-04-01|July 2013|2013-07-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Observational|||Observational Study of Blood Glucose Levels and Gut Microbiota in Healthy Individuals|Observational Study of Blood Glucose Levels and Gut Microbiota in Healthy Individuals|Unknown status|Recruiting|N/A|2000|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"     Blood count, lipids, liver functions, CBP Stool sample for intestinal microbiota   "|||2017-10-11 01:31:34.851822|2017-10-11 01:31:34.851822
NCT01892943|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-05-14|||August 2013||2013-08-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey||Completed||N/A|306|Actual|Santhera Pharmaceuticals|||1||f||||||||||||||2017-10-11 01:31:34.95486|2017-10-11 01:31:34.95486
NCT01892930|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-02-09|||July 11, 2013|Actual|2013-07-11|February 2017|2017-02-01|December 30, 2016|Actual|2016-12-30|December 30, 2015|Actual|2015-12-30||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery|Immunologic Impact of Stereotactic Body Radiation Therapy (SBRT) in Renal Cell Carcinoma|Completed||N/A|15|Actual|Roswell Park Cancer Institute||1|||f||||t|f|f||||||||2017-10-11 01:31:35.065969|2017-10-11 01:31:35.065969
NCT01892904|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-02|2015-09-08|||July 2013||2013-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea|A Multi-center, Randomized, Open-label, Active-controlled, Parallel-group Comparative Study to Assess Efficacy and Safety of a Flexible Extended Regimen of BAY 86-5300 (0.02 mg Ethinylestradiol [β-CDC] and 3 mg Drospirenone) Compared to the 28-day (24 + 4-day) Regimen of BAY 86-5300 in the Treatment of Dysmenorrhea for 24 Weeks|Completed||Phase 3|216|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:31:35.298212|2017-10-11 01:31:35.298212
NCT01892891|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-12-27|||July 2013||2013-07-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|VBY036P1B||Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing|A Double-Blind, Randomized, Placebo-Controlled, Sequential, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of VBY-036 in Healthy Subjects|Completed||Phase 1|40|Actual|Virobay Inc.||2|||f||||t||||||||||2017-10-11 01:31:35.452097|2017-10-11 01:31:35.452097
NCT01892878|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-01|||July 2013||2013-07-01|July 2013|2013-07-01||||July 2015|Anticipated|2015-07-01||Interventional|||Clinical Outcome and Fusion Results Using the VerteLoc® Facet Fixation Device|A Prospective, Single Arm Clinical Trial Evaluating Clinical Outcome and Fusion Results Using the VerteLoc® Facet Fixation Device|Unknown status|Not yet recruiting|N/A|25|Anticipated|VG Innovations, LLC||1|||f||||f||||||||||2017-10-11 01:31:35.554955|2017-10-11 01:31:35.554955
NCT01892852|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-07-16|||June 2013||2013-06-01|July 2013|2013-07-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Acupuncture for Chemotherapy-induced Peripheral Neuropathy|Acupuncture Therapy for Chemotherapy-induced Peripheral Neuropathy in Lymphoma or Multiple Myeloma Patients: a Pilot Study|Unknown status|Recruiting|N/A|36|Anticipated|Pusan National University Hospital||2|||f||||f||||||||||2017-10-11 01:31:35.74635|2017-10-11 01:31:35.74635
NCT01892839|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-07-09|||July 2013||2013-07-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis|Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis|Unknown status|Recruiting|N/A|24|Anticipated|Palo Alto Veterans Institute for Research||2|||f||||t||||||||||2017-10-11 01:31:35.846955|2017-10-11 01:31:35.846955
NCT01892826|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-03|||February 2009||2009-02-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|February 2012|Actual|2012-02-01||Interventional|||Frozen Blastocyst Transfer in Natural Cycle|Cryopreserved Thawed Blastocyst Transfer in Natural Cycle With or Without hCG Administration|Completed||N/A|120|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 01:31:35.938157|2017-10-11 01:31:35.938157
NCT01892813|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-07-06|||July 2013||2013-07-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers|Tailored Tobacco Intervention|Active, not recruiting||Phase 3|411|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 01:31:36.022244|2017-10-11 01:31:36.022244
NCT01892800|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-05-12|||August 2013||2013-08-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|September 2014|Actual|2014-09-01||Observational|||Right Side of Heart Function After Lung Surgery|The Pulmonary Vascular / Right Ventricular Response to Lung Resection|Active, not recruiting||N/A|25|Anticipated|University of Glasgow|||1||f||||f||||||Samples Without DNA|"     Blood Endo-bronchial aspirate   "|||2017-10-11 01:31:36.149952|2017-10-11 01:31:36.149952
NCT01892787|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-03-04|||July 2013||2013-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MAN03||Effects of Particle Size in Small Airways Dysfunction|Randomised Controlled Single and Chronic Dosing Crossover Comparison of Extra Fine Particle Formoterol and Coarse Particle Salmeterol in Asthmatic Patients With Persistent Small Airways Dysfunction|Completed||Phase 4|17|Actual|University of Dundee||2|||f||||f||||||||||2017-10-11 01:31:36.247732|2017-10-11 01:31:36.247732
NCT01892774|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-10-17|||January 2010||2010-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|Exercise||Impact of the Pulmonary Vein Isolation on Exercise Capacity in Patients With Chronic Atrial Fibrillation|Impact of the Pulmonary Vein Isolation on Exercise Capacity in Patients With Chronic Atrial Fibrillation|Recruiting||N/A|150|Anticipated|Texas Cardiac Arrhythmia Research Foundation|||1||f||||f||||||||||2017-10-11 01:31:36.344864|2017-10-11 01:31:36.344864
NCT01892761|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-07-03|||September 2002||2002-09-01|June 2013|2013-06-01|June 2005|Actual|2005-06-01|March 2003|Actual|2003-03-01||Observational|||MPA Pharmacokinetics in Renal Transplantation|THE PROFILE OF MYCOPHENOLIC ACID IN CONSECUTIVE PHARMACOKINETICS AFTER RENAL TRANSPLANTATION:EFFECTS OF TIME AND CALCINEURIN-INHIBITORS|Completed||N/A|52|Actual|University of Sao Paulo General Hospital|||2||f||||f||||||||||2017-10-11 01:31:36.456331|2017-10-11 01:31:36.456331
NCT01892748|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-05-10|||July 2012||2012-07-01|May 2016|2016-05-01|February 2014|Actual|2014-02-01|August 2013|Actual|2013-08-01||Interventional|||Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus.|Effects of Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Onset Systemic Lupus Erythematosus.|Completed||N/A|60|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:31:36.550736|2017-10-11 01:31:36.550736
NCT01892722|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-08-22|||July 26, 2013|Actual|2013-07-26|August 2017|2017-08-01|March 15, 2023|Anticipated|2023-03-15|March 15, 2023|Anticipated|2023-03-15||Interventional|||Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis|Two-year, Double-blind, Randomzied, Multicenter, Active-controlled Study to Evaluate Safety and Efficacy of Oral Fingolimod Versus Interferon Beta-1a i.m. in Pediatric Patients With Multiple Sclerosis|Active, not recruiting||Phase 3|208|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:31:36.68601|2017-10-11 01:31:36.68601
NCT01892709|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-07-01|||June 2013||2013-06-01|July 2013|2013-07-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Titration of Intravenous Hydromorphone|Titration of Intravenous Hydromorphone in Adult Emergency Department Patients With Pain|Unknown status|Recruiting|Phase 4|286|Anticipated|Montefiore Medical Center||1|||f||||f||||||||||2017-10-11 01:31:36.933514|2017-10-11 01:31:36.933514
NCT01892696|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-11-07|||May 2013||2013-05-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Inspiratory Flow Waveforms on Preload|Arterial Pulse Pressure Variation and Inferior Vena Cava Distensibility Affected by Inspiratory Flow Waveforms in Mechanically Ventilated Patients: Time for a Change|Completed||N/A|60|Actual|Military Hospital of Tunis||1|||f||||t||||||||||2017-10-11 01:31:37.031833|2017-10-11 01:31:37.031833
NCT01892683|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-11-11|||May 2013||2013-05-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Breath Monitoring of Propofol (Observational Study)|Breath Monitoring of Propofol in Patients Undergoing Anesthesia for Surgical Procedures(Observational Study)|Completed||N/A|30|Actual|Ludwig-Maximilians - University of Munich|||1||f||||f||||||Samples Without DNA|"     Blood plasma   "|||2017-10-11 01:31:37.114809|2017-10-11 01:31:37.114809
NCT01892670|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-08-08|||March 2013||2013-03-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|BFF||Storage Temperature and Quality of Leucoreduced Whole Blood|Storage Temperature and Quality of Leucoreduced Whole Blood|Completed||N/A|87|Actual|Haukeland University Hospital||6|||f||||f||||||||||2017-10-11 01:31:37.191342|2017-10-11 01:31:37.191342
NCT01892657|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2013-07-23|2013-07-23||March 2008||2008-03-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional||All subjects who were enrolled in the study and participated in all scheduled visits during the study were analyzed.|Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test|Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Semi-occlusive Patch)|Completed||Phase 4|128|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:31:37.473383|2017-10-11 01:31:37.473383
NCT01892644|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-01-20|||May 2013||2013-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|DefeHEMY||Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome|Deferasirox Versus Venesection in Patients With Hemochromatosis and for Treatment of Transfusional Siderosis in Myelodysplastic Syndrome: Diagnostics and New Biomarkers.|Terminated||Phase 2|50|Actual|Haukeland University Hospital||4||Failure to recruit patients with hemochromatosis to the Deferasirox arm|f||||f||||||||||2017-10-11 01:31:37.793512|2017-10-11 01:31:37.793512
NCT01892631|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-10-21|||September 2013||2013-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TXT4FLUJAB||Text Messaging Reminders for Influenza Vaccine in Primary Care|A Feasibility Study for a Cluster Randomised Trial of Text Messaging Reminders for Influenza Vaccine in Patients Under 65 in Clinical Risk Groups in English Primary Care.|Completed||N/A|156|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 01:31:37.907832|2017-10-11 01:31:37.907832
NCT01892618|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-01-14|||August 2013||2013-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pneumococcal Vaccine in Untreated CLL Patients|A Randomized Phase III Trial to Determine Whether Conjugated Pneumococcal Vaccine Can Improve the Immune Responsiveness Compared to Polyclonal Pneumococcal Vaccine in Patients With Untreated Chronic Lymphocytic Leukemia|Completed||Phase 3|134|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 01:31:37.979682|2017-10-11 01:31:37.979682
NCT01892605|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-07-01|||April 2009||2009-04-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||The Clinical Application and Mechanism of Music Therapy (Mozart's Effect) on Epilepsy|The Clinical Application and Mechanism of Music Therapy (Mozart's Effect) on Epilepsy|Completed||N/A|46|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||||2017-10-11 01:31:38.062476|2017-10-11 01:31:38.062476
NCT01892592|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-10-04|||June 2013||2013-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|DIADS||Discovering Healthcare Innovations to Address Disparities in Stroke (DIADS)|Discovering Healthcare Innovations to Address Disparities in Stroke|Completed||N/A|3698|Actual|Kaiser Permanente||3|||f||||f||||||||||2017-10-11 01:31:38.149562|2017-10-11 01:31:38.149562
NCT01892566|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-08-29|||September 2013||2013-09-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|mReach||Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV|Using mHealth to Respond Early to Acute Exacerbations of COPD in HIV (mREACH)|Recruiting||N/A|200|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 01:31:38.320013|2017-10-11 01:31:38.320013
NCT01892553|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2014-05-05|||July 2013||2013-07-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|tDCS-Dyspnea||Effect of Non Invasive Brain Stimulation on Experimentally Induced Dyspnea (Breathlessness)|Effect of Transcranial Direct Current Stimulation (tDCS) on Acutely Induced Dyspnea in Healthy Volunteers : a Pilot Study|Completed||N/A|30|Actual|Centre d'Investigation Clinique et Technologique 805||2|||f||||t||||||||||2017-10-11 01:31:38.411362|2017-10-11 01:31:38.411362
NCT01892540|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-11-06|||May 2013||2013-05-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer|Positron Mammographic Imaging (PMI)|Completed||N/A|43|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:31:38.603788|2017-10-11 01:31:38.603788
NCT01892527|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-02-15|||March 2013||2013-03-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|May 2016|Anticipated|2016-05-01||Interventional|||Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects|A Single-Arm Phase II Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects With Locally Advanced or Metastatic Colorectal Cancer With Wild-Type KRAS|Active, not recruiting||Phase 2|43|Actual|Istituto Clinico Humanitas||1|||f||||t||||||||||2017-10-11 01:31:38.735196|2017-10-11 01:31:38.735196
NCT01892514|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-03-07|||April 2013||2013-04-01|April 2014|2014-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|AVN-13||Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral Head|Combined Treatment of Early and Advanced Osteonecrosis of the Femoral Head With Core Decompression and Grafting With Demineralized Bone Matrix (DBM) or Homologous Lyophilized Bone Chips (LBC) Together With Platelet-rich-fibrin (PRF) and Concentrated Bone Marrow (CBM)|Recruiting||Phase 3|104|Anticipated|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-11 01:31:38.846712|2017-10-11 01:31:38.846712
NCT01892501|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-09-28|||March 8, 2013|Actual|2013-03-08|November 2016|2016-11-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|APOGEE||Feasability Study on the Contribution of Guided Puncture With Echoendoscopy|Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy in Evaluation of Hypermetabolic Lymphadenopathy Mediastinum Lower, Rear and Middle, Detected in PET-CT to 18 FDG (PET)|Recruiting||N/A|100|Anticipated|Institut Bergonié||1|||f||||f||||||||||2017-10-11 01:31:38.976804|2017-10-11 01:31:38.976804
NCT01892488|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-02-22|||June 2013||2013-06-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|April 2018|Anticipated|2018-04-01||Interventional|||Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD|Randomized Double Blind Placebo-controlled Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD - The ABACOPD Study|Recruiting||Phase 4|980|Anticipated|Hannover Medical School||2|||f||||t||||||||||2017-10-11 01:31:39.101417|2017-10-11 01:31:39.101417
NCT01892475|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2016-01-03|||November 2013||2013-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TAKSI||TAKing Steps for Incentives|TAKing Steps for Incentives (TAKSI) - A Randomized Controlled Trial to Motivate and Sustain Physical Activity Using Financial Incentives|Completed||N/A|314|Actual|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-11 01:31:39.255554|2017-10-11 01:31:39.255554
NCT01892462|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-04-05|||June 2012|Actual|2012-06-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|LIFEMARKER||Circulating Biomarkers and Ventricular Tachyarrhythmia|Circulating Biomarkers and Ventricular Tachyarrhythmia|Completed||N/A|220|Actual|Ochsner Health System|||1||f||||t||||||Samples With DNA|"     Blood samples will be stored frozen for future analysis.   "|||2017-10-11 01:31:39.365237|2017-10-11 01:31:39.365237
NCT01892449|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2014-05-22|||June 2013||2013-06-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of Different Inspiratory to Expiratory Ratios on Respiratory Mechanics and Oxygenation in Robot-assisted Laparoscopic Radical Prostatectomy With Steep Trendelenburg Position and Pneumoperitoneum||Completed||N/A|80|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:31:39.444758|2017-10-11 01:31:39.444758
NCT01892436|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-02-23|||September 30, 2013|Actual|2013-09-30|February 2017|2017-02-01|November 20, 2017|Anticipated|2017-11-20|November 20, 2017|Anticipated|2017-11-20||Interventional|FUTURE 1 ext||Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis|A Three-year Extension Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Psoriatic Arthritis|Active, not recruiting||Phase 3|461|Actual|Novartis||2|||f||||||||||||||2017-10-11 01:31:39.556827|2017-10-11 01:31:39.556827
NCT01892423|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-01|||August 2006||2006-08-01|June 2013|2013-06-01||||September 2006|Actual|2006-09-01||Interventional|||Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion|Daily Advance Cetaphil Moisturizing Lotion: Human Repeat Insult Patch Test|Completed||N/A|146|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:31:39.890516|2017-10-11 01:31:39.890516
NCT01892410|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-07-01|||December 2012||2012-12-01|June 2013|2013-06-01||||January 2013|Actual|2013-01-01||Interventional|||Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash|100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Semi-Occlusive Patch)|Completed||N/A|100|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:31:39.971279|2017-10-11 01:31:39.971279
NCT01892397|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-01-31|||June 2013|Actual|2013-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma|Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma|Active, not recruiting||N/A|6|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:31:40.088211|2017-10-11 01:31:40.088211
NCT01892384|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2015-07-21|||June 2013||2013-06-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Tolerability of BI 409306 in Patients With Schizophrenia|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 409306 Film-coated Tablets Given Orally q.d. for 14 Days in Patients With Schizophrenia (Randomized, Parallel-group, Double-blind, Placebo-controlled Study)|Completed||Phase 1|40|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 01:31:40.193151|2017-10-11 01:31:40.193151
NCT01892371|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-08-16|||November 2013|Actual|2013-11-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||AC220 With 5-Aza or Low Dose Cytarabine|Phase I/II Study of the Combination of Quizartinib (AC220) With 5-Azacytidine or Low-Dose Cytarabine for the Treatment of Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Recruiting||Phase 1/Phase 2|64|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 01:31:40.316149|2017-10-11 01:31:40.316149
NCT01892358|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-07-17|||September 2013||2013-09-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Preventing Bacterial and Viral Infections Among Injection Drug Users|Preventing Bacterial and Viral Infections Among Injection Drug Users|Recruiting||N/A|350|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-11 01:31:40.442255|2017-10-11 01:31:40.442255
NCT01892345|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-09-26|||January 2014||2014-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Double Blind Trial To Evaluate The Safety And Efficacy Of Eculizumab In Relapsing NMO Patients (PREVENT Study)|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients With Relapsing Neuromyelitis Optica (NMO)|Active, not recruiting||Phase 3|132|Anticipated|Alexion Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:31:40.536814|2017-10-11 01:31:40.536814
NCT01892332|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2014-07-24|||June 2013||2013-06-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly Patients||Completed||N/A|20|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 01:31:40.949367|2017-10-11 01:31:40.949367
NCT01892319|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-09-19|||September 30, 2013|Actual|2013-09-30|September 2017|2017-09-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Observational|||An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry|An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Levemir® (Insulin Detemir) in Pregnant Women With Diabetes Mellitus|Enrolling by invitation||N/A|3055|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:31:41.038421|2017-10-11 01:31:41.038421
NCT01892306|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-05-10|2016-03-21||June 2013||2013-06-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pilot Study of Cognitive Behavioral Therapy for Anxiety and Bipolar I Disorder|Transdiagnostic Treatment for Anxiety and Bipolar I Disorder|Completed||N/A|34|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:31:41.323051|2017-10-11 01:31:41.323051
NCT01892293|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-06-28|||July 2013||2013-07-01|June 2017|2017-06-01|April 2031|Anticipated|2031-04-01|December 2017|Anticipated|2017-12-01||Interventional|||CT Antigen TCR-Engineered T Cells for Myeloma|A Phase I/IIa, Open Label, Multiple Site Clinical Trial Evaluating the Safety and Activity of Engineered Autologous T Cells Expressing an Affinity-enhanced TCR Specific for NY-ESO-1 and LAGE-1 in Patients With Relapsed or Progressive Disease in Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|10|Anticipated|Adaptimmune||1|||f||||f||||||||||2017-10-11 01:31:41.87149|2017-10-11 01:31:41.87149
NCT01892280|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-08-01|||November 2013||2013-11-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|||Optimizing Self-Management Adherence and Glycemic Control in Older Teens With Type 1 Diabetes: The Teenwork Study|Optimizing Self-Management Adherence and Glycemic Control in Older Teens With Type 1 Diabetes: The Teenwork Study|Completed||N/A|310|Actual|Joslin Diabetes Center||4|||f||||t||||||||||2017-10-11 01:31:41.946433|2017-10-11 01:31:41.946433
NCT01892267|ClinicalTrials.gov processed this data on October 10, 2017|2013-07-01|2017-04-13|2016-08-19||September 6, 2013|Actual|2013-09-06|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT|Comparison Outcomes and Complications of Self-Propelled vs. Standard Percutaneous Endoscopic Gastrojejunostomy (PEG-J); a Randomized Single Blind Clinical Trial|Terminated||Phase 2|19|Actual|Johns Hopkins University||2||Study was terminated prematurely as costs incurred were more than the available funds.|f||||t||||||||||2017-10-11 01:31:42.032658|2017-10-11 01:31:42.032658
NCT01892254|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-05-02|||June 2013||2013-06-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|||Incretin Effect in PCOS Women|Inkretineffekten Hos Patienter Med Polycystisk Ovariesyndrom før og Efter Behandling af Insulinresistens (Incretin Effect in Patients With Polycystic Ovary Syndrome Before and After Treatment of Insulin Resistance)|Recruiting||Phase 4|20|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-10-11 01:31:44.033416|2017-10-11 01:31:44.033416
NCT01892241|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2013-09-28|||January 2010||2010-01-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNA||Completed||Phase 3|74|Actual|Third Affiliated Hospital, Sun Yat-Sen University||3|||f||||t||||||||||2017-10-11 01:31:44.121739|2017-10-11 01:31:44.121739
NCT01892215|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2017-06-20|||October 2012||2012-10-01|June 2017|2017-06-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad,|Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad. A Randomized, Controlled Trial.|Completed||N/A|839|Actual|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-11 01:31:44.308118|2017-10-11 01:31:44.308118
NCT01892202|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-10-26|||February 2011||2011-02-01|October 2016|2016-10-01|February 2011|Anticipated|2011-02-01|February 2011|Anticipated|2011-02-01||Expanded Access|||A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on Dialysis|Efficacy of C.E.R.A for Correction of Anemia and Maintenance of the Hb Levels in CKD Patients in Stage III - IV , Not on Dialysis , Treated According to Routine Clinical Practice|No longer available||N/A|||Hoffmann-La Roche||||Investigators lost interest in conducting the trail due to unexplained reasons|f||||||||||||||2017-10-11 01:31:44.403719|2017-10-11 01:31:44.403719
NCT01892189|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-11-11|2016-11-11||August 2013||2013-08-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Randomized set included all participants who were randomized to either 1 of the 9 treatment sequences.|Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults|A Randomized, Investigator and Subject-Blind, Placebo-Controlled, Single-Dose, 3-Period, Incomplete Block Cross-Over Study to Evaluate the Effects of Single Oral Administration of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults|Completed||Phase 1|27|Actual|Takeda||9|||f||||f||||||||||2017-10-11 01:31:44.518598|2017-10-11 01:31:44.518598
NCT01892176|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2013-07-08|||June 2012||2012-06-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of High-dose Coenzyme Q10 on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson Disease|Effects of High-dose Coenzyme Q10 on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson Disease|Completed||Phase 2/Phase 3|20|Actual|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 01:31:46.809391|2017-10-11 01:31:46.809391
NCT01892163|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-01-03|2016-09-13||March 2013||2013-03-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|OZDRY||Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone|A Multicentre Prospective Open-label Randomised Clinical Trial Comparing the Efficacy of Fixed Versus PRN Dosing of 700 μg Dexamethasone Posterior Segment Drug Delivery System (Ozurdex) in Patients With Refractory Diabetic Macular Oedema|Completed||Phase 3|100|Actual|Moorfields Eye Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:31:46.90939|2017-10-11 01:31:46.90939
NCT01892150|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2014-03-27|||March 2013||2013-03-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Histologic Response to UVA and UVB Exposure During the Use of Sunscreen|Histologic Response to UVA and UVB Exposure During the Use of Sunscreen With Anti-inflammatory and Anti-oxidant Properties - A Pilot Study|Completed||N/A|2|Actual|Mahidol University||1|||f||||t||||||||||2017-10-11 01:31:47.468337|2017-10-11 01:31:47.468337
NCT01892137|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2016-04-04|||July 2013||2013-07-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%|Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%|Completed||Phase 1|137|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-11 01:31:47.56381|2017-10-11 01:31:47.56381
NCT01892124|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-12-11|||November 2013||2013-11-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms|Healthy Hearts, Healthy Minds|Completed||N/A|34|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 01:31:47.674223|2017-10-11 01:31:47.674223
NCT01892111|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2013-06-28|||October 2013||2013-10-01|June 2013|2013-06-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Interventional|SETART||Physical Activity and ARTs|Structured Exerise Training in Infertile Obese Patients Treated With Assisted Reproductive Techniques: a Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|University of Modena and Reggio Emilia||2|||f||||||||||||||2017-10-11 01:31:47.795283|2017-10-11 01:31:47.795283
NCT01892098|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2013-07-02|||February 2007||2007-02-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Zinc and Bone Turnover Study in Adolescent Females|Supplemental Zinc and Bone Turnover in Early Pubertal Females|Completed||N/A|147|Actual|University of Georgia||2|||f||||t||||||||||2017-10-11 01:31:47.929636|2017-10-11 01:31:47.929636
NCT01892085|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-09-07|||November 2013||2013-11-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Early Initiation of Milk Expression in Mothers of Very Low Birth Weight Infants|Adequate Breast Milk for Improved Health of Very Low Birth Weight Preterm Infants|Completed||N/A|414|Actual|University of Florida||3|||f||||f|f|f||||||||2017-10-11 01:31:48.015552|2017-10-11 01:31:48.015552
NCT01892072|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2013-07-10|||October 2012||2012-10-01|July 2013|2013-07-01|March 2014|Anticipated|2014-03-01|October 2013|Anticipated|2013-10-01||Observational|HCC||VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway|VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway|Unknown status|Active, not recruiting|N/A|50|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||f||||||Samples Without DNA|"     Cut tissue into small pieces (~2 mm2)and wash in drops of saline (1x PBS). Place pieces     individually into LN2 in Styrofoam cup. Transfer pieces into LN2-cooled 1.5 mL cryovial. Pour     out excess LN2 from vial, then seal and keep in LN2 until freezer storage.   "|||2017-10-11 01:31:48.131995|2017-10-11 01:31:48.131995
NCT01892059|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2013-07-02|||May 2013||2013-05-01|June 2013|2013-06-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy|A Randomized Controlled Trial Comparing the Segmental Artery Clamping and Main Renal Artery Clamping During Laparoscopic Partial Nephrectomy|Unknown status|Recruiting|N/A|100|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||f||||||||||2017-10-11 01:31:48.221937|2017-10-11 01:31:48.221937
NCT01892046|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-30|2017-07-25|||November 2013||2013-11-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|February 2017|Actual|2017-02-01||Interventional|||Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors|A Phase 1, Open-label, Dose-escalation Study of SNX 5422 Plus Carboplatin and Paclitaxel in Subjects With Selected Solid Tumors.|Completed||Phase 1|18|Actual|Esanex Inc.||1|||f||||f||||||||||2017-10-11 01:31:48.368406|2017-10-11 01:31:48.368406
NCT01892033|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-09-23|||August 2011||2011-08-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Pilot Exercise Study for PTSD in Women Veterans|Aerobic Exercise: Feasibility and Safety Assessment in Women Veterans With PTSD (AESAP)|Completed||N/A|31|Actual|North Texas Veterans Healthcare System||1|||f||||f||||||||||2017-10-11 01:31:48.486381|2017-10-11 01:31:48.486381
NCT01891838|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-29|2016-10-28|||June 2013||2013-06-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Vent-Hyp||Mode of Ventilation and Bleeding During Transsphenoidal Surgery|Transsphenoidal Surgery for Pituitary Adenomas: Influence of the Ventilation Mode on Intraoperative Bleeding|Completed||N/A|101|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 01:31:52.676903|2017-10-11 01:31:52.676903
NCT01892020|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-06-16|2015-05-04||June 2013||2013-06-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus|A Multi-centre, Randomised, Open-labelled, 2-sequence, 2-period Crossover Trial to Investigate the Efficacy and Safety of Biphasic Insulin Aspart 50 (BIAsp 50) Twice Daily Versus Biphasic Human Insulin 50 (BHI 50) Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|161|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:31:48.600394|2017-10-11 01:31:48.600394
NCT01892007|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-11-10|||September 2012||2012-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|TEACH2||Evaluation of Cogmed Working Memory Training for Adult Hearing Aid Users|Evaluation of Cogmed Working Memory Training to Improve Cognition, Speech Perception and Self-reported Hearing Abilities for Adult Hearing Aid Users: a Double-blind, Randomised, Active-controlled Trial.|Completed||Phase 2|62|Anticipated|Nottingham University Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 01:31:48.971859|2017-10-11 01:31:48.971859
NCT01891994|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-08-04|||June 17, 2013||2013-06-17|July 27, 2017|2017-07-27|May 1, 2020|Anticipated|2020-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Extended Dosing With Eltrombopag for Severe Aplastic Anemia|Extended Dosing With Eltrombopag in Refractory Severe Aplastic Anemia|Active, not recruiting||Phase 2|38|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:31:49.069658|2017-10-11 01:31:49.069658
NCT01891981|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-04-13|||December 17, 2013|Actual|2013-12-17|April 2017|2017-04-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|||Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)|Phase I/II Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1/Phase 2|16|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:31:49.156231|2017-10-11 01:31:49.156231
NCT01891968|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-01-24|||August 7, 2013|Actual|2013-08-07|January 2017|2017-01-01|January 18, 2017|Actual|2017-01-18|January 18, 2017|Actual|2017-01-18||Interventional|||Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation|Phase II Study of Subcutaneous Bortezomib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome|Completed||Phase 2|15|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:31:49.240341|2017-10-11 01:31:49.240341
NCT01891955|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-03-20|||November 2013||2013-11-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ADILAN||Alimentation and Diabetes in Lanzarote - ADILAN: a Pilot Trial|Alimentation and Diabetes in Lanzarote - ADILAN: a Randomized Cross-over Pilot Trial Comparing a Healthy Diet With Grains and Dairy to a Healthy Diet Without Grains and Dairy in Patients With Type 2 Diabetes|Completed||N/A|14|Actual|Lund University||2|||f||||||||||||||2017-10-11 01:31:49.364452|2017-10-11 01:31:49.364452
NCT01891942|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-02|||June 2012||2012-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Influence of Trigger Threshold on Controlled Twitch Mouth Pressure|Influence of Trigger Threshold on Controlled Twitch Mouth Pressure|Completed||N/A|30|Actual|Guangzhou Institute of Respiratory Disease||2|||f||||t||||||||||2017-10-11 01:31:49.467272|2017-10-11 01:31:49.467272
NCT01891929|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-02-22|||July 2013|Actual|2013-07-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|RemedRehab||Cognitive Remediation and Sheltered Employment in Schizophrenia|Specific Cognitive Remediation for Schizophrenia (RECOS) and Sheltered Employment: a Multicentre Controlled Randomized Trial.|Recruiting||N/A|260|Anticipated|Hôpital le Vinatier||2|||f||||t||||||||No||2017-10-11 01:31:49.550967|2017-10-11 01:31:49.550967
NCT01891916|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2013-07-15|||October 2008||2008-10-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect Of Lactobacillus GG on Atopic March|Preventive Effect of Lactobacillus GG on Atopic Manifestation in Children With Cow's Milk Allergy|Unknown status|Recruiting|N/A|180|Anticipated|Federico II University||2|||f||||f||||||||||2017-10-11 01:31:49.705381|2017-10-11 01:31:49.705381
NCT01891903|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-28|||May 2013||2013-05-01|June 2013|2013-06-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01|20 Days|Observational [Patient Registry]|spanishTopas||to Translate and Validate the TOPAS TORONTO PSORIATIC SCREENING QUESTIONNAIRE)Into Spanish|TO TRANSLATE AND VALIDATE THE ToPAS (TORONTO PSORIATIC SCREENING QUESTIONNAIRE) FOR THE SCREENING OF PSORIATHIC ARTHRITIS PATIENTS IN DERMATOLOGY CLINICS|Unknown status|Recruiting|N/A|60|Anticipated|Reumatologia Integral LTDA|||1||f||||t||||||||||2017-10-11 01:31:49.791279|2017-10-11 01:31:49.791279
NCT01891890|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2017-08-20|2017-07-14||August 2013||2013-08-01|July 2017|2017-07-01|October 23, 2015|Actual|2015-10-23|October 23, 2015|Actual|2015-10-23||Interventional|COPE|Patients who were eligible to participate and were randomized to a study arm are included in the baseline description.|Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)|Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)|Terminated||Phase 3|72|Actual|Emory University|The study was terminated early due to inability to meet enrollment goals.|3||Poor recruitment|f||||f|t|f||||||||2017-10-11 01:31:50.010061|2017-10-11 01:31:50.010061
NCT01891877|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2014-10-17|||October 2012||2012-10-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Sickle Cell Trait in Football Players|Is Sickle Cell Trait as Benign as is Usually Assumed?|Unknown status|Recruiting|N/A|20|Anticipated|University of South Florida|||1||f||||f||||||Samples With DNA|"     Buccal swabs will be collected from each participant.   "|||2017-10-11 01:31:50.840205|2017-10-11 01:31:50.840205
NCT01891864|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-02-06|2016-09-26||June 2013||2013-06-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Interventional|EGALITY|All patients randomized in GP15-302 study|Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel|A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Etanercept (GP2015) and Enbrel® in Patients With Moderate to Severe Chronic Plaque-type Psoriasis|Completed||Phase 3|531|Actual|Sandoz|None reported|2|||f||||t||||||||No||2017-10-11 01:31:50.963489|2017-10-11 01:31:50.963489
NCT01891851|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2013-10-11|||October 2007||2007-10-01|October 2013|2013-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Drug-drug Interaction Between Ritonavir and TMC435350 in Healthy Volunteers|Phase I, Open-label Trial in Healthy Subjects to Evaluate the Drug-drug Interaction Between Ritonavir at Steady-state and TMC435350, a Viral Protease Inhibitor Against Hepatitis C Virus, After the First and the Last Dose of a Multiple Dosing Regimen|Completed||Phase 1|12|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||f||||||||||2017-10-11 01:31:52.588586|2017-10-11 01:31:52.588586
NCT01891799|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-01-28|||August 2013||2013-08-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Swaziland Safe Generations|Situkulwane Lesiphephile-Safe Generations: Improving Approaches to Antiretroviral Therapy for HIV-Positive Pregnant Women|Active, not recruiting||N/A|4200|Anticipated|Columbia University|||1||f||||f||||||None Retained|"     50 microliters of capillary blood will be drawn via heelstick or finger prick phlebotomy from     infants using filter paper. Blood will be collected from infants at 6mos of age to conduct     DNA PCR HIV testing, specifically for this study.   "|||2017-10-11 01:31:52.964832|2017-10-11 01:31:52.964832
NCT01891786|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2016-08-03|||July 2013||2013-07-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CORDIA||Coronary Heart Disease Risk in Type 2 Diabetes|A Randomised Control Trial (RCT) to Investigate the Effectiveness of a Selfmanagement Intervention and Personalised Genetic Risk Information to Reduce Risk of Coronary Heart Disease in Patients With Type 2 Diabetes.|Completed||N/A|211|Actual|City, University of London||3|||f||||t||||||||No||2017-10-11 01:31:53.108282|2017-10-11 01:31:53.108282
NCT01891773|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-09-10|||August 2013||2013-08-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|ISIS||Improving Pediatric Asthma Care Through Inhaled Steroids in Schools|Improving Pediatric Asthma Care Through Inhaled Steroids in Schools (ISIS)|Completed||N/A|48|Actual|Children's Research Institute||2|||f||||f||||||||||2017-10-11 01:31:53.218816|2017-10-11 01:31:53.218816
NCT01891747|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-03-15|||July 2013||2013-07-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|February 2020|Anticipated|2020-02-01||Interventional|||A Phase I/II Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma|A Phase I/II Study of High-dose L-methylfolate in With Combination Temozolomide and Bevacizumab in Recurrent High Grade Glioma.|Active, not recruiting||Phase 1/Phase 2|12|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-11 01:31:53.591719|2017-10-11 01:31:53.591719
NCT01891734|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-10-17|2016-05-02||April 2014||2014-04-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Participants completed a demographic questionnaire, which inquired about age, race/ethnicity, gender, marital status, educational history, branch of military, war era, service connection, and familiarity with SmartPhone technology.|Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology|Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology|Completed||Phase 1/Phase 2|33|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 01:31:53.699516|2017-10-11 01:31:53.699516
NCT01891721|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-07-07|||November 21, 2013|Actual|2013-11-21|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia|Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia|Recruiting||N/A|120|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||||2017-10-11 01:31:54.124484|2017-10-11 01:31:54.124484
NCT01891708|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-07-02|||June 2013||2013-06-01|July 2013|2013-07-01|December 2018|Anticipated|2018-12-01|December 2014|Anticipated|2014-12-01|2 Months|Observational [Patient Registry]|||VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer|VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer|Recruiting||N/A|40|Anticipated|Huazhong University of Science and Technology|||1||f||||t||||||Samples Without DNA|"     peripheral blood   "|||2017-10-11 01:31:54.290352|2017-10-11 01:31:54.290352
NCT01891695|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-05-04|||June 2013||2013-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2016|Actual|2016-06-01||Interventional|||OPSCC N0 Nodal Control With Reduced IMRT|A Pilot Single Arm Study of Intensity Modulated Radiation Therapy Elective Nodal Dose De-Escalation for HPV-Associated Squamous Cell Carcinoma of the Oropharynx|Suspended||N/A|45|Anticipated|University of Virginia||1||To allow us to conduct investigations of recent advances in other treatment modalities|f||||t||||||||||2017-10-11 01:31:54.387741|2017-10-11 01:31:54.387741
NCT01891682|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-03-20|||October 2012||2012-10-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Methionine Metabolism in Parenterally Fed Pediatric Sepsis|Methionine Metabolism in Parenterally Fed Critically Ill Children|Completed||N/A|45|Actual|The Cleveland Clinic|||1||f||||t||||||Samples Without DNA|"     Blood Samples.   "|||2017-10-11 01:31:54.48989|2017-10-11 01:31:54.48989
NCT01891669|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-05-17|2016-05-17||August 2013||2013-08-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study Of PF-06263507 In Patients With Advanced Solid Tumors|A Phase 1, Dose Escalation Study Of PF-06263507 In Patients With Advanced Solid Tumors|Terminated||Phase 1|26|Actual|Pfizer|This study was terminated prematurely before treatment in Part 2 started due to a business-related decision.|1||"The study was terminated on June 23, 2015 due to the company's change in prioritization for the   portfolio and is not due to any safety concerns."|f||||f||||||||||2017-10-11 01:31:54.656304|2017-10-11 01:31:54.656304
NCT01891656|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-04-11|||June 2012||2012-06-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|June 2015|Actual|2015-06-01||Interventional|MAPIT||Motivational Assessment Program to Initiate Treatment|In-Person VS. Computer Interventions for Increasing Probation Compliance|Completed||N/A|380|Actual|University of North Texas Health Science Center||3|||f||||f||||||||No||2017-10-11 01:31:58.946609|2017-10-11 01:31:58.946609
NCT01891630|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-09-02|||July 2013||2013-07-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|TeenAire||Observational Assessment of Baseline Asthma Control in African-American Children|Observational Assessment of Baseline Asthma Control as a Susceptibility Factor for Air Pollution Health Effects in African-American Children With Moderate-severe Asthma (Teen AIRE Study)|Completed||N/A|25|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 01:31:59.351153|2017-10-11 01:31:59.351153
NCT01891604|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-05-11||||||May 2017|2017-05-01||||December 2016|Anticipated|2016-12-01||Interventional|||Study the Safety and Efficacy of Probiotics Use in Premature Infants|Study the Safety and Efficacy of Probiotics Use in Premature Infants|Withdrawn||N/A|0|Actual|University of Manitoba||||Study Never Initiated due to Impact approval from institution not being obtinaed|f||||t||||||||||2017-10-11 01:31:59.588745|2017-10-11 01:31:59.588745
NCT01891591|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-07-02|||March 2008||2008-03-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Assessment of Nutritional Status After Gastric Bypass Surgery|Assessment of Nutritional Status and Vitamin Deficiencies in Obese Subjects After Gastric Bypass Surgery|Completed||N/A|16|Actual|University of Lausanne|||1||f||||f||||||||||2017-10-11 01:31:59.672557|2017-10-11 01:31:59.672557
NCT01891578|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-06-28|||January 2011||2011-01-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation|Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation Using a Nonmyeloablative Preparative Regimen and Post-transplant Cyclophosphamide, in Patients With Poor Prognosis Lymphomas|Unknown status|Active, not recruiting|N/A|23|Actual|Istituto Clinico Humanitas|||1||f||||f||||||||||2017-10-11 01:31:59.785108|2017-10-11 01:31:59.785108
NCT01891565|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-06-28|||July 2013||2013-07-01|June 2013|2013-06-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Stroke Inpatients Rehabilitation Reinforcement of Activity|Stroke Inpatients Rehabilitation With Accelerometer-based Feedback Reinforcement of Activity|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Ibadan||2|||f||||t||||||||||2017-10-11 01:31:59.9058|2017-10-11 01:31:59.9058
NCT01891552|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-05-12|||May 2013||2013-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|12 Months|Observational [Patient Registry]|TACETUX||Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab|Observational Study on Second Line Treatment of Colorectal Liver Metastases (KRas wt) by Hepatic Intra-arterial Chemoembolization With Dc Beads 70-150 μm Microspheres Preloaded With Irinotecan 200 Mgr Plus Systemic Cetuximab|Completed||N/A|40|Actual|International Group of Endovascular Oncology|||2||f||||t||||||||||2017-10-11 01:32:00.440247|2017-10-11 01:32:00.440247
NCT01891539|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-08-02|||May 2013||2013-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01|12 Months|Observational [Patient Registry]|DEBDOX||Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma|Observational Prospective Study on Chemoembolization Using Doxorubicin Drug-eluting Bead in Patients With Unresectable Hepatocellular Carcinoma|Recruiting||N/A|100|Anticipated|International Group of Endovascular Oncology|||1||f||||t||||||||Yes||2017-10-11 01:32:00.570276|2017-10-11 01:32:00.570276
NCT01891526|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-28|||December 2010||2010-12-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Single Dose of 9-cis-retinoic Acid in Hepatic Patients|The Pharmacokinetics of a Single Dose of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Moderate to Severe Hepatic Insufficiency|Completed||N/A|20|Actual|University Hospital, Gentofte, Copenhagen|||2||f||||t||||||Samples Without DNA|"     Serum and urine   "|||2017-10-11 01:32:00.715988|2017-10-11 01:32:00.715988
NCT01891513|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-07-03|||January 2014|Actual|2014-01-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|ACES-P||ACE Inhibitors Combined With Exercise for Seniors - Pilot Study|Multimodal Intervention to Reduce Cardiovascular Risk Among Hypertensive Older Adults|Completed||N/A|104|Actual|University of Florida|||3||f||||t||||||||||2017-10-11 01:32:00.831371|2017-10-11 01:32:00.831371
NCT01891500|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-02-02|||May 2016|Actual|2016-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure|Effect of Early iNO on Oxidative Stress, Vascular Tone and Inflammation in Term and Late-Preterm Infants With Hypoxic Respiratory Failure|Recruiting||Phase 4|24|Anticipated|University of Florida||3|||f||||t|t|f||||||||2017-10-11 01:32:00.973165|2017-10-11 01:32:00.973165
NCT01891474|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-10-23|||August 2013||2013-08-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy and Safety of Voice Inception Technique Based U-healthcare Service in Patients With Type 2 Diabetes Mellitus|An Open, Parallel-group, Randomized, Interventional Study to Compare the Efficacy and Safety of Voice Inception Technique Based U-healthcare Service in Patients With Type 2 Diabetes Mellitus|Completed||N/A|70|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-10-11 01:32:01.339364|2017-10-11 01:32:01.339364
NCT01891461|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-08-08|||January 2012||2012-01-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study to Compare the Addition of Floseal to Our Standard of Care to Control Post Operative Bleeding in TKR|A Prospective, Randomized Study to Compare the Addition of Granules of Gelatine + Thrombin to Our Standard of Care (SOC) to Control Post Operative Bleeding in Total Knee Replacement|Completed||Phase 4|132|Actual|Hopital du Sacre-Coeur de Montreal||2|||f||||f||||||||||2017-10-11 01:32:01.472641|2017-10-11 01:32:01.472641
NCT01891448|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-03-20|||May 2013||2013-05-01|May 2013|2013-05-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|WebCONSORT||Web-based Tool to Improve Reporting of Randomized Controlled Trials|Impact of an Intervention Using a Web-based Tool to Improve the Reporting of Randomized Controlled Trials|Unknown status|Recruiting|N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:32:01.579528|2017-10-11 01:32:01.579528
NCT01891435|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-28|||January 2010||2010-01-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|December 2011|Actual|2011-12-01||Interventional|||The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.|A Randomized Controlled Clinical Trial on the Antipyretic Efficacy of Oral Paracetamol, Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever to Emergency Department|Completed||N/A|434|Actual|Hamad Medical Corporation||3|||f||||||||||||||2017-10-11 01:32:01.698462|2017-10-11 01:32:01.698462
NCT01891422|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-07-31|||August 2009||2009-08-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Longitudinal Studies of the Glycoproteinoses|Longitudinal Studies of the Glycoproteinoses|Recruiting||N/A|100|Anticipated|Greenwood Genetic Center|||1||f||||f||||||Samples With DNA|"     When applicable, plasma, white cells, fibroblasts, urine.   "|||2017-10-11 01:32:01.834313|2017-10-11 01:32:01.834313
NCT01891409|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-01-15|||July 2013||2013-07-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya|Use of the Shang Ring Device in All Four Childhood Age Groups in the African Population|Completed||N/A|80|Actual|EngenderHealth||1|||f||||t||||||||||2017-10-11 01:32:01.95378|2017-10-11 01:32:01.95378
NCT01891396|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2014-12-29|||June 2013||2013-06-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Cingal Study for Knee Osteoarthritis|A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee|Completed||N/A|368|Actual|Anika Therapeutics, Inc.||3|||f||||t||||||||||2017-10-11 01:32:02.049156|2017-10-11 01:32:02.049156
NCT01891383|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-12-30|||July 2013||2013-07-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Observational|||Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel|Endophenotypes of Dementia Associated With Traumatic Brain Injury in Retired Military Personnel|Recruiting||N/A|150|Anticipated|Uniformed Services University of the Health Sciences|||2||f||||f||||||||||2017-10-11 01:32:02.152571|2017-10-11 01:32:02.152571
NCT01891370|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-28|2015-09-25|||July 2013||2013-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Observational|||Median Study for Biochemical Serum Markers in First Trimester of Pregnancy||Completed||N/A|200|Actual|PerkinElmer, Wallac Oy|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:32:02.26608|2017-10-11 01:32:02.26608
NCT01891357|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-08-06|||June 2013||2013-06-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer|A Multicenter Site, Open Label, Phase II Trial to Validate Predictive Markers for the Response Evaluation of a Combined Chemo-immunotherapy in Patients With HER2-positive Early Breast Cancer|Unknown status|Recruiting|Phase 2|80|Anticipated|West German Study Group||1|||f||||t||||||||||2017-10-11 01:32:02.345767|2017-10-11 01:32:02.345767
NCT01891344|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-06-13|||September 2013||2013-09-01|June 2017|2017-06-01||||April 2017|Actual|2017-04-01||Interventional|ARIEL2||A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)|A Phase 2, Open-Label Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)|Active, not recruiting||Phase 2|480|Anticipated|Clovis Oncology, Inc.||1|||f||||f||||||||||2017-10-11 01:32:02.520305|2017-10-11 01:32:02.520305
NCT01891331|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-12-22|||August 2013||2013-08-01|March 2014|2014-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Acute Vaginal Candidiasis (Yeast Infection)|A Phase 2a, Randomized, Double-Blind, Dose Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets Compared to Fluconazole in the Treatment of Patients With Moderate to Severe Acute Vulvovaginal Candidiasis|Completed||Phase 2|55|Actual|Viamet||2|||f||||f||||||||||2017-10-11 01:32:03.037017|2017-10-11 01:32:03.037017
NCT01891318|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-03-27|||July 2013||2013-07-01|March 2017|2017-03-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study|Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study|Recruiting||N/A|36|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-11 01:32:03.149562|2017-10-11 01:32:03.149562
NCT01891305|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-12-22|||August 2013||2013-08-01|October 2014|2014-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets in the Treatment of Patients With Moderate to Severe Interdigital Tinea Pedis|Completed||Phase 2|50|Actual|Viamet||2|||f||||f||||||||||2017-10-11 01:32:03.257228|2017-10-11 01:32:03.257228
NCT01891292|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-06-27|||July 2013||2013-07-01|June 2013|2013-06-01|September 2015|Anticipated|2015-09-01|August 2014|Anticipated|2014-08-01||Interventional|||Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy|A Phase 2 Study of the Efficacy of Antioxidant Therapy Compared With Enalapril in Slowing the Progression of Sickle Nephropathy in Children|Unknown status|Not yet recruiting|N/A|30|Anticipated|The University of The West Indies||3|||f||||t||||||||||2017-10-11 01:32:03.347122|2017-10-11 01:32:03.347122
NCT01891279|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2014-03-28|||November 2011||2011-11-01|March 2014|2014-03-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|||Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?|The Use of Elemental Formula in Neonates Post Small Bowel Resection: Improved Success to Wean From Total Parenteral Nutrition?|Unknown status|Recruiting|N/A|40|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 01:32:03.440998|2017-10-11 01:32:03.440998
NCT01891266|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-27|||September 2013||2013-09-01|June 2013|2013-06-01|September 2016|Anticipated|2016-09-01|November 2014|Anticipated|2014-11-01||Interventional|||Effects of Tourniquet Use on Physical Function and Performance in Primary Total Knee Arthroplasty|Effects of Tourniquet Use on Physical Function and Performance in Primary Total Knee Arthroplasty: A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|80|Anticipated|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 01:32:03.581476|2017-10-11 01:32:03.581476
NCT01891253|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-10-24|||March 2013||2013-03-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Observational|VIGR||Inert Gas Rebreathing in Ventilated Patients|Feasibility of the Non-invasive Determination of Cardiac Output Using Inert Gas Rebreathing in Ventilated Patients|Recruiting||N/A|50|Anticipated|Universitätsmedizin Mannheim|||1||f||||t||||||||||2017-10-11 01:32:03.675561|2017-10-11 01:32:03.675561
NCT01890317|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-05-01|||August 2012||2012-08-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|SHOCK-COOL||Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction|Randomized Pilot Study of Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction|Completed||N/A|40|Anticipated|University of Leipzig||2|||f||||f||||||||||2017-10-11 01:32:20.537852|2017-10-11 01:32:20.537852
NCT01891240|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-11-07|||November 2013||2013-11-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Observational|IMPROvED||IMproved PRegnancy Outcome by Early Detection|Personalized Medicine for Pregnant Women: Novel Metabolomic and Proteomic Biomarkers to Detect Pre-eclampsia and Improve Outcome.|Recruiting||N/A|5000|Anticipated|University College Cork|||1||f||||f||||||Samples With DNA|"     EDTA plasma and serum. Optional urine, hair and baby cord samples   "|||2017-10-11 01:32:03.761482|2017-10-11 01:32:03.761482
NCT01891227|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-09-08|||August 2013||2013-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MBC-6||Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer|Capecitabine in Combination With Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer, a Phase II Trial|Active, not recruiting||Phase 2|40|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||||2017-10-11 01:32:04.013717|2017-10-11 01:32:04.013717
NCT01891214|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-02-14|||December 2013|Actual|2013-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|April 2016|Actual|2016-04-01||Observational|F-IBDQ||Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease|Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease|Completed||N/A|100|Actual|Rennes University Hospital|||1||f||||t||||||||||2017-10-11 01:32:04.145228|2017-10-11 01:32:04.145228
NCT01891201|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-27|||March 2011||2011-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01|6 Months|Observational [Patient Registry]|||Intrapartum Oxytocin Administration Affects Primitive Neonatal Reflexes||Completed||N/A|98|Actual|Puerta de Hierro University Hospital|||1||f||||f||||||||||2017-10-11 01:32:04.253461|2017-10-11 01:32:04.253461
NCT01891188|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-06-29|||June 2013||2013-06-01|June 2013|2013-06-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Observational|||Using Near-infrared Spectroscopy (NIRS) Monitor to Noninvasively Evaluate Hepatic Venous Saturation|Using Near-infrared Spectroscopy (NIRS) Monitor to Noninvasively Evaluate Hepatic Venous Saturation|Unknown status|Active, not recruiting|N/A|100|Anticipated|Phoenix Children's Hospital|||1||f||||t||||||||||2017-10-11 01:32:04.369325|2017-10-11 01:32:04.369325
NCT01891175|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-02-22|||May 2013||2013-05-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|||Prevention of Maternal Hypotension During Elective Caesarean Section Performed With Spinal Anaesthesia, Through Intermittent Pneumatic Compression System in the Lower Extremities|Prevention of Maternal Hypotension During Elective Caesarean Section Performed With Spinal Anaesthesia, Through Intermittent Pneumatic Compression System in the Lower Extremities.|Completed||N/A|120|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 01:32:04.464664|2017-10-11 01:32:04.464664
NCT01891162|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2013-08-30|||December 2013||2013-12-01|August 2013|2013-08-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01|1 Day|Observational [Patient Registry]|||Assessment of Socioeconomic Status by Brazil and Quality of Life for Urinary Incontinence in Brazilian Women|Socioeconomic Profile and QUALITY OF LIFE FOR WOMEN WITH AND WITHOUT PELVIC FLOOR DYSFUNCTION|Unknown status|Enrolling by invitation|N/A|200|Actual|University of Sao Paulo General Hospital|||2||f||||f||||||||||2017-10-11 01:32:04.549838|2017-10-11 01:32:04.549838
NCT01891149|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-02-03|||December 2012||2012-12-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Ultrasonographic and Hormonal Characteristics of Malawian Women With and Without Obstetric Fistula|Ultrasonographic and Hormonal Characteristics of Malawian Women With and Without Obstetric Fistula|Completed||N/A|112|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 01:32:04.624691|2017-10-11 01:32:04.624691
NCT01891136|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-06-24|||April 2004||2004-04-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|PnOIT||Oral Peanut Immunotherapy for Peanut Allergic Patients|Pilot Study: Oral Peanut Immunotherapy for Peanut Allergic Patients|Completed||Early Phase 1|36|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 01:32:04.716491|2017-10-11 01:32:04.716491
NCT01891123|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-12-08|||June 2013||2013-06-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy|An Open-label Randomized Clinical Trial to Compare the Toxicities and Efficacy of Pharmacokinetically-guided and BSA Fixed Dosing Strategy of Docetaxel and Paclitaxel in Chinese Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma, and Breast Cancer Patients.|Recruiting||N/A|300|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:32:04.812268|2017-10-11 01:32:04.812268
NCT01891110|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-05-13|||March 2012||2012-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Prevention of Orthostatic Hypotension With Electric Stimulation in Persons With Acute SCI|Prevention of Orthostatic Hypotension With Electric Stimulation in Persons With Acute SCI|Completed||N/A|20|Actual|Swiss Paraplegic Centre Nottwil||3|||f||||f||||||||||2017-10-11 01:32:04.963176|2017-10-11 01:32:04.963176
NCT01891097|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-05-10|||July 2012||2012-07-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Combined Electroacupuncture and Auricular Acupuncture for Persistent Insomnia|Combined Electroacupuncture and Auricular Acupuncture for Persistent Insomnia: A Randomized Controlled Trial of Dose-Response Effect|Completed||N/A|224|Actual|The University of Hong Kong||3|||f||||f||||||||Yes||2017-10-11 01:32:05.083056|2017-10-11 01:32:05.083056
NCT01891084|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-05-02|||July 2013|Actual|2013-07-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Benefit and Harm of Fever Suppression by Antipyretics in Influenza|A Randomized Controlled Trial on the Effect of Fever Suppression by Antipyretics on Influenza|Recruiting||Phase 4|300|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:32:05.209229|2017-10-11 01:32:05.209229
NCT01891071|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-03-29|||July 2013||2013-07-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis|Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis|Recruiting||N/A|35|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 01:32:05.315359|2017-10-11 01:32:05.315359
NCT01890876|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-07-04|||June 2013||2013-06-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Altitude, Exercise and Glucose Metabolism in Pre-diabetic Men|Altitude-dependent Effects of Concentric and Eccentric Exercise on Glucose Metabolism in Pre-diabetic Men|Unknown status|Enrolling by invitation|N/A|32|Anticipated|Universitaet Innsbruck||2|||f||||f||||||||||2017-10-11 01:32:09.775424|2017-10-11 01:32:09.775424
NCT01891058|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-09-20|||June 2013||2013-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|RAFF-2||Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED|A Randomized, Controlled Comparison of Electrical Versus Pharmacological Cardioversion for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter (RAFF)|Recruiting||N/A|468|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 01:32:05.438334|2017-10-11 01:32:05.438334
NCT01891045|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-06-27|||July 2011||2011-07-01|June 2013|2013-06-01|July 2015|Anticipated|2015-07-01|November 2014|Anticipated|2014-11-01||Interventional|||Impact of Online Patient Feedback (OQ) to Therapist|Addiction Treatment Dropout Prevention - Impact of Online Patient Feedback (OQ-45.2) to Therapist|Unknown status|Recruiting|Phase 2|160|Anticipated|Oslo University Hospital||3|||f||||t||||||||||2017-10-11 01:32:05.600013|2017-10-11 01:32:05.600013
NCT01891032|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-07-24|||June 2013||2013-06-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||Assessment of Acute Renal Injury During Partial Nephrectomy Using Neutrophil Gelatinase-associated Lipocalin (NGAL): Prospective Comparative Study Between Open, Video-assisted Minilaparotomy, Laparoscopic, and Robotic-assisted Laparoscopic Surgery||Completed||N/A|160|Actual|Yonsei University|||4||f||||f||||||||||2017-10-11 01:32:05.706997|2017-10-11 01:32:05.706997
NCT01891019|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-01-24|||April 2003||2003-04-01|January 2017|2017-01-01|June 2009|Actual|2009-06-01|September 2005|Actual|2005-09-01||Interventional|||Thalidomide in the Treatment of Chronic Plaque Psoriasis.|Thalidomide in the Treatment of Chronic Plaque Psoriasis.|Completed||Phase 2|21|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-10-11 01:32:05.783014|2017-10-11 01:32:05.783014
NCT01891006|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-10-14|||May 2011||2011-05-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|November 2014|Actual|2014-11-01||Interventional|APIPICS||Intervention for Postpartum Infections Following Caesarean Section|Intervention for Postpartum Infections Following Caesarean Section - a Randomized Controlled Trial|Completed||N/A|26|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 01:32:05.881789|2017-10-11 01:32:05.881789
NCT01890993|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-05-20|||August 2013||2013-08-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe|Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe|Completed||N/A|952|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-10-11 01:32:06.007138|2017-10-11 01:32:06.007138
NCT01890980|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-10-06|||April 2013||2013-04-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Phase II Study of Adjuvant WT-1 Analog Peptide Vaccine in MPM Patients After MSK10-134|Randomized Phase II Study of Adjuvant WT-1 Analog Peptide Vaccine in Patients With Malignant Pleural Mesothelioma (MPM) After Completion of Combined Modality Therapy (MSK10-134)|Active, not recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 01:32:06.121011|2017-10-11 01:32:06.121011
NCT01890967|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-07-14|2017-05-25|2014-09-29|June 2013||2013-06-01|July 2017|2017-07-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional||All randomized participants who received at least one dose of study drug.|A Study of LY3015014 in Participants With High Cholesterol|A Phase 2 Efficacy and Safety Dose-Ranging Study of LY3015014 in Patients With Primary Hypercholesterolemia|Completed||Phase 2|527|Actual|Eli Lilly and Company||6|||f||||t||||||||||2017-10-11 01:32:06.305715|2017-10-11 01:32:06.305715
NCT01890954|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-05-01|2015-04-03||August 2013||2013-08-01|May 2017|2017-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents|Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents|Completed||N/A|17|Actual|University of Virginia|BG values followed 4 h after the unannounced meals, risk for hypoglycemia could have been detected if followed longer AP system was tested in adolescents with diabetes well controlled (average HbA1c 8.2) adolescents in worst control may benefit most|2|||f||||f||||||||Yes|We will make de-identofoed individual participant data (IPD) collected in this study available to other researchers at the end of the study. Paper published in Pediatric Diabetes|2017-10-11 01:32:08.841974|2017-10-11 01:32:08.841974
NCT01890941|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-10-16||||||October 2015|2015-10-01||||March 2014|Actual|2014-03-01||Interventional|||A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes||Completed||Phase 2|||Kissei Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 01:32:09.185483|2017-10-11 01:32:09.185483
NCT01890928|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-04-26|||March 2011||2011-03-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Gluconeogenesis Rates and Its Precursors in Pediatric Sepsis|Gluconeogenesis Rates and Its Source in Critically Ill Adolescents|Completed||N/A|19|Actual|The Cleveland Clinic|||2||f||||t||||||None Retained|"     Blood and urine samples.   "|Yes||2017-10-11 01:32:09.267464|2017-10-11 01:32:09.267464
NCT01890915|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-02-04|2015-11-24||May 2013||2013-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Body Temperature in Persons With Tetraplegia When Exposed to Heat|Core Temperature During Heat Exposure in Persons With Tetraplegia|Completed||N/A|21|Actual|James J. Peters Veterans Affairs Medical Center|||2||f||||f||||||Samples With DNA|"     Venous blood samples   "|||2017-10-11 01:32:09.349301|2017-10-11 01:32:09.349301
NCT01890902|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-11-08|||August 2013||2013-08-01|November 2013|2013-11-01||||June 2014|Anticipated|2014-06-01||Interventional|||Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee|A Randomized, Multicenter, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee|Withdrawn||Phase 3|0|Actual|Imprimis Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-11 01:32:09.611902|2017-10-11 01:32:09.611902
NCT01890889|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2013-11-21|||July 2013||2013-07-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|AdBiotech||Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health|A Double-blinded, Placebo-controlled Randomized Trial Assessing the Extent to Which Consumption of Two Different Amounts of a Non-Pharmaceutical Food Supplement Can Improve Cardiovascular Health|Unknown status|Recruiting|N/A|150|Anticipated|Integrative Health Technologies, Inc.||3|||f||||t||||||||||2017-10-11 01:32:09.677864|2017-10-11 01:32:09.677864
NCT01890863|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-05-09|||August 5, 2013|Actual|2013-08-05|May 2017|2017-05-01|September 30, 2013|Actual|2013-09-30|September 30, 2013|Actual|2013-09-30||Interventional|||ROTAHALER Device Optimization Study|An Open-Label, Randomised, Two Treatment, Four-Way Cross-Over (Replicate Design), Two Sequence, Repeat Dose, Single Centre Study in Healthy Volunteers to Compare the Pharmacokinetics of Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the Low Airflow Resistance ROTAHALER Inhaler Relative to Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the DISKUS Inhaler|Completed||Phase 1|36|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:32:09.992719|2017-10-11 01:32:09.992719
NCT01890850|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-07-20|||July 2013||2013-07-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants|Risk Factors Associated With Pertussis Among Infants Less Than One-year of Age|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-10-11 01:32:10.114899|2017-10-11 01:32:10.114899
NCT01890837|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-06-09||2015-10-14|August 2013||2013-08-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)|Effect of Daikenchuto (TU-100), a Gastrointestinal Nerve Modulator, on Rectal Sensation in Patients With Irritable Bowel Syndrome|Completed||Phase 1/Phase 2|40|Actual|Tsumura USA||2|||f||||f||||||||||2017-10-11 01:32:10.21082|2017-10-11 01:32:10.21082
NCT01890824|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-02-01|||August 2013||2013-08-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Fat Metabolism Following Chemotherapy in Breast Cancer|The Effect of Chemotherapy on Fat Metabolism and Digestion and Function in Breast Cancer Patients.|Terminated||N/A|5|Actual|Texas A&M University|||3||f||||f||||||Samples With DNA|"     Urine, adipose tissue, serum, plasma   "|||2017-10-11 01:32:10.324754|2017-10-11 01:32:10.324754
NCT01890811|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-04-29|||June 2013||2013-06-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Chronic Kidney Disease in Relation to Alterations in Protein and Amino Acid Metabolism and Function|Chronic Kidney Disease in Relation to Alterations in Protein and Amino Acid Metabolism and Function|Withdrawn||N/A|0|Actual|Texas A&M University||1||Recruitment challenges|f||||f||||||||||2017-10-11 01:32:10.41937|2017-10-11 01:32:10.41937
NCT01890798|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-03-20|||January 2014||2014-01-01|March 2014|2014-03-01|July 2015|Anticipated|2015-07-01|January 2014|Actual|2014-01-01||Interventional|||Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol|A Continued Access Protocol for Eligible US Subjects With Duchenne Muscular Dystrophy Who Previously Participated in an Approved Drisapersen Study|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||1||"Rights for the further development of drisapersen have been transferred to Prosensa. Therefore   this study has been cancelled before enrollment."|f||||f||||||||||2017-10-11 01:32:10.52421|2017-10-11 01:32:10.52421
NCT01890785|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-03-14|2014-03-14||July 2013||2013-07-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers|A Phase 1, Open-label, Randomized, 3-period Crossover Study Evaluating the Relative Bioavailability of SPD489 When the Contents Are Emptied Into a Soft Food and Orange Juice in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Shire||3|||f||||f||||||||||2017-10-11 01:32:10.61599|2017-10-11 01:32:10.61599
NCT01890772|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-05-13|||August 2013||2013-08-01|May 2014|2014-05-01||||October 2015|Anticipated|2015-10-01||Interventional|||Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1|A Pilot Trial of the Safety and Efficacy of Telaprevir +Peginterferon +Ribavirin +Vitamin D3 Among Treatment-naive Veterans Infected With Genotype 1 Hepatitis C Virus|Withdrawn||Phase 2/Phase 3|0|Actual|Southern California Institute for Research and Education||2|||f||||f||||||||||2017-10-11 01:32:11.289325|2017-10-11 01:32:11.289325
NCT01890759|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-07-21|2017-07-18||June 25, 2013|Actual|2013-06-25|July 2017|2017-07-01|April 12, 2016|Actual|2016-04-12|April 12, 2016|Actual|2016-04-12||Interventional|||Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation|Immunogenicity and Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in Subjects Aged 9 to 23 Months in India and in the Russian Federation|Completed||Phase 3|300|Actual|Sanofi||1|||f||||f|t|f|||t|||||2017-10-11 01:32:11.464056|2017-10-11 01:32:11.464056
NCT01890746|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-02-22|2016-03-07||September 5, 2013|Actual|2013-09-05|February 2017|2017-02-01|January 25, 2017|Actual|2017-01-25|March 13, 2015|Actual|2015-03-13||Interventional|||A Safety and Efficacy Study of Eltrombopag in Subjects With AML|A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects With Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy|Completed||Phase 2|148|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:32:12.497075|2017-10-11 01:32:12.497075
NCT01890733|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-10-14|||September 2012||2012-09-01|September 2012|2012-09-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||InSpace™ System in Comparison to Best Repair of Massive Rotator Cuff Tear.|A Randomized, Two-arm, Prospective, Subject Blind Study to Assess the Efficacy and Safety of InSpace™ Device in Comparison to Massive Rotator Cuff Repair in Subjects Scheduled for a Repair Surgery.|Terminated||Phase 4|5|Actual|OrthoSpace Ltd.||2||Very low recruitment rate|f||||f||||||||||2017-10-11 01:32:13.897032|2017-10-11 01:32:13.897032
NCT01890720|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-01-30|||September 10, 2013||2013-09-10|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 13, 2016|Actual|2016-10-13||Interventional|||Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section|Use of Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section in Women With BMI >=30|Completed||N/A|876|Actual|Odense University Hospital||2|||f||||f||||||||No||2017-10-11 01:32:13.964436|2017-10-11 01:32:13.964436
NCT01889355|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-09-01|||January 2014||2014-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||User Study for Enhanced Meter Feature|User Study for the Evaluation of an Enhanced Meter Feature Using an AgaMatrix BGMS|Completed||N/A|121|Actual|AgaMatrix, Inc.||1|||f||||f||||||||||2017-10-11 01:32:31.846449|2017-10-11 01:32:31.846449
NCT01890694|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-10-26|2016-03-10||March 2012||2012-03-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia|Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia|Terminated||Phase 4|2|Actual|New York University School of Medicine|Due to the small sample size, data was not able to be analyzed.|2|||f||||t||||||||||2017-10-11 01:32:14.177206|2017-10-11 01:32:14.177206
NCT01890681|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-08-15|||August 2013|Actual|2013-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Baby Nutrition and Physical Activity Self-Assessment for Child Care (NAP SACC) Intervention Study|Preventing Obesity in Infants and Toddlers in Child Care|Active, not recruiting||N/A|960|Anticipated|Johns Hopkins University||2|||f||||t|f|f||||||||2017-10-11 01:32:14.416826|2017-10-11 01:32:14.416826
NCT01890668|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-11-25|||July 2013||2013-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|NEOSTEO||Efficacy Assessment of Osteopathic Manipulative Treatment in the Suboptimal Breastfeeding Behaviour|Efficacy Assessment of Early Osteopathic Manipulative Treatment (OMT) in the Management of Suboptimal Breastfeeding Behaviour in Healthy Newborns. A Prospective Monocentric Randomized Double-blinded Study.|Completed||N/A|128|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 01:32:14.494993|2017-10-11 01:32:14.494993
NCT01890655|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-04-08|||August 2013||2013-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Extension Study of MT-1303|A Phase II, Multicentre Study to Evaluate the Long-term Safety and Efficacy of MT-1303 in Subjects With Relapsing-remitting Multiple Sclerosis Who Have Completed the MT-1303-E04 Study|Completed||Phase 2|367|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||t||||||||||2017-10-11 01:32:14.573066|2017-10-11 01:32:14.573066
NCT01890642|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-09-02|2015-05-22||July 2013||2013-07-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Use of Jet Injection Lidocaine for Blood Draws in Young Children|Use Of The Needle Free Jet-Injection System With Buffered Lidocaine (J-Tip) For The Treatment Of Pain During Venipuncture For Blood Draws In Young Children|Completed||N/A|205|Actual|Medical College of Wisconsin||3|||f||||t||||||||||2017-10-11 01:32:16.414628|2017-10-11 01:32:16.414628
NCT01890629|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-03-12|||May 2013||2013-05-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|STABLE||Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)|A Multicenter, Randomized, Active-controlled, Parallel Group, Open-label, Exploratory Study to Evaluate the Efficacy on Glucose Variability(MAGE, Glucose SD) and Safety of Initial Combination Therapy of Gemigliptin 50mg q.d., Versus Sitagliptin 100mg q.d., or Glimepiride 2mg q.d. With Metformin 500-1,000mg q.d. in Patients With Type 2 Diabetes|Completed||Phase 4|69|Actual|LG Life Sciences||3|||f||||f||||||||||2017-10-11 01:32:16.957558|2017-10-11 01:32:16.957558
NCT01890616|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-06-27|||May 2013||2013-05-01|June 2013|2013-06-01||||October 2013|Anticipated|2013-10-01||Interventional|||Constipation and Gut Transit in DMD Patients|Constipation and Gut Transit in Duchenne Muscular Dystrophy Patients|Unknown status|Recruiting|N/A|20|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 01:32:17.046839|2017-10-11 01:32:17.046839
NCT01890603|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-07-01|||September 2008||2008-09-01|June 2013|2013-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Enhancing Complex Care Through an Integrated Care Coordination Information System|Ambulatory Safety and Quality Program: Improving Management of Individuals With Complex Healthcare Needs Through Health It|Completed||Phase 3|60000|Actual|Care Management Plus||2|||f||||t||||||||||2017-10-11 01:32:17.124963|2017-10-11 01:32:17.124963
NCT01890590|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-07-27|||July 2013||2013-07-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma|A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma|Recruiting||N/A|46|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:32:17.20158|2017-10-11 01:32:17.20158
NCT01890577|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-06-08|2015-03-31||April 2013||2013-04-01|June 2016|2016-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational||The Full Analysis Set (FAS) consists of all patients enrolled into the study after commencing Aranesp® therapy amd with reported data|Study of South African Dialysis Patients|An Observational Study of South African Dialysis Patients Treated With Aranesp|Terminated||N/A|28|Actual|Amgen|||1|"Study was terminated due to slow enrolment with no reasonable expectation of attaining a   meaningful sample size"|f||||f||||||||||2017-10-11 01:32:17.296176|2017-10-11 01:32:17.296176
NCT01890564|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-03-31|||June 2013||2013-06-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Modes of Ventilation During Laparoscopic Bariatric Surgery||Completed||N/A|30|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 01:32:17.723434|2017-10-11 01:32:17.723434
NCT01890551|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-27|||January 1998||1998-01-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Knee- MRI 2012||Kine-Mri in Patellofemoral Instability|Dynamic Kine-mri in Patellofemoral Instability in Adolescents- an Aid in the Diagnosis|Completed||N/A|50|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-10-11 01:32:17.790222|2017-10-11 01:32:17.790222
NCT01890538|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2014-05-02|||June 2013||2013-06-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo|Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo: A Double Blind Randomized Clinical Trial|Completed||Phase 4|94|Actual|Kocaeli University||2|||f||||t||||||||||2017-10-11 01:32:17.867122|2017-10-11 01:32:17.867122
NCT01890525|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-10-05|||August 2012||2012-08-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|August 2016|Actual|2016-08-01||Observational|PROMISE-SAFER||PROMISE Substudy to Assess For Effective Dose of Radiation (PROMISE-SAFER) Specific Aim 3b|PROMISE Substudy to Assess For Effective Dose of Radiation (PROMISE-SAFER), Specific Aim 3b|Active, not recruiting||N/A|20|Anticipated|Kaiser Permanente|||1||f||||t||||||||||2017-10-11 01:32:17.944693|2017-10-11 01:32:17.944693
NCT01890512|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-01-11|2014-04-24||June 2013||2013-06-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|INFINITE-MRI||INGENIO MRI/ FINELINE II Pacing System Data Collection in Patients Undergoing MRI|INGENIO MRI/ FINELINE II ImageReadyTM Pacing System Data Collection in Patients Undergoing Magnetic Resonance Imaging|Completed||N/A|20|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 01:32:18.022299|2017-10-11 01:32:18.022299
NCT01890499|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-02-02|||November 2012||2012-11-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Prospective Controlled Trial On Clear Feeds Versus Low Residue Diet After Surgery In Elective Colorectal Surgery Patients|PROSPECTIVE RANDOMIZED CONTROLLED TRIAL ON CLEAR FEEDS VERSUS LOW RESIDUE DIET AFTER SURGERY IN ELECTIVE COLORECTAL SURGERY PATIENTS.|Completed||N/A|104|Actual|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-11 01:32:18.180878|2017-10-11 01:32:18.180878
NCT01890486|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-05-25|||May 2001||2001-05-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01|1 Year|Observational [Patient Registry]|||The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen|The Prospective Collection, Storage and Reporting of Data on Patients|Recruiting||N/A|1000|Anticipated|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-11 01:32:18.266282|2017-10-11 01:32:18.266282
NCT01890473|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2015-10-23|2015-10-23||July 2013||2013-07-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||All randomized participants were summarized.|Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe|Phase Ib, Multicenter, Randomized, Open-Label, Parallel-Group Study to Characterize the Pharmacokinetics of a Single Dose of Abatacept 125 mg Administered Subcutaneously Using the BD Physioject™ Autoinjector or the UltraSafe Passive Needle Guard Prefilled Syringe|Completed||Phase 1|356|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 01:32:18.365575|2017-10-11 01:32:18.365575
NCT01890460|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2016-01-21|||June 2013||2013-06-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|SupersonicOR||Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery|Quantitative Evaluation of Liver Disease With Liver Elastography Measurements Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine in Patients Undergoing Liver Transplant Surgery|Completed||N/A|13|Actual|Baylor Research Institute|||1||f||||f||||||||Undecided||2017-10-11 01:32:18.954299|2017-10-11 01:32:18.954299
NCT01890447|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-01-16|||January 2015||2015-01-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation|Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation, in Italy and Spain|Completed||N/A|676|Actual|GlaxoSmithKline|||3||f||||||||||||||2017-10-11 01:32:19.012696|2017-10-11 01:32:19.012696
NCT01890434|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-07-20||2017-07-20|August 2013||2013-08-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|GadaCAD 2||Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)|Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis|Completed||Phase 3|485|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:32:19.112123|2017-10-11 01:32:19.112123
NCT01890421|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2017-08-29||2016-03-08|July 19, 2013|Actual|2013-07-19|August 2017|2017-08-01|August 10, 2017|Actual|2017-08-10|April 10, 2015|Actual|2015-04-10||Interventional|GadaCAD 1||Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)|Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis|Completed||Phase 3|432|Actual|Bayer||1|||f||||f|t|f||||||||2017-10-11 01:32:19.439387|2017-10-11 01:32:19.439387
NCT01890408|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2014-06-25|||November 2013||2013-11-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ROPIHEP||Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity.|Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity|Terminated||Phase 2|5|Actual|Assistance Publique - Hôpitaux de Paris||2||promoter decision|f||||f||||||||||2017-10-11 01:32:19.597748|2017-10-11 01:32:19.597748
NCT01890395|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-05-01|||December 2012||2012-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bioenergetics in Surgical Patients|Bioenergetics in Surgical Patients|Recruiting||N/A|80|Anticipated|University of South Alabama||1|||f||||f||||||||||2017-10-11 01:32:19.689702|2017-10-11 01:32:19.689702
NCT01890382|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-01|||October 2013||2013-10-01|June 2013|2013-06-01|October 2016|Anticipated|2016-10-01|December 2015|Anticipated|2015-12-01||Interventional|||Protein Intake and Resistance Training in Aging|Effect of Protein Intake Associated With Resistance Training in Elderly Frail Individuals.|Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Sao Paulo||5|||f||||f||||||||||2017-10-11 01:32:19.778282|2017-10-11 01:32:19.778282
NCT01890369|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-01-16|||April 2013||2013-04-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|Aj1B||Modulation of Muscle Protein Metabolism by Essential Amino Acids|Modulation of Muscle Protein Metabolism by Essential Amino Acids|Unknown status|Recruiting|N/A|32|Anticipated|University of Nottingham||4|||f||||t||||||||||2017-10-11 01:32:19.887715|2017-10-11 01:32:19.887715
NCT01890356|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-02-01|||June 2013||2013-06-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Maintenance Transcranial Electrical Stimulation for Depression|A Study of Transcranial Electrical Stimulation (TES) as a Maintenance Treatment for Depression|Recruiting||N/A|100|Anticipated|The University of New South Wales||1|||f||||||||||||||2017-10-11 01:32:19.982537|2017-10-11 01:32:19.982537
NCT01890343|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-27|2014-09-16|2014-09-10||September 2009||2009-09-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional||Only subjects who received florbetapir (18F) are included in the baseline analysis population.|Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.|A Study Evaluating the Imaging Characteristics of Florbetapir 18F (18F-AV-45) in Patients With Frontotemporal Dementia Compared to Patients With Alzheimer's Disease and Normal Controls.|Completed||Phase 2|34|Actual|Avid Radiopharmaceuticals||3|||f||||f||||||||||2017-10-11 01:32:20.077734|2017-10-11 01:32:20.077734
NCT01890330|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-05-10|||July 2013||2013-07-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|METCO-2013||Effects of Canola Oil on Vascular and Metabolic Parameters in Individuals With Metabolic Syndrome|Effects of Canola Oil on Vascular and Metabolic Parameters in Individuals With Metabolic Syndrome|Completed||N/A|80|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 01:32:20.415788|2017-10-11 01:32:20.415788
NCT01890304|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-05-16|||July 2013||2013-07-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|GATOR TBI||Longitudinal Study of Traumatic Brain Injury (TBI) in (University of Florida) UF Athletes|Diffusion Tensor Imaging (DTI) Compared to Serum Biomarkers and Standard Clinical Measures of Concussion in Female and Male Collegiate Athletes: a Longitudinal Survey Across the College Years.|Enrolling by invitation||N/A|750|Anticipated|University of Florida||1|||f||||f||||||||||2017-10-11 01:32:20.636312|2017-10-11 01:32:20.636312
NCT01890291|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-08-03|||June 2013||2013-06-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01|3 Years|Observational [Patient Registry]|Immuncell-LC||Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.|Long Term Study of 'Immuncell-LC Groups' and 'Non-treatment Groups' in Patient Undergo Curative Resection (PEIT, Radiofrequency Ablation [RFA] or Operation) for Hepatocellular Carcinoma in Korea|Completed||N/A|162|Actual|Green Cross Cell Corporation|||2||f||||f||||||||||2017-10-11 01:32:20.729699|2017-10-11 01:32:20.729699
NCT01890278|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-06-28|||June 2013||2013-06-01|June 2013|2013-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases|Randomized Phase II Trial of Conventional vs IMRT Whole Brain Radiotherapy for Brain Metastases|Unknown status|Recruiting|N/A|60|Anticipated|Good Samaritan Hospital Medical Center, New York||2|||f||||f||||||||||2017-10-11 01:32:20.824869|2017-10-11 01:32:20.824869
NCT01890265|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-08-17|||June 2013||2013-06-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|July 28, 2017|Actual|2017-07-28||Interventional|||Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis|Active, not recruiting||Phase 2|160|Actual|FibroGen||2|||f||||t||||||||||2017-10-11 01:32:20.964103|2017-10-11 01:32:20.964103
NCT01890252|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-27|||July 2013||2013-07-01|June 2013|2013-06-01|April 2014|Anticipated|2014-04-01|January 2014|Anticipated|2014-01-01||Interventional|||Hyper-CL™ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema|Prospective, Randomized Crossover Study Of The Hyper-CL™ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema|Unknown status|Not yet recruiting|N/A|25|Anticipated|EyeYon Medical||3|||f||||t||||||||||2017-10-11 01:32:21.170841|2017-10-11 01:32:21.170841
NCT01890239|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-07-06|||September 2012||2012-09-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PLaDays||The Effectiveness of the Care Programme for the Last Days of Life|Improving End-of-life Care in Acute Geriatric Hospital Wards Using the Care Programme for the Last Days of Life: a Cluster Randomized Controlled Trial|Completed||N/A|600|Actual|End-of-Life Research Group||2|||f||||f||||||||||2017-10-11 01:32:21.266171|2017-10-11 01:32:21.266171
NCT01890226|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-08-04|||November 2014||2014-11-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|mPHR||A Mobile Personal Health Record for Behavioral Health Homes|A Mobile Personal Health Record for Behavioral Health Homes|Active, not recruiting||N/A|300|Actual|Emory University||2|||f||||t||||||||||2017-10-11 01:32:21.354996|2017-10-11 01:32:21.354996
NCT01890213|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-06-25|||November 2013|Actual|2013-11-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|June 2017|Actual|2017-06-01||Interventional|||Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer|A Pilot Study of Active Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer|Active, not recruiting||Phase 1|12|Anticipated|Duke University||1|||f||||f||||||||||2017-10-11 01:32:21.422138|2017-10-11 01:32:21.422138
NCT01890200|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-04-26|||June 2015||2015-06-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)|A Phase III, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Effects of Adding TCM-700C,Botanical Drug, on the Standard Treatment (Peginterferon and Ribavirin) for Subjects With Naive Genotype 1 Hepatitis C Infection|Withdrawn||Phase 3|0|Actual|TCM Biotech International Corp.||3|||f||||f||||||||No||2017-10-11 01:32:21.510652|2017-10-11 01:32:21.510652
NCT01890187|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-06-27|||November 2010||2010-11-01|June 2013|2013-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium|Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium|Completed||N/A|85|Actual|Carl Zeiss Meditec, Inc.|||1||f||||t||||||||||2017-10-11 01:32:21.622008|2017-10-11 01:32:21.622008
NCT01890174|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-06-27|||February 2011||2011-02-01|June 2013|2013-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation|Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation|Completed||N/A|54|Actual|Carl Zeiss Meditec, Inc.|||1||f||||t||||||||||2017-10-11 01:32:21.6927|2017-10-11 01:32:21.6927
NCT01890161|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-01-08||2016-01-08|August 2013||2013-08-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma|A Phase IIa Randomized Double-blind Placebo-controlled Two-way Cross-over Trial of the Effects of Repeat Doses of 50 mg AXP1275 Daily on the Asthmatic Response to a Pulmonary Allergen Challenge in Adults With Mild-to-Moderate Atopic Asthma|Completed||Phase 2|21|Actual|Axikin Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:32:21.975832|2017-10-11 01:32:21.975832
NCT01890148|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-01-28|2015-06-29||March 2014||2014-03-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069|An Explorative Investigation to Study the Relationship and Distribution of Neutrophils in Bronchial Mucosal Tissue, Induced Sputum and Blood After Administration of 45 mg BD AZD 5069 for 4 Weeks to Patients With Moderate Persistent Neutrophilic Asthma|Completed||Phase 1|13|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 01:32:22.086797|2017-10-11 01:32:22.086797
NCT01890135|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-08-01|||June 2013||2013-06-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication|A Phase II Clinical Trail to Assess the Safety and Effects of ZD4054 (Zibotentan) on Exercise Induced Calf Muscle Perfusion in Patients With Intermittent Claudication (Rutherford II or III).|Completed||Phase 2|31|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 01:32:22.470746|2017-10-11 01:32:22.470746
NCT01890122|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-10-04|2016-10-04||September 2013||2013-09-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional||Randomized set consisted of all enrolled participants who were randomized.|Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Alogliptin and Metformin Fixed Dose Combination, Alogliptin Alone, or Metformin Alone in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|647|Actual|Takeda||4|||f||||f||||||||||2017-10-11 01:32:22.602745|2017-10-11 01:32:22.602745
NCT01890109|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-11-11|||May 2013||2013-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Randomized, Parallel-group, Double-blind, Placebo-controlled, Study to AMG 334 in Women With Hot Flashes|Randomized, Stratified, Parallel-group, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of AMG 334 in Women With Hot Flashes Associated With Menopause|Completed||Phase 1|103|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:32:24.129931|2017-10-11 01:32:24.129931
NCT01890096|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-10-24|||May 2013||2013-05-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer|A Randomized Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer|Active, not recruiting||Phase 2|174|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 01:32:24.241241|2017-10-11 01:32:24.241241
NCT01890083|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-12-28|||June 2013||2013-06-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Health Intervention to Prevent Depression Hepatitis C Patients|An Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C|Terminated||Phase 2/Phase 3|1|Actual|University of Texas Southwestern Medical Center||2||Lack of eligible patients due to introduction of new drugs for Hepatitis C|f||||f||||||||Undecided||2017-10-11 01:32:24.32225|2017-10-11 01:32:24.32225
NCT01890070|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-12-09|||May 2013||2013-05-01|December 2015|2015-12-01||||January 2016|Anticipated|2016-01-01||Interventional|||Study of the Nutraceutical Properties and Health Benefits of Traditional Components of the Mediterranean Diet|Study of the Nutraceutical Properties and Health Benefits of Traditional Components of the Mediterranean Diet - A Cross Over Interventional Study|Recruiting||N/A|50|Anticipated|University of Rome Tor Vergata||28|||f||||f||||||||||2017-10-11 01:32:24.406387|2017-10-11 01:32:24.406387
NCT01890057|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-02-02|||June 2013||2013-06-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients||Completed||N/A|44|Actual|Severance Hospital||2|||f||||f||||||||||2017-10-11 01:32:24.538894|2017-10-11 01:32:24.538894
NCT01890044|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-06-20|||August 2013||2013-08-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01|30 Days|Observational [Patient Registry]|CLOTT||Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients|Consortium of Leaders in the Study Of Traumatic Thromboembolism (CLOTT)|Withdrawn||N/A|0|Actual|Scripps Health|||1|Never proceeded with trial. Failure initiate protocol among other centers.|f||||t||||||||No|No clinical trial data collected.|2017-10-11 01:32:24.608556|2017-10-11 01:32:24.608556
NCT01890031|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-08-05|2015-07-01||January 2012||2012-01-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ICAT||Interactive Cholesterol Advisory Tool|The Interactive Cholesterol Advisory Tool|Completed||Phase 1|131|Actual|University of Rochester||5|||f||||t||||||||||2017-10-11 01:32:24.706148|2017-10-11 01:32:24.706148
NCT01890018|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-05-08|||June 2013||2013-06-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|December 2013|Actual|2013-12-01||Interventional|||Partners and Alerts: A Study of Social Forces in Medication Adherence|Partners and Alerts: A Study of Social Forces in Medication Adherence|Active, not recruiting||N/A|178|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 01:32:25.081314|2017-10-11 01:32:25.081314
NCT01890005|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-06-28|||July 2013||2013-07-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Low Dose Aspirin for the Prevention of Preeclampsia|Low Dose Aspirin Between 13 and 16 Weeks of Pregnancy for the Prevention of Preeclampsia. Double Blind, Randomized, Controlled Trial.|Unknown status|Not yet recruiting|Phase 3|476|Anticipated|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-11 01:32:25.193562|2017-10-11 01:32:25.193562
NCT01889992|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-26|||April 2013||2013-04-01|June 2013|2013-06-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Interventional|CAR||Cardiac Allograft Remodeling and Effects of Sirolimus|Cardiac Allograft Remodeling and Effects of Sirolimus on Its Progression|Unknown status|Recruiting|Phase 1|110|Anticipated|University of Nebraska||7|||f||||f||||||||||2017-10-11 01:32:25.374539|2017-10-11 01:32:25.374539
NCT01889979|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-07|||October 2012||2012-10-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Tramadol for Labour Analgesia in Low Risk Primiparous Women|Tramadol for Labour Analgesia in Low Risk Primiparous Women. Double Blind, Randomized, Controlled Trial.|Completed||Phase 3|100|Actual|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-11 01:32:25.654599|2017-10-11 01:32:25.654599
NCT01889966|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2015-04-26|||April 2013||2013-04-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SIL-REACT||VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension|Vasoreactivity Testing With Intravenous Sildenafil in Patients With Precapillary Pulmonary Hypertension (Treatment Optimisation Study)|Completed||Phase 4|10|Actual|Kerckhoff Heart Center||1|||f||||f||||||||||2017-10-11 01:32:25.74726|2017-10-11 01:32:25.74726
NCT01889953|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-05-22|||December 2012||2012-12-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||EUS-Guided Biliary Drainage in Patients With Inoperable Malignant Distal Biliary Obstruction and Failed ERCP: a Prospective Feasibility Multicenter Trial|EUS-Guided Biliary Drainage in Patients With Inoperable Malignant Distal Biliary Obstruction and Failed ERCP: a Prospective Feasibility Multicenter Trial|Completed||N/A|96|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:32:25.838257|2017-10-11 01:32:25.838257
NCT01889940|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-06-15|||February 2012||2012-02-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|ESPELMA||Effectiveness of Psycho-emotional Support in Acute Spinal Cord Injury. ESPELMA Project|Effectiveness of Psycho-emotional Support in Acute Spinal Cord Injury. ESPELMA Project.|Completed||N/A|90|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-11 01:32:25.964281|2017-10-11 01:32:25.964281
NCT01889927|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-01-31|||May 2012||2012-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|INSPIRE-CF||INSPIRE-CF: an Alternative Physiotherapy Model for Children With Cystic Fibrosis|INSPIRE-CF: A Randomised Controlled Trial Investigating the Clinical and Economic Benefits of an Alternative Model of Physiotherapy Care for Children With Cystic Fibrosis|Active, not recruiting||N/A|71|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:32:26.069608|2017-10-11 01:32:26.069608
NCT01889914|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-28|||January 2012||2012-01-01|June 2013|2013-06-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|TRICIDIA2||TReatment by Insulin Continuous Infusion in Type 2 DIAbetes|Treatment by Subcutaneous Continuous Infusion of Insulin by Portable Pump Versus Discontinuous Infusion of Insulin by Multi-injections in the Type 2 Diabetes: Study of the Insulinosensibility in the 2 Types of Treatments|Unknown status|Recruiting|Phase 4|60|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-11 01:32:26.184844|2017-10-11 01:32:26.184844
NCT01889901|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-03-02|||December 2012||2012-12-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Enhancing Physical Activity Levels in Children With Epilepsy|Enhancing Physical Activity in Children With Epilepsy: Impacts on Health and Quality of Life|Completed||N/A|45|Actual|Children's Hospital of Eastern Ontario||2|||f||||f||||||||||2017-10-11 01:32:26.292782|2017-10-11 01:32:26.292782
NCT01889888|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-26|||June 2013||2013-06-01|June 2013|2013-06-01|May 2015|Anticipated|2015-05-01|October 2014|Anticipated|2014-10-01||Interventional|||Effectiveness and Safety of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral Strictures|Effectiveness and Safety of Endoscopically-Assisted Submucosal Administration of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral Strictures|Unknown status|Enrolling by invitation|Phase 1/Phase 2|12|Anticipated|Burnasyan Federal Medical Biophysical Center||1|||f||||f||||||||||2017-10-11 01:32:26.386295|2017-10-11 01:32:26.386295
NCT01889875|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-06-26|||November 2010||2010-11-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen|Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen|Completed||N/A|40|Actual|Bispebjerg Hospital||3|||f||||t||||||||||2017-10-11 01:32:26.496376|2017-10-11 01:32:26.496376
NCT01889862|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-01-30|||July 2013||2013-07-01|September 2016|2016-09-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|Prism302||Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU|A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)|Active, not recruiting||Phase 3|250|Anticipated|BioMarin Pharmaceutical||4|||f||||t||||||||No||2017-10-11 01:32:26.594888|2017-10-11 01:32:26.594888
NCT01889849|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-28|||October 2010||2010-10-01|June 2013|2013-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers|Comparative Pharmacokinetics and Pharmacodynamics, and Safety of Two Products Containing Recombinant Human Interferon Alpha-2 Conjugated to Polyethylene Glycol in Healthy Volunteers - Phase 1.|Completed||Phase 1|32|Actual|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||2|||f||||t||||||||||2017-10-11 01:32:26.783524|2017-10-11 01:32:26.783524
NCT01889836|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-09-15|||May 2014||2014-05-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos|Brazil's Conjugated Vaccine Project Against Meningococcal C. Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos|Completed||Phase 1|60|Actual|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||2|||f||||t||||||||||2017-10-11 01:32:26.869146|2017-10-11 01:32:26.869146
NCT01889823|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-03-24|||June 2013||2013-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|August 2013|Actual|2013-08-01||Interventional|||Effects of Oxygen Status on Hypoxia Inducible Factor 1-α and Inflammation. A Pilot Proof of Principle Study.||Completed||Phase 1|20|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 01:32:26.964872|2017-10-11 01:32:26.964872
NCT01889810|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-07-08|||August 2013||2013-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Vitamin D3 Supplementation on Insulin Resistance- The DIR Study|Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in People at High Risk of Type 2 Diabetes and Cardiovascular Disease (The DIR Study)|Completed||N/A|81|Actual|Queen's University, Belfast||2|||f||||f||||||||||2017-10-11 01:32:27.091136|2017-10-11 01:32:27.091136
NCT01889797|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-03-23|2016-12-27||December 2013||2013-12-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|PrE0401||Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma|Phase II Randomized Trial Comparing GA101 (Obinutuzumab) and Rituximab in Patients With Previously Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma|Terminated||Phase 2|32|Actual|PrECOG, LLC.|The study closed early due to slow accrual.|2||Closed due prolonged enrollment timelines|f||||t||||||||No|Data is proprietary.|2017-10-11 01:32:27.19406|2017-10-11 01:32:27.19406
NCT01889784|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-06-07|||August 2013||2013-08-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Acute Effect of Phototherapy With Light Emitting Diode (LED) on Muscle and Pulmonary Oxygen Consumption on Diabetes Mellitus|Evaluation of Acute Effect of Phototherapy With Light Emitting Diode (LED) on Muscle and Pulmonary Oxygen Consumption in Patients With Diabetes Mellitus|Recruiting||N/A|60|Anticipated|Universidade Federal de Sao Carlos||4|||f||||f||||||||No|The individual data is shared with each patient. The data will be published in journal with impact in the area, but the personal information of the participants will not be uncovered.|2017-10-11 01:32:27.90454|2017-10-11 01:32:27.90454
NCT01889771|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-02-09|||March 2010||2010-03-01|February 2016|2016-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline|A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline|Completed||N/A|1495|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:32:28.025332|2017-10-11 01:32:28.025332
NCT01889745|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-20||||||June 2013|2013-06-01||||||||Expanded Access|HX-1171||A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.|A Phase I Clinical Study, Randomized, Single-blind,Placebo-controlled, Multiple Doses, Dose Escalation Study fo the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.|Temporarily not available||N/A|||Biotoxtech Co., Ltd|||||f||||t||||||||||2017-10-11 01:32:28.204711|2017-10-11 01:32:28.204711
NCT01889732|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-26|||June 2013||2013-06-01|June 2013|2013-06-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||A Gray Zone Approach of Rotational Thromboelastometry for Predicting Postoperative Bleeding in Cardiac Surgical Patients|The Effectiveness Evaluation of Rotational Thromboelastometry(ROTEM) for Predicting Postoperative Bleeding in Cardiac Surgical Patients Using a Gray Zone Approach : A Preliminary Retrospective Study|Unknown status|Recruiting|N/A|200|Anticipated|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 01:32:28.277342|2017-10-11 01:32:28.277342
NCT01889719|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-02-12|||January 2014||2014-01-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR|Phase I Study to Evaluate the Safety/Immunogenicity of Boost Immunizations With MVA-CMDR in Healthy Volunteers Previously Immunized With Anti-DEC-205 Monoclonal Antibody Targeted HIV Gag p24 Vaccine Plus Poly-ICLC (RV 365 / WRAIR #2006)|Completed||Phase 1|14|Actual|Rockefeller University||2|||f||||t||||||||||2017-10-11 01:32:28.361488|2017-10-11 01:32:28.361488
NCT01889706|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-26|||January 2009||2009-01-01|June 2013|2013-06-01|February 2014|Anticipated|2014-02-01|March 2013|Actual|2013-03-01||Observational|||Metformin Therapy in Type 1 Diabetes Mellitus.|Application of Metformin as Adjuvant Therapy in Overweight and Obese Patients With Type 1 Diabetes Mellitus.|Unknown status|Recruiting|N/A|200|Anticipated|Poznan University of Medical Sciences|||1||f||||f||||||||||2017-10-11 01:32:28.428741|2017-10-11 01:32:28.428741
NCT01889693|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-08-23|||August 2012||2012-08-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Imaging of Atherosclerosis With 68Ga-MSA|Identification of Vascular Inflammatory Image Using a 68Ga-MSA(Gallium-68 Neomannosyl Human Serum Albumin) in Patients With Atherosclerotic Lesions|Completed||N/A|60|Actual|Korea University|||3||f||||f||||||||||2017-10-11 01:32:28.489987|2017-10-11 01:32:28.489987
NCT01889680|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2014-11-25|||November 2014||2014-11-01|November 2014|2014-11-01|May 2018|Anticipated|2018-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer|A Randomized Phase II Trial of Induction Regimen With mFOLFOX6 and Ziv-aflibercept for First-line Therapy of Metastatic Colorectal Cancer Followed by Continuation Regimen With 5-FU/LV Alone or With Ziv-aflibercept Until Disease Progression|Withdrawn||Phase 2|0|Actual|NSABP Foundation Inc||2|||f||||f||||||||||2017-10-11 01:32:28.560776|2017-10-11 01:32:28.560776
NCT01889667|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-03-26|2014-04-28||June 2013||2013-06-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)|Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, PK and PD of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With T2DM Who Are Inadequately Controlled With Diet and Exercise or Diet, Exercise and Metformin|Completed||Phase 2|30|Actual|Oramed, Ltd.||3|||f||||t||||||||||2017-10-11 01:32:28.646571|2017-10-11 01:32:28.646571
NCT01889654|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-09-07|||February 2014|Actual|2014-02-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Anti-nucleosome B Lymphocytes in Lupus|Analysis of Frequency and Phenotype of Anti-nucleosome B Lymphocyte in Systemic Lupus|Terminated||N/A|4|Actual|University Hospital, Strasbourg, France|||2|recrutment difficulty|f||||||||||||||2017-10-11 01:32:29.174964|2017-10-11 01:32:29.174964
NCT01889641|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-09-07|||February 2014|Actual|2014-02-01|September 2017|2017-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||IL-26 and Systemic Lupus Erythematosus|Intérêt de l'IL-26 Comme Nouveau Marqueur Biologique du Lupus érythémateux systémique|Terminated||N/A|23|Actual|University Hospital, Strasbourg, France|||2||f||||f||||||||||2017-10-11 01:32:29.249656|2017-10-11 01:32:29.249656
NCT01889628|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-02-01|||June 2013||2013-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study to Determine Ethnic Differences in the Glycaemic Response to Nutritional Formula Drinks|Ethnic Differences in the Glycaemic Response and Glycaemic Index to Liquid-based Nutritional Formulas Between Chinese, Malays and Indians in Singapore|Completed||N/A|52|Actual|Clinical Nutrition Research Centre, Singapore||3|||f||||f||||||||||2017-10-11 01:32:29.309397|2017-10-11 01:32:29.309397
NCT01889615|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-10-05|||August 2013||2013-08-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01|5 Years|Observational [Patient Registry]|Dual PETOvac||Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer|Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer|Recruiting||N/A|180|Anticipated|Odense University Hospital|||1||f||||f||||||Samples With DNA|"     Tissue samples from the ovarian cancer and metastasis   "|||2017-10-11 01:32:29.409211|2017-10-11 01:32:29.409211
NCT01889602|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-09-13|||July 2013||2013-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Characterizing and Predicting Drug Effects on Cognition|Characterizing and Predicting Drug Effects on Cognition|Completed||Phase 4|78|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-11 01:32:29.501455|2017-10-11 01:32:29.501455
NCT01889589|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-06-27|||April 2010||2010-04-01|June 2013|2013-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|HFUS||NYC Heart Follow-Up Study 2010|Baseline 24 Hour Urine Collection in Population-based Sample of NYC Adults|Completed||N/A|1775|Actual|New York City Department of Health and Mental Hygiene|||1||f||||||||||||||2017-10-11 01:32:29.609667|2017-10-11 01:32:29.609667
NCT01889576|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-27|||January 2010||2010-01-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||The Effect of Magnesium on Early Post-transplantation Glucose Metabolism|The Effect of Magnesium Supplements on Early Post-transplantation Glucose Metabolism: a Randomized Controlled Trial.|Completed||N/A|54|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:32:29.681937|2017-10-11 01:32:29.681937
NCT01889563|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-11-21|2013-06-28||May 2006||2006-05-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|May 2008|Actual|2008-05-01||Interventional|||Physical Training and Heart Rate Variability in COPD|Potential Effects of 6 vs 12-weeks of Physical Training on Cardiac Autonomic Function and Functional Capacity in COPD|Completed||N/A|32|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-10-11 01:32:29.770852|2017-10-11 01:32:29.770852
NCT01889550|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-10-15|||August 2013||2013-08-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|HIIP||Use of eHealth in Communication With Patients About Prenatal Diagnosis|Use of eHealth in Communication With Patients About Prenatal Diagnosis. An Intervention Study Carried Out in a Highly Specialised Unit for Obstetrics|Completed||N/A|1150|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 01:32:30.075289|2017-10-11 01:32:30.075289
NCT01889537|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-08-30|||July 2012||2012-07-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|VRK||Low Dose Ketamine VR Analgesia During Burn Care Procedure|Low Dose Ketamine to Enhance VR Analgesia During Painful Burn Care Procedure.|Completed||Phase 2|3|Actual|National Institute of General Medical Sciences (NIGMS)||2|||f||||t||||||||||2017-10-11 01:32:30.169765|2017-10-11 01:32:30.169765
NCT01889524|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-27|||January 2012||2012-01-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Interventional|||Radioaerossol Pulmonary Deposition Using Mesh in Normal Subjects|RADIOAEROSSOL PULMONARY DEPOSiTION USING MESH AND JET NEBULIZERS DURING NONINVASIVE VENTILATION IN NORMAL SUBJECTS: A RANDOMIZED CROSSOVER CLINICAL TRIAL|Completed||N/A|10|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:32:30.266943|2017-10-11 01:32:30.266943
NCT01889511|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-09-17|||June 2013||2013-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Text Messaging to Improve Adherence to Oral Chemotherapy Agents|Text Messaging to Improve Adherence to Oral Chemotherapy Agents|Completed||N/A|75|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 01:32:30.364154|2017-10-11 01:32:30.364154
NCT01889498|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-12-30|||July 2014||2014-07-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|AZATAAR||Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery|A Randomised Controlled Trial of the Effectiveness of Acetazolamide in Reducing Cerebrospinal Fluid Pressure for Patients Undergoing Thoracic-abdominal Aortic Repair|Unknown status|Recruiting|Phase 4|100|Anticipated|Liverpool Heart and Chest Hospital NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:32:30.471638|2017-10-11 01:32:30.471638
NCT01889485|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-09-18|||April 2013||2013-04-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Screening and Access to Health Care for Vascular Disease|Screening and Access to Health Care for Vascular Disease in Urban and Suburban Patient Populations|Active, not recruiting||N/A|255|Anticipated|NorthShore University HealthSystem|||1||f||||f||||||||||2017-10-11 01:32:30.589807|2017-10-11 01:32:30.589807
NCT01889472|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-05-03|||June 2013||2013-06-01|May 2017|2017-05-01|January 18, 2017|Actual|2017-01-18|January 18, 2017|Actual|2017-01-18||Interventional|||Impact of Interface With/Without Oral Appliance of Sleep Apnea Treatment|Impact of Nasal Mask/Oronasal Mask on Compliance to Treatment With Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea|Terminated||N/A|15|Actual|Laval University||2||Inability to further include additional patients|f||||f||||||||||2017-10-11 01:32:30.682083|2017-10-11 01:32:30.682083
NCT01889459|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-01|||July 2013||2013-07-01|July 2013|2013-07-01|December 2027|Anticipated|2027-12-01|December 2022|Anticipated|2022-12-01||Observational|||Japanese CTO PCI Expert Registry|Patient Registry of Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO) by Japanese Experts|Recruiting||N/A|19000|Anticipated|Kurashiki Central Hospital|||1||f||||||||||||||2017-10-11 01:32:30.781998|2017-10-11 01:32:30.781998
NCT01889446|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2014-09-19|||August 2013||2013-08-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|Walnut||The Effects of the Food Preservative Propionic Acid in Post-prandial Metabolism|Pilot Study to Study the Effects of the Food Preservative Calcium Propionate on Postprandial Hormonal and Metabolic Milieu|Unknown status|Recruiting|N/A|20|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 01:32:30.858918|2017-10-11 01:32:30.858918
NCT01889433|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-11-12|||November 2013||2013-11-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C|An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and Ribavirin With Pegasys (Peginterferon Alfa-2a) and Ribavirin for Treatment of Patients With Chronic Hepatitis C|Active, not recruiting||Phase 3|500|Anticipated|Biocad||2|||f||||f||||||||||2017-10-11 01:32:30.954869|2017-10-11 01:32:30.954869
NCT01889420|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-07-03|2015-07-03||July 2014||2014-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma|Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma|Terminated||Phase 1|1|Actual|New Mexico Cancer Care Alliance|Low accrual led to early termination; only one subject was enrolled.|1||Low accrual|f||||t||||||||||2017-10-11 01:32:31.118239|2017-10-11 01:32:31.118239
NCT01889407|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-04-18|||August 2013||2013-08-01|July 2013|2013-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01|3 Years|Observational [Patient Registry]|||Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients|Idarubicin Overcomes Multidrug Resistant-1(MDR1) Induced Chemoresistance With Higher Induction Remission Rate and Remission Quality Than Daunorubicin in de Novo Acute Myeloid Leukemia Patients|Unknown status|Recruiting|N/A|94|Anticipated|Nanfang Hospital of Southern Medical University|||2||f||||t||||||Samples With DNA|"     Bone marrow   "|||2017-10-11 01:32:31.347814|2017-10-11 01:32:31.347814
NCT01889394|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-08-29|||January 2006||2006-01-01|August 2017|2017-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Primary Wound Closure Using a Limberg Flap Versus Secondary Wound Healing Following Pilonidal Sinus Excision|Primary Wound Closure Using a Limberg Flap Versus Secondary Wound Healing Following Pilonidal Sinus Excision: Short-term Results of a Randomized Controlled Multicenter Trial|Completed||N/A|102|Actual|Kantonsspital Liestal||2|||f||||t||||||||||2017-10-11 01:32:31.472508|2017-10-11 01:32:31.472508
NCT01889381|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-10-04|||August 2012|Actual|2012-08-01|October 2017|2017-10-01|August 2026|Anticipated|2026-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Human Craniomaxillofacial Allotransplantation|Human Craniomaxillofacial Allotransplantation|Recruiting||Phase 2|15|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:32:31.576058|2017-10-11 01:32:31.576058
NCT01889342|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-03-07|||August 2013||2013-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Metacognitive Therapy Versus Cognitive Behavioral Therapy for Mixed Anxiety Disorders: A Randomized Controlled Trial.|Metacognitive Therapy Versus Cognitive Behavioral Therapy for Mixed Anxiety Disorders: A Randomized Controlled Trial.|Completed||N/A|90|Actual|Modum Bad||2|||f||||f||||||||||2017-10-11 01:32:31.917215|2017-10-11 01:32:31.917215
NCT01889329|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-08-29|||April 2013||2013-04-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Development and Field Testing of Ready-to-use-therapeutic Foods Made of Local Ingredients in Bangladesh for SAM Children|Development and Field Testing of Ready-to-use-therapeutic Foods Made of Local Ingredients in Bangladesh for the Treatment of Children With Severe Acute Malnutrition|Completed||Phase 2/Phase 3|490|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||f||||||||||2017-10-11 01:32:32.015956|2017-10-11 01:32:32.015956
NCT01889316|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-02-24|||April 2013||2013-04-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared Method|Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared Method|Completed||N/A|75|Actual|University of Arizona||1|||f||||f||||||||||2017-10-11 01:32:32.102114|2017-10-11 01:32:32.102114
NCT01889303|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-02|2016-04-28|||May 2013||2013-05-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer|Phase II Clinical Trial of Docetaxel Plus Cisplatin as Adjuvant Chemotherapy and Concurrent Chemoradiotherapy Versus FOLFOX6 as Adjuvant and 5-FU/CF as Chemoradiotherapy in Patients of Locally Advanced Gastric Cancer After Radical Surgery|Recruiting||Phase 2|100|Anticipated|Wuhan University||2|||f||||f||||||||Undecided||2017-10-11 01:32:32.19683|2017-10-11 01:32:32.19683
NCT01889290|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-10-25|||February 2014||2014-02-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|RELZH12||Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients|Pharmacokinetics of Once Daily Subcutaneous Methylnaltrexone in Neurointensive Care Patients With High Dose Sufentanil Analgosedation|Completed||Phase 1|9|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 01:32:32.296914|2017-10-11 01:32:32.296914
NCT01889277|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-01-26|||July 2013||2013-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy|A Phase II, Randomised, Double-blind, Placebo-controlled Study of MT-3995 in Subjects With Diabetic Nephropathy|Completed||Phase 1/Phase 2|51|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-10-11 01:32:32.382242|2017-10-11 01:32:32.382242
NCT01889264|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-03-20|||December 2011||2011-12-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Methionine Metabolism in Enterally Fed Pediatric Sepsis|Methionine Metabolism in Enterally Fed Critically Ill Children|Completed||N/A|45|Actual|The Cleveland Clinic|||1||f||||t||||||Samples Without DNA|"     Blood samples.   "|||2017-10-11 01:32:32.457857|2017-10-11 01:32:32.457857
NCT01889251|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2015-11-02|2015-09-30||July 2013||2013-07-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||This analysis population includes all randomized subjects, as randomized.|A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion|A Phase III Study of A01016 125μg Intravitreal Injection in Subjects With Symptomatic Vitreomacular Adhesion - Comparison Study to Sham Injection|Completed||Phase 3|251|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:32:32.535041|2017-10-11 01:32:32.535041
NCT01889238|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-08-02||2016-03-21|June 12, 2013|Actual|2013-06-12|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|March 1, 2015|Actual|2015-03-01||Interventional|||Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer|A Phase 2, Single-arm, Open-label, Multicenter Study Of The Clinical Activity And Safety Of Enzalutamide In Patients With Advanced, Androgen Receptor-positive, Triple-negative Breast Cancer|Active, not recruiting||Phase 2|118|Actual|Pfizer||1|||f||||||||||||||2017-10-11 01:32:32.852696|2017-10-11 01:32:32.852696
NCT01889225|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2014-08-21|||January 2008||2008-01-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Obesity and Mortality||Completed||N/A|311982|Actual|University of Alabama at Birmingham|||19||f||||||||||||||2017-10-11 01:32:33.152167|2017-10-11 01:32:33.152167
NCT01889212|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-10-27|||April 2013||2013-04-01|June 2013|2013-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Imaging With 11C-erlotinib PET/CT to Identify Responders to Erlotinib Treatment in NSCLC|Imaging With 11C-erlotinib PET/CT to Identify Responders to Erlotinib Treatment in NSCLC|Terminated||N/A|4|Actual|University of Aarhus||1||Due to technical problems|f||||f||||||||||2017-10-11 01:32:33.3603|2017-10-11 01:32:33.3603
NCT01889199|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-10-27|||April 2013||2013-04-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Androgen Excess as a Mechanism for Adipogenic Dysfunction in PCOS Women|Androgen Excess as a Mechanism for Adipogenic Dysfunction in PCOS Women|Recruiting||Phase 2|59|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:32:33.451239|2017-10-11 01:32:33.451239
NCT01889173|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2014-09-24|||June 2013||2013-06-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 2.8 mg SL Tablets and Cyclobenzaprine 5 mg Oral Tablet in Healthy Adults|A Single-Dose, Open-Label, Randomized, Parallel-Design Study Of The Comparative Pharmacokinetics And Safety Of TNX-102 2.8 mg SL Tablets (With Potassium Phosphate) At 2.8 mg, TNX-102-B 2.8 mg SL Tablets (With Sodium Phosphate) At 2.8 mg, TNX-102-C 2.8 mg SL Tablets (With Trisodium Citrate) At 2.8 mg, And Cyclobenzaprine 5 mg Oral Tablets In Healthy Adults|Completed||Phase 1|24|Actual|Tonix Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 01:32:33.807494|2017-10-11 01:32:33.807494
NCT01889160|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-06-24|||July 2013||2013-07-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels|A Phase I Single-blind, Randomised, Placebo-controlled, Single-centre Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral AZD4721 Solution After Single Ascending Doses, and to Compare the Oral Bioavailability of Single Doses of Solution and Suspension in Healthy Subjects|Completed||Phase 1|44|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 01:32:33.923229|2017-10-11 01:32:33.923229
NCT01889147|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-10-23|||June 2013||2013-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Microdose and First-In-Human (FIH) Study of Recombinant Human Placental Alkaline Phosphatase (hRESCAP)|A Single Dose Study to Assess the Peak Plasma Concentration of a Microdose of Recombinant Human Placental Alkaline Phosphatase (hRESCAP, Part 1) Followed by a Single Ascending Dose, FIH Study to Assess Safety and Tolerability of hRESCAP (Part 2).|Completed||Early Phase 1|4|Anticipated|TNO||3|||f||||t||||||||||2017-10-11 01:32:34.092474|2017-10-11 01:32:34.092474
NCT01889134|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-25|||January 2009||2009-01-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism|Osteoprotegerin/sRANKL Ratio and Bone Mineral Density in Patients With Primary Hyperparathyroidism Treated With Parathyroidectomy or Alendronate|Completed||N/A|112|Actual|Wroclaw Medical University||3|||f||||f||||||||||2017-10-11 01:32:34.991384|2017-10-11 01:32:34.991384
NCT01889121|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-06-26|||February 2013||2013-02-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|HOPE||Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their Mothers|Retrospective Analysis of the Utility Formal Psychosocial Support in Enhancing the Outcome of Pregnancies in Opiate-addicted Pregnant Women in Agonist Maintenance Programs|Completed||N/A|113|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||||||2017-10-11 01:32:35.153142|2017-10-11 01:32:35.153142
NCT01889108|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-06-27|||July 2012||2012-07-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|SPEEDI||Feasibility Study of SPEEDI|Feasibility Study of Supporting Play, Exploration, & Early Development Intervention (SPEEDI) for Infants Born Preterm|Completed||Phase 1|10|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 01:32:35.249365|2017-10-11 01:32:35.249365
NCT01889095|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-27|||July 2011||2011-07-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|August 2011|Actual|2011-08-01||Interventional|||Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients||Completed||Phase 4|160|Actual|Tehran University of Medical Sciences||2|||f||||||||||||||2017-10-11 01:32:35.354313|2017-10-11 01:32:35.354313
NCT01889082|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-12-16|||January 2013||2013-01-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|SPARKRVA||Recruiting and Retaining Young Adults in Behavioral Weight Loss Treatment|Recruiting and Retaining Young Adults in Behavioral Weight Loss Treatment|Completed||N/A|52|Actual|Virginia Commonwealth University||3|||f||||f||||||||||2017-10-11 01:32:35.514276|2017-10-11 01:32:35.514276
NCT01889069|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-08-14|||July 31, 2013|Actual|2013-07-31|July 2017|2017-07-01|June 15, 2019|Anticipated|2019-06-15|June 15, 2019|Anticipated|2019-06-15||Interventional|||A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)|A Single Arm, Multicentre, Phase IIIB Study to Evaluate Safety, Efficacy and Pharmacokinetic (PK) of Subcutaneous (SC) Rituximab Administered During Induction Phase or Maintenance in Previously Untreated Patients With CD20+ Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)|Active, not recruiting||Phase 3|161|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:32:35.688258|2017-10-11 01:32:35.688258
NCT01889056|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-06-25|||February 2013||2013-02-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Non-erythroid Effects of Erythropoietin on Cognitive Function and Exercise Capacity in Humans||Unknown status|Active, not recruiting|Phase 1/Phase 2|32|Anticipated|University of Zurich||2|||f||||||||||||||2017-10-11 01:32:35.935638|2017-10-11 01:32:35.935638
NCT01889043|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-12-11|||January 2012||2012-01-01|December 2015|2015-12-01||||September 2015|Actual|2015-09-01||Observational|||Monitoring of Non-invasive Ventilation During Sleep in ALS|Monitoring of Non-invasive Ventilation During Sleep in ALS|Completed||N/A|40|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:32:36.044211|2017-10-11 01:32:36.044211
NCT01889030|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2014-07-23|||July 2013||2013-07-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01|1 Day|Observational [Patient Registry]|RISK||Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention|Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention. RISK Study|Completed||N/A|516|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:32:36.142908|2017-10-11 01:32:36.142908
NCT01889017|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-07-15|||July 2013||2013-07-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|March 2014|Anticipated|2014-03-01||Observational|||Generic Immunosuppressive Drugs After Lung Transplantation|Generic Immunosuppressive Drugs After Lung Transplantation - a Crosssectional Observational Study by Patient Questionnaire|Unknown status|Recruiting|N/A|600|Anticipated|Hannover Medical School|||1||f||||f||||||||||2017-10-11 01:32:36.237823|2017-10-11 01:32:36.237823
NCT01889004|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2016-01-08|||February 2014||2014-02-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|LOC-2013||The Neural Mechanisms of Anesthesia and Human Consciousness|The Neural Mechanisms of Anesthesia and Human Consciousness (LOC-2013)|Completed||Phase 4|47|Actual|University of Turku||2|||f||||f||||||||||2017-10-11 01:32:36.771918|2017-10-11 01:32:36.771918
NCT01888991|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-22|2013-06-25|||December 2011||2011-12-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Substrate Oxidation Does Not Affect Short Term Food Intake in Healthy Boys and Men|Substrate Oxidation Does Not Affect Short Term Food Intake in Healthy Boys and Men.|Completed||N/A|30|Actual|University of Toronto||4|||f||||f||||||||||2017-10-11 01:32:36.867954|2017-10-11 01:32:36.867954
NCT01888978|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-07-09|||December 2012||2012-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Molecularly Tailored Therapy for Pancreas Cancer|A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer|Active, not recruiting||Phase 2|20|Anticipated|Georgetown University||7|||f||||t||||||||||2017-10-11 01:32:36.951255|2017-10-11 01:32:36.951255
NCT01888965|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-06-07|2016-02-08||October 2013||2013-10-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||Maintenance Dovitinib for Colorectal and Pancreas Cancer|A Pilot Study of Dovitinib as Maintenance and Adjuvant Therapy in Patients With Colorectal and Pancreas Cancers|Terminated||Phase 2|9|Actual|Georgetown University||1||Adverse Event issues.|f||||t||||||||No||2017-10-11 01:32:37.101068|2017-10-11 01:32:37.101068
NCT01888952|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-01-05|2015-12-23||July 2013||2013-07-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)|Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)|Completed||Early Phase 1|10|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 01:32:37.346244|2017-10-11 01:32:37.346244
NCT01888939|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-06-30|||June 20, 2013||2013-06-20|March 7, 2017|2017-03-07|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Interventional|||Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children|Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children|Completed||Phase 1/Phase 2|89|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:32:37.510248|2017-10-11 01:32:37.510248
NCT01888926|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-06-30|||June 18, 2013||2013-06-18|August 2, 2016|2016-08-02|August 2, 2016|Actual|2016-08-02|August 2, 2016|Actual|2016-08-02||Observational|||The Effects of Repetitive Paired Associative Stimulation in Dystonia|Investigating the Plastic Effects of Repetitive Paired Associative Stimulation (rPAS) in Dystonia|Completed||N/A|19|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:32:37.600069|2017-10-11 01:32:37.600069
NCT01888913|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2017-06-30|||June 21, 2013||2013-06-21|February 16, 2017|2017-02-16|February 10, 2016|Actual|2016-02-10|February 10, 2016|Actual|2016-02-10||Observational|||Patient Perspectives and Doctor Visits|Patient Perspectives and Simulated Clinical Interactions|Completed||N/A|338|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:32:37.66816|2017-10-11 01:32:37.66816
NCT01888900|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-12-14|2016-11-14||May 2013||2013-05-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C|Unraveling the Mechanisms of Non-Response in Patients With and Without Cirrhosis Due to Chronic Hepatitis C|Completed||Phase 2|35|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||Yes|Patients will have serum stored from selected time points during this study. These specimens will be used for repeat virological testing and special tests as needed (such as for viral levels, HCV RNA sequencing, HCV resistance testing or measurement of serum levels of cytokines, IL28b testing or interferon induced genes) and for future research.|2017-10-11 01:32:37.824351|2017-10-11 01:32:37.824351
NCT01888887|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-06-26|||December 2012||2012-12-01|June 2013|2013-06-01||||February 2013|Actual|2013-02-01||Interventional|||Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser|Cetaphil Daily Facial Cleanser: 200 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation|Completed||N/A|200|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:32:38.583196|2017-10-11 01:32:38.583196
NCT01888874|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2016-04-18||2016-04-18|July 2013||2013-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|DARWIN1||Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Patients (DARWIN1)|Randomized, Double-blind, Placebo-controlled, Multicenter, Phase IIb Dose Finding Study of GLPG0634 Administered for 24 Weeks in Combination With Methotrexate to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Alone|Completed||Phase 2|599|Actual|Galapagos NV||7|||f||||t||||||||||2017-10-11 01:32:38.662333|2017-10-11 01:32:38.662333
NCT01888861|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2013-06-27|||February 2013||2013-02-01|June 2013|2013-06-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Effect of Alpha-lipoic Acid on Biochemical Markers and Important Outcomes in Patients Admitted to Intensive Care Units|Evaluating the Effect of Alpha Lipoic Acid on Biochemical Markers, Length of Stay and Other Important Outcomes in Patients Admitted to Intensive Care Units.|Unknown status|Recruiting|Phase 3|80|Anticipated|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:32:40.799407|2017-10-11 01:32:40.799407
NCT01888848|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-05-26|||January 2013||2013-01-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Blueberry on Cognition and Mobility in Older Adults|Effects of Dietary Blueberry Supplementation on Cognition and Mobility in Healthy Older Adults|Completed||N/A|42|Actual|USDA Human Nutrition Research Center on Aging||2|||f||||f||||||||||2017-10-11 01:32:40.897311|2017-10-11 01:32:40.897311
NCT01888835|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-09-22|||August 2013||2013-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)|Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM: a 6-month Randomized Controlled Trial With 3 Months of Follow-up|Active, not recruiting||Phase 2|120|Actual|San Francisco Department of Public Health||2|||f||||t||||||||||2017-10-11 01:32:41.119775|2017-10-11 01:32:41.119775
NCT01888822|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-04-23|||June 2013||2013-06-01|June 2013|2013-06-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Antibiotic Prophylaxis in Laparoscopic Cholecystectomy|Ciprofloxacin, Ampicillin-sulbactam and Placebo Prophylaxis in Laparoscopic Cholecystectomy. A Randomized Controlled Study|Suspended||Phase 4|138|Anticipated|University of Roma La Sapienza||3|||f||||f||||||||||2017-10-11 01:32:41.224919|2017-10-11 01:32:41.224919
NCT01888809|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-08-29|||August 2007||2007-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|BHC||Building Healthy Children|Building Health Children: Randomized Controlled Trial (RCT) Evaluation|Active, not recruiting||N/A|1536|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 01:32:41.34202|2017-10-11 01:32:41.34202
NCT01888796|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-04-10|||September 2013||2013-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Diast Dysfkt||Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus|Effect of Linagliptin Therapy on Myocardial Diastolic Function in Patients With Type 2 Diabetes Mellitus|Terminated||Phase 3|8|Actual|RWTH Aachen University||2||bad recruitment of suitable participants, just 8 patients in one year|f||||t||||||||||2017-10-11 01:32:41.454565|2017-10-11 01:32:41.454565
NCT01888783|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-08-01|||September 2012||2012-09-01|June 2013|2013-06-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Two Measures of Tactile Acuity in CRPS Type I Patients|Comparison of Two Measures of Tactile Acuity in CRPS Type I Patients , Patients With a Neuropathy of the Median Nerve and Healthy Controls.|Unknown status|Recruiting|N/A|150|Anticipated|Ruhr University of Bochum||3|||f||||f||||||||||2017-10-11 01:32:41.549398|2017-10-11 01:32:41.549398
NCT01888770|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-05-23|||August 2011||2011-08-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|EPOCH||The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular Health|The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular Health|Recruiting||N/A|300|Anticipated|University of Oxford|||5||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma   "|||2017-10-11 01:32:41.656882|2017-10-11 01:32:41.656882
NCT01888757|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-06-26|||September 2010||2010-09-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fed Conditions.|Completed||Phase 1|62|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 01:32:41.773899|2017-10-11 01:32:41.773899
NCT01888744|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-27|||September 2010||2010-09-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Avanti||Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist|The Effect of the Type of Ovarian Stimulation Protocol on PGD Results: a Prospective Randomised Trial|Completed||Phase 4|120|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 01:32:41.86279|2017-10-11 01:32:41.86279
NCT01888731|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-06-26|||August 2010||2010-08-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fasting Conditions.|Completed||Phase 1|62|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 01:32:41.971918|2017-10-11 01:32:41.971918
NCT01888718|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-26|2013-06-26|||February 2011||2011-02-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition|Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrating Tablets 30 mg of Dr. Reddy's Laboratories Limited, India Comparing With That of Allegra ® (Containing Fexofenadine Hydrochloride) Orally Disintegrating Tablets 30 mg of Sanofi - Aventis U.S. LLC, Bridgewater, NJ 08807 in Healthy, Adult, Human Subjects Under Fasting Conditions.|Completed||Phase 1|80|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 01:32:42.067867|2017-10-11 01:32:42.067867
NCT01888705|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-27|||March 2010||2010-03-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01|1 Day|Observational [Patient Registry]|||Complexity of the Airflow in COPD|Complexity of the Airflow at Different Levels of Bronchial Obstruction of COPD.|Unknown status|Recruiting|N/A|90|Anticipated|Rio de Janeiro State University|||6||f||||f||||||||||2017-10-11 01:32:42.161844|2017-10-11 01:32:42.161844
NCT01888692|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-25|||April 2007||2007-04-01|June 2013|2013-06-01|December 2010|Actual|2010-12-01|August 2009|Actual|2009-08-01||Observational|||To Evaluate the Impact of PET/CT on Radiation Treatment Planning in Relation to Changes in GTV in Stage 3 NSCLC|A Prospective Observational Study to Evaluate the Impact of PET/CT Simulation on Radiation Treatment Planning in Relation to Changes in GTV in Locally Advanced Non-small Cell Lung Cancer|Terminated||N/A|29|Actual|University of Manitoba|||1|Poor accural|f||||||||||||||2017-10-11 01:32:42.234815|2017-10-11 01:32:42.234815
NCT01888679|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-27|||August 2012||2012-08-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Influence of Head Positioning on the Movement of the Endotracheal Tube|Influence of Head Positioning on the Movement of the Endotracheal Tube|Completed||N/A|50|Actual|University of Lausanne Hospitals||1|||f||||f||||||||||2017-10-11 01:32:42.308179|2017-10-11 01:32:42.308179
NCT01888666|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-08-14|||January 2013||2013-01-01|August 2013|2013-08-01||||August 2013|Actual|2013-08-01||Observational|||Comparison Between Rapid and Slow Palatal Expansion: Evaluation of Periodontal Indices||Completed||N/A|20|Actual|University of L'Aquila|||2||f||||||||||||||2017-10-11 01:32:42.374978|2017-10-11 01:32:42.374978
NCT01888653|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-04-14|||May 2013||2013-05-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|||Attention-Bias Modification Treatment for PTSD|Attention-Bias Modification Treatment for PTSD|Recruiting||N/A|50|Anticipated|Research Foundation for Mental Hygiene, Inc.||1|||f||||f||||||||||2017-10-11 01:32:42.43492|2017-10-11 01:32:42.43492
NCT01888640|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-03-28|||May 2013||2013-05-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|FAST||Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)|Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation|Recruiting||N/A|360|Anticipated|University of Iowa||3|||f||||t|f|t|f||f|||Undecided|By publication|2017-10-11 01:32:42.526053|2017-10-11 01:32:42.526053
NCT01888627|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-08-07|||May 2007||2007-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|ACCESS-II||Integrated Care in Psychotic Disorders With Severe Mental Illness|Integrated Care in Patients With a Psychotic Disorder Fulfilling Definition of Severe Mental Illness (ACCESS-II Study)|Recruiting||N/A|400|Anticipated|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-10-11 01:32:42.76964|2017-10-11 01:32:42.76964
NCT01888614|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-12-21|||June 2013||2013-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study|Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study|Withdrawn||N/A|0|Actual|University Hospitals Cleveland Medical Center|||1|Unable to secure equipment to proceed|f||||f||||||||No||2017-10-11 01:32:42.863563|2017-10-11 01:32:42.863563
NCT01888601|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-11-29|||April 2014||2014-04-01|November 2016|2016-11-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Observational|TRACERx||TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)|TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)|Recruiting||N/A|842|Anticipated|University College, London|||1||f||||t||||||Samples With DNA|"     tissue, blood, plasma and serum   "|||2017-10-11 01:32:42.940597|2017-10-11 01:32:42.940597
NCT01888575|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-05-09|||September 2012||2012-09-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy|Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy for Secondary Prevention|Completed||N/A|35604|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 01:32:43.19289|2017-10-11 01:32:43.19289
NCT01888562|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-12-17|||January 2016||2016-01-01|December 2015|2015-12-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma|A Pilot Evaluation of Ponatinib (AP24534), a Potent Oral Pan-FGFR Inhibitor, in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma: a Multi-Institutional Study|Withdrawn||N/A|0|Actual|Washington University School of Medicine||1||Could not obtain an IDE on the FGFR2 assay|f||||f||||||||||2017-10-11 01:32:43.284327|2017-10-11 01:32:43.284327
NCT01888549|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-06-22|||February 2012||2012-02-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial||Completed||N/A|48|Actual|Yonsei University||3|||f||||t||||||||||2017-10-11 01:32:43.365447|2017-10-11 01:32:43.365447
NCT01888536|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-12-19|||February 2013||2013-02-01|December 2015|2015-12-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional|||A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis|A Randomized, Double-Blind, Comparative, Multi-Center, Phase Ⅳ Clinical Trial to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis|Completed||Phase 4|182|Actual|Yungjin Pharm. Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:32:43.445921|2017-10-11 01:32:43.445921
NCT01888523|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-01-20|||February 2014||2014-02-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|November 2014|Actual|2014-11-01||Interventional|||Stress Management for Cancer Survivors|Stress Management for Cancer Survivors Using a Technologically Adapted Psychosocial Intervention: A Randomized Trial Determining the Effect of Expressive Writing on Psychoneuroimmunology Based Outcomes|Completed||N/A|40|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 01:32:43.560709|2017-10-11 01:32:43.560709
NCT01888510|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-07-06|||May 2013||2013-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||CT in Diagnosing Patients With Lung Cancer|Comparison of Conventional Free Breathing CT, 4D CT, and Integrated Active Breath Hold CT Image Acquisition for Lung Cancer|Completed||N/A|10|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 01:32:43.640081|2017-10-11 01:32:43.640081
NCT01888497|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2014-12-15||2014-12-15|July 2013||2013-07-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers|A Phase 3 Randomized, Double-blind, Cross-over, Placebo-controlled, Multi-center, Single-dose, Clinical Trial to Assess the Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers|Completed||Phase 3|59|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 01:32:43.732978|2017-10-11 01:32:43.732978
NCT01888484|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-09-11|||March 2014||2014-03-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Octanorm Subcutaneous IG in Patients With PID|Clinical Phase III Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability and Safety of Subcutaneous Human Immunoglobulin (Octanorm 16.5%) In Patients With Primary Immunodeficiency Diseases|Recruiting||Phase 3|64|Anticipated|Octapharma||1|||f||||t||||||||||2017-10-11 01:32:43.826938|2017-10-11 01:32:43.826938
NCT01888471|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-07-27|||December 11, 2013|Actual|2013-12-11|July 2017|2017-07-01|July 14, 2014|Actual|2014-07-14|July 14, 2014|Actual|2014-07-14||Interventional|||Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])|Feasibility Study for Identifying a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged Less ≤90 Days|Completed||N/A|3033|Actual|GlaxoSmithKline||2|||f||||f|f|||||||||2017-10-11 01:32:43.949699|2017-10-11 01:32:43.949699
NCT01888458|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-05-19|||September 2013||2013-09-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MycaCOORD||Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)|Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation|Completed||Phase 2|21|Actual|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 01:32:44.051366|2017-10-11 01:32:44.051366
NCT01888445|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2014-10-15|||May 2013||2013-05-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug|ASP1517 Phase 2 Clinical Trial -A Multi-center, Randomized, 4-arm Parallel, Double Blind (Arm 1-3), Open-label (Arm 4), Active-comparator (Darbepoetin Alfa) Study of Intermittent Oral Dosing of ASP1517 in Dialysis Chronic Kidney Disease Patients With Anemia|Completed||Phase 2|130|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 01:32:44.133776|2017-10-11 01:32:44.133776
NCT01888432|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2016-09-21|||September 2013||2013-09-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants|A 24 Month, Randomized, Controlled, Study to Evaluate the Efficacy and Safety of Concentration-controlled Everolimus Plus Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplants and Long Term Extension to Evaluate the Efficacy and Safety of Concentration-controlled Everolimus Plus Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplants in Japan.|Active, not recruiting||Phase 3|286|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:32:44.23215|2017-10-11 01:32:44.23215
NCT01888419|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-02-12|||October 2014||2014-10-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Investigation of the Pain Relieving Properties of Lipotransplantation After Treatment for Breast Cancer|"A Prospective, Randomized Study of the Possible Pain Relieving and Scar Tissue Modifying Properties of Lipotransplantation in a Post Breast Therapy Pain Syndrome Setting"|Completed||N/A|18|Actual|Aarhus University Hospital||2|||f||||f||||||||No||2017-10-11 01:32:44.387327|2017-10-11 01:32:44.387327
NCT01888406|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-24|||January 2013||2013-01-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|BEST4US||Binge Eating Self-help Treatment for University Students|Targeting Binge Eating to Prevent Weight Gain in College Students|Unknown status|Active, not recruiting|N/A|130|Anticipated|Wesleyan University||2|||f||||t||||||||||2017-10-11 01:32:44.476857|2017-10-11 01:32:44.476857
NCT01888393|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-11-18|||June 2013||2013-06-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy Subjects|A Phase 1, Open Label Study to Assess the Pharmacokinetics and Safety of Multiple Doses of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects|Completed||Phase 1|23|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||t||||||||||2017-10-11 01:32:44.549485|2017-10-11 01:32:44.549485
NCT01888380|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-05-02|||January 2014||2014-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||The Paediatric Virtual Autopsy Trial|Post-mortem Cross-sectional Imaging With Guided Biopsy; A Comparative Study With Conventional Autopsy in Foetuses, Neonates, Infants and Children|Recruiting||N/A|100|Anticipated|University of Zurich||3|||f||||f||||||||||2017-10-11 01:32:44.716886|2017-10-11 01:32:44.716886
NCT01888367|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-08-17|2016-03-23||October 2013||2013-10-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery|A Randomized, Blinded, Placebo and Standard of Care Controlled Efficacy, Safety, and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery|Completed||Phase 2|445|Actual|Dr. Reddy's Laboratories Limited|The number of culture positive SSIs were too small to draw any conclusions on antibiotic resistance.|3|||f||||t||||||||||2017-10-11 01:32:44.849888|2017-10-11 01:32:44.849888
NCT01888354|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-09-14|||April 2013||2013-04-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations|Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ) Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations|Completed||Phase 4|25|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 01:32:45.882961|2017-10-11 01:32:45.882961
NCT01888341|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-26|||August 2002||2002-08-01|November 2002|2002-11-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition|An Open Label, Randomized, Single Dose, Oral Bioequivalence Study of Isotretinoin Capsules 20 mg of Dr. Reddy's Laboratories Limited, India Comparing With That of ACCUTANE® Capsules 20 mg of Roche Laboratories Inc., Under Fasting Conditions|Completed||Phase 1|41|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 01:32:45.974205|2017-10-11 01:32:45.974205
NCT01888328|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-26|||May 2001||2001-05-01|August 2001|2001-08-01|June 2001|Actual|2001-06-01|May 2001|Actual|2001-05-01||Interventional|||Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition|An Open Label, Randomized, Single Dose, Oral Bioequivalence Study of Isotretinoin Capsules 40 mg of Dr. Reddy's Laboratories Limited, India Comparing With That of ACCUTANE® Capsules 40 mg of Roche Laboratories Inc., Under Fed Conditions|Completed||Phase 1|26|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 01:32:46.055853|2017-10-11 01:32:46.055853
NCT01888315|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-06-24|||January 2011||2011-01-01|June 2013|2013-06-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity|Safety and Efficacy Study Investigating the Effects of Catheter-based Renal Denervation on Different Organ Systems in Patients With Increased Sympathetic Activity|Recruiting||Phase 1/Phase 2|1000|Anticipated|University Hospital, Saarland||2|||f||||f||||||||||2017-10-11 01:32:46.133192|2017-10-11 01:32:46.133192
NCT01888302|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-06-20|||September 2013||2013-09-01|February 2016|2016-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery|Pilot Trial of Sirolimus, Gemcitabine and Cisplatin for Patients With High Risk for Cholangiocarcinoma Recurrence|Completed||Phase 1|1|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:32:46.228231|2017-10-11 01:32:46.228231
NCT01888289|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-26|||July 2001||2001-07-01|November 2001|2001-11-01|September 2001|Actual|2001-09-01|August 2001|Actual|2001-08-01||Interventional|||Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition|An Open Label, Randomized, Single Dose, Oral Bioequivalence Study of Isotretinoin Capsules 40 mg of Dr. Reddy's Laboratories Limited, India Comparing With That of ACCUTANE® Capsules 40 mg of Roche Laboratories Inc., Under Fasting Conditions|Completed||Phase 1|35|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 01:32:46.357428|2017-10-11 01:32:46.357428
NCT01888276|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-06-10|||February 2012||2012-02-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|FLUENCE||Words Generation in Compulsives Gamblers and Parkinson's Disease Patients|Study of Words Generation in Compulsives Gamblers and Healthy Volunteers: Comparison With a Study of Parkinson's Disease Patients|Completed||N/A|37|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 01:32:46.431283|2017-10-11 01:32:46.431283
NCT01888263|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-25|||August 2010||2010-08-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fed Conditions.|Completed||Phase 1|32|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 01:32:46.500827|2017-10-11 01:32:46.500827
NCT01888250|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-25|||August 2010||2010-08-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fasting Conditions.|Completed||Phase 1|36|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 01:32:46.578422|2017-10-11 01:32:46.578422
NCT01887509|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-08-31|||November 2013||2013-11-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|TRaMA||Evaluation of Rectal Tumor Margin Using Confocal Endomicroscopy and Comparison to Histopathology|Evaluation of Rectal Tumor Margin Using Confocal Endomicroscopy and Comparison to Histopathology|Active, not recruiting||N/A|21|Actual|IHU Strasbourg||1|||f||||f||||||||||2017-10-11 01:32:55.319065|2017-10-11 01:32:55.319065
NCT01888237|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-04-09|||May 2013||2013-05-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication|Randomized Open Labeled Clinical Trial: a Comparative Study of 10-day High Dose PPI-based Triple Therapy vs. 10-day Sequential Therapy for Helicobacter Pylori Eradication in Functional Dyspepsia Patients|Completed||Phase 4|118|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 01:32:46.651754|2017-10-11 01:32:46.651754
NCT01888224|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-25|||June 2011||2011-06-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition|Open Label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Oral Bioequivalence Study of Isotretinoin Capsules 40 mg of Dr. Reddy's Laboratories Limited, India Comparing With Amnesteem Capsules 40 mg of Mylan Pharmaceuticals Inc., in Healthy, Adult, Male Human Subjects Under Fed Conditions.|Completed||Phase 1|61|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 01:32:46.729954|2017-10-11 01:32:46.729954
NCT01888211|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-06-24|||December 2004||2004-12-01|June 2013|2013-06-01|June 2009|Actual|2009-06-01|June 2006|Actual|2006-06-01||Interventional|||Effect of Omega 3 Fatty Acids on Vascular Function|Effect of Omega 3 Fatty Acid Supplementation on Endothelial Function, Endogenous Fibrinolysis and Platelet Activation in Patients With a Previous Myocardial Infarction|Completed||N/A|20|Actual|University of Edinburgh||2|||f||||f||||||||||2017-10-11 01:32:46.808184|2017-10-11 01:32:46.808184
NCT01888198|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-03-21|||June 2013||2013-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|24 Months|Observational [Patient Registry]|||Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment|Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment|Recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 01:32:46.883765|2017-10-11 01:32:46.883765
NCT01888185|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-01-11|||December 2012||2012-12-01|January 2017|2017-01-01||||August 2017|Anticipated|2017-08-01||Observational|||Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)|Multimodal MRI Markers of Nigrostriatal Pathology in Parkinson's Disease|Enrolling by invitation||N/A|230|Anticipated|Milton S. Hershey Medical Center|||4||f||||||||||Samples With DNA|"     Whole blood, serum, plasma, white blood cells, urine, cerebral spinal fluid (CSF), tissue   "|||2017-10-11 01:32:47.00464|2017-10-11 01:32:47.00464
NCT01888159|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-25|||September 2013||2013-09-01|June 2013|2013-06-01||||September 2014|Anticipated|2014-09-01||Interventional|||Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve||Unknown status|Not yet recruiting|N/A|100|Anticipated|Karlstad Central Hospital||2|||f||||f||||||||||2017-10-11 01:32:47.156145|2017-10-11 01:32:47.156145
NCT01888146|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-12-21|||May 2013||2013-05-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PPACT-UH2||Pain Program for Active Coping & Training|Collaborative Care for Chronic Pain in Primary Care|Completed||N/A|20|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 01:32:47.343367|2017-10-11 01:32:47.343367
NCT01888133|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-04-01|||April 2013||2013-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Adopting a Physically Active Lifestyle Through Organized Walk Events Among Joslin Clinic Patients|Adopting a Physically Active Lifestyle Through Organized Walk Events Among Joslin Clinic Patients|Terminated||N/A|22|Actual|Joslin Diabetes Center||2||Lack of funding|f||||t||||||||||2017-10-11 01:32:47.423081|2017-10-11 01:32:47.423081
NCT01888120|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-03-14|||July 2013||2013-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01|18 Months|Observational [Patient Registry]|PRIZM||Patient Registry of Intrathecal Ziconotide Management(PRIZM)|Patient Registry of Intrathecal Ziconotide Management (PRIZM): An Open-Label, Long Term, Multi-Center, Observational Study of PRIALT® (Ziconotide) Solution, Intrathecal Infusion, in Patients With Severe Chronic Pain|Completed||N/A|93|Actual|Jazz Pharmaceuticals|||1||f||||f||||||||||2017-10-11 01:32:47.51972|2017-10-11 01:32:47.51972
NCT01888107|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-06-25|||January 2005||2005-01-01|June 2013|2013-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder|Maintenance of Clinical Response With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|347|Actual|Janssen-Cilag S.p.A.||1|||f||||f||||||||||2017-10-11 01:32:47.672265|2017-10-11 01:32:47.672265
NCT01888094|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-06-24|||June 2013||2013-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SUBGEUS||SUBclavian Central Venous Catheters Guidance and Examination by UltraSound|SUBclavian Central Venous Catheters Guidance and Examination by UltraSound : a Randomized Controlled Study Versus Landmark Method|Completed||Phase 2/Phase 3|300|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:32:47.755693|2017-10-11 01:32:47.755693
NCT01888081|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-11-22|||February 2014||2014-02-01|November 2016|2016-11-01||||December 2020|Anticipated|2020-12-01||Interventional|||A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma|Phase I/II Trial of A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for the Treatment of Stage IV Melanoma|Terminated||Phase 1/Phase 2|2|Actual|Angimmune LLC||1||Protocol replaced with combination therapy adding KEYTRUDA (pembrolizumab)|f||||t||||||||||2017-10-11 01:32:47.836088|2017-10-11 01:32:47.836088
NCT01888068|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-07-31|||June 2013||2013-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Comparison of Bioimpedance Body Composition Device Measurements|Comparison of Bioimpedance Body Composition Device Measurements: Predicate (EFG®) Versus Candidate (Vitality Analyzer™)|Completed||N/A|100|Actual|IPGDx, LLC|||1||f||||||||||None Retained|"     None acquired or retained   "|||2017-10-11 01:32:47.911313|2017-10-11 01:32:47.911313
NCT01888055|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-12-21|||May 2013||2013-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Influence of tDCS on Cortical Plasticity in Healthy Older Adults|Influence of Transcranial Direct-current Stimulation on Cortical Plasticity in Healthy Older Adults|Active, not recruiting||N/A|15|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 01:32:47.971086|2017-10-11 01:32:47.971086
NCT01888042|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-02-09|||July 2011||2011-07-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|POORTOR||Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer|Phase II Study Assessing Everolimus as Fist Line Treatment in Patients With Metastatic Kidney Cancer of Bad Prognosis|Terminated||Phase 2|61|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 01:32:48.036511|2017-10-11 01:32:48.036511
NCT01888029|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-12-21|||May 2013||2013-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Influence of tDCS on Cortical Plasticity in Patients With Mild Cognitive Impairment (MCI)|Influence of Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Mild Cognitive Impairment (MCI)|Active, not recruiting||N/A|15|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 01:32:48.109219|2017-10-11 01:32:48.109219
NCT01888016|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-11-18|||June 2013||2013-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Effectiveness of Fascial Manipulation in Rotator's Cuff Surgery Patients|Effectiveness of Fascial Manipulation in Early Rehabilitation Treatment of Rotator's Cuff Surgery Patients. A Randomized Trial.|Completed||N/A|60|Actual|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-11 01:32:48.188703|2017-10-11 01:32:48.188703
NCT01888003|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-05-26|2015-03-20||April 2013||2013-04-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|PAMP||The Benefits of a Preoperative Anemia Management Program|The Benefits of a Preoperative Anemia Management Program|Terminated||N/A|51|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-10-11 01:32:48.279034|2017-10-11 01:32:48.279034
NCT01887990|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-04-07|2014-11-21||May 2012|Actual|2012-05-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Treatment of Suicidal Ideation With Intravenous Ketamine Infusion|Treatment of Suicidal Ideation With Intravenous Ketamine Infusion|Completed||N/A|18|Actual|University of Alabama at Birmingham|short term followup small sample size|4|||f||||f||||||||||2017-10-11 01:32:48.624732|2017-10-11 01:32:48.624732
NCT01887977|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-06-24|||March 2012||2012-03-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|PUMA||Computational Modeling for Prediction of Acoustic Changes in Vowel Production Due to Orthognathic Surgery|Computational Modeling for Prediction of Acoustic Changes in Vowel Production|Unknown status|Recruiting|N/A|20|Anticipated|Turku University Hospital||1|||f||||f||||||||||2017-10-11 01:32:48.952426|2017-10-11 01:32:48.952426
NCT01887964|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-24|||March 2012||2012-03-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Resistant Starch (Type-4) on Metabolic Syndrome|Dietary Fiber Intervention in Hutterite Population of South Dakota With and Without Signs of Metabolic Syndrome|Completed||N/A|86|Actual|South Dakota State University||2|||f||||f||||||||||2017-10-11 01:32:49.043789|2017-10-11 01:32:49.043789
NCT01887951|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-02-09|||February 2014||2014-02-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|August 2014|Actual|2014-08-01||Interventional|PENTRA||Penthrox Versus Tramadol for SCDF|Clinical Evaluation of Penthrox (Methoxyflurane)and Tramadol for the Singapore Emergency Ambulance Service|Completed||Phase 4|380|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-10-11 01:32:49.146598|2017-10-11 01:32:49.146598
NCT01887938|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-11-02|||May 2013||2013-05-01|November 2016|2016-11-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Open-Label Extension Study Evaluating Safety and Efficacy of HGT-1110 in Patients With Metachromatic Leukodystrophy|An Open-Label Extension of Study HGT-MLD-070 Evaluating Long Term Safety and Efficacy of Intrathecal Administration of HGT-1110 in Patients With Metachromatic Leukodystrophy|Enrolling by invitation||Phase 1/Phase 2|24|Anticipated|Shire||4|||f||||t||||||||||2017-10-11 01:32:49.233955|2017-10-11 01:32:49.233955
NCT01887925|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-11-27|||February 2012||2012-02-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||The Effects of Circadian Gene on Sleep and Associated Symptoms in Breast Cancer Patients Under Chemotherapy|The Effects of Per3, Clock Polymorphism on Sleep and Associated Symptoms in Breast Cancer Patients Under Chemotherapy.|Completed||N/A|224|Actual|Seoul National University Hospital|||1||f||||t||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 01:32:49.365248|2017-10-11 01:32:49.365248
NCT01887912|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-10-04|||July 2013||2013-07-01|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection|Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection (Cdiffense™)|Recruiting||Phase 3|16500|Anticipated|Sanofi||2|||f||||t|t|f||||||||2017-10-11 01:32:49.50284|2017-10-11 01:32:49.50284
NCT01887899|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-12-21|||May 2013||2013-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Influence of tDCS on Cortical Plasticity in Patients With Dementia of the Alzheimer Type|Influence of Transcranial Direct-current Stimulation on Cortical Plasticity in Patients With Dementia of the Alzheimer Type|Active, not recruiting||N/A|15|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 01:32:50.366708|2017-10-11 01:32:50.366708
NCT01887886|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-11-01||2016-07-20|December 2013||2013-12-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation|A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Onartuzumab in Combination With Erlotinib as First-Line Treatment for Patients With MET-Positive Unresectable Stage IIIb or IV Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation|Completed||Phase 3|10|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:32:50.466272|2017-10-11 01:32:50.466272
NCT01887873|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-03-31|||July 2012||2012-07-01|June 2013|2013-06-01||||April 2014|Actual|2014-04-01||Interventional|||Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy|An Open Two-center Study Evaluating the Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy in Patients With Open Angle Glaucoma and Cataract|Completed||Phase 1|16|Anticipated|Croma-Pharma GmbH||1|||f||||f||||||||||2017-10-11 01:32:50.638807|2017-10-11 01:32:50.638807
NCT01887860|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-06-26|||December 2012||2012-12-01|June 2013|2013-06-01||||January 2013|Actual|2013-01-01||Interventional|||Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50|Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)|Completed||N/A|100|Actual|Galderma Laboratories, L.P.||1|||f||||||||||||||2017-10-11 01:32:50.739997|2017-10-11 01:32:50.739997
NCT01887847|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-03-28|||June 2013||2013-06-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge|A Randomized, 2 Way Crossover, Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablets ( Pharmaceutical Productions Inc.) Versus COMMIT Smoking Lozenge ( GLAXOSMITHKLINE) in Healthy Smoking Volunteers|Completed||Phase 1|6|Actual|Pharmaceutical Productions Inc.||2|||f||||f||||||||||2017-10-11 01:32:50.802675|2017-10-11 01:32:50.802675
NCT01887834|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-03-10|||June 2013||2013-06-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|IBS||Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome|The Effect of Kyo-Dophilus 1.5 Billion on the Symptoms of Severe Irritable Bowel Syndrome|Completed||Phase 1/Phase 2|100|Actual|The Canadian College of Naturopathic Medicine||2|||f||||t||||||||||2017-10-11 01:32:50.899243|2017-10-11 01:32:50.899243
NCT01887821|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-09-29|||February 2013||2013-02-01|June 2014|2014-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam|A Randomised Controlled Trial to Assess the Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam|Completed||Phase 4|330|Actual|Oxford University Clinical Research Unit, Vietnam||2|||f||||f||||||||||2017-10-11 01:32:50.985151|2017-10-11 01:32:50.985151
NCT01887808|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-26|||December 2012||2012-12-01|June 2013|2013-06-01||||January 2013|Actual|2013-01-01||Interventional|||Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30|Cetaphil Dermacontrol Oil Control Moisturizer SPF 30- 100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Semi-occlusive Patch)|Completed||N/A|100|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:32:51.072073|2017-10-11 01:32:51.072073
NCT01887795|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-08|2016-08-24|||August 2013||2013-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as ﬁrst-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study||Completed||Phase 3|224|Actual|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:32:51.15548|2017-10-11 01:32:51.15548
NCT01887782|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-01-26|||September 2013||2013-09-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|HFL vs TBS||Randomized Controlled Trial of Conventional vs Theta Burst rTMS|A Randomized Controlled Study of Conventional Versus Theta Burst Repetitive Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder|Completed||N/A|414|Actual|Centre for Addiction and Mental Health||2|||f||||t||||||||Undecided|Individual patient level data will be shared once the investigators have completed all proposed analyses from the data set.|2017-10-11 01:32:51.236056|2017-10-11 01:32:51.236056
NCT01887769|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-01-05|||May 2012||2012-05-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|BAT-SCAN||Body Composition Analysis for Patient With Lung Cancer Using Computed Tomography Image Analysis||Recruiting||N/A|1000|Anticipated|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec|||1||f||||t||||||||||2017-10-11 01:32:51.321218|2017-10-11 01:32:51.321218
NCT01887756|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-02-18|||April 2013||2013-04-01|June 2013|2013-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Research Online Tele-Rehabilitation Program in People After a Stroke Living at Home|Research and Clinical Aspects of the Project Study of Home Based Tele-Rehabilitation Program for Patients With Stroke|Terminated||N/A|2|Actual|Clalit Health Services||1||Halted before intervention due to approval of service.|f||||f||||||||||2017-10-11 01:32:51.39967|2017-10-11 01:32:51.39967
NCT01887743|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-01-05|||June 2013||2013-06-01|March 2014|2014-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study|The Effect of Obesity on the Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD|Unknown status|Recruiting|Phase 1|100|Anticipated|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-10-11 01:32:51.495652|2017-10-11 01:32:51.495652
NCT01887730|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-03-27|||January 2012||2012-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2013|Actual|2013-09-01||Interventional|VirusFight||Hand Hygiene Intervention Study in Finnish Garrison|Can Intensified Hand Hygiene Decrease Morbidity and Lost Service Days in a Garrison|Active, not recruiting||N/A|1120|Actual|National Institute for Health and Welfare, Finland||3|||f||||f||||||||||2017-10-11 01:32:51.610934|2017-10-11 01:32:51.610934
NCT01887717|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-08-22|||June 2013||2013-06-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|YES-P||Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein|A Prospective Randomized Clinical Trial on 90Yttrium Trans-arterial Radio-Embolization (TheraSphere®) vs. Standard of Care (Sorafenib) for the Treatment of Advanced Hepatocellular Carcinoma (HCC) With Portal Vein Thrombosis (PVT)|Active, not recruiting||Phase 3|328|Anticipated|BTG International Inc.||2|||f||||t||||||||||2017-10-11 01:32:51.697112|2017-10-11 01:32:51.697112
NCT01887704|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-25|||January 2010||2010-01-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion|Effect of Rotational Atherectomy on Balloon-resistant Calcified Coronary Lesion the During a Long-term Follow-up Study|Completed||N/A|240|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 01:32:51.834843|2017-10-11 01:32:51.834843
NCT01887691|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-04-04|||October 2012||2012-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|August 2015|Actual|2015-08-01||Interventional|||Sleep Effectiveness and Insulin and Glucose Homeostasis|Sleep Effectiveness and Insulin and Glucose Homeostasis|Active, not recruiting||Phase 1|48|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-10-11 01:32:51.972889|2017-10-11 01:32:51.972889
NCT01887496|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-07-25|||September 2010||2010-09-01|July 2017|2017-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|VARICOMP||Varicella-related Hospitalizations in Turkey|The Epidemiology and Economic Impact of Varicella Related Hospitalization in Turkey (VARICOMP Study)|Completed||N/A|1800|Actual|Eskisehir Osmangazi University|||1||f||||f||||||||||2017-10-11 01:32:55.395735|2017-10-11 01:32:55.395735
NCT01874184|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-01-15|||October 2013||2013-10-01|January 2016|2016-01-01||||April 2015|Actual|2015-04-01||Interventional|DEEM||Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer|Diet, Exercise and Estrogen Metabolites Study (DEEM)|Completed||N/A|17|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 01:36:09.095226|2017-10-11 01:36:09.095226
NCT01887678|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2015-03-10|2015-02-04||June 2013||2013-06-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|MOZArT|In total, 287 patients were enrolled into the study, 55 of them were Lead-In screening failures; therefore, 232 patients could be randomized. 119 patients were randomized to Traumeel/Zeel and 113 patients to Placebo and all randomized patients were included in the Safety Set.|Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee|Multi-center Double-blind Randomized Controlled Trial to Evaluate Effectiveness and Safety of Co-administered Traumeel® / Zeel® Intra-articular Injections vs Placebo in Patients With Moderate-to-Severe Pain With Osteoarthritis of the Knee|Completed||Phase 3|287|Actual|Biologische Heilmittel Heel GmbH||2|||f||||f||||||||||2017-10-11 01:32:52.148834|2017-10-11 01:32:52.148834
NCT01887665|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2016-03-02|||August 2013||2013-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Enhancing Early-Phase Care for Primary Care Patients With Unhealthy Substance Use|Enhancing Early-Phase Care for Primary Care Patients With Unhealthy Substance Use|Completed||N/A|13|Actual|Brandeis University||1|||f||||t||||||||No||2017-10-11 01:32:53.705015|2017-10-11 01:32:53.705015
NCT01887652|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2014-06-24|||March 2012||2012-03-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Individualization of Ovarian Stimulation Using AMH Maximizes the Benefits and Minimizes Complications and Risks|Individualization of Controlled Ovarian Stimulation Using Anti-mullerian Hormone as a Biomarker of Ovarian Response Maximizes the Beneficial Effects of Treatment and Minimizes Complications and Risks.|Completed||N/A|250|Actual|ANDROFERT - Clinica de Andrologia e Reproducao Humana||2|||f||||f||||||||||2017-10-11 01:32:53.809867|2017-10-11 01:32:53.809867
NCT01887639|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2015-07-29|||September 2013||2013-09-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01|12 Weeks|Observational [Patient Registry]|PANTHER||Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant Trial|Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant Trial: PANTHER Study|Completed||N/A|200|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:32:53.924909|2017-10-11 01:32:53.924909
NCT01887626|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2013-09-17|||July 2013||2013-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.|An Open-label, Randomised, 3-period, 3-treatment, Crossover, Single-centre, Single-dose, Bioavailability Study With Alternative Methods of Administration of Crushed Ticagrelor Tablets, 90 mg, Compared to Whole Ticagrelor Tablets, 90 mg, in Healthy Volunteer|Completed||Phase 1|36|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 01:32:54.048698|2017-10-11 01:32:54.048698
NCT01887613|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-06-14|||October 1, 2012|Actual|2012-10-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Specified Drug Use-Results Survey of Regnite|Specified Drug Use-Results Survey of Regnite|Recruiting||N/A|1500|Anticipated|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:32:54.15974|2017-10-11 01:32:54.15974
NCT01887600|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-25|2017-08-18|||September 3, 2013|Actual|2013-09-03|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ALPS||Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis|A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis|Active, not recruiting||Phase 3|597|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 01:32:54.300318|2017-10-11 01:32:54.300318
NCT01887587|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-02-10|||October 2013||2013-10-01|February 2016|2016-02-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia|Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia|Terminated||Phase 1|18|Actual|Medical College of Wisconsin||1||SAE- risk of overall protocol treatment outweighs benefits|f||||t||||||||||2017-10-11 01:32:54.774087|2017-10-11 01:32:54.774087
NCT01887574|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-01-13|||June 2013||2013-06-01|January 2016|2016-01-01|June 2053|Anticipated|2053-06-01|June 2053|Anticipated|2053-06-01||Interventional|||Renal Mass Registry|Renal Mass Registry|Recruiting||N/A|5000|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:32:54.863422|2017-10-11 01:32:54.863422
NCT01887561|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-06-24|||November 2012||2012-11-01|June 2013|2013-06-01||||December 2012|Actual|2012-12-01||Interventional|||Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial|PhaseⅡClinical Trial of Dasatinib for Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase and Stop Therapy After Achieving Complete Molecular Response for Cure D-NewS|Unknown status|Recruiting|Phase 2|100|Anticipated|Kanto CML Study Group||1|||f||||t||||||||||2017-10-11 01:32:54.941801|2017-10-11 01:32:54.941801
NCT01887548|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-24|||March 2012||2012-03-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Personality Traits and Its Impact on Quality of Life and Clinical Outcome Evaluation in Crohn's Patients|Personality Traits and Its Impact on Quality of Life and Clinical Outcome Evaluation in Patients With Crohn's Disease|Unknown status|Active, not recruiting|N/A|80|Actual|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 01:32:55.0254|2017-10-11 01:32:55.0254
NCT01887535|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-01-13|||May 2013||2013-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants|A Double-Blind, Placebo-Controlled, Randomized, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Subjects|Completed||Phase 1|70|Actual|Janssen Research & Development, LLC||6|||f||||f||||||||||2017-10-11 01:32:55.096967|2017-10-11 01:32:55.096967
NCT01887522|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-01-25|||June 2016||2016-06-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|VINILO||Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults|Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma|Recruiting||Phase 2|120|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 01:32:55.184414|2017-10-11 01:32:55.184414
NCT01887483|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-12-21|||March 2014||2014-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|KF_2013||Vetal Laban Intervention Trial Assessing Bowel Symptoms|A Double-Blind Placebo-Controlled Randomized Clinical Trial Assessing the Effect of 2 Month Consumption of Vetal Laban Including L. Acidophilus on Functional Gastrointestinal Symptoms Among Subjects Fulfilling Rome III Criteria for IBS|Terminated||Phase 4|62|Actual|Danisco||2||Slow recruitment, high drop-out|f||||f||||||||||2017-10-11 01:32:55.452901|2017-10-11 01:32:55.452901
NCT01887470|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-05-13|2015-04-06||July 2013||2013-07-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||2 Regimens of Lactulose for Colonoscopy Preparation in Adults|A Randomized, Single-blind Pilot Study to Determine the Safety, Efficacy, and Patient Preference of 2 Regimens of Lactulose for Cleansing of the Colon as a Preparation for Colonoscopy in Adults|Completed||Phase 2|55|Actual|Cumberland Pharmaceuticals||4|||f||||f||||||||||2017-10-11 01:32:55.629823|2017-10-11 01:32:55.629823
NCT01887457|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-10-06|||September 2014||2014-09-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|PIVOTAL||Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy|PIVOTAL: Pharmacological Individualisation of VOriconazole Therapy for AntifungaL Treatment|Suspended||Phase 2|33|Anticipated|The Christie NHS Foundation Trust||1||Transfer of management of study|f||||t||||||||||2017-10-11 01:32:56.210652|2017-10-11 01:32:56.210652
NCT01887444|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-09-16|||October 2013||2013-10-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|PROBIOC||Lactobacillus Reuteri Supplementation in the Treatment of Infantile Colic|The Benefit of Using the Lactobacillus Reuteri Probiotic as a Supplement in the Treatment of Newborn Colic|Withdrawn||N/A|0|Actual|BioGaia AB||2||Never started|f||||f||||||||||2017-10-11 01:32:56.291223|2017-10-11 01:32:56.291223
NCT01887431|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-01-28|||October 2013||2013-10-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump|Telecare in Adults With Type 1 Diabetes Mellitus Treated by Insulin Pump - A Randomized Controlled Trial|Completed||N/A|66|Actual|Assuta Hospital Systems||2|||f||||t|f|f||||||Undecided||2017-10-11 01:32:56.366265|2017-10-11 01:32:56.366265
NCT01887418|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-09-23|2015-07-20||September 2013||2013-09-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||"The Safety Population (39 subjects) was all randomized subjects who received at least 1 dose of investigational product.
The PK Population (39 subjects) was all subjects from Safety Population who did not have a major protocol deviation that impacted the integrity of PK data and had at least 1 valid post-dose plasma concentration value."|Pharmacokinetic Study of Testosterone Enanthate|3 Arm Open-label Randomized Multidose Study of Pharmacokinetics, Safety & Tolerability of Testosterone Enanthate Administered Subcutaneously Via an Auto-injector Device or Intramuscular Testosterone Enanthate in Hypogonadal Adult Males|Completed||Phase 1/Phase 2|39|Actual|Antares Pharma Inc.||3|||f||||f||||||||||2017-10-11 01:32:56.450772|2017-10-11 01:32:56.450772
NCT01887405|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-24|||January 2012||2012-01-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|HEJ||Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext|Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext; the HEJ-study|Completed||Phase 4|91|Actual|ALK Nordic A/S, Danmark Filial||2|||f||||f||||||||||2017-10-11 01:32:56.885681|2017-10-11 01:32:56.885681
NCT01887392|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-12-13|||June 2013||2013-06-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|GOAL||Gaining Optimal Osteoporosis Assessments in Long-Term Care (GOAL)|The Evaluation of a Multifaceted, Knowledge Translation Education Intervention in Long-Term Care and Its Ability to Facilitate the Uptake of Osteoporosis Canada 2010 Clinical Practice Guidelines, Across Ontario LTC Homes|Completed||N/A|6800|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 01:32:56.957185|2017-10-11 01:32:56.957185
NCT01887379|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-12-11|||June 2013||2013-06-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)|Characterisation of Gastric Residence of a Furosemide-containing New Gastric Retention System by Means of MMM Measurement and Determination of Pharmacokinetics, Pharmacodynamics and Safety|Completed||Phase 1|10|Actual|LTS Lohmann Therapie-Systeme AG||2|||f||||f||||||||||2017-10-11 01:32:57.02512|2017-10-11 01:32:57.02512
NCT01887366|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-10-12||2015-10-12|June 2013||2013-06-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects|A 12-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Once-Weekly Intra-Muscular Injections of TV-1380 (150 mg/Week or 300 mg/Week) as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects|Completed||Phase 2|208|Actual|Teva Pharmaceutical Industries||3|||f||||||||||||||2017-10-11 01:32:58.750029|2017-10-11 01:32:58.750029
NCT01887353|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-07-15|2015-04-09||June 2013||2013-06-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|RAD HF||The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure|A Randomized, Double-blind, Placebo Controlled Study, Designed to Investigate the Effect of Ranolazine on Left Ventricular Diastolic Function in Patients With Symptomatic AF and Preserved Ejection Function, After the Subject Has Undergone a Successful External Electrical Cardioversion|Terminated||Phase 2|8|Actual|Intermountain Health Care, Inc.||2||Difficultly in enrolling|f||||f||||||||||2017-10-11 01:32:58.87835|2017-10-11 01:32:58.87835
NCT01887340|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-06-08|||June 2013||2013-06-01|June 2016|2016-06-01|June 2026|Anticipated|2026-06-01|June 2016|Anticipated|2016-06-01||Interventional|SEMITEP||Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma|Therapeutic Strategy Guided by PET-TDM for Patients With Grade I or Metastatic Seminoma|Recruiting||Phase 2|271|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 01:32:59.177698|2017-10-11 01:32:59.177698
NCT01887327|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-07-17||2017-07-17|September 2013||2013-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|JASMINE_204||Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia|A Phase 2 Multicenter, Single Dose, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates|Completed||Phase 2|91|Actual|InfaCare Pharmaceuticals Corporation||3|||f||||f||||||||||2017-10-11 01:32:59.277164|2017-10-11 01:32:59.277164
NCT01887314|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-01-26|||June 2013||2013-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||"Efficacy Study of Ginger (Zingiber Officinale) Extract Ginpax to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy"|Multicenter, Randomized, Double-blind, Placebo Controlled, Study to Evaluate the Activity of a Ginger (Zingiber Officinale) Food Supplement in the Management of Nausea in Patients Receiving Highly Emetogenic Treatments and Standard Anti-emetogenic Therapy.|Completed||N/A|250|Actual|Helsinn Healthcare SA||2|||f||||t||||||||No||2017-10-11 01:32:59.425562|2017-10-11 01:32:59.425562
NCT01887301|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2014-06-03|||July 2013||2013-07-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients|An Open Label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics and Tolerability of a Single Oromucosal Dose of 4 Sprays of Sativex(Containing 10.8 mg Delta-9-tetrahydrocannabinol [THC] and 10 mg Cannabidiol [CBD]) in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function.|Completed||Phase 1|32|Actual|GW Pharmaceuticals Ltd.||4|||f||||f||||||||||2017-10-11 01:32:59.694725|2017-10-11 01:32:59.694725
NCT01887275|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2013-06-25|||March 2010||2010-03-01|October 2012|2012-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B|Medical Ozone Versus Conventional Interferon-α Treatment of Patients With Chronic Hepatitis B —A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B|Completed||Phase 4|439|Actual|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 01:32:59.877545|2017-10-11 01:32:59.877545
NCT01887262|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2014-06-17|||July 2013||2013-07-01|June 2014|2014-06-01|July 2015|Anticipated|2015-07-01|May 2015|Anticipated|2015-05-01||Interventional|COMPASS||Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS|Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS (COMPASS) Trial|Unknown status|Recruiting|Phase 4|138|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:32:59.968266|2017-10-11 01:32:59.968266
NCT01887249|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-08-12|||May 2010||2010-05-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||15-day Sequential Therapy for Helicobacter Pylori Infection in Korea|Randomized Clinical Trial: the Comparison of 15-day Sequential and 10-day Sequential Therapy to PPI-based Triple Therapy for Helicobacter Pylori Infection in Korea|Completed||Phase 4|287|Actual|Seoul National University Bundang Hospital||3|||f||||f||||||||||2017-10-11 01:33:00.085458|2017-10-11 01:33:00.085458
NCT01887236|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2013-06-23|||September 2013||2013-09-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||The Effect of Exercise Training Programs: Step and Stability Ball on Balance and Obstacle Avoidance in Older People||Unknown status|Not yet recruiting|N/A|45|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 01:33:00.200213|2017-10-11 01:33:00.200213
NCT01887223|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-06-26|||May 2010||2010-05-01|June 2013|2013-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Transconjunctival Needling Revision Versus Medical Treatment|Early Transconjunctival Needling Revision With 5-fluorouracil Versus Medical Treatment in Encapsulated Blebs: a 12-month Prospective Study|Completed||Phase 2|40|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 01:33:00.298113|2017-10-11 01:33:00.298113
NCT01887210|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-09-26|||September 2012|Actual|2012-09-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|January 9, 2017|Actual|2017-01-09||Interventional|||A Pilot Gaming Adherence Program for Youth Living With HIV|A Pilot Gaming Adherence Program for Youth Living With HIV|Completed||N/A|65|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-10-11 01:33:01.007743|2017-10-11 01:33:01.007743
NCT01887197|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-07-24|||June 2013||2013-06-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Repeatability and Response Study of Absorptive Clearance Scans|Repeatability and Response Study of Absorptive Clearance Scans|Recruiting||N/A|24|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:33:01.1044|2017-10-11 01:33:01.1044
NCT01887184|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-10-24|||January 2009||2009-01-01|October 2014|2014-10-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Sedation Using Intranasal Dexmedetomidine in Upper Gastrointestinal Endoscopy|A Study to Assess Sedation Using Intranasal Dexmedetomidine in Upper Gastrointestinal Endoscopy|Completed||Phase 3|50|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:33:01.226868|2017-10-11 01:33:01.226868
NCT01887171|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2016-12-31|2016-12-31||July 2013||2013-07-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|PATAC||Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus|A Randomized Study of Effect of Preimplantation Portal Vein and Hepatic Artery Liver Flushing With Tacrolimus on Ischemia-reperfusion Injury, Allograft Dysfunction and Liver Histology|Completed||N/A|86|Actual|Republican Scientific and Practical Center for Organ and Tissue Transplantation||2|||f||||t||||||||||2017-10-11 01:33:01.33956|2017-10-11 01:33:01.33956
NCT01887158|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2014-06-15|||July 2013||2013-07-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PEGOP||Efficacy of 2-Liter Mixed Preparation With Bisacodyl Plus Polyethylene Glycol and 4-Liter Polyethylene Glycol for Colon Cleansing in Patients With Prior History of Colorectal Resection|Phase 4 Study of Comparison of 2-Liter Mixed Preparation With Bisacodyl Plus Polyethylene Glycol and 4-Liter Polyethylene Glycol for Colon Cleansing in Patients With Prior History of Colorectal Resection. A Prospective Randomized Controlled Trial.|Completed||Phase 4|116|Actual|Ospedale Santa Maria delle Croci||2|||f||||||||||||||2017-10-11 01:33:01.678686|2017-10-11 01:33:01.678686
NCT01887145|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-05-05|||September 2013||2013-09-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Comparison of Long-term Outcomes Following Endoscopic or Open Surgery for Carpal Tunnel Syndrome|Endoscopic Versus Open Carpal Tunnel Release: 10 to 15 Years Follow-up of a Randomized Controlled Trial|Completed||N/A|124|Actual|Region Skane||2|||f||||t||||||||||2017-10-11 01:33:01.763144|2017-10-11 01:33:01.763144
NCT01887132|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-22|2017-09-21|2017-08-14||June 2013||2013-06-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism|A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism|Terminated||Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)|Study terminated due to lack of recruitment. No conclusions regarding the use of donepezil can be drawn from small sample size data collection.|3|||f||||||||||||||2017-10-11 01:33:01.853994|2017-10-11 01:33:01.853994
NCT01887119|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-05-18|||October 2013||2013-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Aldosterone Antagonism and Microvascular Function|Effects of Aldosterone Antagonism on Insulin-mediated Microvascular Function in Subjects With the Metabolic Syndrome|Recruiting||Phase 4|60|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 01:33:02.196487|2017-10-11 01:33:02.196487
NCT01887106|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-22|2013-10-13|||June 2013||2013-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||First-in-Human Single and Multiple Dose of GLPG1205|Randomized, Double-blind, Placebo-controlled, Dose-ranging Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of GLPG1205 in Healthy Male Subjects|Completed||Phase 1|40|Actual|Galapagos NV||4|||f||||f||||||||||2017-10-11 01:33:02.296018|2017-10-11 01:33:02.296018
NCT01887093|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-22|2013-06-26|||September 2011||2011-09-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Influence of Walking at Different Times of Day on Blood Lipids and Inflammatory Markers|The Influence of Regular Walking at Different Times of Day on Blood Lipids and Inflammatory Markers in Sedentary Patients With Coronary Artery Disease|Completed||N/A|330|Actual|The First Affiliated Hospital with Nanjing Medical University||3|||f||||t||||||||||2017-10-11 01:33:02.557021|2017-10-11 01:33:02.557021
NCT01887080|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-01-29|||September 2012||2012-09-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Microcurrent in a Cardiovascular Rehabilitation Home-based Program|Effects of Microcurrent in a Cardiovascular Rehabilitation Home-based Program in Patients With Acute Myocardial Infarction|Completed||N/A|40|Actual|Escola Superior de Tecnologia da Saúde do Porto||3|||f||||t||||||||||2017-10-11 01:33:02.65974|2017-10-11 01:33:02.65974
NCT01887067|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-03-28|||June 2013||2013-06-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|HTN2DM||Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus|Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus|Recruiting||N/A|15|Anticipated|Pamela Youde Nethersole Eastern Hospital||1|||f||||t||||||||||2017-10-11 01:33:02.784511|2017-10-11 01:33:02.784511
NCT01887054|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-01-23|||June 2013||2013-06-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|FOG||Freezing of Gait in Parkinson's Disease|Effect of Visuospatial Training Tasks on Freezing of Gait in Parkinson's Disease|Completed||N/A|30|Actual|Duke University||2|||f||||f|f|t|t|f||||||2017-10-11 01:33:02.873279|2017-10-11 01:33:02.873279
NCT01887041|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-02-05|||January 2010||2010-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|BYPAPA||Quality of Life After BDA or Stents to Treat Biliary Obstruction in Pancreas Cancer|Quality of Life After Bilioenteric Anastomosis in Comparison to Endoscopically Placed Stents in Patients With Unresectable Pancreatic Cancer and Jaundice|Terminated||Phase 4|24|Actual|Universitätsklinikum Hamburg-Eppendorf||2||Recruiting problems|f||||t||||||||Undecided||2017-10-11 01:33:02.965732|2017-10-11 01:33:02.965732
NCT01887028|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-07-18|||July 2013||2013-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Interventional|||Impacts of Intraperitoneal Pressure and CO2 Gas on Surgical Peritoneal Environment|A Single-blind, Randomized Study to Compare Impacts of Intraperitoneal Pressure (8mmHg Versus 12 mmHg) and CO2 Gas (Cool, Dry CO2 Gas Versus Warmed; Humidified Co2 Gas) on Surgical Peritoneal Environment During Laparoscopic Surgery|Completed||N/A|82|Actual|University Hospital, Clermont-Ferrand||4|||f||||||||||||||2017-10-11 01:33:03.063195|2017-10-11 01:33:03.063195
NCT01887015|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-03-26|||June 2013||2013-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|OPERA||Optiflow® to Prevent Post-Extubation Hypoxemia afteR Abdominal Surgery (the OPERA Trial)|Early Nasal High Flow Oxygen Therapy for Prevention of Postoperative Hypoxemia After Abdominal Surgery: A Multicenter Randomized Controlled Trial|Completed||Phase 4|220|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:33:03.153394|2017-10-11 01:33:03.153394
NCT01887002|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-01-26||2016-01-26|June 2013||2013-06-01|January 2016|2016-01-01||||January 2015|Actual|2015-01-01||Interventional|RESTORE||Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RESTORE)|Terminated||Phase 2|39|Actual|Ono Pharmaceutical Co. Ltd||2||The study was terminated due to slow accrual of subjects.|f||||f||||||||||2017-10-11 01:33:03.244173|2017-10-11 01:33:03.244173
NCT01886989|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-03-28|||January 2012||2012-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Cocoa Polyphenols and Postprandial Metabolism in Type 2 Diabetes|Postprandial Effects of Polyphenol-rich Cocoa Beverage on Glucose, Insulin, Lipids, Oxidative Stress and Inflammation in Type 2 Diabetic Patients|Completed||N/A|18|Actual|Oklahoma State University||2|||f||||t||||||||||2017-10-11 01:33:03.343158|2017-10-11 01:33:03.343158
NCT01886976|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-01-26|||June 2013||2013-06-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|CART-138||Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138|Clinical Study of Chimeric CD(Cluster of Differentiation)138 Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Multiple Myelomas|Recruiting||Phase 1/Phase 2|10|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:33:03.42551|2017-10-11 01:33:03.42551
NCT01886963|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-05-19|2016-02-12||November 2011||2011-11-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Clinical Trial Using Spy Elite System in Planning Tissue Advancement Flaps After Ventral Hernia Repair|A Randomized, Prospective, Double-Blind Clinical Trial Using Spy Elite System in Planning Tissue Advancement Flaps and Reducing Wound Complications After Complex Ventral Hernia Repairs|Completed||Phase 1/Phase 2|102|Actual|Carolinas Healthcare System||2|||f||||t||||||||Undecided||2017-10-11 01:33:03.524266|2017-10-11 01:33:03.524266
NCT01886950|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-05-12|||August 2010||2010-08-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Evolution of Bone Histomorphometry and Vascular Calcification Before and After Renal Transplantation|A Prospective Observational Study to Investigate the Natural History of Bone Histomorphometry and Vascular Calcification in Dialysis-dependent Patients Before and After Renal Transplantation.|Recruiting||N/A|250|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     Bone biopsy Serum samples A. epigastrica inferior   "|No||2017-10-11 01:33:03.79218|2017-10-11 01:33:03.79218
NCT01886937|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-07-03|2017-03-28||July 2012||2012-07-01|June 2017|2017-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Studying the Effects of Phentermine on Eating Behavior|The Quantification of Ingestive Behavior|Completed||Phase 4|13|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 01:33:03.888187|2017-10-11 01:33:03.888187
NCT01886924|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2016-07-19|||February 2014||2014-02-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MI-HIV||Computer MI for Tobacco Quitline Engagement in Smokers Living With HIV|Computer-based MI to Engage Smokers Living With HIV in Tobacco Quitline Treatment|Completed||N/A|100|Actual|Butler Hospital||2|||f||||f||||||||||2017-10-11 01:33:04.368849|2017-10-11 01:33:04.368849
NCT01886911|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-09-30|||June 2013||2013-06-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|March 2014|Actual|2014-03-01||Interventional|GWB||Games & Well-Being Study|Neural Correlates of Video Game Based Training to Foster Mindfulness and Prosocial Skills in Adolescents|Completed||N/A|192|Actual|University of Wisconsin, Madison||4|||f||||f||||||||||2017-10-11 01:33:04.456111|2017-10-11 01:33:04.456111
NCT01886898|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-06-25|||June 2007||2007-06-01|June 2013|2013-06-01|October 2009|Actual|2009-10-01|February 2009|Actual|2009-02-01||Interventional|||Synbiotics and Growth|Growth of Infants Fed Starter Formula Containing Oligo-saccharides and the Probiotics Bifidobacterium & Lactobacillus|Completed||Phase 3|311|Actual|Nestlé||4|||f||||f||||||||||2017-10-11 01:33:04.561322|2017-10-11 01:33:04.561322
NCT01886885|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-06-25|||January 2013||2013-01-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|MBCPM||Mindfulness Based Chronic Pain Management: A Pilot Study|The Efficacy of Mindfulness-Based Chronic Pain Management: A Pilot Study|Completed||N/A|20|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 01:33:04.650449|2017-10-11 01:33:04.650449
NCT01886859|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-09-28|||April 26, 2013|Actual|2013-04-26|September 2017|2017-09-01||||July 1, 2013|Actual|2013-07-01||Interventional|||Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Dose Escalation Study of Ibrutinib With Lenalidomide for Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Active, not recruiting||Phase 1|26|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:33:07.860798|2017-10-11 01:33:07.860798
NCT01886846|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-22|||July 2008||2008-07-01|June 2013|2013-06-01||||August 2010|Actual|2010-08-01|1 Month|Observational [Patient Registry]|||Plasma Adiponectin Levels and Relations With Cytokines in Children With Acute Rheumatic Fever||Completed||N/A|87|Actual|Eskisehir Osmangazi University|||1||f||||f||||||||||2017-10-11 01:33:08.141262|2017-10-11 01:33:08.141262
NCT01886820|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2017-07-25|||June 2013|Actual|2013-06-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology|A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology|Active, not recruiting||Phase 3|290|Anticipated|Navidea Biopharmaceuticals||1|||f||||f||||||||||2017-10-11 01:33:08.302172|2017-10-11 01:33:08.302172
NCT01886807|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-10-14|2016-04-08||June 2013||2013-06-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||The Use of Apneic Oxygenation During Prolonged Intubation in Pediatric Patients: a Randomized Clinical Trial|The Use of Apneic Oxygenation During Prolonged Intubation in Pediatric Patients: a Randomized Clinical Trial|Completed||N/A|482|Actual|University of Texas Southwestern Medical Center||3|||f||||f||||||||||2017-10-11 01:33:08.420392|2017-10-11 01:33:08.420392
NCT01886794|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-05-01|||June 2013||2013-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse|Role of Hormonal Status on Vascularization and Vaginal Tissue in Women With Pelvic Organ Prolapse|Recruiting||N/A|30|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 01:33:08.685844|2017-10-11 01:33:08.685844
NCT01886781|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-09-24|2014-09-15||January 2011||2011-01-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome|Randomised Controlled Trial: Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome|Completed||Phase 4|81|Actual|University of Stellenbosch||4|||f||||t||||||||||2017-10-11 01:33:08.784895|2017-10-11 01:33:08.784895
NCT01886768|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-06-22|||September 2012||2012-09-01|June 2013|2013-06-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy|Double Versus Single Pledget Method of Nasal Anesthesia for Transnasal Endoscopy: A Randomized Prospective Control Study|Unknown status|Recruiting|N/A|212|Anticipated|Buddhist Tzu Chi General Hospital||2|||f||||f||||||||||2017-10-11 01:33:09.043192|2017-10-11 01:33:09.043192
NCT01886755|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-22|2016-02-20|||July 2013||2013-07-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of an Oral Rehydration Solution Containing the Probiotic Lactobacillus Reuteri Protectis and Zinc in Infants With Acute Gastroenteritis||Completed||N/A|51|Actual|Aghia Sophia Children's Hospital of Athens||2|||f||||t||||||||||2017-10-11 01:33:09.241696|2017-10-11 01:33:09.241696
NCT01886742|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-06-28|||September 1, 2017|Anticipated|2017-09-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients|Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients|Not yet recruiting||Phase 4|75|Anticipated|University of Colorado, Denver||2|||f||||f|t|f||||||No||2017-10-11 01:33:09.331403|2017-10-11 01:33:09.331403
NCT01886729|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-25|||April 2012||2012-04-01|June 2013|2013-06-01||||April 2014|Anticipated|2014-04-01||Interventional|||Effect of Time Shift of Transcranial Direct Current Stimulation (tDCS) for Treatment of Acute Tinnitus||Unknown status|Recruiting|N/A|||University Hospital, Antwerp||2|||f||||||||||||||2017-10-11 01:33:09.432054|2017-10-11 01:33:09.432054
NCT01886716|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-12-15|2016-07-15||July 2013||2013-07-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|AMP|Participants who remained in the study through the initial Week 1 session in which random assignment occurred, as well as who reported current symptoms on alcohol consumption and social anxiety measures at the baseline orientation session (see Pre-Assignment Details and Participant Flow).|Retraining Attention to Treat Alcohol Dependence and Social Anxiety|Cognitive Bias Modification: A Novel Intervention for Alcohol Dependence and Social Anxiety|Completed||N/A|115|Actual|University of Cincinnati||4|||f||||f||||||||No||2017-10-11 01:33:09.536777|2017-10-11 01:33:09.536777
NCT01886703|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2017-05-01|||June 2013||2013-06-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|PEDWAY||Feasibility of a Walking Program for Cancer Survivors Receiving Radiation Therapy|Feasibility of a Supported Walking Program for Breast and Head-and-Neck Cancer Survivors Receiving Adjuvant Radiation Therapy|Completed||N/A|21|Actual|University of Alberta||1|||f||||t||||||||Undecided|No plan in place|2017-10-11 01:33:10.24348|2017-10-11 01:33:10.24348
NCT01886690|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-09-03|2015-09-03||August 2013||2013-08-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery||Completed||Phase 3|148|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:33:10.329442|2017-10-11 01:33:10.329442
NCT01886677|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-02-28|||September 2012||2012-09-01|December 2014|2014-12-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Improving Energy Balance in Men With Prostate Cancer|Exploring the Impact of Negative Energy Balance in Men With Prostate Cancer|Completed||N/A|40|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 01:33:10.655942|2017-10-11 01:33:10.655942
NCT01886664|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2014-06-25|||December 2012||2012-12-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Comparison of PRS According to Inhalation Agent During LDLT||Completed||Phase 4|70|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 01:33:10.743105|2017-10-11 01:33:10.743105
NCT01886651|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-21|||July 2011||2011-07-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia|The Influence of Thiopurine Methyltransferase Activity on Bone Marrow- and Hepato-toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia|Completed||N/A|411|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     whole blood stored for a subset of patients   "|||2017-10-11 01:33:10.817137|2017-10-11 01:33:10.817137
NCT01886638|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2015-05-21|||August 2013||2013-08-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Determining the Effect of Abacavir on Platelet Activation|Determining the Effect of Abacavir on Platelet Activation in Virologically Suppressed HIV Positive Men: an Open Label Interventional Study|Completed||Phase 4|23|Actual|Bayside Health||1|||f||||f||||||||||2017-10-11 01:33:10.882279|2017-10-11 01:33:10.882279
NCT01886625|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2016-02-08|||August 2015||2015-08-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Single-port Thoracoscopic Sympathicotomy in Complex Regional Pain Syndrome Type I (CRPS)|Single-port Thoracoscopic Sympathicotomy for Treatment of Complex Regional Pain Syndrome Type I, a Feasibility Study.|Withdrawn||N/A|0|Actual|University of Groningen||1||No local inclusions|f||||t||||||||||2017-10-11 01:33:10.962404|2017-10-11 01:33:10.962404
NCT01886612|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-08-01|||June 2013||2013-06-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Comparison of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression in Terms of Lower Limb Blood Flow|A Comparison of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression in Terms of Lower Limb Haemodynamics|Completed||N/A|30|Actual|National University of Ireland, Galway, Ireland||1|||f||||f||||||||||2017-10-11 01:33:11.032748|2017-10-11 01:33:11.032748
NCT01886599|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-24|2013-11-08|||November 2012||2012-11-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease|Open-Label, Parallel Group, Multiple-Dose Study to Evaluate the Pharmacokinetics and Safety of Asunaprevir in Subjects With Renal Function Impairment|Completed||Phase 1|48|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-10-11 01:33:11.130202|2017-10-11 01:33:11.130202
NCT01886586|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-01-06|||July 2011||2011-07-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|RECALL||Retaining Cognition While Avoiding Late-Life Depression|RECALL: Retaining Cognition While Avoiding Late-Life Depression|Active, not recruiting||N/A|136|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 01:33:11.237495|2017-10-11 01:33:11.237495
NCT01886573|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-11-17|||June 2013||2013-06-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery|Genome-Wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-Treatment With 5-Azacytidine and Entinostat|Terminated||Phase 1|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 01:33:11.328148|2017-10-11 01:33:11.328148
NCT01886560|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-08-07|||September 2013||2013-09-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Low Dose Doxycycline in the Treatment of Corneal Burn|Prospective, Double-blind, Randomized, Controlled Clinical Trial of Low Dose Doxycycline in the Treatment of Corneal Burn|Unknown status|Not yet recruiting|Phase 2/Phase 3|40|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:33:11.427351|2017-10-11 01:33:11.427351
NCT01886547|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-23|2015-04-05|||June 2013||2013-06-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01|1 Year|Observational [Patient Registry]|||2013 Annual National Digital Rectal Exam (DRE) Day Study|2013 Annual National Digital Rectal Exam (DRE) Day: Impact on Prostate Health Awareness and Disease Detection|Completed||N/A|925|Actual|St. Luke's Medical Center, Philippines|||1||f||||f||||||||||2017-10-11 01:33:11.683713|2017-10-11 01:33:11.683713
NCT01886534|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-12-21|||September 2012||2012-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|April 2014|Actual|2014-04-01||Interventional|CEASE-HF||Caregiver Enhanced Assistance and Support for the Elderly Heart Failure Patient at Hospital Discharge (CEASE-HF)|A Randomized Controlled Trial of Enhanced Caregiver Support Versus Usual Care for Managing Older Heart Failure Patients at Hospital Discharge|Completed||N/A|78|Actual|McMaster University||4|||f||||t||||||||||2017-10-11 01:33:11.796878|2017-10-11 01:33:11.796878
NCT01886521|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2014-10-19|||August 2013||2013-08-01|October 2014|2014-10-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Use of Lumbar Drain to Remove Clots in Patients Admitted to the Neuro-ICU After Subarachnoid Hemorrhage.|Use of Lumbar Drain Versus Ventricular Drain to Remove Clots in Patients Admitted to the Neuro-ICU After Subarachnoid Hemorrhage (a Randomized Trial).|Unknown status|Recruiting|N/A|20|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-11 01:33:11.942028|2017-10-11 01:33:11.942028
NCT01886508|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2013-07-19|||July 2013||2013-07-01|May 2013|2013-05-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multicentre Trial of Nerve-Spring Radical Hysterectomy vs. Radical Hysterectomy for Cervical Cancer||Not yet recruiting||N/A|240|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 01:33:12.046202|2017-10-11 01:33:12.046202
NCT01886495|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-25|||September 2011||2011-09-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children|High Protein Diet , Adiponectin and Inflammatory Factors|Completed||Phase 3|50|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:33:12.171465|2017-10-11 01:33:12.171465
NCT01886482|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-25|||September 2011||2011-09-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese Children||Completed||Phase 3|50|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:33:12.284117|2017-10-11 01:33:12.284117
NCT01886469|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2014-10-02|||July 2013||2013-07-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)|A Phase II, Two-Stage, Open-Label, Single-Treatment, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of up to Three Separate HLD100 Modified Release Formulations of Dextroamphetamine Sulfate in Adolescent (Stage 1) and Pediatric (Stage 2) Patients With Attention-Deficit Hyperactivity Disorder.|Completed||Phase 1/Phase 2|22|Actual|Ironshore Pharmaceuticals and Development, Inc||2|||f||||||||||||||2017-10-11 01:33:12.38891|2017-10-11 01:33:12.38891
NCT01886456|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2013-06-24|||February 2013||2013-02-01|June 2013|2013-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients|Effect of Patterned Laser Trabeculoplasty on Intraocular Pressure Compared to Selective Laser Trabeculoplasty in Treatment Naiv Patients Suffering From Open-angle Glaucoma or Ocular Hypertension|Unknown status|Recruiting|N/A|210|Anticipated|University of Zurich||2|||f||||||||||||||2017-10-11 01:33:12.490331|2017-10-11 01:33:12.490331
NCT01886443|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2014-09-24|||August 2013||2013-08-01|June 2013|2013-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CAPITL||Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers|Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL): a First-in-men Study|Completed||Phase 1|10|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||t||||||||||2017-10-11 01:33:12.588851|2017-10-11 01:33:12.588851
NCT01886430|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-12-02|||May 2009||2009-05-01|April 2013|2013-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Low-frequency Electrical Stimulation in Patients With Advanced HF|Effects of Low-frequency Electrical Stimulation in Sympathetic Nerve Activity and Peripheral Vasoconstriction in Patients With Advanced HF|Completed||N/A|30|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 01:33:12.723253|2017-10-11 01:33:12.723253
NCT01886417|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-03-09|||October 2009||2009-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|HAV||Auditory Verbal Hallucinations in Schizophrenia|Electromyography Study of Lip Muscles During Auditory Verbal Hallucinations Without Subvocalization in Patients With Schizophrenia|Completed||N/A|40|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-11 01:33:12.944566|2017-10-11 01:33:12.944566
NCT01886404|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-08-16|||December 2013||2013-12-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01|12 Months|Observational [Patient Registry]|EFV||EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients|Efavirenz Pharmacokinetics and Pharmacogenomics in Older HIV-infected Patients|Completed||N/A|30|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 01:33:13.030384|2017-10-11 01:33:13.030384
NCT01886391|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-01-07|||November 2011||2011-11-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Health Behavior-Related Outcomes With Diaphragmatic Breathing Retraining in Heart Failure Patients|Health Behavior-Related Outcomes With Diaphragmatic Breathing Retraining in Heart Failure Patients|Withdrawn||N/A|0|Actual|University of Nebraska||1||Major changes in study required new IRB application and approval|f||||t||||||||||2017-10-11 01:33:13.162322|2017-10-11 01:33:13.162322
NCT01886196|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-05-02|||April 2013||2013-04-01|May 2017|2017-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Ibuprofen Supplementation After Resistance Training and Its Effects on Bone in Older Women|Ibuprofen Supplementation After Resistance Training and Its Effects on Bone in Older Women|Completed||N/A|90|Actual|University of Saskatchewan||4|||f||||t||||||||No||2017-10-11 01:33:15.359766|2017-10-11 01:33:15.359766
NCT01886378|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-08-11||2017-08-11|February 2014||2014-02-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||An Open-label Phase 2 Study of UX007 (Triheptanoin) in Subjects With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)|An Open-label Phase 2 Study to Assess Safety and Clinical Effects of UX007 in Subjects With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)|Completed||Phase 2|29|Actual|Ultragenyx Pharmaceutical Inc||1|||f||||t||||||||||2017-10-11 01:33:13.307672|2017-10-11 01:33:13.307672
NCT01886365|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-06-24|||October 2011||2011-10-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Computerized Tight Glycemic Control in Cardiac Surgery|Perioperative Glycemic Control With a Computerized Algorithm vs. Conventional Glycemic Control in Cardio-surgical Patients Undergoing Cardiopulmonary Bypass With Blood Cardioplegia|Completed||N/A|75|Actual|Universitätsklinikum Hamburg-Eppendorf||3|||f||||f||||||||||2017-10-11 01:33:13.410513|2017-10-11 01:33:13.410513
NCT01886352|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2014-12-04|||June 2013||2013-06-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|IPLA||Intraperitoneal Atomization of Levobupivacaine During Gynaecological Laparoscopic Procedures ; Impact on Pain, Opioid Use and Length of Recovery Room Stay (IPLA).|Intraperitoneal Atomization of Levobupivacaine During Gynaecological Laparoscopic Procedures ; Impact on Pain, Opioid Use and Length of Recovery Room Stay (IPLA).|Unknown status|Recruiting|Phase 4|60|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-10-11 01:33:13.48766|2017-10-11 01:33:13.48766
NCT01886339|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-03-17|||June 2010||2010-06-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|SNIF REF V||SNIF (Sniff Nasal Inspiratory Force) Reference Values Of Mediterranean Population|SNIF (Sniff Nasal Inspiratory Force) REFERENCE VALUES OF MEDITERRANEAN POPULATION.|Completed||N/A|439|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||Undecided||2017-10-11 01:33:13.579882|2017-10-11 01:33:13.579882
NCT01886326|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-21|||February 2010||2010-02-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Eating Peanuts for Health|Peanut Consumption and Human Weight Management|Completed||N/A|196|Actual|Purdue University||6|||f||||t||||||||||2017-10-11 01:33:13.637459|2017-10-11 01:33:13.637459
NCT01886313|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-01-10|2016-06-27||March 2014||2014-03-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve|A DOUBLE BLIND, RANDOMIZED, VEHICLE-CONTROLLED, PARALLEL-GROUP EVALUATION OF CIVAMIDE (ZUCAPSAICIN) 0.01% AND VEHICLE NASAL SPRAYS IN THE TREATMENT OF POSTHERPETIC NEURALGIA OF THE TRIGEMINAL NERVE|Terminated||Phase 2|11|Actual|Winston Laboratories||2|||f||||f||||||||||2017-10-11 01:33:13.731685|2017-10-11 01:33:13.731685
NCT01886300|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-05-19|2015-12-31||September 2012||2012-09-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam|A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating Sustained Response in Subjects With HBeAg Positive Chronic Hepatitis B Receiving Therapy With Pegasys (Peginterferon Alfa-2a) in Vietnam|Terminated||N/A|16|Actual|Hoffmann-La Roche|||1|Due to out-of-date design and non-compliance.|f||||||||||||||2017-10-11 01:33:14.12174|2017-10-11 01:33:14.12174
NCT01886287|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-01-06|2015-01-06||December 2013||2013-12-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional||All participants|P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome|Phase II Study of Above-Label Octreotide-LAR in Patients With Insufficiently Controlled Carcinoid Syndrome|Terminated||Phase 2|2|Actual|H. Lee Moffitt Cancer Center and Research Institute|This study was closed early due to slow accrual. There were no evaluable participants at 6 months for the planned Progression Free Survival measure.|1||Slow accrual|f||||f||||||||||2017-10-11 01:33:14.364684|2017-10-11 01:33:14.364684
NCT01886274|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-05-19|||October 2012||2012-10-01|May 2014|2014-05-01|October 2014|Anticipated|2014-10-01|June 2013|Actual|2013-06-01||Interventional|||Does tDCS is Effective in the Prophylactic Treatment of Migraine|Transcranial Direct Current Stimulation in the Visual Cortex of Migraine Patients: Neurophysiological and Clinical Implications|Unknown status|Recruiting|Phase 2|36|Anticipated|Universidade Federal de Pernambuco||3|||f||||t||||||||||2017-10-11 01:33:14.575935|2017-10-11 01:33:14.575935
NCT01886261|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-12-03|||September 2011||2011-09-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Validation of Objective Measures of Place-Based Physical Activity|Validation of Objective Measures of Place-Based Physical Activity|Completed||N/A|144|Actual|University of California, San Diego|||1||f||||f||||||||||2017-10-11 01:33:14.665785|2017-10-11 01:33:14.665785
NCT01886248|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-04-26|||June 2013||2013-06-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation|Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation|Active, not recruiting||Phase 2|32|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:33:14.738805|2017-10-11 01:33:14.738805
NCT01886235|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-06-05|2017-03-30||September 4, 2013|Actual|2013-09-04|June 2017|2017-06-01|June 16, 2018|Anticipated|2018-06-16|June 16, 2015|Actual|2015-06-16||Interventional||All treated and eligible patients|Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery|A Pilot Study of Feasibility of Performing Intravital Microscopy in Melanoma Patients|Active, not recruiting||N/A|10|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 01:33:14.822966|2017-10-11 01:33:14.822966
NCT01886222|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-04-05|||July 2013||2013-07-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|LTH-Ⅰ||Randomized Controlled Trial of Long-term Mild Hypothermia for Severe Traumatic Brain Injury|A Multi-center, Randomized, Controlled Trial to Evaluate the Efficacy and Safety of Long-term Mild Hypothermia in Adult Patients With Severe Traumatic Brain Injury|Recruiting||Phase 3|300|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-11 01:33:15.166517|2017-10-11 01:33:15.166517
NCT01886209|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-08-13|||June 2013||2013-06-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects|An Open-Label, Phase 1 Study to Examine the Pharmacokinetic Interactions Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects|Completed||Phase 1|28|Anticipated|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-11 01:33:15.283912|2017-10-11 01:33:15.283912
NCT01886183|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-04-11|||August 2013||2013-08-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Training in a Virtual Environment in Chronic Stroke Patients|Effects of Training in a Virtual Environment on the Motor Function, Cognition, Postural Control and Gait in Chronic Stroke Patients: A Randomized Controlled Trial|Recruiting||N/A|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 01:33:15.450404|2017-10-11 01:33:15.450404
NCT01886170|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-09-21|||October 2013||2013-10-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Using Patient Feedback to Improve Communication Regarding Glycemic Control to Patients With Diabetes|Using Patient Feedback to Improve the Ways we Communicate Information Regarding Glycemic Control to Patients With Poorly Controlled Diabetes|Completed||N/A|200|Anticipated|University of Pennsylvania||3|||f||||f||||||||||2017-10-11 01:33:15.548972|2017-10-11 01:33:15.548972
NCT01886157|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-03-17|||May 2013||2013-05-01|March 2015|2015-03-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting|Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting: A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|100|Anticipated|The Philadelphia & South Jersey Hand Center||2|||f||||f||||||||||2017-10-11 01:33:15.625721|2017-10-11 01:33:15.625721
NCT01886144|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-05-09|||July 2013||2013-07-01|May 2014|2014-05-01||||May 2014|Actual|2014-05-01||Observational|||Effects of Bracing on Knee Osteoarthritis (OA)|Effectiveness of Decompressive and Stabilizing Knee Bracing in Individuals With Unicompartment Knee Osteoarthritis|Completed||N/A|25|Anticipated|Stony Brook University|||1||f||||f||||||||||2017-10-11 01:33:15.912581|2017-10-11 01:33:15.912581
NCT01886131|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-02-21|||June 2013||2013-06-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|RevesParkNST||Motor Control During Rapid Eye Movement (REM) Sleep Behaviour Disorder|Subthalamic Nuclei (STN) Local Field Potentials to Investigate Motor Control During REM Sleep Behaviour Disorder (TCSP) Secondary to Idiopathic Parkinsons Disease (PD)|Terminated||N/A|3|Actual|University Hospital, Toulouse||1||Recruitment|f||||f||||||||||2017-10-11 01:33:15.996065|2017-10-11 01:33:15.996065
NCT01886118|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-12-23|||March 2013||2013-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|OvoGEN||A Trial Evaluating Autologous Endometrial Co-Culture Versus Conventional Medium in the Treatment of Infertility|A Randomized Trial Evaluating Autologous Endometrial Co-Culture Versus Conventional Medium in the Treatment of Infertility|Completed||N/A|207|Actual|OVO R & D||2|||f||||t||||||||||2017-10-11 01:33:16.094493|2017-10-11 01:33:16.094493
NCT01886105|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-08-15|||June 2013||2013-06-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma|Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma|Recruiting||Phase 2|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:33:16.184572|2017-10-11 01:33:16.184572
NCT01886092|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-10-28|||May 2013||2013-05-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|rTMS||Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus|Verification of the Usefulness of the Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Tinnitus|Unknown status|Enrolling by invitation|N/A|80|Anticipated|Seoul National University Hospital||4|||f||||t||||||||||2017-10-11 01:33:16.307173|2017-10-11 01:33:16.307173
NCT01886079|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-20|||May 2013||2013-05-01|June 2013|2013-06-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Effects of Dexmedetomidine on Postoperative Renal Function in Valvular Heart Surgery||Unknown status|Recruiting|Phase 4|200|Anticipated|Yonsei University||2|||f||||||||||||||2017-10-11 01:33:16.41808|2017-10-11 01:33:16.41808
NCT01886066|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-04-06|||March 2012||2012-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|EndoSLN||Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer|Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer: A Prospective Trial|Recruiting||N/A|60|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 01:33:16.503121|2017-10-11 01:33:16.503121
NCT01886053|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-06-19|||April 2011||2011-04-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia|A Phase II Study to Evaluate the Efficacy and Safety of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia|Completed||Phase 2|189|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||3|||f||||t||||||||||2017-10-11 01:33:16.584997|2017-10-11 01:33:16.584997
NCT01886040|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-09-05|||June 2013||2013-06-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Factors Affecting the Prognosis of Patients With Endometrial Cancer||Completed||N/A|100|Actual|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-10-11 01:33:16.680342|2017-10-11 01:33:16.680342
NCT01886027|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-05-05|||June 2013||2013-06-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Stress Management for Irritable Bowel Syndrome|Stress Management for Irritable Bowel Syndrome|Completed||N/A|106|Actual|Wayne State University||3|||f||||f||||||||||2017-10-11 01:33:16.870578|2017-10-11 01:33:16.870578
NCT01886014|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-25|||January 2012||2012-01-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers|The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers Using a Double-blind Design|Completed||N/A|80|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 01:33:16.989849|2017-10-11 01:33:16.989849
NCT01886001|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-20|||November 2012||2012-11-01|June 2013|2013-06-01|July 2013|Anticipated|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Topical Umbilical Cord Care for the Prevention of Colonization and Invasive Infections|Topical Umbilical Cord Care for the Prevention of Colonization and Invasive Infections|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Virginia||4|||f||||f||||||||||2017-10-11 01:33:17.095592|2017-10-11 01:33:17.095592
NCT01885988|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-06-21|||March 2013||2013-03-01|June 2013|2013-06-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|NEB-ED||Nebivolol Effects on Endothelial Function and Erectile Function|Nebivolol Effects on Endothelial Function and Erectile Function in Non-smoking Pre-hypertensive and Newly Diagnosed Stage 1 Hypertensive Men With Erectile Dysfunction.|Unknown status|Recruiting|Phase 4|70|Anticipated|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 01:33:17.210128|2017-10-11 01:33:17.210128
NCT01885962|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-04-10|||May 2012||2012-05-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|iSHIFTup||Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers|Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers|Completed||N/A|19|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 01:33:17.399929|2017-10-11 01:33:17.399929
NCT01885949|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-06-15|||June 2013||2013-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tivozanib + Enzalutamide in Adv Prostate Cancer|Phase 2 Combination Trial of Tivozanib and Enzalutamide in Men With Advanced Prostate Cancer|Active, not recruiting||Phase 2|5|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-11 01:33:17.487188|2017-10-11 01:33:17.487188
NCT01885936|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-07-25|||June 2013||2013-06-01|October 2016|2016-10-01|December 16, 2016|Actual|2016-12-16|December 16, 2016|Actual|2016-12-16||Interventional|||Safety and Efficacy of Albuterol on Motor Function in Individuals With Late-onset Pompe Disease Receiving Enzyme Replacement Therapy|A Phase 1/2 Double-Blind Study of the Safety and Efficacy of Albuterol on Motor Function in Individuals With Late-onset Pompe Disease Receiving Enzyme Replacement Therapy|Completed||Phase 1/Phase 2|16|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:33:17.596245|2017-10-11 01:33:17.596245
NCT01885910|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-02-26|2014-10-07||July 2013||2013-07-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||subjects at least 12 years of age who have moderate to severe acne vulgaris|Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel|Use of Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel Treatment|Completed||Phase 4|32|Actual|Derm Research, PLLC||1|||f||||f||||||||||2017-10-11 01:33:17.813402|2017-10-11 01:33:17.813402
NCT01885897|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-11-07|||November 2013||2013-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT|IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic Stem Cell Transplantation|Recruiting||Phase 1/Phase 2|61|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 01:33:18.251458|2017-10-11 01:33:18.251458
NCT01885884|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-05-10|||July 2013||2013-07-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SCI-P||Supportive Care Intervention-Pancreas|A Pilot Trial of an Embedded Collaborative Model of Supportive Care for Pancreatic Cancer|Completed||N/A|60|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:33:18.375044|2017-10-11 01:33:18.375044
NCT01885871|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-07-25|2015-03-03||June 2013||2013-06-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Laser Removal of Age (Sun) Spots on Hands|Safety and Efficacy of Cutera Picosecond Q-Switched Nd:YAG Laser in the Treatment of Solar Lentigines|Completed||N/A|20|Actual|Cutera Inc.||1|||f||||f||||||||Yes||2017-10-11 01:33:18.486123|2017-10-11 01:33:18.486123
NCT01885858|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2013-11-11|||September 2012||2012-09-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Interventional|||Measuring Ethnic Disparities in Family Planning Services in Peru|Quality of Health Services in Indigenous Communities in Peru|Completed||N/A|351|Actual|Universidad Peruana Cayetano Heredia||2|||f||||f||||||||||2017-10-11 01:33:18.741261|2017-10-11 01:33:18.741261
NCT01885845|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-24|||November 2005||2005-11-01|June 2013|2013-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Excellent BRASSS-V Drape™ Versus Indirect Measurement Protocol for Measurement of Postpartum Blood Loss|A Comparison of the Excellent BRASSS-V Drape™ and an Indirect Blood Measurement Protocol for the Measurement of Blood Loss During Third Stage of Vaginal Delivery|Completed||N/A|900|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-11 01:33:18.813812|2017-10-11 01:33:18.813812
NCT01885832|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-08-08|||June 2013||2013-06-01|August 2017|2017-08-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis|Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis|Withdrawn||Phase 1/Phase 2|0|Actual|Translational Biosciences||1||per sponsor decision|f||||t||||||||||2017-10-11 01:33:18.890091|2017-10-11 01:33:18.890091
NCT01885819|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-08-08|||June 2013||2013-06-01|August 2017|2017-08-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Autologous Adipose Tissue Stromal Vascular Fraction Cells for Rheumatoid Arthritis|Feasibility Study of Non-Expanded Autologous Adipose Tissue Derived Stromal Vascular Fraction Cells in Disease Modifying Anti-Rheumatic Drugs (DMARD) Resistant Rheumatoid Arthritis|Withdrawn||Phase 1/Phase 2|0|Actual|Translational Biosciences||1||per sponsor decision|f||||t||||||||||2017-10-11 01:33:18.951394|2017-10-11 01:33:18.951394
NCT01885806|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-24|||June 2013||2013-06-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease|Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease: a Randomised, Double-blind, Controlled Study|Unknown status|Recruiting|Phase 2|40|Anticipated|Federal University of Minas Gerais||2|||f||||t||||||||||2017-10-11 01:33:19.027047|2017-10-11 01:33:19.027047
NCT01885793|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-01-30|||April 2013||2013-04-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Cuff Pressure in Patients: Manometer vs Invasive Pressure Monitoring Setup||Completed||N/A|220|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 01:33:19.11702|2017-10-11 01:33:19.11702
NCT01885780|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2014-05-30|||January 2013||2013-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy.|Phase IV Study_Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy Following the Cataract Surgery.|Completed||Phase 4|45|Actual|Technolas Perfect Vision GmbH||1|||f||||f||||||||||2017-10-11 01:33:19.174174|2017-10-11 01:33:19.174174
NCT01885767|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-12-30|||June 2012||2012-06-01|December 2016|2016-12-01|June 2050|Anticipated|2050-06-01|June 2022|Anticipated|2022-06-01|50 Years|Observational [Patient Registry]|||Neurofibromatosis (NF) Registry Portal|Neurofibromatosis (NF) Registry Portal Funded by Children's Tumor Foundation|Recruiting||N/A|10000|Anticipated|The Children's Tumor Foundation|||3||f||||f||||||||No|deidentified data only may be shared|2017-10-11 01:33:19.366419|2017-10-11 01:33:19.366419
NCT01885754|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-01-05|||February 2013||2013-02-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|||Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer|Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer.|Recruiting||N/A|56|Anticipated|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec|||2||f||||t||||||Samples Without DNA|"     Quadriceps Biopsy   "|||2017-10-11 01:33:19.446293|2017-10-11 01:33:19.446293
NCT01885741|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-04-17|||September 2013||2013-09-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Study to Demonstrate the Preliminary Safety and Effectiveness of IPBS in Performing MRI-Guided Targeting and Intervention of Breast Tissue in Female Patients Indicated for MRI-Guided Breast Biopsy|A Prospective, Open-Label, Single-Arm, Single-Site, Study to Demonstrate the Preliminary Safety and Effectiveness of IPBS in Performing MRI-Guided Targeting and Intervention of Breast Tissue in Female Patients Indicated for MRI-Guided Breast Biopsy.|Completed||N/A|9|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 01:33:19.513012|2017-10-11 01:33:19.513012
NCT01885728|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-11-04|||July 2013||2013-07-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients|A Randomized, Controlled Study Evaluating the Immune-Modulatory Effects of Perioperative Administration of Arginine Rich Nutritional Supplements With Mass Cytometry in Patient Undergoing Surgery|Completed||N/A|22|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 01:33:19.577992|2017-10-11 01:33:19.577992
NCT01885715|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2014-06-12|||June 2013||2013-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium|Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium|Completed||N/A|112|Actual|Seoul National University Hospital||8|||f||||f||||||||||2017-10-11 01:33:19.649429|2017-10-11 01:33:19.649429
NCT01885702|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-05-29|||October 2010||2010-10-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|April 2016|Actual|2016-04-01||Interventional|||Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI|Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI|Active, not recruiting||Phase 1/Phase 2|25|Anticipated|Radboud University||2|||f||||f||||||||Yes|Data will be shared in an upcoming publication.|2017-10-11 01:33:19.733867|2017-10-11 01:33:19.733867
NCT01885689|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-07-13|||January 8, 2014|Actual|2014-01-08|July 2017|2017-07-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia|Phase II Study of Clofarabine and High-Dose Melphalan Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation for Myelodysplasia or Acute Leukemia in Remission|Recruiting||Phase 2|77|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:33:19.814422|2017-10-11 01:33:19.814422
NCT01885676|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-24||||||June 2013|2013-06-01||||February 2014|Anticipated|2014-02-01||Interventional|||Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia|A Pilot Randomized, Double-blind, Placebo-controlled Clinical Trial to Obtain Preliminary Data on Efficacy and Safety in the Application of PRGF-Endoret by Mesotherapy, in the Treatment of Male and Female Androgenetic Alopecia of Over 6 Months Duration.|Unknown status|Not yet recruiting|N/A|24||Biotechnology Institute IMASD||2|||f||||||||||||||2017-10-11 01:33:19.927471|2017-10-11 01:33:19.927471
NCT01885650|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-08-01|||July 2013||2013-07-01|August 2017|2017-08-01|May 11, 2017|Actual|2017-05-11|May 11, 2017|Actual|2017-05-11||Interventional|NIV||The Addition of Non-Invasive Ventilation To Airway Clearance Techniques In Adults With Cystic Fibrosis|Non-Invasive Ventilation (NIV) For Positive Pressure Support. A Randomised Cross-Over Trial To Evaluate The Short-Term Effects of NIV As An Adjunct To Airway Clearance Techniques in Adults With Cystic Fibrosis.|Terminated||N/A|14|Actual|Royal Brompton & Harefield NHS Foundation Trust||2||Based upon results of interim data analysis|f||||t||||||||||2017-10-11 01:33:20.165851|2017-10-11 01:33:20.165851
NCT01885637|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-04-24|||June 2013||2013-06-01|April 2017|2017-04-01|February 28, 2019|Anticipated|2019-02-28|February 2017|Actual|2017-02-01||Interventional|DOMUS||DOMUS: A Trial of Accelerated Transition From Oncological Treatment to Continuing Palliative Care at Home|DOMUS: A Randomized Controlled Clinical Trial of Accelerated Transition From Oncological Treatment to Continuing Palliative Care at Home|Active, not recruiting||N/A|340|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:33:20.25802|2017-10-11 01:33:20.25802
NCT01885624|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-02-14|||November 2011||2011-11-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers|Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers|Completed||Phase 1|31|Actual|Theramab LLC||1|||f||||t||||||||No||2017-10-11 01:33:20.347199|2017-10-11 01:33:20.347199
NCT01885611|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-04-03|||June 2013||2013-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Virgin Coconut Oil Oral Supplementation for Leprosy Patients|The Effects of Virgin Coconut Oil Supplementation on Oxidative Stress and Treatment Response Among Hansen's Disease Patients on Multi-Drug Therapy: A Pilot Study|Withdrawn||Phase 1/Phase 2|0|Actual|Philippine Dermatological Society||2||There was a problem with funding and with the acquisition of the lab assays|f||||t||||||||||2017-10-11 01:33:20.412936|2017-10-11 01:33:20.412936
NCT01885598|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-09-26|||July 10, 2013|Actual|2013-07-10|September 2017|2017-09-01|October 2, 2017|Anticipated|2017-10-02|October 2, 2017|Anticipated|2017-10-02||Observational|||Eliquis Regulatory Post Marketing Surveillance|Eliquis (Apixaban) Regulatory Postmarketing Surveillance in Clinical Practice for Stroke Prevention in Nonvalvular Atrial Fibrillation|Active, not recruiting||N/A|3000|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 01:33:20.485546|2017-10-11 01:33:20.485546
NCT01885585|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2016-02-05|||July 2014||2014-07-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Eliquis Regulatory Post Marketing Surveillance (rPMS)|Eliquis (Apixaban) Regulatory Post Marketing Surveillance in Clinical Practice for Venous Thromboembolism (VTE) Prevention|Completed||N/A|100|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 01:33:20.571165|2017-10-11 01:33:20.571165
NCT01885572|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-04-27|||November 2013||2013-11-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|PRO-BRA||"National, Multicenter PMS Study Patient Reported Outcome in Breast Reconstruction Following Mastectomy With TiLOOP Bra"|"National, Multicenter Post-market Surveillance Study Patient Reported Outcome in Breast Reconstruction Following Mastectomy With Titaniferously Coated Polypropylene Mesh (TiLOOP Bra)"|Active, not recruiting||N/A|267|Anticipated|Pfm Medical Mepro Gmbh||1|||f||||t||||||||||2017-10-11 01:33:20.654445|2017-10-11 01:33:20.654445
NCT01885559|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-02-25|2015-02-02||January 2006||2006-01-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|HALT-PKD||HALT Progression of Polycystic Kidney Disease (HALT PKD) Study B|Polycystic Kidney Disease-Treatment Network|Completed||Phase 3|486|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 01:33:20.773765|2017-10-11 01:33:20.773765
NCT01885546|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-07-06|||July 2013||2013-07-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Accuracy Study for Enhanced Meter Feature|Accuracy Study for the Evaluation of Obtaining an Enhanced Meter Feature Using an AgaMatrix BGMS|Completed||N/A|133|Actual|AgaMatrix, Inc.||1|||f||||f||||||||||2017-10-11 01:33:23.352404|2017-10-11 01:33:23.352404
NCT01885533|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-03-29|||March 2013||2013-03-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Observational|PRAGMA||Post-Radioiodine Graves' Management: The PRAGMA-Study|POST-RADIOIODINE GRAVES' MANAGEMENT|Completed||N/A|803|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||3||f||||t||||||||||2017-10-11 01:33:23.417064|2017-10-11 01:33:23.417064
NCT01885520|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2016-03-23|||July 2013||2013-07-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|eperisone||Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg|A Randomized,Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg After Oral Administration in Healthy Adult Male Subjects.|Completed||Phase 1|28|Actual|Navipharm Corporation||2|||f||||f||||||||No||2017-10-11 01:33:23.481716|2017-10-11 01:33:23.481716
NCT01885507|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-02-19|||July 2013||2013-07-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|BI-VILI||Mechanical Ventilation in Brain-injured Patients|Duration of Mechanical Ventilation and Mortality Among Brain-injured Patients - a Before-after Evaluation of a Quality Improvement Project|Completed||N/A|560|Actual|Nantes University Hospital|||2||f||||f||||||||||2017-10-11 01:33:23.565792|2017-10-11 01:33:23.565792
NCT01885494|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2015-08-14|||June 2013||2013-06-01|August 2015|2015-08-01||||February 2015|Actual|2015-02-01||Observational|||AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A|AFF008E:Observational Follow-up Extension Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE® PD01A Applied During AFF008 in Patients With Parkinson's Disease.|Completed||N/A|30|Actual|Affiris AG|||3||f||||t||||||Samples With DNA|"     Analyzing patients' DNA (isolated out of whole blood) for polymorphisms in genes/regions like     REP1 or alpha-synuclein to correlate results with the progression rate of the disease.   "|||2017-10-11 01:33:23.812501|2017-10-11 01:33:23.812501
NCT01885481|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-03-28|||October 2013||2013-10-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or Betamethasone|Evaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or Betamethasone in Patients With Spinal Pain: a Prospective, Randomized, Double-blind Study|Completed||N/A|600|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||No||2017-10-11 01:33:23.895073|2017-10-11 01:33:23.895073
NCT01885468|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-21|2017-01-26|||May 2013||2013-05-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|X-AMIN||X-Ray Verified Accuracy of the proGAV Verification Instrument|X-Ray Verified Accuracy of the Aesculap - Miethke proGAV Adjustable Shunt Pressure Setting Verification Instrument|Completed||N/A|12|Actual|Aesculap, Inc.|||1||f||||f||||||||||2017-10-11 01:33:23.984998|2017-10-11 01:33:23.984998
NCT01885455|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-05-25|||January 2015||2015-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Improving Resection Rates Among African Americans With NSCLC|Improving Resection Rates Among African Americans With NSCLC|Recruiting||N/A|200|Anticipated|Wake Forest University Health Sciences||2|||f||||t|f|f||||||No||2017-10-11 01:33:24.047716|2017-10-11 01:33:24.047716
NCT01885442|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-04-04|||September 2013||2013-09-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|TryCYCLE||TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients|TryCYCLE (Critical Care Cycling to Improve Lower Extremity Strength): A Prospective Pilot Study of the Safety and Feasibility of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients|Completed||N/A|33|Actual|McMaster University||1|||f||||t||||||||||2017-10-11 01:33:24.134937|2017-10-11 01:33:24.134937
NCT01885429|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-07-26|||January 2011||2011-01-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Supplementing a Mixed Macronutrient Beverage With Graded Doses of Leucine on Myofibrillar Protein Synthesis|The Effect of a Leucine 'Spike' of a Sub-optimal Protein Dose on Acute Muscle Protein Synthesis|Completed||N/A|40|Actual|McMaster University||5|||f||||f||||||||||2017-10-11 01:33:24.226574|2017-10-11 01:33:24.226574
NCT01885416|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-11-18|||January 2013||2013-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Impact of Dairy Products on Postprandial Inflammation|The Impact of Dairy Products on Postprandial Inflammation in Obese Males|Completed||N/A|21|Actual|Agroscope Liebefeld-Posieux Research Station ALP||3|||f||||t||||||||||2017-10-11 01:33:24.313868|2017-10-11 01:33:24.313868
NCT01885403|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-09-22|||June 2013||2013-06-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|AcuteCHF||Acute Congestive Heart Failure|Non-Invasive Pulmonary Monitoring in Patients With Cardiogenic Pulmonary Congestion and Edema|Unknown status|Recruiting|N/A|50|Anticipated|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 01:33:24.40217|2017-10-11 01:33:24.40217
NCT01885390|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-09-15|||March 2014||2014-03-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Registry to Evaluate the ROX COUPLER in Patients With Resistant or Uncontrolled Hypertension|ROX CONTROL HTN Registry: To Evaluate the ROX Coupler in Patients With Resistant or Uncontrolled Hypertension|Recruiting||Phase 3|100|Anticipated|ROX Medical, Inc.||1|||f||||t||||||||||2017-10-11 01:33:24.489838|2017-10-11 01:33:24.489838
NCT01885377|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-03-08|||January 2012||2012-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SWESS||SWESS: The SWedish Exercise Shoulder Study in Primary Care for Patients With Subacromial Pain|SWESS: The SWedish Exercise Shoulder Study in Primary Care for Patients With Subacromial Pain - a Randomized Clinical Trial|Completed||N/A|129|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-11 01:33:24.589021|2017-10-11 01:33:24.589021
NCT01885364|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-02-04|||June 2015||2015-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Esmolol Pretreatment on Pain During Injection of Propofol|Esmolol Pretreatment on Pain During Injection of Propofol|Completed||N/A|120|Actual|Kyungpook National University||4|||f||||t||||||||||2017-10-11 01:33:24.688997|2017-10-11 01:33:24.688997
NCT01885351|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-09-05|||August 2013||2013-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MyCRCS||An Interactive Preventive Health Record to Increase Colorectal Cancer Screening|An Interactive Preventive Health Record to Increase Colorectal Cancer Screening|Recruiting||N/A|832|Anticipated|Virginia Commonwealth University||3|||f||||f||||||||||2017-10-11 01:33:24.784265|2017-10-11 01:33:24.784265
NCT01885338|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-06-02|||June 2013||2013-06-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|NACSZ||N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia|Dietary Supplement N-acetylcysteine (NAC) as a Novel Complementary Medicine to Improve Cognitive Disfunction in Schizophrenia|Completed||Phase 1|26|Actual|VA Greater Los Angeles Healthcare System||2|||f||||f||||||||||2017-10-11 01:33:24.885432|2017-10-11 01:33:24.885432
NCT01885325|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-06-19|||August 2008||2008-08-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|SHAPES||Multi-component Intervention to Increase Physical Activity in Preschool Children|Multi-component Intervention to Increase Physical Activity in Preschool Children|Completed||N/A|708|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-11 01:33:24.992784|2017-10-11 01:33:24.992784
NCT01885312|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-10-12|||February 2014||2014-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|||Tailored Mobile Text Messaging to Reduce Problem Drinking|Tailored Mobile Text Messaging to Reduce Problem Drinking|Completed||N/A|174|Actual|Northwell Health||4|||f||||t||||||||Undecided|Once cleaned and published will make available|2017-10-11 01:33:25.072579|2017-10-11 01:33:25.072579
NCT01885299|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-05-24|||March 2012||2012-03-01|May 2017|2017-05-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01|20 Years|Observational [Patient Registry]|||RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT|Multi-Institution Registry of SRS/SBRT Procedures|Enrolling by invitation||N/A|25000|Anticipated|The Radiosurgery Society|||1||f||||f||||||||||2017-10-11 01:33:25.170268|2017-10-11 01:33:25.170268
NCT01885286|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-24|||September 2011||2011-09-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Pilot Trial of Novel Circumcision Device|Simple Circumcision Device: Proof-of-Concept for a Single-visit, Adjustable Device to Facilitate Safe Adult Male Circumcision|Completed||N/A|5|Actual|VA Puget Sound Health Care System||1|||f||||t||||||||||2017-10-11 01:33:25.427123|2017-10-11 01:33:25.427123
NCT01885273|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-20|||April 2008||2008-04-01|June 2013|2013-06-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Is Pressurized Irrigation an Effective Alternative to Swabbing for Wound Cleansing?|A Multicenter, Prospective, Randomised Controlled Trial to Compare the Pressurized Irrigation Method With Conventional Practice of Swabbing for Wound Cleansing|Completed||N/A|256|Actual|Prince of Wales Hospital, Shatin, Hong Kong||2|||f||||f||||||||||2017-10-11 01:33:25.501094|2017-10-11 01:33:25.501094
NCT01885260|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-06-30||2016-06-14|July 2013||2013-07-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes|A Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability and Efficacy of ISIS 449884 Administered Once Weekly to Patients With Type 2 Diabetes Mellitus Being Treated With Metformin|Completed||Phase 2|77|Actual|Ionis Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 01:33:25.597416|2017-10-11 01:33:25.597416
NCT01885247|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-05-09|||June 2013||2013-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|OBALPA||4-10 Week Observational Study Comparing 3 Management Strategies for Obstructive Chronic BronchoPneumopathy (OCBP) in Common Clinical Practice|4-10 Week Observational Study Comparing 3 Management Strategies for Obstructive Chronic BronchoPneumopathy (OCBP) in Common Clinical Practice|Recruiting||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-11 01:33:25.731712|2017-10-11 01:33:25.731712
NCT01885234|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-12-21|||December 2011||2011-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Aerobic Training in Pregnant Women With Gestational Diabetes and Chronic Hypertension|Aerobic Training Effect in Pregnant Women With Gestational Diabetes and Chronic Hypertension: Randomized Clinical Trial|Completed||N/A|9|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 01:33:25.800106|2017-10-11 01:33:25.800106
NCT01885208|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-09-23||2016-09-23|December 2013||2013-12-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|SUSTAIN™ 3||Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes|Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes (SUSTAIN™ 3 - vs. QW GLP-1)|Completed||Phase 3|813|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:33:25.996111|2017-10-11 01:33:25.996111
NCT01885195|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-05-26||2016-11-09|October 2013||2013-10-01|May 2017|2017-05-01|April 11, 2017|Actual|2017-04-11|October 2015|Actual|2015-10-01||Interventional|SIGNATURE||MEK162 for Patients With RAS/RAF/MEK Activated Tumors|Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 3 - MEK162 for Patients With RAS/RAF/MEK Activated Tumors|Completed||Phase 2|110|Actual|Array BioPharma||1|||f||||f||||||||||2017-10-11 01:33:26.313307|2017-10-11 01:33:26.313307
NCT01885182|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-07-28|||June 2013||2013-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Targin Cancer Pain|A Phase III, Randomized, Double-blind, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone / Naloxone Prolonged Release Tablets 5/2.5mg, 10/5mg, 20/10mg or 40/20mg Compared to Oxycodone PR 5mg, 10mg, 20mg or 40mg in Subjects With Moderate to Severe, Chronic Cancer Pain|Completed||Phase 3|232|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 01:33:26.550456|2017-10-11 01:33:26.550456
NCT01885169|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2014-09-15|||August 2013||2013-08-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|April 2014|Actual|2014-04-01||Observational|||LAIV (Flumist®) Administration in CF Patients|Safety of Live-attenuated Influenza Vaccine (LAIV, Flumist®) in Patients With Cystic Fibrosis (CF)|Unknown status|Active, not recruiting|N/A|170|Anticipated|McGill University Health Center|||3||f||||f||||||Samples Without DNA|"     nasal swabs   "|||2017-10-11 01:33:26.713807|2017-10-11 01:33:26.713807
NCT01885156|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-03-26||2015-03-26|August 2013||2013-08-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris|A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris|Completed||Phase 3|65|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-11 01:33:26.817752|2017-10-11 01:33:26.817752
NCT01885143|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2014-12-01|||August 2013||2013-08-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|October 2013|Actual|2013-10-01||Observational|||A Case Collection Study for Digital Breast Tomosynthesis (DBT) Using the Senographe Essential|A Case Collection Study for Digital Breast Tomosynthesis (DBT) Using the Senographe Essential|Completed||N/A|80|Actual|GE Healthcare|||2||f||||f||||||||||2017-10-11 01:33:26.910392|2017-10-11 01:33:26.910392
NCT01885130|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-19|||December 2012||2012-12-01|June 2013|2013-06-01||||January 2013|Actual|2013-01-01||Interventional|||Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion|100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)|Completed||N/A|100|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:33:26.977592|2017-10-11 01:33:26.977592
NCT01885117|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-02-10|2013-10-31||August 2013||2013-08-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above|A Phase III, Open Label, Single Arm, Multi Center Study to Evaluate Safety and Immunogenicity of a Trivalent, Surface Antigen Inactivated Subunit Influenza Virus (Fluvirin®) in Healthy Adults|Completed||Phase 3|125|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:33:27.050828|2017-10-11 01:33:27.050828
NCT01885104|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-02-20|2014-09-17||April 2013||2013-04-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional||Safety Population, which consisted of all participants who received at least 1 dose of PEG 3350 or placebo and had at least 1 postdose safety assessment.|Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003)|Evaluation of Oral Tolerance MiraLAX Solution Concentrate in Subjects With Chronic Constipation|Completed||Phase 2|65|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:33:27.730861|2017-10-11 01:33:27.730861
NCT01885091|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-23|||December 2012||2012-12-01|June 2013|2013-06-01||||March 2013|Actual|2013-03-01||Interventional|||Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage|Kinerase® Interactive Skin-care Study: A Multicentre, Phase IV, Single-arm, Open-label Trial to Evaluate the Efficacy and Safety of Kinetin, N6-furfuryladenine, 0.1% for Treatment of Cutaneous Facial Photodamage|Completed||Phase 4|100|Actual|Menarini (Thailand) Limited||1|||f||||f||||||||||2017-10-11 01:33:28.10322|2017-10-11 01:33:28.10322
NCT01885078|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-10-03|||June 2013||2013-06-01|October 2017|2017-10-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|RA-BEYOND||An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis|A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis|Active, not recruiting||Phase 3|2944|Anticipated|Eli Lilly and Company||2|||f||||t|t|f||||||||2017-10-11 01:33:28.230769|2017-10-11 01:33:28.230769
NCT01885065|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2013-06-19|||July 2012||2012-07-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients|Efficacy Study of Novel Edible Gel-based Artificial Saliva in Xerostomic Cancer Patients|Completed||N/A|25|Actual|Dental Innovation Foundation Under Royal Patronage||1|||f||||f||||||||||2017-10-11 01:33:29.082232|2017-10-11 01:33:29.082232
NCT01885052|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-06-30|||June 12, 2013||2013-06-12|April 27, 2016|2016-04-27|May 28, 2015|Actual|2015-05-28|October 12, 2014|Actual|2014-10-12||Interventional|||Evaluation of National Cancer Institute Young Adult Stop-Smoking Program|NCI Young Adult Smoking Cessation Evaluation|Completed||Phase 2|4432|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 01:33:29.158501|2017-10-11 01:33:29.158501
NCT01885026|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-08-31|||July 2013||2013-07-01|August 2015|2015-08-01||||December 2015|Anticipated|2015-12-01||Interventional|eScreeniPsy||Substance-focused SBI as a Complement to Internet-based Psychiatric Treatment: RCT|Substance-use Focused Screening and Brief Intervention as a Complement to Internet-based Psychiatric Treatment for Depression, Panic Disorder or Social Phobia: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|124|Anticipated|Karolinska Institutet||2|||f||||||||||||||2017-10-11 01:33:29.318339|2017-10-11 01:33:29.318339
NCT01885013|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-12-31|||September 2010||2010-09-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MYME||Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients|Phase II Comparative Study of Myocet Plus Cyclophosphamide in First Line Treatment of HER2 Negative Metastatic Breast Patients|Completed||Phase 2|126|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||||2017-10-11 01:33:29.564591|2017-10-11 01:33:29.564591
NCT01885000|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-01-13|2016-11-17||July 2013||2013-07-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|PROOF||Patient-Reported Outcome Of Facial Erythema (PROOF)||Completed||Phase 3|92|Actual|Galderma||2|||f||||||||||||||2017-10-11 01:33:29.723737|2017-10-11 01:33:29.723737
NCT01884987|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-01-06|||January 2012||2012-01-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01|1 Year|Observational [Patient Registry]|||Treatment of Cerebral Radiation Necrosis With GM1, a Prospective Study|Phase II Study of Monosialotetrahexosylganglioside for Cerebral Radiation Necrosis|Unknown status|Recruiting|Phase 2|30|Anticipated|Fudan University|||1||f||||f||||||||||2017-10-11 01:33:30.271283|2017-10-11 01:33:30.271283
NCT01884974|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2015-06-15|||July 2013||2013-07-01|June 2015|2015-06-01||||June 2016|Anticipated|2016-06-01||Observational|PH-MPD1||A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.|A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases, and Correlation Between Patients Epidemiologic and Clinical Status and the Development of Pulmonary Hypertension.|Unknown status|Recruiting|N/A|150|Anticipated|Carmel Medical Center|||1||f||||t||||||||||2017-10-11 01:33:30.376913|2017-10-11 01:33:30.376913
NCT01884961|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-07-19|||June 2012||2012-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|IL2HD||Radiotherapy as an Immunological Booster in Patients With Metastatic Melanoma or Renal Cell Carcinoma Treated With High-dose Interleukin-2|Radiotherapy as an Immunological Booster in Patients With Metastatic Melanoma or Renal Cell Carcinoma Treated With High-dose Interleukin-2: Evaluation of Biomarkers of Immunologic and Therapeutic Response|Recruiting||Phase 2|19|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||1|||f||||f||||||||||2017-10-11 01:33:30.491159|2017-10-11 01:33:30.491159
NCT01884948|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2014-06-03|||July 2013||2013-07-01|June 2014|2014-06-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Effects of Omega-3 Fatty Acids on Outcome After Major Liver Resection|A Randomized, Double-blind Study of the Effects of Omega-3 Fatty Acids (Omegaven™) on Outcome After Major Liver Resection|Unknown status|Recruiting|Phase 3|258|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 01:33:30.596583|2017-10-11 01:33:30.596583
NCT01884935|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2016-06-21|||July 2013||2013-07-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||PK and PD Study of Natalizumab in Pediatric Subjects With RRMS|A Phase 1, Multicenter, Open-Label, Single-Arm, Multiple Dose Study to Evaluate the the Pharmacokinetics and Pharmacodynamics of Natalizumab in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RMS)|Completed||Phase 1|13|Actual|Biogen||1|||f||||f||||||||||2017-10-11 01:33:30.688102|2017-10-11 01:33:30.688102
NCT01884922|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-01-25|||May 2013||2013-05-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Interventional|VINILO||Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults|PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA|Recruiting||Phase 1|50|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 01:33:30.807346|2017-10-11 01:33:30.807346
NCT01884909|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-19|||April 2013||2013-04-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions|An Open Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Crossover, Balanced, Single Dose Oral Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg of Ipca Laboratories Limited, India and 'Toprol-XL®' (Metoprolol Succinate) Extended Release Tablets 200 mg of Astrazeneca LP, USA In Healthy Adult Human Subjects Under Fed Conditions|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:33:30.957925|2017-10-11 01:33:30.957925
NCT01884896|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-19|||February 2013||2013-02-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions|An Open Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Crossover, Balanced, Single Dose Oral Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg of Ipca Laboratories Limited, India and 'Toprol-XL®' (Metoprolol Succinate) Extended Release Tablets 200 mg of Astrazeneca LP, USA In Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:33:31.05228|2017-10-11 01:33:31.05228
NCT01884883|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-21|||May 2010||2010-05-01|June 2013|2013-06-01||||December 2011|Actual|2011-12-01||Interventional|ORFEVRE||Evaluation of a Distraction-rotation Knee Unloader Brace in Patients With Medial Knee Osteoarthritis.|Evaluation of a Distraction-rotation Knee Unloader Brace in Patients With Medial Knee Osteoarthritis.|Completed||N/A|21|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 01:33:31.146993|2017-10-11 01:33:31.146993
NCT01884870|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-06-02|||November 2012||2012-11-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Silent Ureteral Stone: Impact on Renal Function and Kidney Anatomy|The Impact of Silent Ureteral Stone on Renal Function and Kidney Anatomy: a Prospective Analysis|Unknown status|Recruiting|N/A|25|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 01:33:31.248534|2017-10-11 01:33:31.248534
NCT01884857|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-19|||April 2013||2013-04-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg|An Open Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Crossover, Balanced, Single Dose Oral Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg of Ipca Laboratories Limited, India and 'Toprol-XL®' (Metoprolol Succinate) Extended Release Tablets 50 mg of Astrazeneca LP, USA In Healthy Adult Human Subjects Under Fasting Conditions|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:33:31.349962|2017-10-11 01:33:31.349962
NCT01884844|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-12-10|||June 2013||2013-06-01|May 2015|2015-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Vitamin D Supplementation for Bipolar Depression|Randomized Double-Blind Placebo-Controlled Pilot Study of Vitamin D Supplementation for the Treatment of Bipolar Depression|Completed||N/A|25|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-11 01:33:31.426197|2017-10-11 01:33:31.426197
NCT01884831|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-12-10|||February 2014||2014-02-01|December 2013|2013-12-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|SETES||The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes|Phase 2 The Use of Tissue-equivalent Based on Cultured Cells for Healing Skin Blemishes|Not yet recruiting||Phase 2|1|Anticipated|Ural Medical University||1|||f||||t||||||||||2017-10-11 01:33:31.49826|2017-10-11 01:33:31.49826
NCT01884818|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-08-16|||August 2011||2011-08-01|August 2017|2017-08-01|August 15, 2017|Actual|2017-08-15|August 1, 2017|Actual|2017-08-01||Interventional|||Thoracic Spine Manipulation for Patients With Thoracic Spine Pain|The Effect of Manipulation for Thoracic Spine Pain and Mobility, and Reliability of Used Mobility Measurements.|Completed||N/A|78|Actual|University of Jyvaskyla||2|||f||||f||||||||||2017-10-11 01:33:31.568751|2017-10-11 01:33:31.568751
NCT01884805|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-05-06|||March 2013||2013-03-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|HyperVOPTICA||Feasibility of Measurement of Optical Aberrations in Hyperopia by Using an Adaptive Optics Visual Simulator (AOVIS-I)|Feasibility of Measurement of Optical Aberrations in Hyperopia by Using an Adaptive Optics Visual Simulator (AOVIS-I)|Recruiting||Early Phase 1|60|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-11 01:33:31.631229|2017-10-11 01:33:31.631229
NCT01884792|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-09-12|||March 2013||2013-03-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Standing on Glycemia in Prediabetic Adults|Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study|Completed||N/A|20|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||||2017-10-11 01:33:31.725158|2017-10-11 01:33:31.725158
NCT01884779|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-07-10|||August 2013||2013-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|July 2014|Actual|2014-07-01|90 Days|Observational [Patient Registry]|EDIRAPHIS||Prevalence of Histoplasmosis in HIV + Patients With a Rapid Diagnostic Test in West Indies|Histoplasmosis in the Guiana Shield and the French West Indies: Evaluating Prevalence in HIV + Patients With a Rapid Diagnostic Test Using an ELISA Capture Method for the Detection of Histoplasma Antigens in Blood and Urine.|Active, not recruiting||N/A|727|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||t||||||Samples Without DNA|"     Urine, serum and Histoplasma capsulatum var. capsulatum strains   "|||2017-10-11 01:33:31.817121|2017-10-11 01:33:31.817121
NCT01884766|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-09-18|||April 2013||2013-04-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Observational|EpiCop||Copeptin in Childhood Epilepsy|Prospective Study on Copeptin in Childhood Epilepsy|Completed||N/A|340|Actual|University Hospital, Basel, Switzerland|||2||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:33:31.908554|2017-10-11 01:33:31.908554
NCT01884753|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-08-08|||June 2013||2013-06-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01|12 Weeks|Observational [Patient Registry]|||Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.|Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.|Recruiting||N/A|330|Anticipated|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 01:33:31.986021|2017-10-11 01:33:31.986021
NCT01884740|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-01-12|||June 2013||2013-06-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22|Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux (Cetuximab) And Avastin (Bevacizumab)For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age|Recruiting||Phase 1/Phase 2|30|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-11 01:33:32.069836|2017-10-11 01:33:32.069836
NCT01884727|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-19|||November 2012||2012-11-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effect of ASEA on Energy Expenditure and Fat Oxidation in Humans|A Randomized, Cross-Over Clinical Trial to Evaluate the Acute Effects of ASEA on Energy Expenditure and Fat Oxidation in Humans|Completed||N/A|15|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:33:32.164299|2017-10-11 01:33:32.164299
NCT01884714|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-07-06|||July 2011||2011-07-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|DRA||Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment Study|New and Innovative Bioanalytical Tools to Assess Lifestyle Recommendations for Managing Type-2 Diabetes|Completed||N/A|80|Actual|University of Guelph||1|||f||||f||||||||No||2017-10-11 01:33:32.249135|2017-10-11 01:33:32.249135
NCT01884701|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-10-13|||June 2013||2013-06-01|March 2015|2015-03-01||||October 2016|Anticipated|2016-10-01||Interventional|APOLO-II||Accessing Peripheral Occluded LesiOns II (APOLO-II)|Accessing Peripheral Occluded LesiOns II (APOLO-II)|Withdrawn||Phase 3|0|Actual|EndoCross Ltd.||1|||f||||f||||||||||2017-10-11 01:33:32.338785|2017-10-11 01:33:32.338785
NCT01884688|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-03-03|2017-03-03||April 2013||2013-04-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional||Data includes only those participants that initiated study therapy.|UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma|A Phase II Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma|Completed||Phase 2|3|Actual|University of Arkansas||1|||f||||t||||||||||2017-10-11 01:33:32.39681|2017-10-11 01:33:32.39681
NCT01884675|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2017-01-20|2015-11-12||September 2013||2013-09-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|AMBER I||Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.|A Randomised, Multicentre, Double-Blind, Placebo-Controlled Study Of Ambrisentan In Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH).|Terminated||Phase 3|33|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 01:33:32.731605|2017-10-11 01:33:32.731605
NCT01884662|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-11-11|||September 2012||2012-09-01|January 2016|2016-01-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Virtual Walking for Neuropathic Pain in Spinal Cord Injury|Virtual Walking for Reducing Spinal Cord Injury-Related Neuropathic Pain|Active, not recruiting||N/A|67|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 01:33:33.699767|2017-10-11 01:33:33.699767
NCT01884649|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-21|||May 2012||2012-05-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01|1 Day|Observational [Patient Registry]|||Fetuin A in Hashimoto Thyroiditis|Fetuin A as a New Marker of Inflammation in Hashimoto Thyroiditis|Completed||N/A|97|Actual|Istanbul Medeniyet University|||2||f||||f||||||||||2017-10-11 01:33:33.789202|2017-10-11 01:33:33.789202
NCT01884636|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-20|||February 2013||2013-02-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate|A Phase 1, Open- Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:33:33.848259|2017-10-11 01:33:33.848259
NCT01884623|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-06-08|||June 2013||2013-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|ELAN-UNFIT||Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer|Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation|Recruiting||Phase 3|164|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t||||||||||2017-10-11 01:33:33.93551|2017-10-11 01:33:33.93551
NCT01884610|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-19|||September 2008||2008-09-01|May 2013|2013-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Study on the Impact of Stem Cell Donation and Bone Marrow Harvesting on Unrelated Donors|Multi Centre Controlled Study on the Impact of Stem Cell Donation Either After Mobilisation With Granulocyte Colony Stimulating Factor or Bone Marrow Harvest on Unrelated Bone Marrow Donors.|Completed||N/A|50|Actual|University College, London|||1||f||||t||||||Samples With DNA|"     Fixed ( methanol/acetic acid ) chromosome preparations solution and genomic DNA.   "|||2017-10-11 01:33:34.05051|2017-10-11 01:33:34.05051
NCT01884584|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-03-07|||June 2012||2012-06-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Potential Use of Indocyanine Green as a Fluorescent Agent for Definition of Surgical Margins in Cancer|Assessment of Potential Use of Indocyanine Green as a Fluorescent Agent for Definition of Surgical Margins in Cancer|Completed||Phase 1|24|Actual|Emory University||1|||f||||t|t|f||||||||2017-10-11 01:33:34.976411|2017-10-11 01:33:34.976411
NCT01884571|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-06-30|2017-05-12||October 2013||2013-10-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|NIPALS2013||Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)|A Novel Immunosuppression Intervention for the Treatment of Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|31|Actual|Emory University||1|||f||||t|t|f||||||||2017-10-11 01:33:35.082508|2017-10-11 01:33:35.082508
NCT01884558|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-20|2013-06-20|||February 2013||2013-02-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin|A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Metformin|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:33:35.317534|2017-10-11 01:33:35.317534
NCT01884545|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-06-23|||July 2013||2013-07-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease|Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease|Active, not recruiting||N/A|220|Actual|Duke University||4|||f||||f||||||||||2017-10-11 01:33:35.398715|2017-10-11 01:33:35.398715
NCT01884532|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-09-23|||May 2013||2013-05-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|June 2015|Actual|2015-06-01||Observational|||ASR-XL Metal-on-Metal 522 Post-Market Surveillance Study|Cross-Sectional, Multi-Center Evaluation of 6 Year Metal Ion Trends for ASR-XL Total Hip Replacement System|Completed||N/A|146|Actual|DePuy Orthopaedics|||5||f||||f||||||Samples With DNA|"     Whole blood and serum samples are retained   "|||2017-10-11 01:33:35.481334|2017-10-11 01:33:35.481334
NCT01884519|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-03-09|2014-11-24||July 2013||2013-07-01|March 2017|2017-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older|Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2013/2014 in People 18 Years of Age and Above|Completed||Phase 3|120|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 01:33:35.585643|2017-10-11 01:33:35.585643
NCT01884506|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-10-11|||June 2013||2013-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Evaluation of the Effect of Body Weight and Composition on Iron Absorption and Blood Volume|Evaluation of the Effect of Body Weight and Composition on Iron Absorption and Blood Volume|Completed||N/A|64|Actual|Swiss Federal Institute of Technology||2|||f||||t||||||||||2017-10-11 01:33:36.512924|2017-10-11 01:33:36.512924
NCT01884493|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-08-06|||January 2014||2014-01-01|January 2014|2014-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Electrophysiological Investigation and rTMS Intervention of Ambulatory Central Processing of Freezing of Gait in Parkinson's Disease||Withdrawn||N/A|0|Actual|China Medical University Hospital||2|||f||||||||||||||2017-10-11 01:33:36.603063|2017-10-11 01:33:36.603063
NCT01884480|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-11-18|||June 2013||2013-06-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD|A Retrospective Analysis of Renal Function, Tac Dose Adjustments and CYP3A5 Pharmacogenetics in Stable Renal Transplant Recipients Converted From Tac BID to Tac OD|Completed||N/A|60|Actual|St. Michael's Hospital, Toronto|||2||f||||f||||||||||2017-10-11 01:33:36.697487|2017-10-11 01:33:36.697487
NCT01884467|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-04-08|||May 2013||2013-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Gentamicin Bladder Instillation Trial|Randomized Placebo-Controlled Trial of Gentamicin Bladder Instillation for the Prevention of Urinary Tract Infection in Adults at High Risk for Cystitis Due to Intermittent Catheterization|Unknown status|Recruiting|Phase 4|24|Anticipated|Gillette Children's Specialty Healthcare||2|||f||||f||||||||||2017-10-11 01:33:36.756263|2017-10-11 01:33:36.756263
NCT01884454|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-02-02|||June 2013||2013-06-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|November 2013|Actual|2013-11-01||Observational|PSAR01||SLEEP AND OSA ON REPRODUCTIVE FUNCTION IN MEN|EFFECTS OF SLEEP LOSS AND OBSTRUCTIVE SLEEP APNEA SYNDROME ON REPRODUCTIVE FUNCTION IN MEN|Completed||N/A|60|Actual|Federal University of São Paulo|||4||f||||t||||||||||2017-10-11 01:33:36.862392|2017-10-11 01:33:36.862392
NCT01884441|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-01-28|||July 2011||2011-07-01|January 2014|2014-01-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients|Phase II Study With Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients Before High Dose Chemotherapy With Autologous Hematopoietic Stem Cells Transplant|Unknown status|Recruiting|Phase 2|59|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-10-11 01:33:36.954767|2017-10-11 01:33:36.954767
NCT01884428|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-01-28|||July 2011||2011-07-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|March 2014|Anticipated|2014-03-01||Interventional|||Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma|Phase I, Prospective, Open-label, Multi-centric, Dose Finding Trial of Combination of IGEV and Panobinostat Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 1|24|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-10-11 01:33:37.069535|2017-10-11 01:33:37.069535
NCT01884415|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-08-24|||September 2012||2012-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis|Open-label, Phase III, Randomized, Clinical Trial to Evaluate the Efficacy of Two Different Hepatitis B Virus (HBV) Vaccination Schemes in Patients With Hepatic Cirrhosis Candidates to Liver Transplantation|Recruiting||Phase 3|89|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f||||||||||2017-10-11 01:33:37.187808|2017-10-11 01:33:37.187808
NCT01884402|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-09-03|||October 2010||2010-10-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Observational|OPTIM||Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4|Observational,Post-authorization Prospective Study to Develop and Validate a Prognostic Tool for Optimizing Therapy in Patients With Hepatitis C Virus (HCV) Genotype 1 and 4.|Completed||N/A|770|Actual|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:33:37.305467|2017-10-11 01:33:37.305467
NCT01884389|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-02-01|||June 2013||2013-06-01|February 2017|2017-02-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|||Randomized Trial of an HIV Navigation Program for Early Palliative Care|Randomized Trial of an HIV Navigation Program for Early Palliative Care|Active, not recruiting||Phase 2|179|Actual|Case Western Reserve University||2|||f||||t||||||||Yes|A goal of this project is to test a novel health service model that could be replicated in other sites and with other hospice organizations. Therefore, we will share results with HIV clinicians and researchers, and palliative care and hospice clinicians and researchers. For clinical audiences, we will to target national meetings, including the American Academy of Hospice and Palliative Medicine and Hospice and Palliative Nurses Association annual symposium. The National Hospice and Palliative Care Organization is another avenue for dissemination of this model of care. We also expect to use the Center for AIDS Research, where several of the study team members participate, as an opportunity for reaching researchers. Because previous research shows that specific palliative care needs vary among populations, we will make the de-identified data available so that other centers can evaluate similarities and differences from our population in order to apply our findings.|2017-10-11 01:33:37.406432|2017-10-11 01:33:37.406432
NCT01884376|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2015-06-17|||July 2013||2013-07-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PeRepair||Clinical Study for the Treatment of Peripheral Nerve Defects With Neuromaix|Klinische Interventionsstrategie Zur überbrückenden Behandlung Peripherer Nervendefekte Mit Neuromaix|Completed||N/A|20|Actual|RWTH Aachen University||1|||f||||t||||||||||2017-10-11 01:33:37.502255|2017-10-11 01:33:37.502255
NCT01884363|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-03-16|||June 2013||2013-06-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Walnut Consumption, Endothelial Function, and Biomarkers|Walnut Consumption, Endothelial Function, and Plasma Adipokines in Subjects With Diabetes or Coronary Disease: a Pilot Trial|Completed||N/A|26|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:33:37.607738|2017-10-11 01:33:37.607738
NCT01884337|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-09-14|||March 24, 2015|Actual|2015-03-24|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery|A Phase IV, Open-Label, Multi-center Study to Evaluate the Safety of Apixaban in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery|Recruiting||Phase 4|500|Anticipated|Bristol-Myers Squibb||1|||f||||f|f|f||||||||2017-10-11 01:33:38.642285|2017-10-11 01:33:38.642285
NCT01884324|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-07-11|||June 2013||2013-06-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine Care|Early Delivery in Fetal Gastroschisis: a Randomized Controlled Trial of Elective Early Delivery Versus Routine Obstetrical Care|Terminated||N/A|21|Actual|Baylor College of Medicine||2||Study was stoped according to preliminary analysis.|f||||t||||||||||2017-10-11 01:33:38.802867|2017-10-11 01:33:38.802867
NCT01884311|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-08-04|||August 20, 2015|Actual|2015-08-20|August 2017|2017-08-01|May 25, 2017|Actual|2017-05-25|May 25, 2017|Actual|2017-05-25||Interventional|SCIG03||Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases|A Phase III, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subgam-VF in Primary Immunodeficiency Diseases|Completed||Phase 3|38|Actual|Bio Products Laboratory||1|||f||||f||||||||||2017-10-11 01:33:38.883142|2017-10-11 01:33:38.883142
NCT01884298|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-21|||January 2011||2011-01-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Different Anesthetic Techniques for Isolated Systolic Hypertensive Patients of Abdominal Surgery on Postoperative Hospital Stay and Morbidity|Effect of Different Anesthetic Techniques for Isolated Systolic Hypertensive Patients of Abdominal Surgery on Postoperative Hospital Stay and morbidity---a Prospective, Randomized Study|Completed||N/A|180|Actual|Peking University First Hospital||1|||f||||f||||||||||2017-10-11 01:33:38.982716|2017-10-11 01:33:38.982716
NCT01884285|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-09-15|||July 9, 2013|Actual|2013-07-09|September 2017|2017-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|||AZD8186 First Time In Patient Ascending Dose Study|A Phase I, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Anti-tumour Activity of AZD8186 in Patients With Advanced Castration-resistant Prostate Cancer (CRPC), Squamous Non-Small Cell Lung Cancer (sqNSCLC), Triple Negative Breast Cancer (TNBC) and Patients With Known PTEN-deficient/Mutated or PIK3CB Mutated/ Amplified Advanced Solid Malignancies as Monotherapy and in Combination With Abiraterone Acetate or AZD2014|Recruiting||Phase 1|180|Anticipated|AstraZeneca||6|||f||||f||||||||||2017-10-11 01:33:39.202678|2017-10-11 01:33:39.202678
NCT01884272|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-11-06|||June 2013||2013-06-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||NSAID Drug Interaction Study|A Phase 1 Study to Evaluate the Potential Two-Way Pharmacokinetic Interaction Between Lesinurad and Naproxen and Between Lesinurad and Indomethacin in Healthy Adult Male Subjects|Completed||Phase 1|24|Actual|Ardea Biosciences, Inc.||2|||f||||f||||||||||2017-10-11 01:33:39.351517|2017-10-11 01:33:39.351517
NCT01884259|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-06-26|||May 2013||2013-05-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|HNO-2||Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN|Randomised Phase II Pilot Study: Induction Chemotherapy With Docetaxel, Cisplatin and Cetuximab Versus Docetaxel, Cisplatin and 5 FU Followed by Radiotherapy With Cetuximab for Locally Advanced or Not Resectable Carcinoma of the Head and Neck|Active, not recruiting||Phase 2|100|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||2|||f||||t||||||||||2017-10-11 01:33:39.433496|2017-10-11 01:33:39.433496
NCT01884246|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-03-07|||August 1, 2013|Actual|2013-08-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|HeartHealth||Improving Heart Health in Appalachia|Reducing Health Disparities in Appalachians With Multiple Cardiovascular Disease Risk Factors|Completed||N/A|330|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-11 01:33:39.561112|2017-10-11 01:33:39.561112
NCT01884233|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-11-10|||December 2012||2012-12-01|November 2015|2015-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|TXT-CBT||Cell Phone Technology Targeting ART Adherence and Drug Use|Cell Phone Technology Targeting ART Adherence and Drug Use|Active, not recruiting||Phase 2|50|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 01:33:39.671337|2017-10-11 01:33:39.671337
NCT01884220|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-07-27|||November 2010||2010-11-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up|A Historical Chart Review and Longitudinal Follow-Up of Identified Patients With Wolman Disease or Cholesteryl Ester Storage Disease, Lysosomal Acid Lipase Deficiency|Completed||N/A|4|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||None Retained|"     No biospecimens will be collected specifically for this study. However, participants are     encouraged to send left over biopsy material to the study site for analysis at a later date.   "|||2017-10-11 01:33:39.761663|2017-10-11 01:33:39.761663
NCT01884207|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-12-22|||May 2013||2013-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|July 2014|Actual|2014-07-01||Observational|||Multiparametric Characterization of Orbital Tumors by MRI||Completed||N/A|65|Actual|Charite University, Berlin, Germany|||1||f||||||||||||||2017-10-11 01:33:39.855088|2017-10-11 01:33:39.855088
NCT01884194|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-12-28|||November 2013||2013-11-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging|Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging|Completed||N/A|80|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 01:33:39.919963|2017-10-11 01:33:39.919963
NCT01884181|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2016-08-03|||January 2014||2014-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Accelerated Diffusion MRI for Diagnosis of Hungtington Disease|Accelerated Diffusion MRI as a Potential Image Based Biomarker for Hungtington Disease|Recruiting||N/A|80|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||||||2017-10-11 01:33:39.987275|2017-10-11 01:33:39.987275
NCT01884168|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-02-03|||March 2013||2013-03-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Observational|||Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy|Gene Expression Profiling and Immunological Mechanism Affects the Response of Malignant Cavity Effusion Towards DC-CIK Immunotherapy|Recruiting||N/A|30|Anticipated|Capital Medical University|||1||f||||f||||||||||2017-10-11 01:33:40.102879|2017-10-11 01:33:40.102879
NCT01884142|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-09-05|||March 2008||2008-03-01|June 2013|2013-06-01|October 2013|Anticipated|2013-10-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Exercise Training on Mechanoreflex and Metaboreflex Control in Heart Failure Patients|Effects of Exercise Training on Mechanoreflex and Metaboreflex Control of Muscle Sympathetic Nerve Activity in Heart Failure Patients|Unknown status|Active, not recruiting|N/A|34|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 01:33:40.283632|2017-10-11 01:33:40.283632
NCT01884129|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-12-09|||June 2012||2012-06-01|February 2013|2013-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|12 Months|Observational [Patient Registry]|CTCHNSCC01||Prognostic Value of CTC in HNSCC Patients|Prognostic Value of Circulating Tumor Cells in Patients With Locally Advanced and Metastatic/Recurrent Head and Neck Cancer|Terminated||N/A|53|Actual|Chang Gung Memorial Hospital|||1|participants are no longer being examined or treated|f||||t||||||None Retained|"     Blood samples were drawn by standard procedure, stored in EDTA-coating tubes in 4 degree     temperature, then sent for CTCs counting and analysis.   "|||2017-10-11 01:33:40.360546|2017-10-11 01:33:40.360546
NCT01884116|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-06-18|||March 2011||2011-03-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||Comparison of NSAID Patch Given in Monotherapy and NSAID Patch in Combination With Transcutaneous Electric Nerve Stimulation, Heating Pad, or Topical Capsaicin in the Treatment of Patients With Myofascial Pain Syndrome of the Upper Trapezius: A Pilot Study||Completed||N/A|100|Actual|Yonsei University||4|||f||||f||||||||||2017-10-11 01:33:40.442149|2017-10-11 01:33:40.442149
NCT01884103|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-09-07|||June 2013||2013-06-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Field Triage of Older Adults Who Experience Traumatic Brain Injury|Field Triage of Older Adults Who Experience Traumatic Brain Injury|Completed||N/A|4533|Actual|University of Rochester|||1||f||||f||||||||||2017-10-11 01:33:40.542315|2017-10-11 01:33:40.542315
NCT01884064|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-05-13|2015-08-17||July 2008||2008-07-01|May 2016|2016-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia|Multiple Sessions of Low-frequency Repetitive Transcranial Magnetic Stimulation in Focal Hand Dystonia: Clinical and Physiological Effects|Completed||Phase 1|17|Actual|University of Minnesota - Clinical and Translational Science Institute|In this preliminary study, there were subjects with different types of hand dystonia and large range of symptom duration. An ideal study would have sufficient n to be able to stratify subjects within various groups.|2|||f||||t||||||||No||2017-10-11 01:33:40.843336|2017-10-11 01:33:40.843336
NCT01884051|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-02-16|||September 2012||2012-09-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|||Hormonal, Metabolic, and Signaling Interactions in PAH|Hormonal, Metabolic, and Signaling Interaction in Pulmonary Arterial Hypertension|Recruiting||N/A|2120|Anticipated|Vanderbilt University Medical Center|||2||f||||f||||||Samples With DNA|"     We plan to collect the following samples on all subjects:      DNA, RNA, white cells, plasma, serum, urine      We plan to collect the following samples on selected subjects:      Skin biopsy   "|||2017-10-11 01:33:41.089722|2017-10-11 01:33:41.089722
NCT01884038|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2013-06-20|||June 2008||2008-06-01|June 2013|2013-06-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients|A Single Center, Randomized, Double-Blind, Parallel Placebo-Controlled Study of the Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients|Withdrawn||Phase 2/Phase 3|0|Actual|United Therapeutics||2|||f||||t||||||||||2017-10-11 01:33:41.189397|2017-10-11 01:33:41.189397
NCT01884012|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-05-04|||May 2013||2013-05-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension||Completed||Phase 3|30|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 01:33:41.411577|2017-10-11 01:33:41.411577
NCT01883999|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-10-07|2016-06-22||October 2013||2013-10-01|October 2016|2016-10-01||||April 2016|Actual|2016-04-01||Interventional|||Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis|Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-iliac Aneurysms|Completed||N/A|64|Actual|W.L.Gore & Associates||1|||f||||t||||||||||2017-10-11 01:33:41.502899|2017-10-11 01:33:41.502899
NCT01883986|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-12-06|2016-10-07||February 2014||2014-02-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Supportive Care for Patients Newly Diagnosed With Lung Cancer|Palliative Care Interventions for Outpatients With Newly Diagnosed Lung Cancer|Completed||N/A|41|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 01:33:41.748374|2017-10-11 01:33:41.748374
NCT01883973|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2013-06-20|||May 2011||2011-05-01|June 2013|2013-06-01||||December 2014|Anticipated|2014-12-01||Observational|||MER Versus MRI Guidance DBS in Parkinson's Disease|Randomized Study of Deep Brain Stimulation (DBS) Implantation Using A Microelectrode-Guided Technique Versus DBS Implantation Using MRI Guidance Alone|Unknown status|Recruiting|N/A|20|Anticipated|Baylor College of Medicine|||2||f||||f||||||||||2017-10-11 01:33:42.045367|2017-10-11 01:33:42.045367
NCT01883960|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-02-10|||September 2010||2010-09-01|June 2011|2011-06-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||A Longitudinal Study of Motor Control and Brain Images in Patients With Brain Damage|A Longitudinal Study of Motor Control and Brain Images in Patients With Brain Damage: Clinical Measures and Multimodel Imaging Studies|Completed||N/A|150|Anticipated|Chang Gung Memorial Hospital|||4||f||||t||||||||||2017-10-11 01:33:42.110148|2017-10-11 01:33:42.110148
NCT01883947|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-05-10|||January 2013||2013-01-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|MEST||Effects of Touch Massage in the Sub-acute Phase After Stroke|Touch Massage in the Sub-acute Phase After Stroke - Does it Have Impact on General Health and Independence?|Recruiting||N/A|50|Anticipated|Umeå University||2|||f||||t||||||||No||2017-10-11 01:33:42.175803|2017-10-11 01:33:42.175803
NCT01883921|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2017-09-12|||June 2013||2013-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)|Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data in Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)|Recruiting||N/A|1500|Anticipated|AxelaCare Health Solutions, LLC|||1||f||||f||||||||||2017-10-11 01:33:42.474435|2017-10-11 01:33:42.474435
NCT01883908|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-09-03|2015-04-21||December 2012||2012-12-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional|GCC1229||Acupuncture in Reducing the Severity of Chemoradiation-induced Mucositis in Patients With Oropharyngeal Cancer|A Pilot Randomized Controlled Trial to Evaluate the Efficacy and Explore the Mechanism of Acupuncture in Reducing the Severity of Chemoradiation-induced Mucositis in Patients With Oropharyngeal Cancer.|Terminated||N/A|4|Actual|University of Maryland|The PI left the institution before the end of the study; therefore the study was withdrawn in clinicaltrials.gov and IRB closed.|2||"The project is terminated due to that fact that the PI has moved to another institution and   there are no resources to keep the study open in either institution."|f||||t||||||||||2017-10-11 01:33:42.569065|2017-10-11 01:33:42.569065
NCT01883895|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-06-23|2017-05-15||June 2013||2013-06-01|June 2017|2017-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||"32 subjects completed study
1 subject enrolled, but did not complete any treatments
1 subject enrolled, but only completed the control session 33 baseline, and 1 drop-out = 34 total"|Exercise-induced Hypoalgesia After Comparative Forms of Exercise|Exercise-induced Hypoalgesia After Comparative Forms of Anaerobic Training in Healthy Adults|Completed||N/A|34|Actual|University of Wisconsin, Madison||1|||f||||t||||||||No|There is no plan to share the IPD with any other researchers.|2017-10-11 01:33:42.78434|2017-10-11 01:33:42.78434
NCT01883882|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-10-21|||June 2013||2013-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|POTS||Pilot Trial of Opioid Taper Support|Pilot Randomized Trial of Opioid Taper Support|Completed||N/A|35|Actual|University of Washington||2|||f||||t||||||||No||2017-10-11 01:33:43.05434|2017-10-11 01:33:43.05434
NCT01883869|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-07-15|||June 2013||2013-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|XANTHIPPE||Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor|XANTHIPPE: Examining the Effect of Ticagrelor on Platelet Activation, Platelet-Leukocyte Aggregates, and Acute Lung Injury in Pneumonia|Completed||Phase 1|60|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-11 01:33:43.13731|2017-10-11 01:33:43.13731
NCT01883856|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-12-15|||February 2012||2012-02-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Interventional|||Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves|Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves|Unknown status|Recruiting|Phase 4|88|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-11 01:33:43.228485|2017-10-11 01:33:43.228485
NCT01883843|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2014-12-19|||May 2013||2013-05-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy of TOCT and (tDCS) for Gait Improvement in Patients With Chronic Stroke|Efficacy of a Task-oriented Circuit Training Associated With Transcranial Direct Current Stimulation (tDCS) for Gait Improvement in Chronic Stroke Patients . A Randomized Controlled Trial|Completed||Phase 2|21|Actual|University Hospital of Ferrara||2|||f||||f||||||||||2017-10-11 01:33:43.31497|2017-10-11 01:33:43.31497
NCT01883830|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-02-02|||April 2013||2013-04-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Xbox in the Rehabilitation of Chronic Traumatic Brain Injury|"Feasibility and Efficacy of Virtual Reality With Xbox Kinect in the Rehabilitation of Cronic Traumatic Brain Injuries: a Randomized Controlled Trial."|Completed||N/A|21|Actual|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-11 01:33:43.490742|2017-10-11 01:33:43.490742
NCT01883817|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-03-17|||September 2013||2013-09-01|November 2016|2016-11-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||Effect of Omega-3 Fatty Acid on Cortical Function in ADHD|Docosahexaenoic Acid Augmentation of Cortical Attention Networks in ADHD|Completed||Phase 3|30|Anticipated|University of Cincinnati||2|||f||||t||||||||No||2017-10-11 01:33:43.596145|2017-10-11 01:33:43.596145
NCT01883804|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-04-05|||June 2013||2013-06-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 Diabetes|Open Label Pilot Study of the Effect of Methyldopa on MHC-II Antigen Presentation in Type 1 Diabetes|Completed||N/A|30|Actual|University of Colorado Denver School of Medicine Barbara Davis Center||1|||f||||f||||||||||2017-10-11 01:33:43.694828|2017-10-11 01:33:43.694828
NCT01883791|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-03-10|||March 2013||2013-03-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|SBIRT in MH||Screening, Brief Intervention and Referral to Treatment for Substance Abuse in Mental Health Treatment Settings|Screening, Brief Intervention and Referral to Treatment for Substance Abuse in Mental Health Treatment Settings|Active, not recruiting||N/A|1080|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 01:33:43.79258|2017-10-11 01:33:43.79258
NCT01883778|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-12-22|||August 2012||2012-08-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Evaluating Patient and Physician Cost Knowledge in the Emergency Department|Do Providers and Consumers Know the Cost of Common Tests and Procedures Delivered in the Emergency Department?|Completed||N/A|512|Actual|University of Utah|||2||f||||f||||||||||2017-10-11 01:33:43.899327|2017-10-11 01:33:43.899327
NCT01883765|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-03-08|||February 2013||2013-02-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Neurofeedback Training in Adults With ADHD|Efficacy of a Neurofeedback Treatment in Adults With ADHD: a Triple-blind Randomized Placebo-controlled Study|Completed||N/A|118|Actual|University Hospital Tuebingen||3|||f||||||||||||Undecided||2017-10-11 01:33:43.985346|2017-10-11 01:33:43.985346
NCT01883752|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-02-09|||July 2011||2011-07-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Goal Directed Fluid Management Based on Non-invasive Monitoring|Goal-Directed Fluid Management Based on Non- Invasive Monitoring of Pulse Oximeter-Derived Pleth Variability Index|Completed||N/A|334|Actual|University of California, Irvine||2|||f||||t||||||||||2017-10-11 01:33:44.116482|2017-10-11 01:33:44.116482
NCT01867203|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-29|||December 2012||2012-12-01|May 2013|2013-05-01||||December 2014|Anticipated|2014-12-01|6 Months|Observational [Patient Registry]|||Functional and Clinical Impact of CYP3A Genetic Polymorphisms on Statin Therapy||Unknown status|Recruiting|N/A|150|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-10-11 01:39:01.05104|2017-10-11 01:39:01.05104
NCT01883739|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-12-17|||June 2013||2013-06-01|December 2014|2014-12-01||||July 2014|Actual|2014-07-01||Interventional|||Randomised Controlled Trial to Investigate the Effect of Parental Presence at Intensive Care Unit to Ward Transfer Bedside Rounds on Parental Anxiety and Children's Safety|Randomised Controlled Trial to Investigate the Effect of Parental Presence at Intensive Care Unit to Ward Transfer Bedside Rounds on Parental Anxiety and Children's Safety|Completed||N/A|200|Anticipated|University of Alberta||1|||f||||f||||||||||2017-10-11 01:33:44.223084|2017-10-11 01:33:44.223084
NCT01883726|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-19|||May 2010||2010-05-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|May 2013|Actual|2013-05-01||Interventional|NAM||Comparison of Two Nasoalveolar Molding Techniques in Complete Unilateral Cleft Lip Patient|Comparison of Two Nasoalveolar Molding Techniques in Complete Unilateral Cleft Lip Patient|Unknown status|Enrolling by invitation|N/A|30|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:33:44.32059|2017-10-11 01:33:44.32059
NCT01883713|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-11-20|||January 2013||2013-01-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Study of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilution in Heart Surgery Patients|A Prospective Analysis of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilutional Anemia in Patients Undergoing Heart Surgery|Unknown status|Recruiting|N/A|50|Anticipated|St. Michael's Hospital, Toronto|||1||f||||t||||||Samples With DNA|"     Plasma will be retained for analysis of plasma erythropietin, hepcidin and and     nitrate/nitrite levels   "|||2017-10-11 01:33:44.429|2017-10-11 01:33:44.429
NCT01883700|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-06-19|||August 2010||2010-08-01|June 2013|2013-06-01|September 2013|Anticipated|2013-09-01|September 2011|Actual|2011-09-01||Interventional|HILO||Acute Vascular Response To Meals Varying In Glycemic Index And Glycemic Load|Variability of Acute Response to Equicaloric Test Meals Varying in Glycemic Index and Glycemic Load on Postprandial Glycemia, Arterial Stiffness and Blood Pressure in Healthy Adults|Unknown status|Active, not recruiting|Phase 2|21|Anticipated|St. Michael's Hospital, Toronto||4|||f||||f||||||||||2017-10-11 01:33:44.535535|2017-10-11 01:33:44.535535
NCT01883687|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-06-19|||June 2013||2013-06-01|April 2013|2013-04-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Functional Nasal Surgery at the Time of Le Fort I Osteotomy: A Prospective, Single-blind, Randomized Trial|Functional Nasal Surgery at the Time of Le Fort I Osteotomy: A Prospective, Single-blind, Randomized Trial|Unknown status|Not yet recruiting|N/A|80|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:33:44.646238|2017-10-11 01:33:44.646238
NCT01883674|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-12-01|||May 2012||2012-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|PRO||Milk and Milk-produce to Counteract the Loss of Muscle Mass and Function in Exercising Older Adults.|Milk and Milk-produce to Counteract the Loss of Muscle Mass and Function in Exercising Older Adults.|Completed||N/A|41|Actual|Université de Sherbrooke||3|||f||||f||||||||||2017-10-11 01:33:44.748314|2017-10-11 01:33:44.748314
NCT01883661|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-09-16|||June 2014||2014-06-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)|Role of Autologous Bone Marrow Derived Mono Nuclear Stem Cell (MNCs) In Patient With Multiple Sclerosis .It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:33:44.847822|2017-10-11 01:33:44.847822
NCT01883648|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-04-26|||June 2013||2013-06-01|January 2017|2017-01-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Study to Evaluate Coconut Oil for Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, 6 Month Cross-Over Study to Evaluate the Efficacy of Coconut Oil (Fuel for Thought™) Treatment for Subjects With Mild to Moderate Alzheimer's Disease|Terminated||Phase 2/Phase 3|21|Actual|University of South Florida||2||Funding limitations and enrollment was too low.|f||||t||||||||No||2017-10-11 01:33:44.944886|2017-10-11 01:33:44.944886
NCT01883635|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-01-08|2015-08-24||May 2013||2013-05-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Exercise Intervention for Cancer Survivors and Caregivers|Dyadic Exercise Intervention for Cancer Survivors and Caregivers|Completed||Phase 1|44|Actual|University of Rochester|First, this was a pilot, Phase I trial, and hence had a limited sample size. This study was conducted in a single geographic region. Finally, we analyzed only two time points: baseline and post-intervention.|2|||f||||t||||||||||2017-10-11 01:33:45.04334|2017-10-11 01:33:45.04334
NCT01883622|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-18|||January 2004||2004-01-01|June 2013|2013-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Observational|||Glucose Variability in Pregnancy Complicated by Diabetes|Glucose Fluctuations During Gestation: an Additional Tool for a Better Monitoring of Pregnancy Complicated by Diabetes|Completed||N/A|50|Actual|University of Padova|||3||f||||t||||||||||2017-10-11 01:33:45.440882|2017-10-11 01:33:45.440882
NCT01883609|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-09-30|||September 2013||2013-09-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S|A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of the Combination Malaria Vaccine Candidate Regimen of RTS,S/AS01B + ChAd63 and MVA Encoding ME-TRAP and Also RTS,S/AS01B Alone.|Completed||Phase 1/Phase 2|48|Actual|University of Oxford||4|||f||||f||||||||||2017-10-11 01:33:45.514342|2017-10-11 01:33:45.514342
NCT01883596|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-12-07|||October 2012||2012-10-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.|Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in a Pediatric Intensive Care Unit.|Recruiting||Phase 4|70|Anticipated|Sinaloa Pediatric Hospital||2|||f||||f||||||||||2017-10-11 01:33:45.5999|2017-10-11 01:33:45.5999
NCT01883583|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2013-11-05|||June 2013||2013-06-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|May 2014|Anticipated|2014-05-01||Interventional|||Pilot Study of Contrast-Enhanced Ultrasound of Transplanted Kidney|Pilot Study of Contrast-Enhanced Ultrasound of Transplanted Kidney for Evaluation of Effectiveness of Perfusion Parameter in Assessment of Allograft Nephropathy|Unknown status|Recruiting|N/A|10|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 01:33:45.692266|2017-10-11 01:33:45.692266
NCT01883414|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-03-06|||June 2013||2013-06-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.|Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.|Terminated||N/A|14|Actual|Ulthera, Inc||2||Lack of resources to manage trial; lack of efficacy.|f||||f||||||||||2017-10-11 01:33:47.504356|2017-10-11 01:33:47.504356
NCT01883570|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-20|||June 2013||2013-06-01|June 2013|2013-06-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|||Improving Search Strategy for Identifying Urgent Conditions on the Chest X-ray|Improving Search Strategy for Identifying Urgent Conditions on the Chest X-ray. (Original Title in French: Améliorer la stratégie de Recherche et l'Identification Des Conditions Urgentes Sur Une Radiographie Pulmonaire: Impact de l'Utilisation d'un Logiciel Interactif de Lecture systématique)|Unknown status|Recruiting|Phase 3|40|Anticipated|Université de Montréal||2|||f||||f||||||||||2017-10-11 01:33:45.773401|2017-10-11 01:33:45.773401
NCT01883557|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2013-06-26|||February 2009||2009-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:33:45.838312|2017-10-11 01:33:45.838312
NCT01883544|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-19|2014-03-28|||June 2013||2013-06-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects|A Phase 1, Randomized, Blinded, Placebo-Controlled, Multiple IV Administration, Sequential-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects|Completed||Phase 1|16|Actual|Alexion Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:33:45.993977|2017-10-11 01:33:45.993977
NCT01883531|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-10-12|||June 2013||2013-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years|A Randomised, Multicentre, Double-blind, Placebo-controlled, Crossover Trial Determining the Efficacy of Dry Powder Mannitol in Improving Lung Function in Subjects With Cystic Fibrosis Aged Six to Seventeen Years|Completed||Phase 2|95|Actual|Pharmaxis||2|||f||||f||||||||||2017-10-11 01:33:46.072294|2017-10-11 01:33:46.072294
NCT01883518|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-02-14|||June 2013||2013-06-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ADCVCTAST||Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma|Non-randomized Single-center Study Phase II Evaluating the Efficacy and Toxicity of Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma|Recruiting||Phase 1/Phase 2|48|Anticipated|Petrov Research Institute of Oncology||1|||f||||f||||||||||2017-10-11 01:33:46.172326|2017-10-11 01:33:46.172326
NCT01883505|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2016-03-31|||December 2013||2013-12-01|March 2014|2014-03-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|ND0612-003||A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612|A Phase 2a Multicentre Randomized Double Blind Placebo Controlled Study Followed by an Open Label Period, to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations, Administered With Repeated Continuous Subcutaneous ND0612|Completed||Phase 2|30|Actual|NeuroDerm Ltd.||2|||f||||f||||||||||2017-10-11 01:33:46.263496|2017-10-11 01:33:46.263496
NCT01883492|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-06-20|||March 11, 2013|Actual|2013-03-11|June 2017|2017-06-01|July 2025|Anticipated|2025-07-01|July 2025|Anticipated|2025-07-01||Interventional|||A Prospective Multi-center Study on Total Hip Arthroplasty With E1|A Prospective Multi-center Randomized Study on Total Hip Replacement With E1|Active, not recruiting||N/A|148|Actual|Zimmer Biomet||2|||f||||t|f|t|f||t|||Undecided||2017-10-11 01:33:46.351536|2017-10-11 01:33:46.351536
NCT01883479|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-06-28|||December 2012||2012-12-01|June 2017|2017-06-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|HM2||Effect of Exercise and Wellness Interventions on Preventing Postpartum Depression|Effect of Exercise and Wellness Interventions on Preventing Postpartum Depression.|Completed||N/A|450|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-11 01:33:46.489233|2017-10-11 01:33:46.489233
NCT01883466|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-06-18|||September 2012||2012-09-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|BD100||Health Effects of Biodiesel Exhaust Exposure|Cardiovascular Effects of Exposure to 100% Biodiesel Exhaust in Man|Completed||N/A|19|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 01:33:46.565941|2017-10-11 01:33:46.565941
NCT01883453|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-10-09|2015-04-20||January 2013||2013-01-01|June 2015|2015-06-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional||Healthy adult volunteers. One part of the included participants was from an education in elite skiing at the University and one part was from a military unit. The participants were told to start the treatment as soon as they were convinced that they had caught a common cold|A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold|A Double Blinded Clinical Study Aiming to Shorten an Episode of Common Cold When the Treatment is Started at the Onset of an Episode of Common Cold|Completed||Phase 2|146|Actual|Umeå University|Too few virus positive persons in order to get significant results. Local side effects were mild and about the same as in the placebo Group. Influensa season and few rhinovirus infections.|2|||f||||t||||||||||2017-10-11 01:33:46.647955|2017-10-11 01:33:46.647955
NCT01883440|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-12-19|2015-04-16||January 2013||2013-01-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional||All persons that completed the 7 Days of treatment|Glucose Oxidase as Treatment Against Common Cold|A Placebo Controlled Study With a Nasal Spray Containing Glucose Oxidase, Aiming to Induce a Faster Recovery From an Episode of Common Cold|Completed||Phase 2|90|Actual|Umeå University|Viral samplings were made in order to exclude persons with no viral infection and persons with influenza. Most common Colds are due to Rhinoviruses, Parainfluenza and Coronaviruses. These persons were included in the Groups with significant findings.|2|||f||||t||||||||||2017-10-11 01:33:46.909982|2017-10-11 01:33:46.909982
NCT01883427|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-12-07|2015-04-16||October 2012||2012-10-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional||Pre-school children|Nasal Spray With Glucose Oxidase Preventing Common Cold in Pre-school Children|Placebo Controlled Study Among Children Below Four Years of Age, Investigating Whether a Glucose Oxidase Nasal Spray Can Reduce Days With Upper Respiratory Tract Infection Symptoms|Completed||Phase 2|40|Actual|Umeå University|We wanted 200 Children but only 40 fulfilled the study, which make the results hard to evaluate.|2|||f||||f||||||||||2017-10-11 01:33:47.234986|2017-10-11 01:33:47.234986
NCT01881555|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-10-04|||May 2013||2013-05-01|October 2016|2016-10-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|FUTURE||Functional Testing Underlying Coronary Revascularisation|FUnctional Testing Underlying Coronary REvascularisation.|Active, not recruiting||N/A|941|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:34:13.651312|2017-10-11 01:34:13.651312
NCT01883401|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-06-19|||April 2010||2010-04-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Chronic Effects of Freeze-Dried Strawberry Beverage on Cardiovascular Risk Factors|Chronic Effects of Freeze-dried Strawberry Beverage on Cardiovascular Risk Factors in Subjects With Abdominal Adiposity and Dyslipidemia.|Completed||N/A|60|Actual|Oklahoma State University||4|||f||||t||||||||||2017-10-11 01:33:47.576472|2017-10-11 01:33:47.576472
NCT01883388|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-10-06|||June 2013||2013-06-01|October 2014|2014-10-01||||December 2016|Anticipated|2016-12-01||Observational|||NovellusDx Cancer Early Detection Blood Test- Clinical Trial|Assessing the Ability of An Innovative Screening Method To Identify Proteomic Changes In Cancer Patients- Protocol|Suspended||N/A|500|Anticipated|NovellusDx|||1||f||||f||||||||||2017-10-11 01:33:47.669565|2017-10-11 01:33:47.669565
NCT01883375|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-07-12|||March 2013||2013-03-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Interventional|DTalk||Dignity Talk: Helping Palliative Care Patients and Families Have Important Conversations|Dignity Talk: a Novel Palliative Care Intervention for Patients and Their Families|Recruiting||N/A|100|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 01:33:47.737472|2017-10-11 01:33:47.737472
NCT01883362|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-03-21|||February 6, 2014|Actual|2014-02-06|March 2017|2017-03-01|July 31, 2017|Anticipated|2017-07-31|July 31, 2017|Anticipated|2017-07-31||Interventional|RADIUS||Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML|A Phase II, Randomized Trial of Standard of Care, With or Without Midostaruin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With FLT3-ITD Mutated Acute Myeloid Leukemia|Recruiting||Phase 2|60|Anticipated|Novartis||2|||f||||||||||||||2017-10-11 01:33:49.867317|2017-10-11 01:33:49.867317
NCT01883349|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-11-08|||March 2013||2013-03-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Cognitive Impairment and Imaging Correlates in End Stage Renal Disease|Cognitive Impairment and Imaging Correlates in End Stage Renal Disease|Recruiting||N/A|50|Anticipated|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-11 01:33:50.065825|2017-10-11 01:33:50.065825
NCT01883336|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-10-20|||January 2011||2011-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Observational|||Long Term Follow up of Small Non-inflammatory Pancreatic Cysts|Long Term Follow up of Small Non-inflammatory Pancreatic Cysts - a Retrospective Multicenter Study.|Active, not recruiting||N/A|300|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-11 01:33:50.144386|2017-10-11 01:33:50.144386
NCT01883323|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-06-21|||June 2013||2013-06-01|June 2016|2016-06-01|December 2023|Anticipated|2023-12-01|June 2023|Anticipated|2023-06-01||Interventional|||Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma|Phase II Study Evaluating The Infusion Of Autologous Tumor-Infiltrating Lymphocytes (TILs) And Low-Dose Interleukin-2 (IL-2) Therapy Following A Preparative Regimen Of Non-Myeloablative Lymphodepletion Using Cyclophosphamide And Fludarabine In Patients With Metastatic Melanoma|Recruiting||Phase 2|12|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:33:50.204742|2017-10-11 01:33:50.204742
NCT01883310|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-05-15|||February 1, 2017|Actual|2017-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Task-oriented Circuit Training Combined With Cerebellar tDCS in Multiple Sclerosis Subjects|The Effects of a Task-oriented Circuit Training Combined With Cerebellar Transcranial Direct Current Stimulation on Locomotor Function, Balance and Mobility in Multiple Sclerosis Subjects|Recruiting||N/A|30|Anticipated|University Hospital of Ferrara||2|||f||||t|f|f||||||No||2017-10-11 01:33:50.306431|2017-10-11 01:33:50.306431
NCT01883297|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-04-28|||January 2015||2015-01-01|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|June 2023|Anticipated|2023-06-01||Interventional|||"Re-Stimulated Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy in Patients With Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer"|"A Phase I Study Evaluating the Feasibility and Safety of Infusion of Re-Stimulated Autologous Tumor-Infiltrating Lymphocytes (TILs) Followed by Low-Dose Interleukin-2 Therapy in Patients With Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer"|Recruiting||Phase 1|9|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 01:33:50.397812|2017-10-11 01:33:50.397812
NCT01883284|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-12-02|||January 2012||2012-01-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Mod2EpiCF||Action of Epigenetic Modifiers in Cystic Fibrosis Treatment|Action of Epigenetic Modifiers in Cystic Fibrosis Treatment: ex Vivo Model of Nasal Epithelium of CF Patients|Completed||N/A|39|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 01:33:50.488132|2017-10-11 01:33:50.488132
NCT01883271|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-02-02|||May 2013||2013-05-01|February 2017|2017-02-01|January 29, 2019|Anticipated|2019-01-29|January 29, 2019|Anticipated|2019-01-29||Interventional|||Effect of Aerobic Interval Training on Cardiovascular Function in Aging|Effect of Aerobic Interval vs. Continuous Exercise Training on Cardiovascular Function in Aging|Recruiting||N/A|125|Anticipated|University of Florida||4|||f||||f||||||||||2017-10-11 01:33:50.558117|2017-10-11 01:33:50.558117
NCT01883258|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-12-06|||May 2013||2013-05-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes|Mechanisms of Cardiovascular Dysfunction and Effect of Aerobic Exercise Training in Adults With Type 2 Diabetes|Recruiting||N/A|118|Anticipated|University of Florida||4|||f||||f||||||||||2017-10-11 01:33:50.769869|2017-10-11 01:33:50.769869
NCT01883245|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-03-18|||May 2013||2013-05-01|January 2014|2014-01-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional|||Effects of Transcranial Direct Current Stimulation (tDCS) on Patients With Chronic Orofacial Pain|Effects of Transcranial Direct Current Stimulation (tDCS) in Patients With Chronic Orofacial Pain Unresponsive to Conventional Treatment. A Randomized Controlled Trial.|Terminated||Phase 2|30|Actual|University Hospital of Ferrara||2||We decided to stopped the study because we have difficulties in recruiting subjects phase.|f||||t||||||||||2017-10-11 01:33:50.891778|2017-10-11 01:33:50.891778
NCT01883232|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2015-12-16|||August 2013||2013-08-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||The Efficacy of Analgesic Buffering With Sodium Bicarbonate for the Pediatric Dental Patient|The Efficacy of Analgesic Buffering With Sodium Bicarbonate for the Pediatric Dental Patient|Withdrawn||N/A|0|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 01:33:50.982196|2017-10-11 01:33:50.982196
NCT01883219|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-06-23|||June 2013||2013-06-01|June 2013|2013-06-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia|Tyrosine Kinase Inhibitor Therapy Based on Molecular Monitoring of BCR/ABL Transcript Levels in Allogeneic Hematopoietic Stem Cell Transplant Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 2|80|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||||2017-10-11 01:33:51.067676|2017-10-11 01:33:51.067676
NCT01883206|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-05-26|||September 2013||2013-09-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|August 2015|Anticipated|2015-08-01||Observational|||CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response|Long Term Antibody Response to CMV gB Vaccine in Patients Requiring Liver or Renal Transplant.|Unknown status|Enrolling by invitation|Phase 2|120|Anticipated|University College, London|||1||f||||f||||||Samples With DNA|"     Serum,Lymphocytes.   "|||2017-10-11 01:33:51.164703|2017-10-11 01:33:51.164703
NCT01883193|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-08-24|||August 2013||2013-08-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|WF||Women First: Preconception Maternal Nutrition|Women First: Preconception Maternal Nutrition|Active, not recruiting||N/A|7374|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-10-11 01:33:51.237158|2017-10-11 01:33:51.237158
NCT01883180|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-05-14|||June 2013||2013-06-01|September 2015|2015-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis|Dose Study of Antithymocyteglobulin in Haploidentical Hematopoietic Stem Cell Transplantation for Acute Graft-versus-host Disease Prophylaxis|Recruiting||Phase 2|100|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 01:33:51.357798|2017-10-11 01:33:51.357798
NCT01883167|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-01-08|||June 2013||2013-06-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||RDEA3170 and Febuxostat Drug Interaction Study|A Phase 1 Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interactions Between RDEA3170 and Febuxostat in Healthy Adult Male Subjects|Completed||Phase 1|21|Actual|Ardea Biosciences, Inc.||2|||f||||f||||||||||2017-10-11 01:33:51.456077|2017-10-11 01:33:51.456077
NCT01883154|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-19|||September 2013||2013-09-01|June 2013|2013-06-01|September 2023|Anticipated|2023-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome|The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome|Not yet recruiting||N/A|160|Anticipated|Meir Medical Center|||4||f||||f||||||Samples With DNA|"     placental tissue ,fetal cord blood and maternal blood.   "|||2017-10-11 01:33:51.542113|2017-10-11 01:33:51.542113
NCT01883128|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-05-08|||April 2014|Actual|2014-04-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|FORECAST||FOcal RECurrent Assessment and Salvage Treatment|An Evaluation of a Novel Imaging Based Complex Diagnostic and Therapeutic Pathway Intervention for Men Who Fail Radiotherapy for Prostate Cancer.|Recruiting||Phase 2|177|Anticipated|University College London Hospitals||3|||f||||t||||||||||2017-10-11 01:33:51.725517|2017-10-11 01:33:51.725517
NCT01883115|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2014-04-03|||February 2013||2013-02-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|April 2014|Anticipated|2014-04-01|12 Months|Observational [Patient Registry]|SILTelescopic||A Prospective Study Comparing Telescopic vs. Balloon Dissection in Single Incision Laparoscopic Inguinal Herniorraphy (SILTELESCOPIC)|A Prospective Study Comparing Telescopic vs. Balloon Dissection in Single Incision Laparoscopic Inguinal Herniorraphy (SILTELESCOPIC)|Unknown status|Recruiting|N/A|102|Anticipated|The Sydney Hernia Specialists Clinic|||1||f||||t||||||||||2017-10-11 01:33:51.832826|2017-10-11 01:33:51.832826
NCT01883102|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-19|||June 2013||2013-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream|The Effect of Ablation of Epidermal Nerve Fibers Using 0.1% Capsaicin Cream on Spontaneous Cutaneous Burning Pain, Tactile Hyperalgesia, and Thermal Hyperalgesia: A Controlled, Masked Trial With an N of 1|Completed||Phase 1|1|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:33:51.922023|2017-10-11 01:33:51.922023
NCT01883089|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-05-16|||January 2015||2015-01-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship|Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship|Completed||N/A|100|Actual|University of South Florida||1|||f||||t||||||||||2017-10-11 01:33:51.997096|2017-10-11 01:33:51.997096
NCT01883076|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-06-06|||May 2013||2013-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome|Phase I Safety Study of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Stage II Palliation of Hypoplastic Left Heart Syndrome|Recruiting||Phase 1|10|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:33:52.06607|2017-10-11 01:33:52.06607
NCT01883050|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-09-13|||May 2013||2013-05-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Application for Self-Monitoring of Cardiovascular Risk|Application for Self-Monitoring of Cardiovascular Risk|Completed||N/A|80|Actual|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-11 01:33:52.272129|2017-10-11 01:33:52.272129
NCT01883037|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-11-12|||June 2013||2013-06-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|CFRD||Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT|To Compare the Clinical Accuracy of Glucose Measurement During Oral Glucose Tolerance Test Using Two Methods: i) Laboratory Standard Technique, ii) HemoCue Glucose 201 RT System|Completed||N/A|70|Actual|Royal Brompton & Harefield NHS Foundation Trust|||2||f||||t||||||||||2017-10-11 01:33:52.405125|2017-10-11 01:33:52.405125
NCT01883024|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-09-16|||June 2013||2013-06-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|IPRA||Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.|Prospective Study, Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.|Completed||N/A|6|Actual|Rennes University Hospital||1|||f||||t||||||||||2017-10-11 01:33:52.599224|2017-10-11 01:33:52.599224
NCT01883011|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-08-28|||August 1998||1998-08-01|August 2013|2013-08-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke|Randomized, Double Blind, Placebo Controlled, Two Parallel Group Study to Evaluate the Efficacy and Safety of Piracetam, 12 g Intravenous (IV) Infusion Within 7 Hour (h) Post Stroke Onset, Followed by 12 g/d for 4 Weeks (IV Ampoules, Oral Solution) and 4.8 g/d for 8 Weeks (Tablets) in Adult Subjects With an Acute Ischemic Middle Cerebral Artery Stroke|Terminated||Phase 4|571|Actual|UCB Pharma||2||"This study was terminated after a pre-specified interim analysis. Please see Detailed Study   Description for further information."|f||||t||||||||||2017-10-11 01:33:52.697813|2017-10-11 01:33:52.697813
NCT01882998|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-05-20|||February 2013||2013-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PRIMAL||Primary HIV Prevention in Pregnant and Lactating Ugandan Women|PRIMARY HIV PREVENTION IN PREGNANT AND LACTATING UGANDAN WOMEN: A RANDOMIZED TRIAL|Completed||N/A|1230|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:33:52.901555|2017-10-11 01:33:52.901555
NCT01882985|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-12-06|||December 2010||2010-12-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients|A Phase II Study to Evaluate the Effects of Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients|Active, not recruiting||Phase 2|14|Actual|University of California, Irvine||1|||f||||t||||||||||2017-10-11 01:33:53.025159|2017-10-11 01:33:53.025159
NCT01882972|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-04-14|||June 2013||2013-06-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Strength for Health|Safety and Efficacy of Home-based Resistance Training in Colorectal Cancer Survivors|Withdrawn||N/A|0|Actual|Loyola University||2||investigator left Loyola|f||||f||||||||||2017-10-11 01:33:53.145667|2017-10-11 01:33:53.145667
NCT01882959|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-20|||January 2013||2013-01-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Radiofrequency Denervation for Reducing Chronic Pain: a Meta-analysis|Radiofrequency Denervation for Reducing Chronic Pain: a Meta-analysis|Completed||N/A|374|Actual|Turku University Hospital|||2||f||||f||||||||||2017-10-11 01:33:53.263089|2017-10-11 01:33:53.263089
NCT01882946|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2015-10-06|||June 2013||2013-06-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy Study of DCVax-Direct in Solid Tumors|A PHASE I/II CLINICAL TRIAL EVALUATING DCVax-Direct, AUTOLOGOUS ACTIVATED DENDRITIC CELLS FOR INTRATUMORAL INJECTION, IN PATIENTS WITH SOLID TUMORS|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|Northwest Biotherapeutics||1|||f||||t||||||||||2017-10-11 01:33:53.346084|2017-10-11 01:33:53.346084
NCT01882933|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-05-29|||May 2013||2013-05-01|May 2017|2017-05-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|GASTRICHIP||D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma|GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study.|Recruiting||Phase 3|322|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:33:53.442395|2017-10-11 01:33:53.442395
NCT01882920|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-04-25|||June 2010||2010-06-01|April 2017|2017-04-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)|Cytoreductive Surgery With Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) - Goal Directed Therapy vs. Standard Fluid Therapy. Prospective Randomized Study|Completed||N/A|80|Actual|Regina Elena Cancer Institute||2|||f||||f||||||||||2017-10-11 01:33:53.722398|2017-10-11 01:33:53.722398
NCT01882907|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-03-04|2015-03-04||December 2009||2009-12-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes|An Open-label, Randomized, Active-controlled Study to Compare the Effect of 16 Weeks Treatment With Vildagliptin to Pioglitazone as add-on Therapy to Metformin in Type 2 Diabetic Patients Inadequately Controlled With Metformin Monotherapy|Completed||Phase 4|293|Actual|Pusan National University Hospital||2|||f||||t||||||||||2017-10-11 01:33:53.853175|2017-10-11 01:33:53.853175
NCT01882881|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-02-13|||March 2012|Actual|2012-03-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|CAS||Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors|Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors|Completed||N/A|48|Actual|Penn State University||4|||f||||f||||||||||2017-10-11 01:33:54.33784|2017-10-11 01:33:54.33784
NCT01882868|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-01-24|2016-08-26||July 2013||2013-07-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Evaluable participant (EP) population: all registered participants with measurable disease at study entry & with at least 1 valid post-baseline tumor evaluation. Participants who died due to DP or had documented radiological progressive disease before first post-baseline imaging evaluation were also included.|A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan|A Single-Arm Phase II Study in Japan to Assess the Efficacy and Safety of Aflibercept Administered Every Two Weeks in Combination With FOLFIRI in Patients With Metastatic Colorectal Cancer Who Progressed During or Following an Oxaliplatin-Based Regimen|Completed||Phase 2|62|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:33:54.46274|2017-10-11 01:33:54.46274
NCT01882855|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-03-10|||December 2012||2012-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy|Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy|Withdrawn||N/A|0|Actual|New York University School of Medicine|||1|Dr. Sigal no longer with NYUMC|f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-11 01:33:55.264084|2017-10-11 01:33:55.264084
NCT01882842|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-11-21|||February 2013||2013-02-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Assess if Scratching the Lining of the Womb Prior to IVF Treatment Increases the Chances of Pregnancy|The Efficacy of Endometrial Biopsy on the Outcome of In Vitro Fertilization (IVF) /Intra-Cytoplasmic Sperm Injection (ICSI) Treatment (Endoscratch): A Feasibility Pilot Study|Completed||Phase 2/Phase 3|160|Anticipated|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 01:33:55.345419|2017-10-11 01:33:55.345419
NCT01882816|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-03-21|||June 2013||2013-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer|A Phase II Study of Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer|Active, not recruiting||Phase 2|27|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:33:55.556019|2017-10-11 01:33:55.556019
NCT01882803|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-08-03||2017-05-11|May 2013||2013-05-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 2 Study of Duvelisib in Subjects With Refractory Indolent Non-Hodgkin Lymphoma (DYNAMO)|A Phase 2 Study of Duvelisib in Subjects With Refractory Indolent Non-Hodgkin Lymphoma (DYNAMO)|Active, not recruiting||Phase 2|129|Actual|Verastem, Inc.||1|||f||||t||||||||||2017-10-11 01:33:55.716026|2017-10-11 01:33:55.716026
NCT01882790|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-08-23|||May 2013||2013-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01|5 Years|Observational [Patient Registry]|||The Prevalence of Coronary Spasm in Hypertensive Patients Treated With Antihypertensive Medication|The Association of Acetylcholine-induced Coronary Artery Spasm With the Blood Pressure Level in Hypertensive Patients Treated With Blood Pressure Lowering Drugs|Completed||N/A|1933|Actual|Korea University|||1||f||||f||||||||||2017-10-11 01:33:55.962956|2017-10-11 01:33:55.962956
NCT01882777|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-06-18|||September 2012||2012-09-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of a Project to Distribute Water Filters and Cookstoves in Western Rwanda|ASSESSING THE IMPACT OF WATER FILTERS AND IMPROVED COOK STOVES ON DRINKING WATER QUALITY AND INDOOR AIR POLUTION: A RANDOMISED CONTROLED TRIAL IN RWANDA|Completed||N/A|566|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 01:33:56.053811|2017-10-11 01:33:56.053811
NCT01882764|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-05-03|||June 2013||2013-06-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|NATRUL-4||A Phase III Maintenance Placebo Controlled Maintenance Trial Of HMPL-004 in Subjects With Mild to Moderate Ulcerative Colitis|A Phase III Double Blind, Multi-Center Placebo Controlled Maintenance Trial of HMPL-004 in Subjects With Mild to Moderate Ulcerative Colitis With Clinical Remission or Response From Induction Therapy. (NATRUL-4)|Terminated||Phase 3|1|Actual|Hutchison Medipharma Limited||2|||f||||f||||||||||2017-10-11 01:33:56.137304|2017-10-11 01:33:56.137304
NCT01882751|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-09-18|||June 2013||2013-06-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Observational|||In Vivo Comparison of Knee Kinematics for Subjects Implanted With Either a ConforMIS or Traditional Knee Implant|In Vivo Determination & Comparison of Knee Kinematics for Subjects Implanted With Either a Personalized ConforMIS or Traditional Knee Implant|Completed||N/A|66|Actual|ConforMIS, Inc.|||2||f||||f|f|t|f|f|t|||||2017-10-11 01:33:56.221383|2017-10-11 01:33:56.221383
NCT01882738|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-18|||July 2013||2013-07-01|June 2013|2013-06-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Observational|||Effect of Maternal BMI on Measurement of Cervical Length|Effect of Maternal BMI on Accuracy of Measurement of Cervical Length During the 3rd Trimester of Pregnancy|Unknown status|Not yet recruiting|N/A|300|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 01:33:56.301964|2017-10-11 01:33:56.301964
NCT01882725|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-07-12|2014-04-04||June 2013||2013-06-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study of Low Level Laser Light Therapy to Improve Blood Circulation in People With Chronic Heel Pain|An Evaluation of the Effect of the Erchonia HP Scanner (HPS) Laser on Increasing Blood Circulation in Individuals With Chronic Heel Pain|Completed||N/A|14|Actual|Erchonia Corporation||1|||f||||f||||||||||2017-10-11 01:33:56.386465|2017-10-11 01:33:56.386465
NCT01882712|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2014-11-05||||||November 2014|2014-11-01||||September 2015|Anticipated|2015-09-01||Interventional|||Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema||Withdrawn||Phase 3|0|Actual|Galderma R&D||2|||f||||f||||||||||2017-10-11 01:33:56.59497|2017-10-11 01:33:56.59497
NCT01882699|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-05-05||2015-02-02|May 2013||2013-05-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||30 Days in Home Use and Home Use Patterns Over 6 Months|A Multi-center, Prospective, Non-randomized Study to Determine Durability of Effectiveness of the Cerêve Sleep System Following 30 Days in Home Use and Home Use Patterns Over 6 Months|Completed||N/A|30|Actual|Cereve, Inc.||1|||f||||t||||||||||2017-10-11 01:33:56.666821|2017-10-11 01:33:56.666821
NCT01882686|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-06-18|||December 2012||2012-12-01|June 2013|2013-06-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|||Efficacy of a Classification Based 'Cognitive Functional Therapy' in Nurses With Non Specific Chronic Low Back Pain|Efficacy of a Classification Based 'Cognitive Functional Therapy' in Nurses With Non Specific Chronic Low Back Pain - a Series of Case-controls|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-11 01:33:56.753026|2017-10-11 01:33:56.753026
NCT01882673|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-07-19|||August 2012||2012-08-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|MI-SUD||Motivating Quitline Use Among Smokers in Treatment for Substance Use Disorders|Brief Computer Intervention to Motivate Quitline Use for Smokers in SUD Treatment|Completed||N/A|76|Actual|Butler Hospital||2|||f||||f||||||||||2017-10-11 01:33:56.851091|2017-10-11 01:33:56.851091
NCT01882660|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-07-26|||July 2013||2013-07-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|DECO||Pre-operative Decitabine in Colon Cancer: a Proof of Principle Study|Pre-operative Decitabine in Colon Cancer: a Proof of Principle Study|Recruiting||N/A|88|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-11 01:33:56.93659|2017-10-11 01:33:56.93659
NCT01882647|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-12-20|2016-03-10|2015-05-11|June 2013||2013-06-01|December 2016|2016-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)|A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)|Completed||Phase 3|222|Actual|Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 01:33:57.046742|2017-10-11 01:33:57.046742
NCT01882634|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-11-05|||June 2013||2013-06-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|BarcelonAAA||Screening Programme for Abdominal Aortic Aneurysm by Hand-Held-Ultrasonography in Primary Health Care|Screening Programme for Abdominal Aortic Aneurysm by Hand-Held-Ultrasonography in Primary Health Care|Completed||Early Phase 1|1010|Actual|Consorci d'Atenció Primària de Salut de l'Eixample||1|||f||||t||||||||||2017-10-11 01:33:58.163427|2017-10-11 01:33:58.163427
NCT01882621|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-05-28|||October 2013||2013-10-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients|A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial of Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by First-line Chemotherapy Contained Cisplatin in Non-small Cell Lung Cancer Patients.|Recruiting||Phase 3|300|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:33:58.239491|2017-10-11 01:33:58.239491
NCT01882608|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-04-14|||October 2013||2013-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PATH-MOD||Using Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood Disorders|Using Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood Disorders|Completed||N/A|33|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 01:33:58.341219|2017-10-11 01:33:58.341219
NCT01882595|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-18|||January 2009||2009-01-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|January 2009|Actual|2009-01-01||Interventional|||Influence of Tracheostomy on Lung Deposition in Spontaneously Breathing Patient|Influence of Tracheostomy on Lung Deposition in Spontaneously Breathing Patient|Completed||N/A|9|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 01:33:58.427543|2017-10-11 01:33:58.427543
NCT01882582|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-05-02|||August 2012||2012-08-01|May 2016|2016-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Evaluation of Immune Signaling Networks in Healthy Human Volunteers|Evaluation of Immune Signaling Networks in Healthy Human Volunteers|Completed||N/A|25|Actual|Stanford University|||1||f||||f||||||||||2017-10-11 01:33:58.493729|2017-10-11 01:33:58.493729
NCT01882569|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-05-02|||May 2012||2012-05-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Observational|||Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for Evaluation of Immune Changes Following Surgery|Detection of Immune Changes as a Result of Surgical Trauma in Human Back Surgery Subjects: Optimization of CyTOF Analysis|Completed||N/A|5|Actual|Stanford University|||1||f||||f||||||||||2017-10-11 01:33:58.543184|2017-10-11 01:33:58.543184
NCT01882556|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2014-11-17|||January 2012||2012-01-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|EUBoSS||Early Use of Botulinum Toxin in Spasticity Post Stroke.|Is it Clinically Effective to Treat Arm Flexor Spasticity, With Botulinum Toxin - Type A (BoNTA) and Physiotherapy, as Soon as Signs of Abnormal Muscle Activity Are Observed?|Completed||Phase 2|120|Actual|Sandwell & West Birmingham Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 01:33:58.604549|2017-10-11 01:33:58.604549
NCT01882543|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-08-03|2017-05-05||June 2013||2013-06-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LEADERSHIP||Efficacy and Safety of AQX-1125 in IC/BPS|A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway|Completed||Phase 2|69|Actual|Aquinox Pharmaceuticals (Canada) Inc.||2|||f||||f||||||||||2017-10-11 01:33:58.713803|2017-10-11 01:33:58.713803
NCT01882530|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-04-11|||June 2013||2013-06-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|OCTOPUS||Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia.|Prospective, Controlled Versus Placebo, Randomized, Double-blind Study, Evaluating the Value of Non-opioid Analgesic Combination (Based on Paracetamol, Nefopam, Ketoprofen) for Postoperative Analgesia.|Recruiting||Phase 4|1000|Anticipated|Rennes University Hospital||8|||f||||f||||||||||2017-10-11 01:33:59.657788|2017-10-11 01:33:59.657788
NCT01882517|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-18|||March 2011||2011-03-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Lipid-lowering Effect of Plant Stanol Yogurt|The Cholesterol Lowering Efficacy of Plant Stanol Ester Yoghurt in a Turkish Population|Completed||N/A|70|Actual|Raisio Group||2|||f||||f||||||||||2017-10-11 01:33:59.867012|2017-10-11 01:33:59.867012
NCT01882504|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-02-02|||May 2013||2013-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum|An Open-label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute, Inflammatory Phase of Pyoderma Gangrenosum|Completed||Phase 2|8|Actual|XOMA (US) LLC||1|||f||||f||||||||||2017-10-11 01:33:59.945658|2017-10-11 01:33:59.945658
NCT01882491|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-03-03|||May 2013||2013-05-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand|A Phase 2 Proof-of-concept Study of Gevokizumab in Subjects With Inflammatory Erosive Osteoarthritis of the Hand|Completed||Phase 2|91|Actual|XOMA (US) LLC||2|||f||||f||||||||||2017-10-11 01:34:00.072532|2017-10-11 01:34:00.072532
NCT01882478|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-08-02|||June 2013||2013-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|August 2018|Anticipated|2018-08-01||Observational|||Cryotherapy -BEATS-RF Ablation Trial|CryoSpray Ablation for Barrett's Esophagus After Treatment Failure With Serial RadioFrequency Ablation|Active, not recruiting||N/A|15|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-11 01:34:00.2113|2017-10-11 01:34:00.2113
NCT01882465|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-11-18|2016-06-20||August 2013||2013-08-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||All subjects enrolled into the study.|Corneal Staining Associated With Daily Disposable Beauty Contact Lenses|Corneal Staining Associated With Daily Disposable Beauty Contact Lenses|Terminated||N/A|35|Actual|Johnson & Johnson Vision Care, Inc.||6|||f||||f||||||||||2017-10-11 01:34:00.288081|2017-10-11 01:34:00.288081
NCT01882452|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-05-12|||July 2013||2013-07-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|MEST||A Randomised Controlled Clinical Trial of Memory Specificity Training (MEST) for Depression|A Randomised Controlled Clinical Trial of Memory Specificity Training (MEST) for Depression|Unknown status|Recruiting|N/A|60|Anticipated|Medical Research Council||2|||f||||t||||||||||2017-10-11 01:34:00.616021|2017-10-11 01:34:00.616021
NCT01882439|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-09-08|2017-02-17||August 2013|Actual|2013-08-01|September 2017|2017-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|OPAL BEYOND|All participants who received at least 1 dose of study drug.|Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors|A Phase 3, Randomized, Double-blind, Placebo-controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (Cp-690,550) In Subjects With Active Psoriatic Arthritis And An Inadequate Response To At Least One Tnf Inhibitor|Completed||Phase 3|395|Actual|Pfizer||4|||f||||t||||||||||2017-10-11 01:34:00.812004|2017-10-11 01:34:00.812004
NCT01882426|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-05-12|||May 2014||2014-05-01|May 2016|2016-05-01|May 2016|Anticipated|2016-05-01|November 2015|Actual|2015-11-01||Interventional|CONSTRUCT||Care Path for the Management of Ulcerative Colitis|A Cluster Randomized Controlled Trial of a Care-Path for the Management of Ulcerative Colitis|Terminated||Phase 4|192|Actual|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 01:34:03.865583|2017-10-11 01:34:03.865583
NCT01882413|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-11-02|2015-09-17||June 2013||2013-06-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|REVEAL||A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal||Completed||N/A|204|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:34:03.953562|2017-10-11 01:34:03.953562
NCT01882400|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-10-31|||May 2001||2001-05-01|October 2013|2013-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy|Évaluation Multidimensionnelle de la réponse au Traitement de l'ostéoporose spontanée et Induite Par Les corticostéroïdes à l'Aide d'un Bisphosphonate à Administration Orale Chez Des Malades Porteurs d'Une Dystrophie Musculaire sévère.|Completed||Phase 4|11|Actual|Université de Sherbrooke||1|||f||||t||||||||||2017-10-11 01:34:04.315489|2017-10-11 01:34:04.315489
NCT01882387|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-08-29|||December 2013||2013-12-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation|Phase II Evaluation of the Efficacy of TXA127 (Angiotensin 1-7) to Reduce Acute Graft-vs.-Host Disease in Adults Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation|Withdrawn||Phase 2|0|Actual|Tarix Pharmaceuticals||1||Change in drug product development strategy|f||||t||||||||||2017-10-11 01:34:04.41042|2017-10-11 01:34:04.41042
NCT01882374|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-08-29|||December 2013||2013-12-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation|Phase II Evaluation of the Efficacy of TXA127 (Angiotensin 1-7) to Reduce Acute Graft-vs-Host Disease in Adults Undergoing Double Umbilical Cord Blood Transplantation|Withdrawn||Phase 2|0|Actual|Tarix Pharmaceuticals||1||Change in drug product development strategy|f||||f||||||||||2017-10-11 01:34:04.49206|2017-10-11 01:34:04.49206
NCT01882361|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-07-25|||June 2013||2013-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone|Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone|Recruiting||Phase 2/Phase 3|130|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:34:04.581604|2017-10-11 01:34:04.581604
NCT01882348|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-04-06|||June 2013||2013-06-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Changing Pediatric Office Systems Nationally to Address Parental Tobacco Use|Changing Pediatric Office Systems Nationally to Address Parental Tobacco Use|Unknown status|Recruiting|N/A|4000|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:34:04.681436|2017-10-11 01:34:04.681436
NCT01882335|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-08-01|||April 2013||2013-04-01|April 2013|2013-04-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Interventional|||Saving Brain in Uganda and Burkina Faso|Saving Brains In Uganda And Burkina Faso (PROMISE Saving Brains)|Unknown status|Enrolling by invitation|N/A|600|Anticipated|Makerere University||2|||f||||t||||||||||2017-10-11 01:34:04.771746|2017-10-11 01:34:04.771746
NCT01882322|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-03-08|||January 2013||2013-01-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|Maple||A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects|A Phase IV, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Advagraf® (Modified Release Tacrolimus, Once Daily) After Using Prograf® (Tacrolimus Twice Daily) in de Novo Liver Transplant Recipients|Completed||Phase 4|36|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:34:04.871217|2017-10-11 01:34:04.871217
NCT01882309|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2015-03-19|||July 2013||2013-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:34:04.962142|2017-10-11 01:34:04.962142
NCT01882296|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2013-06-19||||||May 2013|2013-05-01||||September 2013|Anticipated|2013-09-01||Interventional|AGSPT_PD||Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects|A Block-randomized, Open-Label, Multiple Oral Dosing, Phase I Study to Explore Comparability of the Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects|Unknown status|Not yet recruiting|Phase 1|40|Anticipated|Ahn-Gook Pharmaceuticals Co.,Ltd||5|||f||||t||||||||||2017-10-11 01:34:05.010654|2017-10-11 01:34:05.010654
NCT01882270|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-02-06|||January 2008||2008-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Third Molar Clinical Trials: Pericoronitis Studies|Pericoronitis; Oral and Systemic Inflammation|Completed||N/A|115|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples Without DNA|"     GCF samples. biofilm samples serum samples   "|||2017-10-11 01:34:05.197306|2017-10-11 01:34:05.197306
NCT01882257|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-01-10|2016-11-04||October 2011||2011-10-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord Injury|Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord Injury|Completed||N/A|93|Actual|University of Michigan|Although this study demonstrates that home-based overnight testing can identify sleep-disordered breathing in patients with spinal cord injury, it remains an individual clinical decision whether facility-based testing is preferable for some.|3|||f||||f||||||||||2017-10-11 01:34:05.274835|2017-10-11 01:34:05.274835
NCT01882244|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-06-20|||June 2013||2013-06-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|RD||Remotely Deployed TBI Study|Remotely Deployed Training for Cognitive Impairment Associated With TBI|Recruiting||N/A|85|Anticipated|VA Northern California Health Care System||2|||f||||f||||||||||2017-10-11 01:34:05.553543|2017-10-11 01:34:05.553543
NCT01882231|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-05-03|||March 2013||2013-03-01|May 2017|2017-05-01|April 25, 2016|Actual|2016-04-25|April 25, 2016|Actual|2016-04-25||Interventional|||Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma|Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma|Terminated||N/A|6|Actual|Vanderbilt-Ingram Cancer Center||1||Slow accrual and lack of funding|f||||t||||||||||2017-10-11 01:34:05.644772|2017-10-11 01:34:05.644772
NCT01882218|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-05-02|||September 2012||2012-09-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Direct Peritoneal Resuscitation Plus Conventional Resuscitation|A Comparison of Direct Peritoneal Resuscitation Plus Conventional Resuscitation Versus Conventional Resuscitation Alone in Patients Undergoing Hepatic Resection for Cancer|Withdrawn||Phase 4|0|Actual|University of Louisville||2||Not feasable at this site|f||||f|f|f||||||No||2017-10-11 01:34:05.748322|2017-10-11 01:34:05.748322
NCT01882205|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-07-25|||May 2008||2008-05-01|July 2017|2017-07-01||||December 2018|Anticipated|2018-12-01||Interventional|||Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis|Endoscopic Screening for Dysplasia in Patients With Longstanding Ulcerative Colitis: Classical Chromo-endoscopy Versus NBI , FICE and EPK-i.|Recruiting||N/A|402|Anticipated|Universitaire Ziekenhuizen Leuven||6|||f||||f||||||||||2017-10-11 01:34:05.828406|2017-10-11 01:34:05.828406
NCT01882192|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-07-19|||June 2012||2012-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Family Planning to Promote Regular Physical Activity|Family Planning to Promote Regular Physical Activity: A Randomized Controlled Trial|Active, not recruiting||N/A|160|Actual|University of Victoria||2|||f||||t||||||||||2017-10-11 01:34:05.941001|2017-10-11 01:34:05.941001
NCT01882179|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-10-25|||November 2013||2013-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|MINIMISE-STEMI||Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size|MINeralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST-Elevation Myocardial Infarction (STEMI)|Completed||Phase 3|61|Actual|University College, London||2|||f||||t||||||||||2017-10-11 01:34:06.092341|2017-10-11 01:34:06.092341
NCT01882166|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-07-21|||October 2013||2013-10-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment|Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment|Unknown status|Recruiting|N/A|150|Anticipated|St. Olavs Hospital||2|||f||||f||||||||||2017-10-11 01:34:06.191081|2017-10-11 01:34:06.191081
NCT01882153|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-06-06|||February 2010||2010-02-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|||Evaluating Parent Delivered Interventions for Children With Autism|Evaluating Parent Delivered Interventions for Children With Autism|Recruiting||N/A|120|Anticipated|Stanford University||2|||f||||||||||||||2017-10-11 01:34:06.282986|2017-10-11 01:34:06.282986
NCT01882140|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-06-17|||June 2013||2013-06-01|June 2013|2013-06-01|February 2015|Anticipated|2015-02-01|November 2014|Anticipated|2014-11-01||Interventional|||The Use of Electrical Stimulation by Capacitive Field in the Repair of Skin Burns and Quality of Life|The Use of Electrical Stimulation by Capacitive Field in the Repair of Skin Burns and Quality of Life: a Double-blind Randomized Controlled Clinical Trial|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:34:06.373962|2017-10-11 01:34:06.373962
NCT01882127|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-04-18|||February 2013||2013-02-01|June 2013|2013-06-01||||December 2014|Anticipated|2014-12-01||Interventional|||All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)|Clinical Study on All-Trans Retinoic Acid (ATRA) Combining High-dose Dexamethasone Versus High-dose Dexamethasone Alone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)|Withdrawn||Phase 3|0|Actual|Shandong University||2||No eligible patient was enrolled.|f||||t||||||||||2017-10-11 01:34:06.452985|2017-10-11 01:34:06.452985
NCT01882114|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-09-06|||November 2007||2007-11-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Atherosclerosis in Atrial Fibrillation|Study of Atherosclerotic Risk Factors and Oxidative Stress in Atrial Fibrillation. Relation to Cardiovascular Events|Recruiting||N/A|3000|Anticipated|University of Roma La Sapienza|||1||f||||t||||||Samples With DNA|"     After overnight fasting and supine rest for at least 10 minutes, blood was withdrawn from the     antecubital vein. Serum was divided into aliquots and stored at -80°C.   "|Undecided||2017-10-11 01:34:06.533882|2017-10-11 01:34:06.533882
NCT01882101|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-04-25|||January 2014|Actual|2014-01-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Comparison of PTNS and Biofeedback for Fecal Incontinence|Comparison of Posterior Tibial Nerve Stimulation and Biofeedback for Fecal Incontinence: Prospective Randomized Controlled Trial|Withdrawn||Phase 3|0|Actual|Seoul National University Hospital||2||Too small included patients and, not enough cost for PTNS and biofeedback.|f||||f||||||||||2017-10-11 01:34:06.6102|2017-10-11 01:34:06.6102
NCT01882088|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2016-10-20|||April 2012||2012-04-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|September 2016|Actual|2016-09-01||Interventional|OGIG-130-1||Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD|Phase IV Non Comparative Study of the Impact of Dietary Fiber Deficiency Correction Using Mucofalk® on Clinical Features and Motor Function of the Esophagus in Patients With Non-erosive Gastroesophageal Reflux Disease|Active, not recruiting||Phase 4|30|Anticipated|Russian Academy of Medical Sciences||1|||f||||t||||||||Yes||2017-10-11 01:34:06.69758|2017-10-11 01:34:06.69758
NCT01882075|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-10-28|||June 2013||2013-06-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Closed-loop Fluid Administration System: Pilot Study to Evaluate Feasibility|Automated Administration of Fluid Administration Thanks to Hemodynamic Parameters and Cardiac Output During General Anesthesia|Terminated||Phase 4|2|Actual|Hopital Foch||2||Dysfonction of the device|f||||f||||||||||2017-10-11 01:34:06.783033|2017-10-11 01:34:06.783033
NCT01882062|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2016-02-24|2015-04-30||May 2013||2013-05-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|TRIHEP2||Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease||Completed||Phase 2|10|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-11 01:34:08.692146|2017-10-11 01:34:08.692146
NCT01882049|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-05-12|||May 2016||2016-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Use of Adjustable Gastric Band in Adolescents|Use of the REALIZE™ Adjustable Gastric Band (Model 2200-X) in Adolescents|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||1||study never started due to funding issues|f||||f||||||||||2017-10-11 01:34:08.851952|2017-10-11 01:34:08.851952
NCT01882036|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-04-18|||November 2011||2011-11-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Bariatric Surgery And Adipose Inflammation Dysfunction and Type 2 Diabetes Mellitus|The Effects of Roux-en-Y Gastric Bypass on Mitochondrial Dysfunction and Type 2 Diabetes Mellitus|Recruiting||N/A|140|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:34:08.912817|2017-10-11 01:34:08.912817
NCT01882023|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-12-02|||May 2011||2011-05-01|December 2014|2014-12-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|ANfMRI||Comparing Neural Responses to Food Images in EDNOS Patients and Healthy Controls Using fMRI|Comparing Neural Responses to Explicit and Subliminal Food Images in EDNOS Patients and Healthy Controls Using fMRI|Recruiting||N/A|80|Anticipated|Uppsala University|||2||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:34:08.9908|2017-10-11 01:34:08.9908
NCT01882010|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-05-20|||September 2013||2013-09-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Leukine (Sargramostim) for Parkinson's Disease|Leukine (Sargramostim) for Parkinson's Disease|Completed||Phase 1|37|Actual|University of Nebraska||3|||f||||t||||||||||2017-10-11 01:34:09.070276|2017-10-11 01:34:09.070276
NCT01881997|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2013-06-17|||June 2011||2011-06-01|June 2013|2013-06-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Pain Management in ED for Incision and Drainage of Abscess|Randomized Controlled Trial of the Use of Intramuscular Fentanyl for the Incision and Drainage of Abscess in the Emergency Department|Withdrawn||Phase 4|0|Actual|University of California, Los Angeles||2||IRB modifications made study impractical.|f||||f||||||||||2017-10-11 01:34:09.247322|2017-10-11 01:34:09.247322
NCT01881984|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-09-22|2017-02-14||June 2013||2013-06-01|September 2017|2017-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation|Use of Glycerol Phenylbutyrate (Ravicti™) as a Chaperone to Stabilize Enzyme in Patients With MCAD Deficiency Due to the Common MCAD 985A>G (K304E) Mutation|Completed||Phase 1|4|Actual|University of Pittsburgh|The purpose of this phase 1 trial was to establish a safe dose for treatment of patients with MCAD deficiency due to the common mutations, and to evaluate biomarkers of fatty acid metabolism in treated patients vs their pretreatment values.|1|||f||||t||||||||||2017-10-11 01:34:09.327022|2017-10-11 01:34:09.327022
NCT01881958|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-03-19|||January 2015|Anticipated|2015-01-01|March 2017|2017-03-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||The Safety and Efficacy of Administrating DiaPep277® Vaccination in Type 1 Diabetes Patients.||Withdrawn||Phase 1/Phase 2|0|Actual|Hadassah Medical Organization||1||the manufacturer decided to halt manufacturing the vaccine|f||||f||||||||||2017-10-11 01:34:09.717889|2017-10-11 01:34:09.717889
NCT01881945|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-06-17|||September 2008||2008-09-01|June 2013|2013-06-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|ValApPhI||Validation of Study in Respiratory Physiology and it Interactions|Validation of Tools Studying Respiratory Physiology and it Interaction With Swallowing and Cardiac Physiology.|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-11 01:34:09.783302|2017-10-11 01:34:09.783302
NCT01881932|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-09-03|2015-04-21||February 2013||2013-02-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|June 2014|Actual|2014-06-01||Interventional|||Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)|Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients|Terminated||N/A|19|Actual|University of Maryland|The PI left the institution before the end of the study; therefore the study was withdrawn in clinicaltrials.gov and IRB closed.|3||"The PI has moved to another institution, which resulted in significant changes in the study   design and study title."|f||||t||||||||||2017-10-11 01:34:09.875345|2017-10-11 01:34:09.875345
NCT01881919|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-03-20|||February 2013||2013-02-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial|A Double-Blind, Cross-Over, Placebo-Controlled Study Evaluating the Effect of Quercetin 500 mg Tablets on Blood Uric Acid in Healthy Males|Completed||Early Phase 1|22|Actual|University of Leeds||2|||f||||||||||||||2017-10-11 01:34:10.165478|2017-10-11 01:34:10.165478
NCT01881906|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-02-07|||February 2012|Actual|2012-02-01|February 2017|2017-02-01|April 30, 2017|Anticipated|2017-04-30|March 31, 2017|Anticipated|2017-03-31||Interventional|EXHALE||Exercise in Advanced Stage Lung Cancer Patients|"EXHALE A Randomized Clinical Trial Comparing the Effects of a 12 Week Supervised Exercise Intervention Versus Usual Care for Advanced Stage Lung Cancer Patients."|Active, not recruiting||N/A|216|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:34:10.269894|2017-10-11 01:34:10.269894
NCT01881893|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2015-12-23|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ACHD-CARE||Feasibility Study of the Adult Congenital Heart Disease-Coping and Resilience (ACHD-CARE) Trial|Feasibility Study of the Adult Congenital Heart Disease-Coping and Resilience (ACHD-CARE) Trial|Completed||N/A|42|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:34:10.355644|2017-10-11 01:34:10.355644
NCT01881880|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2015-01-08|||December 2012||2012-12-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Value of Tomosynthesis in Breast Lesion Characterization and Breast Cancer Staging|Value of Tomosynthesis in Breast Lesion Characterization and Breast Cancer Staging|Unknown status|Recruiting|N/A|750|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 01:34:10.45798|2017-10-11 01:34:10.45798
NCT01881867|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-08-25|||September 10, 2013|Actual|2013-09-10|August 2017|2017-08-01||||January 20, 2017|Actual|2017-01-20||Interventional|||CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer|A Phase 2 Study of Recombinant Glycosylated Human Interleukin-7 (CYT107) After Completion of Standard FDA Approved Therapy With Sipuleucel-T (Provenge®) for Patients With Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer (mCRPC)|Suspended||Phase 2|54|Actual|Fred Hutchinson Cancer Research Center||2||Drug Supply Issues|f||||f||||||||||2017-10-11 01:34:10.568552|2017-10-11 01:34:10.568552
NCT01881854|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-02-21|||November 2011||2011-11-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2012|Actual|2012-09-01||Observational|||Sleep Wake and Melatonin Pattern in Craniopharyngioma|Cross Sectional Study of Sleep-wake and Melatonin Patterns in Patients Treated for Craniopharyngiomas Compared to Matched Controls|Completed||N/A|30|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||Undecided||2017-10-11 01:34:10.679004|2017-10-11 01:34:10.679004
NCT01881841|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-18|2017-04-18|||January 2015||2015-01-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Computer Adaptation of Screening, Brief MET Intervention to Reduce Teen Drinking|Computer Adaptation of Screening, Brief MET Intervention to Reduce Teen Drinking|Recruiting||N/A|150|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||No||2017-10-11 01:34:10.73567|2017-10-11 01:34:10.73567
NCT01881815|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-07-04|||June 2013||2013-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Swab Sample Collection for the Detection of Bacterial Proteases|Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay|Completed||N/A|141|Actual|Systagenix Wound Management|||1||f||||t||||||None Retained|"     Swabs will be tested on day on collection. Test is destructive. No swabs will be retained.   "|||2017-10-11 01:34:10.947148|2017-10-11 01:34:10.947148
NCT01881802|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-19|||March 2013||2013-03-01|June 2013|2013-06-01||||June 2013|Anticipated|2013-06-01||Observational|||Study of Opioid Immunosuppressive Effects||Unknown status|Enrolling by invitation|N/A|50|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|||2||f||||t||||||Samples With DNA|"     The refrigerator - 80 degrees   "|||2017-10-11 01:34:11.00929|2017-10-11 01:34:11.00929
NCT01881789|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-09-27|||August 2013||2013-08-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Oprozomib and Dexamethasone, in Combination With Lenalidomide or Oral Cyclophosphamide in Patients With Newly Diagnosed Multiple Myeloma|Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone, in Combination With Lenalidomide or Oral Cyclophosphamide in Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|134|Anticipated|Amgen||2|||f||||t||||||||||2017-10-11 01:34:11.066244|2017-10-11 01:34:11.066244
NCT01881776|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-05-05|2013-07-11||August 2011||2011-08-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Continuous Interscalene Block Results in Superior Recovery Throughout the First Postoperative Week|Continuous Interscalene Block in Patients Having Outpatient Rotator Cuff Repair Surgery: a Prospective Randomized Trial|Completed||Early Phase 1|71|Actual|St. Luke's-Roosevelt Hospital Center|1. It was difficult to keep three different groups blinded. 2. The resting and mobilization highest/worst NRS pain scores were ignored and only the highest pain scores of the postoperative days 1, 2, 3, and 7 were recorded.|3|||f||||t||||||||||2017-10-11 01:34:11.359816|2017-10-11 01:34:11.359816
NCT01881763|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-08-08|||June 2010|Actual|2010-06-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression|Comparing Therapeutic Efficacy and Cognitive Side Effects of Electroconvulsive Therapy (ECT) Using Ketamine Versus Methohexital Anesthesia|Completed||Phase 4|35|Anticipated|Northwell Health||2|||f||||f||||||||||2017-10-11 01:34:11.84712|2017-10-11 01:34:11.84712
NCT01881737|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-02-08|2016-08-12||July 2011||2011-07-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||15 subjects were consented; however, 3 of those subjects did not meet the inclusion/exclusion requirements so they could not participate in the trial and were not included in the baseline analysis population.|A Study of Pregnenolone in the Treatment of Individuals With Autism|An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism|Completed||Phase 2|15|Actual|Stanford University|This is an open-label trial with a very small sample size. No measures of plasma or salivary concentrations of metabolites were completed in this study.|1|||f||||t||||||||Yes||2017-10-11 01:34:12.065533|2017-10-11 01:34:12.065533
NCT01881724|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2013-06-19|||May 2013||2013-05-01|June 2013|2013-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients|Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients|Recruiting||N/A|264|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:34:12.381365|2017-10-11 01:34:12.381365
NCT01881711|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-06-22|||May 2013||2013-05-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study|An Operator-Blinded Study of the Efficacy of ShuntCheck-Micro-Pumper, a Non-Invasive Diagnostic Procedure, in Detecting Ventricular Shunt Patency or Occlusion and in Predicting Clinical Outcome in Children and Adolescents Presenting to Emergency Departments and Neurosurgery Clinics|Unknown status|Recruiting|Phase 4|400|Anticipated|NeuroDx Development||6|||f||||t||||||||||2017-10-11 01:34:12.483878|2017-10-11 01:34:12.483878
NCT01881698|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-10-10|||October 2013||2013-10-01|October 2013|2013-10-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01|7 Months|Observational [Patient Registry]|MULPP||Evaluation of Platelet Function in Pregnancy With Multiple Electrode Aggregometry|Multiple Electrode Aggregometry and Platelet Function in Pregnancy|Unknown status|Recruiting|N/A|200|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 01:34:12.665045|2017-10-11 01:34:12.665045
NCT01881685|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2014-09-16|||March 2013||2013-03-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|1 Day|Observational [Patient Registry]|||Fetal Intrapartum Heart Rate FHR/ECG Study|Fetal Intrapartum Heart Rate FHR/ECG Study|Unknown status|Recruiting|N/A|400|Anticipated|Mindchild Medical Inc.|||1||f||||f||||||Samples Without DNA|"     1) umbilical cord arterial and venous blood; 2)placenta for pathological evaluation.   "|||2017-10-11 01:34:12.731128|2017-10-11 01:34:12.731128
NCT01881672|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-08-25|||November 2012||2012-11-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|SPIRE||Syndrome and Aspiration Pneumonia in Intensive Care|Syndrome and Aspiration Pneumonia in Intensive Care|Completed||N/A|250|Anticipated|Centre Hospitalier Departemental Vendee|||1||f||||f||||||||||2017-10-11 01:34:12.82943|2017-10-11 01:34:12.82943
NCT01881659|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-05-16|||June 2013||2013-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|ESTAMPA||Cervical Cancer Screening With Human Papillomavirus Testing|Multicentric Study of Cervical Cancer Screening and Triage With Human Papillomavirus (HPV) Testing|Recruiting||N/A|50000|Anticipated|International Agency for Research on Cancer|||1||f||||t||||||Samples With DNA|"     Three cervical samples will be collected at entry (one dry and two liquid-based). Sample     retaining or discharge will depend on HPV test (done in first liquid sample) results. If HPV     positive (and 2% of HPV negatives): 1) the dry sample will be used for the E6 protein strip     test, 2) the first liquid sample remains will be used for liquid-based cytology and the     p16/ki67 test and, 3) 10 aliquots from the second liquid sample will be stored. If HPV     negative: 1) the dry sample will be stored for the E6 strip test until the end of the study.     Testing will be done based on evidence towards usefulness in primary screening, 2) two     aliquots from the first liquid sample will be stored and, 3) the second liquid sample will be     discharged. At initial colposcopy, a cervical sample (6 aliquots) and a 10mL blood sample     (serum, plasma and buffy-coat) will be collected and stored. All stored samples will be used     for testing of triage techniques, either currently available or develop in the near future.   "|||2017-10-11 01:34:12.911981|2017-10-11 01:34:12.911981
NCT01881646|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-01-10|||June 2013||2013-06-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|POPE||Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery||Completed||Phase 4|8|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 01:34:13.090102|2017-10-11 01:34:13.090102
NCT01881633|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-06-18|||October 2010||2010-10-01|June 2013|2013-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers|A Dose Block-randomized, Double-blind, Placebo-controlled, Single Dosing, Dose-escalation Phase I Clinical Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers|Completed||Phase 1|24|Actual|ISU Abxis Co., Ltd.||4|||f||||||||||||||2017-10-11 01:34:13.155862|2017-10-11 01:34:13.155862
NCT01881620|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2013-06-17|||March 2010||2010-03-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|COMBITEP||PET Enhanced CT Scan Performance in Cancer|PET / Enhanced CT Scan Performance in Cancer (Positron Emission Tomography Combined With Computed Tomography or Vascular Contrast CT Scan). COMBI TEP Study|Completed||N/A|109|Actual|Institut Bergonié||1|||f||||t||||||||||2017-10-11 01:34:13.233955|2017-10-11 01:34:13.233955
NCT01881607|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-18|||May 2006||2006-05-01|June 2013|2013-06-01|September 2008|Actual|2008-09-01|December 2007|Actual|2007-12-01||Interventional|RESPIR·NET||An Integrated Intervention to Reduce Secondhandsmoke in Children|Respiratory Symptoms, Asthma and Passive Smoking in Children: Effectiveness of an Integrated Individual, Family, and School-based Intervention|Completed||N/A|1779|Actual|Institut Català d'Oncologia||2|||f||||f||||||||||2017-10-11 01:34:13.305077|2017-10-11 01:34:13.305077
NCT01881594|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-06-17|||January 2012||2012-01-01|June 2013|2013-06-01||||September 2012|Actual|2012-09-01||Interventional|||Stimulation of Efferent Loop Prior to Ileostomy Closure||Completed||Phase 3|60|Actual|Hospital Universitario Virgen de la Arrixaca||2|||f||||f||||||||||2017-10-11 01:34:13.379838|2017-10-11 01:34:13.379838
NCT01881581|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2013-06-19|||June 2013||2013-06-01|June 2013|2013-06-01|August 2014|Anticipated|2014-08-01|March 2014|Anticipated|2014-03-01||Interventional|||Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS|A Phase I Double-Blind Study to Evaluate the Safety and Immunogenicity of HIV Prime/Boost Vaccine Using DNA and MVA for HIV-1/AIDS|Unknown status|Recruiting|Phase 1|56|Anticipated|Centers for Disease Control and Prevention, China||8|||f||||t||||||||||2017-10-11 01:34:13.451698|2017-10-11 01:34:13.451698
NCT01881542|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-08-15|||June 2013||2013-06-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Observational|PET and urine||Standard 24-hour Urine Protein vs Shorter Period for Diagnosis of Pre-eclampsia|Comparison of the Standard 24-hour Urine Protein With Shorter Collection Periods for the Diagnosis of Preeclampsia|Recruiting||N/A|307|Anticipated|HaEmek Medical Center, Israel|||1||f||||t||||||||||2017-10-11 01:34:13.73191|2017-10-11 01:34:13.73191
NCT01881529|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-04-16|||April 2013||2013-04-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma|A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma|Completed||N/A|29|Actual|Gilead Sciences|||2||f||||f||||||Samples Without DNA|"     -  5 mL blood draw for LOXL2 testing        -  2 Punch Skin Biopsies (one near the scleroderma lesion, the other from normal skin)   "|||2017-10-11 01:34:13.908068|2017-10-11 01:34:13.908068
NCT01881516|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-06-17|||July 2013||2013-07-01|June 2013|2013-06-01||||July 2014|Anticipated|2014-07-01||Interventional|||Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF）|Randomized, Double-Blind, Placebo-Controlled, Stage II Trial of Acupuncture For Lung Cancer Patients With Cancer Related Fatigue（CRF）|Unknown status|Not yet recruiting|Phase 2|32|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 01:34:13.983085|2017-10-11 01:34:13.983085
NCT01881503|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-07-31|||October 2013||2013-10-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia|Expanded Access Protocol for the Treatment Use of HBOC-201|Enrolling by invitation||N/A|50|Anticipated|Englewood Hospital and Medical Center||1|||f||||f||||||||||2017-10-11 01:34:14.081294|2017-10-11 01:34:14.081294
NCT01881490|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-04-27|||January 2013||2013-01-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||The ImageKids Study: Developing the pMEDIC and the PICMI|The ImageKids Study: Developing the Pediatric MR Enterography-based Damage Index in Crohn's Disease (pMEDIC) and the Pediatric Inflammatory Crohn's MRE Index (PICMI)|Completed||N/A|240|Actual|Shaare Zedek Medical Center||2|||f||||t||||||||||2017-10-11 01:34:14.183127|2017-10-11 01:34:14.183127
NCT01881464|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2014-05-15|||May 2014||2014-05-01|June 2013|2013-06-01|June 2018|Anticipated|2018-06-01|June 2014|Anticipated|2014-06-01||Observational|||Anti TNF α Improves Endothelial Dysfunction in IBD Patients|Anti TNF α Improves Endothelial Dysfunction in IBD Patients|Recruiting||Phase 4|20|Anticipated|Carmel Medical Center|||1||f||||f||||||Samples Without DNA|"     CRP, CBC,Serum for future metabolomics perpus.   "|||2017-10-11 01:34:14.460081|2017-10-11 01:34:14.460081
NCT01881451|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-01-04|||August 2013||2013-08-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Observational|||Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer|Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer|Recruiting||N/A|20|Anticipated|British Columbia Cancer Agency|||1||f||||f||||||Samples With DNA|"     The collection of archival tumour blocks from the time of prior surgery/biopsy and any newly     obtained biopsies (newly obtained biopsies are optional) will be used to construct a tumour     tissue microarray (TMA). The TMA will be assessed using multi-parameter staining for LC3A/B     (autophagy), EF5 (hypoxia) and cleaved caspase 3 (apoptosis).   "|||2017-10-11 01:34:14.563682|2017-10-11 01:34:14.563682
NCT01881438|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Observational|||An Observational Study of Oral Fluoroquinolones and the Risk of Retinal Detachment|Oral Fluoroquinolones and the Risk of Retinal Detachment|Completed||Phase 4|119924|Actual|Janssen Research & Development, LLC|||1||f||||f||||||||||2017-10-11 01:34:14.721657|2017-10-11 01:34:14.721657
NCT01881425|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-09-18|||June 2013||2013-06-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|IMS||InnFocus MicroShunt Versus Trabeculectomy Study|A Randomized Study Comparing the Safety and Efficacy of the InnFocus MicroShuntTM Glaucoma Drainage System to Standard Trabeculectomy In Subjects With Primary Open Angle Glaucoma|Recruiting||Phase 2/Phase 3|857|Anticipated|InnFocus Inc.||2|||f||||t||||||||||2017-10-11 01:34:14.863049|2017-10-11 01:34:14.863049
NCT01881412|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-11-14|||August 2012||2012-08-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma|Optimizing Discharge After Emergency Department Visits for Children With Uncontrolled Asthma|Recruiting||N/A|143|Anticipated|Rhode Island Hospital||2|||f||||t||||||||Undecided||2017-10-11 01:34:15.166576|2017-10-11 01:34:15.166576
NCT01881399|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-08-31|||November 2013||2013-11-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|FLARIOC||Fluorescence Versus Intraoperative Cholangiography in the Visualization of Biliary Tree Anatomy|Fluorescence Cholangiography Versus Conventional Intraoperative Cholangiography for Visualization of Biliary Tract Anatomy : a Prospective, Controlled Study|Completed||N/A|66|Actual|IHU Strasbourg||1|||f||||f||||||||||2017-10-11 01:34:15.292787|2017-10-11 01:34:15.292787
NCT01881386|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-09-14|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2017|Actual|2017-09-01||Observational|||Lactate Imaging as a Tumour Biomarker|Investigation of Lactate Measured Using Magnetic Resonance Spectroscopy as a Biomarker of Tumour Response|Active, not recruiting||N/A|37|Actual|Institute of Cancer Research, United Kingdom|||4||f||||f||||||||||2017-10-11 01:34:15.377698|2017-10-11 01:34:15.377698
NCT01881373|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-18|||April 2011||2011-04-01|June 2013|2013-06-01|March 2016|Anticipated|2016-03-01|January 2015|Anticipated|2015-01-01||Interventional|CHL||Children's Healthy Living Program|Children's Healthy Living Program for Remote Underserved Minority Populations in the Pacific Region|Unknown status|Recruiting|Phase 4|5000|Anticipated|University of Hawaii||2|||f||||f||||||||||2017-10-11 01:34:15.484577|2017-10-11 01:34:15.484577
NCT01881360|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-12-01|||January 2013||2013-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy of a Gluten-free Diet for the Treatment of Fibromyalgia|Comparison Between a Gluten-free Diet and a Hypocaloric Diet for the Treatment of Patients With Fibromyalgia and Celiac-type Symptoms|Completed||N/A|81|Actual|Universidad de Granada||2|||f||||f||||||||||2017-10-11 01:34:15.586858|2017-10-11 01:34:15.586858
NCT01881347|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-03-08|||January 1, 2013|Actual|2013-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|March 1, 2015|Actual|2015-03-01||Interventional|||Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus|Randomized Crossover Study of The Effects of Resveratrol on Endothelial Function in Subjects With Type 2 Diabetes Mellitus|Active, not recruiting||N/A|54|Actual|Boston University||2|||f||||f|f|f||||||No||2017-10-11 01:34:15.691106|2017-10-11 01:34:15.691106
NCT01881334|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-06-27||||||June 2017|2017-06-01||||||||Expanded Access|||Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants|A Compassionate Release Protocol: Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Allogeneic Transplantation Using a Related Haplo-Identical Donor and Unrelated, Umbilical Cord Blood Donor(s) for the Treatment of High Risk Malignancies or Non-Malignant Disorders Requiring Allogeneic Transplantation|Available||N/A|||Duke University|||||||||||||||||||2017-10-11 01:34:15.811953|2017-10-11 01:34:15.811953
NCT01881321|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-07-29|||June 2013||2013-06-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|MI RCT||Use of Motivational Interviewing to Increase Contraception Use Among Young Women|Use of Motivational Interviewing to Increase Contraception Use Among Young Women: a Randomized Control Trial|Completed||N/A|60|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 01:34:15.915852|2017-10-11 01:34:15.915852
NCT01881308|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-01-24|||June 2013||2013-06-01|January 2017|2017-01-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|ARCTIC REWIND||Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis|REmission in Rheumatoid Arthritis - Assessing WIthrawal of Disease-modifying Antirheumatic Drugs in a Non-inferiority Design|Recruiting||Phase 4|360|Anticipated|Diakonhjemmet Hospital||5|||f||||f||||||||Undecided||2017-10-11 01:34:16.024174|2017-10-11 01:34:16.024174
NCT01881295|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-17|||March 2013||2013-03-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|Potato||Bioavailability of Potassium From Potatoes and Potassium Gluconate|Bioavailability of Potassium From Potatoes and Potassium Gluconate|Unknown status|Recruiting|N/A|35|Anticipated|Purdue University||9|||f||||f||||||||||2017-10-11 01:34:16.22108|2017-10-11 01:34:16.22108
NCT01881282|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2014-02-27|||December 2006||2006-12-01|February 2014|2014-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Comparative Efficacy and Safety Study of Compound Carraghenates Cream With Mayinglong Musk Hemorrhoid Ointment in the Treatment of Hemorrhoids|A Comparative Clinical Research on Therapeutic Effect and Safety of Compound Carraghenates Cream Versus Mayinglong Musk Hemorrhoid Ointment in the Treatment of Hemorrhoids|Completed||Phase 4|123|Actual|Xian-Janssen Pharmaceutical Ltd.||2|||f||||t||||||||||2017-10-11 01:34:16.354983|2017-10-11 01:34:16.354983
NCT01881269|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-11-04|||June 2013||2013-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Observational|||Respiration Rate Monitoring During Transitions|Assessment of Respiration Rate Monitoring During Transitions From Spontaneous to Controlled Ventilation|Completed||N/A|27|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 01:34:16.460835|2017-10-11 01:34:16.460835
NCT01881256|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-18|||March 2010||2010-03-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|BabyGrow||The BabyGrow Longitudinal Study of Nutrition and Growth in Preterm Infants|The BabyGrow Longitudinal Study of Nutrition and Growth in Preterm Infants|Completed||N/A|70|Actual|University College Cork|||1||f||||f||||||||||2017-10-11 01:34:16.535058|2017-10-11 01:34:16.535058
NCT01881243|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-12-11|||June 2013||2013-06-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|REOX||Reoxygenation After Cardiac Arrest (REOX Study)|Reoxygenation After Cardiac Arrest (REOX Study)|Recruiting||N/A|280|Anticipated|The Cooper Health System|||1||f||||f||||||Samples Without DNA|"     This research will measure biomarkers of oxidative stress (isoprostanes and isofurans) on     plasma samples.   "|||2017-10-11 01:34:16.622293|2017-10-11 01:34:16.622293
NCT01881230|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-06-05|||September 26, 2013|Actual|2013-09-26|June 2017|2017-06-01|October 28, 2016|Actual|2016-10-28|October 28, 2016|Actual|2016-10-28||Interventional|tnAcity||Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)|A Phase 2/3, Multi-Center, Open-Label, Randomized Study of Weekly Nab®-Paclitaxel in Combination With Gemcitabine or Carboplatin, Compared to Gemcitabine/Carboplatin, as First Line Treatment in Subjects With ER, PgR, and HER2 Negative (Triple Negative) Metastatic Breast Cancer|Completed||Phase 2/Phase 3|191|Actual|Celgene||5|||f||||t||||||||||2017-10-11 01:34:16.777256|2017-10-11 01:34:16.777256
NCT01881217|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-09-13|||June 28, 2013|Actual|2013-06-28|September 2017|2017-09-01|August 16, 2016|Actual|2016-08-16|March 18, 2016|Actual|2016-03-18||Interventional|||First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced, Refractory Solid Tumors|An Open-label, Phase I, Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous BAY 1179470 in Subjects With Advanced, Refractory Solid Tumors.|Completed||Phase 1|35|Actual|Bayer||3|||f||||f||||||||||2017-10-11 01:34:17.318591|2017-10-11 01:34:17.318591
NCT01881204|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-17|||April 2011||2011-04-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|Hesperidin||Hesperidin and Bone Health in Postmenopausal Women|Hesperidin and Bone Health in Postmenopausal Women|Completed||N/A|12|Actual|Purdue University||3|||f||||f||||||||||2017-10-11 01:34:17.430131|2017-10-11 01:34:17.430131
NCT01881191|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-02-11|||June 2013||2013-06-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|GZA||Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months|Effect of Teriflunomide (Aubagio®) on Gray Matter Pathology in Multiple Sclerosis: The 12 Months, Prospective, Observational, Single-blinded, Longitudinal Study|Completed||N/A|50|Actual|University at Buffalo|||2||f||||f||||||Samples With DNA|"     Serum to be retained.   "|||2017-10-11 01:34:17.536147|2017-10-11 01:34:17.536147
NCT01881178|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-12-29|||May 2013||2013-05-01|June 2013|2013-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|NOPALEA||The Effect of a Nutritional Supplement Product Containing Cactus Fruit Juice (Nopalea) on C-Reactive Protein|The Effect of a Nutritional Supplement Product Containing Cactus Fruit Juice (Nopalea) on C-Reactive Protein (NOPALEA)|Completed||N/A|287|Actual|University of Bridgeport||2|||f||||f||||||||||2017-10-11 01:34:17.624886|2017-10-11 01:34:17.624886
NCT01881165|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-12-12|||September 2014||2014-09-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Cranberry on Urinary Tract Infections|A Randomized, Double-blind, Placebo Controlled Trial Evaluating the Effectiveness of a Cranberry Concentrate in Preventing Recurrent Urinary Tract Infections in Adult Women|Withdrawn||Phase 4|0|Actual|University of British Columbia||2||Sponsor declined funding|f||||f||||||||||2017-10-11 01:34:17.71751|2017-10-11 01:34:17.71751
NCT01881152|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-01-13|||June 2013||2013-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effectiveness of a Public Campaign to Increase Stroke Awareness in Reducing Prehospital Delay|Cluster Randomized Controlled Trial to Assess the Effectiveness of a Population-based Educational Campaign on Stroke Symptom Recognition in Reducing Pre-hospital Delay|Completed||N/A|1772|Actual|Azienda Ospedaliero-Universitaria di Parma||2|||f||||f||||||||||2017-10-11 01:34:17.834899|2017-10-11 01:34:17.834899
NCT01881139|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-06-17|||December 2012||2012-12-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Impact of Exercise Training on Cardiac Function in Man|Effects of Exercise Training on Cardiac Function and Lipid Metabolism in Mem 18-22 Year Old|Completed||Early Phase 1|46|Actual|No. 150 Central Hospital of the Chinese People Liberation Army||1|||f||||t||||||||||2017-10-11 01:34:17.95456|2017-10-11 01:34:17.95456
NCT01881126|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-10-27|2015-10-27||June 2013||2013-06-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension||Completed||Phase 4|93|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:34:18.078213|2017-10-11 01:34:18.078213
NCT01881100|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2013-06-16|||January 2011||2011-01-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|infiltration||Randomized Trial on Resin Infiltration in Deciduous Teeth|Randomized Clinical Trial on Resin Infiltration Versus Fluoride Varnish Treatment of Early Smooth-surface Caries Lesions in Deciduous Teeth|Completed||N/A|81|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 01:34:18.494252|2017-10-11 01:34:18.494252
NCT01881087|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2017-04-19|2017-04-19||June 2006||2006-06-01|April 2017|2017-04-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|levobupi||Spinal Anesthesia With Hyperbaric Levobupivacaine 0.75% for Ambulatory Knee Arthroscopy|Spinal Anesthesia With Hyperbaric Levobupivacaine 0.75% for Ambulatory Knee Arthroscopy: A Double Blind, Randomized Clinical Trial Comparing Three Low Doses|Completed||Phase 4|180|Actual|Fundacion Clinica Valle del Lili||3|||f||||t|f|f|||f|||Yes|IPD is available if DB is formally requested to the Clinical Research Center of the Fundación Valle del Lili (Info: +57 3319090 Ext 4124. http://www.institutodeinvestigaciones.org/)|2017-10-11 01:34:18.615996|2017-10-11 01:34:18.615996
NCT01881074|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-10-12|||June 2012||2012-06-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Periodontal Treatment Response in Type II Diabetic Patients|The Influence of Periodontal Treatment on Gingival Inflammatory Response of the Type II Diabetic Patient|Completed||Phase 4|74|Actual|University of Florida|||2||f||||f||||||Samples With DNA|"     blood, gingival crevicular fluid, and saliva   "|||2017-10-11 01:34:19.062382|2017-10-11 01:34:19.062382
NCT01881061|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-18|||September 2009||2009-09-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit||Completed||N/A|10|Actual|University of Athens|||1||f||||f||||||||||2017-10-11 01:34:19.161959|2017-10-11 01:34:19.161959
NCT01881048|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-08-18|||December 8, 2009|Actual|2009-12-08|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 14, 2014|Actual|2014-01-14||Interventional|||Window of Opportunity Study Targeting the Inflammatory Milieu|Window of Opportunity Study Targeting the Inflammatory Milieu of Pregnancy Associated Breast Cancer|Active, not recruiting||Early Phase 1|42|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-10-11 01:34:19.231021|2017-10-11 01:34:19.231021
NCT01881035|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-09-22|||May 2013||2013-05-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TreatDialRDN||Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy|Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy|Terminated||N/A|6|Anticipated|Turku University Hospital||1||Recruiting of the whole study population not possible.|f||||f||||||||||2017-10-11 01:34:19.32453|2017-10-11 01:34:19.32453
NCT01881022|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2015-06-16|||August 2013||2013-08-01|June 2015|2015-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|IPSIC||An Internet-based Psychosexual Intervention for Couples Following Treatment for Breast Cancer|An Evaluation of an Internet-based, Psychosexual Intervention for Couples Following Treatment for Breast Cancer: A Phase I Trial|Unknown status|Recruiting|N/A|50|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 01:34:19.407553|2017-10-11 01:34:19.407553
NCT01880996|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-06-10|||August 2014||2014-08-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies|The Effect of Tai-chi/Qi-gong on Quality of Life (QOL), Sleep, and Fatigue in Patients With Gynecological Malignancies|Withdrawn||Phase 1/Phase 2|0|Actual|Sheba Medical Center||2||The deparment failed to detect patients that were willing to participate in this study|f||||f||||||||||2017-10-11 01:34:19.619511|2017-10-11 01:34:19.619511
NCT01880983|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2017-03-17|||November 2011||2011-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))|7202 Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC)|Active, not recruiting||N/A|150|Anticipated|University of Alabama at Birmingham|||1||f||||||||||Samples With DNA|"     whole blood for lymphoblast transformation   "|||2017-10-11 01:34:19.75478|2017-10-11 01:34:19.75478
NCT01880970|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-10-20|||October 2008||2008-10-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Starter Formula on Infection Prevention|Effect of Starter Formula With Synbiotics on Prevention of Gastro-intestinal Infections and All Infections With Fever in Full Term Infants|Completed||N/A|477|Actual|Nestlé||3|||f||||f||||||||||2017-10-11 01:34:19.838738|2017-10-11 01:34:19.838738
NCT01880957|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2016-07-16|||August 2012||2012-08-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||PET and MRI Brain Imaging of Bipolar Disorder|Pathophysiology and Treatment of Bipolar Disorder as Assessed by in Vivo Imaging|Recruiting||N/A|76|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-10-11 01:34:19.952512|2017-10-11 01:34:19.952512
NCT01880944|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-07-01|||June 2013||2013-06-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01|2 Months|Observational [Patient Registry]|||Evaluation of Usefulness of Contrast Enhanced MRI in Evaluation of Spine Trauma: Prospective Study|Evaluation of Usefulness of Contrast Enhanced MRI in Evaluation of Spine Trauma: Prospective Study|Unknown status|Recruiting|N/A|300|Anticipated|Seoul National University Bundang Hospital|||2||f||||f||||||||||2017-10-11 01:34:20.086561|2017-10-11 01:34:20.086561
NCT01880931|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2015-04-08|||June 2013||2013-06-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients||Completed||N/A|44|Actual|Severance Hospital||2|||f||||f||||||||||2017-10-11 01:34:20.227035|2017-10-11 01:34:20.227035
NCT01880918|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-16|2013-06-16|||October 2012||2012-10-01|June 2013|2013-06-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Observational|||A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing|Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417|Unknown status|Recruiting|N/A|200|Anticipated|novoGI|||1||f||||f||||||||||2017-10-11 01:34:20.336956|2017-10-11 01:34:20.336956
NCT01880905|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-18|||July 2013||2013-07-01|April 2013|2013-04-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||The Length of Uteroovarian Ligament and the Risk of Ovarian Torsion||Unknown status|Not yet recruiting|N/A|100|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 01:34:20.453727|2017-10-11 01:34:20.453727
NCT01880892|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-08-07|||June 2013||2013-06-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy|Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy|Recruiting||N/A|30|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:34:20.566503|2017-10-11 01:34:20.566503
NCT01880879|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-20|||January 2013||2013-01-01|January 2013|2013-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|Pro-HOPE||A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment|A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer Sirolimus-eluting Stent Safety and Effectiveness in Treatment of Coronary Artery Disease|Unknown status|Recruiting|Phase 4|800|Anticipated|Kinhely Bio-tech Co.,Ltd.||1|||f||||t||||||||||2017-10-11 01:34:20.653514|2017-10-11 01:34:20.653514
NCT01880866|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-09-09|||July 2013||2013-07-01|September 2014|2014-09-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||(-)-Epicatechin and Pulmonary Arterial Hypertension|An Open Label Pilot Study of Purified (-)-Epicatechin to Improve Hemodynamics in Pulmonary Arterial Hypertension|Withdrawn||Phase 1|0|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 01:34:20.731393|2017-10-11 01:34:20.731393
NCT01880853|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-09-07|||November 2008||2008-11-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Ultrasound and Mammography for Screening Breast Cancer in Chinese Women||Completed||N/A|47709|Actual|Peking Union Medical College Hospital||3|||f||||t||||||||||2017-10-11 01:34:20.809206|2017-10-11 01:34:20.809206
NCT01880840|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2015-06-09|2015-06-09||June 2013||2013-06-01|April 2014|2014-04-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR|Randomized Trial of the Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With Allergic Rhinitis|Completed||Phase 4|191|Actual|Meda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:34:20.911698|2017-10-11 01:34:20.911698
NCT01880827|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-05-11|||January 2013||2013-01-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|GIP-PET||Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery|The Effects of Glucose-dependent Insulinotrophic Peptide (GIP) and Glucagon-like Peptide 1 (GLP-1) on Splanchnic Redistribution of Blood Flow at Postprandial State and After Roux-en-Y Gastric Bypass and Sleeve|Unknown status|Recruiting|Phase 1|50|Anticipated|Turku University Hospital||3|||f||||t||||||||||2017-10-11 01:34:21.201688|2017-10-11 01:34:21.201688
NCT01880814|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-03-23|||June 2013||2013-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Using SMART Experimental Design to Personalize Treatment for Child Depression|Using SMART Experimental Design to Personalize Treatment for Child Depression|Recruiting||N/A|48|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:34:21.463492|2017-10-11 01:34:21.463492
NCT01880801|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2013-06-18|||August 2013||2013-08-01|February 2012|2012-02-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Immunoglobulins Anti Platelets In Breast Milk Of Maternal ITP|IMMUNOGLOBULINS ANTI PLATELETS IN BREAST MILK OF MATERNAL ITP|Unknown status|Not yet recruiting|N/A|22|Anticipated|Laniado Hospital|||1||f||||t||||||||||2017-10-11 01:34:21.581326|2017-10-11 01:34:21.581326
NCT01880242|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-09-19|||May 13, 2014|Actual|2014-05-13|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||BIOFLOW-III Canada Satellite Registry|Safety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Canada|Completed||N/A|250|Actual|Biotronik Canada Inc|||1||f||||f||||||||||2017-10-11 01:34:31.861889|2017-10-11 01:34:31.861889
NCT01880788|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-09-17|||November 2012||2012-11-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Observational|||Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD|Evaluation of Genetic Variants in Patients With Type 1 Neovascularization (Sub-retinal Pigment Epithelium Neovascularization) Who Lack Typical Findings of Age Related Macular Degeneration (AMD) But Present With Findings More Consistent With Long-standing Central Serous Chorioretinopathy (CSC).|Completed||N/A|152|Actual|Sequenom, Inc.|||3||f||||f||||||Samples With DNA|"     Buccal cells   "|||2017-10-11 01:34:21.658682|2017-10-11 01:34:21.658682
NCT01880775|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-06-02|||April 2012||2012-04-01|March 2012|2012-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Discharge Conditions of Spinal Anesthesia With Heavy Prilocaine-Fentanyl and Heavy Bupivacaine-Fentanyl|The Comparison of the Discharge Conditions and Efficacy of Spinal Anesthesia With Heavy Prilocaine-Fentanyl and Heavy Bupivacaine-Fentanyl in Outpatient Minor Perianal Surgery|Completed||Phase 4|50|Actual|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-11 01:34:21.758507|2017-10-11 01:34:21.758507
NCT01880762|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-12-01|||January 2013||2013-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Observational|||Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions|Research Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions|Completed||N/A|44|Actual|New York University School of Medicine|||1||f||||f||||||||||2017-10-11 01:34:21.892477|2017-10-11 01:34:21.892477
NCT01880749|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-07-20|||June 2013||2013-06-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas|Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas|Active, not recruiting||Early Phase 1|5|Actual|New York University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-11 01:34:21.987566|2017-10-11 01:34:21.987566
NCT01880736|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-12-19|2015-10-16||June 2013||2013-06-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||"The full analysis set (FAS) included all randomised subjects. The statistical evaluation of the FAS followed the intention-to-treat (ITT) principle and subjects contributed to the evaluation “as randomised."|A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes|A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes|Completed||Phase 3|458|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 01:34:22.123009|2017-10-11 01:34:22.123009
NCT01880723|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2014-05-21|2014-05-21||May 2009||2009-05-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Interventional|||Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis|Modifying Genes in Cystic Fibrosis: The Beta-2 Adrenergic Receptors and Epithelial Na+ Channels|Completed||N/A|32|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 01:34:23.160286|2017-10-11 01:34:23.160286
NCT01880710|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-09-24|||August 2012||2012-08-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||Total Versus Subtotal Abdominal Hysterectomy|Randomized Clinical Trial of Total Versus Subtotal Abdominal Hysterectomy|Completed||N/A|319|Actual|Nykøbing Falster County Hospital||2|||f||||f||||||||||2017-10-11 01:34:23.563001|2017-10-11 01:34:23.563001
NCT01880697|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-02-21|2013-11-07||August 2013||2013-08-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above|A Phase III, Open-Label, Single-Arm, Multicenter Study to Evaluate the Safety and Immunogenicity of a Trivalent, Surface Antigen Inactivated Subunit Influenza Virus Vaccine Produced in Mammalian Cell Culture (Optaflu®) in Healthy Adults|Completed||Phase 3|126|Actual|Novartis||1|||f||||f||||||||||2017-10-11 01:34:23.675287|2017-10-11 01:34:23.675287
NCT01880684|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2014-04-03|||March 2013||2013-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational|||Validation of Capnography as a Predictor of Cardiac Output Change as Measured by FloTrac|Validation of Capnography as a Predictor of Cardiac Output Change as Measured by FloTrac|Completed||Phase 2|50|Actual|Montreal Heart Institute|||1||f||||f||||||||||2017-10-11 01:34:24.230492|2017-10-11 01:34:24.230492
NCT01880671|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-17|2014-03-31|||May 2013||2013-05-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Interventional|||Evaluation of a New Treatment for Migraine Attacks|Undersökning av ny Behandlingsmetod Vid migränanfall|Completed||N/A|36|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 01:34:24.336047|2017-10-11 01:34:24.336047
NCT01880658|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-02-08|||June 2013||2013-06-01|July 2013|2013-07-01|May 2019|Anticipated|2019-05-01|May 2016|Anticipated|2016-05-01||Interventional|CAMCO||Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer|Phase II Clinical Trial: Capecitabine Maintenance Therapy in Colorectal Cancer Patients With Stage IIIC and R0-R1 Resected Stage IV|Recruiting||Phase 2|100|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 01:34:24.405833|2017-10-11 01:34:24.405833
NCT01880645|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2015-11-17|||March 2012||2012-03-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Selective Image Guided Resection of Axillary Lymph Nodes|Feasibility of Selective Image Guided Resection of Cytologically Documented Axillary Lymph Node Metastases|Completed||N/A|17|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:34:24.490121|2017-10-11 01:34:24.490121
NCT01880632|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-08|2015-12-17|||July 2013||2013-07-01|December 2015|2015-12-01|August 2018|Anticipated|2018-08-01|May 2016|Anticipated|2016-05-01||Interventional|Neo-Classic||Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma|A Multicenter, Single Arm, Open-label Trial of Oxaliplatin Plus Capecitabine (XELOX) in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma|Recruiting||Phase 2|55|Anticipated|Shanghai Zhongshan Hospital||1|||f||||t||||||||||2017-10-11 01:34:24.580112|2017-10-11 01:34:24.580112
NCT01880619|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-11-23|||January 2013||2013-01-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms|A Randomized Clinical Trial Comparing Alpha Blacker (Tamsulosin) and Anticholinergic (Solifenacin) in Treatment of Ureteral Stent Related Symptoms|Completed||Phase 4|131|Actual|Mansoura University||3|||f||||t||||||||||2017-10-11 01:34:24.680478|2017-10-11 01:34:24.680478
NCT01879644|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-11-14|||January 2011||2011-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Neurofeedback Study ADHD||Recruiting||Phase 2|120|Anticipated|Philipps University Marburg Medical Center||4|||f||||f||||||||||2017-10-11 01:34:41.224825|2017-10-11 01:34:41.224825
NCT01880606|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2015-04-24|||August 2011||2011-08-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01|1 Year|Observational [Patient Registry]|pCLE-PSC-IBD||Endomicroscopy in Primary Sclerosing Cholangitis Related Inflammatory Bowel Disease Surveillance|Probe-based Confocal Laser Endomicroscopy in Colonoscopic Surveillance of Patients With Primary Slerosing Cholangitis Related Inflammatory Bowel Disease (PSC-IBD)|Completed||N/A|69|Actual|Karolinska University Hospital|||1||f||||f||||||Samples With DNA|"     whole blood, serum, tissue   "|||2017-10-11 01:34:24.806535|2017-10-11 01:34:24.806535
NCT01880593|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-11-29|||July 2013||2013-07-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Ketamine Plus Lithium in Treatment-Resistant Depression|Ketamine Plus Lithium as a Novel Pharmacotherapeutic Strategy in Treatment-Resistant Depression|Completed||Phase 2|46|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 01:34:24.914566|2017-10-11 01:34:24.914566
NCT01880580|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2013-06-18|||July 2006||2006-07-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Cone Beam CT for Breast Imaging|Cone Beam CT for Breast Imaging: A Pilot Study|Completed||N/A|76|Actual|Koning Corporation|||2||f||||t||||||||||2017-10-11 01:34:25.050965|2017-10-11 01:34:25.050965
NCT01880567|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-09-11|||July 2013|Actual|2013-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Phase 2 Ibrutinib + Rituximab in Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)|A Phase II Study of Ibrutinib Plus Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma or Elderly Patients With Newly Diagnosed Mantle Cell Lymphoma (MCL)|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 01:34:25.117272|2017-10-11 01:34:25.117272
NCT01880554|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-09-28|||June 2011||2011-06-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|September 2016|Actual|2016-09-01||Interventional|ULIIS||Ultrasound Liver Intraoperative Imaging With SonoVue®|Clinical Utility of Contrast-enhanced Intraoperative Ultrasound in Surgery of Colorectal Liver Metastases. Phase II Clinical Trial.|Completed||Phase 2|57|Actual|Institut Bergonié||1|||f||||t||||||||||2017-10-11 01:34:25.212196|2017-10-11 01:34:25.212196
NCT01880541|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-09-29|||December 2010||2010-12-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|HYPNOSEIN||Assessment of Cognitive Function After Surgery in Two Types of Anesthesia in Patients Operated for Breast Cancer|Assessment of Cognitive Function After Surgery in Two Types of Anesthesia (General Anesthesia Hypnosedation or Traditional) in Patients Operated for Breast Cancer|Recruiting||N/A|50|Anticipated|Institut Bergonié||2|||f||||t||||||||||2017-10-11 01:34:25.301346|2017-10-11 01:34:25.301346
NCT01880528|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2017-03-21|||May 2013|Actual|2013-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer|A Double-Blind Pilot Study to Measure the Effect of Lisinopril vs. Placebo on Pulmonary Distress in Patients Receiving External Beam Radiotherapy to the Lung|Active, not recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 01:34:25.401226|2017-10-11 01:34:25.401226
NCT01880515|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-03-01|2015-06-17||December 2010||2010-12-01|March 2017|2017-03-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional||A total of 107 patients were enrolled. Due to progression and lost to follow-up, only 90 patients were evaluated for dermatological toxicities. Forty five patients were assigned to receive reactive treatment; the other 45 received pre-emptive tetracycline.|Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)|Phase II, Open-label, Single Blind, Randomised Clinical Trial With Tetracycline as a Prophylaxis for Rash and Dermatological Recommendations Versus Dermatological Recommendations in Patients With NSCLC Receiving Treatment With BIBW 2992|Completed||Phase 2|107|Actual|Instituto Nacional de Cancerologia de Mexico||2|||f||||t||||||||||2017-10-11 01:34:25.494134|2017-10-11 01:34:25.494134
NCT01880502|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-10-11|||June 2013||2013-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Pharmacokinetic Study of Belviq in Adult Korean Volunteers|A Randomized, Double-blind, Placebo-controlled, Single-dose, Dose Escalation Study (Phase I) to Evaluate the Tolerability and Pharmacokinetics of Belviq in Adult Korean Volunteers|Completed||Phase 1|25|Actual|IlDong Pharmaceutical Co Ltd||3|||f||||f||||||||||2017-10-11 01:34:25.790847|2017-10-11 01:34:25.790847
NCT01880489|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-10-07|||June 2013||2013-06-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Multicomponent Intervention to Reduce Sexual Risk and Substance Use|Multicomponent Intervention to Reduce Sexual Risk and Substance Use|Active, not recruiting||N/A|240|Anticipated|Hunter College of City University of New York||2|||f||||t||||||||||2017-10-11 01:34:25.871508|2017-10-11 01:34:25.871508
NCT01880476|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-07-06|||June 2013||2013-06-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Interprofessional Community-Based Diabetes Intervention for Older Adults|Feasibility, Acceptability and Effects of an Interprofessional Community-Based Health Promotion Intervention on Self-Management in Older Adults With Type 2 Diabetes and Comorbid Chronic Conditions: A Pilot Study|Completed||N/A|45|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 01:34:25.97511|2017-10-11 01:34:25.97511
NCT01880463|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-15|2016-01-17|||July 2010||2010-07-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)|Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)|Active, not recruiting||N/A|25875|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 01:34:26.069266|2017-10-11 01:34:26.069266
NCT01880450|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-01-12|||May 2009||2009-05-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|Prepared||Project Prepared: Risks, Roles and Relationships|Longitudinal Intervention Study to Prepare Early Adolescents for Middle Adolescence, Specifically Focusing on Improving Sexual Health Outcomes|Completed||N/A|397|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 01:34:26.155728|2017-10-11 01:34:26.155728
NCT01880437|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-11-11|2015-11-11||September 2013||2013-09-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||Included all enrolled participants who received at least 1 dose of study drug.|A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myelodysplastic Syndrome|A PHASE IB/II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF VISMODEGIB IN RELAPSED/REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML) AND RELAPSED/REFRACTORY HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)|Terminated||Phase 2|38|Actual|Hoffmann-La Roche|This study was prematurely terminated because of lower-than-expected efficacy observed in interim data analyses.|1|||f||||||||||||||2017-10-11 01:34:26.357747|2017-10-11 01:34:26.357747
NCT01880424|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-08-04|2016-04-28||July 2013||2013-07-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|D5630C00001|Intent to Treat (ITT) Population (all 839 randomized patients)|A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|Completed||Phase 3|1722|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:34:27.977186|2017-10-11 01:34:27.977186
NCT01880411|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-06-14|||June 2013||2013-06-01|June 2013|2013-06-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine|Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity of a Three Dose Regimen of Escalating Doses of PEK Fusion Protein Vaccine (PEK + GPI-0100) in Patients With LSIL or HSIL|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|HealthBanks Biotech Co., Ltd.||1|||f||||||||||||||2017-10-11 01:34:28.627302|2017-10-11 01:34:28.627302
NCT01880398|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2013-12-23|||June 2011||2011-06-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Observational|Bhagandar||Management of Fistula in Ano by Kshar Sutra, Para Surgical Procedure.|Case Study of Fistula in Ano Managed by Kshar Sutra, Para Surgical Procedure|Completed||N/A|1|Actual|Government Ayurved College and Hospital|||1||f||||f||||||||||2017-10-11 01:34:28.689628|2017-10-11 01:34:28.689628
NCT01880385|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2013-06-14|||March 2011||2011-03-01|June 2013|2013-06-01|April 2017|Anticipated|2017-04-01|September 2013|Anticipated|2013-09-01||Interventional|Beva||Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer|Efficacy & Safety of Bevacizumab as Neoadjuvant Treatment in Patients With Locally Advanced Inflammatory Breast Cancer, a Pilot Study.|Unknown status|Recruiting|Phase 1|30|Anticipated|Association Tunisienne de lutte Contre le Cancer||1|||f||||t||||||||||2017-10-11 01:34:28.763808|2017-10-11 01:34:28.763808
NCT01880372|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-05-18|||September 2013||2013-09-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|ALA-TPD||The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy|Pilot Study: The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy|Suspended||Phase 1/Phase 2|200|Anticipated|Ferris State University||2||Low number of patients enrolled|f||||f||||||||||2017-10-11 01:34:28.866472|2017-10-11 01:34:28.866472
NCT01880359|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-06-12|||July 2014||2014-07-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|May 2019|Anticipated|2019-05-01||Interventional|||AF CRT +/- Nimorazole in HNSCC|A Blind Randomized Multicenter Study of Accelerated Fractionated Chemo-radiotherapy With or Without the Hypoxic Cell Radiosensitizer Nimorazole (Nimoral), Using a 15-gene Signature for Hypoxia in the Treatment of Squamous Cell Carcinoma of the Head and Neck.|Recruiting||Phase 3|640|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 01:34:28.952751|2017-10-11 01:34:28.952751
NCT01880346|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2015-11-19|||October 2013||2013-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of Absorption of Vitamin D in Cystic Fibrosis|Vehicles for the Absorption of Vitamin D in Cystic Fibrosis: Comparison of Powder vs Oil|Completed||Phase 4|17|Actual|Emory University||2|||f||||t||||||||||2017-10-11 01:34:29.113797|2017-10-11 01:34:29.113797
NCT01880333|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-07-09|||March 2013||2013-03-01|June 2013|2013-06-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Evaluation of the Modified Atkins Diet in Young Children With Refractory Epilepsy|Phase 2/3 Study of the Modified Atkins Diet in Young Children With Refractory Epilepsy|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|Lady Hardinge Medical College||1|||f||||t||||||||||2017-10-11 01:34:29.202469|2017-10-11 01:34:29.202469
NCT01880320|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-07-25|2016-03-07||July 2013||2013-07-01|July 2016|2016-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris|A Multi-center, Randomized, Double-blind, Parallel-group Vehicle and Active Controlled Study to Compare the Efficacy and Safety of CD0271 0.3% / CD1579 2.5% Topical Gel Versus Topical Gel Vehicle in Subjects With Acne Vulgaris|Completed||Phase 3|503|Actual|Galderma R&D||3|||f||||f||||||||||2017-10-11 01:34:29.293387|2017-10-11 01:34:29.293387
NCT01880307|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-07-01|||January 2013||2013-01-01|July 2015|2015-07-01||||December 2014|Actual|2014-12-01||Interventional|ITSKids||Infliximab Top-down in Pediatric Crohn|Infliximab Top-down Study in Kids With Crohn's Disease|Terminated||Phase 4|13|Actual|Erasmus Medical Center||2||Not enough study subjects|f||||f||||||||||2017-10-11 01:34:29.800854|2017-10-11 01:34:29.800854
NCT01880294|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2015-02-06|||March 2013||2013-03-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|CONSIST||A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia|CONSIST- Constipation Symptoms Observational Study: A Multicenter, Cross-Sectional Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia|Completed||Phase 4|461|Actual|Johnson & Johnson Pte Ltd|||1||f||||f||||||||||2017-10-11 01:34:29.903832|2017-10-11 01:34:29.903832
NCT01880281|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-01-28|||June 2013||2013-06-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|March 2014|Actual|2014-03-01||Interventional|||Effect of the Diet on Urinary Excretion of Alpha-ketoglutarate|Effect of a Meat Versus Vegetarian Diet in 12 Healthy Volunteers on the Excretion of Alpha-ketoglutarate Measured in 24-hours Urine|Completed||N/A|32|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 01:34:31.608947|2017-10-11 01:34:31.608947
NCT01880268|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-01-20|||July 2013||2013-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Wireless Brain-computer-interface-controlled Neurorehabilitation System for Patients With Stroke|Evaluating the Effectiveness of Wireless Electroencephalogram-based Brain-computer-interface-controlled Neurorehabilitation System in Patients With Stroke|Recruiting||N/A|20|Anticipated|China Medical University Hospital||2|||f||||f||||||||||2017-10-11 01:34:31.687318|2017-10-11 01:34:31.687318
NCT01880255|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-07-24|||June 2013||2013-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||rTMS for Working Memory Deficits in Schizophrenia|Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Working Memory Deficits in Schizophrenia and Effects on Brain Structure|Recruiting||N/A|100|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 01:34:31.774342|2017-10-11 01:34:31.774342
NCT01880229|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-01-30|||August 2012||2012-08-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01|12 Months|Observational [Patient Registry]|||Physical Activity Monitoring in Frailty and Falling|Phase II and Phase IIB STTR: Portable Device for Telecare Monitoring of Elderly People|Recruiting||N/A|180|Anticipated|BioSensics|||3||f||||f||||||||||2017-10-11 01:34:31.949356|2017-10-11 01:34:31.949356
NCT01880216|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-02-03|||June 2013||2013-06-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT|A Multinational, Multicentre, Randomized, Open, Parallel Group Study on the Efficacy and Safety of Bemiparin Sodium (LMWH) Compared to Enoxaparin Sodium (LMWH) in the Treatment of Acute Deep Vein Thrombosis (DVT)|Completed||Phase 3|312|Actual|Berlin-Chemie AG Menarini Group||2|||f||||f||||||||Undecided||2017-10-11 01:34:32.033146|2017-10-11 01:34:32.033146
NCT01880203|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-10-20|||May 2013||2013-05-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|SWEETMAC||Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study|Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study|Completed||N/A|140|Actual|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-11 01:34:32.161892|2017-10-11 01:34:32.161892
NCT01880190|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-07-12|||December 2008||2008-12-01|July 2013|2013-07-01||||April 2010|Actual|2010-04-01||Interventional|||A Comparative Study of Volume Replacement With HES 130/0.4 Versus Ringer's Lactate (RL) Regarding Their Effects on Inflammatory Biomarkers (Cytokines and Matrix Metalloproteinases) Responses to Major Abdominal Surgery.|Volume Replacement With HES 130/0.4 Attenuates Inflammatory Response to Major Abdominal Surgery Compared to Ringer's Lactate (RL); the Effect on Cytokines and Matrix Metalloproteinases|Completed||N/A|47|Actual|Attikon Hospital||2|||f||||||||||||||2017-10-11 01:34:32.349339|2017-10-11 01:34:32.349339
NCT01880177|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-05-10|||February 2013||2013-02-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Developing a COPD Case Finding Methodology for Primary Care|A Study Designed to Develop and Validate a New Screening Measure for Identifying Undiagnosed At-Risk COPD Cases|Completed||N/A|346|Actual|University of Michigan|||3||f||||t||||||||||2017-10-11 01:34:32.424932|2017-10-11 01:34:32.424932
NCT01880164|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2017-04-04|||June 2015||2015-06-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|January 2017|Actual|2017-01-01||Observational|HEO||Cost Effectiveness of Nonoperative Management for Adult Spinal Deformity|Cost Effectiveness of Nonoperative Management for Adult Spinal Deformity Associated With Low Grade Scoliosis: A Prospective Pilot Study to Evaluate Disease Burden and Longitudinal Study Feasibility|Completed||N/A|21|Actual|International Spine Study Group Foundation|||1||f||||f||||||||No||2017-10-11 01:34:32.536335|2017-10-11 01:34:32.536335
NCT01880151|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-08-30|||June 2013||2013-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|ESTIMATE||Neuroelectrical Biomarkers for Alzheimer's Disease Stages|NEw approacheS for The dIagnosis of AlzeiMer's diseAse Through neuroElectrical Changes in the Brain|Recruiting||N/A|90|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||f||||||||||2017-10-11 01:34:32.65708|2017-10-11 01:34:32.65708
NCT01880138|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-13|||June 2013||2013-06-01|June 2013|2013-06-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Effect of Animated Cartoon for Prevention of Emergence Agitation in Children Aged 1.5 - 5 yr After General Anesthesia||Unknown status|Recruiting|N/A|100|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:34:32.748235|2017-10-11 01:34:32.748235
NCT01880125|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-06-17|||January 2012||2012-01-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination|Clinical Trial to Compare the Pharmacokinetics Profile of YJAT Sustained Release Tablet and ULTRACET® Immediate Release Tablet After Oral Administration to Healthy Male Subjects|Completed||Phase 1|24|Actual|Yungjin Pharm. Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:34:32.840267|2017-10-11 01:34:32.840267
NCT01880112|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2013-06-17|||June 2011||2011-06-01|June 2013|2013-06-01|June 2013|Anticipated|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Serum and Tissue Cefazolin Concentrations in Normal Weight Patients Undergoing Cesarean Delivery.|Serum and Tissue Cefazolin Concentrations in Normal Weight Patients Undergoing Cesarean Delivery Receiving Two Differing Doses of Pre-operative Cefazolin.|Withdrawn||Phase 4|0|Actual|West Virginia University||2||There is no longer need for this study.|f||||f||||||||||2017-10-11 01:34:32.922059|2017-10-11 01:34:32.922059
NCT01880099|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-09-20|2017-05-17||December 2013||2013-12-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Help People Quit Smoking.|Cholinergic Enhancement as a Treatment for Nicotine Addiction|Completed||N/A|60|Actual|Yale University||3|||f||||t||||||||||2017-10-11 01:34:33.022024|2017-10-11 01:34:33.022024
NCT01880086|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-06-02|2017-01-25||August 2013||2013-08-01|June 2017|2017-06-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|||Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration|Clomiphene Citrate for the Treatment of Opioid-Induced Androgen Deficiency: Randomized Controlled Clinical Trial|Active, not recruiting||Phase 2|13|Actual|Weill Medical College of Cornell University||2|||f||||t|t|f||||||Undecided||2017-10-11 01:34:33.481236|2017-10-11 01:34:33.481236
NCT01880073|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-01-18|||May 2012|Actual|2012-05-01|January 2017|2017-01-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||FemVue and Tubal Patency|Use of FemVue for Assessment of Tubal Patency as Compared to Laparoscopic Chromopertubation|Recruiting||N/A|50|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-10-11 01:34:33.905549|2017-10-11 01:34:33.905549
NCT01880060|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-07-13|||March 2008||2008-03-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Tailored Worksite Weight Control Programs|Tailored Worksite Weight Control Programs|Completed||N/A|1790|Actual|Virginia Polytechnic Institute and State University||2|||f||||f||||||||||2017-10-11 01:34:33.989591|2017-10-11 01:34:33.989591
NCT01880047|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-01-30|||February 2013|Actual|2013-02-01|January 2017|2017-01-01|March 30, 2019|Anticipated|2019-03-30|March 30, 2019|Anticipated|2019-03-30||Interventional|||Safety and Efficacy of Eltrombopag at Escalated Doses|Safety and Efficacy of Eltrombopag at Escalated Doses up to 150mg in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Not Responsive to 75 mg|Recruiting||Phase 2|36|Anticipated|Weill Medical College of Cornell University||2|||f||||t|t|f||||||Undecided||2017-10-11 01:34:34.074596|2017-10-11 01:34:34.074596
NCT01880034|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-05-11|||June 2013||2013-06-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments|Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments|Completed||N/A|18|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-10-11 01:34:34.173207|2017-10-11 01:34:34.173207
NCT01880021|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2016-09-21|||March 2008||2008-03-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Synthetic Mesh Explant Study|Characterization of Explanted Hernia Meshes From Human Subjects: A Prospective Study|Completed||N/A|111|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 01:34:34.238727|2017-10-11 01:34:34.238727
NCT01880008|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-30|2013-06-13|||April 2008||2008-04-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|February 2010|Actual|2010-02-01||Observational|||Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma|An Exploratory Study of Quantitative [18F]FLT-PET and Advanced MRI as Early Indicators of Treatment Response and Molecular Markers for Cell Proliferation in Patients With Glioblastoma Following Subtotal Resection|Completed||N/A|5|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 01:34:34.414812|2017-10-11 01:34:34.414812
NCT01879995|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-02-05|||June 2013||2013-06-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Phenylketonuria and Hyperphenylalaninemia Nutrition Study|Nutrition Status of Adult and Adolescent Patients With Classical Phenylketonuria (PKU) and Hyperphenylalaninemia|Completed||N/A|30|Actual|University of Zurich|||1||f||||||||||||||2017-10-11 01:34:34.499253|2017-10-11 01:34:34.499253
NCT01879982|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-06-13|||May 2013||2013-05-01|June 2013|2013-06-01||||December 2013|Anticipated|2013-12-01||Observational|PSYCHE||PSYCHE (Personalised Monitoring SYstems for Care in Mental Health)|A Personal Wearable and Interactive System for Monitoring and Multivariable Physiological Assessment to Predict Mood Changes: a Pilot Study With Cyclothymic and Rapid Cycling Bipolar Subjects|Unknown status|Recruiting|N/A|8|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 01:34:34.569016|2017-10-11 01:34:34.569016
NCT01879969|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-18|||December 2009||2009-12-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Computer Assisted Orthognathic Surgery. Facial Asymmetry||Completed||N/A|20|Actual|Università degli Studi di Sassari||2|||f||||f||||||||||2017-10-11 01:34:34.657939|2017-10-11 01:34:34.657939
NCT01879956|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-06-17|||February 2012||2012-02-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Interventional|OTSchizo||Occupational Therapy in the Rehabilitation of Executive Functions in Patients With Schizophrenia|Randomized Controlled Trial for the Evaluation of the Efficacy of Occupational Therapy in the Rehabilitation of Executive Functions in Patients With Refractory Schizophrenia|Unknown status|Recruiting|N/A|60|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:34:34.752705|2017-10-11 01:34:34.752705
NCT01879943|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-08-31|||October 2013||2013-10-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Capsule Versus Conventional Colonoscopy in Patient Following Colorectal Surgery|Capsule Versus Conventional Colonoscopy in Patient Following Colorectal Surgery|Active, not recruiting||N/A|100|Anticipated|IHU Strasbourg||1|||f||||f||||||||||2017-10-11 01:34:34.851096|2017-10-11 01:34:34.851096
NCT01879930|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-03-04|||November 2012||2012-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study|Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective, Randomised,Placebo-controlled, Double-blind Study|Terminated||Phase 4|5|Actual|University Hospital Inselspital, Berne||2||Recruitment problems|f||||t||||||||||2017-10-11 01:34:34.940558|2017-10-11 01:34:34.940558
NCT01879917|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2013-11-28|||October 2013||2013-10-01|November 2013|2013-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|NewLira||Liraglutide in Newly Onset Type 1 Diabetes.|A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Trial of Liraglutide Treatment in Subjects With Newly Diagnosed Type 1 Diabetes.|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 01:34:35.064118|2017-10-11 01:34:35.064118
NCT01879904|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-09-17|||February 2010||2010-02-01|June 2013|2013-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|DISSECMUC||Evaluation of Endoscopic Submucosal Dissection (ESD) Efficacy|Evaluation of Endoscopic Submucosal Dissection (ESD) Efficacy|Completed||N/A|48|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:34:35.175256|2017-10-11 01:34:35.175256
NCT01879891|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-10-24|||May 1995||1995-05-01|October 2016|2016-10-01||||August 2016|Actual|2016-08-01||Interventional|||Exercise Intensity, Metabolic Rate and Insulin Sensitivity||Completed||N/A|44|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-10-11 01:34:35.28147|2017-10-11 01:34:35.28147
NCT01879878|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-05-27|||December 2013||2013-12-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|POUDER||Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]|Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]|Unknown status|Recruiting|N/A|40|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-11 01:34:35.365991|2017-10-11 01:34:35.365991
NCT01879865|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-04-02|||June 2013||2013-06-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Dexmedetomidine PKPD Modeling and the Influence of Auditory Stimulation on Dexmedetomidine Effect|Development of a Pharmacokinetic/Pharmacodynamic Model of Dexmedetomidine, and the Effect of Repeated Auditory Stimulation on Pharmacodynamics of Dexmedetomidine.|Completed||N/A|18|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 01:34:35.500495|2017-10-11 01:34:35.500495
NCT01879852|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-09-17|2014-09-04||October 2008||2008-10-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||The target number of participants was determined statistically from preliminary data on primary outcome measures. The final population was based on feasibility.|Muscle Weakness and Post-traumatic Knee OA|Muscle Weakness and Post-traumatic Knee OA|Completed||N/A|29|Actual|University of Florida|Difficulty with subject recruitment due to concomitant injury with meniscal tear|2|||f||||f||||||||||2017-10-11 01:34:35.620149|2017-10-11 01:34:35.620149
NCT01879449|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-01-25|||February 2013||2013-02-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Prevalence of Spasticity in Veterans Living in a Long-term Care Facility|Prevalence of Spasticity in Veterans Living in a Long-term Care Facility|Completed||N/A|54|Actual|Vanderbilt University|||1||f||||f||||||||||2017-10-11 01:34:44.260321|2017-10-11 01:34:44.260321
NCT01879839|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-10-24|||July 2013||2013-07-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|September 2016|Actual|2016-09-01||Interventional|CR_KMN||Effect of a Pre-interventional Diet on Renal Function After Administration of Contrast Agent in Patients at Risk|Phase 4 Study of Effect of a Pre-interventional Calorie Restriction on Renal Function After Administration of Contrast Agent in Patients at Risk|Active, not recruiting||Phase 4|80|Actual|University of Cologne||2|||f||||t||||||||||2017-10-11 01:34:36.059279|2017-10-11 01:34:36.059279
NCT01879813|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-05-19|||October 2012||2012-10-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||The Effect of a Phospholipid Drink on Cognitive Performance Under Acute Stress|A Randomised, Double-blind, Parallel Groups, Placebo-controlled 6 Weeks Human Intervention Study Investigating the Effect of a Phospholipid Drink on Cognitive Performance|Completed||N/A|54|Actual|University of Leeds||2|||f||||f||||||||||2017-10-11 01:34:36.263826|2017-10-11 01:34:36.263826
NCT01879800|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-05-23|2015-06-03||August 2012||2012-08-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||One-Day Acceptance and Commitment Training Intervention in Primary Care Patients|One-Day Acceptance and Commitment Training Intervention in Primary Care Patients|Completed||N/A|44|Actual|University of Iowa||2|||f||||||||||||||2017-10-11 01:34:36.367946|2017-10-11 01:34:36.367946
NCT01879787|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-04-10|||January 2011||2011-01-01|May 2014|2014-05-01|December 2014|Actual|2014-12-01|August 2013|Actual|2013-08-01||Interventional|||Effects of tDCS Combined With mCIMT or Mental Practice in Poststroke Patients|Impact of Transcranial Direct Current Stimulation (tDCS)on the Effects of Mental Practice and Modified Constraint-induced Movement Therapy (mCIMT)in the Rehabilitation of Chronic Stroke Patients|Completed||Phase 2|84|Actual|Universidade Federal de Pernambuco||7|||f||||t||||||||||2017-10-11 01:34:36.733999|2017-10-11 01:34:36.733999
NCT01879774|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-05-02|||June 2012||2012-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia|Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia|Recruiting||N/A|100|Anticipated|University of Cologne||1|||f||||f||||||||||2017-10-11 01:34:36.816792|2017-10-11 01:34:36.816792
NCT01879761|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-12-12|||June 2013||2013-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Immune Resolution After Staphylococcus Aureus Bacteremia||Recruiting||N/A|100|Anticipated|University of Chicago|||2||f||||f||||||Samples Without DNA|"     Isolated monocytes from whole blood for HLA-DR measurement. Serum and plasma for cytokine     measurements   "|||2017-10-11 01:34:36.911178|2017-10-11 01:34:36.911178
NCT01879748|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-12-19|||June 2013||2013-06-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline|A Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses (0.5, 1.0, and 2.0 mg) of Rasagiline Administered to Healthy Japanese and Caucasian Subjects|Completed||Phase 1|64|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 01:34:36.996319|2017-10-11 01:34:36.996319
NCT01879735|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-02-04|2015-01-19||June 2013||2013-06-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT|Hepatic Transport of Conjugated Bile Acids in Humans Quantified by 11C-cholylsarcosine PET/CT|Completed||Phase 1|22|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:34:37.09895|2017-10-11 01:34:37.09895
NCT01879722|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-09-09|2015-06-25||June 2013||2013-06-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||All randomized participants.|Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Subjects With Stable Schizophrenia and Healthy Japanese Subjects|Completed||Phase 1|77|Actual|Takeda||6|||f||||f||||||||||2017-10-11 01:34:37.552244|2017-10-11 01:34:37.552244
NCT01879709|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-11-28|||August 2010||2010-08-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Interventional|||Yoga as Cognitive Remediation in Schizophrenia|The Impact of Yoga Supplementation on Cognitive Function Among Indian Outpatients With Schizophrenia|Completed||N/A|286|Actual|Dr. Ram Manohar Lohia Hospital||3|||f||||t||||||||No||2017-10-11 01:34:40.501587|2017-10-11 01:34:40.501587
NCT01879696|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-13|||June 2013||2013-06-01|June 2013|2013-06-01|June 2015|Anticipated|2015-06-01|May 2014|Anticipated|2014-05-01||Interventional|ECSPRESS||Double Blinded, Randomized Clinical Trial of the Twin Star ECSPRESS Monitoring System for the Reduction of the Incidence of Fasciotomy|Double Blinded Study for the Reduction of the Incidence of Fasciotomy|Unknown status|Not yet recruiting|N/A|150|Anticipated|Twin Star Medical, Inc.||2|||f||||t||||||||||2017-10-11 01:34:40.585061|2017-10-11 01:34:40.585061
NCT01879683|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-11-13|2015-11-13||July 2013||2013-07-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions|A Phase 1b, Multicenter, Open Label Study Evaluating Safety, Tolerability and Preliminary Efficacy of LiRIS® 400 mg in Women With Ulcerative Interstitial Cystitis|Completed||Phase 1|10|Actual|Allergan||1|||f||||f||||||||||2017-10-11 01:34:40.675093|2017-10-11 01:34:40.675093
NCT01879670|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-10-27|||June 2013||2013-06-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Partial Left Ventricular Support in Advanced Heart Failure|Partial Left Ventricular Support in Advanced Heart Failure|Terminated||N/A|2|Actual|Royal Brompton & Harefield NHS Foundation Trust|||2|Withdrawal of CircuLite Synergy from clinical use|f||||f||||||Samples Without DNA|"     Plasma samples   "|||2017-10-11 01:34:40.922788|2017-10-11 01:34:40.922788
NCT01879657|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-08-10|||March 2013||2013-03-01|August 2015|2015-08-01|August 2016|Anticipated|2016-08-01|December 2015|Anticipated|2015-12-01||Interventional|||68-Ga-DOTATATE PET-CT Scan for Diagnosis and Staging of Neuroendocrine Tumors|68-Ga-DOTATATE PET-CT Scan for Diagnosis and Staging of Neuroendocrine Tumors|Unknown status|Recruiting|Phase 1/Phase 2|200|Anticipated|Radio Isotope Therapy of America||1|||f||||t||||||||||2017-10-11 01:34:41.006942|2017-10-11 01:34:41.006942
NCT01879631|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-17|||July 2012||2012-07-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||Efficacy of Radial Keratotomy in the Optical Rehabilitation of Mild to Moderate Keratoconus Cases|Efficacy of Radial Keratotomy in the Optical Rehabilitation of Mild to Moderate Keratoconus Cases|Completed||N/A|36|Actual|Nisa Hastanesi|||1||f||||f||||||||||2017-10-11 01:34:41.332423|2017-10-11 01:34:41.332423
NCT01879618|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-01-30|2016-11-02||October 2013||2013-10-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||The Safety Analysis Set consisted of all participants who received at least one dose of study medication.|Use Of Fragmin In Hemodialysis|A Phase IIIb Open Label Study To Optimize The Single Bolus Dose Of Dalteparin Sodium For The Prevention Of Clotting Within The Extracorporeal System During Hemodialysis Procedures For Subjects With Chronic Renal Insufficiency: The Parrot Study|Completed||Phase 3|152|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:34:41.406919|2017-10-11 01:34:41.406919
NCT01879605|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2013-06-17|||December 2007||2007-12-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study About Effect of Preoperative Bowel Preparation Versus no Bowel Preparation Before Spinal Surgery|Preoperative Bowel Preparation Versus no Preparation Before Spinal Surgery: a Randomised Clinical Trial|Completed||Phase 4|45|Actual|Oslo University Hospital||3|||f||||t||||||||||2017-10-11 01:34:41.620639|2017-10-11 01:34:41.620639
NCT01879592|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-03-27|||June 2011||2011-06-01|March 2017|2017-03-01|February 28, 2016|Actual|2016-02-28|February 28, 2016|Actual|2016-02-28||Observational|MoP-ASC||Molecular Phenotyping of Asthma in Sickle Cell Disease|Molecular Phenotyping of Asthma in Sickle Cell Disease|Completed||N/A|99|Actual|Nemours Children's Clinic|||4||f||||f||||||Samples With DNA|"     Blood (RBC, WBC, DNA), urine, and saliva   "|No|Our consent documents did not include sharing of individual participant data|2017-10-11 01:34:41.709595|2017-10-11 01:34:41.709595
NCT01879579|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-09-15|2015-08-11||June 2013||2013-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|MITI||Mobile Insulin Titration Intervention|The Mobile Insulin Titration Intervention (MITI) Study: Innovative Chronic Disease Management of Diabetes|Completed||N/A|61|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 01:34:41.799758|2017-10-11 01:34:41.799758
NCT01879566|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-05-27|||May 2013||2013-05-01|May 2015|2015-05-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Observational|||Effect of Catheter-based Radiofrequency Ablation Therapy in Patient With Therapy-resistant Hypertension and Sleep Apnea Syndrome|Effect of Catheter-based Radiofrequency Ablation Therapy of the Renal Sympathetic-Nerve System for Patient With Sleep Apnea Syndrome and Therapy Resistant Hypertension|Unknown status|Recruiting|N/A|20|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 01:34:42.30734|2017-10-11 01:34:42.30734
NCT01879553|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-02-10|2013-10-31||July 2013||2013-07-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above|A Phase II, Open-Label, Single-Arm, Multicenter Study to Evaluate the Safety and Immunogenicity of a Trivalent, Surface Antigen Inactivated Subunit Influenza Virus Vaccine (Agrippal®) in Healthy Adults|Completed||Phase 2|126|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:34:42.68895|2017-10-11 01:34:42.68895
NCT01879540|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-02-24|2013-10-31||July 2013||2013-07-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age|A Phase II, Open-Label, Single-Arm, Multicenter Study to Evaluate the Safety and Immunogenicity of a Trivalent, Surface Antigen Inactivated Subunit Influenza Virus Vaccine Including MF59C.1 Adjuvant (Fluad®) in Healthy Adults ≥65 Years of Age|Completed||Phase 2|63|Actual|Novartis||1|||f||||f||||||||||2017-10-11 01:34:43.211205|2017-10-11 01:34:43.211205
NCT01879527|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-05-08|||March 2014||2014-03-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve|A Randomized, Placebo-Controlled, Double-Blind, Phase IIa Study of Amiloride in the Treatment of Acute Autoimmune Optic Neuritis|Unknown status|Recruiting|Phase 2|78|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:34:43.520086|2017-10-11 01:34:43.520086
NCT01879514|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-06-13|||January 2010||2010-01-01|June 2013|2013-06-01||||December 2013|Anticipated|2013-12-01||Interventional|||Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath|Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath|Unknown status|Recruiting|N/A|200|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 01:34:43.700712|2017-10-11 01:34:43.700712
NCT01879501|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-06-14|||January 2013||2013-01-01|June 2013|2013-06-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|ADAPT-LAH||Living Successfully With Chronic Eye Diseases|Living Successfully With Chronic Eye Diseases: the 'Living Successfully With Low Vision' (LSLV) Program - a Randomized Controlled Trial of a Self-management Program for Low Vision|Unknown status|Recruiting|N/A|160|Anticipated|Singapore Eye Research Institute||2|||f||||t||||||||||2017-10-11 01:34:43.819423|2017-10-11 01:34:43.819423
NCT01879488|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-11-16|||July 2013||2013-07-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Ventilation Mode on Lung Deposition of a Radiolabeled Aerosol During Mechanical Ventilation: Barometric Versus Volumetric||Completed||N/A|19|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||||||||||||2017-10-11 01:34:43.930196|2017-10-11 01:34:43.930196
NCT01879475|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-04-06|||June 2013||2013-06-01|April 2015|2015-04-01||||October 2015|Anticipated|2015-10-01||Interventional|||Safety and Performance of 032-11 Haemostat in Cardiac and Thoracic Aortic Surgery|Prospective, Randomised, Controlled Investigation Comparing the Safety and Performance of 032-11 Surgical Haemostat With FLOSEAL® Haemostatic Matrix in Cardiac Surgery and Thoracic Aortic Surgery.|Unknown status|Recruiting|N/A|200|Anticipated|Medtrade||2|||f||||t||||||||||2017-10-11 01:34:44.05346|2017-10-11 01:34:44.05346
NCT01879462|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-05-12|||June 14, 2013|Actual|2013-06-14|May 2017|2017-05-01|January 10, 2014|Actual|2014-01-10|January 10, 2014|Actual|2014-01-10||Interventional|||A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects|A Randomized, Single-Blind, Dose Escalation, First Time in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of GSK2878175 in Healthy Adults|Completed||Phase 1|47|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 01:34:44.143228|2017-10-11 01:34:44.143228
NCT01879436|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-04-21|||November 2013||2013-11-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||The Effect of Human Placental Explants and Pregnant Women Sera on Cancer Cells|The Effect of Human Placental Explants and Pregnant Women Sera on Cancer Cells|Recruiting||N/A|100|Anticipated|Meir Medical Center|||2||f||||t||||||Samples With DNA|"     Placentae will be collected and used in cell culture experiments for a week. Their proteins     and RNA will be analyzed.   "|||2017-10-11 01:34:44.331007|2017-10-11 01:34:44.331007
NCT01879423|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-05-31|||April 28, 2013|Actual|2013-04-28|May 2017|2017-05-01|June 6, 2013|Actual|2013-06-06|June 6, 2013|Actual|2013-06-06||Interventional|||The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects|A Single-Dose, Open-Label, Randomized, Two-Period Crossover Study to Demonstrate the Bioequivalence of Lamotrigine Dispersible/Chewable Tablets (5mg×5) and Lamotrigine Compressed Tablet (25mg) in Healthy Chinese Male Subjects.|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:34:44.433412|2017-10-11 01:34:44.433412
NCT01879410|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-11-18|2014-07-24||June 2013||2013-06-01|November 2016|2016-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|DB2114951: A Randomized, Multi-center, Double-blind, Double-dummy, Parallel Group Study to Evaluate the Efficacy Umeclidinium/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With COPD|Completed||Phase 3|700|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:34:44.566578|2017-10-11 01:34:44.566578
NCT01879397|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-04-13|||May 2013||2013-05-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|UMP||Pilot Study of Ultrasonic Determined Carotid Plaque Composition|Ultrasonic Mapping of Carotid Plaque Composition|Enrolling by invitation||N/A|150|Anticipated|The Cleveland Clinic|||2||f||||f||||||Samples Without DNA|"     Carotid plaque removed during Carotid Endarterectomy (CEA) for subjects in the CEA Cohort     will be collected and processed for production of histology slides.   "|||2017-10-11 01:34:45.117521|2017-10-11 01:34:45.117521
NCT01879384|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-04-25|||February 2011||2011-02-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|MTM||Monitoring of Bone Free Flaps With Microdialysis|Feasibility of Monitoring of Bone Free Flaps With Microdialysis Catheter Directly Positioned in Bone Tissue|Completed||N/A|34|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:34:45.185247|2017-10-11 01:34:45.185247
NCT01879371|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-09-27|2016-09-27||June 2013||2013-06-01|September 2016|2016-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Treated Set (TS): included all subjects who were dispensed study medication and were documented to have taken at least one dose of study drug.|Relative Bioavailability of Ibuprofen From a Single Fixed Dose Combination Tablet of Ibuprofen and Caffeine Compared to Single Tablets of Ibuprofen and Ibuprofen Lysinate|Relative Bioavailability of Ibuprofen From a Fixed Dose Combination (FDC) Tablet of Ibuprofen 400 mg and Caffeine 100 mg Compared to a Tablet of Ibuprofen 400 mg and a Tablet of Ibuprofen Lysinate 400 mg Following Oral Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Three-period Crossover Study)|Completed||Phase 1|36|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 01:34:45.277785|2017-10-11 01:34:45.277785
NCT01879358|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-09-22|||November 2012||2012-11-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2015|Actual|2015-02-01||Interventional|SORT OUT VII||Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent|Randomized Comparison of a Sirolimus Eluting ORSIRO Stent With a Biolimus-eluting NOBORI Stent in Patients Treated With Percutaneous Coronary Intervention|Active, not recruiting||N/A|2314|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 01:34:45.887485|2017-10-11 01:34:45.887485
NCT01879345|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-12-17|2014-11-28||October 2004||2004-10-01|December 2014|2014-12-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers|A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE TOLERABILITY AND PHARMACOKINETICS OF TWO SINGLE AND MULTIPLE HIGH DOSE REGIMENS OF BIA 2-093 IN HEALTHY VOLUNTEERS|Completed||Phase 1|18|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 01:34:45.992362|2017-10-11 01:34:45.992362
NCT01879332|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2014-12-17|2014-11-28||December 2006||2006-12-01|December 2014|2014-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy Volunteers|Completed||Phase 1|16|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 01:34:46.450776|2017-10-11 01:34:46.450776
NCT01879319|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2015-11-19|2015-09-11|2014-05-02|July 2013||2013-07-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Full analysis set (all randomized participants who received at least 1 dose of study drug).|Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen|A Multicenter, Randomized Study in Subjects With Primary Hypercholesterolemia or Mixed Dyslipidemia to Assess Subjects' Ability to Administer a Full Dose of Evolocumab (AMG 145) in Home-use, Using Either a 3.5 mL Personal Injector or a Prefilled Autoinjector/Pen.|Completed||Phase 3|164|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:34:46.832516|2017-10-11 01:34:46.832516
NCT01879293|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-08-15|||July 2013||2013-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease|Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease:A Randomized, Double-Blind, Placebo-Controlled Study|Completed||Phase 4|120|Actual|Wuhan General Hospital of Guangzhou Military Command||2|||f||||t||||||||||2017-10-11 01:34:47.37963|2017-10-11 01:34:47.37963
NCT01879280|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-29|2013-06-12|||May 2010||2010-05-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Craniotomy on Temporalis Function||Withdrawn||N/A|0|Actual|Vanderbilt University||2||low enrollment|f||||f||||||||||2017-10-11 01:34:47.469269|2017-10-11 01:34:47.469269
NCT01879254|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-01-26|||February 2008||2008-02-01|January 2016|2016-01-01||||December 2018|Anticipated|2018-12-01||Observational|||Long-term Follow-up in Patients With Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD).|Long-term Follow-up in Patients With Deep Brain Stimulation (DBS) for Severe Treatment Refractory Obsessive Compulsive Disorder (OCD).|Recruiting||N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:34:47.664258|2017-10-11 01:34:47.664258
NCT01879241|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-10-24|||June 2013||2013-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis|Efficacy, Safety and Tolerability Study of 1 mg Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) Receiving Standard Therapy (Riluzole) - An AMG Trial With a Market Authorized Substance|Completed||Phase 2|252|Actual|University of Ulm||2|||f||||t||||||||||2017-10-11 01:34:47.760427|2017-10-11 01:34:47.760427
NCT01879228|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-09-05|||June 2013||2013-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Chronic Incretin-based Therapy in Cystic Fibrosis|A Randomized, Double-blind, Placebo Controlled Study of the Effectiveness of Chronic Incretin-based Therapy on Insulin Secretion in Cystic Fibrosis|Recruiting||N/A|36|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:34:47.892399|2017-10-11 01:34:47.892399
NCT01879215|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-05-02|||June 2013||2013-06-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||T1Rho MRI Evaluation of Patellofemoral Changes After Tibial IM Nailing|Patella Femoral Changes Following Tibial Nailing: Does Approach Matter?|Recruiting||N/A|20|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:34:48.000227|2017-10-11 01:34:48.000227
NCT01879202|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-05-08|||December 2012||2012-12-01|May 2015|2015-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|MS||Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis|Methylphenidate Modified-release as Treatment of MS-associated Fatigue. A Single-center Randomized Double-blind Placebo-controlled Study.|Unknown status|Recruiting|Phase 2|96|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:34:48.099409|2017-10-11 01:34:48.099409
NCT01879189|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-09-12|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|April 2017|Actual|2017-04-01||Interventional|||PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk|PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool|Active, not recruiting||N/A|1302|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:34:48.220246|2017-10-11 01:34:48.220246
NCT01879176|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-01-09|2016-04-30||August 2013||2013-08-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CytoSorb|Patients, who were allocated to treatment or control after randomization|Cytokine Removal in Cardiopulmonary Bypass Patients|Effect of Cytokine Removal in Cardiopulmonary Bypass Patients Using the Cytosorb ™ Filter|Completed||Phase 3|46|Actual|Medical University of Vienna||2|||f||||f||||||||No||2017-10-11 01:34:48.324423|2017-10-11 01:34:48.324423
NCT01879163|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-12-15|||July 2013||2013-07-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults|A Phase I Randomised Trial to Evaluate the Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in Bacille Calmette-Guérin (BCG) Vaccinated Adults|Completed||Phase 1|30|Actual|University of Oxford||3|||f||||f||||||||||2017-10-11 01:34:48.631137|2017-10-11 01:34:48.631137
NCT01879150|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-02|2013-06-13|||June 2013||2013-06-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|February 2014|Anticipated|2014-02-01||Interventional|CO001||Pilot Study of CyclaPlex Implant, an Enhanced Suture and Button Implant Device in Hallux Valgus Deformity|Single Center, Open-label, Single Arm, Study Designed to Evaluate Safety, Tolerability and Efficacy of CyclaPlex Implant and Tools for Correction of First Inter-metatarsal Angle in Subjects Suffering From Hallux Valgus Deformity|Unknown status|Recruiting|Phase 1|10|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 01:34:48.761633|2017-10-11 01:34:48.761633
NCT01879137|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-07-10|||June 2013||2013-06-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome|Copeptin After Arginine Infusion for the Differential Diagnosis of the Polyuria-Polydipsia Syndrome ''The CARGO-Study''|Completed||N/A|60|Actual|University Hospital, Basel, Switzerland|||2||f||||f|||||||"     Serum EDTA   "|||2017-10-11 01:34:48.877804|2017-10-11 01:34:48.877804
NCT01879124|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-12|||March 2004||2004-03-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Resistive Index Measurements After Kidney Transplantation|Correlation Between Renal Vascular Resistive Index, Renal Allograft Histology and Outcome|Completed||N/A|346|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:34:48.968779|2017-10-11 01:34:48.968779
NCT01879111|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-12-15|||October 2011||2011-10-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional|DEPSCREEN-INFO||Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback|Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback: Randomized Controlled Trial|Completed||N/A|4151|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 01:34:49.043093|2017-10-11 01:34:49.043093
NCT01879098|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-07-09|||August 2013||2013-08-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation|Evaluation of the Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation in Healthy, Middle-aged Adults: a Randomized, Double-blinded, Placebo-controlled Study|Completed||Phase 1|155|Actual|University of Florida||4|||f||||f||||||||||2017-10-11 01:34:49.137572|2017-10-11 01:34:49.137572
NCT01879085|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-09-11|||June 2013||2013-06-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|GemTax||Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma|Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma|Recruiting||Phase 1/Phase 2|67|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 01:34:49.222843|2017-10-11 01:34:49.222843
NCT01878903|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-01-21|||April 2013||2013-04-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|||Electronic Visual Analogue Scale in Acute Postoperative Pain|Prospective Comparative Study of Electronic Visual Analogue Scale and Verbal Numerical Rating Scale in Acute Post-operative Pain.|Completed||N/A|92|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 01:34:50.864985|2017-10-11 01:34:50.864985
NCT01879072|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-09-27|||June 2013|Actual|2013-06-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|||Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)|Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT (BMT CTN #1202)|Active, not recruiting||N/A|1744|Actual|Medical College of Wisconsin|||1||f||||t||||||Samples With DNA|"     10mL serum for Proteomic studies for patients at the following time points: pre-transplant,     days 7, 14, 21, 28, 42, 56, and 90.      Gene Expression studies will include the following:        -  PAXgene Lysates-source whole blood RNA (15 ml blood) for 240 patients collected on days          21, 56, and 90.        -  CytoChex tube for Immunophenotyping (4-5 mL blood) collected on days 21, 56, and 90.   "|||2017-10-11 01:34:49.347756|2017-10-11 01:34:49.347756
NCT01879059|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-01-04|2014-10-14||March 2012||2012-03-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PIA|young, healthy, active men|The Effects of Altering Physical Activity on Cardiometabolic Health|The Effects of Altering Physical Activity on Endothelial Function, Glycemic Control, and the Blood Flow Response to an Oral Glucose Tolerance Test.|Completed||N/A|13|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 01:34:49.517057|2017-10-11 01:34:49.517057
NCT01879046|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2017-02-16|||October 2015||2015-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ARTHROSTEM||Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells|Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells|Completed||N/A|35|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 01:34:49.672079|2017-10-11 01:34:49.672079
NCT01879033|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-12|||March 2011||2011-03-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|June 2013|Anticipated|2013-06-01||Interventional|||Endothelial Function in Obese Adolescents|Effect Of Obesity And Hyperglycemia on Endothelial Function in Inner City Bronx Adolescents|Unknown status|Recruiting|N/A|60|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-10-11 01:34:49.7484|2017-10-11 01:34:49.7484
NCT01879020|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-12|||August 2009||2009-08-01|June 2013|2013-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects|A Randomised Double-blind, Placebo-controlled, Ascending-dose, Phase I Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Adult Male Subjects|Completed||Phase 1|61|Actual|Mitsubishi Tanabe Pharma Corporation||10|||f||||f||||||||||2017-10-11 01:34:49.845259|2017-10-11 01:34:49.845259
NCT01879007|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-13|||January 2006||2006-01-01|June 2013|2013-06-01||||March 2006|Actual|2006-03-01||Interventional|||Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg)|Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg)|Completed||Phase 1|16|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-11 01:34:49.936153|2017-10-11 01:34:49.936153
NCT01878994|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-13|||January 2013||2013-01-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|June 2014|Anticipated|2014-06-01||Interventional|NEREU||Evaluation of a Family Intervention Program for the Management of Overweight or Obese Children|Evaluation of Family Intervention Program for the Treatment of Overweight or Obese Children (Nereu Program): Randomized Clinical Trial|Unknown status|Recruiting|Phase 4|100|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 01:34:50.217935|2017-10-11 01:34:50.217935
NCT01878981|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-06-13|||June 2011||2011-06-01|June 2013|2013-06-01|April 2014|Anticipated|2014-04-01|November 2013|Anticipated|2013-11-01||Observational|||Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China|Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China|Unknown status|Active, not recruiting|N/A|450|Anticipated|Johnson & Johnson Medical, China|||1||f||||f||||||||||2017-10-11 01:34:50.312212|2017-10-11 01:34:50.312212
NCT01878968|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-01-04|||April 2013||2013-04-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?|Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?|Completed||N/A|200|Actual|Jewish Hospital, Cincinnati, Ohio||2|||f||||f||||||||||2017-10-11 01:34:50.38058|2017-10-11 01:34:50.38058
NCT01878955|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-02-22|||February 2016||2016-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||The Use Of AMH for the Discrimination of Polycystic and Multicystic Ovaries in Nonhyperandrogenic Patients|Elevation of AMH Resulted From Ovarian Structural Properties or Effects of Gonadotropines|Active, not recruiting||N/A|60|Anticipated|Izmir Katip Celebi University|||1||f||||f||||||||||2017-10-11 01:34:50.494881|2017-10-11 01:34:50.494881
NCT01878942|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-01-20|||June 2013||2013-06-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study|Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study|Completed||Early Phase 1|16|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 01:34:50.564901|2017-10-11 01:34:50.564901
NCT01878916|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-06-14|||January 2003||2003-01-01|June 2013|2013-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01|12 Months|Observational [Patient Registry]|||Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs|Plasma Cobalamin, Folate, Pyridoxine and Homocysteine Levels and Thrombosis in Patients With Philadelphia-chromosome-negative Myeloproliferative Neoplasms|Completed||N/A|||Istanbul University|||1||f||||f||||||||||2017-10-11 01:34:50.786869|2017-10-11 01:34:50.786869
NCT01878890|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-09-29|||June 2011||2011-06-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|July 2014|Actual|2014-07-01||Interventional|ESCALE||Phase I Dose Escalation Trial of Efavirenz for Patients With Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure.|Phase I Dose Escalation Trial of Efavirenz for Patients With Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure.|Completed||Phase 1|30|Actual|Institut Bergonié||1|||f||||||||||||||2017-10-11 01:34:50.951741|2017-10-11 01:34:50.951741
NCT01878877|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-09-15|||May 2013||2013-05-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Update Prevalence of Chronic Pain in Hong Kong|Update Prevalence of Chronic Pain Among Hong Kong Adult Population: Change Over the Last Decade|Completed||N/A|1570|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 01:34:51.033149|2017-10-11 01:34:51.033149
NCT01878864|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2015-04-01|||November 2012||2012-11-01|April 2015|2015-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Local Anesthesia in Patients With Marginal Periodontitis Undergoing Scaling and Root Planning|Effect of Local Anesthesia in Patients With Marginal Periodontitis Undergoing Scaling and Root Planning|Terminated||Phase 2|12|Actual|Hvidovre University Hospital||2||Too slow patient inclusion and superior effect of the injection|f||||t||||||||||2017-10-11 01:34:51.107049|2017-10-11 01:34:51.107049
NCT01878851|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-12-18|||September 2013||2013-09-01|December 2016|2016-12-01||||September 2018|Anticipated|2018-09-01||Observational|||Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.||Suspended||N/A|50|Anticipated|Hadassah Medical Organization|||1|New data was published in the literature|f||||f||||||||||2017-10-11 01:34:51.312806|2017-10-11 01:34:51.312806
NCT01878838|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2015-08-18|||April 2013||2013-04-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.|A Prospective Randomized Controlled Clinical Trial Comparing the Intra-operative Effects, Safety, Efficacy and Performance of Two Commercially Available Laser Systems in Patients Undergoing Femtosecond Laser-Assisted Cataract Surgery.|Completed||N/A|45|Actual|Hoopes Vision||2|||f||||f||||||||||2017-10-11 01:34:51.384712|2017-10-11 01:34:51.384712
NCT01878825|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2017-01-16|2015-01-12||July 2013||2013-07-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older|Immunogenicity and Safety Study of GSK Biologicals' Trivalent Split Virion Influenza Vaccine (GSK1536489A) Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older|Completed||Phase 3|121|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 01:34:51.530798|2017-10-11 01:34:51.530798
NCT01878812|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-13|2016-12-27|2014-11-20||July 2013||2013-07-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older|Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine (GSK2321138A) Fluarix/Influsplit Tetra® (2013/2014 Season) in Adults 18 Years of Age and Older|Completed||Phase 3|117|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 01:34:52.455973|2017-10-11 01:34:52.455973
NCT01878799|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-14|2016-07-27|2016-03-31||June 2013||2013-06-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV|An Open Label Trial to Assess Safety, Tolerability, and Efficacy of the Fixed Dose Combination of GS-7977 and GS-5885 in HCV Genotype 1 Subjects Coinfected With HIV|Completed||Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||No||2017-10-11 01:34:53.368691|2017-10-11 01:34:53.368691
NCT01878786|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-04-26|||June 2013||2013-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|Evered||A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys|A Pilot Study Comparing the Safety and Efficacy of Zortress (Everolimus) With Low Dose Tacrolimus to Early Conversion to Calcineulin Inhibitor-Free Regimen and Mycophenolic Acid With Standard Dose Tacrolimus in Recipients of ECD/DCD Kidneys|Recruiting||Phase 2/Phase 3|50|Anticipated|Georgetown University||3|||f||||t||||||||||2017-10-11 01:34:53.986011|2017-10-11 01:34:53.986011
NCT01878773|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-08-18|||October 2012||2012-10-01|August 2017|2017-08-01|August 11, 2017|Actual|2017-08-11|August 11, 2017|Actual|2017-08-11||Interventional|||Prostate Delineation: High Quality Volume CT|Prostate Delineation During Radiation Treatment Planning for Prostate Cancer: Comparison of High Quality Volume Computerized Tomography With Conventional Tomography and Magnetic Resonance Imaging|Completed||N/A|10|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 01:34:54.099649|2017-10-11 01:34:54.099649
NCT01878760|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-10-12|||March 2014||2014-03-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Observational|APRICOT||APRICOT: Anaesthesia PRactice In Children Observational Trial|APRICOT: Anaesthesia PRactice In Children Observational Trial - European Prospective Multicenter Observational Study: Epidemiology of Severe Critical Events in Paediatric Anaesthesia|Completed||N/A|30000|Actual|European Society of Anaesthesiology|||1||f||||f||||||||||2017-10-11 01:34:54.18645|2017-10-11 01:34:54.18645
NCT01878747|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-02-17|||June 2011||2011-06-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Healthcare Provider Behavior and Children's Perioperative Distress|Healthcare Provider Behavior and Children's Perioperative Distress|Recruiting||N/A|1920|Anticipated|University of California, Irvine||2|||f||||t||||||||||2017-10-11 01:34:54.359163|2017-10-11 01:34:54.359163
NCT01878734|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-06-02|||June 2013||2013-06-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Zambia Micronutrient Powder Trial Effectiveness Study|MNP Pilot Study for Development of a Micronutrient Powder Home Fortification Program to Combat Anaemia Among Children 6-23 Months in Zambia|Completed||N/A|631|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:34:54.491002|2017-10-11 01:34:54.491002
NCT01878721|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-08-30|||January 2011||2011-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PETU||Positron Emission Tomography of Infection and Vasculitis|Positron Emission Tomography of Infection and Vasculitis (PETU)|Active, not recruiting||N/A|117|Anticipated|Turku University Hospital|||5||f||||f||||||||||2017-10-11 01:34:54.606723|2017-10-11 01:34:54.606723
NCT01878708|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-03-02|||July 2013||2013-07-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma|A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma|Terminated||Early Phase 1|2|Actual|Dana-Farber Cancer Institute||1||Slow accrual|f||||t|t|f||||||No||2017-10-11 01:34:54.687114|2017-10-11 01:34:54.687114
NCT01878695|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-06-20|||July 2012||2012-07-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|NAC||Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer|Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer|Completed||Phase 1|35|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 01:34:54.785129|2017-10-11 01:34:54.785129
NCT01878682|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-08|2013-06-14|||September 2013||2013-09-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||A Study to Evaluate the Performance of VibraTip® by Different Clinical Users|A Study to Evaluate the Performance of the VibraTip® Product by Different Community Medical Practitioners Compared to an Expert Validation by a Diabetologists.|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tameside Hospital NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 01:34:54.860096|2017-10-11 01:34:54.860096
NCT01878669|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-01-18|||January 2013||2013-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|EASE-PCI||Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention|Effects of N-acetyl Cysteine on Periprocedural Myocardial Infarction and Major Cardiac and Cerebral Events in Patients Undergoing Percutaneous Coronary Intervention|Active, not recruiting||Phase 3|390|Anticipated|Suleyman Demirel University||2|||f||||f||||||||||2017-10-11 01:34:54.927122|2017-10-11 01:34:54.927122
NCT01878656|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-04-04|2014-04-04||April 2013||2013-04-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of Emergence Agitation Between Sevoflurane and Desflurane Anesthesia After Orthognathic Surgery||Completed||Phase 4|144|Actual|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||2|||f||||||||||||||2017-10-11 01:34:55.001544|2017-10-11 01:34:55.001544
NCT01878643|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-06-12|||December 2001||2001-12-01|June 2013|2013-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit|Pilot Study of the Effects of Inhaled Antibiotic on Bacterial Resistance|Completed||Early Phase 1|47|Actual|Stony Brook University||2|||f||||f||||||||||2017-10-11 01:34:55.23022|2017-10-11 01:34:55.23022
NCT01878630|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-05-15|||August 2013||2013-08-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2017|Actual|2017-05-01||Interventional|TIM-HF II||Telemedical Interventional Management in Heart Failure II||Active, not recruiting||Phase 3|1535|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:34:55.315764|2017-10-11 01:34:55.315764
NCT01878617|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-09-26|||June 23, 2013|Actual|2013-06-23|September 2017|2017-09-01|December 2026|Anticipated|2026-12-01|June 2023|Anticipated|2023-06-01||Interventional|||A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma|A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma|Recruiting||Phase 2|350|Anticipated|St. Jude Children's Research Hospital||8|||f||||t|t|f||||||||2017-10-11 01:34:57.377906|2017-10-11 01:34:57.377906
NCT01878604|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-02-17|2016-10-31||October 2001||2001-10-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Observational|||Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia|The Study of Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia|Completed||N/A|5|Actual|Central South University|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 01:34:57.707285|2017-10-11 01:34:57.707285
NCT01878591|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2016-10-26|||November 2013||2013-11-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Can Ultrasound Predict Labor Outcome in Operative Vaginal Deliveries?|Can Ultrasound Predict Labor Outcome in Operative Vaginal Deliveries?|Completed||N/A|223|Actual|Helse Stavanger HF|||1||f||||t||||||||No||2017-10-11 01:34:58.024936|2017-10-11 01:34:58.024936
NCT01878578|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-02-26|||November 2002||2002-11-01|February 2014|2014-02-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||The Effect of BIA 2-093 on the Steady-state Pharmacokinetic Profile of Phenytoin in Patients||Terminated||Phase 1|4|Actual|Bial - Portela C S.A.||3||"prematurely terminated due to impossibility of recruiting the planned number of patients by the   study centre."|f||||f||||||||||2017-10-11 01:34:58.11672|2017-10-11 01:34:58.11672
NCT01878565|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-07-23|||June 2013||2013-06-01|July 2013|2013-07-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|||The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion|The Treatment With Nucleoside Analogues in Combination With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion: a Phase I/II, Single-blind, Randomized, GM-CSF-controlled Trial|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||||2017-10-11 01:34:58.199468|2017-10-11 01:34:58.199468
NCT01878552|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-04-27|||April 2013||2013-04-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Energy Load in Patients With Acute Respiratory Distress Syndrome (ARDS)|Energy Load During Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome (ARDS)|Completed||N/A|20|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-10-11 01:34:58.321584|2017-10-11 01:34:58.321584
NCT01878539|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-06-14|||June 2012||2012-06-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Oral Anticoagulation and Self-management|Oral Anticoagulation and Self-management: Analysis of the Factors That Determine the Feasibility of Using Self-testing and Self-management in Primary Care|Unknown status|Recruiting|N/A|333|Anticipated|Osakidetza||1|||f||||f||||||||||2017-10-11 01:34:58.389075|2017-10-11 01:34:58.389075
NCT01878526|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-02-03|2016-08-22||June 2013||2013-06-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|GERD-SSc||Gastroesophageal Reflux Treatment in Scleroderma|The Effectiveness of Domperidone Versus Alginic Acid Add on Omeprazole Therapy in Omeprazole Resistance Gastroesophageal Reflux in Systemic Sclerosis|Completed||Phase 3|80|Actual|Khon Kaen University||2|||f||||t||||||||||2017-10-11 01:34:58.495208|2017-10-11 01:34:58.495208
NCT01878175|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-01-09|2016-08-25||May 2014||2014-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2015|Actual|2015-09-01||Interventional|FMR-THA||Functional Movement Retraining After Hip Replacement|Functional Movement Retraining After Hip Arthroplasty in Veterans: Pilot Study|Completed||N/A|15|Actual|VA Office of Research and Development||1|||f||||f||||||||No||2017-10-11 01:35:02.40781|2017-10-11 01:35:02.40781
NCT01878513|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-07-31|||September 23, 2009|Actual|2009-09-23|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis|Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis|Suspended||N/A|264|Anticipated|Northwell Health||3||Preliminary data analysis is underway to determine need for future recruitment.|f||||f||||||||||2017-10-11 01:34:58.806125|2017-10-11 01:34:58.806125
NCT01878500|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-06-12|||September 2012||2012-09-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Navigation of the Pelvic Floor in Bladder Exstrophy Using Pre-operative MRI|Navigation of the Pelvic Floor in Bladder Exstrophy Using Pre-operative MRI|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:34:58.905788|2017-10-11 01:34:58.905788
NCT01878487|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-10-07|||January 2012||2012-01-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|INVEST-MI||Assessment of Lumen Expansion After Thrombus Extraction in Primary Percutaneous Coronary Intervention|INtra-Vascular Ultrasound Study of Export Thrombectomy in ST Elevation Myocardial Infarction Myocardial Infarction|Completed||N/A|40|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 01:34:59.002246|2017-10-11 01:34:59.002246
NCT01878474|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-12|||March 2008||2008-03-01|June 2013|2013-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects|A Randomised, Double-blind, Placebo-controlled, First Time-in-humans Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Escalating Doses of TA-8995 in Healthy Subjects|Completed||Phase 1|96|Actual|Mitsubishi Tanabe Pharma Corporation||8|||f||||f||||||||||2017-10-11 01:34:59.102812|2017-10-11 01:34:59.102812
NCT01878461|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-08-14||2015-08-14|June 2013||2013-06-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis|A Randomized, Vehicle Controlled, Double Blind, Parallel Group, Multi Center PhaseIII Study to Evaluate the Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis|Completed||Phase 3|542|Actual|Maruho North America Inc.||2|||f||||f||||||||||2017-10-11 01:34:59.223769|2017-10-11 01:34:59.223769
NCT01878448|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-04-05|||April 2013||2013-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|October 2015|Actual|2015-10-01||Interventional|ALTN/STS||A Phase II Study of Anlotinib in STS Patients|Phase 2 Study of Anlotinib in Advanced Soft Tissue Sarcoma|Active, not recruiting||Phase 2|200|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||||||||||||2017-10-11 01:34:59.379829|2017-10-11 01:34:59.379829
NCT01878435|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-09-21|||October 2013||2013-10-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|m-SIMU||Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya|Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya|Completed||N/A|2018|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||||2017-10-11 01:34:59.640211|2017-10-11 01:34:59.640211
NCT01878422|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-07-20|||November 2007||2007-11-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2014|Actual|2014-03-01||Interventional|ITACa||Sequential Treatment Strategy for Metastatic Colorectal Cancer|SEQUENTIAL TREATMENT STRATEGY FOR METASTATIC COLORECTAL CANCER: A PHASE III PROSPECTIVE RANDOMIZED MULTICENTER STUDY OF CHEMOTHERAPY (CT) WITH OR WITHOUT BEVACIZUMAB AS FIRST-LINE THERAPY FOLLOWED BY TWO PHASE III RANDOMIZED STUDIES OF CT ALONE OR CT PLUS BEVACIZUMAB WITH OR WITHOUT CETUXIMAB AS SECOND-LINE THERAPY|Active, not recruiting||Phase 3|350|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||6|||f||||f||||||||||2017-10-11 01:34:59.776382|2017-10-11 01:34:59.776382
NCT01878409|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-14|||January 2010||2010-01-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01|1 Day|Observational [Patient Registry]|Sex-PD||Study of Sexuality in Parkinson Disease|Study of Sexuality in Parkinson Disease|Completed||N/A|244|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||2||f||||t||||||||||2017-10-11 01:34:59.959003|2017-10-11 01:34:59.959003
NCT01878396|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-09-30|||December 2011||2011-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|CMCBRAF||Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors|Predictive Value of Circulating Melanoma Cells (CMCs) in Metastatic Melanoma (MM) Patients Treated With Selective Inhibitors of BRAF|Recruiting||N/A|200|Anticipated|Istituto Oncologico Veneto IRCCS|||1||f||||f||||||Samples Without DNA|"     Whole blood.   "|||2017-10-11 01:35:00.064482|2017-10-11 01:35:00.064482
NCT01878383|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-05-31|||January 2014||2014-01-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture|Device Trial: Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture|Recruiting||N/A|12500|Anticipated|University of Alabama at Birmingham|||2||f||||t||||||||||2017-10-11 01:35:00.175987|2017-10-11 01:35:00.175987
NCT01878370|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-11-21|||June 2013||2013-06-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Audit and Feedback for Primary Care: a Cluster-randomized Trial|Optimizing Audit and Feedback for Primary Care - Testing Scalable Approaches to Providing Feedback Reports, a Cluster-randomized Trial|Completed||N/A|177|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 01:35:00.338087|2017-10-11 01:35:00.338087
NCT01878357|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-01-23|||June 2013||2013-06-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine|Impact of Mass Screening and Selective Treatment With Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in High Endemic Area, Belu Regency, Nusa Tenggara Timur Province, Indonesia: a Randomized Cluster Trial|Completed||Phase 4|1488|Actual|Indonesia University||3|||f||||t||||||||||2017-10-11 01:35:00.437406|2017-10-11 01:35:00.437406
NCT01878162|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2015-07-01|||August 2012||2012-08-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Work Injury Prevention in Law Enforcement Officials|Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials|Suspended||N/A|108|Anticipated|University of the Pacific||1|||f||||f||||||||||2017-10-11 01:35:02.790034|2017-10-11 01:35:02.790034
NCT01878344|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-01-18|||January 2013||2013-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|EASE-PRM-PCI||Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention|Effects of N-acetyl Cysteine on Major Cardiac and Cerebral Events in Patients Undergoing Primary Percutaneous Coronary Intervention Who Have Moderate to High Risk For Contrast Induced Nephropathy|Active, not recruiting||Phase 3|100|Actual|Suleyman Demirel University||2|||f||||f||||||||||2017-10-11 01:35:00.541357|2017-10-11 01:35:00.541357
NCT01878331|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-04-25|||June 2013||2013-06-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Long-term Study to Evaluate Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants|Long-term, Prospective, Cohort Study to Evaluate Safety and Efficacy of Two Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants for Removable Prosthesis in Patients With Edentulous Mandibles|Active, not recruiting||N/A|75|Anticipated|Institut Straumann AG|||2||f||||f||||||||No||2017-10-11 01:35:00.623542|2017-10-11 01:35:00.623542
NCT01878318|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-11-01|||June 2013||2013-06-01|November 2016|2016-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs|Open Label Study to Describe the Effect of Tocilizumab in Combination With MTX in the Evolution of Articular Damage (Synovitis/Osteitis and Erosions) Evaluated by MRI in the Hand of Patients With Moderate to Severe Rheumatoid Arthritis (RA) and Inadequate Response to Non-biological DMARDs|Withdrawn||Phase 4|0|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:35:00.713005|2017-10-11 01:35:00.713005
NCT01878305|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-12|||December 2005||2005-12-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Neuromonitoring of Hepatic Encephalopathy|Frontal Electroencephalogram Variables Are Associated With Outcome and Stage of Hepatic Encephalopathy in Acute Liver Failure|Completed||N/A|20|Actual|Helsinki University|||1||f||||f||||||||||2017-10-11 01:35:00.795948|2017-10-11 01:35:00.795948
NCT01878292|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-10-06|||July 2013||2013-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|VLZ-MD-21||Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder|A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder|Completed||Phase 3|529|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 01:35:00.903462|2017-10-11 01:35:00.903462
NCT01878279|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-12|||September 2008||2008-09-01|June 2013|2013-06-01||||July 2010|Actual|2010-07-01||Observational|||HSV Oral Reactivation in Children|Longitudinal Study to Evaluate the Frequency of HSV-1 Oral Reactivation in Children in Dar es Salaam, Tanzania|Completed||N/A|30|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||f||||||||||2017-10-11 01:35:01.100286|2017-10-11 01:35:01.100286
NCT01878266|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2016-01-11|||February 2013||2013-02-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children|Prospective Randomized Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Pediatric Diffuse Brainstem Glioma|Recruiting||Phase 3|119|Anticipated|Children's Cancer Hospital Egypt 57357||3|||f||||t||||||||||2017-10-11 01:35:01.203993|2017-10-11 01:35:01.203993
NCT01878253|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-15|||July 2013||2013-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:35:01.295707|2017-10-11 01:35:01.295707
NCT01878240|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-05-21|||May 2013||2013-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|April 2017|Actual|2017-04-01||Interventional|SCOPE1||Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac|Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac|Recruiting||N/A|100|Anticipated|Centre Chirurgical Marie Lannelongue||2|||f||||t||||||||||2017-10-11 01:35:01.346652|2017-10-11 01:35:01.346652
NCT01878227|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-11|||July 2010||2010-07-01|June 2013|2013-06-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia|Randomized Head-to-Head Comparison of Coenzyme A Capsule and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia: A Phase III, Multicenter, Double-blinded, Double Dummy Clinical Trial.|Completed||Phase 3|420|Actual|Zhejiang University||2|||f||||t||||||||||2017-10-11 01:35:01.473998|2017-10-11 01:35:01.473998
NCT01878214|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2014-12-03|2014-11-25||April 2012||2012-04-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Promoting Smoking Cessation in Carpenters|Effective Communication Strategies for Promoting Smoking Cessation in Carpenters|Completed||N/A|442|Actual|Washington University School of Medicine|Messages were based on feedback from a small sample that over-represented young workers; messages may not have been applicable to all union members. Intervention reach was low; only 42% of intervention participants reporting receiving postcards.|2|||f||||f||||||||||2017-10-11 01:35:01.561451|2017-10-11 01:35:01.561451
NCT01878201|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-09-05|||May 2013||2013-05-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension|A Randomized, Double-blind, Valsartan 80 Mg-Referenced, Parallel Grouped, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 2|75|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-10-11 01:35:02.031253|2017-10-11 01:35:02.031253
NCT01878188|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2014-03-25|||February 2013||2013-02-01|March 2014|2014-03-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma|Phase I Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma|Unknown status|Recruiting|Phase 1|18|Anticipated|BioCancell Ltd.||3|||f||||f||||||||||2017-10-11 01:35:02.2602|2017-10-11 01:35:02.2602
NCT01878149|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2014-08-11|2014-05-30||June 2013||2013-06-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||Given the nature of this retrospective evaluation, the sample size was not statistically derived but was instead intended to be representative of the body of evidence that exist for real world usage of the VEO® device.|Retrospective Multicenter Clinical Evaluation of Complications for Single or Multilevel VEO® Lateral Access and Interbody Fusion System and eXtreme Lateral Interbody Fusion (XLIF®) Subjects|Retrospective Multicenter Clinical Evaluation of Complications for Single or Multilevel VEO® Lateral Access and Interbody Fusion System and eXtreme Lateral Interbody Fusion (XLIF®) Subjects|Completed||N/A|34|Actual|Baxano Surgical, Inc.|||2||f||||f||||||||||2017-10-11 01:35:02.880741|2017-10-11 01:35:02.880741
NCT01878136|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2015-11-09|||March 2015||2015-03-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage|Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage|Withdrawn||Phase 1/Phase 2|0|Actual|Rush University Medical Center||2||Time constraints|f||||t||||||||||2017-10-11 01:35:03.290149|2017-10-11 01:35:03.290149
NCT01878123|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-09-29|||April 2013||2013-04-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis|A Randomized, Single-Dose, Placebo-Controlled, Study of the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis|Completed||Phase 1|26|Actual|MedImmune LLC||2|||f||||||||||||||2017-10-11 01:35:03.434249|2017-10-11 01:35:03.434249
NCT01878110|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-04-14|||January 2013||2013-01-01|April 2015|2015-04-01||||January 2015|Actual|2015-01-01||Interventional|||Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of Trichotillomania|Treatment Development Study of the COMB Model of Trichotillomania|Completed||N/A|16|Actual|American University||1|||f||||||||||||||2017-10-11 01:35:03.576125|2017-10-11 01:35:03.576125
NCT01878097|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2017-08-03|2017-03-29||November 2009||2009-11-01|August 2017|2017-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Surveys were anonymous. The number of participants analyzed represents the number of analyzable surveys within each group.|Evaluation of Green Dot a Primary Prevention Intervention|Green Dot Across the Bluegrass: Evaluation of a Primary Prevention Intervention|Completed||N/A|89707|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-11 01:35:03.69888|2017-10-11 01:35:03.69888
NCT01878071|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-05-19|||June 2012||2012-06-01|May 2014|2014-05-01||||June 2013|Actual|2013-06-01||Observational|||The Effect of Obesity on Oral Peri-implant Health - A Cross-Sectional Study|The Effect of Obesity on Oral Peri-implant Health - A Cross-Sectional Study|Completed||N/A|73|Actual|University of Iowa|||1||f||||||||||||||2017-10-11 01:35:04.42438|2017-10-11 01:35:04.42438
NCT01878058|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-10-31|||October 2012||2012-10-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Identifying Prostate Brachytherapy Seeds Using MRI|Identifying Prostate Brachytherapy Seeds Using MRI|Completed||N/A|10|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 01:35:04.502373|2017-10-11 01:35:04.502373
NCT01878045|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-08-22|||May 21, 2013||2013-05-21|August 8, 2017|2017-08-08|January 25, 2035|Anticipated|2035-01-25|December 31, 2022|Anticipated|2022-12-31||Observational|||Mechanisms of Diabetic Kidney Disease in American Indians|Determinants of Diabetic Nephropathy in American Indians|Enrolling by invitation||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:35:04.592281|2017-10-11 01:35:04.592281
NCT01878032|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-10-05|||June 3, 2013||2013-06-03|April 14, 2017|2017-04-14|April 14, 2017|Actual|2017-04-14|April 14, 2017|Actual|2017-04-14||Observational|||Color Vision as a Measure for Inherited Retinal Diseases|Color Vision as an Outcome Measure for Clinical Trials of Inherited Retinal Degenerations|Completed||N/A|166|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:35:04.711852|2017-10-11 01:35:04.711852
NCT01878019|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-07-06|||May 28, 2013||2013-05-28|September 8, 2016|2016-09-08|September 8, 2016|Actual|2016-09-08|September 8, 2016|Actual|2016-09-08||Observational|||Brain Response to Pain Control in People With Chronic Pain|Mechanisms of Pain Control in Chronic Pain Patients|Completed||N/A|92|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:35:04.806474|2017-10-11 01:35:04.806474
NCT01878006|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-06-30|||April 16, 2013||2013-04-16|April 27, 2017|2017-04-27|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|||Mu Opioid Receptor Genes, Remifentanil, and Pain Sensitivity|OPRM1 A118G SNP Effect on Striatal Dopamine Response to an IV Opiate|Completed||Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:35:04.897256|2017-10-11 01:35:04.897256
NCT01877993|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-08-23|||May 2013||2013-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01|5 Years|Observational [Patient Registry]|||The Effect of Autonomic Function on Coronary Vasomotion|The Association of Acetylcholine-induced Coronary Artery Spasm With the Blood Pressure Level|Completed||N/A|2169|Actual|Korea University|||1||f||||f||||||||||2017-10-11 01:35:05.007926|2017-10-11 01:35:05.007926
NCT01877980|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-12-02|||April 2013||2013-04-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|SoTu2||Ultrasound and Pediatric Endotracheal Tube Size|Prediction of Uncuffed Endotracheal Tube Size in a Pediatric Population by Sonographic Measurements at Various Structures of the Airway Compared to Age-related Formulas and Little-finger Diameters|Completed||N/A|101|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-11 01:35:05.111128|2017-10-11 01:35:05.111128
NCT01877967|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-05-26|||May 2013||2013-05-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||Investigating the Effect of Dietary Supplement VSL#3 on Cognition and Mood in Healthy Older Adults|A Randomised Double-blind Placebo-controlled Trial Investigating the Effect of Dietary Supplement VSL#3 on Memory, Attention, Executive Function and Mood in Healthy Older Adults.|Unknown status|Active, not recruiting|N/A|80|Anticipated|University of Dublin, Trinity College||2|||f||||t||||||||||2017-10-11 01:35:05.169906|2017-10-11 01:35:05.169906
NCT01877954|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-06-13|||February 2011||2011-02-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Qvar vs FP in Pediatrics|Comparative Effectiveness of Extrafine Hydrofluoroalkane Beclometasone Versus Fluticasone in Paediatric Patients — a Retrospective, Real-life Observational Study in a uk Primary Care Asthma Population|Completed||N/A|2654|Actual|Research in Real-Life Ltd|||2||f||||t||||||||||2017-10-11 01:35:05.273816|2017-10-11 01:35:05.273816
NCT01877941|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-12-30|2014-10-16||December 2012||2012-12-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|esCCO||Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time|Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time|Completed||N/A|39|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 01:35:05.387805|2017-10-11 01:35:05.387805
NCT01877928|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-09-29|||June 2013||2013-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea|Use of the Boussignac CPAP System Immediately Following Extubation to Improve Lung Function in Adults With Moderate to Severe Obstructive Sleep Apnea|Recruiting||N/A|80|Anticipated|Queen's University||2|||f||||t||||||||||2017-10-11 01:35:05.655865|2017-10-11 01:35:05.655865
NCT01877915|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-09-22|||September 10, 2013|Actual|2013-09-10|September 2017|2017-09-01|October 1, 2019|Anticipated|2019-10-01|May 14, 2018|Anticipated|2018-05-14||Interventional|COMMANDER HF||A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure|A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban With Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects With Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure|Recruiting||Phase 3|5000|Anticipated|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 01:35:06.16515|2017-10-11 01:35:06.16515
NCT01877889|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2014-03-25|||July 2013||2013-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers|A Double-Blind, Randomized, 2-Way Crossover Study to Compare the Pharmacodynamics of Canagliflozin 300 mg Versus Dapagliflozin 10 mg in Healthy Subjects|Completed||Phase 1|60|Actual|Janssen-Cilag International NV||3|||f||||f||||||||||2017-10-11 01:35:09.17617|2017-10-11 01:35:09.17617
NCT01877876|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-06-08|||June 2013||2013-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|||Assessing the Accuracy of the RevK Sensor|Assessing the Accuracy of the RevK Sensor for Non-Invasive Hemoglobin Monitoring|Completed||N/A|8|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 01:35:09.37004|2017-10-11 01:35:09.37004
NCT01877863|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-03-19|||May 2013||2013-05-01|March 2014|2014-03-01||||December 2013|Actual|2013-12-01||Interventional|||The Effect of Intradialytic Exercise on the Functional Capacity of Hemodialysis Patients|The Effect of Intradialytic Exercise on the Functional Capacity of Hemodialysis Patients|Completed||N/A|50|Actual|University of Calgary||1|||f||||t||||||||||2017-10-11 01:35:09.447202|2017-10-11 01:35:09.447202
NCT01877850|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2015-04-22|||May 2013||2013-05-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|WEAN||Utility of a Weaning Protocol in ICU|Non Pharmacological Randomized Clinical Trial Designed to Evaluate the Difference of the Duration of Weaning Process From the Ventilator Between Protocol-driven Weaned Patients and Clinical-driven Weaned Patients.|Completed||N/A|60|Actual|Università degli Studi di Brescia|||2||f||||t||||||||||2017-10-11 01:35:09.570469|2017-10-11 01:35:09.570469
NCT01877837|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-01-31|||June 2011||2011-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Stem Cell Transplantation for Sickle Cell Anemia|Reduced Intensity Stem Cell Transplantation for Sickle Cell Anemia in Patients 2-30 Years Old|Recruiting||Phase 3|40|Anticipated|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-11 01:35:09.65644|2017-10-11 01:35:09.65644
NCT01877824|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-06-11|||March 2010||2010-03-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Study of Fast-track Surgery in Hernia Repair and Laparoscopic Cholecystectomy|Consequences of Fast-track Training in Surgery in Denmark in Selected Operative Skills.|Completed||N/A|35|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:35:09.774745|2017-10-11 01:35:09.774745
NCT01877811|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-08-02|||June 2013||2013-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors|An Open-Label, Phase 1/1b, Single-Agent Study of RXDX-105 in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|143|Actual|Ignyta, Inc.||1|||f||||f||||||||||2017-10-11 01:35:09.869591|2017-10-11 01:35:09.869591
NCT01877798|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-06-13|||June 2013||2013-06-01|June 2013|2013-06-01||||June 2016|Anticipated|2016-06-01||Interventional|||Venoarterial PCO2 Difference /Arteriovenous O2 Content Difference Ratio as Goal of Early Septic Shock Therapy|Venoarterial PCO2 Difference /Arteriovenous O2 Content Difference Ratio as Goal of Early Severe Sepsis and Septic Shock Therapy|Unknown status|Not yet recruiting|N/A|300|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 01:35:10.007229|2017-10-11 01:35:10.007229
NCT01877785|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-11-01|||July 2013||2013-07-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MHAA4549A in Healthy Volunteers|Completed||Phase 1|21|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 01:35:10.204216|2017-10-11 01:35:10.204216
NCT01877772|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2016-10-25|||June 2013||2013-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trephination in Arthroscopic Cuff Repair: a Prospective Randomized Controlled|Trephination in Arthroscopic Cuff Repair: a Prospective Randomized Controlled|Recruiting||N/A|166|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 01:35:10.305917|2017-10-11 01:35:10.305917
NCT01877759|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-10-08|||December 2013||2013-12-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis|Role of Bone Marrow Derived Autologous Stem Cells + Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Liver Cirrhosis|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Chaitanya Hospital, Pune||1|||f||||f||||||||||2017-10-11 01:35:10.412347|2017-10-11 01:35:10.412347
NCT01877746|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2013-06-11|||January 2013||2013-01-01|June 2013|2013-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)|RANDOMIZED, MULTICENTRIC STUDY COMPARING THE EFFECT OF TWO REGIMENS OF COMBINED IMMUNOSUPPRESSIVE THERAPY IN THE TREATMENT OF INFLAMMATORY CARDIOMYOPATHY CZECH-ICIT (CZECH INFLAMMATORY CARDIOMYOPATHY IMMUNOSUPPRESSION TRIAL)|Unknown status|Recruiting|Phase 3|234|Anticipated|St. Anne's University Hospital Brno, Czech Republic||3|||f||||f||||||||||2017-10-11 01:35:10.523583|2017-10-11 01:35:10.523583
NCT01877733|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-09-17|||January 2013|Actual|2013-01-01|September 2017|2017-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effective Rehabilitation of Patients Operated With Total Knee Arthroplasty|Effective Rehabilitation of Patients Operated With Total Knee Arthroplasty|Completed||N/A|41|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 01:35:10.638883|2017-10-11 01:35:10.638883
NCT01877720|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-11-18|2015-05-28||November 2013||2013-11-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Physiologic Comparison Between NIV-NAVA and PS in Preterm Infants|Physiologic Comparison Between Noninvasive Neurally Adjusted Ventilatory Assist (NAVA) and Pressure Support (PS) in Preterm Infants|Completed||Phase 2/Phase 3|16|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:35:10.757606|2017-10-11 01:35:10.757606
NCT01877707|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-02-16|||January 2013||2013-01-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional|||Near Patient Microbial Testing in Cystic Fibrosis|A Home-based, Rapid and Quantitative Test for Bacterial Respiratory Infections in Patients With Cystic Fibrosis, to Reduce Admissions and Hospital Stay Length and to Improve Healthcare Outcomes.|Completed||N/A|16|Actual|Papworth Hospital NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 01:35:11.198188|2017-10-11 01:35:11.198188
NCT01877694|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-05-26|||June 2013||2013-06-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|BACTOvation™||Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis|A Multicenter, Randomized Study of the Efficacy and Safety of Auriclosene (NVC-422) Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis|Completed||Phase 2|217|Actual|NovaBay Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:35:11.281182|2017-10-11 01:35:11.281182
NCT01877681|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2015-04-15|||October 2012||2012-10-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Reference Nurse Program for Pressure Ulcers in Primary Care|Chronic Wounds Reference Nurse and Telematic Interconsultation Program for Pressure Ulcers in Primary Care: Evaluation of Effectiveness and Cost Reduction|Completed||Phase 2|58|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 01:35:11.392332|2017-10-11 01:35:11.392332
NCT01877668|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-06-06|2016-12-04||January 20, 2014|Actual|2014-01-20|June 2017|2017-06-01|December 18, 2015|Actual|2015-12-18|December 18, 2015|Actual|2015-12-18||Interventional|OPAL BROADEN|All participants who received at least 1 dose of study drug.|Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of Tofacitinib (CP-690,550) Or Adalimumab In Subjects With Active Psoriatic Arthritis|Completed||Phase 3|422|Actual|Pfizer||5|||f||||t||||||||Yes|"Information relating to our policy on data sharing and the process for requesting data can be found at the following link:
http://www.pfizer.com/research/clinical_trials/trial_data_and_results/data_requests"|2017-10-11 01:35:11.543037|2017-10-11 01:35:11.543037
NCT01877655|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2017-09-08|||September 22, 2013|Actual|2013-09-22|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|October 2017|Anticipated|2017-10-01||Interventional|HELIOS||A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Protective Efficacy and Safety of a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)|Active, not recruiting||Phase 3|514|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 01:35:16.095158|2017-10-11 01:35:16.095158
NCT01877629|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-12|2013-06-13|||June 2011||2011-06-01|June 2013|2013-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Study in Healthy Subjects to Assess the Pharmacokinetics, Safety, and Tolerability of Two Formulations of ACT-129968|A Single-center, Open-label, Two-period, Two-treatment, Crossover, Single-dose Study in Healthy Female and Male Subjects to Assess the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of ACT-129968|Completed||Phase 1|20|Actual|Actelion||2|||f||||f||||||||||2017-10-11 01:35:16.428037|2017-10-11 01:35:16.428037
NCT01877616|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2013-11-24|||June 2013||2013-06-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Sleep Disorders and Their Cardiovascular Correlates in Atahualpa.|Population-bases Study to Asses Prevalence of Sleep Disorders and Their Association With Cardiovascular Risk Factors and Diseases|Completed||N/A|650|Anticipated|Hospital Clínica Kennedy||1|||f||||f||||||||||2017-10-11 01:35:16.603181|2017-10-11 01:35:16.603181
NCT01877603|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-06-12|||July 2013||2013-07-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes|The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes|Completed||N/A|200|Actual|Wuhan General Hospital of Guangzhou Military Command|||1||f||||t||||||||||2017-10-11 01:35:16.720185|2017-10-11 01:35:16.720185
NCT01877590|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-08-19|||November 2013||2013-11-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease|Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease|Completed||Phase 4|66|Actual|Wuhan General Hospital of Guangzhou Military Command||2|||f||||t||||||||||2017-10-11 01:35:16.788334|2017-10-11 01:35:16.788334
NCT01877577|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2014-07-01|||April 2012||2012-04-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D|Supplementation of Vitamin D3 (Cholecalciferol) in Patients With Inflammatory Bowel Diseases (IBD) and Hypovitaminosis D: A Prospective Randomized Controlled Trial.|Completed||N/A|30|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:35:16.870471|2017-10-11 01:35:16.870471
NCT01877551|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-05-20|||September 2013||2013-09-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance|Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance|Recruiting||N/A|48|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:35:17.065277|2017-10-11 01:35:17.065277
NCT01877538|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-02-22|2015-05-31||May 2013||2013-05-01|February 2016|2016-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational||7 healthy control subjects|Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous System|"[11C]Donepezil PET for Imaging the Parasympathetic Nervous System in Healthy Adults"|Completed||Phase 1|7|Actual|University of Aarhus|||1||f||||t||||||||No||2017-10-11 01:35:17.201314|2017-10-11 01:35:17.201314
NCT01877525|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-11|||October 2011||2011-10-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|RD||Resect and Discard Approach to Diminutive Colonic Polyps|"Resect and Discard Approach to Diminutive Colonic Polyps: Real World Applicability Amongst Both Academic and Community Gastroenterologists"|Completed||N/A|618|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 01:35:17.436802|2017-10-11 01:35:17.436802
NCT01877512|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2014-05-06|||May 2013||2013-05-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||GH and Cardiovascular Risk Factors|Effect of Growth Hormone Replacement Therapy on Cardiovascular Risk Factors in Adult Patients With Severe Growth Hormone Deficiency: Association With IGF-I Concentration|Completed||Phase 4|32|Actual|VU University Medical Center||2|||f||||||||||||||2017-10-11 01:35:17.531107|2017-10-11 01:35:17.531107
NCT01877499|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-03-01|||March 28, 2013|Actual|2013-03-28|March 2017|2017-03-01|June 30, 2015|Actual|2015-06-30|March 6, 2015|Actual|2015-03-06||Observational|||Can High Convection Volumes be Achieved in Each Patient During Online Post-dilution Hemodiafiltration?|Can High Convection Volumes be Achieved in Each Patient During Online Post-dilution Hemodiafiltration? Feasibility Study in Preparation of the Convective Transport Study (CONTRAST II)|Completed||N/A|86|Actual|VU University Medical Center|||1||f||||f||||||||||2017-10-11 01:35:17.625312|2017-10-11 01:35:17.625312
NCT01877486|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2016-10-02|||January 2016||2016-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|ABLATE||PVI Using Cryoablation Alone in Paroxysmal AF Patients Converted From Persistent AF With Dofetilide|Pulmonary Vein Isolation Using Cryoablation Alone in Paroxysmal Atrial Fibrillation Patients Converted From Persistent Atrial Fibrillation With Dofetilide|Withdrawn||Phase 4|0|Actual|University of Rochester|||1|funding not available|f||||f||||||||No||2017-10-11 01:35:17.750416|2017-10-11 01:35:17.750416
NCT01877473|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2014-06-16|||May 2013||2013-05-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Reverse Remodeling and PVI Versus CFAE and/or Linear Lesions and PVI for Persistent AF||Withdrawn||Phase 4|0|Actual|Valley Health System||2||No enrollment|f||||f||||||||||2017-10-11 01:35:17.848414|2017-10-11 01:35:17.848414
NCT01877460|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-12|||January 2012||2012-01-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Sodium Alginate in Chocolate Milk, Satiety and Glycemic Control|The Effects of Isovolumetric Preloads of Sodium Alginate-enriched Chocolate Milk on Glycemia, Subjective Appetite and Food Intake in Healthy Young Men|Completed||N/A|24|Actual|University of Toronto||4|||f||||f||||||||||2017-10-11 01:35:17.940118|2017-10-11 01:35:17.940118
NCT01877447|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-12-13|||July 2013||2013-07-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Comparison of Two tDCS Protocols for the Treatment of Major Depressive Disorder|Comparison of Two Transcranial Direct Current Stimulation (tDCS) Protocols for the Treatment of Major Depressive Disorder: a Randomized, Double-blinded, Controlled Clinical Trial.|Completed||N/A|30|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:35:18.039964|2017-10-11 01:35:18.039964
NCT01877434|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-11|||October 2007||2007-10-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|January 2012|Actual|2012-01-01||Observational|RTESS||Reversed TESS Shoulder Artroplasty|The TESS Reverse Shoulder Arthroplasty: Effect of Arm Lengthening and Early Scapular Notching at Three Years Follow-up|Completed||N/A|40|Actual|Sundsvall Hospital|||1||f||||f||||||||||2017-10-11 01:35:18.134029|2017-10-11 01:35:18.134029
NCT01877421|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-08-09|2017-01-30||February 25, 2014|Actual|2014-02-25|August 2017|2017-08-01|March 2016|Actual|2016-03-01|August 25, 2015|Actual|2015-08-25||Interventional|APCG||Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population|A Double-Blind, Randomized, Controlled, Dose Escalation Clinical Trial of an Antiplaque Chewing Gum - Phase 1 Safety and Tolerability and Phase 2a Safety, Tolerability, and Proof of Concept in a Gingivitis Population|Completed||Phase 1/Phase 2|135|Actual|U.S. Army Medical Research and Materiel Command||10|||f||||t|t|f||||||||2017-10-11 01:35:18.293758|2017-10-11 01:35:18.293758
NCT01877408|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2014-01-07|2013-10-29||June 2013||2013-06-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Randomized Controlled Trial of Open Surgical vs. Rapid, Minimally-invasive Voluntary Adult Male Circumcision|A Randomized Controlled Trial of Open Surgical vs. Rapid, Minimally-invasive Voluntary Adult Male Circumcision|Completed||N/A|150|Actual|Simunye Primary Health Care||2|||f||||f||||||||||2017-10-11 01:35:26.171273|2017-10-11 01:35:26.171273
NCT01877096|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-11-03|||August 2013||2013-08-01|November 2015|2015-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Motivational Interviewing for Colonoscopy|Motivational Interviewing for Colonoscopy: A Feasibility and Pilot Study|Completed||N/A|57|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 01:35:30.300663|2017-10-11 01:35:30.300663
NCT01877395|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-11-17||2014-11-17|June 2013||2013-06-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen|Immunogenicity and Safety of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Rabies Human Diploid Cell Vaccine (Imovax® Rabies) Administered in a Simulated Rabies Post-exposure Regimen in Healthy Adults|Completed||Phase 2|342|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:35:26.650178|2017-10-11 01:35:26.650178
NCT01877382|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-09-19|||July 2013||2013-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|April 2018|Anticipated|2018-04-01||Interventional|||A Phase 1 Multiple Ascending Dose Study of DS-3032b, an Oral Murine Double Minute 2 (MDM2) Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas|A Phase 1 Multiple Ascending Dose Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas|Recruiting||Phase 1|80|Anticipated|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-11 01:35:26.772764|2017-10-11 01:35:26.772764
NCT01876264|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-04-05|||June 2013||2013-06-01|April 2016|2016-04-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|CERT||Crohn's Extent of Resection Trial|Crohn's Extent of Resection Trial (CERT): A Randomised Controlled Trial Comparing Anastomotic Disease Recurrence Following 2cm Versus 10cm Resection Margins for Patients With Ileocolic Crohn's Disease|Recruiting||N/A|190|Anticipated|Oxford University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 01:35:27.047444|2017-10-11 01:35:27.047444
NCT01876238|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-11-25|||May 2013||2013-05-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|March 2014|Actual|2014-03-01||Interventional|||Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer|Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals With Patients Diagnosed With Advanced Breast Cancer|Completed||N/A|29|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:35:27.302402|2017-10-11 01:35:27.302402
NCT01876225|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2014-05-18|||June 2013||2013-06-01|June 2013|2013-06-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Evaluating Pain and Discomfort Associated With Cervical Punch Biopsy|Evaluating Pain and Discomfort Associated With Cervical Punch Biopsy|Unknown status|Recruiting|N/A|90|Anticipated|Carmel Medical Center||2|||f||||f||||||||||2017-10-11 01:35:27.411943|2017-10-11 01:35:27.411943
NCT01877369|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-01-20|||June 2013||2013-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:35:27.508299|2017-10-11 01:35:27.508299
NCT01877356|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2015-04-23|||December 2012||2012-12-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparative Study Between Bilateral and Unilateral Spinal Anaesthesia|Unilateral Versus Bilateral Spinal Anesthesia in Day Case Procedures: Difference in Block Characteristics, Micturition Quality and Discharge Time|Terminated||N/A|25|Actual|University Hospital, Antwerp||2||intermittent evaluation of results: high incendence of complications|f||||t||||||||||2017-10-11 01:35:27.557079|2017-10-11 01:35:27.557079
NCT01877343|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2016-02-09|2015-02-20||June 2013||2013-06-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Developing a Non-invasive Cardiac Functional Health Status Measurement Device|Developing a Non-invasive Cardiac Functional Health Status Measurement Device to be Used in a Critical Population of Adults and Children With Heart Failure.|Terminated||N/A|10|Actual|University of Florida|Early termination due concerns for severity of stress test on high risk patients. Only control and post-transplant groups had enrollment. Statistical analysis cannot be performed.|1||Challenges associated with study enrollment due to stress test, study terminated|f||||f||||||||||2017-10-11 01:35:27.658403|2017-10-11 01:35:27.658403
NCT01877330|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-04-12|||January 2013||2013-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block|Intraplexus vs Extraplexus Injection of Local Anesthetic for Interscalene Block for Patients Undergoing Arthroscopic Shoulder Surgery|Completed||N/A|208|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:35:27.958324|2017-10-11 01:35:27.958324
NCT01877317|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-10-21|||May 2013||2013-05-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|SelfFit||Study of SelfFit Mobile Medical App for Hearing Loss Diagnostics and Hearing Device Fitting / Fine Tuning|Study of SelfFit App for Hearing Loss Diagnostics Based on Threshold Measurements Through In-situ Audiometry and Adjustment of Hearing Device Amplification Parameters in Agreement With Prescriptive Formulas as NAL-NL1,DSL-i/o|Completed||N/A|20|Actual|Two Pi Signalprocessing Applications GmbH||1|||f||||t||||||||No||2017-10-11 01:35:28.053492|2017-10-11 01:35:28.053492
NCT01877304|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-06-10|||June 2010||2010-06-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effect of Drug Targeting Nebulization on Lung Deposition|Effect of Drug Targeting Nebulization on Lung Deposition|Completed||N/A|10|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 01:35:28.170162|2017-10-11 01:35:28.170162
NCT01877291|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-14|||April 2012||2012-04-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Observational|||Young Smokers Have Impaired Airway Defense|Young Smokers Have Impaired Airway Defense That is Not Associated With Pulmonary Function|Completed||N/A|72|Actual|University of Sao Paulo|||3||f||||t||||||||||2017-10-11 01:35:28.264303|2017-10-11 01:35:28.264303
NCT01876082|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-10-04|||July 2012||2012-07-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|DESMOPAZ||PAZOPANIB Efficacy and Tolerance in Desmoids Tumors|PAZOPANIB Efficacy and Tolerance in Desmoids Tumors : Phase 2 Clinical Trial|Recruiting||Phase 2|94|Anticipated|Institut Bergonié||2|||f||||t||||||||||2017-10-11 01:35:45.469443|2017-10-11 01:35:45.469443
NCT01877278|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-01-22|2014-12-01||June 2013||2013-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Wearable Pulsed Electromagnetic Fields Device in Knee Osteoarthritis: Double Blinded, Randomized Clinical Trial|Wearable Pulsed Electromagnetic Fields Device in Knee Osteoarthritis Patients: a Double Blinded, Randomized Clinical Trial|Completed||N/A|66|Actual|University of Messina||2|||f||||f||||||||||2017-10-11 01:35:28.363039|2017-10-11 01:35:28.363039
NCT01877265|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-10-30|||June 2013||2013-06-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of LY2605541 in Healthy Participants|Assessment of the Impact of Monomethoxy Polyethylene Glycols on the Pharmacokinetics and Glucodynamics of Single Doses of LY2605541 in Healthy Subjects|Completed||Phase 1|18|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 01:35:28.651906|2017-10-11 01:35:28.651906
NCT01877252|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-11-18|||January 2013||2013-01-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01|2 Years|Observational [Patient Registry]|CRITISCH||Registry of First-line Treatments in Patients With Critical Limb Ischemia|National Registry Investigating the Effectiveness of Different First-line Treatment Strategies in Patients With Critical Limb Ischemia|Completed||N/A|1200|Actual|St. Franziskus Hospital|||4||f||||t||||||||||2017-10-11 01:35:28.733455|2017-10-11 01:35:28.733455
NCT01877239|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-02-15|||December 2012||2012-12-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|||Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria|A Multicenter Non-interventional Study To Observe The Safety And Efficacy Of Etanercept (Enbrel (Registered)) In Patients With Moderately Active Rheumatoid Arthritis In Every Day Clinical Practice In Austria|Completed||N/A|119|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:35:29.023315|2017-10-11 01:35:29.023315
NCT01877226|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-06-11|||September 2008||2008-09-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants|An Open-Label, Sequential Treatment Study to Assess the Single and Multiple Dose Pharmacokinetics of a New Tapentadol Prolonged-Release 250 mg Formulation in Healthy Subjects|Completed||Phase 1|18|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||f||||||||||2017-10-11 01:35:29.123801|2017-10-11 01:35:29.123801
NCT01877213|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-05-02|||June 2013||2013-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|SORTIDIAB||Coaching of Diabetic Patients After Hospital Discharge|Coaching of Difficult Diabetic Patients by a Care Coordinating Team After Hospital Discharge|Recruiting||N/A|600|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:35:29.222002|2017-10-11 01:35:29.222002
NCT01877200|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-01-20|||June 2013||2013-06-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|DiabCare Asia||A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh|A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh|Completed||N/A|2092|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:35:29.306821|2017-10-11 01:35:29.306821
NCT01877187|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-04-21|||April 2013|Actual|2013-04-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer|Lipiodol as an Imaging Biomarker of Tumor Necrosis After Transcatheter Chemoembolization Therapy in Patients With Primary and Metastatic Liver Cancer|Active, not recruiting||Phase 2|39|Actual|Yale University||1|||f||||t||||||||||2017-10-11 01:35:29.386063|2017-10-11 01:35:29.386063
NCT01877174|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-09-02|||May 2013||2013-05-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||MICHI™ Neuroprotection System (NPS+f) Filter Debris Analysis Study (The F-1 Study)|MICHI™ Neuroprotection System (NPS+f) Filter Debris Analysis Study (The F-1 Study)|Completed||N/A|24|Actual|Silk Road Medical|||1||f||||f||||||Samples With DNA|"     The inline filter of the MICHI(TM) NPS+f System may contain debris that is released from the     lesion during carotid stenting. It is the objective of the study to determine the volume and     characteristics of the debris.   "|||2017-10-11 01:35:29.464528|2017-10-11 01:35:29.464528
NCT01877161|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-06-26|2014-01-23||December 2012||2012-12-01|June 2017|2017-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Same patients were stimulated over 2 different regions and with sham stimulation in a random order|Effects of Navigated Repetitive Transcranial Magnetic Stimulation According to Post-stroke Aphasia Types|Effects of Navigated Repetitive Transcranial Magnetic Stimulation According to Post-stroke Aphasia Types|Completed||N/A|12|Actual|Seoul National University Bundang Hospital||3|||f||||||||||||||2017-10-11 01:35:29.543101|2017-10-11 01:35:29.543101
NCT01877148|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-05-14|2015-02-26||January 2010||2010-01-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Effects Of tDCS With Physical Therapy On Rehabilitation In Parkinson's Disease|Effects of Transcranial Direct Current Stimulation Associated With Physical Therapy on Motor Rehabilitation in Parkinson´s Disease Patients|Completed||Phase 2|12|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:35:29.74617|2017-10-11 01:35:29.74617
NCT01877135|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-03-04|||August 2013||2013-08-01|September 2013|2013-09-01|June 2019|Anticipated|2019-06-01|June 2016|Anticipated|2016-06-01||Observational|AIN3||Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients|Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients|Recruiting||N/A|1000|Anticipated|French Society of Coloproctology|||1||f||||f||||||Samples Without DNA|"     A liquid phase anal smear   "|||2017-10-11 01:35:30.060227|2017-10-11 01:35:30.060227
NCT01877122|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-06-24|||April 2013||2013-04-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparative Study of Safety and Efficacy of Heavyweight and Partially Absorbable Mesh in Inguinal Hernia Repair||Completed||Phase 4|50|Actual|Samyang Biopharmaceuticals Corporation||2|||f||||f||||||||||2017-10-11 01:35:30.150282|2017-10-11 01:35:30.150282
NCT01877109|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-10|||January 2012||2012-01-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01|5 Years|Observational [Patient Registry]|SMC-LCS-II||Samsung Medical Center-Lymphoma Cohort Study-II|Prospective Observation Cohort Study of Malignant Lymphoma Patients|Unknown status|Recruiting|N/A|1000|Anticipated|Samsung Medical Center|||1||f||||f||||||Samples With DNA|"     1. Serum        2. Tissue specimen        3. DNA from peripheral blood mononuclear cells   "|||2017-10-11 01:35:30.224035|2017-10-11 01:35:30.224035
NCT01877083|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2016-09-15|||April 2013||2013-04-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|February 2016|Actual|2016-02-01||Interventional|||Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung|A Multicenter, Open-Label Phase 2 Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung|Active, not recruiting||Phase 2|25|Actual|Eisai Inc.||1|||f||||t||||||||||2017-10-11 01:35:30.402645|2017-10-11 01:35:30.402645
NCT01877070|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-08-09|||June 2013||2013-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies|Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies|Recruiting||N/A|561|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 01:35:30.566921|2017-10-11 01:35:30.566921
NCT01877057|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-07-06|||March 2013||2013-03-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Protected Pea Protein Extract and Satiety Hormone Release|Assessment of the Effects of Gastric Degradation-protected Pea Protein Extract on Mucosal Satiety Hormone Release by Human Duodenal Tissue|Completed||N/A|31|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-11 01:35:32.45175|2017-10-11 01:35:32.45175
NCT01877044|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-07-06|||January 2013||2013-01-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Long-term Effects of Arabinoxylans on Intestinal Barrier Function|The Effects of Long-term Arabinoxylan Administration on Intestinal Barrier Function and Innate Immunity|Completed||N/A|46|Actual|Maastricht University Medical Center||3|||f||||t||||||||||2017-10-11 01:35:32.564923|2017-10-11 01:35:32.564923
NCT01877031|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2013-06-12|||April 2013||2013-04-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Virtual Reality With Ultrasound Versus Ultrasound For Central Line Insertion|Needle Guidance With Virtual Reality Augmented Ultrasound Versus Ultrasound Guidance Alone For Central Line Insertion: A Randomized Trial.|Unknown status|Recruiting|N/A|192|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:35:32.673589|2017-10-11 01:35:32.673589
NCT01877018|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-02|2016-08-29|||September 2010||2010-09-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|COLO-ALERT||Colorectal Cancer Screening in Primary Care|Effectiveness of an Electronic Alert Into the Primary Care Medical Health Record to Increase Participation in a Population Colorectal Cancer Screening Program.|Completed||N/A|41042|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 01:35:32.845287|2017-10-11 01:35:32.845287
NCT01877005|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-09-07|||July 2013||2013-07-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|June 2015|Actual|2015-06-01||Interventional|HIJAK||A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma|A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma|Active, not recruiting||Phase 2|33|Actual|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-11 01:35:33.007191|2017-10-11 01:35:33.007191
NCT01876992|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-08-28|2016-08-02||January 2012||2012-01-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Metformin at the Cellular Level and Dosing for Diabetes Mellitus (DM)|Pilot Study of Metformin-induced CBP Phosphorylation at the Cellular Level and Corresponding Clinical Dose Response in Adults and Children|Terminated||N/A|10|Actual|Johns Hopkins University||2||All investigators/co-investigators relocating to other institutions.|f||||t||||||||||2017-10-11 01:35:33.142922|2017-10-11 01:35:33.142922
NCT01876979|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-05-26|2016-11-22||July 2013||2013-07-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Arch Bars vs. IMF (Intermaxillary Fixation) Screws: Cost Effectiveness Based on Time Duration of Device Placement.|Erich Arch Bars vs. IMF Screws for Placement of Maxillomandibular Fixation: Which is More Time Effective in the Operating Room Setting?|Terminated||N/A|5|Actual|Christiana Care Health Services||2||Extended study duration|f||||f||||||||||2017-10-11 01:35:33.555097|2017-10-11 01:35:33.555097
NCT01876966|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2013-06-11|||March 2011||2011-03-01|June 2013|2013-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|DDI Coartem||Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine|A Phase I, Partially Randomized, Open Label, Two-way, Two Period Cross-over Study to Investigate the Pharmacokinetic Interaction Between Etravirine or Darunavir/Rtv and Artemether/Lumefantrine at Steady-state in Healthy HIV-negative Subjects|Completed||Phase 1|33|Actual|Janssen Pharmaceutica N.V., Belgium||2|||f||||f||||||||||2017-10-11 01:35:33.983462|2017-10-11 01:35:33.983462
NCT01876953|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-05-08|||September 10, 2013|Actual|2013-09-10|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia|Phase I/II Study of the Combination of Dasatinib With Chemotherapy for High Risk Acute Myeloid Leukemia (AML) Patients|Active, not recruiting||Phase 1/Phase 2|52|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:35:34.10136|2017-10-11 01:35:34.10136
NCT01876940|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2013-07-29|||June 2013||2013-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparison of Fiberoptic Intubation With Fiberoptic Intubation Through an Air-Q Intubating Laryngeal Airway in Infants and Small Children|A Randomized Comparison of Free-handed Fiberoptic Intubation Compared With Fiberoptic Intubation Through an Air-QTM Intubating Laryngeal Airway in Children Less Than Two Years of Age: Does Operator Experience Affect Time to Successful Tracheal Intubation?|Completed||N/A|80|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 01:35:34.253889|2017-10-11 01:35:34.253889
NCT01876927|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-07-19|||September 2010||2010-09-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|GastroDOC||Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer|A Randomised Phase Ii Study Of Pre-Operative Or Peri-Operative Docetaxel, Oxaliplatin, Capecitabine (Dox) Regimen In Patients With Locally Advanced Resectable Gastric Cancer|Completed||Phase 2|90|Actual|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||||2017-10-11 01:35:34.385415|2017-10-11 01:35:34.385415
NCT01876914|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-04-21|||June 2013||2013-06-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|OCT and DME||Pilot Study of OCT Versus Fluorescein Angiography in DME|Pilot Study of OCT Versus Fluorescein Angiography in Diabetic Macular Edema in Eyes With Good and Poor Macular Capillary Perfusion|Unknown status|Active, not recruiting|N/A|28|Anticipated|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 01:35:34.565338|2017-10-11 01:35:34.565338
NCT01876901|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-09-29|||May 2010||2010-05-01|September 2017|2017-09-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|CASCADOR||Efficacy of Delayed Coloanal Anastomosis for Medium and Lower Rectum Cancer Treatment. Phase 2 Clinical Trial (CASCADOR)|Efficacy of Delayed Coloanal Anastomosis for Medium and Lower Rectum Cancer Treatment. Phase 2 Clinical Trial.|Active, not recruiting||Phase 2|116|Anticipated|Institut Bergonié||2|||f||||t||||||||||2017-10-11 01:35:34.675183|2017-10-11 01:35:34.675183
NCT01876888|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-06-12|||April 2011||2011-04-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01|15 Days|Observational [Patient Registry]|||Turkish Cultural Adaptation, Validation and Reliability Study of MedRisk Instrument|Turkish Version of MedRisk Instrument for Measuring Patient Satisfaction With Physical Therapy Care: Its Cultural Adaptation, Validation and Reliability Study|Completed||N/A|317|Actual|Hacettepe University|||1||f||||f||||||||||2017-10-11 01:35:34.8047|2017-10-11 01:35:34.8047
NCT01876875|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-11|||April 2007||2007-04-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|PSO||n-3 Polysaturated Fatty Acids-rich Diet in Psoriasis|Energy-restricted, n-3 Polysaturated Fatty Acids-rich Diet Improves the Clinical Response to Immuno-modulating Drugs in Obese Patients With Plaque-type Psoriasis: a Randomized Control Clinical Trial.|Completed||Phase 4|44|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 01:35:34.885361|2017-10-11 01:35:34.885361
NCT01876862|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2015-09-28|||September 2013||2013-09-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|ULTRASTOP||Towards HIV Functional Cure|A Pilot Study Evaluating the Maintenance of Viral Suppression After 24 Weeks of Therapeutic Interruption in Chronically HIV-1 Infected Patients With a Low Circulating HIV-DNA Reservoir|Completed||N/A|15|Actual|Objectif Recherche Vaccins SIDA||1|||f||||t||||||||||2017-10-11 01:35:34.99881|2017-10-11 01:35:34.99881
NCT01876849|ClinicalTrials.gov processed this data on October 10, 2017|2009-07-14|2015-02-23|||December 2003||2003-12-01|January 2015|2015-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus|An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|275|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 01:35:35.100857|2017-10-11 01:35:35.100857
NCT01876836|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-11|||July 2013||2013-07-01|June 2013|2013-06-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|C-LMA||Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications|Comparation the Effect of C-LMA and I-gel in Regurgitation and Postoperative Complications|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||2|||f||||t||||||||||2017-10-11 01:35:35.20681|2017-10-11 01:35:35.20681
NCT01876823|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-10-23|2013-09-23||April 2006||2006-04-01|September 2013|2013-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment|Effects of Combined Memantine (Namenda) Plus Escitalopram (Lexapro) Treatment in Elderly Depressed Patients With Cognitive Impairment|Completed||Phase 2/Phase 3|60|Actual|New York State Psychiatric Institute|"The inclusion criteria required all patients to have an MMSE of 24 or higher, which may have lowered the conversion rate to dementia
small sample size
cognitive improvement may have been due in part to combined es-citalopram and memantine"|1|||f||||f||||||||||2017-10-11 01:35:35.353364|2017-10-11 01:35:35.353364
NCT01876810|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-04-18|2016-12-21||February 2014||2014-02-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction|Testing the PPAR Hypothesis of Nicotine Dependence in Humans: Gemfibrozil as a Novel Treatment for Tobacco Addiction|Completed||Phase 2|28|Actual|Centre for Addiction and Mental Health||2|||f||||t||||||||Yes||2017-10-11 01:35:35.784255|2017-10-11 01:35:35.784255
NCT01876797|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-02-27|||July 2013||2013-07-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||PKPD Study of Ticagrelor and Prasugrel in Healthy Korean Males|A Single Dose, Open-label, One Sequence, 2-period, Crossover Study to Characterize the Pharmacokinetics and Pharmacodynamics of Ticagrelor and Prasugrel in Healthy Male Adult Subjects|Completed||Phase 1|12|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 01:35:36.276215|2017-10-11 01:35:36.276215
NCT01876784|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-08-07|2017-01-23||September 17, 2013|Actual|2013-09-17|August 2017|2017-08-01|July 27, 2017|Actual|2017-07-27|August 30, 2015|Actual|2015-08-30||Interventional|VERIFY||Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer|A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™; SAR390530 (Formerly AstraZeneca ZD6474)) 300 mg in Patients With Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy.|Completed||Phase 3|243|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:35:36.413674|2017-10-11 01:35:36.413674
NCT01876771|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-11-16|||April 2014||2014-04-01|April 2015|2015-04-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|NAP||A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours|An Open-label, Phase II, Registry Study of Lutetium-177 [DOTA0, Tyr3] Octreotate (Lu-DOTA-TATE) Treatment in Subjects With Somatostatin Receptor Positive Tumours|Recruiting||Phase 2|400|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 01:35:37.331102|2017-10-11 01:35:37.331102
NCT01876758|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-07-13|||September 2012||2012-09-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|August 2015|Actual|2015-08-01||Interventional|||Cognitive Training for Memory Deficits Associated With Electroconvulsive Therapy|Cognitive Training for Memory Deficits Associated With Electroconvulsive Therapy|Completed||N/A|59|Actual|New York State Psychiatric Institute||3|||f||||f||||||||||2017-10-11 01:35:37.478295|2017-10-11 01:35:37.478295
NCT01876745|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-07-10|||October 7, 2014|Actual|2014-10-07|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|||A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan|A Multicentre, Non-interventional, Observational Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan|Completed||N/A|4|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:35:37.614609|2017-10-11 01:35:37.614609
NCT01876732|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-09-05|2014-02-06||June 2009||2009-06-01|September 2014|2014-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients|Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients|Completed||N/A|132|Actual|Northwell Health|There were too few patients with MMA levels over 800 to determine sensitivity.|1|||f||||t||||||||||2017-10-11 01:35:37.747034|2017-10-11 01:35:37.747034
NCT01876719|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2015-11-10||2015-06-05|June 2013||2013-06-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||AR08 for Treatment of ADHD in Children|A Randomized, Double-Blind, Placebo-Controlled, Forced Titration, Proof-of-Concept Study of AR08 in the Treatment of Attention Deficit Hyperactivity Disorder in Children (Ages 6 - 17)|Completed||Phase 2|122|Actual|Arbor Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 01:35:38.289703|2017-10-11 01:35:38.289703
NCT01876706|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-06-29|2015-04-29||April 2013||2013-04-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|October 2014|Actual|2014-10-01||Interventional|LOCAL||UroLift System TOlerability and ReCovery When Administering Local Anesthesia|L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia|Active, not recruiting||N/A|51|Actual|NeoTract, Inc.||1|||f||||f||||||||||2017-10-11 01:35:38.453543|2017-10-11 01:35:38.453543
NCT01876693|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-03-29|||May 2013||2013-05-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||A Prospective Study of Prophylactic Gastrostomy in Head and Neck Cancer Patients Undergoing Chemoradiotherapy|A Prospective Study of Prophylactic Gastrostomy in Head and Neck Cancer Patients Undergoing Chemoradiotherapy in Medical Practice|Terminated||N/A|95|Actual|Mahidol University||2||slow accrual in experiment arm|f||||f||||||||No||2017-10-11 01:35:39.1159|2017-10-11 01:35:39.1159
NCT01876680|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2013-06-10|||September 2009||2009-09-01|June 2013|2013-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Effects of Two Different Home-exercise Programmes on Women Suffering Long Term Neck/Shoulder Muscle Pain|The Effects (Pain, Function, Biochemistry and Psychological Factors) of Two Different Home-exercise Programmes on Women Suffering Long Term Nack/Shoulder Muscle Pain|Completed||Phase 2|57|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-11 01:35:39.246672|2017-10-11 01:35:39.246672
NCT01876667|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-10-03|||July 2010||2010-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||An Evaluation of Clinical Pharmacist-led Intervention on Clinical Outcomes in Patients With Ischemic Stroke|An Evaluation of Clinical Pharmacist-led Intervention on Clinical Outcomes in Patients With Ischemic Stroke|Active, not recruiting||N/A|400|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 01:35:39.397189|2017-10-11 01:35:39.397189
NCT01876654|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-05-10|||June 2013|Actual|2013-06-01|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Evaluation of the TruMatch® System in Knee Prosthetic Surgery|Evaluation of the TruMatch® Personalized Solutions System in Knee Prosthetic Surgery|Completed||N/A|64|Actual|University of Milan||2|||f||||f||||||||No||2017-10-11 01:35:39.537737|2017-10-11 01:35:39.537737
NCT01876641|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-08-03|||October 2013||2013-10-01|August 2017|2017-08-01||||June 2018|Anticipated|2018-06-01||Interventional|ML28604||Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib|Phase 1/2 Study Epigenetic Modification of BRAF-mutated Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib|Recruiting||Phase 1/Phase 2|38|Anticipated|University of Iowa||1|||f||||t||||||||||2017-10-11 01:35:39.699352|2017-10-11 01:35:39.699352
NCT01876615|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-12-31|||July 2013||2013-07-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Pharmacokinetic Drug Interaction Between YH4808 and Diclofenac|A Randomized, Open-Label, Single-dosing and Cross-over Clinical Trial to Investigate the Safety and Pharmacokinetic Drug-Drug Interaction of YH4808 and Diclofenac in Healthy Male Volunteers|Completed||Phase 1|49|Actual|Yuhan Corporation||6|||f||||f||||||||||2017-10-11 01:35:40.015153|2017-10-11 01:35:40.015153
NCT01876602|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-12-04|||April 2011||2011-04-01|December 2015|2015-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Test of an Intervention to Increase Physical Activity Among School Children|Feeling States and Heart Rates; A Translational Study|Active, not recruiting||N/A|140|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-10-11 01:35:40.172812|2017-10-11 01:35:40.172812
NCT01876589|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-07-30|||June 2013||2013-06-01|July 2016|2016-07-01||||June 2018|Anticipated|2018-06-01||Interventional|VANISH||Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion:a Randomized H215O PET/CT Study|Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion: a Randomized H215O PET/CT Study|Active, not recruiting||N/A|60|Actual|VU University Medical Center||2|||f||||f||||||||||2017-10-11 01:35:40.262643|2017-10-11 01:35:40.262643
NCT01876576|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-11|||April 2012||2012-04-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||The Impact of Diet Liberalization on Bowel Preparation for Colonoscopy|The Impact of Diet Liberalization on Bowel Preparation for Colonoscopy|Completed||N/A|175|Actual|Thomas Jefferson University||2|||f||||f||||||||||2017-10-11 01:35:40.345406|2017-10-11 01:35:40.345406
NCT01876563|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-10|||August 2012||2012-08-01|June 2013|2013-06-01|July 2014|Anticipated|2014-07-01|February 2014|Anticipated|2014-02-01||Interventional|||the Effect of Vitamin D on the Serum Thioredoxin, TBP-2, Thioredoxin Reductase, Gene Expression of TBP-2 in Patients With Type II Diabetes||Unknown status|Enrolling by invitation|Phase 4|30|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:35:40.469322|2017-10-11 01:35:40.469322
NCT01876550|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-05-03|||February 2013||2013-02-01|May 2017|2017-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.|A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of a Generic Mupirocin Calcium Cream, 2% and Reference Listed Bactroban® Cream (Mupirocin Calcium Cream, 2%) and Compare Both Active Treatments to a Vehicle Control in the Treatment of Secondarily Infected Traumatic Skin Lesions.|Completed||Phase 1|696|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 01:35:40.590698|2017-10-11 01:35:40.590698
NCT01876537|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-11|||January 2011||2011-01-01|June 2013|2013-06-01||||June 2013|Actual|2013-06-01||Interventional|HWHPSD||Hardware Wound Healing In Surgical Treatment Of Sacrococcygeal Pilonidal Sinus Disease|Phase 1 STRENGTHENING OF THE SACROCOCCYGEAL FASCIA IN THE SURGICAL TREATMENT OF PILONIDAL SINUS DISEASE|Unknown status|Active, not recruiting|N/A|||Voronezh N.N. Burdenko State Medical Academy||2|||f||||t||||||||||2017-10-11 01:35:40.722604|2017-10-11 01:35:40.722604
NCT01876524|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-10-16|||July 2013||2013-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|tRND&SUDs||tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients|Transcranial Random Noise Stimulation in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients|Completed||N/A|225|Actual|Spanish Foundation for Neurometrics Development||3|||f||||t||||||||||2017-10-11 01:35:40.820588|2017-10-11 01:35:40.820588
NCT01876511|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-10-05|||September 2013||2013-09-01|October 2017|2017-10-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors|Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors|Recruiting||Phase 2|171|Anticipated|Sidney Kimmel Comprehensive Cancer Center||4|||f||||t||||||||||2017-10-11 01:35:40.982598|2017-10-11 01:35:40.982598
NCT01876498|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-08-19|||August 2013||2013-08-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01|1 Year|Observational [Patient Registry]|||Registry of Patient With M. Dupuytren and Validation of the Brief MHQ|Buildup of a Registry of Patient With M. Dupuytren and Validation of the Brief Michigan Hand Questionnaire|Completed||N/A|60|Actual|Schulthess Klinik|||1||f||||f||||||||||2017-10-11 01:35:41.151481|2017-10-11 01:35:41.151481
NCT01876485|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-08-09|||July 13, 2015|Actual|2015-07-13|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|February 23, 2018|Anticipated|2018-02-23||Interventional|EPIC||Point-of-care Health Literacy and Activation Information to Improve Diabetes Care|Point-of-care Health Literacy and Activation Information to Improve Diabetes Care|Active, not recruiting||N/A|284|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 01:35:41.258482|2017-10-11 01:35:41.258482
NCT01876472|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-10|||November 2011||2011-11-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Differences in Music Perception Skills Between Child, Teen and Adult Cochlear Implant Recipients|Differences in Music Perception Skills Between Child, Teen and Adult Cochlear Implant Recipients|Completed||Phase 2|50|Actual|University of Zurich|||3||f||||f||||||||||2017-10-11 01:35:41.399788|2017-10-11 01:35:41.399788
NCT01876459|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-17|||April 2013||2013-04-01|June 2013|2013-06-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|AlphaLewyMa||Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.|Rate of Alpha-synuclein in Cerebrospinal Fluid to Differentiate Patient With Alzheimer's Disease From Those With Lewy Body Disease.|Unknown status|Recruiting|N/A|265|Anticipated|University Hospital, Strasbourg, France||2|||f||||||||||||||2017-10-11 01:35:41.554743|2017-10-11 01:35:41.554743
NCT01876446|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-10-05|||August 29, 2013|Actual|2013-08-29|October 2017|2017-10-01|May 5, 2018|Anticipated|2018-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer|A Phase II Study of Single Agent Topoisomerase-I Inhibitor Polymer Conjugate, Etirinotecan Pegol (NKTR-102), in Patients With Relapsed Small Cell Lung Cancer|Active, not recruiting||Phase 2|38|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 01:35:41.685888|2017-10-11 01:35:41.685888
NCT01876433|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-06-09|||September 2013||2013-09-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|Beat-HF||Beta 3 Agonist Treatment in Heart Failure|Beta 3 Agonist Treatment in Heart Failure|Unknown status|Recruiting|Phase 2|70|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:35:41.824979|2017-10-11 01:35:41.824979
NCT01876407|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-02-04|||January 2013||2013-01-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer||Recruiting||Phase 4|126|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||t||||||||||2017-10-11 01:35:42.107984|2017-10-11 01:35:42.107984
NCT01876394|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2016-03-09|||June 2014||2014-06-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|COIL||Comparison of Dietary Fats on Vascular Parameters|Acute Effects of Dietary Fats on Postprandial Vascular Function in Healthy Individuals: Pilot Double Blind, Randomized, Controlled Trial|Recruiting||N/A|24|Anticipated|St. Michael's Hospital, Toronto||5|||f||||f||||||||||2017-10-11 01:35:42.233249|2017-10-11 01:35:42.233249
NCT01876381|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2014-07-31|||June 2013||2013-06-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration|A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration|Completed||Phase 2|26|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 01:35:42.379039|2017-10-11 01:35:42.379039
NCT01876368|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2015-11-03|2015-07-29||September 2013||2013-09-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Subject demographics and background characteristics by treatment group (Full analysis set)|Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan|A Randomized 8-week Double-blind, Parallel-group, Active-controlled, Multicenter Study to Evaluate Efficacy and Safety of LCZ696 200 mg in Comparison With Olmesartan 20 mg in Essential Hypertensive Patients Not Responsive to Olmesartan|Completed||Phase 3|376|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:35:42.514051|2017-10-11 01:35:42.514051
NCT01876355|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-01-21|||January 2018||2018-01-01|January 2016|2016-01-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|CATAPRES||The Effect of Clonidine-enhanced Sedation on Delirium in Ventilated Critically Ill Patients|The Effect of Clonidine-enhanced Sedation on Delirium in Ventilated Critically Ill Patients CATAPRES (Confusion and Alpha-Two Agonist Prescription Randomised Efficacy Study)|Not yet recruiting||Phase 3|115|Anticipated|Deventer Ziekenhuis||2|||f||||t||||||||||2017-10-11 01:35:43.286957|2017-10-11 01:35:43.286957
NCT01866280|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-04-17|||November 2012||2012-11-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Sleep Timing and Energy Balance|Effect of Sleep Timing, Independent of Duration, on Food Intake and Metabolic Control of Energy Balance|Completed||N/A|5|Actual|St. Luke's-Roosevelt Hospital Center||4|||f||||t||||||||||2017-10-11 01:39:18.224016|2017-10-11 01:39:18.224016
NCT01876342|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2017-03-07|||June 2013||2013-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|sports hernia||TEP Versus Open Repair of Sportsman's Hernia|Total ExtraPeritoneal (TEP) Versus Open Minimal Suture Repair for Treatment of Sportsman's Hernia/Athletic Pubalgia: A Randomized Multi-center Trial|Recruiting||N/A|60|Anticipated|Kuopio University Hospital||2|||f||||f||||||||Undecided||2017-10-11 01:35:43.391832|2017-10-11 01:35:43.391832
NCT01876329|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2015-05-11|2015-04-09||June 2013||2013-06-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients|Presence of Autoantibodies to Gastric Parietal Cells and Subsequent Vitamin B12 Deficiency in Rheumatoid Arthritis Patients|Completed||N/A|125|Actual|Keesler Air Force Base Medical Center|||3||f||||f||||||||||2017-10-11 01:35:43.525389|2017-10-11 01:35:43.525389
NCT01876316|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-09|2013-06-11|||November 2011||2011-11-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects|A Randomized, Double-blind, Placebo-controlled, Two-way Crossover Trial to Compare Moxifloxacin Induced QT Interval Prolongation in Japanese and Korean Healthy Subjects|Completed||N/A|40|Actual|Inje University||2|||f||||f||||||||||2017-10-11 01:35:44.037746|2017-10-11 01:35:44.037746
NCT01876303|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-07-13|||December 2012||2012-12-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma|Genetic Epidemiology of Ewing's Sarcoma|Completed||N/A|1650|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     saliva   "|||2017-10-11 01:35:44.155005|2017-10-11 01:35:44.155005
NCT01876290|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-10-28|||May 2013||2013-05-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|January 2014|Actual|2014-01-01||Interventional|Loop-NVPO||Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting|Should we Associate Dexamethasone and Ondansetron to Closed-loop Anesthesia to Reduce the Incidence of Postoperative Nausea and Vomiting After Bariatric Surgery?|Completed||Phase 4|122|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 01:35:44.264703|2017-10-11 01:35:44.264703
NCT01876212|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-07-28|||November 2013||2013-11-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma|A Randomized Phase 2 Pilot Study of Type I-Polarized Autologous Dendritic Cell Vaccines Incorporating Tumor Blood Vessel Antigen (TBVA)-Derived Peptides in Combination With Dasatinib in Patients With Metastatic Melanoma|Recruiting||Phase 2|28|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:35:44.384371|2017-10-11 01:35:44.384371
NCT01876199|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-08-01|||February 2013||2013-02-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|AHI||Targeted Screening of At-Risk Adults for Acute HIV-1 Infection|Targeted Screening of At-Risk Adults for Acute HIV-1 Infection|Completed||N/A|522|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 01:35:44.513879|2017-10-11 01:35:44.513879
NCT01876186|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-07-05|||May 2013||2013-05-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients|Comparisons of Urodynamic Effects, Urinary Nerve Growth Factor Levels and Outcomes in Female Overactive Bladder Patients After 3-month Versus 6-month Solifenacin Treatment: a Randomized Prospective Study|Unknown status|Recruiting|Phase 4|200|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:35:44.595333|2017-10-11 01:35:44.595333
NCT01876173|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-03-16|||June 2012||2012-06-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Feasibility Testing of Decision Support for Patients Who Are Candidates for an Implantable Defibrillator|Development of and Feasibility Testing of Decision Support for Patients Who Are Candidates for an Implantable Defibrillator|Completed||N/A|82|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 01:35:44.693285|2017-10-11 01:35:44.693285
NCT01876160|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-06-08|||March 2011||2011-03-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Analysis of Sensory and Motor Thresholds During Transcutaneous Electrical Stimulation in Different Sexes and Ages||Completed||N/A|86|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:35:44.801916|2017-10-11 01:35:44.801916
NCT01876147|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-03-16|||June 2013||2013-06-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Observational|||Visual and Functional Assessment in Low Vision Patients|A Randomised Crossover Study to Assess the Usability of Two New Vision Tests in Patients With Low Vision, and Relationship of the Measures to Daily Living Tasks.|Active, not recruiting||N/A|50|Actual|University of Oxford|||2||f||||f||||||||||2017-10-11 01:35:44.875141|2017-10-11 01:35:44.875141
NCT01876134|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2013-06-10|||April 2013||2013-04-01|June 2013|2013-06-01||||June 2014|Anticipated|2014-06-01|1 Week|Observational [Patient Registry]|||The Diagnostic Role of Cystein-rich Protein 61 (Cyr61) in Acute Kidney Injury: Correlation With the Harmonic Analysis of Arterial Pressure Pulse Waves.|The Diagnostic Role of Cystein-rich Protein 61 (Cyr61) in Acute Kidney Injury: Correlation With the Harmonic Analysis of Arterial Pressure Pulse Waves.|Unknown status|Active, not recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-11 01:35:44.987095|2017-10-11 01:35:44.987095
NCT01876121|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-09-04|||July 2012||2012-07-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Celecoxib Japan Observational Study for the Patients With Acute Pain|Celecoxib Japan Observational Study for the Patients With Acute Pain|Completed||N/A|784|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:35:45.065161|2017-10-11 01:35:45.065161
NCT01876108|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-08|2013-07-04|||July 2012||2012-07-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease|The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Subjects With Non-alcoholic Fatty Liver Disease|Completed||Phase 2|100|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:35:45.192464|2017-10-11 01:35:45.192464
NCT01876095|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-03-20|||June 2014||2014-06-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Discontinuing Inappropriate Medication in Nursing Home Residents|Discontinuing Inappropriate Medication in Nursing Home Residents (the DIM NHR Study): a Cluster Randomized Controlled Trial|Completed||N/A|992|Actual|University of Groningen||2|||f||||f||||||||||2017-10-11 01:35:45.343131|2017-10-11 01:35:45.343131
NCT01876069|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-04-25|||July 2013||2013-07-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer|Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Endoscopic Ultrasonography-guided Sampling of Suspected Unresectable Pancreatic Cancer|Completed||N/A|65|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 01:35:45.621581|2017-10-11 01:35:45.621581
NCT01876056|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-10-27|||February 2013||2013-02-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Brief Culturally Adapted Cognitive Behavior Therapy for Psychosis|A Randomized Controlled Trial of Brief Culturally Adapted CBT for Schizophrenia in Pakistan|Completed||N/A|120|Actual|Pakistan Association of Cognitive Therapists||2|||f||||t||||||||||2017-10-11 01:35:45.745355|2017-10-11 01:35:45.745355
NCT01876030|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-05-02|||June 2013||2013-06-01|April 2013|2013-04-01||||June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Different Treatment Methods for Gait Rehabilitation of Sub-Acute Post Stroke Patients With Dropped Foot||Unknown status|Recruiting|N/A|40|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 01:35:45.969032|2017-10-11 01:35:45.969032
NCT01876017|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-08|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure|An Open Labeled Clinical Study to Evaluate the Safety and Efficacy of of Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) in Chronic Renal Failure Patients. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Chaitanya Hospital, Pune||1|||f||||f||||||||||2017-10-11 01:35:46.108134|2017-10-11 01:35:46.108134
NCT01876004|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-10|||September 2011||2011-09-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy|Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy|Completed||Phase 4|25|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 01:35:46.231123|2017-10-11 01:35:46.231123
NCT01875991|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2015-05-01|2015-03-03||June 2013||2013-06-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept|An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept|Completed||Phase 4|217|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:35:46.35409|2017-10-11 01:35:46.35409
NCT01875978|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-05-12|2013-11-07||October 2012||2012-10-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional||Fatty liver was diagnosed by abdominal echo, except hepatitis B,C,alcohol consumption. Totally 40 patients randomized divided to group A for phytosterols-placebo sequence and group B for placebo-phytosterols sequence.|Effect of Phytosterols on Nonalcoholic Fatty Liver Disease|Clinical Study of Phytosterols for Insulin-like Growth Factor-1 and Endothelial Progenitor Cell Levels in Patients With Nonalcoholic Fatty Liver Disease|Completed||N/A|40|Actual|China Medical University Hospital|"The sample size of this study is small amount
Abdominal ultrasound related nonalcoholic fatty liver disease diagnosis is not compatible completely"|1|||f||||t||||||||||2017-10-11 01:35:47.129082|2017-10-11 01:35:47.129082
NCT01875965|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-06-10|||June 2013||2013-06-01|February 2013|2013-02-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01|24 Months|Observational [Patient Registry]|||IAN Injury After BSSO in Oral Clefts|Inferior Alveolar Nerve Injury After Bilateral Sagittal Split Osteotomy in Oral Clefts|Unknown status|Not yet recruiting|N/A|200|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||||||2017-10-11 01:35:47.547777|2017-10-11 01:35:47.547777
NCT01875952|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2013-06-11|||May 2010||2010-05-01|June 2013|2013-06-01|June 2013|Anticipated|2013-06-01|June 2012|Actual|2012-06-01||Interventional|HIV/TB||Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)|Integral Research of the Managing and Treatment of the Infection With Human Immunodeficiency (VIH) /Human Immunodeficiency Syndrome(SIDA) Co-infection With Latent Tuberculosis Infection. A Multidisciplinary and Interinstitucional Approach|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|Instituto Nacional de Salud Publica, Mexico||1|||f||||f||||||||||2017-10-11 01:35:47.618462|2017-10-11 01:35:47.618462
NCT01875939|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-08-21|||June 2013||2013-06-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers|Phase-I Randomized, Open Label, Crossover Food-Effect and Absolute Bioavailability Study of WCK 2349 and WCK 771 in Healthy Adult Human Volunteers|Completed||Phase 1|12|Actual|Wockhardt||2|||f||||f||||||||||2017-10-11 01:35:47.716914|2017-10-11 01:35:47.716914
NCT01875926|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-01-02|||June 2013||2013-06-01|January 2014|2014-01-01||||October 2013|Actual|2013-10-01||Interventional|||ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers|Phase I, Single-centre, Open-label Study to Evaluate the Pharmacokinetics of ALX-0171, Administered by Oral Inhalation or Intravenously, in Healthy Male Volunteers|Completed||Phase 1|44|Actual|Ablynx||3|||f||||f||||||||||2017-10-11 01:35:48.025295|2017-10-11 01:35:48.025295
NCT01875913|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-08-29|||June 2013||2013-06-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Power of Curiosity: Leveraging Curiosity to Motivate People to Complete Health Risk Assessments|The Power of Curiosity|Completed||N/A|10095|Actual|Harvard University||2|||f||||f||||||||||2017-10-11 01:35:48.14112|2017-10-11 01:35:48.14112
NCT01875900|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2014-06-02|||June 2013||2013-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Instructor-led Simulation Training Versus Self-directed Simulator Training During Simulated Neonatal Resuscitation|Instructor-led Simulation Training Versus Self-directed Simulator Training During Simulated Neonatal Resuscitation - A Randomized Controlled Trial|Completed||N/A|38|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 01:35:48.254045|2017-10-11 01:35:48.254045
NCT01875887|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-07|||May 2008||2008-05-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Observational|||Treatment of Bilateral Maxillofacial Post-traumatic Deformities|Application of Surgery Planning Software, Rapid Prototyping Model and Preshaped Titanium Plates in Treatment of Bilateral Maxillofacial Post-traumatic Deformities|Completed||N/A|1|Actual|West China Hospital|||1||f||||t||||||||||2017-10-11 01:35:48.392537|2017-10-11 01:35:48.392537
NCT01875874|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-10-20|||October 2014||2014-10-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Efficacy of ELAD to Treat Acute Liver Failure (ALF)|An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)|Terminated||Phase 2|8|Actual|Vital Therapies, Inc.||1||"Due to results from the 1st pivotal study, the ELAD clinical plan is being re-evaluated, and   the VTI-212 study has been terminated."|f||||t||||||||||2017-10-11 01:35:48.491986|2017-10-11 01:35:48.491986
NCT01875848|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-10-28|2016-06-09||December 2013||2013-12-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Bup|Participants were recruited and enrolled at VACT West Haven, CT. Participants are aged 18 and older and have 3 months or more of continuous opioid therapy for chronic pain. Participants are actively prescribed 30-100mg of morphine equivalent opioid dose based on pharmacy records. Primary Care Providers will assent for patient participation.|Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain|Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain|Terminated||Phase 4|7|Actual|VA Office of Research and Development|Aim 1 of the study was achieved: we found that despite moderate to high levels of pain interference, only a small proportion of eligible patients entered the trial. For this reason, the data & safety monitoring board recommended early termination.|2||Data safety monitoring board recommended due to low recruitment yield.|f||||t||||||||No||2017-10-11 01:35:48.799218|2017-10-11 01:35:48.799218
NCT01875835|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-12-19|||June 2013||2013-06-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|February 2016|Actual|2016-02-01||Interventional|NeoCover||Evaluation of Neointimal Coverage of EES and BMS After Implantation in STEMI Patients by Optical Coherence Tomography|Evaluation of Neointimal Coverage of Everolimus-Eluting Stent and Bare-metal Stent After Implantation in STEMI Patients by Optical Coherence Tomography|Active, not recruiting||Phase 4|60|Anticipated|Harbin Medical University||2|||f||||f||||||||||2017-10-11 01:35:49.167346|2017-10-11 01:35:49.167346
NCT01875822|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-09|||June 2009||2009-06-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Interventional|||Open-label Study of Curcumin C-3 Complex in Schizophrenia|Open Label Study of Curcumin C-3 Complex, the Prototypal Epigenetic Modulator, as an Augmentation Strategy to Antipsychotic Therapy,for Improving Negative Symptoms and Cognition in Schizophrenia|Completed||Phase 1/Phase 2|17|Actual|Woodbury, Michel, M.D.||1|||f||||t||||||||||2017-10-11 01:35:49.282344|2017-10-11 01:35:49.282344
NCT01875809|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-11|||March 2013||2013-03-01|June 2013|2013-06-01||||February 2015|Anticipated|2015-02-01||Observational|RDN-Cath-1||Impact of Catecholamine Spill-over on Outcome After RDN and EP Ablation|Impact of Patient-specific and Procedural Characteristics Like Catecholamine Spill-over on the Long-term Outcome After Renal Denervation and EP Ablation|Unknown status|Recruiting|N/A|80|Anticipated|University of Witten/Herdecke|||2||f||||f||||||None Retained|"     Blood for measurement of catecholamines.   "|||2017-10-11 01:35:49.428199|2017-10-11 01:35:49.428199
NCT01875796|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2016-08-24|||June 2013||2013-06-01|August 2016|2016-08-01||||July 2016|Actual|2016-07-01||Interventional|||Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders|Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders|Completed||Phase 1|68|Actual|Louisiana State University and A&M College||2|||f||||t||||||||||2017-10-11 01:35:49.524373|2017-10-11 01:35:49.524373
NCT01875783|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-08-24|2017-08-24||March 17, 2014|Actual|2014-03-17|August 2017|2017-08-01|July 15, 2016|Actual|2016-07-15|May 14, 2015|Actual|2015-05-14||Interventional|DME FOUND||OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits|Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits|Completed||N/A|385|Actual|Joslin Diabetes Center||1|||f||||f||||||||||2017-10-11 01:35:49.656739|2017-10-11 01:35:49.656739
NCT01875770|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-08-15|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|CAPTURE||Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)|Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)|Active, not recruiting||N/A|115|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 01:35:49.879443|2017-10-11 01:35:49.879443
NCT01875757|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-03-21|||November 2013||2013-11-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|VitDBR2012||Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life|Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life|Completed||Phase 3|200|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||||||||||||2017-10-11 01:35:49.953215|2017-10-11 01:35:49.953215
NCT01875744|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-11-01|||June 2013||2013-06-01|November 2013|2013-11-01||||November 2013|Anticipated|2013-11-01||Interventional|||Polyethylene Glycol for Childhood Constipation||Unknown status|Recruiting|Phase 4|84|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 01:35:50.055932|2017-10-11 01:35:50.055932
NCT01875731|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-01-17|2015-04-16||July 2013||2013-07-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine|Efficacy of BPS (Bacterial Pneumonia Score) Guided Antibiotic Use in Children With Community Acquired Pneumonia on Reducing Antibiotic Use as Compared to Standard Care Practice (Current Guidelines for CAP) in the Era of Pneumococcal Vaccine|Completed||N/A|66|Actual|Hospital General de Niños Pedro de Elizalde||2|||f||||t||||||||No||2017-10-11 01:35:50.158413|2017-10-11 01:35:50.158413
NCT01875536|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-11|||November 2011||2011-11-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||rTMS and Conventional Physical Therapy After Stroke|Efficacy of Coupling Repetitive Transcranial Magnetic Stimulation and Conventional Physical Therapy to Reduce Upper Limb Spasticity in Stroke Patients|Completed||Phase 2|20|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:35:51.684031|2017-10-11 01:35:51.684031
NCT01875718|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-01-19|||January 2013||2013-01-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)|A Randomized, Double-blind, Placebo-controlled Parallel-group Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of UC1010 Administered Subcutaneously, Single-dosing in Healthy Women (Part 1) and Multiple Dosing in PMDD Women (Part 2) - Phase I/II Study|Completed||Phase 1/Phase 2|146|Anticipated|Umecrine Mood AB||3|||f||||||||||||||2017-10-11 01:35:50.413097|2017-10-11 01:35:50.413097
NCT01875705|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-10|2017-05-08|||June 21, 2013|Actual|2013-06-21|May 2017|2017-05-01|September 23, 2016|Actual|2016-09-23|September 23, 2016|Actual|2016-09-23||Interventional|||A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors|An Open-Label, Phase I, Dose-Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|40|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 01:35:50.491937|2017-10-11 01:35:50.491937
NCT01875692|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-12-02|||October 2012||2012-10-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Can we Better Understand the Development of VAP and Eventually Predict and Prevent it?|Culture Versus Genomics: Study of Oropharyngeal and Tracheal Flora in Intubated Patients. Can we Better Understand the Development of Ventilator-Acquired Pneumonia (VAP) and Predict Its Causing Pathogen(s)?|Completed||N/A|286|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 01:35:50.570436|2017-10-11 01:35:50.570436
NCT01875679|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-05-19|||May 2013||2013-05-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Comprehensive Surgical Coaching|Surgical Coaching -Using Error Debriefing, Behavioral Modeling and Error Recognition to Enhance Surgical Skill|Completed||N/A|20|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:35:50.645651|2017-10-11 01:35:50.645651
NCT01875666|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-04-17|||September 2013||2013-09-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2016|Actual|2016-12-01||Interventional|||Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib|Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib|Active, not recruiting||Early Phase 1|40|Anticipated|UNC Lineberger Comprehensive Cancer Center||4|||f||||t||||||||||2017-10-11 01:35:50.72975|2017-10-11 01:35:50.72975
NCT01875653|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-04-25|||October 2014||2014-10-01|January 2016|2016-01-01|June 2022|Anticipated|2022-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma|Phase III, Randomized, Double-Blind, Multicenter Trial of Autologous Dendritic Cells and Irradiated Autologous Tumor Cells In Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) vs. Autologous Peripheral Blood Mononuclear Cells (PBMCs) In GM-CSF for The Treatment Of Metastatic Melanoma|Terminated||Phase 3|250|Anticipated|Caladrius Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 01:35:50.834044|2017-10-11 01:35:50.834044
NCT01875640|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-06-14|||June 2013||2013-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Observational|DSD DST||Decision Support for Parents Receiving Information About Child's Rare Disease|Decision Support for Parents Receiving Information About Child's Rare Disease|Active, not recruiting||N/A|45|Anticipated|University of Michigan|||2||f||||f||||||||||2017-10-11 01:35:50.937862|2017-10-11 01:35:50.937862
NCT01875627|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-06-09|||November 2010||2010-11-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|InGel||Satiety Study of a Carbohydrate Meal to a Highly Viscous Gel Meal|Comparing the Satiety Scores of a Carbohydrate Meal to a Meal of Equal Volume in Which Half of the Volume is Replaced With a Highly Viscous Gel.|Completed||Phase 1|15|Actual|St. Michael's Hospital, Toronto||3|||f||||f||||||||||2017-10-11 01:35:51.032222|2017-10-11 01:35:51.032222
NCT01875614|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-03-06|||March 2015||2015-03-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|DDRAMATIC-SVT||Dipole Density Mapping in Supraventricular Tachycardia|Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia|Active, not recruiting||N/A|29|Actual|Acutus Medical||1|||f||||f||f||||||No||2017-10-11 01:35:51.132417|2017-10-11 01:35:51.132417
NCT01875601|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-07-06|||May 21, 2013||2013-05-21|October 27, 2016|2016-10-27|September 8, 2015|Actual|2015-09-08|September 8, 2015|Actual|2015-09-08||Interventional|||NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors|A Phase I Study of Autologous Activated Natural Killer (NK) Cells +/- rhIL15 in Children and Young Adults With Refractory Solid Tumors|Completed||Phase 1|16|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:35:51.274429|2017-10-11 01:35:51.274429
NCT01875588|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-11|2017-06-30|||June 3, 2013||2013-06-03|June 21, 2017|2017-06-21|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Observational|||Thinking and Memory Problems in People With HIV|Screening and Recruitment for HIV-associated Neurocognitive Disorders (HAND) Studies and an Evaluation of HIV-associated Neurocognitive Disorders in Virologically Controlled Patients|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:35:51.370149|2017-10-11 01:35:51.370149
NCT01875575|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-06-11|||February 2013||2013-02-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Oral Glucose Stimulation in Normal-weight and Obese Volunteers|Oral Glucose in Normal-weight and Obese Volunteers|Completed||N/A|24|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-11 01:35:51.441146|2017-10-11 01:35:51.441146
NCT01875562|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-06-11|||May 2012||2012-05-01|June 2013|2013-06-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy|A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy|Unknown status|Recruiting|Phase 4|2400|Anticipated|Shanghai University of Traditional Chinese Medicine||1|||f||||t||||||||||2017-10-11 01:35:51.520731|2017-10-11 01:35:51.520731
NCT01875549|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-04-24|||May 2013||2013-05-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent|Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a Large Cell Niti-S (LCD) Stent|Withdrawn||N/A|0|Actual|Samsung Medical Center||2||no enrollment|f||||t||||||||||2017-10-11 01:35:51.617718|2017-10-11 01:35:51.617718
NCT01875523|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2014-04-02|||August 2013||2013-08-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CRLX030A2102||PK of Serelaxin in Severe Renal Impairment and ESRD|A Single Dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of Serelaxin in Patients With Severe Renal Impairment or End-Stage Renal Disease on Hemodialysis Compared to Matched Healthy Control Subjects|Completed||Phase 1|36|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:35:51.751834|2017-10-11 01:35:51.751834
NCT01875510|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-06-05|2013-11-11||January 2013||2013-01-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities|The Effect of Fish-oil Lipid Emulsions on Neonatal Cholestasis and Retinopathy of Prematurity|Completed||N/A|80|Actual|Dr. Sami Ulus Children's Hospital|The limitation of our study is that participants are mostly above 1000 grams. It was a single center study and DHA levels were not measured.|2|||f||||f||||||||||2017-10-11 01:35:51.829592|2017-10-11 01:35:51.829592
NCT01875497|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-11|||January 2013||2013-01-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effect of Vitis Vinifera Extract on Oxidative Stress, Inflamatory Biomarkers and Hormones in High Trained Subjects|Effect of Vitis Vinifera Extract on Oxidative Stress, Inflammatory Biomarkers and Hormones in High Trained Subjects After Resting and Intensive Physical Activity.|Unknown status|Recruiting|N/A|55|Anticipated|Rio de Janeiro State University||1|||f||||t||||||||||2017-10-11 01:35:52.072388|2017-10-11 01:35:52.072388
NCT01875484|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-07-28|||February 2012||2012-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|PMIR-miR-126||Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling|Impact of Circulating miR-126 on Left Ventricular Remodeling and Clinical Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention. The PMIR-miR-126 Study.|Completed||N/A|1200|Actual|Qilu Hospital of Shandong University|||3||f||||t||||||Samples With DNA|"     Blood Samples: serum, plasma, RNA, DNA, microRNAs, CD34+ cells   "|||2017-10-11 01:35:52.154142|2017-10-11 01:35:52.154142
NCT01875471|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-05-04|2015-05-06||June 2013||2013-06-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Clinical Evaluation of Two Daily Disposable Contact Lenses|Clinical Evaluation of Two Daily Disposable Contact Lenses|Completed||N/A|279|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 01:35:54.415341|2017-10-11 01:35:54.415341
NCT01875458|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-05-03|||May 2013||2013-05-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use|Biomarker Identification in Orthopaedic and Oral Maxillofacial Subjects|Recruiting||N/A|500|Anticipated|University of Pennsylvania|||4||f||||f||||||Samples With DNA|"     Saliva will be collected from online participants and DNA analysis will be performed.      Blood and tissue samples will be collected from in-person participants. DNA and RNA analysis     will be performed.   "|||2017-10-11 01:35:54.790742|2017-10-11 01:35:54.790742
NCT01875445|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-04-10|2017-02-27||May 2013||2013-05-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Inositol in Trichotillomania|A Double-Blind, Placebo-Controlled Study of Inositol in Trichotillomania|Completed||Phase 2|38|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 01:35:54.966591|2017-10-11 01:35:54.966591
NCT01875419|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-05-02|||July 2014||2014-07-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Non-invasive Brain Stimulation and Cognitive Processing in Depression||Active, not recruiting||N/A|60|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 01:35:55.34576|2017-10-11 01:35:55.34576
NCT01875406|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-04-11|||June 2013|Actual|2013-06-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|July 2015|Actual|2015-07-01||Interventional|||a Diagnostic SIJ Injection Following a Composite of 3 Diagnostic Tests and a Pain Referral Diagram|Diagnosis of Sacroiliac Joint Pain: Predictive Value of a Diagnostic SIJ Injection Following a Composite of 3 Diagnostic Tests and a Pain Referral Diagram|Completed||N/A|200|Actual|The Cleveland Clinic||1|||f||||f||||||||No||2017-10-11 01:35:55.483239|2017-10-11 01:35:55.483239
NCT01875393|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-04-17|||May 2013||2013-05-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|PCM304||Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer|Study of the Efficacy,Safety and Quality of Life After TOOKAD® Soluble Vascular Targeted Photodynamic Therapy (VTP) for Minimally Invasive Treatment of Localized Prostate Cancer|Completed||Phase 3|81|Actual|Steba Biotech S.A.||1|||f||||f||||||||Yes|The data are available in case report form for each patient|2017-10-11 01:35:55.646197|2017-10-11 01:35:55.646197
NCT01875380|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-07-31|||June 2013||2013-06-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|REFRAME||Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer|A Phase II Study of Single-agent Regorafenib in the First Line Treatment of Frail and/or Unfit for Polychemotherapy Patients With Metastatic Colorectal Cancer (mCRC)|Completed||Phase 2|46|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1|||f||||f||||||||||2017-10-11 01:35:55.755897|2017-10-11 01:35:55.755897
NCT01875367|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-03-30|||September 2013|Actual|2013-09-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|ChangHER-SC||A Phase III Clinical Trial to Evaluate Patient´s Preference of Subcutaneous Trastuzumab (SC) Versus Intravenous (IV) Administration in Patients With HER2 Positive Advanced Breast Cancer (ABC).|Clinical Trial to Evaluate Patient´s Preference of Subcutaneous Trastuzumab (SC) Versus Intravenous (IV) Administration in Patients With HER2 Positive Advanced Breast Cancer (ABC) Who Have Received Intravenous Trastuzumab at Least 4 Months and Without Disease Progression|Active, not recruiting||Phase 3|160|Actual|Spanish Breast Cancer Research Group||2|||f||||f||||||||||2017-10-11 01:35:55.880234|2017-10-11 01:35:55.880234
NCT01875354|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-04-03|||May 2013||2013-05-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Prospective Study Investigating the Effects of a Novel Weight Management Program|A Prospective, Randomized, Blinded, Controlled Study Investigating the Effects of a Novel Body Weight Management Program Over 90-days and Weight Maintenance at One Year.|Completed||N/A|141|Actual|Pharmanex||2|||f||||t||||||||||2017-10-11 01:35:56.053946|2017-10-11 01:35:56.053946
NCT01875328|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-04-20|||May 2013||2013-05-01|April 2015|2015-04-01||||June 2016|Anticipated|2016-06-01||Interventional|STEP TO IT||Stroke Therapy, Education, Prevention: Telemedicine Outpatient Initiative Trial|Stroke Therapy, Education, Prevention: Telemedicine Outpatient Initiative Trial|Unknown status|Recruiting|N/A|150|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 01:35:56.319461|2017-10-11 01:35:56.319461
NCT01875315|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-09-19|||September 2012||2012-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|EXACT-COST||Comparative Effectiveness of Stress Tests|EXACT-COST: Exercise CMR's Accuracy for Cardiovascular Stress Testing-Comparative Effectiveness of Stress Tests|Active, not recruiting||N/A|130|Actual|Ohio State University||1|||f||||t||||||||||2017-10-11 01:35:56.423062|2017-10-11 01:35:56.423062
NCT01875302|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-06-17|||February 2013||2013-02-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Observational|||Comparison of an Electronic Version of Selected COPD PRO Instruments With the Original Versions|Comparison of an Electronic Version of Selected COPD PRO Instruments With the Original Versions|Completed||N/A|20|Actual|nSpire Health, Inc.|||1||f||||f||||||||||2017-10-11 01:35:56.501242|2017-10-11 01:35:56.501242
NCT01875289|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2014-03-20|||July 2013||2013-07-01|March 2014|2014-03-01||||March 2014|Actual|2014-03-01||Interventional|||Efficacy of a Modified Obturator Nerve Block Technique||Completed||N/A|36|Anticipated|Medical University of Graz||2|||f||||||||||||||2017-10-11 01:35:56.564127|2017-10-11 01:35:56.564127
NCT01875276|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-06-07|||January 2013||2013-01-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|MEDA||Evaluating the Need for New Rhinitis Treatment|Evaluating the Need for a New Combination Nasal Spray in the Treatment of Seasonal Rhinitis|Completed||N/A|21203|Actual|Research in Real-Life Ltd|||2||f||||f||||||||||2017-10-11 01:35:56.641789|2017-10-11 01:35:56.641789
NCT01875263|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-08-04|||May 2013||2013-05-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.|Efficacy of a Short-term Sequential Therapy Versus Intravenous Standard Treatment for Patients With Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.|Terminated||Phase 3|1|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2||Not participants inclusion|f||||t||||||||||2017-10-11 01:35:56.738473|2017-10-11 01:35:56.738473
NCT01875250|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-07-06|||May 28, 2013||2013-05-28|April 27, 2017|2017-04-27|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer|A Phase II Trial of Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer|Active, not recruiting||Phase 2|38|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:35:56.848139|2017-10-11 01:35:56.848139
NCT01875237|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-03-09|||December 27, 2013|Actual|2013-12-27|March 2017|2017-03-01|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene|A Phase 1/2 Trial Evaluating Treatment of Emergent Graft Versus Host Disease (GvHD) With AP1903 After Planned Donor Infusions (DLIs) of T-cells Genetically Modified With the iCasp9 Suicide Gene in Patients With Hematologic Malignancies|Terminated||Phase 1/Phase 2|3|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:35:56.935665|2017-10-11 01:35:56.935665
NCT01875224|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-06-07|||August 2013||2013-08-01|June 2013|2013-06-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression|Open-Label, Randomized Comparison of NODAT in Renal Transplant Patients Receiving a Nulojix (Belatacept) Regimen Versus Standard Therapy Immunosuppression|Unknown status|Not yet recruiting|Phase 4|32|Anticipated|University of Arizona||2|||f||||t||||||||||2017-10-11 01:35:57.059013|2017-10-11 01:35:57.059013
NCT01875198|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-11-19|||April 2013||2013-04-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer||Terminated||N/A|1|Actual|Yonsei University||2||because of difficulties of enrolling appropriate participants|f||||f||||||||||2017-10-11 01:35:57.145282|2017-10-11 01:35:57.145282
NCT01875172|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2013-06-10|||October 2001||2001-10-01|June 2013|2013-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Bupropion for Smoking Cessation in Pregnancy|Smoking Cessation in Pregnancy: A Pilot Study Comparing Counseling With and Without Sustained-Release Bupropion|Completed||Phase 2|135|Actual|Watching Over Mothers & Babies Foundation||2|||f||||t||||||||||2017-10-11 01:35:57.317975|2017-10-11 01:35:57.317975
NCT01875159|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-03-16|2014-01-14||July 2010||2010-07-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm|Pilot Study of Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm|Completed||Phase 3|98|Actual|American SIDS Institute||2|||f||||f||||||||||2017-10-11 01:35:57.518018|2017-10-11 01:35:57.518018
NCT01875146|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-01-06|||January 2013||2013-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of High-intensity Interval Training in Combination With Side-alternating Whole-body Vibration|Effects of High-intensity Interval Training in Combination With Side-alternating Whole-body Vibration|Completed||N/A|33|Actual|University of Zurich||4|||f||||||||||||||2017-10-11 01:35:57.912945|2017-10-11 01:35:57.912945
NCT01875133|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-05-18|||May 2013||2013-05-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Patients With Chronic Obstructive Pulmonary Disease At Altitude|Effect of Altitude on Exercise Performance of Patients With Chronic Obstructive Lung Disease|Completed||N/A|50|Anticipated|University of Zurich||4|||f||||f||||||||||2017-10-11 01:35:57.99241|2017-10-11 01:35:57.99241
NCT01875120|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-11-08|||October 2012||2012-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|somPONV||Study to Evaluate Anxiety Sensitivity and Somatic Symptoms as Risk Factors for PONV|Prospective Observational Study to Evaluate Somatic Symptom Load and Anxiety Sensitivity as Risk Factors for Postoperative Nausea and Vomiting (PONV)|Completed||N/A|160|Actual|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-11 01:35:58.085736|2017-10-11 01:35:58.085736
NCT01875107|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-09-10|||August 2013||2013-08-01|September 2014|2014-09-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients|Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients|Withdrawn||Phase 4|0|Actual|University of Minnesota - Clinical and Translational Science Institute||1||Time constraints of primary investigator.|f||||f||||||||||2017-10-11 01:35:58.16142|2017-10-11 01:35:58.16142
NCT01875094|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-06-23|||October 2012||2012-10-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Self-Management in Stroke Survivors|Promoting Self-Management in Stroke Survivors Using Health IT|Completed||Phase 1/Phase 2|56|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 01:35:58.232412|2017-10-11 01:35:58.232412
NCT01875081|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-03-16|||November 2012||2012-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)|Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient.|Completed||Phase 2|72|Actual|Pharmicell Co., Ltd.||3|||f||||||||||||||2017-10-11 01:35:58.307543|2017-10-11 01:35:58.307543
NCT01875068|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-08-13|||July 2013||2013-07-01|August 2014|2014-08-01||||July 2015|Anticipated|2015-07-01||Interventional|||A Program of Physician Supervision to Improve the Quality of Patient Referrals From Nurse Practitioners and Physician Assistants|Implementing a Program of Physician Supervision to Improve the Quality of Patient Referrals From Nurse Practitioners and Physician Assistants|Unknown status|Recruiting|N/A|100|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:35:58.385319|2017-10-11 01:35:58.385319
NCT01875055|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-08-12|||May 2013||2013-05-01|February 2013|2013-02-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Interventional|NIRS ICU||Reversing Cerebral Oxygen Desaturations Greater That 10% of Baseline Values Using NIRS in the ICU|A Pilot Trial to Assess the Feasibility and Efficacy of Treating Post-Cardiac Surgery Cerebral Desaturation in the Intensive Care Unit|Unknown status|Recruiting|N/A|50|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 01:35:58.468125|2017-10-11 01:35:58.468125
NCT01875042|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-04-11|||December 2012||2012-12-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|ETRELKA||Effect of Transcutaneous Electrostimulation (TENS) on Pain and Physical Function in Patients With Knee Osteoarthritis|Does Transcutaneous Electrical Nerve Stimulation (TENS) Affect Pain and Function in Patients With Osteoarthritis of the Knee? ETRELKA, a Randomised Controlled Trial|Completed||N/A|220|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 01:35:58.566856|2017-10-11 01:35:58.566856
NCT01875029|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-01-15|||January 2012||2012-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||tDCS Effects on Chronic Low Back Pain|The Effects of Transcranial Direct Current Stimulation (tDCS)Combined With Back School in Subjects With Chronic Low Back Pain. Randomised Control Trial Study.|Completed||Phase 2|45|Actual|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-11 01:35:58.654044|2017-10-11 01:35:58.654044
NCT01875016|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-05|||June 2013||2013-06-01|June 2013|2013-06-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Interventional|CRASH||CRyo-Ablation to Treat Patients With HOCM.|Endocardial Catheter CRyo-Ablation of Septal Hypertrophy for Hypertrophic Obstructive Cardiomyopathy|Unknown status|Not yet recruiting|N/A|15|Anticipated|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-10-11 01:35:58.740094|2017-10-11 01:35:58.740094
NCT01875003|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-05-15|||August 31, 2013|Actual|2013-08-31|May 2017|2017-05-01|December 28, 2016|Actual|2016-12-28|December 28, 2016|Actual|2016-12-28||Interventional|||A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication||Completed||Phase 3|348|Actual|Hoffmann-La Roche||3|||f|||||t|||||||||2017-10-11 01:35:58.829669|2017-10-11 01:35:58.829669
NCT01874990|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2013-06-06|||December 2009||2009-12-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|November 2011|Actual|2011-11-01||Interventional|||Increased Salt Sensitivity of Ambulatory Blood Pressure in Women With a History of Severe Preeclampsia||Completed||N/A|40|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 01:35:59.223036|2017-10-11 01:35:59.223036
NCT01874977|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-05-10|||November 2013||2013-11-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Trial of a Physical Activity Intervention for RA Fatigue|Randomized Controlled Trial of a Physical Activity Intervention for RA Fatigue|Completed||N/A|96|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-10-11 01:35:59.298202|2017-10-11 01:35:59.298202
NCT01874964|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-07|||June 2010||2010-06-01|December 2010|2010-12-01|May 2014|Anticipated|2014-05-01|June 2013|Actual|2013-06-01||Interventional|||Trial of Methadone Maintenance Versus Methadone Detox in Jail|A Randomized Trail of Continues Methadone Maintenance Versus Detoxification in Jail|Unknown status|Active, not recruiting|N/A|450|Anticipated|The Miriam Hospital||2|||f||||t||||||||||2017-10-11 01:35:59.489703|2017-10-11 01:35:59.489703
NCT01874951|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-01-05|2016-11-04||June 2013||2013-06-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Twenty-one patients were screened, of which twelve patients were admitted into the study, all men and women with major depressive disorder who had relapsed on a pro-dopaminergic antidepressant regimen.|Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence|Randomized, Proof-Of-Concept Trial of Augmentation of Antidepressants by Low Dose Naltrexone (LDN) for Patients With Breakthrough Symptoms of Major Depressive Disorder on Antidepressant Therapy|Completed||Phase 2|12|Actual|Massachusetts General Hospital|1) Very small sample. 2) No detailed data about the total number of relapses or recurrences prior to the patients’ current regimen. 3) Short double blind treatment period. 4) Focus on antidepressants with dopaminergic activity only.|2|||f||||f||||||||No||2017-10-11 01:35:59.628448|2017-10-11 01:35:59.628448
NCT01874938|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-01-07||2014-09-29|August 2013||2013-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer|A Non-Randomized, Open-Label, Single-Arm, Phase 2 Study of LY2875358 in Patients With MET Diagnostic Positive, Advanced Gastric Cancer|Completed||Phase 2|15|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:36:00.332446|2017-10-11 01:36:00.332446
NCT01874899|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-08-29|||June 2013||2013-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|RestoreSensor||Prospective Randomized Feasibility Study Comparing Manual vs. Automatic Position-Adaptive Spinal Cord Stimulation With Surgical Leads|Prospective Randomized Feasibility Study Comparing Manual vs. Automatic Position-Adaptive Spinal Cord Stimulation With Surgical Leads|Recruiting||N/A|20|Anticipated|Justin Parker Neurological Institute||2|||f||||f||||||||||2017-10-11 01:36:00.550449|2017-10-11 01:36:00.550449
NCT01874886|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-07-07|||January 2013||2013-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CAN||Cannabis Effects on Brain Morphology in Aging|Effects of Heavy Adolescent Cannabis Use on Brain Morphology in Aging|Active, not recruiting||N/A|60|Actual|University of California, Los Angeles|||2||f||||f||||||||||2017-10-11 01:36:00.640307|2017-10-11 01:36:00.640307
NCT01874873|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-04-05|||April 2013||2013-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ALTN/MTC||A Phase II Study of Anlotinib in MTC Patients|Phase 2 Study of Anlotinib in Advanced Medullary Thyroid Carcinoma|Active, not recruiting||Phase 2|47|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||t||||||||||2017-10-11 01:36:00.711942|2017-10-11 01:36:00.711942
NCT01874860|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-11-21|||August 2013||2013-08-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients|Preemptive Therapy Study of Cetuximab(Erbitux®)Induced Skin Rash Using Doxycycline, Sunscreen, Hydrocortisone and Moisturizer in Colorectal and Head and Neck Cancer Patients|Recruiting||Phase 1|100|Anticipated|James Graham Brown Cancer Center||2|||f||||t||||||||||2017-10-11 01:36:00.81186|2017-10-11 01:36:00.81186
NCT01874847|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-04-14|||September 2013||2013-09-01|April 2017|2017-04-01|September 2019|Anticipated|2019-09-01|April 2017|Actual|2017-04-01||Interventional|PLAYGAME||PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin|PLAY GAME: Post-concussion Syndrome Affecting Youth: GABAergic Effects of Melatonin. A Randomized Double-blind Placebo-controlled Trial of MELATONIN|Active, not recruiting||Phase 2/Phase 3|99|Actual|University of Calgary||3|||f||||t||||||||No|No plan to share IPD|2017-10-11 01:36:00.951757|2017-10-11 01:36:00.951757
NCT01874834|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-06-10|||August 2010||2010-08-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|April 2012|Actual|2012-04-01||Interventional|DEPOZ||Cardiopulmonary Responses to Exposure to Ozone and Diesel Exhaust|Cardiopulmonary Responses to Exposure to Ozone and Diesel Exhaust With Moderate Exercise in Healthy Adults|Completed||N/A|15|Actual|Environmental Protection Agency (EPA)||4|||f||||f||||||||||2017-10-11 01:36:01.064047|2017-10-11 01:36:01.064047
NCT01874821|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-08-08|||January 2013||2013-01-01|August 2013|2013-08-01||||December 2015|Anticipated|2015-12-01||Interventional|||Adhesive Capsulitis and Dynamic Splinting|Adhesive Capsulitis and Dynamic Splinting: a Randomized, Controlled Trial|Terminated||N/A|5|Actual|Dynasplint Systems, Inc.||2||Unrelated to trial|f||||f||||||||||2017-10-11 01:36:01.168876|2017-10-11 01:36:01.168876
NCT01874808|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-08-07|||June 2013||2013-06-01|March 2013|2013-03-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Observational|GAITALS||From Movement Preparation to Gait Execution in ALS|From Movement Preparation to Gait Execution in ALS: : Combined Neurophysiological and Neuroimaging Approaches|Unknown status|Recruiting|N/A|70|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||3||f||||t||||||||||2017-10-11 01:36:01.264417|2017-10-11 01:36:01.264417
NCT01874795|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-06-06|||March 2012||2012-03-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Ganglionar Electrical Stimulation on Central Arterial Pressure|Effect of Ganglionar Transcutaneous Electrical Nerve Stimulation on Central Arterial Pressure in Healthy Young Population|Completed||N/A|30|Actual|University of Brasilia||2|||f||||t||||||||||2017-10-11 01:36:01.389668|2017-10-11 01:36:01.389668
NCT01874782|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-08-20|||May 2013||2013-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Transcranial Electrical Stimulation for Management of Orthostatic Instability in Acute Cervical Spinal Cord Injury|Transcranial Electrical Stimulation for Management of Orthostatic Instability in Acute Cervical Spinal Cord Injury|Completed||Phase 2|4|Actual|University of British Columbia||1|||f||||t||||||||||2017-10-11 01:36:01.484539|2017-10-11 01:36:01.484539
NCT01874769|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-12-17|||June 2013||2013-06-01|December 2013|2013-12-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Observational|RDEB||Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)|Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)|Unknown status|Recruiting|N/A|30|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||t||||||Samples With DNA|"     All patients will have a blood sample of 5 ml on EDTA, 10 ml on heparin and 5 ml on dry tube     collected for genomic DNA extraction to identify or verify COL7A1 mutations: mutation     screening of the patients will be performed to identify COL7A1 mutations on both alleles. 2)     HLA genotyping: patients selected on the clinical and molecular criteria will be     HLA-genotyped by PCR to determine the likelihood of an immune response to the type VII     collagen wild-type protein. A 5-mm punch skin biopsy performed under local anaesthesic will     be undertaken during visit 1 for diagnostic purposes .The consequences of COL7A1 mutations on     collagen VII protein expression will be determined, if not performed previously. Two     additional 5-mm punch skin biopsies will be taken from different areas from up to 10 patients     during the second visit. Keratinocytes and fibroblasts will be expanded and stored in     vapor-phase liquid-nitrogen.   "|||2017-10-11 01:36:01.587164|2017-10-11 01:36:01.587164
NCT01874743|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2013-06-11|||March 2012||2012-03-01|December 2012|2012-12-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|CESAR||Rosuvastatin to Decrease Residual Immune Activation in HIV Infection|Pilot Study of the Impact of Rosuvastatin Administration on Residual Chronic Immune Activation Under Antiretroviral Therapy: CESAR (Crestor En Sus Des AntiRétroviraux)|Unknown status|Recruiting|Phase 2|40|Anticipated|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba||1|||f||||t||||||||||2017-10-11 01:36:01.917081|2017-10-11 01:36:01.917081
NCT01874730|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-08-05|||July 2013||2013-07-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|KEROS||KOREAN Enhanced RecOvery Strategy for Colorectal Surgery|KOREAN Enhanced RecOvery Strategy for Colorectal Surgery|Terminated||N/A|101|Actual|Duke University||2||Very slow accrual because sites have few open colorectal surgery|f||||f||||||||||2017-10-11 01:36:02.064599|2017-10-11 01:36:02.064599
NCT01874717|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-06-10|||June 2005||2005-06-01|June 2013|2013-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Midazolam Sedation in Dentally Anxious Patients|Conscious Sedation With Midazolam in Dentally Anxious Patients: Effect of the Administration Route (Oral Versus Intravenous Administration)|Completed||Phase 3|131|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:36:02.1968|2017-10-11 01:36:02.1968
NCT01874704|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-06-07|||April 2010||2010-04-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|JOBSTRESS||Comparison of Biomarkers of Stress in Emergency Physicians Working a 24-hour Shift or a 14-hour Night Shift - the JOBSTRESS Randomized Trial|Comparison of Biomarkers of Stress in Emergency Physicians Working a 24-hour Shift or a 14-hour Night Shift - the JOBSTRESS Randomized Trial|Completed||N/A|19|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 01:36:02.313978|2017-10-11 01:36:02.313978
NCT01874691|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-01-26|||January 2013||2013-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|CAMIRegistry||China Acute Myocardial Infarction Registry|China Acute Myocardial Infarction Registry|Recruiting||N/A|20000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t||||||||||2017-10-11 01:36:02.395182|2017-10-11 01:36:02.395182
NCT01874678|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-01-10|||March 2011||2011-03-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer|A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer|Completed||N/A|45|Actual|TTY Biopharm||1|||f||||f||||||||||2017-10-11 01:36:02.480739|2017-10-11 01:36:02.480739
NCT01874665|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-10-27|2016-03-14||June 2013||2013-06-01|March 2016|2016-03-01|July 2016|Actual|2016-07-01|February 2015|Actual|2015-02-01||Interventional|GIST|Intention To Treat Population|A Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor|Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor Following Failure of Prior Tyrosine Kinase Inhibitor Therapy|Completed||Phase 2|45|Actual|Ariad Pharmaceuticals|Study is ongoing. Uncontrolled Study. Small patient population. Non-randomized.|2|||f||||||||||||||2017-10-11 01:36:02.577906|2017-10-11 01:36:02.577906
NCT01874652|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-11-02|||December 2013||2013-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Assessment of Safety & Efficacy of Light Weight Breast Implant|Assessment of Safety & Efficacy of Light Weight Breast Implant|Completed||Phase 2|50|Actual|Bnai Zion Medical Center||1|||f||||f||||||||||2017-10-11 01:36:03.356384|2017-10-11 01:36:03.356384
NCT01874639|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-07-28|||June 2013||2013-06-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of Transcollation Device to Decrease Blood Loss During Hepatic Resections: a Randomized Cohort Study (HEPACOLL)|Use of Transcollation Device to Decrease Blood Loss During Hepatic Resections: a Randomized Cohort Study|Recruiting||Phase 2|140|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:36:03.444769|2017-10-11 01:36:03.444769
NCT01874626|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-12-07||2015-02-05|July 2013||2013-07-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy and Safety of SST 0225, a Topical Ibuprofen Cream, in the Treatment of Pain Associated With Acute Ankle Sprain|A Randomized, Double-blind, Placebo-controlled, Multi-dose, Pivotal Study to Determine the Efficacy and Safety of SST 0225, a Topical Ibuprofen Cream, in the Treatment of Pain Associated With Acute Ankle Sprain.|Active, not recruiting||Phase 3|305|Actual|Strategic Science & Technologies, LLC||2|||f||||||||||||||2017-10-11 01:36:03.565958|2017-10-11 01:36:03.565958
NCT01874613|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-02-18|||January 2013||2013-01-01|February 2015|2015-02-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Interventional|Cranio-2||Clinical Study of FRC Implant to Treat Skull Bone Defects|Clinical Study of Skull Defect Reconstruction With Patient-specific Fibre-reinforced Composite Implant|Active, not recruiting||N/A|19|Actual|Turku University Hospital||2|||f||||f||||||||||2017-10-11 01:36:03.660407|2017-10-11 01:36:03.660407
NCT01874587|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-06-20|||July 2013||2013-07-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|ARTIX||Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma|Phase III Trial Testing the Benefit of Intensity-modulated Radiotherapy With Weekly Replanifications Versus Intensity Modulated Radiotherapy With Only One Planification in Locally Advanced Oropharynx Carcinoma for Decreasing Xerostomia|Recruiting||Phase 3|174|Anticipated|Center Eugene Marquis||2|||f||||t||||||||||2017-10-11 01:36:03.844473|2017-10-11 01:36:03.844473
NCT01874574|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-04-21|||January 2011||2011-01-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Intra-articular Corticosteroid Injection Compared With Single-Shot Hyaluronic Acid for Treatment of Osteoarthritis Knee|Intra-articular Corticosteroid Injection Compared With Single-Shot Hyaluronic Acid for Treatment of Osteoarthritis Knee: A Prospective, Double-blind Randomized Controlled Trial|Completed||Phase 4|100|Actual|Thammasat University||2|||f||||t||||||||||2017-10-11 01:36:03.964333|2017-10-11 01:36:03.964333
NCT01874561|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-10-07|||May 2013||2013-05-01|October 2016|2016-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization|A Single-Center, Double-Blind, Randomized, Placebo- and Positive-Controlled, Parallel Group, Thorough QT/QTc Study to Evaluate the Effect of Custirsen (640 mg) on Cardiac Repolarization in Healthy Men|Completed||Phase 1|155|Actual|Achieve Life Sciences||3|||f||||f||||||||||2017-10-11 01:36:04.057275|2017-10-11 01:36:04.057275
NCT01874548|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-08-12|||July 2013||2013-07-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||MR Metabolic Biomarkers for Cervical Cancer|Magnetic Resonance Study on Metabolism Biomarkers for Cervical Cancer.|Completed||N/A|136|Actual|Chang Gung Memorial Hospital|||2||f||||f||||||Samples Without DNA|"     Tumor tissue will be collected during the operation or biopsy and will be store in liquid     nitrogen within 5 minutes removal from body. Standard dual phase tissue extraction will be     performed for tumor and cell samples for high resolution MRS analysis.   "|No||2017-10-11 01:36:04.182974|2017-10-11 01:36:04.182974
NCT01874522|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-12-21|||July 2013||2013-07-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI|A Phase 1, Open-label, Randomized, Crossover Study Evaluating the Bioavailability of TAS-102 Tablets Relative to an Oral Solution Containing Equivalent Amounts of FTD and TPI|Completed||Phase 1|46|Actual|Taiho Oncology, Inc.||2|||f||||f||||||||||2017-10-11 01:36:04.34176|2017-10-11 01:36:04.34176
NCT01874509|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-03-25|||June 2013||2013-06-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|||Randomized Controlled Trial of a Minimal Versus Extended Internet-based Intervention for Problem Drinkers|Randomized Controlled Trial of a Minimal Versus Extended Internet-based Intervention for Problem Drinkers|Completed||N/A|490|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 01:36:04.464424|2017-10-11 01:36:04.464424
NCT01874496|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-09-12|||May 2013||2013-05-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Iron Absorption From GDS Capsules|Iron Absorption Mechanism From a Slow Release Iron Capsule Using the Gastric Delivery System|Completed||N/A|4|Actual|Swiss Federal Institute of Technology||4|||f||||f||||||||||2017-10-11 01:36:04.555454|2017-10-11 01:36:04.555454
NCT01874483|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2016-01-26|||June 2013||2013-06-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes Mellitus|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 187004 CL in Patients With Type 2 Diabetes Mellitus (Randomized, Double-blind Placebo-controlled Within Dose Groups)|Completed||Phase 1|71|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-11 01:36:04.655372|2017-10-11 01:36:04.655372
NCT01874470|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2016-10-19|||May 2013||2013-05-01|December 2013|2013-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Renal Denervation by Allegro System in Patients With Resistant Hypertension|Renal Denervation by Allegro System in Patients With Resistant Hypertension|Terminated||Phase 3|3|Actual|Shanghai AngioCare Medical||2|||f||||t||||||||||2017-10-11 01:36:04.797786|2017-10-11 01:36:04.797786
NCT01874457|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2013-06-13|||May 2008||2008-05-01|June 2013|2013-06-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Observational|||Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)|A Serological Study of Measles, Mumps and Rubella in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella) in Health Centers Where a Phase III Study Should be Conducted|Completed||N/A|150|Actual|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)|||1||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:36:04.934261|2017-10-11 01:36:04.934261
NCT01874431|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-07-23||2015-06-04|June 2013||2013-06-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|ARTS-DN||Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy|A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy|Completed||Phase 2|823|Actual|Bayer||8|||f||||t||||||||||2017-10-11 01:36:05.162197|2017-10-11 01:36:05.162197
NCT01874405|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2013-06-06|||March 2003||2003-03-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox Therapy|Effectiveness of Deferasirox Therapy on Comprehensive Management of Iron Overload in Adult and Pediatric Transfusion-dependent Patients: a Long Term Retrospective Study|Completed||N/A|80|Actual|"University of Campania Luigi Vanvitelli"|||1||f||||t||||||||||2017-10-11 01:36:05.757054|2017-10-11 01:36:05.757054
NCT01874392|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-04-20|||October 2012||2012-10-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp|Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS) and Technosphere® Insulin Inhalation System From MannnKind Corp.|Completed||N/A|9|Actual|William Sansum Diabetes Center||1|||f||||f||||||||||2017-10-11 01:36:05.813212|2017-10-11 01:36:05.813212
NCT01874379|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-06-06|||December 2012||2012-12-01|June 2013|2013-06-01||||June 2014|Anticipated|2014-06-01||Interventional|M•TIJRP||'M'-Technique, Guided Imagery, or Standard of Care on Anxiety and Pain Pre- & Post-operatively in Elective Joint Replacement Patients|Investigating the Effect of the 'M'-Technique, Guided Imagery, or Standard of Care on Anxiety and Pain Pre- & Post-operatively in Elective Joint Replacement Patients.|Unknown status|Recruiting|N/A|225|Anticipated|Saint Clare's Health System||3|||f||||f||||||||||2017-10-11 01:36:05.890808|2017-10-11 01:36:05.890808
NCT01874366|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-08-27|||June 2013||2013-06-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187|A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P11187|Unknown status|Recruiting|Phase 1|96|Anticipated|Piramal Enterprises Limited||2|||f||||f||||||||||2017-10-11 01:36:06.136345|2017-10-11 01:36:06.136345
NCT01874340|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-05-14|2015-04-13||June 2013||2013-06-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis|A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis|Terminated||Phase 2|28|Actual|Novartis|Due to early termination this trial was not powered for efficacy no statistical analysis was performed|4||"Study terminated early based upon development of another anti-IL17 fully human monoclonal   antibody with better potential for treating MS patients"|f||||t||||||||||2017-10-11 01:36:06.581159|2017-10-11 01:36:06.581159
NCT01874327|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2016-03-30|||January 2013||2013-01-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|BabyJ||Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)|Joint Engagement in Infants at Risk for ASD: Integrating Treatment With Biomarkers|Recruiting||N/A|72|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-10-11 01:36:07.061573|2017-10-11 01:36:07.061573
NCT01874314|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2014-03-20||||||May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Effects of SQ109 on QTc Interval in Healthy Subjects|Phase 1 Crossover Study to Assess the Effects of SQ109 on QTc Interval in Healthy Subjects|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 01:36:07.19232|2017-10-11 01:36:07.19232
NCT01874301|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2015-11-09|||November 2013||2013-11-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Probiotics and Gut Health|Evaluation of Changes in Gut Transit Time and Gastrointestinal Symptoms Following the Consumption of a Probiotic Food Product in Adults With Constipation|Completed||N/A|120|Anticipated|Nestlé||3|||f||||f||||||||||2017-10-11 01:36:07.305967|2017-10-11 01:36:07.305967
NCT01874288|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2017-03-16|||July 2013||2013-07-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|DI-Leu16-IL2||Phase I/II Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered Subcutaneously in Patients With B-cell NHL|A Phase I/II Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered Subcutaneously in Patients With B-cell Non-Hodgkin Lymphoma (NHL)|Completed||Phase 1/Phase 2|24|Actual|Alopexx Oncology, LLC||7|||f||||t||||||||No||2017-10-11 01:36:07.837387|2017-10-11 01:36:07.837387
NCT01874275|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-07|2015-04-14|2014-11-04||June 2013||2013-06-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|DMD||Duchenne Muscular Dystrophy Clinical Trial|Double-blind, Randomized, Placebo-controlled Study of VECTTOR Treatment for Duchenne Muscular Dystrophy|Completed||N/A|6|Actual|Alan Neuromedical Technologies, LLC||2|||f||||f||||||||||2017-10-11 01:36:07.993041|2017-10-11 01:36:07.993041
NCT01874262|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-01-25|2015-11-17||June 2013||2013-06-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SUPPORT||A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction|A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction - SUPPORT|Completed||N/A|174|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:36:08.343329|2017-10-11 01:36:08.343329
NCT01874249|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-07-02|||July 2012||2012-07-01|June 2013|2013-06-01||||August 2015|Anticipated|2015-08-01||Interventional|||Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease|Randomized Clinical Trial to Detect Advanced Fibrosis by Non-invasive Methods in Subjects With Non-alcoholic Fatty Liver Disease|Unknown status|Active, not recruiting|N/A|594|Anticipated|Fundación Clínica Médica Sur||5|||f||||t||||||||||2017-10-11 01:36:08.622172|2017-10-11 01:36:08.622172
NCT01874236|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-10-04|||May 6, 2014|Actual|2014-05-06|March 2015|2015-03-01|March 23, 2015|Actual|2015-03-23|March 23, 2015|Actual|2015-03-23||Interventional|VaReFi||Validity and Reliability of Diagnostic Findings of SI Joint Blocking|VaReFi Validity and Reliability of Diagnostic Findings of SI Joint Blocking|Terminated||Phase 4|28|Actual|SI-BONE, Inc.||3||Data could not be interpreted. Re-design efforts failed.|f||||f||||||||||2017-10-11 01:36:08.725224|2017-10-11 01:36:08.725224
NCT01874223|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-06-06|||June 2013||2013-06-01|June 2013|2013-06-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Observational|||Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Unknown status|Not yet recruiting|N/A|40|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 01:36:08.837196|2017-10-11 01:36:08.837196
NCT01874210|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-05-17|||February 2008||2008-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Study on Colonic Fermentation in Chronic Kidney Disease Patients|Study on Colonic Fermentation in Chronic Kidney Disease Patients|Completed||N/A|65|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||Samples Without DNA|"     Fecal sample, serum   "|||2017-10-11 01:36:08.924747|2017-10-11 01:36:08.924747
NCT01874197|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-04-06|||August 2012||2012-08-01|April 2017|2017-04-01|August 2023|Anticipated|2023-08-01|August 2018|Anticipated|2018-08-01||Interventional|B-TEVAR||Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic|Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic Aneurysms: An Investigator-Initiated Study|Recruiting||N/A|60|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-11 01:36:08.997818|2017-10-11 01:36:08.997818
NCT01874171|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-05-04|||November 15, 2012|Actual|2012-11-15|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|De-ESCALaTE||Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC|Determination of Epidermal Growth Factor Receptor-inhibitor (Cetuximab) Versus Standard Chemotherapy (Cisplatin) Early And Late Toxicity Events in Human Papillomavirus-positive Oropharyngeal Squamous Cell Carcinoma|Active, not recruiting||Phase 3|334|Actual|University of Warwick||2|||f||||t||||||||||2017-10-11 01:36:09.227672|2017-10-11 01:36:09.227672
NCT01874158|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-12-16|||November 2012||2012-11-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women|DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women|Completed||Phase 4|99|Actual|Tulane University|||1||f||||f||||||Samples With DNA|"     1 vaginal swab collected at screening for In-pouch 3 vaginal swabs collected at enrollment,     PCR, gram stain, and future microbiome study At each of 3 follow-up visits, 3 vaginal swabs,     PCR, In-pouch, and future microbiome study At the 4th follow-up visit, 4 vaginal swabs, PCR,     In-pouch, gram stain, and future microbiome study.      All swabs, except at screening, are self-collected.   "|No||2017-10-11 01:36:09.368479|2017-10-11 01:36:09.368479
NCT01874145|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-12-10|2015-10-12|2015-07-08|June 2013||2013-06-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|GLACIER|Intent to treat analysis set|Safety and Tolerability of Glatiramer Acetate|An Open-Label, Randomized, Multi-Center, Parallel-Arm Study to Assess the Safety and Tolerability of Glatiramer Acetate 40 mg/mL Three Times a Week Compared to 20 mg/mL Daily Subcutaneous Injections in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|209|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 01:36:09.451823|2017-10-11 01:36:09.451823
NCT01874132|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-03-24|2016-10-18||May 2011||2011-05-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2011|Actual|2011-09-01||Interventional|||Study of the Long-term Effects of Exercise on Heath Indicators in Older People|A Randomised Longitudinal Study of Exercise Prescription for Older Adults: Mode and Intensity to Induce the Highest Cardiovascular Health-related Benefits|Completed||N/A|66|Actual|University of Trás-os-Montes and Alto Douro||3|||f||||t||||||||||2017-10-11 01:36:10.489882|2017-10-11 01:36:10.489882
NCT01874119|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-10-12|||September 2013||2013-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|HD IL-2/Emend||Fosaprepitant for Nausea and Vomiting During High-dose Interleukin-2 (HD IL-2) for Metastatic Melanoma and Renal Cell Carcinoma|Phase 2B Double-blind Placebo-controlled Crossover Study Evaluating the Efficacy of Intravenous Fosaprepitant for Chemotherapy-induced Nausea and Vomiting (CINV) Associated With High-dose Interleukin-2 (HD IL-2) for Metastatic Melanoma and Metastatic Renal Cell Carcinoma|Terminated||Phase 2|12|Actual|St. Louis University||2||Enrollment issues|f||||f||||||||||2017-10-11 01:36:10.94764|2017-10-11 01:36:10.94764
NCT01874106|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2014-01-07|||October 2012||2012-10-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Anti-inflammatory Diet on Inflammatory, Oxidative and Nutritional Markers in Hemodialysis Patients|Effect of Anti-inflammatory Diet on Inflammatory, Oxidative and Nutritional Markers in Hemodialysis Patients|Completed||N/A|120|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:36:11.0513|2017-10-11 01:36:11.0513
NCT01874093|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-09-26|||May 2013||2013-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|IMPACT-24Bt||IMPACT- 24Bt Post Mech. Thrombectomy and/or rtPA TRIAL IMPlant Augmenting Cerebral Blood Flow 24 Hours From Stroke Onset|A Multi-center, Rand., Double Blind, Sham Control, Parallel Arm Post Mech. Thrombectomy and/or rtPA Trial to Assess Safety and Effectiveness of the Ischemic Stroke System, as an Adjunct to Stand. of Care in Subjects With Acute Isch. Stroke|Recruiting||Phase 3|150|Anticipated|BrainsGate||2|||f||||f||||||||||2017-10-11 01:36:11.159804|2017-10-11 01:36:11.159804
NCT01874080|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-04-21|||June 2013||2013-06-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Bioequivalence Study|Bioequivalence Study of the Fixed Dosed Combination of 5 mg Saxagliptin and 1000 mg Metformin Extended Release Tablet Manufactured in Mt. Vernon, Indiana and Humacao, Puerto Rico Relative to the Fixed Dosed Combination Tablet Manufactured in Mt. Vernon, Indiana and Bioequivalence Study of the Fixed Dosed Combination of 5 mg Saxagliptin and 500 mg Metformin Extended Release Tablet Manufactured in Mt. Vernon, Indiana and Humacao, Puerto Rico Relative to the Fixed Dosed Combination Tablet Manufactured in Mt. Vernon, Indiana Administered to Healthy Subjects Under Fed Conditions|Completed||Phase 1|56|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 01:36:11.322159|2017-10-11 01:36:11.322159
NCT01874067|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-03-01|||October 2013||2013-10-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Observational|C-GLOVES||C-GLOVES: the Effectiveness of Compression Gloves in Arthritis|C-GLOVES: an Evaluation of the Effectiveness of Compression Gloves in Arthritis: a Feasibility Study|Completed||N/A|75|Actual|University of Salford|||1||f||||f||||||||No||2017-10-11 01:36:11.443881|2017-10-11 01:36:11.443881
NCT01874054|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-07-31|2016-12-22||June 2013||2013-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional||All subjects who enrolled and received at least 1 dose of brentuximab vedotin.|Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma|A Phase 1/2 Single-arm, Open-label Study to Evaluate the Safety and Efficacy of Brentuximab Vedotin in Combination With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL)|Active, not recruiting||Phase 1/Phase 2|55|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-10-11 01:36:11.569837|2017-10-11 01:36:11.569837
NCT01874041|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2014-08-18|||January 2010||2010-01-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|January 2011|Actual|2011-01-01||Interventional|||Effect of Massage Therapy and Occlusal Splint Therapy on the Electromyographic Activity and Mandibular Range of Motion in Individuals With Temporomandibular Disorder||Completed||N/A|42|Actual|University of Nove de Julho||3|||f||||t||||||||||2017-10-11 01:36:12.109922|2017-10-11 01:36:12.109922
NCT01874028|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2014-09-18|||May 2013||2013-05-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients|A Phase 1 Pharmacokinetic Profiling Study in Patients Receiving Trientine Dihydrochloride for the Treatment of Wilson's Disease.|Completed||Phase 1|20|Actual|Univar BV||1|||f||||f||||||||||2017-10-11 01:36:12.20485|2017-10-11 01:36:12.20485
NCT01874015|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-04-26|||February 2013|Actual|2013-02-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease|Transplantation of Bone Marrow Mesenchymal Stem Cell in Moderate to Severe Fistulizing Crohn's Disease|Recruiting||Phase 1|10|Anticipated|Royan Institute||2|||f||||t||||||||||2017-10-11 01:36:12.275688|2017-10-11 01:36:12.275688
NCT01874002|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-12-29|||June 2013||2013-06-01|December 2015|2015-12-01|March 2019|Anticipated|2019-03-01|March 2015|Actual|2015-03-01|5 Years|Observational [Patient Registry]|REMEDEE Reg||Prospective Registry to Asses the Long-term Safety and Performance of the Combo Stent|Multicenter, Prospective, Clinical Outcomes After Deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio- Engineered Sirolimus Eluting Stent) Post Market Registry|Active, not recruiting||N/A|1000|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-11 01:36:12.36993|2017-10-11 01:36:12.36993
NCT01873989|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-06-08|2016-12-06||April 2012||2012-04-01|June 2017|2017-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Testosterone Replacement for Male Opioid Agonist Maintained Patients|Testosterone Replacement for Male Opioid Agonist Maintained Patients|Completed||Phase 1/Phase 2|15|Actual|Yale University||2|||f||||f||||||||||2017-10-11 01:36:12.503684|2017-10-11 01:36:12.503684
NCT01873976|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-02-08|||June 2013||2013-06-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|January 2017|Actual|2017-01-01||Observational|||Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)|Cardiac Biomarkers in Pediatric Cardiomyopathy|Active, not recruiting||N/A|288|Actual|Wayne State University|||3||f||||t||||||Samples Without DNA|"     Plasma, Serum   "|||2017-10-11 01:36:12.797245|2017-10-11 01:36:12.797245
NCT01873963|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-02-08|||April 2013||2013-04-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|February 2017|Actual|2017-02-01||Observational|||Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)|Genotype-Phenotype Associations in Pediatric Cardiomyopathy|Active, not recruiting||N/A|544|Actual|Wayne State University|||1||f||||t||||||Samples With DNA|"     Bio specimen blood samples were collected for patients enrolled in the PCM Genes study.   "|||2017-10-11 01:36:12.929013|2017-10-11 01:36:12.929013
NCT01873950|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-12-14|2015-03-16||May 2013||2013-05-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|||Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects|A Double-Blind, Randomized, Placebo-Controlled Single-Dose, Five Period Crossover Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects|Completed||Phase 1|22|Actual|Food and Drug Administration (FDA)||5|||f||||t||||||||||2017-10-11 01:36:13.039277|2017-10-11 01:36:13.039277
NCT01873937|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-07-11|||April 2009||2009-04-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|LED/TMD||Analgesic Effects of LED Light on Temporomandibular Disorders.|COMPARATIVE CLINICAL STUDY OF LIGHT ANALGESIC EFFECT ON TEMPOROMANDIBULAR DISORDER (TMD) USING RED AND INFRARED LED-THERAPY|Completed||N/A|30|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 01:36:13.524475|2017-10-11 01:36:13.524475
NCT01873924|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-08-26|||August 2004||2004-08-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01|10 Years|Observational [Patient Registry]|||Clinical and Neuropsychological Investigations in Batten Disease|Clinical and Neuropsychological Investigations in Batten Disease|Recruiting||N/A|400|Anticipated|University of Rochester|||1||f||||f||||||Samples With DNA|"     whole blood, buccal epithelial cells   "|||2017-10-11 01:36:13.605502|2017-10-11 01:36:13.605502
NCT01873911|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-11-19|||December 2010||2010-12-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational|||Neurobehavioral Phenotypes in MPS III|Characterizing the Neurobehavioral Phenotype(s) in MPS III|Completed||N/A|30|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||||2017-10-11 01:36:13.682068|2017-10-11 01:36:13.682068
NCT01873898|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-09-26|||June 2013||2013-06-01|September 2017|2017-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Clinical Investigation of the Rex Medical -Closer™ Vascular Closure System -Reduced Time to Ambulation Trial|Clinical Investigation of the Rex Medical -Closer™ Vascular Closure System -Reduced Time to Ambulation Trial|Completed||N/A|30|Actual|Rex Medical||1|||f||||f|f|t|t|f|t|||||2017-10-11 01:36:15.494924|2017-10-11 01:36:15.494924
NCT01873885|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2014-04-08|||June 2013||2013-06-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension|Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension|Completed||Phase 1|20|Actual|PhaseBio Pharmaceuticals Inc.||3|||f||||t||||||||||2017-10-11 01:36:15.573406|2017-10-11 01:36:15.573406
NCT01873872|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-03-26|||July 2013||2013-07-01|June 2013|2013-06-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics|Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics|Unknown status|Recruiting|N/A|120|Anticipated|St. Vincent's East, Birmingham, Alabama||3|||f||||f||||||||||2017-10-11 01:36:15.659888|2017-10-11 01:36:15.659888
NCT01873859|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-05-16|2014-03-31||May 2013||2013-05-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||166 metformin consumping patients were enrolled. Patients were randomly allocated to continue metformin during peri-angiography period or to stop the medication 24 hours prior the procedure. Four patients in the M (-) group did not complete the study protocol and were excluded from the study.|Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast Media|Incidence of Lactic Acidosis After Coronary Angiography and Angioplasty in Diabetic Patients on Continued Metformin Therapy With Normal Renal Function.|Completed||N/A|166|Actual|Shahid Beheshti University of Medical Sciences|unable to follow patient's creatinine and acidosis for more than 48 hr.|2|||f||||f||||||||||2017-10-11 01:36:15.761525|2017-10-11 01:36:15.761525
NCT01871948|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-12-12|||October 2008||2008-10-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|CanComm||Effective Communication for Preventing and Responding to Oncology Adverse Events|Effective Communication for Preventing and Responding to Oncology Adverse Events|Completed||N/A|500|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-11 01:36:37.714474|2017-10-11 01:36:37.714474
NCT01872741|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-04|||October 2010||2010-10-01|June 2013|2013-06-01|July 2013|Anticipated|2013-07-01|October 2012|Actual|2012-10-01||Interventional|||Minipterional Versus Pterional Craniotomy|"Prospective Randomized Study Comparing Clinical, Functional and Aesthetics Results of Classical Pterional and Minipterional Craniotomies."|Unknown status|Active, not recruiting|N/A|58|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 01:36:15.98142|2017-10-11 01:36:15.98142
NCT01873846|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-09-22|||April 2013||2013-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:36:16.057067|2017-10-11 01:36:16.057067
NCT01873833|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-03-22|||July 29, 2013|Actual|2013-07-29|March 2017|2017-03-01|July 27, 2019|Anticipated|2019-07-27|July 27, 2018|Anticipated|2018-07-27||Interventional|||Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer|Phase II Trial of Metronomic Capecitabine and Cyclophosphamide With Lapatinib and Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-Based Regimen|Recruiting||Phase 2|40|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-11 01:36:16.100694|2017-10-11 01:36:16.100694
NCT01873820|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-06-06|||March 2008||2008-03-01|June 2013|2013-06-01||||June 2008|Actual|2008-06-01||Interventional|||Tolerance of Two Forms of Vitamin C in Acid-sensitive Adults|A Randomized, Double-blind, Crossover Study Comparing the Tolerance of Two Forms of Vitamin C in Acid Sensitive Adults|Completed||N/A|50|Actual|NBTY, Inc.||2|||f||||f||||||||||2017-10-11 01:36:16.212951|2017-10-11 01:36:16.212951
NCT01873807|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-10-07|||May 2013||2013-05-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|HITA||HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL|An Open-label,Multi-center,Prospective Study of Idarubicin and Etoposide Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 4|100|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 01:36:16.307014|2017-10-11 01:36:16.307014
NCT01873794|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-04-07|||January 2012||2012-01-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Treating Cancer-Related Fatigue Through Systematic Light Exposure|Treating Cancer-Related Fatigue Through Systematic Light Exposure|Completed||N/A|54|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f|f|f||||||||2017-10-11 01:36:16.60561|2017-10-11 01:36:16.60561
NCT01873781|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-08-28|||April 2013||2013-04-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||A Pilot Study Simulating Multifocal Intraocular Lenses in Healthy Subjects||Completed||N/A|30|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-11 01:36:16.744234|2017-10-11 01:36:16.744234
NCT01873768|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-03-18|||January 2014||2014-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement|A Randomized Controlled Trial of Tranexamic Acid and ε-Aminocaproic Acid to Reduce Blood Loss Following Total Knee Arthroplasty|Completed||Phase 4|194|Actual|Miller Orthopedic Specialists||2|||f||||t||||||||||2017-10-11 01:36:16.846187|2017-10-11 01:36:16.846187
NCT01873755|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-09-18|||October 2012||2012-10-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Addressing Barriers to Physical Activity in Inner-City Schoolchildren With Asthma|Addressing Barriers to Physical Activity in Inner-City Schoolchildren With Asthma|Active, not recruiting||N/A|250|Anticipated|Montefiore Medical Center||1|||f||||f||||||||No||2017-10-11 01:36:16.962651|2017-10-11 01:36:16.962651
NCT01873742|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-01-04|||June 2013||2013-06-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|STICNorway||The STIC Norway RCT Study: Using Feedback in Psychotherapy.|The STIC Online Feedback System in Psychotherapy Process-outcome Research: A Multi-site, Multi-modality, International RCT-study.|Completed||N/A|200|Actual|Modum Bad||2|||f||||t||||||||||2017-10-11 01:36:17.079331|2017-10-11 01:36:17.079331
NCT01873729|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-11-16|2016-07-29||November 2013||2013-11-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.|An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.|Completed||Phase 4|3|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:36:17.209118|2017-10-11 01:36:17.209118
NCT01873716|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-01-31|||May 2013||2013-05-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|BRIGHT-CEA||Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque|Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque -- A Pilot Study|Completed||Phase 1|5|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:36:17.411718|2017-10-11 01:36:17.411718
NCT01873703|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-04-21|||June 2013||2013-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome|A Phase 2 Randomized Double-Blind Placebo-Controlled Study of Pracinostat in Combination With Azacitidine in Patients With Previously Untreated International Prognostic Scoring System (IPSS) Intermediate Risk-2 or High-Risk Myelodysplastic Syndrome (MDS)|Active, not recruiting||Phase 2|102|Actual|Helsinn Healthcare SA||2|||f||||t||||||||||2017-10-11 01:36:17.505985|2017-10-11 01:36:17.505985
NCT01873690|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-02-04|||November 2013||2013-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Antimicrobial Prophylaxis for Shock Wave Lithotripsy (SWL) on Reducing Urinary Tract Infection (UTI)|A Randomized Controlled Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on Reducing Urinary Tract Infection|Terminated||Phase 3|360|Actual|Lawson Health Research Institute||2||Due to the low recruitment rate and the large number lost to follow-up|f||||f||||||||No||2017-10-11 01:36:17.65729|2017-10-11 01:36:17.65729
NCT01873677|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-08-14||2015-08-14|June 2013||2013-06-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis|A Randomized, Vehicle Controlled, Double Blind, Parallel Group, Multi Center Phase III Study to Evaluate the Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis|Completed||Phase 3|537|Actual|Maruho North America Inc.||2|||f||||f||||||||||2017-10-11 01:36:17.74646|2017-10-11 01:36:17.74646
NCT01873664|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-07|||May 2009||2009-05-01|June 2013|2013-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Functional Magnetic Resonance Imaging Study of Jaw-tapping Movement on Memory Function|Brain Activity During Jaw Tapping Movement in Healthy Subjects and Mild Cognitive Impairment Patients Using Functional Magnetic Resonance Imaging|Unknown status|Recruiting|N/A|30|Anticipated|Kyunghee University Medical Center||1|||f||||t||||||||||2017-10-11 01:36:17.872692|2017-10-11 01:36:17.872692
NCT01873651|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-08-08|||October 2013||2013-10-01|August 2014|2014-08-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Longterm Outcome of the Delta III Inverse Prosthesis|The Reverse Delta III Total Shoulder Prosthesis - Longerm Results in 98 Patients|Withdrawn||Phase 4|0|Actual|Schulthess Klinik||1||The study has been withdrawn due to too few patients|f||||f||||||||||2017-10-11 01:36:17.968998|2017-10-11 01:36:17.968998
NCT01873638|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-07|||February 2006||2006-02-01|June 2013|2013-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparing Minilaparotomy and Laparoscopic Cholecystectomy as a Day Surgery Procedure||Completed||N/A|60|Actual|Kuopio University Hospital||2|||f||||||||||||||2017-10-11 01:36:18.047309|2017-10-11 01:36:18.047309
NCT01873625|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-07|||October 2009||2009-10-01|August 2009|2009-08-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis|Resurfacing Articular Cartilage With Mesenchymal Stem Cells Transplantation in Patients With Knee Joint Osteoarthritis Affected by Rheumatoid Arthritis: Randomized Triple Blind Clinical Trial Phase II/III (ACRCT)|Completed||Phase 2/Phase 3|60|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 01:36:18.124577|2017-10-11 01:36:18.124577
NCT01873612|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-02-25|||May 2013||2013-05-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers||Completed||Phase 4|11|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 01:36:18.219907|2017-10-11 01:36:18.219907
NCT01873599|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-07-09|||June 2013||2013-06-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Impact of an Online Positive Affect Journaling Intervention|Impact of an Online Positive Affect Journaling Intervention|Completed||N/A|70|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 01:36:18.481301|2017-10-11 01:36:18.481301
NCT01873586|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-04-24|||October 2012||2012-10-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion|Efficacy and Safety of OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion|Completed||N/A|30|Actual|SeaSpine, Inc.||1|||f||||f||||||||||2017-10-11 01:36:18.57119|2017-10-11 01:36:18.57119
NCT01873573|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-07-28|||July 18, 2013|Actual|2013-07-18|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|August 25, 2016|Actual|2016-08-25||Interventional|||Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection|Randomized Controlled Trial of Endoscopic Dilation With or Without Triamcinolone Injection in Patients With Non-malignant Radiation or Anastomotic Esophageal Strictures|Active, not recruiting||N/A|10|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|f|f||||||||2017-10-11 01:36:18.655779|2017-10-11 01:36:18.655779
NCT01873560|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-09-03|||May 2013||2013-05-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01|2 Years|Observational [Patient Registry]|PERSPECTIVE||Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention|Influence of Fractional Flow Reserve (FFR) on the Clinical OutcomEs of PERcutaneouS Coronary Intervention (PCI): A ProspECTIVE, Multicenter FFR Registry|Completed||N/A|1250|Actual|Inje University|||1||f||||t||||||||||2017-10-11 01:36:18.768964|2017-10-11 01:36:18.768964
NCT01873547|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-06|||June 2012||2012-06-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|October 2013|Anticipated|2013-10-01||Interventional|SCI-III||Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China|Different Efficacy Between Rehabilitation Therapy and Umbilical Cord Derived Mesenchymal Stem Cells Transplantation in Patients With Chronic Spinal Cord Injury in China|Unknown status|Recruiting|Phase 3|300|Anticipated|General Hospital of Chinese Armed Police Forces||3|||f||||t||||||||||2017-10-11 01:36:18.876235|2017-10-11 01:36:18.876235
NCT01873534|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-07-21||2015-06-02|June 2013||2013-06-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD|A Phase 2A, Uncontrolled, Open-labeled Trial to Evaluate the Effect of FMX-8 Treatment for Anemia in Patients With End Stage Renal Disease (ESRD) on Hemodialysis (HD)|Terminated||Phase 2|6|Actual|FerruMax Pharmaceuticals, Inc.||3||Unable to recruit patients meeting the inclusion criteria|f||||f||||||||||2017-10-11 01:36:18.975754|2017-10-11 01:36:18.975754
NCT01873521|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2014-04-15|||February 2014||2014-02-01|April 2014|2014-04-01|December 2016|Anticipated|2016-12-01|September 2014|Anticipated|2014-09-01||Interventional|NiNAVAped||Neurally Adjusted Ventilatory Assist (NAVA) vs. Pressure Support in Pediatric Acute Respiratory Failure|A Multicentre, Randomized, Clinical Trial of Noninvasive Ventilation: Neurally Adjusted Ventilatory Assist (NAVA) vs. Pressure Support in Pediatric Acute Respiratory Failure - NINAVAPed Protocol|Unknown status|Recruiting|Phase 4|350|Anticipated|Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-11 01:36:19.078401|2017-10-11 01:36:19.078401
NCT01873508|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2015-09-09|||June 2013||2013-06-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers|A Single-center, Open Label, Randomized Cross-over Study to Compare 3 Modified-release Formulations With Different Release Profiles of RO4917523 Along With a Reference Intravenous Microdose Infusion|Completed||Phase 1|24|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 01:36:19.193847|2017-10-11 01:36:19.193847
NCT01873495|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-03-28|||May 2013||2013-05-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Omacetaxine for Consolidation and Maintenance|Omacetaxine for Consolidation and Maintenance in Patients Age ≥ 55 With AML in First Remission: A Pilot Study|Recruiting||Phase 2|45|Anticipated|Emory University||1|||f||||t|t|f||||||Undecided||2017-10-11 01:36:19.280579|2017-10-11 01:36:19.280579
NCT01873482|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-10-31|||May 2014||2014-05-01|October 2014|2014-10-01||||May 2014|Actual|2014-05-01||Interventional|||Traditional African Healing Ceremony in a U.S. Population|Traditional African Healing Ceremony in a U.S. Population|Completed||N/A|17|Actual|Duke University||1|||f||||||||||||||2017-10-11 01:36:19.379027|2017-10-11 01:36:19.379027
NCT01873469|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-06-19|||July 2013||2013-07-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|||Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme|Observational Study of Impact of [11C]-Methionine PET/MRI as a Tool for Individual Tailoring Postoperative Radiochemotherapy for Patients With Glioblastoma Multiforme|Active, not recruiting||N/A|102|Actual|Technische Universität Dresden|||1||f||||f||||||Samples With DNA|"     fresh tumour pieces, blood samples   "|No||2017-10-11 01:36:19.460465|2017-10-11 01:36:19.460465
NCT01873456|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2014-01-31|||January 2013||2013-01-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|CES||Is Multifactorial Nutritional Treatment for Undernutrition in Older Adults in Primary Care Cost-effective?|Is Multifactorial Nutritional Treatment for Undernutrition in Older Adults in Primary Care Cost-effective?|Completed||N/A|120|Actual|Copenhagen University Hospital at Herlev||2|||f||||f||||||||||2017-10-11 01:36:19.535177|2017-10-11 01:36:19.535177
NCT01873443|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-11-25|||May 2013||2013-05-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Long-Term Efficacy and Safety of CT-P10 in Patients With RA|An Open-Label, Single-Arm, Maintenance Study to Demonstrate Long-Term Efficacy and Safety of CT-P10 in Patients With Rheumatoid Arthritis Who Were Treated With Rituximab (MabThera or CT-P10) in Study CT-P10 1.1|Completed||Phase 1|87|Actual|Celltrion||1|||f||||f||||||||||2017-10-11 01:36:19.619177|2017-10-11 01:36:19.619177
NCT01873430|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-08-28|||May 2013||2013-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||The Sun Protective Effect of Melatonin|The Sun Protective Effect of Melatonin: a Randomized, Placebo-controlled, Double-blind Study on Healthy Volunteers|Completed||Phase 1|22|Actual|Herlev Hospital||5|||f||||f||||||||||2017-10-11 01:36:19.699995|2017-10-11 01:36:19.699995
NCT01873417|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-02-14|2014-11-04||May 2013||2013-05-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|MANAGE|Safety Population (participants who received at least 1 dose of DMF, recorded in diary data)|Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States|A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules|Completed||Phase 4|237|Actual|Biogen||1|||f||||f||||||||||2017-10-11 01:36:19.824125|2017-10-11 01:36:19.824125
NCT01873404|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-08-27||2015-08-27|June 2013||2013-06-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SPRINT||BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy|A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy|Completed||Phase 2|183|Actual|Biogen||2|||f||||f||||||||||2017-10-11 01:36:20.40824|2017-10-11 01:36:20.40824
NCT01873391|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2014-02-05|||May 2013||2013-05-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pain in Diagnostic Hysteroscopy|Pain in Diagnostic Hysteroscopy: a Multivariate Analysis.|Completed||N/A|603|Actual|Azienda Ospedaliera S. Maria della Misericordia||2|||f||||t||||||||||2017-10-11 01:36:20.545287|2017-10-11 01:36:20.545287
NCT01873378|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2015-08-10|||January 2013||2013-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||GnRH Agonist Pretreatment in Hysteroscopic Myomectomy|Surgical Effects of GnRH Agonist Pretreatment on Cold Loop Hysteroscopic Myomectomy.|Completed||N/A|84|Actual|Azienda Ospedaliera S. Maria della Misericordia||2|||f||||f||||||||||2017-10-11 01:36:20.620337|2017-10-11 01:36:20.620337
NCT01873365|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-01-16|||June 2013||2013-06-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above|Physician-practice Based Cohort Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Japan|Completed||N/A|448|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 01:36:20.70293|2017-10-11 01:36:20.70293
NCT01873352|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-09-24|||June 2013||2013-06-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|October 2016|Anticipated|2016-10-01||Interventional|ERADICATE--AF||Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation|Evaluate Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation (ERADICATE--AF) Trial|Unknown status|Recruiting|Phase 3|300|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 01:36:20.932477|2017-10-11 01:36:20.932477
NCT01873339|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2017-05-12|||June 19, 2013|Actual|2013-06-19|May 2017|2017-05-01|September 12, 2013|Actual|2013-09-12|September 12, 2013|Actual|2013-09-12||Interventional|||Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects|An Open-label, Single-sequence Study to Evaluate the Potential CYP 3A4 Pharmacokinetic Interaction of Darapladib (SB-480848) in Healthy Subjects|Completed||Phase 1|26|Actual|GlaxoSmithKline||1|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:36:21.068677|2017-10-11 01:36:21.068677
NCT01873326|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-09-27|||June 2013||2013-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors|Randomized Phase II Trial of Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-Risk Germ Cell Tumors|Active, not recruiting||Phase 2|92|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:36:21.180339|2017-10-11 01:36:21.180339
NCT01873313|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2013-06-10|||August 2012||2012-08-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|BLOCKS||Blood Levels of Local Anaesthetic in Knee Arthroplasty|Blood Levels of Local Anaesthetic in Knee Arthroplasty: A Pharmacological Study of Ropivacaine Blood Levels During the Caledonian Technique for Knee Arthroplasty|Completed||N/A|20|Actual|Golden Jubilee National Hospital|||1||f||||f||||||Samples Without DNA|"     Up to 20 blood samples per patient   "|||2017-10-11 01:36:21.344269|2017-10-11 01:36:21.344269
NCT01873300|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-04-08|||February 2012||2012-02-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|POEM||Endoscopic Myotomy for the Treatment of Achalasia (Motility Disorder) of the Esophagus - POEM Procedure|Endoscopic Esophageal Myotomy for the Treatment of Achalasia|Completed||Phase 1/Phase 2|5|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:36:21.447238|2017-10-11 01:36:21.447238
NCT01873287|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-06|2016-01-27|||August 2013||2013-08-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|5P||Predicting Persistent Postconcussive Problems in Pediatrics (5P)|Predicting Persistent Postconcussive Problems in Pediatrics: A Clinical Prediction Rule Derivation and Validation Study|Completed||N/A|3063|Actual|Children's Hospital of Eastern Ontario|||1||f||||f||||||||||2017-10-11 01:36:21.563949|2017-10-11 01:36:21.563949
NCT01873274|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-12|||April 2012||2012-04-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|October 2012|Actual|2012-10-01||Interventional|||Comparative Study Menaquinone-7|Comparative Study of Three Delivery Systems of Menaquinone-7|Completed||N/A|107|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 01:36:21.65596|2017-10-11 01:36:21.65596
NCT01873261|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-06-07|||March 2012||2012-03-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|NINAVAPed||NIV NAVA Versus NIV-PS in Pediatric Patients - Pilot Study|Neurally Adjusted Ventilatory Assist (NAVA) Versus Pressure Support in Pediatric Acute Respiratory Failure - Pilot Study|Unknown status|Recruiting|N/A|60|Anticipated|Hospital Universitario La Paz|||1||f||||f||||||||||2017-10-11 01:36:21.757126|2017-10-11 01:36:21.757126
NCT01873248|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-06-12|||August 26, 2013|Actual|2013-08-26|July 2016|2016-07-01|May 31, 2019|Anticipated|2019-05-31|August 31, 2018|Anticipated|2018-08-31||Interventional|||Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients|Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients|Recruiting||Phase 1/Phase 2|100|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||No||2017-10-11 01:36:21.893864|2017-10-11 01:36:21.893864
NCT01873235|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-04-04|||March 2013||2013-03-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01|4 Years|Observational [Patient Registry]|||PKD Clinical and Translational Core Study|The Baltimore Polycystic Kidney Disease Clinical and Translational Core Study|Recruiting||N/A|200|Anticipated|University of Maryland|||1||f||||f||||||Samples With DNA|"     Plasma, serum,urine, and DNA will be collected at the baseline visit and stored in a     biorepository.   "|||2017-10-11 01:36:22.016314|2017-10-11 01:36:22.016314
NCT01873222|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-07-13|||June 2013||2013-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging|OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging|Completed||Phase 3|106|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t||||||||||2017-10-11 01:36:22.117532|2017-10-11 01:36:22.117532
NCT01873196|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-02-02|||July 2013||2013-07-01|February 2015|2015-02-01||||July 2014|Actual|2014-07-01||Interventional|FAQR-Malawi||Food Aid Quality Review: Feasibility and Acceptability Study of Corn Soy Blend and Fortified Vegetable Oil in Malawi|Food Aid Quality Review: Feasibility and Acceptability Study of Corn Soy Blend and Fortified Vegetable Oil in Malawi|Completed||N/A|6811|Actual|Tufts University||4|||f||||||||||||||2017-10-11 01:36:22.220673|2017-10-11 01:36:22.220673
NCT01873183|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-03-13|||January 2011||2011-01-01|June 2013|2013-06-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Perioperative Fluid Management in Morbidly Obese Patients|Perioperative Fluid Management With Transthoracic Echocardiography and Pulse-contour Device in Morbidly Obese Patients|Completed||N/A|50|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 01:36:22.307209|2017-10-11 01:36:22.307209
NCT01873170|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-05-03|||August 2013|Actual|2013-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|February 20, 2017|Actual|2017-02-20||Observational|CHIC-II||Quantification of Immune Cells in Women Using Contraception (CHIC II)|Quantification of Immune Cells in Women Using Contraception|Active, not recruiting||N/A|275|Anticipated|University of Pittsburgh|||6||f||||t||||||Samples With DNA|"     whole blood, plasma archive, vaginal swabs, serum   "|||2017-10-11 01:36:22.419388|2017-10-11 01:36:22.419388
NCT01873157|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2017-03-22|||December 2013||2013-12-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 2015|Actual|2015-02-01||Interventional|BORTEJECT||Bortezomib in Late Antibody-mediated Kidney Transplant Rejection|Bortezomib in Late Antibody-mediated Kidney Transplant Rejection (BORTEJECT Study)|Completed||Phase 2|44|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:36:22.554039|2017-10-11 01:36:22.554039
NCT01873144|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-06-05|||October 2010||2010-10-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||High Flow Therapy vs Hypertonic Saline in Bronchiolitis|High Flow Therapy vs Hypertonic Saline in Bronchiolitis Treatment. Randomized Controlled Trial|Completed||Phase 3|75|Actual|Ministry of Health, Spain||2|||f||||f||||||||||2017-10-11 01:36:22.68556|2017-10-11 01:36:22.68556
NCT01873131|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-01-07|||February 2011||2011-02-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn|Preventing Growth of Hemangioma Tumors in Newborn: A Prospective Randomized Clinical Study|Recruiting||N/A|126|Anticipated|Massachusetts General Hospital||3|||f||||f||||||||||2017-10-11 01:36:22.794347|2017-10-11 01:36:22.794347
NCT01873118|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-10-10|||July 2014||2014-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|READI||READI (Readiness Evaluation And Discharge Interventions) Study|READI (Readiness Evaluation And Discharge Interventions): Implementation as a Standard Nursing Practice for Hospital Discharge|Recruiting||N/A|24000|Anticipated|Marquette University||2|||f||||f||||||||||2017-10-11 01:36:22.900893|2017-10-11 01:36:22.900893
NCT01873105|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-10-10|||March 2013||2013-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||The CARS Study: Communicating About Readiness (for Discharge)|The CARS Study: Communicating About Readiness (for Discharge)|Recruiting||N/A|1000|Anticipated|Marquette University||1|||f||||f||||||||||2017-10-11 01:36:22.983264|2017-10-11 01:36:22.983264
NCT01873092|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-05|||May 2003||2003-05-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Observational|||AMBULATORY OXIMETRY MONITORING (AOM): a New Approach to Quantify Oxygen Desaturation in Ambulatory COPD Patients|AMBULATORY OXIMETRY MONITORING (AOM): a New Approach to Quantify Oxygen Desaturation in Ambulatory COPD Patients|Unknown status|Active, not recruiting|N/A|100|Anticipated|VA New York Harbor Healthcare System|||1||f||||f||||||||||2017-10-11 01:36:23.063519|2017-10-11 01:36:23.063519
NCT01873079|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-07-15|||April 2013||2013-04-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||PPI for Prevention of Post-sphincterotomy Bleeding|Prevention of Delayed Post-sphincterotomy Bleeding by High Dose Proton Pump Inhibitor|Completed||Phase 3|185|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:36:23.14666|2017-10-11 01:36:23.14666
NCT01873066|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-02-28|||August 28, 2014|Actual|2014-08-28|February 2017|2017-02-01|January 1, 2016|Actual|2016-01-01|July 31, 2015|Actual|2015-07-31||Interventional|DAN04||Closing the Loop 24/7 in Adolescents With Type 1 Diabetes|An Open-label, Single-centre, Randomised, Two-period Crossover Study to Assess the Efficacy, Safety and Utility of Automated Closed-loop Glucose Control, Day and Night Over 7 Days (Phase 1) and 21 Days (Phase 2) in Comparison With Continuous Subcutaneous Insulin Infusion Combined With Continuous Glucose Monitoring in the Home Setting in Children and Adolescents T1D|Completed||N/A|24|Actual|University of Cambridge||2|||f||||t||||||||||2017-10-11 01:36:23.233073|2017-10-11 01:36:23.233073
NCT01873053|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-11-20|||April 2013||2013-04-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||A 12 Week, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee|A 12 Week, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee|Completed||Phase 2|150|Actual|Kyunghee University Medical Center||3|||f||||f||||||||||2017-10-11 01:36:23.326659|2017-10-11 01:36:23.326659
NCT01873040|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-12-07|||August 2013||2013-08-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|VSMRCT||Vaccine Social Media Randomized Intervention Trial|Randomized Intervention Trial to Evaluate a Vaccine Social Media Website|Completed||N/A|1675|Actual|Kaiser Permanente||3|||f||||f||||||||||2017-10-11 01:36:23.412896|2017-10-11 01:36:23.412896
NCT01873027|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2016-07-13|||June 2013||2013-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|OPINION||OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON|OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON (OPINION)|Completed||Phase 3|829|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t||||||||||2017-10-11 01:36:23.505874|2017-10-11 01:36:23.505874
NCT01873014|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-02-14|||June 2012||2012-06-01|May 2012|2012-05-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake|the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake|Unknown status|Active, not recruiting|Phase 1/Phase 2|400|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 01:36:23.590974|2017-10-11 01:36:23.590974
NCT01873001|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-04-16|||May 2013||2013-05-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants|An Open-Label Drug-Drug Interaction Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Subjects|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 01:36:23.662879|2017-10-11 01:36:23.662879
NCT01872988|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-09-03|||September 2012||2012-09-01|September 2014|2014-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma|Tenofovir Disoproxil Fumarate Improves Outcomes Following Palliative Transarterial Chemoembolization for Hepatitis B Virus Related Hepatocellular Carcinoma|Terminated||Phase 3|320|Anticipated|Taichung Veterans General Hospital||2||Difficult in patient enrollment|f||||t||||||||||2017-10-11 01:36:23.753221|2017-10-11 01:36:23.753221
NCT01872975|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-05-12|||August 2013||2013-08-01|May 2017|2017-05-01|August 2028|Anticipated|2028-08-01|July 2023|Anticipated|2023-07-01||Interventional|||Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery|A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy|Recruiting||N/A|1636|Anticipated|NSABP Foundation Inc||4|||f||||t||||||||||2017-10-11 01:36:24.032558|2017-10-11 01:36:24.032558
NCT01872962|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-02-19|||November 2013||2013-11-01|February 2017|2017-02-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Prospective Randomized Trial Comparing Concurrent Chemoradiotherapy With or Without Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Active, not recruiting||Phase 3|480|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:36:26.800083|2017-10-11 01:36:26.800083
NCT01872949|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-03-03|||May 2013||2013-05-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|OPTIONS HF||C-Pulse® System European Multicenter Study|C-Pulse System eurOPean mulTicenter Study, Implantable cOuNterpulsation System in patIents With Moderate to Severe Heart Failure|Active, not recruiting||N/A|50|Anticipated|Sunshine Heart Inc.|||1||f||||f||||||||||2017-10-11 01:36:26.903125|2017-10-11 01:36:26.903125
NCT01872936|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-11-17|||June 2013||2013-06-01|November 2014|2014-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection|Phase 2, Open-Label, Clinical Trial of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Null Responders to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Genotype 1 Infection|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Santaris Pharma A/S||2|||f||||f||||||||||2017-10-11 01:36:26.991805|2017-10-11 01:36:26.991805
NCT01872923|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-06-13|||January 2012||2012-01-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|||Dose Escalating Study for Amphinex-based PCI of Bleomycin.|Dose Escalating Study to Evaluate the Tolerability, Efficacy and Safety of Amphinex 0.125 mg/kg or Lower in Amphinex-based PCI of Bleomycin in Patients With Local Recurrence or Advanced/Metastatic, Cutaneous or Sub-cutaneous Malignancies.|Completed||Phase 1|3|Actual|PCI Biotech AS||1|||f||||f||||||||||2017-10-11 01:36:27.076541|2017-10-11 01:36:27.076541
NCT01872897|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-01-08|||June 2013||2013-06-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients|A Multi-centred, Randomised, Open Label, Placebo-controlled, Two-period Crossover Study to Evaluate 4-hour Esophageal pH Change in GERD Patients After Administration of Compound Sodium Alginate Double Action Tablets or Placebo Tablets|Completed||Phase 3|45|Actual|Reckitt Benckiser Healthcare (UK) Limited||2|||f||||f||||||||||2017-10-11 01:36:27.248425|2017-10-11 01:36:27.248425
NCT01872858|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-05|||November 2010||2010-11-01|June 2013|2013-06-01|November 2015|Anticipated|2015-11-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)||Unknown status|Recruiting|N/A|200|Anticipated|Huashan Hospital||2|||f||||||||||||||2017-10-11 01:36:27.674238|2017-10-11 01:36:27.674238
NCT01872845|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-09-05|||June 2013||2013-06-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT||Recruiting||N/A|740|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:36:27.751858|2017-10-11 01:36:27.751858
NCT01872832|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-01-08|||June 2013||2013-06-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Single and Multiple Dose Study in Japanese Subjects|A Phase 1, Randomized, Single-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of RDEA3170 in Healthy Male Japanese Subjects|Completed||Phase 1|46|Actual|Ardea Biosciences, Inc.||4|||f||||f||||||||||2017-10-11 01:36:27.835182|2017-10-11 01:36:27.835182
NCT01872819|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-08-07|2017-03-04||July 2013||2013-07-01|August 2017|2017-08-01||||April 2015|Actual|2015-04-01||Interventional||relapsed, refractory AML patients. 16 patients were enrolled, 15 patients were treated.|Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay|Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay|Active, not recruiting||N/A|16|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 01:36:27.917583|2017-10-11 01:36:27.917583
NCT01872806|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-04-09|||June 2013||2013-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Electrophysiological Reactivity Due to Mobile Phone Radiation|Radiation Meter Controlled Electrophysiological Reactivity (EEG and ECG) Due to Mobile Phone Radiation.|Completed||N/A|93|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-11 01:36:28.270957|2017-10-11 01:36:28.270957
NCT01872793|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-10-07|||January 2010||2010-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Observational|||Validation of BIVA for Nutritional Assessment in Cirrhotic Patients|Validation of Bioelectrical Impedance Vector Analysis for Nutritional Assessment in Patients With Cirrhosis|Completed||N/A|250|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||f||||||||No||2017-10-11 01:36:28.349526|2017-10-11 01:36:28.349526
NCT01872780|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-06-05|||August 2008||2008-08-01|June 2013|2013-06-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Identification of Null Allelic Variant of CYP2C8 In A Korean Population|The Effect of CYP2C8 E274Q, a Novel 23452 G>T SNP, on the Disposition of Rosiglitazone in Healthy Subjects: The Genetic Polymorphisms of CYP2C8 in a Korean Population|Completed||Phase 1|11|Actual|Inje University||2|||f||||f||||||||||2017-10-11 01:36:28.415896|2017-10-11 01:36:28.415896
NCT01872767|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2015-05-23|||June 2013||2013-06-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure|Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure Admitted in Liver Specialty ICU (Intensive Care Unit)- An Observational Study|Completed||N/A|522|Actual|Institute of Liver and Biliary Sciences, India|||1||f||||f||||||||||2017-10-11 01:36:28.641309|2017-10-11 01:36:28.641309
NCT01872754|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-05-09|||July 31, 2013|Actual|2013-07-31|May 2017|2017-05-01|April 3, 2017|Actual|2017-04-03|April 3, 2017|Actual|2017-04-03||Interventional|REVPRO||Study Comparing the Use of Remifentanil Versus Propofol for Performing Bronchial Fibroscopy|Randomized and Single Blind Study Comparing Remifentanil Sedation Versus Propofol for Performing Bronchial Fibroscopies Under Intravenous Anesthesia|Completed||Phase 4|71|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:36:28.742598|2017-10-11 01:36:28.742598
NCT01872728|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2014-03-17|||June 2013||2013-06-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2013|Actual|2013-12-01||Interventional|FABLORA||Facial Block for Outpatient Rhinoplasty Analgesia|Efficacy of Facial Block for Outpatient Rhinoplasty Analgesia|Unknown status|Active, not recruiting|Phase 3|40|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 01:36:28.865872|2017-10-11 01:36:28.865872
NCT01872715|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2016-01-20|2014-08-12||March 2013||2013-03-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Safety population|Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea|Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea|Completed||Phase 4|24|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-10-11 01:36:28.985377|2017-10-11 01:36:28.985377
NCT01872702|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-08-08|||April 2013|Actual|2013-04-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|TME||Targeted Chemo-elimination (TCE) of Malaria|Targeted Chemo-elimination (TCE) to Eradicate Malaria in Areas of Suspected or Proven Artemisinin Resistance in Southeast Asia and South Asia|Completed||N/A|8000|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 01:36:29.573935|2017-10-11 01:36:29.573935
NCT01872689|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-07-20|||October 30, 2013|Actual|2013-10-30|July 2017|2017-07-01|November 15, 2017|Anticipated|2017-11-15|November 15, 2017|Anticipated|2017-11-15||Interventional|||A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis|Active, not recruiting||Phase 2|507|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 01:36:29.770294|2017-10-11 01:36:29.770294
NCT01872676|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-04|||January 2011||2011-01-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|||Immediate Effects of Upper Thoracic Manipulation on Skin Surface Temperature of T3 Vertebral Region and Biceps Brachii Muscle||Completed||N/A|26|Actual|Universidade Metodista de Piracicaba||2|||f||||f||||||||||2017-10-11 01:36:30.542951|2017-10-11 01:36:30.542951
NCT01872663|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-12-02|||August 2013||2013-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Influence of Different Physical Therapy Resources Application After Reduction Stomach Surgery|Influence of Different Physical Therapy Resources Application After Abdominal Surgery|Completed||N/A|140|Actual|Universidade Metodista de Piracicaba||7|||f||||f||||||||||2017-10-11 01:36:30.62916|2017-10-11 01:36:30.62916
NCT01872650|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-12-03|||September 2014||2014-09-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|CLIPEUS||A Trial to Assess the Effect and Safety of the C-Qur™ Film|A Randomized, Controlled, Clinical Trial to Assess the Effect and Safety of the C-Qur™ fiLm, an antI-adhesive Barrier for the PrevEntion of sUrgical adhesionS|Unknown status|Recruiting|N/A|80|Anticipated|University Medical Center Nijmegen||2|||f||||t||||||||||2017-10-11 01:36:30.741849|2017-10-11 01:36:30.741849
NCT01872637|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-05-15|||June 2011||2011-06-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|March 2017|Actual|2017-03-01||Interventional|||Improving Function, Participation and Function After Acute Hospitalization in Older Adults|Improving Activity, Participation And Function After Acute Hospitalization In Older Adults With Multiple Chronic Conditions: Phase II Randomized Controlled Trial|Completed||N/A|30|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:36:30.825425|2017-10-11 01:36:30.825425
NCT01872624|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-03-24|||May 2013||2013-05-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema|Bone-marrow Derived Mesenchymal Stromal Cells Associated With One-way Endobronchial Valves in Patients With Pulmonary Emphysema: Safety Study|Completed||N/A|10|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 01:36:30.913996|2017-10-11 01:36:30.913996
NCT01872611|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-06-22|2016-05-24||June 2013||2013-06-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Full analysis set, defined as all randomized participants who completed implant surgery and had at least one on-therapy postsurgical visit.|Nepafenac Once Daily for Macular Edema - Study 2|Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery|Completed||Phase 3|819|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:36:31.02832|2017-10-11 01:36:31.02832
NCT01872598|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-06|||January 2012||2012-01-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Phase 3 Study to Evaluate the Safety and Efficacy of Masitinib in Patients With Mild to Moderate Alzheimer's Disease|A Multicenter, Double-blind, Placebo-controlled, Randomised, Parallel-group Phase 3 Study to Evaluate the Safety and Efficacy of Masitinib in Patients With Mild to Moderate Alzheimer's Disease|Unknown status|Recruiting|Phase 3|396|Anticipated|AB Science||3|||f||||t||||||||||2017-10-11 01:36:31.843647|2017-10-11 01:36:31.843647
NCT01872585|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-11-04|||April 2012||2012-04-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Program for Caregivers Involved With Mental Health Services|Feasibility Study of a Mentalization-based Parenting Program for Female Caregivers Involved in Mental Health Services.|Completed||Early Phase 1|18|Actual|Yale University||1|||f||||t||||||||No||2017-10-11 01:36:31.96887|2017-10-11 01:36:31.96887
NCT01872572|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-02|2013-06-04|||August 2009||2009-08-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|SC101||Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD|A Phase 1 Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RB006 Administered Subcutaneously, With and Without IV RB007, in Healthy Young Volunteers|Completed||Phase 1|36|Actual|Regado Biosciences, Inc.||5|||f||||t||||||||||2017-10-11 01:36:32.0725|2017-10-11 01:36:32.0725
NCT01872559|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-05-03|||December 2012|Actual|2012-12-01|May 2017|2017-05-01|September 16, 2016|Actual|2016-09-16|September 13, 2016|Actual|2016-09-13||Observational|||3 Dimensional Sonography Imaging|3D Sonographic Volumetric Analysis of Ovarian Follicles.|Completed||N/A|2|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-10-11 01:36:32.174789|2017-10-11 01:36:32.174789
NCT01872546|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-10-10||||||October 2016|2016-10-01||||September 2013|Actual|2013-09-01||Interventional|||Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy||Completed||Phase 2|15|Actual|Poitiers University Hospital||1|||f||||||||||||||2017-10-11 01:36:32.244648|2017-10-11 01:36:32.244648
NCT01872533|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-12-01|||July 2011||2011-07-01|December 2015|2015-12-01|May 2013|Actual|2013-05-01|September 2012|Actual|2012-09-01||Interventional|SLEEP HIGH||Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)|Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)|Completed||Early Phase 1|9|Actual|Pennington Biomedical Research Center||1|||f||||f||||||||||2017-10-11 01:36:32.332284|2017-10-11 01:36:32.332284
NCT01872520|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2015-10-26|||June 2012||2012-06-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01|2 Weeks|Observational [Patient Registry]|||Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study|Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan (the Injection of Depsides Salts From Salvia Miltiorrhiza): A Real World Study|Completed||N/A|30180|Actual|Peking University Third Hospital|||1||f||||t||||||||||2017-10-11 01:36:32.430115|2017-10-11 01:36:32.430115
NCT01872507|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-06-05|||July 2013||2013-07-01|June 2013|2013-06-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||BioFeedBack Breathing Training Influence Cardiac Autonomic Nervous System in Children With Cerebral-Palsy.|The Effect of Breathing Biofeedback Training to Influence the Function of the Cardiac Autonomic Nervous System at Rest and in Activity in Children With Cerebral Palsy.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 01:36:32.61684|2017-10-11 01:36:32.61684
NCT01872494|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2014-05-01|||May 2013||2013-05-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Impact of Local Analgesia for Postoperative Analgesia in Posterior Thoracolumbar Operation|Pain Treatment in Posterior Thoracolumbar Operation a Randomized Study to Assess the Effect of Local Analgesia After Operation|Completed||Phase 4|71|Actual|Guangzhou General Hospital of Guangzhou Military Command||2|||f||||f||||||||||2017-10-11 01:36:32.744078|2017-10-11 01:36:32.744078
NCT01872481|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-02-04|||June 2013||2013-06-01|June 2013|2013-06-01|October 2014|Actual|2014-10-01|September 2013|Actual|2013-09-01||Interventional|ANTARES||Effects of Repetitive Transcranial Magnetic Stimulation in the Treatment of Phantom Limb Pain in Landmine Victims: ANTARES|Double Blind, Randomized, Placebo Controlled Clinical Trial to Evaluate the Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients Victims of Landmines With Phantom Limb Pain|Completed||Phase 3|54|Actual|Fundación Cardiovascular de Colombia||2|||f||||t||||||||||2017-10-11 01:36:32.878082|2017-10-11 01:36:32.878082
NCT01872468|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-04-10|||September 2011||2011-09-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|RENAP||Effectiveness of a Structured Intervention to Reduce the Progression of Chronic Kidney (RENAP Study)|Effectiveness of an Structured Intervention in Patients With Chronic Kidney Failure to Reduce the Progression of the Illness.|Completed||N/A|269|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||t||||||||||2017-10-11 01:36:33.04155|2017-10-11 01:36:33.04155
NCT01872455|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2013-06-05|||January 2010||2010-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Diet Rich in N-3 Polyunsaturated Fatty Acids in Renal Transplant Recipients|EFFECTS OF A DIET RICH IN N-3 POLYUNSATURATED FATTY ACIDS ON SYSTEMIC INFLAMMATION IN RENAL TRANSPLANT RECIPIENTS|Completed||Phase 4|60|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 01:36:33.126827|2017-10-11 01:36:33.126827
NCT01872442|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-06-09|||October 2013||2013-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase||Active, not recruiting||Phase 2|||Poitiers University Hospital||2|||f|||||f|f||||||||2017-10-11 01:36:33.201786|2017-10-11 01:36:33.201786
NCT01872429|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-06|||November 2012||2012-11-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients||Completed||N/A|401|Actual|Far Eastern Memorial Hospital|||2||f||||f||||||||||2017-10-11 01:36:33.276111|2017-10-11 01:36:33.276111
NCT01872416|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-06-17|||October 2012||2012-10-01|June 2013|2013-06-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Interventional|||A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer|A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer: Single Center, Single-arm Study|Unknown status|Recruiting|Phase 2|30|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||1|||f||||f||||||||||2017-10-11 01:36:33.342467|2017-10-11 01:36:33.342467
NCT01872403|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-06-06|||October 2012||2012-10-01|June 2013|2013-06-01|December 2017|Anticipated|2017-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung|Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung: Parallel Control and Single Center|Recruiting||Phase 2|120|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||1|||f||||f||||||||||2017-10-11 01:36:33.430647|2017-10-11 01:36:33.430647
NCT01872390|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2016-05-17|||April 2013||2013-04-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|January 2016|Actual|2016-01-01||Interventional|START||Start TB Patients on ART and Retain on Treatment (START Study)|Start TB Patients on ART and Retain on Treatment: Combination Intervention Package to Enhance Antiretroviral Therapy Uptake and Retention During TB Treatment in Lesotho|Active, not recruiting||N/A|415|Actual|Columbia University||2|||f||||f||||||||Undecided||2017-10-11 01:36:33.52728|2017-10-11 01:36:33.52728
NCT01872377|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-09-15|||July 2013||2013-07-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Cancer|Phase I Time-to-Event Continual Reassessment (TITE-CRM) Dose Escalation Trial of CyberKnife® Stereotactic Body Radiotherapy (SBRT) Boost With Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Pancreatic Cancer|Recruiting||Phase 1|30|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-11 01:36:33.644467|2017-10-11 01:36:33.644467
NCT01872364|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2013-12-16|||May 2013||2013-05-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Dominican Republic Mission Cost Analysis|A Material Cost-Minimization Analysis for Hernia Repairs and Minor Procedures During a Surgical Mission in the Dominican Republic|Completed||N/A|110|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 01:36:33.724888|2017-10-11 01:36:33.724888
NCT01872351|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2016-10-13|||November 2011||2011-11-01|October 2016|2016-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder|Assessment of Chronic Fatigue Syndrome as a Mitochondrial Disorder|Withdrawn||Phase 1|0|Actual|Columbia University|||1|PI left the institution|f||||t||||||||||2017-10-11 01:36:33.832984|2017-10-11 01:36:33.832984
NCT01872338|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-10-05|||December 1, 2013|Actual|2013-12-01|October 2017|2017-10-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|MBCT-S||Mindfulness-Based Cognitive Therapy for Suicide Prevention|Mindfulness-Based Cognitive Therapy for Preventing Suicide in Military Veterans|Enrolling by invitation||N/A|164|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 01:36:34.083653|2017-10-11 01:36:34.083653
NCT01872325|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-03-13|||June 2013||2013-06-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Improving Cardiac Arrest Diagnostic Accuracy of Emergency Medical Dispatchers|Improving the Cardiac Arrest Diagnostic Accuracy of 9-1-1 Emergency Medical Dispatchers|Completed||N/A|1076|Actual|Ottawa Hospital Research Institute|||2||f||||t||||||||||2017-10-11 01:36:34.172476|2017-10-11 01:36:34.172476
NCT01864590|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2016-10-26|||June 2011||2011-06-01|October 2016|2016-10-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Open Abdomen: Vacuum Pack Versus Sylo Bag and Mesh Protocol|Open Abdomen: Vacuum Pack Versus Sylo Bag and Mesh Protocol - A Randomized Trial|Completed||N/A|52|Actual|Universidad de Antioquia||2|||f||||f||||||||No||2017-10-11 01:39:39.6076|2017-10-11 01:39:39.6076
NCT01872312|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-02-07|||March 2012||2012-03-01|February 2014|2014-02-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Spiration IBV® Valve System and Spiration Airway Sizing Kit|The Humanatarian Use of the Spiration IBV® Valve System and Spiration Airway Sizing Kit for Use in Patients at The Ohio State University Medical Center.|Unknown status|Recruiting|N/A|20|Anticipated|Ohio State University||1|||f||||t||||||||||2017-10-11 01:36:34.244866|2017-10-11 01:36:34.244866
NCT01872299|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-07-25|||March 2010||2010-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|April 2015|Actual|2015-04-01|4 Years|Observational [Patient Registry]|SICA-HF||Studies Investigating Co-morbidities Aggravating Heart Failure|Studies Investigating Co-morbidities Aggravating Heart Failure|Completed||N/A|1600|Actual|Charite University, Berlin, Germany|||4||f||||t||||||Samples With DNA|"     Whole blood, serum, plasma, DNA, biopsies from fat and muscle.   "|||2017-10-11 01:36:34.333382|2017-10-11 01:36:34.333382
NCT01872286|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-02-28|||November 2011||2011-11-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2|A Double-center Randomized Head-to-head Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2|Completed||N/A|53|Actual|Changhai Hospital||2|||f||||t||||||||||2017-10-11 01:36:34.458229|2017-10-11 01:36:34.458229
NCT01872273|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-06-29|||February 2013||2013-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Blood Cell Response to Exercise|Blood Cell Response to Exercise|Withdrawn||N/A|0|Actual|USDA Grand Forks Human Nutrition Research Center|||1|Project never funded. No subjects were recruited.|f||||f||||||||No||2017-10-11 01:36:34.573567|2017-10-11 01:36:34.573567
NCT01872247|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-06-05|||January 2012||2012-01-01|May 2013|2013-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Effect of Ovarian Stimulation With r-hLH/r-hFSH,r-hFSH and hMG in Reducing Apoptosis Rate in Cumulus Cells of Patients Undergoing ICSI|A Pilot Study on the Effect of Ovarian Stimulation With r-hLH/r-hFSH, r-hFSH and hMG in Reducing Apoptosis Rate in Cumulus Cells of Patients Undergoing ICSI|Completed||N/A|61|Actual|Centro di Biologia della Riproduzione, Palermo, Italy|||1||f||||f||||||||||2017-10-11 01:36:35.051578|2017-10-11 01:36:35.051578
NCT01872234|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-04-29|||February 2014||2014-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|MADIT-ASIA||MADIT ASIA Cardiac Resynchronization Trial|MADIT ASIA Cardiac Resynchronization Trial (MADIT-ASIA)|Terminated||Phase 3|1|Actual|Boston Scientific Corporation||2||The study encountered significant difficulties in patient enrollment.|f||||t||||||||||2017-10-11 01:36:35.144665|2017-10-11 01:36:35.144665
NCT01872221|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-05-26|||May 2013||2013-05-01|March 2015|2015-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|STEMRI||Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study|Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study|Recruiting||N/A|16|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||||2017-10-11 01:36:35.283038|2017-10-11 01:36:35.283038
NCT01872208|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-02-13|||October 2013||2013-10-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of the Safety and Efficacy of a Vascular Prosthesis as an Above-Knee Bypass Graft in Patients With PAD|A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-Knee Femoro-Popliteal Bypass Graft in Patients With Peripheral Arterial Disease|Active, not recruiting||N/A|20|Actual|Humacyte, Inc.||1|||f||||t||||||||No||2017-10-11 01:36:35.415879|2017-10-11 01:36:35.415879
NCT01872195|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-06-10|||June 2013||2013-06-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Checklists in Surgical Care - a Study on Complications, Death and Quality of Patient Administrative Data|Effects of Checklists in Surgical Care - a Study on Morbidity, Mortality and Data Quality|Completed||N/A|21000|Actual|Haukeland University Hospital||2|||f||||f||||||||||2017-10-11 01:36:35.536629|2017-10-11 01:36:35.536629
NCT01872182|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-10-10|||May 2013||2013-05-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome|A Randomized, Double-Blind, Placebo Controlled, Multicenter, 12-week Phase 3 Study to Evaluate Efficacy and Safety of ALS-L1023 Tablet in Patients With Abdominal Obesity of Metabolic Syndrome|Terminated||Phase 3|200|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 01:36:35.652772|2017-10-11 01:36:35.652772
NCT01872169|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-06-03|||July 2013||2013-07-01|June 2013|2013-06-01||||November 2014|Anticipated|2014-11-01||Interventional|||Investigating Prevalence of Disordered Eating in Children With GI Disorders|Investigating the Prevalence of Disordered Eating in Children and Adolescents Attending the Great Ormond Street Gastroenterology Clinic|Unknown status|Not yet recruiting|N/A|300|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||1|||f||||||||||||||2017-10-11 01:36:35.743411|2017-10-11 01:36:35.743411
NCT01872156|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-08-11|||December 2013|Actual|2013-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|December 2014|Actual|2014-12-01||Interventional|GESTABAC||Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women|Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women: Cluster Randomized Controlled Trial.|Completed||N/A|350|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||t||||||||||2017-10-11 01:36:35.832484|2017-10-11 01:36:35.832484
NCT01872143|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-06-03|||May 2013||2013-05-01|June 2013|2013-06-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Non-invasive Brain Stimulation for the Treatment of Psychiatric Disorders|Non-invasive Brain Stimulation for the Treatment of Psychiatric Disorders|Unknown status|Recruiting|Phase 2|100|Anticipated|Federico II University||1|||f||||t||||||||||2017-10-11 01:36:35.91998|2017-10-11 01:36:35.91998
NCT01871935|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-01-30|||June 2013||2013-06-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|October 2013|Actual|2013-10-01||Interventional|||Atropine Effects in Anaesthesia With Sufentanil vs. Remifentanil|Comparison of the Effects of Atropine on Haemodynamics and Tissue Oxygenation in Anaesthesia With Propofol and Sufentanil Versus Propofol and Remifentanil|Unknown status|Recruiting|N/A|70|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 01:36:37.823635|2017-10-11 01:36:37.823635
NCT01872130|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-08-10|||May 2013||2013-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins|Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins|Recruiting||N/A|60|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 01:36:36.02278|2017-10-11 01:36:36.02278
NCT01872117|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2017-07-19|||May 2013|Actual|2013-05-01|July 2017|2017-07-01|May 2015|Actual|2015-05-01|September 2014|Actual|2014-09-01||Interventional|||Assessment of Temperature by Infrared Thermography and Blood Conduction Velocity by Doppler After Applying Shortwave Diathermy and Microwave - Correlations With Cardiovascular and Hemodynamic Parameters|Assessment of Temperature by Infrared Thermography and Blood Conduction Velocity by Doppler After Applying Shortwave Diathermy and Microwave - Correlations With Cardiovascular and Hemodynamic Parameters|Completed||N/A|40|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:36:36.117774|2017-10-11 01:36:36.117774
NCT01872104|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-05|||August 2013||2013-08-01|June 2013|2013-06-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Interventional|PDT-R-01||Safety and Efficiency of Photodynamic Therapy for Rectal Cancer|Longterm Outcome of Photodynamic Therapy Compared With Chemotherapy Alone in Patients With Advanced Rectal Cancer|Suspended||Phase 2/Phase 3|100|Anticipated|Central South University||2||Modifying the clinnicaltrials|f||||t||||||||||2017-10-11 01:36:36.192252|2017-10-11 01:36:36.192252
NCT01872091|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2017-07-19|||May 2013|Actual|2013-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|||Analysis of Neuromuscular, Circulatory and Biomechanical Responses After Cryotherapy|Analysis of Neuromuscular, Circulatory and Biomechanical Responses After Cryotherapy by Immersion of the Forearm|Enrolling by invitation||N/A|40|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:36:36.269227|2017-10-11 01:36:36.269227
NCT01872078|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-09-14|2015-07-22||June 2013||2013-06-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study of AZD4901 in Females With Polycystic Ovary Syndrome|A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome|Completed||Phase 2|67|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 01:36:36.354811|2017-10-11 01:36:36.354811
NCT01872065|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-12-09|||July 2013||2013-07-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Tolerability Study of ARC-520 in Healthy Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ARC-520 in Normal Adult Volunteers|Completed||Phase 1|54|Actual|Arrowhead Pharmaceuticals||2|||f||||||||||||||2017-10-11 01:36:36.902303|2017-10-11 01:36:36.902303
NCT01872052|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-03-06|||March 2013||2013-03-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|DDRAMATIC||Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter|Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter|Completed||N/A|9|Actual|Acutus Medical||1|||f||||f||f||||||Undecided||2017-10-11 01:36:37.001773|2017-10-11 01:36:37.001773
NCT01872039|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2015-11-13|||March 2013||2013-03-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients|A Multi-center, Randomized and Controlled Phase IV Study on the Efficacy and Safety of Two Dose Adjustment Regimens of Nicardipine Injection for Hypertensive Emergency|Completed||Phase 4|163|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:36:37.0887|2017-10-11 01:36:37.0887
NCT01872026|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-07-08|||November 2012||2012-11-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis|ASP7991 Clinical Pharmacological Study -Examination of Pharmacokinetics and Pharmacodynamics in Chronic Kidney Disease Patients Undergoing Hemodialysis|Completed||Phase 1|14|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:36:37.204317|2017-10-11 01:36:37.204317
NCT01872013|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2013-06-05|||November 2012||2012-11-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects|Randomized, Double-blinded, Placebo-controlled, Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects|Completed||Phase 1|36|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 01:36:37.288835|2017-10-11 01:36:37.288835
NCT01872000|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-02-19|||April 2013||2013-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BVMP||Binocular Vision in Monocular Pseudophakia|A Prospective Randomised Controlled Trial to Assess Improved Binocular Visual Function in Young Patients Undergoing Monocular Cataract Surgery With a Bifocal Intraocular Lens.|Recruiting||N/A|40|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-11 01:36:37.367197|2017-10-11 01:36:37.367197
NCT01871987|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-03-07|||June 2009||2009-06-01|March 2017|2017-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy Volunteers|Pharmacokinetic Study of FK949E -A Pharmacokinetic Study in Healthy Male Volunteers to Investigate the Effect of Food on the Pharmacokinetics of FK949E|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 01:36:37.454152|2017-10-11 01:36:37.454152
NCT01871974|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-05|2017-02-14|||May 2009||2009-05-01|February 2017|2017-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder|Phase I Study of FK949E - Multiple Dose Study of Non-Elderly Adult Patients With Major Depressive Disorder (MDD)|Completed||Phase 1|16|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:36:37.541172|2017-10-11 01:36:37.541172
NCT01871961|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-03-13|||October 2012||2012-10-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient|Evaluation of Rheumatoid Arthritis Patient Performance Using the Metoject® Prefilled Pen (Methotrexate 50 mg/mL, Prefilled Pen) for Subcutaneous Injection and Subsequent Pharmacokinetic Assessment of Drug Delivery|Completed||Phase 1|105|Actual|medac GmbH||1|||f||||||||||||||2017-10-11 01:36:37.629141|2017-10-11 01:36:37.629141
NCT01871922|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-01-30|||October 2012||2012-10-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Atropine-effect During Propofol/Remifentanil Induction|Evaluation of the Effects of the Addition of Atropine During Propofol/Remifentanil Induction of Anesthesia on Hemodynamics, Microvascular Blood Flow and Tissue Oxygenenation in Patients Undergoing Ophthalmic Surgery|Completed||N/A|60|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 01:36:37.902171|2017-10-11 01:36:37.902171
NCT01871909|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-12-01|||October 2013||2013-10-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Validation of Lower Body Negative Pressure (LBNP) Model of Human Hemorrhage in Trauma Patients|Validation of LBNP Model of Human Hemorrhage in Trauma Patients|Active, not recruiting||N/A|50|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 01:36:38.195551|2017-10-11 01:36:38.195551
NCT01871896|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-11|2014-09-09|||January 2014||2014-01-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Endoscopic Surgery for Bariatric Revision After Weight Loss Failure|Apollo OverStitch for Bariatric Surgery Revision After Weight Loss Failure|Unknown status|Recruiting|N/A|20|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 01:36:38.270305|2017-10-11 01:36:38.270305
NCT01871883|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-11-30|||May 2013||2013-05-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||TRPV Expression in Subjects With Sensitive Skin|Distribution and Expression of Non-neuronal Transient Receptor Potential (TRPV) Ion Channels in Sensitive Skin Syndrome.|Enrolling by invitation||Phase 4|30|Anticipated|Universidad Autonoma de San Luis Potosí||2|||f||||f||||||||||2017-10-11 01:36:38.370733|2017-10-11 01:36:38.370733
NCT01871870|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-05-13|2015-04-10||May 2013||2013-05-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Artificial Pancreas Control System in an Outpatient Setting|Sensor-controlled Insulin- and Glucagon Delivery in Subjects With Type 1 Diabetes: Testing of an Automated System in an Outpatient (Hotel) Setting.|Completed||Phase 2|20|Actual|Legacy Health System||1|||f||||f||||||||||2017-10-11 01:36:38.472099|2017-10-11 01:36:38.472099
NCT01871844|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-06-04|||January 2012||2012-01-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|September 2012|Actual|2012-09-01||Interventional|MAD||ITF2984 Repeated Doses Study in Healthy Volunteers|A Within Group, Randomised, Phase I, Repeated Doses, Placebo and Octreotide Controlled Study in Healthy Volunteers to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Incremental Doses of ITF2984|Completed||Phase 1|46|Actual|Italfarmaco||4|||f||||f||||||||||2017-10-11 01:36:38.731414|2017-10-11 01:36:38.731414
NCT01871831|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-01-13|||June 2013||2013-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|IDT-1326-IU||Assessment of Blood Glucose Monitoring Systems - Evaluation of Oxygen Dependency|Prüfung Von Blutzuckermesssystemen - Bewertung Der Sauerstoffabhängigkeit|Completed||N/A|20|Anticipated|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm|||||f||||||||||||||2017-10-11 01:36:38.828057|2017-10-11 01:36:38.828057
NCT01871818|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-11-03|||May 2013||2013-05-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|REHABMUSCLE||A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis Patients|A Multi-centre Randomised Controlled Trial to Compare the Effectiveness of Two Rehabilitation Programs in Patients With Multiple Sclerosis.|Recruiting||N/A|240|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:37:48.196295|2017-10-11 01:37:48.196295
NCT01871805|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-07-04|2016-01-14||September 30, 2013|Actual|2013-09-30|July 2017|2017-07-01|August 31, 2017|Anticipated|2017-08-31|October 24, 2014|Actual|2014-10-24||Interventional||Safety Population included all participants who received any dose of alectinib.|A Study of CH5424802/RO5424802 in Patients With ALK-Rearranged Non-Small Cell Lung Cancer|A Phase I/II Study of the ALK Inhibitor CH5424802/ RO5424802 in Patients With ALK-Rearranged Non-Small Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib|Active, not recruiting||Phase 2|127|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-11 01:37:48.374519|2017-10-11 01:37:48.374519
NCT01871792|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2013-06-04|||June 2013||2013-06-01|June 2013|2013-06-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction|Preventive Effect of the PRetreatment With pItavastatiN on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndErgoing Coronary Angiography/Intervention (PRINCIPLE-II Study)|Unknown status|Not yet recruiting|Phase 4|404|Anticipated|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 01:37:52.128731|2017-10-11 01:37:52.128731
NCT01871779|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2013-06-04|||October 2010||2010-10-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease|The Effect of Different Forms of Exercise on Both the Clinical, Systemic and Local Biological Responses in Intermittent Claudication|Completed||N/A|35|Actual|Flinders University||2|||f||||f||||||||||2017-10-11 01:37:52.248122|2017-10-11 01:37:52.248122
NCT01871766|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-04-25|||December 4, 2013|Actual|2013-12-04|January 2017|2017-01-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy|Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy|Recruiting||Phase 2|100|Anticipated|St. Jude Children's Research Hospital||4|||f||||f|t|f||||||||2017-10-11 01:37:52.368876|2017-10-11 01:37:52.368876
NCT01871753|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2016-08-03|||January 2014||2014-01-01|August 2016|2016-08-01||||July 2018|Anticipated|2018-07-01||Interventional|BiRT||The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria|The Bacteriuria in Renal Transplantation (BiRT) Study: A Prospective, Randomized, Parallel-group, Multicenter, Open-label, Superiority Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria|Recruiting||Phase 4|198|Anticipated|Erasme University Hospital||2|||f||||t||||||||||2017-10-11 01:37:52.579357|2017-10-11 01:37:52.579357
NCT01871740|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-01-18|||May 2008||2008-05-01|January 2016|2016-01-01|August 2014|Anticipated|2014-08-01|June 2014|Actual|2014-06-01||Interventional|CSPPT-CKD||CSPPT- Chronic Kidney Diseases Study|Enalapril Maleate and Folic Acid Tablets for Prevention of Chronic Kidney Diseases in Patients With Hypertension: a Double-blind Randomized Controlled Trial|Withdrawn||Phase 4|0|Actual|Shenzhen Ausa Pharmed Co.,Ltd||2||"The sponsor and the PIs both agreed that the CSPPT-CKD should be a sub-study of the CSPPT   insted of an independent randomized trial."|f||||t||||||||||2017-10-11 01:37:52.868649|2017-10-11 01:37:52.868649
NCT01871727|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-09-12|||May 9, 2016|Actual|2016-05-09|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|March 31, 2019|Anticipated|2019-03-31||Interventional|||A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma|A Clinical Study to Demonstrate Safety and Efficacy of E7777 in Persistent or Recurrent Cutaneous T-Cell Lymphoma|Recruiting||Phase 3|90|Anticipated|Eisai Inc.||1|||f||||f||||||||||2017-10-11 01:37:52.978931|2017-10-11 01:37:52.978931
NCT01871714|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-11-25|||May 2013||2013-05-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Observational|ECP-014||Phenotypic Properties in Individuals Affected With XLHED|Phenotypic Properties in Individuals Affected With X-linked Hypohidrotic Ectodermal Dysplasia: Symptoms and Facial Recognition|Completed||N/A|30|Actual|Edimer Pharmaceuticals|||3||f||||f||||||Samples With DNA|"     Genetic tests will be carried out in a subset of subject in order to confirm XLHED status.   "|||2017-10-11 01:37:53.083037|2017-10-11 01:37:53.083037
NCT01871701|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-05-30|||November 2012||2012-11-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs|Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs in Healthy Korean Adults After a Single Oral Administration of Escitalopram, Quetiapine, and Moxifloxacin|Completed||Phase 1|40|Actual|Seoul National University Hospital||4|||f||||f||||||||||2017-10-11 01:37:53.155692|2017-10-11 01:37:53.155692
NCT01871688|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-06-04|||April 2013||2013-04-01|June 2013|2013-06-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Pelvic Floor Rehabilitation for Gynecological Cancer Patients|Neuromodulation System for Pelvic Floor Dysfunction Based on the Myo-neurophysiological Assessment for Gynecological Cancer Patients|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Seoul National University Bundang Hospital||1|||f||||f||||||||||2017-10-11 01:37:53.251132|2017-10-11 01:37:53.251132
NCT01871675|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2016-07-07|||May 2013||2013-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies|An Open-label, Phase Ib Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Select Subjects With Lymphoma or Chronic Lymphocytic Leukemia|Completed||Phase 1|48|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-10-11 01:37:53.342773|2017-10-11 01:37:53.342773
NCT01871662|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-03-04|||August 2013||2013-08-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|HEPASIL||Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C|A Randomized, Single Center, Comparative Study to Evaluate the Efficacy and Safety of Silibinin (Legalon® SIL) in Combination With Ribavirin or With Peginterferon and Ribavirin, Versus Peginterferon and Ribavirin Based Standard of Care (SoC) in Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C|Withdrawn||Phase 2/Phase 3|0|Actual|Rottapharm||3|||f||||t||||||||||2017-10-11 01:37:53.444927|2017-10-11 01:37:53.444927
NCT01871649|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-03-02|||September 2013||2013-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Initial Treatment With Golimumab in Early PsA|A Randomized, Double-blind, Placebo-controlled Trial of Golimumab+Methotrexate Versus Methotrexate Alone in Methotrexate-naïve Patients With Psoriatic Arthritis|Recruiting||Phase 3|60|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 01:37:53.532711|2017-10-11 01:37:53.532711
NCT01871636|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2015-09-07|||December 2012||2012-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|May 2014|Actual|2014-05-01||Interventional|||ESD Versus EMR for Treatment of Early Barrett`s Adenocarcinoma|Water-jet Assisted Endoscopic Submucosal Dissection (ESD) Versus Endoscopic Mucosal Resection (EMR) for Treatment of Early Barrett`s Adenocarcinoma|Completed||N/A|40|Actual|Evangelisches Krankenhaus Düsseldorf||2|||f||||f||||||||||2017-10-11 01:37:53.640797|2017-10-11 01:37:53.640797
NCT01871623|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-06-03|||April 2013||2013-04-01|March 2013|2013-03-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||One-Piece Le Fort I Osteotomy Versus Segmental Le Fort I Osteotomy|Stability of One-Piece Le Fort I Osteotomy Versus Segmental Le Fort I Osteotomy: A Prospective Study|Unknown status|Recruiting|N/A|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-11 01:37:53.728886|2017-10-11 01:37:53.728886
NCT01871610|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-06-03|||November 2012||2012-11-01|June 2012|2012-06-01|October 2013|Anticipated|2013-10-01|November 2012|Actual|2012-11-01||Interventional|||Amyloid Accumulation After Mild Traumatic Brain Injury|Amyloid Accumulation After Mild Traumatic Brain Injury|Unknown status|Enrolling by invitation|Phase 2|40|Anticipated|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-11 01:37:53.821273|2017-10-11 01:37:53.821273
NCT01871597|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-09-23|||December 2012||2012-12-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Pulmonary Artery Energy Sealing for VATS Procedure|Ex-Vivo Evaluation of the Effectiveness of Pulmonary Artery Sealing for VATS Procedure|Completed||N/A|15|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 01:37:53.892488|2017-10-11 01:37:53.892488
NCT01871584|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-04|||June 2013||2013-06-01|June 2013|2013-06-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||A Post Marketing Study of Angel of Water™ for Colon Cleansing as Preparation for Colonoscopy|A Prospective, Single Center, Single-blinded, Randomized Study, of the Angel of Water™ for Colon Cleansing as Preparation for Colonoscopy|Unknown status|Recruiting|N/A|160|Anticipated|novoGI||2|||f||||f||||||||||2017-10-11 01:37:53.961497|2017-10-11 01:37:53.961497
NCT01871571|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-04-11|||August 2, 2013|Actual|2013-08-02|April 2017|2017-04-01|August 2, 2019|Anticipated|2019-08-02|August 2, 2018|Anticipated|2018-08-02||Interventional|||Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer|Phase II Trial Of Neoadjuvant Bevacizumab With Modified FOLFOX7 In Patients With Stage II And III Rectal Cancer|Recruiting||Phase 2|43|Anticipated|University of Southern California||1|||f||||t|t|f|||f|||||2017-10-11 01:37:54.061456|2017-10-11 01:37:54.061456
NCT01871558|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-03-22|2016-02-22||June 2013||2013-06-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|ADDONIS||Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin|Randomized, Open-label, SU-controlled Study of 24-week Duration to Compare Metformin/Vildagliptin + Basal Insulin Versus Metformin/SU + Basal Insulin in T2DM Patients Starting Basal Insulin After Failing Metformin/SU|Completed||Phase 3|42|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:37:54.294711|2017-10-11 01:37:54.294711
NCT01871545|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-10-03|||June 2013||2013-06-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)|Evaluation of HCC Response to Systemic Therapy With Quantitative MRI|Recruiting||N/A|141|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 01:37:54.695686|2017-10-11 01:37:54.695686
NCT01871532|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-06-30|2016-04-18||July 2013||2013-07-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01||Interventional|LoGo|Intent-to-Treat (ITT) included all subjects randomized and that had received at least 1 Gonal-f injection and had number of follicles measured at any point.|Low-dose Gonal-f® in Ovulation Induction|A Multi-Centre, Two-Arm, Interventional, Phase IV Study to Evaluate Tailoring of Recombinant FSH Treatment in Subjects With Chronic Anovulation Using the Gonal-f® Prefilled Pen in Women Undergoing Ovulation Induction|Terminated||Phase 4|24|Actual|Merck KGaA|Study was terminated because of delays in sourcing replacement Investigational Medicinal Product (IMP) for the study due to manufacturing delays hence the outcome measure was not assessed.|2||"Study was terminated because of delays in sourcing replacement Investigational Medicinal   Product for the study due to manufacturing delays."|f||||f||||||||||2017-10-11 01:37:54.808709|2017-10-11 01:37:54.808709
NCT01871519|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-02-28|2016-12-14||May 2013||2013-05-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|EVOLVE||Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs|A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures|Completed||N/A|354|Actual|Medtronic Spinal and Biologics||1|||f||||f||||||||||2017-10-11 01:37:55.36838|2017-10-11 01:37:55.36838
NCT01871506|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-08-28|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Integrating Tobacco Treatment Into Cancer Care: A Randomized Controlled Comparative Effectiveness Trial|Integrating Tobacco Treatment Into Cancer Care: A Randomized Controlled Comparative Effectiveness Trial|Active, not recruiting||N/A|303|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 01:37:56.451596|2017-10-11 01:37:56.451596
NCT01871493|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-10-20|||June 2013||2013-06-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants|A Phase 1 Study to Evaluate the Pharmacokinetics of LY2605541 Injection and Insulin Lispro Injection Administered as Mixture or as Individual Components in Healthy Subjects|Completed||Phase 1|40|Anticipated|Eli Lilly and Company||8|||f||||f||||||||||2017-10-11 01:37:56.554099|2017-10-11 01:37:56.554099
NCT01871480|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-12-26|||May 2013||2013-05-01|December 2013|2013-12-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Interventional|||CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer|An Open-label, Randomized, Controlled Study of Gefitinib Plus Autologous Cytokine-Induced Killer Cell Immunotherapy（CIK）Versus Gefitinib Alone As Second Or Third-Line Treatment in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer|Terminated||Phase 2|50|Anticipated|Kunming Medical University||2|||f||||t||||||||||2017-10-11 01:37:56.660764|2017-10-11 01:37:56.660764
NCT01871467|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-08-17|||May 2013||2013-05-01|August 2017|2017-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Sargramostim for Myeloid Dendritic Cell Deficiency|Sargramostim for Myeloid Dendritic Cell Deficiency - Phase I|Completed||Phase 1|2|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 01:37:56.759147|2017-10-11 01:37:56.759147
NCT01871454|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-11-21|||October 2013||2013-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers|Effect of Pentoxifylline and Vitamin E in Preventing Radiation-induced Toxicity in the Treatment of Recurrent or New Primary NSCLC Using Stereotactic Ablative Radiotherapy in Patients Previously Treated With Thoracic Radiation|Recruiting||Phase 2|59|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-10-11 01:37:56.850038|2017-10-11 01:37:56.850038
NCT01871428|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-11-01||2016-08-09|June 2013||2013-06-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy|A Multicenter, Randomized, Doubleblind, Placebo-Controlled, Phase III Study to Assess the Efficacy, Safety and Tolerability of Aleglitazar Monotherapy Compared With Placebo in Patients With Type 2 Diabetes Mellitus (T2D) Who Are Drug-Naïve to Antihyperglycemic Therapy|Completed||Phase 3|13|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:37:57.304231|2017-10-11 01:37:57.304231
NCT01871415|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-11-01||2016-08-09|May 2013||2013-05-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy|A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF ALEGLITAZAR PLUS METFORMIN COMBINATION THERAPY COMPARED WITH PLACEBO PLUS METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY|Completed||Phase 3|7|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:37:57.425986|2017-10-11 01:37:57.425986
NCT01861613|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2013-05-23|||September 2009||2009-09-01|May 2013|2013-05-01||||November 2011|Actual|2011-11-01||Interventional|||Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students||Completed||Phase 4|2040|Actual|Peking University||1|||f||||||||||||||2017-10-11 01:40:22.410286|2017-10-11 01:40:22.410286
NCT01871402|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-04-11|2016-03-10|2015-02-13|May 2013||2013-05-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)|A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)|Completed||Phase 3|221|Actual|Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 01:37:57.557177|2017-10-11 01:37:57.557177
NCT01871389|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-05-07|||February 2012||2012-02-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Impact of Monthly High Dose Oral Cholecalciferol on Serum 25 Hydroxy Vitamin D Levels in Bariatric Surgery Subjects||Completed||N/A|31|Actual|Texas Tech University|||2||f||||f||||||||||2017-10-11 01:37:58.109756|2017-10-11 01:37:58.109756
NCT01871376|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-11-22|||May 2013||2013-05-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|EPIC||Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation|Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation|Completed||Phase 4|25|Actual|Hawaii Pacific Health||2|||f||||f||||||||||2017-10-11 01:37:58.170807|2017-10-11 01:37:58.170807
NCT01871363|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2013-06-03|||October 2012||2012-10-01|June 2013|2013-06-01||||October 2015|Anticipated|2015-10-01||Interventional|||Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer|Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer|Unknown status|Recruiting|Phase 2|35|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 01:37:58.267206|2017-10-11 01:37:58.267206
NCT01871350|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-10-17|||April 2013||2013-04-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Nutrition Intervention During Chemotherapy|Effects of Chemotherapy and Nutritional Intervention on Gut Function and Metabolism in Cancer|Recruiting||N/A|91|Anticipated|Texas A&M University||3|||f||||f||||||||||2017-10-11 01:37:58.347944|2017-10-11 01:37:58.347944
NCT01871337|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-09-20|||February 2014||2014-02-01|December 2012|2012-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|UI-MS||Exercises for Urinary Incontinence(UI) of Women With Multiple Sclerosis (MS)|A Clinical Trial for the Efficacy of Paula Method ( Circular Muscle Exercise) in Women With Multiple Sclerosis Who Suffer From Urinary Incontinence|Completed||N/A|12|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 01:37:58.440777|2017-10-11 01:37:58.440777
NCT01871324|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-03-22|||September 2013||2013-09-01|March 2015|2015-03-01||||September 2015|Anticipated|2015-09-01||Interventional|||The Efficacy of Group Therapy in Ultra-Orthodox Jewish Young Men Diagnosed With Type One Diabetes||Withdrawn||N/A|0|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 01:37:58.576015|2017-10-11 01:37:58.576015
NCT01871311|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-02-01|||May 2014||2014-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors|A Phase I Study of the BCR-ABL Tyrosine Kinase Inhibitor Nilontinib and Cetuximab in Patients With Solid Tumors That Can be Treated With Cetuximab|Recruiting||Phase 1|22|Anticipated|Georgetown University||1|||f||||t||||||||No||2017-10-11 01:37:58.650752|2017-10-11 01:37:58.650752
NCT01871298|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-11-25|||December 2014||2014-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Drug User Internet and Mobile Tech Use|Exploratory Study of Drug User Health-related Internet and Mobile Technology Use|Completed||N/A|212|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:37:58.750874|2017-10-11 01:37:58.750874
NCT01871285|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-01-12|2015-11-02|2015-10-06|June 2013||2013-06-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Analysis is based on Safety population; all subjects who received at least 1 dose of double-blind double dummy treatment.|Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film|An Evaluation of the Tolerability of Switching Subjects on Chronic Around-the-Clock (ATC) Opioid Therapy to Buprenorphine HCl Buccal Film|Completed||Phase 2|39|Actual|BioDelivery Sciences International||2|||f||||f||||||||||2017-10-11 01:37:58.863556|2017-10-11 01:37:58.863556
NCT01871272|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-06-29|||February 2013||2013-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|KACS||Knee Arthroscopy Cohort Southern Denmark (KACS)|Knee Arthroscopy Cohort Southern Denmark (KACS)|Completed||N/A|491|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 01:38:02.251187|2017-10-11 01:38:02.251187
NCT01871259|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-05|||November 2008||2008-11-01|June 2013|2013-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|sleeposa||Clinical Predictors of Apnea-hypopnea During Propofol Sedation|Clinical Predictors of Apnea-hypopnea During Propofol Sedation in Patients Undergoing Spinal Anaesthesia|Terminated||N/A|29|Actual|Samsung Medical Center|||1|Finished|f||||t||||||||||2017-10-11 01:38:02.34886|2017-10-11 01:38:02.34886
NCT01871246|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-05-03|||February 2013||2013-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Observational|||Acute Exacerbation of COPD and Physical Activity - Preliminary Study|Acute Exacerbation of COPD and Physical Activity - Preliminary Study|Active, not recruiting||N/A|23|Actual|University of Michigan|||1||f||||f||||||||||2017-10-11 01:38:02.427375|2017-10-11 01:38:02.427375
NCT01871233|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-09-19||||||September 2017|2017-09-01||||||||Expanded Access|||An Extended Access Program for Perampanel|An Extended Access Program for Perampanel|Available||N/A|||Eisai Inc.|||||||||||||||||||2017-10-11 01:38:02.512309|2017-10-11 01:38:02.512309
NCT01871220|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-05-10|||September 2013||2013-09-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Periimplant Mucosa Dynamics Around Divergent and Concave Atlantis Abutment Transition Profiles||Recruiting||Phase 4|60|Anticipated|University of Iowa||2|||f||||f||||||||||2017-10-11 01:38:03.719849|2017-10-11 01:38:03.719849
NCT01871207|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-05|||May 2011||2011-05-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|UVA-EVA||Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy||Completed||N/A|53|Actual|Università degli Studi di Brescia|||2||f||||f||||||||||2017-10-11 01:38:03.806211|2017-10-11 01:38:03.806211
NCT01871012|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-10-15|||June 2013||2013-06-01|October 2013|2013-10-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01|7 Days|Observational [Patient Registry]|TKRDM2013||The Assessment of Postoperative Recovery in Elder Diabetic Patients|The Assessment of the Management of Intraoperation and Postoperative Quality of Recovery for Total Knee Replacement in Elder Diabetic Patients|Unknown status|Recruiting|N/A|80|Anticipated|Chinese PLA General Hospital|||2||f||||t||||||||||2017-10-11 01:38:06.0089|2017-10-11 01:38:06.0089
NCT01871194|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-10-27|||May 2013||2013-05-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|January 2016|Actual|2016-01-01|12 Weeks|Observational [Patient Registry]|ROSE||An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).|An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®) for the Prevention of Stroke in Patients With Atrial Fibrillation (AF), Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and the Prevention of Recurrent DVT and PE in the Secondary Care Hospital Setting in England and Wales.|Active, not recruiting||N/A|3400|Actual|Drug Safety Research Unit, Southampton, UK|||2||f||||t||||||||||2017-10-11 01:38:03.874367|2017-10-11 01:38:03.874367
NCT01871181|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-10-24|||May 2013||2013-05-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||US-guided Ilioinguinal Blocks Versus Local Infiltration|The Short and Long-term Effects of Ultrasound-guided Ilioinguinal and Iliohypogastric Nerve Block on Postoperative Pain Control Following Open Inguinal Hernia Repair|Active, not recruiting||N/A|60|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 01:38:03.94097|2017-10-11 01:38:03.94097
NCT01871168|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-10-24|||May 2013||2013-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Continuous TAP Blocks - Pain & Plasma LA Levels|Continuous Transversus Abdominis Plane Blocks for Patients Undergoing Major Abdominal Surgery: A Prospective, Controlled, Randomized, Double-blind Trial|Recruiting||N/A|40|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 01:38:04.017802|2017-10-11 01:38:04.017802
NCT01871155|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-04|||January 2012||2012-01-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effect of Nutri-jelly on Quality of Life in Head and Neck Cancer Patients|Efficacy Study of Nutri-jelly Intake on Quality of Life in Head and Neck Cancer Patients Undergoing Radiotherapy|Completed||N/A|64|Actual|Dental Innovation Foundation Under Royal Patronage||2|||f||||f||||||||||2017-10-11 01:38:04.107982|2017-10-11 01:38:04.107982
NCT01871142|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2014-10-23|2014-08-21||March 2013||2013-03-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional||Baseline characteristics were analyzed for all subjects that completed study.|Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance|Double-Blind, Placebo Controlled Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance in Healthy Adult Humans|Completed||Phase 1/Phase 2|12|Actual|Colorado State University||1|||f||||f||||||||||2017-10-11 01:38:04.196485|2017-10-11 01:38:04.196485
NCT01871129|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-05-04|||June 2013|Actual|2013-06-01|May 2017|2017-05-01|April 30, 2014|Actual|2014-04-30|April 2014|Actual|2014-04-01||Interventional|||The Effects of Dexmedetomidine to Postoperative Awakening and Extubation-related Changes in Blood Pressure|The Effects of Postoperative Dexmedetomidine Sedation to Haemodynamics During Extubation|Completed||Phase 4|50|Actual|Tampere University Hospital||2|||f||||t||||||||||2017-10-11 01:38:04.498276|2017-10-11 01:38:04.498276
NCT01871116|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-07-28|||July 2013||2013-07-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||POWER-remote Weight Loss Program in Early Stage Breast Cancer|A Randomized Study Evaluating the Effect of a Remote-Based Weight Loss Program (POWER-remote) on Biomarkers in Women With Early Stage Breast Cancer|Completed||N/A|96|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:38:04.739769|2017-10-11 01:38:04.739769
NCT01871103|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-05|||January 2006||2006-01-01|January 2007|2007-01-01|March 2013|Actual|2013-03-01|January 2009|Actual|2009-01-01||Interventional|||The Dorsal Homodigital Island Flap Based on the Dorsal Branch of the Digital Artery: A Review of 171 Cases||Completed||N/A|173|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 01:38:04.842648|2017-10-11 01:38:04.842648
NCT01871090|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-11-01|2016-06-02||September 2013||2013-09-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|REMEDY||Remote Device Interrogation In The Emergency Department|Remote Device Interrogation In The Emergency Department|Completed||N/A|99|Actual|St. Jude Medical|23 subjects in the control group and 2 in the study group were not included due to their interrogation not being done in the emergency department.|2|||f||||f||||||||No||2017-10-11 01:38:04.940841|2017-10-11 01:38:04.940841
NCT01871077|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-05-19|||September 2013||2013-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers.|Phase I Clinical Trial to Assess the Safety and Tolerability of the Ophthalmic Solution PRO-156 Over the Ocular Surface of Ophthalmologically Healthy Volunteers.|Completed||Phase 1|30|Actual|Laboratorios Sophia S.A de C.V.||1|||f||||f||||||||||2017-10-11 01:38:05.405736|2017-10-11 01:38:05.405736
NCT01871064|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-11-09|||December 2012||2012-12-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2013|Actual|2013-09-01||Observational|RECITE-China||Residual Curarization and Its Incidence at Tracheal Extubation in China|Residual Curarization and Its Incidence at Tracheal Extubation in China|Completed||N/A|1571|Actual|Peking University First Hospital|||1||f||||t||||||||||2017-10-11 01:38:05.505768|2017-10-11 01:38:05.505768
NCT01871051|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-04|||September 2007||2007-09-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|March 2012|Actual|2012-03-01||Observational|||Risk Factors For Postoperative Respiratory Complications After Anesthesia|Risk Factors For Postoperative Respiratory Complications After Anesthesia|Unknown status|Active, not recruiting|N/A|16000|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 01:38:05.681284|2017-10-11 01:38:05.681284
NCT01871038|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-06-04|||July 2009||2009-07-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Rotarix Vaccine Effectiveness|A Case-Control Study to Assess the Effectiveness of Rotarix Vaccine (RV1)|Completed||N/A|2268|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples Without DNA|"     Stool specimen   "|||2017-10-11 01:38:05.770947|2017-10-11 01:38:05.770947
NCT01871025|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-09-19|||June 2013||2013-06-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|TIME||Early Incentive and Mobilization During COPD Exacerbation|Early Incentive and Mobilization During COPD Exacerbation|Recruiting||N/A|30|Anticipated|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 01:38:05.860235|2017-10-11 01:38:05.860235
NCT01870440|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-03-09|||May 2013||2013-05-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema|TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema|Completed||Phase 4|10|Actual|Northern California Retina Vitreous Associates||1|||f||||f||||||||||2017-10-11 01:38:17.435569|2017-10-11 01:38:17.435569
NCT01870999|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-12-03|2013-08-12||November 2007||2007-11-01|December 2013|2013-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||All participants randomized|A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot|An Open-label Parallel Arm Multiple Dose Tolerability, Pharmacokinetics and Safety Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot Formulation Once Every Four Weeks|Completed||Phase 1|41|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||f||||||||||2017-10-11 01:38:06.156537|2017-10-11 01:38:06.156537
NCT01870986|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-02-13|||May 2013||2013-05-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)|Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study Of PF-06410293 and Adalimumab Sourced From US And EU Administered To Healthy Subjects|Completed||Phase 1|210|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:38:07.485996|2017-10-11 01:38:07.485996
NCT01870973|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-06-01|2015-04-20||March 2013||2013-03-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Root Canal Treatment (Versus no Treatment) for Patients With Tooth Infections and Toothaches|Effect on Initial Endodontic Treatment on Postoperative Pain in Symptomatic Teeth With Pulpal Necrosis|Completed||N/A|108|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 01:38:07.63715|2017-10-11 01:38:07.63715
NCT01870960|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-03-18|||June 2013||2013-06-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|June 2015|Actual|2015-06-01||Interventional|EMDOGAIM||Maxillary Sinus Floor Augmentation With Bioss® and Enamel Matrix Derivative: Evaluation of Osteogenic Properties|Maxillary Sinus Floor Augmentation With Bioss® and Enamel Matrix Derivative: Evaluation of Osteogenic Properties|Recruiting||N/A|14|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 01:38:08.387762|2017-10-11 01:38:08.387762
NCT01870947|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2017-04-24|||September 7, 2011|Actual|2011-09-07|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Assisted Exercise in Obese Endometrial Cancer Patients|REWARD (Revving-Up Exercise for Sustained Weight Loss by Altering Neurological Reward and Drive): A Randomized Trial of Assisted Exercise in Obese Endometrial Cancer Patients|Recruiting||N/A|120|Anticipated|Case Comprehensive Cancer Center||2|||f||||t|f|f||||||||2017-10-11 01:38:08.502832|2017-10-11 01:38:08.502832
NCT01870934|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-10-28|||January 2013||2013-01-01|October 2013|2013-10-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Observational|||3D Camera - Telemedical Foot Ulcer Treatment|A Feasibility Study on the Development of 3D Optic Ulcer Camera|Unknown status|Recruiting|N/A|36|Anticipated|Odense University Hospital|||1||f||||t||||||||||2017-10-11 01:38:08.677199|2017-10-11 01:38:08.677199
NCT01870921|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-12-19|2016-09-22||June 2013||2013-06-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|DaYu|Based on the safety population, i.e. all enrolled patients who received at least one dose of Investigational product (IP)|Brilinta DaYu Study|A Multicenter, Single Arm, Open Label, Phase IV Study to Evaluate Safety and to Describe the Incidence of Major Cardiovascular Events of Ticagrelor in Chinese Patients With Acute Coronary Syndrome(ACS)|Completed||Phase 4|2004|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 01:38:08.814942|2017-10-11 01:38:08.814942
NCT01870908|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-10-02|||August 2012||2012-08-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients|Drug Use-result Survey to Assess the Safety and Efficacy of the Combination of Tacrolimus + Biological Agents in Daily Clinical Settings|Completed||N/A|664|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:38:09.395705|2017-10-11 01:38:09.395705
NCT01870895|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2015-10-09|||February 2013||2013-02-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)|A Double-blind, Parallel-group, Comparative Study in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome|Completed||Phase 3|577|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:38:09.536653|2017-10-11 01:38:09.536653
NCT01870882|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-07-15|||June 2013||2013-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Attention Training for Opioid-maintained Cocaine Users|Attention Training for Opioid-maintained Cocaine Users|Completed||Phase 4|8|Actual|Yale University||2|||f||||t||||||||||2017-10-11 01:38:09.651539|2017-10-11 01:38:09.651539
NCT01870869|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-04-18|||May 2013||2013-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:38:09.752951|2017-10-11 01:38:09.752951
NCT01870856|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2014-10-28|2014-10-24||July 2013||2013-07-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||This analysis population includes all participants/eyes exposed to investigational products (test and control).|Lid Wiper Epitheliopathy Trial|Evaluation of Lid Wiper Epitheliopathy With and Without Daily Disposable Contact Lenses|Terminated||N/A|187|Actual|Alcon Research||4||Primary efficacy was not demonstrated in Stage 1|f||||f||||||||||2017-10-11 01:38:09.797208|2017-10-11 01:38:09.797208
NCT01870843|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-05-31|2016-04-01||March 2014||2014-03-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Full Analysis Set (FAS): All randomized participants taking at least one dose of study drug and having at least one visit evaluation in treatment phase were included in the FAS.|A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom|Improving Quality of Life and Social Functionality With Escitalopram in the Treatment of Major Depressive Disorder With Anxiety Symptom|Completed||Phase 4|261|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||||||||||2017-10-11 01:38:10.173261|2017-10-11 01:38:10.173261
NCT01870830|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-05-18|||June 2013||2013-06-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Nocturnal Breathing and Sleep in Patients With Chronic Obstructive Pulmonary Disease Staying at Altitude|Nocturnal Breathing and Sleep in Patients With Chronic Obstructive Pulmonary Disease Staying at Altitude|Completed||N/A|50|Actual|University of Zurich||4|||f||||f||||||||||2017-10-11 01:38:10.626728|2017-10-11 01:38:10.626728
NCT01869673|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-04-01|||June 2013||2013-06-01|May 2013|2013-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Comparison of the Face Mask and Oral Mask Ventilation After Nasal Surgery|A Comparison of the Face Mask and Oral Mask Ventilation After Nasal Surgery.|Completed||Phase 4|24|Actual|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-11 01:38:28.13843|2017-10-11 01:38:28.13843
NCT01870817|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-12-03|||July 2012||2012-07-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Home Jejunostomy Feeding Following Esophagectomy/Gastrectomy|A Pilot Study Investigating the Effect of Post-operative Home Jejunostomy Feeding on Quality of Life and Nutritional Parameters in Patients With Oesophago-gastric Cancer|Completed||N/A|54|Actual|University Hospitals, Leicester||2|||f||||t||||||||||2017-10-11 01:38:10.712678|2017-10-11 01:38:10.712678
NCT01870804|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-10-05|||May 2013||2013-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|PRATO-ACS-2||Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)|Impact of Early High-dose Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury in Unselected Patients With Non- ST Elevation Acute Coronary Syndromes Scheduled for Early Invasive Strategy.|Completed||Phase 4|760|Actual|Centro Cardiopatici Toscani||2|||f||||t||||||||||2017-10-11 01:38:10.827174|2017-10-11 01:38:10.827174
NCT01870791|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-05-25|||May 2012||2012-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer|Phase II Trial of Palliative Epirubicin, Oxaliplatin & Capecitabine (EOX) Chemotherapy Combined With Omega-3 Fish Oil Infusion (Omegaven) in Patients With Oesophagogastric Carcinoma|Terminated||Phase 2|21|Actual|University Hospitals, Leicester||1||Interim analysis|f||||t||||||||||2017-10-11 01:38:10.958959|2017-10-11 01:38:10.958959
NCT01870765|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-02-24|||July 2013||2013-07-01|February 2014|2014-02-01||||February 2014|Actual|2014-02-01||Interventional|||Safety Study of Non-invasive Ventilation Versus High-flow Oxygen in Patients With Hypoxemic Respiratory Failure Undergoing Fiberoptic Bronchoscopy.|Prospective Randomised Study on the Safety of Non-invasive Ventilation Versus High-flow Oxygen in Patients With Hypoxemic Respiratory Failure Undergoing Fiberoptic Bronchoscopy.|Completed||N/A|40|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||||||||||||2017-10-11 01:38:12.709888|2017-10-11 01:38:12.709888
NCT01870752|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2016-09-23|||June 2013||2013-06-01|September 2016|2016-09-01||||June 2018|Anticipated|2018-06-01||Interventional|||Ovarian Tissue Transplantation|Autologous Orthotopic Transplantation of Previously Cryopreserved Ovarian Tissue|Recruiting||N/A|10|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:38:12.805691|2017-10-11 01:38:12.805691
NCT01870739|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-07-20|2016-05-31||October 2013||2013-10-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Safety analysis set: All patients that received study drug|A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension|A Randomized, Double-blind, Active-controlled, Parallel Group, 52-week Study to Evaluate the Effect of LCZ696 Compared to Olmesartan on Regional Aortic Stiffness in Subjects With Essential Hypertension|Completed||Phase 2|115|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:38:12.951974|2017-10-11 01:38:12.951974
NCT01870726|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-02-12|||January 9, 2014|Actual|2014-01-09|February 2017|2017-02-01|December 23, 2016|Actual|2016-12-23|December 23, 2016|Actual|2016-12-23||Interventional|||Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Gliobastoma|A Phase Ib/II, Multi-center, Open-label Study of INC280 in Combination With Buparlisib in Patients With Recurrent Glioblastoma|Completed||Phase 1/Phase 2|42|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:38:13.782379|2017-10-11 01:38:13.782379
NCT01870713|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-04|2013-06-04|||October 2010||2010-10-01|June 2013|2013-06-01|October 2013|Anticipated|2013-10-01|October 2012|Actual|2012-10-01|1 Year|Observational [Patient Registry]|||Proteomics Study of Gastric Bypass Surgery to Treat Type 2 Diabetes Mellitus|Serum Proteomics Research in Bypassing Surgery to Treat Type 2 Diabetes in China|Unknown status|Active, not recruiting|N/A|50|Actual|No. 150 Central Hospital of the Chinese People Liberation Army|||2||f||||||||||Samples With DNA|"     whole blood, serum, urine   "|||2017-10-11 01:38:14.02232|2017-10-11 01:38:14.02232
NCT01870700|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2013-06-04|||January 2012||2012-01-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Lactobacillus Reuteri in Adult With Functional Chronic Constipation|The Effect of Lactobacillus Reuteri Supplementation to Adult With Functional Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 3|40|Actual|Catholic University, Italy||2|||f||||f||||||||||2017-10-11 01:38:14.099092|2017-10-11 01:38:14.099092
NCT01870687|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-09-12|||June 2013||2013-06-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS|Prospective, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Randomized Clinical Trial to Proof Efficacy and Safety of 20 mg (2 Tablets of 10 mg) VAC BNO 1095 FCT in Patients Suffering From Cyclic Mastodynia and PMS|Terminated||Phase 3|96|Actual|Bionorica SE||2|||f||||f||||||||||2017-10-11 01:38:14.196888|2017-10-11 01:38:14.196888
NCT01870674|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-05-07|||August 2013||2013-08-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects|A Randomized, Double-blind, Placebo/Active-controlled, Single/Multiple Dose Phase 1 Clinical Study to Investigate the Safety/Tolerability and PK/PD of YH12852 After Oral Administration in Healthy Subjects|Completed||Phase 1|127|Actual|Yuhan Corporation||3|||f||||t||||||||||2017-10-11 01:38:14.299836|2017-10-11 01:38:14.299836
NCT01870661|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-06-24|||May 2013||2013-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Ultrasound Guided Peripheral Intravenous Catheter Insertion in the Hospitalized Patient: Long vs. Short Axis Placement|Ultrasound Guided Peripheral Intravenous Catheter Insertion in the Hospitalized Patient: Long vs. Short Axis Placement|Withdrawn||N/A|0|Actual|Beth Israel Medical Center||2||No participants enrolled|f||||f||||||||||2017-10-11 01:38:14.38901|2017-10-11 01:38:14.38901
NCT01870648|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-01-06|||May 2014||2014-05-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|OSEP||Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan|Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in Emergency Departments in Pakistan|Recruiting||Phase 4|868|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-11 01:38:14.481699|2017-10-11 01:38:14.481699
NCT01870635|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-04-18|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|February 3, 2017|Actual|2017-02-03|January 20, 2017|Actual|2017-01-20||Interventional|OWEP||Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan|Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in Emergency Departments in Pakistan|Completed||Phase 4|625|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 01:38:14.614075|2017-10-11 01:38:14.614075
NCT01870622|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-03-13|||June 2013||2013-06-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Confirmation of Correct Tracheal Tube Placement in Newborn Infants - a Randomized Control Trial|Confirmation of Correct Tracheal Tube Placement in Newborn Infants - a Randomized Control Trial|Completed||N/A|100|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 01:38:14.736093|2017-10-11 01:38:14.736093
NCT01870609|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-01-26||2016-03-31|September 2013||2013-09-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|COMMAND||Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma|A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma|Terminated||Phase 2|344|Actual|Verastem, Inc.||2||Interim analysis-DSMB stated good safety profile but lack of efficacy|f||||t||||||||||2017-10-11 01:38:14.852953|2017-10-11 01:38:14.852953
NCT01870596|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-07-20|2015-09-11||May 2013||2013-05-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia|Randomized Phase II Trial of Timed Sequential Cytosine Arabinoside (Ara-C) With and Without the Checkpoint Kinase 1 (CHK1) Inhibitor MK-8776 in Adults With Relapsed AML|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 01:38:15.258439|2017-10-11 01:38:15.258439
NCT01870583|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-09-02|2017-05-19||February 2013||2013-02-01|September 2017|2017-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Comparison of Surgical Skin Preps During Cesarean Deliveries|Comparison of Surgical Skin Preps During Cesarean Deliveries|Completed||N/A|1404|Actual|Montefiore Medical Center||3|||f||||t||||||||||2017-10-11 01:38:15.881516|2017-10-11 01:38:15.881516
NCT01870570|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-08-20|||June 2013||2013-06-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Determination of Glycaemic Index and Insulinaemic Index Values of 6 Food Products in 3 Separate Research Centers|Determination of Glycaemic Index and Insulinaemic Index Values of 6 Cereal Products in 3 Separate Research Centers|Completed||N/A|48|Actual|Mondelēz International, Inc.||7|||f||||f||||||||||2017-10-11 01:38:16.235098|2017-10-11 01:38:16.235098
NCT01870557|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-05-27|||March 2013||2013-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Observational|Diabone||Markers of Bone Status in Diabetes Mellitus (Type 1 and Type 2)|Markers of Bone Status in Diabetes Mellitus (Type 1 and Type 2)|Completed||N/A|197|Actual|University of Aarhus|||2||f||||f||||||Samples Without DNA|"     Serum Plasma EDTA Plasma Heparin Urine   "|||2017-10-11 01:38:16.393006|2017-10-11 01:38:16.393006
NCT01870544|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-02-09|||September 2013||2013-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||"Does Weight Loss Surgery and Probiotic Supplementation Lead to a Lean Gut Microbiota?"|"Does Weight Loss Surgery and Probiotic Supplementation Lead to a Lean Gut Microbiota?"|Completed||Phase 1/Phase 2|18|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-10-11 01:38:16.512758|2017-10-11 01:38:16.512758
NCT01870531|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-06-06|||July 2010||2010-07-01|June 2015|2015-06-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01|90 Days|Observational [Patient Registry]|KTX registry||Korean Transient Ischemic Attack eXpression Registry|Transient Ischemic Attacks in Korean: Hospital-based, Multi-center Prospective Registry|Completed||N/A|500|Actual|Seoul National University Boramae Hospital|||1||f||||f||||||||||2017-10-11 01:38:16.616987|2017-10-11 01:38:16.616987
NCT01870505|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-07-27|||May 2013|Actual|2013-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer|A Phase I Trial of BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer|Active, not recruiting||Phase 1|52|Actual|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-11 01:38:16.823922|2017-10-11 01:38:16.823922
NCT01870492|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-03-01|||January 2014||2014-01-01|March 2017|2017-03-01|September 29, 2015|Actual|2015-09-29|September 29, 2015|Actual|2015-09-29||Observational|IMPACT||Improving Patient Access to Stroke Therapy Study|Improving Patient Access to Stroke Therapy Study|Terminated||N/A|500|Actual|Medical College of Wisconsin|||1|Principle Investigator relocated to a new institution|f||||f||||||||||2017-10-11 01:38:16.938177|2017-10-11 01:38:16.938177
NCT01870479|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-06-02|||May 2013||2013-05-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Music & Cancer - Live Music During Chemotherapy|Music & Cancer - Live Music During Chemotherapy. Randomized Study of the Effect of Live Music During Chemotherapy Treatment|Unknown status|Recruiting|N/A|105|Anticipated|University of Southern Denmark||3|||f||||t||||||||||2017-10-11 01:38:17.046071|2017-10-11 01:38:17.046071
NCT01870466|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-05-22|||June 2012||2012-06-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|SMCCPT-100||Pharmacodynamic Drug Interaction Between Cilostazol and Statins|A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacodynamic Drug Interaction Between Cilostazol and Statins in Healthy Male Volunteer|Completed||Phase 1|63|Actual|Samsung Medical Center||6|||f||||f||||||||||2017-10-11 01:38:17.224266|2017-10-11 01:38:17.224266
NCT01870453|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-02-06|||October 2013||2013-10-01|February 2014|2014-02-01|April 2016|Anticipated|2016-04-01|August 2015|Anticipated|2015-08-01||Observational|||Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's Disease|Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's Disease|Unknown status|Recruiting|N/A|100|Anticipated|Massachusetts General Hospital|||4||f||||t||||||||||2017-10-11 01:38:17.32928|2017-10-11 01:38:17.32928
NCT01870427|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2016-12-07|||June 2013||2013-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|NEWTON||NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions|NEWTON: A Single-center Open Label Study Evaluating Intravitreal Aflibercept Injection (IAI) for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions|Completed||Phase 4|20|Actual|Northern California Retina Vitreous Associates||1|||f||||f||||||||||2017-10-11 01:38:17.532955|2017-10-11 01:38:17.532955
NCT01870414|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-06-05|||March 2012||2012-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|March 2012|Actual|2012-03-01||Interventional|||Electromyographic Analysis And Body Balance In The Use Of Athletes After Cryotherapy By Immersion Ankle|Electromyographic Analysis And Body Balance In The Use Of Athletes After Cryotherapy By Immersion Ankle|Completed||N/A|40|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 01:38:17.629582|2017-10-11 01:38:17.629582
NCT01870388|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-05-15|2017-03-10||June 2013||2013-06-01|May 2017|2017-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||All enrolled participants.|A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease|A Pharmacokinetic Study of Baricitinib in Subjects With Hepatic Dysfunction|Completed||Phase 1|16|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 01:38:18.275274|2017-10-11 01:38:18.275274
NCT01870375|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-08-30|||September 2009||2009-09-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Longitudinal Studies of Brain Structure and Function in MPS Disorders|Longitudinal Studies of Brain Structure and Function in MPS Disorders|Recruiting||N/A|100|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||5||f||||t|f|f||||||||2017-10-11 01:38:18.638555|2017-10-11 01:38:18.638555
NCT01870362|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-07-22|||June 2013||2013-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis|Improvement of Periodontal Health and Reduction in Periodontal Plaque Micro-flora Using a Probiotic Lozenge in Patients With Chronic Periodontitis|Completed||Phase 3|28|Actual|CD Pharma India Pvt. Ltd.||2|||f||||f||||||||||2017-10-11 01:38:18.772635|2017-10-11 01:38:18.772635
NCT01870349|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-03|||December 2010||2010-12-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Observational|||A Comparison of Inflammatory Mediators Surrounding Titanium or Zirconium Implant Abutments|Evaluation of Pro-inflammatory Mediators Around Astra Tech Dental Implant Abutments Following a Minimum of 6 Months of Clinical Function|Completed||N/A|46|Actual|University of Iowa|||2||f||||f||||||Samples Without DNA|"     Gingival crevicular fluids   "|||2017-10-11 01:38:18.839346|2017-10-11 01:38:18.839346
NCT01870336|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-03-03|||September 2012||2012-09-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Combination of Lateral Foot Orthoses and Knee Brace for Treatment of the Knee Osteoarthritis|Combination of Lateral Foot Orthoses and Knee Brace for Treatment of the Medial Knee Osteoarthritis|Completed||N/A|22|Actual|Laval University||3|||f||||t||||||||||2017-10-11 01:38:18.907564|2017-10-11 01:38:18.907564
NCT01870323|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2014-12-08|||November 2012||2012-11-01|March 2014|2014-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|SMART||The Social Media and Activity Research in Teens Trial|The Social Media and Activity Research in Teens Trial|Completed||N/A|21|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-11 01:38:18.970472|2017-10-11 01:38:18.970472
NCT01870310|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2013-06-03|||June 2012||2012-06-01|June 2013|2013-06-01|June 2016|Anticipated|2016-06-01|September 2013|Anticipated|2013-09-01||Interventional|||Renal Denervation in Patients With Heart Failure and Severe Left Ventricular Dysfunction.|Long Term Study on the Possible Beneficial Effects of Catheterised Renal Denervation in Patients With Heart Failure and Left Ventricular Systolic Dysfunction Who Are Already on Standard Medical Therapy.|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital Olomouc||2|||f||||f||||||||||2017-10-11 01:38:19.130642|2017-10-11 01:38:19.130642
NCT01870284|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-09-15|||July 2014||2014-07-01|September 2014|2014-09-01|April 2018|Anticipated|2018-04-01|April 2016|Anticipated|2016-04-01||Interventional|SPIRIT A1||Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)|A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Patients With Active Ankylosing Spondylitis|Withdrawn||Phase 3|0|Actual|Eli Lilly and Company||4||Due to unexpected operational issues outside of Lilly's control the study has been closed|f||||t||||||||||2017-10-11 01:38:19.39067|2017-10-11 01:38:19.39067
NCT01870271|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-05-23|||November 2012||2012-11-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|March 2014|Actual|2014-03-01||Interventional|Pilot-DCPT||Pilot-Study DCPT for PTSD in Adolescents and Young Adults|Pilotstudie Developmentally Adapted Cognitive Processing Therapy für Jugendliche Und Junge Erwachsene Mit Posttraumatischer Belastungsstörung Nach Sexualisierter Und /Oder körperlicher Gewalt (Pilot DCPT)|Completed||N/A|12|Actual|Goethe University||1|||f||||f||||||||No||2017-10-11 01:38:19.759669|2017-10-11 01:38:19.759669
NCT01870258|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-06-04|||January 2011||2011-01-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Myocardial Infarction Prediction|Prediction of Acute Myocardial Infarction With Artificial Neural Networks in Patients With Nondiagnostic Electrocardiogram|Completed||N/A|1100|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:38:19.839115|2017-10-11 01:38:19.839115
NCT01870245|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-06-28|||May 2013||2013-05-01|June 2013|2013-06-01||||June 2013|Actual|2013-06-01||Interventional|||A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers|A Phase 1 Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 Administered Intravenously to Healthy Volunteers|Terminated||Phase 1|4|Actual|Achaogen, Inc.||2|||f||||||||||||||2017-10-11 01:38:19.919874|2017-10-11 01:38:19.919874
NCT01870232|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-03-07|||June 2013||2013-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Use of Ultrasound for Greater Palatine Nerve Block and Inferior Alveolar Nerve Blocks: An Open Label Feasibility Study|EVALUATION OF USE OF ULTRASOUND FOR GREATER PALATINE NERVE BLOCK AND INFERIOR ALVEOLAR NERVE BLOCKS: AN OPEN LABEL FEASIBILITY STUDY|Active, not recruiting||N/A|20|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 01:38:19.999145|2017-10-11 01:38:19.999145
NCT01870219|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-05|||February 2012||2012-02-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy|The Effects of Sevoflurane or Ketamine on QTc Interval During Electroconvulsive Therapy|Completed||Phase 4|24|Actual|Inonu University||2|||f||||t||||||||||2017-10-11 01:38:20.100631|2017-10-11 01:38:20.100631
NCT01870206|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-09-27|||June 2013||2013-06-01|September 2013|2013-09-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns|Phase III Immunogenicity, Safety, Poliovirus Excretion and Acceptance of Vaccination OPV (Vero Cells) in Newborns Mexicans|Unknown status|Recruiting|Phase 3|320|Anticipated|Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.||2|||f||||t||||||||||2017-10-11 01:38:20.20251|2017-10-11 01:38:20.20251
NCT01870193|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-01-05|||October 2012||2012-10-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Glutathione and Fuel Oxidation in Aging|Glutathione and Fuel Oxidation in Aging|Recruiting||N/A|36|Anticipated|Baylor College of Medicine|||2||f||||f||||||Samples With DNA|"     Breath, blood and muscle tissue   "|No||2017-10-11 01:38:20.324341|2017-10-11 01:38:20.324341
NCT01870180|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-01-14|||May 2013||2013-05-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|MGD||EyeBag Effectiveness in Meibomian Gland Dysfunction|Investigating the Efficacy of the MGDRx EyeBag in Patients With Meibomian Gland Dysfunction Related Evaporative Dry Eye|Completed||N/A|18|Actual|Aston University||2|||f||||f||||||||||2017-10-11 01:38:20.458366|2017-10-11 01:38:20.458366
NCT01870167|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-06-04|||January 2013||2013-01-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Antibiotic Prophylaxis for PEG in Children|Antibiotic Prophylaxis for Percutaneous Endoscopic Gastrostomy (PEG) in Children: a Randomised Controlled Trial.|Unknown status|Recruiting|Phase 4|90|Anticipated|Azienda Policlinico Umberto I||2|||f||||t||||||||||2017-10-11 01:38:20.560545|2017-10-11 01:38:20.560545
NCT01870154|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-02|2013-06-04|||March 2010||2010-03-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EDESPROAP||Effectiveness of an Intervention for Prevention and Treatment of Burnout in Primary Care|Effectiveness of an Intervention for Prevention and Treatment of Burnout in Primary Health Care Professionals|Completed||N/A|300|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||f||||||||||2017-10-11 01:38:20.644493|2017-10-11 01:38:20.644493
NCT01870141|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-06-03|||October 2012||2012-10-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|COPEST||Psychological Distress and Type 2 Diabetes|Glycaemic Control, Body Weight and Psychological Distress in Type 2 Diabetes: The Role of Self-Efficacy|Unknown status|Recruiting|N/A|80|Anticipated|Azienda Ospedaliera Universitaria Integrata Verona||2|||f||||t||||||||||2017-10-11 01:38:20.720917|2017-10-11 01:38:20.720917
NCT01870128|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-03|||August 2009||2009-08-01|June 2013|2013-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial|Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial|Completed||Phase 3|60|Actual|All India Institute of Medical Sciences, New Delhi||3|||f||||t||||||||||2017-10-11 01:38:20.822289|2017-10-11 01:38:20.822289
NCT01870115|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-02-10|||August 2013||2013-08-01|February 2017|2017-02-01|February 9, 2017|Actual|2017-02-09|February 9, 2017|Actual|2017-02-09||Interventional|MOTS||Melatonin-Micronutrients for Osteopenia Treatment Study|Phase 1 Study of Combination Strontium, Melatonin and Nutritional Co-factors on Bone Health and Quality of Life in Postmenopausal Women With Osteopenia|Completed||Phase 1|23|Actual|Duquesne University||2|||f||||f|f|f||||||No||2017-10-11 01:38:20.909308|2017-10-11 01:38:20.909308
NCT01870102|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-01-13||||||January 2014|2014-01-01||||August 2013|Actual|2013-08-01||Interventional|||Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects|A Randomized, Open Label, Cross-over, Phase 1 Trial to Investigate the Pharmacokinetics in Multi-dose and the Food Effect in Single-dose of Pelubiprofen IR and Pelubiprofen SR in Healthy Male Volunteers|Completed||Phase 1|||Daewon Pharmaceutical Co., Ltd.||4|||f||||||||||||||2017-10-11 01:38:20.994844|2017-10-11 01:38:20.994844
NCT01870089|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-05-03|||May 2013||2013-05-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||SmartCare Driven Pressure Support-Non Invasive Ventilation Feasibility Study|Clinical Evaluation of an Automated Knowledge-based Computer Driven System (SmartCare/PS-NIV) Designed to Automatically Adapt Pressure Support Level and Expiratory Cycling During Non Invasive Ventilation, a Feasability Study.|Terminated||N/A|11|Actual|University of Lausanne Hospitals||1||Enough data to conclude|f||||f||||||||||2017-10-11 01:38:21.065465|2017-10-11 01:38:21.065465
NCT01870063|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-08-05|||June 2013||2013-06-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01|1 Week|Observational [Patient Registry]|||Comparision of FIBTEM and Blood-loss||Completed||N/A|71|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-10-11 01:38:21.240445|2017-10-11 01:38:21.240445
NCT01870050|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-04|||September 2013||2013-09-01|June 2013|2013-06-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Dapsone Prurigo Study|A Double-blind, Randomized, Parallel-group, Side-by-side Single-center Study Comparing a Topical Steroid / Vehicle Combination to a Topical Steroid / Topical Dapsone Combination in Patients With Lichen Simplex Chronicus and/or Prurigo Nodularis|Not yet recruiting||N/A|20|Anticipated|John H. Stroger Hospital||2|||f||||f||||||||||2017-10-11 01:38:21.304531|2017-10-11 01:38:21.304531
NCT01870037|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-03-03|||January 2013|Actual|2013-01-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|June 2016|Actual|2016-06-01||Interventional|OAB||Phase 1 Study in Subjects With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer|Phase 1 Double Blind, Placebo Controlled Study Assessing Safety and Activity Of 2 Escalating Doses of hMaxi-K Gene Transfer By Direct Injection Into the Bladder Wall In Female Subjects With OAB (Overactive Bladder Syndrome and Detrusor Overactivity)|Active, not recruiting||Phase 1|13|Actual|Ion Channel Innovations||2|||f||||t||||||||Undecided||2017-10-11 01:38:21.5839|2017-10-11 01:38:21.5839
NCT01870024|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2016-12-12|||June 2013||2013-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|LORACLOFT||Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus|Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus in Adults Patients|Recruiting||Phase 3|522|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 01:38:21.681749|2017-10-11 01:38:21.681749
NCT01870011|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-08-16|||December 2013||2013-12-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Renal Protection During Deceased Brain Dead Donor Kidney Transplantation - A Prospective, Randomized Trial||Completed||Phase 4|6|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:38:21.808898|2017-10-11 01:38:21.808898
NCT01869998|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-05-06|||February 2012||2012-02-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Implication of Left veNtricle Vortex Flow Guided aNticOagulation Therapy for preVenting Apical Thrombus Formation In Patients With Acute myOcardial infarctioN: Multicenter Prospective Randomized Clinical Trial; INNOVATION Study||Completed||N/A|111|Actual|Yonsei University|||3||f||||f||||||||||2017-10-11 01:38:21.895148|2017-10-11 01:38:21.895148
NCT01869985|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2014-03-08|||August 2013||2013-08-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|||Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers|A Randomized, Open-label, Single Dose, 3-sequence and 3-period Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers|Completed||Phase 1|30|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 01:38:21.962471|2017-10-11 01:38:21.962471
NCT01869972|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2015-12-10|||May 2013||2013-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia|Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia|Completed||N/A|32|Actual|Hamilton Health Sciences Corporation|||4||f||||f||||||||||2017-10-11 01:38:22.044245|2017-10-11 01:38:22.044245
NCT01869959|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-01-27|2016-10-27||April 2009||2009-04-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional||All participants who received at least 1 dose of study drug.|A Study of LY2405319 in Participants With Type 2 Diabetes|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2405319 With 28 Days of Subcutaneous Injections in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|47|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 01:38:22.176964|2017-10-11 01:38:22.176964
NCT01869946|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2013-06-04|||August 2012||2012-08-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|BLAST||Blood Levels of Local Anaesthetic in Hip Arthroplasty|Blood Levels of Local Anaesthetic in Hip Arthroplasty: A Pharmacological Study of Ropivacaine Blood Levels During the Caledonian Technique for Hip Arthroplasty|Completed||N/A|20|Actual|Golden Jubilee National Hospital|||1||f||||f||||||Samples Without DNA|"     Up to 10 blood samples per patient   "|||2017-10-11 01:38:23.427723|2017-10-11 01:38:23.427723
NCT01869933|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-01-20|||April 2013||2013-04-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X|An Open Label Phase I Placebo Controlled, Dose Escalation Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X|Completed||Phase 1|10|Actual|OcuCure Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 01:38:23.504696|2017-10-11 01:38:23.504696
NCT01869920|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-03|2017-08-21|||February 2015||2015-02-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|PROLACT||Effectiveness of an Educational Intervention to Maintain Exclusive Breastfeeding|Effectiveness of an Educational Group Intervention in Primary Care to Maintain Exclusive Breastfeeding. Cluster Randomised Clinical Trial. PROLACT Study.|Completed||N/A|434|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||t||||||||||2017-10-11 01:38:23.589005|2017-10-11 01:38:23.589005
NCT01869907|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-01-24|||September 2011||2011-09-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|EMON||Effect of Minocycline on Pain Caused by Nerve Damage|Effect of Minocycline on Neuropathic Pain|Completed||Phase 4|60|Actual|Ziekenhuis Oost-Limburg||3|||f||||t||||||||||2017-10-11 01:38:23.674764|2017-10-11 01:38:23.674764
NCT01869894|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-09-29|||June 2013||2013-06-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Prospective Randomized Study for Efficacy of Uncovered Double Bare Metallic Stent Compared to Uncovered Single Bare Metallic Stent in Malignant Biliary Obstruction||Completed||N/A|73|Actual|Yonsei University||3|||f||||||||||||||2017-10-11 01:38:23.775028|2017-10-11 01:38:23.775028
NCT01869881|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-07-08|||February 2013||2013-02-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)|Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 4|166|Anticipated|Yuhan Corporation||2|||f||||f||||||||||2017-10-11 01:38:25.487172|2017-10-11 01:38:25.487172
NCT01869868|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-02|2015-04-28|||December 2013||2013-12-01|April 2015|2015-04-01||||December 2015|Anticipated|2015-12-01|3 Months|Observational [Patient Registry]|||Neurobiological Changes When Treating Depression With Electroconvulsive Therapy - a Longitudinal Observational Study|Neurobiological Changes and Clinical Outcome When Treating Depression With Electroconvulsive Therapy.|Unknown status|Recruiting|N/A|50|Anticipated|Linkoeping University|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:38:25.560425|2017-10-11 01:38:25.560425
NCT01869855|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-02|2017-06-24|||April 2013|Actual|2013-04-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Prospective Randomized Study Evaluating the Recurrence Rate of Chronic Subdural Hematoma After Placing a Subperiosteal Drainage Compared to a Subdural Drainage|Use of Subperiosteal Drainage Versus Subdural Drainage in Chronic Subdural Hematomas Treated With Burr-Hole Trepanation: a Randomized Controlled Trial|Completed||N/A|220|Actual|Kantonsspital Aarau||2|||f||||||||||||||2017-10-11 01:38:25.624809|2017-10-11 01:38:25.624809
NCT01869842|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2013-06-04|||December 2011||2011-12-01|May 2013|2013-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Randomized Controlled Study of the Traditional Percutaneous Coronary Intervention and Intervention Using Optical Coherence Tomography of Incomplete Stent Adhesion and Extent of the Formation of Neointima by Resolute Zotarolimus-eluting Stent Insertion||Unknown status|Recruiting|N/A|115|Anticipated|Yonsei University||4|||f||||f||||||||||2017-10-11 01:38:25.704982|2017-10-11 01:38:25.704982
NCT01869829|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-07-11|||July 2013||2013-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01|7 Weeks|Observational [Patient Registry]|PEACE||PEACE: Pediatric Antifungal Comparative Effectiveness|International Pediatric Fungal Network: Multi-Center Studies to Improve Diagnosis and Treatment of Pediatric Candidiasis|Recruiting||N/A|750|Anticipated|Duke University|||1||f||||t||||||||||2017-10-11 01:38:25.8096|2017-10-11 01:38:25.8096
NCT01869816|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-02|2013-06-02|||March 2011||2011-03-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||CTRP3 and Progranulin in Patients With Coronary Artery Disease||Completed||N/A|362|Actual|Korea University|||1||f||||||||||||||2017-10-11 01:38:25.979337|2017-10-11 01:38:25.979337
NCT01869803|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-05-25|||August 2013||2013-08-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia|Compassionate Use of Gemtuzumab Ozogamicin (Mylotarg) for Treatment of Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia (AML) or Acute Promyelocytic Leukemia (APL)|Suspended||Phase 2|30|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 01:38:26.032161|2017-10-11 01:38:26.032161
NCT01869790|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-02|2017-04-25|||June 2013||2013-06-01|April 2017|2017-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|Nabucco||Evaluation of Fats on Postprandial Glucose Control|"Development of Fat Bolus for Coverage of Higher Fat Meals."|Completed||N/A|10|Actual|Joslin Diabetes Center||1|||f||||t||||||||No||2017-10-11 01:38:26.112689|2017-10-11 01:38:26.112689
NCT01869777|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-08-14|||July 2013||2013-07-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia|INVESTIGATING THE PROGNOSTIC IMPORTANCE OF BIOELECTRICAL IMPEDANCE PHASE ANGLE IN ADULTS TREATED FOR NEWLY DIAGNOSED ACUTE LEUKEMIA|Recruiting||N/A|102|Anticipated|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 01:38:26.2696|2017-10-11 01:38:26.2696
NCT01869764|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-05-30|||November 2013||2013-11-01|May 2017|2017-05-01||||November 2017|Anticipated|2017-11-01||Interventional|||Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer|A Randomized, Placebo-Controlled Phase II Clinical Trial of Omega-3 PUFA Dietary Supplementation in Patients With Stage I-III Breast Carcinoma|Recruiting||N/A|60|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-11 01:38:26.386924|2017-10-11 01:38:26.386924
NCT01869751|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-05-03|||May 2013||2013-05-01|May 2017|2017-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||The Colonic Transit Time: a Modifiable Determinant of Intestinal Production and Uptake of Microbial Metabolites?|The Colonic Transit Time: a Modifiable Determinant of Intestinal Production and Uptake of Microbial Metabolites?|Withdrawn||N/A|0|Actual|Universitaire Ziekenhuizen Leuven|||1|failure to recruit patients|f||||f||||||Samples Without DNA|"     serum, urine   "|||2017-10-11 01:38:26.503498|2017-10-11 01:38:26.503498
NCT01869738|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-08-31|||June 2013||2013-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MASTER-II||MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction|MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction|Terminated||N/A|310|Actual|InspireMD||2||low enrollment rate|f||||t||||||||||2017-10-11 01:38:26.593574|2017-10-11 01:38:26.593574
NCT01869725|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-08-23|||April 2013||2013-04-01|August 2017|2017-08-01||||July 2018|Anticipated|2018-07-01||Interventional|||Ga-DOTATOC Versus Octreoscan + CT|Comparator Study of 68Ga-DOTATOC PET/CT With Octreoscan + High-resolution, Contrast-enhanced CT for Diagnosis and Staging in Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors|Suspended||N/A|112|Anticipated|University of Iowa||1||Interim analysis. Decision has not yet been made regarding additional enrollment.|f||||t||||||||||2017-10-11 01:38:26.818547|2017-10-11 01:38:26.818547
NCT01869712|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-10-15|||July 2013||2013-07-01|October 2013|2013-10-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Interventional|||PRPP Model for Evaluation the Effect of Non-pharmaceutical Therapies|Using Partially Randomized Patient Preference Research Model for Evaluation the Therapeutic Effect of Non-pharmaceutical Therapies: Protocol for a Feasibility Study|Unknown status|Recruiting|N/A|100|Anticipated|Beijing University of Chinese Medicine||4|||f||||t||||||||||2017-10-11 01:38:26.919576|2017-10-11 01:38:26.919576
NCT01869699|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-07-11|2017-06-09||September 2013||2013-09-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|ICUFeverAPAP||Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults|Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults: a Randomized Controlled Trial|Completed||Phase 4|41|Actual|University of California, San Francisco|The generalizability of our findings is limited due to the use of a single site and our sample size was modest. Also, patients in this study had baseline stable and normal or high BP, so unclear if same results in patients with unstable or low BP.|2|||f||||t||||||||||2017-10-11 01:38:27.071889|2017-10-11 01:38:27.071889
NCT01869686|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-11-05|2014-09-22||June 2013||2013-06-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous Dose|An Open-label Study to Evaluate the Concentration of Denosumab in Seminal Fluid After a Single Subcutaneous Injection in Healthy Men|Completed||Phase 1|12|Actual|Amgen||1|||f||||f||||||||||2017-10-11 01:38:27.856307|2017-10-11 01:38:27.856307
NCT01869660|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-12-29|||June 2013||2013-06-01|August 2015|2015-08-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Shared Decision Making for Patients With First-admission Schizophrenia|Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|23|Actual|Yokohama City University||2|||f||||f||||||||||2017-10-11 01:38:28.356896|2017-10-11 01:38:28.356896
NCT01869647|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-07-28|2016-06-17||April 2013||2013-04-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone|Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone|Completed||N/A|264|Actual|Yale University||3|||f||||t||||||||No||2017-10-11 01:38:28.455718|2017-10-11 01:38:28.455718
NCT01869634|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2017-05-24|||June 2013||2013-06-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART|Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART|Completed||Phase 4|37|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 01:38:28.903714|2017-10-11 01:38:28.903714
NCT01869621|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-12-02|||April 2013||2013-04-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Study of Metformin Pharmacogenetics in Twins|The Relation Between Heritability and the Trough Concentration of Metformin in Plasma Under Steady-state in Twins|Completed||Phase 1|34|Actual|University of Southern Denmark||1|||f||||f||||||||||2017-10-11 01:38:29.015417|2017-10-11 01:38:29.015417
NCT01869608|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-12-22|||April 2014||2014-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|Tot ou tard||Postpartum Screening of Type 2 Diabetes|Can we Screen Type 2 Diabetes on the 2nd Day After Delivery in Women Who Had Gestational Diabetes Mellitus?|Active, not recruiting||N/A|145|Anticipated|Université de Sherbrooke||1|||f||||f||||||||||2017-10-11 01:38:29.112843|2017-10-11 01:38:29.112843
NCT01869595|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2016-10-19|||November 2012||2012-11-01|October 2016|2016-10-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01|2 Years|Observational [Patient Registry]|||Thai MSM/TG Test and Treat Study|Prospective Study of Study to Evaluate the Feasibility of Universal HIV Testing and Antiretroviral Treatment Regardless of CD4 Count Using the Test and Treat Strategy Among Men Who Have Sex With Men and Transgender Women in Thailand|Active, not recruiting||N/A|600|Anticipated|Thai Red Cross AIDS Research Centre|||1||f||||t||||||||||2017-10-11 01:38:29.21168|2017-10-11 01:38:29.21168
NCT01869582|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-05-18|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Safer Births - Reducing Perinatal Mortality|Safer Births - New Knowledge and Innovations to Decrease Perinatal Mortality and Morbidity Worldwide|Recruiting||N/A|20000|Anticipated|Helse Stavanger HF||4|||f||||t||||||||No||2017-10-11 01:38:29.30585|2017-10-11 01:38:29.30585
NCT01869569|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2017-07-16|||February 2013|Actual|2013-02-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effect of Pregabalin in Patients With Radiotherapy-related Neuropathic Pain|Effect of Pregabalin in Patients With Radiotherapy-Related Neuropathic Pain: a Randomized, Double-blind, Placebo-controlled Trial|Recruiting||Phase 3|138|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 01:38:29.44138|2017-10-11 01:38:29.44138
NCT01869556|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-05-23|||May 2013||2013-05-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress|Comparison of Intravenous Ergonovine With Intramuscular Carboprost, Both in Combination With Oxytocin Infusion, During Cesarean Section for Failure to Progress in Labor: A Double-blinded Placebo-controlled Randomized Controlled Trial|Recruiting||N/A|75|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||3|||f||||f||||||||||2017-10-11 01:38:29.589716|2017-10-11 01:38:29.589716
NCT01869543|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-06-26|||July 2012|Actual|2012-07-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|AIRE||Asthma and Indoor-air: Reducing Exposures|Benefits of High Efficiency Filtration to Children With Asthma|Active, not recruiting||N/A|200|Anticipated|University of California, Davis||4|||f||||f||||||||||2017-10-11 01:38:29.723915|2017-10-11 01:38:29.723915
NCT01869530|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-11-16|||July 2008||2008-07-01|November 2015|2015-11-01||||June 2030|Anticipated|2030-06-01|10 Years|Observational [Patient Registry]|TARGet Kids!||TARGet Kids!: Measuring Nutrition in Young Preschool Children in the Primary Care Practice Setting||Recruiting||N/A|10000|Anticipated|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 01:38:29.839224|2017-10-11 01:38:29.839224
NCT01869517|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-06-01|||May 2013||2013-05-01|June 2013|2013-06-01||||May 2015|Anticipated|2015-05-01||Interventional|||Myoring Versus Keraring Implantation for Keratoconus||Unknown status|Recruiting|Phase 2|23||Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:38:29.946049|2017-10-11 01:38:29.946049
NCT01869504|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-05-19|||February 2014||2014-02-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Feasibility and Safety Study of the Use of a Dedicated Ballooned Intercostal Drain|A Feasibility and Safety Study of the Use of a Dedicated Ballooned Intercostal Drain|Completed||N/A|19|Actual|Sherwood Forest Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:38:30.084416|2017-10-11 01:38:30.084416
NCT01869491|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2014-05-12|||June 2013||2013-06-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study|A Multi-centre, Randomised, Double-blind, Two Arm, Parallel Group, Placebo-controlled Study to Assess the Effect of Compound Sodium Alginate Double Action Chewable Tablets in Patients With Gastro-esophageal Reflux Disease|Completed||Phase 3|1107|Actual|Reckitt Benckiser Healthcare (UK) Limited||2|||f||||f||||||||||2017-10-11 01:38:30.18752|2017-10-11 01:38:30.18752
NCT01869478|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2016-08-12|2016-08-12||January 2013||2013-01-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|EARLY||Feasibility Study of IV Recombinant Tissue Plasminogen Activator (rtPA) vs. Primary Endovascular Therapy for Acute Ischemic Stroke|Endovascular Arterial Reperfusion vs. Intravenous ThromboLYsis for Acute Ischemic Stroke (EARLY): A Randomized Pilot Study of Ultra-early (<2 Hours) and Early (2-4.5 Hours) Reperfusion Therapy|Terminated||Phase 2|1|Actual|Mayo Clinic|This study was terminated due to difficulty in recruiting subjects.|2||Poor recruitment|f||||f||||||||No||2017-10-11 01:38:30.34545|2017-10-11 01:38:30.34545
NCT01869465|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-06-01|||October 2012||2012-10-01|June 2013|2013-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|ESIUPT||Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis|Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis Among School Children in Jinja District, Uganda: a Stratified Cluster Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|1277|Actual|Makerere University||2|||f||||f||||||||||2017-10-11 01:38:30.63173|2017-10-11 01:38:30.63173
NCT01869452|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-05-04|||May 2010||2010-05-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|METISCARDIO||Platform Therapeutic Education in Heart Failure and Coronary Disease|Telephonic Platform of Follow up, Therapeutical Education and Coordination in Secondary Prevention in Patients With Heart Failure and Coronary Disease|Completed||N/A|555|Actual|Resicard||3|||f||||f||||||||||2017-10-11 01:38:30.726035|2017-10-11 01:38:30.726035
NCT01869426|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-04-30|||June 2013||2013-06-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|June 2015|Anticipated|2015-06-01||Interventional|||Impact of Probiotic Preparation VSL#3 on Infants Colics|Impact of VSL#3 on Infants Colics as Assessed by Average Crying Time|Unknown status|Recruiting|Phase 4|62|Anticipated|Policlinico Hospital||2|||f||||f||||||||||2017-10-11 01:38:30.947501|2017-10-11 01:38:30.947501
NCT01869413|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2016-11-17|||June 2013||2013-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|TACT||Tranexamic Acid During Cystectomy Trial (TACT)|Tranexamic Acid During Cystectomy Trial (TACT)|Recruiting||Phase 2/Phase 3|354|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||No||2017-10-11 01:38:31.033422|2017-10-11 01:38:31.033422
NCT01869400|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-04-13|||April 2013|Actual|2013-04-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|NIS-OvaYond||An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer|An Observational, Multicenter, Open-label Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer|Completed||N/A|180|Anticipated|PharmaMar, Spain|||1||f||||f||||||||Undecided||2017-10-11 01:38:31.18283|2017-10-11 01:38:31.18283
NCT01869387|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-05-31|||June 2013||2013-06-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Respiratory Muscle Function in COPD Exacerbations|Improvement of Respiratory Muscle Function With Noninvasive Ventilation in Exacerbated COPD Patients Presenting Hypercapnic Respiratory Failure Without Acidosis|Unknown status|Not yet recruiting|N/A|46|Anticipated|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 01:38:31.262446|2017-10-11 01:38:31.262446
NCT01869374|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-10-11|||August 2012||2012-08-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|MSTvsEST||Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults|Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy|Recruiting||Phase 1/Phase 2|30|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-10-11 01:38:31.57754|2017-10-11 01:38:31.57754
NCT01869361|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-08-25|||November 1, 2017|Anticipated|2017-11-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Indomethacin for Tocolysis|Randomized, Placebo Controlled Trial of Indomethacin for Tocolysis|Not yet recruiting||Early Phase 1|84|Anticipated|MetroHealth Medical Center||2|||f||||t|t|f||||||||2017-10-11 01:38:31.68926|2017-10-11 01:38:31.68926
NCT01869348|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-05-10|2017-05-10||June 2014|Actual|2014-06-01|May 2015|2015-05-01|April 15, 2016|Actual|2016-04-15|April 15, 2016|Actual|2016-04-15||Interventional|IMPACT||IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial|IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial|Completed||N/A|40|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-11 01:38:31.831151|2017-10-11 01:38:31.831151
NCT01869335|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-06-04|||May 2013||2013-05-01|May 2013|2013-05-01|May 2015|Anticipated|2015-05-01|December 2014|Anticipated|2014-12-01||Interventional|||A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens|A Randomized Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens in Evaluating Tumor-free Margins After Surgical Resection of Breast Microcalcifications|Unknown status|Not yet recruiting|N/A|260|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-11 01:38:32.289959|2017-10-11 01:38:32.289959
NCT01869322|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2015-10-19|||May 2013||2013-05-01|October 2015|2015-10-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Acute Management of Humeral Shaft Fractures: Sling vs. Splint||Recruiting||N/A|80|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:38:32.416383|2017-10-11 01:38:32.416383
NCT01869309|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-11-20|||January 2014||2014-01-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|HEIGHTEN||Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor|Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy|Unknown status|Recruiting|Phase 4|400|Anticipated|LifeBridge Health||2|||f||||f||||||||||2017-10-11 01:38:32.523435|2017-10-11 01:38:32.523435
NCT01869296|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2016-08-09|||May 2013||2013-05-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Endoscope Water Pump Flow Rates on Successful Unsedated Colonoscopy by Water Immersion Method: a Randomized Controlled Trial|The Effect of Endoscopy Water Pump Flow Rates on Successful Unsedated Colonoscopy by Water Immersion Method: a Randomized Controlled Trial|Completed||Phase 2|132|Actual|Gadjah Mada University||2|||f||||||||||||||2017-10-11 01:38:32.627186|2017-10-11 01:38:32.627186
NCT01869283|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-05-30|||May 2013||2013-05-01|May 2013|2013-05-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Effectiveness of Physical Therapy Treatments of Myofascial Trigger Points in Subjects With Neck Pain||Unknown status|Not yet recruiting|N/A|80|Anticipated|University of Sao Paulo||4|||f||||t||||||||||2017-10-11 01:38:32.709782|2017-10-11 01:38:32.709782
NCT01869270|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2014-12-03|||December 2010||2010-12-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational|||Gene Therapy for Tay-Sachs Disease|Gene Therapy for Tay-Sachs Disease (Phase 1: Natural History Data Gather)|Completed||N/A|4|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||||2017-10-11 01:38:32.820516|2017-10-11 01:38:32.820516
NCT01869257|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-05-30|||May 2009||2009-05-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Impact of Triclosan-coated Suture on Surgical Site Infection After Colorectal Surgery|Impact of Triclosan-coated Suture on Surgical Site Infection After Colorectal Surgery|Completed||Phase 3|279|Actual|University of Milano Bicocca||2|||f||||t||||||||||2017-10-11 01:38:32.914049|2017-10-11 01:38:32.914049
NCT01869244|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-06-13|||April 2013||2013-04-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||WOODCAST Hand Resting Splint - Study of User Experience|User Experience From WOODCAST 2mm Hand Resting Splint|Completed||N/A|18|Actual|Onbone Oy|||1||f||||f||||||||No||2017-10-11 01:38:33.019251|2017-10-11 01:38:33.019251
NCT01869231|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-06-04|||April 2010||2010-04-01|May 2013|2013-05-01||||December 2012|Actual|2012-12-01||Interventional|||Evaluating the Efficacy of Current Treatments for Reducing Postoperative Ileus||Completed||N/A|360|Actual|Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo||4|||f||||t||||||||||2017-10-11 01:38:33.109818|2017-10-11 01:38:33.109818
NCT01869218|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-08-18|||April 2, 2013|Actual|2013-04-02|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|August 3, 2015|Actual|2015-08-03||Observational|||Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy|Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy in Patients With Advanced Malignancies|Active, not recruiting||N/A|40|Actual|University of Colorado, Denver|||1||f||||t||||||Samples With DNA|"     Tumor tissue, whole blood   "|||2017-10-11 01:38:33.221346|2017-10-11 01:38:33.221346
NCT01869205|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2017-06-26|||March 2013||2013-03-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|April 2014|Actual|2014-04-01||Interventional|||The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients|The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients|Completed||Phase 3|43|Actual|Asan Medical Center||1|||f||||t||||||||||2017-10-11 01:38:33.330312|2017-10-11 01:38:33.330312
NCT01869192|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-09-06|||March 5, 2003|Actual|2003-03-05|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 18, 2009|Actual|2009-12-18||Interventional|||Phase II Trial for Large ER-Negative Breast Cancers|Differential Gene Regulation During Neoadjuvant Therapy Trial of Epirubicin/Cyclophosphamide (EC) vs Docetaxel/Capecitabine (DX) Regimens in Patients With Large ER-positive and ER-negative Breast Cancers: A Randomized Phase II Trial.|Active, not recruiting||Phase 2|73|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 01:38:33.465096|2017-10-11 01:38:33.465096
NCT01869179|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-01-13|||February 2013||2013-02-01|January 2015|2015-01-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Community Choirs To Promote Healthy Aging; Community of Voices Chorus|Community Choirs To Promote Healthy Aging And Independence Of Older Adults|Unknown status|Recruiting|N/A|450|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:38:33.607256|2017-10-11 01:38:33.607256
NCT01869166|ClinicalTrials.gov processed this data on October 10, 2017|2013-06-01|2015-09-27|||May 2013||2013-05-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CART-EGFR||Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)|Clinical Study of Chimeric EGFR Antigen Receptor-modified T Cells in Chemotherapy Refractory Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|60|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:38:33.730827|2017-10-11 01:38:33.730827
NCT01869140|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-10-04|||November 2013||2013-11-01|October 2013|2013-10-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||the Hypoalgesic Effect of Spinal Manual Therapy|the Hypoalgesic Effect of Spinal Manual Therapy on an Healthy Population: a Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|90|Anticipated|Institut Franco Europeen de Chiropratique||3|||f||||t||||||||||2017-10-11 01:38:33.905046|2017-10-11 01:38:33.905046
NCT01869127|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-06-01|||July 2011||2011-07-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|SKIP||Study to Test Whether Shoes Protect Children Against Hookworm Infection on Pemba Island, Zanzibar|Shoes for Kids on the Island of Pemba (SKIP): A Pragmatic, Cluster Randomised Controlled Trial to Test if Shoes Reduce Hookworm Infection and Transmission in School-aged Children on Pemba Island, Zanzibar|Completed||N/A|1056|Actual|Bird, Christopher||2|||f||||f||||||||||2017-10-11 01:38:33.994557|2017-10-11 01:38:33.994557
NCT01869114|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-09-05|||July 8, 2013|Actual|2013-07-08|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy|A Phase II Study of Azacitidine and Sirolimus for the Treatment of High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Refractory to or Not Eligible for Intensive Chemotherapy|Recruiting||Phase 2|112|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 01:38:34.100003|2017-10-11 01:38:34.100003
NCT01869101|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-05-30|||June 2013||2013-06-01|May 2013|2013-05-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Observational|||Prospective Observational Study Assessing Treatment and Outcomes of Patients With Prediabetes|A Multicenter, 26-Week, Prospective Observational Study in Adult Patients With Prediabetes Assessing Patient Treatment and Outcomes in Community-Based Clinical Practice|Unknown status|Not yet recruiting|N/A|560|Anticipated|Tethys Bioscience, Inc.|||1||f||||f||||||Samples Without DNA|"     Serum and plasma   "|||2017-10-11 01:38:34.278124|2017-10-11 01:38:34.278124
NCT01869088|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2017-03-14|||January 2013||2013-01-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma|Phase Ⅲ Trial of Transcatheter Arterial Chemoembolization(TACE) Plus Recombinant Human Adenovirus Type 5 Injection for Unresectable Hepatocellular Carcinoma (HCC)|Active, not recruiting||Phase 3|266|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:38:34.354258|2017-10-11 01:38:34.354258
NCT01869075|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-09-16|2014-08-11||July 2006||2006-07-01|September 2014|2014-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|TOPPS|Baseline data collection was conducted to establish baseline rates of appropriate prophylaxis. Baseline patients were not included in the active phases of the study.|Toronto Thromboprophylaxis Patient Safety Initiative|Toronto Thromboprophylaxis Patient Safety Initiative (TOPPS): A Cluster Randomized Trial|Completed||N/A|1895|Actual|Sunnybrook Health Sciences Centre||6|||f||||f||||||||||2017-10-11 01:38:34.46917|2017-10-11 01:38:34.46917
NCT01869062|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2017-09-12|||June 2013|Actual|2013-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Interventional|SonR-ECHO||Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography|Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography|Active, not recruiting||Phase 4|348|Actual|LivaNova||2|||f||||t||||||||||2017-10-11 01:38:34.802788|2017-10-11 01:38:34.802788
NCT01869049|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2016-04-18|||November 2012||2012-11-01|April 2013|2013-04-01||||September 2013|Anticipated|2013-09-01||Observational|ITP||The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia|A Study on the Alteration of Macrophage Function in the Spleen Tissue From Patients With Primary Immune Thrombocytopenia (ITP): a Multicenter, Perspective, Clinical Trial|Withdrawn||N/A|0|Actual|Shandong University|||2|No eligible patient was enrolled.|f||||t||||||Samples With DNA|"     The biospecimens were retained for PCR, western blotting and FACS analysis.   "|||2017-10-11 01:38:34.893879|2017-10-11 01:38:34.893879
NCT01869036|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-12-03|||July 2012||2012-07-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Use of Caudal Anesthesia Supplemented With Morphine in Children Undergoing Renal Surgery|Use of Caudal Anesthesia Supplemented With Morphine in Children Undergoing Renal Surgery - Prospective Study|Completed||Phase 4|40|Actual|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-11 01:38:34.984122|2017-10-11 01:38:34.984122
NCT01869023|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-03-01|||November 2010||2010-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma|Phase II Study of Six Hours, Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma.|Active, not recruiting||Phase 2|26|Anticipated|Instituto Nacional de Cancerologia de Mexico||1|||f||||f||||||||Yes||2017-10-11 01:38:35.106845|2017-10-11 01:38:35.106845
NCT01869010|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-31|||January 2010||2010-01-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Observational|||Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection||Completed||N/A|30|Actual|Hospital Italiano de Buenos Aires|||3||f||||f||||||||||2017-10-11 01:38:35.228858|2017-10-11 01:38:35.228858
NCT01868997|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-08-10|2017-08-10||July 2013||2013-07-01|August 2017|2017-08-01|February 21, 2017|Actual|2017-02-21|March 2016|Actual|2016-03-01||Interventional||Baseline characteristics shown are from the safety population (44 participants in the placebo group and 43 participants in the teprotumumab group), which differs from the intention-to-treat population (45 in the placebo group and 42 in the teprotumumab group), since 1 participant in the placebo group received teprotumumab in error.|Teprotumumab Treatment in Patients With Active Thyroid Eye Disease|A Multicenter, Double-Masked, Placebo-Controlled, Efficacy And Safety Study Of RV 001, An Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist Antibody (Fully Human), Administered Every 3 Weeks (q3W) By Intravenous (IV) Infusion In Patients Suffering From Active Thyroid Eye Disease (TED)|Completed||Phase 2|88|Actual|Horizon Pharma USA, Inc.||2|||f||||t||||||||||2017-10-11 01:38:35.397357|2017-10-11 01:38:35.397357
NCT01868984|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-09-14|||May 2013||2013-05-01|January 2015|2015-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PaciFIST-1||Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis|The Use of Intravascular Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis: A Randomized Study|Terminated||Phase 2|50|Anticipated|Englewood Hospital and Medical Center||2||catheters no longer available - difficult to recruit subjects|f||||f||||||||||2017-10-11 01:38:36.428222|2017-10-11 01:38:36.428222
NCT01868971|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-07-26|||April 2013||2013-04-01|July 2017|2017-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Clinical Study to Establish the Feasibility and Usability of the EndoRings™|EndoRings™ - Clinical Protocol|Completed||N/A|60|Actual|EndoAid||1|||f||||t||f|||f|||||2017-10-11 01:38:36.531787|2017-10-11 01:38:36.531787
NCT01868958|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-07-14|||January 2013||2013-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||DTI of the Brain and Cervical Spine: Evaluation in Normal Subjects and Patients With Cervical Spondylotic Myelopathy|Diffusion Tensor Imaging of the Brain and Cervical Spine: Evaluation of Reproducibility in Normal Subjects and Diagnostic Utility in Patients With Cervical Spondylotic Myelopathy|Completed||N/A|26|Actual|Emory University|||2||f||||f||||||||||2017-10-11 01:38:36.648159|2017-10-11 01:38:36.648159
NCT01868945|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-03-26|||April 2013||2013-04-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|D-DOSE||Dose Finding Study in Physically Frail Elderly to Measure 25(OH) Vitamin D Levels After Supplementation With Hy.D Calcifediol 25 SD/S and Vitamin D3|Dose Finding Study in Physically Frail Elderly to Measure 25(OH) Vitamin D Levels After Supplementation With Hy.D Calcifediol 25 SD/S and Vitamin D3|Completed||Phase 1|59|Actual|DSM Nutritional Products, Inc.||4|||f||||f||||||||||2017-10-11 01:38:36.75171|2017-10-11 01:38:36.75171
NCT01868932|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-11-12|||October 2013||2013-10-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|TWICS||Treating Wheezing in Children With Hypertonic Saline (TWICS)|Treating Wheezing in Children With Hypertonic Saline (TWICS)|Withdrawn||Phase 2|0|Actual|Queen's University||2||Funding declined. Study never initiated.|f||||t||||||||||2017-10-11 01:38:36.89598|2017-10-11 01:38:36.89598
NCT01868919|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-19|2013-05-30|||November 2011||2011-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|TriplePChile||Triple P to Improve Behaviour in Children|Implementation Research of a Parenting Intervention to Improve Behaviour in Children in Primary Care|Completed||N/A|87|Actual|Pontificia Universidad Catolica de Chile||1|||f||||f||||||||||2017-10-11 01:38:36.997771|2017-10-11 01:38:36.997771
NCT01868906|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-24|2017-02-09|||June 2013||2013-06-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|FMISOPETSCS||FMISO-PET in Brain Tumors and SCS Effect|Positron Emission Tomography With Fluoro-misonidazole (PET-FMISO) in High Grade Gliomas: Assessment of Tumor Hypoxia and Effect of Spinal Cord Stimulation|Recruiting||Phase 2|20|Anticipated|Dr. Negrin University Hospital||2|||f||||f||||||||||2017-10-11 01:38:37.098219|2017-10-11 01:38:37.098219
NCT01868893|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-03-20|2016-09-19||August 2013||2013-08-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Safety population which included all enrolled patients who received at least one dose of study drug (obinutuzumab).|An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia|An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia|Completed||Phase 2|20|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 01:38:37.295883|2017-10-11 01:38:37.295883
NCT01868880|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-04-05|||February 2016||2016-02-01|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Effect of Ivabradine and Beta-blockers Combination Versus Beta-blockers Up-titration on Right Ventricular Pacing|Effect of Heart Rate Control Using Ivabradine and Beta-blockers Combination Versus Beta-blockers Up-titration on Ventricular Pacing in Heart Failure Patients With an Implanted Cardioverter Defibrillator.|Suspended||Phase 4|70|Anticipated|Policlinico Casilino ASL RMB||2||difficulties in recruiting patients|f||||f||||||||||2017-10-11 01:38:37.69498|2017-10-11 01:38:37.69498
NCT01868867|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-02-01|||May 2013||2013-05-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||New Technologies for Cognitive Behavior Therapy (CBT) Treatment of Adolescent Depression|New Technologies for Cognitive Behavior Therapy (CBT) Treatment of Adolescent Depression|Completed||N/A|18|Actual|Center for Psychological Consultation||2|||f||||t||||||||||2017-10-11 01:38:37.815492|2017-10-11 01:38:37.815492
NCT01868854|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-06-04|||March 2013||2013-03-01|May 2013|2013-05-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01|7 Days|Observational [Patient Registry]|TIP-DP||Risk Assessment of Peritoneal Dialysis Failure Based on Catheter Tip Location.|Risk Assessment of Peritoneal Dialysis Failure Based on Catheter Tip Location. Multicentric Study.|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Instituto Nacional de Cardiologia Ignacio Chavez|||4||f||||f||||||||||2017-10-11 01:38:37.954394|2017-10-11 01:38:37.954394
NCT01868841|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-10-30|||December 2013||2013-12-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT System|123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging|Completed||Phase 4|45|Actual|Aspire Foundation||2|||f||||f||||||||||2017-10-11 01:38:38.049998|2017-10-11 01:38:38.049998
NCT01868828|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-06-04|||May 2013||2013-05-01|June 2013|2013-06-01|May 2017|Anticipated|2017-05-01|May 2015|Anticipated|2015-05-01||Interventional|||A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma|A Multicenter, Double Arms, Prospective Phase 4 Study to Evaluating the Efficacy and Safety of Combination Therapy of PAD Versus VCD Treatment in Previously Untreated Subjects With Multiple Myeloma.|Unknown status|Recruiting|Phase 4|50|Anticipated|Peking University People's Hospital||2|||f||||f||||||||||2017-10-11 01:38:38.144494|2017-10-11 01:38:38.144494
NCT01868802|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-03-13|||September 2013||2013-09-01|March 2015|2015-03-01||||May 2016|Anticipated|2016-05-01||Interventional|||Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population|Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population|Unknown status|Recruiting|Phase 2|60|Anticipated|American British Cowdray Medical Center||2|||f||||t||||||||||2017-10-11 01:38:38.259454|2017-10-11 01:38:38.259454
NCT01868776|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-10-13|2015-04-20||March 2013||2013-03-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Buffered Numbing Solution on Patients With Toothaches|Effect of Buffered Lidocaine on the Success of the Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis|Completed||N/A|100|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 01:38:38.445925|2017-10-11 01:38:38.445925
NCT01868763|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-04|||August 2012||2012-08-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|FitMeFit||TeleLifestyleCoaching for Weight Loss|TeleLifestyleCoaching Use of Telemedicine for Weight Loss and Care of Weight Associated Illnesses|Completed||N/A|180|Actual|West German Center of Diabetes and Health||3|||f||||f||||||||||2017-10-11 01:38:38.678482|2017-10-11 01:38:38.678482
NCT01868750|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-19|||May 2013||2013-05-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Phase II Pre-operative Vitamin D Supplementation to Prevent Post-thyroidectomy Hypocalcemia|A Phase 2, Placebo-controlled, Randomized Study to Evaluate the Effect of Pre-operative Vitamin D Supplementation on Hypocalcemia Following Total or Near-total Thyroidectomy|Unknown status|Recruiting|Phase 2|53|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 01:38:38.767151|2017-10-11 01:38:38.767151
NCT01868737|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-07-19|||July 2011||2011-07-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature Infants|The Use of Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature and Very-low Birth Weight Infants|Completed||Phase 3|184|Actual|University of Stellenbosch||4|||f||||f||||||||||2017-10-11 01:38:38.867185|2017-10-11 01:38:38.867185
NCT01868724|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-03-12|||June 2013||2013-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Identification and Validation of Biomarkers of Acute Kidney Injury Recovery|Identification and Validation of Biomarkers of Acute Kidney Injury Recovery|Completed||N/A|362|Actual|Astute Medical, Inc.|||1||f||||f||||||||||2017-10-11 01:38:38.979272|2017-10-11 01:38:38.979272
NCT01868711|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-09-14|||July 2009||2009-07-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Cognitive Behavior Therapy for Depression Depression|Psychological Mindedness as a Predictor of Success in Cognitive Behavior Therapy for Depressed Patients|Recruiting||N/A|70|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 01:38:39.117451|2017-10-11 01:38:39.117451
NCT01868698|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-05-30|||January 2009||2009-01-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|January 2010|Actual|2010-01-01||Interventional|||Effects of High Voltage Electrical Stimulation, Shortwave Diathermy and Kinesiotherapy on Arterial Blood Flow in the Lower Limbs of Diabetic Women||Completed||N/A|15|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 01:38:39.211432|2017-10-11 01:38:39.211432
NCT01868685|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-01-06|||April 2014||2014-04-01|January 2015|2015-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Study of Muscle Effects of BYM338 in Mechanically Ventilated Patients|An Exploratory, Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of BYM338 on Muscle in Patients Requiring Prolonged Mechanical Ventilation|Withdrawn||Phase 2|0|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:38:39.309015|2017-10-11 01:38:39.309015
NCT01868672|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-08-01|||June 2013||2013-06-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Brief Intervention to Create Smoke-Free Homes Policies in Low-Income Households: North Carolina Effectiveness Trial|Brief Intervention to Create Smoke-Free Homes Policies in Low-Income Households: North Carolina Effectiveness Trial|Completed||N/A|500|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:38:39.406437|2017-10-11 01:38:39.406437
NCT01868659|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-05-10|||April 2010||2010-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Diagnostic Time-Out: A Randomized Clinical Trial of a Checklist to Improve Diagnostic Accuracy|Diagnostic Time-Out: A Randomized Clinical Trial of a Checklist to Improve Diagnostic Accuracy|Completed||N/A|114|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 01:38:39.514903|2017-10-11 01:38:39.514903
NCT01868646|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-12-28|||May 2013||2013-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus|Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus|Completed||Phase 4|190|Actual|Materia Medica Holding||2|||f||||f||||||||||2017-10-11 01:38:39.623322|2017-10-11 01:38:39.623322
NCT01868633|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-08-24|2016-10-26||March 2013||2013-03-01|August 2017|2017-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Dexamethasone for Post Cesarean Delivery Analgesia|The Effect of a Single Intraoperative Dose of Dexamethasone in Combination With Intrathecal Morphine for Post Cesarean Delivery Analgesia|Completed||Phase 4|52|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 01:38:39.828742|2017-10-11 01:38:39.828742
NCT01868620|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-12-01|||May 2013||2013-05-01|December 2015|2015-12-01|May 2017|Anticipated|2017-05-01|June 2016|Anticipated|2016-06-01||Interventional|IONTO-CXL||Non-inferiority Trial of Iontophoretic Corneal Collagen Crosslinking (CXL) Compared to Standard Corneal Collagen Crosslinking in Progressive Keratoconus.|Non-inferiority Trial of Iontophoretic Corneal Collagen Crosslinking (CXL) Compared to Standard Corneal Collagen Crosslinking in Progressive Keratoconus.|Recruiting||Phase 3|162|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-11 01:38:40.528001|2017-10-11 01:38:40.528001
NCT01868607|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-02-06|||June 2013||2013-06-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Reliability of Different FOT Devices to Measure the Human Respiratory Impedance|Comparison of the Reliability of Different Devices to Measure Lung Function With the Forced Oscillation Technique|Completed||N/A|80|Actual|University Hospital, Antwerp|||1||f||||f||||||||||2017-10-11 01:38:40.738073|2017-10-11 01:38:40.738073
NCT01868594|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-12-28|||May 2013||2013-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus|Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficiency and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus|Completed||Phase 4|200|Actual|Materia Medica Holding||2|||f||||f||||||||||2017-10-11 01:38:40.863002|2017-10-11 01:38:40.863002
NCT01868581|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-10-23|||May 2008||2008-05-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects|A Randomised, Single Centre, Double-blind, Two-period Crossover, Glucose Clamp Trial to Test for Bioequivalence Between Two Insulin 454 Formulations, With or Without Buffer, and Between Two SIAC Formulations, With or Without Buffer, in Healthy Male Subjects|Completed||Phase 1|58|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:38:41.004518|2017-10-11 01:38:41.004518
NCT01868568|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-10-21|||April 2008||2008-04-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes|A Randomised, Double-blind, Multiple Period Cross-over Trial Comparing Insulin 454 and Insulin Aspart Fixed Combination Products With Separately Injected, Simultaneous Doses of Insulin 454 and Insulin Aspart, Compared to Biphasic Insulin Aspart 30 (NovoMix® 30) in Subjects With Type 1 Diabetes|Completed||Phase 1|55|Actual|Novo Nordisk A/S||9|||f||||f||||||||||2017-10-11 01:38:41.147311|2017-10-11 01:38:41.147311
NCT01868555|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-10-21|||December 2007||2007-12-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects|A Randomised, Double-blind, Single Centre, Placebocontrolled, Parallel Group, Multiple s.c. Dose Trial to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Two SIAC Preparations and Two Insulin 454 (SIBA) Preparations in Healthy Japanese Male Subjects|Completed||Phase 1|32|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 01:38:41.310302|2017-10-11 01:38:41.310302
NCT01868542|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-01-18|2016-05-19||June 2013||2013-06-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Full analysis set (FAS) - included all randomised subjects.|A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)|A 20-week, Randomised, Multi-centre, Open-labelled Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Titration Algorithms (3-0-3 Algorithm and 2-4-6-8 Algorithm) After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment in Korea|Completed||Phase 4|46|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:38:41.451626|2017-10-11 01:38:41.451626
NCT01868529|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-09-24|||January 2008||2008-01-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus|A Randomised, Single Centre, Double-blind, Two-Period Cross-over, Multiple Dose Trial Comparing the Pharmacodynamic Response of Insulin 454 With Insulin Glargine at Steady-State Conditions in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|63|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 01:38:42.047185|2017-10-11 01:38:42.047185
NCT01868516|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-05-11||2015-05-11|May 2013||2013-05-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder||Completed||Phase 2|1635|Actual|Targacept Inc.||4|||f||||f||||||||||2017-10-11 01:38:42.202432|2017-10-11 01:38:42.202432
NCT01868503|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-06-21|2016-11-21||July 2013||2013-07-01|June 2017|2017-06-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer|Phase II Study to Investigate Concurrent Lapatinib and Radiotherapy in Locally Advanced or Locally Recurrent Breast Cancer and the Impact on Breast Cancer Stem Cells|Terminated||Phase 2|7|Actual|Stanford University||1||Protocol modification|f||||t||||||||||2017-10-11 01:38:42.652263|2017-10-11 01:38:42.652263
NCT01868490|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-04-08|||April 2009||2009-04-01|April 2015|2015-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells|Phase 1 Study of The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells.|Unknown status|Recruiting|Phase 1/Phase 2|13|Anticipated|Siriraj Hospital||1|||f||||t||||||||||2017-10-11 01:38:43.031914|2017-10-11 01:38:43.031914
NCT01868477|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-02-14|||January 28, 2014|Actual|2014-01-28|February 2017|2017-02-01|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.|An Open-label, Phase II, Randomized, Pilot Study to Assess the Effect in Term of Erythroid Improvement of Deferasirox Combined With Erythropoietin Compared to Erythropoietin Alone in Patients With low-and Int-1-risk Myelodysplastic Syndrome.|Recruiting||Phase 2|60|Anticipated|Novartis||2|||f||||f||||||||||2017-10-11 01:38:43.164469|2017-10-11 01:38:43.164469
NCT01868464|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-09-14|||June 9, 2014|Actual|2014-06-09|July 19, 2017|2017-07-19|October 1, 2018|Anticipated|2018-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Challenge Model for Assessment of Human TB Immunity|Phase I Open-Label Dose Escalation Trial for the Development of a Human BCG Challenge Model for Assessment of TB Immunity|Active, not recruiting||Phase 1|92|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f|||||t|f|||f|||||2017-10-11 01:38:43.372452|2017-10-11 01:38:43.372452
NCT01868451|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-08-09|||May 2013|Actual|2013-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma|A Pilot Study of Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma|Recruiting||N/A|117|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||t||||||||||2017-10-11 01:38:43.473202|2017-10-11 01:38:43.473202
NCT01868438|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-03-28|||May 2013||2013-05-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations, in Healthy Volunteers|Phase 1, Open-label, Cross-over Study to Investigate the Relative Bioavailability of Pyramax (Pyronaridine-artesunate) in Tablet and Granule Formulations, in Healthy Volunteers|Completed||Phase 1|60|Actual|Medicines for Malaria Venture||2|||f||||f||||||||||2017-10-11 01:38:43.634199|2017-10-11 01:38:43.634199
NCT01868425|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-09-21|||April 2013||2013-04-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||ACL Repair and Multimodal Analgesia|ACL Repair and Multimodal Analgesia|Recruiting||N/A|112|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 01:38:43.726963|2017-10-11 01:38:43.726963
NCT01868412|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-01-15|||May 2013||2013-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Resin Salve Versus Honey Treatment in Wound Care|Comparison of Resin Salve and Medical Honey in Wound Care in Vascular Surgery Patients - A Prospective, Randomized and Controlled Clinical Trial|Completed||N/A|40|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-10-11 01:38:43.841175|2017-10-11 01:38:43.841175
NCT01868399|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2017-03-05|||March 22, 2013||2013-03-22|August 2016|2016-08-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|1 Day|Observational [Patient Registry]|||Pilot Survey of Dengue Fever in Solomon Islands|Pilot Survey of Dengue Fever in Solomon Islands|Completed||N/A|2200|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||2||f||||t||||||Samples Without DNA|"     Remaining samples will be provided to the BioBank for the studies of other infectious     diseases pathogens.   "|Undecided||2017-10-11 01:38:43.941405|2017-10-11 01:38:43.941405
NCT01868386|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-10-24|||April 2013||2013-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate|Hypofractionated Post-prostatectomy Radiotherapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase I/II Trial|Recruiting||Phase 1/Phase 2|52|Anticipated|University of Virginia||4|||f||||t||||||||||2017-10-11 01:38:44.03098|2017-10-11 01:38:44.03098
NCT01868373|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2017-01-30|||February 2013||2013-02-01|January 2017|2017-01-01|February 2022|Anticipated|2022-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea|Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea|Enrolling by invitation||Phase 1|12|Actual|Baylor College of Medicine||1|||f||||f||||||||No||2017-10-11 01:38:44.196645|2017-10-11 01:38:44.196645
NCT01868360|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-10-05|||June 2013||2013-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea|Subconjunctival Aflibercept Injection for Corneal Neovascularization|Terminated||Phase 1|2|Actual|University of Utah||2||Lack of enrollment|f||||t||||||||||2017-10-11 01:38:44.31914|2017-10-11 01:38:44.31914
NCT01868347|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-06-05|||February 2013||2013-02-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|OPERA||Obese Patient During RARP: the Role of a Preemptive Ventilator Strategy to Contrast Pneumoperitoneum and Trendelenburg Position|The Obese Patient in the Urologic Robotic Surgery: the Role of a Preemptive Ventilator Strategy and Partitioning to Contrast Pneumoperitoneum and Trendelenburg Position|Unknown status|Recruiting|Phase 3|40|Anticipated|University of Turin, Italy||2|||f||||f||||||||||2017-10-11 01:38:44.467062|2017-10-11 01:38:44.467062
NCT01868165|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-02-17|||June 2013||2013-06-01|May 2014|2014-05-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Observational|||Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)|Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)|Completed||N/A|335|Actual|Imperial College London|||1||f||||f||||||||||2017-10-11 01:38:49.063834|2017-10-11 01:38:49.063834
NCT01868334|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-05-02|2017-01-04||April 2013||2013-04-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|SOP|Information provided for baseline demographics comes from the Tdap citation: Nowalk MP, Lin CJ, Pavlik VN, et al. Using the 4 Pillars™ Practice Transformation Program to increase adult Tdap immunization in a randomized controlled cluster trial. Vaccine. 2016 Sep 22;34(41):5026-33. Epub 2016 Aug 26. PubMed ID: 27576073|SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM|A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM|Completed||N/A|70549|Actual|University of Pittsburgh|The limitations of this study included late delivery of influenza vaccine in Year 1 in the Pittsburgh sites, delay of EMR data for reporting study progress to sites (all vaccines) and vaccine increases in control arm (Tdap and PPSV) during Year 1.|2|||f||||f||||||||No||2017-10-11 01:38:44.586401|2017-10-11 01:38:44.586401
NCT01868321|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-04-25|||April 2014||2014-04-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|PRoVENT||Practice of Ventilation in Critically Ill Patients Without ARDS|Practice of Ventilation in Critically Ill Patients Without Acute Respiratory Distress Syndrome - An International Observational Study|Completed||N/A|1030|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-11 01:38:45.102514|2017-10-11 01:38:45.102514
NCT01868308|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-03-28|||January 2013||2013-01-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Observational|STOP||Screening To Obviate Preterm Birth|Screening To Obviate Preterm Birth|Completed||N/A|589|Actual|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     A vaginal swab will be collected during the patients clinical admission exam by a nurse.   "|||2017-10-11 01:38:45.254148|2017-10-11 01:38:45.254148
NCT01868295|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-05-01|||April 2014||2014-04-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||The Effect of Nocturnal Wear of Dentures on Sleep and Oral Health Related Quality of Life|The Effect of Nocturnal Wear of Dentures on Sleep and Oral Health Related Quality of Life: a Randomized Cross-Over Trial|Enrolling by invitation||N/A|70|Anticipated|Université de Montréal||2|||f||||t||||||||Undecided||2017-10-11 01:38:47.297385|2017-10-11 01:38:47.297385
NCT01868282|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-08-31|||June 2013||2013-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of Pain Management Techniques Following Anterior Cruciate Ligament Repair Surgery|Comparison of Efficacy and Safety of Perihamstring Local Anesthetic Injection to Obturator Nerve Block When Combined With Subsartorial Saphenous Block for Anterior Cruciate Ligament Repair. A Randomized Double Blinded Study.|Completed||Phase 2/Phase 3|105|Actual|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-11 01:38:47.39734|2017-10-11 01:38:47.39734
NCT01868269|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2017-09-15|||April 18, 2013|Actual|2013-04-18|September 2017|2017-09-01|April 2031|Anticipated|2031-04-01|February 2027|Anticipated|2027-02-01||Interventional|||Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)|Multinational European Trial for Children With the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome|Recruiting||Phase 3|100|Anticipated|Institut Curie||1|||f||||t||||||||||2017-10-11 01:38:47.542652|2017-10-11 01:38:47.542652
NCT01868256|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-05-30|||January 2012||2012-01-01|May 2013|2013-05-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|EDAMI||Safety of Early Discharge Following Low Risk Myocardial Infarction|Safety of a Early Discharge Strategy in Patients With Low-risk ST-segment Elevation Myocardial Infarction Treated With Primary Coronary Intervention: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|1558|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 01:38:47.831087|2017-10-11 01:38:47.831087
NCT01868243|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-09-14|2015-06-24||August 2013||2013-08-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|DAWA||Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively|Dabigatran Versus Warfarin After Mitral and Aortic Bioprosthesis Replacement for the Management of Atrial Fibrillation Postoperatively: Pilot Study|Terminated||Phase 2/Phase 3|27|Actual|Hospital Ana Nery||2||because a significant decrease of viable candidates for the study.|f||||t||||||||||2017-10-11 01:38:47.954337|2017-10-11 01:38:47.954337
NCT01868230|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-10-24|||January 2014||2014-01-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women||Recruiting||N/A|333|Anticipated|University of Massachusetts, Amherst||2|||f||||f||||||||No||2017-10-11 01:38:48.51018|2017-10-11 01:38:48.51018
NCT01868217|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-05-30|||January 2013||2013-01-01|May 2013|2013-05-01||||March 2013|Actual|2013-03-01||Observational|||A Retrospective Study to Investigate Prevalence of Capsular Bag Distention Syndrome and Its Influencing Factors||Completed||N/A|239|Actual|Evidence Based Cataract Study Group|||1||f||||||||||||||2017-10-11 01:38:48.627586|2017-10-11 01:38:48.627586
NCT01868204|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-03|||June 2013||2013-06-01|May 2013|2013-05-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Observational|||Pharmacogenetic and Neurofunctional Brain Areas Study in Obese Patients With Binge Eating Disorder|Pharmacogenetic Study of Neurofunctional Brain Areas Related to Food Craving in Obese Patients With Binge Eating Disorder Treated With Topiramate|Unknown status|Not yet recruiting|N/A|60|Anticipated|Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente|||1||f||||t||||||Samples With DNA|"     Genomic DNA will be extracted from 5 ml of peripheral blood using standard method.   "|||2017-10-11 01:38:48.698392|2017-10-11 01:38:48.698392
NCT01868191|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2013-05-30|||July 2013||2013-07-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)|Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)and Diabetic Neuropathy in Subjects With Sensorimotor Diabetic Polyneuropathy: a Double-blind, Randomized, Placebo-controlled Parallel Group Pilot Study Over 12 Months.|Unknown status|Not yet recruiting|Phase 3|22|Anticipated|Diabetes Schwerpunktpraxis||2|||f||||f||||||||||2017-10-11 01:38:48.81729|2017-10-11 01:38:48.81729
NCT01868178|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-05-30|||September 2008||2008-09-01|May 2013|2013-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Relationship Between Bispectral Index (BIS) and Spectral Entropy (SpEn) During Desflurane Anaesthesia|Relationship Between Bispectral Index (BIS) and Spectral Entropy (SpEn) During Desflurane Anaesthesia|Completed||N/A|50|Actual|Catholic University of the Sacred Heart|||1||f||||t||||||||||2017-10-11 01:38:48.944336|2017-10-11 01:38:48.944336
NCT01868139|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2015-10-06|||June 2013||2013-06-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ICE-CANCER||Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)|A Phase II, Multi-Center Study of Interventional Spray Cryotherapy for Early-Stage Esophageal Cancer (ICE-CANCER)|Terminated||N/A|1|Actual|University of Maryland||1||insufficient accrual|f||||t||||||||||2017-10-11 01:38:49.241891|2017-10-11 01:38:49.241891
NCT01868126|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2014-01-06|||May 2013||2013-05-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension|A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension|Completed||Phase 2|91|Actual|Santen Inc.||6|||f||||f||||||||||2017-10-11 01:38:49.356835|2017-10-11 01:38:49.356835
NCT01868113|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-10-25|||December 2012||2012-12-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ICS||Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial|Acute Respiratory Infections and Asthma in U-5 Children: Improved Treatment to Reduce Morbidity and Mortality in Uganda, A Randomized Controlled Trial|Completed||Phase 3|1010|Actual|Makerere University||2|||f||||t||||||||||2017-10-11 01:38:49.45902|2017-10-11 01:38:49.45902
NCT01868100|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-09-02|||March 2013||2013-03-01|June 2013|2013-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DIFIC||Financial Distress in Patients With Advanced Cancer|Preliminary Study of Financial Distress and Quality of Life in Patients With Advanced Cancer|Completed||N/A|144|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 01:38:49.564022|2017-10-11 01:38:49.564022
NCT01868087|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-04-05|||July 2013||2013-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study|Impact Advanced Recovery® for Radical Cystectomy (RC) Patients|Completed||Early Phase 1|30|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 01:38:49.627462|2017-10-11 01:38:49.627462
NCT01868074|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-06-21|2015-06-10||May 2013||2013-05-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|||Study of Changes in the Feet With Pregnancy|Enhancing Women's Health Through Assessing Foot Plasticity With Pregnancy|Completed||N/A|72|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 01:38:49.714357|2017-10-11 01:38:49.714357
NCT01868061|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-05-18|||July 31, 2013|Actual|2013-07-31|May 2017|2017-05-01|January 2, 2017|Actual|2017-01-02|January 2, 2017|Actual|2017-01-02||Interventional|||A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication|Completed||Phase 3|1068|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 01:38:50.118578|2017-10-11 01:38:50.118578
NCT01868048|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-08-10||||||August 2016|2016-08-01||||June 2017|Anticipated|2017-06-01||Interventional|||Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.|A Phase 3 Dose Response Study to Assess the Safety and Efficacy of Nabiximols Oromucosal Spray (Sativex) in the Symptomatic Relief of Spasticity in Subjects With Spasticity Due to Multiple Sclerosis.|Withdrawn||Phase 3|0|Actual|GW Research Ltd||2|||||||f||||||||||2017-10-11 01:38:50.832225|2017-10-11 01:38:50.832225
NCT01868035|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-11-18|2013-06-20||May 2000||2000-05-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP|Phase II Multicenter Study of Iodine-131 Anti-B1 Antibody Consolidation For Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Following First-line CHOP|Completed||Phase 2|15|Actual|GlaxoSmithKline||1|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:38:50.946468|2017-10-11 01:38:50.946468
NCT01868009|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2014-01-16|2014-01-16||May 2013||2013-05-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)|RLV116669, A Preference Study of Device Attributes Between Two Placebo Dry Powder Inhalers; ELLIPTA and DISKUS, in Adult Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|287|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:38:51.720921|2017-10-11 01:38:51.720921
NCT01867996|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-05-10|||June 11, 2013|Actual|2013-06-11|May 2017|2017-05-01|September 26, 2013|Actual|2013-09-26|September 26, 2013|Actual|2013-09-26||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)|To Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) Co-administered With EFAVIRENZ|Completed||Phase 1|18|Actual|GlaxoSmithKline||1|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:38:52.264908|2017-10-11 01:38:52.264908
NCT01867983|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-04-14|||August 2013||2013-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparative Effectiveness of Adding Weight Control to Smoking Cessation Quitlines|Comparative Effectiveness of Adding Weight Control to Smoking Cessation Quitlines|Completed||N/A|2540|Actual|Alere Wellbeing||3|||f||||t||||||||||2017-10-11 01:38:52.373266|2017-10-11 01:38:52.373266
NCT01867775|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-03|||May 2012||2012-05-01|May 2013|2013-05-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Mirtazapine for Sleep Disorders in Alzheimer's Disease|Mirtazapine for the Treatment of Sleep Disorders in Alzheimer's Disease: a Randomized, Double-blind, Placebo-controlled Study|Unknown status|Recruiting|Phase 3|30|Anticipated|Brasilia University Hospital||2|||f||||f||||||||||2017-10-11 01:38:53.926298|2017-10-11 01:38:53.926298
NCT01867970|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2015-04-09|||April 2013||2013-04-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|RCTIt'sLiFe!||Interactive Tool to Support Self-management Through Lifestyle Feedback, Aimed at Physical Activity of COPD/DM Patients|RCT It's LiFe! to Evaluate the Effectiveness of the Monitoring and Feedback Tool and the Corresponding Counseling Protocol (Self-management Support Program) to be Executed by Practice Nurses in Primary Care|Completed||N/A|240|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 01:38:52.477053|2017-10-11 01:38:52.477053
NCT01867957|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2013-06-03|||February 2009||2009-02-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of Anthrax Vaccine, GC1109|A Single Blind, Randomized, Placebo Control, Phase I Study to Evaluate the Safety and Immunogenicity of the GC1109 Administered by the Intramuscular Route in Healthy Men|Completed||Phase 1|20|Actual|Seoul National University Hospital||4|||f||||||||||||||2017-10-11 01:38:52.588898|2017-10-11 01:38:52.588898
NCT01867944|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-11-23|||June 2013||2013-06-01|November 2016|2016-11-01||||June 2014|Actual|2014-06-01||Interventional|||Perineal Self-Acupressure|A Randomized Controlled Trial of Perineal Self-Acupressure for Chronic Constipation|Completed||N/A|100|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:38:52.690035|2017-10-11 01:38:52.690035
NCT01867931|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2015-02-19|||April 2013||2013-04-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Observational|||Epithelial Damage in GERD|Characterisation of Esophageal Epithelial Damage in Patients With Non-erosive Reflux Disease (NERD) and Erosive Esophagitis (EE): Role of Epithelial Permeability|Completed||N/A|34|Actual|Maastricht University Medical Center|||3||f||||||||||||||2017-10-11 01:38:52.76826|2017-10-11 01:38:52.76826
NCT01867918|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-01-06|||May 2013||2013-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|LOTCOL||LOTCOL Study: Local Treatment of Colo-rectal Liver Met|A Randomized Study With Palliative Chemotherapy With or Without Local Treatment of Liver Metastases in Patients With Colo-rectal Cancer|Terminated||N/A|3|Actual|Oslo University Hospital||2||Insuffisient recruitment|f||||f||||||||||2017-10-11 01:38:52.839293|2017-10-11 01:38:52.839293
NCT01867892|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-27|||June 2013||2013-06-01|May 2013|2013-05-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Phase II Study of Locally Advanced Pancreatic Cancer|A Phase II Randomized Study of Induction Chemotherapy Followed by Concurrent Chemo-radiotherapy in Locally Advanced Pancreatic Cancer|Enrolling by invitation||Phase 2|86|Anticipated|National Health Research Institutes, Taiwan||2|||f||||t||||||||||2017-10-11 01:38:53.044221|2017-10-11 01:38:53.044221
NCT01867879|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-11-06|||June 2013||2013-06-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|||Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors|A Phase 1 Study to Evaluate the Cardiac Safety of Orally Administered TAS-102 in Patients With Advanced Solid Tumors|Completed||Phase 1|44|Actual|Taiho Oncology, Inc.||2|||f||||f||||||||||2017-10-11 01:38:53.129349|2017-10-11 01:38:53.129349
NCT01867866|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-09-29|||May 2013|Actual|2013-05-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|October 2013|Actual|2013-10-01||Interventional|||Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD Alone|A Phase 1, Open-Label, Randomized, Parallel Group Study Evaluating the Pharmacokinetics of FTD as a Component of TAS-102 Compared With FTD Alone|Completed||Phase 1|44|Actual|Taiho Oncology, Inc.||2|||f||||f||||||||||2017-10-11 01:38:53.230842|2017-10-11 01:38:53.230842
NCT01867853|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-06-03|||October 2012||2012-10-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|6 Months|Observational [Patient Registry]|weaning||Volume Responsiveness Before SBT Predicts the Outcome of Mechanical Ventilation Weaning in Critically Ill Patients|Volume Responsiveness Before Spontaneous Breath Trial Predicts the Outcome of Mechanical Ventilation Weaning in Critically Ill Patients|Completed||N/A|82|Actual|Southeast University, China|||2||f||||t||||||||||2017-10-11 01:38:53.327957|2017-10-11 01:38:53.327957
NCT01867840|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-10-20|||November 2012||2012-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2014|Actual|2014-12-01||Observational|||Role of ASICs in Human Inflammatory Pain|Study of the Role of Acid Sensing Ion Channels (ASICs) in Human Inflammatory Pain|Recruiting||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||||||||||||2017-10-11 01:38:53.449293|2017-10-11 01:38:53.449293
NCT01867827|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-06-20|||March 2013||2013-03-01|June 2017|2017-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease|Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease|Completed||N/A|30|Actual|Cardiff University||2|||f||||||||||||||2017-10-11 01:38:53.567815|2017-10-11 01:38:53.567815
NCT01867814|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-08-04|||May 2013||2013-05-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|SPV-PnP||Arterial and Plethysmographic Waveforms Variables as Predictors of Hemodynamic Response to Pneumoperitoneum|Clinical Trial for Evaluation of Arterial and Plethysmographic Waveform Variations as Predictors of Hemodynamic Response to Pneumoperitoneum During Laparoscopic Surgery|Unknown status|Recruiting|N/A|150|Anticipated|Carmel Medical Center||1|||f||||t||||||||||2017-10-11 01:38:53.661405|2017-10-11 01:38:53.661405
NCT01867801|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-06-08|||January 2002||2002-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|PRIC||Portuguese Registry on Interventional Cardiology|Portuguese Registry on Interventional Cardiology|Recruiting||N/A|50000|Anticipated|Portuguese Society of Cardiology|||1||f||||f||||||||||2017-10-11 01:38:53.756659|2017-10-11 01:38:53.756659
NCT01867788|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-01-11|||September 2012||2012-09-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01|36 Months|Observational [Patient Registry]|HBS2||Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2|Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2|Active, not recruiting||N/A|76|Actual|Brigham and Women's Hospital|||2||f||||f||||||Samples With DNA|"     Whole blood, plasma, CSF, RNA, DNA   "|||2017-10-11 01:38:53.847727|2017-10-11 01:38:53.847727
NCT01867762|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2016-09-02||2015-08-05|September 2013||2013-09-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Phase 2, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ 49095397 (RV568) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 2|211|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 01:38:54.039947|2017-10-11 01:38:54.039947
NCT01867749|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-01-12|||June 2010||2010-06-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss|Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss|Completed||N/A|62|Actual|Brown University||2|||f||||t||||||||||2017-10-11 01:38:54.235046|2017-10-11 01:38:54.235046
NCT01867736|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-02-06|||July 2012||2012-07-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|BIOLUX P-II||BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries|BIOTRONIK's - First in Men Study of the Passeo-18 LUX Drug Releasing PTA Balloon Catheter vs. the Uncoated Passeo 18 Balloon Catheter in Subjects Requiring Revascularization of Infrapopliteal Arteries (BIOLUX P-II).|Completed||N/A|72|Actual|Biotronik AG||2|||f||||t||||||||||2017-10-11 01:38:54.334111|2017-10-11 01:38:54.334111
NCT01867723|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-10-27|||April 2012||2012-04-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Improving Symptom Management for Cancer Patients and Their Caregivers Through Internet|Improving Symptom Management for Cancer Patients and Their Caregivers Through Internet Support: A Randomized Clinical Trial|Completed||Phase 1|560|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:38:54.437019|2017-10-11 01:38:54.437019
NCT01867710|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-08-17|2016-04-06||July 16, 2013|Actual|2013-07-16|August 2017|2017-08-01|July 16, 2018|Anticipated|2018-07-16|April 20, 2015|Actual|2015-04-20||Interventional|||Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy|A Randomized Phase 2 Study Evaluating Abiraterone Acetate With Different Steroid Regimens for Preventing Symptoms Associated With Mineralocorticoid Excess in Asymptomatic, Chemotherapy-naïve and Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients|Active, not recruiting||Phase 2|163|Actual|Janssen Pharmaceutica N.V., Belgium|Data of the first 24 weeks of study treatment was collected and reported. Study is still ongoing.|4|||f||||t||f||||||||2017-10-11 01:38:54.534689|2017-10-11 01:38:54.534689
NCT01867697|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-01-20|||May 2012||2012-05-01|January 2015|2015-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Nordic 8 - A Phase II Trial|Potentially Resectable Metastatic Colorectal Cancer With Wild-type KRAS and BRAF: Alternating Chemotherapy Plus Cetuximab - A Randomised Phase II Trial|Unknown status|Recruiting|Phase 2|180|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-11 01:38:55.520138|2017-10-11 01:38:55.520138
NCT01867684|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-01-07|||July 2013||2013-07-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|PoPsTAR||Positive PsychoTherapy in Acquired Brain Injury (ABI) Rehabilitation|Brief Positive Psychotherapy After Acquired Brain Injury: A Pilot Randomised Controlled Trial|Completed||N/A|37|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 01:38:55.704914|2017-10-11 01:38:55.704914
NCT01867671|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-12-07|||August 2013||2013-08-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|IMPACT||Peanut Oral Immunotherapy in Children|Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)|Active, not recruiting||Phase 2|146|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 01:38:55.80273|2017-10-11 01:38:55.80273
NCT01867658|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-02-21|2016-06-15||June 2013||2013-06-01|February 2017|2017-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery|A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery|Completed||N/A|207|Actual|C. R. Bard||1|||f||||f||||||||No||2017-10-11 01:38:55.932138|2017-10-11 01:38:55.932138
NCT01867645|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-05-29|||December 2004||2004-12-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|April 2009|Actual|2009-04-01||Interventional|CIPNM||The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis|The Impact of Early Treatment With IgM-enriched IVIG on Critical Illness Polyneuropathy and/or Myopathy in Patients With Multiple Organ Failure and SIRS/Sepsis: A Prospective, Randomized, Placebo-controlled, Double-blinded Trial|Terminated||Phase 1|38|Actual|Medical University of Vienna||2||The trial was terminated early due to futility in reaching the primary endpoint.|f||||f||||||||||2017-10-11 01:38:56.305841|2017-10-11 01:38:56.305841
NCT01867632|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2017-06-21|2017-04-01||September 2012||2012-09-01|June 2017|2017-06-01|March 31, 2017|Actual|2017-03-31|December 31, 2016|Actual|2016-12-31||Observational|||Acellular Dermal Matrix in Primary Palatoplasty|Does Acellular Dermal Matrix Reduce Fistula Rate in Primary Palatoplasty|Completed||N/A|131|Actual|McGill University Health Center|||2||f||||f||||||||No||2017-10-11 01:38:56.417753|2017-10-11 01:38:56.417753
NCT01867619|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-29|||February 2006||2006-02-01|May 2013|2013-05-01||||February 2012|Actual|2012-02-01||Interventional|||Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients|A Phase II Study of Temozolomide, Thalidomide, and Lomustine (TTL) in Patients With Metastatic Melanoma in the Brain|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Phase I study did not progress to Phase II.|f||||f||||||||||2017-10-11 01:38:56.650482|2017-10-11 01:38:56.650482
NCT01867606|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-08-28|||October 2013|Actual|2013-10-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery|MC1267, A Randomized, Blinded Pilot Placebo-Controlled Trial With Oral Serum Bovine Immunoglobulin (SBI) to Assess Quality of Life and the Faster Post-Operative Recovery of Gynecological Cancer Patients|Active, not recruiting||Phase 2|100|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:38:56.747333|2017-10-11 01:38:56.747333
NCT01867580|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-11-30|||May 2013||2013-05-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||A Prospective, Multi-Center Trial Evaluating the Effectiveness of the V.A.C. Ulta Negative Pressure Wound Therapy System With V.A.C. VeraFlo Dressing System in Operatively Debrided Wounds|A Prospective, Randomized, Multi-Center Trial Evaluating the Effectiveness of the V.A.C. Ulta Negative Pressure Wound Therapy System With V.A.C. VeraFlo Dressing System in Operatively Debrided Wounds|Completed||N/A|183|Actual|KCI USA, Inc.||2|||f||||t||||||||||2017-10-11 01:38:57.487221|2017-10-11 01:38:57.487221
NCT01867567|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2015-12-29|||August 2013||2013-08-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Early Bandage Removal Post-Cesarean Delivery|Early Bandage Removal Post-Cesarean Delivery|Completed||N/A|320|Actual|Ziv Hospital||2|||f||||t||||||||||2017-10-11 01:38:57.593825|2017-10-11 01:38:57.593825
NCT01867554|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-12-06|||December 2012||2012-12-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|GeneDefi||Research and Characterization of New Genes Involved in Intellectual Disability|Recherche et caractérisation de Nouveaux gènes impliqués Dans la déficience Intellectuelle.|Recruiting||N/A|8500|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples With DNA|"     DNA RNA Plasma Urines   "|||2017-10-11 01:38:57.68307|2017-10-11 01:38:57.68307
NCT01867541|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2013-05-29|||December 2010||2010-12-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Observational|||Intra-operative Measurements to Predict the Position of the Intraocular Lens Post-operatively|Predictability of the IOL Position Using an Intra-operative OCT|Completed||N/A|70|Actual|Vienna Institute for Research in Ocular Surgery|||1||f||||f||||||||||2017-10-11 01:38:57.812282|2017-10-11 01:38:57.812282
NCT01867528|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2016-12-04|||July 2013||2013-07-01|December 2016|2016-12-01||||July 2018|Anticipated|2018-07-01||Interventional|||Comparison of Laparoscopic Surgery Versus Open Surgery in the Treatment of Adhesive Small Bowel Obstruction|Laparoscopic Versus Open Adhesiolysis for Small Bowel Obstruction - A Multicenter, Prospective, Randomized, Controlled Trial|Recruiting||N/A|102||Helsinki University Central Hospital||2|||f||||||||||||||2017-10-11 01:38:57.900259|2017-10-11 01:38:57.900259
NCT01867502|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-05-05|||April 2014||2014-04-01|May 2014|2014-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|DIABEX-VILDA||Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes|A 12-week Study to Compare the Effects of Vildagliptin Versus Glibenclamide on Glycemic Variability After a Sub Maximal Exercise Test in Patients With Type 2 Diabetes Inadequately Controlled With Metformin.|Unknown status|Recruiting|Phase 4|20|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 01:38:58.14044|2017-10-11 01:38:58.14044
NCT01867489|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2014-11-17|||September 2012||2012-09-01|November 2014|2014-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||A Qualitative Study Into How Patients Deal With Chemotherapy-related Side Effects at Home|A Qualitative Study Into How Patients With Cancer Deal With Chemotherapy-Related Side Effects at Home|Completed||N/A|28|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:38:58.260051|2017-10-11 01:38:58.260051
NCT01867476|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-05-29|||January 2013||2013-01-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Adherence Monitoring For Substance Abuse Clinical Trials||Completed||N/A|8|Actual|California Pacific Medical Center Research Institute|||1||f||||||||||||||2017-10-11 01:38:58.340281|2017-10-11 01:38:58.340281
NCT01867463|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-06-30|||March 27, 2013||2013-03-27|December 19, 2016|2016-12-19|December 19, 2016|Actual|2016-12-19|December 22, 2015|Actual|2015-12-22||Interventional|||Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine|Double Blind Dose-Escalating Randomized Controlled Phase 1 Study in Malaria Exposed Adults of the Safety and Immunogenicity of Pfs25-EPA/ Alhydrogel, a Transmission Blocking Vaccine Against Plasmodium Falciparum in Bancoumana, Mali|Completed||Phase 1|350|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 01:38:58.414198|2017-10-11 01:38:58.414198
NCT01867450|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-06-30|||March 27, 2013||2013-03-27|December 5, 2016|2016-12-05|December 9, 2013|Actual|2013-12-09|December 9, 2013|Actual|2013-12-09||Observational|||Study of Lung Health Among Workers Exposed to Diesel Exhaust|A Cross-Sectional Molecular Epidemiology Study of Occupational Exposure to Diesel Exhaust and Biomarkers in China|Completed||N/A|115|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:38:58.511162|2017-10-11 01:38:58.511162
NCT01867437|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-04-18|||May 2013|Actual|2013-05-01|April 2017|2017-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effects of RM-493 on Energy Expenditure in Obese Individuals|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, 2-Period Crossover Study to Evaluate the Effect of RM-493 on Energy Expenditure in Obese Subjects|Completed||Phase 1|15|Actual|Rhythm Pharmaceuticals, Inc.||2|||f||||f|t|f||||||No||2017-10-11 01:38:58.608477|2017-10-11 01:38:58.608477
NCT01867411|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-10-05|||April 29, 2013||2013-04-29|September 29, 2017|2017-09-29|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity|Multimodal Neuroimaging Genetic Biomarkers of Nicotine Addiction Severity|Recruiting||Phase 1|360|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:38:58.821925|2017-10-11 01:38:58.821925
NCT01867398|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-06-30|||April 29, 2013||2013-04-29|May 18, 2015|2015-05-18|May 18, 2015|Actual|2015-05-18|May 18, 2015|Actual|2015-05-18||Observational|||Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct Disorders|The Investigation of the Impact of Atypical Antipsychotics on Brain Functioning in Youths With Conduct Disorder|Terminated||N/A|320|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:38:58.913794|2017-10-11 01:38:58.913794
NCT01867385|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-31|2017-06-30|||May 13, 2013||2013-05-13|November 14, 2016|2016-11-14|September 11, 2015|Actual|2015-09-11|September 11, 2015|Actual|2015-09-11||Observational|||The Physiology of Fatigue in Patients With Chronic Liver Disease|The Physiology of Fatigue in Patients With Chronic Liver Disease|Completed||N/A|12|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:38:58.991259|2017-10-11 01:38:58.991259
NCT01867372|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-30|2017-07-06|||March 10, 2003||2003-03-10|September 22, 2014|2014-09-22|September 22, 2014||2014-09-22|September 22, 2014|Actual|2014-09-22||Observational|||Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes|Early Markers of Alzheimer's Disease in BLSA Participants: Structural and Functional Brain Changes|Terminated||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:38:59.068027|2017-10-11 01:38:59.068027
NCT01867359|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-06-30|||March 14, 2003||2003-03-14|September 20, 2016|2016-09-20|September 20, 2016||2016-09-20|September 20, 2016|Actual|2016-09-20||Observational|||The Genetic Characterization of Dementia|The Genetic Characterization of Dementia|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:38:59.138599|2017-10-11 01:38:59.138599
NCT01867346|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-06-30|||March 19, 2003||2003-03-19|January 2, 2015|2015-01-02|January 2, 2015||2015-01-02|June 16, 2014|Actual|2014-06-16||Observational|||Early Markers of Cognitive Change and Alzheimer s Disease|Early Markers of Cognitive Change and Alzheimer's Disease: A Propsective Study of the Effects of Aging on Cognition and Brain Pathology|Completed||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:38:59.199004|2017-10-11 01:38:59.199004
NCT01867320|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-06-30|||May 6, 2013||2013-05-06|December 12, 2016|2016-12-12|December 30, 2018|Anticipated|2018-12-30|October 31, 2017|Anticipated|2017-10-31||Interventional|||Raltegravir for HAM/TSP|Pilot Study of Raltegravir, an Integrase Inhibitor, in Human T-Cell Lymphotrophic Virus-1(HTLV-1) Associated Myelopathy, Tropical Spastic Paraparesis (HAM/TSP)|Recruiting||Early Phase 1|22|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:38:59.52806|2017-10-11 01:38:59.52806
NCT01867294|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2016-07-20|||August 2012||2012-08-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|June 2015|Actual|2015-06-01||Interventional|||Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab|A Two-Part, Phase II Randomized Trial to Explore Topical Spironolactone to Prevent/Attenuate Rash From Epidermal Growth Factor Receptor Inhibitors (Panitumumab and Cetuximab) in Advanced Cancer Patients|Active, not recruiting||Phase 2|19|Actual|Academic and Community Cancer Research United||4|||f||||t||||||||||2017-10-11 01:39:00.112212|2017-10-11 01:39:00.112212
NCT01867281|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2014-06-28|||June 2013||2013-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases|The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases|Completed||Phase 4|32|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:39:00.319411|2017-10-11 01:39:00.319411
NCT01867268|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-04-17|||October 2012||2012-10-01|April 2015|2015-04-01|September 2015|Anticipated|2015-09-01|April 2015|Anticipated|2015-04-01||Interventional|||Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence|Evaluating the Effect of Acetazolamide Administration and Prone Positioning Following Lumbosacral Spinal Surgery in Preventing Cerebro Spinal Fluid Leakage and Collection and Wound Dehiscence in Children.|Unknown status|Recruiting|Phase 2|144|Anticipated|Tehran University of Medical Sciences||4|||f||||t||||||||||2017-10-11 01:39:00.460548|2017-10-11 01:39:00.460548
NCT01867255|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-12-21|||October 2013||2013-10-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels|Pharmacokinetic Study Comparing Area Under the Curve for a Single Dose of Venlafaxine ER Pre- and Post-gastric Bypass|Completed||Phase 1|10|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:39:00.617799|2017-10-11 01:39:00.617799
NCT01867242|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-12-02|||July 2013||2013-07-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Methods Project 4: Clinical Trial|"PROJECT 4: CLINICAL TRIAL METHODS FOR ASSESSING A TOBACCO PRODUCT Part of MODELS FOR TOBACCO PRODUCT EVALUATION"|Completed||Phase 3|224|Actual|University of Minnesota - Clinical and Translational Science Institute||5|||f||||f||||||||||2017-10-11 01:39:00.711001|2017-10-11 01:39:00.711001
NCT01867229|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-31|||October 2011||2011-10-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|chemo-ameno||Breast Cancer and Chemo-amennorhea|Etude Prospective Multicentrique de l'aménorrhée Chimio-induite et de sa réversibilité Dans le Cancer du Sein Chez Des Patientes préménopausées Recevant Une chimiothérapie Adjuvante ou néoadjuvante. Etude Améno-Chimio.|Unknown status|Recruiting|N/A|500|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-10-11 01:39:00.818754|2017-10-11 01:39:00.818754
NCT01867190|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-04-20|||May 2013||2013-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CLI||Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia|An Open-label Single Arm Phase 2 Proof of Concept Study to Assess the Efficacy and Safety of ASCT01 in Patients With Critical Limb Ischemia|Completed||Phase 1/Phase 2|24|Actual|Lifecells, LLC.||1|||f||||t||||||||||2017-10-11 01:39:01.146014|2017-10-11 01:39:01.146014
NCT01867177|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-09-20|||June 2013||2013-06-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Community-based Interventions to Increase HIV Testing and HIV Care Utilization|Community-based Interventions to Increase HIV Testing and HIV Care Utilization|Recruiting||N/A|800|Anticipated|Kaiser Permanente||3|||f||||t||||||||||2017-10-11 01:39:01.244376|2017-10-11 01:39:01.244376
NCT01867164|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-11-01|2013-07-12||December 2007||2007-12-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in Intent-to-treat (ITT) population.|A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis|A Prospective, Open-Label, Comparative, Parallel Double-Arm, Multicentric Clinical Study to Evaluate the Efficacy of an Ovule With Triple Active Agents (Terconazole, Clindamycin, Fluocinolone) Administered Once Per Day for Three Days Versus an Ovule With Triple Active Agents (Metronidazole, Nystatin, Fluocinolone) Administered Once Per Day for Ten Days to Treat Secondary Vulvar/Vaginal Symptoms of Vaginitis/Infectious Vaginosis (Bacterial and/or Mycotic and/or Parasitic)|Completed||Phase 3|160|Actual|Janssen-Cilag, S.A.||2|||f||||f||||||||||2017-10-11 01:39:01.392597|2017-10-11 01:39:01.392597
NCT01867151|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-31|||May 2013||2013-05-01|May 2013|2013-05-01|March 2014|Anticipated|2014-03-01|May 2013|Anticipated|2013-05-01||Interventional|||Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome|Effetto Della Dieta Priva di Glutine in Soggetti Con BMS|Unknown status|Recruiting|N/A|40|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||t||||||||||2017-10-11 01:39:01.949019|2017-10-11 01:39:01.949019
NCT01867138|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-31|||March 2007||2007-03-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|August 2010|Actual|2010-08-01||Interventional|||Neonatal Suspected Sepsis Treated With Cefazolin or Vancomycin|Clinical Outcome of Newborn Infants With Suspected Nosocomial Coagulase-negative Staphylococcal Sepsis Treated With Cefazolin or Vancomycin. A Non-inferiority, Randomized, Controlled Trial|Completed||Phase 3|109|Actual|Hospital Italiano de Buenos Aires||2|||f||||t||||||||||2017-10-11 01:39:02.084316|2017-10-11 01:39:02.084316
NCT01867125|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-05-18|||July 31, 2013|Actual|2013-07-31|May 2017|2017-05-01|January 2, 2017|Actual|2017-01-02|January 2, 2017|Actual|2017-01-02||Interventional|||A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication|Completed||Phase 3|1081|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 01:39:02.24258|2017-10-11 01:39:02.24258
NCT01867112|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-29|||June 2013||2013-06-01|May 2013|2013-05-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Physical Activity for Improving Quality of Life and Reducing Frailty in Advanced Age|Physical Activity for Improving Quality of Life and Reducing Frailty in Advanced Age: Individually Tailored Program vs the General Guidelines Recommended by Offical Health Organizations.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 01:39:02.811882|2017-10-11 01:39:02.811882
NCT01867099|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2014-12-13|||December 2002||2002-12-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01|10 Years|Observational [Patient Registry]|||Ten-year Outcomes After AF Ablation|Long-term Outcome After Initially Successful Catheter Ablation of Atrial Fibrillation by Pulmonary Vein Isolation: a Ten-Year Cohort Study|Completed||N/A|445|Actual|Valley Health System|||1||f||||f||||||||||2017-10-11 01:39:02.879088|2017-10-11 01:39:02.879088
NCT01867086|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-08-02|||June 2013||2013-06-01|August 2017|2017-08-01|April 8, 2016|Actual|2016-04-08|April 2016|Actual|2016-04-01||Interventional|||Salvage Ovarian FANG™ Vaccine + Carboplatinum|Phase II Trial of Adjuvant Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Vaccine (FANG™) Integrated With Chemotherapy for Patients With Recurrent Cisplatinum Sensitive Ovarian Cancer Participating in Study CL-PTL 105|Completed||Phase 2|1|Actual|Gradalis, Inc.||1|||f||||t||||||||||2017-10-11 01:39:02.942368|2017-10-11 01:39:02.942368
NCT01867073|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2013-05-27|||May 2011||2011-05-01|May 2013|2013-05-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Observational|||A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours||Unknown status|Active, not recruiting|N/A|20|Anticipated|National University Hospital, Singapore|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 01:39:03.02742|2017-10-11 01:39:03.02742
NCT01867060|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-04-24|||May 2013||2013-05-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|||Using a Personal Heart Rhythm Monitor to Diagnose Paroxsymal Atrial Fibrillation in the Community|Using a Personal Heart Rhythm Monitor (PHRM) to Diagnose Paroxsymal Atrial Fibrillation (PAF) in the Community; and the PREDICT-PAF Substudy - an Investigation of Biomarkers to Detect PAF.|Completed||Phase 3|194|Actual|University of Surrey||1|||f||||t||||||||||2017-10-11 01:39:03.100401|2017-10-11 01:39:03.100401
NCT01867034|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-29|||March 2013||2013-03-01|March 2012|2012-03-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Soluble Receptors for Advanced Glycation End-Products and PCI|Soluble Receptors for Advanced Glycation End-Products to Predict the Type of Stent Implant|Unknown status|Recruiting|N/A|30|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 01:39:03.617604|2017-10-11 01:39:03.617604
NCT01867021|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2014-09-29|2014-08-26||May 2013||2013-05-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above|A Multi-Center, Phase IV, Randomized, Controlled, Observer Blind Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Trivalent Subunit Inactivated Influenza Vaccine in Healthy Subjects Aged 50 Years and Above|Completed||Phase 4|2902|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:39:03.879841|2017-10-11 01:39:03.879841
NCT01867008|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-04-04|||August 2013||2013-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:39:04.64703|2017-10-11 01:39:04.64703
NCT01866995|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-29|||May 2013||2013-05-01|May 2013|2013-05-01||||September 2013|Anticipated|2013-09-01||Interventional|||"Efficacy Study of Phytotherapy Raylis In Congestive Processes Of The Pelvic Organs (Prostatostasis)"|"Phase 3 Study of Phytotherapy Raylis In Congestive Processes Of The Pelvic Organs (Prostatostasis)Caused By Decrease Of Sexual Activity In Men."|Unknown status|Recruiting|Phase 3|50|Anticipated|The Clinic of Men's Health and Couple Longevity, Russia||3|||f||||||||||||||2017-10-11 01:39:04.706451|2017-10-11 01:39:04.706451
NCT01866982|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-04-24|||July 2, 2013|Actual|2013-07-02|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 1, 2014|Actual|2014-12-01||Interventional|PREMOD||The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants|The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants|Active, not recruiting||N/A|200|Anticipated|Sharp HealthCare||2|||f||||t||||||||||2017-10-11 01:39:04.813095|2017-10-11 01:39:04.813095
NCT01866969|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2015-06-03|||June 2013||2013-06-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Quality of Life in Caregivers of Hospitalized Older Patients With Cancer|Physical, Emotional and Social Stressors and Their Impact on Quality of Life of Caregivers of Hospitalized Older Adults With Cancer|Completed||N/A|211|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:39:04.953066|2017-10-11 01:39:04.953066
NCT01866956|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-02-07|||September 1, 2016|Actual|2016-09-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Observational|||Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders|Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders|Recruiting||N/A|20|Anticipated|Center for Psychological Consultation|||1||f||||f||||||||||2017-10-11 01:39:05.14919|2017-10-11 01:39:05.14919
NCT01866943|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2016-10-13|||November 2011||2011-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|TXA||Role of Topical Tranexamic Acid in Total Hip Arthroplasty|Role of Topical Tranexamic Acid in Total Hip Arthroplasty|Terminated||Phase 2|41|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 01:39:05.305698|2017-10-11 01:39:05.305698
NCT01866930|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-03-22||2017-03-22|July 11, 2013|Actual|2013-07-11|March 2017|2017-03-01|August 27, 2015|Actual|2015-08-27|August 27, 2015|Actual|2015-08-27||Interventional|DIMENSION||Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV|Phase 3 Open Label Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination With Ribavirin and Daclatasvir, for Treatment of Chronic HCV Infection With Treatment naïve Genotypes 1, 2, 3 or 4 in Subjects Co-infected With HIV|Completed||Phase 3|453|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 01:39:05.493772|2017-10-11 01:39:05.493772
NCT01866917|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2013-05-31|||April 2013||2013-04-01|May 2013|2013-05-01||||April 2014|Anticipated|2014-04-01||Interventional|||Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women|Effectiveness of Transversus Abdominis Plane Block in Reducing Immediate Postoperative Pain in Obese Women After Laparoscopic or Robotic Gynecologic Procedures|Unknown status|Recruiting|Early Phase 1|70|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 01:39:05.791176|2017-10-11 01:39:05.791176
NCT01866904|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-05-29|||June 19, 2013|Actual|2013-06-19|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Observational|TIGRIS||Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients|TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients|Terminated||N/A|9284|Actual|AstraZeneca|||1|"Study was terminated in order to secure the data quality of the study in terms of follow-up   rates and data completeness."|f||||f||||||||||2017-10-11 01:39:05.921295|2017-10-11 01:39:05.921295
NCT01866891|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-08-26|||April 2012||2012-04-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ACTIVDIAL||Effects of Physical Activity on the Microcirculation in Hemodialysis Patients|Effects of Regular Perdialytic Physical Activity on the Peripheral Microcirculation in Chronic Hemodialysis Patients|Completed||N/A|27|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 01:39:06.801367|2017-10-11 01:39:06.801367
NCT01866878|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2015-08-31|||July 2013||2013-07-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|FINGER||Rehabilitation Protocol for Disorders on Hand Sensitivity in Multiple Sclerosis Patients.|Rehabilitation Protocol for Disorders on Hand Sensitivity in Multiple Sclerosis Patients.|Unknown status|Recruiting|N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 01:39:06.882772|2017-10-11 01:39:06.882772
NCT01866865|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-06-30|||May 2, 2013||2013-05-02|November 22, 2016|2016-11-22|February 20, 2014|Actual|2014-02-20|February 20, 2014|Actual|2014-02-20||Observational|||Adaptation to Living With a BRCA1/2 Mutation|Adaptation to Living With a BRCA l/2 Mutation in Carriers and Their Partners|Completed||N/A|460|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:39:06.970407|2017-10-11 01:39:06.970407
NCT01866852|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-06-30|||April 27, 2013||2013-04-27|March 27, 2017|2017-03-27|December 31, 2022|Anticipated|2022-12-31|December 31, 2022|Anticipated|2022-12-31||Observational|||Expansion of Childhood Relationship Study to Young Adult Romantic Relationships|The Formation of Healthy, Stable Romantic Relationships During Young Adulthood: A Developmental and Dyadic Perspective|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:39:07.027067|2017-10-11 01:39:07.027067
NCT01865526|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-05-30|||March 2010||2010-03-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|PIS||Efficacy of the 6-point Diet|Effects of the 6-point Diet on the Metabolic Control, the Compliance and the Nutritional Status of CKD Patients Stage 3b-5|Completed||N/A|54|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 01:39:27.789346|2017-10-11 01:39:27.789346
NCT01866839|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-06-30|||May 20, 2013||2013-05-20|May 19, 2017|2017-05-19|February 3, 2018|Anticipated|2018-02-03|February 3, 2018|Anticipated|2018-02-03||Interventional|||Preventing Stem Cell Transplant Complications With a Blood Separator Machine|Peripheral Blood Stem Cell Allotransplantation For Hematological Malignancies Using Ex Vivo CD34 Selection - a Platform For Adoptive Cellular Therapies|Recruiting||Phase 1/Phase 2|192|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:39:07.095266|2017-10-11 01:39:07.095266
NCT01866826|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-29|2017-01-24|||January 18, 2013||2013-01-18|December 15, 2016|2016-12-15|May 18, 2018|Anticipated|2018-05-18|June 30, 2016|Actual|2016-06-30||Interventional|||Rifaximin for Chronic Immune Activation in People With HIV|A Double Blind Randomized Placebo Controlled Study Examining the Effects of a Non-Absorbable (Rifaximin) Antibiotic on the Chronic Immune Activation Observed In HIV-infected Subjects|Active, not recruiting||Phase 1/Phase 2|35|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:39:08.898992|2017-10-11 01:39:08.898992
NCT01866813|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-01-09|||May 2013||2013-05-01|May 2013|2013-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Internet-Delivered Cognitive Training For Breast Cancer Survivors With Cognitive Complaints|Feasibility And Efficacy Of An Internet-Delivered Cognitive Training Program For Breast Cancer Survivors With Cognitive Complaints|Completed||N/A|160|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 01:39:08.985283|2017-10-11 01:39:08.985283
NCT01866800|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-07-06|||June 2013||2013-06-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|REDUCE-AKI||The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI|Reducing Acute Kidney Injury in TAVI Patients (REDUCE Trial)|Recruiting||Phase 4|220|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-11 01:39:09.084473|2017-10-11 01:39:09.084473
NCT01866787|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2015-01-15|||January 2013||2013-01-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Study on Baroreceptor Function in Relation to Orthostatic Blood Pressure Regulation After Hip Surgery|Baroreceptor Function and Inflammation in Relation to Orthostatic Intolerance During Early Mobilization After Elective Hip Arthroplasty|Unknown status|Recruiting|N/A|30|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples Without DNA|"     Blood samples for Hemoglobin measurement and plasma for inflammatory markers.   "|||2017-10-11 01:39:09.193517|2017-10-11 01:39:09.193517
NCT01866774|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-10-22|||May 2013||2013-05-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service|Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service - A Randomized, Controlled Trial|Terminated||N/A|15|Actual|Queen's University||2||Primary Investigator (AJN) left institution|f||||t||||||||||2017-10-11 01:39:09.292981|2017-10-11 01:39:09.292981
NCT01866761|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-27|||November 2008||2008-11-01|May 2013|2013-05-01||||January 2012|Actual|2012-01-01|2 Years|Observational [Patient Registry]|RAPA-JMCS||Relationship Analysis Between Periodontal Disease and Atherosclerosis in Japanese Medical Cooperation Services|Analysis of the Relationship Between Periodontal Disease and Atherosclerosis Within a Local Cooperation System of Japanese Medical Services|Completed||N/A|116|Actual|Okayama University|||1||f||||f||||||Samples Without DNA|"     blood   "|||2017-10-11 01:39:09.382201|2017-10-11 01:39:09.382201
NCT01866748|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2014-04-25|||May 2013||2013-05-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects|Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects|Completed||Phase 1|170|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:39:09.468713|2017-10-11 01:39:09.468713
NCT01866735|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-08-10|||May 2013||2013-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|April 2015|Actual|2015-04-01||Interventional|||Early Mobility for the Critically Injured Burn Patient|Early ICU Standardized Rehabilitation Therapy for the Critically Injured Burn Patient|Suspended||N/A|150|Anticipated|Wake Forest University Health Sciences||2||"Results from trial in another population lead investigators to determine study outcome may not   reach statistical significance. Suspended for futility."|f|||||f|f||||||||2017-10-11 01:39:09.577857|2017-10-11 01:39:09.577857
NCT01866722|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-07-26|||September 2013|Actual|2013-09-01|July 2017|2017-07-01|July 14, 2015|Actual|2015-07-14|January 10, 2015|Actual|2015-01-10||Interventional|||Not Quite Ready to Quit|A Test of Two Clinical Methods to Prompt a Quit Attempt Among Smokers|Completed||N/A|560|Anticipated|University of Vermont||3|||f||||f||||||||||2017-10-11 01:39:09.671488|2017-10-11 01:39:09.671488
NCT01866709|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-08-29|2014-08-20||May 2013||2013-05-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional||Mean i-STAT serum potassium values between 5.0 - 6.5 mmol/l inclusive at screening (Study Day 0) plus meeting inclusion/exclusion eligibility criteria.|Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia|A Phase 4, Single-center, Prospective, Double-blind, Placebo-controlled, Randomized Study to Investigate the Safety and Efficacy of Sodium Polystyrene Sulfonate (SPS) in Subjects With Hyperkalemia.|Terminated||Phase 4|32|Actual|ZS Pharma, Inc.|Due to the high frequency of adverse events in the SPS group, the independent Data Monitoring Committee (iDMC) recommended termination of the study.|2||Risk/benefit determination showed study revealed negative safety issues.|f||||t||||||||||2017-10-11 01:39:09.786516|2017-10-11 01:39:09.786516
NCT01866696|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-28|||April 2006||2006-04-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Computer Assisted Implant Surgery and Immediate Loading|Computer Assisted Implant Surgery and Immediate Loading With Full-arch Screw Retained Prosthesis|Completed||N/A|20|Actual|Università degli Studi di Sassari||1|||f||||f||||||||||2017-10-11 01:39:10.261577|2017-10-11 01:39:10.261577
NCT01866683|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-06-11|||January 2013||2013-01-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Yoga Effects on Heart Rate Variability and Electroencephalography|Effects of Yoga on Heart Rate Variability, Electroencephalography, Quality of Life and Salivary Cortisol of Healthy Adult Subjets|Completed||N/A|30|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:39:10.363443|2017-10-11 01:39:10.363443
NCT01866670|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-30|||March 2013||2013-03-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||"Effect of the Nursing Intervention Spiritual Support"|"Effect of the Nursing Intervention Spiritual Support in the Level of Spirituality and Clinical Parameters in Women With Breast Cancer: a Randomized Clinical Trial"|Unknown status|Recruiting|Phase 2|25|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:39:10.487565|2017-10-11 01:39:10.487565
NCT01866657|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2013-05-28|||June 2013||2013-06-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery|NIRS-Based Cerebral Oximetry Monitoring in Elderly Thoracic Surgical Patients Undergoing Single Lung Ventilation Procedures: A Single Center, Prospective, Randomized Controlled Pilot Study Assessing the Clinical Impact of NIRS-Guided Intervention|Unknown status|Not yet recruiting|N/A|100|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 01:39:10.602966|2017-10-11 01:39:10.602966
NCT01866644|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2015-07-21|||September 2011||2011-09-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Effectiveness of N-acetylcysteine on Preservation Solution During Liver Transplantation|Effectiveness of N-acetylcysteine on Preservation Solution During Liver Transplantation|Unknown status|Active, not recruiting|Phase 3|214|Anticipated|Instituto de Investigacion Sanitaria La Fe||2|||f||||t||||||||||2017-10-11 01:39:10.835389|2017-10-11 01:39:10.835389
NCT01866631|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-12-08|||December 2010||2010-12-01|December 2013|2013-12-01||||December 2013|Anticipated|2013-12-01||Observational|||Using National University Cancer Institute of Singapore (NCIS) Registry to Measure Time Trends in Quality of Care for Breast Cancer Patients in a National Cancer Centre||Unknown status|Recruiting|N/A|2000|Anticipated|National University Hospital, Singapore|||1||f||||f||||||||||2017-10-11 01:39:10.968728|2017-10-11 01:39:10.968728
NCT01866618|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-03-16|||April 2013||2013-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Natural Cycle In Vitro Fertilization|Natural Cycle In Vitro Fertilization|Completed||N/A|524|Actual|Reproductive Medicine Associates of New Jersey||1|||f||||f||||||||||2017-10-11 01:39:11.04979|2017-10-11 01:39:11.04979
NCT01866605|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-05-30|||July 2008||2008-07-01|February 2009|2009-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study of Methods to Reduce Anxiety in Preoperative Elective Surgical Patients|A Study of Methods to Reduce Anxiety in Preoperative Elective Surgical Patients|Completed||Phase 4|120|Actual|Melbourne Health||3|||f||||f||||||||||2017-10-11 01:39:11.143608|2017-10-11 01:39:11.143608
NCT01866579|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-05-19|||May 2013||2013-05-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography||Completed||N/A|49|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:39:11.375209|2017-10-11 01:39:11.375209
NCT01866566|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-06-25|||June 2013||2013-06-01|May 2013|2013-05-01|January 2016|Anticipated|2016-01-01|January 2014|Anticipated|2014-01-01||Interventional|||The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination|Phase 4 Study of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination|Unknown status|Recruiting|Phase 4|1800|Anticipated|Beijing Center for Disease Control and Prevention||4|||f||||f||||||||||2017-10-11 01:39:11.453771|2017-10-11 01:39:11.453771
NCT01866553|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-06-07|||April 2013||2013-04-01|June 2013|2013-06-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Interventional|||Nilotinib Plus Pegylated Interferon-α2b in CML|A Phase II, Single Arm, Multicenter Study of Nilotinib in Combination With Pegylated Interferon-α2b in Patients With Suboptimal Molecular Response or Stable Detectable Molecular Residual Disease After at Least Two Years of Imatinib Treatment (NordDutchCML009)|Unknown status|Recruiting|Phase 2|60|Anticipated|VU University Medical Center||1|||f||||t||||||||||2017-10-11 01:39:11.595797|2017-10-11 01:39:11.595797
NCT01866540|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-09-19|||October 2012||2012-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Immune Response To Intranasal Influenza Vaccination|The Systemic And Local Immune Response To Intranasal Influenza Vaccination|Enrolling by invitation||N/A|300|Anticipated|University of Bergen||1|||f||||f||||||||||2017-10-11 01:39:11.775298|2017-10-11 01:39:11.775298
NCT01866527|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-05-28|||January 1991||1991-01-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Selective Ultrasound Screening for DDH 1991-2006|Selective Ultrasound Screening for Developmental Hip Dysplasia: Effect on Management and Late Detected Cases. A Prospective Survey During 1991-2006.|Completed||N/A|81564|Actual|University of Bergen|||1||f||||t||||||||||2017-10-11 01:39:11.870952|2017-10-11 01:39:11.870952
NCT01866514|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-06-05|||May 2013||2013-05-01|May 2013|2013-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Proximal Humerus Site for Anesthesia|A Study Evaluating Use of the Proximal Humerus Intraosseous Vascular Access Site for Anesthesia Patient Positioning|Completed||N/A|5|Actual|Vidacare Corporation||1|||f||||f||||||||||2017-10-11 01:39:11.970174|2017-10-11 01:39:11.970174
NCT01866501|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-05-30|||May 2013||2013-05-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Follow-Up Study Validating a Blended Technique|A Follow-up Study Validating a Blended Technique for Identifying the Proximal Humerus Intraosseous Vascular Access Insertion Site|Completed||N/A|10|Actual|Vidacare Corporation||1|||f||||f||||||||||2017-10-11 01:39:12.077125|2017-10-11 01:39:12.077125
NCT01866488|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-08-27|||April 2013||2013-04-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||The Obstetric Cook Double Balloon Catheter in Combination With Oral Misoprostol for Induction of Labor|The Obstetric Cook Double Balloon Catheter in Combination With Oral Misoprostol for Induction of Labor: A Double-Blinded, Randomized Controlled Trial|Recruiting||Phase 2|200|Anticipated|University of Arizona||2|||f||||f||||||||||2017-10-11 01:39:12.314481|2017-10-11 01:39:12.314481
NCT01866475|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-12-05|||November 2014||2014-11-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Continuous Intraosseous Vascular Access Over 48 Hours|A Study to Determine the Safety of Continuous Intraosseous Vascular Access Over a Period of 48 Hours|Completed||N/A|125|Actual|Vidacare Corporation||4|||f||||f||||||||||2017-10-11 01:39:12.461141|2017-10-11 01:39:12.461141
NCT01866462|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-07-23|||May 2013||2013-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin|A Pilot Study of the Effect of NM-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin in Patients With Metformin Intolerance|Completed||Early Phase 1|10|Anticipated|NuMe Health||2|||f||||f||||||||||2017-10-11 01:39:12.592333|2017-10-11 01:39:12.592333
NCT01866449|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-02-23|||October 2013||2013-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme|Prospective Controlled Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme (GBM)- The C-GBM Study -|Active, not recruiting||Phase 2|24|Actual|University of Ulm||1|||f||||t||||||||||2017-10-11 01:39:12.719115|2017-10-11 01:39:12.719115
NCT01866436|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-05-30|||October 2011||2011-10-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Educational Study of Multimedia in Surgical Skills Training in Colorectal Surgery|The Role of Multimedia in Cognitive Surgical Skill Acquisition in Open and Laparoscopic Colorectal Surgery|Completed||N/A|59|Actual|University of Sheffield||2|||f||||f||||||||||2017-10-11 01:39:12.855188|2017-10-11 01:39:12.855188
NCT01866423|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-07-31|2017-07-03||October 25, 2013|Actual|2013-10-25|June 2017|2017-06-01|July 26, 2016|Actual|2016-07-26|July 23, 2015|Actual|2015-07-23||Interventional|||Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer|Phase 2 Trial of TAK-700 (Also Known as Orteronel) Without Prednisone for Metastatic Castration-Resistant Prostate Cancer|Terminated||Phase 2|4|Actual|University of Southern California|The trial was terminated early due to the discontinuation of the development program for the study drug, TAK-700 (orteronel) for prostate cancer.|1||Not progressing toward scientific goals|f||||t||||||||||2017-10-11 01:39:12.998542|2017-10-11 01:39:12.998542
NCT01866410|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-09-12|||May 20, 2013|Actual|2013-05-20|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer|Phase II Trial of XL184 (Cabozantinib) Plus Erlotinib in Patients With Advanced EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy|Active, not recruiting||Phase 2|37|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 01:39:13.423346|2017-10-11 01:39:13.423346
NCT01866397|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-06-04|||March 2002||2002-03-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration|Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration|Completed||Phase 4|1|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 01:39:13.571484|2017-10-11 01:39:13.571484
NCT01866384|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-12-16|||September 2012||2012-09-01|December 2014|2014-12-01||||September 2015|Anticipated|2015-09-01||Interventional|||Targeted Temperature Management After Intracerebral Hemorrhage|Safety and Tolerability of a Protocol of Targeted Temperature Management After Intracerebral Hemorrhage|Unknown status|Recruiting|Phase 2|100|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 01:39:13.695327|2017-10-11 01:39:13.695327
NCT01866371|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-06-19|||May 2013||2013-05-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|AOSLO||High Resolution Retinal Imaging|High Resolution Retinal Imaging|Recruiting||N/A|600|Anticipated|University of Pennsylvania|||2||f||||f||||||||||2017-10-11 01:39:13.836521|2017-10-11 01:39:13.836521
NCT01866358|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-11-13|||May 2013||2013-05-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional|||Intraosseous Infusion for Neonatal Asphyxiated Resuscitation|Intraosseous Infusion for Neonatal Asphyxiated Resuscitation|Completed||N/A|60|Actual|Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:39:13.967999|2017-10-11 01:39:13.967999
NCT01866345|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-02-12|||August 2013||2013-08-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Randomized, Blinded, Controlled Clinical Trial of Surgically Facilitated Orthodontic Treatment|Randomized, Blinded, Controlled Clinical Trial of Surgically Facilitated Orthodontic Treatment in the Mandibular Anterior Region|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Cannot find subjects to particpate|f||||f||||||||||2017-10-11 01:39:14.078701|2017-10-11 01:39:14.078701
NCT01866332|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-01-14|||June 2013||2013-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Effectiveness of the Addition of the Kinesio Taping Method to Conventional Physical Therapy Treatment in Patients With Chronic Nonspecific Low Back Pain|Effectiveness of the Addition of the Kinesio Taping Method to Conventional Physical Therapy Treatment in Patients With Chronic Nonspecific Low Back Pain: A Randomized Controlled Trial|Completed||N/A|148|Actual|Universidade Cidade de Sao Paulo||2|||f||||f||||||||||2017-10-11 01:39:14.199184|2017-10-11 01:39:14.199184
NCT01866319|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-09-06|2015-12-09||August 28, 2013|Actual|2013-08-28|September 2017|2017-09-01|July 2, 2018|Anticipated|2018-07-02|March 24, 2015|Actual|2015-03-24||Interventional||The Intent-to-Treat (ITT) population consisted of all randomized participants. Participants were included in the group to which they were randomized for Baseline Characteristics.|Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)|A Multicenter, Randomized, Controlled, Three-Arm, Phase III Study to Evaluate the Safety and Efficacy of Two Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Patients With Advanced Melanoma|Active, not recruiting||Phase 3|834|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 01:39:14.403469|2017-10-11 01:39:14.403469
NCT01866306|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-01-23|2016-11-14||October 2013||2013-10-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218)|"A Dose-Finding and Longitudinal Biomarker Study of Rhinovirus Challenge in Healthy Volunteers and Mild-Moderate Asthmatics to Evaluate the Safety and Use of a Human Rhinovirus Preparation in Developing High Dimensionality Phenotypes (Handprints) for Asthma"|Completed||Phase 1|59|Actual|Merck Sharp & Dohme Corp.||7|||f||||f||||||||||2017-10-11 01:39:16.729072|2017-10-11 01:39:16.729072
NCT01866293|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-08-01|2017-08-01||May 28, 2013||2013-05-28|February 2017|2017-02-01|August 18, 2016|Actual|2016-08-18|August 18, 2016|Actual|2016-08-18||Interventional|||Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma|A Phase I/II Trial of Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma|Completed||Phase 1/Phase 2|11|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:39:17.855093|2017-10-11 01:39:17.855093
NCT01866254|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-02-02|||May 2013||2013-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries|Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries|Recruiting||Early Phase 1|50|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 01:39:18.411031|2017-10-11 01:39:18.411031
NCT01866241|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-09-05|||November 2012||2012-11-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage|Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage|Completed||Phase 3|1140|Actual|Mbarara University of Science and Technology||2|||f||||t||||||||||2017-10-11 01:39:18.521117|2017-10-11 01:39:18.521117
NCT01866228|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-05-09|||June 2013||2013-06-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|February 2017|Actual|2017-02-01||Interventional|||Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes|Impact of Treatment Consultation Recordings on Cancer Patient Outcomes: A Prospective, Parallel, Randomized Controlled Trial|Active, not recruiting||N/A|140|Actual|University of Manitoba||2|||f||||f||||||||No||2017-10-11 01:39:18.620005|2017-10-11 01:39:18.620005
NCT01866215|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-06-03|||May 2013||2013-05-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|FruEx2||Effects of Exercise on Fructose Metabolism|Effects of Exercise on Fructose Metabolism|Completed||N/A|8|Actual|University of Lausanne||5|||f||||f||||||||||2017-10-11 01:39:18.744024|2017-10-11 01:39:18.744024
NCT01866202|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2013-12-10|||March 2012||2012-03-01|December 2013|2013-12-01||||February 2016|Anticipated|2016-02-01||Observational|||Study of Circulating and Tumor Biomarkers in Breast Cancer Patients||Unknown status|Recruiting|N/A|100|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 01:39:18.840047|2017-10-11 01:39:18.840047
NCT01866189|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-05-06|||September 2016||2016-09-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|STROKE F-MISO||Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke|Assessment of Hypoxic Tissues in Acute Ischemic Stroke With 18F-FMISOnidazole PET and Comparison With MRI : A Prospective Multicenter Study|Withdrawn||N/A|0|Actual|University Hospital, Toulouse||1||default recruitment|f||||t||||||||||2017-10-11 01:39:18.930604|2017-10-11 01:39:18.930604
NCT01866176|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2014-03-05|||October 2011||2011-10-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Effects of a New Knee Brace for Treatment of the Knee Osteoarthritis|Effects of a New Knee Brace for Treatment of the Knee Osteoarthritis on the Medial Knee Loading During Gait|Completed||N/A|24|Actual|Laval University||1|||f||||t||||||||||2017-10-11 01:39:19.023825|2017-10-11 01:39:19.023825
NCT01866163|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-04-06|2015-11-13|2015-07-13|June 2013||2013-06-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris|LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris|Completed||Phase 3|426|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 01:39:19.122721|2017-10-11 01:39:19.122721
NCT01866150|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-09-01|2015-07-17||April 2013||2013-04-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Observational||All participants entered analysis set: All participants entered in this retrospective chart review were included.|A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis|A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Rheumatoid Arthritis: A Comparison of the Effectiveness of Biologic Monotreatment and Biologic and Methotrexate (MTX) Combination Treatment|Completed||N/A|476|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:39:19.467711|2017-10-11 01:39:19.467711
NCT01866137|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-09-08|||March 2013||2013-03-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|June 2013|Actual|2013-06-01||Observational|PsyCo||Copeptin During a Standardized Psychological Stress Test|Copeptin During a Standardized Psychological Stress Test|Completed||N/A|20|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     7.5 ml of EDTA blood, 7.5 ml of serum   "|||2017-10-11 01:39:20.127557|2017-10-11 01:39:20.127557
NCT01866124|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-10-09|||May 2013||2013-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|MAM'Out||MAM'Out Project - Evaluation of Multiannual and Seasonal Cash Transfers to Prevent Acute Malnutrition|MAM'Out Project - Evaluation of Multiannual and Seasonal Cash Transfers to Prevent Acute Malnutrition|Completed||N/A|1278|Actual|Action Contre la Faim||2|||f||||f||||||||||2017-10-11 01:39:20.205844|2017-10-11 01:39:20.205844
NCT01866111|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-10-12||2016-10-12|July 2013||2013-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2015|Actual|2015-07-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension|Active, not recruiting||Phase 2|437|Actual|SK Life Science||4|||f||||t||||||||||2017-10-11 01:39:20.334673|2017-10-11 01:39:20.334673
NCT01865955|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-01-30|||May 2013||2013-05-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Comparison Between Palpatory and Preprocedural Ultrasound Guided Techniques on Performance of Spinal Anesthesia|Comparison Between Palpatory and Preprocedural Ultrasound Guided Techniques on Performance of Spinal Anesthesia in Term Parturients Undergoing Elective Caesarian Section- A Randomized Control Trial|Completed||N/A|100|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 01:39:21.925828|2017-10-11 01:39:21.925828
NCT01865942|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-03-30|||August 28, 2014|Actual|2014-08-28|March 2017|2017-03-01|March 30, 2017|Actual|2017-03-30|January 2, 2017|Actual|2017-01-02||Interventional|||Surgical Spinal Decompression of Metastatic Spinal Cord Compression, Minimal Access Versus Open Surgery|Surgical Spinal Decompression of Metastatic Spinal Cord Compression, Minimal Access Versus Open Surgery. A Randomized Clinical Trial.|Completed||N/A|50|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 01:39:21.993896|2017-10-11 01:39:21.993896
NCT01866098|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-04-17|||May 2013||2013-05-01|June 2016|2016-06-01|April 7, 2018|Anticipated|2018-04-07|April 7, 2018|Anticipated|2018-04-07||Interventional|NTX||Naltrexone for Antipsychotic-Induced Weight Gain|Naltrexone for Antipsychotic-Induced Weight Gain|Active, not recruiting||N/A|144|Actual|Yale University||3|||f||||t||||||||Yes|All de-identified data resulting from this award involving human subjects will be submitted to the NIMH Data Archive (NDA) - National Database for Clinical Trials Related to Mental Illness (NDCT) The Principal Investigator will work with NDA support staff to plan an appropriate data submission schedule and provide information on the steps for submission and sharing of data. Communication of this data sharing plan to appropriate research staff to ensure the timely submission of data. All human subject data provided will include an NDA Global Unique Identifier (GUID) and will not include personally identifiable information (PII). Analyzed data will be submitted no later than the time of publication. Even if a publication focuses on only part of an analyzed dataset, the entire analyzed dataset will be submitted when the first paper is published. All data made available for public use via NDA will be de-identified data.|2017-10-11 01:39:20.628486|2017-10-11 01:39:20.628486
NCT01866085|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-05-30|||June 2012||2012-06-01|May 2013|2013-05-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||AdVance® vs ARGUS® Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence|Randomised Clinical Trial to Evaluate Efficacy of AdVance® vs ARGUS® Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence|Unknown status|Recruiting|N/A|128|Anticipated|Jewish General Hospital||2|||f||||t||||||||||2017-10-11 01:39:20.730103|2017-10-11 01:39:20.730103
NCT01866072|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2013-06-03|||May 2013||2013-05-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|November 2013|Anticipated|2013-11-01||Observational|ACLF||Evaluation of Role of Transient Elastography (Fibroscan) in Differentiating Patients of Acute Severe Viral Hepatitis and Acute on Chronic Liver Failure|A Prospective Evaluation of the Role of Transient Elastography (Fibroscan) in Differentiating Patients of Acute Severe Viral Hepatitis and Acute on Chronic Liver Failure|Unknown status|Recruiting|N/A|100|Anticipated|Sir Ganga Ram Hospital|||2||f||||f||||||||||2017-10-11 01:39:20.827357|2017-10-11 01:39:20.827357
NCT01866059|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-05-10|||July 2012||2012-07-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Treatment of Root Caries in an Older Irish Population.|Randomised Controlled Clinical Trial to Compare Restorative Materials in the Treatment of Root Caries in an Older Irish Population.|Active, not recruiting||N/A|130|Anticipated|University College Cork||3|||f||||t||||||||||2017-10-11 01:39:20.929413|2017-10-11 01:39:20.929413
NCT01866046|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-03-24|||January 2013||2013-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Rapid HIV Testing and Counseling in High Risk Women in Shelters|Rapid HIV Testing and Counseling in High Risk Women in Shelters|Completed||Phase 1|98|Actual|The University of Akron||1|||f||||t||||||||||2017-10-11 01:39:21.021935|2017-10-11 01:39:21.021935
NCT01866033|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-03-16|||June 2013||2013-06-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy Participants|An Open-Label, Sequential and 2-Way Crossover Pharmacokinetic Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy Subjects|Completed||Phase 1|8|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 01:39:21.101081|2017-10-11 01:39:21.101081
NCT01866020|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-05-28|||January 2013||2013-01-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|July 2014|Actual|2014-07-01||Observational|DipA||Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients|Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients - a Prospective Clinical Trial in the Department of Intensive Care, University Medical Center Hamburg-Eppendorf (UKE)|Completed||N/A|85|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-11 01:39:21.197355|2017-10-11 01:39:21.197355
NCT01866007|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-03-10|||May 2013||2013-05-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants|Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects|Completed||Phase 1|141|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-11 01:39:21.602476|2017-10-11 01:39:21.602476
NCT01865994|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-12-02|||August 2012||2012-08-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Correlation of Estimated Continuous Cardiac Output (esCCO) and TEE in Pediatric Cardiac Surgery|Study to Examine the Correlation of 'Estimated Continuous Cardiac Output' (esCCO) With Transesophageal Echocardiography (TEE) in Pediatric Cardiac Surgery|Completed||N/A|44|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-11 01:39:21.714786|2017-10-11 01:39:21.714786
NCT01865981|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-10-24|||June 2013||2013-06-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|CLUE||Investigating Hereditary Cardiac Disease by Reprogramming Skin Cells to Heart Muscle|Cellular Reprogramming as a Tool to Characterise the Cellular Electrophysiology of Familial Arrhythmia|Active, not recruiting||N/A|5|Anticipated|University of Dundee|||2||f||||f||||||None Retained|"     Skin biopsies will be extracted and used to derive fibroblasts. These will be retained and     reprogrammed to iPS cells (also to be retained). Derived cell lines are not considered a     tissue under the UK Human Tissue Act   "|||2017-10-11 01:39:21.784305|2017-10-11 01:39:21.784305
NCT01865968|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-05-13|||October 2008||2008-10-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults|Phase IV Trial to Compare the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) With One- or Two-dose Regimen and Live Attenuated HAV With One-dose Regimen in Chinese Young Adults, and to Evaluate the Immunogenicity of a Booster Dose.|Completed||Phase 4|239|Actual|Sinovac Biotech Co., Ltd||3|||f||||f||||||||||2017-10-11 01:39:21.845323|2017-10-11 01:39:21.845323
NCT01865929|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-05-30|||January 2010||2010-01-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Minimally Invasive Benign Hysterectomy|Benign Hysterectomy; a Randomized Controlled Trial Comparing Robotic Hysterectomy With Vaginal Hysterectomy and Traditional Laparoscopic Hysterectomy|Unknown status|Recruiting|N/A|200|Anticipated|Region Skane||2|||f||||f||||||||||2017-10-11 01:39:22.065517|2017-10-11 01:39:22.065517
NCT01865916|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-06-16|||April 2013||2013-04-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation|2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation: A Randomized, Non-Inferiority Open Trial|Completed||Phase 4|309|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:39:22.159385|2017-10-11 01:39:22.159385
NCT01865903|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-07-13|||June 2013||2013-06-01|May 2013|2013-05-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Observational|LEKS||Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS)|Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer; Incidence, Development and Impact on Quality of Life, Adverse Effects and Survival.|Terminated||N/A|17|Actual|Oslo University Hospital|||2|To Low recruitment and competing studies|f||||f||||||Samples With DNA|"     Bloodsamples for biobank   "|||2017-10-11 01:39:22.242328|2017-10-11 01:39:22.242328
NCT01865890|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-09|2013-05-30|||June 2010||2010-06-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients|Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients|Completed||N/A|100|Actual|Northwell Health|||1||f||||f||||||||||2017-10-11 01:39:22.304535|2017-10-11 01:39:22.304535
NCT01865877|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-03-01|||August 2012||2012-08-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01|2 Years|Observational [Patient Registry]|ReMePARK||Motor, Non-motor and Genetic Determinants of Progression in Parkinson's Disease: A Mexican Multicenter Cohort Study|Motor, Non-motor and Genetic Determinants of Progression and Complications in Parkinson's Disease: A Multicenter Cohort Study in Mexican Population (ReMePArk)|Completed||N/A|550|Actual|El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez|||1||f||||t||||||Samples With DNA|"     Serum and/or saliva   "|||2017-10-11 01:39:22.366184|2017-10-11 01:39:22.366184
NCT01865864|ClinicalTrials.gov processed this data on October 10, 2017|2008-12-26|2013-05-28|||July 2008||2008-07-01|May 2013|2013-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Effect of Continuous Positive Airway Pressure (CPAP) Therapy on Changes of Blood Pressure Between Day and Night|Changes In Diurnal Blood Pressure Pattern In Obstructive Sleep Apnea (OSA) Patients After CPAP Therapy|Terminated||N/A|2|Actual|Northwell Health|||2|Difficulty Recruiting subjects|f||||t||||||||||2017-10-11 01:39:22.511156|2017-10-11 01:39:22.511156
NCT01865851|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-09-13|||May 2013||2013-05-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparison of the Classic Face Mask Versus NuMask for Preoxygenation|Comparison of the Classic Face Mask Versus NuMask for Preoxygenation|Recruiting||N/A|30|Anticipated|Nimmagadda, Usharani, M.D.||2|||f||||t||||||||||2017-10-11 01:39:22.581379|2017-10-11 01:39:22.581379
NCT01865838|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-04-10|||May 2013||2013-05-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study Into the Effect of Seprafilm in Open Total Thyroidectomy|A Study Into the Effect of Seprafilm on Post Operative Adhesions After Open Total Thyroidectomy.|Terminated||N/A|19|Actual|National Cancer Centre, Singapore||2||safety issue|f||||t||||||||||2017-10-11 01:39:22.706553|2017-10-11 01:39:22.706553
NCT01865825|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-03-21|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Observational|||Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?|PPI Responsive Esophageal Eosinophilia: GERD or Eosinophilic Esophagitis?|Completed||N/A|20|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 01:39:22.831556|2017-10-11 01:39:22.831556
NCT01865812|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-05-18|2016-08-25||November 2013||2013-11-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|August 2014|Actual|2014-08-01||Interventional|||Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis|A Phase 2 Clinical Trial Investigating the Effects of Obeticholic Acid on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis|Completed||Phase 2|26|Actual|Intercept Pharmaceuticals||1|||f||||t||||||||||2017-10-11 01:39:22.950657|2017-10-11 01:39:22.950657
NCT01865799|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-08-07|||April 2013||2013-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA|A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA|Active, not recruiting||N/A|400|Anticipated|Gilead Sciences|||1||f||||f||||||||||2017-10-11 01:39:23.273339|2017-10-11 01:39:23.273339
NCT01865786|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-02-22|||January 1, 2013|Actual|2013-01-01|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Observational|||A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication|A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication Nested in the Antiretroviral Pregnancy Registry|Completed||N/A|99|Actual|Gilead Sciences|||2||f||||f||||||||||2017-10-11 01:39:23.353565|2017-10-11 01:39:23.353565
NCT01865760|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-06-03|||June 2013||2013-06-01|August 2013|2013-08-01|March 2016|Anticipated|2016-03-01|September 2015|Anticipated|2015-09-01||Interventional|||Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia|Incidence of Medical and Nutritional Complications After Bariatric Surgery, Especially Focusing on Assessment and Treatment of Severe Hypoglycemia|Unknown status|Recruiting|N/A|40|Anticipated|University of Aarhus||4|||f||||f||||||||||2017-10-11 01:39:23.568228|2017-10-11 01:39:23.568228
NCT01865747|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-06-19|2017-04-21||June 2013||2013-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 22, 2015|Actual|2015-05-22||Interventional|METEOR||A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma|A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma That Has Progressed After Prior VEGFR Tyrosine Kinase Inhibitor Therapy|Active, not recruiting||Phase 3|658|Actual|Exelixis||2|||f||||t||||||||||2017-10-11 01:39:23.778498|2017-10-11 01:39:23.778498
NCT01865734|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-02-06|||December 2013||2013-12-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|||Comparison of Usual Podiatric Care and Early Physical Therapy for Plantar Heel Pain|Comparison of Usual Podiatric Care and Early Physical Therapy for Plantar Heel Pain: A Randomized Clinical Trial|Active, not recruiting||N/A|95|Actual|Des Moines University||2|||f||||t||||||||Undecided||2017-10-11 01:39:26.173708|2017-10-11 01:39:26.173708
NCT01865721|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-07-17|||January 2013||2013-01-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Optimizing the Use of Entonox® During Screening Colonoscopy|Optimizing the Use of Entonox® During Screening Colonoscopy: an Open Randomised Controlled Trial|Completed||Phase 4|100|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:39:26.294214|2017-10-11 01:39:26.294214
NCT01865695|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-03-10|||May 2013||2013-05-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase|Randomized, Double Blind, Placebo-controlled Trial of Creon in Patients With Low Faecal Pancreatic Elastase|Terminated||Phase 4|2|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2||Lack of participant enrolment|f||||t||||||||||2017-10-11 01:39:26.509404|2017-10-11 01:39:26.509404
NCT01865682|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-10-05|||December 2012|Actual|2012-12-01|October 2017|2017-10-01|June 2017|Actual|2017-06-01|March 2015|Actual|2015-03-01||Observational|||Effect of Ankle-foot Orthoses Trim Line Modifications on Ankle and Knee Motion and Force.|Effects of Varying Trim Lines of Solid Ankle-foot Orthoses on Ankle and Knee Kinematics and Kinetics During Stance Phase.|Completed||N/A|10|Actual|Southern California Institute for Research and Education|||1||f||||f||||||||||2017-10-11 01:39:26.61283|2017-10-11 01:39:26.61283
NCT01865669|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-07-12|||May 2013||2013-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||In-vitro Myometrial Contractility After Oxytocin Pre-exposure in Women With Advanced Maternal Age and Morbid Obesity|In-vitro Myometrial Contractility After Oxytocin Pre-exposure in Women With Advanced Maternal Age and Morbid Obesity|Recruiting||N/A|60|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 01:39:26.69527|2017-10-11 01:39:26.69527
NCT01865656|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-01-26|||July 2013||2013-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||A Skills and Drills Intervention for Emergency Obstetrics and Neonatal Care at First Referral Units of North Karnataka|Skills and Drills Intervention for Improving Emergency Obstetric and Neonatal Care in Select First Referral Units in Northern Karnataka|Completed||N/A|15018|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-11 01:39:26.815557|2017-10-11 01:39:26.815557
NCT01865643|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2014-08-19|||May 2013||2013-05-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Comparison of Two GlideScope Intubation Techniques|A Comparison of Two GlideScope Intubation Techniques - Effect on Hemodynamic Changes and Injury Rate|Completed||N/A|81|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 01:39:26.941346|2017-10-11 01:39:26.941346
NCT01865630|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-05-02|||December 2016||2016-12-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Efficacy Study of Etanercept for Aneurysmal Subarachnoid Hemorrhage|Phase I Safety, Blood Brain Barrier Permeability and Potential Efficacy of Etanercept for Aneurysmal Subarachnoid Hemorrhage|Not yet recruiting||Phase 1|20|Anticipated|St. Michael's Hospital, Toronto||1|||f||||t||||||||No||2017-10-11 01:39:27.042414|2017-10-11 01:39:27.042414
NCT01865617|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2017-07-06|||May 22, 2013|Actual|2013-05-22|July 2017|2017-07-01||||April 1, 2029|Anticipated|2029-04-01||Interventional|||Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia|Phase I/II Study of Immunotherapy for Advanced CD19+ Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia/Lymphoma and Non-Hodgkin Lymphoma With Defined Subsets of Autologous T Cells Engineered to Express a CD19-Specific Chimeric Antigen Receptor|Recruiting||Phase 1/Phase 2|189|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 01:39:27.14908|2017-10-11 01:39:27.14908
NCT01865604|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-03-15|||April 2012||2012-04-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Impact of tDCS on Cerebral Autoregulation||Completed||N/A|60|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 01:39:27.268187|2017-10-11 01:39:27.268187
NCT01865591|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-05-30|||April 2012||2012-04-01|May 2013|2013-05-01||||July 2013|Anticipated|2013-07-01||Interventional|SoundITV||Feasibility Study of Renal Denervation for the Treatment of Resistant Hypertension|A Clinical Trial for the Assessment of Safety and Efficacy of the UltraSOUND Mediated InTerVentional Treatment of Resistant Hypertension|Unknown status|Recruiting|Early Phase 1|30|Anticipated|Sound Interventions, Inc.||1|||f||||f||||||||||2017-10-11 01:39:27.358552|2017-10-11 01:39:27.358552
NCT01865578|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-03-16|||April 2012||2012-04-01|March 2016|2016-03-01||||May 2015|Actual|2015-05-01||Interventional|||Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis||Completed||N/A|40|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 01:39:27.460768|2017-10-11 01:39:27.460768
NCT01865565|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-28|||April 2012||2012-04-01|May 2013|2013-05-01|December 2019|Anticipated|2019-12-01|April 2018|Anticipated|2018-04-01||Observational|||Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy|A Trial for Surgical Treatment in Patients With Initially Locally Unresectable Advanced GIST Without Metastasis During Therapy With Imatinib|Recruiting||Phase 2|50|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||Samples With DNA|"     Histologically verified GIST and exon genotype.   "|||2017-10-11 01:39:27.533701|2017-10-11 01:39:27.533701
NCT01865552|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-12-10|||May 2013||2013-05-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB4 in Healthy Male Subjects|A Randomised, Single-blind, Three-part, Two-period, Two-sequence, Single-dose, Cross-over Study to Compare the Pharmacokinetics, Safety, Tolerability and Immunogenicity of Three Formulations of Etanercept (SB4, EU Sourced Enbrel® and US Sourced Enbrel®) in Healthy Male Subjects|Completed||Phase 1|138|Actual|Samsung Bioepis Co., Ltd.||6|||f||||f||||||||||2017-10-11 01:39:27.617506|2017-10-11 01:39:27.617506
NCT01865513|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2015-10-13|||June 2014||2014-06-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Observational|POPULAR||POPULAR: POst-operative PULmonary Complications After Use of Muscle Relaxants in Europe|POPULAR: POst-operative PULmonary Complications After Use of Muscle Relaxants in Europe - A European Prospective Multicenter Observational Study|Completed||N/A|22000|Actual|European Society of Anaesthesiology|||1||f||||f||||||||||2017-10-11 01:39:27.865989|2017-10-11 01:39:27.865989
NCT01865500|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-30|||January 2013||2013-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations||Completed||Phase 4|100|Actual|Ataturk University||3|||f||||f||||||||||2017-10-11 01:39:27.940721|2017-10-11 01:39:27.940721
NCT01865487|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-01-04|||August 2013||2013-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||A Phase I/IIa Safety & Immunogenicity of AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)|A Phase I/IIa Double-Blind, Randomized, Placebo-controlled Dose-Finding Study to Evaluate the Safety and Immunogenicity of AERAS-456 in HIV-Negative Adults With and Without Latent Tuberculosis Infection|Completed||Phase 1/Phase 2|98|Actual|Aeras||4|||f||||t||||||||||2017-10-11 01:39:28.026932|2017-10-11 01:39:28.026932
NCT01865474|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-28|2016-08-03|||May 2013||2013-05-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus|DLBS1033 Therapy in Improving Hypercoagulation State in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|122|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 01:39:28.115965|2017-10-11 01:39:28.115965
NCT01865461|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2017-08-21|||June 2013||2013-06-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|HEPAT_MR||Evaluation of MRI Sequences in Hepatic Overload|Evaluation of MRI Sequences in Hepatic Overload.|Recruiting||N/A|300|Anticipated|Rennes University Hospital|||1||f||||t||||||||||2017-10-11 01:39:28.203012|2017-10-11 01:39:28.203012
NCT01865435|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-09-29|||March 2014||2014-03-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||IN UTERO SMOKING AND PREMATURE CELLULAR SENESCENCE|IN UTERO SMOKING AND PREMATURE CELLULAR SENESCENCE|Completed||N/A|40|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:39:28.578131|2017-10-11 01:39:28.578131
NCT01865422|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-08-29|||May 2013||2013-05-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|PC-QOL||French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL)|French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL)|Completed||N/A|120|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:39:28.652651|2017-10-11 01:39:28.652651
NCT01865409|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2014-09-07|||June 2013||2013-06-01|September 2014|2014-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Effect of Kangaroo Care on Heart Rate Variability|Does Kangaroo Care Effects on Heart Rate Variability in Neonates|Unknown status|Recruiting|N/A|30|Anticipated|Fatih University||1|||f||||t||||||||||2017-10-11 01:39:28.730206|2017-10-11 01:39:28.730206
NCT01865396|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-07-01|||April 2013||2013-04-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|IPaC||Effect of Early Palliative Care on Quality of Life of Patients With Advanced Cancer: a Randomised Controlled Trial.|Effect of Early Palliative Care on Quality of Life of Patients With Advanced Cancer: a Randomised Controlled Trial.|Active, not recruiting||N/A|186|Anticipated|University Ghent||2|||f||||f||||||||||2017-10-11 01:39:28.819766|2017-10-11 01:39:28.819766
NCT01865383|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-04-17|||July 2013||2013-07-01|April 2017|2017-04-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania|Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania|Active, not recruiting||N/A|2623|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||Yes|Data will be made available on request, and per NIH regulations.|2017-10-11 01:39:28.904226|2017-10-11 01:39:28.904226
NCT01865370|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-05-27|||November 2011||2011-11-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects||Completed||Phase 2/Phase 3|30|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 01:39:29.003843|2017-10-11 01:39:29.003843
NCT01865357|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-03-10|||August 2012||2012-08-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SCI-COG||Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRI|"Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRI:SCI-COG Study"|Active, not recruiting||N/A|120|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 01:39:29.074234|2017-10-11 01:39:29.074234
NCT01865344|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-12-03|||May 2013||2013-05-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Skin Conductance Fluctuations Per Sec and NRS to Monitor Pain|A Pilot Study for the PainMonitor During Standardized Painful Stimuli and no Stimuli to Calculate the Sensitivity and Specificity and Thereby the Accuracy of the Monitor|Completed||N/A|20|Actual|Oslo University Hospital|||1||f||||t||||||||||2017-10-11 01:39:29.156195|2017-10-11 01:39:29.156195
NCT01865331|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-01-14|||December 2006||2006-12-01|January 2016|2016-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects|A Randomised, Double-blind, Placebo-controlled, Single-dose, Parallel Group Trial With Insulin 454 and SIAM 50 in Healthy Male Japanese Subjects|Completed||Phase 1|32|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 01:39:29.228323|2017-10-11 01:39:29.228323
NCT01865318|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-10-21|||September 2006||2006-09-01|October 2015|2015-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes|A Single Centre, Open-Label, Multiple Dose Trial Examining the Pharmacodynamic Characteristics of Insulin 454 Under Single-Dose and Steady-State Conditions in Male Subjects With Type 1 Diabetes|Completed||Phase 1|36|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 01:39:29.318497|2017-10-11 01:39:29.318497
NCT01865305|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-10-22|||September 2006||2006-09-01|October 2015|2015-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes|A Randomised, Double-blind, Multiple Period Crossover Trial Comparing Insulin 454 and Insulin Aspart Premixes With Separately Injected, Simultaneous Doses of Insulin 454 and Insulin Aspart, Compared With Biphasic Insulin Aspart 30 (NovoMix® 30) in Male Subjects With Type 1 and Type 2 Diabetes Mellitus|Completed||Phase 1|59|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:39:29.500755|2017-10-11 01:39:29.500755
NCT01865292|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-10-16|||August 2006||2006-08-01|October 2015|2015-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes|A Randomised, Double-Blind, Single Dose, Six-Period Cross-over Dose Response Trial Comparing the Pharmacodynamics and Pharmacokinetics of Insulin 454 With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes|Completed||Phase 1|40|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:39:29.619525|2017-10-11 01:39:29.619525
NCT01865279|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2015-10-22|||December 2005||2005-12-01|October 2015|2015-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec|A Randomised, Double-blind, Placebo-controlled Single Dose, Dose Escalation Trial With Insulin 454 in Healthy Male Subjects, Followed by a Two-period Cross-over Trial With Insulin 454 and Insulatard® in Male Subjects With Type 1 and Type 2 Diabetes Mellitus|Completed||Phase 1|64|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:39:29.717193|2017-10-11 01:39:29.717193
NCT01865266|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2013-05-29|||January 2014||2014-01-01|May 2013|2013-05-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia|The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia|Unknown status|Not yet recruiting|Phase 2/Phase 3|60|Anticipated|Shanghai Minhang Central Hospital||3|||f||||t||||||||||2017-10-11 01:39:29.828844|2017-10-11 01:39:29.828844
NCT01865253|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-07-20|||May 2012||2012-05-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|RDNP-2012-03||Renal Denervation for Complicated Hypertension|Renal Denervation for Complicated Hypertension (RDNP-2012-03)|Terminated||Phase 4|23|Actual|Baker IDI Heart and Diabetes Institute||1||No new participants enrolled. Protocol superseded.|f||||f||||||||||2017-10-11 01:39:29.954118|2017-10-11 01:39:29.954118
NCT01865240|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2016-07-20|||February 2012||2012-02-01|July 2016|2016-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|RDNP-2012-01||Renal Denervation for Resistant Hypertension|Renal Denervation for Resistant Hypertension|Terminated||Phase 4|5|Actual|Baker IDI Heart and Diabetes Institute||2||No new participants enrolled. Protocol has been superseded|f||||f||||||||||2017-10-11 01:39:30.059911|2017-10-11 01:39:30.059911
NCT01865227|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2013-06-13|||November 2012||2012-11-01|June 2013|2013-06-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Obesity Surgery, Counseling, and Psychological Well-Being|Impact of Counseling on Obesity Surgery Outcomes and Psychological Functioning: A Randomized Clinical Trial in 2 Arab Countries|Unknown status|Recruiting|N/A|100|Anticipated|American University of Sharfah||2|||f||||f||||||||||2017-10-11 01:39:30.161946|2017-10-11 01:39:30.161946
NCT01865201|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2013-12-11|||March 2009||2009-03-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis|Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis in Patients With Nasopharyngeal Carcinoma After Radiotherapy|Completed||Phase 2|154|Actual|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 01:39:30.263425|2017-10-11 01:39:30.263425
NCT01865188|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2014-08-04|||April 2014||2014-04-01|August 2014|2014-08-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension|An 8-week Randomized, Double-blind, Placebo-controlled Factorial Study to Evaluate the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Essential Hypertension|Withdrawn||Phase 3|0|Actual|Novartis||9|||f||||t||||||||||2017-10-11 01:39:30.365304|2017-10-11 01:39:30.365304
NCT01865175|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2016-09-12|||January 2016||2016-01-01|September 2016|2016-09-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron|A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron|Withdrawn||Phase 4|0|Actual|Milton S. Hershey Medical Center||2||Institution required IND, although FDA did not, so institution did not allow enrollment|f||||f||||||||||2017-10-11 01:39:30.502746|2017-10-11 01:39:30.502746
NCT01865162|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-03-17|||January 2013||2013-01-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|KGDinGBM||Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study|Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study|Recruiting||Phase 1|6|Anticipated|Mid-Atlantic Epilepsy and Sleep Center, LLC||1|||f||||f||||||||Undecided||2017-10-11 01:39:30.600588|2017-10-11 01:39:30.600588
NCT01865149|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-26|||May 2013||2013-05-01|May 2013|2013-05-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||Comparison of Optic Nerve Sheath Diameter on Retrobulbar Ultrasonography Before and After Drainage of Cerebrospinal Fluid in Pediatric Patient With Hydrocephalus||Unknown status|Recruiting|N/A|38|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 01:39:30.712097|2017-10-11 01:39:30.712097
NCT01865136|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-26|2016-08-30|||September 2013||2013-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Post-abortion Care and Contraceptive Counselling by Midwives or Physicians|Post-abortion Care and Contraceptive Counselling by Midwives or Physicians - a Randomized Controlled Trial in Kisumu, Western Kenya|Completed||Phase 4|890|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 01:39:30.810147|2017-10-11 01:39:30.810147
NCT01865123|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-08-03|||June 2013||2013-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A RCT of Meditation Compared to Exposure Therapy and Education Control on PTSD in Veterans|A Randomized Controlled Trial of Meditation Compared to Exposure Therapy and Education Control on PTSD in Veterans|Completed||N/A|200|Actual|United States Department of Defense||3|||f||||t||||||||Undecided||2017-10-11 01:39:30.912533|2017-10-11 01:39:30.912533
NCT01865110|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-09-08|||November 2013||2013-11-01|September 2016|2016-09-01|March 2024|Anticipated|2024-03-01|June 2021|Anticipated|2021-06-01||Interventional|||R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL|Efficacy of Alternating Immunochemotherapy Consisting of R-CHOP + R-HAD vs R-CHOP Alone, Followed by Maintenance Therapy Consisting of Additional Lenalidomide + Rituximab vs Rituximab Alone for Older Patients With Mantle Cell Lymphoma|Recruiting||Phase 3|633|Anticipated|The Lymphoma Academic Research Organisation||4|||f||||t||||||||||2017-10-11 01:39:31.072792|2017-10-11 01:39:31.072792
NCT01865097|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2014-11-05|||June 2013||2013-06-01|November 2014|2014-11-01||||December 2015|Anticipated|2015-12-01||Interventional|||Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease|Pilot Study of Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease|Unknown status|Enrolling by invitation|Phase 1|50|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 01:39:32.174963|2017-10-11 01:39:32.174963
NCT01865084|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-01-10|2016-09-30||September 2013||2013-09-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional||All participants who were randomized to study drug.|A Study of Tadalafil for Duchenne Muscular Dystrophy|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Tadalafil for Duchenne Muscular Dystrophy|Terminated||Phase 3|331|Actual|Eli Lilly and Company|The Sponsor concluded that the efficacy results do not provide sufficient justification for continuance of the open-label extension (OLE) period of the study, where all participants were receiving daily treatment with tadalafil.|3||The study is being terminated for lack of efficacy|f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 01:39:32.286578|2017-10-11 01:39:32.286578
NCT01865071|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2014-02-04|||September 2011||2011-09-01|February 2014|2014-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Early Closure of Temporary Loop Ileostomy After Rectal Resection for Cancer|Early Closure of Temporary Loop Ileostomy After Rectal Resection for Cancer|Unknown status|Recruiting|N/A|150|Anticipated|Odense University Hospital||1|||f||||f||||||||||2017-10-11 01:39:33.996944|2017-10-11 01:39:33.996944
NCT01865058|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-26|||June 2011||2011-06-01|May 2013|2013-05-01|August 2014|Anticipated|2014-08-01|February 2014|Anticipated|2014-02-01||Observational|||The Use of PET for the Early Response Evaluation in Patients With Diffuse Large B-cell Lymphoma.|The Use of 18 F-FDG Positron Emission Tomography (PET) in the Early Response Evaluation of Diffuse Large B-cell Lymphoma.|Unknown status|Recruiting|N/A|50|Anticipated|Odense University Hospital|||1||f||||f||||||||||2017-10-11 01:39:34.11402|2017-10-11 01:39:34.11402
NCT01865045|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-27|2017-02-09|||November 2012||2012-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients|Pharmacogenetics of Vinorelbine in Malignant Pleural Mesothelioma Patient|Active, not recruiting||N/A|150|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples Without DNA|"     tissue   "|No|not planned|2017-10-11 01:39:34.207894|2017-10-11 01:39:34.207894
NCT01865019|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-05-26|||April 2013||2013-04-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01|7 Days|Observational [Patient Registry]|||Pressure Controlled Versus Volume Controlled Mechanical Ventilation During Anesthesia for Living Donor Liver Transplantation Recipients||Unknown status|Recruiting|N/A|60|Anticipated|Mansoura University|||2||f||||f||||||||||2017-10-11 01:39:34.359396|2017-10-11 01:39:34.359396
NCT01865006|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-05-26|||May 2013||2013-05-01|May 2013|2013-05-01||||April 2014|Anticipated|2014-04-01||Observational|||Phoniatric Evaluation and Comparison of Patients Who Underwent Sutureless Thyroidectomy With Vessel Closure Devices and Conventional Total Thyroidectomy With Suture|Phoniatric Evaluation and Comparison of Patients Who Underwent Sutureless Thyroidectomy With Vessel Closure Devices and Conventional Total Thyroidectomy With Suture|Unknown status|Recruiting|N/A|90|Anticipated|Istanbul University|||3||f||||||||||||||2017-10-11 01:39:34.43316|2017-10-11 01:39:34.43316
NCT01864993|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2016-02-22|||March 2013||2013-03-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|Glutox||Symptomatic Response to Gluten Challenge in Patients With Suspected Non Celiac Gluten Sensitivity|Glutox Trial. Symptomatic Response to Gluten Challenge in Patients With Suspected Non Celiac Gluten Sensitivity: a Double Blind Crossover Controlled Trial|Completed||N/A|150|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||t||||||||||2017-10-11 01:39:34.518167|2017-10-11 01:39:34.518167
NCT01864980|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-05-26|||June 2013||2013-06-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Intra-operative Monitoring of Blood Loss|Monitoring of Intraoperative Blood Loss: Benefit of Continuous Noninvasive Haemoglobin Monitoring?|Completed||N/A|30|Actual|University Medical Center Groningen|||2||f||||f||||||||||2017-10-11 01:39:34.607981|2017-10-11 01:39:34.607981
NCT01864967|ClinicalTrials.gov processed this data on October 10, 2017|2008-11-23|2013-05-23|||March 2007||2007-03-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Observational|||Carbon Dioxide Infusion:Clinical and Histological Appraisal in Chronic Wounds|Carbon Dioxide Infusion:Clinical and Histological Appraisal in Chronic Wounds|Completed||N/A|10|Actual|Institute of Assistance in Plastic Surgery, Sao Paulo|||2||f||||f||||||||||2017-10-11 01:39:34.677881|2017-10-11 01:39:34.677881
NCT01864954|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-08-17|||December 2013||2013-12-01|August 2017|2017-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|StayQuit||Web and Phone Intervention to Maintain Postpartum Tobacco Abstinence|Web and Phone Intervention to Maintain Postpartum Tobacco Abstinence|Completed||N/A|62|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-10-11 01:39:34.741379|2017-10-11 01:39:34.741379
NCT01864941|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-11-09|||May 2013||2013-05-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|||Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients|Phase I/II Interventional Clinical Trial of Balloon Venoplasty for Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis Patients|Active, not recruiting||Phase 1/Phase 2|100|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 01:39:34.823381|2017-10-11 01:39:34.823381
NCT01864928|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-06-20|||July 2013||2013-07-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31|90 Days|Observational [Patient Registry]|RESOLVE||Rapid Evaluation for Stroke Outcomes Using Lytics in Vascular Event (RESOLVE) Registry and Implementation Quality Improvement Study|Reperfusion in Acute Stroke - Creating the Clinical Decision-Making Tool (RESOLVE)|Completed||N/A|192|Actual|Saint Luke's Health System|||1||f||||f||||||||||2017-10-11 01:39:34.90659|2017-10-11 01:39:34.90659
NCT01864915|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2017-02-14|||June 2013||2013-06-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule|Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule|Completed||Phase 3|60|Actual|Queen's University||3|||f||||t||||||||Yes|final analysis dataset shared with Janssen Inc (study sponsor)|2017-10-11 01:39:34.966836|2017-10-11 01:39:34.966836
NCT01864902|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-01-26|||April 2013||2013-04-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|CART33||Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33|Clinical Study of Chimeric CD(Cluster of Differentiation)33 Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Acute Myeloid Leukemias|Recruiting||Phase 1/Phase 2|10|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:39:35.056313|2017-10-11 01:39:35.056313
NCT01864889|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-01-26|||April 2013||2013-04-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|CART19||Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19|Clinical Study of Chimeric CD(Cluster of Differentiation)19 Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory B-cell Leukemias and Lymphomas|Recruiting||N/A|12|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:39:35.408046|2017-10-11 01:39:35.408046
NCT01864876|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2014-02-24|||September 2012||2012-09-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of GLA (5 mcg) on Human Volunteers|A Randomized, Single-Blinded Phase 1 Study to Evaluate the Safety and Immunogenicity of a Single Administration of 5 mcg GLA in Healthy Volunteers|Completed||Phase 1|17|Actual|IDRI||3|||f||||f||||||||||2017-10-11 01:39:35.503106|2017-10-11 01:39:35.503106
NCT01864863|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-10-19|||April 2013||2013-04-01|October 2016|2016-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers|An Open-label, Randomized, Single-dose, 2-way Crossover Study to Compare the Pharmacokinetics of Traclear 62.5 mg 2 Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers|Completed||Phase 1|28|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-11 01:39:35.603985|2017-10-11 01:39:35.603985
NCT01864850|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-03-23|||June 2013||2013-06-01|March 2015|2015-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|GORTEC-ELAN-RT||Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC|Non Inferiority Randomized Trial of Standard Radiotherapy Versus Hypofractionated Split Course Radiotherapy in Elderly Vulnerable Patients With Inoperable Head and Neck Squamous Cell Carcinoma|Recruiting||Phase 3|202|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||2|||f||||t||||||||||2017-10-11 01:39:35.743806|2017-10-11 01:39:35.743806
NCT01864837|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-24|||February 2013||2013-02-01|May 2013|2013-05-01|November 2013|Anticipated|2013-11-01|September 2013|Anticipated|2013-09-01||Observational|||Evaluation on the Availability of Tongue Diagnosis System|Availability of Tongue Diagnosis System for Assessing Tongue Coating Thickness of Patients With Functional Dyspepsia: Study Protocol for Comparative Trial With Conventional Method|Unknown status|Recruiting|N/A|60|Anticipated|Korea Health Industry Development Institute|||1||f||||f||||||||||2017-10-11 01:39:35.884324|2017-10-11 01:39:35.884324
NCT01864824|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-05-10|||June 2013||2013-06-01|May 2017|2017-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|EPI-Air||Air Pollution, Epigenetics and Cardiovascular Health: A Human Intervention Trial|Air Pollution, Epigenetics and Cardiovascular Health: A Human Intervention Trial|Completed||Phase 1|10|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 01:39:35.976047|2017-10-11 01:39:35.976047
NCT01864811|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-03-07|||September 2012||2012-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|B-CIMT||Effect of Baby-CIMT in Infants Younger Than 12 Months|The Efficacy of Constraint Induced Movement Therapy for Babies (Baby-CIMT) in Infants Below 12 Month With Risk of Developing Unilateral Cerebral Palsy, a Study Protocol of a Randomized Controlled Trial|Completed||N/A|35|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:39:36.103397|2017-10-11 01:39:36.103397
NCT01864798|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-09-01|||July 2013||2013-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|D-Beyond||A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer|A Pre‐Operative Window Study Evaluating Denosumab, a RANKligand (RANKL) Inhibitor and Its Biological Effects in Young Premenopausal Women Diagnosed With Early Breast Cancer|Terminated||Phase 2|27|Actual|Jules Bordet Institute||1||Poor recruitment|f||||f||||||||||2017-10-11 01:39:36.214906|2017-10-11 01:39:36.214906
NCT01864785|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2013-06-12|||February 2013||2013-02-01|June 2013|2013-06-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Comparison of Posterior Fixation Alone and Combined With Articular Process Fusion in Thoracolumbar Burst Fractures|Posterior Fixation Alone Versus Posterior Fixation Combined With Articular Process Fusion in Thoracolumbar Burst Fractures|Unknown status|Recruiting|N/A|60|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 01:39:36.338339|2017-10-11 01:39:36.338339
NCT01864772|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-03-23|||June 2013||2013-06-01|March 2015|2015-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|GORTEC-ELANFIT||Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC|Phase II Multicenter Trial Evaluating First Line Carboplatin, 5-Fluorouracil and Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer, Aged 70 and Over, Ranked as Fit (no Frailty) by Geriatric Assessment|Recruiting||Phase 2|82|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||1|||f||||t||||||||||2017-10-11 01:39:36.443151|2017-10-11 01:39:36.443151
NCT01864759|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-08-28|||January 11, 2013|Actual|2013-01-11|August 2017|2017-08-01|April 26, 2017|Actual|2017-04-26|December 20, 2016|Actual|2016-12-20||Interventional|||Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma|Phase I Clinical Trial of Endovenous Administration of Conditionally Replicative Adenovirus ICOVIR-5 in Patients With Locally Advanced or Metastatic Melanoma|Completed||Phase 1|14|Actual|Institut Català d'Oncologia||1|||f||||t||||||||||2017-10-11 01:39:36.536787|2017-10-11 01:39:36.536787
NCT01864746|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-08-15|||November 2013||2013-11-01|August 2017|2017-08-01|November 2023|Anticipated|2023-11-01|December 2020|Anticipated|2020-12-01||Interventional|PENELOPE-B||A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery|"Phase III Study Evaluating Palbociclib (PD-0332991), a Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor in Patients With Hormone-receptor-positive, HER2-normal Primary Breast Cancer With High Relapse Risk After Neoadjuvant Chemotherapy PENELOPEB"|Recruiting||Phase 3|1250|Anticipated|German Breast Group||2|||f||||t||||||||||2017-10-11 01:39:36.631508|2017-10-11 01:39:36.631508
NCT01864733|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-05-24|||May 2013||2013-05-01|May 2013|2013-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|NUTRICARD||Multimodal Approach of Undernutrition in Chronic Heart Failure|Multimodal Approach of Undernutrition in Chronic Heart Failure : a Controlled, Randomized Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:39:36.797973|2017-10-11 01:39:36.797973
NCT01864720|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-09-20|||September 2013||2013-09-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|Stepped Care||Stepped Care Model for the Wider Dissemination of Cognitive-Behavioural Therapy for Insomnia Among Cancer Patients|A Stepped Care Model for the Wider Dissemination of Cognitive-Behavioural Therapy for Insomnia Among Cancer Patients : Efficacy and Cost-Effectiveness.|Active, not recruiting||N/A|178|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 01:39:36.903751|2017-10-11 01:39:36.903751
NCT01864707|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-01-27|||April 2013||2013-04-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|MS-Fatigue||Acupuncture or MBSR for Patients With Fatigue and MS|Randomized Controlled Trial on the Efficacy of Acupuncture and the Efficacy of Mindfulness-Based Stress Reduction (MBSR) in Patients With Multiple Sclerosis Suffering From Fatigue|Completed||N/A|104|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 01:39:37.002073|2017-10-11 01:39:37.002073
NCT01864694|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-05-24|||November 2008||2008-11-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Improving Dietary Behavior Through Tailored Messages|Improving Dietary Behavior Through Tailored Messages|Completed||N/A|1224|Actual|Boston Medical Center||3|||f||||f||||||||||2017-10-11 01:39:37.107861|2017-10-11 01:39:37.107861
NCT01864681|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-25|2016-01-30|||May 2013||2013-05-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|December 2015|Actual|2015-12-01||Interventional|CGMT||Combination of Metformin With Gefitinib to Treat NSCLC|A Phase II, Randomized, Placebo Controlled Study to Evaluate the Efficacy of the Combination of Gefitinib and Metformin in Patients With Locally Advanced and Metastatic Non-Small-Cell-Lung-Cancer|Active, not recruiting||Phase 2|168|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:39:37.217756|2017-10-11 01:39:37.217756
NCT01864668|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-02-08|||June 2013||2013-06-01|May 2013|2013-05-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||the Influence of Tidal Volume to Lung Strain|the Influence of Different Tidal Volume to Lung Strain of ARDS Patients|Unknown status|Recruiting|N/A|25|Anticipated|Zhongda Hospital|||1||f||||f||||||||||2017-10-11 01:39:38.970474|2017-10-11 01:39:38.970474
NCT01864655|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2014-06-12|||July 2013||2013-07-01|June 2014|2014-06-01||||March 2014|Actual|2014-03-01||Interventional|||Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease|A Phase Ib Multiple Ascending Dose Study of the Safety, Tolerability, and CNS Availability of AZD0530 in Alzheimer's Disease|Completed||Phase 1|24|Actual|Yale University||4|||f||||t||||||||||2017-10-11 01:39:39.059795|2017-10-11 01:39:39.059795
NCT01864642|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-08-14|||July 2013||2013-07-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|OMT4OHT||Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects|A Study of the Effects of a Single Osteopathic Manipulative Treatment (OMT) on Intraocular Pressure (IOP)in Un-medicated Confirmed Ocular Hypertensive (OHT) or Glaucoma Suspect Subjects|Completed||N/A|28|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 01:39:39.149207|2017-10-11 01:39:39.149207
NCT01864629|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-11|2017-02-02|||April 2013||2013-04-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|October 2014|Actual|2014-10-01||Interventional|||Optimizing Postpartum Contraception in Women With Preterm Births|Optimizing Postpartum Contraception in Women With Preterm Births|Completed||N/A|134|Actual|University of Utah||2|||f||||f||||||||No||2017-10-11 01:39:39.238788|2017-10-11 01:39:39.238788
NCT01864616|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-24|||July 2013||2013-07-01|May 2013|2013-05-01||||March 2014|Anticipated|2014-03-01||Interventional|||The Impact of Vitamin D on Disease Activity in Crohn's Disease||Unknown status|Not yet recruiting|Phase 2|60|Anticipated|University of Saskatchewan||3|||f||||||||||||||2017-10-11 01:39:39.316327|2017-10-11 01:39:39.316327
NCT01864603|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-06-07|||April 2013||2013-04-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|SEARCH||Sustainable East Africa Research in Community Health|Sustainable East Africa Research in Community Health|Recruiting||N/A|340000|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:39:39.44333|2017-10-11 01:39:39.44333
NCT01864577|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-24|||March 2012||2012-03-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Negative Pleural Suction for Tube Thoracostomy in Patients With Chest Trauma|Efficacy of Negative Pleural Suction in Tube Thoracostomy for Patients With Penetrating and/or Blunt Chest Trauma: a Randomized Clinical Trial|Completed||N/A|110|Actual|Universidad de Antioquia||2|||f||||||||||||||2017-10-11 01:39:39.691231|2017-10-11 01:39:39.691231
NCT01864551|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-05-24|||August 2008||2008-08-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|July 2009|Actual|2009-07-01||Interventional|OCTLPODEPWBD||Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder|Comparison of Olanzapine and Lamotrigine in the Prevention of Recurrence of Depressive Episode in the Patients With Bipolar Disorders|Completed||Phase 4|60|Actual|Tri-Service General Hospital||2|||f||||f||||||||||2017-10-11 01:39:40.036052|2017-10-11 01:39:40.036052
NCT01864538|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-08-23|2017-07-14||May 2013|Actual|2013-05-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma|A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma|Terminated||Phase 2|11|Actual|Threshold Pharmaceuticals||1||Lack of enrollment|f||||f||||||||||2017-10-11 01:39:40.14209|2017-10-11 01:39:40.14209
NCT01864525|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-04-25|||July 2013||2013-07-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|||Effects of Octanoic Acid for Treatment of Essential Voice Tremor|Effects of Octanoic Acid for Treatment of Essential Voice Tremor|Completed||Phase 1/Phase 2|17|Actual|Syracuse University||2|||f||||f||||||||No||2017-10-11 01:39:40.465058|2017-10-11 01:39:40.465058
NCT01864512|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-04-18|||March 2013||2013-03-01|June 2013|2013-06-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Observational|||Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment|A Prospective, Multicenter Study on the Alteration of Different Immune Parameters in ITP Patients Receiving Eltrombopag Treatment.|Withdrawn||N/A|0|Actual|Shandong University|||1|No eligible patient was enrolled.|f||||t||||||Samples With DNA|"     The biospecimens were retained for PCR, western blotting and FACS analysis.   "|||2017-10-11 01:39:40.571007|2017-10-11 01:39:40.571007
NCT01864499|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-10-10||||||October 2016|2016-10-01||||June 2015|Actual|2015-06-01||Interventional|||Perioperative Evaluation of Intracranial Hypertension by Ultrasound Measurement of Variations in the Diameter of the Sheath of the Optic Nerve in the Excision of a Tumor or Biopsy Supratentorial Brain||Completed||N/A|||Poitiers University Hospital||2|||f||||||||||||||2017-10-11 01:39:40.652763|2017-10-11 01:39:40.652763
NCT01864486|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-09-21|||April 2013||2013-04-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|October 2017|Anticipated|2017-10-01||Interventional|IRIS-1||Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy|Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy (Title in France: Compensation of Vision With the Intelligent Retinal Implant System (IRIS V1) in Patients With Retinal Dystrophy)|Active, not recruiting||N/A|20|Anticipated|Pixium Vision SA||1|||f||||t||||||||||2017-10-11 01:39:40.734901|2017-10-11 01:39:40.734901
NCT01864460|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-07-21|||November 14, 2013|Actual|2013-11-14|July 2017|2017-07-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|IMABIN||Improving Autonomic Function and Balance in Diabetic Neuropathy|Improving Autonomic Function and Balance in Diabetic Neuropathy|Recruiting||N/A|60|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:39:40.936783|2017-10-11 01:39:40.936783
NCT01864447|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-12-03|||May 2013||2013-05-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|TRAIN ABC||Exercise Training After an Acute Blood Clot|An Exercise Training and Behavioral Weight Loss Program After an Acute Blood Clot: TRAIN ABC|Completed||N/A|20|Actual|University of Vermont||2|||f||||t||||||||||2017-10-11 01:39:41.039715|2017-10-11 01:39:41.039715
NCT01864434|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-09-09|2014-12-15||June 2013||2013-06-01|September 2016|2016-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||In Vivo Kinematics Comparison of Stryker or Zimmer Total Knee Arthroplasty|In Vivo Comparison of Kinematics for Patients Implanted With Either a Stryker or a Zimmer Posterior Cruciate Retaining Total Knee Arthroplasty|Completed||N/A|50|Actual|The University of Tennessee, Knoxville|||2||f||||f||||||||||2017-10-11 01:39:41.151648|2017-10-11 01:39:41.151648
NCT01864421|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-02-25|||May 2013||2013-05-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|DoppCord||Physiological Effects of Deferred Cord Clamping|Delivery Room and Postnatal Assessment of the Physiological Effects of Deferred Cord Clamping on the Newborn: A Feasibility Study|Recruiting||N/A|60|Anticipated|University of Nottingham|||2||f||||f||||||Samples Without DNA|"     Umbilical Cord and Blood   "|||2017-10-11 01:39:41.567728|2017-10-11 01:39:41.567728
NCT01864408|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-04-21|||May 2012||2012-05-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|iPad||Interactive Web-Based Tool for Pelvic Organ Prolapse: Impact on Patient Understanding and Provider Counseling|Interactive Patient and Provider Counseling on Pelvic Organ Prolapse: Do Patients Better Understand and Do Providers Better Counsel|Completed||N/A|90|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:39:41.677416|2017-10-11 01:39:41.677416
NCT01864395|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-05-22|||July 2013||2013-07-01|May 2013|2013-05-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Interventional|MUF||Clinical and Chemical Outcomes Following Cardiac Surgery: The Post-Operative Effects of MUF|Clinical and Chemical Outcomes Following Cardiac Surgery: The Post-Operative Effects of Modified Ultrafiltration (On-line MUF) and Off-line (MUF)|Unknown status|Not yet recruiting|N/A|90|Anticipated|University of Saskatchewan||3|||f||||f||||||||||2017-10-11 01:39:41.781506|2017-10-11 01:39:41.781506
NCT01864382|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-09-15|||October 2012||2012-10-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Fisionet||"Core Stability Exercises to Improve Sitting Balance in Stroke Patients"|"Effects of the Inclusion of Exercises Core Stability in the Treatment of Inpatient Physiotherapy to Improve Balance in Post-stroke Patients Sitting in Subacute Phase. Randomized Clinical Trial."|Completed||N/A|80|Anticipated|Universitat Internacional de Catalunya||2|||f||||t||||||||||2017-10-11 01:39:41.917149|2017-10-11 01:39:41.917149
NCT01864369|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-06-18|||September 2013||2013-09-01|May 2013|2013-05-01|October 2016|Anticipated|2016-10-01|October 2015|Anticipated|2015-10-01||Interventional|CHF-CePPORT||Canadian e-Platform to Promote Behavioral Self-Management in Chronic Heart Failure: CHF-CePPORT|Canadian e-Platform to Promote Behavioral Self-Management in Chronic Heart Failure: CHF-CePPORT|Unknown status|Recruiting|N/A|298|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 01:39:42.154287|2017-10-11 01:39:42.154287
NCT01864356|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-11-18|||May 2013||2013-05-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Thrive-IVF||A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF)|A Randomized, Double Blind, Multi-Center, Placebo Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Doses Of NT100 Following IVF In Women With A History Of Repeated IVF Failures (Thrive-IVF)|Completed||Phase 2|157|Actual|Nora Therapeutics, Inc.||3|||f||||t||||||||||2017-10-11 01:39:42.289789|2017-10-11 01:39:42.289789
NCT01864343|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-24|||September 2011||2011-09-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Target Temperature Management In Myocardial Infarction - A Pilot Study|Target Temperature Management In Myocardial Infarction - A Pilot Study|Completed||N/A|19|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 01:39:42.473477|2017-10-11 01:39:42.473477
NCT01864330|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-11-26|||May 2013||2013-05-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome|Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome|Completed||Phase 4|60|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-10-11 01:39:42.585924|2017-10-11 01:39:42.585924
NCT01864317|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-12-01|||November 2016||2016-11-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging|Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging|Recruiting||Phase 2|120|Anticipated|Medical University of Vienna||4|||f||||t||||||||||2017-10-11 01:39:42.695848|2017-10-11 01:39:42.695848
NCT01864304|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-01-06|||December 2013||2013-12-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Fat Distribution and Glucose Metabolism in Williams Syndrome|Characterization of Fat Distribution and Glucose Metabolism in Individuals With and Without Williams Syndrome|Completed||N/A|24|Actual|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-11 01:39:42.826352|2017-10-11 01:39:42.826352
NCT01864291|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-10-03|||May 2013||2013-05-01|October 2017|2017-10-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|ABI||Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects|Study of the Nucleus 24 and ABI541 Auditory Brainstem Implants in Pediatric Non-Neurofibromatosis Type 2|Recruiting||N/A|15|Anticipated|Massachusetts Eye and Ear Infirmary||1|||f||||t||||||||||2017-10-11 01:39:42.916034|2017-10-11 01:39:42.916034
NCT01864278|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-11-07|||December 2012||2012-12-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|July 2015|Actual|2015-07-01|2 Years|Observational [Patient Registry]|||Lutonix Global SFA Registry|A Prospective, Global Multicenter, Single Arm Real-World Registry Investigating the Clinical Use and Safety of the LUTONIX Drug Coated PTA Dilatation Catheter|Completed||N/A|691|Actual|C. R. Bard|||1||f||||f||||||||||2017-10-11 01:39:43.056847|2017-10-11 01:39:43.056847
NCT01864265|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-05-16|||July 2013||2013-07-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|PreCePRA||Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain|Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain. A Multi-center, Randomized Double-blind Controlled Study Prediction of Response to Certolizumab-Pegol in RA (PreCePRA)|Recruiting||Phase 3|156|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 01:39:43.215126|2017-10-11 01:39:43.215126
NCT01864252|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-07-07|||January 2014||2014-01-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|ERIC-GTN||Investigation Into the Role of GTN & RIPC in Cardiac Surgery|The Effect of Remote Ischaemic Preconditioning and Glyceryl Trinitrate on Peri-operative Myocardial Injury in Cardiac Bypass Surgery Patients (ERIC-GTN Study)|Unknown status|Recruiting|Phase 3|260|Anticipated|University College, London||4|||f||||t||||||||||2017-10-11 01:39:43.396757|2017-10-11 01:39:43.396757
NCT01864239|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-05-26|||November 2012||2012-11-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Medicines Advice Service Evaluation|The Medicines Advice Service: A Randomised Controlled Trial of a Pharmacy-based Telephone Intervention to Support Patients Taking Medication for a Long-term Condition|Completed||N/A|677|Actual|University College, London||2|||f||||t||||||||||2017-10-11 01:39:43.514203|2017-10-11 01:39:43.514203
NCT01864226|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2016-11-01|||June 2013||2013-06-01|November 2016|2016-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 in Healthy Volunteers|A Single-Center, Randomized, Investigator/Subject-Blind, Adaptive Multiple Ascending-Dose, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 Following Oral Administration in Healthy Subjects.|Completed||Phase 1|44|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:39:43.617521|2017-10-11 01:39:43.617521
NCT01864187|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-03-11|||June 2013||2013-06-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Pharmacokinetics of Dexmedetomidine in Morbid Obesity|A Study of the Pharmacokinetics of Dexmedetomidine in Morbid Obesity.|Unknown status|Recruiting|Phase 4|20|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||1|||f||||f||||||||||2017-10-11 01:39:43.888269|2017-10-11 01:39:43.888269
NCT01864174|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-08-24|2017-05-31||June 20, 2013|Actual|2013-06-20|August 2017|2017-08-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional||All Treated Data Set (n=568) are the randomized participants who received at least 1 dose of study drug during the double blind treatment period (up to rescue). 29 participants were excluded from the baseline Randomized Data Set; therefore, the number of participants included in the baseline population is 539. n = number of evaluable participants|Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes|A 24-Week International, Multi-center, Randomized, Parallel-group, Double-blind Trial to Evaluate Metformin Extended Release Monotherapy Compared to Metformin Immediate Release Monotherapy in Adults Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise|Completed||Phase 4|1736|Actual|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-11 01:39:44.007274|2017-10-11 01:39:44.007274
NCT01864161|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2014-07-23|||October 2011||2011-10-01|January 2013|2013-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Endovenous Versus Liposomal Iron in CKD||Completed||Phase 4|100|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 01:39:45.019802|2017-10-11 01:39:45.019802
NCT01864148|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2017-03-23|2017-03-23|2016-12-20|August 2013||2013-08-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|SYNERGY|Intent-to-treat population: all randomized participants who received at least 1 dose of study treatment.|Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex|Completed||Phase 2|419|Actual|Biogen||5|||f||||t||||||||||2017-10-11 01:39:45.158869|2017-10-11 01:39:45.158869
NCT01864135|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-01-20|||March 2013||2013-03-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Interventional|IMPROD||Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging and Biomarkers|Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging|Completed||N/A|175|Actual|Turku University Hospital||1|||f||||f||||||||||2017-10-11 01:39:46.718407|2017-10-11 01:39:46.718407
NCT01864122|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-05-21|||January 2007||2007-01-01|May 2014|2014-05-01||||October 2010|Actual|2010-10-01||Observational|WHI||Predictive Value of Coronary Heart Disease (CHD) Biomarkers for CHD Death||Completed||N/A|2448|Actual|Tufts University|||1||f||||f||||||||||2017-10-11 01:39:46.797464|2017-10-11 01:39:46.797464
NCT01864109|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-08-02|||May 2013||2013-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma|A Phase II Trial of Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma|Recruiting||Phase 2|83|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:39:46.877393|2017-10-11 01:39:46.877393
NCT01864096|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-11-15|||October 2013||2013-10-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|MAST||The Metformin Active Surveillance Trial (MAST) Study|A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin in Reducing Progression Among Men on Expectant Management for Low Risk Prostate Cancer: The MAST (Metformin Active Surveillance Trial) Study|Recruiting||Phase 3|408|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 01:39:47.030048|2017-10-11 01:39:47.030048
NCT01864083|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-08-30|||May 2013|Actual|2013-05-01|August 2017|2017-08-01|August 29, 2017|Actual|2017-08-29|August 29, 2017|Actual|2017-08-29||Interventional|||FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients|FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients|Completed||Early Phase 1|30|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:39:47.18116|2017-10-11 01:39:47.18116
NCT01864070|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2014-07-18|||May 2014||2014-05-01|July 2014|2014-07-01||||May 2018|Anticipated|2018-05-01||Interventional|||Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease|Phase I Study of TheraSphere and Everolimus Among Patients With Neuroendocrine Tumors and Liver Only or Liver Dominant Disease|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:39:47.274736|2017-10-11 01:39:47.274736
NCT01864057|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-05-23|||January 2012||2012-01-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Pharmacokinetics of Thiamine in Breastfeeding Mothers and Infants|Pharmacokinetics of Thiamine in Breastfeeding Mothers and Infants|Completed||Phase 1|24|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:39:47.499173|2017-10-11 01:39:47.499173
NCT01864044|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-23|||September 2009||2009-09-01|May 2013|2013-05-01||||March 2011|Actual|2011-03-01||Observational|POLIT||Prospective Observational Lymphoedema Intensive Treatment||Completed||N/A|306|Actual|Thuasne|||1||f||||||||||||||2017-10-11 01:39:47.616315|2017-10-11 01:39:47.616315
NCT01864031|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-05-28|||January 1997||1997-01-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study|The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study Using Linked Electronic Health Records|Unknown status|Active, not recruiting|N/A|2240000|Actual|University College, London|||1||f||||t||||||||||2017-10-11 01:39:47.681024|2017-10-11 01:39:47.681024
NCT01864018|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||August 20, 2013|Actual|2013-08-20|June 2017|2017-06-01|October 22, 2018|Anticipated|2018-10-22|October 22, 2018|Anticipated|2018-10-22||Interventional|||Ixazomib Citrate, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis|Phase 1/2 Trial of Ixazomib in Combination With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis|Recruiting||Phase 1/Phase 2|51|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:39:47.807376|2017-10-11 01:39:47.807376
NCT01864005|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-04-28|2015-02-17||May 2013||2013-05-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|HouYi|Three randomized patients were excluded from the full analysis set (FAS) due to any of the following reasons: 1) did not meet exclusion requirments but was randomized, 2)post-treatment blood PRU was not available, 3) pre-treatment blood PRU was missing, and 4) use of prohibited medications.|A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS|A Multicentre, Open-label, Randomized, 6-week, Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel With Aspirin as Background Therapy in Chinese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)|Completed||Phase 4|60|Actual|AstraZeneca|(1) Sample size was relatively small. (2) Study duration with 6 weeks seemed limited. (3) Sampling time-points seemed relatively scarce, such as missing the time point for 1-hour and 4-hour after loading dose.|2|||f||||f||||||||||2017-10-11 01:39:48.055516|2017-10-11 01:39:48.055516
NCT01863992|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-09-19|||September 2013|Actual|2013-09-01|September 2017|2017-09-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|||The Quality of Life and Direct Financial Costs Associated With Home Ventilation of Children: A Prospective Study|The Quality of Life a Direct Financial Costs Associated With Home Ventilation of Children: A Prospective Study|Completed||N/A|90|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 01:39:48.63248|2017-10-11 01:39:48.63248
NCT01863979|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2013-05-23|||January 2007||2007-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||New Causes and Predictors for the Development of Atrial Fibrillation and Its Complications|New Causes and Predictors for the Development of Atrial Fibrillation and Its Complications|Completed||N/A|500|Actual|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 01:39:48.704958|2017-10-11 01:39:48.704958
NCT01863966|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-05-23|||March 2010||2010-03-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|AHW||Hot Water Drinking Therapy in Achalasia|Efficacy and Safety Study of Hot Water Drinking Therapy in Achalasia Patients|Unknown status|Recruiting|N/A|100|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 01:39:48.78433|2017-10-11 01:39:48.78433
NCT01863953|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-24|2015-01-16|2015-01-16||June 2013||2013-06-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension||Completed||Phase 2|112|Actual|Allergan||3|||f||||f||||||||||2017-10-11 01:39:48.947742|2017-10-11 01:39:48.947742
NCT01863940|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-10-07|||August 2013||2013-08-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|August 2014|Actual|2014-08-01||Interventional|||Continuous Infusion of Local Anesthetic for Post-operative Pain Control in Ukraine||Suspended||N/A|200|Anticipated|Massachusetts General Hospital||2||Political unrest in study country|f||||t||||||||||2017-10-11 01:39:49.412344|2017-10-11 01:39:49.412344
NCT01863927|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2014-05-07|||November 2014||2014-11-01|May 2014|2014-05-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||The Effect of Ventilated Vest on Thermoregulation During Exercise in Hot Environment|The Effect of Ventilated Vest on Thermoregulation During Exercise in Hot|Unknown status|Not yet recruiting|N/A|10|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 01:39:49.481487|2017-10-11 01:39:49.481487
NCT01863914|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-09-24|||November 2012||2012-11-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula|Effect of Rosuvastatin in the Mobilization of Endothelial Progenitor Cells and Graft Vascular Function Following Creation of Arteriovenous Fistula in Diabetic Patients With Chronic Renal Failure|Recruiting||Phase 2|80|Anticipated|National Cheng-Kung University Hospital||2|||f||||f||||||||No|The study is now still recruting new cases. This study included 50 cases so far and is followed under review by Institution Review Borad in National Cheng Kung University Hospital. Extension of the study period from Dec. 2016 to Dec. 2018 is expected according to the rectuiting rate to reach an estimated case number of 80 patients. Application of the extension to the IRB in National Cheng Kung University will be processed in October, 2016. Individual participant data will not be presented in public; only summarized data will be available once the study had been completed (target case number fulfilled).|2017-10-11 01:39:49.558907|2017-10-11 01:39:49.558907
NCT01863901|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-04-14|||April 2013||2013-04-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device|A Prospective, Non-Randomized, Unblinded Study Evaluating the Treatment With the Cryo-Touch III Device for Upper Limb Spasticity|Completed||N/A|19|Actual|MyoScience, Inc||1|||f||||f||||||||||2017-10-11 01:39:49.658037|2017-10-11 01:39:49.658037
NCT01863888|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-03-12|||October 2013||2013-10-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TERI-DYNAMIC||Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis|Exploratory Open Label Study to Investigate the Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Relapsing Forms of Multiple Sclerosis|Completed||Phase 3|70|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:39:49.735645|2017-10-11 01:39:49.735645
NCT01863875|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-04-06|||January 2013||2013-01-01|April 2016|2016-04-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Observational|||Language Proficiency and Quality of Life After Receiving Cochlear Implantation as a Child|Assessment of Listening, Speech, and Language Proficiency, and of Experienced Quality of Life in People Who Have Received Cochlear Implants as Children.|Recruiting||N/A|530|Anticipated|Oslo University Hospital|||2||f||||t||||||||No||2017-10-11 01:39:49.841434|2017-10-11 01:39:49.841434
NCT01863862|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-08-28|||August 2012||2012-08-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Organ Preservation in Elderly Patients With Rectal Cancer|Organ Preservation in Elderly Patients With Rectal Cancer: a Prospective Observational Study|Recruiting||N/A|90|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||1|||f||||f||||||||||2017-10-11 01:39:49.934356|2017-10-11 01:39:49.934356
NCT01863849|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-10-19|||August 2013||2013-08-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection|Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection (Trivalent, Seasonal Influenza Vaccine, Active Ingredient Content: 15 μgHA/Strain/0.5mL) for the Use in the Season 2013/2014 in Adult and Elderly Subjects|Completed||Phase 4|119|Actual|Fluart Innovative Vaccine Ltd, Hungary||1|||f||||||||||||||2017-10-11 01:39:50.068001|2017-10-11 01:39:50.068001
NCT01863836|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-09-19|||April 2013||2013-04-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study on the Influence of Fluoroscopy in the Diagnosis of Peripheral Lung Lesions With Endobronchial Ultrasound Guidance|Randomized Trial of Fluoroscopy Use for Radial Endobronchial Ultrasound-guided Biopsy of Peripheral Lung Lesions|Completed||N/A|133|Actual|Laval University||2|||f||||f||||||||No||2017-10-11 01:39:50.156044|2017-10-11 01:39:50.156044
NCT01863823|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-05-28|||August 2011||2011-08-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Effective Treatment of Oral Helicobacter Pylori With the Success Rate of Gastric Eradication|Director of Research Division|Completed||Phase 1/Phase 2|350|Actual|Ameritek USA||2|||f||||f||||||||||2017-10-11 01:39:50.240608|2017-10-11 01:39:50.240608
NCT01863810|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-05-28|||August 2013||2013-08-01|May 2013|2013-05-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain|Randomized, Double-blinded, Double-dummy, Active-controlled, Multi-center Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of KW21052 for 8 Weeks Compared to Pregabalin (Lyrica) in the Diabetic Patients With Neuropathic Pain|Unknown status|Not yet recruiting|Phase 3|394|Anticipated|KunWha Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:39:50.334471|2017-10-11 01:39:50.334471
NCT01863797|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-23|||June 2007||2007-06-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Trial on Early Induction Versus Expectant Management of Nulliparous Women With a Prolonged Latent Phase||Completed||N/A|138|Actual|Karolinska Institutet||2|||f||||||||||||||2017-10-11 01:39:50.465924|2017-10-11 01:39:50.465924
NCT01863784|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-05-10|||April 2013||2013-04-01|May 2016|2016-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic Function|An Open-Label Study to Evaluate the Pharmacokinetics of Multiple Oral Doses of 30 mg JNJ-38518168 in Subjects With Mild and Moderate Hepatic Impairment Compared With Subjects With Normal Hepatic Function|Completed||Phase 1|28|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 01:39:50.549358|2017-10-11 01:39:50.549358
NCT01863771|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-03-08|2016-10-13||March 15, 2013|Actual|2013-03-15|March 2017|2017-03-01|January 29, 2016|Actual|2016-01-29|January 29, 2016|Actual|2016-01-29||Interventional||Efficacy full analysis set for induction phase (FAS-I) included all participants who were treated in the induction phase.|A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.|A Phase 3 Multicenter, Placebo-controlled, Double-blind, Randomized-withdrawal Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis|Completed||Phase 3|144|Actual|Janssen Pharmaceutical K.K.||2|||f||||f||||||||||2017-10-11 01:39:50.661996|2017-10-11 01:39:50.661996
NCT01863732|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2016-08-03|||November 2013||2013-11-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|MEASURE 1 ext||Extension in AS: Sustainability of Benefits, Safety and Tolerability|An Extension Study to Evaluate the Sustainability of Clinical Benefits, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis|Active, not recruiting||Phase 3|274|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:39:51.653682|2017-10-11 01:39:51.653682
NCT01863719|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-08-10|||August 6, 2013|Actual|2013-08-06|April 5, 2017|2017-04-05|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Interventional|||Aerosolized and Intravenous Colistin in Healthy Adults|A Phase 1, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of Aerosolized Colistimethate Sodium After Multiple Doses Administered Separately or in Combination With Intravenous Colistimethate Sodium in Healthy Adults|Terminated||Phase 1|27|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4||Completion of cohort 3, safety concerns|f|||||t|f|||f|||||2017-10-11 01:39:51.979354|2017-10-11 01:39:51.979354
NCT01863706|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-03-25|||May 2013||2013-05-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage|Safety and Efficacy of Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage|Completed||Phase 1|400|Anticipated|Hormozgan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:39:52.109947|2017-10-11 01:39:52.109947
NCT01863693|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-08|||May 2013|Actual|2013-05-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)|AN OBSERVATIONAL STUDY OF AVASTIN® (BEVACIZUMAB) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED OVARIAN CANCER|Active, not recruiting||N/A|300|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:39:52.225345|2017-10-11 01:39:52.225345
NCT01863680|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-11-16|2015-11-16||July 2013||2013-07-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Safety analysis population included all the subjects who received at least one dose of study drug.|Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel|Open-label, Single-arm, Multicenter Phase III Trial to Evaluate the Efficacy and Safety of COL-1620 8% Vaginal Progesterone Gel for Luteal Phase Support in In-vitro Fertilization and Embryo Transfer (IVF/ET) Cycles in Japanese Women|Completed||Phase 3|178|Actual|Merck KGaA|This study was not a randomized controlled study and did not included an active control arm, however it was designed to allow for comparison with historical IVF-ET data from Japan.|1|||f||||f||||||||||2017-10-11 01:39:52.39139|2017-10-11 01:39:52.39139
NCT01863667|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-05|2015-09-29||July 8, 2013|Actual|2013-07-08|June 2017|2017-06-01|April 3, 2014|Actual|2014-04-03|April 3, 2014|Actual|2014-04-03||Interventional|||A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)|A Phase III, Multicenter, Double-Blind, Randomized Trial to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Subjects With Type 2 Diabetes Mellitus For Whom Metformin is Inappropriate Due to Intolerance or Contraindication|Terminated||Phase 3|65|Actual|Merck Sharp & Dohme Corp.|The study was terminated based on business decisions only, and not due to any unexpected safety or efficacy concerns.|2|||f||||t||||||||||2017-10-11 01:39:52.790397|2017-10-11 01:39:52.790397
NCT01863654|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-13|||May 16, 2010|Actual|2010-05-16|June 2017|2017-06-01|May 26, 2010|Actual|2010-05-26|May 26, 2010|Actual|2010-05-26||Interventional|||Bioequivalence Study of Montelukast 5 mg Chewable|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparations of Chewable Tablets of Montelukast 5 mg (Product of GlaxoSmithKline México, S.A. de C.V. vs. Singulair™, Merck Sharp & Dohme de México, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|32|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:39:53.16778|2017-10-11 01:39:53.16778
NCT01863641|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-28|||April 2013||2013-04-01|May 2013|2013-05-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Interventional|||The Effect of Calcitriol on Progress and Activity of Lupus Nephritis|The Effect of Calcitriol on Progress and Activity of Lupus Nephritis|Unknown status|Recruiting|Phase 2|50|Anticipated|Guilan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:39:53.273755|2017-10-11 01:39:53.273755
NCT01863628|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-03-14|||March 2013||2013-03-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Recognition and Early Intervention on Prodrome in Bipolar Disorders|Recognition and Early Intervention on Prodrome in Bipolar Disorders: a Longitudinal Prospective Study of the Offspring of Parents With Bipolar Disorder|Unknown status|Recruiting|N/A|120|Anticipated|Guangzhou Psychiatric Hospital||2|||f||||t||||||||||2017-10-11 01:39:53.397216|2017-10-11 01:39:53.397216
NCT01863615|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-07-13|||August 26, 2011|Actual|2011-08-26|July 2017|2017-07-01|September 23, 2011|Actual|2011-09-23|September 23, 2011|Actual|2011-09-23||Interventional|||Bioequivalence Study for an Isotretinoin|Bioequivalence Study for an Isotretinoin Pharmaceutical Preparation - Capsules. Crossover, Randomized, Single Dose, Two Treatments, Two Periods and Two Sequences With Meal (Breakfast) Study|Completed||Phase 1|36|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 01:39:53.551995|2017-10-11 01:39:53.551995
NCT01863602|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-11-08|||April 2009||2009-04-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Special Drug Use Investigation for LAMICTAL® (Long Term)|Special Drug Use Investigation for LAMICTAL (Long Term)|Completed||N/A|850|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 01:39:53.660201|2017-10-11 01:39:53.660201
NCT01863589|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2013-05-23|||February 2005||2005-02-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|June 2007|Actual|2007-06-01||Observational|||Drug Use Investigation for HEPSERA (Adefovir) Tablet|Drug Use Investigation for HEPSERA (Adefovir) Tablet|Completed||N/A|436|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 01:39:53.735175|2017-10-11 01:39:53.735175
NCT01863576|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-09-08|||March 2013||2013-03-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|||Effects of Omega-3 Supplementation on the Cytokine and Lipid Profiles in Patients With Chronic Chagas Cardiomyopathy|Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on the Cytokine and Lipid Profiles in Patients With Chronic Chagas Cardiomyopathy: a Randomized Controlled Clinical Trial|Completed||Early Phase 1|40|Actual|Evandro Chagas Institute of Clinical Research||2|||f||||f||||||||||2017-10-11 01:39:53.832464|2017-10-11 01:39:53.832464
NCT01863550|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-04-14|||November 2013||2013-11-01|April 2016|2016-04-01||||May 2016|Anticipated|2016-05-01||Interventional|||Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma|Randomized Phase III Trial of Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, Dexamethasone (CRd) Followed by Limited or Indefinite Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma|Recruiting||Phase 3|756|Anticipated|Eastern Cooperative Oncology Group||4|||f||||||||||||||2017-10-11 01:39:54.539461|2017-10-11 01:39:54.539461
NCT01863537|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-07-29|||May 2007||2007-05-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|September 2011|Actual|2011-09-01||Interventional|||Using Multimedia Technologies to Disseminate an HIV Prevention|Using Multimedia Technologies to Disseminate an HIV Prevention Program for Couples|Completed||N/A|253|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:39:58.650358|2017-10-11 01:39:58.650358
NCT01863524|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-12-05|||May 2013||2013-05-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Screening for Abdominal Aortic Aneurysm Using a Portable Transthoracic Echocardiography Among Patients With Acute Coronary Syndrome|Screening for Abdominal Aortic Aneurysm Using a Portable Transthoracic Echocardiography (TTE) Among Patients With Acute Coronary Syndrome in Intensive Cardiac Care Unit.|Completed||N/A|90|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||No||2017-10-11 01:39:58.729131|2017-10-11 01:39:58.729131
NCT01863511|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-01-27|||May 2013||2013-05-01|February 2015|2015-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TUF||Tolvaptan/Ultrafiltration in the Treatment of Acute Heart Failure|Primary Mode of Therapy in Acute Decompensated Heart Failure:Comparison Between Usual Care Plus Tolvaptan and Ultrafiltration.|Completed||Phase 4|45|Actual|The Christ Hospital||3|||f||||t||||||||||2017-10-11 01:39:58.810202|2017-10-11 01:39:58.810202
NCT01863498|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-01-06|||May 2013||2013-05-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|PectusEpiPCA||Prospective Trial: Pain Management After Pectus Excavatum Repair, Epidural Versus PCA|Prospective Randomized Trial: Pain Management After Pectus Excavatum Repair, Epidural Versus PCA|Recruiting||N/A|100|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||No||2017-10-11 01:39:58.927636|2017-10-11 01:39:58.927636
NCT01863485|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-02-04|||May 2013||2013-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China|Phase 1 Safety, Tolerability, and Pharmacokinetic Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China|Active, not recruiting||Phase 1|50|Anticipated|AnewPharma||1|||f||||f||||||||||2017-10-11 01:39:59.0444|2017-10-11 01:39:59.0444
NCT01863472|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2016-11-18|||June 2013||2013-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation|Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation|Completed||N/A|152|Actual|Cardioangiologisches Centrum Bethanien||2|||f||||f||||||||||2017-10-11 01:39:59.130864|2017-10-11 01:39:59.130864
NCT01863459|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-08-01|||April 2013||2013-04-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity|Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity|Completed||Phase 4|42|Actual|Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada||2|||f||||f||||||||||2017-10-11 01:39:59.233727|2017-10-11 01:39:59.233727
NCT01863446|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-27|||May 2013||2013-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Light on Melatonin and Contractions in Pregnant Women|Effects of Light on Melatonin and Contractions in Pregnant Women|Recruiting||N/A|40|Anticipated|Brigham and Women's Hospital||3|||f||||f||||||||||2017-10-11 01:39:59.357518|2017-10-11 01:39:59.357518
NCT01863433|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2014-01-14|2013-11-26||May 2013||2013-05-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers|A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2013/2014 Formulation of a bioCSL Split Virion, Inactivated Influenza Vaccine in Healthy Volunteers Aged 18-60 Years|Completed||Phase 4|120|Actual|Seqirus||1|||f||||f||||||||||2017-10-11 01:40:01.118801|2017-10-11 01:40:01.118801
NCT01863407|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2013-05-28|||April 2013||2013-04-01|May 2013|2013-05-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI)|A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Parallel Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI) in Subjects Undergoing Abdominal Operation|Unknown status|Recruiting|Phase 3|480|Anticipated|Beijing Bozhiyin T&S Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:40:01.622852|2017-10-11 01:40:01.622852
NCT01863394|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-07-14|||May 2013||2013-05-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|MàLÉ||Evaluation of Two Community Based Screening Strategies for Severe Acute Malnutrition in Children 6-59 Months in Mirria District, Niger|Evaluation of Two Community Based Screening Strategies for Severe Acute Malnutrition in Children Aged 6-59 Months in the Mirria District, Niger|Completed||N/A|4429|Anticipated|Alliance for International Medical Action||2|||f||||t||||||||||2017-10-11 01:40:01.834742|2017-10-11 01:40:01.834742
NCT01863381|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-08-09|||September 2014||2014-09-01|August 2017|2017-08-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement|Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol|Terminated||N/A|5|Actual|LifeBridge Health||1||Inadequate enrollment|f||||f||||||||||2017-10-11 01:40:01.986826|2017-10-11 01:40:01.986826
NCT01863368|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2015-07-09|2015-06-17||September 2013||2013-09-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||This analysis group includes all randomized subjects.|Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining|Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining|Completed||N/A|105|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:40:02.096069|2017-10-11 01:40:02.096069
NCT01863355|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-22|||May 2013||2013-05-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Comparison of Analgesic Efficacy and Occurrence of Emesis Among Different Background Infusion and Bolus Administration Regimens of Fentanyl Based Intravenous Patient-controlled Analgesia in Patients After Laparoscopic Assisted Gastrectomy - a Randomized Blind Study -||Unknown status|Recruiting|N/A|225|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-11 01:40:03.709407|2017-10-11 01:40:03.709407
NCT01863342|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-22|||May 2013||2013-05-01|May 2013|2013-05-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||Influence of Central Sensitization on Efficacy of Patient-controlled Epidural Analgesia in Osteoarthritis Patients Undergoing Total Knee Replacement||Unknown status|Recruiting|N/A|98|Anticipated|Yonsei University|||2||f||||f||||||||||2017-10-11 01:40:03.833792|2017-10-11 01:40:03.833792
NCT01863329|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-24|||March 2013||2013-03-01|May 2013|2013-05-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Comparison of Optic Nerve Sheath Diameter on Retrobulbar Ultrasound Before and After Drainage of Cerebrospinal Fluid in Patient With Hydrocephalus||Unknown status|Recruiting|N/A|38|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 01:40:03.920706|2017-10-11 01:40:03.920706
NCT01863316|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-22|||May 2013||2013-05-01|May 2013|2013-05-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Comparison of the Clinical Efficacy Between I-gel and LMA-Supreme, the Two Most Recently Developed Supraglottic Airway Devices, in Infants||Unknown status|Recruiting|N/A|100|Anticipated|Yonsei University||2|||f||||||||||||||2017-10-11 01:40:03.996102|2017-10-11 01:40:03.996102
NCT01863303|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-24|||June 2012||2012-06-01|May 2013|2013-05-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||Epidemiological Study of Colorectal Cancer in WuHan|Epidemiological Study of Colorectal Cancer in WuHan|Active, not recruiting||N/A|1|Anticipated|Wuhan Pu-Ai Hospital|||1||f||||t||||||Samples With DNA|"     Blood sample or neoplasm from high risk group   "|||2017-10-11 01:40:04.082197|2017-10-11 01:40:04.082197
NCT01863290|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-08-23|||May 2013||2013-05-01|August 2016|2016-08-01||||May 2016|Actual|2016-05-01||Observational|||Linking Former Inmates to Primary Care|Transitions Clinic Network: Linking High-Risk Medicaid Patients From Prison to Community Primary Care|Active, not recruiting||N/A|816|Actual|Yale University|||1||f||||f||||||||||2017-10-11 01:40:04.154581|2017-10-11 01:40:04.154581
NCT01863277|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-24|||July 2013||2013-07-01|April 2013|2013-04-01||||April 2014|Anticipated|2014-04-01||Interventional|||Safety Study of Melatonin in Stroke Patients|A Double Blind, Placebo Controlled Study to Evaluate the Efficacy of Melatonin in Acute Ischemic Stroke.|Unknown status|Not yet recruiting|Phase 4|140|Anticipated|Wolfson Medical Center||2|||f||||f||||||||||2017-10-11 01:40:04.253204|2017-10-11 01:40:04.253204
NCT01863264|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-12-29|||December 2013||2013-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effects of Cold Liquids on the Swallowing Mechanism in Preterm Infants|A Pilot Study on The Effects of Cold Liquids on the Pharyngeal Swallow in Preterm Infants With Dysphagia.|Completed||N/A|10|Actual|Winthrop University Hospital||1|||f||||f||||||||||2017-10-11 01:40:04.348806|2017-10-11 01:40:04.348806
NCT01863251|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-04-25|||May 2013||2013-05-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia|Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia|Completed||Phase 2|90|Actual|Yale University||2|||f||||f|f|f|||f|||||2017-10-11 01:40:04.450042|2017-10-11 01:40:04.450042
NCT01863238|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-08-22|||May 2013||2013-05-01|July 2015|2015-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis|An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis|Completed||N/A|95|Actual|Vertex Pharmaceuticals Incorporated|||1||f||||f||||||||||2017-10-11 01:40:04.558444|2017-10-11 01:40:04.558444
NCT01863225|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-05-08|||May 2013||2013-05-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia|A Phase 2 Multiple-Dose Study to Characterize the Pharmacokinetics of RVX000222 Capsule Formulation in Combination With Either Atorvastatin or Rosuvastatin in Patients With Dyslipidemia|Terminated||Phase 2|13|Actual|Resverlogix Corp||4|||f||||f||||||||||2017-10-11 01:40:04.865805|2017-10-11 01:40:04.865805
NCT01863212|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-05-22|||September 2010||2010-09-01|May 2013|2013-05-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|FTO||The Role of the FTO Gene in Reward System Activation in Obese and Healthy Subjects|Investigating the Role of the FTO Gene in Reward System Activation During Visual Presentation of Food Images With fMRI Technique|Unknown status|Recruiting|N/A|500|Anticipated|Uppsala University||2|||f||||t||||||||||2017-10-11 01:40:04.995567|2017-10-11 01:40:04.995567
NCT01863199|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-10-02|||May 2013||2013-05-01|October 2017|2017-10-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|Liberty||Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)|A Clinical Trial to Assess the Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Macular Degeneration (the LIBERTY Study).|Completed||Phase 4|60|Actual|Retinal Consultants of Arizona||3|||f||||f||||||||||2017-10-11 01:40:05.111248|2017-10-11 01:40:05.111248
NCT01863186|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-05-01||2015-02-12|June 2013||2013-06-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal|Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy, Safety, and Dose-Response Study of Lofexidine for Treatment of Opioid Withdrawal (Days 1-7) Followed by Open-Label, Variable Dose Lofexidine Treatment (Days 8-14)|Completed||Phase 3|603|Actual|US WorldMeds LLC||4|||f||||t||||||||||2017-10-11 01:40:05.222774|2017-10-11 01:40:05.222774
NCT01863173|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2013-05-22|||January 2012||2012-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Metoprolol on Thalassemia Cardiomyopathy|The Effect of Metoprolol Succinate on the Cardiac Function of Patients With Thalassemia Cardiomyopathy a Double Blind Randomized Study|Completed||Phase 2/Phase 3|45|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:40:05.367482|2017-10-11 01:40:05.367482
NCT01863160|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-02-19|||July 2013||2013-07-01|August 2013|2013-08-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-escalating Study to Assess Safety, Tolerability and Pharmacokinetics of 0.1% and 1.0% ZEP-3 Cream, Administered Topically in Healthy Volunteers.|Completed||Phase 1|22|Actual|Shulov Innovate for Science Ltd. 2012||2|||f||||t||||||||||2017-10-11 01:40:05.467461|2017-10-11 01:40:05.467461
NCT01863147|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-08-15|||July 2013||2013-07-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease|Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease|Completed||Phase 4|66|Actual|Wuhan General Hospital of Guangzhou Military Command||2|||f||||t||||||||||2017-10-11 01:40:05.564453|2017-10-11 01:40:05.564453
NCT01863134|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2013-08-19|2013-05-30||January 2005||2005-01-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up||Completed||Phase 4|140|Actual|Medical University of Silesia||2|||f||||t||||||||||2017-10-11 01:40:05.664429|2017-10-11 01:40:05.664429
NCT01863121|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-04-27|||May 2013||2013-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver Cirrhosis|A Prospective Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver Cirrhosis|Recruiting||N/A|500|Anticipated|Sir Ganga Ram Hospital|||1||f||||f||||||||||2017-10-11 01:40:05.938168|2017-10-11 01:40:05.938168
NCT01863108|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-06-28|||June 2013||2013-06-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|GeniusVac-Mel4||Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma|Dose-escalation Study to Assess the Safety and Tolerability of Sub-cutaneous Injections of a Peptide-loaded Plasmacytoid Dendritic Cell Line (GeniusVac-Mel4) in Patients With Melanoma|Recruiting||Phase 1|15|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 01:40:06.041155|2017-10-11 01:40:06.041155
NCT01863095|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-01-29|||October 2014||2014-10-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||An Exercise App to Reduce Young Adults' MJ Use|Use of Exercise to Reduce Young Adult Marijuana Use: There is an App for That|Completed||N/A|36|Actual|State University of New York at Buffalo||2|||f||||t||||||||||2017-10-11 01:40:06.155414|2017-10-11 01:40:06.155414
NCT01863082|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-03-19|||November 2011||2011-11-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|HAR||Resistant Hypertension and Physical Activity Performed in a Heated Pool|Effects of Training in a Heated Pool in Patients With Refractory Hypertension|Unknown status|Recruiting|N/A|28|Anticipated|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 01:40:06.237059|2017-10-11 01:40:06.237059
NCT01863069|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-22|||January 2001||2001-01-01|May 2013|2013-05-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|C-851||Avonex®: Safety, Blood Levels and Effects|A Single-centre Study to Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of a New Inhaled Formulation of AVONEX® (Interferon Beta-1a) in Healthy Volunteers|Completed||Phase 1|77|Actual|Trio Medicines Ltd.|||||f||||f||||||||||2017-10-11 01:40:06.332694|2017-10-11 01:40:06.332694
NCT01863043|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-02-06|||August 20, 2013|Actual|2013-08-20|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|January 26, 2017|Actual|2017-01-26||Interventional|||Aspiration of Residual Gastric Contents|Routine Aspiration of Residual Gastric Contents in Very Low Birth Weight Infants|Active, not recruiting||N/A|146|Actual|University of Florida||2|||f||||f|f|f||||||Undecided||2017-10-11 01:40:06.633155|2017-10-11 01:40:06.633155
NCT01863017|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-09-22|||April 2013||2013-04-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome|Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation- Induced Modulation of Hyperphagia in Prader-Willi Syndrome|Recruiting||N/A|60|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 01:40:06.86176|2017-10-11 01:40:06.86176
NCT01863004|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-09-20|||December 2012||2012-12-01|September 2017|2017-09-01|September 15, 2017|Actual|2017-09-15|September 15, 2017|Actual|2017-09-15||Interventional|Dysferlin||Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin|Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin|Terminated||Phase 1|3|Actual|University Hospital, Basel, Switzerland||1||insufficient enrollment rate|f||||t||||||||||2017-10-11 01:40:07.001133|2017-10-11 01:40:07.001133
NCT01862991|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-04-26|2017-02-07||July 2013||2013-07-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|POEM||Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services|Protocol Title: Reducing Complications and Patient Barriers in Second Trimester Abortion: Pre-Operative Effects of Mifepristone (POEM) on Dilatation and Evacuation Services|Completed||N/A|80|Actual|Stanford University||3|||f||||t||||||||||2017-10-11 01:40:07.10776|2017-10-11 01:40:07.10776
NCT01862978|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-08-14|||May 2013||2013-05-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|Heparinas||Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke|Monitoring the Efficacy and Safety of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke|Unknown status|Recruiting|Phase 4|150|Anticipated|University Hospital, Martin||3|||f||||f||||||||||2017-10-11 01:40:07.486531|2017-10-11 01:40:07.486531
NCT01862965|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-05-07|||October 2012||2012-10-01|May 2017|2017-05-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|PredEver first||Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus|Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus (PredEver First) - A Prospective Multicenter Phase IIA Study -|Active, not recruiting||Phase 2|38|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||t||||||||||2017-10-11 01:40:07.646143|2017-10-11 01:40:07.646143
NCT01862939|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-05-24|||April 2011||2011-04-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus|A Double Blind, Placebo-Controlled, Randomized, Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|52|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||||2017-10-11 01:40:07.962895|2017-10-11 01:40:07.962895
NCT01862926|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-06-07|||November 2014|Actual|2014-11-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|RECITAL||Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD|A Randomized, Double Blind Controlled Trial Comparing Rituximab Against Intravenous Cyclophosphamide in Connective Tissue Disease Associated Interstitial Lung Disease|Recruiting||Phase 2/Phase 3|116|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:40:08.112459|2017-10-11 01:40:08.112459
NCT01862913|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-11-08|||June 2013||2013-06-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|YPSA-M||Computer-Assisted Cognitive-Behavioral Therapy for Adolescent Depression|Computer-Assisted Cognitive-Behavioral Therapy for Adolescent Depression in Primary Care Clinics in Santiago, Chile (YPSA-M): A Randomized Controlled Trial|Completed||N/A|216|Actual|University of Chile||2|||f||||f||||||||||2017-10-11 01:40:08.28768|2017-10-11 01:40:08.28768
NCT01862900|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-08-08|||February 2013||2013-02-01|August 2017|2017-08-01|February 2023|Anticipated|2023-02-01|February 2018|Anticipated|2018-02-01||Interventional|OX40 Breast||Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions|Phase I/II Study of Stereotactic Body Radiation Therapy to Metastatic Lesions in the Liver or Lung in Combination With Monoclonal Antibody to OX40 (MEDI6469) in Patients With Progressive Metastatic Breast Cancer After Systemic Therapy.|Active, not recruiting||Phase 1/Phase 2|14|Actual|Providence Health & Services||3|||f||||f||||||||||2017-10-11 01:40:08.845898|2017-10-11 01:40:08.845898
NCT01862887|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-08-14|||April 2013||2013-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study to Investigate the Effect of PH-797804 on QTc Interval|A Phase 1, Randomized, Placebo-And Positive-Controlled Crossover Study To Determine The Effect Of A Single-Dose Of PH-797804 On QTc Interval In Healthy Volunteers|Completed||Phase 1|48|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:40:08.976023|2017-10-11 01:40:08.976023
NCT01862874|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-10-05|||June 27, 2013|Actual|2013-06-27|October 2017|2017-10-01|August 30, 2017|Actual|2017-08-30|August 30, 2017|Actual|2017-08-30||Interventional|||Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)|A Phase III Placebo-controlled Clinical Trial to Study the Tolerability, Immunogenicity and Efficacy of V501 in 16- to 26-year-old Japanese Men|Completed||Phase 3|1124|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 01:40:09.094393|2017-10-11 01:40:09.094393
NCT01862861|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2014-07-30|||November 2012||2012-11-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|REVERT||Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study|Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study|Completed||N/A|69|Actual|Medimix Specialty Pharmacy, LLC|||1||f||||t||||||||||2017-10-11 01:40:09.197639|2017-10-11 01:40:09.197639
NCT01862848|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-06-12|||November 2012||2012-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01|12 Weeks|Observational [Patient Registry]|TOPCAPP||Topical Compounded Pain Creams And Pain Perception (TOPCAPP)|Topical Compounded Pain Creams And Pain Perception (TOPCAPP)|Completed||N/A|285|Actual|Medimix Specialty Pharmacy, LLC|||1||f||||t||||||||||2017-10-11 01:40:09.307383|2017-10-11 01:40:09.307383
NCT01862835|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-08-28|||May 2013||2013-05-01|November 2016|2016-11-01|March 30, 2018|Anticipated|2018-03-30|September 30, 2016|Actual|2016-09-30||Interventional|||Impact of Estradiol Addback|Impact of Estradiol Addback on Somatostatin Rebound in Older Men|Active, not recruiting||Phase 1|60|Anticipated|Mayo Clinic||4|||f||||f||||||||||2017-10-11 01:40:09.394913|2017-10-11 01:40:09.394913
NCT01862822|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-08-19|||May 2013||2013-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|PUCES||Position of Children During Urine Collection: Evaluation Study|Position of Children During Urine Collection: Evaluation Study|Recruiting||N/A|1360|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 01:40:09.495659|2017-10-11 01:40:09.495659
NCT01862809|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||March 27, 2013||2013-03-27|November 30, 2016|2016-11-30|December 5, 2014|Actual|2014-12-05|December 5, 2014|Actual|2014-12-05||Observational|||Cigarette Smoking and Oral Microbiota|The Effect of Smoking on Oral Microbiota|Completed||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:40:09.578086|2017-10-11 01:40:09.578086
NCT01862796|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||March 5, 2013||2013-03-05|May 19, 2017|2017-05-19|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Interventional|||Predicting Adherence to a Heart-Healthy Diet in Lean and Obese Individuals|Is Non-Adherence Unique to Weight-Loss? Predictors of Adherence to a Heart-Healthy Diet in Lean vs. Obese Individuals|Recruiting||Phase 2|150|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 01:40:09.647231|2017-10-11 01:40:09.647231
NCT01862783|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||February 10, 2013||2013-02-10|March 15, 2016|2016-03-15|March 15, 2016|Actual|2016-03-15|October 19, 2015|Actual|2015-10-19||Observational|||Collection of Biological Material From Pregnant Women in a Malarial Region|In-Vitro Evaluation of Anti-Adhesion Activity by Antibodies to Pregnancy Malaria Vaccine Candidates|Terminated||N/A|2500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:40:09.741225|2017-10-11 01:40:09.741225
NCT01862770|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||December 18, 2012||2012-12-18|February 25, 2016|2016-02-25|February 25, 2016|Actual|2016-02-25|November 25, 2013|Actual|2013-11-25||Observational|||Effect of Lung Cancer Diagnoses on Family Behaviors|Impact of a Patient's Lung Cancer Diagnosis on Relatives' Understanding of Genetic Risk Information and Receptivity to Quit Smoking|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:40:09.823444|2017-10-11 01:40:09.823444
NCT01862757|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||May 6, 2013||2013-05-06|March 13, 2015|2015-03-13|March 13, 2015|Actual|2015-03-13|June 14, 2013|Actual|2013-06-14||Observational|||Pilot Study of Strength Testing in Overweight Women With or Without Insulin Resistance|Pilot Study of Strength Testing in Overweight Women With or Without Insulin Resistance|Completed||N/A|13|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:40:09.910507|2017-10-11 01:40:09.910507
NCT01862744|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||April 4, 2013||2013-04-04|February 3, 2015|2015-02-03|February 3, 2015|Actual|2015-02-03|January 30, 2015|Actual|2015-01-30||Observational|||Imaging Studies of Cognitive Impairment in Parkinson s Disease|Neural Correlates of Cognitive Impairment in Parkinson Disease|Completed||N/A|76|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:40:10.013349|2017-10-11 01:40:10.013349
NCT01862731|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||March 26, 2013||2013-03-26|October 18, 2016|2016-10-18|February 3, 2020|Anticipated|2020-02-03|February 1, 2018|Anticipated|2018-02-01||Observational|||Muscle Strength Loss and Its Effect on Knee Cap Motion in Volunteers With Anterior Knee Pain|Vasti Control of Patellofemoral Kinematics in Patients With Chronic Patellofemoral Pain|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:40:10.115796|2017-10-11 01:40:10.115796
NCT01862718|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-23|2017-06-30|||February 1, 2013||2013-02-01|June 2, 2017|2017-06-02|December 31, 2018|Anticipated|2018-12-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms|Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms|Recruiting||Phase 1|10|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:40:10.227794|2017-10-11 01:40:10.227794
NCT01862705|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2015-05-12|||May 2013||2013-05-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Using fMRI to Determine if Cerebral Hemodynamic Responses to Pain Change Following Thoracic Spine Manipulation in Individuals With Mechanical Neck Pain|Using fMRI to Determine if Cerebral Hemodynamic Responses to Pain Change Following Thoracic Spine Manipulation in Individuals With Mechanical Neck Pain|Completed||N/A|24|Actual|OSF Healthcare System||2|||f||||f||||||||||2017-10-11 01:40:10.553872|2017-10-11 01:40:10.553872
NCT01862692|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-09-29|||August 2011||2011-08-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|Baby-Net||Web-based Parenting Intervention for Mothers of Infants At-Risk for Maltreatment (Baby-Net)|Web-based Parenting Intervention for Mothers of Infants At-Risk for Maltreatment|Completed||N/A|222|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-10-11 01:40:10.650807|2017-10-11 01:40:10.650807
NCT01862679|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-06-06|||July 2013||2013-07-01|June 2016|2016-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Randomised Study of High-flux Haemodialysis and Haemodiafiltration|Single Blind, Prospective, Randomised Comparative Study of High-flux Haemodialysis and Haemodiafiltration|Completed||N/A|100|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 01:40:10.774315|2017-10-11 01:40:10.774315
NCT01862666|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-06-17|||May 2013||2013-05-01|March 2014|2014-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||A Comparison of Volumetric Laser Endomicroscopy (VLE) and Endoscopic Mucosal Resection (EMR) in Patients With Barrett's Dysplasia or Intramucosal Adenocarcinoma||Completed||N/A|30|Actual|NinePoint Medical|||1||f||||f||||||Samples Without DNA|"     Endoscopic Mucosal Resection (EMR). With this technique, the mucosa is resected by injecting     a liquid in the submucosal space, after which the thus created pseudopolyp can be resected     using a snare and electrocoagulation. The histological processing of the ex-vivo EMR specimen     will be carried out according to hospital standards   "|||2017-10-11 01:40:10.911067|2017-10-11 01:40:10.911067
NCT01862653|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2014-09-30|||February 2013||2013-02-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Acupuncture for Sleep Disturbances in OEF/OIF Veterans With Post Traumatic Stress Disorder|Acupuncture for Sleep Disturbances in OEF/OIF Veterans With Post Traumatic Stress Disorder|Completed||N/A|30|Actual|United States Naval Medical Center, San Diego||2|||f||||t||||||||||2017-10-11 01:40:11.013909|2017-10-11 01:40:11.013909
NCT01862640|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-07-25|||July 2013|Actual|2013-07-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Safety and Tolerability Study of Two Fixed-doses of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type|A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type|Completed||Phase 3|433|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||t||||||||||2017-10-11 01:40:11.192873|2017-10-11 01:40:11.192873
NCT01862627|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-08-18|||December 2004||2004-12-01|August 2014|2014-08-01||||April 2013|Actual|2013-04-01||Observational|||Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy|Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy But Without Optic Disc Pit Nor High Myopia|Completed||N/A|11|Actual|Kyorin University|||1||f||||f||||||||||2017-10-11 01:40:11.536102|2017-10-11 01:40:11.536102
NCT01862601|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-05-30|||September 2013||2013-09-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||JetTouch Injection System to Deliver Saline Into the Bladder Wall of Healthy Volunteers|Study to Evaluate the Safety and Performance of the JetTouch Needle-Free Endoscopic Injection System to Deliver Saline Into the Bladder Wall of Healthy Subjects|Completed||Phase 1|20|Actual|American Medical Systems||1|||f||||t||||||||||2017-10-11 01:40:11.723839|2017-10-11 01:40:11.723839
NCT01862588|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-01-14|||January 2013||2013-01-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|CORRI||Renal Resistive Index and Cardiac Output Changes During Resuscitation Predict the Occurrence of Acute Kidney Injury in Septic Shock Patients|Clinical Study of Renal Resistive Index and Hemodynamic Parameters Changes Caused by Fluid Resuscitation to Predict the Occurrence of Acute Kidney Injury in Septic Shock Patients|Unknown status|Recruiting|N/A|40|Anticipated|Zhongda Hospital|||1||f||||f||||||Samples Without DNA|"     For every enrolled patient,we will collect 5ml blood plasma for renal function examination,     and this point will fully informed and approved by the Ethic Committee.   "|||2017-10-11 01:40:11.812925|2017-10-11 01:40:11.812925
NCT01861600|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-05-21|||April 2009||2009-04-01|May 2013|2013-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Stool Composition and Stool Characteristics in Healthy Term Infants Fed Human Milk or Infant Formulas|Stool Composition and Stool Characteristics in Healthy Term Infants Fed Human Milk or Infant Formulas|Completed||Phase 3|375|Actual|Nestlé||5|||f||||f||||||||||2017-10-11 01:40:22.493009|2017-10-11 01:40:22.493009
NCT01862562|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-11-24|||August 2008||2008-08-01|November 2013|2013-11-01|August 2017|Anticipated|2017-08-01|August 2012|Actual|2012-08-01||Interventional|||Trial to Evaluate Laparoscopic Versus Open Surgery in Elderly Colorectal Cancer Patients|Randomized Controlled Trial to Evaluate Laparoscopic Versus Open Surgery in Elderly Colorectal Cancer Patients Who Were 75 Years Old or Over|Unknown status|Active, not recruiting|Phase 3|200|Actual|Yokohama City University Medical Center||2|||f||||f||||||||||2017-10-11 01:40:11.915011|2017-10-11 01:40:11.915011
NCT01862549|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-05-10|||May 2013||2013-05-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Adapting DBT for Children With DMDD: Pilot RCT|Adapting Dialectical Behavior Therapy for Children With Disruptive Mood Dysregulation Disorder: Pilot Randomized Clinical Trial|Active, not recruiting||Phase 1|44|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 01:40:12.030968|2017-10-11 01:40:12.030968
NCT01862536|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-06-15|||October 1, 2013|Actual|2013-10-01|June 2017|2017-06-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|TADA-PHILD||Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease|Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease|Recruiting||N/A|150|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Undecided||2017-10-11 01:40:12.143665|2017-10-11 01:40:12.143665
NCT01862523|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-12-04|||February 2012||2012-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls|Unraveling the Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls by Measuring Mucosal Potentials in the Nose.|Completed||Phase 4|39|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||t||||||||||2017-10-11 01:40:12.298215|2017-10-11 01:40:12.298215
NCT01862510|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-12-05|||March 2012||2012-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Detection of Celiac Disease in Patients With Hypothyroidism|Detection of Celiac Disease in Patients With Hypothyroidism|Completed||N/A|500|Actual|University of Vermont|||1||f||||f||||||||||2017-10-11 01:40:12.427427|2017-10-11 01:40:12.427427
NCT01862497|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2016-11-04|||January 2013||2013-01-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension|Mechanism of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension and Hemodialysis Controls: A Case Control Study and Crossover Trial Comparing Carvedilol and Prazosin Hydrochloride|Recruiting||N/A|140|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 01:40:12.520887|2017-10-11 01:40:12.520887
NCT01862484|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2015-03-10|2015-02-03||May 2013||2013-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|FTF|Children age 9 to 12 with ADHD.|Neuroimaging of Diet in ADHD: Phase I|Neuroimaging of Diet and Medication in the Treatment of ADHD|Completed||N/A|40|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 01:40:12.669303|2017-10-11 01:40:12.669303
NCT01862471|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2013-06-19|||May 2013||2013-05-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Neuromuscular Electrical Stimulation Versus Intermittent Pneumatic Compression for Blood Flow|Improved Lower Limb Haemodynamics Using Neuromuscular Electrical Stimulation (NMES); Potential Novel DVT Prophylaxis|Completed||N/A|30|Actual|National University of Ireland, Galway, Ireland||1|||f||||f||||||||||2017-10-11 01:40:13.039018|2017-10-11 01:40:13.039018
NCT01862458|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-01-27|||January 2016||2016-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Empyema Treated With tPA & DNAse|Prospective Randomized Trial: Fibrinolysis With tPA (Tissue Plasminogen Activator) Versus tPA and DNAse in Children With Empyema|Withdrawn||Phase 3|0|Actual|Children's Mercy Hospital Kansas City||2||funding difficulty|f||||f||||||||||2017-10-11 01:40:13.137401|2017-10-11 01:40:13.137401
NCT01862432|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-21|||June 2011||2011-06-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|CALIN||Immediate Skin-to-skin Contact After C-section|Immediate Skin-to-skin Contact After Caesarean Delivery to Improve Neonatal|Completed||N/A|60|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 01:40:13.480763|2017-10-11 01:40:13.480763
NCT01862419|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-03-13|2015-03-13||September 2013||2013-09-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||An Electronic Alert System for In-Hospital Acute Kidney Injury|An Electronic Alert System for In-Hospital Acute Kidney Injury: A Randomized, Controlled Trial|Completed||N/A|2393|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:40:13.569676|2017-10-11 01:40:13.569676
NCT01862406|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-08-07|||October 2010||2010-10-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Impact of Generic Labels on Compliance|The Impact of Generic Labels on Consumption Dosage and Medication Compliance|Completed||N/A|101|Actual|Universidade Federal de Santa Catarina||2|||f||||f||||||||||2017-10-11 01:40:14.087743|2017-10-11 01:40:14.087743
NCT01862393|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-08-31|||August 2008||2008-08-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Stimulus Phase Duration on Discomfort and Electrically Induced Torque of Quadriceps Femoris|The Influence of Stimulus Phase Duration on Discomfort and Electrically Induced Torque of Quadriceps Femoris|Completed||N/A|38|Actual|Universidade Cidade de Sao Paulo||3|||f||||f||||||||Undecided||2017-10-11 01:40:14.17936|2017-10-11 01:40:14.17936
NCT01862380|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-09-28|||February 2013||2013-02-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|December 2015|Actual|2015-12-01||Interventional|EVAF-21||Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.|Evaluation of Adrenocortical Functions by Insulin Tolerance Test and Sodium Depletion in Women With Nonclassical Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Comparison With Healthy Volunteers.|Active, not recruiting||N/A|41|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:40:14.265581|2017-10-11 01:40:14.265581
NCT01862367|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-09-22|||May 2013||2013-05-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|mentor™6||Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study|Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study|Enrolling by invitation||N/A|30|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:40:14.388035|2017-10-11 01:40:14.388035
NCT01862354|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-03-22|||June 2013||2013-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Analgesic Effect Between TAP Block and Continuous Wound Infusion in Abdominoplasty Surgery|Comparative Analgesic Effect Between Continuous Wound Infusion and Transverse Abdominal Plan Block for Abdominoplasty Surgery|Recruiting||N/A|50|Anticipated|University Hospital of Liege||2|||f||||f||||||||||2017-10-11 01:40:14.648927|2017-10-11 01:40:14.648927
NCT01862341|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-08-06|||May 2013||2013-05-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Effect of Milk Powder With Fiber and Probiotics on Digestive Habits and General Health Well-being of Selected Filipino Mothers.|The Effect of Milk Powder With Fiber and Probiotics on Digestive Habits and General Health Well-being of Selected Filipino Mothers.|Completed||N/A|72|Actual|Fonterra Research Centre||1|||f||||||||||||||2017-10-11 01:40:14.769733|2017-10-11 01:40:14.769733
NCT01862328|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-09-14|||July 1, 2013|Actual|2013-07-01|September 2017|2017-09-01|March 28, 2018|Anticipated|2018-03-28|February 15, 2016|Actual|2016-02-15||Interventional|||Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Patients With Solid Tumors|A Phase 1b, Open-Label, Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Patients With Solid Tumors|Active, not recruiting||Phase 1|72|Anticipated|Takeda||3|||f||||f||||||||||2017-10-11 01:40:14.855754|2017-10-11 01:40:14.855754
NCT01862315|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-06-21|||May 2013||2013-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)|A Phase II Study of Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)|Recruiting||Phase 2|86|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-11 01:40:14.972957|2017-10-11 01:40:14.972957
NCT01862302|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-09-15|||August 2013||2013-08-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Interventional|HALPCARD||Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium|Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium: A Randomized Placebo-Controlled Pilot Study|Completed||Phase 3|25|Actual|McMaster University||2|||f||||t||||||||||2017-10-11 01:40:15.179137|2017-10-11 01:40:15.179137
NCT01862289|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-10-07|||April 2013||2013-04-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|PRESH||Prevalence of Hyperventilation Syndrome in Difficult Asthma|Prevalence of Hyperventilation Syndrome in Difficult Asthmatics Uncontrolled Despite a Daily Maximal Doses of Inhaled Treatment|Recruiting||N/A|150|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:40:15.276707|2017-10-11 01:40:15.276707
NCT01862276|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-06-29|||March 2013||2013-03-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma|Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma|Completed||N/A|200|Actual|Kansai Hepatobiliary Oncology Group|||1||f||||t||||||||||2017-10-11 01:40:15.406344|2017-10-11 01:40:15.406344
NCT01862263|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2016-11-03|||May 2013||2013-05-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|VIDA||Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes|A Multicenter, Double-Blind, Randomized, Parallel-Group Placebo-Controlled Study to Compare the Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type 2 Diabetes Mellitus Patients Inadequately Controlled With Insulin.|Completed||Phase 4|191|Actual|Novartis||2|||f||||t||||||||||2017-10-11 01:40:15.497827|2017-10-11 01:40:15.497827
NCT01862250|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-09-11|||October 3, 2013|Actual|2013-10-03|September 2017|2017-09-01|April 14, 2015|Actual|2015-04-14|April 14, 2015|Actual|2015-04-14||Interventional|HIE||Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia|Phase I-II Clinical Trial to Determine the Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia|Completed||Phase 1/Phase 2|13|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:40:15.669111|2017-10-11 01:40:15.669111
NCT01862237|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2014-08-28|||December 2012||2012-12-01|August 2014|2014-08-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|DIAPASON||Type II Diabetes Influence on Left Ventricular Remodeling and Outcomes in Patients Undergoing Aortic Valve Replacement Surgery.|Does Type II Diabetes Influence Prognosis and Left Ventricular Remodeling in Patients With Aortic Valve Stenosis Referred for Aortic Valve Replacement ?|Unknown status|Recruiting|N/A|100|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 01:40:15.795321|2017-10-11 01:40:15.795321
NCT01862224|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-06-12||2015-05-06|July 2013||2013-07-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Synovial Biopsy Study of JNJ-38518168 in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Terminated||Phase 2|21|Actual|Janssen Research & Development, LLC||2||"The study was stopped due to lack of efficacy in a study conducted in a similar   population,38518168ARA2002-NCT01679951."|f||||t||||||||||2017-10-11 01:40:15.924573|2017-10-11 01:40:15.924573
NCT01862211|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-02-07|||May 2013||2013-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|Polygen||Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort|POLYGEN DEFI-ALPHA : Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort|Recruiting||N/A|420|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 01:40:16.046808|2017-10-11 01:40:16.046808
NCT01862198|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2013-11-29|||September 2011||2011-09-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Usefulness of Endoscopic Ultrasound-guided Biliary Drainage With a Newly Designed Hybrid Metallic Stent|Pilot Study on the Usefulness of Endoscopic Ultrasound-guided Biliary Drainage With a Newly Designed Hybrid Metallic Stent|Completed||Phase 4|27|Actual|Inje University||1|||f||||t||||||||||2017-10-11 01:40:16.239168|2017-10-11 01:40:16.239168
NCT01862185|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-03-06|||December 2012||2012-12-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Semi-quantitative Procalcitonin Assay to The Adequacy of Empirical Antibiotics and Mortality in Septic Patients|Pengaruh Pemeriksaan Procalcitonin Semikuantitatif Terhadap Adekuasi Terapi Antibiotik Empirik Awal Dan Mortalitas Pada Pasien Sepsis|Completed||Phase 3|205|Actual|Indonesia University||2|||f||||t||||||||||2017-10-11 01:40:16.33025|2017-10-11 01:40:16.33025
NCT01862172|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-02-21|||February 2013||2013-02-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ACFI||Focal Cortical Atrophy After Myocardial Internal Capsule|FOCAL CORTICAL ATROPHY AFTER MYOCARDIAL INTERNAL CAPSULE: CORRELATION FRACTION ANISOTROPY BEAM PYRAMID AND DISABILITY|Completed||N/A|21|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-11 01:40:16.433798|2017-10-11 01:40:16.433798
NCT01862159|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-04-30|2017-04-30||May 2007||2007-05-01|April 2017|2017-04-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01|30 Days|Observational [Patient Registry]|||Risk Factors Predicting Serious Complications With Laparoscopic Gastric Bypass Surgery|Risk Factors Predicting Serious Complications With Laparoscopic Gastric Bypass Surgery|Completed||N/A|25038|Actual|Region Örebro County|||1||f||||f||||||||No||2017-10-11 01:40:16.574467|2017-10-11 01:40:16.574467
NCT01862146|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2014-06-03|||April 2013||2013-04-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|TCA||Arterial Remodeling in Smokers|Response-to-injury in Patients Undergoing Transradial Coronary Angiography: Arterial Remodeling in Smokers|Completed||N/A|50|Actual|Heinrich-Heine University, Duesseldorf|||2||f||||f||||||||||2017-10-11 01:40:16.794146|2017-10-11 01:40:16.794146
NCT01862133|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-04-10|2015-03-12||August 2013||2013-08-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational||Data collected from enrolled patients was limited to gender, race/ethnicity, age, and whether they had highly sensitive information (as defined in Methods) in their electronic health records. This information was obtained from patients' electronic medical records only.|Aspiring to Awesome- Patient Preference Privacy Selections in EMR|Aspiring to Awesome- Patient Preference Privacy Selections in EMR|Completed||N/A|136|Actual|Indiana University|We could not separate the anonymous post-study provider survey results and comments by provider type because the numbers within the physicians and nurses were sufficiently small that anonymity could have been lost.||2||f||||f||||||||||2017-10-11 01:40:16.87702|2017-10-11 01:40:16.87702
NCT01862120|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-04-18|||June 2013||2013-06-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|DFIL2-Child||Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes|Induction of Regulatory T Cells for the Treatment of Recently Diagnosed Type 1 Diabetes: Dose Finding Study of the Lowest Active Dose of IL-2 in Children|Active, not recruiting||Phase 2|24|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||t||||||||||2017-10-11 01:40:17.087721|2017-10-11 01:40:17.087721
NCT01862107|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-06-30|||May 10, 2013||2013-05-10|February 15, 2017|2017-02-15|April 30, 2030|Anticipated|2030-04-30|July 29, 2024|Anticipated|2024-07-29||Observational|||Cerebrospinal Fluid Collection and Repository Storage|Cerebrospinal Fluid Collection and Repository Storage|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:40:17.21655|2017-10-11 01:40:17.21655
NCT01862081|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-08-24|||July 16, 2013|Actual|2013-07-16|August 2017|2017-08-01|May 15, 2017|Actual|2017-05-15|May 15, 2017|Actual|2017-05-15||Interventional|||A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer||Completed||Phase 1|80|Actual|Genentech, Inc.||7|||f|||||t|f||||||||2017-10-11 01:40:17.339511|2017-10-11 01:40:17.339511
NCT01862068|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-12-15|||May 2012||2012-05-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Observational|NeutroVasc||Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)|Neutrophils Function and Identification of Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis).|Recruiting||N/A|210|Anticipated|Assistance Publique - Hôpitaux de Paris|||5||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 01:40:17.494297|2017-10-11 01:40:17.494297
NCT01862055|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2015-03-06|||December 2011||2011-12-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|SAS||"Acute Preoperative Stress and Hypotension After Spinal Anesthesia. SAS for Salivary Amylase and Stress "|Effect of Acute Preoperative Stress Assessed With Salivary Amylase on the Severity of Maternal Hypotension After Spinal Anesthesia for Planned Cesarean Section|Completed||N/A|79|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     Salivary samples   "|||2017-10-11 01:40:17.595975|2017-10-11 01:40:17.595975
NCT01862042|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-06-23|||June 2012||2012-06-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|ASI1||Palliative Care in Spinal Muscular Atrophy (SMA) 1|Evaluation of Palliative and Supportive Care for Spinal Muscular Atrophy (SMA) Type 1 Patients|Active, not recruiting||N/A|39|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-11 01:40:17.670208|2017-10-11 01:40:17.670208
NCT01862029|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-07-26|||April 25, 2013||2013-04-25|July 25, 2017|2017-07-25|July 25, 2017|Actual|2017-07-25|July 25, 2017|Actual|2017-07-25||Interventional|||Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals|An Exploratory Study to Evaluate the Effects of Roflumilast on Insulin Sensitivity and Metabolic Parameters in Prediabetic Overweight and Obese Individuals|Completed||Phase 1/Phase 2|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:40:17.752058|2017-10-11 01:40:17.752058
NCT01862016|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-03-11|||January 2013||2013-01-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|BiRDS||Early Spontaneous Breathing in Acute Respiratory Distress Syndrome|Early Spontaneous Breathing in Acute Respiratory Distress Syndrome|Recruiting||N/A|700|Anticipated|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 01:40:17.841515|2017-10-11 01:40:17.841515
NCT01862003|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-09-08|||May 2014||2014-05-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|August 2020|Anticipated|2020-08-01||Interventional|PANTHER||Phase I/II Trial of Antagonism of HER in GI Cancer|AZD8931, an Inhibitor of EGFR, ERBB2 and ERBB3 Signalling, in Combination With FOLFIRI: a Phase I/II Study to Determine the Importance of Schedule and Activity in Colorectal Cancer|Active, not recruiting||Phase 2|24|Actual|University College, London||1|||f||||t||||||||||2017-10-11 01:40:17.952788|2017-10-11 01:40:17.952788
NCT01861990|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2015-05-21|||May 2013||2013-05-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Valproic Acid in Childhood Progressive Brain Tumors|Valproic Acid for Children With Recurrent and Progressive Brain Tumors|Withdrawn||Phase 1|0|Actual|Medical University of South Carolina||1||Feasibility of the trial was proven to be absent.|f||||t||||||||||2017-10-11 01:40:18.06601|2017-10-11 01:40:18.06601
NCT01861977|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-12-01|||May 2013||2013-05-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Healthy Habits Program for High Cardiovascular Risk Patients: Randomized Controlled Clinical Trial|Healthy Habits Program for High Cardiovascular Risk Patients: Randomized Controlled Clinical Trial. Effectiveness of a Program Using Cognitive Behavioral Therapy to Improve Healthy Habits in a Population With Cardiovascular Disease.|Active, not recruiting||N/A|110|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||||2017-10-11 01:40:18.16398|2017-10-11 01:40:18.16398
NCT01861964|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-11-23|||February 2012||2012-02-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|XOS||Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora|Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora|Completed||Phase 2/Phase 3|30|Actual|University of California, Los Angeles||3|||f||||f||||||||||2017-10-11 01:40:18.261706|2017-10-11 01:40:18.261706
NCT01861951|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-08-16|||October 2012||2012-10-01|October 2016|2016-10-01|July 11, 2017|Actual|2017-07-11|July 11, 2017|Actual|2017-07-11||Interventional|EPAZ||A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma|A Randomized Phase II Trial Comparing Pazopanib With Doxorubicin as First Line Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma|Completed||Phase 2|120|Actual|Hannover Medical School||2|||f||||f||||||||||2017-10-11 01:40:18.342807|2017-10-11 01:40:18.342807
NCT01861938|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-05-23|||June 2013||2013-06-01|December 2012|2012-12-01||||December 2014|Anticipated|2014-12-01||Interventional|||Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients|Allogeneic Vaccine Modified to Express HLA A2/4-1BB Ligand for High Risk or Low Residual Disease Melanoma Patients|Unknown status|Not yet recruiting|Phase 2/Phase 3|50|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 01:40:18.452053|2017-10-11 01:40:18.452053
NCT01861925|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-05-13|2014-03-03||June 2013||2013-06-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Study of Clinical Performance of Corneal Topography Measurement Using an Optical Biometer|Lenstar LS 900 Topography|Completed||N/A|50|Actual|Haag-Streit AG|||3||f||||f||||||||||2017-10-11 01:40:18.535803|2017-10-11 01:40:18.535803
NCT01861912|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-06-04|||June 2013||2013-06-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|ACTION||Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma|Arsenic Trioxide TACE and Intravenous Administration Compared With Arsenic Trioxide TACE Alone in Unresectable Hepatocellular Carcinoma: a Randomized, Parallel, Controlled, Multi-center Clinical Study|Unknown status|Enrolling by invitation|Phase 2/Phase 3|258|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-10-11 01:40:19.089506|2017-10-11 01:40:19.089506
NCT01861899|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-05-19|||May 2013||2013-05-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|August 2018|Anticipated|2018-08-01||Observational|||Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK|Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation System|Recruiting||N/A|55|Anticipated|Globus Medical Inc|||1||f||||f||||||||No||2017-10-11 01:40:19.222876|2017-10-11 01:40:19.222876
NCT01861886|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-03-20|||January 31, 2013|Actual|2013-01-31|March 2017|2017-03-01|September 30, 2014|Actual|2014-09-30|December 19, 2013|Actual|2013-12-19||Interventional|||The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women|A Multi-Centre Clinical Study to Evaluate the Safety and Effectiveness of the ESS505® Device to Prevent Pregnancy in Women Who Are Seeking Permanent Contraception|Completed||N/A|73|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:40:19.35965|2017-10-11 01:40:19.35965
NCT01861873|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-21|||August 2013||2013-08-01|May 2013|2013-05-01|March 2016|Anticipated|2016-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Functional Treatment Planning Utilizing 18-FDGal PET/CT in SBRT for Liver Metastases|Phase 2 Study: Functional Treatment Planning Utilizing 18-FDGal PET/CT in SBRT for Liver Metastases|Unknown status|Not yet recruiting|Phase 2|28|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-10-11 01:40:19.506327|2017-10-11 01:40:19.506327
NCT01861860|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-05-21|||October 2012||2012-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|April 2017|Actual|2017-04-01||Interventional|OPERA||OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA|OPtimized Stenting Using IVUS in Long lEsion: Rationale for Simplified criteriA|Active, not recruiting||N/A|300|Anticipated|Centre Chirurgical Marie Lannelongue||1|||f||||f||||||||||2017-10-11 01:40:19.613253|2017-10-11 01:40:19.613253
NCT01861847|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-10-07||2015-09-22|February 2013||2013-02-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||7-Keto DHEA for the Treatment of PTSD|7-Keto DHEA for the Treatment of PTSD|Completed||Phase 2|71|Actual|Humanetics Corporation||2|||f||||t||||||||||2017-10-11 01:40:19.726202|2017-10-11 01:40:19.726202
NCT01861834|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-22|2017-01-24||||||June 2016|2016-06-01||||||||Expanded Access|||Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver Damage|A Safer Approach to Total Parenteral Nutrition in Pediatric Short Bowel Syndrome Intended to Decrease the Frequency and Severity of Liver Damage|Available||N/A|||Georgetown University|||||||||||||||||||2017-10-11 01:40:19.84202|2017-10-11 01:40:19.84202
NCT01861821|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2015-08-05|||November 2011||2011-11-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Analgesic Efficacy of a Multiport Versus Uniport Flexible Catheter for Labor Epidural Analgesia|Prospective, Controlled, Randomized, Blinded, Single-center Study of the Clinical Efficacy and Outcomes of a Multiport Versus Uniport Flexible Catheter for Epidural Analgesia During Labor and Delivery|Completed||N/A|650|Actual|Baylor Research Institute||2|||f||||f||||||||||2017-10-11 01:40:19.945457|2017-10-11 01:40:19.945457
NCT01861808|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-04-21|||August 24, 2013|Actual|2013-08-24|April 2017|2017-04-01|August 31, 2017|Anticipated|2017-08-31|September 1, 2016|Actual|2016-09-01||Interventional|||Prognostic Value of Biochemical Markers in Cerebrospinal Fluid for Functional Outcome of Spinal Cord Injured Patients|Investigation on the Prognostic Value of Biochemical Markers in the Cerebrospinal Fluid for the Functional Outcome of Spinal Cord Injured Patients|Active, not recruiting||Phase 2|30|Anticipated|Azienda Usl di Bologna||1|||f||||f||||||||||2017-10-11 01:40:20.152824|2017-10-11 01:40:20.152824
NCT01861795|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2014-08-20|||June 2013||2013-06-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Observational Study in Preterm Neonates Who Are Sufficiently Stable on Non-Invasive Ventilatory Support|An Oligo-center Observational Study to Collect Data in Preterm Neonates Born at or Above 27+0 Weeks of Gestational Age Who Are Sufficiently Stable on Non-Invasive Ventilatory Support|Completed||N/A|40|Anticipated|Takeda|||1||f||||f||||||||||2017-10-11 01:40:20.279963|2017-10-11 01:40:20.279963
NCT01861782|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2014-03-25|||June 2013||2013-06-01|March 2014|2014-03-01||||June 2015|Anticipated|2015-06-01||Interventional|||Comparison Between Dead Sea Solar and Water Treatment to Sulfur Pool and Medicinal Mud Treatment in Patients With RA|"Comparison Between Dead Sea Solar and Water Treatment to Sulfur Pool and Medicinal Mud Treatment in Patients With Rheumatoid Arthritis"|Unknown status|Active, not recruiting|N/A|30|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-10-11 01:40:20.469974|2017-10-11 01:40:20.469974
NCT01861769|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-11-03|||February 2012||2012-02-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Implementation of Evidence-based Psychotherapy for PTSD|Implementation of Evidence-based Psychotherapy for PTSD: An Empirical Investigation of Post-workshop Consultation in Treatment Fidelity and Patient Outcomes|Completed||N/A|120|Actual|Ryerson University||3|||f||||f||||||||||2017-10-11 01:40:20.582053|2017-10-11 01:40:20.582053
NCT01861756|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-01-23|2017-01-23||May 2013||2013-05-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||The Diabetes Medication Choice Cards Trial in Greece|The Diabetes Medication Choice Cards Trial in Greece|Completed||N/A|204|Actual|Aristotle University Of Thessaloniki||2|||f||||||||||||||2017-10-11 01:40:20.694389|2017-10-11 01:40:20.694389
NCT01861743|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-04-26|||April 2013||2013-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 31, 2016|Actual|2016-12-31||Interventional|MMA||Multimodal Analgesia Versus Routine Care Pain Management|Multimodal Analgesia Versus Routine Care Pain Management for Minimally Invasive Spine Surgery: A Prospective Randomized Study|Suspended||N/A|42|Actual|Rush University Medical Center||2||data review|f||||f||||||||Undecided||2017-10-11 01:40:21.060498|2017-10-11 01:40:21.060498
NCT01861730|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-01-23|||July 1, 2013|Actual|2013-07-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|C-015-404||Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants|Phase 1/II, Safety and Immunogenicity Study of a Recombinant Protein Tuberculosis Vaccine (AERAS-404) in BCG-Primed Infants|Active, not recruiting||Phase 1/Phase 2|243|Actual|Aeras||7|||f||||t||||||||||2017-10-11 01:40:21.183331|2017-10-11 01:40:21.183331
NCT01861717|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-08-15|||May 2013|Actual|2013-05-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.|A Pilot Study of Pre- and Post-operative Somatuline Depot Therapy in Acromegalic Patients Treated by Endonasal Endoscopic Surgery: Impact on Early Remission Rates and Perioperative Morbidity|Terminated||Phase 4|4|Actual|John Wayne Cancer Institute||1||Didn't enroll enough subjects|f||||f|t|f|||f|||||2017-10-11 01:40:21.332239|2017-10-11 01:40:21.332239
NCT01861704|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-04-16|2013-12-19||April 2011||2011-04-01|April 2014|2014-04-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Interventional|||Post-market Study to Capture Information Regarding Performance of Lyric2|Post-market Study to Capture Information Regarding Performance of Extended Wear Hearing Aid Lyric2 Compared to Lyric|Completed||N/A|177|Actual|Phonak AG, Switzerland||2|||f||||f||||||||||2017-10-11 01:40:21.474407|2017-10-11 01:40:21.474407
NCT01861691|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-11-24|||August 2008||2008-08-01|November 2013|2013-11-01|October 2017|Anticipated|2017-10-01|October 2012|Actual|2012-10-01||Interventional|||Randomized Controlled Trial Between Laparoscopic and Open Surgery in Transverse and Descending Colon Cancer Patients|Randomized Controlled Trial to Evaluate Laparoscopic Versus Open Surgery in Transverse and Descending Colon Cancer Patients|Unknown status|Active, not recruiting|Phase 2|66|Actual|Yokohama City University Medical Center||2|||f||||f||||||||||2017-10-11 01:40:21.797973|2017-10-11 01:40:21.797973
NCT01861678|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-08-04|||July 2006||2006-07-01|August 2013|2013-08-01|September 2017|Anticipated|2017-09-01|September 2012|Actual|2012-09-01||Interventional|||Randomized Controlled Trial to Evaluate High Tie Versus Low Tie of the Inferior Mesenteric Artery in Anterior Resection|Randomized Controlled Trial to Evaluate High Tie Versus Low Tie of the Inferior Mesenteric Artery in Rectal Anterior Resection for Rectal Cancer Patients|Unknown status|Active, not recruiting|Phase 3|331|Actual|Yokohama City University Medical Center||2|||f||||f||||||||||2017-10-11 01:40:21.904726|2017-10-11 01:40:21.904726
NCT01861665|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-01-06|||June 2010||2010-06-01|January 2014|2014-01-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|Marcaine||Marcaine Use in Laparoscopic Gynecological Surgery|A Comparative Trial of Marcaine Administration in Laparoscopic Gynecologic Surgery Using Either a Pre- or Post-operative Injection.|Terminated||N/A|25|Actual|Weill Medical College of Cornell University||2||Investigator no longer recruiting subjects.|f||||f||||||||||2017-10-11 01:40:22.009905|2017-10-11 01:40:22.009905
NCT01861652|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-06-12|||July 2013||2013-07-01|May 2013|2013-05-01||||January 2014|Anticipated|2014-01-01||Interventional|||Vasculaire Leg Compression Device for the Treatment of Restless Legs Syndrome - A Prospective Clinical Study|The Use of the Vasculaire Leg Compression Device for the Treatment of Restless Legs Syndrome - A Prospective Clinical Study|Withdrawn||N/A|0|Actual|Walter Reed National Military Medical Center||1||sponsor withdrew support|f||||f||||||||||2017-10-11 01:40:22.101575|2017-10-11 01:40:22.101575
NCT01861639|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-04-18|||May 2013||2013-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Stability of rTMS on Cognition and Brain Networks on Healthy Subjects.|Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cognition and Brain Networks in Healthy Subjects in 2 Sessions 15 Days Apart|Terminated||N/A|158|Actual|Qualissima||8||Timeframe of the IMI project couldn't be expended|f||||||||||||||2017-10-11 01:40:22.206872|2017-10-11 01:40:22.206872
NCT01861626|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-06-18|||May 2013||2013-05-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects||Completed||Phase 1|45|Actual|Pierre Fabre Dermatology||2|||f||||||||||||||2017-10-11 01:40:22.321492|2017-10-11 01:40:22.321492
NCT01861574|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-05-21|||February 2005||2005-02-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception|TMS Effects on Pain Perception|Completed||Early Phase 1|123|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:40:22.647354|2017-10-11 01:40:22.647354
NCT01861561|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2017-04-01|||May 2013||2013-05-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|Low/highIVCY||Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children|Efficacy and Infectious Complications of Induction Therapy With Low-dose Versus High-dose Intravenous Cyclophosphamide for Proliferative Lupus Nephritis in Children|Recruiting||Phase 4|70|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-11 01:40:22.736969|2017-10-11 01:40:22.736969
NCT01861548|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-21|||January 2007||2007-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|REPRO_PL||Polish Mother and Child Cohort Study (REPRO_PL) - Follow up of the Children.|Polish Mother and Child Cohort Study (REPRO_PL).Follow up of the Children.|Completed||N/A|479|Actual|Medical Universtity of Lodz|||1||f||||t||||||Samples With DNA|"     blood, urine, hair, saliva   "|||2017-10-11 01:40:22.907642|2017-10-11 01:40:22.907642
NCT01861535|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-08-16|||June 2013||2013-06-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|PITVIN||Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia|Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia|Recruiting||Phase 3|110|Anticipated|Medical University of Graz||2|||f||||t||||||||||2017-10-11 01:40:23.026391|2017-10-11 01:40:23.026391
NCT01861522|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2015-11-10|2015-09-17||April 2013||2013-04-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis|A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis (A Randomized, Double-blind, Placebo-controlled Study)|Completed||Phase 3|473|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 01:40:23.199309|2017-10-11 01:40:23.199309
NCT01861509|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-02-12|||June 2013|Actual|2013-06-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||BP-C1 in Metastatic Breast Cancer Patients|Pharmacokinetic, Pharmacodynamic and Interleukin Profile of Intramuscularly Administered BP-C1 in Women With Metastatic Breast Cancer: A Phase I(D) Study|Completed||Phase 1|6|Actual|Meabco A/S||1|||f||||t||||||||No||2017-10-11 01:40:23.460918|2017-10-11 01:40:23.460918
NCT01861496|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-08-02|||April 2013||2013-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|LiPlaCis||Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours|Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis (Liposomal Cisplatin Formulation) in Patients With Advanced or Refractory Tumours|Recruiting||Phase 1/Phase 2|35|Anticipated|Oncology Venture||1|||f||||t||||||||||2017-10-11 01:40:23.583349|2017-10-11 01:40:23.583349
NCT01861483|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-06-29|||March 2013||2013-03-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Vessel Resection and Reconstruction of Biliary Tract Cancers|Resection and Reconstruction of Major Vessels in Biliary Tract Cancers|Completed||N/A|100|Actual|Kansai Hepatobiliary Oncology Group|||1||f||||t||||||||||2017-10-11 01:40:23.730728|2017-10-11 01:40:23.730728
NCT01861470|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-10-07|||November 2013||2013-11-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|REDEXAM||REDEXAM - Reducing Painful Eye Examinations in Preterm Infants|Reducing Painful Eye Examinations in Preterm Infants|Completed||N/A|500|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-11 01:40:23.805767|2017-10-11 01:40:23.805767
NCT01861457|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-04-07|2014-08-14||January 2013||2013-01-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic|Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer®|Completed||N/A|39|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:40:25.527455|2017-10-11 01:40:25.527455
NCT01861444|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-11-01|||March 2011||2011-03-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)|National, Multicenter, Observational Study Evaluating Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta in Romania and Assess Efficacy of Peg-interferon Alfa-2a Treatment in Patients With Chronic Hepatitis D (CHD)|Terminated||N/A|45|Actual|Hoffmann-La Roche|||1|Terminated due to financial reasons.|f||||||||||||||2017-10-11 01:40:25.796812|2017-10-11 01:40:25.796812
NCT01861431|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-03-17|||April 2010||2010-04-01|July 2013|2013-07-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Evaluating a Microfinance Intervention for High Risk Women in Mongolia|Evaluating a Microfinance Intervention for High Risk Women in Mongolia|Completed||N/A|107|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:40:25.895609|2017-10-11 01:40:25.895609
NCT01861405|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-12-16|||March 2013||2013-03-01|December 2014|2014-12-01||||March 2015|Anticipated|2015-03-01||Observational|||Neurococognitive and Functioal Assessment of Patients With Brain Metastases|Neurocognitive and fMRI Activation Changes Observed at Baseline and After Whole Brain Radiation vs. Radiosurgery for Patients With Cerebral Metastases: a Prospective Case-control Analysis.|Unknown status|Recruiting|N/A|60|Anticipated|Thomas Jefferson University|||2||f||||||||||||||2017-10-11 01:40:26.082953|2017-10-11 01:40:26.082953
NCT01861197|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-05-22|||March 2013||2013-03-01|May 2013|2013-05-01||||January 2015|Anticipated|2015-01-01||Interventional|||Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer||Unknown status|Recruiting|Phase 2|27|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 01:40:28.372279|2017-10-11 01:40:28.372279
NCT01861392|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-05-22|||May 2013||2013-05-01|May 2013|2013-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Analisys of Neuromuscular Response, Postural Balance and Quality of Life of Diabetics Type 2 After Sensory-motor Training: Blind Random Controled Clinical Trial|Analisys of Neuromuscular Response, Postural Balance and Quality of Life of Diabetics Type 2 After Sensory-motor Training: Blind Random Controled Clinical Trial|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:40:26.210474|2017-10-11 01:40:26.210474
NCT01861379|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-11-20|||January 2007||2007-01-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|GILRR||The Role of Ghost Ileostomy in Laparoscopic Rectal Resection|The Role of Ghost Ileostomy in Laparoscopic Rectal Resection|Completed||Phase 3|107|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 01:40:26.323282|2017-10-11 01:40:26.323282
NCT01861366|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-05-22|||May 2009||2009-05-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Implementation of Nutritional Guidelines and Effects in Nursing Home Residents|Clinical Outcome in Nursing Home Residents After Implementation of Nutritional Guidelines|Completed||N/A|101|Actual|Uppsala University||2|||f||||t||||||||||2017-10-11 01:40:26.424387|2017-10-11 01:40:26.424387
NCT01861353|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-05-10|||May 2013||2013-05-01|May 2016|2016-05-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|||Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children|Randomized Controlled Trial of the Effect of Cranberry-lingonberry Juice on the Occurrence of Urinary Tract Infections, the Gut Microbiota, and the Uropathogenic Escherichia Coli|Recruiting||N/A|260|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-11 01:40:26.51389|2017-10-11 01:40:26.51389
NCT01861340|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-09-27|||May 2014||2014-05-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma|Pilot Study of Lenalidomide and Dexamethasone in Combination With MEDI-551 in Previously Untreated Multiple Myeloma.|Active, not recruiting||Early Phase 1|15|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:40:26.797581|2017-10-11 01:40:26.797581
NCT01861327|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-02-23|||April 2012||2012-04-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|July 2014|Actual|2014-07-01||Interventional|||The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures|The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures|Active, not recruiting||N/A|120|Anticipated|Hospital Israelita Albert Einstein||6|||f||||f||||||||||2017-10-11 01:40:26.894911|2017-10-11 01:40:26.894911
NCT01861314|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-09-04|||July 3, 2013|Actual|2013-07-03|May 2017|2017-05-01||||December 31, 2016|Actual|2016-12-31||Interventional|||Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia|Phase I Study of The Combination of Bortezomib and Sorafenib Followed by Decitabine in Patients With Acute Myeloid Leukemia|Active, not recruiting||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 01:40:27.029767|2017-10-11 01:40:27.029767
NCT01861301|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-08-26|2016-08-26||January 2013||2013-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma|A Phase 2 Study of ARQ 197 in Patients With Previously-Treated Malignant Mesothelioma|Terminated||Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 01:40:27.165564|2017-10-11 01:40:27.165564
NCT01861288|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-08-15|||July 2013||2013-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease|Development of a New Algorithm to Determine the Activity of Disease: Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With IBD.|Enrolling by invitation||N/A|180|Anticipated|Herlev Hospital|||1||f||||f||||||Samples Without DNA|"     Feces   "|||2017-10-11 01:40:27.63487|2017-10-11 01:40:27.63487
NCT01861275|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-05-23|||April 2013||2013-04-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01|6 Months|Observational [Patient Registry]|||Ischaemic Stroke and Sleep Apnea in Northern Part of Finland|Obstructive Sleep Apnea as a Risk Factor for Ischaemic Stroke , a Prospective Study|Completed||N/A|256|Actual|University of Oulu|||2||f||||t||||||||Yes|Write a paper.|2017-10-11 01:40:27.749481|2017-10-11 01:40:27.749481
NCT01861262|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-05-29|||April 2013||2013-04-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|August 2013|Actual|2013-08-01||Interventional|IMACS||StO2 Performance Measured on Admission to the Emergency Department in the Assessment of Drug Poisoning|Percentage of Oxygen Saturation of Haemoglobin in Tissues (StO2) Performance Measured on Admission to the Emergency Department in the Assessment of Drug Poisoning|Completed||N/A|300|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-11 01:40:27.869009|2017-10-11 01:40:27.869009
NCT01861249|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-07-12||2015-11-03|July 2013||2013-07-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|May 2014|Actual|2014-05-01||Interventional|||Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)|A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)|Terminated||Phase 2|6|Actual|Sanofi||1||Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.|f||||t||||||||||2017-10-11 01:40:27.981919|2017-10-11 01:40:27.981919
NCT01861236|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-05-02|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01|3 Years|Observational [Patient Registry]|FAST AR||Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina|Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina|Active, not recruiting||N/A|103|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 01:40:28.093331|2017-10-11 01:40:28.093331
NCT01861223|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2014-02-23|||May 2013||2013-05-01|February 2014|2014-02-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Afatinib Plus Nimotuzumb for NSCLC|A Phase Ib Study of Afatinib Plus Nimotuzumab in Non-small Cell Lung Cancer Patients Who Progressed With Reversible EGFR TKI|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 01:40:28.175841|2017-10-11 01:40:28.175841
NCT01861210|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-05-20|||September 2010||2010-09-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|CVCT||Couples HIV Counseling and Testing for Male Couples in the United States|Couples HIV Counseling and Testing for Male Couples in the United States|Completed||N/A|216|Actual|Emory University||2|||f||||f||||||||||2017-10-11 01:40:28.270981|2017-10-11 01:40:28.270981
NCT01861184|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-05-08|||January 2013||2013-01-01|May 2013|2013-05-01|November 2014|Actual|2014-11-01|January 2014|Actual|2014-01-01||Observational|||Pneumococcal Carriage in Patients With Lower Respiratory Tract Infection (LRTI)|A Study of Pneumococcal Carriage in Hospitalised Patients With Lower Respiratory Tract Infections|Completed||N/A|38|Actual|Royal Liverpool and Broadgreen University Hospitals NHS Trust|||2||f||||t||||||Samples With DNA|"     Blood samples Nasal wash samples Nasopharyngeal swabs (where nasal wash not possible) Urine     samples   "|||2017-10-11 01:40:28.463601|2017-10-11 01:40:28.463601
NCT01861171|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-05-21|||July 2010||2010-07-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Effect of Green Tea in Obese Pre-hypertensive Women|Effect of Green Tea on Adiposity, Metabolic Profile, Blood Pressure and Endothelial Function in Obese Pre-hypertensive Women|Completed||N/A|30|Actual|Rio de Janeiro State University||2|||f||||f||||||||||2017-10-11 01:40:28.554425|2017-10-11 01:40:28.554425
NCT01861158|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-02-13|||September 2012||2012-09-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PW2||Online Parent Training for Children With Behavior Disorders|Online Parent Training for Children With Behavior Disorders: Phase II|Completed||N/A|306|Actual|Family Works Incorporated||3|||f||||f||||||||||2017-10-11 01:40:28.641242|2017-10-11 01:40:28.641242
NCT01861145|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-12-17|||May 2013||2013-05-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea|Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea|Withdrawn||Phase 4|0|Actual|University of Alberta||2||Unable to sufficiently enroll or collect follow-up|f||||f||||||||||2017-10-11 01:40:28.743845|2017-10-11 01:40:28.743845
NCT01861132|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-11-04|||May 2013||2013-05-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Validation of a Non-invasive Hemodynamic Monitor (NexFin) in Pregnant Women|Validation of Non-invasive Monitoring of Blood Pressure and Cardiac Output in Healthy Pregnant Women During Cesarean Section|Completed||N/A|20|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 01:40:28.996347|2017-10-11 01:40:28.996347
NCT01861119|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-04-07|||April 2013||2013-04-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Silicone Gel Versus Onion Extract Gel as Prevention for Postsurgical Scars|Silicone Gel Versus Onion Extract Gel as Prevention for Postsurgical Scars: a Randomized Controlled Trial|Recruiting||Phase 3|90|Anticipated|CHA University||3|||f||||f||||||||||2017-10-11 01:40:29.065695|2017-10-11 01:40:29.065695
NCT01861106|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-08-31|||April 26, 2013||2013-04-26|August 30, 2017|2017-08-30|December 31, 2020|Anticipated|2020-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations|Allogeneic Hematopoietic Stem Cell Transplant for Patients With Mutations in GATA2 or the MonoMAC Syndrome|Recruiting||Phase 2|144|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-11 01:40:29.16151|2017-10-11 01:40:29.16151
NCT01861093|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-10-05|||April 16, 2013||2013-04-16|January 12, 2017|2017-01-12|November 30, 2037|Anticipated|2037-11-30|November 30, 2037|Anticipated|2037-11-30||Interventional|||Safety Study of Cord Blood Units for Stem Cell Transplants|A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients|Recruiting||Phase 2|500|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:40:29.307169|2017-10-11 01:40:29.307169
NCT01861080|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-08-29|||May 2013||2013-05-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01|36 Months|Observational [Patient Registry]|KorHR||Korean Registry of Target Organ Damages in Hypertension|Observational Study of Clinical Characteristics and Prognostic Factors of Korean Hypertensives|Recruiting||N/A|5000|Anticipated|Dongtan Sacred Heart Hospital|||1||f||||t||||||||Undecided||2017-10-11 01:40:29.450871|2017-10-11 01:40:29.450871
NCT01861067|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-04-15|||April 2013||2013-04-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||LESS-TLH Versus LESS-LAVH|A Randomized Comparison of Laparoendoscopic Single-site (LESS) Hysterectomies: Total Laparoscopic Hysterectomy (TLH) Versus Laparoscopically Assisted Vaginal Hysterectomy (LAVH)|Completed||Phase 3|76|Actual|CHA University||2|||f||||f||||||||||2017-10-11 01:40:29.569733|2017-10-11 01:40:29.569733
NCT01861054|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-02-02|||February 2013||2013-02-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2015|Actual|2015-03-01||Interventional|||Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients|A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery|Terminated||Phase 2|20|Actual|Dompé Farmaceutici S.p.A||1||Enrollment target not reached|f||||t||||||||No||2017-10-11 01:40:29.650769|2017-10-11 01:40:29.650769
NCT01861041|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-21|||May 2013||2013-05-01|May 2013|2013-05-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|TURP||Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.|Low Dose, Low Concentration Different Baricity Bupivacaine for Transuretral Prostatectomy.|Unknown status|Not yet recruiting|Phase 4|52|Anticipated|Diskapi Yildirim Beyazit Education and Research Hospital||2|||f||||f||||||||||2017-10-11 01:40:29.776948|2017-10-11 01:40:29.776948
NCT01861028|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-06-18|||February 2013||2013-02-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|||Study Comparing Fit of the iTotal Versus Standard Total Knee Implants|Study Comparing Fit of the iTotal Versus Standard Total Knee Implants|Unknown status|Recruiting|N/A|75|Anticipated|ConforMIS, Inc.|||2||f||||f||||||||||2017-10-11 01:40:29.894561|2017-10-11 01:40:29.894561
NCT01861015|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-01-21|||May 2013||2013-05-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Vasopressin Versus Epinephrine in Myomectomy|Use of Vasopressin Versus Epinephrine to Reduce Hemorrhage During Myomectomy: a Randomized Controlled Trial|Completed||Phase 3|60|Actual|CHA University||2|||f||||f||||||||||2017-10-11 01:40:30.014295|2017-10-11 01:40:30.014295
NCT01861002|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-05-31|||May 2013||2013-05-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML|A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML|Completed||Phase 1|15|Actual|Therapeutic Advances in Childhood Leukemia Consortium||2|||f||||t||||||||No||2017-10-11 01:40:30.117279|2017-10-11 01:40:30.117279
NCT01860989|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-09-08|2015-08-05||July 2013||2013-07-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection|An Open Label, Single Dose Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum Malaria Mono-infection|Completed||Phase 2|11|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:40:30.316849|2017-10-11 01:40:30.316849
NCT01860976|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-08-01|2017-07-10|2016-06-03|June 5, 2013|Actual|2013-06-05|August 2017|2017-08-01|July 6, 2020|Anticipated|2020-07-06|July 14, 2015|Actual|2015-07-14||Interventional|ASTRAEA|All randomized participants|Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis|A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis|Active, not recruiting||Phase 3|489|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 01:40:30.64352|2017-10-11 01:40:30.64352
NCT01860963|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2013-09-30|||January 2010||2010-01-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ADIBD||Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls|Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls|Completed||N/A|310|Anticipated|Stanford University||3|||f||||t||||||||||2017-10-11 01:40:31.568133|2017-10-11 01:40:31.568133
NCT01860950|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-05-03|||October 2012||2012-10-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|tDCS-CBT||Effects of Transcranial Direct Current Stimulation on Pain Perception|Effects of Transcranial Direct Current Stimulation on Pain Perception|Recruiting||N/A|240|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:40:31.674359|2017-10-11 01:40:31.674359
NCT01860937|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-04-19|||May 2013|Actual|2013-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia|A Phase I Trial of T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 1|23|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:40:31.892478|2017-10-11 01:40:31.892478
NCT01860924|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-01-12|||May 2013||2013-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Vigorous Exercise for Depressed Smokers|Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers|Completed||N/A|30|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:40:32.01727|2017-10-11 01:40:32.01727
NCT01860911|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-10-27|||April 2013||2013-04-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Plasma Triglyceride Extraction by The Muscle|Regulation of the Plasma Triglyceride Extraction in Muscle in Insulin Resistance|Recruiting||Phase 1|30|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:40:32.152007|2017-10-11 01:40:32.152007
NCT01860898|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-07-03|||September 2009||2009-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase I Study of iPS Cell Generation From Patients With COPD|A Phase I Study of iPS Cell Generation From Patients With COPD|Active, not recruiting||N/A|50|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:40:32.301296|2017-10-11 01:40:32.301296
NCT01860885|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-21|||August 2012||2012-08-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure|Study of Hospital-wide Critical Respiratory Events Requiring Naloxone in a Pediatric Institution|Completed||N/A|95|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 01:40:32.416865|2017-10-11 01:40:32.416865
NCT01860872|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-07-25|||April 2013||2013-04-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Observational|||Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)|Study of Cardiac MRI to Assess Pulmonary Perfusion and Pulmonary Hemodynamics in Patients With Cystic Fibrosis Study (Pilot 3)|Recruiting||N/A|48|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples With DNA|"     serum   "|||2017-10-11 01:40:32.50272|2017-10-11 01:40:32.50272
NCT01860859|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2015-05-14|||March 2013||2013-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SUTURE||Suture of UTerus and Ultrasound Repair Evaluation|Randomized Controlled Trial Comparing Three Techniques of Uterine Closure on the Myometrium Thickness Evaluated With Ultrasound Six Months After a Primary Cesarean|Completed||N/A|81|Actual|CHU de Quebec-Universite Laval||3|||f||||t||||||||||2017-10-11 01:40:32.621023|2017-10-11 01:40:32.621023
NCT01860846|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-03-31|2017-02-06||May 2013||2013-05-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|IDEA|All enrolled participants|Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease|Improvement of Work Productivity and Quality of Life With Anti-TNF Therapies Used in Crohn's Disease in Routine Clinical Practice in Turkey|Completed||N/A|106|Actual|AbbVie|Participants lost to follow-up were not replaced. Participant selection bias and lower number of participants completing questionnaires at later study visits.||1||f||||f||||||||No||2017-10-11 01:40:32.759493|2017-10-11 01:40:32.759493
NCT01860833|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-22|||April 2010||2010-04-01|May 2013|2013-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|NSKO||NSAID Treatment in Knee Osteoarthritis|EFFECTS OF NSAIDs ON CLINICAL OUTCOMES, SYNOVIAL FLUID CYTOKINE CONCENTRATION AND SIGNAL TRANSDUCTION PATHWAYS IN KNEE OSTEOARTHRITIS|Completed||Phase 4|90|Actual|University of Cantanzaro||6|||f||||t||||||||||2017-10-11 01:40:33.259549|2017-10-11 01:40:33.259549
NCT01860820|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-03-09|||June 2015||2015-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effect of Neuromuscular Stimulation on Post-Transplant Leg Edema|The Effect of Neuromuscular Stimulation on Post-Transplant Leg Edema|Enrolling by invitation||N/A|100|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-11 01:40:33.403009|2017-10-11 01:40:33.403009
NCT01860807|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-09-21|||July 2013||2013-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|IBUD ph II||Trial of Ibudilast for Methamphetamine Dependence|Randomized Trial of Ibudilast for Methamphetamine Dependence|Active, not recruiting||Phase 2|140|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 01:40:33.538989|2017-10-11 01:40:33.538989
NCT01860794|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-05-21|||May 2013||2013-05-01|May 2013|2013-05-01|February 2018|Anticipated|2018-02-01|April 2017|Anticipated|2017-04-01||Interventional|||Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease|Investigator Clinical Trial for Evaluation of Safety and Tolerability After Transplantation of Fetal Mesencephalic Dopamine Neuronal Precursor Cells in Patients With Parkinson's Disease|Recruiting||Phase 1/Phase 2|15|Anticipated|Bundang CHA Hospital||1|||f||||f||||||||||2017-10-11 01:40:33.68831|2017-10-11 01:40:33.68831
NCT01860781|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2015-12-06|||August 2011||2011-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|sustenna||The Effect of Paliperidone Palmitate in Schizophrenia|The Effect of Paliperidone Palmitate in Schizophrenia: A Prospective Naturalistic Case Series Study|Completed||Phase 4|30|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 01:40:33.847771|2017-10-11 01:40:33.847771
NCT01860755|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-23|||November 2010||2010-11-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|PTConc||Effects of Physiotherapy in Individuals With Persistent Symptoms Following Concussion|Physiotherapy Treatment (Including Vestibular Rehabilitation) Compared to Rest in Individuals With Persistent Symptoms of Dizziness, Neck Pain and/or Headache Following Sport-related Concussion.|Completed||N/A|31|Actual|Sport Injury Prevention Research Centre||2|||f||||f||||||||||2017-10-11 01:40:34.082715|2017-10-11 01:40:34.082715
NCT01860742|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2016-04-04|||December 2014||2014-12-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|CASTOR||Randomized Phase III of PRRT Versus Interferon|Carcinoid Tumors After Failure of Somatostatin Analogs: a Randomized Phase III of Octreotide Lutate Peptid Receptor Radionuclide Therapy (PRRT) Versus Interferon α-2b|Withdrawn||Phase 3|0|Actual|Jules Bordet Institute||2|||f||||f||||||||No||2017-10-11 01:40:34.216378|2017-10-11 01:40:34.216378
NCT01860729|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-08-26|||May 2013||2013-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)|A 24-Week, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo- Controlled Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Statin Therapy With or Without Other Lipid Modifying Medication(s) in Patients With Hypercholesterolemia or Low HDL-C|Completed||Phase 3|589|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 01:40:34.347789|2017-10-11 01:40:34.347789
NCT01860716|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-22|||May 2013||2013-05-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Impact of Melatonin in the Pretreatment of Organ Donor and the Influence in the Evolution of Liver Transplant.|Impact of Melatonin in the Pretreatment of Organ Donor and the Influence in the Evolution of Liver Transplant: a Prospective, Randomised Double-blind Study.|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Aragon Institute of Health Sciences||2|||f||||t||||||||||2017-10-11 01:40:34.455269|2017-10-11 01:40:34.455269
NCT01860703|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2014-11-07|2014-07-21||November 2012||2012-11-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional||Fifty subjects were enrolled in order to have at least 33 subjects complete the study. The sample size calculations were based on the ICH E14 Guidance which defines a negative TQT study as one “in which the upper bound of the 95% one-sided CI for the largest time-matched mean effect of the drug on the QTc interval excludes 10 msec.”|Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects|A Double-Blind, Randomized, Crossover, Thorough QT/QTc Trial to Evaluate the Potential of Deferiprone to Prolong the QT Interval in Healthy Subjects|Completed||Phase 4|50|Actual|ApoPharma||4|||f||||f||||||||||2017-10-11 01:40:34.598079|2017-10-11 01:40:34.598079
NCT01860690|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-05-22|||November 2011||2011-11-01|December 2012|2012-12-01|February 2014|Anticipated|2014-02-01|November 2013|Anticipated|2013-11-01||Interventional|BHCG||BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success|BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success|Unknown status|Recruiting|Phase 4|100|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 01:40:35.571059|2017-10-11 01:40:35.571059
NCT01860677|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-05-15|2014-10-01||May 2010||2010-05-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|CES||The Effects of Cranial Electrotherapy Stimulation (CES) on Brain Function, Brain Chemistry and Mood|The Effects of Cranial Electrotherapy Stimulation (CES) on Brain Function, Brain Chemistry and Mood: An fMRI/MRS Study|Completed||N/A|8|Actual|Mclean Hospital|Small number of subjects analyzed.|2|||f||||f||||||||No||2017-10-11 01:40:35.668095|2017-10-11 01:40:35.668095
NCT01860664|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-08-15|||May 2013||2013-05-01|August 2017|2017-08-01|January 1, 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Interventional|||Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis|Phase 2 EFFICACY AND SAFETY OF HYDROCORTISONE OPHTHALMIC OINTMENT - VERSUS PLACEBO IN THE TREATMENT OF ALLERGIC CONJUNCTIVITIS|Terminated||Phase 2|15|Actual|Koffler Vision Group||2||The Sponsor has stopped responding to calls and emails|f||||f||||||||||2017-10-11 01:40:36.029144|2017-10-11 01:40:36.029144
NCT01860638|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-21|2017-07-26|||August 19, 2013|Actual|2013-08-19|July 2017|2017-07-01|May 5, 2017|Actual|2017-05-05|January 13, 2017|Actual|2017-01-13||Interventional|||A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma|A Double-Blind, Placebo-Controlled, Randomised, Phase II Study Evaluating the Efficacy and Safety of Addition of Continuous Multiple Line Bevacizumab Treatment to Lomustine in Second (2nd)-Line Followed by Standard of Care (SOC) in Third (3rd)-Line and Beyond Compared to Addition of Placebo, Following First Progression of Disease (PD1) in Patients With Glioblastoma (GBM) After First (1st)-Line Treatment With Radiotherapy, Temozolomide and Bevacizumab|Completed||Phase 2|299|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:40:36.426801|2017-10-11 01:40:36.426801
NCT01860625|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-06-27|||April 2013||2013-04-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects||Completed||Phase 1|36|Actual|Icure Pharmaceutical Inc.||3|||f||||||||||||||2017-10-11 01:40:36.722662|2017-10-11 01:40:36.722662
NCT01860612|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-04-07|||October 2013||2013-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects|Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects|Recruiting||N/A|520|Anticipated|Clinical Research Consultants, Inc.||3|||f||||f|f|t|t|f||||||2017-10-11 01:40:36.830201|2017-10-11 01:40:36.830201
NCT01860599|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2014-07-16|||March 2010||2010-03-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effects of Aerobic Exercise in Patients With Pre-diabetes|The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study|Completed||N/A|30|Anticipated|Baystate Medical Center||2|||f||||f||||||||||2017-10-11 01:40:37.026975|2017-10-11 01:40:37.026975
NCT01860586|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-03-03|2017-03-03||June 2013||2013-06-01|March 2017|2017-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.|A Prospective Pilot Study Evaluating the Effect of Intravitreal Injection of Bevacizumab on Recurrent Retinal Detachment Due to Proliferative Vitreoretinopathy|Completed||N/A|20|Actual|Wills Eye|This pilot study has several limitations, including small sample size, its non-randomized nature, and use of historical controls for outcome comparisons.|1|||f||||f||||||||Yes||2017-10-11 01:40:37.151469|2017-10-11 01:40:37.151469
NCT01860573|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-02-23|2016-11-01||November 2008||2008-11-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|March 2013|Actual|2013-03-01||Interventional|||Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants||Completed||N/A|168|Actual|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||||2017-10-11 01:40:37.460429|2017-10-11 01:40:37.460429
NCT01860560|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-04-18|||May 2013||2013-05-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Non-Inferiority Trial of Acute HFT Versus nCPAP|Effect of High Flow Nasal Cannula (Flowrest®) on Mild-Moderate Sleep Disordered Breathing: A Non-Inferiority Study Versus Nasal Continuous Positive Airway Pressure (CPAP) Therapy|Completed||N/A|56|Actual|Vapotherm, Inc.||2|||f||||f||||||||||2017-10-11 01:40:37.955812|2017-10-11 01:40:37.955812
NCT01860547|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-20|||June 2008||2008-06-01|May 2013|2013-05-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Berries and Berry Fractions on Metabolic Diseases|The Effect of the Bioactives of Sea Buckthorn and Bilberry on the Risk of Metabolic Diseases|Completed||N/A|110|Actual|University of Turku||4|||f||||f||||||||||2017-10-11 01:40:38.086809|2017-10-11 01:40:38.086809
NCT01860534|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-12-08|2013-05-28||July 2011||2011-07-01|May 2014|2014-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"|"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"|Completed||N/A|28|Actual|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 01:40:38.230882|2017-10-11 01:40:38.230882
NCT01860521|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-08-19|2013-06-10||September 2011||2011-09-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Termination of Pregnancy Analgesia|Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Second Trimester Voluntary Termination of Pregnancy Analgesia: a Randomized Study.|Completed||N/A|104|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||2|||f||||f||||||||||2017-10-11 01:40:38.70123|2017-10-11 01:40:38.70123
NCT01860508|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-07-04|||February 2013||2013-02-01|July 2013|2013-07-01||||February 2014|Anticipated|2014-02-01||Interventional|||A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers|Advanced Metastatic Non-small Cell Lung Cancer Patients Aged or PS Score 2 Points for First Line Application Pemetrexed/Carboplatin Chemotherapy Regimens Sequential Pemetrexed Single Drug Maintenance Treatment of Clinical Research and Related Predictive Biomarkers of Exploratory Research|Unknown status|Recruiting|N/A|94|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-11 01:40:39.136309|2017-10-11 01:40:39.136309
NCT01860495|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2013-05-21|||March 2012||2012-03-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01|6 Months|Observational [Patient Registry]|MPM||Gingival Crevicular Fluid Bone Morphogenetic Protein - 2 Release Profile Following the Use of Perforated Membrane|Gingival Crevicular Fluid Bone Morphogenetic Protein - 2 Release Profile Following the Use of Modified Perforated Membrane Barriers in Localized Intrabony Defects (An in Vivo Study)|Completed||Phase 2|15|Actual|Al-Azhar University|||2||f||||t||||||||||2017-10-11 01:40:39.220248|2017-10-11 01:40:39.220248
NCT01860482|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-09-22|||April 2013||2013-04-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD|An 8-weeks, Multicenter, Single Arm, Non-comparative, Phase 4 Clinical Trial to Assess the Efficacy and Safety of Newrabell® Tab. at 10mg b.i.d in Patients With Refractory Reflux Esophagitis(rGERD) to the Prior Standard PPIs Regimen|Completed||Phase 4|39|Actual|Chong Kun Dang Pharmaceutical||1|||f||||f||||||||||2017-10-11 01:40:39.317027|2017-10-11 01:40:39.317027
NCT01860469|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2013-05-18|||June 2013||2013-06-01|May 2013|2013-05-01||||June 2014|Anticipated|2014-06-01||Interventional|||Reducing Mesh Infections in Open Hernia Repairs|Does Soaking Synthetic Mesh in Vancomycin Solution Reduce Mesh Infections in Open Hernia Repairs?|Unknown status|Not yet recruiting|Phase 2/Phase 3|||University of Saskatchewan||2|||f||||t||||||||||2017-10-11 01:40:39.407343|2017-10-11 01:40:39.407343
NCT01860456|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-18|||May 2013||2013-05-01|May 2013|2013-05-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Observational|TIKlet||TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study|Tyrosine Kinase Inhibitors of BCR/ABL: Pharmacokinetic and Pharmacogenetic Study in Patients Affected by Chronic Myeloid Leukemia. Evaluation of Efficacy and Tolerability|Unknown status|Recruiting|N/A|412|Anticipated|University of Pisa|||1||f||||t||||||Samples With DNA|"     Whole blood, plasma, DNA   "|||2017-10-11 01:40:39.507702|2017-10-11 01:40:39.507702
NCT01860443|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2016-05-15|||June 2013||2013-06-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Telepsychiatry to Improve the Management of Adolescent Depression in Primary Care|Telepsychiatry-Based Collaborative Program to Improve the Management of Adolescent Depression in Primary Care Clinics in the Araucanía Region, Chile: A Randomized Controlled Trial|Terminated||N/A|143|Actual|University of Chile||2||Because there are enough data to present the conclusions|f||||f||||||||||2017-10-11 01:40:39.626158|2017-10-11 01:40:39.626158
NCT01860430|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-01-19|||April 2013||2013-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|||A Phase Ib Trial of Concurrent Cetuximab (ERBITUX®) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOY®) in Locally Advanced Head and Neck Cancer|A Phase Ib Trial of Concurrent Cetuximab (ERBITUX®) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOY®) in Locally Advanced Head and Neck Cancer|Active, not recruiting||Phase 1|18|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 01:40:39.724855|2017-10-11 01:40:39.724855
NCT01860417|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2017-04-25|||April 2013||2013-04-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|Disc_allo||Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)|Treatment of Lumbar Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Bone Marrow Mesenchymal Stromal Cells Expanded Using the Valladolid IBGM Procedure|Completed||Phase 1/Phase 2|25|Actual|Red de Terapia Celular||2|||f||||t||||||||||2017-10-11 01:40:39.804147|2017-10-11 01:40:39.804147
NCT01860404|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-08-12|||January 2014||2014-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|HIT HEADS||BCAA's in Sports-related Concussion|Head Injury Treatment With Healthy and Advanced Dietary Supplements (HIT HEADS): A Randomized, Placebo-controlled, Double-blinded, Therapeutic Exploratory Clinical Trial of Branched Chain Amino Acids (BCAA's) in the Treatment of Sports-related Concussion|Recruiting||Phase 2|50|Anticipated|Children's Hospital of Philadelphia||5|||f||||f||||||||||2017-10-11 01:40:39.924897|2017-10-11 01:40:39.924897
NCT01860378|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-04-02|||July 2013||2013-07-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Vouchers to Promote Tdap Vaccination|Retail Pharmacy Vouchers to Promote Tdap Vaccination for Adults Living With Infants|Completed||Early Phase 1|149|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 01:40:40.152241|2017-10-11 01:40:40.152241
NCT01860365|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-08-01|||July 2009||2009-07-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Measuring Concerns of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within Oncology Service|Measuring Concerns and Needs of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within the Oncology Service|Recruiting||N/A|980|Anticipated|Carmel Medical Center||2|||f||||t||||||||Undecided||2017-10-11 01:40:40.252368|2017-10-11 01:40:40.252368
NCT01860352|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-02-27|||May 2013|Actual|2013-05-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Fish Oil on the Colon Mucosa|Phase Ib Study of the Effects of Omega-3 Supplementation on Fatty Acid Metabolism in the Colon|Completed||Phase 1|48|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 01:40:40.346817|2017-10-11 01:40:40.346817
NCT01860339|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-05-31|||July 2005||2005-07-01|May 2017|2017-05-01||||August 2018|Anticipated|2018-08-01||Observational|Kids-HD||Growth and Development of the Striatum in Huntington's Disease|Growth and Development of the Striatum in Huntington's Disease|Recruiting||N/A|400|Anticipated|University of Iowa|||5||f||||f||||||Samples With DNA|"     Biospecimens are collected and retained for both case and control participants for genetic     testing purposes. Specimens are either a single sample of 1-2 teaspoons of blood drawn from     the arm or 1 teaspoon of saliva via collection device.      Biospecimens will be tested for the number of CAG repeats in the Huntingtin Gene. Each sample     obtained will be coded with a randomly assigned number and never linked with personal     identifiers. The results from the genetic analysis will be sent directly to the data manager     on the project, who is the ONLY research member with access to this data. This person has no     direct contact with study participants.   "|No|Aggregate, de-identified data may be shared with approved collaborators, but individual participant data will not be shared.|2017-10-11 01:40:40.432162|2017-10-11 01:40:40.432162
NCT01860326|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-04-27|||March 2011||2011-03-01|April 2016|2016-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects|An Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Single Oral Doses of DEB025 in Subjects With Mild and Moderate Hepatic Impairment Compared to Matched Healthy Subjects With Normal Liver Function|Completed||Phase 1|32|Actual|Debiopharm International SA||1|||f||||||||||||||2017-10-11 01:40:40.510557|2017-10-11 01:40:40.510557
NCT01860313|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-19|||January 2010||2010-01-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|December 2011|Actual|2011-12-01||Interventional|||Mental Health Training for Elementary Teachers Through Tele-education and Its Impact on the School Atmosphere|Mental Health Training for Elementary Teachers Through Tele-education and Its Impact on the School Atmosphere|Completed||Early Phase 1|213|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 01:40:40.59658|2017-10-11 01:40:40.59658
NCT01860300|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2016-05-10|||March 2013||2013-03-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|AntibioTICS||Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus|Multicentre, Randomised, Double-blinded, Placebo-controlled Trial of Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus|Recruiting||N/A|46|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 01:40:40.683833|2017-10-11 01:40:40.683833
NCT01860287|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-02-10|||September 2013||2013-09-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The Effects of Buprenorphine on Responses to Verbal Tasks|The Effects of Buprenorphine on Responses to Verbal Tasks|Completed||Phase 4|50|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 01:40:40.804402|2017-10-11 01:40:40.804402
NCT01860274|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-09-20|||January 6, 2016|Actual|2016-01-06|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||Meshed Safein Graft Patency Trial - VEST|Randomized Prospective Comparison of Patency in Safen Vein Graft|Recruiting||N/A|40|Anticipated|Cardiochirurgia E.H.||2|||f||||t||||||||||2017-10-11 01:40:40.885725|2017-10-11 01:40:40.885725
NCT01860261|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-01-16|||January 2013||2013-01-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|SEA||Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV|Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV|Completed||N/A|34|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:40:41.107833|2017-10-11 01:40:41.107833
NCT01860248|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-07-16|||May 2012||2012-05-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Vapocoolant Spray Effectiveness On Arterial Puncture Pain: Randomized Double Blind Placebo-Controlled Trial|Topical Alkane Vapocoolant Spray Effectiveness On Arterial Puncture Pain Reduction In Emergency Department: Randomized Double Blind Placebo-Controlled Trial|Completed||N/A|80|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:40:41.232508|2017-10-11 01:40:41.232508
NCT01860235|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-05-18|||June 2010||2010-06-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||EMLA Topical Anesthetic During Scaling and Root Planing|Topical Intrapocket Anesthesia With Prilocaine and Lidocaine as Alternative to Injectable Anesthesia During Scaling and Root Planing - A Randomized Clinical Trial|Completed||N/A|32|Actual|Franciscan University Center||4|||f||||f||||||||||2017-10-11 01:40:41.343413|2017-10-11 01:40:41.343413
NCT01860222|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-03-30|||January 2011||2011-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|||Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma|A Prospective Randomized Trial of Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma Complicating Clinically Significant Portal Hypertension Within the Milan Criteria|Recruiting||N/A|160|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 01:40:41.492593|2017-10-11 01:40:41.492593
NCT01860209|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2013-12-19|||March 2013||2013-03-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|SASinHD||Effect of Intermittent Hemodialysis on Sleep Apnea Syndrome in End Stage Renal Disease Patients|Effect of Intermittent Hemodialysis on Sleep Apnea Syndrome and Its Correlation to Nocturnal Rostral Fluid Shift, in End Stage Renal Disease Patients|Completed||N/A|20|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||||2017-10-11 01:40:41.621179|2017-10-11 01:40:41.621179
NCT01860196|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-08-19|||June 2013||2013-06-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|March 2017|Actual|2017-03-01||Interventional|ATHETOID_CD||Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy|A Placebo Controlled, Cross-over, Double Blind, Randomized, Clinical Trial to Compare the Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy|Completed||Phase 4|17|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 01:40:41.75531|2017-10-11 01:40:41.75531
NCT01860183|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2014-01-29|||May 2013||2013-05-01|January 2014|2014-01-01||||May 2015|Anticipated|2015-05-01||Interventional|||Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis|Comparison of 3g Versus 2g Mycophenolate Mofetil in Combination With Tacrolimus on Progression of Chronic Histology Changes in Kidney Transplant Recipients|Unknown status|Recruiting|Phase 4|80|Anticipated|Clinical Hospital Merkur||2|||f||||f||||||||||2017-10-11 01:40:41.850947|2017-10-11 01:40:41.850947
NCT01860170|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-04-07|2017-04-07||April 2012||2012-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2016|Actual|2016-03-01||Interventional|||Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis|A Phase I Trial of Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)|Active, not recruiting||Phase 1/Phase 2|28|Actual|Spectrum Health Hospitals||3|||f||||t||||||||No||2017-10-11 01:40:41.972695|2017-10-11 01:40:41.972695
NCT01860157|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-18|2017-05-27|||June 2013||2013-06-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|rTMS||Deep rTMS for Treatment-Resistant Late-life Depression|A Randomized Controlled Study of H1-Coil rTMS for Treatment-Resistant Late-Life Depression|Completed||N/A|58|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 01:40:42.541123|2017-10-11 01:40:42.541123
NCT01860144|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2015-05-17|||June 2012||2012-06-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|2 Years|Observational [Patient Registry]|||An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer||Unknown status|Recruiting|N/A|250|Anticipated|Peking University|||1||f||||f||||||||||2017-10-11 01:40:42.675133|2017-10-11 01:40:42.675133
NCT01860131|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-03-30|||March 2013||2013-03-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|EVOLUTION||Self-Management and Educational Support in Extremely Obese Patients Awaiting Bariatric Care|Evaluating Self-Management and Educational Support in Extremely Obese Patients Awaiting Multidisciplinary Bariatric Care|Completed||N/A|651|Actual|University of Alberta||3|||f||||f||||||||||2017-10-11 01:40:42.791818|2017-10-11 01:40:42.791818
NCT01860118|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-04-04|||January 2013||2013-01-01|April 2017|2017-04-01|June 21, 2016|Actual|2016-06-21|June 21, 2016|Actual|2016-06-21||Observational|||LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease|LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease|Completed||N/A|601|Actual|University of Alabama at Birmingham|||2||f||||f||||||Samples With DNA|"     Whole blood samples and urine   "|||2017-10-11 01:40:42.922967|2017-10-11 01:40:42.922967
NCT01860105|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-05-20|||September 2012||2012-09-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|AMPHORE||Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation|Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Open-label, Randomized, Cross-over Evaluation: The AMPHORE Study|Completed||Phase 1|37|Actual|The Medicines Company||4|||f||||f||||||||||2017-10-11 01:40:43.029097|2017-10-11 01:40:43.029097
NCT01860079|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-03-09|2015-12-17||May 2013||2013-05-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|EDAPPCI|Patients baseline characteristics|Early Discharge After Primary Percutaneous Coronary Intervention|Early Discharge After Primary Percutaneous Coronary Intervention: A Prospective Randomized Multi-center Trial (the EDAP PCI Trial)|Completed||N/A|900|Actual|Acibadem University||2|||f||||t||||||||No||2017-10-11 01:40:43.306078|2017-10-11 01:40:43.306078
NCT01860066|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-11-08|||December 2013||2013-12-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD|A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation|Withdrawn||Phase 3|0|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:40:43.722954|2017-10-11 01:40:43.722954
NCT01860053|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-19|||May 2009||2009-05-01|May 2013|2013-05-01||||February 2011|Actual|2011-02-01||Interventional|||A Behavioral Intervention to Decrease Vomiting and Improve Weight Loss in Post-Operative Laparoscopic Adjustable Gastric Banding (LAGB) Patients||Suspended||Phase 2/Phase 3|5|Actual|The Miriam Hospital||2|||f||||||||||||||2017-10-11 01:40:43.9334|2017-10-11 01:40:43.9334
NCT01860027|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-05-18|||December 2013||2013-12-01|December 2013|2013-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|EOMRD||Eye Movements and Reading Disabilities|Reliability of Clinical Eye Movement Tests as Screening Devices for Reading Disabilities|Terminated||N/A|1|Actual|Scripps Health|||3|Lack of enrollment|f||||t||||||||||2017-10-11 01:40:44.139066|2017-10-11 01:40:44.139066
NCT01860001|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-20|||October 2012||2012-10-01|May 2013|2013-05-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|POKACID||Incidence of Postoperative Ketosis and Metabolic Acidosis|Incidence of Postoperative Ketosis and Metabolic Acidosis|Unknown status|Recruiting|N/A|100|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 01:40:44.328834|2017-10-11 01:40:44.328834
NCT01859988|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2017-07-26|2017-07-26|2015-04-01|May 2013||2013-05-01|July 2017|2017-07-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional||Baseline population included safety analysis set (SAF) that included all randomized participants who received any investigational product and analyzed as treated. One participant randomized into Dupilumab 200 mg q2w arm was not treated and hence, excluded from the baseline population.|Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis|Completed||Phase 2|380|Actual|Regeneron Pharmaceuticals||6|||f||||f||||||||||2017-10-11 01:40:44.464249|2017-10-11 01:40:44.464249
NCT01859975|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-08-28|||February 2014||2014-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:40:48.05044|2017-10-11 01:40:48.05044
NCT01859962|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2015-11-24||2015-10-20|May 2013||2013-05-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C|A Phase 2a Study of PPI-668 in Combination With BI 207127 and Faldaprevir, With and Without Ribavirin, in Treatment-Naive Patients With Chronic Hepatitis C (HCV Genotype 1a)|Completed||Phase 2|38|Actual|Presidio Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 01:40:48.104949|2017-10-11 01:40:48.104949
NCT01859949|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-03-28|2016-02-16||October 2002||2002-10-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)|Long Term Study Of Pnu-180307 For Short Children Born Small For Gestational Age (Sga) Without Epiphyseal Closure (Extension Of The Study 307-met-0021-002)|Completed||Phase 4|62|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:40:48.25039|2017-10-11 01:40:48.25039
NCT01859936|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-05-27|||February 2008||2008-02-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|February 2011|Actual|2011-02-01||Interventional|POMB||Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment|Randomized Multicenter Trial Assessing if Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Will Change Primary Treatment|Completed||Phase 4|440|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 01:40:49.284201|2017-10-11 01:40:49.284201
NCT01859923|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-03-10|||August 2013||2013-08-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||A 6-Month Safety, Efficacy, and PK Trial of Delamanid in Pediatric Patients With Multidrug Resistant Tuberculosis|Phase 2, Open-label, Multiple-dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Delamanid (OPC-67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therapy With an Optimized Background Regimen of Anti-tuberculosis Drugs Over a 6-Month Treatment Period|Recruiting||Phase 2|36|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||t||||||||||2017-10-11 01:40:49.37481|2017-10-11 01:40:49.37481
NCT01859910|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-05-20|||October 2011||2011-10-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Interventional|||Compression of the Lid Margin Increase Microbial Contamination Risk of Patients Undergoing Cataract Surgery|Compression of the Lid Margin Increase Microbial Contamination Risk of Patients Undergoing Cataract Surgery|Completed||N/A|306|Actual|Orbis||2|||f||||||||||||||2017-10-11 01:40:49.520499|2017-10-11 01:40:49.520499
NCT01859897|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2016-03-29|||June 2013||2013-06-01|March 2016|2016-03-01||||June 2019|Anticipated|2019-06-01|5 Years|Observational [Patient Registry]|CAVI-J||A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan|A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan|Active, not recruiting||N/A|3000|Anticipated|Okayama University|||1||f||||t||||||||||2017-10-11 01:40:49.617833|2017-10-11 01:40:49.617833
NCT01859884|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-11-18|||October 2013||2013-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Interventional|||Optimizing Kidney Transplant Informed Consent|Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors|Completed||N/A|288|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:40:49.723146|2017-10-11 01:40:49.723146
NCT01859871|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2015-11-18|||May 2013||2013-05-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of a Website on Living Kidney Donation for Hispanics|Evaluation of a Culturally Competent Website on Living Kidney Donation for Hispanics|Completed||N/A|123|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:40:49.847674|2017-10-11 01:40:49.847674
NCT01859858|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-03-17|||June 2013||2013-06-01|March 2017|2017-03-01|October 5, 2018|Anticipated|2018-10-05|October 5, 2016|Actual|2016-10-05||Interventional|||Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors|A Prospective Evaluation of the Effect of Curcumin on Dose-limiting Toxicity and Pharmacokinetics of Irinotecan in Colorectal Cancer Patients|Active, not recruiting||Phase 1|23|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:40:49.946979|2017-10-11 01:40:49.946979
NCT01859845|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2014-07-30|||April 2013||2013-04-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma|Melanoma Simulation Model With Smartphone Devices: Training Physicians to Perform Opportunistic Surveillance for Early Detection of Melanoma|Completed||N/A|63|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 01:40:50.065704|2017-10-11 01:40:50.065704
NCT01859832|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-08-31|||May 2010||2010-05-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay|Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay|Completed||N/A|19|Actual|Lawson Health Research Institute|||1||f||||f||||||None Retained|"     Collected blood samples will be discarded immediately following testing   "|||2017-10-11 01:40:50.164841|2017-10-11 01:40:50.164841
NCT01859819|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-07-29|||January 2013||2013-01-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|REBOOT||Treatment for Advanced B-Cell Lymphoma|Reduced Burden of Oncologic Therapy in Advanced B-cell Lymphoma (REBOOT ABLY) in Children, Adolescents and Young Adults With CD20+ Mature B-Cell Lymphoma|Recruiting||Phase 2|24|Anticipated|New York Medical College||3|||f||||t||||||||||2017-10-11 01:40:50.244748|2017-10-11 01:40:50.244748
NCT01859806|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-05-20|||January 2011||2011-01-01|January 2011|2011-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|PD||Isolated Roux Loop Pancreaticojejunostomy Versus Pancreaticogastrostomy After Pancreaticoduodenectomy|Isolated Roux Loop Pancreaticojejunostomy Versus Pancreaticogastrostomy After Pancreaticoduodenectomy|Completed||N/A|80|Actual|Mansoura University||2|||f||||f||||||||||2017-10-11 01:40:50.400982|2017-10-11 01:40:50.400982
NCT01859793|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-08-29|2016-07-18||June 2013||2013-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy|A Randomized, Crossover Design Study of Acute and Chronic Effects of Sitagliptin on Endothelial Function in Humans With Type 2 Diabetes on Background Metformin|Completed||Phase 4|38|Actual|Medical College of Wisconsin|No limitations noted.|2|||f||||f||||||||Yes|Data set may be shared in a de-identified manner by request from qualified investigators with appropriate qualifications|2017-10-11 01:40:50.531518|2017-10-11 01:40:50.531518
NCT01859780|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-04-06|||August 2013||2013-08-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|VDCR||Visual Distraction as a Means of Enhancing Child Resistance|Visual Distraction as a Means of Enhancing Child Resistance|Completed||N/A|229|Actual|Michigan State University||1|||f||||f||||||||||2017-10-11 01:40:51.345371|2017-10-11 01:40:51.345371
NCT01859767|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-12-15|||April 2013||2013-04-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs.|An Exploratory, Open-label, Non-randomized Phase 1 Study to Evaluate the Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in Patients With Alzheimer's Disease Compared to Healthy Volunteers.|Completed||Phase 1|6|Actual|Molecular NeuroImaging||1|||f||||f||||||||No||2017-10-11 01:40:51.515739|2017-10-11 01:40:51.515739
NCT01859754|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-09-11|||May 2013||2013-05-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Octagam 5% Versus Comparator Post Marketing Trial|Postmarketing Requirement Non-Interventional 2-armed Study to Evaluate the Safety of Octagam® Immune Globulin Intravenous (Human) 5% Liquid Preparation, With a Special Emphasis on Monitoring, Analysis and Reporting of Thromboembolic Events|Recruiting||N/A|500|Anticipated|Octapharma|||2||f||||t||||||||||2017-10-11 01:40:51.631321|2017-10-11 01:40:51.631321
NCT01859741|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-09-13|||May 2013|Actual|2013-05-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|May 2017|Actual|2017-05-01||Interventional|PINNACLE||A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE)|A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE)|Active, not recruiting||Phase 1/Phase 2|145|Actual|OncoMed Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 01:40:51.784213|2017-10-11 01:40:51.784213
NCT01859728|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-08-05|||January 2013||2013-01-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|GAMBIT||GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer|GAMBIT Trial: A Randomized,Non-comparative, Open-label Clinical Trial Evaluating Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer|Recruiting||Phase 2|48|Anticipated|Barretos Cancer Hospital||2|||f||||t||||||||||2017-10-11 01:40:51.98102|2017-10-11 01:40:51.98102
NCT01859715|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-04-01|2015-06-09||June 2012||2012-06-01|April 2016|2016-04-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Emergency Department (ED) Drug Interaction in Emergency Department Patients|Hepatic Cytochrome Drug Interactions in Emergency Department Patients|Completed||N/A|502|Actual|University of Colorado, Denver|These data are limited by the nature of self-reported medication ingestion histories and self-reported effectiveness measures for opioid pain medications.|3|||f||||f||||||||||2017-10-11 01:40:52.12865|2017-10-11 01:40:52.12865
NCT01859702|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-20|2013-06-06|2013-06-06||April 2012||2012-04-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||This reporting group includes all enrolled subjects who received all doses of the test product.|Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients|Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients|Completed||Phase 4|36|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 01:40:52.488752|2017-10-11 01:40:52.488752
NCT01859689|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-01-27|||March 2012||2012-03-01|January 2014|2014-01-01||||September 2013|Actual|2013-09-01||Interventional|||Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer|A Phase II Study of Targeted Brachytherapy for Low Risk Prostate Cancer Patients|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||1||no participants enrolled|f||||t||||||||||2017-10-11 01:40:52.691537|2017-10-11 01:40:52.691537
NCT01859663|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-01-06|||May 2013||2013-05-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary Syndrome|Baseline Assessment of Dietary Intake and Physical Activity in Women With Polycystic Ovary Syndrome (PCOS)|Recruiting||N/A|80|Anticipated|Cornell University|||1||f||||f||||||Samples With DNA|"     Whole blood and urine samples   "|||2017-10-11 01:40:52.836932|2017-10-11 01:40:52.836932
NCT01859650|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-05-04|||December 2014|Actual|2014-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|HeXeRT||Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients|Lung HeXeRT: Advanced Proton, Hyperpolarised 3-helium and 129-xenon Magnetic Resonance Imaging for Lung Cancer Radiotherapy Planning and Evaluation|Recruiting||N/A|20|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 01:40:52.99086|2017-10-11 01:40:52.99086
NCT01859637|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-02-24|2016-01-20||July 2011||2011-07-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|March 2014|Actual|2014-03-01||Interventional||"Intent-to treat (ITT): All patients with at least one dose EP2006. Safety population (SAF): ITT and at least one post-baseline safety assessment. Immunogenicity population: ITT and at least one available anti-rhG-CSF antibody assessment.
No patient was excluded of any of the populations. Results presented for SAF."|Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia|Twelve-month Study on the Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia|Terminated||Phase 4|6|Actual|Sandoz|This was an Additional Pharmacovigilance Activity (MEA005). Based on interim study data, complemented with clinical data from continued global development & extensive post-marketing experience MEA005 was considered fulfilled and the study terminated.|1||Additional pharmacovigilance activity was considered as fulfilled by the EMA.|f||||f||||||||Yes|Since there are only six patients enrolled, all the patient data is already provided in the registry.|2017-10-11 01:40:53.16059|2017-10-11 01:40:53.16059
NCT01859624|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-02-11|||June 2012||2012-06-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Albuterol in Individuals With Late Onset Pompe Disease (LOPD)|A Clinical Investigation of the Safety and Efficacy of Albuterol on Motor Function in Individuals With Late-onset Pompe Disease, Whether or Not Receiving Enzyme Replacement Therapy|Completed||Phase 1|8|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:40:53.56734|2017-10-11 01:40:53.56734
NCT01859611|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-03-18|2015-02-11||May 2013||2013-05-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||TriActive+ Radiofrequency (RF) for Non-Invasive Treatment of Wrinkles and Rhytides|Clinical Study to Evaluate the Performance of TriActive+ RF for the Non-Invasive Treatment of Wrinkles and Rhytides|Completed||N/A|51|Actual|El. En. SpA||1|||f||||f||||||||||2017-10-11 01:40:53.674586|2017-10-11 01:40:53.674586
NCT01859598|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-08-17|2016-02-15||December 2011||2011-12-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01|6 Months|Observational [Patient Registry]|||Observational Registry for Basal Insulin Treatment Study (ORBIT)|A Prospective, Observational Registry Study Focusing on the Real World Use, Effectiveness and Safety of Initial Basal Insulin Regimen in Type 2 Diabetic Patients Uncontrolled by Oral Antidiabetic Drugs in China|Completed||N/A|19894|Actual|The George Institute for Global Health, China|The characteristics of patients receiving different treatment modalities may not be consistent, and the use of Basal Insulin (BI) depended on individual choices of doctors and patients, resulting in differences in insulin usage among various regions.||1||f||||f||||||||||2017-10-11 01:40:53.929223|2017-10-11 01:40:53.929223
NCT01859585|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-21|||March 2011||2011-03-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion|Comparing the Efficacy of Parecoxib and Ketorolac as Preemptive Analgesia in Patients Undergoing Posterior Lumbar Spinal Fusion|Completed||Phase 4|96|Actual|Prince of Songkla University||3|||f||||t||||||||||2017-10-11 01:40:54.369702|2017-10-11 01:40:54.369702
NCT01859572|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-12-16|||February 2014||2014-02-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|OSIS||Observational Study of Ischaemic Stroke|A Non-interventional Observational Study to Document the Clinical Course of Patients Following Ischaemic Stroke and to Establish a Pool of Patients for Future Trials in the Ischaemic Stroke Setting|Completed||N/A|110|Actual|ReNeuron Limited|||1||f||||f||||||||||2017-10-11 01:40:54.45686|2017-10-11 01:40:54.45686
NCT01859559|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-08-11|||August 2013||2013-08-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Evaluate Initial Success Rate of Ultrasound Guided Versus Landmark Approach For Peripheral Intravenous Access|A Randomized Controlled Trial To Compare The Initial Success Rate of Ultrasound Guided Versus Landmark Approach For Placement of Peripheral Intravenous Access Lines in Emergency Department Patients|Completed||N/A|1189|Actual|George Washington University||3|||f||||f||||||||||2017-10-11 01:40:54.525929|2017-10-11 01:40:54.525929
NCT01859546|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-05-20|||March 2013||2013-03-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||SMS Reminders to Improve the on Time Vaccination Rates Among Children in Pakistan|Automated SMS Reminders to Parents on Their Cell Phones Can Significantly Improve the on Time Vaccination Rates for Children in Pakistan|Unknown status|Recruiting|N/A|300|Anticipated|Aga Khan University||2|||f||||f||||||||||2017-10-11 01:40:54.756214|2017-10-11 01:40:54.756214
NCT01858948|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-07-19|||July 2013||2013-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||SGA-induced Metabolic Syndrome in Bipolar Youth|Risk and Protective Factors for SGA-induced Metabolic Syndrome in Bipolar Youth|Recruiting||Phase 3|94|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-10-11 01:41:02.98444|2017-10-11 01:41:02.98444
NCT01859533|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-05-20|||November 2011||2011-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Positive End Expiratory Pressure With A T-piece Resuscitator For Near-Term and Term Infants With Respiratory Distress|Positive End Expiratory Pressure With A T-piece Resuscitator (Neopuff) For Near-Term and Term Infants With Respiratory Distress: A Randomized, Controlled Trial|Completed||Phase 2|64|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-11 01:40:54.855574|2017-10-11 01:40:54.855574
NCT01859520|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-05-21|||July 2012||2012-07-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Swim up and Gradient Methods Used in Assisted Reproduction Techniques on DNA Fragmentation of Spermatozoa|The Effect of Swim up and Gradient Methods Used in Assisted Reproduction Techniques on DNA Fragmentation of Spermatozoa|Completed||N/A|65|Actual|Gazi University||1|||f||||f||||||||||2017-10-11 01:40:54.938345|2017-10-11 01:40:54.938345
NCT01859507|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2015-04-09|2015-03-20||January 2013||2013-01-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|VginsmsBOTOX|All participants who completed the study|Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm|Study of the Effectiveness and Safety of Clostridium Botulinum Type A Neurotoxin Complex Injection in the Perineal Muscles in Resistant Cases of Vaginismus|Completed||N/A|32|Actual|Cairo University||1|||f||||t||||||||||2017-10-11 01:40:55.187904|2017-10-11 01:40:55.187904
NCT01859494|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2016-12-20|2016-09-09||April 2013||2013-04-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Two subjects were screen failures due to not meeting enrollment criteria. 221 consented but only 219 enrolled into study.|Evaluation of an Investigational Blood Glucose Monitoring System|Performance of the Ninja 3 Blood Glucose Monitoring System|Completed||N/A|219|Actual|Ascensia Diabetes Care||1|||f||||f||||||||Yes|When it is cleared, results data will be provided.|2017-10-11 01:40:55.450229|2017-10-11 01:40:55.450229
NCT01859481|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-17|||March 2000||2000-03-01|May 2013|2013-05-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study|A Multicentre, Dose Optimisation Study to Assess the Consistency of Efficacy of Eletriptan for the Treatment of Migraine (With and Without Aura)|Completed||Phase 3|971|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:40:55.796243|2017-10-11 01:40:55.796243
NCT01859468|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-19|2016-08-03|||June 2013||2013-06-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures|A Prospective, Randomized, Parallel, Double-blind, Active Controlled Pilot Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) Versus Placebo on Functional Outcome and Radiographic Healing Time of Distal Radius Fractures|Terminated||Phase 1/Phase 2|15|Actual|Amorphical Ltd.||2||Low Recruitment|f||||f||||||||||2017-10-11 01:40:56.185944|2017-10-11 01:40:56.185944
NCT01859455|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-03-29|||July 2011|Actual|2011-07-01|March 2017|2017-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins|A Randomized, Double-blind, Placebo-controlled, Single Dose, Parallel Group Study to Assess the Safety, Tolerability, Bioavailability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous LGT209 in Hypercholesterolemic Patients on Stable Doses of Atorvastatin or Simvastatin and in Healthy Volunteers|Completed||Phase 1|25|Actual|Novartis||5|||f||||f||||||||||2017-10-11 01:40:56.293581|2017-10-11 01:40:56.293581
NCT01859442|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-05-05|||January 2012||2012-01-01|September 2013|2013-09-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness|Phase 1 Study of Mitochondrial Energetics After Long Course Chemoradiotherapy and a Short Term Exercise Programme in Locally Advanced Rectal Cancer Patients - A Randomized Controlled Trial.|Completed||Early Phase 1|12|Actual|Aintree University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:40:56.402803|2017-10-11 01:40:56.402803
NCT01859429|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-11-12|||April 2012||2012-04-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|STEPPEDCARE||Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis|Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis|Unknown status|Active, not recruiting|N/A|800|Anticipated|University of Leipzig||2|||f||||f||||||||||2017-10-11 01:40:56.485478|2017-10-11 01:40:56.485478
NCT01859416|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-17|||March 2009||2009-03-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Oral Nutritional Supplements in Nursing Home Residents|Effects of Oral Nutritional Supplements in Nursing Home Residents|Completed||N/A|87|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-11 01:40:56.598868|2017-10-11 01:40:56.598868
NCT01859403|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-09-22|||November 2012||2012-11-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Nutrigenomics: Personalizing Weight Loss for Obese Veterans|Nutrigenomics: Personalizing Weight Loss for Obese Veterans|Completed||N/A|51|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:40:56.668601|2017-10-11 01:40:56.668601
NCT01859390|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-06-19|2017-03-10||June 2013||2013-06-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|April 2015|Actual|2015-04-01||Interventional|AquADEKs-2||Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis|A Multi-Center, Randomized, Controlled, Double-Blind Study of the Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Patients|Completed||Phase 2|73|Actual|University of Colorado, Denver|We did not meet the complete enrollment of 80 subjects due to the expiration dates of the antioxidant-enriched and control multivitamins produced for the study.|2|||f||||t||||||||No||2017-10-11 01:40:56.781963|2017-10-11 01:40:56.781963
NCT01859377|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-06-21|||May 2013||2013-05-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations||Completed||Phase 1|26|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 01:40:57.685872|2017-10-11 01:40:57.685872
NCT01859364|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-06-30|||April 27, 2013||2013-04-27|July 8, 2014|2014-07-08|March 1, 2023|Anticipated|2023-03-01|March 1, 2023|Anticipated|2023-03-01||Observational|||Tobacco Cessation: Treatment Delivery and Predictors of Outcome|Tobacco Cessation:Treatment Delivery and Predictors of Outcome|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:40:57.763723|2017-10-11 01:40:57.763723
NCT01859351|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-05-15|||July 2013||2013-07-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours|A Phase I Open-label, Dose-escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the PI3K Inhibitor WX-037, Given as a Single Agent and in Combination With the MEK Inhibitor WX-554, in Patients With Solid Tumors|Terminated||Phase 1|13|Actual|Wilex||2||Study terminated for business reasons|f||||f||||||||||2017-10-11 01:40:57.847537|2017-10-11 01:40:57.847537
NCT01859338|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-02-06|||March 6, 2012||2012-03-06|February 2017|2017-02-01|January 24, 2017|Actual|2017-01-24|January 18, 2017|Actual|2017-01-18||Interventional|||MRI, Cone Beam CT, and Fan Beam CT in Detecting Soft Tissue in Patients With Prostate and Lung Cancer Undergoing Radiation Therapy|Clinical Evaluation of Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MR Imaging Into Radiotherapy Planning|Terminated||N/A|26|Actual|Virginia Commonwealth University||1||Slow accrual|f||||t|f|f||||||||2017-10-11 01:40:57.935207|2017-10-11 01:40:57.935207
NCT01859325|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-07-06|||May 10, 2013||2013-05-10|April 11, 2017|2017-04-11|August 28, 2019|Anticipated|2019-08-28|August 28, 2019|Anticipated|2019-08-28||Interventional|||Therapeutic Vaccine for HIV|A Phase I Randomized, Double-Blind, Placebo-Controlled Study of a Multi-Antigen DNA Vaccine Prime Delivered by In Vivo Electroporation, rVSV Booster Vaccine in HIV-Infected Patients Who Began Antiretroviral Therapy During Acute/Early Infection|Active, not recruiting||Phase 1|33|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:40:58.07284|2017-10-11 01:40:58.07284
NCT01859286|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2013-05-17|||February 2012||2012-02-01|May 2013|2013-05-01||||May 2012|Actual|2012-05-01||Observational|SAID-ED||Improving Signout Accuracy and Information Delivery in the Emergency Department|Improving Transfer of Care Accuracy and Information Delivery in the Emergency Department|Completed||N/A|321|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-11 01:40:58.445345|2017-10-11 01:40:58.445345
NCT01859273|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-06-08|||September 2011||2011-09-01|June 2016|2016-06-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Adherence Enhancement for Renal Transplant Patients|Adherence Enhancement for Renal Transplant Patients|Completed||N/A|18|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:40:58.534972|2017-10-11 01:40:58.534972
NCT01859260|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-17|||June 2013||2013-06-01|May 2013|2013-05-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||Using Continuous Positive Airway Pressure to Reduce the Incidence of Acute Kidney Injury in Hospitalized Patients With Chronic Kidney Disease|Using CPAP to Prevent Acute Kidney Injury in Hospitalized Patients With Chronic Kidney Disease|Unknown status|Not yet recruiting|N/A|125|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-11 01:40:58.631066|2017-10-11 01:40:58.631066
NCT01859247|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-06-16|2016-01-08||March 2013||2013-03-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study|Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study|Completed||N/A|8|Actual|University of New Mexico||5|||f||||f||||||||||2017-10-11 01:40:58.752046|2017-10-11 01:40:58.752046
NCT01859234|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-17|||May 2013||2013-05-01|May 2013|2013-05-01||||May 2014|Anticipated|2014-05-01||Interventional|||89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma|Evaluation of VEGF Expression With 89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma; a Feasibility Study|Unknown status|Recruiting|N/A|20|Anticipated|University Medical Center Groningen||1|||f||||f||||||||||2017-10-11 01:40:59.538172|2017-10-11 01:40:59.538172
NCT01859221|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-09-01|||May 2013||2013-05-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Radiotherapy for Oligometastatic Prostate Cancer|Phase II Stereotactic Body Radiotherapy (SBRT) and Stereotactic Hypofractionated Radiotherapy (SHRT) for Oligometastatic Prostate Cancer|Active, not recruiting||N/A|48|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-11 01:40:59.645498|2017-10-11 01:40:59.645498
NCT01859182|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-09-08|||January 2013||2013-01-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery|A Multicenter Phase II Study of the Combination of AZD6244 Hydrogen Sulfate and MK-2206 in Patients With Refractory Advanced Biliary Cancers|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 01:40:59.887838|2017-10-11 01:40:59.887838
NCT01859169|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-05-17|||June 2013||2013-06-01|May 2013|2013-05-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Observational|||Safety and Efficiency of Photodynamic Therapy for Blie Duct Carcinoma|Longterm Outcome of Photodynamic Therapy Compared With Biliary Drainage Alone in Patients With Unresectable Cholangiocarcinoma|Suspended||Phase 2/Phase 3|100|Anticipated|Central South University|||2|Modifying the clinnicaltrials|f||||t||||||||||2017-10-11 01:41:00.02802|2017-10-11 01:41:00.02802
NCT01859156|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2014-10-28|||October 2006||2006-10-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning|End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide|Completed||N/A|151|Actual|Minneapolis Medical Research Foundation|||1||f||||||||||||||2017-10-11 01:41:00.13469|2017-10-11 01:41:00.13469
NCT01859143|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-11-07|2014-10-30||May 2013||2013-05-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Analysis population included all randomized participants.|Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults|Completed||Phase 4|300|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 01:41:00.231562|2017-10-11 01:41:00.231562
NCT01859130|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-11-21|||April 2013||2013-04-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Zimmer POLAR - Total Knee Arthroplasty (TKA)|Persona Outcomes Led Assessment Research in Total Knee Arthroplasty|Active, not recruiting||N/A|300|Actual|Zimmer Biomet||1|||f||||f||||||||Undecided||2017-10-11 01:41:00.916376|2017-10-11 01:41:00.916376
NCT01859117|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-02-22|||May 2013||2013-05-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU|A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer|Completed||Phase 1|15|Actual|Celgene||4|||f||||t||||||||||2017-10-11 01:41:01.023493|2017-10-11 01:41:01.023493
NCT01859104|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-01-27|||September 2015||2015-09-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Feasibility of Use of BariCare App in Pre-transplant Population|Feasibility and Efficacy of Engagement Modules for Renal and Liver Transplant Candidates|Suspended||N/A|20|Anticipated|Mayo Clinic||1||App to be used in study needs revision.|f||||f||||||||Undecided||2017-10-11 01:41:01.151692|2017-10-11 01:41:01.151692
NCT01859078|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-05-15|2017-03-10||May 2013||2013-05-01|May 2017|2017-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||All enrolled participants.|A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants|Effect of Baricitinib on the Pharmacokinetics of Digoxin in Healthy Subjects|Completed||Phase 1|28|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:41:01.314658|2017-10-11 01:41:01.314658
NCT01859065|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-17|||December 2011||2011-12-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||"Anticipatory Guidance in the Nursery and Its Impact on Non-urgent Emergency Department Visits"|"Anticipatory Guidance in the Nursery and Its Impact on Non-urgent Emergency Department Visits"|Completed||N/A|323|Actual|Bronx-Lebanon Hospital Center Health Care System||2|||f||||f||||||||||2017-10-11 01:41:01.643659|2017-10-11 01:41:01.643659
NCT01859052|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-08-31|||July 2012||2012-07-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Diet and Migraine Study|Diet and Migraine Study|Terminated||N/A|32|Actual|Johns Hopkins University||3||Study team was unable to effectively conduct the study.|f||||f||||||||||2017-10-11 01:41:01.752805|2017-10-11 01:41:01.752805
NCT01859039|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2015-05-27|||September 2013||2013-09-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|SNIFFLE||Safety of Nasal Influenza Immunisation in Egg Allergic Children|Phase 4 Study to Assess the Safety of Nasal Influenza Immunisation in Egg Allergic Children - a Multicentre Observational Study|Completed||N/A|282|Actual|Imperial College London|||1||f||||t||||||||||2017-10-11 01:41:01.842508|2017-10-11 01:41:01.842508
NCT01859026|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-06-23|||December 10, 2013|Actual|2013-12-10|June 2017|2017-06-01|March 31, 2020|Anticipated|2020-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation|A Phase I/IB Trial of MEK162 in Combination With Erlotinib in Non-Small Cell Lung Cancer (NSCLC) Harboring KRAS or EGFR Mutation|Recruiting||Phase 1|44|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f|t|f||||||||2017-10-11 01:41:01.973701|2017-10-11 01:41:01.973701
NCT01859013|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-06-01|2017-02-07||June 2013||2013-06-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|December 2015|Actual|2015-12-01||Interventional|||Topiramate in Adolescents With Severe Obesity|BMI Reduction With Meal Replacements + Topiramate in Adolescents With Severe Obesity|Completed||Phase 2|34|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 01:41:02.105817|2017-10-11 01:41:02.105817
NCT01859000|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-05-16|||January 2007||2007-01-01|May 2013|2013-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|Katrina||Family-Based Drug Services for Young Disaster Victims|Family-Based Drug Services for Young Disaster Victims|Completed||N/A|80|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 01:41:02.376576|2017-10-11 01:41:02.376576
NCT01858974|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-02-18|||June 2013||2013-06-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|||Fast Identification of Pathogen in the Setting of Pneumonia Using Multiplex PCR|Identification of Microbes Through Detection of Pathogen Specific DNA Using Multiplex PCR as a Point of Care Diagnostic Tool in the Setting of Pneumonia|Completed||N/A|60|Actual|University of Göttingen|||1||f||||f||||||Samples With DNA|"     aspiration samples from the respiratory system (tracheal secretion sample, BAL) containing     microbial DNA   "|||2017-10-11 01:41:02.723601|2017-10-11 01:41:02.723601
NCT01858961|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-01-22|||May 2013||2013-05-01|January 2014|2014-01-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients|A Phase III, Randomised, Open Label, Active-controlled Study of an Interferon-free Regimen of BI 207127 in Combination With Faldaprevir and Ribavirin Compared to Telaprevir in Combination With Pegylated interferon-a and Ribavirin in Treatment-naive Patients With Chronic Genotype 1b Hepatitis C Virus Infection|Withdrawn||Phase 3|0|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:41:02.819887|2017-10-11 01:41:02.819887
NCT01858935|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-05-09|||May 2013||2013-05-01|May 2017|2017-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection, a Vitamin A-Coupled Lipid Nanoparticle Containing siRNA Against HSP47, in Healthy Normal Subjects|Completed||Phase 1|56|Actual|Bristol-Myers Squibb||8|||f||||t||||||||No||2017-10-11 01:41:03.101747|2017-10-11 01:41:03.101747
NCT01858922|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-07-12|||December 2012||2012-12-01|July 2017|2017-07-01|March 2021|Anticipated|2021-03-01|June 2019|Anticipated|2019-06-01||Interventional|TXCH-HD-12A||Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A|Immune Reconstitution and Biomarker Identification in Patients With Newly Diagnosed Low and Intermediate Risk Hodgkins Lymphoma Receiving Chemotherapy With or Without Radiation Therapy: TXCH-HD-12A|Recruiting||Phase 2|40|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 01:41:03.203026|2017-10-11 01:41:03.203026
NCT01858909|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-17|||May 2013||2013-05-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock|Phase III, Prospective, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock|Unknown status|Not yet recruiting|Phase 3|110|Anticipated|Aragon Institute of Health Sciences||2|||f||||t||||||||||2017-10-11 01:41:03.335681|2017-10-11 01:41:03.335681
NCT01858896|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-02-09|||July 2013||2013-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||GLP-1 and Hypoglycemia|Hypoglycemia Associated Autonomic Dysfunction|Recruiting||Early Phase 1|28|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-11 01:41:03.434934|2017-10-11 01:41:03.434934
NCT01858883|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-04-18||2017-04-18|June 2013||2013-06-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors|Official Title: A Phase 1B/2 Study of the Safety and Tolerability of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors|Completed||Phase 1/Phase 2|55|Actual|Incyte Corporation||1|||f||||f||||||||||2017-10-11 01:41:03.53645|2017-10-11 01:41:03.53645
NCT01858870|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-20|||April 2012||2012-04-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication|Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication|Completed||N/A|860|Actual|Instituto de Investigacion Sanitaria La Fe|||1||f||||t||||||||||2017-10-11 01:41:03.657746|2017-10-11 01:41:03.657746
NCT01858857|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-27|||May 2013||2013-05-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Observational|GAP||Geriatric Psychiatry and Pharmacovigilance|Pharmacovigilance in Gerontopsychiatric Patients|Unknown status|Recruiting|N/A|4000|Anticipated|Hannover Medical School|||1||f||||t||||||||||2017-10-11 01:41:03.755597|2017-10-11 01:41:03.755597
NCT01858844|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-16|||August 2012||2012-08-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Chest Compression Technique in Infants|EVALUATION OF THE EFFECTS OF MANUAL CHEST COMPRESSION TECHNIQUE IN INFANTS WITH PULMONARY ATELECTASIS- Clinical CONTROLLED TRIAL|Completed||N/A|38|Actual|Hospital Sirio-Libanes||2|||f||||t||||||||||2017-10-11 01:41:03.861306|2017-10-11 01:41:03.861306
NCT01858831|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-03-21|||April 2012||2012-04-01|March 2017|2017-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension|Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension. - A Single Oral Dose Study to Investigate Pharmacokinetics of Atovaquone and Proguanil From Combination Tablets and Atovaquone From Atovaquone Suspension in Japanese Healthy Males. -|Completed||Phase 1|30|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 01:41:03.934803|2017-10-11 01:41:03.934803
NCT01858818|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2015-02-11|||June 2013||2013-06-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|LeAD_P4||Project 4: Acute Effects of Alcohol on Learning and Habitization in Healthy Young Adults|Project 4: Acute Effects of Alcohol on Learning and Habitization in Healthy Young Adults|Completed||N/A|75|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 01:41:04.04338|2017-10-11 01:41:04.04338
NCT01858805|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-11-17|||April 2010||2010-04-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer|Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer|Completed||N/A|123|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-11 01:41:04.139789|2017-10-11 01:41:04.139789
NCT01858792|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-05-16|||May 2011||2011-05-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies|Efficacy and Safety of Belimumab in a Subgroup of Systemic Lupus Erythematosus (SLE) Patients With Higher Disease Activity (Anti-dsDNA Positive and Low Complement): A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||t||||||||||2017-10-11 01:41:04.223822|2017-10-11 01:41:04.223822
NCT01858779|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-31|||May 2013||2013-05-01|May 2013|2013-05-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Observational|||Know Your Pulse Post Stroke-Measurement of Peripheral Pulse for Detection of Atrial Fibrillation After Ischemic Stroke|Know Your Pulse Post Stroke - Peripheral Pulse Taking to Detect Paroxysmal Atrial Fibrillation After Ischemic Stroke|Unknown status|Recruiting|N/A|300|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-10-11 01:41:04.347288|2017-10-11 01:41:04.347288
NCT01858766|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-07-27|2016-07-27|2015-01-16|April 2013||2013-04-01|July 2016|2016-07-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug.|Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection|A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Naive Subjects With Chronic HCV Infection|Completed||Phase 2|379|Actual|Gilead Sciences||14|||f||||f||||||||||2017-10-11 01:41:04.517404|2017-10-11 01:41:04.517404
NCT01858753|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-08-08|||May 2013||2013-05-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars|A Phase II, Double-Blind, Randomized, Placebo-Controlled Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars|Terminated||Phase 2|3|Actual|Fibrocell Technologies, Inc.||2||unable to enroll|f||||f||||||||||2017-10-11 01:41:08.137459|2017-10-11 01:41:08.137459
NCT01858740|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-04-28|||December 17, 2013|Actual|2013-12-17|April 2017|2017-04-01|January 30, 2022|Anticipated|2022-01-30|January 30, 2022|Anticipated|2022-01-30||Interventional|||Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children|A Phase II Study of Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children|Active, not recruiting||Phase 2|20|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 01:41:08.365521|2017-10-11 01:41:08.365521
NCT01858727|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-20|||May 2013||2013-05-01|May 2013|2013-05-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||The Effect of Preoperative Warming on Postoperative Hypothermia|The Effect of Preoperative Warming on Postoperative Hypothermia in TURP Surgery|Unknown status|Active, not recruiting|N/A|30|Actual|Etlik Zubeyde Hanim Womens' Health and Teaching Hospital||2|||f||||t||||||||||2017-10-11 01:41:08.558008|2017-10-11 01:41:08.558008
NCT01858714|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-08-03|||September 2011||2011-09-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ENACT||Environmental and Acceptance-Based Innovations for Weight Loss Maintenance|Environmental and Acceptance-Based Innovations for Weight Loss Maintenance|Completed||N/A|238|Actual|Drexel University||3|||f||||t||||||||||2017-10-11 01:41:08.659082|2017-10-11 01:41:08.659082
NCT01858701|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2014-10-17|2014-10-17||May 2013||2013-05-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|CARDINAL|This analysis population includes all enrolled participants.|Visual Performance Investigation of Two Toric Soft Contact Lenses|Visual Performance Investigation of Two Toric Soft Contact Lenses|Completed||N/A|49|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:41:08.75929|2017-10-11 01:41:08.75929
NCT01858688|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-09-11|||June 2013||2013-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer|A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer|Active, not recruiting||N/A|130|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:41:09.721948|2017-10-11 01:41:09.721948
NCT01858675|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-12-02|||March 2012||2012-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|ENVOL||Biomarkers Correlation With Volemia|Predictive Value of Biomarkers on Volemia, Extra and Intra Vascular Varation and Hydroelectrolytic Disorders in Different ICU Patients|Completed||N/A|66|Actual|ThermoFisher Scientific Brahms Biomarkers France||1|||f||||f||||||||||2017-10-11 01:41:09.834775|2017-10-11 01:41:09.834775
NCT01858662|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-04-13|||January 2014||2014-01-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors|Randomised Phase 2 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors|Terminated||Phase 2|4|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2||due to poor recrutment|f||||t||||||||||2017-10-11 01:41:09.944118|2017-10-11 01:41:09.944118
NCT01858649|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-06-27|||May 2013||2013-05-01|April 2017|2017-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|BEV-ONCO2012||Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.|Randomized Phase 2 Study Comparing Pathological Responses on Colorectal Cancer Metastases After Preoperative Treatment Combining Bevacizumab With FOLFOX or FOLFIRI|Recruiting||Phase 2|60|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 01:41:10.173256|2017-10-11 01:41:10.173256
NCT01858636|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-11-17|2014-10-24||May 2013||2013-05-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|SEAL PM|All subects with deployed devices|Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device||Completed||N/A|235|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 01:41:10.448643|2017-10-11 01:41:10.448643
NCT01858623|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2013-05-24|||February 2013||2013-02-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|PKLH||Pharmacokinetic Interactions of Losartan and Hydrochlorothiazide||Completed||N/A|18|Actual|Damanhour University||3|||f||||t||||||||||2017-10-11 01:41:10.773799|2017-10-11 01:41:10.773799
NCT01858610|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2013-05-24|||March 2013||2013-03-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Drug Interaction Between Irbesartan and Hydrochlorothiazide||Completed||N/A|18|Actual|Damanhour University||3|||f||||t||||||||||2017-10-11 01:41:10.874116|2017-10-11 01:41:10.874116
NCT01858597|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-04-13|||March 2013||2013-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Fibroblast Growth Factors 19 and 21 in Gestational Diabetes Mellitus|Endocrine Fibroblast Growth Factor 19 and 21 Regulate the Insulin Resistance State in Gestational Diabetes Mellitus|Completed||N/A|155|Actual|First Affiliated Hospital, Sun Yat-Sen University|||2||f||||t||||||||||2017-10-11 01:41:11.005455|2017-10-11 01:41:11.005455
NCT01858584|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2013-05-29|||February 2013||2013-02-01|May 2013|2013-05-01||||December 2013|Anticipated|2013-12-01||Interventional|||Prospective, Comparative, Randomized, Controlled Trial on the Efficacy of the Treatment of Gastroesophageal Reflux Infant With Magnesium Alginate|Prospective, Comparative, Randomized, Controlled Trial on the Efficacy of the Treatment of Gastroesophageal Reflux Infant With Magnesium Alginate|Unknown status|Recruiting|N/A|75|Anticipated|Federico II University||3|||f||||t||||||||||2017-10-11 01:41:11.105834|2017-10-11 01:41:11.105834
NCT01858571|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-01-24|||October 2013||2013-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric Malignancies|Low Dose Chemotherapy (Metronomic Therapy) Versus Best Supportive Care in Progressive and/or Refractory Pediatric Malignancies: a Double Blind Placebo Controlled Randomized Study|Completed||Phase 3|108|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 01:41:11.210606|2017-10-11 01:41:11.210606
NCT01858558|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-10-14|||September 2013||2013-09-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma|Randomized Phase II Study of Autologous Stem Cell Transplantation With Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma|Recruiting||Phase 2|90|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:41:11.295364|2017-10-11 01:41:11.295364
NCT01858545|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-03-17|||May 2013||2013-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers|An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial|Terminated||Phase 4|56|Actual|ACell Inc.||2|||f||||f||||||||||2017-10-11 01:41:11.381698|2017-10-11 01:41:11.381698
NCT01858532|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2017-08-16|||May 17, 2013||2013-05-17|August 2017|2017-08-01|April 8, 2020|Anticipated|2020-04-08|July 31, 2018|Anticipated|2018-07-31||Interventional|SONAR||Study Of Diabetic Nephropathy With Atrasentan|A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan|Recruiting||Phase 3|4148|Anticipated|AbbVie||2|||f||||t||||||||||2017-10-11 01:41:11.790728|2017-10-11 01:41:11.790728
NCT01858519|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2016-09-19|||August 2013||2013-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy|A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Who Are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors|Completed||N/A|1310|Actual|AbbVie|||2||f||||f||||||Samples Without DNA|"     Serum specimens for subsequent assay for antibodies to HEV and other selected porcine viruses   "|||2017-10-11 01:41:14.433887|2017-10-11 01:41:14.433887
NCT01858506|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2016-04-14|||August 2014||2014-08-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|I-ACE||Diabetes Lifestyle Assessment and Educational Tools|Development and Evaluation of Lifestyle Assessment and Educational Tools for Diabetic People With Limited Literacy|Completed||N/A|50|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 01:41:14.61169|2017-10-11 01:41:14.61169
NCT01858493|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-07-20|||May 2013||2013-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|CACTUS-D||Continence Across Continents to Upend Stigma and Dependency|Phase 3 Cluster Randomised Trial Testing the Efficacy of a Continence Promotion Intervention to Improve Urinary Symptoms and Quality of Life, and Reduce Stigma and Falls in Older Community-dwelling Women With Untreated Incontinence|Completed||N/A|910|Actual|Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal||2|||f||||f||||||||||2017-10-11 01:41:14.722754|2017-10-11 01:41:14.722754
NCT01858480|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-07-12|||July 2013||2013-07-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure|Randomized, Double-Blind, Placebo-Controlled Study To Evaluate D-Ribose For The Treatment Of Congestive Heart Failure|Withdrawn||Phase 2|0|Actual|RiboCor, Inc.||2||Terminated due to slow enrollment|f||||f||||||||No|Study terminated due to slow enrollment|2017-10-11 01:41:14.86334|2017-10-11 01:41:14.86334
NCT01858467|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2013-05-26|||May 2013||2013-05-01|May 2013|2013-05-01|July 2014|Anticipated|2014-07-01|May 2014|Anticipated|2014-05-01||Interventional|||Supreme LMA and Endotracheal Intubation Use in Caesarean Section|Supreme LMA Versus Endotracheal Intubation in General Anaesthesia for Elective Caesarean Section- a Randomised Controlled Trial|Unknown status|Not yet recruiting|N/A|920|Anticipated|QuanZhou Women and Children's Hospital||2|||f||||t||||||||||2017-10-11 01:41:15.016285|2017-10-11 01:41:15.016285
NCT01858454|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-17|2015-04-15|||March 2013||2013-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Hand-assisted Laparoscopic Surgery (HALS) for Myomectomy|A Randomized Controlled Trial of Hand-assisted Laparoscopic Myomectomy Versus Abdominal Myomectomy: Surgical Outcomes and Patient Satisfactions|Terminated||Phase 3|21|Actual|CHA University||2||The study enrollment is not enough|f||||f||||||||||2017-10-11 01:41:15.155824|2017-10-11 01:41:15.155824
NCT01858441|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-07-25|||April 2013||2013-04-01|July 2016|2016-07-01|June 2021|Anticipated|2021-06-01|June 2018|Anticipated|2018-06-01||Interventional|ABIGENE||Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate|Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate|Recruiting||N/A|330|Anticipated|Centre Antoine Lacassagne||1|||f||||f||||||||||2017-10-11 01:41:15.256661|2017-10-11 01:41:15.256661
NCT01858389|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-07-17|2016-09-13|2015-12-15|July 2013||2013-07-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All participants who received at least 1 dose of study medication.|A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer|Phase 2 Open Label Trial Of Oral Intermittent Dacomitinib In Patients With Advanced Nsclc|Completed||Phase 2|41|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:41:17.55467|2017-10-11 01:41:17.55467
NCT01858376|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-05-15|2015-03-19||March 2013||2013-03-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|Capros||Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans|Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans|Completed||N/A|24|Actual|Ohio State University||1|||f||||f||||||||||2017-10-11 01:41:19.862975|2017-10-11 01:41:19.862975
NCT01858350|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-16|||August 2009||2009-08-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing Sedation|Comparison of the Effectiveness of Complementary and Alternative Medicine (CAM) Therapies in Pediatric Patients Undergoing Medical Resonance Imagining (MRI) Studies|Completed||N/A|471|Actual|Wayne State University||4|||f||||t||||||||||2017-10-11 01:41:20.296062|2017-10-11 01:41:20.296062
NCT01858337|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-05-16|||February 2009||2009-02-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|VaVo||Mum Can I Have Vegetables Again? Development of Vegetable Preferences|Mum Can I Have Vegetables Again? Development of Vegetable Preferences.|Completed||N/A|101|Actual|Wageningen University||4|||f||||t||||||||||2017-10-11 01:41:20.403548|2017-10-11 01:41:20.403548
NCT01858324|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-12-02|||March 2014||2014-03-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of Educational Tools for Pregnant Women|Evaluation of Educational Tools Concerning Hypertension in Ambulatory Pregnant Women, Compared With Usual Antenatal Care|Completed||N/A|247|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 01:41:20.538228|2017-10-11 01:41:20.538228
NCT01858311|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-01-20|||March 2013||2013-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|September 2016|Actual|2016-09-01||Observational|NIIB||Nutrition Blood Outcomes Following Tocotrienol N2B|Human Blood Outcomes Following Tocotrienol Supplementation - Nutrition Phase IIB NUTRITION PHASE IIB|Active, not recruiting||N/A|300|Anticipated|Ohio State University|||3||f||||t||||||Samples With DNA|"     Blood Draw   "|||2017-10-11 01:41:20.652434|2017-10-11 01:41:20.652434
NCT01858298|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2015-05-26|||December 2013||2013-12-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Conservative Versus Non-conservative Treatment for Severe Dental Caries|Conservative Versus Non-conservative Treatment for Severe Dental Caries in Preschool Children and Its Impact on Oral Health-related Quality of Life, Anthropometric Measures, Space Loss and Anxiety: a Randomized Clinical Trial|Completed||N/A|100|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:41:20.762949|2017-10-11 01:41:20.762949
NCT01858285|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-08-24|||November 2010||2010-11-01|August 2017|2017-08-01||||December 2020|Anticipated|2020-12-01||Observational|||Genetics of Severe Early Onset Epilepsies|Genetics of Epilepsy and Related Disorders|Recruiting||N/A|500|Anticipated|Boston Children’s Hospital|||1||f||||f||||||Samples With DNA|"     DNA from whole blood or saliva   "|||2017-10-11 01:41:20.855706|2017-10-11 01:41:20.855706
NCT01858272|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-01-10|||September 2004||2004-09-01|January 2017|2017-01-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||Preliminary Testing of New Treatment for Chronic Leg Wounds|Phase I Trial to Evaluate the Safety of H5.020CMV.PDGF-b and Limb Compression Bandage for the Treatment of Venous Leg Ulcer (Trial A)|Completed||Phase 1|15|Actual|University of Pennsylvania||1|||f||||||||||||||2017-10-11 01:41:21.132976|2017-10-11 01:41:21.132976
NCT01858259|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-08-12|||May 2013||2013-05-01|August 2014|2014-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01|12 Months|Observational [Patient Registry]|||Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis|Prevention and Treatment of Interstitial Lung Disease in Systemic Sclerosis|Unknown status|Recruiting|N/A|1372|Anticipated|Charite University, Berlin, Germany|||5||f||||t||||||||||2017-10-11 01:41:21.249893|2017-10-11 01:41:21.249893
NCT01858246|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-03-29|||January 2014||2014-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge|A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge|Recruiting||N/A|60|Anticipated|Ninewells Hospital||2|||f||||f||||||||||2017-10-11 01:41:21.451197|2017-10-11 01:41:21.451197
NCT01858233|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-12-03|||November 2012||2012-11-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|IBEP||The IBEP Study: an Intervention for Lifestyle Modification in Women With Gestational Diabetes|The IBEP Study: a Randomized Control Trial of an Educational Intervention for Lifestyle Modification in Women With Gestational Diabetes.|Completed||N/A|110|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:41:21.588019|2017-10-11 01:41:21.588019
NCT01858194|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-04-15|||March 2013||2013-03-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|RESET-VT||REnal Sympathetic dEnervaTion as an a Adjunct to Catheter-based VT Ablation|REnal Sympathetic dEnervaTion as an a Adjunct to Catheter-based VT Ablation|Active, not recruiting||N/A|202|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-11 01:41:21.927012|2017-10-11 01:41:21.927012
NCT01858181|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-02-28|||January 2015||2015-01-01|February 2014|2014-02-01||||December 2015|Anticipated|2015-12-01||Interventional|||Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies|A Phase I Study of Subcutaneous Ocaratuzumab (Fab- and Fc-engineered Anti-CD20 Monoclonal Antibody) in Patients With Previously Treated CD20+ B-Cell Malignancies|Unknown status|Not yet recruiting|Phase 1|9|Anticipated|Mentrik Biotech, LLC||3|||f||||f||||||||||2017-10-11 01:41:22.084214|2017-10-11 01:41:22.084214
NCT01858168|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-05-09|||July 2013||2013-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma|Phase I Study of Olaparib and Temozolomide in Adult Patients With Recurrent/Metastatic Ewing's Sarcoma Following Failure of Prior Chemotherapy|Recruiting||Phase 1|93|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-11 01:41:22.175888|2017-10-11 01:41:22.175888
NCT01858155|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-01-30|||May 2013||2013-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors|Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors|Recruiting||Phase 1|9|Anticipated|C17 Council||1|||f||||t||||||||||2017-10-11 01:41:22.316177|2017-10-11 01:41:22.316177
NCT01858142|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-03-18|||June 2013||2013-06-01|March 2016|2016-03-01||||August 2013|Actual|2013-08-01||Interventional|PPDT||Helping Parents to Decide Whether They Want to be With Their Child During Anesthesia Induction|Preparing Parents to be Present for Their Child's Anesthesia Induction: A Randomized Control Effectiveness Trial|Completed||N/A|104|Actual|IWK Health Centre||2|||f||||f||||||||||2017-10-11 01:41:22.427663|2017-10-11 01:41:22.427663
NCT01858129|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-01-28|||March 2012||2012-03-01|January 2015|2015-01-01||||May 2015|Anticipated|2015-05-01||Interventional|||Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn|Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn in Infants Born at >34 Weeks Gestation: A Prospective, Randomized, Double Blind, Placebo Controlled Study.|Unknown status|Recruiting|Phase 2|56|Anticipated|Bnai Zion Medical Center||2|||f||||f||||||||||2017-10-11 01:41:22.504812|2017-10-11 01:41:22.504812
NCT01858116|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-01-12|||April 2013||2013-04-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||PET Study of Breast Cancer Patients Using [68Ga]ABY-025|An Exploratory Study to Evaluate [68Ga]ABY-025 for PET Imaging of HER2 Expression in Subjects With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|16|Actual|Biomedical Radiation Sciences||1|||f||||f||||||||||2017-10-11 01:41:22.607771|2017-10-11 01:41:22.607771
NCT01858103|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-03-31||||||March 2014|2014-03-01||||||||Expanded Access|||BMN 110 US Expanded Access Program|A Multicenter, Open-label BMN 110 US Expanded Access Program (BMN 110 US EAP) to Provide BMN 110 to Patients Diagnosed With MPS IVA|Approved for marketing||N/A|||BioMarin Pharmaceutical|||||||||||||||||||2017-10-11 01:41:22.690448|2017-10-11 01:41:22.690448
NCT01858090|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-05-20|||January 2009||2009-01-01|May 2013|2013-05-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Intrathecal Levobupivacaine With Opioids for Caesarean Section|Comparison of Intrathecal Levobupivacaine Combined With Sufentanil, Fentanyl, or Placebo for Elective Caesarean Section: A Prospective, Randomized, Double-blind, Controlled Study|Completed||Phase 3|93|Actual|Baskent University||3|||f||||t||||||||||2017-10-11 01:41:22.803387|2017-10-11 01:41:22.803387
NCT01858077|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-09-22|||August 2013||2013-08-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|AIDA||Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial|Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial (AIDA Trial): A Clinical Evaluation Comparing the Efficacy and Performance of ABSORB™ Everolimus Eluting Bioresorbable Vascular Scaffold Strategy Versus the XIENCE Family (XIENCE PRIME™ or XIENCE Xpedition™) Everolimus Eluting Coronary Stent Strategy in the Treatment of Coronary Lesions in Consecutive All-comers.|Active, not recruiting||N/A|1845|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 01:41:23.033373|2017-10-11 01:41:23.033373
NCT01858064|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-04-27|||April 2015||2015-04-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging|Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||1||Competing Departmental Studies|f||||f||||||||||2017-10-11 01:41:23.230687|2017-10-11 01:41:23.230687
NCT01858051|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-03-28|||January 2015||2015-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients|Bolus vs. Divided Cholecalciferol Dosing to Optimize Perioperative Vitamin D Status for Joint Replacement Surgery|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 01:41:23.336437|2017-10-11 01:41:23.336437
NCT01858038|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-01-15|||May 2013||2013-05-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Gene Expression During Surgical Scar Remodeling by Fractional Photothermolysis|Gene Expression During Surgical Scar Remodeling by Fractional Photothermolysis|Unknown status|Recruiting|Phase 1|10|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:41:23.438239|2017-10-11 01:41:23.438239
NCT01858025|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-08-14|||July 2013||2013-07-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|July 2017|Actual|2017-07-01||Interventional|||Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma|A Pilot Feasibility Study of Definitive Concurrent Chemoradiation With Pencil Beam Scanning Proton Beam in Combination With 5-Fluorouracil and Mitomycin-C for Carcinoma of the Anal Canal|Active, not recruiting||Early Phase 1|25|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:41:23.557682|2017-10-11 01:41:23.557682
NCT01858012|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-05-29|||May 2008||2008-05-01|May 2015|2015-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Insulin Resistance in HCV Infection|Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos|Recruiting||N/A|200|Anticipated|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     serum samples for analysis   "|||2017-10-11 01:41:23.662525|2017-10-11 01:41:23.662525
NCT01857999|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-05-17|||September 2008||2008-09-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Losartan in Decompensated Heart Failure|Short-term add-on Therapy With Angiotensin Receptor Blocker for End-stage Inotrope-dependent Heart Failure Patients: B-type Natriuretic Peptide Reduction in a Randomized Clinical Trial|Completed||Phase 4|21|Actual|InCor Heart Institute||2|||f||||t||||||||||2017-10-11 01:41:23.758136|2017-10-11 01:41:23.758136
NCT01857986|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-05-21|2016-09-06||September 2013||2013-09-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Evaluating Air Leak Detection in Intubated Patients|A Study to Evaluate Air Leak Detection Above the Endotracheal Cuff in Intubated Patients Using the AnapnoGuard 100 System|Completed||N/A|76|Actual|Hospitech Respiration||2|||f||||f||||||||||2017-10-11 01:41:23.878766|2017-10-11 01:41:23.878766
NCT01857973|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-08-30|||June 2013||2013-06-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|OCL||Overnight Closed Loop Study in U.S.|In-Clinic Feasibility Study to Observe the Overnight Closed Loop System|Completed||N/A|78|Actual|Medtronic Diabetes||1|||f||||f||||||||||2017-10-11 01:41:24.188606|2017-10-11 01:41:24.188606
NCT01857960|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-12-01|||May 2012||2012-05-01|December 2014|2014-12-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Observational|||Attitudes and Knowledge of Acne in Mexican Adolescents|Survey About Knowledge and Attitudes Regarding Acne in Mexican Adolescents|Unknown status|Recruiting|N/A|1000|Anticipated|Universidad Autonoma de San Luis Potosí|||1||f||||f||||||||||2017-10-11 01:41:24.275179|2017-10-11 01:41:24.275179
NCT01857947|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-12-02|||March 2013||2013-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|UTAPE BPCO||Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER|Usefulness of Pro-adrenomedullin (MR proADM)as a Predictor of Outcome in Acute Exacerbations of COPD Visiting the Emergency Room|Completed||N/A|370|Actual|ThermoFisher Scientific Brahms Biomarkers France||1|||f||||f||||||||||2017-10-11 01:41:24.3716|2017-10-11 01:41:24.3716
NCT01857934|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-06-07|||July 5, 2013|Actual|2013-07-05|June 2017|2017-06-01|July 31, 2021|Anticipated|2021-07-31|January 31, 2021|Anticipated|2021-01-31||Interventional|||Therapy for Children With Advanced Stage Neuroblastoma|Neuroblastoma Protocol 2012: Therapy for Children With Advanced Stage High-Risk Neuroblastoma|Recruiting||Phase 2|210|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|t|t|f||||||2017-10-11 01:41:24.462553|2017-10-11 01:41:24.462553
NCT01857921|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-02-04|||December 2010||2010-12-01|February 2014|2014-02-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery||Unknown status|Recruiting|N/A|376|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:41:24.682736|2017-10-11 01:41:24.682736
NCT01857908|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-06-19|||June 2012||2012-06-01|June 2015|2015-06-01||||November 2014|Actual|2014-11-01||Observational|||A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone||Completed||N/A|20|Actual|University Health Network, Toronto|||1||f||||||||||||||2017-10-11 01:41:24.764871|2017-10-11 01:41:24.764871
NCT01857895|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-05-12|||May 16, 2013|Actual|2013-05-16|May 2017|2017-05-01|November 1, 2013|Actual|2013-11-01|November 1, 2013|Actual|2013-11-01||Interventional|||Feasibility Study of Exenatide by Continuous Subcutaneous Infusion|An Open-Label Exploratory Study to Investigate the Feasibility of Administering Exenatide by Continuous Subcutaneous Infusion to Healthy Subjects|Completed||Phase 1|8|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:41:24.842201|2017-10-11 01:41:24.842201
NCT01857882|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-06-16|2015-03-19||September 2012||2012-09-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|DSW|All patients reported baseline clinical characteristics. One patient in each arm did not have evaluable decisional self-efficacy and conflict scores post-treatment, so their baseline scores were not included in the analysis of these variables. Therefore, for these measures at baseline, n=19 in the standard care arm and n=20 in the workshop arm.|Decision Support Workshop for Breast Reconstruction|Breast Reconstruction Decision Workshop Pilot RCT (Randomized Controlled Trial)|Completed||N/A|41|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:41:24.94328|2017-10-11 01:41:24.94328
NCT01857856|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-10-24|||May 2013||2013-05-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|January 2020|Anticipated|2020-01-01||Interventional|i-PHORECAST||PHOspholamban RElated CArdiomyopathy STudy - Intervention|PHOspholamban RElated CArdiomyopathy STudy - Intervention (Efficacy Study of Eplerenone in Presymptomatic PLN-R14del Carriers)|Recruiting||Phase 3|150|Anticipated|University Medical Center Groningen||2|||f||||t||||||||||2017-10-11 01:41:25.307989|2017-10-11 01:41:25.307989
NCT01857843|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-02-04|||November 2009||2009-11-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome||Completed||Phase 4|160|Actual|Yonsei University||4|||f||||f||||||||||2017-10-11 01:41:25.422364|2017-10-11 01:41:25.422364
NCT01857830|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2013-08-19|||April 2013||2013-04-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|R&R||The Relaxation vs. Retreat Study|The Effect of a Short Term Meditation Retreat on Markers of Cellular Stress and Aging|Completed||N/A|96|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:41:25.504568|2017-10-11 01:41:25.504568
NCT01857817|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-05-19|||June 2013||2013-06-01|December 2015|2015-12-01||||April 2016|Actual|2016-04-01||Interventional|||Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer|A Randomized, Placebo Controlled, Multicenter Phase 2 Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer|Active, not recruiting||Phase 2|90|Anticipated|Vicus Therapeutics||2|||f||||||||||||||2017-10-11 01:41:25.584114|2017-10-11 01:41:25.584114
NCT01857804|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-11-12|||January 2013||2013-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Surgical Treatment of Peri-implantitis|Surgical Treatment of Peri-implantitis With and Without Adjunctive Use of Antibiotics : a Controlled and Randomized Clinical Study|Completed||Phase 4|100|Actual|Göteborg University||4|||f||||f||||||||||2017-10-11 01:41:25.739975|2017-10-11 01:41:25.739975
NCT01857791|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-09-09|||January 2011||2011-01-01|September 2015|2015-09-01||||December 2016|Anticipated|2016-12-01||Interventional|REWARD Teens||Efficacy of a Clinic-based, Multi- Disciplinary, Pediatric Weight Management Program|Efficacy of a Clinic-based, Multi- Disciplinary, Pediatric Weight Management Program|Unknown status|Recruiting|N/A|40|Anticipated|University of Vermont||1|||f||||f||||||||||2017-10-11 01:41:25.927048|2017-10-11 01:41:25.927048
NCT01857765|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2014-10-10|||May 2013||2013-05-01|October 2014|2014-10-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Breast Augmentation Rehabilitation Program|How Rehabilitation Affects the Time to Pain-free Living After Endoscopic Transaxillary Subpectoral Breast Augmentation|Withdrawn||N/A|0|Actual|University of British Columbia||2||The resident in charge of the project has graduated so we decided to close this study|f||||||||||||||2017-10-11 01:41:26.094073|2017-10-11 01:41:26.094073
NCT01857752|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-01-26|||March 2012|Actual|2012-03-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala|Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala|Terminated||Phase 2|3|Actual|Stanford University||1||accrual|f||||||||||||||2017-10-11 01:41:26.195245|2017-10-11 01:41:26.195245
NCT01857726|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-04-27|||July 2013||2013-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion|A Randomized Open Label Pilot Study Comparing Transarterial Chemoembolization Versus Transarterial Chemoembolization/Transarterial Chemoinfusion Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion|Withdrawn||N/A|0|Actual|Seoul National University Hospital||2||No participants were enrolled|f||||f||||||||||2017-10-11 01:41:26.288947|2017-10-11 01:41:26.288947
NCT01857713|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-05-20|2013-12-17||April 2013||2013-04-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Patients who enrolled in the study and had a Reza Band fitted by the Investigator and who had at least one post-baseline RSI assessment were included.|Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device|A Multi-Center, Non-Randomized, Prospective Study of the Reza Band™ Upper Esophageal Sphincter (UES) Assist Device for the Treatment of Esophagopharyngeal Reflux|Completed||N/A|95|Actual|Somna Therapeutics, L.L.C.||1|||f||||f||||||||||2017-10-11 01:41:26.397318|2017-10-11 01:41:26.397318
NCT01857700|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-04-23|||June 2013||2013-06-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|CTT-VMMC||Economic Compensation to Increase Demand for Voluntary Medical Male Circumcision|Compensation for Transport Costs and Lost Wages Associated With Voluntary Medical Male Circumcision (VMMC) Uptake: an Intervention to Increase VMMC Demand Among Older Men in Nyanza Province|Completed||N/A|1504|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:41:26.68979|2017-10-11 01:41:26.68979
NCT01857687|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-11-26|||May 2013||2013-05-01|November 2013|2013-11-01||||May 2014|Anticipated|2014-05-01||Observational|||Evaluation of FFR, WSS, and TPF Using CCTA|Noninvasive Evaluation of Ischemia Causing Coronary Stenosis, Wall Shear Stress, and Total Plaque Force Using Coronary CT Angiography (CCTA) and Physics-based Analytic Model Derived From Conservation of Energy|Unknown status|Recruiting|N/A|100|Anticipated|Seoul National University Hospital|||1||f||||||||||||||2017-10-11 01:41:26.78185|2017-10-11 01:41:26.78185
NCT01857674|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-08-01|||May 2013||2013-05-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|ECHOLPE||Evaluation of Laryngeal Ultrasonography Performance in Predicting Major Post Extubation Laryngeal Edema in Intensive Care Patients|Evaluation of Laryngeal Ultrasonography Performance in Predicting Major Post Extubation Laryngeal Edema in Intensive Care Patients|Unknown status|Recruiting|N/A|1000|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-11 01:41:26.88034|2017-10-11 01:41:26.88034
NCT01857648|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-17|||March 2011||2011-03-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Physical Activity Promotion in the Brazilian Primary Health Care Using Community Health Workers Counseling|Physical Activity Promotion in the Brazilian Primary Health Care Using Community Health Workers Counseling|Completed||N/A|176|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 01:41:27.082595|2017-10-11 01:41:27.082595
NCT01857635|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-06-07|||February 2013||2013-02-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|TpCO2-NIV||Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure|Use of TpCO2 (Transcutaneous CO2 Measurement)as PaCO2 Predictor During Non Invasive Ventilation (NIV) in Case of Acute Hypercapnic Respiratory Failure|Completed||N/A|20|Actual|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 01:41:27.186858|2017-10-11 01:41:27.186858
NCT01857622|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-01-15|2015-01-15||November 2011||2011-11-01|January 2015|2015-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment|Phase III Clinical Study of DU-176b (Non-valvular Atrial Fibrillation): Japanese, Multicenter, Open-label Study of DU-176b in Patients With Non-valvular Atrial Fibrillation and Severe Renal Impairment (SRI)|Completed||Phase 3|93|Actual|Daiichi Sankyo, Inc.||3|||f||||t||||||||||2017-10-11 01:41:27.274374|2017-10-11 01:41:27.274374
NCT01857609|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-05-15|||August 2012||2012-08-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|MPI||Clinical Trial to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin|The Cross-Over Study to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Korean Men.|Completed||Phase 1|24|Actual|Seoul National University Hospital||3|||f||||f||||||||||2017-10-11 01:41:27.844037|2017-10-11 01:41:27.844037
NCT01857596|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-10-26|||April 2013||2013-04-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PURPLE||Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety|A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder|Completed||Phase 1/Phase 2|30|Actual|S1 Biopharma, Inc.||1|||f||||f||||||||||2017-10-11 01:41:27.950092|2017-10-11 01:41:27.950092
NCT01857583|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-02-25|2015-01-15||March 2012||2012-03-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||The number of baseline participants reflects the safety analysis population.|Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs|Phase III Clinical Study of DU-176b (Venous Thromboembolism): Japanese, Multicenter, Open-label Study of DU-176b in Patients With Severe Renal Impairment (SRI) Undergoing Orthopedic Surgery of the Lower Limbs|Completed||Phase 3|80|Actual|Daiichi Sankyo, Inc.||4|||f||||t||||||||||2017-10-11 01:41:28.081146|2017-10-11 01:41:28.081146
NCT01857570|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-05-13|||June 2013||2013-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2014|Actual|2014-04-01||Observational|VuisT||Volume CT of the Wrist and Carpus After Trauma|Volume CT of the Wrist and Carpus After Trauma: A Pilot Study|Completed||N/A|100|Actual|Radboud University|||1||f||||f||||||||||2017-10-11 01:41:28.860528|2017-10-11 01:41:28.860528
NCT01857557|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-08-16|||August 2012||2012-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of an Aerobic Exercise Program in Migraine Management|Evaluation of an Aerobic Exercise Program in Migraine Management|Recruiting||N/A|80|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 01:41:28.951957|2017-10-11 01:41:28.951957
NCT01857544|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-10-27|||June 2013||2013-06-01|October 2014|2014-10-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy|Phase 4 Study of Intravitreal Aflibercept Injection for Recalcitrant Central Retinal Vein Occlusion Associated Macular Edema Despite Prior Anti-Vascular Endothelial Growth Factor (VEGF) Therapy. (ARChiMEDES)|Unknown status|Active, not recruiting|Phase 4|10|Actual|Tennessee Retina||1|||f||||f||||||||||2017-10-11 01:41:29.05701|2017-10-11 01:41:29.05701
NCT01857531|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-09-05|2014-08-13||June 2013||2013-06-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Interventional|Ganaxolone||Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate|Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate|Completed||Phase 2|36|Actual|Duke University||1|||f||||t||||||||||2017-10-11 01:41:29.176177|2017-10-11 01:41:29.176177
NCT01857518|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-02-11|||August 2013||2013-08-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|ADODEP||Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study|Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study.|Recruiting||N/A|80|Anticipated|Centre Hospitalier St Anne||2|||f||||f||||||||||2017-10-11 01:41:29.472477|2017-10-11 01:41:29.472477
NCT01857505|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-12-17||||||December 2014|2014-12-01||||January 2014|Actual|2014-01-01||Observational|||Hip Replacement in a High Volume Community Hospital: Effect on Length of Stay and Hospital Cost|Introduction of the Direct Anterior Approach to Hip Replacement Into a High Volume Community Hospital: Effect on Length of Stay and Hospital Cost|Withdrawn||N/A|0|Actual|Anne Arundel Health System Research Institute|||2|Funding|f||||f||||||||||2017-10-11 01:41:29.578063|2017-10-11 01:41:29.578063
NCT01857492|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2015-03-10|||March 2013||2013-03-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|tDCS||tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis|tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center||2||Inactive|f||||f||||||||||2017-10-11 01:41:29.80898|2017-10-11 01:41:29.80898
NCT01857479|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-08-04|||May 2013||2013-05-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis||Completed||Phase 2/Phase 3|21|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 01:41:29.928308|2017-10-11 01:41:29.928308
NCT01857466|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-06-24|||December 2012||2012-12-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix|Additional Benefit of Hemostatic Sealant in Preserving Ovarian Reserve During Laparoscopic Ovarian Cystectomy: a Randomized Controlled Trial|Completed||Phase 3|100|Actual|CHA University||2|||f||||f||||||||||2017-10-11 01:41:30.04018|2017-10-11 01:41:30.04018
NCT01857453|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-03-07|||April 2013||2013-04-01|March 2016|2016-03-01||||October 2017|Anticipated|2017-10-01||Interventional|RSMA2010||Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas|National, Multicentric, Prospective Phase II Study Estimating the Interest of a Dose Decrease for Radiation Therapy Associated With a Carboplatine and Etoposide Based Chemotherapy for the Treatment of Standard Risk Adult Medulloblastomas|Recruiting||Phase 2|97|Anticipated|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-11 01:41:30.134278|2017-10-11 01:41:30.134278
NCT01857440|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-09-20|||May 2013||2013-05-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|FLIPR||The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study|The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study|Completed||N/A|32|Actual|Ohio State University|||2||f||||f||||||||||2017-10-11 01:41:30.32603|2017-10-11 01:41:30.32603
NCT01857427|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-09-27|||August 2012||2012-08-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|August 2018|Anticipated|2018-08-01||Observational|||A Prospective Observational Cohort to Study the Genetics of Obstructive Sleep Apnea and Associated Co-Morbidities|A Prospective Observational Cohort to Study the Genetics of Obstructive Sleep Apnea and Associated Co-Morbidities|Recruiting||N/A|5000|Anticipated|Ohio State University|||1||f||||t||||||Samples With DNA|"     blood or saliva sample   "|||2017-10-11 01:41:30.430132|2017-10-11 01:41:30.430132
NCT01856517|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-07-26|||August 2013||2013-08-01|July 2017|2017-07-01|September 2014|Actual|2014-09-01|August 2013|Actual|2013-08-01||Interventional|CATACHOC||Upregulation of Alpha-1 Receptors Upon Septic Shock?|Up Regulation of Alpha-1 Receptors Upon Septic Shock ?|Terminated||Phase 2/Phase 3|40|Anticipated|Direction Centrale du Service de Santé des Armées||2|||f||||t||||||||||2017-10-11 01:41:45.410508|2017-10-11 01:41:45.410508
NCT01857414|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-07-13|||November 2013||2013-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|November 2017|Anticipated|2017-11-01||Interventional|CONDI2||Effect of RIC on Clinical Outcomes in STEMI Patients Undergoing pPCI|Effect of Remote Ischaemic Conditioning on Clinical Outcomes in ST-elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Multinational Multicentre Randomised Controlled Clinical Study|Recruiting||N/A|2600|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:41:30.50792|2017-10-11 01:41:30.50792
NCT01857401|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-09-02|||April 2012||2012-04-01|September 2014|2014-09-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Development of a Novel Human In Vitro Sarcoidosis Model|Development of a Novel Human In Vitro Sarcoidosis Model|Unknown status|Recruiting|N/A|60|Anticipated|Ohio State University|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 01:41:30.650884|2017-10-11 01:41:30.650884
NCT01857388|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-03-30|||January 2014||2014-01-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||School-Based Mental Health Program Implementation in Uganda|Implementing a School-based Mental Health Prevention Program in Ugandan Schools|Completed||N/A|79|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 01:41:30.761092|2017-10-11 01:41:30.761092
NCT01857375|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-20|||October 2009||2009-10-01|May 2013|2013-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||A Study of Improved Efficacy, Safety and Compliance to Administer Insulin in Pen vs. Vial and Syringe|A Study of Improved Efficacy, Safety and Compliance to Administer Insulin in Pen vs. Vial and Syringe|Completed||N/A|35|Actual|Northwell Health|||2||f||||t||||||||||2017-10-11 01:41:30.852873|2017-10-11 01:41:30.852873
NCT01857362|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-10-23|2014-06-09||May 2013||2013-05-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Bioequivalence of Orfadin 20 mg Compared to Orfadin 10 mg Capsules.|A Study to Evaluate the Bioequivalence of Orfadin Capsules 20 mg Compared to Orfadin Capsules 10 mg. An Open-label, Randomized, Cross-over, Single-dose Study in Healthy Volunteers.|Completed||Phase 1|12|Actual|Swedish Orphan Biovitrum||2|||f||||f||||||||||2017-10-11 01:41:30.949169|2017-10-11 01:41:30.949169
NCT01857336|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-11-25|||March 2013||2013-03-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation|Infusion of Recombinant Human Granulocyte Colony Stimulating Factor Mobilized Peripheral Harvest for Poor Engraftment After Hematopoietic Stem Cell Transplantation|Recruiting||N/A|20|Anticipated|Peking University People's Hospital||1|||f||||t||||||||||2017-10-11 01:41:31.32136|2017-10-11 01:41:31.32136
NCT01857323|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-05-19|2015-05-19|2014-05-08|May 2013||2013-05-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional||ITT population|Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)|A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter|Completed||Phase 3|317|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-11 01:41:31.452921|2017-10-11 01:41:31.452921
NCT01857310|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-03-30|||June 2013||2013-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|FAZST||Folic Acid and Zinc Supplementation Trial (FAZST)|Folic Acid and Zinc Supplementation Trial: A Multi-center, Double-blind, Block-randomized, Placebo-controlled Trial|Recruiting||N/A|2400|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-10-11 01:41:31.917051|2017-10-11 01:41:31.917051
NCT01857297|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2016-07-17|2013-11-26||May 2013||2013-05-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers|A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2013/2014 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: 'Adults' (Aged 18 to 59 Years) and 'Older Adults' (Aged 60 Years or Older).|Completed||Phase 4|120|Actual|Seqirus||2|||f||||f||||||||||2017-10-11 01:41:32.088763|2017-10-11 01:41:32.088763
NCT01857284|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2013-05-16|||September 2009||2009-09-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis|A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Clinical Trial to Investigate Safety and Efficacy of Tauroursodeoxycholic Acid Capsules in Treatment of Adult Primary Biliary Cirrhosis|Completed||Phase 3|216|Actual|Beijing Friendship Hospital||2|||f||||t||||||||||2017-10-11 01:41:32.534307|2017-10-11 01:41:32.534307
NCT01857271|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-01-23|||November 2013||2013-11-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|EVENT||Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer|EValuation of Erlotinib as a Neoadjuvant Therapy in Stage III NSCLC Patients With EGFR Mutations (EVENT Trial)|Recruiting||Phase 2|55|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 01:41:32.708371|2017-10-11 01:41:32.708371
NCT01857258|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-02-14|2016-09-30||May 2013||2013-05-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Interventional|||Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction|Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction|Completed||N/A|15|Actual|Ohio State University|This study was limited to normoglycemic adults who were healthy. Future studies may consider populations having glucose intolerance to examine the extent to which green tea attenuates starch-induced hyperglycemia.|2|||f||||f||||||||Yes||2017-10-11 01:41:32.85695|2017-10-11 01:41:32.85695
NCT01857245|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-01-22|||July 2013||2013-07-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Intensive Models of HCV Care for Injection Drug Users|Intensive Models of HCV Care for Injection Drug Users|Active, not recruiting||N/A|150|Anticipated|Albert Einstein College of Medicine, Inc.||3|||f||||t||||||||||2017-10-11 01:41:33.249643|2017-10-11 01:41:33.249643
NCT01854333|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-06-23|||January 2011||2011-01-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||The Swedish Versions of ADOS and ADI-R: Psychometric Validation|The Swedish Versions of ADOS and ADI-R: Psychometric Validation|Completed||N/A|50|Actual|Karolinska Institutet||1|||f||||t||||||||||2017-10-11 01:42:32.332292|2017-10-11 01:42:32.332292
NCT01857232|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2016-07-28||2016-07-28|October 2013||2013-10-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy|Randomised, Double-blind, Dose-finding Phase II Study to Assess the Efficacy of APD403 in the Prevention of Nausea and Vomiting Caused by Cisplatin- or Anthracycline/Cyclophosphamide (AC)-Based Chemotherapy|Completed||Phase 2|343|Actual|Acacia Pharma Ltd||5|||f||||t||||||||||2017-10-11 01:41:33.399868|2017-10-11 01:41:33.399868
NCT01857219|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-01-27|||January 2013||2013-01-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2015|Actual|2015-11-01||Interventional|||A Brain Imaging Study of Tai Chi on Fibromyalgia|A Brain Imaging Study of Tai Chi on Fibromyalgia|Active, not recruiting||N/A|60|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:41:33.4836|2017-10-11 01:41:33.4836
NCT01857206|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-11-18|2014-09-18||May 2013||2013-05-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age|A Phase III, Observer Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Chicken Eggs (Fluvirin®), in Healthy Children and Adolescents 4 to 17 Years of Age.|Completed||Phase 3|2055|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:41:33.61168|2017-10-11 01:41:33.61168
NCT01857193|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-05-28|||September 6, 2013|Actual|2013-09-06|May 2017|2017-05-01|September 28, 2018|Anticipated|2018-09-28|September 28, 2018|Anticipated|2018-09-28||Interventional|||Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer|A Phase Ib Trial of LEE011 in Combination With Everolimus (RAD001) and Exemestane in the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer|Recruiting||Phase 1|142|Anticipated|Novartis||2|||f||||f|t|f||||||No||2017-10-11 01:41:35.006178|2017-10-11 01:41:35.006178
NCT01857180|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-11-16|||June 2012||2012-06-01|November 2015|2015-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comprehensive Laparoscopic Curriculum for Medical Students|Introduction of a Comprehensive Training Curriculum in Laparoscopic Surgery for Medical Students: a Randomized Trial.|Completed||N/A|24|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:41:35.179687|2017-10-11 01:41:35.179687
NCT01857167|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-03-11|||June 2013||2013-06-01|March 2015|2015-03-01||||December 2014|Actual|2014-12-01||Interventional|||Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients||Completed||N/A|185|Actual|Zhejiang University||3|||f||||||||||||||2017-10-11 01:41:35.263263|2017-10-11 01:41:35.263263
NCT01857154|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-11-21|||May 2013||2013-05-01|November 2013|2013-11-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||A Study of Changes in Bone Mineral Density as a Function of Consuming Two Different Forms of Calcium Carbonate|A Double-Blinded Randomized Controlled CER Study of Changes in Bone Mineral Density, Blood Chemistries, Self-Reported Quality of Life and Compliance as a Function of Consuming Micronized Versus Non-micronized Calcium Carbonate|Unknown status|Recruiting|N/A|160|Anticipated|Integrative Health Technologies, Inc.||4|||f||||f||||||||||2017-10-11 01:41:35.383375|2017-10-11 01:41:35.383375
NCT01857141|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2014-02-04|||February 2012||2012-02-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Comparative Study on the Effects of Epidural Dexmedetomidine on Heart Rate Variability During General Anesthesia in Patients Undergoing Gastrectomy||Completed||N/A|38|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:41:35.543398|2017-10-11 01:41:35.543398
NCT01857128|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-17|||March 2013||2013-03-01|May 2013|2013-05-01||||December 2014|Anticipated|2014-12-01||Interventional|||Pilonidal Disease Wound Healing Study|A Prospective Randomized Open-Label Study Examining the Efficacy of Drawtex® Hydroconductive Wound Dressing and Negative Pressure Wound Therapy in Pilonidal Cystectomy Wounds Healing by Secondary Intention - A Pilot Study|Unknown status|Recruiting|Phase 4|30|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||||2017-10-11 01:41:35.659707|2017-10-11 01:41:35.659707
NCT01857115|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-05-09|||April 2013||2013-04-01|May 2016|2016-05-01|April 2019|Anticipated|2019-04-01|November 2013|Actual|2013-11-01||Interventional|wCCyd||Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)|A MULTICENTER, OPEN LABEL STUDY OF WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (wCCyd) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS|Active, not recruiting||Phase 1/Phase 2|63|Actual|Stichting Hemato-Oncologie voor Volwassenen Nederland||1|||f||||||||||||||2017-10-11 01:41:35.788382|2017-10-11 01:41:35.788382
NCT01857102|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-05-05|2016-07-19||September 2013||2013-09-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Analysis population consists of all subjects that were dispensed at least one study lens.|Toric Eye Strain and Stability Study||Completed||N/A|159|Actual|Johnson & Johnson Vision Care, Inc.|Data collected on Neophyte population was for exploratory purpose only. The study was not powered to show differences in this population.|2|||f||||f||||||||||2017-10-11 01:41:35.911196|2017-10-11 01:41:35.911196
NCT01857089|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2014-04-10|||May 2013||2013-05-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|CaPAS||Characterization of Sitting Postures in Healthy Subjects|Characterization of Sitting Postures in Healthy Subjects|Completed||N/A|30|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 01:41:36.26507|2017-10-11 01:41:36.26507
NCT01857076|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-08-18|||February 2013||2013-02-01|May 2013|2013-05-01||||May 2015|Actual|2015-05-01||Interventional|||Surgical Treatment in Diabetic Patients With Grade 1 Obesity|Surgical Treatment in Diabetic Patients With Grade 1 Obesity|Completed||N/A|75|Actual|Hospital Sirio-Libanes||3|||f||||f||||||||||2017-10-11 01:41:36.368475|2017-10-11 01:41:36.368475
NCT01857063|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2017-03-10|2014-03-24||June 2013||2013-06-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)|A Phase III, Double-Blind, Randomized, Placebo-Controlled Cross-over Clinical Trial to Study the Efficacy and Safety of MK-0476 in Japanese Pediatric Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|220|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:41:36.480849|2017-10-11 01:41:36.480849
NCT01857050|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-16|2014-02-24|||April 2013||2013-04-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins|Assessment of INR Prolongation in Patients Treated Simultaneously With Warfarin and Antibiotics From the Cephalosporins Family,Observational Retrospective Study.|Completed||N/A|236|Actual|Meir Medical Center|||1||f||||f||||||||||2017-10-11 01:41:37.049327|2017-10-11 01:41:37.049327
NCT01857037|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-02-26|||May 2011||2011-05-01|April 2011|2011-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|HISTO-RAD||Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI|Detection and Localization of Prostate Cancer Local Recurrences After Radiation Therapy Using Histoscanning™ and Multiparametric MRI|Completed||N/A|30|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 01:41:37.112895|2017-10-11 01:41:37.112895
NCT01857024|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-03-19|||September 2010||2010-09-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia|Renvela® Post-Marketing Observational Study to Monitor the Clinical Use in Adult Hyperphosphataemic Chronic Kidney Disease Patients Not On Dialysis With Serum Phosphorus ≥1.78 mmol/L|Completed||N/A|210|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 01:41:37.196116|2017-10-11 01:41:37.196116
NCT01857011|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-01-23|||April 2014|Actual|2014-04-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|ISAPA||Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty|Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty: a Randomized Controlled Trial|Completed||Phase 3|56|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 01:41:37.322673|2017-10-11 01:41:37.322673
NCT01856998|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2014-02-20|||May 2013||2013-05-01|February 2014|2014-02-01||||February 2014|Actual|2014-02-01||Interventional|PropofolTE||Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective Surgery|Therapeutic Equivalence Study of Propofol Using Target-Controlled Infusion of Propofol 2% (20 mg/mL) MCT Fresenius Compared With Diprivan® 20 mg/mL (AstraZeneca) in Patients Undergoing Elective Surgery|Completed||Phase 3|71|Actual|Fresenius Kabi||2|||f||||f||||||||||2017-10-11 01:41:37.422538|2017-10-11 01:41:37.422538
NCT01856985|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-10-09|||April 2013||2013-04-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation|The Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered Buccally or Sublingually at 78-84 Days Gestation: Two Pilot Studies|Completed||Phase 4|50|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-10-11 01:41:37.548469|2017-10-11 01:41:37.548469
NCT01856972|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-06-10|||May 2013||2013-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Does the Addition of Manual Therapy Techniques Increase Gastrocnemius/Soleus Length More Than Stretching Alone?|Does the Addition of Manual Therapy Techniques Increase Gastrocnemius/Soleus Length More Than Stretching Alone?|Completed||N/A|20|Actual|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-11 01:41:37.635858|2017-10-11 01:41:37.635858
NCT01856959|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-05-17|||November 2011||2011-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4|Response of Asthmatic Children's Lung Function to Nebulized Magnesium Sulfate After Acetylcholine Provocation Test: a Clinical Trail|Completed||N/A|330|Actual|Chongqing Medical University||3|||f||||f||||||||||2017-10-11 01:41:37.722939|2017-10-11 01:41:37.722939
NCT01856946|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-10-06|||May 2013||2013-05-01|October 2016|2016-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effect of Vitamin D Supplementation on Oral Glucose Tolerance Among Obese Adolescents|Effect of 4,000 IU Vitamin D3 Supplementation on Oral Glucose Tolerance Among Vitamin D Deficient Obese Adolescent|Completed||N/A|15|Actual|University of Missouri-Columbia||1|||f||||f||||||||||2017-10-11 01:41:37.802663|2017-10-11 01:41:37.802663
NCT01856933|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-06-23|2015-03-05||May 2013||2013-05-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)|BrUOG 263: PSMA ADC for Recurrent Glioblastoma Multiforme (GBM): A Phase II Brown University Oncology Research Group Study|Completed||Phase 2|6|Actual|Brown University||1|||f||||t||||||||||2017-10-11 01:41:37.894368|2017-10-11 01:41:37.894368
NCT01856920|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-08-24|||March 4, 2013||2013-03-04|August 18, 2017|2017-08-18|March 1, 2020|Anticipated|2020-03-01|September 1, 2019|Anticipated|2019-09-01||Interventional|||GI-6207 for Advanced Medullary Thyroid Cancer|A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer|Recruiting||Phase 2|37|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:41:38.161471|2017-10-11 01:41:38.161471
NCT01856894|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-02-16|||May 2013||2013-05-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries|Is Serum Anti-Mullerian Hormone (AMH) Level Associated With Body Weight, Glycemic and Lipidemic Markers in Adolescent Girls With Polycystic Ovaries?|Completed||N/A|90|Actual|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||1||f||||f||||||||||2017-10-11 01:41:38.358578|2017-10-11 01:41:38.358578
NCT01856881|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-11-05|||March 2013||2013-03-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Multiple Ascending Dose Study in Subjects With Type 2 Diabetes|A Randomized, Double-blind, Placebo-controlled, Ascending Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 876 in Subjects With Type 2 Diabetes|Terminated||Phase 1|86|Actual|Amgen||2||"This study was terminated on August 29th, 2014 due to a business decision by the Sponsor. The   study was not terminated due to a safety reason."|f||||f||||||||||2017-10-11 01:41:38.438072|2017-10-11 01:41:38.438072
NCT01856868|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-03-10|||May 2013||2013-05-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)|An Open-label Pilot Study of Purified Tea-derived Epicatechin to Improve Mitochondrial Function, Strength and Skeletal Muscle Exercise Response in Becker Muscular Dystrophy.|Recruiting||Phase 1/Phase 2|10|Anticipated|University of California, Davis||1|||f||||||||||||||2017-10-11 01:41:40.220569|2017-10-11 01:41:40.220569
NCT01856855|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-07-13|||February 2013||2013-02-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)|RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer|Active, not recruiting||N/A|25|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 01:41:40.327544|2017-10-11 01:41:40.327544
NCT01856842|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-05-17|||April 2013||2013-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy|Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy. A Randomized Trial of Interlock™ Fibered IDC™ Occlusion System vs. Nester Coils|Recruiting||N/A|40|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||Undecided||2017-10-11 01:41:40.420908|2017-10-11 01:41:40.420908
NCT01856829|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-28|||May 2013||2013-05-01|May 2013|2013-05-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Effect of Omega-3 Phospholipids on Perceptual-cognitive Training|Effect of Omega-3 Phospholipids on Attentional Abilities and Perceptual-cognitive Training|Unknown status|Recruiting|N/A|80|Anticipated|Université de Montréal||2|||f||||t||||||||||2017-10-11 01:41:40.510522|2017-10-11 01:41:40.510522
NCT01856816|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2013-05-15|||May 2011||2011-05-01|May 2013|2013-05-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|S26||Effect of Meal Patterning on Carotenoid Absorption From Vegetables|Effect of Meal Patterning on Carotenoid Absorption From Vegetables|Completed||N/A|6|Actual|Purdue University||3|||f||||||||||||||2017-10-11 01:41:40.619507|2017-10-11 01:41:40.619507
NCT01856803|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-11-25|||October 2013||2013-10-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis|Anti-thymocyte Globulins for GVHD Prophylaxis After HLA-matched Sibling Stem Cell Transplantation in Patients at 40 Years of Age or More With Hematological Malignancies|Recruiting||Phase 4|300|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-11 01:41:40.687102|2017-10-11 01:41:40.687102
NCT01856777|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-05-12|||June 2013||2013-06-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy|Evaluating the Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy After Early Medical Abortion|Completed||N/A|600|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-11 01:41:40.863581|2017-10-11 01:41:40.863581
NCT01856764|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-12-02|2015-03-11||June 2013||2013-06-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Full Analysis Set|Topical Roflumilast in Adults With Atopic Dermatitis|A Phase 2a, 15-Day, Randomized, Parallel Group, Double-Blind, Multi-Centre, Vehicle Controlled Trial to Assess the Efficacy and Local Safety of a Cream Containing 0.5% Roflumilast - a Phosphodiesterase Type 4 Inhibitor (PDE4i) Dermal Formulation - on Atopic Dermatitis Patients With Skin Lesions of Moderate Severity|Completed||Phase 2|40|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:41:40.954356|2017-10-11 01:41:40.954356
NCT01856751|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-12-17|||April 2014||2014-04-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Observational|Thrombus||Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa|Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa Concentrate in Patients With Acquired Haemophilia and in Patients With Haemophilia A With Inhibitors|Recruiting||N/A|80|Anticipated|Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus|||1||f||||f||||||Samples Without DNA|"     this data is not applicable   "|||2017-10-11 01:41:41.586544|2017-10-11 01:41:41.586544
NCT01856738|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-12-08|||November 2013||2013-11-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|CHEVAL||Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease|Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease:a Multi-center Placebo-controlled Trial.|Recruiting||Phase 4|168|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 01:41:41.715793|2017-10-11 01:41:41.715793
NCT01856725|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-05-05|||May 2013||2013-05-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||MPP Programming Study|Evaluation of Programming Strategies for MultiPoint™ Pacing in Cardiac Resynchronization Therapy Patients|Completed||N/A|40|Actual|St. Jude Medical||2|||f||||t||||||||||2017-10-11 01:41:41.861869|2017-10-11 01:41:41.861869
NCT01856712|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-05-02|||May 2013||2013-05-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence|Pharmacotherapeutic Intervention to Improve Treatment Engagement Among Alcohol-dependent Veterans After Hospital Discharge|Completed||Phase 3|54|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 01:41:41.947253|2017-10-11 01:41:41.947253
NCT01856699|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-08-09|||May 2013||2013-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Observational|SuSPect-CAA||Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy|Observational Study on the Prognostic Relevance of Supratentorial Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy|Active, not recruiting||N/A|302|Actual|Ludwig-Maximilians - University of Munich|||2||f||||f||||||Samples With DNA|"     whole blood, serum, plasma, CSF   "|||2017-10-11 01:41:42.027583|2017-10-11 01:41:42.027583
NCT01856673|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-01-21|2015-07-10||June 2012||2012-06-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|ACOPLE||Evaluation of Two Community-based Mental Health Interventions for Violence-Displaced Afro-Descendants in Colombia.|Evaluation of Two Mental Health Interventions Based on the Community for Violence-Displaced Afro-Descendants in Colombia.|Completed||N/A|521|Actual|Universidad del Valle, Colombia|This study will include a subsequent follow-up to assess middle-term effects of the interventions. The proportion of participants lost to follow-up represents a limitation. The low male participation in the study did not allow for a gender subgroup.|3|||f||||t||||||||||2017-10-11 01:41:43.257374|2017-10-11 01:41:43.257374
NCT01856660|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-09-26|||September 2012||2012-09-01|September 2017|2017-09-01|August 2016|Actual|2016-08-01|June 2015|Actual|2015-06-01||Interventional|||Bitter Taste and Weight Loss in Women|Bitter Taste Phenotype as an Adjunct to Behavioral Weight-loss Intervention in Women|Completed||N/A|107|Actual|Rutgers University||2|||f||||f||||||||||2017-10-11 01:41:43.726287|2017-10-11 01:41:43.726287
NCT01856647|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-12-18|||February 2013||2013-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects|A Pilot Study to Characterize Adipose Tissue Leukocytes by Flow Cytometry and Microscopy in Lean, Obese and Psoriatic Subjects (Lean/Obese)|Terminated||N/A|1|Actual|Rockefeller University|||4|Low enrollment|f||||f||||||Samples Without DNA|"     Fat Biopsy   "|||2017-10-11 01:41:43.834142|2017-10-11 01:41:43.834142
NCT01856634|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-03-10|||July 2013||2013-07-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis|Phase 1, Open-label, Multiple-dose, and Age De-escalation Trial to Assess the Pharmacokinetics, Safety and Tolerability of Delamanid (OPC 67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therapy With an Optimized Background Regimen of Anti-tuberculosis Drugs|Recruiting||Phase 1|36|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||t||||||||||2017-10-11 01:41:43.931587|2017-10-11 01:41:43.931587
NCT01856621|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-01-02|||May 2013||2013-05-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus|Pharmacokinetic Study Comparing Two Salmeterol Fluticasone Propionate Device-metered Dry Powder Inhalers, Salmeterol/Fluticasone Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; a Randomised, Doubleblind,Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|48|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-10-11 01:41:44.053818|2017-10-11 01:41:44.053818
NCT01856608|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2014-09-15|||July 2012||2012-07-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Assessing the Team SA Instrument in Measuring the Effectiveness of Communication Across Disciplines During ICU Rounds|Assessing the Utility of the Team SA Instrument in Measuring the Effectiveness of Communication Across Disciplines During ICU Rounds|Completed||N/A|240|Actual|Ohio State University|||1||f||||f||||||||||2017-10-11 01:41:44.134337|2017-10-11 01:41:44.134337
NCT01856582|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-06-06|||October 2010||2010-10-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||CD34+ Stem Cell Infusion to Augment Graft Function|Post Transplant CD34+ Selected Stem Cell Infusion to Augment Graft Function in Children With Primary Immunodeficiency Diseases and Bone Marrow Failure Syndromes|Terminated||Phase 2|23|Actual|Children's Hospital Medical Center, Cincinnati||1||"CliniMACS CD34 Reagent System was FDA approved for clinical use; therefore, patients were   treated clinically."|f||||f||||||||||2017-10-11 01:41:44.340706|2017-10-11 01:41:44.340706
NCT01856569|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-01-19|2017-01-19||July 2013||2013-07-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|ASSIAL|Full analysis set (FAS) included all participants who met the inclusion criteria.|Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy|Assial - Anti Tnf Treatment In Ankylosing Spondylitis: An Observational Cohort Study In Italy|Completed||N/A|152|Actual|Pfizer|Data for change from baseline in ASQoL score was not collected as per change in planned analyses.||1||f||||f||||||||||2017-10-11 01:41:44.455771|2017-10-11 01:41:44.455771
NCT01856556|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-01-25|||May 2013||2013-05-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Pharmacokinetics of NRX-1074 in Normal Volunteers|A Randomized, Double-Blind, Placebo-Controlled Single Intravenous and Oral Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers|Completed||Phase 1|100|Actual|Naurex, Inc||7|||f||||t||||||||||2017-10-11 01:41:44.754904|2017-10-11 01:41:44.754904
NCT01856543|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-01-27|||May 2013|Actual|2013-05-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation|Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation:A Randomized Trial, Double Blind Trial|Completed||Phase 3|143|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:41:44.861437|2017-10-11 01:41:44.861437
NCT01856530|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-08-12|2014-06-25||July 2012||2012-07-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder|Effect of Oxytocin on Pro-Social Behavior in Social Anxiety Disorder|Completed||Phase 1/Phase 2|60|Actual|Boston University||2|||f||||t||||||||||2017-10-11 01:41:44.967577|2017-10-11 01:41:44.967577
NCT01856504|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-03-31|||May 2013||2013-05-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01|1 Day|Observational [Patient Registry]|VICTORY||Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY|Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY: A Prospective Multicenter Study|Completed||N/A|218|Actual|MDDX LLC|||1||f||||f||||||||||2017-10-11 01:41:45.63057|2017-10-11 01:41:45.63057
NCT01856478|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-10-03|||May 23, 2013|Actual|2013-05-23|October 2017|2017-10-01|November 28, 2018|Anticipated|2018-11-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy|A Randomised, Open-label, Phase III Study to Evaluate the Efficacy and Safety of Oral Afatinib (BIBW 2992) Versus Intravenous Methotrexate in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Who Have Progressed After Platinum-based Therapy|Recruiting||Phase 3|330|Anticipated|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:41:45.853787|2017-10-11 01:41:45.853787
NCT01856465|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-11-25|||June 2013||2013-06-01|November 2014|2014-11-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Observational|||Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery|Role of Intestinal Microbiota in Non-alcoholic Fatty Liver Disease Pre and Post bAriatric Surgery|Unknown status|Recruiting|N/A|120|Anticipated|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     Liver biopsy and stool samples   "|||2017-10-11 01:41:46.072579|2017-10-11 01:41:46.072579
NCT01856452|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-05-14|||September 2011||2011-09-01|May 2013|2013-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer|Phase II Study of Comparison of Sentinel Lymph Node Biopsy Guided by The Multimodal Method of Indocyanine Green Fluorescence, Radioisotope and Blue Dye Versus the Radioisotope in Breast Cancer|Completed||Phase 2|86|Actual|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 01:41:46.183272|2017-10-11 01:41:46.183272
NCT01856439|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-06-09|||May 2011||2011-05-01|June 2014|2014-06-01|May 2022|Anticipated|2022-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease|A Multicentre, Open-label Study to Determine the Long Term Safety, Tolerability and Efficacy of ProSavin in Patients With Bilateral, Idiopathic Parkinson's Disease.|Active, not recruiting||Phase 1/Phase 2|15|Anticipated|Oxford BioMedica||1|||f||||t||||||||||2017-10-11 01:41:46.268691|2017-10-11 01:41:46.268691
NCT01856426|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-01-28|||June 2013||2013-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Interventional|||Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects|Double-Blind, Randomized, Placebo-controlled, Multi-center Trial to Determine the Safety and Antiviral Effect of Single Doses of EDP239 in Hepatitis C Virus (HCV) Infected Subjects|Completed||Phase 1|28|Actual|Enanta Pharmaceuticals||5|||f||||f||||||||||2017-10-11 01:41:46.352488|2017-10-11 01:41:46.352488
NCT01856413|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2015-03-24|||December 2012||2012-12-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ZEUS||A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant|An Open, Prospective, Single Arm Study Investigating Efficacy and Safety of Human Hepatitis B Immunoglobulin Zutectra in Liver Transplanted Patients - the ZEUS Study|Completed||Phase 3|49|Actual|Biotest||1|||f||||f||||||||||2017-10-11 01:41:46.474881|2017-10-11 01:41:46.474881
NCT01856400|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-01-31|||January 2010||2010-01-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Ventricular Arrhythmias in Uremic Cardiomyopathy|Understanding the Molecular Basis of Ventricular Arrhythmias in Uremic Cardiomyopathy|Completed||N/A|36|Actual|Northwell Health|||1||f||||t||||||Samples With DNA|"     blood vessel tissue sample   "|||2017-10-11 01:41:46.597891|2017-10-11 01:41:46.597891
NCT01856387|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2014-03-16|||May 2013||2013-05-01|May 2013|2013-05-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Observational|||The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia|the Predictive Value of neutrophil-to Lymphocyte Ratio on Preeclampsia- Eclampsia|Unknown status|Recruiting|N/A|600|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||2||f||||f||||||None Retained|"     whole blood, serum, white cells   "|||2017-10-11 01:41:46.681488|2017-10-11 01:41:46.681488
NCT01856374|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-07-25|||August 2011||2011-08-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study||Completed||Phase 4|60|Actual|Yonsei University||4|||f||||f||||||||||2017-10-11 01:41:46.804712|2017-10-11 01:41:46.804712
NCT01856361|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-04-27|2017-01-13||July 2013||2013-07-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Ramipril for the Treatment of Oligospermia|Ramipril for the Treatment of Oligospermia: A Double-Blind Randomized Control Trial|Terminated||N/A|2|Actual|Weill Medical College of Cornell University||2||We did not accrue as much as anticipated and the PI (Dabaja) is no longer at Weill Cornell.|f||||t||||||||Undecided||2017-10-11 01:41:46.90301|2017-10-11 01:41:46.90301
NCT01856348|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-08-09|||May 2013||2013-05-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Vitamin D3, Folic Acid and Fexofenadine in Healthy Volunteers|Effects of Vitamin D3 (1,25 Dihydroxyvitamin D3) on Pharmacokinetics and Absorption of Folic Acid and Fexofenadine in Healthy Volunteers|Completed||Phase 1|10|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 01:41:47.246879|2017-10-11 01:41:47.246879
NCT01856335|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-07-28|||April 19, 2013||2013-04-19|January 25, 2017|2017-01-25|January 25, 2017|Actual|2017-01-25|January 25, 2017|Actual|2017-01-25||Interventional|||Exercise Education for Adults With Seizure Disorders|Increasing Self-Efficacy and Outcome Expectations For Exercise in Adults With Epilepsy: An Educational Motivation Intervention - E-MOVE|Completed||Early Phase 1|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:41:47.348521|2017-10-11 01:41:47.348521
NCT01856322|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-10-22|2015-03-25||April 2013||2013-04-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer|Phase 2 Prospective Randomized Double Blind Trial Comparing Metastasectomy Plus Sulindac Versus Metastasectomy Alone in Patients With Stage IV Colorectal Cancer|Terminated||Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)||3||The trial was prematurely closed due to lack of accrual.|f||||f||||||||||2017-10-11 01:41:47.45379|2017-10-11 01:41:47.45379
NCT01856309|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2017-07-11|||August 7, 2013|Actual|2013-08-07|July 2017|2017-07-01|April 15, 2020|Anticipated|2020-04-15|November 25, 2019|Anticipated|2019-11-25||Interventional|SIRROUND-LTE||Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003|A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (Sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T)|Active, not recruiting||Phase 3|1820|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 01:41:47.868395|2017-10-11 01:41:47.868395
NCT01856296|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-15|2016-08-25|||April 2013||2013-04-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|WINTHER||A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies|WINTHER: A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies|Suspended||N/A|200|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 01:41:48.578501|2017-10-11 01:41:48.578501
NCT01856283|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-03-31|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|June 2019|Anticipated|2019-06-01|June 2015|Actual|2015-06-01||Interventional|||Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells|An Open Label, Single Arm, Phase II Study of Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients, in Order to Verify Disappearance of CD34+/Lin-Ph+ Cells From Bone Marrow During Treatment|Active, not recruiting||Phase 2|87|Actual|Niguarda Hospital||1|||f||||f||||||||||2017-10-11 01:41:48.704365|2017-10-11 01:41:48.704365
NCT01856257|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-07-28|2017-06-23||July 2013||2013-07-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Randomized Participants|Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen|Steroid and Tacrolimus Avoidance Using NULOJIX® (Belatacept) in Renal Transplantation (CTOT-16)|Terminated||Phase 2|71|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3||Safety: Stopping rule not met.|f||||t||||||||||2017-10-11 01:41:49.030902|2017-10-11 01:41:49.030902
NCT01856244|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-10-04|||June 2013||2013-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|StaBLE||Stability and Balance in Locomotion Through Exercise|Sensorimotor Treadmill Training to Improve Gait and Balance in Parkinson's Disease|Completed||Phase 1|48|Actual|University of Erlangen-Nürnberg||2|||f||||f||||||||||2017-10-11 01:41:51.139771|2017-10-11 01:41:51.139771
NCT01856231|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-09-22|||August 2011||2011-08-01|September 2017|2017-09-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Interventional|||Lifestyle Physical Activity for People With COPD|Lifestyle Physical Activity for People With COPD|Completed||N/A|54|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 01:41:51.234425|2017-10-11 01:41:51.234425
NCT01856218|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-05-08||2017-05-08|October 2013||2013-10-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With MPS 7|An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of UX003 rhGUS Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)|Completed||Phase 1/Phase 2|3|Actual|Ultragenyx Pharmaceutical Inc||1|||f||||t||||||||||2017-10-11 01:41:51.319122|2017-10-11 01:41:51.319122
NCT01856205|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2013-05-18|||May 2009||2009-05-01|May 2013|2013-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis|A Randomized Double Blind Placebo Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin (IVIG) in Children With Japanese Encephalitis in Nepal|Completed||Phase 2|22|Actual|University of Liverpool||2|||f||||t||||||||||2017-10-11 01:41:51.402338|2017-10-11 01:41:51.402338
NCT01856179|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2013-05-14|||March 2011||2011-03-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|August 2011|Actual|2011-08-01||Interventional|||Supplementation of Land-based Stearidonic Acid (SDA)-Rich Oils in Humans|Accumulation of n-3 Long-chain (LC)-PUFA by Supplementation of SDA-rich Echium Oil in Humans Depending on Age, Gender and Physiological Stage|Completed||Early Phase 1|78|Actual|University of Jena||3|||f||||t||||||||||2017-10-11 01:41:53.39573|2017-10-11 01:41:53.39573
NCT01856166|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-01-08|||June 2013||2013-06-01|May 2013|2013-05-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|PIEB||PIEB-PCEA Versus CEI-PCEA for Labor Analgesia in Nulliparous|Programmed Intermittent Epidural Bolus Coupled With PCEA (PIEB-PCEA) Versus Continuous Epidural Infusion Coupled With PCEA (CEI-PCEA) for Labor Analgesia in Nulliparous: Effects on Labor Outcomes|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 01:41:53.489835|2017-10-11 01:41:53.489835
NCT01856153|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-02-08|||July 2013||2013-07-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Maximizing the Anti-inflammatory Effects of Strawberry Bioavailability|Maximizing the Anti-inflammatory Effects of Strawberries: Understanding the Influence of Strawberry Anthocyanin Bioavailability in the Context of Meals|Active, not recruiting||N/A|18|Anticipated|Institute for Food Safety and Health, United States||3|||f||||f|f|f||||||Undecided||2017-10-11 01:41:53.612818|2017-10-11 01:41:53.612818
NCT01856140|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-11-22|||May 2013||2013-05-01|November 2013|2013-11-01|April 2014|Anticipated|2014-04-01|January 2014|Anticipated|2014-01-01||Interventional|ALLO-ASC||Treatment of Tendon Injury Using Mesenchymal Stem Cells|Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells(ALLO-ASC):A Pilot Study|Unknown status|Recruiting|Early Phase 1|12|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:41:53.70245|2017-10-11 01:41:53.70245
NCT01856127|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-08-24|||January 2013||2013-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?|A Randomized, Double-Blind, Active Controlled Clinical Trial of Switching to Vilazodone for Antidepressant-Associated Sexual Dysfunction|Terminated||Phase 4|4|Actual|Thomas Jefferson University||2||PI left institution|f||||f||||||||No||2017-10-11 01:41:53.792998|2017-10-11 01:41:53.792998
NCT01856114|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-05-30|||May 2014|Actual|2014-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea|A Preliminary Study of Prophylactic Fentanyl Buccal Tablets (FBT) for Exercise Induced Breakthrough Dyspnea|Active, not recruiting||Phase 2|25|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:41:53.8934|2017-10-11 01:41:53.8934
NCT01856101|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2014-05-13|||February 2013||2013-02-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|BEZ235||Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based Chemotherapy|A Single Arm, Multicenter, Phase II Study of BEZ235 as Monotherapy in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) After Failure of Platinum Based Chemotherapy.|Terminated||Phase 2|22|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1||Novartis decided to stop the marketing of BEZ235|f||||f||||||||||2017-10-11 01:41:53.992827|2017-10-11 01:41:53.992827
NCT01856088|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2017-04-24|||May 2013||2013-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|September 2014|Actual|2014-09-01||Interventional|||DESTINY TRIAL (Inspiron x Biomatrix)|Stents Coated With the Biodegradable Polymer on Their Abluminal Faces and Elution of Sirolimus Versus Biolimus Elution for the Treatment of de Novo Coronary Lesions - Destiny Trial|Active, not recruiting||Phase 4|170|Anticipated|Scitech Produtos Medicos Ltda||2|||f||||t||||||||||2017-10-11 01:41:54.091603|2017-10-11 01:41:54.091603
NCT01856075|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2015-09-07|||October 2012||2012-10-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|EFFECT-AF||Effectiveness Study of Atrial Fibrillation|Relative Effectiveness of Dronedarone vs. Other Treatments of Atrial Fibrillation|Completed||N/A|1015|Actual|La-ser Europe Limited|||2||f||||t||||||||||2017-10-11 01:41:54.205178|2017-10-11 01:41:54.205178
NCT01856062|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2014-02-27|||May 2013||2013-05-01|February 2014|2014-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Ovulation Induction With Clomiphene Citrate and Dexamethasone|Ovulation Induction With Clomiphene Citrate and Dexamethasone|Unknown status|Recruiting|Phase 4|140|Anticipated|San Antonio Military Medical Center||2|||f||||f||||||||||2017-10-11 01:41:54.456986|2017-10-11 01:41:54.456986
NCT01856049|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-08-05|||May 2012||2012-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Umbilical Cord Blood Collection and Processing for Cardiac Regeneration in Hypoplastic Left Heart Syndrome Patients|Umbilical Cord Blood Collection and Processing for Cardiac Regeneration in Hypoplastic Left Heart Syndrome Patients|Recruiting||N/A|100|Anticipated|Mayo Clinic||1|||f||||f||||||||No||2017-10-11 01:41:54.588664|2017-10-11 01:41:54.588664
NCT01856036|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-02-03|||April 2013|Actual|2013-04-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers|CHUM-CRYOABLATION: Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers|Terminated||N/A|2|Actual|John Wayne Cancer Institute||1||PI left institute and contacted IRB to close study.|f||||f||||||||No||2017-10-11 01:41:54.685381|2017-10-11 01:41:54.685381
NCT01856023|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-07-15|||May 2013||2013-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PROCLIVITY 02||HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma|Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients With Metastatic Melanoma|Terminated||Phase 4|29|Actual|Prometheus Laboratories||2||A shift in the melanoma treatment landscape adversely affected accrual & early closure|f||||t||||||||||2017-10-11 01:41:54.783072|2017-10-11 01:41:54.783072
NCT01856010|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-02-13|||March 2011||2011-03-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Study of Electroconvulsive Therapy (ECT) Treatment for Agitation and Aggression in Dementia|Short-term Efficacy and Cognitive Side Effects of Acute Electroconvulsive Therapy (ECT) for Agitation and Aggression in Dementia|Completed||N/A|23|Actual|Pine Rest Christian Mental Health Services|||2||f||||f||||||||||2017-10-11 01:41:54.92172|2017-10-11 01:41:54.92172
NCT01855997|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-03-08|2016-03-08||August 20, 2013|Actual|2013-08-20|March 2017|2017-03-01|November 28, 2014|Actual|2014-11-28|November 28, 2014|Actual|2014-11-28||Observational||All Enrolled Population: All participants for whom genotype data were available.|A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue|A Phase IV, Blood Sample Collection Study For Exploratory Evaluation of the Association of Single Nucleotide Polymorphisms With Treatment Responses From Subjects With HBe-Antigen Positive or Negative Chronic Hepatitis B, Who Received Therapy for Hepatitis B With Peginterferon Alfa-2a 40kD (Peg-IFN) ± Nucleos(t)Ide Analogue|Completed||N/A|1669|Actual|Hoffmann-La Roche|||1||f||||||||||Samples With DNA|"     Whole blood samples   "|||2017-10-11 01:41:55.127934|2017-10-11 01:41:55.127934
NCT01855984|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-06-13|||February 2012||2012-02-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|TOCAT||Tocotrienols for School-going Children With ADHD|Tocotrienols Supplementation in School Going Children With Attention Deficit/Hyperactivity Disorder(ADHD) - A Randomized Controlled Trial|Completed||Phase 2/Phase 3|160|Anticipated|Penang Medical College||2|||f||||f||||||||||2017-10-11 01:41:57.317243|2017-10-11 01:41:57.317243
NCT01855971|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-04-11|||June 11, 2013|Actual|2013-06-11|April 2017|2017-04-01|October 31, 2015|Actual|2015-10-31|July 31, 2015|Actual|2015-07-31||Interventional|||"Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome (TESFX)"|Estrogen Receptors Beta (ER-B) as Therapeutic Targets for the Improvement of Cognitive Performance in Fragile-X (TESXF)|Completed||N/A|44|Actual|Parc de Salut Mar||2|||f||||f|f|f||||||No||2017-10-11 01:41:57.430033|2017-10-11 01:41:57.430033
NCT01855958|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-08-17|2013-07-03||February 2012||2012-02-01|August 2015|2015-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Motor Cortex Plasticity and the Effect of Deep Intramuscular Needling Stimulation Therapy (DIMST) in Osteoarthritis Pain|Primary Motor Cortex Plasticity and the Bottom up Effect of Deep Intramuscular Needling Stimulation Therapy (DIMST)in Osteoarthritis Chronic Pain|Completed||N/A|26|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 01:41:57.560018|2017-10-11 01:41:57.560018
NCT01855945|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-01-19|2015-09-17||May 2013||2013-05-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Baseline analysis was done on all enrolled set.|Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.|Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.|Completed||Phase 1|627|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:41:58.067664|2017-10-11 01:41:58.067664
NCT01855932|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-09-20|||May 2013||2013-05-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Enlighten: An Adaptive Technology Weight Loss Intervention|Enlighten: An Adaptive Technology Weight Loss Intervention|Completed||N/A|10|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 01:42:02.403461|2017-10-11 01:42:02.403461
NCT01855919|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-06-26|2015-06-26||May 2013||2013-05-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Full Analysis Set (FAS): All randomized participants who received at least 1 dose of study drug and had at least 1 post-dose Brief Pain Inventory (BPI) pain severity (average pain) scores.|A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain|Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Low Back Pain in Japan|Completed||Phase 3|458|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:42:02.618129|2017-10-11 01:42:02.618129
NCT01855906|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-03-09|||September 2013||2013-09-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||The Impact of Total Knee Arthroplasty Surgical Technique on Coronal Plane Motion and PatelloFemoral Articulation|The Impact of Total Knee Arthroplasty Surgical Technique on Coronal Plane Motion and PatelloFemoral Articulation|Withdrawn||N/A|0|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:42:04.360555|2017-10-11 01:42:04.360555
NCT01855893|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-06-08|||July 2013||2013-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Auto-acupressure: Effectiveness for Diminishing Neck Pain of Benign Origin|Effectiveness of the Auto-acupressure for Diminishing Neck Pain of Benign Origin|Completed||N/A|160|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||t||||||||||2017-10-11 01:42:04.478068|2017-10-11 01:42:04.478068
NCT01855880|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-04-22||2015-04-20|May 2013||2013-05-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|AbGn-168H||Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients|Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of AbGn-168H Administered by Intravenous Infusion to Patients With Moderate to Severe Chronic Plaque Psoriasis (Randomised, Double-blind, Placebo-controlled)|Completed||Phase 2|54|Actual|AbGenomics B.V Taiwan Branch||3|||f||||f||||||||||2017-10-11 01:42:04.574972|2017-10-11 01:42:04.574972
NCT01855854|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-07-14|||May 2013||2013-05-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|||Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH|A Phase II, Prospective Study for Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression or Positive FISH as Second-line Treatment|Unknown status|Recruiting|Phase 2|50|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 01:42:04.844551|2017-10-11 01:42:04.844551
NCT01855841|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-03-07|||April 2012||2012-04-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis|Prevention of Post-ERCP Acute Pancreatitis by Heme-oxygenase Activation Through the Administration of Hemin : a Prospective, Randomized Double Blind Controlled Trial|Recruiting||Phase 2|284|Anticipated|Erasme University Hospital||2|||f||||f||||||||||2017-10-11 01:42:04.946808|2017-10-11 01:42:04.946808
NCT01855828|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-04-12|||September 2013||2013-09-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer|Single Arm, Neoadjuvant, Phase II Trial of Pertuzumab and Trastuzumab Administered Concomitantly With Weekly Paclitaxel and FEC for Clinical Stage I-II HER2-Positive Breast Cancer|Recruiting||Phase 2|64|Anticipated|Yale University||1|||f||||t||||||||||2017-10-11 01:42:05.125122|2017-10-11 01:42:05.125122
NCT01855815|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-01-26|||April 2013||2013-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Hemolung RAS Registry Program|HL-CA-1600, Hemolung RAS Registry. A Retrospective Registry Involving Voluntary Reporting of De-identified, Standard of Care Data Following the Commercial Use of the Hemolung Respiratory Assist System (RAS)|Enrolling by invitation||N/A|99|Anticipated|Alung Technologies|||1||f||||f||||||||||2017-10-11 01:42:05.535511|2017-10-11 01:42:05.535511
NCT01855802|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-01-14|||April 2013||2013-04-01|January 2017|2017-01-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma|Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma|Completed||N/A|70|Actual|Democritus University of Thrace|||1||f||||f||||||||||2017-10-11 01:42:05.616854|2017-10-11 01:42:05.616854
NCT01855776|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-01-03|||May 2013||2013-05-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Randomized Trial of Economic Incentives to Promote Walking Among Full Time Employees|A Randomized Trial of Economic Incentives to Promote Walking Among Full Time Employees|Completed||N/A|800|Actual|Duke-NUS Graduate Medical School||4|||f||||f||||||||||2017-10-11 01:42:06.230276|2017-10-11 01:42:06.230276
NCT01855763|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-13|||December 2008||2008-12-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|migdm&t2dm||Metformin Treatment in Gestational Diabetes and Noninsulin Dependent Diabetes in Pregnancy in a Developing Country|Metformin in Gestational Diabetes and type2 Diabetes in Pregnancy in a Developing Country|Unknown status|Active, not recruiting|Phase 2/Phase 3|300|Actual|Dow University of Health Sciences||2|||f||||t||||||||||2017-10-11 01:42:06.36456|2017-10-11 01:42:06.36456
NCT01855750|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-07-03|||September 3, 2013|Actual|2013-09-03|July 2017|2017-07-01|June 16, 2022|Anticipated|2022-06-16|June 18, 2018|Anticipated|2018-06-18||Interventional|||A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma|A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma|Active, not recruiting||Phase 3|839|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 01:42:06.512348|2017-10-11 01:42:06.512348
NCT01855737|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-06-02|||June 2013||2013-06-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Observational|WADCH||The Study of Warfarin Maintenance Dose in Chinese Patients|Clinical Study of the Relationship Between Pharmacogenomics and Warfarin Dose in Chinese Patients|Unknown status|Recruiting|Phase 4|1000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t||||||Samples With DNA|"     Samples with DNA frozen in -80℃   "|||2017-10-11 01:42:07.53444|2017-10-11 01:42:07.53444
NCT01855724|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-09-20|||June 2013||2013-06-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|April 2019|Anticipated|2019-04-01||Interventional|||Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer|Phase II Single-arm Study of First Line Treatment With Gemcitabine and Pazopanib in Patients With Inoperable Locally Advanced or Metastatic Biliary Tree Cancer (Cholangiocarcinoma or Gallbladder Carcinoma)|Recruiting||Phase 2|46|Anticipated|Hellenic Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 01:42:07.655163|2017-10-11 01:42:07.655163
NCT01855711|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-04-28|||September 18, 2003|Actual|2003-09-18|April 2017|2017-04-01|May 10, 2005|Actual|2005-05-10|May 10, 2005|Actual|2005-05-10||Interventional|||Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)|A Four-week, Open, Multicenter Study to Assess the Safety and Efficacy of 1 mg Once Daily (QD) of GR68755 in Female Subjects With Severe Diarrhea-predominant Irritable Bowel Syndrome (IBS) Who Have Frequent Bowel Urgency|Completed||Phase 2|32|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 01:42:07.859696|2017-10-11 01:42:07.859696
NCT01855698|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-08-31|||June 2013|Actual|2013-06-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism|Clinical Practice in the Prophylaxis and Treatment of Arterial and Venous Thromboembolism in Patients With hEmatological NEoplasms and LOw PlatElets (PENELOPE Observational Study)|Recruiting||N/A|100|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||||2017-10-11 01:42:07.954641|2017-10-11 01:42:07.954641
NCT01855685|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-02-07|||February 2013||2013-02-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|CGD||Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)|A Phase I/II, Non Randomized, Multicenter, Open-label Study of Autologous CD34+ Cells Transduced With the G1XCGD Lentiviral Vector in Patients With X-linked Chronic Granulomatous Disease|Recruiting||Phase 1/Phase 2|5|Anticipated|Genethon||1|||f||||f||||||||||2017-10-11 01:42:08.214559|2017-10-11 01:42:08.214559
NCT01855672|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-07-15|||April 2013||2013-04-01|June 2013|2013-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Verona||Occipital Nerve Stimulation in the Treatment of Migraine|A Multicenter, Randomized, Controlled, Double-Blind, Proof-of-Concept Study Assessing the Safety and Effectiveness of a Signal Generator Device (NMS EBox) for the Treatment of Chronic Migraine|Terminated||Phase 1|1|Actual|Ethicon, Inc.||2||Business strategic decision not related to safety.|f||||f||||||||||2017-10-11 01:42:08.464666|2017-10-11 01:42:08.464666
NCT01855659|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2013-12-02|||June 2013||2013-06-01|May 2013|2013-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|INSPIRE||A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method.|A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method.|Completed||N/A|210|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 01:42:08.584725|2017-10-11 01:42:08.584725
NCT01855646|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-11-23||||||April 2014|2014-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Improved Patient Handoffs to Prevent Sentinel Events|Patient Acuity Score With Improved Patient Handoffs to Prevent Sentinel Events|Completed||N/A|4344|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:42:08.666344|2017-10-11 01:42:08.666344
NCT01855633|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-08-02|||April 2013||2013-04-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke|Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke|Recruiting||N/A|48|Anticipated|Dongtan Sacred Heart Hospital||3|||f||||f||||||||||2017-10-11 01:42:08.740462|2017-10-11 01:42:08.740462
NCT01855620|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-04-11|||December 2012||2012-12-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Observational|Eto BMI||The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive Implant|The Effect of Body Mass Index on Etonogestrel Levels in Women Using the Single-rod Contraceptive Implant|Completed||N/A|52|Actual|Columbia University|||3||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:42:08.870845|2017-10-11 01:42:08.870845
NCT01852240|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2014-05-12|||May 2013||2013-05-01|May 2014|2014-05-01||||December 2015|Anticipated|2015-12-01||Observational|||Periodontal Disease as a Risk Indicator for Erectile Dysfunction - A Cross-sectional Study on 100 Patients||Unknown status|Recruiting|N/A|100|Anticipated|Medical University of Vienna|||1||f||||||||||||||2017-10-11 01:43:10.712172|2017-10-11 01:43:10.712172
NCT01855607|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-06-30|||August 2013||2013-08-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy|Topical Menthol for CIPN: a Randomized, Placebo Controlled Phase II Trial|Unknown status|Recruiting|Phase 2|60|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-11 01:42:08.978367|2017-10-11 01:42:08.978367
NCT01855594|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2016-01-26|||May 2013||2013-05-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain|Double Blind, Randomized Placebo-controlled Clinical Study Evaluating the Efficacy of Lithium Carbonate in the Treatment of Neuropathic Pain of Patients With Spinal Cord Injury|Completed||Phase 2|60|Actual|China Spinal Cord Injury Network||2|||f||||t||||||||||2017-10-11 01:42:09.116679|2017-10-11 01:42:09.116679
NCT01855581|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-13|||November 2012||2012-11-01|May 2013|2013-05-01|October 2013|Anticipated|2013-10-01|July 2013|Anticipated|2013-07-01||Observational|||The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Retrospective Study||Unknown status|Recruiting|N/A|3739|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 01:42:09.249982|2017-10-11 01:42:09.249982
NCT01855568|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-01-21|||May 2013||2013-05-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Methotrexate Treatment for Ectopic Pregnancy|Comparison of Two-dose and Single-dose Methotrexate Protocol for Ectopic Pregnancy: a Randomized Controlled Trial|Completed||Phase 3|92|Actual|CHA University||2|||f||||f||||||||||2017-10-11 01:42:09.358296|2017-10-11 01:42:09.358296
NCT01855555|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2015-01-18|||November 2012||2012-11-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Prospective Study||Completed||N/A|2948|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:42:09.890861|2017-10-11 01:42:09.890861
NCT01855542|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-13|||March 2012||2012-03-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Aim of This Investigation is to Compare the Influence of 0.9% Saline and Plasmalyte Solution on Acid-base Balance and Electrolytes in Healthy Patients Undergoing Major Spine Surgeries.||Completed||N/A|50|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:42:10.012076|2017-10-11 01:42:10.012076
NCT01855529|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-09-11|||April 2013||2013-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ROPI||ROPI Study : Ropivacaine Interest in Postsurgical Pain After Mastectomy|ROPI Study: Evaluation of the Interest of Ropivacaine Streaming in Postoperative Pain After Mastectomy.|Completed||Phase 2|150|Actual|Centre Jean Perrin||2|||f||||f||||||||||2017-10-11 01:42:10.101536|2017-10-11 01:42:10.101536
NCT01855516|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-01-25|||September 2013||2013-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin|Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin: Comparison of a 2 Times Per Day Versus a 3 Times Per Day Dosage.|Completed||N/A|83|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 01:42:10.196532|2017-10-11 01:42:10.196532
NCT01855503|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-11-16|||May 2013||2013-05-01|November 2016|2016-11-01||||August 2016|Actual|2016-08-01||Observational|MAP-IT||Breast Cancer Molecular Analysis Protocol|Breast Cancer Molecular Analysis Prior to Investigational Therapy|Completed||N/A|121|Actual|Yale University|||1||f||||f||||||Samples With DNA|"     Biopsies of metastatic cancer   "|||2017-10-11 01:42:10.282875|2017-10-11 01:42:10.282875
NCT01855490|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-07-05|||January 2012||2012-01-01|July 2016|2016-07-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes|A Pilot Study to Determine the Effects of a Single Dose of Exenatide (Byetta ®) on the Acute Metabolic Responses to a Mixed Meal or Intravenous Glucose Tolerance Test in Patients With Type 1 Diabetes|Completed||Phase 1|17|Actual|Yale University||1|||f||||f||||||||||2017-10-11 01:42:10.368049|2017-10-11 01:42:10.368049
NCT01855477|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-02-23|||August 2011||2011-08-01|February 2014|2014-02-01||||August 2019|Anticipated|2019-08-01||Interventional|CPCT-02||CPCT-02 Umbrella Biopsy Protocol|Development of a Platform for Next-generation DNA Sequencing Based Personalized Treatment for Cancer Patients: Protocol to Obtain Biopsies From Patients With Locally Advanced (Incurable) or Metastatic Cancer (CPCT - 02 Biopsy Protocol)|Recruiting||N/A|2500|Anticipated|UMC Utrecht||1|||f||||t||||||||||2017-10-11 01:42:10.457575|2017-10-11 01:42:10.457575
NCT01855464|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-05-02|||November 2013||2013-11-01|November 2016|2016-11-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|WOPP||Wedge Resection or Parietal Pleurectomy for the Treatment of Recurrent Pneumothorax (WOPP)|Pulmonary Wedge Resection Plus Parietal Pleurectomy (WRPP) Versus Parietal Pleurectomy (PP) for the Treatment of Recurrent Primary Pneumothorax|Recruiting||N/A|360|Anticipated|Wuerzburg University Hospital||2|||f||||t||||||||No||2017-10-11 01:42:10.581047|2017-10-11 01:42:10.581047
NCT01855451|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-07-10|||June 2013||2013-06-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|HPVOropharynx||Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma|TROG12.01 A Randomised Trial of Weekly Cetuximab and Radiation Versus Weekly Cisplatin and Radiation in Good Prognosis Locoregionally Advanced HPV-Associated Oropharyngeal Squamous Cell Carcinoma|Recruiting||Phase 3|200|Anticipated|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||t||||||||||2017-10-11 01:42:10.840512|2017-10-11 01:42:10.840512
NCT01855438|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-06-09|||May 2013||2013-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|||Increasing Communication About Live Donor Kidney Transplant|Increasing Communication About Live Donor Kidney Transplant: A Proof of Concept|Active, not recruiting||N/A|240|Anticipated|Virginia Commonwealth University||3|||f||||f||||||||||2017-10-11 01:42:11.272786|2017-10-11 01:42:11.272786
NCT01855412|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-06-19|||May 2013||2013-05-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|LIBERTY||Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes|LIBERTY 360: Prospective, Observational, Multi-Center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients With Distal Outflow Peripheral Arterial Disease (PAD)|Active, not recruiting||N/A|1204|Actual|Cardiovascular Systems Inc|||3||f||||f||||||||||2017-10-11 01:42:11.463463|2017-10-11 01:42:11.463463
NCT01855399|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-08-18|||September 9, 2014|Actual|2014-09-09|August 2017|2017-08-01|September 29, 2017|Anticipated|2017-09-29|April 3, 2017|Actual|2017-04-03||Interventional|VA-TEC||Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes|Technologically Enhanced Coaching (TEC):A Program for Improving Diabetes Outcomes|Active, not recruiting||N/A|609|Anticipated|VA Office of Research and Development||4|||f||||f|f|f|||f|||||2017-10-11 01:42:11.661096|2017-10-11 01:42:11.661096
NCT01855386|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-08-15|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|May 2017|Actual|2017-05-01||Observational|||The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes|Non-Alcoholic Fatty Liver Disease in Gestational Diabetes - An Opportunity for Prevention of Type 2 Diabetes Mellitus?|Active, not recruiting||N/A|126|Actual|University of Florida|||2||f||||f|f|f||||||||2017-10-11 01:42:11.761717|2017-10-11 01:42:11.761717
NCT01855373|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-04-14|||July 2012||2012-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements|A Randomized, Double-blind, Placebo-controlled Study Comparing the Healthy Levels of Blood Sugar and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplementation Versus Placebo|Completed||N/A|60|Anticipated|Supplement Formulators, Inc.||4|||f||||f||||||||||2017-10-11 01:42:11.854734|2017-10-11 01:42:11.854734
NCT01855347|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2015-08-23|||February 2016||2016-02-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01|3 Months|Observational [Patient Registry]|||Evaluation of Abdominal Tissue Oxygenation in Premature Infants Using Near Infrared Spectroscopy|Evaluation of Abdominal Tissue Oxygenation in Premature Infants Using Near Infrared Spectroscopy|Unknown status|Not yet recruiting|N/A|10|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||||2017-10-11 01:42:12.17384|2017-10-11 01:42:12.17384
NCT01855334|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-05-02|||September 2013|Anticipated|2013-09-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|LAST-D||L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD|A Randomized, Controlled Trial of L-arginine and Spironolactone in Dialysis-dependant End Stage Renal Disease|Withdrawn||Phase 4|0|Actual|Brigham and Women's Hospital||4||change of funding leading to major redesign|f||||t||||||||||2017-10-11 01:42:12.317194|2017-10-11 01:42:12.317194
NCT01855321|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-06-25|||August 2010||2010-08-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Treating Vitamin D Deficiency in Poorly Controlled Type 2 Diabetes|Effects of Treating Vitamin D Deficiency in Poorly Controlled Type 2 Diabetes|Completed||Phase 1|76|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:42:12.459678|2017-10-11 01:42:12.459678
NCT01855308|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-09-22|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|SSRC||Single Site Robotic Cholecystectomy in Non Selected Patients|Single Site Robotic Cholecystectomy in Non Selected Patients|Completed||N/A|160|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 01:42:12.582535|2017-10-11 01:42:12.582535
NCT01855295|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-08-09|||November 2009||2009-11-01|August 2016|2016-08-01|August 2012|Actual|2012-08-01|December 2010|Actual|2010-12-01||Interventional|||Protein Supplementation in Dialysis Patients|Protein Supplementation in Dialysis Patients|Completed||N/A|73|Actual|University of Utah||1|||f||||f||||||||||2017-10-11 01:42:12.690916|2017-10-11 01:42:12.690916
NCT01855282|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-05-11|||April 2010||2010-04-01|May 2017|2017-05-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|Pasos||Assessment of an Intervention to Prevent Obesity and Diabetes in Latino Farm Workers|Pasos Saludables: A Pilot Intervention to Prevent Obesity and Diabetes Among Latino Farm Workers|Completed||N/A|254|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 01:42:12.772873|2017-10-11 01:42:12.772873
NCT01855269|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-15|||April 2012||2012-04-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||Lactobacillus Reuteri Versus Herbal Drop in the Treatment of Infantile Colic: a Prospective Study|A Prospective Randomized Controlled Study: Lactobacillus Reuteri Versus Herbal Drop in the Treatment of Infantile Colic|Completed||N/A|74|Actual|Dr. Sami Ulus Children's Hospital||3|||f||||t||||||||||2017-10-11 01:42:12.868299|2017-10-11 01:42:12.868299
NCT01855256|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-07-07|||June 2013||2013-06-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|H²O||Treatment of Hyperhidrosis With Oxybutynin|Treatment of Hyperhidrosis With Oxybutynin: a Randomized Controlled Double Blind Against Placebo|Completed||Phase 3|62|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 01:42:12.961472|2017-10-11 01:42:12.961472
NCT01855230|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-12-15|||August 2013||2013-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Placebo-controlled, Two-Way Crossover Study to Evaluate the Safety, Tolerability and Clinical Activity of ASM-024 Administered by Dry Power Inhalation to Patients With GOLD 2 (Moderate) or GOLD 3 (Severe) Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|14|Actual|Asmacure Ltée||2|||f||||t||||||||||2017-10-11 01:42:13.137325|2017-10-11 01:42:13.137325
NCT01855217|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-05-16|||April 2013||2013-04-01|May 2013|2013-05-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|MOS||Pilot Study on the Pharmacodynamics of Sugammadex in Morbidly Obese Patients: Reversal of Deep Neuromuscular Blockade|Pilot Study on the Pharmacodynamics of Sugammadex in Morbidly Obese Patients: Reversal of Deep Neuromuscular Blockade|Unknown status|Recruiting|Phase 3|25|Anticipated|St. Antonius Hospital||3|||f||||t||||||||||2017-10-11 01:42:13.232029|2017-10-11 01:42:13.232029
NCT01855204|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2013-12-03|||April 2013||2013-04-01|December 2013|2013-12-01|April 2014|Anticipated|2014-04-01|February 2014|Anticipated|2014-02-01||Interventional|||Low Tube Voltage Computed Tomographic (CT) Urography Using Low Concentration Iodine Contrast Agent|Low Tube Voltage Computed Tomographic (CT) Urography Using Low Concentration Iodine Contrast Agent: a Comparison Study With Conventional CT Urography|Unknown status|Recruiting|N/A|64|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:42:13.332583|2017-10-11 01:42:13.332583
NCT01855191|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-06-06|||June 2013||2013-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|SDC lung||SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation|Standardized Data Collection (SDC) for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SDC Lung).|Recruiting||N/A|864|Anticipated|Maastricht Radiation Oncology|||2||f||||f||||||||||2017-10-11 01:42:13.431711|2017-10-11 01:42:13.431711
NCT01855178|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-09-02|||October 2010||2010-10-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|PedsBedAlarm||Pediatric Seizure Movement Bed Alarm|Pediatric Seizure Alarm: A Pilot Study to Establish Efficacy Parameters|Completed||N/A|136|Actual|Le Bonheur Children's Hospital|||1||f||||f||||||||||2017-10-11 01:42:13.54494|2017-10-11 01:42:13.54494
NCT01855165|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-15|||April 2013||2013-04-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Role of Clinical Pharmacist in Management of DDIs in CHF Patients|The Role of Clinical Pharmacist's Intervention in Management of Clinically Relevant Drug-drug Interactions in Patients With Chronic Heart Failure|Unknown status|Recruiting|N/A|60|Anticipated|The University Clinic of Pulmonary and Allergic Diseases Golnik||2|||f||||f||||||||||2017-10-11 01:42:13.658074|2017-10-11 01:42:13.658074
NCT01855152|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-13|||August 2013||2013-08-01|May 2013|2013-05-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|WHELD||Improving Well-being and Health for People With Dementia|An Optimized Person Centred Intervention to Improve Quality of Life for People With Dementia Living in Care Homes. A Cluster Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|1000|Anticipated|King's College London||2|||f||||t||||||||||2017-10-11 01:42:13.774105|2017-10-11 01:42:13.774105
NCT01855139|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-01-17|||July 2013||2013-07-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|BOX-AF||Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism|Belgian Real Life Non-interventional Study (NIS) on Xarelto® in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism (BOX-AF)|Completed||N/A|106|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:42:13.918909|2017-10-11 01:42:13.918909
NCT01855126|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-04-10|||March 2013||2013-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Individually Tailored Lighting System to Improve Sleep in Older Adults|Individually Tailored Lighting System to Improve Sleep in Older Adults|Completed||Phase 1|28|Actual|Rensselaer Polytechnic Institute||2|||f||||f||||||||No||2017-10-11 01:42:14.029534|2017-10-11 01:42:14.029534
NCT01855113|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-05-13|||June 2013||2013-06-01|March 2013|2013-03-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Observational|||COMPARISON OF THE PERCEPTION OF PAIN BETWEEN ORTHODONTIC TREATMENT WITH Invisalign ® AND TREATMENT WITH BRACKETS|COMPARISON OF THE PERCEPTION OF PAIN BETWEEN ORTHODONTIC TREATMENT WITH Invisalign ® AND TREATMENT WITH BRACKETS|Unknown status|Not yet recruiting|N/A|60|Anticipated|Université de Montréal|||2||f||||f||||||||||2017-10-11 01:42:14.119204|2017-10-11 01:42:14.119204
NCT01855100|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-01-17|||July 2013||2013-07-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|BOX-DVT||Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)|Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto® Following an Acute Deep Vein Thrombosis (DVT)|Completed||N/A|131|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:42:14.185457|2017-10-11 01:42:14.185457
NCT01855087|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-05-13||||||May 2013|2013-05-01||||March 2013|Actual|2013-03-01||Observational|ASSIST-K||Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes|A Study of Safety and Efficacy of Sitagliptin Added to Insulin Therapy in the Treatment of Type 2 Diabetes in Kanagawa|Completed||N/A|||Kanagawa Physicians Association|||1||f||||||||||||||2017-10-11 01:42:14.268323|2017-10-11 01:42:14.268323
NCT01855074|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-08-06|2013-05-27||November 2007||2007-11-01|August 2013|2013-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders|Evaluation of Efficacy and Safety of Risperidone in Long-acting Microspheres in Patients With Schizophrenia, Schizophreniform or Schizoaffective Disorders Diagnosed According to the DSM-IV Criteria, After Switching Treatment With Any Antipsychotic Therapy With Long-acting Microspheres of Risperidone|Completed||Phase 4|80|Actual|Janssen-Cilag Ltd.|The planned sample size was not reached and a high dropout rate of participants was observed. Due to the high number of protocol violations, analysis was performed as intention-to-treat instead of per protocol as was planned.|1|||f||||f||||||||||2017-10-11 01:42:14.34248|2017-10-11 01:42:14.34248
NCT01855061|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-02-23|||May 2011||2011-05-01|February 2014|2014-02-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Observational|CPCT-01||Biomarker Development for Response Prediction by DNA Mutational Analysis|Feasibility Study of Biomarker Development for Response Prediction by Large Scale DNA Mutational Analysis of Metastatic Lesions|Unknown status|Recruiting|N/A|80|Anticipated|UMC Utrecht|||1||f||||t||||||Samples With DNA|"     Histological biopsies Blood samples   "|||2017-10-11 01:42:14.622845|2017-10-11 01:42:14.622845
NCT01854853|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-10-11|||August 2012||2012-08-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health Disorder|Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health|Completed||Phase 1|305|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 01:42:18.136068|2017-10-11 01:42:18.136068
NCT01855048|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-03-12|||August 2013||2013-08-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers|A Randomized, Double-blind, Placebo-controlled, Clinical Study to Evaluate the Safety, Pharmacokinetics and Phyarmacodynamcs of a Single Intravenous Dose of N-Rephasin® SAL200, in Healthy Male Valunteers|Completed||Phase 1|36|Actual|Intron Biotechnology, Inc.||2|||f||||t||||||||||2017-10-11 01:42:14.735489|2017-10-11 01:42:14.735489
NCT01855035|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-02-24|||May 2013||2013-05-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|||Finding Atrial Fibrillation in Stroke - Evaluation of Enhanced and Prolonged Holter Monitoring|A Prospective, Randomised, Controlled Study to Determine the Detection of Atrial Fibrillation by Prolonged and Enhanced Holter Monitoring as Compared to Usual Care in Stroke Patients|Active, not recruiting||N/A|400|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||2|||f||||f||||||||||2017-10-11 01:42:14.831103|2017-10-11 01:42:14.831103
NCT01855022|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-05-13|||June 2010||2010-06-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response|A Hospital-based Intervention Using Motivational Interviewing and Interactive Voice Response to Reduce Readmissions in Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial|Completed||N/A|512|Actual|Asante Health System||2|||f||||f||||||||||2017-10-11 01:42:15.168787|2017-10-11 01:42:15.168787
NCT01855009|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-06-21|||May 2013||2013-05-01|June 2013|2013-06-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Study of Parental Ratings of Quality of Life and Body Composition in 5-19 Year Olds While Participating in the Good NEWS 4 Kids Program|A Comparative Effectiveness Research Study Comparing Changes in Body Composition and Parent Ratings of Quality of Life in 5-19 Year Olds as a Function of Participation in One of Four Versions of the Good NEWS 4 Kids Program (GN4K)|Unknown status|Recruiting|N/A|200|Anticipated|Integrative Health Technologies, Inc.||3|||f||||f||||||||||2017-10-11 01:42:15.269067|2017-10-11 01:42:15.269067
NCT01854996|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-06-24|||May 2013||2013-05-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Relative Bioavailability With PF-05089771 Capsule Versus Oral Dispersion|A Phase I, Randomized, Single-Dose Study To Determine The Relative Bioavailability Of Capsule Vs Oral Dispersion And The Effect Of Food On The Pharmacokinetics Of Orally Administered PF-05089771 As Capsule In Healthy Volunteers|Completed||Phase 1|12|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:42:15.371223|2017-10-11 01:42:15.371223
NCT01854983|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-05-27|||May 2013||2013-05-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer|Clinical Trial to Access Significance of Fluorescence Colposcopy With Autofluorescence Imaging for the Screening of Cervical Cancer|Completed||N/A|80|Actual|Asan Medical Center|||1||f||||t||||||||||2017-10-11 01:42:15.459709|2017-10-11 01:42:15.459709
NCT01854970|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2015-07-22|||May 2013||2013-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PHARO||Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux|Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux|Completed||N/A|30|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-11 01:42:15.538033|2017-10-11 01:42:15.538033
NCT01854957|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-05-13|||July 2012||2012-07-01|May 2013|2013-05-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|MESEMS||MEsenchymal StEm Cells for Multiple Sclerosis|MEsenchymal StEm Cells for Multiple Sclerosis (MESEMS) Phase I-II Clinical Trial With Autologous Mesenchymal Stem Cells (MSCs) for the Therapy of Multiple Sclerosis|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|University of Genova||2|||f||||t||||||||||2017-10-11 01:42:15.617527|2017-10-11 01:42:15.617527
NCT01854944|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-01-05|2015-09-17||September 2013||2013-09-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia||Completed||Phase 1|12|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 01:42:15.733582|2017-10-11 01:42:15.733582
NCT01854918|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-06-14|||April 23, 2013|Actual|2013-04-23|June 2017|2017-06-01|August 27, 2018|Anticipated|2018-08-27|August 27, 2018|Anticipated|2018-08-27||Interventional|OSLER-2||Open Label Study of Long Term Evaluation Against LDL-C Trial-2|A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145-2|Active, not recruiting||Phase 3|3681|Actual|Amgen||2|||f||||t||||||||||2017-10-11 01:42:16.779223|2017-10-11 01:42:16.779223
NCT01854905|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2014-01-28|2014-01-28||May 2013||2013-05-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||An Observational Study of Dry Eye Prior to Laser-Assisted in Situ Keratomileusis (LASIK) Therapy||Completed||N/A|400|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:42:17.577046|2017-10-11 01:42:17.577046
NCT01854892|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-05-11|||June 2013||2013-06-01|May 2017|2017-05-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||The RELIEF Study - Researching the Effectiveness of Lumbar Interventions for Enhancing Function|The RELIEF Study - Researching the Effectiveness of Lumbar Interventions for Enhancing Function|Completed||N/A|162|Actual|Ohio University||3|||f||||t||||||||||2017-10-11 01:42:17.738639|2017-10-11 01:42:17.738639
NCT01854879|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-09-23|||March 2013||2013-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:42:17.828871|2017-10-11 01:42:17.828871
NCT01854866|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2013-09-28|||May 2013||2013-05-01|September 2013|2013-09-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion|Phase II Study of Tumor Cell-derived Microparticles Used as Vectors of Chemotherapeutic Drugs to Treat Malignant Ascites and Pleural Effusion|Unknown status|Enrolling by invitation|Phase 2|30|Anticipated|Huazhong University of Science and Technology||1|||f||||f||||||||||2017-10-11 01:42:18.02225|2017-10-11 01:42:18.02225
NCT01854840|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-08-23|||January 2012||2012-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|b-Mhyalines||Betamethasone and Severity of Hyaline Membrane Disease|Betamethasone and Severity of Hyaline Membrane Disease in the Newborn Premature|Recruiting||N/A|150|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Plasma samples will be collected. The effect of covariates as genetic polymorphism for     CYP3A4, CYP3A5 and P-glycoprotein will be tested to explain the variability of placental     transfer   "|||2017-10-11 01:42:18.23037|2017-10-11 01:42:18.23037
NCT01854827|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-08-05|||October 2013||2013-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PRIME||Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia|A Phase 1/2A Trial of Intravenous Immunoglobulin (IVIG) Therapy Following Portoenterostomy in Infants With Biliary Atresia|Completed||Phase 1/Phase 2|30|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-10-11 01:42:18.331034|2017-10-11 01:42:18.331034
NCT01854814|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-11-11|||July 2013||2013-07-01|November 2016|2016-11-01||||June 2018|Anticipated|2018-06-01||Interventional|MAIN||The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients|The Effects of Mycophenolate Mofetil on Renal Outcomes in Patients With Advanced IgA Nephropathy: a Randomized Open-label Study|Recruiting||N/A|232|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||||||||||||2017-10-11 01:42:18.452953|2017-10-11 01:42:18.452953
NCT01854801|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-07-31|||March 9, 2012|Actual|2012-03-09|July 2017|2017-07-01|April 30, 2016|Actual|2016-04-30|May 30, 2015|Actual|2015-05-30||Interventional|IEI-CEM||Evaluation of a Specialized Therapeutic Care of Patients Presenting an Intolerance Attributed to Electromagnetic Fields|Evaluation of a Specialized Therapeutic Care of Patients Presenting an Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields|Completed||N/A|79|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:42:18.56932|2017-10-11 01:42:18.56932
NCT01854788|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2013-05-13|||September 2010||2010-09-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||3 Airway Clearance Techniques in Non Cystic Fibrosis Bronchiectasis|A Comparative Study of Three Airway Clearance Techniques With Different Autonomy Degrees in Non Cystic Fibrosis Bronchiectasis: Randomized Cross-over Trial.|Completed||N/A|31|Actual|Hospital Clinic of Barcelona||3|||f||||f||||||||||2017-10-11 01:42:18.664531|2017-10-11 01:42:18.664531
NCT01854775|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-08-15|||May 6, 2013|Actual|2013-05-06|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children|A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children|Active, not recruiting||Phase 2/Phase 3|100|Anticipated|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-11 01:42:18.778012|2017-10-11 01:42:18.778012
NCT01854749|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-02-22|||November 2011||2011-11-01|February 2016|2016-02-01||||December 2015|Actual|2015-12-01||Interventional|||S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study|S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study|Completed||Phase 2|57|Actual|Fudan University||1|||f||||t||||||||||2017-10-11 01:42:19.012205|2017-10-11 01:42:19.012205
NCT01854736|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-06-27|||April 2013|Actual|2013-04-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate|Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate|Completed||Phase 4|51|Actual|ALK-Abelló A/S||2|||f||||f||||||||No||2017-10-11 01:42:19.105145|2017-10-11 01:42:19.105145
NCT01854723|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-21|||April 2013||2013-04-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Comparison Study of Insulin Glargine and NPH Insulin|Basal Insulin Therapy in Patients With Insulin Resistance: A 6 Month Comparison of Insulin Glargine and NPH Insulin|Unknown status|Enrolling by invitation|Phase 4|500|Anticipated|Providence Health & Services||2|||f||||f||||||||||2017-10-11 01:42:19.20029|2017-10-11 01:42:19.20029
NCT01854697|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-07-08|2015-11-04||March 2013||2013-03-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|November 2014|Actual|2014-11-01||Interventional|MALACHITE 1||A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before|A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered With and Without Ribavirin Compared to Telaprevir Co-administered With Pegylated Interferon α-2a and Ribavirin in Treatment-Naïve Adults With Chronic Hepatitis C Genotype 1 Virus Infection (MALACHITE I)|Completed||Phase 3|311|Actual|AbbVie||5|||f||||f||||||||||2017-10-11 01:42:19.462285|2017-10-11 01:42:19.462285
NCT01854684|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-10-05|||February 21, 2014|Actual|2014-02-21|October 2017|2017-10-01|September 21, 2018|Anticipated|2018-09-21|December 21, 2017|Anticipated|2017-12-21||Interventional|||Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery|A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) With Temoporfin in Patients With Resectable Primary Non-small Cell Lung Cancer (NSCLC) With Ipsilateral Thoracic Nodal (N1 or N2) or T3/T4 Disease|Recruiting||Phase 1|12|Anticipated|Roswell Park Cancer Institute||1|||f||||f||||||||||2017-10-11 01:42:22.620372|2017-10-11 01:42:22.620372
NCT01854671|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-08-14|||August 2013||2013-08-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Investigating the Effect of a Prenatal Family Planning Counseling Intervention Led by Community Health Workers on Postpartum Contraceptive Use Among Women in the West Bank|Investigating the Effect of a Prenatal Family Planning Counseling Intervention Led by Community Health Workers on Postpartum Contraceptive Use Among Women in the West Bank|Completed||N/A|176|Actual|Planned Parenthood League of Massachusetts||2|||f||||f||||||||||2017-10-11 01:42:22.74167|2017-10-11 01:42:22.74167
NCT01854658|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-02-07|2016-05-21|2015-07-07|July 2013||2013-07-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||"5 subjects participated in more than one Phase 3 Pearl study (a protocol violation) and had overlapping treatment exposure - these subjects were removed from the ITT and safety populations;
1 subject participated in more than one Phase 3 Pearl study but did not have overlapping treatment exposure - this subject was removed from the ITT population"|Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)|A Randomized, Double-Blind (Test Products and Placebo), Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo|Completed||Phase 3|1615|Actual|Pearl Therapeutics, Inc.||4|||f||||t||||||||||2017-10-11 01:42:22.880901|2017-10-11 01:42:22.880901
NCT01854645|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-02-07|2016-05-20|2015-07-07|May 2013||2013-05-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||7 subjects were excluded from analysis.|Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)|A Randomized, Double Blind, Chronic Dosing, Placebo-Controlled, Parallel Group, Multi Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo and Spiriva® Handihaler® (Tiotropium Bromide 18 µg Open-Label) as an Active Control|Completed||Phase 3|2103|Actual|Pearl Therapeutics, Inc.||5|||f||||t||||||||||2017-10-11 01:42:25.751362|2017-10-11 01:42:25.751362
NCT01854632|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-06-01|2015-04-30||May 2013||2013-05-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All enrolled participants receiving the single dose of study vaccine.|Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal|A Randomized, Double-Blind, Placebo-Controlled Trial of the Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal|Completed||Phase 3|1761|Actual|PATH||2|||f||||f||||||||||2017-10-11 01:42:28.001598|2017-10-11 01:42:28.001598
NCT01854619|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-15|||May 2013||2013-05-01|May 2013|2013-05-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis|Photodisinfection for the Treatment of Chronic Rhinosinusitis|Unknown status|Recruiting|N/A|48|Anticipated|Ondine Biomedical Inc.||3|||f||||f||||||||||2017-10-11 01:42:28.374485|2017-10-11 01:42:28.374485
NCT01854606|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-05-24|||December 5, 2013|Actual|2013-12-05|May 2017|2017-05-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|COEB071X2103||Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma|An Open-Label, Single-arm, Phase Ib/II Study of AEB071 (a Protein Kinase C Inhibitor) and Everolimus (mTOR Inhibitor) in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma|Completed||Phase 1|31|Actual|Novartis||1|||f||||f|t|f||||||No||2017-10-11 01:42:28.492098|2017-10-11 01:42:28.492098
NCT01854593|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-06-11|2013-12-29||May 2012||2012-05-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|August 2013|Actual|2013-08-01||Interventional|||Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy|Prospective Randomized Controlled Study of Intravitreal Injection of 0.16 mg Bevacizumab One Day Before Surgery for Proliferative Diabetic Retinopathy|Completed||Phase 4|69|Actual|Nihon University||2|||f||||t||||||||||2017-10-11 01:42:28.630348|2017-10-11 01:42:28.630348
NCT01854580|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-03-07|||March 2013||2013-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ediva||Evaluation of an Integrated Care Project|Evaluation of an Integrated Care Project of the Statutory Health Insurance Techniker Krankenkasse [Evaluation Des Integrierten Versorgungsangebots Der Techniker Krankenkasse]|Enrolling by invitation||N/A|3960|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 01:42:29.369844|2017-10-11 01:42:29.369844
NCT01854567|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-07-21|||February 2013||2013-02-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|February 2018|Anticipated|2018-02-01||Interventional|||P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies|A 1-Year, Multicenter, Randomized, Open-Label Controlled Study to Evaluate the Efficacy and Safety of Cord Blood Cells Expanded With MPCs for Hematopoetic Recovery in Patients With Hematologic Malignancies After Myeloablative Treatment|Active, not recruiting||Phase 3|240|Anticipated|Mesoblast, Ltd.||2|||f||||t||||||||||2017-10-11 01:42:29.555373|2017-10-11 01:42:29.555373
NCT01854554|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-08-11|||May 2013|Actual|2013-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)|A Prospective Phase II Randomized Trial to Compare Intensity Modulated Proton Radiotherapy (IMPT) vs. Intensity Modulated Radiotherapy (IMRT) for Newly Diagnosed Glioblastoma (WHO Grade IV)|Active, not recruiting||Phase 2|90|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 01:42:29.677319|2017-10-11 01:42:29.677319
NCT01854541|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-04-09|||March 2013||2013-03-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01|3 Months|Observational [Patient Registry]|VMRTP||Visual Management for the Radiotherapy Process|Visual Management for the Radiotherapy Process|Completed||N/A|10000|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-11 01:42:29.801381|2017-10-11 01:42:29.801381
NCT01854528|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-06-03|2015-11-24||June 2013||2013-06-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|November 2014|Actual|2014-11-01||Interventional|MALACHITE II|All randomized participants who received at least 1 dose of study drug (ITT population) were included in baseline analysis population.|A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults|A Randomized, Open-Labeled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered With Ribavirin Compared to Telaprevir Co-administered With Pegylated Interferon a-2a and Ribavirin in Treatment-Experienced Adults With Chronic Hepatitis C Genotype 1 Virus Infection (MALACHITE-II)|Completed||Phase 3|148|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 01:42:29.901064|2017-10-11 01:42:29.901064
NCT01854515|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2013-05-14|||March 2012||2012-03-01|May 2013|2013-05-01||||September 2014|Anticipated|2014-09-01||Interventional|||Comparison of Efficacy of Nebulizing Budesonide and Intravenous Dexamethasone Before Extubation on Prevention of Post-extubation Complications in Intensive Care Unit Patients||Unknown status|Recruiting|N/A|90|Anticipated|Isfahan University of Medical Sciences||2|||f||||||||||||||2017-10-11 01:42:30.49308|2017-10-11 01:42:30.49308
NCT01854502|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-05-03|||January 2008||2008-01-01|May 2017|2017-05-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Family-based Counseling Models for Young Children|Organizing Family-based Health Promotion for Young Children in Public Dental Service|Completed||N/A|804|Actual|University of Turku||3|||f||||t||||||||No|The individual participant data is not planned to be shared with other researchers, it will be destroyed after the study.|2017-10-11 01:42:30.5914|2017-10-11 01:42:30.5914
NCT01854489|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2014-11-19|||April 2013||2013-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine|Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine: A Four-phase Cross-over Study in Healthy Subjects.|Completed||Phase 4|12|Actual|Turku University Hospital||3|||f||||f||||||||||2017-10-11 01:42:30.719183|2017-10-11 01:42:30.719183
NCT01854463|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-05-09|||December 2011||2011-12-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|VD2000||The Effect of Vitamin D Supplementation in Type 2 Diabetes|The Effect of Vitamin D Supplementation on the Glycemic Control and Non-alcoholic Fatty Liver Disease in Type 2 Diabetes|Completed||Phase 4|158|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||||2017-10-11 01:42:30.982891|2017-10-11 01:42:30.982891
NCT01854450|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-05-19|||May 2013||2013-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|EVADELA||Evaluation of Asymmetrical Lateral Decubitus for Rotation of Occipitoposterior Fetal Position|Evaluation of Asymmetrical Lateral Decubitus for Rotation of Occipitoposterior Fetal Position During Labor : EVADELA Multicentre Randomized Trial|Completed||N/A|326|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:42:31.113351|2017-10-11 01:42:31.113351
NCT01854437|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2013-05-12|||June 2012||2012-06-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01|4 Months|Observational [Patient Registry]|||The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients||Completed||Phase 1|42|Actual|Shiraz University of Medical Sciences|||2||f||||f||||||||||2017-10-11 01:42:31.273165|2017-10-11 01:42:31.273165
NCT01854424|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-03-21|||November 2013||2013-11-01|March 2017|2017-03-01|July 11, 2016|Actual|2016-07-11|July 2016|Actual|2016-07-01||Observational|IFRA2||Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDS|Involvement of Fibrocytes in Repair Processes During Acute Respiratory Distress Syndrome (Validation Study-2)|Completed||N/A|84|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Patients or relatives will be informed of the study. The samples (Bronchoalveolar lavage     fluid -BALF-and blood samples) will be obtained in current care and stored in an authorized     center of biological resources (CRB Bichat- DC 2009-940)   "|||2017-10-11 01:42:31.409376|2017-10-11 01:42:31.409376
NCT01854411|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-04-20|||September 2011||2011-09-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Observational|ANTALAIT||Study of Analgesics Drug and Human Milk Transfer in Mature Milk, to Avoid Breastfeeding Cessation Without Scientific Probes|"Ibuprofen and Ketoprofen Concentrations in Human Mature Milk. PK Study in Breastmilk AOR-10127 Antalait Study"|Completed||N/A|35|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     human breast milk   "|||2017-10-11 01:42:31.552708|2017-10-11 01:42:31.552708
NCT01854398|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-01-24|||May 2013||2013-05-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Continuous Positive Airway Pressure on Diastolic Function in Patients With Obstructive Sleep Apnea||Completed||N/A|60|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:42:31.676502|2017-10-11 01:42:31.676502
NCT01854385|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-05-13|||June 2013||2013-06-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|TWIST||Sumatriptan as Treatment for Post-traumatic Headache|Sumatriptan as Treatment for Moderate to Severe Post-Traumatic Headache|Recruiting||Phase 2|40|Anticipated|University of Washington||1|||f||||t||||||||Undecided||2017-10-11 01:42:31.780373|2017-10-11 01:42:31.780373
NCT01854372|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-12-09|||June 2013||2013-06-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.|Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement. A Phase 2, Multi-Center, Open Label Study (CTRC# 11-53)|Withdrawn||Phase 2|0|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 01:42:31.938301|2017-10-11 01:42:31.938301
NCT01854346|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2017-08-18|||August 2012||2012-08-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|KONTAKT-RCT||"Social Skills Group Training (KONTAKT) for Children and Adolescent With High-functioning Autism Spectrum Disorders"|Genotype and Behavioral Effects of Social Skills Training in Children and Adolescents With High-functioning Autism Spectrum Disorders, a Randomized Controlled Trial (RCT) and Multicenter Study.|Completed||N/A|296|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:42:32.178003|2017-10-11 01:42:32.178003
NCT01854320|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2016-05-20|||July 2012||2012-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MYH-II||Acceptance-based Behavioral Treatment for Obesity: Maintenance and Mechanisms|Acceptance-based Behavioral Treatment for Obesity: Maintenance and Mechanisms|Active, not recruiting||N/A|200|Anticipated|Drexel University||2|||f||||||||||||||2017-10-11 01:42:32.431401|2017-10-11 01:42:32.431401
NCT01854307|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-01-21|||May 2013||2013-05-01|January 2016|2016-01-01||||August 2015|Actual|2015-08-01||Interventional|||The Influence of Pneumoperitoneum on Minimal Invasive Cardiac Output Measurements|The Influence of Pneumoperitoneum on Minimal Invasive Cardiac Output Measurements|Terminated||N/A|5|Actual|Haukeland University Hospital||1||Low inclusion rate|f||||f||||||||||2017-10-11 01:42:32.536158|2017-10-11 01:42:32.536158
NCT01854294|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-08-02||2017-08-01|August 2013||2013-08-01|August 2017|2017-08-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|GALS||GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)|GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)|Completed||Phase 2|12|Actual|Genervon Biopharmaceuticals, LLC||2|||f||||f||||||||||2017-10-11 01:42:32.665187|2017-10-11 01:42:32.665187
NCT01854281|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-10-28|2013-07-08||May 2013||2013-05-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Nitrogen Bubble Detection After Simulated Dives in Divers With PFO and After PFO Closure|Nitrogen Bubble Detection After Simulated Dives in Divers With PFO and After PFO Closure|Completed||N/A|47|Actual|University Hospital, Motol|||4||f||||f||||||||||2017-10-11 01:42:32.863506|2017-10-11 01:42:32.863506
NCT01854268|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-09-15|2014-12-10||May 2013||2013-05-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||All participants were evaluated one time. Therefore baseline evaluations were the only measures completed.|Respiratory Kinematics During Voluntary and Reflex Cough in Healthy Adults|Respiratory Kinematics During Voluntary and Reflex Cough in Healthy Adults|Completed||Phase 1/Phase 2|25|Actual|University of Florida||1|||f||||t||||||||||2017-10-11 01:42:33.524941|2017-10-11 01:42:33.524941
NCT01854255|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2016-11-13|||November 2013||2013-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|PIPAC-GA01||Intraperitoneal Aerosol Chemotherapy in Gastric Cancer|Feasibility, Efficacy and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Cisplatin and Doxorubicin in Patients With Gastric Cancer and Peritoneal Carcinomatosis: an Open-label, Single-arm, Phase II Clinical Trial|Completed||Phase 2|35|Actual|Ruhr University of Bochum||1|||f||||f||||||||||2017-10-11 01:42:33.796168|2017-10-11 01:42:33.796168
NCT01854242|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-12-22|2014-12-10||November 2013||2013-11-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease|Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease: A New Comorbidity or Secondary Consequence|Completed||N/A|50|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 01:42:33.935373|2017-10-11 01:42:33.935373
NCT01854229|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-02-02|||June 2013||2013-06-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Prometra Post-Approval Study|A Prospective, Non-randomized, Open-label, Multicenter Study to Evaluate the Long-term Safety of the Prometra Programmable Pump System|Recruiting||N/A|400|Anticipated|Flowonix Medical||2|||f||||f||||||||||2017-10-11 01:42:34.198575|2017-10-11 01:42:34.198575
NCT01854216|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-10-17|||December 2002||2002-12-01|May 2013|2013-05-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects|Parallel Group Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Repeated Dose Treatment With Rotigotine Continuous Delivery System (5 cm^2/2.25 mg, 10 cm^2/4.5 mg, 20 cm^2/9 mg) in Japanese and Caucasian Healthy Subjects|Completed||Phase 1|26|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 01:42:35.247064|2017-10-11 01:42:35.247064
NCT01854203|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-07-28|||July 2013||2013-07-01|July 2013|2013-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NPC||Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC|Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated Radiotherapy With or Without Concurrent Cisplatin for Locoregionally Advanced Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2/Phase 3|300|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:42:35.367491|2017-10-11 01:42:35.367491
NCT01854190|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2013-05-12|||July 2012||2012-07-01|February 2013|2013-02-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01|2 Days|Observational [Patient Registry]|||Obstructive Sleep Apnea and Endothelial Function in Patients With Resistant Hypertension|Evaluation of Obstructive Sleep Apnea and Endothelial Function in Resistant Hypertension Patients|Completed||N/A|40|Actual|Rio de Janeiro State University|||2||f||||t||||||||||2017-10-11 01:42:35.5004|2017-10-11 01:42:35.5004
NCT01854177|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-01-30|||July 2013||2013-07-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Differentiating the Effects of Substance P and Beta-endorphin|Differentiating the Effects of Substance P and Beta-endorphin in the Perception of Breathlessness During Resistive Load Breathing in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|10|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-11 01:42:35.641732|2017-10-11 01:42:35.641732
NCT01854164|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-03-13|||June 2009||2009-06-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of Hydrolyzed Ginseng Extract on Impaired Fasting Glucose|An 8 Weeks, Randomized, Double-blind, Placebo-controlled Clinical Trial for Anti-diabetic Effects of Hydrolyzed Ginseng Extract|Completed||N/A|20|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 01:42:35.77446|2017-10-11 01:42:35.77446
NCT01854151|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-14|2017-04-19|||July 2012||2012-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Promoting Safe Use of Pediatric Liquid Medications|Promoting Safe Use of Pediatric Liquid Medications: A Health Literacy Approach|Recruiting||N/A|800|Anticipated|New York University School of Medicine||2|||f||||t|f|f||||||||2017-10-11 01:42:35.871083|2017-10-11 01:42:35.871083
NCT01854138|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2015-05-04|||January 2014||2014-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Evaluating Advantages of Prevena After Hip and Knee Arthroplasty|Evaluating the Efficacy of the Prevena Incision Management System in Patients Undergoing Total Knee and Hip Arthroplasty|Completed||Phase 4|200|Actual|ProMedica Health System||3|||f||||f||||||||||2017-10-11 01:42:35.982121|2017-10-11 01:42:35.982121
NCT01854112|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2014-08-05|||November 2012||2012-11-01|May 2013|2013-05-01||||December 2017|Anticipated|2017-12-01||Observational|||Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma||Enrolling by invitation||N/A|1|Actual|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-10-11 01:42:36.209027|2017-10-11 01:42:36.209027
NCT01854099|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-11|2014-01-13|||January 2014||2014-01-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PERFORMANCE||Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens|Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens|Withdrawn||Phase 1|0|Actual|University of Florida||3||Investigator decided not to open study.|f||||f||||||||||2017-10-11 01:42:36.304706|2017-10-11 01:42:36.304706
NCT01854086|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-12|||September 2013||2013-09-01|May 2013|2013-05-01||||February 2014|Anticipated|2014-02-01|1 Day|Observational [Patient Registry]|CONTINUITY||Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday|Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday: Data From a Single Outpatient Endocrine Clinic.|Unknown status|Not yet recruiting|N/A|150|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 01:42:36.405765|2017-10-11 01:42:36.405765
NCT01854073|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-11|2017-03-09|||February 2014||2014-02-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Hyoscine Butyl Bromide for Management of Prolonged Labor|Use of Hyoscine Butyl Bromide for Management of Prolonged Labor in Nulliparous Women, A Randomized Controlled Trial|Recruiting||Phase 3|500|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 01:42:36.584227|2017-10-11 01:42:36.584227
NCT01854047|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-06-07|2017-04-27|2015-11-27|June 2013||2013-06-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|||An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma|Completed||Phase 2|776|Actual|Sanofi||5|||f||||t||||||||||2017-10-11 01:42:36.915317|2017-10-11 01:42:36.915317
NCT01854034|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2017-09-19|||July 2013||2013-07-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR|Phase II Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR|Completed||Phase 2|30|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:42:41.032094|2017-10-11 01:42:41.032094
NCT01854021|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-16|||May 2013||2013-05-01|May 2013|2013-05-01||||August 2013|Anticipated|2013-08-01||Interventional|||Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer|Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer|Unknown status|Recruiting|N/A|60|Anticipated|Wuhan University||3|||f||||||||||||||2017-10-11 01:42:41.164289|2017-10-11 01:42:41.164289
NCT01854008|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-12|2013-05-12|||April 2008||2008-04-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Urban Walking Circuits|Improving Physical Activity in Patients With Severe Chronic Obstructive Pulmonary Disease With Urban Walking Circuits|Completed||N/A|82|Actual|Hospital de Mataró||2|||f||||f||||||||||2017-10-11 01:42:41.290813|2017-10-11 01:42:41.290813
NCT01853995|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2014-03-21||2014-02-03|May 2009||2009-05-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|July 2011|Actual|2011-07-01||Interventional|FLMGM||Mechanism of Class II Correction With Fixed Lingual Mandibular Growth Modificator (FLMGM)|Class II Division 1 Malocclusions Treated With Fixed Lingual Mandibular Growth Modificator (FLMGM): The Mechanism of Sagittal Occlusal Correction|Completed||Phase 2|43|Actual|Damascus University||2|||f||||t||||||||||2017-10-11 01:42:41.390034|2017-10-11 01:42:41.390034
NCT01853982|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2016-01-06|2015-04-19||July 2013||2013-07-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia|A Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of Intravenous Ceftolozane/Tazobactam With That of Piperacillin/Tazobactam in Ventilator Associated Pneumonia|Terminated||Phase 3|4|Actual|Cubist Pharmaceuticals LLC|This study was electively terminated to focus on a larger registrational study, which was also part of the clinical development program for nosocomial pneumonia.|2||Terminated to focus on a larger study within the clinical development program.|f||||f||||||||||2017-10-11 01:42:41.497964|2017-10-11 01:42:41.497964
NCT01853969|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2015-09-15|||May 2013||2013-05-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Typing Proficiency Following Carpal Tunnel Release|Typing Proficiency Following Carpal Tunnel Release|Completed||N/A|38|Actual|Vanderbilt University|||1||f||||f||||||||||2017-10-11 01:42:41.797954|2017-10-11 01:42:41.797954
NCT01853956|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-12|||December 2, 2010|Actual|2010-12-02|June 2017|2017-06-01|December 10, 2010|Actual|2010-12-10|December 10, 2010|Actual|2010-12-10||Interventional|||Bioequivalence Trial of Alprazolam 0.25 mg Tablets|Open,Two-period, Two-treatment, Two-sequence, Cross-over, Randomized Trial of Single Doses of Two Oral Preparations With 0.25 mg of Alprazolam (Zamoprax® GlaxoSmithKline México, S.A. de C.V. vs. Tafil® 0.25mg, Pharmacia &Upjohn, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:42:41.866393|2017-10-11 01:42:41.866393
NCT01853943|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-03-02|||July 2012||2012-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|HANGAR||Hand Grip Test and Transradial Coronary Procedures|Hand Grip Test After Transradial Percutaneous Coronary Procedures|Completed||N/A|107|Actual|Ospedale Sandro Pertini, Roma|||2||f||||f||||||||||2017-10-11 01:42:41.942212|2017-10-11 01:42:41.942212
NCT01853930|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-03-24|||January 1, 2014|Actual|2014-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Translation of Eye Movement Reading Training to Clinical Practice|Translation of Eye Movement Reading Training to Clinical Practice|Recruiting||Phase 1|70|Anticipated|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 01:42:42.006017|2017-10-11 01:42:42.006017
NCT01853917|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-12-02|||January 2012||2012-01-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Observational|||Evaluation of Barriers to Postpartum Care in HIV Infected Women|Evaluation of Barriers to Postpartum Care in HIV Infected Women|Completed||N/A|38|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-11 01:42:42.098407|2017-10-11 01:42:42.098407
NCT01853904|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-01-06|||July 2012||2012-07-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Utility of Syringe Based Suction Versus Channel Suction in Bronchoalveolar Lavage|Utility of Syringe Based Suction Versus Channel Suction in Bronchoalveolar Lavage|Completed||N/A|50|Actual|University of Oklahoma||2|||f||||f||||||||||2017-10-11 01:42:42.171486|2017-10-11 01:42:42.171486
NCT01853891|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-03-28|||February 2013||2013-02-01|March 2016|2016-03-01||||November 2013|Actual|2013-11-01||Interventional|||Dim Light at Night in Patients With Obstructive Sleep Apnea|Effects of Sleeping With Dim Light at Night in Patients With Obstructive Sleep Apnea|Withdrawn||N/A|0|Actual|Ohio State University||2||The study was stopped due to lack of funding.|f||||t||||||||||2017-10-11 01:42:42.240679|2017-10-11 01:42:42.240679
NCT01853865|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-04-03|||May 2013||2013-05-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|OPAL||Follow-up of Endometrial Cancer Patients|Follow-up of Endometrial Cancer Patients: A Valuable Medical Intervention or a Dispensable Force of Habit?|Active, not recruiting||N/A|211|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 01:42:42.585546|2017-10-11 01:42:42.585546
NCT01853852|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2013-12-17|||September 2011||2011-09-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese Subjects|A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese Subjects|Completed||Phase 1|14|Actual|Amicus Therapeutics||4|||f||||||||||||||2017-10-11 01:42:42.689973|2017-10-11 01:42:42.689973
NCT01853839|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-07-15|2015-07-15||October 2011||2011-10-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational||All subjects included in the study according to the study protocol i.e. patients who did not violate any inclusion or exclusion criteria|Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients|Treatment Adherence to JNC 7(Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, 7th Report) Guidelines in Cardiovascular (CV)-Risk Patients Across the Middle East - the Impact of Ramadan Fasting on Achieving Treatment Goals in Daily Practice|Completed||N/A|1674|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 01:42:42.826761|2017-10-11 01:42:42.826761
NCT01853826|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-09-14|||July 17, 2013|Actual|2013-07-17|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)|An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)|Active, not recruiting||Phase 3|481|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 01:42:43.506391|2017-10-11 01:42:43.506391
NCT01853813|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-07-14|||May 2013||2013-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|CENTRAL||First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer|First-line FOLFIRI and Bevacizumab in Patients With Advanced Colorectal Cancer Prospectively Stratified According to Serum LDH|Completed||Phase 2|85|Actual|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente||1|||f||||f||||||||||2017-10-11 01:42:44.070443|2017-10-11 01:42:44.070443
NCT01853800|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-01-20|||May 2013||2013-05-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Relative Bioavailability of Oral Suspension of Rivaroxaban Compared to Standard Tablet|Single-dose, Open-label, Randomized, 4-way Crossover Study to Compare 10 mg of an Oral Suspension of Rivaroxaban Under Fasting (2 Different Batches) and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions in Healthy Subjects|Completed||Phase 1|14|Actual|Bayer||4|||f||||f||||||||||2017-10-11 01:42:44.191203|2017-10-11 01:42:44.191203
NCT01853787|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2015-07-09|||July 2014||2014-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SANOB||Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study|Acute Bronchodilation and Bronchial Inflammation: Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients. Stretching of Airways and Nitric Oxide in Bronchodilation, SANOB Study|Completed||Phase 4|49|Actual|University of Milan||2|||f||||t||||||||||2017-10-11 01:42:44.294461|2017-10-11 01:42:44.294461
NCT01853774|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2017-04-21|||April 2012|Actual|2012-04-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|December 2016|Actual|2016-12-01||Interventional|||Navigation From Community to Clinic to Promote CRC Screening in Underserved Populations|Navigation From Community to Clinic to Promote CRC Screening in Underserved Populations|Completed||N/A|419|Actual|Arizona State University||2|||f||||f||||||||No||2017-10-11 01:42:44.425416|2017-10-11 01:42:44.425416
NCT01853761|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-05-09|||July 2011||2011-07-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Microcurrent and Aerobic Exercise Effects on Abdominal Fat|Microcurrent and Aerobic Exercise Effects on Abdominal Fat|Completed||N/A|45|Actual|Escola Superior de Tecnologia da Saúde do Porto||5|||f||||t||||||||||2017-10-11 01:42:44.570272|2017-10-11 01:42:44.570272
NCT01853748|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-08-24|||May 2013||2013-05-01|August 2016|2016-08-01||||May 2017|Anticipated|2017-05-01||Interventional|||T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)|A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)|Recruiting||Phase 2|500|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 01:42:44.763671|2017-10-11 01:42:44.763671
NCT01853735|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-11-28|||January 2013||2013-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Enteral Feeding in the Post-Injury Open Abdomen||Recruiting||N/A|500|Anticipated|Denver Health and Hospital Authority|||4||f||||f||||||||||2017-10-11 01:42:45.340332|2017-10-11 01:42:45.340332
NCT01853722|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-01-19||2016-01-19|April 2013||2013-04-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers|A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers|Completed||Phase 2|62|Actual|Deacon Biosciences, Inc.||2|||f||||f||||||||||2017-10-11 01:42:45.430896|2017-10-11 01:42:45.430896
NCT01853709|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-09|||May 2013||2013-05-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Multidisciplinary Approach Versus Conventional Approach in Colonic Preparation of Hospitalized Patients|Multidisciplinary Approach Versus Conventional Approach in Colonic Preparation of Hospitalized Patients. A Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 4|162|Anticipated|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-11 01:42:45.537505|2017-10-11 01:42:45.537505
NCT01853696|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-04-29|2015-04-02||March 2013||2013-03-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty|Prospective, Randomized Comparison of Corticosteroid Dosing Regimens Following Endothelial Keratoplasty|Completed||Phase 4|167|Actual|Cornea Research Foundation of America||2|||f||||t||||||||||2017-10-11 01:42:45.701074|2017-10-11 01:42:45.701074
NCT01853683|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-11-08|||April 2013||2013-04-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Is Interval Appendectomy Necessary?|Interval Appendectomy in Children, is it Really Necessary? A Randomized, Noninferiority Trial|Terminated||N/A|5|Actual|Children's Hospital of Eastern Ontario||2||Low recruitment|f||||t||||||||||2017-10-11 01:42:46.063171|2017-10-11 01:42:46.063171
NCT01853670|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-03-27|||August 2009||2009-08-01|September 2014|2014-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|IGRT||Adaptive Radiation Therapy for Head & Neck Cancer Patients|Kilovoltage Conebeam Imaging Based Adaptive Radiation Therapy for Head & Neck Patients Treated With Intensity Modulated Radiation Therapy|Completed||N/A|6|Actual|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-11 01:42:46.137058|2017-10-11 01:42:46.137058
NCT01853657|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-02-13|||June 2012||2012-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KCS||Kumasi Cohort Study|Efficacy of First and Second Line ART in HIV Patients Treated at the Komfo Anokye Teaching Hospital, Kumasi|Active, not recruiting||N/A|3000|Anticipated|Bernhard Nocht Institute for Tropical Medicine||2|||f||||f||||||||||2017-10-11 01:42:46.214673|2017-10-11 01:42:46.214673
NCT01853644|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-02-19|||May 2013||2013-05-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|March 2018|Anticipated|2018-03-01||Interventional|TIVO||Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer|The Efficacy and Safety of Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Recruiting||Phase 2|30|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 01:42:46.307921|2017-10-11 01:42:46.307921
NCT01853631|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-12-01|||February 2014||2014-02-01|December 2016|2016-12-01|February 2033|Anticipated|2033-02-01|February 2018|Anticipated|2018-02-01||Interventional|SAGAN||Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)|Phase I Study of Activated T-Cells Expressing Second or Third Generation CD19-Specific Chimeric Antigen Receptors for Advanced B-Cell Non-Hodgkin's Lymphoma, Acute Lymphocytic Leukemia and Chronic Lymphocytic Leukemia (SAGAN)|Recruiting||Phase 1|64|Anticipated|Baylor College of Medicine||4|||f||||t||||||||No||2017-10-11 01:42:46.412137|2017-10-11 01:42:46.412137
NCT01853618|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-10-03|||April 9, 2013||2013-04-09|September 21, 2017|2017-09-21|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Tremelimumab With Chemoembolization or Ablation for Liver Cancer|A Pilot Study of Tremelimumab - A Monoclonal Antibody Against CTLA-4 in Combination With Trans-Arterial Catheter Chemoembolization (TACE), Radiofrequency Ablation (RFA), or Cryoablation in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)|Active, not recruiting||Phase 1|61|Actual|National Institutes of Health Clinical Center (CC)||5|||f||||||||||||||2017-10-11 01:42:46.530447|2017-10-11 01:42:46.530447
NCT01853605|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-13|2015-07-16|2015-07-16||April 2003||2003-04-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study||Terminated||N/A|3811|Actual|Allergan||4||The study was discontinued following product approval.|f||||f||||||||||2017-10-11 01:42:46.666573|2017-10-11 01:42:46.666573
NCT01853592|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-06-30|||March 8, 2013||2013-03-08|December 13, 2016|2016-12-13|December 13, 2016|Actual|2016-12-13|February 11, 2014|Actual|2014-02-11||Observational|||Gadofosveset Trisodium for Heart Imaging Studies|A Pilot Dosing Study for Gadofosveset Trisodium (Ablavar) for Coronary Magnetic Resonance Angiography (MRA)|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:42:47.295735|2017-10-11 01:42:47.295735
NCT01853579|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-10-19|||March 2013||2013-03-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TRUST||The TRUST Study - Depression Substudy|Thyroid Hormone Replacement for Subclinical Hypothyroidism (TRUST) - Subanalysis on Subclinical Hypothyroidism and Depression|Recruiting||Phase 4|450|Anticipated|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 01:42:47.381702|2017-10-11 01:42:47.381702
NCT01853566|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-08-31|||January 2012||2012-01-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old|Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old|Completed||Phase 4|13|Actual|Universidade Federal do Rio de Janeiro||1|||f||||f||||||||||2017-10-11 01:42:47.518305|2017-10-11 01:42:47.518305
NCT01853553|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-03-23|||July 2013||2013-07-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney|Completed||N/A|60|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:42:47.618556|2017-10-11 01:42:47.618556
NCT01853527|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-12-02|||April 2013||2013-04-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|MicroCAD||Myocardial Ischemia in Non-obstructive Coronary Artery Disease|Myocardial Ischemia in Non-obstructive Coronary Artery Disease|Unknown status|Active, not recruiting|N/A|132|Anticipated|University of Bergen|||1||f||||f||||||Samples With DNA|"     Blood and urin test for biobank   "|||2017-10-11 01:42:47.845374|2017-10-11 01:42:47.845374
NCT01853514|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-02-06|||February 2012||2012-02-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Fresh Fruit and Vegetable Purchasing Behavior|Assessing Consumer Behavior Regarding the Purchasing of Fresh Produce in Low-income Population|Active, not recruiting||N/A|510|Actual|Institute for Food Safety and Health, United States|||1||f||||f||||||||Undecided||2017-10-11 01:42:47.940109|2017-10-11 01:42:47.940109
NCT01853488|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-11-25|||October 2010||2010-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Bone Strength After Spinal Cord Injury|Impact of Spinal Cord Injury on Bone Strength in Paralysed Extremities.|Completed||N/A|273|Actual|Swiss Paraplegic Centre Nottwil|||2||f||||f||||||||||2017-10-11 01:42:48.140948|2017-10-11 01:42:48.140948
NCT01853475|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-04-08|2015-03-27||April 2013||2013-04-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||All 24 subjects who had received at least one treatment of randomised study medication and for whom any post-treatment data was available.|Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State|Open Label, Parallel Group Study to Investigate the Pharmacokinetics (PK) Following Oral Co-administration of Piperaquine Phosphate (PQP) Tablets With a Prototype OZ439 + TPGS Formulation in the Fasted State in Healthy Volunteers|Completed||Phase 1|24|Actual|Medicines for Malaria Venture||3|||f||||f||||||||||2017-10-11 01:42:48.250291|2017-10-11 01:42:48.250291
NCT01853449|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-02-10|||June 2013||2013-06-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Inhaled Fentanyl Citrate & Dyspnea|Effects of Inhaled Fentanyl Citrate on Perceived Respiratory Discomfort (Dyspnea) During Exercise in the Presence of External Thoracic Restriction|Completed||Early Phase 1|14|Actual|McGill University||4|||f||||f||||||||No||2017-10-11 01:42:48.965817|2017-10-11 01:42:48.965817
NCT01853436|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-05-23|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|April 2017|Actual|2017-04-01||Interventional|||Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava)|Impact of Acellular Dermal Matrix in Reduction of Surgical Complexity of Breast Reconstructions With Implants|Terminated||N/A|36|Actual|LifeCell||2||Lifecell became part of Allergan; company deciscion|f||||f||||||||||2017-10-11 01:42:49.108815|2017-10-11 01:42:49.108815
NCT01853423|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-08-17|||October 2013||2013-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|||Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream|Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream|Completed||Phase 1|11|Actual|Le Bonheur Children's Hospital||1|||f||||f||||||||||2017-10-11 01:42:49.218476|2017-10-11 01:42:49.218476
NCT01853410|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-11-25|||July 2013||2013-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|July 2014|Actual|2014-07-01||Interventional|PERCCAD||Peripheral Stimulation Device to Improve Coronary Flow Reserve in Coronary Artery Disease|Peripheral Stimulation Device to Improve Coronary Flow Reserve in Coronary Artery Disease|Completed||Phase 1|10|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 01:42:49.33128|2017-10-11 01:42:49.33128
NCT01853397|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-03-26|2015-03-17||April 2013||2013-04-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method|An Evaluation of the Safety and Effectiveness of Treatment of Adipose Tissue With the Liposonix System (Model 2) Using a New Treatment Method|Completed||N/A|72|Actual|Valeant Pharmaceuticals||4|||f||||f||||||||||2017-10-11 01:42:49.460716|2017-10-11 01:42:49.460716
NCT01853384|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-09-19|2016-09-19|2015-01-05|November 2013||2013-11-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers|A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU)|Terminated||Phase 3|252|Actual|Healthpoint||2||based on outcome of trial NCT01656889.|f||||t||||||||||2017-10-11 01:42:50.331523|2017-10-11 01:42:50.331523
NCT01853371|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-11-24|2014-05-11||June 2013||2013-06-01|November 2014|2014-11-01||||November 2013|Actual|2013-11-01||Interventional|||Efficacy of Wet Cupping on Blood Pressure Among Hypertension Patients|The Efficacy of Wet Cupping on Blood Pressure Among Hypertension Patients in Jeddah, 2013, A Pilot Study|Completed||N/A|20|Actual|King Abdulaziz University||2|||f||||t||||||||||2017-10-11 01:42:51.577226|2017-10-11 01:42:51.577226
NCT01850290|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-01-15|||May 2013||2013-05-01|January 2016|2016-01-01||||August 2017|Anticipated|2017-08-01||Observational|||Imaging Dopamine Function and Its Impact on Outcome After Traumatic Brain Injury (TBI)|Imaging Dopamine Function and Its Impact on Outcome After Traumatic Brain Injury (TBI)|Recruiting||N/A|35|Anticipated|Baylor Research Institute|||1||f||||f||||||||||2017-10-11 01:43:39.008817|2017-10-11 01:43:39.008817
NCT01853358|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-03-27|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2017|Actual|2017-03-01||Interventional|DLI-NK||Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation|Phase I of Infusion of Selected Donor NK Cells After HLA Identical Allogeneic Stem Cell Transplantation Prepared With Reduced Intensity Conditioning - DLI-NK/IPC 2012-003|Active, not recruiting||Phase 1|17|Anticipated|Institut Paoli-Calmettes||1|||f||||t||||||||||2017-10-11 01:42:52.050142|2017-10-11 01:42:52.050142
NCT01853345|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-02-09|||August 2012||2012-08-01|February 2015|2015-02-01||||September 2014|Actual|2014-09-01|99 Years|Observational [Patient Registry]|||iCAT for Recurrent/Refractory/HR Solid Tumors|Individualized Cancer Therapy (iCAT) Recommendation for Patients With Recurrent, Refractory or High Risk Solid Tumors|Completed||N/A|101|Actual|Dana-Farber Cancer Institute|||1||f||||f||||||Samples With DNA|"     Blood samples, tumor samples   "|||2017-10-11 01:42:52.137539|2017-10-11 01:42:52.137539
NCT01853332|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-04-25|2017-01-05||January 2009||2009-01-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Physical Health in Midlife: Influences of Adversity and Relationships Over Time|Physical Health in Midlife: Influences of Adversity and Relationships Over Time|Completed||N/A|210|Actual|Beth Israel Deaconess Medical Center|||2||f||||f||||||Samples Without DNA|"     Serum and plasma are stored to be analyzed for biomarkers related to metabolic syndrome.   "|||2017-10-11 01:42:52.230142|2017-10-11 01:42:52.230142
NCT01853319|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-09-06|||July 24, 2013|Actual|2013-07-24|August 2017|2017-08-01|September 29, 2017|Anticipated|2017-09-29|April 24, 2015|Actual|2015-04-24||Interventional|REGARD||Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy|An Open-label Phase III Study of Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy|Active, not recruiting||Phase 3|100|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-11 01:42:52.483744|2017-10-11 01:42:52.483744
NCT01853306|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-07-19|||March 18, 2013||2013-03-18|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|May 3, 2017|Actual|2017-05-03||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors|A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors|Completed||Phase 1|71|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 01:42:52.579448|2017-10-11 01:42:52.579448
NCT01853293|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-10-06|||March 2014||2014-03-01|October 2015|2015-10-01||||September 2015|Actual|2015-09-01||Interventional|||Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons|Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons|Withdrawn||Phase 2|0|Actual|Mclean Hospital||2||Grant was not funded|f||||f||||||||||2017-10-11 01:42:52.686079|2017-10-11 01:42:52.686079
NCT01853267|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-05-20|||May 2011||2011-05-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Perianal Abscess Packing Randomized ControlledTrial Pilot Study|A Randomized Controlled Trial Evaluating the Requirement for Post-operative Packing of Perianal Abscesses|Completed||N/A|14|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 01:42:52.952146|2017-10-11 01:42:52.952146
NCT01853254|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-06-25|2013-06-25||September 2003||2003-09-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials|An Open-label, Multicenter Protocol Providing Pegylated Interferon Alfa-2a (Pegasys®) as Monotherapy or in Combination With Ribavirin (Copegus®) for Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols|Completed||Phase 3|272|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:42:53.061662|2017-10-11 01:42:53.061662
NCT01853241|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-05-13|||May 2010||2010-05-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Prospective Randomized Trial of Anterograde Single Balloon Versus Spirus Enteroscopy|Prospective Randomized Trial of Anterograde Single Balloon Versus Spirus Enteroscopy in Patients With Suspected Small Bowel Disease|Terminated||N/A|30|Actual|Johns Hopkins University|||2|SE system by Spirus Medical withdrawn from market in 2011|f||||f||||||||||2017-10-11 01:42:53.487286|2017-10-11 01:42:53.487286
NCT01853228|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-07-05|||October 22, 2013|Actual|2013-10-22|July 2017|2017-07-01|September 18, 2017|Anticipated|2017-09-18|August 31, 2017|Anticipated|2017-08-31||Interventional|||A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia|Phase 1-2 Safety and Efficacy Study of DACOGEN in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia|Suspended||Phase 2|27|Anticipated|Janssen Research & Development, LLC||1||"Dacogen priming unlikely to provide significant clinical benefit. Recruitment hold whilst   discussions ongoing with PDCO."|f||||t||f||||||||2017-10-11 01:42:53.61026|2017-10-11 01:42:53.61026
NCT01853215|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-08-09|2013-06-06||April 2013||2013-04-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum|A Follow-Up Volunteer Study Evaluating Intraosseous Vascular Access Infusion in the Sternum Using the EZ-IO T.A.L.O.N.Intraosseous System.|Completed||N/A|24|Actual|Vidacare Corporation||1|||f||||f||||||||||2017-10-11 01:42:53.754047|2017-10-11 01:42:53.754047
NCT01853202|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2014-12-03|||March 2013||2013-03-01|December 2014|2014-12-01||||March 2014|Actual|2014-03-01||Interventional|EXPECT||EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial|EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial|Completed||N/A|40|Actual|University of Vermont||2|||f||||t||||||||||2017-10-11 01:42:54.02786|2017-10-11 01:42:54.02786
NCT01853189|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-04-24|||November 2014||2014-11-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|OMT||Effectiveness of Osteopathic Manipulative Treatment in Pediatric Asthma||Unknown status|Not yet recruiting|N/A|150|Anticipated|European Institute for Evidence Based Osteopathic Medicine||2|||f||||f||||||||||2017-10-11 01:42:54.162923|2017-10-11 01:42:54.162923
NCT01853176|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-10-29|2014-10-29||May 2013||2013-05-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Did not meet target accrual before study terminated.|Exparel vs. Standard Bupivicaine for Abdominoplasty|Is Liposomal Injection Bupivacaine (Exparel) Superior to Standard Bupivacaine for Abdominoplasty? A Randomized Controlled Trial|Terminated||Phase 4|4|Actual|Emory University|Trial terminated prior to any meaningful patient accrual so no analysis performed.|2||required documentation too onerous|f||||f||||||||||2017-10-11 01:42:54.26451|2017-10-11 01:42:54.26451
NCT01853163|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2017-05-02|||May 2013||2013-05-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Long-Term Retention of Gadolinium in Bone|Exploratory Evaluation of the Potential for Long-term Retention of Gadolinium in the Bones of Patients Who Have Received Gadolinium Based Contrast Agents According to Their Medical History|Recruiting||Phase 4|99|Anticipated|Ecron Acunova GmbH||1|||f||||f||||||||||2017-10-11 01:42:54.570983|2017-10-11 01:42:54.570983
NCT01853150|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-08-02|||April 2013||2013-04-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for Freezing of Gait|Repetitive Transcranial Magnetic Stimulation for Freezing of Gait|Recruiting||N/A|40|Anticipated|Dongtan Sacred Heart Hospital||2|||f||||f||||||||||2017-10-11 01:42:54.796413|2017-10-11 01:42:54.796413
NCT01853124|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-06-26|||November 2013|Actual|2013-11-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|May 2017|Actual|2017-05-01||Interventional|||Emergency Department Probiotic Treatment of Pediatric Gastroenteritis|Impact of Emergency Department Probiotic Treatment of Pediatric Gastroenteritis: Randomized Controlled Trial|Active, not recruiting||Phase 3|886|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 01:42:55.013995|2017-10-11 01:42:55.013995
NCT01853111|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-07-18|||March 2014||2014-03-01|July 2016|2016-07-01||||April 2018|Anticipated|2018-04-01||Interventional|||Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants|Biomarker-guided Withdrawal of Immunosuppression in Recipients of Vascularized Composite Tissue Transplants|Recruiting||Phase 1|6|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 01:42:55.144431|2017-10-11 01:42:55.144431
NCT01853098|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-06-15|||September 2013||2013-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Pilot Study of Positive Affect Training|Effect of a Novel Mindfulness Based Loving Kindness Meditation on Positive and Negative Affect|Completed||N/A|10|Actual|Boston University||1|||f||||f||||||||||2017-10-11 01:42:55.279486|2017-10-11 01:42:55.279486
NCT01853085|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2015-05-12|2015-05-12||April 2013||2013-04-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons||Completed||Phase 4|1830|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:42:55.404029|2017-10-11 01:42:55.404029
NCT01853072|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-06-23|2016-05-13||June 2013||2013-06-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Full analysis set, defined as including all randomized participants who completed implant surgery and had at least one on-therapy postsurgical visit.|Nepafenac Once Daily for Macular Edema - Study 1|Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery|Completed||Phase 3|881|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:42:55.789039|2017-10-11 01:42:55.789039
NCT01853059|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2013-05-13|||October 2013||2013-10-01|May 2013|2013-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|FOFACT||Functional Outcomes Following Anal Cancer Treatment|Observational Study of Functional Outcomes After Chemoradiotherapy for Squamous Cell Cancer of the Anus|Unknown status|Not yet recruiting|N/A|176|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||2||f||||f||||||||||2017-10-11 01:42:56.969539|2017-10-11 01:42:56.969539
NCT01853046|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2016-12-23|2016-07-12||June 2013||2013-06-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment|A Phase I, Multi-center, Non-randomized, Open Label, Parallel-group Study Evaluating the Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment Compared to a Control Group|Completed||Phase 1|24|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:42:57.106875|2017-10-11 01:42:57.106875
NCT01853033|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-10|2014-06-03|||July 2013||2013-07-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis|A Study in Patients With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ABT-122|Completed||Phase 1|19|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 01:42:58.804469|2017-10-11 01:42:58.804469
NCT01853020|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-02-02|||December 2012||2012-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cannabinoids and Cerebellar-Motor Functioning|Cannabinoids and Cerebellar-Motor Functioning|Active, not recruiting||Phase 1|68|Actual|Yale University||2|||f||||t||||||||||2017-10-11 01:42:58.944436|2017-10-11 01:42:58.944436
NCT01853007|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-02-21|||June 2013||2013-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|COACH||Communicating About Choices in Transplantation|Communicating About Choices in Transplantation (COACH)|Active, not recruiting||N/A|158|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 01:42:59.074157|2017-10-11 01:42:59.074157
NCT01852994|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-12-14|||July 2009||2009-07-01|May 2013|2013-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Exercise Training and Testosterone Replacement in Heart Failure Patients|Exercise Training and Testosterone Replacement in Heart Failure Patients|Completed||Phase 4|39|Actual|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-11 01:42:59.183682|2017-10-11 01:42:59.183682
NCT01852227|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-09-29|||June 2013||2013-06-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|March 2014|Actual|2014-03-01||Observational|||ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke|ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke|Completed||N/A|500|Actual|Medical University of South Carolina|||1||f||||t||||||||||2017-10-11 01:43:10.792442|2017-10-11 01:43:10.792442
NCT01852981|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-19|2013-05-09|||February 2011||2011-02-01|May 2013|2013-05-01|October 2012|Actual|2012-10-01|February 2012|Actual|2012-02-01||Interventional|PACTIVEM||Evaluation Study of Interventions for Physical Activity Promotion in Primary Health Care in Brazil.|Evaluation Study of Interventions for Physical Activity Promotion in Primary Health Care/Health Family Strategy in Brazil.|Completed||N/A|157|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 01:42:59.327159|2017-10-11 01:42:59.327159
NCT01852968|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-01-11|||May 2013||2013-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Hippocampal Metabolism and Function in Patients With Type 1 Diabetes|Hippocampal Metabolism and Function in Patients With Type 1 Diabetes|Active, not recruiting||N/A|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||Samples Without DNA|"     blood smaple will be drawn measurement of blood glucose, HgbA1C, insulin and hormone levels   "|||2017-10-11 01:42:59.479855|2017-10-11 01:42:59.479855
NCT01852955|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-02-16|2016-01-19||November 2013||2013-11-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Perioperative Systemic Acetaminophen to Improve Postoperative Quality of Recovery After Ambulatory Breast Surgery|Perioperative Systemic Acetaminophen to Improve Postoperative Quality of Recovery After Ambulatory Breast Surgery|Completed||N/A|70|Actual|Northwestern University||2|||f||||f||||||||No||2017-10-11 01:42:59.570644|2017-10-11 01:42:59.570644
NCT01852942|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-09-20|||September 2014||2014-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV|Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV|Active, not recruiting||Phase 2|52|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 01:42:59.87445|2017-10-11 01:42:59.87445
NCT01852929|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2013-05-13|||November 2009||2009-11-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Sleep Apnea and Visual Perceptual Skill Learning|The Effect of Sleep Apnea on Sleep Dependent Learning Using the Visual Discrimination Task.|Completed||N/A|14|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:42:59.987808|2017-10-11 01:42:59.987808
NCT01852916|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-08-03|||September 2013||2013-09-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||NHFOV Versus NCPAP to Prevent Exubation Failure|Nasal High Frequency Oscillatory Ventilation (NHFOV) Versus Nasal Continuous Positive Airway Pressure (NCPAP) Ventilation: a Pilot Trial|Suspended||N/A|20|Anticipated|University of Manitoba||2||Poor recruitment rate|f||||f||||||||||2017-10-11 01:43:00.135896|2017-10-11 01:43:00.135896
NCT01852903|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-09|||May 2011||2011-05-01|May 2013|2013-05-01||||July 2011|Actual|2011-07-01||Interventional|||Comparative Bioavailability of Two Forms of Vitamin C|A Randomized, Double-blind, Placebo-controlled Crossover Study Comparing the Bioavailability of Two Forms of Vitamin C in Plasma and Leukocytes Over 24 Hours.|Completed||N/A|40|Actual|NBTY, Inc.||3|||f||||||||||||||2017-10-11 01:43:00.267301|2017-10-11 01:43:00.267301
NCT01852890|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-01-25|||January 2014||2014-01-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|July 2017|Anticipated|2017-07-01||Interventional|||Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I|Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I|Active, not recruiting||Phase 1|30|Anticipated|University of Iowa||4|||f||||t||||||||Yes|Data will be shared via results in clinicaltrials.gov|2017-10-11 01:43:00.897237|2017-10-11 01:43:00.897237
NCT01852877|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-02-28|||July 2013|Actual|2013-07-01|March 2017|2017-03-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Observational|||Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois|Seek, Test, Treat: An Integrated Jail-Prison-Community Model for Illinois|Completed||N/A|784|Actual|University of Illinois at Chicago|||2||f||||||||||Samples Without DNA|"     Blood serum   "|||2017-10-11 01:43:01.014825|2017-10-11 01:43:01.014825
NCT01852864|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2014-12-15|||July 2011||2011-07-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Degarelix Before Radical Prostatectomy|A Study of the Early Biological Effects of Testosterone Suppression in Prostate Cancer Using Neoadjuvant Degarelix Prior to Radical Prostatectomy|Unknown status|Recruiting|Early Phase 1|40|Anticipated|University of Cambridge||1|||f||||f||||||||||2017-10-11 01:43:01.108929|2017-10-11 01:43:01.108929
NCT01852851|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-02-03|||June 2013||2013-06-01|February 2015|2015-02-01|June 2023|Anticipated|2023-06-01|June 2020|Anticipated|2020-06-01||Interventional|MIW||Employment and Arthritis: Making it Work|Employment and Arthritis: Making it Work: A Randomized Controlled Trial Evaluating an On-line Program to Help People With Inflammatory Arthritis Remain Employed|Recruiting||N/A|526|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:43:01.218862|2017-10-11 01:43:01.218862
NCT01852838|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2014-02-20|||September 2013||2013-09-01|February 2014|2014-02-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer|The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer|Unknown status|Recruiting|N/A|70|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 01:43:01.377783|2017-10-11 01:43:01.377783
NCT01852825|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-12-20|2016-12-20||November 2013||2013-11-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009)|A Two Part, Randomized Clinical Trial to Study Biomarkers of MK-8237 (SCH 900237) Treatment in Subjects With House Dust Mite Induced Allergic Rhinitis or Rhinoconjunctivitis|Completed||Phase 1|26|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 01:43:01.685447|2017-10-11 01:43:01.685447
NCT01852812|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-03-09|2014-09-25||June 2013||2013-06-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)|A Phase III, Open-Label Clinical Trial to Study the Safety and Pharmacokinetics of MK-0476 in Japanese Pediatric Subjects Aged 1 to 15 Years Old With Perennial Allergic Rhinitis|Completed||Phase 3|87|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:43:02.332897|2017-10-11 01:43:02.332897
NCT01852786|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-13|||February 2013||2013-02-01|May 2013|2013-05-01|February 2016|Anticipated|2016-02-01|February 2015|Anticipated|2015-02-01||Observational|HORMCONTRA||The Effect of Hormonal Contraception on Female|Metabolic, Androgen, Blood Coagulation Parameters and Female Sexual Function in Relation to Oral Contraceptive Use and Androgen Receptor Polymorphisms in Healthy Lithuanian Women|Unknown status|Active, not recruiting|N/A|340|Anticipated|Lithuanian University of Health Sciences|||2||f||||t||||||Samples With DNA|"     1. Lipidogram, glycemia;        2. Hormonal analyses by radioimmunoassay method ׃ total testosterone (T), free testosterone          (FT), sex hormone binding globulin (SHBG), dehidroepiandrosterone sulphate (DHEAs),          thyrotropin hormone (TSH), free thyroxine (FT4);        3. Blood coagulation test׃ clotting time according to Ovren, fibrinogen, aPTT.        4. Total blood picture test;        5. Androgen receptor (AR) polymorphism test.   "|||2017-10-11 01:43:02.846845|2017-10-11 01:43:02.846845
NCT01852773|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-09-09|||May 2013||2013-05-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|TEVAR||Thoracic Endovascular Repair Versus Open Surgery for Blunt Injury|Thoracic Endovascular Repair Versus Open Surgery for Blunt Injury|Withdrawn||N/A|0|Actual|Scripps Health|||1|Only observational retrospective study performed. No enrollees collected.|f||||t||||||||Undecided||2017-10-11 01:43:02.942587|2017-10-11 01:43:02.942587
NCT01852760|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-10-01|||September 2013||2013-09-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound|Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound|Completed||N/A|60|Actual|Lawson Health Research Institute|||3||f||||f||||||||||2017-10-11 01:43:03.024963|2017-10-11 01:43:03.024963
NCT01852747|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-04-26|||March 2013||2013-03-01|February 2014|2014-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Comparison of Actifuse ABX and Local Bone in Spinal Surgery|Actifuse ABX and Local Bone Have Comparable Outcomes to Local Bone in Instrumented Multi-Level Adult Spinal Deformity Patients|Terminated||Phase 4|14|Actual|Ohio State University||2||"The sponsor merged with another company and decided they did not want to continue with the   study."|f||||f||||||||||2017-10-11 01:43:03.115183|2017-10-11 01:43:03.115183
NCT01852734|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-11-23|||November 2013||2013-11-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives|Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives|Completed||N/A|52|Actual|Odense University Hospital||1|||f||||t||||||||||2017-10-11 01:43:03.195736|2017-10-11 01:43:03.195736
NCT01852721|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-09-05|||March 2010||2010-03-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women (ALIMED)-Part 2|Gender Differences in Response to the Mediterranean Diet-Part 2|Completed||N/A|123|Actual|Laval University||2|||f||||f||||||||||2017-10-11 01:43:03.273014|2017-10-11 01:43:03.273014
NCT01852708|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-09-21|||November 2012||2012-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood|Development of Non-invasive Prenatal Diagnostic Test for Microdeletion/Microduplication and Other Genetic Disorders Based on Fetal DNA Isolated From Maternal Blood|Recruiting||N/A|100|Anticipated|Natera, Inc.|||1||f||||f||||||Samples With DNA|"     The mother and biological father (if available) will be asked to provide a blood sample.     There will be 4 tubes collected from the mother (approximately 3 tablespoons) and 1 tube     collected from the father (2 teaspoons).   "|||2017-10-11 01:43:03.373511|2017-10-11 01:43:03.373511
NCT01852695|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-10-03|||March 2013||2013-03-01|October 2015|2015-10-01|March 2017|Anticipated|2017-03-01|October 2015|Actual|2015-10-01||Interventional|FICare||Family Integrated Care in the NICU|A Family Integrated Care Model For The Neonatal Intensive Care Unit: A Cluster Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|720|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||No||2017-10-11 01:43:03.49901|2017-10-11 01:43:03.49901
NCT01852682|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-11-11||||||November 2014|2014-11-01||||March 2014|Actual|2014-03-01||Interventional|||A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia||Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 01:43:03.604845|2017-10-11 01:43:03.604845
NCT01852669|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-04-17|2015-04-06||January 2002||2002-01-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Adjunct Inversion for Lower Pole Stone|A Prospective, Randomized, Double Blind, Controlled Study Comparing Extracorporeal Shock Wave Lithotripsy (ESWL) With and Without Simultaneous Adjunct Controlled Inversion Therapy in the Treatment of Lower Pole Caliceal Stone|Completed||N/A|140|Actual|Monash University||2|||f||||f||||||||||2017-10-11 01:43:05.489586|2017-10-11 01:43:05.489586
NCT01852656|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2013-05-09|||September 2012||2012-09-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effectiveness of Influenza Vaccine Reminder Systems|The Effectiveness and Cost of Different Methods of Reminders for Annual Influenza Immunization Among Adults With Asthma and Chronic Obstructive Pulmonary Disease|Completed||N/A|12255|Actual|Kaiser Permanente||3|||f||||f||||||||||2017-10-11 01:43:05.711677|2017-10-11 01:43:05.711677
NCT01852643|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-13|||February 2012||2012-02-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Spreader Graft and Lateral Crural Overlay Technique in Rhinoplasty|Determine and Compare the Finding of Rhinomanometry Before and After Treatment in Two Ways of Rhinoplasty Surgery (Spreader Graft and Lateral Crural Over Lapping)|Completed||Phase 2/Phase 3|50|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:43:05.794123|2017-10-11 01:43:05.794123
NCT01852032|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-04-17|||November 2010||2010-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis|Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis|Active, not recruiting||N/A|112|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-11 01:43:13.76469|2017-10-11 01:43:13.76469
NCT01852630|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-11-21|||December 2012||2012-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure|A Randomized, Comparative Open Label Study of Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure.|Completed||N/A|175|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 01:43:05.867063|2017-10-11 01:43:05.867063
NCT01852617|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-01-29|||October 2011||2011-10-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|November 2013|Actual|2013-11-01||Interventional|||A Smoking Cessation Intervention During Pregnancy in Argentina and Uruguay|A Smoking Cessation Intervention During Pregnancy in Argentina and Uruguay|Completed||N/A|6858|Actual|Institute for Clinical Effectiveness and Health Policy||2|||f||||f||||||||||2017-10-11 01:43:05.958253|2017-10-11 01:43:05.958253
NCT01852604|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-04-22|||March 2013||2013-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)|A Randomized Study to Evaluate the Safety and Efficacy of IDX719 in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Subjects With Chronic Hepatitis C Infection|Completed||Phase 2|143|Actual|Merck Sharp & Dohme Corp.||8|||f||||t||||||||||2017-10-11 01:43:06.081202|2017-10-11 01:43:06.081202
NCT01852591|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2016-12-07|2016-01-28||February 2013||2013-02-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|February 2015|Actual|2015-02-01||Interventional|PCV13|All participants.|Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant|Exploration of Immune Response to Pneumococcal Conjugate Vaccine (PCV13) Administered Before and Early After Autologous Peripheral Stem Cell Transplant (Auto-PSCT) in Patients With Multiple Myeloma|Completed||N/A|8|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 01:43:06.202453|2017-10-11 01:43:06.202453
NCT01852578|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2015-09-25|||September 2012||2012-09-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Cabazitaxel in Relapsed and Metastatic NSCLC|A Pilot Phase II Trial of Cabazitaxel in Patients With Metastatic NSCLC Progressing After Docetaxel-based Treatment|Completed||Phase 2|46|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-10-11 01:43:06.603207|2017-10-11 01:43:06.603207
NCT01852565|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-07-10|||May 14, 2013|Actual|2013-05-14|July 2017|2017-07-01|September 30, 2013|Actual|2013-09-30|September 30, 2013|Actual|2013-09-30||Interventional|||Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848).|An Open-Label, Three Period, Single Sequence Study To Determine The Effect Of Repeat Oral Dosing Of Diltiazem On The Pharmacokinetics Of Repeat Oral Dosing Of Darapladib (SB-480848).|Completed||Phase 1|36|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-10-11 01:43:06.712766|2017-10-11 01:43:06.712766
NCT01852552|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-11-11|||December 2011||2011-12-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01|12 Months|Observational [Patient Registry]|CCQ||Costs, Cognitive Abilities and Quality of Life After Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement|Costs, Cognitive Abilities and Quality of Life After Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement|Completed||N/A|518|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||2||f||||t||||||||||2017-10-11 01:43:06.81508|2017-10-11 01:43:06.81508
NCT01852539|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-04-20|||July 2013||2013-07-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Dexmedetomidine for Laryngeal Mask Airway Insertion|Optimal Dose of Dexmedetomidine for Laryngeal Mask Airway Insertion During Propofol Induction|Completed||Phase 4|22|Actual|Ajou University School of Medicine||1|||f||||t||||||||||2017-10-11 01:43:07.000057|2017-10-11 01:43:07.000057
NCT01852526|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-09-15|||March 2013||2013-03-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|D-Rod||Efficacy of Hybrid Systems in Comparison to the Rigid Spondylodesis in Lumbar-spine Fusion|Clinical Trial (Phase II, Therapeutic Explorative) of the Efficacy of Hybrid Systems in Comparison to the Rigid Spondylodesis in Fusion-surgery in the Lumbar Spine: a Prospective, Randomised, Monocenter Pilotstudy|Terminated||N/A|5|Actual|University of Cologne||2||device failure|f||||t||||||||||2017-10-11 01:43:07.179907|2017-10-11 01:43:07.179907
NCT01852500|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-09|||November 2010||2010-11-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Are Newborns Conscious of the Placebo Effect? Result From an RCT in Osteopathy||Completed||Phase 4|250|Actual|European Institute for Evidence Based Osteopathic Medicine||2|||f||||||||||||||2017-10-11 01:43:07.536633|2017-10-11 01:43:07.536633
NCT01852487|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2013-05-10|||February 2012||2012-02-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia||Completed||N/A|80|Actual|Dream Plus||2|||f||||||||||||||2017-10-11 01:43:07.642482|2017-10-11 01:43:07.642482
NCT01852474|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-03-17|||May 2013|Actual|2013-05-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Transcranial Direct Current Stimulation (tDCS) and Motor Learning in Children With Cerebral Palsy (CP)|Effects of tDCS in Cortical Plasticity and Motor Learning in Children With Cerebral Palsy|Completed||N/A|5|Actual|Spaulding Rehabilitation Hospital||1|||f||||f|f|f||||||||2017-10-11 01:43:07.73341|2017-10-11 01:43:07.73341
NCT01852461|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-10|||August 2011||2011-08-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Perfusion Index Variability in Respiratory Distress Syndrome|Perfusion Index Variability in Preterm Infants Treated With Two Different Natural Surfactants for Respiratory Distress Syndrome|Completed||N/A|92|Actual|Dr. Sami Ulus Children's Hospital||2|||f||||f||||||||||2017-10-11 01:43:07.820846|2017-10-11 01:43:07.820846
NCT01852448|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-07-10|||May 2013||2013-05-01|July 2017|2017-07-01|June 2021|Anticipated|2021-06-01|July 2018|Anticipated|2018-07-01||Observational|||Genetics of Insulin and Incretins in Cystic Fibrosis|Evaluation of the Enteroinsular Axis in Cystic Fibrosis|Recruiting||N/A|350|Anticipated|Children's Hospital of Philadelphia|||1||f||||t||||||||||2017-10-11 01:43:07.914137|2017-10-11 01:43:07.914137
NCT01852435|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-08-15|||May 2013||2013-05-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B|A Multi-center, Prospective, Randomized Phase III Study of the Safety and Efficacy of R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B|Active, not recruiting||Phase 3|648|Actual|Ruijin Hospital||3|||f||||t||||||||||2017-10-11 01:43:08.019187|2017-10-11 01:43:08.019187
NCT01852422|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-10-27|||June 2013||2013-06-01|October 2013|2013-10-01||||September 2013|Actual|2013-09-01||Observational|||Location and Anatomic Characterization of the Sacrospinous Ligaments in Women With Pelvic Organ Prolapse||Completed||N/A|||Pop Medical Solutions|||1||f||||||||||||||2017-10-11 01:43:08.141239|2017-10-11 01:43:08.141239
NCT01852409|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-05-19|||May 2013||2013-05-01|May 2013|2013-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites|Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites.|Unknown status|Recruiting|Phase 1|18|Anticipated|Peking University||1|||f||||f||||||||||2017-10-11 01:43:08.220949|2017-10-11 01:43:08.220949
NCT01852396|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-08-09|||April 2013||2013-04-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Retroclavicular Approach for Regional Anesthesia|Ultrasound-Guided Brachial Plexus Regional Anesthesia by the Novel Retroclavicular Approach : A Feasibility Study|Completed||Phase 4|50|Anticipated|Université de Sherbrooke||1|||f||||f||||||||||2017-10-11 01:43:08.312581|2017-10-11 01:43:08.312581
NCT01852383|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2014-04-01|2013-12-05||January 2006||2006-01-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|September 2010|Actual|2010-09-01||Interventional|||Duloxetine Treatment in Elderly With Dysthymia|An Open Treatment Trial of Duloxetine in Elderly Patients With Dysthymic Disorder|Completed||Phase 4|30|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-11 01:43:08.423018|2017-10-11 01:43:08.423018
NCT01852370|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-06-21|||June 2013||2013-06-01|June 2017|2017-06-01|August 2022|Anticipated|2022-08-01|June 2019|Anticipated|2019-06-01||Interventional|BOLT+BMT||Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases|Bilateral Orthotopic Lung Transplant in Tandem With CD3+ and CD19+ Cell Depleted Bone Marrow Transplant From Partially HLA-Matched Cadaveric Donors|Recruiting||Phase 1/Phase 2|16|Anticipated|University of Pittsburgh||1|||f||||t||||||||No||2017-10-11 01:43:08.975299|2017-10-11 01:43:08.975299
NCT01852357|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-10-24|||April 2013||2013-04-01|June 2014|2014-06-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||An Evaluation of Neurofeedback Efficacy in Adults With ADHD|A Placebo-Control Evaluation of Neurofeedback Efficacy in Adults With ADHD|Completed||N/A|30|Actual|University of North Carolina, Wilmington||2|||f||||t||||||||||2017-10-11 01:43:09.105155|2017-10-11 01:43:09.105155
NCT01852344|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-04-27|||June 2012||2012-06-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|BDEC||Behavioral Differences in Effortful Control|Behavioral Differences in Effortful Control|Active, not recruiting||N/A|120|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 01:43:09.204759|2017-10-11 01:43:09.204759
NCT01852331|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-05-06|||January 2013||2013-01-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|PGD-RCT||Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia|The Herbal Medicine Peony-Glycyrrhiza Decoction (PGD) as an Adjunctive Therapy to Treat Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia: a Double-blind, Randomized, Placebo-controlled Study|Completed||Phase 2|103|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 01:43:09.328824|2017-10-11 01:43:09.328824
NCT01852318|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2014-04-13|||April 2014||2014-04-01|April 2014|2014-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Pregabalin for the Treatment of Uremic Pruritus|A Multicenter, Double-blind, Randomized, Placebo and Active-controlled Study of Pregabalin for the Treatment of Uremic Pruritus|Unknown status|Not yet recruiting|Phase 4|210|Anticipated|National Taiwan University Hospital||3|||f||||f||||||||||2017-10-11 01:43:09.901178|2017-10-11 01:43:09.901178
NCT01852305|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-05-25|||April 2013||2013-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Obstructive Sleep Apnea in Bariatric Surgical Patients|Would A New Pathway Managing Obstructive Sleep Apnea in Bariatric Surgical Patients Be Safe and Cost-effective?|Recruiting||N/A|316|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:43:10.01218|2017-10-11 01:43:10.01218
NCT01852292|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-09-17|||October 1, 2013|Actual|2013-10-01|September 2017|2017-09-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|||Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy|Double Blind, Placebo Controlled Study Assessing the Efficacy of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Patients With Platinum Pre-treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)|Completed||Phase 2|157|Actual|Novartis||2|||f||||t|t|f||||||||2017-10-11 01:43:10.159932|2017-10-11 01:43:10.159932
NCT01852279|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-08-16|||May 2013||2013-05-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||BCI and FES for Hand Therapy in Spinal Cord Injury|Brain Computer Interface Control of Functional Electrical Stimulation for a Hand Therapy in Tetraplegic Patients|Recruiting||N/A|20|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 01:43:10.41465|2017-10-11 01:43:10.41465
NCT01852266|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-09-13|||October 2013||2013-10-01|September 2016|2016-09-01||||July 2015|Actual|2015-07-01||Interventional|||Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children|A Phase I Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV cps2, Lot RSV#005A, Delivered as Nose Drops to RSV-Seronegative Infants and Children 6 to 24 Months of Age|Completed||Phase 1|50|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 01:43:10.512216|2017-10-11 01:43:10.512216
NCT01852253|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-05-10|||March 2010||2010-03-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Implant Surface Decontamination With 2 % Chlorhexidine in Peri-implantitis Treatment|Clinical and Microbiological Evaluation Implant Surface Decontamination With 2% Chlorhexidine in the Surgical Treatment of Peri-implantitis; a Double Blind Controlled Randomized Clinical Study|Completed||N/A|44|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 01:43:10.606691|2017-10-11 01:43:10.606691
NCT01852214|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-08-22|2016-04-15||February 2013||2013-02-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional||All analyses of platelet function were conducted on the pharmacodynamic population, which was defined as all randomized subjects who received study drug, successfully completed at least one treatment period of the study and had valid data for the primary end point (n=46)|Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes|A Pharmacodynamic Comparison of Prasugrel vs. Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease|Completed||N/A|50|Actual|University of Florida||2|||f||||t||||||||No||2017-10-11 01:43:10.874829|2017-10-11 01:43:10.874829
NCT01852201|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-09-29|||September 2013||2013-09-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||POSITIVE Stroke Clinical Trial|POSITIVE: PerfusiOn Imaging Selection of Ischemic STroke PatIents for EndoVascular ThErapy|Active, not recruiting||N/A|33|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 01:43:11.235649|2017-10-11 01:43:11.235649
NCT01852188|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-05-08|||May 2011||2011-05-01|May 2013|2013-05-01||||August 2013|Anticipated|2013-08-01||Interventional|||Intrapartum Study of Sterile and Clean Gloves|A Comparison of Sterile and Non-sterile Gloves for the Incidence of Chorioamnionitis During Labor: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|470|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:43:11.359282|2017-10-11 01:43:11.359282
NCT01852175|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-05-26|2015-05-04||January 2012||2012-01-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease|A head-to Head Comparison of the Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease|Completed||N/A|110|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 01:43:11.450409|2017-10-11 01:43:11.450409
NCT01852162|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-03-10|2015-02-03||February 2012||2012-02-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional||Patients were considered for analysis of the PD end points if they completed both visits and had a compliance >80% to study drug, clopidogrel and aspirin. All patients who received any dose of study medication were considered for analysis of safety and any other adverse events.|Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy|Pharmacodynamic Effects of Dabigatran in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel|Completed||N/A|35|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 01:43:11.776321|2017-10-11 01:43:11.776321
NCT01852149|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-03-16|||August 2009||2009-08-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|March 2014|Actual|2014-03-01||Interventional|||Mitralign Percutaneous Annuloplasty First in Man Study|Mitralign Percutaneous Annuloplasty First in Man (FIM) Study|Completed||N/A|35|Actual|Mitralign, Inc.||1|||f||||f||||||||||2017-10-11 01:43:12.399469|2017-10-11 01:43:12.399469
NCT01852136|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-02-08|||September 2012||2012-09-01|February 2017|2017-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Clinical Evaluation of BD NEXT Pen Needle|Clinical Evaluation of the BD NEXT (Extra Thin Wall Pen Needles) Compared to the Currently Marketed Pen Needles|Completed||N/A|217|Actual|Becton, Dickinson and Company|||3||f||||f||||||||No||2017-10-11 01:43:12.517231|2017-10-11 01:43:12.517231
NCT01852123|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-11-02|||May 2013||2013-05-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|High-STEACS||High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome|High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome: A Randomized Controlled Trial|Active, not recruiting||N/A|70000|Anticipated|University of Edinburgh||2|||f||||t||||||||||2017-10-11 01:43:12.659742|2017-10-11 01:43:12.659742
NCT01852110|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-04-06|||October 2013||2013-10-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)|A Seamless Phase IIa/IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Evaluate the Efficacy and Safety of MK-7622 as an Adjunctive Therapy for Symptomatic Treatment in Subjects With Alzheimer's Disease|Terminated||Phase 2|240|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 01:43:12.796032|2017-10-11 01:43:12.796032
NCT01852097|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-05-10|||May 2013||2013-05-01|February 2013|2013-02-01|January 2014|Anticipated|2014-01-01|November 2013|Anticipated|2013-11-01||Interventional|||An Online Intervention to Address Barriers to IBD Medication Adherence|A Pilot Randomised Controlled Trial to Determine the Feasibility, Acceptability and Effectiveness of a CBT Based Online Intervention to Address Practical and Perceptual Barriers to Medication Adherence in Inflammatory Bowel Disease.|Unknown status|Not yet recruiting|N/A|240|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 01:43:12.943766|2017-10-11 01:43:12.943766
NCT01852084|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-04-05|||March 6, 2013||2013-03-06||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:43:13.057992|2017-10-11 01:43:13.057992
NCT01852071|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-09-25|||May 2013||2013-05-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|||Autologous Transplant of EFS-ADA Modified Bone Marrow Cells for ADA-Deficient Severe Combined Immunodeficiency (SCID)|Autologous Transplantation of Bone Marrow CD34+ Stem/Progenitor Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector for Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)|Active, not recruiting||Phase 1/Phase 2|20|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-10-11 01:43:13.114979|2017-10-11 01:43:13.114979
NCT01852058|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-07-26|||January 6, 2014|Actual|2014-01-06|July 2017|2017-07-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2021|Anticipated|2021-01-31||Interventional|||A Long-Term Extension Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity|Long-term Extension Study of BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age|Recruiting||Phase 3|100|Anticipated|Allergan||3|||f||||t|t|f||||||||2017-10-11 01:43:13.249978|2017-10-11 01:43:13.249978
NCT01852045|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-07-26|||June 2, 2013|Actual|2013-06-02|July 2017|2017-07-01|November 1, 2019|Anticipated|2019-11-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients|BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age|Recruiting||Phase 3|132|Anticipated|Allergan||3|||f||||t|t|f||||||||2017-10-11 01:43:13.510402|2017-10-11 01:43:13.510402
NCT01852019|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-05-27|2014-08-01||June 2013||2013-06-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Intent-to-treat (ITT) population|Cangrelor Prasugrel Transition Study|A Study of the Transition From IV Cangrelor to Oral Prasugrel, and Prasugrel to Cangrelor, in Patients With Coronary Artery Disease.|Completed||Phase 2|12|Actual|The Medicines Company||5|||f||||f||||||||||2017-10-11 01:43:13.897208|2017-10-11 01:43:13.897208
NCT01852006|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-08-24|||January 2014||2014-01-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Abdominal Binding in Chronic Obstructive Pulmonary Disease|Abdominal Binding: a Novel Intervention to Relieve Dyspnea and Improve Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease?|Completed||N/A|20|Actual|McGill University||2|||f||||f||||||||||2017-10-11 01:43:14.673647|2017-10-11 01:43:14.673647
NCT01851993|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-08-24|||June 2013||2013-06-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Inhaled Ondansetron & Dyspnea|Effects of Inhaled Ondansetron on Perceived Respiratory Discomfort (Dyspnea) During Exercise in the Presence of External Thoracic Restriction|Completed||Early Phase 1|30|Actual|McGill University||2|||f||||f||||||||||2017-10-11 01:43:14.762275|2017-10-11 01:43:14.762275
NCT01851980|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-02-10|||April 2016||2016-04-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Inhaled Nebulized Furosemide & Physical Activity-Related Breathlessness|Effects of Inhaled Furosemide on Breathlessness During Exercise in the Presence of External Thoracic Restriction: A Dose-Reponse Study|Recruiting||Phase 1|30|Anticipated|McGill University||3|||f||||f||||||||No||2017-10-11 01:43:14.851964|2017-10-11 01:43:14.851964
NCT01851967|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-11-30|||September 2014||2014-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans|Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans|Completed||N/A|112|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 01:43:14.975466|2017-10-11 01:43:14.975466
NCT01851954|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2014-11-17|||February 2013||2013-02-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)|Pharmacokinetic Study of Clarithromycin in Premature Infants With Safety Evaluation|Terminated||Phase 2|6|Actual|Seoul National University Hospital||1||declined enrollment|f||||t||||||||||2017-10-11 01:43:15.079049|2017-10-11 01:43:15.079049
NCT01851941|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-08|||October 2004||2004-10-01|May 2013|2013-05-01||||June 2008|Actual|2008-06-01||Interventional|||A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer||Completed||Phase 2|52|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:43:15.158972|2017-10-11 01:43:15.158972
NCT01851928|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-05-08|||July 2011||2011-07-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Observational|||Validation of a Nutrition Screening Tool|The Validation of Two Inpatient Adult Nutrition Screening Tools in Cancer Care - a Prospective Study|Completed||N/A|128|Actual|Royal Marsden NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 01:43:15.244527|2017-10-11 01:43:15.244527
NCT01851915|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-05-10|||January 2011||2011-01-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|CIPPS||Cognitive Behavioral Therapy and Interpersonal Psychotherapy as Treatment for Major Depressive Disorder|Randomized Trial of Treatment of Depression With Interpersonal Psychotherapy and Cognitive Behavioral Therapy|Unknown status|Recruiting|N/A|96|Anticipated|Linkoeping University||2|||f||||f||||||||||2017-10-11 01:43:15.310801|2017-10-11 01:43:15.310801
NCT01851902|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-01-01|||May 2013||2013-05-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|PREDATE-AF||PREdicting Atrial Fibrillation or Flutter|"PREdicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF)"|Active, not recruiting||N/A|360|Anticipated|Keesler Air Force Base Medical Center|||3||f||||f||||||||||2017-10-11 01:43:15.414332|2017-10-11 01:43:15.414332
NCT01851889|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-10-26|||April 2013||2013-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|December 2013|Actual|2013-12-01||Observational|||Optimizing Continuous-flow Left Ventricular Assist Device Settings and Identification of Pump Malfunction - A Comparative Study of Echocardiography and Invasive Hemodynamics||Completed||N/A|15|Anticipated|Rigshospitalet, Denmark|||1||f||||||||||||||2017-10-11 01:43:15.497947|2017-10-11 01:43:15.497947
NCT01851876|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-05-11|2013-05-11||September 2010||2010-09-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Endometrial Injury and Single Embryo Transfer|Endometrial Injury May Increase the Clinical Pregnancy Rate in Normoresponders Underwent Long Agonist Protocol Intracytoplasmic Sperm Injection Cycles With Single Embryo Transfer|Completed||N/A|118|Actual|Karadeniz Technical University|No limitations.|2|||f||||f||||||||||2017-10-11 01:43:15.576966|2017-10-11 01:43:15.576966
NCT01851863|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2015-02-10|2014-04-13||May 2013||2013-05-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia|Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia: A Randomized Comparison of Different Prescribing Behaviors|Completed||Phase 4|262|Actual|RenJi Hospital||4|||f||||t||||||||||2017-10-11 01:43:15.841105|2017-10-11 01:43:15.841105
NCT01851850|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-10|||May 2013||2013-05-01|January 2013|2013-01-01||||May 2016|Anticipated|2016-05-01||Interventional|||Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial|Continue Providing Care for Patient Who Participated in the BIA 9-1067-302 Clinical Trial|Unknown status|Not yet recruiting|Phase 3|1|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 01:43:16.306018|2017-10-11 01:43:16.306018
NCT01851837|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2017-02-17|||September 2012||2012-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Exercise Time in Sedentary Middle-aged Female|Response Of Weight And Lipid Profile To Exercise Time In Sedentary Overweight/Obese Middle-Aged And Older Women|Completed||N/A|115|Actual|P.L.Shupik National Medical Academy of Post-Graduate Education||2|||f||||t|f|f||||||||2017-10-11 01:43:16.410833|2017-10-11 01:43:16.410833
NCT01851499|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-10-19|||May 2013||2013-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|||Ultramicronized PEA (Normast) in Spinal Cord Injury Neuropathic Pain|Ultramicronized PEA (Normast) in Spinal Cord Injury Neuropathic Pain: a Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center Study|Completed||N/A|73|Actual|Danish Pain Research Center||2|||f||||f||||||||||2017-10-11 01:43:21.069855|2017-10-11 01:43:21.069855
NCT01851824|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-11-01|||August 2013||2013-08-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy|A PHASE I, OPEN-LABEL, MULTICENTER, 3-PERIOD, FIXED-SEQUENCE STUDY TO INVESTIGATE THE EFFECT OF VEMURAFENIB ON THE PHARMACOKINETICS OF A SINGLE ORAL DOSE OF ACENOCOUMAROL IN PATIENTS WITH BRAFV600 MUTATION-POSITIVE METASTATIC MALIGNANCY|Completed||Phase 1|9|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:43:16.559817|2017-10-11 01:43:16.559817
NCT01851811|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-02-02|||October 2008||2008-10-01|February 2014|2014-02-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Observational|TLMECC||Correlation Between CPAP Compliance and Food Intake Timing|To Examine the Correlation Between Continuous Positive Airway Pressure (CPAP) and the Timing of Last Meal Before Bed Time.|Completed||N/A|50|Actual|Hackensack University Medical Center|||1||f||||f||||||||||2017-10-11 01:43:16.819466|2017-10-11 01:43:16.819466
NCT01851798|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-12-14|||April 2013||2013-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Evaluation of Sleep Disordered Breathing Following Ambulatory Surgery|Postoperative Home Sleep Test Changes in Ambulatory Surgical Patients With and Without Obstructive Sleep Apnea: A Prospective Clinical Trial|Terminated||N/A|203|Actual|Walter Reed National Military Medical Center|||2|Staffing changes precluded sleep study interpretation|f||||t||||||||||2017-10-11 01:43:16.921329|2017-10-11 01:43:16.921329
NCT01851785|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-07-17|||July 2010||2010-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|May 2015|Actual|2015-05-01||Interventional|ACTION||African American Preference for Knee Replacement: A Patient-Centered Intervention|Behavioral & Social Science Research on Understanding and Reducing Health Disparities|Active, not recruiting||N/A|340|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:43:17.049675|2017-10-11 01:43:17.049675
NCT01851772|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-05-16|2015-11-09||November 2013||2013-11-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer|Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer|Completed||N/A|3|Actual|Xoft, Inc.||1|||f||||f||||||||Undecided||2017-10-11 01:43:17.2147|2017-10-11 01:43:17.2147
NCT01851759|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-07|||October 2013||2013-10-01|May 2013|2013-05-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction|A Random, Double-blind, Placebo- Controlled and Dose-finding, Multi-center, Phase II Clinical Trial of Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction|Unknown status|Not yet recruiting|Phase 2|288|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 01:43:17.650483|2017-10-11 01:43:17.650483
NCT01851746|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-09|||March 2013||2013-03-01|May 2013|2013-05-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer|A Study of Docetaxel and Lobaplatin vs. Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer|Unknown status|Active, not recruiting|N/A|200|Anticipated|Wuhan University|||1||f||||f||||||Samples Without DNA|"     Boold,Urine   "|||2017-10-11 01:43:17.768804|2017-10-11 01:43:17.768804
NCT01851733|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-06-29|||August 13, 2013|Actual|2013-08-13|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme|A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Doxorubicin in the Treatment of Recurrent Glioblastoma Multiforme|Recruiting||Phase 1|45|Anticipated|Washington University School of Medicine||2|||f||||t|t|t|f|f|f|||||2017-10-11 01:43:17.879671|2017-10-11 01:43:17.879671
NCT01851720|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-06-20|2017-04-24||July 2012||2012-07-01|June 2017|2017-06-01|September 15, 2014|Actual|2014-09-15|September 15, 2014|Actual|2014-09-15||Interventional|||Randomized Trial for Pain Management in Low-grade Subarachnoid Hemorrhage|Randomized Trial for Pain Management in Low-grade Subarachnoid Hemorrhage|Terminated||Phase 2/Phase 3|1|Actual|Johns Hopkins University||2||Inclusion criteria were too strict and therefore we were not able to recruit more patients.|f||||||||||||||2017-10-11 01:43:18.050284|2017-10-11 01:43:18.050284
NCT01851707|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-07-31|||April 2013||2013-04-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|ASPIRA||A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone|A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate Multiple Dose Levels of Duvelisib With Background Methotrexate in Subjects With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone|Completed||Phase 2|322|Actual|Verastem, Inc.||4|||f||||t||||||||||2017-10-11 01:43:18.365006|2017-10-11 01:43:18.365006
NCT01851694|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2016-11-07|||May 2013||2013-05-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Beta-cell Response to Incretin Hormones in Cystic Fibrosis|Determination of Beta-cell Responsiveness to the Incretin Hormones GLP-1 and GIP in Cystic Fibrosis|Recruiting||N/A|45|Anticipated|University of Pennsylvania||2|||f||||t||||||||Yes|Upon completion of enrollment.|2017-10-11 01:43:18.613381|2017-10-11 01:43:18.613381
NCT01851681|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-05-01|||July 2014||2014-07-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Comparison Between Two Different Antibiotic Regimens for the Placement of Dental Implants|Comparison Between Two Different Antibiotic Regimens for the Placement of Dental Implants: a Randomized Clinical Trial|Completed||Phase 1|42|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-11 01:43:18.723875|2017-10-11 01:43:18.723875
NCT01851668|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-09-11|||June 2013||2013-06-01|January 2017|2017-01-01|September 1, 2017|Actual|2017-09-01|August 31, 2017|Actual|2017-08-31||Observational|PremiTranS||Preterm Infant Transport Stress (PremiTranS) Study|Preterm Infant Transport Stress (PremiTranS) Study - A Feasibility Study of the Impact of Inter-hospital Transport on the Preterm Infant|Completed||N/A|30|Actual|University of Nottingham|||3||f||||f||||||Samples Without DNA|"     Blood and urine   "|||2017-10-11 01:43:18.82854|2017-10-11 01:43:18.82854
NCT01851486|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-10-01|||January 2013|Actual|2013-01-01|October 2017|2017-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Relationships Between the Noradrenergic, Opioid and Pain System||Withdrawn||N/A|0|Actual|Rambam Health Care Campus||4||Labortory focus was changed and study was not opened at all|f||||t||||||||||2017-10-11 01:43:21.218825|2017-10-11 01:43:21.218825
NCT01851655|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2014-09-17|2014-08-27||July 2008||2008-07-01|September 2014|2014-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||Sample size was based on the minimal detectable change in IKDC-SKF scores and from urinary CTX-II concentrations in uninjured athletes.|Anterior Cruciate Ligament Reconstruction and Plyometric Exercise|The Effect of Plyometric Exercise Intensity on Function & Articular Cartilage Metabolism After ACL Reconstruction|Completed||N/A|25|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:43:18.930107|2017-10-11 01:43:18.930107
NCT01851642|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-04-24|||September 2007|Actual|2007-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs|The Role of Conformational Diseases on Macrophage Function|Recruiting||N/A|200|Anticipated|University of Florida|||3||f||||f|f|f||||Samples With DNA|"     Whole blood and plasma.   "|Yes|Enrolled subjects may request a copy of their clinical testing done while enrolled in the clinical trial. All other data used for publication purposes will be de-identified.|2017-10-11 01:43:19.250789|2017-10-11 01:43:19.250789
NCT01851629|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-04-30|||June 2013||2013-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Walking Adaptability Post-Spinal Cord Injury|Adaptive Walking Responses Critical for Effective Community Ambulation Post-Incomplete Spinal Cord Injury|Completed||N/A|7|Actual|University of Florida||3|||f||||t||||||||||2017-10-11 01:43:19.401583|2017-10-11 01:43:19.401583
NCT01851616|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-05-09|||January 2013||2013-01-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Oral Glucosestimulation After Gastric Bypass Surgery|Oral Glucosestimulation After Gastric Bypass Surgery|Completed||N/A|8|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 01:43:19.504135|2017-10-11 01:43:19.504135
NCT01851603|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-12-28|||June 2013||2013-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|AVL3288||Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects|Phase I, Single-center, Inpatient, Randomized, Double-blind, Placebo-controlled, Dose Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profiles of Single Oral Doses of AVL-3288 (Anvylic-3288) Healthy Subjects.|Terminated||Phase 1|12|Actual|University of Colorado, Denver||2||PI left institution|f||||t||||||||||2017-10-11 01:43:19.586816|2017-10-11 01:43:19.586816
NCT01851590|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-10-24|2015-03-20||October 2013||2013-10-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Primary and secondary outcome analyses were based on the intent-to-treat (ITT) population and missing values were imputed using the last observation carried forward (LOCF) method. At baseline, 73 patients who met the entry criteria were randomized to one of the three arms: topical Resin Lacquer, topical Amorolfine Lacquer or oral Terbinafine.|Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis|Efficacy of Topical Resin Lacquer, Amorolfine, and Oral Terbinafine for Treating Toenail Onychomycosis: a Prospective, Randomized, Controlled, Investigator-blinded, Parallel-group Clinical Trial|Completed||Phase 4|129|Actual|Helsinki University Central Hospital|"Relatively short treatment period for the toenail onychomycosis (9 months).
Patients with total dystrophic onychomycosis (46%) - the most difficult subtype to treat - may not have been amenable to monotherapy with a topical antifungal treatment."|3|||f||||f||||||||||2017-10-11 01:43:19.691114|2017-10-11 01:43:19.691114
NCT01851577|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-09-09|||May 2013||2013-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FF Project||Engaging Fathers in Home Visitation|Engaging Fathers in Home Visitation: Incorporation of a Coparenting Intervention|Recruiting||N/A|600|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 01:43:20.288895|2017-10-11 01:43:20.288895
NCT01851564|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2016-09-19|||August 2012||2012-08-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|SOV||RCT of Stent Versus Standard Therapy in Oesophageal Variceal Haemorrhage|Effective Haemostasis Using Self-expandable Covered Mesh-metal Oesophageal Stents Versus Standard Endoscopic Therapy in the Treatment of Oesophageal Variceal Haemorrhage: A Multicentre, Open, Prospective, Randomised, Controlled Study.|Completed||N/A|14|Actual|University College, London||4|||f||||t||||||||||2017-10-11 01:43:20.398318|2017-10-11 01:43:20.398318
NCT01851551|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-12-02|||September 2001||2001-09-01|December 2013|2013-12-01|April 2005|Actual|2005-04-01|April 2004|Actual|2004-04-01||Interventional|||Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL|A Phase I/II Study of Rituximab Plus Vincristine Sulfate Liposomes Injection in the Treatment of Relapsed or Refractory Aggressive Non Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|22|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-11 01:43:20.524757|2017-10-11 01:43:20.524757
NCT01851538|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-08-02|||August 2011||2011-08-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|Bio-SHiFT||The Role of Biomarkers and Echocardiography in Prediction of Prognosis of Chronic Heart Failure Patients|Serial Biomarker Measurements and New Echocardiographic Techniques in Chronic Heart Failure Patients Result in Tailored Prediction of Prognosis|Recruiting||N/A|400|Anticipated|Erasmus Medical Center|||1||f||||||||||Samples With DNA|"     Blood (EDTA plasma, citrate plasma, serum, DNA) and urine samples are taken at the day of     inclusion and at follow-up visits, which will be performed every 3 months, until the end of     the scheduled follow-up, or until the patient dies. The maximum total number of samples per     patient is 11 (in patients with 30 months follow-up).   "|||2017-10-11 01:43:20.660096|2017-10-11 01:43:20.660096
NCT01851525|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2017-04-24|||June 2013||2013-06-01|April 2017|2017-04-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|TOUCH AF||Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation|Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation|Completed||N/A|120|Anticipated|Southlake Regional Health Centre||2|||f||||f||||||||||2017-10-11 01:43:20.797435|2017-10-11 01:43:20.797435
NCT01851512|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-05-15|||May 2010||2010-05-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|August 2010|Actual|2010-08-01||Interventional|||A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803|Single-Blind, Randomized, Comparative, Phase I Study to Evaluate the Tolerability, Safety, and Pharmacokinetic Characteristics of Human Chorionic Gonadotropin Between Two Recombinant hCG Products, DA-3803 Injection and Ovidrel Liquid Injection, in Healthy Subjects|Completed||Phase 1|27|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:43:20.946667|2017-10-11 01:43:20.946667
NCT01851473|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-10-05|||October 24, 2012||2012-10-24|October 7, 2015|2015-10-07|October 7, 2015|Actual|2015-10-07|October 7, 2015|Actual|2015-10-07||Interventional|||Interactions Between Intravenous Cocaine and Acetazolamide or Quinine|Pharmacodynamic and Pharmacokinetic Interactions Between Intravenous Cocaine and Acetazolamide or Quinine|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:43:21.340921|2017-10-11 01:43:21.340921
NCT01851460|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-07-13|||April 18, 2013||2013-04-18|July 12, 2017|2017-07-12|January 1, 2031|Anticipated|2031-01-01|January 1, 2030|Anticipated|2030-01-01||Interventional|||Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease|Radiofrequency Ablation (RFA) for the Treatment of Liver Abscesses in Patients With Chronic Granulomatous Disease|Recruiting||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:43:21.473847|2017-10-11 01:43:21.473847
NCT01851447|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-07-18|||April 4, 2013||2013-04-04|July 13, 2017|2017-07-13|February 20, 2018|Anticipated|2018-02-20|February 20, 2018|Anticipated|2018-02-20||Observational|||Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy|Pilot Study to Assess Biomarkers of Changes in Barrier Function of Skeletal Muscle in Patients With a Fragile Sarcolemmal Muscular Dystrophy|Recruiting||N/A|11|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:43:21.709008|2017-10-11 01:43:21.709008
NCT01851434|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-06-30|||March 15, 2013||2013-03-15|December 8, 2016|2016-12-08|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Natural History of Optic Neuritis|Natural History of Optic Neuritis|Suspended||N/A|8|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:43:21.850749|2017-10-11 01:43:21.850749
NCT01851421|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2017-10-05|||March 18, 2013||2013-03-18|August 17, 2017|2017-08-17|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Fat Metabolism and Melanocortin 3 Receptors in African Americans|Fat Metabolism and Function Altering Polymorphisms in MC3R|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:43:21.981353|2017-10-11 01:43:21.981353
NCT01851408|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-09|2015-04-14|||April 2006||2006-04-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma|Phase 2 Study of the Combination of BAY 43-9006 (Sorafenib) and CCI-779 (Temsirolimus) in Patients With Metastatic Melanoma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)||1||No progression of Phase 1 trial to Phase 2.|f||||f||||||||||2017-10-11 01:43:22.107543|2017-10-11 01:43:22.107543
NCT01851382|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-10-05|||April 25, 2013||2013-04-25|December 30, 2016|2016-12-30|February 12, 2015|Actual|2015-02-12|July 10, 2014|Actual|2014-07-10||Observational|||Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research|Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research|Completed||N/A|29|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:43:22.365747|2017-10-11 01:43:22.365747
NCT01851369|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-09-12|||April 9, 2013||2013-04-09|September 7, 2017|2017-09-07|December 24, 2019|Anticipated|2019-12-24|December 24, 2019|Anticipated|2019-12-24||Interventional|||TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas|A Phase I/II Trial of TRC102 (Methoxyamine HCl) in Combination With Temozolomide in Patients With Relapsed Solid Tumors and Lymphomas|Recruiting||Phase 1/Phase 2|65|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:43:22.461139|2017-10-11 01:43:22.461139
NCT01851356|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-07-28|||March 18, 2013||2013-03-18|July 27, 2017|2017-07-27|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Observational|||Brain Inflammation in Major Depressive Disorder Background|Brain Inflammation In Major Depressive Disorder|Completed||N/A|61|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:43:22.556692|2017-10-11 01:43:22.556692
NCT01851343|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-07-13|||January 27, 2013||2013-01-27|July 12, 2017|2017-07-12|July 12, 2017|Actual|2017-07-12|July 12, 2017|Actual|2017-07-12||Interventional|||Bone Marrow Stromal Cells for Inflammatory Bowel Diseases|An Open-Label, Phase 1 Study to Assess the Safety and Tolerability of Bone Marrow Stromal Cell Infusion for the Treatment of Moderate to Severe Inflammatory Bowel Disease|Terminated||Phase 1|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:43:22.648559|2017-10-11 01:43:22.648559
NCT01851330|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-12-18|2014-12-18||May 2013||2013-05-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional||Safety Analysis Set: participants were randomized and received at least one dose of study medication.|Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)|A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin for 8 Weeks and Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1 HCV Infection|Completed||Phase 3|647|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 01:43:22.801207|2017-10-11 01:43:22.801207
NCT01851317|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-05-07|||April 2013||2013-04-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||The Relationship Between Patients' Head Position and ETT Intracuff Pressure|The Relationship Between Patients' Position and Endotracheal Tube Intracuff Pressure in Pediatric Population|Completed||N/A|200|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 01:43:24.312519|2017-10-11 01:43:24.312519
NCT01851304|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2015-09-30|||September 2014||2014-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|CHECKMATE||Metabolic Effect of New Foods Through Gut-brain Axis|Checking Melanoidins and Bitter Compound Satiating Efficiency Through Evaluation of Human Gut-brain Response to Novel-food Ingestion|Completed||N/A|15|Actual|Federico II University||7|||f||||t||||||||||2017-10-11 01:43:24.418054|2017-10-11 01:43:24.418054
NCT01851278|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2013-05-09|||April 2013||2013-04-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Interventional|||Effectiveness Intraarticular Corticosteroid|Effectiveness and Tolerance Infiltration Intraarticular Corticosteroid According to Dose|Unknown status|Recruiting|N/A|60|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 01:43:24.547676|2017-10-11 01:43:24.547676
NCT01851265|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-08-25|||July 4, 2013|Actual|2013-07-04|August 2017|2017-08-01|June 6, 2017|Actual|2017-06-06|October 18, 2013|Actual|2013-10-18||Interventional|||D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours|A Two-part, Randomised, Open-label, Multicentre, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of Olaparib Following Single 400 mg Doses of the Capsule Formulation in Patients With Advanced Solid Tumours.|Completed||Phase 1|32|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 01:43:24.649958|2017-10-11 01:43:24.649958
NCT01851252|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-08-15|||October 2013|Actual|2013-10-01|January 2017|2017-01-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy|Pilot Study to Evaluate the Correlation Between ¹³C Methacetin Breath Test (MBT) and HVPG Measurement as a Tool for Identifying Responders to Portal Hypertension Therapy|Completed||Phase 1|19|Actual|Exalenz Bioscience LTD.||1|||f||||f||||||||||2017-10-11 01:43:24.752229|2017-10-11 01:43:24.752229
NCT01851239|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2014-05-02|||February 2013||2013-02-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|July 2013|Actual|2013-07-01||Observational|||Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital||Completed||N/A|1000|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 01:43:24.840736|2017-10-11 01:43:24.840736
NCT01851226|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2014-04-01|||May 2013||2013-05-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ERCP||Effect of Different Length of Time for Trainees to Attempt Cannulation on Success Rate of Selective Cannulation During hands-on ERCP Training|Effect of Different Length of Time for Trainees to Attempt Cannulation on Success Rate of Selective Cannulation During hands-on ERCP Training|Completed||N/A|256|Actual|Fourth Military Medical University||3|||f||||t||||||||||2017-10-11 01:43:24.901129|2017-10-11 01:43:24.901129
NCT01851213|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-08-08|||March 2013||2013-03-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01|1 Year|Observational [Patient Registry]|FMI Registry||FoundationOne™ Test Registry Study|A Prospective Observational Study to Examine, in Routine Clinical Practice in the US, Practice Patterns and Impact on Clinical Decision Making Associated With the FoundationOne™ Next Generation Sequencing (NGS) Test|Completed||N/A|510|Actual|Foundation Medicine|||1||f||||f||||||||||2017-10-11 01:43:24.986129|2017-10-11 01:43:24.986129
NCT01851200|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2016-04-07|||May 2013||2013-05-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors|Brentuximab Vedotin (SGN-35) as Salvage Therapy for Males With Advanced and Platinum-resistant Germ-cell Tumors. An Open Label, Single Group, Phase 2 Trial.|Active, not recruiting||Phase 2|9|Actual|Fondazione Michelangelo||1|||f||||t||||||||||2017-10-11 01:43:25.084747|2017-10-11 01:43:25.084747
NCT01851187|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-05-10|||September 2008||2008-09-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Perinatal Emotional Management on Maternal Emotion and Delivery Outcomes|A Randomized Control Study of Prenatal Emotion Management on Maternal Emotion and the Delivery Outcomes|Completed||N/A|200|Actual|First People's Hospital of Hangzhou||2|||f||||t||||||||||2017-10-11 01:43:25.17884|2017-10-11 01:43:25.17884
NCT01851161|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-09-16|||May 2010||2010-05-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Observational|||Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy|Pulmonary Tumor Motion Reduction and Improved Breathing Reproducibility by Prone Patient Positioning in Radiation Therapy|Terminated||N/A|23|Actual|Virginia Commonwealth University|||1|Data analysis completed|f||||t||||||||||2017-10-11 01:43:25.391262|2017-10-11 01:43:25.391262
NCT01851148|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2013-08-31|||March 2010||2010-03-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Interventional|||Clinical Effectiveness of Osteopathic Manipulative Treatment in Chronic Migraine|Clinical Effectiveness of Osteopathic Manipulative Treatment Versus Sham Therapy and Usual Care in Chronic Migraine: 3 Armed RCT|Completed||N/A|105|Actual|European Institute for Evidence Based Osteopathic Medicine||3|||f||||t||||||||||2017-10-11 01:43:25.468121|2017-10-11 01:43:25.468121
NCT01851135|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-07-05|||May 2013||2013-05-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|NF1-QDV||Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1|Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1|Completed||N/A|286|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 01:43:25.562975|2017-10-11 01:43:25.562975
NCT01851122|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-05-07|||November 2011||2011-11-01|May 2013|2013-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Effect of the Amino Acid L-Theanine on Alertness and Vigilance|The Effect of the Amino Acid L-Theanine on Alertness and Vigilance|Completed||N/A|26|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 01:43:25.647863|2017-10-11 01:43:25.647863
NCT01851109|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-01-27|||July 2008||2008-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2013|Actual|2013-05-01||Interventional|||Prevention of Ovarian Cancer in Women Participating in Mammography|Prevention of Ovarian Cancer in Women Participating in Mammography|Completed||N/A|458|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 01:43:25.725243|2017-10-11 01:43:25.725243
NCT01851096|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2016-08-15|||March 2013||2013-03-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|October 2015|Actual|2015-10-01||Interventional|||Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung Adenocarcinoma|"A Phase 1, Open-label, Dose-escalation Study of SNX 5422 and Erlotinib in Subjects With Lung Adenocarcinoma With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors."|Completed||Phase 1|17|Actual|Esanex Inc.||1|||f||||f||||||||No|Phase 1 pharmacology study|2017-10-11 01:43:25.810257|2017-10-11 01:43:25.810257
NCT01851083|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2017-06-22|||August 2013||2013-08-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury|A Phase 2 Multicenter Trial of Pediatric Autologous Bone Marrow Mononuclear Cells (BMMNCs) for Severe Traumatic Brain Injury (TBI)|Enrolling by invitation||Phase 1/Phase 2|50|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 01:43:25.897135|2017-10-11 01:43:25.897135
NCT01851070|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-12-21|||May 2013||2013-05-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|May 2016|Actual|2016-05-01||Interventional|||A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor|A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor.|Active, not recruiting||Phase 2|48|Actual|Mesoblast, Ltd.||2|||f||||t||||||||||2017-10-11 01:43:25.993715|2017-10-11 01:43:25.993715
NCT01851057|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-01-31|||April 2013||2013-04-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Supporting Treatment Adherence Regimens in Pediatric Epilepsy: The STAR Trial|Supporting Treatment Adherence Regimens in Pediatric Epilepsy: The STAR Trial|Recruiting||N/A|200|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No|Not being shared|2017-10-11 01:43:26.093131|2017-10-11 01:43:26.093131
NCT01851044|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2017-06-25|||February 2011||2011-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Platelet Rich Plasma on Lateral Epicondylitis|The Treatment of Lateral Epicondylitis: the Effect of Platelet Rich Plasma on Healing -- A Randomized Controlled Double-Blinded Trial|Recruiting||N/A|120|Anticipated|University of Tampere||3|||f||||f||||||||||2017-10-11 01:43:27.74718|2017-10-11 01:43:27.74718
NCT01851031|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2013-05-08|||February 2009||2009-02-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A New Surgical Approach to Treat Medial or Low Condylar Fractures|A New Surgical Approach to Treat Medial or Low Condylar Fractures:The Minor Parotid Anterior Approach|Completed||N/A|60|Actual|West China College of Stomatology||2|||f||||t||||||||||2017-10-11 01:43:27.885484|2017-10-11 01:43:27.885484
NCT01851018|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-05-08|||May 2012||2012-05-01|May 2013|2013-05-01|July 2018|Anticipated|2018-07-01|May 2015|Anticipated|2015-05-01||Interventional|HyBraFi||Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment|Match Pair Analysis Study, Comparing Toxicities Between 2 Treatment Regiments Including Neo-adjuvant Hormonal Therapy Plus Hypofractionated RT With HDR Brachytherapy Boost Compare to Our Current Clinical Standard Approach at CHU de Quebec|Active, not recruiting||Phase 2|30|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 01:43:27.993358|2017-10-11 01:43:27.993358
NCT01851005|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2014-03-18|||May 2013||2013-05-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|CSUHAPM||Effect of Dexmedetomidine on Recovery Profiles of Elderly Patients|Effect of Dexmedetomidine on Recovery Profiles of Elderly Patients|Completed||N/A|120|Actual|Chosun University Hospital||4|||f||||f||||||||||2017-10-11 01:43:28.100948|2017-10-11 01:43:28.100948
NCT01850992|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-01-08|||May 2013||2013-05-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Reproductive Aging and Obstructive Sleep Apnea|Reproductive Aging and Obstructive Sleep Apnea|Withdrawn||N/A|0|Actual|Los Angeles Biomedical Research Institute||2||This study is non-funded study and experienced difficulty in recruitment.|f||||f||||||||||2017-10-11 01:43:28.23269|2017-10-11 01:43:28.23269
NCT01850979|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-09|||February 2010||2010-02-01|May 2013|2013-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops|Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops: Prospective Double-Blind Randomized Study|Completed||Phase 4|24|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 01:43:28.336602|2017-10-11 01:43:28.336602
NCT01850966|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-08|2017-02-23|||September 12, 2012|Actual|2012-09-12|January 2017|2017-01-01|December 22, 2016|Actual|2016-12-22|April 13, 2014|Actual|2014-04-13||Observational|||Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis|Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis|Completed||N/A|2747|Actual|Eisai Inc.|||1||f||||f||||||||||2017-10-11 01:43:28.492162|2017-10-11 01:43:28.492162
NCT01850953|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-01-26|||June 2013||2013-06-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia|Evaluating the Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia: Implications for Treatment|Completed||Phase 4|28|Actual|Centre for Addiction and Mental Health||2|||f||||t||||||||||2017-10-11 01:43:29.798032|2017-10-11 01:43:29.798032
NCT01850940|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-07-27|||January 2013||2013-01-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|September 2014|Actual|2014-09-01||Observational|OASIS||Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia|Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia - A Multi-center Prospective Cohort Study|Completed||Phase 3|98|Actual|Beijing Friendship Hospital|||2||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 01:43:29.893374|2017-10-11 01:43:29.893374
NCT01850927|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-08-29|||June 2013||2013-06-01|March 2016|2016-03-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|PRIME||Perioperative Reduction of Inapparent Myocardial Injury|Effect of Remote Ischemic Preconditioning on Subclinical Myocardial Injury in Major Abdominal Surgery: a Randomised Controlled Trial|Completed||N/A|84|Actual|London Surgical Research Group||2|||f||||f||||||||||2017-10-11 01:43:30.033454|2017-10-11 01:43:30.033454
NCT01850914|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-05-27|||January 2010||2010-01-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Vascular Risk Factors in INPH-patients|Vascular Risk Factors, Subclinical and Manifest Vascular Disease in Patients With Idiopathic Normal Pressure Hydrocephalus|Completed||N/A|860|Actual|Umeå University|||2||f||||f||||||||||2017-10-11 01:43:30.1515|2017-10-11 01:43:30.1515
NCT01850901|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-01-31|||May 2013||2013-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|SYMPATHY||Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension|Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension - A Multicenter Randomized Controlled Trial|Completed||Phase 3|139|Actual|UMC Utrecht||2|||f||||t||||||||||2017-10-11 01:43:30.237449|2017-10-11 01:43:30.237449
NCT01850888|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-10-04|||December 2013||2013-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||MIBG for Refractory Neuroblastoma and Pheochromocytoma|131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Refractory Neuroblastoma and Pheochromocytoma|Recruiting||N/A|100|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-10-11 01:43:30.319184|2017-10-11 01:43:30.319184
NCT01850875|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-05-13|||May 2013||2013-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional|LOGIN - EMDR||Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain|Localized and Generalized Musculoskeletal Pain: Psychobiological Mechanisms and Implications for Treatment (LOGIN) - Subgroups Characterized by Psychological Trauma, Mental Comorbidity, and Psychobiological Patterns and Their Specialized Treatment - Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain|Completed||N/A|40|Actual|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-11 01:43:30.449821|2017-10-11 01:43:30.449821
NCT01850862|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2013-05-15|||June 2011||2011-06-01|May 2013|2013-05-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Progressive Collective-exercise Program on the Knee Osteoarthritis||Completed||N/A|30|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||||||||||||2017-10-11 01:43:30.572407|2017-10-11 01:43:30.572407
NCT01850849|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-01-21|||May 2013||2013-05-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream|A Phase I, First-in-Human, Vehicle Controlled, Single Ascending Dose Trial Evaluating the Safety, Tolerability and Pharmacokinetics in Male Subjects With AD and in Healthy Male Subjects of Cutaneous Application of LEO 39652 Cream|Completed||Phase 1|23|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 01:43:30.696029|2017-10-11 01:43:30.696029
NCT01850836|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-05-08|||December 2010||2010-12-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Dual Hemisphere rTMS for Rehabilitation of Post Stroke Aphasia|Treatment of Aphasic Stroke Patients With rTMS|Completed||N/A|29|Actual|Assiut University||2|||f||||f||||||||||2017-10-11 01:43:30.94067|2017-10-11 01:43:30.94067
NCT01850823|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2014-08-18|||February 2013||2013-02-01|August 2014|2014-08-01||||December 2013|Actual|2013-12-01||Interventional|||Clinical Equivalence Study of Mometasone Nasal Spray||Completed||Phase 3|875|Actual|Actavis Inc.||3|||f||||f||||||||||2017-10-11 01:43:31.056775|2017-10-11 01:43:31.056775
NCT01850810|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-03-02|||May 2013||2013-05-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Evaluation of a Nutritional Product for People With Type 2 Diabetes|Evaluation of a Nutritional Product for People With Type 2 Diabetes (T2DM)|Completed||N/A|33|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-11 01:43:31.314537|2017-10-11 01:43:31.314537
NCT01850797|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-08-15|||January 2012||2012-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Observational|RASUNOA||Registry of Acute Stroke Under New Oral Anticoagulants -Pilot (RASUNOA-Pilot)|Registry of Acute Stroke Under New Oral Anticoagulants -Pilot (RASUNOA-Pilot)|Completed||N/A|353|Actual|University Hospital Heidelberg|||1||f||||f||||||||||2017-10-11 01:43:31.426656|2017-10-11 01:43:31.426656
NCT01850784|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-08|||February 2013||2013-02-01|May 2013|2013-05-01|October 2014|Anticipated|2014-10-01|February 2014|Anticipated|2014-02-01||Interventional|||High Energy Formula Feeding in Infants With Congenital Heart Disease|High Energy Formula Feeding in Infants With Congenital Heart Disease|Unknown status|Recruiting|N/A|100|Anticipated|Dr. Sami Ulus Children's Hospital||2|||f||||t||||||||||2017-10-11 01:43:31.553032|2017-10-11 01:43:31.553032
NCT01850771|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-06-01|||May 2013||2013-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Regenexx™ PL-Disc Versus Steroid Epidurals for Lumbar Radiculopathy|A Single-Blinded, Randomized Controlled Trial of Regenexx™ PL-Disc Versus Steroid Epidurals for Treatment of Lumbar Radiculopathy|Terminated||N/A|8|Actual|Regenerative Sciences, LLC||2||Difficulties in recruitment|f||||f||||||||No||2017-10-11 01:43:31.707065|2017-10-11 01:43:31.707065
NCT01850758|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-12-19|||May 2013||2013-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Regenexx™ SD Versus Exercise Therapy for ACL Tears|A Randomized Controlled Trial of Regenexx™ SD Versus Exercise Therapy for Treatment of Partial and Complete, Non-retracted Anterior Cruciate Ligament Tears|Recruiting||N/A|50|Anticipated|Regenerative Sciences, LLC||2|||f||||f||||||||No||2017-10-11 01:43:31.842302|2017-10-11 01:43:31.842302
NCT01850732|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-06-25|||May 2013||2013-05-01|June 2014|2014-06-01||||June 2014|Actual|2014-06-01||Interventional|||Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms|Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms|Completed||N/A|||North Karelia Central Hospital||1|||f||||f||||||||||2017-10-11 01:43:32.126804|2017-10-11 01:43:32.126804
NCT01850719|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-05-02|||July 2013|Actual|2013-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|September 2017|Anticipated|2017-09-01||Interventional|ESCAPE||Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients|Cost-effectiveness of Early Surgery Versus Conservative Treatment With Optional Delayed Meniscectomy in Older Patients. A Randomized Controlled Trial.|Active, not recruiting||N/A|321|Actual|Onze Lieve Vrouwe Gasthuis||2|||f||||f||||||||||2017-10-11 01:43:32.254169|2017-10-11 01:43:32.254169
NCT01850706|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-10-24|||August 2011||2011-08-01|October 2015|2015-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation|Evaluation of Urinary Nerve Growth Factor as an Objective Tool to Assess Therapeutic Outcome in Patients With Detrusor Overactivity Undergoing Treatment With Sacral Neuromodulation|Completed||N/A|50|Actual|Northwell Health|||1||f||||f||||||||||2017-10-11 01:43:32.459997|2017-10-11 01:43:32.459997
NCT01850693|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2015-11-08|||July 2006||2006-07-01|May 2013|2013-05-01|June 2015|Actual|2015-06-01|December 2012|Actual|2012-12-01|5 Years|Observational [Patient Registry]|ACADIS||Assessment of Coronary Artery Disease in Stroke Patients|Prevalence and Characteristics of Coronary Atherosclerosis in Stroke Patients Using Coronary CT Angiography|Completed||N/A|1657|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 01:43:32.556691|2017-10-11 01:43:32.556691
NCT01850680|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-01-27|||April 2013||2013-04-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety and Tolerability of Subcutaneously Administered Sarilumab in Japanese Patients With Rheumatoid Arthritis Receiving Concomitant Methotrexate|Completed||Phase 1|61|Actual|Sanofi||5|||f||||f||||||||||2017-10-11 01:43:32.673198|2017-10-11 01:43:32.673198
NCT01850667|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-12-22|||January 2012||2012-01-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2015|Actual|2015-04-01||Interventional|||Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma|Phase II Multicenter Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Toxicity and Outcome|Active, not recruiting||Phase 2|71|Anticipated|Korea Cancer Center Hospital||1|||f||||f||||||||Undecided||2017-10-11 01:43:32.81937|2017-10-11 01:43:32.81937
NCT01850641|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-11-11||||||November 2014|2014-11-01||||December 2013|Actual|2013-12-01||Interventional|||A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia||Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 01:43:33.281699|2017-10-11 01:43:33.281699
NCT01850628|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-08-31|||July 2013||2013-07-01|July 2016|2016-07-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Observational|||NSABP Biospecimen Discovery Project|NSABP Biospecimen Discovery Project|Recruiting||N/A|50|Anticipated|NSABP Foundation Inc|||1||f||||f||||||Samples With DNA|"     fresh tumor tissue and blood samples   "|||2017-10-11 01:43:33.379166|2017-10-11 01:43:33.379166
NCT01850602|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-11-11||||||November 2014|2014-11-01||||December 2013|Actual|2013-12-01||Interventional|||A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia||Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 01:43:33.965382|2017-10-11 01:43:33.965382
NCT01850589|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-07-28|2014-03-26||March 2011||2011-03-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||There were a total of 44 subjects enrolled. 36 successfully completed the therapy. 14 subjects: Conservative management, 22 subjects: Aggressive Managment. 8 subjects withdrew from the study.|Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice|Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice|Terminated||N/A|44|Actual|Northwell Health||2||Use of bupropion with counseling works better to help patients quit smoking.|f||||t||||||||||2017-10-11 01:43:34.136146|2017-10-11 01:43:34.136146
NCT01850576|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-05-07|||September 2013||2013-09-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|TEACH||Project TEACH-Kenya|Project Tailoring Effective And Community-based HIV Interventions in Kenya|Withdrawn||N/A|0|Actual|North Bronx Healthcare Network||2||We did not receive proper funding to complete this study|f||||f||||||||||2017-10-11 01:43:34.512573|2017-10-11 01:43:34.512573
NCT01850563|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-08-15|||May 2013||2013-05-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Proof-of-principle Study of Hyperbaric Oxygen as a Radiosensitizer Prior to Stereotactic Radiosurgery for Brain Metastases|A Proof-of-principle Study of Hyperbaric Oxygen as a Radiosensitizer Prior to Stereotactic Radiosurgery for Brain Metastases|Recruiting||N/A|22|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 01:43:34.655238|2017-10-11 01:43:34.655238
NCT01850550|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-05-27|2015-05-07||February 2013||2013-02-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|KL2||Impact of Volunteer Peer-Led Intervention for Weight Control in Primary Care|Impact of Volunteer Peer-Led Intervention for Weight Control in Primary Care|Completed||N/A|80|Actual|Milton S. Hershey Medical Center|This was a pilot study. No other limitations noted.|2|||f||||f||||||||||2017-10-11 01:43:34.848941|2017-10-11 01:43:34.848941
NCT01850537|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-05-06|||May 2013||2013-05-01|May 2013|2013-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prospective Study To Assess The Safety and Efficacy of the PROW LIF Procedure|Prospective Study To Assess The Safety and Efficacy of the PROW LIF Procedure|Unknown status|Not yet recruiting|N/A|15|Anticipated|NLT Spine||1|||f||||f||||||||||2017-10-11 01:43:35.37552|2017-10-11 01:43:35.37552
NCT01850524|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-06-05|||May 17, 2013|Actual|2013-05-17|June 2017|2017-06-01|February 22, 2021|Anticipated|2021-02-22|March 22, 2018|Anticipated|2018-03-22||Interventional|||IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma|A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral IXAZOMIB (MLN9708) Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 3|701|Actual|Takeda||2|||f||||t|t|f||||||||2017-10-11 01:43:35.514142|2017-10-11 01:43:35.514142
NCT01850511|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-01-20|||May 2013||2013-05-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||The Effect of Nasal Hair on Nasal Obstruction|The Effect of Vibrissae on Subjective and Objective Measures of Nasal Obstruction|Completed||N/A|60|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:43:35.945284|2017-10-11 01:43:35.945284
NCT01850498|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2013-05-06|||May 2012||2012-05-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Epilepsy Motion Sensing|Motion Sensing Study in Epilepsy Patients|Completed||N/A|19|Actual|MedtronicNeuro|||2||f||||f||||||||||2017-10-11 01:43:36.044095|2017-10-11 01:43:36.044095
NCT01850485|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-06-22|2014-12-01||February 2012||2012-02-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Observational|||Microcirculatory Perfusion in Patients With Coma After Out-of-hospital Cardiac Arrest|Microcirculatory Perfusion as Measured by Sublingual SDF Imaging and NIRS in Patients With Coma After Out-of-hospital Cardiac Arrest Treated With Mild Therapeutic Hypothermia (TH) or Not Treated With Mild-TH|Completed||N/A|22|Actual|Medical Centre Leeuwarden|Relative small sample size Large inter individual variability in microvascular reactivity||2||f||||f||||||||||2017-10-11 01:43:36.138688|2017-10-11 01:43:36.138688
NCT01850459|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-04-17|||January 2013||2013-01-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|ERK||Extracellular Signal-Related Kinase Biomarker Development in Autism|Extracellular Signal-Related Kinase Biomarker Development in Autism|Completed||N/A|213|Actual|Children's Hospital Medical Center, Cincinnati|||4||f||||f||||||Samples Without DNA|"     For the ERK activation assay, about 5 mL of whole blood is layered onto 3 mL Histopaque in a     15 mL centrifuge tube, and centrifuged. The lymphocyte-containing cell layer is removed and     transferred for washing. After a second wash, cells are resuspended and rested. They are then     stimulated by addition of phorbol myristate acetate and sample aliquots are removed at short     intervals, fixed and permeabilized. Fixed, permeabilized cells are stained by addition of     Alexafluor488-labeled monoclonal antibody to phospho-ERK in the dark for 30 min. Washed,     resuspended cells are analyzed in a Coulter flow cytometer.   "|||2017-10-11 01:43:36.610998|2017-10-11 01:43:36.610998
NCT01850446|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-10-04|||February 20, 2015|Actual|2015-02-20|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Comparative Clinical Trial of Efficiency and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza|Comparative Parallel-group Randomized Clinical Trial of Efficiency and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza|Recruiting||Phase 4|150|Anticipated|Materia Medica Holding||2|||f||||f||||||||||2017-10-11 01:43:36.691797|2017-10-11 01:43:36.691797
NCT01850433|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-08-15|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Internet Cognitive Behavior Therapy (CBT) for Body Dysmorphic Disorder (BDD)|Internet-based Cognitive Behavior Therapy for Body Dysmorphic Disorder: A Pilot Study|Completed||N/A|23|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 01:43:36.827189|2017-10-11 01:43:36.827189
NCT01850420|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-03-25|||May 2013||2013-05-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||A Study of IMC-1 In Patients With Fibromyalgia|A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia|Completed||Phase 2|143|Actual|Innovative Med Concepts, LLC||2|||f||||f||||||||||2017-10-11 01:43:36.9257|2017-10-11 01:43:36.9257
NCT01850407|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2014-02-01|||August 2007||2007-08-01|February 2014|2014-02-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Preparing Caregivers for the Child Sexual Abuse Examination: Are Informational Leaflets Helpful?|Preparing Caregivers for the Child Sexual Abuse Examination: Are Informational Leaflets Helpful?|Completed||N/A|37|Actual|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-11 01:43:37.046019|2017-10-11 01:43:37.046019
NCT01850394|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-10-24|2013-05-09||January 2010||2010-01-01|October 2013|2013-10-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement|Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement; A Prospective Triple-blinded Randomized Controlled Trial.|Completed||N/A|152|Actual|Mahidol University||3|||f||||t||||||||||2017-10-11 01:43:37.297865|2017-10-11 01:43:37.297865
NCT01850381|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2017-08-02||2017-08-01|June 2013||2013-06-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|GAP-PD||Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease|GM 608 in A Phase IIA Pilot Double-blinded, Randomized, Placebo Controlled Trial in Mild to Moderate Parkinson Disease|Completed||Phase 2|6|Actual|Genervon Biopharmaceuticals, LLC||2|||f||||f||||||||||2017-10-11 01:43:37.968001|2017-10-11 01:43:37.968001
NCT01850368|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-12-22|||October 2012||2012-10-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2015|Actual|2015-07-01||Interventional|||Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion|Multicenter Phase II Study of Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion|Active, not recruiting||Phase 2|28|Anticipated|Korea Cancer Center Hospital||1|||f||||f||||||||Undecided||2017-10-11 01:43:38.097899|2017-10-11 01:43:38.097899
NCT01850355|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-07-12|||July 2013||2013-07-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders|An Open-label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders|Recruiting||N/A|40|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 01:43:38.248634|2017-10-11 01:43:38.248634
NCT01850342|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2013-05-08|||May 2013||2013-05-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|March 2014|Anticipated|2014-03-01||Interventional|||Effectiveness and Safety of Cell-Assisted Lipotransfer for the Treatment of Stress Urinary Incontinence|Effectiveness and Safety of Cell-Assisted Lipotransfer for the Treatment of Stress Urinary Incontinence Via Endoscopically-Assisted Administration of Fat Tissue Micrografts Enriched by Autologous Adipose-Derived Regenerative Cells|Unknown status|Enrolling by invitation|Phase 1/Phase 2|12|Anticipated|Burnasyan Federal Medical Biophysical Center||1|||f||||f||||||||||2017-10-11 01:43:38.369986|2017-10-11 01:43:38.369986
NCT01850329|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-04-05|||December 7, 2009|Actual|2009-12-07|April 2017|2017-04-01|September 9, 2014|Actual|2014-09-09|September 9, 2014|Actual|2014-09-09||Interventional|||A Parental Educational Intervention to Facilitate Informed Consent for Pediatric Procedural Sedation in the Emergency Department|A Parental Educational Intervention to Facilitate Informed Consent for Pediatric Procedural Sedation in the Emergency Department|Completed||N/A|67|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-11 01:43:38.467433|2017-10-11 01:43:38.467433
NCT01850316|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-07-19|||July 2013||2013-07-01|July 2016|2016-07-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy|A Phase II Study for the Treatment of Unresectable or Medically Inoperable Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy (SBRT) in British Columbia|Active, not recruiting||Phase 2|13|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 01:43:38.569277|2017-10-11 01:43:38.569277
NCT01850303|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-10-24|||May 2013||2013-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|April 2017|Anticipated|2017-04-01||Interventional|||MODEL (Maintenance Versus Observation After inDuction Chemotherapy in Non-progressing Elderly Patients With Advanced Non-small Cell Lung Cancer)|Phase III Study Comparing Maintenance With Pemetrexed or Gemcitabine to a Surveillance in Elderly Patients (70 Years Old and More) With a Advanced Non Small Cell Lung Cancer Controlled by Induction Chemotherapy.|Active, not recruiting||Phase 3|632|Actual|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||t||||||||||2017-10-11 01:43:38.680887|2017-10-11 01:43:38.680887
NCT01850277|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-03-09|||October 2013||2013-10-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|Pilot-CRAfT||Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study|Comparison of a Rhythm Control Treatment Strategy Versus a Rate Control Strategy in Patients With Permanent or Long-term Persistent Atrial Fibrillation and Heart Failure Treated With Cardiac Resynchronization Therapy - a Pilot Study|Unknown status|Recruiting|Phase 4|60|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||f||||||||||2017-10-11 01:43:39.113927|2017-10-11 01:43:39.113927
NCT01850264|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-10-04|||March 2013||2013-03-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|QUOTA||Quartet™ Bad Oeynhausen Trial|Quartet™ Bad Oeynhausen Trial|Recruiting||N/A|80|Anticipated|Heart and Diabetes Center North-Rhine Westfalia||2|||f||||f||||||||||2017-10-11 01:43:39.283082|2017-10-11 01:43:39.283082
NCT01850251|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2015-08-18|||June 2013||2013-06-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture|Randomized Controlled, Pilot Study to Assess the Effect of a High Protein and Calorie Nutritional Supplementation Enriched Hydroxymethylbutyrate and Vitamin D on Muscle Strength and Function in Patients With Hip Fracture.|Terminated||Phase 4|2|Actual|Hospital Clinic of Barcelona||2||Recruiting problems.|f||||f||||||||||2017-10-11 01:43:39.398892|2017-10-11 01:43:39.398892
NCT01850238|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2015-10-09|||May 2013||2013-05-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease|A 3-months Randomized, Placebo-controlled, Parallel Group, Double-blinded, Multi-centre, Phase I Study to Assess Tolerability & Safety of AADvac1 Applied to Patients With Mild-Moderate Alzheimer's Disease With 3-months Open Label Extension|Completed||Phase 1|30|Actual|Axon Neuroscience SE||2|||f||||t||||||||||2017-10-11 01:43:39.525601|2017-10-11 01:43:39.525601
NCT01850225|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-03-17|||October 2013||2013-10-01|October 2013|2013-10-01|September 2017|Anticipated|2017-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Feasibility Study of Auditory Brainstem Implant in Young Children|A Feasibility Study of the Placement, Use, and Safety of the Nucleus 24 Auditory Brainstem Implant in Non-Neurofibromatosis Type 2 (NF2) Pediatric Patients|Withdrawn||Phase 1|0|Actual|House Research Institute||1|||f||||f||||||||||2017-10-11 01:43:39.637102|2017-10-11 01:43:39.637102
NCT01850212|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-10-30|||February 2013||2013-02-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects|A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects|Completed||Phase 4|476|Actual|Gilead Sciences|||4||f||||f||||||||||2017-10-11 01:43:39.742223|2017-10-11 01:43:39.742223
NCT01850199|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-07-27|||January 2014||2014-01-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Intelligent and Educational System for Gestational Diabetes Management||Completed||N/A|120|Actual|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-11 01:43:39.978032|2017-10-11 01:43:39.978032
NCT01850186|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-02-13|||February 2012||2012-02-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Comparative Study of Dual Yellow Laser Versus Stabilized Kilnman Preparation in the Treatment of Melasma|Comparative Study of Dual Yellow Laser Versus Stabilized Kilnman Preparation in the Treatment of Melasma|Completed||N/A|20|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 01:43:40.090497|2017-10-11 01:43:40.090497
NCT01850173|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-05-06|||February 2010||2010-02-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Whole Body Vibration in Chronic Obstructive Pulmonary Disease|Effects of Whole Body Vibration Training in Severe Chronic Obstructive Pulmonary Disease Patients|Completed||N/A|60|Actual|Hospital de Mataró||2|||f||||f||||||||||2017-10-11 01:43:40.192003|2017-10-11 01:43:40.192003
NCT01850160|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-01-25|||April 2013||2013-04-01|March 2015|2015-03-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension|Efficacy and Safety of the Fixed-dose Combination of Valsartan Plus Chlorthalidone Vs Valsartan or Chlorthalidone Alone in the Treatment of Arterial Hypertension, Open-label, Controlled, Randomized and Multicenter Trial|Completed||Phase 3|124|Actual|Farma de Colombia SA||3|||f||||f||||||||No||2017-10-11 01:43:40.284704|2017-10-11 01:43:40.284704
NCT01850147|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-05-07|||March 2013||2013-03-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen|Study of Efficacy and Safety of Sequential Low-dose Sunitinib With Chemotherapy in Advanced Non-small Cell Lung Cancer After Failure of Conventional Regimen|Unknown status|Recruiting|Phase 2|50|Anticipated|Chinese Academy of Medical Sciences||1|||f||||||||||||||2017-10-11 01:43:40.410395|2017-10-11 01:43:40.410395
NCT01850134|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-07|2016-07-12|||June 2013||2013-06-01|July 2016|2016-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.|Evaluation of a Nutritional Supplement for People With Type 2 Diabetes (T2DM).|Withdrawn||N/A|0|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-11 01:43:40.504729|2017-10-11 01:43:40.504729
NCT01850121|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-08-08|||January 2003||2003-01-01|August 2016|2016-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Remicade in the Treatment of Patients With Active Ankylosing Spondylitis|Remicade in the Treatment of Patients With Active Ankylosing Spondylitis|Completed||Phase 2/Phase 3|19|Actual|Göteborg University|||1||f||||f||||||Samples Without DNA|"     Serum samples   "|||2017-10-11 01:43:40.59474|2017-10-11 01:43:40.59474
NCT01850108|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-06-14|||May 2013||2013-05-01|June 2017|2017-06-01|November 2018|Anticipated|2018-11-01|May 2018|Anticipated|2018-05-01||Interventional|||Non-Myeloablative Conditioning and Bone Marrow Transplantation|A Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients With Sickle Cell Disease and Other Hemoglobinopathies|Recruiting||N/A|25|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-11 01:43:40.693581|2017-10-11 01:43:40.693581
NCT01850095|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-08|||March 2012||2012-03-01|May 2013|2013-05-01|January 2015|Anticipated|2015-01-01|June 2013|Anticipated|2013-06-01||Interventional|||The Influence of Peripheral Androgen Conversion at Women Adult Acne|The Influence of Peripheral Androgen Conversion at Toll-like Receptors-2 and CD1d Expressions in Human Keratinocytes as Well as Their Modulation After 6 Months Treatment With Oral Contraceptive.|Unknown status|Recruiting|N/A|60|Anticipated|Federal University of São Paulo||3|||f||||t||||||||||2017-10-11 01:43:40.813285|2017-10-11 01:43:40.813285
NCT01850082|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-05-05|||September 30, 2013|Actual|2013-09-30|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|September 2019|Anticipated|2019-09-01||Interventional|REGROUP||Randomized Endo-Vein Graft Prospective|CSP #588 - Randomized Endo-Vein Graft Prospective (REGROUP) Trial|Active, not recruiting||N/A|1150|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Undecided||2017-10-11 01:43:41.067642|2017-10-11 01:43:41.067642
NCT01850069|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-10-24|||June 2014||2014-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Use of Near Infrared Spectroscopy (NIRS) to Estimate Intracranial Pressure (ICP)|The Use of Near Infrared Spectroscopy (NIRS) to Estimate Intracranial Pressure (ICP)|Recruiting||N/A|59|Anticipated|University of Virginia|||1||f||||f||||||||No||2017-10-11 01:43:41.216024|2017-10-11 01:43:41.216024
NCT01850056|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2016-01-04|||April 2013||2013-04-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|August 2016|Anticipated|2016-08-01||Interventional|||AcoArt Ⅰ / SFA China|Prospective, Multi-center and Randomized Controlled Clinical Study to Verify Effectiveness and Safety of Drug-eluting Balloon in PTA Procedure (AcoArt I Study)|Active, not recruiting||N/A|200|Anticipated|Acotec Scientific Co., Ltd||2|||f||||t||||||||||2017-10-11 01:43:41.322247|2017-10-11 01:43:41.322247
NCT01850043|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-12-11|||May 2005||2005-05-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||The Epidemiology of TST Change in Korea|The Trend of Tuberculin Skin Test in Korea|Completed||N/A|5552|Actual|Asan Medical Center|||1||f||||f||||||||||2017-10-11 01:43:41.472035|2017-10-11 01:43:41.472035
NCT01850017|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-05-04|||August 2012|Actual|2012-08-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of Dexmedetomidine in Spine Surgery|Prospective Randomized Double Blind Study of Intraoperative Dexmedetomidine and Postoperative Pain Control in Patients Undergoing Multi-level Thoraco-lumbar Spine Surgery|Completed||Phase 4|142|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 01:43:41.792555|2017-10-11 01:43:41.792555
NCT01849991|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-05-10|||September 2013||2013-09-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic|Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic|Completed||Phase 1|21|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 01:43:42.159124|2017-10-11 01:43:42.159124
NCT01849978|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-01-12|||May 2014||2014-05-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Enhancing Exercise in Breast Cancer Survivors|Enhancing Exercise in Breast Cancer Survivors|Completed||N/A|81|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 01:43:42.274715|2017-10-11 01:43:42.274715
NCT01849965|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-11-18|||April 2013||2013-04-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|STRIDE 2||Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers|A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects With Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 3|633|Anticipated|Derma Sciences, Inc.||3|||f||||f||||||||||2017-10-11 01:43:42.378517|2017-10-11 01:43:42.378517
NCT01849952|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-08-18|||May 2013||2013-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas|Evaluating the Expression Levels of microRNA-10b in Patients With Gliomas|Recruiting||N/A|200|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||Samples With DNA|"     Blood, tumor tissue, cerebrospinal fluid.   "|||2017-10-11 01:43:42.635092|2017-10-11 01:43:42.635092
NCT01849939|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-05-08|||September 2012||2012-09-01|May 2013|2013-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|RICAC||Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia|Reduced Intensity Conditioning Allogeneic Transplantation for CLL With Preemptive MDR Management (ICLL 03 RICAC-PMM)|Unknown status|Recruiting|Phase 2|43|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 01:43:42.749534|2017-10-11 01:43:42.749534
NCT01849926|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-01-29|||May 2013||2013-05-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|IMUTI||Ibuprofen Versus Mecillinam for Uncomplicated Cystitis|Ibuprofen Versus Mecillinam for Uncomplicated Cystitis in Adult, Non-pregnant Women|Completed||Phase 1|383|Actual|University of Oslo||2|||f||||f||||||||||2017-10-11 01:43:42.847508|2017-10-11 01:43:42.847508
NCT01849913|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-05-08|||February 2013||2013-02-01|May 2013|2013-05-01|January 2014|Anticipated|2014-01-01|September 2013|Anticipated|2013-09-01||Interventional|Cervicalgia||Laser Therapy on Neck Pain in Adolescents|Evaluation of the Effect of Low-level Laser Therapy on Neck Pain In Adolescents|Unknown status|Recruiting|N/A|75|Anticipated|University of Nove de Julho||2|||f||||t||||||||||2017-10-11 01:43:42.947901|2017-10-11 01:43:42.947901
NCT01849900|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-04-08|||February 2013||2013-02-01|April 2017|2017-04-01|June 30, 2017|Anticipated|2017-06-30|April 30, 2017|Anticipated|2017-04-30||Interventional|PREKNOP||Preconception Reproductive Knowledge Promotion (PREKNOP)|Efficacy Study of the Preconception Reproductive Knowledge Promotion Intervention|Active, not recruiting||N/A|120|Anticipated|Calvin College||2|||f||||t||||||||||2017-10-11 01:43:43.0564|2017-10-11 01:43:43.0564
NCT01849887|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-01-20|||January 2016||2016-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke|Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke|Withdrawn||Phase 1/Phase 2|0|Actual|University of California, Irvine||2||Study was never started|f||||f||||||||||2017-10-11 01:43:43.180869|2017-10-11 01:43:43.180869
NCT01849874|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-04-03||2017-04-03|June 2013||2013-06-01|April 2017|2017-04-01|April 1, 2018|Anticipated|2018-04-01|April 1, 2016|Actual|2016-04-01||Interventional|||A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer||Active, not recruiting||Phase 3|360|Anticipated|Array BioPharma||2|||f||||t||||||||||2017-10-11 01:43:43.283963|2017-10-11 01:43:43.283963
NCT01849861|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-05-10|||September 2011||2011-09-01|May 2013|2013-05-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|||Cardiopulmonary Capacity in Elderly With Different Ranges of Serum Thyroid Stimulating Hormone|Cardiopulmonary Capacity In Different Quartiles Ranges Of Reference For Serum Thyroid Stimulating Hormone (TSH): Sectional Evaluation And Effect Of The Use Of Methimazole In Elderly Population|Unknown status|Recruiting|Phase 4|200|Anticipated|Universidade Federal do Rio de Janeiro||1|||f||||f||||||||||2017-10-11 01:43:43.672517|2017-10-11 01:43:43.672517
NCT01849848|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-01-21|2014-12-26||November 2011||2011-11-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma|A Multicenter, Open-Label Phase II Study of SyB L-0501 in Patients With Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|17|Actual|SymBio Pharmaceuticals||1|||f||||||||||||||2017-10-11 01:43:43.796326|2017-10-11 01:43:43.796326
NCT01849835|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-05-04|||January 2013||2013-01-01|May 2014|2014-05-01||||December 2014|Anticipated|2014-12-01||Interventional|RCT||A Test of the Comparison Between Trans-rectal and Trans-perineal Biopsy of Prostate||Unknown status|Recruiting|N/A|120|Anticipated|Shanghai 10th People's Hospital||2|||f||||t||||||||||2017-10-11 01:43:44.421309|2017-10-11 01:43:44.421309
NCT01849822|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-04-14|||February 2013||2013-02-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia|A Feasibility Study of the Ability of the Neural Prosthetic System to Provide Direct Brain Control of Extracorporeal Devices in Patients With Quadriplegia Due to High Spinal Cord Injury|Active, not recruiting||N/A|2|Anticipated|California Institute of Technology||1|||f||||t||||||||||2017-10-11 01:43:44.50338|2017-10-11 01:43:44.50338
NCT01849809|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-08-09|||February 1993||1993-02-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2011|Actual|2011-08-01||Interventional|||Safety and Effectiveness of Gamma Capsulotomy in Intractable OCD|Safety and Effectiveness of Gamma Capsulotomy in Intractable Obsessive Compulsive Disorder|Completed||N/A|57|Actual|Butler Hospital||1|||f||||f||||||||||2017-10-11 01:43:44.584246|2017-10-11 01:43:44.584246
NCT01849796|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2015-12-09|||October 2010||2010-10-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|TDCS||Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain|Transcranial Stimulation (TDCS) For The Treatment of Neuropathic Facial Pain.|Terminated||Phase 2|21|Actual|Beth Israel Medical Center||2||Investigators moved to other institutions|f||||f||||||||||2017-10-11 01:43:44.752799|2017-10-11 01:43:44.752799
NCT01849783|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-07-11|||April 2013||2013-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma|Single Autologous Transplant Followed by Consolidation and Maintenance for Participants ≥ 65 Years of Age Diagnosed With Multiple Myeloma or a Related Plasma Cell Malignancy|Recruiting||Phase 2|41|Anticipated|University of Iowa||1|||f||||t||||||||||2017-10-11 01:43:44.857648|2017-10-11 01:43:44.857648
NCT01849770|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-09-10|2015-07-07||July 2013||2013-07-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|MX-ALS-001||Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)|A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)|Completed||Phase 2|75|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 01:43:45.069876|2017-10-11 01:43:45.069876
NCT01849757|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-08|||November 2013||2013-11-01|May 2013|2013-05-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%|Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%|Not yet recruiting||N/A|7000|Anticipated|University of Saskatchewan||3|||f||||f||||||||||2017-10-11 01:43:46.637889|2017-10-11 01:43:46.637889
NCT01849744|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-07-25|||June 2013||2013-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|||Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies|A Phase I Study of VS-4718, a Focal Adhesion Kinase Inhibitor, in Subjects With Metastatic Non-Hematologic Malignancies|Terminated||Phase 1|48|Actual|Verastem, Inc.||1||Sponsor's decision to deprioritize the program.|f||||f||||||||||2017-10-11 01:43:46.776721|2017-10-11 01:43:46.776721
NCT01849731|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-06|||February 2011||2011-02-01|May 2013|2013-05-01||||December 2012|Actual|2012-12-01||Interventional|||Effectiveness of Two Interventions in Patients With Low Educational Level With Diabetes to Reduce Inequalities in Self-care Behavior||Completed||N/A|184|Actual|Andalusian School of Public Health||3|||f||||f||||||||||2017-10-11 01:43:46.885498|2017-10-11 01:43:46.885498
NCT01849718|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-12-18|||August 2013||2013-08-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Observational|NEST||Nacadia Effect Study (NEST)|Nacadia Effect Study - Studying the Effect of Garden Therapy in Relations to People Suffering From Stress|Active, not recruiting||N/A|80|Anticipated|University of Copenhagen|||2||f||||f||||||||||2017-10-11 01:43:46.957476|2017-10-11 01:43:46.957476
NCT01849705|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-06|||October 2012||2012-10-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|Mc4Obes||Melanocortin 4 Receptor Mutations and Obesity-associated Diseases|Mutations in the Melanocortin 4 Receptor and Obesity-associated Diseases|Completed||N/A|226|Actual|University of Copenhagen|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:43:47.030739|2017-10-11 01:43:47.030739
NCT01847807|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-10-07|||January 2011||2011-01-01|October 2015|2015-10-01||||June 2015|Actual|2015-06-01||Interventional|||The Organ Protection of Astragalus in Subjects With Metabolic Syndrome|The Cardiac and Kidney Protection of Astragalus in Subjects With Metabolic Syndrome|Completed||Phase 3|210|Actual|LanZhou University||3|||f||||t||||||||||2017-10-11 01:44:21.6906|2017-10-11 01:44:21.6906
NCT01849692|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-02-25|2016-01-29||June 2013||2013-06-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||"This analysis population includes all subjects who were randomized, received the initial injection or infusion, and had a baseline value and at least 1 postbaseline measurement for the period up to Day 28 for the primary efficacy variables (BCVA and/or CSFT). Here, n is the number of subjects in each cohort for each arm group, respectively."|ESBA1008 Microvolume Study|A Prospective, Two-Staged, Single-Masked Study to Evaluate the Effect of ESBA1008 Applied by Microvolume Injection or Infusion in Subjects With Exudative Age-Related Macular Degeneration|Completed||Phase 2|107|Actual|Alcon Research||5|||f||||f||||||||||2017-10-11 01:43:47.173024|2017-10-11 01:43:47.173024
NCT01849679|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-10-31|||March 2013||2013-03-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Post Extubation Dysphagia|The Effect on Time After Extubation on Aspiration Risk|Completed||N/A|71|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-10-11 01:43:48.487733|2017-10-11 01:43:48.487733
NCT01849666|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-11-01|||September 2013||2013-09-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy|A PHASE I, OPEN-LABEL, MULTICENTER, RANDOMINZED, PARALELL STUDY TO INVESTIGATE THE EFFECT OF VEMURAFENIB ON THE PHARMACOKINETICS OF A SINGLE ORAL DOSE OF PHENPROCOUMON IN PATIENTS WITH BRAFV600 MUTATION-POSITIVE METASTATIC MALIGNANCY|Completed||Phase 1|2|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:43:48.565664|2017-10-11 01:43:48.565664
NCT01849653|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-06-01|||August 2014||2014-08-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|SOVS-CTG||Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing|Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing: Concurrence in Non-Clinical Settings vs. Clinical Settings|Completed||N/A|3500|Actual|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     Residual vaginal swab specimens collected with the APTIMA® Vaginal Swab Specimen Collection     Kit.   "|||2017-10-11 01:43:48.679488|2017-10-11 01:43:48.679488
NCT01849640|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-07-13|||December 2012||2012-12-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|December 2014|Actual|2014-12-01||Interventional|||Antimalarial Drug Resistance With Assessment of Transmission Blocking Activity|Active Surveillance for P. Falciparum Drug Resistance With Assessment of Transmission Blocking Activity of Single Dose Primaquine in Cambodia|Suspended||N/A|150|Anticipated|Armed Forces Research Institute of Medical Sciences, Thailand||2||Poor efficacy of DHA-piperaquine due to likely drug resistance.|f||||t||||||||||2017-10-11 01:43:48.780416|2017-10-11 01:43:48.780416
NCT01849627|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-07-13|||August 2014|Actual|2014-08-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Eat Well for Life: A Weight Loss Maintenance Study|Eat Well for Life: A Weight Loss Maintenance Study|Active, not recruiting||N/A|345|Anticipated|University of Tennessee||2|||f||||t||||||||||2017-10-11 01:43:48.882225|2017-10-11 01:43:48.882225
NCT01849614|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-05-10|||March 2013||2013-03-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart|Prospective Pilot Study of Assessment of Breath Hold as a Means to Mitigate the Risk of Radiation-associated Reductions in Regional Cardiac Perfusion in Patients With Left-sided Breast Cancer|Completed||N/A|25|Actual|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 01:43:49.019419|2017-10-11 01:43:49.019419
NCT01849601|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2015-03-19|||December 2012||2012-12-01|November 2012|2012-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure|A Prospective, Multicenter and Single-arm Target Value Clinical Study on the Efficacy and Safety of Peripheral Balloon Dilatation Catheter in PTA Procedure|Completed||N/A|167|Actual|Acotec Scientific Co., Ltd||1|||f||||t||||||||||2017-10-11 01:43:51.005097|2017-10-11 01:43:51.005097
NCT01849588|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-03-22|2017-01-23||May 2013||2013-05-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)|A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C|Terminated||Phase 4|3|Actual|Massachusetts General Hospital|Study was terminated early due to slow accrual, therefore a small number of participants were analyzed and the data are not statistically significant.|1||Slow Accrual|f||||f||||||||No||2017-10-11 01:43:51.081261|2017-10-11 01:43:51.081261
NCT01849575|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-09-21|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|June 2021|Anticipated|2021-06-01|June 2019|Anticipated|2019-06-01||Interventional|VIPVIZA||Visualization of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention|Direct VIsualiZAtion of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention. A Population Based Pragmatic Randomised Controlled Trial Within Västerbotten Intervention Programme (VIP) and Ordinary Care.|Active, not recruiting||N/A|3813|Actual|Umeå University||2|||f||||f|f|f||||||||2017-10-11 01:43:51.357943|2017-10-11 01:43:51.357943
NCT01849562|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-09-01|2015-01-26||April 2013||2013-04-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional||The analysis population for baseline characteristics was the safety population, defined as all randomized subjects who received at least one dose of study drug.|Safety, Tolerability and Efficacy of 12-weeks of Sovaprevir, ACH-3102 and Ribavirin in Treatment-naive GT-1 HCV Subjects|A Phase 2a Trial to Evaluate the Safety, Tolerability and Efficacy of 12 Weeks of Sovaprevir, ACH-0143102 and Ribavirin in Treatment-Naive Subjects With Chronic Hepatitis C Genotype-1 Viral Infection|Completed||Phase 2|30|Actual|Achillion Pharmaceuticals||3|||f||||t||||||||||2017-10-11 01:43:51.480114|2017-10-11 01:43:51.480114
NCT01849549|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-12-06|||May 2013||2013-05-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|CORAC||Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage|Anatomical Clinical Correlations. Neuropsychological and Brain Medical Imaging Study in Brain Damaged Subjects.|Recruiting||N/A|400|Anticipated|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 01:43:52.391425|2017-10-11 01:43:52.391425
NCT01849536|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-11-21|||January 2013||2013-01-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|BIOLENS||Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients|Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients|Completed||N/A|30|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-10-11 01:43:52.495997|2017-10-11 01:43:52.495997
NCT01849523|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-09-01|||October 2013||2013-10-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|WIN||Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study|Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study (Pilot WIN-study).|Completed||N/A|20|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 01:43:52.576224|2017-10-11 01:43:52.576224
NCT01849510|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-08-09|||March 2013||2013-03-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|SPIN-MET||Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost|Efficacy of Dose Intensified Radiotherapy of Spinal Metastases of Solid Tumors by Dose Increased, Homogeneous Radiation of Vertebral Body and Simultaneous Application of Stereotactic Boost.|Recruiting||Phase 2|155|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 01:43:52.663718|2017-10-11 01:43:52.663718
NCT01849497|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-09-11|2015-09-11|2014-05-02|April 2013||2013-04-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Full analysis set (all randomized participants who received at least 1 dose of study drug).|Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen|A Multi-center, Randomized Study in Subjects With Primary Hypercholesterolemia or Mixed Dyslipidemia to Assess Subjects' Ability to Administer a Full Dose of Evolocumab (AMG 145) in Home-use, Using Either a Prefilled Syringe or a Prefilled Autoinjector/Pen|Completed||Phase 3|149|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:43:52.785604|2017-10-11 01:43:52.785604
NCT01849484|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-07-29|||March 2013||2013-03-01|July 2016|2016-07-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|HIPPO-SPARE 01||Enhancement of Neurocognitive Functions by Hippocampal Sparing Radiotherapy|Effect of Hippocampal Sparing on Neurocognitive Functions and Quality of Live in Patients Irradiated in the Neurocranial Area|Recruiting||Phase 2|150|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 01:43:53.274822|2017-10-11 01:43:53.274822
NCT01849471|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-07-29|||April 2013||2013-04-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|ECOPRO||Socioeconomic Aspects Before and After Radiation Therapy in Patient With Prostate Cancer|Evaluation of Socioeconomic Aspects Before and After Primary Radiation Therapy (Percutaneous or Interstitial or Combined Percutaneous and Interstitial) in Patients With Prostate Cancer|Recruiting||N/A|60|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-10-11 01:43:53.36148|2017-10-11 01:43:53.36148
NCT01849458|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-06-20|2016-11-29||March 2013||2013-03-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||BioFiber Scaffold Post-Market Observational Study|BioFiber and BioFiber-CM Absorbable Biologic Scaffold for Soft Tissue Repair and Reinforcement Post-Market Surveillance Clinical Study|Completed||N/A|50|Actual|Tornier, Inc.|||1||f||||f||||||||No||2017-10-11 01:43:53.482298|2017-10-11 01:43:53.482298
NCT01849445|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-06-26|||September 2013|Actual|2013-09-01|May 2015|2015-05-01|November 30, 2017|Anticipated|2017-11-30|June 2017|Anticipated|2017-06-01||Interventional|TRIO-Physio||Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study|Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study (TRIO-Physio)|Active, not recruiting||N/A|334|Actual|University of Edinburgh||2|||f||||f||||||||Undecided||2017-10-11 01:43:53.791305|2017-10-11 01:43:53.791305
NCT01849432|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-05-07|||December 2006||2006-12-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Study of Brain Circuitry in Anxiety Disorders|Probing Amygdalo-Cortical Circuitry in Anxiety Disorders|Completed||N/A|42|Actual|Mclean Hospital|||4||f||||f||||||||||2017-10-11 01:43:54.055962|2017-10-11 01:43:54.055962
NCT01849419|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-12-17|2014-05-29||July 2010||2010-07-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effects of MDMA on Social and Emotional Processing|Effects of MDMA on Social and Emotional Processing|Completed||N/A|65|Actual|University of Chicago|Behavioral measures may not have been obtained at optimal times to detect oxytocin effects. Placebo and oxytocin nasal spray formulations differed slightly. Other potential limitations are the selection of participants, or the doses administered.|1|||f||||f||||||||||2017-10-11 01:43:54.238885|2017-10-11 01:43:54.238885
NCT01849406|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2013-09-12|||April 2013||2013-04-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Nasal Steroids in Snoring Intensity|A Randomized Crossover Trial of the Effect of Nasal Steroids in Snoring Intensity|Completed||Phase 1|24|Actual|University of Athens||2|||f||||t||||||||||2017-10-11 01:43:54.798224|2017-10-11 01:43:54.798224
NCT01849393|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-12-12|||June 2013||2013-06-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents|Incentives and Technology Survey 2013: Evaluation of Acceptance of Incentive-Based Adherence Programs and Electronic Medication Monitoring Among HIV-Positive Adolescents|Completed||N/A|100|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 01:43:54.899537|2017-10-11 01:43:54.899537
NCT01849380|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-06|||June 2013||2013-06-01|May 2013|2013-05-01|June 2018|Anticipated|2018-06-01|October 2013|Anticipated|2013-10-01||Interventional|||Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer|Neoadjuvant Epirubicin-cyclophosphamide-S-1 (ECS) Versus Epirubicin-cyclophosphamide-5-FU (ECF) in Local Advanced Breast Cancer|Not yet recruiting||Phase 4|240|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-11 01:43:54.997692|2017-10-11 01:43:54.997692
NCT01849367|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2015-09-15|||May 2013||2013-05-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Trial of Bilateral tDCS for Depression||Completed||Phase 1/Phase 2|4|Actual|The University of New South Wales||2|||f||||t||||||||||2017-10-11 01:43:55.121276|2017-10-11 01:43:55.121276
NCT01849354|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-05-03|||January 2013||2013-01-01|May 2013|2013-05-01||||December 2015|Anticipated|2015-12-01|3 Years|Observational [Patient Registry]|ProEndo||Operative Treatment of Endometriosis Patients in Turku University Hospital||Unknown status|Recruiting|N/A|600|Anticipated|Turku University Hospital|||2||f||||f||||||Samples With DNA|"     Blood and urine samples. Peritoneal fluid, helthy peritoneum, endometriosis tissue and     endometrium samples.   "|||2017-10-11 01:43:55.202025|2017-10-11 01:43:55.202025
NCT01848587|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-05-12|||September 2012||2012-09-01|June 2014|2014-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|GAME||Trial of Acupuncture Pelvic and Low Back Pain in Pregnancy (Medical and Economical Assessment)|Trial of Acupuncture Pelvic and Low Back Pain in Pregnancy (TAPPP)|Completed||Phase 3|200|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:44:10.866248|2017-10-11 01:44:10.866248
NCT01849341|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2015-07-07|||July 2012||2012-07-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|ROFLU2011||Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily|Clinical Trial Phase III Blind, Parallel Group to Analyze Differences in the Safety of Roflumilast Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily|Completed||Phase 4|105|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||t||||||||||2017-10-11 01:43:55.294717|2017-10-11 01:43:55.294717
NCT01849328|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-11-18|||May 2013||2013-05-01|November 2013|2013-11-01||||May 2014|Anticipated|2014-05-01||Observational|||Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air||Unknown status|Recruiting|N/A|600|Anticipated|Rauscher, Gregory E., M.D. PA|||2||f||||f||||||||||2017-10-11 01:43:55.410055|2017-10-11 01:43:55.410055
NCT01849315|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-05-06|||September 2012||2012-09-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Physical Activity on Disease Risk Factors|Effects of an Empirically-Based Physical Activity Intervention on Chronic Disease Risk Factors in Children|Completed||N/A|13|Actual|Ohio University||2|||f||||f||||||||||2017-10-11 01:43:55.501487|2017-10-11 01:43:55.501487
NCT01849302|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-03-06|||March 2013||2013-03-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of Beverages Varying in Protein Quantity on Appetite and Energy Intake|The Acute Effect of Beverages Varying in Macro-nutrient Content on Subjective Appetite Ratings and ad Libitum Energy Intake in Healthy Subjects|Completed||N/A|36|Actual|Lund University||7|||f||||f||||||||||2017-10-11 01:43:55.575916|2017-10-11 01:43:55.575916
NCT01849289|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-03-09|2015-10-16||June 2, 2013|Actual|2013-06-02|March 2017|2017-03-01|May 15, 2014|Actual|2014-05-15|May 15, 2014|Actual|2014-05-15||Interventional|BEGIN™|The full analysis set (FAS) included all randomised subjects.|A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes|A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes (BEGIN™: ONCE)|Completed||Phase 3|833|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:43:55.73739|2017-10-11 01:43:55.73739
NCT01849276|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-09-12|||July 2013||2013-07-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|July 2018|Anticipated|2018-07-01||Interventional|||Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML|A Phase I Study of Metformin and Cytarabine for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia|Active, not recruiting||Phase 1|2|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 01:43:56.360918|2017-10-11 01:43:56.360918
NCT01849250|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-06-20|||May 2013||2013-05-01|March 2016|2016-03-01||||January 2016|Actual|2016-01-01||Interventional|||Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors|A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease|Active, not recruiting||Phase 2|14|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 01:43:56.692154|2017-10-11 01:43:56.692154
NCT01849237|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-08|||December 2012||2012-12-01|May 2013|2013-05-01|May 2015|Anticipated|2015-05-01|April 2013|Actual|2013-04-01||Interventional|||Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia|Russian Single-center Open Randomized Clinical Trial of the Impact of Mesenchymal Stromal Cells Therapy on Organ Dysfunction and 28-day Mortality in Patients With Septic Shock and Severe Neutropenia.|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|National Research Center for Hematology, Russia||2|||f||||f||||||||||2017-10-11 01:43:56.848874|2017-10-11 01:43:56.848874
NCT01849224|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2013-07-15|||May 2013||2013-05-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Randomized Trial of Exercise on Lower Extremity Edema After Lymphadenectomy in Gynecologic Cancer|Randomized Trial of Pelvic and Lower Extremity Exercise in Patients Who Underwent Pelvic Lymphadenectomy With Lower Extremity Edema-related Symptoms|Unknown status|Recruiting|Phase 3|148|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 01:43:57.490174|2017-10-11 01:43:57.490174
NCT01849211|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-09-05|||April 2013||2013-04-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Influence of Neuromuscular Block on Mask Ventilation|Influence of a Neuromuscular Block on Face Mask Ventilation Conditions During Induction of Anaesthesia|Recruiting||N/A|250|Anticipated|Kreiskrankenhaus Dormagen||1|||f||||f||||||||||2017-10-11 01:43:57.634937|2017-10-11 01:43:57.634937
NCT01849198|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-09-05|||April 2013||2013-04-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Accelerometry at the Neck: Comparison With m. Adductor Pollicis Stimulation||Completed||N/A|60|Actual|Kreiskrankenhaus Dormagen||2|||f||||f||||||||||2017-10-11 01:43:57.749368|2017-10-11 01:43:57.749368
NCT01849185|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2013-05-07|||May 2013||2013-05-01|May 2013|2013-05-01|March 2014|Anticipated|2014-03-01|January 2014|Anticipated|2014-01-01||Interventional|||Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia||Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 01:43:57.845788|2017-10-11 01:43:57.845788
NCT01849172|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2016-10-30|||June 2013||2013-06-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect and Safety of Electroacupuncture for Symptoms of Menopausal Transition|Effect and Safety of Electroacupuncture for Symptoms of Menopausal Transition —a Multicenter Randomized Controlled Trial|Completed||Phase 2|360|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||No||2017-10-11 01:43:57.957974|2017-10-11 01:43:57.957974
NCT01849159|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-10-26|||March 2014||2014-03-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema|Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Federal Research Clinical Center of Federal Medical & Biological Agency, Russia||2|||f||||t||||||||||2017-10-11 01:43:58.072344|2017-10-11 01:43:58.072344
NCT01849146|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-09-12|||August 19, 2013|Actual|2013-08-19|September 2017|2017-09-01||||August 15, 2018|Anticipated|2018-08-15||Interventional|||WEE1 Inhibitor AZD1775, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma|Phase I Study of AZD1775 (MK-1775) With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma and Evaluation of Intratumoral Drug Distribution in Patients With Recurrent Glioblastoma|Recruiting||Phase 1|36|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 01:43:58.203608|2017-10-11 01:43:58.203608
NCT01849133|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-05|2013-05-05|||November 2000||2000-11-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ELIOT||Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy|Randomized Clinical Trial: Comparison Between Quadrantectomy Followed by External Fractionated Radiotherapy and Quadrantectomy Associated With Intraoperative Radiotherapy in Women >= 48 Years of Age Affected by Early-stage Breast Carcinoma.|Completed||N/A|1305|Actual|European Institute of Oncology||2|||f||||f||||||||||2017-10-11 01:43:58.40874|2017-10-11 01:43:58.40874
NCT01849120|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2017-04-12|||May 2013||2013-05-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery|Does Near Infrared Spectroscopy Predict Low Cardiac Output State in Neonates and Infants Following Cardiac Surgery for Congenital Heart Disease?|Completed||N/A|35|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 01:43:58.535511|2017-10-11 01:43:58.535511
NCT01849107|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2013-05-05|||April 2013||2013-04-01|May 2013|2013-05-01||||December 2013|Anticipated|2013-12-01||Interventional|||Plasma Citrulline: A Marker for Monitoring & Quantifying Radiation-Induced Small Bowel Toxicity||Unknown status|Recruiting|N/A|50|Anticipated|Asan Medical Center||1|||f||||||||||||||2017-10-11 01:43:58.6229|2017-10-11 01:43:58.6229
NCT01849094|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2015-01-12|||May 2013||2013-05-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone||Completed||Phase 1/Phase 2|9|Actual|The Alfred||3|||f||||f||||||||||2017-10-11 01:43:58.728006|2017-10-11 01:43:58.728006
NCT01849081|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-10-30|||July 2016||2016-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver|Evaluating the Efficacy of CPAP Therapy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)|Not yet recruiting||Phase 2/Phase 3|40|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 01:43:58.854163|2017-10-11 01:43:58.854163
NCT01849068|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-03-14|2016-02-15||June 2013||2013-06-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|June 2015|Actual|2015-06-01||Interventional|EZEmRNA||Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study|Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study|Completed||Phase 3|20|Actual|Laval University||2|||f||||f||||||||||2017-10-11 01:43:58.95632|2017-10-11 01:43:58.95632
NCT01849042|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2014-08-12|||January 2013||2013-01-01|August 2014|2014-08-01|August 2015|Anticipated|2015-08-01|August 2014|Anticipated|2014-08-01||Interventional|ROMEO-AD||Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease|A Multicenter, Randomized, Open-label, Prospective Study to Estimate the add-on Effects of Memantine as Ebixa Oral Pump on Language in Moderate to Severe Alzheimer's Disease Patients Already Receiving Donepezil.|Unknown status|Recruiting|Phase 4|188|Anticipated|Konkuk University Medical Center||2|||f||||t||||||||||2017-10-11 01:43:59.456088|2017-10-11 01:43:59.456088
NCT01849029|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2017-08-17|||October 15, 2013|Actual|2013-10-15|August 2017|2017-08-01|July 30, 2017|Actual|2017-07-30|March 30, 2017|Actual|2017-03-30||Interventional|||Cognitive Processing Intervention for Trauma, HIV/STI Risks, and Substance Use Among Native Women|Cognitive Processing Intervention for HIV/STI and Substance Use Among Native Women|Completed||N/A|60|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 01:43:59.571432|2017-10-11 01:43:59.571432
NCT01849016|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2016-06-30|||April 2013||2013-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|NAC||N-Acetylcysteine in Patients With Sickle Cell Disease|N-Acetylcysteine in Patients With Sickle Cell Disease - Reducing the Incidence of Daily Life Pain|Completed||Phase 3|96|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 01:43:59.700253|2017-10-11 01:43:59.700253
NCT01849003|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-06|2014-11-13|||May 2013||2013-05-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study of the Effect of GS-6615 in Subjects With LQT-3|An Open-label Study to Evaluate the Effect of Single Dose GS-6615 on QT, Safety and Tolerability in Subjects With Long QT-3 Syndrome|Completed||Phase 1|24|Actual|Gilead Sciences||6|||f||||f||||||||||2017-10-11 01:43:59.855886|2017-10-11 01:43:59.855886
NCT01848990|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-10-23|2014-10-23||March 2013||2013-03-01|October 2014|2014-10-01|August 2015|Anticipated|2015-08-01|February 2014|Actual|2014-02-01||Interventional||All participants who received at least one dose of study drug.|CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)|CONtinuous Subcutaneous Insulin Infusion STudy ENrolling Type 1 (CONSISTENT 1): Evaluation of Metabolic Outcomes and Safety of Hylenex Recombinant (Hyaluronidase Human Injection) Used as a Preadministration Infusion Site Treatment in Subjects With Type 1 Diabetes (T1DM) Using Continuous Subcutaneous Insulin Infusion (CSII)|Unknown status|Active, not recruiting|Phase 4|456|Actual|Halozyme Therapeutics||3|||f||||f||||||||||2017-10-11 01:44:00.009669|2017-10-11 01:44:00.009669
NCT01848977|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2015-01-09|2014-12-02||January 2013||2013-01-01|January 2015|2015-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Comparison of Two Devices Using Near-infra Red Spectroscopy During a Vascular Occlusion Test|Comparison of Two Devices Using Near-infra Red Spectroscopy for the Measurement of Tissue Oxygenation During a Vascular Occlusion Test (INVOS® Versus Inspectra™)|Completed||N/A|20|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:44:02.10304|2017-10-11 01:44:02.10304
NCT01848964|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2015-05-28|||April 2013||2013-04-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||Analyzing Stump-socket Interface Pressure to Improve Gait in Above-knee Amputee|Peut-on améliorer la Marche de l'amputé fémoral en Guidant la Correction prothétique Par l'Analyse Des Pressions Dans l'emboîture ?|Completed||Phase 1/Phase 2|80|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 01:44:02.321074|2017-10-11 01:44:02.321074
NCT01848951|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-12-16|||February 2014||2014-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Comparison of Epidural and TAP Block in Abdominal Surgery|Comparison of Epidural Analgesia With Bilateral Dual TAP Infiltration Block With Liposomal Bupivacaine in Patients With Major Abdominal Surgery|Completed||N/A|72|Actual|University of Nebraska|||2||f||||t||||||||||2017-10-11 01:44:02.400349|2017-10-11 01:44:02.400349
NCT01848938|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-02-21|2016-10-17||March 2013||2013-03-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Treatment of Stress Urinary Incontinence Via Smartphone|Treatment of Stress Urinary Incontinence Via Smartphone|Completed||N/A|123|Actual|Umeå University||2|||f||||f||||||||No||2017-10-11 01:44:02.496582|2017-10-11 01:44:02.496582
NCT01848925|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-12-02|||May 2013||2013-05-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Study of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients|A Phase I Open-label, Randomized, Safety and Efficacy Study of SANGUINATE™ at Two Doses Levels Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients.|Completed||Phase 1|24|Actual|Prolong Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:44:03.127086|2017-10-11 01:44:03.127086
NCT01848912|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-06-09|||March 2013||2013-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|THRRIVES||Temperature, Heart and Respiratory Rate Investigation Along With Variability Evaluation and Serum Biomarkers (THRRIVES)|Temperature, Heart and Respiratory Rate Investigation Along With Variability Evaluation and Serum Biomarkers (THRRIVES)|Active, not recruiting||N/A|86|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||Samples Without DNA|"     blood serum   "|Undecided||2017-10-11 01:44:03.228911|2017-10-11 01:44:03.228911
NCT01848899|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-03-07|2016-01-29||February 2013||2013-02-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|||Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography|The Assesment of Thrombotic Markers Utilizing Ionic Versus Non-Ionic Contrast During Coronary Angiography and Intervention (AToMIC) Trial|Completed||Phase 4|100|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 01:44:03.32541|2017-10-11 01:44:03.32541
NCT01848886|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-07-05|||May 2013||2013-05-01|July 2016|2016-07-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|NEO||Neurological Complications Comparing Endoscopically vs. Open Harvest of the Radial Artery|Endoscopic Versus Open Radial Artery Harvest and Mammario-radial Versus Aorto-radial Grafting in Patients Undergoing Coronary Artery Bypass Surgery (The 2x2 Factorial Designed Randomised NEO Trial)|Recruiting||N/A|300|Anticipated|Rigshospitalet, Denmark||4|||f||||t||||||||||2017-10-11 01:44:03.732632|2017-10-11 01:44:03.732632
NCT01848873|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2013-05-07|||January 2013||2013-01-01|May 2013|2013-05-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine|Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension and Hyperhomocysteinemia ：a Double-blind Randomized Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|756|Anticipated|Shenzhen Ausa Pharmed Co.,Ltd||3|||f||||t||||||||||2017-10-11 01:44:03.874|2017-10-11 01:44:03.874
NCT01848860|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-04|2015-07-05|||May 2013||2013-05-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Absorbable Mesh Pleurodesis in Thoracoscopic Treatment of Spontaneous Pneumothorax|Thoracoscopic Bullectomy With Absorbable Mesh Coverage of the Staple Line Versus Thoracoscopic Bullectomy Only for the Treatment of Primary Spontaneous Pneumothorax: a Single-blind, Parallel-group, Prospective, Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|204|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:44:04.035773|2017-10-11 01:44:04.035773
NCT01848847|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-10-28|2013-07-26||April 2013||2013-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Relationship Between Bladder Distention and Hysteroscopy Application|The Impact of Bladder Distention on Execution of Diagnostic Hysteroscopy Procedure; a Randomised Controlled Trial.|Completed||N/A|102|Actual|Namik Kemal University|difficulties in introduction of hysteroscopy|2|||f||||f||||||||||2017-10-11 01:44:04.146883|2017-10-11 01:44:04.146883
NCT01848834|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-04-07|2017-04-07||May 7, 2013|Actual|2013-05-07|April 2017|2017-04-01|January 17, 2018|Anticipated|2018-01-17|April 26, 2016|Actual|2016-04-26||Interventional||The baseline analysis population consisted of all participants who received at least one dose of study treatment. One additional participant was enrolled in Cohort B, but did not receive any study treatment.|Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012)|A Phase Ib Multi-Cohort Study of MK-3475 in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|297|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 01:44:04.53372|2017-10-11 01:44:04.53372
NCT01848808|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-04-01|||April 2013||2013-04-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|WO||The Effect of Wobenzym PS on Inflammation|The Effect of Wobenzym PS on Inflammation|Completed||N/A|27|Actual|Laval University||2|||f||||f||||||||||2017-10-11 01:44:08.086485|2017-10-11 01:44:08.086485
NCT01848795|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2015-03-23|||May 2013||2013-05-01|March 2015|2015-03-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||EndoBarrier Versus Intragastric Balloon in Obese Diabetic Patients|Study of Metabolic Effects of EndoBarrier Versus Intragastric Balloon in Obese Patients With Type 2 Diabetes.|Recruiting||Phase 4|90|Anticipated|The Mediterranean Institute for Transplantation and Advanced Specialized Therapies||2|||f||||f||||||||||2017-10-11 01:44:08.193352|2017-10-11 01:44:08.193352
NCT01848782|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-09-08|||June 2013||2013-06-01|April 2013|2013-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|ILMARI 2||Impact of Adding a Limitation Section in Abstract of Systematic Review|Impact of Adding a Limitation Section in Abstract of Systematic Review on Interpretation by Readers: a Randomised Controlled Trial|Completed||N/A|300|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:44:08.312836|2017-10-11 01:44:08.312836
NCT01848769|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-03-28|||September 2009||2009-09-01|March 2017|2017-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|PAED1||Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old|A Single-dose, Open-Label, 2-Way Cross-Over, Clinical Pharmacology Study Of Chf 1535 50/6 HFA pMDI (Fixed Combination Of Beclomethasone Dipropionate 50µg Plus Formoterol Fumarate 6 µg) Using The Aerochamber Plus™ Spacer Device Versus The Free Combination Of Beclomethasone HFA pMDI And Formoterol HFA pMDI Available On The Market Using The Aerochamber Plus™ Spacer Device In Asthmatic Children|Completed||Phase 2|20|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 01:44:08.402905|2017-10-11 01:44:08.402905
NCT01848756|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-12-15|2016-04-01||April 2013||2013-04-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers|A Single Arm, Phase 1/2 Study of SNX-5422 in Subjects With Selected HER2 Positive Cancers.|Terminated||Phase 1/Phase 2|15|Actual|Esanex Inc.||1||Business reasons|f||||f||||||||||2017-10-11 01:44:08.555374|2017-10-11 01:44:08.555374
NCT01848743|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2014-09-12|||April 2013||2013-04-01|September 2014|2014-09-01|October 2016|Anticipated|2016-10-01|April 2016|Anticipated|2016-04-01||Interventional|HBSAE||Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation|Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation|Unknown status|Recruiting|Phase 3|120|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-11 01:44:08.965332|2017-10-11 01:44:08.965332
NCT01848730|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-10-29|||April 2013||2013-04-01|January 2014|2014-01-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia|A Randomised Double-blind Crossover Study to Compare the Efficacy and Safety of CNV2197944 75 mg Tid Versus Placebo in Patients With Post-herpetic Neuralgia|Completed||Phase 2|103|Actual|Convergence Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:44:09.07433|2017-10-11 01:44:09.07433
NCT01848717|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-05-03|||November 2012||2012-11-01|May 2013|2013-05-01||||December 2013|Anticipated|2013-12-01||Interventional|||Evaluate the Efficacy and Safety of MINTLIFT® Group for Nasolabial Fold|A Single‐Center, Single Arm, Pre-post Test Design, Open Clinical Study to Evaluate the Efficacy and Safety of MINTLIFT® Group for Nasolabial Fold|Unknown status|Recruiting|N/A|62|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||1|||f||||||||||||||2017-10-11 01:44:09.160734|2017-10-11 01:44:09.160734
NCT01848704|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-07-26|||May 2013||2013-05-01|April 2013|2013-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|SPIIN||"Impact of Spin on the Interpretation of Results of Randomized Trials in the Field of Cancer"|"Impact of Spin on the Interpretation of Results of Randomized Trials in the Field of Cancer"|Completed||N/A|300|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:44:09.240822|2017-10-11 01:44:09.240822
NCT01848691|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-05-29|||October 2012||2012-10-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without Hemolysis|Phase 1 Study of Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without Hemolysis|Completed||N/A|40|Actual|Children's Hospital & Research Center Oakland||2|||f||||f||||||||||2017-10-11 01:44:09.326925|2017-10-11 01:44:09.326925
NCT01848665|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-01-11|||May 2013||2013-05-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||The Influence of Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Passive Heat Stress|The Influence of Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Passive Heat Stress|Active, not recruiting||Phase 4|10|Anticipated|Brock University||2|||f||||||||||||||2017-10-11 01:44:09.416469|2017-10-11 01:44:09.416469
NCT01848652|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2015-07-13|||October 2013||2013-10-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MYLY||Phase II Study Evaluating a Combination of Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy With High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine.|Phase II Study Evaluating the Combination Pegylated Liposomal Doxorubicin and Dexamethasone for the Treatment of Immunocompetent Patients With Cerebral Lymphoma Relapsed or Refractory to First-line Chemotherapy Containing High Dose Methotrexate (MTXHD) and / or High-dose Cytarabine.|Terminated||Phase 2|5|Actual|University Hospital, Brest||1||"The laboratory's partner on this study decides to terminate the contract with the CHRU Brest,   because of the difficulty of the recruitment."|f||||t||||||||||2017-10-11 01:44:09.513313|2017-10-11 01:44:09.513313
NCT01848639|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-05-04|||June 2013||2013-06-01|May 2017|2017-05-01|June 2024|Anticipated|2024-06-01|June 2023|Anticipated|2023-06-01||Interventional|ALCHEMIST||ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial|ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST), Phase III b|Recruiting||Phase 3|825|Anticipated|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 01:44:10.076914|2017-10-11 01:44:10.076914
NCT01848626|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2014-07-14|||April 2013||2013-04-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Observational|||Study With Advanced Vaginal Tactile Imager|Study With Advanced Vaginal Tactile Imager|Completed||N/A|22|Actual|Artann Laboratories|||1||f||||f||||||||||2017-10-11 01:44:10.608353|2017-10-11 01:44:10.608353
NCT01848613|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-07-19|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|VIVOS||Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC|Randomized Cross-over Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC. A Phase IV Study.|Active, not recruiting||Phase 4|120|Anticipated|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori||2|||f||||f||||||||||2017-10-11 01:44:10.666305|2017-10-11 01:44:10.666305
NCT01848600|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-04-17|||April 2013||2013-04-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|ILMARI||Impact of a Limitation Section on the Meta-analysis Results' Interpretation|Impact of a Limitation Section on the Meta-analysis Results' Interpretation: a Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Assistance Publique - Hôpitaux de Paris||2||Lack of funding|f||||f||||||||||2017-10-11 01:44:10.781198|2017-10-11 01:44:10.781198
NCT01848574|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-09-24|||February 2012||2012-02-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|SUPER4||Satisfaction Understanding of Patients and Relatives in Emergency Room|Satisfaction Understanding of Patients and Relatives in Emergency Room|Completed||N/A|1816|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:44:10.95811|2017-10-11 01:44:10.95811
NCT01848548|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-06-02|||April 2013||2013-04-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study|Superior Laryngeal Nerve Block For Airway Anesthesia Efficacy Study|Suspended||N/A|95|Anticipated|Wake Forest University Health Sciences|||1|Unable to reliable recruit subjects|f||||f|f|f||||||||2017-10-11 01:44:13.036504|2017-10-11 01:44:13.036504
NCT01848535|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-11-19|||May 2013||2013-05-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|GOS||Effect of GOS Supplementation on Amoxicillin-treated Gut Microbiota From Healthy Adults|Effect of Galacto-Oligosaccharides Supplementation on Amoxicillin-treated Gut Microbiota From Healthy Adults : a Proof of Principal Study|Completed||N/A|12|Actual|Wageningen University||2|||f||||t||||||||||2017-10-11 01:44:13.112744|2017-10-11 01:44:13.112744
NCT01848522|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2014-07-25|||October 2012||2012-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Observational|EMCIQUAL||Creation and Setting up of Therapeutic Programs, Interprofessional Communication, Patients' Education and Counseling|Creation and Setting up of Therapeutic Programs, Interprofessional Communication, Patients' Education and Counseling: a Qualitative Study in 3 Physical Therapy and Rehabilitation Departments|Completed||N/A|63|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 01:44:13.201672|2017-10-11 01:44:13.201672
NCT01848509|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-12-03|||April 2013||2013-04-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|Respir@dom||Telemedicine for Sleep Apnea Patients|A Telemedicine System for the Follow-up of Patients With SAS|Completed||N/A|201|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:44:13.282411|2017-10-11 01:44:13.282411
NCT01848496|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2013-05-03|||January 2012||2012-01-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Clinical Trial of Two Techniques for Gingival Displacement|A Double-blind Randomized Clinical Trial of Two Techniques for Gingival Displacement|Completed||Phase 1|22|Actual|Federal University of Pelotas||2|||f||||f||||||||||2017-10-11 01:44:13.369658|2017-10-11 01:44:13.369658
NCT01848483|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-07-27|||June 2014||2014-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Living Well Project for Persons With AIDS|The Living Well Project: Early Palliative Care and Motivational Interviewing (MI) for Persons With AIDS|Completed||N/A|121|Actual|Emory University||2|||f||||t||||||||||2017-10-11 01:44:13.44795|2017-10-11 01:44:13.44795
NCT01848470|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-05-03|||May 2010||2010-05-01|May 2013|2013-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Multiple Ascending Doses Study of CG400549|Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of Multiple Ascending Doses of CG400549 in Healthy Volunteers|Completed||Phase 1|32|Actual|CrystalGenomics, Inc.||8|||f||||f||||||||||2017-10-11 01:44:13.544099|2017-10-11 01:44:13.544099
NCT01848457|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-07-03|||April 2013||2013-04-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|December 2016|Actual|2016-12-01||Interventional|||Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy|Pilot Study to Prevent Nephrotoxicity of High-Dose Methotrexate by Prolonging the Infusion Duration and Prevent Nephrotoxicity and Ototoxicity of Cisplatin With Pantoprazole in Children, Adolescents and Young Adults With Osteosarcoma|Active, not recruiting||Phase 2|13|Actual|Children's Hospital of Philadelphia||4|||f||||f||||||||||2017-10-11 01:44:13.701134|2017-10-11 01:44:13.701134
NCT01848444|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-10-08|||October 2013||2013-10-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|Conta-Lait||Levels of Contaminants in Human Milk|Evaluation of Different Chemical Substances in the Milk of Breastfed Infant|Completed||N/A|187|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     4*200 ml of breastmilk homogenizated and frozen -18° Celsius in the milk bank   "|||2017-10-11 01:44:13.830936|2017-10-11 01:44:13.830936
NCT01848431|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-12-04|||May 2013||2013-05-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Randomized Study on the Effects of Moderate Anaemia in Free Microvascular Tissue Transfer|Randomized Study on the Effects of Moderate Anaemia in Free Microvascular Tissue Transfer|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Zurich|||2||f||||t||||||Samples Without DNA|"     Blood analysis   "|||2017-10-11 01:44:13.924991|2017-10-11 01:44:13.924991
NCT01848418|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-06-27|||January 2013||2013-01-01|June 2016|2016-06-01|September 2018|Anticipated|2018-09-01|February 2018|Anticipated|2018-02-01||Observational|SCISCIF||Conception of an ICF Core Set for Systemic Sclerosis|Conception of an ICF Core Set for Systemic Sclerosis|Recruiting||N/A|130|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-11 01:44:14.018992|2017-10-11 01:44:14.018992
NCT01848392|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-07-31|||February 21, 2013|Actual|2013-02-21|July 2017|2017-07-01|March 30, 2016|Actual|2016-03-30|July 30, 2014|Actual|2014-07-30||Observational|MUCO-DAP||Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.|Extra Pulmonary Determinants of Physical Activity in Adults With Cystic Fibrosis.|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 01:44:14.123748|2017-10-11 01:44:14.123748
NCT01848379|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-06-30|||January 2012||2012-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DMS||White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis|Human Polymorphonuclear Neutrophil (PMN) Cytosolic Signaling and Effector Functions in Patients With Diabetes Mellitus Type 2 and Periodontitis|Active, not recruiting||N/A|45|Anticipated|Zentrum fuer Zahn-, Mund- und Kieferheilkunde||3|||f||||t||||||||||2017-10-11 01:44:14.209764|2017-10-11 01:44:14.209764
NCT01848366|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-10-13|2016-08-12||May 2013||2013-05-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|OAB||Utilization of the BIOWAVE Device to Treat Overactive Bladder|Biowave Overactive Bladder (OAB) Trial|Completed||N/A|8|Actual|William Beaumont Hospitals|Due to the small number of subjects enrolled, the results of this preliminary study are limited and not generalizable.|1|||f||||f||||||||No|There is no plan to share individual participant data|2017-10-11 01:44:14.376095|2017-10-11 01:44:14.376095
NCT01848353|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-08-21|||May 2013||2013-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|April 2017|Actual|2017-04-01||Interventional|MOVE||Financial Incentives to Exercise for Adolescents|Incentivizing Behavior: Promoting More Physical Activity in American Indian Youth|Active, not recruiting||N/A|142|Actual|University of Oklahoma||8|||f||||f||||||||||2017-10-11 01:44:14.62641|2017-10-11 01:44:14.62641
NCT01848340|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-10-31|||May 2013||2013-05-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects|An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects|Completed||Phase 1|16|Actual|ViiV Healthcare||3|||f||||f||||||||||2017-10-11 01:44:14.749806|2017-10-11 01:44:14.749806
NCT01848327|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-03-02|||February 2013||2013-02-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis|A Randomized Double-Blind Placebo-Controlled Study of Caprylic Triglyceride for Cognitive Impairment in Subjects With Multiple Sclerosis.|Recruiting||N/A|158|Anticipated|University of Miami||2|||f||||t||||||||Yes|Via Publications|2017-10-11 01:44:14.877341|2017-10-11 01:44:14.877341
NCT01848314|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-06-04|||April 2013||2013-04-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Effect of Renal Denervation on Renal Flow in Humans|The Effect of Renal Denervation on Renal Flow in Humans|Completed||N/A|15|Actual|UMC Utrecht||1|||f||||f||||||||||2017-10-11 01:44:14.989847|2017-10-11 01:44:14.989847
NCT01848301|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-09-01|||September 2012||2012-09-01|September 2017|2017-09-01|May 1, 2017|Actual|2017-05-01|September 2014|Actual|2014-09-01||Interventional|||Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation|Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation|Terminated||Phase 1|12|Actual|University of Pittsburgh||1||loss of funding|f||||t||||||||||2017-10-11 01:44:15.332007|2017-10-11 01:44:15.332007
NCT01848288|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-03-18|2015-02-27||July 2013||2013-07-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||This reporting group includes all participants randomized to a surgical system.|Intra-Operative Metrics With CENTURION® and INFINITI® Vision Systems|Intra-Operative Metrics and Clinical Outcomes After Cataract Surgery With the CENTURION® Vision System and the INFINITI® Vision System|Completed||N/A|112|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:44:15.429316|2017-10-11 01:44:15.429316
NCT01848275|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-07-13|||March 2011|Actual|2011-03-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Full Length Versus Proximal Renal Arteries Ablation|The Clinical Efficacy Comparison of Two Renal Sympathetic Denervation Strategies ---- Full Length Versus Proximal Renal Arteries Ablation|Completed||N/A|47|Actual|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||||2017-10-11 01:44:15.644699|2017-10-11 01:44:15.644699
NCT01848262|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-02-09|||June 2013||2013-06-01|February 2014|2014-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|ECALMIST||ECALMIST Versus InSurE in Preterm Infant < 32 Weeks,Multicenter, Multinational RCT|ECALMIST (Early CPAP And Large Volume Minimal Invasive Surfactant Therapy) Versus InSurE (Intubate, Surfactant, Extubate) in Preterm Infants With Respiratory Distress Syndrome (RDS): Prospective Randomised Control Clinical Trial|Unknown status|Recruiting|N/A|100|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-11 01:44:15.737202|2017-10-11 01:44:15.737202
NCT01848249|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-06-21|||May 2010||2010-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|DDS||Deceased Donor Biomarkers and Recipient Outcomes|Deceased Donor Urinary Biomarkers to Predict Kidney Transplant Outcomes|Active, not recruiting||N/A|1679|Anticipated|Yale University|||2||f||||f||||||Samples Without DNA|"     ((A)) Urine Samples: At time of deceased donor nephrectomy ((B)) Perfusates: At time of     initiation and stopping of machine perfusion   "|||2017-10-11 01:44:15.934895|2017-10-11 01:44:15.934895
NCT01848236|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-01-12|||August 2010||2010-08-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of Vitamin D Insufficiency in Man|Effects of Vitamin D Insufficiency in Man|Recruiting||Early Phase 1|300|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:44:16.119178|2017-10-11 01:44:16.119178
NCT01848223|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-05-02|||November 2012||2012-11-01|May 2013|2013-05-01|December 2016|Anticipated|2016-12-01|May 2014|Anticipated|2014-05-01||Observational|QoL||The Quality of Life in Late Menopause|The Quality of Life in Late Menopause. A Seventeen Years Follow-up Study.|Unknown status|Recruiting|N/A|64|Anticipated|Turku University Hospital|||1||f||||f||||||||||2017-10-11 01:44:16.489198|2017-10-11 01:44:16.489198
NCT01848210|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-09-21|2016-09-21||May 2013||2013-05-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||ITT population included all eligible participants who received study drug and had at least one efficacy assessment at Visit 1 (28 ± 5 days after start of treatment).|Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency|Evaluation of Efficacy and Safety of the Fixed-dose Combination of Coumarin and Troxerutin (Venalot®) Versus Placebo in the Symptomatic Treatment of Chronic Venous Insufficiency - VENACT|Completed||Phase 4|829|Actual|Takeda||2|||f||||f||||||||||2017-10-11 01:44:16.580018|2017-10-11 01:44:16.580018
NCT01848197|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-05-06|||May 2013||2013-05-01|May 2013|2013-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|PATEN||Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer|An Open, Randomized, Parallel-group, Multicenter Clinical Study to Evaluate Efficacy and Safety of Paclitaxel Every 2 Weeks Compared Weekly in Adjuvant Treatment of Breast Cancer|Not yet recruiting||N/A|1000|Anticipated|Taizhou Hospital||2|||f||||||||||||||2017-10-11 01:44:17.017779|2017-10-11 01:44:17.017779
NCT01848171|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-04-25|||July 2013||2013-07-01|April 2017|2017-04-01|July 2023|Anticipated|2023-07-01|July 2023|Anticipated|2023-07-01||Interventional|||Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism|Effects of Long-term L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Patients With Hypothyroidism|Active, not recruiting||Phase 4|700|Anticipated|Shandong Provincial Hospital||2|||f||||t||||||||||2017-10-11 01:44:17.213163|2017-10-11 01:44:17.213163
NCT01848158|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-12-08|||March 2013||2013-03-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care Unit|Safety, Feasibility & Effectiveness of Acupuncture as an Adjunct to Pharmacologic Treatment for Sedation and Analgesia in Mechanically Ventilated PICU Patients - A Pilot Study|Completed||N/A|17|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 01:44:17.306878|2017-10-11 01:44:17.306878
NCT01848145|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-05-03|2016-11-22||July 2013||2013-07-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Interventional|||Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia|Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia, a Phase II Trial|Completed||Phase 2|34|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 01:44:17.547438|2017-10-11 01:44:17.547438
NCT01848132|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-06-08|||October 3, 2013|Actual|2013-10-03|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.|Multicenter Randomized Phase II Study of Treatment With R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.|Active, not recruiting||Phase 2|121|Anticipated|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||2|||f||||f|f|f||||||No||2017-10-11 01:44:18.060111|2017-10-11 01:44:18.060111
NCT01848119|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-10-09|||May 2013||2013-05-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Does a Perioperative Course of Gabapentin Improve Analgesia After Cesarean Delivery?|Does a Perioperative Course of Gabapentin Improve Analgesia After Cesarean Delivery? A Randomised, Double-blind, Placebo Controlled Trial|Completed||N/A|204|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 01:44:18.250671|2017-10-11 01:44:18.250671
NCT01848106|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-10-22|||September 2013||2013-09-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|Regulate||A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI|A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention|Terminated||Phase 3|3232|Actual|Regado Biosciences, Inc.||2||Clinical Hold|f||||t||||||||||2017-10-11 01:44:18.357383|2017-10-11 01:44:18.357383
NCT01848093|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-11-14|||December 2008||2008-12-01|May 2013|2013-05-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|mucinCOPDex||Mucin Concentration in Sputum From COPD Patients During a Pulmonary Exacerbation|Molekularbiologische Eigenschaften Des Sputums während Einer Pulmonalen COPD Exacerbation|Withdrawn||N/A|0|Actual|Philipps University Marburg Medical Center|||1||f||||f||||||Samples Without DNA|"     sputum   "|||2017-10-11 01:44:18.465296|2017-10-11 01:44:18.465296
NCT01848080|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-05-17|||June 2013||2013-06-01|May 2016|2016-05-01||||October 2017|Anticipated|2017-10-01||Interventional|||A Randomized, Non-inferiority Clinical Trial of CVA Telerehabilitation Treatments - TelePhysioTaiChi|A Tai Chi Based Exercise Program Provided Via Telerehabilitation Compared to During Home Visits in Persons Post-Stroke Who Have Returned Home Without Intensive Rehabilitation: A Randomized, Non-inferiority Clinical Trial|Recruiting||N/A|240|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 01:44:18.556894|2017-10-11 01:44:18.556894
NCT01848067|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-10-18|||August 2013||2013-08-01|October 2016|2016-10-01||||May 2018|Anticipated|2018-05-01||Interventional|||Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer|A Phase I/II Study of Alisertib in Combination With Abiraterone and Prednisone for Patients With Castration-Resistant Prostate Cancer After Progression on Abiraterone|Active, not recruiting||Phase 1/Phase 2|9|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 01:44:18.679217|2017-10-11 01:44:18.679217
NCT01848054|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-04-03|2015-04-10||June 2013||2013-06-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence|A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence|Completed||Phase 3|313|Actual|Orexo AB||2|||f||||f||||||||||2017-10-11 01:44:18.839488|2017-10-11 01:44:18.839488
NCT01848041|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2016-01-12|||May 2013||2013-05-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis|A Randomized, Double-Masked, Placebo-Controlled Phase 1/2a Study of the Efficacy and Safety of Two Dosing Regimens of RVL-1201 in the Treatment of Acquired Blepharoptosis|Completed||Phase 1/Phase 2|46|Actual|RevitaLid Inc.||3|||f||||f||||||||||2017-10-11 01:44:19.463822|2017-10-11 01:44:19.463822
NCT01848028|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2016-09-06|||January 2008||2008-01-01|September 2016|2016-09-01|July 2026|Anticipated|2026-07-01|December 2025|Anticipated|2025-12-01|10 Years|Observational [Patient Registry]|||PsoBest - The German Psoriasis Registry|Long-Term Benefits and Safety of Systemic Psoriasis Therapy: German Registry on the Treatment of Psoriasis With Biologics and Systemic Therapeutics|Recruiting||N/A|3500|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||15||f||||f||||||||Undecided||2017-10-11 01:44:19.559829|2017-10-11 01:44:19.559829
NCT01848015|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2015-05-17|||June 2013||2013-06-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer|Prediction of Recurrence in Advanced Gastric Cancer After Radical Resection by Circulating Tumor Cells （CTCs）|Unknown status|Recruiting|N/A|200|Anticipated|Peking University|||1||f||||||||||||||2017-10-11 01:44:19.714301|2017-10-11 01:44:19.714301
NCT01848002|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-11-25|||May 2003||2003-05-01|November 2013|2013-11-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers|A Randomized, Placebo-Controlled, Double-Blind, Multi-dose Study of the Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:44:19.787107|2017-10-11 01:44:19.787107
NCT01847989|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-01-10|||January 2003||2003-01-01|January 2017|2017-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers|A Randomized, Placebo-controlled Single-dose, Double-blind Study of the Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers|Completed||Phase 1|50|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:44:19.874899|2017-10-11 01:44:19.874899
NCT01847976|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2017-04-03|||August 2013||2013-08-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|OTT12-05||Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer|A Phase 2 Trial Exploring the Clinical and Correlative Effects of Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer|Active, not recruiting||Phase 2|37|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||No||2017-10-11 01:44:19.96657|2017-10-11 01:44:19.96657
NCT01847963|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-12-30|||June 2012||2012-06-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|SVMKK||A Clinical Study to Evaluate the Efficacy of Two Siddha Drugs Sindhuvallathy Mezhugu and Kalladaippu Kudineer for Kidney Stones|Standardization and Clinical Evaluation of Siddha Formulations for Urolithiasis /Kalladaippu.|Completed||N/A|120|Actual|Tamil Nadu Dr.M.G.R.Medical University||3|||f||||f||||||||||2017-10-11 01:44:20.122553|2017-10-11 01:44:20.122553
NCT01847950|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2013-05-06|||November 2012||2012-11-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effects of scFOS on Stool Frequency in People With Functionnal Constipation|Randomized, Placebo-controlled Double-blind Study to Evaluate the Effects of Fructo-oligosachharides on Increase of Stool Frequency in Constipated People|Unknown status|Recruiting|N/A|120|Anticipated|Syral||2|||f||||f||||||||||2017-10-11 01:44:20.249735|2017-10-11 01:44:20.249735
NCT01847937|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-02-02|||May 2013||2013-05-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy|Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy|Completed||N/A|115|Actual|Aarhus University Hospital|||6||f||||t||||||Samples Without DNA|"     Blood sample less then 250ml to determine Hba1c (blood glucose level).   "|||2017-10-11 01:44:20.342643|2017-10-11 01:44:20.342643
NCT01847924|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-03|2013-05-07|||March 2013||2013-03-01|May 2013|2013-05-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|NEURITES||NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects|NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects : a Pilot Double Blind, Placebo-controlled Randomized Trial on Efficacy and Safety (NEURITES) Study|Unknown status|Recruiting|Phase 2|100|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 01:44:20.451482|2017-10-11 01:44:20.451482
NCT01847911|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-04-03|||November 2015||2015-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Self-directed Video Versus Instructor-based Neonatal Resuscitation Training|Self-directed Video Versus Instructor-based Neonatal Resuscitation Training of Novice Providers. A Controlled Blinded Randomized Non-inferiority Multicenter Study|Recruiting||N/A|252|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 01:44:20.772558|2017-10-11 01:44:20.772558
NCT01847898|ClinicalTrials.gov processed this data on October 10, 2017|2009-08-27|2017-03-10|||September 1, 2009|Actual|2009-09-01|March 2017|2017-03-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Study on the Treatment of Osteoporotic Vertebral Fractures Using Vertebral Body Stenting|Study to Evaluate the Clinical Performance of the VBS System for the Treatment of Osteoporotic Vertebral Fractures in a Multicenter, Randomized, Controlled Setting|Completed||Phase 4|100|Actual|Synthes GmbH||2|||f||||f||||||||||2017-10-11 01:44:20.914717|2017-10-11 01:44:20.914717
NCT01847872|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-07-18|||July 2013||2013-07-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|IPV||IPV Clinical Trial - The Gambia|A Phase 4, Randomized Trial to Assess the Safety and Immunogenicity of Inactivated Poliovirus Vaccine When Given Concomitantly With Measles and Rubella Combined Vaccine and Yellow Fever Vaccine at Nine Months and When Administered Via Different Vaccination Routes|Completed||Phase 4|1504|Actual|Medical Research Council Unit, The Gambia||8|||f||||t||||||||||2017-10-11 01:44:21.135492|2017-10-11 01:44:21.135492
NCT01847859|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-01-13|||May 2013||2013-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Pocket-size Ultrasound by Nurses in Cardiothoracic Post-operative Patients|Feasibility and Reliability of Routine Ultrasound Examination Performed by Nurses in Cardiothoracic Post-operative Patients|Completed||N/A|59|Actual|Levanger Hospital||1|||f||||t||||||||||2017-10-11 01:44:21.259307|2017-10-11 01:44:21.259307
NCT01847846|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-11-06|||July 2014||2014-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:44:21.340413|2017-10-11 01:44:21.340413
NCT01847833|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-07-08|||January 2014||2014-01-01|July 2015|2015-07-01||||December 2017|Anticipated|2017-12-01||Observational|||Advanced MRI Applications Development|Advanced MRI Applications Development|Recruiting||N/A|||Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 01:44:21.382087|2017-10-11 01:44:21.382087
NCT01847820|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-07-12|||August 2013||2013-08-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Clinical Evaluation of the AmniSure ROM Test|Clinical Evaluation of the AmniSure ROM Test|Terminated||N/A|383|Actual|QIAGEN Gaithersburg, Inc|||1||f||||f||||||||||2017-10-11 01:44:21.466403|2017-10-11 01:44:21.466403
NCT01847794|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-02|||June 2013||2013-06-01|May 2013|2013-05-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|AGC-HER2CTC||HER2 Positive CTC in Advanced Gastric Cancer|Clinical Significance of HER2 Positive Circulating Tumor Cells(CTCs) in the Peripheral Blood of Patients With Advanced Gastric Cancer|Unknown status|Not yet recruiting|N/A|50|Anticipated|Peking University||1|||f||||||||||||||2017-10-11 01:44:21.790507|2017-10-11 01:44:21.790507
NCT01847781|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-06-13|||May 2013||2013-05-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|PNEUMOCELL||PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency|PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency|Completed||Phase 2|20|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 01:44:21.890288|2017-10-11 01:44:21.890288
NCT01847768|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-08-12|||April 2013||2013-04-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Human Rhinovirus Infection and Airway Remodeling Mediators|Comparison of Airway Remodeling Mediators Following Experimental Human Rhinovirus Infection in Subjects With Mild to Moderate Asthma, and in Healthy, Non-asthmatic Control Subjects (AADCRC-UC-01)|Terminated||N/A|2|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2||Lack of Enrollment|f||||f||||||||||2017-10-11 01:44:22.015124|2017-10-11 01:44:22.015124
NCT01847755|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-08-15|||April 2013||2013-04-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|TBI||Hyperbaric Treatment of Traumatic Brain Injury (TBI)|Phase 1-2 Study of Hyperbaric Treatment of Traumatic Brain Injury|Recruiting||Phase 1/Phase 2|100|Anticipated|Jupiter Medical Center||1|||f||||t||||||||||2017-10-11 01:44:22.180578|2017-10-11 01:44:22.180578
NCT01847742|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2013-08-07|||April 2013||2013-04-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||EMDR Intervention for Psychological Trauma Among Syrian Refugees|EMDR Treatment for Psychological Trauma Among Syrian Refugees in Kilis, Randomized Controlled Trial.|Unknown status|Recruiting|N/A|80|Anticipated|Istanbul Sehir University||2|||f||||t||||||||||2017-10-11 01:44:22.290157|2017-10-11 01:44:22.290157
NCT01847729|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-08-09|||July 11, 2013|Actual|2013-07-11|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|July 21, 2016|Actual|2016-07-21||Observational|OPAL||"OPAL: Opiates and PhArmacoLogy"|A Multicenter Study Assessing the Prevalence of Co-addictions in Subjects Receiving Maintenance Treatment for Opiate Dependence. Determination of Clinical and Pharmacological Profil.|Active, not recruiting||N/A|263|Actual|Nantes University Hospital|||1||f||||f||||||Samples With DNA|"     Collecting 2 EDTA tubes of 5 mL (blood)   "|||2017-10-11 01:44:22.388464|2017-10-11 01:44:22.388464
NCT01847716|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-05-09|||October 2013||2013-10-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension|Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension|Recruiting||N/A|93|Anticipated|Imperial College London|||3||f||||t||||||Samples With DNA|"     Muscle biopsy and blood specimens will be retained by Imperial College and are subject to     thier restrictions ad regulations   "|Undecided||2017-10-11 01:44:22.512206|2017-10-11 01:44:22.512206
NCT01847703|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-08-29|||April 2013||2013-04-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|July 2016|Actual|2016-07-01||Interventional|RASHEC||Robotic Versus Abdominal Surgery for Endometrial Cancer|Randomized Trial Comparing Robotic and Abdominal Surgery for High Risk Endometrial Cancer|Active, not recruiting||N/A|120|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:44:22.629863|2017-10-11 01:44:22.629863
NCT01847677|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-06-17|||April 2013||2013-04-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|May 2015|Actual|2015-05-01||Interventional|NOVA||Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin|A Randomized Phase II Multi-centric Open Label Clinical Trial to Determine the Efficacy and Toxicity of Preoperative Chemotherapy With or Without Bevacizumab in Patients With Advanced Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|71|Actual|Grupo Español de Investigación en Cáncer de Ovario||2|||f||||f||||||||||2017-10-11 01:44:22.857766|2017-10-11 01:44:22.857766
NCT01847664|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-07-25|||August 2013||2013-08-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis|A Randomised, Double-blind, Double-dummy, Multi-centre, Comparative Parallel-group Study to Evaluate the Efficacy of Oral Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in the Treatment of Acute Uncomplicated Diverticulitis|Completed||Phase 2|204|Actual|Dr. Falk Pharma GmbH||3|||f||||t||||||||||2017-10-11 01:44:23.00539|2017-10-11 01:44:23.00539
NCT01847651|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-10-21|||August 2013||2013-08-01|May 2013|2013-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate|LOLA in Hepatic Encephalopathy Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate A Phase iv Randomised Double Blind Placebo- Controlled Trial|Completed||Phase 4|42|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 01:44:23.10294|2017-10-11 01:44:23.10294
NCT01847638|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-06-10|||April 2013||2013-04-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|QD||Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery|Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD for Treatment of Ocular Inflammation Associated With Cataract Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Discover Vision Centers||2|||f||||f||||||||||2017-10-11 01:44:23.250386|2017-10-11 01:44:23.250386
NCT01847625|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-07-03|||April 2013||2013-04-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|STOP||Safe Traction During Ongoing Lead Extraction Procedure (STOP)|Safe Traction During Ongoing Lead Extraction Procedure|Completed||N/A|20|Actual|Deutsches Herzzentrum Muenchen|||1||f||||f||||||||||2017-10-11 01:44:23.356014|2017-10-11 01:44:23.356014
NCT01847612|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-08-02|||May 2013||2013-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|CAMFIB||Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy|Evaluation of Indocyanine Green Fluorescent Cholangiography Versus Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy: Randomized Controlled Study|Recruiting||Phase 3|132|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||t||||||||||2017-10-11 01:44:23.416744|2017-10-11 01:44:23.416744
NCT01847599|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-07-18|||September 6, 2011|Actual|2011-09-06|July 2017|2017-07-01|July 2, 2017|Actual|2017-07-02|October 13, 2016|Actual|2016-10-13||Interventional|ProMETheX||Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib|Implementation of a Therapeutic Educational Program Applicated to Adherence of Patients Treated by Capecitabine Alone or in Combination With Lapatinib|Terminated||N/A|65|Actual|Centre Jean Perrin||2||interim analysis : discontinuation for efficacy of the intervention|f||||f||||||||||2017-10-11 01:44:23.508357|2017-10-11 01:44:23.508357
NCT01847586|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-04-04|||April 2013||2013-04-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|TMS-AD||Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease|Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease|Active, not recruiting||N/A|49|Actual|Centre for Addiction and Mental Health||3|||f||||t||||||||No||2017-10-11 01:44:23.595892|2017-10-11 01:44:23.595892
NCT01847573|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-07-05|||May 2013||2013-05-01|July 2017|2017-07-01|April 21, 2017|Actual|2017-04-21|April 21, 2017|Actual|2017-04-21||Interventional|||Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy|A Phase 1b Open Label, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT-100 in Patients With Duchenne Muscular Dystrophy|Terminated||Phase 1/Phase 2|17|Actual|Akashi Therapeutics||6||Dosing stopped|f||||t||||||||||2017-10-11 01:44:23.682598|2017-10-11 01:44:23.682598
NCT01847560|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-10-03|||April 17, 2013|Actual|2013-04-17|October 2017|2017-10-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Observational|||Anticoagulant Utilization Pattern|A Description of Warfarin and NOAC Utilization Patterns Including Initiation, Switching, and Discontinuation|Recruiting||N/A|99999|Anticipated|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 01:44:23.796608|2017-10-11 01:44:23.796608
NCT01847547|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-06-03|2014-04-22||April 2013||2013-04-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational||This initial cohort study includes matched treatment groups of 2,991 patients with non-valvular atrial fibrillation who initiated dabigatran and 2,991 patients who initiated warfarin that were drawn from a pool of 11,882 eligible initiators. These first feasibility data are limited by a small sample size.|Comparative Effectiveness of Oral Anticoagulants|Comparative Effectiveness of Oral Anticoagulants: A Cohort Study|Completed||N/A|5982|Actual|Boehringer Ingelheim|These first data are limited by small sample size, short follow up, few events resulting in wide confidence intervals. No comparative conclusions are possible. After the feasibility analysis future analysis will increase patient numbers and follow up||2||f||||||||||||||2017-10-11 01:44:23.894085|2017-10-11 01:44:23.894085
NCT01847534|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-07-31|||February 2014||2014-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|January 2016|Actual|2016-01-01||Interventional|||Supplemental Parenteral Nutrition in Critically Ill Adults: A Pilot Randomised Controlled Trial|Supplemental Parenteral Nutrition in Critically Ill Adults: A Pilot Randomised Controlled Trial|Completed||Phase 2/Phase 3|100|Actual|Australian and New Zealand Intensive Care Research Centre||2|||f||||f||||||||||2017-10-11 01:44:24.742428|2017-10-11 01:44:24.742428
NCT01847521|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-02|||December 2011||2011-12-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Effects of the Anti-inflammatory Flavonoid Luteolin on Behavior in Children With Autism Spectrum Disorders||Completed||Phase 2|50|Actual|Attikon Hospital||1|||f||||||||||||||2017-10-11 01:44:24.824859|2017-10-11 01:44:24.824859
NCT01847508|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-07-07|||October 2013|Actual|2013-10-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Interventional|||PHILOS Augmented - a Multicenter Randomized Controlled Trial|A Multicenter Randomized Controlled Trial to Investigate the Treatment Outcome of PHILOS Screw Augmentation Compared to PHILOS Without Augmentation in Older Adult Patients With Proximal Humerus Fractures|Active, not recruiting||N/A|69|Actual|AO Clinical Investigation and Documentation||2|||f||||t||||||||||2017-10-11 01:44:24.925165|2017-10-11 01:44:24.925165
NCT01847495|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-01-26|||October 2013||2013-10-01|January 2017|2017-01-01|October 2025|Anticipated|2025-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis|Prospective Evaluation of Low-dose Irinotecan and Cyberknife® Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis|Recruiting||N/A|41|Anticipated|Advocate Health Care||1|||f||||t||||||||||2017-10-11 01:44:25.09935|2017-10-11 01:44:25.09935
NCT01847482|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-05-30|||March 2013||2013-03-01|June 2014|2014-06-01|January 19, 2016|Actual|2016-01-19|June 2014|Actual|2014-06-01||Interventional|||Therapeutic Hypothermia With IntraVascular Temperature Management (IVTM) in Post-Cardiogenic Cardiac Arrest and Post-Return of Spontaneous Circulation Patients in Japan|COOL-ARREST JP: A Multicenter, Prospective, Single-arm Interventional Trial to Evaluate Therapeutic Hypothermia With IntraVascular Temperature Management (IVTM) in Post-Cardiogenic Cardiac Arrest and Post-Return of Spontaneous Circulation Patients|Completed||N/A|26|Actual|ZOLL Circulation, Inc., USA||1|||f||||t||||||||||2017-10-11 01:44:25.210286|2017-10-11 01:44:25.210286
NCT01847469|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-08-04|||June 2013||2013-06-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence|Zonisamide in Addition to Enhanced Cognitive Processing Therapy-C (E-CPT-C) for Veterans With PTSD and Comorbid Alcohol Dependence|Recruiting||Phase 2|30|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 01:44:25.326798|2017-10-11 01:44:25.326798
NCT01847456|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2013-12-20|||April 2013||2013-04-01|December 2013|2013-12-01||||November 2013|Actual|2013-11-01||Interventional|||Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity|Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity|Completed||N/A|10|Actual|University Hospital Tuebingen||2|||f||||||||||||||2017-10-11 01:44:25.42511|2017-10-11 01:44:25.42511
NCT01847443|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-03-06|2014-03-06||May 2013||2013-05-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations|A Pharmacokinetic Study Comparing Two Nicotine Gum Formulations in a Single Dose Design|Completed||Phase 1|84|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 01:44:25.526227|2017-10-11 01:44:25.526227
NCT01847430|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-02-04|2015-02-19||July 2013||2013-07-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder|Long-term Persistence of Hepatitis B Antibodies and Immune Response to a Challenge Dose of GSK Biologicals' Hepatitis B Virus Vaccine, Engerix™-B Kinder (SKF103860), in 15-16 Years Old Adolescents, Vaccinated in Infancy With Engerix™-B Kinder|Completed||Phase 4|303|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 01:44:26.23556|2017-10-11 01:44:26.23556
NCT01847417|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-07-10|||May 16, 2013|Actual|2013-05-16|July 2017|2017-07-01|July 1, 2013|Actual|2013-07-01|July 1, 2013|Actual|2013-07-01||Interventional|||Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions|An Open Label, Balanced, Randomized, Three-treatment, Three-period, Six-sequence, Cross-over, Single Dose, Comparative Bioavailability Pilot Study of Two Test Formulations of Fixed Dose Combination Capsules of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Manufactured by Piramal Healthcare Limited, India for GSK Comparing With Aspirin® Protect 100 mg Tablets by Bayer Vital GmbH, and Protium® 20 mg Gastro-resistant Tablets by Nycomed GmbH, in Healthy, Adult, Human Subjects, Under Fed Conditions|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 01:44:28.739648|2017-10-11 01:44:28.739648
NCT01847404|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-07-10|||May 14, 2013|Actual|2013-05-14|July 2017|2017-07-01|June 28, 2013|Actual|2013-06-28|June 28, 2013|Actual|2013-06-28||Interventional|||Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions|An Open Label, Balanced, Randomized, Three-treatment, Three-period, Six-sequence, Cross-over, Single Dose, Comparative Bioavailability Pilot Study of Two Test Formulations of Fixed Dose Combination Capsules of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Manufactured by Piramal Healthcare Limited, India for GSK Comparing With Aspirin® Protect 100 mg Tablets by Bayer Vital GmbH, and Protium® 20 mg Gastro-resistant Tablets by Nycomed GmbH, in Healthy, Adult, Human Subjects, Under Fasting Conditions|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 01:44:28.84216|2017-10-11 01:44:28.84216
NCT01847391|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-11-11|||May 2013||2013-05-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects|A Phase 1, Single-Blind, Randomized, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects|Completed||Phase 1|36|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-11 01:44:28.948371|2017-10-11 01:44:28.948371
NCT01847378|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2014-10-17|||June 2013||2013-06-01|October 2014|2014-10-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Observational|EPICONTAC-VT||Feasibility of Contact Force Catheter Mapping and Ablation in Epicardial and Endocardial Ventricular Tachycardias|EPIcardial and Endocardial Mapping and Ablation Using Contact Force Catheter in Chagasic Patients With Sustained Ventricular Tachycardia|Unknown status|Recruiting|N/A|10|Anticipated|Federal University of São Paulo|||1||f||||f||||||||||2017-10-11 01:44:29.047233|2017-10-11 01:44:29.047233
NCT01847365|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-03-10|||April 2013||2013-04-01|June 2014|2014-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TESOLAUK||TES for the Treatment of RP|Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Multicentre Safety Study of the Okustim® System|Completed||N/A|14|Actual|University of Oxford||1|||f||||t||||||||||2017-10-11 01:44:29.139332|2017-10-11 01:44:29.139332
NCT01847352|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-05-05|||February 2013||2013-02-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Iron Status and Hypoxic Pulmonary Vascular Responses|Effect of Endogenous Iron Status on Hypoxic Pulmonary Vascular Responses and Their Attenuation by Intravenous Iron|Completed||N/A|31|Actual|University of Oxford||2|||f||||f||||||||No||2017-10-11 01:44:29.218402|2017-10-11 01:44:29.218402
NCT01847339|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-12-15|||April 2013||2013-04-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Study of Epidural Bupivacain-soaked Absorbable Gelatin Sponge on Post-operative Pain in Lumbar Laminectomy||Recruiting||N/A|80|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 01:44:29.334662|2017-10-11 01:44:29.334662
NCT01847326|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-05-22|||March 2013||2013-03-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer|Nab-Paclitaxel-based Re-induction Chemotherapy Followed by Response-stratified Chemoradiotherapy in Patients With Previously Treated Squamous Cell Carcinoma of the Head and Neck.|Recruiting||Phase 1|61|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 01:44:29.433557|2017-10-11 01:44:29.433557
NCT01847313|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-07-29|||April 2013||2013-04-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease|Phase 3 Study of the Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Renal Outcomes in Humans With Diabetic Kidney Disease|Completed||Phase 3|20|Actual|University College Dublin||2|||f||||t||||||||||2017-10-11 01:44:29.71853|2017-10-11 01:44:29.71853
NCT01847300|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2016-10-06|||September 2013||2013-09-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||cSBI-M for Young Military Personnel|Computerized Screening and Brief Intervention for Young Military Personnel|Withdrawn||N/A|0|Actual|Boston Children’s Hospital||2||not funded|f||||f||||||||No||2017-10-11 01:44:29.8461|2017-10-11 01:44:29.8461
NCT01847287|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-06|||May 2012||2012-05-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|TST||A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years|A Prospective, Observational, Single-blinded, Longitudinal Study of Natalizumab Effect on Brain Atrophy and Disability in Multiple Sclerosis Patients Over 5 Years.|Completed||N/A|60|Actual|University at Buffalo|||1||f||||f||||||||||2017-10-11 01:44:29.96477|2017-10-11 01:44:29.96477
NCT01847274|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2016-12-12|||June 2013||2013-06-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer|A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.|Completed||Phase 3|597|Actual|Tesaro, Inc.||2|||f||||t||||||||||2017-10-11 01:44:30.087266|2017-10-11 01:44:30.087266
NCT01847261|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-05-01|||April 2013||2013-04-01|May 2013|2013-05-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Interventional|||Effects of Protein Blends on Muscle Protein Synthesis in Healthy Older Adults|A Randomized, Controlled Double Blind Acute Study: Effects of Protein Blends on Muscle Protein Synthesis and Breakdown in Healthy Older Adults|Unknown status|Recruiting|N/A|20|Anticipated|Solae, LLC||2|||f||||f||||||||||2017-10-11 01:44:30.450848|2017-10-11 01:44:30.450848
NCT01847248|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-11-22|||May 2011||2011-05-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|March 2013|Actual|2013-03-01||Observational|||HSPA12B as a Potential Biomarker for Sepsis and Severe Sepsis||Completed||N/A|118|Actual|Changhai Hospital|||4||f||||t||||||Samples Without DNA|"     Plasma   "|||2017-10-11 01:44:30.551588|2017-10-11 01:44:30.551588
NCT01847235|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-04-22|||May 2013||2013-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial|The Efficacy and Safety of Temozolomide in Patients With Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: a Multicenter, Single-arm, Phase II Trial|Completed||Phase 2|23|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 01:44:30.632044|2017-10-11 01:44:30.632044
NCT01847222|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-01-05|||May 2013||2013-05-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers.|An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers.|Terminated||Phase 1|2|Actual|Prolong Pharmaceuticals||2||Terminated due to completion of competing study.|f||||f||||||||||2017-10-11 01:44:30.719748|2017-10-11 01:44:30.719748
NCT01847196|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-08-14|2015-02-18||November 2013||2013-11-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Angel® Catheter Early Feasibility Clinical Study|A Multi-center, Early Feasibility Study of the Angel® Catheter in Critically Ill Subjects at High Risk of Pulmonary Embolism|Terminated||N/A|6|Actual|BiO2 Medical|Due to the small number of patients, analysis is descriptive only.|1||IDE approval received for larger Pivotal Study|f||||t||||||||||2017-10-11 01:44:30.897865|2017-10-11 01:44:30.897865
NCT01847183|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-10-05|||November 2012||2012-11-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Interventional|AlcoholINET||Evaluation of an School-based Alcohol Prevention Program for Middle School Students|Evaluation of an Intranet-Based Alcohol Prevention Program in Middle School|Completed||Phase 2|2300|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-10-11 01:44:31.518311|2017-10-11 01:44:31.518311
NCT01847170|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2017-03-02|||May 2013||2013-05-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease||Completed||Phase 1|22|Actual|Beth Israel Deaconess Medical Center||1|||f||||t||||||||||2017-10-11 01:44:31.634532|2017-10-11 01:44:31.634532
NCT01847157|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-02-16|||January 2013||2013-01-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Transcranial Direct Current Stimulation Combined Sensory Modulation Intervention in Chronic Stroke Patients|The Effect of the Transcranial Direct Current Stimulation Combined Sensory Modulation Intervention on Upper Extremity Functional Rehabilitation in Patients With Chronic Stroke|Completed||N/A|25|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:44:31.754296|2017-10-11 01:44:31.754296
NCT01847144|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-07-27|||April 2013||2013-04-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Mastermind||MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes|MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2|Completed||Phase 4|143|Actual|NIHR Exeter Clinical Research Facility||2|||f||||f||||||||||2017-10-11 01:44:31.926949|2017-10-11 01:44:31.926949
NCT01847131|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2015-01-03|2014-12-09||April 2013||2013-04-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Baseline analysis were performed to compared between 2 groups on age, gender results of allergy skin tests and baseline nasal congestion scores.|Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction|Effectiveness of Oxymetazoline Added on Intranasal Steroid in the Treatment of Allergic and Nonallergic Rhinitis With Persistent Nasal Obstruction|Completed||Phase 4|50|Actual|Mahidol University|Further studies with larger numbers of subjects and longer period of follow-up would probably have led to significant differences between both treatment groups in NPIF, Rcq scores and the possible rebound nasal congestion or other adverse events.|2|||f||||f||||||||||2017-10-11 01:44:32.065015|2017-10-11 01:44:32.065015
NCT01847118|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-03-22|||April 2013||2013-04-01|July 2014|2014-07-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors|A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors|Unknown status|Recruiting|Phase 1|31|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 01:44:32.399932|2017-10-11 01:44:32.399932
NCT01847105|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-05-25|||June 2013||2013-06-01|May 2013|2013-05-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutions|Assessing Patient Comfort in Silicone Hydrogel Contact Lenses When Cleaned and Stored in Two Different Multi-Purpose Disinfecting Solutions|Unknown status|Enrolling by invitation|N/A|54|Anticipated|Hom, Milton M., OD, FAAO||1|||f||||f||||||||||2017-10-11 01:44:32.493383|2017-10-11 01:44:32.493383
NCT01847092|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2015-09-18|||May 2013||2013-05-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria|An Exploratory Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD1722 in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria|Completed||Phase 2|154|Actual|Ardelyx||2|||f||||f||||||||||2017-10-11 01:44:32.589937|2017-10-11 01:44:32.589937
NCT01847079|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2014-10-13|||January 2013||2013-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ProBIC/ICIS||Procalcitonin to Guide Obtaining Bloodcultures in the ICU Intensive Care Infection Score|Procalcitonin to Guide Obtaining Bloodcultures in the ICU. Intensive Care Infection Score.|Completed||N/A|1130|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 01:44:32.685775|2017-10-11 01:44:32.685775
NCT01847066|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-02|2013-05-02|||May 2013||2013-05-01|May 2013|2013-05-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Epidermal Delivery of Ani-Aging Ingredients|Fractional Erbium 2940nm Laser & Impact US for Trans-Epidermal Delivery of Cosmetic Anti-Aging Ingredients for Wrinkles, Acne Scars and Pigmented Skin: A Randomized Split Face & Dorsal Hand Side by Side Study|Unknown status|Enrolling by invitation|N/A|21|Anticipated|Alma Lasers Inc.||4|||f||||f||||||||||2017-10-11 01:44:32.784326|2017-10-11 01:44:32.784326
NCT01847053|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-04-06|||January 2013||2013-01-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||Bioavailability Study of Cinnamon in Healthy Subjects|A Single-Center, Partial Double-Blind, Randomized, Four-Treatment Crossover Bioavailability Study of Cinnamon in Healthy Subjects|Completed||Phase 1/Phase 2|8|Actual|McCormick and Company, Inc.||4|||f||||t||||||||||2017-10-11 01:44:32.887223|2017-10-11 01:44:32.887223
NCT01847040|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-05-01|||September 2009||2009-09-01|May 2013|2013-05-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Deployment Related Mild Traumatic Brain Injury (mTBI)|Deployment Related Mild Traumatic Brain Injury (mTBI): Incidence, Natural History, and Predictors of Recovery in Soldiers Returning From OIF/OEF|Unknown status|Enrolling by invitation|N/A|1500|Anticipated|The Defense and Veterans Brain Injury Center|||2||f||||f||||||||||2017-10-11 01:44:32.986991|2017-10-11 01:44:32.986991
NCT01847027|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-07-26|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|July 17, 2017|Actual|2017-07-17|July 17, 2017|Actual|2017-07-17||Interventional|||Exercise and NutraStem (NT-020): Effects on Stem Cells|Phase 2 Study of the Effect of a Nutritional Supplement and Exercise on Human Stem Cells|Completed||Phase 2|24|Anticipated|University of North Texas Health Science Center||2|||f||||f||||||||||2017-10-11 01:44:33.088479|2017-10-11 01:44:33.088479
NCT01847001|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-08-29|||October 2012||2012-10-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy|A Phase II Study of the Beta-blocker Propranolol Alone and With Chemotherapy in Patients Receiving Neoadjuvant Treatment for Newly Diagnosed Breast Cancer|Active, not recruiting||Phase 2|10|Actual|Columbia University||1|||f||||t|t|f|||f|||||2017-10-11 01:44:33.316278|2017-10-11 01:44:33.316278
NCT01846988|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-08-19|||October 2012||2012-10-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparing Auto-adjustable Positive Airway Pressure to Continuous Positive Airway Pressure in Children With Sleep Apnea|Efficacy of Auto-adjustable Positive Airway Pressure (APAP) in Pediatric Patients With Obstructive Sleep Apnea (OSA).|Recruiting||N/A|40|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||No|There is no plan to share individual participant data at this time.|2017-10-11 01:44:33.499386|2017-10-11 01:44:33.499386
NCT01846975|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2015-03-02|||May 2013||2013-05-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|A-BREAK||Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday|A Phase IV, Open Label Study Introducing a Single IV Treatment With Abatacept in Patients With Rheumatoid Arthritis Currently Receiving Weekly Injections of SC Abatacept to Simulate a Holiday or Patient Vacation|Completed||Phase 4|49|Actual|Cantonal Hospital of St. Gallen||1|||f||||t||||||||||2017-10-11 01:44:33.616724|2017-10-11 01:44:33.616724
NCT01846962|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-05-03|||November 2012||2012-11-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis|COMPARISON OF TREATMENT FOR PEDIATRIC EOSINOPHILIC ESOPHAGITIS: A RANDOMIZED CLINICAL TRIAL (DIETETIC Versus TOPICAL STEROIDS)|Unknown status|Recruiting|Phase 4|60|Anticipated|Azienda Policlinico Umberto I||3|||f||||f||||||||||2017-10-11 01:44:33.732203|2017-10-11 01:44:33.732203
NCT01846949|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-05-01|||May 2013||2013-05-01|May 2013|2013-05-01|October 2020|Anticipated|2020-10-01|October 2015|Anticipated|2015-10-01||Observational|ALDUS||Surveillance Study for HCC (ALDUS)|Study for Clinical Significance of Use of AFP, AFP-L3 and DCP Versus US Alone in Surveillance for HCC|Not yet recruiting||N/A|1000|Anticipated|ALDUS Study Group|||1||f||||f||||||None Retained|"     Serum   "|||2017-10-11 01:44:33.832663|2017-10-11 01:44:33.832663
NCT01846936|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-06-22|||August 2012||2012-08-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Disconnection Technique With a Bronchial Blocker for Improving Lung Deflation|A Randomized, Prospective Trial Comparing Double-lumen Tube and Bronchial Blocker With or Without Modified Disconnection Technique|Completed||N/A|54|Actual|Ajou University School of Medicine||3|||f||||f||||||||||2017-10-11 01:44:33.896108|2017-10-11 01:44:33.896108
NCT01846923|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-01|||October 2010||2010-10-01|May 2013|2013-05-01||||February 2012|Actual|2012-02-01||Interventional|||B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals|Study of the B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals With Beta-thalassemia Major|Unknown status|Active, not recruiting|Phase 4|37|Actual|Aghia Sophia Children's Hospital of Athens||1|||f||||t||||||||||2017-10-11 01:44:33.984758|2017-10-11 01:44:33.984758
NCT01846910|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-10-25|||October 2013||2013-10-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Prepare to Quit - A Clinical Trial to Help People Quit Smoking in a Community Dental Clinic Setting|Prepare to Quit - A Randomized Clinical Trial to Help People Quit Smoking in a Community Dental Clinic Setting|Recruiting||N/A|156|Anticipated|University of Manitoba||2|||f||||f||||||||Undecided|Undecided|2017-10-11 01:44:34.05788|2017-10-11 01:44:34.05788
NCT01846858|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-12-17|||April 2013||2013-04-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Histological Characterization of Vaginal Cuff Tissue Using Different Energy Sources During Robotic Hysterectomy|Histological Characterization of Vaginal Cuff Tissue Using Different Energy Sources During Robotic Hysterectomy|Completed||N/A|31|Actual|Mayo Clinic|||2||f||||f||||||Samples Without DNA|"     10 vaginal tissue specimens from each group of energy modality will be compared and analyzed.     Tissue from the specimen side of the hysterectomy will be sent (after marking the most distal     edge with a marker) for pathological evaluation such that the vaginal length is not     compromised.   "|||2017-10-11 01:44:34.45246|2017-10-11 01:44:34.45246
NCT01846845|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-06-27|||March 2013||2013-03-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Evaluation of a Novel Transfemoral Prosthetic Socket System|Prosthetic Socket System: Pilot Assessment|Unknown status|Recruiting|N/A|8|Anticipated|Ohio Willow Wood||2|||f||||||||||||||2017-10-11 01:44:34.528117|2017-10-11 01:44:34.528117
NCT01846832|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-09-20|||September 2013||2013-09-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection|A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects With Chronic Genotype 1 or Genotype 4 HCV Infection|Completed||Phase 3|232|Actual|Janssen-Cilag International NV||1|||f||||t||||||||||2017-10-11 01:44:34.680366|2017-10-11 01:44:34.680366
NCT01846819|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-01-24|||July 2012||2012-07-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|||Factors Associated With End Stage Liver Disease|Factors Associated With End Stage Liver Disease|Terminated||N/A|27|Actual|New York University School of Medicine|||1||f||||t||||||||||2017-10-11 01:44:34.849919|2017-10-11 01:44:34.849919
NCT01846806|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-08-03|||September 2012||2012-09-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.|The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy|Terminated||N/A|10|Actual|New York University School of Medicine||1||PI no longer at NYUMC|f||||t|f|f|||f|||||2017-10-11 01:44:34.921152|2017-10-11 01:44:34.921152
NCT01846793|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-03-09||2017-03-09|April 2013||2013-04-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)|Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-8 Years Apart|Completed||Phase 3|160|Actual|Nymox Corporation||1|||f||||f||||||||||2017-10-11 01:44:35.000655|2017-10-11 01:44:35.000655
NCT01846780|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-10-20|||December 2013||2013-12-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Treadmill Pilot Study (Invasive Pressure Measurements in PTS)|The Effect of PTA & Stenting on Intravenous Pressure in Deep Venous Obstructive Disease Before, After and During Ambulation on a Treadmill - Pilot Study.|Completed||N/A|24|Actual|Maastricht University Medical Center|||1||f||||f||||||Samples With DNA|"     Blood samples for possible future research   "|||2017-10-11 01:44:35.142463|2017-10-11 01:44:35.142463
NCT01846767|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-11-25|||April 2012||2012-04-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|EGOBT||Exogenous Glucose Oxidation Breath Test|Study of the Metabolism of 13C Labelled Glucose to 13CO2 in Human Breath|Completed||N/A|46|Actual|National University of Ireland, Galway, Ireland||2|||f||||f||||||||||2017-10-11 01:44:35.221833|2017-10-11 01:44:35.221833
NCT01846754|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-04-17|||June 2013||2013-06-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Prevalence of Fatigue in Hemodialysis Patients|Prevalence of Fatigue and Its Related Factors in Hemodialysis Patients|Completed||N/A|88|Actual|National Taiwan University Hospital|||1||f||||t||||||Samples Without DNA|"     human blood: 5c.c.   "|||2017-10-11 01:44:35.332522|2017-10-11 01:44:35.332522
NCT01846741|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2015-10-26|2015-07-10||July 2013||2013-07-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|E-37|Subjects implanted with VNS Therapy system|VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)|VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia|Completed||N/A|20|Actual|Cyberonics, Inc.|The small sample size and the absence of randomization did not allow conclusions about whether the AutoStim alone, or the combination of AutoStim and traditional VNS therapy modes, or some other factor was a cause of the observed beneficial effects.|1|||f||||f||||||||||2017-10-11 01:44:35.455826|2017-10-11 01:44:35.455826
NCT01846728|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-10-04|||April 2013||2013-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Interventional|||Effects of Estrogen Deficiency on Energy Expenditure|Ovarian Function and Facultative Thermogenesis|Completed||N/A|6|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 01:44:36.88431|2017-10-11 01:44:36.88431
NCT01846715|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2014-12-10|||April 2013||2013-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease|A Phase 1, Open-Label Safety and Delivery Optimization Study of an Autologous Neo-Kidney Augment (NKA) in Patients With Chronic Kidney Disease (CKD)|Terminated||Phase 1|6|Actual|Tengion||1||lack of funding|f||||f||||||||||2017-10-11 01:44:36.964596|2017-10-11 01:44:36.964596
NCT01846702|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-01-08|||May 2013||2013-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of LY3084077 in Healthy Participants|A Single-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of LY3084077 in Healthy Subjects|Completed||Phase 1|54|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:44:37.045754|2017-10-11 01:44:37.045754
NCT01846689|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-04-30|||June 2013||2013-06-01|April 2013|2013-04-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease|An Open-label Trial of an Erythropoietin Stimulating System to Determine Increased Red Blood Cell Production in Subjects Diagnosed With Anemia of Chronic Disease|Unknown status|Not yet recruiting|Phase 3|30|Anticipated|Targeted Medical Pharma||1|||f||||t||||||||||2017-10-11 01:44:37.123778|2017-10-11 01:44:37.123778
NCT01846676|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-01-11|||October 2012||2012-10-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Assessment of the ACE Program for Rehabilitation in Hearing Loss|"Assessment of the Active Communication Education Program for Audiological Rehabilitation in Patients With Hearing Loss Users of Hearing Aids"|Completed||N/A|180|Actual|University of Chile||2|||f||||t||||||||||2017-10-11 01:44:37.207544|2017-10-11 01:44:37.207544
NCT01846663|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-04-26|||April 3, 2013|Actual|2013-04-03|April 2017|2017-04-01|June 2021|Anticipated|2021-06-01|May 2021|Anticipated|2021-05-01||Interventional|||Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Rifaximin 550 Mg In Subjects With Severe Hepatic Impairment And Overt Hepatic Encephalopathy|Recruiting||Phase 4|100|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||t||||||||Yes||2017-10-11 01:44:37.400177|2017-10-11 01:44:37.400177
NCT01846650|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-09-28|||December 2012||2012-12-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Bioequivalence Study of Capecitabine Tablets|A Bioequivalence Study of Capecitabine Tablets in Patients of Locally Advanced or Metastatic Breast Cancer or Metastatic Colorectal Cancer|Completed||Phase 1|36|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-11 01:44:37.616993|2017-10-11 01:44:37.616993
NCT01846637|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2013-05-02|||June 2010||2010-06-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Two or Five cm From Pylorus During Laparoscopic Sleeve Gastrectomy|Comparative Study Between Two and Five cm Resection During Laparoscopic Sleeve Gastrectomy|Completed||N/A|50|Anticipated|Mansoura University||2|||f||||||||||||||2017-10-11 01:44:37.696604|2017-10-11 01:44:37.696604
NCT01846624|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-10-03|||June 2013||2013-06-01|October 2017|2017-10-01|December 2024|Anticipated|2024-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia|Active, not recruiting||Phase 2|36|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 01:44:37.770441|2017-10-11 01:44:37.770441
NCT01846611|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-08-24|||October 16, 2013|Actual|2013-10-16|August 2017|2017-08-01|December 16, 2019|Anticipated|2019-12-16|September 12, 2018|Anticipated|2018-09-12||Interventional|||A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Recruiting||Phase 3|670|Anticipated|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 01:44:37.899801|2017-10-11 01:44:37.899801
NCT01846598|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-04-13|||May 2013||2013-05-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01|14 Days|Observational [Patient Registry]|||48 Hours After Surgery Shower Patient's Wound Infection Rate, Pain Score, Patient Satisfaction and Cost.|Comparison of 48 Hours After Surgery That Shower and Non-shower Patient's Wound Infection Rate, Pain Score, Patient Satisfaction and Cost.|Completed||N/A|444|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:44:38.410342|2017-10-11 01:44:38.410342
NCT01846585|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-04-13|||April 2013||2013-04-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Treatment for Insomnia During Pregnancy|The Effectiveness of Non-Pharmacological Treatment for Insomnia During Pregnancy|Active, not recruiting||N/A|184|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 01:44:38.509009|2017-10-11 01:44:38.509009
NCT01846572|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-05-02|||July 2010||2010-07-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|Bo-CRISP||Clopidogrel Response in Acute Ischemic Stroke|Prevalence of Low Response to Clopidogrel in Patients After Acute Ischemic Stroke. The Bochumer CRISP Study|Completed||N/A|159|Actual|Ruhr University of Bochum|||1||f||||f||||||||||2017-10-11 01:44:38.613586|2017-10-11 01:44:38.613586
NCT01846559|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-06-27|||April 2013||2013-04-01|January 2013|2013-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Antiplatelet and Immune Response Trial|Study of the Effect of Ticagrelor and Clopidogrel on the Immune Response of Healthy Volunteers|Completed||Phase 4|30|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||3|||f||||t||||||||||2017-10-11 01:44:38.69067|2017-10-11 01:44:38.69067
NCT01846546|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-09-08|||October 2006||2006-10-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01|6 Months|Observational [Patient Registry]|||Cerebrospinal Fluid Endostatin/Collagen XVIII Concentrations in Patients With Severe Traumatic Brain Injury|Dynamic Changes of Cerebrospinal Fluid Endostatin Concentrations in Patients With Severe Traumatic Brain Injury.|Completed||N/A|30|Actual|Shanghai 6th People's Hospital|||1||f||||f||||||Samples Without DNA|"     Cerebrospinal fluid   "|||2017-10-11 01:44:38.807208|2017-10-11 01:44:38.807208
NCT01846533|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-07-28|||May 2013||2013-05-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Osteoprosis in Type 2 Diabetic Patients- a Cohort Study|Osteoprosis in Type 2 Diabetic Patients- a Cohort Study|Unknown status|Recruiting|N/A|1200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     CBC/DC & BCS   "|||2017-10-11 01:44:38.904496|2017-10-11 01:44:38.904496
NCT01846520|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-02-08|||October 2013||2013-10-01|February 2017|2017-02-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers|A Randomized Trial of a Family Caregiver Palliative Care Intervention|Recruiting||N/A|200|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 01:44:38.990359|2017-10-11 01:44:38.990359
NCT01846507|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-02-10|||April 2013||2013-04-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding|Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding|Active, not recruiting||Phase 4|30|Actual|Nationwide Children's Hospital||1|||f||||t||||||||||2017-10-11 01:44:39.166494|2017-10-11 01:44:39.166494
NCT01846130|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-05-26|||January 2013||2013-01-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|EBR||Preserving Muscle Mass and Function in Bedridden Older Adults|Preserving Muscle Mass and Function in Bedridden Older Adults|Recruiting||N/A|96|Anticipated|The University of Texas Medical Branch, Galveston||7|||f||||t||||||||||2017-10-11 01:44:49.928659|2017-10-11 01:44:49.928659
NCT01846494|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-02-22|||April 2013||2013-04-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01|5 Years|Observational [Patient Registry]|CARE-Hep C||Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)|Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)|Active, not recruiting||N/A|113|Actual|Duke University|||2||f||||t||||||Samples Without DNA|"     Plasma, serum, and urine   "|||2017-10-11 01:44:39.288144|2017-10-11 01:44:39.288144
NCT01846481|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-09-09||2015-08-05|April 2013||2013-04-01|September 2016|2016-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|RBP-8000||A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse|A Randomized, Double-blind, Placebo-controlled, Dose of RBP-8000 Following IV Cocaine to Evaluate the Pharmacokinetics Parameters of RBP-8000 and Cocaine and to Assess the Effects of Drug on Cocaine-induced Physiologic and Behavioral Effects in Cocaine Abusing Subjects|Completed||Phase 2|40|Actual|Indivior Inc.||4|||f||||f||||||||||2017-10-11 01:44:39.405081|2017-10-11 01:44:39.405081
NCT01846468|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-02-28|||March 1, 2013|Actual|2013-03-01|February 2017|2017-02-01|June 28, 2014|Actual|2014-06-28|June 28, 2014|Actual|2014-06-28||Interventional|||An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction|A Partially-blinded, Randomized, Placebo-controlled, Adaptive Single and Multiple Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction|Completed||Phase 1|205|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:44:39.526814|2017-10-11 01:44:39.526814
NCT01846455|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-09-09|2015-08-07||September 2012||2012-09-01|September 2016|2016-09-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional||Safety population|Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects|Pharmacokinetics of Buprenorphine and Naloxone in Subjects With Mild to Severe Hepatic Impairment (Child-Pugh Classes, A, B, and C), in HCV-Seropositive Subjects, and in Healthy Volunteers|Completed||Phase 4|43|Actual|Indivior Inc.||5|||f||||f||||||||No||2017-10-11 01:44:39.67804|2017-10-11 01:44:39.67804
NCT01846442|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-07-28|2017-03-20|2013-05-02|June 2007||2007-06-01|July 2017|2017-07-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional||Baseline Analysis Population corresponds to the Safety Population which includes all subjects who received any amount of prasterone or placebo, and who have any safety information available.|Topical DHEA Against Vaginal Atrophy|Topical DHEA Against Vaginal Atrophy (3-Month Placebo-Controlled Double-Blind Randomized Phase III Study)|Completed||Phase 3|218|Actual|EndoCeutics Inc.||4|||f||||f||||||||||2017-10-11 01:44:41.882363|2017-10-11 01:44:41.882363
NCT01846429|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-06-02|||September 2013||2013-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain|A Phase I/II Study of Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain|Terminated||Phase 1|9|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||Drugs unavailable. Study did not progress to Phase 2.|f||||f||||||||||2017-10-11 01:44:42.882801|2017-10-11 01:44:42.882801
NCT01846416|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-08-01|2016-10-24||May 30, 2013|Actual|2013-05-30|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|January 7, 2015|Actual|2015-01-07||Interventional||All participants who received any dose of atezolizumab during the study.|A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]|A Phase II, Multicenter, Single-arm Study of MPDL3280A in Patients With PD-L1-Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|138|Actual|Genentech, Inc.|Not specified.|3|||f||||||||||||||2017-10-11 01:44:43.040994|2017-10-11 01:44:43.040994
NCT01846403|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-05-12|||June 2013||2013-06-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility Setting|Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test to Replace Sequential Serum hCG Testing in an Assisted Fertility Setting|Completed||N/A|50|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-10-11 01:44:44.609478|2017-10-11 01:44:44.609478
NCT01846390|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-07-10|||April 30, 2013|Actual|2013-04-30|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 6, 2016|Actual|2016-07-06||Interventional|||Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma|A Phase I Study of Romidepsin, Gemcitabine, Dexamethasone and Cisplatin Combination Therapy in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma|Active, not recruiting||Phase 1|21|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-11 01:44:44.687565|2017-10-11 01:44:44.687565
NCT01846377|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-11-28|||April 2014||2014-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|G4H-DiabNano||Video Games for Obesity and Diabetes Prevention-Diab & Nano|Video Games for Obesity and Diabetes Prevention: Efficacy Trial|Recruiting||N/A|444|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 01:44:44.794683|2017-10-11 01:44:44.794683
NCT01846364|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-04-30|||November 2006||2006-11-01|April 2013|2013-04-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||DIM as a Treatment for Thyroid Disease|Diindolymethane: Anti-proliferation Agent in Thyroid Disease—Non-surgical Protocol|Terminated||Early Phase 1|7|Actual|The New York Eye & Ear Infirmary||1||Lack of sufficient enrollment|f||||f||||||||||2017-10-11 01:44:44.898067|2017-10-11 01:44:44.898067
NCT01846351|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-01|||July 2006||2006-07-01|May 2013|2013-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes|Visual and Anatomic Outcomes of Intravitreal Anti-VEGF Therapy for Exudative Age-related Macular Degeneration With Concurrent Significant Epiretinal Membrane.|Completed||N/A|16|Actual|New England Retina Associates|||1||f||||t||||||||||2017-10-11 01:44:44.968537|2017-10-11 01:44:44.968537
NCT01846338|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-05-02|||October 2012||2012-10-01|May 2013|2013-05-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Interventional|||The Effect of「GTT-EGCG」on Acne Women|The Effect of「GTT-EGCG」on Acne Women|Unknown status|Enrolling by invitation|N/A|80|Anticipated|National Yang Ming University||2|||f||||t||||||||||2017-10-11 01:44:45.069259|2017-10-11 01:44:45.069259
NCT01846325|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-06-14|||December 2013||2013-12-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia||Completed||Phase 2/Phase 3|180|Actual|National Nutrition and Food Technology Institute||4|||f||||||||||||||2017-10-11 01:44:45.159119|2017-10-11 01:44:45.159119
NCT01846312|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2015-09-22|||May 2013||2013-05-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes|The Longitudinal Diabetes Biomarker Study: An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes|Completed||N/A|40|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"     Blood sampling for biomarkers. A portion of each sample collected will be tested for five     different islet autoantibodies (presence and precise titers). The remaining portion of each     sample will be coded and then assessed for autoantibody isotypes, phenotyping of peripheral     blood mononuclear cells (PBMC), and profiling of cytokines, and pharmacogenetic markers.   "|||2017-10-11 01:44:45.268527|2017-10-11 01:44:45.268527
NCT01846299|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-04-14|2016-02-29||October 2013||2013-10-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema|A 12-month, Randomized, Double-masked, Sham-controlled, Multicenter Study to Evaluate the Efficacy and Safety of 0.5mg Ranibizumab Intravtitreal Injections in Patients With Visual Impairment Due to Vascular Endothelial Growth Factor (VEGF)Driven Macular Edema|Completed||Phase 3|181|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:44:45.42366|2017-10-11 01:44:45.42366
NCT01846286|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-10-02|||October 2012|Actual|2012-10-01|October 2017|2017-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Neuropathic Pain in Head and Neck Cancer|Molecular Epidemiology of Neuropathic Pain in Head and Neck Cancer|Recruiting||N/A|1200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     Blood specimen   "|||2017-10-11 01:44:48.508262|2017-10-11 01:44:48.508262
NCT01846273|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-05-02|||August 7, 2013|Actual|2013-08-07|May 2017|2017-05-01|March 2, 2017|Actual|2017-03-02|March 2, 2017|Actual|2017-03-02||Interventional|EVEREST II||Visual Outcome in Patients With Symptomatic Macular PCV Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy.|A 24-month, Phase IV, Randomized, Double Masked, Multi-center Study of Ranibizumab Monotherapy or Ranibizumab in Combination With Verteporfin Photodynamic Therapy on Visual Outcome in Patients With Symptomatic Macular PCV|Completed||Phase 4|321|Actual|Novartis||2|||f||||f|f|f||||||No||2017-10-11 01:44:48.627183|2017-10-11 01:44:48.627183
NCT01846260|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-03-21|||April 2013||2013-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|CONCEPT||Predictive Value of the Distress Thermometer as a Predictive Screening Instrument to Detect Cancer-related Cognitive Impairment in Cancer Patients|Predictive Value of the Distress Thermometer as a Predictive Screening Instrument to Detect Cancer-related Cognitive Impairment in Cancer Patients|Completed||N/A|125|Actual|General Hospital Groeninge|||1||f||||||||||||||2017-10-11 01:44:48.864265|2017-10-11 01:44:48.864265
NCT01846247|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2015-04-13|||June 2006||2006-06-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|AVERT||A Very Early Rehabilitation Trial|A Phase 3, Multicentre, Randomised Controlled Trial of Very Early Rehabilitation After Stroke.|Completed||N/A|2014|Anticipated|Neuroscience Trials Australia||2|||f||||t||||||||||2017-10-11 01:44:48.948761|2017-10-11 01:44:48.948761
NCT01846234|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2013-10-21|||November 2010||2010-11-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|SALT||Sodium Intake in Multiple Sclerosis|Effect of Sodium Intake in Multiple Sclerosis Disease Activity|Completed||N/A|132|Actual|Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia|||1||f||||f||||||Samples Without DNA|"     Blood, urine   "|||2017-10-11 01:44:49.08351|2017-10-11 01:44:49.08351
NCT01846221|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-07-23|||July 15, 2014|Actual|2014-07-15|July 2017|2017-07-01|January 19, 2017|Actual|2017-01-19|January 19, 2017|Actual|2017-01-19||Interventional|Clon/Fent||Comparison of Epidural Fentanyl and Clonidine for Breakthrough Pain|Comparison of Fentanyl-bupivacaine and Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor in Patients With Continuous Epidural Analgesia|Completed||Phase 4|101|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:44:49.186114|2017-10-11 01:44:49.186114
NCT01846208|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-02-13|||July 2013||2013-07-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|November 2017|Anticipated|2017-11-01||Interventional|CoFAR7||Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy|Oral Desensitization to Egg With Subsequent Induction of Sustained Unresponsiveness for Egg-Allergic Children Using Baked Egg or Egg Oral Immunotherapy (OIT)|Active, not recruiting||Phase 2|92|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||||2017-10-11 01:44:49.295576|2017-10-11 01:44:49.295576
NCT01846195|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-04-30|||September 2012||2012-09-01|April 2013|2013-04-01||||August 2013|Anticipated|2013-08-01||Interventional|||Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw|Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Adult Patients During a Blood Draw|Unknown status|Recruiting|Phase 1|60|Anticipated|Zynex Monitoring Solutions||2|||f||||f||||||||||2017-10-11 01:44:49.414938|2017-10-11 01:44:49.414938
NCT01846182|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-09-01|||June 24, 2015|Actual|2015-06-24|September 2017|2017-09-01|January 1, 2021|Anticipated|2021-01-01|December 31, 2019|Anticipated|2019-12-31||Interventional|REGIONS||Research Examining Gulf War Illness in Our Nations Service Members|RCT of Duloxetine & Pregabalin for the Treatment of Gulf War Illness in Veterans|Recruiting||Phase 2|180|Anticipated|VA Office of Research and Development||3|||f||||t|t|f|||f|||||2017-10-11 01:44:49.519047|2017-10-11 01:44:49.519047
NCT01846169|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-08-21|||September 2012||2012-09-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study to Improve Healthy Eating for At-Risk Older Adults|Healthy Eating for At-Risk Older Adults (HERO)|Completed||N/A|101|Actual|Boston Medical Center||1|||f||||f||||||||||2017-10-11 01:44:49.633449|2017-10-11 01:44:49.633449
NCT01846156|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2014-08-21|||May 2013||2013-05-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||New Magnesium Sulphate Protocol for Pre-eclampsia|The Best Magnesium Sulphate Protocol for Severe Pre-eclampsia : A Randomized Controlled Trial|Completed||Phase 3|240|Actual|Cairo University||3|||f||||t||||||||||2017-10-11 01:44:49.714579|2017-10-11 01:44:49.714579
NCT01846143|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-08-11|||May 2013||2013-05-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|Mel59||Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies|Evaluation of the Safety and Immunogenicity of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies (Mel59)|Completed||Phase 1|15|Actual|University of Virginia||3|||f||||t||||||||||2017-10-11 01:44:49.807608|2017-10-11 01:44:49.807608
NCT01846104|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-11-22|2015-12-10||June 2013||2013-06-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|RVEc||Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults|Safety and Immunogenicity of a Booster Dose (50 µg) of Recombinant Ricin Toxin A-Chain 1-33/44-198 (rRTA 1-33/44-198) Vaccine (RVEc™) in Previously Vaccinated Healthy Adults|Completed||Phase 1|4|Actual|U.S. Army Medical Research and Materiel Command|Four subjects were enrolled and vaccinated. Three subject completed the study and one was withdrawn due to relocation.|1|||f||||f||||||||||2017-10-11 01:44:50.303531|2017-10-11 01:44:50.303531
NCT01846091|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-01-31|||April 2013||2013-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer|Phase I Trial of Intratumoral Administration of a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck or Metastatic Breast Cancer|Recruiting||Phase 1|30|Anticipated|Mayo Clinic||1|||f||||||||||||||2017-10-11 01:44:50.670282|2017-10-11 01:44:50.670282
NCT01846078|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-05-02|||June 2012||2012-06-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Accuracy of Holladay 2 Formula in the Absence of Lens Thickness|Accuracy of Holladay 2 Formula Using IOLMaster Parameters in the Absence of Lens Thickness|Completed||N/A|143|Actual|Mahidol University||1|||f||||||||||||||2017-10-11 01:44:50.792545|2017-10-11 01:44:50.792545
NCT01846065|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-08-08|||September 2013||2013-09-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 2016|Actual|2016-06-01||Observational|||Tobacco Craving and Triggers in Persons With Schizophrenia||Completed||N/A|45|Actual|University of Maryland|||1||f||||f||||||||||2017-10-11 01:44:50.889737|2017-10-11 01:44:50.889737
NCT01846039|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2015-09-11|2015-09-11||April 2013||2013-04-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|September 2013|Actual|2013-09-01||Interventional|||JUVÉDERM VOLUMA® to Enhance the Appearance of the Asian Nose|A Prospective, Open-label Study of the Safety and Efficacy of JUVÉDERM VOLUMA® to Enhance the Aesthetic Appearance of the Asian Nose|Completed||N/A|29|Actual|Allergan||1|||f||||t||||||||||2017-10-11 01:44:51.057802|2017-10-11 01:44:51.057802
NCT01846026|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2015-06-01|||April 2013||2013-04-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|April 2014|Actual|2014-04-01||Interventional|||Ulcerative Colitis and Vitamin D Supplementation|Immunomodulating and Clinical Effects of Vitamin D on Remission Induction in Patients With Moderate and Severe Ulcerative Colitis, Undergoing Treatment With Infliximab.|Withdrawn||Phase 1/Phase 2|0|Actual|University Hospital of North Norway||2||"At the planned study start new treatment guidelines for this disease with new drugs were   implemented in clinical practice."|f||||t||||||||||2017-10-11 01:44:51.420115|2017-10-11 01:44:51.420115
NCT01846013|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2014-09-29|||February 2013||2013-02-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Increasing Workplace Physical Activity in Sedentary Office Workers|Increasing Workplace Physical Activity in Sedentary Office Workers|Completed||N/A|260|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||||2017-10-11 01:44:51.572207|2017-10-11 01:44:51.572207
NCT01846000|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-04-30|||February 2013||2013-02-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Low-level Laser Therapy on Temporomandibular Disorder|Evaluation of Effect of Low-level Laser Therapy on Adolescents With Temporomandibular Disorder|Unknown status|Recruiting|N/A|75|Anticipated|University of Nove de Julho||5|||f||||t||||||||||2017-10-11 01:44:51.712702|2017-10-11 01:44:51.712702
NCT01845987|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2015-10-26||2015-10-26|June 2013||2013-06-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody, Following Subcutaneous Administration in Subjects With Palmoplantar Pustulosis|Completed||Phase 2|49|Actual|Janssen Pharmaceutical K.K.||2|||f||||f||||||||||2017-10-11 01:44:51.850359|2017-10-11 01:44:51.850359
NCT01845961|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2016-09-23|||January 2013||2013-01-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effect of Galantamine on Short-term Abstinence|Repurposing Cholinesterase Inhibitors for Smoking Cessation|Recruiting||Phase 2|107|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:44:52.066365|2017-10-11 01:44:52.066365
NCT01845948|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2013-04-30|||March 2009||2009-03-01|April 2013|2013-04-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Effectiveness of a Parental Training Programme to Enhance Parent-child Relationship and Reduce Harsh Parenting Practices and Parental Stress in the Preparation of Children for Transition to Primary School|Effectiveness of a Parental Training Programme to Enhance Parent-child Relationship and Reduce Harsh Parenting Practices and Parental Stress in the Preparation of Children for Transition to Primary School: A Randomized Controlled Trial|Completed||N/A|142|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 01:44:52.145047|2017-10-11 01:44:52.145047
NCT01845935|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-08-19|||April 2013||2013-04-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|CRYOMAV||Cryoablation of Venous Vascular Malformations|Cryoablation of Venous Vascular Malformations Located in Soft Tissues|Completed||Phase 1/Phase 2|14|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-10-11 01:44:52.247906|2017-10-11 01:44:52.247906
NCT01845922|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-05-05|||May 2013||2013-05-01|May 2013|2013-05-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||The Effect of a Diet Based on Low Sodium and Slowly Absorbed Carbohydrates on the Incidence of Refeeding Syndrome in Patients With Head and Neck Cancer|The Prevention of Refeeding Syndrome by a Diet Regime in Patient With Head and Neck Cancer|Unknown status|Recruiting|Phase 4|52|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-11 01:44:52.370422|2017-10-11 01:44:52.370422
NCT01845909|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2017-06-09|||February 2012||2012-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 2013|Actual|2013-05-01||Observational|SCD-SOS||Sudden Cardiac Death - Screening Of Risk Factors|Sudden Cardiac Death: Evaluation of a New Strategy to Identify Young Adults at Risk|Active, not recruiting||N/A|15351|Actual|University of Coimbra|||1||f||||f||||||||||2017-10-11 01:44:52.467694|2017-10-11 01:44:52.467694
NCT01845896|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2014-05-03|||March 2013||2013-03-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis|Rehabilitation in MS: Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis|Completed||N/A|34|Actual|Hasselt University||3|||f||||t||||||||||2017-10-11 01:44:52.551943|2017-10-11 01:44:52.551943
NCT01845883|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-12-17|||April 2013||2013-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Perceptual Decision Making Under Conditions of Visual Uncertainty|Perceptual Decision Making Under Conditions of Visual Uncertainty|Recruiting||N/A|120|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 01:44:52.636603|2017-10-11 01:44:52.636603
NCT01845870|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-06-05|||February 2012||2012-02-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|DM||Serum 1,25-dihydroxyvitamin D Levels in Type 2 Diabetes Mellitus Patients With Different Levels of Albuminuria|Study Whether Serum 1,25-dihydroxyvitamin D Levels Could be an Indicator for Dysfunction of Renal Tubules|Completed||N/A|162|Actual|Tianjin Medical University General Hospital|||3||f||||f|||||||"     Blood samples were collected after an overnight fast to evaluate glycosylated hemoglobin     A1c（HbA1c）, hemoglobin (Hb), serum albumin (ALB), serum creatinine (SCR), serum urea nitrogen     (BUN), uric acid (UA), serum calcium (Ca), serum phosphate (P), serum alanine transferase     (ALT), serum aspartate aminotransferase (AST), serum alkaline phosphatase (ALP), serum     25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Urine albumin, calcium and phosphate of 24     hour were also evaluated.   "|||2017-10-11 01:44:52.712316|2017-10-11 01:44:52.712316
NCT01845857|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-09|2013-04-30|||August 2010||2010-08-01|August 2010|2010-08-01|April 2013|Actual|2013-04-01|April 2011|Actual|2011-04-01||Interventional|||A National Study of the Chronic Disease Self-Management Program|A National Study of the Chronic Disease Self-Management Program|Completed||N/A|1170|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 01:44:52.786414|2017-10-11 01:44:52.786414
NCT01845844|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-09-16|||April 2013||2013-04-01|September 2014|2014-09-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|ROTATE||Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab|Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (ROTATE Trial)|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Southeast Retina Center, Georgia||2|||f||||f||||||||||2017-10-11 01:44:52.874025|2017-10-11 01:44:52.874025
NCT01845831|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-04-24|2017-03-08||August 2013||2013-08-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||The number of participants who received at least one dose of study drug.|Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes|Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes|Completed||Phase 4|292|Actual|Emory University|As a single DPP-4 inhibitor, sitagliptin, was used, results cannot be generalized to other incretin-based drugs. Additionally, the proportion of surgical patients was small, and the results may not be generalized to all surgical patients.|5|||f||||t||||||||||2017-10-11 01:44:53.051342|2017-10-11 01:44:53.051342
NCT01845818|ClinicalTrials.gov processed this data on October 10, 2017|2013-05-01|2017-07-06|||June 5, 2013||2013-06-05|July 2017|2017-07-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Observational|SPACTIVE||Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium|Observational Study in AS and PsA Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium|Completed||N/A|183|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 01:44:53.696878|2017-10-11 01:44:53.696878
NCT01845792|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-03-06|||July 2013|Actual|2013-07-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer|Phase II Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel, Compared to Cabazitaxel Alone, in Patients With Metastatic Castrate Resistant Prostate Cancer.|Completed||Phase 2|8|Actual|University of Colorado, Denver||2|||f||||t||||||||No||2017-10-11 01:44:53.977674|2017-10-11 01:44:53.977674
NCT01845779|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2016-08-04|||September 2012||2012-09-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|Epitopes-HPV01||Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal|Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal|Recruiting||N/A|4|Anticipated|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-11 01:44:54.072398|2017-10-11 01:44:54.072398
NCT01845766|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-04-11|||February 2013||2013-02-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Early Exercise Rehabilitation on Long-term Functional Recovery in Patients With Severe Sepsis||Completed||N/A|40|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:44:54.15446|2017-10-11 01:44:54.15446
NCT01845740|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-10-01|||January 2015||2015-01-01|October 2015|2015-10-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Phase Ib Study of SC Milatuzumab in SLE|A Phase Ib Study of Milatuzumab Administered Subcutaneously in Patients With Active Systemic Lupus Erythematosus (SLE)|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Immunomedics, Inc.||3|||f||||f||||||||||2017-10-11 01:44:54.331134|2017-10-11 01:44:54.331134
NCT01845727|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-07-25|||February 2014||2014-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2016|Actual|2016-05-01||Interventional|Anfoleish||Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia|Safety, Pharmacokinetics, and Efficacy of Topical 3% Amphotericin B Cream for the Treatment of Uncomplicated Cutaneous Leishmaniasis in Colombia|Completed||Phase 1/Phase 2|80|Actual|Drugs for Neglected Diseases||2|||f||||f||||||||||2017-10-11 01:44:54.44312|2017-10-11 01:44:54.44312
NCT01845714|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-01-14|||April 2009||2009-04-01|January 2017|2017-01-01|October 2012|Actual|2012-10-01|April 2011|Actual|2011-04-01||Interventional|||Impact of Keratoconus, Cross-linking and Cross-linking Combined With Topo-guided Photorefractive Keratectomy on Self-reported Quality of Life. A Three-year Update.|Impact of Keratoconus, Cross-linking and Cross-linking Combined With Topo-guided Photorefractive Keratectomy on Self-reported Quality of Life. A Three-year Update.|Completed||N/A|28|Actual|Democritus University of Thrace||2|||f||||||||||||||2017-10-11 01:44:54.526497|2017-10-11 01:44:54.526497
NCT01845701|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2015-05-27|||March 2010||2010-03-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|||Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon|Phase III Study to Study the Clinical Response to ACT Fixed Dose Combination in 42 Days in Uncomplicated Malaria in Cameroon|Completed||Phase 3|720|Actual|University of Yaounde 1||3|||f||||t||||||||||2017-10-11 01:44:54.611499|2017-10-11 01:44:54.611499
NCT01845688|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-11-30|||November 2011||2011-11-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|February 2016|Anticipated|2016-02-01||Interventional|||Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy|Efficacy and Safety Evaluation of QingReMoShen Granule in the Treatment of Idiopathic Membranous Nephropathy : A Randomized Double-Blind Controlled Clinical Study|Active, not recruiting||N/A|72|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-11 01:44:54.712955|2017-10-11 01:44:54.712955
NCT01845675|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-04-12|||April 2013||2013-04-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|November 30, 2016|Actual|2016-11-30||Interventional|||Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor|Temozolomide or Dacarbazine-based Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor|Completed||Phase 2|14|Actual|Peking Union Medical College Hospital||1|||f|||||f|f||||||No||2017-10-11 01:44:54.798746|2017-10-11 01:44:54.798746
NCT01845662|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-04-29|||April 2013||2013-04-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||Non-traumatic Rupture of the Spleen. Can Splenectomy be Applied Selectively?|Non-traumatic Rupture of the Spleen. Can Splenectomy be Applied Selectively?|Unknown status|Active, not recruiting|N/A|40|Anticipated|Ziv Hospital|||1||f||||f||||||||||2017-10-11 01:44:54.881553|2017-10-11 01:44:54.881553
NCT01845649|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-02-24||2015-02-24|April 2013||2013-04-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Study to Evaluate Safety & Efficacy of WC3011 in Postmenopausal Women With Dyspareunia|A Randomized, Multicenter, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of WC3011 in Postmenopausal Women With Dyspareunia|Completed||Phase 3|550|Actual|Warner Chilcott||2|||f||||f||||||||||2017-10-11 01:44:54.989488|2017-10-11 01:44:54.989488
NCT01845623|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-04-19|||August 2013||2013-08-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture|A Randomized, Double-blind, Double-dummy, Placebo-controlled, 3-period Crossover Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Orally Inhaled Indacaterol Administered Via the EPIC Test Fixture and the Concept1 Device in Adult Patients With Persistent Asthma|Withdrawn||Phase 2|0|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:44:55.319451|2017-10-11 01:44:55.319451
NCT01845610|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-05-06|||September 2013||2013-09-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|TSWAKA||Randomized Controlled Trial in South Africa Comparing the Efficacy of Complementary Food Products on Child Growth|Randomized Controlled Trial in South Africa Comparing the Efficacy of Complementary Food Products on Child Growth|Unknown status|Active, not recruiting|Phase 2|750|Anticipated|North-West University, South Africa||3|||f||||t||||||||||2017-10-11 01:44:55.426374|2017-10-11 01:44:55.426374
NCT01845597|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-07-14|||April 2013||2013-04-01|July 2017|2017-07-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|||Survivorship and Outcomes of Robot Assisted Medial Partial Knee Replacement|Survivorship and Outcomes of Robotically Assisted Medial UKA|Active, not recruiting||N/A|134|Actual|Northwest Surgical Specialists, Vancouver|||1||f||||f||||||||||2017-10-11 01:44:55.520381|2017-10-11 01:44:55.520381
NCT01845584|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-04-11|||May 2013|Actual|2013-05-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.|NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.|Completed||Phase 2|7|Actual|Nihon Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-11 01:44:55.596061|2017-10-11 01:44:55.596061
NCT01845571|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-05-23|||October 2011||2011-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Retinal Detachment - Demographic and Clinical Survey|Long-term Anatomic and Funcional Succes After Surgery in Eyes With Retinal Detachment|Recruiting||N/A|400|Anticipated|Medical University of Vienna|||1||f||||f||||||Samples Without DNA|"     vitreous body samples and blood plasmsa for evaluation of cytocines levels.   "|||2017-10-11 01:44:55.679389|2017-10-11 01:44:55.679389
NCT01845558|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-08-27|||February 2013||2013-02-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|2012-005003-40||Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise|Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise - a Randomized, Two-stage, Double-blind, Placebo-controlled Cross-over Trial|Completed||Phase 4|69|Actual|Mucos Pharma GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 01:44:55.74713|2017-10-11 01:44:55.74713
NCT01845545|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-02-10|||August 2013||2013-08-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Study of Effect of Microfinance on Under 5 Health in Rural India|A Feasibility and Pilot Study of the Effects of Microfinance on Under 5 Mortality and Nutrition, Amongst the Very Poor in India|Completed||N/A|2469|Actual|University of Nottingham||2|||f||||t||||||||||2017-10-11 01:44:55.858941|2017-10-11 01:44:55.858941
NCT01845532|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-02-04|||April 2013||2013-04-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Analgesic Effect of Trigger Point Injection and EMLA for Shoulder Pain in Laparoscopic Hysterectomy||Completed||N/A|75|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 01:44:55.957806|2017-10-11 01:44:55.957806
NCT01845519|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-05-28|||July 2013||2013-07-01|December 2013|2013-12-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors|Feasibility of a Technology-based Intervention to Reach Inactive Breast Cancer Survivors and Objectively Track Step Activity.|Completed||N/A|90|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 01:44:56.036548|2017-10-11 01:44:56.036548
NCT01845506|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-09-09|||January 2016||2016-01-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Application of a Wireless Sensor Technology for Vital Statistics in CHILDREN AND ADULTS||Not yet recruiting||N/A|500|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:44:56.121981|2017-10-11 01:44:56.121981
NCT01845493|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-03-07|||April 2013||2013-04-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|brasma||Sulforaphane Supplementation in Atopic Asthmatics|Sulforaphane Supplementation in Atopic Asthmatics|Completed||Phase 1|16|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:44:56.279356|2017-10-11 01:44:56.279356
NCT01845480|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-02-22|||August 20, 2012|Actual|2012-08-20|February 2017|2017-02-01|October 13, 2017|Anticipated|2017-10-13|September 20, 2017|Anticipated|2017-09-20||Interventional|||The Wildcat Wellness Coaching Trial|The Wildcat Wellness Coaching Trial: Home-based Obesity Prevention and Health Promotion in Children and Adolescents|Active, not recruiting||N/A|66|Actual|Kansas State University||2|||f||||f|f|f||||||No||2017-10-11 01:44:56.50194|2017-10-11 01:44:56.50194
NCT01845467|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-30|||February 2013||2013-02-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|February 2014|Anticipated|2014-02-01||Observational|S-MRCP||Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis|Efficacy of Secretin Assisted Dynamic MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis(AIP)|Unknown status|Recruiting|Phase 4|100|Anticipated|Johns Hopkins University|||1||f||||t||||||||||2017-10-11 01:44:56.628568|2017-10-11 01:44:56.628568
NCT01845454|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-04-27|||April 2013||2013-04-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|DOSE||A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy|"A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy (DOSE Trial)"|Terminated||N/A|36|Actual|CSA Medical, Inc.||4||poor enrollment and study design|f||||f||||||||No||2017-10-11 01:44:56.76536|2017-10-11 01:44:56.76536
NCT01845441|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-01|||April 2012||2012-04-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions|A Randomized, Controlled Trial on Dexmedetomidine for Providing Adequate Sedation and Preserved Neurologic Examination for Endovascular Treatment of Acute Ischemic Stroke or Cerebral Vasospasm.|Unknown status|Recruiting|Phase 2|32|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 01:44:56.886908|2017-10-11 01:44:56.886908
NCT01845428|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-05-03|||May 2012||2012-05-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|OxLDL||Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome|Assessment of the Efficacy of Lipid-lowering Agents to Limit Lipid Oxidation and Activation of the Clotting System in Patients With the Nephrotic Syndrome: a Pilot Study.|Completed||Phase 1|7|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 01:44:57.063716|2017-10-11 01:44:57.063716
NCT01845415|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-12-21|||October 2013||2013-10-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Intervention to Prevent Fall Injuries to Young Children in the Home|A Community-Based Intervention to Prevent Fall Injuries to Young Children in the Home|Recruiting||N/A|100000|Anticipated|University of Guelph||3|||f||||f||||||||||2017-10-11 01:44:57.162703|2017-10-11 01:44:57.162703
NCT01845402|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-06-30|||February 2013||2013-02-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|December 2015|Actual|2015-12-01||Observational|PRECARDIO||Chronic Kidney Disease in Teenagers With Congenital Cardiac Disease|The Prevalence of Chronic Kidney Disease at Adolescence in Patients With Congenital Cardiac Disease, Having Undergone Corrective Surgery During Childhood|Active, not recruiting||N/A|120|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     sample of blood and urine   "|No||2017-10-11 01:44:57.277987|2017-10-11 01:44:57.277987
NCT01845389|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-03-09|||June 2013||2013-06-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|||Comparative Study Between Continuous Epidural Anesthesia And Continuous Spinal Anesthesia Using Wiley™ Spinal Catheter|Comparative Study Between Continuous Epidural Anesthesia Using Standard Epidural Catheter And Continuous Spinal Anesthesia Using Wiley™ Spinal Catheter In Geriatric Patients Undergoing TURP|Completed||N/A|30|Actual|Theodor Bilharz Research Institute||2|||f||||f||||||||No||2017-10-11 01:44:57.400874|2017-10-11 01:44:57.400874
NCT01845376|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-07-28|||April 2014||2014-04-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Local or Regional or General Anesthesia for Hernia Repair: a Randomized Controlled Trial|Postoperative Clinical Outcomes and Inflammatory Markers After Inguinal Hernia Repair With Local or Spinal or General Anesthesia: A Randomized Trial|Completed||N/A|54|Actual|Siriraj Hospital||3|||f||||f||||||||No||2017-10-11 01:44:57.509942|2017-10-11 01:44:57.509942
NCT01845350|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-11-03|||October 2012||2012-10-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|April 2014|Actual|2014-04-01||Interventional|||Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients|Safety and Feasibility of Autologous M2 Macrophage Transplantation in Treatment of Non-Acute Stroke Patients|Completed||Phase 1|13|Actual|Siberian Branch of the Russian Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 01:44:57.752328|2017-10-11 01:44:57.752328
NCT01845337|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-06-05|||February 5, 2014|Actual|2014-02-05|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|TOFFEE||Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine|Toxicity OF Fluoropyrimidines: A Comparative Study of the Cardiotoxicity of capEcitabine and tEysuno|Recruiting||Phase 2|60|Anticipated|University of Edinburgh||4|||f||||t||||||||Undecided||2017-10-11 01:44:57.846536|2017-10-11 01:44:57.846536
NCT01845324|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-30|||May 2013||2013-05-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Observational|||Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers|Relation Between Fetal Heart Interventricular Septum Size and Gestational Diabetes Mellitus Control. a Prospective Trial|Unknown status|Not yet recruiting|N/A|300|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 01:44:57.964732|2017-10-11 01:44:57.964732
NCT01845311|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-04-26|||April 2013||2013-04-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2014|Actual|2014-01-01||Interventional|RESTORE II||ReZolve2 Clinical Investigation|RESTORE II Trial: Safety & Performance Study of the ReZolve2 Sirolimus-Eluting Bioresorbable Coronary Scaffold|Active, not recruiting||N/A|89|Actual|REVA Medical, Inc.||1|||f||||t||||||||||2017-10-11 01:44:58.047685|2017-10-11 01:44:58.047685
NCT01845285|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-02-23|||March 2013||2013-03-01|February 2016|2016-02-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01|3 Years|Observational [Patient Registry]|DISCOVER||A Registry to Evaluate the Direct Flow Medical Transcatheter Aortic Valve System|A Registry to Evaluate the Direct Flow Medical Transcatheter Aortic Valve System for the Treatment of Patients With Severe Aortic Stenosis|Recruiting||N/A|1000|Anticipated|Direct Flow Medical, Inc.|||1||f||||t||||||||Undecided||2017-10-11 01:44:58.239358|2017-10-11 01:44:58.239358
NCT01845272|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-30|||April 2013||2013-04-01|April 2013|2013-04-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|CCA||Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate|Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate in Healthy Male Volunteers.|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 01:44:58.372784|2017-10-11 01:44:58.372784
NCT01845259|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2016-05-04|||April 2013||2013-04-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2016|Actual|2016-03-01||Interventional|GREAT||Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?|Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients? A Randomized, Double-blinded, Placebo-controlled Clinical Trial|Active, not recruiting||Phase 2|103|Actual|Psychiatric Centre Rigshospitalet||2|||f||||t||||||||||2017-10-11 01:44:58.48138|2017-10-11 01:44:58.48138
NCT01845246|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-04-10|||January 2012||2012-01-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin|Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin.|Completed||N/A|101|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 01:44:58.603001|2017-10-11 01:44:58.603001
NCT01845233|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-08-22|||May 2013||2013-05-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Monitoring of Non-invasive Ventilation|Monitoring of Non-invasive Ventilation|Completed||N/A|67|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 01:44:58.703702|2017-10-11 01:44:58.703702
NCT01845220|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-08-31|2017-07-05||April 2014||2014-04-01|August 2017|2017-08-01|July 1, 2015|Actual|2015-07-01|July 1, 2015|Actual|2015-07-01||Interventional||"Total number of subjects is 30 -- each subject is own control. Skin area is the unit of analysis, thus there are both broccoli sprout extract treated and placebo treated skin areas on each subject (totalling 60 skin areas)."|Prevention of Alcohol Intolerance||Completed||Phase 2|30|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:44:58.805379|2017-10-11 01:44:58.805379
NCT01845207|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-08-29|||January 2012||2012-01-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|December 2014|Actual|2014-12-01|1 Year|Observational [Patient Registry]|||Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions|Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions|Completed||N/A|800|Anticipated|Jewish General Hospital|||1||f||||f||||||Samples Without DNA|"     Tissue specimens   "|||2017-10-11 01:44:59.114585|2017-10-11 01:44:59.114585
NCT01845194|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2014-04-17|||December 2009||2009-12-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics|Open Label Repeated Dose Study for the Evaluation of Heritability of and Genetic Influences on Drug Pharmacokinetics (TWINS II)|Completed||Phase 1|117|Actual|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||1|||f||||f||||||||||2017-10-11 01:44:59.294573|2017-10-11 01:44:59.294573
NCT01845181|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-03-07|||April 2013||2013-04-01|March 2016|2016-03-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||"First-in-human Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers"|"Randomized, Double Blind, Placebo Controlled First-in-human Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-680 in Male Healthy Volunteers"|Completed||Phase 1|32|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||8|||f||||t||||||||||2017-10-11 01:44:59.417322|2017-10-11 01:44:59.417322
NCT01845168|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-10-28|||April 2013||2013-04-01|October 2013|2013-10-01|April 2015|Anticipated|2015-04-01|February 2014|Anticipated|2014-02-01||Interventional|||"Prevention of Gastric Ulcer Bleeding by Using Computer-alert in General Practice"|"Prevention of Peptic Ulcer Bleeding Related to the Use of NSAIDs and Aspirin by Using Computer-alert - a Randomized Study in General Practice"|Unknown status|Recruiting|N/A|220|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 01:44:59.556229|2017-10-11 01:44:59.556229
NCT01845155|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2014-02-19|2013-09-04||March 2006||2006-03-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Neuro-Music-Therapy for Patients With Chronic Tinnitus - a Controlled Clinical Trial|Neuro-Music-Therapy for Patients With Chronic Tinnitus - a Controlled Clinical Trial|Completed||N/A|300|Actual|German Center for Music Therapy Research||2|||f||||||||||||||2017-10-11 01:44:59.711885|2017-10-11 01:44:59.711885
NCT01845142|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-06-24|||February 2013||2013-02-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Interventional|ViDImmun||Immunologic Action of a Single Dose Cholecalciferol|Immunologic Functions of a Single Dose of 100.000 I.U. Cholecalciferol (Vitamin D3)|Completed||Phase 4|40|Actual|Charite University, Berlin, Germany||4|||f||||t||||||||||2017-10-11 01:45:00.036295|2017-10-11 01:45:00.036295
NCT01845129|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2013-04-30|||April 2013||2013-04-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|StimRAph||Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia|Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia|Unknown status|Recruiting|N/A|16|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 01:45:00.140462|2017-10-11 01:45:00.140462
NCT01845116|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-07-12|||July 2010||2010-07-01|July 2017|2017-07-01|July 2025|Anticipated|2025-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury|Use of a Fish Oil-Based Intravenous Lipid Emulsion (Omegaven®) in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury|Recruiting||Phase 2|20|Anticipated|Carolinas Healthcare System||1|||f||||t|t|f||||||||2017-10-11 01:45:00.235108|2017-10-11 01:45:00.235108
NCT01845103|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2016-08-26|2015-08-28||September 2013||2013-09-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||The PEARL 8.0 Post-Approval Study|Post-Approval Study of the PEARL 8.0 Handpiece for Transmyocardial Revascularization (TMR) With the Cardiogenesis Holmium:YAG Laser System|Terminated||N/A|1|Actual|Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.|||1|Due to the product being discontinued|f||||f||||||||||2017-10-11 01:45:00.331381|2017-10-11 01:45:00.331381
NCT01845090|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-05-01|||August 2011||2011-08-01|August 2011|2011-08-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23|Compared the Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 With Calcium Carbonate in Hemodialysis Patients|Unknown status|Recruiting|Phase 4|30|Anticipated|Camillians Saint Mary's Hospital Luodong||2|||f||||t||||||||||2017-10-11 01:45:00.51515|2017-10-11 01:45:00.51515
NCT01845077|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2014-07-29|2014-07-29||May 2013||2013-05-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Treated set (TS) including all subjects who had been dispensed study medication and were documented to have taken at least 1 dose of study medication.|Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets|Relative Bioavailability of Two Newly Developed Extended Release FDC Tablet Strengths (5mg/1000mg and 2.5 mg/750 mg) of Linagliptin/Metformin Extended Release Compared With the Free Combination of Linagliptin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)|Completed||Phase 1|72|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 01:45:00.634053|2017-10-11 01:45:00.634053
NCT01845064|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-12-17|||April 2013||2013-04-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients|A Double-Blinded, Placebo-Controlled, Single-Dose and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Proof of Concept of DM199 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|98|Actual|DiaMedica USA Inc.||8|||f||||t||||||||||2017-10-11 01:45:01.70168|2017-10-11 01:45:01.70168
NCT01845051|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-01|||November 2012||2012-11-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Is There a Comorbidity Between Migraine and Allergic Rhinitis?||Completed||N/A|80|Actual|Baskent University|||2||f||||f||||||||||2017-10-11 01:45:01.918703|2017-10-11 01:45:01.918703
NCT01845038|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-12-08|||April 2013||2013-04-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma|A Prospective, Multicenter, Randomized, Double-Masked, Multi-Arm Feasibility Study Evaluating the Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension|Completed||Phase 1|41|Actual|Ocular Therapeutix, Inc.||3|||f||||f||||||||||2017-10-11 01:45:02.07242|2017-10-11 01:45:02.07242
NCT01845025|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-01-30|2016-11-10||May 2013||2013-05-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Study of Safety of Foradil in Patients With Persistent Asthma|A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.|Terminated||Phase 4|827|Actual|Novartis||2||"Due to the action to withdraw the Foradil Aerolizer NDA in US; study was discontinued. This was   a commercial reason and not due to any change in benefit-risk."|f||||t||||||||||2017-10-11 01:45:02.236838|2017-10-11 01:45:02.236838
NCT01845012|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-03-16|||July 2012||2012-07-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|HDQ200||Evaluation of Daily HemoDialysis at Low Dialysate Flow in Patients Previously Treated With Conventional Hemodialysis|Evaluation of Daily HemoDialysis at Low Dialysate Flow in Patients Previously Treated With Conventional Hemodialysis|Terminated||N/A|2|Actual|Association Pour L'utilisation Rein Artificiel Région Lyonnaise||1||Study has been prematurely halted because of failure of patient recruitment.|f||||f||||||||||2017-10-11 01:45:03.205402|2017-10-11 01:45:03.205402
NCT01844492|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-05-03|||April 2013||2013-04-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|PARTNER||Improving Patient and Family Centered Care in Advanced Critical Illness|Improving Patient and Family Centered Care in Advanced Critical Illness|Recruiting||N/A|1000|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:45:24.65613|2017-10-11 01:45:24.65613
NCT01844999|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-01-19|||September 2013||2013-09-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|||Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks|Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks|Active, not recruiting||N/A|392|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 01:45:03.378815|2017-10-11 01:45:03.378815
NCT01844986|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-06-29|||August 26, 2013|Actual|2013-08-26|June 2017|2017-06-01|March 29, 2023|Anticipated|2023-03-29|September 13, 2017|Anticipated|2017-09-13||Interventional|SOLO-1||Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.|A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer Following First Line Platinum Based Chemotherapy.|Active, not recruiting||Phase 3|450|Actual|AstraZeneca||2|||t||||t||||||||||2017-10-11 01:45:03.506825|2017-10-11 01:45:03.506825
NCT01844973|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-08-15|||April 2013||2013-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients||Completed||Phase 1|30|Actual|Maruho North America Inc.||2|||f||||f||||||||||2017-10-11 01:45:04.100635|2017-10-11 01:45:04.100635
NCT01844960|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-09-01|||November 2011||2011-11-01|April 2013|2013-04-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|SIMIS||Laparoscopic Single Incision -Vs- Multiple Incision Gastric Band Surgery|A Prospective Double Blinded Randomised Control Trial Comparing Laparoscopic Single Incision Versus Multiple Incision Adjustable Gastric Band Surgery in Patients With Morbid Obesity|Completed||N/A|44|Actual|King's College Hospital NHS Trust||2|||f||||f||||||||||2017-10-11 01:45:04.193071|2017-10-11 01:45:04.193071
NCT01844947|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-08-31|||June 2012||2012-06-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|VINSOR||Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract|An Exploratory Phase I Study With Sorafenib in Addition to Vinflunine in Progressive Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract|Recruiting||Phase 1|22|Anticipated|Karolinska University Hospital||1|||f||||t||||||||Undecided||2017-10-11 01:45:04.29445|2017-10-11 01:45:04.29445
NCT01844934|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-30|2017-02-09|||January 1, 2014|Actual|2014-01-01|February 2017|2017-02-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|||Impact of Prehabilitation in Total Knee Replacement|Impact of Prehabilitation in Total Knee Arthroplasty: Outcomes and Healthcare Service Utilization|Completed||N/A|43|Actual|Allina Health System||2|||f||||f||||||||No||2017-10-11 01:45:04.437232|2017-10-11 01:45:04.437232
NCT01844921|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-05-16|||April 2013||2013-04-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||High Resolution Optical Imaging of the Esophagus Using the Nvision Volumetric Laser Endomicroscopy (VLE™) Imaging System|High Resolution Optical Imaging of the Esophagus Using the NvisionVLE™ Imaging System|Completed||N/A|10|Actual|NinePoint Medical|||1||f||||f||||||||||2017-10-11 01:45:04.548902|2017-10-11 01:45:04.548902
NCT01844908|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2014-02-10|||May 2013||2013-05-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Electroacupuncture for Postoperative Ileus After Laparoscopic Rectal Cancer Surgery|Can Electroacupuncture Prevent Prolonged Ileus After Laparoscopic Surgery for Mid and Low Rectal Cancer? A Prospective Study With Matched Historical Controls|Unknown status|Recruiting|N/A|50|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 01:45:04.623916|2017-10-11 01:45:04.623916
NCT01844895|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-06-30|2015-06-05||April 2013||2013-04-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|MTX-IR|The Treated Analysis population included all enrolled participants who received at least 1 dose of study medication administered with the autoinjector during the substudy period.|Methotrexate-Inadequate Response Autoinjector Device Sub Study|Substudy-A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate|Completed||Phase 3|120|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 01:45:04.795218|2017-10-11 01:45:04.795218
NCT01844882|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-11-20|||January 2012||2012-01-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||The Effects of Dietary Fiber in CKD: A Systematic Review and Meta-analysis|The Effects of Dietary Fiber on Uremic Retention Solutes in CKD: A Systematic Review and Meta-analysis|Completed||N/A|1|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-11 01:45:05.366856|2017-10-11 01:45:05.366856
NCT01844869|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-01-29|||July 2013||2013-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate|An Open-Label Study to Investigate the Pharmacokinetics (Absorption, Distribution, Metabolism, and Excretion) of Omacetaxine Mepesuccinate Following Subcutaneous Administration of [14C]Omacetaxine Mepesuccinate in Patients With Relapsed and/or Refractory Hematologic Malignancies or Advanced Solid Tumors|Completed||Phase 1|6|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-11 01:45:05.482084|2017-10-11 01:45:05.482084
NCT01844856|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-02-29|2016-01-26||August 2013||2013-08-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|IGNITE1|All randomized participants (Intent-to-treat [ITT] population)|Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections|A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections|Completed||Phase 3|541|Actual|Tetraphase Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:45:05.626544|2017-10-11 01:45:05.626544
NCT01844843|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-07-03|||January 2014||2014-01-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|DISCOVERY123||Optical Frequency Domain Imaging (OFDI) Assessed Strut Coverage of New Terumo DES|Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent (Development Code TCD-10023) With Biodegradable Polymer at 1, 2 and 3 Months|Active, not recruiting||Phase 3|60|Anticipated|Terumo Europe N.V.||1|||f||||t||||||||||2017-10-11 01:45:08.16064|2017-10-11 01:45:08.16064
NCT01843322|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-03-10|||April 2011|Actual|2011-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Endoleak Repair Guided by Navigation Technology|Endoleak Repair Guided by Navigation Technology|Completed||N/A|27|Actual|Norwegian University of Science and Technology||1|||f||||f|f|f||||||||2017-10-11 01:45:47.532076|2017-10-11 01:45:47.532076
NCT01844830|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-07-28|2016-10-24|2015-05-27|May 2013||2013-05-01|July 2017|2017-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Pediatric Patients|A Phase 3, Multi-Center, Randomized, Double-Blind, Parallel-Groups Clinical Trial Comparing The Efficacy And Safety Of Intranasally Administered Kovacaine Mist To Placebo For Anesthetizing Maxillary Teeth In Pediatric Patients|Completed||Phase 3|90|Actual|St. Renatus, LLC||2|||f||||f||||||||||2017-10-11 01:45:08.336327|2017-10-11 01:45:08.336327
NCT01844817|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-04-11|2017-02-08||September 2013||2013-09-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|Rainier|Intent-to-Treat Population: All patients who met eligibility requirements and gave written informed consent.|Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer|A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel Combined With OGX-427 Or Placebo In Patients With Metastatic Pancreatic Cancer (The Rainier Trial)|Completed||Phase 2|132|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-10-11 01:45:09.060394|2017-10-11 01:45:09.060394
NCT01844804|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-01-06|||May 2013||2013-05-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)|Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study of PF-06438179 and Infliximab Sourced From US and EU Administered to Healthy Volunteers|Completed||Phase 1|146|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:45:10.530976|2017-10-11 01:45:10.530976
NCT01844791|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-10-20|||September 2012||2012-09-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients|A Phase IIa Exploratory Study of OCZ103-OS in Combination With Platinum-Gemcitabine Based Doublet First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients|Completed||Phase 2|25|Actual|Oncozyme Pharma Inc.||1|||f||||t||||||||||2017-10-11 01:45:10.654501|2017-10-11 01:45:10.654501
NCT01844778|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-07-26|2016-04-15||August 2013||2013-08-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)|An Open-label, Crossover, Interventional Phase IV Study to Compare the Ease of Use of TIP With Nebulized TIS and Nebulized COLI for the Treatment of Pulmonary Pseudomonas Aeruginosa (P.a) in Patients With Cystic Fibrosis|Completed||Phase 4|60|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:45:10.830895|2017-10-11 01:45:10.830895
NCT01844765|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-07-05|||August 20, 2013|Actual|2013-08-20|July 2017|2017-07-01|October 7, 2020|Anticipated|2020-10-07|October 7, 2020|Anticipated|2020-10-07||Interventional|Dialog||Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.|A Multi-center, Open Label, Non-controlled Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Pediatric Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP) or With Ph+ CML in CP or Accelerated Phase (AP) Resistant or Intolerant to Either Imatinib or Dasatinib|Active, not recruiting||Phase 2|59|Actual|Novartis||3|||f||||t|t|f||||||||2017-10-11 01:45:12.462506|2017-10-11 01:45:12.462506
NCT01844752|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-01-10|||April 2013||2013-04-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne|A Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled, Parallel Group, 3-arm Study Comparing the Efficacy, Tolerability and Safety of 2 Concentrations of NVN1000 Gel and Vehicle Gel Twice Daily in the Treatment of Acne Vulgaris.|Completed||Phase 2|153|Actual|Novan, Inc.||3|||f||||f||||||||||2017-10-11 01:45:12.854662|2017-10-11 01:45:12.854662
NCT01844739|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-01-10|||April 2013||2013-04-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel|A Phase 1, Multiple-dose, Evaluator-blind, Randomized, Parallel Group Study Evaluating the Safety and Cutaneous Tolerability of SB204 (NVN1000 Gel) in Healthy Volunteers|Completed||Phase 1|30|Actual|Novan, Inc.||2|||f||||f||||||||||2017-10-11 01:45:13.000222|2017-10-11 01:45:13.000222
NCT01844726|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-01-25|||May 2013||2013-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness|Functional Neuroimaging Effects of the N-methyl-D-aspartate Receptor (NMDAR) Partial Agonist, GLYX-13, on Learning and Memory in Healthy Individuals|Completed||Phase 2|104|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 01:45:13.147948|2017-10-11 01:45:13.147948
NCT01844713|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-07-30|||May 2013||2013-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of Sun Protection Education for Kidney Transplant Recipients|Evaluation of Sun Protection Education for Kidney Transplant Recipients|Completed||N/A|153|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 01:45:13.304299|2017-10-11 01:45:13.304299
NCT01844700|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-01-06|2015-08-19||July 2013||2013-07-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain|1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain|Terminated||Phase 4|14|Actual|Northwell Health||2||very slow recruitment, no sufficient results|f||||t||||||||||2017-10-11 01:45:13.426359|2017-10-11 01:45:13.426359
NCT01844687|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-04-05|2017-01-07||May 2013||2013-05-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||count - only those participants who completed all 8 visits (31)|Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana|Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana|Completed||Phase 2|50|Actual|National Institute on Drug Abuse (NIDA)||8|||f||||t||||||||No||2017-10-11 01:45:13.953944|2017-10-11 01:45:13.953944
NCT01844674|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-03-16|||September 2, 2013|Actual|2013-09-02|March 2017|2017-03-01|August 26, 2014|Actual|2014-08-26|August 26, 2014|Actual|2014-08-26||Interventional|||A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies|A Phase I, Open-Label, Multicenter, 3- Period, Fixed-Sequence Study to Investigate the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy|Completed||Phase 1|18|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 01:45:15.440239|2017-10-11 01:45:15.440239
NCT01844661|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-02-18|||January 2013||2013-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.|Phase 1 Trial of Celyvir in Children and Adults With Metastatic and Refractory Solid Tumors.|Completed||Phase 1/Phase 2|20|Actual|Hospital Infantil Universitario Niño Jesús, Madrid, Spain||1|||f||||f||||||||||2017-10-11 01:45:15.564758|2017-10-11 01:45:15.564758
NCT01844648|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-12-08|||April 2013||2013-04-01|April 2014|2014-04-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients|A Randomized, Double-blind, Placebo-controlled, Crossover Study of the Safety and Efficacy of Tropicamide 1 mg Intra-oral Slow Dissolving Muco-adhesive Thin Films to Reduce Hypersalivation in PD Patients Manifesting Sialorrhea Complaints|Completed||Phase 2|30|Actual|NeuroHealing Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-11 01:45:15.639376|2017-10-11 01:45:15.639376
NCT01844635|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-03-31|||May 2012||2012-05-01|March 2016|2016-03-01||||May 2016|Anticipated|2016-05-01||Interventional|||Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA|A Prospective Randomized Multicenter Study Comparing Different Dosages of Rabbit Antithymocyte Globulin (Thymoglobuline) in Patients With Severe Aplastic Anemia|Recruiting||Phase 3|320|Anticipated|Nagoya University||2|||f||||t||||||||||2017-10-11 01:45:15.733757|2017-10-11 01:45:15.733757
NCT01844622|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-05-15|||December 2007||2007-12-01|May 2017|2017-05-01|February 19, 2015|Actual|2015-02-19|February 19, 2015|Actual|2015-02-19||Interventional|||Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying|Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying|Completed||N/A|37|Actual|Mt. Sinai Medical Center, Miami||1|||f||||t||||||||||2017-10-11 01:45:15.843889|2017-10-11 01:45:15.843889
NCT01844609|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-10-24|||May 2013||2013-05-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|COG-JOCS||China Obstetrics and Gynecology Journal Club|An English Language Obstetrics and Gynecology Journal Club to Improve Medical English in China: A Randomized Controlled Trial|Completed||N/A|50|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 01:45:15.933908|2017-10-11 01:45:15.933908
NCT01844596|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-08-09|||April 2014||2014-04-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Optimizing Linkage and Retention to Hypertension Care in Rural Kenya|Optimizing Linkage and Retention to Hypertension Care in Rural Kenya|Recruiting||N/A|1800|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||||2017-10-11 01:45:16.034022|2017-10-11 01:45:16.034022
NCT01844583|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-09-29|||July 2013||2013-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Tolerability and PK of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib|Study of the Effect of Esomeprazole or Rifampin on the Pharmacokinetics of Alisertib and Evaluation of the Effect of Alisertib on the QTc Interval in Patients With Advanced Solid Tumors or Lymphomas|Completed||Phase 1|55|Actual|Takeda||1|||f||||||||||||||2017-10-11 01:45:16.15309|2017-10-11 01:45:16.15309
NCT01844570|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2013-04-30|||February 2013||2013-02-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|LEADER||Levamlodipine Maleate or Amlodipine Besylate for Treatment of Hypertension: A Comparative Effectiveness Research|Levamlodipine Maleate (Xuanning) or Amlodipine Besylate (Norvasc) for Treatment of Hypertension: A Comparative Effectiveness Research|Unknown status|Active, not recruiting|N/A|10000|Anticipated|Peking University First Hospital|||2||f||||f||||||||||2017-10-11 01:45:16.267227|2017-10-11 01:45:16.267227
NCT01844557|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-05-15|||May 2013|Actual|2013-05-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Testing Accountability in Patient Adherence|Testing Accountability in Patient Adherence|Active, not recruiting||N/A|225|Anticipated|M.D. Anderson Cancer Center|||3||f||||t||||||||||2017-10-11 01:45:16.352602|2017-10-11 01:45:16.352602
NCT01844544|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-02-24|||June 2013||2013-06-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01|7 Days|Observational [Patient Registry]|||Drug Related Problems Among Patients With Femoral Neck Fractures in an Orthopedic Ward|Identification and Characterization of Drug Related Problems Among Patients With Femoral Neck Fractures in an Orthopedic Ward|Completed||N/A|104|Actual|Meir Medical Center|||1||f||||f||||||||||2017-10-11 01:45:16.615647|2017-10-11 01:45:16.615647
NCT01844531|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-06-26|2015-06-26||April 2013||2013-04-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Treated set, included all subjects that entered the study and had taken at least 1 dose of trial medication.|Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets|Bioequivalence of Empagliflozin/Metformin (500 mg) Fixed Dose Combination Tablets Compared to Single Tablets Administered Together in Healthy Male and Female Volunteers Under Fed Conditions (an Open-label, Randomised, Single-dose, Four-way Crossover Study)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 01:45:16.725273|2017-10-11 01:45:16.725273
NCT01844518|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-06-29|2016-02-23||June 28, 2013|Actual|2013-06-28|June 2017|2017-06-01|December 29, 2023|Anticipated|2023-12-29|March 12, 2015|Actual|2015-03-12||Interventional||All treated participants 6 to17 years of age|Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)|A Phase 3 Multi-center, Open-Label Study to Evaluate Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)|Active, not recruiting||Phase 3|234|Actual|Bristol-Myers Squibb||1|||f||||t||||||||||2017-10-11 01:45:17.539359|2017-10-11 01:45:17.539359
NCT01844505|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2017-08-28|2017-07-14||June 11, 2013|Actual|2013-06-11|August 2017|2017-08-01|October 13, 2019|Anticipated|2019-10-13|August 1, 2016|Actual|2016-08-01||Interventional||All randomized participants|Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)|A Phase 3, Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab Versus Ipilimumab Monotherapy in Subjects With Previously Untreated Unresectable or Metastatic Melanoma|Active, not recruiting||Phase 3|1296|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-10-11 01:45:18.467794|2017-10-11 01:45:18.467794
NCT01844479|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-08-26|2015-06-12||December 2012||2012-12-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Multi-layer Insoles for a Patient-specific Approach to Shear and Pressure Reduction in Diabetes-related Foot Ulcer|Multi-material, Layer, and Density Insoles for a Patient-specific Approach to Shear and Pressure Reduction in the Treatment and Prevention of Diabetes-related Foot Ulcer|Completed||N/A|27|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 01:45:24.807406|2017-10-11 01:45:24.807406
NCT01844466|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-10-24|||January 2012||2012-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Correlation of Visual and Motor Deficits in Stroke Patients||Completed||N/A|25|Actual|University of Ioannina||1|||f||||f||||||||||2017-10-11 01:45:25.304499|2017-10-11 01:45:25.304499
NCT01844453|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-04-29|||August 2013||2013-08-01|April 2013|2013-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|LEI||Local Endometrial Injury in Fresh Embryo Transfer Cycles|Impact of Local Endometrial Injury on Implantation Rates in Fresh Embryo Transfer Cycles|Unknown status|Not yet recruiting|Phase 3|360|Anticipated|McGill University||3|||f||||f||||||||||2017-10-11 01:45:25.396551|2017-10-11 01:45:25.396551
NCT01844440|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2014-07-01|||April 2013||2013-04-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|HRM RTSIO||Diagnostic of Transient Lower Esophageal Sphincter Relaxation With Combined Impedance and High Resolution Manometry in Patients With GERD|Diagnostic of Transient Lower Esophageal Sphincter Relaxation With Combined Impedance and High Resolution Manometry in Patients With GERD.|Completed||N/A|15|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-10-11 01:45:25.515167|2017-10-11 01:45:25.515167
NCT01844427|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-09-23|||July 2013||2013-07-01|September 2013|2013-09-01||||March 2015|Anticipated|2015-03-01||Interventional|||Memantine Monotherapy for Executive Dysfunction and ADHD|Memantine Monotherapy for Executive Dysfunction and ADHD: A Pilot Study|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:45:25.596964|2017-10-11 01:45:25.596964
NCT01844414|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-05-26|||February 2010||2010-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|January 2014|Actual|2014-01-01||Interventional|||UCLA-Amity Parolee Health Promotion Study|Health Promotion Coaching/Vaccine for Homeless Parolees|Completed||N/A|600|Actual|University of California, Los Angeles||3|||f||||t||||||||||2017-10-11 01:45:25.699132|2017-10-11 01:45:25.699132
NCT01844401|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-11-13|||April 2013||2013-04-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma|Comparison of the Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma|Completed||Phase 1|15|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 01:45:25.83576|2017-10-11 01:45:25.83576
NCT01844388|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-09-25|2014-09-25||April 2013||2013-04-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Compare a New Eye Drop Formulation With Refresh Contacts®||Completed||Phase 3|365|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:45:25.939745|2017-10-11 01:45:25.939745
NCT01844375|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-06-01|||May 2013||2013-05-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||A Trial of Preoperative CHO Drinks on Postoperative Walking Capacity in Colorectal Surgery|A Randomized Controlled Trial of Preoperative Carbohydrate Drinks on Postoperative Walking Capacity in Colorectal Surgery.|Recruiting||N/A|70|Anticipated|Siriraj Hospital||2|||f||||f||||||||||2017-10-11 01:45:26.245319|2017-10-11 01:45:26.245319
NCT01844362|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-11-29|||September 2012||2012-09-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|utx||Uterus Transplantation From Live Donor|Prospective Case Series of Human Uterus Transplantation From Live Donor|Active, not recruiting||N/A|10|Anticipated|Sahlgrenska University Hospital, Sweden||1|||f||||t||||||||Yes|Scientific publications|2017-10-11 01:45:26.358803|2017-10-11 01:45:26.358803
NCT01844349|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2013-05-04|||March 2009||2009-03-01|May 2013|2013-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|Obe-Maghreb||Nutritional Transition in the Maghreb and Prevention of Obesity and Non-communicable Diseases|Understanding the Nutritional Transition in the Maghreb to Contribute to the Prevention of Obesity and Non-communicable Diseases|Completed||N/A|8218|Actual|Institute of Research for Development, France|||1||f||||f||||||||||2017-10-11 01:45:26.47103|2017-10-11 01:45:26.47103
NCT01844336|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2014-09-08||||||September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||PBASE System Idiopathic Rhinitis Clinical Investigation||Completed||N/A|208|Actual|Chordate Medical||2|||f||||f||||||||||2017-10-11 01:45:26.548315|2017-10-11 01:45:26.548315
NCT01844323|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-08-27|||June 2013||2013-06-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal Tract|A Phase 1, Open-Label 4 Sequence 4 Period Crossover Study In Healthy Volunteers To Estimate The Effect Of Active Pharmaceutical Ingredient Particle Size And Lubrication On The Bioavailability Of A Single 125 Mg Dose Of Palbociclib (PD-0332991) Administered Under Fasted Conditions|Completed||Phase 1|24|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 01:45:26.630317|2017-10-11 01:45:26.630317
NCT01844310|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-25|2013-04-26|||May 2013||2013-05-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection|Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection in China|Unknown status|Not yet recruiting|N/A|300|Anticipated|Peking Union Medical College||2|||f||||t||||||||||2017-10-11 01:45:26.7259|2017-10-11 01:45:26.7259
NCT01844297|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2013-04-26|||May 2013||2013-05-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy|Efficacy and Safety of Tenofovir Disoproxil Fumarate Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy for ART-naive Chinese Patients With HIV-1 Infection|Unknown status|Not yet recruiting|N/A|500|Anticipated|Peking Union Medical College||1|||f||||t||||||||||2017-10-11 01:45:26.817512|2017-10-11 01:45:26.817512
NCT01843894|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2014-08-20|||April 2013||2013-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye|A Phase 1/2, First-in-Human, Double-Masked, Placebo-Controlled, Dose-Escalation Study Evaluating the Safety, Tolerability, and Efficacy of RU-101 Ophthalmic Solution in Patients With Severe Dry Eye|Completed||Phase 1/Phase 2|104|Actual|R-Tech Ueno, Ltd.||2|||f||||t||||||||||2017-10-11 01:45:32.416041|2017-10-11 01:45:32.416041
NCT01844271|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2014-12-04|||May 2013||2013-05-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|LLLT||Low Level Laser Therapy in Muscle Fatigue and Muscle Recovery|Low Level Laser Therapy in Muscle Fatigue and Muscle Recovery After Exercise: What is the Ideal Dose?|Completed||N/A|28|Actual|University of Nove de Julho||6|||f||||f||||||||||2017-10-11 01:45:26.996114|2017-10-11 01:45:26.996114
NCT01844258|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2015-12-21|||March 2013||2013-03-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Modified Surgical Techniques for Pediatric Cataract Treatment|Modified Surgical Techniques for Pediatric Cataract Treatment|Completed||N/A|37|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:45:27.08719|2017-10-11 01:45:27.08719
NCT01844245|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2017-08-09|||May 2013||2013-05-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Endobiliary RFA for Unresectable Malignant Biliary Strictures|Endoscopic Radiofrequency Ablation for Malignant Biliary Strictures Due to Unresectable Cholangiocarcinoma or Ampullary Carcinoma: a Randomised, Controlled, Multicentre Clinical Trial|Recruiting||N/A|240|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||f||||||||||2017-10-11 01:45:27.179588|2017-10-11 01:45:27.179588
NCT01844232|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-05-14|||April 2013||2013-04-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity|A One Year, Open Label, Dose Escalation Study To Evaluate the Long-Term Safety of Arbaclofen Extended Release Tablets (AERT) in Multiple Sclerosis Subjects With Spasticity|Completed||Phase 3|150|Actual|Osmotica Pharmaceutical US LLC||1|||f||||t||||||||||2017-10-11 01:45:27.297648|2017-10-11 01:45:27.297648
NCT01844219|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2013-12-24|||April 2013||2013-04-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Accuracy of Pre-existing Risk Scoring Models for Predicting Acute Kidney Injury in Patients Who Underwent Aortic Surgery Using a Gray Zone Approach|Accuracy of Pre-existing Risk Scoring Models for Predicting Acute Kidney Injury in Patients Who Underwent Aortic Surgery Using a Gray Zone Approach|Completed||N/A|375|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 01:45:27.835069|2017-10-11 01:45:27.835069
NCT01844206|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-11-19|2015-10-16||June 2013||2013-06-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Two Dose Epidural Morphine for Post-cesarean Analgesia|Two Dose Epidural Morphine for Post-cesarean Analgesia|Terminated||Phase 4|5|Actual|Columbia University||2||Slow recruitment of subjects|f||||f||||||||||2017-10-11 01:45:27.92666|2017-10-11 01:45:27.92666
NCT01844193|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-04-03|||January 2013||2013-01-01|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients|A 12-Month Prospective, Post-Market Study of Early Postoperative Compex® Rehab NMES Use in Total Knee Arthroplasty Patients|Completed||N/A|60|Actual|Orthopaedic Research Foundation||2|||f||||f||||||||No||2017-10-11 01:45:28.220331|2017-10-11 01:45:28.220331
NCT01844180|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-03-17||2016-01-26|April 2013||2013-04-01|March 2016|2016-03-01||||July 2014|Actual|2014-07-01||Interventional|RESTORE||A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|Completed||Phase 2|200|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||f||||||||||2017-10-11 01:45:28.322304|2017-10-11 01:45:28.322304
NCT01844167|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-12-01|||April 2013||2013-04-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Effect of Noxipoint Therapy Versus Physical Therapy With TENS on Chronic Neck Pain|The Effect of Noxipoint™ Therapy Versus Physical Therapy With Transcutaneous Electrical Never Stimulation on Chronic Cervical Pain|Completed||N/A|42|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:45:28.508223|2017-10-11 01:45:28.508223
NCT01844154|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-03-02|||October 2012||2012-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Fracture and Fall Prevention in Elderly With Osteoporosis|Fracture and Fall Prevention in Elderly With Osteoporosis: Long-term Follow up|Recruiting||N/A|120|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 01:45:28.680857|2017-10-11 01:45:28.680857
NCT01844128|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-28|2013-06-10|||May 2013||2013-05-01|April 2013|2013-04-01||||April 2014|Anticipated|2014-04-01|1 Year|Observational [Patient Registry]|||The Effect of Weight Loss on Ovarian Reserve||Unknown status|Recruiting|N/A|100|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-11 01:45:28.900995|2017-10-11 01:45:28.900995
NCT01844115|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2015-02-27||2015-02-27|April 2013||2013-04-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder|A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.|Completed||Phase 3|415|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 01:45:29.015956|2017-10-11 01:45:29.015956
NCT01844102|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2014-05-12|||October 2013||2013-10-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia|Evaluation of the Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia|Completed||Phase 4|500|Actual|FHI 360||1|||f||||f||||||||||2017-10-11 01:45:29.194308|2017-10-11 01:45:29.194308
NCT01844089|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-02-12|||October 2013||2013-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||The Use of the Bakri Postpartum Balloon in the Management of Postpartum Hemorrhage Refractory to Conservative Measures|The Use of the Bakri Postpartum Balloon in the Management of Postpartum Hemorrhage Refractory to Conservative Measures: A Multi-Site Longitudinal Study An Initiative Under the East African Women's Health Network (EAWoHNet)|Completed||N/A|57|Actual|Duke University|||1||f||||t||||||||||2017-10-11 01:45:29.29809|2017-10-11 01:45:29.29809
NCT01844076|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-01-26|||March 2014|Actual|2014-03-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|April 2014|Actual|2014-04-01||Interventional|||Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal ADenocarcinoma|Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma:|Active, not recruiting||Phase 1/Phase 2|1|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||No|Started study at new Institution|2017-10-11 01:45:29.373935|2017-10-11 01:45:29.373935
NCT01844063|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2013-07-04|||July 2013||2013-07-01|July 2013|2013-07-01|January 2019|Anticipated|2019-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure|Clinical Comparison of Safety and Efficacy of Allogeneic Umbilical-Cord and Bone Marrow-derived Mesenchymal Stem Cells Transplantation for HBV-related Liver Failure|Recruiting||Phase 1/Phase 2|210|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||3|||f||||f||||||||||2017-10-11 01:45:29.482168|2017-10-11 01:45:29.482168
NCT01844050|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-05-21|||September 2008||2008-09-01|May 2013|2013-05-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms||Completed||N/A|120|Actual|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 01:45:29.583487|2017-10-11 01:45:29.583487
NCT01844037|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2015-08-31|||July 2014||2014-07-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||OneShot Renal Denervation Registry|Renal Denervation Using the OneShot Ablation System|Terminated||Phase 2/Phase 3|51|Actual|Medtronic Endovascular||1|||f||||||||||||||2017-10-11 01:45:29.673747|2017-10-11 01:45:29.673747
NCT01844024|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2014-08-27|||April 2013||2013-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Task Sharing to Improve Post Abortion Care at District Health Care Level- Trial in Uganda|Task Sharing to Improve Post Abortion Care at District Health Care Level- Trial in Uganda|Completed||Phase 4|1010|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 01:45:29.761691|2017-10-11 01:45:29.761691
NCT01844011|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2014-01-06|||March 2013||2013-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Promoting Fetal Movement Monitoring: Improving Birth Outcomes|Promoting Fetal Movement Monitoring: Improving Birth Outcomes|Completed||N/A|40|Actual|Mercy Medical Center||2|||f||||f||||||||||2017-10-11 01:45:29.840804|2017-10-11 01:45:29.840804
NCT01843998|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-06-03|||February 2014||2014-02-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)|Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)|Withdrawn||Phase 2|0|Actual|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 01:45:29.922475|2017-10-11 01:45:29.922475
NCT01843985|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2013-04-27|||June 2013||2013-06-01|April 2013|2013-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Observational Study of Survival Outcomes of Stage IV Cancer Patients|Observational Study of Survival Times of Stage IV Cancer Patients|Not yet recruiting||N/A|120|Anticipated|Cure Cancer Worldwide Corporation|||5||f||||f||||||||||2017-10-11 01:45:30.044997|2017-10-11 01:45:30.044997
NCT01843972|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-29|2016-05-17|2015-11-11||April 2013||2013-04-01|May 2016|2016-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Treated Set (TS): includes all subjects who were documented to have taken at least 1 dose of study medication.|Safety of Single Rising Doses and Relative Bioavailability of BI 691751|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses of BI 691751 in Healthy Male Volunteers in a Randomised, Single-blind, Placebo-controlled Design (Part I) and Investigation of Relative Bioavailability of BI 691751 Given as Tablet and Oral Solution to Healthy Male Subjects in an Open, Randomised, Single-dose, Single Period Parallel Group Design (Part II).|Completed||Phase 1|81|Actual|Boehringer Ingelheim||10|||f||||||||||||||2017-10-11 01:45:30.153964|2017-10-11 01:45:30.153964
NCT01843959|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-03-01|||March 2013||2013-03-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Abu Dhabi Diabetes and Obesity Study|Abu Dhabi Diabetes and Obesity Study (ADOS) - A Study on the Aetiology and Associated Risk Factors of Patients With Obesity/Diabetes Within the Emirati Population.|Active, not recruiting||N/A|2000|Anticipated|Imperial College London Diabetes Centre|||1||f||||||||||||||2017-10-11 01:45:31.455813|2017-10-11 01:45:31.455813
NCT01843946|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-27|2013-04-30|||March 2011||2011-03-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Clinical Efficacy of Roxithromycin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome||Completed||N/A|75|Actual|The Catholic University of Korea|||1||f||||||||||||||2017-10-11 01:45:31.527767|2017-10-11 01:45:31.527767
NCT01843933|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-01-26|2015-12-14||June 2013||2013-06-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Detecting Post-Operative Respiratory Depression in Children|Detecting Post-Operative Respiratory Depression in Children: Are Our Current Standards Good Enough?|Completed||N/A|211|Actual|Yale University||2|||f||||f||||||||||2017-10-11 01:45:31.589231|2017-10-11 01:45:31.589231
NCT01843920|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-12-13|2014-05-27||June 2011||2011-06-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble|A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on Intraocular Gas Duration Following Scleral Buckling and Pneumatic Retinopexy.|Completed||N/A|21|Actual|Wills Eye||2|||f||||f||||||||No||2017-10-11 01:45:31.847597|2017-10-11 01:45:31.847597
NCT01843907|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-07-30|||January 2013||2013-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Patient Participation in Prevention of Loss of Functions|Cross-sectorial Patient Participation in Prevention of Loss of Functions in Older Short-stay Medical Patients|Completed||N/A|300|Actual|Herlev Hospital||3|||f||||t||||||||||2017-10-11 01:45:32.317713|2017-10-11 01:45:32.317713
NCT01843699|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-30|||June 2009||2009-06-01|April 2013|2013-04-01||||November 2010|Actual|2010-11-01||Interventional|||Topiramate Trial for Pathological Gamblers|Double-blind Placebo Controlled Topiramate Trial for Pathological Gamblers|Completed||Phase 2|38|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-11 01:45:34.619276|2017-10-11 01:45:34.619276
NCT01843881|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-12-03|||March 2012||2012-03-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass|The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass|Completed||Early Phase 1|20|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:45:32.523804|2017-10-11 01:45:32.523804
NCT01843868|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-28|||May 2013||2013-05-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP|A Single Arm Study to Evaluate the Control of Chemotherapy Induced Nausea and Vomiting in Non-Hodgkin Lymphoma Patients Receiving R-CHOP.|Unknown status|Not yet recruiting|N/A|130|Anticipated|Australasian Leukaemia and Lymphoma Group||1|||f||||t||||||||||2017-10-11 01:45:32.613148|2017-10-11 01:45:32.613148
NCT01843855|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-12-03|||June 2011||2011-06-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass|The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass|Completed||Early Phase 1|12|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:45:32.717901|2017-10-11 01:45:32.717901
NCT01843829|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-03-21|||October 2013||2013-10-01|March 2014|2014-03-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|NeoSCOPE||A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer|A Randomised Phase II Study of Two Pre-operative Chemoradiotherapy Regimens (Oxaliplatin and Capecitabine Followed by Radiotherapy With Either Oxaliplatin and Capecitabine or Paclitaxel and Carboplatin) for Resectable Oesophageal Cancer|Unknown status|Recruiting|Phase 2|85|Anticipated|Velindre NHS Trust||2|||f||||t||||||||||2017-10-11 01:45:32.901927|2017-10-11 01:45:32.901927
NCT01843816|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-09-30|||February 2012||2012-02-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||The Effect of Body Shape on Tragus-Wall Measurement|The Effect of Body Shape on Tragus-Wall Measurement|Completed||N/A|465|Actual|Vakif Gureba Training and Research Hospital|||1||f||||f||||||||||2017-10-11 01:45:33.046818|2017-10-11 01:45:33.046818
NCT01843790|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-08-31|||June 2013||2013-06-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease|A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease|Completed||Phase 2|120|Actual|La Jolla Pharmaceutical Company||3|||f||||f||||||||||2017-10-11 01:45:33.372136|2017-10-11 01:45:33.372136
NCT01843777|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-10-06|2016-10-06||November 2013||2013-11-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Per protocol population reported: One subject randomized to the “Treatment” erroneously received “Standard of Care” and is not included in this baseline report.|Applying the Use of Motivational Tools to Auditory Rehabilitation|Applying the Use of Motivational Tools to Auditory Rehabilitation|Completed||N/A|25|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 01:45:33.545348|2017-10-11 01:45:33.545348
NCT01843764|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-05-02|||June 2009||2009-06-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|April 2011|Actual|2011-04-01||Observational|||Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Malaria Infections|Efficacy of Plasmodium Falciparum Specific Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Infections After Antimalarial Treatment|Completed||N/A|53|Actual|Karolinska University Hospital|||1||f||||t||||||Samples With DNA|"     Whole capillary blood collected for Rapid Diagnostic tests, microscopy and PCR   "|||2017-10-11 01:45:33.959908|2017-10-11 01:45:33.959908
NCT01843751|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-10-09|||March 2013||2013-03-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Dane County Drug Court Study for Addicted Offenders|Health Promotion and Public Safety: Community-based Collaborative Services to Addicted Offenders|Unknown status|Enrolling by invitation|Phase 3|40|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 01:45:34.09046|2017-10-11 01:45:34.09046
NCT01843738|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-05-22|||June 2017|Anticipated|2017-06-01|May 2017|2017-05-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Interventional|||Radiation Use During Vemurafenib Treatment|Radiation Use During Vemurafenib and Cobimetinib Treatment in Patients With BRAFV600 Mutated Stage IV or Unresectable Stage III Melanoma|Withdrawn||Phase 1|0|Actual|University of Utah||1||Competing Trials|f||||t|t|f|||f|||||2017-10-11 01:45:34.203891|2017-10-11 01:45:34.203891
NCT01843725|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-08-21|||September 2013||2013-09-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|MOMENTUM1||Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers|Modulation of Metabolic Index in Tailoring Treatment of Incurable Metastatic ColoRectal Cancer (CRC) Program 1.|Completed||Phase 1|42|Anticipated|Jules Bordet Institute||2|||f||||f|f|f||||||||2017-10-11 01:45:34.323562|2017-10-11 01:45:34.323562
NCT01843712|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-04-30|||February 2011||2011-02-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|HabEatWP31||Eating in the Absence of Hunger and Caloric Compensation in Preschool Children, Link With Parental Feeding Practices|Study of Eating in the Absence of Hunger and of Caloric Compensation in French Children, and of Their Relationships With Parental Feeding Practices|Completed||N/A|236|Actual|Centre des Sciences du Goût et de l'Alimentation|||1||f||||t||||||||||2017-10-11 01:45:34.499736|2017-10-11 01:45:34.499736
NCT01843686|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-06-26|||April 2013|Actual|2013-04-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns|Use of Autologous Platelet Rich Plasma (PRP) Gel as an Adjunct to the Treatment of Deep 2nd and 3rd Degree Burns|Active, not recruiting||Phase 1|42|Anticipated|Arteriocyte, Inc.||2|||f||||t||||||||||2017-10-11 01:45:34.748965|2017-10-11 01:45:34.748965
NCT01843673|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-05-26|2015-12-18||January 2009||2009-01-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer|Image-Guided Adaptive Radiotherapy for Head And Neck Cancer: Patient Image Acquisition|Completed||N/A|16|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 01:45:34.887511|2017-10-11 01:45:34.887511
NCT01843660|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-06-18|2013-06-18||September 2007||2007-09-01|June 2013|2013-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Out of a total of 1059 participants, baseline characteristic (age and gender) was available for only 1035 participants who were included in the full analysis set.|An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back Pain|The Clinical Efficacy and Safety Study of Tramadol Hydrochloride - Paracetamol Tablets in the Treatment of Moderate to Severe Acute Neck-shoulder Pain and Low Back Pain in Orthopaedics Outpatient or Emergency Setting|Completed||Phase 4|1059|Actual|Xian-Janssen Pharmaceutical Ltd.|Results are reported for 'number of participants who required additional dosage administration' instead of 'time to achieve analgesic effect' due to change in planned analysis.|1|||f||||f||||||||||2017-10-11 01:45:35.355731|2017-10-11 01:45:35.355731
NCT01843647|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-07-14|||April 2013||2013-04-01|December 2014|2014-12-01|February 2018|Anticipated|2018-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients|Randomized, Controlled, Multicenter Study of Neoadjuvant Therapy With Icotinib in IIIA NSCLC Patients With Epidermal Growth Factor Receptor Mutation|Recruiting||Phase 2|100|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 01:45:35.935539|2017-10-11 01:45:35.935539
NCT01843634|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-03-22|||August 2013||2013-08-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia|A Pilot Study to Evaluate the Safety and Preliminary Evidence of a Therapeutic Effect of ODSH (2-0, 3-0, Desulfated Heparin) in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia|Completed||Early Phase 1|10|Actual|Cantex Pharmaceuticals||1|||f||||t||||||||||2017-10-11 01:45:36.064654|2017-10-11 01:45:36.064654
NCT01843595|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2014-10-20|||July 2013||2013-07-01|September 2014|2014-09-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|REFIT||Rethinking Eating and FITness for Men|Efficacy Trial of the REFIT (Rethinking Eating and FITness) Weight Loss Intervention for Men|Completed||N/A|107|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:45:36.449707|2017-10-11 01:45:36.449707
NCT01843582|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-02-26|||May 2013||2013-05-01|May 2013|2013-05-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01|1 Day|Observational [Patient Registry]|||A Study to Determine the Location of the Blind Spot and the Macula-disc Centre Distance on a Fundus Photograph|A Study to Develop Both a Novel Method for Evaluating the True Size of a Retinal Object on Fundus Photographs and a New Reaction-time Based Method for Studying the Visual Field on Healthy Volunteers|Completed||N/A|17|Actual|Turku University Hospital|||1||f||||f||||||||||2017-10-11 01:45:36.553133|2017-10-11 01:45:36.553133
NCT01843569|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-10-06|||January 2015||2015-01-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|IVM||In Vitro Maturation (IVM) of Human Oocytes|In Vitro Maturation (IVM) of Human Oocytes|Active, not recruiting||N/A|50|Anticipated|Northwell Health||1|||f||||f||||||||||2017-10-11 01:45:36.627664|2017-10-11 01:45:36.627664
NCT01843556|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2014-02-17|||December 2012||2012-12-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males|A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals|Completed||Phase 1|48|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 01:45:36.748237|2017-10-11 01:45:36.748237
NCT01843543|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2014-10-16|||April 2013||2013-04-01|October 2014|2014-10-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Examining Bladder Control Using Mindful Based Approach|Assessing the Therapeutic Effect of Mindfulness-based Stress Reduction Intervention in Women With Urgency Incontinence Using Advanced Brain Imaging|Unknown status|Active, not recruiting|N/A|15|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:45:36.833197|2017-10-11 01:45:36.833197
NCT01843530|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-04-28|||November 2013||2013-11-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema|Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema|Recruiting||Phase 3|31|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-11 01:45:36.932867|2017-10-11 01:45:36.932867
NCT01843517|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-05-30|||April 2013||2013-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Endogenous Pain Facilitation and Inhibition in Postpartum Women|Endogenous Pain Facilitation and Inhibition in Postpartum Women|Recruiting||N/A|80|Anticipated|Wake Forest University Health Sciences|||2||f||||f||||||||||2017-10-11 01:45:37.231696|2017-10-11 01:45:37.231696
NCT01843504|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-05-04|||March 2013||2013-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PRP||Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy|The Clinical, Biomechanical, and Tissue Regenerating Effects of a Single Platelet-rich Plasma Injection for the Treatment of Chronic Patellar Tendinopathy: a Randomized Controlled Trial|Enrolling by invitation||Phase 2|44|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 01:45:37.306469|2017-10-11 01:45:37.306469
NCT01843491|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-04-28|||June 2013||2013-06-01|April 2015|2015-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|AdBa||A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents|A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents for Refining Immunologic Assays Supporting the Development of the Protective Malaria Vaccine NMRC-M3V-D/Ad-PfCA (AdBa)|Withdrawn||Phase 1|0|Actual|U.S. Army Medical Research and Materiel Command||1||Did not go forward with study.|f||||f||||||||||2017-10-11 01:45:37.399218|2017-10-11 01:45:37.399218
NCT01843478|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-04-26|||October 2012||2012-10-01|April 2013|2013-04-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling|A Test of an Intervention to Improve Pap Testing Among Women With HIV|Unknown status|Enrolling by invitation|Phase 4|111|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:45:37.483177|2017-10-11 01:45:37.483177
NCT01843465|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-10-18|2013-08-10||April 2013||2013-04-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Observational|||Cryoablation of AF: Improving the Use of the Achieve Catheter|Improving the Assessment of Pulmonary Vein Disconnection With the Achieve Catheter During Atrial Fibrillation Cryoablation|Completed||N/A|34|Actual|Clinique Pasteur|||1||f||||f||||||||||2017-10-11 01:45:37.579695|2017-10-11 01:45:37.579695
NCT01843452|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-05-18|||December 2012||2012-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal|Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal|Terminated||Phase 2|8|Actual|Centre Hospitalier Universitaire Vaudois||1||Poor recruitment|f||||f||||||||||2017-10-11 01:45:37.760642|2017-10-11 01:45:37.760642
NCT01843439|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-04-26|||June 2012||2012-06-01|April 2013|2013-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||Effects of Multidisciplinary Interventions in Elderly Asthma Patients With Risk of Acute Exacerbation||Unknown status|Active, not recruiting|N/A|360|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:45:37.860248|2017-10-11 01:45:37.860248
NCT01843426|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-03-21|||February 2013||2013-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Aortic Stenosis Pre-Transcatheter Aortic Valve Replacement (TAVR) Procedure CT Scan|Diagnostic Image Quality and Safety of Low-Volume, Low-Concentration, Iso-Osmolar Contrast Medium in the Computed Tomographic Workup of Patients Considered for TAVR|Active, not recruiting||N/A|40|Anticipated|Medical University of South Carolina||1|||f||||f||||||||||2017-10-11 01:45:37.949189|2017-10-11 01:45:37.949189
NCT01843413|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-03-16|||July 2, 2013|Actual|2013-07-02|March 2017|2017-03-01|September 22, 2017|Anticipated|2017-09-22|September 22, 2017|Anticipated|2017-09-22||Interventional|||Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases|Dose Escalation for Larger Brain Metastases: Phase I/II Study|Recruiting||N/A|40|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|f|f||||||||2017-10-11 01:45:38.025567|2017-10-11 01:45:38.025567
NCT01843387|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-10-12|||July 2013||2013-07-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy|A Randomized, Controlled, Dose-Escalation Pilot Study to Assess the Safety and Efficacy of a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Diabetic Nephropathy and Type 2 Diabetes|Completed||Phase 1/Phase 2|30|Actual|Mesoblast, Ltd.||2|||f||||t||||||||||2017-10-11 01:45:38.218358|2017-10-11 01:45:38.218358
NCT01843374|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-08-15|2017-04-10|2017-01-24|May 17, 2013|Actual|2013-05-17|August 2017|2017-08-01|April 2, 2018|Anticipated|2018-04-02|January 24, 2016|Actual|2016-01-24||Interventional|Tremelimumab||Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma|A Phase 2b, Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second- or Third-line Treatment of Subjects With Unresectable Pleural or Peritoneal Malignant Mesothelioma|Active, not recruiting||Phase 2|571|Actual|MedImmune LLC||2|||f||||t||||||||||2017-10-11 01:45:38.358815|2017-10-11 01:45:38.358815
NCT01843361|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2013-04-26|||July 2010||2010-07-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|Bo-CRISP||Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study|Prevalence of Low Response to Clopidogrel in Patients After Acute Ischemic Stroke.|Completed||N/A|159|Actual|Ruhr University of Bochum|||1||f||||f||||||||||2017-10-11 01:45:43.457398|2017-10-11 01:45:43.457398
NCT01843348|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-03-21|2017-03-21||December 27, 2012|Actual|2012-12-27|March 2017|2017-03-01|March 23, 2016|Actual|2016-03-23|March 23, 2016|Actual|2016-03-23||Interventional|ATHENA|Full analysis set consisted of all randomized patients who received at least one dose of study drug|12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients|12 Month, Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Certican® Based Regimen Either in Combination With Cyclosporin A or Tacrolimus|Completed||Phase 3|612|Actual|Novartis||3|||f||||t||||||||||2017-10-11 01:45:43.59252|2017-10-11 01:45:43.59252
NCT01843335|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-02-02|||September 2014||2014-09-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair|Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair|Active, not recruiting||N/A|60|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 01:45:47.305893|2017-10-11 01:45:47.305893
NCT01843309|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2015-07-02|||May 2013||2013-05-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B|Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B|Terminated||Phase 4|36|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||3||Not possible to complete the sample within the estimated time by the use of new antifungals|f||||||||||||||2017-10-11 01:45:47.651012|2017-10-11 01:45:47.651012
NCT01843296|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-06-30|||November 2012||2012-11-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Addition of Magnesium Sulfate in Spinal Anesthesia on Sensory-Motor Blocks and Postoperative Pain in Lumbar Disk Herniation Surgery|Comparison of the Effects of Three Methods of Intrathecal Bupivacaine; Bupivacaine-Fentanyl and Bupivacaine-Fentanyl-Magnesium Sulfate on Sensory-Motor Blocks and Postoperative Pain in Patients Undergoing Lumbar Disk Herniation Surgery|Completed||Phase 4|105|Actual|Isfahan University of Medical Sciences||3|||f||||t||||||||||2017-10-11 01:45:47.77782|2017-10-11 01:45:47.77782
NCT01843283|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-10-24|||July 2012||2012-07-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|March 2015|Actual|2015-03-01||Interventional|||Meaningful Activity Intervention for Persons With Mild Cognitive Impairment|Meaningful Activity Intervention for Persons With Mild Cognitive Impairment|Completed||Phase 1|80|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 01:45:47.944435|2017-10-11 01:45:47.944435
NCT01843270|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-09-25|||November 2013||2013-11-01|January 2014|2014-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Appropriate Laryngeal Mask Airway Size in Patients With Overweight: A Comparison of the Actual Body Weight and Ideal Body Weight||Completed||N/A|100|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:45:48.096116|2017-10-11 01:45:48.096116
NCT01843257|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-01-23|||April 2013||2013-04-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|RBA||Effects of Alcohol After Bariatric Surgery|Pharmacokinetics and Pharmacological Effects of Alcohol After Bariatric Surgery|Recruiting||N/A|100|Anticipated|University of Illinois at Urbana-Champaign|||7||f||||t||||||Samples With DNA|"     Blood and plasma   "|||2017-10-11 01:45:48.221544|2017-10-11 01:45:48.221544
NCT01843244|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-04-29|||July 2010||2010-07-01|April 2013|2013-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Plethysmography as a Useful Intraoperative Monitor|Plethysmography as a Useful Intraoperative Monitor|Completed||N/A|15|Actual|University of Virginia|||1||f||||f||||||||||2017-10-11 01:45:48.366108|2017-10-11 01:45:48.366108
NCT01843218|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-03-03|||March 2008||2008-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|METEORR||Erectile Rating During the Treatment of Rectal Cancers Localized|Erectile Rating During the Treatment of Rectal Cancers Localized. Exploratory Study|Terminated||N/A|12|Actual|Institut Bergonié||1|||f||||t||||||||||2017-10-11 01:45:48.595393|2017-10-11 01:45:48.595393
NCT01843205|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-10-02|||April 2013||2013-04-01|October 2017|2017-10-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Buspirone as a Candidate Medication for Methamphetamine Abuse|Buspirone as a Candidate Medication for Methamphetamine Abuse|Completed||Phase 1|9|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-11 01:45:48.719676|2017-10-11 01:45:48.719676
NCT01843192|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2015-05-21|2015-03-06||May 2013||2013-05-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||All subjects who consented to the study, had surgery for wedge resection, lobectomy, or wedge resection with lobectomy and were not converted to an open procedure|Powered Echelon Device in VATS Surgery|A Prospective, Multi-Center Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures|Completed||N/A|71|Actual|Ethicon Endo-Surgery|||1||f||||f||||||||||2017-10-11 01:45:48.862291|2017-10-11 01:45:48.862291
NCT01843179|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-02-15|||January 2014||2014-01-01|February 2017|2017-02-01|January 2014||2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Sulindac for Patients With AML|A Phase II Study of Sulindac, a COX Inhibitor, in Older Patients With Acute Myeloid Leukemia in First Complete Remission|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||1||Lack of Funding|f||||t||||||||||2017-10-11 01:45:49.799928|2017-10-11 01:45:49.799928
NCT01843166|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2013-04-25|||July 2012||2012-07-01|April 2013|2013-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Vaginal Estrogen With Pessary Treatment|Use of Vaginal Estrogen With Pessary Treatment of Pelvic Organ Prolapse and Urinary Incontinence|Unknown status|Recruiting|N/A|150|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:45:49.916938|2017-10-11 01:45:49.916938
NCT01843153|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-03-30|||April 2013||2013-04-01|April 2013|2013-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty|Continuous Versus Intermittent Sciatic Block Combined With a Continuous Femoral Block for Patients Undergoing Total Knee Arthroplasty: a Prospective, Randomized Trial.|Completed||Phase 4|140|Actual|Kreiskrankenhaus Dormagen||2|||f||||f||||||||||2017-10-11 01:45:50.05143|2017-10-11 01:45:50.05143
NCT01843140|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-05-12|||May 2011||2011-05-01|May 2016|2016-05-01||||April 2017|Anticipated|2017-04-01||Observational|||Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry|Fertility Information Research Study|Recruiting||N/A|500|Anticipated|University of California, San Diego|||1||f||||f||||||Samples Without DNA|"     Dried blood spots   "|||2017-10-11 01:45:50.156351|2017-10-11 01:45:50.156351
NCT01843127|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-03-28|||April 2013||2013-04-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.|A Phase 1, Randomized, Single-blind, Placebo-controlled, Multiple-dose, Two-sequence, Cross-over Study to Evaluate the Effect of Ranolazine on Glucagon Secretion in Subjects With Type 2 Diabetes Mellitus, Followed by An Open-label, Single Dose, Exenatide Active-control Period|Completed||Phase 1|24|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 01:45:50.245343|2017-10-11 01:45:50.245343
NCT01843114|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-03-17|||January 12, 2015|Actual|2015-01-12|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|August 26, 2016|Actual|2016-08-26||Interventional|||Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects|Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects|Completed||N/A|48|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:45:50.368209|2017-10-11 01:45:50.368209
NCT01843101|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-11-30|||July 2013||2013-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study|Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study|Recruiting||Phase 2|20|Anticipated|Medical University of Vienna||3|||f||||t||||||||||2017-10-11 01:45:50.471911|2017-10-11 01:45:50.471911
NCT01843088|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-10-10|||May 2013||2013-05-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|PainCream||Trial of Mannitol Cream for Pain Relief After a Long Run|Randomized Trial of Mannitol Cream for Pain Relief After a Long Run|Completed||Phase 1|170|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 01:45:50.567329|2017-10-11 01:45:50.567329
NCT01843075|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-03-23|||January 2014||2014-01-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|ELAD||Evaluating Liraglutide in Alzheimer's Disease|Evaluating the Effects of the Novel GLP-1 Analogue, Liraglutide, in Patients With Mild Alzheimer's Disease (ELAD Study)|Recruiting||Phase 2|206|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 01:45:50.666601|2017-10-11 01:45:50.666601
NCT01843062|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-08-02|||August 27, 2013|Actual|2013-08-27|July 2017|2017-07-01|July 5, 2019|Anticipated|2019-07-05|January 8, 2018|Anticipated|2018-01-08||Interventional|ASTRA||Study Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer|A Randomised, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients With Differentiated Thyroid Cancer|Active, not recruiting||Phase 3|233|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:45:50.89875|2017-10-11 01:45:50.89875
NCT01843049|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-26|||January 2013||2013-01-01|April 2013|2013-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer|Dose Escalation Using a Simultaneous Integrated Boost Technique Based on 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer: a Phase I/II Trial|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-11 01:45:51.153357|2017-10-11 01:45:51.153357
NCT01843036|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2017-04-06|||January 2014||2014-01-01|April 2017|2017-04-01|June 2026|Anticipated|2026-06-01|June 2026|Anticipated|2026-06-01||Interventional|||Durham Connects RCT Evaluation II|Second RCT Evaluation of the Durham Connects Universal Newborn Nurse Home Visiting Program|Active, not recruiting||N/A|1650|Anticipated|Duke University||2|||f||||t||||||||No||2017-10-11 01:45:51.255342|2017-10-11 01:45:51.255342
NCT01843023|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-09-29|||June 2013||2013-06-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Extended Release Naltrexone for Opioid-Dependent Youth|Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth|Recruiting||Phase 4|340|Anticipated|Friends Research Institute, Inc.||2|||f||||t||||||||No||2017-10-11 01:45:51.374437|2017-10-11 01:45:51.374437
NCT01843010|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-02-15|||May 2013||2013-05-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Parecoxib on the Change of Shoulder Pain Threshold After Gynecological Laparoscopies|Effect of Parecoxib on the Change of Shoulder Pain Threshold After Gynecological Laparoscopies|Completed||Phase 4|140|Actual|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 01:45:51.578358|2017-10-11 01:45:51.578358
NCT01842997|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-25|||October 2009||2009-10-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety of H1N1 Influenza Vaccination in Pregnant Women|A Stratified and Controlled Clinical Trial With Split-virion, Non-adjuvanted Influenza A/H1N1 Vaccines in Healthy Pregnant Women|Completed||Phase 4|122|Actual|Jiangsu Province Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-10-11 01:45:51.714319|2017-10-11 01:45:51.714319
NCT01842984|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-06-13|||March 2013||2013-03-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|I-SOCIAL||Decreasing Loneliness in Older Adults|Increasing Social Competence and Social Integration of Older Adults Experiencing Loneliness|Active, not recruiting||N/A|40|Anticipated|Tel Aviv University||2|||f||||f||||||||Undecided||2017-10-11 01:45:51.832888|2017-10-11 01:45:51.832888
NCT01842971|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-01-30|||May 2013||2013-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ALPPS (Liver Partition and Portal Vein Ligation) for Two-stage Hepatectomy for Colorectal Liver Metastasis|Associating Liver Partition and Portal Vein Ligation (ALPPS) for Potentially Resectable Liver Metastasis From Colorectal Cancer: Prospective Evaluation of the Early Two-stage Hepatectomy by the Simon's Methods|Recruiting||Phase 3|44|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:45:51.944457|2017-10-11 01:45:51.944457
NCT01842945|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-03-05|||August 2013||2013-08-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Internet Based Cognitive Behavior Therapy for Procrastination: A Randomized Controlled Trial|Internet Based Cognitive Behavior Therapy for Procrastination: A Randomized Controlled Trial|Completed||N/A|150|Actual|Stockholm University||3|||f||||f||||||||Undecided||2017-10-11 01:45:52.277047|2017-10-11 01:45:52.277047
NCT01842932|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2014-06-25|||December 2009||2009-12-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||Usefulness Of Flospan As A Premedication For Colonoscopy|Usefulness Of Flospan As A Premedication For Colonoscopy : A Randomized Double Blind Controlled Trial|Unknown status|Recruiting|Phase 4|260|Anticipated|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-11 01:45:52.386952|2017-10-11 01:45:52.386952
NCT01842906|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-03-09|2016-08-09||October 2013||2013-10-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|SLEEP-AID||Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID)|Randomized Controlled Trial for Assessment of a Novel Non-Pharmacologic Intervention for Decrease in Altitude Illness|Completed||N/A|219|Actual|Stanford University||2|||f||||t||||||||No||2017-10-11 01:45:52.620275|2017-10-11 01:45:52.620275
NCT01842893|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-05-02|||November 2011||2011-11-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|ETHYFYL||Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer|Randomized, Placebo-controlled Study of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer|Completed||Phase 3|91|Actual|Ethypharm||1|||f||||f||||||||||2017-10-11 01:45:52.963463|2017-10-11 01:45:52.963463
NCT01842880|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-02-19|||January 2011||2011-01-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|||MicroRNAs as Biomarkers in Patients With Chagas Disease|Validation of MicroRNAs as Biomarkers for Determining Patients Prognosis With Chagas Disease|Completed||N/A|60|Actual|Hospital Sao Rafael|||1||f||||f||||||Samples With DNA|"     Plasma, Serum, Whole Blood   "|||2017-10-11 01:45:53.064193|2017-10-11 01:45:53.064193
NCT01842867|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-10-09|||January 2011||2011-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Syndecan-4 as a Biomarker in Patients With Chagas Disease|Validation of Syndecan-4 as a Biomarker for Determining Patients Prognosis With Chagas Disease.|Completed||N/A|60|Actual|Hospital Sao Rafael|||1||f||||f||||||Samples With DNA|"     Plasma, Serum, Whole Blood   "|||2017-10-11 01:45:53.1673|2017-10-11 01:45:53.1673
NCT01842854|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-10-09|||January 2011||2011-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Galectin-3 as a Biomarker in Patients With Chagas Disease|Validation of Galectin-3 as a Biomarker for Determining Patients Prognosis With Chagas Disease|Completed||N/A|60|Actual|Hospital Sao Rafael|||1||f||||f||||||Samples With DNA|"     Plasma, Serum, Whole Blood   "|||2017-10-11 01:45:53.270786|2017-10-11 01:45:53.270786
NCT01842841|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-11-09|2015-09-28||March 2013||2013-03-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Safety population included all enrolled participants who received at least 1 investigational product infusion (full or partial).|Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease|A Multicenter, Open-label Extension Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease|Completed||Phase 3|5|Actual|Shire||1|||f||||f||||||||||2017-10-11 01:45:53.389775|2017-10-11 01:45:53.389775
NCT01842828|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-11-15|||December 2013||2013-12-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|(SUKCES)||UK-Czech E-cigarette Study|E-Cigarettes as an Addition to Multi-component Treatment for Tobacco Dependence: A Pilot Study|Active, not recruiting||N/A|350|Anticipated|Queen Mary University of London||2|||f||||f||||||||||2017-10-11 01:45:53.925407|2017-10-11 01:45:53.925407
NCT01842815|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2016-02-16|||March 2013||2013-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of the 755nm Alexandrite for Unwanted Tattoos||Completed||N/A|20|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 01:45:54.020869|2017-10-11 01:45:54.020869
NCT01842802|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-26|2014-03-25|||January 2012||2012-01-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Clinical Investigation of Non Invasive Fat Reduction||Completed||N/A|8|Actual|Cynosure, Inc.||2|||f||||f||||||||||2017-10-11 01:45:54.107519|2017-10-11 01:45:54.107519
NCT01842789|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-07-18|2017-05-27||April 2013||2013-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|TAG||Post Market Evaluation of Acessa With TAG|Post Market Evaluation of the Acessa System With Targeting Animation Guidance (TAG)|Terminated||N/A|18|Actual|Acessa Health, Inc.||2||"Results to date adequately demonstrated user preference and recovery time. Time to target (Part   II) was not studied. ."|f||||f||||||||||2017-10-11 01:45:54.19285|2017-10-11 01:45:54.19285
NCT01842776|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-04-25|||March 2013||2013-03-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|CT||Care Transitions in Renal Disease Patients|Care Transitions in Renal Disease Patients|Unknown status|Recruiting|N/A|3300|Anticipated|Fresenius Medical Care North America|||1||f||||f||||||||||2017-10-11 01:45:54.453157|2017-10-11 01:45:54.453157
NCT01842763|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-03-18|||March 2013||2013-03-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|NGO||French Database of Occipital Nerves Stimulation in the Treatment of Refractory Chronic Headache Disorders|French Database of Occipital Nerves Stimulation in the Treatment of Refractory Chronic Headache Disorders|Recruiting||N/A|50|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||||2017-10-11 01:45:54.536998|2017-10-11 01:45:54.536998
NCT01842750|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-07-29|||August 2013||2013-08-01|June 2014|2014-06-01||||December 2014|Anticipated|2014-12-01||Interventional|BRAD||The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study|The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study|Unknown status|Recruiting|N/A|10|Anticipated|The Christie NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:45:54.625811|2017-10-11 01:45:54.625811
NCT01842737|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-03-28|||April 2013||2013-04-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PRoGReSS-PS||PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Study|PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Randomized Controlled Trial|Completed||N/A|8|Actual|Palmer College of Chiropractic||2|||f||||t||||||||No|Feasibility/pilot study|2017-10-11 01:45:54.707826|2017-10-11 01:45:54.707826
NCT01842724|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-09-24|||August 2014||2014-08-01|September 2017|2017-09-01||||August 2019|Anticipated|2019-08-01||Interventional|||Motec Versus Remotion Total Wrist Arthroplasty - A Prospective Study|Motec Versus Remotion Total Wrist Arthroplasty - A Prospective Randomized Study.|Recruiting||N/A|||Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:45:54.899782|2017-10-11 01:45:54.899782
NCT01842711|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-29|||September 2012||2012-09-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Cumulative Irritation Patch Test|Exclusive Cumulative Irritation Patch Test (21 Day) With Challenge Patch Application|Completed||N/A|224|Actual|Chattem, Inc.|||1||f||||t||||||||||2017-10-11 01:45:54.992588|2017-10-11 01:45:54.992588
NCT01839539|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2013-04-22|||March 2013||2013-03-01|April 2013|2013-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of DC-CIK to Treat Colorectal Cancer|Phase Ⅱ Study of Dendritic and Cytokine-induced Killer Cells (DC-CIK) Treatment in Patients With Stage Ⅲ Colorectal Cancer|Recruiting||Phase 2|60|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-11 01:46:42.048935|2017-10-11 01:46:42.048935
NCT01842698|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-03-19|||April 2013||2013-04-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|BPV échoguidé||Ultrasound-guided PVB|Feasibility of the Use of Ultrasound-guided Paravertebral Catheterisation for the Analgesic Management of Thoracotomy|Terminated||Phase 2|60|Anticipated|Centre Jean Perrin||1||"The study was stopped because there was a technical problem with the ultrasound used in the   trial."|f||||f||||||||||2017-10-11 01:45:55.264882|2017-10-11 01:45:55.264882
NCT01842685|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2013-04-25|||April 2013||2013-04-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|OAB||Bladder Thermal Distention for Patients With Refractory Overactive Bladder|Bladder Thermal Distention for Patients With Refractory Overactive Bladder|Unknown status|Recruiting|N/A|20|Anticipated|Assaf-Harofeh Medical Center||1|||f||||f||||||||||2017-10-11 01:45:55.375305|2017-10-11 01:45:55.375305
NCT01842672|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-07-29|||March 2013||2013-03-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MITCL||Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia|A Pilot Study of Mitoxantrone in Combination With Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) With Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin Lymphoma|Recruiting||Phase 1/Phase 2|55|Anticipated|New York Medical College||1|||f||||f||||||||||2017-10-11 01:45:55.486225|2017-10-11 01:45:55.486225
NCT01842659|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-08-23|||May 2013||2013-05-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|December 2015|Actual|2015-12-01||Interventional|DASIRUWIBE||Prenatal Screening for Imprinting Anomalies Implicated in Beckwith Wiedemann and Silver Russell Syndromes|Prenatal Screening for Imprinting Anomalies Implicated in Beckwith Wiedemann and Silver Russell Syndromes|Active, not recruiting||N/A|67|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:45:55.654296|2017-10-11 01:45:55.654296
NCT01842646|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-07-25|2017-01-24||August 2013|Actual|2013-08-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|January 2016|Actual|2016-01-01||Interventional||All participants|Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)|A Phase II Study Evaluating the Oral Smoothened Inhibitor PF-04449913 in Patients With Myelodysplastic Syndrome (MDS)|Active, not recruiting||Phase 2|35|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 01:45:55.793389|2017-10-11 01:45:55.793389
NCT01842633|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-08-02|2016-06-02||April 1, 2013|Actual|2013-04-01|August 2017|2017-08-01|March 31, 2015|Actual|2015-03-31|March 31, 2015|Actual|2015-03-31||Interventional||Demography data is available for 157 Participants only (safety Population).|Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache|A Study to Assess Efficacy Over Placebo and Speed of Onset of Pain Relief of New Paracetamol and Caffeine Tablets as Compared to Ibuprofen in Episodic Tension Type Headache|Terminated||Phase 3|365|Actual|GlaxoSmithKline|Enrollment into the trial was terminated after randomization of 62% of the plan resulting in a significant reduction in study power. The originally planned inferential statistics (p-values) were therefore not presented in tables summarizing results.|3|||f||||f||||||||||2017-10-11 01:45:56.38655|2017-10-11 01:45:56.38655
NCT01842607|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-09-07|2015-11-23||May 27, 2013|Actual|2013-05-27|September 2017|2017-09-01|March 13, 2015|Actual|2015-03-13|March 13, 2015|Actual|2015-03-13||Interventional|||A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects|A Multi-centre, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects Who Participated in theMEA115588 or MEA115575 Trials|Completed||Phase 3|651|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-10-11 01:45:57.689184|2017-10-11 01:45:57.689184
NCT01842594|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-10-05|2015-06-08||August 2012||2012-08-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma|A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma|Terminated||Phase 2|13|Actual|Shin Kong Wu Ho-Su Memorial Hospital||1||"Most patients completed only the primary objective (PET) and not went throught the secondary   outcome (efficacy phase) of 8wks period."|f||||t||||||||||2017-10-11 01:45:59.332702|2017-10-11 01:45:59.332702
NCT01842581|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-04-26|||January 2013||2013-01-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy|A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy|Completed||Phase 4|222|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||t||||||||||2017-10-11 01:45:59.550544|2017-10-11 01:45:59.550544
NCT01842568|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-10-04|||May 2013||2013-05-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|||Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery|Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery|Recruiting||N/A|15000|Anticipated|Population Health Research Institute|||1||f||||f||||||||||2017-10-11 01:45:59.775496|2017-10-11 01:45:59.775496
NCT01842555|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-03-29|||November 2012||2012-11-01|March 2017|2017-03-01|December 30, 2024|Anticipated|2024-12-30|November 2018|Anticipated|2018-11-01|3 Years|Observational [Patient Registry]|PDT Registry||Photodynamic Therapy (PDT) Oncology Registry|Photodynamic Therapy (PDT) Oncology Registry|Recruiting||N/A|1000|Anticipated|Main Line Health|||1||f||||f||||||||Yes||2017-10-11 01:45:59.96386|2017-10-11 01:45:59.96386
NCT01842542|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2015-10-26|||December 2013||2013-12-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset|An Open-Label Study to Evaluate the Efficacy and Safety of the Neuronetics NeuroStar TMS Therapy System in Patients With Major Depressive Disorder (MDD) With Postpartum Onset.|Completed||N/A|25|Actual|Neuronetics||1|||f||||f||||||||||2017-10-11 01:46:00.222547|2017-10-11 01:46:00.222547
NCT01842529|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-01-30|||September 2012||2012-09-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery|Botulinum Toxin Injection in Epicardial Fat Pads Can Prevent Recurrences of Atrial Fibrillation After Cardiac Surgery: Randomized Pilot Study|Completed||Phase 2|60|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 01:46:00.334486|2017-10-11 01:46:00.334486
NCT01842516|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2014-11-14|||March 2013||2013-03-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Multiple Ascending Dose Study for LCB01-0371|A Phase I Clinical Study, Randomized, Double-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability, and Population Pharmacokinetics of LCB01-0371 in Healthy Male Subjects.|Completed||Phase 1|30|Actual|LegoChem Biosciences, Inc||3|||f||||f||||||||||2017-10-11 01:46:00.489457|2017-10-11 01:46:00.489457
NCT01842503|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-09-01|||November 2014||2014-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|SPAD||Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent|A Phase 1b/2a, Cross-over, Randomised, Double-blind, Placebo Controlled Study to Investigate the Safety and Pharmacodynamic Effects of GET 73 in Alcohol Dependent Subjects|Recruiting||Phase 1/Phase 2|25|Anticipated|Laboratorio Farmaceutico Ct S.r.l.||2|||f||||f||||||||||2017-10-11 01:46:00.645924|2017-10-11 01:46:00.645924
NCT01842490|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2014-08-22|||May 2010||2010-05-01|April 2013|2013-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Observational|||Serum Biomarker of Plaque Vulnerability and Contrast Ultrasound of Carotid Artery|Can Serum Biomarker of Plaque Vulnerability be Identified Through the Contrast-enhanced Ultrasound of Carotid Artery|Completed||N/A|120|Anticipated|Kyunghee University Medical Center|||1||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 01:46:00.803076|2017-10-11 01:46:00.803076
NCT01842477|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-02-24|||May 2013||2013-05-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|OrthoCT1||Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing|Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing in Patients With Delayed Consolidation After Long Bone Fracture Requiring Graft Apposition or Alternative Orthobiologics|Recruiting||Phase 1/Phase 2|30|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-11 01:46:00.927425|2017-10-11 01:46:00.927425
NCT01842464|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-06-17|2013-07-31||September 2011||2011-09-01|June 2015|2015-06-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|||Sacro-Spinous Ligaments Anterior Apical Anchoring|Sacro-Spinous Ligaments Anterior Apical Anchoring for Needle-Guided Mesh in Advanced Pelvic Organ Prolapse|Completed||N/A|44|Actual|Western Galilee Hospital-Nahariya|||1||f||||t||||||||||2017-10-11 01:46:01.103548|2017-10-11 01:46:01.103548
NCT01842451|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-11-30||2015-10-23|June 2013||2013-06-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C|A Phase 2, Multicenter, Randomized, Partially-Blind, Dose-Ranging Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Treatment-Naïve Adult Subjects With Genotype 1 Chronic Hepatitis C|Completed||Phase 2|23|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-11 01:46:01.464343|2017-10-11 01:46:01.464343
NCT01842438|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-05-02|2015-12-01||October 2012||2012-10-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||A Couple Support Intervention for Prostate Cancer|Psychosexual Support Following Prostate Cancer Surgery: Feasibility and Outcomes of a Couple-based Intervention|Completed||N/A|86|Actual|University of Stirling|Under-recruitment means the study is not powered (though the study was designed as a pilot, so not hypothesis testing).|2|||f||||t||||||||No|Consent was not gained for data sharing in this manner|2017-10-11 01:46:01.618372|2017-10-11 01:46:01.618372
NCT01842425|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-29|||October 2012||2012-10-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Changes in Body- and Liver-composition During Low Calorie Diet in Morbidly Obese|Changes in Body- and Liver-composition During Low Calorie Diet in Morbidly Obese|Unknown status|Recruiting|N/A|30|Anticipated|Uppsala University|||1||f||||f||||||Samples With DNA|"     Two serum samples from each patient at each examination. Biopsies of subcutananeous fat and     visceral fat, approximately 1 mililiter each, taken during laparoscopic gastric bypass     surgery   "|||2017-10-11 01:46:02.114633|2017-10-11 01:46:02.114633
NCT01842412|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2016-10-24|||April 2013||2013-04-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Observational|||The Initial Effect of Training on Mitochondrial Function in Patients With Intermittent Claudication|The Initial Effect of Training on Mitochondrial Function in Patients With Intermittent Claudication|Completed||Early Phase 1|50|Actual|Norwegian University of Science and Technology|||2||f||||f||||||Samples Without DNA|"     muscle tissue   "|||2017-10-11 01:46:02.219122|2017-10-11 01:46:02.219122
NCT01842399|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-10-05|||February 9, 2013||2013-02-09|August 17, 2017|2017-08-17|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Resveratrol and Cardiovascular Health in the Elderly|Resveratrol and Cardiovascular Health in the Elderly: The Reache Trial|Recruiting||Phase 1/Phase 2|300|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 01:46:02.304053|2017-10-11 01:46:02.304053
NCT01842386|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-08-22|||February 11, 2013||2013-02-11|August 7, 2017|2017-08-07|January 1, 2025|Anticipated|2025-01-01|January 1, 2025|Anticipated|2025-01-01||Interventional|||Rituximab for Anti-cytokine Autoantibody-Associated Diseases|Rituximab (Anti-CD20) for the Treatment of Subjects With Anticytokine Autoantibody-Associated Diseases|Recruiting||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:46:02.418843|2017-10-11 01:46:02.418843
NCT01842373|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-01-24|||July 2013||2013-07-01|January 2017|2017-01-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Comparison Study on Topical Anesthetic Agents (LMX4 and BLT) Prior to Fractional Skin Resurfacing|A Double-Blind, Randomized, Split-Face Comparison Trial on Topical Anesthetic Agents Prior to Fractional Skin Resurfacing|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center||2||Funding not secured|f||||t||||||||||2017-10-11 01:46:02.544097|2017-10-11 01:46:02.544097
NCT01838993|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2013-04-23|||January 2013||2013-01-01|April 2013|2013-04-01||||May 2013|Anticipated|2013-05-01||Interventional|||Inhalation of Lidocaine Before Intubation|The Effect of Ultrasonic Nebulizer Delivered Lidocaine on Circulatory Responses During Tracheal Intubation and Postoperative Sore Throat|Unknown status|Recruiting|N/A|70|Anticipated|New Taipei City Hospital||2|||f||||t||||||||||2017-10-11 01:46:49.260841|2017-10-11 01:46:49.260841
NCT01842360|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-03-02|||April 2013||2013-04-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|MV130||Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD)|Randomized Double-blind Placebo-controlled Prospective, Parallel, Multicentre Clinical Trial of Bacterial Vaccine Administered by Sublingual Mucosa in Subjects With COPD for Efficacy and Safety Evaluation and Immunomodulatory Response|Recruiting||Phase 2/Phase 3|180|Anticipated|Inmunotek S.L.||2|||f||||f||||||||No||2017-10-11 01:46:02.667439|2017-10-11 01:46:02.667439
NCT01842347|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2013-12-12|||August 2013||2013-08-01|December 2013|2013-12-01||||August 2016|Anticipated|2016-08-01||Interventional|||Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT)|Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT)|Withdrawn||N/A|0|Actual|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 01:46:02.834848|2017-10-11 01:46:02.834848
NCT01842334|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-04-26|||April 2013||2013-04-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|DCS||D-cycloserine (DCS) Pretreatment + Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Smoking Cessation (DCS)|D-cycloserine (DCS) Pretreatment + Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Smoking Cessation|Recruiting||Phase 1/Phase 2|40|Anticipated|Mclean Hospital||2|||f||||f||||||||||2017-10-11 01:46:02.926519|2017-10-11 01:46:02.926519
NCT01842321|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-03-17|||July 2013||2013-07-01|March 2016|2016-03-01|July 2018|Anticipated|2018-07-01|June 2015|Actual|2015-06-01||Interventional|AMA||Abiraterone Acetate in Molecular Apocrine Breast Cancer|A Phase II Trial Evaluating the Activity of Abiraterone Acetate Plus Prednisone in Patients With a Molecular Apocrine HER2-negative Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 2|31|Anticipated|UNICANCER||1|||f||||f||||||||||2017-10-11 01:46:03.06828|2017-10-11 01:46:03.06828
NCT01842295|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-07-05|||February 2013||2013-02-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|March 2016|Actual|2016-03-01||Interventional|BARIASPERM||Bariatric Surgery and Sperm Quality|Bariatric Surgery, Nutrition, and Sperm Quality of Adult Obese Men on Childbearing Age : A Multicentric Cohort Study|Active, not recruiting||N/A|46|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:46:03.492809|2017-10-11 01:46:03.492809
NCT01842282|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-08-17|||April 2013||2013-04-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Amlexanox for Type 2 Diabetes and Obesity|Clinical Protocol to Investigate the Efficacy of Amlexanox for Treatment of Glucose and Lipid Abnormalities in Obese Type 2 Diabetics|Active, not recruiting||Phase 2|15|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-11 01:46:03.60097|2017-10-11 01:46:03.60097
NCT01842269|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-08-18|||January 2013||2013-01-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|My-Rept_KT_P4||Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients|Open Label, Randomized, Multi-center, Phase 4 Trial to Evaluate the Efficacy and Safety of My-Rept® Tablet(Mycophenolate Mofetil 500mg/Tab.) Versus My-Rept® Capsule(Mycophenolate Mofetil 250mg/Cap.) in Combination With Tacrolimus for 26 Weeks in Kidney Transplant Patients|Completed||Phase 4|156|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 01:46:03.730866|2017-10-11 01:46:03.730866
NCT01842256|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2013-07-31|||April 2013||2013-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|CKD-345||Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.|A Randomized, Open-label, Single Dose, Two-treatment, Two-period, Two-sequence Crossover Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin After Oral Administration in Healthy Volunteers|Completed||Phase 1|24|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 01:46:03.889084|2017-10-11 01:46:03.889084
NCT01842243|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-29|||February 2012||2012-02-01|January 2013|2013-01-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|MAPS||Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI|Multiparametric CMR Assessment of Apical Versus Septal Pacing Study|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital of South Manchester NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:46:04.032221|2017-10-11 01:46:04.032221
NCT01842230|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2013-07-31|||April 2013||2013-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|CKD-345 DDI||Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine|A Randomized, Open-label, Single Dose, Two-treatment, Two-period, Two-sequence Crossover Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine After Oral Administration in Healthy Volunteers|Completed||Phase 1|24|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 01:46:04.183119|2017-10-11 01:46:04.183119
NCT01842217|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-11-11|||November 2013||2013-11-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Validation of [18F]FES for Imaging of Brain Estrogen Receptors|Validation of [18F]FES for Imaging of Brain Estrogen Receptors|Unknown status|Recruiting|N/A|12|Anticipated|University Medical Center Groningen||2|||f||||t||||||||||2017-10-11 01:46:04.269471|2017-10-11 01:46:04.269471
NCT01842204|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-06-02|||May 2013||2013-05-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ELEFANT||Evaluation of the Efficacy of Electromagnetic Therapy on Postoperative Surgical Pain After Uni- and Bilateral Inguinal Hernia Repair.|Evaluation of the Efficacy of Electromagnetic Therapy on Postoperative Surgical Pain After Uni- and Bilateral Inguinal Hernia Repair.|Unknown status|Recruiting|Phase 1|75|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:46:04.386074|2017-10-11 01:46:04.386074
NCT01842191|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2013-05-20|||May 2010||2010-05-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|EFOMS||Efficacy of Fish Oil in Multiple Sclerosis|Efficacy of Fish Oil on Serum TNFα, IL-1β, IL-6, Oxidative Stress Markers in Multiple Sclerosis Treated With Interferon Beta 1-b|Completed||Phase 4|50|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||||2017-10-11 01:46:04.512193|2017-10-11 01:46:04.512193
NCT01842178|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-05-09|||April 2013||2013-04-01|May 2017|2017-05-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Endometrial Scratching in In Vitro Fertilization Cycles With Oocyte Donation|Randomized Prospective Study of Endometrial Injury in In Vitro Fertilization Cycles With Oocyte Donation|Withdrawn||N/A|0|Actual|Centro de Infertilidad y Reproducción Humana||2||Principal investigator retired from the project|f||||f||||||||No||2017-10-11 01:46:04.791257|2017-10-11 01:46:04.791257
NCT01842165|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2017-09-01|||May 2013||2013-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|LUMEN||177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs|The LuMEn Study: 177Lu-octreotate Treatment Outcome Prediction Using Multimodality Imaging in Refractory Neuroendocrine Tumours.|Recruiting||Phase 3|39|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 01:46:04.905135|2017-10-11 01:46:04.905135
NCT01842139|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-04-18|||December 2011||2011-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission|Randomized Phase I Study Combining Suppression of T Regulatory Cells With WT1 Vaccine Therapy for AML Patients in Complete Remission|Active, not recruiting||Phase 1|36|Anticipated|University of Chicago||3|||f||||f||||||||||2017-10-11 01:46:05.142497|2017-10-11 01:46:05.142497
NCT01842126|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-25|2015-02-05|||April 2013||2013-04-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin)|Study of Safety, Tolerability, and Pharmacokinetics of BG00010 (Neublastin) Intravenous and Subcutaneous Single Ascending Doses in Healthy Volunteers, and Subcutaneous Multiple Ascending Doses in Subjects With Painful Lumbar Radiculopathy|Completed||Phase 1|54|Actual|Biogen||4|||f||||f||||||||||2017-10-11 01:46:05.330683|2017-10-11 01:46:05.330683
NCT01842113|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-09-20|||April 2013||2013-04-01|September 2013|2013-09-01||||May 2014|Anticipated|2014-05-01||Interventional|||Quality of Life and Nutritional Improvements in Cirrhotic Patients|Quality of Life and Nutritional Improvements in Cirrhotic Patients Following Hepatic Encephalopathy Using Rifaximin.|Terminated||Phase 4|4|Actual|Tampa General Hospital||2||PI Initiated study - PI left facility|f||||f||||||||||2017-10-11 01:46:05.545911|2017-10-11 01:46:05.545911
NCT01842100|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2013-04-24|||September 1999||1999-09-01|April 2013|2013-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy|To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy|Completed||N/A|2193|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 01:46:05.691548|2017-10-11 01:46:05.691548
NCT01842087|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-26|||April 2010||2010-04-01|April 2013|2013-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease Patients|An Investigation Into Pulse Fiber Fermentation and Nitrogen Excretion in Patients With Chronic Renal Failure|Completed||N/A|15|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 01:46:05.804008|2017-10-11 01:46:05.804008
NCT01842074|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-09-28|||March 2013||2013-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|VELDON||Desensitization With Bortezomib Before a Living Kidney Donation|Desensitization With Bortezomib Before a Living Kidney Donation|Recruiting||Phase 4|10|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:46:05.941006|2017-10-11 01:46:05.941006
NCT01842061|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-05-13|||May 2013||2013-05-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EASY-Pilot||Everyday Activity Supports You (EASY) Pilot Study|Everyday Activity Supports You (EASY) Pilot Study|Completed||N/A|25|Actual|University of British Columbia||2|||f||||t||||||||No||2017-10-11 01:46:06.136522|2017-10-11 01:46:06.136522
NCT01842035|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-03-17|||February 2013||2013-02-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Heart Rate Response to Regadenoson and Sudden Cardiac Death|Heart Rate Response to Regadenoson and Sudden Cardiac Death|Enrolling by invitation||N/A|150|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 01:46:06.389295|2017-10-11 01:46:06.389295
NCT01842022|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-12-10|||September 2011||2011-09-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|||The Effect of the Glycemic Load of Meals on the Cognition and Mood of Older Adults|The Effect of the Glycemic Load of Meals on the Cognition and Mood of Older Adults With Differences in Glucose Tolerance|Completed||N/A|155|Actual|Swansea University||4|||f||||t||||||||||2017-10-11 01:46:06.52993|2017-10-11 01:46:06.52993
NCT01842009|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-07-11|||March 2013|Actual|2013-03-01|July 2017|2017-07-01|June 7, 2016|Actual|2016-06-07|July 2014|Actual|2014-07-01||Interventional|||Single-arm, Open-label, Phase II Trial of HD-tDCS in Fibromyalgia Patients|Single-arm, Open-label, Phase II Trial of HD-tDCS in Fibromyalgia Patients|Completed||N/A|20|Actual|Spaulding Rehabilitation Hospital||1|||f||||f||f||||||||2017-10-11 01:46:06.654037|2017-10-11 01:46:06.654037
NCT01841996|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-12-15|||March 2013||2013-03-01|December 2013|2013-12-01||||August 2013|Actual|2013-08-01||Interventional|||Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients|A Phase 1 Randomized, Double-Blind, Vehicle-Controlled, Multiple-Dose Study of the Safety, Absorption and Systemic Pharmacokinetics of ME1111 Topical Agent Applied to All Toenails of Adult Moderate to Severe Onychomycosis Patients for 28 Days|Completed||Phase 1|24|Actual|Meiji Seika Pharma Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:46:06.761419|2017-10-11 01:46:06.761419
NCT01841983|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-05-06|||April 2012||2012-04-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Project A: Integrated Approaches to Improving the Health and Safety of Health Care Workers|Project A: Integrated Approaches to Improving the Health and Safety of Health Care Workers|Completed||N/A|9500|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-11 01:46:06.871152|2017-10-11 01:46:06.871152
NCT01841970|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-11-17|2016-05-06||April 2013||2013-04-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Efficacy Study of HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids|Multi-Center, Prospective Study of the Safety and Efficacy of the HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids|Completed||N/A|20|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-11 01:46:07.036329|2017-10-11 01:46:07.036329
NCT01841957|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-10-02|||April 2013||2013-04-01|October 2016|2016-10-01||||April 2018|Anticipated|2018-04-01||Interventional|ISBCS||Immediate Simultaneous Bilateral Cataract Surgery|Immediate Simultaneous Bilateral Cataract Surgery: A Prospective, Case-controlled Clinical Trial in the United States|Recruiting||N/A|2000|Anticipated|Panhandle Eye Group, LLP||2|||f||||t||||||||||2017-10-11 01:46:07.550207|2017-10-11 01:46:07.550207
NCT01841944|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-04-24|||November 2012||2012-11-01|October 2014|2014-10-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|OMEMI||Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction|Giving Omega-3 Fatty Acids to Elderly Patients Diagnosed With Acute Myocardial Infarction to Investigate the Effect on Cardiovascular Morbidity and Mortality|Recruiting||N/A|1400|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 01:46:07.674262|2017-10-11 01:46:07.674262
NCT01841931|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-07-16|||February 2013||2013-02-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients|Buprenorphine Tx:A Safe Alternative for Opioid Dependent Pain Patients|Unknown status|Recruiting|N/A|30|Anticipated|Maimonides Medical Center||1|||f||||f||||||||||2017-10-11 01:46:07.795932|2017-10-11 01:46:07.795932
NCT01841918|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-07-06|||January 2013||2013-01-01|July 2017|2017-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Immunogenicity of Live Attenuated Influenza H5N2|Phase II Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers|Completed||Phase 2|150|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 01:46:07.969699|2017-10-11 01:46:07.969699
NCT01841905|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-01-18|||July 2013||2013-07-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|Scope||Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease|Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease|Active, not recruiting||N/A|60|Anticipated|Rhode Island Hospital|||1||f||||t||||||||||2017-10-11 01:46:08.088122|2017-10-11 01:46:08.088122
NCT01841892|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-05-02|||April 2013||2013-04-01|May 2017|2017-05-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||The Therapeutic Workplace Intervention in Community Settings|The Therapeutic Workplace Intervention in Community Settings|Withdrawn||N/A|0|Actual|University of Maryland, Baltimore County||2||Dr. Sirgusson moved to another institution = Florida Institute of Technology in June 2013|f||||f||||||||||2017-10-11 01:46:08.230244|2017-10-11 01:46:08.230244
NCT01841879|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-04-14|||June 2010||2010-06-01|April 2017|2017-04-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Mumbai Worksite Tobacco Control Study|Mumbai Worksite Tobacco Control Study|Completed||N/A|6880|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-11 01:46:08.339129|2017-10-11 01:46:08.339129
NCT01841866|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-26|||May 2013||2013-05-01|April 2013|2013-04-01|October 2014|Anticipated|2014-10-01|December 2013|Anticipated|2013-12-01||Interventional|||Laryngeal Mask Airway Removal During Deep Anesthesia in Children|Does Laryngeal Mask Airway Removal During Deep Anesthesia Reduce Postoperative Sore Throat in Children?|Unknown status|Not yet recruiting|N/A|456|Anticipated|Prince of Songkla University||2|||f||||t||||||||||2017-10-11 01:46:08.467916|2017-10-11 01:46:08.467916
NCT01841853|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-09-25|||August 2012||2012-08-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||RCT of Health-promoting Intervention for Older Foreign-born Adults|Livslots Angered - A Randomized Controlled Trial of a Community-based Health-promoting and Disease-preventive Program for Older Foreign Born Adults|Completed||N/A|131|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 01:46:08.573753|2017-10-11 01:46:08.573753
NCT01841840|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-24|||January 2012||2012-01-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke|The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke|Completed||N/A|11|Actual|Florida State University||3|||f||||f||||||||||2017-10-11 01:46:08.675923|2017-10-11 01:46:08.675923
NCT01841827|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2014-06-05|||April 2013||2013-04-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Headache Inducing Effects of Cilostazol on Migraine Patients|The Headache Inducing Effects of Cilostazol on Migraine Patients|Completed||N/A|14|Actual|Danish Headache Center||2|||f||||f||||||||||2017-10-11 01:46:08.765885|2017-10-11 01:46:08.765885
NCT01841814|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-12-02|||April 2013||2013-04-01|December 2016|2016-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|LYMPHOS||Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy|Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy: Prospective Longitudinal Study Over 12 Months.|Withdrawn||Phase 4|0|Actual|Centre Hospitalier Universitaire, Amiens||1||physician departure|f||||f||||||||||2017-10-11 01:46:08.838288|2017-10-11 01:46:08.838288
NCT01841801|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-03-15|||October 2012||2012-10-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches|Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches|Completed||N/A|157|Actual|Chattem, Inc.||3|||f||||t||||||||No||2017-10-11 01:46:08.92115|2017-10-11 01:46:08.92115
NCT01841788|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-03-15|||October 2012||2012-10-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Evaluation of Experimental Heat Patch|Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches|Completed||N/A|40|Actual|Chattem, Inc.||3|||f||||t||||||||No||2017-10-11 01:46:09.000146|2017-10-11 01:46:09.000146
NCT01841775|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-04-24|||May 2009||2009-05-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Interferon α 2b Pharmacovigilance Study|Pharmacovigilance Study of the Interferon α 2b Produced by Bio-Manguinhos / Fiocruz and Used by Genotype 2/3 Chronic Hepatitis C Patients (Estudo de farmacovigilância da Alfainterferona 2b Humana Recombinante Produzida Por Bio-Manguinhos - Fiocruz, Utilizada em Portadores de Hepatite C crônica genótipos 2 e 3 Atendidos Pelo Programa de Medicamentos de Dispensação em Caráter Excepcional no Estado do Rio de Janeiro)|Completed||Phase 4|85|Actual|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||1|||f||||t||||||||||2017-10-11 01:46:09.23745|2017-10-11 01:46:09.23745
NCT01841749|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-08-24|||January 2008||2008-01-01|August 2016|2016-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|CINNAMOME||Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast|Management of Ductal Carcinoma in Situ (DCIS) or Pure Micro-invasive (DCIS-MI) Extended Breast, Axillary Node Sentinel Site (GAS) When the Diagnosis is Made by Biopsy and Treatment by Mastectomy Immediately. Descriptive Study|Completed||N/A|231|Actual|Institut Bergonié||1|||f||||t||||||||||2017-10-11 01:46:09.657399|2017-10-11 01:46:09.657399
NCT01841723|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-09-12|||April 1, 2013|Actual|2013-04-01|September 2017|2017-09-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia|A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia|Recruiting||Phase 2|44|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:46:13.677954|2017-10-11 01:46:13.677954
NCT01841710|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-03-14|||December 2012||2012-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Genetic Variability in Taste Perception|Genetic Variability in Taste Perception|Completed||N/A|90|Actual|Monell Chemical Senses Center|||1||f||||f||||||Samples With DNA|"     Saliva   "|||2017-10-11 01:46:13.822031|2017-10-11 01:46:13.822031
NCT01841697|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-06-01|2015-10-23||June 13, 2013|Actual|2013-06-13|June 2017|2017-06-01|November 17, 2014|Actual|2014-11-17|November 17, 2014|Actual|2014-11-17||Interventional|||Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)|A Phase III, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK-3102 Compared With the Addition of Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin|Completed||Phase 3|642|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 01:46:13.915573|2017-10-11 01:46:13.915573
NCT01841684|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-05-29|||June 2013||2013-06-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)|A Worldwide, Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Lipid-Lowering Therapy in Adult Patients With Homozygous Familial Hypercholesterolemia (HoFH)|Terminated||Phase 3|2|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 01:46:14.694807|2017-10-11 01:46:14.694807
NCT01841671|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2014-05-19|||April 2013||2013-04-01|April 2014|2014-04-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Interventional|IPV002ABMG||Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine|A Phase 4, Randomized, Open-Label Study to Assess Humoral and Intestinal Polio Immunity Following a Three-Dose Trivalent Inactivated Polio Vaccine Schedule Relative to Two Sequential Schedules of IPV/Bivalent Oral Polio Vaccines|Unknown status|Active, not recruiting|Phase 4|570|Anticipated|University of Chile||3|||f||||t||||||||||2017-10-11 01:46:14.786939|2017-10-11 01:46:14.786939
NCT01841658|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-07-01|||April 2013||2013-04-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|August 2015|Actual|2015-08-01||Interventional|FASUPP||Folic Acid Supplementation in Women of Child Bearing Age|Effect of Obesity and Folic Acid Supplementation on Gene-specific DNA Methylation in Women of Reproductive Age|Completed||N/A|50|Actual|University of Georgia||2|||f||||f||||||||||2017-10-11 01:46:14.89352|2017-10-11 01:46:14.89352
NCT01841645|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-05-02|||July 2009||2009-07-01|May 2013|2013-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||CLA Metabolism and Effects on Human Health|Conjugated Linoleic Acid (CLA) Depletion-repletion: Metabolism and Bioactivity in Humans|Completed||N/A|29|Actual|Universidade Federal do Rio de Janeiro||1|||f||||f||||||||||2017-10-11 01:46:15.031471|2017-10-11 01:46:15.031471
NCT01841632|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-03-24|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation|Safety and Feasibility of Multipotent Adult Progenitor Cells for Immunomodulation Therapy After Liver Transplantation: A Phase I Study of the MiSOT Study Consortium|Terminated||Phase 1|3|Actual|University Hospital Regensburg||1|||f||||t||||||||||2017-10-11 01:46:15.13529|2017-10-11 01:46:15.13529
NCT01841619|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2015-07-14|2014-12-08||March 2013||2013-03-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus|Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus|Completed||Early Phase 1|16|Actual|University of California, Irvine||1|||f||||t||||||||||2017-10-11 01:46:15.246385|2017-10-11 01:46:15.246385
NCT01841593|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-09-23|2014-07-14||April 2013||2013-04-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||All enrolled participants who completed at least two of three pharmacokinetic sessions for comparison were included in the analysis.|A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers|A Two Way Cross Over Pharmacokinetic (PK) Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers|Completed||Phase 1|19|Actual|St Stephens Aids Trust||2|||f||||f||||||||||2017-10-11 01:46:15.69257|2017-10-11 01:46:15.69257
NCT01841580|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-10-04|||November 2013||2013-11-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Proteomic Profiles in Trabeculectomy Patients|Long-term Observation of Tear Proteomic Profiles and Ocular Surface in Trabeculectomy Patients Before and After Surgery|Recruiting||N/A|120|Anticipated|Singapore National Eye Centre|||1||f||||f||||||||||2017-10-11 01:46:16.057909|2017-10-11 01:46:16.057909
NCT01841567|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-09-26|2014-04-16||April 2013||2013-04-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|MxB Po01||Post Market Clinical Follow-up Study|A Multi-centre, Post CE-mark, Open Investigation to Evaluate the Performance of a Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip or Knee Arthroplasty|Completed||Phase 4|60|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 01:46:16.26273|2017-10-11 01:46:16.26273
NCT01841554|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-08-28|||April 2013||2013-04-01|August 2016|2016-08-01||||July 2016|Actual|2016-07-01||Interventional|||Cardioband With Transfemoral Delivery System|Cardioband Adjustable Annuloplasty System For Transcatheter Repair of Mitral Valve Regurgitation|Active, not recruiting||N/A|51|Actual|Valtech Cardio Ltd||1|||f||||t||||||||||2017-10-11 01:46:16.48352|2017-10-11 01:46:16.48352
NCT01841541|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-25|||January 2009||2009-01-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|Triage-Plus||The Impact of Involving Informal Health Providers for Tuberculosis Control in Sudan|Triage Plus for TB: Improving Community‐Based Provision for TB in Africa. The Impact of Involving Informal Health Providers for Tuberculosis Control in Sudan|Completed||N/A|380|Actual|Liverpool School of Tropical Medicine||2|||f||||t||||||||||2017-10-11 01:46:16.581007|2017-10-11 01:46:16.581007
NCT01841528|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-04-14|||June 2013||2013-06-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|FreFro-PCOS||Live Birth After Fresh Embryo Transfer Vs Frozen-thawed Embryo Transfer in Women With Polycystic Ovary Syndrome|Live Birth After Fresh Embryo Transfer vs Elective Embryo Cryopreservation/Frozen Embryo Transfer in Women With Polycystic Ovary Syndrome Undergoing IVF: A Multi-center Prospective Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|1180|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-11 01:46:16.674077|2017-10-11 01:46:16.674077
NCT01841515|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-05-09|||August 2012||2012-08-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug|Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Agent Who Need Emergent Temporary Catheter Insertion for Hemodialysis|Completed||Phase 1|25|Actual|University of Ulsan||1|||f||||t||||||||||2017-10-11 01:46:16.810909|2017-10-11 01:46:16.810909
NCT01841502|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-10-27|||May 2013||2013-05-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ROLEX||Interaction Between Paroxetine and Telaprevir|The ROLE of ParoXetine in Patients Taking Telaprevir-based Hepatitis C Therapy: Lack of a Drug-drug Interaction? (ROLEX)|Terminated||Phase 2|3|Actual|Radboud University||2||Telaprevir will not be used in NL, no more inclusions are expected.|f||||f||||||||||2017-10-11 01:46:16.905071|2017-10-11 01:46:16.905071
NCT01841489|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2014-02-05|||May 2013||2013-05-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics|A Phase 1, Open-Label, Adaptive Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics|Completed||Phase 1|56|Actual|Gilead Sciences||4|||f||||f||||||||||2017-10-11 01:46:17.014807|2017-10-11 01:46:17.014807
NCT01841476|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-11-24|||February 2012||2012-02-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers|POL6326 - A Phase I, Open, Single Intravenous Infusion Dose, Pharmacokinetic and Pharmacodynamic Study in Healthy Volunteers Who Are Volunteering as Haematopoietic Stem Cell (HSC) Donors|Completed||Phase 1|27|Actual|Polyphor Ltd.||1|||f||||t||||||||||2017-10-11 01:46:17.126985|2017-10-11 01:46:17.126985
NCT01841463|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-09-03|||August 2013||2013-08-01|September 2014|2014-09-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation|An Open Label, Multicenter, Phase I Extension Study of an Oral Cdk Inhibitor P1446A-05 Administered With an Oral BRAF Inhibitor Vemurafenib (Zelboraf®) in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation|Suspended||Phase 1|100|Anticipated|Piramal Enterprises Limited||1||Sponsor decision not related to patient safety|f||||f||||||||||2017-10-11 01:46:17.210247|2017-10-11 01:46:17.210247
NCT01841450|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-06-03|||July 2013||2013-07-01|June 2015|2015-06-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery|A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery|Recruiting||Phase 4|360|Anticipated|Glaukos Corporation||2|||f||||t||||||||||2017-10-11 01:46:17.326362|2017-10-11 01:46:17.326362
NCT01841437|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-03-23|||September 2013||2013-09-01|March 2016|2016-03-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01|36 Months|Observational [Patient Registry]|||Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry|Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry|Active, not recruiting||Phase 4|500|Anticipated|Glaukos Corporation|||1||f||||f||||||||||2017-10-11 01:46:17.525636|2017-10-11 01:46:17.525636
NCT01840852|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2014-02-24|||April 2013||2013-04-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Sleep and Cytokines During Acute Diverticulitis|the Effects of Inflammatory Cytokines on Sleep During Acute Diverticulitis|Completed||N/A|13|Actual|Herlev Hospital|||1||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 01:46:24.179435|2017-10-11 01:46:24.179435
NCT01841424|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-01-04|||June 2013||2013-06-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CO-OP||CO-OP Trial: Community-based Outreach on Obesity in Pregnancy|CO-OP Trial: Community-based Outreach on Obesity in Pregnancy: Using Community-based Participatory Research to Modify Dietary Interventions to Prevent Excessive Weight Gain During Pregnancy in Obese and Under-resourced Women|Recruiting||N/A|100|Anticipated|University of Missouri, Kansas City||2|||f||||t||||||||Undecided||2017-10-11 01:46:17.646086|2017-10-11 01:46:17.646086
NCT01841411|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2013-04-23|||March 2013||2013-03-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis|Studying the Role of N-Acetyl Cysteine Either Alone or in Combination With Metronidazole in Treatment of Bacterial Vaginosis|Unknown status|Recruiting|Phase 4|90|Anticipated|Minia University||3|||f||||t||||||||||2017-10-11 01:46:17.785491|2017-10-11 01:46:17.785491
NCT01841398|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-06-08|||June 2012||2012-06-01|June 2016|2016-06-01||||December 2014|Actual|2014-12-01||Interventional|SAHARA||South Asian HeArt Risk Assessment Project - Trial (SAHARA-Trial)|South Asian HeArt Risk Assessment Project - Trial|Active, not recruiting||N/A|343|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 01:46:17.915355|2017-10-11 01:46:17.915355
NCT01841385|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-26|||October 2011||2011-10-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effects of Pilates on Respiratory Mechanics|Influence of Application of the Pilates Method on Pulmonary Function, Thoracic Mobility and Respiratory Muscle Strength|Completed||N/A|21|Actual|Universidade Metodista de Piracicaba||2|||f||||f||||||||||2017-10-11 01:46:18.057002|2017-10-11 01:46:18.057002
NCT01841372|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-03-15|||September 2013||2013-09-01|March 2017|2017-03-01|March 30, 2018|Anticipated|2018-03-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||A Virtual Reality Intervention to Improve Weight Maintenance|A Virtual Reality Intervention (Second Life) to Improve Weight Maintenance|Active, not recruiting||N/A|202|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 01:46:18.180793|2017-10-11 01:46:18.180793
NCT01841359|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-04-25|||June 2013||2013-06-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|July 2016|Actual|2016-07-01||Interventional|||Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery|Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery|Active, not recruiting||Phase 4|22|Actual|Joslin Diabetes Center||1|||f||||f||||||||||2017-10-11 01:46:18.292221|2017-10-11 01:46:18.292221
NCT01841346|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-01-07|||March 2013||2013-03-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01|1 Year|Observational [Patient Registry]|JoPCR1||The First Jordanian PCI Registry: Events at 1 Year|The First Jordanian Percutaneous Coronary Intervention (PCI) Registry|Completed||N/A|2000|Actual|Jordan Collaborating Cardiology Group|||1||f||||t||||||||||2017-10-11 01:46:18.422367|2017-10-11 01:46:18.422367
NCT01841333|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-08-18|||April 29, 2013|Actual|2013-04-29|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant|A Phase 2 Study of PF-04449913 for the Treatment of Acute Myeloid Leukemia Patients With High Risk of Post-Allogeneic Stem Cell Transplantation Relapse|Recruiting||Phase 2|28|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 01:46:18.548867|2017-10-11 01:46:18.548867
NCT01841320|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-10-04|||October 2011||2011-10-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|VISTA||Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial|Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial|Completed||N/A|378|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 01:46:18.696772|2017-10-11 01:46:18.696772
NCT01841307|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-08-10|||June 2014||2014-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Cromolyn Detection of Silent Aspiration|Development and Validation of Test for Gastro-esophageal Reflux and Aspiration|Recruiting||Phase 1|20|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 01:46:18.809646|2017-10-11 01:46:18.809646
NCT01841294|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-04-25|||January 2012||2012-01-01|January 2012|2012-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||NK Activity Modulation Induced by Intravenous Lidocaine During Colorectal Laparoscopic Surgery|NK Activity Modulation by Intravenous Lidocaine During Laparoscopic Colorectal Surgery|Unknown status|Recruiting|Phase 4|50|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||t||||||||||2017-10-11 01:46:18.930985|2017-10-11 01:46:18.930985
NCT01841268|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-05-18|||May 2010||2010-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|4 Weeks|Observational [Patient Registry]|||Skin Lipid Profiles in Term and Preterm Infants|Skin Lipid Profiles in Term and Preterm Infants|Completed||N/A|25|Actual|University of California, Davis|||2||f||||f||||||Samples With DNA|"     Blood, epidermal skin cells, breast milk   "|||2017-10-11 01:46:19.443691|2017-10-11 01:46:19.443691
NCT01841255|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-04-25|||September 2008||2008-09-01|January 2013|2013-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||UMOX™: A New Device for Preoxygenation|UMOX™: A New Device for Preoxygenation|Completed||N/A|49|Actual|Maisonneuve-Rosemont Hospital||4|||f||||t||||||||||2017-10-11 01:46:19.583182|2017-10-11 01:46:19.583182
NCT01841242|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2017-03-16|||April 23, 2013|Actual|2013-04-23|March 2017|2017-03-01|January 31, 2021|Anticipated|2021-01-31|January 31, 2021|Anticipated|2021-01-31||Interventional|CHLOVIS||Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation|Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation|Recruiting||Phase 4|2276|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||No||2017-10-11 01:46:19.73224|2017-10-11 01:46:19.73224
NCT01841229|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-05-22|||October 2012||2012-10-01|May 2013|2013-05-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Effect of Ginseng on Glycemic Control|Effect of Ginseng on Glycemic Control: A Systematic Review and Meta-analysis of Controlled Trials to Provide Evidence-based Clinical Recommendations|Unknown status|Active, not recruiting|N/A|770|Actual|St. Michael's Hospital, Toronto|||1||f||||t||||||||||2017-10-11 01:46:19.995675|2017-10-11 01:46:19.995675
NCT01841216|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-01-30|2014-12-30||April 2013||2013-04-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|GlutEMG02||EMG Activation of Gluteal Musculature During Exercises With and Without Resistance|EMG Activation of Gluteal Musculature and Perceived Exertion During Therapeutic Exercises With and Without Thera-Band® Resistance|Completed||N/A|30|Actual|Sport and Spine Rehab Clinical Research Foundation||2|||f||||f||||||||||2017-10-11 01:46:20.086711|2017-10-11 01:46:20.086711
NCT01841203|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2014-11-14|||April 2013||2013-04-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|YARADI||Dual Point-of-care Test for the Diagnosis of Yaws|Evaluation of a Rapid Dual Point-of-care Assay for Targeting Antibiotic Treatment for Yaws Eradication: a Prospective Descriptive Study|Completed||N/A|703|Actual|Lihir Medical Centre|||1||f||||f||||||||||2017-10-11 01:46:20.599067|2017-10-11 01:46:20.599067
NCT01841190|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2013-04-25|||May 2012||2012-05-01|March 2013|2013-03-01||||January 2013|Actual|2013-01-01||Observational|||Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa|PROGNOSTIC EVALUATION OF SEVERE SEPSIS AND SEPTIC SHOCK. PROCALCITONIN VERSUS DELTA SOFA|Unknown status|Recruiting|N/A|128|Anticipated|Hospital Sao Domingos|||2||f||||t||||||||||2017-10-11 01:46:20.706846|2017-10-11 01:46:20.706846
NCT01841177|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-05-12|||April 2013||2013-04-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluating Precision of Therapy - Milrinone|Evaluating Precision of Therapy - Milrinone|Recruiting||Phase 2|40|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||No||2017-10-11 01:46:20.812913|2017-10-11 01:46:20.812913
NCT01841164|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-23|||May 2012||2012-05-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|E-Type||A Mechanistic Study to Evaluate the Efficacy of Montelukast on Airway Function in Asthma|A Study of the Effects of the Selective CysLT1 Antagonist Montelukast on Bronchoconstriction and Airway Inflammation Induced by Inhalation of Leukotriene E4 in Subjects With Asthma|Unknown status|Recruiting|N/A|14|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 01:46:20.954638|2017-10-11 01:46:20.954638
NCT01841151|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2017-08-18|||August 2013||2013-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|KITE||Neurofeedback and Working Memory Training for Children and Adolescents With ADHD|Does Neurofeedback and Working Memory Training Improve Core Symptoms of ADHD in Children and Adolescents? A Comparative, Randomized and Controlled Study.|Recruiting||N/A|220|Anticipated|Karolinska Institutet||4|||f||||f||||||||||2017-10-11 01:46:21.112895|2017-10-11 01:46:21.112895
NCT01841138|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-04-23|||July 2010||2010-07-01|April 2013|2013-04-01||||December 2014|Anticipated|2014-12-01||Observational|||Changes of Serum Electrolytes During Bowel Prep With PEG 3350 + Ascorbic Acid - a Prospective Study|Changes of Serum Electrolytes During Bowel Prep With PEG 3350 + Ascorbic Acid - a Prospective Study|Unknown status|Recruiting|N/A|190|Anticipated|Klinik Bogenhausen|||1||f||||f||||||||||2017-10-11 01:46:21.216059|2017-10-11 01:46:21.216059
NCT01841125|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-08-12|||November 2011||2011-11-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|Escitalopram||Escitalopram for the Treatment of Depression in Alzheimer's Disease|A 12-Week Randomized, Double-blind, Parallel-group, Placebo-controlled Trial With and Open-label, 12-week Extension, Multicenter to Evaluation of the Efficacy of Escitalopram for the Treatment of Depression in Alzheimer's Disease|Completed||Phase 4|84|Actual|Konkuk University Medical Center||2|||f||||f||||||||||2017-10-11 01:46:21.294577|2017-10-11 01:46:21.294577
NCT01841112|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2015-07-21|||April 2013||2013-04-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety, Tolerability and Pharmacokinetics of BI 409306 Tablets in Healthy Asian Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Oral Doses of BI 409306 (Tablet) in Healthy Chinese and Japanese Male Volunteers and Multiple Oral Doses of BI 409306 (Tablet) in Healthy Japanese Male Volunteers (Randomised, Double-blind, Placebo-controlled Within Dose Groups)|Completed||Phase 1|65|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-11 01:46:21.415343|2017-10-11 01:46:21.415343
NCT01841099|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2014-07-10|||June 2013||2013-06-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Mesalamine in Environmental Enteropathy|Randomised Placebo-controlled Trial of a Gut Immunomodulatory Agent (Mesalamine) to Tackle Environmental Enteropathy in Acutely Malnourished Children: A Pilot Study.|Completed||Phase 1/Phase 2|44|Actual|KEMRI-Wellcome Trust Collaborative Research Program||2|||f||||t||||||||||2017-10-11 01:46:21.520936|2017-10-11 01:46:21.520936
NCT01841086|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2013-04-23|||September 2011||2011-09-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation|A Randomized, Open-label, Single Dose, 3-Treatment, 3-Period Williams-Design to Assess the Pharmacokinetic Characteristics and Food Effect of Sarpogrelate HCl CR Tablets Compared With Sarpogrelate HCl IR Tablets in Healthy Male Subjects|Completed||Phase 1|50|Actual|Korea United Pharm. Inc.||2|||f||||||||||||||2017-10-11 01:46:21.618405|2017-10-11 01:46:21.618405
NCT01841073|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-11-18|||March 2011||2011-03-01|April 2013|2013-04-01|August 2014|Actual|2014-08-01|August 2013|Actual|2013-08-01||Interventional|FermCarb||Effect of Fermentable Carbohydrate on Glucose Homeostasis|Effect of Fermentable Carbohydrate on Glucose Homeostasis and Weight Management in Subjects With Prediabetes|Completed||N/A|93|Actual|Imperial College London||2|||f||||f||||||||Yes|Anonamised data will be shared via a web site|2017-10-11 01:46:21.702158|2017-10-11 01:46:21.702158
NCT01841060|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2013-04-23|||November 2008||2008-11-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|PARF2008||Assessment of the Effectiveness of Local Ablathermy Radio Frequency Bronchial Tumors Primitive|Assessment of the Effectiveness of Local Ablathermy Radio Frequency (RF) Bronchial Tumors Primitive Stage IA Non-surgical Patients. Phase II Multicenter National|Completed||Phase 2|43|Actual|Institut Bergonié||1|||f||||f||||||||||2017-10-11 01:46:21.802335|2017-10-11 01:46:21.802335
NCT01841047|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-09-29|||January 2009||2009-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2013|Actual|2013-09-01||Interventional|TOMOREP||Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma|Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma|Active, not recruiting||Phase 2|44|Actual|Institut Bergonié||1|||f||||t||||||||||2017-10-11 01:46:21.904257|2017-10-11 01:46:21.904257
NCT01835639|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-07-28|||April 2013||2013-04-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Vitamin D Supplementation in Glomerular Disease|Pilot Study: Efficacy and Safety of Vitamin D Supplementation in Glomerular Disease|Recruiting||N/A|35|Anticipated|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-10-11 01:47:46.03033|2017-10-11 01:47:46.03033
NCT01841034|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2013-04-25|||September 2011||2011-09-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Observational|||Impact of an Antioxidant Alimentary Complement on Sperm Data|Evaluation of a 6 Months Treatment of Conceptio (EA) on Sperm Data in Infertile Men With Oligoasthenozoospermia|Unknown status|Recruiting|N/A|200|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||||||||||||2017-10-11 01:46:21.993906|2017-10-11 01:46:21.993906
NCT01841021|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-24|2016-11-22|2016-11-22||April 2014||2014-04-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional||All participants.|Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30|Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 Receptor|Terminated||N/A|1|Actual|H. Lee Moffitt Cancer Center and Research Institute|Planned accrual: 20. Sponsor withdrew support soon after one enrollment. Accrual was terminated; analysis unable to be performed. Participant stopped treatment after 14 cycles due to progressive lymphadenopathy; entered another clinical trial.|1||Slow accrual, loss of sponsor support|f||||f||||||||No||2017-10-11 01:46:22.117207|2017-10-11 01:46:22.117207
NCT01841008|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2014-09-04|||December 2011||2011-12-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control|Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control, Randomized and Double Blind Study|Terminated||Phase 2/Phase 3|35|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 01:46:22.380371|2017-10-11 01:46:22.380371
NCT01840995|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2015-01-26|||April 2013||2013-04-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Effect of Stellate Ganglion Block on Intracranial Pressure Predicted by Ultrasonographic Assessment of Optic Nerve Sheath Diameter||Completed||N/A|35|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:46:22.460413|2017-10-11 01:46:22.460413
NCT01840982|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-23|||October 2010||2010-10-01|April 2013|2013-04-01||||November 2010|Actual|2010-11-01||Interventional|||The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male|A Randomized, Crossover Clinical Trial, The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male|Completed||N/A|20|Actual|Chonbuk National University Hospital||4|||f||||t||||||||||2017-10-11 01:46:22.530487|2017-10-11 01:46:22.530487
NCT01840969|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-25|||September 2011||2011-09-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Association of Carotid Arterial Circumferential Strain With Left Ventricular Function and Hemodynamic Compromise During Off-pump Coronary Artery Bypass Surgery||Completed||N/A|96|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:46:22.63276|2017-10-11 01:46:22.63276
NCT01840956|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-02-13|||May 2013||2013-05-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2016|Actual|2016-05-01||Interventional|||Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease|A Phase I Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease|Active, not recruiting||Phase 1|20|Actual|Humacyte, Inc.||1|||f||||t||||||||No||2017-10-11 01:46:22.720797|2017-10-11 01:46:22.720797
NCT01840943|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-11-17|2015-05-22||June 2013||2013-06-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional||The modified intent-to-treat population included (mITT) included all randomized participants.|A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy|A Phase 3, Randomized, Open-Label, Comparative Bridging Study of CAELYX® Versus Topotecan HCl in Subjects With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy|Terminated||Phase 3|32|Actual|Xian-Janssen Pharmaceutical Ltd.|The study was terminated early as the total number of participants treated in this study was low and only descriptive analysis was used for efficacy and safety evaluation.|2||the study was terminated due to medication supply issue from current manufacturer|f||||f||||||||||2017-10-11 01:46:22.832431|2017-10-11 01:46:22.832431
NCT01840930|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-01-19|||September 2009||2009-09-01|January 2016|2016-01-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|CPCohort||Cohort of Children With Severe Cerebral Palsy|Longitudinal Study of a Children Population With Bilateral Severe Cerebral Palsy: Incidence and Evolution of Orthopaedic Complications and Pain Related With These Complications.|Recruiting||N/A|385|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-11 01:46:23.650362|2017-10-11 01:46:23.650362
NCT01840917|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2014-02-24|||April 2013||2013-04-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Heart Rate Variability During Acute Diverticulitis|Heart Rate Variability in the Course of Acute Uncomplicated Diverticulitis|Completed||N/A|13|Actual|Herlev Hospital|||1||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 01:46:23.743366|2017-10-11 01:46:23.743366
NCT01840904|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2014-02-24|||April 2013||2013-04-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Subjective Sleep and Fatigue During and After Acute Diverticulitis|Subjective Sleep Quality and Fatigue During and After Acute Uncomplicated Diverticulitis|Completed||N/A|13|Actual|Herlev Hospital|||1||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 01:46:23.825728|2017-10-11 01:46:23.825728
NCT01840891|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-12-17|||April 2013||2013-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Secondary Lactose Intolerance Due to Chronic Norovirus Infection|Secondary Lactose Intolerance Due to Chronic Norovirus Infection in Renal Transplant Recipients|Completed||N/A|15|Actual|University of Zurich||2|||f||||t||||||||||2017-10-11 01:46:23.918733|2017-10-11 01:46:23.918733
NCT01840878|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2014-02-24|||April 2013||2013-04-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Validation of Actigraph Measured Sleep During Acute Diverticulitis|Accuracy of Actigraph Measured Sleep Compared to Polysomnography During Acute Uncomplicated Diverticulitis|Completed||N/A|13|Actual|Herlev Hospital|||1||f||||t||||||||||2017-10-11 01:46:24.002869|2017-10-11 01:46:24.002869
NCT01840865|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-03-15|||October 2013||2013-10-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Brain Stimulation During Daytime Nap on Memory Consolidation in Younger, Healthy Subjects|Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Daytime Slow Wave Sleep in Younger, Healthy Subjects|Completed||N/A|22|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:46:24.084237|2017-10-11 01:46:24.084237
NCT01840839|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-07-04|||October 2013||2013-10-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Brain Stimulation During a Daytime Nap on Memory Consolidation in Older Adults|Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Slow Wave Sleep in Older Adults|Completed||N/A|18|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:46:24.263928|2017-10-11 01:46:24.263928
NCT01840826|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-07-26|||February 2013|Actual|2013-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|RED-D||Reducing Hospital Readmissions in Patients With Depressive Symptoms|Reducing Hospital Readmission Among Medical Patients With Depressive Symptoms|Active, not recruiting||N/A|709|Actual|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-11 01:46:24.399715|2017-10-11 01:46:24.399715
NCT01840813|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-11-01|||April 2011||2011-04-01|November 2013|2013-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Intraumbilical Misoprostol in Retained Placenta|Intra-umbilical Injection of Misoprostol Versus Normal Saline in the Management of Retained Placenta: Intrapartum Placebo-controlled Trial|Completed||Phase 1|46|Actual|Hawler Medical University||2|||f||||||||||||||2017-10-11 01:46:24.495495|2017-10-11 01:46:24.495495
NCT01840800|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2014-07-30|||February 2013||2013-02-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||USG Nerve Blocks for ACL Reconstruction|Ultrasound Guided Nerve Block Combinations for Anterior Cruciate Ligament Reconstruction; Femoral, Saphenous and Obturator (Posterior Branch)Nerves.|Completed||N/A|82|Actual|Bispebjerg Hospital||3|||f||||t||||||||||2017-10-11 01:46:24.606499|2017-10-11 01:46:24.606499
NCT01840787|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2015-12-15|||April 2013||2013-04-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|NAISMITH||A Pilot Study on the Use of a Sensory Panel to Assess Comfort Between Three Different Contact Lenses|A Pilot Study on the Use of a Sensory Panel to Assess Comfort Between Three Different Contact Lenses|Completed||N/A|63|Actual|University of Waterloo||1|||f||||f||||||||||2017-10-11 01:46:24.732283|2017-10-11 01:46:24.732283
NCT01840774|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-25|||April 2013||2013-04-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Modifying Virtual Reality Analgesia With Low-Dose Pain Medication|Modifying Virtual Reality Analgesia With Low-Dose Pain Medication|Unknown status|Recruiting|N/A|60|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-11 01:46:24.853718|2017-10-11 01:46:24.853718
NCT01840761|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-04-25|||July 2010||2010-07-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine|Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine|Unknown status|Recruiting|Phase 4|60|Anticipated|Guangzhou University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 01:46:24.969718|2017-10-11 01:46:24.969718
NCT01840748|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-04-23|||April 2013||2013-04-01|April 2013|2013-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|2 Years|Observational [Patient Registry]|||Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis||Unknown status|Recruiting|N/A|960|Anticipated|University of Paris 5 - Rene Descartes|||3||f||||f||||||||||2017-10-11 01:46:25.118822|2017-10-11 01:46:25.118822
NCT01840735|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2014-08-08|||May 2013||2013-05-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of GS-5737 in Subjects With Cystic Fibrosis|Completed||Phase 1|8|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 01:46:25.263883|2017-10-11 01:46:25.263883
NCT01840722|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-08-03|||April 2013||2013-04-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|WISH||Brief Intervention for Rural Women at High Risk for HIV/HCV|Brief Intervention for Rural Women at High Risk for HIV/HCV|Recruiting||N/A|350|Anticipated|University of Kentucky||2|||f||||f||||||||||2017-10-11 01:46:25.343866|2017-10-11 01:46:25.343866
NCT01840709|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2014-01-08|||August 2010||2010-08-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|PSYCHO||Effectiveness Study of Psychotherapy in Systemic Lupus Erythematosus|Effectiveness Study of Brief Group Psychoanalytic Psychotherapy (BGPP) to Improve Quality of Life in Patients With Systemic Lupus Erythematosus.|Unknown status|Active, not recruiting|N/A|80|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 01:46:25.463563|2017-10-11 01:46:25.463563
NCT01840696|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-05-29|||October 2013||2013-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase Analysis and Obstructive CAD on Rubidium PET|Regional and Global Left Ventricular Mechanical Dyssynchrony in the Diagnosis of Obstructive Coronary Artery Disease on Rest and Regadenoson Stress Rubidium Myocardial Perfusion PET|Withdrawn||Phase 2|0|Actual|Emory University||1||PI leaving facility|f||||f||||||||||2017-10-11 01:46:25.560665|2017-10-11 01:46:25.560665
NCT01840683|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-11-22|||May 2013||2013-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|HELPuc||HELP Therapy for Dry AMD|An Open-label, Single Center Study to Evaluate the Efficacy and Safety of Heparin-induced Extracorporeal Lipoprotein Precipitation (H.E.L.P.) Therapy as a Treatment for Non-exudative (Dry) Age-related Macular Degeneration (AMD)|Completed||N/A|22|Actual|B.Braun Avitum AG||1|||f||||f||||||||||2017-10-11 01:46:25.683105|2017-10-11 01:46:25.683105
NCT01840670|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-08-06|||May 2013||2013-05-01|August 2013|2013-08-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Central Venous and Abdominal Pressures and the Inferior Vena Cava|Influence of Central Venous and Abdominal Pressures on the Inferior Vena Cava Shape and Size|Unknown status|Recruiting|N/A|16|Anticipated|Catholic University of the Sacred Heart|||1||f||||f||||||||||2017-10-11 01:46:25.84049|2017-10-11 01:46:25.84049
NCT01840657|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-01-30|||April 2013|Actual|2013-04-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|MTMES||Myotubular Myopathy Event Study|Prospective Study of Adverse Event Rates in Males With X-Linked Myotubular Myopathy|Completed||N/A|33|Actual|Cure CMD|||1||f||||f||||||||||2017-10-11 01:46:25.954157|2017-10-11 01:46:25.954157
NCT01840644|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-15|2015-06-22|||July 2013||2013-07-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Validity and Reliability of Perceived Exertion Rating Scale in Children With Brain Damage|Validity and Reliability of Perceived Exertion Rating Scale in Children With Traumatic Brain Injury, Cerebral Palsy and Typically Developed|Completed||N/A|25|Actual|Alyn Pediatric & Adolecent Rehabilitation Center|||1||f||||f||||||||||2017-10-11 01:46:26.08175|2017-10-11 01:46:26.08175
NCT01840631|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2015-06-24|||April 2013||2013-04-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Trial To Study The Effects Of Group Versus Individual Dietary Counseling In Pediatric Obesity|A Randomized Controlled Trial To Study The Effects Of Group Versus Individual Dietary Counseling In Pediatric Obesity|Unknown status|Recruiting|N/A|80|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 01:46:26.18951|2017-10-11 01:46:26.18951
NCT01840618|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-06-24|||February 2012||2012-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents|Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents|Completed||N/A|50|Actual|Albert Einstein College of Medicine, Inc.|||5||f||||t||||||Samples Without DNA|"     Blood   "|||2017-10-11 01:46:26.304683|2017-10-11 01:46:26.304683
NCT01840605|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-09-17|2015-09-17||March 2013||2013-03-01|September 2015|2015-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis|A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis (Ketotifen Fumarate-controlled, Double-blind, Comparative Study)|Completed||Phase 3|303|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 01:46:26.423649|2017-10-11 01:46:26.423649
NCT01840592|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-06-16|||April 2013|Actual|2013-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib|Phase II Study of Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib|Active, not recruiting||Phase 2|30|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:46:26.746345|2017-10-11 01:46:26.746345
NCT01840566|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-04-26|||April 2013||2013-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma|A Phase I Trial of High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma|Active, not recruiting||Phase 1|17|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:46:27.015223|2017-10-11 01:46:27.015223
NCT01840553|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-03-21|||May 2013||2013-05-01|November 2013|2013-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel Cleansing|A Randomized Assessor-blinded Multicenter International Study Investigating Efficacy Patients Acceptance Safety and Tolerability of Sodium Phosphate Tablets Compared to Split Dose Polyethylene Glycol for Colon Cleansing Prior to Colonoscopy|Completed||Phase 3|461|Actual|Laboratoires Mayoly Spindler||2|||f||||f||||||||||2017-10-11 01:46:27.152829|2017-10-11 01:46:27.152829
NCT01840540|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-08-04|||April 2013||2013-04-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2014|Actual|2014-03-01||Interventional|||MSC for Occlusive Disease of the Kidney|Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis|Completed||Phase 1|6|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:46:27.301203|2017-10-11 01:46:27.301203
NCT01840527|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-07-31|||May 2013||2013-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|March 29, 2017|Actual|2017-03-29||Observational|||Utility of Novel BRAF Test for Melanoma|Exploring the Utility of a Novel BRAF Test in Patients With Melanoma|Active, not recruiting||N/A|220|Actual|Massachusetts General Hospital|||2||f||||f||||||Samples With DNA|"     Peripheral blood lymphocytes (PBLs); Plasma; Tumor Tissue   "|||2017-10-11 01:46:27.406768|2017-10-11 01:46:27.406768
NCT01840514|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-10-04|||December 2012||2012-12-01|October 2013|2013-10-01|September 2015|Anticipated|2015-09-01|April 2015|Anticipated|2015-04-01|1 Day|Observational [Patient Registry]|||Cardiac Functions in Living Donor Liver Transplant Recipients. An Echocardiographic Study.|Cardiac Functions in Living Donor Liver Transplant Recipients. An Echocardiographic Study.|Unknown status|Recruiting|N/A|60|Anticipated|Mansoura University|||1||f||||||||||||||2017-10-11 01:46:27.514649|2017-10-11 01:46:27.514649
NCT01840501|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-05-05|||April 2013||2013-04-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42721458 in Healthy Male Participants|A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single- and Multiple-Doses of JNJ-42721458 in Healthy Male Subjects|Completed||Phase 1|108|Actual|Janssen Research & Development, LLC||18|||f||||f||||||||||2017-10-11 01:46:27.765377|2017-10-11 01:46:27.765377
NCT01840488|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-23|||April 2007||2007-04-01|April 2013|2013-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||BN83495 Phase I in Post-menopausal Women|A Phase I Dose Escalation Study To Determine The Optimal Biological Dose Of BN83495 - An Oral Steroid Sulphatase Inhibitor - In Postmenopausal Women With Oestrogen-Receptor Positive Breast Cancer Whose Disease Progressed After Prior Therapy For Locally Advanced/Metastatic Disease|Completed||Phase 1|50|Actual|Ipsen||1|||f||||f||||||||||2017-10-11 01:46:27.958918|2017-10-11 01:46:27.958918
NCT01840475|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-05-29|||March 2013||2013-03-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Arm Spasticity - Non-Interventional Study Early BIRD (BoNT Treatment: Initial and Repeated Documentation) [AS-NIS Early BIRD]|International, Multicenter, Non-interventional, Prospective, Longitudinal Study to Investigate the Effectiveness of Botulinum Toxin A (Dysport®) Injections in Patients Suffering From Post-stroke Arm Spasticity With Respect to Early, Medium or Late Start of Treatment.|Active, not recruiting||N/A|302|Actual|Ipsen|||2||f||||f||||||||||2017-10-11 01:46:28.115307|2017-10-11 01:46:28.115307
NCT01840462|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-03-31|||July 2012||2012-07-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Observational|CDNISLongterm||Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]|A National, Multicenter, Non-interventional, Prospective, Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia (Dysport®)|Completed||N/A|372|Actual|Ipsen|||2||f||||f||||||||||2017-10-11 01:46:28.228428|2017-10-11 01:46:28.228428
NCT01840449|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-07-13|||June 2012||2012-06-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|July 2016|Actual|2016-07-01||Observational|SOPRANo||Somatuline Predictive Factors in Acromegaly and NET|Non-interventional, Observational Study to Evaluate Common Therapeutic Algorithms and Possible Predictive Parameters for Somatuline Autogel® (ATG) Treatment in Subjects With Either Acromegaly or Neuroendocrine Tumours (NET)|Completed||N/A|156|Actual|Ipsen|||2||f||||f||||||||||2017-10-11 01:46:28.335081|2017-10-11 01:46:28.335081
NCT01840436|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-05-04|||March 2013||2013-03-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|MUCIPLIQ||Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral Cancer|A Randomized Controlled Study Evaluating the Effect of MUCIPLIQ Versus Placebo on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering of Upper Aerodigestive Tract Carcinomas|Completed||N/A|136|Actual|Organ, Tissue, Regeneration, Repair and Replacement||3|||f||||t||||||||||2017-10-11 01:46:28.472081|2017-10-11 01:46:28.472081
NCT01840423|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-03-31|||May 2013||2013-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NOCIFIM||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Repeated Escalating Doses of ODM-104: a Randomised, Double-blind, Placebo- and Entacapone-controlled Single Centre First-in-man Study in Healthy Volunteers.|Completed||Phase 1|101|Actual|Orion Corporation, Orion Pharma||3|||f||||t||||||||||2017-10-11 01:46:28.622462|2017-10-11 01:46:28.622462
NCT01840410|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-08-15|2016-04-27||September 2013||2013-09-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.|A 12-month, Randomized, Double-masked, Sham-controlled, Multicenter Study to Evaluate the Efficacy and Safety of 0.5mg Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Vascular Endothelial Growth Factor (VEGF) Driven Choroidal Neovascularization.|Completed||Phase 3|183|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:46:28.832733|2017-10-11 01:46:28.832733
NCT01840397|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-11-20|||March 2013||2013-03-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|SpineSurgery||Neuromarker S-100B as Diagnostic Tool|Elevated Levels of S-100B and Neuron-specific Enolase (NSE) in Spine Surgery: A Comparison of Serum Levels With Surgery for Long-bone Fractures|Completed||N/A|30|Anticipated|Medical University of Vienna|||2||f||||f||||||Samples Without DNA|"     serum levels of the biomarkers S-100B and NSE are measured   "|||2017-10-11 01:46:30.99121|2017-10-11 01:46:30.99121
NCT01840384|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-23|||July 2013||2013-07-01|April 2013|2013-04-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|Babytop||Efficacy Study of Multiple Micro Nutrients Supplementation|Longitudinal Study on the Effect of Multiple Micro Nutrients Supplementation on Haemoglobin Level of 8 to 22-month-old Indonesian Children.|Unknown status|Not yet recruiting|N/A|239|Anticipated|PT. Sari Husada||2|||f||||f||||||||||2017-10-11 01:46:31.080272|2017-10-11 01:46:31.080272
NCT01840371|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-06-02|||April 2013||2013-04-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Randomized Controlled Study for Analyzing Clinical Benefit of Pain Focused Sedation With Combination of Fentanyl and Propofol During Endoscopic Retrograde Cholangiopancreatography (ERCP)||Completed||N/A|220|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:46:31.192127|2017-10-11 01:46:31.192127
NCT01840358|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-04-25|||April 2013||2013-04-01|April 2013|2013-04-01||||December 2013|Anticipated|2013-12-01||Interventional|||Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes|Evaluation of the Frequency of Hypoglycemia at Initiation of Insulin Pump Therapy in Children With Type 1 Diabetes|Unknown status|Recruiting|N/A|30|Anticipated|St. Justine's Hospital||1|||f||||f||||||||||2017-10-11 01:46:31.290951|2017-10-11 01:46:31.290951
NCT01840332|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-03-13|||April 2013||2013-04-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer|Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer|Completed||N/A|20|Actual|University of Tartu||1|||f||||f||||||||||2017-10-11 01:46:31.505564|2017-10-11 01:46:31.505564
NCT01840319|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-06-27|2014-06-27||February 2013||2013-02-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational||Intent-to-treat (ITT) population included all participants of the initial study 3074A1-4448 (B1811030) (NCT00799591).|Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)|Retrospective Observational Study Of Patients Previously Treated With Tigecycline In ICU And Included In The Previous French Prospective Observational Study|Completed||N/A|156|Actual|Pfizer|As this was an observational study therefore, no randomization and control groups were included. This limitation did not allow the comparison of tigecycline treatment.||1||f||||f||||||||||2017-10-11 01:46:31.604031|2017-10-11 01:46:31.604031
NCT01840306|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-10-05|||October 2012||2012-10-01|October 2016|2016-10-01||||December 2020|Anticipated|2020-12-01||Observational|||Exosomal and Free Extracellular RNAs and Proteins as Predictive. ICORG 10-15, V2|Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer|Recruiting||N/A|330|Anticipated|Cancer Trials Ireland|||2||f||||f||||||||||2017-10-11 01:46:31.917388|2017-10-11 01:46:31.917388
NCT01840293|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-08-09|||February 2013||2013-02-01|August 2017|2017-08-01||||February 2023|Anticipated|2023-02-01||Observational|||Breast Cancer Proteomics and Molecular Heterogeneity|Breast Cancer Proteomics and Molecular Heterogeneity|Recruiting||N/A|1780|Anticipated|Cancer Trials Ireland|||2||f||||f||||||||||2017-10-11 01:46:32.072656|2017-10-11 01:46:32.072656
NCT01840280|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-11-21|||May 2013||2013-05-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer|Open, Multicenter Observational Study of Irinotecan Utilized in Mono- or Combination Therapy for the Treatment of Advanced Colorectal Carcinoma.|Recruiting||N/A|350|Anticipated|Onkovis GmbH|||1||f||||f||||||||||2017-10-11 01:46:32.185455|2017-10-11 01:46:32.185455
NCT01840267|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-09-25|||April 2013||2013-04-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||The Effect of Pneumoperitoneum on Intracranial Pressure in Pediatric Laparoscopic Surgery: Ultrasonographic Measurement of Optic Nerve Sheath Diameter||Completed||N/A|25|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:46:32.281401|2017-10-11 01:46:32.281401
NCT01840254|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-02-05|||September 2012||2012-09-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Combination Dexmedetomidine Added to Fentanyl-based Intravenous Patient-controlled Analgesia on Nausea Vomiting in Highly Susceptible Patients Undergoing Lumbar Spinal Surgery: Prospective Double Blinded Randomized Controlled Trial||Completed||N/A|108|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:46:32.357576|2017-10-11 01:46:32.357576
NCT01840241|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-02-17|||April 2013||2013-04-01|February 2014|2014-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Effect of Sodium Bicarbonate on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass (OPCAB)||Unknown status|Recruiting|N/A|162|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:46:32.443196|2017-10-11 01:46:32.443196
NCT01840228|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-06-07|||May 2013||2013-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|PAL||Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor|Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor|Recruiting||N/A|120|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:46:32.545765|2017-10-11 01:46:32.545765
NCT01840215|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-05-28|||February 2013||2013-02-01|February 2013|2013-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Study on the Impact of Ocular Anesthetic Procedures in Ocular Blood Flow|Impact of Topical, Retrobulbar and General Anesthesia in Ocular Blood Flow|Completed||N/A|240|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||||||2017-10-11 01:46:32.66903|2017-10-11 01:46:32.66903
NCT01840202|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-05-28|||February 2013||2013-02-01|January 2013|2013-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study|Correlation Between Submacular and Peripapillary Choroidal Tissue and Ocular Blood Flow in Glaucoma Patients|Completed||N/A|770|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||||||2017-10-11 01:46:32.7601|2017-10-11 01:46:32.7601
NCT01840189|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-01-31|||May 2013||2013-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Continuous Subcutaneous Hydrocortisone Infusion In Addison`s Disease and Type 1 Diabetes|Continuous Subcutaneous Hydrocortisone Infusion In Addison`s Disease and Type 1 Diabetes|Completed||Phase 2|2|Actual|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 01:46:32.847586|2017-10-11 01:46:32.847586
NCT01840176|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-04-16|||May 2013|Actual|2013-05-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Prophylactic Modified McCall Culdoplasty During Total Laparoscopic Hysterectomy|Prophylactic Modified McCall Culdoplasty During Total Laparoscopic Hysterectomy|Completed||N/A|50|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:46:34.695164|2017-10-11 01:46:34.695164
NCT01840150|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-01-24|||August 23, 2012|Actual|2012-08-23|January 2017|2017-01-01|November 18, 2020|Anticipated|2020-11-18|December 31, 2018|Anticipated|2018-12-31||Interventional|||Nanoscale Artificial Nose in Monitoring Response and Detecting Recurrence After Surgery or Radiation Therapy in Patients With Stage I or Stage II Non-Small Cell Lung Cancer|A Single-center Study to Evaluate the Feasibility of a Novel NA-NOSE for Monitoring Response to and Detecting Recurrence After Surgery or Radiation in Early Stage Lung Cancer|Recruiting||N/A|35|Anticipated|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-11 01:46:34.846798|2017-10-11 01:46:34.846798
NCT01840137|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-07-06|||June 2012||2012-06-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer|Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer|Recruiting||N/A|70|Anticipated|University of Michigan||1|||f||||t||||||||||2017-10-11 01:46:34.928999|2017-10-11 01:46:34.928999
NCT01840124|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-01-23|||July 2013||2013-07-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|ULTRA||Uterine Leiomyoma Treatment With Radiofrequency Ablation|Uterine Leiomyoma Treatment With Radiofrequency Ablation|Active, not recruiting||Phase 4|100|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:46:35.011299|2017-10-11 01:46:35.011299
NCT01840111|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-01-30|||December 2012||2012-12-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments (CameraCue)|Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments|Completed||N/A|67|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:46:35.108311|2017-10-11 01:46:35.108311
NCT01840098|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-11-04|||January 2014||2014-01-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Leucine and Beta-hydroxy-beta-methylbutyrate (HMB) as Anabolic Nutrients After 36 Hours of Fasting|Leucine and Beta-hydroxy-beta-methylbutyrate (HMB) as Anabolic Nutrients After 36 Hours of Fasting|Completed||N/A|8|Actual|University of Aarhus||4|||f||||t||||||||||2017-10-11 01:46:35.174239|2017-10-11 01:46:35.174239
NCT01839903|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-11-12|||July 2011||2011-07-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|STTEPS||System Based Tracking and Treatment for Emergency Patients Who Smoke: STTEPS|System Based Tracking and Treatment for Emergency Patients Who Smoke: STTEPS|Recruiting||N/A|692|Anticipated|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 01:46:37.206783|2017-10-11 01:46:37.206783
NCT01840085|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2015-11-02|||June 2013||2013-06-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|STRIDE 5||Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use|"Open-Label Phase III Clinical Trial to Evaluate the Safety of 0.03% DSC127 Gel in Chronic Use for Treating Diabetic Foot Ulcers (DFU)"|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|Derma Sciences, Inc.||1|||f||||f||||||||||2017-10-11 01:46:35.261155|2017-10-11 01:46:35.261155
NCT01840072|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2017-03-12|2014-11-13||August 2009||2009-08-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2013|Actual|2013-05-01||Interventional|CATIS||China Antihypertensive Trial in Acute Ischemic Stroke|Inner Mongolia Stroke Project A Randomized Controlled Trial of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic Stroke in China|Completed||N/A|4071|Actual|Tulane University||2|||f||||t||||||||No||2017-10-11 01:46:35.39896|2017-10-11 01:46:35.39896
NCT01840059|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-09-14|||April 2013||2013-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|RDT-PEF||Renal Denervation in Heart Failure With Preserved Ejection Fraction|A Randomised Controlled Trial Investigating the Effect of Transcatheter Renal Sympathetic Denervation on Symptoms and Cardiac Function in Patients With Heart Failure With Preserved Ejection Fraction.|Completed||Phase 2|25|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:46:35.927003|2017-10-11 01:46:35.927003
NCT01840046|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-24|||November 2012||2012-11-01|March 2013|2013-03-01|November 2013|Anticipated|2013-11-01|November 2012|Actual|2012-11-01||Interventional|IL2||Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata|Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe Alopecia Areata Resistant to Conventional Systemic Treatment|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 01:46:36.033903|2017-10-11 01:46:36.033903
NCT01840033|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-23|||April 2013||2013-04-01|April 2013|2013-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|PICCNUT||A Monocenter Prospective Study to Evaluate the Efficacy of Peripherally Inserted Central Catheter to Tunnelled Central Catheter With Cuff in Home Parenteral Nutrition for Long-term Used.|A Monocenter Prospective Study to Evaluate the Efficacy of Peripherally Inserted Central Catheter to Tunnelled Central Catheter With Cuff in Home Parenteral Nutrition for Long-term Used: the PICCnut Study.|Unknown status|Recruiting|N/A|122|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 01:46:36.130663|2017-10-11 01:46:36.130663
NCT01840007|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-23|||August 2011||2011-08-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|||Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma|Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma|Unknown status|Recruiting|Phase 2|20|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 01:46:36.315138|2017-10-11 01:46:36.315138
NCT01839994|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-04-24|||June 2013||2013-06-01|April 2013|2013-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer|Phase III Clinical Trial on Conventionally Fractionated Conformal Radiotherapy (CF-CRT) Versus CF-CRT Combined With High-dose-rate Brachytherapy or Stereotactic Body Radiotherapy for Intermediate and High-risk Prostate Cancer.|Not yet recruiting||Phase 3|350|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||f||||||||||2017-10-11 01:46:36.417027|2017-10-11 01:46:36.417027
NCT01839981|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-05-30|||July 2013||2013-07-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Pilot Study: Open-Label Clinical Trial of CPI-613 in Patients With Metastatic Pancreatic Adenocarcinoma and Poor Performance Status|Completed||Phase 1|10|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 01:46:36.543739|2017-10-11 01:46:36.543739
NCT01839968|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-08-18|||September 2011||2011-09-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|||Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel||Completed||N/A|32|Actual|University Hospital, Geneva|||1||f||||||||||Samples Without DNA|"     Plasma   "|||2017-10-11 01:46:36.646598|2017-10-11 01:46:36.646598
NCT01839955|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-10-28|||September 2013||2013-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer|A Phase I Study of Erlotinib in Combination With Quinacrine in Patients With Advanced Non-Small-Cell Lung Cancer|Completed||Phase 1|12|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:46:36.721508|2017-10-11 01:46:36.721508
NCT01839942|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2014-02-17|||May 2013||2013-05-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|SGChirIPOM||Recurrence and Patient Satisfaction After Laparoscopic Hernia Repair With Intraperitoneal Onlay-mesh (IPOM)|Recurrence and Patient Satisfaction After Laparoscopic Hernia Repair With Intraperitoneal Onlay-mesh (IPOM)|Completed||N/A|348|Actual|Cantonal Hospital of St. Gallen|||3||f||||f||||||||||2017-10-11 01:46:36.847088|2017-10-11 01:46:36.847088
NCT01839929|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2013-04-30|||September 2010||2010-09-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|PeACE||A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF|A Multicenter, Open-label, Single-arm, Non-inferiority Study to Assess the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF® in Stable Kidney Transplant Patients Converted From a PROGRAF® Based Immunosuppressive Regimen|Completed||Phase 4|138|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:46:36.935301|2017-10-11 01:46:36.935301
NCT01839916|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-07-24|||April 4, 2013|Actual|2013-04-04|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies|Pilot Study of Prophylactic Dose-Escalation Donor Lymphocyte Infusion After T Cell Depleted Allogeneic Stem Cell Transplant in High Risk Patients With Hematologic Malignancies|Recruiting||Phase 2|56|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 01:46:37.034142|2017-10-11 01:46:37.034142
NCT01839890|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-02-05|||April 2012||2012-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PEBSI-01||Paclitaxel Eluting Balloon in St Elevation Myocardial Infarction|Study to Evaluate the Efficacy and Safety of Paclitaxel Eluting Balloon in St Elevation Myocardial Infarction After Bare Metal Stent Insertion|Completed||Phase 3|202|Actual|Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular||2|||f||||f||||||||||2017-10-11 01:46:37.320235|2017-10-11 01:46:37.320235
NCT01839877|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-07-10|||May 2013||2013-05-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study|Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study|Active, not recruiting||Phase 2|58|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||t||||||||||2017-10-11 01:46:37.625013|2017-10-11 01:46:37.625013
NCT01839864|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-02-13|||September 2013||2013-09-01|February 2017|2017-02-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|FMRIMetSynd||Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial|Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial|Withdrawn||N/A|0|Actual|Family Medicine Residency of Idaho||1||Funding for the study was not received. No recruitment ever occurred.|f||||t||||||||No|No plan to share IPD as funding for the study was not successful so no recruiting occurred, thus, no IPD.|2017-10-11 01:46:37.771201|2017-10-11 01:46:37.771201
NCT01839851|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-03-09|||May 2013||2013-05-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids|Evaluation of Hair Cortisol in Patients With Asthma or Allergic Rhinitis Treated With Topical (Inhaled or Intranasal) Corticosteroids|Unknown status|Recruiting|N/A|60|Anticipated|Meir Medical Center|||3||f||||f||||||Samples Without DNA|"     Hair   "|||2017-10-11 01:46:37.908867|2017-10-11 01:46:37.908867
NCT01839838|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2016-09-23|||April 2013||2013-04-01|September 2016|2016-09-01||||April 2024|Anticipated|2024-04-01||Interventional|||APBI Proton Feasibility and Phase II Study|A FEASIBILITY AND PHASE II TRIAL OF ACCELERATED PARTIAL BREAST IRRADIATION USING PROTON THERAPY FOR WOMEN WITH STAGE IA-IIA BREAST CANCER|Recruiting||Phase 2|57|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 01:46:38.045469|2017-10-11 01:46:38.045469
NCT01839825|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2014-09-25|||December 2012||2012-12-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparative Study of QuietCare|Randomized Comparative Study of QuietCare (Motion Sensor System) in Elderly Subjects Living in Assisted/ Independent Living Facilities|Completed||N/A|202|Actual|National Center for Geriatrics and Gerontology, Japan||2|||f||||t||||||||||2017-10-11 01:46:38.153713|2017-10-11 01:46:38.153713
NCT01839812|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-06-13|||March 2009||2009-03-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery|Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery|Completed||Phase 1|35|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:46:38.274448|2017-10-11 01:46:38.274448
NCT01839799|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-23|2017-07-31|||April 2013||2013-04-01|July 2017|2017-07-01||||April 2018|Anticipated|2018-04-01||Interventional|||A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma|A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma|Recruiting||Phase 2|50|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:46:38.41109|2017-10-11 01:46:38.41109
NCT01839786|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-03-19|||May 2013||2013-05-01|April 2013|2013-04-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Observational|||Evaluation of Lung Doppler Signals in Pulmonary Hypertension|Evaluation of Lung Doppler Signals in Pulmonary Hypertension|Terminated||N/A|45|Actual|Echosense Ltd.|||1||f||||f||||||||||2017-10-11 01:46:38.550268|2017-10-11 01:46:38.550268
NCT01839773|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-08-09|||March 2013||2013-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|DREAM||A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy|A Randomized, Open, Multicenter Phase 3 Study for Efficacy and Safety Assessment of DHP107 (Oral Paclitaxel) vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy With Fluoropyrimidine +/- Platinum|Completed||Phase 3|238|Actual|Daehwa Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:46:38.695827|2017-10-11 01:46:38.695827
NCT01839760|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2014-08-21|||December 2012||2012-12-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients|Prospective Study to Evaluate Viral Shedding Patterns and Clinical Outcomes of Hospitalized Adult Influenza Patients|Completed||N/A|150|Actual|Crucell Holland BV|||2||f||||f||||||||||2017-10-11 01:46:38.918143|2017-10-11 01:46:38.918143
NCT01839747|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-02-02|||October 2012||2012-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of PET/MRI in Children With Cancer|Evaluation of PET/MRI in Children With Cancer|Recruiting||N/A|20|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:46:39.01926|2017-10-11 01:46:39.01926
NCT01839734|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-03-23|||June 2013||2013-06-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|April 2014|Actual|2014-04-01||Interventional|LAMBCHOP||Pilot Study of Lubiprostone as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Persons With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy|LAMBCHOP-Lubiprostone Activity Among the MicroBiota of the Colon in HIV in Opposing Permeability: A Pilot Study of Lubiprostone as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Persons With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Ruth M. Rothstein CORE Center||2|||f||||f||||||||||2017-10-11 01:46:39.126591|2017-10-11 01:46:39.126591
NCT01839721|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-05-16|||December 2006||2006-12-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation|Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation|Completed||Phase 3|246|Actual|CHU de Quebec-Universite Laval||3|||f||||t||||||||||2017-10-11 01:46:39.22465|2017-10-11 01:46:39.22465
NCT01839708|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-02-03|||September 2011||2011-09-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|MIM||Mothers in Motion Program to Prevent Weight Gain in WIC Mothers (MIM)|Mothers in Motion Program to Prevent Weight Gain in Overweight/Obese WIC Mothers (MIM)|Unknown status|Active, not recruiting|Phase 3|620|Anticipated|Michigan State University||2|||f||||t||||||||||2017-10-11 01:46:39.3317|2017-10-11 01:46:39.3317
NCT01839695|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-01-31|2014-10-24||April 2013||2013-04-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Efficacy of Valiant Mona LSA Stent Graft System|Valiant Mona LSA Stent Graft System Early Feasibility Study|Active, not recruiting||N/A|9|Actual|Medtronic Endovascular||1|||f||||f||||||||||2017-10-11 01:46:39.444378|2017-10-11 01:46:39.444378
NCT01839682|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-25|||June 2009||2009-06-01|April 2013|2013-04-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Observational|||Evaluation of Outcomes of DFine StabiliT Kyphoplasty in Vertebral Compression Fractures Due to Osteoporosis|Prospective, Single Arm, Open Label Post-Market Pilot Study to Evaluate the StabiliT Vertebral Augmentation System Treat Vertebral Compression Fractures Due to Osteoporosis|Completed||N/A|23|Actual|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-11 01:46:39.706882|2017-10-11 01:46:39.706882
NCT01839669|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-07-11|||July 2013||2013-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||The CurePPaC Study - Analysing Non-surgical Treatment Strategies to Cure Pes Planovalgus Associated Complaints|The CurePPaC Study - Analysing Non-surgical Treatment Strategies to Cure Pes Planovalgus Associated Complaints|Recruiting||N/A|60|Anticipated|Bern University of Applied Sciences||3|||f||||f||||||||||2017-10-11 01:46:39.792257|2017-10-11 01:46:39.792257
NCT01839656|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-07-28|||May 31, 2013|Actual|2013-05-31|July 2017|2017-07-01|August 31, 2017|Anticipated|2017-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|||A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA)|A Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ISIS 396443 Delivered Intrathecally to Patients With Infantile-Onset Spinal Muscular Atrophy|Active, not recruiting||Phase 2|20|Actual|Biogen||2|||t||||t|t|f||||||||2017-10-11 01:46:39.931058|2017-10-11 01:46:39.931058
NCT01839643|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-08-04|||December 2012||2012-12-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women|Phase 1 Study of Assessment of Local Absortion of a Non-steroidal Antiinflammatory Drug (NSAID), Inhibitor of Cyclooxygenase 2 (COX-2) Meloxicam, Through a Vaginal Ring and Its Effect on Ovarian Cycle in Fertile Women|Completed||Phase 1/Phase 2|13|Actual|Laboratorios Andromaco S.A.||2|||f||||t||||||||||2017-10-11 01:46:40.077964|2017-10-11 01:46:40.077964
NCT01839630|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2017-06-08|||May 30, 2013|Actual|2013-05-30|June 2017|2017-06-01|December 29, 2016|Actual|2016-12-29|August 6, 2016|Actual|2016-08-06||Observational|SUCCESS||Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China|Study of Unresectable HCC Treated Concomitantly With TACE and Sorafenib in Chinese Patients|Completed||N/A|302|Actual|Bayer|||1||f||||f|f|||||||||2017-10-11 01:46:40.159701|2017-10-11 01:46:40.159701
NCT01839617|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-10-28|||May 2013||2013-05-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|PaNCS||Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery|Early Versus Late Parenteral Nutrition in Cancer Patients Undergoing Abdominal Surgery|Unknown status|Recruiting|Phase 3|335|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||t||||||||||2017-10-11 01:46:40.288843|2017-10-11 01:46:40.288843
NCT01839604|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-01-13|2016-02-01||May 2013||2013-05-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma|A Phase I/Ib, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of AZD9150 in Patients With Advanced/Metastatic Hepatocellular Carcinoma|Completed||Phase 1|58|Actual|AstraZeneca|The overall study objectives were achieved earlier than anticipated, so recruitment was stopped and the study was considered complete. In turn multiple dose PK profiles were not obtained during the study expansion phase.|1|||f||||f||||||||||2017-10-11 01:46:40.41348|2017-10-11 01:46:40.41348
NCT01839591|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-03-31|||March 2013||2013-03-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Interventional|BT-ASMN||Bronchial Thermoplasty: Effect on Neuronal and Chemosensitive Component of the Bronchial Mucosa|Treatment of Bronchial Severe Asthma With Bronchial Thermoplasty. Assessment of Efficacy and Safety of Treatment, Study of Effects on Neuronal and Chemosensitive Component of the Bronchial Mucosa Pre and Post Treatment|Unknown status|Recruiting|N/A|12|Anticipated|Arcispedale Santa Maria Nuova-IRCCS||1|||f||||f||||||||||2017-10-11 01:46:41.562377|2017-10-11 01:46:41.562377
NCT01839578|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-08-26|||May 2013||2013-05-01|August 2014|2014-08-01|April 2015|Anticipated|2015-04-01|November 2014|Anticipated|2014-11-01||Interventional|RCA-SHA||Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances|Regional Citrate Versus Systemic Heparin Anticoagulation for Super High-flux Continuous Hemodialysis in Septic Shock: Effect on Middle Molecular Weight Molecules Clearances|Unknown status|Recruiting|N/A|30|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 01:46:41.711289|2017-10-11 01:46:41.711289
NCT01839565|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-01-24|||October 2012||2012-10-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01|24 Months|Observational [Patient Registry]|||Quadrilateral Surface Plate (QSP) Focused Registry|"A Prospective and Retrospective Multicenter Registry for Surgeon-based Evaluation of the Quadrilateral Surface Plate Used for Acetabular Fractures"|Active, not recruiting||N/A|13|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 01:46:41.838886|2017-10-11 01:46:41.838886
NCT01839552|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-02-29|||October 2014||2014-10-01|January 2016|2016-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|FCNS||An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.|An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients Without a Timely Response to Their Short-acting Opioids.|Withdrawn||Phase 4|0|Actual|James Graham Brown Cancer Center||1||Site chose to close due to lack of enrollment|f||||t||||||||||2017-10-11 01:46:41.958546|2017-10-11 01:46:41.958546
NCT01833689|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-08-31|||June 2013||2013-06-01|August 2016|2016-08-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|GI||Glycaemic Index of Foods in Healthy Volunteers|Glycaemic Index Testing of Carbohydrate Containing Foods Using a Standardised Method|Recruiting||N/A|20|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 01:48:16.010216|2017-10-11 01:48:16.010216
NCT01839526|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2016-10-05|||May 2013||2013-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease|A Cross-sectional Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease|Terminated||N/A|39|Actual|Sanofi||1||"Enrollment period not extended and screening stopped for slow recruitment and in accordance   with provisions of the protocol. Not linked to any safety concern"|f||||f||||||||||2017-10-11 01:46:42.154824|2017-10-11 01:46:42.154824
NCT01839513|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-11-01|||May 2013||2013-05-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|||Prediction of Hemodynamic Reactivity During General Anesthesia Using Analgesia/Nociception Index (ANI)|Prediction of Hemodynamic Reactivity During Desflurane/Remifentanil General Anesthesia Using Analgesia/Nociception Index (ANI)|Completed||N/A|100|Actual|Hôpital Edouard Herriot|||1||f||||t||||||||||2017-10-11 01:46:42.288905|2017-10-11 01:46:42.288905
NCT01839500|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-08-09|||April 25, 2013|Actual|2013-04-25|August 2017|2017-08-01|November 21, 2017|Anticipated|2017-11-21|November 21, 2017|Anticipated|2017-11-21||Observational|EVIDENCE||A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer|A Non-Interventional, Registry Study for Chinese Gastric Cancer Patients With HER2 Status: Clinical and Pathological Characteristics, Treatment Patterns and Clinical Outcomes (EVIDENCE)|Active, not recruiting||N/A|1600|Anticipated|Hoffmann-La Roche|||5||f||||||||||||||2017-10-11 01:46:42.384976|2017-10-11 01:46:42.384976
NCT01839487|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-02-25|||April 2013||2013-04-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|April 2016|Anticipated|2016-04-01||Interventional|HALO-109-202||PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer|A Phase 2, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase)Combined With Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Previously Untreated Pancreatic Cancer|Active, not recruiting||Phase 2|279|Anticipated|Halozyme Therapeutics||2|||f||||t||||||||||2017-10-11 01:46:42.659367|2017-10-11 01:46:42.659367
NCT01839474|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-02-02|||January 2014|Actual|2014-01-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||CPAP Survival Study in Ghana|Clinical Trial Evaluating the Difference in Mortality Rates in Children in Ghana Receiving CPAP Versus Those Who Do Not|Completed||N/A|2200|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 01:46:42.927922|2017-10-11 01:46:42.927922
NCT01839461|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-07-28|||July 2009||2009-07-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Pharmacogenetic Morphine Spine Study|Personalizing Perioperative Morphine Analgesia for Adolescents Undergoing Major Spine Surgeries|Enrolling by invitation||N/A|300|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     De-identified study subjects' genetic information and their responses to pain and pain     medications, side-effects will be included in a study database. No patient identifiers will     be included in the database and there will be a confidential (access limited to investigators     only) code or link between the database and other information about the participant   "|||2017-10-11 01:46:43.043985|2017-10-11 01:46:43.043985
NCT01839448|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-10-18|||March 2014||2014-03-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|DG Post-Partum||Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation|Frequency of Abnormal Glucose Metabolism (Diabetes, Impaired Glucose Tolerance, Impaired Fasting Glucose) in the Immediate Postpartum Period Following Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation|Active, not recruiting||N/A|500|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 01:46:43.175754|2017-10-11 01:46:43.175754
NCT01839435|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-04-27|||April 2013||2013-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|APPENDAMBU||Feasibility of Outpatient Appendectomy for Acute Appendicitis|PROSPECTIVE EVALUATION OF OUTPATIENT APPENDECTOMY FOR NON COMPLICATED ACUTE APPENDICITIS: Intention-to-treat Study|Completed||Phase 3|120|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:46:43.309084|2017-10-11 01:46:43.309084
NCT01839422|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-04-08|||January 2012||2012-01-01|April 2014|2014-04-01||||December 2015|Anticipated|2015-12-01||Interventional|INCAS||Imaging of New Learning in Severe Alzheimer's Disease Patients|Functionnal Magnetic Resonnance Imaging (fMRI)Study of Cerebral Substrates of New Musical and Pictorial Learning in Alzheimer Patients|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Caen||3|||f||||t||||||||||2017-10-11 01:46:43.405383|2017-10-11 01:46:43.405383
NCT01839409|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-11-02|||April 2013||2013-04-01|November 2015|2015-11-01||||April 2016|Anticipated|2016-04-01||Interventional|REHAB_Rn'V||Biological Rhythms and Vestibular System|Biological Rhythms and Vestibular System|Recruiting||N/A|96|Anticipated|University Hospital, Caen||4|||f||||t||||||||||2017-10-11 01:46:43.525296|2017-10-11 01:46:43.525296
NCT01839396|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-11-15|||April 2013||2013-04-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|July 2017|Anticipated|2017-07-01||Interventional|INTREPID||Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease|Implantable Neurostimulator for the Treatment of Parkinson's Disease|Recruiting||N/A|310|Anticipated|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-11 01:46:43.757183|2017-10-11 01:46:43.757183
NCT01839383|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-04-29|||June 2013||2013-06-01|April 2013|2013-04-01||||June 2015|Anticipated|2015-06-01||Interventional|||The Effects of Different Dialysate Calcium Concentration|The Effects of Different Dialysate Calcium Concentration on Mineral-bone Metabolism in Chinese Patients on Maintenance Hemodialysis|Unknown status|Not yet recruiting|N/A|90|Anticipated|Beijing Friendship Hospital||3|||f||||||||||||||2017-10-11 01:46:43.874437|2017-10-11 01:46:43.874437
NCT01839370|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2014-02-18|||July 2013||2013-07-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus|Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus|Completed||N/A|9|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 01:46:43.985257|2017-10-11 01:46:43.985257
NCT01838980|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2016-12-26|2014-02-04||April 2013||2013-04-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of the Motus GI CleanUp System During Screening Colonoscopy|Evaluation of the Motus GI CleanUp System During Screening|Completed||N/A|15|Actual|Motus GI Medical Technologies Ltd||1|||f||||t||||||||Undecided|De-identified individual participant data for all primary and secondary outcome measures may be made available in the future|2017-10-11 01:46:49.415261|2017-10-11 01:46:49.415261
NCT01839357|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-07-22|||August 2013||2013-08-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|X-TRA||Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter|An Open-label, International, Multicenter, Interventional Study Exploring the Efficacy of Once-daily Oral Rivaroxaban (BAY 59-7939) for the Treatment of Left Atrial/Left Atrial Appendage Thrombus in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter|Completed||Phase 3|60|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:46:44.091906|2017-10-11 01:46:44.091906
NCT01839344|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-03-16|||May 2013||2013-05-01|February 2014|2014-02-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.|Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance and Postprandial Endothelial Function.|Completed||Phase 2|19|Actual|Bastyr University||3|||f||||f||||||||||2017-10-11 01:46:44.346676|2017-10-11 01:46:44.346676
NCT01839331|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-07-27|||March 2013||2013-03-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||AP-003-A A Efficacy and Safety Study of Two Doses of Intra-Articular Injection of Ampion™ in Adults With Pain Due to Osteoarthritis of the Knee|A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Two Doses of Intra-Articular Injection of Ampion™ in Adults With Pain Due to Osteoarthritis of the Knee|Completed||Phase 3|329|Actual|Ampio Pharmaceuticals. Inc.||4|||f||||t||||||||||2017-10-11 01:46:44.525921|2017-10-11 01:46:44.525921
NCT01839318|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2014-05-21|2014-05-21||April 2013||2013-04-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||This analysis population includes all participants who were exposed to a study product.|Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses|Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection|Completed||N/A|30|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 01:46:44.623397|2017-10-11 01:46:44.623397
NCT01839305|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-06-23|||July 2011||2011-07-01|June 2016|2016-06-01|March 2014|Actual|2014-03-01|April 2013|Actual|2013-04-01||Interventional|||Effects of Hydrotherapy on Physical Function and Quality of Life of Women With Fibromyalgia|Effects of Hydrotherapy on 3D Scapular Kinematics, Electromyography, Pain, Quality of Life, Balance and Cardiorespiratory Variables in Women With Fibromyalgia|Completed||N/A|20|Actual|Universidade Federal de Sao Carlos||1|||f||||f||||||||No||2017-10-11 01:46:44.966403|2017-10-11 01:46:44.966403
NCT01839292|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-22|||April 2010||2010-04-01|April 2013|2013-04-01||||August 2012|Actual|2012-08-01||Interventional|||ComVi and D-type Stent in Malignant GOO|A Newly Designed Conformable Uncovered Versus Covered Self-expandable Metallic Stent for Palliation of Malignant Gastric Outlet Obstruction: a Prospective, Randomized Multicenter Study|Completed||N/A|89|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-11 01:46:45.093912|2017-10-11 01:46:45.093912
NCT01839279|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2015-05-12|2015-02-27||April 2013||2013-04-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|TQT|Safety Population|A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial|A Partial-Blind, Randomized, Parallel Design Study With a Nested Crossover Comparison to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial|Completed||Phase 2|136|Actual|Acorda Therapeutics||3|||f||||t||||||||||2017-10-11 01:46:45.213522|2017-10-11 01:46:45.213522
NCT01839266|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-21|||November 2011||2011-11-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Observational|||Prognostic Factors for Acute Pulmonary Embolism in Critically Ill Patients||Completed||N/A|200|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:46:46.120523|2017-10-11 01:46:46.120523
NCT01839253|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-03-31|||August 2012||2012-08-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of Antihypertensive Agents Concerning With Hemodynamics and Reduction of Anaesthetics in Orthognathic Surgery||Completed||N/A|75|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 01:46:46.211826|2017-10-11 01:46:46.211826
NCT01839240|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-09-08|||June 6, 2012|Actual|2012-06-06|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia|Phase I Investigation of the Feasibility of Combining 5-azacytidine With Highdose Cytarabine (HiDAC) and Mitoxantrone Chemotherapy in a Sequential Manner for Remission Induction in High-risk Acute Myelogenous Leukemia (AML)|Active, not recruiting||Phase 1|30|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 01:46:46.353318|2017-10-11 01:46:46.353318
NCT01839227|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-01-27|||November 2012||2012-11-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Post-operative Cognitive Dysfunction and the Change of Regional Cerebral Oxygen Saturation in Elderly Patients Undergoing Spinal Surgery||Completed||N/A|87|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 01:46:46.512973|2017-10-11 01:46:46.512973
NCT01839214|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2015-03-26|||January 2013||2013-01-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis|A Randomized, Double-Blind, 12-Week, Placebo-Controlled Study Followed by a 12-Week Extension Phase Without Placebo to Evaluate the Efficacy and Safety of Oral VB-201 in Subjects With Mild to Moderate Ulcerative Colitis|Completed||Phase 2|112|Actual|Vascular Biogenics Ltd. operating as VBL Therapeutics||2|||f||||f||||||||||2017-10-11 01:46:46.629498|2017-10-11 01:46:46.629498
NCT01839201|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2013-04-25|||November 2009||2009-11-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|dream||The Effect of Preoperative Suggestions on Perioperative Dreams and Dream Recalls|Guiding Dreaming During Anaesthesia by Means of Communication Through Suggestions. What Influences Our Suggestions? What do Our Suggestions Influence?|Completed||N/A|270|Actual|University of Debrecen||3|||f||||t||||||||||2017-10-11 01:46:46.757347|2017-10-11 01:46:46.757347
NCT01839188|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-02-27|||May 2013||2013-05-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Spanish Mixed HEXA/PENTA/HEXA Schedule|A Phase 3 Open-label Study to Evaluate the Immunogenicity and Safety of a Mixed (HEXA/PENTA/HEXA) Primary Series Schedule That Includes V419 (PR5I) at 2 and 6 Months of Age and Pediacel at 4 Months of Age.|Completed||Phase 3|385|Actual|MCM Vaccines B.V.||1|||f||||f||||||||||2017-10-11 01:46:46.934949|2017-10-11 01:46:46.934949
NCT01839175|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-09-08|||April 2013|Actual|2013-04-01|September 2017|2017-09-01|February 2015|Actual|2015-02-01|July 2014|Actual|2014-07-01||Interventional|||Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination|A Phase III Open-label Randomised Study to Evaluate the Immunogenicity and Safety of the Concomitant Administration of a New Hexavalent DTaP-IPV-HepB-PRP-T Combined Vaccine (Hexavalent Vaccine) Given at 2, 3, and 4 Months of Age With a Meningococcal Serogroup C Conjugate (MenC) Vaccine Given at 2 and 4 Months of Age|Completed||Phase 3|350|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:46:47.106723|2017-10-11 01:46:47.106723
NCT01839162|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-01-27|||April 2013||2013-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|RADIATION||RAdiation Dose In percutAneuos Coronary Procedures Through TransradIal apprOach Using Dedicated radiatioN Shields|RAdiation Dose In percutAneuos Coronary Procedures Through TransradIal apprOach Using Dedicated radiatioN Shields (The RADIATION Study)|Completed||N/A|452|Actual|Ospedale Sandro Pertini, Roma||4|||f||||f||||||||||2017-10-11 01:46:47.314763|2017-10-11 01:46:47.314763
NCT01839149|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-05-11|||May 2013||2013-05-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine|A Phase 2, Enriched-enrollment, Randomized-withdrawal, Double-blinded, Placebo-Controlled Study to Assess the Efficacy, Tolerability, and Safety of Intranasal Oxytocin in Subjects With Chronic Migraine|Completed||Phase 2|240|Actual|Trigemina, Inc||2|||f||||f||||||||||2017-10-11 01:46:47.43743|2017-10-11 01:46:47.43743
NCT01839136|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2014-06-30|||May 2013||2013-05-01|June 2014|2014-06-01||||February 2014|Actual|2014-02-01||Interventional|||Gametes Transfer vs. Embryo Transfer for Women Undergoing Assisted Reproductive Techniques: a Randomized Controlled Trial|Gametes Transfer vs. Embryo Transfer for Women Undergoing Assisted Reproductive Techniques: a Randomized Controlled Trial|Terminated||N/A|40|Actual|University of Sao Paulo||2||Low pregnancy rates in both groups|f||||t||||||||||2017-10-11 01:46:47.553762|2017-10-11 01:46:47.553762
NCT01839123|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-06-27|||April 2013||2013-04-01|June 2013|2013-06-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Evaluation of Limb Health Associated With a Prosthetic Vacuum Socket System|Prosthetic Socket System: Pilot Assessment|Unknown status|Recruiting|N/A|10|Anticipated|Ohio Willow Wood||2|||f||||||||||||||2017-10-11 01:46:47.668446|2017-10-11 01:46:47.668446
NCT01839110|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-06-22|||July 2013||2013-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Targeting the Right Ventricle in Pulmonary Hypertension|A Randomized, Double-blind, Placebo Controlled, Multi-center Study to Assess the Effect of Ranolazine on Outcomes in Subjects With Pulmonary Hypertension and Right Ventricular Dysfunction Accompanied by a Comparative Study of Cellular Metabolism in Subjects With Pulmonary Hypertension With and Without Right Ventricular Dysfunction|Active, not recruiting||N/A|40|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-10-11 01:46:47.846837|2017-10-11 01:46:47.846837
NCT01839097|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-04-18|||May 2013||2013-05-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)|Phase 1 Dose Finding Study of Belinostat Plus Cyclophosphamide/Vincristine/Doxorubicin/Prednisone (CHOP) Regimen (BelCHOP) for Treatment of Patients With Peripheral T-cell Lymphoma(PTCL)|Completed||Phase 1|23|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-11 01:46:47.981853|2017-10-11 01:46:47.981853
NCT01839084|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-02-17|||July 2013||2013-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PaNeX||PaNeX: Partial Nephrectomy Under Xenon|Impact of Xenon-anesthesia on the Renal Function After Partial Nephrectomy - PaNeX: Partial Nephrectomy Under Xenon:a Pilot Study|Completed||Phase 3|46|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 01:46:48.118175|2017-10-11 01:46:48.118175
NCT01839071|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-06-24|||June 2010||2010-06-01|November 2013|2013-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Influence of Vasculary Inflammation on Development of Diabetes|Influence of Vasculary Inflammation on Development of Diabetes|Completed||N/A|109|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 01:46:48.233202|2017-10-11 01:46:48.233202
NCT01839058|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-04-25|2017-04-25||October 2013||2013-10-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Is Non-Cardiac Chest Pain Caused by Sustained Longitudinal Smooth Muscle Contraction?|Is Non-Cardiac Chest Pain Caused by Sustained Longitudinal Smooth Muscle Contraction?|Completed||N/A|40|Actual|Queen's University|||2||f||||f||||||||||2017-10-11 01:46:48.332021|2017-10-11 01:46:48.332021
NCT01839045|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-06-06|||March 2013||2013-03-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|June 2014|Actual|2014-06-01|6 Months|Observational [Patient Registry]|||Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification|Breast Cancer Biomarker Sample Collection for the DtectDx Assay Proof of Concept|Unknown status|Active, not recruiting|N/A|350|Anticipated|Provista Diagnostics, Inc|||1||f||||t||||||Samples Without DNA|"     At each visit, 35mL or 2 1/2 tablespoons of blood will be drawn from your arm.   "|||2017-10-11 01:46:48.767709|2017-10-11 01:46:48.767709
NCT01839032|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-19|||May 2005||2005-05-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy|A Phase II Study of Cisplatin With Intravenous and Oral Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemotherapy With Oral Vinorelbine and Cisplatine for Locally Advances Non-small Cell Lung Cancer|Completed||Phase 2|70|Actual|Pierre Fabre Medicament||1|||f||||t||||||||||2017-10-11 01:46:48.899467|2017-10-11 01:46:48.899467
NCT01839019|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-02-07|||April 2013||2013-04-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Tolerability Study With Single Ascending Doses of ODM-102|Safety, Tolerability and Pharmacokinetics of Single Escalating Doses of ODM-102: A Randomised, Double-blind, Placebo-controlled, Single Centre Study in Healthy Males|Completed||Phase 1|22|Actual|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-10-11 01:46:49.023132|2017-10-11 01:46:49.023132
NCT01839006|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-25|2013-04-21|||June 2011||2011-06-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Clinical Significance of Supranormal Differential Renal Function in the Recovery of Hydronephrosis|Clinical Significance of Supranormal Differential Renal Function in the Recovery of Unilateral Hydronephrosis After Surgery: Long-term Results|Completed||N/A|34|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 01:46:49.134358|2017-10-11 01:46:49.134358
NCT01838967|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-10-11|||April 2013||2013-04-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||A Drug Interaction Study of Cilnidipine and Valsartan|A Randomized, Open-label, Single Dosing, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Cilnidipine 10 mg and Valsartan 160 mg After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|54|Actual|IlDong Pharmaceutical Co Ltd||6|||f||||f||||||||||2017-10-11 01:46:49.647095|2017-10-11 01:46:49.647095
NCT01838954|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-04-09|||March 2012||2012-03-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Interventional|||Short-wave Diathermy in Patients With Osteoarthritis of the Hand|The Effect of Short-wave Diathermy in Patients With Osteoarthritis of the Hand: A Randomized, Double Blinded, Placebo Controlled Trial|Unknown status|Recruiting|N/A|90|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 01:46:49.796991|2017-10-11 01:46:49.796991
NCT01838941|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-05-20|2015-06-08||March 2013||2013-03-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional||Participants seen at research site; evaluation included physical examination, collection of medical history, measure of hematology, laboratory, and biochemical parameters.|Betaine and Peroxisome Biogenesis Disorders|A Pilot, Open Label Trial Assessing the Safety and Efficacy of Betaine in Children With Peroxisome Biogenesis Disorders.|Completed||Phase 3|12|Actual|McGill University Health Center|Large intra- and inter-individual variations in peroxisome functions, variation in phenotype severity, variation in age, number of participants; blood metabolite markers may be less sensitive than direct measurements of cell responses.|1|||f||||f||||||||No||2017-10-11 01:46:49.90109|2017-10-11 01:46:49.90109
NCT01838928|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2013-04-23|||August 2010||2010-08-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Interventional|||Minimum Effective Concentration of Bupivacaine in Ultrasound-guided Axillary Brachial Plexus Block|Minimum Effective Concentration of Bupivacaine in Ultrasound-guided Axillary Brachial Plexus Block|Completed||N/A|46|Actual|Federal University of São Paulo||1|||f||||||||||||||2017-10-11 01:46:50.179634|2017-10-11 01:46:50.179634
NCT01838915|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-10-05|||January 10, 2017|Actual|2017-01-10|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MicroVIH||Randomized Placebo-controlled Pilot Trial of Prebiotics+Glutamine in HIV Infection|Gut Microbiota, Bacterial Translocation, Immune Activation and Endothelial Dysfunction in HIV Infection|Active, not recruiting||Phase 1/Phase 2|45|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||t||||||||||2017-10-11 01:46:50.269248|2017-10-11 01:46:50.269248
NCT01838902|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-03-15|||August 2013||2013-08-01|September 2015|2015-09-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|PRINOGAM||Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers|Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers Treated With Dihydroartemisinin-piperaquine in The Gambia|Completed||Phase 3|467|Actual|Medical Research Council Unit, The Gambia||4|||f||||t||||||||||2017-10-11 01:46:50.368111|2017-10-11 01:46:50.368111
NCT01838889|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2014-12-05|||March 2011||2011-03-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|ROSHNI-D||Exploratory Trial of a Group Psychological Intervention for Postnatal Depression in British Mother's of South Asian Origin|Exploratory RCT of a Group Psychological Intervention for Postnatal Depression in British Mother's of South Asian Origin|Completed||N/A|83|Actual|Lancashire Care NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:46:50.474396|2017-10-11 01:46:50.474396
NCT01838876|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2016-08-02||2016-08-02|May 2013||2013-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2015|Actual|2015-07-01||Interventional|||To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)|A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder|Completed||Phase 3|347|Actual|Forest Laboratories||1|||f||||f||||||||||2017-10-11 01:46:50.609865|2017-10-11 01:46:50.609865
NCT01838863|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-04-07|||April 7, 2014|Actual|2014-04-07|April 2017|2017-04-01|April 3, 2018|Anticipated|2018-04-03|April 3, 2017|Actual|2017-04-03||Interventional|COMBAT||Control of Major Bleeding After Trauma Study|A Prospective, Randomized Comparison of Fresh Frozen Plasma Versus Standard Crystalloid Intravenous Fluid as Initial Resuscitation Fluid|Terminated||Phase 2|144|Actual|Denver Health and Hospital Authority||2||Futility.|f||||t||||||||||2017-10-11 01:46:50.909313|2017-10-11 01:46:50.909313
NCT01838850|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-22|2017-08-23|||April 2013||2013-04-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy|A Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Triple Fixed Dose Combination Therapy With Olmesartan Medoxomil 20mg, Amlodipine 5mg and Hydrochlorothiazide 12.5mg in Patients With Hypertension Not Controlled With Dual Fixed Dose Combination Therapy With Olmesartan Medoxomil 20mg and Hydrochlorothiazide 12.5mg|Completed||Phase 3|344|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 01:46:51.061838|2017-10-11 01:46:51.061838
NCT01838824|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-06-30|||November 2011||2011-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SPTMS||Applying Speed of Processing Training to Individuals With Multiple Sclerosis|Applying Speed of Processing Training (SPT) to Individuals With Multiple Sclerosis|Recruiting||N/A|38|Anticipated|Kessler Foundation||2|||f||||f||||||||||2017-10-11 01:46:51.331431|2017-10-11 01:46:51.331431
NCT01838811|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2015-04-01|||November 2011||2011-11-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SPTTBI||Applying Speed of Processing Training to Individuals With Traumatic Brain Injury|Applying Speed of Processing Training (SPT) to Individuals With TBI|Completed||N/A|20|Anticipated|Kessler Foundation||1|||f||||f||||||||||2017-10-11 01:46:51.443417|2017-10-11 01:46:51.443417
NCT01838798|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2016-10-24|||November 2013||2013-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|NeuroPsy Réa||Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients|Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients|Completed||N/A|125|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 01:46:51.554351|2017-10-11 01:46:51.554351
NCT01838603|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-09-12|||April 2013||2013-04-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Patient Experience of Interventional Pain Management. Qualitative Study|Patient Experience of Interventional Pain Management. Qualitative Study|Recruiting||N/A|20|Anticipated|Eques Indolor AB|||1||f||||f||||||||||2017-10-11 01:46:57.871263|2017-10-11 01:46:57.871263
NCT01838785|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-21|2017-08-25|2017-02-06||July 2012||2012-07-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Positron-Emission Tomography With Vesicular Monoamine Transporter Ligand ([18F]-DTBZ) In Healthy Elderly And Young Subjects|Positron-Emission Tomography With Vesicular Monoamine Transporter Ligand ([18F]-DTBZ) In Healthy Elderly And Young Subjects|Completed||Phase 2|25|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 01:46:51.690125|2017-10-11 01:46:51.690125
NCT01838772|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-10-26|||December 2013||2013-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||HCV Treatment in HIV Co-Infected Patients in Asia|Effectiveness and Tolerability of Hepatitis C Treatment in HIV Co-infected Patients in Routine Care Services in Asia: A Pilot Model of Care Project|Completed||Phase 4|188|Actual|amfAR, The Foundation for AIDS Research||1|||f||||f||||||||||2017-10-11 01:46:51.892132|2017-10-11 01:46:51.892132
NCT01838759|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2014-10-30|||February 2013||2013-02-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01|6 Months|Observational [Patient Registry]|||Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia|Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia|Completed||N/A|58|Actual|Zonguldak Karaelmas University|||2||f||||f||||||||||2017-10-11 01:46:52.010813|2017-10-11 01:46:52.010813
NCT01838746|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-05-27|||April 2013||2013-04-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Observational|CRAGS||CRAGS (Coronary aRtery diseAse in younG adultS)|Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients Aged < 50 Years: a Multicenter Study|Unknown status|Active, not recruiting|N/A|2000|Anticipated|University of Turku|||2||f||||f||||||||||2017-10-11 01:46:52.097593|2017-10-11 01:46:52.097593
NCT01838733|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2016-11-11|||April 2014||2014-04-01|November 2016|2016-11-01||||May 2017|Anticipated|2017-05-01||Observational|||Cerebral Oximetry and Perioperative Outcome in Non-Cardiac Surgery|Cerebral Oximetry and Perioperative Outcome in Non-Cardiac Surgery|Recruiting||N/A|200|Anticipated|University of Manitoba|||1||f||||f||||||||||2017-10-11 01:46:52.232158|2017-10-11 01:46:52.232158
NCT01838720|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2014-08-12|||April 2013||2013-04-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage|Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage : Clinical Outcomes of a Randomised Controlled Trial|Unknown status|Recruiting|N/A|90|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-11 01:46:52.339857|2017-10-11 01:46:52.339857
NCT01838707|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2013-04-24|||December 2007||2007-12-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Postoperative Epidural Analgesia in Spine Fusion Surgery|Postoperative Epidural Analgesia in Spine Fusion Surgery|Completed||Phase 2|60|Actual|Assiut University||3|||f||||||||||||||2017-10-11 01:46:52.463834|2017-10-11 01:46:52.463834
NCT01838694|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-12-05|2016-09-01||July 2013||2013-07-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.||Completed||Phase 1/Phase 2|30|Actual|Invion, Inc.||2|||f||||f||||||||||2017-10-11 01:46:52.563998|2017-10-11 01:46:52.563998
NCT01838681|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2017-07-11|2017-06-08||June 2013||2013-06-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment|Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment|Completed||Phase 3|1986|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 01:46:52.974323|2017-10-11 01:46:52.974323
NCT01838668|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2017-08-31|||March 28, 2013|Actual|2013-03-28|August 2017|2017-08-01|October 16, 2019|Anticipated|2019-10-16|June 16, 2015|Actual|2015-06-16||Interventional|||An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of BG00012 in Subjects From the Asia-Pacific Region and Other Countries With Relapsing-Remitting Multiple Sclerosis|Active, not recruiting||Phase 3|225|Actual|Biogen||3|||f||||f||||||||||2017-10-11 01:46:54.246924|2017-10-11 01:46:54.246924
NCT01838642|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-20|2016-12-30|2016-02-18||March 2013||2013-03-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional||No participants were enrolled in the RET mutation negative group; study closed prematurely.|Ponatinib for Advanced Medullary Thyroid Cancer|A Phase II Study of Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer|Terminated||Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)||2||Recruiting halted prematurely and will not resume. New study to open soon.|f||||f||||||||No||2017-10-11 01:46:54.63312|2017-10-11 01:46:54.63312
NCT01838629|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-05-04|||July 2009||2009-07-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01|1 Year|Observational [Patient Registry]|||the Effect of Universal Salt Iodization on Thyroid Diseases||Completed||N/A|12438|Actual|Hangzhou Center of Disease Control and Prevention|||1||f||||||||||Samples With DNA|"     The participants were invited to local community health center before 8:00 am after 8-hour     fasting overnight. Firstly, each participant provided 10 ml spot urine samples. Then, 5 ml     venous blood was collected using vacuum blood collection tube.   "|||2017-10-11 01:46:55.224435|2017-10-11 01:46:55.224435
NCT01838616|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-01-25|2015-04-28||April 2013||2013-04-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.|Evaluation of the Effectiveness, Safety, and Tolerability of Tapentadol PR Versus Oxycodone/Naloxone PR in Non-opioid Pre-treated Subjects With Uncontrolled Severe Chronic Low Back Pain With a Neuropathic Pain Component.|Completed||Phase 4|367|Actual|Grünenthal GmbH||2|||f||||f||||||||||2017-10-11 01:46:55.397142|2017-10-11 01:46:55.397142
NCT01838590|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2015-05-07|2015-05-05||March 2013||2013-03-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug|Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection|A Phase 3, Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naïve and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 HCV Infection.|Completed||Phase 3|103|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 01:46:58.005769|2017-10-11 01:46:58.005769
NCT01838577|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-10-11|||September 2013||2013-09-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01|3 Years|Observational [Patient Registry]|GEM||Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study|Genetics of EGFR Mutation Study (GEM): a Translational Study of the EORTC Lung Group.|Recruiting||N/A|2000|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||2||f||||f||||||||||2017-10-11 01:47:00.933666|2017-10-11 01:47:00.933666
NCT01838564|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-04-26|||November 2004||2004-11-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology|The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology|Completed||N/A|104|Actual|Dana-Farber Cancer Institute||2|||f||||f||||||||||2017-10-11 01:47:01.057592|2017-10-11 01:47:01.057592
NCT01838551|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-09-08|||August 2014||2014-08-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Treatment for Endogenous Cushing's Syndrome|An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome|Active, not recruiting||Phase 3|90|Actual|Cortendo AB||1|||f||||f||||||||||2017-10-11 01:47:01.225826|2017-10-11 01:47:01.225826
NCT01838538|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-04-19|||June 2011||2011-06-01|April 2013|2013-04-01||||June 2013|Anticipated|2013-06-01||Interventional|||Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy||Unknown status|Recruiting|Phase 2|54|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-11 01:47:01.430097|2017-10-11 01:47:01.430097
NCT01838525|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-04-23|||April 2011||2011-04-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||Alpha-1-acid Glycoprotein as a Biomarker of Developmental Diagnosing and Monitoring Effectiveness in Sepsis||Unknown status|Recruiting|N/A|1|Anticipated|Chinese PLA General Hospital|||3||f||||t||||||||||2017-10-11 01:47:01.711744|2017-10-11 01:47:01.711744
NCT01838512|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-03-02|||June 2012||2012-06-01|March 2017|2017-03-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Observational|PREAMBLE||Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)|Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)|Recruiting||N/A|1700|Anticipated|Bristol-Myers Squibb|||3||f||||f||||||||||2017-10-11 01:47:01.832854|2017-10-11 01:47:01.832854
NCT01838499|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2016-07-21|2015-10-13||May 2013||2013-05-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Full Analysis Set|Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa|A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa|Terminated||Phase 2|224|Actual|AstraZeneca|The trial terminated early due to lack of efficacy. An interim analysis was conducted after the first 61 subjects at 12 weeks and showed no evidence of MEDI8968 activity in reducing (HS) severity or pain over that seen with placebo.|2||"At the planned IA for decision making, no evidence was demonstrated of MEDI8968 activity in   reducing (HS) severity or pain over that seen with placebo."|f||||f||||||||||2017-10-11 01:47:02.130399|2017-10-11 01:47:02.130399
NCT01838486|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2013-04-23|||June 2012||2012-06-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|IC||Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome|Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome|Unknown status|Recruiting|N/A|20|Anticipated|Assaf-Harofeh Medical Center||1|||f||||f||||||||||2017-10-11 01:47:02.623126|2017-10-11 01:47:02.623126
NCT01838473|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2013-04-19|||May 2004||2004-05-01|April 2013|2013-04-01|April 2005|Actual|2005-04-01|August 2004|Actual|2004-08-01||Interventional|SMWS03||In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users|In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Four Brands of Swedish 'Snus' in Regular Snus Users.|Completed||Phase 1|32|Actual|Contract Research Organization el AB||4|||f||||f||||||||||2017-10-11 01:47:02.738196|2017-10-11 01:47:02.738196
NCT01838460|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-04-19|||May 2012||2012-05-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|August 2012|Actual|2012-08-01||Interventional|||Sublingual Nicotine Tablets Compared With Swedish Snus|Elevated Dose of Sublingual Nicotine Tablets Compared With Swedish Snus. Nicotine Pharmacokinetics and Subjective Effects of Single Doses.|Completed||Phase 1/Phase 2|16|Actual|Contract Research Organization el AB||5|||f||||f||||||||||2017-10-11 01:47:02.859836|2017-10-11 01:47:02.859836
NCT01838447|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2016-01-26|||July 2013||2013-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HICCUPS 2||Prevention of Vitamin D Deficiency Following Pediatric CHD Surgery: a Phase II Dose Evaluation Randomized Controlled Trial Comparing Usual Care With a High Dose Pre-operative Supplementation Regimen Based on the Institute of Medicine Daily Upper Tolerable Intake Level|Prevention of Post-Cardiac Surgery Vitamin D Deficiency in Children With Congenital Heart Disease: A Pilot Dose Evaluation Randomized Controlled Trial|Completed||Phase 2|46|Actual|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-11 01:47:02.96908|2017-10-11 01:47:02.96908
NCT01838434|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-19|2017-05-03|||July 2013||2013-07-01|May 2017|2017-05-01||||May 2017|Actual|2017-05-01||Interventional|||Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma|A Phase I/Randomized Phase II Trial of Idelalisib and Lenalidomide in Patients With Relapsed/Refractory Mantle Cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|106|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 01:47:03.148386|2017-10-11 01:47:03.148386
NCT01838421|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-19|||January 2011||2011-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Observational|||Correlation of the Paediatric Tracheal Tube Size|Correlation of the Paediatric Tracheal Tube Size With the Known Formulas for the Calculation of the Size|Completed||N/A|3000|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 01:47:03.272229|2017-10-11 01:47:03.272229
NCT01838408|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-01-26|||April 2013||2013-04-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Evaluation of Proposed EZ2go Complete Bowel Cleansing System|Randomized, Single Blinded Study of Proposed EZ2go Complete Bowel Cleansing System: Evaluation of Its Safety, Efficacy and Patient Tolerance Compared to LOSO Prep, an Over the Counter Laxative Kit for Colonoscopy Bowel Preparation|Completed||N/A|185|Actual|Borland-Groover Clinic||2|||f||||f||||||||||2017-10-11 01:47:03.343487|2017-10-11 01:47:03.343487
NCT01838382|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-01-12|||March 2013||2013-03-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Pain Characteristics After Total Laparoscopic Hysterectomy||Completed||N/A|50|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 01:47:03.78312|2017-10-11 01:47:03.78312
NCT01838369|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-05-25|||March 2013||2013-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase II Study of BI-505 in Smoldering Multiple Myeloma|A Single-arm, Open-label, Phase 2 Clinical Trial Evaluating Disease Response Following Treatment With BI-505, a Human Anti-Intercellular Adhesion Molecule 1 Monoclonal Antibody, In Patients With Smoldering Multiple Myeloma|Terminated||Phase 2|4|Actual|BioInvent International AB||1||Sponsor's decision|f||||f||||||||||2017-10-11 01:47:03.881398|2017-10-11 01:47:03.881398
NCT01838356|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-02-03|||September 2012||2012-09-01|February 2017|2017-02-01||||August 2016|Actual|2016-08-01||Observational|NOAHS||Intracranial Atherosclerosis and Depression After Coronary Artery Bypass Graft|Intracranial Atherosclerosis and Predictors of Post-CABG Depression|Completed||N/A|169|Actual|Yale University|||1||f||||f||||||||||2017-10-11 01:47:03.992878|2017-10-11 01:47:03.992878
NCT01838343|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-12-29|||March 2013||2013-03-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy of Ultrasound to Guide Management During a Rapid Response Event|Efficacy of Ultrasound to Guide Management During a Rapid Response Event|Completed||N/A|200|Anticipated|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-11 01:47:04.088567|2017-10-11 01:47:04.088567
NCT01838330|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-08-09|||June 2012||2012-06-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of High Dietary Fiber Supplementation in Diabetic Chronic Kidney Disease|Effects of High Dietary Fiber Supplementation on Uremic Retention Molecules and Inflammation in Diabetic Chronic Kidney Disease (CKD)|Completed||N/A|44|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 01:47:04.199056|2017-10-11 01:47:04.199056
NCT01838317|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-06-07|||May 2013||2013-05-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas|A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas|Recruiting||Phase 2|15|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 01:47:04.315833|2017-10-11 01:47:04.315833
NCT01838291|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-19|||June 2010||2010-06-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Active Drug Surveillance Program of Ferriprox Use|Active Drug Surveillance Program of Ferriprox Use|Completed||N/A|294|Actual|ApoPharma|||1||f||||f||||||||||2017-10-11 01:47:04.595321|2017-10-11 01:47:04.595321
NCT01838278|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-05-06|||January 2013||2013-01-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|March 2013|Actual|2013-03-01||Interventional|||Effectiveness of Vojta Therapy in Motor Development of Preterm Children|Effectiveness of Vojta Therapy in Motor Development of Preterm Children|Unknown status|Enrolling by invitation|Phase 3|120|Actual|Universidad de Murcia||1|||f||||t||||||||||2017-10-11 01:47:04.737602|2017-10-11 01:47:04.737602
NCT01838265|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-12-05|||August 2012||2012-08-01|December 2014|2014-12-01||||August 2018|Anticipated|2018-08-01||Observational|MGM||Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management|A Randomized Two-Arm Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management: The MGM Trial|Withdrawn||N/A|0|Actual|University of Miami|||2|Unlikely to Accrue|f||||t||||||Samples With DNA|"     Biopsy tumor tissue, blood and urine samples for correlative studies (circulating tumor cells     (CTC), free-circulating DNA (fcDNA) and single nucleotide polymorphisms (SNPs)   "|||2017-10-11 01:47:04.873396|2017-10-11 01:47:04.873396
NCT01838252|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-12-02|||February 2013||2013-02-01|December 2014|2014-12-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Interventional|||Hyaluronic Acid Gels for Lower Lid Retraction||Withdrawn||Phase 4|0|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:47:05.057515|2017-10-11 01:47:05.057515
NCT01838239|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-05-25|||June 2008||2008-06-01|May 2017|2017-05-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Development of a Metabolic Assessment Tool for Chronic Kidney Disease|Development of a Metabolic Assessment Tool for Chronic Kidney Disease|Completed||N/A|12|Actual|University of California, Davis||1|||f||||||||||||||2017-10-11 01:47:05.163766|2017-10-11 01:47:05.163766
NCT01838226|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-08-30|||August 29, 2014|Actual|2014-08-29|August 2017|2017-08-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Interventional|||Randomized Controlled Trial of Group Prevention Coaching|Randomized Controlled Trial of Group Prevention Coaching|Recruiting||N/A|400|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:47:05.274333|2017-10-11 01:47:05.274333
NCT01837875|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-07-24|||April 2013||2013-04-01|July 2015|2015-07-01||||August 2016|Anticipated|2016-08-01||Interventional|IQAN||Intervention to Improve Quality of Life in African American Lupus Patients|Intervention to Improve Quality of Life for African-AmericaN Lupus Patients (IQAN)|Unknown status|Active, not recruiting|N/A|150|Anticipated|Medical University of South Carolina||3|||f||||t||||||||||2017-10-11 01:47:10.16251|2017-10-11 01:47:10.16251
NCT01838213|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-10-21|2015-07-24||February 2009||2009-02-01|October 2015|2015-10-01||||December 2014|Actual|2014-12-01||Observational|ESCAPE||Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients|Extended Spectrum Beta-lactamases - Treatment, Carriage, Environmental Dissemination And Population Epidemiology|Completed||N/A|760|Actual|Vestre Viken Hospital Trust|"Publication of results:
High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085889"||1||f||||f||||||Samples Without DNA|"     Bacterial cultures   "|||2017-10-11 01:47:05.449095|2017-10-11 01:47:05.449095
NCT01838200|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-06-16|||April 2013||2013-04-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|||A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumab Therapy in Patients With Advanced Metastatic Melanoma|A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumab Therapy in Patients With Advanced Metastatic Melanoma|Terminated||Phase 1|6|Actual|Ludwig Institute for Cancer Research||2||Slow recruitment due to changes in standard of care|f||||f||||||||||2017-10-11 01:47:05.74696|2017-10-11 01:47:05.74696
NCT01838187|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-08-26||||||August 2016|2016-08-01||||||||Expanded Access|||Expanded Access Protocol Using 131I-MIBG Therapy for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma|An Open Label, Expanded Access Protocol Using 131I-METAIODOBENZYLGUANIDINE (131I-MIBG) Therapy in Patients With Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma|Available||N/A|||Children's Hospital Medical Center, Cincinnati|||||||||||||||||||2017-10-11 01:47:05.861002|2017-10-11 01:47:05.861002
NCT01838174|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-03-27|||May 2013||2013-05-01|March 2014|2014-03-01|April 2015|Anticipated|2015-04-01|August 2014|Anticipated|2014-08-01||Interventional|ACTHAR||A Phase IV Trial of Neuroprotection With ACTH in Acute Optic Neuritis|A Phase IV Trial of Neuroprotection With ACTH in Acute Optic Neuritis|Unknown status|Recruiting|Phase 4|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 01:47:05.951379|2017-10-11 01:47:05.951379
NCT01838148|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-07-25|||May 2004||2004-05-01|July 2017|2017-07-01|April 2022|Anticipated|2022-04-01|April 2020|Anticipated|2020-04-01||Observational|BASEL VIII||Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia|BASEL VIII Trial - Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia|Active, not recruiting||N/A|4000|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     EDTA, plasma   "|||2017-10-11 01:47:06.1825|2017-10-11 01:47:06.1825
NCT01838135|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-05-18|||March 2013||2013-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||WheelSeeU Feasibility Study|Wheelchair Self-efficacy Enhanced Training Program to Improve Wheelchair Use in Older Adults|Active, not recruiting||N/A|40|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:47:06.26589|2017-10-11 01:47:06.26589
NCT01838122|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-18|||April 2013||2013-04-01|April 2013|2013-04-01|November 2013|Anticipated|2013-11-01|September 2013|Anticipated|2013-09-01||Observational|WHI||Prevalence of HbA1C in Women With PCOS|Prevalence of HbA1C in Different Categories of Obesity in Women With PCOS'A Propective Randomized Control Study|Unknown status|Active, not recruiting|N/A|300|Anticipated|Southern Cross Fertility Centre|||2||f||||t||||||||||2017-10-11 01:47:06.35556|2017-10-11 01:47:06.35556
NCT01838109|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-05-25|||April 2013||2013-04-01|September 2013|2013-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery|Multicenter, Prospective Randomized Controlled Trial Evaluating Postoperative Oral Nutritional Supplementation for the Patients Who Received Major Gastrointestinal Surgery|Completed||N/A|174|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 01:47:06.441124|2017-10-11 01:47:06.441124
NCT01838096|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-01-04|||March 2008||2008-03-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Alumina Matrix Composite Ceramic Bearing Total Hip Arthroplasty in Patients Younger Than 30 Years||Active, not recruiting||Phase 4|92|Actual|Seoul National University Bundang Hospital||1|||f||||f||||||||||2017-10-11 01:47:06.538016|2017-10-11 01:47:06.538016
NCT01838083|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-08-09|||April 2013||2013-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus|A Double-blind, Randomized, Two-treatment Crossover Bioequivalence Study Comparing Two New Insulin Glargine Formulations Using the Euglycemic Clamp Technique in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|50|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 01:47:06.603555|2017-10-11 01:47:06.603555
NCT01838070|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-07-25|||April 2013||2013-04-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Observational|||Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)|Regulatory Post-Marketing Surveillance (PMS) Study for AVAXIM 160U (Hepatitis A Vaccine)|Completed||Phase 4|614|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 01:47:06.868356|2017-10-11 01:47:06.868356
NCT01838057|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2015-04-15|||June 2013||2013-06-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting|Evaluation of the Clinical and Economic Impact of Pfizer's painPRIMER Program in the Treatment of Low Back Pain in a Primary Care Setting|Terminated||N/A|103|Actual|Pfizer|||2|"The study was terminated on 02-Jun-2014 due to slow enrollment. The study was not terminated   for reasons of either safety or efficacy."|f||||f||||||||||2017-10-11 01:47:06.982361|2017-10-11 01:47:06.982361
NCT01837862|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-01-30|||April 2015||2015-04-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas|A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas|Recruiting||Phase 1/Phase 2|36|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-11 01:47:10.260759|2017-10-11 01:47:10.260759
NCT01837472|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-22|||April 2012||2012-04-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Probiotics in the Treatment of Irritable Bowel Syndrome|Evaluating The Effects of Probiotics on Symptoms of Patients With Irritable Bowel Syndrome|Completed||Phase 2/Phase 3|132|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:47:17.862321|2017-10-11 01:47:17.862321
NCT01838044|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2016-07-20|2016-05-12||October 2013||2013-10-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional||Safety population was composed of all participants who took at least one dose of study medication (either pregabalin or celecoxib).|Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component|A Randomized Double Blind Placebo Controlled Parallel Group Study Of The Efficacy And Safety Of Concomitant Administration Of Celecoxib And Pregabalin Compared With Celecoxib Monotherapy, In Patients With Chronic Low Back Pain Having A Neuropathic Component|Terminated||Phase 4|180|Actual|Pfizer|The study was terminated as it had been determined that it was no longer operationally feasible to continue the trial. The study termination was not due to a safety issue or finding.|2||"Recruitment terminated on 3Apr2015 due to slow recruitment rate and lack of operational   feasibility. Study was not terminated for reasons of safety/efficacy."|f||||t||||||||||2017-10-11 01:47:07.140726|2017-10-11 01:47:07.140726
NCT01838018|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-09-27|||April 2013||2013-04-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)|Brain Perfusion in Pantothenate Kinase-Associated Neurodegeneration (PKAN)|Recruiting||N/A|12|Anticipated|Oregon Health and Science University|||2||f||||f||||||||||2017-10-11 01:47:08.562338|2017-10-11 01:47:08.562338
NCT01838005|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-04-21|||April 2013||2013-04-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services|Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services|Completed||N/A|433|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:47:08.677484|2017-10-11 01:47:08.677484
NCT01837992|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-11-07|||May 2013||2013-05-01|November 2013|2013-11-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Safety and Efficacy of Primaquine for P. Vivax|Evaluation of Safety and Efficacy of Two Primaquine Dosing Regimens for the Radical Treatment of Plasmodium Vivax Malaria in Vanuatu and Solomon Islands|Unknown status|Not yet recruiting|N/A|180|Anticipated|Menzies School of Health Research||3|||f||||t||||||||||2017-10-11 01:47:08.804885|2017-10-11 01:47:08.804885
NCT01837979|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2013-04-18|||April 2013||2013-04-01|April 2013|2013-04-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|DBS&CFF||Down Syndrome Screening Based on Dried Blood Spots and Cell-free Fetal DNA|A Clinical Trial to Explore a New Prenatal Screening and Diagnosis Pattern for Fetal Chromosomal Abnormalities With Dried Blood Spots and Cell-free Fetal DNA.|Unknown status|Enrolling by invitation|N/A|2000|Anticipated|Peking Union Medical College Hospital|||2||f||||t||||||||||2017-10-11 01:47:08.938881|2017-10-11 01:47:08.938881
NCT01837966|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-01-19|2014-12-22||January 2013||2013-01-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional||93 patients were enrolled into the study, but only 88 had useable data. 43 patients in the lavender arm and 45 in the placebo/unscented oil arm had usable data.|Randomized, Placebo-Controlled Study: Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Patients|A Randomized Prospective Placebo-Controlled Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients|Completed||N/A|93|Actual|New York University School of Medicine||2|||f||||f||||||||No||2017-10-11 01:47:09.051307|2017-10-11 01:47:09.051307
NCT01837953|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-10-03|||November 2012||2012-11-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|||Stepped Care for Binge Eating Disorder: Predicting Response to Minimal Intervention in a Randomized Controlled Trial|Stepped Care for Binge Eating Disorder: Predicting Response to Minimal Intervention in a Randomized Controlled Trial|Active, not recruiting||N/A|150|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 01:47:09.492452|2017-10-11 01:47:09.492452
NCT01837940|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2014-12-04|||April 2013||2013-04-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy of a Dietary Supplementation With Lactobacillus Reuteri for Digestive Health in an Elderly Population|Efficacy of a Dietary Supplementation With Lactobacillus Reuteri DSM 17938 for Digestive Health in an Elderly Population|Completed||Phase 3|290|Actual|Örebro University, Sweden||2|||f||||||||||||||2017-10-11 01:47:09.608043|2017-10-11 01:47:09.608043
NCT01837927|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-08-19|||April 2014||2014-04-01|August 2016|2016-08-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients.|A 52-week Treatment, Multi-center, Randomized, Open Label, Parallel Group Study to Assess the Efficacy of NVA237 (50 μg o.d.) Using Tiotropium (5 μg o.d.) as an Active Control in Brazilian Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.|Withdrawn||Phase 3|0|Actual|Novartis||2|||f||||||||||||||2017-10-11 01:47:09.703835|2017-10-11 01:47:09.703835
NCT01837914|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-06-22|||May 2013||2013-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Maxillary Expansion Treatment of Pediatric OSA|Maxillary Expansion Treatment of Pediatric Obstructive Sleep Apnea|Recruiting||N/A|30|Anticipated|University of British Columbia||2|||f||||f|f|f||||||No|NA no IPD will be shared|2017-10-11 01:47:09.810335|2017-10-11 01:47:09.810335
NCT01837901|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-04-28|||July 2011||2011-07-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|August 2013|Actual|2013-08-01||Interventional|||Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa|Transkorneale Elektrostimulation Zur Therapie Bei Retinitis Pigmentosa - Eine Prospektive, Randomisierte, Einfach Blinde Folgestudie|Completed||N/A|55|Actual|Okuvision GmbH||3|||f||||f||||||||||2017-10-11 01:47:09.92691|2017-10-11 01:47:09.92691
NCT01837888|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-05-27|||November 2011||2011-11-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|June 2013|Actual|2013-06-01||Interventional|||WheelSee Feasibility Study|A Feasibility Study to Evaluate and Refine a Manual Wheelchair Training Program That is Enhanced for Self-efficacy(WheelSee): A Pilot Controlled Trial|Completed||N/A|24|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:47:10.075876|2017-10-11 01:47:10.075876
NCT01837849|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2013-04-18|||January 2011||2011-01-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||A Comparison of Recombinant Human Brain Natriuretic Peptide and Dobutamine|Comparative Effects of Recombinant Human Brain Natriuretic Peptide and Dobutamine on Acute Decompensated Heart Failure Patients With Different Blood BNP Levels|Completed||N/A|104|Actual|Nantong University|||1||f||||t||||||||||2017-10-11 01:47:10.461103|2017-10-11 01:47:10.461103
NCT01837836|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-22|||April 2013||2013-04-01|April 2013|2013-04-01||||April 2014|Anticipated|2014-04-01||Interventional|||Effect of Health Education on Water Handling Practices in Rural Pondicherry|Effect of Health Education on Water Handling Practices in Rural Pondicherry|Unknown status|Not yet recruiting|N/A|980|Anticipated|Sri Manakula Vinayagar Medical College and Hospital||1|||f||||f||||||||||2017-10-11 01:47:10.534559|2017-10-11 01:47:10.534559
NCT01837810|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-22|||April 2013||2013-04-01|April 2013|2013-04-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|||Safety Study of Post Tonsillectomy Ibuprofen Use in Adults|NSAID Post-Tonsillectomy Hemorrhage: A Randomized, Double-Blinded Controlled Noninferiority Trial|Unknown status|Recruiting|N/A|810|Anticipated|Brooke Army Medical Center||2|||f||||t||||||||||2017-10-11 01:47:10.757746|2017-10-11 01:47:10.757746
NCT01837797|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-02-04|2015-08-17||April 2013||2013-04-01|February 2016|2016-02-01||||May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment|Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study to Evaluate the Efficacy and Safety of Brexpiprazole (1 and 3 mg/Day) as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment|Terminated||Phase 3|129|Actual|H. Lundbeck A/S|Because the study was terminated, few efficacy data were collected. These data have not been reported in accordance with the ICH E3 regarding abbreviated clinical study reports. Furthermore, no firm conclusions can be drawn regarding safety.|3||The study was terminated because of recruitment challenges|f||||f||||||||||2017-10-11 01:47:10.906828|2017-10-11 01:47:10.906828
NCT01837784|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-04-18|||April 2013||2013-04-01|April 2013|2013-04-01||||March 2016|Anticipated|2016-03-01||Observational|||Central Hemodynamics|Value of Non-invasively Measured Arterial Stiffness and Central Hemodynamics for Guiding Antihypertensive Treatment in Selected Patient Populations|Unknown status|Recruiting|N/A|100|Anticipated|Luzerner Kantonsspital|||4||f||||||||||||||2017-10-11 01:47:11.73934|2017-10-11 01:47:11.73934
NCT01837771|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-04-18|||April 2013||2013-04-01|April 2013|2013-04-01||||March 2016|Anticipated|2016-03-01||Interventional|||Epiphrenic III Pilot Trial|Uni- or Biventricular Pacing and Diaphragmatic Stimulation for Severe Heart Failure (Epiphrenic III Pilot Trial)|Unknown status|Recruiting|N/A|25|Anticipated|Luzerner Kantonsspital||2|||f||||||||||||||2017-10-11 01:47:11.842473|2017-10-11 01:47:11.842473
NCT01837758|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-03-02|||December 2012||2012-12-01|March 2017|2017-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Monitoring Platelet Function During Continuous Hemodialysis|Changes in Platelet Function During Continuous Veno-venous Hemodialysis Using the Multiplate Device|Completed||N/A|50|Actual|Goethe University|||1||f||||f||||||||||2017-10-11 01:47:11.955978|2017-10-11 01:47:11.955978
NCT01837745|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-05-15|||April 2013||2013-04-01|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|April 2020|Anticipated|2020-04-01||Interventional|ESTIMABL2||Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?|Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?|Recruiting||Phase 3|780|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 01:47:12.08145|2017-10-11 01:47:12.08145
NCT01837732|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-01-03|||March 2013||2013-03-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EFFITOUREL||Effectiveness of Relational Touch in Painful Elderly|Effectiveness of Relational Touch in the Management of Chronic Pain in Institutionalized Elderly|Completed||N/A|74|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:47:12.211179|2017-10-11 01:47:12.211179
NCT01837719|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-08-19|2014-06-09||April 2013||2013-04-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Atazanavir|All participants who received at least 1 dose of study drug|Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat|A Randomized, 5-Period, Crossover Study in Healthy Subjects to Assess the Bioequivalence of Atazanavir When Co-Administered With Cobicistat as a Fixed Dose Combination Relative to the Single Agents Following a Light Meal, the Relative Bioavailability of Atazanavir When Co-Administered With Cobicistat as a Fixed Dose Combination Relative to the Single Agents Under Fasted Conditions, and the Effect of Food on the Bioavailability of Atazanavir in the Fixed Dose Combination|Completed||Phase 1|64|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-10-11 01:47:12.351529|2017-10-11 01:47:12.351529
NCT01837706|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2014-10-01|||April 2013||2013-04-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|||The Impact of Emergency Physician Empathy on Litigation Propensity|The Impact of Emergency Physician Empathy on Litigation Propensity|Completed||N/A|437|Actual|Loma Linda University|||1||f||||t||||||||||2017-10-11 01:47:14.270938|2017-10-11 01:47:14.270938
NCT01837693|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-18|||June 2013||2013-06-01|May 2012|2012-05-01|December 2019|Anticipated|2019-12-01|June 2015|Anticipated|2015-06-01||Interventional|NTCC2||Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2|HPV as Primary Screening Test in Cervical Cancer Prevention: From DNA to mRNA? A Randomised Controlled Trial Nested in a Double Testing Study With Long Term Follow up|Not yet recruiting||N/A|60000|Anticipated|Azienda Unità Sanitaria Locale Reggio Emilia||2|||f||||f||||||||||2017-10-11 01:47:14.36864|2017-10-11 01:47:14.36864
NCT01837680|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-05-24|2017-01-12||March 2013||2013-03-01|May 2017|2017-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy|Insulin Detemir Versus Insulin NPH: A Randomized Prospective Study Comparing Glycemic Control in Pregnant Women With Diabetes|Completed||N/A|105|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||f||||||||||2017-10-11 01:47:14.538716|2017-10-11 01:47:14.538716
NCT01837667|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-01-23|||February 2013||2013-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Phase I Study of LB-100 With Docetaxel in Solid Tumors|A Phase I Study of Intravenous LB-100 for Injection as a Single Agent and in Combination With Docetaxel in the Treatment of Patients With Advanced Solid Tumors|Completed||Phase 1|29|Actual|Lixte Biotechnology Holdings, Inc.||1|||f||||f||||||||||2017-10-11 01:47:15.538678|2017-10-11 01:47:15.538678
NCT01837641|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-09-20|||May 3, 2013|Actual|2013-05-03|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study of LY3002813 in Participants With Alzheimer's Disease|A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3002813 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease|Active, not recruiting||Phase 1|100|Anticipated|Eli Lilly and Company||8|||f||||f||||||||||2017-10-11 01:47:15.770862|2017-10-11 01:47:15.770862
NCT01837628|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-22|||February 2013||2013-02-01|April 2013|2013-04-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Reducing Urethral Pain During Urodynamic Test - Comparison Between Lidocaine Gel and Paraffin Oil|Reducing Urethral Pain During Urodynamic Test - Comparison Between Lidocaine Gel and Paraffin Oil|Unknown status|Recruiting|N/A|40|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 01:47:15.885958|2017-10-11 01:47:15.885958
NCT01837615|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-06-22|||January 2013||2013-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|Photopill||Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis|Assessment of the Photopill Capsule Treatment for Safety and Feasibility in Patients With Ulcerative Proctitis|Completed||Phase 2|8|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-11 01:47:15.991446|2017-10-11 01:47:15.991446
NCT01837602|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-06-26|||April 2013||2013-04-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||cMet CAR RNA T Cells Targeting Breast Cancer|Clinical Trial of Autologous cMet Redirected T Cells Administered Intratumorally in Patients With Breast Cancer|Active, not recruiting||Phase 1|15|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:47:16.069414|2017-10-11 01:47:16.069414
NCT01837589|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-06-23|||January 2012||2012-01-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|May 2015|Actual|2015-05-01||Interventional|TOMODENS||Quantitative Computed Tomodensitometry in Patients With Cystic Fibrosis|Evaluation of the Bone Mineralization by Quantitative Computed Tomodensitometry in Patients With Cystic Fibrosis : Validation Study|Active, not recruiting||N/A|131|Actual|Hôpital Necker-Enfants Malades||1|||f||||f||||||||No||2017-10-11 01:47:16.14614|2017-10-11 01:47:16.14614
NCT01837576|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-07-22|||April 2013||2013-04-01|April 2013|2013-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris||Completed||Phase 1|24|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-11 01:47:16.241137|2017-10-11 01:47:16.241137
NCT01837563|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-09-28|||September 2006||2006-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer|Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer|Terminated||N/A|36|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||||2017-10-11 01:47:16.330678|2017-10-11 01:47:16.330678
NCT01837550|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2016-03-22|2016-01-12||April 2013||2013-04-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Educational Program for Hearing Aid Users With Internet Support|A Randomized, Controlled Trial Evaluating the Short- and Long-term Effects of an Internet-based Aural Rehabilitation Program for Hearing Aid Users Implemented in a General Clinical Practice|Completed||N/A|74|Actual|Sodra Alvsborgs Hospital||2|||f||||t||||||||No||2017-10-11 01:47:16.408631|2017-10-11 01:47:16.408631
NCT01837537|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-06-19|2015-04-30||March 2013||2013-03-01|June 2017|2017-06-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Observational|||Respiration Rate V2.0 in a Hospital Setting|Evaluation of Respiration Rate Parameters in a Hospital Population Using a Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0|Completed||N/A|90|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 01:47:17.03818|2017-10-11 01:47:17.03818
NCT01837524|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-03-01|2015-04-01||June 2013||2013-06-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||The KP Personal Shopper: A Pilot to Improve the Impact of Dietary Advice||Completed||N/A|55|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 01:47:17.258847|2017-10-11 01:47:17.258847
NCT01837511|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-18|||August 2007||2007-08-01|April 2013|2013-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients|Analysis of the Incidence of Expression of Tumor Antigens MAGE-A3, MAGE-C2, NY-ESO-1, LAGE-1, WT1 and PRAME in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer in Asiatic Patients|Completed||N/A|377|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 01:47:17.57607|2017-10-11 01:47:17.57607
NCT01837498|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-03-14|||February 2013||2013-02-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Reversal of Neuromuscular Blockade in Thoracic Surgical Patients|Reversal of Neuromuscular Blockade in Thoracic Surgical Patients|Recruiting||N/A|240|Anticipated|NorthShore University HealthSystem Research Institute|||2||f||||f||||||||||2017-10-11 01:47:17.673425|2017-10-11 01:47:17.673425
NCT01837485|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-18|||August 2011||2011-08-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Probiotics in the Treatment of Irritable Bowel Syndrome|Evaluation of the Effects of Lactol Probiotic in Comparison With Placebo on Symptoms of Irritable Bowel Syndrome|Completed||Phase 2/Phase 3|82|Actual|Islamic Azad University, Najafabad Branch||2|||f||||f||||||||||2017-10-11 01:47:17.773801|2017-10-11 01:47:17.773801
NCT01837459|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-04-13|||November 2006||2006-11-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||A Research Study for Children About Heart Changes and Obstructive Sleep Apnea (OSA)|Vascular Function in Children With Obstructive Sleep Apnea|Completed||N/A|231|Actual|Children's Hospital Medical Center, Cincinnati|||4||f||||f||||||Samples With DNA|"     Serum, plasma, tissue   "|Undecided|Analysis is in progress and may take up to an additional year due to complexity of data.|2017-10-11 01:47:17.965696|2017-10-11 01:47:17.965696
NCT01837446|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-04-22|||July 2011||2011-07-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer|Evaluating the Effectiveness of Topical Morphine Compared With a Routine Mouthwash in Managing Cancer Treatment-induced Mucositis in Patients With Head and Neck Cancer in Isfahan|Completed||Phase 2/Phase 3|30|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:47:18.074282|2017-10-11 01:47:18.074282
NCT01837433|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2015-05-18|||March 2013||2013-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|STA||Short-term Prednisone to Treat STA Study(SPTSS)|Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis|Completed||Phase 4|40|Actual|Xinqiao Hospital of Chongqing||2|||f||||f||||||||||2017-10-11 01:47:18.181132|2017-10-11 01:47:18.181132
NCT01837420|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2015-03-26|||November 2012||2012-11-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis|A Randomized, Double Blind, Dose Ranging, Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral VB-201 in Patients With Moderate to Severe Plaque Psoriasis|Completed||Phase 2|194|Actual|Vascular Biogenics Ltd. operating as VBL Therapeutics||3|||f||||f||||||||||2017-10-11 01:47:18.299941|2017-10-11 01:47:18.299941
NCT01837407|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2013-04-22|||March 2008||2008-03-01|June 2011|2011-06-01|March 2013|Actual|2013-03-01|September 2011|Actual|2011-09-01||Interventional|||Reconstruction of a Neurocutaneous Defect of the Proximal Phalanx With a Heterodigital Arterialized Nerve Pedicle Flap||Completed||N/A|9|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 01:47:18.392184|2017-10-11 01:47:18.392184
NCT01837394|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-11-05|||August 2012||2012-08-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Ultrasound-guided Blocks for Ambulatory Knee Arthroscopy|Ultrasound-guided Block of the Saphenous Nerve and Obturator Nerve, Posterior Branch, for Postoperative Pain Management After Ambulatory Knee Arthroscopy|Completed||Phase 4|60|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 01:47:18.478405|2017-10-11 01:47:18.478405
NCT01837381|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-08-28|||February 2007||2007-02-01|April 2017|2017-04-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)|A Comprehensive Analysis of Clinical Outcome, Treatment Toxicity and Tumor Response of Transarterial Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)|Completed||Phase 2|200|Anticipated|Chinese University of Hong Kong||1|||f||||t||||||||||2017-10-11 01:47:18.595053|2017-10-11 01:47:18.595053
NCT01837368|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-05-09|||December 2012||2012-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Research Project About Psychological Strain, Quality of Life and Emotional Awareness in Patients With Tinnitus|Research Project About Psychological Strain, Quality of Life and Emotional Awareness in Patients With Tinnitus|Completed||N/A|250|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 01:47:18.686573|2017-10-11 01:47:18.686573
NCT01837355|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-01-26|||March 2013||2013-03-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|MoHuM-1||Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic Fibrosis|Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Rhamnosus Diet Supplementation in Pediatric Cystic Fibrosis (MoHuM-1)|Recruiting||N/A|68|Anticipated|Cantonal Hospital of St. Gallen||2|||f||||t||||||||||2017-10-11 01:47:18.773467|2017-10-11 01:47:18.773467
NCT01837342|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-04-17|||November 2012||2012-11-01|April 2013|2013-04-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|SIGMOIDITE||Multicenter Study Comparing Morbidity and Quality of Life Associated in the Treatment by Surgical Resection and the Conservative Treatment, After Favorable Evolution of Purulent Peritonitis That Originates From Diverticulitis Treated by Mini-invasive Surgery|Multicenter Randomized Study Comparing Morbidity and Quality of Life Associated in the Treatment by Surgical Resection and the Conservative Treatment, After Favorable Evolution of Purulent Peritonitis That Originates From Diverticulitis Treated by Mini-invasive Surgery.|Recruiting||N/A|120|Anticipated|University Hospital, Strasbourg, France||2|||f||||t||||||||||2017-10-11 01:47:18.875021|2017-10-11 01:47:18.875021
NCT01837329|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-10-03|||November 2013||2013-11-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer|A Phase I Study of Tetrathiomolybdate (TM) in Combination With Carboplatin and Pemetrexed in Chemo-Naive Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer|Recruiting||Phase 1|28|Anticipated|University of Rochester||1|||f||||t||||||||Undecided||2017-10-11 01:47:19.031632|2017-10-11 01:47:19.031632
NCT01837316|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2017-05-05|||October 21, 2013|Actual|2013-10-21|May 2017|2017-05-01|August 8, 2014|Actual|2014-08-08|August 8, 2014|Actual|2014-08-08||Interventional|||A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma|A Randomized, Double-blind, Placebo-controlled Cross-over Study to Determine the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 mcg Combination Administered in the Morning in Adult Patients With Asthma|Completed||Phase 1|32|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:47:19.168943|2017-10-11 01:47:19.168943
NCT01837303|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-12-03|||May 2013||2013-05-01|April 2013|2013-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||chemQbiosciences:Manual Liquid Based Cytology|chemQbiosciences:Manual Liquid Based Cytology|Completed||N/A|76|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 01:47:19.272534|2017-10-11 01:47:19.272534
NCT01833494|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-04-22||||||April 2015|2015-04-01||||August 2014|Actual|2014-08-01||Interventional|||A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia|A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia|Completed||Phase 3|||Kissei Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 01:48:18.215665|2017-10-11 01:48:18.215665
NCT01837290|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-01-26|||December 2012||2012-12-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery|The Effect of Dexmedetomine Premedication on the Bispectral Index Values Using Sedation With Propofol During Spinal Anesthesia on Geriatric Chronic Renal Failure Patients Undergoing Hip Fracture Surgery The Effect of Dexmedetomine Premedication on the Bispectral Index Values Using Sedation With Propofol During Spinal Anesthesia on Geriatric Chronic Renal Failure Patients Undergoing Hip Fracture Surgery|Completed||Phase 3|60|Actual|Baskent University||2|||f||||t||||||||||2017-10-11 01:47:19.377917|2017-10-11 01:47:19.377917
NCT01837277|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-18|2015-03-05|||March 2015||2015-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Impact of a Raltegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients||Unknown status|Not yet recruiting|Phase 2/Phase 3|92|Anticipated|Fundação Bahiana de Infectologia||2|||f||||||||||||||2017-10-11 01:47:19.540326|2017-10-11 01:47:19.540326
NCT01837264|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-04-12|||January 2013||2013-01-01|January 2017|2017-01-01|January 31, 2017|Actual|2017-01-31|September 2016|Actual|2016-09-01||Interventional|Magellan MAR01||Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma|Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma Study Protocol|Completed||Phase 1|5|Actual|Arteriocyte, Inc.||1|||f||||t||||||||||2017-10-11 01:47:19.631307|2017-10-11 01:47:19.631307
NCT01837251|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-02-22|||May 2013|Actual|2013-05-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|September 2019|Anticipated|2019-09-01||Interventional|||Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer|A Prospective Randomized Phase III Trial of Carboplatin/Gemcitabine/Bevacizumab vs. Carboplatin/Pegylated Liposomal Doxorubicin/Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer|Active, not recruiting||Phase 3|682|Actual|AGO Research GmbH||2|||f||||t||||||||||2017-10-11 01:47:19.737976|2017-10-11 01:47:19.737976
NCT01837238|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-10-28|||November 2012||2012-11-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients|Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients|Completed||N/A|41|Actual|University of Illinois at Urbana-Champaign||2|||f||||t||||||||||2017-10-11 01:47:20.337792|2017-10-11 01:47:20.337792
NCT01837225|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-05-16|||September 2010||2010-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI Imaging Device|ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI Imaging Device|Enrolling by invitation||N/A|45|Anticipated|University Health Network, Toronto|||3||f||||f||||||Samples Without DNA|"     Punch biopsies of healthy and cancerous breast tissue will be acquired from the surgical bed     and from the ex-vivo samples.   "|Yes|Aggregate data will be made available through publication|2017-10-11 01:47:20.446225|2017-10-11 01:47:20.446225
NCT01837199|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-17|||July 2011||2011-07-01|April 2013|2013-04-01||||December 2012|Actual|2012-12-01||Interventional|||MTZ Plus AMX in the Treatment of Smokers and Non-smokers|Clinical and Microbiological Effects of Adjunctive Metronidazole Plus Amoxicillin in the Treatment of Generalized Chronic Periodontitis: Smokers Versus Non-Smokers.|Completed||Phase 4|64|Actual|University of Guarulhos||2|||f||||t||||||||||2017-10-11 01:47:20.539413|2017-10-11 01:47:20.539413
NCT01837186|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-22|||January 2012||2012-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Observational|||Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)|Incidence, Risk Factors and Outcome of Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)|Completed||N/A|600|Actual|University Hospital, Gasthuisberg|||2||f||||f||||||||||2017-10-11 01:47:20.644459|2017-10-11 01:47:20.644459
NCT01837173|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-17|||March 2013||2013-03-01|April 2013|2013-04-01|November 2013|Anticipated|2013-11-01|July 2013|Anticipated|2013-07-01||Observational|ECLNI-MC||Multicentric Retrospective Review of Extracapsular Lymph Node Involvement After Esophagectomy|Can Extracapsular Lymph Node Involvement be a Tool to Fine-tune UICC TNM 7th Edition for Esophageal Carcinoma?|Unknown status|Enrolling by invitation|N/A|2000|Anticipated|University Hospital, Gasthuisberg|||2||f||||f||||||||||2017-10-11 01:47:20.858987|2017-10-11 01:47:20.858987
NCT01837160|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-08-29|||April 2013||2013-04-01|March 2015|2015-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Angiogenesis and Fibrosis in Aortic Stenosis|The Identification of In Vivo Angiogenesis and Fibrosis in Aortic Stenosis Using Positron Emission Tomography|Completed||N/A|21|Actual|University of Edinburgh|||5||f||||t||||||Samples Without DNA|"     Blood samples will be taken, and the serum frozen and stored for further analysis pending     ethical approval.   "|||2017-10-11 01:47:20.976789|2017-10-11 01:47:20.976789
NCT01837147|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2014-04-27|||April 2013||2013-04-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)|Using Technology to Promote Activity in Women at Elevated Breast Cancer Risk|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:47:21.185547|2017-10-11 01:47:21.185547
NCT01837134|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2014-05-28|||May 2013||2013-05-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|July 2013|Actual|2013-07-01||Interventional|Fit||Telemedical Coaching for Weight Loss|TeleLifestyleCoaching Study - Telemedical Coaching for Weight Loss|Completed||N/A|100|Actual|West German Center of Diabetes and Health||3|||f||||f||||||||||2017-10-11 01:47:21.284212|2017-10-11 01:47:21.284212
NCT01837121|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2016-10-10|||January 2015||2015-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SMS||a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China|a Randomized Controlled Trail to Determine the Impact of a SMS Reminder Among Diabetic Retinopathy Patients in Rural China|Active, not recruiting||N/A|230|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:47:21.408726|2017-10-11 01:47:21.408726
NCT01837108|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2014-01-08|||April 2013||2013-04-01|April 2013|2013-04-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|eplerenone01||Eplerenone and Extracellular Adenosine Formation|Effects of the Selective Mineralocorticoid Receptor Antagonist Eplerenone on Extracellular Adenosine Formation in Humans in Vivo|Completed||Phase 4|14|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 01:47:21.541821|2017-10-11 01:47:21.541821
NCT01837095|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-01-31|||June 2013||2013-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer|A Phase I Dose Escalation Study of POL6326 With Eribulin in Patients With Relapsed, Triple Negative and Hormone Refractory ER Positive Metastatic Breast Cancer|Active, not recruiting||Phase 1|54|Actual|Polyphor Ltd.||1|||f||||t||||||||||2017-10-11 01:47:21.644332|2017-10-11 01:47:21.644332
NCT01837082|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-05-11|||April 2013||2013-04-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|iCHF||Iron in Congestive Heart Failure|Randomized, Double-blind, Placebo-controlled Trial of Ferric Carboxymaltose Versus Placebo in Patients With Congestive Heart Failure|Terminated||Phase 3|18|Actual|University of Ulm||2||Insufficient recruitment|f||||t||||||||||2017-10-11 01:47:21.761511|2017-10-11 01:47:21.761511
NCT01837069|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-06-09|||February 2014||2014-02-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Risk Factor Control Before Orthopedic Surgery|OPTMIZE-OS: Optimization of Pre-surgical Testing With an Intensive Multifactorial Intervention to MinimiZe Cardiovascular Events in Orthopedic Surgery|Terminated||Phase 4|198|Actual|New York University School of Medicine||2||Low recruitment / DSMB approval to halt recruitment|f||||t||||||||||2017-10-11 01:47:21.904056|2017-10-11 01:47:21.904056
NCT01837056|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2013-04-17|||January 2011||2011-01-01|April 2013|2013-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01|14 Days|Observational [Patient Registry]|||Prevalence of Toxoplasma Gondii and Toxocara Canis Among Patients With Uveitis|Prevalence of Toxoplasma Gondii and Toxocara Canis Among Patients With Uveitis|Completed||N/A|98|Actual|National Institute of Health, Korea|||1||f||||t||||||||||2017-10-11 01:47:22.065691|2017-10-11 01:47:22.065691
NCT01837043|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-01-27|||June 2013||2013-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function|A Randomized Trial of Early Conversion From Calcineurin Inhibitors (CNI) to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function|Recruiting||Phase 2|90|Anticipated|Nair, Vinay, D.O.||2|||f||||t||||||||||2017-10-11 01:47:22.164832|2017-10-11 01:47:22.164832
NCT01837030|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-04-17|||March 2013||2013-03-01|March 2013|2013-03-01||||July 2016|Anticipated|2016-07-01||Interventional|||Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding|Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding|Unknown status|Recruiting|N/A|62|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 01:47:22.296575|2017-10-11 01:47:22.296575
NCT01837017|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-11-23|||June 2012||2012-06-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|FARMS-1||Project FARMS: Fall Risk Reduction in Multiple Sclerosis|Project FARMS: Fall Risk Reduction in Multiple Sclerosis|Completed||Phase 1|33|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-11 01:47:22.453124|2017-10-11 01:47:22.453124
NCT01837004|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-12-08|||January 2013||2013-01-01|March 2014|2014-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CORTEX||Cognitive Regulation Training and Exercise|Cognitive Regulation Training and Exercise (CORTEX) Trial|Completed||N/A|133|Actual|University of Illinois at Urbana-Champaign||1|||f||||f||||||||||2017-10-11 01:47:22.576289|2017-10-11 01:47:22.576289
NCT01836991|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-04-22|||January 2012||2012-01-01|April 2013|2013-04-01|January 2017|Anticipated|2017-01-01|January 2014|Anticipated|2014-01-01||Interventional|||D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer|Phase 2 Study of D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer|Unknown status|Recruiting|Phase 2|200|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-11 01:47:22.689483|2017-10-11 01:47:22.689483
NCT01836978|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-10-03|||June 2013||2013-06-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy|Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy: Combining Physical Exercise to Stress Reduction Strategies and Nutritional Supplementation|Recruiting||N/A|60|Anticipated|McGill University Health Center||2|||f||||f||||||||Undecided||2017-10-11 01:47:22.835998|2017-10-11 01:47:22.835998
NCT01836965|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-01-20|||March 2013||2013-03-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Replication of the The Multi-Media Social Skills Project for Adolescents With Autism Spectrum Disorders|Replication of the The Multi-Media Social Skills Project for Adolescents With Autism Spectrum Disorders|Recruiting||N/A|300|Anticipated|Milton S. Hershey Medical Center||1|||f||||f||||||||No||2017-10-11 01:47:23.026749|2017-10-11 01:47:23.026749
NCT01836952|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-10-28|||October 2012||2012-10-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Sweet Cheeks: How Early Nutrition Affects Oral Microbiota Populations and Disease Incidence|Sweet Cheeks: How Early Nutrition Affects Oral Microbiota Populations and Disease Incidence|Completed||N/A|15|Actual|University of Illinois at Urbana-Champaign|||1||f||||f||||||Samples With DNA|"     Oral swabs of tongue and cheeks. Bacterial DNA to be extracted, no human DNA will be     extracted   "|||2017-10-11 01:47:23.191456|2017-10-11 01:47:23.191456
NCT01836939|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-01-13|||March 2013||2013-03-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis|A Randomized Open-label Two-arm Pilot Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis. Protocol: Psoriasis IIT|Completed||Phase 1|8|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 01:47:23.284282|2017-10-11 01:47:23.284282
NCT01836926|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2015-10-06|||December 2012||2012-12-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|ISR||Short Term Outcomes of Laparoscopic Intersphincteric Resection for Low Rectal Cancer|Short Term Outcomes of Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer:A Multicentric Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 2/Phase 3|106|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 01:47:23.416078|2017-10-11 01:47:23.416078
NCT01836913|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-03-22|||May 2009||2009-05-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2012|Actual|2012-04-01||Observational|RESPECT||Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal Cancer|Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal Cancer|Completed||N/A|90|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-11 01:47:23.566863|2017-10-11 01:47:23.566863
NCT01836900|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-17|||March 2013||2013-03-01|April 2013|2013-04-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|STING||Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy|Endoscopic Treatment of Recurrent Upper GI Bleeding From Gastroduodenal Ulcers: OTSC [Over the Scope Clip] Versus Standard Therapy|Unknown status|Recruiting|N/A|64|Anticipated|Kliniken Ludwigsburg-Bietigheim gGmbH||2|||f||||f||||||||||2017-10-11 01:47:23.669548|2017-10-11 01:47:23.669548
NCT01836887|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-04-17|||February 2013||2013-02-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health(2)|Fruit Polyphenols: Maximising Knowledge of Their Metabolic Health Benefits and Practical Applications (Phase 2)|Completed||N/A|22|Actual|King's College London||3|||f||||f||||||||||2017-10-11 01:47:23.820313|2017-10-11 01:47:23.820313
NCT01836874|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-04-17|||May 2007||2007-05-01|April 2013|2013-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|PROMPT-IN||A Study of Prophylaxis for Migraine Patients With Topiramate in India|Prophylaxis of Migraine Patients With Topiramate in India (PROMPT-IN)|Completed||Phase 4|209|Actual|Janssen-Cilag Ltd.|||1||f||||||||||||||2017-10-11 01:47:23.917929|2017-10-11 01:47:23.917929
NCT01836861|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-07-28|||March 2013||2013-03-01|July 2017|2017-07-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||IPI-145 ADME and Absolute Bioavailability Study|A Phase 1, Open-Label Study of the Absorption, Distribution, Metabolism and Excretion of 14C-Labeled IPI-145 and the Absolute Bioavailability of IPI-145 in Healthy Subjects|Completed||Phase 1|6|Actual|Verastem, Inc.||1|||f||||f||||||||||2017-10-11 01:47:23.99863|2017-10-11 01:47:23.99863
NCT01836848|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-04-17|||June 2013||2013-06-01|April 2013|2013-04-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG|Continuous, Non-invasive Monitoring of Cerebral Oxygenation and Perfusion Using Near-infrared Spectroscopy With Indocyanine Green Perfusion Measurement in Patients With Traumatic Brain Injury, Intracerebral or Subarachnoid Hemorrhage|Unknown status|Not yet recruiting|N/A|30|Anticipated|University of Cologne||1|||f||||f||||||||||2017-10-11 01:47:24.101565|2017-10-11 01:47:24.101565
NCT01836835|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-03-27|||May 2013||2013-05-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|April 2014|Actual|2014-04-01|9 Months|Observational [Patient Registry]|PUQE-N||Pregnancy Specific Nausea Questionnaire (PUQE) Translated and Tested in Norwegian|Case-cohort Validation Study of Pregnancy Unique Questionnaire of Emesis (PUQE) in Norwegian|Completed||N/A|69|Actual|Haukeland University Hospital|||2||f||||f||||||||||2017-10-11 01:47:24.20506|2017-10-11 01:47:24.20506
NCT01836822|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-02-11|||March 2013||2013-03-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|||Bronchoscopic Sampling Techniques in Sarcoidosis|Diagnostic Accuracy of Different Bronchoscopic Sampling Techniques in Patients With Mediastinal Lymph Node Enlargement Suspected of Sarcoidosis|Unknown status|Recruiting|N/A|90|Anticipated|Medical University of Warsaw||1|||f||||f||||||||||2017-10-11 01:47:24.467079|2017-10-11 01:47:24.467079
NCT01836809|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-01-13|2014-07-07||April 2013||2013-04-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Nesiritide and Renal Function After the Total Artificial Heart|The Impact of Nesiritide on Renal Function After Implantation of the Total Artificial Heart and Left Ventricular Assist Devices|Terminated||Phase 4|2|Actual|Virginia Commonwealth University|Enrollment closed. Total Artificial Hearts (TAH) are rarely done as advances with Left Ventricular Assist Devices have improved. We were unable to meet enrollment goal based on the funding timeline due to the lack of TAH's for comparison to LVAD.|4||Futility for enrollment|f||||t||||||||||2017-10-11 01:47:24.596579|2017-10-11 01:47:24.596579
NCT01836796|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-10-24|||May 2012||2012-05-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes|Metabolic Effects of Dietary Supplementation With Lactobacillus Reuteri DSM 17938 - a Randomised Placebo Controlled Proof-of-concept Study in Type 2 Diabetes|Completed||N/A|46|Actual|Vastra Gotaland Region||3|||f||||f||||||||||2017-10-11 01:47:25.058257|2017-10-11 01:47:25.058257
NCT01836770|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-04-17|||August 2010||2010-08-01|April 2013|2013-04-01||||December 2013|Anticipated|2013-12-01||Observational|||Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.|Epidural Contrast Flow Patterns of Transforaminal Epidural Steroid Injections Using the Inferior-Anterior Position as the Final Needle Tip Position.|Unknown status|Recruiting|N/A|100|Anticipated|George Washington University|||1||f||||t||||||||||2017-10-11 01:47:25.256035|2017-10-11 01:47:25.256035
NCT01836757|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-04-17|||September 2012||2012-09-01|April 2013|2013-04-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|msm||Effect of Methyl-Sulphonyl-Methane on Osteoarthritis and Cartilage|The Effect of Methyl-Sulphonyl-Methane on Osteoarthritis and Joint Cartilage Associated With the Degeneration of the Chondrocyte|Unknown status|Recruiting|Phase 1|100|Anticipated|G.Papanikolaou Research Group||2|||f||||t||||||||||2017-10-11 01:47:25.378751|2017-10-11 01:47:25.378751
NCT01836744|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-06-22|||March 2013||2013-03-01|June 2017|2017-06-01|March 2022|Anticipated|2022-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Survival Rate of Dental Implants Placed in Sinus Lift Performed With Two Different Grafts|Survival Rate of Dental Implants Placed in Sinus Lift Performed With Two Different Grafts|Active, not recruiting||Phase 4|12|Actual|Grupo de Investigação: Cirurgia Oral, Peridontologia, Implantologia||2|||f||||t||||||||||2017-10-11 01:47:25.518394|2017-10-11 01:47:25.518394
NCT01836731|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-07-12|||April 2013||2013-04-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|December 2016|Actual|2016-12-01||Interventional|CBEHPP||Impact Evaluation of Community-Based Health Programs in Rwanda|"Health Impact Evaluation of the Community-Based Environmental Health Promotion Programme in Rwanda"|Completed||N/A|8718|Actual|Georgetown University||3|||f||||f||||||||||2017-10-11 01:47:25.630345|2017-10-11 01:47:25.630345
NCT01836003|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-11|||July 2011||2011-07-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana|Programmatic CD4 Testing and HAART Initiation Among HIV-Infected Pregnant Women in Gaborone, Botswana: A Randomized Staged Trial of an Improvement Intervention|Completed||N/A|422|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-11 01:47:41.348119|2017-10-11 01:47:41.348119
NCT01836718|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-01-27|||June 2013||2013-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation|An Assessment of Intrahepatic HCV RNA Levels at the Time of Liver Transplantation in Patients With HCV Receiving Antiviral Therapy While on the Liver Transplant Waiting List Compared to Those Not Currently Receiving Therapy|Active, not recruiting||N/A|20|Anticipated|Schiano, Thomas D., MD|||3||f||||f||||||Samples With DNA|"     Whole blood, serum, liver explant tissue and hilar lymph nodes will be obtained for testing.     With subject consent, any unused specimens will be retained indefinitely for use in future     research either related or unrelated to this study, which may include genetic testing.   "|||2017-10-11 01:47:25.787865|2017-10-11 01:47:25.787865
NCT01836705|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-06-03|||May 2013||2013-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional|||Effect of SAR302503 on ECG Activity in Patients With Solid Tumors|Effect of 14-day Repeated Oral Doses of SAR302503 on Ventricular Repolarization, Compared to 1-day Placebo in Adult Patients With Refractory Solid Tumors|Completed||Phase 1|60|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 01:47:25.915115|2017-10-11 01:47:25.915115
NCT01836692|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-01-31|||April 2014||2014-04-01|January 2017|2017-01-01|April 2021|Anticipated|2021-04-01|October 2016|Actual|2016-10-01||Interventional|Isotoxic-IMRT||Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study|Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study|Active, not recruiting||N/A|38|Actual|The Christie NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:47:26.086956|2017-10-11 01:47:26.086956
NCT01836679|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-01-28|||April 2013||2013-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer|A Phase II Study of Chidamide or Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|124|Actual|Chipscreen Biosciences, Ltd.||2|||f||||f||||||||No||2017-10-11 01:47:26.225848|2017-10-11 01:47:26.225848
NCT01836666|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-09-12|||January 2008||2008-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|||Effects on Health Related Quality of Life Among Patients With Chronic Pain by Interventional Pain Management|Effects on Health Related Quality of Life Among Patients With Chronic Pain by Interventional Pain Management|Recruiting||N/A|500|Anticipated|Eques Indolor AB|||1||f||||f||||||||||2017-10-11 01:47:26.402068|2017-10-11 01:47:26.402068
NCT01836653|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2017-08-01|||May 2013||2013-05-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|ATOM||Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases|Randomized Phase II Study of mFOLFOX6 + Bevacizumab or mFOLFOX6 + Cetuximab in Liver Only Metastasis From KRAS Wild Type Colorectal Cancer|Completed||Phase 2|122|Actual|EPS Corporation||2|||f||||t||||||||||2017-10-11 01:47:26.51283|2017-10-11 01:47:26.51283
NCT01836640|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-08-15|||December 2013||2013-12-01|March 2013|2013-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer|Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer|Terminated||N/A|9|Actual|Dartmouth-Hitchcock Medical Center|||1|Primary goal not achievable|f||||t||||||||||2017-10-11 01:47:26.651094|2017-10-11 01:47:26.651094
NCT01836627|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-07-25|||April 2013||2013-04-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||A Study to Test Lung Stretch Therapy (Hyperinsufflation) in Children With Collagen VI Muscular Dystrophy|Congenital Muscular Dystrophy (CMD) and the Feasibility of Hyperinsufflation Therapy to Slow Rate of Decline in Lung Volume|Completed||N/A|34|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 01:47:26.734896|2017-10-11 01:47:26.734896
NCT01836614|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-03-07|||January 2015||2015-01-01|March 2016|2016-03-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Intravenous Lidocaine Infusion in the Management of Post-operative Pain in Colorectal Patients|Intravenous Lidocaine Infusion in the Management of Post-operative Pain in Colorectal Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Children's Hospital Medical Center, Cincinnati||2||Study was closed due to recommendations of performing a PK study first.|f||||t||||||||||2017-10-11 01:47:28.992984|2017-10-11 01:47:28.992984
NCT01836601|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-07-28|||April 2013||2013-04-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Nighttime Communication Study|The Effect of a Family-Centered Nighttime Communication Bundle on Shared Mental-Model Building, Safety, and Patient Experience|Completed||N/A|1334|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 01:47:29.114582|2017-10-11 01:47:29.114582
NCT01836588|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-04-17|||March 2013||2013-03-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||New Gentle Biopsy Method of Cervix Lesions Using Superficial Curettage/Protocol ID: CX-CUR||Unknown status|Enrolling by invitation|N/A|300|Actual|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 01:47:29.214705|2017-10-11 01:47:29.214705
NCT01836575|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-30|2013-04-18|||April 2008||2008-04-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|PS2||Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2|Phase III Trial of Single-Agent Pemetrexed (Alimta®) Versus the Combination of Carboplatin and Pemetrexed in Patients With Advanced Non-small-cell Lung Cancer and Performance Status of 2|Completed||Phase 3|228|Actual|Instituto Nacional de Cancer, Brazil||2|||f||||t||||||||||2017-10-11 01:47:29.325199|2017-10-11 01:47:29.325199
NCT01836562|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|BMCA||A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism|A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:47:29.453911|2017-10-11 01:47:29.453911
NCT01834443|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-04-15|||May 2011||2011-05-01|April 2013|2013-04-01|March 2014|Anticipated|2014-03-01|January 2014|Anticipated|2014-01-01||Interventional|GVS||Therapeutic Effects of Galvanic Vestibular Stimulation (GVS) on Spatial Neglect|Therapeutic Effects of Galvanic Vestibular Stimulation (GVS) on Spatial Neglect|Unknown status|Recruiting|N/A|45|Anticipated|Schoen Clinic Bad Aibling||3|||f||||f||||||||||2017-10-11 01:48:04.829855|2017-10-11 01:48:04.829855
NCT01836536|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-02-28|||September 2012||2012-09-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|AVA-CELL||Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients|Analysis of Different Circulating Immune Cells in Patients With Recurrent Glioblastoma or Mixed Anaplasic Glioma Treated With Bevacizumab and Search for a Link With Response to Treatment|Completed||N/A|30|Actual|Center Eugene Marquis||1|||f||||f||||||||||2017-10-11 01:47:29.705305|2017-10-11 01:47:29.705305
NCT01836523|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-01-16|2016-05-23||November 2013||2013-11-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ADJUNCT ONE™|Full analysis set (FAS) included all randomised subjects who received at least one dose and had any post-randomisation data. Five subjects, who started the study, were excluded because of no exposure to study drug and 4 subjects were excluded because of non-availability of post-baseline data.|The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes|The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes. A 52-week Randomised, Treat-to-target, Placebo-controlled, Double Blinded, Parallel Group, Multinational, Multi-centre Trial|Completed||Phase 3|1398|Actual|Novo Nordisk A/S||6|||f||||f||||||||||2017-10-11 01:47:29.864963|2017-10-11 01:47:29.864963
NCT01836510|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-05-11|||May 2012|Actual|2012-05-01|May 2017|2017-05-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Observational|BioDetectHFIV||Selection of Potential Predictors of Worsening Heart Failure|Selection of Potential Predictors of Worsening Heart Failure|Completed||N/A|922|Actual|Biotronik SE & Co. KG|||1||f||||t||||||||||2017-10-11 01:47:32.358636|2017-10-11 01:47:32.358636
NCT01836497|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-03-09|||May 2013||2013-05-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||SD01 Master Study (Safety and Efficacy Study)|SD01 Master Study (Safety and Efficacy Study)|Active, not recruiting||N/A|160|Anticipated|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 01:47:32.555974|2017-10-11 01:47:32.555974
NCT01836484|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-08-30|||October 2012||2012-10-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|MAPPING||Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma|Diagnostic Accuracy of MRI, Diffusion-weighted MRI, FDG-PET/CT and Fluoro-ethyl-choline PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma|Active, not recruiting||N/A|150|Anticipated|Barts & The London NHS Trust|||1||f||||t||||||Samples With DNA|"     Lymph node tissue samples   "|||2017-10-11 01:47:32.66413|2017-10-11 01:47:32.66413
NCT01836471|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-01-30|2017-01-30||May 2013||2013-05-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients|A Double-blind, Placebo-controlled, Study Examining the Effect of Orally Administered QAW039 (450 mg QD) on FEV1 and ACQ in Non-atopic, Asthmatic Patients With a Baseline, Pre-bronchodilator FEV1 of 40-80% Predicted, Inadequately Controlled With Low Dose ICS Therapy|Completed||Phase 2|345|Actual|Novartis||5|||f||||f||||||||No||2017-10-11 01:47:32.860548|2017-10-11 01:47:32.860548
NCT01836458|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-09-14|2016-03-08||January 2014||2014-01-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection|An Open-label Study to Find the Minimum Inhibitory Concentration(MIC) of KAE609 in Adult Male Patients With Acute, Uncomplicated Malaria Due to Plasmodium Falciparum Monoinfection|Completed||Phase 2|25|Actual|Novartis||4|||f||||f||||||||||2017-10-11 01:47:35.306682|2017-10-11 01:47:35.306682
NCT01836445|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-09-12|||May 2013|Actual|2013-05-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|KIU!||Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men|Efficacy of Internet-based HIV Prevention|Completed||N/A|901|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:47:35.76359|2017-10-11 01:47:35.76359
NCT01836432|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-12-21|||May 2013||2013-05-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|PILLAR||Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer|A Phase III Study of Chemotherapy With or Without Algenpantucel-L (HyperAcute®-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer|Active, not recruiting||Phase 3|302|Actual|NewLink Genetics Corporation||4|||f||||t||||||||||2017-10-11 01:47:35.909588|2017-10-11 01:47:35.909588
NCT01836419|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-02-17|||December 2012||2012-12-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Clinical Efficacy of Laryngeal Mask Airway in Elderly Patients: Comparison With Young Adults||Completed||N/A|100|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:47:36.164561|2017-10-11 01:47:36.164561
NCT01836406|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-02-17|||December 2012||2012-12-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy||Completed||N/A|16|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:47:36.2902|2017-10-11 01:47:36.2902
NCT01836393|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-04-05|||January 2013||2013-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Interventional|OA knee Plai||Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 14% of Plai (Plaivana®) to Placebo Gels|Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 14% of Plai (Plaivana®) to Placebo Gels|Completed||Phase 3|120|Actual|Khon Kaen University||1|||f||||t||||||||||2017-10-11 01:47:36.412059|2017-10-11 01:47:36.412059
NCT01836380|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-03-25|||January 2013||2013-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|OA||Regular Swimming, Vascular Function, and Arthritis|Effects of Swimming Exercise and Cycling Exercise Interventions on Vascular Function, Inflammation and Pain in Middle-aged and Older Adults With Osteoarthritis.|Completed||N/A|48|Actual|University of Texas at Austin||2|||f||||f||||||||||2017-10-11 01:47:37.192297|2017-10-11 01:47:37.192297
NCT01836367|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-12-30|||March 2013||2013-03-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp|An Investigator-Initiated Study to Assess the Degree of Irritation After a Second Cycle of Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp|Completed||Phase 1|20|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 01:47:37.291722|2017-10-11 01:47:37.291722
NCT01836354|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-03-21|||August 2012||2012-08-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|DESERVE||Discharge Educational Strategies for Reduction of Vascular Events|Discharge Educational Strategies for Reduction of Vascular Events|Recruiting||N/A|800|Anticipated|New York University School of Medicine||2|||f||||t|f|f||||||||2017-10-11 01:47:37.383813|2017-10-11 01:47:37.383813
NCT01836341|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-12-18|||April 2013||2013-04-01|December 2013|2013-12-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation|A Dose-Finding Study Of Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation|Withdrawn||Phase 1|0|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:47:37.507376|2017-10-11 01:47:37.507376
NCT01836328|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-03-14|||August 2011||2011-08-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|RATIOMTD||Conversion From Parenteral to Oral Methadone.|Prospective Randomized Simple Blinded Study Comparing Two Conversion Ratios From Parenteral to Oral Methadone in Patients With Cancer Pain.|Completed||Phase 3|44|Actual|L'Hospitalet de Llobregat||2|||f||||t||||||||||2017-10-11 01:47:37.604148|2017-10-11 01:47:37.604148
NCT01836315|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-12-06|||January 2013||2013-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Inflammation in Obese Parturients: Surgical Outcomes After Elective Caesarean Section|Inflammation in Obese Parturients: Surgical Outcomes After Elective Caesarean Section|Completed||N/A|25|Actual|University of Manitoba|||2||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 01:47:37.751669|2017-10-11 01:47:37.751669
NCT01836302|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-12-06|||August 2012||2012-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Septic Shock and Delirium Because of rSO2 Abnormalities in Intensive Care Unit Patients (The SAD BRAIN Study)|Septic Shock and Delirium Because of rSO2 Abnormalities in Intensive Care Unit Patients (The SAD BRAIN Study)|Completed||N/A|16|Actual|University of Manitoba|||2||f||||f||||||||||2017-10-11 01:47:37.858986|2017-10-11 01:47:37.858986
NCT01836289|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-03-01|||March 2015||2015-03-01|March 2015|2015-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||High-dose Cyclophosphamide for Severe Refractory Crohn Disease|High-dose Cyclophosphamide for Severe Refractory Crohn Disease|Recruiting||Phase 1/Phase 2|10|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:47:37.944002|2017-10-11 01:47:37.944002
NCT01836276|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-08-30|||February 2013|Actual|2013-02-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Understanding Disparities in Quitting in African American and White Smokers|Understanding Disparities in Quitting in African American and White Smokers|Completed||Phase 4|449|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 01:47:38.077537|2017-10-11 01:47:38.077537
NCT01836263|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-04-24|||April 2013||2013-04-01|April 2013|2013-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|24 Months|Observational [Patient Registry]|||Prevention and Treatment of Digital Ulcers in Systemic Sclerosis||Unknown status|Recruiting|N/A|420|Anticipated|University of Florence|||4||f||||f||||||||||2017-10-11 01:47:38.180152|2017-10-11 01:47:38.180152
NCT01836237|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-05-11|||February 2013||2013-02-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||The Use of Wound Protector in Whipple's Procedure With Intrabiliary Stent|The Use of Wound Protectors to Prevent Surgical Site Infection for Whipples (Pancreatoduodenectomy) With Intrabiliary Stents: A Randomized Controlled Trial.|Recruiting||N/A|78|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-11 01:47:38.362164|2017-10-11 01:47:38.362164
NCT01836224|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-11-21|||October 2012||2012-10-01|December 2013|2013-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit|A Prospective Open Label Randomized Non Inferiority Trial to Compare the Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit.|Completed||N/A|84|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 01:47:38.486918|2017-10-11 01:47:38.486918
NCT01836211|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-04-11|||September 2011||2011-09-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Interventional|TRUE||High-Sensitivity Troponin T and Coronary Computed Tomography Angiography for Rapid Diagnosis of Emergency Chest Pain|High-Sensitivity Troponin T and Coronary Computed Tomography Angiography for Rapid Diagnosis of Emergency Chest Pain: a Randomized Controlled Study|Terminated||N/A|101|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2||low recruitment|f||||t||||||||||2017-10-11 01:47:38.679563|2017-10-11 01:47:38.679563
NCT01836198|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2013-11-27|||May 2013||2013-05-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream|Effects of Potent Inhibition of CYP2C8, CYP2J2, and CYP3A4, Using Gemfibrozil, Ketoconazole, and Clarithromycin as Probes, on the Pharmacokinetics of LY2409021 in Healthy Subjects|Completed||Phase 1|45|Anticipated|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 01:47:38.767656|2017-10-11 01:47:38.767656
NCT01836185|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-10-30|||April 2013||2013-04-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment|Pharmacokinetics of Evacetrapib (LY2484595) in Subjects With Hepatic Impairment|Completed||Phase 1|48|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 01:47:38.984403|2017-10-11 01:47:38.984403
NCT01836172|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-08-16|||April 2013||2013-04-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus|Multicenter, Randomized, Double Blind, Placebo-controlled, Phase II Clinical Trial to Evaluate the Safety and Efficacy of YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus|Active, not recruiting||Phase 2|136|Anticipated|Han Wha Pharma Co., Ltd.||4|||f||||t||||||||||2017-10-11 01:47:39.085729|2017-10-11 01:47:39.085729
NCT01836159|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-11-16|||June 2013||2013-06-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||iPad Technology for HOME Rehabilitation in Patients After Stroke: iHOME Acute/Chronic|iPad Technology for HOME Rehabilitation in Patients After Stroke: iHOME Acute/Chronic|Recruiting||N/A|30|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:47:39.205667|2017-10-11 01:47:39.205667
NCT01836146|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-10-19|||April 2013||2013-04-01|October 2014|2014-10-01|September 2015|Actual|2015-09-01|March 2014|Actual|2014-03-01||Interventional|EnligHTN III||International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension||Completed||N/A|39|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 01:47:39.32067|2017-10-11 01:47:39.32067
NCT01836133|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-03-23|2017-02-02||May 2013||2013-05-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|ELEMENT|Baseline analysis population included all enrolled participants.|An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)|Efficacy and Safety of Erlotinib (Tarceva® ) Therapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) , Subtype Adenocarcinoma, Who Have Good Performance Status (PS 0-1) - ELEMENT|Completed||N/A|70|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:47:39.425254|2017-10-11 01:47:39.425254
NCT01836120|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2013-04-18|||April 2013||2013-04-01|April 2013|2013-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer|A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Hebei Tumor Hospital||2|||f||||t||||||||||2017-10-11 01:47:39.704268|2017-10-11 01:47:39.704268
NCT01836107|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-03-22|||April 2013||2013-04-01|April 2013|2013-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Adaptation and Validation of a Score From English to Spanish for Evaluating Quality of Clinical Notes|Cross-cultural Adaptation and Validation of a Score for Evaluating Quality of Inpatient Clinical Notes|Completed||N/A|38|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 01:47:39.796236|2017-10-11 01:47:39.796236
NCT01836094|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-04-07|||August 2013||2013-08-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effects of USP Methylene Blue on Cognitive and fMRI Brain Activity|Beneficial Effects of Methylene Blue on Human Cognitive and fMRI Measures|Completed||Early Phase 1|36|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 01:47:39.874447|2017-10-11 01:47:39.874447
NCT01836081|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-18|||December 2011||2011-12-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Respirophasic Carotid Artery Peak Velocity Variation as a Predictor of Fluid Responsiveness in Patients With Coronary Disease||Completed||N/A|40|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 01:47:40.002067|2017-10-11 01:47:40.002067
NCT01836068|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-05-01|||July 2013||2013-07-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals|Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1-infected Individuals|Recruiting||Early Phase 1|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-11 01:47:40.104833|2017-10-11 01:47:40.104833
NCT01836055|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2014-12-08|||January 2012||2012-01-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Observational|||Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist|Comparing Lesion Contrast With Both Magnevist and Gadavist and Understanding the Cerebral Perfusion Patterns of Patients With Multiple Sclerosis (MS) Using Magnetic Resonance Imaging (MRI)|Terminated||N/A|19|Actual|Wayne State University|||3|The study didn't have sufficient flow of subjects (discontinued by the Sponsor)|f||||t||||||||||2017-10-11 01:47:40.265233|2017-10-11 01:47:40.265233
NCT01836042|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-03-16|2015-06-16||July 2013||2013-07-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational||Note: 108 of the subjects in the original pivotal trial participated in the follow-up study. There were 51 subjects from the randomized stent group, 35 from the cataract only group, and 22 from the non-randomized stent group who participated in this study|Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort|Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent System In Conjunction With Cataract Surgery: Extended Follow-up of the Premarket Cohort|Completed||N/A|108|Actual|Glaukos Corporation|||3||f||||f||||||||||2017-10-11 01:47:40.43535|2017-10-11 01:47:40.43535
NCT01836029|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-01-05|||July 2013||2013-07-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination With VTX 2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 2|175|Anticipated|VentiRx Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 01:47:40.907412|2017-10-11 01:47:40.907412
NCT01836016|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-11|||May 2013||2013-05-01|April 2013|2013-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients|Comparison of Conventional Medicine, TCM Treatment and Combination of Both Conventional Medicine and TCM Treatment for Patients With Chronic Obstructive Pulmonary Disease: A Randomized Comparative Effectiveness Research Trial|Unknown status|Not yet recruiting|Phase 3|360|Anticipated|Henan University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-11 01:47:41.200426|2017-10-11 01:47:41.200426
NCT01835652|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-05-08|||April 2013||2013-04-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PET||The Effects of Exercise in Parkinson's Disease|The Effects of Exercise in Parkinson's Disease.|Completed||N/A|18|Actual|Pacific Parkinson's Research Centre||2|||f||||f||||||||||2017-10-11 01:47:45.93793|2017-10-11 01:47:45.93793
NCT01835977|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-07-25|||June 2015||2015-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer|Multi-Center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer|Enrolling by invitation||Phase 2|200|Anticipated|Clinical Research Office of the Endourological Society||2|||f||||t||||||||||2017-10-11 01:47:41.546713|2017-10-11 01:47:41.546713
NCT01835964|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-02-18|||April 2013||2013-04-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Biobehavioral Mechanisms of Glucose Variability|Biobehavioral Mechanisms of Glucose Variability|Completed||N/A|30|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 01:47:41.649691|2017-10-11 01:47:41.649691
NCT01835951|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-10-23|||March 2013||2013-03-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|DEBRIEF-SIM||Individual Versus Grouped Debriefing Approaches in Anaesthesia Crisis Simulation-Based Training. What Impact On The Technical Score ?|Individual Versus Grouped Debriefing Approaches in Anaesthesia Crisis Simulation-Based Training. What Impact On The Technical Score ?|Completed||N/A|48|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-11 01:47:41.753889|2017-10-11 01:47:41.753889
NCT01835938|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-06-14|||May 2013||2013-05-01|June 2014|2014-06-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Clinical Investigation of Erlotinib as an HCV Entry Inhibitor|Dose Finding and Early Efficacy Study of Erlotinib in Treatment of Chronic Hepatitis C Virus infection_proof of Concept Study|Unknown status|Not yet recruiting|Phase 1/Phase 2|12|Anticipated|University Hospital, Strasbourg, France||2|||f||||t||||||||||2017-10-11 01:47:41.878678|2017-10-11 01:47:41.878678
NCT01835925|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-04-30|||July 2013||2013-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Rectal Cancer Consortium|Rectal Cancer Consortium: BrUOG 285: A Comprehensive Program to Identify Therapeutic Targets and Develop Targeted Agents for Testing With Total Neoadjuvant Treatment for Stage II-III Rectal Cancer BrUOG= Brown University Oncology Research Group|Completed||N/A|12|Actual|Brown University|||1||f||||t||||||Samples With DNA|"     Tissue specimen from diagnosis from rectal cancer   "|||2017-10-11 01:47:42.021802|2017-10-11 01:47:42.021802
NCT01835912|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-07-23|2014-03-19||September 2012||2012-09-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Chronic Versus Acute Dosing of Sodium Citrate for Swimming 200m|Chronic vs. Acute Ingestion of Sodium Citrate: a Randomised Placebo Controlled Cross-over Trial for Swimming a 200 Metres in Well-trained Swimmers Age 13-17|Completed||Phase 3|10|Actual|Brock University||4|||f||||t||||||||||2017-10-11 01:47:42.118092|2017-10-11 01:47:42.118092
NCT01835899|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-12-16|2015-11-11||April 2013||2013-04-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||The treated set (TS) included all subjects who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution|Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution in Healthy Male Volunteers q.d. or b.i.d.for 14 Days (a Randomised, Double-blind, Placebo-controlled Within Dose Groups Phase I Trial)|Completed||Phase 1|24|Actual|Boehringer Ingelheim|The study was prematurely completed as per protocol after 2 of the originally planned 4 dose groups ie., 1 mg BI 1015550 and 6 mg BI 1015550 because of higher than expected drug exposure.|5|||f||||||||||||||2017-10-11 01:47:42.443574|2017-10-11 01:47:42.443574
NCT01835886|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-05-05|||March 2013||2013-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|TSCT||Study to Assess Stairs as an Outcome Measure in Individuals With Pulmonary Disease|Study to Assess if Ability to Ascend and Descend Stairs Within 30 Seconds Will Prove to be a Reliable and Valid Outcome Measure in Individuals With Pulmonary Disease|Completed||N/A|29|Actual|Beth Israel Medical Center||1|||f||||f||||||||||2017-10-11 01:47:42.819884|2017-10-11 01:47:42.819884
NCT01835873|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2013-07-12|||March 2011||2011-03-01|July 2013|2013-07-01||||January 2012|Actual|2012-01-01||Interventional|||The Effect of Intravenous Prehydration on the Hemodynamic Status of Healthy Parturients Undergoing Spinal Anesthesia for Cesarean Delivery|Comparative Study of the Effect of 6% Hydroxyethyl Starch 130/0.42 vs Lactated Ringer's Preload on the Hemodynamic Status of Parturients Undergoing Spinal Anesthesia for Elective Cesarean Delivery. Arterial Pulse Contour Analysis (FloTrac/VigileoTM) is Employed for Continuous Monitoring of Maternal Hemodynamic Parameters|Completed||N/A|32|Actual|Attikon Hospital||2|||f||||||||||||||2017-10-11 01:47:42.923735|2017-10-11 01:47:42.923735
NCT01835860|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-04-05|||March 2013||2013-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Prostatic Artery Embolization for Benign Prostatic Hyperplasia||Completed||Phase 2/Phase 3|13|Actual|Regina Qu'Appelle Health Region||1|||f||||||||||||||2017-10-11 01:47:43.022463|2017-10-11 01:47:43.022463
NCT01835847|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-05-22|||April 2013||2013-04-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression|Tipepidine for Adolescent Depression|Completed||Phase 2|10|Actual|Chiba University||1|||f||||||||||||||2017-10-11 01:47:43.286549|2017-10-11 01:47:43.286549
NCT01835834|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-07-04|||January 2010||2010-01-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Clinical Study on Zirconia Bridges||Unknown status|Active, not recruiting|N/A|9|Actual|University of Siena||1|||f||||f||||||||||2017-10-11 01:47:43.37702|2017-10-11 01:47:43.37702
NCT01835821|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-07-04|||March 2010||2010-03-01|July 2014|2014-07-01|March 2016|Anticipated|2016-03-01|September 2015|Anticipated|2015-09-01||Interventional|||Clinical Study of Porcelain-fused and IPS e.Max CAD Crowns|A Clinical Evaluation of Hand-veneered, Porcelain-fused NobelProcera(TM) Crown Shaded Zirconia and NobelProcera(TM) Full Contour Crown IPS e.Max CAD on Molars|Unknown status|Active, not recruiting|N/A|11|Anticipated|University of Siena||1|||f||||f||||||||||2017-10-11 01:47:43.473766|2017-10-11 01:47:43.473766
NCT01835808|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-05-22|||March 2012||2012-03-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01|1 Year|Observational [Patient Registry]|POST-IT||Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease|Observational Study of the Evaluation of FFR in the Treatment of Coronary Artery Disease|Completed||N/A|918|Actual|Portuguese Society of Cardiology|||1||f||||t||||||||||2017-10-11 01:47:43.578876|2017-10-11 01:47:43.578876
NCT01835795|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2013-04-18|||January 2013||2013-01-01|April 2013|2013-04-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Interventional|||Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain|Prospective, Comparative, Randomized Study of the Effectiveness of Shock Wave Treatment in Myofascial Pain Syndrome in Low Back Pain|Unknown status|Recruiting|N/A|40|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 01:47:43.680819|2017-10-11 01:47:43.680819
NCT01834820|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-07-04|||January 2013||2013-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Epinephrine, Dexamethasone, and Hypertonic Saline in Bronchiolitis, Randomised Clinical Trial of Efficacy and Safety|Pilot Study: Epinephrine, Dexamethasone, and Hypertonic Saline in Children With Bronchiolitis, Randomised Clinical Trial of Efficacy and Safety|Completed||Phase 4|120|Actual|Hospital General Naval de Alta Especialidad - Escuela Medico Naval||3|||f||||t||||||||||2017-10-11 01:47:43.891187|2017-10-11 01:47:43.891187
NCT01834807|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2016-11-01|||April 2013||2013-04-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis|Retrospective Study on the Use of Biologicals in Monotherapy in Rheumatoid Arthritis|Completed||N/A|180|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:47:44.017842|2017-10-11 01:47:44.017842
NCT01834794|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2015-08-03|||March 2013||2013-03-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders|Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders|Completed||Phase 1|33|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 01:47:44.11536|2017-10-11 01:47:44.11536
NCT01834781|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2014-04-15|||April 2013||2013-04-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity|Transcranial Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity: a Study Protocol for a Randomized, Double-blind, Placebo-controlled Trial|Completed||N/A|39|Actual|The Danish Research Centre for Chemical Sensitivities||2|||f||||t||||||||||2017-10-11 01:47:44.208659|2017-10-11 01:47:44.208659
NCT01835769|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-07-10|||April 2013||2013-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:47:44.318604|2017-10-11 01:47:44.318604
NCT01835756|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2015-12-31|2015-07-09||September 2012||2012-09-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of Low Level Laser Therapy to Treat Low Back Pain|A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia ML Scanner (MLS) on Low Back Pain Clinical Study|Completed||N/A|62|Actual|Erchonia Corporation||2|||f||||f||||||||||2017-10-11 01:47:44.369841|2017-10-11 01:47:44.369841
NCT01835743|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-05-08|2014-04-04||February 2012||2012-02-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|||Study of Low Level Laser Therapy to Treat Chronic Heel Pain Arising From Plantar Fasciitis|A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia HP Scanner (HPS) Laser on Chronic Heel Pain|Completed||N/A|69|Actual|Erchonia Corporation||2|||f||||f||||||||||2017-10-11 01:47:44.813666|2017-10-11 01:47:44.813666
NCT01835730|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-10-13|||April 2013||2013-04-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus|Phase 1 Multicenter, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|37|Actual|PhaseBio Pharmaceuticals Inc.||2|||f||||f||||||||||2017-10-11 01:47:45.214071|2017-10-11 01:47:45.214071
NCT01835717|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-03-01|||April 2013||2013-04-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population|Cross-sectional Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population|Active, not recruiting||N/A|2743|Actual|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation|||1||f||||f||||||Samples With DNA|"     serum; white cells   "|||2017-10-11 01:47:45.320307|2017-10-11 01:47:45.320307
NCT01835704|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-09-12|||January 2008||2008-01-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Observational|||Health-economic Evaulation of Interventional Pain Mangement|Health-economic Evaluation of Interventional Pain Management Among Patients With Chronic Pain|Recruiting||N/A|300|Anticipated|Eques Indolor AB|||2||f||||f||||||||||2017-10-11 01:47:45.428263|2017-10-11 01:47:45.428263
NCT01835691|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-03-22|||October 2011||2011-10-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease|Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease|Completed||N/A|44|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 01:47:45.575238|2017-10-11 01:47:45.575238
NCT01835678|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-04-09|||October 2012||2012-10-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.|Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes|Completed||Phase 3|65|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-11 01:47:45.715699|2017-10-11 01:47:45.715699
NCT01835665|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-05-12|||March 2013||2013-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations|An Open Label Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations|Completed||Phase 1|8|Actual|University of California, San Francisco||1|||f||||f||||||||Undecided|Data analysis is underway|2017-10-11 01:47:45.834736|2017-10-11 01:47:45.834736
NCT01835626|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-05-03|||May 2013||2013-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma|A Phase II Study of Radiation Therapy and Vismodegib, for the Treatment of Locally Advanced Basal Cell Carcinoma of the Head and Neck|Recruiting||Phase 2|24|Anticipated|University of California, San Francisco||1|||f||||t||||||||No||2017-10-11 01:47:46.168331|2017-10-11 01:47:46.168331
NCT01835613|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-18|||January 2013||2013-01-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.|Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.|Unknown status|Recruiting|Phase 4|150|Anticipated|Osservatorio Epidemiologico GISEA||1|||f||||f||||||||||2017-10-11 01:47:46.324569|2017-10-11 01:47:46.324569
NCT01835600|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-11|||April 2013||2013-04-01|April 2013|2013-04-01|November 2013|Anticipated|2013-11-01|September 2013|Anticipated|2013-09-01||Interventional|||Suspension of Mechanical Ventilation in Ureteroscopic Lithotripsy Under General Anesthesia||Unknown status|Not yet recruiting|N/A|150|Anticipated|Chinese Medical Association||2|||f||||t||||||||||2017-10-11 01:47:46.435265|2017-10-11 01:47:46.435265
NCT01835587|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2017-09-28|||July 18, 2013|Actual|2013-07-18|September 2017|2017-09-01|May 19, 2017|Actual|2017-05-19|November 13, 2016|Actual|2016-11-13||Interventional|||Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation in Subjects With Acute Myeloid Leukemia or Myelodysplastic Syndromes|A Phase 1/2 Dose and Schedule Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Oral Azacitidine (CC-486) in Subjects With Acute Myelogenous Leukemia and Myelodysplastic Syndromes After Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 1/Phase 2|31|Actual|Celgene||1|||f||||f||||||||||2017-10-11 01:47:46.531763|2017-10-11 01:47:46.531763
NCT01835574|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-05-19|||April 2013||2013-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CIPI||Cambodia Integrated HIV and Drug Prevention Implementation Program|Cambodia Integrated HIV and Drug Prevention Implementation Program|Completed||N/A|1198|Actual|University of California, San Francisco||1|||f||||t||||||||No|No plan to share individual level data at this time outside of study investigators.|2017-10-11 01:47:46.64992|2017-10-11 01:47:46.64992
NCT01835561|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-09-24|||March 2013||2013-03-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired Males|A Phase 1, Open‐Label, Two‐Part Study to Evaluate the Pharmacokinetics of Pomalidomide (CC‐4047) in Hepatically Impaired Male Subjects|Completed||Phase 1|32|Actual|Celgene||2|||f||||f||||||||||2017-10-11 01:47:46.760756|2017-10-11 01:47:46.760756
NCT01835548|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-01-30||2015-01-30|July 2013||2013-07-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)|A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder|Completed||Phase 3|87|Actual|Neos Therapeutics, Inc||2|||f||||f||||||||||2017-10-11 01:47:46.879515|2017-10-11 01:47:46.879515
NCT01835535|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2014-03-25|||August 2013||2013-08-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Continued Safety and Performance of the TIVUS System|Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Renal Denervation in Patients With Resistant Hypertension|Unknown status|Active, not recruiting|Phase 2/Phase 3|80|Anticipated|Cardiosonic||1|||f||||f||||||||||2017-10-11 01:47:46.973365|2017-10-11 01:47:46.973365
NCT01835522|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-08-03|||July 2009||2009-07-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||A Survey of Sexual Function in Schizophrenic Patients|A Survey of Sexual Function in Schizophrenic Patients|Withdrawn||N/A|0|Actual|Beth Israel Medical Center|||1||f||||f||||||||||2017-10-11 01:47:47.078921|2017-10-11 01:47:47.078921
NCT01835509|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-02-24|||February 2013||2013-02-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Group Intervention to Increase Physical Activity in Childhood Cancer Survivors|Group Intervention to Increase Physical Activity in Childhood Cancer Survivors|Completed||Early Phase 1|20|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:47:47.182284|2017-10-11 01:47:47.182284
NCT01835496|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-07-22|2015-06-26||May 2013||2013-05-01|April 2013|2013-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease|The Pharmacokinetic Profile of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease|Completed||Phase 1|8|Actual|ApoPharma||1|||f||||f||||||||||2017-10-11 01:47:47.268599|2017-10-11 01:47:47.268599
NCT01835483|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-01-16|||May 2013||2013-05-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test|A Multicenter Clinical Study to Determine the Performance Characteristics of the MassPLEX Factor II and Factor V Leiden Genotyping Test in Patients With Suspected Thrombophilia|Completed||N/A|867|Actual|Sequenom, Inc.|||1||f||||f||||||Samples With DNA|"     De-identified banked genomic DNA   "|||2017-10-11 01:47:47.522564|2017-10-11 01:47:47.522564
NCT01835470|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-17|2016-11-15|2016-11-15||August 2013||2013-08-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|November 2015|Actual|2015-11-01||Interventional||All Treated Participants: All participants who received at least one dose of study medication|Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan|A Phase III, Multicenter, Open-Label Study to Assess Efficacy, Safety, Pharmacokinetics and Immunogenicity of Abatacept Administered Intravenously in Japanese Children and Adolescents With Active Juvenile Idiopathic Arthritis Who Have a History of an Inadequate Response or Intolerance to Methotrexate or Biologics|Active, not recruiting||Phase 3|23|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 01:47:47.609508|2017-10-11 01:47:47.609508
NCT01835457|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-07-22|||February 2013||2013-02-01|March 2013|2013-03-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Concentration/Meditation Limits Inflammation|Concentration/Meditation as a Novel Means to Limit Inflammation: a Randomized Controlled Pilot Study|Completed||N/A|30|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-11 01:47:48.239098|2017-10-11 01:47:48.239098
NCT01835444|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-05-13|||April 2013||2013-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||A Multicenter Research on the Effects of Substitution of Hospital Ward Care From Medical Doctors to Physician Assistants|Worthy Assistants: Does Substituting Hospital Ward Care From Medical Residents to Physician Assistants Result in Cost Savings?|Completed||N/A|2382|Actual|Radboud University|||2||f||||f||||||||||2017-10-11 01:47:48.351236|2017-10-11 01:47:48.351236
NCT01835431|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-01-26|2015-10-13||October 2013||2013-10-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||The Full Analysis set (FAS) included all randomised subjects.|A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus|A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus|Completed||Phase 3|362|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:47:48.506003|2017-10-11 01:47:48.506003
NCT01835405|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-01-23|||February 20, 2013|Actual|2013-02-20|January 2017|2017-01-01|February 14, 2014|Actual|2014-02-14|February 14, 2014|Actual|2014-02-14||Interventional|||LiquiBand Versus Dermabond Versus Sutures for Closure of Surgical Wounds|A Prospective, Single-centre Study to Compare the Use of LiquiBand® Flex, Dermabond Advanced™ or Conventional Sutures for the Topical Closure of Surgical Wounds|Completed||N/A|66|Actual|Advanced Medical Solutions (Plymouth) Ltd||3|||f||||||||||||||2017-10-11 01:47:49.199158|2017-10-11 01:47:49.199158
NCT01835392|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-01-05|||September 2011||2011-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neuroprotective Effects of Remote Ischemic Preconditioning (RIPC) During Infant Cardiac Surgery|Neuroprotective Effects of Remote Ischemic Preconditioning (RIPC) During Infant Cardiac Surgery|Recruiting||N/A|150|Anticipated|Nemours Children's Clinic||2|||f||||f||||||||No||2017-10-11 01:47:49.27945|2017-10-11 01:47:49.27945
NCT01835379|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-01-20|2015-01-05||May 2013||2013-05-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of Oasis Ultra in Diabetic Foot Ulcers|A Randomized, Open Label Controlled Trial of OASIS® Ultra Tri-Layer Matrix Compared to Standard Care in the Healing of Diabetic Foot Ulcers|Completed||Phase 4|82|Actual|Healthpoint||2|||f||||f||||||||||2017-10-11 01:47:49.402494|2017-10-11 01:47:49.402494
NCT01835366|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-07-01|||November 2012||2012-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:47:50.013348|2017-10-11 01:47:50.013348
NCT01835353|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-09-20|||June 2012||2012-06-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)|High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)|Completed||Phase 3|82|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 01:47:50.074833|2017-10-11 01:47:50.074833
NCT01835340|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-17|||October 2012||2012-10-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological Procedures|Study to Estimate Central Propofol Effect by Measuring Exhaled Propofol Concentrations in Patients|Unknown status|Recruiting|N/A|30|Anticipated|University of Luebeck||1|||f||||f||||||||||2017-10-11 01:47:50.163334|2017-10-11 01:47:50.163334
NCT01835327|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-02-13|||September 2012|Actual|2012-09-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Cerebral Oxygen Monitoring During Surgery and Recovery After Surgery in Patients Having Lung Surgery|Cerebral Oximetry and Recovery Following Thoracic Surgery|Terminated||N/A|130|Actual|Icahn School of Medicine at Mount Sinai|||2|PI no longer at institution|f||||f||||||||||2017-10-11 01:47:50.270973|2017-10-11 01:47:50.270973
NCT01835314|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-04-03||||||December 2016|2016-12-01||||||||Expanded Access|||Compassionate Use of Stiripentol in Dravet Syndrome|Compassionate Use of Stiripentol in Dravet Syndrome|Available||N/A|||University of Colorado, Denver|||||||||||||||||||2017-10-11 01:47:50.37725|2017-10-11 01:47:50.37725
NCT01835301|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2014-08-08|||November 2011||2011-11-01|August 2014|2014-08-01||||December 2015|Anticipated|2015-12-01||Observational|||Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation|Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation|Unknown status|Active, not recruiting|N/A|40|Anticipated|Medstar Health Research Institute|||2||f||||f||||||||||2017-10-11 01:47:50.468164|2017-10-11 01:47:50.468164
NCT01835288|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2016-10-04|||May 2013||2013-05-01|October 2016|2016-10-01||||May 2015|Anticipated|2015-05-01||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase II Study of Arsenic Trioxide in Patients With Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Mutated Nucleophosmin 1 (NPM1) Gene|Withdrawn||Phase 2|0|Actual|Stanford University||1|||f||||||||||||||2017-10-11 01:47:50.530265|2017-10-11 01:47:50.530265
NCT01835275|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-03-10|||June 2012||2012-06-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Audio-enhanced Analgesia in Healthy Subjects|Audio-enhanced Analgesia in Healthy Subjects|Completed||N/A|60|Actual|Massachusetts General Hospital||3|||f||||f||||||||No||2017-10-11 01:47:50.623688|2017-10-11 01:47:50.623688
NCT01835262|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-01-29|2015-07-29||April 2013||2013-04-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Low Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department|Low Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department: A Prospective, Randomized, Double-Blind Study|Completed||Phase 4|90|Actual|Maimonides Medical Center|This was a single center study in which patients were enrolled as a convenience. There was the potential for unblinding as some participants exhibited ketamine specific reactions such as nystagmus.|2|||f||||f||||||||No||2017-10-11 01:47:50.712432|2017-10-11 01:47:50.712432
NCT01835249|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-05-01|||June 2013||2013-06-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT|Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure|Enrolling by invitation||N/A|600|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:47:50.941853|2017-10-11 01:47:50.941853
NCT01835236|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-07-04|||April 29, 2013|Actual|2013-04-29|July 2017|2017-07-01|November 30, 2019|Anticipated|2019-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Trastuzumab & Pertuzumab Followed by T-DM1 in MBC|A Randomized Phase II Trial of Pertuzumab in Combination With Trastuzumab With or Without Chemotherapy, Both Followed by T-DM1 in Case of Progression, in Patients With HER2-positive Metastatic Breast Cancer|Active, not recruiting||Phase 2|208|Actual|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||||2017-10-11 01:47:51.091873|2017-10-11 01:47:51.091873
NCT01835223|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-05-17|||July 11, 2013|Actual|2013-07-11|May 2017|2017-05-01|August 14, 2018|Anticipated|2018-08-14|May 16, 2017|Actual|2017-05-16||Interventional|||Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery|Multicenter Phase 1b/2 Study of Tivozanib in Patients With Advanced Inoperable Hepatocellular Carcinoma|Active, not recruiting||Phase 1/Phase 2|21|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 01:47:51.321081|2017-10-11 01:47:51.321081
NCT01835210|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-01-26|||August 2012||2012-08-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Observational|||Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life|Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life|Completed||N/A|60|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||||||||||||2017-10-11 01:47:51.410845|2017-10-11 01:47:51.410845
NCT01835197|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2014-06-19|||May 2013||2013-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects|A Phase 1, Within Cohort, Randomized, Double Blind, Third-Party Open, Placebo-Controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-04965842 In Healthy Western and Japanese Subjects|Completed||Phase 1|79|Actual|Pfizer||10|||f||||f||||||||||2017-10-11 01:47:51.482848|2017-10-11 01:47:51.482848
NCT01835184|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-09-23|||May 2013||2013-05-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery|Phase I Dose Escalation of the MET Inhibitor XL184 and the BRAF Inhibitor Vemurafenib|Terminated||Phase 1|5|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 01:47:53.2411|2017-10-11 01:47:53.2411
NCT01835158|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-09-29|||July 8, 2013|Actual|2013-07-08|September 2017|2017-09-01||||September 30, 2017|Anticipated|2017-09-30||Interventional|||Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer|Randomized Phase II Study Comparing Cabozantinib (NSC #761968) With Commercially Supplied Sunitinib in Patients With Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma|Active, not recruiting||Phase 2|150|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 01:47:53.422467|2017-10-11 01:47:53.422467
NCT01835145|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-09-13|||July 31, 2013|Actual|2013-07-31|September 2017|2017-09-01||||November 1, 2017|Anticipated|2017-11-01||Interventional|||Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery|Randomized Phase II Study Comparing the MET Inhibitor Cabozantinib to Temozolomide/Dacarbazine in Ocular Melanoma|Active, not recruiting||Phase 2|69|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 01:47:54.923251|2017-10-11 01:47:54.923251
NCT01835132|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-10-26|2015-07-28||March 2013||2013-03-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|July 2014|Actual|2014-07-01||Interventional|||Gevokizumab for Active Scleritis|Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)|Completed||Phase 1/Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||No||2017-10-11 01:47:55.644792|2017-10-11 01:47:55.644792
NCT01835119|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-17|||January 2012||2012-01-01|April 2013|2013-04-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Influence of Gum Chewing on Postoperative Bowel Activity After Complete Staging Surgery for Gynecological Malignancies|Influence of Gum Chewing on Postoperative Bowel Activity After Complete Staging Surgery for Gynecological Malignancies|Unknown status|Recruiting|Phase 4|152|Anticipated|Erzincan Military Hospital||2|||f||||t||||||||||2017-10-11 01:47:56.545288|2017-10-11 01:47:56.545288
NCT01835106|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-08-09|||April 2013||2013-04-01|August 2017|2017-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy of an Epidural Versus a Fascia Iliaca Compartment Catheter After Hip Surgery|A Prospective, Randomized, Double-blind, Placebo-controlled, Crossover Trial of Epidural Analgesia Versus a Surgically-placed Fascia Iliaca Compartment Catheter for Postoperative Pain After Periacetabular Osteotomy|Withdrawn||N/A|0|Actual|Boston Children’s Hospital||2||The study was proposed but never started due to other commitments|f||||||||||||||2017-10-11 01:47:56.622701|2017-10-11 01:47:56.622701
NCT01835093|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-02-19|||April 2013||2013-04-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)|Tipepidine for ADHD|Completed||Phase 2|10|Actual|Chiba University||1|||f||||||||||||||2017-10-11 01:47:56.708699|2017-10-11 01:47:56.708699
NCT01835080|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-06-27|||April 2013||2013-04-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|OSA in PAH||Obstructive Sleep Apnea in Pulmonary Arterial Hypertension (OSA in PAH)|Effect of Pulmonary Arterial Hypertension Treatment on Obstructive Sleep Apnea|Terminated||N/A|2|Actual|Inova Health Care Services|||1|low enrollment|f||||f||||||||||2017-10-11 01:47:56.793356|2017-10-11 01:47:56.793356
NCT01835067|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-01-22|||September 2013||2013-09-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|TAPAS||Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular Age-related Macular Degeneration|Intravitreal Tissue Plasminogen Activator (tPA) And Perfluoropropane (C3F8) for the Treatment of Neovascular Age-related Macular Degeneration With Associated Submacular Haemorrhage (TAPAS): a Multi-centre, Randomized, Double-masked, Sham-controlled, Factorial, Feasibility Study|Recruiting||Phase 2/Phase 3|55|Anticipated|King's College Hospital NHS Trust||4|||f||||f||||||||||2017-10-11 01:47:56.884326|2017-10-11 01:47:56.884326
NCT01835054|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-09-01|||December 2008||2008-12-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|PROGRAM||Determinants of the Progression and Outcome of Mitral Regurgitation|Determinants of the Progression and Outcome of Mitral Regurgitation-PROGRAM STUDY|Recruiting||N/A|440|Anticipated|Laval University|||1||f||||f||||||Samples With DNA|"     Fasting blood sample (serum, lithium-heparin, EDTA) and white cells - Tissue (explanted     mitral valves)   "|||2017-10-11 01:47:57.020195|2017-10-11 01:47:57.020195
NCT01835041|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-05-30|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer|A Phase I Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer and Good Performance Status|Active, not recruiting||Phase 1|21|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 01:47:57.175487|2017-10-11 01:47:57.175487
NCT01835028|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-09-01|||June 2002||2002-06-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis (TOPAS Study)|Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis (TOPAS Study Phase III)|Recruiting||N/A|320|Anticipated|Laval University|||2||f||||f||||||Samples Without DNA|"     Blood sample (lithium-heparin, EDTA), Tissue (explanted aortic valves)   "|||2017-10-11 01:47:57.283485|2017-10-11 01:47:57.283485
NCT01835015|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2016-02-24|2016-01-12||May 2013||2013-05-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||This analysis population includes all enrolled subjects who received CLG561.|Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration|A Multi-Center, Open-Label, Single Ascending Dose Study To Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal CLG561 in Subjects With Advanced Age-Related Macular Degeneration|Completed||Phase 1|50|Actual|Alcon Research||5|||f||||f||||||||||2017-10-11 01:47:57.614408|2017-10-11 01:47:57.614408
NCT01835002|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2015-09-07|||September 2012||2012-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2014|Actual|2014-07-01||Interventional|||Transcorneal Electrical Stimulation - Multicenter Safety Study|Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Multicenter Safety Study of the Okustim ® System|Completed||N/A|105|Actual|Okuvision GmbH||1|||f||||f||||||||||2017-10-11 01:47:59.209528|2017-10-11 01:47:59.209528
NCT01834989|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2017-02-07|||April 2013|Actual|2013-04-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|February 1, 2017|Actual|2017-02-01||Interventional|IGF-I||Patellar Tendinopathy - Effect of Training and Enhancement of the Collagen Synthesis by Insulin-like Growth Factor-I|Effect of Training and Local Infusion of Insulin-like Growth Factor-I and Training on Tendon Structure in Patients With Patellar Tendinopathy|Active, not recruiting||Early Phase 1|40|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 01:47:59.310068|2017-10-11 01:47:59.310068
NCT01834976|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2015-12-27|||November 2012||2012-11-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Cardiac Biomarker in Pediatric Heart Disease|Observational Study of Cardiac Biomarker During Perioperative Management in Pediatric Heart Disease|Completed||N/A|74|Actual|Okayama University|||1||f||||||||||Samples With DNA|"     serum,urine   "|||2017-10-11 01:47:59.398125|2017-10-11 01:47:59.398125
NCT01834950|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-06-08|||February 2013||2013-02-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|HERBIN||Identification of Early Markers of Response and Resistance to Trastuzumab|Identification of Early Markers of Response and Resistance to Trastuzumab in Patients With Localized Human Epidermal Growth Factor Receptor-2(HER-2)-Positive Breast Cancer Candidates for Breast Conserving Surgery|Recruiting||N/A|100|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 01:47:59.556587|2017-10-11 01:47:59.556587
NCT01834937|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-05-17|||June 2013||2013-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01|4 Months|Observational [Patient Registry]|BM019-Registry||ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain|A Post Approval Registry: ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain|Completed||N/A|17|Actual|InSightec|||1||f||||f||||||||||2017-10-11 01:47:59.647691|2017-10-11 01:47:59.647691
NCT01834924|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-06-09|||May 2010||2010-05-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Communication of Medication Instructions to Parents|Dissemination of a Health Literacy Intervention to Improve Provider-Patient Communication of Medication Instructions and Decrease Outpatient Pediatric Medication Errors|Active, not recruiting||N/A|17500|Anticipated|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 01:47:59.723987|2017-10-11 01:47:59.723987
NCT01834911|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-03-27|||March 2013||2013-03-01|March 2017|2017-03-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Effect of Tetrabenazine on Stroop Interference in HD|Effect of Tetrabenazine on Stroop Interference in Huntington Disease|Recruiting||Phase 4|10|Anticipated|New York Medical College||1|||f||||f||||||||||2017-10-11 01:47:59.804573|2017-10-11 01:47:59.804573
NCT01834898|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-16|||October 2010||2010-10-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery|Phase 4 Study, Open, Observational, to Evaluate the Safety and Tolerability of Hydrochloride Controlled-release Oxycodone in Moderate and Severe Postoperative Pain in Oncologic Head and Neck Surgery.|Completed||N/A|83|Actual|Instituto Nacional de Cancer, Brazil|||1||f||||t||||||||||2017-10-11 01:47:59.884103|2017-10-11 01:47:59.884103
NCT01834885|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-11-08|||December 2013||2013-12-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD|A 12-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 Compared to Fluticasone/Salmeterol in COPD Patients With Moderate to Severe Airflow Limitation|Withdrawn||Phase 3|0|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:47:59.972821|2017-10-11 01:47:59.972821
NCT01834859|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2016-10-25|||August 2013||2013-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Weight Loss Maintenance and Compensatory Mechanisms Activated With a Very-low Calorie Diet|How to Optimize Weight Loss Maintenance After a Very-low Calorie Diet?|Completed||N/A|100|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 01:48:00.347524|2017-10-11 01:48:00.347524
NCT01834833|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-06-13|||May 2013||2013-05-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|April 2017|Actual|2017-04-01||Interventional|CHIC||Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient|Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient.|Active, not recruiting||N/A|326|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-11 01:48:01.155669|2017-10-11 01:48:01.155669
NCT01834768|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-04-16|||February 2013||2013-02-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|April 2013|Anticipated|2013-04-01||Interventional|EpleCsAT||EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety|Study of the Safety of Eplerenone in Cyclosporine A-treated Transplant Recipients|Unknown status|Recruiting|Phase 2|31|Anticipated|CHU de Reims||1|||f||||t||||||||||2017-10-11 01:48:01.248087|2017-10-11 01:48:01.248087
NCT01834755|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-04-16|||February 2013||2013-02-01|April 2013|2013-04-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Physical and Psychological Profiles Associated With Patient's Preference for ESRD Treatment|Physical and Psychological Evaluation of Patients Reaching End Stage Renal Disease : Effects on the Choice of Renal Replacement Therapy|Unknown status|Recruiting|N/A|80|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 01:48:01.353868|2017-10-11 01:48:01.353868
NCT01834742|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-15|||April 2011||2011-04-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|OUT||Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects|Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects|Completed||Phase 1|161|Actual|Norgine||8|||f||||f||||||||||2017-10-11 01:48:01.45798|2017-10-11 01:48:01.45798
NCT01834729|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-07-18|||March 2013||2013-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions|Effect of Stress and a Alpha-1 Antagonist on Anorectal Functions|Active, not recruiting||Phase 2|72|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:48:01.578046|2017-10-11 01:48:01.578046
NCT01834716|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2015-04-07|||April 2013||2013-04-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study|Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study/ 18F-AV-45-A14 - CLINICAL EVALUATION OF FLORBETAPIR F 18 (18F-AV-45) Sponsor of 18F-AV-45-A14: Avid Radiopharmaceuticals|Completed||N/A|16|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 01:48:01.678701|2017-10-11 01:48:01.678701
NCT01834703|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-08-18|||May 2009||2009-05-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids|Randomized Controlled Trial of Uterine Artery Embolization (UAE) Versus High-Intensity-Focused-Ultrasound (HIFU) for Treatment of Patients With Uterine Fibroids|Terminated||N/A|85|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 01:48:01.773886|2017-10-11 01:48:01.773886
NCT01834690|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-02-15|||April 2013||2013-04-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Uses of Immunosuppression Therapy in Patients With Liver Transplantation|Trends of Immunosuppression Therapy and Their Effectiveness in Patients With Liver Transplantation|Completed||N/A|314|Actual|Chang Gung Memorial Hospital|||1||f||||f||||||None Retained|"     no biospecimens are to be retained   "|||2017-10-11 01:48:01.898874|2017-10-11 01:48:01.898874
NCT01834677|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2015-12-01|||April 2013||2013-04-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|TREC-MP||Translational Research Evaluating Neurocognitive Memory Processes|Translational Research Evaluating Neurocognitive Memory Processes|Completed||N/A|76|Actual|Duke University|||4||f||||f||||||||||2017-10-11 01:48:02.028524|2017-10-11 01:48:02.028524
NCT01834664|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2014-09-16|||March 2013||2013-03-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|BMACCP||Safety and Efficacy of Bone Marrow Derived Autologous Cells Treatment of Cerebral Palsy in Subjects Above 15 Years|Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Cerebral Palsy in Subjects Above Years (BMACCP) .It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Chaitanya Hospital, Pune||1|||f||||f||||||||||2017-10-11 01:48:02.145703|2017-10-11 01:48:02.145703
NCT01834651|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-08-31|2017-07-16||April 30, 2013|Actual|2013-04-30|August 2017|2017-08-01|July 18, 2016|Actual|2016-07-18|July 18, 2016|Actual|2016-07-18||Interventional|||A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases|A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases|Completed||Phase 2|17|Actual|Cedars-Sinai Medical Center||1|||f||||t|t|f||||||||2017-10-11 01:48:02.298869|2017-10-11 01:48:02.298869
NCT01833897|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-04-25|2016-03-17||March 2013||2013-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|July 2014|Actual|2014-07-01||Interventional|||NMDA Antagonists in Bipolar Depression|NMDA Antagonists in Bipolar Depression|Completed||Phase 4|8|Actual|New York State Psychiatric Institute|Limitations include the small-sample and a non-placebo controlled, open-label design.|1|||f||||f||||||||||2017-10-11 01:48:12.573896|2017-10-11 01:48:12.573896
NCT01834638|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-16|2014-10-27|||March 2013||2013-03-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|||Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)|Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855|Terminated||Phase 2|268|Actual|AbbVie||3||Study endpoint in preceding base study M10-855 not met.|f||||f||||||||||2017-10-11 01:48:02.870803|2017-10-11 01:48:02.870803
NCT01834625|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-03-21|||April 2013||2013-04-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Interventional|||Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement|Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement|Terminated||N/A|25|Anticipated|Mayo Clinic||2||not recruiting|f||||f||||||||||2017-10-11 01:48:03.296851|2017-10-11 01:48:03.296851
NCT01834612|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-04-17|||January 2013||2013-01-01|April 2013|2013-04-01||||July 2013|Anticipated|2013-07-01||Interventional|||Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw|Clinical Evaluation of the Zynex Blood Volume Monitor (CM1500) in Healthy Adult Volunteers During a Blood Draw|Unknown status|Recruiting|Phase 1|40|Anticipated|Zynex Monitoring Solutions||2|||f||||f||||||||||2017-10-11 01:48:03.374015|2017-10-11 01:48:03.374015
NCT01834599|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2016-04-14|||April 2013||2013-04-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Could the Cerebral Oximetry be a Good Technology to Measure Placental Oxygenation?|Could the Cerebral Oximetry (NIRS) be a Good Technology to Measure Placental Oxygenation in Pregnant Woman?|Completed||N/A|20|Actual|Maisonneuve-Rosemont Hospital|||1||f||||f||||||||||2017-10-11 01:48:03.467679|2017-10-11 01:48:03.467679
NCT01834586|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-11-02|||March 2013||2013-03-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|OUCH||Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications|Pilot Study of Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications (OUCH)|Completed||Phase 4|30|Actual|Brown, Theodore R., M.D., MPH||1|||f||||f||||||||Undecided||2017-10-11 01:48:03.556276|2017-10-11 01:48:03.556276
NCT01834573|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2013-12-22|||April 2013||2013-04-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Impact of Physical Exercise on Quality of Life in Patients With Inflammatory Bowel Disease - a Pilot Study.|Impact of Physical Exercise on Quality of Life in Patients With Inflammatory Bowel Disease - a Pilot Study.|Completed||N/A|36|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-11 01:48:03.672256|2017-10-11 01:48:03.672256
NCT01834560|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-05-13|||December 2007||2007-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Observational|CG25||SubGenual CG25 Deep Brain Stimulation in Severe Resistant Depression|Subgenual Cingulate Stimulation in Resistant Depression|Active, not recruiting||N/A|5|Actual|University Hospital, Grenoble|||1||f||||t||||||||||2017-10-11 01:48:03.750786|2017-10-11 01:48:03.750786
NCT01834547|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2013-04-17|||May 2011||2011-05-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|CHESS||Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players|Phase I Study About Effects of Caffeine, Methylphenidate, Modafinil and Placebo on Cognitive Performance of Chess Players.|Completed||Phase 1|40|Actual|Johannes Gutenberg University Mainz||4|||f||||t||||||||||2017-10-11 01:48:03.826759|2017-10-11 01:48:03.826759
NCT01834534|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-09-18|||September 2013||2013-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Telemonitoring Enhanced Support for Depression Self Management|Telemonitoring Enhanced Support for Depression Self Management|Enrolling by invitation||Phase 3|270|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-11 01:48:03.922719|2017-10-11 01:48:03.922719
NCT01834521|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-02-02|||January 2013||2013-01-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ENCOURAGE||Web-based Screening and Tailored Support|Web-based Screening and Tailored Support for Breast Cancer Patients at the Onset of the Survivorship Phase|Completed||N/A|128|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 01:48:04.129314|2017-10-11 01:48:04.129314
NCT01834508|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2014-06-17|||March 2013||2013-03-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|3E Ex||3E Extension Study|A 3-year, Open-lable, Multi-center Extension Trial of Entecavir Plus Adefovir Combination Treatment for Patients Previously Treated in EXPLORE, EXCEL and EFFORT Ex Study|Unknown status|Active, not recruiting|Phase 4|600|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||||2017-10-11 01:48:04.230596|2017-10-11 01:48:04.230596
NCT01834495|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-04-24|||October 2012|Actual|2012-10-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Balloon-Expandable Stent Versus Self-Expandable Stent for the Atherosclerotic ILIAC Arterial Disease|Phase 4 Study of Efficacy of Balloon-Expandable Cobalt Chromium SCUBA Stent Versus Self-Expandable Stent COMPLETE-SE Nitinol Stenting for the Atherosclerotic ILIAC Arterial Disease: Prospective, Multicenter, Randomized, Controlled Trial|Recruiting||N/A|280|Anticipated|Korea University Guro Hospital||2|||f||||t||||||||No||2017-10-11 01:48:04.387346|2017-10-11 01:48:04.387346
NCT01834482|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-03-12|||March 2013||2013-03-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Modified Atkins Diet Plus KetoCal for Adult Epilepsy|A Randomized, Open-label Evaluation of KetoCal® in Initial Combination With the Modified Atkins Diet for the Dietary Management of Intractable Adult Epilepsy.|Active, not recruiting||N/A|80|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:48:04.517574|2017-10-11 01:48:04.517574
NCT01834469|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2014-10-14|||March 2013||2013-03-01|July 2014|2014-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|OV-AP-ICG-IV||Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients|Feasibility Study of the (Intravenously Injected) Indocyanine Green (ICG) Imaging of Tumoral Implants in Patients With Peritoneal Carcinomatosis From Ovarian Carcinoma|Completed||Phase 1/Phase 2|10|Anticipated|Jules Bordet Institute||1|||f||||t||||||||||2017-10-11 01:48:04.643645|2017-10-11 01:48:04.643645
NCT01834456|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-11-30|||November 2011||2011-11-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Comprehensive Care of Children With Medical Complexity|Comprehensive Care of Children With Medical Complexity: Piloting an Innovative Model|Active, not recruiting||N/A|450|Anticipated|Seton Healthcare Family||2|||f||||t||||||||||2017-10-11 01:48:04.728217|2017-10-11 01:48:04.728217
NCT01834430|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2013-04-15|||February 2010||2010-02-01|April 2013|2013-04-01||||February 2012|Actual|2012-02-01||Interventional|||Effects of Delayed Enteral Nutrition on Inflammatory Responses and Immune Function Competence in Critically Ill Patients With Prolonged Fasting|Effects of Delayed Enteral Nutrition on Inflammatory Responses and Immune Function Competence in Critically Ill Patients With Prolonged Fasting|Completed||Phase 3|45|Actual|Nanjing PLA General Hospital||2|||f||||||||||||||2017-10-11 01:48:04.94423|2017-10-11 01:48:04.94423
NCT01834417|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-03-22|||April 2013||2013-04-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|PRESDIE||Preliminary Study Leading to Prevention of Pressure Ulcers by the Use of an On-board Device : Ergonomic Assessment of Wheelchair-seat Pressures in Spinal Cord Injured (SCI) Patients ( PRESDIE)|Preliminary Study Leading to Prevention of Pressure Ulcers by the Use of an On-board Device : Ergonomic Assessment of Wheelchair-seat Pressures in Spinal Cord Injured (SCI) Patients|Recruiting||N/A|90|Anticipated|Nantes University Hospital|||||f||||||||||||||2017-10-11 01:48:05.02608|2017-10-11 01:48:05.02608
NCT01834404|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-02-10|2015-01-20||April 2013||2013-04-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients|Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients|Completed||Phase 4|24|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:48:05.159733|2017-10-11 01:48:05.159733
NCT01834391|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-04-26|||March 2013||2013-03-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2013|Actual|2013-09-01||Observational|||Diagnosis of Subclinical Urinary Tract Infections Using Advanced Microbiome Survey Techniques in High Risk Trauma Patients|Diagnosis of Subclinical Urinary Tract Infections Using Advanced Microbiome Survey Techniques in High Risk Trauma Patients|Completed||N/A|129|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Urine   "|||2017-10-11 01:48:05.763217|2017-10-11 01:48:05.763217
NCT01834378|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2016-08-22|||October 2009||2009-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|DIAVIP||Diabetes Prevention in Clinical Practice.|Diabetes Prevention in Primary Health Care With Special Emphasis on Physical Activity.|Completed||N/A|96|Actual|Göteborg University||3|||f||||||||||||||2017-10-11 01:48:05.827919|2017-10-11 01:48:05.827919
NCT01834365|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-16|||October 2012||2012-10-01|April 2013|2013-04-01|May 2013|Anticipated|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Structured Education to Decrease Blood Pressure for Hypertension in Elderly|Effect of Structured Education to Decrease Blood Pressure for Hypertension in Elderly : a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|188|Actual|Indonesia University||3|||f||||f||||||||||2017-10-11 01:48:05.893065|2017-10-11 01:48:05.893065
NCT01834352|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-06-16|||November 2013||2013-11-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|WOIT||Walnut Oral Immunotherapy for Tree Nut Allergy|Walnut Oral Immunotherapy for Tree Nut Allergy|Withdrawn||Phase 1/Phase 2|0|Actual|University of North Carolina, Chapel Hill||2||Concern for cross contamination in weighing tree nuts in facility with peanuts|f||||t||||||||No||2017-10-11 01:48:05.97813|2017-10-11 01:48:05.97813
NCT01834339|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-11-16||2016-11-16|September 2013||2013-09-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional|||EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection|A Randomized, Parallel-Group (Autogenous EVPOME Versus AlloDerm Without Incorporation of Keratinocytes) Study in Subjects Reconstructed With Large Defect Mandibular Resection in Need of Vestibuloplasty for Dental Rehabilitation|Terminated||Phase 2|1|Actual|University of Michigan||2||Loss of cGMP facility to manufacture product used in clinical trial.|f||||t||||||||No||2017-10-11 01:48:06.053253|2017-10-11 01:48:06.053253
NCT01834326|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-11-17|||April 2014||2014-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Phase II Clinical Trial of Intraoral Grafting of Human Tissue Engineered Oral Mucosa|A Randomized, Parallel-group Autogenous ex Vivo Produced Oral Mucosa Equivalent vs. Palatal Oral Mucosa Safety and Efficacy Study in Subjects Requiring Additional Keratinized Oral Mucosa for Dental Implants|Recruiting||Phase 1/Phase 2|60|Anticipated|University of Michigan||2|||f||||t||||||||No||2017-10-11 01:48:06.13798|2017-10-11 01:48:06.13798
NCT01834313|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2013-07-22|||November 2012||2012-11-01|July 2013|2013-07-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Observational|||Willingness to Pay for Patient-centred Care|Identifying Patients' and Healht Insurers' Preferences Regarding Patient-centred Care by Determining Their Willingness-to-pay for Patient-centred Care|Unknown status|Recruiting|N/A|600|Anticipated|University Medical Center Nijmegen|||1||f||||f||||||||||2017-10-11 01:48:06.220836|2017-10-11 01:48:06.220836
NCT01834300|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2014-09-16|||February 2009||2009-02-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)|The Effects of Exercise Training on Visceral Fat, Insulin Sensitivity, β-cell Function and Triglyceride Kinetics in Patients With Non-alcoholic Fatty Liver Disease (NAFLD).|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Liverpool||2|||f||||t||||||||||2017-10-11 01:48:06.290454|2017-10-11 01:48:06.290454
NCT01834287|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-06-03|||December 2011||2011-12-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Pasos Hacia La Salud - Physical Activity Intervention for Latinas|Promoting Physical Activity in Latinas Via Interactive Web-Based Technology|Completed||N/A|207|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 01:48:06.39667|2017-10-11 01:48:06.39667
NCT01834274|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-08-26|2015-03-27||June 2013||2013-06-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||All randomized participants.|Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes|A Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, 24-Week Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 50 mg Compared With Sitagliptin 100 mg When Used in Combination With Metformin in Subjects With Type 2 Diabetes|Terminated||Phase 3|96|Actual|Takeda||2||Due to potential concerns about liver safety (See Detailed Description)|f||||t||||||||||2017-10-11 01:48:06.501822|2017-10-11 01:48:06.501822
NCT01834261|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-01-27|2016-04-28||April 2013||2013-04-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Includes only subjects who completed the study; i.e., received both oxytocin and placebo (19 at MIT and 20 at MGH).|Brain Dynamics of Oxytocin|Computational Modeling of Oxytocin in the Regulation of Trust|Completed||Phase 1|51|Actual|Stony Brook University|Data collection has been completed, but data analysis is ongoing.|2|||f||||t||||||||||2017-10-11 01:48:07.494494|2017-10-11 01:48:07.494494
NCT01834248|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-07-20|||July 30, 2013|Actual|2013-07-30|July 2017|2017-07-01|March 21, 2016|Actual|2016-03-21|June 9, 2015|Actual|2015-06-09||Interventional|||DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia|A Phase I Study of DEC205mAb-NY-ESO-1 Fusion Protein (CDX-1401) Given With Adjuvant PoIylCLC in Conjunction With 5-Aza-2'Deoxycytidine (Decitabine) in Patients With MDS or Low Blast Count AML|Completed||Phase 1|9|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 01:48:07.929184|2017-10-11 01:48:07.929184
NCT01834235|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-03-15|||April 2013||2013-04-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|March 13, 2017|Actual|2017-03-13||Interventional|||QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer|A Multicenter Phase I/II Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel With or Without NPC-1C in Patients With Metastatic or Locally Advanced Pancreatic Cancer Previously Treated With FOLFIRINOX|Active, not recruiting||Phase 1/Phase 2|81|Actual|Precision Biologics, Inc||2|||f||||f||||||||||2017-10-11 01:48:08.058641|2017-10-11 01:48:08.058641
NCT01834222|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-03-06|2017-03-06||December 2013||2013-12-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational||Safety analysis set included all participants who received at least 1 dose of Prevenar 13.|Post Market Surveillance to Observe Safety of Prevenar13™ in Adults|Post Marketing Surveillance To Observe Safety Of Prevenar 13 In Adults|Completed||N/A|659|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:48:08.211646|2017-10-11 01:48:08.211646
NCT01834209|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2015-10-02|||June 2013||2013-06-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer|Open-Label Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Subjects With Metastatic Castration-Resistant Prostate Cancer|Completed||Phase 3|19|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 01:48:08.609195|2017-10-11 01:48:08.609195
NCT01834196|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-03-20|||August 2012||2012-08-01|February 2015|2015-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|SWEPT||Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging|Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging|Terminated||N/A|13|Actual|Duke University||1||No active study enrollment for a 2 years.|f||||f||||||||||2017-10-11 01:48:08.758|2017-10-11 01:48:08.758
NCT01834183|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2013-06-17|||June 2013||2013-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Tivozanib + Gemcitabine in Metastatic RCC|A Phase II and Biomarker Study of Tivozanib With Gemcitabine Addition Upon Progression in Patients With Metastatic Refractory Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|Dana-Farber Cancer Institute||1||Sponsor Aveo has withdrawn support for this trial.|f||||t||||||||||2017-10-11 01:48:08.850918|2017-10-11 01:48:08.850918
NCT01834170|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2014-12-01|||April 2013||2013-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer|EUS-guided Intratumoral Gemcitabine Therapy in Locally Advanced Unresectable Pancreatic Cancer: A Phase 1 Study|Completed||Phase 1|12|Actual|University of Tehran||1|||f||||t||||||||||2017-10-11 01:48:08.949584|2017-10-11 01:48:08.949584
NCT01834157|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-12-21|||April 2013||2013-04-01|December 2015|2015-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01|12 Months|Observational [Patient Registry]|||Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis|"The DeSScipher Project - to Decipher the Best Treatment for Systemic Sclerosis - Observational Trial 2: Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis"|Recruiting||N/A|160|Anticipated|University of Pecs|||7||f||||f||||||||||2017-10-11 01:48:09.050127|2017-10-11 01:48:09.050127
NCT01834144|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-09-02|||May 2013||2013-05-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|January 2018|Anticipated|2018-01-01||Interventional|VIGOR||The VIGORous Physical Activity for Glycaemic Control in Type 1 Diabetes (VIGOR) Trial|The VIGORous Physical Activity for Glycaemic Control in Type 1 Diabetes (VIGOR) Trial|Active, not recruiting||Phase 4|70|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-11 01:48:09.262609|2017-10-11 01:48:09.262609
NCT01834131|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2017-07-12|||June 2013||2013-06-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Hypertension Control Program in Argentina (HCPIA)|Comprehensive Approach for Hypertension Prevention and Control in Argentina|Completed||N/A|1954|Actual|Tulane University||2|||f||||f||||||||||2017-10-11 01:48:09.361842|2017-10-11 01:48:09.361842
NCT01834118|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2016-07-27|||June 2013||2013-06-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|1 Year|Observational [Patient Registry]|RETREAT||Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension|Reintervention After Previous Renal Denervation in Non-responding Patients With Severe Hypertension|Completed||N/A|10|Actual|Cardiovascular Center Frankfurt|||1||f||||f||||||||||2017-10-11 01:48:09.464789|2017-10-11 01:48:09.464789
NCT01834105|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2013-04-17|||January 2012||2012-01-01|April 2013|2013-04-01||||December 2014|Anticipated|2014-12-01||Interventional|pop||Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1|Study on the Molecular Mechanism of Postmenopausal Osteoporosis With Kidney Yin Deficiency Syndrome From CLCF1 Interventing on JAK-STAT Signaling Pathways|Unknown status|Recruiting|Phase 2|25|Anticipated|Fujian Academy of Traditional Chinese Medicine||1|||f||||t||||||||||2017-10-11 01:48:09.543716|2017-10-11 01:48:09.543716
NCT01834092|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2013-04-16|||April 2013||2013-04-01|April 2013|2013-04-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|Endo_eAAA||Study of the Glycocalyx in Abdominal Aortic Aneurysm|Measurement of the Endothelial Function in Patients With a Abdominal Aortic Aneurism.|Unknown status|Recruiting|N/A|50|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:48:09.64084|2017-10-11 01:48:09.64084
NCT01834079|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|OND||Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease|Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|24|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:48:09.767011|2017-10-11 01:48:09.767011
NCT01833091|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-12|||April 2012||2012-04-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Creating an Artificial Night on Physiological Changes in Preterm Infants||Completed||Phase 2/Phase 3|38|Actual|Mashhad University of Medical Sciences||2|||f||||||||||||||2017-10-11 01:48:24.918051|2017-10-11 01:48:24.918051
NCT01834066|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|mdp||Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.|Safety and Efficacy of Bone Marrow Autologous Cells in Muscular Dystrophy. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|25|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:48:09.9017|2017-10-11 01:48:09.9017
NCT01834053|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|BMACHC||Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.|Safety and Efficacy of Bone Marrow Derived MNCs for the Treatment of Huntingtons Chorea. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:48:10.015404|2017-10-11 01:48:10.015404
NCT01834040|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|BMMNC||Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy|Study Safety and Efficacy of of AUTOLOGOUS Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) for the Patient With Duchenne Muscular Dystrophy. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:48:10.299534|2017-10-11 01:48:10.299534
NCT01834027|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-03-17|2014-07-10||March 2013||2013-03-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||The statistical plan and sample size justification were based on the results of a previous study (Nilsson, U. Heart Lung 2009;38(3):201-207) comparing the change in heart rate from pre- to post-surgery between a music and control group.|The Effect of Jazz on Postoperative Pain and Stress in Patients Undergoing Elective Hysterectomy|The Effect of Jazz on Postoperative Pain and Stress in Patients Undergoing Elective Hysterectomy|Completed||N/A|56|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 01:48:10.425275|2017-10-11 01:48:10.425275
NCT01834014|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2017-08-01|||May 2013||2013-05-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|ATOM ES||Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases|An Exploratory Study to Evaluate Biomarkers as Predictive and /or Prognostic Factors of Benefit From Randomized Phase ll Study of mFOLFOX6+Bevacizumab or mFOLFOX6+Cetuximab in Liver Only Metastasis From KRAS Wild Type Colorectal Cancer|Completed||N/A|110|Actual|EPS Corporation||2|||f||||t||||||||||2017-10-11 01:48:10.80054|2017-10-11 01:48:10.80054
NCT01834001|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2017-06-30|||April 8, 2013||2013-04-08|April 5, 2017|2017-04-05|February 25, 2021|Anticipated|2021-02-25|February 25, 2020|Anticipated|2020-02-25||Observational|||Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy|Evaluation of Local Response of Prostate Cancer to Irradiation Using Multiparametric MRI and MR-Guided Biopsies|Recruiting||N/A|190|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:48:10.91821|2017-10-11 01:48:10.91821
NCT01833988|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2017-08-10|2015-09-10||April 2013||2013-04-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|August 2013|Actual|2013-08-01||Interventional||Cross over design, 16 participants in each arm and then switched to second arm after a 1 day washout period.|The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas|The Summer Camp Study: Feasibility of Outpatient Automated Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas in a Pediatric Population at the Clara Barton Diabetes Camps|Completed||N/A|32|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 01:48:11.06458|2017-10-11 01:48:11.06458
NCT01833975|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|SCI||Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury|Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury . It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:48:12.090282|2017-10-11 01:48:12.090282
NCT01833962|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-04-20|||January 2013||2013-01-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|||A Retrospective Study of Actifuse Synthetic Bone Graft Versus Other Bone Graft Substitutes in Patients Requiring Lumbar Fusion|A Retrospective Study of Actifuse Synthetic Bone Graft Versus Other Bone Graft Substitutes in Patients Requiring Lumbar Fusion|Unknown status|Active, not recruiting|N/A|100|Anticipated|OrthoGeorgia|||1||f||||t||||||||||2017-10-11 01:48:12.175937|2017-10-11 01:48:12.175937
NCT01833949|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-13|||September 2009||2009-09-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Unilateral Laparoscopic Diathermy Adjusted to Ovarian Volume|This Prospective Longitudinal Cohort Study Included Infertile Women With PCOS Unresponsive to Clomiphene Citrate Treatment, Who Underwent Either Unilateral (ULOD) or Bilateral (BLOD)Laparoscopic Diathermy|Completed||N/A|96|Actual|KBC Split||2|||f||||t||||||||||2017-10-11 01:48:12.253592|2017-10-11 01:48:12.253592
NCT01833936|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-04-11|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|September 22, 2016|Actual|2016-09-22|September 22, 2016|Actual|2016-09-22||Interventional|E-Stim||E-Stim and Achilles Tendon Repair Study|The Use of Electrical Stimulation on Muscle Cross Sectional Area and Muscle Fascicle Length Following Postoperative Achilles Tendon Repair|Completed||N/A|40|Actual|Orthopedic Foot and Ankle Center, Ohio||2|||f||||f||||||||||2017-10-11 01:48:12.322402|2017-10-11 01:48:12.322402
NCT01833923|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2015-10-27|||May 2011||2011-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ALTN||A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics|A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics|Completed||Phase 1|35|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||t||||||||||2017-10-11 01:48:12.406267|2017-10-11 01:48:12.406267
NCT01833910|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2014-12-08|||October 2012||2012-10-01|February 2013|2013-02-01|October 2014|Actual|2014-10-01|April 2013|Actual|2013-04-01||Interventional|||A Mannequin Study to Assess Various CPR Training Methods Using a Student Population|A Mannequin Study to Assess Various CPR Training Methods Using a Student Population|Completed||N/A|25|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 01:48:12.485544|2017-10-11 01:48:12.485544
NCT01833078|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-09-09|2014-09-12||February 2013||2013-02-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|GRD||Ghrelin Repeated Dose Study|Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study|Completed||Phase 2|5|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 01:48:24.984324|2017-10-11 01:48:24.984324
NCT01833884|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-07-19|||April 2010||2010-04-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|CYTOKINES-LH||Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic|Hodgkin's Lymphoma: Prognostic Value of the Kinetic of Decrease of 5 Cytokines Concentration During Treatment|Completed||N/A|50|Actual|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-11 01:48:13.036594|2017-10-11 01:48:13.036594
NCT01833845|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2014-08-27|2014-07-30||April 2013||2013-04-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||40 subjects were planned to be included in the study; however, due to the Sponsor's decision, the study was terminated prematurely after 4 subjects had completed the study, due to failure to recruit subjects|Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C|An Open-Label Study to Evaluate the Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C|Terminated||Phase 1/Phase 2|4|Actual|BioLineRx, Ltd.||1||due to failure to recruit subjects|f||||f||||||||||2017-10-11 01:48:14.163132|2017-10-11 01:48:14.163132
NCT01833819|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-11-12|||June 2012||2012-06-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Anesthesia With Propofol, Dexmedetomidine and Lidocaine Infusions for Laparoscopic Cholecystectomy|Opioid-free Total Intravenous Anesthesia With Propofol, Dexmedetomidine and Lidocaine Infusions for Laparoscopic Cholecystectomy; Comparison With Propofol, Remifentanil Infusions|Completed||Phase 4|80|Actual|Bezmialem Vakif University||2|||f||||f||||||||||2017-10-11 01:48:14.601207|2017-10-11 01:48:14.601207
NCT01833806|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-09-05|||September 2013||2013-09-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain|A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain|Recruiting||N/A|70|Anticipated|InSightec||1|||f||||f||||||||||2017-10-11 01:48:14.745014|2017-10-11 01:48:14.745014
NCT01833793|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-09-10|||February 2013||2013-02-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Observational|MARILIA||Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice|Mirena and Amenorrhea Related acceptabILity in Contraception indIcAtion|Completed||N/A|35|Actual|Bayer|||1||f||||t||||||||||2017-10-11 01:48:14.909428|2017-10-11 01:48:14.909428
NCT01833780|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-17|||May 2013||2013-05-01|April 2013|2013-04-01||||December 2013|Anticipated|2013-12-01|2 Years|Observational [Patient Registry]|||Effectiveness of Intrapartum Group B Streptococcus (GBS) Polimerase Chain Reaction Reaction (PCR) Screening||Unknown status|Not yet recruiting|N/A|||The Baruch Padeh Medical Center, Poriya|||2||f||||||||||||||2017-10-11 01:48:15.017135|2017-10-11 01:48:15.017135
NCT01833767|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2017-08-22|||October 2012||2012-10-01|August 2017|2017-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma|Phase 2 Trial of T-cell Based Low-dose Cyclophosphamide and Outpatient Intravenous Interleukin-2 in Metastatic Melanoma|Withdrawn||Phase 2|0|Actual|Western Regional Medical Center||1||No participants enrolled|f||||f||||||||||2017-10-11 01:48:15.09712|2017-10-11 01:48:15.09712
NCT01833754|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2017-06-07|||April 22, 2013|Actual|2013-04-22|June 2017|2017-06-01|February 19, 2014|Actual|2014-02-19|February 19, 2014|Actual|2014-02-19||Interventional|||Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis|A Phase 1, Open-label, Single-dose Study of Romosozumab (AMG 785) Administered Subcutaneously to Healthy Subjects and Subjects With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis|Completed||Phase 1|24|Actual|Amgen||3|||f||||f||||||||||2017-10-11 01:48:15.23085|2017-10-11 01:48:15.23085
NCT01833741|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-15|2013-09-24|2013-07-09||December 2009||2009-12-01|September 2013|2013-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study of LUMIGAN® RC in the Clinical Setting||Completed||Phase 4|1137|Actual|Allergan||1|||f||||f||||||||||2017-10-11 01:48:15.352732|2017-10-11 01:48:15.352732
NCT01833728|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-14|2014-02-17|||April 2013||2013-04-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy||Completed||N/A|16|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:48:15.755192|2017-10-11 01:48:15.755192
NCT01833715|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2017-04-22|||March 2013|Actual|2013-03-01|April 2017|2017-04-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy Methadone for Management Postoperative Pain After the Use of Anesthesia Intravenous in Laparoscopic Cholecystectomy|Efficacy Methadone for Management Postoperative Pain After the Use of Anesthesia Intravenous in Laparoscopic Cholecystectomy|Completed||N/A|86|Actual|Universidad de Valparaiso||2|||f||||t|f|f||||||No||2017-10-11 01:48:15.834827|2017-10-11 01:48:15.834827
NCT01833702|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-13|2017-07-27|||January 2015||2015-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|SMART||Use of a Mobile-based App for SCD Patients|Use of a Mobile-based Pain Assessment Application for SCD Patients|Recruiting||N/A|100|Anticipated|Duke University|||2||f||||f||||||||||2017-10-11 01:48:15.918775|2017-10-11 01:48:15.918775
NCT01833676|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2013-12-04|||March 2012||2012-03-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||To Compare Effect of Sevoflurane Versus Desflurane on the Return of Swallowing Reflexes in the Elderly|To Compare Effect of Sevoflurane Versus Desflurane on the Return of Protective Airway Reflexes in the Elderly Population|Completed||Phase 4|51|Actual|University of Malaya||2|||f||||f||||||||||2017-10-11 01:48:16.123147|2017-10-11 01:48:16.123147
NCT01833663|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-03-19|||October 2011||2011-10-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|OAB||Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women|Multi-site, Randomized, Opened and Controlled Comparison Study on the Effectiveness and Safety of Solifenacin Succinate Tablets and Solifenacin Succinate Tablets + Estrogen for Overactive Bladder in the Post-menopausal Women|Completed||Phase 4|200|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 01:48:16.245826|2017-10-11 01:48:16.245826
NCT01833650|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-02-09|||May 2013||2013-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer|A Randomized Controlled Trial of the Effectiveness of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer|Recruiting||N/A|120|Anticipated|Cyprus University of Technology||4|||f||||t||||||||||2017-10-11 01:48:16.365709|2017-10-11 01:48:16.365709
NCT01833637|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-07-13|||October 2012||2012-10-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Electronic Patient Reported Symptom Assessment|Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.|Completed||N/A|6|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 01:48:16.487648|2017-10-11 01:48:16.487648
NCT01833624|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2016-08-04|||June 2012||2012-06-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|NUTRI_REA||Efficiency of a Small-peptide Enteral Feeding Formula Compared to a Whole-protein Formula|Efficiency and Tolerance of a Small-peptide Enteral Feeding Formula Compared to a Whole-protein Formula in the Critically Ill Patient : a Prospective Randomized Trial|Recruiting||Phase 4|206|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-11 01:48:16.595171|2017-10-11 01:48:16.595171
NCT01833611|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-04-14|||September 2008||2008-09-01|April 2013|2013-04-01|May 2015|Anticipated|2015-05-01|November 2014|Anticipated|2014-11-01||Interventional|||Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT|Phase IV Study of the Efficacy of Entecavir in Patients With Chronic Hepatitis B Virus Infection and Persistently Normal Alanine Aminotransferase|Unknown status|Active, not recruiting|Phase 4|130|Anticipated|National Cheng-Kung University Hospital||2|||f||||t||||||||||2017-10-11 01:48:16.716948|2017-10-11 01:48:16.716948
NCT01833598|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2017-04-10|||September 2012||2012-09-01|November 2016|2016-11-01||||June 2018|Anticipated|2018-06-01||Interventional|||Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis|The Efficacy of Ultrasound Guided Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis|Recruiting||N/A|86|Anticipated|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-11 01:48:17.0306|2017-10-11 01:48:17.0306
NCT01833585|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-03-31|||April 2013||2013-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells|Pilot Study of Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells|Recruiting||Phase 3|10|Anticipated|Mahidol University||1|||f||||f||||||||||2017-10-11 01:48:17.174993|2017-10-11 01:48:17.174993
NCT01833572|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-05-27|||May 2013||2013-05-01|May 2013|2013-05-01||||December 2014|Anticipated|2014-12-01||Interventional|||Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC|A Single-arm, Phase II Study of Preoperative Gefitinib for Stage II-IIIa NSCLC With Activating EGFR Mutation|Unknown status|Recruiting|Phase 2|42|Anticipated|Fudan University||1|||f||||||||||||||2017-10-11 01:48:17.292723|2017-10-11 01:48:17.292723
NCT01833559|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-03-16|||June 2012||2012-06-01|March 2014|2014-03-01|August 2021|Anticipated|2021-08-01|May 2021|Anticipated|2021-05-01||Interventional|||Impact of Blood Glucose at the First Trimester of Pregnant Women With Gestational Diabetes on Maternal and Fetal Outcomes and Metabolic Disorders: a Multi-central Prospective Cohort Study|Impact of Blood Glucose at the First Trimester of Pregnant Women With Gestational Diabetes on Maternal and Fetal Outcomes and Metabolic Disorders: a Multi-central Prospective Cohort Study|Recruiting||N/A|3|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||3|||f||||t||||||||||2017-10-11 01:48:17.408506|2017-10-11 01:48:17.408506
NCT01833546|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-11-16|||April 2013||2013-04-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer|A Japanese Single Center, Open-label, Phase I Trial of TH-302 Given Intravenously to Subjects With Solid Tumors as Monotherapy or to Subjects With Advanced Pancreatic Cancer in Combination With Gemcitabine|Completed||Phase 1|20|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-11 01:48:17.527914|2017-10-11 01:48:17.527914
NCT01833533|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-09-04|2014-12-23||March 2013||2013-03-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional|PEARL-IV||A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection|A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in Treatment-Naïve Adults With Genotype 1a Chronic Hepatitis C Virus (HCV) Infection (PEARL-IV)|Completed||Phase 3|305|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 01:48:17.654275|2017-10-11 01:48:17.654275
NCT01833520|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-10-17|||October 2013||2013-10-01|October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|||Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma|Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma|Active, not recruiting||Phase 1/Phase 2|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:48:18.052444|2017-10-11 01:48:18.052444
NCT01833507|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-01-13|||April 2013||2013-04-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|PAHO||Physical Activity and Health Outcomes|Relationship Between Physical Activity and Health Outcomes in Overweight and Obese Medically Complex Adults, a Randomized Trial|Completed||Phase 2/Phase 3|130|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:48:18.144066|2017-10-11 01:48:18.144066
NCT01833481|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-10-31|2014-10-31||June 2013||2013-06-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|THA||THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches|In Vivo Determination of THA Kinematics and Sound for Subject Implanted Using Various Surgical Approaches|Completed||N/A|30|Actual|The University of Tennessee, Knoxville|||3||f||||f||||||||||2017-10-11 01:48:18.292503|2017-10-11 01:48:18.292503
NCT01833468|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-16|||February 2013||2013-02-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Functional Limitations Due To The Foot Involvement In Spondyloarthritis|FUNCTIONAL LIMITATIONS DUE TO the FOOT INVOLVEMENT IN SPONDYLOARTHRITIS|Completed||N/A|30|Actual|Vakif Gureba Training and Research Hospital|||1||f||||f||||||||||2017-10-11 01:48:18.642143|2017-10-11 01:48:18.642143
NCT01833455|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-05-12|||February 2013||2013-02-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Premature Ventricular Contractions (PVCs) and Blood Pressure Control|The Effects of PVC Suppression on Blood Pressure Control in Patients With Frequent PVCs|Recruiting||N/A|66|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 01:48:18.698847|2017-10-11 01:48:18.698847
NCT01833429|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-12|||September 2011||2011-09-01|February 2012|2012-02-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01|10 Months|Observational [Patient Registry]|RH||Autonomic Dysfunction in Resistant Hypertension|Circadian Autonomic Disturbances in Resistant Hypertension With and Without White-coat Phenomenon|Completed||N/A|44|Actual|University of Campinas, Brazil|||1||f||||f||||||||||2017-10-11 01:48:18.872436|2017-10-11 01:48:18.872436
NCT01833416|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-03-20|||April 2013||2013-04-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Observational|||Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients|Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients|Completed||N/A|150|Actual|Hospital do Rim e Hipertensão|||1||f||||f||||||||||2017-10-11 01:48:18.941531|2017-10-11 01:48:18.941531
NCT01833403|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-03-22|2015-05-29||April 2013||2013-04-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Metabolomic Analysis of Hepatic Insulin Resistance|Metabolomic Analysis of Hepatic Insulin Resistance|Completed||N/A|4|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f|f|f||||||No|Data too small (n=4) to be shared publicly, although we will share deidentified data upon case-by-case request|2017-10-11 01:48:20.877282|2017-10-11 01:48:20.877282
NCT01833390|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-03-10|||September 2011||2011-09-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|HXe-VENT||MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects|Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation|Completed||Phase 2|58|Actual|Xemed LLC||1|||f||||f||||||||||2017-10-11 01:48:21.070496|2017-10-11 01:48:21.070496
NCT01833377|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-04-15|||September 2012||2012-09-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Consumption of Caraway on Treatment of Obesity|Caraway Intake as a Sustainable Dietary Practice: Impact on Overweight & Obese Women|Completed||N/A|120|Actual|University of Malaya||2|||f||||t||||||||||2017-10-11 01:48:21.149162|2017-10-11 01:48:21.149162
NCT01833364|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-03-08|||April 2013||2013-04-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Autologous Peripheral Nerve Grafts Into the Substantia Nigra of Subjects With PD Undergoing Deep Brain Stimulation|A Pilot Study to Evaluate the Safety and Feasibility of Implanting Autologous Peripheral Nerve Grafts Into the Substantia Nigra of Subjects With Parkinson's Disease Undergoing Deep Brain Stimulation Surgery and Treatment|Completed||N/A|8|Actual|University of Kentucky||1|||f||||t||||||||||2017-10-11 01:48:21.233913|2017-10-11 01:48:21.233913
NCT01833351|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-11-05|||May 2011||2011-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of Intravenous Ascorbic Acid|Pharmacokinetic Evaluation of Intravenous Ascorbic Acid|Completed||Phase 1|34|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 01:48:21.313415|2017-10-11 01:48:21.313415
NCT01833338|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-09-10|||June 2011||2011-06-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Non-invasive and Invasive Plaque Characterisation|Coronary Artery Plaque Characterisation With Non-invasive Multi-Slice Computed Tomography and Invasive Intravascular Ultrasound and Optical Coherence Tomography in Patients With Acute Coronary Syndromes Without ST-segment Elevation|Terminated||N/A|30|Actual|University Medical Center Groningen||1||The study was terminated based on an included stopping rule in the study protocol|f||||f||||||||||2017-10-11 01:48:21.404218|2017-10-11 01:48:21.404218
NCT01833325|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-08-10|||May 2013||2013-05-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Proton Radiation Therapy for Macular Degeneration|A Pilot Study to Assess the Safety of Proton Therapy for Subfoveal Neovascularization Associated With Age-Related Macular Degeneration|Active, not recruiting||N/A|10|Anticipated|University of Florida||1|||f||||t|f|f||||||||2017-10-11 01:48:21.476135|2017-10-11 01:48:21.476135
NCT01833312|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-11-03|||July 2013||2013-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|EuroHYP-1||Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke|EuroHYP-1: European Multicentre, Randomised, Phase III Clinical Trial of Therapeutic Hypothermia Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke|Recruiting||Phase 3|800|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 01:48:21.574199|2017-10-11 01:48:21.574199
NCT01833299|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2013-04-12|||January 2010||2010-01-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma|Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|120|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:48:21.672021|2017-10-11 01:48:21.672021
NCT01833286|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-12|||July 2013||2013-07-01|April 2013|2013-04-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|TACE-RFA||TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma|Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Re-resection for Recurrent Hepatocellular Carcinoma|Not yet recruiting||Phase 3|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:48:21.957967|2017-10-11 01:48:21.957967
NCT01833273|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-22|2016-06-02|||July 2010||2010-07-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|October 2013|Actual|2013-10-01||Interventional|DESSTINI_A||Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA|Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA|Completed||Phase 1|13|Actual|Stony Brook University||1|||f||||t||||||||||2017-10-11 01:48:22.094023|2017-10-11 01:48:22.094023
NCT01833260|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-07-17|||May 2013||2013-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Music and Perceived Rate of Exertion|Influence of a Distractive Auditory Stimulus on the Rate of Exertion During Pulmonary Rehabilitation Sessions|Completed||N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 01:48:22.179574|2017-10-11 01:48:22.179574
NCT01833247|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-05-03|2016-04-12||July 2012||2012-07-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational||Patients with epilepsy in hospital for video-EEG recording|Lactic Acidosis During and After Seizures|Lactic Acidosis During and After Seizures|Completed||N/A|12|Actual|Stanford University|Salivary lactic acid levels were difficult to reliably obtain with commercial devices designed to measure blood salivary levels. Because of low reliability, we did not pursue the study.||1||f||||f||||||||Yes|If subjects wish to know their lactic acid levels after a seizure, we will provide the information, although it currently has no therapeutic or prognostic implications.|2017-10-11 01:48:22.269306|2017-10-11 01:48:22.269306
NCT01833234|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-04-12|||July 2012||2012-07-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Epilepsy Impact Scale|Questionnaire Development for a Comprehensive Scale to Measure the Impact of Epilepsy on Life.|Completed||N/A|51|Actual|Stanford University|||1||f||||f||||||||||2017-10-11 01:48:22.546588|2017-10-11 01:48:22.546588
NCT01833221|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-05-24|||April 2013||2013-04-01|April 2014|2014-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|FacialReinn||Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty|Study of the Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty|Terminated||Phase 4|10|Actual|University Hospital, Caen||1||The study reach enough significance at the intermediary analysis|f||||f||||||||||2017-10-11 01:48:22.645867|2017-10-11 01:48:22.645867
NCT01833208|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-04-24|||July 3, 2013|Actual|2013-07-03|April 2017|2017-04-01|December 5, 2018|Anticipated|2018-12-05|December 5, 2017|Anticipated|2017-12-05||Interventional|||Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T|Pilot: Impact of High-Dose, Single Fraction Radiation on Immunogenicity of Sipuleucel-T in Metastatic Castration Recurrent Prostate Cancer Patients|Recruiting||N/A|15|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 01:48:22.744041|2017-10-11 01:48:22.744041
NCT01833195|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-08-10|||March 2013||2013-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|OAR||Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing|Outcomes AlloMap Registry Study: the Clinical Long-term Management and Outcomes of Heart Transplant Recipients With Regular Rejection Surveillance Including Use of AlloMap Gene-expression Profiling Testing|Recruiting||N/A|2000|Anticipated|CareDx|||1||f||||f||||||Samples Without DNA|"     RNA isolated from peripheral blood mononuclear cells (PBMC)   "|||2017-10-11 01:48:22.876377|2017-10-11 01:48:22.876377
NCT01833182|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-12-01|||May 2010||2010-05-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|ADL||The Effectiveness of a Fall Prevention Program|The Effectiveness of a Fall Prevention Program|Completed||N/A|129|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:48:23.133288|2017-10-11 01:48:23.133288
NCT01833156|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-06-09|||March 2013||2013-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Validation of the MoistureMeterD in Local Edema by Histamine|A Clinimetric Research to Test the Validity of the MoistureMeterD, Conducted by the Local Edema (Urticaria Acuta) Into the Administering of Intradermal Histamine.|Completed||N/A|25|Actual|Nij Smellinghe Hosptial||1|||f||||f||||||||||2017-10-11 01:48:23.398467|2017-10-11 01:48:23.398467
NCT01833143|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-05-05|||April 2013||2013-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D|A Phase 2 Trial of Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D|Active, not recruiting||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:48:23.478322|2017-10-11 01:48:23.478322
NCT01833130|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-09-18|2015-09-18||April 2013||2013-04-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Intent-to-Treat Population: all randomized patients (7 patients were withdrawn from the study due to a randomization error and excluded from the Intent-to-Treat population)|Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®)||Completed||Phase 4|52|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:48:23.740702|2017-10-11 01:48:23.740702
NCT01833117|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2014-06-27|2014-05-29||May 2013||2013-05-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||This analysis group includes all randomized participants who received study medication.|Efficacy and Safety Study of FID 119515A|A Randomized, Observer-Masked, Efficacy and Safety Study of FID 119515A in Dry Eye|Completed||N/A|75|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:48:24.444813|2017-10-11 01:48:24.444813
NCT01833104|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-12-13|||January 2013||2013-01-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Plasticity of the Compassionate Brain|A Longitudinal Study on the Trainability of Socio-affective and Cognitive Functions and Abilities.|Completed||N/A|332|Actual|Max Planck Institute for Human Cognitive and Brain Sciences||5|||f||||f||||||||||2017-10-11 01:48:24.697689|2017-10-11 01:48:24.697689
NCT01833065|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2015-09-22|2015-07-17|2015-03-16|April 2013||2013-04-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional||Intention-to-treat (ITT) analysis set.|Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation|A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 12 Weeks Followed by a 4-week Withdrawal Period|Terminated||Phase 3|314|Actual|Ferring Pharmaceuticals|Due to the early termination of the study, outcomes were presented only for descriptive purposes.|3||Terminated due to a distribution issue with the trial medication|f||||f||||||||||2017-10-11 01:48:25.200679|2017-10-11 01:48:25.200679
NCT01833052|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-05-02|||April 2013||2013-04-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|June 2014|Actual|2014-06-01||Interventional|CLEAN-TAVI||CLaret Embolic Protection ANd TAVI - Trial||Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Leipzig||2|||f||||||||||||||2017-10-11 01:48:26.383411|2017-10-11 01:48:26.383411
NCT01833039|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2017-09-20|||May 15, 2013|Actual|2013-05-15|September 2017|2017-09-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Interventional|||An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma|An Open-Label Treatment Use Protocol for Ibrutinib (PCI-32765) in Subjects With Relapsed or Refractory Mantle Cell Lymphoma|Active, not recruiting||Phase 4|163|Actual|Janssen Biotech, Inc.||1|||f||||f||f||||||||2017-10-11 01:48:26.461627|2017-10-11 01:48:26.461627
NCT01833026|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2016-10-24|||March 2013||2013-03-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||COPD Assessment and Management Bundle Versus Usual Care|Comparative Effectiveness of COPD Assessment and Management Bundle Versus Usual Care in Patients Suspected of Having COPD|Completed||N/A|122|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 01:48:26.648866|2017-10-11 01:48:26.648866
NCT01833013|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-01-08|||April 2013||2013-04-01|April 2013|2013-04-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|EndoFertil||Infertility and Endometriosis Cohort|Infertility and Endometriosis : a Prospective Cohort Study|Recruiting||N/A|200|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 01:48:26.765415|2017-10-11 01:48:26.765415
NCT01833000|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-04-11|||February 2013||2013-02-01|April 2013|2013-04-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|NeoNIRS||NIRS and Doppler to Predict NEC in Risk Neonates|Assessment of Splanchnic Oxygenation and Circulation in Neonates at Risk for Necrotizing Enterocolitis Using NIRS and Doppler|Unknown status|Recruiting|N/A|69|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 01:48:26.86687|2017-10-11 01:48:26.86687
NCT01832987|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-09-15|||October 2013||2013-10-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pharmacokinetic Parameters of Co-trimoxazole|Pharmacokinetic Parameters of 960 mg Co-trimoxazole Once Daily in Patients With Tuberculosis|Completed||Phase 2|12|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-11 01:48:26.965902|2017-10-11 01:48:26.965902
NCT01832974|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-04-24|||December 2012||2012-12-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|||Possible New Therapy for Advanced Cancer|A Phase I/II Trial of IL-13-PE in Patients With Treatment Refractory Malignancies With a Focus on Metastatic and Locally Advanced Adrenocortical Carcinoma|Terminated||Phase 1|9|Actual|INSYS Therapeutics Inc||4||Business decision by the sponsor during Phase 1.|f||||||||||||||2017-10-11 01:48:27.064581|2017-10-11 01:48:27.064581
NCT01832961|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-07-12|||April 2013||2013-04-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|AEFLUC||Acute Effects of a Flutter Device in COPD|Acute Effects of a Flutter Device on Airways Resistance in Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Recruiting|N/A|15|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 01:48:27.165894|2017-10-11 01:48:27.165894
NCT01832948|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2013-04-11|||January 2013||2013-01-01|April 2013|2013-04-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer|Study of Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer and Efficacy Prediction|Unknown status|Recruiting|Phase 2|30|Anticipated|Zhejiang Cancer Hospital||1|||f||||f||||||||||2017-10-11 01:48:27.274094|2017-10-11 01:48:27.274094
NCT01832935|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-04-15|||July 2011||2011-07-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Cost Effectiveness of Glargine Insulin Versus NPH Insulin|Cost Effectiveness of Glargine Insulin Versus NPH Insulin in Diabetic Patients in Iran|Completed||Phase 4|200|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:48:27.376692|2017-10-11 01:48:27.376692
NCT01832922|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-05-04|||April 2013||2013-04-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||BR in Patients With CLL With Comorbidities and/or Renal Dysfunction|A Dose-Ranging Study of Bendamustine and Rituximab in Chronic Lymphocytic Leukemia (CLL) Patients With Comorbidities and/or Renal Dysfunction|Active, not recruiting||Phase 1|49|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 01:48:27.465483|2017-10-11 01:48:27.465483
NCT01832909|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-09-16|||April 2013||2013-04-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Measured Energy Value of Walnuts in the Human Diet|Macronutrient Absorption From Walnuts: The Measured Energy Value of Walnuts in the Human Diet|Completed||N/A|18|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 01:48:27.572461|2017-10-11 01:48:27.572461
NCT01832896|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-01-03|||August 2013||2013-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema|A Multicenter, Open-Label Study to Assess the Tolerability and Safety of a Single, Subcutaneous Administration of Ecallantide in Children and Adolescents With Hereditary Angioedema|Recruiting||Phase 2|10|Anticipated|Winthrop University Hospital||1|||f||||f||||||||||2017-10-11 01:48:27.665423|2017-10-11 01:48:27.665423
NCT01832883|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2013-04-11|||December 2010||2010-12-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner|Pediatric Vision Scanner 4 (PVS4)|Completed||N/A|78|Actual|Rebiscan, Inc.|||3||f||||||||||||||2017-10-11 01:48:27.765631|2017-10-11 01:48:27.765631
NCT01832870|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-08-23|||April 2013||2013-04-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer|Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer|Completed||Phase 1|9|Actual|Prostate Oncology Specialists, Inc.||1|||f||||t||||||||||2017-10-11 01:48:27.840965|2017-10-11 01:48:27.840965
NCT01832857|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-12-27|||June 2013||2013-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients|An Open Label, Phase 2 Trial to Evaluate the Safety, Tolerability and Efficacy of CPI-613 in Cancer Patients|Terminated||Phase 2|7|Actual|Cornerstone Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 01:48:27.920975|2017-10-11 01:48:27.920975
NCT01832844|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-03-21|||April 2013||2013-04-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ECHORACHIS||Effects of Control Scan for Presumed Difficult Epidural Infiltrations (ECHORACHIS)|Effects of Scan Control for Presumed Difficult Epidural Infiltrations: a Monocentric, Prospective, Randomized, Controlled, Simple Blind Trial|Completed||N/A|80|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 01:48:28.00713|2017-10-11 01:48:28.00713
NCT01832831|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-04-20|||May 2010||2010-05-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|February 2013|Actual|2013-02-01||Observational|||Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy||Terminated||N/A|24|Actual|University of Michigan|||2|The study was completed as planned|f||||||||||||||2017-10-11 01:48:28.095872|2017-10-11 01:48:28.095872
NCT01832818|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-12-12|||March 2012||2012-03-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Post-Market Study Evaluating the Safety and Effectiveness of NuNec® Cervical Arthroplasty System|A Prospective, Feasibility, Multi-Center Nonrandomized Clinical Trial Evaluating the Safety and Effectiveness of NuNec® Cervical Arthroplasty System|Recruiting||N/A|20|Anticipated|Pioneer Surgical Technology, Inc.||1|||f||||f||||||||Undecided||2017-10-11 01:48:28.174194|2017-10-11 01:48:28.174194
NCT01832805|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-02-01|||April 2013||2013-04-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TBS Ghent||Theta Burst Study Ghent|The Effects of Thetaburst Stimulation in Treatment Resistant Unipolar Depressed Patients|Completed||N/A|40|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 01:48:28.28604|2017-10-11 01:48:28.28604
NCT01832792|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-03-31|||August 2013||2013-08-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Guided Self-help for Binge Eating|Guided Self-help for Binge Eating|Completed||N/A|122|Actual|Oxford Health NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 01:48:28.373598|2017-10-11 01:48:28.373598
NCT01832779|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-09-14|||March 2013||2013-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|POEM||Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia|Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy (POEM)|Recruiting||N/A|600|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-11 01:48:28.473788|2017-10-11 01:48:28.473788
NCT01832766|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-08-18|2014-06-30||June 2005||2005-06-01|August 2015|2015-08-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes|The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes|Terminated||Phase 1/Phase 2|13|Actual|University of Colorado, Denver|early termination as recruitment of subjects with only cannabis use was difficult leading to small number of subjects analyzed|2||Unable to find subjects with schizophrenia that were using only cannabis|f||||t||||||||||2017-10-11 01:48:28.603493|2017-10-11 01:48:28.603493
NCT01832753|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-06-02|||January 2013||2013-01-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Treatment Trial of Subclinical Hypothyroidism in Down Syndrome|Levothyroxine Treatment and Cardiometabolic Outcomes in Adolescents With Down Syndrome|Active, not recruiting||N/A|40|Anticipated|Children's Hospital of Philadelphia||2|||f||||t||||||||No||2017-10-11 01:48:28.903237|2017-10-11 01:48:28.903237
NCT01832740|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-03-15|||January 2013||2013-01-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Younger, Healthy Subjects|Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Younger, Healthy Subjects|Completed||N/A|22|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:48:29.001813|2017-10-11 01:48:29.001813
NCT01832727|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-07-14|||May 2013||2013-05-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma|Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|128|Anticipated|Amgen||2|||f||||f||||||||||2017-10-11 01:48:29.231852|2017-10-11 01:48:29.231852
NCT01832714|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-09-25|||September 2013||2013-09-01|September 2014|2014-09-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Observational|NKI-RIF1||Assessment of Oculomotor, Vestibular and Reaction Time Response Following a Concussive Event|Assessment of Oculomotor, Vestibular and Reaction Time Response Following a Concussive Event|Unknown status|Recruiting|N/A|180|Anticipated|Neuro Kinetics|||1||f||||f||||||||||2017-10-11 01:48:29.352711|2017-10-11 01:48:29.352711
NCT01832701|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2014-04-17|||March 2012||2012-03-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Coffee, Exercise, and Oxidative Stress|Coffee and Oxidative Stress During Exercise in Healthy Humans|Completed||N/A|24|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 01:48:29.466382|2017-10-11 01:48:29.466382
NCT01832688|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-05-26|||February 2014||2014-02-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Assessment of the Nutritional Status of Pregnant Women and Optimization of Prenatal Care Services|Assessment of the Nutritional Status of Pregnant Women in Zinder, Niger and Optimization of Prenatal Care Services|Completed||N/A|2306|Actual|University of California, Davis|||2||f||||f||||||Samples Without DNA|"     Blood and urine sample for assessment of nutritional status   "|||2017-10-11 01:48:29.558739|2017-10-11 01:48:29.558739
NCT01832480|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-08-03|||October 6, 2014|Actual|2014-10-06|August 2017|2017-08-01|June 5, 2017|Actual|2017-06-05|June 5, 2017|Actual|2017-06-05||Interventional|||Trichomonas Vaginalis Repeat Infections Among HIV Negative Women|Trichomonas Vaginalis Repeat Infections Among HIV Negative Women|Completed||Phase 3|623|Actual|Tulane University||2|||f||||t||||||||||2017-10-11 01:48:32.109749|2017-10-11 01:48:32.109749
NCT01832675|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-04-12|||March 2012||2012-03-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Interventional|||Clinical Trial With Bupivacaine Lozenges as Local Anaesthesia Under Upper Gastrointestinal Endoscopy|New Bupivacaine Lozenge as Topical Anesthesia Compared to Lidocaine Pharyngeal Spray Before Upper Gastrointestinal Endoscopy in Unsedated Patients|Completed||Phase 2|100|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 01:48:29.659986|2017-10-11 01:48:29.659986
NCT01832662|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2014-04-17|||March 2011||2011-03-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|April 2012|Actual|2012-04-01||Interventional|||Coffee Polyphenols Antioxidants|Coffee Antioxidant Efficacy in Humans|Completed||N/A|60|Actual|Nestlé||3|||f||||f||||||||||2017-10-11 01:48:29.751524|2017-10-11 01:48:29.751524
NCT01832649|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-12|||January 2012||2012-01-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Exercise as an Adjunctive Treatment for Cocaine Dependent Patients|Effectiveness of an Exercise Program in the Treatment of Cocaine Dependence|Completed||N/A|19|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 01:48:29.834357|2017-10-11 01:48:29.834357
NCT01832636|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-07-28|||October 2013||2013-10-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IMAGINE||Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy|Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy (IMAGINE)|Completed||Phase 3|112|Actual|Children's Hospital Medical Center, Cincinnati||4|||f||||t||||||||||2017-10-11 01:48:29.956461|2017-10-11 01:48:29.956461
NCT01832623|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-05-28|||February 2013||2013-02-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|VITADOS||Vitamin D, Bones, Nutritional and Cardiovascular Status|Are Bone, Nutritional and Cardiovascular Status of French Children and Adolescents, Correlated With Their Vitamin D Status?|Unknown status|Recruiting|N/A|200|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 01:48:30.078387|2017-10-11 01:48:30.078387
NCT01832610|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-07-31|||January 2013||2013-01-01|July 2015|2015-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|HW-PAS-03||Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials|A Multi Center, Post Approval Study Providing Continued Evaluation and Follow-up on Patients Who Received a HeartWare® Ventricular Assist System During IDE Trials for the Treatment of Advanced Heart Failure|Active, not recruiting||N/A|115|Anticipated|HeartWare, Inc.|||1||f||||f||||||||||2017-10-11 01:48:30.196348|2017-10-11 01:48:30.196348
NCT01832597|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-12|||November 2010||2010-11-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Observational|||Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders|A Retrospective Multicenter Trial on Efficacy and Toxicity of Bendamustine Alone or Associated With Rituximab, As Salvage Therapy in Patients With Chronic Lymphoproliferative Disorders|Completed||N/A|109|Actual|Gruppo Italiano Studio Linfomi|||1||f||||t||||||||||2017-10-11 01:48:30.32356|2017-10-11 01:48:30.32356
NCT01832584|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-07-13|||April 2013||2013-04-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness and Mood|A Double-blind, Randomized, Placebo Controlled Study of the Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness, Body Composition and Mood|Completed||N/A|45|Actual|Fruitura Bioscience Ltd.||3|||f||||f||||||||||2017-10-11 01:48:30.426859|2017-10-11 01:48:30.426859
NCT01832571|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-07-11|||June 2013||2013-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|SCOPE||SCOPE: Strategies to Combine PrEP With Prevention Efforts|Open Label Prospective Study of Strategies to Combine Pre-Exposure Prophylaxis (PrEP)With Prevention Efforts|Withdrawn||N/A|0|Actual|FHI 360||1||Study is closed early due to withdrawal of funding. No study procedures were implemented.|f||||f||||||||||2017-10-11 01:48:30.546162|2017-10-11 01:48:30.546162
NCT01832558|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-03-14|||November 2012||2012-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)||Recruiting||Phase 1/Phase 2|||Medical University of Vienna||2|||f||||||||||||||2017-10-11 01:48:30.661408|2017-10-11 01:48:30.661408
NCT01832545|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-15|||November 2011||2011-11-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Interventional|PICO||Aquatic Exercise Program for Knee Osteoarthritis|The PICO Project: Aquatic Exercise for Knee Osteoarthritis in Overweight and Obese Individuals|Completed||N/A|50|Actual|Technical University of Lisbon||2|||f||||f||||||||||2017-10-11 01:48:30.770764|2017-10-11 01:48:30.770764
NCT01832532|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-04-13|||April 2013||2013-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks|Pilot 2: Glucagon-like Peptide-1 in Sleep Disordered Breathing|Completed||Phase 1/Phase 2|28|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||Undecided|Manuscript is in progress.|2017-10-11 01:48:30.873936|2017-10-11 01:48:30.873936
NCT01832519|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-08-21|||February 2013||2013-02-01|August 2017|2017-08-01|January 9, 2017|Actual|2017-01-09|January 9, 2017|Actual|2017-01-09||Observational|MRIinfantCF||Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF|MRI Predictors of Infection, Inflammation, and Structural Lung Damage in CF (Cystic Fibrosis)|Completed||N/A|20|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 01:48:30.9708|2017-10-11 01:48:30.9708
NCT01832506|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-10-14|2016-10-14||April 2013||2013-04-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional||Safety analysis set included all subjects who had received at least 1 dose of the investigational medicinal product (IMP).|A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors|A Japanese Multicenter, Open Label, Phase I Trial of c-Met Inhibitor MSC2156119J Given Orally as Monotherapy to Subjects With Solid Tumors|Completed||Phase 1|12|Actual|Merck KGaA||1|||f||||f||||||||||2017-10-11 01:48:31.068161|2017-10-11 01:48:31.068161
NCT01832493|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-07-18|2016-07-18||July 2013||2013-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|SOCR|Patients undergoing the research procedure|Sensor Optimization of Cardiac Resynchronization Therapy Response|Sensor Optimization of CRT Response|Completed||N/A|50|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||No||2017-10-11 01:48:31.862236|2017-10-11 01:48:31.862236
NCT01832467|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-02-08|||April 2013||2013-04-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Cetuximab Rechallenge Study|A Pilot Case-control Study of Second or Third Line Treatment With Cetuximab-containing Chemotherapy in Patients With Metastatic Colorectal Cancer Who Were Previously Treated With Cetuximab-based Chemotherapy|Recruiting||Phase 2|35|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 01:48:32.206564|2017-10-11 01:48:32.206564
NCT01832454|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-09-16|||March 2011||2011-03-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|BMCP2||Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years|Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below Years. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Chaitanya Hospital, Pune||1|||f||||t||||||||||2017-10-11 01:48:32.298357|2017-10-11 01:48:32.298357
NCT01832441|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|BMACD||Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus.|Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Chaitanya Hospital, Pune||1|||f||||f||||||||||2017-10-11 01:48:32.389051|2017-10-11 01:48:32.389051
NCT01832428|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-09-16|||September 2014||2014-09-01|September 2014|2014-09-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|BMACS||A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke.|A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke. It is Self Funded (Patients' Own Funding) Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Chaitanya Hospital, Pune||1|||f||||f||||||||||2017-10-11 01:48:32.464151|2017-10-11 01:48:32.464151
NCT01832415|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-03-15|||April 2013||2013-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|February 2015|Actual|2015-02-01|36 Months|Observational [Patient Registry]|ENCOURAGE||First Line Ovarian Cancer Treatment - Cohort Study|Non Interventional Study Dealing With the Use of Bevacizumab (Avastin®) in Patients With Epithelial Ovarian Cancer, Fallopian Tube or Primary Peritoneal and Treated in First-line Therapy|Completed||N/A|500|Actual|ARCAGY/ GINECO GROUP|||1||f||||f||||||||||2017-10-11 01:48:32.569694|2017-10-11 01:48:32.569694
NCT01832402|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-06-28|||June 2013|Actual|2013-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea|A Preliminary Study of Prophylactic Fentanyl Pectin Nasal Spray (FPNS) for Exercise-Induced Breakthrough Dyspnea|Active, not recruiting||Phase 2|20|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:48:32.712882|2017-10-11 01:48:32.712882
NCT01832389|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-05-03|||March 2013||2013-03-01|July 2015|2015-07-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|PiSAH||Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage|Does a PiCCO-controlled Advanced Haemodynamic Monitoring Improve the Outcome After Aneurysmal Subarachnoid Haemorrhage?|Completed||N/A|108|Actual|Technische Universität München||2|||f||||t||||||||||2017-10-11 01:48:32.829257|2017-10-11 01:48:32.829257
NCT01832376|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-09-14|||June 2011||2011-06-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2016|Actual|2016-02-01||Interventional|||Treatment of Calcific Tendinitis by Ultrasound-guided Needle Lavage|Treatment of Calcific Tendinitis by Ultrasound-guided Needle Lavage - a Multicenter, Randomized and Sham Controlled Study (KALK Study)|Active, not recruiting||N/A|50|Anticipated|Martina Hansen's Hospital||1|||f||||t||||||||||2017-10-11 01:48:32.940595|2017-10-11 01:48:32.940595
NCT01832363|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-01-23|||March 2013||2013-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|HXe-BT||Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI|Single-Session Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI|Recruiting||Phase 1/Phase 2|30|Anticipated|Xemed LLC||2|||f||||t||||||||||2017-10-11 01:48:33.031808|2017-10-11 01:48:33.031808
NCT01832350|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-07-10|||December 2012||2012-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease|Clinical Protocol of a Prospective, Open-label Study to Assess the Safety and Efficacy of Nuedexta (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Alzheimer's Disease|Active, not recruiting||Phase 4|60|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||1|||f||||t||||||||||2017-10-11 01:48:33.170881|2017-10-11 01:48:33.170881
NCT01832337|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2013-04-11|||October 2012||2012-10-01|April 2013|2013-04-01||||May 2013|Anticipated|2013-05-01||Interventional|||Limb Remote Ischemic Preconditioning for Heart and Intestinal Protection During Laparoscopic Colorectal Surgery||Unknown status|Recruiting|N/A|120|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||1|||f||||||||||||||2017-10-11 01:48:33.40764|2017-10-11 01:48:33.40764
NCT01832324|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-12|2016-12-05|||January 2011||2011-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Molecular Basis of Food Allergy|Molecular Basis of Food Allergy and Food Tolerance|Recruiting||N/A|1300|Anticipated|Children's Hospital of Philadelphia|||1||f||||f||||||Samples With DNA|"     DNA, sera and PBMC   "|No||2017-10-11 01:48:33.518906|2017-10-11 01:48:33.518906
NCT01832311|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-10|||January 2009||2009-01-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Protein Profile of Immunoregulatory Factors in Diabetic Cataract|Protein Profile of Immunoregulatory Factors in Diabetic Cataract|Completed||Phase 4|61|Actual|University of Zagreb||4|||f||||f||||||||||2017-10-11 01:48:33.63091|2017-10-11 01:48:33.63091
NCT01832298|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-12-18|||December 2012||2012-12-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid Tumor|Phase I Study of Simmitecan Hydrochloride for Injection in Patients With Advanced Solid Tumor：Tolerability and Pharmacokinetics|Completed||Phase 1|39|Actual|ShangHai HaiHe Pharmaceutical||1|||f||||f||||||||||2017-10-11 01:48:33.787758|2017-10-11 01:48:33.787758
NCT01832077|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-05-20|||April 2013||2013-04-01|May 2013|2013-05-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01|1 Year|Observational [Patient Registry]|||Uptake of Telemedicine System Trial in Rual Canton|The Impact of Telemedicine System to the Diagnosis and Treatment of Diabetes Retinopathy in Rural Canton|Unknown status|Active, not recruiting|N/A|5000|Anticipated|Sun Yat-sen University|||2||f||||t||||||||||2017-10-11 01:48:35.742603|2017-10-11 01:48:35.742603
NCT01832285|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-04-22|||December 2012||2012-12-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients|Effect of Fluvoxamine Augmentation on Cognitive Function , Aggressive Behavior , Clinical Symptoms and mRNA and Protein Expression in Human Peripheral Mononuclear Blood Cells (PMC) in Medicated Schizophrenia Patients|Unknown status|Recruiting|N/A|40|Anticipated|Sha’ar Menashe Mental Health Center||1|||f||||t||||||||||2017-10-11 01:48:33.876985|2017-10-11 01:48:33.876985
NCT01832272|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-05-18|||February 2013||2013-02-01|May 2014|2014-05-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Interventional|||Reinflation After Early Tourniquet Release in Total Knee Arthroplasty|The Effects of Tourniquet Reinflation After Early Tourniquet Release in Total Knee Arthroplasty|Unknown status|Recruiting|Phase 4|174|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:48:33.982671|2017-10-11 01:48:33.982671
NCT01832259|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-03-06|||August 2013||2013-08-01|March 2017|2017-03-01|August 15, 2018|Anticipated|2018-08-15|February 7, 2017|Actual|2017-02-07||Interventional|||A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection|A Neoadjuvant, Randomized, Phase II Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection|Active, not recruiting||Phase 2|30|Actual|University of Utah||2|||f||||t|t|f||||||||2017-10-11 01:48:34.094179|2017-10-11 01:48:34.094179
NCT01832246|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2014-11-17|||December 2014||2014-12-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer|Prospective Study of Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion and Endoscopic Tumor Size Estimation for Early Gastric Cancer|Unknown status|Not yet recruiting|N/A|560|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 01:48:34.17512|2017-10-11 01:48:34.17512
NCT01832233|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-04-18|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Renal Denervation in Patients With Chronic Kidney Disease|Prairie Renal Denervation Study|Active, not recruiting||N/A|26|Actual|Regina Qu'Appelle Health Region||1|||f||||f||||||||No||2017-10-11 01:48:34.29426|2017-10-11 01:48:34.29426
NCT01832220|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-01-11|||May 2013||2013-05-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Observational|GRADS Alpha-1||Genomic Research in Alpha-1 Antitrypsin Deficiency|Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) - Alpha-1 Protocol|Completed||N/A|140|Actual|University of Pittsburgh|||4||f||||t||||||Samples With DNA|"     Serum, plasma, urine, stool, BAL fluid.   "|||2017-10-11 01:48:34.426346|2017-10-11 01:48:34.426346
NCT01832194|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-08-28|||March 2013||2013-03-01|April 2013|2013-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Use of Botox to Treat Scrotal Pain|Use of Botox to Treat Scrotal Pain|Completed||Phase 1|20|Actual|Mount Sinai Hospital, Canada||1|||f||||f||||||||||2017-10-11 01:48:34.63826|2017-10-11 01:48:34.63826
NCT01832181|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-10-18|||April 2013||2013-04-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||MiTy Kids (Metformin in Women With Type 2 Diabetes in Pregnancy Kids Trial)|Metformin in Women With Type 2 Diabetes in Pregnancy Kids Trial (MiTy Kids)|Recruiting||N/A|450|Anticipated|Mount Sinai Hospital, Canada|||2||f||||||||||||||2017-10-11 01:48:34.717436|2017-10-11 01:48:34.717436
NCT01832168|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-03-16|||February 2013||2013-02-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy|A Prospective Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy (RALP)- Effect on Nerve Protection.|Completed||N/A|34|Actual|MiMedx Group, Inc.||2|||f||||f||||||||||2017-10-11 01:48:34.809358|2017-10-11 01:48:34.809358
NCT01832155|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2015-04-03|2013-07-19||January 2011||2011-01-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Yoga for Managing Knee Osteoarthritis in Older Women: a Feasibility Study|A Pilot Study Testing a Hatha Yoga Exercise Program in Older Women With Knee Osteoarthritis|Completed||N/A|36|Actual|University of Minnesota - Clinical and Translational Science Institute|Limitations: Small sample size without blinding. Strengths: Randomized controlled design, data collection at multiple time points and the use of a yoga expert panel to design the yoga program specifically for older women with knee osteoarthritis.|2|||f||||t||||||||||2017-10-11 01:48:34.910568|2017-10-11 01:48:34.910568
NCT01832129|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-06-12|||May 2013||2013-05-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Vitamin B12 Acceptance and Biomarker Response Study|Acceptance and Biomarker Response With Oral vs. Intramuscular Supplementation of Vitamin B12 in Primary Care|Completed||Phase 4|37|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 01:48:35.433346|2017-10-11 01:48:35.433346
NCT01832116|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-10-27|||March 2013||2013-03-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|MMOT||89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients|89Zr-MMOT0530A PET Imaging in Patients With Unresectable Pancreatic or Platinum-resistant Ovarian Cancer Before Treatment With DMOT4039A. A Separate Study to the Phase I Study Protocol DMO4993g|Completed||Phase 1|11|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 01:48:35.528702|2017-10-11 01:48:35.528702
NCT01832103|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-09-23|||August 2013||2013-08-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)|A Phase I Study to Evaluate the Pharmacokinetics of MK-7145 Following Single Dose Administration in Patients With Moderate Renal Insufficiency|Withdrawn||Phase 1|0|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 01:48:35.635398|2017-10-11 01:48:35.635398
NCT01832051|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2015-11-04|||March 2013||2013-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Clinical Value of 89Zr-trastuzumab PET|HER2-PET as a Diagnostic Tool in Breast Cancer Patients With a Clinical Dilemma|Completed||Phase 2|20|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-11 01:48:35.905072|2017-10-11 01:48:35.905072
NCT01832038|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-09-14|||March 2013||2013-03-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures|A Multi-center, Open-label, Uncontrolled, Long-term, Extension Study to Evaluate the Safety and Efficacy of Lacosamide as Adjunctive Therapy in Japanese and Chinese Adults With Partial-onset Seizures With or Without Secondary Generalization|Active, not recruiting||Phase 3|473|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 01:48:35.997538|2017-10-11 01:48:35.997538
NCT01832025|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-02-21|||March 2013||2013-03-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Comparison of Incidence Between Two Techniques|Comparison of the Intraoperative, Postoperative Complications and Patient's Discomfort Involving External and Internal Maxillary Sinus Floor Elevation Techniques With Simultaneous Implant Placement: a Randomized Clinical Trial|Completed||N/A|40|Actual|Tufts University School of Dental Medicine||2|||f||||f||||||||No||2017-10-11 01:48:36.217042|2017-10-11 01:48:36.217042
NCT01832012|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-12|||July 2012||2012-07-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Basic Life Support Cardiopulmonary Resuscitation Refresher in MS2 at St George's University|Practical Skill Retention in Medical Students: Improving Cardiopulmonary Resuscitation With Hands-On Practice|Completed||N/A|175|Actual|Windward Islands Research and Education Foundation||3|||f||||f||||||||||2017-10-11 01:48:36.410596|2017-10-11 01:48:36.410596
NCT01831999|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-08-31|||June 2012||2012-06-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients|Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients|Completed||N/A|139|Actual|Treatment Research Institute||2|||f||||f||||||||Undecided||2017-10-11 01:48:36.485774|2017-10-11 01:48:36.485774
NCT01831986|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-14|2013-12-04|||January 2011||2011-01-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders|Addition of Both Pregnenolone and L-theanine to Ongoing Antipsychotic Treatment for Schizophrenia and Schizoaffective Disorders: an 8-week, Randomized, Double-blind, Placebo-controlled Multicenter Study|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Sha’ar Menashe Mental Health Center||2|||f||||t||||||||||2017-10-11 01:48:36.576092|2017-10-11 01:48:36.576092
NCT01831973|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-04-10|||October 2012||2012-10-01|April 2013|2013-04-01||||July 2015|Anticipated|2015-07-01||Interventional|||A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC Patients|An Open-Label, Single-Arm, Multi-center Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Patients With Advanced/Metastatic Renal Cell Carcinoma|Unknown status|Recruiting|Phase 2|40|Anticipated|Taiwan Liposome Company||1|||f||||f||||||||||2017-10-11 01:48:36.676677|2017-10-11 01:48:36.676677
NCT01831960|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-03-27||2015-03-27|April 2013||2013-04-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris|An Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Cortexolone 17α-Propionate (CB-03-01) Cream Applied Every Twelve Hours for Two Weeks in Subjects With Acne Vulgaris|Completed||Phase 2|42|Actual|Intrepid Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 01:48:36.775344|2017-10-11 01:48:36.775344
NCT01831947|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-04-11|||April 2010||2010-04-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|RABIMO||Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.|Efficacy of Ranibizumab Treatment Every 2 Month Compared to Treatment on Demand on Patients With Choroidal Neo-vascularization (CNV) as a Consequence of Age-related Macular Degeneration (AMD)|Completed||Phase 4|40|Actual|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||2|||f||||f||||||||||2017-10-11 01:48:36.851914|2017-10-11 01:48:36.851914
NCT01831934|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-04-25|2017-01-11||September 2010||2010-09-01|April 2017|2017-04-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)|Metabolic and Immune Responses to TIV in Patients With Mitochondrial Disease|Completed||Phase 4|22|Actual|Stanford University||2|||f||||f|t|f||||||No||2017-10-11 01:48:36.959987|2017-10-11 01:48:36.959987
NCT01831921|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-07-14|||April 2013|Actual|2013-04-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|La Comunidad||Latinos Combating Diabetes|Latinos Combatiendo la Diabetes (Latinos Combating Diabetes)|Completed||N/A|225|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 01:48:37.322924|2017-10-11 01:48:37.322924
NCT01831908|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2014-08-15|||February 2014||2014-02-01|August 2014|2014-08-01|August 2018|Anticipated|2018-08-01|August 2014|Actual|2014-08-01||Interventional|||"The Know Your Numbers Program in Atahualpa"|"The Know Your Numbers Program in Atahualpa - An Interventional Study Aimed to Reduce Cardiovascular Diseases and Stroke Burden in Rural Coastal Ecuador."|Recruiting||N/A|300|Anticipated|Hospital Clínica Kennedy||2|||f||||f||||||||||2017-10-11 01:48:38.974548|2017-10-11 01:48:38.974548
NCT01831895|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-05-30|||May 2013||2013-05-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Interventional|CALM-FIM_US||Controlling and Lowering Blood Pressure With The MOBIUSHD™|CALM-FIM_US -Controlling and Lowering Blood Pressure With the MobiusHD™ - A Prospective Multicenter Safety Study|Active, not recruiting||N/A|20|Anticipated|Vascular Dynamics, Inc.||1|||f||||t||||||||||2017-10-11 01:48:39.069054|2017-10-11 01:48:39.069054
NCT01831882|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-10-18|||July 2013||2013-07-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Identifying Biological Markers for Severe Depression|Identifying Biological Markers for Severe Depression|Recruiting||N/A|500|Anticipated|Stanford University|||2||f||||f||||||Samples With DNA|"     We will be retaining biospecimens including, whole blood, serum, hair and saliva tissues     samples.   "|||2017-10-11 01:48:39.162722|2017-10-11 01:48:39.162722
NCT01830595|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-12-20|||September 2014||2014-09-01|December 2016|2016-12-01||||December 2016|Actual|2016-12-01||Interventional|||Lactoferrin Treatment in HIV Patients|Recombinant Lactoferrin to Reduce Immune Activation and Coagulation Among HIV Positive Patients|Completed||Phase 2|56|Actual|Minneapolis Medical Research Foundation||2|||f||||t||||||||||2017-10-11 01:49:09.410882|2017-10-11 01:49:09.410882
NCT01831869|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2016-06-01|||April 2013||2013-04-01|June 2016|2016-06-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|||Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism|The Beneficial Effect of L-Thyroxine Long -Term Replacement on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism: A Prospective Study|Active, not recruiting||Phase 4|400|Anticipated|Shandong Provincial Hospital||2|||f||||t||||||||||2017-10-11 01:48:39.279172|2017-10-11 01:48:39.279172
NCT01831856|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-02-23|||April 2013||2013-04-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Efficacy and Safety Study of F373280|Efficacy and Safety Study of F373280 for Maintenance of Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation and Chronic Heart Failure. International, Multicentric, Randomised, Double-blind, Placebo Controlled Study.|Active, not recruiting||Phase 2|135|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 01:48:39.359272|2017-10-11 01:48:39.359272
NCT01831830|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-06-22|||October 2011||2011-10-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|VIP||Evaluation of the Veterans' In-home Program|Evaluation of the Veterans' In-home Programs for Veterans With TBI and Families|Completed||N/A|172|Actual|Corporal Michael J. Crescenz VA Medical Center||2|||f||||f||||||||||2017-10-11 01:48:39.571384|2017-10-11 01:48:39.571384
NCT01831817|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-03-23|2014-03-06||January 2013||2013-01-01|February 2015|2015-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||ITT population consisted of all subjects who were randomized, administered at least one study treatment and provided at least one post-baseline assessment of efficacy. The data of 1 subject in 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate group who was lost to follow up was included in the ITT population.|Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity|A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity|Completed||Phase 2|140|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 01:48:39.709441|2017-10-11 01:48:39.709441
NCT01831804|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-05-16|||June 17, 2013|Actual|2013-06-17|May 2017|2017-05-01|February 10, 2017|Actual|2017-02-10|February 10, 2017|Actual|2017-02-10||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863|Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Topical GSK1278863 in Healthy Volunteers and Diabetic Patients, and Repeat Doses of GSK1278863 in Diabetic Patients for the Treatment of Diabetic Foot Ulcer|Completed||Phase 1|65|Actual|GlaxoSmithKline||7|||f||||f||||||||||2017-10-11 01:48:40.850171|2017-10-11 01:48:40.850171
NCT01831791|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-02-26|2015-02-26||April 2013||2013-04-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia|Study ARI114264: A Long-Term Study of the Safety and Efficacy of Dutasteride in the Treatment of Male Subjects With Androgenetic Alopecia|Completed||Phase 3|120|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 01:48:41.010523|2017-10-11 01:48:41.010523
NCT01831752|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-11-17|||February 2013||2013-02-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2|Performance Evaluation of a Non-Invasive Glucose Monitor (Spectral Data Acquisition) as Compared to CGM Data Acquired by the iPro2|Completed||N/A|9|Actual|William Sansum Diabetes Center|||1||f||||f||||||||||2017-10-11 01:48:42.956243|2017-10-11 01:48:42.956243
NCT01831739|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-01-11|||May 2013||2013-05-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Observational|GRADS Sarc||Genomic Research in Sarcoidosis|Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) - Sarcoidosis Protocol|Completed||N/A|368|Actual|University of Pittsburgh|||9||f||||t||||||Samples With DNA|"     Serum, plasma, urine, stool, BAL fluid.   "|||2017-10-11 01:48:43.031856|2017-10-11 01:48:43.031856
NCT01831726|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-01-30|2017-01-30||August 2013||2013-08-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SIGNATURE||Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib|Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 2 - Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib Including Tumors With Mutations or Translocations of FGFR, PDGFR, VEGF, cKIT, FLT3, CSFR1, Trk and RET|Completed||Phase 2|80|Actual|Novartis||1|||f||||f||||||||||2017-10-11 01:48:43.142167|2017-10-11 01:48:43.142167
NCT01831713|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2015-07-14|||September 2012||2012-09-01|August 2012|2012-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Pulmonary Blood Flow Measurements in CHF Patients|Evaluation of Pulmonary Blood Flow Patterns Using Transthoracic Doppler in Patients With Congestive Heart Failure|Terminated||N/A|200|Anticipated|Echosense Ltd.|||1|Changing staff|f||||f||||||||||2017-10-11 01:48:43.812357|2017-10-11 01:48:43.812357
NCT01831700|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-10|||October 2012||2012-10-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg of M/s Ipca Laboratories Ltd., India With Zestoretic® 20/25 Lisinopril/Hydrochlorothiazide Tablets of M/s AstraZeneca Pharmaceuticals LP, USA in Normal, Healthy, Adult, Human Subjects Under Fasting Condition|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:48:43.888364|2017-10-11 01:48:43.888364
NCT01831687|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2013-04-10|||December 2012||2012-12-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition|An Open Label, Balanced, Randomized, Single-dose, Two-treatment, Two-sequence, Two-period, Crossover, Oral Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg of Ipca Laboratories Limited, India and Etodolac Extended Release Tablets 600mg of Teva Pharmaceutical Ind. Ltd., USA in Healthy, Adult, Human Subjects Under Fed Condition|Completed||Phase 1|36|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:48:43.998481|2017-10-11 01:48:43.998481
NCT01831674|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2013-04-10|||December 2012||2012-12-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition|A Randomized, Open Label, Two-treatment, Two -Period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg of Ipca Laboratories Ltd, India and GLUCOPHAGE®XR (Metformin HCl Extended-release Tablets) 750 mg of Bristol-Myers Squibb Company, USA in Normal, Healthy, Adult, Human Subjects Under Fed Condition|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:48:44.105778|2017-10-11 01:48:44.105778
NCT01831661|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2013-04-10|||December 2012||2012-12-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition|A Randomized, Open Label, Two-treatment, Two -Period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg of Ipca Laboratories Ltd, India and GLUCOPHAGE®XR (Metformin HCl Extended-release Tablets) 750 mg of Bristol-Myers Squibb Company, USA in Normal, Healthy, Adult, Human Subjects Under Fasting Condition|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:48:44.217645|2017-10-11 01:48:44.217645
NCT01831648|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-04-10|||May 2010||2010-05-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|VARIETE||Establishment of Reference Values for Insulin-like Growth Factor 1 (IGF1) in the General Population|An Open, Prospective, National, Multicenter, Non Randomised, Study Based on Healthy Volunteers for Establishing Normative Data for IGF1 in the General Population|Completed||N/A|924|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 01:48:44.321437|2017-10-11 01:48:44.321437
NCT01831622|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-12-01|||June 2013||2013-06-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder|Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder|Completed||Phase 4|131|Actual|University of Oslo||2|||f||||t||||||||||2017-10-11 01:48:44.573096|2017-10-11 01:48:44.573096
NCT01831609|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2017-04-25|||August 31, 2011|Actual|2011-08-31|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer|Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer|Recruiting||N/A|1000|Anticipated|Samsung Medical Center|||1||f||||t||||||Samples With DNA|"     Pleural fluid, ascites, fine needle aspirations, other body fluids (i.e. CSFs)prospectively.     Primary cultures, Xenografts.   "|||2017-10-11 01:48:44.69444|2017-10-11 01:48:44.69444
NCT01831596|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-09|||June 2010||2010-06-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Evaluation of a Novel Post-Surgical Dressing|Evaluation of a Novel Post-Surgical Dressing|Unknown status|Active, not recruiting|N/A|120|Anticipated|Spiracur, Inc.||1|||f||||f||||||||||2017-10-11 01:48:44.774932|2017-10-11 01:48:44.774932
NCT01831583|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-04-09|||May 2013||2013-05-01|April 2013|2013-04-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Assessment of PPG & PAT to Detect Upper Airway Obstruction in Patients With Obstructive Sleep Apnea|Assessment of a New Photoplethysmographic (PPG) Method and a Pulse Arrival Time Method to Detect Upper Airway Obstruction in Patients With Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) in a Sleep Laboratory|Unknown status|Not yet recruiting|N/A|15|Anticipated|Sotera Wireless, Inc.||2|||f||||f||||||||||2017-10-11 01:48:44.87356|2017-10-11 01:48:44.87356
NCT01831570|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-06-08|||April 2013||2013-04-01|May 2016|2016-05-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|DIGICOD||DIGItal Cohort Osteoarthritis Design|Prospective 6 Years Follow up of Patients With Hand Osteoarthritis|Recruiting||N/A|500|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 01:48:45.001517|2017-10-11 01:48:45.001517
NCT01831557|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-04-10|||June 2013||2013-06-01|April 2013|2013-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||The Genetic Basis of the Influence of Dairy Product Intake on Body Measures in Children||Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:48:45.134055|2017-10-11 01:48:45.134055
NCT01831544|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-09-20|||July 2015||2015-07-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage)|Multi Center, Prospective, Non-Randomized, Single-Arm Trial Evaluating the Clinical Safety and Performance Of the HeartWare MVAD® System For the Treatment of Advanced Heart Failure|Suspended||N/A|60|Anticipated|HeartWare, Inc.||1||"The sponsor has decided to voluntary pause enrollment for this trial on 1 Sep 15 due to an   anomaly in a solder joint between components in the PAL™ controller."|f||||t||||||||||2017-10-11 01:48:45.238236|2017-10-11 01:48:45.238236
NCT01831531|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-02-01|||March 2013||2013-03-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Study of S-1 in Combination With Radiotherapy in Esophageal Cancer|Phase II Study of S-1 in Combination With Radiotherapy in Esophageal Squamous Cell Carcinoma|Active, not recruiting||Phase 2|105|Actual|Fudan University||1|||f||||t||||||||||2017-10-11 01:48:45.392214|2017-10-11 01:48:45.392214
NCT01831518|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2015-07-24|||July 2014||2014-07-01|July 2015|2015-07-01||||February 2016|Anticipated|2016-02-01||Interventional|||Predicting Response to CRT Using Body Surface ECG Mapping|Evaluation of a Novel Method of Non-surface Electrocardiographic Mapping in Predicting Clinical, Structural and Neurohormonal Responses in Patients Undergoing Cardiac Resynchronization Therapy.|Unknown status|Recruiting|N/A|30|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 01:48:45.48944|2017-10-11 01:48:45.48944
NCT01831505|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-02-24|||November 2012||2012-11-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents|Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents Using the CIVO(tm) Microdosing System|Completed||Phase 1|4|Actual|Presage Biosciences||1|||f||||t||||||||No||2017-10-11 01:48:45.60274|2017-10-11 01:48:45.60274
NCT01831492|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-02-09|||April 2013||2013-04-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Zeolite + Dolomite on Performance and Acidosis|Effects of Dietary Zeolite + Dolomite on Performance, Exercise-induced Acidosis, Oxidative Stress, Inflammation and Intestinal Barrier Dysfunction in Trained People|Completed||N/A|56|Actual|Green Beat||2|||f||||t||||||||||2017-10-11 01:48:45.689148|2017-10-11 01:48:45.689148
NCT01831479|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-04-09|||August 2011||2011-08-01|April 2013|2013-04-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers||Completed||Phase 1|36|Actual|Severance Hospital||1|||f||||||||||||||2017-10-11 01:48:45.781954|2017-10-11 01:48:45.781954
NCT01831466|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-10-26|2015-09-15||May 2013||2013-05-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Full Analysis Set (FAS) - included all participants who were randomized to the study, received at least one dose of the randomized investigational drug (tofacitinib or vehicle), and were in a baseline PGA-C category of mild (2), moderate (3) or severe (4).|Tofacitinib Ointment For Chronic Plaque Psoriasis|A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.|Completed||Phase 2|476|Actual|Pfizer|Efficacy results for participants in the severe population were not reported since this was considered an exploratory population.|6|||f||||t||||||||||2017-10-11 01:48:45.955813|2017-10-11 01:48:45.955813
NCT01831453|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-10|||April 2012||2012-04-01|April 2013|2013-04-01|May 2013|Anticipated|2013-05-01|April 2013|Anticipated|2013-04-01||Interventional|||Omega-3 and Quality of Life in Recurrent Aphthous Stomatitis Patients|Therapeutic Effect of Systemic Omega-3 Polyunsaturated Fatty Acids On Quality of Life in Patients Suffering From Recurrent Aphthous Stomatitis Unresponsive to Topical Therapy.|Unknown status|Active, not recruiting|Phase 2|50|Actual|October 6 University||2|||f||||f||||||||||2017-10-11 01:48:50.47177|2017-10-11 01:48:50.47177
NCT01831440|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-12|||January 2011||2011-01-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Interventional|||Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging|The Influence of Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging：A Comparative Longitudinal Study|Unknown status|Recruiting|N/A|200|Anticipated|Nanjing Medical University||2|||f||||f||||||||||2017-10-11 01:48:50.569665|2017-10-11 01:48:50.569665
NCT01831427|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-02-26|||March 2013||2013-03-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Evaluating the Safety, Pharmacokinetics and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis|A Phase 1 Double-blind, Randomized, Placebo-Controlled, Staggered, Single and Multiple Ascending Dose, Multicenter Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 in Subjects With Moderate to Severe Ulcerative Colitis|Completed||Phase 1|74|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 01:48:50.780591|2017-10-11 01:48:50.780591
NCT01831414|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-05-03|||June 2009||2009-06-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|BALNEORESPI||Effect of Immersion Level on Respiratory Function of Spinal Cord Injury Patients During Balneotherapy|Etude Pilote évaluant l'Effet du Niveau d'Immersion Sur la Fonction Respiratoire Des Patients tétraplégiques bénéficiant de balnéothérapie|Completed||N/A|15|Actual|Centre d'Investigation Clinique et Technologique 805||2|||f||||f||||||||||2017-10-11 01:48:50.895576|2017-10-11 01:48:50.895576
NCT01831401|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-03-20|||August 2013||2013-08-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study Investigating the Effect of Patient Pelvic Positioning and Method of Acetabular Component Insertion on Acetabular Component Inclination During Total Hip Arthroplasty (THA)|A Randomised Controlled Study Investigating the Effect of Patient Pelvic Positioning and Method of Acetabular Component Insertion on Acetabular Component Inclination During Total Hip Arthroplasty (THA).|Completed||N/A|270|Actual|Musgrave Park Hospital||9|||f||||t||||||||||2017-10-11 01:48:50.978814|2017-10-11 01:48:50.978814
NCT01831388|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-05-02|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Breath Training Exercise for the Reduction of Chronic Dyspnea|Breath Training Exercise for the Reduction of Chronic Dyspnea: a Pilot Study|Active, not recruiting||N/A|40|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:48:51.094789|2017-10-11 01:48:51.094789
NCT01831375|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-01-31|||January 2011||2011-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Cancer Prevention and Care Among Aged|Health Care Partners in Cancer Prevention and Care Among Aged|Completed||N/A|697|Actual|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 01:48:51.190747|2017-10-11 01:48:51.190747
NCT01831362|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-01-31|||February 2013||2013-02-01|January 2017|2017-01-01|March 15, 2016|Actual|2016-03-15|March 15, 2016|Actual|2016-03-15||Interventional|||Dismantling Mindfulness|Dismantling Mindfulness: Contributions of Attention vs. Acceptance|Completed||N/A|104|Actual|Brown University||3|||f||||t||||||||||2017-10-11 01:48:51.276097|2017-10-11 01:48:51.276097
NCT01831336|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2017-09-26|||February 2013|Actual|2013-02-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||BIOFLOW-III Belgium Satellite Registry|BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Belgium|Completed||N/A|332|Actual|Biotronik Belgium NV|||1||f||||f||||||||||2017-10-11 01:48:51.36896|2017-10-11 01:48:51.36896
NCT01831323|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-10-16|||December 2012||2012-12-01|October 2014|2014-10-01|May 2015|Anticipated|2015-05-01|December 2014|Anticipated|2014-12-01||Observational|||Evaluation of the Metabolome in Diverticular Disease|Evaluation of the Metabolome in Diverticular Disease and Effects of Probiotic Mixture VSL#3 vs Fibers, Rifaximin and Mesalazine on the Metabolome in Diverticular Disease of the Colon|Unknown status|Recruiting|N/A|40|Anticipated|S.Eugenio Hospital|||4||f||||f||||||Samples Without DNA|"     urine and stools   "|||2017-10-11 01:48:51.475863|2017-10-11 01:48:51.475863
NCT01831310|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-10|||January 2007||2007-01-01|April 2013|2013-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Nutrition for Colorectal Cancer Patients and Neutrophil Functions|Effects Of Standard And/Or Glutamine Dipeptide And/Or Omega-3 Fatty Ascid-Supplemented Parenteral Nutrition On Neutrophil Functions, Interleukin-8 Level And Length Of Stay-A Double Blind,Controlled, Randomized Study|Completed||Phase 4|36|Actual|Kocaeli University||4|||f||||f||||||||||2017-10-11 01:48:51.597884|2017-10-11 01:48:51.597884
NCT01831297|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-11-26|||August 2012||2012-08-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Haemodynamic Feasibility Study of Sensors Within a Tilting Table Examination||Completed||N/A|10|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 01:48:51.690411|2017-10-11 01:48:51.690411
NCT01831284|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2014-11-04|||December 2012||2012-12-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Correlates and Consequences of Increased Immune Activation in Injection Drug Users|Correlates and Consequences of Increased Immune Activation in Injection Drug Users|Completed||N/A|201|Actual|Rockefeller University|||3||f||||f||||||Samples Without DNA|"     Sigmoidoscopy with biopsy   "|||2017-10-11 01:48:51.773828|2017-10-11 01:48:51.773828
NCT01831271|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-09-06|||August 2010||2010-08-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|January 2016|Actual|2016-01-01||Interventional|||Neck-specific Training or Prescribed Physical Activity for Patients With Cervical Radiculopathy|Interventions for Patients With Cervical Radiculopathy- Neck-specific Training With a Cognitive Behavioural Approach Compared With Prescribed Physical Activity in a Prospective Randomised Controlled Trial|Completed||N/A|144|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 01:48:51.861603|2017-10-11 01:48:51.861603
NCT01831258|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-06-20|2017-05-25||March 2013||2013-03-01|June 2017|2017-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Comparison Study of the ICON™ CPAP Series With and Without SensAwake™||Completed||N/A|70|Actual|Fisher and Paykel Healthcare||2|||f||||||||||||||2017-10-11 01:48:51.989727|2017-10-11 01:48:51.989727
NCT01831245|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-02-19|||January 2011||2011-01-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01|2 Years|Observational [Patient Registry]|||Right-sided Colon Tumor, Laparoscopic Versus Open Surgery, in an ERAS Protocol|Right-sided Colon Tumor, Laparoscopic and Open Surgery, in an ERAS Protocol|Completed||N/A|125|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 01:48:52.364887|2017-10-11 01:48:52.364887
NCT01831219|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-11-14|2016-07-27||April 2013||2013-04-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational||Patients enrolled in IDE G920035 trial or IDE G000071 trial and underwent total hip arthroplasty using either the ROBODOC Surgical Assistant System or a manual technique.|ROBODOC® Clinical Trials: Long-Term Follow-Up|A Follow-Up Study of Subjects Enrolled in the Pin-Based (IDE G920035) and Pinless (IDE G000071) ROBODOC® Surgical System Clinical Trial|Completed||N/A|118|Actual|Curexo Technology Corporation|||2||f||||f||||||||Undecided||2017-10-11 01:48:52.888743|2017-10-11 01:48:52.888743
NCT01831206|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2015-05-01|||March 2013||2013-03-01|April 2013|2013-04-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|||Collagen Cross-linking in Infectious Keratitis Trial|Collagen Cross-linking in Infectious Keratitis Trial|Completed||Phase 2|30|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-11 01:48:53.26374|2017-10-11 01:48:53.26374
NCT01831193|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-07-23|||February 2013||2013-02-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease|Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease|Completed||Phase 3|120|Actual|Instituto Nacional de Cardiologia Ignacio Chavez||2|||f||||||||||||||2017-10-11 01:48:53.336946|2017-10-11 01:48:53.336946
NCT01831180|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-01-24|||September 2013||2013-09-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||A Comparison of Scalp Blood Flow and Hair Shaft In Premenopausal Women Versus Postmenopausal Women|A Comparison of Scalp Blood Flow and Hair Shaft In Premenopausal Women Versus Postmenopausal Women: II-Scalp & Blood Flow 2012|Completed||N/A|50|Actual|Wake Forest University Health Sciences|||2||f||||f||||||||No||2017-10-11 01:48:53.409798|2017-10-11 01:48:53.409798
NCT01831167|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-04-10|||January 2013||2013-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|Tefflon||Effect of Dynamic Light Application on Performance of ICU Nurses|Effect of Dynamic Light Application on Performance of ICU Nurses|Completed||N/A|10|Actual|Jeroen Bosch Ziekenhuis||2|||f||||f||||||||||2017-10-11 01:48:53.491107|2017-10-11 01:48:53.491107
NCT01831154|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-03-13|2016-04-27||May 2010||2010-05-01|March 2017|2017-03-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||The Effect of Tight Glycemic Control on Surgical Site Infection Rates in Patients Undergoing Open Heart Surgery|The Effect of Intraoperative Tight Glycemic Control on Surgical Site Infection Rates in Patients Undergoing Open Heart Surgery|Completed||N/A|37|Actual|James A. Haley Veterans Administration Hospital|This study was conducted in a single center and homogenous sample. Statistical power was not sufficient to draw conclusion on the effect of tight glycemic control on postoperative outcomes.|3|||f||||t||||||||Undecided||2017-10-11 01:48:53.584018|2017-10-11 01:48:53.584018
NCT01831141|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-11|2013-04-11|||June 2010||2010-06-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|CSKP||Long Term Outcome of Congenital Solitary Kidney|Renal Outcome in Children With Congenital Solitary Kidney: a Longitudinal Prognostic Study|Unknown status|Recruiting|N/A|120|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||f||||||||||2017-10-11 01:48:54.326734|2017-10-11 01:48:54.326734
NCT01831128|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-04-11|||November 2009||2009-11-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|FACE||French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS)|Prospective Multicentre Observational French Cohort Study of Patients With Heart Failure and Central Sleep Apnoea Requiring Adaptive Servo-Ventilation (PaceWave, AutoSet CS) Treatment|Recruiting||N/A|300|Anticipated|ResMed|||2||f||||f||||||||||2017-10-11 01:48:54.407566|2017-10-11 01:48:54.407566
NCT01831115|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-07-25|||April 2006||2006-04-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|August 2015|Actual|2015-08-01||Observational|BASEL V||Basics in Acute Shortness of Breath EvaLuation (BASEL V) Study|Basics in Acute Shortness of Breath EvaLuation (BASEL V) Study|Active, not recruiting||N/A|3000|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     EDTA, Plasma and Urine   "|||2017-10-11 01:48:54.567409|2017-10-11 01:48:54.567409
NCT01831102|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-09|||March 2011||2011-03-01|April 2013|2013-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Adiponectin and Ethnic Differences in Insulin Resistance|Adiponectin as an Independent Determinant of Ethnic Differences in Insulin Resistance|Completed||N/A|43|Actual|University of Colorado, Denver|||2||f||||||||||||||2017-10-11 01:48:54.649391|2017-10-11 01:48:54.649391
NCT01831076|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-10-03|||April 2002||2002-04-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors|Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors. A Phase II Study to Identify Molecular Predictors for Hormone Responsiveness and/or Resistance.|Active, not recruiting||Phase 2|36|Actual|University of Colorado, Denver||1|||f||||t||||||||No||2017-10-11 01:48:54.82741|2017-10-11 01:48:54.82741
NCT01831063|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-12|||October 2011||2011-10-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Simulation-based Intervention for Caregivers of Children With Seizures|Simulation for Family Centered Care: Improving Caregivers Skills, Self-Efficacy and Quality of Life Using a Practice-Until-Perfect Simulation Intervention for Seizure Management in the Home Environment|Completed||N/A|61|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 01:48:54.937892|2017-10-11 01:48:54.937892
NCT01831037|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-01-27|||July 2015||2015-07-01|January 2015|2015-01-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Observational|ROLFH||The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study|The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study|Withdrawn||N/A|0|Actual|University of Arkansas|||2|Unable to obtain funding|f||||t||||||Samples With DNA|"     Serum, plasma, PBMC for DNA isolation   "|||2017-10-11 01:48:55.19979|2017-10-11 01:48:55.19979
NCT01831024|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2016-10-18|||July 2013||2013-07-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia|Clinical Performance, Efficacy and Safety of the DigniCap™ System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia in Patients With Early Stage Breast Cancer|Active, not recruiting||N/A|110|Anticipated|Target Health Inc.||2|||f||||t||||||||||2017-10-11 01:48:55.327775|2017-10-11 01:48:55.327775
NCT01831011|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-10|||July 2008||2008-07-01|April 2013|2013-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Mildronate for Acute Ischemic Stroke|Efficacy and Safety of Mildronate for Acute Ischemic Stroke: a Randomized, Double-blind, Active-controlled Phase II Multicenter Trial|Completed||Phase 2|227|Actual|Xijing Hospital||2|||f||||t||||||||||2017-10-11 01:48:55.434484|2017-10-11 01:48:55.434484
NCT01830998|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-12-09|||January 2012||2012-01-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Early Detection of Cognitive Dysfunction in Diabetes|Study of Cognitive Dysfunction and Diabetes|Unknown status|Recruiting|N/A|400|Anticipated|Wuhan General Hospital of Guangzhou Military Command|||4||f||||f||||||None Retained|"     serum   "|||2017-10-11 01:48:55.532362|2017-10-11 01:48:55.532362
NCT01830985|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-10-23||2015-10-23|April 2013||2013-04-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Phase 2/3 Open-label Extension Study to Evaluate Long-Term Safety and Efficacy With VX-509 in Subjects With Rheumatoid Arthritis|A Phase 2/3 Open-label Extension Study to Evaluate Long-Term Safety and Efficacy With VX-509 in a Treat to Target Setting in Subjects With Rheumatoid Arthritis on Disease-Modifying Antirheumatic Drugs|Completed||Phase 2/Phase 3|39|Actual|Vertex Pharmaceuticals Incorporated||1|||f||||t||||||||||2017-10-11 01:48:55.629876|2017-10-11 01:48:55.629876
NCT01830972|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-09-14|||June 4, 2013|Actual|2013-06-04|September 2017|2017-09-01|February 14, 2017|Actual|2017-02-14|February 14, 2017|Actual|2017-02-14||Interventional|||An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid (ER Tablets + IR Capsules) in Patients With GNE Myopathy|An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy|Completed||Phase 2|59|Actual|Ultragenyx Pharmaceutical Inc||6|||f||||t||||||||||2017-10-11 01:48:55.770503|2017-10-11 01:48:55.770503
NCT01830959|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-12-04|||April 2013||2013-04-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|May 2016|Anticipated|2016-05-01||Interventional|REFS||Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)|Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)|Active, not recruiting||Phase 4|50|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-10-11 01:48:55.86355|2017-10-11 01:48:55.86355
NCT01830946|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-11|||September 2011||2011-09-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Nighttime Macronutrient Choice and Combined Resistance and High-intensity Interval Training|The Effect of Nighttime Macronutrient Choice and Combined Resistance and High-Intensity Interval Training on Body Composition, Cardiovascular Health, Resting Metabolism, Appetite and Strength in Overweight and Obese Adults|Completed||N/A|59|Actual|Florida State University||3|||f||||f||||||||||2017-10-11 01:48:55.957417|2017-10-11 01:48:55.957417
NCT01830933|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-08-14|2013-05-15||June 2011||2011-06-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|BreastCARE|Number of participants who completed follow-up.|Breast Cancer Risk Reduction: A Patient Doctor Intervention|Breast Cancer Risk Reduction: A Patient Doctor Intervention|Completed||N/A|1235|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:48:56.056093|2017-10-11 01:48:56.056093
NCT01830920|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-03-08|2016-11-17||May 2013||2013-05-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)|A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)|Completed||Phase 2|452|Actual|Thrasos Innovation, Inc.|A limitation of this analysis was that if a subject left the hospital with AKI, the duration of AKI was automatically assigned as 7 days.|5|||f||||t||||||||||2017-10-11 01:48:56.458535|2017-10-11 01:48:56.458535
NCT01830907|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-11|||January 2012||2012-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy of Preoperative Nutritional Support on Postoperative Outcome in Gastric Cancer Patients at Nutritional Risk by NRS-2002|Efficacy of Preoperative Nutritional Support on Postoperative Outcome in Gastric Cancer Patients at Nutritional Risk by NRS-2002- A Prospective, Randomized Clinical Trial|Completed||Early Phase 1|460|Actual|First Hospital of Jilin University||2|||f||||f||||||||||2017-10-11 01:49:00.612725|2017-10-11 01:49:00.612725
NCT01830894|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-10|||April 2013||2013-04-01|March 2013|2013-03-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|BBBD||Feasibility Study of New MRI Protocol in Assessing Early Blood Brain Barrier Disruption (BBBD)in Related to Delay Brain Edema|Evaluation and Correlation Between the Disruption in Blood-brain-barrier and the Development of Secondary Brain Edema Associated With Brain Damage by Using MRI in Patients With Various Types of Intra-cranial Bleeding|Unknown status|Not yet recruiting|Phase 1/Phase 2|30|Anticipated|Sheba Medical Center||3|||f||||f||||||||||2017-10-11 01:49:00.697402|2017-10-11 01:49:00.697402
NCT01830881|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-05-16|2016-04-21||April 2013||2013-04-01|May 2017|2017-05-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional||1 subject in the placebo group did not complete the study after changing mind to have abortion. Baseline information and characteristics on that subject was still collected and included where applicable in study outcomes and data.|Evaluation of Oral Midazolam in First-trimester Surgical Abortions|An Evaluation of Oral Midazolam for Anxiety and Pain in First-trimester Surgical Abortion: a Randomized Controlled Trial|Completed||Phase 4|124|Actual|Oregon Health and Science University||2|||f||||f||||||||No||2017-10-11 01:49:00.806709|2017-10-11 01:49:00.806709
NCT01830868|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-11|||March 2012||2012-03-01|April 2013|2013-04-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|ZOOM||A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410)|An Open-label, Multi-centre, Multi-national Post-marketing Non-interventional Observational Study of the Use of Zonisamide (ZNS) in the Adjunctive Treatment of Adult Patients With Partial Onset Seizures Treated With One Antiepileptic Drug (AED) as Baseline Medication|Unknown status|Active, not recruiting|N/A|700|Anticipated|Eisai Inc.|||1||f||||f||||||||||2017-10-11 01:49:01.763577|2017-10-11 01:49:01.763577
NCT01830855|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2016-05-05|2015-10-14||April 2013||2013-04-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Safety population included all the participants who received at least 1 dose of the investigational product (rLP2086 or HAV/saline) and had safety data available.|A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years|A Phase 3, Randomized, Active-controlled, Observer-blinded Trial To Assess The Lot Consistency, Safety, Tolerability, And Immunogenicity Of A Meningococcal Serogroup B Bivalent Rlp2086 Vaccine In Healthy Subjects Aged >/=10 To <19 Years|Completed||Phase 3|3596|Actual|Pfizer||4|||f||||t||||||||||2017-10-11 01:49:02.223285|2017-10-11 01:49:02.223285
NCT01830842|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-06-01|||February 2014||2014-02-01|September 2016|2016-09-01|August 31, 2016|Actual|2016-08-31|August 31, 2016|Actual|2016-08-31||Interventional|NicLearning||Acute and Chronic Nicotine Modulation of Reinforcement Learning|Acute and Chronic Nicotine Modulation of Reinforcement Learning|Completed||N/A|48|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:49:06.595027|2017-10-11 01:49:06.595027
NCT01830829|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-10-21|||April 2013||2013-04-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)|A Multi-center Randomized Placebo Controlled Trial Evaluating the Efficacy of JALYN in Improving Symptoms in Men Diagnosed With Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)|Terminated||Phase 3|1|Actual|Queen's University||2||Difficulty in enrolling particpants|f||||f||||||||||2017-10-11 01:49:06.730813|2017-10-11 01:49:06.730813
NCT01830816|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-08-04|||September 24, 2013|Actual|2013-09-24|August 2017|2017-08-01|November 18, 2016|Actual|2016-11-18|August 1, 2015|Actual|2015-08-01||Interventional|||Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Patients With Normal Renal Function or Severe Renal Impairment|Phase 1/1b Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Patients With Normal Renal Function or Severe Renal Impairment|Completed||Phase 1|41|Actual|Takeda||2|||f||||f||||||||||2017-10-11 01:49:06.865371|2017-10-11 01:49:06.865371
NCT01830803|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-04-10|||February 2013||2013-02-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Reliability of howRU and howRwe Questionnaires|Reliability of howRU and howRwe Questionnaires|Completed||N/A|101|Actual|Medical Research Foundation, The Netherlands|||1||f||||f||||||||||2017-10-11 01:49:07.006279|2017-10-11 01:49:07.006279
NCT01830023|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-09-22|||May 2009||2009-05-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational|||Vitality Trial - Sampling Examination Data||Completed||N/A|2019|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 01:49:21.560806|2017-10-11 01:49:21.560806
NCT01830790|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-05-27|2015-04-29||March 2013||2013-03-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Sildenafil on Choroidal Thickness in AMD|Effects of Sildenafil on Choroidal Thickness in Age-Related Macular Degeneration|Terminated||Phase 2|10|Actual|Duke University|Study was terminated early due to inadequate support to complete recruitment/data analysis.|2||Inadequate support to complete recruitment/data analysis.|f||||t||||||||||2017-10-11 01:49:07.112787|2017-10-11 01:49:07.112787
NCT01830777|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-08-15|||May 2013|Actual|2013-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brentuximab Vedotin + Re-induction Chemotherapy for AML|Phase I Trial of Brentuximab Vedotin With Re-induction Chemotherapy in Patients With Relapsed, CD30 Expressing, Acute Myeloid Leukemia (AML)|Recruiting||Phase 1|28|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:49:07.373062|2017-10-11 01:49:07.373062
NCT01830764|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-09-05|||April 2013||2013-04-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers|An Open-label Safety and Tolerability Study of LTS 0.3% With Red Light Applied to the Backs of Healthy Volunteers|Completed||Phase 1|12|Actual|Dermira, Inc.||2|||f||||f||||||||||2017-10-11 01:49:07.492574|2017-10-11 01:49:07.492574
NCT01830751|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2017-06-02|||March 2013|Actual|2013-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|RST||Limiting Trunk Flexion as a Self-treatment for Low Back Pain|Influencing Diurnal Variation in Disc Hydration as a Treatment for Non-specific Low Back Pain|Active, not recruiting||N/A|120|Anticipated|Liberty Mutual Research Institute for Safety||2|||f||||f||||||||||2017-10-11 01:49:07.578252|2017-10-11 01:49:07.578252
NCT01830738|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-10-21|||February 2014||2014-02-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|HOT||Laparoscopic Hysterectomy Via a Single Port, Peri-umbilical Technique Versus a Conventional Laparoscopic Technique|Laparoscopic Hysterectomy Via a Single Port, Peri-umbilical Technique Versus a Conventional Laparoscopic Technique : a Prospective, Randomized, Multicenter Study Evaluating the Length of Hospital Stay|Terminated||N/A|7|Actual|Centre Hospitalier Universitaire de Nīmes||2||Inclusion curve too poor.|f||||f||||||||||2017-10-11 01:49:07.692271|2017-10-11 01:49:07.692271
NCT01830725|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-08-29|||December 2012||2012-12-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Purine Metabolism Enzyme SNP to Uric Acid Production|Relationship of Purine Metabolism Enzyme Single-Nucleotide Polymorphisms to Uric Acid Production and Response to Xanthine Oxidase Inhibitors|Completed||N/A|100|Actual|Keesler Air Force Base Medical Center|||2||f||||t||||||Samples With DNA|"     DNA will be banked for future studies as allowed by patient consent   "|||2017-10-11 01:49:07.794167|2017-10-11 01:49:07.794167
NCT01830712|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2014-04-14|||April 2011||2011-04-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors|A Long-Term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors. A Retrospective Follow-up Assessment to F7HAEM/USA/3/USA and F7HAEM/USA/4/USA|Completed||N/A|15|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:49:07.870211|2017-10-11 01:49:07.870211
NCT01830699|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2014-07-13|2014-05-10||March 2013||2013-03-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Prior to starting the trial, we anticipated having to recruit 150 subjects total (75 in each arm). At our first analysis of the data, the effect size of both the rilonacept and triamcinolone were larger than expected, and a re-calculated 'n' was 29 for an alpha of 0.05 and power of 1.0000 (effect size 1.1).|Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis|Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis|Completed||N/A|33|Actual|Keesler Air Force Base Medical Center||2|||f||||t||||||||||2017-10-11 01:49:07.966125|2017-10-11 01:49:07.966125
NCT01830686|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-02-01|||April 2013||2013-04-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Interventional|BROWNIE||Metabolic Effects of Short Term Sugarcane Bagasse Supplementation|Metabolic Effects of Short Term Sugarcane Bagasse Supplementation|Completed||N/A|23|Actual|Pennington Biomedical Research Center||3|||f||||f||||||||No||2017-10-11 01:49:08.583109|2017-10-11 01:49:08.583109
NCT01830673|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-07-24|||October 2011||2011-10-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Observational|RTCAS||Regulatory T-cells After Subcutaneous Immunotherapy|Investigation of T-regulatory Cells After Subcutaneous Immunotherapy|Completed||N/A|68|Actual|Johann Wolfgang Goethe University Hospital|||3||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 01:49:08.688248|2017-10-11 01:49:08.688248
NCT01830660|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2015-04-03|||April 2012||2012-04-01|April 2013|2013-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers|A Phase I, Randomized, Placebo-controlled, Ascending Single And Multiple Oral Dose Study To Investigate Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Hetrombopag Olamine (SHR8735 Olamine) In Healthy Subjects|Completed||Phase 1|96|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:49:08.769723|2017-10-11 01:49:08.769723
NCT01830647|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-11-01|||April 2013||2013-04-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Cancer of the Colon or Rectum|Non-interventional Local Study to Describe the Safety, Tolerability and Efficacy of Bevacizumab in Combination With Standard Chemotherapy Regimens as First Line in Patients With Metastatic Cancer of the Colon or the Rectum|Completed||N/A|35|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:49:08.854635|2017-10-11 01:49:08.854635
NCT01830634|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-11|||June 2005||2005-06-01|April 2013|2013-04-01|July 2006|Actual|2006-07-01|January 2006|Actual|2006-01-01||Interventional|||Lower-limb Strength and Flexibility Program on Prevention of Recurrent Falls in the Community-dwelling Elderly||Completed||N/A|107|Actual|Changhua Christian Hospital||1|||f||||||||||||||2017-10-11 01:49:08.920749|2017-10-11 01:49:08.920749
NCT01830621|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2016-05-12|||April 2013||2013-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Interventional|||BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma|A Phase III Randomized Study of BBI608 and Best Supportive Care Versus Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma|Completed||Phase 3|282|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 01:49:09.021041|2017-10-11 01:49:09.021041
NCT01830582|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2017-06-21|||April 9, 2013|Actual|2013-04-09|June 2017|2017-06-01|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Interventional|||Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer|Pilot Study of Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer|Completed||N/A|28|Actual|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-11 01:49:09.489993|2017-10-11 01:49:09.489993
NCT01830569|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-07-29|||September 2015||2015-09-01|July 2015|2015-07-01||||September 2016|Anticipated|2016-09-01||Interventional|||Impact of an Evidence-based Electronic Decision Support System on Diabetes Care|Feasibility and Impact of an Evidence-based Electronic Decision Support System on Diabetes Care in Family Medicine: a Cluster Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|618|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 01:49:09.582024|2017-10-11 01:49:09.582024
NCT01830556|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-05-19|||November 2011||2011-11-01|May 2013|2013-05-01|November 2015|Anticipated|2015-11-01|November 2013|Anticipated|2013-11-01||Interventional|CETMET||Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck|Cetuximab 5-FU and Cisplatin or Carboplatin Versus Cetuximab With Paclitaxel and Carboplatin Treatment of Metastatic Squamous Cell Carcinoma of Head and Neck|Unknown status|Recruiting|Phase 2|120|Anticipated|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 01:49:09.684521|2017-10-11 01:49:09.684521
NCT01830543|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-08-21|2017-06-30||May 10, 2013|Actual|2013-05-10|August 2017|2017-08-01|July 28, 2016|Actual|2016-07-28|July 28, 2016|Actual|2016-07-28||Interventional|PIONEER AF-PCI|The intent-to-treat analysis set included all randomized participants.|A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention|An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention|Completed||Phase 3|2124|Actual|Janssen Scientific Affairs, LLC|First the stratification to either 1, 6 or 12 months of DAPT was based upon clinician choice and was not randomized. Secondly there was not sufficient power to definitively assess efficacy due to the modest number of adverse CV events.|3|||f||||t||f||||||||2017-10-11 01:49:09.928826|2017-10-11 01:49:09.928826
NCT01830530|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-04-09|||May 2012||2012-05-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|HIGHCARE-A||HIGH Altitude CArdiovascular REsearch in the ANDES|HIGH Altitude CArdiovascular REsearch in the ANDES|Completed||Phase 4|100|Actual|Istituto Auxologico Italiano||2|||f||||f||||||||||2017-10-11 01:49:15.089571|2017-10-11 01:49:15.089571
NCT01830517|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-11|||August 2007||2007-08-01|April 2013|2013-04-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Interventional|||Diurnal Variation in Hypertensive Stroke Patients|Comparison of the Effects of Amlodipine and Losartan on Blood Pressure and Diurnal Variation in Hypertensive Stroke Patients|Completed||Phase 4|84|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 01:49:15.203377|2017-10-11 01:49:15.203377
NCT01830504|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-10-04|||April 2013||2013-04-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|April 2013|Actual|2013-04-01||Interventional|BKM120||A Multicenter Phase II Pilot Open Label|A Multicenter Phase II Pilot Open Label Study to Evaluate the Efficacy and Safety of BKM120 in the Treatment of Patients With Advanced or Metastatic Differentiated Thyroid Cancers|Active, not recruiting||Phase 2|47|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 01:49:15.305862|2017-10-11 01:49:15.305862
NCT01830491|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-10-10|||March 2009||2009-03-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients|Comparison of Antiplatelet Effect and Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients: Multi-center, Randomized, Double-blind, Phase IV Clinical Trial|Completed||Phase 4|162|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||No||2017-10-11 01:49:15.412818|2017-10-11 01:49:15.412818
NCT01830465|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-28|2013-04-11|||August 2006||2006-08-01|April 2013|2013-04-01|May 2011|Actual|2011-05-01|August 2008|Actual|2008-08-01||Interventional|||VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma|Phase II Study of VELCADE in Combination With Rituximab in Patients With Relapsed or Progressed Non Hodgkin's Follicular Lymphoma|Completed||Phase 2|45|Actual|Gruppo Italiano Studio Linfomi||1|||f||||f||||||||||2017-10-11 01:49:15.614853|2017-10-11 01:49:15.614853
NCT01830452|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-04-09|||September 2010||2010-09-01|April 2013|2013-04-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|HIPPO||Less Chronic Pain After Lichtenstein Hernioplasty Using the Self-gripping Parietex Progrip Mesh|Multicentre Randomised Controled Trial Comparing the Effect of a New Self-gripping Lightweight Polyester Mesh and a Normal Sutured Lightweight Polyester Mesh on the Incidence of Chronic Inguinodynia in Lichtenstein Hernioplasty.|Unknown status|Recruiting|Phase 4|400|Anticipated|Groene Hart Ziekenhuis||2|||f||||f||||||||||2017-10-11 01:49:15.721993|2017-10-11 01:49:15.721993
NCT01830439|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-01-12|||September 2009||2009-09-01|August 2015|2015-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|CL-009||Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009)|A Phase 1, Randomized, Balanced, Single-Dose, Two-Period, Two-Sequence, Crossover, Open-Label Study of the Effect of Food on the Bioavailability and Pharmacokinetics of PA-824 Tablets in Healthy Adult Subjects|Completed||Phase 1|32|Actual|Global Alliance for TB Drug Development||4|||f||||f||||||||||2017-10-11 01:49:15.847999|2017-10-11 01:49:15.847999
NCT01830426|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-01-20|||November 2012||2012-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|LDx||Circulating Tumor Cells in Non-Small Cell Lung Carcinoma|Phase 2 Study of Circulating Tumor Cell in Non-Small Cell Lung Carcinoma|Completed||N/A|232|Actual|Epic Sciences|||1||f||||t||||||Samples With DNA|"     Cell solution plated onto slides and frozen for storage   "|||2017-10-11 01:49:15.953821|2017-10-11 01:49:15.953821
NCT01830413|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-18|||April 2013||2013-04-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01|12 Months|Observational [Patient Registry]|||Stenting for Symptomatic Intracranial Artery Stenosis Registry in China|Stenting for Symtomatic Intracranial Artery Stenosis Registry in China|Unknown status|Not yet recruiting|N/A|450|Anticipated|Beijing Tiantan Hospital|||1||f||||t||||||||||2017-10-11 01:49:16.034943|2017-10-11 01:49:16.034943
NCT01830387|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2016-04-15|||April 2013||2013-04-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Comparative Study of Polymetric Clips (Hem-o-Lok) Versus Historical Endoscopic Staplers for Laparoscopic Appendectomy|Comparative Study of Polymetric Clips (Hem-o-Lok) Versus Historical Endoscopic Staplers for Laparoscopic Appendectomy|Completed||N/A|26|Actual|Duke University|||2||f||||f||||||||No||2017-10-11 01:49:16.551065|2017-10-11 01:49:16.551065
NCT01830374|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2017-03-29|||August 2012||2012-08-01|March 2017|2017-03-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Observational|TEDS||Bulimia Nervosa: A Biobehavioral Study (The Eating Disorder Study)|Weight Suppression, Dieting, and Bulimia Nervosa: A Biobehavioral Study|Recruiting||N/A|132|Anticipated|Drexel University|||1||f||||f||||||||||2017-10-11 01:49:16.635875|2017-10-11 01:49:16.635875
NCT01830361|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-09-11|||April 2012||2012-04-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|May 2018|Anticipated|2018-05-01||Interventional|MIDOKIT||Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML|A Single-arm Phase II Trial to Assess the Efficacy of Midostaurin (PKC412) Added to Standard Primary Therapy in Patients With Newly Diagnosed c-KIT or FLT3-ITD Mutated t(8;21) AML|Recruiting||Phase 2|18|Anticipated|Technische Universität Dresden||1|||f||||t||||||||||2017-10-11 01:49:16.733051|2017-10-11 01:49:16.733051
NCT01830348|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2015-11-18|||February 2013||2013-02-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|STRIDE 1||Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers|A Randomized, Double-blind, Parallel-group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects With Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 3|422|Anticipated|Derma Sciences, Inc.||2|||f||||f||||||||||2017-10-11 01:49:16.868916|2017-10-11 01:49:16.868916
NCT01830335|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-01-11|||April 2013||2013-04-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Environmental Stress|The Influence of Cerebral Blood Flow and Alkalosis on Neuromuscular Function During Environmental Stress|Active, not recruiting||Phase 4|10|Anticipated|Brock University||2|||f||||f||||||||||2017-10-11 01:49:17.008908|2017-10-11 01:49:17.008908
NCT01830322|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-08-13|||January 2014||2014-01-01|August 2013|2013-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer|A Phase II Open-Label Clinical Trial of CPI-613 Given Alone, or in Combination With Gemcitabine, in Patients With Metastatic Pancreatic Cancer|Withdrawn||Phase 2|0|Actual|Cornerstone Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 01:49:17.125827|2017-10-11 01:49:17.125827
NCT01830309|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-04-09|||January 2013||2013-01-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Food-Effect on PK and PD of Single Oral Dose of CJ-12420 in Healthy Male Subjects|Clinical Study to Evaluate Food-Effect on Pharmacokinetics and Pharmacodynamics of Single Oral Dose of CJ-12420 in Healthy Male Subjects|Completed||Phase 1|24|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 01:49:17.562014|2017-10-11 01:49:17.562014
NCT01830296|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-04-10|||May 2011||2011-05-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Intravenous Remifentanil Plus Morphine or Morphine Alone for Postthoracotomy Pain|COADMINISTRATION OF INTRAVENOUS REMIFENTANIL AND MORPHINE FOR POSTTHORACOTOMY PAIN; COMPARISON WITH IV MORPHINE ALONE|Completed||Phase 4|60|Actual|Cukurova University||2|||f||||f||||||||||2017-10-11 01:49:17.644203|2017-10-11 01:49:17.644203
NCT01830283|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-05-27|||April 2013||2013-04-01|April 2013|2013-04-01|April 2018|Anticipated|2018-04-01|June 2013|Anticipated|2013-06-01||Interventional|||The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination|Phase 4 Study of the Varicella Vaccine After the 2nd Dose Vaccination|Enrolling by invitation||Phase 4|50000|Anticipated|Beijing Center for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 01:49:17.722069|2017-10-11 01:49:17.722069
NCT01830270|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-02-23|||May 2011||2011-05-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|April 2015|Actual|2015-04-01||Interventional|IPEC-GC||Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer|Preoperative Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel (Intensified PET) in Patients With Locally Gastric Cancer : a Phase II Proof-of-concept Study.|Terminated||Phase 2|30|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-11 01:49:17.817966|2017-10-11 01:49:17.817966
NCT01830257|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2013-04-11|||April 2013||2013-04-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|AEFI||Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)|Phase 4 Study of MR and APDT Vaccine|Unknown status|Enrolling by invitation|Phase 4|1000|Anticipated|Beijing Center for Disease Control and Prevention||1|||f||||f||||||||||2017-10-11 01:49:17.913517|2017-10-11 01:49:17.913517
NCT01830244|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-06-28|||April 2013||2013-04-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|September 2015|Actual|2015-09-01||Interventional|Neonab||IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer|Tailored Neoadjuvant Epirubicin and Cyclophosphamide (EC) and Nanoparticle Albumin Bound (Nab) Paclitaxel for Newly Diagnosed Breast Cancer|Active, not recruiting||Phase 2|60|Anticipated|Barwon Health||1|||f||||f||||||||||2017-10-11 01:49:17.990352|2017-10-11 01:49:17.990352
NCT01830231|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-01-27|||October 2012||2012-10-01|January 2014|2014-01-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)|A Randomised Phase II/III Study of Cabazitaxel Versus Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium|Unknown status|Recruiting|Phase 2/Phase 3|372|Anticipated|Associació per a la Recerca Oncologica, Spain||2|||f||||t||||||||||2017-10-11 01:49:18.13122|2017-10-11 01:49:18.13122
NCT01830218|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2013-04-11|||November 2011||2011-11-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|OBAAMA||Obstetric Anesthesia and Analgesia Month Attributes in Czech Republic|A National Survey on Obstetric Anesthesia and Analgesia Care in Czech Republic|Completed||N/A|1940|Actual|Charles University, Czech Republic|||1||f||||t||||||||||2017-10-11 01:49:18.32744|2017-10-11 01:49:18.32744
NCT01830205|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-11-13|2015-08-19||September 2012||2012-09-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment|Single Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment|Completed||Phase 1|58|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 01:49:18.503927|2017-10-11 01:49:18.503927
NCT01830192|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-11|||January 2010||2010-01-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|REM||REM (Risk Of Endometrial Malignancy)|REM (Risk Of Endometrial Malignancy): A Proposal for a New Scoring System to Evaluate Risk of Endometrial Malignancy|Completed||N/A|741|Actual|Campus Bio-Medico University||2|||f||||f||||||||||2017-10-11 01:49:19.492068|2017-10-11 01:49:19.492068
NCT01830166|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-07-11|||May 2013||2013-05-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|FTPC||Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy|FTPC (Focal Therapy for Prostate Cancer): A Pilot Study Using Focal Low Dose Rate Brachytherapy as an Alternative to Active Surveillance and Radical Treatment for Favourable Risk Prostate Cancer.|Active, not recruiting||N/A|10|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 01:49:19.594608|2017-10-11 01:49:19.594608
NCT01830153|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2013-04-11|||April 2010||2010-04-01|April 2013|2013-04-01||||January 2013|Actual|2013-01-01||Interventional|||RAD001 in Advanced Sarcoma|A Phase II Multicenter Trial of RAD001 in Patients With Metastatic or Recurrent Sarcomas|Completed||Phase 2|41|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 01:49:19.691336|2017-10-11 01:49:19.691336
NCT01830140|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-10|2015-04-21|2015-04-21||July 2013||2013-07-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|466|Actual|Allergan||2|||f||||f||||||||||2017-10-11 01:49:19.822151|2017-10-11 01:49:19.822151
NCT01830127|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2015-10-20|2015-10-20|2014-10-23|April 2013||2013-04-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||(Treated Set) All patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment, regardless of randomization.|BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3|A Phase IIb Open Label Study of BI 207127 in Combination With Faldaprevir and Ribavirin in Patients With Moderate Hepatic Impairment (Child-Pugh B) With Genotype 1b Chronic Hepatitis C Infection|Completed||Phase 2|35|Actual|Boehringer Ingelheim|Because the company decided to stop the DBV development program, analyses for this trial were limited to the basic requirement for efficacy, and only the primary endpoint and secondary endpoint were analyzed.|2|||f||||||||||||||2017-10-11 01:49:20.115884|2017-10-11 01:49:20.115884
NCT01830114|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-06-13|||April 2013||2013-04-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Web App for Patients With Alcohol and Drug Use Problems in Primary Care|A Web App for Patients With Alcohol and Drug Use Problems in Primary Care|Completed||N/A|10|Actual|Behavior Therapy Associates, LLP||1|||f||||f||||||||||2017-10-11 01:49:20.973246|2017-10-11 01:49:20.973246
NCT01830101|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-03-14|||February 2014||2014-02-01|February 2014|2014-02-01|November 2017|Anticipated|2017-11-01|May 2015|Anticipated|2015-05-01||Interventional|||A Phase III Study of Re-Irradiation in Recurrent Glioblastoma|A Randomized Phase III Study of Re-Irradiation in Recurrent Glioblastoma|Withdrawn||Phase 3|0|Actual|AHS Cancer Control Alberta||2||This study will not be proceeding due to lack of funding from anticipated sources|f||||t||||||||||2017-10-11 01:49:21.059268|2017-10-11 01:49:21.059268
NCT01830088|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-03-17|||October 2013||2013-10-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|BudFam2||Family Based Treatment of Depressed Adolescents (AHUS)|Family-based Treatment of Depressed Adolescents: An Empirical Study With Norwegian Adolescents in Specialty Mental Health Care|Completed||N/A|62|Actual|University Hospital, Akershus||2|||f||||t||||||||||2017-10-11 01:49:21.148236|2017-10-11 01:49:21.148236
NCT01830075|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-07-26|||May 2014||2014-05-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|LISA||The Life InSight Application Study (LISA)|The Life InSight Application Study: the Role of an Assisted Structured Reflection on Life Events and Ultimate Life Goals to Improve Quality of Life of Cancer Patients|Completed||N/A|153|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 01:49:21.244115|2017-10-11 01:49:21.244115
NCT01830062|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-07-01|||November 2013||2013-11-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Interventional|||Atherosclerotic Coronary Vulnerable Plaque: Correlation With Coronary Artery Calcium|Atherosclerotic Coronary Vulnerable Plaque: Correlation With Coronary Artery Calcium|Recruiting||N/A|60|Anticipated|Medstar Health Research Institute||1|||f||||f||||||||||2017-10-11 01:49:21.317269|2017-10-11 01:49:21.317269
NCT01830049|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-10|||March 2013||2013-03-01|April 2013|2013-04-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Observational|||Differential Plasma MicroRNA Profiles in ED and Normal Erectile Function in Older Males||Unknown status|Recruiting|N/A|30|Anticipated|Nanjing Medical University|||3||f||||||||||||||2017-10-11 01:49:21.409955|2017-10-11 01:49:21.409955
NCT01830036|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-09-22|||June 2011||2011-06-01|September 2015|2015-09-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01|12 Months|Observational [Patient Registry]|RehaSleep||RehaSleep Register - Prevalence of Sleep Apnea in Cardiac Rehabilitation|RehaSleep Register - Prevalence of Sleep Apnea in Cardiac Rehabilitation|Unknown status|Active, not recruiting|N/A|1300|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 01:49:21.491889|2017-10-11 01:49:21.491889
NCT01830010|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-07-10|||June 29, 2013|Actual|2013-06-29|July 2017|2017-07-01|January 27, 2020|Anticipated|2020-01-27|January 27, 2020|Anticipated|2020-01-27||Interventional|||A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies|A Two-part, Single- and Two Arm Randomized, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy (in Part 2 Only) of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies|Recruiting||Phase 1|30|Anticipated|Novartis||3|||f||||f|f|f||||||||2017-10-11 01:49:21.627559|2017-10-11 01:49:21.627559
NCT01829997|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-12-12|||April 2013||2013-04-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Assessment of nanOss Bioactive 3D in the Posterolateral Spine|A Prospective, Post-Market Assessment Of NanOss Bioactive 3D in the Posterolateral Spine|Recruiting||N/A|50|Anticipated|Pioneer Surgical Technology, Inc.||1|||f||||f||||||||No||2017-10-11 01:49:21.828359|2017-10-11 01:49:21.828359
NCT01829984|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-09-03|||April 2013||2013-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers|A Comparison of Strategies for Injection Teaching: Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers|Completed||N/A|51|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 01:49:21.929692|2017-10-11 01:49:21.929692
NCT01829971|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-09-26|||April 2013||2013-04-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Interventional|||A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection|A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection|Terminated||Phase 1|155|Actual|Mirna Therapeutics, Inc.||1||Five immune related serious adverse events|f||||t||||||||No||2017-10-11 01:49:22.015319|2017-10-11 01:49:22.015319
NCT01829958|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-05-15|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy|Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy|Recruiting||N/A|200|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:49:22.155548|2017-10-11 01:49:22.155548
NCT01829945|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-10|||October 2009||2009-10-01|April 2013|2013-04-01|February 2011|Actual|2011-02-01|February 2010|Actual|2010-02-01||Observational|||Study of the Relationships Between Apolipoprotein B-48 Kinetics and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With the Metabolic Syndrome (SMB48)|Study of the Relationships Between Apolipoprotein B-48 Kinetics and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With the Metabolic Syndrome.|Completed||N/A|30|Actual|Laval University|||1||f||||f||||||Samples With DNA|"     Serum Plasma Intestinal tissue   "|||2017-10-11 01:49:22.300754|2017-10-11 01:49:22.300754
NCT01829932|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-10-13|||April 2013||2013-04-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study|The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study|Completed||N/A|30|Actual|Queen's University||2|||f||||f||||||||||2017-10-11 01:49:22.378331|2017-10-11 01:49:22.378331
NCT01829919|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-10-14|2013-07-16||July 2011||2011-07-01|October 2015|2015-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|N30-005|24|Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women|Evaluation of Pharmacokinetics of Paroxetine Following Single and Repeat Oral Administration of Mesafem (7.5 mg Paroxetine Mesylate) Capsules in Healthy Postmenopausal Women|Completed||Phase 1|24|Actual|Noven Therapeutics||1|||f||||f||||||||||2017-10-11 01:49:22.474238|2017-10-11 01:49:22.474238
NCT01829906|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-10-02|||August 2013|Actual|2013-08-01|September 2017|2017-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Suboptimal Weight Loss After Gastric Bypass Surgery|Evaluation of the Efficacy of Two Lifestyle Interventions for Suboptimal Weight Loss After Gastric Bypass Surgery|Terminated||N/A|49|Actual|Norwegian University of Science and Technology||2||too few candidates for enrollment|f||||f|f|f||||||||2017-10-11 01:49:22.837141|2017-10-11 01:49:22.837141
NCT01829893|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-08|||January 2012||2012-01-01|December 2011|2011-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination|Open Label, Randomized Comparative Study to Evaluate the Pharmacokinetic Characteristics Between Coadministered Finasteride Tablet and Tamsulosin HCl Tablet and GL2701 Capsule, in Healthy Subjects|Completed||Phase 1|26|Actual|Korea University Anam Hospital||2|||f||||f||||||||||2017-10-11 01:49:22.923945|2017-10-11 01:49:22.923945
NCT01829880|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-08|||October 2011||2011-10-01|April 2013|2013-04-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Observational|||Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure|Impact of Body Composition Changes and Cachexia on Bisoprolol and Ramipril Pharmacokinetics and Renal Function Estimation in Patients With Chronic Heart Failure|Unknown status|Recruiting|N/A|60|Anticipated|The University Clinic of Pulmonary and Allergic Diseases Golnik|||1||f||||||||||Samples Without DNA|"     Plasma, serum   "|||2017-10-11 01:49:23.016682|2017-10-11 01:49:23.016682
NCT01829867|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-01-26|||April 2013||2013-04-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.|A Phase I, Open-label Study in Patients With Parkinson's Disease to Further Assess Safety and Tolerability of sNN0031 Administered at the Total Dose of 95 μg by Intracerebroventricular Infusion|Terminated||Phase 1|5|Actual|Newron Sweden AB||1||"Issues with development and supply of infusion system for delivery of IMP. Prolonged approval   process for the clinical study sNN0031-004."|f||||t||||||||||2017-10-11 01:49:23.117733|2017-10-11 01:49:23.117733
NCT01829854|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-10|||June 2012||2012-06-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Observational|||To Investigate the Incidence of Obstructive Sleep Apnoea in Patient Undergoing Open Heart Surgery|Unrecognised Obstructive Sleep Apnoea In Cardiac Surgery Patient In The Asian Population|Unknown status|Recruiting|N/A|400|Anticipated|University of Malaya|||1||f||||t||||||||||2017-10-11 01:49:23.202817|2017-10-11 01:49:23.202817
NCT01829841|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-08|||May 2011||2011-05-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|May 2013|Anticipated|2013-05-01||Interventional|||A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer|A Randomized, Positive-controlled, Double-blind, Multicenter, Phase II Study of Famitinib as First/Second Line Treatment in Patients With Advanced Metastatic Renal Cell Cancer|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:49:23.288418|2017-10-11 01:49:23.288418
NCT01829828|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-08|||January 2012||2012-01-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management|To Evaluate the Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management; Multicenter, Cross-sectional Study|Completed||Phase 4|587|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 01:49:23.378977|2017-10-11 01:49:23.378977
NCT01829815|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-01-22|||August 2012||2012-08-01|January 2016|2016-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Impact of a Parenting Program in Liberia to Improve Parenting, Education, and Health Outcomes for Children in Liberia|Impact Evaluation of a Parenting Program to Improve Parenting, Education, and Health Outcomes for Young Children in Liberia|Completed||N/A|270|Actual|International Rescue Committee||2|||f||||f||||||||Undecided|File needs to be anonymized|2017-10-11 01:49:23.457328|2017-10-11 01:49:23.457328
NCT01829802|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-01-23|||May 2014||2014-05-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ARTE||RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients|A Pilot Randomized, Open Label Study to Evaluate Efficacy and Safety of the Combination of RAL+ATV/r in Comparison With TDF/FTC+ATV/r in HIV Infected Patients, Who Failed an Initial NNRTI Containing Regimen|Active, not recruiting||Phase 4|50|Anticipated|The Huesped Foundation||2|||f||||f||||||||Undecided||2017-10-11 01:49:23.55861|2017-10-11 01:49:23.55861
NCT01829789|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-09-29|||April 2013||2013-04-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|POP||Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth|Group Community Reinforcement Training for Parents of Treatment-Elusive Youth|Completed||N/A|60|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-10-11 01:49:23.667496|2017-10-11 01:49:23.667496
NCT01829776|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-11-03|||April 2013||2013-04-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|FFF||Pilot Study of Free From Falls Program in Multiple Sclerosis|Pilot Study on the Effect of the Free From Falls Program on Falls in People With Multiple Sclerosis|Completed||N/A|13|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-10-11 01:49:23.761649|2017-10-11 01:49:23.761649
NCT01829763|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2014-07-23|||April 2013||2013-04-01|July 2014|2014-07-01|November 2015|Anticipated|2015-11-01|April 2015|Anticipated|2015-04-01||Interventional|||Central Effects of Botulinum Toxin: Neurophysiological Study in Stroke Patients With Spastic Lower Limb|Central Effects of Botulinum Toxin: Neurophysiological Study in Stroke Patients With Spastic Lower Limb|Unknown status|Recruiting|Phase 3|20|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:49:23.848771|2017-10-11 01:49:23.848771
NCT01829750|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-01-03|||April 2013||2013-04-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS)|Phase 2 Study of Intracoronary Infusion of Cardiac Progenitor Cells in Patients With Univentricular Heart Disease|Completed||Phase 2|34|Actual|Okayama University||2|||f||||t||||||||No||2017-10-11 01:49:23.925882|2017-10-11 01:49:23.925882
NCT01829737|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-10-05|||March 20, 2013||2013-03-20|January 20, 2015|2015-01-20|January 20, 2015|Actual|2015-01-20|January 20, 2015|Actual|2015-01-20||Observational|||Malaria Transmission Studies in Mali|Epidemiologic Studies of Plasmodium Falciparum Gametocytemia and Transmission-blocking Immunity in Kenieroba, Mali|Completed||N/A|650|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:49:24.011875|2017-10-11 01:49:24.011875
NCT01829724|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-08-22|||April 2, 2013||2013-04-02|August 9, 2017|2017-08-09|February 28, 2025|Anticipated|2025-02-28|February 28, 2025|Anticipated|2025-02-28||Observational|||Cerebral Palsy and the Study of Brain Activity During Motor Tasks|Near-infrared Spectroscopy and Electroencephalography to Assess and Train Cortical Activation During Motor Tasks|Recruiting||N/A|320|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:49:24.090469|2017-10-11 01:49:24.090469
NCT01829711|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-08-04|||April 29, 2013|Actual|2013-04-29|August 2017|2017-08-01|May 30, 2018|Anticipated|2018-05-30|May 24, 2017|Actual|2017-05-24||Interventional|||Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia|A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/ Refractory Hairy Cell Leukemia|Active, not recruiting||Phase 3|80|Actual|MedImmune LLC||1|||f||||t|t|f||||||||2017-10-11 01:49:24.184219|2017-10-11 01:49:24.184219
NCT01829698|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-03-21|||August 2009||2009-08-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBC|Evaluate the Efficacy And Safety Of TUDCA Compare UDCA In The Treatment Of Cholestatic Liver Disease-PBC by A Randomized,Double-Blind,Double Dummy,Parallel-Controlled,Multicenter Trial and The Consecutive Treatment By TUDCA|Completed||Phase 3|199|Actual|Beijing Trendful Kangjian Medical Information Consulting Limited Company||2|||f||||t||||||||||2017-10-11 01:49:24.513178|2017-10-11 01:49:24.513178
NCT01829685|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-06-17|||March 2013||2013-03-01|June 2014|2014-06-01||||June 2016|Anticipated|2016-06-01||Interventional|Dragon-Ex||Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy|A 3-year, Open-lable, Multi-center Extension Trial of Entecavir Therapy for Patients Previously Treated in Dragon Study|Unknown status|Active, not recruiting|Phase 4|360|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 01:49:24.635986|2017-10-11 01:49:24.635986
NCT01829672|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-07-07|||March 2013||2013-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography|Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography - Prospective Study|Completed||N/A|55|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-11 01:49:24.75094|2017-10-11 01:49:24.75094
NCT01829659|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-08-08|||May 2013||2013-05-01|August 2014|2014-08-01||||February 2015|Anticipated|2015-02-01||Observational|||The ACS Ethnicity Platelet Function Study|The ACS Ethnicity Platelet Function Study|Unknown status|Recruiting|N/A|30|Anticipated|Medstar Health Research Institute|||1||f||||f||||||||||2017-10-11 01:49:24.865263|2017-10-11 01:49:24.865263
NCT01829646|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-04-15|||March 2013||2013-03-01|April 2013|2013-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology|Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology. A Prospective, Non-commercial and Mono-centric Study.|Unknown status|Recruiting|N/A|120|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 01:49:24.950501|2017-10-11 01:49:24.950501
NCT01829633|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-09-14|||March 2012||2012-03-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|February 2016|Actual|2016-02-01||Observational|||Anatomic and Clinical Long-term Follow-up of Conservatively Treated Rotator Cuff Tears|Anatomic and Clinical Long-term Follow-up of Conservatively Treated Rotator Cuff Tears|Enrolling by invitation||N/A|80|Anticipated|Martina Hansen's Hospital|||1||f||||t||||||||||2017-10-11 01:49:25.040187|2017-10-11 01:49:25.040187
NCT01829620|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2016-10-24|||April 2013||2013-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|MCP||Military Continuity Project|Military Continuity Project (MCP): A Suicide Prevention Study|Active, not recruiting||N/A|800|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-11 01:49:25.108879|2017-10-11 01:49:25.108879
NCT01829607|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-10|||January 2011||2011-01-01|April 2013|2013-04-01||||October 2012|Actual|2012-10-01||Interventional|||Functional Electrical Stimulation of Peripheral Muscles in Heart Failure With Preserved Left Ventricular Ejection Fraction||Completed||Phase 2|30|Actual|Attikon Hospital||2|||f||||||||||||||2017-10-11 01:49:25.220181|2017-10-11 01:49:25.220181
NCT01829594|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-09|||October 2006||2006-10-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2011|Actual|2011-04-01||Interventional|||Case Managers to Frail Older People a Randomized Controlled Trial|Case Managers to Frail Older People a Randomized Controlled Trial|Completed||N/A|153|Actual|Lund University||1|||f||||f||||||||||2017-10-11 01:49:25.401521|2017-10-11 01:49:25.401521
NCT01829581|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-02-25|||September 2011||2011-09-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Observational|RETRACE||geRman-widE mulTicenter Analysis of oRal Anticoagulation-associated intraCerebral hEmorrhage|German-wide Multicenter Analysis of Oral Anticoagulant-associated Intracerebral Hemorrhage|Completed||N/A|1205|Actual|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-10-11 01:49:25.514641|2017-10-11 01:49:25.514641
NCT01829568|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-09-04|||June 21, 2013|Actual|2013-06-21|August 2017|2017-08-01||||September 1, 2015|Actual|2015-09-01||Interventional|||Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma|A Phase I Study of Rituximab, Lenalidomide, and Ibrutinib in Previously Untreated Follicular Lymphoma|Active, not recruiting||Phase 1|33|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:49:25.614073|2017-10-11 01:49:25.614073
NCT01829555|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-11-06|||February 2013||2013-02-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Pilot Study Examining a Reinforcement Approach to Improve Diabetes Management|A Pilot Study Examining a Reinforcement Approach to Improve Diabetes Management|Completed||N/A|10|Actual|UConn Health||1|||f||||t||||||||||2017-10-11 01:49:25.782336|2017-10-11 01:49:25.782336
NCT01829542|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-10|||May 2012||2012-05-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|BB2||Dose-dependent Effects of Blueberry Polyphenols on Endothelial Function in Healthy Individuals|Dose-dependent Effects of Blueberry Polyphenols on Endothelial Function in Healthy Individuals|Completed||N/A|11|Actual|University of Reading||6|||f||||f||||||||||2017-10-11 01:49:25.86623|2017-10-11 01:49:25.86623
NCT01829529|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-09-01|||September 2013||2013-09-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Interventional|||Antibiotic Prophylaxis - Amoxicillin|Susceptibility Changes Among Oral Microorganisms Following Single Dose Antibiotic Prophylaxis|Completed||Phase 3|29|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 01:49:25.957053|2017-10-11 01:49:25.957053
NCT01829516|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-06-25|2015-12-09||May 2013||2013-05-01|June 2016|2016-06-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Intranasal Oxytocin and Social Cognition, Implicit Preferences and Craving in Alcohol Drinkers|The Effects of Intranasal Oxytocin on Social Cognition, Implicit Preferences and Craving in Moderate to Heavy Social Alcohol Drinkers|Completed||Phase 4|32|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:49:26.052072|2017-10-11 01:49:26.052072
NCT01829503|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-08-16|2016-10-20||February 2013||2013-02-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2015|Actual|2015-10-01||Interventional||Number of participants with each of the observed demographic and clinical characteristics.|Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)|Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed AML|Active, not recruiting||Phase 2|44|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 01:49:26.348819|2017-10-11 01:49:26.348819
NCT01829490|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-05-10|||July 2013||2013-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults|Phase I Trial to Evaluate the Safety and Immunogenicity of a ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy BCG Vaccinated Adults|Completed||Phase 1|42|Actual|University of Oxford||4|||f||||t||||||||||2017-10-11 01:49:27.206666|2017-10-11 01:49:27.206666
NCT01829477|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-04-24|2015-07-22||April 2013||2013-04-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Analysis population included all randomized participants.|Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-Week Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 50 mg Compared With Placebo as an Add-on to Glimepiride in Subjects With Type 2 Diabetes|Terminated||Phase 3|33|Actual|Takeda||2||Due to potential concerns about liver safety (See Detailed Description)|f||||t||||||||||2017-10-11 01:49:27.30822|2017-10-11 01:49:27.30822
NCT01829464|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-04-24|2015-07-24||May 2013||2013-05-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional||Full analysis set (FAS) included all randomized participants who received at least 1 dose of double blind study medication.|TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral Fasiglifam 25 mg and 50 mg Compared to Placebo When Used in Combination With Sitagliptin in Subjects With Type 2 Diabetes|Terminated||Phase 3|90|Actual|Takeda||3||Due to potential concerns about liver safety (See Detailed Description)|f||||t||||||||||2017-10-11 01:49:27.985252|2017-10-11 01:49:27.985252
NCT01829451|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-04-10|||January 2011||2011-01-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Hyaluronic Acid Gel in Prevention of Intrauterine Adhesions After Endometrial Ablation|Autocrosslinked Hyaluronic Acid Gel in Prevention of Intrauterine Adhesions After Bipolar Radiofrequency Endometrial Ablation: a Randomised, Controlled and Double Blind Study|Completed||N/A|32|Actual|University of Oulu||2|||f||||f||||||||||2017-10-11 01:49:28.744638|2017-10-11 01:49:28.744638
NCT01829438|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-10|||June 2010||2010-06-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Influence of Music on 6 Minutes Walking Distance in Healthy Children|Influence of a Distractive Auditory Stimulus on 6 Minute Walking Test in Healthy Children|Completed||N/A|97|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||4|||f||||f||||||||||2017-10-11 01:49:28.818185|2017-10-11 01:49:28.818185
NCT01829425|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-08-17|||March 2013||2013-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|Hyp-hOP||Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy|Protocol for Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence An RCT: Hypnotherapy Or Pharmacotherapy|Active, not recruiting||N/A|196|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-11 01:49:28.897895|2017-10-11 01:49:28.897895
NCT01829412|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-09|||July 2008||2008-07-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|MMY-MRI-08||Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma|Comparison of Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) With Skeletal X-Ray and MRI of the Spine for the Assessment of Bone Disease in Multiple Myeloma|Completed||N/A|50|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||f||||||||||2017-10-11 01:49:29.000912|2017-10-11 01:49:29.000912
NCT01829399|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-10-21|2015-08-17||April 2013||2013-04-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Control of Tourniquet Pain With an Axillary Ring of Subcutaneous Local Anesthetic|Control of Tourniquet Pain With an Axillary Ring of Subcutaneous Local Anesthetic|Completed||Phase 4|24|Actual|University of North Carolina, Chapel Hill|Originally this was designed as a crossover study. However, there was a very strong crossover effect which invalidated the results from the second series of injections. Therefore, we have only analyzed the data from the first visit.|2|||f||||f||||||||||2017-10-11 01:49:29.085277|2017-10-11 01:49:29.085277
NCT01829386|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-04-26|||January 2013||2013-01-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke|Non-Heme Iron Load Quantification in the Brain on MRI in Patients With Hemorrhagic Stroke|Recruiting||N/A|10|Anticipated|University of Michigan|||1||f||||t||||||||No||2017-10-11 01:49:29.41179|2017-10-11 01:49:29.41179
NCT01829373|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-10|||October 2011||2011-10-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|June 2012|Actual|2012-06-01||Interventional|||Lung Cancer Vaccine Plus Oral Dietary Supplement|Lung Cancer Immunotherapy With Vaccine 1650-G and Yeast Derived β-Glucan|Completed||Phase 1|5|Actual|University of Kentucky||1|||f||||t||||||||||2017-10-11 01:49:31.562373|2017-10-11 01:49:31.562373
NCT01829360|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-10-25|||March 2013||2013-03-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Accelerating Word Learning in Children With Language Impairment|Interactive Book Reading to Accelerate Word Learning by Children With SLI|Recruiting||Phase 1/Phase 2|104|Anticipated|University of Kansas||3|||f||||f||||||||||2017-10-11 01:49:31.741985|2017-10-11 01:49:31.741985
NCT01829347|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-10-20|||April 2014||2014-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Study to Assess Safety and Efficacy of ELAD in Subjects With Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure|A Randomized, Open-Label, Multicenter, Controlled Study to Assess Safety and Efficacy of ELAD® in Subjects With Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure|Terminated||Phase 3|18|Actual|Vital Therapies, Inc.||2||"Due to results from the 1st pivotal study, the ELAD clinical plan is being re-evaluated, and   the VTI-210 study has been terminated."|f||||t||||||||||2017-10-11 01:49:31.835962|2017-10-11 01:49:31.835962
NCT01829334|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-08|||June 2006||2006-06-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Cost-effectiveness of Four Methods in Preventing Fissure Caries in Permanent Teeth|A Comparative Study on the Cost-effectiveness of Four Methods in Preventing Fissure Caries in Permanent Teeth|Completed||Phase 2|329|Actual|The University of Hong Kong||4|||f||||f||||||||||2017-10-11 01:49:32.055151|2017-10-11 01:49:32.055151
NCT01829321|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-04-24|||April 2013||2013-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis|Exploratory, Phase II, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GLPG0974 in Subjects With Mild to Moderate Ulcerative Colitis|Completed||Phase 2|45|Actual|Galapagos NV||2|||f||||t||||||||||2017-10-11 01:49:32.159262|2017-10-11 01:49:32.159262
NCT01829308|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-09-29|||April 2013||2013-04-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|ST@T||SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers|SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers|Active, not recruiting||N/A|98|Actual|Friends Research Institute, Inc.||2|||f||||f||||||||No||2017-10-11 01:49:32.279759|2017-10-11 01:49:32.279759
NCT01829295|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-04-24|||August 2013||2013-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|FAST||Methotrexate and Mycophenolate Mofetil for UVEITIS|First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial|Recruiting||Phase 3|216|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:49:32.395769|2017-10-11 01:49:32.395769
NCT01829282|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-02-08|||July 2012||2012-07-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|||Eban II: Intervention for HIV Sero-Discordant Couples|Implementing Eban II: An Evidence-Based Intervention for HIV Sero-Discordant Couples|Recruiting||N/A|400|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 01:49:32.713719|2017-10-11 01:49:32.713719
NCT01829269|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2015-02-12|||April 2013||2013-04-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01|2 Years|Observational [Patient Registry]|FRAGILE||French Attitude Registry in Case of ICD Lead Replacement|French Attitude Registry in Case of ICD Lead Replacement|Recruiting||N/A|500|Anticipated|French Cardiology Society|||1||f||||f||||||||||2017-10-11 01:49:32.835279|2017-10-11 01:49:32.835279
NCT01829256|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-02-01|||May 2014||2014-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|STOP-DKD||Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)|Simultaneous Risk Factor Control Using Telehealth to SlOw Progression of Diabetic Kidney Disease (STOP-DKD)|Active, not recruiting||N/A|285|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:49:32.944298|2017-10-11 01:49:32.944298
NCT01829243|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2014-08-27|2014-07-16||July 2011||2011-07-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Baseline information is presented for subjects who completed the study.|Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial|Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia: A 13-week Randomized, Placebo Controlled Cross Over Trial|Completed||Phase 3|26|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:49:33.055878|2017-10-11 01:49:33.055878
NCT01829230|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-07-01|2014-09-18||March 2010||2010-03-01|July 2015|2015-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||Baseline summary was conducted on all randomized subjects in the study.|Myopia Progression After Ceasing Myopia Control Contact Lens Wear|Myopia Progression After Ceasing Myopia Control Contact Lens Wear|Completed||N/A|82|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 01:49:33.493954|2017-10-11 01:49:33.493954
NCT01829217|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2017-01-19|||May 2013||2013-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Sunitinib in Never-Smokers With Lung Adenocarcinoma|A Phase II Trial of Sunitinib in Never-smokers With Lung Adenocarcinoma: Identification of Oncogenic Alterations Underlying Sunitinib Sensitivity|Active, not recruiting||Phase 2|13|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:49:33.804883|2017-10-11 01:49:33.804883
NCT01829204|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-11-09|||April 2013||2013-04-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01|12 Months|Observational [Patient Registry]|CRIPB-13-002||Prospective Data Bank Creation to Study Vaginal Conditions|A Prospective Longitudinal Data Bank Creation to Study Vaginal Conditions With a Novel Diagnostic Approach|Recruiting||N/A|550|Anticipated|Texas Tech University Health Sciences Center|||4||f||||t||||||||||2017-10-11 01:49:33.898661|2017-10-11 01:49:33.898661
NCT01829191|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-05-04|2015-07-01||April 2008||2008-04-01|May 2016|2016-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||Baseline summary was conducted on all subjects who randomized in the study.|Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)|Controlling Myopia Progression With Soft Contact Lenses|Completed||N/A|174|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 01:49:33.998446|2017-10-11 01:49:33.998446
NCT01829178|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-05-11|||August 2013||2013-08-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma|Phase 2-3 Study of Silymarin on Cisplatin Induced Nephrotoxicity|Completed||Phase 2/Phase 3|30|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:49:34.326717|2017-10-11 01:49:34.326717
NCT01829165|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-05-25|||September 2012||2012-09-01|May 2017|2017-05-01|January 20, 2017|Actual|2017-01-20|January 20, 2017|Actual|2017-01-20||Interventional|||Brain Imaging of rTMS Treatment for Depression|A Causal Neural Network-level Understanding of Depression and Its Treatment Through Concurrent TMS and fMRI|Completed||N/A|59|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 01:49:34.439318|2017-10-11 01:49:34.439318
NCT01829152|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2014-07-25|||December 2013||2013-12-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure|Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure|Unknown status|Active, not recruiting|N/A|100|Anticipated|Verizon Wireless||2|||f||||f||||||||||2017-10-11 01:49:34.526158|2017-10-11 01:49:34.526158
NCT01829139|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-04-08|||March 2012||2012-03-01|April 2013|2013-04-01|December 2021|Anticipated|2021-12-01|February 2014|Anticipated|2014-02-01|2 Years|Observational [Patient Registry]|||Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones|A Prospective Multicenter Comparative Study for Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones|Recruiting||N/A|200|Anticipated|Soon Chun Hyang University|||2||f||||f||||||||||2017-10-11 01:49:34.773716|2017-10-11 01:49:34.773716
NCT01829126|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-11-07|||April 2013||2013-04-01|November 2013|2013-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01|1 Year|Observational [Patient Registry]|||Development and Prevention of Severe Heart Disease in Systemic Sclerosis||Unknown status|Recruiting|N/A|765|Anticipated|"University of Campania Luigi Vanvitelli"|||4||f||||f||||||||||2017-10-11 01:49:34.894222|2017-10-11 01:49:34.894222
NCT01829113|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-08-17|||July 2013|Actual|2013-07-01|August 2017|2017-08-01|April 19, 2017|Actual|2017-04-19|April 19, 2017|Actual|2017-04-19||Interventional|Spruce||Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer|Double-Blind Randomized Phase II Trial of Carboplatin and Pemetrexed With or Without OGX-427 in Patients With Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer (The Spruce Clinical Trial)|Completed||Phase 2|155|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-10-11 01:49:35.092484|2017-10-11 01:49:35.092484
NCT01829100|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-04-10|||September 2009||2009-09-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression|The Function of Avoidance in Depressed Behavior and a Pilot of Transdiagnostic Behavioral Activation Therapy|Completed||Phase 1/Phase 2|895|Actual|Rutgers University||2|||f||||t||||||||||2017-10-11 01:49:35.278764|2017-10-11 01:49:35.278764
NCT01829074|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-10|||April 2013||2013-04-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||Predictive Value of Subjective and Objective Measurement Tools for Extraesophageal Reflux||Unknown status|Enrolling by invitation|N/A|150|Anticipated|Respiratory Technology Corporation|||1||f||||||||||||||2017-10-11 01:49:35.51066|2017-10-11 01:49:35.51066
NCT01829061|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-03-28|||April 2013||2013-04-01|November 2013|2013-11-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Observational|||Reproducibility and Method Comparison Studies of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver Study of the Quo-Test™ A1C System|Reproducibility and Method Comparison of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver of the Quo-Test™ A1C System|Terminated||N/A|360|Actual|Quotient Diagnostics Limited|||1|Data for Study Devices vs. Predicate not within allowable ranges.|f||||f||||||Samples Without DNA|"     Whole Blood Venous Draw and Capillary Blood - IVD Study   "|||2017-10-11 01:49:35.586817|2017-10-11 01:49:35.586817
NCT01829048|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-12-04|||March 2013||2013-03-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia|A Randomized, Double-Blind, Placebo Controlled, Sponsor Open, Phase 1b Study To Examine The Adjunctive Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia|Completed||Phase 1|37|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 01:49:35.672303|2017-10-11 01:49:35.672303
NCT01829035|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2016-04-05|||February 2013||2013-02-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC|A Randomized, Controlled Phase III Trial of Sorafenib With or Without Conventional Transarterial Chemoembolization in Patients With Advanced Hepatocellular Carcinoma (STAH Study)|Active, not recruiting||Phase 3|338|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 01:49:35.763107|2017-10-11 01:49:35.763107
NCT01829022|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2014-06-24|||April 2013||2013-04-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|E-NOTES||Multi-center Prospective Study on E-NOTES for Myomectomy With Traction of Multidirectional Sutures|Multi-center Prospective Study on Embryonic-Natural Orifice Transumbilical Endoscopic Surgery for Myomectomy With Traction of Multidirectional Sutures|Completed||N/A|35|Actual|National Cancer Center, Korea|||1||f||||t||||||||||2017-10-11 01:49:35.861875|2017-10-11 01:49:35.861875
NCT01829009|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-04-20||||||April 2015|2015-04-01||||April 2013|Actual|2013-04-01||Interventional|||Resistance Exercise Effect on Physical Performance and Functional Status in Sarcopenic Older Women|Resistance Exercise Effect on Physical Performance and Functional Status in Sarcopenic Older Women|Withdrawn||N/A|0|Actual|National Institute of Medical Sciences and Nutrition, Salvador Zubiran||2||Financial issues|f||||t||||||||||2017-10-11 01:49:35.95338|2017-10-11 01:49:35.95338
NCT01828996|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-04-27|||February 2013||2013-02-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CPPS||Shocking Therapy for Chronic Pelvic Pain Syndrome|Shocking Therapy for Pelvic Pain: Evaluation of Shock Wave Therapy to Treat Chronic Pelvic Pain in Men|Enrolling by invitation||N/A|40|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-11 01:49:36.047793|2017-10-11 01:49:36.047793
NCT01828970|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2013-04-09|||January 2010||2010-01-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|GlyCEDIA||Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients|Glycemic Control Assessed by Continuous Glucose Monitoring in Hemodialyzed Patients With Diabetes Mellitus Treated Via the Basal-Bolus Detemir-Aspart Insulin Regimen: A Pilot Study|Completed||Phase 4|38|Actual|Centre Europeen d'Etude du Diabete||1|||f||||f||||||||||2017-10-11 01:49:36.252877|2017-10-11 01:49:36.252877
NCT01828957|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-04-18|||April 2013||2013-04-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants|Randomized, Double-blind, Multi-center, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Pneumostem® Versus a Control Group for Treatment of Bronchopulmonary Dysplasia in Premature Infants|Completed||Phase 2|70|Anticipated|Medipost Co Ltd.||2|||f||||t||||||||||2017-10-11 01:49:36.402125|2017-10-11 01:49:36.402125
NCT01828944|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-04-28|||December 2012||2012-12-01|January 2015|2015-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PolivD3||Olive Oil Polyphenols, Vitamin D, Docosahexaenoic Acid (DHA) and Locomotor Function (PolivD3)|Olive Oil Polyphenols, Vitamin D and Docosahexaenoic Acid (DHA) Synergistic Effects on Locomotor Function|Completed||N/A|149|Actual|Lesieur||3|||f||||f||||||||||2017-10-11 01:49:36.507531|2017-10-11 01:49:36.507531
NCT01828931|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-09|2016-06-15|||December 2012||2012-12-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|Healthy_LIFE||Lifestyle Intervention for Diabetes and Weight Management in Psychosis|Effectiveness of Intensive Lifestyle Interventions in the Management of Diabetes in Individuals With Psychosis|Completed||N/A|120|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||Undecided||2017-10-11 01:49:36.606605|2017-10-11 01:49:36.606605
NCT01828918|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2013-04-10|||June 2012||2012-06-01|June 2012|2012-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal Cancers|Kaohsiung Medical University Hospital|Unknown status|Recruiting|Phase 1|300|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||t||||||||||2017-10-11 01:49:36.688879|2017-10-11 01:49:36.688879
NCT01828905|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-09-07|||April 2013||2013-04-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CERTiFy||Cerament Treatment of Fracture Defects|"A Prospective, Multicenter, Randomized Study Investigating the Use of CERAMENT™|BONE VOID FILLER as Bone Graft Substitute in Tibia Plateau Fractures"|Recruiting||N/A|136|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-11 01:49:36.773931|2017-10-11 01:49:36.773931
NCT01828892|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-06-09|||March 2014||2014-03-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|FG-treatment||Glue Application in the Treatment of Low-Output Fistulas|A Randomized Controlled Trial to Evaluate Fibrin Glue Application in the Treatment of Low-Output Enterocutaneous Fistulas|Recruiting||N/A|30|Anticipated|Jinling Hospital, China||3|||f||||t||||||||||2017-10-11 01:49:36.936108|2017-10-11 01:49:36.936108
NCT01828307|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-08-18|||April 2013||2013-04-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Exercise: Addressing Stress in Relapse Prevention for Substance Use Disorders||Enrolling by invitation||N/A|150|Anticipated|St. Louis University||2|||f||||t||||||||||2017-10-11 01:49:43.048078|2017-10-11 01:49:43.048078
NCT01828879|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-04-08|||November 2007||2007-11-01|April 2013|2013-04-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis|The Efficacy and Safety of Tacrolimus Ointment in Adult Patients With Moderate to Severe Atopic Dermatitis|Completed||Phase 4|74|Actual|Janssen-Cilag Ltd.,Thailand||1|||f||||f||||||||||2017-10-11 01:49:37.030846|2017-10-11 01:49:37.030846
NCT01828866|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-09-14|||September 2013||2013-09-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients|From Feasibility to Efficacy: the Use of EMDR to Reduce Craving and Drinking Behaviour in Alcohol Dependent Outpatients - A Multiple Baseline Study and Randomized Controlled Trial (RCT)|Completed||N/A|109|Actual|IrisZorg||2|||f||||f||||||||||2017-10-11 01:49:37.122609|2017-10-11 01:49:37.122609
NCT01828853|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-04-08|||April 2013||2013-04-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01|1 Month|Observational [Patient Registry]|Stripping||Maternal and Neonatal Outcomes After Membrane Sweeping|Maternal and Neonatal Outcomes After Membrane Sweeping|Unknown status|Not yet recruiting|N/A|1200|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 01:49:37.242817|2017-10-11 01:49:37.242817
NCT01828840|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2016-03-23|||April 2014||2014-04-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||A Prospective Comparison of Methadone, Fentanyl, and Morphine for Post-laparotomy Epidural Analgesia|A Prospective Double Blind Randomized Comparison of Methadone, Fentanyl, and Morphine for Post-laparotomy Epidural Analgesia.|Recruiting||N/A|100|Anticipated|Hadassah Medical Organization||4|||f||||||||||||||2017-10-11 01:49:37.331998|2017-10-11 01:49:37.331998
NCT01828827|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-01-12|||March 2007||2007-03-01|August 2015|2015-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|CL-003||Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects|A Phase 1, Randomized, Balanced, Single-Dose, Two-Treatment, Two-Period, Two-Sequence, Crossover, Open-Label Study of the Effect of Food on the Bioavailability and Pharmacokinetics of PA-824 Tablets in Healthy Adult Subjects|Completed||Phase 1|16|Actual|Global Alliance for TB Drug Development||2|||f||||f||||||||||2017-10-11 01:49:37.615309|2017-10-11 01:49:37.615309
NCT01828814|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-04-27|||July 2011||2011-07-01|April 2017|2017-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Different Strategies for Preventing Severe Acute Malnutrition in Niger|Different Strategies for Preventing Severe Acute Malnutrition in Niger: a Pragmatic Trial|Completed||N/A|7836|Actual|Epicentre|||7||f||||f||||||||||2017-10-11 01:49:37.715804|2017-10-11 01:49:37.715804
NCT01828801|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-09-23|||March 2013||2013-03-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|November 2015|Actual|2015-11-01||Observational|||Pinnacle Metal-on-Metal 522 Post-Market Surveillance Study|Cross-Sectional, Multi-Center Evaluation of 8 Year Metal Ion Trends for Pinnacle MoM System Used in Primary Hip Arthroplasty|Completed||N/A|276|Actual|DePuy Orthopaedics|||9||f||||f||||||Samples With DNA|"     Whole blood and serum samples are retained.   "|||2017-10-11 01:49:37.821226|2017-10-11 01:49:37.821226
NCT01828788|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-09-24|||September 2013||2013-09-01|September 2013|2013-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|BLS-Sterno||Postoperative Rehabilitation After Cardiac Surgery in Patients at Risk of Respiratory Complications. Effects of a Continuous Bi-laterosternal Infusion of Ropivacaine Through Multihole Catheters|Postoperative Rehabilitation After Cardiac Surgery in Patients at Risk of Respiratory Complications. Effects of a Continuous Bi-laterosternal Infusion of Ropivacaine Through Multihole Catheters.|Unknown status|Recruiting|Phase 2|120|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:49:37.979719|2017-10-11 01:49:37.979719
NCT01828775|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-05-31|||September 8, 2014|Actual|2014-09-08|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment|Integration of Palliative Care for Cancer Patients on Phase I Trials|Recruiting||N/A|480|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 01:49:38.113018|2017-10-11 01:49:38.113018
NCT01828762|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-12-20|||December 2012||2012-12-01|April 2013|2013-04-01||||December 2013|Actual|2013-12-01||Interventional|DC-TC||Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy|Clinical Study of the Safety of Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy|Completed||N/A|8|Actual|Cellular Biomedicine Group Ltd.||1|||f||||t||||||||||2017-10-11 01:49:38.260827|2017-10-11 01:49:38.260827
NCT01828749|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-12-21|||February 2013||2013-02-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|November 2013|Actual|2013-11-01||Observational|||Pelvic CT Imaging in Blunt Abdominal Trauma|Pelvic CT Imaging in Blunt Trauma: Limiting Low Yield Radiation Exposure in Carefully Selected Adult and Pediatric Patients|Completed||N/A|230|Actual|Carolinas Healthcare System|||1||f||||f||||||||||2017-10-11 01:49:38.346256|2017-10-11 01:49:38.346256
NCT01828736|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-02-03|||February 9, 2004|Actual|2004-02-09|February 2017|2017-02-01|February 23, 2010|Actual|2010-02-23|February 23, 2010|Actual|2010-02-23||Interventional|CVH-CT02||Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma|Multicenter Randomized Phase 2 Trial of Gemcitabine - Platinum With or Without Trastuzumab in Advanced or Metastatic Urothelial Carcinoma With HER2 Overexpression|Completed||Phase 2|61|Actual|Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie||2|||f||||f||||||||||2017-10-11 01:49:38.43684|2017-10-11 01:49:38.43684
NCT01828723|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-01-26|||April 2013||2013-04-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells|A Phase One, Open Label, Single Arm Study to Demonstrate the Safety of Antria Cell Preparation Process During Facial Fat Grafting Assisted With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)|Completed||Phase 1|6|Anticipated|Antria||1|||f||||t||||||||||2017-10-11 01:49:38.608418|2017-10-11 01:49:38.608418
NCT01828710|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-04-10|||August 2012||2012-08-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Myo-inositol on Human Semen Parameters|Effect of Treatment With Myo-inositol on Human Semen Parameters in Patients Undergoing IVF Cycles|Completed||Phase 2/Phase 3|62|Actual|AGUNCO Obstetrics and Gynecology Centre||3|||f||||t||||||||||2017-10-11 01:49:38.697169|2017-10-11 01:49:38.697169
NCT01828697|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-07-12|||April 2013||2013-04-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy|Low-molecular-weight Heparin to Prevent Recurrent VTE in Pregnancy: a Randomized Controlled Trial of Two Doses|Recruiting||Phase 4|1000|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 01:49:38.814827|2017-10-11 01:49:38.814827
NCT01828684|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2016-03-30|||March 2013||2013-03-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine|Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine.|Completed||N/A|48|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 01:49:39.102632|2017-10-11 01:49:39.102632
NCT01828671|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2014-05-13|||December 2013||2013-12-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|SOYT-2013||A Study to Examine the Glycemic Response of Corn and Soy Tortillas in Healthy Individuals|A Double-Blind, Randomized, Controlled Study to Examine the Glycemic Response of Corn and Soy Tortillas in Healthy Individuals.|Completed||N/A|10|Actual|University of Manitoba||5|||f||||f||||||||||2017-10-11 01:49:39.193855|2017-10-11 01:49:39.193855
NCT01828658|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2013-10-13|||July 2008||2008-07-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|BIAHD||Randomized Bioimpedance vs Clinical Methods in Guiding Ultrafiltration in Hemodialysis Patients|Bioimpedance Versus Clinical Methods in Guiding Ultrafiltration in Hemodialysis Patients: a Randomized Trial|Completed||N/A|131|Actual|Grigore T. Popa University of Medicine and Pharmacy||2|||f||||f||||||||||2017-10-11 01:49:39.315368|2017-10-11 01:49:39.315368
NCT01828645|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-08|||February 2013||2013-02-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein|Residual Gastric Volume Measured by Upper Digestive Endoscopy 2h After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein. A Controlled, Randomized Clinical Trial|Completed||Phase 2/Phase 3|30|Actual|Federal University of Mato Grosso do Sul||2|||f||||f||||||||||2017-10-11 01:49:39.395473|2017-10-11 01:49:39.395473
NCT01828632|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2016-02-04|||March 2011||2011-03-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effects of Preoperative Respiratory Physical Therapy on Postoperative Respiratory Function After Bariatric Surgery|Effects of Preoperative Respiratory Physical Therapy on Postoperative Respiratory Function in Morbidly Obese Patients Undergoing Bariatric Surgery. A Randomized, Controlled, Clinical Trial|Completed||N/A|44|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||||2017-10-11 01:49:39.49016|2017-10-11 01:49:39.49016
NCT01828619|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2013-04-09|||February 2013||2013-02-01|April 2013|2013-04-01||||December 2015|Anticipated|2015-12-01||Observational|||Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients|The Study of New RIC Regimen of BuFlu in Older or Intolerable Patients With Hematologic Malignant Diseases|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Peking University People's Hospital|||1||f||||||||||||||2017-10-11 01:49:39.590484|2017-10-11 01:49:39.590484
NCT01828606|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2015-02-07|||April 2013||2013-04-01|February 2014|2014-02-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|||Comparative Trial to Monitor Interface Pressure in Relation to Volume Change in Leg Lymphoedema|Randomised Controlled Trial to Compare the Influence of Sub-bandage Pressure on Percentage Volume Reduction of Leg Lymphoedema|Completed||N/A|60|Actual|Nij Smellinghe Hosptial||2|||f||||f||||||||||2017-10-11 01:49:39.675367|2017-10-11 01:49:39.675367
NCT01828593|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2017-05-25|2016-02-09||April 2013||2013-04-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|January 2014|Actual|2014-01-01||Interventional|||Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy|Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Study Evaluating the Impact of Serum-derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in HIV+ Subjects With HIV-associated Enteropathy.|Completed||N/A|103|Actual|Entera Health, Inc||3|||f||||f||||||||No||2017-10-11 01:49:39.790733|2017-10-11 01:49:39.790733
NCT01828580|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-12-30|||December 2012||2012-12-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Performance Evaluation of the AutoLap System|Safety and Performance Evaluation of the AutoLap System - a Feasibility Study|Completed||N/A|36|Actual|M.S.T. Medical Surgery Technology LTD.||1|||f||||f||||||||||2017-10-11 01:49:40.408503|2017-10-11 01:49:40.408503
NCT01828567|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-08-07|||October 1, 2014|Actual|2014-10-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|December 30, 2016|Actual|2016-12-30||Interventional|ACTIVATE||Will Veterans Engage in Prevention After HRA-guided Shared Decision Making?|Will Veterans Engage in Prevention After HRA-guided Shared Decision Making?|Active, not recruiting||N/A|417|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:49:40.482633|2017-10-11 01:49:40.482633
NCT01828554|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-01-30|||June 2013||2013-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight|Pilot Study Evaluating Pharmacokinetic Parameters of Capecitabine Dosing in Patients With Advanced Cancer and Elevated Body Mass Index|Recruiting||N/A|10|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 01:49:40.569812|2017-10-11 01:49:40.569812
NCT01828541|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2017-05-10|||May 2013||2013-05-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Hypnosis for Pain and Itch Following Burn Injuries|A Randomized Controlled Trial of Hypnosis for Pain and Itch Following Burn Injuries|Active, not recruiting||N/A|60|Anticipated|University of Washington||2|||f||||f||||||||Undecided||2017-10-11 01:49:40.654202|2017-10-11 01:49:40.654202
NCT01828528|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2016-11-23|||April 2013||2013-04-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease|The Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Utilizing Non-invasive Measures|Completed||N/A|26|Actual|Sheba Medical Center|||1||f||||f||||||Samples With DNA|"     Whole blood, Liver tissue   "|||2017-10-11 01:49:40.744195|2017-10-11 01:49:40.744195
NCT01828515|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-03-24|||December 2012||2012-12-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Vilazodone for Corticosteroid-Induced Memory Impairment|Vilazodone for Corticosteroid-Induced Memory Impairment|Completed||Phase 2|24|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 01:49:40.84156|2017-10-11 01:49:40.84156
NCT01828502|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-10-28|||October 2013||2013-10-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer|Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer|Withdrawn||Phase 2|0|Actual|University of South Florida||2||The study was closed due to poor accrual. No patients were enrolled.|f||||t||||||||||2017-10-11 01:49:40.928303|2017-10-11 01:49:40.928303
NCT01828489|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2017-01-09|||March 2013||2013-03-01|January 2017|2017-01-01|March 2023|Anticipated|2023-03-01|March 2018|Anticipated|2018-03-01||Interventional|AML2012||Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years|NOPHO-DBH AML 2012 Protocol. Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years|Recruiting||Phase 3|300|Anticipated|Vastra Gotaland Region||4|||f||||t||||||||||2017-10-11 01:49:41.260084|2017-10-11 01:49:41.260084
NCT01828476|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-03-30|2017-02-14||June 2013||2013-06-01|March 2017|2017-03-01|March 3, 2016|Actual|2016-03-03|February 2016|Actual|2016-02-01||Interventional|||Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer|A Phase II Study of ABT-263/Abiraterone (Arm A) or ABT-263/Abiraterone and Hydroxychloroquine (Arm B) in Patients With Metastatic Castrate Refractory Prostate Cancer (CRPC) and Progression Following Chemotherapy and Abiraterone|Terminated||Phase 2|13|Actual|Rutgers, The State University of New Jersey||2||The Investigator left the organization.|f||||f||||||||||2017-10-11 01:49:41.529248|2017-10-11 01:49:41.529248
NCT01828463|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-06-10|||May 2013||2013-05-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|SONIA1||Dose Response Study of Nitisinone in Alkaptonuria|An International, Multicentre, Randomised, Open-label, No-treatment Controlled, Parallel-group, Dose-response Study to Investigate the Effect of Once Daily Nitisinone on 24-hour Urinary Homogentisic Acid Excretion in Patients With Alkaptonuria After 4 Weeks Treatment.|Completed||Phase 2|40|Actual|University of Liverpool||5|||f||||t||||||||||2017-10-11 01:49:41.984234|2017-10-11 01:49:41.984234
NCT01828437|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2013-04-09|||March 2013||2013-03-01|April 2013|2013-04-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|||Addition of Pyridoxine to Prednisolone in Infantile Spasms|Addition of Pyridoxine to Prednisolone in the Treatment of Infantile Spasms: A Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|58|Anticipated|Lady Hardinge Medical College||2|||f||||||||||||||2017-10-11 01:49:42.067074|2017-10-11 01:49:42.067074
NCT01828424|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-07-10|||June 2013|Actual|2013-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|PREPOP||Prediction of Postoperative Pain by Measuring Nociception at the End of Surgery|Prediction of Postoperative Pain by Measuring Nociception at the End of Surgery|Completed||N/A|100|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 01:49:42.165845|2017-10-11 01:49:42.165845
NCT01828411|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-02-02|||April 2013||2013-04-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|TP-Echo||Cerebral Perfusion Monitoring With Transpharyngeal Ultrasonography|Monitoring the Brain in On-pump Cardiovascular Surgery: The Role of Transpharyngeal Ultrasonography as a Non-invasive Adjunct to Assess Cerebral Perfusion|Active, not recruiting||N/A|32|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-11 01:49:42.243605|2017-10-11 01:49:42.243605
NCT01828398|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-01-15|||November 2011||2011-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||tDCS and Robotic Therapy in Stroke||Completed||Phase 2|40|Actual|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-11 01:49:42.337865|2017-10-11 01:49:42.337865
NCT01828385|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-01-17|||October 2012||2012-10-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex|Effect of Magnesium Sulfate on the Reversal of Neuromuscular Blockade With Sugammadex: a Prospective, Randomized Double-blind Trial|Completed||Phase 4|80|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 01:49:42.423091|2017-10-11 01:49:42.423091
NCT01828372|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-04-05|||May 2013||2013-05-01|April 2013|2013-04-01|March 2017|Anticipated|2017-03-01|April 2016|Anticipated|2016-04-01||Interventional|||Quantification of Drugs and Their Degradation Products|Quantification of Drugs and Their Metabolites in Patients at the Cologne University Hospital|Unknown status|Not yet recruiting|N/A|1000|Anticipated|University of Cologne||1|||f||||t||||||||||2017-10-11 01:49:42.526477|2017-10-11 01:49:42.526477
NCT01828359|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-07|2013-04-09|||August 2010||2010-08-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.|An Eight-week, Randomized, Double-blind Multicenter Study to Compare the Efficacy and Safety of Amosartan® Tab 5/100mg Versus Cozaar® Plus Pro Tab in Patients With Essential Hypertension Uncontrolled With Losartan 100mg Monotherapy|Completed||Phase 4|199|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 01:49:42.625168|2017-10-11 01:49:42.625168
NCT01828346|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-04-19|||June 2013||2013-06-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|||Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy|A Phase 1b/2a, Open-label, Non-randomized Study of Birinapant in Combination With 5-azacitidine in Subjects With Myelodysplastic Syndrome Who Are Naïve, Refractory or Have Relapsed to 5-azacitidine Therapy|Completed||Phase 1/Phase 2|21|Actual|TetraLogic Pharmaceuticals||1|||f||||f||||||||No|Not available|2017-10-11 01:49:42.712076|2017-10-11 01:49:42.712076
NCT01828333|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-09-12|||April 2013||2013-04-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|MATIAS||Malaria Treatment With Injectable ArteSunate|Treatment of Severe Malaria - An Operational Comparative Study Between Quinine and Artesunate for the Treatment of Severe Malaria in Hospitals and Health Centers of Kinshasa and Lower Congo|Completed||N/A|350|Actual|Swiss Tropical & Public Health Institute|||1||f||||f||||||||||2017-10-11 01:49:42.815118|2017-10-11 01:49:42.815118
NCT01828320|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-10-04|||March 2013||2013-03-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Triple Vulnerability? Circadian Tendency, Sleep Deprivation and Adolescence|Triple Vulnerability? Circadian Tendency, Sleep Deprivation and Adolescence|Active, not recruiting||Phase 1/Phase 2|176|Actual|University of California, Berkeley||2|||f||||t||||||||||2017-10-11 01:49:42.929547|2017-10-11 01:49:42.929547
NCT01828294|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-01-09|||October 2011||2011-10-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SIMM||Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis|Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis|Terminated||N/A|4|Actual|St. Louis University||1||Study stopped by sponsor due to difficulty enrolling at site|f||||t||||||||||2017-10-11 01:49:43.126573|2017-10-11 01:49:43.126573
NCT01828281|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2015-10-15|2015-08-13||February 2012||2012-02-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|October 2013|Actual|2013-10-01||Interventional|||Effects of CPAP on Visceral Fat Thickness|A Randomized Controlled Study on the Effects of Continuous Positive Airway Pressure (CPAP) on Visceral Fat Thickness, Carotid Intima-media Thickness and Adipokines in Patients With Obstructive Sleep Apnoea Syndrome (OSAS)|Completed||N/A|141|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:49:43.237727|2017-10-11 01:49:43.237727
NCT01828268|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-04-26|||March 2013||2013-03-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Observational|||Metabolomics Fingerprinting and Metabolic Dynamics After HIV Infection|Metabolic Fingerprintings and Metabolic Dynamics After HIV Infection:Impact of Metabolic Changes and Anti-Retroviral Therapy, Life Style and Clinical Conditions|Recruiting||N/A|100|Anticipated|Sichuan Academy of Medical Sciences|||1||f||||t||||||Samples Without DNA|"     Plasma from peripheral blood   "|||2017-10-11 01:49:43.568164|2017-10-11 01:49:43.568164
NCT01828242|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-06-30|||January 2013||2013-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|EDMID||The Empowerment Model Towards Type 2 Diabetic Adults To Enhance Vegetable Intake in Achieving Glycemic Control|The Empowerment Model Towards Type 2 Diabetic Adults To Enhance Vegetable Intake in Achieving Glycemic Control|Completed||Phase 2|84|Actual|SEAMEO Regional Centre for Food and Nutrition||2|||f||||t||||||||||2017-10-11 01:49:43.719429|2017-10-11 01:49:43.719429
NCT01828229|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-06-17|||January 2009||2009-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Consequences of Human Inactivity|Consequences of Human Inactivity|Completed||N/A|50|Anticipated|Rigshospitalet, Denmark||5|||f||||t||||||||||2017-10-11 01:49:43.808114|2017-10-11 01:49:43.808114
NCT01828216|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2016-02-26|2016-01-27||January 2013||2013-01-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Ambulatory Versus Conventional Approach Diagnosing OSA|A Randomized Controlled Study Assessing the Role of an Ambulatory Approach Versus the Conventional Approach in Managing Suspected Obstructive Sleep Apnoea Syndrome|Completed||N/A|316|Actual|Chinese University of Hong Kong||2|||f||||f||||||||Yes||2017-10-11 01:49:43.904648|2017-10-11 01:49:43.904648
NCT01828203|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-10-29|||June 2013||2013-06-01|October 2014|2014-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Minocycline in Acute Spinal Cord Injury (MASC)|Phase III Study of Minocycline in Acute Spinal Cord Injury|Recruiting||Phase 3|248|Anticipated|Rick Hansen Institute||2|||f||||t||||||||||2017-10-11 01:49:44.118559|2017-10-11 01:49:44.118559
NCT01828190|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-08|2013-04-08|||March 2013||2013-03-01|April 2013|2013-04-01|July 2015|Anticipated|2015-07-01|March 2015|Anticipated|2015-03-01||Interventional|||The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers|Prospective Open-label Study of the Efficacy of the Addition of Hyperbaric Oxygen to the Treatment of Patients With Perianal Fistulas Already Treated With TNF Alpha Blockers|Unknown status|Recruiting|N/A|50|Anticipated|Assaf-Harofeh Medical Center||1|||f||||f||||||||||2017-10-11 01:49:44.242966|2017-10-11 01:49:44.242966
NCT01828177|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-05-27|||June 2013||2013-06-01|May 2014|2014-05-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea|A Multicenter Randomized Evaluator-Blinded Vehicle-Controlled Parallel Group Evaluation of Twice Daily PDI-320 in Comparison to Its Monads in Adults With Rosacea|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|PreCision Dermatology, Inc.||4|||f||||f||||||||||2017-10-11 01:49:44.340245|2017-10-11 01:49:44.340245
NCT01828164|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-04-11|2016-10-20||January 2013||2013-01-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Ultrasound on Orthodontic Tooth Movement|The Effect of Ultrasound on Orthodontic Tooth Movement|Completed||N/A|60|Actual|SmileSonica Inc.||2|||f||||f||||||||Undecided||2017-10-11 01:49:44.446147|2017-10-11 01:49:44.446147
NCT01828151|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-04-05|||December 2009||2009-12-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|December 2011|Actual|2011-12-01||Observational|||Noninvasive Positive Airway Pressure Ventilation and Risk of Facial Pressure Ulcers|Noninvasive Positive Airway Pressure Ventilation and Risk of Facial Pressure Ulcers in Patients With Acute Respiratory Failure|Completed||N/A|170|Actual|Ospedale S. Giovanni Bosco|||1||f||||f||||||||||2017-10-11 01:49:44.684352|2017-10-11 01:49:44.684352
NCT01828138|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-10-15|||May 2013||2013-05-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|HUPP||Hypertension and Urine Protease Activity in Preeclampsia|HUPP-study -Hypertension and Urine Protease Activity in Preeclampsia|Completed||N/A|35|Actual|Odense University Hospital||3|||f||||t||||||||||2017-10-11 01:49:44.764495|2017-10-11 01:49:44.764495
NCT01828125|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-12-03|||April 2013||2013-04-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes|A Double-blinded, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Small Subcutaneous Glucagon Dose Against the Conventional 1 mg Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes|Withdrawn||Phase 2|0|Actual|Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||||2017-10-11 01:49:44.867662|2017-10-11 01:49:44.867662
NCT01827943|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-09-29|||June 2009||2009-06-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01||Interventional|VESTOR||Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer|Phase II Trial, Evaluating Efficacy of Temsirolimus (Torisel ®) in Second Line Therapy for Patients With Advanced Bladder Cancer|Completed||Phase 2|55|Actual|Institut Bergonié||1|||f||||f||||||||||2017-10-11 01:49:51.176473|2017-10-11 01:49:51.176473
NCT01828112|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-08-03|2017-06-24||June 28, 2013|Actual|2013-06-28|August 2017|2017-08-01|July 27, 2020|Anticipated|2020-07-27|January 26, 2016|Actual|2016-01-26||Interventional||The Full Analysis Set (FAS) consisted of all patients to whom study treatment had been assigned by randomization.|LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib|A Phase III, Multicenter, Randomized, Open-label Study of Oral LDK378 Versus Standard Chemotherapy in Adult Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer Who Have Been Treated Previously With Chemotherapy (Platinum Doublet) and Crizotinib|Active, not recruiting||Phase 3|230|Actual|Novartis|Although 116 patients were randomized to the Chemotherapy arm, 3 did not receive study drug and were excluded form the Safety set.|2|||f||||t|t|f||||||||2017-10-11 01:49:44.991463|2017-10-11 01:49:44.991463
NCT01828099|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-08-24|2017-06-23||July 9, 2013|Actual|2013-07-09|August 2017|2017-08-01|July 22, 2019|Anticipated|2019-07-22|June 24, 2016|Actual|2016-06-24||Interventional||The Full Analysis Set (FAS) consisted of all patients to whom study treatment had been assigned by randomization. According to the intent to treat principle, patients were analyzed according to the treatment and strata to which they had been assigned during the randomization procedure.|LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer|A Phase III Multicenter, Randomized Study of Oral LDK378 Versus Standard Chemotherapy in Previously Untreated Adult Patients With ALK Rearranged (ALK-positive), Stage IIIB or IV, Non-squamous Non-small Cell Lung Cancer|Active, not recruiting||Phase 3|375|Actual|Novartis|Among the 187 patients randomized to chemotherapy arm, 12 patients were not treated.|2|||f||||t|t|f||||||||2017-10-11 01:49:46.534018|2017-10-11 01:49:46.534018
NCT01828086|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-06-27|||June 2013||2013-06-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis|A Randomized, Double-blind, Placebo and Positive Controlled, Single and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJM112 in Chronic Plaque-type Psoriasis Patients|Completed||Phase 1/Phase 2|95|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:49:47.988081|2017-10-11 01:49:47.988081
NCT01828073|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-10-04|||April 2011||2011-04-01|October 2017|2017-10-01||||December 2018|Anticipated|2018-12-01||Observational|||Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants|Raltegravir Pharmacokinetics and Safety in Neonates|Recruiting||N/A|45|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||||||2017-10-11 01:49:48.162967|2017-10-11 01:49:48.162967
NCT01828060|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-09-23|||April 2013||2013-04-01|September 2014|2014-09-01||||August 2013|Actual|2013-08-01||Interventional|||Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population|Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population.|Completed||Phase 1/Phase 2|25|Actual|Natural Immune Systems Inc||2|||f||||||||||||||2017-10-11 01:49:48.390186|2017-10-11 01:49:48.390186
NCT01828047|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-03-16|||November 2013||2013-11-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Sublingual Microcirculation and Postoperative Ileus|Correlation Between Sublingual Microcirculation and Postoperative Ileus Symptoms in Patients Undergoing Colorectal Surgery - a Pilot Study|Completed||N/A|34|Actual|McGill University Health Center|||1||f||||f||||||||||2017-10-11 01:49:48.489853|2017-10-11 01:49:48.489853
NCT01828034|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-05-17|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma|A Phase I/II Study of First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma|Active, not recruiting||Phase 1/Phase 2|42|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:49:48.59797|2017-10-11 01:49:48.59797
NCT01828021|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-07-25|||March 2013|Actual|2013-03-01|July 2017|2017-07-01|April 14, 2017|Actual|2017-04-14|December 7, 2016|Actual|2016-12-07||Interventional|||Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer|A Single Arm, Open-Label, Phase 2 Study of MGAH22 (Fc-optimized Chimeric Anti-HER2 Monoclonal Antibody) in Patients With Relapsed or Refractory Advanced Breast Cancer Whose Tumors Express HER2 at the 2+ Level by Immunohistochemistry and Lack Evidence of HER2 Gene Amplification by FISH|Completed||Phase 2|25|Actual|MacroGenics||1|||f||||f|t|f||||||||2017-10-11 01:49:48.707785|2017-10-11 01:49:48.707785
NCT01828008|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-06|2013-04-09|||April 2013||2013-04-01|January 2013|2013-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01|5 Years|Observational [Patient Registry]|CIK||Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas||Unknown status|Not yet recruiting|N/A|20|Anticipated|Chinese PLA General Hospital|||1||f||||t||||||||||2017-10-11 01:49:48.826686|2017-10-11 01:49:48.826686
NCT01827995|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-08-13|||April 2013||2013-04-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Simplified Medical Abortion in Rural India||Completed||Phase 4|731|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 01:49:48.892364|2017-10-11 01:49:48.892364
NCT01827982|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2014-11-07|||March 2013||2013-03-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo|A Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study To Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Subjects|Completed||Phase 1|56|Actual|Janssen Research & Development, LLC||9|||f||||f||||||||||2017-10-11 01:49:48.988517|2017-10-11 01:49:48.988517
NCT01827969|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2013-04-09|||December 2009||2009-12-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|USF||Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy|Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy|Terminated||N/A|1|Actual|Institut Bergonié||1||Recruitment difficulties|f||||t||||||||||2017-10-11 01:49:51.012003|2017-10-11 01:49:51.012003
NCT01827956|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2013-04-09|||October 2009||2009-10-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|FCRVADS||Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms|Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms in Cetuximab Activity Used in Palliative Treatment of Upper Aerodigestive Tract Tumours|Completed||N/A|121|Actual|Institut Bergonié|||1||f||||t||||||||||2017-10-11 01:49:51.090701|2017-10-11 01:49:51.090701
NCT01827176|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-03-21|||March 2013||2013-03-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Observational|||Clinical Characteristic of Recurrent Acute Rhinosinusitis in Children|Clinical Characteristic of Recurrent Acute Rhinosinusitis in Children|Completed||N/A|94|Actual|Mahidol University|||1||f||||t||||||||No||2017-10-11 01:50:07.971559|2017-10-11 01:50:07.971559
NCT01827930|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-11-08|||July 2009||2009-07-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MIM||Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response|Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of IM on the Molecular Response in Patients With LMC in Chronic Phase Treated With IM 400 mg / Day for at Least Two Years, Complete Cytogenetic Response for at Least One Year|Recruiting||Phase 3|268|Anticipated|Institut Bergonié||1|||f||||t||||||||||2017-10-11 01:49:51.278582|2017-10-11 01:49:51.278582
NCT01827917|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-01-19|||February 2013||2013-02-01|April 2013|2013-04-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||The Protection Effect of Speeda® Rabies Vaccine for Human Use|Phase 4 Study of Speeda® Rabies Vaccinia That Use for Protection the Crowd Bitten by Animals to Three-level|Completed||Phase 4|37|Actual|Beijing Center for Disease Control and Prevention||1|||f||||f||||||||||2017-10-11 01:49:51.368906|2017-10-11 01:49:51.368906
NCT01827904|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-01-17|||May 2013||2013-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors|A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects|Active, not recruiting||N/A|72|Anticipated|InSightec||2|||f||||t||||||||||2017-10-11 01:49:51.440793|2017-10-11 01:49:51.440793
NCT01827891|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2013-04-09|||March 2012||2012-03-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|January 2013|Actual|2013-01-01||Interventional|REPAIR||Remote Ischemic Preconditioning and Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Stent Implantation|Remote Ischemic Preconditioning and Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Stent Implantation|Unknown status|Active, not recruiting|N/A|310|Actual|Beijing Anzhen Hospital||2|||f||||t||||||||||2017-10-11 01:49:51.540224|2017-10-11 01:49:51.540224
NCT01827878|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-05|||October 2012||2012-10-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg of M/s Ipca Laboratories Ltd., India With Zestoretic® 20/25 Lisinopril/Hydrochlorothiazide Tablets of M/s AstraZeneca Pharmaceuticals LP, USA in Normal, Healthy, Adult, Human Subjects Under Fed Condition.|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:49:51.6287|2017-10-11 01:49:51.6287
NCT01827865|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-04-05|||November 2012||2012-11-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition|An Open Label, Balanced, Randomized, Single-dose, Two-treatment, Two-sequence, Two-period, Crossover, Oral Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg of Ipca Laboratories Limited, India and Etodolac Extended Release Tablets 600mg of Teva Pharmaceutical Ind. Ltd., USA in Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|36|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 01:49:51.714431|2017-10-11 01:49:51.714431
NCT01827852|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-07-25|||March 14, 2013|Actual|2013-03-14|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|||AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung|AVAdeno: Non-interventional Study of Avastin 1st Line Therapy in Adenocarcinoma Patients of the Lung|Completed||N/A|1107|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:49:51.935377|2017-10-11 01:49:51.935377
NCT01827839|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-04-12|2016-12-08|2014-05-29|June 10, 2013||2013-06-10|March 2017|2017-03-01|November 25, 2014|Actual|2014-11-25|February 10, 2014|Actual|2014-02-10||Interventional|||Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster|Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster|Completed||Phase 3|96|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 01:49:52.053316|2017-10-11 01:49:52.053316
NCT01827813|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-09|||June 2007||2007-06-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|June 2012|Actual|2012-06-01||Interventional|||Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies|Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies|Completed||N/A|74|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 01:49:52.89111|2017-10-11 01:49:52.89111
NCT01827800|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-09-08|||June 2013||2013-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|September 2015|Actual|2015-09-01||Interventional|||New Media Obesity Treatment in Community Health Centers|New Media Obesity Treatment in Community Health Centers|Active, not recruiting||N/A|351|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:49:52.992511|2017-10-11 01:49:52.992511
NCT01827787|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-07-27|||June 2013||2013-06-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|June 2017|Actual|2017-06-01||Interventional|||Eribulin in HER2 Negative Metastatic BrCa|A Phase 2 Study of Eribulin in Patients With HER2-Negative, Metastatic Breast Cancer: Evaluation of Efficacy, Toxicity and Patient-Reported Outcomes|Active, not recruiting||Phase 2|83|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 01:49:53.077024|2017-10-11 01:49:53.077024
NCT01827774|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-03-22|||March 2013||2013-03-01|March 2017|2017-03-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|POP||Soft Tissue Graft for Repair of Pelvic Organ Prolapse|A Post-Market Study of Surgisis® Soft Tissue Graft for Repair of Pelvic Organ Prolapse|Completed||N/A|31|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 01:49:53.204648|2017-10-11 01:49:53.204648
NCT01827761|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-05-09|||October 2011||2011-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258|Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258|Completed||N/A|196|Actual|Brown University|||1||f||||t||||||||||2017-10-11 01:49:53.287155|2017-10-11 01:49:53.287155
NCT01827748|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-04-11|||March 2013||2013-03-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of a Surgical Microscope Mounted Autorefractor When Used on Patients Lying in a Supine Position|Evaluation of a Surgical Microscope Mounted Autorefractor When Used on Patients Lying in a Supine Position|Completed||N/A|20|Actual|Adventus Technology||2|||f||||f||||||||||2017-10-11 01:49:53.385311|2017-10-11 01:49:53.385311
NCT01827722|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2015-12-10|||May 2013||2013-05-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|ORION||Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion|Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein|Recruiting||Phase 4|45|Anticipated|Valley Retina Institute||3|||f||||f||||||||||2017-10-11 01:49:53.580139|2017-10-11 01:49:53.580139
NCT01827709|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-04-15|||March 2013||2013-03-01|April 2013|2013-04-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma|Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma. A Prospective, Non-commercial and Mono-centric Study|Unknown status|Recruiting|N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 01:49:53.724584|2017-10-11 01:49:53.724584
NCT01827696|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-03-01|||May 2013||2013-05-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Effect of American Ginseng on Exercise-induced Muscle Soreness|Effect of American Ginseng on Exercise-induced Muscle Soreness|Completed||Phase 1|10|Actual|Lawson Health Research Institute||2|||f||||t||||||||No||2017-10-11 01:49:53.972253|2017-10-11 01:49:53.972253
NCT01827683|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2013-04-08|||May 2010||2010-05-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Hyperbaric Oxygen and Fibromyalgia: Randomised Prospective Clinical Trial|The Effect of Hyperbaric Oxygen on Patients Suffering From Chronic Pain Syndrome (Fibromyalgia)|Completed||N/A|60|Actual|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 01:49:54.098518|2017-10-11 01:49:54.098518
NCT01827670|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-01-22|2014-02-27||February 2013||2013-02-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity|Completed||Phase 3|119|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:49:54.199107|2017-10-11 01:49:54.199107
NCT01827657|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-06-12|||May 28, 2013|Actual|2013-05-28|June 2017|2017-06-01|March 20, 2014|Actual|2014-03-20|March 20, 2014|Actual|2014-03-20||Interventional|||Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects|A Phase I, Open-Label, Parallel-Group, Two-Part Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects (HAI117380)|Completed||Phase 1|31|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 01:49:54.626433|2017-10-11 01:49:54.626433
NCT01827644|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-07-25|||April 2013||2013-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers|A Single Center, Randomized, Open-Label, Sequential, Single Dose, 4-Period Crossover Study to Evaluate the Bioavailability and Food Effect of a Gelatin Formulation and Two Prototype Formulations of Afuresertib, an AKT Inhibitor, in Normal Healthy Volunteers|Completed||Phase 1|36|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 01:49:54.758298|2017-10-11 01:49:54.758298
NCT01827631|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-06-05|||May 27, 2013|Actual|2013-05-27|June 2017|2017-06-01|June 25, 2013|Actual|2013-06-25|June 14, 2013|Actual|2013-06-14||Interventional|||Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects|Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects|Completed||Phase 1|21|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:49:54.892965|2017-10-11 01:49:54.892965
NCT01827618|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2015-06-30|||April 2012||2012-04-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy|An Immunopharmacodynamic Phase 0/I Study of Rapamycin in Patients Undergoing Radical Cystectomy for Bladder Cancer|Completed||Early Phase 1|29|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 01:49:55.026846|2017-10-11 01:49:55.026846
NCT01827605|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-08-16|||January 2012||2012-01-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|March 2017|Anticipated|2017-03-01||Interventional|||A Phase III Multicenter, Randomized Study Comparing Consolidation With 90yttrium-Labeled Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy Versus Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory Follicular Lymphoma (FL)|A Phase III Multicenter, Randomized Study Comparing Consolidation With 90yttrium-Labeled Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy Versus Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory Follicular Lymphoma (FL) Aged 18-65 Years|Recruiting||Phase 3|265|Anticipated|Fondazione Italiana Linfomi ONLUS||2|||f||||f||||||||||2017-10-11 01:49:55.135534|2017-10-11 01:49:55.135534
NCT01827592|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2015-09-22|2015-07-17|2015-04-07|April 2013||2013-04-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional||Intention-to-treat population|26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation|A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks|Terminated||Phase 3|376|Actual|Ferring Pharmaceuticals|Due to the early termination of the study, outcomes were presented only for descriptive purposes.|3||Terminated due to a distribution issue with the trial medication|f||||f||||||||||2017-10-11 01:49:55.520351|2017-10-11 01:49:55.520351
NCT01827579|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-05-09|||July 2014||2014-07-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|ICAT||Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)|Adoptive Immunotherapy With CD25/71 Allodepleted Donor T Cells to Improve Immunity After Unrelated Donor Stem Cell Transplant|Recruiting||Phase 1/Phase 2|24|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 01:49:56.773094|2017-10-11 01:49:56.773094
NCT01827566|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-12-05|||July 2012||2012-07-01|December 2014|2014-12-01||||March 2013|Actual|2013-03-01||Interventional|||Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet|Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial With a Cross-over Design to Assess the Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet|Unknown status|Active, not recruiting|N/A|26|Actual|Università degli Studi di Brescia||2|||f||||f||||||||||2017-10-11 01:49:56.894377|2017-10-11 01:49:56.894377
NCT01827553|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-08-09|||March 2013||2013-03-01|August 2017|2017-08-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Interventional|CONKO-007||Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy|Significance of Chemoradiation Following Induction Chemotherapy in Locally Advanced,Unresectable Pancreatic Cancer -a Randomised Phase 3 Trial: Chemoradiation Following Induction Chemotherapy Compared With Chemotherapy Alone|Recruiting||Phase 3|830|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 01:49:57.016047|2017-10-11 01:49:57.016047
NCT01827540|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2014-04-08|||March 2013||2013-03-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam|A Phase I, Multiple-Dose, Open-Label, Crossover Study in Healthy Subjects to Assess the Effect of Dolutegravir (DTG) on the Pharmacokinetics (PK) of Cenicriviroc (CVC) and the Effect of CVC on the PK of DTG and on a Single Dose of Midazolam|Completed||Phase 1|20|Actual|Tobira Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 01:49:57.516999|2017-10-11 01:49:57.516999
NCT01827527|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-01-12|||March 2013||2013-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Magnetic Resonance & Optical Spectroscopy Validation|Development and Validation of 31P Magnetic Resonance and Optical Spectroscopy for the Characterization of ATP in Whole Body Human Applications|Recruiting||N/A|150|Anticipated|Translational Research Institute for Metabolism and Diabetes, Florida|||1||f||||t||||||||||2017-10-11 01:49:57.624452|2017-10-11 01:49:57.624452
NCT01827514|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-04-04|||January 2013||2013-01-01|April 2013|2013-04-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Observational|EPO-CAN||Studying Erythropoietin Receptor Presence and Function in Human Cancer Specimens|Studying Erythropoietin Receptor Presence and Function in Human Cancer Specimens|Unknown status|Active, not recruiting|N/A|500|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"     Retrospective part: prepared slides from already taken preparations (specimens from     Biopsy/Bone Marrow tests) will serve as the basis for that part of the work - samples without     available DNA.      Prospective part: fresh material samples will be taken from biopsies in the operating room     from Biopsy/Bone Marrow tests and will be used to prapare the slides for the study tests.     There is an available DNA before slide staining.   "|||2017-10-11 01:49:57.728036|2017-10-11 01:49:57.728036
NCT01827501|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-10-20|||April 2013||2013-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|ADOM||Avoidance of Delirium in Older Patients After Major Non-cardiac Surgery|Can Perioperative Goal Directed Hemodynamic Management Reduce the Incidence of Delirium in Older Patients After Major Non-cardiac Surgery?|Recruiting||N/A|172|Anticipated|Technische Universität München||2|||f||||f||||||||No||2017-10-11 01:49:57.80881|2017-10-11 01:49:57.80881
NCT01826383|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2015-04-13|||April 2013||2013-04-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Improving Parental Soothing by Video|Improving Parental Soothing by Video: A Randomized Controlled Trial|Completed||N/A|128|Actual|York University||2|||f||||f||||||||||2017-10-11 01:49:57.926373|2017-10-11 01:49:57.926373
NCT01826370|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-09-17|2014-09-10||May 2012||2012-05-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational||Safety analysis set which consisted of all patients who have taken at least one dose of linagliptin and participated in the follow-up visit, thus, having a baseline and end-point evaluation.|Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus|A Post-Marketing Surveillance Study on the Safety, Tolerability and Efficacy of Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus|Terminated||N/A|678|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 01:49:58.020512|2017-10-11 01:49:58.020512
NCT01826344|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2015-12-08|||June 2010||2010-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|5 Years|Observational [Patient Registry]|||The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance Study||Terminated||N/A|628|Actual|Vascutek Ltd.|||1||f||||f||||||||||2017-10-11 01:49:58.357906|2017-10-11 01:49:58.357906
NCT01826331|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2015-05-26|||March 2014||2014-03-01|May 2015|2015-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Incentives for Participation Versus Outcomes|Incentives for Participation Versus Outcomes for Population Cessation of Smoking|Unknown status|Active, not recruiting|N/A|880|Anticipated|University of Rhode Island||3|||f||||t||||||||||2017-10-11 01:49:58.578041|2017-10-11 01:49:58.578041
NCT01826318|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-04-03|||December 2007||2007-12-01|April 2013|2013-04-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Stress Coping Strategy on Perceived Stress Levels and Performance During a Simulated Cardiopulmonary Resuscitation|Impact of a Stress Coping Strategy on Perceived Stress Levels and Performance During a Simulated Cardiopulmonary Resuscitation: A Randomized Controlled Trial|Completed||N/A|124|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 01:49:58.664537|2017-10-11 01:49:58.664537
NCT01826305|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-08-14|||July 2014||2014-07-01|August 2014|2014-08-01||||July 2015|Anticipated|2015-07-01||Interventional|||Independent Exercise Compared With Formal Rehabilitation Following Primary Total Knee Replacement|Independent Exercise Compared With Formal Rehabilitation Following Primary Total Knee Replacement|Unknown status|Recruiting|N/A|80|Anticipated|University of California, San Francisco||2|||f||||||||||||||2017-10-11 01:49:58.749833|2017-10-11 01:49:58.749833
NCT01827384|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-09-28|||December 31, 2013|Actual|2013-12-31|September 2017|2017-09-01||||May 5, 2019|Anticipated|2019-05-05||Interventional|||Molecular Profiling-Based Targeted Therapy in Treating Patients With Advanced Solid Tumors|Molecular Profiling-Based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors|Recruiting||Phase 2|700|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 01:50:01.556495|2017-10-11 01:50:01.556495
NCT01826292|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-04-17|||November 2012||2012-11-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||The Association Between Anesthetic and Surgical Practices and Patient Length of Stay in the Post Anesthesia Care Unit|The Association Between Anesthetic and Surgical Practices and Patient Length of Stay in the Post Anesthesia Care Unit|Withdrawn||N/A|0|Actual|University of California, Davis|||1|Principle Investigator was not able to proceed with the study|f||||f||||||None Retained|"     Cross-sectional cart review   "|||2017-10-11 01:49:58.844517|2017-10-11 01:49:58.844517
NCT01826279|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-01-29|||May 2013||2013-05-01|May 2013|2013-05-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Short-term Investigation of Resveratrol on Fat Metabolism in Morbidly Obese Women Undergoing Gastric Bypass Surgery|Short-term Investigation of Resveratrol on Lipid Turnover in Morbidly Obese Women Undergoing Gastric Bypass Surgery. Effects on Basal and Insulin Stimulated FFA and VLDL-triglyceride Metabolism and Liver VLDL-triglyceride Uptake.|Unknown status|Active, not recruiting|N/A|16|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:49:58.905189|2017-10-11 01:49:58.905189
NCT01826266|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-09-28|||July 2013||2013-07-01|September 2017|2017-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PER977-P1||Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban|Phase I Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban|Completed||Phase 1|83|Actual|Perosphere, Inc.||7|||f||||t||||||||||2017-10-11 01:49:58.982605|2017-10-11 01:49:58.982605
NCT01826253|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2014-06-13|||April 2013||2013-04-01|May 2013|2013-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|OR||Observational Study of Oxygen Delivery During a Fractional Fluid Expansion|Observational Study of Oxygen Delivery During a Fractional Fluid Expansion|Completed||N/A|20|Anticipated|University Hospital, Caen|||1||f||||f||||||||||2017-10-11 01:49:59.098808|2017-10-11 01:49:59.098808
NCT01826240|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-12-03|||March 2013||2013-03-01|April 2013|2013-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior|Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior: A Treatment Development Study|Completed||Phase 1|20|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 01:49:59.189347|2017-10-11 01:49:59.189347
NCT01827488|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-10-12|||April 2013||2013-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:49:59.331964|2017-10-11 01:49:59.331964
NCT01827475|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-12-29|2013-04-09||July 2010||2010-07-01|December 2014|2014-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Ibuprofen Versus Acetaminophen vs Their Combination in the Relief of Musculoskeletal Pain in the Emergency Setting|Ibuprofen Versus Acetaminophen vs Their Combination in the Relief of Musculoskeletal Pain in the Emergency Setting|Completed||Phase 2|90|Actual|Stony Brook University|Small sample size, single center, short follow up|3|||f||||f||||||||||2017-10-11 01:49:59.380568|2017-10-11 01:49:59.380568
NCT01827462|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-06-09|2017-03-30||October 2007|Actual|2007-10-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)|Immune Senescence in the Elderly: Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages|Completed||Phase 4|136|Actual|Stanford University||3|||f||||f||||||||Yes|The NIH Human Immunology Project Consortium (HIPC) data repositories (ImmPORT) may store the results of the research assays results. Genetic data that is developed in this study may be made available to other researchers through the National Center for Biotechnology Information (NCBI) databases. Results from research assays will be labeled with a unique ID code and the volunteer identity (except for age) will not be disclosed.|2017-10-11 01:49:59.879054|2017-10-11 01:49:59.879054
NCT01827449|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2015-12-02|||May 2013||2013-05-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Hypothermia Rewarming With Distal Limb Warming|Hypothermia Rewarming Effectiveness of Distal Limb Warming With Either Fluidotherapy or Warm Water Immersion|Completed||N/A|8|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 01:50:01.054268|2017-10-11 01:50:01.054268
NCT01827436|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-01-05|||April 2013||2013-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Asymmetrical Gait Training After Pediatric Stroke|Motor Outcomes and Neural Correlates of Asymmetrical Gait Training in Children With Acquired Hemiplegia|Recruiting||Early Phase 1|12|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 01:50:01.133363|2017-10-11 01:50:01.133363
NCT01827423|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-04-04|||January 2000||2000-01-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava|Squamous Cell Carcinoma Antigen as a Marker of Sinonasal Inverted Papilloma|Completed||N/A|20|Actual|University Hospital Ostrava||1|||f||||f||||||||||2017-10-11 01:50:01.253109|2017-10-11 01:50:01.253109
NCT01827410|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-04-08|||October 2010||2010-10-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|October 2011|Actual|2011-10-01||Observational|||High Agreement Between the Danish Ventral Hernia Database and Hospital Files in Region Zealand|High Agreement Between the Danish Ventral Hernia Database and Hospital Files in Region Zealand|Completed||N/A|408|Actual|University Hospital Koge|||1||f||||f||||||||||2017-10-11 01:50:01.367353|2017-10-11 01:50:01.367353
NCT01827397|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-05-20|||April 2013||2013-04-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine|Phase 1 Randomised, Single-centre, Observer-blind, Placebo-controlled Trial of Safety and Immunogenicity of EN41-UGR7C HIV Vaccine Candidate Administered Intramuscularly in Healthy Female Volunteers|Completed||Phase 1|24|Actual|PX'Therapeutics||2|||f||||t||||||||||2017-10-11 01:50:01.45147|2017-10-11 01:50:01.45147
NCT01827371|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-07-28|2015-11-05||June 2013||2013-06-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All participants are included in the baseline analysis population|Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®|A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of IMVAMUNE® Using Three Immunization Schedules and Two Modes of Delivery|Completed||Phase 2|435|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 01:50:01.83868|2017-10-11 01:50:01.83868
NCT01827358|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-06-29|2017-06-01||April 30, 2014||2014-04-30|April 13, 2016|2016-04-13|June 21, 2016|Actual|2016-06-21|June 7, 2016|Actual|2016-06-07||Interventional|||Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants|Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial|Completed||Phase 2|155|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-11 01:50:02.945291|2017-10-11 01:50:02.945291
NCT01827345|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-12-23|||April 2013||2013-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|D-SAFE||Vitamin D as a Supplement Against Falls in Elderly Study|Effects of Vitamin D Supplementation on Fall Risk and Functional Outcomes in Older Adults With Insufficient Vitamin D Levels: A Pilot Study|Completed||N/A|25|Actual|University of Florida||1|||f||||t||||||||||2017-10-11 01:50:04.457734|2017-10-11 01:50:04.457734
NCT01827332|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-11-14|2016-09-22||March 2013||2013-03-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Oxytocin on Craving and Therapy Response|Effect of Oxytocin on Craving and Therapy Response in Marijuana-dependent Individuals|Completed||N/A|16|Actual|Medical University of South Carolina|Limitations included small sample size and limited generalizability as individuals with other substance use disorders were excluded from participation.|2|||f||||f||||||||||2017-10-11 01:50:04.553462|2017-10-11 01:50:04.553462
NCT01827319|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2016-07-06|2016-05-23||May 2013||2013-05-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01|30 Days|Observational [Patient Registry]|ANGINA RELIEF||Cardiogenesis Transmyocardial Revascularization Registry|A Multi-Center Single Arm Observational Registry of the Cardiogenesis Holmium: YAG Laser System Transmyocardial Revascularization for Angina Reduction|Completed||N/A|203|Actual|Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.|||1||f||||f||||||||No||2017-10-11 01:50:04.82368|2017-10-11 01:50:04.82368
NCT01827306|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-01-11|2015-09-21||March 2013||2013-03-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|BFShld01||Effectiveness of Biofreeze® on Shoulder Pain and In-office Exercise Performance|Effectiveness of Biofreeze® on Shoulder Pain and In-office Exercise Performance: A Preliminary Pilot Study|Completed||N/A|34|Actual|Sport and Spine Rehab Clinical Research Foundation||2|||f||||f||||||||||2017-10-11 01:50:05.047232|2017-10-11 01:50:05.047232
NCT01827293|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-06-13|||April 2013||2013-04-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Promethazine vs. Lorazepam for Treatment of Vertigo|Promethazine vs. Lorazepam for Treatment of Vertigo in the Emergency Department: A Randomized Clinical Trial|Completed||Phase 3|210|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:50:05.299604|2017-10-11 01:50:05.299604
NCT01827280|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-05-30|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|August 2016|Actual|2016-08-01||Interventional|||Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women|Acute and Short-term Chronic Effects of Galvus (Vildagliptin) on Endothelial Function and Oxidative Stress on Recently Diagnosed Type 2 Diabetic Obese Women: the Role of Intestinal Peptides During Lipid Overload|Completed||Phase 4|40|Actual|Rio de Janeiro State University||2|||f||||t||||||||||2017-10-11 01:50:05.401981|2017-10-11 01:50:05.401981
NCT01827267|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-08-08|2017-08-08|2016-03-02|July 1, 2013|Actual|2013-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 20, 2016|Actual|2016-09-20||Interventional||All subjects who received at least one dose of study medication|Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer|A Phase 2 Study of Neratinib and Neratinib Plus Temsirolimus in Patients With Non-Small Cell Lung Cancer Carrying Known HER2 Activating Mutations|Active, not recruiting||Phase 2|62|Actual|Puma Biotechnology, Inc.||2|||f||||f|t|f||||||||2017-10-11 01:50:05.528495|2017-10-11 01:50:05.528495
NCT01827254|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-04-28|2015-04-08||July 2013||2013-07-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|RESUME|Evaluable population: All participants included in the analysis.|Sutent Rechallenge In mRCC Patients|Etude Resume (Retraitement Sunitinib Rein Metastatique)|Completed||N/A|61|Actual|Pfizer|||1||f||||t||||||||||2017-10-11 01:50:06.972712|2017-10-11 01:50:06.972712
NCT01827241|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-10-20|||September 2011||2011-09-01|October 2016|2016-10-01||||December 2021|Anticipated|2021-12-01||Observational|||Outcome of Colonoscopy Screening and Surveillance|Outcome of Colonoscopy Screening and Surveillance|Recruiting||N/A|5000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 01:50:07.46546|2017-10-11 01:50:07.46546
NCT01827228|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-04-05|||April 2013||2013-04-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|TRIP||Transmission Reduction Intervention Project|Preventing HIV Transmission by Recently-Infected Drug Users|Enrolling by invitation||N/A|3000|Anticipated|National Development and Research Institutes, Inc.||3|||f||||f||||||||||2017-10-11 01:50:07.570405|2017-10-11 01:50:07.570405
NCT01827215|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-07-26|||September 2013||2013-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Randomized Control Trial of a Virtual Patient Advocate for Preconception Care|Using Innovative Communication Technology to Improve the Health of Young African American Women|Active, not recruiting||N/A|531|Actual|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-11 01:50:07.701263|2017-10-11 01:50:07.701263
NCT01827202|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-03-14|||December 2012||2012-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|RASQAL||RAS Quantification in Patients With Aliskiren or Candesartan|Renin-Angiotensin-System Quantification in Patients Treated With Aliskiren or Candesartan (RASQAL)|Completed||Phase 4|24|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:50:07.788468|2017-10-11 01:50:07.788468
NCT01827189|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-09-28|||October 2012||2012-10-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|October 2016|Anticipated|2016-10-01||Observational|cpc||Staffing Patterns of Comprehensive Primary Care Practices|Evaluation of the Comprehensive Primary Care Initiative|Unknown status|Enrolling by invitation|N/A|15000|Anticipated|Mathematica Policy Research, Inc.|||2||f||||f||||||||||2017-10-11 01:50:07.874643|2017-10-11 01:50:07.874643
NCT01827163|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-04-17|||April 2013|Actual|2013-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer|The Feasibility of Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer|Active, not recruiting||Phase 2|55|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:50:08.065801|2017-10-11 01:50:08.065801
NCT01827150|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-07-22|||June 2013||2013-06-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Interventional|||The Influence of Energy Drinks on the Blood Oxygenation Concentration of the Optic Nerve|The Influence of Energy Drinks on the Blood Oxygenation Concentration of the Optic Nerve|Unknown status|Recruiting|Early Phase 1|15|Anticipated|Université de Montréal||1|||f||||t||||||||||2017-10-11 01:50:08.325793|2017-10-11 01:50:08.325793
NCT01827137|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-02-08|||April 2013|Actual|2013-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation|A Pilot Trial of a WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation|Active, not recruiting||N/A|22|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:50:08.429811|2017-10-11 01:50:08.429811
NCT01827124|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2013-10-07|||April 2013||2013-04-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption||Unknown status|Recruiting|Phase 4|140|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 01:50:08.528128|2017-10-11 01:50:08.528128
NCT01827111|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-05-08|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma|Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma|Active, not recruiting||Phase 2|21|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:50:08.659869|2017-10-11 01:50:08.659869
NCT01827098|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-06-19|||October 2012||2012-10-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||A Clinical Study to Compare Two Revascularization Protocols to Treat Non-vital Teeth With Incomplete Root Formation|A Randomized Controlled Clinical Trial of Regenerative Protocols to Treat Immature Necrotic Teeth|Recruiting||Phase 2|80|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-11 01:50:08.816818|2017-10-11 01:50:08.816818
NCT01827085|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-10-06|||May 2012||2012-05-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|TTI||Time to Intubation (TTI) of Obese Patients. A Comparison Macintosh Laryngoscope and Stortz Video Laryngoscope|Time to Intubation in Obese Patients. A Comparison Between Macintosh Laryngoscope and Stortz Video Laryngoscope|Completed||N/A|80|Actual|Örebro University, Sweden|||2||f||||f||||||||||2017-10-11 01:50:08.934339|2017-10-11 01:50:08.934339
NCT01827072|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-01-17|||April 2013||2013-04-01|October 2014|2014-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.|NPB-01(Intravenous Immunoglobulin) Maintenance Therapy for Patients With Multifocal Motor Neuropathy.|Completed||Phase 3|13|Actual|Nihon Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-11 01:50:09.028435|2017-10-11 01:50:09.028435
NCT01827059|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-05|2017-08-14|||October 2013||2013-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|BICYCLE||Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE|A Randomized Placebo Controlled Trial to Analyze Changes in Pulmonary Arterial Pressures at Peak Exercise in Congenital Heart Disease Patients With Exercise-induced Pulmonary Arterial Hypertension Before and After Treatment With Bosentan, Compared to Placebo|Active, not recruiting||Phase 2|12|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 01:50:09.126798|2017-10-11 01:50:09.126798
NCT01827046|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-08-17|||December 30, 2013|Actual|2013-12-30|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|MISTIE III||Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III|Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III|Active, not recruiting||Phase 3|500|Anticipated|Johns Hopkins University||2|||f||||t|t|f||||||||2017-10-11 01:50:09.254149|2017-10-11 01:50:09.254149
NCT01827033|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2015-09-14|||March 2013||2013-03-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Meditation||Terminated||N/A|6|Actual|Johns Hopkins University||1||The Principal Investigator is leaving Johns Hopkins.|f||||f||||||||||2017-10-11 01:50:09.624582|2017-10-11 01:50:09.624582
NCT01827020|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-08|||January 2013||2013-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Ketamine Addition to Lidocaine in Rhinoplasty|Effect of Ketamine Addition to Lidocaine for Postoperative Pain Management in Rhinoplasty|Completed||Phase 4|90|Actual|Inonu University||3|||f||||t||||||||||2017-10-11 01:50:09.711199|2017-10-11 01:50:09.711199
NCT01827007|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-04|||January 2008||2008-01-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Assessment of Fluid Responsiveness by Elevation of PEEP in Patients With Septic Shock|Assessment of Fluid Responsiveness by Elevation of PEEP in Patients With Septic Shock|Completed||N/A|20|Actual|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-11 01:50:09.828492|2017-10-11 01:50:09.828492
NCT01826994|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-04-10|||September 2013||2013-09-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|RAPIDA||Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome|Incremental Value of Heart-type Fatty Acid-Binding Protein (H-FABP) in Evaluating Patients Presenting With Symptoms Possibly Matching Acute Coronary Syndrome in Primary Care|Completed||N/A|303|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-10-11 01:50:09.914858|2017-10-11 01:50:09.914858
NCT01826981|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-09-23|2016-07-28|2016-01-22|April 2013||2013-04-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional||Safety analysis set: Participants who were randomized and received at least 1 dose of study drug.|Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection|A Phase 2, Multicenter, Open-Label Study to Assess the Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection|Completed||Phase 2|359|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|15|||f||||f||||||||||2017-10-11 01:50:10.109095|2017-10-11 01:50:10.109095
NCT01826968|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2015-06-22|||January 2013||2013-01-01|November 2013|2013-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|CSRecGHPyr||Alveolar Recruitment Maneuver During Cesarean Section Improves Lung Compliance|Phase 2 Study of the Alveolar Recruitment Maneuver in Cesarean Section|Completed||Phase 2|90|Actual|General Hospital Of Pyrgos||2|||f||||t||||||||||2017-10-11 01:50:17.23269|2017-10-11 01:50:17.23269
NCT01826955|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-02|2015-12-22|||April 2013||2013-04-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01|5 Days|Observational [Patient Registry]|rSO2pneumo||Effect of Pneumoperitoneum on Cognitive Function and Regional Cerebral Oxygen Saturation|Effect of Pneumoperitoneum on Cognitive Function and Regional Cerebral Oxygen|Completed||N/A|60|Actual|Gachon University Gil Medical Center|||2||f||||t||||||||||2017-10-11 01:50:17.321265|2017-10-11 01:50:17.321265
NCT01826942|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-03-25|||January 2013||2013-01-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Scar Prevention Using Fractional Carbon Dioxide Laser Treatment|Scar Prevention Using Fractional Carbon Dioxide Laser Treatment|Terminated||N/A|10|Actual|Lumenis Ltd.||2||Cooperation stooped with PI|f||||f||||||||||2017-10-11 01:50:17.4006|2017-10-11 01:50:17.4006
NCT01826929|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-04-09|||January 2013||2013-01-01|April 2013|2013-04-01||||January 2014|Anticipated|2014-01-01||Interventional|PROPRESE||Effectiveness New Health Care Organization Model in Primary Care for Chronic Cardiovascular Disease Patients Based|Effectiveness of a New Health Care Organization Model in Primary Care for Chronic Cardiovascular Disease Patients Based on a Multifactorial Intervention: The PROPRESE Randomized Controlled Trial.|Unknown status|Recruiting|N/A|300|Anticipated|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||2|||f||||f||||||||||2017-10-11 01:50:17.482338|2017-10-11 01:50:17.482338
NCT01826916|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-04-20|||November 2003||2003-11-01|April 2016|2016-04-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||EDEMA2: Evaluation of DX-88's Effect in Mitigating Angioedema|EDEMA2: An Open-Label Study to Assess the Efficacy and Tolerability of Repeated Doses of DX-88 (Recombinant Plasma Kallikrein Inhibitor) in Patients With Hereditary Angioedema|Completed||Phase 2|77|Actual|Shire||4|||f||||t||||||||||2017-10-11 01:50:17.6677|2017-10-11 01:50:17.6677
NCT01826903|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-04-17|||July 2012||2012-07-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Observational|||Perinatal Depression Treatment and Child Development|Perinatal Depression Treatment and Child Development: A Follow-Up of the Thinking Healthy Programme|Completed||N/A|964|Anticipated|Duke University|||3||f||||f||||||||||2017-10-11 01:50:17.74223|2017-10-11 01:50:17.74223
NCT01826890|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-12-07|||May 2013||2013-05-01|April 2013|2013-04-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|RESTUS||Neurally Adjusted Ventilatory Assist in Adults at Risk of Delayed Weaning From Mechanical Ventilation|A Randomised Feasibility Study Examining Neurally-adjusted Ventilatory Assist (NAVA) in Patients at High Risk of Prolonged Ventilatory Failure During Recovery From Critical Illness.|Recruiting||N/A|76|Anticipated|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-11 01:50:17.844246|2017-10-11 01:50:17.844246
NCT01826877|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-01-11|||December 2012||2012-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer|A Phase I, Open Label, Dose Escalation and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With Ad-GMCAIX in Patients With Metastatic Renal Cell Carcinoma|Recruiting||Phase 1|18|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:50:17.943578|2017-10-11 01:50:17.943578
NCT01826864|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-04-25|||August 5, 2011|Actual|2011-08-05|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma|Randomized Phase III Trial to Compare the Immunodulatory Effects of Leukine vs. Saline for Early-stage Melanoma Patients Undergoing Sentinel Lymph Node Dissection|Recruiting||Phase 3|380|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:50:18.047025|2017-10-11 01:50:18.047025
NCT01826851|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-08-14|||March 2013||2013-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Parasternal Nerve Block in Cardiac Patients|Parasternal Intercostal Nerve Block in Post-Cardiac Surgery Patients: A Randomized, Controlled Trial of Extended-release Liposomal Bupivacaine (Exparel) Versus Placebo|Completed||Phase 2|78|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 01:50:18.149808|2017-10-11 01:50:18.149808
NCT01826838|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-06-09|||January 2013||2013-01-01|June 2015|2015-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|BrUOG PR255||Study of Dasatinib, Androgen Deprivation Therapy and Radiation|A Phase I Study of Dasatinib, Androgen Deprivation Therapy and Radiation For Intermediate and High Risk Prostate Cancer|Withdrawn||Phase 1|0|Actual|Brown University||1||Lack of patients|f||||t||||||||||2017-10-11 01:50:18.257869|2017-10-11 01:50:18.257869
NCT01826825|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-09-03|||May 2013||2013-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|October 2013|Actual|2013-10-01||Observational|||Preoperative Cognitive Screening of Elderly Surgical Patients|Preoperative Cognitive Screening of Elderly Surgical Patients|Completed||N/A|200|Actual|Brigham and Women's Hospital|||2||f||||f||||||||||2017-10-11 01:50:18.353495|2017-10-11 01:50:18.353495
NCT01826812|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-03-16|2016-01-12||April 2013||2013-04-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Impairment of Reading Ability in Dry Eye Patients|Functional Impairment of Reading Ability in Dry Eye Patients and Effects of Sustained Reading on the Ocular Surface|Completed||N/A|200|Actual|Johns Hopkins University|||2||f||||f||||||Samples With DNA|"     Tears   "|Undecided||2017-10-11 01:50:18.451962|2017-10-11 01:50:18.451962
NCT01826799|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2016-01-13|||April 2013||2013-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|||Noise in the Intensive Care Unit|Noise in the Intensive Care Unit and Its Influence on Sleep Quality: a Nationwide Survey in Dutch Intensive Care Units|Completed||N/A|75|Actual|Jeroen Bosch Ziekenhuis|||1||f||||t||||||||||2017-10-11 01:50:18.843016|2017-10-11 01:50:18.843016
NCT01826786|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-10-14|||August 2013||2013-08-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Volunteers|The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Subjects|Completed||Phase 1|43|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 01:50:18.927917|2017-10-11 01:50:18.927917
NCT01826773|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2017-03-08|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects|A Phase II Open-Labeled Study to Evaluate CardioPET™ as a PET Imaging Agent for Evaluation of Myocardial Perfusion and Fatty Acid Uptake in Subjects With Coronary Artery Disease|Completed||Phase 2|34|Actual|Fluoropharma, Inc.||2|||f||||f|t|f||||||Undecided||2017-10-11 01:50:19.004195|2017-10-11 01:50:19.004195
NCT01826760|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2013-04-03|||April 2010||2010-04-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Observational|||Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure|Study of 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure Using Artificial Neural Network|Completed||N/A|583|Actual|Wenzhou Medical University|||2||f||||t||||||||||2017-10-11 01:50:19.085459|2017-10-11 01:50:19.085459
NCT01826747|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-06-25|||April 2011||2011-04-01|November 2012|2012-11-01||||May 2015|Anticipated|2015-05-01||Interventional|||Intrauterine Insemination and Luteal Fase Support|Impact of Luteal Phase Support With Vaginal Progesterone on the Clinical Pregnancy Rate in Intrauterine Insemination Cycles Stimulated With Gonadotrophins: a Prospective Randomized Multicentre Study.|Unknown status|Enrolling by invitation|Phase 4|198|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||t||||||||||2017-10-11 01:50:19.162089|2017-10-11 01:50:19.162089
NCT01826734|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-09-02|||January 1994||1994-01-01|September 2016|2016-09-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|||Analysis of 86 Dacryoliths at the University Hospital Ostrava|Lacrimal Sac Dacryoliths (86 Samples): Chemical and Mineralogic Analyses|Completed||N/A|86|Actual|University Hospital Ostrava|||1||f||||f||||||Samples Without DNA|"     Dacryolits during the DCR procedure.   "|No||2017-10-11 01:50:19.231748|2017-10-11 01:50:19.231748
NCT01826721|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-03|||May 2011||2011-05-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||Impact of an E-learning Tool on Patient Satisfaction, Knowledge and Medication Adherence in Solid Organ Transplantation: A Randomized Controlled Trial|Impact of an E-learning Tool on Patient Satisfaction, Knowledge and Medication Adherence in Solid Organ Transplantation: A Randomized Controlled Trial|Completed||N/A|246|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:50:19.364366|2017-10-11 01:50:19.364366
NCT01826708|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-12-30|||October 2011||2011-10-01|April 2013|2013-04-01|April 2015|Anticipated|2015-04-01|January 2013|Actual|2013-01-01||Interventional|||Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations|Development of a Technique to Identify New Genes by Studying and Cloning the Breakpoints of de Novo Apparently Balanced Chromosomal Translocations in Patients Presenting With Syndromic Psychomotor Retardation|Unknown status|Active, not recruiting|Early Phase 1|10|Anticipated|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 01:50:19.457901|2017-10-11 01:50:19.457901
NCT01826695|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-10-27|||January 2014||2014-01-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|FM||Neurodynamic Intervention in Fibromyalgia|Study of the Effectiveness of a Neurodynamic Intervention in Women With Fibromyalgia.|Completed||N/A|48|Actual|Universidad de Granada||2|||f||||t||||||||Undecided||2017-10-11 01:50:19.538636|2017-10-11 01:50:19.538636
NCT01826682|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-11-02|||March 2013||2013-03-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Physiotherapy in Exacerbation Chronic Obstructive Pulmonary Disease|Physiotherapy Program Intervention in Exacerbation of Chronic Obstructive Pulmonary Disease.|Completed||N/A|58|Actual|Universidad de Granada||2|||f||||t||||||||No||2017-10-11 01:50:19.654815|2017-10-11 01:50:19.654815
NCT01826669|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2013-04-03|||May 2011||2011-05-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||Chest Wall Muscle Stretching and Acute Effects in Chronic Obstructive Pulmonary Disease|Chest Wall Muscle Stretching and Acute Effects on Volume Variation of Thoracoabdominal Wall and Electromyographic Activity in Chronic Obstructive Pulmonary Disease|Completed||N/A|28|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:50:19.760849|2017-10-11 01:50:19.760849
NCT01826656|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-05-26|||May 2014||2014-05-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||Bone Healing in Healthy and Post-menopausal Osteoporotic Women|A Clinical/Real Time Model of Intramembranous Jawbone Healing in Post-menopausal Osteoporotic and Non-osteoporotic Women. A Pilot Study.|Unknown status|Recruiting|N/A|20|Anticipated|University College, London||2|||f||||f||||||||||2017-10-11 01:50:19.849086|2017-10-11 01:50:19.849086
NCT01826630|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-11-13|||July 2013||2013-07-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema|A Double-Blind Pilot Study To Assess The Feasibility of a Larger Study to Assess The Efficacy of A Novel Gel Wash Cleanser Formulated With Sodium Hypochlorite To Reduce Skin Fauna In Patients With Chronic Hand Dermatitis/Atopic Dermatitis.|Terminated||Phase 2/Phase 3|4|Actual|TopMD Skin Care, Inc.||2||Difficulty enrolling patients|f||||t||||||||||2017-10-11 01:50:19.951424|2017-10-11 01:50:19.951424
NCT01826617|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-04-05|||December 2010||2010-12-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01|1 Year|Observational [Patient Registry]|||Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome|Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome Correlating Clinical Indicators Among Asian Adult Males With Elevated Prostate Specific Antigen (PSA)|Completed||N/A|400|Anticipated|St. Luke's Medical Center, Philippines|||5||f||||t||||||||||2017-10-11 01:50:20.029394|2017-10-11 01:50:20.029394
NCT01826604|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-08-09|2015-10-26||January 2013||2013-01-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Alexis||Self-Retaining Retractor in Obese Patients Undergoing Cesarean Section|The Effect of a Barrier Self-Retaining Retractor in Obese Patients Undergoing Cesarean Section|Completed||N/A|301|Actual|St. Louis University||2|||f||||t||||||||No||2017-10-11 01:50:20.109283|2017-10-11 01:50:20.109283
NCT01826591|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-07-27|||January 2013|Actual|2013-01-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|DIETFITS||DIETFITS Study (Diet Intervention Examining the Factors Interacting With Treatment Success|Do Insulin Secretion or Genotype Pattern Predict Low Fat vs Low Carb Weight Loss Success?|Completed||N/A|609|Actual|Stanford University||2|||f||||f|f|f||||||||2017-10-11 01:50:22.098224|2017-10-11 01:50:22.098224
NCT01826019|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2017-06-27|||August 2014||2014-08-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|HOPE-4||Heart Outcomes Prevention and Evaluation 4|Heart Outcomes Prevention and Evaluation 4 (HOPE-4)|Recruiting||Phase 4|9500|Anticipated|Hamilton Health Sciences Corporation||2|||f||||t||||||||||2017-10-11 01:50:26.653721|2017-10-11 01:50:26.653721
NCT01826578|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-04-03|||May 2013||2013-05-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|SM||Single Port Myomectomy Versus Conventional Myomectomy|Prospective Randomized Controlled Trial to Analyze the Benefits of Single Port Laparoscopic Myomectomy in the View of Cosmetics and Patient Satisfaction|Unknown status|Not yet recruiting|N/A|106|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:50:22.196063|2017-10-11 01:50:22.196063
NCT01826552|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-03|2016-04-19|||September 2013||2013-09-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ORIENT||Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent|Multicenter, Randomized, Open Label, Parallel Group Study to Evaluate the Safety and Efficacy of Orsiro Hybrid Drug Eluting Stent|Completed||Phase 4|372|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 01:50:22.403425|2017-10-11 01:50:22.403425
NCT01826539|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-05|||January 2011||2011-01-01|April 2011|2011-04-01|September 2012|Actual|2012-09-01|February 2012|Actual|2012-02-01||Interventional|||A Comparison of Dorsal Branch of the Digital Nerve Versus Dorsal Digital Nerve for Finger Pulp Reconstruction||Completed||N/A|71|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 01:50:22.511676|2017-10-11 01:50:22.511676
NCT01826526|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2016-12-03|||June 2013||2013-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%|Taurolidine 2% Catheter Locking to Prevent Catheter-related Bloodstream Infections in Patients on Home Parenteral Nutrition With a High Infection Risk and Those With a New Central Venous Access Device|Completed||N/A|105|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 01:50:22.582854|2017-10-11 01:50:22.582854
NCT01826513|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-02-06|2016-10-12||May 2013||2013-05-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||AutoSet for Her Clinical Trial Protocol|AutoSet for Her Clinical Trial Protocol|Completed||N/A|25|Actual|ResMed||3|||f||||f||||||||||2017-10-11 01:50:22.684918|2017-10-11 01:50:22.684918
NCT01826500|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-01-16|||January 2013||2013-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|VARITI-5||VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological Situations|VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological Situations.|Completed||N/A|163|Actual|Rennes University Hospital|||2||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 01:50:23.218722|2017-10-11 01:50:23.218722
NCT01826487|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-05-30|||March 2013||2013-03-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|ACT DMD||Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy|A Phase 3 Efficacy and Safety Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy|Completed||Phase 3|230|Actual|PTC Therapeutics||2|||f||||t||||||||No||2017-10-11 01:50:23.321499|2017-10-11 01:50:23.321499
NCT01826474|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-10-27|||January 2013||2013-01-01|June 2015|2015-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy|A Phase IIb, Open-label Study to Assess the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Multiple Subcutaneous Doses of PRO045 in Subjects With Duchenne Muscular Dystrophy|Terminated||Phase 1/Phase 2|15|Actual|BioMarin Pharmaceutical||6|||f||||t||||||||||2017-10-11 01:50:23.529161|2017-10-11 01:50:23.529161
NCT01826461|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-05-27|||March 2013||2013-03-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis|A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Evaluation of Twice Daily PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis in Subjects 3 Months to Less Than 18 Years of Age|Completed||Phase 2|151|Actual|PreCision Dermatology, Inc.||3|||f||||f||||||||||2017-10-11 01:50:23.644812|2017-10-11 01:50:23.644812
NCT01826448|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-09-25|||June 2013||2013-06-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma|A Phase 1b Open Label, Dose Escalation Study to Assess Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Unresectable or Metastatic Melanoma|Terminated||Phase 1|13|Actual|Plexxikon||4|||f||||f||||||||||2017-10-11 01:50:23.790041|2017-10-11 01:50:23.790041
NCT01826435|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2014-01-24|||January 2014||2014-01-01|January 2014|2014-01-01|May 2015|Anticipated|2015-05-01|August 2014|Anticipated|2014-08-01||Interventional|HTNmobile||Improving Medication Adherence in Hypertensive Patients|Improving Medication Adherence in Hypertensive Patients|Withdrawn||N/A|0|Actual|Duke University||1||Collaborator was not clear on how best to proceed with this project.|f||||f||||||||||2017-10-11 01:50:23.884044|2017-10-11 01:50:23.884044
NCT01826409|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-08-28|||March 2008||2008-03-01|August 2013|2013-08-01||||September 2009|Actual|2009-09-01||Interventional|||Hypoglycemic Effects of Fermented Red Ginseng in Subject With Impaired Fasting Glucose or Type 2 Diabetes||Completed||Phase 2/Phase 3|42|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 01:50:24.053175|2017-10-11 01:50:24.053175
NCT01826032|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2015-01-21|||November 2011||2011-11-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Obstructive Sleep Apneas in Elderly:Neuroimaging Changes and Neurocognitive Function Before and After Treatment|Obstructive Sleep Apneas in Elderly:Neuroimaging Changes and Neurocognitive Function Before and After Treatment|Completed||N/A|33|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 01:50:26.584072|2017-10-11 01:50:26.584072
NCT01826396|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-04|2013-04-04|||April 2013||2013-04-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|April 2014|Anticipated|2014-04-01||Interventional|||Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer|Comparison of Standard and High Dose Irinotecan Based on UGT1A1 Genotype, 5-fluorouracil, and Leucovorin (FOLFIRI) for First-line Treatment of Locally Advanced Colon Cancer: a Prospective Phase II Clinical Study|Unknown status|Recruiting|Phase 2|100|Anticipated|Colorectal Cancer Institute of the Heilongjiang Academy of Medical Sciences||1|||f||||||||||||||2017-10-11 01:50:24.144085|2017-10-11 01:50:24.144085
NCT01826214|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-07-26|2016-04-14||May 2013||2013-05-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||"Full analysis set (FAS): comprised of all patients who were randomized to a study treatment.
According to the intent-to-treat principle, patient data were analyzed according to the treatment to which they had been randomized."|Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia|A Phase II Multi-center, Open Label, Randomized Study to Assess Safety and Efficacy of Two Different Schedules of Oral LDE225 in Adult Patients With Relapsed/Refractory or Untreated Elderly Patients With Acute Leukemia|Completed||Phase 2|70|Actual|Novartis|Only 34 of the 35 patients in the LDE225 800 mg once daily arm received at least dose of study drug were analyzed for safety.|2|||f||||t||||||||||2017-10-11 01:50:24.244887|2017-10-11 01:50:24.244887
NCT01826201|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-12-22|2014-11-11||March 2013||2013-03-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis|A Phase 2a, Randomized, Blinded, Paired Psoriasis Lesion, Comparative, Placebo-controlled Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of Epidermal Administrations of MOL4239 in Adults With Plaque Psoriasis|Completed||Phase 2|21|Actual|Moleculin, LLC||1|||f||||f||||||||||2017-10-11 01:50:25.354782|2017-10-11 01:50:25.354782
NCT01826188|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-02-23|||March 2013||2013-03-01|April 2013|2013-04-01||||March 2015|Anticipated|2015-03-01||Interventional|||Combined THC and CBD Drops for Treatment of Crohn's Disease|Combined THC and CBD Drops for Treatment of Crohn's Disease, a Phase II Double Blind Placebo Controlled Trial|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 01:50:25.585713|2017-10-11 01:50:25.585713
NCT01826175|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-12-19|||May 2013||2013-05-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study|Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During Percutaneous Coronary Intervention: an Optical Coherence Tomography Study|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||2||Study terminated mutually by sponsor & PI due to no enrollment|f||||f||||||||No||2017-10-11 01:50:25.686487|2017-10-11 01:50:25.686487
NCT01826162|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-09-14|||April 2013||2013-04-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Short Chain Fatty Acid Metabolism and Energy Metabolism|The Effects of Differential Short Chain Fatty Acid Availability on Human Substrate and Energy Metabolism|Completed||N/A|10|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 01:50:25.786339|2017-10-11 01:50:25.786339
NCT01826136|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-05-13|||January 2013||2013-01-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Effect of Vibratory Expiratory Pressure on Pulmonary Function After Lung Resection Surgery||Completed||N/A|78|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:50:25.970562|2017-10-11 01:50:25.970562
NCT01826123|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-05-03|||July 2013||2013-07-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|MultiPOC||Point-of-Care Testing in Coagulopathic Patients Undergoing Cardiac Surgery - a Multicenter Study|Point-of-Care Testing - A Prospective, Randomized, Controlled Multicenter Study of Efficacy in Coagulopathic Cardiac Surgery Patients|Active, not recruiting||N/A|160|Anticipated|Goethe University||2|||f||||t||||||||||2017-10-11 01:50:26.045916|2017-10-11 01:50:26.045916
NCT01826110|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-03-03|||September 2013||2013-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers|"[11C] PIB Comparison Study to [18F] AV-45 in Subjects With Alzheimer's Disease (AD) and Age Matched Healthy Controls"|Active, not recruiting||Phase 1|21|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 01:50:26.157305|2017-10-11 01:50:26.157305
NCT01826097|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-04-03|||January 2013||2013-01-01|April 2013|2013-04-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Improving Sensitivity of Urine Cytology for Bladder Cancer|Non-Invasive Vibrational Device to Improve Sensitivity of Urine Cytology for Bladder Cancer|Unknown status|Recruiting|Early Phase 1|20|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:50:26.230142|2017-10-11 01:50:26.230142
NCT01826071|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-04-05|||October 2012||2012-10-01|March 2013|2013-03-01||||November 2013|Anticipated|2013-11-01||Interventional|||Comparison of Three Treatments for Lower Extremity Apophysitis|Comparison of Three Treatments for Lower Extremity Apophysitis|Unknown status|Recruiting|N/A|90|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||3|||f||||t||||||||||2017-10-11 01:50:26.302788|2017-10-11 01:50:26.302788
NCT01826058|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-11-27|||October 2012||2012-10-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Spine Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord Compression|Spine Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord: Prospective Phase II Study|Unknown status|Recruiting|Phase 2|43|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 01:50:26.396872|2017-10-11 01:50:26.396872
NCT01826045|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-01-28|||June 2013||2013-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|PGA||Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia|A Multi-center, Randomized, Double Blind, Placebo Control, Parallel Design, Phase 2a Trial to Evaluate the Efficacy and Safety of PGA (Poly-gamma Glutamic Acid) for the Fertile Women With Cervical Intraepithelial Neoplasia 1 (CIN1)|Completed||Phase 2|200|Actual|BioLeaders Corporation||2|||f||||t||||||||||2017-10-11 01:50:26.485048|2017-10-11 01:50:26.485048
NCT01826006|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-11-11|||April 2014||2014-04-01|November 2014|2014-11-01||||April 2015|Anticipated|2015-04-01||Interventional|LASER-AMI||THE LASER-AMI STUDY - Excimer Laser Versus Manual Thrombus Aspiration in Acute Myocardial Infarction|A Randomized Comparison of Excimer LASER vs Manual Thrombus Aspiration for the Prevention of No-reflow During Primary Percutaneous Coronary Intervention of St-elevation Myocardial Infarction(LASER-AMI Study)|Unknown status|Recruiting|N/A|194|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 01:50:26.768753|2017-10-11 01:50:26.768753
NCT01825993|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-04-05|||April 2013||2013-04-01|April 2013|2013-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|2013/004||RANDOMISED STUDY OF EPIDURAL VS MPCA MORPHINE VS TAPP IN LAPAROSCOPIC SIGMOIDECTOMY|RANDOMISED STUDY ABOUT POTSOTERATORY PAIN CONTROL IN LAPAROSCOPIC SIGMOIDECTOMY|Unknown status|Not yet recruiting|Phase 3|225|Anticipated|Corporacion Parc Tauli||3|||f||||f||||||||||2017-10-11 01:50:26.921597|2017-10-11 01:50:26.921597
NCT01825980|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2016-05-09|||March 2013||2013-03-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CBZF961X2201||Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients|Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Determine the Safety and Antiviral Effect of 3 Days of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus (HCV) Infected Patients|Completed||Phase 1/Phase 2|54|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:50:27.088819|2017-10-11 01:50:27.088819
NCT01825967|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-04-09|||April 2013||2013-04-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01|30 Days|Observational [Patient Registry]|||Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker|Predictive Value of C-Reactive Protein in Acute Diverticulitis|Unknown status|Not yet recruiting|N/A|30|Anticipated|Corporacion Parc Tauli|||1||f||||f||||||||||2017-10-11 01:50:27.184293|2017-10-11 01:50:27.184293
NCT01825954|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-09-02||2015-07-27|March 2013||2013-03-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|PERRFECT-SJMO||Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - St. Joseph Mercy Oakland|A Double-Blinded, Randomized, Sham-Controlled, Proof of Concept Study Exploring the Safety and Efficacy of RINCE Technology for the Treatment of Patients With Fibromyalgia|Completed||N/A|46|Actual|Cerephex Corporation||3|||f||||||||||||||2017-10-11 01:50:27.283934|2017-10-11 01:50:27.283934
NCT01825941|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-03-19|||April 2013||2013-04-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Diphenhydramine for Acute Migraine|Diphenhydramine as Adjuvant Therapy for Acute Migraine. A Randomized Trial.|Completed||Phase 4|374|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 01:50:27.384982|2017-10-11 01:50:27.384982
NCT01825928|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-07-11|||February 2013||2013-02-01|July 2017|2017-07-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence|Randomized, Double-blind, Placebo-controlled Trial of Paliperidone Extended-Release Tablets for The Treatment of Methamphetamine Dependence in Chinese Patients After Detoxification|Completed||N/A|80|Actual|Central South University||2|||f||||t||||||||||2017-10-11 01:50:27.468817|2017-10-11 01:50:27.468817
NCT01825915|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-04-05|||September 2010||2010-09-01|April 2013|2013-04-01|May 2013|Anticipated|2013-05-01|November 2012|Actual|2012-11-01||Interventional|LaHoST||Feasibility of a Trial of Laparoscopic Hysterectomy Versus Laparoscopic Sub-Total Hysterectomy|Feasibility of a Randomised Controlled Trial of Laparoscopic Hysterectomy Versus Laparoscopic Sub-Total Hysterectomy|Unknown status|Active, not recruiting|N/A|50|Actual|Medway NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:50:27.553267|2017-10-11 01:50:27.553267
NCT01825902|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-05-23|||March 2013|Actual|2013-03-01|March 2016|2016-03-01|November 23, 2015|Actual|2015-11-23|January 2014|Actual|2014-01-01||Interventional|||18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma|A Pilot Study of the Utility of 18F-FLT-PET and Diffusion-Weighted MRI for Surgical Planning, Radiotherapy Target Delineation, and Treatment Response Evaluation in Ewing Sarcoma Patients|Completed||N/A|1|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:50:27.646696|2017-10-11 01:50:27.646696
NCT01825889|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-10-30|||April 2013||2013-04-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study of Evacetrapib (LY2484595) in Participants With Kidney Impairment and in Healthy Participants|Pharmacokinetics of Evacetrapib (LY2484595) Following Administration to Subjects With Impaired Renal Function|Completed||Phase 1|20|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:50:27.742427|2017-10-11 01:50:27.742427
NCT01825876|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-06-27|||April 2013||2013-04-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants|Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects|Completed||Phase 1|17|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:50:27.822878|2017-10-11 01:50:27.822878
NCT01825863|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-07-20|||June 2013||2013-06-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|BD-TAP APP||Ultrasound-guided Abdominal Wall Nerve Blockade in Laparoscopic Surgery for Acute Appendicitis.|Optimal Postoperative Pain Management by Ultrasound-guided Abdominal Wall Nerve Blockade in Laparoscopic Surgery for Acute Appendicitis - a Randomised Controlled Trial.|Completed||N/A|56|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 01:50:27.914829|2017-10-11 01:50:27.914829
NCT01825850|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-12-29|||June 2013||2013-06-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|||Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects|A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Irbesartan in Healthy Male Subjects|Completed||Phase 1|30|Actual|LG Life Sciences||3|||f||||f||||||||||2017-10-11 01:50:27.995832|2017-10-11 01:50:27.995832
NCT01825837|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-02-26|2013-04-09||March 2006||2006-03-01|February 2014|2014-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional||The study was comprised of 2 sequential parts. Part I followed an open-label design in which all participants received open-label treatment with BIA 2-093 900 mg once daily for 2 weeks. Part II followed a double-blind, parallel-group design in which participants who completed part I. 17 patients did not complete part I.|Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder|Extension Study to Investigate the Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate (BIA 2-093) in the Recurrence Prevention of Bipolar I Disorder|Completed||Phase 2|104|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 01:50:28.083254|2017-10-11 01:50:28.083254
NCT01825824|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2016-12-22|||June 2012||2012-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2015|Actual|2015-06-01||Interventional|||Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm|Multicenter Phase II Study of Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm|Active, not recruiting||Phase 2|54|Anticipated|Korea Cancer Center Hospital||1|||f||||f||||||||Undecided||2017-10-11 01:50:28.588059|2017-10-11 01:50:28.588059
NCT01825811|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2015-01-20|||October 2012||2012-10-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis|A Single-blind, Randomized, Parallel-group, Multi-center Phase 2 Study to Determine the Efficacy and Safety of TissueGene-C Mixed With Fibrin-glue in Patients With Degenerative Arthritis|Completed||Phase 2|18|Actual|Kolon Life Science||2|||f||||t||||||||||2017-10-11 01:50:28.708684|2017-10-11 01:50:28.708684
NCT01825785|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-04-03|||October 2007||2007-10-01|April 2013|2013-04-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|||A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 785|A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 785 in Healthy Men and Postmenopausal Women With Low Bone Mass|Completed||Phase 1|48|Actual|Amgen||4|||f||||f||||||||||2017-10-11 01:50:28.949227|2017-10-11 01:50:28.949227
NCT01825772|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2014-02-03|||January 2013||2013-01-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Clinical and Radiographic Outcomes of Dental Implant Therapy|Clinical and Radiographic Outcomes of Dental Implant Therapy|Completed||N/A|596|Actual|Göteborg University|||1||f||||f||||||||||2017-10-11 01:50:29.050776|2017-10-11 01:50:29.050776
NCT01825759|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-04-05|||January 2013||2013-01-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function|The Impact of Compound Danshen Dropping Pill for Coronary Heart Disease With Hypertension Patient Heart and Artery Structure and Function|Unknown status|Recruiting|Phase 4|200|Anticipated|West China Hospital||1|||f||||t||||||||||2017-10-11 01:50:29.143064|2017-10-11 01:50:29.143064
NCT01825746|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2015-05-12|||March 2013||2013-03-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|MOHR||Goal Setting for Health Behavior and Psychosocial Issues in Primary Care|My Own Health Report (MOHR): A Pragmatic Evaluation to Enhance Primary Care Based Goal Setting and Evidence-Based Support for Health Behavior and Psychosocial Issues Through Meaningful Use of Patient-Centered Data and Tools|Completed||N/A|3591|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 01:50:29.243935|2017-10-11 01:50:29.243935
NCT01825733|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2014-02-17|||August 2011||2011-08-01|February 2014|2014-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery||Completed||N/A|196|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:50:29.349094|2017-10-11 01:50:29.349094
NCT01825720|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-10-10|||March 2013||2013-03-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery||Completed||N/A|106|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:50:29.423385|2017-10-11 01:50:29.423385
NCT01825707|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-07-11|||January 2013||2013-01-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||AME Study of [14C]-YH4808 in Healthy Male Subjects|A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-YH4808 Following Single Oral Dose Administration in Healthy Male Subjects|Completed||Phase 1|8|Actual|Yuhan Corporation||1|||f||||f||||||||||2017-10-11 01:50:29.495448|2017-10-11 01:50:29.495448
NCT01825694|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2013-06-25|||April 2013||2013-04-01|June 2013|2013-06-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents|An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 01:50:29.574395|2017-10-11 01:50:29.574395
NCT01825681|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-01-04|||October 2013||2013-10-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|LEAF||Life Enhancing Activities for Family Caregivers|Life Enhancing Activities for Family Caregivers (LEAF)|Active, not recruiting||N/A|175|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:50:29.653126|2017-10-11 01:50:29.653126
NCT01825668|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-02-02|||March 2013||2013-03-01|March 2013|2013-03-01|June 2016|Anticipated|2016-06-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Plant Sterol Enriched Milk on Plasma Lipid Levels of Humans Breast-fed During Infancy|Effect of a Plant Sterol-Fortified Low-fat Milk Product on Plasma Lipid Levels of Humans in Relation to Different Infant Feeding Practices and Later Life Cholesterol Metabolism|Unknown status|Active, not recruiting|N/A|55|Actual|University of Manitoba||3|||f||||t||||||||||2017-10-11 01:50:29.743224|2017-10-11 01:50:29.743224
NCT01825655|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-12-06|||September 2014||2014-09-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching|Effect of Long Acting Antihistamine on Opioid- Induced Pruritus: A Double-blind Placebo Controlled Study|Recruiting||Phase 4|73|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 01:50:29.826838|2017-10-11 01:50:29.826838
NCT01825642|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-04-01|||September 2006||2006-09-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer|Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer|Completed||Phase 2/Phase 3|140|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 01:50:29.91036|2017-10-11 01:50:29.91036
NCT01825629|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-12-09|||April 2013||2013-04-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Multidisciplinary Therapy in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome|Benefits of a Multidisciplinary Therapy in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome: a Randomized Clinical Trial|Completed||N/A|70|Anticipated|Universidad de Almeria||2|||f||||f||||||||||2017-10-11 01:50:29.994988|2017-10-11 01:50:29.994988
NCT01825616|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-04-08|||October 2012||2012-10-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Vitamin D2, Muscle Damage, NASCAR Pitcrew|Influence of 6-weeks Supplementation With Vitamin D Portobello Mushroom Powder on Muscle Function and Performance, Innate Immune Function, and Exercise-induced Muscle Damage and DOMS in NASCAR Pit Crew Members|Completed||N/A|33|Actual|Appalachian State University||2|||f||||f||||||||||2017-10-11 01:50:30.120859|2017-10-11 01:50:30.120859
NCT01825603|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-05-07|||April 2013||2013-04-01|May 2013|2013-05-01||||December 2018|Anticipated|2018-12-01||Interventional|||ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery|A Phase I Study of ADH-1 and Gemcitabine Plus Cisplatin in Patients With Unresectable or Metastatic Pancreatic and Biliary Tract Cancers|Recruiting||Phase 1|24|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-11 01:50:30.389634|2017-10-11 01:50:30.389634
NCT01825590|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-02-23|||May 2011||2011-05-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Effects of Simple Sodium Alignment on Clinical Outcomes|Effects of Simple Sodium Alignment on Short-, Medium- and Long-term Clinical and Laboratory Outcome Measures|Completed||N/A|148|Actual|Renal Research Institute|||2||f||||f||||||||||2017-10-11 01:50:30.570961|2017-10-11 01:50:30.570961
NCT01825577|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-08-19|2016-04-07||November 2012||2012-11-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.|Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.|Terminated||Phase 4|14|Actual|St. Louis University||1||Administrative Reasons|f||||t||||||||||2017-10-11 01:50:30.690181|2017-10-11 01:50:30.690181
NCT01825564|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-01-20|||March 14, 2013|Actual|2013-03-14|January 2017|2017-01-01|May 25, 2016|Actual|2016-05-25|May 25, 2016|Actual|2016-05-25||Observational|||Comparison of RightSpot pH Indicator & RightLevel pH Detector With X-Ray Verification for FT or G-Tube Placement|Comparison of the RightSpot pH Indicator & RightLevel pH Detector With the Gold Standard of Radiographic Verification of Feeding Tube Placement & Gastrostomy Tube Replacement|Terminated||N/A|11|Actual|St. Louis University|||1|Insufficient patient population & problems with device use in subjects enrolled.|f||||f||||||||||2017-10-11 01:50:30.952233|2017-10-11 01:50:30.952233
NCT01825551|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-11-10|||November 2012||2012-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Effect of GCSF in the Treatment of ALS Patients|The Effect of Granulocyte Colony Stimulating Factor (GCSF) in the Treatment of Amyotrophic Lateral Sclerosis (ALS) Patients Referred to Tehran Imam Khomeini and Shariati Hospital Centers in 2013|Completed||Phase 2/Phase 3|40|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:50:31.030842|2017-10-11 01:50:31.030842
NCT01825538|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-07-24|||February 2013||2013-02-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases|Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases|Completed||N/A|93|Actual|Ohio State University|||1||f||||t||||||||||2017-10-11 01:50:31.124304|2017-10-11 01:50:31.124304
NCT01825525|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-04-05|||August 2012||2012-08-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Safety of the Colonoscope Magnetic Imaging Device (ScopeGuide®) in Patients With Implantable Cardiac Devices|Safety of the Colonoscope Magnetic Imaging Device (ScopeGuide®) in Patients With Implantable Cardiac Devices|Completed||N/A|100|Actual|Cambridge University Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 01:50:31.201439|2017-10-11 01:50:31.201439
NCT01825512|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2017-03-21|||March 2014||2014-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients|Multicentre, Randomised, Open Label, Non-inferiority Trial to Evaluate the Efficacy and Safety of Deferiprone Compared to Deferasirox in Patients Aged From 1 Month to Less Than 18 Years Affected by Transfusion Dependent Haemoglobinopathies|Active, not recruiting||Phase 3|434|Actual|Consorzio per Valutazioni Biologiche e Farmacologiche||2|||f||||t||||||||No||2017-10-11 01:50:31.278703|2017-10-11 01:50:31.278703
NCT01825499|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-05-08|||January 1990||1990-01-01|May 2017|2017-05-01|December 2040|Anticipated|2040-12-01|December 2040|Anticipated|2040-12-01|1 Year|Observational [Patient Registry]|VON VLBW||Vermont Oxford Network Very Low Birth Weight Database|Vermont Oxford Network Very Low Birth Weight Database of Infants 401 to 1500 Grams or 22 to 29 Weeks Gestational Age at Birth|Recruiting||N/A|60000|Anticipated|Vermont Oxford Network|||1||f||||f||||||||No||2017-10-11 01:50:31.427213|2017-10-11 01:50:31.427213
NCT01825486|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-03|2013-04-04|||August 2005||2005-08-01|April 2013|2013-04-01|July 2007|Actual|2007-07-01|July 2006|Actual|2006-07-01||Observational|||Balance and Gait Characteristics to Predict Accidental Falls in Community-dwelling Stroke Elderly||Completed||N/A|||Changhua Christian Hospital|||1||f||||||||||||||2017-10-11 01:50:31.559387|2017-10-11 01:50:31.559387
NCT01825473|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-04-02|||September 2012||2012-09-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|SEGAN||Study of Erythromycin in GER-Associated Apnea of the Newborn|Study of Erythromycin in GER-Associated Apnea of the Newborn|Unknown status|Recruiting|N/A|40|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-11 01:50:31.645234|2017-10-11 01:50:31.645234
NCT01825460|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-09-22|||April 2013||2013-04-01|May 2013|2013-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Manual Therapy to Treat Acute Whiplash Injury|Short-Term Effects of a Manual Therapy Protocol|Completed||N/A|60|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-11 01:50:31.75553|2017-10-11 01:50:31.75553
NCT01825265|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-04|||November 2005||2005-11-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase II: RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer|Phase II, Open Label, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of the Combination RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Study did not progress to second phase.|f||||f||||||||||2017-10-11 01:50:33.410725|2017-10-11 01:50:33.410725
NCT01825447|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-10-07|||July 2013||2013-07-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users|A Randomized, Single-Dose, Placebo-Controlled, Double-Blind, 3-Way Crossover Study to Determine the Relative Abuse Potential of Intravenous Oxycodone Hydrochloride Alone or in Combination With Intravenous Naltrexone Hydrochloride in Opioid Experienced Non-Dependent Subjects|Completed||Phase 1|89|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 01:50:31.845899|2017-10-11 01:50:31.845899
NCT01825434|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-04-02|||February 2010||2010-02-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Yogurt With Polydextrose,L Acidophilus and B Lactis in Chronic Constipation|Effect of Yogurt Containing Polydextrose, Lactobacillus Acidophilus NCFM and Bifidobacterium Lactis HN019: a Randomized, Double-blind, Controlled Study in Chronic Constipation|Completed||N/A|30|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-11 01:50:32.005511|2017-10-11 01:50:32.005511
NCT01825421|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-07-14|||October 2014||2014-10-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64|A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64|Withdrawn||N/A|0|Actual|Yale University||2||No funding obtained|f||||f||||||||||2017-10-11 01:50:32.075467|2017-10-11 01:50:32.075467
NCT01825408|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-02-16|2017-02-16||February 2013|Actual|2013-02-01|February 2017|2017-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis|A Randomized Cohort Trial Evaluating Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis|Completed||Phase 4|40|Actual|University of North Carolina, Chapel Hill||4|||f||||f|t|f|||f|||No||2017-10-11 01:50:32.162739|2017-10-11 01:50:32.162739
NCT01825395|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-12-21|||July 2004||2004-07-01|December 2016|2016-12-01|March 2050|Anticipated|2050-03-01|February 2050|Anticipated|2050-02-01||Expanded Access|3 4-DAP||Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome|Use of 3,4-Diaminopyridine(3 4-DAP)in the Treatment of Lambert-Eaton Syndrome (LEMS)|Available||N/A|||University of Colorado, Denver|||||||||||||||||||2017-10-11 01:50:32.505036|2017-10-11 01:50:32.505036
NCT01825382|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-05-19|||December 2012||2012-12-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|REMOTE-T1D||Role of Mobile Technology to Improve Diabetes Care in Adults With Type 1 Diabetes: the REMOTE-T1D Study, a Pilot Study|Role of Mobile Technology to Improve Diabetes Care in Adults With Type 1 Diabetes: the REMOTE-T1D Study, a Pilot Study|Completed||Phase 4|100|Actual|University of Colorado Denver School of Medicine Barbara Davis Center||2|||f||||t||||||||||2017-10-11 01:50:32.580651|2017-10-11 01:50:32.580651
NCT01825369|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-01-12|||December 2014||2014-12-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|L-carn||Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow|Phase 1 Study of the Safety and Pharmacokinetics of Perioperative IV L-carnitine Administration in Patients With Congenital Heart Disease With Increased Pulmonary Blood Flow|Unknown status|Recruiting|Phase 1|15|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:50:32.667078|2017-10-11 01:50:32.667078
NCT01825356|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-09-26|||April 8, 2013|Actual|2013-04-08|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Amniotic Membrane as an Adjunct Treatment for Hallux Rigidus||Active, not recruiting||Phase 4|60|Anticipated|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-11 01:50:32.81361|2017-10-11 01:50:32.81361
NCT01825343|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-04|||April 2013||2013-04-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||Preventable Paediatric Trauma - Retrospective Analysis|Preventable Paediatric Trauma - Retrospective Analysis|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Ziv Hospital|||1||f||||t||||||None Retained|"     We are looking retrospectively at data already stored on the hospital database. We have no     human subjects and will only analyse hospital records. We will not be contacting patients.   "|||2017-10-11 01:50:32.885906|2017-10-11 01:50:32.885906
NCT01825330|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2016-03-29|||October 2013||2013-10-01|October 2015|2015-10-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Effect of NeuroAD on the Cognitive Function of Alzheimer Patients|Effect of NeuroAD, Combined TMS Stimulation and Cognitive Training, on the Cognitive Function of Mild to Moderate Alzheimer Patients|Completed||N/A|131|Actual|Neuronix Ltd||2|||f||||f||||||||||2017-10-11 01:50:32.950533|2017-10-11 01:50:32.950533
NCT01825317|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-04-17|||March 2013||2013-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of NeuroAD on Alzheimer Patients|Effect of NeuroAD, Combined TMS Stimulation and Cognitive Training, on the Cognitive Function of Mild to Moderate Alzheimer Patients|Completed||N/A|32|Actual|Neuronix Ltd||2|||f||||f||||||||||2017-10-11 01:50:33.063585|2017-10-11 01:50:33.063585
NCT01825304|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-04|||October 2011||2011-10-01|October 2011|2011-10-01|June 2013|Anticipated|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||The Study of Using Esophageal Pressure to Guide the PEEP Setting in Abdominal Hypertension Patients Who Undergoing Mechanical Ventilation|the Study of Using Esophageal Pressure to Guide the PEEP Setting in Abdominal Hypertension Patients Who Undergoing Mechanical Ventilation|Unknown status|Recruiting|Phase 4|60|Anticipated|Nanjing Medical University||2|||f||||t||||||||||2017-10-11 01:50:33.154288|2017-10-11 01:50:33.154288
NCT01825291|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2015-11-11|||January 1999||1999-01-01|November 2015|2015-11-01||||January 2017|Anticipated|2017-01-01||Observational|||Sleep-disordered Breathing in Postmenopausal Women|Sleep-disordered Breathing in Postmenopausal Women and CPAP Treatment|Active, not recruiting||N/A|800|Anticipated|Turku University Hospital|||1||f||||||||||||||2017-10-11 01:50:33.262853|2017-10-11 01:50:33.262853
NCT01825278|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-03-27|||February 2013||2013-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Evaluation of a Respiratory Monitor in Surgical Patients With a BMI>35|The Evaluation of a Respiratory Monitor in Surgical Patients With a BMI >35 Undergoing Elective Surgery Under General Anesthesia|Active, not recruiting||N/A|100|Anticipated|Tufts Medical Center|||1||f||||f||||||||||2017-10-11 01:50:33.325035|2017-10-11 01:50:33.325035
NCT01824511|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-03-11|||April 2013||2013-04-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Quitting Study A Test of Pre-clinical Findings|Does Smoking Cessation Increase Anhedonia? A Test of Pre-clinical Findings|Completed||N/A|287|Actual|University of Vermont||1|||f||||f||||||||||2017-10-11 01:50:44.89882|2017-10-11 01:50:44.89882
NCT01825252|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-11-29|||August 2011||2011-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|C3||Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)|Prevention of HIV Infection in High-Risk Social Networks of African American MSM|Active, not recruiting||N/A|960|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 01:50:33.504379|2017-10-11 01:50:33.504379
NCT01825239|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-08-05|||April 2014||2014-04-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Virtual LV Lead Navigation in Patients With Ischemic Cardiomyopathy|Virtual Left Ventricular Lead Navigation in Patients With Ischemic Cardiomyopathy|Withdrawn||N/A|0|Actual|University of Pittsburgh||1||Problems with execution|f||||f||||||||||2017-10-11 01:50:33.592987|2017-10-11 01:50:33.592987
NCT01825226|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-09-15|||February 2010||2010-02-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|June 2013|Actual|2013-06-01||Interventional|EHFP||Helen Keller International's Enhanced-Homestead Food Production Program in Burkina Faso|THE IMPACT OF THE ENHANCED HOMESTEAD FOOD PRODUCTION PROGRAM ON CHILD HEALTH|Active, not recruiting||N/A|1763|Actual|International Food Policy Research Institute||2|||f||||f||||||||||2017-10-11 01:50:33.690361|2017-10-11 01:50:33.690361
NCT01825213|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-04-13|||November 2013||2013-11-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT|Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT|Completed||N/A|10|Actual|Massachusetts General Hospital|||1||f||||f|f|f||||||No||2017-10-11 01:50:33.769905|2017-10-11 01:50:33.769905
NCT01825200|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-01-29|2014-12-19||March 2013||2013-03-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||The primary analysis population includes all randomized subjects who received a dose of study vaccine and for whom some safety data were available after administration of vaccine. Subjects were analyzed according to the vaccine received, regardless of whether this was the treatment group to which they were randomized.|Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age|Comparison of the Safety of Flublok® Versus Licensed Inactivated Influenza Vaccine in Healthy, Medically Stable Adults ≥ 50 Years of Age|Completed||Phase 3|2640|Actual|Protein Sciences Corporation|Rash, urticaria, swelling and edema were self-reported by subjects and most were not observed by investigators. Review by independent experts indicated that 42 of 52 subject-reported events did not represent Type 1 (IgE-mediated) hypersensitivity.|2|||f||||f||||||||||2017-10-11 01:50:33.871291|2017-10-11 01:50:33.871291
NCT01825187|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-11-29|||June 2014||2014-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Trial Comparing Two Different Polypropylene Meshes for Inguinal Hernias|Prospective Randomized Controlled Trial Comparing Resident Performance and Clinical Outcomes With Two Different Polypropylene Meshes for Laparoscopic Inguinal Hernias|Recruiting||N/A|511|Anticipated|South East Area Health Education Center, Wilmington, NC||3|||f||||f||||||||No||2017-10-11 01:50:34.347586|2017-10-11 01:50:34.347586
NCT01825174|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-04|||June 2006||2006-06-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Overweight Children - Musculoskeletal Consequences|Musculoskeletal Consequences of Pediatric Overweight - Efficiency of Different Interventions on Health, Motor and Psychosocial Development in Overweight and Obese Children|Completed||N/A|137|Actual|University Hospital Heidelberg||6|||f||||f||||||||||2017-10-11 01:50:34.42564|2017-10-11 01:50:34.42564
NCT01825161|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-02-03|||August 2013||2013-08-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|EPOSO||The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)|The Epidemiology, Process and Outcomes of Spine Oncology|Recruiting||N/A|350|Anticipated|AOSpine International|||1||f||||f||||||||||2017-10-11 01:50:34.667288|2017-10-11 01:50:34.667288
NCT01825148|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-11-27|||December 2012||2012-12-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|GLP-1-CPOP||GLP-1 Receptor Targeting in Diabetic and Healthy Individuals|Clinical Proof-of-principle of the Determination of the Beta Cell Mass in Vivo by SPECT Imaging With the 111-In-labeled GLP-1 Analogue DTPA(Diethylenetriamine Pentaacetic Acid)-[K40]-Exendin 4|Completed||N/A|20|Actual|Radboud University|||2||f||||t||||||Samples Without DNA|"     blood samples   "|||2017-10-11 01:50:34.845713|2017-10-11 01:50:34.845713
NCT01825135|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-05-01|||March 2011||2011-03-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|October 2014|Actual|2014-10-01||Interventional|||Electrical Stimulation to Strengthen Muscles in the Lower Legs in Patients Requiring Prolonged Mechanical Ventilation|Electrical Stimulation to Strengthen the Quadriceps Muscles in Patients Requiring Prolonged Mechanical Ventilation|Completed||N/A|57|Actual|RML Specialty Hospital||2|||f||||f||||||||||2017-10-11 01:50:34.920369|2017-10-11 01:50:34.920369
NCT01825122|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-12-05|2016-09-01||March 2014||2014-03-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction||Completed||Phase 2|155|Actual|Invion, Inc.||2|||f||||f||||||||||2017-10-11 01:50:35.021691|2017-10-11 01:50:35.021691
NCT01825109|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-04|||July 2010||2010-07-01|December 2009|2009-12-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|||Improving Rotavirus Vaccine Immune Response|Improving the Immune Response to Rotavirus Vaccine|Completed||Phase 3|300|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||t||||||||||2017-10-11 01:50:35.338029|2017-10-11 01:50:35.338029
NCT01825096|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-01-03|||March 2012||2012-03-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism|Multi-Modal fMRI/NIRS for Estimation of CMRO2 for Neuroimaging Studies of Drug Abuse and Psychiatric Illness Problems|Completed||N/A|1|Actual|Mclean Hospital|||1||f||||f||||||||||2017-10-11 01:50:35.458388|2017-10-11 01:50:35.458388
NCT01825083|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2014-05-07||||||May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of Ketamine in the Prevention of Hypoventilation in Patients Undergoing Deep Sedation Using Propofol and Fentanyl|The Effect of Ketamine in the Prevention of Hypoventilation in Patients Undergoing Deep Sedation Using Propofol and Fentanyl|Withdrawn||N/A|0|Actual|Northwestern University||2||Change in personnel|f||||f||||||||||2017-10-11 01:50:35.530993|2017-10-11 01:50:35.530993
NCT01825070|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-04-02|||March 2012||2012-03-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|July 2012|Actual|2012-07-01||Interventional|||Montmorency Cherry Juice and Uric Acid Metabolism|The Influence of Tart Montmorency Cherries on Indices of Uric Acid Metabolism|Completed||N/A|12|Actual|Northumbria University||2|||f||||t||||||||||2017-10-11 01:50:35.626015|2017-10-11 01:50:35.626015
NCT01825057|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-01-10|||May 2013||2013-05-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units|Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units: See One, Do One, Order One|Active, not recruiting||Phase 4|1173|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 01:50:35.705905|2017-10-11 01:50:35.705905
NCT01825044|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-10-02|||April 2013|Actual|2013-04-01|October 2017|2017-10-01|September 21, 2017|Actual|2017-09-21|September 21, 2017|Actual|2017-09-21||Interventional|CHIC||Copenhagen Head Injury Ciclosporin (CHIC) Study|An Open-label, Uncontrolled Phase II-study to Investigate Pharmacokinetics, Safety and Biomarkers of Effectiveness of NeuroSTAT® (Ciclosporin) in Patients With Severe Traumatic Brain Injury (TBI)|Completed||Phase 2|16|Actual|NeuroVive Pharmaceutical AB||2|||f||||t||||||||||2017-10-11 01:50:35.804195|2017-10-11 01:50:35.804195
NCT01825031|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-04-19|||June 2013||2013-06-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|REALITY||Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy|Reduction of Early mortALITY in HIV-infected African Adults and Children Starting Antiretroviral Therapy: a Randomised Controlled Trial|Completed||Phase 3|1805|Actual|Medical Research Council||3|||f||||t||||||||||2017-10-11 01:50:35.915885|2017-10-11 01:50:35.915885
NCT01825018|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-06-20|||May 2013||2013-05-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Social Network Intervention to Engage Out-of-Care PLH Into Treatment|Social Network Intervention to Engage Out-of-Care PLH Into Treatment|Enrolling by invitation||N/A|750|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 01:50:36.061357|2017-10-11 01:50:36.061357
NCT01825005|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-03-21|||February 2013||2013-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01|5 Years|Observational [Patient Registry]|POCER||Predicting Outcome in Cervix Carcinoma: a Prospective Study|Predicting Outcome in Cervix Carcinoma: a Prospective Study|Suspended||N/A|90|Anticipated|Maastricht Radiation Oncology|||4|logistics|f||||t||||||||||2017-10-11 01:50:36.150165|2017-10-11 01:50:36.150165
NCT01824992|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-04-04|||March 2011||2011-03-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections|a Multi-sites, Randomized, Parallel, Controlled Clinical Study to Evaluated the Efficacy and Safety of Recombinant Human Interferon Alpha-2b Gel (Yallaferon®) in HPV Infection|Completed||Phase 2/Phase 3|325|Actual|Lee's Pharmaceutical Limited||2|||f||||||||||||||2017-10-11 01:50:36.233156|2017-10-11 01:50:36.233156
NCT01824966|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-04|||March 2012||2012-03-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|SRCC||Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma|Signet Ring Cells in Esophageal and GE Junction Carcinomas Have a More Aggressive Biological Behavior|Completed||N/A|82|Actual|University Hospital, Gasthuisberg|||2||f||||f||||||||||2017-10-11 01:50:36.392838|2017-10-11 01:50:36.392838
NCT01824953|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-08-15|||January 2010||2010-01-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01|3 Years|Observational [Patient Registry]|||Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years|Significance of Helicobacter Pylori Infection and Pepsinogen Levels on the Prognosis of Atrophic Gastritis - Observational Study|Completed||N/A|3328|Actual|Konkuk University Medical Center|||4||f||||f||||||Samples Without DNA|"     Serum for Helicobacter pylori antibody and pepsinogen levels Gastric biopsy for the diagnosis     of intestinal metaplasia, atrophy, inflammatory cells, Helicobacter pylori, and the presence     of gastric neoplasm if any.   "|||2017-10-11 01:50:36.476012|2017-10-11 01:50:36.476012
NCT01824940|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-03-01|||November 2012||2012-11-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|SHINE||SHINE Sanitation, Hygiene, Infant Nutrition Efficacy Project|Sanitation, Hygiene, Infant Nutrition Efficacy Project|Active, not recruiting||N/A|5280|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||t||||||||Yes||2017-10-11 01:50:36.563981|2017-10-11 01:50:36.563981
NCT01824927|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-04-04|||January 2013||2013-01-01|April 2013|2013-04-01||||May 2013|Anticipated|2013-05-01||Interventional|||Pain Expression in the Perioperative Period of Cataract Surgery|Pain Expression in the Perioperative Period of Cataract Surgery|Unknown status|Recruiting|N/A|150|Anticipated|Evidence Based Cataract Study Group||3|||f||||||||||||||2017-10-11 01:50:36.687492|2017-10-11 01:50:36.687492
NCT01824914|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2014-11-06|||April 2013||2013-04-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Airway Evaluation by McGrath Videolaryngoscope|Comparison of Cormack-Lehane Score in Sedation and Anesthesia Condition by McGrath Videolaryngoscope|Completed||N/A|97|Actual|Huazhong University of Science and Technology||1|||f||||t||||||||||2017-10-11 01:50:36.784499|2017-10-11 01:50:36.784499
NCT01824901|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-02-01|2015-12-15||September 2013||2013-09-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|July 2014|Actual|2014-07-01||Interventional|||Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer|A Phase I/Randomized Phase II Study of Docetaxel With or Without AZD4547 in Recurrent FGFR1-Amplified Squamous Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|2|Actual|Eastern Cooperative Oncology Group||4|||f||||t||||||||No||2017-10-11 01:50:36.86092|2017-10-11 01:50:36.86092
NCT01824888|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2014-12-10|||June 2012||2012-06-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|JUC||Efficacy of JUC as Hand Rub Evaluated by Using European Standard 1500|The Effectiveness and Efficacy of Using JUC Antimicrobial Spray for Controlling the Infection Transmission|Completed||Phase 2|15|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 01:50:37.086115|2017-10-11 01:50:37.086115
NCT01824875|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-03-08|||May 2013||2013-05-01|March 2016|2016-03-01||||July 2017|Anticipated|2017-07-01||Interventional|||Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors|A Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors|Active, not recruiting||Phase 2|145|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 01:50:37.214638|2017-10-11 01:50:37.214638
NCT01824862|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-07-10|||January 2013||2013-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01|1 Day|Observational [Patient Registry]|||Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema|Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Oedema, With and Without Centre Involvement|Completed||N/A|60|Actual|Hospital Juarez de Mexico|||3||f||||t||||||||||2017-10-11 01:50:40.055534|2017-10-11 01:50:40.055534
NCT01824849|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-04|||January 2011||2011-01-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Total Versus Partial Arytenoidectomy in Bilateral Vocal Fold Paralysis|The Comparison of Voice and Swallowing Parameters After Endoscopic Total and Partial Arytenoidectomy Using Medially Based Mucosal Advancement Flap Technique for Bilateral Abductor Vocal Fold Paralysis: A Randomized Trial|Completed||N/A|20|Actual|Hacettepe University||2|||f||||f||||||||||2017-10-11 01:50:40.157874|2017-10-11 01:50:40.157874
NCT01824836|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-05-07|||May 2013||2013-05-01|September 2014|2014-09-01||||January 2020|Anticipated|2020-01-01||Interventional|||A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)|A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)|Recruiting||N/A|1000|Anticipated|Eastern Cooperative Oncology Group||1|||f||||t||||||||||2017-10-11 01:50:40.279701|2017-10-11 01:50:40.279701
NCT01824823|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2016-03-04|2015-12-22||July 2013||2013-07-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|March 2015|Actual|2015-03-01||Interventional||All randomized patients|Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence|A Randomized Placebo Controlled Phase II Trial of Afatinib (BIBW2992) as Adjuvant Therapy Following Chemoradiation in Patients With Head and Neck Squamous Cell Carcinoma at High Risk of Recurrence|Terminated||Phase 2|3|Actual|Eastern Cooperative Oncology Group|Due to the small sample size, estimates on median DFS and 95% confidence intervals could be unreliable.|2||Slow accrual|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-10-11 01:50:40.633448|2017-10-11 01:50:40.633448
NCT01824810|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2015-08-24|||June 2013||2013-06-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Whiplash-associated Disorders - Needling Treatments Pilot Study|A Pilot Case Randomized Control Study Analysing the Effectiveness of 3 Needling Techniques: Intramuscular Stimulation, Neural Prolotherapy, and Myofascial Release in the Treatment of Chronic Whiplash Associated Disorder.|Unknown status|Recruiting|N/A|32|Anticipated|University of British Columbia||4|||f||||f||||||||||2017-10-11 01:50:41.706739|2017-10-11 01:50:41.706739
NCT01824797|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-04-25|||May 2013||2013-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Bone Metabolism After Bariatric Surgery|Determining Changes in Bone Metabolism After Bariatric Surgery in Postmenopausal Women|Active, not recruiting||N/A|40|Anticipated|Duke University|||2||f||||f||||||Samples With DNA|"     Serum will be collected from the subjects preoperatively and 12 months postoperatively. The     serum will be used at the completion of the study to run enzyme-linked immunosorbent assay     (ELISA) to determine biochemical changes in their bone metabolism.   "|||2017-10-11 01:50:41.840344|2017-10-11 01:50:41.840344
NCT01824784|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2014-10-21|||February 2013||2013-02-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Observational|||TopQ Cut-Off Determination Study|TopQ Cut-off Determination Study|Completed||N/A|10|Actual|Topcon Medical Systems, Inc.|||1||f||||f||||||||||2017-10-11 01:50:41.918179|2017-10-11 01:50:41.918179
NCT01824771|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-03-05|||March 2013||2013-03-01|March 2015|2015-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01|1 Day|Observational [Patient Registry]|||Effects of Continuous Veno-venous Haemofiltration on Plasma Lactate in Critically Ill Patients||Unknown status|Recruiting|N/A|15|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||||||2017-10-11 01:50:41.980382|2017-10-11 01:50:41.980382
NCT01824758|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-04-04|||April 2013||2013-04-01|March 2013|2013-03-01|May 2013|Anticipated|2013-05-01|April 2013|Anticipated|2013-04-01||Interventional|||Effect of Esmolol on Pain Due to Rocuronium|The Effect of Esmolol on Pain Due to Rocuronium Injection Pain|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Etlik Zubeyde Hanim Womens' Health and Teaching Hospital||3|||f||||t||||||||||2017-10-11 01:50:42.044146|2017-10-11 01:50:42.044146
NCT01824745|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-09-14|||July 15, 2013|Actual|2013-07-15|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors|Survivorship Care Planning for At Risk Breast Cancer Survivors|Active, not recruiting||N/A|100|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 01:50:42.121318|2017-10-11 01:50:42.121318
NCT01824706|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-06-09|||December 1, 2012|Actual|2012-12-01|June 2017|2017-06-01|May 1, 2016|Actual|2016-05-01|May 1, 2016|Actual|2016-05-01|2 Years|Observational [Patient Registry]|CUSTOMBONE||Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant|A Prospective, Multicenter Observational Study Evaluating the Long Term Safety in Terms of Explantation Rate and Number of Infections of the Custom-made Bioceramic Implant CustomBone™|Completed||N/A|110|Actual|Codman & Shurtleff|||1||f||||t|f|t|f|f|f|||||2017-10-11 01:50:42.386458|2017-10-11 01:50:42.386458
NCT01824498|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2013-08-01|2013-04-04||January 2004||2004-01-01|August 2013|2013-08-01|November 2010|Actual|2010-11-01|December 2008|Actual|2008-12-01||Interventional|||Dietary Fat, Eicosanoids and Breast Cancer Risk|Dietary Fat, Eicosanoids and Breast Cancer Risk|Completed||N/A|18|Actual|USDA Grand Forks Human Nutrition Research Center||6|||f||||f||||||||||2017-10-11 01:50:44.984856|2017-10-11 01:50:44.984856
NCT01824693|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-01-11|||June 2013||2013-06-01|January 2017|2017-01-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia|A Randomized Phase II Study Comparing Two Different Conditioning Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Children With Juvenile Myelomonocytic Leukemia (JMML)|Active, not recruiting||Phase 2|30|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 01:50:42.49535|2017-10-11 01:50:42.49535
NCT01824680|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-04-02|||October 2012||2012-10-01|April 2013|2013-04-01|July 2014|Anticipated|2014-07-01|May 2014|Anticipated|2014-05-01||Interventional|APHRO||Effect of a Physical Activity Program on the Hormonal Regulation of Food Intake|Effect of a 3 Months Physical Activity Program on the Hormonal Regulation of Food Intake by Intense Physical Activity in Overweight Adolescents|Suspended||N/A|30|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 01:50:42.833012|2017-10-11 01:50:42.833012
NCT01824667|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-11-26|||February 2013||2013-02-01|April 2013|2013-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effect of B-GOS on GI Discomfort in Healthy Adults|Double-blind, Placebo Controlled, Randomised, Multicentered, of Parallel Design Study to Determine the Effect of B-GOS on GI Discomfort in Healthy Adults|Completed||Phase 3|400|Actual|Clasado Limited||2|||f||||f||||||||||2017-10-11 01:50:42.917448|2017-10-11 01:50:42.917448
NCT01824654|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2017-08-02|||April 2013||2013-04-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|June 2017|Actual|2017-06-01||Interventional|AAA 2D/3D II||Enhanced Guidance for Endovascular Repair of Abdominal Aortic Aneurysm|Endovascular Repair of Abdominal Aortic Aneurysm: Enhanced Guidance by Elastic Registration Between CT-Scanner and Fluoroscopy|Recruiting||N/A|40|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 01:50:42.994852|2017-10-11 01:50:42.994852
NCT01824641|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-04-02|||September 2012||2012-09-01|April 2013|2013-04-01|November 2013|Anticipated|2013-11-01|May 2013|Anticipated|2013-05-01||Interventional|PATA-STEMI||Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients|The Randomized Physiologic Assessment of Thrombus Aspiration in Patients With Acute ST-segment Elevation Myocardial Infarction Trial|Unknown status|Recruiting|Phase 3|128|Anticipated|Clinical Centre of Serbia||2|||f||||t||||||||||2017-10-11 01:50:43.11587|2017-10-11 01:50:43.11587
NCT01824628|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-02|2013-11-25|||March 2013||2013-03-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|QTVIE||Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts|Comparaison Des Intervalles QT/QTc Entre Une Population HIV Positive Ambulatoire Sous thérapie antirétrovirale et Une Population Ambulatoire HIV négative|Completed||N/A|160|Actual|Centre hospitalier de l'Université de Montréal (CHUM)|||2||f||||f||||||Samples With DNA|"     10 mL whole blood in a purple Vacutainer EDTA tube   "|||2017-10-11 01:50:43.238376|2017-10-11 01:50:43.238376
NCT01824615|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-04-07|||January 2013||2013-01-01|April 2013|2013-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma|Evaluation of the Efficacy of Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma|Unknown status|Recruiting|Phase 2|30|Anticipated|Cathay General Hospital||1|||f||||f||||||||||2017-10-11 01:50:43.323465|2017-10-11 01:50:43.323465
NCT01824602|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-02-26|2013-04-08||February 2006||2006-02-01|August 2013|2013-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder|Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder in a Double-blind, Fixed Multiple Dose, Randomised, Placebo-controlled,Multicentre Clinical Trial.|Terminated||Phase 2|38|Actual|Bial - Portela C S.A.||4||Due to a slow recruitment rate|f||||f||||||||||2017-10-11 01:50:43.442588|2017-10-11 01:50:43.442588
NCT01824589|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2015-02-12|2014-08-25||August 2012||2012-08-01|February 2015|2015-02-01||||August 2012|Actual|2012-08-01||Interventional|||Effect of Intrathoracic Pressure Regulation on Traumatic Brain Injury|Effects of Intrathoracic Pressure Regulation Therapy in Patients With Elevated Intracranial Pressure Due to Brain Injury or Intracranial Pathology|Terminated||Phase 4|1|Actual|Advanced Circulatory Systems||4|||f||||f||||||||||2017-10-11 01:50:43.966435|2017-10-11 01:50:43.966435
NCT01824576|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2017-08-30|2017-07-06||April 2013||2013-04-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion|Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology|Terminated||N/A|9|Actual|Advanced Circulatory Systems||1||Enrollment was slower than anticipated.|f||||f||||||||||2017-10-11 01:50:44.317201|2017-10-11 01:50:44.317201
NCT01824563|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-01-05|||June 2013||2013-06-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Benefits of the HiResolutionTM Bionic Ear System in Adults With Low-Frequency Hearing|Benefits of the HiResolutionTM Bionic Ear System in Adults With Low-Frequency Hearing.|Recruiting||N/A|120|Anticipated|Advanced Bionics AG|||1||f||||t||||||||||2017-10-11 01:50:44.574405|2017-10-11 01:50:44.574405
NCT01824550|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-05-01|||August 2013||2013-08-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Interventional|HOMS||Home Exercise Intervention in Persons With Multiple Sclerosis|Exercise, Subclinical Atherosclerosis and Walking Mobility in Multiple Sclerosis|Active, not recruiting||N/A|54|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-11 01:50:44.651812|2017-10-11 01:50:44.651812
NCT01824537|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-08-28|||September 2013||2013-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|TRAP-HPV||Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study|Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study: A Randomized Controlled Trial of the Efficacy of HPV Vaccination in Preventing Transmission of HPV Infection in Heterosexual Couples|Recruiting||Phase 4|1000|Anticipated|McGill University||2|||f||||t||||||||||2017-10-11 01:50:44.721543|2017-10-11 01:50:44.721543
NCT01824524|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-08-14|||December 2011||2011-12-01|August 2014|2014-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer|An Open-Label Study to Evaluate the Single Dose Pharmacokinetic Profile and Safety of OROS® Hydromorphone in Chinese Subjects With Cancer Who Are Not Opioid Tolerant|Completed||Phase 1|12|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||||||||||2017-10-11 01:50:44.807212|2017-10-11 01:50:44.807212
NCT01824485|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-01-05|||March 2013||2013-03-01|September 2013|2013-09-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Comparison of Two Application Regimens for Viscosupplementation|Best Effect of Viscosupplementation With Hyaluronic Acid and Triamcinolone in Patients With Knee Osteoarthritis. Prospective Randomized Study Between Two Different Applications Regimens|Completed||Phase 4|104|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 01:50:45.647384|2017-10-11 01:50:45.647384
NCT01824472|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-05-03|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Understanding the Sleep Apnea/Insomnia Interaction|Understanding the Sleep Apnea/Insomnia Interaction: a CPAP/Sham-CPAP Trial|Completed||N/A|45|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-10-11 01:50:45.735154|2017-10-11 01:50:45.735154
NCT01824459|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-09-11|||April 2013||2013-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients|A Randomized, Open, Multi-center, Phase III Study of S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment in Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma Patients|Recruiting||Phase 3|446|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 01:50:45.841402|2017-10-11 01:50:45.841402
NCT01824446|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-04-11|2014-04-11||April 2013||2013-04-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184|A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]SSP-004184 Following a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|6|Actual|Shire||1|||f||||||||||||||2017-10-11 01:50:45.971758|2017-10-11 01:50:45.971758
NCT01824433|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-09-12|||March 7, 2013|Actual|2013-03-07|September 2017|2017-09-01|March 16, 2017|Actual|2017-03-16|March 16, 2017|Actual|2017-03-16||Interventional|||Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression|A 8-week, Rater-blind, Active-controlled, Randomized Study to Compare the Effectiveness of Venlafaxine With Fluoxetine in the Treatment of Postmenopausal Women With Major Depressive Disorder|Completed||Phase 4|189|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 01:50:46.345964|2017-10-11 01:50:46.345964
NCT01824420|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-03-07|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome|Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome - A Prospective Randomized Controlled Comparative Study With Mono-antimuscarinic Therapy|Completed||Phase 4|129|Actual|Buddhist Tzu Chi General Hospital||2|||f||||t|t|f|||f|||No|IPD cannot be released unless approval by the Ethics Committee of the Buddhist Tzu Chi General Hospital, Hualien, Taiwan|2017-10-11 01:50:46.425529|2017-10-11 01:50:46.425529
NCT01824407|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-03-04|||March 2013||2013-03-01|March 2014|2014-03-01||||April 2014|Anticipated|2014-04-01||Interventional|||A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers|A Double-Blind, Multi-center, Randomized, Sham-Controlled, Parallel Group Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers|Unknown status|Recruiting|Phase 3|90|Anticipated|SANUWAVE, Inc.||2|||f||||t||||||||||2017-10-11 01:50:46.523536|2017-10-11 01:50:46.523536
NCT01824394|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-09-19|||March 1, 2013|Actual|2013-03-01|September 2017|2017-09-01|April 1, 2020|Anticipated|2020-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation|reMARQable nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation|Active, not recruiting||Phase 3|700|Anticipated|Biosense Webster, Inc.||2|||f||||f|f|t|f|||||||2017-10-11 01:50:46.687168|2017-10-11 01:50:46.687168
NCT01824381|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-03-29|||July 2012||2012-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|MA/GH||Use of the Amniotic Membrane in Large Wound Epithelialization|Use of the Amniotic Membrane in Large Wound Epithelialization. Phase I Clinical Trial.|Completed||Phase 1|6|Actual|Red de Terapia Celular||1|||f||||t||||||||||2017-10-11 01:50:46.851128|2017-10-11 01:50:46.851128
NCT01824368|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-03-29|||April 2013||2013-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|FEC-TH||Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.|FOTOAFERESIS EXTRACORPÓREA EN EL TRASPLANTE HEPÁTICO. ENSAYO CLINICO EN FASE II DE SEGURIDAD Y EFICACIA EN PACIENTES CON RETIRADA PROGRESIVA DE LA INMUNOSUPRESIÓN|Completed||Phase 1/Phase 2|10|Actual|Red de Terapia Celular||1|||f||||t||||||||||2017-10-11 01:50:46.938764|2017-10-11 01:50:46.938764
NCT01824355|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-01-29|2014-03-28||March 2013||2013-03-01|January 2016|2016-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||All enrollees|Performance of an Investigational Blood Glucose Monitoring System|Performance of the Ninja 3 Plus Blood Glucose Monitoring System|Completed||N/A|113|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 01:50:47.024321|2017-10-11 01:50:47.024321
NCT01824342|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-02-19|2015-02-19||January 2011||2011-01-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer|An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer|Completed||Phase 3|18|Actual|Amgen||1|||f||||||||||||||2017-10-11 01:50:47.319018|2017-10-11 01:50:47.319018
NCT01824329|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2015-08-17|||June 2006||2006-06-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|SPARC||Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer|Prospective Phase II Randomized Trial of Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer|Completed||Phase 2|40|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 01:50:48.248383|2017-10-11 01:50:48.248383
NCT01824316|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-04-03|||January 2013||2013-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Observational|||A Comparison of Management Strategies of Asthma in Pregnancy|A Comparison of Management Strategies of Asthma in Pregnancy|Completed||N/A|108|Actual|Ohio State University|||1||f||||||||||||||2017-10-11 01:50:48.389313|2017-10-11 01:50:48.389313
NCT01824303|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2015-12-16|2015-10-23||March 2013||2013-03-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis|A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension|Terminated||Phase 2|31|Actual|Allergan|Due to technical issues with the patient electronic diary used for the collection of the outcome measures data, as well as the small evaluable sample size and large variability, the efficacy data should be interpreted with caution.|2||This study was terminated early due to company decision.|f||||t||||||||||2017-10-11 01:50:48.475069|2017-10-11 01:50:48.475069
NCT01824290|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-10-02|||February 2014||2014-02-01|October 2017|2017-10-01|January 2023|Anticipated|2023-01-01|January 2021|Anticipated|2021-01-01||Interventional|||A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)|A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients With Pulmonary Arterial Hypertension|Recruiting||Phase 3|134|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 01:50:49.14112|2017-10-11 01:50:49.14112
NCT01824277|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2017-04-24|||October 2013||2013-10-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2015|Actual|2015-12-01||Interventional|||DCI: A Community Based Pre-cardiac Surgery Diabetes Care Project|Diabetes Cardiac Surgery Initiative (DCI): A Community Based Pre-cardiac Surgery Diabetes Care Project|Active, not recruiting||N/A|33|Actual|St. Boniface General Hospital Research Centre||2|||f||||f||||||||||2017-10-11 01:50:49.446045|2017-10-11 01:50:49.446045
NCT01824264|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2014-04-02|||November 2015||2015-11-01|April 2014|2014-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes|A Multi-center, Randomized, Double-blind, Parallel-group Dose-finding Study to Evaluate Change in HbA1c After 12 Weeks Monotherapy With 7 Doses of LIK066 Compared With Placebo or Sitagliptin in Patients With Type 2 Diabetes|Withdrawn||Phase 2|0|Actual|Novartis||9|||f||||f||||||||||2017-10-11 01:50:49.52305|2017-10-11 01:50:49.52305
NCT01824251|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-01-17|||April 2013||2013-04-01|October 2014|2014-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.|NPB-01(Intravenous Immunoglobulin) Maintenance Therapy for Patients With Chronic Inflammatory Demyelinating Polyneuropathy.|Completed||Phase 3|49|Actual|Nihon Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-11 01:50:49.614515|2017-10-11 01:50:49.614515
NCT01824238|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-04-22|||May 2013||2013-05-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050)|A 12-Week, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess the Efficacy and Safety of MK-0859 When Added to Ongoing Statin Therapy With or Without Other Lipid Modifying Therapies in Japanese Patients With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|68|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 01:50:49.690929|2017-10-11 01:50:49.690929
NCT01824225|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2015-10-05|||March 2013||2013-03-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration|Study of PRN and Every 2months Intravitreal Aflibercept After 3 Initial Monthly Injection for Age Related Macular Degeneration|Completed||Phase 4|100|Actual|Nihon University||2|||f||||f||||||||||2017-10-11 01:50:49.768987|2017-10-11 01:50:49.768987
NCT01824212|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-03-22|||November 2013||2013-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Recognizing Ventricular Fibrillation From an Area of a Mobile Phone|Recognizing Ventricular Fibrillation From an Area of a Mobile Phone|Completed||N/A|22|Actual|North Karelia Central Hospital|||1||f||||f||||||||||2017-10-11 01:50:49.841128|2017-10-11 01:50:49.841128
NCT01824186|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-03-31|||October 2010||2010-10-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy|A Randomized Controlled Trial Comparing Post-operative Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy|Completed||N/A|100|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 01:50:50.031821|2017-10-11 01:50:50.031821
NCT01824173|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-10-27|||October 2012||2012-10-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Muscle Protein Metabolism in Obesity|Regulation of Muscle ATP Synthase Beta Subunit Metabolism in Obesity|Recruiting||Phase 1|84|Anticipated|Mayo Clinic||4|||f||||f||||||||||2017-10-11 01:50:50.119051|2017-10-11 01:50:50.119051
NCT01824160|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-02-15|2016-02-15||December 2012||2012-12-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|September 2014|Actual|2014-09-01||Interventional|PARCS|Participants receiving a Covered CP stent for repair of pulmonary artery injury|Pulmonary Artery Repair With Covered Stents|Pulmonary Artery Repair With Covered Stents|Active, not recruiting||N/A|50|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:50:50.201004|2017-10-11 01:50:50.201004
NCT01824147|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-02-23|||August 2013||2013-08-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Observational|||ASS-Nonresponse Following Cardiac Surgery as Assessed With Multiple Electrode Aggregometry|ASS-Nonresponse Following Cardiac Surgery as Assessed With Multiple Electrode Aggregometry|Completed||N/A|400|Actual|Goethe University|||1||f||||f||||||||||2017-10-11 01:50:50.420387|2017-10-11 01:50:50.420387
NCT01824134|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-09-15|||October 2012||2012-10-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Aloe Vera on Irradiated Breast Tissue|A Phase III Double Blind Study on the Efficacy of Topical Aloe Vera Gel on Irradiated Breast Tissue|Completed||Phase 3|40|Actual|John D. Archbold Memorial Hospital||2|||f||||f||||||||||2017-10-11 01:50:50.498312|2017-10-11 01:50:50.498312
NCT01824121|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-31|2013-03-31|||December 2012||2012-12-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism|Autologous Mesenchymal Stem Cell Therapy in Progressive Supranuclear Palsy: a Randomized, Double-blind, Controlled Clinical Trial|Unknown status|Recruiting|Phase 1/Phase 2|25|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||||2017-10-11 01:50:50.560743|2017-10-11 01:50:50.560743
NCT01824108|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-31|||July 2008||2008-07-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Wallis Interspinous Dynamic Stability System for Lumbar Disc Herniation: a Prospective Study|Effectiveness of Wallis Interspinous Dynamic Stability System for Lumbar Disc Herniation: a Prospective Randomised Controlled Study|Completed||Phase 3|80|Actual|Guangdong General Hospital||2|||f||||f||||||||||2017-10-11 01:50:50.647354|2017-10-11 01:50:50.647354
NCT01824095|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-01-22|||January 2013||2013-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ASP||Chiropractic Care and a Specific Regimen of Nutritional Supplementation for Patients With Acute Ankle Sprain|Chiropractic Care and a Specific Regimen of Nutritional Supplementation for Patients With Acute Ankle Sprain: a Multisite Randomized Controlled Trial|Terminated||Phase 3|73|Actual|Logan University, Inc.||2||Unable to recruit enough subjects to attain the minimum sample size.|f||||t||||||||||2017-10-11 01:50:50.728982|2017-10-11 01:50:50.728982
NCT01824082|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2016-10-27|||December 2013||2013-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|DoD-PLP-Tx||Treating Phantom Limb Pain Using Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study|Treating Intractable Post-Amputation Phantom Limb Pain With Ambulatory Continuous Peripheral Nerve Blocks|Recruiting||Phase 4|180|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-11 01:50:50.817598|2017-10-11 01:50:50.817598
NCT01824069|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2016-06-14|||April 2013||2013-04-01|April 2013|2013-04-01|September 2015|Actual|2015-09-01|April 2014|Actual|2014-04-01||Interventional|HULPVAS||Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy|Phase IIa Clinical Trial to Safety of Treatment in Critical Ischemia Nonrevascularizable Lower Limb by Mesenchymal Stem Cells|Completed||Phase 1/Phase 2|10|Actual|Instituto de Investigación Hospital Universitario La Paz||1|||f||||t||||||||||2017-10-11 01:50:50.920642|2017-10-11 01:50:50.920642
NCT01824056|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-11-10|||August 2010||2010-08-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography|The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography With Vesicular Monoamine Transporter Ligand (18F-DTBZ)|Completed||Phase 2|120|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 01:50:50.999881|2017-10-11 01:50:50.999881
NCT01824043|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-04-01|||March 2013||2013-03-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage|Pilot Study Investigating the Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage in Proliferative Diabetic Retinopathy|Unknown status|Recruiting|Phase 4|20|Anticipated|Hospital Regional de São José - Dr. Homero de Miranda Gomes||1|||f||||f||||||||||2017-10-11 01:50:51.069931|2017-10-11 01:50:51.069931
NCT01824030|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-08|||April 2013||2013-04-01|April 2013|2013-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|FORZA||FFR or OCT Guidance to RevasculariZe Intermediate Coronary Stenosis Using Angioplasty|FFR or OCT Guidance to RevasculariZe Intermediate Coronary Stenosis Using Angioplasty|Unknown status|Recruiting|Phase 3|400|Anticipated|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-11 01:50:51.166221|2017-10-11 01:50:51.166221
NCT01824017|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-09-07|||December 2012||2012-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Validation of an RLIP76 Assay in Humans|Validation of RLIP76 Assay and Exploratory Study of RLIP76 Correlation Among Patients With Type 2 Diabetes and Metabolic Syndrome|Completed||N/A|35|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:50:51.257691|2017-10-11 01:50:51.257691
NCT01824004|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-03|||April 2009||2009-04-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|October 2010|Actual|2010-10-01||Interventional|||Postoperative Chemoradiotherapy With S-1 in Gastric Cancer|A Phase II Study of Adjuvant S-1/Cisplatin Chemotherapy Followed by S-1-based Chemoradiotherapy in Advanced Gastric Cancer|Completed||Phase 2|46|Actual|Chonnam National University Hospital||1|||f||||t||||||||||2017-10-11 01:50:51.323088|2017-10-11 01:50:51.323088
NCT01823991|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-08-18|||February 19, 2014|Actual|2014-02-19|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||COGNUTRIN in Breast Cancer Survivors|Pilot Clinical Trial of COGNUTRIN in Breast Cancer Survivors|Active, not recruiting||Early Phase 1|36|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|t|f||||||||2017-10-11 01:50:51.448401|2017-10-11 01:50:51.448401
NCT01823978|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-07-11|||April 2013||2013-04-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|May 2016|Actual|2016-05-01||Interventional|||Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer|A Phase I Study of BPX-201 Vaccine Plus AP1903 in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)|Active, not recruiting||Phase 1|19|Actual|Bellicum Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:50:51.610605|2017-10-11 01:50:51.610605
NCT01823965|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-03-29|||October 2011||2011-10-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment||Completed||Phase 2|35|Actual|Poitiers University Hospital||1|||f||||||||||||||2017-10-11 01:50:51.696405|2017-10-11 01:50:51.696405
NCT01823952|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2014-04-02|||April 2013||2013-04-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|RESTORS||High Amylose Maize Starch for Treatment of Cholera|Phase 2, Single Centre, Randomized, Double-blind Study Conducted in Adult Males With Acute Dehydrating Diarrhea Due to Cholera With the Aim Being to Select One or More of the Three Fermentable Starches (FS) for an FS-HO-ORS Formulation.|Terminated||N/A|106|Actual|PATH|||1|The study was closed early due to slow enrollment.|f||||t||||||Samples Without DNA|"     Analysis of the sample for starch, short chain fatty acids and faecal microbiota.   "|||2017-10-11 01:50:51.779792|2017-10-11 01:50:51.779792
NCT01823744|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2014-08-04|||March 2013||2013-03-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Harmonized Micronutrient Project|A New Strategy to Analyze Gene-Nutrient Interaction in Children and Adolescents|Completed||N/A|146|Actual|Nestlé||1|||f||||t||||||||||2017-10-11 01:50:53.317186|2017-10-11 01:50:53.317186
NCT01823939|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-06-09|||May 2013||2013-05-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Interventional|PISCES||PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera|Two-Part, Single-Centre Pharmacokinetic Study of iOWH032 in Adult Male and Female Healthy Volunteers, and Adult Males With Cholera|Completed||Phase 1|26|Actual|PATH||2|||f||||t||||||||||2017-10-11 01:50:51.874714|2017-10-11 01:50:51.874714
NCT01823926|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-03-30|||October 2011||2011-10-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|October 2011|Actual|2011-10-01||Interventional|||Asthma and Quantifying Delivery Of Radio Labeled Aerosol|Quantifying Delivery Of Radio Labeled Aerosol During Noninvasive Ventilation To Stable Moderate And Severe Asthmatics: A Randomized, Cross-Over Clinical Trial|Completed||N/A|13|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 01:50:51.994289|2017-10-11 01:50:51.994289
NCT01823913|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-04-09|||July 2012||2012-07-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers||Completed||Phase 1|50|Actual|Severance Hospital||1|||f||||||||||||||2017-10-11 01:50:52.081089|2017-10-11 01:50:52.081089
NCT01823900|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-04-09|||January 2012||2012-01-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers|A Randomized, Open Label, Single-Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 in Healthy Male Volunteers|Completed||Phase 1|58|Actual|Severance Hospital||1|||f||||||||||||||2017-10-11 01:50:52.145549|2017-10-11 01:50:52.145549
NCT01823887|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2015-02-17|||July 2012||2012-07-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|ANTHEM-HF||Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study|Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study|Completed||Phase 1/Phase 2|60|Actual|Cyberonics, Inc.||2|||f||||t||||||||||2017-10-11 01:50:52.212502|2017-10-11 01:50:52.212502
NCT01823874|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-12-12|||April 2013||2013-04-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|ID||Firsthand ID for Pain Control|The 3D Immersive Display: Validation of a Virtual Reality Technique for Pain Control|Completed||N/A|100|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 01:50:52.30437|2017-10-11 01:50:52.30437
NCT01823861|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2014-05-27|||May 2013||2013-05-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|MOTIF||Mobile Technology for Improved Family Planning||Unknown status|Active, not recruiting|N/A|500|Actual|Marie Stopes International||2|||f||||f||||||||||2017-10-11 01:50:52.394322|2017-10-11 01:50:52.394322
NCT01823848|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-01-05|||April 2013||2013-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children|A Randomized Controlled Trial of Three Types of Enemas Used to Treat Functional Constipation in Children|Suspended||N/A|120|Anticipated|Children's Hospital Los Angeles||3||insufficient staff to enroll|f||||f||||||||||2017-10-11 01:50:52.466037|2017-10-11 01:50:52.466037
NCT01823835|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-08-17|||December 29, 2014|Actual|2014-12-29|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer|An Open-label, Phase Ia/Ib/IIa Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or an LHRH Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer|Active, not recruiting||Phase 1/Phase 2|152|Actual|Genentech, Inc.||2|||f|||||t|f||||||||2017-10-11 01:50:52.56576|2017-10-11 01:50:52.56576
NCT01823822|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-04-02|||June 2008||2008-06-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa|Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa|Completed||Phase 2/Phase 3|62|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 01:50:52.710735|2017-10-11 01:50:52.710735
NCT01823809|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-10-24|||November 2011||2011-11-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|COMFORT||Non-invasive and Invasive Assessment of Coronary Artery Disease|Assessment of Coronary Artery Disease With Multi-Slice Computed Tomography Combined With Stress Cardiac Magnetic Resonance Imaging Compared to Coronary Angiography Combined With Fractional Flow Reserve Trial|Suspended||N/A|120|Anticipated|University Medical Center Groningen||1||Problems with inclusion, >80% of patients included|f||||f||||||||||2017-10-11 01:50:52.79467|2017-10-11 01:50:52.79467
NCT01823796|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2014-12-09|||March 2013||2013-03-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Observational|FM||Risk of Falls in Patients With Fibromyalgia|Assessment of Balance and Risk of Falls in Women With Fibromyalgia|Completed||N/A|60|Actual|Universidad de Granada|||2||f||||t||||||||||2017-10-11 01:50:52.868431|2017-10-11 01:50:52.868431
NCT01823783|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-03-29|||November 2012||2012-11-01|March 2013|2013-03-01|November 2016|Anticipated|2016-11-01|April 2016|Anticipated|2016-04-01||Interventional|||Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy|Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction : Potential Links and Targeted Pharmacotherapy in Duchenne Muscular Dystrophy (DMD).|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 01:50:52.958553|2017-10-11 01:50:52.958553
NCT01823770|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-04-02|||December 2012||2012-12-01|March 2013|2013-03-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome|Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome : a Pilot Randomized, Placebo-controlled Study|Unknown status|Recruiting|Phase 4|130|Anticipated|University Hospital, Montpellier||3|||f||||t||||||||||2017-10-11 01:50:53.073543|2017-10-11 01:50:53.073543
NCT01823757|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2014-08-27|||April 2013||2013-04-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Observational|||Pharmaceutical Care in VA Nursing Home|The Impacts of Pharmaceutical Cares on the Elderly in a VA Nursing Home.|Unknown status|Active, not recruiting|N/A|100|Anticipated|Taichung Veterans General Hospital|||2||f||||f||||||||||2017-10-11 01:50:53.192125|2017-10-11 01:50:53.192125
NCT01823731|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-06-04|||January 2013||2013-01-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index||Unknown status|Enrolling by invitation|N/A|50|Actual|National Cancer Center, Korea|||1||f||||t||||||||||2017-10-11 01:50:53.402147|2017-10-11 01:50:53.402147
NCT01823718|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-11-14|||February 2007||2007-02-01|March 2013|2013-03-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Cell Bank of Epstein Barr Virus Specific Cytotoxic T Lymphocytes||Unknown status|Active, not recruiting|Phase 1|18|Anticipated|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 01:50:53.456059|2017-10-11 01:50:53.456059
NCT01823705|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-06-10|||March 2013||2013-03-01|June 2016|2016-06-01||||January 2017|Anticipated|2017-01-01||Interventional|GES||Gastric Electrical Stimulation (GES) for the Treatment of Obesity|Gastric Electrical Stimulation (GES) for the Treatment of Obesity|Active, not recruiting||N/A|30|Anticipated|Medtronic Corporate Technologies and New Ventures||1|||f||||t||||||||||2017-10-11 01:50:53.522017|2017-10-11 01:50:53.522017
NCT01823692|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2013-04-02|||September 2011||2011-09-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Evaluating Validity of Ultrasonography in Determining Distal Radius Fracture Reduction|Study of Accuracy of Ultrasonography in Determining the Adequacy of Distal Radius Fracture Reduction|Completed||Phase 2|184|Actual|Isfahan University of Medical Sciences||1|||f||||t||||||||||2017-10-11 01:50:53.593104|2017-10-11 01:50:53.593104
NCT01823679|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2017-01-20|2017-01-20||March 2013||2013-03-01|January 2017|2017-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin|A Phase 2 Study of Capecitabine in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin|Terminated||Phase 2|2|Actual|Stanford University||1||Low accrual|f||||t||||||||No||2017-10-11 01:50:53.67338|2017-10-11 01:50:53.67338
NCT01823666|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2016-06-06|||September 2012||2012-09-01|June 2016|2016-06-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|PCMCItoD||Predicting the Conversion From Mild Cognitive Impairment to Dementia|Study on Risk Factors for Prediction of Conversion to Dementia in Patients With Mild Cognitive Impairment|Completed||N/A|250|Actual|Dongzhimen Hospital, Beijing|||2||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 01:50:53.943644|2017-10-11 01:50:53.943644
NCT01823653|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2014-12-10|2014-03-25||July 2012||2012-07-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Intent to Treat Cohort|Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound|A Study to Investigate the Safety and Efficacy of Treatment of Subcutaneous Adipose Tissue in the Thighs Using the Liposonix System (Model 2)|Completed||N/A|60|Actual|Valeant Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:50:54.023157|2017-10-11 01:50:54.023157
NCT01823640|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2014-10-13|||March 2013||2013-03-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|EHRVI||Experimental Human Rhinovirus Infection|Experimental Human Rhinovirus Infection, a Randomized Placebo-controlled Pilot Study|Completed||Phase 1|40|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 01:50:54.21481|2017-10-11 01:50:54.21481
NCT01823627|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-04-02|||March 2013||2013-03-01|April 2013|2013-04-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Pulmonary Disease in a Psychiatric Inpatient Population|Pulmonary Disease in a Psychiatric Inpatient Population, a Screening Study|Unknown status|Enrolling by invitation|N/A|80|Anticipated|Psykiatrien Syd|||1||f||||f||||||||||2017-10-11 01:50:54.293925|2017-10-11 01:50:54.293925
NCT01823614|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2014-02-04|2014-02-04||November 2012||2012-11-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Observational|CoTrAST|The overall number of naive patients should be more than number of treatment-experienced patients.|Co-receptor Tropism Determination of HIV-1 Subtype A Spread in the Russian Federation Using V3-based Genotyping Tools|Epidemiological Study of the Co-receptor Tropism of HIV-1 Subtype A Spread in the Russian Federation Among naïve and ART-experienced Patients Using V3-based Genotyping Tools|Completed||N/A|943|Actual|Central Institute of Epidemiology, Moscow, Russia|||6||f||||f||||||Samples With DNA|"     plasma peripheral blood mononuclear cells   "|||2017-10-11 01:50:54.369879|2017-10-11 01:50:54.369879
NCT01823601|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-30|2013-04-02|||January 2013||2013-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Behavioral Management and Psychological Well-Being|A Cognitive-Behavioral Program Of Emotional Management and Feeling Of Psychological Well-Being|Completed||N/A|64|Actual|Centro de Estudos em Medicina Comportamental||2|||f||||f||||||||||2017-10-11 01:50:54.752169|2017-10-11 01:50:54.752169
NCT01823588|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-07-20|||April 2013||2013-04-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Nurse-led Reminder Program for the Prevention of Cardiovascular Diseases|Efficacy of a Nurse-led Reminder Program for the Management of the Risk Factors for Cardiovascular Diseases in Hypertensive Patients: a Randomized Controlled Trial|Completed||N/A|203|Actual|Università degli Studi 'G. d'Annunzio' Chieti e Pescara||2|||f||||f||||||||||2017-10-11 01:50:54.817883|2017-10-11 01:50:54.817883
NCT01823575|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2013-04-02|||March 2013||2013-03-01|March 2013|2013-03-01|September 2014|Anticipated|2014-09-01|August 2014|Anticipated|2014-08-01||Interventional|||Comparison of Silicone-covered Metallic Ureteral Stent and Double-J Stent for Malignant Ureteral Obstruction|Comparison of the Efficacy of Silicone-covered Metallic Ureteral Stent and Double-J Stent for Malignant Ureteral Obstruction: A Prospective Randomized Controlled Trial Based on Exploratory Research|Unknown status|Active, not recruiting|Phase 2|78|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:50:54.882816|2017-10-11 01:50:54.882816
NCT01823562|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-10-06|||October 2012||2012-10-01|October 2016|2016-10-01||||August 2013|Actual|2013-08-01||Interventional|||Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery|Dietary Fruit Bioactives and Prostate Cancer|Active, not recruiting||Phase 1|56|Actual|Ohio State University Comprehensive Cancer Center||7|||f||||t||||||||||2017-10-11 01:50:54.945273|2017-10-11 01:50:54.945273
NCT01823549|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-04-04|||October 2011||2011-10-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|September 2014|Actual|2014-09-01||Observational|||Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients|Use of Nutritional Supplements and CAM (Complementary and Alternative Medicine) by Prostate and Breast Cancer Patients Undergoing Radiotherapy|Active, not recruiting||N/A|120|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 01:50:55.050148|2017-10-11 01:50:55.050148
NCT01823536|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-07-23|2014-07-23||May 2013||2013-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|October 2013|Actual|2013-10-01||Interventional||Analysis was done on the all enrolled population.|Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose|A Phase IV, Open-label, Controlled, Multi-center Study to Evaluate the 5-year Antibody Persistence Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine at 2 to 10 Years of Age and to Assess the Immune Response to a Single Dose of Novartis MenACWY Conjugate Vaccine|Completed||Phase 4|465|Actual|Novartis||5|||f||||f||||||||||2017-10-11 01:50:55.128416|2017-10-11 01:50:55.128416
NCT01823523|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2015-01-12|||June 2013||2013-06-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Orthognathic Surgery and Postoperative Antibiotic Use|Orthognathic Surgery and Postoperative Antibiotic Use|Unknown status|Recruiting|N/A|300|Anticipated|Atlantic Center for Oral and Maxillofacial Surgery||2|||f||||t||||||||||2017-10-11 01:50:56.323268|2017-10-11 01:50:56.323268
NCT01823510|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2017-08-02|2017-06-19||July 2013||2013-07-01|August 2017|2017-08-01|May 10, 2016|Actual|2016-05-10|May 10, 2016|Actual|2016-05-10||Interventional|||Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients|Comparative Study of the Antithrombotic Effects of Ticagrelor and Clopidogrel in Type 2 Diabetic Patients|Completed||Phase 4|20|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 01:50:56.433269|2017-10-11 01:50:56.433269
NCT01823497|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2017-08-23|||April 2013|Actual|2013-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|PNCA||Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit|Parent/Nurse Controlled Analgesia for Post-Operative Pain Management in Neonates: A Preliminary Randomized Controlled Trial|Active, not recruiting||N/A|60|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 01:50:56.834989|2017-10-11 01:50:56.834989
NCT01823484|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2014-01-13|||January 2012||2012-01-01|January 2014|2014-01-01||||May 2014|Anticipated|2014-05-01||Interventional|||Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill|Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill|Unknown status|Recruiting|N/A|40|Anticipated|Zhongda Hospital||2|||f||||||||||||||2017-10-11 01:50:56.959694|2017-10-11 01:50:56.959694
NCT01823471|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-07-25|||November 2010||2010-11-01|September 2010|2010-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||I-Scan For Colon Polyp Detection In HNPCC|High Definition Endoscopy Versus Virtual Chromoendoscopy In The Detection Of Colonic Polyps In HNPCC|Completed||N/A|70|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 01:50:57.109758|2017-10-11 01:50:57.109758
NCT01823458|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-03-31|||April 2012||2012-04-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Behavioral Economics Incentives for Health Management|Evaluation of Behavioral Economics Patient Incentive Strategies for Health Management|Completed||N/A|152|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 01:50:57.239878|2017-10-11 01:50:57.239878
NCT01823445|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-12-01|||March 2013||2013-03-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Xylitol Disk Use in Adults With Dry Mouth|XyliMelts Ability to Reduce Mutans Streptococci in Adults With the Perception of Dry Mouth|Completed||N/A|7|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 01:50:57.342552|2017-10-11 01:50:57.342552
NCT01823432|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-05-01|||March 2012||2012-03-01|May 2017|2017-05-01|November 2022|Anticipated|2022-11-01|May 2021|Anticipated|2021-05-01|10 Years|Observational [Patient Registry]|||Genetic Risks for Bicuspid Aortic Valve Disease|Genetic Risks for Bicuspid Aortic Valve Disease|Recruiting||N/A|400|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples With DNA|"     Genomic DNA from whole blood Genomic DNA from saliva Aortic valve tissue preserved in     RNALater   "|No||2017-10-11 01:50:57.439184|2017-10-11 01:50:57.439184
NCT01823419|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-29|||October 2010||2010-10-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Omega-6 to Omega-3 Fatty Acid Ratio and Higher Order Cognitive Function in 7-to 9-year-olds|Omega-6 to Omega-3 Fatty Acid Ratio and Higher Order Cognitive Function in 7-to 9-year-olds|Completed||N/A|70|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||None Retained|"     No biospecimens will be collected.   "|||2017-10-11 01:50:57.546936|2017-10-11 01:50:57.546936
NCT01823406|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-06-27|||May 2012||2012-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|DP3||Tissue-Specific Metabolic Reprogramming in Diabetic Complications|Tissue-Specific Metabolic Reprogramming in Diabetic Complications. Glycemic Clamp Studies to Determine the Real Time Synthesis Rates of Glucose Derived Metabolites in Individuals With Type 1 Diabetes and Healthy Controls.|Recruiting||N/A|40|Anticipated|University of Michigan||4|||f||||f||||||||||2017-10-11 01:50:57.636544|2017-10-11 01:50:57.636544
NCT01823393|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-11-30|||January 2013||2013-01-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|October 2016|Actual|2016-10-01||Interventional|HEPAVALV||Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure|Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure|Terminated||Phase 4|94|Actual|University Hospital, Montpellier||2||Difficulty of inclusion|f||||f||||||||||2017-10-11 01:50:57.738281|2017-10-11 01:50:57.738281
NCT01823380|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2015-12-04|||September 2012||2012-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|February 2014|Actual|2014-02-01||Interventional|||Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype|Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype|Completed||N/A|127|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 01:50:57.851037|2017-10-11 01:50:57.851037
NCT01823367|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-08-24|||December 2012||2012-12-01|August 2017|2017-08-01|April 27, 2016|Actual|2016-04-27|April 27, 2016|Actual|2016-04-27||Interventional|Encourage||Encourage Healthy Families|Primary Prevention of Diabetes in Children and Mothers at Increased Risk: Encourage Healthy Families.|Completed||N/A|335|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 01:50:57.939272|2017-10-11 01:50:57.939272
NCT01823354|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-04-02|||November 2012||2012-11-01|March 2013|2013-03-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Interventional|||Executive Dysfunction in Restless Legs Syndrome: Clinical Correlates and Outcome After Therapeutic Management|Executive Dysfunction in Restless Legs Syndrome: Determination of Clinical Correlates and Outcome After Therapeutic Management|Unknown status|Recruiting|N/A|140|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 01:50:58.03974|2017-10-11 01:50:58.03974
NCT01823341|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-08-26|2015-06-25||May 2013||2013-05-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|PSO4|45 Subjects age 11-14 years and 37 subjects age 4-10 years|Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children|Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children|Completed||Phase 2|97|Actual|Jaeb Center for Health Research|Only selected participants prone to nocturnal hypoglycemia and only tested one continuous glucose sensor. Participants didn't know if system was active before activation so could not observe what would happen if the participants knew it was.|2|||f||||t||||||||||2017-10-11 01:50:58.193692|2017-10-11 01:50:58.193692
NCT01823328|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-11-06|||September 2013||2013-09-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ketamine Versus Etomidate for Rapid Sequence Intubation|Ketamine Versus Etomidate for Sedation of Emergency Department Patients During Rapid Sequence Intubation|Completed||Phase 4|128|Actual|Minneapolis Medical Research Foundation||2|||f||||t||||||||||2017-10-11 01:50:58.895504|2017-10-11 01:50:58.895504
NCT01823302|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-03-28|||February 2010||2010-02-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effect of a New Growing-up Milk on Growth and Nutrient Adequacy in Children With Picky-eating Behaviors|Effect of a New Growing-up Milk on Growth and Nutrient Adequacy in Children With Picky-eating Behaviors|Completed||Phase 4|165|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 01:50:59.129529|2017-10-11 01:50:59.129529
NCT01823289|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-04-12|2013-04-12||June 2007||2007-06-01|April 2013|2013-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections|Clinical Efficacy and Safety of Itraconazole Injection/Oral Solution Sequential Therapy for Treatment of Invasive Pulmonary Fungal Infections|Completed||Phase 4|71|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||||||||||2017-10-11 01:50:59.222844|2017-10-11 01:50:59.222844
NCT01823276|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2014-05-20|||May 2013||2013-05-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effect of Tyrosine on Behavioral, Physiological and Nutritional Status During Survive, Evade, Resist, Escape (SERE) School|Effect of Tyrosine on Behavioral, Physiological and Nutritional Status During Survive, Evade, Resist, Escape School|Completed||N/A|73|Actual|United States Army Research Institute of Environmental Medicine||2|||f||||f||||||||||2017-10-11 01:50:59.456776|2017-10-11 01:50:59.456776
NCT01823263|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-11-27|||April 2013||2013-04-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Metabolic and Cognitive Parameters Following Partial Sleep Deprivation|Metabolic and Cognitive Effects of Sleep Deprivation|Unknown status|Recruiting|N/A|20|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-11 01:50:59.581886|2017-10-11 01:50:59.581886
NCT01823250|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2015-12-15|||January 2011||2011-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CIFFTA||Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial|Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial|Completed||Phase 2|190|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 01:50:59.692301|2017-10-11 01:50:59.692301
NCT01823224|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-29|2016-05-05|2015-10-02||February 2013||2013-02-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Comparing Effectiveness of IV vs Oral Acetaminophen Given Perioperatively for Lap Choles for Pain Control,|A Prospective, Randomized, Double Blind, Comparative-effectiveness Study Comparing Perioperative Administration of Oral Versus Intravenous Acetaminophen for Laparoscopic Cholecystectomy|Completed||N/A|67|Actual|Defense and Veterans Center for Integrative Pain Management|Small sample size Only one institution utilized|2|||f||||f||||||||No||2017-10-11 01:50:59.90592|2017-10-11 01:50:59.90592
NCT01823211|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-10-27|||March 2013||2013-03-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01|36 Months|Observational [Patient Registry]|HAPPIER||Profitability Trial in Primary Preventive Implantable Cardioverter-defibrillator Recipients|Heart Rate Variability, Microvolt T-wave Alternans and Cardiac Magnetic Resonance Imaging Analysis in Primary Preventive ImplantablE Cardioverter-defibrillator Recipients Profitability Trial - HAPPIER Trial|Terminated||N/A|50|Actual|University Hospital Ostrava|||2|Problems with ensuring patient examinations defined in the protocol of the study|f||||f||||||||||2017-10-11 01:51:00.418044|2017-10-11 01:51:00.418044
NCT01823198|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-06-22|||June 2013|Actual|2013-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies|Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies|Recruiting||Phase 1/Phase 2|72|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:51:00.538602|2017-10-11 01:51:00.538602
NCT01823185|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-01-20|||March 2013||2013-03-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy|Bedside Testing of the CYP2C19 Gene to Asses Effectiveness of Clopidogrel in Coronary Artery Disease Patients Treated With Percutaneous Coronary Intervention : Individualized Antiplatelet Drugs Treatment to Improve Prognosis|Recruiting||Phase 4|1500|Anticipated|Dammam University||2|||f||||t||||||||||2017-10-11 01:51:00.6809|2017-10-11 01:51:00.6809
NCT01823172|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-10-05|||April 2013||2013-04-01|October 2016|2016-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Second Echelon Node Study With Methylene Blue|Feasibility of Lymphatic Mapping of Second Echelon Lymph Nodes With Methylene Blue|Completed||Phase 1|21|Actual|Mayo Clinic||1|||f||||f||||||||No|no plan to share data|2017-10-11 01:51:02.604048|2017-10-11 01:51:02.604048
NCT01823159|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2014-12-01|||April 2013||2013-04-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|CERETI||Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study|Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study|Completed||Phase 3|15|Actual|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-10-11 01:51:02.7197|2017-10-11 01:51:02.7197
NCT01823146|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-08-24|2015-06-24||July 2013||2013-07-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Oxytocin's Effect on Socioemotional Aging|Oxytocin and Aging: Neuro-Behavioral Effects on Social Cognition and Prosocial Behavior|Completed||N/A|106|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:51:02.8093|2017-10-11 01:51:02.8093
NCT01823133|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-08-27|||April 2013||2013-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin|A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin in Healthy Male Subjects|Completed||Phase 1|30|Anticipated|LG Life Sciences||3|||f||||t||||||||||2017-10-11 01:51:03.071993|2017-10-11 01:51:03.071993
NCT01823120|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2014-09-09|||March 2015||2015-03-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Text Message Intervention to Reduce Repeat Self-harm|Text Message Intervention to Reduce Repeat Self-harm in Patients Presenting to the Emergency Department|Terminated||N/A|10|Actual|University of Dublin, Trinity College||2||Resignation of critical volunteer staff and lack of funding|f||||t||||||||||2017-10-11 01:51:03.162229|2017-10-11 01:51:03.162229
NCT01823107|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-08-02|||October 2012|Actual|2012-10-01|August 2017|2017-08-01|June 29, 2017|Actual|2017-06-29|June 2017|Actual|2017-06-01||Interventional|||Feasibility Study of Meso BioMatrix Device for Breast Reconstruction|Meso BioMatrix Acellular Peritoneum Matrix Breast Reconstruction Feasibility Trial|Completed||N/A|25|Actual|Kensey Nash Corporation||1|||f||||f|f|t|f|||||||2017-10-11 01:51:03.266559|2017-10-11 01:51:03.266559
NCT01823094|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-01-22|||March 2013||2013-03-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|CTPLC||CTP Imaging of Lung Cancer|CTP (Computed Tomography Perfusion) Imaging of Lung Cancer|Completed||N/A|14|Actual|University of California, Davis|||2||f||||f||||||||||2017-10-11 01:51:03.35831|2017-10-11 01:51:03.35831
NCT01823081|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-05-10|||January 2013|Actual|2013-01-01|July 2012|2012-07-01|December 2015|Actual|2015-12-01|June 2013|Actual|2013-06-01||Interventional|||Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema||Completed||Phase 3|74|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:51:03.436859|2017-10-11 01:51:03.436859
NCT01823068|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-04-19|||April 2013||2013-04-01|April 2016|2016-04-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|||Vandetanib in Advanced NSCLC With RET Rearrangement|A Phase II Study of Vandetanib in Patients With Non-small Cell Lung Cancer Harboring RET Rearrangement|Recruiting||Phase 2|17|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 01:51:03.51616|2017-10-11 01:51:03.51616
NCT01823055|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-02|||January 2012||2012-01-01|March 2013|2013-03-01||||March 2013|Actual|2013-03-01||Interventional|||Safety and Efficacy of a Transvaginal Suture Capturing Mesh Device|Safety and Efficacy of a Transvaginal Suture Capturing Mesh Device: The Nordic Uphold LITE Trial|Completed||N/A|214|Actual|Karolinska Institutet||1|||f||||t||||||||||2017-10-11 01:51:03.755651|2017-10-11 01:51:03.755651
NCT01823042|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-28|||October 2012||2012-10-01|March 2013|2013-03-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)|A Randomized, Controlled, Open-label Study to Assess the the Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD).|Unknown status|Recruiting|N/A|100|Anticipated|Jinling Hospital, China||2|||f||||f||||||||||2017-10-11 01:51:03.827086|2017-10-11 01:51:03.827086
NCT01823029|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-11-26|||November 2012||2012-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|CD-AT1||Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia||Completed||N/A|387|Actual|Jinling Hospital, China||2|||f||||f||||||||||2017-10-11 01:51:03.949856|2017-10-11 01:51:03.949856
NCT01823016|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-05-03||2016-05-03|September 2013||2013-09-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study of JNJ-38518168 in Symptomatic Adult Subjects With Uncontrolled, Persistent Asthma|Completed||Phase 2|166|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 01:51:04.065884|2017-10-11 01:51:04.065884
NCT01823003|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-12-28|||June 2012||2012-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|sbrtlungfff||Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases|Risk Adapted Free Flattering Filter Based Stereotactic Ablative Radiotherapy (Sabr) in Stage i Nsclc and Lung Metastases|Active, not recruiting||Phase 2|67|Anticipated|Institut Català d'Oncologia||4|||f||||f||||||||||2017-10-11 01:51:04.33798|2017-10-11 01:51:04.33798
NCT01822990|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-03-28|||February 2011||2011-02-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01|12 Months|Observational [Patient Registry]|||Circulating Anti-Beta2-glycoprotein Antibodies and Endothelial Dysfunction|Influence of Circulating Anti-beta2-glycoprotein I Antibodies on the Endothelial Function and NO Metabolism in Peripheral Arterial Disease Patients.|Completed||N/A|60|Actual|Hospital Universitario Getafe|||2||f||||f||||||Samples Without DNA|"     Serum samples of all the subjects included.   "|||2017-10-11 01:51:04.455762|2017-10-11 01:51:04.455762
NCT01822977|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2014-08-18|||March 2013||2013-03-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Impact of Proton Pump Inhibitors on the Fecal Microbiome|The Impact of Proton Pump Inhibitors on the Fecal Microbiome and Their Relationship to Clostridium Difficile Infection|Completed||Phase 1|15|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:51:04.546454|2017-10-11 01:51:04.546454
NCT01822964|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-04-02|||March 2013||2013-03-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|March 2014|Anticipated|2014-03-01||Interventional|||Oxygenation of the Cerebrum and Cooling During Transcatheter Aortic Valve Implantation (TAVI) Procedures - Part II||Unknown status|Recruiting|N/A|30|Anticipated|Hasselt University||2|||f||||t||||||||||2017-10-11 01:51:04.635065|2017-10-11 01:51:04.635065
NCT01822951|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-10-23||||||October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|DAT||Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)|Comparison of Cerebrolysin and Donepezil: A Randomized, Double-blind, Controlled Trial on Efficacy and Safety in Patients With Mild to Moderate Alzheimer's Disease|Withdrawn||Phase 4|0|Actual|Ever Neuro Pharma GmbH||2|||f||||t||||||||||2017-10-11 01:51:04.730049|2017-10-11 01:51:04.730049
NCT01822938|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2014-03-19|||March 2013||2013-03-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01||Interventional|TICAA'DOM||Follow-up of Patients' Physical Activity in Post-hospitalization|Follow-up of Patients' Physical Activity in Post-hospitalization by Implementation of Systems of Active Monitoring.|Unknown status|Recruiting|N/A|84|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 01:51:04.848178|2017-10-11 01:51:04.848178
NCT01822925|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-05-18|||November 2013||2013-11-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study of DA-9801 to Treat Diabetic Neuropathy|A Phase II Randomized, Double-Blind, Parallel Group, Dose-Ranging, Placebo-Controlled Study to Assess the Safety And Effectiveness Of DA-9801 in the Treatment of Subjects With Diabetic Neuropathy|Completed||Phase 2|128|Actual|Dong-A ST Co., Ltd.||4|||f||||t||||||||||2017-10-11 01:51:04.928454|2017-10-11 01:51:04.928454
NCT01822912|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-11-22|||January 2013||2013-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Heart Failure Management Program Versus Usual Care|Evaluation of a Skilled Nursing Facility Heart Failure Disease Management Program Versus Usual Care|Recruiting||N/A|1400|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:51:05.048124|2017-10-11 01:51:05.048124
NCT01822899|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-08-07|2014-04-24||April 4, 2013||2013-04-04|August 2017|2017-08-01|October 7, 2013|Actual|2013-10-07|October 1, 2013|Actual|2013-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|DB2116134: A Randomized, Multi-center, Double-blind, Double-dummy, Parallel Group Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With COPD|Completed||Phase 3|717|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:51:05.154467|2017-10-11 01:51:05.154467
NCT01822886|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-07-31|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|December 2014|Actual|2014-12-01||Interventional|FIL_GEMRO||Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients|Phase IIa Study on the Role of Gemcitabine Plus Romidepsin (GEMRO Regimen) in the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma Patients.|Active, not recruiting||Phase 2|20|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-11 01:51:05.74179|2017-10-11 01:51:05.74179
NCT01822873|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-11-22|||March 2013||2013-03-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Observational|||Study on Visual Function Impairments in Dry Age-related Macular Degeneration|Evaluation of Visual Function Impairments in Patients With Early Dry Age-related Macular Degeneration|Active, not recruiting||N/A|210|Anticipated|Duke University|||2||f||||f||||||||||2017-10-11 01:51:05.852448|2017-10-11 01:51:05.852448
NCT01822860|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-03-24|||March 2013||2013-03-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function|The Effect of Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function in Hypertensive Patients: A Pilot Study|Withdrawn||Phase 4|0|Actual|Creighton University||3||Study subjects were not able to be recruited|f||||t||||||||||2017-10-11 01:51:05.922422|2017-10-11 01:51:05.922422
NCT01822847|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-02-24|||March 2013||2013-03-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Physiological Response of Cortisol to Cardiac Catheterization|Physiological Response of Cortisol to Cardiac Catheterization|Completed||N/A|24|Actual|Creighton University|||1||f||||f||||||||||2017-10-11 01:51:06.021826|2017-10-11 01:51:06.021826
NCT01822834|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2016-07-25|||January 2008||2008-01-01|July 2016|2016-07-01||||December 2050|Anticipated|2050-12-01|20 Years|Observational [Patient Registry]|||Bronchiectasis Research Registry||Recruiting||N/A|5000|Anticipated|COPD Foundation|||2||f||||||||||||||2017-10-11 01:51:06.104112|2017-10-11 01:51:06.104112
NCT01822821|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-04-06|2017-01-20||March 2013||2013-03-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Pain Control After Cardiac Surgery Using Intravenous Acetaminophen|Intravenous Acetaminophen Analgesia After Cardiac Surgery: A Randomized, Blinded, Controlled Superiority Trial|Completed||N/A|150|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 01:51:06.19752|2017-10-11 01:51:06.19752
NCT01822808|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-08-13|||January 2013||2013-01-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|B-AHEF||Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure|A Prospective, Placebo-controlled, Double-blind, Randomized Study to Compare Hydralazine-isosorbide-dinitrate(HYIS) Versus Placebo on Top of Std Care in African Patients With Acute Heart Failure (AHF) and Left Ventricular Dysfunction|Unknown status|Active, not recruiting|Phase 3|500|Anticipated|University of Cape Town||2|||f||||t||||||||||2017-10-11 01:51:06.747348|2017-10-11 01:51:06.747348
NCT01822795|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-04-29|||March 2013||2013-03-01|April 2014|2014-04-01|December 2019|Anticipated|2019-12-01|March 2015|Anticipated|2015-03-01||Interventional|STICREVOLENS||Lung Volume Reduction Coil Treatment in Emphysema.|Cost-effectiveness of Lung Volume Reduction Coil Treatment in Emphysema.|Active, not recruiting||Phase 3|100|Anticipated|CHU de Reims||2|||f||||t||||||||||2017-10-11 01:51:06.857157|2017-10-11 01:51:06.857157
NCT01822782|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-03-25|||June 2013||2013-06-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Abnormal Vaginal Flora and Vaginal Lesions at Delivery: is There a Relationship?|Abnormal Vaginal Flora and Vaginal Lesions at Delivery: is There a Relationship?|Completed||N/A|1100|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 01:51:06.960142|2017-10-11 01:51:06.960142
NCT01822769|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-01-18|||April 2013||2013-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|||Cardiopulmonary Rehabilitation for Adolescents and Adults With Congenital Heart Disease|Cardiopulmonary Rehabilitation for Adolescents and Adults With Congenital Heart Disease|Active, not recruiting||N/A|60|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 01:51:07.033247|2017-10-11 01:51:07.033247
NCT01822756|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-03-02|2016-09-20||April 2013||2013-04-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|September 2015|Actual|2015-09-01||Interventional||Intent-to-Treat Subjects (ITT): All subjects who received at least 1 dose of Ruxolitinib (RUX).|An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors|A Phase 1b Study of the Safety and Tolerability of Ruxolitinib in Combination With Gemcitabine With or Without Nab-Paclitaxel in Subjects With Advanced Solid Tumors|Terminated||Phase 1|42|Actual|Incyte Corporation|In October 2014, further enrollment of additional study cohorts was stopped; Part 2 of the study wasn't conducted. Pharmacokinetic and Pharmacodynamics analyses weren't performed due to early termination. Maximum tolerated dose (MTD) was not reached.|2||Dose escalation ended after Cohort B1, RUX 10 mg BID - GCSF in October 2014.|f||||f||||||||||2017-10-11 01:51:07.15988|2017-10-11 01:51:07.15988
NCT01822743|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-06-13|||January 2012||2012-01-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|OSTEOSAOSII||Osteopathy and Obstructive Sleep Apnea Syndrome II|A Single Blind Cross Over Trial to Compare Osteopathic Compression of Pterygopalatine Node to Sham in Patients With Obstructive Sleep Apnea Syndrome and in Healthy Subjects|Completed||Phase 3|52|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:51:09.439934|2017-10-11 01:51:09.439934
NCT01822730|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-02-02|||February 2013||2013-02-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis|A Multiple-Center, Randomized, Double-Blind Study of Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis|Completed||Phase 4|120|Actual|Central South University||2|||f||||t||||||||||2017-10-11 01:51:09.532402|2017-10-11 01:51:09.532402
NCT01822717|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-03-28|||September 2010||2010-09-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Nonvisual Foot Inspection for People With Visual Imapirment|Nonvisual Foot Inspection for People With Visual Impairment|Completed||N/A|30|Actual|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 01:51:09.620277|2017-10-11 01:51:09.620277
NCT01822704|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-01|||March 2013||2013-03-01|April 2013|2013-04-01|May 2015|Anticipated|2015-05-01|November 2014|Anticipated|2014-11-01||Interventional|||Whole Body Vibration in Chronic Stroke|Application of Vertical Whole Body Vibration in Stroke Patients: Neuromuscular Effects, and Clinical Efficacy|Unknown status|Recruiting|N/A|81|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-11 01:51:09.720729|2017-10-11 01:51:09.720729
NCT01822691|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2015-12-14|2015-12-14||July 2013||2013-07-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional||All participants|Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)|A Phase II Study to Determine the Safety and Efficacy of INCB024360 in Patients With Myelodysplastic Syndromes|Completed||Phase 2|15|Actual|H. Lee Moffitt Cancer Center and Research Institute|The study was closed prior to meeting the overall survival criteria.|1|||f||||f||||||||||2017-10-11 01:51:09.84868|2017-10-11 01:51:09.84868
NCT01822678|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-02-26|2013-04-05||December 2005||2005-12-01|February 2014|2014-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional||Demographic characteristics of patients (Safety population)|Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder|Efficacy and Safety of Eslicarbazepine Acetate (BIA 2 093) in Acute Manic Episodes Associated With Bipolar I Disorder in a Double Blind, Randomised, Dose Titration, Placebo Controlled, Multicentre Clinical Trial|Completed||Phase 2|161|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 01:51:10.30101|2017-10-11 01:51:10.30101
NCT01822665|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2014-02-13|2013-06-20||February 2012||2012-02-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics|A Study to Investigate the Gastrointestinal Safety of OTC Analgesics in Healthy Volunteers by Endoscopic Examination|Completed||Phase 4|28|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 01:51:10.723985|2017-10-11 01:51:10.723985
NCT01822652|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-01-09|||August 2013||2013-08-01|January 2017|2017-01-01|October 2030|Anticipated|2030-10-01|December 2015|Actual|2015-12-01||Interventional|GRAIN||3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN|AUTOLOGOUS ACTIVATED T-CELLS TRANSDUCED WITH A 3rd GENERATION GD-2 CHIMERIC ANTIGEN RECEPTOR AND iCASPASE9 SAFETY SWITCH ADMINISTERED TO PATIENTS WITH RELAPSED OR REFRACTORY NEUROBLASTOMA (GRAIN)|Active, not recruiting||Phase 1|11|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-10-11 01:51:11.362887|2017-10-11 01:51:11.362887
NCT01822639|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-06-02|||April 3, 2013|Actual|2013-04-03|June 2017|2017-06-01|May 24, 2013|Actual|2013-05-24|May 24, 2013|Actual|2013-05-24||Interventional|||A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study|An Open-Label, Randomized, Single Dose, Two-Way Crossover Pilot Study to Evaluate the Relative Bioavailability of One Amlodipine 5 mg Tablet and One Enalapril Maleate 20mg Tablet to a Fixed Dose Combination Tablet Formulation of Amlodipine (5 mg) and Enalapril Maleate (20 mg), in Healthy Adult Male and Female Subjects Under Fasting Conditions|Completed||Phase 1|15|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:51:11.483906|2017-10-11 01:51:11.483906
NCT01822626|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-02|||June 2011||2011-06-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pediatrician-lead Motivational Counselling to Control BMI in Overweight Children: a RCT in Primary Care|Pediatrician-lead Motivational Counselling to Control BMI in Overweight Children: a RCT in Primary Care|Completed||N/A|372|Actual|Azienda Unità Sanitaria Locale Reggio Emilia||2|||f||||f||||||||||2017-10-11 01:51:11.579137|2017-10-11 01:51:11.579137
NCT01822613|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-05-31|||July 26, 2013|Actual|2013-07-26|May 2017|2017-05-01|June 3, 2016|Actual|2016-06-03|June 3, 2016|Actual|2016-06-03||Interventional|||Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)|A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)|Completed||Phase 1|48|Actual|Novartis||2|||f||||f|t|f||||||No||2017-10-11 01:51:11.659555|2017-10-11 01:51:11.659555
NCT01822600|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-27|||January 2010||2010-01-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia|The Therapeutic Role of Albumin Supply on Peptic Ulcer Bleeding and the Correlation Between Clinical Course and Expression of Serum Response Factor on Ulcer Tissue and Superoxide Free Radical in Blood|Completed||Phase 4|91|Actual|National Cheng-Kung University Hospital||3|||f||||t||||||||||2017-10-11 01:51:11.789738|2017-10-11 01:51:11.789738
NCT01822587|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-09-29|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving|Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving, Reactivity and Use|Recruiting||Phase 2|180|Anticipated|Medical University of South Carolina||3|||f||||t||||||||||2017-10-11 01:51:11.895465|2017-10-11 01:51:11.895465
NCT01822574|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-02-03|2016-02-03||March 2013||2013-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparison of Three Surgical Techniques to Achieve Patella Symmetry During Resection|Effect of Surgical Technique on Resection Symmetry of the Patella in Total Knee Arthroplasty|Completed||N/A|90|Actual|Mayo Clinic||3|||f||||f||||||||No||2017-10-11 01:51:12.019364|2017-10-11 01:51:12.019364
NCT01822561|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-06-20|||May 2013||2013-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|April 2017|Actual|2017-04-01||Interventional|||Eplerenone for Central Serous Chorioretinopathy|Eplerenone for Central Serous Chorioretinopathy: A Pilot Study|Active, not recruiting||Phase 2|17|Actual|Tufts Medical Center||1|||f||||t||||||||Undecided||2017-10-11 01:51:12.341163|2017-10-11 01:51:12.341163
NCT01822548|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2017-04-19|2017-03-06||October 2010||2010-10-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes|Randomized, Open Label, Two Parallel Arms, Intervention Trial Comparing the Effect of DPP-IV Inhibitor Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number in Patients With Type 2 Diabetes in Metformin Failure|Completed||Phase 3|64|Actual|Azienda Ospedaliero-Universitaria di Parma||2|||f||||t||||||||||2017-10-11 01:51:12.439924|2017-10-11 01:51:12.439924
NCT01822535|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-02-05|2015-11-23||July 2011||2011-07-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Body Temperature in Persons With Tetraplegia When Exposed to Cold|Core Temperature During Cold Exposure in Persons With Tetraplegia|Completed||Phase 4|30|Actual|James J. Peters Veterans Affairs Medical Center|"Did not assess cognitive performance a third time, after Tcore in the group with tetraplegia had returned to baseline levels.
Study had a small sample size, and only included males."|3|||f||||f||||||||||2017-10-11 01:51:13.121954|2017-10-11 01:51:13.121954
NCT01822522|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-09-12|||June 21, 2013|Actual|2013-06-21|September 2017|2017-09-01||||November 1, 2017|Anticipated|2017-11-01||Interventional|||Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus|Phase I Trial of Cabozantinib (XL184) for Advanced Solid Tumors in Persons With HIV Infection|Recruiting||Phase 1|42|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:51:13.492729|2017-10-11 01:51:13.492729
NCT01822509|ClinicalTrials.gov processed this data on October 10, 2017|2013-04-01|2017-09-04|||April 9, 2013|Actual|2013-04-09|May 2017|2017-05-01||||December 31, 2018|Anticipated|2018-12-31||Interventional|||Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant|A Phase I/Ib Study of Ipilimumab or Nivolumab in Patients With Relapsed Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation|Recruiting||Phase 1|113|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 01:51:13.701104|2017-10-11 01:51:13.701104
NCT01822483|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-04-01|||April 2013||2013-04-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|AUC-MPA||A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)|A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)|Completed||Phase 4|100|Actual|Irmandade Santa Casa de Misericórdia de Porto Alegre||2|||f||||f||||||||||2017-10-11 01:51:15.245573|2017-10-11 01:51:15.245573
NCT01822470|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-04-21|||January 2013||2013-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|1 Year|Observational [Patient Registry]|SIBO||Small Intestinal Bacterial Overgrowth: A Prospective Registry|Small Intestinal Bacterial Overgrowth: A Prospective Registry|Recruiting||N/A|200|Anticipated|Indiana University|||2||f||||f||||||Samples With DNA|"     DNA will be kept from patients jejunal aspirate and mucosal biopsy. In addition, patient     serum will be kept   "|||2017-10-11 01:51:15.381695|2017-10-11 01:51:15.381695
NCT01822457|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-08-10|||August 2013||2013-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|||Effect of Nike FuelBand on Exercise and Function in Claudicants; a Randomised Controlled Trial|Effect of Nike FuelBand on Exercise and Function in Claudicants; a Randomised Controlled Trial|Completed||N/A|40|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 01:51:15.491548|2017-10-11 01:51:15.491548
NCT01822444|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-08-09|||November 2012||2012-11-01|August 2017|2017-08-01||||October 2017|Anticipated|2017-10-01||Observational|||ANGIOPREDICT. ICORG 12-16, V3|Exploratory Phase II Clinical Trial Comprising Biomarker Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (FOLFOX) in Combination With Bevacizumab (Bvz) in First Line Treatment of Metastatic Colorectal Cancer (CRC) Expressing Mutant K-ras - AC-ANGIOPREDICT|Active, not recruiting||N/A|224|Anticipated|Cancer Trials Ireland|||1||f||||||||||||||2017-10-11 01:51:15.614365|2017-10-11 01:51:15.614365
NCT01822431|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-28|2013-04-01|||June 2011||2011-06-01|March 2013|2013-03-01||||June 2013|Anticipated|2013-06-01||Observational|||A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes||Unknown status|Enrolling by invitation|N/A|100|Anticipated|AHEPA University Hospital|||2||f||||t||||||||||2017-10-11 01:51:15.763295|2017-10-11 01:51:15.763295
NCT01822418|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-27|||January 2013||2013-01-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|AGOPSYCH||Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)|Agomelatine Treatment of Major Depressive Episodes in the Course of Schizophrenic Psychoses (AGOPSYCH)|Unknown status|Recruiting|Phase 4|27|Anticipated|Central Institute of Mental Health, Mannheim||1|||f||||t||||||||||2017-10-11 01:51:15.86525|2017-10-11 01:51:15.86525
NCT01822392|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2015-02-04|||November 2012||2012-11-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||On-line Treatment for Conduct Problems||Completed||N/A|86|Actual|Yale University||2|||f||||f||||||||||2017-10-11 01:51:16.107557|2017-10-11 01:51:16.107557
NCT01822379|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-12|2017-03-08|||May 2010||2010-05-01|March 2017|2017-03-01|July 2012|Actual|2012-07-01|July 2011|Actual|2011-07-01||Interventional|||Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo|Comparative Study of the Use of Trypsin Versus Dispase in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo|Withdrawn||Phase 2/Phase 3|0|Actual|Henry Ford Health System||1||This study was never initiated.|f||||t||||||||||2017-10-11 01:51:16.257956|2017-10-11 01:51:16.257956
NCT01822366|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-11-23|||August 2012||2012-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized Controlled Trial of Trauma-focused CBT in Tanzania and Kenya|Improving Health Outcomes by Preventing HIV/STD Risk|Active, not recruiting||N/A|640|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 01:51:16.60813|2017-10-11 01:51:16.60813
NCT01822353|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-01-19|||January 2013||2013-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||The Effect of Per Oral Immunotherapy in Severe IgE Mediated Egg, Milk, and Nut Allergy in Adults|The Effect of Per Oral Immunotherapy in Severe IgE Mediated Egg, Milk and Nut Allergy in Adults|Active, not recruiting||Phase 2|100|Anticipated|Helsinki University Central Hospital||3|||f||||f||||||||Yes|Milk desensitisation data may be shared with BC Remington, TNO Zeist Netherlands|2017-10-11 01:51:16.732709|2017-10-11 01:51:16.732709
NCT01822340|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-02-17|||October 2011||2011-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|June 2015|Actual|2015-06-01||Interventional|HM10560A||Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients|A Phase II, Randomized, Active Controlled, Open Label Study of Safety and Efficacy of HM10560A a Long-acting rhGH-HMC001 Conjugate in Treatment of Subjects Suffering From Adult Growth Hormone Deficiency (AGHD)|Completed||Phase 2|72|Actual|Hanmi Pharmaceutical Company Limited||5|||f||||t||||||||||2017-10-11 01:51:16.84821|2017-10-11 01:51:16.84821
NCT01822327|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-03-27|||December 2007||2007-12-01|March 2013|2013-03-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Treating Cocaine Abuse: A Behavioral Approach|Treating Cocaine Abuse: A Behavioral Approach|Unknown status|Active, not recruiting|Phase 2|124|Anticipated|University of Vermont||3|||f||||f||||||||||2017-10-11 01:51:16.948574|2017-10-11 01:51:16.948574
NCT01822314|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-10-10|||April 2013||2013-04-01|October 2016|2016-10-01|October 2025|Anticipated|2025-10-01|September 2016|Actual|2016-09-01||Interventional|ETNA||Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer|"Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer  ETNA (Evaluating Treatment With Neoadjuvant Abraxane)"|Active, not recruiting||Phase 3|632|Anticipated|Fondazione Michelangelo||2|||f||||t||||||||||2017-10-11 01:51:17.06598|2017-10-11 01:51:17.06598
NCT01822301|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-06-09|2016-11-10||April 2013||2013-04-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|BTIPlusUp||Structural Fat Grafting for Craniofacial Trauma: Repeat Fat Grafting Injection-5 Subject Cohort|Structural Fat Grafting for Craniofacial Trauma: Repeat Fat Grafting Injection-5 Subject Cohort|Completed||N/A|5|Actual|University of Pittsburgh||1|||f||||t||||||||Yes|It is the Principal Investigator's intention to make stored samples and subject de-identified information available to secondary investigators after all research study testing has been completed. These stored samples and associated subject information will not include subject identifiers.|2017-10-11 01:51:17.379098|2017-10-11 01:51:17.379098
NCT01822288|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-02-09|||December 2012||2012-12-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder|The Impact of Different Hormone Therapy Regimens on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder|Recruiting||Phase 4|120|Anticipated|Far Eastern Memorial Hospital||2|||f||||f||||||||||2017-10-11 01:51:17.650582|2017-10-11 01:51:17.650582
NCT01822275|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-07-28|||May 2013||2013-05-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|GCC 1224||Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme|Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme|Recruiting||Phase 2|47|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-11 01:51:17.770531|2017-10-11 01:51:17.770531
NCT01822262|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-03-06|||January 2011||2011-01-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Contrastive Study for Minimally Invasive Cholecystolithotomy With Gallbladder Reservation and Laparoscopic Cholecystectomy|All the Phases Study Will be Operated by the Department of Hepatobiliary Surgery, The Affiliated Hospital of Guiyang Medical College|Recruiting||Phase 4|100|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 01:51:17.872029|2017-10-11 01:51:17.872029
NCT01822249|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-08-03|||January 2013||2013-01-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Phase 2 Study of EPI-743 for Treatment of Rett Syndrome|A Phase 2A Randomized, Placebo Controlled Trial of EPI-743 in Children With Rett Syndrome|Completed||Phase 2|24|Actual|Edison Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-11 01:51:17.982576|2017-10-11 01:51:17.982576
NCT01822236|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2015-03-23|||April 2013||2013-04-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Craniosacral Therapy to Treat Chronic Low Back Pain|Effectiveness of a Craniosacral Therapy Program on Disability, Quality of Life, Autonomic Nervous System and Oxidative Stress Indicators in Chronic Low Back Pain: a Randomized Controlled Clinical Trial|Completed||N/A|70|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-11 01:51:18.081893|2017-10-11 01:51:18.081893
NCT01822223|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2016-11-29|2015-10-23||November 2010||2010-11-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Evaluate the Effectiveness of Laser-Ablated Implant-Abutments to Promote Tissue Healing|A Controlled, Double-Blind, Randomized, Parallel-Arm, Clinical Trial to Evaluate the Effectiveness of Laser-Ablated Implant-Abutments for Enhanced Oral Mucosal Healing|Completed||N/A|20|Actual|University of Alabama at Birmingham||2|||f||||f||||||||Undecided||2017-10-11 01:51:18.215525|2017-10-11 01:51:18.215525
NCT01822210|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-07-11|||January 2013||2013-01-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Botulinum Toxin for Stomach Cancer Treatment|Botulinum Toxin (BOTOX) for Stomach Cancer Treatment|Completed||Phase 2|7|Actual|St. Olavs Hospital||1|||f||||t||||||||||2017-10-11 01:51:18.54882|2017-10-11 01:51:18.54882
NCT01822197|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-10-26|2016-07-25||March 2013||2013-03-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|PHOTO||Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients|Pilot Trial of Phototherapy for Acute Depression in Hospitalized CF Patients|Completed||N/A|30|Actual|Nationwide Children's Hospital||1|||f||||f||||||||No||2017-10-11 01:51:18.646841|2017-10-11 01:51:18.646841
NCT01822184|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-10-19|||January 2013||2013-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)|A Prospective, Longitudinal, Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)|Completed||N/A|100|Actual|Shire|||1||f||||f||||||Samples With DNA|"     Genotyping of the iduronate-2-sulfatase gene will be required ONLY for those patients who     have not had a previous genotyping sample analysis performed at the selected diagnostic     laboratory.   "|||2017-10-11 01:51:18.84386|2017-10-11 01:51:18.84386
NCT01822171|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-05-21|||January 2013||2013-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MTM||Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients|Multi-Disciplinary Discharge Counseling and MTM Services After Discharge for Heart Failure Patients|Terminated||N/A|1|Actual|Providence Health & Services||1||Unable to enroll and study intended patient population.|f||||f||||||||||2017-10-11 01:51:18.932253|2017-10-11 01:51:18.932253
NCT01822158|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-05-21|||May 2013||2013-05-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|VDD||Vaginal Delivery Debrief Checklist to Improve Team Communication|Vaginal Delivery Debrief: A Nursing Research Study|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Providence Health & Services||1|||f||||f||||||||||2017-10-11 01:51:19.01583|2017-10-11 01:51:19.01583
NCT01822145|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2015-09-03|||March 2013||2013-03-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|PREDICT-ICDS||A Feasibility Study on Prediction of an ICD Shock by ICD-derived Data|PREDICTion of Implantable-Cardioverter Defibrillator Shock Study|Unknown status|Recruiting|N/A|60|Anticipated|Princess Margaret Hospital, Hong Kong|||1||f||||f||||||||||2017-10-11 01:51:19.090445|2017-10-11 01:51:19.090445
NCT01822119|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-12-12|2016-08-24||March 2013||2013-03-01|December 2016|2016-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System)|Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System). A Multicentre, Open, Prospective Clinical Investigation. 3 Months Investigation With a 6 Months Follow-up|Completed||N/A|27|Actual|Cochlear Bone Anchored Solutions||1|||f||||f||||||||||2017-10-11 01:51:19.335173|2017-10-11 01:51:19.335173
NCT01822106|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-03-27|||February 2013||2013-02-01|March 2013|2013-03-01||||December 2014|Anticipated|2014-12-01||Interventional|||Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD)||Unknown status|Recruiting|Phase 4|90|Anticipated|China Medical University Hospital||2|||f||||f||||||||||2017-10-11 01:51:20.079028|2017-10-11 01:51:20.079028
NCT01822093|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-01-23|||December 2012||2012-12-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|ASPIRE||Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT|Phase I/II Study Investigating the Safety of ADV Specific T Cells in High-risk Paediatric Patients Post Allo-HSCT to Treat ADV Reactivation|Completed||Phase 1/Phase 2|8|Actual|Cell Medica Ltd||1|||f||||t||||||||||2017-10-11 01:51:20.398904|2017-10-11 01:51:20.398904
NCT01822080|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-11-24|||March 2013||2013-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients|A Multicenter Study to Investigate the Efficacy and Safety of Daily Oral Administration of 2 mg Dienogest Tablets (Visanne/SH T00660AA) for the Treatment of Endometriosis in Chinese Patients: a Double-blind, Randomized, Placebo-controlled, Parallel Group Phase Over 24 Weeks Followed by an Open-label, Single-group Follow up Over 28 Weeks|Completed||Phase 3|250|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:51:20.506189|2017-10-11 01:51:20.506189
NCT01822067|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-06-28|||August 2012||2012-08-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|June 2018|Anticipated|2018-06-01||Observational|||Effects of Maternal Body Composition on Offspring Brain Structure and Function|Effects of Maternal Body Composition on Offspring Brain Structure and Function|Active, not recruiting||N/A|100|Anticipated|Arkansas Children's Hospital Research Institute|||2||f||||f||||||||||2017-10-11 01:51:20.651004|2017-10-11 01:51:20.651004
NCT01822054|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-06-28|||January 2012||2012-01-01|June 2017|2017-06-01|August 2014|Actual|2014-08-01|August 2013|Actual|2013-08-01||Observational|||Childhood Body Composition and Brain Structure and Function|Childhood Body Composition and Brain Structure and Function|Completed||N/A|27|Actual|Arkansas Children's Hospital Research Institute|||2||f||||f||||||||||2017-10-11 01:51:20.714663|2017-10-11 01:51:20.714663
NCT01822041|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-09-12|||March 2013||2013-03-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||14C-ARN-509 Microtracer Label AME and Absolute BA Study|14C-ARN-509 Microdose Absolute Bioavailability and Microtracer Absorption, Metabolism, and Excretion Study in Healthy Volunteers|Completed||Phase 1|12|Actual|Aragon Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 01:51:20.779951|2017-10-11 01:51:20.779951
NCT01822028|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-03-09|||March 2013||2013-03-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca®|A Single-center, Double-blind, Randomized, Placebo-controlled, Two Period / Two Treatment Cross-over Study to Assess the Effect of Florastor® (Saccharomyces Boulardii Lyo) on Gastrointestinal Tolerability, Safety, and Pharmacokinetics of Zavesca® (Miglustat) in Healthy Subjects|Completed||Phase 1|42|Actual|Actelion||2|||f||||f||||||||||2017-10-11 01:51:20.856714|2017-10-11 01:51:20.856714
NCT01822015|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-05-10|||March 15, 2013|Actual|2013-03-15|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Pilot, Pharmacodynamic Correlate Trial of Sirolimus in Combination With Chemotherapy (Idarubicin, Cytarabine) for the Treatment of Newly Diagnosed Acute Myelogenous Leukemia|Active, not recruiting||Early Phase 1|55|Actual|Thomas Jefferson University||1|||f||||t|t|f|||t|||||2017-10-11 01:51:20.954959|2017-10-11 01:51:20.954959
NCT01822002|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-29|||February 2013||2013-02-01|March 2013|2013-03-01|February 2015|Anticipated|2015-02-01|February 2014|Anticipated|2014-02-01||Interventional|PC-BPPV||Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo|Randomized Controlled Trials for Treatment of Benign Paroxysmal Positional Vertigo|Unknown status|Recruiting|N/A|1500|Anticipated|Chonbuk National University||2|||f||||t||||||||||2017-10-11 01:51:21.10796|2017-10-11 01:51:21.10796
NCT01821989|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2014-05-08|||June 2013||2013-06-01|May 2014|2014-05-01||||January 2016|Anticipated|2016-01-01||Interventional|||Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm Neonate|Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm Neonate.|Unknown status|Not yet recruiting|Early Phase 1|180|Anticipated|Mooselmokadem||3|||f||||||||||||||2017-10-11 01:51:21.280548|2017-10-11 01:51:21.280548
NCT01821976|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-06-12|||March 2013||2013-03-01|April 2017|2017-04-01|June 2022|Anticipated|2022-06-01|January 2021|Anticipated|2021-01-01||Interventional|TAOS||Transtibial Amputation Outcomes Study|Transtibial Amputation Outcomes Study (TAOS): Comparing Transtibial Amputation With (Ertl) and Without a Tibia-fibula Synostosis Procedure|Recruiting||N/A|250|Anticipated|Major Extremity Trauma Research Consortium||2|||f||||t||||||||||2017-10-11 01:51:21.387778|2017-10-11 01:51:21.387778
NCT01821963|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-02-23|2015-02-23||April 2013||2013-04-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Study terminated with one participant, no analysis performed.|Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)|Telaprevir in Combination With Standard of Care in Hepatitis C Genotype 1 Infection in Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation|Terminated||Phase 3|1|Actual|M.D. Anderson Cancer Center||1||Low referral rate due to new therapeutic options.|f||||f||||||||||2017-10-11 01:51:21.607709|2017-10-11 01:51:21.607709
NCT01821950|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-02-12|||September 2013||2013-09-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Evaluation of Yoga for Substance Use Risk Factors in a School Setting|Evaluation of Yoga for Substance Use Risk Factors in a School Setting|Active, not recruiting||N/A|283|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:51:21.814981|2017-10-11 01:51:21.814981
NCT01821937|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-07-03|2015-07-03||March 2013||2013-03-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Treated Set (TS): This set included all 25 subjects who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Pharmacokinetics of Faldaprevir of Soft Capsule|Pharmacokinetics of Single and Multiple Oral Doses of 120 mg and 240 mg BI 201335 in Healthy Chinese Volunteers|Completed||Phase 1|25|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:51:21.945147|2017-10-11 01:51:21.945147
NCT01821924|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-03-29|||January 2012||2012-01-01|March 2013|2013-03-01||||January 2016|Anticipated|2016-01-01||Observational|||Role of Stress Cardiac MRI in Predicting Adverse Clinical Events in Patients With Known or Suspected Ischemic Heart Disease||Unknown status|Active, not recruiting|N/A|400|Anticipated|Brigham and Women's Hospital|||1||f||||||||||||||2017-10-11 01:51:22.738308|2017-10-11 01:51:22.738308
NCT01821911|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-01-19|||July 2012||2012-07-01|April 2013|2013-04-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use|Phase 4 Study of Speeda® Rabies Vaccine for Human Use|Completed||Phase 4|10500|Actual|Beijing Center for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 01:51:22.821395|2017-10-11 01:51:22.821395
NCT01821898|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-08-01|||March 2013||2013-03-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Eosinophilic Esophagitis Clinical Therapy Comparison Trial|Eosinophilic Esophagitis Clinical Therapy Comparison Trial|Recruiting||Phase 2|60|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 01:51:22.946475|2017-10-11 01:51:22.946475
NCT01821885|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-01-26|||April 2012||2012-04-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2013|Actual|2013-12-01||Interventional|ESPIMOAT||Effectiveness of Spirometry as a Motivational Tool to Quit Smoking|Effectiveness of Spirometry and the Report of Spirometric Test Results by a Primary Care Physician on Smoking Cessation Rate in Adult Smokers: a Randomized Controlled Trial.|Completed||N/A|335|Actual|Basque Health Service||2|||f||||||||||||||2017-10-11 01:51:23.052417|2017-10-11 01:51:23.052417
NCT01821872|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-04-02|||May 2011||2011-05-01|April 2013|2013-04-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Paracetamol CSF Pharmacokinetics Study|A Single Centre Prospective Randomised Study to Investigate the Cerebrospinal Fluid (CSF) Pharmacokinetics of Intravenous Paracetamol in Humans|Completed||Phase 4|30|Actual|Barts & The London NHS Trust||3|||f||||t||||||||||2017-10-11 01:51:23.132937|2017-10-11 01:51:23.132937
NCT01821859|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-07-18|2013-04-01||January 2010||2010-01-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Abraxane/Bevacizumab|A Phase II Evaluation of Abraxane Plus Bevacizumab for the Treatment of Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Terminated||Phase 2|5|Actual|OHSU Knight Cancer Institute||1||Terminated due to low enrollment|f||||t||||||||||2017-10-11 01:51:23.224408|2017-10-11 01:51:23.224408
NCT01821846|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-08-18|||November 20, 2013|Actual|2013-11-20|August 2017|2017-08-01|March 8, 2017|Actual|2017-03-08|March 8, 2017|Actual|2017-03-08||Observational|||Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus|A 6-month, Multi-centre, Open Labelled, Non-randomized, Non-interventional, Safety Study of Liraglutide (Victoza®) in Subjects With Type 2 Diabetes Mellitus in Korea|Completed||N/A|64|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 01:51:23.367776|2017-10-11 01:51:23.367776
NCT01821833|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-09-15|||February 2013||2013-02-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel|A Pilot Randomized, Placebo Controlled, Double Blind Study of Omega-3 Fatty Acids to Prevent Paclitaxel Associated Acute Pain Syndrome|Recruiting||N/A|60|Anticipated|New Mexico Cancer Care Alliance||2|||f||||t||||||||||2017-10-11 01:51:23.464732|2017-10-11 01:51:23.464732
NCT01821820|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-01-30|||March 2013||2013-03-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Pistachios, Performance, Metabolomics|Influence of Pistachios on Performance and Exercise-induced Inflammation, Oxidative Stress, and Immune Dysfunction in Athletes: a Metabolomics-based Approach.|Completed||N/A|40|Actual|Appalachian State University||2|||f||||f||||||||||2017-10-11 01:51:23.593281|2017-10-11 01:51:23.593281
NCT01821807|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2014-01-17|2013-08-05||June 2013||2013-06-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Comparison of Two Spinal Needles Regarding Postdural Puncture Headache|Postdural Puncture Headache After Spinal Anesthesia for Cesarean Section, Two Different Needles.|Completed||N/A|256|Actual|Adiyaman University Research Hospital|We have planned to enroll 150 patients in the Atraucan group, but the circumstances forced us to finish the recruitment at 110.||2||f||||f||||||||||2017-10-11 01:51:23.868174|2017-10-11 01:51:23.868174
NCT01821781|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-11-01|||March 2013||2013-03-01|November 2016|2016-11-01||||March 2017|Anticipated|2017-03-01||Interventional|||Immune Disorder HSCT Protocol|A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Immune Function Disorders Using a Reduced Intensity Preparatory Regime|Recruiting||Phase 2|20|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 01:51:24.186699|2017-10-11 01:51:24.186699
NCT01821768|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-02-22|||April 4, 2013|Actual|2013-04-04|February 2017|2017-02-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2020|Anticipated|2020-07-31||Interventional|||Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy|A Prospective Randomized Trial of Sentinel Lymph Node Biopsy Versus no Additional Staging in Patients With Clinical T1-T2 N0 M0 Invasive Breast Cancer and Negative Axillary Ultrasound|Recruiting||N/A|460|Anticipated|Washington University School of Medicine||2|||f||||t|f|f||||||No||2017-10-11 01:51:24.307474|2017-10-11 01:51:24.307474
NCT01821755|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-04-04|||January 2011||2011-01-01|April 2013|2013-04-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|PVO||Effectiveness of a Foster Parent Intervention: Results of a Trial|Development, Implementation and Evaluation of a Foster Parent Intervention|Unknown status|Active, not recruiting|N/A|63|Actual|Vrije Universiteit Brussel||2|||f||||f||||||||||2017-10-11 01:51:24.430872|2017-10-11 01:51:24.430872
NCT01821742|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-01-13|||March 2013||2013-03-01|March 2013|2013-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|ECHOKIDS||Echocardiography in Kids Intensive Care Decision Support|Echocardiography in Kids Intensive Care Decision Support - is Focused Echocardiography Superior to Pressure Derived Measurements at Predicting Fluid Responsiveness in Critically Ill Children?|Completed||N/A|25|Actual|Imperial College London|||1||f||||f||||||||||2017-10-11 01:51:24.515813|2017-10-11 01:51:24.515813
NCT01821729|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-07-24|||July 2013||2013-07-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer|Phase II Feasibility Study of FOLFIRINOX-Losartan Followed by Accelerated Short Course Radiation Therapy With Capecitabine for Locally Advanced Pancreatic Cancer|Recruiting||Phase 2|50|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:51:24.622752|2017-10-11 01:51:24.622752
NCT01821716|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2014-05-22|||March 2013||2013-03-01|March 2013|2013-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract|Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract to Determine the Biological Activity in HEP Units.|Completed||Phase 2|42|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 01:51:24.754386|2017-10-11 01:51:24.754386
NCT01821703|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-10-09|||May 2013||2013-05-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants|A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3045697 After Multiple Oral Dosing in Healthy Subjects|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 01:51:24.860269|2017-10-11 01:51:24.860269
NCT01821690|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-10-05|||May 2013||2013-05-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression|Brain Research in Aggression and Irritability Network (BRAIN): Building Evidence-Based Approaches to Managing Traumatic Brain Injury|Recruiting||N/A|74|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 01:51:24.958921|2017-10-11 01:51:24.958921
NCT01821677|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-05-04|||February 2013||2013-02-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema|A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina in Adult Patients With Diabetic Macular Edema|Completed||Phase 3|355|Actual|Ampio Pharmaceuticals. Inc.||2|||f||||t||||||||||2017-10-11 01:51:25.157005|2017-10-11 01:51:25.157005
NCT01821664|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-05-05|||May 2013||2013-05-01|May 2015|2015-05-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01|10 Years|Observational [Patient Registry]|VASGRA||Vascular Graft Infections|Vascular Graft Infections - Epidemiology, Best Treatment Options, Imaging Modalities and Impact of Negative Pressure Wound Therapy|Recruiting||N/A|1800|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 01:51:25.227964|2017-10-11 01:51:25.227964
NCT01821651|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-06-18|||January 2012||2012-01-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Use of Standardized Diagnostic Imaging Data for Image Fusion in the Hybrid Operating Room|Use of Standardized Diagnostic Imaging Data (Computertomography, Angiography, Echocardiography) for Image Fusion in the Hybrid Operating Room|Unknown status|Recruiting|N/A|140|Anticipated|University of Zurich||4|||f||||t||||||||||2017-10-11 01:51:25.355495|2017-10-11 01:51:25.355495
NCT01821638|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-06-21|||April 2013||2013-04-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Brain Alterations and Cognitive Impairment in Older Adults With Heart Failure|Brain Alterations and Cognitive Impairment in Older Adults With Heart Failure|Active, not recruiting||N/A|40|Actual|University of Wisconsin, Madison|||1||f||||f||||||||No||2017-10-11 01:51:25.449381|2017-10-11 01:51:25.449381
NCT01821625|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2013-08-15|||April 2013||2013-04-01|March 2013|2013-03-01||||April 2016|Anticipated|2016-04-01||Interventional|SQUELCH-C||Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C|Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 01:51:25.521891|2017-10-11 01:51:25.521891
NCT01821612|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-06-26|||May 2013||2013-05-01|June 2017|2017-06-01||||July 2020|Anticipated|2020-07-01||Interventional|||Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer|Neoadjuvant FOLFIRINOX and Chemoradiation Followed by Definitive Surgery and Postoperative Gemcitabine for Patients With Borderline Resectable Pancreatic Adenocarcinoma: An Intergroup Single-Arm Pilot Study|Active, not recruiting||N/A|20|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 01:51:25.613317|2017-10-11 01:51:25.613317
NCT01821599|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-04-12|||January 2013||2013-01-01|December 2014|2014-12-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Comparative Study Between Two Physiotherapy Protocols Conventional X Accelerated in Individuals Undergoing Reconstruction of the Anterior Cruciate Ligament.|Comparative Study Between Two Physiotherapy Protocols Conventional X Accelerated in Individuals Undergoing Reconstruction of the Anterior Cruciate Ligament.|Completed||N/A|29|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:51:25.747728|2017-10-11 01:51:25.747728
NCT01821586|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-12-19|||April 2006||2006-04-01|January 2006|2006-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Modified ORS Solution for Severely Malnourished Children|Optimisation of Oral Rehydration Solution and Evaluation of the Efficacy of Benefiber(Partially Hydrolyzed Guar Gum) Containing Modified Oral Rehydration Solution in the Treatment of Severely Malnourished Children With Watery Diarrhoea|Completed||Phase 2|189|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||t||||||||||2017-10-11 01:51:25.823813|2017-10-11 01:51:25.823813
NCT01821560|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-08-15|||March 2013||2013-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|BAC||Baclofen Effects in Cigarette Smokers|Baclofen Effects on Brain and Behavior in Cigarette Smokers|Completed||Phase 2|56|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:51:27.640582|2017-10-11 01:51:27.640582
NCT01821547|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-06-23|||March 2013||2013-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|April 2014|Actual|2014-04-01||Interventional|||New Methods to Measure the Immune Response to Hepatitis B Vaccine|Hepatitis B Immunisation: A Two-part Study Investigating Antigen Specific B Cell Receptors|Completed||Phase 4|21|Actual|University of Oxford||1|||f||||f||||||||||2017-10-11 01:51:27.716595|2017-10-11 01:51:27.716595
NCT01821534|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2014-03-28|2014-03-28||March 2013||2013-03-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification||Completed||N/A|201|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:51:27.799254|2017-10-11 01:51:27.799254
NCT01821521|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-29|||June 2013||2013-06-01|March 2013|2013-03-01||||August 2013|Anticipated|2013-08-01||Interventional|S-Pantoprazole||Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects|A Randomized, Open Label, Single-dose, 2x2 Crossover Study to Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects|Unknown status|Not yet recruiting|Phase 1|44|Anticipated|Ahn-Gook Pharmaceuticals Co.,Ltd||2|||f||||f||||||||||2017-10-11 01:51:27.973257|2017-10-11 01:51:27.973257
NCT01821508|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-06-10|||March 2013||2013-03-01|June 2016|2016-06-01|March 2021|Anticipated|2021-03-01|March 2017|Anticipated|2017-03-01||Interventional|MOMS||Clinical Study on Metabolic Surgery Compared to the Best Clinical Treatment in Patients With Type 2 Diabetes Mellitus|Prospective, Open,Randomized, Unicenter Study Comparing Roux-en-Y Gastric Bypass With the Best Clinical Treatment Regarding Improvement of Microvascular Complications of Type 2 Diabetes Mellitus in Obese Patients.|Active, not recruiting||N/A|100|Actual|Hospital Alemão Oswaldo Cruz||2|||f||||t||||||||||2017-10-11 01:51:28.059597|2017-10-11 01:51:28.059597
NCT01821495|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-04-11|||May 2013||2013-05-01|April 2013|2013-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Study of DC-CIK to Treat NPC|A Randomized Controlled Study of Dendritic and Cytokine-induced Killer Cells (DC-CIK) Treatment in Patients With Staging Ⅱ-Ⅲ of Nasopharyngeal Carcinoma|Not yet recruiting||Phase 2|100|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-11 01:51:28.153234|2017-10-11 01:51:28.153234
NCT01821482|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-04-11|||May 2013||2013-05-01|April 2013|2013-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of DC-CIK to Treat Hepatocellular Carcinoma|A Randomized Controlled Study of Dendritic and Cytokine-induced Killer Cells (DC-CIK) Treatment in Patients With Hepatocellular Carcinoma|Not yet recruiting||Phase 2|100|Anticipated|Guangxi Medical University||2|||f||||t||||||||||2017-10-11 01:51:28.230857|2017-10-11 01:51:28.230857
NCT01821469|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-01-27|||May 2011||2011-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|BIP-ED||Functional Correlates of Bipolar Disorders and Effects of the Psychoeducation. an fMRI Study|Functional Correlates of Bipolar Disorders and Effects of the Psychoeducation. Assessment by Functional and Anatomic Neuroimaging.|Completed||N/A|45|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 01:51:28.318165|2017-10-11 01:51:28.318165
NCT01821456|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-26|||January 1995||1995-01-01|March 2013|2013-03-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|CoCoNut||Cologne Cohort of Neutropenic Patients (CoCoNut)|The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections|Recruiting||N/A|100000|Anticipated|University Hospital of Cologne|||1||f||||t||||||||||2017-10-11 01:51:28.511215|2017-10-11 01:51:28.511215
NCT01821443|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2014-09-15|||December 2012||2012-12-01|September 2014|2014-09-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)|A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed Primarily With Stereotactic Radiosurgery (SRS)|Recruiting||N/A|45|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 01:51:28.633809|2017-10-11 01:51:28.633809
NCT01821430|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-02-07|||March 2013|Actual|2013-03-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Increased Sensitivity to Pain Caused by Opioids in People Who Have Abused Prescription Opioids|Opioid-Induced Hyperalgesia in Prescription Opioid Abusers: Effects of Pregabalin|Terminated||Phase 2|4|Actual|Georgetown University||2||poor recruitment|f||||f|f|f||||||Undecided||2017-10-11 01:51:28.755868|2017-10-11 01:51:28.755868
NCT01821417|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-01-26|2015-07-29||May 2011||2011-05-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|June 2014|Actual|2014-06-01||Interventional|||Performance of MicroTextured Dental Implants|A Randomized Clinical Trial to Assess the Performance of MicroTextured Dental Implants With or Without a Machined Collar|Completed||N/A|68|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 01:51:28.903924|2017-10-11 01:51:28.903924
NCT01821404|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-11-29|||August 2012||2012-08-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|ESTO1||Atorvastatin Before Prostatectomy and Prostate Cancer|The Impact of Atorvastatin on Prostate Cancer - a Randomized, Pre-surgical Clinical Trial|Active, not recruiting||Phase 2|160|Actual|Tampere University Hospital||2|||f||||t||||||||||2017-10-11 01:51:29.373898|2017-10-11 01:51:29.373898
NCT01821391|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2014-09-11|||July 2013||2013-07-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|COMET2||Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses|Multi-centre, Randomized, Investigator-blind, Intra-individual Active and Vehicle-controlled Study, Comparing Metvix Natural Daylight Photodynamic Therapy Versus Metvix Conventional Photodynamic Therapy in Subjects With Actinic Keratosis|Completed||Phase 3|131|Actual|Galderma||2|||f||||f||||||||||2017-10-11 01:51:29.515|2017-10-11 01:51:29.515
NCT01821378|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-07-19|2015-06-05||May 2013||2013-05-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Safety population: subjects randomized and took at least one dose of study medication (there was one subject was randomized but did not take study medication).|Lurasidone Low-Dose - High-Dose Study Study|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Low-dose Lurasidone in Acutely Psychotic Subjects With Schizophrenia|Completed||Phase 3|412|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 01:51:29.68572|2017-10-11 01:51:29.68572
NCT01821365|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2013-04-04|||March 2013||2013-03-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01|2 Days|Observational [Patient Registry]|||End Tidal Carbon Dioxide Monitoring for Evaluating Changes of PaCO2 After Noninvasive Mechanical Ventilation in COPD|End Tidal Carbon Dioxide Monitoring for Evaluating Changes of Arterial Carbon Dioxide After Noninvasive Mechanical Ventilation in Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|40|Anticipated|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||t||||||||||2017-10-11 01:51:31.12564|2017-10-11 01:51:31.12564
NCT01821352|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-11-07|2015-07-10||March 2013||2013-03-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals|A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia Obesity Laser on the Reduction of Circumference of the Hips, Waist and Upper Abdomen for Individuals With a Body Mass Index (BMI) of 30 to 40 kg/m2|Completed||N/A|53|Actual|Erchonia Corporation||2|||f||||f||||||||||2017-10-11 01:51:31.228361|2017-10-11 01:51:31.228361
NCT01821339|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2016-07-26|||March 2013||2013-03-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Observational|||Pelvic Ring Injury|Does Residual Displacement On Standard Radiographic Views Correlate With Pelvic Ring Injury Clinical Outcome?|Completed||N/A|40|Actual|Duke University|||1||f||||t||||||||||2017-10-11 01:51:31.681941|2017-10-11 01:51:31.681941
NCT01821326|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2016-11-30|2013-11-20||June 2002||2002-06-01|November 2016|2016-11-01||||January 2013|Actual|2013-01-01||Observational|||Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding|Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding|Completed||N/A|339|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||||||||||||2017-10-11 01:51:31.760301|2017-10-11 01:51:31.760301
NCT01821313|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2015-04-23|||September 2012||2012-09-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|CASH||CASH- Children Active to Stay Healthy|Effects of High Intensity Interval Exercise on Inflammation and Endothelial Function in Children & Adolescents With Obesity|Completed||N/A|43|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 01:51:31.926815|2017-10-11 01:51:31.926815
NCT01821300|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-27|2017-08-09|||February 2013||2013-02-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Down Syndrome Metabolic Health Study|Cardiometabolic Risk and Obesity in Adolescents With Down Syndrome|Recruiting||N/A|250|Anticipated|Children's Hospital of Philadelphia|||2||f||||f||||||Samples Without DNA|"     Blood serum will be retained.   "|||2017-10-11 01:51:32.047607|2017-10-11 01:51:32.047607
NCT01821287|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-04-11|||September 2010||2010-09-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease|Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease|Completed||N/A|75|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 01:51:32.184784|2017-10-11 01:51:32.184784
NCT01821196|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-05-15|||December 2012||2012-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2013|Actual|2013-12-01||Interventional|||Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma|Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma|Active, not recruiting||N/A|15|Actual|St. Olavs Hospital||1|||f||||f|f|f||||||||2017-10-11 01:51:33.69282|2017-10-11 01:51:33.69282
NCT01820325|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-11-14|||September 2013||2013-09-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|BASALT-2||Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer|A Dose-finding Phase Ib Study Followed by a Randomized, Double-blind Phase II Study of Carboplatin and Paclitaxel With or Without Buparlisib in Patients With Previously Untreated Metastatic Non-small Cell Lung Cancer (NSCLC) of Squamous Histology|Terminated||Phase 1/Phase 2|6|Actual|Novartis||2||Due to DLTs/AEs safety profile considered challenging; required dose reductions/interruptions.|f||||t||||||||||2017-10-11 01:51:32.373822|2017-10-11 01:51:32.373822
NCT01820312|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-08-05|||January 2013||2013-01-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)|A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT) and Chemotherapy in Recurrent and Inoperable Squamous Cell Carcinoma (SCC) of the Head and Neck After Radiotherapy Failure|Withdrawn||Phase 2|0|Actual|University of Arkansas||1||Due to no enrollment.|f||||f||||||||No||2017-10-11 01:51:32.505672|2017-10-11 01:51:32.505672
NCT01820299|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-01-30|||March 2013||2013-03-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer|Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer|Completed||Phase 1|22|Actual|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 01:51:32.578985|2017-10-11 01:51:32.578985
NCT01820286|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-09-01|||March 2013||2013-03-01|September 2017|2017-09-01|June 10, 2016|Actual|2016-06-10|June 10, 2016|Actual|2016-06-10||Interventional|PPBPAD||Positive Psychology for Mood Disorders|Trial of a Positive Psychology Intervention to Reduce Suicide Risk in Patients With Mood Disorders|Completed||N/A|25|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:51:32.656531|2017-10-11 01:51:32.656531
NCT01820273|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-09-23|||April 2013||2013-04-01|September 2013|2013-09-01|August 2014|Anticipated|2014-08-01|April 2014|Anticipated|2014-04-01||Observational|||Changes in Incretine Response and Glycemic Control After Gastric Bypass Surgery in Type 2 Diabetic Patients Versus Healthy|Study of Incretine Response and Glycemic Control: Pre Diet, After Conventional Weight Loss and in the Early Postoperative Phase After Gastric Bypass in T2D-patients.|Unknown status|Recruiting|N/A|20|Anticipated|Lund University|||1||f||||f||||||Samples Without DNA|"     Bloodsamples   "|||2017-10-11 01:51:32.729313|2017-10-11 01:51:32.729313
NCT01820260|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-07-02||2015-07-02|April 2013||2013-04-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis|Safety and Efficacy of Escalating Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days When Used on Full Face, Full Balding Scalp or Approximately 250 cm2 on the Chest in Subjects With Actinic Keratosis|Completed||Phase 1/Phase 2|315|Actual|LEO Pharma||7|||f||||f||||||||||2017-10-11 01:51:32.800413|2017-10-11 01:51:32.800413
NCT01820247|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-27|||December 2012||2012-12-01|March 2013|2013-03-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission|Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission|Unknown status|Recruiting|N/A|100|Anticipated|Jinling Hospital, China||3|||f||||f||||||||||2017-10-11 01:51:32.890517|2017-10-11 01:51:32.890517
NCT01820234|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-04|2017-07-17|||September 2010||2010-09-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event|Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event|Completed||N/A|170|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 01:51:32.97765|2017-10-11 01:51:32.97765
NCT01820221|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-02-02|||March 2013||2013-03-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Sutures vs. Staples Skin Closure After C-section in Obese Patients|Staples Compared With Subcuticular Suture for Skin Closure After Cesarean Delivery in Obese Patients|Terminated||N/A|148|Actual|University of Arkansas||2||Low enrollment and Pi had no time.|f||||f||||||||||2017-10-11 01:51:33.07085|2017-10-11 01:51:33.07085
NCT01821261|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2015-04-09|||April 2014||2014-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:51:33.148089|2017-10-11 01:51:33.148089
NCT01821235|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2014-01-28|||April 2013||2013-04-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|DRUG13-GABA||Evaluation of Individual Bioequivalence of Gabasandoz® Relative to Neurontin® in Healthy Volunteers|A Single Centre, Single-blind, Randomized, Two-part, 6-way Cross-over Study to Investigate the Individual Bioequivalence of Gabasandoz® Relative to Neurontin® in Healthy Volunteers.|Completed||Phase 1|51|Actual|University Hospital, Ghent||4|||f||||f||||||||||2017-10-11 01:51:33.389719|2017-10-11 01:51:33.389719
NCT01821222|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-03-28|||February 2009||2009-02-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Wired Mothers - Use of Mobile Phones to Improve Maternal and Neonatal Health in Zanzibar|Mobile Phones as a Health Communication Tool to Improve Maternal and Neonatal Health in Zanzibar|Completed||N/A|2550|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 01:51:33.490005|2017-10-11 01:51:33.490005
NCT01821209|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-05-26|||April 2013||2013-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Sling||A Study of Intra-operative Autologous Retropubic Urethral Sling on Urinary Control After Robot Assisted Radical Prostatectomy|A Randomized Study of Intra-operative Autologous Retropubic Urethral Sling on Urinary Control After Robot Assisted Radical Prostatectomy|Completed||N/A|203|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:51:33.583049|2017-10-11 01:51:33.583049
NCT01821183|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-08-05|||April 2013||2013-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Strength and Strength-ratio of Hip Rotator Muscles at Soccer Players|Strength and Strength-ratio of Hip Rotator Muscles at Soccer Players Compared to Non-soccer Players|Completed||N/A|30|Actual|University Hospital, Basel, Switzerland|||2||f||||t||||||||||2017-10-11 01:51:33.774316|2017-10-11 01:51:33.774316
NCT01821170|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-01-12|||April 2013||2013-04-01|January 2015|2015-01-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|RECOGNITA||Cognitive Remediation in ADHD Children : Comparison Between Three Therapeutic Strategies : Cognitive Remediation With a Virtual Classroom Software and Methylphenidate and Supportive Psychotherapy||Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Bordeaux||3|||f||||f||||||||||2017-10-11 01:51:33.845309|2017-10-11 01:51:33.845309
NCT01821157|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-03-29|||January 2011||2011-01-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Flapless Esthetic Crown Lengthening for the Treatment of Excessive Gingival Display|Open-flap Versus Flapless Esthetic Crown Lengthening: 12-month Clinical Outcomes of a Randomized Controlled Clinical Trial|Completed||N/A|28|Actual|University of Guarulhos||2|||f||||t||||||||||2017-10-11 01:51:33.970247|2017-10-11 01:51:33.970247
NCT01821144|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-03-26|||March 2013||2013-03-01|March 2013|2013-03-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|School-EduSalt||A School-based Education Programme to Reduce Salt Intake in Children and Their Families|A School-based Education Programme to Reduce Salt Intake in Children and Their Families (School-EduSalt)|Unknown status|Recruiting|N/A|840|Anticipated|Queen Mary University of London||2|||f||||f||||||||||2017-10-11 01:51:34.064973|2017-10-11 01:51:34.064973
NCT01821131|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-10-02|||January 2014||2014-01-01|October 2017|2017-10-01|March 2018|Anticipated|2018-03-01|November 2015|Actual|2015-11-01||Interventional|||Flax Muffins and Cholesterol Lowering|A Dose Response, Randomized, Controlled, Double-blind, Cross-over Trial to Determine the LDL Cholesterol Lowering Effect of Ground Flaxseed in Adults With Above Optimal Plasma LDL Concentrations|Active, not recruiting||N/A|76|Anticipated|St. Boniface General Hospital Research Centre||3|||f||||f||||||||||2017-10-11 01:51:34.153003|2017-10-11 01:51:34.153003
NCT01821118|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-04-03|2016-09-14||June 2013||2013-06-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All participants assigned to study treatment were included in the baseline analysis population.|Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy|A Phase 2, Randomized, Double Blind Placebo Controlled Trial To Evaluate The Safety, Tolerability, Pharmacokinetics And Efficacy Of Pf-04360365 (Ponezumab) In Adult Subjects With Probable Cerebral Amyloid Angiopathy|Completed||Phase 2|36|Actual|Pfizer||2|||f||||f|t|f||||||||2017-10-11 01:51:34.341272|2017-10-11 01:51:34.341272
NCT01821105|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2016-02-03|2015-11-23||March 2004||2004-03-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer|A 2 Phase Comparison of Pre-operative CT AND PET Images in the Intraoperative Detection of Disease to a Hand-held Probe, and to an Intraoperative CT Scan in Patients Undergoing Surgery for Metastatic Colorectal Cancer.|Completed||Phase 2|21|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:51:35.460453|2017-10-11 01:51:35.460453
NCT01821092|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-09-01|||March 2013||2013-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|October 2014|Actual|2014-10-01||Interventional|||Dimensional Changes of Peri-implant Facial Bone|Horizontal and Vertical Dimensional Changes of Peri-implant Facial Bone Following Placement of T3 Implants: a 1-year Cone Beam Computed Tomography Study|Completed||Phase 4|40|Actual|Proed||2|||f||||f||||||||No||2017-10-11 01:51:35.737015|2017-10-11 01:51:35.737015
NCT01821079|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-05-20|||March 2013||2013-03-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation|A Phase 1, Single-Dose, Open-Label, Crossover Study To Assess The Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation Of Pf-05175157 And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation In Healthy Volunteers|Completed||Phase 1|12|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 01:51:35.830606|2017-10-11 01:51:35.830606
NCT01821066|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-10-06|||April 2013||2013-04-01|October 2015|2015-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers|A Phase 1 Open-Label Fixed-Sequence Two-Period Crossover Study Of The Effect Of Multiple Doses Of Tamoxifen On PD-0332991 Pharmacokinetics In Healthy Male Volunteers|Completed||Phase 1|25|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:51:35.918673|2017-10-11 01:51:35.918673
NCT01821053|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-10-15|||June 2013||2013-06-01|October 2014|2014-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|||Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus|Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus|Completed||N/A|85|Actual|Odense University Hospital|||1||f||||t||||||Samples With DNA|"     whole blood serum plasma urine   "|||2017-10-11 01:51:36.019136|2017-10-11 01:51:36.019136
NCT01821040|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-04-09|||March 2013||2013-03-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR|A Randomised, Multi-centre, Double-blind, Active-controlled, Parallel Group Study to Assess the Efficacy and Safety of Modified Release Prednisone (Lodotra®) Compared to Immediate Release Prednisone (Prednisone IR) in Subjects Suffering From Polymyalgia Rheumatica (PMR).|Terminated||Phase 3|62|Actual|Mundipharma Research Limited||2|||f||||f||||||||||2017-10-11 01:51:36.100519|2017-10-11 01:51:36.100519
NCT01821027|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-03-26|||August 2008||2008-08-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Simvastatin in Healthy Volunteers|A Open-Label, Single Sequence Study to Assess the Pharmacokinetics and Pharmacodynamics of Simvastatin Alone and of Simvastatin in Combination With JNJ-28431754 in Healthy Adult Subjects|Completed||Phase 1|22|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 01:51:36.186676|2017-10-11 01:51:36.186676
NCT01821014|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2014-05-08|||February 2013||2013-02-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Satellite-supplementation of Medical Outreach Clinics: a Feasibility Study|Satellite-supplementation of Medical Outreach Clinics: a Feasibility Study|Completed||N/A|144|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 01:51:36.266069|2017-10-11 01:51:36.266069
NCT01821001|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-03-23|||March 2013||2013-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Vaginal Bromocriptine for Treatment of Adenomyosis|Vaginal Bromocriptine for the Treatment of Adenomyosis|Active, not recruiting||Phase 1|33|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:51:36.369984|2017-10-11 01:51:36.369984
NCT01820988|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-01-18|||May 2013||2013-05-01|April 2015|2015-04-01|December 2015|Actual|2015-12-01|March 2014|Actual|2014-03-01||Observational|MaSS||MaSS - Maastricht Sarcopenia Study|Cross-sectional Study on the Identification and Characterization of Community-dwelling Older People With Sarcopenia|Completed||N/A|247|Actual|Maastricht University Medical Center|||1||f||||f||||||Samples With DNA|"     Blood sample.   "|||2017-10-11 01:51:36.462416|2017-10-11 01:51:36.462416
NCT01820975|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-03-21|||April 2013||2013-04-01|May 2015|2015-05-01|February 1, 2017|Actual|2017-02-01|March 2015|Actual|2015-03-01||Interventional|PRO-ADAPT||Manipulation of Dietary Protein and the Anabolic Response|The Manipulation of Dietary Protein Intake on the Anabolic Response in Healthy Young Men|Completed||N/A|28|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 01:51:36.537015|2017-10-11 01:51:36.537015
NCT01820962|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-26|||July 2006||2006-07-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|December 2010|Actual|2010-12-01||Interventional|||Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients|Concentrated Citrate Locking to Reduce the Incidence of Central Venous Catheter-related Infections and Thrombosis: a Randomized Phase III Study in a Hematological Patient Population|Terminated||Phase 3|212|Actual|Maastricht University Medical Center||2||Because the inclusion rate was lower than expected.|f||||f||||||||||2017-10-11 01:51:36.602896|2017-10-11 01:51:36.602896
NCT01820949|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-09-04|||January 2013||2013-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Observational|PBM||Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients|Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients|Completed||N/A|110000|Actual|Johann Wolfgang Goethe University Hospital|||2||f||||t||||||||||2017-10-11 01:51:36.709553|2017-10-11 01:51:36.709553
NCT01820936|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-07-14|||March 2013||2013-03-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765|Open-Label, Randomized, 4-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765|Completed||Phase 1|52|Actual|Janssen Research & Development, LLC||5|||f||||f||||||||||2017-10-11 01:51:36.938822|2017-10-11 01:51:36.938822
NCT01820923|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-03-24|||July 2011||2011-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Transcranial Brain Stimulation in Vegetative State Patients|Study on the Use of Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation to Promote Diagnosis, Prognosis and Innovative Rehabilitation in Patients in Vegetative and Minimally Conscious State.|Completed||N/A|40|Actual|IRCCS San Camillo, Venezia, Italy||1|||f||||t||||||||||2017-10-11 01:51:37.094117|2017-10-11 01:51:37.094117
NCT01820910|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-08-22|||March 2013||2013-03-01|July 2017|2017-07-01|September 2023|Anticipated|2023-09-01|May 2016|Actual|2016-05-01||Interventional|||Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment|International Prospective Phase 2 Trial Addressing the Efficacy of First-line Chlamydophila Psittaci-eradicating Therapy With Protracted Administration of Doxycycline Followed by Eradication Monitoring and Antibiotic Re-treatment at Infection Re-occurrence in Patients With Newly Diagnosed Ocular Adnexal Marginal Zone Lymphoma (OAMZL)|Active, not recruiting||Phase 2|34|Actual|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||||||||||||2017-10-11 01:51:37.181862|2017-10-11 01:51:37.181862
NCT01820897|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-03-25|||April 2013||2013-04-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation|Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation. Randomized Controlled Trial.|Completed||Phase 4|130|Anticipated|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-11 01:51:37.297897|2017-10-11 01:51:37.297897
NCT01820871|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-11-26|||November 2012||2012-11-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Self-Management Using Smartphone Application for Type2 DM in Real siTuation (SMART-DM)|A Pilot Study of Self Management Using Application for Chronic Disease Care in Real siTuation (SMART) - DM|Completed||N/A|60|Actual|Inje University||2|||f||||f||||||||||2017-10-11 01:51:37.520131|2017-10-11 01:51:37.520131
NCT01820845|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-12-03|||December 2012||2012-12-01|December 2012|2012-12-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|PVI||Accuracy of Pleth Variability Index (PVI) in Children|Accuracy of Pleth Variability Index (PVI) in Predicting Response to Intravenous Fluid Load During Scoliosis Surgery in Children|Completed||N/A|50|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 01:51:37.768738|2017-10-11 01:51:37.768738
NCT01820832|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-28|||March 2013||2013-03-01|March 2013|2013-03-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD|Phase 4 Study of Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-11 01:51:37.872289|2017-10-11 01:51:37.872289
NCT01820819|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-12-15|||September 2012||2012-09-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|TRANSALC||Is Access to Liver Transplantation Similar in Alcoholic or Not Patients?|Is Access to Liver Transplantation Similar in Alcoholic or Not Patients? A Prospective Cohort Study|Active, not recruiting||N/A|115|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 01:51:37.972829|2017-10-11 01:51:37.972829
NCT01820806|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-05-05|||March 2013||2013-03-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects|Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects Following a Single Oral Administration of [14C] GLPG0634|Completed||Phase 1|6|Actual|Galapagos NV||1|||f||||f||||||||||2017-10-11 01:51:38.065117|2017-10-11 01:51:38.065117
NCT01820793|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-12-12|||May 2013||2013-05-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|FOXICOLI||Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli|Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli.|Terminated||N/A|40|Anticipated|Assistance Publique - Hôpitaux de Paris||1||Not enought inclusion|f||||t||||||||||2017-10-11 01:51:38.148869|2017-10-11 01:51:38.148869
NCT01820780|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-08-28|||June 10, 2013|Actual|2013-06-10|August 2017|2017-08-01|June 10, 2019|Anticipated|2019-06-10|December 10, 2018|Anticipated|2018-12-10||Interventional|ECAD-HF||Early Care After Discharge of HF Patients|Usefulness of a Short-time But Very Early Specialized Follow-up After Hospitalization for Acute Heart Failure: a Randomized Controlled Trial.|Recruiting||N/A|534|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:51:38.246643|2017-10-11 01:51:38.246643
NCT01820767|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2014-09-08|||August 2012||2012-08-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|SENPARIC||Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients|Paricalcitol Action on Parameters of Inflammation and Oxidative Stress in Patients With Chronic Kidney Disease Stage Vd Carriers Tunneled Hemodialysis Catheters|Completed||Phase 3|31|Actual|Hospital El Bierzo||3|||f||||f||||||||||2017-10-11 01:51:38.362656|2017-10-11 01:51:38.362656
NCT01820754|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-12-30|||March 2013||2013-03-01|September 2016|2016-09-01|March 2021|Anticipated|2021-03-01|March 2018|Anticipated|2018-03-01||Interventional|TOP1201 IPI||Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)|Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes With Specificities Against Tumor Associated Antigens During and After Neoadjuvant Chemotherapy and Phased Ipilimumab in Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|30|Anticipated|Duke University||1|||f||||t||||||||||2017-10-11 01:51:38.501743|2017-10-11 01:51:38.501743
NCT01820741|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-03-28|||March 2013||2013-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:51:38.60259|2017-10-11 01:51:38.60259
NCT01820728|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-26|||January 2007||2007-01-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®|A Phase III Clinical Study for the Comparison Evaluation of DA-3801 and Gonal-F® in Infertile Female Patients With Chronic Anovulation Syndrome|Completed||Phase 3|93|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:51:38.652467|2017-10-11 01:51:38.652467
NCT01820715|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2013-08-12|||June 2010||2010-06-01|August 2013|2013-08-01||||April 2013|Actual|2013-04-01||Interventional|||A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain|A Phase I Study of the DA-3030 Injection to Evaluate Its Safety and Explore the Efficacy for Diabetic Neuropathic Pain|Completed||Phase 1|31|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:51:38.739719|2017-10-11 01:51:38.739719
NCT01820702|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-03-26|||November 2010||2010-11-01|March 2013|2013-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|SAG||Short Term Bed Rest Study: Evaluation of the Use of Artificial Gravity, Induced by Short-arm Centrifugation|Short Term Bed Rest Study: Evaluation of the Use of Artificial Gravity, Induced by Short-arm Centrifugation or the Appliance of Definite Combined Training Program to Counteract Effects of Bed Rest (Acronym: SAG Study)|Completed||N/A|10|Actual|DLR German Aerospace Center||2|||f||||||||||||||2017-10-11 01:51:38.819849|2017-10-11 01:51:38.819849
NCT01820689|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-26|||January 2012||2012-01-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Tympanometric Analysis in Cleft Palate|Tympanometric Analysis in Post Surgical Individuals With Cleft Palate|Completed||N/A|16|Actual|Centro de Diagnostico Auditivo de Cuiaba||1|||f||||t||||||||||2017-10-11 01:51:38.901853|2017-10-11 01:51:38.901853
NCT01820676|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-07-14|||July 15, 2013|Actual|2013-07-15|July 2017|2017-07-01|July 2027|Anticipated|2027-07-01|July 1, 2017|Actual|2017-07-01||Observational|||iUni G2+ Prospective Study|A Prospective, Multi-Center Study to Evaluate the ConforMIS iUni® G2+ Unicompartmental Knee Resurfacing Device|Active, not recruiting||N/A|28|Actual|ConforMIS, Inc.|||1||f||||f||||||||||2017-10-11 01:51:38.980111|2017-10-11 01:51:38.980111
NCT01820663|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-02-22|||March 2012||2012-03-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Dietary Intervention With the Modified Atkins Diet in Stroke Rehabilitation|Dietary Intervention in Stroke Recovery in the Acute Rehabilitation Setting With the Modified Atkins Diet.|Completed||Phase 1/Phase 2|20|Actual|Burke Rehabilitation Hospital||2|||f||||f||||||||No|Individual Participant Data will not be disclosed.|2017-10-11 01:51:39.060256|2017-10-11 01:51:39.060256
NCT01820650|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-05-11|||February 2013||2013-02-01|May 2017|2017-05-01|March 2026|Anticipated|2026-03-01|March 2017|Actual|2017-03-01||Observational|||A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System|A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System|Active, not recruiting||N/A|359|Actual|ConforMIS, Inc.|||1||f||||f|f|t|f|f|t|||No||2017-10-11 01:51:39.155504|2017-10-11 01:51:39.155504
NCT01820637|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-03-08|||July 2013|Actual|2013-07-01|March 2017|2017-03-01|February 20, 2017|Actual|2017-02-20|December 2014|Actual|2014-12-01||Interventional|MAJESTIC||Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project|Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project With Boston Scientific's Innova Drug Eluting Stent|Completed||N/A|57|Actual|Boston Scientific Corporation||1|||f||||f||||||||No||2017-10-11 01:51:39.269735|2017-10-11 01:51:39.269735
NCT01820624|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2017-04-25|||April 30, 2013||2013-04-30|April 2017|2017-04-01|November 13, 2015|Actual|2015-11-13|October 9, 2015|Actual|2015-10-09||Interventional|||Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|Phase I Trial of Lithium and Tretinoin for Treatment of Non-Promyelocytic Acute Myeloid Leukemia in Patients Intolerant or Relapsed/Refractory to Standard Chemotherapy.|Completed||Phase 1|12|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:51:39.422243|2017-10-11 01:51:39.422243
NCT01820611|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-09-19|||February 2013||2013-02-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Observational|||Arcos Revision Stem: Evaluation of Clinical Performance|Arcos Revision Stem: Evaluation of Clinical Performance|Active, not recruiting||N/A|200|Anticipated|Zimmer Biomet|||2||f||||f||||||||||2017-10-11 01:51:39.538812|2017-10-11 01:51:39.538812
NCT01820598|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-01-27|||January 2013||2013-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|StimobII||Phase II Study of Neuromuscular Electrical Multisite System on Cardiovascular Effects in Severe Obese Patients|Acute and Medium-term Effects of Neuromuscular Electrical Multisite System (Kneehab®) on Cardiovascular Parameters and Induced Muscle Fatigue in Morbidly Obese Patients: Comparison With the Unidirectional Standard Device|Recruiting||N/A|30|Anticipated|AGIR à Dom||2|||f||||t||||||||||2017-10-11 01:51:39.644206|2017-10-11 01:51:39.644206
NCT01820585|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-06-18|2013-04-04||April 2009||2009-04-01|June 2013|2013-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia|Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia: a Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre Clinical Trial|Completed||Phase 2|528|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 01:51:39.766845|2017-10-11 01:51:39.766845
NCT01820572|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-09-27|||March 27, 2013|Actual|2013-03-27|September 2017|2017-09-01|January 9, 2020|Anticipated|2020-01-09|January 9, 2020|Anticipated|2020-01-09||Interventional|||A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based|Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based Immunosuppression|Active, not recruiting||Phase 3|440|Anticipated|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-11 01:51:40.491164|2017-10-11 01:51:40.491164
NCT01820559|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-04-05|2013-04-05||April 2009||2009-04-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine|Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine: a Doubleblind,Randomised, Placebo-controlled, Parallel-group, Multicentre Clinical Trial|Completed||Phase 2|452|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 01:51:40.842987|2017-10-11 01:51:40.842987
NCT01820546|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2016-01-04|||January 2013||2013-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Cancer Stem Cells in Multiple Myeloma|Flow Cytometric Definition and Prognostic Effects of Multiple Myeloma Cancer Stem Cells|Completed||N/A|96|Actual|Ankara University|||1||f||||f||||||Samples With DNA|"     Bone Marrow   "|||2017-10-11 01:51:41.403106|2017-10-11 01:51:41.403106
NCT01820533|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2014-08-21|||April 2013||2013-04-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Survey of Smokers Treated in the Emergency Department (ED) on Ownership and Usage of Cell Phones|Survey of Smokers Treated in the ED on Ownership and Usage of Cell Phones|Completed||N/A|775|Actual|Yale University|||1||f||||f||||||||||2017-10-11 01:51:41.478977|2017-10-11 01:51:41.478977
NCT01820520|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-03-27|||January 2013||2013-01-01|March 2013|2013-03-01||||September 2013|Anticipated|2013-09-01||Interventional|||Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery|Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery|Unknown status|Recruiting|Phase 3|30|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||f||||||||||2017-10-11 01:51:41.56682|2017-10-11 01:51:41.56682
NCT01820507|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2015-01-29|||March 2013||2013-03-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Extubation Failure Prevention in High Risk Patients by High-flow Conditioned Oxygen Therapy vs. Standard Oxygen Therapy|Prevention of Post-extubation Respiratory Failure in High Risk Patients by High-flow Conditioned Oxygen Therapy Versus Standard Oxygen Therapy|Terminated||N/A|155|Actual|Althaia Xarxa Assistencial Universitària de Manresa||2||Slow recruitment, interim analysis|f||||f||||||||||2017-10-11 01:51:41.663443|2017-10-11 01:51:41.663443
NCT01820494|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-26|2013-03-27|||October 2000||2000-10-01|March 2013|2013-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Nutritional Management of Infants With Chronic Diarrhea|Nutritional Management of Infants With Chronic Diarrhea|Completed||N/A|27|Actual|Abbott Nutrition||1|||f||||f||||||||||2017-10-11 01:51:41.758348|2017-10-11 01:51:41.758348
NCT01820481|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-12-05|||September 2012||2012-09-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Safety and Efficacy of WIN-901X in Asthma|Double Blinded, Randomized, Placebo Controlled, Multi-center, Phase 2 : Exploratory Clinical Study to Evaluate the Efficacy, Dose-response and Safety of WIN-901X in Asthma Patients|Completed||Phase 2|209|Actual|Whanin Pharmaceutical Company||4|||f||||f||||||||||2017-10-11 01:51:41.853266|2017-10-11 01:51:41.853266
NCT01820468|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-01-09|||July 2013||2013-07-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Adapting a Model for Veterans on a Psychiatric Inpatient Unit|Adapting a Critical Time Intervention Model for Veterans on a Psychiatric Inpatient Unit|Withdrawn||N/A|0|Actual|VA Connecticut Healthcare System||2||"This study was terminated before any participants were enrolled due to unforseen problems with   participant enrollment and study design."|f||||t||||||||||2017-10-11 01:51:41.953362|2017-10-11 01:51:41.953362
NCT01819961|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-27|||April 2013||2013-04-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery|Randomized Clinical Trial of Omega-3 Fatty Acid-supplemented Parenteral Nutrition Versus Standard Parenteral Nutrition in Patients Undergoing Major Laparoscopic Abdominal Surgery|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Sir Run Run Shaw Hospital||2|||f||||f||||||||||2017-10-11 01:51:46.979311|2017-10-11 01:51:46.979311
NCT01820442|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-05-01|||March 2013||2013-03-01|May 2017|2017-05-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|||Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Electrocardiographic Effects of Lofexidine When Administered Orally to Buprenorphine-Maintained Adult Subjects|Completed||Phase 1|30|Actual|US WorldMeds LLC||2|||f||||f||||||||||2017-10-11 01:51:42.125268|2017-10-11 01:51:42.125268
NCT01820429|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-03-25|||December 2009||2009-12-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Observational|||Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease|Residual Platelet Activity Despite Aspirin Utilization in Patients With Non ST Elevation Acute Coronary Syndromes: Comparison Between the Acute and Chronic Phases|Completed||N/A|70|Actual|University of Sao Paulo General Hospital|||2||f||||t||||||||||2017-10-11 01:51:42.23645|2017-10-11 01:51:42.23645
NCT01820416|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-04-26|2017-03-01||September 2009||2009-09-01|April 2017|2017-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Effect of Low-Level Laser Stimulation on Hearing Thresholds|The Effect of Low-Level Laser Stimulation on Hearing Thresholds|Terminated||N/A|35|Actual|University of Iowa||3||Analysis showed no clinically or statistically significant effects|f||||f||||||||||2017-10-11 01:51:42.329315|2017-10-11 01:51:42.329315
NCT01820403|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-12-05|||September 2010||2010-09-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Portion Size Effects on Body Weight:Free Living Setting|Portion Size Effects on Body Weight: Free Living Setting|Completed||N/A|233|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||t||||||||||2017-10-11 01:51:42.621133|2017-10-11 01:51:42.621133
NCT01820390|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2014-02-18|||March 2013||2013-03-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Observational|||Optimizing DBS Electrode Placement and Programming|Optimizing DBS Electrode Placement and Programming Using a Combination of High‐Field MRI, Intraoperative Electrophysiology, and Computational Modeling.|Withdrawn||N/A|0|Actual|University of Colorado, Denver|||1|Funding discontinued.|f||||t||||||||||2017-10-11 01:51:42.705062|2017-10-11 01:51:42.705062
NCT01820377|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-09-02|||October 2010||2010-10-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|AYMP||The Aboriginal Youth Mentorship Program|Northern Lights Physical Activity Program for Management of Type 2 Diabetes Early in Life: Aboriginal Youth Mentorship Program|Completed||N/A|246|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 01:51:42.790405|2017-10-11 01:51:42.790405
NCT01820364|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2016-11-10|2016-04-13||November 2013||2013-11-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|LOGIC|The analysis population for Baseline Demographics is composed of the Full Analysis Set, which consists of all patients who received at least one dose of LGX818.|LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma|Phase II, Multi-center, Open-label Study of Single-agent LGX818 Followed by a Rational Combination With Agents After Progression on LGX818, in Adult Patients With Locally Advanced or Metastatic BRAF V600 Melanoma|Terminated||Phase 2|15|Actual|Array BioPharma|Recruitment halted on 26-Jul-2014, which led to small numbers of subjects analyzed. This recruitment halt was not a consequence of any safety concern and patients who were ongoing in the study continued to be treated as per protocol.|1||Study was withdrawn due to scientific and business considerations.|f||||||||||||||2017-10-11 01:51:42.932942|2017-10-11 01:51:42.932942
NCT01820338|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-03-19|||July 2009||2009-07-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|E-FLIP||Extension Family Lifestyle Intervention Project (E-FLIP for Kids)|Extension Family Lifestyle Intervention Project (E-FLIP for Kids)|Completed||N/A|314|Actual|University of Florida||3|||f||||t||||||||||2017-10-11 01:51:43.506993|2017-10-11 01:51:43.506993
NCT01820208|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-08-08|||March 2014||2014-03-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis|Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis. - A Double Blind Randomized Control Trial.|Recruiting||N/A|56|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||t||||||||||2017-10-11 01:51:43.585522|2017-10-11 01:51:43.585522
NCT01820195|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-27|||March 2013||2013-03-01|March 2013|2013-03-01|November 2014|Anticipated|2014-11-01|August 2014|Anticipated|2014-08-01||Interventional|||N-Acetyl Cystein and Contrast Nephropathy|The Effect of N-Acetyl Cystein in Preventing Contrast Induced Nephropathy: A Double Blind Double Dummy Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|549|Anticipated|Imam Khomeini Hospital||3|||f||||t||||||||||2017-10-11 01:51:43.662978|2017-10-11 01:51:43.662978
NCT01820182|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-08-29|||January 2011||2011-01-01|October 2010|2010-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam Capsule|Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam Capsule in Patients With Obscure Digestive Bleedings|Completed||N/A|73|Actual|Hôpital Edouard Herriot||1|||f||||t||||||||No||2017-10-11 01:51:43.744147|2017-10-11 01:51:43.744147
NCT01820169|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-09-02|||April 2013||2013-04-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG|Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG|Terminated||N/A|2|Actual|Hoffmann-La Roche||1||Only 2 patients screened but none of them were enrolled.|f||||||||||||||2017-10-11 01:51:43.808119|2017-10-11 01:51:43.808119
NCT01820156|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-03-23|||February 2012||2012-02-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|October 2012|Actual|2012-10-01||Interventional|||Diagnosis of Patients With Low or Intermediate Suspicion of SAHS or With Comorbidity: Standard Laboratory Polysomnography Compared With Three Nights of Home Respiratory Polygraphy.|Diagnosis, Cost and Therapeutic Decision-Making of Home Respiratory Polygraphy for Patients Without High Suspicion of OSA or With Comorbidity - Hospital Polysomnography in Comparison With Three Nights of Home Respiratory Polygraphy|Completed||N/A|56|Anticipated|Hospital Clinic of Barcelona||2|||f||||||||||||||2017-10-11 01:51:43.939995|2017-10-11 01:51:43.939995
NCT01820143|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-25|||February 2005||2005-02-01|June 2005|2005-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety|A Phase 1, Randomized, Open-Label, Four-Period Crossover, Multiple-Dose, Single-Center Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety Following Administration of Oral Doses of 10, 20 and 40 mg of Ilaprazole and 40 mg of Esomeprazole in Healthy Subjects|Completed||Phase 1|40|Actual|Il-Yang Pharm. Co., Ltd.||4|||||||f||||||||||2017-10-11 01:51:44.014657|2017-10-11 01:51:44.014657
NCT01820130|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2015-10-26|||March 2013||2013-03-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|TAME-HF||Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure|Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure|Withdrawn||N/A|0|Actual|St. Jude Medical||1||end of inclusion period without patient enrolled|f||||t||||||||||2017-10-11 01:51:44.100724|2017-10-11 01:51:44.100724
NCT01820117|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-03-28|||April 26, 2013|Actual|2013-04-26|March 2017|2017-03-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation|Brain Integrity in Survivors of Hodgkin Lymphoma (HL) Treated With Thoracic Radiation|Recruiting||N/A|450|Anticipated|St. Jude Children's Research Hospital|||2||f||||f|f|f||||Samples Without DNA|"     Blood (5 ml) will be collected, frozen and stored for future serum biomarker assays.   "|||2017-10-11 01:51:44.174031|2017-10-11 01:51:44.174031
NCT01820104|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-17|2013-05-01|||March 2013||2013-03-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover Study|Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males|Completed||Phase 1|16|Actual|Xijing Hospital||2|||f||||f||||||||||2017-10-11 01:51:44.286725|2017-10-11 01:51:44.286725
NCT01820091|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-09-03|||April 2013||2013-04-01|September 2013|2013-09-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®|An Open Label, Multicenter, Dose Finding, Single Arm, Phase 1 Study of Fusilev® (Levoleucovorin) to Prevent or Reduce Mucositis in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer Receiving Folotyn® (Pralatrexate)|Withdrawn||Phase 1|0|Actual|Spectrum Pharmaceuticals, Inc||5|||f||||f||||||||||2017-10-11 01:51:44.35437|2017-10-11 01:51:44.35437
NCT01820078|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2013-11-27|||May 2012||2012-05-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|September 2013|Actual|2013-09-01||Interventional|PALIFE||Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)|Effect of Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study): a Randomized Study|Terminated||Phase 4|127|Actual|Fundación Renal Iñigo Alvarez De Toledo||2||Recruitment not reached|f||||f||||||||||2017-10-11 01:51:44.444952|2017-10-11 01:51:44.444952
NCT01820065|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-27|||June 2005||2005-06-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Long-term Evaluation of Single-piece ACrysof IOL Implantation on Development of Posterior Capsule Opacification|A Long-term Evaluation of Single-piece Hydrophobic Acrylic Intraocular Lens Implantation on the Development of Posterior Capsule Opacification|Completed||N/A|390|Actual|Iladevi Cataract and IOL Research Center|||1||f||||||||||||||2017-10-11 01:51:44.566652|2017-10-11 01:51:44.566652
NCT01820052|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-04-20|||April 2013||2013-04-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||A Randomized Trial of Oral Iron Therapy in Fibromyalgia|A Double-blind , Randomized, Placebo-controlled Trial of Oral Iron Therapy in Fibromyalgia|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|Sanjay Gandhi Postgraduate Institute of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:51:44.648694|2017-10-11 01:51:44.648694
NCT01820039|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-12-13|||June 2013||2013-06-01|March 2013|2013-03-01||||May 2015|Anticipated|2015-05-01||Interventional|||FertiScreen: an Online Application to Improve the Quality of Fertility Care|FertiScreen: an Online Application to Improve the Quality of Fertility Care|Unknown status|Recruiting|N/A|152|Anticipated|Radboud University||1|||f||||f||||||||||2017-10-11 01:51:46.299448|2017-10-11 01:51:46.299448
NCT01820013|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2015-12-23|||November 2012||2012-11-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|MAPS||Single Centre Blinded Randomized Controlled Trial Evaluating the Effectiveness of Two Pelvic Support Garments|Management of Antenatal Pelvic Girdle Pain Study (MAPS): a Single Centre Blinded Randomized Trial Evaluating the Effectiveness of Two Pelvic Support Garments|Completed||N/A|72|Actual|University of Plymouth||2|||f||||t||||||||||2017-10-11 01:51:46.536464|2017-10-11 01:51:46.536464
NCT01820000|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-10-18|||December 2009||2009-12-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy of Non Contrast DWI(Diffusion Weighted Imaging) Imaging Compared to DMR-DE|Prospective Study to Obtain Preliminary Data to Determine the Efficacy of Non Contrast DWI Imaging Compared to CMR-DE|Completed||N/A|23|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-11 01:51:46.665639|2017-10-11 01:51:46.665639
NCT01819987|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-05-09|||January 2014|Actual|2014-01-01|May 2017|2017-05-01|June 1, 2016|Actual|2016-06-01|June 1, 2016|Actual|2016-06-01||Interventional|||HomeTech Healthy Lifestyle Program for Mothers With Young Children|Home-based & Technology-centered Childhood Obesity Prevention for Mothers With Young Children|Completed||Phase 1/Phase 2|32|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:51:46.759204|2017-10-11 01:51:46.759204
NCT01819974|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-11-27|||April 2013||2013-04-01|November 2013|2013-11-01|May 2014|Anticipated|2014-05-01|November 2013|Anticipated|2013-11-01||Interventional|||Effect of Medication Reviews Performed in High Risk Patients|Effect of Medication Reviews in Hospitalized High-risk Patients - a Randomised Controlled Trial|Unknown status|Recruiting|N/A|600|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 01:51:46.889187|2017-10-11 01:51:46.889187
NCT01819948|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-02-24|||June 2012||2012-06-01|February 2016|2016-02-01||||December 2015|Actual|2015-12-01||Interventional|||Changes in Biomarkers of Cancer in Women With Breast Cancer and Without Evidence of Disease Who Were Given PhytoMed™|Pilot Clinical Trial to Assess Changes in Biomarkers of Cancer Related to Inflammation in Women With Stage 0-IIIA Breast Cancer and Without Evidence of Disease Who Were Given the PhytoMed™ Complement.|Completed||N/A|46|Actual|Phytogen Medical Foods S.L.||1|||f||||f||||||||||2017-10-11 01:51:47.089517|2017-10-11 01:51:47.089517
NCT01819935|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-12-12|2013-12-12||December 2012||2012-12-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational||Full analysis set (FAS) included all participants who were admitted to veterans affairs hospitals between 1 January 2001 and 30 September 2010 (3559 days) with an ICD-9 code for MRSA and pneumonia.|Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia|Clinical Outcomes Among a National Veterans Affairs Methicillin Resistant Staphylococcus Aureus (MRSA) Pneumonia Cohort Treated With Linezolid Or Vancomycin|Completed||N/A|5271|Actual|Pfizer|Results for 'time to intubation' was reported and not 'time to extubation' due to change in planned analysis.||2||f||||f||||||||||2017-10-11 01:51:47.215248|2017-10-11 01:51:47.215248
NCT01819922|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2016-03-30|2016-02-29||April 2013||2013-04-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Baseline analysis population included all participants who performed the peak aerobic capacity test, were randomized and had at least 1 dose of randomized treatment.|Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters|A Phase 1 Randomized, Double-blind, Placebo-controlled, Two-way Crossover Study To Assess The Effect Of Pf-05175157 As A Single Oral Dose On Metabolic And Cardiopulmonary Parameters During Steady State And Graded Exercise In Healthy Subjects|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:51:47.770122|2017-10-11 01:51:47.770122
NCT01819909|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2013-03-25|||November 2008||2008-11-01|March 2013|2013-03-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Effectiveness Study of Postoperative Rotator Cuff Repair Rehabilitation|Prospective Randomized Trial of Rotator Cuff Repair Postoperative Rehabilitation: Jackins' Exercises Versus Pulleys|Unknown status|Active, not recruiting|N/A|56|Anticipated|Orthopedic Institute, Sioux Falls, SD||2|||f||||f||||||||||2017-10-11 01:51:48.895276|2017-10-11 01:51:48.895276
NCT01819896|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-02-12|||February 2013||2013-02-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|October 2013|Actual|2013-10-01||Observational|||Safety of Smartphones Among Patients With Cardiac Implantable Electronic Devices|Safety of Smartphones Among Patients With Cardiac Implantable Electronic Devices|Completed||N/A|300|Anticipated|Deutsches Herzzentrum Muenchen|||1||f||||f||||||||||2017-10-11 01:51:48.975783|2017-10-11 01:51:48.975783
NCT01819870|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-29|||April 2013||2013-04-01|January 2013|2013-01-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|||Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg|A Randomized, Open-label, Multiple-dose, Crossover Phase I Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32 mg and Dilatrend Tablet 25 mg in Healthy Male Subjects|Unknown status|Not yet recruiting|Phase 1|48|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 01:51:49.107291|2017-10-11 01:51:49.107291
NCT01819857|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2013-08-05|||June 2011||2011-06-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Droperidol and Cardiac Repolarization|The Influence of Droperidol on Cardiac Repolarization. A Double-blind, Ondansetron-controlled Study.|Completed||Phase 4|75|Anticipated|Medical University of Gdansk||3|||f||||f||||||||||2017-10-11 01:51:49.294653|2017-10-11 01:51:49.294653
NCT01819844|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-07-20|2016-11-01||March 2013||2013-03-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|June 2014|Actual|2014-06-01||Interventional|||Inpatient Closed-loop Glucose Control|Subcutaneous Continuous Glucose Monitoring and Intravenous Dosing of Insulin and Dextrose for Automated Glycemic Control in the Inpatient Setting|Active, not recruiting||N/A|12|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:51:49.393826|2017-10-11 01:51:49.393826
NCT01819831|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-12-14|||March 2013||2013-03-01|August 2016|2016-08-01|March 2022|Anticipated|2022-03-01|March 2019|Anticipated|2019-03-01||Interventional|||A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall|A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall|Recruiting||Phase 2|51|Anticipated|Loma Linda University||1|||f||||f||||||||No||2017-10-11 01:51:49.78112|2017-10-11 01:51:49.78112
NCT01819818|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-07-14|||June 1, 2011|Actual|2011-06-01|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Observational|||A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients|Korea Post-Marketing Surveillance of Invega Sustenna|Completed||N/A|2113|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||f||||||||2017-10-11 01:51:49.921737|2017-10-11 01:51:49.921737
NCT01819805|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-12-31|||September 2011||2011-09-01|December 2014|2014-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen|Evaluation of the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol HCl (75mg)/Acetaminophen (650mg) Extended Release Tablet: Multicenter, Open Label, Prospective, Observational Study|Completed||Phase 4|1065|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 01:51:50.05191|2017-10-11 01:51:50.05191
NCT01819792|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-11-29|||April 2013||2013-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|LAMVIRE||Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia|Incidence of Respiratory Viral Infections During AML Induction and Consolidation Chemotherapy|Active, not recruiting||Phase 4|115|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:51:50.180355|2017-10-11 01:51:50.180355
NCT01819194|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2016-05-13|2014-12-02||March 2013||2013-03-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||64 subjects enrolled with 60 Completing|Contact Lens Comfort Relative to Meibomian Gland Status||Completed||N/A|64|Actual|Johnson & Johnson Vision Care, Inc.||1|||f||||f||||||||||2017-10-11 01:51:57.018974|2017-10-11 01:51:57.018974
NCT01819779|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-27|||March 2013||2013-03-01|March 2013|2013-03-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)|Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects|Unknown status|Recruiting|Phase 1|60|Anticipated|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:51:50.275052|2017-10-11 01:51:50.275052
NCT01819766|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2017-02-16|||March 2013||2013-03-01|August 2016|2016-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|OCEANIA||Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease|Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study|Completed||N/A|440|Anticipated|Exact Sciences Corporation|||1||f||||f||||||Samples With DNA|"     Residual samples may be archived for further research. Clinical data and samples will be kept     in a manner that preserves anonymity of the subject. Specimens will be stored in a commercial     biorepository contracted by Exact Sciences or at Exact Sciences and may be used for future     research.   "|||2017-10-11 01:51:50.36427|2017-10-11 01:51:50.36427
NCT01819753|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-27|||June 2007||2007-06-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Assessment of the Effects of Access Count in Percutaneous Nephrolithotomy on Renal Functions by Technetium-99M-Dimercaptosuccinic Acid Scintigraphy||Completed||N/A|37|Actual|TC Erciyes University||2|||f||||||||||||||2017-10-11 01:51:50.495699|2017-10-11 01:51:50.495699
NCT01819740|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2013-03-27|||April 2013||2013-04-01|March 2013|2013-03-01||||April 2013|Anticipated|2013-04-01||Observational|HEM||Analysis of a New Biomarker for Prostate Cancer Diagnosis||Unknown status|Not yet recruiting|N/A|28|Anticipated|Corporacion Parc Tauli|||1||f||||||||||||||2017-10-11 01:51:50.576599|2017-10-11 01:51:50.576599
NCT01819727|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-08-17||2017-08-17|May 2013||2013-05-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|Prism301||An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165|A Phase 3, Open-Label, Randomized, Multi-Center Study to Assess the Safety & Tolerability of an Induction, Titration, and Maintenance Dose Regimen of BMN 165 Self Administered by Adults With PKU Not Previously Treated With BMN 165|Completed||Phase 3|261|Actual|BioMarin Pharmaceutical||2|||f||||t||||||||||2017-10-11 01:51:50.672565|2017-10-11 01:51:50.672565
NCT01819714|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-25|2015-04-28|||June 2013||2013-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|May 2014|Actual|2014-05-01||Interventional|SensiCare||Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease|Evaluation of the Impact of Care Based on Sensory Support for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease|Completed||N/A|31|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-11 01:51:50.834233|2017-10-11 01:51:50.834233
NCT01819701|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-03-12|||January 2013||2013-01-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||L-carnitine and Coenzyme Q10 in Relation to the Oxidative Stress, Antioxidant Enzymes Activities, Inflammation, and the Risk of Coronary Artery Disease||Completed||Phase 2/Phase 3|47|Actual|Taichung Veterans General Hospital||2|||f||||t||||||||||2017-10-11 01:51:50.917637|2017-10-11 01:51:50.917637
NCT01819688|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-22|||August 2007||2007-08-01|March 2013|2013-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Surgical Stress After Laparoscopic Compared to Open Liver Resection|Surgical Stress Induced Insulin Resistance and Cytokine Response After Laparoscopic Compared to Open Liver Resection|Completed||N/A|52|Actual|Sir Run Run Shaw Hospital||1|||f||||t||||||||||2017-10-11 01:51:50.997607|2017-10-11 01:51:50.997607
NCT01819675|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-06-26|||March 2013||2013-03-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) Over the Brain on the Neurotransmitter Binding|Effect of rTMS Over Primary Motor Cortex on Gamma-aminobutyric Acid A (GABAA)-[18F]Flumazenil Binding: A Positron Emission Tomography (PET) Study|Terminated||N/A|6|Actual|Seoul National University Bundang Hospital||3||exposure to radiation due to repetitive PET evaluation|f||||f||||||||||2017-10-11 01:51:51.067645|2017-10-11 01:51:51.067645
NCT01819662|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2017-05-01|||August 2013||2013-08-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|OPT-pace||Optimised Pacing Program|Stratified Management of Patients With Pacemakers|Recruiting||Phase 3|2100|Anticipated|University of Leeds||3|||f||||t||||||||||2017-10-11 01:51:51.167017|2017-10-11 01:51:51.167017
NCT01819649|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-09-13|||November 1998||1998-11-01|September 2017|2017-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|DK PRECISE||Selenium in the Prevention of Cancer|Prevention of Cancer by Intervention With Selenium - A Pilot Study in a Danish Population|Completed||N/A|491|Actual|Odense University Hospital||4|||f||||t||||||||||2017-10-11 01:51:51.267545|2017-10-11 01:51:51.267545
NCT01819636|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-07-28|||March 2013||2013-03-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Effects Of Consumption Of A Highly Mineralized Sodium Bicarbonated Water On Blood Lipid Profile|Effects Of Consumption Of A Highly Mineralized Sodium Bicarbonated Water On Blood Lipid Profile|Completed||N/A|162|Actual|Neptune||2|||f||||t||||||||||2017-10-11 01:51:51.359352|2017-10-11 01:51:51.359352
NCT01819623|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-04-20||||||April 2015|2015-04-01||||March 2014|Anticipated|2014-03-01||Interventional|||Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment|Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment|Withdrawn||N/A|0|Actual|National Institute of Medical Sciences and Nutrition, Salvador Zubiran||2||Financial issues (no participants enrolled)|f||||f||||||||||2017-10-11 01:51:51.460859|2017-10-11 01:51:51.460859
NCT01819597|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2016-09-08|||March 2013||2013-03-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|ERSIAS||Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis|EDAS (Surgical) Revascularization for Symptomatic Intracranial Arterial Stenosis|Recruiting||Phase 2|55|Anticipated|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-10-11 01:51:51.603179|2017-10-11 01:51:51.603179
NCT01819584|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-03-24|||April 2013||2013-04-01|March 2013|2013-03-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|||Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism|Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism|Unknown status|Not yet recruiting|N/A|30|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 01:51:51.702327|2017-10-11 01:51:51.702327
NCT01819571|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-02-17|||January 2012||2012-01-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Pulse Pressure Variation for Prediction of Fluid Responsiveness in Coronary Artery Disease Patients With Diastolic Dysfunction||Completed||N/A|66|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:51:51.869253|2017-10-11 01:51:51.869253
NCT01819558|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-03-19|||March 2013||2013-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ALLO-WT1||Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy|Etude Phase I/II d'immunothérapie Par protéine recWT1-A10+AS01B après Greffe allogénique de Cellules Souches|Completed||Phase 1/Phase 2|2|Actual|Institut Paoli-Calmettes||1|||f||||t||||||||||2017-10-11 01:51:51.953509|2017-10-11 01:51:51.953509
NCT01819545|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2014-02-16|||January 2012||2012-01-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|July 2014|Anticipated|2014-07-01||Observational|||The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease|Shanghai Mental Health Center|Unknown status|Recruiting|N/A|300|Anticipated|Shanghai Mental Health Center|||3||f||||t||||||Samples With DNA|"     Plasma miRNA107 and BACE1mRNA are to be retained.   "|||2017-10-11 01:51:52.044788|2017-10-11 01:51:52.044788
NCT01819532|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-03-22|||September 2011||2011-09-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Interventional|||Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks|Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants <33 Weeks: A Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|80|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:51:52.135397|2017-10-11 01:51:52.135397
NCT01819519|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-06-01|||March 2013||2013-03-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CDC/CMV||Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus|Development and Evaluation of a Clinic-Based Screening and Brief Intervention for Changing Behaviors Related to Cytomegalovirus Transmission in Pregnant Women|Completed||N/A|223|Actual|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||||2017-10-11 01:51:52.230722|2017-10-11 01:51:52.230722
NCT01819506|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-08-23|||March 1, 2013|Actual|2013-03-01|August 2017|2017-08-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|TARG||Patient Targeted Upper Extremity Rehabilitation After Stroke|Patient-Targeted Upper Extremity Rehabilitation After Stroke|Completed||N/A|103|Actual|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 01:51:52.315676|2017-10-11 01:51:52.315676
NCT01819493|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-06-13|||March 2013||2013-03-01|June 2017|2017-06-01|April 16, 2015|Actual|2015-04-16|April 16, 2015|Actual|2015-04-16||Interventional|PACT PD||Parents and Children Together Preventing Diabetes (PACT PD)|Parents and Children Together Preventing Diabetes|Completed||N/A|33|Actual|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-11 01:51:52.409991|2017-10-11 01:51:52.409991
NCT01819480|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-06-09|||March 2013||2013-03-01|June 2016|2016-06-01||||September 2019|Anticipated|2019-09-01||Interventional|||Efficacy and Safety of TORS for SCCA|A Single Arm Study of Efficacy and Functional Quality of Life in Patients Treated With Transoral Robotic Surgery for Oropharyngeal and Supraglottic Squamous Cell Carcinoma|Recruiting||N/A|85|Anticipated|University of Virginia||1|||f||||t||||||||||2017-10-11 01:51:52.483946|2017-10-11 01:51:52.483946
NCT01819467|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-06-29|||June 2014||2014-06-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Trial to Reduce Adhesions Following a Primary Cesarean Section|A Randomized Controlled Trial to Reduce Adhesions Following a Primary Cesarean Section|Terminated||N/A|29|Actual|South East Area Health Education Center, Wilmington, NC||2||Slow to accrue, lack of qualified participants|f||||f||||||||No||2017-10-11 01:51:52.561222|2017-10-11 01:51:52.561222
NCT01819454|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-09-07|||August 2012||2012-08-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||The Diagnostics of Extraesophageal Reflux With the Restech System|The Diagnostics of Extraesophageal Reflux With the Restech System in Patients With Chronic Rhinosinusitis|Completed||N/A|90|Actual|University Hospital Ostrava||3|||f||||f||||||||||2017-10-11 01:51:52.644107|2017-10-11 01:51:52.644107
NCT01819441|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2015-10-22|||May 2012||2012-05-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|APPROVE||Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients|Azelnidipine vs Perindopril and Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients (APPROVE):Multi-center Randomized Controlled Clinical Trial|Unknown status|Recruiting|Phase 4|1200|Anticipated|Peking University First Hospital||2|||f||||t||||||||||2017-10-11 01:51:52.734406|2017-10-11 01:51:52.734406
NCT01819428|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-02-26|||March 2013||2013-03-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma|A Prospective, Open-label, Single Arm, Multi-center, Phase II Exploratory Trial to Evaluate the Efficacy and Safety of NOV120101 (Poziotinib) as the First-line Treatment Medication in Patients With Harboring EGFR Mutations|Terminated||Phase 2|22|Actual|National OncoVenture||1||Low recruitment|f||||f||||||||||2017-10-11 01:51:52.827425|2017-10-11 01:51:52.827425
NCT01819415|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2017-03-23|2013-04-28||February 2011||2011-02-01|March 2017|2017-03-01|February 2013|Actual|2013-02-01|August 2011|Actual|2011-08-01||Interventional|||Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD|Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD|Completed||N/A|40|Actual|Maisonneuve-Rosemont Hospital||4|||f||||f||||||||No||2017-10-11 01:51:52.939471|2017-10-11 01:51:52.939471
NCT01819402|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-03-24|||March 2012||2012-03-01|March 2013|2013-03-01||||April 2013|Anticipated|2013-04-01||Interventional|||Pioglitazone Decreases Visceral Fat Metabolism|Effects of Pioglitazone on Visceral Fat Metabolic Activity|Unknown status|Recruiting|N/A|60|Anticipated|Kurume University||2|||f||||t||||||||||2017-10-11 01:51:53.323877|2017-10-11 01:51:53.323877
NCT01819389|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-01-03|||October 2012||2012-10-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance|Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance.|Completed||Phase 3|10|Actual|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||t||||||||||2017-10-11 01:51:53.427688|2017-10-11 01:51:53.427688
NCT01819376|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-11-11|||March 2013||2013-03-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Use of Facebook as a Motivating Factor in a Weight-reduction Program for Obese and Overweight Adolescents|Use of Facebook as a Motivating Factor in a Weight-reduction Program for Obese and Overweight Adolescents.|Unknown status|Recruiting|N/A|26|Anticipated|Hospital San Jose Tec de Monterrey||2|||f||||f||||||||||2017-10-11 01:51:53.522015|2017-10-11 01:51:53.522015
NCT01819363|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2013-03-24|||February 2012||2012-02-01|March 2013|2013-03-01|January 2016|Anticipated|2016-01-01|||||Observational|||Relationship Between Pleural Elastance and Effectiveness of Pleurodesis on Recurrent Malignant Pleural Effusion|Relationship Between Pleural Elastance and Effectiveness of Pleurodesis on Recurrent Malignant Pleural Effusion|Unknown status|Recruiting|N/A|140|Anticipated|Grupo de Pesquisa em Pleura e Oncologia Toracica|||1||f||||f||||||||||2017-10-11 01:51:53.630719|2017-10-11 01:51:53.630719
NCT01819350|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2013-03-24|||August 2011||2011-08-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|SPMedicines||In Vivo Study of Sucrose and Liquid Oral Pediatric Medicines of Long-term Effect on Dental Biofilm pH|Avaliação in Vivo do Potencial cariogênico e Erosivo de Bebidas e Medicamentos pediátricos líquidos Intra-orais|Completed||Phase 2|12|Actual|Federal University of Paraíba||2|||f||||f||||||||||2017-10-11 01:51:53.777294|2017-10-11 01:51:53.777294
NCT01819337|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-09-15|||March 2013||2013-03-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Observational|||The Influence of Preoperative Cardiopulmonary Capacity on the Perioperative Lactate Level|The Influence of Preoperative Cardiopulmonary Capacity Mesured in MET's (Metabolic Equivalents) on the Perioperative Lactate Level|Completed||N/A|1502|Actual|University of Witten/Herdecke|||1||f||||f||||||||||2017-10-11 01:51:53.879996|2017-10-11 01:51:53.879996
NCT01819324|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-12-02|||April 2011||2011-04-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|November 2013|Actual|2013-11-01||Interventional|TTMI||A Lifestyle Intervention for Breast Cancer Survivors|Targeting the Teachable Moment: A Lifestyle Intervention for Breast Cancer Survivors|Completed||N/A|173|Actual|Hartford Hospital||3|||f||||t||||||||||2017-10-11 01:51:53.973672|2017-10-11 01:51:53.973672
NCT01819311|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-08-01|2017-07-05||April 1, 2013|Actual|2013-04-01|August 2017|2017-08-01|June 23, 2017|Actual|2017-06-23|June 23, 2017|Actual|2017-06-23||Interventional|||Attention Bias Modification Training for Child Anxiety CBT Nonresponders|Attention Bias Modification Training for Child Anxiety CBT Nonresponders|Completed||N/A|64|Actual|Florida International University||2|||f||||t||||||||||2017-10-11 01:51:54.107188|2017-10-11 01:51:54.107188
NCT01819298|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-22|||March 2011||2011-03-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Observational|||Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy|The Influence on Airway Bacteria Colonization in Chronic Obstructive Pulmonary Disease by the Combination of Inhaled Corticosteroid and Long-acting β2 Agonist|Completed||N/A|17|Actual|Far Eastern Memorial Hospital|||4||f||||t||||||||||2017-10-11 01:51:54.596548|2017-10-11 01:51:54.596548
NCT01819285|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-22|||February 1990||1990-02-01|March 2013|2013-03-01|September 2010|Actual|2010-09-01|July 2004|Actual|2004-07-01||Interventional|||Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer|Phase III Comparison of Early vs Delayed Endocrine Manipulation (Orchiectomy or LHRH Agonist Therapy) in Previously Untreated Patients With Nonmetastatic Asymptomatic Carcinoma of the Prostate|Completed||Phase 3|985|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 01:51:54.67116|2017-10-11 01:51:54.67116
NCT01819272|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-02-06|2015-08-21||April 2013||2013-04-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||ITT Population|Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Delayed-Release Metformin in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|240|Actual|Elcelyx Therapeutics, Inc.||6|||f||||f||||||||||2017-10-11 01:51:54.785867|2017-10-11 01:51:54.785867
NCT01819259|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-08-31|||January 2013||2013-01-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|NNSG||Nicotine, Non-Smokers With and Without ADHD, and Genetics Study|Nicotine, Non-Smokers With and Without ADHD, and Genetics Study|Recruiting||Phase 1|150|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 01:51:56.362996|2017-10-11 01:51:56.362996
NCT01819246|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-03-17|||January 2013||2013-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||High Yield Intraoperative, Autologous Platelet Apheresis|High Yield Intraoperative, Autologous Platelet Apheresis-Optomizing Transfusion Practice In Cardiac Surgery|Completed||N/A|57|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:51:56.514992|2017-10-11 01:51:56.514992
NCT01819233|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-09-25|||March 8, 2013|Actual|2013-03-08|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 14, 2017|Actual|2017-09-14||Interventional|CAREFOR||Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy|A Feasibility Pilot Trial Evaluating Caloric Restriction for Oncology Research in Early Stage Breast Cancer Patients|Active, not recruiting||N/A|38|Actual|Thomas Jefferson University||1|||f||||t|f|f||||||||2017-10-11 01:51:56.633207|2017-10-11 01:51:56.633207
NCT01819220|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2015-06-09|||April 2009||2009-04-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome||Completed||Phase 4|16|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:51:56.817058|2017-10-11 01:51:56.817058
NCT01819207|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-24|2016-05-31|||April 2013||2013-04-01|March 2013|2013-03-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|||Evaluation of the Coagulation Profile by Thromboelastography in Bariatric Patients||Completed||N/A|93|Actual|Western Galilee Hospital-Nahariya||1|||f||||t||||||||||2017-10-11 01:51:56.912518|2017-10-11 01:51:56.912518
NCT01819181|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-01-26|||March 2013||2013-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|May 2016|Actual|2016-05-01|5 Years|Observational [Patient Registry]|WINTAVI||Women's INternational Transcatheter Aortic Valve Implantation Registry|Women's INternational Transcatheter Aortic Valve Implantation Registry|Active, not recruiting||N/A|1019|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||||||2017-10-11 01:51:57.264032|2017-10-11 01:51:57.264032
NCT01819168|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-09-04|||March 2013||2013-03-01|February 2016|2016-02-01|April 2016|Actual|2016-04-01|March 2015|Actual|2015-03-01||Observational|||Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing||Completed||N/A|38|Actual|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 01:51:57.412199|2017-10-11 01:51:57.412199
NCT01819155|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2013-10-18|||April 2013||2013-04-01|June 2013|2013-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa|Assessment of the Immunogenicity and Safety of an MF59™- Adjuvanted Trivalent Influenza Vaccine and a Non-adjuvanted Trivalent Influenza Vaccine Among Children in Senegal|Completed||Phase 2|296|Actual|PATH||3|||f||||f||||||||||2017-10-11 01:51:57.498456|2017-10-11 01:51:57.498456
NCT01819142|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-10-19|||April 2013||2013-04-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers|A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in Stage II-IV Pressure Ulcers|Terminated||N/A|2|Actual|Cytomedix||1||Protocol study design was re-worked in collaboration with CMS|f||||t||||||||||2017-10-11 01:51:57.634962|2017-10-11 01:51:57.634962
NCT01819116|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-01-26|||April 2013||2013-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor|Tissue Oxygen Saturation During Management of the Deceased by Neurological Criteria Organ Donor as a Predictor of Number of Organs to Transplant Per Donor|Completed||N/A|60|Actual|The Cleveland Clinic|||1||f||||f||||||||||2017-10-11 01:51:58.183461|2017-10-11 01:51:58.183461
NCT01819103|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2013-04-03|||March 2011||2011-03-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01|12 Months|Observational [Patient Registry]|||Investigating Variation in Hospital Acute Coronary Syndrome Outcomes|Evaluation of the Methods and Management of Acute Coronary Events-4: Investigating Variation in Hospital Acute Coronary Syndrome Outcomes|Completed||N/A|5555|Actual|University of Leeds|||1||f||||f||||||Samples With DNA|"     Blood, Urine   "|||2017-10-11 01:51:58.307372|2017-10-11 01:51:58.307372
NCT01819090|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-02-12|||November 2013||2013-11-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PHONOVNI||Optimizing Communication During Ventilation|Optimizing Communication During Nasal Mechanical Ventilation|Completed||N/A|10|Actual|Centre d'Investigation Clinique et Technologique 805||2|||f||||f||||||||||2017-10-11 01:51:58.41469|2017-10-11 01:51:58.41469
NCT01819077|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-05-26|||March 2013||2013-03-01|May 2015|2015-05-01|March 2018|Anticipated|2018-03-01|January 2017|Anticipated|2017-01-01|5 Years|Observational [Patient Registry]|TMMR-RS||TMMR (Total Mesometrial Resection) Register Study|Register Study: TMMR and Therapeutic Lymphadenectomy According to M.Hoeckel for Treatment of Cervical Cancer FIGO IB-IIA|Recruiting||N/A|500|Anticipated|University Hospital, Essen|||1||f||||f||||||||||2017-10-11 01:51:58.516044|2017-10-11 01:51:58.516044
NCT01819051|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-09-12|||March 2013||2013-03-01|September 2017|2017-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Pilot Study to Evaluate Plasma Treatment of Onychomycosis|A Single Center, Pilot Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of the Plasma Treatment System in Treating Onychomycosis|Completed||N/A|15|Actual|Moe Medical Devices||1|||f||||||||||||||2017-10-11 01:51:58.763689|2017-10-11 01:51:58.763689
NCT01819038|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-01-26|||January 2013||2013-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EarlyRRT||Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury||Completed||N/A|60|Actual|Chulalongkorn University||3|||f||||t||||||||||2017-10-11 01:51:58.866818|2017-10-11 01:51:58.866818
NCT01819025|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2014-02-06|||March 2013||2013-03-01|July 2013|2013-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Cognitive Behavioral Therapy Treatment of Depression With Smartphone Support|Face-to-face CBT Treatment of Depression With Smartphone Support|Completed||N/A|88|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-11 01:51:58.95306|2017-10-11 01:51:58.95306
NCT01819012|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-10-31|||March 2013||2013-03-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery|Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery|Completed||N/A|20|Actual|Konkuk University Medical Center||3|||f||||t||||||||No||2017-10-11 01:51:59.057143|2017-10-11 01:51:59.057143
NCT01818999|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-10-23|||August 2013||2013-08-01|October 2015|2015-10-01|December 2023|Anticipated|2023-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Ixabepilone and SBRT For Metastatic Breast Cancer|A Phase II Trial Of Ixabepilone and Stereotactic Body Radiation Therapy (SBRT) For Patients With Triple Negative Metastatic Breast Cancer|Terminated||Phase 2|1|Actual|University of Texas Southwestern Medical Center||1||low accrual|f||||t||||||||||2017-10-11 01:51:59.153789|2017-10-11 01:51:59.153789
NCT01818804|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-02-17|||March 2013||2013-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic Arthritis|The Effect of n-3 Polyunsaturated Fatty Acids on Risk Markers for Cardiovascular Disease and Inflammation in Patients With Psoriatic Arthritis|Completed||N/A|145|Actual|Aalborg Universitetshospital||2|||f||||t||||||||Yes||2017-10-11 01:52:01.333679|2017-10-11 01:52:01.333679
NCT01818986|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-04-11|||August 2013||2013-08-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)|Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC)|Recruiting||Phase 2|41|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 01:51:59.260034|2017-10-11 01:51:59.260034
NCT01818973|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2015-06-03|||March 2013||2013-03-01|June 2015|2015-06-01|March 2020|Anticipated|2020-03-01|June 2015|Anticipated|2015-06-01||Interventional|||Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer||Recruiting||Phase 2|45|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 01:51:59.364479|2017-10-11 01:51:59.364479
NCT01818960|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2016-07-28|||April 2014||2014-04-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|ASSIST-CMR||Revascularization Strategies for STEMI; The CMR Endpoint Study|Revascularization Strategies for ST Elevation Myocardial Infarction; The Cardiac Magnetic Resonance Endpoint Study|Recruiting||N/A|250|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||Undecided||2017-10-11 01:51:59.504735|2017-10-11 01:51:59.504735
NCT01818947|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2014-01-22|||June 2013||2013-06-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Gefitinib Usage and Outcomes in Routine Treatment|A Multicentre, Retrospective Chart Review Study to Characterise Gefitinib Usage and Outcomes in Routine Treatment|Completed||N/A|157|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:51:59.613836|2017-10-11 01:51:59.613836
NCT01818934|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-03-21|||January 1988||1988-01-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|June 1990|Actual|1990-06-01||Interventional|||Ultrasound Screening for Developmental Dysplasia of the Hip in Newborns|Ultrasound Screening for Developmental Dysplasia of the Hip in the Neonate: The Effect on Treatment Rate and Prevalence of Late Cases|Completed||N/A|11925|Actual|University of Bergen||3|||f||||t||||||||||2017-10-11 01:51:59.854664|2017-10-11 01:51:59.854664
NCT01818921|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-07-14||2016-07-14|June 2013||2013-06-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome|Randomized, Double-Blind, Placebo Controlled, Parallel Dose Ranging Phase 2a Trial of ZGN-440 (Subcutaneous Beloranib in Suspension), A Novel Methionine Aminopeptidase 2 Inhibitor, in Over-weight and Obese Subjects With Prader-Willi Syndrome to Evaluate Weight Reduction, Food-related Behavior, Safety, and Pharmacokinetics Over 4 Weeks Followed by Optional 4-Week Open-Label Extension|Completed||Phase 2|17|Actual|Zafgen, Inc.||3|||f||||f||||||||||2017-10-11 01:51:59.968248|2017-10-11 01:51:59.968248
NCT01818908|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2013-03-23|||June 2012||2012-06-01|March 2013|2013-03-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Interventional|||Trial of DA-EPOCH Regimen for NHL With HLH|Clinical Study of Dose-adjusted EPOCH Regimen for Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis|Unknown status|Recruiting|Phase 2|50|Anticipated|The First Affiliated Hospital with Nanjing Medical University||1|||f||||t||||||||||2017-10-11 01:52:00.11969|2017-10-11 01:52:00.11969
NCT01818895|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-07-09|||April 2013||2013-04-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Observational|ARREVE||Terminal Weaning of Mechanical Ventilation or Extubation in Anticipation of Death in the Intensive Care Unit|Terminal Weaning of Mechanical Ventilation or Extubation in Anticipation of Death in the Intensive Care Unit: Impact on Relatives, Care Givers and the Dying Process - A Prospective, Multicenter, Observational Study|Completed||N/A|458|Actual|Centre Hospitalier Departemental Vendee|||1||f||||f||||||||||2017-10-11 01:52:00.356162|2017-10-11 01:52:00.356162
NCT01818882|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2016-04-05|||April 2014||2014-04-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|VSCAN-DYSP||Diagnostic Value of Portable Ultrasound for Dyspneic Patient Support in the Emergency Department|Evaluation of the Diagnostic Value of Portable Ultrasound for Dyspneic Patient Support in the Emergency Department: a Randomized Study|Terminated||N/A|85|Actual|Centre Hospitalier Universitaire de Nīmes||2||Inclusion curve too slow.|f||||f||||||||||2017-10-11 01:52:00.666696|2017-10-11 01:52:00.666696
NCT01818869|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-08-13|||January 2014||2014-01-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects|A Phase 1, Single Centre, Double-blind, Randomised, Placebo-controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Administration of Multiple Ascending (MAD) Once Weekly Inhaled Doses of AZD8848 in Healthy Subjects|Completed||Phase 1|8|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 01:52:00.85298|2017-10-11 01:52:00.85298
NCT01818856|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2013-04-19|||December 2012||2012-12-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir|Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir in HIV/HCV-co-infected Patients Under Treatment for Genotype 1 Chronic Hepatitis C.|Completed||Phase 1|14|Anticipated|Hospitales Universitarios Virgen del Rocío||1|||f||||t||||||||||2017-10-11 01:52:00.970205|2017-10-11 01:52:00.970205
NCT01818843|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-03-26|||April 2012||2012-04-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|January 2013|Actual|2013-01-01||Interventional|CO||The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide|Phase 1 Study of Inhaled Carbon Monoxide on the Effectiveness of Neonatal Pulmonary Hypertension|Unknown status|Enrolling by invitation|N/A|24|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University||1|||f||||t||||||||||2017-10-11 01:52:01.078882|2017-10-11 01:52:01.078882
NCT01818830|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2013-03-23|||March 2012||2012-03-01|March 2013|2013-03-01||||May 2013|Anticipated|2013-05-01||Observational|||Amino Acids Expression Profiling of Patients With Sepsis|Amino Acids Expression Profiling of Patients With Sepsis|Unknown status|Active, not recruiting|N/A|100|Anticipated|Chinese PLA General Hospital|||3||f||||t||||||||||2017-10-11 01:52:01.160394|2017-10-11 01:52:01.160394
NCT01818817|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-23|2013-03-23|||November 2011||2011-11-01|September 2011|2011-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Ultrasound Paravertebral Block in Breast Surgery.|Single Injection, Ultrasound Guided Paravertebral Block for Anesthesia in Breast Surgery.|Completed||N/A|20|Actual|Campus Bio-Medico University|||2||f||||t||||||||||2017-10-11 01:52:01.237069|2017-10-11 01:52:01.237069
NCT01816945|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-06-02|||April 2013||2013-04-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|MOMBA||The Momba Mobile Application-based Community|The Momba Mobile Application-based Community|Completed||N/A|47|Actual|Yale University||2|||f||||f||||||||||2017-10-11 01:52:31.187168|2017-10-11 01:52:31.187168
NCT01818791|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-09-26|||July 2012||2012-07-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|December 2014|Actual|2014-12-01||Interventional|EQUIPS||Enhancing Quality Interventions Promoting Healthy Sexuality|Enhancing Quality Interventions Promoting Healthy Sexuality|Active, not recruiting||N/A|960|Anticipated|RAND||2|||f||||f||||||||||2017-10-11 01:52:01.467812|2017-10-11 01:52:01.467812
NCT01818778|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2014-05-15|||May 2013||2013-05-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|VolCogStim||The Efficacy of Using Volunteers to Implement a Cognitive Stimulation Program in Two Long-Term Care Homes|The Efficacy of Using Volunteers to Implement a Cognitive Stimulation Program in Two Long-Term Care Homes|Completed||N/A|52|Actual|Queen's University||2|||f||||f||||||||||2017-10-11 01:52:01.593958|2017-10-11 01:52:01.593958
NCT01818765|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-11-21|||May 2013||2013-05-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|September 2016|Actual|2016-09-01||Interventional|LV-CONSEPT||A Pilot Study of Interventricular Septal Puncture for Cardiac Resynchronization Therapy to Treat Heart Failure|Left Ventricular Endocardial Pacing Through the Ventricular Septum|Active, not recruiting||N/A|20|Actual|Oxford University Hospitals NHS Trust||1|||f||||t||||||||||2017-10-11 01:52:01.700076|2017-10-11 01:52:01.700076
NCT01818752|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-08-01|2017-07-03||July 8, 2013|Actual|2013-07-08|July 2017|2017-07-01|November 4, 2016|Actual|2016-11-04|July 15, 2016|Actual|2016-07-15||Interventional|CLARION||Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma|A Randomized, Open-label Phase 3 Study of Carfilzomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma|Completed||Phase 3|955|Actual|Amgen||2|||f||||t||||||||||2017-10-11 01:52:01.910034|2017-10-11 01:52:01.910034
NCT01818739|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-09-28|||February 2013|Actual|2013-02-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|November 16, 2016|Actual|2016-11-16||Interventional|||Lymph Node Mapping in Patients With Endometrial Cancer|Detection of Sentinel Lymph Nodes in Patients With Endometrial Cancer Undergoing Robotic-Assisted Staging: Comparison of Isosulfan Blue and Indocyanine Green Dyes With Fluorescence Imaging|Completed||N/A|204|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:52:06.577503|2017-10-11 01:52:06.577503
NCT01818726|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-08-25|||June 23, 2014|Actual|2014-06-23|August 2017|2017-08-01|October 17, 2016|Actual|2016-10-17|October 17, 2016|Actual|2016-10-17||Interventional|||Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients|Open-label Study of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients Undergoing Treatment Programs in Comparison With Control Group|Completed||Phase 4|14|Actual|Novartis||2|||f||||t|f|f||||||||2017-10-11 01:52:06.69502|2017-10-11 01:52:06.69502
NCT01818713|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-10-28|||October 2013||2013-10-01|October 2013|2013-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases|Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases|Unknown status|Recruiting|Phase 2|6|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-11 01:52:06.802855|2017-10-11 01:52:06.802855
NCT01818700|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2015-10-01|2014-02-14||September 2012||2012-09-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|NOBLE|The No. of enrolled patients: 245 No. of patient for Safety set: 241(excluded 4 patients who were not applied study drug) No. of patient for FAS analysis set: 210 No. of patient for PP analysis set: 105|An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders|A Multicenter, Phase IV, Interventional Study to Assess the Efficacy and Safety of NORSPAN® (Buprenorphine) in Korean Patients With Spinal Disorders (NOBLE)|Completed||Phase 4|245|Actual|Mundipharma Korea Ltd||1|||f||||t||||||||||2017-10-11 01:52:06.928495|2017-10-11 01:52:06.928495
NCT01818687|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-25|||August 2013||2013-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Tolerability Study of MCI-196|A Multi-centre, Open-label Study Evaluating the Safety and Tolerability of Colestilan (MCI-196) in Paediatric Subjects With Chronic Kidney Disease Stages 3b to 5 and With Hyperphosphataemia Not on Dialysis|Terminated||Phase 3|4|Actual|Mitsubishi Tanabe Pharma Corporation||1||This study has been terminated because of insufficient patient recruitment.|f||||t||||||||||2017-10-11 01:52:07.502915|2017-10-11 01:52:07.502915
NCT01818674|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-08-28|||January 2012|Actual|2012-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||Microclinic Social Network Behavioral Health Trial in Jordan|Microclinic Social Network Behavioral Health Trial for Obesity and Metabolic Risk Factor Control in Jordan|Active, not recruiting||N/A|500|Anticipated|Microclinic International||3|||f||||f||||||||||2017-10-11 01:52:07.615728|2017-10-11 01:52:07.615728
NCT01818661|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-12-22|||March 2013||2013-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech|Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech|Recruiting||N/A|75|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:52:07.748755|2017-10-11 01:52:07.748755
NCT01818648|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2014-01-10|||March 2013||2013-03-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome|Acute Effects of a Glucagon-like Peptide 1 Analog, Exenatide, on Gastrointestinal Motor Function and Permeability in Patients With Short Bowel Syndrome on Home Parenteral Nutrition|Withdrawn||Phase 4|0|Actual|Mayo Clinic||2||Study was withdrawn by PI due to decision to study a different medication.|f||||f||||||||||2017-10-11 01:52:07.851249|2017-10-11 01:52:07.851249
NCT01818635|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2015-08-12|||March 2013||2013-03-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01|3 Months|Observational [Patient Registry]|||To Investigate the Effect of Montelukast on Behavior Problems in Children With Asthma|Phase 4 Study of to Investigation the Effect of Montelukast on Behavior Problems in Children With Asthma|Completed||N/A|600|Anticipated|Fatih University|||1||f||||t||||||||||2017-10-11 01:52:07.964013|2017-10-11 01:52:07.964013
NCT01818622|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2015-03-18|||February 2012||2012-02-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|VATMAN||Virtual Darkness as Additive Treatment in Mania|Virtual Darkness as Additive Treatment in Mania- a Randomized Controlled Trial|Completed||N/A|69|Actual|Helse Fonna||3|||f||||t||||||||||2017-10-11 01:52:08.054154|2017-10-11 01:52:08.054154
NCT01816737|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||March 2013||2013-03-01|March 2013|2013-03-01||||October 2013|Anticipated|2013-10-01||Observational|||Fetal Blood Flow Response to Partial Occlusion by External Compression||Unknown status|Not yet recruiting|N/A|50|Anticipated|Meir Medical Center|||1||f||||||||||||||2017-10-11 01:52:34.730964|2017-10-11 01:52:34.730964
NCT01818609|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-03-21|||September 2011||2011-09-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Study of Inactivity on Metabolism of Elderly Muscles|Influence of Reduce Daily Step Count on Muscle Protein Metabolism in Older Persons|Completed||Phase 1|10|Actual|McMaster University||1|||f||||t||||||||||2017-10-11 01:52:08.189891|2017-10-11 01:52:08.189891
NCT01818596|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2017-08-16|2015-12-04|2014-09-16|March 27, 2013|Actual|2013-03-27|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|July 31, 2014|Actual|2014-07-31||Interventional||Safety Analysis Set: participants were enrolled and received at least 1 dose of study drug|Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment|A Phase 3 Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment|Active, not recruiting||Phase 3|252|Actual|Gilead Sciences|Enrollment in Cohort 2 (treatment-naive) was low, which affects the interpretation of the data.|1|||f||||t|t|f||||||||2017-10-11 01:52:08.339099|2017-10-11 01:52:08.339099
NCT01818583|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2016-12-24|||March 2013||2013-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter|Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter|Recruiting||Phase 4|150|Anticipated|Diakonhjemmet Hospital||2|||f||||t||||||||No||2017-10-11 01:52:09.952749|2017-10-11 01:52:09.952749
NCT01818570|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-22|2014-05-13|||January 2013||2013-01-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus|A Single-center, Randomized, Double-blind, Cross-over Trial in Healthy Volunteers Investigating the Local Efficacy and Safety of a Single Intra-luminal Administration of PPC-5650 on Reflux Pain and Hyperalgesia During Multimodal Stimulation of the Esophagus|Completed||Phase 1|25|Actual|Aalborg Universitetshospital||2|||f||||t||||||||||2017-10-11 01:52:10.083283|2017-10-11 01:52:10.083283
NCT01818557|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-06-18|||May 2013||2013-05-01|June 2015|2015-06-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|GLIMPSE||Frequency of Blood Glucose Monitoring in Patients With Gestational Diabetes|Frequency of Blood Glucose Monitoring in Patients With Gestational Diabetes: A Randomized, Non-Inferiority Pilot Study|Unknown status|Recruiting|N/A|286|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 01:52:10.175541|2017-10-11 01:52:10.175541
NCT01818544|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2015-07-08|||April 2013||2013-04-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis|A Phase IIa, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Safety and Efficacy of 28 Day Oral Administration of BAY85-8501 in Patients With Non-Cystic Fibrosis Bronchiectasis|Completed||Phase 2|94|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:52:10.303743|2017-10-11 01:52:10.303743
NCT01818531|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-01-21|||April 2013||2013-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Adductor Canal Block for Medial Compartment Knee Arthroplasty|Evaluation of Ultrasound-Guided Adductor Canal Blockade for Postoperative Analgesia Following Robotic Medial Unicompartmental Knee Replacement|Completed||N/A|150|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 01:52:10.46883|2017-10-11 01:52:10.46883
NCT01818518|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-09-25|||July 2013||2013-07-01|September 2017|2017-09-01|July 25, 2016|Actual|2016-07-25|May 3, 2016|Actual|2016-05-03||Observational|||Neonatal Outcome by Reason for Delivery|Neonatal Outcome by Reason for Delivery - A Prospective, Observational Study|Completed||N/A|1290|Actual|Mednax Center for Research, Education and Quality|||3||f||||f||||||||||2017-10-11 01:52:10.556934|2017-10-11 01:52:10.556934
NCT01818505|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-04-11|||March 2013||2013-03-01|April 2014|2014-04-01||||December 2015|Anticipated|2015-12-01||Observational|URIC||The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome|The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome|Unknown status|Recruiting|N/A|210|Anticipated|National Taiwan University Hospital|||3||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 01:52:10.668833|2017-10-11 01:52:10.668833
NCT01818492|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-06-22|||January 2013||2013-01-01|June 2017|2017-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study to Investigate the Safety and Efficacy of an Anti-IFNγ mAb in Children Affected by Primary Haemophagocytic Lymphohistiocytosis|A Phase 2/3, Open-label, Single Arm, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, in Paediatric Patients With Primary Haemophagocytic Lymphohistiocytosis|Recruiting||Phase 2/Phase 3|32|Anticipated|NovImmune SA||1|||f||||t||||||||||2017-10-11 01:52:10.762317|2017-10-11 01:52:10.762317
NCT01818479|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-08-07|||July 2013||2013-07-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Phase I/II Study of Treg/Tcon Addback to CD34 Selected Partially Matched Related Donor Stem Cells With Myeloablative Conditioning for High Risk Hematologic Malignancies|Phase I/II Study of Treg/Tcon Addback to CD34 Selected Partially Matched Related Donor Stem Cells With Myeloablative Conditioning for High Risk Hematologic Malignancies|Suspended||Phase 1/Phase 2|24|Anticipated|University of Utah||1||Study suspended due to GVHD Assessments|f||||t||||||||||2017-10-11 01:52:10.943046|2017-10-11 01:52:10.943046
NCT01818466|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-06-27|||November 2012||2012-11-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Anterior Tibiotalar Arthrodesis With Blade Plate Fixation|Anterior Tibiotalar Arthrodesis With Blade Plate Fixation in Treatment of Post-traumatic Arthritis Secondary to Pilon Fracture|Withdrawn||N/A|0|Actual|University of Utah|||1|Dr. Higgins does not have a sub-investigator that can complete the study.|f||||f||||||||||2017-10-11 01:52:11.022119|2017-10-11 01:52:11.022119
NCT01818453|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-11-06|||March 2013||2013-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Can Genetics Predict Treatment Response to a Computerized Self-help Program for Depression?|Genetic Predictors of Response to a Computerized Self-help Program for Depression|Completed||N/A|500|Anticipated|University of Texas at Austin||2|||f||||t||||||||||2017-10-11 01:52:11.08129|2017-10-11 01:52:11.08129
NCT01818440|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-09-21|||February 27, 2013||2013-02-27|September 12, 2017|2017-09-12|September 16, 2015|Actual|2015-09-16|September 16, 2015|Actual|2015-09-16||Interventional|||Fluoroscopy or 3-D Roadmap Imaging Software for Liver Tumor Treatment|Prospective Randomized Trial Comparing Navigation With 3D Roadmap vs. Conventional Angiography During Transarterial Embolization|Completed||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:52:11.154255|2017-10-11 01:52:11.154255
NCT01818427|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-09-14|||May 2014||2014-05-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|PAMPer||PreHospital Air Medical Plasma Trial|Prehospital Air Medical Plasma (PAMPer) Phase III Multicenter, Prospective, Randomized, Open-label, Interventional Trial A Four Year Multicenter Open Label Randomized Trial|Completed||Phase 3|563|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:52:11.240918|2017-10-11 01:52:11.240918
NCT01818414|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-01-16|2016-02-22||October 2013||2013-10-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|DAM||Same-day Dilapan-S With Adjunctive Misoprostol|Dilapan-S With Adjunctive Misoprostol for Same-day Second Trimester Dilation and Evacuation: A Randomized Trial|Terminated||N/A|29|Actual|University of Pittsburgh||2||Concerns for safety|f||||f||||||||Undecided||2017-10-11 01:52:11.319846|2017-10-11 01:52:11.319846
NCT01818388|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-04-25|||July 2014||2014-07-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|COOL-ARREST||COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest|A Multicenter, Prospective, Single Arm Observational Trial to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest|Completed||N/A|50|Actual|ZOLL Circulation, Inc., USA|||1||f||||t||||||||Undecided||2017-10-11 01:52:11.679595|2017-10-11 01:52:11.679595
NCT01818375|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-10-01|||February 2013||2013-02-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Goal Directed Fluid Therapy and Postoperative Ileus|Goal-directed Fluid Therapy and Postoperative Ileus After Elective Laparoscopic Colorectal Surgery Using an Enhanced Recovery Program: a Randomized Controlled Trial|Completed||N/A|128|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 01:52:11.809212|2017-10-11 01:52:11.809212
NCT01818362|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-12-14|||April 2013||2013-04-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1|A Phase I Study to Determine the Safety and Immunogenicity of Vaccination Regimens Employing the Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1|Completed||Phase 1|72|Actual|University of Oxford||6|||f||||t||||||||||2017-10-11 01:52:11.971286|2017-10-11 01:52:11.971286
NCT01818349|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2013-03-21|||March 2002||2002-03-01|March 2013|2013-03-01|December 2007|Actual|2007-12-01|December 2005|Actual|2005-12-01||Interventional|||Impact of Training on Gait and Strength in Stroke Survivors|Gait Performance and Lower-limb Muscle Strength Improved in Both Upper-limb and Lower-limb Isokinetic Training Programs in Individuals With Chronic Stroke|Completed||N/A|30|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-11 01:52:12.061541|2017-10-11 01:52:12.061541
NCT01818336|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-11-06|2016-09-09||December 2012||2012-12-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Total subjects enrolled in the study|Evaluation of Skin Testing Reagents for Penicillin Allergy|Confirmatory Study to Examine Negative Predictive Value (NPV) and Safety of Skin Testing With PRE-PEN, a Minor Determinant MIxture (MDM) of Penicillin Antigens, and Amoxicillin Reagent Against an Oral Challenge With Amoxicillin|Completed||Phase 3|481|Actual|AllerQuest LLC||1|||f||||f||||||||||2017-10-11 01:52:12.158009|2017-10-11 01:52:12.158009
NCT01818323|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-08-15|||June 2015||2015-06-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Phase I Trial: T4 Immunotherapy of Head and Neck Cancer|Phase I Trial: T4 Immunotherapy of Head and Neck Cancer|Recruiting||Phase 1|30|Anticipated|King's College London||1|||f||||t||||||||||2017-10-11 01:52:12.538746|2017-10-11 01:52:12.538746
NCT01818310|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-02-28|||September 2012||2012-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|DIALEG||Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia|Randomised Clinical Study of Safety and Efficacy of Autologous Bone Marrow Aspirate Concentrate (BMAC) for No-option_critical Limb Ischemia in Type-II Diabetes Mellitus Patients. (DIALEG)|Active, not recruiting||Phase 2/Phase 3|80|Anticipated|University Hospital Ostrava||4|||f||||t||||||||No||2017-10-11 01:52:12.642659|2017-10-11 01:52:12.642659
NCT01818297|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-09-19|2017-03-02||April 2013||2013-04-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SubQStim||Subcutaneous Nerve Stimulation for Failed Back Surgery Syndrome (FBSS) Patients|SubQStim Pivotal Study: A Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Nerve Stimulation. Protocol 1666|Terminated||N/A|137|Actual|MedtronicNeuro|Due to early study termination prior to completion of planned enrollment, the summaries describe the available data, and no conclusions can be made on the efficacy of the therapy based on the data available.|2||Sponsor decision|f||||f||||||||||2017-10-11 01:52:12.756133|2017-10-11 01:52:12.756133
NCT01818271|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-12-18|||April 2013||2013-04-01|March 2013|2013-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of a Community-based Group Rehabilitation Program for Dynamic Balance and Mobility Post Stroke|Phase 1 Study of the Effects of a Community-based Group Rehabilitation Program for Dynamic Balance and Mobility; as an Alternate to Out-patient Rehabilitation Post Stroke;|Completed||N/A|24|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 01:52:13.403158|2017-10-11 01:52:13.403158
NCT01818258|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-07-13|||October 26, 2015|Actual|2015-10-26|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|April 11, 2017|Actual|2017-04-11||Interventional|||IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children|IMPAACT 1092: Phase IV Evaluation Of The Steady State Pharmacokinetics Of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1-Infected Children|Active, not recruiting||Phase 4|52|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 01:52:13.510939|2017-10-11 01:52:13.510939
NCT01818245|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-07-25|||March 2013||2013-03-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study of LY2605541 in Healthy Participants and in the Elderly|Effect of Injection Site on the Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Doses of LY2605541 in Healthy Subjects, and Impact of Body Mass Index and Age on the Pharmacokinetics of LY2605541|Completed||Phase 1|52|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 01:52:13.627952|2017-10-11 01:52:13.627952
NCT01818232|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-06-17|||March 2013||2013-03-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|AME||Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects|A Phase 1, Open-label, Nonrandomized, Single Dose Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-LX4211, Following Oral Administration, in Healthy Male Subjects|Completed||Phase 1|8|Actual|Lexicon Pharmaceuticals||1|||f||||||||||||||2017-10-11 01:52:13.730765|2017-10-11 01:52:13.730765
NCT01818219|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2014-11-24|||February 2013||2013-02-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|RegAIN||Effects of Abnormal Respiratory Mechanics and Assisted Mechanical Ventilation on Neuro-regulation of Respiration|Effects of Abnormal Respiratory Mechanics and Assisted Mechanical Ventilation on Neuro Regulation of Respiration|Terminated||N/A|15|Actual|University Hospital, Angers||1||"Only half recruitment : restrictive respiratory mechanics group not achievable for technical   problems"|f||||f||||||||||2017-10-11 01:52:13.831796|2017-10-11 01:52:13.831796
NCT01818206|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-09-04|||February 2012||2012-02-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|MUCOPHAGES||Bacteriophage Effects on Pseudomonas Aeruginosa|Bacteriophages Effects on Pseudomonas Aeruginosa Presents in Sputum of Cystic Fibrosis (CF) Patients|Completed||N/A|59|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 01:52:13.930364|2017-10-11 01:52:13.930364
NCT01818193|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-10-28|||June 2012||2012-06-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|||Neurological Complications - Pulmonary Transplant|Neurological Complications - Pulmonary Transplant|Terminated||N/A|28|Actual|Hopital Foch|||1|Recruitment difficulties|f||||f||||||||No||2017-10-11 01:52:14.034536|2017-10-11 01:52:14.034536
NCT01818180|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-21|||May 2010||2010-05-01|March 2013|2013-03-01||||September 2012|Actual|2012-09-01||Interventional|||Urell and Pregnancy|Effect of URELL(Cranberry Vaccinium Macrocarpon)Consumption on the Prevalence of Recurrent Urinary Tract Infection and Asymptomatic Bacteriuria During Pregnancy.|Terminated||N/A|11|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 01:52:14.109251|2017-10-11 01:52:14.109251
NCT01818167|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||March 2013||2013-03-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.|A Prospective Multi-Center Blinded, Randomized, Controlled Clinical Trial Comparing the Efficacy of Provodine Topical Body Wash Versus 10% Benzoyl Peroxide Topical Body Wash for the Treatment of Hidradenitis Suppurativa|Unknown status|Recruiting|N/A|25|Anticipated|Henry Ford Health System||2|||f||||f||||||||||2017-10-11 01:52:14.202019|2017-10-11 01:52:14.202019
NCT01818154|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-25|||May 2012||2012-05-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)|Validation of a New Hand Held Light Emitting Diode (LED) Device for the Determination of Minimal Erythema Dose (MED) for Narrowband Ultraviolet B.|Suspended||N/A|20|Anticipated|Henry Ford Health System||2||Under evaluation for need for further enrollment|f||||f||||||||||2017-10-11 01:52:14.319215|2017-10-11 01:52:14.319215
NCT01818141|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-05-26|2017-02-28||October 17, 2012|Actual|2012-10-17|May 2017|2017-05-01|December 15, 2014|Actual|2014-12-15|December 15, 2014|Actual|2014-12-15||Interventional|||Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin|An Open-label, Randomized Study to Assess Inhibition of Spore Production in Patients With Clostridium Difficile Infections: Fidaxomicin Versus Vancomycin|Completed||Phase 4|34|Actual|Hartford Hospital||2|||f||||f||||||||||2017-10-11 01:52:14.439718|2017-10-11 01:52:14.439718
NCT01818128|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-20|||March 2013||2013-03-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Pretreatment of a Left-sided Double-lumen Tube to Prevent Its Misplacement to the Right Mainstem Bronchus||Completed||N/A|1540|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 01:52:15.725518|2017-10-11 01:52:15.725518
NCT01818115|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-02-22|||January 2011||2011-01-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|Hydrus II||Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery.|A Prospective, Multi-Center, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery.|Completed||N/A|100|Actual|Ivantis, Inc.||2|||f||||f||||||||No||2017-10-11 01:52:15.806444|2017-10-11 01:52:15.806444
NCT01818102|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-20|||February 2013||2013-02-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||CT Window Setting to Select Double-lumen Tube Size||Completed||N/A|228|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 01:52:15.927658|2017-10-11 01:52:15.927658
NCT01818089|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2015-09-22|||April 2013||2013-04-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Monitoring of Lung Sounds of Patients With Pneumonia|Monitoring of Lung Sounds of Patients With Pneumonia|Completed||N/A|17|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 01:52:16.011043|2017-10-11 01:52:16.011043
NCT01818076|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2014-04-14||2013-12-18|February 2013||2013-02-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines||Terminated||Phase 3|311|Actual|Revance Therapeutics, Inc.||1||Sponsor decision to terminate study (not due to safety reasons)|f||||||||||||||2017-10-11 01:52:16.111888|2017-10-11 01:52:16.111888
NCT01818063|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-05-10|||April 25, 2013|Actual|2013-04-25|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|April 2018|Anticipated|2018-04-01||Interventional|||Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer|An Adaptive, Randomized Phase II Trial to Determine Pathologic Complete Response With the Addition of Carboplatin With and Without Veliparib to Standard Chemotherapy in the Neoadjuvant Treatment of Triple-Negative Breast Cancer|Active, not recruiting||Phase 2|9|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 01:52:16.222004|2017-10-11 01:52:16.222004
NCT01818050|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-04-04|||March 2013||2013-03-01|April 2013|2013-04-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Prospective Evaluation of Stent Patency in Patients With Benign Biliary Obstruction of the Wing Biliary Stent (Viaduct™)|Prospective Evaluation of Stent Patency in Patients With Benign Biliary Obstruction of the Wing Biliary Stent (Viaduct™)|Unknown status|Recruiting|Phase 4|50|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 01:52:16.395453|2017-10-11 01:52:16.395453
NCT01818037|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-03-25|||January 2003||2003-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Long-term Postoperative Outcomes After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos|A Long-term Postoperative Outcome After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos|Completed||N/A|36|Actual|Iladevi Cataract and IOL Research Center|||1||f||||t||||||||||2017-10-11 01:52:16.621803|2017-10-11 01:52:16.621803
NCT01818024|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-05-12|||February 22, 2013|Actual|2013-02-22|May 2017|2017-05-01|October 25, 2013|Actual|2013-10-25|October 25, 2013|Actual|2013-10-25||Interventional|||A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers|A Three Part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of Inhaled and Intravenous GSK2862277 in Healthy Volunteers|Completed||Phase 1|54|Actual|GlaxoSmithKline||11|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:52:16.844876|2017-10-11 01:52:16.844876
NCT01818011|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-07-10|||August 7, 2013|Actual|2013-08-07|July 2017|2017-07-01|October 18, 2013|Actual|2013-10-18|October 18, 2013|Actual|2013-10-18||Interventional|||A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects|A Three-Part Phase I, Open-Label, Single Ascending Dose, and A Single-Blind, Placebo-Controlled, Repeat Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Relative Bioavailability of Intravenous and Oral GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects|Terminated||Phase 1|12|Actual|GlaxoSmithKline||5||"Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen   that changed the risk: benefit profile and led to a termination"|f||||f||||||||||2017-10-11 01:52:17.020841|2017-10-11 01:52:17.020841
NCT01817998|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-02-22|||November 2012||2012-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|EXAF||Atrial Fibrillation (AF) and Physical Exercise|Role of Physical Exercise in Patients With Atrial Fibrillation.|Completed||N/A|76|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 01:52:17.202632|2017-10-11 01:52:17.202632
NCT01817985|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-08-28|||March 2013||2013-03-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment|A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment|Completed||Phase 1|33|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 01:52:17.332098|2017-10-11 01:52:17.332098
NCT01817972|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-21|||March 2013||2013-03-01|March 2013|2013-03-01|November 2014|Anticipated|2014-11-01|June 2014|Anticipated|2014-06-01||Interventional|||Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease|A Phase III, Randomized, Double-blind Trial in the Comparison of Cimzia Versus Cimzia Plus Azathioprine in the Change in Mean SES-CD (Simple Endoscopic Scores-Crohn's Disease) Scores in the Treatment of Active, Moderate to Severe Crohn's Disease|Unknown status|Not yet recruiting|Phase 3|65|Anticipated|Gastroenterology Research of America||2|||f||||f||||||||||2017-10-11 01:52:17.461087|2017-10-11 01:52:17.461087
NCT01817959|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-07-30|||October 2012||2012-10-01|July 2015|2015-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|REP0211||Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation|A Phase 3, Multicenter, Randomized, Double-blind, Parallel Assignment Study to Assess the Efficacy and Safety of Reparixin in Pancreatic Islet Transplantation|Unknown status|Active, not recruiting|Phase 3|42|Anticipated|Dompé Farmaceutici S.p.A||2|||f||||f||||||||||2017-10-11 01:52:17.594521|2017-10-11 01:52:17.594521
NCT01817946|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-07-25|||March 2013||2013-03-01|July 2016|2016-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Myotubular Myopathy Genetic Testing Study|Myotubular Myopathy Genetic Testing Study|Recruiting||N/A|40|Anticipated|Cure CMD|||1||f||||f||||||Samples With DNA|"     saliva, whole blood, or other source   "|||2017-10-11 01:52:17.758245|2017-10-11 01:52:17.758245
NCT01817933|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||July 2010||2010-07-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Interventional|||Integrated Rehabilitation Program for Fractures||Completed||N/A|||Changhua Christian Hospital||1|||f||||||||||||||2017-10-11 01:52:17.918507|2017-10-11 01:52:17.918507
NCT01817920|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||January 2004||2004-01-01|March 2013|2013-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Integrated Interdisciplinary Program for Fall Prevention in Hospitalized Patients||Completed||N/A|3000|Actual|Changhua Christian Hospital||1|||f||||||||||||||2017-10-11 01:52:18.023142|2017-10-11 01:52:18.023142
NCT01817907|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-01-06|2016-11-01||March 2013||2013-03-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|||The Effects of Trazodone on Sleep Apnea Severity|The Effects of Trazodone on the Severity of Obstructive Sleep Apnea|Completed||N/A|15|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:52:18.114126|2017-10-11 01:52:18.114126
NCT01817894|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-11-29|||January 2012||2012-01-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism|Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism|Completed||Phase 4|22|Actual|Bispebjerg Hospital||1|||f||||f||||||||||2017-10-11 01:52:18.440424|2017-10-11 01:52:18.440424
NCT01817881|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-06-18|||March 2013||2013-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Investigation of the Accuracy of Temporal Artery Thermometers|Investigation of the Accuracy in the Use of Temporal Artery Thermometers for Non-invasive Temperature Measurement|Completed||N/A|385|Actual|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-11 01:52:18.547421|2017-10-11 01:52:18.547421
NCT01815216|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-06-01|||March 2013||2013-03-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Gastric Bypass Surgery on Brain Responses|The Effects of Bariatric Surgery on Impulsivity and Attentional Bias to Food Cues|Suspended||N/A|48|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-11 01:52:58.898312|2017-10-11 01:52:58.898312
NCT01817868|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-09-11|||January 4, 2013|Actual|2013-01-04|September 2017|2017-09-01|August 30, 2018|Anticipated|2018-08-30|June 28, 2018|Anticipated|2018-06-28||Observational|||Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients|Evaluation of Efficacy, Safety and Costs of Recombinant FVIII Products Applied to Severe Hemophilia A Patients: Observational Data Collection Study Evaluating On-demand Treatment and Secondary Prophylaxis|Active, not recruiting||N/A|73|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:52:18.619041|2017-10-11 01:52:18.619041
NCT01817855|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-02-29|2015-10-23||September 2013||2013-09-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||All subjects who received at least 1 dose of the investigational product, AZD7624 or placebo and for whom any postdose data were available were included in the analysis (safety population).|To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD Patients|A Phase I, Randomized, DoubleBlind Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Inhaled Doses (MAD) of AZD7624 to Healthy Subjects and Patients With COPD|Completed||Phase 1|52|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 01:52:18.739956|2017-10-11 01:52:18.739956
NCT01817842|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||July 2010||2010-07-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study of Mobile Phone Support for the DC Tobacco Quitline|Comparative Effectiveness of Web-based Mobile Support for the DC Tobacco Quitline|Completed||N/A|803|Actual|Truth Initiative||2|||f||||t||||||||||2017-10-11 01:52:19.322754|2017-10-11 01:52:19.322754
NCT01817829|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-03-21|||December 2011||2011-12-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Oral Paracetamol as Preemptive Analgesia for Labor Pain|Oral Paracetamol as Preemptive Analgesia for Labor Pain|Completed||Phase 3|100|Actual|Ain Shams University||2|||f||||f||||||||||2017-10-11 01:52:19.434365|2017-10-11 01:52:19.434365
NCT01817816|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2015-11-03|||January 2009||2009-01-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients||Completed||N/A|80|Actual|Changhua Christian Hospital||4|||f||||||||||||||2017-10-11 01:52:19.524245|2017-10-11 01:52:19.524245
NCT01817803|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2014-02-17|||March 2013||2013-03-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)||Withdrawn||N/A|0|Actual|Yonsei University||4|||f||||f||||||||||2017-10-11 01:52:19.618985|2017-10-11 01:52:19.618985
NCT01817790|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-03-06|2013-12-12||December 2012||2012-12-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Assessment of Fluticasone Propionate on Ocular Allergy Symptoms|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy of Once-Daily Fluticasone Propionate Aqueous Nasal Spray 200mcg for 14 Days on Ocular Symptoms Associated With Seasonal Allergic Rhinitis|Completed||Phase 3|626|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:52:19.740932|2017-10-11 01:52:19.740932
NCT01817777|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-11-18|2014-09-25||May 2013||2013-05-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes|A Pharmacy Based Open Study to Evaluate Whether Pack Size Affects Compliance for Subjects Diagnosed With Diabetes Type II Who Are Established on Metformin Treatment|Terminated||Phase 4|31|Actual|GlaxoSmithKline||2||"It's no longer feasible to continue to recruit patients into the study as severe recruitment   difficulties have been experienced since the study start"|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:52:20.732808|2017-10-11 01:52:20.732808
NCT01817764|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-03-03|2014-04-24||March 2013||2013-03-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|DB2114930: A Randomized, Multi-center, Double-blind, Double-dummy, Parallel Group Study to Evaluate the Efficacy and Safety of Umeclidinium/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With COPD|Completed||Phase 3|707|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:52:21.218828|2017-10-11 01:52:21.218828
NCT01817751|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-09-11|||April 11, 2013||2013-04-11|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients With Recurrent High-Grade Glioma|Phase 2 Study of Sorafenib, Valproic Acid, and Sildenafil in the Treatment of Recurrent High-Grade Glioma|Recruiting||Phase 2|66|Anticipated|Virginia Commonwealth University||1|||f||||t|t|f|||t|||||2017-10-11 01:52:21.777357|2017-10-11 01:52:21.777357
NCT01817738|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-02-15|||August 2012||2012-08-01|April 2016|2016-04-01|January 2017|Actual|2017-01-01|August 2016|Actual|2016-08-01||Interventional|||Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer|A Randomised, Double-blind, Placebo-controlled, Phase I/II Trial of RNActive®-Derived Cancer Vaccine (CV9104) in Asymptomatic or Minimally Symptomatic Patients With Metastatic Castrate-refractory Prostate Cancer|Terminated||Phase 1/Phase 2|197|Actual|CureVac AG||2||"Follow up period after primary analysis was prematurely stopped because more mature data will   not impact the study outcome"|f||||t||||||||||2017-10-11 01:52:22.021223|2017-10-11 01:52:22.021223
NCT01817725|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-03-22|2017-02-02||March 2013||2013-03-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg|Effect of Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAg—a Pilot Study|Completed||Phase 1|20|Actual|Chang Gung Memorial Hospital|This is a pilot study. A control arm is not included. However, from literature review, natural HBsAg decay without seroconversion was around 0.054~0.058 log IU/ml/year.|1|||f||||t||||||||No||2017-10-11 01:52:22.251163|2017-10-11 01:52:22.251163
NCT01817712|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-03-24|||December 31, 2013|Actual|2013-12-31|March 2017|2017-03-01|February 3, 2017|Actual|2017-02-03|October 31, 2016|Actual|2016-10-31||Interventional|VIP-STAR||Veterans Individual Placement and Support Towards Advancing Recovery|CSP #589 - Veterans Individual Placement and Support Towards Advancing Recovery|Completed||Phase 4|541|Actual|VA Office of Research and Development||2|||f||||t||||||||No||2017-10-11 01:52:22.497562|2017-10-11 01:52:22.497562
NCT01817699|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-01-30|||April 2013||2013-04-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|July 2019|Anticipated|2019-07-01||Interventional|CANDLE-KIT||Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients|A Factorial Randomized Controlled Trial of Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients|Enrolling by invitation||Phase 4|246|Anticipated|CANDLE-KIT Trial Study Group||4|||f||||t||||||||||2017-10-11 01:52:22.658204|2017-10-11 01:52:22.658204
NCT01817686|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-06-29|||March 2013||2013-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study of Default Options in Advance Directives|Default Options in Advance Directives for Veterans With Serious Illnesses: A Randomized Clinical Trial|Completed||N/A|62|Actual|Corporal Michael J. Crescenz VA Medical Center||3|||f||||f||||||||||2017-10-11 01:52:22.822997|2017-10-11 01:52:22.822997
NCT01817673|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-22|||July 2011||2011-07-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Creatine Supplementation on Kidney Function in Resistance-trained Individuals||Completed||N/A|46|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 01:52:22.963471|2017-10-11 01:52:22.963471
NCT01817660|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-01-12|||February 2013||2013-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|OVERPAR||Open Versus Endovascular Repair of Popliteal Artery Aneurysm Trial|Open Versus Endovascular Repair of Popliteal Artery Aneurysm Trial|Terminated||N/A|6|Actual|Boston Medical Center||2||Due to unsuccessful trial accrual|f||||t||||||||||2017-10-11 01:52:23.059363|2017-10-11 01:52:23.059363
NCT01817647|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2014-09-26|||December 2012||2012-12-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01|2 Years|Observational [Patient Registry]|PREDICS||PREDICS Study: PCT Reveals Early Dehiscence in Colorectal Surgery|PREDICS Study: Procalcitonin Reveals Early Dehiscence in Colorectal Surgery|Completed||N/A|504|Actual|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 01:52:23.173208|2017-10-11 01:52:23.173208
NCT01817634|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-05-03|||November 2013||2013-11-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|OME³Jim||ω3 LCPUFAs for Healthy Growth and Development of Infants and Young Children in Southwest Ethiopia|ω3 Long-chain Polyunsaturated Fatty Acids for Healthy Growth and Development of Infants and Young Children in the Gilgel Gibe Hydroelectric Dam Area, Ethiopia.|Completed||N/A|720|Actual|University Ghent||4|||f||||f||||||||||2017-10-11 01:52:23.265678|2017-10-11 01:52:23.265678
NCT01817621|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-04-06|||February 2013||2013-02-01|April 2015|2015-04-01||||June 2017|Anticipated|2017-06-01||Interventional|BUILD||Body Image and Self-Care in HIV-Infected MSM|Body Image and Self-Care in HIV-Infected MSM|Unknown status|Recruiting|N/A|69|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 01:52:23.400776|2017-10-11 01:52:23.400776
NCT01817608|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2013-03-20|||September 2004||2004-09-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Weaning From Mechanical Ventilation in the ICU|Weaning From Mechanical Ventilation in the ICU|Completed||N/A|66|Actual|Loyola University|||1||f||||f||||||||||2017-10-11 01:52:23.523229|2017-10-11 01:52:23.523229
NCT01817595|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-12-03|||April 2013||2013-04-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Evaluation of Iphone Technology in Diabetes Treatment|Evaluation of Iphone Technology in Diabetes Treatment|Completed||N/A|43|Actual|Endocrine Research Society||2|||f||||f||||||||||2017-10-11 01:52:23.586509|2017-10-11 01:52:23.586509
NCT01817582|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2014-08-20|||May 2013||2013-05-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca|A Randomized, Multi-Center, Parallel-Group, Safety and Efficacy Study of Lotemax® Gel 0.5% and Restasis 0.05% for 12 Weeks in Subjects With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease; DED)|Completed||Phase 2|102|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-10-11 01:52:23.680881|2017-10-11 01:52:23.680881
NCT01817569|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-08-24|||February 1, 2011|Actual|2011-02-01|August 2017|2017-08-01|April 30, 2020|Anticipated|2020-04-30|April 30, 2020|Anticipated|2020-04-30||Observational|||Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)|Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)|Active, not recruiting||N/A|3100|Anticipated|AstraZeneca|||1||f||||||||||||||2017-10-11 01:52:23.789558|2017-10-11 01:52:23.789558
NCT01817556|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2013-11-05|||October 2012||2012-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.|A Multicenter, Active-controlled, Randomized, Double-blind Paralleled-group Clinical Trial to Evaluate the Efficacy of 4-week Treatment With Stillen Tab. in Patients With Acute or Chronic Gastritis|Completed||Phase 4|258|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:52:23.99155|2017-10-11 01:52:23.99155
NCT01817543|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-10-19|||October 2013||2013-10-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers|A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers|Terminated||N/A|2|Actual|Cytomedix||1||Protocol study design was re-done in collaboration with CMS|f||||t||||||||||2017-10-11 01:52:24.089774|2017-10-11 01:52:24.089774
NCT01817530|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2016-06-15||2016-06-15|January 2013||2013-01-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)|A Phase 2b Study to Evaluate the Safety and Efficacy of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids|Completed||Phase 2|571|Actual|AbbVie||8|||f||||f||||||||||2017-10-11 01:52:24.208298|2017-10-11 01:52:24.208298
NCT01817517|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-08-15|||March 2014||2014-03-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome|Phase 1 Study of Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome|Recruiting||N/A|10|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:52:24.573815|2017-10-11 01:52:24.573815
NCT01817504|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-05-29|||August 2012||2012-08-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|DESYRE||Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure|Interest of Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure|Recruiting||N/A|118|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:52:24.665345|2017-10-11 01:52:24.665345
NCT01817478|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-22|||January 2013||2013-01-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||The Influence of Hospital Environment on Eyes Infections in Medical Staff||Unknown status|Recruiting|N/A|90|Anticipated|Ziv Hospital||1|||f||||||||||||||2017-10-11 01:52:24.935263|2017-10-11 01:52:24.935263
NCT01817465|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-01-25|||August 2012||2012-08-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Demonstrate the Efficacy and Safety of Motilitone®|A Multi-centers, Randomized, Double-blinded, Parallel Study Study to Evaluate the Efficacy and Safety of Motilitone® in Patients With Functional Dyspepsia.|Completed||Phase 4|389|Actual|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:52:25.057539|2017-10-11 01:52:25.057539
NCT01817452|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-18|||March 2014||2014-03-01|May 2015|2015-05-01|August 2020|Anticipated|2020-08-01|August 2015|Anticipated|2015-08-01||Interventional|ADAPT||A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol|A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol|Recruiting||Phase 2|220|Anticipated|West German Study Group||2|||f||||t||||||||||2017-10-11 01:52:25.156519|2017-10-11 01:52:25.156519
NCT01817439|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-22|||May 2013||2013-05-01|March 2013|2013-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF|The Effect of Intravenous vs. Oral Administration of Amiodarone on the Incidence Rate of Phlebitis Among Patients With Recent Onset of Atrial Fibrillation (AF)|Unknown status|Not yet recruiting|Phase 3|104|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||f||||||||||2017-10-11 01:52:25.260072|2017-10-11 01:52:25.260072
NCT01817426|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-10-31|||November 2012||2012-11-01|October 2014|2014-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|STOP IT||Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission|Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission: A Multi-center, Double Blinded, Randomized, Placebo Controlled Study|Unknown status|Recruiting|Phase 4|136|Anticipated|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 01:52:25.352271|2017-10-11 01:52:25.352271
NCT01817413|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-12-09|||February 2011||2011-02-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Two Dental Techniques Used to Treat Teeth Which Have Become Infected or Painful Following Trauma|Revascularisation Versus Mineral Trioxide Aggregate in the Management of Non-Vital Immature Permanent Incisors in a Young Population: A Randomised Controlled Trial (Pilot Study)|Completed||Phase 4|30|Actual|University of Liverpool||2|||f||||f||||||||||2017-10-11 01:52:25.482058|2017-10-11 01:52:25.482058
NCT01817400|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2015-03-12|||March 2013||2013-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MARO||Mediators of Abnormal Reproductive Function in Obesity (MARO)|Mediators of Abnormal Reproductive Function in Obesity|Completed||Early Phase 1|10|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-10-11 01:52:25.587754|2017-10-11 01:52:25.587754
NCT01817387|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-11-14|||July 2014||2014-07-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|PRIME||Enhancing Motivation in Recent Onset Schizophrenia|Developing an Intervention Strategy to Enhance Motivation in Recent Onset Schizophrenia|Active, not recruiting||N/A|70|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 01:52:25.691438|2017-10-11 01:52:25.691438
NCT01817361|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-03-27|||October 2007||2007-10-01|March 2017|2017-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Oral Health and People With Systemic Sclerosis|Oral Health and People With Systemic Sclerosis|Completed||N/A|210|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-10-11 01:52:25.898496|2017-10-11 01:52:25.898496
NCT01817348|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-10-27|||January 2013||2013-01-01|October 2016|2016-10-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Combined Intra-articular Injection of Lidocaine Plus Physiotherapy in Treatment of Frozen Shoulder|Effect of Combined Intra-articular Injection of Lidocaine Plus Physiotherapy in Treatment of Frozen Shoulder|Completed||N/A|60|Actual|Shin Kong Wu Ho-Su Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:52:25.978896|2017-10-11 01:52:25.978896
NCT01817335|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-05-29|||August 2013||2013-08-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Psycho-Educational Program in Increasing Knowledge and Satisfaction and Decreasing Distress in Younger Patients With Cancer Receiving Treatment|Pilot Study of Psycho-Educational Group for Young Adults (YA) on Treatment: Impact on Knowledge, Distress, and Satisfaction|Completed||N/A|22|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:52:27.758686|2017-10-11 01:52:27.758686
NCT01817322|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-10-02|||June 2011||2011-06-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|MyLowCsA||Kidney Graft Function Under the Immunosuppression Strategies|Kidney Graft Function Under the Immunosuppression Strategies With Low Dose of Neoral®(Cyclosporine) and Standard Dose of Myfortic®(Enteric-Coated Mycophenolate Sodium) vs. With Conventional Dose of Neoral®(Cyclosporine) and Reduced Dose of Myfortic®(Enteric-Coated Mycophenolate Sodium) in De Novo Renal Transplant Recipients|Completed||Phase 4|140|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 01:52:27.887688|2017-10-11 01:52:27.887688
NCT01817309|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-07-27|||June 2013||2013-06-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis|Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis|Completed||Phase 4|325|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 01:52:27.981757|2017-10-11 01:52:27.981757
NCT01817296|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2014-05-14|||March 2013||2013-03-01|May 2014|2014-05-01||||April 2014|Actual|2014-04-01||Interventional|||Klinefelter Fertility Preservation|Klinefelter Syndrome: Are we Missing the Optimal Time for Fertility Preservation?|Completed||N/A|15|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 01:52:28.060203|2017-10-11 01:52:28.060203
NCT01817283|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-22|||January 2013||2013-01-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|July 2014|Anticipated|2014-07-01||Interventional|CACTrip12||Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders|Study of Triptolide Woldifiion T Cell Immune Activation and Inflammation Biomarkers in HIV-infected Immunological Non-responders|Unknown status|Recruiting|Phase 1/Phase 2|150|Anticipated|Peking Union Medical College||2|||f||||t||||||||||2017-10-11 01:52:28.140805|2017-10-11 01:52:28.140805
NCT01817257|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2013-03-20|||March 2013||2013-03-01|March 2013|2013-03-01|February 2015|Anticipated|2015-02-01|November 2014|Anticipated|2014-11-01||Interventional|ALICAT||Anticoagulation Length in Cancer Associated Thrombosis|A Feasibility Study to Inform the Design of a Randomised Controlled Trial to Identify the Most Clinically and Cost Effective Length of Anticoagulation With Low Molecular Weight Heparin In the Treatment of Cancer Associated Thrombosis|Unknown status|Not yet recruiting|Phase 2|200|Anticipated|Cardiff University||2|||f||||t||||||||||2017-10-11 01:52:28.311468|2017-10-11 01:52:28.311468
NCT01817244|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-01-18|||March 2013|Actual|2013-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Long Term Effect of Collaborative Care on Depression Treatment in a Community Dwelling Elderly||Completed||N/A|82|Actual|National Clinical Research Coordination Center, Seoul, Korea||2|||f||||||||||||||2017-10-11 01:52:28.418697|2017-10-11 01:52:28.418697
NCT01817231|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-22|||May 2009||2009-05-01|March 2013|2013-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Epidemiological Analysis of Vitamin D and Breast Cancer Risk in Saudi Arabian Women|Vitamin D Status and Breast Cancer in Saudi Arabian Women: Case Control Study|Completed||N/A|240|Actual|University of Arizona|||1||f||||f||||||Samples Without DNA|"     serum for vitamin D levels   "|||2017-10-11 01:52:28.486567|2017-10-11 01:52:28.486567
NCT01817218|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-07-22|||June 2013||2013-06-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|PRP-2012||Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers|Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers Compared to Moist Wound Care in a Primary Care Setting|Completed||Phase 1/Phase 2|40|Anticipated|Basque Health Service||2|||f||||t||||||||||2017-10-11 01:52:28.553788|2017-10-11 01:52:28.553788
NCT01817205|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-21|2017-08-18|||March 2013||2013-03-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma|A Pilot Study on the Feasibility of Combined Chemoembolization and Adjuvant Systemic Hyperthermia for Palliative Treatment of Unresectable Hepatocellular Carcinoma(HCC)|Terminated||Phase 1|10|Anticipated|Chinese University of Hong Kong||1||poor case accrual|f||||t||||||||||2017-10-11 01:52:28.721713|2017-10-11 01:52:28.721713
NCT01817192|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2014-03-19|||May 2013||2013-05-01|March 2014|2014-03-01||||April 2021|Anticipated|2021-04-01||Interventional|||Adjuvant Chemotherapy in Patients With High Risk Stage I Non-squamous Non-Small Cell Lung Cancer|A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I Non-Squamous Non-Small Cell Lung Cancer Identified as High Risk by the Pervenio™ Lung RS Assay|Active, not recruiting||N/A|700|Anticipated|Encore Clinical||2|||f||||t||||||||||2017-10-11 01:52:28.797643|2017-10-11 01:52:28.797643
NCT01817179|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-01-27|||March 2013||2013-03-01|March 2013|2013-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Functional Electrical Stimulation for Hemiplegic Cerebral Palsy|Effects of Functional Electrical Stimulation Neuroprosthesis in Children With Hemiplegic Cerebral Palsy|Completed||N/A|12|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 01:52:28.907238|2017-10-11 01:52:28.907238
NCT01817166|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-06-21|||July 2013||2013-07-01|July 2016|2016-07-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|D-Lay-MS||Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome|Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.|Recruiting||Phase 3|316|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||||2017-10-11 01:52:29.003442|2017-10-11 01:52:29.003442
NCT01817153|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-03-28|||November 2013||2013-11-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|HyStOON||Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.|Effect of Intravenous Hydrocortison on Post-ischemic Brachial Artery Dilation and on Thenar Oxygen Saturation in Adult Septic Shock. A Human Placebo-controlled Randomized Study.|Recruiting||Phase 2/Phase 3|60|Anticipated|Centre Hospitalier Régional d'Orléans||2|||f||||f||||||||||2017-10-11 01:52:29.391643|2017-10-11 01:52:29.391643
NCT01817140|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-10-28|||April 2013||2013-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Assessment of Mandibular Bone Invasion With MRI Using SWIFT|Assessment of Mandibular Bone Invasion With Magnetic Resonance Imaging (MRI) Using Sweep Imaging Fourier Transformation (SWIFT)|Enrolling by invitation||N/A|10|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||||2017-10-11 01:52:29.485313|2017-10-11 01:52:29.485313
NCT01817127|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-07-10|||April 2009|Actual|2009-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study|Functional Deconstruction of Human Milk Oligosaccharides and Lipids|Active, not recruiting||N/A|395|Actual|University of California, Davis|||6||f||||f||||||Samples With DNA|"     Breast milk, blood, saliva, urine, stool, epidermal skin cells   "|||2017-10-11 01:52:29.553891|2017-10-11 01:52:29.553891
NCT01817114|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-07-13|||March 2013||2013-03-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|CRIC-RCT||Chronic Remote Ischemic Conditioning to Modify Post-MI Remodeling|Chronic Remote Ischemic Conditioning Following Primary Percutaneous Intervention for ST-Elevated Myocardial Infarction|Recruiting||N/A|20|Anticipated|The Hospital for Sick Children||2|||f||||||||||||||2017-10-11 01:52:29.660549|2017-10-11 01:52:29.660549
NCT01817101|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-07-16|||January 2012||2012-01-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population.|Field Trial With Omega-3 Fatty Acid Supplementation for the Prevention of Cognitive Decline in a Very Elderly Population|Unknown status|Active, not recruiting|N/A|170|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||f||||||||||2017-10-11 01:52:29.750007|2017-10-11 01:52:29.750007
NCT01817088|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-08-22|||March 11, 2013|Actual|2013-03-11|August 2017|2017-08-01|September 9, 2016|Actual|2016-09-09|September 9, 2016|Actual|2016-09-09||Interventional|PARKEO||Sub-thalamic Nucleus Stimulation in Parkinson Disease|Sub-thalamic Nucleus Stimulation in Parkinson Disease: Comparison of a Two-steps Electrophysiological Approach Under Local and General Anesthesia and a One-step Approach Under General Anesthesia|Completed||N/A|30|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 01:52:29.831851|2017-10-11 01:52:29.831851
NCT01817075|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-04-24|||November 2013||2013-11-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant|Impact of Cleansing With Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children With Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)|Active, not recruiting||Phase 3|177|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 01:52:29.933194|2017-10-11 01:52:29.933194
NCT01817062|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-05-07|||January 2001||2001-01-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|December 2011|Actual|2011-12-01||Observational|NeoNec||Neonates With Very Low Birth Weight and Surgery Therapy of Acute Abdomen|Retrospective Analysis of Intraoperative Volume Administration in Neonates Without Congenital Malformations With Very Low Birth Weight and Acute Abdomen.|Completed||N/A|89|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 01:52:30.243173|2017-10-11 01:52:30.243173
NCT01817049|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-28|||March 2013||2013-03-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Effect of a Behavioural Intervention on Injury Prevention Program Adherence in Female Youth Soccer|Examining the Effect of a Behavioural-based Intervention on Injury Prevention Program Adherence in Canadian Female Youth Soccer Players|Completed||N/A|214|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 01:52:30.319521|2017-10-11 01:52:30.319521
NCT01817036|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-01-15|||January 2013||2013-01-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Vitamin D Intervention Trial in Healthy Chinese|Knowledge Innovation Project of CAS - Genetic and Nutritional Association Studies on Metabolism-related Diseases in Chinese Population -- Vitamin D Intervention Study：A Pilot Study|Completed||Phase 1|75|Actual|Chinese Academy of Sciences||5|||f||||||||||||||2017-10-11 01:52:30.41527|2017-10-11 01:52:30.41527
NCT01817023|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2014-09-09|||April 2013||2013-04-01|September 2014|2014-09-01|April 2018|Anticipated|2018-04-01|April 2015|Anticipated|2015-04-01||Interventional|||The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT|Multicenter Phase III Study of Intensity-modulated Radiotherapy Alone Compared to Intensity-modulated Radiotherapy Combined Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 3|590|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:52:30.518487|2017-10-11 01:52:30.518487
NCT01817010|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-07-08|||September 2012||2012-09-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Strength and Function Following Total Hip Arthroplasty|Strength and Function Following Total Hip Arthroplasty|Completed||N/A|68|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:52:30.634415|2017-10-11 01:52:30.634415
NCT01816997|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-11-15|||January 2012||2012-01-01|November 2013|2013-11-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose|The Influence of Statins on Glucose Homeostasis and the Biomarkers of Diabetes in Subjects With Impaired Fasting Glucose|Recruiting||Phase 4|160|Anticipated|Taipei Veterans General Hospital, Taiwan||3|||f||||f||||||||||2017-10-11 01:52:30.715366|2017-10-11 01:52:30.715366
NCT01816984|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-05-22|||May 2013||2013-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Biomarker Driven Pilot Study of the Pan-class I PI3K Inhibitor NVP-BKM120 in Combination With Cetuximab in Patients With Recurrent/Metastatic Head and Neck Cancer|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 01:52:30.82609|2017-10-11 01:52:30.82609
NCT01816971|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-05-22|||January 2013||2013-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma|Open-label, Single-arm, Phase 2 Study of the Initial and Post-Transplant Treatment With Carfilzomib, Lenalidomide and Low Dose Dexamethasone (CRd) in Transplant Candidates With Newly Diagnosed, Multiple Myeloma Requiring Systemic Chemotherapy|Active, not recruiting||Phase 2|44|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 01:52:30.971335|2017-10-11 01:52:30.971335
NCT01816958|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-20|||January 2011||2011-01-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|TMS/ketamine||Neuromodulation to Facilitate the Effect of Ketamine|Treatment of Thalamocortical Dysrhythmia Using External Neuromodulation to Facilitate the Therapeutic Effect of Ketamine.|Completed||N/A|35|Actual|The Neuroscience Center, LLC|||1||f||||t||||||||||2017-10-11 01:52:31.102309|2017-10-11 01:52:31.102309
NCT01816932|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2014-03-10|||June 2013||2013-06-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Home or Office Visit for the Insertion of Implantable Birth Control|Home or Office Visit for Insertion of Etonogestrel Implant: A Pilot Study|Unknown status|Active, not recruiting|N/A|50|Anticipated|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 01:52:31.273861|2017-10-11 01:52:31.273861
NCT01816919|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-07-30|||November 2010||2010-11-01|March 2013|2013-03-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional|HNeNose||Characterization of Head and Neck Malignant Tumors Using an Electronic Nose|Characterization of Head and Neck Malignant Tumors Using an Electronic Nose|Completed||N/A|100|Actual|Carmel Medical Center||1|||f||||t||||||||||2017-10-11 01:52:31.377155|2017-10-11 01:52:31.377155
NCT01816906|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-05-17|||May 2012||2012-05-01|May 2016|2016-05-01|May 2016|Anticipated|2016-05-01|April 2016|Actual|2016-04-01||Interventional|DiaBSmart||Development and Testing of a New Generation of Diabetic Footwear|Development of a New Generation of DIABetic Footwear Using an Integrated Approach and SMART Materials|Active, not recruiting||N/A|70|Anticipated|Staffordshire University||2|||f||||t||||||||||2017-10-11 01:52:31.452952|2017-10-11 01:52:31.452952
NCT01816893|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-07-21|||January 2005||2005-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|HypoANS||Hypoglycemia and Autonomic Nervous System Function|Hypoglycemia and Autonomic Nervous System Function|Recruiting||N/A|260|Anticipated|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-11 01:52:31.537847|2017-10-11 01:52:31.537847
NCT01816880|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-10-14|||June 2012||2012-06-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort|Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort (HSC# 004789)|Completed||N/A|15|Actual|Scripps Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     Blood sample of approximately 20mL   "|||2017-10-11 01:52:31.657876|2017-10-11 01:52:31.657876
NCT01816867|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-05-21|||January 2013||2013-01-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01|12 Months|Observational [Patient Registry]|||Laparoscopic and Open Ventral Hernia Repair Using the Intramesh T1|Laparoscopic and Open Ventral Hernia Repair Using the Intramesh T1: a Prospective, Multicenter Registry|Completed||N/A|96|Actual|be Medical|||1||f||||f||||||||||2017-10-11 01:52:31.725517|2017-10-11 01:52:31.725517
NCT01816854|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-07-15|||January 2013||2013-01-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01|12 Months|Observational [Patient Registry]|||Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent|Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent|Unknown status|Recruiting|N/A|300|Anticipated|be Medical|||1||f||||f||||||||||2017-10-11 01:52:31.803296|2017-10-11 01:52:31.803296
NCT01816841|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-02-22|||November 11, 2008|Actual|2008-11-11|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care|The Role of Direct Visual Fluorescence in Oral Examination|Recruiting||N/A|283|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:52:31.893401|2017-10-11 01:52:31.893401
NCT01816828|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-07-06|||March 2013||2013-03-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men|A Small Group Intervention to Reduce HIV Sexual Transmission Risk Behaviour Among HIV Positive Men Who Have Sex With Men: Gay Poz Sex (GPS)|Active, not recruiting||N/A|173|Actual|Ryerson University||2|||f||||t||||||||||2017-10-11 01:52:32.006572|2017-10-11 01:52:32.006572
NCT01816815|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2014-04-18|||November 2011||2011-11-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study in 60 Healthy Tubal-ligated Women Aged 18 to 45 Years Investigating the Pharmacodynamic Effects of 5 Different Doses (0.1 - 5 mg) BAY1002670 After Daily Oral Administration Over 84 Days|Completed||Phase 1|73|Actual|Bayer||6|||f||||f||||||||||2017-10-11 01:52:32.0952|2017-10-11 01:52:32.0952
NCT01816802|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-03-25|||February 2013||2013-02-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01|12 Months|Observational [Patient Registry]|MERGE||Registry Study of Traditional Morphology Grading Combined With Eeva in IVF Treatment|MERGE: MulticEnter ReGistry With Eeva|Unknown status|Active, not recruiting|N/A|1200|Anticipated|Progyny, Inc.|||1||f||||f||||||||||2017-10-11 01:52:32.192478|2017-10-11 01:52:32.192478
NCT01816789|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-12-22|||March 2013||2013-03-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles|Age Versus Ovarian Reserve Markers Based Therapy in IN Vitro Fertilization|Terminated||Phase 4|194|Actual|Andros Day Surgery Clinic||2||Optimal response: 63% nomogram, 42% controls, overcoming the stopping rule for interim analysis|f||||f||||||||||2017-10-11 01:52:32.297825|2017-10-11 01:52:32.297825
NCT01816776|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-08-10|2017-06-13||March 2013||2013-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 10, 2016|Actual|2016-09-10||Interventional||Intent-to-treat|Respicardia, Inc. Pivotal Trial of the remedē System|A Randomized Trial Evaluating the Safety and Effectiveness of the remedē® System in Patients With Central Sleep Apnea|Active, not recruiting||N/A|151|Actual|Respicardia, Inc.||2|||f||||t||||||||||2017-10-11 01:52:32.421074|2017-10-11 01:52:32.421074
NCT01816750|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-10-21|||April 2013||2013-04-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Cardiac GSI Feasibility Study|Pilot Study to Assess the Feasibility and Diagnostic Performance of Computed Tomographic Coronary Angiography Using Cardiac Gemstone Spectral Imaging (Cardiac GSI) in Patients With High-risk of Significant Coronary Artery Disease and Myocardial Scar|Completed||N/A|60|Actual|Plymouth Hospitals NHS Trust||3|||f||||f||||||||||2017-10-11 01:52:34.11287|2017-10-11 01:52:34.11287
NCT01816724|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-05-31|||March 2013||2013-03-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Observational|||Spanish (Spain) Validation of a Specific Symptomatic Questionnaire for Patients With Nocturia|Spanish (Spain) Validation of a Specific Symptomatic Questionnaire for Patients With Nocturia|Completed||N/A|129|Actual|Corporacion Parc Tauli|||2||f||||f||||||||||2017-10-11 01:52:34.789247|2017-10-11 01:52:34.789247
NCT01816711|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-04-04|||January 2010||2010-01-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Vitamin D Levels in Frail Elderly Patients With a Hip Fracture|Vitamin D Levels in Frail Elderly Patients With a Hip Fracture|Completed||N/A|447|Actual|University of Aarhus|||2||f||||f||||||||||2017-10-11 01:52:34.877021|2017-10-11 01:52:34.877021
NCT01816698|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-11-23|||December 2012||2012-12-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ESTAB||Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive|A Randomized, Double-Blind, Placebo Control Trial Comparing Effects and Safety of TAURINE GRANULE and Placebo on Blood Pressure in Prehypertensive.|Completed||Phase 3|120|Actual|Third Military Medical University||2|||f||||t||||||||||2017-10-11 01:52:34.960412|2017-10-11 01:52:34.960412
NCT01816685|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-08-04|2015-06-28||June 2013||2013-06-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of CPAP on Postoperative Delirium|The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)|Completed||N/A|135|Actual|Duke University||2|||f||||||||||||||2017-10-11 01:52:35.084273|2017-10-11 01:52:35.084273
NCT01816672|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-10-19|||April 2013||2013-04-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.|A Multi-Center, Prospective, Clinical Trial Comparing the Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner 1 and 2 Diabetic Foot Ulcers|Terminated||N/A|4|Actual|Cytomedix||2||Low enrollment|f||||f||||||||||2017-10-11 01:52:35.398849|2017-10-11 01:52:35.398849
NCT01816659|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-11-16|||May 2013||2013-05-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin|An Open-Labeled Pilot Study of Biomarker Response in Patients With Colorectal Cancer or Endoscopically Non-Resectable Adenomas Following Short-Term Exposure to Metformin Extended Release (ER)|Terminated||Phase 1|3|Actual|M.D. Anderson Cancer Center||2||Slow Accrual|f||||t||||||||||2017-10-11 01:52:35.499531|2017-10-11 01:52:35.499531
NCT01816646|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-12-02|||September 2013||2013-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Intravesical Cidofovir for Hemorrhagic Cystitis|Intravesical Cidofovir Instillation in HSCT Recipients With Hemorrhagic Cystitis: A Single Dose Pharmacokinetic Study|Completed||Phase 1|6|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:52:35.598123|2017-10-11 01:52:35.598123
NCT01816633|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-10-19|||October 2013||2013-10-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers|A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers|Terminated||N/A|3|Actual|Cytomedix||1||Protocol study design was re-done in collaboration with CMS|f||||t||||||||||2017-10-11 01:52:35.691462|2017-10-11 01:52:35.691462
NCT01816607|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2015-06-22|||October 2013||2013-10-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|OxyTarget||Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness|Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Akershus|||1||f||||f||||||Samples With DNA|"     Blood, rectal cancer tissue, normal tissue, lymph nodes   "|||2017-10-11 01:52:35.949738|2017-10-11 01:52:35.949738
NCT01816581|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-03-25|||July 2011||2011-07-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|May 2012|Actual|2012-05-01||Interventional|||Oral Oxycodone After Major Cardiac Surgery|Prospective, Randomized Clinical Pilot Study: Oral Opiate Targin In Treatment Of Postoperative Pain After Major Cardiac Surgery|Completed||Phase 4|50|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 01:52:36.224416|2017-10-11 01:52:36.224416
NCT01816568|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||February 2010||2010-02-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||The Comparison of Single Incision Laparoscopic Appendectomy and Three Port Laparoscopic Appendectomy|The Comparison of Single Incision Laparoscopic Appendectomy and Three Port Laparoscopic Appendectomy|Completed||N/A|50|Actual|Maltepe University||2|||f||||t||||||||||2017-10-11 01:52:36.314506|2017-10-11 01:52:36.314506
NCT01816555|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-07-20|||January 2013||2013-01-01|August 2014|2014-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma|Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II|Terminated||Phase 1|1|Actual|Medical University of South Carolina||2||Study closed due to low accrual.|f||||t||||||||||2017-10-11 01:52:37.317394|2017-10-11 01:52:37.317394
NCT01815203|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-09-23|||March 2013||2013-03-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Caffein Consumption and Response Inhibition|Does Caffeine Consumption Improve Response Inhibition to Food Cues?|Completed||N/A|21|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 01:52:59.008689|2017-10-11 01:52:59.008689
NCT01816542|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-03-19|||June 2013||2013-06-01|March 2013|2013-03-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests|"Dermatologically Tested - Patch Tests - to Assess the Irritancy/Allergic Sensitivity of the Natural Personal-care Products Developed by Mother's Choice."|Unknown status|Not yet recruiting|N/A|100|Anticipated|Mother's Choice Ltd||1|||f||||t||||||||||2017-10-11 01:52:37.414248|2017-10-11 01:52:37.414248
NCT01816516|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-05-30|||February 2010||2010-02-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|HB||Healthy Babies Through Infant Centered Feeding|Healthy Babies Through Infant Centered Feeding|Completed||N/A|546|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 01:52:37.624438|2017-10-11 01:52:37.624438
NCT01816503|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-20|||December 2008||2008-12-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study|High-dose Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study|Completed||Phase 4|636|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 01:52:37.721528|2017-10-11 01:52:37.721528
NCT01816490|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2015-03-04|||April 2013||2013-04-01|September 2013|2013-09-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|THISTLE||THISTLE - The HIV-HCV Silibinin Trial|A Phase II, Multi-center, Open-label, Interventional Study to Evaluate the Safety of Intravenous Silibinin (iSIL) and Its Effect on the Hepatitis C Virus Load in Treatment-experienced HCV-HIV Co-infected Individuals With Advanced Liver Fibrosis in the Swiss HIV Cohort Study (SHCS)|Completed||Phase 2|20|Anticipated|University of Zurich|||||f||||||||||||||2017-10-11 01:52:37.801373|2017-10-11 01:52:37.801373
NCT01816477|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-02-15|2016-08-02||April 2013|Actual|2013-04-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Baseline characteristics are provided for subjects who completed the study.|Post Operative Pain Control Using Ropivacaine and the ON-Q System in the Adult Pectus Excavatum Patient|A Prospective, Randomized, Controlled Trial of Post Operative Pain Control Using Ropivacaine and the ON-Q System in the Adult Pectus Excavatum Patient After Minimally Invasive Repair|Completed||N/A|85|Actual|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-11 01:52:38.033372|2017-10-11 01:52:38.033372
NCT01816464|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-01-09|||September 2013||2013-09-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women|Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Non-pregnant HIV-Uninfected Women: An Open Label Trial|Completed||Phase 4|150|Actual|University of Witwatersrand, South Africa||1|||f||||t||||||||||2017-10-11 01:52:38.585859|2017-10-11 01:52:38.585859
NCT01816451|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-04-10|2013-06-15||March 2012||2012-03-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Physiologic Adaptations to Interval and Continuous Running at Low Volume and Vigorous Intensity Over 14-Weeks.|Physiological Responses to Constant-load (Continuous) vs. Variable-intensity (Interval) During 14 Weeks of Supervised Aerobic Exercise on Active Men.|Completed||N/A|35|Actual|University of Trás-os-Montes and Alto Douro||3|||f||||t||||||||||2017-10-11 01:52:38.779508|2017-10-11 01:52:38.779508
NCT01816438|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2017-08-18|||July 2013||2013-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01|4 Years|Observational [Patient Registry]|||A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia|A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia in Intestinal Inflammatory Diseases|Recruiting||N/A|300|Anticipated|Hôpital Edouard Herriot|||1||f||||f||||||Samples Without DNA|"     pathological lesion slides   "|||2017-10-11 01:52:39.782179|2017-10-11 01:52:39.782179
NCT01816425|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-03-22|||February 2012||2012-02-01|March 2013|2013-03-01|July 2014|Anticipated|2014-07-01|November 2013|Anticipated|2013-11-01||Interventional|Flex||Comparison Between Cobalt-chromium Partial Dentures and Thermoplastic Partial Dentures|Comparison Between Cobalt-chromium Partial Dentures and Thermoplastic Partial Dentures: Random Clinical Trial|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 01:52:39.860876|2017-10-11 01:52:39.860876
NCT01816412|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-09-27|||March 2013||2013-03-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|December 2014|Actual|2014-12-01||Interventional|||LEVANT Japan Clinical Trial|A Prospective, Multicenter, Single Blind, Randomized, Controlled Japanese Population Trial Comparing MD02-LDCB Versus Standard Balloon Angioplasty for Treatment of Femoropopliteal Arteries|Completed||Phase 2|110|Actual|C. R. Bard||2|||f||||t||||||||||2017-10-11 01:52:39.969923|2017-10-11 01:52:39.969923
NCT01816399|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||April 2013||2013-04-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||New Vectorcardiogram Analysis a Good Predictor of Coronary Disease in Patients With Normal Rest 12-leads ECG|Spacial Relation of QRS-T Vectocardiogram is a Good Predictor of Coronary Disease in Patients With Normal Rest 12-leads ECG|Unknown status|Not yet recruiting|N/A|300|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 01:52:40.082128|2017-10-11 01:52:40.082128
NCT01816386|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2015-01-12|||June 2012||2012-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Acupuncture Trial for Post Anaesthetic Recovery and Postoperative Pain|Acupuncture Randomized Trial for Post Anaesthetic Recovery and Postoperative Pain - a Pilot Study|Completed||N/A|75|Actual|Ludwig-Maximilians - University of Munich||3|||f||||f||||||||||2017-10-11 01:52:40.166308|2017-10-11 01:52:40.166308
NCT01816373|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-05-23|||March 2013||2013-03-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Non-invasive Negative Pressure Treatment for Pectus Excavatum|Efficacy Evaluation of the Non-invasive Negative Pressure Treatment for Pectus Excavatum|Completed||N/A|30|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 01:52:40.257106|2017-10-11 01:52:40.257106
NCT01816178|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-21|||February 2004||2004-02-01|March 2013|2013-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Using a Voice Output Communication Aid to Facilitate Language Development in Young Children With ASD|Using a Voice Output Communication Aid to Facilitate Language Development in Young Children With Autism Disorders|Completed||N/A|5|Actual|University of South Alabama||1|||f||||f||||||||||2017-10-11 01:52:44.970487|2017-10-11 01:52:44.970487
NCT01816360|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-19|||January 2010||2010-01-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Aromatherapy and Yogatherapy for Hot Flashes|The Effects of Olfactory Aromatherapy and Yogatherapy Breathing Exercises on the Quality of Life, Stress Levels, Coping Strategies and Hot Flashes Intensity and Frequence in Climacteric Women|Completed||N/A|108|Actual|University of Sao Paulo||4|||f||||f||||||||||2017-10-11 01:52:40.339899|2017-10-11 01:52:40.339899
NCT01816347|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||April 2013||2013-04-01|March 2013|2013-03-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Evaluation of Pre-deployment Device-to-artery Relative Axial Motion in Coronary Catheterizations||Unknown status|Not yet recruiting|N/A|250|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 01:52:40.444989|2017-10-11 01:52:40.444989
NCT01816334|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-03-23|||January 2013||2013-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|TéAGS||Safety and Efficacy of Nonsteroidal Antiinflammatory (NSAI)Drug and Glucocorticoids in Acute Sciatica|Safety and Efficacy of Nonsteroidal Antiinflammatory Drug and Glucocorticoids in Acute Sciatica|Completed||Phase 4|50|Actual|University Hospital, Grenoble||3|||f||||t||||||||||2017-10-11 01:52:40.534499|2017-10-11 01:52:40.534499
NCT01816321|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2016-06-21|||March 2013||2013-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|COMPORT||Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial|Corifollitropin Alfa Followed by Hp-HMG Versus Recombinant FSH in Young Poor Ovarian Responders. A Multicentre Randomized Controlled Clinical Trial|Completed||Phase 3|150|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 01:52:40.653444|2017-10-11 01:52:40.653444
NCT01816308|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2016-10-17|||July 2014||2014-07-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01|2 Years|Observational [Patient Registry]|DIAL-F||Cognitive Impairment in Atrial Fibrillation|Mild Cognitive Impairment (MCI) in Patients With Atrial Fibrillation (AF), Trajectories of the Progression of MCI and Factors Associated With the Progression|Recruiting||N/A|888|Anticipated|Texas Cardiac Arrhythmia Research Foundation|||1||f||||f||||||||||2017-10-11 01:52:40.773778|2017-10-11 01:52:40.773778
NCT01816295|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-11-24|2015-09-01||May 2013||2013-05-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional||All randomized participants.|A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy|A Randomized, Double-Blind, Placebo-Controlled Parallel Study With an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men|Completed||Phase 3|715|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 01:52:40.94691|2017-10-11 01:52:40.94691
NCT01816282|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2013-03-22|||March 2011||2011-03-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||The Use of Fibrin Sealant to Reduce Bleeding After Total Knee Replacement||Completed||N/A|62|Actual|University of Milan||2|||f||||f||||||||||2017-10-11 01:52:43.974576|2017-10-11 01:52:43.974576
NCT01816269|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-20|2013-03-21|||March 2013||2013-03-01|March 2013|2013-03-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|Scaling and Hp||Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection|Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection|Unknown status|Enrolling by invitation|N/A|300|Anticipated|Goztepe Training and Research Hospital|||2||f||||f||||||||||2017-10-11 01:52:44.090765|2017-10-11 01:52:44.090765
NCT01816256|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-09-27|||May 2013||2013-05-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms|Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms|Recruiting||N/A|100|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 01:52:44.177679|2017-10-11 01:52:44.177679
NCT01816243|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2014-04-09|2013-04-12||April 2004||2004-04-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||The demographics was reported for only 38 participants who were eligible for the study.|An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Thai Participants With Chronic Non-Malignant Pain|Evaluation Study of Efficacy and Safety of TTS-Fentanyl in Chronic Non-Malignant Pain|Completed||Phase 4|39|Actual|Janssen-Cilag Ltd.,Thailand|Some limitations of this study were non randomization and uncontrolled design.|1|||f||||f||||||||||2017-10-11 01:52:44.269966|2017-10-11 01:52:44.269966
NCT01816230|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-08-06|||April 2013||2013-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2017|Actual|2017-06-01||Interventional|||Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM|Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells, in Adolescent and Adult Patients With Hematological Malignancies|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Gamida Cell ltd||1|||f||||t||||||||||2017-10-11 01:52:44.616118|2017-10-11 01:52:44.616118
NCT01816217|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-08-28|||October 2011||2011-10-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Difficult Intubation in Intensive Care|Comparison of Difficult Intubation Rates Using McGrath Mac Video Laryngoscope vs Standard Macintosh Laryngoscope in Critically Ill Patients - a Prospective Interventional Study|Terminated||N/A|70|Actual|University Hospital, Montpellier||1||The interim analysis has shown a significative difference between the two groups of patients.|f||||f||||||||||2017-10-11 01:52:44.716677|2017-10-11 01:52:44.716677
NCT01816204|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-08-29|||July 2013||2013-07-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|TAO-anxiety||Therapist Assisted Online Treatment for Anxiety|Therapist Assisted Online Treatment for Anxiety|Completed||N/A|300|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:52:44.812554|2017-10-11 01:52:44.812554
NCT01815398|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-03-27|||July 2012|Actual|2012-07-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|December 2015|Actual|2015-12-01||Interventional|||Cognitive Skills Training for Homeless Youth|Cognitive Skills Training to Improve Vocational Outcome in Homeless Youth|Completed||N/A|188|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 01:52:57.446999|2017-10-11 01:52:57.446999
NCT01816165|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-04-13|||June 2011||2011-06-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|AcT1||Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes|Role of Lipotoxicity in Insulin Resistance, Vascular, and Mitochondrial Dysfunction in Type 1 Diabetes|Active, not recruiting||Phase 3|40|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 01:52:45.101833|2017-10-11 01:52:45.101833
NCT01816152|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2016-10-05|||December 2010||2010-12-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Methodology Issues in a Tailored Light Treatment for Persons With Dementia|Phase 1 Methodology Issues in a Tailored Light Treatment for Persons With Dementia|Recruiting||N/A|60|Anticipated|Rensselaer Polytechnic Institute||2|||f||||f||||||||||2017-10-11 01:52:45.202098|2017-10-11 01:52:45.202098
NCT01816139|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-02-24||2015-02-24|February 2013||2013-02-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Multicenter Study to Evaluate Safety and Efficacy of WC3011 in Postmenopausal Women|A Randomized, Multicenter, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of WC3011 in Postmenopausal Women|Completed||Phase 3|576|Actual|Warner Chilcott||2|||f||||f||||||||||2017-10-11 01:52:45.314965|2017-10-11 01:52:45.314965
NCT01816126|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-18|||February 2013||2013-02-01|March 2013|2013-03-01||||May 2013|Anticipated|2013-05-01||Observational|||One-or Two Person Technique and Quality Performance of Colonoscopy||Unknown status|Recruiting|N/A|||Valduce Hospital|||2||f||||t||||||||||2017-10-11 01:52:45.49649|2017-10-11 01:52:45.49649
NCT01816113|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-05-05|||April 2013||2013-04-01|May 2017|2017-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Phase Ia Study of ChAd63/MVA PvDBP|A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Vivax Malaria Vaccine Candidates ChAd63 PvDBP Alone and With MVA PvDBP|Completed||Phase 1|24|Actual|University of Oxford||4|||f||||t||||||||||2017-10-11 01:52:45.587769|2017-10-11 01:52:45.587769
NCT01816100|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-12-11|||April 2013||2013-04-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|remapping||The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis Patients|The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis Patients: A Multimodal Neuroimaging Investigation|Completed||N/A|6|Actual|University of Nebraska||1|||f||||t||||||||||2017-10-11 01:52:45.672861|2017-10-11 01:52:45.672861
NCT01816087|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-05-29|||May 2013||2013-05-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians|Study AGE - Part 2 (Active Geriatric Evaluation for General Practitioner), Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians|Completed||N/A|86|Actual|University of Lausanne||1|||f||||f||||||||||2017-10-11 01:52:45.756321|2017-10-11 01:52:45.756321
NCT01816074|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-03-07|||October 2012||2012-10-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|October 2016|Actual|2016-10-01||Interventional|TMF||Sequencing Treatments for Mothers With ADHD and Their At - Risk Children|Sequencing Treatments for Mothers With ADHD and Their At - Risk Children|Recruiting||Phase 4|20|Anticipated|Seattle Children's Hospital||4|||f||||t||||||||||2017-10-11 01:52:47.427302|2017-10-11 01:52:47.427302
NCT01816061|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-04-12|||March 12, 2014|Actual|2014-03-12|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 6, 2017|Actual|2017-03-06||Interventional|COMPASS||Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS|Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS|Active, not recruiting||N/A|110|Anticipated|VA Office of Research and Development||2|||f||||f||||||||Undecided||2017-10-11 01:52:47.542104|2017-10-11 01:52:47.542104
NCT01816035|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-05-19|||June 2014||2014-06-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery|Thrombokinetic Studies of Ado-Trastuzumab Emtansine|Completed||Phase 1|13|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 01:52:48.135702|2017-10-11 01:52:48.135702
NCT01816022|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2013-03-20|||March 2012||2012-03-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|March 2014|Anticipated|2014-03-01||Observational|||Myeloproliferative Neoplasms and Bone Structure|Myeloproliferative Neoplasms and Bone Structure|Unknown status|Recruiting|N/A|125|Anticipated|University of Southern Denmark|||1||f||||f||||||Samples With DNA|"     Blood samples to compare groups and to look for endocrine abnormalities   "|||2017-10-11 01:52:48.253239|2017-10-11 01:52:48.253239
NCT01816009|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-03-20|||November 2011||2011-11-01|March 2015|2015-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|DATIPO||Treatment of the Infections on Osteo-articular Prostheses by 6 Versus 12 Weeks of Antibiotherapy|Multicentric Study, of Non Inferiority, Randomized, Opened, to Evaluate the Two Durations Effectiveness of Antibiotherapy (6 Weeks Versus 12 Weeks) in the Treatment of Osteo-articular Prostheses Infections, With Prosthetic Change (in 1 Time or 2 Long Times) or Not (Articular Washing)|Unknown status|Active, not recruiting|Phase 2/Phase 3|410|Anticipated|University Hospital, Tours||2|||f||||f||||||||||2017-10-11 01:52:48.470001|2017-10-11 01:52:48.470001
NCT01815996|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-07-27|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Observational|BARDA II||Identify Clinical Conditions That Increase Circulating DNA Levels|Identify Clinical Conditions That Increase Circulating DNA Levels|Active, not recruiting||N/A|130|Actual|University of Florida|||5||f||||f|f|f||||Samples With DNA|"     4-5 ml of blood will be processed and the plasma will be divided into 150 μl aliquots   "|||2017-10-11 01:52:48.644873|2017-10-11 01:52:48.644873
NCT01815983|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-10-03|||February 2013|Actual|2013-02-01|October 2017|2017-10-01|June 2027|Anticipated|2027-06-01|June 2027|Anticipated|2027-06-01||Interventional|||Video-Assisted Laryngoscopy Education|Does Video-Assisted Self Review Help Students Learn a New Skill Faster?|Recruiting||N/A|40|Anticipated|University of California, Davis||1|||f||||f||||||||||2017-10-11 01:52:48.779606|2017-10-11 01:52:48.779606
NCT01815970|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-05-03|||May 2018|Anticipated|2018-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|PR-COPD||Does Pulmonary Rehabilitation Improve Breathing of COPD Patients|Does Pulmonary Rehabilitation Reduce Neuromechanical Uncoupling of the Respiratory System in COPD|Not yet recruiting||N/A|12|Anticipated|University of British Columbia||1|||f||||f|f|f||||||||2017-10-11 01:52:48.863071|2017-10-11 01:52:48.863071
NCT01815957|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-06-01|||May 2012||2012-05-01|June 2015|2015-06-01||||June 2016|Anticipated|2016-06-01||Interventional|||Impact of Ranolazine on Coronary Microcirculatory Resistance|Impact of Ranalozine on Coronary Microcirculatory Resistance- A Prospective Single Center Study to Evaluate the Effect of Ranalozine in Microcirculatory Resistance (MICRO Study)|Unknown status|Recruiting|N/A|20|Anticipated|University of New Mexico||1|||f||||f||||||||||2017-10-11 01:52:48.974902|2017-10-11 01:52:48.974902
NCT01815944|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-19|||December 2011||2011-12-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Onset Time of Brachial Plexus Block Using Local Anaesthetic Diluted With 0.9% Saline vs 5% Dextrose|Onset Time of Brachial Plexus Block Using Local Anaesthetic Diluted With 0.9% Saline vs 5% Dextrose|Completed||N/A|55|Actual|University of Malaya||2|||f||||t||||||||||2017-10-11 01:52:49.087971|2017-10-11 01:52:49.087971
NCT01815931|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-11-08|||June 2013||2013-06-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Hemolysis in Blood Samples in the ER||Completed||N/A|2800|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 01:52:49.193389|2017-10-11 01:52:49.193389
NCT01815918|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-05-18|2014-05-12||February 2011||2011-02-01|May 2017|2017-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||Unilateral Total Knee Replacement|Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty|The Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty|Completed||Phase 4|60|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-11 01:52:49.265353|2017-10-11 01:52:49.265353
NCT01815905|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-03-03|||March 2013||2013-03-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effect of U-Health Service in Stroke Patients|U-Health Service Using Mobile Device for Improvement of Post-Stroke Upper Limb Function and Aphasia|Completed||N/A|36|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 01:52:49.642045|2017-10-11 01:52:49.642045
NCT01815892|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-08-09|||May 2015||2015-05-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Use of Furosemide in Patients on Dialysis|The Determinants of the Effectiveness of the Use of Furosemide in Patients on Dialysis|Recruiting||Phase 4|51|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 01:52:49.719481|2017-10-11 01:52:49.719481
NCT01815879|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-03-20|||December 2012||2012-12-01|March 2013|2013-03-01||||June 2013|Anticipated|2013-06-01||Observational|MORE||Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project|Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Sarah Cannon|||1||f||||f||||||||||2017-10-11 01:52:49.806805|2017-10-11 01:52:49.806805
NCT01815866|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-10-13|||April 2013||2013-04-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Cough-Generated Aerosols of NTM in Cystic Fibrosis|Cough-Generated Aerosols of Nontuberculous Mycobacteria in Patients With Cystic Fibrosis|Completed||N/A|5|Actual|University of Florida|||1||f||||t||||||Samples Without DNA|"     Sputum cultures   "|||2017-10-11 01:52:49.873363|2017-10-11 01:52:49.873363
NCT01815853|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-21|||July 2012||2012-07-01|March 2013|2013-03-01||||June 2022|Anticipated|2022-06-01||Interventional|||Pre-operative Chemoradiotherapy or Chemotherapy Following Surgery and Adjuvent Chemotherapy in Patients With Gastric Cancer||Recruiting||Phase 3|620|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 01:52:49.953074|2017-10-11 01:52:49.953074
NCT01815840|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-08-30|2016-06-27||April 30, 2013|Actual|2013-04-30|August 2017|2017-08-01|August 31, 2016|Actual|2016-08-31|August 27, 2015|Actual|2015-08-27||Interventional||Intent-to-Treat Analysis Population, defined as all randomized participants.|A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas|A Randomized, Double-blinded, Regimen-controlled, Phase II, Multicenter Study to Assess the Efficacy and Safety of Two Different Vismodegib Regimens in Patients With Multiple Basal Cell Carcinomas|Completed||Phase 2|229|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 01:52:50.07778|2017-10-11 01:52:50.07778
NCT01815827|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-11-01|||June 2013||2013-06-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study of Single Dose Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy Volunteers|An Open-label, Parallel Group Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy Volunteers|Completed||Phase 1|62|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:52:51.258871|2017-10-11 01:52:51.258871
NCT01815814|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-07-04|||November 2011||2011-11-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy|Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy|Completed||N/A|38|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 01:52:51.345314|2017-10-11 01:52:51.345314
NCT01815801|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-04-19|||March 2013||2013-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Mechanical Ventilation on the Incidence of Pneumothorax After Subclavian Vein Catheterization||Completed||N/A|334|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:52:51.468399|2017-10-11 01:52:51.468399
NCT01815788|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2014-07-28|||April 2013||2013-04-01|March 2013|2013-03-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|TEO FIRST||Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid|Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid.|Completed||N/A|31|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 01:52:51.532462|2017-10-11 01:52:51.532462
NCT01815775|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-19|||March 2006||2006-03-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|||Predictive Value of Flow MRI in Normal Pressure Hydrocephalus Surgery|Predictive Value of Flow MRI in Normal Pressure Hydrocephalus Surgery|Completed||Early Phase 1|30|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:52:51.600804|2017-10-11 01:52:51.600804
NCT01815762|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-03-01|||March 2013||2013-03-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|BUST||Extravascular Lung Water Monitoring by Combined Ultrasound and Bioimpedance as a Guide for Treatment in Hemodialysis Patients|Extravascular Lung Water Monitoring by Combined Ultrasound and Bioimpedance as a Guide for Treatment in Hemodialysis Patients|Completed||N/A|250|Actual|Grigore T. Popa University of Medicine and Pharmacy||2|||f||||f||||||||||2017-10-11 01:52:51.714726|2017-10-11 01:52:51.714726
NCT01815749|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-07-27|||September 27, 2013|Actual|2013-09-27|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma|Phase I Study of Cellular Immunotherapy Using Central Memory-Enriched T Cells Lentivirally Transduced to Express a CD19-Specific, CD28-Costimulatory Chimeric Receptor and a Truncated EGFR Following Peripheral Blood Stem Cell Transplantation for Patients With High-Risk Intermediate Grade B-Lineage Non-Hodgkin Lymphoma|Active, not recruiting||Phase 1|30|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 01:52:51.804392|2017-10-11 01:52:51.804392
NCT01815736|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-08-15|2016-03-15|2014-10-30|March 27, 2013|Actual|2013-03-27|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|March 16, 2015|Actual|2015-03-16||Interventional||Safety Analysis Set: participants who were randomized and received at least one dose of study drug|Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants|A Phase 3, Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects|Active, not recruiting||Phase 3|1443|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||t|t|f||||||||2017-10-11 01:52:51.963256|2017-10-11 01:52:51.963256
NCT01815723|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2016-08-08|||June 2016||2016-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis|A Randomised, Double Blind, Double Dummy, Active Comparator and Placebo Controlled Confirmative Non-inferiority Trial of FP187 Compared to Fumaderm® in Moderate to Severe Plaque Psoriasis|Withdrawn||Phase 3|0|Actual|Forward-Pharma GmbH||3|||f||||||||||||||2017-10-11 01:52:53.899058|2017-10-11 01:52:53.899058
NCT01815710|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-07-18|||January 2013||2013-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|||Best Strategies for Implementation of Clinical Pathways in Emergency Department Settings|Best Strategies for Implementation of Clinical Pathways in Emergency Department Settings|Enrolling by invitation||N/A|6400|Anticipated|Children's Hospital of Eastern Ontario|||2||f||||f||||||||||2017-10-11 01:52:54.0111|2017-10-11 01:52:54.0111
NCT01815697|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-04-03|||April 2013|Actual|2013-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|EECPLUTS||Effect of Enhanced External Counterpulsation on Lower Urinary Tract Symptoms|A Prospective, Randomized Study of Enhanced External Counterpulsation in Patients With Lower Urinary Tract Symptoms|Recruiting||N/A|120|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t|f|f||||||No||2017-10-11 01:52:54.100332|2017-10-11 01:52:54.100332
NCT01815684|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-19|||August 2012||2012-08-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects|A Phase I, Double Blind, Placebo-controlled, Randomized 4-way Alternating Cross-over Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Single Ascending Doses of ASP3652 in Healthy Young Caucasian Male and Female Subjects|Completed||Phase 1|26|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 01:52:54.202669|2017-10-11 01:52:54.202669
NCT01815671|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-02-04|2013-06-02||May 2012||2012-05-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|CTDTTIE||Evaluate the Safety and Diagnostic Advantages of Tilt Down Verses Standard Horizontal Colonoscopy Positioning|The Effect of Body Positioning for Colonoscopy in Women: Randomized, Study of Left Lateral Tilt Down Versus Left Lateral Horizontal Positioning|Terminated||N/A|173|Actual|Specialists in Gastroenterology, LLC|Early termination owing to increased incidence of oxygen desaturation in the tilt down group.|2||Increased number of oxygen desaturation in tilt down position|f||||f||||||||||2017-10-11 01:52:54.339957|2017-10-11 01:52:54.339957
NCT01815658|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-19|||April 2013||2013-04-01|March 2013|2013-03-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||"Bio-logical Carbon Fiber Intramedullary Nail Biomechanical Test and Preliminary Clinical Results"||Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 01:52:54.723222|2017-10-11 01:52:54.723222
NCT01815645|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-07-26|2015-08-10||May 2012||2012-05-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Contingency Management Treatment for Crack Addiction - Study With Brazilian Population|Evaluating the Efficacy of Including Contingency Management to Standard Ambulatory Treatment for Crack Addiction - A Randomized Controlled Trial|Completed||N/A|65|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 01:52:54.83517|2017-10-11 01:52:54.83517
NCT01815632|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-01-29|||January 2014||2014-01-01|August 2013|2013-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|ACTiMuS||Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)|Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)|Recruiting||Phase 2|80|Anticipated|North Bristol NHS Trust||2|||f||||t||||||||||2017-10-11 01:52:55.329692|2017-10-11 01:52:55.329692
NCT01815619|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-07-17|||February 2013||2013-02-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of On-Site Verus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct|Comparison of On-Site Verus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct|Recruiting||N/A|66|Anticipated|Florida Hospital||2|||f||||f||||||||||2017-10-11 01:52:55.436748|2017-10-11 01:52:55.436748
NCT01815606|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-08-02|||February 2013||2013-02-01|August 2017|2017-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm|Randomized Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm|Completed||N/A|51|Actual|Florida Hospital||2|||f||||t||||||||||2017-10-11 01:52:55.5662|2017-10-11 01:52:55.5662
NCT01815593|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2017-04-02|||April 2013|Actual|2013-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|EECPED||The Value of Enhanced External Counterpulsation on Erectile Dysfunction|A Prospective, Randomized Study of Enhanced External Counterpulsation for Patients With Erectile Dysfunction|Recruiting||N/A|120|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t|f|f||||||No||2017-10-11 01:52:55.661551|2017-10-11 01:52:55.661551
NCT01815580|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-08-31|||July 2013||2013-07-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|June 2020|Anticipated|2020-06-01||Interventional|SABES?||HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women|HIV Testing and Treatment to Prevent Onward HIV Transmission Among MSM and Transgender Women in Lima, Peru|Recruiting||Phase 4|150|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 01:52:55.801487|2017-10-11 01:52:55.801487
NCT01815567|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-12-21|||November 2012||2012-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||DETECT and Retinal Outcomes in Hypertension|The Effects of Blood Pressure on Cognitive Function: Examining the Use of Bedside Neuropsychological Testing During Acute Hypertensive Events|Recruiting||N/A|300|Anticipated|Emory University|||4||f||||f||||||||||2017-10-11 01:52:55.926762|2017-10-11 01:52:55.926762
NCT01815554|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-01-30|||January 2013||2013-01-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Follow up Study of Diaphragm Pacing for Patients With High Tetraplegia|Long-term Follow-up of Patients With Ventilatory Dependent High Tetraplegia Managed With Diaphragmatic Pacing Systems|Completed||N/A|31|Actual|Craig Hospital|||1||f||||f||||||||||2017-10-11 01:52:56.034949|2017-10-11 01:52:56.034949
NCT01815541|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2016-08-01|||March 2013||2013-03-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|TEICOPLANIN||Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study|Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study|Completed||Phase 2|30|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:52:56.128474|2017-10-11 01:52:56.128474
NCT01815528|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-02-17|||March 2013||2013-03-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer|Single -Arm, Multicenter Phase-II Trial for Catumaxomab and Chemotherapy in Patients With Recurrent Ovarian Cancer to Investigate the Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy Regimes|Completed||Phase 2|2|Actual|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-10-11 01:52:56.235714|2017-10-11 01:52:56.235714
NCT01815515|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-04-24|||March 2013||2013-03-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer|Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer.|Active, not recruiting||Phase 1/Phase 2|19|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 01:52:56.346431|2017-10-11 01:52:56.346431
NCT01815502|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2013-03-19|||February 2013||2013-02-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Study of Effects of Sildenafil on Patients With Fontan Heart Circulation|Response to Sildenafil in Patients With Fontan Physiology, A Pressure-volume Loop Analysis|Unknown status|Recruiting|Phase 4|20|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 01:52:56.45627|2017-10-11 01:52:56.45627
NCT01815489|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-05-22|||July 2011||2011-07-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Observational|||Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis|Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis|Completed||N/A|20|Actual|Carolinas Healthcare System|||1||f||||f||||||Samples With DNA|"     Peripancreatic fluid, pancreatic tissue, blood sample, stool sample   "|||2017-10-11 01:52:56.694948|2017-10-11 01:52:56.694948
NCT01815463|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-09-26|||August 2006||2006-08-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|NIPCON||Non-Invasive Prediction of Colorectal Neoplasia|Non-Invasive Prediction of Colorectal Neoplasia|Terminated||N/A|2282|Actual|Corporal Michael J. Crescenz VA Medical Center|||1|Local PI did not submit annual renewal, still active in Detroit, not recruiting.|f||||f||||||Samples With DNA|"     Stool Urine Saliva Blood Tissue   "|No||2017-10-11 01:52:56.873121|2017-10-11 01:52:56.873121
NCT01815450|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-01-26||2015-01-26|February 2013||2013-02-01|January 2015|2015-01-01||||November 2013|Actual|2013-11-01||Interventional|||BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris||Completed||Phase 2|369|Actual|Braintree Laboratories||3|||f||||f||||||||||2017-10-11 01:52:56.973713|2017-10-11 01:52:56.973713
NCT01815437|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-03-23|||January 2012||2012-01-01|March 2017|2017-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Evaluating Vitamin D Content in Mushrooms|Evaluation of Vitamin D in a Mushroom Supplement|Completed||N/A|80|Actual|Boston University||4|||f||||f|f|f||||||No||2017-10-11 01:52:57.121462|2017-10-11 01:52:57.121462
NCT01815411|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-06-06|||May 2016||2016-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|Andosan-RA||Effect of Andosan in Patients With Rheumatoid Arthritis|Effect of the Mushroom Extract Andosan on Symptoms and Inflammatory Parameters in Patients With Rheumatoid Arthritis (RA)|Recruiting||N/A|15|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:52:57.350146|2017-10-11 01:52:57.350146
NCT01815385|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2015-09-21|||March 2013||2013-03-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Epigenetic and Developmental Effects of In Utero Exposure to Environmental Toxicants|Early Life Exposure to Polycyclic Aromatic Hydrocarbons: Metabolic Perturbations and Epigenetic Biomarkers|Unknown status|Recruiting|N/A|150|Anticipated|Montefiore Medical Center|||1||f||||f||||||Samples With DNA|"     Maternal blood sample Cord blood sample Infant saliva Peripheral blood sample from enrolled     patients at 12 and 24 months of age   "|||2017-10-11 01:52:57.529395|2017-10-11 01:52:57.529395
NCT01815372|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-11-05|||October 2012||2012-10-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Ultrasound-guided Nerve Blocks for the Sciatic and Saphenous Nerves: Characteristics of the Single Penetration Dual Injection (SPEDI) Technique|Ultrasound-guided Nerve Blocks for the Sciatic and Saphenous Nerves: Characteristics of the Single Penetration Dual Injection (SPEDI) Technique|Completed||N/A|60|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 01:52:57.606808|2017-10-11 01:52:57.606808
NCT01815359|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-08-17|||March 2013||2013-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|ICARuS||ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis|ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multi-center, Randomized Phase II Trial of Early Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis|Recruiting||Phase 2|220|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-11 01:52:57.694016|2017-10-11 01:52:57.694016
NCT01815346|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-09-07|||July 6, 2014|Actual|2014-07-06|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG|A Phase I-II Study of Acupuncture for the Treatment of Chronic, Taxane-Induced Peripheral Neuropathy in Breast Cancer Survivors|Terminated||Phase 1/Phase 2|4|Actual|M.D. Anderson Cancer Center||2||Slow Accrual|f||||t||||||||||2017-10-11 01:52:57.833972|2017-10-11 01:52:57.833972
NCT01815333|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-19|2017-05-15|||July 2013|Actual|2013-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging|Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging|Active, not recruiting||N/A|18|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:52:57.953833|2017-10-11 01:52:57.953833
NCT01815320|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-10-28|||April 2011||2011-04-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|October 2012|Actual|2012-10-01||Interventional|||CE-US in Renal Transplantation|A PILOT, EXPLORATIVE STUDY TO IDENTIFY CONTRAST-ENHANCED ULTRASOUND (CE-US) PATTERNS THAT CHARACTERIZE ACUTE ALLOGRAFT REJECTION AND OTHER CAUSES OF ACUTE ALLOGRAFT DYSFUNCTION IN RENAL TRANSPLANT RECIPIENTS|Completed||Phase 2|20|Actual|Mario Negri Institute for Pharmacological Research||1|||f||||f||||||||||2017-10-11 01:52:58.042853|2017-10-11 01:52:58.042853
NCT01815307|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-10-03|||January 2013||2013-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Interventional|||Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer|Randomized Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer|Active, not recruiting||Phase 2|70|Actual|Kansai Hepatobiliary Oncology Group||2|||f||||t||||||||||2017-10-11 01:52:58.129834|2017-10-11 01:52:58.129834
NCT01815294|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-12-03|||May 2013||2013-05-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer|A Pivotal Bioequivalence Study of DOXIL/CAELYX Manufactured at a New Site in Subjects With Advanced or Refractory Solid Malignancies Including Subjects With Ovarian Cancer.|Completed||Phase 1|54|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 01:52:58.228132|2017-10-11 01:52:58.228132
NCT01815281|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-03-16|||July 2013||2013-07-01|March 2015|2015-03-01|April 2015|Anticipated|2015-04-01|November 2013|Actual|2013-11-01||Interventional|GONDOLAPILOTA||Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy.|Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease|Unknown status|Recruiting|N/A|||IRCCS San Raffaele||2|||f||||f||||||||||2017-10-11 01:52:58.348371|2017-10-11 01:52:58.348371
NCT01815268|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-12-16|||February 2013||2013-02-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||High-Dose Influenza Vaccine in Nursing Homes|High Dose Influenza Vaccination and Morbidity & Mortality in U.S. Nursing Homes|Active, not recruiting||Phase 4|823|Actual|Insight Therapeutics, LLC||4|||f||||f||||||||No||2017-10-11 01:52:58.463774|2017-10-11 01:52:58.463774
NCT01815255|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-03-26|||December 2010||2010-12-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||TDF Long Term Study|Efficacy and Safety Evaluation of TDF-based Regimen in Thai HIV-infected Children|Completed||N/A|36|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||f||||||None Retained|"     Phlebotomy will be for safety evaluation and will be drawn according to the schedule of     visit.   "|||2017-10-11 01:52:58.598083|2017-10-11 01:52:58.598083
NCT01815242|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-06-18|||June 2013||2013-06-01|June 2015|2015-06-01|May 2020|Anticipated|2020-05-01|March 2015|Actual|2015-03-01||Interventional|ADAPT||Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer|Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer|Active, not recruiting||Phase 2|336|Anticipated|West German Study Group||2|||f||||t||||||||||2017-10-11 01:52:58.698664|2017-10-11 01:52:58.698664
NCT01815229|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-04-04|||March 2013||2013-03-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||Role of Neutrophil Activation|Sore Throat Secondary to Endotracheal Intubation: the Role of Neutrophil Activation|Recruiting||N/A|60|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 01:52:58.799543|2017-10-11 01:52:58.799543
NCT01815190|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-11-30|||January 2011||2011-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||IgA-positive Versus IgA-negative Immune Complex Vasculitis|Retrospective Analysis of Frequency of Systemic Involvement in IgA-positive Cutaneous Immune Complex Vasculitis Versus IgA-negative Cutaneous Immune Complex Vasculitis|Recruiting||N/A|300|Anticipated|University Hospital Muenster|||2||f||||f||||||||||2017-10-11 01:52:59.131206|2017-10-11 01:52:59.131206
NCT01815177|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-02-16|||March 2013||2013-03-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||Arthroscopic Rotator Cuff Repair: Suture Anchors Versus Arthroscopic Transosseous Fixation|Advantages of Arthroscopic Rotator Cuff Repair With Transosseous Suture Technique. A Prospective Randomized Controlled Trial|Completed||N/A|75|Actual|University of Milan||2|||f||||f||||||||No||2017-10-11 01:52:59.241346|2017-10-11 01:52:59.241346
NCT01815164|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-03-20|||August 2007||2007-08-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Hypnotherapy and Educational Intervention in Irritable Bowel Syndrome|Effect of Hypnotherapy and Educational Intervention on Brain Response to Visceral Stimulus Perception in the Irritable Bowel Syndrome|Completed||N/A|44|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-11 01:52:59.357118|2017-10-11 01:52:59.357118
NCT01815138|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2017-08-25|2017-04-17||March 2013||2013-03-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Interventional|||Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS|A Prospective Double-blind Randomized Trial Comparing Pregnancy Rates After Low Dose Human Chorionic Gonadotropin (hCG) at the Time of Gonadotropin Releasing Hormone (GnRH) Agonist Trigger or 35 Hours Later for the Prevention of OHSS|Completed||Phase 4|89|Actual|UConn Health||2|||f||||t||||||||||2017-10-11 01:52:59.455681|2017-10-11 01:52:59.455681
NCT01815125|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-09-28|||March 2013||2013-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Ondansetron for Pediatric Mild Traumatic Brain Injury|Ondansetron for Pediatric Mild Traumatic Brain Injury; a Pilot Randomized Controlled Trial.|Completed||Phase 1|16|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 01:52:59.854135|2017-10-11 01:52:59.854135
NCT01815112|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-03-09|||February 2008||2008-02-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|||Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging|Benefit of MRI and 18F-FDG PET Imaging in the Early Diagnosis of Alzheimer-like Dementia|Terminated||N/A|60|Actual|Centre Hospitalier Universitaire, Amiens||5||Administrative re-organization of the department. Referent physician left the hospital.|f||||f||||||||||2017-10-11 01:52:59.953134|2017-10-11 01:52:59.953134
NCT01815099|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-02-24|2016-12-21||May 2014||2014-05-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder|Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder: Substudy #2|Terminated||N/A|4|Actual|Hartford Hospital||1||The remaining eligible participants declined to participate.|f||||f||||||||No||2017-10-11 01:53:00.121943|2017-10-11 01:53:00.121943
NCT01815086|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-09-17|||December 2008||2008-12-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Radioimmunoimaging of Light Chain (AL) Amyloidosis|Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody (mAb) Murine (Mu) 11-F4|Completed||Phase 1|30|Actual|University of Tennessee||1|||f||||f||||||||||2017-10-11 01:53:01.127328|2017-10-11 01:53:01.127328
NCT01815047|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-02-06|||December 2012||2012-12-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|December 2015|Actual|2015-12-01||Interventional|||Vitamin D Status Impacts Inflammation and Risk of Infections During Pregnancy|Vitamin D Status Impacts Inflammation and Risk of Infections During Pregnancy|Active, not recruiting||N/A|85|Actual|Cornell University||2|||f||||t||||||||||2017-10-11 01:53:01.501871|2017-10-11 01:53:01.501871
NCT01815034|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-08-18|||March 2013||2013-03-01|March 2013|2013-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|TCO2||Trancutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations|Transcutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations: a Joint Quality Initiative Pilot From Cardiac Electrophysiology and Anesthesiology|Completed||N/A|50|Actual|The Cleveland Clinic|||1||f||||f||||||||||2017-10-11 01:53:01.626958|2017-10-11 01:53:01.626958
NCT01815021|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-03-30|||April 2013||2013-04-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|AMCS009||A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients|A Randomized, Two Phase, Adaptive Then Crossover Open-label, Study Comparing Amorphous Calcium Carbonate (ACC) Supplement Versus Commercially Available Crystalline Calcium Supplements (CCS) in the Management of Primary Hypoparathyroidism.|Completed||Phase 1/Phase 2|10|Actual|Amorphical Ltd.||2|||f||||f||||||||||2017-10-11 01:53:01.715332|2017-10-11 01:53:01.715332
NCT01815008|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-11-10|2016-08-01||October 2012||2012-10-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PARes-I||Pharmacogenomics of Antiplatelet Response - I|PHARMACOGENOMICS OF ANTI-PLATELET RESPONSE - I|Completed||Phase 4|19|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:53:01.869072|2017-10-11 01:53:01.869072
NCT01814995|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-09-10|||January 2012||2012-01-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|MoMM||Motivational Support and Meal Preparation Training to Reduce Vascular Risk After Gestational Diabetes|Combining Motivational Support, Meal Preparation Training, and a Tapering Course of Meal Replacements To Achieve Vascular Risk Reduction in Women With a Gestational Diabetes History (MoMM)|Completed||N/A|36|Actual|McGill University Health Center||1|||f||||f||||||||||2017-10-11 01:53:02.136926|2017-10-11 01:53:02.136926
NCT01814826|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-09-04|||April 15, 2013|Actual|2013-04-15|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|May 3, 2016|Actual|2016-05-03||Interventional|||Study of MLN4924 Plus Azacitidine in Treatment-Naïve Patients With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older|A Phase 1b, Open-Label, Dose-Escalation Study of MLN4924 Plus Azacitidine in Treatment-Naïve Patients With Acute Myelogenous Leukemia Who Are 60 Years or Older|Active, not recruiting||Phase 1|64|Anticipated|Takeda||1|||f||||f||||||||||2017-10-11 01:53:04.325934|2017-10-11 01:53:04.325934
NCT01814982|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-04-30|||August 2007||2007-08-01|April 2013|2013-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||An Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of JNJ-17299425 in Participants With Traumatic Brain Injury|An Open-Label, Single and Repeat Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-17299425 in Patients With Traumatic Brain Injury|Terminated||Phase 2|7|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2||reprioritization of company activities|f||||t||||||||||2017-10-11 01:53:02.307941|2017-10-11 01:53:02.307941
NCT01814969|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-04|||March 2014||2014-03-01|May 2015|2015-05-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer.|Preoperative Hyperfractionated Radiotherapy Versus Combined Radiochemotherapy for Patients With Locally Advanced Rectal Cancer: a Phase III Randomized Trial.|Recruiting||Phase 3|260|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||t||||||||||2017-10-11 01:53:02.456463|2017-10-11 01:53:02.456463
NCT01814956|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-07-19|||March 2013||2013-03-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Different Lipid Emulsions in Acute Lung Injury Patients|Prospective, Randomized, Controlled, Double-blind, Parallel-group, Mono-center, Explorative Phase IV Trial on the Efficacy and Safety of a Fish Oil Containing Lipid Emulsion Versus a Standard Soybean-oil Based Lipid Emulsion in Patients With Acute Lung Injury|Terminated||Phase 4|1|Actual|B. Braun Melsungen AG||2||Low recruitment|f||||f||||||||||2017-10-11 01:53:02.613133|2017-10-11 01:53:02.613133
NCT01814943|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-06-17|||November 2012||2012-11-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users|The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users|Completed||N/A|39000|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:53:02.719444|2017-10-11 01:53:02.719444
NCT01814930|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-06-03|||March 2012||2012-03-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PPCI||Adolescent Postpartum Contraceptive Counseling Intervention|Evaluation of a Brief Standardized Postpartum Counseling Intervention's Effect on Repeat Pregnancy Rates Contraceptive Choice/Use/Continuation/Satisfaction in Adolescents|Completed||N/A|100|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 01:53:02.817501|2017-10-11 01:53:02.817501
NCT01814917|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-25|||August 2013||2013-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Long-term Extension Study of MCI-196|A Multi-centre, Flexible Dose, Parallel Group, Open-label, Active Control (Calcium-based Phosphate Binder), Long-term Extension Study Evaluating the Efficacy, Safety and Tolerability of Colestilan (MCI-196) in Paediatric Subjects With Hyperphosphataemia and With Either Chronic Kidney Disease Stage 5 on Dialysis or Chronic Kidney Disease Stages 3b to 5 Not on Dialysis|Terminated||Phase 3|6|Actual|Mitsubishi Tanabe Pharma Corporation||2||This study has been terminated because of insufficient patient recruitment.|f||||t||||||||||2017-10-11 01:53:02.929227|2017-10-11 01:53:02.929227
NCT01814904|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-25|||April 2014||2014-04-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Dose-finding Study of MCI-196|A Multi-centre, Randomised, Controlled, Parallel Group, Open-label Study Evaluating the Efficacy, Safety and Tolerability of Three Doses of Colestilan (MCI-196) Compared to Standard Therapy With a Calcium-based Phosphate Binder, in Paediatric Subjects With Chronic Kidney Disease Stage 5 on Dialysis and With Hyperphosphataemia|Terminated||Phase 3|10|Actual|Mitsubishi Tanabe Pharma Corporation||4||This study has been terminated because of insufficient patient recruitment.|f||||t||||||||||2017-10-11 01:53:03.071155|2017-10-11 01:53:03.071155
NCT01814891|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-19|||May 2012||2012-05-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Determination of Changes in Total Body Stores of Vitamin A in Response to Orange Maize Consumption by Zambian Children|Determination of Changes in Total Body Stores of Vitamin A in Response to Orange Maize Consumption by Zambian Children|Completed||N/A|143|Actual|University of Wisconsin, Madison||3|||f||||f||||||||||2017-10-11 01:53:03.188187|2017-10-11 01:53:03.188187
NCT01814878|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2013-06-18|2013-03-30||November 2009||2009-11-01|June 2013|2013-06-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||A Study Comparing the Effectiveness and Safety of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen With Immediate Release (IR) Tramadol HCl/Acetaminophen in Participants With Moderate to Severe Postoperative Pain|A Randomized, Active-Controlled, Parallel Group, Double-Blind Study to Compare the Efficacy and Safety of Tramadol HCl/Acetaminophen ER and IR in Subjects Who Complain of Moderate to Severe Postoperative Pain|Completed||Phase 3|320|Actual|Janssen Korea, Ltd., Korea||2|||f||||f||||||||||2017-10-11 01:53:03.302878|2017-10-11 01:53:03.302878
NCT01814865|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-12-19|||May 2013||2013-05-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer|Pre-operative Assessment of the Anti-Proliferative Effects and Genomic Alterations of 2 Weeks of Abiraterone Acetate Compared to 2 Weeks of an Aromatase Inhibitor in Post-menopausal Hormone Receptor Positive Operable Breast Cancer|Withdrawn||Phase 2|0|Actual|British Columbia Cancer Agency||2||Funding was not acquired|f||||f||||||||||2017-10-11 01:53:04.039238|2017-10-11 01:53:04.039238
NCT01814852|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-05-11|||December 2012||2012-12-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' for Patients With Erectile Dysfunction|A Prospective, Randomized, Double Blind With Sham Control, Clinical Study to Assess the Safety and Efficacy of Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' in Patients With Erectile Dysfunction|Completed||N/A|60|Actual|Initia||2|||f||||f||||||||||2017-10-11 01:53:04.146059|2017-10-11 01:53:04.146059
NCT01814839|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-02-04|||March 2013||2013-03-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy Volunteers|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC in Healthy Volunteers|Completed||Phase 1|85|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:53:04.23546|2017-10-11 01:53:04.23546
NCT01814813|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-03-06|||May 2013||2013-05-01|March 2017|2017-03-01||||July 2017|Anticipated|2017-07-01||Interventional|||Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery|A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)|Active, not recruiting||Phase 2|90|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 01:53:04.500478|2017-10-11 01:53:04.500478
NCT01814800|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-08-10|2015-12-15||February 2014||2014-02-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)|An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)|Completed||Phase 3|59|Actual|ADMA Biologics, Inc.||1|||f||||f||||||||||2017-10-11 01:53:07.372562|2017-10-11 01:53:07.372562
NCT01814787|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-04-10|2016-12-08||October 2013||2013-10-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes|Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes|Completed||N/A|1369|Actual|Indiana University||2|||f||||f||||||||Undecided||2017-10-11 01:53:08.634824|2017-10-11 01:53:08.634824
NCT01814774|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2014-06-04|2014-06-04||January 2013||2013-01-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm||Completed||N/A|48|Actual|Allergan|||2||f||||f||||||||||2017-10-11 01:53:09.015244|2017-10-11 01:53:09.015244
NCT01814761|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-09-28|2015-09-28||May 2013||2013-05-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|APPEAL-Taiwan||A Study of Bimatoprost 0.01% in the Clinical Setting||Completed||Phase 4|312|Actual|Allergan|||2||f||||f||||||||||2017-10-11 01:53:09.31002|2017-10-11 01:53:09.31002
NCT01814748|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-07-25|2016-06-07||May 2013||2013-05-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-3102 in ≥18 and <45 Year-Old Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control|Completed||Phase 3|203|Actual|Merck Sharp & Dohme Corp.|Investigations indicate that the presence of metformin in future biomedical research (FBR) samples from non-rescued participants was due to participant self-administration of metformin outside of the protocol and without investigator knowledge.|2|||f||||t||||||||||2017-10-11 01:53:09.694541|2017-10-11 01:53:09.694541
NCT01814735|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-03-26|||August 2010||2010-08-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Substituting Brown Rice For White Rice: Effect On Diabetes Risk Factors In India|Substituting Brown Rice For White Rice: Effect On Diabetes Risk Factors In India|Completed||N/A|150|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-11 01:53:10.360461|2017-10-11 01:53:10.360461
NCT01814722|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-03-23|2014-10-06||November 9, 2012|Actual|2012-11-09|March 2017|2017-03-01|October 31, 2013|Actual|2013-10-31|October 31, 2013|Actual|2013-10-31||Observational||Gender and Age data for one participant from the Raltegravir, and two participants from the NNRTI groups were missing, resulting in a n = 60.|Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)|Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens|Terminated||N/A|63|Actual|Merck Sharp & Dohme Corp.|||3|The trial was terminated early due to slow recruitment.|f||||f||||||||||2017-10-11 01:53:10.455825|2017-10-11 01:53:10.455825
NCT01814709|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-11-01|||April 2013||2013-04-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers|A Phase 1, Open-Label Study to Evaluate the Effect of Rifampin or Itraconazole on the Pharmacokinetics of GDC-0032 in Healthy Subjects|Completed||Phase 1|32|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 01:53:10.707519|2017-10-11 01:53:10.707519
NCT01814696|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-11-07|2015-10-20||March 2013||2013-03-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|||The Effect of the MedSentry System on Medication Adherence|The Effect of the MedSentry System on Medication Adherence for Patients With Congestive Heart Failure: A Pilot Study|Terminated||N/A|26|Actual|Massachusetts General Hospital|The initial goal was to enroll a total of 70 participants with 35 randomized to each of the two study arms. However, due to slow enrollment the study was ended early with 26 participants having completed enrollment and randomization.|2||Slow enrollment and reached number needed for analysis.|f||||f||||||||||2017-10-11 01:53:10.958721|2017-10-11 01:53:10.958721
NCT01814683|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-10-05|||July 2014|Actual|2014-07-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||IMPROV (Improving the Radical Cure of Vivax Malaria)|Improving the Radical Cure of Vivax Malaria: A Multicentre Randomised Comparison of Short and Long Course Primaquine Regimens|Recruiting||N/A|3150|Anticipated|University of Oxford||3|||f||||t||||||||||2017-10-11 01:53:12.045065|2017-10-11 01:53:12.045065
NCT01814670|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2015-08-05|2015-08-05||March 2013||2013-03-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines||Completed||Phase 4|185|Actual|Allergan||1|||f||||f||||||||||2017-10-11 01:53:12.189193|2017-10-11 01:53:12.189193
NCT01814657|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-12-31|||March 2013||2013-03-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Optimizing Patient Analgesic Experience During IVF|Optimizing Patient Analgesic Experience During IVF|Unknown status|Recruiting|N/A|308|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 01:53:12.455185|2017-10-11 01:53:12.455185
NCT01814644|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2015-01-14|||July 2011||2011-07-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|TRIMM||Interactive Mobile Messaging for Weight Control Among the Underserved|Tailored Rapid Interactive Mobile Messaging (TRIMM) for Weight Control Among the Underserved|Completed||N/A|124|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 01:53:12.576282|2017-10-11 01:53:12.576282
NCT01814631|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-04-12|||March 2013||2013-03-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Observational|||Endoscopic Ultrasound (EUS) Processor Comparison|Prospective Comparison of Two EUS Processors for Imaging of the Pancreas|Withdrawn||N/A|0|Actual|Florida Hospital|||1|Closed at PI discretion|f||||f||||||||No||2017-10-11 01:53:12.654648|2017-10-11 01:53:12.654648
NCT01814618|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2016-04-05|||March 2013||2013-03-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery|Trial of Directed High-dose Nasal Steroids on Residual Olfactory Dysfunction in Patients With Chronic Rhinosinusitis Following Endoscopic Sinus Surgery|Withdrawn||Phase 2|0|Actual|University of North Carolina, Chapel Hill||2||Difficulty recruiting|f||||f||||||||||2017-10-11 01:53:12.745704|2017-10-11 01:53:12.745704
NCT01814605|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-03-15|||June 2011||2011-06-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Sciatic Nerve Block Using the Subgluteal Space Approach: A Comparison With the Infragluteal Approach|Ultrasound-guided Sciatic Nerve Block Using the Subgluteal Space Injection Approach: A Comparison With the Infragluteal Approach|Completed||N/A|27|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:53:12.847451|2017-10-11 01:53:12.847451
NCT01814592|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-23|||March 2013||2013-03-01|March 2013|2013-03-01|August 2014|Anticipated|2014-08-01|April 2014|Anticipated|2014-04-01||Interventional|||Comparison Between Two Coronally Positioned Flap With Connective Tissue|Comparison of Two Bilaminar Techniques for Root Covering of Miller´s Recessions Class I and II: A Blind, Randomized Controlled Clinical Trial|Unknown status|Enrolling by invitation|Phase 2|72|Anticipated|Universidad El Bosque, Bogotá||2|||f||||t||||||||||2017-10-11 01:53:12.946312|2017-10-11 01:53:12.946312
NCT01814579|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2013-03-25|||July 2012||2012-07-01|March 2013|2013-03-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|||Vaginal Cuff Closure Time Using Unidirectional Barbed Suture in Robotic Hysterectomy|Vaginal Cuff Closure Time Using Unidirectional Barbed Suture in Robotic Hysterectomy, a Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|80|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-11 01:53:13.052978|2017-10-11 01:53:13.052978
NCT01814553|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-09-08|2016-07-01||April 2013||2013-04-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Treated Set : This analysis set includes all entered patients who received at least one dose of investigational treatment (afatinib) and for whom there was documentation that they took at least 1 dose.|ADAM-Afatinib Diarrhea Assessment and Management|A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM)|Completed||Phase 3|40|Actual|Boehringer Ingelheim|In this study, Nine patients experienced diarrhea episodes that were not managed according to the protocol specified afatinib treatment interruptions and dose reductions. No patients were excluded from the primary analysis.|2|||f||||||||||||||2017-10-11 01:53:13.275595|2017-10-11 01:53:13.275595
NCT01814540|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-05-26|||August 2012||2012-08-01|May 2017|2017-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|BMO||Bovine Milk Oligosaccharide Study|Pilot Study: Tolerability of Feeding Different Doses of Bovine Milk Oligosaccharides for Modifying Gastrointestinal Function in Healthy Individuals|Completed||N/A|12|Actual|University of California, Davis||3|||f||||t||||||||||2017-10-11 01:53:14.378906|2017-10-11 01:53:14.378906
NCT01814527|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-18|2017-09-18|||July 2013|Actual|2013-07-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions|High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions|Completed||N/A|62|Actual|East Carolina University||2|||f||||f||||||||||2017-10-11 01:53:14.493683|2017-10-11 01:53:14.493683
NCT01814514|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-19|||January 2011||2011-01-01|March 2013|2013-03-01||||March 2013|Anticipated|2013-03-01||Interventional|||Safety Study of Aqueous Suppression After Ahmed Glaucoma Valve (AGV) Implantation|Early Intra Ocular- Pressure Control Using Aqueous Suppressive Agents After Ahmed Glaucoma Valve Implantation|Unknown status|Recruiting|Phase 2|94|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:53:14.612295|2017-10-11 01:53:14.612295
NCT01814501|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-11-07|||February 2013||2013-02-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab|A Phase II Study of Panitumumab in Combination With FOLFIRI After Progression on FOLFIRI Plus Bevacizumab in KRAS(Kirsten Rat Sarcoma) and NRAS Wild-Type Metastatic Colorectal Cancer.|Recruiting||Phase 2|35|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:53:14.726522|2017-10-11 01:53:14.726522
NCT01814488|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-08-08|||July 2013||2013-07-01|August 2017|2017-08-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|Gandalf-01||A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia|A Phase II Multicentre Open-label Study on Allogeneic Stem Cell Transplantation From Unrelated, Cord-blood and Family Haploidentical Donors in Patients With Active Acute Leukemia|Completed||Phase 2|101|Actual|Gruppo Italiano Trapianto di Midollo Osseo||1|||f||||t||||||||||2017-10-11 01:53:14.876755|2017-10-11 01:53:14.876755
NCT01814475|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-06-22|||July 2011||2011-07-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|GITMO-MF2010||Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis|Prospective, Phase II Randomized Study to Compare Busulfan-fludarabine Reduced-intensity Conditioning (RIC) With Thiotepa-fludarabine RIC Regimen Prior to Allogeneic Transplantation of Hematopoietic Cells for the Treatment of Myelofibrosis|Completed||Phase 2|62|Actual|Gruppo Italiano Trapianto di Midollo Osseo||2|||f||||t||||||||||2017-10-11 01:53:15.057874|2017-10-11 01:53:15.057874
NCT01814462|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-01-05|||March 2013||2013-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of CPAP Therapy in Obstructive Sleep Apnea on Parameters of Nocturnal Pulse Wave Analysis|Impact of CPAP Therapy in Obstructive Sleep Apnea on Parameters of Nocturnal Pulse Wave Analysis|Recruiting||N/A|300|Anticipated|Wissenschaftliches Institut Bethanien e.V||1|||f||||f||||||||||2017-10-11 01:53:15.671834|2017-10-11 01:53:15.671834
NCT01814449|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2013-03-19|||March 2012||2012-03-01|March 2013|2013-03-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01|6 Months|Observational [Patient Registry]|||Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer|Department of Breast Surgery And Department of Nuclear Medicine, Fudan University Shanghai Cancer Center,|Unknown status|Recruiting|N/A|130|Anticipated|Fudan University|||2||f||||t||||||Samples With DNA|"     Each patient underwent diagnostic core-needle biopsy on the primary site at baseline. A     therapeutic surgery or a second core-needle biopsy on the primary site was planned in a     subset of patients after at least 3 months of primary letrozole therapy. Both biopsy and     surgical samples of primary tumors were routinely embedded in paraffin wax and cut to 3- to     5-mm thickness and dried overnight for immunohistochemistry testing.Immunohistochemistry     staining for HIF-1-alpha and Ki67 were performed on 3- to 5-mm serial sections on coated     slides.   "|||2017-10-11 01:53:15.792294|2017-10-11 01:53:15.792294
NCT01814436|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2016-04-26|||February 2013||2013-02-01|April 2016|2016-04-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Revitalization of Immature Permanent Teeth With Necrotic Pulps Using SHED Cells|Revitalization of Young Immature Permanent Teeth With Necrotic Pulps Using Autologous Stem Cells From Human Exfoliated Deciduous Teeth|Recruiting||N/A|80|Anticipated|Fourth Military Medical University||1|||f||||t||||||||||2017-10-11 01:53:15.921296|2017-10-11 01:53:15.921296
NCT01814423|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-16|2014-03-10|||April 2013||2013-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Pharmacokinetic Study of Multi-dose Chloroquine|Pharmacokinetic Study of Multi-dose Chloroquine|Completed||Phase 4|30|Actual|Bandim Health Project||2|||f||||f||||||||||2017-10-11 01:53:16.02012|2017-10-11 01:53:16.02012
NCT01814410|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-08-22|||February 22, 2013|Actual|2013-02-22|July 2017|2017-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Interactive Effects of IV Ethanol and IV Nicotine|A Laboratory Study on the Interactive Effects of IV Ethanol and IV Nicotine on Subjective Effects and Cognition|Completed||Early Phase 1|5|Actual|Yale University||3|||f||||f||||||||||2017-10-11 01:53:16.143021|2017-10-11 01:53:16.143021
NCT01814397|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-07-07|2014-06-05||July 2009||2009-07-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|July 2012|Actual|2012-07-01||Observational|||Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients|Prospective Pilot Study to Determine the Effect of Aromatase Inhibitor-induced Estrogen Depletion on Evoked Pain Threshold and Psychosocial Factors in Breast Cancer Patients|Completed||N/A|50|Actual|University of Michigan Cancer Center|||1||f||||t||||||Samples With DNA|"     Baseline: whole blood for DNA, serum, plasma 3 month: serum, plasma 6 month: serum   "|||2017-10-11 01:53:16.266577|2017-10-11 01:53:16.266577
NCT01814384|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-09-03|||March 2013||2013-03-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Medico-economic Study of Patient Matched Cutting Blocks (Ancillary) MyKnee ® LBS During Knee Arthroplasty GMK ®.|Medico-economic Study of Patient Matched Cutting Blocks (Ancillary) MyKnee ® LBS During Knee Arthroplasty GMK ®. Multicentric, Prospective, Controlled, Opened, Randomised Study About Medical Device.|Unknown status|Active, not recruiting|N/A|100|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 01:53:16.712137|2017-10-11 01:53:16.712137
NCT01814371|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-05-11|||April 2013||2013-04-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|February 26, 2017|Actual|2017-02-26||Interventional|HOME2DS||Individualized vs. Household MRSA Decolonization|Individualized vs. Household Eradication of MRSA in Households With Children|Enrolling by invitation||N/A|600|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:53:16.812306|2017-10-11 01:53:16.812306
NCT01814358|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-11-06|||March 2013||2013-03-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Whey Protein Effects on Gycemic Control and Vascular Function|Effects of Pre-meal Whey Protein Ingestion on Daily Glycemic Control and Oxidative Stress Mediated Postprandial Inflammation and Vascular Dysfunction Evoked by Consumption of a High-glycemic Meal|Withdrawn||Phase 1|0|Actual|University of California, Los Angeles||3|||f||||f||||||||||2017-10-11 01:53:16.950805|2017-10-11 01:53:16.950805
NCT01814345|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-04-25|||June 2013|Actual|2013-06-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Her 2 Testing in Indian Patients With Gastric Cancer|"An Observational Study to Determine the Incidence of of Her 2 Positivity in 100 Consecutive Gastric Cancers"|Terminated||N/A|100|Actual|Tata Memorial Hospital|||1||f||||t||||||||Undecided||2017-10-11 01:53:17.041756|2017-10-11 01:53:17.041756
NCT01814332|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-05-04|2016-03-23||January 2010||2010-01-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|AFTER||Analyzing Female Trauma Exposed Responses to a Medication|CRF Receptor Antagonist for PTSD and Related Sleep Disturbances in Women|Completed||Phase 2|128|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 01:53:17.124118|2017-10-11 01:53:17.124118
NCT01814319|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-08-24|||March 2013||2013-03-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ReProsperHF||Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure|Initial Study on the Use of Probenecid as a Positive Inotrope for the Treatment of Systolic Heart Failure in Stable NYHA Class II to IV Patients|Completed||Phase 2|20|Actual|University of Cincinnati||2|||f||||t||||||||||2017-10-11 01:53:17.540097|2017-10-11 01:53:17.540097
NCT01814306|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-03-15|||October 2011||2011-10-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Interventional|SPLMA||Supreme LMA and Proseal LMA in Prone Anesthetized Patient|Comparison of the Effectiveness Between the LMA SupremeTM and the LMA ProsealTM for Airway Management in Patient Undergoing Elective Orthopaedic Surgery in Prone Position|Unknown status|Enrolling by invitation|N/A|100|Actual|Prince of Songkla University||2|||f||||t||||||||||2017-10-11 01:53:17.622172|2017-10-11 01:53:17.622172
NCT01814293|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-05-13|||May 2013||2013-05-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Supportive Therapies for Symptom Relief From Pediatric Upper Respiratory Infections (URIs)|Comparison of Supportive Therapies for Symptom Relief From Pediatric Upper Respiratory Infections (URIs)|Withdrawn||N/A|0|Actual|University of California, San Francisco||2||loss of funding. No data was collected.|f||||f||||||||||2017-10-11 01:53:17.70308|2017-10-11 01:53:17.70308
NCT01814280|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-11-27|||January 2013||2013-01-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|MERIS1||Reducing Medication Errors on Basis of an Individual Risk Assessment|Differentiated Intervention Aimed at Reducing Medication Errors on Basis of an Individual Risk Assessment - a Pilot Study|Completed||N/A|100|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-10-11 01:53:17.804986|2017-10-11 01:53:17.804986
NCT01814267|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2015-05-27|||March 2013||2013-03-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|AIRPEDIA||Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management||Unknown status|Active, not recruiting|Phase 2/Phase 3|64|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 01:53:17.872208|2017-10-11 01:53:17.872208
NCT01814254|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2016-02-22|||July 2011||2011-07-01|February 2016|2016-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Comparison of Body Hydration State in Hemodialysis Patients|Comparison of Body Hydration State in Hemodialysis Patients With the Hydra 4200 and ZOE (100 and 5 kHZ) Bioimpedance Devices|Terminated||N/A|67|Actual|Renal Research Institute|||1|Change of Institutional Affiliation & Funding|f||||f||||||||||2017-10-11 01:53:17.967311|2017-10-11 01:53:17.967311
NCT01814241|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-07-26|2017-01-22||April 2013||2013-04-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PnOIT4||Mechanisms of Desensitization During Peanut Oral Immunotherapy|Mechanisms of Desensitization During Peanut Oral Immunotherapy|Completed||Phase 2|20|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 01:53:18.068191|2017-10-11 01:53:18.068191
NCT01814228|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2016-09-29|||September 2013||2013-09-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory Syncope|Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory Syncope|Recruiting||Phase 3|20|Anticipated|Policlinico Casilino ASL RMB||1|||f||||f||||||||||2017-10-11 01:53:18.329825|2017-10-11 01:53:18.329825
NCT01814215|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2016-06-07|||April 2013||2013-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Keys to Healthy Family Child Care Homes|The Business of Childcare Homes & Child Health: Innovations for Nurturing Growth|Completed||N/A|805|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 01:53:18.40756|2017-10-11 01:53:18.40756
NCT01814202|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2013-10-04|||March 2013||2013-03-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea|A Double-blind, Randomized, Placebo-controlled Clinical Trial (Pilot Phase) to Evaluate the Efficacy of a Medical Nutrition Product, PTM202, in Children With Acute Diarrhea|Completed||N/A|68|Actual|PanTheryx, Inc.||2|||f||||f||||||||||2017-10-11 01:53:18.649743|2017-10-11 01:53:18.649743
NCT01814189|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-07-28|||January 2013||2013-01-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment|Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment: a Randomized, Double Blind Clinical Trial|Completed||Phase 3|350|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:53:18.73549|2017-10-11 01:53:18.73549
NCT01814176|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2016-12-06|||July 2011||2011-07-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Measurement of Forces Applied Using a Macintosh Direct Laryngoscope Compared to GlideScope Video Laryngoscope|Measurement of Forces Applied Using a Macintosh Direct Laryngoscope Compared to GlideScope Video Laryngoscope in Patients With at Least One Difficult Intubation Risk Factor|Completed||N/A|44|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:53:18.81482|2017-10-11 01:53:18.81482
NCT01814163|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2013-03-18|||February 2011||2011-02-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|ANGIOMET||Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab|Observational Studies to Explore the Relation Between Angiogenic Markers and the Treatment Response With Carboplatin, Paclitaxel and Bevacizumab in First Line of Advanced Non-small-cell Lung Cancer With Non- Squamous Histology|Completed||N/A|200|Actual|Spanish Lung Cancer Group|||1||f||||t||||||||||2017-10-11 01:53:18.885462|2017-10-11 01:53:18.885462
NCT01814150|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-03-22|||April 2013||2013-04-01|March 2013|2013-03-01|April 2018|Anticipated|2018-04-01|April 2016|Anticipated|2016-04-01||Observational|||The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel|The Association Between Alpha 1 Acid Glycoprotein Level and Outcome of Patients With Metastatic Cancer Treated With Docetaxel Based Chemotherapy|Not yet recruiting||N/A|200|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 01:53:19.018211|2017-10-11 01:53:19.018211
NCT01814137|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-02-10|2015-10-14|2014-11-20|March 2013||2013-03-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|BOOST®|Full analysis set (FAS) included all randomised subjects.|A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily|A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily (BOOST®: INTENSIFY BID)|Completed||Phase 3|40|Actual|Novo Nordisk A/S|Due to the highly selected trial population randomised in this trial (N=40), the results should be interpreted with caution.|2|||f||||f||||||||||2017-10-11 01:53:19.123563|2017-10-11 01:53:19.123563
NCT01814124|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-02-24|||March 2013||2013-03-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Conservative Management of Femoroacetabular Impingement|Therapeutic Effectiveness of Manual Therapy Plus Exercise for Femoroacetabular Impingement of the Hip: a Randomized Controlled Clinical Trial Pilot Study|Completed||N/A|18|Actual|High Point University||2|||f||||f||||||||||2017-10-11 01:53:19.759097|2017-10-11 01:53:19.759097
NCT01813903|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-06-05|||April 2013||2013-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|HYPE||Family Welfare Pilot Intervention Study|Family Welfare Pilot Intervention Study at Finnish Welfare Clinics|Completed||N/A|59|Actual|National Institute for Health and Welfare, Finland||3|||f||||t||||||||||2017-10-11 01:53:22.128055|2017-10-11 01:53:22.128055
NCT01814111|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-15|||July 2012||2012-07-01|March 2013|2013-03-01|June 2015|Anticipated|2015-06-01|October 2014|Anticipated|2014-10-01||Interventional|RSDforPAF||Renal Sympathetic Denervation in Patients With Hypertension and Paroxysmal Atrial Fibrillation|Safety and Effectiveness Study of Percutaneous Catheter-based Sympathetic Denervation of the Renal Arteries in Patients With Hypertension and Paroxysmal Atrial Fibrillation|Unknown status|Recruiting|N/A|100|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 01:53:19.839825|2017-10-11 01:53:19.839825
NCT01814098|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-09-28|||July 7, 2009|Actual|2009-07-07|September 2017|2017-09-01|November 30, 2011|Actual|2011-11-30|May 31, 2011|Actual|2011-05-31||Interventional|Lexapro||An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms|Escitalopram in the Long-term Treatment of Major Depressive Disorder With Associated Anxiety Symptom|Completed||Phase 4|318|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||f||||||||2017-10-11 01:53:19.94294|2017-10-11 01:53:19.94294
NCT01814085|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-01-02|||February 2010||2010-02-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression|A Single-arm, Open-label, Multi-center Study to Investigate Efficacy and Safety of Lexapro on Acute Treatment of Severe Depression|Completed||Phase 4|225|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||||||||||2017-10-11 01:53:20.072953|2017-10-11 01:53:20.072953
NCT01814072|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-07-06|||September 2013||2013-09-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Opt-IN||Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity|Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity|Active, not recruiting||Phase 2/Phase 3|562|Actual|Northwestern University||32|||f||||t||||||||||2017-10-11 01:53:20.18473|2017-10-11 01:53:20.18473
NCT01814059|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-06-30|||March 7, 2013||2013-03-07|May 12, 2015|2015-05-12|May 12, 2015|Actual|2015-05-12|May 12, 2015|Actual|2015-05-12||Interventional|||Sirolimus for Eosinophil-Associated Gastrointestinal Disorders|A Phase 1, Open-Label Study of Sirolimus in Eosinophil-Associated Gastrointestinal Disorders|Terminated||Phase 1|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:53:20.480609|2017-10-11 01:53:20.480609
NCT01814046|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-06-22|2017-05-31||March 1, 2013|Actual|2013-03-01|June 2017|2017-06-01|May 1, 2019|Anticipated|2019-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma|Phase II Study in Patients With Metastatic Ocular Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Autologous Tumor-Infiltrating Lymphocytes With or Without High Dose Aldesleukin|Active, not recruiting||Phase 2|24|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f|t|f||||||No||2017-10-11 01:53:20.628243|2017-10-11 01:53:20.628243
NCT01814033|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2015-10-08|||November 2015||2015-11-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|LRU||Use of the LRU Pillow in the Acute Setting Following Total Knee Arthroplasty|Use of the LRU Pillow in the Acute Setting Following Total Knee Arthroplasty|Unknown status|Not yet recruiting|N/A|40|Anticipated|Newton-Wellesley Hospital||2|||f||||f||||||||||2017-10-11 01:53:21.312197|2017-10-11 01:53:21.312197
NCT01814020|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-09-19|||December 2012||2012-12-01|June 2013|2013-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)||Completed||Phase 2|||Moberg Pharma AB|||||f||||||||||||||2017-10-11 01:53:21.40765|2017-10-11 01:53:21.40765
NCT01814007|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-06-20|||March 2013||2013-03-01|March 2013|2013-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Multiple Treatment Study|SAFETY EVALUATION OF MULTIPLE COOLSCULPTING TREATMENTS|Completed||N/A|35|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 01:53:21.475446|2017-10-11 01:53:21.475446
NCT01813994|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-05-26|||February 2013||2013-02-01|February 2014|2014-02-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer||Unknown status|Recruiting|N/A|110|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 01:53:21.550703|2017-10-11 01:53:21.550703
NCT01813981|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-14|||May 2011||2011-05-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|September 2011|Actual|2011-09-01||Interventional|||The Effect of High and Low Roasted Coffee on Vascular Response|The Effect of High and Low Roasted Coffee on Vascular Response|Completed||N/A|19|Actual|University of Reading||3|||f||||t||||||||||2017-10-11 01:53:21.644288|2017-10-11 01:53:21.644288
NCT01813968|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-10-13|||January 2013||2013-01-01|October 2015|2015-10-01||||August 2016|Anticipated|2016-08-01||Interventional|IPICS||Ischemic Postconditioning in Cardiac Surgery|Ischemic Postconditioning in Cardiac Surgery|Unknown status|Recruiting|N/A|250|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 01:53:21.727301|2017-10-11 01:53:21.727301
NCT01813955|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2015-05-27|||June 2011||2011-06-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia|PDE Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia|Terminated||Early Phase 1|5|Actual|University of Copenhagen||1||Patient recruitment insufficient|f||||f||||||||||2017-10-11 01:53:21.810275|2017-10-11 01:53:21.810275
NCT01813942|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-10-25|||March 2013||2013-03-01|October 2013|2013-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Platform for Medical Information Extraction From Incomplete Data|Platform for Medical Information Extraction From Incomplete Data|Unknown status|Recruiting|N/A|10000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:53:21.893959|2017-10-11 01:53:21.893959
NCT01813929|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-03-16|||June 2011||2011-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|MeT1||Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes|Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes|Active, not recruiting||Phase 4|100|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:53:21.96579|2017-10-11 01:53:21.96579
NCT01813916|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-03-14|||May 2008||2008-05-01|March 2013|2013-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Identification and Characterization of the Biomarker in Synovial Fluid for Hyaluronic Acid Therapy in Osteoarthritis|Identification and Characterization of the Biomarker in Synovial Fluid for Hyaluronic Acid Therapy in Osteoarthritis|Completed||N/A|30|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 01:53:22.056728|2017-10-11 01:53:22.056728
NCT01813890|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-12-31|2014-12-31||January 2013||2013-01-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Tapentadol Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy|Completed||Phase 3|60|Actual|Janssen-Cilag International NV||3|||f||||f||||||||||2017-10-11 01:53:22.217881|2017-10-11 01:53:22.217881
NCT01813877|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-12-19|||September 2012||2012-09-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma|Randomized Metabolic Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma F-DOPA PET/CT|Recruiting||N/A|360|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 01:53:22.91089|2017-10-11 01:53:22.91089
NCT01813864|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-24|2013-03-14|||August 2004||2004-08-01|March 2013|2013-03-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|CASPAR||Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR)|Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR)|Completed||N/A|352|Actual|Treatment Research Institute||1|||f||||f||||||||||2017-10-11 01:53:23.030738|2017-10-11 01:53:23.030738
NCT01813851|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-04-29|||March 2013||2013-03-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ACTINUT||"Effect of Intradialytic Physical ACTIvity in Addition to a NUTritional Support on Protein Energy Wasting and Physical Functioning in Chronic Hemodialysis Patients (ACTINUT Study)"|"Effect of Intradialytic Physical ACTIvity in Addition to a NUTritional Support on Protein Energy Wasting and Physical Functioning in Chronic Hemodialysis Patients (ACTINUT Study), Multicenter, Randomized, Controlled Open Label Trial Study Multicenter, Prospective, Randomized Study"|Terminated||N/A|21|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 01:53:23.243891|2017-10-11 01:53:23.243891
NCT01813838|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-11-07|||June 2013||2013-06-01|August 2013|2013-08-01|June 2015|Actual|2015-06-01|June 2013|Actual|2013-06-01||Interventional|Acadesine||GFM-Acadesine: A Phase I-II Trial of Acadesine|A Phase I-II Trial of Acadesine in IPSS High and Int-2 SMD, LAM With 20-30% Marrow Blasts and CMML Type 2 Not Responding to Azacitidine or Decitabine for at Least 6 Courses or Relapsing After a Response|Terminated||Phase 1/Phase 2|5|Actual|Groupe Francophone des Myelodysplasies||3||Renal toxicity|f||||t||||||||No||2017-10-11 01:53:23.41317|2017-10-11 01:53:23.41317
NCT01813825|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-14|||November 2004||2004-11-01|March 2013|2013-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|7 Years|Observational [Patient Registry]|||A Single Site Prospective, Non-randomized Study of Partial Breast Intracavitary Brachytherapy Devices to Evaluate Local Tumor Control, Cosmetic Outcome and Toxicities.||Unknown status|Recruiting|N/A|300|Anticipated|St. Vincent's Medical Center|||1||f||||f||||||||||2017-10-11 01:53:23.602393|2017-10-11 01:53:23.602393
NCT01813812|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-20|||October 2010||2010-10-01|March 2013|2013-03-01||||August 2013|Anticipated|2013-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034|A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 Compared With Rebamipide in Patients With Acute or Chronic Gastritis|Unknown status|Recruiting|Phase 3|492|Anticipated|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-11 01:53:23.703907|2017-10-11 01:53:23.703907
NCT01813799|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-08-12|||November 2011||2011-11-01|August 2013|2013-08-01||||August 2013|Anticipated|2013-08-01||Interventional|||Study of DA-9801 to Treat Diabetic Neuropathic Pain|Phase 2 Clinical Study to Evaluate DA-9801 Tablet's Effectiveness and Safety and to Decide Optimal Volume for Neuropathic Pains With Diabetic Neuropathy Patients as the Target|Unknown status|Recruiting|Phase 2|120|Anticipated|Dong-A ST Co., Ltd.||4|||f||||f||||||||||2017-10-11 01:53:23.860677|2017-10-11 01:53:23.860677
NCT01813786|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-02-07|||December 2012||2012-12-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Clinical and Histological Evaluation of the 755nm Alexandrite Laser With Handpiece for the Treatment of Scars||Completed||N/A|9|Actual|Cynosure, Inc.||3|||f||||f||||||||||2017-10-11 01:53:23.995054|2017-10-11 01:53:23.995054
NCT01813773|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-06-03|||March 2013||2013-03-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ACT||Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study|Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study|Completed||Phase 2/Phase 3|20|Actual|Ophthalmic Consultants of Long Island||2|||f||||f||||||||Undecided||2017-10-11 01:53:24.099229|2017-10-11 01:53:24.099229
NCT01813760|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-03-25|||November 2012||2012-11-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Treatment of Periorbital and Perioral Wrinkles With the Applications of the Iluminage Diode Laser||Completed||N/A|60|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 01:53:24.229588|2017-10-11 01:53:24.229588
NCT01813747|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-02-03|||August 2012||2012-08-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Mandible and Sub-mandible Using the 1440nm Wavelength Laser and Hand Piece||Completed||N/A|12|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 01:53:24.350684|2017-10-11 01:53:24.350684
NCT01813734|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-04-12|||September 2013||2013-09-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ponatinib in Advanced NSCLC w/ RET Translocations|A Phase II, Open-Label Study of Ponatinib, A Multi-Targeted Oral Tyrosine Kinase Inhibitor, in Advanced Non-Small Cell Lung Cancer Harboring RET Translocations|Recruiting||Phase 2|20|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 01:53:24.452396|2017-10-11 01:53:24.452396
NCT01813721|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-02-07|2014-12-04||December 2012||2012-12-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational||Primary Analysis Set (PAS) is the set of all participants who satisfy the eligibility criteria and had at least one FN risk factor ranked by the investigator in their Subject Assessment.|Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.|Study to Investigate Which Clinical Risk Factors Are Considered by Physicians When Conducting Overall Febrile Neutropenia Risk Assessments for Patients Receiving Chemotherapy With an Intermediate (10% - 20%) Febrile Neutropenia Risk.|Completed||N/A|1007|Actual|Amgen|||1||f||||f||||||||||2017-10-11 01:53:24.887008|2017-10-11 01:53:24.887008
NCT01813708|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-03-20|||November 2004||2004-11-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|June 2005|Actual|2005-06-01||Interventional|||Intensive Life-Style Intervention in Type 2 Diabetes Patients|The Effectiveness of an Intensive Life-Style Intervention Compared to an Collaborative Educational Intervention On Metabolic Control, and Its Impact on Weight, Physical Activity, Quality of Life, Self-Efficacy in Type 2 Diabetes Patients|Completed||N/A|200|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||||2017-10-11 01:53:27.987362|2017-10-11 01:53:27.987362
NCT01813695|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-02-04|||March 2013||2013-03-01|February 2016|2016-02-01|April 2021|Anticipated|2021-04-01|March 2019|Anticipated|2019-03-01||Observational|||Preemptive Genotyping and Pain Management|Preemptive Genotyping of Children and Adolescents at Risk for Surgery and Subsequent Pain Management|Active, not recruiting||N/A|748|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples With DNA|"     Saliva Blood   "|||2017-10-11 01:53:28.067834|2017-10-11 01:53:28.067834
NCT01813682|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-20|||September 2012||2012-09-01|March 2013|2013-03-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Effect of Iron-fortified TPN on Preterm Infants Anemia|Effect of Iron-fortified TPN on Preterm Infants Anemia|Unknown status|Recruiting|N/A|118|Anticipated|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine||3|||f||||t||||||||||2017-10-11 01:53:30.012418|2017-10-11 01:53:30.012418
NCT01813669|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-08-19|||October 2012||2012-10-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|ToPSY||Integrative Coping Group for Children|Treatment of Psychosomatic Pain in Youth (ToPSY): A Pilot Study|Completed||N/A|28|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:53:30.153129|2017-10-11 01:53:30.153129
NCT01813656|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-02-02|||September 2012||2012-09-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||An Study of Aripiprazole in the Treatment of Methamphetamine Dependence|A Multiple-Center, Randomized, Double-Blind Study of Aripiprazole for Treatment of Methamphetamine Dependence|Terminated||Phase 4|10|Actual|Central South University||2||Aripiprazole arm had obvious adverse reactions,especially akathisia.|f||||t||||||||||2017-10-11 01:53:30.22699|2017-10-11 01:53:30.22699
NCT01813643|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2015-02-02|||July 2012||2012-07-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional|||A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis|A Multiple-Center, Randomized, Double-Blind Study of Comparison of Risperidone and Aripiprazole for Treatment|Terminated||Phase 4|50|Actual|Central South University||2||Effects of aripiprazole was not obvious and showed adverse reaction obviously|f||||t||||||||||2017-10-11 01:53:30.307402|2017-10-11 01:53:30.307402
NCT01813630|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-09-19|||February 2013||2013-02-01|September 2017|2017-09-01||||May 2018|Anticipated|2018-05-01||Interventional|||A Clinical Study to Assess the Efficacy and Safety of DA-3002|Phase III Clinical Trial for Assessment of Efficacy and Safety of DA-3002 (Recombinant Human Growth Hormone) in Patients With Turner's Syndrome|Active, not recruiting||Phase 3|58|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:53:30.392954|2017-10-11 01:53:30.392954
NCT01813617|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-14|||September 2010||2010-09-01|March 2013|2013-03-01||||June 2012|Actual|2012-06-01|12 Months|Observational [Patient Registry]|||Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis|Outcome of Muscle Function and Disease Activity in Patients With Recent Onset Polymyositis and Dermatomyositis - a 1-year Follow-up Register Study|Completed||N/A|72|Actual|Karolinska University Hospital|||1||f||||f||||||||||2017-10-11 01:53:30.495581|2017-10-11 01:53:30.495581
NCT01813604|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-01-07|||November 2012||2012-11-01|March 2013|2013-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Immunogenicity of Inactivated and Live Polio Vaccines|Phase III Clinical Trial to Assess the Immunogenicity of a Sequential Dose of Fractional Inactivated Polio Vaccine (f-IPV) and Oral Polio Vaccine (OPV)|Completed||Phase 3|1206|Anticipated|Centers for Disease Control and Prevention||5|||f||||t||||||||||2017-10-11 01:53:30.585929|2017-10-11 01:53:30.585929
NCT01813591|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-08-19|||April 2013||2013-04-01|August 2014|2014-08-01||||December 2014|Anticipated|2014-12-01||Interventional|||A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines|A Randomized, Open-Label, Parallel Two-Arm Study Evaluating the Efficacy of H.P. Acthar Injection Gel in the Treatment of Adults With Intractable Chronic Migraine|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Dent Neuroscience Research Center||2|||f||||f||||||||||2017-10-11 01:53:30.69307|2017-10-11 01:53:30.69307
NCT01813578|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-14|||October 2009||2009-10-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis - a Pilot Study|Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis - a Pilot Study|Completed||N/A|4|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 01:53:30.793411|2017-10-11 01:53:30.793411
NCT01813565|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-07-06|||March 2013||2013-03-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|March 2013|Actual|2013-03-01||Interventional|||The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.|The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.|Recruiting||N/A|32|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 01:53:30.911175|2017-10-11 01:53:30.911175
NCT01813552|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-01-21|||February 2013||2013-02-01|January 2016|2016-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)|A Phase I, Randomized, Open-label Study to Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of IDX719 in Healthy Subjects|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 01:53:31.157129|2017-10-11 01:53:31.157129
NCT01813539|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-08-31|||February 2013||2013-02-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase 1/2 Study of ARGX-110 in Patients With Advanced Malignancies|A Phase I/II Study of ARGX-110 in Patients With Advanced Malignancies Expressing CD70.|Recruiting||Phase 1/Phase 2|100|Anticipated|arGEN-X BVBA||5|||f||||f||||||||||2017-10-11 01:53:31.256424|2017-10-11 01:53:31.256424
NCT01813526|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-03-15|||November 1999||1999-11-01|March 2013|2013-03-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Infants With Protein Sensitive Colitis|Evaluation of an Elemental Formula in Infants With Protein Sensitive Colitis|Completed||N/A|53|Actual|Abbott Nutrition||1|||f||||f||||||||||2017-10-11 01:53:31.424632|2017-10-11 01:53:31.424632
NCT01813513|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-01-25|||January 2013||2013-01-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)|A Phase I, Randomized, Multiple-Dose Study to Evaluate the Pharmacokinetic Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Subjects|Completed||Phase 1|42|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 01:53:31.517156|2017-10-11 01:53:31.517156
NCT01813500|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-04-25|||October 2011|Actual|2011-10-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|September 2015|Actual|2015-09-01||Observational|||Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients|Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients|Completed||N/A|400|Actual|Boston Medical Center|||2||f||||t|f|f||||Samples Without DNA|"     Serum, stool   "|Undecided||2017-10-11 01:53:31.626114|2017-10-11 01:53:31.626114
NCT01813487|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-12-26|||February 2013||2013-02-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E|Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy in Patients Who Have Been Treated With HB110E Hepatitis B DNA Vaccine|Completed||N/A|6|Actual|Genexine, Inc.||1|||f||||f||||||||||2017-10-11 01:53:31.724982|2017-10-11 01:53:31.724982
NCT01813461|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2013-03-15|||October 2012||2012-10-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects|A Phase 1 Open-Label Mass Balance Study to Evaluate the Pharmacokinetics of Isavuconazole After a Single Oral Dose of 14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects|Completed||Phase 1|8|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:53:31.915251|2017-10-11 01:53:31.915251
NCT01813448|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-05-19|||February 2013||2013-02-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects|Completed||Phase 1|36|Actual|Astellas Pharma Inc||5|||f||||f||||||||||2017-10-11 01:53:32.018549|2017-10-11 01:53:32.018549
NCT01813435|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-07-25|||May 2013||2013-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation|Comparative Effectiveness of 1 Month of Ticagrelor Plus Aspirin Followed by Ticagrelor Monotherapy Versus a Current-day Intensive Dual Antiplatelet Therapy in All-comers Patients Undergoing Percutaneous Coronary Intervention With Bivalirudin and BioMatrix Family Drug-eluting Stent Use|Active, not recruiting||Phase 3|16000|Actual|ECRI bv||2|||f||||t||||||||||2017-10-11 01:53:32.17043|2017-10-11 01:53:32.17043
NCT01813422|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2017-06-19||2017-06-19|April 18, 2013|Actual|2013-04-18|June 2017|2017-06-01|July 29, 2016|Actual|2016-07-29|July 12, 2016|Actual|2016-07-12||Interventional|GLAGOV||GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound|A Double-blind, Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Determine the Effects of Evolocumab (AMG 145) Treatment on Atherosclerotic Disease Burden as Measured by Intravascular Ultrasound in Subjects Undergoing Coronary Catheterization|Completed||Phase 3|970|Actual|Amgen||2|||f||||t||||||||||2017-10-11 01:53:32.715151|2017-10-11 01:53:32.715151
NCT01813409|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-15|2014-08-29|||August 2009||2009-08-01|August 2014|2014-08-01||||December 2015|Anticipated|2015-12-01|1 Year|Observational [Patient Registry]|RCR||Rheumatology Clinical Registry|American College of Rheumatology Clinical Registry|Unknown status|Recruiting|N/A|820|Anticipated|American College of Rheumatology|||1||f||||f||||||||||2017-10-11 01:53:33.25887|2017-10-11 01:53:33.25887
NCT01813396|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-10-31|||December 2011||2011-12-01|October 2013|2013-10-01||||March 2013|Actual|2013-03-01||Interventional|||Prediction of Functional Disability and Clinical Trial in Subjects With Stiff Shoulders|Prediction of Functional Disability and Randomized Clinical Trial in Subjects With Stiff Shoulders: Joint Mobility, Range of Motion, Muscle Stiffness, and Shoulder Physical Activity|Unknown status|Recruiting|N/A|45|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 01:53:33.322692|2017-10-11 01:53:33.322692
NCT01813383|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-14|||January 2010||2010-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Observational|HLA||Clinical Relevance of Typing HLA-DR7-DQ2|Clinical Relevance of Typing HLA-DR7-DQ2|Completed||N/A|92|Actual|Corporacion Parc Tauli|||2||f||||t||||||||||2017-10-11 01:53:33.432057|2017-10-11 01:53:33.432057
NCT01813370|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-05-19|||March 2013||2013-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01|36 Months|Observational [Patient Registry]|||A Registry for Patients Treated on the Clinical Trial TAX 3503|A Registry for Patients Treated on the Clinical Trial TAX 3503 (A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA Following Definitive Local Therapy)|Enrolling by invitation||N/A|19|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     Serum PSA evaluations Serum testosterone levels   "|||2017-10-11 01:53:33.53664|2017-10-11 01:53:33.53664
NCT01813357|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2014-07-12|||March 2013||2013-03-01|July 2014|2014-07-01|January 2017|Anticipated|2017-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Does Rosuvastatin Delay Progression of Atherosclerosis in HIV|Does Rosuvastatin Delay Progression of Atherosclerosis in People With HIV Infection at Moderate Cardiovascular Risk? A Multicentre Randomized, Double Blind Placebo-controlled Trial|Unknown status|Recruiting|Phase 4|102|Anticipated|Bayside Health||2|||f||||t||||||||||2017-10-11 01:53:33.66953|2017-10-11 01:53:33.66953
NCT01812798|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-09-13|||May 2013||2013-05-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Canadian Peanut Thresholds Study|Disease Management: Canadian Peanut Thresholds Study|Active, not recruiting||N/A|30|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 01:53:39.05241|2017-10-11 01:53:39.05241
NCT01813344|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-14|||January 2012||2012-01-01|March 2013|2013-03-01||||June 2013|Anticipated|2013-06-01||Observational|LBL-CISL-1||Hyper-CVAD Treatment in Lymphoblastic Lymphoma|The Clinical Outcomes of Hyper-CVAD Treatment in Lymphoblastic Lymphoma|Unknown status|Recruiting|N/A|50|Anticipated|Ajou University School of Medicine|||1||f||||t||||||||||2017-10-11 01:53:33.766774|2017-10-11 01:53:33.766774
NCT01813331|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-13|||November 2012||2012-11-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01|3 Months|Observational [Patient Registry]|ALERT-HF||ALERT-HF: Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure|ALERT-HF:Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure|Completed||N/A|660|Actual|Federico II University|||1||f||||||||||||||2017-10-11 01:53:33.839746|2017-10-11 01:53:33.839746
NCT01813318|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-07-18|||April 2013||2013-04-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of Acamprosate in Autism|Double-Blind Placebo-Controlled Study of Acamprosate in Autism|Recruiting||Phase 2/Phase 3|36|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 01:53:33.9004|2017-10-11 01:53:33.9004
NCT01813305|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-02-14|||March 2013||2013-03-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||CSTC1 for Diabetic Foot Ulcers Phase II Study|A Randomized,Double-Blind,Vehicle-controlled,Parallel,Phase II Study to Evaluate Efficacy and Safety of CSTC1 in Patient With Diabetic Foot Ulcers|Recruiting||Phase 2|100|Anticipated|Charsire Biotechnology Corp.||2|||f||||f||||||||Undecided||2017-10-11 01:53:33.993024|2017-10-11 01:53:33.993024
NCT01813292|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-11-21|||May 2013||2013-05-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Observational|||Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine|Comparative Study of Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV + Men Being Given Tenofovir With FTC, Emtricitabine (TRUVADA®), or Without (VIREAD®), as Part of Their Antiretroviral Therapy.|Completed||N/A|103|Actual|Hopital Lariboisière|||1||f||||f||||||||No||2017-10-11 01:53:34.075629|2017-10-11 01:53:34.075629
NCT01813279|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-08-29|||November 2012||2012-11-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis|Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis|Completed||N/A|12|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||t||||||||||2017-10-11 01:53:34.140273|2017-10-11 01:53:34.140273
NCT01813266|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-13|||May 2013||2013-05-01|March 2013|2013-03-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01|3 Months|Observational [Patient Registry]|TPEGHCVS||Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors|Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors.|Unknown status|Not yet recruiting|N/A|6000|Anticipated|Intermountain Health Care, Inc.|||3||f||||f||||||Samples With DNA|"     Hepatitis C virues enzyme immunosorbent assay screening; if positivie follow up testing   "|||2017-10-11 01:53:34.212798|2017-10-11 01:53:34.212798
NCT01813253|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-04-26|||March 2013||2013-03-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer|A Randomized, Open-label, Japan-Korea-Taiwan Collaborative Phase 3 Study to Compare the Efficacy of Nimotuzumab and Irinotecan Combination Therapy Versus Irinotecan Monotherapy as Second Line Treatment in Subjects With Advanced or Recurrent Gastric and Gastroesophageal Junction Cancer|Recruiting||Phase 3|400|Anticipated|Kuhnil Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:53:34.306398|2017-10-11 01:53:34.306398
NCT01813240|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-15|||May 2013||2013-05-01|March 2013|2013-03-01||||April 2015|Anticipated|2015-04-01||Interventional|||Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement||Unknown status|Not yet recruiting|Phase 2/Phase 3|444|Anticipated|Hadassah Medical Organization||4|||f||||f||||||||||2017-10-11 01:53:34.60016|2017-10-11 01:53:34.60016
NCT01813227|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-08-21|||April 2013||2013-04-01|August 2015|2015-08-01|April 2016|Anticipated|2016-04-01|September 2015|Anticipated|2015-09-01||Interventional|||A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531|A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531|Unknown status|Active, not recruiting|Phase 2|55|Anticipated|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-11 01:53:34.70208|2017-10-11 01:53:34.70208
NCT01813214|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-03-02|||March 2013|Actual|2013-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma|Analysis of the Kinetics and Effects of Vemurafenib + Cobimetinib on Intratumoral and Host Immunity in Patients With Advanced BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy|Terminated||Phase 2|5|Actual|Georgetown University||1||Recruitment difficulties.|f||||t||||||||||2017-10-11 01:53:34.80679|2017-10-11 01:53:34.80679
NCT01813201|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-03-12|||March 2011||2011-03-01|March 2014|2014-03-01|March 2016|Anticipated|2016-03-01|March 2015|Actual|2015-03-01||Interventional|TIC||Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects|A Randomized and Double-blind Study to Evaluate the Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects|Unknown status|Active, not recruiting|Phase 4|126|Anticipated|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||2|||f||||t||||||||||2017-10-11 01:53:34.926511|2017-10-11 01:53:34.926511
NCT01813188|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-03-29|||April 2011||2011-04-01|March 2014|2014-03-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Clinical Trial Based on the Use of Mononuclear Cells From Autologous Bone Marrow in Patients With Pseudoarthrosis|Phase II Clinical Trial of Tissue Engineering Based on the Use of Mononuclear Cells From Autologous Bone Marrow Seeded on Porous Tricalcium Phosphate Biomaterial in Patients With Pseudoarthrosis|Completed||Phase 2|5|Actual|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||2|||f||||t||||||||||2017-10-11 01:53:35.07757|2017-10-11 01:53:35.07757
NCT01813175|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-09-04|||May 2013||2013-05-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Color Synbiotics Study|Randomised, Controlled, Double-blind Exploratory Study to Investigate the Effect of Specific Synbiotics Mixtures on Gut Microbiota Composition in Healthy Infants.|Completed||N/A|290|Actual|Danone Asia Pacific Holdings Pte, Ltd.||4|||f||||f||||||||||2017-10-11 01:53:35.192838|2017-10-11 01:53:35.192838
NCT01813162|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-05-21|||December 2013||2013-12-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products|In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products|Completed||Phase 1|101|Actual|CONRAD||3|||f||||f||||||||||2017-10-11 01:53:35.290932|2017-10-11 01:53:35.290932
NCT01813149|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-04-06|||August 2012||2012-08-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Mechanism and Treatment of Sympathetically Maintained Pain||Completed||N/A|9|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-10-11 01:53:35.421956|2017-10-11 01:53:35.421956
NCT01813136|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-09-18|||March 2013||2013-03-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma|A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma|Recruiting||Phase 2|168|Anticipated|Centre Leon Berard||2|||f||||t||||||||||2017-10-11 01:53:35.537183|2017-10-11 01:53:35.537183
NCT01813123|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-05-12|||March 2013||2013-03-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls|A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls|Active, not recruiting||N/A|788|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:53:35.755064|2017-10-11 01:53:35.755064
NCT01813110|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-07-05|2017-05-23||May 2014||2014-05-01|July 2017|2017-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PRONOVA|Only the 20 participants who completed the study are included in the baseline characteristics analysis|Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation|Effects of a Prescription Omega-3 Fatty Acid Concentrate in a Placebo-controlled Trial of Human Endotoxemia|Completed||N/A|21|Actual|Penn State University||2|||f||||t||||||||||2017-10-11 01:53:35.844488|2017-10-11 01:53:35.844488
NCT01813097|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-15|||February 2008||2008-02-01|February 2008|2008-02-01||||March 2013|Actual|2013-03-01||Observational|||Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer||Completed||N/A|60|Actual|Chinese PLA General Hospital|||2||f||||t||||||||||2017-10-11 01:53:36.038796|2017-10-11 01:53:36.038796
NCT01813084|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-04-23|||May 2013||2013-05-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729|A Randomised, Double Blind, Placebo-controlled, Three Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treatment With Single and Repeat Doses of Inhaled RV1729 in Healthy Subjects and Subjects With Mild to Moderate Asthma|Completed||Phase 1|63|Actual|Respivert Ltd||3|||f||||f||||||||||2017-10-11 01:53:36.104099|2017-10-11 01:53:36.104099
NCT01813071|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-05-23|||August 2013||2013-08-01|August 2015|2015-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety Study of Live Shigella Vaccine in Bangladeshi Adults and Children|A Randomized, Double-Blinded, Placebo-controlled, Dose-Escalation, Age-Descending Study to Assess the Safety and Tolerability of Live Attenuated, Oral Shigella WRSS1 Vaccine in Bangladeshi Adults and Children|Completed||N/A|103|Actual|PATH||7|||f||||t||||||||||2017-10-11 01:53:36.20499|2017-10-11 01:53:36.20499
NCT01813058|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-04-11|||January 2013||2013-01-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Does Tranexamic Acid Decrease Blood Loss in Pediatric Idiopathic Scoliosis Surgery?|The Efficacy of Intravenous Tranexamic Acid in Decreasing Blood Loss in Pediatric Idiopathic Scoliosis Surgery?|Completed||Phase 1/Phase 2|120|Actual|Boston Children’s Hospital||2|||f||||t||||||||No||2017-10-11 01:53:36.318385|2017-10-11 01:53:36.318385
NCT01813045|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-08-29|||April 2013||2013-04-01|March 2015|2015-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Angiogenesis and Fibrosis in Myocardial Infarction|The Identification of In Vivo Angiogenesis and Fibrosis in Myocardial Infarction Using Positron Emission Tomography.|Completed||N/A|30|Actual|University of Edinburgh|||3||f||||t||||||Samples Without DNA|"     Blood samples will be taken, and the serum frozen and stored for further analysis pending     ethical approval.   "|||2017-10-11 01:53:36.418096|2017-10-11 01:53:36.418096
NCT01813032|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-03-14|||April 2012||2012-04-01|March 2013|2013-03-01||||April 2013|Anticipated|2013-04-01||Observational|FIRECOP||Comparison of Vascular Function in Emergency Service Professionals|Comparison of Vascular Function in Emergency Service Professionals|Unknown status|Recruiting|N/A|40|Anticipated|University of Edinburgh|||2||f||||t||||||Samples Without DNA|"     Plasma and urine.   "|||2017-10-11 01:53:36.51107|2017-10-11 01:53:36.51107
NCT01813019|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-11-15|2015-11-10||November 2013||2013-11-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy|A Randomized, Double-blind, Placebo-controlled, Parallel-group Proof of Concept Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy|Terminated||Phase 2|50|Actual|Novartis||2||"Study was prematurely terminated at the time of the first Interim Analysis (IA) as the study   did not meet its primary efficacy objective."|f||||t||||||||||2017-10-11 01:53:36.621976|2017-10-11 01:53:36.621976
NCT01813006|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-03-14|||March 2013||2013-03-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect of Omega-3 Fatty Acid on Endothelial Function|Effect of Omega-3 Polyunsaturated Fat on Endothelial Function and Inflammatory Parameters in Familial Hypercholesterolemia - a Double Blind, Placebo-controlled Crossover Study|Unknown status|Not yet recruiting|Phase 3|50|Anticipated|Nordlandssykehuset HF||2|||f||||f||||||||||2017-10-11 01:53:36.974857|2017-10-11 01:53:36.974857
NCT01812785|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-03-14|||January 2008||2008-01-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2008|Actual|2008-12-01||Observational|||Study to Investigate the Causes of Fever in Children Living in Urban Dar es Salaam and Rural Ifakara|Study to Investigate the Causes of Fever in Children Living in Urban Dar es Salaam and Rural Ifakara|Completed||N/A|1010|Actual|Swiss Tropical & Public Health Institute|||1||f||||f||||||||||2017-10-11 01:53:39.130172|2017-10-11 01:53:39.130172
NCT01812993|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-02-10|||March 2013||2013-03-01|February 2015|2015-02-01||||December 2015|Anticipated|2015-12-01||Interventional|Reverse-STEAL||Reversal of the Neurological Deficit in Acute Stroke With the Signal of Efficacy Trial of Auto BPAP to Limit Damage From Suspected Sleep Apnea|Reversal of the Neurological Deficit in Acute Stroke With the Signal of Efficacy Trial of Auto BPAP to Limit Damage From Suspected Sleep Apnea (Reverse-STEAL): A Multicenter Randomized Study|Unknown status|Recruiting|Phase 2|60|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 01:53:37.080944|2017-10-11 01:53:37.080944
NCT01812980|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-12-10|||May 2013||2013-05-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women|Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV- Infected Women: An Open Label Trial.|Completed||Phase 4|105|Actual|University of Witwatersrand, South Africa||1|||f||||t||||||||||2017-10-11 01:53:37.183351|2017-10-11 01:53:37.183351
NCT01812967|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-15||||||March 2013|2013-03-01||||September 2011|Actual|2011-09-01||Interventional|||Mechanism of Action of Milk and Its Components on Glycemic Control in Healthy Young Men||Completed||N/A|12|Actual|University of Toronto|||||f||||||||||||||2017-10-11 01:53:37.268327|2017-10-11 01:53:37.268327
NCT01812954|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-08-10|||March 2013||2013-03-01|August 2017|2017-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis||Completed||N/A|1|Actual|Technische Universität Dresden|||1||f||||t||||||||||2017-10-11 01:53:37.347745|2017-10-11 01:53:37.347745
NCT01812941|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-11-07|||September 2011||2011-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients|Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients|Recruiting||N/A|50|Anticipated|University of South Alabama||3|||f||||f||||||||||2017-10-11 01:53:37.429295|2017-10-11 01:53:37.429295
NCT01812928|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-12-14|||March 2013||2013-03-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|DUF||Diclofenac Suppository to Control Pain During Flexible Cystoscopy|Phase 2 Study of Diclofenac Suppository to Control Pain During Flexible Cystoscopy|Completed||Phase 2|60|Actual|Aga Khan University||2|||f||||t||||||||||2017-10-11 01:53:37.5439|2017-10-11 01:53:37.5439
NCT01812915|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-04-05|||January 2014||2014-01-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Comparison of Tapered- vs. Cylindrical-shaped Tube Cuffs Pressure Alteration With Nitrous Oxide|Comparison of Tapered- vs. Cylindrical-shaped Tube Cuffs Pressure Alteration With Nitrous Oxide Diffusion Under General Anesthesia|Completed||N/A|38|Actual|DongGuk University||2|||f||||f||||||||No||2017-10-11 01:53:37.852207|2017-10-11 01:53:37.852207
NCT01812902|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-08-23|||February 2012||2012-02-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|LFD||Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy|Prospective Randomized Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy|Recruiting||Phase 2|260|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:53:37.98142|2017-10-11 01:53:37.98142
NCT01812889|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-05-15|||April 2013||2013-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463|A Two Part Randomized, Open-Label Phase I Safety and Pharmacokinetic Evaluation of Gel and Ovule Formulations of TOL-463 (Intravaginal Therapy) in 18-45 Year Old Healthy Female Subjects and Women With Vaginitis|Completed||Phase 1|26|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 01:53:38.116487|2017-10-11 01:53:38.116487
NCT01812863|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-12-09|||July 2012||2012-07-01|July 2015|2015-07-01|September 2017|Anticipated|2017-09-01|July 2017|Anticipated|2017-07-01||Interventional|||Pain Management in Children Undergoing Supracondylar Humerus Fracture Repair|Pain Management in Children Undergoing Supracondylar Humerus Fracture Repair: Can a Local Supraclavicular Block Improve Their Postoperative Outcome?|Unknown status|Recruiting|N/A|46|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-11 01:53:38.276236|2017-10-11 01:53:38.276236
NCT01812850|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-05-10|||April 2013||2013-04-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Observational|||Effects of the Continuous Wear of Invisalign® Trays on the Temporomandibular Joints and Orofacial Muscular Complex|Effects of the Continuous Wear of Invisalign® Trays on the Temporomandibular Joints and Orofacial Muscular Complex|Completed||N/A|40|Anticipated|Université de Montréal|||1||f||||t||||||||||2017-10-11 01:53:38.381757|2017-10-11 01:53:38.381757
NCT01812837|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-05-24|2016-12-02||July 2012||2012-07-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Use of Microneedles in Photodynamic Therapy|The Use of Microneedles in Photodynamic Therapy|Completed||N/A|51|Actual|University of California, Davis||4|||f||||f||||||||||2017-10-11 01:53:38.465509|2017-10-11 01:53:38.465509
NCT01812824|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-07-26|||February 2011||2011-02-01|July 2017|2017-07-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional|"Gabby"||Study of Virtual Patient Advocate for Preconception Care for African American Women|Using Innovative Communication Technology to Improve the Health of Young African American Women|Completed||N/A|100|Actual|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-11 01:53:38.872937|2017-10-11 01:53:38.872937
NCT01812811|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-12-10|||September 2012||2012-09-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes|Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes|Completed||N/A|22|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 01:53:38.971428|2017-10-11 01:53:38.971428
NCT01812772|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-05-19|||March 2013||2013-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Effect of Ureteric Stent Tethers on Patient Symptoms and Urinary Infection|The Effect of Ureteric Stent Tethers on Patient Symptoms, Stent Bacterial Colonization and Urinary Tract Infection|Terminated||N/A|11|Actual|St. Michael's Hospital, Toronto||2||Low enrollment|f||||f||||||||||2017-10-11 01:53:39.206752|2017-10-11 01:53:39.206752
NCT01812759|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-08-22|||February 20, 2013|Actual|2013-02-20|August 2017|2017-08-01|October 22, 2014|Actual|2014-10-22|October 22, 2014|Actual|2014-10-22||Interventional|||Fentanyl for Breakthrough Pain in the Emergency Department|A Randomized Controlled Double-Blind Trial of Fentanyl Nasal Spray (Lazanda) Plus Hydromorphone Demand PCA Versus Placebo Nasal Spray Plus Hydromorphone Demand PCA for Treatment of Breakthrough Cancer Pain in the Emergency Department|Terminated||Phase 4|3|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:53:39.308595|2017-10-11 01:53:39.308595
NCT01812746|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-04-14|||April 2013||2013-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer|An Open Label, Multicenter, Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer|Completed||Phase 2|42|Actual|BIND Therapeutics||1|||f||||||||||||||2017-10-11 01:53:39.412104|2017-10-11 01:53:39.412104
NCT01812733|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-08-06|||June 2013||2013-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives|An Observational Study of Quality of Life, Resource Use and Costs Associated With Treatment of Severe Pain - a Comparison of a Combination of Oxycodone and Naloxone (Targiniq) Versus Oxycodone and Laxatives|Completed||N/A|37|Actual|Mundipharma AB|||1||f||||f||||||||||2017-10-11 01:53:39.515749|2017-10-11 01:53:39.515749
NCT01812720|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-12-15|||August 2013||2013-08-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|CARAMEL 2||Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant|A Phase 2 Trial of Carfilzomib Consolidation After Autologous Stem Cell Transplantation for Multiple Myeloma(CARAMEL 2)|Withdrawn||Phase 2|0|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:53:39.586401|2017-10-11 01:53:39.586401
NCT01812707|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-09-27|2015-08-21|2015-01-22|March 2013||2013-03-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Randomized population.|Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan|A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Evaluating the Efficacy and Safety of Three Doses of SAR236553 (REGN727) Over 12 Weeks in Patients With Primary Hypercholesterolemia and LDL-cholesterol ≥100 mg/dL (≥2.59 mmol/L) on Ongoing Stable Atorvastatin Therapy|Completed||Phase 2|100|Actual|Sanofi||4|||f||||t||||||||||2017-10-11 01:53:39.721536|2017-10-11 01:53:39.721536
NCT01812694|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-06-30|||December 21, 2012||2012-12-21|March 27, 2017|2017-03-27|March 27, 2017|Actual|2017-03-27|March 27, 2017|Actual|2017-03-27||Interventional|||Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix|Lifestyle Interventions for Expectant Moms (LIFE-Moms) - Phoenix|Completed||Phase 3|1500|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 01:53:40.508126|2017-10-11 01:53:40.508126
NCT01812681|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-08-12|2014-07-17||October 2012||2012-10-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|||Cord Blood 25(oh)-Vitamin D Level in Preterm Infants and Associated Morbidities|Is Higher Cord Blood 25(Oh)-Vitamin D Level Preventive For Any Morbidity Including Rds, Pda, Nec, Bpd And Rop In Preterm Infants|Completed||N/A|81|Actual|Dr. Sami Ulus Children's Hospital|||2||f||||f||||||||||2017-10-11 01:53:40.616948|2017-10-11 01:53:40.616948
NCT01812668|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-04-03|||March 2013||2013-03-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer|Pilot Trial of Oral Cabozantinib/XL184 in Metastatic Castrate Resistant Prostate Cancer to Explore the Changes in Bone and Tumor Imaging Related Pathways|Active, not recruiting||N/A|25|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 01:53:40.954414|2017-10-11 01:53:40.954414
NCT01812655|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-08-05|2013-03-27||June 2010||2010-06-01|August 2013|2013-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Comparison of Virtual Reality and Passive Distraction on Burn Wound Care Pain in Adolescents|Comparison of Virtual Reality and Passive Distraction on Burn Wound Care|Terminated||N/A|30|Actual|University of Arkansas|Early termination of study due to fewer subjects available than expected resulting in small sample size.|3||"Early termination of study due to fewer subjects available than expected resulting in small   sample size."|f||||t||||||||||2017-10-11 01:53:41.094985|2017-10-11 01:53:41.094985
NCT01812642|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-03-16|||July 2008||2008-07-01|March 2014|2014-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia|A Double-Blind, Multiple Dose Titration Study to Investigate the Safety, Tolerability and Pharmacokinetics of Once Daily and Twice Daily Doses of JNJ-37822681 in Male and Female Patients With Stable Schizophrenia|Completed||Phase 2|33|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 01:53:41.665876|2017-10-11 01:53:41.665876
NCT01812629|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-03-14|||July 1997||1997-07-01|March 2013|2013-03-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||Nutritional Management of Children With Chronic Diarrhea|Clinical Management of Children With Chronic Diarrhea|Completed||N/A|19|Actual|Abbott Nutrition||1|||f||||f||||||||||2017-10-11 01:53:41.802477|2017-10-11 01:53:41.802477
NCT01812616|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-08-10|||September 2014||2014-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients|A Two Part Study to Assess the Tolerability, Safety and Pharmacodynamics of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma|Completed||Phase 1/Phase 2|21|Actual|GW Research Ltd||2|||f||||f||||||||||2017-10-11 01:53:41.922774|2017-10-11 01:53:41.922774
NCT01811836|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-12|||March 2013||2013-03-01|March 2013|2013-03-01|March 2014|Anticipated|2014-03-01|July 2013|Anticipated|2013-07-01||Interventional|||Zinc Resistant Starch Project|The Effect of Resistant Starch Consumption on Zinc Hemostasis in Malawian Children at Risk for Zinc Deficiency|Unknown status|Recruiting|N/A|20|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 01:53:51.663094|2017-10-11 01:53:51.663094
NCT01812603|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-08-10|||September 2013||2013-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|January 2015|Actual|2015-01-01||Interventional|||A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma|A Two Part Study to Assess the Tolerability, Safety and Pharmacodynamics of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma|Completed||Phase 1/Phase 2|6|Actual|GW Research Ltd||1|||f||||f||||||||||2017-10-11 01:53:42.046872|2017-10-11 01:53:42.046872
NCT01812590|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-01-30|||January 2013||2013-01-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Acute Exercise and Pancreatic Endocrine Function||Completed||N/A|14|Actual|Rigshospitalet, Denmark||2|||f||||||||||||||2017-10-11 01:53:42.141425|2017-10-11 01:53:42.141425
NCT01812577|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-03-18|||December 2012||2012-12-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|TPVB||Paravertebral Block for Percutaneous Radiofrequency Ablation of Liver Lesions|Evaluation of the Analgesic Efficacy of the Ultrasound Guided Thoracic Paravertebral Block for Percutaneous Radiofrequency Ablation of Liver Lesions|Unknown status|Recruiting|N/A|40|Anticipated|Campus Bio-Medico University|||2||f||||t||||||||||2017-10-11 01:53:42.377959|2017-10-11 01:53:42.377959
NCT01812564|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-01-13|||November 2009||2009-11-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|||Use of Platelet Rich Plasma in the Management of Acute Hamstring Muscle Strain Injury|Clinical Utilization of Growth Factors Preparations in the Management of Acute Hamstring Muscle Strain Injury|Completed||Phase 2|90|Actual|Aspetar||3|||f||||f||||||||||2017-10-11 01:53:42.468629|2017-10-11 01:53:42.468629
NCT01812551|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2014-03-05|||October 2002||2002-10-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2006|Actual|2006-07-01||Interventional|OSCYF||Treatment of Low Bone Density in Cystic Fibrosis.|Osteoporosis in Cystic Fibrosis: Study of Bone Mass and Bone Metabolism, and Prospective Randomized Therapeutic Trial.|Completed||Phase 3|171|Actual|Istituto Auxologico Italiano||2|||f||||f||||||||||2017-10-11 01:53:42.591458|2017-10-11 01:53:42.591458
NCT01812538|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-07-23|||May 2009||2009-05-01|July 2015|2015-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of DIC075V on QTc Intervals in Healthy Subjects|A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of DIC075V on QTc Intervals in Healthy Subjects|Completed||Phase 1|70|Actual|Hospira, now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-10-11 01:53:42.751639|2017-10-11 01:53:42.751639
NCT01812525|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-08-17|||March 2013||2013-03-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations|Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3%|Completed||Phase 3|120|Actual|Hôpital de L'Enfance||2|||f||||t||||||||||2017-10-11 01:53:42.864974|2017-10-11 01:53:42.864974
NCT01812512|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-11-25|||November 2014||2014-11-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|TSM-CHF||Telehealth Self Management for CHF|Communication Skills Training for Heart Failure Self-Management in Telehealth|Withdrawn||Phase 1/Phase 2|0|Actual|VA Office of Research and Development||2||Never funded.|f||||f||||||||||2017-10-11 01:53:42.982827|2017-10-11 01:53:42.982827
NCT01812499|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-03-13|||January 2013||2013-01-01|February 2013|2013-02-01||||February 2013|Actual|2013-02-01||Observational|||Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports|Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports.|Completed||N/A|131|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:53:43.092472|2017-10-11 01:53:43.092472
NCT01812486|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-15|||May 2008||2008-05-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer|Dose De-escalation to the Elective Nodal Sites, the Swallowing Apparatus and Neck Soft Tissues for Head and Neck Cancer: Multi-centre, Randomized Phase III Trial Using Image-guided Intensity-modulated Radiotherapy (IG-IMRT)|Completed||Phase 3|200|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 01:53:43.177663|2017-10-11 01:53:43.177663
NCT01812473|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-03-03|2015-01-13||February 2013||2013-02-01|March 2013|2013-03-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|||Plasma Protein Binding Characteristics of Voriconazole|Impact of Hypoalbuminemia on Voriconazole Pharmacokinetics in Critically Ill Adult Patients.|Completed||N/A|35|Actual|Universitaire Ziekenhuizen Leuven|"Relatively small data set.
Only adult ICU patients.
No data are available for plasma albumin concentrations above 40 g/liter."||1||f||||f||||||Samples With DNA|"     Plasma and serum samples are obtained to determine the albumin and alpha-1-acid-glycoprotein     level.   "|||2017-10-11 01:53:43.271192|2017-10-11 01:53:43.271192
NCT01812460|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-10-25|||December 2012||2012-12-01|October 2013|2013-10-01|November 2013|Anticipated|2013-11-01|February 2013|Actual|2013-02-01||Interventional|||Progressive Resistance Training of the Extensor Muscle of the Thigh in COPD-patients Hospitalized With an Exacerbation|Progressive Resistance Training of the Extensor Muscle of the Thigh in COPD-patients Hospitalized With an Exacerbation|Withdrawn||N/A|0|Actual|Frederikssunds Hospital, Denmark||2||The Study had to stop due to organizational changes in Nordsjællands Hospital|f||||t||||||||||2017-10-11 01:53:43.732014|2017-10-11 01:53:43.732014
NCT01812447|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-09-13|||June 2013||2013-06-01|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|November 2017|Anticipated|2017-11-01||Interventional|EMPROVE||Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function|A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema|Active, not recruiting||N/A|172|Actual|Spiration, Inc.||3|||f||||t||||||||||2017-10-11 01:53:43.827433|2017-10-11 01:53:43.827433
NCT01812434|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-04-21|||October 2010||2010-10-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients|Evaluation of Phosphodiesterase-5 Inhibition on Endothelial Function in Heart Transplant Recipients|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||PI Left University|f||||t||||||||||2017-10-11 01:53:43.990791|2017-10-11 01:53:43.990791
NCT01812421|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2013-04-01|||April 2013||2013-04-01|April 2013|2013-04-01||||April 2015|Anticipated|2015-04-01||Interventional|||A Nested Case-control Study on the Secondary Prevention of Ischemic Stroke and TIA by Hypertension Health Education Protocol (HHEP): The Post-Stroke Preventive Trial||Unknown status|Recruiting|N/A|500|Anticipated|Guangzhou University of Traditional Chinese Medicine||1|||f||||||||||||||2017-10-11 01:53:44.080454|2017-10-11 01:53:44.080454
NCT01812395|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-03-21|||March 2013||2013-03-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|||Thyroidectomy Using Ultrasonic Dissector: Is Superior Laryngeal Nerve Really Safe ?|Is Superior Laryngeal Nerve Really Safe During Thyroidectomy Using Ultrasonic Dissector.|Unknown status|Recruiting|N/A|100|Anticipated|S.B. Konya Education and Research Hospital||2|||f||||f||||||||||2017-10-11 01:53:44.180848|2017-10-11 01:53:44.180848
NCT01812382|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-05-12|||April 2, 2014|Actual|2014-04-02|May 2017|2017-05-01|May 27, 2014|Actual|2014-05-27|May 27, 2014|Actual|2014-05-27||Interventional|||Retapamulin Microdialysis Feasibility Study|A Study to Evaluate the Feasibility of Microdialysis to Determine Skin Concentrations of Retapamulin in Healthy Volunteers|Completed||Phase 1|3|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:53:44.303106|2017-10-11 01:53:44.303106
NCT01812369|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-12-06|||March 2013||2013-03-01|December 2016|2016-12-01|August 2021|Anticipated|2021-08-01|July 2019|Anticipated|2019-07-01||Interventional|VESPER||Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer|Randomized Phase III Study of Gemcitabine/Cisplatine (GC) Versus High-dose Intensity Methotrexate, Vinblastine, Doxorubicine and Cisplatin (HD-MVAC) in the Perioperative Setting for Patients With Locally Advanced Transitional Cell Cancer of the Bladder|Recruiting||Phase 3|500|Anticipated|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 01:53:44.381561|2017-10-11 01:53:44.381561
NCT01812356|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-08-22|||March 2013||2013-03-01|March 2016|2016-03-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|||The Concomitant Cryomaze Procedure Using Nitreous Oxide Cryoprobe: Comparison With Argon Based Cryoprobe|Study of Cryomaze Procedure Using Nitrous Oxide Versus Argon Gas|Completed||N/A|60|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 01:53:44.473311|2017-10-11 01:53:44.473311
NCT01812343|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-12-15|||September 2009||2009-09-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|VICTOR||Value of Ankle Pressure Index After Maximal Exercise Tests|Mesure de l'Index de Pression Systolique de Cheville après Test d'Effort Maximal.|Recruiting||N/A|880|Anticipated|University Hospital, Angers||1|||f||||t||||||||||2017-10-11 01:53:44.577184|2017-10-11 01:53:44.577184
NCT01812330|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2015-06-23|||January 2013||2013-01-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety Study of Ticagrelor|The Effect of Ticagrelor on Acute Coronary Syndrome Patients With Clopidogrel Resistance Undergoing Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 3|180|Anticipated|General Hospital of Chinese Armed Police Forces||3|||f||||t||||||||||2017-10-11 01:53:44.660915|2017-10-11 01:53:44.660915
NCT01812317|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-03-13|||April 2012||2012-04-01|March 2013|2013-03-01||||April 2013|Anticipated|2013-04-01||Interventional|FIREPROOF||Effect of Real-fire Training on Vascular Function|Effect of Real-fire Training on Vascular Function|Unknown status|Recruiting|N/A|20|Anticipated|University of Edinburgh||2|||f||||t||||||||||2017-10-11 01:53:44.781588|2017-10-11 01:53:44.781588
NCT01812304|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2013-11-10|||October 2011||2011-10-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Theoretical Compared With hands-on Training of Vaginal Breech Management|Objective Structured Assessment of Technical Skills Evaluation of Theoretical Compared With hands-on Training of Shoulder Dystocia Management: a Randomized Controlled Trial.|Completed||Phase 3|172|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-11 01:53:44.906263|2017-10-11 01:53:44.906263
NCT01812291|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-01-13|||February 2012||2012-02-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|Ecce_homo||Evaluation of a Stepped Care Approach to Manage Depression in Diabetes|Efficacy of a Stepped Care Approach to Manage Depression in Diabetic Patients and Putative Inflammatory Mechanisms Between Diabetes and Depression|Completed||N/A|260|Actual|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||t||||||||||2017-10-11 01:53:45.009951|2017-10-11 01:53:45.009951
NCT01812278|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2016-11-02|||March 2014||2014-03-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)|Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation|Active, not recruiting||N/A|2637|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 01:53:45.187526|2017-10-11 01:53:45.187526
NCT01812265|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-09-16|||June 2013||2013-06-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Cold Pressor Test is Used in This Study to Assess the Effect of PF-06305591 on Pain Intensity Evoked by Cold in Healthy Male Subjects|A Double Blind (3rd Party Open), Randomized, Placebo Controlled, Crossover Study To Investigate The Effects Of Pf-06305591 On Cold Pain In Healthy Male Subjects|Completed||Phase 1|16|Actual|Pfizer||3|||f||||||||||||||2017-10-11 01:53:45.261324|2017-10-11 01:53:45.261324
NCT01812252|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-14|2017-09-25|||April 2013||2013-04-01|September 2017|2017-09-01||||September 2018|Anticipated|2018-09-01||Interventional|ICT-HCT||Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant|Initial Cytoreductive Therapy for Myelodysplastic Syndrome Prior to Allogeneic Hematopoietic Cell Transplantation (the ICT-HCT Study)|Recruiting||Phase 2|60|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 01:53:45.357646|2017-10-11 01:53:45.357646
NCT01812239|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-12-17|||March 2014||2014-03-01|December 2014|2014-12-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Vaginal Progesterone in Twins With Short Cervix|Vaginal Progesterone to Prevent Early Preterm Birth In Twin Pregnancy With Short Cervix. Double-Blind, Placebo-Controlled, Randomized Clinical Trial|Withdrawn||Phase 2/Phase 3|0|Actual|Mednax Center for Research, Education and Quality||2||inability to retain study drug with comparable placebo.|f||||t||||||||||2017-10-11 01:53:45.497146|2017-10-11 01:53:45.497146
NCT01812226|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-11-03|||March 2013||2013-03-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Alcohol Biomarkers in Post-Liver Transplant Patients|Alcohol Biomarkers in Post-Liver Transplant Patients|Completed||N/A|214|Actual|Northwestern University|||2||f||||f||||||Samples With DNA|"     Blood samples collected to detect PEth levels.   "|No||2017-10-11 01:53:45.602734|2017-10-11 01:53:45.602734
NCT01812031|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-02-26|||August 2009||2009-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2013|Actual|2013-02-01||Interventional|PneumoTEP||Benefits Study of Respiratory-gated PET Acquisition in Lung Disease|Benefits Study of a Respiratory Gating Protocol for Positron Emission Tomography: Application on the Lungs|Completed||N/A|103|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 01:53:48.982925|2017-10-11 01:53:48.982925
NCT01812213|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-07-25|||March 2013|Actual|2013-03-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|NAV4-04||Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)|Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)|Active, not recruiting||Phase 2|120|Anticipated|Navidea Biopharmaceuticals||1|||f||||f||||||||||2017-10-11 01:53:45.713906|2017-10-11 01:53:45.713906
NCT01812200|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2014-03-05|||October 2012||2012-10-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Antithrombotic Triple Therapy in Humans|A Prospective, Randomized, Controlled, Analyst-blinded, Parallel Group Study to Investigate the Effect of Antithrombotic Triple Therapy With Ticagrelor and Acetylsalicylic Acid in Combination With Dabigatran or Rivaroxaban or Phenprocoumon on Markers of Coagulation Activation in Venous and Shed Blood in Healthy Male Subjects|Completed||Phase 4|60|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-10-11 01:53:45.914376|2017-10-11 01:53:45.914376
NCT01812187|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-09-21|||April 2015||2015-04-01|September 2015|2015-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Designing a Mobile App for Veterans With Substance Use Problems|Development of an Interactive, Adaptable and Transportable Treatment for Veterans With Substance Use Disorders|Unknown status|Recruiting|N/A|20|Anticipated|Michael Debakey Veterans Affairs Medical Center||1|||f||||f||||||||||2017-10-11 01:53:46.059606|2017-10-11 01:53:46.059606
NCT01812174|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-09-25|||January 2012||2012-01-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||On-X Heart Valve - 17mm Aortic and 23mm Mitral|On-X Heart Valve - 17mm Aortic and 23mm Mitral|Recruiting||N/A|30|Anticipated|On-X Life Technologies, Inc.||2|||f||||t||||||||||2017-10-11 01:53:46.159745|2017-10-11 01:53:46.159745
NCT01812161|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2016-02-21|||September 2012||2012-09-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Effect of Low-frequency Electroacupuncture (EA) on Polycystic Ovary Syndrome|Effect of Low-frequency Electroacupuncture (EA) on Polycystic Ovary Syndrome|Recruiting||N/A|54|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||Yes|we use the Clinical Trial Management Public Platform to manage and share our date.|2017-10-11 01:53:46.332571|2017-10-11 01:53:46.332571
NCT01812148|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-15|||January 2012||2012-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)|Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)|Completed||N/A|19|Actual|Maisonneuve-Rosemont Hospital|||1||f||||t||||||||||2017-10-11 01:53:46.452754|2017-10-11 01:53:46.452754
NCT01812135|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-13|||September 2011||2011-09-01|March 2013|2013-03-01|December 2011|Anticipated|2011-12-01|November 2011|Anticipated|2011-11-01||Interventional|||Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants|A Double-blind and Randomized, Phase II -02 Study With Inactivated EV71 Vaccines in Healthy Infants|Withdrawn||Phase 2|0|Actual|Sinovac Biotech Co., Ltd||3||"Based on the previous study results, inactivated EV71 vaccine with aluminum adjuvant was   elected to be used for the efficacy Phase III study."|f||||t||||||||||2017-10-11 01:53:46.539672|2017-10-11 01:53:46.539672
NCT01812122|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-11-19|||March 2013||2013-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Effects of Vildagliptine and Glimepiride on Glucose Variability|Effects of Vildagliptine and Glimepiride on Glycemic Variability and Cardiovascular Parameters in Patients With Type 2 Diabetes by CGMS|Completed||Phase 4|16|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:53:46.619524|2017-10-11 01:53:46.619524
NCT01812109|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-03-13|||May 2011||2011-05-01|March 2013|2013-03-01|May 2018|Anticipated|2018-05-01|May 2016|Anticipated|2016-05-01||Interventional|NIRS||Near-Infrared Spectroscopy for Pediatric Acute Scrotum and Testicular Torsion|Near-Infrared Spectroscopy for Pediatric Acute Scrotum and Testicular Torsion|Recruiting||N/A|750|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 01:53:46.704308|2017-10-11 01:53:46.704308
NCT01812096|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-08-17|||May 2014||2014-05-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|January 2016|Anticipated|2016-01-01||Interventional|MM||Study of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma in China|Prospective Comparison the Pharmacokinetics of Subcutaneous Versus Intravenous Administration of Bortezomib in Newly Diagnosed Patients of Multiple Myeloma in China.|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|The First Affiliated Hospital of Soochow University||2|||f||||||||||||||2017-10-11 01:53:46.812635|2017-10-11 01:53:46.812635
NCT01812083|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-14|||January 2004||2004-01-01|March 2013|2013-03-01|February 2005|Actual|2005-02-01|June 2004|Actual|2004-06-01||Observational|IRAGPAAOITW||Interleukin-1 Receptor Antagonist Gene Polymorphism and Adverse Pregnancy Outcome in Turkish Women|Interleukin-1 Receptor Antagonist Gene Polymorphism and Adverse Pregnancy Outcome in Turkish Women|Completed||N/A|156|Actual|Selcuk University|||1||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:53:46.894479|2017-10-11 01:53:46.894479
NCT01812070|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-03-04|||March 2013||2013-03-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Innovative Smartphone Application of a New Behavioral Method to Quit Smoking: Pilot Trial (Smart Quit)|Innovative Smartphone Application of a New Behavioral Method to Quit Smoking: Pilot Randomized Trial|Completed||N/A|196|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 01:53:46.997942|2017-10-11 01:53:46.997942
NCT01812057|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-06-26|2017-05-25||December 2012||2012-12-01|June 2017|2017-06-01|September 21, 2016|Actual|2016-09-21|May 27, 2016|Actual|2016-05-27||Interventional|||Dexamethasone for Post-cesarean Delivery Pain|Dexamethasone as an Analgesic Adjunct for Post-cesarean Delivery Pain Relief|Completed||Phase 4|53|Actual|Duke University|The study was ended prior to completion of total planned enrollment of 104 subjects due to a change in clinical practice regarding post-operative pain medications that would have confounded the results of the study.|2|||f||||f||||||||||2017-10-11 01:53:47.289727|2017-10-11 01:53:47.289727
NCT01812044|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-03-24|2015-12-01||March 2013||2013-03-01|March 2016|2016-03-01||||December 2014|Actual|2014-12-01||Interventional|||Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery|Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery|Completed||N/A|57|Actual|Duke University||3|||f||||||||||||||2017-10-11 01:53:48.430016|2017-10-11 01:53:48.430016
NCT01812018|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-13|||November 2012||2012-11-01|March 2013|2013-03-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Interventional|||Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma|An Open-label, Single-arm, Phase II Study to Assess the Efficacy and Safety of Endostar® (Recombinant Human Endostatin Injection) Plus Gemcitabine and Docetaxel in Treatment of Soft Tissue Sarcoma Patients With Pulmonary Metastases|Unknown status|Recruiting|Phase 2|30|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 01:53:49.10386|2017-10-11 01:53:49.10386
NCT01811992|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2016-10-20|||December 2013||2013-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma|A Non-randomized, Open-label Dose-finding Trial of Combined Cytotoxic and Immune-Stimulatory Strategy for the Treatment of Resectable Primary Malignant Glioma|Recruiting||Phase 1|18|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-11 01:53:49.439575|2017-10-11 01:53:49.439575
NCT01811979|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-05-07|||April 2012||2012-04-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy of Oral Sucrose and Topical Anesthetics to Reduce Pain During Eye Examination for Retinopathy of Prematurity|Efficacy of Oral Sucrose and Topical Anesthetics to Reduce Pain During Eye Examination|Completed||N/A|60|Actual|Dr. Sami Ulus Children's Hospital||2|||f||||f||||||||||2017-10-11 01:53:49.578679|2017-10-11 01:53:49.578679
NCT01811966|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-07-28|||March 2013||2013-03-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Preoperative Volume Substitution in Elective Surgery Patients|Preoperative Volume Substitution in Fasting Patients Undergoing Elective Surgery - Impact on Hemodynamic Stability During Anesthesia|Completed||N/A|220|Actual|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-10-11 01:53:49.698648|2017-10-11 01:53:49.698648
NCT01811953|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-06-26|2015-06-26||March 2013||2013-03-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Treated Set (TS): includes all subjects who were dispensed study medication and were documented to have taken at least one dose of investigational treatment|Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together|Bioequivalence of Empagliflozin/Metformin Fixed Dose Combination Tablets Compared to Single Tablets Administered Together in Healthy Male and Female Volunteers Under Fed and Fasted Conditions (an Open-label, Randomised, Single-dose, Crossover Study)|Completed||Phase 1|48|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 01:53:49.863921|2017-10-11 01:53:49.863921
NCT01811940|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-08-07|||July 2013||2013-07-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|TACT2||Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence|Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence|Completed||Phase 2/Phase 3|168|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 01:53:50.83012|2017-10-11 01:53:50.83012
NCT01811927|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-03-23|||March 2013||2013-03-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|BIOHELIX-II||The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent|The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent (BIOHELIX-II)|Terminated||N/A|43|Actual|Biotronik AG||1|||f||||t||||||||||2017-10-11 01:53:50.951222|2017-10-11 01:53:50.951222
NCT01811914|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2014-04-16|||March 2013||2013-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||Focused TTE for Hemodynamic Instable High Risk Patients|Intraoperative Focused TTE - Impact on High Risk Patients´ Management in Hemodynamic Instabilities|Completed||N/A|50|Actual|Philipps University Marburg Medical Center||1|||f||||f||||||||||2017-10-11 01:53:51.056905|2017-10-11 01:53:51.056905
NCT01811901|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-14|||January 2013||2013-01-01|March 2013|2013-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|SITS-WATCH||Reduction of In-hospital Delays in Stroke Thrombolysis: SITS-WATCH|Reduction of In-hospital Delays in Stroke Thrombolysis: SITS-WATCH|Unknown status|Recruiting|N/A|3000|Anticipated|SITS International||2|||f||||t||||||||||2017-10-11 01:53:51.131937|2017-10-11 01:53:51.131937
NCT01811888|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2016-03-29|||January 2013||2013-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Painful Knee Prosthesis. Relationship Between Endogenous Analgesia and Persistent Post Surgical Pain.|Painful Knee Prosthesis. Relationship Between Endogenous Analgesia and Persistent Post Surgical Pain.|Completed||N/A|180|Actual|Parc de Salut Mar|||1||f||||f||||||||||2017-10-11 01:53:51.223724|2017-10-11 01:53:51.223724
NCT01811875|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-07-12|||June 2013||2013-06-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Multicentre, Non-controlled, Prospective, Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A|Multicentre, Non-controlled, Prospective, Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A|Terminated||Phase 4|6|Actual|Bio Products Laboratory||1||"The study was a post-marketing commitment requested by the PEI and is no longer required as the   Optivate German license will be allowed to expire in Sep-2017."|f||||f||||||||||2017-10-11 01:53:51.304014|2017-10-11 01:53:51.304014
NCT01811862|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-02-21|||March 2013||2013-03-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients|Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients: A Pilot Study|Active, not recruiting||N/A|63|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 01:53:51.462665|2017-10-11 01:53:51.462665
NCT01811849|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2013-03-14|||August 2012||2012-08-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes|A Double-blind Study of the Pharmacokinetic Properties of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Safety and Injection Site Toleration|Completed||Phase 1|12|Actual|Biodel||3|||f||||||||||||||2017-10-11 01:53:51.55412|2017-10-11 01:53:51.55412
NCT01811823|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-08-11|||March 2014||2014-03-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|TIV_HIV_TB||Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults|Effect of HIV and/or Active Tuberculosis on the Humoral and Cell Mediated Immune Responses to Un-adjuvanted Trivalent Sub-unit Influenza Vaccine (TIV) in Adults|Unknown status|Recruiting|Phase 4|360|Anticipated|University of Witwatersrand, South Africa||1|||f||||f||||||||||2017-10-11 01:53:51.79101|2017-10-11 01:53:51.79101
NCT01811810|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-12-14|||March 2013||2013-03-01|December 2015|2015-12-01||||April 2014|Actual|2014-04-01||Interventional|||Proton Therapy for High Risk Prostate Cancer|Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy|Active, not recruiting||Phase 2/Phase 3|120|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:53:51.89474|2017-10-11 01:53:51.89474
NCT01811797|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-05-11|||October 2013||2013-10-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova|A Prospective, Randomized, Double Blind With Sham Control, Clinical Study to Assess the Safety and Efficacy Associated With Treating Patients Suffering From Erectile Dysfunction With Low Intensity Shockwaves by Renova|Terminated||N/A|2|Actual|Initia||2|||f||||f||||||||||2017-10-11 01:53:51.991832|2017-10-11 01:53:51.991832
NCT01811784|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2017-03-05|||November 2012||2012-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Community Intervention to Prevent Nipah Spillover|A Community Intervention Trial Utilizing Behavior Change to Reduce the Risk of Nipah Spillover Through Date Palm Sap in Bangladesh|Recruiting||Phase 1/Phase 2|7782|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||t||||||||||2017-10-11 01:53:52.07476|2017-10-11 01:53:52.07476
NCT01811758|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-07-09|||August 2011||2011-08-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|SB2||Culturally Specific Interventions: African American Smokers|Culturally Specific Interventions and Acculturation in African American Smokers|Completed||Phase 1/Phase 2|345|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 01:53:52.243369|2017-10-11 01:53:52.243369
NCT01811745|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-10-31|||February 2013||2013-02-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|EPHYCOS||Physical Exercise and Jaques-Dalcroze Eurhythmics: Effects on Physical and Cognitive Functions, and Falls in Seniors|Physical Exercise and Jaques-Dalcroze Eurhythmics: Effects on Physical and Cognitive Functions, and Falls in Seniors (EPHYCOS Study)|Completed||N/A|142|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 01:53:52.312591|2017-10-11 01:53:52.312591
NCT01811732|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-08-29|2017-07-25|2015-06-22|April 2013|Actual|2013-04-01|August 2017|2017-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Intent-to-Treat (ITT) Population included all patients who were randomly assigned to treatment.|Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections|A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections|Completed||Phase 3|660|Actual|Melinta Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 01:53:54.37549|2017-10-11 01:53:54.37549
NCT01811719|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2013-03-18|||January 2007||2007-01-01|March 2013|2013-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Enhanced Nurse Home Visitation to Prevent Intimate Partner Violence|An Enhanced Nurse Home Visitation Program To Prevent Intimate Partner Violence|Completed||N/A|238|Actual|Portland State University||2|||f||||f||||||||||2017-10-11 01:53:55.120316|2017-10-11 01:53:55.120316
NCT01811706|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-01-08|2014-12-10||February 2013||2013-02-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Dalfampridine and Gait in Spinocerebellar Ataxias|Therapeutic Effect of Dalfampridine on Gait Incoordination in Spinocerebellar Ataxias- A Randomized, Double-blinded, Placebo-controlled, Crossover Clinical Trial|Completed||N/A|20|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 01:53:55.310004|2017-10-11 01:53:55.310004
NCT01811693|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-06-02|||April 2013||2013-04-01|June 2015|2015-06-01||||December 2015|Anticipated|2015-12-01||Interventional|FAST-BP||Field Administration of Stroke Therapy-Blood Pressure Lowering|The Field Administration of Stroke Therapy-Blood Pressure Lowering Pilot Trial|Unknown status|Recruiting|Phase 2|45|Anticipated|University of California, Los Angeles||3|||f||||t||||||||||2017-10-11 01:53:55.693433|2017-10-11 01:53:55.693433
NCT01811680|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2015-01-02|2014-09-12||August 2012||2012-08-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|VASST||An Exploratory Clinical Study on a Variable Speed and Sensing Treadmill System (VASST) for Hemiparetic Gait Rehabilitation|"A Phase 1 Study of An Exploratory Feasibility Clinical Study on a Variable Speed and Sensing Treadmill System (VASST) for Hemiparetic Gait Rehabilitation in Subacute Stroke Patients."|Completed||Phase 1|10|Actual|Tan Tock Seng Hospital|There were technical limitations due to Gaitrite walkway malfunction midway in the trial leading to unreliable cadence results. Step length results were not affected.|1|||f||||f||||||||||2017-10-11 01:53:55.841533|2017-10-11 01:53:55.841533
NCT01811667|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-04-13|||May 2012||2012-05-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|vasca-LM||Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations|Clinical Study on Efficacy and Safety of the mTor Rapamycin Inhibitor Found in the Complex Vascular Malformations|Completed||Phase 3|19|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-11 01:53:56.102774|2017-10-11 01:53:56.102774
NCT01811654|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-02-23|||April 2013||2013-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|PFPS||Effectiveness Trial for Evaluating IAHA for PFPS|A Randomized, Pragmatic, Effectiveness Trial Evaluating Intra-articular Hyaluronan for the Symptomatic Treatment of Chronic Patellofemoral Pain Syndrome|Active, not recruiting||N/A|68|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 01:53:56.202879|2017-10-11 01:53:56.202879
NCT01811641|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-03-21|||January 2009||2009-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|June 2012|Actual|2012-06-01||Observational|MDEG||Methyl-Donors and EpiGenetics in The Gambia|Epigenesis in Humans: Can Maternal Methyl-donor-deficient Diets Induce Epigenetic Alterations in Their Offspring?|Completed||N/A|166|Actual|Medical Research Council|||1||f||||f||||||Samples With DNA|"     blood, buccal swab, hair follicles   "|||2017-10-11 01:53:56.306468|2017-10-11 01:53:56.306468
NCT01811628|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-07-17|||July 17, 2013|Actual|2013-07-17|July 2017|2017-07-01|July 14, 2017|Actual|2017-07-14|July 14, 2017|Actual|2017-07-14||Observational|||Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers|Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers|Completed||N/A|26|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 01:53:56.376718|2017-10-11 01:53:56.376718
NCT01811615|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-03-13|||February 2010||2010-02-01|March 2013|2013-03-01||||February 2011|Actual|2011-02-01||Interventional|||Efficacy of New Alcohol Free Mouthrinses|A Clinical Study to Investigate the Efficacy of New Alcohol Free Mouthrinses|Completed||N/A|160|Actual|University of Witten/Herdecke||4|||f||||f||||||||||2017-10-11 01:53:56.495423|2017-10-11 01:53:56.495423
NCT01811602|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-04-10|||December 2013||2013-12-01|April 2015|2015-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Gynecological Pelvic Floor Muscle Training|The Efficacy of Pelvic Floor Muscle Training in Gynecological Cancer Survivors: A Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:53:56.613996|2017-10-11 01:53:56.613996
NCT01811589|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-13|2015-01-26|||May 2013||2013-05-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|GAVCA||Guided Application of Ventricular Catheters|Randomized Controlled Multi-center Trial Comparing the Ventricular Catheter Location Between Instrument Guided and Freehand Placement.|Completed||N/A|144|Actual|Aesculap AG||2|||f||||f||||||||||2017-10-11 01:53:56.717237|2017-10-11 01:53:56.717237
NCT01811576|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-02-26|||March 2013||2013-03-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency|A 64-Week (12-week Core Phase and 52-week Safety Extension), Phase II, Multicenter, Randomized, Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency|Completed||Phase 2|52|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 01:53:56.819193|2017-10-11 01:53:56.819193
NCT01811563|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-04-28|2017-02-22||February 2013||2013-02-01|April 2017|2017-04-01|February 26, 2016|Actual|2016-02-26|February 26, 2016|Actual|2016-02-26||Interventional|||Total Knee Arthroplasty: Functional and Clinical Outcomes|Clinical and Functional Outcomes Following Total Knee Replacement Using Two Different Implants|Completed||N/A|60|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:53:56.978916|2017-10-11 01:53:56.978916
NCT01811550|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-03-31|||August 2012||2012-08-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|I-SPOT||Study of Procoagulation Markers in Stroke Patients|Insights on Selected Procoagulation Markers and Outcomes in Stroke Trial (I-SPOT)|Recruiting||N/A|315|Anticipated|Temple University|||1||f||||t||||||Samples With DNA|"     Whole blood and plasma   "|||2017-10-11 01:53:58.262388|2017-10-11 01:53:58.262388
NCT01811537|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-12|||August 2012||2012-08-01|March 2013|2013-03-01|August 2014|Anticipated|2014-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Safety and Efficacy Study of a New Device for Making Neochordae in Mitral Valve Repair|Phase II Study of Using a New Device (Neochordameter) in Making Artificial Chordae for Mitral Valve Repair|Unknown status|Enrolling by invitation|Phase 1/Phase 2|20|Anticipated|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-10-11 01:53:58.57563|2017-10-11 01:53:58.57563
NCT01811524|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-18|||September 1983||1983-09-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|December 2009|Actual|2009-12-01||Observational|||The Etiology and Progression of Brain Tumors|The Etiology and Progression of Brain Tumors - Molecular Genetic Changes and Heredity|Completed||N/A|2000|Actual|Tampere University Hospital|||1||f||||f||||||Samples With DNA|"     Paraffin-embedded and frozen brain tumor tissue   "|||2017-10-11 01:53:58.652872|2017-10-11 01:53:58.652872
NCT01811511|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-02-08|||March 2013||2013-03-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy and Safety of Chungkookjang on Improvement of Metabolic Syndrome||Completed||Phase 2/Phase 3|120|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 01:53:58.723856|2017-10-11 01:53:58.723856
NCT01811498|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-03-27|||February 2013||2013-02-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM|Phase I/II Trial of Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed Glioblastoma Multiforme|Recruiting||Phase 1/Phase 2|25|Anticipated|Northwell Health||1|||f||||t||||||||||2017-10-11 01:53:58.812105|2017-10-11 01:53:58.812105
NCT01811485|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-02-04|2015-02-04||May 2013||2013-05-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|CLMF237A1303|Randomized Set|Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy|A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 14 Weeks Treatment With LMF237 Bid to Placebo in Patients With Type 2 Diabetes Inadequately Controlled With Vildagliptin 50 mg Bid Monotherapy|Completed||Phase 3|171|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:53:58.926938|2017-10-11 01:53:58.926938
NCT01811472|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-01-05|2015-09-08||June 2013||2013-06-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Full analysis set included patients to whom study treatment was assigned excluding patients who were miss-randomized and did not take investigational drug. Mis-randomized patients were those who were not qualified for randomization, but were inadvertently randomized into the study.|Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients|A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group, 24-week Pilot Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in Patients With Non-alcoholic Fatty Liver Disease|Completed||Phase 2|52|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:53:59.564456|2017-10-11 01:53:59.564456
NCT01811459|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-02-09|||February 2013||2013-02-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|Haloquet||Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium|Randomized Controlled Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium : The Haloquet Trial|Unknown status|Recruiting|Phase 3|45|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||3|||f||||f||||||||||2017-10-11 01:54:01.01711|2017-10-11 01:54:01.01711
NCT01811446|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-01-29|||March 2013||2013-03-01|January 2014|2014-01-01||||September 2013|Actual|2013-09-01||Interventional|||Evaluation of Muscle Activation Efficiency in Challenging Subjects|Evaluation of Muscle Stimulation Efficiency in Challenging Subjects: A Pilot Study|Completed||N/A|30|Actual|Niveus Medical, Inc.||2|||f||||||||||||||2017-10-11 01:54:01.266204|2017-10-11 01:54:01.266204
NCT01811433|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-09-18|||March 2013||2013-03-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|Halo||"Halo Index and Adaptive Alarm Thresholds During Routine PACU Inpatient Care: Normal vs. Non-normal Recovery"|"Halo Index and Adaptive Alarm Thresholds During Routine PACU Inpatient Care: Normal vs. Non-normal Recovery"|Completed||N/A|500|Actual|University of Vermont|||1||f||||f||||||||||2017-10-11 01:54:01.373137|2017-10-11 01:54:01.373137
NCT01811420|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-03-12|||March 2009||2009-03-01|March 2013|2013-03-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|CMCR09||Chemomechanical Caries Removal Using Papain Gel|Chemomechanical Caries Removal Using a Papain-Based Gel: A Randomized Clinical Trial|Completed||N/A|20|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-11 01:54:01.45854|2017-10-11 01:54:01.45854
NCT01811407|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-12-02|||July 2013||2013-07-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Impacts of Public Announcements of Goals and Outcomes on Goal Completion (Commit to Steps)|Impacts of Public Announcements of Goals and Outcomes on Goal Completion|Completed||N/A|165|Actual|University of Michigan||3|||f||||f||||||||||2017-10-11 01:54:01.582811|2017-10-11 01:54:01.582811
NCT01811394|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2017-05-01|||January 2013||2013-01-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|ISAC||Ion Irradiation of Sacrococcygeal Chordoma|Hypofractionated Ion Irradiation (Protons or Carbon Ions) of Sacrococcygeal Chordoma|Recruiting||Phase 2|100|Anticipated|Heidelberg University||2|||f||||t||||||||||2017-10-11 01:54:01.690162|2017-10-11 01:54:01.690162
NCT01811381|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-06-28|||January 20, 2014|Actual|2014-01-20|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|June 1, 2018|Anticipated|2018-06-01||Interventional|||Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease|Curcumin and Yoga Exercise Effects in Veterans at Risk for Alzheimer's Disease|Recruiting||Phase 2|80|Anticipated|VA Office of Research and Development||4|||f||||t|t|f|||f|||Undecided||2017-10-11 01:54:01.825051|2017-10-11 01:54:01.825051
NCT01811368|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-03-20|||March 2013||2013-03-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma|Use of Zevalin to Enhance the Efficacy of Non-Myeloablative Allogeneic Transplantation in Patients With Relapsed or Refractory CD20+ Non-Hodgkin's Lymphoma|Recruiting||Phase 2|20|Anticipated|University of California, Davis||1|||f||||t|t|f||||||||2017-10-11 01:54:02.008774|2017-10-11 01:54:02.008774
NCT01811355|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-07-28|2017-04-03||May 2013||2013-05-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Interventional|||Mexiletine for the Treatment of Muscle Cramps in ALS|Mexiletine for the Treatment of Muscle Cramps in ALS|Completed||Phase 4|23|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 01:54:02.160674|2017-10-11 01:54:02.160674
NCT01811342|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-05-24|||November 2012|Actual|2012-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Continuous Hemoglobin Evaluation|Evaluation of the Masimo Continuous Hemoglobin Monitor With Polar Plot Methodology|Recruiting||N/A|70|Anticipated|University of California, Davis|||1||f||||f||||||||||2017-10-11 01:54:02.611341|2017-10-11 01:54:02.611341
NCT01811329|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-05-18|||August 2013||2013-08-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Determine How Consumption of Dairy Fat Fractions Rich in Phospholipids and Proteins Influence Inflammation in the Fed State-Phase 1|Effects of Dairy Fat on Postprandial Inflammation- Phase 2|Completed||N/A|38|Actual|University of California, Davis||4|||f||||f||||||||||2017-10-11 01:54:02.702303|2017-10-11 01:54:02.702303
NCT01811303|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-06-28|2013-04-03||September 2012||2012-09-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Added D-fagomine on Glycaemic Responses to Sucrose|Effects of Added D-fagomine on Glycaemic Responses to Sucrose|Completed||N/A|14|Actual|Bioglane||2|||f||||f||||||||||2017-10-11 01:54:03.50915|2017-10-11 01:54:03.50915
NCT01811290|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-05-05|||January 2013||2013-01-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|MS-BMD||A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis|A Single Center Prospective, Open Label, Pilot Study to Assess Change in Bone Mass Density and Select Bone Turnover Biomarkers in Gilenya Treated Versus Non-Gilenya Treated Ambulatory Subjects With a Relapsing Form of Multiple Sclerosis|Active, not recruiting||N/A|36|Anticipated|Simnad, Virginia, M.D.|||2||f||||f||||||||No||2017-10-11 01:54:03.876204|2017-10-11 01:54:03.876204
NCT01811277|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-13|||July 2010||2010-07-01|July 2010|2010-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer|Phase II Exploratory Study of S-1 Combined With Oxaliplatin Sequential S-1 Single-agent First-line Treatment of Unresectable Metastatic or Locally Advanced Biliary System, Periampullary Cancer and Pancreatic Cancer|Unknown status|Recruiting|Phase 2|40|Anticipated|Peking University||1|||f||||f||||||||||2017-10-11 01:54:03.99199|2017-10-11 01:54:03.99199
NCT01811264|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-07-11|||December 2013||2013-12-01|July 2017|2017-07-01|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer|Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer|Completed||N/A|150|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 01:54:04.142682|2017-10-11 01:54:04.142682
NCT01811238|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-04-06|2014-02-14||September 2012||2012-09-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|TALENT|Total 240 patients were enrolled. However, 20 patients were excluded due to no administeration of investigational drug during the study. The 220 is Safety set population included all subjects who had at least one dose of the study drug.|An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders|A Multicenter, Phase IV, Interventional Study to Assess the Efficacy and Safety of TARGIN(R) (Oxycodone/Naloxone) in Korean Patients With Spinal Disorders|Completed||Phase 4|240|Actual|Mundipharma Korea Ltd||1|||f||||f||||||||||2017-10-11 01:54:04.476633|2017-10-11 01:54:04.476633
NCT01811225|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-06-28|||December 2012||2012-12-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Smoking, Sex Hormones, and Pregnancy|Smoking, Sex Hormones, and Pregnancy|Completed||N/A|204|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 01:54:04.946467|2017-10-11 01:54:04.946467
NCT01811212|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-08-21|||May 8, 2013|Actual|2013-05-08|August 2017|2017-08-01||||July 13, 2015|Actual|2015-07-13||Interventional|||Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer|Phase II Study of Cabozantinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy|Active, not recruiting||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 01:54:05.091046|2017-10-11 01:54:05.091046
NCT01811199|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-03-12|||February 2011||2011-02-01|March 2013|2013-03-01|May 2013|Anticipated|2013-05-01|April 2013|Anticipated|2013-04-01||Observational|||Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels|Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels|Unknown status|Active, not recruiting|N/A|100|Anticipated|Marmara University|||1||f||||f||||||||||2017-10-11 01:54:05.224956|2017-10-11 01:54:05.224956
NCT01811186|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-01-19|2016-05-31||December 2012||2012-12-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional||Safety set: 261 ITT set: 258(3 patients were deviated inclusion/exclusion criteria among 261)|An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)|An Interventional Study to Compare the Efficacy and Tolerability of Current and Slow Titration With Targin® in the Treatment of Moderate to Severe Non-malignant Chronic Pain (GLORY)|Completed||Phase 4|261|Actual|Mundipharma Korea Ltd||2|||f||||f||||||||No||2017-10-11 01:54:05.345669|2017-10-11 01:54:05.345669
NCT01811173|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-04-28|||March 2013||2013-03-01|February 2013|2013-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|CCMAP||Comprehensive-Care for Multimorbid Adults Effectiveness Study|The Clalit Comprehensive-Care for Multimorbid Adults Project|Unknown status|Active, not recruiting|N/A|1800|Anticipated|Meir Medical Center||3|||f||||t||||||||||2017-10-11 01:54:06.24397|2017-10-11 01:54:06.24397
NCT01811160|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-12|||October 2008||2008-10-01|March 2013|2013-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics|Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics|Completed||Phase 4|50|Actual|Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente||2|||f||||f||||||||||2017-10-11 01:54:06.380341|2017-10-11 01:54:06.380341
NCT01811147|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-12-14|||November 2011||2011-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI|Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI|Recruiting||Phase 4|200|Anticipated|The Cleveland Clinic||4|||f||||f||||||||Undecided||2017-10-11 01:54:06.542691|2017-10-11 01:54:06.542691
NCT01811134|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-12-10|||November 2012||2012-11-01|December 2013|2013-12-01|November 2017|Anticipated|2017-11-01|November 2015|Anticipated|2015-11-01||Interventional|EVIDENCE||Flow Diverter Stent for Endovascular Treatment of Unruptured Saccular Wide-necked Intracranial Aneurysms|Multicenter Randomized Study for Medico-economic Evaluation of Embolization With Flow Diverter Stent in the Endovascular Treatment of Unruptured Saccular Wide-necked Intracranial Aneurysms|Recruiting||N/A|130|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:54:06.674021|2017-10-11 01:54:06.674021
NCT01811121|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-10-04|||February 2013||2013-02-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|March 2013|Actual|2013-03-01||Interventional|RESECT||MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS|Randomized, Prospective, Multicenter Blinding Singles With Arm A and Arm B Innovative Strategy Strategy Conventional|Active, not recruiting||Phase 3|170|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:54:06.820633|2017-10-11 01:54:06.820633
NCT01811108|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-10-23|||July 2009||2009-07-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer|Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) Retrospectively (From 1/7/2009) and Prospectively (up to 31/12/2013) as First Line Treatment for Patients With Locally Advanced or Metastatic Colorectal Cancer (With or Without KRAS Mutation). Assessment of Toxicity, Compliance and Survival of Patients.|Completed||N/A|670|Actual|Hellenic Oncology Research Group|||1||f||||f||||||||||2017-10-11 01:54:06.988996|2017-10-11 01:54:06.988996
NCT01811095|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-09-11|||March 2013||2013-03-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing|A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing|Completed||N/A|27|Actual|McGill University||2|||f||||t||||||||||2017-10-11 01:54:07.087736|2017-10-11 01:54:07.087736
NCT01811082|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2013-03-14|||July 2010||2010-07-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia|Randomized Head-to-Head Comparison of Coenzyme A Capsule and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia: A Phase III, Multicenter, Double-blinded, Double Dummy Clinical Trial.|Completed||Phase 3|240|Actual|Zhejiang University||2|||f||||t||||||||||2017-10-11 01:54:07.204979|2017-10-11 01:54:07.204979
NCT01811069|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-01-15|||April 2013||2013-04-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01|1 Day|Observational [Patient Registry]|||Effect of Body Positioning on Upper Airway Patency During Induction of Anesthesia in Obese Patients|Effect of Body Positioning on Upper Airway Patency During Induction of Anesthesia in Obese Patients|Completed||N/A|13|Actual|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-11 01:54:07.30849|2017-10-11 01:54:07.30849
NCT01811056|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-08-11|||April 2013||2013-04-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion|Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion|Completed||N/A|401|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-11 01:54:07.412723|2017-10-11 01:54:07.412723
NCT01811043|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-11-18|||August 2012||2012-08-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2014|Actual|2014-03-01||Interventional|IBEST||Improving Biopsy Experiences Study for Women|Improving Biopsy Experiences Study for Women|Active, not recruiting||N/A|243|Anticipated|Duke University||3|||f||||f||||||||||2017-10-11 01:54:07.564169|2017-10-11 01:54:07.564169
NCT01811030|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2015-07-29|||June 2012||2012-06-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of the 755nm Alexandrite Laser for the Treatment of Scars||Completed||N/A|27|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 01:54:07.662287|2017-10-11 01:54:07.662287
NCT01811017|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-02-03|||June 2012||2012-06-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Clinical Evaluation of 755nm Alexandrite Laser Versus Nanosecond 755nm Alexandrite||Withdrawn||N/A|0|Actual|Cynosure, Inc.||2|||f||||f||||||||||2017-10-11 01:54:07.771831|2017-10-11 01:54:07.771831
NCT01811004|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-02-16|||September 2012||2012-09-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis||Completed||N/A|14|Actual|Cynosure, Inc.||3|||f||||f||||||||||2017-10-11 01:54:07.858751|2017-10-11 01:54:07.858751
NCT01810991|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2015-07-29|||June 2012||2012-06-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser||Completed||N/A|18|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 01:54:07.966259|2017-10-11 01:54:07.966259
NCT01810965|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-09-26|||June 3, 2013|Actual|2013-06-03|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|SAIFER||Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis|Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis: Pathophysiological and Clinical Implications. Pilot Study.|Recruiting||N/A|14|Anticipated|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 01:54:08.177418|2017-10-11 01:54:08.177418
NCT01810952|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-02-07|2016-07-20||September 2010||2010-09-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|GIH||The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients|The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients|Completed||Phase 4|37|Actual|Baylor College of Medicine|The number of participants is limited, and some were discharged in less than 5 days.|2|||f||||f||||||||No||2017-10-11 01:54:08.321218|2017-10-11 01:54:08.321218
NCT01810939|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-03-11|2015-11-11|2014-10-29|February 2013||2013-02-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|OPAL||A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)|A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia|Completed||Phase 3|243|Actual|Relypsa, Inc.||2|||f||||f||||||||||2017-10-11 01:54:08.913732|2017-10-11 01:54:08.913732
NCT01810926|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-03-12|||September 2011||2011-09-01|March 2013|2013-03-01|October 2016|Anticipated|2016-10-01|August 2015|Anticipated|2015-08-01||Interventional|||T&B Depletion Non Malignant|A Phase II Multicentre, Randomized, Controlled Open-label Study on the Use of Anti-thymocyte Globulin and Rituximab for Immunomodulation of Graft-versus-host Disease in Allogeneic Matched Transplants for Non Malignancies|Unknown status|Recruiting|Phase 2|130|Anticipated|Bambino Gesù Hospital and Research Institute||4|||f||||t||||||||||2017-10-11 01:54:09.51488|2017-10-11 01:54:09.51488
NCT01810913|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-05-18|||March 2013|Actual|2013-03-01|May 2017|2017-05-01||||May 2020|Anticipated|2020-05-01||Interventional|||Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer|Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck|Active, not recruiting||Phase 2/Phase 3|675|Anticipated|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-10-11 01:54:09.740734|2017-10-11 01:54:09.740734
NCT01810900|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-03-09|||September 2012||2012-09-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||To Assess the Anti-adhesive Effect and Safety of Protescal|To Assess the Anti-adhesive Effect and Safety of Protescal Following Laparoscopic Surgery|Terminated||Phase 3|50|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 01:54:10.656152|2017-10-11 01:54:10.656152
NCT01810887|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-04-09|||May 2008||2008-05-01|April 2013|2013-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Phase 4 Study to Evaluate Pharmacokinetics and Safety of Darunavir Along With Ritonavir in Healthy Male Japanese Participants|A Study to Evaluate the Pharmacokinetics and Safety of Oral Single-Dose JNS011 Tablet in Combination With Low-Dose Ritonavir Capsule in Healthy Japanese Adult Males|Completed||Phase 4|8|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 01:54:10.745132|2017-10-11 01:54:10.745132
NCT01810874|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-04-28|||June 2012||2012-06-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|July 2014|Actual|2014-07-01||Interventional|STELLA||STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer|STELLA Trial: Staging of Endometrial and Ovarian Cancer Comparing the Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Lymphadenectomy of Aortic Nodes|Completed||N/A|60|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-11 01:54:10.879141|2017-10-11 01:54:10.879141
NCT01810848|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-03-28|||June 2014||2014-06-01|March 2015|2015-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CORT||Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity|Pilot Study of the Impact of Viscosupplementation Therapy With Hylan G-F 20 (Single Injection) on Exercise Tolerance - Implications for Patients With Cardiovascular Risk|Terminated||Phase 1|9|Actual|OhioHealth||2||Enrollment too low.|f||||f||||||||||2017-10-11 01:54:11.176507|2017-10-11 01:54:11.176507
NCT01810835|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-12-05|||November 2011||2011-11-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination.|Prevention of Hepatitis B Virus (HBV) Mother-to-child Transmission (MTCT): Impact of Serovaccination in Lariboisiere Hospital, Paris, France.|Completed||N/A|28|Actual|Hopital Lariboisière|||1||f||||f||||||||||2017-10-11 01:54:11.281769|2017-10-11 01:54:11.281769
NCT01810822|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-13|||May 1994||1994-05-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|May 1994|Actual|1994-05-01||Observational|||Sex-specific Association With Kidney Disease|Sex-specific Associations of Variants in the Regulatory Regions of NADPH Oxidase-2 (CYBB) and Gluthatione Peroxidase 4 (GPX4) Genes With Kidney Disease in Type 1 Diabetes.|Completed||N/A|1396|Actual|University of Sao Paulo General Hospital|||3||f||||t||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 01:54:11.365271|2017-10-11 01:54:11.365271
NCT01810809|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-09-10|||April 2013||2013-04-01|September 2013|2013-09-01|November 2014|Anticipated|2014-11-01|June 2014|Anticipated|2014-06-01||Interventional|Hip VS||Hip Viscosupplementation: What is the Best Dosage?|Hip Viscosupplementation: What is the Best Dosage?|Unknown status|Recruiting|Phase 4|80|Anticipated|University of Sao Paulo General Hospital||4|||f||||f||||||||||2017-10-11 01:54:11.454907|2017-10-11 01:54:11.454907
NCT01810796|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-13|||December 2013||2013-12-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial|Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial|Not yet recruiting||Phase 3|300|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 01:54:11.590455|2017-10-11 01:54:11.590455
NCT01810783|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-02-22|2016-12-30||July 2013||2013-07-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Brexpiprazole in Patients With Schizophrenia|Interventional, Open-label, Flexible-dose Extension Study of Brexpiprazole in Patients With Schizophrenia|Completed||Phase 3|210|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 01:54:11.720149|2017-10-11 01:54:11.720149
NCT01810770|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-08-08|||March 26, 2013|Actual|2013-03-26|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis|A Single-arm, International, Prospective, Interventional, Open-label, Multicenter Study of Radium-223 Dichloride in the Treatment of Patients With Castration-Resistant Prostate Cancer (CRPC) With Bone Metastasis.|Active, not recruiting||Phase 3|244|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-11 01:54:12.201108|2017-10-11 01:54:12.201108
NCT01810757|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-08-09|||April 2014||2014-04-01|August 2016|2016-08-01|January 2025|Anticipated|2025-01-01|July 2017|Anticipated|2017-07-01||Interventional|HYBRID||Study of Weekly Radiotherapy for Bladder Cancer|A Multicentre Randomised Phase II Study of HYpofractionated Bladder Radiotherapy With or Without Image Guided aDaptive Planning|Active, not recruiting||N/A|64|Actual|Institute of Cancer Research, United Kingdom||2|||f||||t||||||||||2017-10-11 01:54:12.365403|2017-10-11 01:54:12.365403
NCT01810744|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2017-09-14|||May 2013|Actual|2013-05-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2015|Actual|2015-06-01||Interventional|BEVACAPI||Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma|Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma|Active, not recruiting||N/A|98|Anticipated|Centre Georges Francois Leclerc||2|||f||||f||||||||||2017-10-11 01:54:12.469152|2017-10-11 01:54:12.469152
NCT01810731|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2014-04-08|||April 2014||2014-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya|A Double-Blind, Randomized, Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Standard Dose Quadrivalent Inactivated Influenza Vaccine, and Double Dose Quadrivalent Inactivated Influenza Vaccine in HIV-Infected and HIV-Uninfected Pregnant Women in a Malaria-Endemic Area of Rural Western Kenya|Withdrawn||Phase 2/Phase 3|0|Actual|Centers for Disease Control and Prevention||3||"Scientific review positive from 3 manufacturers; internal committees did not support due to   deploying new flu vaccines in HIV+ pregnant women in Kenya."|f||||t||||||||||2017-10-11 01:54:12.558947|2017-10-11 01:54:12.558947
NCT01810718|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-07-05|||November 2011||2011-11-01|September 2015|2015-09-01|March 2016|Actual|2016-03-01|February 2015|Actual|2015-02-01||Interventional|Nilo-cGVHD||Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD|Prospective, Phase I/II, Non-randomized, Open Label, Multicenter Study to Determine Safety and Efficacy of Nilotinib in a Population With Steroid-refractory/or Steroid-dependent cGVHD.|Completed||Phase 1|22|Actual|Gruppo Italiano Trapianto di Midollo Osseo||1|||f||||t||||||||||2017-10-11 01:54:12.668117|2017-10-11 01:54:12.668117
NCT01810705|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-07-10|||February 2013|Actual|2013-02-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ENFORCE||GRASPA Treatment for Patients With Acute Myeloblastic Leukemia|A Multicenter, Open, Randomized, Controlled Phase IIb Trial Evaluating Efficacy and Tolerability of GRASPA (L-asparaginase Encapsulated in Red Blood Cells, Eryaspase) Plus Low-dose Cytarabine vs Low-dose Cytarabine Alone, in Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Elderly Patients, Unfit for Intensive Chemotherapy|Active, not recruiting||Phase 2|123|Actual|ERYtech Pharma||2|||f||||t||||||||||2017-10-11 01:54:12.773004|2017-10-11 01:54:12.773004
NCT01810692|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-03-16|2015-03-16||March 2013||2013-03-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||Patients from the Treated Set (TS) who reported information about the last prescription of inhalation devices before the start of the study.|Preference Tiotropium Respimat Study in COPD|Cross-sectional Study to Assess the Handling , Patient Satisfaction, and Preference for Inhalation Devices in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||N/A|150|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 01:54:12.912762|2017-10-11 01:54:12.912762
NCT01810679|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-11-15|||April 2013||2013-04-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|February 2016|Actual|2016-02-01||Interventional|||Perceval S Aortic Heart Valve Study- North America|Clinical Investigation of the Perceval S Sutureless Heart Valve|Terminated||N/A|355|Actual|Sorin Group USA, Inc.||1||FDA approval|f||||t||||||||||2017-10-11 01:54:13.330558|2017-10-11 01:54:13.330558
NCT01810666|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-04-30|2014-12-22||March 2013||2013-03-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Prophylaxis Versus on Demand Treatment for Children With Hemophilia A|Routine Prophylaxis Treatment Versus On-demand Treatment for Children With Severe Hemophilia A: Comparison of All Bleeding Events in Chinese Hemophilia Patients|Completed||Phase 4|30|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:54:13.46267|2017-10-11 01:54:13.46267
NCT01810653|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2015-08-12|||April 2006||2006-04-01|August 2015|2015-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Compare the Effect of Transipeg 2.95 g or Forlax Junior 4 g in Children With Constipation|A Double-blind, Randomized, Uninational, Multicenter, Two Parallel Groups, Active Controlled Study to Compare the Effect of the Treatment With Transipeg 2.95 g or Forlax Junior 4 g in Children With Constipation|Completed||Phase 4|97|Actual|Bayer||2|||f||||f||||||||||2017-10-11 01:54:13.727222|2017-10-11 01:54:13.727222
NCT01810640|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-05-11|||February 2013||2013-02-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|PPB||Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors|Pre-recovery Percutaneous Biopsy of Livers in Neurological Death Organ Donors - A Pilot Study|Terminated||N/A|6|Actual|Rutgers, The State University of New Jersey||2||Complications encountered with biopsy in first 6 patients|f||||f||||||||||2017-10-11 01:54:13.844186|2017-10-11 01:54:13.844186
NCT01810627|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-09-22|||September 2013||2013-09-01|September 2017|2017-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Application of Megavoltage Imaging to Reduce Artifact After Seed Implants|Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma|Completed||N/A|10|Actual|University of Kentucky|||1||f||||t||||||||||2017-10-11 01:54:13.92755|2017-10-11 01:54:13.92755
NCT01810614|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-08-11|||February 2013||2013-02-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)|A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)|Completed||N/A|12|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 01:54:15.936009|2017-10-11 01:54:15.936009
NCT01810601|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2013-03-25|||September 2009||2009-09-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|ET||Effect of Ultrasound Guided Embryo Transfer on Pregnancy Rates|Effect of Ultrasound Guided Embryo Transfer on Pregnancy Rates|Completed||N/A|90|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-11 01:54:16.073603|2017-10-11 01:54:16.073603
NCT01810588|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-03-01|||October 16, 2012|Actual|2012-10-16|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Targeting the IPA and Matching for the Non-Inherited Maternal Antigenfor Haplo-Cord Transplantation|A Prospective Study of Optimal Cord Selection for Haplo-Cord Transplantation: Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA)|Recruiting||N/A|50|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-10-11 01:54:16.20096|2017-10-11 01:54:16.20096
NCT01810575|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2014-08-08||2014-06-16|February 2013||2013-02-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction|A Study to Assess the Relative Efficacy and Safety of a Single Dose of Alprostadil Cream Combined With 2 Concentrations of WC3036 Compared to Vehicle in Subjects With Erectile Dysfunction|Terminated||Phase 2|16|Actual|Warner Chilcott||3||Re-assessment of study|f||||f||||||||||2017-10-11 01:54:16.333299|2017-10-11 01:54:16.333299
NCT01810562|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-04-03|||March 2013||2013-03-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||SlagSens (Effect of Tactile Stimulation After Stroke)|Study on Effect of Tactile Stimulation on Reduced Sensibility of the Affected Extremities After Stroke.|Unknown status|Recruiting|N/A|56|Anticipated|Vestre Viken Hospital Trust||2|||f||||t||||||||||2017-10-11 01:54:16.467444|2017-10-11 01:54:16.467444
NCT01810549|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-12-16|||March 2013||2013-03-01|March 2013|2013-03-01||||December 2013|Actual|2013-12-01||Interventional|||Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study|Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study. A Randomized, Double-blind, Single Dose of Anakinra, Placebo-controlled, Cross-over Proof-of-concept Study.|Completed||Phase 1|20|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 01:54:16.622962|2017-10-11 01:54:16.622962
NCT01810536|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-07-03|||April 2013||2013-04-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|HIFLOWCF||High Flow Nasal Oxygen for Children With Cystic Fibrosis Presenting With Respiratory Failure - a Randomized Controlled Study|High Flow Nasal Oxygen for Children With Cystic Fibrosis Presenting With Respiratory Failure - a Randomized Controlled Study|Terminated||N/A|4|Actual|University of Sao Paulo||2||It was impossible for us to include patients|f||||f||||||||||2017-10-11 01:54:16.747681|2017-10-11 01:54:16.747681
NCT01810523|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-08-18|||March 2013||2013-03-01|August 2016|2016-08-01||||June 2013|Anticipated|2013-06-01||Interventional|||Stories to Educate Patients With Ankle, Foot, and Knee Injuries|Comparative Effectiveness of Descriptive Versus Narrative Emergency Department Discharge Instructions for Patient Education on Unnecessary Testing for Ankle, Foot and Knee Injuries|Withdrawn||N/A|0|Actual|University of Pennsylvania||2||"The study was stopped due to methodological issues that require additional consideration prior   to resuming the trial."|f||||||||||||||2017-10-11 01:54:16.859752|2017-10-11 01:54:16.859752
NCT01810510|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-11-04|||April 2010||2010-04-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading|Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||2||Not subjects enrolled|f||||t||||||||||2017-10-11 01:54:16.969092|2017-10-11 01:54:16.969092
NCT01810497|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2015-05-28|||May 2012||2012-05-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Analysis of Postoperative Bandage Use Protocols in Otoplasty|Analysis of the Influence of Different Protocols of Postoperative Elastic Bandage Use in the Results of Otoplasty|Completed||N/A|70|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 01:54:17.075761|2017-10-11 01:54:17.075761
NCT01810484|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2015-01-08|||January 2013||2013-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment|Feasibility Study: Evaluation of the Ulthera® System in Combination With 70W Alma Pixel CO2 Fractional Ablative Laser for Improvement of Abdominal Striae|Completed||N/A|14|Actual|Ulthera, Inc||3|||f||||f||||||||||2017-10-11 01:54:17.253474|2017-10-11 01:54:17.253474
NCT01810471|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2013-03-13|||February 2010||2010-02-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||External Ankle Supports - 3D Motion Analysis||Completed||N/A|40|Actual|University Hospital Heidelberg||1|||f||||f||||||||||2017-10-11 01:54:17.670145|2017-10-11 01:54:17.670145
NCT01810458|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-08-17|||October 2013||2013-10-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|May 2018|Anticipated|2018-05-01||Observational|||Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (AATD)|Clinical Predictors and Epigenetic Markers for Liver Fibrosis in Alpha-1 Antitrypsin Deficiency|Active, not recruiting||N/A|109|Actual|University of Florida|||1||f||||f||||||Samples With DNA|"     Liver tissue and whole blood.   "|||2017-10-11 01:54:17.799981|2017-10-11 01:54:17.799981
NCT01810445|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-03-11|||January 1999||1999-01-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Endoscopic Subsurface Optical Imaging for Cancer Detection|Endoscopic Subsurface Optical Imaging for Cancer Detection|Completed||N/A|26|Actual|University of California, Davis|||1||f||||t||||||||||2017-10-11 01:54:18.073558|2017-10-11 01:54:18.073558
NCT01810432|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-08-23|||March 2013||2013-03-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study of Food on Evacetrapib (LY2484595) in Healthy Participants|Effect of Food on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects|Completed||Phase 1|86|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:54:18.182885|2017-10-11 01:54:18.182885
NCT01810419|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-04-12|||March 2013||2013-03-01|April 2017|2017-04-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|||Ultrasound Estimation of Spleen Size|Estimation of Spleen Size With Hand Held Ultrasound|Completed||N/A|16|Actual|University of British Columbia||1|||f||||t||||||||No||2017-10-11 01:54:18.337194|2017-10-11 01:54:18.337194
NCT01810406|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-04-22|||March 2013||2013-03-01|April 2014|2014-04-01||||April 2014|Actual|2014-04-01||Interventional|||Epidural Volume Extension During a Combined Spinal-Epidural Technique for Labor Analgesia.|A Randomized Controlled Trial of Epidural Volume Extension During a Combined Spinal-Epidural Technique for Labor Analgesia.|Completed||N/A|60|Actual|IWK Health Centre||2|||f||||t||||||||||2017-10-11 01:54:18.466896|2017-10-11 01:54:18.466896
NCT01810393|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-08-23|||June 11, 2013|Actual|2013-06-11|August 2017|2017-08-01|August 10, 2019|Anticipated|2019-08-10|August 10, 2019|Anticipated|2019-08-10||Interventional|||A Study to Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 Years|An Open-Label, Randomized, Multicenter Phase III Study in Patients With HER2-Positive Metastatic Breast Cancer Responding to First Line Treatment With Intravenous Trastuzumab for at Least 3 Years and Investigating Patient Preference for Subcutaneous Trastuzumab|Active, not recruiting||Phase 3|114|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:54:18.590203|2017-10-11 01:54:18.590203
NCT01810380|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-02-08|2015-12-30||March 2013||2013-03-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||all-patients-treated set (APTS)|Brexpiprazole in Patients With Acute Schizophrenia|Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-reference, Flexible-dose Study of Brexpiprazole in Patients With Acute Schizophrenia|Completed||Phase 3|468|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-10-11 01:54:18.928953|2017-10-11 01:54:18.928953
NCT01810367|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-02-22|||December 2011||2011-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC|ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in First Line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer Stage II Randomized Controlled Trials|Completed||Phase 2|84|Actual|Fudan University||2|||f||||t||||||||||2017-10-11 01:54:20.334277|2017-10-11 01:54:20.334277
NCT01810354|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-07-22|||April 2013||2013-04-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||PROPHYLACTIC ANTIBIOTICS PRIOR TO CESAREAN SECTION IN OBESE WOMEN|PROPHYLACTIC ANTIBIOTICS PRIOR TO CESAREAN SECTION IN OBESE WOMEN: Does Increasing the Dose Increase the Tissue Concentration?|Completed||N/A|58|Actual|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||||2017-10-11 01:54:20.426002|2017-10-11 01:54:20.426002
NCT01810341|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-12-15|||March 2013||2013-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Observational|STORY||SynapDx Autism Gene Expression Analysis Study (STORY)|SynapDx Autism Spectrum Disorder Gene Expression Analysis Study|Completed||N/A|880|Anticipated|SynapDx|||2||f||||f||||||Samples With DNA|"     Peripheral blood   "|||2017-10-11 01:54:20.521759|2017-10-11 01:54:20.521759
NCT01810328|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-09-07|||October 2013||2013-10-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|November 2016|Actual|2016-11-01||Interventional|||A Validation of a Genomics Based Prognostic in Severe Trauma|Validation of a Genomics Based Prognostic in Severe Trauma|Active, not recruiting||N/A|120|Actual|University of Florida||2|||f||||f|f|f||||||||2017-10-11 01:54:20.648128|2017-10-11 01:54:20.648128
NCT01810315|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-04-09|||September 2013||2013-09-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity|Influence of Female Reproductive Cycle and Menopause on Cervicovaginal Tissue Susceptibility to HIV-1 Infections and Tenofovir 1% Gel Activity|Completed||Phase 1|40|Actual|CONRAD||4|||f||||f||||||||||2017-10-11 01:54:20.756565|2017-10-11 01:54:20.756565
NCT01810302|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-08-18|2014-08-18||August 2013||2013-08-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety Study of Nicardipine to Treat Cerebral Vasospasm|Intraventricular Nicardipine for the Treatment of Cerebral Vasospasm: Prospective Pilot Study|Terminated||Phase 2|2|Actual|University of Florida|This single center study was terminated early due to inability to maintain an adequate drug supply; therefore, statistical analysis of the 2 participants was not done.|2||Unable to secure drug.|f||||t||||||||||2017-10-11 01:54:20.850275|2017-10-11 01:54:20.850275
NCT01810289|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-01-09|2017-01-09||April 2013||2013-04-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|START-ART|A patient is considered in pre-intervention group (control) if becoming eligible for ART initiation during a time period prior to the roll out of the intervention at the clinic. A patient is grouped into the intervention if becoming eligible for ART initiation during a time period after the roll out of the intervention at the clinic.|"The START (a Streamlined ART Initiation Strategy) Study"|"The START (a Streamlined ART Initiation Strategy) Study"|Completed||N/A|12024|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 01:54:21.203736|2017-10-11 01:54:21.203736
NCT01810276|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-04-14|||June 2012||2012-06-01|April 2017|2017-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|PUNCH||Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury|The Safety and Efficacy of Platelet Transfusion in Patients Receiving Antiplatelet Therapy That Sustain Traumatic Intracranial Hemorrhage|Terminated||N/A|40|Actual|Christiana Care Health Services||2||Patient population not available|f||||t||||||||||2017-10-11 01:54:21.422482|2017-10-11 01:54:21.422482
NCT01810263|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2015-07-01|2015-05-18||May 2012||2012-05-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Efficacy of Intensive Nutritional Supplement in Patient With Stroke|The Efficacy of Intensive Nutritional Supplement in Patient With Stroke: a Prospective Randomized Controlled Trial|Terminated||Phase 2/Phase 3|34|Actual|Seoul National University Bundang Hospital||2||The study does not seem to provide benefits to patients.|f||||t||||||||||2017-10-11 01:54:21.531169|2017-10-11 01:54:21.531169
NCT01810250|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-03-11|||November 2012||2012-11-01|April 2012|2012-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|5 Years|Observational [Patient Registry]|EAGLE||Endurant for Challenging Anatomy: Global Experience Registry|EVAR Treatment With the Endurant Stent Graft of Challenging Anatomy in Experienced Hands, the Real World Experience|Recruiting||N/A|350|Anticipated|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||||2017-10-11 01:54:21.779519|2017-10-11 01:54:21.779519
NCT01810237|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-01-30|||March 2013||2013-03-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy|Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy|Withdrawn||N/A|0|Actual|Nova Scotia Health Authority||1||No patients recruited|f||||f||||||||||2017-10-11 01:54:21.882027|2017-10-11 01:54:21.882027
NCT01810224|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2013-03-11|||March 2013||2013-03-01|March 2013|2013-03-01||||December 2015|Anticipated|2015-12-01||Interventional|GRAFFITI||Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial|Graft Patency After FFR-guided Versus Angio-guided CABG: a Prospective, Multicenter, Multinational, Randomized (1:1) Controlled Trial|Unknown status|Recruiting|Phase 4|206|Anticipated|Onze Lieve Vrouw Hospital||2|||f||||f||||||||||2017-10-11 01:54:21.98015|2017-10-11 01:54:21.98015
NCT01810211|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-09-24|||September 2012||2012-09-01|March 2014|2014-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Most Effective Intervention for Reducing Posterior Shoulder Tightness Acutely in the Post-operative Population|The Most Effective Intervention for Reducing Posterior Shoulder Tightness Acutely in the Post-operative Population: A Double Blinded Randomized Control Trial.|Completed||N/A|63|Actual|Nova Southeastern University||3|||f||||f||||||||||2017-10-11 01:54:22.086155|2017-10-11 01:54:22.086155
NCT01810198|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-03-21|||December 2012||2012-12-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|CONSERVE||Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization|Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization: Relation to CardioVascular Outcomes, Cost Effectiveness and Quality of Life|Completed||N/A|1631|Actual|MDDX LLC||2|||f||||t||||||||||2017-10-11 01:54:22.188779|2017-10-11 01:54:22.188779
NCT01810185|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-11-19|||March 2013||2013-03-01|November 2014|2014-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease|Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease|Withdrawn||Phase 2|0|Actual|Santa Barbara Cottage Hospital||2||Low patient enrollment|f||||f||||||||||2017-10-11 01:54:22.314965|2017-10-11 01:54:22.314965
NCT01810172|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-01-31|||April 2013||2013-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|April 2016|Actual|2016-04-01||Interventional|||Digital Air Leak Monitoring for Patients Undergoing Lung Resection|Digital Air Leak Monitoring for Patients Undergoing Lung Resection: A Randomized Controlled Clinical Trial|Completed||N/A|216|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 01:54:22.4379|2017-10-11 01:54:22.4379
NCT01810159|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-04-25|||June 2014||2014-06-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|SUMMIT||Integrated Collaborative Care for Substance Use Disorders|Integrated Collaborative Care for Substance Use Disorders|Completed||N/A|397|Actual|RAND||2|||f||||f|f|f||||||||2017-10-11 01:54:22.553572|2017-10-11 01:54:22.553572
NCT01810146|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-11-20|||September 2012||2012-09-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Characterization of the Digestive Functions and the Enteric Nervous System in Obesity. Investigations of Relationships With Metabolism Disorders (EnteroNeurObesity)|Characterization of the Digestive Functions and the Enteric Nervous System in Obesity. Investigations of Relationships With Metabolism Disorders(EnteroNeurObesity)|Completed||N/A|40|Actual|Nantes University Hospital||1|||f||||||||||||||2017-10-11 01:54:22.644845|2017-10-11 01:54:22.644845
NCT01810133|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-10-16|||January 2006||2006-01-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Observational|Ko-MoSkau||Evaluation of Co-morbidity Scales|Retrospective Data Analysis: Evaluation of Co-morbidity Scales in Peri-operative Medicine|Completed||N/A|230034|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 01:54:22.723016|2017-10-11 01:54:22.723016
NCT01810120|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-01-20|||January 2012|Actual|2012-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT|Phase I/II Study of Allogeneic Hematopoietic Stem Cell Transplantation From an HLA-partially Matched Family Donor After TCR Alfa Beta Negative Selection in Pediatric Patients Affected by Hematological Disorders|Completed||Phase 1/Phase 2|30|Actual|Bambino Gesù Hospital and Research Institute||1|||f||||f|f|f||||||No||2017-10-11 01:54:22.798559|2017-10-11 01:54:22.798559
NCT01810107|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-12-16|||July 2011||2011-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Study to Evaluate the Efficacy of Optical Imaging to Evaluate the Anatomy of the Developing Pediatric Vocal Fold|Study to Evaluate the Efficacy of Optical Imaging to Evaluate the Anatomy of the Developing Pediatric Vocal Fold|Recruiting||Early Phase 1|720|Anticipated|Massachusetts Eye and Ear Infirmary|||1||f||||f||||||||No||2017-10-11 01:54:22.90914|2017-10-11 01:54:22.90914
NCT01810094|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-01-25|||February 2013|Actual|2013-02-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|October 2014|Actual|2014-10-01||Observational|FRIFIX||Minimally Invasive Reduction and Fixation of Thoracolumbar Fractures|Prospective Observational Study of Minimally Invasive Fixation of Thoracolumbar Fractures With the Fracture Fixation System S4, Performed With the Fracture Reduction Instrumentation FRI (FRIFIX)|Completed||N/A|24|Actual|Aesculap AG|||1||f||||t||||||||||2017-10-11 01:54:22.995578|2017-10-11 01:54:22.995578
NCT01810081|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-03-11|||March 2013||2013-03-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Observational|||Gallstones and Concomitant Gastric Helicobacter Pylori Infection|Study of Relationship Between Gallstones and Concomitant Gastric Helicobacter Pylori Infection|Unknown status|Not yet recruiting|N/A|94|Anticipated|Marmara University|||1||f||||t||||||||||2017-10-11 01:54:23.311521|2017-10-11 01:54:23.311521
NCT01810068|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2015-05-08|||January 2013||2013-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|||Evaluation of the Effects of Different Prostate Surgeries on Urinary and Sexual Function|Evaluation of the Effects of Monopolar Transurethral Resection Versus Bipolar Transurethral Resection and Holmium Laser Enucleation of the Prostate on Urinary and Sexual Function; a Prospective Comparative Study.|Completed||Phase 4|262|Actual|Mansoura University||4|||f||||t||||||||||2017-10-11 01:54:23.405555|2017-10-11 01:54:23.405555
NCT01810042|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-03-29|2014-01-27||October 2010||2010-10-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Of 39 patients completed the study, 8 patients were excluded because 6 patients had polypoidal choroidal vasculopathy, and 2 patients had poor quality of indocyanine green angiography.|Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab|A Prospective, Interventional Case Series, Effect of Lucentis on Indocyanine Angiographic Changes in Patients With Wet Age-related Macular Degeneration|Completed||Phase 4|49|Actual|Pusan National University Hospital|Small number of cases, high rate of follow-up loss. Technical problem with measuring caliber of choroidal new vessels.|1|||f||||f||||||||||2017-10-11 01:54:23.527137|2017-10-11 01:54:23.527137
NCT01810029|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-03-11|||October 2009||2009-10-01|April 2012|2012-04-01|May 2013|Anticipated|2013-05-01|April 2013|Anticipated|2013-04-01||Interventional|CCR||A Trial of Stress Reduction in the Secondary Prevention of Coronary Heart Disease in Blacks|A Randomized Controlled Trial of Stress Reduction in the Secondary Prevention of Coronary Heart Disease in African Americans|Unknown status|Active, not recruiting|Phase 2|56|Anticipated|Maharishi University of Management||2|||f||||t||||||||||2017-10-11 01:54:23.781055|2017-10-11 01:54:23.781055
NCT01810016|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-06-16|||March 2013||2013-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma|Phase I Study of NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma, for Whom Treatment With Ipilimumab is Indicated.|Terminated||Phase 1|27|Anticipated|Ludwig Institute for Cancer Research||3||Low recruitment due to change in standard of care|f||||f||||||||||2017-10-11 01:54:23.874372|2017-10-11 01:54:23.874372
NCT01810003|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-08-29|||March 2013||2013-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Interventional|n3||Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3)|Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation in Men and Women With Metabolic Syndrome|Active, not recruiting||N/A|170|Anticipated|Laval University||3|||f||||f||||||||||2017-10-11 01:54:23.997254|2017-10-11 01:54:23.997254
NCT01809990|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2014-06-27|||January 2013||2013-01-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Internet-delivered CBT for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study|Internet-delivered Cognitive Behavior Therapy for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study|Completed||N/A|21|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 01:54:24.108939|2017-10-11 01:54:24.108939
NCT01809977|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2013-03-11|||July 2012||2012-07-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Partial Removal and Total Removal of the Corneal Epithelium on Keratoconus|Study of Surgical Methods for Keratoconus|Completed||Phase 2|22|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:54:24.203843|2017-10-11 01:54:24.203843
NCT01809964|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-12-10||2013-11-15|March 2013||2013-03-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial to Evaluate ANT-1401 in Crow's Feet|Clinical Trial to Evaluate ANT-1401 in Subjects With Lateral Canthal Lines|Completed||Phase 2|109|Actual|Anterios Inc.||3|||f||||f||||||||||2017-10-11 01:54:24.29651|2017-10-11 01:54:24.29651
NCT01809951|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-06-14|||August 2011|Actual|2011-08-01|June 2017|2017-06-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Observational|||Isomil Post Marketing Observational Study|A Prospective, Open-label, Post-marketing Observational Study to Document the Use of Soy-based Infant Formula With Low Chain Polyunsaturates (LCP) in Infants With Symptoms Suggestive to Cow's Milk Allergy|Completed||N/A|534|Actual|Indonesia University|||1||f||||f||||||||No||2017-10-11 01:54:24.387995|2017-10-11 01:54:24.387995
NCT01809938|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-11-24|2013-08-25||November 2011||2011-11-01|November 2013|2013-11-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|GETEAM|The the total number of participants was 10, each participant completed both arms of the trial.|Does Adding Milk to Tea Delay Gastric Emptying?|Gastric Emptying of Tea With Milk, Compared With Tea Without Milk. Does Milk Delay Gastric Emptying?|Completed||N/A|10|Actual|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:54:24.469313|2017-10-11 01:54:24.469313
NCT01809925|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-10-27|||March 2013||2013-03-01|March 2013|2013-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Study of Psyllium 6.8 g Versus Placebo on Satiety in Healthy Volunteers|Randomized, Double-blind, Placebo-controlled, 2-treatment, 3-period Crossover Design Study of the Efficacy and Tolerability of Psyllium 6.8 g Provided as Sugarfree Metamucil® Fiber Supplement Powder Versus Placebo on Satiety in Healthy Volunteers|Completed||N/A|45|Actual|Procter and Gamble||2|||f||||f||||||||||2017-10-11 01:54:24.734213|2017-10-11 01:54:24.734213
NCT01809912|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-11-25|||November 2010||2010-11-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety Study of MG1102 in Patients With Solid Tumors|A PHASE 1, OPEN LABEL, DOSE ESCALATION STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF MG1102 IN PATIENTS WITH SOLID TUMORS|Terminated||Phase 1|16|Actual|Green Cross Corporation||1|||f||||t||||||||||2017-10-11 01:54:24.864423|2017-10-11 01:54:24.864423
NCT01809886|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-03-05|||October 2011||2011-10-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|SUGAPED-01||Reversal With Sugammadex From Deep Neuromuscular Blockade Induced by Rocuronium in Children: Randomised Clinical Trial|Reversal With Sugammadex (BRIDION ®) From Deep Neuromuscular Blockade Induced by Rocuronium in Children: Randomised Clinical Trial of Efficacy and Safety|Completed||Phase 3|100|Actual|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||2|||f||||f||||||||||2017-10-11 01:54:25.066067|2017-10-11 01:54:25.066067
NCT01809873|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-03-09|||September 2012||2012-09-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||Sustainable Financial Incentives To Improve Prescription Practices For Malaria|Sustainable Financial Incentives To Improve Prescription Practices For Malaria|Completed||N/A|14862|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:54:25.165989|2017-10-11 01:54:25.165989
NCT01809860|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-11|||November 2011||2011-11-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects|Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus: A Phase 1, Open-Label, Sequential Study in Healthy Adult Subjects|Completed||Phase 1|22|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 01:54:25.257722|2017-10-11 01:54:25.257722
NCT01809847|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-09-16|||March 2013||2013-03-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation|Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial)|Completed||Phase 2|20|Actual|Technische Universität Dresden||1|||f||||f||||||||No||2017-10-11 01:54:25.371474|2017-10-11 01:54:25.371474
NCT01809834|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2014-06-26|2014-03-24||November 2012||2012-11-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of Stenfilcon A Versus Etafilcon A|Evaluation of Stenfilcon A Versus Etafilcon A|Completed||Phase 4|46|Actual|Coopervision, Inc.|One participant temporarily discontinued after 12-hour visit. (Primary outcome 1 and 4,1-week visit, n=43)|2|||f||||f||||||||||2017-10-11 01:54:25.529592|2017-10-11 01:54:25.529592
NCT01809821|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-09-01|||May 2013||2013-05-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|SLEPT||Sleep to Lower Elevated Blood Pressure|Sleep to Lower Elevated Blood Pressure: A Randomised Controlled Trial|Completed||N/A|134|Actual|University College Hospital Galway||2|||f||||f||||||||||2017-10-11 01:54:26.123761|2017-10-11 01:54:26.123761
NCT01809808|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-02-02|||September 2003||2003-09-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||A Prospective Study of Outcome After Therapy for Acromegaly|A Prospective Study of Outcome After Therapy for Acromegaly|Recruiting||N/A|250|Anticipated|Columbia University|||2||f||||f|f|f||||Samples Without DNA|"     Serum and blood samples   "|Undecided||2017-10-11 01:54:26.223786|2017-10-11 01:54:26.223786
NCT01809795|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-12-16|||March 2013||2013-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|October 2013|Actual|2013-10-01||Interventional|Wild Blueberry||The Health Effects of a Blueberry Enriched Diet on Obese Children|The Health Effects of a Blueberry Enriched Diet on Obese Children: A Feasibility Study|Completed||N/A|10|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 01:54:26.332646|2017-10-11 01:54:26.332646
NCT01809782|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-09-15|||March 2013||2013-03-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Observational|2-StaLi||Cognitive Outcome After Two-stage Liver-Operation|Post-operative Cognitive Dysfunction (POCD) and Delirium in Patients Undergoing Two-stage Liver Operation - a Pilotstudy|Recruiting||N/A|40|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 01:54:26.456315|2017-10-11 01:54:26.456315
NCT01809769|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-04-01|||March 2013||2013-03-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis|Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis by Intra-articular Injection: A PhaseⅠ/Ⅱa, Randomized and Double-blinded Clinical Trial|Completed||Phase 1/Phase 2|18|Actual|Cellular Biomedicine Group Ltd.||3|||f||||t||||||||||2017-10-11 01:54:26.572297|2017-10-11 01:54:26.572297
NCT01809756|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-03-11||||||March 2013|2013-03-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|CARACTER||The Effect of Caphosol® on the Development of Esophagitis in Small Cell Lung Cancer (SCLC) Patients Treated With Concurrent Chemo/Radiotherapy|The Effect of Caphosol® on the Development of Esophagitis in Small Cell Lung Cancer (SCLC)Patients Treated With Concurrent Chemo/Radiotherapy A Prospective Study of Caphosol + Standard of Care Versus Standard of Care|Unknown status|Not yet recruiting|N/A|||Amphia Hospital||2|||f||||f||||||||||2017-10-11 01:54:26.725951|2017-10-11 01:54:26.725951
NCT01809743|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-11-11|||January 2013||2013-01-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Regadenoson and Adenosine|Comparison of Regadenoson (Rapiscan) and Central Intravenous Adenosine for Measurement of Fractional Flow Reserve|Completed||Phase 3|100|Actual|Catharina Ziekenhuis Eindhoven||4|||f||||f||||||||||2017-10-11 01:54:26.966346|2017-10-11 01:54:26.966346
NCT01809730|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2015-11-16|||May 2012||2012-05-01|November 2015|2015-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients|Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients|Withdrawn||N/A|0|Actual|New York University School of Medicine|||1|no participants enrolled|f||||f||||||Samples Without DNA|"     CV biomarkers - inflammatory, metabolic, hypercoagulable and platelet.   "|||2017-10-11 01:54:27.094081|2017-10-11 01:54:27.094081
NCT01809717|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-10-10|||March 2013||2013-03-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Multiple Myeloma and Exercise|Modulating The Toxicity And Efficacy Of High Dose Chemotherapy For Multiple Myeloma Through An Intervention To Increase Lean Body Mass|Completed||N/A|10|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:54:27.192441|2017-10-11 01:54:27.192441
NCT01809704|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-01-22|||February 2013||2013-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|||Clinical Validation of New OCT System|Topcon DRI OCT-1 Optical Coherence Tomography System for the Acquisition of Retinal Thickness Measurements and Ocular Images of the Posterior Chamber: Agreement and Precision Study|Completed||N/A|150|Anticipated|Topcon Medical Systems, Inc.|||3||f||||f||||||||||2017-10-11 01:54:27.276546|2017-10-11 01:54:27.276546
NCT01809691|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-08-14|||March 2013||2013-03-01|August 2017|2017-08-01|October 2027|Anticipated|2027-10-01|March 2022|Anticipated|2022-03-01||Interventional|S1216||S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer|A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer|Active, not recruiting||Phase 3|1313|Actual|Southwest Oncology Group||2|||f||||t|t|f||||||||2017-10-11 01:54:27.488081|2017-10-11 01:54:27.488081
NCT01809678|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-09-11|||July 2012|Actual|2012-07-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|July 2016|Actual|2016-07-01||Interventional|||Yoga as a Complementary Therapy for Smoking Cessation|Efficacy of Yoga as a Complementary Therapy for Smoking Cessation|Completed||N/A|255|Actual|The Miriam Hospital||2|||f||||t||||||||||2017-10-11 01:54:29.193508|2017-10-11 01:54:29.193508
NCT01809665|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-12|2016-03-01|||June 2013||2013-06-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Observational|||ProMRI PROVEN Master Study|Master Study for the MRI Compatibility of the Solia S and Solia T Pacing Lead, the Linoxsmart ProMRI and Linoxsmart ProMRI DF4 ICD (Implantable Cardioverter-defibrillator) Lead and the Corox ProMRI OTW Coronary Sinus Lead in Combination With the Ilesto/Iforia ICD or the Evia/Entovis Triple Chamber Pacemaker|Completed||N/A|174|Actual|Biotronik SE & Co. KG|||1||f||||t||||||||||2017-10-11 01:54:29.303949|2017-10-11 01:54:29.303949
NCT01809652|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-04-23|||December 2013||2013-12-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Feasibility Study of Remote Support for Implantable Pulse Generator (IPG)/Implantable Cardioverter Defibrillator (ICD) Implant|Remote Implant Support|Completed||N/A|37|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-10-11 01:54:29.469502|2017-10-11 01:54:29.469502
NCT01809639|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-06-05|2016-04-28||June 2013||2013-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Does Oral Micronized Progesterone Shorten Time of Symptoms From Concussion|Micronized Oral Progesterone and Effect on Time Symptomatic From Concussion: A Pilot Study|Completed||Phase 4|25|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 01:54:29.555165|2017-10-11 01:54:29.555165
NCT01809626|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2013-03-12|||May 2010||2010-05-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Proton MRS Study of SSRI-Zolpidem Interactions|Proton MRS Study of SSRI-Zolpidem Interactions|Completed||Early Phase 1|14|Actual|Mclean Hospital||2|||f||||f||||||||||2017-10-11 01:54:29.772202|2017-10-11 01:54:29.772202
NCT01809613|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2017-08-01|||March 2013||2013-03-01|August 2017|2017-08-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Observational|||Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease|Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease|Completed||N/A|88|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 01:54:29.854721|2017-10-11 01:54:29.854721
NCT01809600|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-02-22|||February 2013||2013-02-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|RBL||Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults|Rituximab-Containing Immunochemotherapy for Burkitt's Lymphoma (BL) and High-Grade B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL|Completed||N/A|43|Actual|Gachon University Gil Medical Center|||1||f||||f||||||||||2017-10-11 01:54:29.930501|2017-10-11 01:54:29.930501
NCT01809587|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-01-13|||March 2013||2013-03-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||IQP-PO-101 for the Regulation of Bowel Movement Frequency|Open Label Study to Assess the Safety and Efficacy of IQP-PO-101 in Regulating Bowel Movement Frequency|Completed||Phase 3|50|Actual|InQpharm Group||1|||f||||f||||||||||2017-10-11 01:54:29.998999|2017-10-11 01:54:29.998999
NCT01809574|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2015-04-08|||May 2013||2013-05-01|October 2013|2013-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease|The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease|Unknown status|Recruiting|N/A|60|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 01:54:30.083779|2017-10-11 01:54:30.083779
NCT01809561|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2013-04-07|||May 2013||2013-05-01|February 2013|2013-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01|6 Weeks|Observational [Patient Registry]|||Telomeres Evaluation in Endometriosis|Telomeres Evaluation in Endometriosis|Unknown status|Not yet recruiting|N/A|30|Anticipated|Meir Medical Center|||2||f||||t||||||Samples With DNA|"     whole blood, endometrial tissue biopsy, lesion of endometriosis   "|||2017-10-11 01:54:30.150917|2017-10-11 01:54:30.150917
NCT01809548|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-09-25|||October 2013||2013-10-01|September 2017|2017-09-01|July 2023|Anticipated|2023-07-01|January 2018|Anticipated|2018-01-01||Interventional|PIES-Project||Preterm Infants on Early Solid Foods|Early Introduction of Solid Foods in Preterm Infants: Effects on Growth, Atopy and Neurodevelopment|Recruiting||N/A|198|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 01:54:30.374308|2017-10-11 01:54:30.374308
NCT01809535|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-09|||January 2009||2009-01-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Monthly Versus Biweekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding|A Randomized Controlled Trial of Monthly Versus Biweekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding|Completed||N/A|70|Actual|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-11 01:54:30.469459|2017-10-11 01:54:30.469459
NCT01807312|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-08-26|||March 2013||2013-03-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Application of CO2 Insufflations in Routine Colonoscopy Examination for Duration in Toilet After Examination Compared With Air Insufflations||Completed||N/A|120|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:55:27.184726|2017-10-11 01:55:27.184726
NCT01809522|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2013-03-12|||January 2013||2013-01-01|March 2013|2013-03-01||||March 2015|Anticipated|2015-03-01||Interventional|PRR||Does Posterior Reconstruction of the Rhabdosphincter Improve Early Recovery of Continence After Robotic-Assisted Radical Prostatectomy?|Does the Posterior Reconstruction of the Rhabdosphincter Improve Early Recovery of Continence After Robotic-Assisted Radical Prostatectomy? A Multicenter Randomized Controlled Trial. A Phase III Open-label Prospective International Multicenter Randomized Controlled Study for the Evaluation of the Efficacy of PRR, in Patients Subjected to RALP, Measured in Terms of Early Recovery of the Continence.|Unknown status|Recruiting|Phase 3|1500|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||||||||||||2017-10-11 01:54:30.565434|2017-10-11 01:54:30.565434
NCT01809509|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2013-03-09|||January 2012||2012-01-01|March 2013|2013-03-01|November 2013|Anticipated|2013-11-01|June 2013|Anticipated|2013-06-01||Observational|||Pilot Study on Molecular Quantitation and Sequencing of Endometrial Cytokines Gene Expression and Their Effect on the Outcome of In-vitro Fertilization (IVF) Cycle|A Prestudy of Impact of Cytokines and Gene Expression on Outcome of IVF|Unknown status|Enrolling by invitation|N/A|15|Anticipated|Cairo University|||1||f||||f||||||||||2017-10-11 01:54:30.645258|2017-10-11 01:54:30.645258
NCT01809496|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-12-08|||March 2013||2013-03-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Hearing Aids, Counseling and the Significant Other|Auditory Rehabilitation From the Perspective of the Significant Other|Terminated||N/A|10|Actual|VA National Center for Rehabilitative Auditory Research||4||Funding ended|f||||f||||||||||2017-10-11 01:54:30.706829|2017-10-11 01:54:30.706829
NCT01809457|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2013-03-11|||March 2011||2011-03-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|||Effectiveness of Dental Trauma Educational Poster to Secondary Students|Effectiveness of Educational Poster to Secondary Students Regarding Knowledge of Emergency Management of Dental Trauma - A Cluster Randomised Controlled Trial|Completed||N/A|671|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:54:30.954361|2017-10-11 01:54:30.954361
NCT01809444|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2013-12-07|||November 2012||2012-11-01|December 2013|2013-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy|The Effect of Prednisone Versus Doxycycline in Active, Moderately Severe Graves' Orbitopathy: A Randomized, Multi-center, Double-blind, Parallel-controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|146|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:54:31.03346|2017-10-11 01:54:31.03346
NCT01809431|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2015-06-01|||May 2012||2012-05-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants|Optimizing Outcomes in Women With Gestational Diabetes Mellitus and Their Infants|Completed||N/A|200|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 01:54:31.221356|2017-10-11 01:54:31.221356
NCT01809418|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2017-09-25|||July 2013||2013-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||keePAP Device for Treatment of Obstructive Sleep Apnea|Efficacy Study of the keePAP Device in Reducing the Number of Obstructive Breathing Events|Active, not recruiting||N/A|50|Anticipated|Ninox Medical Ltd||1|||f||||f|f|f|||f|||||2017-10-11 01:54:31.351816|2017-10-11 01:54:31.351816
NCT01809392|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-03-10|||January 2013||2013-01-01|March 2013|2013-03-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome||Unknown status|Active, not recruiting|Phase 2/Phase 3|15|Anticipated|The First Affiliated Hospital of Soochow University||2|||f||||||||||||||2017-10-11 01:54:31.582066|2017-10-11 01:54:31.582066
NCT01809379|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-10-12|||February 2013||2013-02-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|||Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer|Feasibility, Efficacy and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Cisplatin and Doxorubicin in Women With Recurrent Ovarian Cancer: an Open-label, Single-arm Phase II Clinical Trial|Completed||Phase 2|69|Actual|Ruhr University of Bochum||1|||f||||t||||||||||2017-10-11 01:54:31.751692|2017-10-11 01:54:31.751692
NCT01809366|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-10|2013-03-10|||January 2012||2012-01-01|January 2013|2013-01-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Seminal Plasma Insemination on Pregnancy Rates After IVF-ET||Completed||N/A|200|Actual|Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-10-11 01:54:31.857974|2017-10-11 01:54:31.857974
NCT01809353|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2015-03-20|||July 2013||2013-07-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants|A Phase 1 Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate the Pharmacokinetics and Safety of JNJ-54452840 Following Single Intravenous Doses to Healthy Japanese and Caucasian Subjects|Completed||Phase 1|32|Actual|Janssen Research & Development, LLC||8|||f||||f||||||||||2017-10-11 01:54:31.959558|2017-10-11 01:54:31.959558
NCT01809002|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-01-24|||June 2015||2015-06-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RECON||Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair|A Multicenter, Prospective, Randomized, Subject and Evaluator Blinded Comparative Study of Nerve Cuffs and Avance® Nerve Graft Evaluating Recovery Outcomes for the Repair of Nerve Discontinuities|Recruiting||Phase 3|150|Anticipated|AxoGen, Inc||2|||f||||f||||||||||2017-10-11 01:54:38.724855|2017-10-11 01:54:38.724855
NCT01809340|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2015-06-29|||June 2013||2013-06-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression|An Exploratory, Blinded, Randomized, Placebo-controlled Study in Subjects With Depressive Disorder to Investigate the Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced (Partial) Symptoms Response|Terminated||Phase 2|29|Actual|Janssen Research & Development, LLC||3||study team decision because of IP supply issue and necessary amendment to protocol|f||||f||||||||||2017-10-11 01:54:32.062424|2017-10-11 01:54:32.062424
NCT01809327|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-06-12|2015-12-01||June 4, 2013|Actual|2013-06-04|June 2017|2017-06-01|December 2, 2014|Actual|2014-12-02|December 2, 2014|Actual|2014-12-02||Interventional|||A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise|A Randomized, Double-Blind, 5-Arm, Parallel-Group, 26-Week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in Combination With Metformin as Initial Combination Therapy in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise|Completed||Phase 3|1186|Actual|Janssen Research & Development, LLC||5|||f||||t||f||||||||2017-10-11 01:54:32.232447|2017-10-11 01:54:32.232447
NCT01809314|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-07-08|2016-07-08||March 2008||2008-03-01|June 2016|2016-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational||All Participants Enrolled: All participants who were enrolled into the study regardless of whether treatment was received. Number of participants with available data for age = 1134.|An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy|Non-Interventional Study to Evaluate Treatment of Symptomatic Anemia in Patients With Malignancies Receiving Chemo- and NeoRecormon-Therapy|Completed||N/A|1167|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:54:34.101373|2017-10-11 01:54:34.101373
NCT01809301|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2013-08-21|||March 2013||2013-03-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions|A Single-Dose, Randomized, Open-Label, Crossover, Comparative Bioavailability Study of TRIA-662 500 mg Immediate-Release Tablets and NIASPAN 1000 mg Extended-Release Tablets in Healthy Male and Female Volunteers Under Fed Conditions|Completed||Phase 1|20|Actual|Cortria Corporation||2|||f||||f||||||||||2017-10-11 01:54:34.480305|2017-10-11 01:54:34.480305
NCT01809288|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2017-08-04|||February 26, 2013||2013-02-26|August 1, 2017|2017-08-01|April 30, 2022|Anticipated|2022-04-30|April 30, 2022|Anticipated|2022-04-30||Observational|||Identifying Risk for Diabetes and Heart Disease in Women|Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors|Recruiting||N/A|360|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:54:34.583198|2017-10-11 01:54:34.583198
NCT01809275|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-08-19|||March 2013||2013-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease|A Phase 1/2 Randomized, Placebo-Controlled, Double-Blind Study of the Induction of Clinical Response and Remission by QBECO in Subjects With Moderate to Severe Crohn's Disease|Completed||Phase 1/Phase 2|68|Actual|Qu Biologics Inc.||2|||f||||t||||||||||2017-10-11 01:54:34.687936|2017-10-11 01:54:34.687936
NCT01809262|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-05-27|2014-03-28||December 2005||2005-12-01|May 2014|2014-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease|Single Dose Preliminary Dose-ranging and Safety in Patients With COPD|Completed||Phase 2|36|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 01:54:34.847511|2017-10-11 01:54:34.847511
NCT01809249|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-09|2013-03-09|||June 2010||2010-06-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01|3 Months|Observational [Patient Registry]|||Causes of Disqualification of Egyptian Potential Living Liver Donors||Completed||N/A|192|Actual|Ain Shams University|||1||f||||t||||||||||2017-10-11 01:54:36.063426|2017-10-11 01:54:36.063426
NCT01809236|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-03-25|||May 2012||2012-05-01|March 2014|2014-03-01|March 2014|Anticipated|2014-03-01|November 2013|Actual|2013-11-01||Interventional|FALCON||Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion|An Open Label, Single Arm Clinical Study of Intravitreal Injection of Conbercept in Patients With Maculae Edema Secondary to Retinal Vein Occlusion (the FALCON Study)|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.||1|||f||||f||||||||||2017-10-11 01:54:36.15624|2017-10-11 01:54:36.15624
NCT01809223|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2014-06-03|||August 2012||2012-08-01|March 2014|2014-03-01|March 2015|Anticipated|2015-03-01|February 2014|Actual|2014-02-01||Interventional|SHINY||A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV|The Safety and Efficacy of Conbercept in the Treatment of Choroidal Neovascularization (CNV) Secondary to High Myopia|Unknown status|Active, not recruiting|Phase 3|176|Anticipated|Chengdu Kanghong Biotech Co.,Ltd.||2|||f||||f||||||||||2017-10-11 01:54:36.25317|2017-10-11 01:54:36.25317
NCT01809197|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-06-25|2014-06-25||April 2013||2013-04-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||This analysis population includes all subjects who were randomized and received study regimen (test or control). Note: 1 subject randomized to Acuvue Oasys was not dispensed with study lenses.|Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution|Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution|Completed||N/A|387|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:54:36.481857|2017-10-11 01:54:36.481857
NCT01809184|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-02-28|||March 4, 2013|Actual|2013-03-04|February 2017|2017-02-01|September 6, 2013|Actual|2013-09-06|September 6, 2013|Actual|2013-09-06||Interventional|||A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects|A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects|Completed||Phase 1|84|Actual|Novo Nordisk A/S||7|||f||||f||||||||||2017-10-11 01:54:36.71606|2017-10-11 01:54:36.71606
NCT01809171|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2015-10-20|||October 2013||2013-10-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients|Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients|Terminated||Phase 2/Phase 3|15|Actual|Universitaire Ziekenhuizen Leuven||2||Inclusion problems|f||||f||||||||||2017-10-11 01:54:36.819125|2017-10-11 01:54:36.819125
NCT01809158|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-11|2016-06-29|||April 2013||2013-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|MINOS||Minocycline for Schizophrenia|A Double-blind Randomized Placebo-controlled Trial of Adjuvant Therapy With Minocycline for Schizophrenia|Completed||Phase 4|150|Actual|Addis Ababa University||2|||f||||t||||||||||2017-10-11 01:54:36.89591|2017-10-11 01:54:36.89591
NCT01809145|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-10|||March 2013||2013-03-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Testing Hypersensitivity to Metals in Sarcoidosis Patients by Applying the MELISA Test.|Testing Hypersensitivity to Metals in Sarcoidosis Patients With Occupational Exposure, Using the MELISA Test.|Unknown status|Recruiting|N/A|10|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 01:54:36.972358|2017-10-11 01:54:36.972358
NCT01809132|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2017-05-10|||September 2013||2013-09-01|May 2017|2017-05-01||||December 2018|Anticipated|2018-12-01||Interventional|||Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis|Double-blind Randomized Controlled Trial of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis|Recruiting||Phase 2/Phase 3|130|Anticipated|University of Texas Southwestern Medical Center||3|||f||||t||||||||||2017-10-11 01:54:37.056741|2017-10-11 01:54:37.056741
NCT01809119|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2016-08-23|||December 2012||2012-12-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Prospective Randomized Study Comparing Laparoscopic Versus Open Partial Nephrectomy|Prospective Randomized Study Comparing Laparoscopic Versus Open Partial Nephrectomy|Recruiting||Phase 2/Phase 3|242|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 01:54:37.191373|2017-10-11 01:54:37.191373
NCT01809106|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2015-11-20|2015-10-20||April 2011||2011-04-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CERP||RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder.|RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder.|Completed||Phase 4|518|Actual|Mario Negri Institute for Pharmacological Research||4|||f||||f||||||||||2017-10-11 01:54:37.29966|2017-10-11 01:54:37.29966
NCT01809093|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-02-17|||March 2010||2010-03-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|PEDF||Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus.|Modulation of Thrombospondin-1 and Pigment Epithelium Derived Factor Levels in Vitreous Fluid and Plasma of Patients With Diabetes|Completed||N/A|90|Actual|Wills Eye|||1||f||||f||||||Samples Without DNA|"     The level of TSP1 and PEDF in the vitreous and plasma.   "|No||2017-10-11 01:54:37.75231|2017-10-11 01:54:37.75231
NCT01809080|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-09-19|||May 2007||2007-05-01|December 2016|2016-12-01||||July 2027|Anticipated|2027-07-01||Observational|||Intern Health Study|Investigation Into the Interaction Between Genes and Stress in the Etiology of Depression in Interns|Enrolling by invitation||N/A|4380|Actual|University of Michigan|||1||f||||f||||||Samples With DNA|"     Saliva: DNA collection kits are sent via postal mail and participants are asked to provide a     small sample of saliva.      Blood samples (up to 50 mL via venopuncture): whole blood and serum will be assessed.      Hair: The total diameter taken from the scalp's posterior vertex will be about 3 mm, which is     about half of the diameter of pencil (approximately 100 hair strands with a minimum of 50 mg     of hair for a 3-cm segment).   "|||2017-10-11 01:54:37.83395|2017-10-11 01:54:37.83395
NCT01809067|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-09-07|||March 2013||2013-03-01|March 2013|2013-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effects of Lavender Aromatherapy on Reducing Stress and Anxiety During MRI Procedures.|The Effects of Lavender Aromatherapy on the Reduction of Stress and Anxiety During MRI Procedures. A Randomized Study Comparing the Use of Lavender Aromatherapy to no Aromatherapy.|Completed||N/A|60|Actual|Allina Health System||2|||f||||f||||||||||2017-10-11 01:54:37.908461|2017-10-11 01:54:37.908461
NCT01809054|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-03-18|2014-03-18||April 2012||2012-04-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty|Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty|Completed||Phase 4|54|Actual|LifeBridge Health||2|||f||||f||||||||||2017-10-11 01:54:37.99564|2017-10-11 01:54:37.99564
NCT01809041|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-03-17|||March 2013||2013-03-01|March 2017|2017-03-01||||June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Intravenous Anesthetics to Volatile Anesthetics on Postoperative Cognitive Dysfunction|Comparison of Total Intravenous Anesthesia With Sevoflurane-based Balanced Anesthesia on Postoperative Cognitive Dysfunction in Elderly Patients for Major Elective Intra-abdominal Surgery|Recruiting||Phase 4|684|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 01:54:38.40128|2017-10-11 01:54:38.40128
NCT01809028|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-08-02|||February 2013||2013-02-01|August 2017|2017-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions|A Randomized Trial Evaluating the Number of Passes Required for Diagnostic Cell Block During Endoscopic Ultrasound-Fine Needle Aspiration of Solid Pancreatic Mass Lesions|Completed||N/A|62|Actual|Florida Hospital||2|||f||||t||||||||||2017-10-11 01:54:38.523128|2017-10-11 01:54:38.523128
NCT01809015|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-08|2014-05-14|||January 2011||2011-01-01|May 2014|2014-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|thrombEVAL||Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme|A Study Programme for the Evaluation of Oral Anticoagulation Therapy With Vitamin K Antagonists|Active, not recruiting||N/A|2500|Anticipated|Johannes Gutenberg University Mainz|||2||f||||t||||||||||2017-10-11 01:54:38.635993|2017-10-11 01:54:38.635993
NCT01808976|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-05-03|||April 2013||2013-04-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|January 2017|Actual|2017-01-01||Interventional|||Can Mental Health Apps Work in the Real World? A Feasibility Pilot Study.|Can Mental Health Apps Work in the Real World? A Feasibility Pilot Study.|Completed||N/A|1000|Actual|University of California, San Francisco||3|||f||||t||||||||Yes|We plan to release data for sharing once the study is complete.|2017-10-11 01:54:38.945592|2017-10-11 01:54:38.945592
NCT01808963|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-05-24|2013-07-17||December 2012||2012-12-01|May 2017|2017-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Evaluation of Respiratory Heast Loss as a Physiologic Patient Monitor for Acute Care Medicine|Evaluation of Respiratory Heat Loss as a Physiologic Patient Monitor for Acute Care Medicine|Completed||N/A|13|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 01:54:39.03506|2017-10-11 01:54:39.03506
NCT01808950|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2016-05-12|2015-12-03||February 2013||2013-02-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma|Bi-center, Open Label, Non-comparative Trial Exploring Efficacy and Safety of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma (nBCC)|Terminated||Phase 1/Phase 2|4|Actual|Spirig Pharma Ltd.||3||safety issues|f||||f||||||||No||2017-10-11 01:54:39.271263|2017-10-11 01:54:39.271263
NCT01808937|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-12-02|||May 2007||2007-05-01|December 2014|2014-12-01||||January 2020|Anticipated|2020-01-01|6 Years|Observational [Patient Registry]|MAC||Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository|Immunologic and Genetic Profiles in Subsets of Morphea Patients|Recruiting||N/A|500|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples With DNA|"     serum, WBC, tissue   "|||2017-10-11 01:54:39.731307|2017-10-11 01:54:39.731307
NCT01808911|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-11-18|||May 2012||2012-05-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|CREHA||Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)|Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)|Recruiting||Phase 3|164|Anticipated|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 01:54:39.855253|2017-10-11 01:54:39.855253
NCT01808898|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2015-05-27|||February 2013||2013-02-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|ICOB||Role of Intrauterine Cornual Block in Combination With Direct Cervical Block in Outpatient Endometrial Ablation|Randomized Double-blind Placebo Controlled Trial to Assess the Role of Intrauterine Cornual Block (ICOB) in Combination With Direct Cervical Block in Outpatient Endometrial Ablation|Completed||Phase 4|93|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-11 01:54:40.228034|2017-10-11 01:54:40.228034
NCT01808885|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-11-21|||April 2013||2013-04-01|November 2016|2016-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|MSREPAIR||Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.|A 24-Week, Ph1b, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study, to Assess the Safety Profile of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.|Completed||Phase 1|44|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 01:54:40.40223|2017-10-11 01:54:40.40223
NCT01808872|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-05-02|||March 2013||2013-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP|Clinical Sensitivity and Specificity Study of AQT90 FLEX BNP and NT-proBNP|Completed||N/A|569|Actual|Radiometer Medical ApS|||1||f||||f||||||Samples Without DNA|"     Samples are retained only for this study (troubleshooting purposes).   "|||2017-10-11 01:54:40.573468|2017-10-11 01:54:40.573468
NCT01808859|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2014-11-05|||February 2013||2013-02-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Tourniquet and Quadricepsforce|The Effect of Tourniquet Use During Total Knee Arthroplasty Surgery on the Postoperative Loss of Quadricepsforce|Completed||N/A|64|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 01:54:40.705267|2017-10-11 01:54:40.705267
NCT01808846|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-04-25|||July 2010|Actual|2010-07-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Neural Functioning of Feeding Centers in Obese Youth|Neural Functioning of Feeding Centers in Obese Youth|Completed||N/A|51|Actual|Yale University|||3||f||||f||||||Samples Without DNA|"     Serum   "|No||2017-10-11 01:54:40.865319|2017-10-11 01:54:40.865319
NCT01808833|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-01-28|||February 2012||2012-02-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy|A Pilot Trial of Frailty Assessment in Older Adults (Age 70 >) Requiring Concurrent Chemotherapy Plus Radiation Therapy for Cancer (CTRC# 12-22)|Terminated||N/A|4|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||t||||||||||2017-10-11 01:54:41.002028|2017-10-11 01:54:41.002028
NCT01808820|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-08-16|||August 21, 2013|Actual|2013-08-21|August 2017|2017-08-01|July 2023|Anticipated|2023-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma|Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects|Recruiting||Phase 1|20|Anticipated|University of Miami||2|||f||||t|t|f||||||||2017-10-11 01:54:41.114509|2017-10-11 01:54:41.114509
NCT01808807|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-08-16|||December 2012||2012-12-01|March 2013|2013-03-01||||April 2013|Actual|2013-04-01||Observational|||Factors Influencing Cesarean Section Rate: Does the Audit Still Work?|Factors Influencing Cesarean Section Rate: Does the Audit Still Work?|Completed||N/A|4000|Actual|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 01:54:41.27492|2017-10-11 01:54:41.27492
NCT01808794|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-08-03|||January 2013||2013-01-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Comparison of Two Different Membranes|Clinical, Radiographic, and Histological Comparison of Healing After Alveolar Ridge Preservation Using Bone Allograft With Two Different Xenogeneic Membranes|Completed||N/A|27|Actual|Tufts University School of Dental Medicine||2|||f||||f||||||||||2017-10-11 01:54:41.351572|2017-10-11 01:54:41.351572
NCT01808755|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-04-25|2013-04-01||January 2012||2012-01-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||D Mannose in Recurrent Urinary Tract Infections|Recurrent Urinary Tract Infections in Adult Women: a Pilot Study With Oral D Mannose|Completed||Phase 3|60|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-11 01:54:41.743223|2017-10-11 01:54:41.743223
NCT01808742|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-03-23|||November 2012||2012-11-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Observational|||Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device|A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines Utilizing Optimized Algorithms With the Cryo-Touch III Device|Completed||N/A|17|Actual|MyoScience, Inc|||1||f||||f||||||||||2017-10-11 01:54:42.029197|2017-10-11 01:54:42.029197
NCT01808729|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-11-04|||February 2013||2013-02-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium|The CAUSE Trial: Genomics of Extreme Trait-Coronary Artery Disease Cells and Fibromuscular Dysplasia Using Induced Pluripotent Stem Cell-Derived Endothelial Cells|Completed||N/A|34|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||Samples With DNA|"     DNA from leukocytes, plasma, fibroblasts and fibroblast-derived cell lines   "|||2017-10-11 01:54:42.162149|2017-10-11 01:54:42.162149
NCT01808716|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-07|||February 2011||2011-02-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Low-level Laser Therapy (808nm) on Marker of Muscle Damage|Effect of Low-level Laser Therapy (808nm) on Marker of Muscle Damage: Randomized Double-blind Placebo-controlled Study|Completed||N/A|22|Actual|Universidade Federal de Sao Carlos||2|||f||||||||||||||2017-10-11 01:54:42.295816|2017-10-11 01:54:42.295816
NCT01808703|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-07|||March 2013||2013-03-01|March 2013|2013-03-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Clinical Trial of PeriZone PerioPatch in Subjects With Chronic Periodontitis||Unknown status|Recruiting|N/A|80|Anticipated|MIS Implant Technologies, Ltd||2|||f||||f||||||||||2017-10-11 01:54:42.412953|2017-10-11 01:54:42.412953
NCT01808690|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-12-19|||March 2013||2013-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|EMERALD||EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes|Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes|Active, not recruiting||Phase 3|52|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 01:54:42.571549|2017-10-11 01:54:42.571549
NCT01808677|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-08-23|||June 2012||2012-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01|5 Years|Observational [Patient Registry]|||Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy|Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy|Completed||N/A|49|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 01:54:42.688388|2017-10-11 01:54:42.688388
NCT01808664|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-05-25|||April 2013||2013-04-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Promoting Patient-Centered Counseling to Reduce Inappropriate Diagnostic Tests|Promoting Patient-Centered Counseling to Reduce Inappropriate Diagnostic Tests: Randomized Clinical Trial|Completed||N/A|61|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 01:54:42.805049|2017-10-11 01:54:42.805049
NCT01808651|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-10-22|2015-10-22||May 2013||2013-05-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing|A Phase 3, Open-label, Long-Term Study to Evaluate the Safety of LY110140 Once Daily Dosing for 52-week in Japanese Patients With Major Depressive Disorder|Completed||Phase 3|200|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 01:54:42.937272|2017-10-11 01:54:42.937272
NCT01808638|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-03-10|||March 2013||2013-03-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|Atu027-I-02||Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)|A PHASE Ib/IIa STUDY OF COMBINATION THERAPY WITH GEMCITABINE AND ATU027 IN SUBJECTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC ADENOCARCINOMA|Completed||Phase 1/Phase 2|29|Actual|Silence Therapeutics GmbH||3|||f||||t||||||||||2017-10-11 01:54:45.433996|2017-10-11 01:54:45.433996
NCT01808625|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-05-24|||March 2013||2013-03-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Hyperbaric Oxygen Stimulation for Patients With Brain Malignancies After Radiation Therapy.|Hyperbaric Oxygen Stimulation for Patients With Brain Malignancies After Radiation Therapy.|Terminated||N/A|2|Actual|Sheba Medical Center||1||Tecnical problem|f||||||||||||||2017-10-11 01:54:45.574439|2017-10-11 01:54:45.574439
NCT01808612|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-04-24|2015-04-24||March 2013||2013-03-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||All randomized participants who received at least 1 dose of study drug.|A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing|A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Parallel-Design Study to Evaluate the Short-Term, Fixed Dose Efficacy and Safety of LY110140 Once Daily Dosing in Japanese Patients With Major Depressive Disorder|Completed||Phase 3|513|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 01:54:45.689058|2017-10-11 01:54:45.689058
NCT01808599|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-08-22|||December 2013||2013-12-01|July 2017|2017-07-01|September 2028|Anticipated|2028-09-01|March 2016|Actual|2016-03-01||Interventional|||Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma|A Phase II Study of Chlorambucil in Combination With Subcutaneous Rituximab Followed by Maintenance Therapy With Subcutaneous Rituximab in Patients With Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)|Active, not recruiting||Phase 2|112|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||f||||||||||2017-10-11 01:54:49.635129|2017-10-11 01:54:49.635129
NCT01806935|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-09-25|||April 2013||2013-04-01|February 2013|2013-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Xerotic Dermatitis in Aged People||Completed||N/A|442|Actual|Pierre Fabre Medicament||2|||f||||f||||||||||2017-10-11 01:55:32.86304|2017-10-11 01:55:32.86304
NCT01808586|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-03-01|||May 2013||2013-05-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Facet Versus Trigger Point Injections for Chronic Neck Pain|Facet Versus Trigger Point Injection for Management of Chronic Muscular Neck Pain: A Randomized Clinical Trial and Creation of a Clinical Prediction Algorithm|Recruiting||Phase 2|43|Anticipated|Lawson Health Research Institute||4|||f||||f||||||||||2017-10-11 01:54:49.807218|2017-10-11 01:54:49.807218
NCT01808560|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-02-04|||March 2013||2013-03-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery|Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery|Completed||N/A|34|Actual|TearScience, Inc.||3|||f||||f||||||||||2017-10-11 01:54:51.633357|2017-10-11 01:54:51.633357
NCT01808547|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-06-02|2016-04-26|2015-03-30|May 2013||2013-05-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Modified Intent–to-Treat: subjects who were randomized into the trial, underwent cataract surgery, and received at least one dose of study drug|Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects|A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects|Completed||Phase 3|268|Actual|InSite Vision||2|||f||||||||||||||2017-10-11 01:54:51.758971|2017-10-11 01:54:51.758971
NCT01808534|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-06-11|2015-06-11||February 2013||2013-02-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors|Multicenter Single Arm Phase II Study of Single Agent Palifosfamide in Recurrent and Incurable Germ Cell Tumors|Terminated||Phase 2|5|Actual|Indiana University||1||Due to Low Accrual|f||||f||||||||||2017-10-11 01:54:52.039378|2017-10-11 01:54:52.039378
NCT01808521|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-09-18|||May 2013||2013-05-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|NACinTTP||A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura|A Pilot Study of N-acetylcysteine in Suspected Thrombotic Thrombocytopenia Purpura|Completed||Early Phase 1|3|Actual|Bloodworks (Puget Sound Blood Center)||1|||f||||t||||||||||2017-10-11 01:54:52.557342|2017-10-11 01:54:52.557342
NCT01808508|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-01-08|2015-12-04||September 2010||2010-09-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|TRIO||Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome|Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome|Completed||N/A|27|Actual|Children's Hospital of Philadelphia|This preliminary study was limited by the small sample size, and the few children with Down Syndrome but normal breathing during sleep.|3|||f||||t||||||||||2017-10-11 01:54:52.706738|2017-10-11 01:54:52.706738
NCT01808495|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-08-10|||August 2012||2012-08-01|August 2015|2015-08-01|August 2015|Anticipated|2015-08-01|July 2013|Actual|2013-07-01||Observational|||Function and Modulation of Fibulin-1 Assembly in Nucleus of Corneal Fibroblasts||Unknown status|Active, not recruiting|N/A|5|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 01:54:53.408348|2017-10-11 01:54:53.408348
NCT01808482|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-06-06|||March 13, 2013|Actual|2013-03-13|June 2017|2017-06-01|August 6, 2013|Actual|2013-08-06|August 6, 2013|Actual|2013-08-06||Interventional|||A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)|A First Time in Human Study Exploring Preliminary Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis|Terminated||Phase 1|16|Actual|GlaxoSmithKline||5||"GSK confirmed misrepresentation of preclinical data that supported the rationale for GSK2618960   in MS. This decreased benefit assessment for MS"|f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:54:53.496588|2017-10-11 01:54:53.496588
NCT01808469|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-10-23|||November 2012||2012-11-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|NI-0101-01||First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers|A Randomized, Double Blind, Placebo-controlled, Pharmacokinetics/Pharmacodynamics-guided, Phase I Study in Healthy Volunteers Given Escalating, Single Intravenous Doses of NI-0101 in the Absence and Then in the Presence of a Systemic Lipopolysaccharide Challenge.|Completed||Phase 1|80|Anticipated|NovImmune SA||2|||f||||f||||||||||2017-10-11 01:54:53.621437|2017-10-11 01:54:53.621437
NCT01808456|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-03-01|||October 2013||2013-10-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.|Phase IV, Pilot, Randomized, Investigator-blinded, Study to Evaluate the Reactogenicity and Immunogenicity of Standard-dose Versus High-dose Inactivated Influenza Vaccine After Kidney, Heart and Lung Transplantation.|Completed||Phase 4|62|Actual|Inova Health Care Services||2|||f||||f||||||||||2017-10-11 01:54:53.743672|2017-10-11 01:54:53.743672
NCT01808443|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-08|||March 2013||2013-03-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy of Laser Versus Cryotherapy in the Treatment of Warts|Cryotherapy Versus Laser for the Treatment of Nongenital Cutaneous Warts: A Randomized Controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|The 306 Hospital of People's Liberation Army||2|||f||||t||||||||||2017-10-11 01:54:53.890903|2017-10-11 01:54:53.890903
NCT01808430|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-02-11|||March 2013||2013-03-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01|6 Weeks|Observational [Patient Registry]|||Powered Echelon Device in VATS Surgery|Real World Outcomes of Video-Assisted Thoracoscopic Surgery for Lung Cancer Using ECHELON FLEX™ Powered ENDOPATH® Stapler: a Prospective European Multicenter Study|Completed||N/A|158|Actual|Ethicon Endo-Surgery (Europe) GmbH|||1||f||||t||||||||||2017-10-11 01:54:53.991896|2017-10-11 01:54:53.991896
NCT01808417|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-05-11|||May 2013||2013-05-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer|Intraoperative NIR-Guided Sentinel Lymph Node Mapping in Esophageal Cancer|Active, not recruiting||Phase 1|10|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||Undecided|As of right now, there is no plan to make IPD available to other researchers.|2017-10-11 01:54:54.089605|2017-10-11 01:54:54.089605
NCT01808404|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-01-27|||February 2013||2013-02-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help|Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help (Phase 1)|Completed||Phase 1|113|Actual|Contextual Change LLC||1|||f||||t||||||||||2017-10-11 01:54:54.312449|2017-10-11 01:54:54.312449
NCT01808391|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-01-26|||March 2013||2013-03-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|May 2014|Actual|2014-05-01|12 Months|Observational [Patient Registry]|||A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)|A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease|Completed||N/A|1204|Actual|Associations for Establishment of Evidence in Interventions|||2||f||||t||||||||||2017-10-11 01:54:54.45178|2017-10-11 01:54:54.45178
NCT01808378|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-03-07|||February 2013||2013-02-01|September 2012|2012-09-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|HULPOFT||Stem Cells Treatment for Bilateral Limbic Associated Keratopathy (HULPOFT)|Phase IIa Clinical Trial to Study the Feasability and Security of the Expanded Autologous Stem Cells (ASC) From Lipoaspirate in the Bilateral Limbic Associated Keratopathy Treatment|Unknown status|Recruiting|Phase 2|8|Anticipated|Instituto de Investigación Hospital Universitario La Paz||1|||f||||t||||||||||2017-10-11 01:54:54.563353|2017-10-11 01:54:54.563353
NCT01808365|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-07-30|||August 2013||2013-08-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||N. Meningitidis Carriage Study|Neisseria Meningitidis Carriage Study|Completed||N/A|1000|Actual|GlaxoSmithKline|||1||f||||||||||Samples With DNA|"     Throat swab   "|||2017-10-11 01:54:54.706773|2017-10-11 01:54:54.706773
NCT01808352|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2016-01-20|||August 2013||2013-08-01|March 2014|2014-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)|Pre-Exposure Prophylaxis (PrEP) Initiation and Adherence Among Black Men Who Have Sex With Men (BMSM) in Three U.S. Cities|Completed||Phase 4|225|Actual|HIV Prevention Trials Network||1|||f||||f||||||||No||2017-10-11 01:54:54.851403|2017-10-11 01:54:54.851403
NCT01808339|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-11-18|2014-08-21||March 2013||2013-03-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma|A Randomised, Repeat-dose, Placebo-controlled, Three-way Crossover, Double Dummy Study to Evaluate and Compare the Efficacy of Fluticasone Furoate Inhalation Powder Delivered Via the Single Strip Dry Powder Inhaler When Administered Either in the Morning or in the Evening, in Male and Female Asthmatic Subjects|Completed||Phase 2|28|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:54:54.990652|2017-10-11 01:54:54.990652
NCT01808326|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-06-04|2015-06-04||April 2013||2013-04-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia|A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|5|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 01:54:55.807545|2017-10-11 01:54:55.807545
NCT01808313|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-05-09|2015-04-02||December 1, 2012|Actual|2012-12-01|May 2017|2017-05-01|August 15, 2014|Actual|2014-08-15|August 15, 2014|Actual|2014-08-15||Interventional|||Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)|An Open Label Phase IIIb Study to Evaluate Efficacy and Safety of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 3|134|Actual|GlaxoSmithKline||1|||f|||||f|f||||||||2017-10-11 01:54:56.988696|2017-10-11 01:54:56.988696
NCT01808300|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-03|2013-08-21|||February 2013||2013-02-01|March 2013|2013-03-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid.|A Randomized,Open-label,Six-sequence,Three-period,Three-treatment,Multiple Dosing Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|42|Actual|Unimed Pharmaceuticals||6|||||||f||||||||||2017-10-11 01:54:59.060167|2017-10-11 01:54:59.060167
NCT01808287|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-02-07|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|December 2013|Actual|2013-12-01||Interventional|SAPIEN3||Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study|Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve|Active, not recruiting||N/A|250|Actual|Edwards Lifesciences||2|||f||||t|f|f||||||Undecided||2017-10-11 01:54:59.190733|2017-10-11 01:54:59.190733
NCT01808274|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-08-24|||February 1, 2013|Actual|2013-02-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|CENTERA-1||Safety and Performance Study of the Edwards CENTERA Self-Expanding Transcatheter Heart Valve|Safety and Performance Study of the Edwards CENTERA Self-Expanding Transcatheter Heart Valve|Active, not recruiting||N/A|34|Actual|Edwards Lifesciences||1|||f||||t||||||||||2017-10-11 01:54:59.414132|2017-10-11 01:54:59.414132
NCT01808261|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-09-29|2017-06-09|2016-03-21|May 18, 2013|Actual|2013-05-18|August 2017|2017-08-01|July 28, 2014|Actual|2014-07-28|July 28, 2014|Actual|2014-07-28||Interventional|||Proof of Concept (POC) in Patients With Ischaemic Stroke|Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients|Terminated||Phase 2|134|Actual|GlaxoSmithKline|The study was terminated early, on 27 May 2014, at the planned interim analysis for futility.|2||This study was terminated for futility.|f||||t||||||||||2017-10-11 01:54:59.691028|2017-10-11 01:54:59.691028
NCT01806727|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-09-28|||April 2013||2013-04-01|September 2017|2017-09-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Interventional|LIFTDiabetes||Lifestyle Intervention for Treatment of Diabetes|Lifestyle Intervention for Treatment of Diabetes|Completed||N/A|260|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 01:55:37.398764|2017-10-11 01:55:37.398764
NCT01808248|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2014-09-05|2014-09-05||February 2013||2013-02-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional||Safety Analysis Set: participants enrolled and received at least 1 dose of study drug|Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3|A Phase 2, Open-Label Study of Sofosbuvir in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3|Completed||Phase 2|47|Actual|Gilead Sciences||1|||t||||f||||||||||2017-10-11 01:55:01.857273|2017-10-11 01:55:01.857273
NCT01808235|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-03-29|||July 2012||2012-07-01|March 2017|2017-03-01|February 3, 2017|Actual|2017-02-03|February 3, 2017|Actual|2017-02-03||Interventional|||Oral Health Intervention Pilot Study for Individuals With Memory Problems|Developing a Caregiver-assisted Oral Health Intervention for Individuals With Memory Problems|Completed||N/A|12|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:55:02.768984|2017-10-11 01:55:02.768984
NCT01808222|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2016-11-08|||November 2013||2013-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||FACBC for Recurrent Prostate Cancer|Transmolecular Imaging of Recurrent Prostate Carcinoma With Exploration of Genomic Markers Differences Between Local and Distant Recurrence|Active, not recruiting||Phase 2|25|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 01:55:02.863002|2017-10-11 01:55:02.863002
NCT01808209|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-01-14|2014-11-03||January 2013||2013-01-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional||All participants completing the study wore both sets of study lenses.Participants were randomized to wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.|Clinical Performance of Stenfilcon A Versus Filcon II 3|Clinical Performance of Stenfilcon A Versus Filcon II 3|Completed||Phase 4|60|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 01:55:02.986045|2017-10-11 01:55:02.986045
NCT01808196|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-01-20|||April 2013||2013-04-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD|A Preliminary, Open-label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) With or Without a Connective Tissue Disorder.|Active, not recruiting||Phase 2|6|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 01:55:03.929544|2017-10-11 01:55:03.929544
NCT01808183|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-08-09|||February 2012||2012-02-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|||Pediatric Supracondylar Humerus Fracture NIRS Study|Near Infrared Spectroscopy for the Evaluation of Pediatric Forearm Compartment Perfusion After Supracondylar Humerus Fracture|Completed||N/A|90|Actual|Carolinas Healthcare System|||1||f||||t||||||||||2017-10-11 01:55:04.067834|2017-10-11 01:55:04.067834
NCT01808170|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-03-25|||March 2013||2013-03-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve|Effect of Laparoscopic Ovarian Cystectomy of Endometrioma Versus Cyst Deroofing on Ovarian Reserve as Determined by Anti-mullerian Hormone and Antral Follicle Count: a Prospective Randomized Study.|Completed||N/A|122|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 01:55:04.192938|2017-10-11 01:55:04.192938
NCT01808157|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-11-24|||July 2013||2013-07-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis|A Phase II Randomised, Double Blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of CT327 Topical Ointment (0.05% and 0.5% w/w) Compared to Vehicle, in Subjects With Mild or Moderate Atopic Dermatitis and at Least Moderate Pruritus|Completed||Phase 2|188|Actual|Creabilis SA||3|||f||||f||||||||||2017-10-11 01:55:04.316552|2017-10-11 01:55:04.316552
NCT01808118|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-02-22|||May 2013||2013-05-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis|A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis|Completed||Phase 4|673|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 01:55:05.975053|2017-10-11 01:55:05.975053
NCT01808105|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-05-30|||April 2013||2013-04-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Growth and Tolerance of Infants Fed Infant Formulas|Growth and Tolerance of Young Infants Fed Infant Formulas|Completed||N/A|424|Actual|Abbott Nutrition||4|||f||||f||||||||||2017-10-11 01:55:06.496377|2017-10-11 01:55:06.496377
NCT01808092|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-09-01|2016-12-09||April 2013||2013-04-01|September 2017|2017-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Baseline characteristics analysis is based on safety analysis set: randomized patients who received any amount of study therapy. 9 patients were randomized but not treated.|A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia|A Phase III, Randomized, Multicentre, Double-blind, Double-dummy, Parallel-group Comparative Study to Determine the Efficacy, Safety And Tolerability of Ceftazidime-Avibactam Versus Meropenem in the Treatment of Nosocomial Pneumonia Including Ventilator-Associated Pneumonia in Hospitalized Adults|Completed||Phase 3|969|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 01:55:06.820984|2017-10-11 01:55:06.820984
NCT01808079|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-08-18|||October 2009||2009-10-01|July 2016|2016-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Gene Analysis in Studying Susceptibility to Wilms Tumor|A Genome-Wide Association Study in Wilms Tumor|Completed||N/A|1|Actual|Children's Oncology Group|||1||f||||||||||||||2017-10-11 01:55:10.002898|2017-10-11 01:55:10.002898
NCT01808066|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-07-29|2014-07-23||January 2013||2013-01-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||students at school grades K-6|GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs|GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs|Completed||N/A|21|Actual|CogCubed, Corp|Technical difficulties resulting from firewall at school affected set up time, difficulty with log in instructions and the cubes sliding on desktops.|1|||f||||t||||||||||2017-10-11 01:55:10.127355|2017-10-11 01:55:10.127355
NCT01808053|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-01-06|||March 2013||2013-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects|Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects|Completed||N/A|20|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 01:55:10.311654|2017-10-11 01:55:10.311654
NCT01808040|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-09-20|||November 2012||2012-11-01|September 2017|2017-09-01|December 9, 2016|Actual|2016-12-09|July 2014|Actual|2014-07-01||Interventional|||A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer|A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer|Completed||Phase 1|8|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 01:55:10.377861|2017-10-11 01:55:10.377861
NCT01808027|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-07|||February 2011||2011-02-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01|12 Months|Observational [Patient Registry]|||Investigating Variation in Hospital Acute Coronary Syndrome Outcomes|Evaluation of the Methods and Management of Acute Coronary Events: 3. Investigating Variation in Hospital Acute Coronary Syndrome Outcomes|Completed||N/A|5555|Actual|University of Leeds|||1||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-11 01:55:10.457707|2017-10-11 01:55:10.457707
NCT01808014|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2014-02-17|||February 2013||2013-02-01|February 2014|2014-02-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|||The Analgesic Effect of Nefopam on the Fentanyl Based PCA (Patient-controlled Analgesia) After Lumbar Spinal Surgery||Unknown status|Recruiting|N/A|54|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 01:55:10.521998|2017-10-11 01:55:10.521998
NCT01808001|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-11-15|||June 2013||2013-06-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Observational|CEC||Simulation Team Training and Critical Event Checklist Use for Optimizing the Management of Critical Perioperative Events in an Ambulatory Surgical Facility|Critical Event Checklist Use for Management of Critical Events in Ambulatory Surgery|Unknown status|Active, not recruiting|N/A|30|Anticipated|Women's College Hospital|||1||f||||f||||||||||2017-10-11 01:55:10.591781|2017-10-11 01:55:10.591781
NCT01807988|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-01-22|||April 2013||2013-04-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|ISAK||Internetbased Relapse Prevention for Partially Remitted Depression|Regional Study of Internet-based Relapse Prevention as an Adjunct to Partially Successful Antidepressant Medication|Unknown status|Recruiting|N/A|264|Anticipated|Örebro County Council||2|||f||||f||||||||||2017-10-11 01:55:10.640841|2017-10-11 01:55:10.640841
NCT01807975|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-07-27|||September 2011||2011-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|OSCILLOPOUMON||Forced Oscillation Versus Spirometry in Diagnosing Post Pulmonary Transplant Bronchiolitis Obliterans Syndrome||Completed||N/A|110|Actual|Hopital Foch||1|||f||||||||||||||2017-10-11 01:55:10.724263|2017-10-11 01:55:10.724263
NCT01807962|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-06-07|||November 2011||2011-11-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Local Injection Under US Control in GTPS.|A Randomised Double Blind Controlled Trial of Injection of Local Anaesthetic and Corticosteroid Under Ultrasound Control in the Greater Trochanteric Pain Syndrome.|Terminated||Phase 3|46|Actual|University Hospital, Geneva||2||Slower than planned recruitement|f||||t||||||||Undecided||2017-10-11 01:55:10.782022|2017-10-11 01:55:10.782022
NCT01807949|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-08-15|2015-08-01|2015-05-08|April 2013||2013-04-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|TRANSPORT|Full Analysis Set (FAS) included all randomized participants who received any amount of study drug.|A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation|A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation|Completed||Phase 3|563|Actual|Vertex Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-10-11 01:55:13.059592|2017-10-11 01:55:13.059592
NCT01807936|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-07-31|||February 2013|Actual|2013-02-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2016|Actual|2016-12-01||Interventional|||Esophagectomy:Three-field Versus Two-field Lymphadenectomy|A Phase Ⅲ Study of Three-field Versus Two-field Lymphadenectomy For Middle or Lower Third Intrathoracic Esophageal Cancer|Active, not recruiting||Phase 3|400|Actual|Fudan University||2|||f||||f||||||||||2017-10-11 01:55:17.235527|2017-10-11 01:55:17.235527
NCT01807923|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-08-01|2015-08-01|2015-05-08|May 2013||2013-05-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|TRAFFIC|Full Analysis Set (FAS) included all randomized participants who received any amount of study drug.|A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation|A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation|Completed||Phase 3|559|Actual|Vertex Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-10-11 01:55:17.440156|2017-10-11 01:55:17.440156
NCT01807910|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-10-22|||October 2013||2013-10-01|October 2013|2013-10-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||ER Stress in NAFLD|Phospholipid Endoplasmic Reticulum Stress in Nonalcoholic Fatty Liver Disease|Withdrawn||Early Phase 1|0|Actual|Vanderbilt University||2||The study was not funded|f||||f||||||||||2017-10-11 01:55:20.856172|2017-10-11 01:55:20.856172
NCT01807897|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-07-07|||June 23, 2014|Actual|2014-06-23|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 29, 2017|Anticipated|2017-12-29||Interventional|OPTIMAL-HF||Oxygen Versus PAP for Sleep Apnea in Heart Failure|Oxygen Versus PAP for Treatment of Sleep Apnea in Chronic Heart Failure|Recruiting||Phase 4|161|Anticipated|VA Office of Research and Development||3|||f||||t|f|t|f|f|f|||||2017-10-11 01:55:20.948041|2017-10-11 01:55:20.948041
NCT01807884|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-07-10|||November 12, 2014|Actual|2014-11-12|July 2017|2017-07-01|March 4, 2016|Actual|2016-03-04|March 4, 2016|Actual|2016-03-04||Interventional|AMYLASPI||Comparison of Two Strategies of Oropharyngeal and Tracheal Suctioning in Mechanically Ventilated Patients|Comparison of Two Strategies of Oropharyngeal and Tracheal Suctioning in Mechanically Ventilated Patients: a Pilot Trial|Completed||N/A|24|Actual|University Hospital, Bordeaux||2|||f||||f|f|f||||||||2017-10-11 01:55:21.070188|2017-10-11 01:55:21.070188
NCT01807845|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-13|||January 2013||2013-01-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Interventional|VD||Bioavailability of Vitamin D Encapsulated in Casein Micelles, Compared to Its Bioavailability in a Synthetic Emulsifier Currently Used for Supplementation and Enrichment.||Unknown status|Recruiting|N/A|90|Anticipated|Rambam Health Care Campus||3|||f||||f||||||||||2017-10-11 01:55:21.69591|2017-10-11 01:55:21.69591
NCT01807832|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-07|||March 2013||2013-03-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough.|The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough.|Unknown status|Not yet recruiting|N/A|25|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 01:55:21.900901|2017-10-11 01:55:21.900901
NCT01807819|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2017-06-13|||August 2013|Actual|2013-08-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Observational|DIMPLE||The Determination of Important Mechanical Patterns of Left Ventricular Efficiency-MV02 Study|The Determination of Important Mechanical Patterns of Left Ventricular Efficiency-MV02 Study|Recruiting||N/A|100|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-11 01:55:21.976187|2017-10-11 01:55:21.976187
NCT01807806|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-05-02|||March 2013||2013-03-01|May 2017|2017-05-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|RPG||Safety and Effectiveness Study: Role Playing Game for Friends and Family of Service Members|Safety and Effectiveness Study: Interactive Game-Based System for Psychological Health Education|Completed||N/A|65|Actual|University of Southern California||1|||f||||f|f|f||||||||2017-10-11 01:55:22.071503|2017-10-11 01:55:22.071503
NCT01807793|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-01-31|||May 2012||2012-05-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|TEAM||Targeted Management Intervention for African-American Men With TIA or Stroke|Targeted Management Intervention for African-American Men With TIA or Stroke.|Completed||N/A|43|Actual|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 01:55:22.151057|2017-10-11 01:55:22.151057
NCT01807780|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-05-02|||September 2012||2012-09-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Interventional|||Safety, Immunogenicity And Efficacy Of Vaccination In Military Personnel||Completed||Phase 4|262|Actual|University of Roma La Sapienza||1|||f||||||||||||No||2017-10-11 01:55:22.225884|2017-10-11 01:55:22.225884
NCT01807767|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-08-07|||March 2013||2013-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Myfortic in High MELD Liver Transplantation|Prospective Evaluation of the Efficacy and Safety of Zortress (Everolimus)/Myfortic (Enteric Coated Mycophenolate Sodium) Conversion in High MELD Liver Transplantation|Completed||N/A|6|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:55:22.314242|2017-10-11 01:55:22.314242
NCT01807754|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-04-21|||December 2012||2012-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Simulated Screening Study for Breast Imaging|Simulated Screening Study of Combined Digital X-Ray, Ultrasound and Photoacoustic Breast Imaging|Enrolling by invitation||N/A|160|Anticipated|University of Michigan|||1||f||||t||||||||No||2017-10-11 01:55:22.420826|2017-10-11 01:55:22.420826
NCT01807741|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-07-20|||September 2013||2013-09-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Asenapine for Bipolar Depression|Asenapine for Bipolar Depression|Terminated||Phase 2|51|Actual|University of Cincinnati||2||funding ended due to recruitment delays|f||||t||||||||||2017-10-11 01:55:22.500379|2017-10-11 01:55:22.500379
NCT01807728|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-10-24|||August 2013||2013-08-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Training Programs to Improve Outcomes for Individuals With Spinal Cord Injury|Training Programs to Improve Outcomes for Individuals With Spinal Cord Injury|Recruiting||N/A|680|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:55:22.587476|2017-10-11 01:55:22.587476
NCT01807715|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-07-13|||December 2012||2012-12-01|July 2016|2016-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Understanding Women's Contraceptive Expectations at the Time of a First Trimester Surgical Abortion|Understanding Women's Contraceptive Expectations at the Time of a First Trimester Surgical Abortion|Completed||N/A|202|Actual|University of California, Davis|||1||f||||f||||||||No||2017-10-11 01:55:22.692704|2017-10-11 01:55:22.692704
NCT01807702|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2015-11-30|||March 2013||2013-03-01|November 2015|2015-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|PBT||13C-Pyruvate Breath Test|13C-Pyruvate Breath Test Pilot Study|Completed||Phase 1|5|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 01:55:22.779017|2017-10-11 01:55:22.779017
NCT01807689|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-02-02|||April 2013||2013-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Observational|||Salivary Biomarkers for Sjögren's Syndrome Detection|Salivary Biomarkers for Sjögren's Syndrome Detection - A Multi-Center Study|Active, not recruiting||N/A|420|Anticipated|University of California, Los Angeles|||1||f||||t||||||Samples With DNA|"     Saliva   "|||2017-10-11 01:55:22.859657|2017-10-11 01:55:22.859657
NCT01807676|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-04-25|||March 2013||2013-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Prospective, Randomized Clinical Trial Evaluating the ETView Double-Lumen Tube|Prospective, Randomized Clinical Trial Evaluating the ETView Double-Lumen Tube|Completed||Phase 4|40|Actual|University of Zurich||2|||f||||||||||||||2017-10-11 01:55:22.930515|2017-10-11 01:55:22.930515
NCT01807663|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-09-25|||November 2012||2012-11-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|November 2012|Actual|2012-11-01||Interventional|TELERESP||Validation of a Dynamic Evaluation Tool in Respiratory Failure|Validation of a Dynamic Evaluation Tool in Respiratory Failure by Ambulatory Inductance Plethysmography|Terminated||N/A|10|Actual|Centre d'Investigation Clinique et Technologique 805||3||Healthy volonteers study results show that the device is not enough reliable|f||||f||||||||||2017-10-11 01:55:23.023757|2017-10-11 01:55:23.023757
NCT01807637|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-11-07|||March 2013||2013-03-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Transcranial Direct Current Stimulation for Improving Gait Training in Stroke|Using Transcranial Direct Current Stimulation to Jump Start Gait Training in Chronic Stroke Patients|Recruiting||N/A|88|Anticipated|University of Arkansas||2|||f||||t||||||||||2017-10-11 01:55:23.25703|2017-10-11 01:55:23.25703
NCT01807624|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-07-31|2016-11-02|2015-05-15|March 2013||2013-03-01|July 2017|2017-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)|The Pharmacokinetics Of Tetracaine, Para-Butylaminobenzoic Acid, And Oxymetazoline After Intranasal Administration Of The Highest Phase 3 Dose Of Kovacaine™ Mist To Healthy Volunteers|Completed||Phase 2|24|Actual|St. Renatus, LLC||1|||f||||f||||||||||2017-10-11 01:55:23.358259|2017-10-11 01:55:23.358259
NCT01807611|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-03-24|||May 16, 2013|Actual|2013-05-16|March 2017|2017-03-01|July 31, 2020|Anticipated|2020-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy|Haploidentical Donor Hematopoietic Progenitor Cell and Natural Killer Cell Transplantation With a TLI Based Conditioning Regimen in Patients With Hematologic Malignancies|Recruiting||Phase 2|150|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|t|t|f||||||2017-10-11 01:55:23.728734|2017-10-11 01:55:23.728734
NCT01807598|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-06-27|||September 2013||2013-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia|A Study of Brentuximab Vedotin (SGN-35) in CD30-Positive Systemic Mastocytosis With or Without an Associated Hematological Clonal Non-Mast Cell Lineage Disease (AHNMD)|Recruiting||Phase 2|11|Anticipated|Stanford University||1|||f||||t||||||||No||2017-10-11 01:55:24.122315|2017-10-11 01:55:24.122315
NCT01807585|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2015-04-02|||March 2013||2013-03-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|December 2013|Actual|2013-12-01||Interventional|VeClose||VenaSeal Sapheon Closure System Pivotal Study|Randomized Control Trial Comparing VenaSeal Sapheon Closure System With Radiofrequency Ablation|Unknown status|Active, not recruiting|Phase 2|244|Anticipated|Sapheon, Inc.||2|||f||||t||||||||||2017-10-11 01:55:24.299412|2017-10-11 01:55:24.299412
NCT01807572|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-09-29|||June 2009||2009-06-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Observational|||Relation of Consummatory and Anticipatory Food Reward to Obesity|Relation of Consummatory and Anticipatory Food Reward to Obesity|Completed||N/A|162|Actual|Oregon Research Institute|||1||f||||t||||||Samples With DNA|"     All DNA samples will be stored at the Sequencing and Genomics lab of the University of     Colorado. Only authorized staff will have access to remove the DNA samples for analysis. The     DNA samples will be analyzed in this lab using standard DNA procedures. Data will be kept on     the password protected server for a period of six months. After six months, the data will be     destroyed. The DNA samples will be stored with a unique identification number, connected to a     code list accessed only by our research team. Once the analysis has been completed, the     saliva sample will be destroyed by soaking it in bleach. This will remove all DNA. In     addition, by the end of the study the code list connecting subject numbers with DNA numbers     will be destroyed. No individual samples, analyzed results, or any other individual data will     be shared with other researchers.   "|||2017-10-11 01:55:24.469124|2017-10-11 01:55:24.469124
NCT01807559|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-05-02|||March 2013||2013-03-01|May 2013|2013-05-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||SoundBite Hearing System 24 Month Multi Site Patient Use Study|SoundBite Hearing System 24 Month Multi Site Patient Use Study|Unknown status|Recruiting|N/A|75|Anticipated|Sonitus Medical Inc|||1||f||||f||||||||||2017-10-11 01:55:24.592688|2017-10-11 01:55:24.592688
NCT01807546|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-06-22||2016-04-04|March 2013||2013-03-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|March 2015|Actual|2015-03-01||Interventional|||Oral Rigosertib for Squamous Cell Carcinoma|A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma|Completed||Phase 2|64|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 01:55:24.774599|2017-10-11 01:55:24.774599
NCT01807533|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-04-12|||May 2012||2012-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Family-Centered Intervention Program for Preterm Infants: Effects and Their Biosocial Pathways|A Family-Centered Intervention Program for Preterm Infants: Effects and Their Biosocial Pathways|Active, not recruiting||Phase 2|250|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||Undecided||2017-10-11 01:55:24.965827|2017-10-11 01:55:24.965827
NCT01807520|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-05-05|||June 20, 2013|Actual|2013-06-20|May 2017|2017-05-01|January 3, 2017|Actual|2017-01-03|January 3, 2017|Actual|2017-01-03||Interventional|TRANSFIGURE||Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis|A Randomized, Double-blind, Placebo-controlled, Multicenter, Study to Demonstrate the Efficacy at 16 Weeks of Secukinumab 150 and 300 mg s.c. and to Assess Safety, Tolerability and Longterm Efficacy up to 132 Weeks in Subjects With Moderate to Severe Nail Psoriasis|Completed||Phase 3|198|Actual|Novartis||3|||f||||f|t|f||||||||2017-10-11 01:55:25.173032|2017-10-11 01:55:25.173032
NCT01807507|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-01-30|||October 2011||2011-10-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|January 2012|Actual|2012-01-01||Observational|||Clinical Verification Evaluation of VeinViewer® Device|Clinical Verification Evaluation of VeinViewer® Device|Completed||N/A|400|Actual|Christie Medical Holdings, Inc.|||1||f||||f||||||||||2017-10-11 01:55:25.616127|2017-10-11 01:55:25.616127
NCT01807494|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-10-05|||November 2012||2012-11-01|October 2015|2015-10-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Interventional|||Direct Anterior Versus Posterior Total Hip Arthroplasty Surgical Approaches|Direct Anterior Versus Posterior Total Hip Arthroplasty Surgical Approaches|Active, not recruiting||N/A|60|Anticipated|New Lexington Clinic||2|||f||||f||||||||||2017-10-11 01:55:25.696684|2017-10-11 01:55:25.696684
NCT01807481|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-06-11|||March 2013||2013-03-01|June 2013|2013-06-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01||Interventional|||Phase IV Study to Evaluate the Efficacy and Safety of Mircera in PD|A Prospective,Single-arm,Multicenter Study to Evaluate the Efficacy and Safety of Mircera in Peritoneal Patients Who Already Had Been Treated With ESA|Unknown status|Recruiting|Phase 4|101|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 01:55:25.799775|2017-10-11 01:55:25.799775
NCT01807468|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-10-15|||May 2013||2013-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|||Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors|Haploidentical Stem Cell Transplantation Followed by NK Cell Infusion in Patients With High-risk Solid Tumors Who Failed Autologous Stem Cell Transplantation|Active, not recruiting||Phase 2|12|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 01:55:25.947221|2017-10-11 01:55:25.947221
NCT01807455|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-12-16|2015-11-09||April 2013||2013-04-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine|An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine|Completed||Phase 4|12|Actual|Q-Med AB||1|||f||||f||||||||||2017-10-11 01:55:26.080296|2017-10-11 01:55:26.080296
NCT01807442|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-09-15|||March 2013||2013-03-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|PEACE||Positive Psychology to Improve Cardiac Health Behaviors|Developing a Positive Psychology Intervention to Improve Cardiac Health Behaviors: Qualitative Research Phase|Completed||N/A|30|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:55:26.316567|2017-10-11 01:55:26.316567
NCT01807429|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-03-06|||December 2012||2012-12-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Is Analgesic Effect of Low Dose Ketamine-midazolam the Same as Morphine|Comparing Low Dose IV Ketamine-midazolam Versus IV Morphine Regarding ED Pain Control in Patients Sustaining Closed Limb Fracture(s)|Completed||Phase 2/Phase 3|236|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:55:26.405975|2017-10-11 01:55:26.405975
NCT01807416|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-09-01|||March 2013||2013-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|March 2014|Actual|2014-03-01||Interventional|||Bone Dimensional Changes at Different Implant-to-abutment Connections: a 1-year Clinical and Radiological Study|Bone Dimensional Changes at Different Implant-to-abutment Connections: a 1-year Clinical and Radiological Study|Completed||Phase 4|80|Actual|Proed||4|||f||||f||||||||No||2017-10-11 01:55:26.495906|2017-10-11 01:55:26.495906
NCT01807403|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-05-17|||October 2010||2010-10-01|April 2015|2015-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PRESTOC2||Comparison of DBS Targets in Obsessive-compulsive Disorder|Comparison of the Efficacy of Subthalamic Nucleus, Caudate Nucleus and Nucleus Accumbens Electric Stimulation in Severe and Resistant Obsessive-compulsive Disorder.|Completed||Phase 3|8|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||No||2017-10-11 01:55:26.579305|2017-10-11 01:55:26.579305
NCT01807390|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-06-09|||July 2012||2012-07-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|PROMIS||Perspectives of Receiving Open Versus Minimally Invasive Surgery|Perspectives for Receiving Open Versus MIS (PROMIS) - Patients' Perspectives on Surgical Treatment of Lung and Esophageal Cancer|Recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||Undecided||2017-10-11 01:55:26.67709|2017-10-11 01:55:26.67709
NCT01807377|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-09-16|||April 2013||2013-04-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects|A Phase 1 Placebo-Controlled Study To Assess Safety, Tolerability, Pharmacokinetics And Effect On Midazolam Pharmacokinetics Of Multiple Oral Doses Of PF-05175157 Administered In A Tablet Formulation In Otherwise Healthy Overweight And Obese Subjects|Completed||Phase 1|15|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:55:26.770072|2017-10-11 01:55:26.770072
NCT01807364|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-06-16|||May 2011||2011-05-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|September 2015|Actual|2015-09-01||Observational|cardiohcs||Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia|Evaluation of Cardiovascular Risk Profile in Adult Patients With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency Diagnosed During Childhood|Completed||N/A|170|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     serum   "|No||2017-10-11 01:55:26.880691|2017-10-11 01:55:26.880691
NCT01807351|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-07|||July 2012||2012-07-01|March 2013|2013-03-01||||December 2012|Actual|2012-12-01||Observational|IFG to DM||Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting|Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting|Completed||N/A|10000|Actual|Kowloon Hospital, Hong Kong|||1||f||||t||||||||||2017-10-11 01:55:26.967713|2017-10-11 01:55:26.967713
NCT01807338|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2014-10-08|||August 2011||2011-08-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease|A Follow-up Study on Safety and Tolerability and Pharmacodynamic Effect, of Patients With Idiopathic Parkinson's Disease (PD) of Moderate Severity, Who Have Previously Been Treated With sNN0031, Using an Implanted Catheter and a SynchroMed® II Pump|Completed||N/A|11|Actual|Newron Sweden AB|||1||f||||f||||||||||2017-10-11 01:55:27.037703|2017-10-11 01:55:27.037703
NCT01807325|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-10-14|||December 2012||2012-12-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||RNA Sequencing of Solid and Cystic Lesions of the Pancreas|RNA Sequencing of Solid and Cystic Lesions of the Pancreas|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Oregon Health and Science University|||1||f||||t||||||Samples With DNA|"     pancreas biopsies   "|||2017-10-11 01:55:27.105162|2017-10-11 01:55:27.105162
NCT01807299|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2013-03-07|||May 2011||2011-05-01|March 2013|2013-03-01|May 2015|Anticipated|2015-05-01|March 2013|Actual|2013-03-01||Interventional|AOE||The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children|The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit|Unknown status|Recruiting|Phase 3|68|Anticipated|Federal University of São Paulo||4|||f||||t||||||||||2017-10-11 01:55:27.273015|2017-10-11 01:55:27.273015
NCT01807286|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-05-11|||January 2014||2014-01-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis|A Phase I/II Clinical Trial of Pomalidomide With Melphalan and Dexamethasone in Patients With Newly Diagnosed Untreated Systemic AL Amyloidosis: Trial Stopped During Phase I|Terminated||Phase 1|3|Actual|M.D. Anderson Cancer Center||1||Sponsor requested termination|f||||f||||||||||2017-10-11 01:55:27.403266|2017-10-11 01:55:27.403266
NCT01807273|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-02-03|||March 2013||2013-03-01|January 2014|2014-01-01|November 2014|Actual|2014-11-01|March 2013|Actual|2013-03-01||Observational|TUG||Time Up and go in Hemiplegic Patients|Quantification of Biomechanical Parameters of Functional Task Time Up and Go in Hemiplegic Patients|Completed||N/A|60|Actual|Centre d'Investigation Clinique et Technologique 805|||1||f||||f||||||||||2017-10-11 01:55:27.512173|2017-10-11 01:55:27.512173
NCT01807260|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-06|||March 2008||2008-03-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Stepwise Shock Wave Lithotripsy in Pediatric Urolithiasis|STEPWISE SHOCK WAVE LITHOTRIPSY IN PEDIATRIC UROLITHIASIS: A COMPARATIVE STUDY.|Completed||N/A|81|Actual|TC Erciyes University||2|||f||||f||||||||||2017-10-11 01:55:27.603269|2017-10-11 01:55:27.603269
NCT01807247|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2015-02-03|||February 2013||2013-02-01|March 2013|2013-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Short Effects of a Rehabilitation Session on Gait in Patients With CNS|Evaluation of the Short Effects of a Rehabilitation Session on Gait Parameters in Patients With a Lesion of the Central Nervous System|Completed||N/A|60|Actual|Centre d'Investigation Clinique et Technologique 805|||3||f||||f||||||||||2017-10-11 01:55:27.691418|2017-10-11 01:55:27.691418
NCT01807234|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-03-10|2016-01-27||February 2013||2013-02-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|KSPN|Of the 72 randomized participants, 54 (75%) treated at least one attack and 49 (68%) completed all three treatments, for a total of 152 treated migraine attacks.|Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine|Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine (The KSPN Migraine Study)|Completed||Phase 4|72|Actual|Johns Hopkins University|Small study size (n=54)|3|||f||||f||||||||Undecided||2017-10-11 01:55:27.78661|2017-10-11 01:55:27.78661
NCT01807221|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-07|2016-10-14||2015-06-04|June 2013||2013-06-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|ARTS-HF||Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone|A Randomized, Double-blind, Double-dummy, Multi-center Study to Assess Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Emergency Presentation at the Hospital Because of Worsening Chronic Heart Failure With Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone Versus Eplerenone|Completed||Phase 2|1058|Actual|Bayer||6|||f||||t||||||||||2017-10-11 01:55:28.601271|2017-10-11 01:55:28.601271
NCT01807208|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-05-24|||March 2013||2013-03-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||PLATFORM to Maximize Patient Knowledge of Health Goals After Acute Myocardial Infarction|PLATFORM to Maximize Patient Knowledge of Health Goals After Acute Myocardial Infarction|Completed||N/A|192|Actual|Duke University||2|||f||||f||||||||No||2017-10-11 01:55:29.447173|2017-10-11 01:55:29.447173
NCT01807195|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-06-05|||February 2013||2013-02-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Acute Renal Injury Associated Contrast in Intensive Care Unit Patients||Completed||N/A|886|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 01:55:29.552916|2017-10-11 01:55:29.552916
NCT01807182|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-01-19|||July 26, 2013|Actual|2013-07-26|January 2017|2017-01-01||||October 2017|Anticipated|2017-10-01||Interventional|||Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma|Cellular Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes Following Lymphodepletion With Cyclophosphamide and Fludarabine for Patients With Metastatic Melanoma|Recruiting||Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 01:55:29.657148|2017-10-11 01:55:29.657148
NCT01807169|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-08-31|||May 2013||2013-05-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|MEDOC||Recto Colonic Endoscopic Mucosal Resection and Polypectomy Under Clopidogrel|"Recto Colonic Endoscopic Mucosal Resection and Polypectomy Under Clopidogrel: the MEDOCStudy."|Unknown status|Recruiting|Phase 4|300|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||t||||||||||2017-10-11 01:55:29.877223|2017-10-11 01:55:29.877223
NCT01807156|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-03-22|2016-02-19||March 2013||2013-03-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer|Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer|Terminated||Phase 2|7|Actual|Emory University||1||Primary endpoint not met|f||||t||||||||||2017-10-11 01:55:30.050446|2017-10-11 01:55:30.050446
NCT01807143|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-03-04|||January 2010||2010-01-01|March 2016|2016-03-01||||December 2012|Actual|2012-12-01||Observational|||Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma|Observational - Gene Discovery in Osteosarcoma|Completed||N/A|10|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     tissue   "|||2017-10-11 01:55:30.350819|2017-10-11 01:55:30.350819
NCT01807130|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-12-09|||September 2013||2013-09-01|August 2014|2014-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|AMERICA-HF||Automated MEdical Record Driven Implantable CArdioverter-defibrillator Heart Failure Trial (AMERICA-HF)|Automated MEdical Record Driven Implantable CArdioverter-defibrillator Heart Failure Trial (AMERICA-HF)|Terminated||N/A|77|Actual|Duke University||2||"We observed a very high referral rate for patients with HF in the Duke Health System,   eliminating the need for an automated referral process."|f||||t||||||||||2017-10-11 01:55:30.470853|2017-10-11 01:55:30.470853
NCT01807117|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-11-25|||April 2013||2013-04-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||PET-MRI in Diagnosing Patients With Colon or Rectal Cancer|Evaluation of PET-MRI in Initial Staging of High Grade Rectal Cancer Patients and in the Follow up of Colorectal Cancer Patients.|Completed||N/A|15|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:55:30.590664|2017-10-11 01:55:30.590664
NCT01807104|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-01-30|||January 2010||2010-01-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Total Hip Arthroplasty (THA) Surgical Techniques Comparing the Direct Anterior Approach to the Posterior Approach|Prospective Randomized Single Center Clinical Evaluation of THA Surgical Techniques Comparing the Direct Anterior Approach to the Posterior Approach|Active, not recruiting||N/A|88|Anticipated|Barrett, William, M.D.||2|||f||||f||||||||||2017-10-11 01:55:30.733254|2017-10-11 01:55:30.733254
NCT01807091|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-07-03|||May 21, 2013|Actual|2013-05-21|July 2017|2017-07-01||||April 1, 2018|Anticipated|2018-04-01||Interventional|||Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome|Feasibility of Outpatient Induction Chemotherapy for Adult Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome|Recruiting||N/A|25|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 01:55:30.856256|2017-10-11 01:55:30.856256
NCT01807078|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|CHOLESS||Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients|Randomized Comparison of the CHOlesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant patientS - The CHOLESS Trial|Not yet recruiting||Phase 4|200|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 01:55:31.032546|2017-10-11 01:55:31.032546
NCT01807065|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-07-27|||June 7, 2013|Actual|2013-06-07|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer|Randomized Phase II Trial of Sipuleucel T Immunotherapy Preceded by Sensitizing Radiation Therapy and Sipuleucel-T Alone in Patients With Castrate Resistant Metastatic Prostate Cancer|Active, not recruiting||Phase 2|50|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 01:55:31.15253|2017-10-11 01:55:31.15253
NCT01807052|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-05-17|||November 2009||2009-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas|Observational - Tissue Factor Expression in Bone Sarcomas|Completed||N/A|34|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 01:55:31.269506|2017-10-11 01:55:31.269506
NCT01807039|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-07-22|||December 2012||2012-12-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|HipMo||Mortality Following Surgery for Proximal Femoral Fractures|Mortality Following Surgery for Proximal Femoral Fractures|Completed||N/A|369|Actual|Brno University Hospital|||1||f||||f||||||||||2017-10-11 01:55:31.374182|2017-10-11 01:55:31.374182
NCT01807026|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-05-31|||March 2013||2013-03-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease|A Safety, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects and Patients Diagnosed With Alzheimer's Disease|Completed||Phase 1|36|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 01:55:31.49509|2017-10-11 01:55:31.49509
NCT01807013|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-01-20|||February 2011||2011-02-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|August 2014|Actual|2014-08-01||Observational|||Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.|Prospective Study to Evaluate the Diagnostic Value of B-mode Ultrasound, Elastometry and Minilaparoscopic Guided Liver Biopsy for the Diagnosis of Compensated Liver Cirrhosis.|Recruiting||N/A|200|Anticipated|University Hospital Erlangen|||1||f||||f||||||||||2017-10-11 01:55:31.641089|2017-10-11 01:55:31.641089
NCT01807000|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-08-22|2014-08-22||March 2013||2013-03-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers|A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C] Prucalopride Succinate Following a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|6|Actual|Shire||1|||f||||f||||||||||2017-10-11 01:55:31.762887|2017-10-11 01:55:31.762887
NCT01806987|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-09-18|||March 2013||2013-03-01|September 2017|2017-09-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|KITS-PN||A Test of the Kids in Transition to School (KITS) Program in Disadvantaged Neighborhoods|A Randomized Efficacy Trial of the Kids in Transition to School (KITS) Program to Improve School Readiness of Children in Disadvantaged Communities|Completed||N/A|265|Actual|Oregon Social Learning Center||2|||f||||f||||||||||2017-10-11 01:55:32.150287|2017-10-11 01:55:32.150287
NCT01806974|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-11-02|||December 2012||2012-12-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ParoPAR||Consequences of Anti-interleukin 6 Immunotherapy Treatment for Rheumatoid Arthritis on Periodontium|Multicenter, Prospective Study, on the Consequences of Anti-interleukin 6 Immunotherapy Treatment for Rheumatoid Arthritis on: - Healthy and Pathological Periodontium - The Level of Expression of Some Markers of Inflammation and Periodontal Pathogenic Bacteria in Periodontal Sulci and Periodontal Pockets|Terminated||Phase 4|16|Actual|Nantes University Hospital||2||"as the recruitment rate was very low, a futility study was conducted and it was decided to   discontinue inclusions"|f||||f||||||||||2017-10-11 01:55:32.278091|2017-10-11 01:55:32.278091
NCT01806961|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-06-21|2015-12-14||January 2013||2013-01-01|May 2016|2016-05-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Observational|||Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.|Observational (Non-interventional), Follow-up Trial Assessing Long-term Local Tolerability and Efficacy (Recurrence Rate) of Resiquimod Gel in Patients Treated for Actinic Keratosis.|Terminated||N/A|16|Actual|Spirig Pharma Ltd.|No efficacy analysis was carried out since due to premature study termination (upon Sponsor's decision) no data was available for analysis||1|sponsor decision|f||||f||||||||||2017-10-11 01:55:32.382171|2017-10-11 01:55:32.382171
NCT01806948|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-03-19|||April 2013||2013-04-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy Study of Antiemetics to Reduce Postoperative Nausea and Vomiting||Completed||Phase 2|96|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:55:32.765459|2017-10-11 01:55:32.765459
NCT01806922|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2014-02-09|||March 2013||2013-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Yoga Exercise for Improving Balance in Patients With Subacute &Ｃhronic Stroke|Yoga Exercise for Improving Balance in Patients With Subacute &Ｃhronic Stroke : A Pilot Study|Completed||N/A|40|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 01:55:32.997277|2017-10-11 01:55:32.997277
NCT01806909|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-07-13|||February 7, 2013||2013-02-07|July 12, 2017|2017-07-12|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Intranasal AD4-H5-VTN as an Adenovirus Vaccine|Phase 1 Study of Safety and Immunogenicity of Intranasal Ad4-H5-VTN in Ad4 Seronegative and Seropositive Volunteers|Active, not recruiting||Phase 1|46|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:55:33.099705|2017-10-11 01:55:33.099705
NCT01806883|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-11-02|||January 2013||2013-01-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|WII||"Evaluation of the Effects of Rehabilitation Using the Wii on Upper Limb Kinematics in Chronic Stroke Patients."|"Evaluation of the Effects of Rehabilitation Using the Wii on Upper Limb Kinematics in Chronic Stroke Patients."|Recruiting||N/A|70|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:55:33.306573|2017-10-11 01:55:33.306573
NCT01806870|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2017-09-05|||March 2013||2013-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|IMMUNE||Immune Enhancement for Immunological Non-responders to ART|Immune Enhancement for Immunological Non-responders to ART|Active, not recruiting||N/A|60|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 01:55:33.41583|2017-10-11 01:55:33.41583
NCT01806857|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-02-03|2016-08-09||April 2013||2013-04-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||All patients who signed a consent form and had a baseline visit.|Clinical Trial Nuedexta in Subjects With ALS|The Experimental Treatment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|90|Actual|Center for Neurologic Study, La Jolla, California,||2|||f||||f||||||||Undecided||2017-10-11 01:55:33.521807|2017-10-11 01:55:33.521807
NCT01806844|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2016-04-19|||May 2013||2013-05-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Prehospital Cerebral Oxygenation During Cardiopulmonary Resuscitation (CPR)|Cerebral Oxygenation During Resuscitation and Post-resuscitation Phase|Completed||N/A|200|Actual|Hasselt University|||1||f||||f||||||||||2017-10-11 01:55:34.142764|2017-10-11 01:55:34.142764
NCT01806831|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2015-03-10|||September 2012||2012-09-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||"Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent (Biocellulose Mask, Farhorm®) in Patients Receiving Laser Treatment"|"Efficacy and Safety of Biocellulose Sheet From Coconut Juice Containing Anti-hyperpigmentation Agent (Biocellulose Mask, Farhorm®) in Patients Receiving Laser Treatment"|Completed||N/A|30|Actual|Chulalongkorn University||1|||f||||t||||||||||2017-10-11 01:55:34.220962|2017-10-11 01:55:34.220962
NCT01806818|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-08-22|||February 2013||2013-02-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients|A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled, Multi-center Study to Compare Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients|Completed||Phase 2|98|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 01:55:34.300309|2017-10-11 01:55:34.300309
NCT01806805|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-04-23|||February 2012||2012-02-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|EpsilonZêta||Efficacy Trial of Zonisamide for Myoclonus Dystonia|Comparative Study of the Efficiency of Zonisamide in Myoclonus Dystonia: A Monocentric , Randomized in Cross Over and Double Blind Study Versus Placebo Study|Completed||Phase 3|24|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:55:34.408997|2017-10-11 01:55:34.408997
NCT01806792|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-03-06|||November 2009||2009-11-01|March 2013|2013-03-01|March 2011|Actual|2011-03-01|August 2010|Actual|2010-08-01||Interventional|||Post-menopausal Women Osteoporosis(Phase III)|For 4 Months, the Multi Center, Double Blinded, Randomized, Active Controlled, Comparative Clinical Study to Assess the Efficacy and the Safety to Improvement Effect of Vit.D of Risenex Plus M Tablet in Patients With In Post-menopausal Women Osteoporosis|Completed||Phase 3|150|Actual|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:55:34.500257|2017-10-11 01:55:34.500257
NCT01806779|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2015-12-14|2015-09-03||March 2013||2013-03-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|ConNic5||Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers|Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers|Completed||Phase 2|376|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:55:34.613042|2017-10-11 01:55:34.613042
NCT01806766|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-03-06|||January 1998||1998-01-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|January 2000|Actual|2000-01-01||Interventional|||Comparison of Ceramic-on-Ceramic and Ceramic-on-Highly-Cross-Linked Polyethylene Bearings|Comparison of Ceramic-on-Ceramic and Ceramic-on-Highly-Cross-Linked Polyethylene Bearings in Primary Cementless Total Hip Arthroplasty in the Same Patients|Completed||Phase 4|100|Actual|Ewha Womans University||2|||f||||f||||||||||2017-10-11 01:55:37.111406|2017-10-11 01:55:37.111406
NCT01806753|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-01-28|||March 2013||2013-03-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Performance of Endoscopic Submucosal Dissection According to the Sedation Method||Completed||N/A|157|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 01:55:37.204776|2017-10-11 01:55:37.204776
NCT01806740|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-02-23|||March 2013||2013-03-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|May 2016|Actual|2016-05-01||Interventional|DCE-MRI||DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC|Phase IV Study of DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC|Active, not recruiting||Phase 4|37|Actual|Guerbet||1|||f||||f||||||||Undecided|It will be decided after study completion.|2017-10-11 01:55:37.291701|2017-10-11 01:55:37.291701
NCT01806714|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-06-05|2015-12-30||July 2013||2013-07-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TRIO||Text Reminders to Immunize in a Managed Care Organization|Text Reminders to Immunize in a Managed Care Organization|Completed||N/A|3812|Actual|University of Rochester||2|||f||||f||||||||Undecided||2017-10-11 01:55:37.523928|2017-10-11 01:55:37.523928
NCT01806701|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2016-10-12|||April 2013||2013-04-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Brain Response to Treatment for Pediatric PTSD|Biomarkers of Clinical Response to Cognitive Treatment of PTSD in Youth|Completed||N/A|68|Actual|Stanford University||1|||f||||t||||||||No||2017-10-11 01:55:38.106801|2017-10-11 01:55:38.106801
NCT01806688|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-10-02|||June 2013||2013-06-01|October 2017|2017-10-01|November 2017|Anticipated|2017-11-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Snacks on Appetite Control|A Randomized, Controlled, Cross-over Study of the Effect of Snacks on Appetite Control|Active, not recruiting||N/A|38|Anticipated|St. Boniface General Hospital Research Centre||6|||f||||f||||||||||2017-10-11 01:55:38.23578|2017-10-11 01:55:38.23578
NCT01806675|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-03-12|||March 2013||2013-03-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy|Phase I/II 18F FPPRGD2 PET/CT or PET/MRI Imaging of αvβ3 Integrins Expression as a Biomarker of Angiogenesis|Recruiting||Phase 1/Phase 2|150|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 01:55:38.407391|2017-10-11 01:55:38.407391
NCT01806649|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-10-19|||January 2013||2013-01-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapy|A Phase II Study of BKM120; a Pan-PI3K Inhibitor in Patients With Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapy|Unknown status|Recruiting|Phase 2|41|Anticipated|Prince of Songkla University||1|||f||||t||||||||||2017-10-11 01:55:38.786192|2017-10-11 01:55:38.786192
NCT01806636|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2016-04-19|||May 2013||2013-05-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01|5 Years|Observational [Patient Registry]|||Post Market Observational, Prospective, Multi-center Study|Post Market Observational, Prospective, Multi-center Registry Using the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) System|Recruiting||N/A|1000|Anticipated|PneumRx, Inc.|||1||f||||f||||||||||2017-10-11 01:55:38.944184|2017-10-11 01:55:38.944184
NCT01806623|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-03-02|2014-08-14||March 5, 2013|Actual|2013-03-05|March 2017|2017-03-01|November 22, 2013|Actual|2013-11-22|November 22, 2013|Actual|2013-11-22||Interventional|||The Study Of Fluconazole For Vulvovaginal Candidiasis|A Multicenter Open-label Non-comparative Study Of Fluconazole For The Treatment Of Vulvovaginal Candidiasis.|Completed||Phase 3|157|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:55:39.217437|2017-10-11 01:55:39.217437
NCT01806610|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-03|2013-10-30|||August 2013||2013-08-01|October 2013|2013-10-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease|A Randomized, Placebo-controlled Trial of BPS804 on Safety and Tolerability in Patients With Late-stage Chronic Kidney Disease|Withdrawn||Phase 2|0|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:55:39.708056|2017-10-11 01:55:39.708056
NCT01806597|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-02-28|||June 19, 2013|Actual|2013-06-19|February 2017|2017-02-01|November 2, 2016|Actual|2016-11-02|November 2, 2016|Actual|2016-11-02||Interventional|GESTURE||Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Demonstrate the Efficacy at 16 Weeks of Secukinumab 150 and 300 mg s.c. and to Assess Safety, Tolerability and Long-term Efficacy up to 132 Weeks in Subjects With Moderate to Severe Palmoplantar Psoriasis|Completed||Phase 3|205|Actual|Novartis||3|||f||||f||||||||||2017-10-11 01:55:39.817712|2017-10-11 01:55:39.817712
NCT01806584|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2015-11-25|2015-10-16||March 2013||2013-03-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||The Intent-to-Treat population, defined as all randomly assigned participants regardless of the treatment received or having post-baseline outcome data.|An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis Access|A Phase 2, Single-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy and Safety of SRM003 (Vascugel®) in the Treatment of Subjects With Vascular Injury Resulting From Arteriovenous Graft Surgery for Hemodialysis Access|Terminated||Phase 2|32|Actual|Shire|Study was discontinued early due to Sponsor decision.|2||Development of SRM003 was discontinued based on portfolio prioritization.|f||||t||||||||||2017-10-11 01:55:40.23255|2017-10-11 01:55:40.23255
NCT01806571|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-03-21|||March 12, 2015|Actual|2015-03-12|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase II Study of Combination Daunorubicin and Cytarabine (Ara-c) and Nilotinib (Tasigna) (DATA) in Patients Newly Diagnosed With Acute Myeloid Leukemia and KIT Overexpression|Recruiting||Phase 2|43|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 01:55:41.220542|2017-10-11 01:55:41.220542
NCT01806558|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-08-28|||September 2012|Actual|2012-09-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|May 31, 2017|Actual|2017-05-31||Interventional|MBI/US||Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions|Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions|Completed||N/A|12|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 01:55:41.389237|2017-10-11 01:55:41.389237
NCT01806545|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2015-11-20|2015-10-16||March 2013||2013-03-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||The Intent -to-Treat (ITT) population, defined as all randomly assigned participants regardless of receiving treatments or having post-baseline outcome data.|An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access|A Phase 2, Single-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy and Safety of SRM003 (Vascugel®) in Improving the Rate of Arteriovenous Fistula Maturation and Use in Subjects Undergoing Surgery for Creation of an Arteriovenous Fistula for Hemodialysis Access|Completed||Phase 2|64|Actual|Shire||2|||f||||t||||||||||2017-10-11 01:55:41.512592|2017-10-11 01:55:41.512592
NCT01806532|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-03-28|||January 2008||2008-01-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Observational|||Regional Lung Inflammation and Expansion in Mechanically Ventilated Patients - a PET/CT Study|Regional Lung Inflammation and Expansion in Mechanically Ventilated Patients - a PET/CT Study|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples Without DNA|"     Blood samples will be drawn and plasma stored for future potential biomarker studies.   "|||2017-10-11 01:55:42.501679|2017-10-11 01:55:42.501679
NCT01806519|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-03-06|||September 2009||2009-09-01|March 2013|2013-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Motor_Control_Neck_SSED|A Motor Control Intervention of Patients With Forward Head Posture and Persistent Neck Pain - A Single System Experimental Design With 12 Month Follow-up|Completed||N/A|3|Actual|Luleå Tekniska Universitet||1|||f||||f||||||||||2017-10-11 01:55:42.579377|2017-10-11 01:55:42.579377
NCT01806506|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-03-06|||November 2008||2008-11-01|January 2013|2013-01-01||||March 2012|Actual|2012-03-01||Interventional|||Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity|Randomized Clinical Trial Comparing Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity and Underlying Metabolic and Hormonal Abnormalities|Unknown status|Active, not recruiting|N/A|72|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 01:55:42.657038|2017-10-11 01:55:42.657038
NCT01806493|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-06|||March 2011||2011-03-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Fat Mass Estimation in Overweight and Obesity|Body Composition Evaluation in Overweight and Obesity|Completed||N/A|103|Actual|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 01:55:42.790154|2017-10-11 01:55:42.790154
NCT01806480|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-01-13|||March 2013||2013-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effectiveness of Proactive Telephone Support Provided to Breastfeeding Mothers of Preterm Infants|The Effectiveness of Proactive Telephone Support Provided to Breastfeeding Mothers of Preterm Infants - a Randomized Controlled Trial|Completed||N/A|493|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 01:55:42.87121|2017-10-11 01:55:42.87121
NCT01806467|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-03-06|||August 2011||2011-08-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Observational|||Validation of a New Method to Measure Cardiac Output: Comparison With Thermodilution|Continuous Thermodilution, Transpulmonary Thermodilution and Pressure Recording Analytical Method for Cardiac Output Measurement During Hemodynamic Instability: a Prospective Clinical Study|Completed||N/A|36|Actual|Università Politecnica delle Marche|||2||f||||f||||||||||2017-10-11 01:55:43.009777|2017-10-11 01:55:43.009777
NCT01806454|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-08-24|||October 2013||2013-10-01|April 2014|2014-04-01||||November 2015|Anticipated|2015-11-01||Interventional|||Calcium Supplementation to Prevent Preeclampsia in Sichuan Province of China|Calcium Supplementation to Prevent Preeclampsia in Sichuan Province of China: a Multi-center, Prospective Random Trial|Unknown status|Recruiting|N/A|11000|Anticipated|West China Second University Hospital||2|||f||||||||||||||2017-10-11 01:55:43.098647|2017-10-11 01:55:43.098647
NCT01806441|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-03-05|||February 2009||2009-02-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|May 2009|Actual|2009-05-01||Interventional|DGENES||Impact of a Short-Term High Fat or Low Fat Diet on Intestinal Genes Expression Involved in the Cholesterol and Fatty Acid Metabolism|Impact of a Short-Term High Fat Diet Versus A Short-Term Low Fat Diet on Expression of the Key Intestinal Genes Involved in the Cholesterol and Fatty Acid Metabolism Pathways|Completed||N/A|12|Actual|Laval University||2|||f||||f||||||||||2017-10-11 01:55:43.195028|2017-10-11 01:55:43.195028
NCT01806428|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-06|2013-10-20|||July 2009||2009-07-01|October 2013|2013-10-01|August 2011|Actual|2011-08-01|December 2010|Actual|2010-12-01||Observational|||Activated Protein C and Microcirculation|THE Activated Protein C (aPC) TREATMENT IMPROVES MICROCIRCULATION IN SEVERE SEPSIS/ SEPTIC SHOCK SYNDROME|Completed||N/A|22|Actual|Università Politecnica delle Marche|||2||f||||f||||||||||2017-10-11 01:55:43.275915|2017-10-11 01:55:43.275915
NCT01806415|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-02|2015-12-07|||May 2013||2013-05-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers|A Double Blind, Randomized, Single Dose, Placebo Controlled Study of the Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers|Completed||Phase 1|32|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-10-11 01:55:43.357958|2017-10-11 01:55:43.357958
NCT01806402|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-01-20|||February 2013||2013-02-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Evaluation of OCT Measurements|Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients|Completed||N/A|135|Actual|Optovue|||2||f||||f||||||||||2017-10-11 01:55:43.449328|2017-10-11 01:55:43.449328
NCT01806389|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-05-24|2016-11-14||February 2013||2013-02-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||A Study of Breastfeeding in Buprenorphine Maintained Women|Lactation Among Buprenorphine Maintained Women: A Pilot Study|Completed||N/A|10|Actual|Johns Hopkins University|Small group size Variable amounts of breast milk received by the majority of the sample Reports of exclusive breastfeeding vs formula supplementation were by maternal report||1||f||||f||||||Samples Without DNA|"     Maternal urine, plasma and breast milk INnfant plasma   "|No||2017-10-11 01:55:43.528202|2017-10-11 01:55:43.528202
NCT01806376|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-07|||March 2013||2013-03-01|March 2013|2013-03-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics|A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics|Unknown status|Recruiting|Phase 1|20|Anticipated|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||1|||f||||t||||||||||2017-10-11 01:55:43.855578|2017-10-11 01:55:43.855578
NCT01806363|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-02-24|||November 2012||2012-11-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone|A Phase I Clinical Trial to Evaluate the Pharmacokinetic Interactions and Safety Between Telmisartan and Chlorthalidone in Healthy Male Volunteers.|Completed||Phase 1|60|Anticipated|HanAll BioPharma Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:55:43.952461|2017-10-11 01:55:43.952461
NCT01806350|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-03-06|||November 2009||2009-11-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors|A Pilot Randomized Control Trial to Evaluate Pelvic Floor Muscle Training for Urinary Incontinence Among Gynecologic Cancer Survivors|Completed||N/A|40|Actual|New Mexico Cancer Care Alliance||2|||f||||t||||||||||2017-10-11 01:55:44.077608|2017-10-11 01:55:44.077608
NCT01806337|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-03-06|||July 2003||2003-07-01|March 2013|2013-03-01|February 2011|Actual|2011-02-01|July 2006|Actual|2006-07-01||Interventional|||CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma|Prospective Phase II Study for Treatment Peripheral T-cell Lymphoma, CHOP-14 Plus PEG-Filgrastim Followed by Alemtuzumab Consolidation|Completed||Phase 2|41|Actual|University of Göttingen||1|||f||||t||||||||||2017-10-11 01:55:44.220112|2017-10-11 01:55:44.220112
NCT01806324|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-03-05|||April 2012||2012-04-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects||Completed||Phase 1|30|Actual|HanAll BioPharma Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:55:44.318906|2017-10-11 01:55:44.318906
NCT01806311|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-02-24|||December 2012||2012-12-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg|An Open-label, Multiple-dose, Two-arm, One-sequence, Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of amlodipine10mg and candesartan32mg in Healthy Male Volunteers|Completed||Phase 1|34|Anticipated|HanAll BioPharma Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:55:44.442684|2017-10-11 01:55:44.442684
NCT01806298|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-02-15|2017-02-15||June 2013||2013-06-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||The safety analysis set included all treated subjects who had received at least 1 administration of Saizen®.|An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)|Open-label, Single-arm, Phase IV, Multicenter Trial to Explore the Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)|Completed||Phase 4|78|Actual|Merck KGaA||1|||f||||||||||||||2017-10-11 01:55:44.587354|2017-10-11 01:55:44.587354
NCT01806285|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-12-23|||February 2013||2013-02-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|May 2014|Actual|2014-05-01||Observational|||Sample Collection to Evaluate an Investigational Instrument for the Detection of Respiratory Viruses in Nasopharyngeal Swabs||Completed||N/A|205|Actual|GenMark Diagnostics|||1||f||||f||||||Samples With DNA|"     Nasopharyngeal swabs   "|||2017-10-11 01:55:45.259028|2017-10-11 01:55:45.259028
NCT01806272|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-03-27|||March 2013||2013-03-01|March 2013|2013-03-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis|A Open,Randomized Phase II Trial Comparing Local Use of rhGM-CSF and Compound Vitamin B12 Solution to Compound Vitamin B12 Solution Alone Treating Chemoradiotherapy-induced Oral Mucositis in Patients With Primary Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2|160|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:55:45.322769|2017-10-11 01:55:45.322769
NCT01806259|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-03-23|||February 2013||2013-02-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|October 2015|Actual|2015-10-01||Interventional|KBCt||Ketorolac in Breast Cancer Surgery|Perioperative Ketorolac in High Risk Breast Cancer Patients With and Without Inflammation. A Prospective Randomized Placebo-controlled Trial.|Active, not recruiting||Phase 3|200|Anticipated|Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 01:55:45.432685|2017-10-11 01:55:45.432685
NCT01806246|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-10-22|||February 2013||2013-02-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Rehabilitation Program for Adolescents With Chronic Fatigue Syndrome|An Integrative Approach Based Psychoeducation, Heart Rate Variability Coherence Biofeedback and Elements of, Pacing Cognitive Behavior Therapy|Completed||N/A|13|Actual|St. Olavs Hospital||1|||f||||f||||||||||2017-10-11 01:55:45.535003|2017-10-11 01:55:45.535003
NCT01806233|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-01-29|||March 2013||2013-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LAMTS||Lu's Acupuncture and Moxibustion Treatment on Stroke|Lu' Acupuncture and Moxibustion Treatment on Ischemic Stroke|Recruiting||N/A|120|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||No||2017-10-11 01:55:45.650201|2017-10-11 01:55:45.650201
NCT01806220|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-03-18|||January 2004||2004-01-01|March 2015|2015-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|EGFR||Laryngeal and Esophageal EGF-r Expression in Patients With Reflux Laryngitis|Laryngeal and Esophageal EGF-r Expression in Patients With Reflux Laryngitis|Completed||N/A|24|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||t||||||||||2017-10-11 01:55:45.774736|2017-10-11 01:55:45.774736
NCT01806207|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-03-06|||February 2003||2003-02-01|March 2013|2013-03-01||||April 2004|Actual|2004-04-01||Interventional|||Durolane Compared to Saline in Patients With Unilateral Knee Osteoarthritis|A Double-blind, Randomized, Multi-centre Study of the Efficacy and Safety of a Single Intra-articular Injection With Durolane Compared to Saline in Patients With Unilateral Knee Osteoarthritis|Completed||Phase 4|218|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-11 01:55:45.893822|2017-10-11 01:55:45.893822
NCT01806194|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-01-19|||January 2012||2012-01-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|EMPOWER||Empowering Rural African American Women and Communities to Improve Diabetes Outcomes|Empowering Rural African American Women and Communities to Improve Diabetes Outcomes|Completed||N/A|200|Actual|East Carolina University||2|||f||||f||||||||||2017-10-11 01:55:45.988495|2017-10-11 01:55:45.988495
NCT01806181|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-04-20|||August 6, 2013|Actual|2013-08-06|April 2017|2017-04-01|December 3, 2016|Actual|2016-12-03|January 13, 2016|Actual|2016-01-13||Interventional|NExT||NEXT (Nutrition and EXercise During Adjuvant Treatment) Study|Nutrition and Exercise During Adjuvant Treatment (NEXT) Study Implementation of a Physician-referred Exercise and Healthy Eating Intervention as Supportive Care in Breast Cancer Survivors|Completed||N/A|73|Actual|University of British Columbia||1|||f||||t||||||||||2017-10-11 01:55:46.104895|2017-10-11 01:55:46.104895
NCT01806168|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-05-19|||September 2013|Actual|2013-09-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||rTMS in the Treatment of PTSD|The Role of Fast or Slow Repetitive Transcranial Magnetic Stimulation as Adjunct Therapy in Civilian Post-Traumatic Stress Disorder|Recruiting||N/A|27|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-10-11 01:55:46.405364|2017-10-11 01:55:46.405364
NCT01806155|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-03|2013-08-16|||March 2013||2013-03-01|August 2013|2013-08-01|October 2014|Anticipated|2014-10-01|March 2014|Anticipated|2014-03-01||Observational|||Prevalence of Post-craniotomy Headache in Siriraj Hospital|Prevalence of Post-craniotomy Headache in Siriraj Hospital|Unknown status|Recruiting|N/A|200|Anticipated|Mahidol University|||1||f||||f||||||||||2017-10-11 01:55:46.563049|2017-10-11 01:55:46.563049
NCT01806142|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-03-06|||February 2011||2011-02-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|April 2012|Actual|2012-04-01||Interventional|MCT||Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome|Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome|Completed||N/A|28|Actual|Laval University||2|||f||||f||||||||||2017-10-11 01:55:46.669965|2017-10-11 01:55:46.669965
NCT01806129|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-10-19|||September 2015||2015-09-01|October 2016|2016-10-01||||November 2026|Anticipated|2026-11-01||Interventional|||Reproductive Health Program in Patients With Cancer|EROS: Engendering Reproductive Health Within Oncologic Survivorship|Recruiting||N/A|612|Anticipated|Eastern Cooperative Oncology Group||2|||f||||||||||||||2017-10-11 01:55:46.785573|2017-10-11 01:55:46.785573
NCT01806116|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-03-11|||September 2009||2009-09-01|March 2013|2013-03-01|May 2014|Anticipated|2014-05-01|March 2013|Anticipated|2013-03-01||Interventional|DFMBHSCT||Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation|Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|The First Affiliated Hospital of Soochow University||1|||f||||||||||||||2017-10-11 01:55:46.909154|2017-10-11 01:55:46.909154
NCT01806103|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-03-05|||June 2010||2010-06-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|June 2011|Actual|2011-06-01||Interventional|PARTI||Antimicrobial Stewardship for Primary Care Pediatricians|Reducing Inappropriate Prescribing of Antibiotics by Primary Care Clinicians|Completed||N/A|170|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 01:55:47.019875|2017-10-11 01:55:47.019875
NCT01806090|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-04-20|||February 2012||2012-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy Bleeding|Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy Bleeding|Recruiting||Phase 4|216|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:55:47.161055|2017-10-11 01:55:47.161055
NCT01806077|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-04-20|||April 2013||2013-04-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors|Demonstration of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Antiplatelet Effect of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors|Completed||Phase 1|32|Actual|Tufts Medical Center||1|||f||||t||||||||||2017-10-11 01:55:47.293951|2017-10-11 01:55:47.293951
NCT01806064|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-10-04|||March 2013||2013-03-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients With Advanced or Metastatic Renal Cell Carcinoma|A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone (Including a lead-in Phase 1B Dose Escalation Portion) in Patients With Advanced or Metastatic Renal Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|168|Anticipated|Tracon Pharmaceuticals Inc.||1|||f||||t||||||||||2017-10-11 01:55:47.417185|2017-10-11 01:55:47.417185
NCT01806051|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-03-21|2016-03-21||March 2013||2013-03-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Participants withdrew before baseline characteristics were collected.|A Pilot Study on Diurnal Variation|A Pilot Study on the Diurnal Variation in PKU Patients With Kuvan|Terminated||N/A|6|Actual|Children's Hospital Los Angeles||2||"Participants found the study procedures to be too cumbersome and no longer wanted to   participate"|f||||f||||||||||2017-10-11 01:55:47.634134|2017-10-11 01:55:47.634134
NCT01806038|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-11-11|||March 2013||2013-03-01|April 2014|2014-04-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Drug-Related Problems and Healthcare Utilization Post-Hospital Discharge|The Effect of Pharmacist-Provided Counseling Combined With Outpatient Dispensing at Hospital Discharge on the Incidence of Post-Discharge Drug-Related Problems and Healthcare Utilization|Completed||N/A|44|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:55:47.835749|2017-10-11 01:55:47.835749
NCT01806025|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2016-07-27|||April 2013||2013-04-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|Hp-in-CF||Correlation Between Haptoglobin Phenotypes and Infectious and Other Complications in Cystic Fibrosis Patients|Correlation Between Haptoglobin Phenotypes and Infectious and Other Complications in Cystic Fibrosis Patients|Completed||N/A|142|Actual|Carmel Medical Center|||1||f||||f||||||Samples Without DNA|"     Peripheral blood serum   "|No||2017-10-11 01:55:47.955919|2017-10-11 01:55:47.955919
NCT01806012|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-03-05|||August 2010||2010-08-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Use of the Enseal Intrument for Laparoscopic Supracervical Hysterectomy|Use of the Enseal Intrument for Laparoscopic Supracervical Hysterectomy: a Randomized, Single-Blinded Study Comparing the Efficacy to the Routine Procedure|Completed||N/A|160|Actual|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-11 01:55:48.049416|2017-10-11 01:55:48.049416
NCT01805999|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-02-21|||March 2013||2013-03-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|October 2013|Actual|2013-10-01||Interventional|||Ispaghula and Colonic Water Content|Effect of Ispaghula on Colonic Water Content|Completed||N/A|15|Anticipated|University of Nottingham||3|||f||||||||||||||2017-10-11 01:55:48.124686|2017-10-11 01:55:48.124686
NCT01805986|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-05-16|||March 2013||2013-03-01|May 2013|2013-05-01|February 2015|Anticipated|2015-02-01|February 2014|Anticipated|2014-02-01||Observational|||Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner|Investigation of Grey Matter Pathology Using Ultra High Field (7T) MRI Scanner|Unknown status|Enrolling by invitation|N/A|100|Anticipated|University of Nottingham|||1||f||||f||||||||||2017-10-11 01:55:48.224875|2017-10-11 01:55:48.224875
NCT01805973|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-06|||June 2013||2013-06-01|March 2013|2013-03-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|SAS||Surviving Aneurysm Surgery: A Pilot Study on Exercise Training in Abdominal Aortic Aneurysm Patients|Surviving Aneurysm Surgery: A Pilot Randomised Controlled Trial on Exercise Training in Abdominal Aortic Aneurysm Patients|Unknown status|Not yet recruiting|N/A|100|Anticipated|University Hospital of South Manchester NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 01:55:48.292023|2017-10-11 01:55:48.292023
NCT01805596|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-10-04|||April 2013||2013-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Ticagrelor on Endothelial Function|Effect of Ticagrelor on Endothelial Function|Completed||Phase 3|45|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 01:55:54.171786|2017-10-11 01:55:54.171786
NCT01805960|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-02-13|||June 2013||2013-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CONVERT-AF||Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AF|Canakinumab for the Prevention of Recurrences After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation (CONVERT-AF) Trial - A Randomized Double Blind Placebo Controlled Study|Terminated||Phase 2|24|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 01:55:48.396768|2017-10-11 01:55:48.396768
NCT01805947|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2015-09-03|||January 2013||2013-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Observational|POSITAG||Lifestyle Modification Program for Patients With Chronic Pain Conditions|Process-outcome-study in the Context of a Lifestyle Modification Program for Patients With Chronic Pain Conditions|Completed||N/A|200|Actual|Universität Duisburg-Essen|||1||f||||f||||||||||2017-10-11 01:55:48.497759|2017-10-11 01:55:48.497759
NCT01805934|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-05|||May 2012||2012-05-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection|Quadruple Therapy With Furazolidone Versus Dual Therapy With High Doses of Amoxicillin as Rescue Regimens for Helicobacter Pylori Infection|Completed||Phase 2|114|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||||2017-10-11 01:55:48.608384|2017-10-11 01:55:48.608384
NCT01805921|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2016-04-24|||May 2013||2013-05-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.|A Phase I Study to Assess Safety and Immunogenicity of a New Respiratory Syncytial Virus (RSV) Vaccine Based on the RSV Viral Proteins F, N and M2-1 Encoded by Simian Adenovirus (PanAd3-RSV) and Modified Vaccinia Virus Ankara (MVA-RSV)|Completed||Phase 1|72|Actual|ReiThera Srl||9|||f||||t||||||||||2017-10-11 01:55:48.719257|2017-10-11 01:55:48.719257
NCT01805908|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-06-03|||November 2013||2013-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PETRA||Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC) or Locally Advanced Breast Cancer (LABC)|Imaging With 111In-Pertuzumab to Predict Response to Trastuzumab in HER2 Positive Metastatic or Locally Advanced Breast Cancer|Terminated||Phase 1|3|Actual|Ontario Clinical Oncology Group (OCOG)||1||Accrual is very poor|f||||t||||||||||2017-10-11 01:55:48.888302|2017-10-11 01:55:48.888302
NCT01805882|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-05-12|2017-02-28||January 2013||2013-01-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Combination Therapy for Chronic Hepatitis C Infection|A Pilot Study to Evaluate the Safety and Efficacy of Multiple Anti-HCV Combination Therapy in Chronically Infected Hepatitis C Patients|Completed||Phase 2|229|Actual|National Institutes of Health Clinical Center (CC)||9|||f||||f|t|f||||||Yes|The NIH Biomedical Translational Research Information System|2017-10-11 01:55:49.15431|2017-10-11 01:55:49.15431
NCT01805869|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-08-08|||November 16, 2012||2012-11-16|August 2, 2017|2017-08-02|January 1, 2020|Anticipated|2020-01-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Tooth and Tissue Sample Collection During Wisdom Teeth Removal|Diagnosis and Treatment of Patients in Need of Third Molar Removal and Oral Specimen Acquisition|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:55:51.684793|2017-10-11 01:55:51.684793
NCT01805856|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2013-03-05|||November 2010||2010-11-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|Ito-RCT1||Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery|Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Thyroid and Parathyroid Surgery|Completed||N/A|2164|Actual|Ito Hospital||3|||f||||f||||||||||2017-10-11 01:55:51.777569|2017-10-11 01:55:51.777569
NCT01805843|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-09-07|||July 2012||2012-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia|Pulmonary Vascular Changes in Patients With Chronic Myeloid Leukemia With Second-line Therapy Dasatinib vs. Nilotinib|Completed||N/A|16|Actual|Medical University of Graz|||1||f||||t||||||Samples With DNA|"     Samples with DNA will be retained for later examinations at the Biobank, in case that the     patient agrees (extra patient information). The blood samples are taken only during routine     tests.   "|||2017-10-11 01:55:51.866596|2017-10-11 01:55:51.866596
NCT01805830|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2015-10-05|||May 2012||2012-05-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|T2DM||Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy|Phase III, Double Blind, Parallel-group, Randomized, Placebo Controlled Study to Compare the Efficacy and Safety of MP-513 When Added to Ongoing Metformin Monotherapy In Patients With Type 2 DM|Completed||Phase 3|189|Actual|Handok Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:55:52.076314|2017-10-11 01:55:52.076314
NCT01805817|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-03-06|||December 2012||2012-12-01|March 2013|2013-03-01||||December 2013|Anticipated|2013-12-01||Interventional|||Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality|Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality|Unknown status|Recruiting|Phase 4|5|Anticipated|Istanbul Training and Research Hospital||3|||f||||t||||||||||2017-10-11 01:55:52.180252|2017-10-11 01:55:52.180252
NCT01805804|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-02|2017-01-01|||January 2017||2017-01-01|January 2017|2017-01-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients|Randomized, Placebo Controlled Blinded Study to Assess the Efficacy of Valsartan to Prevent Left Ventricle Remodeling in Patients With Dual Chamber Pacemaker|Recruiting||Phase 4|100|Anticipated|Medical University of Silesia||3|||f||||f||||||||||2017-10-11 01:55:52.309091|2017-10-11 01:55:52.309091
NCT01805791|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-05-03|||March 2013||2013-03-01|March 2014|2014-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis|A Phase III, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis|Terminated||Phase 3|201|Actual|Hutchison Medipharma Limited||3||Interim futility analysis results|f||||||||||||||2017-10-11 01:55:52.420746|2017-10-11 01:55:52.420746
NCT01805778|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-05-04|||December 2012||2012-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|PCS2||Preventing Cardiac Sequelae in Pediatric Cancer Survivors|Novel Approaches to the Prediction, Diagnosis and Treatment of Cardiac Late Effects in Survivors of Childhood Cancer: A Multi-centre Observational Study|Active, not recruiting||N/A|1128|Actual|The Hospital for Sick Children|||2||f||||f||||||Samples With DNA|"     The study will retain plasma for biomarker and genomic analysis. The study will also retain     saliva for those patient who are unable or unwilling to provide a blood specimen for genomic     analysis.   "|||2017-10-11 01:55:52.500328|2017-10-11 01:55:52.500328
NCT01805765|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-03-04|||March 2013||2013-03-01|March 2013|2013-03-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Qing'E Formula Therapy on Menopausal Symptoms|A Randomized, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial on the Effects of Chinese Medicine Formula (Qing'E) on Menopausal Symptoms|Unknown status|Recruiting|Phase 2/Phase 3|240|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 01:55:52.611495|2017-10-11 01:55:52.611495
NCT01805752|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-11-01|||March 2013||2013-03-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Optimizing Integrated PMTCT Services in Rural North-Central Nigeria|Optimizing Integrated PMTCT Services in Rural North-Central Nigeria: A Cluster Randomized Trial|Completed||N/A|369|Actual|Vanderbilt University||2|||f||||f||||||||No|IPD will not be available to other researchers.|2017-10-11 01:55:52.711072|2017-10-11 01:55:52.711072
NCT01805739|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-10-19|||January 2013||2013-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|12 Months|Observational [Patient Registry]|||Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation|Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation (TAVI)|Recruiting||N/A|500|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 01:55:52.823042|2017-10-11 01:55:52.823042
NCT01805726|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2014-11-22|||February 2013||2013-02-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|March 2013|Actual|2013-03-01||Interventional|||Sedation During Bronchoscopy:Dexmedetomidine vs Alfentanil|Success of Sedation During Bronchoscopy: Comparison of the Effects of Dexmedetomidine, Alfentanil and Local Anesthesia|Completed||Phase 3|162|Actual|Saint-Joseph University||3|||f||||t||||||||||2017-10-11 01:55:52.919713|2017-10-11 01:55:52.919713
NCT01805713|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-05-11|||December 2012||2012-12-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung|Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung|Recruiting||N/A|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||Samples Without DNA|"     Blood, Urine, BALF and Sputum.   "|||2017-10-11 01:55:53.015742|2017-10-11 01:55:53.015742
NCT01805700|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-04|||January 2010||2010-01-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|REDBULL||Effects of Acute Intake of Caffeinated Beverages in Type 1 Diabetes|Effects of Acute Intake of Caffeine Enhanced Energy Drinks on Blood Glucose, Some Physiological Parameters and Cognitive Performance in Patients With Type 1 Diabetes|Completed||N/A|20|Actual|The Royal Bournemouth Hospital||3|||f||||f||||||||||2017-10-11 01:55:53.099868|2017-10-11 01:55:53.099868
NCT01805687|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-08-22|2014-07-30||March 2013||2013-03-01|August 2014|2014-08-01||||June 2013|Actual|2013-06-01||Interventional|||Single Dose Bronchodilatory Study in Asthma|A Single-Center, Open-Label, Single-Dose Evaluation of the Duration and Extent of Bronchodilation Following Administration of Zileuton CR 1200 mg in Subjects With Stable, Chronic Asthma|Completed||Phase 4|25|Actual|Cornerstone Therapeutics Inc.||1|||f||||||||||||||2017-10-11 01:55:53.231333|2017-10-11 01:55:53.231333
NCT01805674|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2014-11-04|||March 2013||2013-03-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Observational|ESTROCALVI||Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women|Study to Evaluate the Changes in Quality of Life in Menopausal Women After the Administration of Soy Isoflavones Combined With Magnolia Extract|Completed||N/A|100|Actual|Rottapharm Spain|||1||f||||f||||||||||2017-10-11 01:55:53.415752|2017-10-11 01:55:53.415752
NCT01805661|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-03-16|||March 2013||2013-03-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement|Assessment of Early Ambulation and Participation in Rehabilitation Program in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection vs Continuous Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement.|Completed||N/A|56|Actual|Saint Francis Care||2|||f||||f||||||||||2017-10-11 01:55:53.516939|2017-10-11 01:55:53.516939
NCT01805648|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-03-04|||February 2011||2011-02-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP|A Multicenter, Single-Arm, Open Label Study Evaluating the Efficacy and Safety of Maintenance Treatment With Recombinant Human Thrombopoietin in Thrombocytopenic Subjects With Immune Thrombocytopenia|Unknown status|Recruiting|Phase 3|120|Anticipated|Peking Union Medical College||1|||f||||t||||||||||2017-10-11 01:55:53.64141|2017-10-11 01:55:53.64141
NCT01805635|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-09-06|||February 2013||2013-02-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Observational|||PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases|Evaluation of the Relationship Between the Parameters of Pulmonary Function (PF) and the Concentration of Fractional Exhaled Nitric Oxide (FeNO) and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases|Unknown status|Recruiting|N/A|5500|Anticipated|Medical Universtity of Lodz|||1||f||||t||||||Samples With DNA|"     IgE specific allergen antibodies   "|||2017-10-11 01:55:53.765823|2017-10-11 01:55:53.765823
NCT01805622|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-04|||August 2012||2012-08-01|March 2013|2013-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|EPICS||Educational Program to Increase Colorectal Cancer Screening: a Cluster Trial|Efficacy to Effectiveness Transition of an Educational Program to Increase Colorectal Cancer Screening|Unknown status|Recruiting|N/A|7200|Anticipated|Morehouse School of Medicine||4|||f||||f||||||||||2017-10-11 01:55:53.907718|2017-10-11 01:55:53.907718
NCT01805609|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-03-01|||February 2013|Actual|2013-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology Setting|Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology Setting|Active, not recruiting||N/A|80|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:55:54.059002|2017-10-11 01:55:54.059002
NCT01805583|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-03-18|||March 2013||2013-03-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SAFARI||Return to Work: Promoting Health and Productivity in Workers With Common Mental Disorders|SAFARI-Return to Work: Promoting Health and Productivity in Workers With Common Mental Disorders|Completed||N/A|352|Actual|Karolinska Institutet||4|||f||||f||||||||||2017-10-11 01:55:54.289509|2017-10-11 01:55:54.289509
NCT01805570|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-09-24|||November 2012||2012-11-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Rapid Activity of Platelet Inhibitor Drugs Study 2|Rapid Activity of Platelet Inhibitor Drugs Study (RAPID 2)|Completed||Phase 4|50|Actual|Careggi Hospital||2|||f||||t||||||||||2017-10-11 01:55:54.407264|2017-10-11 01:55:54.407264
NCT01805557|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2016-02-29|||February 2013||2013-02-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|FIL_VERAL12||Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.|Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.|Recruiting||Phase 2/Phase 3|108|Anticipated|Fondazione Italiana Linfomi ONLUS||2|||f||||f||||||||||2017-10-11 01:55:54.524102|2017-10-11 01:55:54.524102
NCT01805544|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-01-20|||May 2013||2013-05-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|SATORI||Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication|Satisfaction and Quality of Life in Patients With a Diagnosis of DVT (Deep Venous Thrombosis) Who Take Rivaroxaban|Completed||N/A|113|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:55:54.907005|2017-10-11 01:55:54.907005
NCT01805531|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2017-01-17|||April 2013||2013-04-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|SAFARI||Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication|Satisfaction and Quality of Life in Patients With a Diagnosis of Non Valvular Atrial Fibrillation Who Take Rivaroxaban for Stroke Prevention|Completed||N/A|411|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:55:55.024478|2017-10-11 01:55:55.024478
NCT01805518|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2013-03-04|||June 2011||2011-06-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety Study of the Effect of Scelectium Tortuosum (as Zembrin®)in Aged Normals|9 wk, Randomized, 2-blind, Placebo-controlled, 2X2 Cross-over Phase 1 Study of 25 mg of Scelectium Tortuosum (as Zembrin®) in Aged Normals to Find Effects on Mental, Emotional and Cognitive Safety Measures and Cytokines.|Completed||Phase 1|20|Actual|Woodbury, Michel, M.D.||2|||f||||f||||||||||2017-10-11 01:55:55.136782|2017-10-11 01:55:55.136782
NCT01805505|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-03-05|||February 2012||2012-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound|Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound|Terminated||Early Phase 1|346|Actual|IVI Madrid||2||slow recruitment rate|f||||f||||||||||2017-10-11 01:55:55.254638|2017-10-11 01:55:55.254638
NCT01805492|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-03-04|||January 2000||2000-01-01|March 2013|2013-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Global Profiling of Gene and Protein Expression Associated With Coronary Heart Disease Reversal|Global Profiling of Gene and Protein Expression Associated With Coronary Heart Disease Reversal|Completed||N/A|422|Actual|Windber Research Institute||2|||f||||f||||||||||2017-10-11 01:55:55.37977|2017-10-11 01:55:55.37977
NCT01805479|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-12-18|||February 2013||2013-02-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Exercise Training in Depressed Traumatic Brain Injury Survivors|Exercise Training in Depressed Traumatic Brain Injury Survivors|Withdrawn||N/A|0|Actual|Virginia Commonwealth University||2||Unable to enroll participants. Sponsor requested study closure.|f||||t||||||||||2017-10-11 01:55:55.488972|2017-10-11 01:55:55.488972
NCT01805466|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-02-19|||October 2012||2012-10-01|February 2013|2013-02-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|EVADO||Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO)|A New Cardiopulmonary By-pass System That Minimizes Haemodilution, Hemolysis and Systemic Inflammation. Effects on Organ Damage and Surgical Outcome|Completed||N/A|300|Actual|IRCCS San Raffaele||2|||f||||t||||||||||2017-10-11 01:55:55.756181|2017-10-11 01:55:55.756181
NCT01805453|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-02-27|||March 29, 2013|Actual|2013-03-29|February 2017|2017-02-01|May 15, 2017|Anticipated|2017-05-15|January 15, 2015|Actual|2015-01-15||Interventional|ASTER||Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma|Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma- A Randomized Multicenter Trial|Active, not recruiting||Phase 3|80|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 01:55:55.906418|2017-10-11 01:55:55.906418
NCT01805440|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-04-06|||August 2013||2013-08-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Uridine Adolescent Bipolar Depression Randomized Controlled Trial|Placebo-Controlled Study of Uridine for Adolescent Bipolar Depression: a Magnetic Resonance Spectroscopy Study|Completed||N/A|63|Actual|University of Utah||2|||f||||t||||||||No|Informed Consent to publicly share individual participant data, e.g. MRI and MRS brain scans, was not obtained.|2017-10-11 01:55:56.260419|2017-10-11 01:55:56.260419
NCT01805427|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-12-05|||September 2012||2012-09-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|EXTATIC||Antiretroviral Therapy and Extreme Weight|Extreme Weights and Antiretroviral Therapy Individual Concentrations|Completed||N/A|140|Actual|Hopital Lariboisière|||3||f||||f||||||||||2017-10-11 01:55:56.375756|2017-10-11 01:55:56.375756
NCT01805414|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-10-11|||September 2012||2012-09-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Breakfast Nutrition and Inpatient Glycemia|The Effect of a Targeted Breakfast Intervention on Inpatient Glycemic Control|Completed||N/A|237|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:55:56.441888|2017-10-11 01:55:56.441888
NCT01805401|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-10-02|||January 2013||2013-01-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||tDCS Applied to the OFC: Effects on Decision-Making and Impulse Control|Modulating Decision-Making and Impulse Control With Transcranial Direct Current Stimulation (tDCS) Over the Orbitofrontal Cortex (OFC): A Randomized and Sham-Controlled Study|Completed||N/A|45|Actual|Douglas Mental Health University Institute||3|||f||||f||||||||||2017-10-11 01:55:56.518665|2017-10-11 01:55:56.518665
NCT01805388|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-02-04|||February 2013||2013-02-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Comparison of Tissue in Regenerative Endodontic Procedures and Apexification|Comparison of Tissue Formation in Regenerative Endodontic Procedures and Apexification|Withdrawn||Phase 1|0|Actual|The University of Texas Health Science Center at San Antonio||2||Lack of pediatric recruitment ability|f||||t||||||||||2017-10-11 01:55:56.608508|2017-10-11 01:55:56.608508
NCT01805375|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2016-10-25|||April 2013||2013-04-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies|A Cancer Research UK Phase I Trial of the Anti-CD19 DI-B4 Monoclonal Antibody Given Intravenously, Weekly for Four Weeks, in Patients With Advanced CD19 Positive Indolent B-cell Malignancies|Active, not recruiting||Phase 1|28|Actual|Cancer Research UK|||||f||||f||||||||||2017-10-11 01:55:56.693388|2017-10-11 01:55:56.693388
NCT01805362|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-09-14|||February 2013||2013-02-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|IRAB2||RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough|RAS Blockade at Bedtime Versus on Awakening for the Prevention of Aldosterone Breakthrough|Recruiting||N/A|106|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 01:55:56.806229|2017-10-11 01:55:56.806229
NCT01805349|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-05|||March 2013||2013-03-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|March 2013|Anticipated|2013-03-01||Interventional|Khoala||Study of Association Between Digital Osteoarthritis and Lower Limb Osteoarthritis|Study of the Association Between Digital Osteoarthritis and Lower Limb Osteoarthritis (Knee and Hip) in Terms of Severity and Evolution - Khoala Group Ancillary Project / Cohort Khoala|Unknown status|Not yet recruiting|N/A|860|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 01:55:56.917539|2017-10-11 01:55:56.917539
NCT01805336|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-07-21|||March 2013||2013-03-01|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2019|Anticipated|2019-09-30||Interventional|SEPREV||Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality|Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality|Recruiting||N/A|60|Anticipated|University Hospital, Caen||2|||f||||f||||||||||2017-10-11 01:55:57.123844|2017-10-11 01:55:57.123844
NCT01805323|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-05|2014-04-28|2014-04-28||September 2012||2012-09-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema||Completed||N/A|101|Actual|Allergan|||1||f||||f||||||||||2017-10-11 01:55:57.286259|2017-10-11 01:55:57.286259
NCT01805310|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-08-25|||February 2013||2013-02-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Pre-operative Bowel Preparation Prior to Minimally Invasive Sacral Colpopexy|Pre-operative Bowel Preparation Prior to Minimally Invasive Sacral Colpopexy|Active, not recruiting||Phase 4|120|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:55:57.570089|2017-10-11 01:55:57.570089
NCT01805297|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-08-14|2017-04-07||March 2013||2013-03-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|February 2014|Actual|2014-02-01||Interventional|||Aflibercept Injection for Proliferative Diabetic Retinopathy|Intravitreal Aflibercept Injection as a Surgical Adjuvant in Severe Proliferative Diabetic Retinopathy|Completed||Phase 2|12|Actual|University of Oklahoma||2|||f||||f||||||||||2017-10-11 01:55:57.693142|2017-10-11 01:55:57.693142
NCT01805284|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-06-03|||February 2013||2013-02-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|UGENT_LIMOP||Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia|Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia|Unknown status|Recruiting|Phase 4|20|Anticipated|University Ghent||1|||f||||f||||||||||2017-10-11 01:55:58.281974|2017-10-11 01:55:58.281974
NCT01805271|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-06-02|||March 2013||2013-03-01|June 2016|2016-06-01|June 2031|Anticipated|2031-06-01|June 2021|Anticipated|2021-06-01||Interventional|||Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy|Randomized, Double Blind, Multicentric Phase III Trial Evaluating the Safety and Benefit of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer Who Remain Free of Disease After Receiving at Least 1 Year of Adjuvant Hormone Therapy|Recruiting||Phase 3|1984|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-11 01:55:58.426319|2017-10-11 01:55:58.426319
NCT01805258|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-25|||June 2007||2007-06-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|"NVP"||Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB|Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin in Antiretroviral Naive Patients Co-infected With HIV and Tuberculosis in India.|Completed||Phase 3|135|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-10-11 01:55:58.588338|2017-10-11 01:55:58.588338
NCT01805245|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-04-17|||January 2012||2012-01-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional|||Mindfulness: a Novel Approach for the Management of Diabetes-related Distress|Mindfulness: a Novel Approach for the Management of Diabetes-related Distress|Completed||N/A|78|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 01:55:58.763411|2017-10-11 01:55:58.763411
NCT01805232|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-02|2013-03-04|||March 2013||2013-03-01|March 2013|2013-03-01|July 2013|Anticipated|2013-07-01|May 2013|Anticipated|2013-05-01||Interventional|IVAS||Intravenous Artesunate and Malaria|Intravenous Artesunate Versus Quinine in Severe Malaria at Kassla, Sudan|Unknown status|Recruiting|Phase 4|80|Anticipated|University of Khartoum||2|||f||||f||||||||||2017-10-11 01:55:58.921158|2017-10-11 01:55:58.921158
NCT01805219|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2016-02-11|||February 2013||2013-02-01|February 2016|2016-02-01||||February 2016|Actual|2016-02-01||Observational|ActiGPS||Global Positioning Satellite and Accelerometry to Assess Human Locomotion (ACTI GPS)|Assessment of Human Locomotion and Energy Expenditure Using Global Positioning Satellite and Accelerometry|Recruiting||N/A|160|Anticipated|University Hospital, Angers|||1||f||||t||||||||||2017-10-11 01:55:59.047738|2017-10-11 01:55:59.047738
NCT01805206|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-05-13|||November 2014||2014-11-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Prediction of NEC With Urinary iFABP|An Assessment of Urinary Intestinal Fatty Acid Binding Protein as a Early Predictor of Necrotizing Enterocolitis|Withdrawn||Phase 2|0|Actual|Loma Linda University||1||PI left institution prior to receiving funding|f||||t||||||||||2017-10-11 01:55:59.147839|2017-10-11 01:55:59.147839
NCT01805193|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-03-04|||December 2012||2012-12-01|March 2013|2013-03-01||||August 2013|Anticipated|2013-08-01||Observational|||Myocardial Blood Flow by 15O Water PET|Validation of Computed Tomography Myocardial Perfusion Imaging Using Quantification of Myocardial Blood Flow by Positron Emission Tomography With 15O-water|Unknown status|Recruiting|N/A|30|Anticipated|University of Edinburgh|||1||f||||f||||||||||2017-10-11 01:55:59.263296|2017-10-11 01:55:59.263296
NCT01805180|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-02-27|2014-06-27||February 2013||2013-02-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|PMNC|Subjects in the Full Set Analysis (n=32) were randomized to either Arm 1 or Arm 2 and completed both procedures as assigned. Subjects who did not complete the collection (withdrawn n=10) did not have data and could not be included in the full set analysis.|Evaluation of the Spectra Optia PMN Cell Collection Procedure|A Controlled Evaluation of the Spectra Optia® Apheresis System's Granulocyte / Polymorphonuclear (PMN) Cell Collection Procedure|Completed||N/A|42|Actual|Terumo BCT|The Full Analysis Set included 32 subjects who completed both procedures of the cross-over study design presented here. Two subjects did not meet pre-defined criteria for evaluable and 30 subjects were included in the Evaluable Analysis Population.|2|||f||||f||||||||||2017-10-11 01:55:59.378845|2017-10-11 01:55:59.378845
NCT01805167|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-03-05|||February 2013||2013-02-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Electrophysiological Study of Interindividual Differences in Speech-understanding Among Cochlear Implant Patients|Electrophysiological Study of Interindividual Differences in Speech-understanding Among Cochlear Implant Patients|Unknown status|Recruiting|N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||t||||||||||2017-10-11 01:55:59.934954|2017-10-11 01:55:59.934954
NCT01805154|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-10-03|||January 2013|Actual|2013-01-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|November 2016|Actual|2016-11-01|12 Months|Observational [Patient Registry]|||Advance Cardiac Resynchronization Therapy (CRT) Registry|Registry That Aims to Understand the Definition Used and Treatment Options Utilized by Clinicials for CRT Non-responders|Completed||N/A|1500|Anticipated|St. Jude Medical|||1||f||||f||||||||||2017-10-11 01:56:00.026504|2017-10-11 01:56:00.026504
NCT01805141|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-03-15|||August 2013||2013-08-01|March 2017|2017-03-01|June 1, 2018|Anticipated|2018-06-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer|Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer|Recruiting||N/A|20|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 01:56:00.348897|2017-10-11 01:56:00.348897
NCT01805128|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-05-27|||January 2013||2013-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum|EXPLORATION OF THE SOCIAL COGNITION IN ADOLESCENTS WITH A Dissociative Disorder OR AUTISM SPECTRUM|Completed||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 01:56:00.44386|2017-10-11 01:56:00.44386
NCT01805115|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-12-24|||March 2013||2013-03-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Misoprostol Administration Before Operative Hysteroscopy|A Randomized Comparison of Oral, Sublingual and Vaginal Misoprostol Administration in Premenopausal Women Before Operative Hysteroscopy|Completed||Phase 3|120|Actual|CHA University||4|||f||||f||||||||||2017-10-11 01:56:00.557545|2017-10-11 01:56:00.557545
NCT01805102|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-05|||September 2012||2012-09-01|March 2013|2013-03-01||||August 2014|Anticipated|2014-08-01||Observational|PIFBlood1||Correlation Between PIF Maternal Serum Levels and Pregnancy Outcome|Preimplantation Factor (PIF): Biomarker Detection in Maternal Blood - Correlation With Live Birth.|Unknown status|Enrolling by invitation|N/A|500|Anticipated|BioIncept LLC|||1||f||||f||||||Samples Without DNA|"     maternal blood   "|||2017-10-11 01:56:00.647144|2017-10-11 01:56:00.647144
NCT01805089|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-03-03|2014-04-30||October 2006||2006-10-01|February 2015|2015-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Melatonin Versus Placebo in Breast Cancer|A Randomized Trial of Oral Melatonin Supplementation in Breast Cancer Survivors|Completed||Early Phase 1|95|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 01:56:00.749184|2017-10-11 01:56:00.749184
NCT01805076|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2017-09-29|||February 2014||2014-02-01|September 2017|2017-09-01||||September 2019|Anticipated|2019-09-01||Interventional|||MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer|Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer|Recruiting||Phase 3|536|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 01:56:01.277482|2017-10-11 01:56:01.277482
NCT01805063|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-03-04|||February 2012||2012-02-01|March 2013|2013-03-01||||August 2014|Anticipated|2014-08-01||Observational|||Effect of Fire Suppression and Emergency Duties on Vascular Function|Effect of Fire Suppression and Emergency Duties on Vascular Function in Firefighters|Unknown status|Recruiting|N/A|30|Anticipated|University of Edinburgh|||3||f||||t||||||Samples Without DNA|"     Plasma and urine samples   "|||2017-10-11 01:56:03.719644|2017-10-11 01:56:03.719644
NCT01805050|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-03-20|||November 2013||2013-11-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Case Study: HAGL-lesion (HAGL:Humeral Avulsion Glenohumeral Ligament)|Arthroscopically Repair of the Anterior Instability of the Shoulder Due an HAGL - Lesion - A Case Serie|Completed||N/A|6|Actual|Schulthess Klinik|||1||f||||f||||||||||2017-10-11 01:56:03.874278|2017-10-11 01:56:03.874278
NCT01805037|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-04-28|||March 2013||2013-03-01|April 2015|2015-04-01||||January 2016|Anticipated|2016-01-01||Interventional|||Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas|A Phase I-II Trial of Brentuximab Vedotin Plus Rituximab as Frontline Therapy for Patients With CD30+ and/or EBV+ Lymphomas|Unknown status|Recruiting|Phase 1/Phase 2|33|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 01:56:03.982312|2017-10-11 01:56:03.982312
NCT01805024|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-08-29|||December 2014||2014-12-01|August 2017|2017-08-01||||December 15, 2017|Anticipated|2017-12-15||Interventional|CALLISTO||Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)|Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)|Active, not recruiting||Phase 1|20|Anticipated|Santhera Pharmaceuticals||1|||f||||||||||||||2017-10-11 01:56:04.18293|2017-10-11 01:56:04.18293
NCT01805011|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-03-04|||July 2011||2011-07-01|September 2011|2011-09-01||||May 2012|Actual|2012-05-01||Observational|||Study on Normal Ranges of Lipids in Breast Milk of Healthy Mothers||Completed||Early Phase 1|50|Actual|Nestlé|||1||f||||||||||||||2017-10-11 01:56:04.407811|2017-10-11 01:56:04.407811
NCT01804998|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-02-05|||March 2013||2013-03-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|March 2020|Anticipated|2020-03-01||Interventional|||Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy|Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy and Stomach Preserving Surgery in Early Gastric Cancer|Active, not recruiting||Phase 3|580|Actual|National Cancer Center, Korea||2|||f||||t||||||||Undecided|We will discuss this topic in the research meeting later.|2017-10-11 01:56:04.495805|2017-10-11 01:56:04.495805
NCT01804985|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-03|2017-05-03|||December 2013||2013-12-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|DESTINY||De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia|A Trial of De-escalation and Stopping Treatment in Chronic Myeloid Leukaemia Patients With Excellent Responses to Tyrosine Kinase Inhibitor Therapy|Active, not recruiting||Phase 2|168|Anticipated|University of Liverpool||1|||f||||t||||||||||2017-10-11 01:56:04.628497|2017-10-11 01:56:04.628497
NCT01804972|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-03-24|||May 2013||2013-05-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of Patient Centred Information for Vascular Disease|Efficacy of Patient Centred Information for Vascular Disease|Completed||Phase 2|50|Actual|Mid Western Regional Hospital, Ireland||2|||f||||t||||||||||2017-10-11 01:56:04.767195|2017-10-11 01:56:04.767195
NCT01804946|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-06-01|2015-04-13||February 2011||2011-02-01|March 2013|2013-03-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional||FAS included 78 patients per group: 5 patients excluded with the entry criteria violations (3, EG; 1, OG) and the lack of data (1, OG). PPSet contained 75 patients in EG and 72 ones in OG: 9 were excluded due to protocol violation (3, EG; 2, OG), the failure to satisfy not major entry criteria (3, OG) and due to assigning a prohibited drug (1, OG).|Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza|Multicentre Open Label Comparative Parallel-group Randomized Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza|Completed||Phase 4|161|Actual|Materia Medica Holding||2|||f||||f||||||||||2017-10-11 01:56:05.043272|2017-10-11 01:56:05.043272
NCT01804933|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-03-04|||July 2012||2012-07-01|March 2013|2013-03-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|||Influence of Profound Muscle Relaxation on Muscle Trauma and Postoperative Pulmonary Function||Unknown status|Recruiting|Phase 4|72|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||3|||f||||f||||||||||2017-10-11 01:56:05.715064|2017-10-11 01:56:05.715064
NCT01804920|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-03|2016-08-23|||January 2013||2013-01-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Interventional|||D-Serine Treatment For Tardive Dyskinesia|D-SERINE TREATMENT FOR TARDIVE DYSKINESIA|Active, not recruiting||Phase 2/Phase 3|16|Actual|Herzog Hospital||2|||f||||t||||||||||2017-10-11 01:56:05.808091|2017-10-11 01:56:05.808091
NCT01804907|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-04-17|||March 2012||2012-03-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Feasibility of Non-pharmacological Insomnia Therapy in People Living With HIV||Completed||N/A|36|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:56:05.884361|2017-10-11 01:56:05.884361
NCT01804894|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-03-31|||March 2013||2013-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01|3 Years|Observational [Patient Registry]|TEAM||Do Common Physical Tests Predict Injury or Performance|Field Tests and Their Correlation With Injury and Performance|Completed||N/A|359|Actual|High Point University|||1||f||||f||||||||||2017-10-11 01:56:05.968757|2017-10-11 01:56:05.968757
NCT01804881|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-02|2014-06-04|2014-02-07||March 2013||2013-03-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Managing Problematic Eating Behaviours With Dietary Management on Chronic Disease Self-management|Effect of Beyond the Fork on Chronic Disease Self-management: a Pilot RCT|Completed||N/A|30|Actual|University of Toronto Practice Based Research Network|Small sample size is limitation and was affected by small number recruited due to some participants declining participation due to being unable to come in for the day/time group program was offered and some participants dropped out during the study.|2|||f||||f||||||||||2017-10-11 01:56:06.033868|2017-10-11 01:56:06.033868
NCT01804868|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-04-17|||May 2013||2013-05-01|May 2013|2013-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Web Tutorial Based on Case Vignettes for Teaching Literature Critical Assessment to Nursing Students|Efficacy of a Web Tutorial Based on Case Vignettes for Teaching Literature Critical Assessment to Nursing Students: a Randomized Controlled Trial|Completed||N/A|506|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:56:06.474796|2017-10-11 01:56:06.474796
NCT01804855|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-08-11|||February 2013||2013-02-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Effectiveness of a Smartphone App for Adolescent Obesity Management|An Investigation of the Clinical Effectiveness of Adolescent Weight-management Delivered Via a Portable Device|Unknown status|Recruiting|N/A|126|Anticipated|Children's University Hospital, Ireland||2|||f||||f||||||||||2017-10-11 01:56:06.60539|2017-10-11 01:56:06.60539
NCT01804829|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-03-14||2017-03-09|June 2013||2013-06-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.|A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients|Completed||Phase 3|80|Actual|Biotest Pharmaceuticals Corporation||3|||f||||t||||||||Undecided||2017-10-11 01:56:07.807707|2017-10-11 01:56:07.807707
NCT01804816|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-01-30|||February 2013||2013-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|January 2014|Actual|2014-01-01||Interventional|||Acupuncture on Cardiac and Autonomic Function in Human Heart Failure|Acupuncture on Cardiac and Autonomic Function in Human Heart Failure|Active, not recruiting||N/A|20|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No|There is no plan to make individual patient data available.|2017-10-11 01:56:08.021892|2017-10-11 01:56:08.021892
NCT01804803|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-08-02|||May 2013||2013-05-01|August 2013|2013-08-01|July 2014|Anticipated|2014-07-01|May 2014|Anticipated|2014-05-01||Interventional|DIAMONDS||DIgital Assisted MONitoring for DiabeteS - I|A Telemedicine-based Intervention Study Involving Real-time and Anywhere Transmission of Blood Glucose Data to a Decision Supported Software-assisted Server With Web-based Analysis of Data and Medical Feedback on Metabolic Control.|Unknown status|Recruiting|Phase 3|250|Anticipated|University of Bari||2|||f||||t||||||||||2017-10-11 01:56:08.145059|2017-10-11 01:56:08.145059
NCT01804790|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-06-16|||January 2012||2012-01-01|June 2016|2016-06-01|January 2022|Anticipated|2022-01-01|June 2017|Anticipated|2017-06-01||Interventional|Néofirinox||Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed by Preoperative Chemoradiotherapy for Patients With Resectable Locally Advanced Rectal Cancer|- Randomized Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed by Preoperative Chemoradiotherapy for Patients With Resectable Locally Advanced Rectal Cancer|Recruiting||Phase 3|460|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-11 01:56:08.318819|2017-10-11 01:56:08.318819
NCT01804777|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2014-09-26|||March 2013||2013-03-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes|ENaC as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes|Terminated||Early Phase 1|9|Actual|University of New Mexico||2||Currently closed for data analysis.|f||||t||||||||||2017-10-11 01:56:08.593603|2017-10-11 01:56:08.593603
NCT01804764|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-04|||June 2011||2011-06-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||Lotta Alla Sepsi Ospedaliera - Fighting Hospital Sepsis|Educational and Organizational Intervention's Effect on Severe Sepsis and Septic Shock Management Out of Intensive Care Units: Medical Wards and Emergency Departments|Unknown status|Recruiting|N/A|1000|Anticipated|University of Milano Bicocca|||1||f||||t||||||||||2017-10-11 01:56:08.724725|2017-10-11 01:56:08.724725
NCT01804751|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-08-24|||January 2016||2016-01-01|June 2013|2013-06-01||||December 2016|Anticipated|2016-12-01||Observational|||Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China||Unknown status|Not yet recruiting|N/A|||West China Second University Hospital|||1||f||||f||||||||||2017-10-11 01:56:08.838018|2017-10-11 01:56:08.838018
NCT01804738|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-05-20|||March 2013||2013-03-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Investigating Inter-individual Variability in Glycemic and Insulin Responses|Investigating Inter-individual Variability in Glycemic and Insulin Responses|Completed||N/A|75|Actual|Singapore Institute for Clinical Sciences||3|||f||||t||||||||||2017-10-11 01:56:08.907337|2017-10-11 01:56:08.907337
NCT01804725|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-10-24|||August 2008||2008-08-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Study of Bicycle Seat Effects on Male Perineal Blood Flow|Phase 1: To Compare Perineal Artery Occlusion in Road and Stationary Models. Phase 2: To Test Different Seats for Perineal Arterial Occlusion.|Enrolling by invitation||N/A|40|Anticipated|University of Illinois at Chicago|||1||f||||t||||||||||2017-10-11 01:56:09.021937|2017-10-11 01:56:09.021937
NCT01804712|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-05-17|||July 2013||2013-07-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy|A Pilot Study of Rituximab Neoadjuvant Therapy in Patients With High Risk Prostate Cancer Scheduled to Undergo Radical Prostatectomy|Active, not recruiting||Early Phase 1|18|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 01:56:09.098009|2017-10-11 01:56:09.098009
NCT01804699|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-10-31|||January 2013||2013-01-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|January 2020|Anticipated|2020-01-01|3 Years|Observational [Patient Registry]|ARVCRegistry||National ARVC DATA Registry and Bio Bank|Canadian National Arrhythmogenic Right Ventricular Cardiomyopathy|Enrolling by invitation||N/A|1500|Anticipated|University of British Columbia|||2||f||||f||||||Samples With DNA|"     If the participant consents to the biobanking arm of the study an additional blood sample     (Please see the ARVC Lab Manual for details) will be collected at baseline and stored for     subsequent analysis. These analyses may include measurement of serum Troponin T, NT-pro-BNP,     C-reactive protein and other biomarkers to determine their association with the progression     of disease; both in terms of cardiac structure (i.e. change in right ventricular volume) and     electrical substrate (i.e. number of ICD shocks) over time.   "|No||2017-10-11 01:56:09.216251|2017-10-11 01:56:09.216251
NCT01804686|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2017-08-24|||September 9, 2013|Actual|2013-09-09|August 2017|2017-08-01|January 1, 2025|Anticipated|2025-01-01|December 29, 2021|Anticipated|2021-12-29||Interventional|||A Long-term Extension Study of PCI-32765 (Ibrutinib)|A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study|Recruiting||Phase 3|700|Anticipated|Janssen Research & Development, LLC||1|||f||||f|t|f||||||||2017-10-11 01:56:09.337562|2017-10-11 01:56:09.337562
NCT01804673|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2013-08-02|2013-05-01||March 2008||2008-03-01|August 2013|2013-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain|Global Assessment of Treatment With IONSYS and Its Handling by Patients, Doctors and Nursing Staff in the Management of Acute Moderate to Severe Post-Surgery Pain in Hospitalised Patients|Terminated||Phase 4|174|Actual|Janssen-Cilag G.m.b.H|The study was prematurely discontinued after enrolling 184 of 200 planned participants because the study medication was no longer available.|1||The study was prematurely discontinued since study medication was no longer available.|f||||f||||||||||2017-10-11 01:56:09.963|2017-10-11 01:56:09.963
NCT01804660|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2014-01-27|||October 2012||2012-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|CONTROL||Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population|A One Year Longitudinal Therapeutically Non-Interventional Study of MSRV-Env Burden in Normal Population as Assessed by PCR and ELISA in Blood|Completed||N/A|25|Actual|GeNeuro Innovation SAS|||1||f||||f||||||Samples Without DNA|"     Serum, plasma and PBMC.   "|||2017-10-11 01:56:10.753255|2017-10-11 01:56:10.753255
NCT01804647|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-04|2015-03-16|||November 2012||2012-11-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|LOMBARD||Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease|A One Year Longitudinal Therapeutically Non-Interventional Study of MSRV-Env Burden in Multiple Sclerosis Patients (RRMS - SPMS - PPMS - CIS) as Assessed by PCR and ELISA in Blood|Completed||N/A|58|Actual|GeNeuro Innovation SAS|||4||f||||f||||||Samples Without DNA|"     Plasma, serum and PBMC   "|||2017-10-11 01:56:10.833816|2017-10-11 01:56:10.833816
NCT01804634|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-06-16|||February 2013||2013-02-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase II Trial of Reduced Intensity Conditioning and Haploidentical BMT for High-risk Solid Tumors|A Phase II Trial of Reduced Intensity Conditioning and Partially HLA-mismatched (HLA-haploidentical) Bone Marrow Transplantation for High-risk Solid Tumors|Recruiting||Phase 2|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:56:10.942946|2017-10-11 01:56:10.942946
NCT01804621|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-03-04|||April 2010||2010-04-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||RCT to Examine the Effects of Scanning|An RCT to Examine the Effects of Scanning; a Major Step on the Path Towards Population Intervention|Completed||N/A|15824|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 01:56:11.107167|2017-10-11 01:56:11.107167
NCT01804608|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-10-24|||March 2013||2013-03-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Kinematics of Lower Limb, Pain and Function of the Women With Patellofemoral Pain Syndrome|Kinematics of Lower Limb, Pain and Function of the Women With Patellofemoral Pain Syndrome Who Underwent Two Types Treatment: Randomized Clinical Trial|Completed||N/A|34|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-11 01:56:11.213169|2017-10-11 01:56:11.213169
NCT01804595|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-05-19|||February 2012||2012-02-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Randomized Control Trial of Sun Protection Interventions for Operating Engineers|A Randomized Control Trial of Sun Protection Interventions for Operating Engineers|Completed||Phase 2/Phase 3|357|Actual|University of Michigan||4|||f||||f||||||||||2017-10-11 01:56:11.29809|2017-10-11 01:56:11.29809
NCT01804569|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-02|2013-09-08|||April 2013||2013-04-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|moxa||The Effects of Self-Moxibustion Therapy on Subjective Physical Symptoms and Health-related Quality of Life of the Elderly. The Effects of Self-Moxibustion Therapy|The Effects of Self-Moxibustion Therapy on Subjective Physical Symptoms and Health-related Quality of Life of the Elderly.|Completed||N/A|70|Actual|Pusan National University||1|||f||||f||||||||||2017-10-11 01:56:11.49624|2017-10-11 01:56:11.49624
NCT01804556|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-03|2015-01-26|||June 2012||2012-06-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of the Myofascial Trigger Point Injections on Pain and Sleep Disturbance in Patients With Nocturnal Leg Cramps With Trigger Points on Gastrocnemius Muscle||Completed||N/A|13|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 01:56:11.571984|2017-10-11 01:56:11.571984
NCT01804543|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2013-03-04|||June 2012||2012-06-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy|Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy|Unknown status|Recruiting|N/A|30|Anticipated|Westside Medical Associates of Los Angeles|||1||f||||f||||||||||2017-10-11 01:56:11.664764|2017-10-11 01:56:11.664764
NCT01804530|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-09-20|||August 2013||2013-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors|A Phase 1 Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX7486 as a Single Agent in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|59|Actual|Plexxikon||1|||f||||f||||||||||2017-10-11 01:56:11.788217|2017-10-11 01:56:11.788217
NCT01804517|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2016-12-06|||February 2013||2013-02-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01|1 Year|Observational [Patient Registry]|IMPACT||Impact of a Nurse for Migraine Management: the IMPACT Project|Impact of a Nursing Intervention on the Clinical Evolution of Patients at a University Migraine Clinic|Completed||N/A|200|Anticipated|Notre-Dame Hospital, Montreal, Quebec, Canada|||2||f||||f||||||||||2017-10-11 01:56:11.890922|2017-10-11 01:56:11.890922
NCT01804504|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-03-05|||March 2013||2013-03-01|March 2013|2013-03-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||Nutrition Education on the Metabolic Syndrome of Subjects Who Are Frequently Eating Out|Survey on Eating Out Behavior and Dietary Structure in Urban Chinese Citizens and the Effect of Nutrition Education|Unknown status|Enrolling by invitation|N/A|78|Anticipated|Second Military Medical University||2|||f||||f||||||||||2017-10-11 01:56:11.976448|2017-10-11 01:56:11.976448
NCT01804491|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-01|||October 2006||2006-10-01|March 2013|2013-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Motion Analysis in Patients With Hallux Rigidus|Motion Analysis in Patients With Hallux Rigidus Before and After Different Types of Surgery|Completed||N/A|56|Actual|University Hospital Heidelberg|||7||f||||f||||||||||2017-10-11 01:56:12.055145|2017-10-11 01:56:12.055145
NCT01804478|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-03-04|||May 2005||2005-05-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Non-invasive Measurement of Microvascular Blood Flow During Mild External Compression of the Leg|Non-invasive Measurement of Microvascular Blood Flow During Mild External Compression of the Leg|Completed||N/A|20|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 01:56:12.134766|2017-10-11 01:56:12.134766
NCT01804465|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-06-09|||January 2014||2014-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Randomized Phase 2 Trial of Combining Sipuleucel-T With Immediate vs. Delayed CTLA-4 Blockade for Prostate Cancer|A Randomized Phase 2 Trial of Immediate vs. Delayed Anti-CTLA4 Blockade Following Sipuleucel-T Treatment for Prostate Cancer Immunotherapy|Recruiting||Phase 2|54|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 01:56:12.35865|2017-10-11 01:56:12.35865
NCT01804452|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-05-05|||January 2011||2011-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|4RTNI||4 Repeat Tauopathy Neuroimaging Initiative|Observational Longitudinal Study of Magnetic Resonance Imaging, Specimen Biomarkers, and Clinical Progression in Progressive Supranuclear Palsy and Corticobasal Degeneration|Active, not recruiting||N/A|110|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     Plasma, serum, urine, cell lines and cerebrospinal fluid will be retained by study     investigators.   "|||2017-10-11 01:56:12.510481|2017-10-11 01:56:12.510481
NCT01804439|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-03-03|||January 1997||1997-01-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01|10 Years|Observational [Patient Registry]|||Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes|Cardiovascular Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes: a CALIBER Proposal Using Linked GPRD-MINAP-HES Data|Completed||N/A|2240000|Actual|University College, London|||1||f||||f||||||||||2017-10-11 01:56:12.608798|2017-10-11 01:56:12.608798
NCT01804426|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-04-19|||March 2013||2013-03-01|April 2016|2016-04-01|January 2016|Anticipated|2016-01-01|July 2015|Anticipated|2015-07-01||Observational|||Hair Cortisol Level as a Predictor of PTSD Development|Hair Cortisol Level as a Predictor of PTSD Development|Withdrawn||N/A|0|Actual|Shalvata Mental Health Center|||1|Lack of funding.|f||||f||||||Samples Without DNA|"     -  Blood        -  Saliva        -  Hair   "|||2017-10-11 01:56:12.713585|2017-10-11 01:56:12.713585
NCT01804413|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-10-23|||March 2011||2011-03-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency|Effects of Pegvisomant-Priming With the Glucagon Stimulation Test in Assessing GH and Cortisol Reserve in Adults: a Randomized Proof-of-Concept Pilot Study|Unknown status|Recruiting|N/A|10|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 01:56:12.800029|2017-10-11 01:56:12.800029
NCT01804400|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-11-16|||October 2012||2012-10-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber|A Randomized, Double-blind, Placebo-controlled Three-period Incomplete Cross Over Study to Compare the Efficacy of QAW039 Alone and in Combination With Montelukast in Patients With Allergic Rhinitis Using an Environmental Exposure Chamber|Completed||Phase 2|188|Actual|Novartis||5|||f||||f||||||||||2017-10-11 01:56:12.919561|2017-10-11 01:56:12.919561
NCT01804387|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2013-03-03|||May 2011||2011-05-01|March 2013|2013-03-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|TeSLA||Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study|Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study|Unknown status|Recruiting|Phase 4|60|Anticipated|Korea University||2|||f||||t||||||||||2017-10-11 01:56:13.029758|2017-10-11 01:56:13.029758
NCT01804374|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-06-16|||June 2011||2011-06-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SERIO||Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma|A Phase II, Open Label, Non-randomized Study of Second or Third Line Treatment With the Combination of Sorafenib and Everolimus in Patients Affected by Relapsed and Non-resectable High-grade Osteosarcoma|Completed||Phase 2|38|Actual|Italian Sarcoma Group||1|||f||||t||||||||||2017-10-11 01:56:13.143037|2017-10-11 01:56:13.143037
NCT01804361|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-07-20|||March 2013||2013-03-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes|Efficacy and Safety Study of Haporine-S in Subjects With Moderate to Severe Dry Eye, A Multicenter, Investigator(Assessor)Blind, Parallel Design, Non-inferiority Phase III Trial|Completed||Phase 3|90|Actual|DH Bio Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:56:13.251401|2017-10-11 01:56:13.251401
NCT01804348|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-03-04|||April 2013||2013-04-01|November 2012|2012-11-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|ROM||AL-SENSE 1-Step - Determination of Product Specificity|AL-SENSE 1-Step - Determination of Product Specificity|Unknown status|Not yet recruiting|N/A|150|Anticipated|Common Sense||1|||f||||f||||||||||2017-10-11 01:56:13.385322|2017-10-11 01:56:13.385322
NCT01804335|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-04-11|||February 2013||2013-02-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)|Exploratory Study to Evaluate the Safety and Efficacy of CD5789 in Subjects With Early Stage Cutaneous T-Cell Lymphoma|Completed||Phase 1|11|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 01:56:13.49459|2017-10-11 01:56:13.49459
NCT01804322|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-05|||February 2009||2009-02-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|EDU-COM||Standardized Educational Plan for Epilepsy Patients With Comorbidities|Comprehensive Information Imparted to Patients With Epilepsy and Comorbidity and Decreased Prevalence of Adverse Treatment Effects. The EDU-COM Study.|Completed||Phase 4|187|Actual|San Gerardo Hospital||2|||f||||t||||||||||2017-10-11 01:56:13.58434|2017-10-11 01:56:13.58434
NCT01804309|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2015-10-05|||March 2013||2013-03-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Functional Anatomical Examination of Axillary Sentinel Lymph Node Drainage in the Axillary Subregions in Early Breast Cancer|Functional Anatomical Examination of Axillary Sentinel Lymph Node Drainage in the Axillary Subregions in Early Breast Cancer|Completed||N/A|350|Actual|National Institute of Oncology, Hungary|||1||f||||t||||||||||2017-10-11 01:56:13.667507|2017-10-11 01:56:13.667507
NCT01804296|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-04-20|||March 2013||2013-03-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2|A Randomized, Double-Blinded, Sham-Controlled Trial of Repetitive Transcranial Magnetic Stimulation in Depressed Adolescents|Enrolling by invitation||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 01:56:13.750449|2017-10-11 01:56:13.750449
NCT01804283|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2013-03-03|||March 2013||2013-03-01|March 2013|2013-03-01||||March 2013|Anticipated|2013-03-01||Interventional|||Effects of Ischemic Postconditioning on MicroRNAs in Double Valve Replacement|Effects of Ischemic Postconditioning on Expression of Apoptosis-related MicroRNAs and Genes in Human Double Valve Replacement|Unknown status|Not yet recruiting|N/A|8|Anticipated|Central South University||2|||f||||t||||||||||2017-10-11 01:56:13.844434|2017-10-11 01:56:13.844434
NCT01804270|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-04-20|||April 2013||2013-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||rTMS for Depressed Teens: A Sham-Controlled Trial, Part 1|A Randomized, Double-Blinded, Sham-Controlled Trial of Repetitive Transcranial Magnetic Stimulation in Depressed Adolescents|Active, not recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 01:56:13.936219|2017-10-11 01:56:13.936219
NCT01804257|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-04-03|2015-09-15||May 2010||2010-05-01|March 2013|2013-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|EMITTER3PSY||Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study|Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study (EMITTER 3.0 PSY)|Completed||N/A|28|Actual|Proteus Digital Health, Inc.||1|||f||||f||||||||||2017-10-11 01:56:14.035953|2017-10-11 01:56:14.035953
NCT01804244|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2014-03-18|||March 2013||2013-03-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Single-Dose Pharmacokinetics and Safety Study of TMC278 in Healthy Adult Japanese Participants|An Open-label, Single-dose Study to Investigate the Pharmacokinetics and Safety of TMC278 After Oral Administration of TMC278 25 mg Tablet Under Fed Condition in Healthy Japanese Adult Male Subjects|Completed||Phase 4|8|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 01:56:14.236419|2017-10-11 01:56:14.236419
NCT01804231|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2016-01-19|||April 2013||2013-04-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|IGPC-3||Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer|A Prospective Study of Hybrid PET/MRI in the Evaluation of Men With Suspected Prostate Cancer Recurrence Following Definitive Local Therapy|Active, not recruiting||N/A|22|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 01:56:14.333801|2017-10-11 01:56:14.333801
NCT01804218|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-08-05|||March 2013||2013-03-01|August 2016|2016-08-01||||May 2016|Actual|2016-05-01||Interventional|||Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma||Active, not recruiting||Phase 2|60|Anticipated|Invion, Inc.||2|||f||||t||||||||||2017-10-11 01:56:14.433896|2017-10-11 01:56:14.433896
NCT01804205|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-02|||September 2008||2008-09-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Magnesium Sulphate and Rocuronium in Patients Over 60|Effects of Magnesium Sulphate on the Pharmacodynamics of Rocuronium in Patients 60 Years or Older: Randomised and Double-Blind Study|Completed||Phase 1|64|Actual|Instituto Nacional de Cancer, Brazil||2|||f||||f||||||||||2017-10-11 01:56:14.547902|2017-10-11 01:56:14.547902
NCT01804192|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-03-02|||February 2013||2013-02-01|March 2013|2013-03-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|Acu-TENS||Is Acupoints Sensation Necessary for Acu-TENS to Elicit Physiological Changes in Healthy Subjects?|Is Acupoints Sensation Necessary for Acu-TENS to Elicit Physiological Changes in Healthy Subjects?|Unknown status|Recruiting|N/A|36|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-11 01:56:14.670652|2017-10-11 01:56:14.670652
NCT01804179|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-06-13|||February 11, 2011|Actual|2011-02-11|June 2017|2017-06-01|March 31, 2018|Anticipated|2018-03-31|January 31, 2015|Actual|2015-01-31||Interventional|||Colorectal Cancer Awareness, Research, Education and Screening (CARES)|Colorectal Cancer Awareness, Research, Education and Screening (CARES)|Active, not recruiting||N/A|512|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|f|f||||||||2017-10-11 01:56:14.805743|2017-10-11 01:56:14.805743
NCT01804166|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-09-11|||March 21, 2013|Actual|2013-03-21|September 2017|2017-09-01|June 25, 2020|Anticipated|2020-06-25|June 25, 2020|Anticipated|2020-06-25||Interventional|||A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)|A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)|Recruiting||Phase 4|40|Anticipated|Janssen Scientific Affairs, LLC||1|||f||||f||f||||||||2017-10-11 01:56:14.960383|2017-10-11 01:56:14.960383
NCT01804153|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-03-01|||September 2012||2012-09-01|March 2013|2013-03-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Interventional|HULPURO||Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO)|Phase II Clinical Trial to Study the Feasibility and Safety of the Expanded Autologous Mesenchymal Stem Cells Use Derived From Adipose Tissue (ASC) for the Local Feminine Stress Urinary Incontinence|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Instituto de Investigación Hospital Universitario La Paz||1|||f||||||||||||||2017-10-11 01:56:15.089724|2017-10-11 01:56:15.089724
NCT01804140|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-11-01|2015-06-16||December 2012||2012-12-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational||All the participants who were enrolled and were evaluable for the BRAF V600 mutations were included in the analysis.|A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)|Screening Protocol to Detect BRAF V600 Mutation-Positive Patients for Enrollment Into Clinical Research Studies of Vemurafenib|Completed||N/A|662|Actual|Genentech, Inc.|||1||f||||||||||None Retained|"     Formalin-fixed paraffin-embedded (FFPE) tumor samples   "|||2017-10-11 01:56:15.23126|2017-10-11 01:56:15.23126
NCT01804127|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-02|2013-03-02|||February 2013||2013-02-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL|Interim PET/CT Guided Cycle Numbers of R-CHOP in Patients With Diffuse Large B-cell Lymphoma: a Exploratory Phase II Study Study|Recruiting||Phase 2|196|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 01:56:15.515712|2017-10-11 01:56:15.515712
NCT01804114|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-11-05|||March 2012||2012-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Continuous Local Anesthetic Infusion Following Hernia Repair|Continuous Preperitoneal Infusion of Local Anesthetic Via Pain Pump for Laparoscopic Ventral Hernia Repair|Completed||N/A|31|Actual|NorthShore University HealthSystem Research Institute||2|||f||||t||||||||||2017-10-11 01:56:15.637669|2017-10-11 01:56:15.637669
NCT01804101|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-06-15|||May 7, 2013|Actual|2013-05-07|June 2017|2017-06-01||||January 10, 2017|Actual|2017-01-10||Interventional|||Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia|Liposomal Cytarabine and Daunorubicin (CPX-351) for Adults With Untreated High-Risk MDS and Non-APL AML at High Risk of Treatment-Related Mortality|Active, not recruiting||N/A|90|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 01:56:15.761357|2017-10-11 01:56:15.761357
NCT01804075|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-08-31|2017-07-27||January 2011||2011-01-01|August 2017|2017-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|NAS||Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal|Evaluation of Efficacy of Methadone Versus Morphine for Treatment of Neonatal Abstinence Syndrome (NAS).|Completed||Phase 4|31|Actual|Eastern Maine Medical Center||2|||f||||f||||||||||2017-10-11 01:56:16.005878|2017-10-11 01:56:16.005878
NCT01804062|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-07-14|2015-07-14||February 2013||2013-02-01|July 2015|2015-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Respiration Rate V2.0 in Healthy Volunteers|Evaluation of Respiration Rate Parameters in Healthy Volunteers Using a Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0|Completed||N/A|30|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 01:56:16.307081|2017-10-11 01:56:16.307081
NCT01804049|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-08-10|||April 8, 2014|Actual|2014-04-08|August 2017|2017-08-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|M&M||Metformin and Muscle in Insulin-resistant Older Veterans|Metformin and Muscle in Insulin-resistant Older Veterans|Active, not recruiting||Phase 1/Phase 2|120|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 01:56:16.677694|2017-10-11 01:56:16.677694
NCT01804036|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-02-10|2016-08-08||March 2013||2013-03-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional||In Mind-Body Bridging, 41 participants consented, but one participant did not provide baseline assessment data; consequently, 40 Mind-Body Bridging participants' baseline data were included in the analyses.|Two Contrasting Interventions for Sleep Management|A Pilot Study of Two Contrasting Intervention Programs for Sleep Management|Completed||Phase 2/Phase 3|72|Actual|University of Utah||2|||f||||f||||||||No||2017-10-11 01:56:16.850286|2017-10-11 01:56:16.850286
NCT01804010|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-03-04|||May 2007||2007-05-01|March 2013|2013-03-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Pharmacokinetic, Pharmacodynamic Profiles and Safety After Oral Administration of Ivabradine in Male Healthy Korean Volunteers||Completed||Phase 1|48|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 01:56:18.178359|2017-10-11 01:56:18.178359
NCT01803997|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-03-06|||August 2012||2012-08-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Pink and Dude Chef|Pink and Dude Chef Afterschool Cooking Program: Improving Food Knowledge and Skills in Middle School Students|Completed||N/A|60|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 01:56:18.260865|2017-10-11 01:56:18.260865
NCT01803984|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-01-13|||March 2013||2013-03-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|MIBRAIN||MIBRAIN - Migraine and the Brain: Consequences, Causes, and Vascular Interaction|MIBRAIN - Migraine and the Brain: Consequences, Causes, and Vascular Interaction|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Bordeaux|||2||f||||f||||||||||2017-10-11 01:56:18.346765|2017-10-11 01:56:18.346765
NCT01803971|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-09-26|||June 2012||2012-06-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|ACCIO||Cardiac Arrest and Intra Osseous Infusion|Obtaining Vascular Access (Venous or Intraosseous) During Cardiac Arrest in Out-of-hospital Care: Delays and Failure Risk Factors|Completed||N/A|200|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-11 01:56:18.491853|2017-10-11 01:56:18.491853
NCT01803958|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-04-24|||April 2007||2007-04-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Breast Cancer With Low Risk Of Local Recurrence: Partial and Accelerated Radiation With Three-Dimensional Conformal Radiotherapy (3DCRT) Vs. Standard Radiotherapy After Conserving Surgery (Phase III Study|BREAST CANCER WITH LOW RISK OF LOCAL RECURRENCE: PARTIAL AND ACCELERATED RADIATION WITH THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY (3DCRT) VS. STANDARD RADIOTHERAPY AFTER CONSERVING SURGERY (PHASE III STUDY|Recruiting||N/A|3302|Anticipated|Regione Emilia-Romagna||2|||f||||t||||||||||2017-10-11 01:56:18.616541|2017-10-11 01:56:18.616541
NCT01803945|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-10-02|||January 2013||2013-01-01|April 2015|2015-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease|A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease|Terminated||Phase 1|32|Anticipated|Michael J. Fox Foundation for Parkinson's Research||2||First milestone was not met.|f||||t||||||||||2017-10-11 01:56:18.755349|2017-10-11 01:56:18.755349
NCT01803932|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-03-01|||September 2008||2008-09-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|November 2010|Actual|2010-11-01||Interventional|||Evaluation of a Male-focused Intervention to Prevent Intimate Partner Violence in a Conflict-affected Setting|Evaluation of a Male-focused Primary Prevention Intervention to Prevent Intimate Partner Violence in a Conflict-affected Setting: A Cluster Randomized Controlled Trial in Cote d'Ivoire|Completed||N/A|601|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 01:56:18.904965|2017-10-11 01:56:18.904965
NCT01803919|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-09-19|||November 2012||2012-11-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|ESCALE||Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients|Multicentric, Controlled, Randomized Clinical Trial to Assess the Efficacy and Cost-effectiveness of Urinary Catheters With Silver Alloy Coating Versus Conventional Catheters in Spinal Cord Injured Patients|Terminated||N/A|489|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2||Difficulties in recruitment|f||||t||||||||Yes||2017-10-11 01:56:19.016654|2017-10-11 01:56:19.016654
NCT01803906|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-08-09|||February 2012||2012-02-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Tissue Sample Study for Mitochondrial Disorders|Tissue Study for Mitochondrial Disorders|Enrolling by invitation||N/A|6900|Anticipated|Columbia University|||1||f||||f||||||Samples With DNA|"     Any type of tissue could be submitted, however, generally blood, urine, buccal cell (cheek),     and muscle are sent.   "|Yes|When applicable we will submit manuscript (s) describing the findings|2017-10-11 01:56:19.200907|2017-10-11 01:56:19.200907
NCT01803893|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-01|||September 2012||2012-09-01|March 2013|2013-03-01||||August 2014|Anticipated|2014-08-01||Observational|PIF-SET1||Prognostic Value of PIF Detection in Embryo Culture Media Correlation With Pregnancy Outcome|Preimplantation Factor (PIF): Prognostic Value of a Non-invasive Embryo Viability Biomarker Detection in Culture Media Followed by Single Embryo Transfer - Correlation With Live Birth.|Unknown status|Enrolling by invitation|N/A|500|Anticipated|BioIncept LLC|||2||f||||f||||||Samples Without DNA|"     embryo culture media   "|||2017-10-11 01:56:19.321331|2017-10-11 01:56:19.321331
NCT01803880|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-07-05|||March 2013||2013-03-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Interventional|ACT||Mechanical vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions|A Prospective, Double Blinded, Multicenter, Randomized, Controlled Trial to Evaluate Mechanical Debridement vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions|Terminated||N/A|148|Actual|Smith & Nephew, Inc.||2||Unable to meet enrollment goals|f||||t||||||||||2017-10-11 01:56:19.417054|2017-10-11 01:56:19.417054
NCT01803867|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-02-26|||March 2013||2013-03-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|M22||An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis|A Double-Blind, Placebo-Controlled, Single Ascending Intravenous Infusion Study of Recombinant Human Immunoglobulin M (rHIgM22) in Patients With Multiple Sclerosis (MS)|Completed||Phase 1|72|Actual|Acorda Therapeutics||1|||f||||t||||||||||2017-10-11 01:56:19.535468|2017-10-11 01:56:19.535468
NCT01803854|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-07-31|||September 2, 2014|Actual|2014-09-02|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|CSP# 585||Gulf War Era Cohort and Biorepository|CSP # 585 - Pilot Study: Gulf War Era Cohort and Biorepository|Active, not recruiting||N/A|1276|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|Samples With DNA|"     One EDTA tube of blood was collected from participants. All specimens have been processed and     stored at the VA Central Biorepository (VACB) for use in future research. One vial of buffy     coat containing the DNA is stored. One aliquot of plasma was also extracted for storage from     all samples.   "|||2017-10-11 01:56:19.652911|2017-10-11 01:56:19.652911
NCT01803841|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-11-14|||February 2013||2013-02-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|KOTRI||Korea Transradial Coronary Intervention Prospective Registry (KOTRI)|Korea Transradial Coronary Intervention Prospective Registry (KOTRI)|Completed||Phase 4|7300|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 01:56:19.754287|2017-10-11 01:56:19.754287
NCT01803828|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-07-07|||May 2014||2014-05-01|July 2014|2014-07-01|March 2018|Anticipated|2018-03-01|January 2017|Anticipated|2017-01-01||Interventional|RECOGITO||REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs|Phase IV Study on New Insights in Remodeling of Diabetic Cardiomyopathy: Gender Difference in Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A|Recruiting||Phase 4|164|Anticipated|University of Roma La Sapienza||2|||f||||||||||||||2017-10-11 01:56:19.877399|2017-10-11 01:56:19.877399
NCT01803815|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2014-10-31|||April 2010||2010-04-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Observational|ADOSA||Evaluation of Antihypertensive Drugs in OSA Patients|Evaluation of Antihypertensive Drugs in Patients With Obstructive Sleep Apnea|Completed||N/A|369|Actual|Universidade Nova de Lisboa|||1||f||||f||||||||||2017-10-11 01:56:20.058085|2017-10-11 01:56:20.058085
NCT01803802|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-12-01|||April 2005||2005-04-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2011|Actual|2011-08-01||Interventional|||Effects of Early Abuse on Adult Intimate Relationships|Effects of Early Abuse on Adult Intimate Relationships|Completed||N/A|148|Actual|University of Texas at Austin||3|||f||||f||||||||||2017-10-11 01:56:20.152431|2017-10-11 01:56:20.152431
NCT01803789|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-05-11|||May 2013||2013-05-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|1-2-KiWI||Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures|Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures|Recruiting||N/A|320|Anticipated|University Medicine Greifswald||2|||f||||f||||||||No||2017-10-11 01:56:20.270589|2017-10-11 01:56:20.270589
NCT01803776|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-10-31|||October 2007||2007-10-01|October 2016|2016-10-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|PANIC||Physical Activity and Nutrition in Children Study|Physical Activity and Diet Intervention Study to Improve Health and Wellbeing of Children|Active, not recruiting||N/A|512|Actual|University of Eastern Finland||1|||f||||f||||||||||2017-10-11 01:56:20.472051|2017-10-11 01:56:20.472051
NCT01803763|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2014-04-14|||September 2012||2012-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients|Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients|Completed||Phase 2/Phase 3|30|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 01:56:20.631329|2017-10-11 01:56:20.631329
NCT01803750|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-02-19|||February 2013||2013-02-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations|Building a Network of Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations|Terminated||N/A|3|Actual|Memorial Sloan Kettering Cancer Center|||1|Lack of accrual|f||||||||||||||2017-10-11 01:56:20.739221|2017-10-11 01:56:20.739221
NCT01803737|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2014-01-03|2013-11-04||January 2013||2013-01-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Statistical analyses were performed using the Statistical Package for the Social Sciences (IBM-SPSS, version 21.0). Statistical significance was accepted at the p<0.05 level of confidence. Analyses were conducted using individuals who completed assessments at week 0 and 12, with intent-to-treat (ITT) analysis carrying the baseline data forward.|Feasibility of a Campaign Intervention Compared to a Standard Behavioral Weight Loss Intervention in Overweight and Obese Adults|Feasibility of a Campaign Intervention Compared to a Standard Behavioral Weight Loss Intervention in Overweight and Obese Adults|Completed||N/A|26|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:56:20.863144|2017-10-11 01:56:20.863144
NCT01803165|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-09-20|||May 2013||2013-05-01|September 2017|2017-09-01|May 2014|Anticipated|2014-05-01|October 2013|Anticipated|2013-10-01||Observational|||Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting|Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting|Withdrawn||N/A|0|Actual|University of Nebraska|||2|Inadequate patient population|f||||f||||||||||2017-10-11 01:56:28.756762|2017-10-11 01:56:28.756762
NCT01803724|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-01|||May 2013||2013-05-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|||Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome|Comparison Between Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome Patients|Unknown status|Not yet recruiting|N/A|120|Anticipated|Pontificia Universidad Catolica de Chile|||1||f||||f||||||||||2017-10-11 01:56:21.481339|2017-10-11 01:56:21.481339
NCT01803698|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-11-17|||January 2017||2017-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Management of Gestational Weight Gain by Family Physicians: Seeking Congruence With Guidelines|MANAGEMENT OF GESTATIONAL WEIGHT GAIN BY FAMILY PHYSICIANS: SEEKING CONGRUENCE WITH GUIDELINES|Not yet recruiting||N/A|530|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 01:56:21.719648|2017-10-11 01:56:21.719648
NCT01803685|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-01|||February 2013||2013-02-01|March 2013|2013-03-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01|6 Months|Observational [Patient Registry]|NTSIAVMC||Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China|A Nationwide Treatment Survey of Intracranial Arteriovenous Malformation: a Multicenter Retrospective and Prospective Register Study in China|Unknown status|Recruiting|N/A|1000|Anticipated|Beijing Tiantan Hospital|||5||f||||t||||||||||2017-10-11 01:56:21.792474|2017-10-11 01:56:21.792474
NCT01803672|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-04-25|||January 2012||2012-01-01|April 2016|2016-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effectiveness of an Integrated Programme in Promoting the Regular Physical Activity Among Childhood Cancer Survivors|Effectiveness of an Integrated Adventure-Based Training and Health Education Programme in Promoting the Adoption and Maintenance of Regular Physical Activity Among Childhood Cancer Survivors|Completed||N/A|71|Actual|The University of Hong Kong||2|||f||||t||||||||No||2017-10-11 01:56:21.872837|2017-10-11 01:56:21.872837
NCT01803659|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-06-10|||January 2013||2013-01-01|June 2015|2015-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Small Daily Doses of B-carotene on Breast Milk Retinol|Effect of Small Daily Doses of B-carotene or Vitamin A on Breast Milk Retinol Concentration in Lactating Filipino Women.|Completed||N/A|85|Actual|University of California, Davis||3|||f||||f||||||||||2017-10-11 01:56:21.966916|2017-10-11 01:56:21.966916
NCT01803646|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-07-05|||February 2014||2014-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TACTT2||AM-101 in the Treatment of Acute Tinnitus 2|Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 2|Completed||Phase 3|332|Actual|Auris Medical, Inc.||2|||f||||f||||||||||2017-10-11 01:56:22.053819|2017-10-11 01:56:22.053819
NCT01803633|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-05-18|||September 2012||2012-09-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Determine How Consumption of Dairy Fat as Cheese Influences Inflammation-Phase 2|Effects of Dairy Fat on Postprandial Inflammation- Phase 2|Completed||N/A|20|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 01:56:22.145193|2017-10-11 01:56:22.145193
NCT01803607|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-04-12|2017-02-27||March 2013||2013-03-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)|A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Overall Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate|Terminated||Phase 3|135|Actual|Merck Sharp & Dohme Corp.||2||Study halted prematurely due to low enrollment.|f||||t||||||||||2017-10-11 01:56:22.456079|2017-10-11 01:56:22.456079
NCT01803594|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-02-03|||August 2012||2012-08-01|February 2016|2016-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|HDL||Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism|Postprandial Modulation of HDL Metabolism|Completed||N/A|18|Actual|University of California, Davis||3|||f||||f||||||||||2017-10-11 01:56:23.026769|2017-10-11 01:56:23.026769
NCT01803581|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-03-01|||February 2013||2013-02-01|March 2013|2013-03-01||||May 2013|Anticipated|2013-05-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice|A Randomized, Controlled, Investigator-blinded, Comparative Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice|Unknown status|Enrolling by invitation|Phase 3|50|Anticipated|Oystershell NV||2|||f||||f||||||||||2017-10-11 01:56:23.16313|2017-10-11 01:56:23.16313
NCT01803568|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-03-01|||September 2011||2011-09-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|MyoGlu||Skeletal Muscles, Myokines and Glucose Metabolism MYOGLU|Skeletal Muscles, Myokines and Glucose Metabolism|Completed||N/A|31|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:56:23.262187|2017-10-11 01:56:23.262187
NCT01803555|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2014-08-01|||June 2013||2013-06-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®|A 12-Week Efficacy and Safety Evaluation of Budesonidel/Formoterol SPIROMAX® 160/4.5 mcg Inhalation Powder Versus SYMBICORT® TURBOHALER® 200/6 mcg in Adult and Adolescent Patients With Persistent Asthma|Completed||Phase 3|605|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 01:56:23.375368|2017-10-11 01:56:23.375368
NCT01803542|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-10|2017-09-19|||March 2006||2006-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Stereotactic Radiotherapy (SBRT) of Lung Metastasis|Lung Stereotactic Radiation Therapy for Patients With Non-small Cell Lung Cancer and Other Cancers|Recruiting||Phase 2|200|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 01:56:23.749927|2017-10-11 01:56:23.749927
NCT01803529|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-01-18|||October 2003||2003-10-01|January 2016|2016-01-01|October 2009|Actual|2009-10-01|September 2008|Actual|2008-09-01||Interventional|||Deep Friction Massage for Intercostal Pain in Patients With Heart Disease|Standard Heat-pack With or Without Deep Friction Massage for Intercostal Pain in Patients With Heart Disease|Completed||N/A|29|Actual|St. Olavs Hospital||2|||f||||f||||||||||2017-10-11 01:56:23.859278|2017-10-11 01:56:23.859278
NCT01803516|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-02-15|||February 2013||2013-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser|Quality of Life Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser|Active, not recruiting||N/A|22|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 01:56:23.960923|2017-10-11 01:56:23.960923
NCT01803503|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2016-06-21|||May 2013||2013-05-01|June 2016|2016-06-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors|Phase II Randomized Study of Docetaxel With or Without Low-dose, Short Course Sunitinib in the Treatment of Advanced Solid Tumors|Recruiting||Phase 2|80|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 01:56:24.065303|2017-10-11 01:56:24.065303
NCT01803490|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-05-07|||January 2013||2013-01-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Bacterial Colonization of Suction Drains Following Spine Surgery|Bacterial Colonization of Suction Drains Following Spine Surgery|Recruiting||N/A|300|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||f||||||||||2017-10-11 01:56:24.204334|2017-10-11 01:56:24.204334
NCT01803477|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2014-09-08|||February 2013||2013-02-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm|A Seamless Phase 1/2 Exploratory Multi-centre, Investigator-blind, Dose Escalation Study (Study Part 1), Followed by a Randomised, Intra-subject, Active Controlled Efficacy Study of Different Ingenol Mebutate Formulations Applied to the Forearm for 2 Consecutive Days (Study Part 2)|Completed||Phase 1/Phase 2|37|Actual|LEO Pharma||4|||f||||f||||||||||2017-10-11 01:56:24.285326|2017-10-11 01:56:24.285326
NCT01803438|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-01-26|||June 2014||2014-06-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|November 2019|Anticipated|2019-11-01||Interventional|||Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation|Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation.|Recruiting||Phase 4|218|Anticipated|Medtronic Atrial Fibrillation Solutions||2|||f||||t||||||||||2017-10-11 01:56:24.628239|2017-10-11 01:56:24.628239
NCT01803425|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-09-05|||April 2013||2013-04-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka|Post-marketing Surveillance (PMS) of GlaxoSmithKline Biologicals' 10-valent Pneumococcal Conjugate Vaccine (Synflorix™) When Administered to Healthy Infants and Children According to the Prescribing Information in Sri Lanka|Withdrawn||N/A|0|Actual|GlaxoSmithKline|||1|"Lack of clarity regarding the PMS study requirement from the RA and Ethics committee hence it   was concluded GSK will submit local PSURs."|f||||||||||||||2017-10-11 01:56:24.791011|2017-10-11 01:56:24.791011
NCT01803412|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-10-27|||May 2013||2013-05-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects|An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in US and Canadian Subjects With Duchenne Muscular Dystrophy.|Terminated||Phase 3|53|Actual|BioMarin Pharmaceutical||3|||f||||f||||||||||2017-10-11 01:56:24.880434|2017-10-11 01:56:24.880434
NCT01803399|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-01-26|||August 2014||2014-08-01|January 2015|2015-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers|A Phase I, Randomized, Partially Blinded, Placebo- and Moxifloxacin-Controlled, 4-Period Crossover Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers (PDF112166)|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||4||"Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen   that changed the risk: benefit profile and led to a termination"|f||||f||||||||||2017-10-11 01:56:24.997992|2017-10-11 01:56:24.997992
NCT01803386|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-07-21|||January 2013||2013-01-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography|Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography|Completed||N/A|20|Actual|Skulpt, Inc.|||2||f||||t||||||||||2017-10-11 01:56:25.118187|2017-10-11 01:56:25.118187
NCT01803373|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2014-03-16|||April 2013||2013-04-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study to Assess the Relative Bioavailability of TMC207 Following Single-Dose Administrations of Two Pediatric Formulations in Healthy Adult Participants|A Phase I, Open-label, Randomized, 3-way Crossover Study in 3 Panels of Healthy, Adult Subjects to Assess the Relative Bioavailability of TMC207 Following Single-dose Administration of Two Pediatric Formulations Using a 100 mg Tablet Formulation as the Reference, With and Without Food.|Completed||Phase 1|36|Actual|Janssen Infectious Diseases BVBA||6|||f||||f||||||||||2017-10-11 01:56:25.229379|2017-10-11 01:56:25.229379
NCT01803360|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-13|||March 2013||2013-03-01|March 2013|2013-03-01|September 2013|Anticipated|2013-09-01|July 2013|Anticipated|2013-07-01||Interventional|||Efficacy Study of Neridronate to Treat Painful Osteoarthritis of the Knee With Bone Marrow Lesions.|A Randomized, Double-blind, Placebo Controlled Trial to Assess the Efficacy of Neridronate 100 mg -4 i.v. Infusions- in Patients With Painful Osteoarthritis of the Knee With Bone Marrow Lesions.|Unknown status|Recruiting|Phase 2|60|Anticipated|ASST Gaetano Pini-CTO||2|||f||||||||||||||2017-10-11 01:56:25.33789|2017-10-11 01:56:25.33789
NCT01803347|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2013-03-01|||February 2013||2013-02-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|March 2014|Anticipated|2014-03-01||Interventional|FISPAC||Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells|Multicentre,Randomized,Comparative,Add-on,Into Two Parallel Groups Clinical Trial to Evaluate Efficacy and Safety of Autologous Mesenchymal Stem Cells Derived From Expanded Adipose Tissue (ASC), for Treatment of Complex Perianal Fistulizing Disease in Patients Without IBD.|Unknown status|Recruiting|Phase 3|80|Anticipated|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-11 01:56:25.445129|2017-10-11 01:56:25.445129
NCT01803334|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-03-01|||June 2012||2012-06-01|February 2013|2013-02-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Impact of Marking Surgical Incision on Patient's Abdomen|Impact of Marking Surgical Incision Size and Location on the Patient's Abdomen During Preoperative Counseling in Minimally Invasive Gynecologic Surgery. A Randomized Control Trial.|Unknown status|Recruiting|N/A|54|Anticipated|Florida Hospital||2|||f||||f||||||||||2017-10-11 01:56:25.584282|2017-10-11 01:56:25.584282
NCT01803321|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2013-02-28|||November 2005||2005-11-01|February 2013|2013-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)|A Pilot, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Safety, Tolerability and Preliminary Efficacy Study of Two Dose Levels of IL-1 Trap Administered Subcutaneously in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)|Completed||Phase 1|24|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-11 01:56:25.673131|2017-10-11 01:56:25.673131
NCT01803308|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2014-12-08|||March 2013||2013-03-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection|A Phase 1a/1b Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of SB 9200 in Treatment Naïve HCV Infected Adults|Completed||Phase 1|37|Actual|INC Research||2|||f||||t||||||||||2017-10-11 01:56:25.767002|2017-10-11 01:56:25.767002
NCT01803295|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-06-15|||June 2013||2013-06-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|July 2016|Actual|2016-07-01||Interventional|OPTIMA||Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC|Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)|Completed||N/A|80|Actual|UroGen Pharma Ltd.||3|||f||||f||||||||||2017-10-11 01:56:25.960627|2017-10-11 01:56:25.960627
NCT01803282|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-08-24|||March 29, 2013|Actual|2013-03-29|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Safety and Tolerability Study in Solid Tumors|A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5745 as Monotherapy and in Combination With Chemotherapy in Subjects With Advanced Solid Tumors|Recruiting||Phase 1|261|Anticipated|Gilead Sciences||2|||f||||f|t|f||||||||2017-10-11 01:56:26.08977|2017-10-11 01:56:26.08977
NCT01803269|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-08-07|||January 16, 2013|Actual|2013-01-16|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|March 2016|Actual|2016-03-01||Interventional|||Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer|A Randomized Phase II Study of IV Topotecan Versus CRLX101 in the Second Line Treatment of Recurrent Small Cell Lung Cancer|Terminated||Phase 2|33|Actual|University of Chicago||2||Due to lack of activity and slow accrual|f||||f||||||||||2017-10-11 01:56:26.341159|2017-10-11 01:56:26.341159
NCT01803256|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-11-25|||April 2013||2013-04-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|September 2014|Actual|2014-09-01||Observational|||Possibilities and Limitations of a New Method for the Measurement of Spine Dynamics During Gait|The Measurement of Spine Dynamics During Gait for the Quantification of Intervention Outcomes in Patients With Different Pathologies|Completed||N/A|30|Actual|University Children's Hospital Basel|||2||f||||f||||||||||2017-10-11 01:56:26.461351|2017-10-11 01:56:26.461351
NCT01803243|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-11-25|||July 2013||2013-07-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Spine Biomechanics During Gait Following Lower Extremity Treatment in Different Patient Groups|The Measurement of Spine Dynamics During Gait for the Quantification of Intervention Outcomes in Patients With Different Pathologies|Recruiting||N/A|45|Anticipated|University Children's Hospital Basel||4|||f||||f||||||||||2017-10-11 01:56:26.539389|2017-10-11 01:56:26.539389
NCT01803230|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-03-01|||February 2013||2013-02-01|February 2013|2013-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Creatine Supplementation on Cognition in Children|Effects of Creatine Supplementation on Cognitive Function in Children|Unknown status|Recruiting|N/A|100|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 01:56:26.639276|2017-10-11 01:56:26.639276
NCT01803217|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-04-07|||November 2007|Actual|2007-11-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|December 2011|Actual|2011-12-01||Interventional|ADVANTAGE||Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing|AV-Hysteresis Versus Mode Switch to AAI (MVP) for the Avoidance of Unnecessary Right Ventricular Pacing|Completed||N/A|70|Actual|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||||2017-10-11 01:56:28.389071|2017-10-11 01:56:28.389071
NCT01803191|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-03-24|||August 2012|Actual|2012-08-01|March 2017|2017-03-01|January 25, 2016|Actual|2016-01-25|January 25, 2016|Actual|2016-01-25||Interventional|BIPROST||Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy|Randomized Controlled Clinical Trial of Efficacy of Fosfomycin Versus Ciprofloxacin as Antibiotic Prophylaxis Prior to Ultrasound Guided Transrectal Prostate Biopsy|Completed||Phase 4|461|Actual|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||2|||f||||f||||||||||2017-10-11 01:56:28.576584|2017-10-11 01:56:28.576584
NCT01803178|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-10-25|||February 2013||2013-02-01|February 2013|2013-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of Plant Sterols on Vascular Function|The Effect of Plant Sterols on Vascular Function|Completed||N/A|240|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-11 01:56:28.665573|2017-10-11 01:56:28.665573
NCT01803152|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-09-18|||January 6, 2014|Actual|2014-01-06|September 2017|2017-09-01|August 2024|Anticipated|2024-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma|A Phase I Trial of Dendritic Cell Vaccination With and Without Inhibition of Myeloid Derived Suppressor Cells by Gemcitabine Pre-Treatment For Children And Adults With Sarcoma|Suspended||Phase 1|56|Anticipated|University of Miami||2||Investigator Decision Pending Amendment|f||||t|t|f||||||||2017-10-11 01:56:28.853641|2017-10-11 01:56:28.853641
NCT01803139|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-03-01|||April 2013||2013-04-01|March 2013|2013-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|IMRT-FU||Long Term Results of the Canadian Breast IMRT Study|Long Term Outcomes of a Multicentre Controlled Clinical Trial of Breast Irradiation Using Intensity-Modulated Radiation Therapy|Unknown status|Not yet recruiting|Phase 3|358|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 01:56:28.965232|2017-10-11 01:56:28.965232
NCT01803126|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2017-05-10|||June 2012||2012-06-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||A Proposed Study of Atherosclerotic Plaques in Leg Arteries|A Proposed Study of Atherosclerotic Plaques in Leg Arteries|Active, not recruiting||N/A|10|Anticipated|Southwest Regional Wound Care Center|||1||f||||f||||||||No||2017-10-11 01:56:29.107058|2017-10-11 01:56:29.107058
NCT01803113|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-03-11|||January 2013||2013-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Sofia hCG FIA Field Study|Sofia hCG FIA Field Study|Completed||N/A|975|Actual|Quidel Corporation|||1||f||||f||||||Samples Without DNA|"     Leftover urine specimens may be retained to be used for further product testing.   "|||2017-10-11 01:56:29.194566|2017-10-11 01:56:29.194566
NCT01803100|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-10-23|||January 2013||2013-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Observational|||Characterizing and Comparing the Profile of Microorganisms From Specific Body Sites and Environmental Surfaces in Newly Disinfected Patient Rooms|Study of the Temporal Profile and Bi-directional Transmission of Microorganisms Between Patients and Environmental Surfaces.|Completed||N/A|80|Actual|Duke University|||1||f||||f||||||Samples Without DNA|"     Swabs from nares, oropharynx, axillae, peri-rectal. Fecal specimens   "|||2017-10-11 01:56:29.424264|2017-10-11 01:56:29.424264
NCT01803087|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2013-03-01|||February 2012||2012-02-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|ADO pMDI||Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients|A SINGLE-DOSE, OPEN LABEL, RANDOMIZED, 3-WAY CROSSOVER, CLINICAL PHARMACOLOGY STUDY OF CHF 1535 100/6 pMDI (FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 100 µg PLUS FORMOTEROL FUMARATE 6 µg) WITH OR WITHOUT SPACER DEVICE VERSUS THE FREE COMBINATION OF LICENSED BECLOMETHASONE pMDI AND FORMOTEROL pMDI IN ASTHMATIC ADOLESCENT PATIENTS AND ONE OPEN ARM FOR ADULT PATIENTS AS CONTROL GROUP TREATED WITH CHF 1535 100/6 pMDI.|Completed||Phase 2|60|Actual|Chiesi Farmaceutici S.p.A.||4|||f||||f||||||||||2017-10-11 01:56:29.576675|2017-10-11 01:56:29.576675
NCT01803074|ClinicalTrials.gov processed this data on October 10, 2017|2013-03-01|2017-01-19|||April 2013||2013-04-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study to Evaluate a HIV Drug for the Treatment of HIV Infection|Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacodynamics, Safety and Pharmacokinetics of BMS-955176 (Double-Blinded) and BMS-955176 With Atazanavir +/- Ritonavir (Open-Labeled) in HIV-1 Infected Subjects|Completed||Phase 2|107|Actual|ViiV Healthcare||13|||f||||f||||||||||2017-10-11 01:56:29.739708|2017-10-11 01:56:29.739708
NCT01803061|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-03-05|||September 2010||2010-09-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care|Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care|Completed||N/A|300|Anticipated|Danish Cancer Society||2|||f||||f||||||||||2017-10-11 01:56:29.964831|2017-10-11 01:56:29.964831
NCT01803048|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-05-01|||February 2013|Actual|2013-02-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Predicting Cognitive and Emotional Health From Neurocircuitry Following TBI|A Model for Predicting Cognitive and Emotional Health From Structural and Functional Neurocircuitry Following Traumatic Brain Injury|Recruiting||N/A|180|Anticipated|University of Arizona|||2||f||||||||||||||2017-10-11 01:56:30.087865|2017-10-11 01:56:30.087865
NCT01803035|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-04-25|||February 2013||2013-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo|A Phase II, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 (1 % and 2 %) Versus Placebo in Impetigo|Completed||Phase 2|210|Anticipated|Lytix Biopharma AS||3|||f||||f||||||||||2017-10-11 01:56:30.201682|2017-10-11 01:56:30.201682
NCT01803022|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-09-18|||November 2012||2012-11-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer|Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer|Completed||N/A|419|Actual|LEO Pharma|||1||f||||f||||||||||2017-10-11 01:56:30.323485|2017-10-11 01:56:30.323485
NCT01803009|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-04-01|||November 2012||2012-11-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|March 2013|Actual|2013-03-01||Interventional|CRC-RAT||Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool|Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool|Completed||N/A|63|Actual|Indiana University||1|||f||||f||||||||||2017-10-11 01:56:30.439497|2017-10-11 01:56:30.439497
NCT01802996|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-10-29|||March 2013||2013-03-01|October 2013|2013-10-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|MAGIC||Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury|A Randomized, Controlled, Multi-center Collaborative Study to Evaluate the Efficacy of Magnesium Isoglycyrrhizinate Injection in the Prevention of Antineoplastic Chemotherapy Related Acute Liver Injury|Unknown status|Recruiting|Phase 4|2040|Anticipated|Cttq||2|||f||||f||||||||||2017-10-11 01:56:30.552924|2017-10-11 01:56:30.552924
NCT01802983|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-03-01|||January 2009||2009-01-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||The Prognostic Assessment of Extubation in Aged Patients With Multiple Organ Dysfunction Syndrome|Key Technology Research of the Comprehensive Treatment of Multiple Organ Dysfunction Syndrome|Unknown status|Recruiting|N/A|1|Anticipated|Chinese PLA General Hospital|||1||f||||t||||||||||2017-10-11 01:56:30.826873|2017-10-11 01:56:30.826873
NCT01802970|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-01-13|||December 2012||2012-12-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients|Pilot Safety and Blood Immune Cell Transcriptional Profiling Study of Anakinra Plus the Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients|Recruiting||Phase 1|20|Anticipated|Baylor Research Institute||1|||f||||f||||||||||2017-10-11 01:56:30.928252|2017-10-11 01:56:30.928252
NCT01802957|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2015-01-26|||March 2013||2013-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Health Facility Networking for Maternal Health|Health Facility Networking for Maternal Health|Completed||N/A|10787|Actual|Harvard School of Public Health||1|||f||||t||||||||||2017-10-11 01:56:31.077915|2017-10-11 01:56:31.077915
NCT01802944|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-10-04|||April 2014|Actual|2014-04-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intranasal Insulin: A Novel Treatment for Gulf War Multisymptom Illness|Intranasal Insulin: A Novel Treatment for Gulf War Multisymptom Illness|Recruiting||Phase 2|114|Anticipated|Bronx Veterans Medical Research Foundation, Inc||3|||f||||f||||||||||2017-10-11 01:56:31.242192|2017-10-11 01:56:31.242192
NCT01802931|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-07-24|||January 7, 2013|Actual|2013-01-07|July 2017|2017-07-01|April 15, 2013|Actual|2013-04-15|April 15, 2013|Actual|2013-04-15||Interventional|||GSK239512 DDI Study|An Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole on the Pharmacokinetics of GSK239512|Completed||Phase 1|22|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:56:31.395786|2017-10-11 01:56:31.395786
NCT01802918|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-05-05|||February 18, 2013|Actual|2013-02-18|May 2017|2017-05-01|November 21, 2013|Actual|2013-11-21|November 21, 2013|Actual|2013-11-21||Interventional|||Single Dose Escalation Study of GSK2838232 in Healthy Subjects|A Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 and to Evaluate the Effect of Food and Ritonavir on GSK2838232 in Healthy Subjects|Completed||Phase 1|17|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:56:31.539905|2017-10-11 01:56:31.539905
NCT01802905|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-02-04|||June 2012||2012-06-01|February 2013|2013-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies|Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies|Completed||N/A|100|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 01:56:31.665473|2017-10-11 01:56:31.665473
NCT01802892|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-06-06|||November 2, 2012|Actual|2012-11-02|June 2017|2017-06-01|April 2, 2013|Actual|2013-04-02|April 2, 2013|Actual|2013-04-02||Interventional|||Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret)|An Open Label, Single Center, Adaptive Phase I Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret; a Calcium Sensing Receptor Antagonist)|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 01:56:31.884348|2017-10-11 01:56:31.884348
NCT01802879|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-02-07|||June 24, 2013|Actual|2013-06-24|February 2017|2017-02-01|November 9, 2018|Anticipated|2018-11-09|November 9, 2018|Anticipated|2018-11-09||Interventional|||Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator|An Open-label Multi-center Single Agent Panobinostat Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Panobinostat Study and Are Judged by the Investigator to Benefit From Continued Single Agent Panobinostat Treatment|Active, not recruiting||Phase 2|9|Actual|Novartis||1|||f||||f||||||||||2017-10-11 01:56:31.992125|2017-10-11 01:56:31.992125
NCT01802866|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-06-26||2017-06-26|February 2013||2013-02-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|SEATTLE||Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride|A Phase 2b/3 Multicenter, Randomized, Double-Masked, Dose-Ranging Study Comparing the Efficacy and Safety of Emixustat Hydrochloride (ACU-4429) With Placebo for the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration|Completed||Phase 2/Phase 3|508|Actual|Acucela Inc.||4|||f||||t||||||||Undecided||2017-10-11 01:56:32.111476|2017-10-11 01:56:32.111476
NCT01802853|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-11-01|||May 2013||2013-05-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers|Open Label, Randomized, 2 Way-crossover Study to Investigate the Absolute Bioavailability and Pharmacokinetics of RO6811135, Following Single Dose Administration by Subcutaneous and Intravenous Route in Healthy Subjects.|Completed||Phase 1|12|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:56:32.218909|2017-10-11 01:56:32.218909
NCT01802840|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2013-02-28|||March 2012||2012-03-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Soy Fiber Improves Weight Loss and Lipid Profile|Soy Fiber Improves Weight Loss And Lipid Profile In Overweight And Obese Adults: A Randomized Controlled Trial|Completed||N/A|39|Actual|Zhejiang University||2|||f||||t||||||||||2017-10-11 01:56:32.308957|2017-10-11 01:56:32.308957
NCT01802827|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2013-02-28|||June 2009||2009-06-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Observational|||Ventilator Associated Tracheobronchitis in the First 14 Days in ICU||Completed||N/A|236|Actual|University of Thessaly|||3||f||||t||||||Samples Without DNA|"     blood, sputum   "|||2017-10-11 01:56:32.403955|2017-10-11 01:56:32.403955
NCT01802814|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-05-04|||May 2014||2014-05-01|May 2017|2017-05-01|July 2021|Anticipated|2021-07-01|April 2021|Anticipated|2021-04-01||Interventional|||International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010|International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group|Recruiting||Phase 3|1242|Anticipated|University Hospital of Berlin||4|||f||||t||||||||||2017-10-11 01:56:32.485446|2017-10-11 01:56:32.485446
NCT01802801|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-25|2013-02-28|||December 2007||2007-12-01|February 2013|2013-02-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|||Intra- and Interobserver Agreement in the Assessment of Human Embryos|Intra-and Inter-observer Agreement in the Morphological Assessment of Human Embryos|Completed||N/A|50|Actual|University Hospital, Gasthuisberg|||1||f||||||||||||||2017-10-11 01:56:32.680144|2017-10-11 01:56:32.680144
NCT01802788|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-11-23|||April 2013||2013-04-01|November 2016|2016-11-01|August 2022|Anticipated|2022-08-01|May 2018|Anticipated|2018-05-01||Observational|PORTICO-1||5 Year Observation of Patients With PORTICO Valves|International Long-term Follow-up Study of Patients Implanted With a Portico™ Valve|Recruiting||N/A|1050|Anticipated|St. Jude Medical|||2||f||||t||||||||No||2017-10-11 01:56:32.764399|2017-10-11 01:56:32.764399
NCT01802775|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-11-18||2015-11-18|January 2013||2013-01-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ePAD||Edoxaban in Peripheral Arterial Disease|A Randomized, Open-Label, Parallel-Group, Multi-Center Study Of Adding Edoxaban Or Clopidogrel To Aspirin To Maintain Patency In Subjects With Peripheral Arterial Disease Following Femoropopliteal Endovascular Intervention|Completed||Phase 2|200|Anticipated|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 01:56:33.164941|2017-10-11 01:56:33.164941
NCT01802762|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2017-09-04|||January 2013|Actual|2013-01-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|||A New Multi-parameter Neuromonitoring System to Save Patients' Lives in Stroke and Brain Injury|A New Multi-parameter Neuromonitoring System to Save Patients' Lives in Stroke and Brain Injury|Completed||N/A|16|Actual|NeMoDevices AG||1|||f||||f||||||||||2017-10-11 01:56:33.370093|2017-10-11 01:56:33.370093
NCT01802749|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2016-12-20|||November 2013||2013-11-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|MITO16MANGO2b||Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer|Multicenter Phase III Randomized Study With Second Line Chemotherapy Plus or Minus Bevacizumab in Patients With Platinum Sensitive Epithelial Ovarian Cancer Recurrence After a Bevacizumab/Chemotherapy First Line|Active, not recruiting||Phase 3|406|Actual|National Cancer Institute, Naples||2|||f||||t||||||||||2017-10-11 01:56:33.485243|2017-10-11 01:56:33.485243
NCT01802736|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-02-28|||February 2013||2013-02-01|February 2013|2013-02-01|March 2014|Anticipated|2014-03-01|September 2013|Anticipated|2013-09-01||Interventional|ASK||Alcohol Use and Risky Sexual Behaviors Among HIV Infected Subjects in Kampala Uganda|Alcohol Consumption and Alcohol Reduction Intervention Among HIV Infected Persons in a Large Urban HIV Clinic in Uganda|Unknown status|Active, not recruiting|N/A|510|Anticipated|Makerere University||2|||f||||f||||||||||2017-10-11 01:56:33.799636|2017-10-11 01:56:33.799636
NCT01802723|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-03-05||2015-03-05|February 2013||2013-02-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|RESET||Dose Ranging Study|A Dose Ranging Study of the Safety and Efficacy of LIPO-202 Healthy Patients With Subcutaneous Fat in the Periumbilical Area|Completed||Phase 2|472|Actual|Neothetics, Inc||4|||f||||f||||||||||2017-10-11 01:56:33.916443|2017-10-11 01:56:33.916443
NCT01802697|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-01-18|||February 2013||2013-02-01|January 2017|2017-01-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Safety Study on IdeS in Healthy Volounteers|A Phase i Single Center Study to Evalute the Safety, Tolerability and Pharmacokinetics of Intravenous IdeS After Administration of Single Ascending Doses in Healthy Male Subjects|Completed||Phase 1|29|Actual|Hansa Medical AB||2|||f||||t||||||||No||2017-10-11 01:56:34.281733|2017-10-11 01:56:34.281733
NCT01802684|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-02-28|||May 2013||2013-05-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|November 2014|Actual|2014-11-01||Interventional|VELVET||OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer|OPTIMOX-aflibercept as First-line Therapy in 49 Patients With Unresectable Metastatic Colorectal Cancer. A GERCOR Feasibility Single-arm Phase II Study.|Completed||Phase 2|49|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||t||||||||||2017-10-11 01:56:34.37583|2017-10-11 01:56:34.37583
NCT01802671|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-02-28|||April 2013||2013-04-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|POETS||Efficacy Study of Cognitive Behavioural Treatment With Support on Communication and Information Technologies for the Management of Chronic Low Back Pain|Cognitive Behavioural Treatment With Support on Communication and Information Technologies for the Management of Chronic Low Back Pain: A Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|180|Anticipated|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana||3|||f||||f||||||||||2017-10-11 01:56:34.487846|2017-10-11 01:56:34.487846
NCT01802658|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2016-01-12|||November 2012||2012-11-01|January 2016|2016-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|DBMZol||Bone Demineralization Lesions in the Injured Marrow: Efficacy and Tolerability of Administration Early and Repeated the Zoledronic Acid. Comparative Study, Prospective, Double-blind Controlled (DBMZol)|Bone Demineralization Lesions in the Injured Marrow: Efficacy and Tolerability of Administration Early and Repeated the Zoledronic Acid. Comparative Study, Prospective, Double-blind Controlled|Recruiting||Phase 3|100|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 01:56:34.617198|2017-10-11 01:56:34.617198
NCT01802645|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-09-25|||February 2013||2013-02-01|September 2014|2014-09-01|July 2020|Anticipated|2020-07-01|July 2017|Anticipated|2017-07-01||Interventional|CELIM2||Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases|Open, Randomized, Multicenter Phase II Trial With Cetuximab /5-FU/FA/Irinotecan or Cetuximab/5-FU/FA /Irinotecan/Oxaliplatin in K-ras/B-raf Wild Type Patients or With Irinotecan/Oxaliplatin/5-FU/FA With or Without Bevacizumab in K-ras Mutant Patients as Neoadjuvant Treatment in Patients With Non- Resectable Colorectal Liver Metastases.|Recruiting||Phase 2|256|Anticipated|Technische Universität Dresden||4|||f||||t||||||||||2017-10-11 01:56:34.758371|2017-10-11 01:56:34.758371
NCT01802632|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-03-21|2016-04-29||March 4, 2013|Actual|2013-03-04|March 2017|2017-03-01|November 1, 2017|Anticipated|2017-11-01|May 1, 2015|Actual|2015-05-01||Interventional|AURA||AZD9291 First Time In Patients Ascending Dose Study|Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AZD9291 in Patients With Advanced Non Small Cell Lung Cancer Who Progressed on Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Agent|Active, not recruiting||Phase 1/Phase 2|975|Actual|AstraZeneca|All 6 cohorts are still on-going. Data cut-off on 1st May 2015 was for primary analyses in main cohorts of dose escalation, dose expansion, extension. AEs presented for all cohorts.|1|||f||||f||||||||||2017-10-11 01:56:35.056384|2017-10-11 01:56:35.056384
NCT01802619|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-01-23|||August 2013|Actual|2013-08-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.|Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass: A Double Blind Randomized Controlled Trial.|Completed||Phase 1/Phase 2|212|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 01:56:38.473955|2017-10-11 01:56:38.473955
NCT01802593|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2015-12-21|||February 2013||2013-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|WITHDRAW||Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure|Phase 4, Open Label Multicenter Randomized Controlled Trial. Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Immunomodulator Failure|Terminated||Phase 4|20|Actual|Wolfson Medical Center||2||lack of budget and failure to reach milestones|f||||t||||||||||2017-10-11 01:56:38.700082|2017-10-11 01:56:38.700082
NCT01802580|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-03-22|||October 2012||2012-10-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Using an Internet Study to Improve Adherence for Psoriasis Patients|Using an Internet Study to Improve Adherence for Psoriasis Patients|Completed||N/A|40|Actual|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-11 01:56:38.863872|2017-10-11 01:56:38.863872
NCT01802567|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-04-25|||February 2013||2013-02-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer|A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancer|Active, not recruiting||N/A|48|Anticipated|Spectrum Health Hospitals||1|||f||||t||||||||||2017-10-11 01:56:39.004932|2017-10-11 01:56:39.004932
NCT01802554|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-05-10|2013-12-10||April 2008||2008-04-01|May 2016|2016-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention|Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention|Completed||N/A|100|Actual|University of California, San Diego||2|||f||||t||||||||Undecided||2017-10-11 01:56:39.168021|2017-10-11 01:56:39.168021
NCT01802541|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-02-28||||||February 2013|2013-02-01||||February 2006|Actual|2006-02-01||Interventional|||Effect of Diacylglycerol Oil on Risk Factors of Type 2 Diabetes and Complicating Disease, and Mechanism|Effect of Diacylglycerol Oil on Risk Factors of Type 2 Diabetes and Complicating Disease, and Mechanism|Completed||N/A|127|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-10-11 01:56:39.71859|2017-10-11 01:56:39.71859
NCT01802528|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-02-27|||March 2012||2012-03-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients||Completed||N/A|23|Actual|Yonsei University|||1||f||||t||||||||||2017-10-11 01:56:39.814734|2017-10-11 01:56:39.814734
NCT01802515|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2016-10-13|2016-07-07||December 2012||2012-12-01|July 2016|2016-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment|Atomoxetine Treatment for Opioid Maintained Cocaine Users|Terminated||N/A|14|Actual|Yale University|Study terminated after 14 subjects enrolled. 11 completers. 3 subjects dropped out in treatment week 7. There were no serious adverse events. Only descriptive statistics were computed.|3||No funding stopped recruitment march 2014 with only 14 enrolled|f||||t||||||||No||2017-10-11 01:56:39.917934|2017-10-11 01:56:39.917934
NCT01802502|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2014-06-15|||June 2013||2013-06-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|REMOVER||Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation|Explorative PK Study Comparing 600 mg Rifampicin i.v. With 750 mg and 900 mg Rifampicin Oral in Tuberculous Meningitis Patients|Completed||Phase 2|30|Actual|Universitas Padjadjaran||3|||f||||t||||||||||2017-10-11 01:56:40.444187|2017-10-11 01:56:40.444187
NCT01802489|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-02-03|||February 2013||2013-02-01|March 2013|2013-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|ACTION||Amiloride Clinical Trial In Optic Neuritis|A Double Blind Randomised Control Trial on Neuroprotection of Amiloride in Optic Neuritis|Unknown status|Active, not recruiting|Phase 2|46|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-11 01:56:40.570228|2017-10-11 01:56:40.570228
NCT01802476|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-12-16|||May 2013||2013-05-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study Comparing the Plasma Drug Exposure of an Oral Dose of Palbociclib (PD-0332991) to an Intravenous Dose of Palbociclib (PD-0332991)|A Phase 1, Single Dose, Fixed Sequence, 2-Period Cross-Over Absolute Oral Bioavailability Study In Healthy Volunteers Comparing Oral To Intravenous Administration Of PD-0332991|Completed||Phase 1|14|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:56:40.681753|2017-10-11 01:56:40.681753
NCT01802463|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-01-31|||January 2013||2013-01-01|January 2013|2013-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Study on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in Glaucoma|Correlation Between Ocular Blood Flow and the Optic Nerve Sheath Diameter in Patients With Primary Open-angle Glaucoma|Completed||N/A|197|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||||||2017-10-11 01:56:40.792566|2017-10-11 01:56:40.792566
NCT01802437|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-06-10|||November 2010||2010-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PTAD||An Adaptive Treatment Strategy for Adolescent Depression|An Adaptive Treatment Strategy for Adolescent Depression|Completed||Phase 1/Phase 2|45|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 01:56:41.026151|2017-10-11 01:56:41.026151
NCT01802424|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-12-04|||February 2012||2012-02-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||FRIENDS as an Indicative Prevention Program in Norway|The FRIENDS-program as Indicative Prevention for Children and Adolescents With Symptoms of Anxiety and Depression|Completed||N/A|80|Actual|Uni Research||1|||f||||f||||||||No||2017-10-11 01:56:41.120874|2017-10-11 01:56:41.120874
NCT01802411|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-10-09||2013-10-09|December 2012||2012-12-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy|A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy|Completed||Phase 3|191|Actual|Pacira Pharmaceuticals, Inc||2|||f||||t||||||||||2017-10-11 01:56:41.199895|2017-10-11 01:56:41.199895
NCT01802398|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-04-03|||April 2013||2013-04-01|April 2017|2017-04-01|December 14, 2016|Actual|2016-12-14|September 21, 2016|Actual|2016-09-21||Observational|SRS||Improving Syncope Risk Stratification in Older Adults|Improving Syncope Risk Stratification in Older Adults|Completed||N/A|3707|Actual|Oregon Health and Science University|||1||f||||f||||||Samples Without DNA|"     Serum samples will be collected for standardized cardiac biomarker testing. Samples will be     split into two aliquots for testing and long-term storage. Aliquots in long-term -80˚C     storage will be used for future studies of novel tests.   "|||2017-10-11 01:56:41.297183|2017-10-11 01:56:41.297183
NCT01802385|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-06-15|||March 9, 2015|Actual|2015-03-09|June 2017|2017-06-01|September 27, 2017|Anticipated|2017-09-27|September 2017|Anticipated|2017-09-01||Interventional|ASTRO-CM||Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis|Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis|Active, not recruiting||Phase 3|550|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||Yes||2017-10-11 01:56:41.390564|2017-10-11 01:56:41.390564
NCT01802372|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-05-04|||May 1, 2012|Actual|2012-05-01|May 2017|2017-05-01|October 1, 2016|Actual|2016-10-01|October 1, 2016|Actual|2016-10-01||Interventional|TASSH||Task Shifting and Blood Pressure Control in Ghana|Task Shifting and Blood Pressure Control in Ghana: A Cluster-Randomized Trial|Completed||N/A|757|Actual|New York University School of Medicine||2|||f||||t|f|f||||||||2017-10-11 01:56:41.503765|2017-10-11 01:56:41.503765
NCT01802359|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-28|2017-06-21|||November 7, 2011|Actual|2011-11-07|June 2017|2017-06-01|May 31, 2012|Actual|2012-05-31|May 31, 2012|Actual|2012-05-31||Observational|||A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction|Post-Marketing Surveillance of Bravonto in Korea|Terminated||N/A|379|Actual|Janssen Korea, Ltd., Korea|||1|This prodect will be transferred to another company.|f||||f||f||||||||2017-10-11 01:56:41.59827|2017-10-11 01:56:41.59827
NCT01802346|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-04-11|||January 29, 2013|Actual|2013-01-29|April 2017|2017-04-01|January 29, 2019|Anticipated|2019-01-29|January 29, 2018|Anticipated|2018-01-29||Interventional|||Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer|A Randomized, Phase II Clinical Trial of a Controlled Diet Prior to Selected Chemotherapy Treatment in Breast and Prostate Cancer to Evaluate the Impact on Toxicity and Efficacy|Recruiting||N/A|120|Anticipated|University of Southern California||2|||f||||t|f|f||||||||2017-10-11 01:56:41.706947|2017-10-11 01:56:41.706947
NCT01802320|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-06-26|2017-04-20||March 2013|Actual|2013-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Interventional|||Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery|A Phase 2 Study of MK-2206 in Previously Treated Metastatic Colorectal Cancer Patients Enriched for PTEN Loss and PIK3CA Mutation|Active, not recruiting||Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 01:56:43.606466|2017-10-11 01:56:43.606466
NCT01802307|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-02-27||||||February 2013|2013-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Focal Therapy for Prostate Cancer|Focal Therapy for the Treatment of Organ Confined Prostate Cancer|Not yet recruiting||Phase 2|50|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-11 01:56:44.096014|2017-10-11 01:56:44.096014
NCT01802294|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-06-12|||February 2013||2013-02-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|SCFP||Sinovuyo Caring Families Project - Pilot Trial|Sinovuyo Caring Families Project - Pilot Randomised Controlled Trial of a Parenting Program to Reduce Child Behavior Problems in Xhosa Children Ages 3 to 8 in South Africa|Completed||Phase 1|68|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-11 01:56:44.229552|2017-10-11 01:56:44.229552
NCT01802281|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-08-23|||April 2013||2013-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|SUPeR||Study of Uterine Prolapse Procedures - Randomized Trial|A Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy With Native Tissue Vault Suspension vs. Mesh Hysteropexy Suspension|Active, not recruiting||N/A|180|Anticipated|NICHD Pelvic Floor Disorders Network||2|||f||||t||||||||No||2017-10-11 01:56:44.341592|2017-10-11 01:56:44.341592
NCT01802268|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-02-27|||February 2008||2008-02-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Interventional|||Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients|Outcomes of Planned Conversion From Tacrolimus to Sirolimus-based Immunosuppressive Regimen in de Novo Kidney Transplant Recipients|Completed||Phase 4|320|Actual|Hospital do Rim e Hipertensão||2|||f||||t||||||||||2017-10-11 01:56:44.464509|2017-10-11 01:56:44.464509
NCT01802255|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2017-03-23|||March 2013||2013-03-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|March 2020|Anticipated|2020-03-01||Interventional|||Sevoflurane- Safety in Long-term Sedation Procedures|Study of the Safety of Administration of Sevoflurane for Long-term Critically Ill Patients Sedation Undergoing Mechanical Ventilation. Prospective, Controlled, Randomized, Multicenter, Clinical Trial.|Recruiting||Phase 3|50|Anticipated|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||t||||||||Yes|Shared data will be anonymous|2017-10-11 01:56:44.573664|2017-10-11 01:56:44.573664
NCT01802242|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-09-20|||October 2012||2012-10-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Tumor TARGET Prostate Cancer|Tumor Targeted Radiotherapy for Patients With Localized Prostate Cancer|Recruiting||Phase 2|110|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 01:56:44.67815|2017-10-11 01:56:44.67815
NCT01802229|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-02-28|||January 2011||2011-01-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prevention of Umbilical Port-site Hernia After Laparoscopic Cholecystectomy Using a Prosthetic Mesh Versus Simple Suture||Completed||Phase 3|106|Actual|Hospital General Universitario Elche||2|||f||||||||||||||2017-10-11 01:56:44.770261|2017-10-11 01:56:44.770261
NCT01802216|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-10-25|||February 2014||2014-02-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|KAPD||Kidney and Periodontal Disease Study|Kidney and Periodontal Disease Study|Active, not recruiting||N/A|51|Actual|University of California, San Francisco||2|||f||||t||||||||No||2017-10-11 01:56:44.834906|2017-10-11 01:56:44.834906
NCT01802190|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-07-20|||March 2011||2011-03-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Prevalence of POU4F3 and SLC17A8 Mutations|Prevalence of POU4F3 (DFNA15) and SLC17A8 (DFNA25) Genes Mutations in Dominant Autosomal Deafness and Phenotypic Characterization of Carrier Patients.|Terminated||N/A|50|Actual|University Hospital, Montpellier|||1|No convincing results|f||||f||||||Samples With DNA|"     Samples with DNA   "|||2017-10-11 01:56:45.06038|2017-10-11 01:56:45.06038
NCT01802177|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-06-30|||February 2013||2013-02-01|June 2015|2015-06-01||||October 2015|Anticipated|2015-10-01||Interventional|||Excimer Light for Alopecia Areata|Efficacy and Safety of UVB Excimer Light in Alopecia Areata: A Prospective, Single-Blind Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|18|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:56:45.138309|2017-10-11 01:56:45.138309
NCT01802164|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2015-06-15|||March 2013||2013-03-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PerProMe||Prophylactic Mesh Implantation in Patients With Peritonitis for the Prevention of Incisional Hernia|Prophylactic Mesh Implantation in Patients With Peritonitis for the Prevention of Incisional Hernia: A Randomized Controlled Trial|Terminated||N/A|5|Actual|University Hospital Inselspital, Berne||2||Recruitment problems due to very restricted inclusion criteria|f||||t||||||||||2017-10-11 01:56:45.223206|2017-10-11 01:56:45.223206
NCT01802151|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-11-13|2015-03-30||July 2012||2012-07-01|November 2015|2015-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Participants who completed all study requirements were included in the baseline analysis population. 2 participants in the 1 Billion CFU group were excluded from the baseline analysis because they did not complete all study requirements.|Evaluation of Bacillus Subtilis R0179 in Healthy Young Adults|Evaluation of Bacillus Subtilis R0179 in Capsules on Gastrointestinal Survival, Transit Time, Gastrointestinal Symptoms, and General Wellness in Healthy Young Adults|Completed||N/A|83|Actual|University of Florida||4|||f||||f||||||||||2017-10-11 01:56:45.347043|2017-10-11 01:56:45.347043
NCT01802138|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-04-26|||February 2013||2013-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma|A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma|Active, not recruiting||N/A|6|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:56:47.107117|2017-10-11 01:56:47.107117
NCT01802125|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2016-07-13|||February 2013||2013-02-01|July 2016|2016-07-01||||July 2014|Actual|2014-07-01||Observational|||Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas|Observational - SNP Array Analysis of Undifferentiated Sarcomas|Completed||N/A|49|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples Without DNA|"     tissue   "|||2017-10-11 01:56:47.299942|2017-10-11 01:56:47.299942
NCT01802112|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-02-27|||February 2013||2013-02-01|February 2013|2013-02-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Interventional|||Randomised Controlled Trial of Efficacy of Resistant Maltodextrins on Reducing Colonic Transit Time|Randomised Controlled Trial of Efficacy of Resistant Maltodextrins on Reducing Colonic Transit Time|Unknown status|Recruiting|N/A|60|Anticipated|San Antonio Technologies - San Antonio Catholic University of Murcia||2|||f||||f||||||||||2017-10-11 01:56:47.391607|2017-10-11 01:56:47.391607
NCT01802099|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2016-08-25|||March 2013||2013-03-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|NUTRIREA2||Impact of Early Enteral vs. Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines|Impact of Early Enteral vs. Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines: Multicenter, Randomized Controlled Trial (NUTRIREA-2)|Terminated||N/A|2411|Actual|Centre Hospitalier Departemental Vendee||2||stopped on Data Safety and Monitoring Board 's request|f||||t||||||||||2017-10-11 01:56:47.512192|2017-10-11 01:56:47.512192
NCT01802086|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-04-27|||May 2013||2013-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|October 2017|Anticipated|2017-10-01||Interventional|||Emla-Cream as Pain Relief During Pneumococcal Vaccination|Emla-Cream as Pain Relief During Pneumococcal Vaccination|Recruiting||N/A|72|Anticipated|Sormland County Council, Sweden||2|||f||||t||||||||||2017-10-11 01:56:47.72144|2017-10-11 01:56:47.72144
NCT01802073|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-10-12|||January 2012||2012-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PSC||Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects|Treatment of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects|Active, not recruiting||Phase 3|40|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 01:56:47.837489|2017-10-11 01:56:47.837489
NCT01802060|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-11-27|||February 2013||2013-02-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation|Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation|Completed||N/A|51|Actual|SPD Development Company Limited|||1||f||||f||||||Samples Without DNA|"     Urine samples Serum samples   "|||2017-10-11 01:56:47.935873|2017-10-11 01:56:47.935873
NCT01802047|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-03-27|||August 2013||2013-08-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Different Electric Pumping Modalities on Milk Volume Production in Mothers of Preterm Infants|Milk Volume Production in Mothers of Preterm Infants: Electric Pumping Modalities|Withdrawn||N/A|0|Actual|Tel-Aviv Sourasky Medical Center||1||d/t changes in routine modality of milk expression by electric pump.|f||||f||||||||||2017-10-11 01:56:48.015738|2017-10-11 01:56:48.015738
NCT01802034|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-06-12|||February 2013||2013-02-01|June 2017|2017-06-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01|10 Years|Observational [Patient Registry]|RENAL AID||Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)|Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)|Recruiting||N/A|2000|Anticipated|The Rogosin Institute|||3||f||||f||||||Samples With DNA|"     Blood, urine, tissue   "|||2017-10-11 01:56:48.111057|2017-10-11 01:56:48.111057
NCT01802021|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-02-28|||May 2009||2009-05-01|April 2009|2009-04-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|QSYQT||Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients|Efficacy Study of Chinese Medicine on Modulating Immune Alterations in Advanced Stage, Non-small Cell Lung Cancer Patients Receiving 1st Line Doublet Chemotherapy and 2nd Line Target Therapy|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 01:56:48.217224|2017-10-11 01:56:48.217224
NCT01802008|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-04-28|||September 2012||2012-09-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times|Comparison of Adenoma Detection and Miss Rates at Colonoscopy Associated With a Six-minute Withdrawal Time vs a Three-minute Withdrawal Time|Completed||N/A|200|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 01:56:48.303982|2017-10-11 01:56:48.303982
NCT01801995|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-12-08|||May 2013||2013-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:56:48.394705|2017-10-11 01:56:48.394705
NCT01801982|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-12-02|2014-12-02||November 2012||2012-11-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational||Full Analysis Set (FAS) included all enrolled participants.|A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)|A Follow Up Investigation For Patients Completing Study A1481276 To Investigate Developmental Progress 12 And 24 Months Following Completion Of Sildenafil Treatment|Completed||Phase 2|1|Actual|Pfizer|Results at Month 24 were not reported as the participant lost to follow-up after Month 12.||1||f||||f||||||||||2017-10-11 01:56:48.449058|2017-10-11 01:56:48.449058
NCT01801969|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-03-17|||February 2013||2013-02-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|March 2015|Actual|2015-03-01||Observational|||Return to Work and QOL Following TBI. Impact of Rehabilitation Service.|Return to Work and QOL Following TBI. Impact of Rehabilitation Service.|Active, not recruiting||N/A|653|Actual|University of Aarhus|||1||f||||f||||||||No||2017-10-11 01:56:48.702346|2017-10-11 01:56:48.702346
NCT01801943|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-06-06|||February 2013||2013-02-01|June 2014|2014-06-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment|Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment|Unknown status|Recruiting|N/A|80|Anticipated|Pennington Biomedical Research Center||4|||f||||f||||||||||2017-10-11 01:56:48.924374|2017-10-11 01:56:48.924374
NCT01801930|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2016-09-23|||March 2013||2013-03-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer|A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer Who Are Refractory or Intolerant to Standard Chemotherapy|Completed||Phase 1|24|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-11 01:56:49.041896|2017-10-11 01:56:49.041896
NCT01801904|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-03-28|||December 2012||2012-12-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|September 2017|Anticipated|2017-09-01||Interventional|PACER||A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer|A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|52|Actual|National Cancer Institute, Naples||1|||f||||f||||||||||2017-10-11 01:56:49.309544|2017-10-11 01:56:49.309544
NCT01801891|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-12-11|||May 2013||2013-05-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers|"Surface NeuroMuscular Electrical Stimulation in the Treatment of Chronic Venous Leg Ulcers: A Randomised Controlled Trial of the VASGARD Device"|Completed||Phase 2|25|Actual|Mid Western Regional Hospital, Ireland||2|||f||||t||||||||||2017-10-11 01:56:49.442889|2017-10-11 01:56:49.442889
NCT01801878|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2017-05-12|||October 1, 2017|Anticipated|2017-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts|Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts|Not yet recruiting||N/A|10|Anticipated|Seoul National University Hospital||2|||f||||f|f|f||||||Undecided||2017-10-11 01:56:49.563233|2017-10-11 01:56:49.563233
NCT01801865|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2014-09-23|||April 2012||2012-04-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Clinical Use of a New Neonatal MRI System|Clinical Use of a New Neonatal MRI System|Unknown status|Enrolling by invitation|N/A|700|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 01:56:49.691183|2017-10-11 01:56:49.691183
NCT01801852|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-01-26|||January 2013||2013-01-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Autologous Natural Killer T Cells Infusion for the Treatment of Cancer|Phase 1 Study of Autologous Natural Killer T Cells Infusion in Treating Patients With Tumors|Recruiting||N/A|300|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:56:49.789877|2017-10-11 01:56:49.789877
NCT01801826|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-03-23|||January 2013||2013-01-01|March 2013|2013-03-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|||A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device|A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines Utilizing Optimized Algorithms With the Cryo-Touch IV Device|Completed||N/A|61|Actual|MyoScience, Inc|||1||f||||f||||||||||2017-10-11 01:56:50.227031|2017-10-11 01:56:50.227031
NCT01801813|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-08-09|||January 2013||2013-01-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01|2 Months|Observational [Patient Registry]|Cranioscore||Risk Factors of Complications Regarding Patients Undergoing Brain Tumour Neuro-surgery (Cranioscore).|Observational Study of Risk Factors of Neuro-critical Care Complications Regarding Patients Undergoing Brain Tumour Neuro-surgery : a Prospective Validation of the Cranioscore.|Completed||N/A|795|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 01:56:50.312145|2017-10-11 01:56:50.312145
NCT01801800|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-05-09|||January 2012||2012-01-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01|2 Months|Observational [Patient Registry]|SPLASH||Cardiac Function in Severe Aneurysmal Subarachnoid Haemorrhage Patients|Speckle Tracking Assessment of Cardiac Function in Severe Aneurysmal Subarachnoid Haemorrhage and Impact on Neurologic Outcome (SPLASH)|Completed||N/A|80|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 01:56:50.395365|2017-10-11 01:56:50.395365
NCT01801787|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-08-13|||March 2013||2013-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia|The Mechanism of Non-invasive Brain Stimulation for Therapy of Chronic Auditory Verbal Hallucinations in Schizophrenia|Completed||N/A|30|Actual|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 01:56:50.493733|2017-10-11 01:56:50.493733
NCT01801774|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-03-31|||May 2012||2012-05-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Efficacy Comparison Study of Steroids to Control Post-operative Inflammation|Quantitative Comparison of the Efficacy of Subtenon 20-mg Triamcinolone Injection With 0.1% Dexamethasone Eye Drop in Controlling Intraocular Inflammation After Phacoemulsification|Unknown status|Recruiting|Phase 4|140|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-11 01:56:50.575801|2017-10-11 01:56:50.575801
NCT01801761|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2016-11-28|||December 2012||2012-12-01|December 2012|2012-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||A Simplified Questionnaire to Detect OSA in COPD Patients|A Simplified Screening Questionnaire to Detect the Existence of Severe Obstructive Sleep Apnea in Chronic Obstructive Pulmonary Disease Patients|Completed||N/A|67|Actual|Chang Gung Memorial Hospital|||2||f||||t||||||||||2017-10-11 01:56:50.674296|2017-10-11 01:56:50.674296
NCT01801748|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-04-07|||November 2012||2012-11-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Natural History of Wheat Hypersensitivity in Thai Children|The Natural History of Wheat Hypersensitivity in Thai Children|Completed||N/A|43|Actual|Mahidol University||1|||f||||f||||||||||2017-10-11 01:56:50.735299|2017-10-11 01:56:50.735299
NCT01801735|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-04-24|2015-04-24||March 2013||2013-03-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip|A Multicenter, Open-Label, Safety Study of Meloxicam SoluMatrix™ Capsules in Subjects With Osteoarthritis of the Knee or Hip|Completed||Phase 3|600|Actual|Iroko Pharmaceuticals, LLC||1|||f||||f||||||||||2017-10-11 01:56:50.829249|2017-10-11 01:56:50.829249
NCT01801722|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-02-28|||April 2008||2008-04-01|February 2013|2013-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|NT-proBNP||Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease|Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary Disease.|Completed||N/A|75|Actual|Lund University|||1||f||||f||||||||||2017-10-11 01:56:51.369287|2017-10-11 01:56:51.369287
NCT01801709|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-07-20|||March 2013||2013-03-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|March 2018|Anticipated|2018-03-01||Interventional|TG-MLD||Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy|A Phase I/II, Open Labeled, Monocentric Study of Direct Intracranial Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Serotype rh.10 Expressing the Human ARSA cDNA to Children With Metachromatic Leukodystrophy.|Active, not recruiting||Phase 1/Phase 2|5|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-11 01:56:51.452608|2017-10-11 01:56:51.452608
NCT01801696|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-04-27|||September 2012||2012-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|November 2014|Actual|2014-11-01||Interventional|||Parent-delivered Massage for Children With Autism|Phase 2 Study of the Parent-delivered Massage Treatment Protocol for Children With Autism|Completed||Phase 2/Phase 3|103|Actual|Western Oregon University||2|||f||||f||||||||||2017-10-11 01:56:51.551374|2017-10-11 01:56:51.551374
NCT01801683|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-05-27|||January 2012||2012-01-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|EBMINGP||Evidence Based Medicine in General Practice|Application of Evidence Based Medicine in General Practice|Completed||N/A|98|Actual|University Hospital of Split||2|||f||||f||||||||||2017-10-11 01:56:51.654844|2017-10-11 01:56:51.654844
NCT01801670|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-01-26|||January 2015||2015-01-01|January 2015|2015-01-01|January 2015|Anticipated|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study|A Phase IV Study Of The Impact Of Vorinostat On Cellular Signaling And Cytokine Production In Cutaneous T-Cell Lymphoma Patients With Pruritus|Withdrawn||Phase 4|0|Actual|Boston University|||1|Enrollment was too slow, so no participants were ever enrolled.|f||||f||||||Samples With DNA|"     Blood Samples Skin biopsies   "|||2017-10-11 01:56:51.732555|2017-10-11 01:56:51.732555
NCT01801657|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-03-11|||February 2013||2013-02-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in Adults|The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in Adults|Unknown status|Recruiting|N/A|100|Anticipated|The First Affiliated Hospital of Guangzhou Medical University|||2||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 01:56:51.827927|2017-10-11 01:56:51.827927
NCT01801644|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-28|||April 2007||2007-04-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer|Neoadjuvant Gemcitabine and Cisplatin in Locally Advanced Bladder Cancer|Completed||N/A|60|Actual|Barmherzige Brüder Vienna||1|||f||||f||||||||||2017-10-11 01:56:51.933891|2017-10-11 01:56:51.933891
NCT01801631|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-07-25|||October 2011||2011-10-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Diacourse||Tailored Support for Type 2 Diabetes Patients With an Acute Coronary Event After Discharge From Hospital|Tailored Support for Type 2 Diabetes Patients With an Acute Coronary Event After Discharge From Hospital|Completed||N/A|201|Actual|UMC Utrecht||2|||f||||f||||||||||2017-10-11 01:56:52.035279|2017-10-11 01:56:52.035279
NCT01801618|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-07-20|||February 2013||2013-02-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01|6 Months|Observational [Patient Registry]|||National Evaluation of PI-based 2nd Line Efficacy in Cambodia|National Evaluation of PI-based 2nd Line Efficacy in Cambodia|Completed||N/A|15001351|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f||||||Samples With DNA|"     Plasma HIV RNA and cDNA   "|||2017-10-11 01:56:52.178948|2017-10-11 01:56:52.178948
NCT01801605|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-17|2013-02-28|||August 2008||2008-08-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Repetitive Transcranial Magnetic Stimulation in Irritable Bowel Syndrome|Does Repetitive Transcranial Magnetic Stimulation (rTMS) Reduce Rectal Hypersensitivity in Patients With IBS ?|Completed||Phase 2|20|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 01:56:52.269746|2017-10-11 01:56:52.269746
NCT01801592|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2016-02-11|||February 2013||2013-02-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|WITH-SAS||Obstructive Sleep Apnoea in Patients With Intermittent Claudication|Prevalence of Obstructive Sleep Apnoea in Patients With Intermittent Claudication|Recruiting||N/A|160|Anticipated|University Hospital, Angers|||1||f||||t||||||||||2017-10-11 01:56:52.36742|2017-10-11 01:56:52.36742
NCT01801579|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2016-02-11|||November 2012||2012-11-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|RICATEM||Reproducibility of Ankle Brachial Index After Maximal Exercise|Reproducibility of the Ankle-Brachial Index Measurements After a Maximal Exercise|Completed||N/A|15|Actual|University Hospital, Angers|||1||f||||t||||||||||2017-10-11 01:56:52.45842|2017-10-11 01:56:52.45842
NCT01801566|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-03-14|||April 2013||2013-04-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|SIOver||Effectiveness of the Single Implant-retained Mandibular Overdenture Treatment|Effectiveness of the Single Implant-retained Mandibular Overdenture Treatment: Radiographic Evaluations, Patient's Satisfaction, and Oral-health-related Quality of Life|Completed||N/A|60|Actual|Universidade Federal de Goias||2|||f||||t||||||||||2017-10-11 01:56:52.551185|2017-10-11 01:56:52.551185
NCT01801553|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2014-06-24|||May 2013||2013-05-01|June 2014|2014-06-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Interventional|||Study of the Efficacy of Manual Therapy for a Subgroup of Acute Non-specific Low Back Pain|A Randomized Controlled Double Blind Study on the Pragmatic Application of a Clinical Prediction Rule in Primary Care to Treat Low Back Pain Patients With a Brief Spinal Manipulation Intervention: a Validation Study|Terminated||N/A|100|Anticipated|Université Catholique de Louvain||2||problem of recruitment (not enough patients)|f||||t||||||||||2017-10-11 01:56:52.645084|2017-10-11 01:56:52.645084
NCT01801540|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-02-27|||December 2010||2010-12-01|February 2013|2013-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||The Effects of L-arabinose in a Meal in Healthy Men|The Effects of L-arabinose in a Meal on Glucose Metabolism in Healthy Men|Completed||N/A|17|Actual|University of Copenhagen||6|||f||||t||||||||||2017-10-11 01:56:52.764449|2017-10-11 01:56:52.764449
NCT01801527|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2015-05-11|||March 2012||2012-03-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|||Telehealth System to Improve Quality of Life in Breast Cancer Survivors|E-Cuidate: Effectiveness of a Telerehabilitation System in Women Breast Cancer Survivors|Completed||Phase 2|72|Actual|Universidad de Granada||2|||f||||t||||||||||2017-10-11 01:56:52.857156|2017-10-11 01:56:52.857156
NCT01801514|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2014-11-10|||November 2012||2012-11-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Applications of Dual-Energy Computed Tomography|Applications of Dual-Energy Computed Tomography|Completed||N/A|337|Actual|Philips Healthcare||1|||f||||t||||||||||2017-10-11 01:56:52.950597|2017-10-11 01:56:52.950597
NCT01801501|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-02-23|||January 2012||2012-01-01|February 2014|2014-02-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01|1 Month|Observational [Patient Registry]|||Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients|Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients|Unknown status|Recruiting|N/A|100|Anticipated|University of Chile|||1||f||||t||||||Samples Without DNA|"     Venous blood samples will be obtained. Serum samples will be extracted, with elimination of     other material. Serum will be stored at -20ºC until determination of FGF-23 by ELISA     technique.   "|||2017-10-11 01:56:53.032255|2017-10-11 01:56:53.032255
NCT01801488|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-11-24|||November 2011||2011-11-01|February 2013|2013-02-01||||March 2014|Actual|2014-03-01||Observational|||Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm|Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm|Terminated||N/A|5|Actual|State University of New York - Upstate Medical University|||3|Low enrollment|f||||f||||||Samples With DNA|"     Tissue samples of intracranial arterial-venous malformations (AVM) or aneurysm and blood     samples.   "|||2017-10-11 01:56:53.152494|2017-10-11 01:56:53.152494
NCT01801475|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-05-28|2015-01-23||January 2013||2013-01-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Zofran_PK|3 groups of individual subjects|How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women|Prevention of Neonatal Abstinence Syndrome|Completed||Phase 1/Phase 2|100|Actual|Stanford University|Since the neonate was not given a dose of study medication (ondansetron) directly it was not possible to estimate the volume of distribution in the neonate.|3|||f||||f||||||||||2017-10-11 01:56:53.247993|2017-10-11 01:56:53.247993
NCT01801462|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2015-05-04|||March 2013||2013-03-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Simulation-based Ultrasound Training to Improve Patient Comfort and Decrease the Need for Re-examination. A Randomized Trial.|Simulation-based Ultrasound Training to Improve Patient Comfort and Decrease the Need for Re-examination. A Randomized Trial.|Completed||N/A|52|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:56:53.591951|2017-10-11 01:56:53.591951
NCT01801059|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-10-14|||September 2007||2007-09-01|October 2014|2014-10-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer|Patient Activation To Increase Colon Cancer Screening (THE CHAT STUDY)|Completed||N/A|284|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 01:57:04.564828|2017-10-11 01:57:04.564828
NCT01801436|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-03-28|2013-03-28||December 2006||2006-12-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma|A Post Approval Commitment Study for Pharmacokinetic Analysis and Providing Expanded Access to Bortezomib (Velcade) for Patients With Multiple Myeloma Who Have Received at Least Two Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma in Taiwan|Completed||Phase 3|14|Actual|Johnson & Johnson Taiwan Ltd||1|||f||||f||||||||||2017-10-11 01:56:53.773317|2017-10-11 01:56:53.773317
NCT01801423|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-03-24|||February 2013||2013-02-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|SPIN||Sickle Cell Disease - Stroke Prevention in Nigeria Trial|Primary Prevention of Strokes in Nigerian Children With Sickle Cell Disease Affiliated Titles: Sickle Cell Disease - Stroke Prevention in Nigeria (SPIN) Trial|Active, not recruiting||N/A|60|Anticipated|Vanderbilt University Medical Center||1|||f||||t|f|f||||||No||2017-10-11 01:56:54.742698|2017-10-11 01:56:54.742698
NCT01801410|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-12-11|||December 2013||2013-12-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|INFORM||Induction With Foley OR Misoprostol (INFORM) Study|Induction of Labour in Pre-eclamptic Women: a Randomised Trial Comparing the Foley Balloon Catheter With Oral Misoprostol|Completed||Phase 3|602|Actual|University of Liverpool||2|||f||||t||||||||||2017-10-11 01:56:54.834373|2017-10-11 01:56:54.834373
NCT01801397|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2014-03-25|||March 2014||2014-03-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)||Unknown status|Recruiting|Phase 3|10|Anticipated|University of Zurich||1|||f||||||||||||||2017-10-11 01:56:54.936113|2017-10-11 01:56:54.936113
NCT01801384|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-03-26|||April 2006||2006-04-01|March 2013|2013-03-01||||May 2011|Actual|2011-05-01||Interventional|||Voucher Based Incentives to Treat Pregnant Smokers|Phase 2 Study of the Efficacy of Voucher-Based Incentives to Treat Pregnant Smokers|Unknown status|Active, not recruiting|N/A|166|Actual|University of Vermont||3|||f||||f||||||||||2017-10-11 01:56:55.025457|2017-10-11 01:56:55.025457
NCT01801371|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-04-05|||October 2012||2012-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GRGDG||68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma|Diagnostic Performance and Evaluation Efficacy of Brain 68Ga-BNOTA-PRGD2 PET/CT in Pre-surgery Glioma Patients|Recruiting||Early Phase 1|30|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-11 01:56:55.127276|2017-10-11 01:56:55.127276
NCT01801358|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-08-29|2016-05-12|2016-02-11|August 2013||2013-08-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Baseline Demographics data represents the Full Analysis Set (FAS), which includes all patients who received at least one full or partial dose of sotrastaurin or binimetinib.|A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma|A Phase Ib/II, Open-label, Multicenter Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma|Terminated||Phase 1/Phase 2|38|Actual|Array BioPharma|Due to an enrollment halt, the Phase II part of the study was not conducted. The sponsor decided to permanently stop recruitment for the study prior to MTD determination.|2||The trial was terminated for scientific reasons.|f||||f||||||||||2017-10-11 01:56:55.290508|2017-10-11 01:56:55.290508
NCT01801345|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-04-22|||August 2012||2012-08-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||The Effect of Fatigue on the Clinical Performance|The Effect of Fatigue on the Clinical Performance of Experienced Physicians: A Simulation Study|Completed||N/A|13|Actual|NorthShore University HealthSystem||2|||f||||f||||||||||2017-10-11 01:56:58.538153|2017-10-11 01:56:58.538153
NCT01801332|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-27|2013-02-27|||February 2010||2010-02-01|February 2013|2013-02-01||||February 2013|Actual|2013-02-01||Interventional|||Intensive Enteral Nutrition and Acute Alcoholic Hepatitis|Intensive Enteral Nutrition in Association With Corticosteroids in Severe Acute Alcoholic Hepatitis: a Multicenter, Randomized, Controlled Trial|Completed||N/A|136|Actual|Erasme University Hospital||2|||f||||t||||||||||2017-10-11 01:56:58.662672|2017-10-11 01:56:58.662672
NCT01801319|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-04-24|||June 2011||2011-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression|A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression|Active, not recruiting||N/A|40|Anticipated|St. Jude Medical||2|||f||||f||||||||||2017-10-11 01:56:58.786907|2017-10-11 01:56:58.786907
NCT01801306|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-06-17|||March 2013||2013-03-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A New Minimal-invasive Brain Tissue Probe Applying Near Infrared Spectroscopy|A New Multi-parameter Monitoring System Applying Near Infrared Spectroscopy and Indocyanine Green to Detect Cerebrovascular Events in Patients With Subarachnoid Hemorrhage|Completed||N/A|3|Actual|NeMoDevices AG||1|||f||||t||||||||||2017-10-11 01:56:59.054017|2017-10-11 01:56:59.054017
NCT01801293|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-06-06|||March 2013||2013-03-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806|A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806|Completed||Phase 1|8|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 01:56:59.170808|2017-10-11 01:56:59.170808
NCT01801280|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2016-07-25|2014-12-17||January 2012||2012-01-01|July 2016|2016-07-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|||Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS|Single Center, Open Labeled, Cross-over Study in Maintenance Renal Transplant Patients to Evaluate Pnatoprazole Influence on MPA Bioavailabiliy Administered as Mycophenolate Mofetil and Enteric Coated Mycophenolate Sodium|Completed||Phase 4|20|Actual|Charite University, Berlin, Germany||4|||f||||f||||||||||2017-10-11 01:56:59.283494|2017-10-11 01:56:59.283494
NCT01801267|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-03-07|||August 2013||2013-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Third Ventriculostomy Versus Shunt for Children With Hydrocephalus|A Randomized Controlled Trial of Endoscopic Third Ventriculostomy Versus Ventricular Shunt for Children With Communicating Hydrocephalus|Completed||N/A|8|Actual|Duke University||2|||f||||f||||||||No||2017-10-11 01:56:59.758891|2017-10-11 01:56:59.758891
NCT01801254|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-04-29|||February 2013||2013-02-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|August 2013|Actual|2013-08-01||Interventional|||Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior|Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior|Completed||Phase 1|16|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 01:56:59.887599|2017-10-11 01:56:59.887599
NCT01801241|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-09-21|||January 2013||2013-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:56:59.985325|2017-10-11 01:56:59.985325
NCT01801228|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-01-14|||February 2013||2013-02-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects|Swedish, Multicentered, Randomized Study of Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis Regarding Efficacy and Side Effects|Withdrawn||Phase 2|0|Actual|Region Skane||2||difficulties to include patients|f||||t||||||||||2017-10-11 01:57:00.119196|2017-10-11 01:57:00.119196
NCT01801189|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-03-03|||February 2013||2013-02-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Preoperative Pain Control in Gastric Bypass Surgery Patients|A Randomized Placebo-Controlled Study of Whether Pre-operative Pregabalin 300 mg Will Improve Pain Control in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass (Bariatric Surgery)|Completed||Phase 4|80|Actual|Legacy Health System||2|||f||||f||||||||No||2017-10-11 01:57:00.309441|2017-10-11 01:57:00.309441
NCT01801176|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-06-08|||May 2012||2012-05-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|WS-RT Fibro||Peripheral Primitive Fibromatosis|Peripheral Primitive Fibromatosis. Study Evaluating a Simple Initial Monitoring With Search of Scalability Predictive Factors and Registration of Treatments in Case of Progression|Recruiting||N/A|100|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 01:57:00.448514|2017-10-11 01:57:00.448514
NCT01801163|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-04-15|||February 2012||2012-02-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|||A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)|A Phase Ib Study of Stereotactic Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)|Withdrawn||Phase 1|0|Actual|Indiana University||1||Trial had no patients accrued while open|f||||||||||||||2017-10-11 01:57:00.554516|2017-10-11 01:57:00.554516
NCT01801150|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2015-03-19|||October 2011||2011-10-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|DM-SAHS||CPAP in Diabetes Type 2 Patients With Sleep Apnea|Effect Of Nasal CPAP On Glycemic Control In Patients With Poorly Controlled Type 2 Diabetes And Sleep Apnea-Hypopnea Syndrome|Completed||Phase 4|61|Actual|Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-11 01:57:00.670524|2017-10-11 01:57:00.670524
NCT01801137|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-06-20|||June 2011||2011-06-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|AFINIVEST||The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium|A Multicentre Phase III Trial to Determine the Efficacy of RAD 001 (Everolimus, Afinitor) as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium Which Failed or Progressed After First Line Chemotherapy|Completed||Phase 2|54|Actual|Hopital Foch||1|||f||||||||||||||2017-10-11 01:57:00.780699|2017-10-11 01:57:00.780699
NCT01801124|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-07-02|2013-07-02||April 2012||2012-04-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|702||EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair|Evaluation of the Safety and Efficacy of EXPAREL® When Infiltrated Into the Transversus Abdominis Plane (TAP) for Prolonged Postoperative Analgesia in Subjects Undergoing Unilateral Abdominal Hernia Repair|Completed||Phase 4|13|Actual|Pacira Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-11 01:57:00.889782|2017-10-11 01:57:00.889782
NCT01801111|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-07-04|2015-08-19||June 20, 2013|Actual|2013-06-20|July 2017|2017-07-01|August 31, 2017|Anticipated|2017-08-31|October 24, 2014|Actual|2014-10-24||Interventional||Safety population: All participants who received at least one dose of alectinib.|A Study of RO5424802 in Patients With Non-Small Cell Lung Cancer Who Have ALK Mutation and Failed Crizotinib Treatment|AN OPEN-LABEL, NON-RANDOMIZED, MULTICENTER PHASE I/II TRIAL OF RO5424802 GIVEN ORALLY TO NON - SMALL CELL LUNG CANCER PATIENTS WHO HAVE ALK MUTATION AND FAILED CRIZOTINIB TREATMENT|Active, not recruiting||Phase 2|138|Actual|Hoffmann-La Roche|Part 1 analysis was not conducted as during the conduct of the study the RP2D was confirmed in study NP28761 (NCT01871805).|1|||f|||||t|f||||||||2017-10-11 01:57:01.149011|2017-10-11 01:57:01.149011
NCT01801098|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-11-12|||December 2012||2012-12-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After TAVI|Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation With a Self-expanding Bioprosthesis|Completed||N/A|25|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-10-11 01:57:03.986349|2017-10-11 01:57:03.986349
NCT01801085|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-02-01|||October 2011||2011-10-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Nursing and Pharmacy Time for Delivering Xeloda® Versus 5-Fluoruracil Regimens|The Impact of Nursing and Pharmacy Care Between Xeloda® and 5-Fluoruracil Regimens in the Management of Colorectal Cancer (CRC) in Hong Kong|Terminated||N/A|21|Actual|Chinese University of Hong Kong|||2|Slow recruitment pace|f||||f||||||||||2017-10-11 01:57:04.255527|2017-10-11 01:57:04.255527
NCT01801046|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-04-18|||March 6, 2013|Actual|2013-03-06|April 2017|2017-04-01|March 6, 2019|Anticipated|2019-03-06|March 6, 2018|Anticipated|2018-03-06||Interventional|||Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia|HLA-mismatched Allogeneic Cellular Therapy (HMMACT) After Chemotherapy in High Risk Acute Myeloid Leukemia|Recruiting||Phase 1|35|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-11 01:57:04.708377|2017-10-11 01:57:04.708377
NCT01801033|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-10-05|||January 4, 2013||2013-01-04|November 29, 2013|2013-11-29|November 29, 2013|Actual|2013-11-29|November 29, 2013|Actual|2013-11-29||Observational|||Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism|Effects of Pharmacologic Block of Type-1 Deiodinase on Thyroid Hormone Action and on the Circulating Levels of T3 in Hypothyroid Patients|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:57:04.921456|2017-10-11 01:57:04.921456
NCT01801020|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-06-17|||March 2013||2013-03-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Different Modes of Temperature Measurement in the Emergency Department|Different Modes of Temperature Measurement in the Emergency Department|Withdrawn||Phase 3|0|Actual|HaEmek Medical Center, Israel||1||The investigator left the organization|f||||t||||||||||2017-10-11 01:57:05.016473|2017-10-11 01:57:05.016473
NCT01801007|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-08-30|||July 2013||2013-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FRED||Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms|Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms|Active, not recruiting||Phase 3|195|Anticipated|Microvention-Terumo, Inc.||1|||f||||t||||||||||2017-10-11 01:57:05.143523|2017-10-11 01:57:05.143523
NCT01800994|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-08-18|||February 2013||2013-02-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|P A I R||Prospective evAluatIon foR Inhalation Devices Study|Multicenter, Prospective, Observational, Non Interventional Clinical Trial to Assess the Asthma and COPD Treatment by Inhalation Devices|Completed||N/A|750|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 01:57:05.31555|2017-10-11 01:57:05.31555
NCT01800981|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-02-27|||March 2013||2013-03-01|February 2013|2013-02-01||||July 2013|Anticipated|2013-07-01||Observational|||Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care|Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care (SOC) Protocol MW2012-12-12|Unknown status|Not yet recruiting|N/A|53|Anticipated|MediWound Ltd|||2||f||||f||||||||||2017-10-11 01:57:05.486366|2017-10-11 01:57:05.486366
NCT01800968|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-02-14|2016-09-12||April 2013||2013-04-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|FIGHT|All patients randomized.|Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)|Functional Impact of GLP-1 for Heart Failure Treatment|Completed||Phase 2|300|Actual|Duke University||2|||f||||t||||||||||2017-10-11 01:57:05.617636|2017-10-11 01:57:05.617636
NCT01800955|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-04-02|||August 2012||2012-08-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness of Resistive Capacitive Diathermy in Patients Affected by Knee Osteoarthritis|The Effectiveness of Resistive Capacitive Diathermy in Patients Affected by Knee Osteoarthritis: a Sham-controlled Study|Completed||N/A|60|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 01:57:06.965515|2017-10-11 01:57:06.965515
NCT01800942|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-10-07|||February 2013||2013-02-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|PregnAnZI||Prevention of Bacterial Infections in Newborn|Prevention of Bacterial Infections in the Newborn by Pre-delivery Administration of Azithromycin (AZI): a Placebo-controlled Randomized Trial|Completed||Phase 3|829|Actual|Medical Research Council Unit, The Gambia||2|||f||||t||||||||||2017-10-11 01:57:07.060819|2017-10-11 01:57:07.060819
NCT01800929|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2013-02-28|||November 2012||2012-11-01|February 2013|2013-02-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Evaluation of Performance and Usability of N6 in the Paediatric Population|Evaluation of Performance and Usability of N6 in the Paediatric Population|Unknown status|Recruiting|N/A|30|Anticipated|Cochlear, Asia Pacific||2|||f||||f||||||||||2017-10-11 01:57:07.150739|2017-10-11 01:57:07.150739
NCT01800916|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-03-17|2014-04-27||February 2013||2013-02-01|March 2017|2017-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Baseline data was obtained on the ITT population. Two subjects were not included in the ITT population. One was discovered before randomization (this subject is not found in the Participant flow), the other was randomized before it was seen that the subjects was screen failure and included in the randomized population but not in the ITT population|Safety and Performance of New 1-piece Ostomy Product|Investigating the Safety and Performance of New 1-piece Ostomy Product Concepts Compared With SenSura 1-piece in Subjects With an Ileostomy|Completed||N/A|65|Actual|Coloplast A/S||3|||f||||f||||||||||2017-10-11 01:57:07.305171|2017-10-11 01:57:07.305171
NCT01800903|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-08-23|2013-11-29||February 2013||2013-02-01|August 2016|2016-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Safety and Performance of a New Coating for Urinary Intermittent Catheters|Clinical Study Investigating Safety and Performance of a New Coating for Urinary Intermittent Catheters in Healthy Volunteers|Completed||N/A|36|Actual|Coloplast A/S||6|||f||||t||||||||||2017-10-11 01:57:07.796852|2017-10-11 01:57:07.796852
NCT01800890|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-07-14|2014-04-28||February 2013||2013-02-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||"Only includes the ITT population. The two screen failures and the subject who did not complete the Test B period as planned are not included.
The subject that did not complete the test B period was also a screen failure, however it was first discovered after applying a product. Thus, no endpoint data has been recorded for this subject."|Safety and Performance of New 2-piece Ostomy Product Concept Compared With SenSura Click in Subjects With Ileostomy|Investigating the Safety and Performance of New 2-piece Ostomy Product Concept Compared With SenSura Click in Subjects With Ileostomy|Completed||N/A|31|Actual|Coloplast A/S||3|||f||||f||||||||||2017-10-11 01:57:08.054924|2017-10-11 01:57:08.054924
NCT01800877|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2015-04-14|||April 2013||2013-04-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|OVATION||Optimal Vasopressor Titration|Optimal Vasopressor Titration Pilot Randomized Controlled Trial|Completed||N/A|120|Actual|Clinical Evaluation Research Unit at Kingston General Hospital||2|||f||||t||||||||||2017-10-11 01:57:08.385861|2017-10-11 01:57:08.385861
NCT01800864|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-11-08|||August 2011||2011-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Leptin Biology in Adipose Tissue|Leptin Biology in Adipose Tissue|Completed||N/A|5|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:57:08.501372|2017-10-11 01:57:08.501372
NCT01800851|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-07-04|||January 2008||2008-01-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CALIMERO||Calorimetry, Insulin Resistance and Energy Metabolism Study to Understand the Risk of Obesity in Kidney Transplanted Patients|Calorimetry, Insulin Resistance and Energy Metabolism Study to Understand the Risk of Obesity in Kidney Transplanted Patients|Completed||N/A|30|Actual|University Hospital, Clermont-Ferrand||3|||f||||||||||||||2017-10-11 01:57:08.573867|2017-10-11 01:57:08.573867
NCT01800825|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-07-15|||July 2013||2013-07-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Clindamycin to Reduce Preterm Birth in a Low Resource Setting|Clindamycin to Reduce Preterm Birth in a Low Resource Setting: A Randomized Placebo-controlled Trial|Completed||Phase 4|1726|Actual|Christiana Care Health Services||2|||f||||t||||||||||2017-10-11 01:57:08.753716|2017-10-11 01:57:08.753716
NCT01800812|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-02-26|||March 2007||2007-03-01|February 2013|2013-02-01||||January 2008|Actual|2008-01-01||Interventional|OM-174||Effects of OM-174 in Adult Patients With Solid Tumors|Phase One Study With Direct Individual Benefit: Effects of OM-174 in Adult Patients With Solid Tumors.|Completed||Phase 1|27||Centre Hospitalier Universitaire Dijon|||||f||||||||||||||2017-10-11 01:57:08.876354|2017-10-11 01:57:08.876354
NCT01800799|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-02-16|||February 2013|Actual|2013-02-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Urinary NGF as A Biomarker for Acute Bacterial Cystitis|Use of Urinary Nerve Growth Factor as A Biomarker to Determine Complete Resolution of Bladder Inflammation After Acute Bacterial Cystitis in Women|Completed||N/A|37|Actual|Buddhist Tzu Chi General Hospital||3|||f||||f||||||||||2017-10-11 01:57:09.129691|2017-10-11 01:57:09.129691
NCT01800786|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2017-05-08|2017-03-10||August 2011|Actual|2011-08-01|May 2017|2017-05-01|June 30, 2016|Actual|2016-06-30|December 2015|Actual|2015-12-01||Interventional|||Memory Consolidation in Obstructive Sleep Apnea|Memory Consolidation in Obstructive Sleep Apnea|Completed||N/A|33|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 01:57:09.273477|2017-10-11 01:57:09.273477
NCT01800773|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-02-28|||March 2013||2013-03-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|WET||Written Exposure Therapy for Posttraumatic Stress Disorder|Written Exposure Therapy for Post Traumatic Stress Disorder: A Randomized Noninferiority Trial|Active, not recruiting||N/A|126|Actual|Boston University||2|||f||||t||||||||||2017-10-11 01:57:09.54002|2017-10-11 01:57:09.54002
NCT01800760|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-06-28|||April 2012|Actual|2012-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Probiotics to Improve Women's Health|Probiotics to Improve Women's Health|Active, not recruiting||N/A|20|Actual|Arkansas Children's Hospital Research Institute||1|||f||||f||||||||||2017-10-11 01:57:09.632283|2017-10-11 01:57:09.632283
NCT01800747|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-07-27|||June 2012|Actual|2012-06-01|July 2017|2017-07-01|June 7, 2016|Actual|2016-06-07|June 7, 2016|Actual|2016-06-07||Interventional|DAP||Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)|Clinical Trial for the Assessment of Delayed Antibiotic Treatment in the Non-complicated Acute Respiratory Tract Infections in Pediatric (Study DAP-Pediatrics)|Completed||Phase 4|450|Actual|Asociacion Colaboracion Cochrane Iberoamericana||3|||f||||t||||||||||2017-10-11 01:57:09.72528|2017-10-11 01:57:09.72528
NCT01800734|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-11-18|||October 2012||2012-10-01|August 2012|2012-08-01|February 2015|Anticipated|2015-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study|Absorption and Utilization of a Mixed Meal in Type 1 Diabetes: Creation of a Biological and In Silico Biobank for the Optimization of Artificial Pancreas Systems. A Pilot Study.|Unknown status|Recruiting|Phase 4|20|Anticipated|Azienda Ospedaliera Universitaria Integrata Verona||1|||f||||f||||||||||2017-10-11 01:57:09.844691|2017-10-11 01:57:09.844691
NCT01800721|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2017-03-07|||July 30, 2011|Actual|2011-07-30|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|SNAP||Social Networks and Prevention for HIV Care and Prevention|A Randomized Controlled Trial to Train Black MSM as Peer Health Educators for HIV Testing and Prevention|Active, not recruiting||N/A|559|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||Undecided||2017-10-11 01:57:09.952646|2017-10-11 01:57:09.952646
NCT01800708|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-08-13|||January 2010||2010-01-01|August 2013|2013-08-01||||March 2013|Actual|2013-03-01||Interventional|||Cataract Surgery With Intracameral Triamcinolone in Infants|The Use of Intraocular Triamcinolone in the Perioperative Period of Congenital Cataract Surgery|Completed||N/A|60|Actual|Fundação Altino Ventura||2|||f||||f||||||||||2017-10-11 01:57:10.06122|2017-10-11 01:57:10.06122
NCT01800695|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-07-06|||April 2, 2013|Actual|2013-04-02|July 2017|2017-07-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Interventional|||Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme|A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme|Completed||Phase 1|202|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 01:57:10.194735|2017-10-11 01:57:10.194735
NCT01800682|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-02-26|||July 2011||2011-07-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Pharmacokinetic Study to Evaluate the Dose-Proportionality of Tramadol (ULTRAM) Extended-Release (ER) in Healthy Participants|A Single-Dose, Open-Label, Randomized, Crossover Dose-Proportionality Study to Evaluate the Effect of Dose on the Pharmacokinetics of 25, 50, and 100 mg ULTRAM ER Under Fasted Conditions in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Janssen Research & Development, LLC||3|||f||||f||||||||||2017-10-11 01:57:10.340448|2017-10-11 01:57:10.340448
NCT01800669|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2016-11-09|||February 2013||2013-02-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|CHICA-MLP||Computer-Supported Management of Medical-Legal Issues Impacting Child Health|Computer-Supported Management of Medical-Legal Issues Impacting Child Health|Completed||N/A|582|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 01:57:10.445088|2017-10-11 01:57:10.445088
NCT01800656|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-26|2013-02-27|||January 2004||2004-01-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Assessing Endoloop-assisted Polypectomy in Patients With Antiplatelet Therapy|"Endoloop-assisted Colorectal Polypectomy or Ligate and Let go in Patients With Long-term Antiplatelet Therapy"|Completed||N/A|36|Actual|Hospital Danilo I Cetinje||2|||f||||t||||||||||2017-10-11 01:57:10.531342|2017-10-11 01:57:10.531342
NCT01800643|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2014-12-02|||March 2010||2010-03-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation|Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Hospital Israelita Albert Einstein||2|||f||||t||||||||||2017-10-11 01:57:10.599734|2017-10-11 01:57:10.599734
NCT01800630|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2016-08-30|||April 2013||2013-04-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas|An Open Label, Phase 1, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity of Gemcitabine Hydrochloride Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas|Completed||Phase 1|37|Actual|InnoPharmax Inc.||1|||f||||f||||||||||2017-10-11 01:57:10.718068|2017-10-11 01:57:10.718068
NCT01800617|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-07-01|||March 2013||2013-03-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Interventional|||A Study of T3 Therapy in Patients With Hypothyroidism|Phase II Single Daily-Dose Response Study of a New Liothyronine Sodium (T3) Preparation With Sustained Effects in Hypothyroid Patients|Completed||Phase 2|18|Actual|Ipe, LLC||1|||f||||t||||||||||2017-10-11 01:57:10.81514|2017-10-11 01:57:10.81514
NCT01800604|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-09-29|||February 2013|Actual|2013-02-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|POP||Power Over Pain (POP) Study|Psychological Treatment of Disability-Related Pain: Efficacy and Mechanisms|Active, not recruiting||N/A|177|Actual|University of Washington||4|||f||||f||||||||||2017-10-11 01:57:10.88887|2017-10-11 01:57:10.88887
NCT01800591|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2015-05-04|||April 2013||2013-04-01|December 2013|2013-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||UPHS Weight Loss Study|UPHS Weight Loss Study: Evaluating Methods to Use Health Benefits Design to Encourage Employee Weight Loss|Completed||N/A|201|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 01:57:11.003709|2017-10-11 01:57:11.003709
NCT01800578|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-02-25|||September 2005||2005-09-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Awareness During Blended Anaesthesia|Relationships Between Bispectral Index (BIS), Implicit Memory Dream Recall and MAC in Blended Anaesthesia|Completed||N/A|36|Actual|Catholic University of the Sacred Heart|||1||f||||f||||||||||2017-10-11 01:57:11.109986|2017-10-11 01:57:11.109986
NCT01800565|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-25|||June 2006||2006-06-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty|Urinary LH in the Diagnosis of Precocious Puberty|Unknown status|Recruiting|N/A|65|Anticipated|Kaplan Medical Center||1|||f||||t||||||||||2017-10-11 01:57:11.212476|2017-10-11 01:57:11.212476
NCT01800552|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-02-25|||February 2013||2013-02-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Ultrasound Detection of Peripheral IV Infiltration|Ultrasound Detection of Peripheral IV Infiltration|Completed||N/A|20|Actual|ivWatch, LLC|||1||f||||f||||||||||2017-10-11 01:57:11.307099|2017-10-11 01:57:11.307099
NCT01800539|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-02-16|||February 2014||2014-02-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Improving Services and Outcomes for Children With Autism Spectrum Disorder (ASD)|Improving Part C Services and Outcomes for Under-resourced Children With ASD|Recruiting||N/A|80|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||||2017-10-11 01:57:11.377507|2017-10-11 01:57:11.377507
NCT01800526|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-05-15|||March 2013||2013-03-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|NACinSCD||A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease|A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease|Enrolling by invitation||Phase 1/Phase 2|20|Anticipated|Bloodworks (Puget Sound Blood Center)||2|||f||||t||||||||Yes|Data will be published at end of study and data made available to outside investigators after results are published by investigators|2017-10-11 01:57:11.467146|2017-10-11 01:57:11.467146
NCT01800513|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-25|||February 2013||2013-02-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|EMBX/IVF||Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure|EVAULATION OF IMPLANTATION AND PREGNANCY AFTER ENDOMETRIAL INJURY VIA ENDOMETRIAL PIPELLE BIOPSY IN THE CYCLE PRIOR TO IVF: A RANDOMIZED, SINGLE-BLINDED, CONTROLLED TRIAL.|Unknown status|Recruiting|N/A|254|Anticipated|Shady Grove Fertility Reproductive Science Center||2|||f||||t||||||||||2017-10-11 01:57:11.569653|2017-10-11 01:57:11.569653
NCT01800500|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-06-03|||September 2011||2011-09-01|June 2015|2015-06-01||||May 2015|Actual|2015-05-01||Interventional|||Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers|Exploring Current Smokers' Interest in Using Smokeless Tobacco Products Smokeless Tobacco Substitution for Cigarettes|Terminated||N/A|72|Actual|Roswell Park Cancer Institute||2||Difficulty accruing|f||||f||||||||||2017-10-11 01:57:11.663911|2017-10-11 01:57:11.663911
NCT01800487|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-12-23|||January 2012||2012-01-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs|The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs|Completed||N/A|80|Anticipated|Ramathibodi Hospital||2|||f||||f||||||||||2017-10-11 01:57:11.760205|2017-10-11 01:57:11.760205
NCT01800474|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-02-27|||February 2013||2013-02-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice|A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice|Completed||N/A|582|Actual|Q-Med AB|||1||f||||f||||||||||2017-10-11 01:57:11.83699|2017-10-11 01:57:11.83699
NCT01800448|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-07-05|||June 2012||2012-06-01|July 2017|2017-07-01|June 2013|Actual|2013-06-01|September 2012|Actual|2012-09-01||Observational|NM3||Variability Analysis During Weaning and Extubation in Critically Ill Patients|Cardiopulmonary Monitoring, Skin Conductance and Variability Analysis During Weaning and Extubation in Critically Ill Patients|Completed||N/A|12|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-11 01:57:11.997007|2017-10-11 01:57:11.997007
NCT01800435|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-28|||October 2011||2011-10-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|BPATXAS||A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor|Whole Blood Clot Stability and Thrombin Generating Capacity Following Treatment With Bypassing Agents (BPA) With and Without and Tranexamic Acid (TXA) in Haemophilia A Patients With inhibitor-an In-vivo Prospective Crossover Study|Completed||Phase 4|6|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:57:12.066152|2017-10-11 01:57:12.066152
NCT01800422|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2016-03-21|||June 2013||2013-06-01|March 2016|2016-03-01||||February 2018|Anticipated|2018-02-01||Interventional|||Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer|Presurgical Phase IIB Trial of Oral CDB-4124 vs. Placebo in Women With Stage I-II Primary Breast Cancer|Active, not recruiting||Phase 2|50|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-11 01:57:12.158102|2017-10-11 01:57:12.158102
NCT01800409|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-02-27|||February 2013||2013-02-01|February 2013|2013-02-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Abdominal Functional Electrical Stimulation Training and Its Effect on Mechanical Insufflation-Exsufflation|Abdominal Functional Electrical Stimulation Training and Its Effect on Mechanical Insufflation-Exsufflation|Unknown status|Recruiting|N/A|10|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 01:57:12.482001|2017-10-11 01:57:12.482001
NCT01800396|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-08-26|||February 2013||2013-02-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MIRAGE||Milk Ingredients and Resistance Against E-coli-induced GastroEnteritis (MIRAGE)|A Randomized, Placebo-controlled, Double Blind Volunteer Study Into the Effect of Milk Ingredients on Gastroenteritis Caused by an Attenuated E.Coli.|Completed||N/A|60|Actual|NIZO Food Research||2|||f||||t||||||||||2017-10-11 01:57:12.616792|2017-10-11 01:57:12.616792
NCT01800383|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-03-14|||February 2013||2013-02-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Cerebral GABA and Fear Conditioning in PTSD||Recruiting||N/A|93|Anticipated|Mclean Hospital|||3||f||||||||||||||2017-10-11 01:57:12.735885|2017-10-11 01:57:12.735885
NCT01800370|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-05-09|||February 2013||2013-02-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men|The Effect of Mixed Exercise and Metabolic Stress Upon Pituitary Secretion in Relationship to Age in Healthy Men: a Pilot Study|Completed||Phase 1|40|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 01:57:12.851635|2017-10-11 01:57:12.851635
NCT01800357|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-02-25|||January 2013||2013-01-01|January 2013|2013-01-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||Efficacy and Safety of Mildronate for Acute Ischemic Stroke|Efficacy and Safety of Mildronate for Acute Ischemic Stroke: Study Protocol for a Randomized, Double-blind, Placebo-controlled Phase II Multicenter Trial|Unknown status|Recruiting|Phase 2|240|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 01:57:12.967847|2017-10-11 01:57:12.967847
NCT01800344|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-25|||January 2012||2012-01-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator|The Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator on Postoperative Pharyngolaryngeal Adverse Events: A Prospective, Randomized Trial|Completed||N/A|170|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:57:13.099754|2017-10-11 01:57:13.099754
NCT01800331|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-05-08|||March 2013||2013-03-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Text2bHealthy: Using Innovative Methods in Childhood Obesity Treatment|Text2bHealthy: Enhancing Adherence to Childhood Obesity Treatment Through the Use of Innovative Methods|Terminated||N/A|2|Actual|University of British Columbia||2||"My post-doctoral fellow did not return from her mat leave and I have no other students to take   on this project."|f||||f||||||||||2017-10-11 01:57:13.195365|2017-10-11 01:57:13.195365
NCT01800318|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-01-12|2015-08-25||March 2013||2013-03-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Newborns randomized to treatment groups during routine newborn screening|Does Noninvasive Electrical Stimulation of Acupuncture Points (NESAP) Reduce Heelstick Pain in Infants?|Does Noninvasive Electrical Stimulation of Acupuncture Points (NESAP) Reduce Heelstick Pain in Infants?|Completed||N/A|162|Actual|University of Arkansas|We had difficulty collecting adequate saliva for salivary cortisol analysis. Many infants had insufficient saliva to run a reliable analysis, and numbers of infants with adequate saliva samples both before and after the heel stick were limited.|4|||f||||t||||||||||2017-10-11 01:57:13.324301|2017-10-11 01:57:13.324301
NCT01800305|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2015-08-27|||September 2012||2012-09-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual|A Randomized, Positive-controlled, Single-dose, Dose-escalation Phase I Trial to Evaluate Safety & Tolerability, and Explore the Pharmacokinetics and Pharmacodynamics Profile of Pegylated rhEPO in Male Healthy Individual|Completed||Phase 1|150|Actual|Xiamen Amoytop Biotech Co., Ltd.||2|||f||||t||||||||||2017-10-11 01:57:14.211185|2017-10-11 01:57:14.211185
NCT01800292|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2015-11-03|||February 2013||2013-02-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|LV strain||Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.|Echo Study - Characterization of LV Strain Patterns in Patients With Mildly Elevated PCWP and Pulmonary Hypertension|Completed||Phase 4|9|Actual|University of Arizona||1|||f||||f||||||||||2017-10-11 01:57:14.304396|2017-10-11 01:57:14.304396
NCT01800279|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-12-09|||March 2013||2013-03-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Physiotherapy and Deontology in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome.|Comparative Study on the Effectiveness of Physical Therapy and Deontology for Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome.|Completed||N/A|70|Anticipated|Universidad de Almeria||2|||f||||f||||||||||2017-10-11 01:57:14.425685|2017-10-11 01:57:14.425685
NCT01800266|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2015-04-30|||July 2012||2012-07-01|April 2015|2015-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|STEPS||Randomized Controlled Trial of Supervision Strategies to Improve Clinician Fidelity to Trauma-focused CBT|Improving Practice in Community-based Settings: A Randomized Trial of Supervision Strategies|Unknown status|Recruiting|N/A|1280|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-11 01:57:14.551927|2017-10-11 01:57:14.551927
NCT01800253|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-12-06|||March 2013||2013-03-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||The Effects of Acute Total Sleep Deprivation Versus Normal Sleep on Metabolism|The Role of Acute Total Sleep Deprivation in the Regulation of Metabolism, Neuroendocrine Responses, and Behavioral Measures|Completed||N/A|17|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 01:57:14.654071|2017-10-11 01:57:14.654071
NCT01800240|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-02-25||||||February 2013|2013-02-01||||March 2010|Actual|2010-03-01||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fed Conditions|An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of FDC of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets 15 mg/850 mg (Test Formulation, Torrent Pharmaceuticals Ltd., India) Versus Actoplus Met® 15 mg/850 mg Tablets (Reference Formulation, Takeda Pharmaceuticals America Inc., USA) in Healthy Human Volunteers Under Fed Conditions.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 01:57:14.74905|2017-10-11 01:57:14.74905
NCT01800227|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-02-25||||||February 2013|2013-02-01||||March 2010|Actual|2010-03-01||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fasting Conditions|An Open Label, Randomised, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of FDC of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets 15 mg/850 mg (Test Formulation, Torrent Pharmaceuticals Ltd., India) Versus Actoplus Met® 15 mg/850 mg Tablets (Reference Formulation, Takeda Pharmaceuticals America Inc., USA) in Healthy Human Volunteers Under Fasting Conditions.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 01:57:14.815428|2017-10-11 01:57:14.815428
NCT01800214|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-05-19|||September 1995||1995-09-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Observational|||The Sunnybrook Dementia Study: Mapping Brain Changes in Alzheimer's, Vascular and Other Dementias|In Vivo Brain Mapping in Cognitive Impairment From Alzheimer's, Vascular and Other Demenitas: A Longitudinal Brain-Behaviour Study With a Focus on Cerebrovascular Disease|Unknown status|Active, not recruiting|N/A|1200|Anticipated|Sunnybrook Health Sciences Centre|||6||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:57:14.880416|2017-10-11 01:57:14.880416
NCT01800201|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-09-19|||March 2013|Actual|2013-03-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|December 2015|Actual|2015-12-01||Interventional|Heartstrong||Automated Hovering to Improve Medication Adherence Among Myocardial Infarction Patients (Heartstrong)|Automated Hovering to Improve Medication Adherence Among Myocardial Infarction Patients (Heartstrong)|Completed||N/A|1509|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 01:57:14.967706|2017-10-11 01:57:14.967706
NCT01800188|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-11-18|||February 2013||2013-02-01|November 2013|2013-11-01||||September 2013|Actual|2013-09-01||Observational|||Glucose Metabolism During Hemodialysis|Glucose Metabolism During Hemodialysis|Completed||N/A|10|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     Serum of blood specimens will be retained for analysis at the end of the study   "|||2017-10-11 01:57:15.069973|2017-10-11 01:57:15.069973
NCT01800175|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-02-10|||February 2013||2013-02-01|February 2016|2016-02-01||||December 2016|Anticipated|2016-12-01||Interventional|||Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug||Active, not recruiting||Phase 1|60|Anticipated|Ocular Therapeutix, Inc.||2|||f||||f||||||||||2017-10-11 01:57:15.153004|2017-10-11 01:57:15.153004
NCT01800162|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-05-02|2017-03-22||February 2013||2013-02-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PPUL||RCT for Women With a Persisting Pregnancy of Unknown Location|Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location -- a Randomized Clinical Trial of Women at Risk for an Ectopic Pregnancy|Terminated||N/A|2|Actual|University of Pennsylvania||3||A new protocol was written to replace this protocol.|f||||t||||||||||2017-10-11 01:57:15.22178|2017-10-11 01:57:15.22178
NCT01800149|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-09-01|||February 2013||2013-02-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Healing of Post-ext Sites Using Bovine Bone Mineral: a CBCT and Histologic RCCT|Healing of Post-extraction Sites Using Bovine-bone Mineral: a CBCT and Histologic Randomized Controlled Clinical Study|Completed||Phase 4|20|Actual|Proed||2|||f||||f||||||||No||2017-10-11 01:57:15.543784|2017-10-11 01:57:15.543784
NCT01800136|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2016-06-17|||June 2012||2012-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|NI-MCS||Analgesic Effect of Non Invasive Stimulation : Comparison of rTMS and tDCS Efficacy|Non-invasive Cortical Stimulation for Pharmacoresistant Neuropathic Pain: rTMS Versus tDCS|Recruiting||Phase 4|40|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 01:57:15.622341|2017-10-11 01:57:15.622341
NCT01800123|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-02-25|||March 2012||2012-03-01|February 2013|2013-02-01||||November 2013|Anticipated|2013-11-01||Observational|CAPNOTOX||EtCO2 Monitoring in Acute Self-poisoning|Continuous EtCO2 Monitoring in Acute Self Poisoned Patients Admitted in an Emergency Department|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-11 01:57:15.701067|2017-10-11 01:57:15.701067
NCT01800110|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-25|||April 2013||2013-04-01|February 2013|2013-02-01||||April 2015|Anticipated|2015-04-01||Interventional|||Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk|Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 01:57:15.764035|2017-10-11 01:57:15.764035
NCT01800097|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-06-23|||October 2012||2012-10-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent|Treatment of Post Stroke Fatigue With Modafinil, Effect on Rehabilitation, Fatigue and Bonemass Index|Terminated||Phase 3|41|Actual|Herlev Hospital||2||Slow recruitment|f||||t||||||||||2017-10-11 01:57:15.823969|2017-10-11 01:57:15.823969
NCT01800084|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-03-25|||August 2013||2013-08-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|AsirTest||Impact of Reconstruction Method (ASIR, FBP) Used in CT on Bone SPECT/CT Image Quality|Impact of Reconstruction Method (Adaptive Statistical Iterative Reconstruction, Filtered Back Projection) Used in Computed Tomography on Bone Single-Photon- Emission-Computed-Tomography/Computed-Tomography Image Quality|Completed||N/A|75|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-11 01:57:15.924431|2017-10-11 01:57:15.924431
NCT01800071|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-08-30|||March 2013||2013-03-01|August 2016|2016-08-01||||March 2017|Anticipated|2017-03-01||Interventional|||A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma|A Cancer Research UK (CR-UK) Phase Ib Trial to Determine the Safety, Tolerability and Immunogenicity of Extended Schedule Vaccination With MVA-EBNA1/LMP2 in Patients With Epstein Barr Virus Positive (EBV+) Nasopharyngeal Carcinoma (NPC).|Active, not recruiting||Phase 1|22|Actual|Cancer Research UK|||||f||||f||||||||||2017-10-11 01:57:16.012192|2017-10-11 01:57:16.012192
NCT01800058|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-02-25|||March 2013||2013-03-01|February 2013|2013-02-01|April 2016|Anticipated|2016-04-01|April 2014|Anticipated|2014-04-01||Observational|||Prognostic Value of the Levels of CTCs in Peripheral Blood in Patients With Prostate Cancer at High Risk (Clinical Stages IIB-III) Treated Radically With Radiotherapy and Hormone Therapy.|Prognostic Value of the Levels of Circulating Tumor Cells (CTCs) in Peripheral Blood in Patients With Prostate Cancer at High Risk (Clinical Stages IIB-III) Treated Radically With Radiotherapy and Hormone Therapy.|Unknown status|Not yet recruiting|N/A|65|Anticipated|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa|||1||f||||f||||||Samples Without DNA|"     Prospective analysis of biological material from samples of peripheral blood (PB) of patients     diagnosed with prostate cancer at high risk (NCCN 2011), AJCC stage IIB-III, treated with     3D-CRT, IMRT dose escalation (with androgen deprivation (DA))      The sampling of peripheral blood (PB) for detection of CTCs in three treatment periods:        -  Before starting any treatment-DA initially neoadjuvant        -  Prior to the start of RT (DA after neoadjuvant)        -  At the end of RT (1-3 months) The analysis-quantification of CTCs obtained in these          phases, will correlate with treatment outcomes in terms of biochemical failure (BF)          according to the criteria of Phoenix 2006 and overall survival and metastasis-free to          identify potential prognostic value. Likewise determinations are compared before and          after CTCs DA and RT to evaluate the effect of such treatments on modular quantifying          CTCs (predictive value).   "|||2017-10-11 01:57:16.099362|2017-10-11 01:57:16.099362
NCT01800045|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2016-08-30|||April 2013||2013-04-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)|A Randomized, Double Blind Study Comparing Pitolisant (BF2.649) to Placebo in Two Parallel Groups on the Weekly Frequency of Cataplexy Attacks and Excessive Daytime Sleepiness in Narcoleptic Patients With Cataplexy.|Completed||Phase 3|103|Actual|Bioprojet||2|||f||||t||||||||||2017-10-11 01:57:16.207444|2017-10-11 01:57:16.207444
NCT01800032|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-10-03|||January 16, 2013|Actual|2013-01-16|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)|Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography- Magnetic Resonance Imaging (FDG-PET-MRI) in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)|Active, not recruiting||N/A|30|Actual|UNC Lineberger Comprehensive Cancer Center|||2||f||||t||||||||||2017-10-11 01:57:16.286902|2017-10-11 01:57:16.286902
NCT01800006|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-06-20|||January 14, 2013|Actual|2013-01-14|June 2017|2017-06-01|June 20, 2016|Actual|2016-06-20|January 16, 2016|Actual|2016-01-16||Observational|XANTUS-EL||Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region|XANTUS-EL, Xarelto® on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A Non-interventional Study|Completed||N/A|2101|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:57:16.599925|2017-10-11 01:57:16.599925
NCT01799993|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-07-05|||April 13, 2013|Actual|2013-04-13|July 2017|2017-07-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|INHALE 1||Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Patients With Gram-Negative Pneumonia|Completed||Phase 3|264|Actual|Bayer||2|||f||||t|t|f||||||||2017-10-11 01:57:16.770476|2017-10-11 01:57:16.770476
NCT01799980|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-09-18|||June 2012||2012-06-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|EBUS||Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer|Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer|Active, not recruiting||N/A|37|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||||||2017-10-11 01:57:17.585119|2017-10-11 01:57:17.585119
NCT01799967|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-06-09|||November 2007||2007-11-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|MISGEJ||Minimally Invasive Surgery of the Gastro-esophageal Junction|Functional Assessment Following Minimally Invasive Surgery of the Gastro-Esophageal Junction|Recruiting||N/A|200|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||Undecided||2017-10-11 01:57:17.672409|2017-10-11 01:57:17.672409
NCT01799954|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2015-03-23|||August 2012||2012-08-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults|A Phase 1 Double Blind Placebo-controlled Clinical Trial to Evaluate the Safety and to Compare the Priming Ability of NYVAC Alone Versus NYVAC + AIDSVAX® B/E, and DNA Alone Versus DNA + AIDSVAX® B/E When Followed by NYVAC + AIDSVAX® B/E Boosts in Healthy, HIV-1-uninfected Adult Participants|Completed||Phase 1|96|Actual|HIV Vaccine Trials Network||4|||f||||t||||||||||2017-10-11 01:57:17.780974|2017-10-11 01:57:17.780974
NCT01799941|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-01-26|2016-05-05||February 2013||2013-02-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PRISM II||Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)|A Study to Assess the Safety, Tolerability and Effectiveness of Nuedexta (Dextromethorphan 20 mg/Quinidine 10 mg) in the Treatment of Pseudobulbar Affect (PBA)|Completed||Phase 4|367|Actual|Avanir Pharmaceuticals||1|||f||||f||||||||||2017-10-11 01:57:17.953774|2017-10-11 01:57:17.953774
NCT01799915|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-08-09|||June 2011||2011-06-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Natural History Study of Synucleinopathies|Natural History Study of Synucleinopathies|Recruiting||N/A|800|Anticipated|New York University School of Medicine|||5||f||||t||||||Samples With DNA|"     Blood Sample for DNA processing   "|||2017-10-11 01:57:19.256606|2017-10-11 01:57:19.256606
NCT01799902|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-12-18|||December 2011||2011-12-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|VENICE||Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome)|Belgian Observational Study to Evaluate Storage and Voiding Symptoms Improvement in Male Subjects With Lower Urinary Tract Predominant Storage Symptoms (Overactive Bladder Syndrome) Being Treated With Solifenacin in Monotherapy or Combination|Completed||N/A|86|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:57:19.374269|2017-10-11 01:57:19.374269
NCT01799889|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-06-15|||March 14, 2013|Actual|2013-03-14|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies|A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies|Active, not recruiting||Phase 2|326|Actual|Gilead Sciences||8|||f||||f|t|f||||||||2017-10-11 01:57:19.490092|2017-10-11 01:57:19.490092
NCT01799876|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-08-08|||February 2013||2013-02-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Use of Cell Therapy to Enhance Arthroscopic Knee Cartilage Surgery|Autologous Cell Therapy Enhancement of Microfracture Surgery|Active, not recruiting||N/A|48|Actual|Fondren Orthopedic Group L.L.P.||2|||f||||f||||||||||2017-10-11 01:57:19.761433|2017-10-11 01:57:19.761433
NCT01799863|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2015-04-07|||June 2012||2012-06-01|April 2015|2015-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis|Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Treatment of Acute Viral Conjunctivitis|Completed||Phase 2/Phase 3|50|Actual|Fundação Altino Ventura||2|||f||||t||||||||||2017-10-11 01:57:19.860854|2017-10-11 01:57:19.860854
NCT01799850|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-02-25|||March 2002||2002-03-01|February 2013|2013-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle|The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle|Completed||Phase 4|12|Actual|East Tennessee State University||2|||f||||f||||||||||2017-10-11 01:57:19.992008|2017-10-11 01:57:19.992008
NCT01799837|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-09-10|||June 2012||2012-06-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||Norepinephrine Transporter Availability in PTSD|Kinetic Modeling of Norepinephrine Transporter Availability in PTSD|Completed||Phase 1|9|Actual|Emory University||2|||f||||||||||||||2017-10-11 01:57:20.12528|2017-10-11 01:57:20.12528
NCT01799824|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-11-15||2013-11-15|February 2013||2013-02-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis|Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis in Adults|Completed||Phase 2|52|Actual|Anterios Inc.||2|||f||||f||||||||||2017-10-11 01:57:20.235012|2017-10-11 01:57:20.235012
NCT01799811|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-07-08|||February 2013||2013-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|LIMBSAVE||Cryopreserved Saphenous Vein Allograft in Patients With Critical Limb Ischemia for Peripheral Revascularization|Prospective, Multicenter, Primary Below the Knee Bypass Evaluation With CryoVein® Cryopreserved Saphenous Vein Allograft in Patients With Critical Limb Ischemia|Completed||N/A|30|Actual|CryoLife, Inc.|||1||f||||f||||||Samples With DNA|"     During the Study follow-up period, a patient may present with an event requiring an open     surgical revision, surgical explant or limb amputation on the (allograft) recipient limb. At     the time of related planned intervention a tissue sample of the affected area of the     allograft may be obtained and, if so, will placed into 10% buffered formalin solution and     returned to CryoLife for histologic analysis.   "|No|Post market study of 361 product; not supporting any FDA approvals.|2017-10-11 01:57:20.359846|2017-10-11 01:57:20.359846
NCT01799798|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-01-26|||February 2013||2013-02-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|OI-AK||Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab|TRANSLATIONAL THERAPY IN PATIENTS WITH OSTEOGENESIS IMPERFECTA - A PILOT TRIAL ON TREATMENT WITH THE RANKL-ANTIBODY DENOSUMAB|Completed||Phase 2|10|Actual|University of Cologne||1|||f||||f||||||||||2017-10-11 01:57:20.463781|2017-10-11 01:57:20.463781
NCT01799785|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-10-08|||February 2013||2013-02-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Aerobic Training on Exercise Capacity in Patients With Cirrhosis|Aerobic Training in Patients With Cirrhosis|Completed||N/A|20|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 01:57:20.544765|2017-10-11 01:57:20.544765
NCT01799772|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2014-09-09|||September 2011||2011-09-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||The Feasibility of a Comprehensive Behavioral Intervention in Patient Post TKA|The Feasibility of a Comprehensive Behavioral Intervention in Patient Post Total Knee Arthroplasty|Completed||Phase 1/Phase 2|50|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:57:20.636384|2017-10-11 01:57:20.636384
NCT01799759|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2017-09-22|||February 2013||2013-02-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Project Fun: Parents And Youth Together|Project Fun: Parents And Youth Together|Completed||N/A|276|Actual|Marquette University||2|||f||||f||||||||||2017-10-11 01:57:20.713303|2017-10-11 01:57:20.713303
NCT01799746|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-04-06|||March 2013||2013-03-01|April 2017|2017-04-01|December 31, 2015|Actual|2015-12-31|December 2015|Actual|2015-12-01||Observational|||Mechanisms of Response to Diesel Exhaust in Subjects With Asthma|Mechanisms of Response to Diesel Exhaust in Subjects With Asthma|Withdrawn||N/A|0|Actual|University of Pennsylvania|||1|"The Airways Biology Initiative closed in December, 2015. This study was closed with the Penn   IRB at that time. No subjects were recruited for this trial."|f||||||||||||Undecided||2017-10-11 01:57:20.802048|2017-10-11 01:57:20.802048
NCT01799733|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-11-15|||June 2013||2013-06-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Alternative Treatments for Premenstrual Dysphoric Disorder|Alternative Treatments for Premenstrual Dysphoric Disorder|Recruiting||N/A|40|Anticipated|University of California, San Diego||2|||f||||t||||||||No||2017-10-11 01:57:21.095901|2017-10-11 01:57:21.095901
NCT01799720|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-07-12|2014-01-07||October 2010||2010-10-01|July 2015|2015-07-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|GPTPASPAD||Oxidized Omega-3 Supplements With Different Oxidation|Effect of Omega-3 Dietary Supplements With Different Oxidation Levels in the Lipidic Profile of Women: a Randomized Controlled Trial|Completed||N/A|71|Actual|Universidad Miguel Hernandez de Elche||3|||f||||t||||||||||2017-10-11 01:57:21.296371|2017-10-11 01:57:21.296371
NCT01799707|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-26|||July 2004||2004-07-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|August 2007|Actual|2007-08-01||Interventional|VRT-G||Vision Restoration Training in Glaucoma|Vision Restoration Training in Glaucoma - A Double-blind, Randomized, Placebo-controlled Clinical Trial|Unknown status|Active, not recruiting|Phase 2|30|Actual|University of Magdeburg||2|||f||||f||||||||||2017-10-11 01:57:22.195347|2017-10-11 01:57:22.195347
NCT01799694|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-03-07|||July 2011||2011-07-01|September 2012|2012-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|FLPURO||Stem Cells Treatment for the Local Urinary Incontinence After a Radical Prostate Cancer Surgery (HULPURO)|Phase II Clinical Trial to Study the Feasibility and Safety of the Expanded Autologous Stem Cells Use Derived From Adipose Tissue (e-ASC) for the Local Urinary Incontinence After a Radical Prostate Cancer Surgery|Completed||Phase 2|10|Actual|Instituto de Investigación Hospital Universitario La Paz||1|||f||||f||||||||||2017-10-11 01:57:22.312502|2017-10-11 01:57:22.312502
NCT01799681|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-03-18|||August 2011||2011-08-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Interventional|||The Effects of the Hopeful Outdoor Parkinson Exercise (HOPE) Program on Improving Balance Performance in Parkinsonian Non-fallers and Single Fallers|The Effects of the Hopeful Outdoor Parkinson Exercise (HOPE) Program on Improving Balance, Gait and Functional Performance in Parkinsonian Non-fallers and Single Fallers - a Randomized Controlled Trial With 12-month Follow-up|Completed||N/A|84|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 01:57:22.435255|2017-10-11 01:57:22.435255
NCT01799668|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2013-02-26|||February 2013||2013-02-01|February 2013|2013-02-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01|3 Weeks|Observational [Patient Registry]|||Therapists' Preferences for Client Characteristics and Their Influence on the Therapeutic Alliance|Therapists' Preferences for Client Characteristics and Their Influence on the Therapeutic Alliance|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 01:57:22.541207|2017-10-11 01:57:22.541207
NCT01799655|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-05-04|||April 2013||2013-04-01|February 2013|2013-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01|1 Day|Observational [Patient Registry]|||Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?|Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?|Completed||N/A|100|Anticipated|HaEmek Medical Center, Israel|||1||f||||t||||||||||2017-10-11 01:57:22.636757|2017-10-11 01:57:22.636757
NCT01799642|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-11-19|||June 2013||2013-06-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|CF_Dyspnea||Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis|Qualitative Descriptors of Dyspnea During Exercise in Cystic Fibrosis|Completed||N/A|50|Actual|University of British Columbia|||2||f||||f||||||||||2017-10-11 01:57:22.729749|2017-10-11 01:57:22.729749
NCT01799629|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2016-08-30|||March 2013||2013-03-01|August 2016|2016-08-01||||September 2017|Anticipated|2017-09-01||Interventional|||Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial|Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial|Recruiting||N/A|220|Anticipated|King Faisal Specialist Hospital & Research Center||2|||f||||f||||||||||2017-10-11 01:57:22.819812|2017-10-11 01:57:22.819812
NCT01799616|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-25|||January 2013||2013-01-01|February 2013|2013-02-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|||Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease||Unknown status|Recruiting|Phase 2|48|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:57:22.960249|2017-10-11 01:57:22.960249
NCT01799603|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-04-25|||May 2012||2012-05-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435|A Single-dose, Open-label, Randomized, Two-way Crossover Study to Assess the Effect of Food on the Pharmacokinetics of TMC435 in Japanese Healthy Adult Male Subjects|Completed||Phase 1|24|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 01:57:23.112818|2017-10-11 01:57:23.112818
NCT01799590|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2013-05-24|2013-03-19||August 2007||2007-08-01|May 2013|2013-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Continuous Treatment Study of Topiramate in Migraine Participants|A Continuous Treatment Study of JNS019 (Topiramate) in Migraine Patients|Completed||Phase 2|296|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 01:57:23.266478|2017-10-11 01:57:23.266478
NCT01799577|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-12-31|||January 2013||2013-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Comparison of 2-Dimensional and 3-Dimensional Laparoscopic Visions|Comparison of 2-Dimensional and New Generation 3-Dimensional Laparoscopic Visions In An Experimental Model|Completed||N/A|24|Actual|Bagcilar Training and Research Hospital|||1||f||||f||||||||||2017-10-11 01:57:24.274377|2017-10-11 01:57:24.274377
NCT01799564|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-25|2015-03-23|||August 2012||2012-08-01|March 2015|2015-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|MPL4DRY||Micropulse Laser for Geographic Atrophy|A Phase I Study to Establish the Safety and Efficacy of Retinal Pigment Epithelium Micropulse Laser in Subjects With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration|Unknown status|Recruiting|Phase 1|15|Anticipated|Institut de la Macula y la Retina||2|||f||||f||||||||||2017-10-11 01:57:24.372557|2017-10-11 01:57:24.372557
NCT01799551|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2014-10-27|||November 2012||2012-11-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Brief Culturally Adapted Cognitive Behaviour Therapy for Depression|A Randomised Controlled Trial of Brief Culturally Adapted CBT for Depression in Pakistan|Completed||N/A|140|Anticipated|Pakistan Association of Cognitive Therapists||2|||f||||t||||||||||2017-10-11 01:57:24.468652|2017-10-11 01:57:24.468652
NCT01799538|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2017-09-21|||December 18, 2012||2012-12-18|September 15, 2017|2017-09-15|November 1, 2019|Anticipated|2019-11-01|October 1, 2019|Anticipated|2019-10-01||Interventional|||Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis|Bronchodilator Effects of Nebulized Versus Inhaled Albuterol In Subjects With Lymphangioleiomyomatosis|Recruiting||Phase 2|150|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:57:24.579145|2017-10-11 01:57:24.579145
NCT01799525|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-12-09|||January 2013||2013-01-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|SAHCO2||Hypercapnia to Prevent Secondary Ischemia in SAH|Therapeutical Hypercapnia to Prevent Secondary Ischemic Events in Aneurysmal Subarachnoid Hemorrhage (aSAH)|Completed||Phase 1|10|Actual|Wuerzburg University Hospital||1|||f||||t||||||||||2017-10-11 01:57:24.675372|2017-10-11 01:57:24.675372
NCT01799512|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-02-22|||July 2007||2007-07-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|September 2010|Actual|2010-09-01||Interventional|REGIMEN||Glucose Control in the ICU Using Continuous Glucose Monitoring|Randomized Evaluation of Glycaemic Control in the Medical Intensive Care Unit Using Continuous Glucose Monitoring (REGIMEN Trial)|Completed||N/A|35|Actual|University Hospital, Antwerp||2|||f||||f||||||||||2017-10-11 01:57:24.764644|2017-10-11 01:57:24.764644
NCT01799499|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-08-30|||March 2013||2013-03-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|NMIBC TURBT HG||A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)|A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)|Withdrawn||N/A|0|Actual|UroGen Pharma Ltd.||3||Change in the company clinical trials priority|f||||||||||||||2017-10-11 01:57:24.869948|2017-10-11 01:57:24.869948
NCT01799486|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-23|||February 2013||2013-02-01|February 2013|2013-02-01|March 2015|Anticipated|2015-03-01|February 2013|Actual|2013-02-01||Interventional|||Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial|Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 4|300|Anticipated|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 01:57:25.07092|2017-10-11 01:57:25.07092
NCT01799473|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-03-20|||January 2013||2013-01-01|May 2014|2014-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|6 Months|Observational [Patient Registry]|||Tyvaso Dosing and Titration Evaluation: TyTRATE Registry|A Patient Registry to Observe the Real-World Dosing and Titration of Tyvaso®|Completed||N/A|98|Actual|United Therapeutics|||1||f||||f||||||||||2017-10-11 01:57:25.173812|2017-10-11 01:57:25.173812
NCT01799447|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-05-03|||May 2012|Actual|2012-05-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|TiMM||Early Intervention With the Marte Meo Method|The Relations Between Infants and Vulnerable First Time Mothers. Does Video Guidances With the Marte Meo Method Promote the Process? Intervention Study in a Community Setting|Completed||N/A|150|Actual|University of Aarhus||1|||f||||f||||||||Undecided||2017-10-11 01:57:25.472684|2017-10-11 01:57:25.472684
NCT01799434|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-25|||February 2006||2006-02-01|February 2013|2013-02-01||||December 2007|Actual|2007-12-01||Interventional|||Dynamic Postural Control After Exercise|Influence of an Exercise on the Dynamic Postural Control in Athletes|Completed||N/A|83|Actual|University Hospital Heidelberg||1|||f||||f||||||||||2017-10-11 01:57:25.570566|2017-10-11 01:57:25.570566
NCT01799421|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2016-11-18|||October 2011||2011-10-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|NEURISK||Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy|Predictive Models of Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy.|Completed||N/A|420|Actual|Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología|||1||f||||f||||||||||2017-10-11 01:57:25.640777|2017-10-11 01:57:25.640777
NCT01799408|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-23|||October 2012||2012-10-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis|The Effect of Intra-articular Injection of Betamethasone Acetate/Betamethasone Sodium Phosphate at the Knee Joint on the Hypothalamic-pituitary-adrenal Axis: a Case Controlled Study|Completed||N/A|40|Actual|The Nazareth Hospital, Israel|||2||f||||t||||||||||2017-10-11 01:57:27.713975|2017-10-11 01:57:27.713975
NCT01799395|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2017-09-11|||February 2013||2013-02-01|September 2017|2017-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer|Prevalence, Incidence and Predictors of Central Airway Obstruction in Patients With Advanced Lung Cancer|Terminated||N/A|45|Actual|Maggiore Bellaria Hospital, Bologna|||1|"Staff constraints made it impossibile to enroll consecutive patients, making the sample not   representative of the true cancer population"|f||||f||||||||||2017-10-11 01:57:27.779045|2017-10-11 01:57:27.779045
NCT01799382|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2014-10-05|||February 2013||2013-02-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens|Mutational Analysis of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) Specimens in Patients With Advanced Non-small Cell Lung Cancer: a Randomized Trial of Rapid On-site Evaluation|Completed||N/A|126|Actual|Maggiore Bellaria Hospital, Bologna||2|||f||||f||||||||||2017-10-11 01:57:27.847996|2017-10-11 01:57:27.847996
NCT01799369|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2016-03-05|||April 2011||2011-04-01|March 2016|2016-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|SAS||Surgical Apgar Score in Clinical Practice: a Pilot Study|Surgical Apgar Score in Clinical Practice: a Pilot Study|Completed||N/A|143|Actual|London Surgical Research Group||2|||f||||f||||||||||2017-10-11 01:57:27.918466|2017-10-11 01:57:27.918466
NCT01799356|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2013-08-27|||June 2010||2010-06-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials||Completed||Phase 4|1303|Actual|Istanbul Bakirkoy Maternity and Children Diseases Hospital||2|||f||||||||||||||2017-10-11 01:57:27.983397|2017-10-11 01:57:27.983397
NCT01799343|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-23|||February 2011||2011-02-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Water Immersion and Changes in the Fetoplacental Circulation|Water Immersion and Changes in the Fetoplacental Circulation. A Case-Control Study With the Case as it's Own Control.|Completed||N/A|25|Actual|Hvidovre University Hospital||1|||f||||f||||||||||2017-10-11 01:57:28.0785|2017-10-11 01:57:28.0785
NCT01799330|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-06-13|||December 2008||2008-12-01|June 2014|2014-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Rehabilitation of Patients With COPD Using Electrical Muscle Stimulation|Rehabilitation of Patients With COPD Using Electrical Muscle Stimulation|Unknown status|Recruiting|N/A|160|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 01:57:28.158579|2017-10-11 01:57:28.158579
NCT01799317|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-02-22|||March 2009||2009-03-01|February 2013|2013-02-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||How Bone is Made in Children Receiving Dialysis|Regulation of Bone Mineralization in Renal Osteodystrophy|Unknown status|Recruiting|Phase 4|60|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 01:57:28.248291|2017-10-11 01:57:28.248291
NCT01799304|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-03-22|||February 2013||2013-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|Dual-Task||Static and Dynamic Postural Stability in Cerebral Palsy Children|Is it Possible to Improve Static and Dynamic Postural Stability in Cerebral Palsy Children by Modulating Attention?|Completed||Phase 3|24|Actual|University Hospital, Grenoble||4|||f||||f||||||||||2017-10-11 01:57:28.344202|2017-10-11 01:57:28.344202
NCT01799291|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2017-04-21|||September 2012||2012-09-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Cognitive De-Biasing and the Assessment of Pediatric Bipolar Disorder|Decision Making and Mental Health: Cognitive De-Biasing and the Assessment of Pediatric Bipolar Disorder|Completed||N/A|240|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:57:28.501256|2017-10-11 01:57:28.501256
NCT01799278|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-01-19|||February 2013|Actual|2013-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|July 2016|Actual|2016-07-01||Interventional|||A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer|A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer|Active, not recruiting||Phase 2|60|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-11 01:57:28.659854|2017-10-11 01:57:28.659854
NCT01799265|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-06-13|||February 2013||2013-02-01|June 2013|2013-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Transcend Auto Clinical Evaluation|Transcend Auto Clinical Evaluation|Unknown status|Active, not recruiting|N/A|36|Anticipated|Somnetics International, Inc.||2|||f||||f||||||||||2017-10-11 01:57:28.78309|2017-10-11 01:57:28.78309
NCT01799252|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2014-01-30|||November 2012||2012-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion|Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion|Completed||N/A|582|Actual|Gynuity Health Projects|||2||f||||f||||||||||2017-10-11 01:57:28.890285|2017-10-11 01:57:28.890285
NCT01799239|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-08-23|2013-10-07||February 2013||2013-02-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Three subjects were excluded from the intention to treat (ITT) population. Two of the were inclusion criteria violaters; 1 convex user and 1 colostomist. with the last subject it was uncertain in which order the subject tested the test products. the subejct was excluded from the analysis|Safety and Performance of Newly Developed 1-piece Ostomy Product Compared With SenSura|Investigating the Safety and Performance of Newly Developed 1-piece Ostomy Product Concept Compared With SenSura 1-piece in Subjects With an Ileostomy|Completed||N/A|32|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 01:57:29.013389|2017-10-11 01:57:29.013389
NCT01799226|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2016-01-11|2015-07-23||March 2013||2013-03-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Data analysis only included examining the test (triclosan dentifrice) or control (fluoride dentifrice).|Study of the Anti-Inflammatory Effects of Colgate Total® During an Experimental Gingivitis Model|Study of the Anti-Inflammatory Effects of Colgate Total® During an Experimental Gingivitis Model|Completed||N/A|32|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 01:57:29.260561|2017-10-11 01:57:29.260561
NCT01799213|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-05-22|||September 2, 2013|Actual|2013-09-02|May 2017|2017-05-01|August 31, 2018|Anticipated|2018-08-31|March 30, 2018|Anticipated|2018-03-30||Interventional|||Discontinuing NSAIDs|Discontinuing NSAIDs in Veterans With Knee Osteoarthritis|Recruiting||Phase 2|680|Anticipated|VA Office of Research and Development||2|||f||||t|t|f||||||No||2017-10-11 01:57:29.765968|2017-10-11 01:57:29.765968
NCT01799200|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-08-12|||June 2012||2012-06-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Hip Pathomorphology in Collegiate Athletes and Controls|Prevalence of Hip Pathomorphology in Collegiate Athletes and Age-Matched Controls: Radiographic and Physical Exam Findings|Completed||N/A|63|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 01:57:29.894598|2017-10-11 01:57:29.894598
NCT01799187|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2014-07-19|||July 2012||2012-07-01|July 2014|2014-07-01|July 2021|Anticipated|2021-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Research of Revascularization in Immature Teeth With Periapical Periodontitis|Randomized Controlled Research of Revascularization in Immature Permanent Teeth With Periapical Periodontitis|Recruiting||N/A|190|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:57:29.97057|2017-10-11 01:57:29.97057
NCT01799174|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-12-02|||May 2012||2012-05-01|December 2014|2014-12-01||||May 2015|Anticipated|2015-05-01||Interventional|||Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea|Something New Under the Sun: A Randomized, Double-Blinded, Controlled Trial of UVA1 Phototherapy in Morphea|Unknown status|Recruiting|N/A|40|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 01:57:30.090653|2017-10-11 01:57:30.090653
NCT01799161|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-11-14|||December 2014||2014-12-01|November 2014|2014-11-01||||April 2018|Anticipated|2018-04-01||Interventional|||Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer|Phase 1 Study of the Combination of gp96-Ig Cell Based Lung Cancer Vaccine With Suppression of Adenosinergic Pathways With Theophylline and Oxygen for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Patients With Advanced (Stage IIIB), Relapsed or Metastatic (Stage IV) Disease Who Have Failed Palliative Therapy.|Withdrawn||Phase 1|0|Actual|University of Miami||3||Insufficient funding|f||||t||||||||||2017-10-11 01:57:30.190373|2017-10-11 01:57:30.190373
NCT01799148|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-23|2015-01-19|||November 2011||2011-11-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01|360 Days|Observational [Patient Registry]|AIRACOS||Air Pollution, Inflammation and Acute Coronary Syndrome|Impact of AIR Pollution on Inflammation, Oxidative Stress and 1-year Prognosis in Patients Hospitalized for Acute COronary Syndrome|Completed||N/A|307|Actual|Fundación Canaria Rafael Clavijo para la Investigación Biomédica|||1||f||||||||||||||2017-10-11 01:57:30.302686|2017-10-11 01:57:30.302686
NCT01799135|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-03-17|||April 2012||2012-04-01|March 2016|2016-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)|Feasibility Study of the Utility of Pulmonary Dynamic Contrast Enhanced MRI for Assessment of Tumor Response and Lung Injury and for Treatment Planning for Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer|Recruiting||Early Phase 1|20|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:57:30.394033|2017-10-11 01:57:30.394033
NCT01799122|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-01-08||||||January 2016|2016-01-01||||February 2017|Anticipated|2017-02-01||Interventional|||Trial Comparing Mini-Arc Precise Pro and the Trans Vaginal Obturator Tape for Stress Urinary Incontinence|Randomized Clinical Trial Comparing Mini-Arc Precise Pro and the Trans Vaginal Obturator Tape for Surgical Management of Stress Urinary Incontinence|Not yet recruiting||Phase 3|||University of Manitoba||1|||f||||||||||||||2017-10-11 01:57:30.508499|2017-10-11 01:57:30.508499
NCT01799109|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-05-17|||November 2011||2011-11-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Lung Function of Asthmatic Children by Nebulized MgSO4|Lung Function Changes of Mild to Moderate Asthmatic Children Treated by Nebulized MgSO4|Completed||N/A|90|Actual|Chongqing Medical University||3|||f||||f||||||||||2017-10-11 01:57:30.59195|2017-10-11 01:57:30.59195
NCT01799096|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-01-26|||September 2006||2006-09-01|January 2016|2016-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effects of the Sugar Sucrose on Bodyweight and Energy Intake Over 28 Days in Obese Women|Effects of the Sugar Sucrose on Bodyweight and Energy Intake Over 28 Days in Obese Women|Completed||N/A|41|Actual|University of Hull||2|||f||||f||||||||||2017-10-11 01:57:30.81419|2017-10-11 01:57:30.81419
NCT01799083|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-01-26|||December 2012||2012-12-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CIK||Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas|Phase 1/2 Study of Decitabine Alone and/or in Combination With Chemotherapy and/or Cytokine Induced Killer Cell Transfusion in Patients With Relapsed or Refractory Solid Tumors and B Cell Lymphomas|Recruiting||Phase 1/Phase 2|100|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 01:57:30.896198|2017-10-11 01:57:30.896198
NCT01799070|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2013-02-25|||March 2013||2013-03-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Observational|||Accuracy of TCD Monitoring in Predicting Cerebral Hyperperfusion Syndrome After Carotid Endarterectomy|Velocity Systolic Blood Pressure Index in Accurately Predicting Cerebral Hyperperfusion Syndrome After Carotid Endarterectomy|Unknown status|Not yet recruiting|N/A|200|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||||||2017-10-11 01:57:31.015283|2017-10-11 01:57:31.015283
NCT01799057|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-02-07|||July 2013||2013-07-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication|Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of Metformin for the Assessment of Changes in Functional Capacity, Endothelial Function, and Hemodynamics in Individuals With Peripheral Artery Disease-Related Intermittent Claudication|Terminated||Phase 4|2|Actual|Baker IDI Heart and Diabetes Institute||2||The trial has been terminated due to difficulties with recruitment.|f||||f||||||||||2017-10-11 01:57:31.136214|2017-10-11 01:57:31.136214
NCT01799044|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-09-03|||November 2012||2012-11-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|IRE||Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases|"Pilot-study: Non-thermal Ablation Using Irreversible Electroporation (IRE) to Treat Colorectal Liver Metastases - Ablate and Resect"|Completed||Phase 1|10|Actual|VU University Medical Center||1|||f||||t||||||||||2017-10-11 01:57:31.286144|2017-10-11 01:57:31.286144
NCT01799031|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-07-20|||July 2015||2015-07-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|October 2015|Actual|2015-10-01||Interventional|||Educational Intervention for Reducing Work Disability in Breast Cancer Survivors|Reducing Work Disability in Breast Cancer Survivors|Completed||N/A|44|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 01:57:31.4246|2017-10-11 01:57:31.4246
NCT01799018|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-11-19|||April 2011||2011-04-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage|Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage|Completed||N/A|40|Actual|State University of New York - Upstate Medical University|||2||f||||f||||||Samples With DNA|"     Cerebrospinal Fluid (CSF)   "|||2017-10-11 01:57:31.576116|2017-10-11 01:57:31.576116
NCT01799005|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2015-02-01|||February 2013||2013-02-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|FHS||FLAVIOLA Health Study|Impact of Dietary Flavanols on Vascular Health in a General Population of Healthy Middle-aged Europeans: a Randomized Controlled Study|Completed||N/A|100|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 01:57:31.660749|2017-10-11 01:57:31.660749
NCT01798992|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-12-27|2016-06-06||September 2000||2000-09-01|December 2016|2016-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|BORG|Patients who gave informed consent and underwent baseline imaging and endomyocardial biopsy.|Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart|Beta-blocker Effect on Structural Remodeling and Gene Expression in the Failing Human Heart|Completed||Phase 4|56|Actual|University of Colorado, Denver||4|||f||||t||||||||||2017-10-11 01:57:31.768854|2017-10-11 01:57:31.768854
NCT01798979|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-24|2013-05-05|||February 2013||2013-02-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects|A Phase I, Open Interaction Study Between Oral Doses of GLPG0634 (200 mg QD) and Single Oral Doses of Midazolam (2 mg) in Healthy Subjects|Completed||Phase 1|20|Actual|Galapagos NV||1|||f||||f||||||||||2017-10-11 01:57:32.341523|2017-10-11 01:57:32.341523
NCT01798966|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-02-15|2014-12-04||February 2013||2013-02-01|February 2016|2016-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease|The Effects of Orbital Decompression Surgery on Intraocular Pressure Patterns in Patient With Thyroid Eye Disease Undergoing 24 Hour Continuous IOP Monitoring With the SENSIMED Triggerfish®|Completed||N/A|10|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 01:57:32.440269|2017-10-11 01:57:32.440269
NCT01798953|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-04-18|||January 2010||2010-01-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|February 2013|Actual|2013-02-01||Observational|||Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis|Ileal Pouch-anal Anastomosis or Ileo-rectal Anastomosis for Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis?|Completed||N/A|175|Actual|Sahlgrenska University Hospital, Sweden|||4||f||||f||||||||Yes|PubMed|2017-10-11 01:57:32.661515|2017-10-11 01:57:32.661515
NCT01798940|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-02-22||||||February 2013|2013-02-01||||September 2008|Actual|2008-09-01||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride Tablets Under Fed Conditions|An Open Label, Randomized, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Pioglitazone Hydrochloride Tablet 45mg [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Actos® (Pioglitazone Hydrochloride) Tablet 45mg [Reference Formulation, Takeda Pharmaceuticals America, Inc.] in Healthy Human Volunteers Under Fed Conditions.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 01:57:32.770083|2017-10-11 01:57:32.770083
NCT01798927|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-07-06|2015-05-13||December 2012||2012-12-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Lower Extremity Ankle Foot Orthoses in Parkinson's Disease|Investigation of Lower Extremity Orthoses on Gait in Persons With Parkinson's Disease: a Case Series.|Terminated||N/A|4|Actual|University of Texas Southwestern Medical Center||1||Modifications are being made to protocol|f||||f||||||||||2017-10-11 01:57:32.857268|2017-10-11 01:57:32.857268
NCT01798914|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-01-19|||October 2008||2008-10-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Expanded Access|||Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder|Patient Transfer Program for Transitioning From Exubera® (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere® Insulin (Insulin Human [rDNA Origin]) Inhalation Powder|No longer available||N/A|||Mannkind Corporation|||||||||||||||||||2017-10-11 01:57:33.096299|2017-10-11 01:57:33.096299
NCT01798901|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-01-19|||September 17, 2013|Actual|2013-09-17|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|August 24, 2016|Actual|2016-08-24||Interventional|||AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia|Phase I Study of AR-42 and Decitabine in Acute Myeloid Leukemia|Active, not recruiting||Phase 1|54|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:57:33.206359|2017-10-11 01:57:33.206359
NCT01798888|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-07-06|||November 30, 2012||2012-11-30|November 13, 2015|2015-11-13|November 13, 2015|Actual|2015-11-13|November 13, 2015|Actual|2015-11-13||Interventional|||Deep Brain Stimulation for Refractory Alcoholism|Pilot Study of Deep Brain Stimulation (DBS) for Refractory Alcoholism|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:57:33.330418|2017-10-11 01:57:33.330418
NCT01798875|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-02-28|||April 2012||2012-04-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||PCOS, Therapy and Markers of Cardiovascular Risk|Effects of Different Therapies on Surrogate Markers of Cardiovascular Risk in Women With Polycystic Ovary Syndrome (PCOS)|Unknown status|Recruiting|Phase 4|50|Anticipated|Medical University of Gdansk||2|||f||||f||||||||||2017-10-11 01:57:33.402345|2017-10-11 01:57:33.402345
NCT01798862|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-06-08|||March 2013||2013-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles|The Effect of Endometrial Injury on IVF Outcome Parameters in Patients With Repeated Implantation Failures|Completed||Phase 2/Phase 3|100|Actual|National and Kapodistrian University of Athens||2|||f||||f||||||||Yes||2017-10-11 01:57:33.494855|2017-10-11 01:57:33.494855
NCT01798849|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2015-08-10|||March 2013||2013-03-01|August 2015|2015-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)|A Single Rising Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8892|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 01:57:33.607874|2017-10-11 01:57:33.607874
NCT01798836|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-08-04|||February 2013||2013-02-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF|Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF|Terminated||Phase 2/Phase 3|17|Actual|National and Kapodistrian University of Athens||2||Obtained results were not good. Protocol was proved ineffective.|f||||f||||||||||2017-10-11 01:57:33.691569|2017-10-11 01:57:33.691569
NCT01798823|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-22|||February 2013||2013-02-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|||Exercise-induced Bronchoconstriction in School Children|Exercise-induced Bronchoconstriction in School Children - Prevalence, Environmental/Individual Risk Factors and Its Mechanism|Unknown status|Recruiting|N/A|1200|Anticipated|Medical Universtity of Lodz|||4||f||||t||||||Samples With DNA|"     -  exhaled breath condensate sample        -  blood sample (5 ml sample): tryptase, lipoxin A4 serum levels        -  blood sample also will be taken before and after challenge together with exhaled breath          condensate sample in order to detect markers of inflammation (such as IL-1a, IL-2, IL-5,          IL-6, IL-8, IL-9, IL-12p70, IL-13, IL-17, IL-22, MCP1, TLR2, MIP1a, PDGFBB, TIMP2,          TNFalfa, CRP, TGF-b1, TSLP- ELISA and cysteinyl leukotrienes, LTB4, PGE2-HPLC/mass          spectrometry).   "|||2017-10-11 01:57:33.790949|2017-10-11 01:57:33.790949
NCT01798810|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-04-15|||June 2013||2013-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|OXYGEN||Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High Energy Fracture Surgery|Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High Energy Fracture Surgery (OXYGEN Study)|Recruiting||N/A|1000|Anticipated|Major Extremity Trauma Research Consortium||2|||f||||t||||||||||2017-10-11 01:57:34.009955|2017-10-11 01:57:34.009955
NCT01798797|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-11-03|||August 2013||2013-08-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Integrated Diagnostic for Heart Failure|Integrated Diagnostic for Heart Failure|Completed||Phase 4|100|Actual|Medtronic|||1||f||||f||||||||No||2017-10-11 01:57:34.128908|2017-10-11 01:57:34.128908
NCT01798784|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-06-19|||July 2013||2013-07-01|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|September 2017|Anticipated|2017-09-01||Interventional|||Habit Formation for Adherence to Statin Use and LDL Reduction|Testing Behavioral Economic Interventions to Improve Statin Use and Reduce CVD Risk|Active, not recruiting||Phase 3|805|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 01:57:34.225537|2017-10-11 01:57:34.225537
NCT01798771|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-02-25|||March 2013||2013-03-01|February 2013|2013-02-01|February 2016|Anticipated|2016-02-01|February 2015|Anticipated|2015-02-01||Interventional|IMAGER||Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery|Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery|Unknown status|Not yet recruiting|N/A|108|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||||||||||||2017-10-11 01:57:34.749344|2017-10-11 01:57:34.749344
NCT01798745|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-04-08|||November 2014||2014-11-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies|A Randomized, Double-blind, Placebo-controlled Pharmacokinetic and Pharmacodynamic Two Part Cohort Study of JNJ-54452840 in Subjects With Reduced Systolic Function Heart Failure and Elevated Levels of Anti-Beta 1 Adrenergic Receptor Autoantibodies|Withdrawn||Phase 2|0|Actual|Janssen Research & Development, LLC||14||study not required for development|f||||t||||||||||2017-10-11 01:57:34.882353|2017-10-11 01:57:34.882353
NCT01798732|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-11-14|||August 2011||2011-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|PIO laser SPNP||PIO Laser Sclerectomy IOP SLT Sclerectomy|Effect of Selective Laser Trabeculoplasty on the Intraocular Pressure Nycthemeral Rhythm.|Completed||N/A|26|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-11 01:57:35.002321|2017-10-11 01:57:35.002321
NCT01798719|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2013-02-26|||February 2011||2011-02-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|Nutriepa||Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease|Low Glycemic Index Mediterranean Diet Effect on Moderate or Severe Non-alcoholic Fatty Liver Disease|Completed||N/A|50|Actual|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis||2|||f||||t||||||||||2017-10-11 01:57:35.137116|2017-10-11 01:57:35.137116
NCT01798706|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2017-03-21|2016-08-22|2016-02-11|June 2013||2013-06-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|GetGoal-O||Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients|A Randomized, Double-blind, Placebo-controlled, 2-arm Parallel-group, Multicenter, 24 Week Study Assessing the Safety and Efficacy of Lixisenatide in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Diabetes Treatment Regimen|Completed||Phase 3|350|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 01:57:35.252867|2017-10-11 01:57:35.252867
NCT01798693|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-05-11|||August 2013||2013-08-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Nutritional Supplementation Effects on Rehabilitation Outcomes in Rotator Cuff Pathology|Nutritional Supplementation Effects on Rehabilitation Outcomes in Rotator Cuff Pathology|Terminated||Early Phase 1|5|Actual|University of North Carolina, Chapel Hill||2||Poor subject compliance and inadequate recruitment|f||||t||||||||||2017-10-11 01:57:36.3671|2017-10-11 01:57:36.3671
NCT01798680|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-03-14|||February 2014|Actual|2014-02-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|TOV4||Trial of Vitamin D in HIV Progression|Trial of Vitamin D in HIV Progression|Active, not recruiting||Phase 3|4000|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 01:57:36.455149|2017-10-11 01:57:36.455149
NCT01798667|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2013-08-14|||January 2013||2013-01-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|April 2013|Actual|2013-04-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation|A Randomized, Double-blind, Double-dummy, Placebo-controlled, Therapeutic Exploratory Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 After Oral Administration in Male Patients With Premature Ejaculation|Unknown status|Recruiting|Phase 2|220|Anticipated|Dong-A ST Co., Ltd.||4|||f||||||||||||||2017-10-11 01:57:36.562286|2017-10-11 01:57:36.562286
NCT01798654|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-02-18|||September 2012||2012-09-01|February 2016|2016-02-01||||September 2015|Actual|2015-09-01||Observational|||EUS-FNA for Patients With Antithrombotic Agents|Safety of Endoscopic Ultrasound-guided Fine Needle Aspiration for Patients With Antithrombotic Agents|Completed||N/A|84|Actual|Hokkaido Pancreatobiliary Endoscopic Intervention Study Group|||1||f||||f||||||||||2017-10-11 01:57:37.172563|2017-10-11 01:57:37.172563
NCT01798641|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-03-21|||January 2013||2013-01-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|ARCS NPH||A Randomized Cross-over Study for Normal Pressure Hydrocephalus|Efficacy of Shunt Surgery in Normal Pressure Hydrocephalus: a Randomized Cross-over Study|Recruiting||N/A|48|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:57:37.248125|2017-10-11 01:57:37.248125
NCT01798628|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-02-22|||September 2009||2009-09-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients|A Phase 1, Single Dose, Open-Label, Three-Period, Crossover Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Subjects|Completed||Phase 1|36|Actual|Cougar Biotechnology, Inc.||6|||f||||f||||||||||2017-10-11 01:57:37.361338|2017-10-11 01:57:37.361338
NCT01798602|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-22|||December 2009||2009-12-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|CHAT Pilot||Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial|Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial|Terminated||Phase 2|8|Actual|Canadian Critical Care Trials Group||2||H1N1 pandemic concluded|f||||f||||||||||2017-10-11 01:57:37.473529|2017-10-11 01:57:37.473529
NCT01798381|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-21|||December 2012||2012-12-01|February 2013|2013-02-01||||December 2014|Anticipated|2014-12-01||Interventional|OCEAN-GER||Essential Fatty Acids in Adult ADHD|The Relationship of Essential Fatty Acids to Cognitive, Electrophysiological and Behavioural Function in Adults With Attention Deficit Hyperactivity Disorder and Controls|Unknown status|Recruiting|Phase 3|100|Anticipated|Saarland University||2|||f||||t||||||||||2017-10-11 01:57:42.404982|2017-10-11 01:57:42.404982
NCT01798576|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2016-09-14|||November 2012||2012-11-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure|Non-interventional, Observational Study on Retreatment of Chronic Hepatitis C Patients Previous Treatment Failure, Using Peginterferon Alfa-2a and Ribavirin Based Regimens|Terminated||N/A|282|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:57:37.674881|2017-10-11 01:57:37.674881
NCT01798563|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-12-05|||June 2011||2011-06-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||Functional Connectivity Parkinson Disease|Functional Connectivity of the Motor Network in Two Major Subtypes of Parkinson Disease|Recruiting||N/A|72|Anticipated|University of Colorado, Denver|||3||f||||f||||||||||2017-10-11 01:57:37.782104|2017-10-11 01:57:37.782104
NCT01798537|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2013-02-25|||June 2013||2013-06-01|February 2013|2013-02-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|SDDICU||Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections|Simplified Selective Digestive Tract Decontamination for the Prevention of ICU Infections in the Setting of High-level Antibiotic Resistance|Unknown status|Not yet recruiting|Phase 2/Phase 3|2400|Anticipated|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-11 01:57:37.979268|2017-10-11 01:57:37.979268
NCT01798524|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-21|||November 2011||2011-11-01|February 2013|2013-02-01||||February 2013|Actual|2013-02-01||Observational|KARE||Kidney Allograft Recipients in England - an Observational Cohort Study|An Observation Cohort Study of Kidney Allograft Recipients in England by Data Linkage Analysis|Completed||N/A|19688|Actual|University Hospital Birmingham NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 01:57:38.110543|2017-10-11 01:57:38.110543
NCT01798511|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-02-25|||April 2013||2013-04-01|February 2013|2013-02-01||||April 2015|Anticipated|2015-04-01||Interventional|ORION||Oral Refeeding IntOlerance After Nasogastric Tube Feeding (ORION)|A Randomized Controlled Trial of Oral Refeeding Intolerance After Nasogastric Tube Feeding|Unknown status|Not yet recruiting|N/A|82|Anticipated|University of Auckland, New Zealand||2|||f||||f||||||||||2017-10-11 01:57:38.185519|2017-10-11 01:57:38.185519
NCT01798498|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-22|2014-07-29|||April 2013||2013-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Study for the Evaluation of the Efficacy and Safety of the Dermal Filler Princess® VOLUME in Nasolabial Folds|Open-label Uncontrolled, Multicenter Study for the Evaluation of the Efficacy and Safety of the Dermal Filler Princess® VOLUME in Nasolabial Folds|Completed||N/A|48|Actual|Croma-Pharma GmbH||1|||f||||f||||||||||2017-10-11 01:57:38.295012|2017-10-11 01:57:38.295012
NCT01798485|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-05-26|2016-03-07||April 2013||2013-04-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Galaxy 2|All randomized participants as of 23 December 2015|A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC|A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma|Terminated||Phase 3|696|Actual|Synta Pharmaceuticals Corp.||2||The study was stopped after the first Interim Analysis due to futility.|f||||t||||||||||2017-10-11 01:57:38.474217|2017-10-11 01:57:38.474217
NCT01798472|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-01-15|||November 2009||2009-11-01|January 2015|2015-01-01|November 2018|Anticipated|2018-11-01|November 2016|Anticipated|2016-11-01||Interventional|HUA||Hip Fractures Treated With Uncemented Arthroplasties|Cemented Versus Uncemented Arthroplasty in Elderly Patients With Displaced Femoral Neck Fractures: a Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|140|Anticipated|Stockholm South General Hospital||4|||f||||f||||||||||2017-10-11 01:57:41.320917|2017-10-11 01:57:41.320917
NCT01798459|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-03-20|||February 2013||2013-02-01|March 2015|2015-03-01|May 2016|Anticipated|2016-05-01|October 2015|Anticipated|2015-10-01||Interventional|||The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.|A Double Blind Randomized Crossover Study of the Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.|Unknown status|Recruiting|N/A|30|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 01:57:41.483328|2017-10-11 01:57:41.483328
NCT01798446|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-05-23|||February 2013||2013-02-01|February 2013|2013-02-01|December 2016|Anticipated|2016-12-01|June 2015|Anticipated|2015-06-01||Interventional|||A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus|A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus|Unknown status|Recruiting|Phase 2|41|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 01:57:41.596839|2017-10-11 01:57:41.596839
NCT01798433|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-03-01|||March 18, 2013|Actual|2013-03-18|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|December 23, 2017|Anticipated|2017-12-23||Interventional|STRATEGY-II||STRATEGY for Left Main Coronary Bifurcation Lesion II|A Prospective, Multi-center, Randomized Study to Evaluate the Optimal Strategy for Side Branch Treatment in Patients With Left Main Coronary Bifurcation Lesion|Active, not recruiting||N/A|200|Actual|Samsung Medical Center||4|||f||||t||||||||||2017-10-11 01:57:41.723441|2017-10-11 01:57:41.723441
NCT01798420|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-22|||April 2012||2012-04-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|||Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation|The Impact of Corticosteroid Treatment on Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation|Completed||N/A|42|Actual|The Nazareth Hospital, Israel|||2||f||||t||||||||||2017-10-11 01:57:41.833393|2017-10-11 01:57:41.833393
NCT01798407|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-09-27|||February 2013|Actual|2013-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|August 2019|Anticipated|2019-08-01||Interventional|||DBS of the Lateral Habenula in Treatment-Resistant Depression|A Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression|Recruiting||N/A|6|Anticipated|Baylor College of Medicine||2|||||||t|f|t|f|f||||||2017-10-11 01:57:41.909031|2017-10-11 01:57:41.909031
NCT01798394|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-11-10|2016-07-26||June 2014||2014-06-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Progesterone & Postpartum Relapse to Smoking|Progesterone & Postpartum Relapse to Smoking|Completed||N/A|46|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-11 01:57:42.05722|2017-10-11 01:57:42.05722
NCT01798368|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-07-01|||January 2013||2013-01-01|July 2013|2013-07-01||||April 2013|Actual|2013-04-01||Interventional|||PBASE-system Safety and Tolerability Clinical Investigation|An Open Label Study to Evaluate the Safety and Tolerability of Nasal Stimulation Using the PBASE System in Non-patient Volunteers|Completed||Phase 1|12|Actual|Chordate Medical||1|||f||||||||||||||2017-10-11 01:57:42.482079|2017-10-11 01:57:42.482079
NCT01798355|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-10-25|||January 2013||2013-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Children and Adolescents With Dental Anxiety - Randomized Controlled Study of Cognitive Behavioral Therapy|Children and Adolescents With Dental Anxiety - Randomized Controlled Study of Cognitive Behavioral Therapy|Completed||N/A|30|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:57:42.543292|2017-10-11 01:57:42.543292
NCT01798342|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-22|||March 2012||2012-03-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Safety of Gastric Volume Emptying After the Intake of Maltodextrin and Glutamine|Gastric Residual Volume After He Intake Of Maltodextrin And Glutamine. A Randomized Double-Blind, Crossover Study|Completed||Phase 2|11|Actual|Federal University of Mato Grosso do Sul||2|||f||||f||||||||||2017-10-11 01:57:42.756849|2017-10-11 01:57:42.756849
NCT01798329|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-21|||March 2013||2013-03-01|February 2013|2013-02-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|ETOS||ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study|Minimal Hepatic Encephalopathy in Pre-hepatic Portal Hypertension Due to Portal Vein Thrombosis in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study.|Unknown status|Not yet recruiting|Phase 3|50|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||t||||||||||2017-10-11 01:57:42.863547|2017-10-11 01:57:42.863547
NCT01798316|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-05-30|2016-11-18||March 2013||2013-03-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||IV Acetaminophen for Postoperative Analgesia|IV Acetaminophen for Postoperative Analgesia After Laparoscopic Cholecystectomy|Terminated||Phase 4|105|Actual|Northwell Health||2||Principal Investigator left the institution|f||||f||||||||No||2017-10-11 01:57:43.001958|2017-10-11 01:57:43.001958
NCT01798303|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-02-01||2014-09-29|July 2013||2013-07-01|February 2017|2017-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study of LY2940094 in Participants With Alcohol Dependency|Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Patients With Alcohol Dependence|Completed||Phase 2|88|Actual|BlackThorn Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 01:57:43.508982|2017-10-11 01:57:43.508982
NCT01798290|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-04-17|||December 2012||2012-12-01|November 2012|2012-11-01||||June 2013|Actual|2013-06-01||Interventional|INAMEDI||Impact of Narrative Medicine (Workshop Reading Diaries)|Impact of an Educational Program 'Narrative Medicine (Workshop Reading Diaries) ' Dedicated to Medical Students. A Randomized Controlled Trial.|Completed||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:57:43.5948|2017-10-11 01:57:43.5948
NCT01798277|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-01-26|||April 2013||2013-04-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|VeTAMed||Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia|Ablation Versus Medical Therapy in Patients With Coronary Artery Disease and Sustained Ventricular Tachycardia Randomized Trial (VeTAMed)|Withdrawn||Phase 3|0|Actual|Newmarket Electrophysiology Research Group Inc||2||Low Enrolment|f||||f||||||||||2017-10-11 01:57:43.666435|2017-10-11 01:57:43.666435
NCT01798264|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-04-05|2013-02-25||February 2009||2009-02-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes|A Phase Ib, Randomized, Open-Label, Multi-Center, 4-Week Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITCA 650 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|44|Actual|Intarcia Therapeutics||4|||f||||||||||||||2017-10-11 01:57:43.787861|2017-10-11 01:57:43.787861
NCT01798251|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-05-03|||December 2012||2012-12-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach|A Randomized Single Center Phase II Study Comparing XELOX With Capecitabine Maintenance or XELOX Treatment in Elderly Metastatic Adenocarcinoma of Stomach|Unknown status|Recruiting|Phase 2|40|Anticipated|Harbin Medical University||2|||f||||t||||||||||2017-10-11 01:57:44.400341|2017-10-11 01:57:44.400341
NCT01798238|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-08-04|||November 2012||2012-11-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus|A Phase III Double-blind, Parallel Group, Randomized, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of MP-513 Monotherapy in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|142|Actual|Handok Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-10-11 01:57:44.5297|2017-10-11 01:57:44.5297
NCT01798212|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-02-28|||August 2013||2013-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD.|A Prospective Multi Center Case Controlled Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD.|Completed||N/A|40|Actual|Krankenhaus Barmherzige Schwestern Linz||1|||f||||t||||||||||2017-10-11 01:57:44.767383|2017-10-11 01:57:44.767383
NCT01798199|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-08-31|||May 2013||2013-05-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|VERVE||Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project|VERVE* PROJECT: Study of the Acceptability of a Virtual Reality System on the Cognitive Stimulation of Patients With Alzheimer's Disease or Related Conditions. (*Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment)|Completed||N/A|21|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||t||||||||||2017-10-11 01:57:44.880958|2017-10-11 01:57:44.880958
NCT01798186|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-08-02|2017-04-17||May 2013||2013-05-01|August 2017|2017-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation|Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation|Completed||Phase 1|26|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-10-11 01:57:44.989986|2017-10-11 01:57:44.989986
NCT01798173|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-07-28|||June 2008||2008-06-01|February 2013|2013-02-01||||December 2017|Anticipated|2017-12-01||Interventional|CIRCE||Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients|CIRCE: Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients|Recruiting||N/A|1200|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||||||||||||2017-10-11 01:57:45.660077|2017-10-11 01:57:45.660077
NCT01798160|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2015-10-18|||February 2010||2010-02-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).|Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).|Completed||Phase 4|24|Anticipated|Johannes Gutenberg University Mainz||2|||f||||t||||||||||2017-10-11 01:57:45.848688|2017-10-11 01:57:45.848688
NCT01798147|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2017-05-21|||February 2011||2011-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).|Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).|Recruiting||Phase 2|24|Anticipated|Johannes Gutenberg University Mainz||2|||f||||t||||||||||2017-10-11 01:57:45.952288|2017-10-11 01:57:45.952288
NCT01798134|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-08-24|2016-05-18||December 2012||2012-12-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|MIRACLE I||Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma|Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma|Completed||N/A|25|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-10-11 01:57:46.068203|2017-10-11 01:57:46.068203
NCT01798121|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-21|||February 2013||2013-02-01|February 2013|2013-02-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Interventional|02||Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)|A Randomized, Double-blind, Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard Tuberculin Purified Protein Derivative (PPD-S2) for Detection of Tuberculosis in Subjects With a Confirmed Diagnosis of Tuberculosis.|Unknown status|Not yet recruiting|Phase 2|90|Anticipated|JHP Pharmaceuticals LLC||2|||f||||f||||||||||2017-10-11 01:57:46.552157|2017-10-11 01:57:46.552157
NCT01798108|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-05-18|||August 14, 2001|Actual|2001-08-14|May 2017|2017-05-01|June 25, 2003|Actual|2003-06-25|June 25, 2003|Actual|2003-06-25||Interventional|||Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases|A Phase I Open-label, Multicenter, Dose-escalating Study of Radium-223 in Patients With Advanced Skeletal Metastases|Completed||Phase 1|31|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-11 01:57:46.657308|2017-10-11 01:57:46.657308
NCT01798095|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-21|||February 2013||2013-02-01|February 2013|2013-02-01|July 2013|Anticipated|2013-07-01|May 2013|Anticipated|2013-05-01||Interventional|03||Equivalence Study of Specificity of PPD|A Randomized, Double-blind, Equivalence Study of the Specificity of Tuberculin Purified Protein Derivative (PPD) (Aplisol®) in Comparison With a Reference Standard|Unknown status|Not yet recruiting|Phase 2|152|Anticipated|JHP Pharmaceuticals LLC||2|||f||||f||||||||||2017-10-11 01:57:46.782862|2017-10-11 01:57:46.782862
NCT01798082|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-08-27|||December 2012||2012-12-01|August 2013|2013-08-01||||October 2013|Anticipated|2013-10-01||Interventional|||Effect of a Decision Aid on Decision Making for the Treatment of Pelvic Organ Prolapse||Unknown status|Active, not recruiting|N/A|126|Anticipated|Hartford Hospital||2|||f||||f||||||||||2017-10-11 01:57:46.895468|2017-10-11 01:57:46.895468
NCT01798069|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-04-17|||December 2012||2012-12-01|February 2013|2013-02-01||||July 2013|Actual|2013-07-01||Interventional|INAMERE||Impact of Narrative Medicine (Workshop Reflexive Writing)|Impact of an Educational Program 'Narrative Medicine (Workshop Reflexive Writing) ' Dedicated to Medical Students. A Randomized Controlled Trial.|Completed||N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:57:46.98609|2017-10-11 01:57:46.98609
NCT01798043|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-05-03|||January 2013||2013-01-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|||Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance|Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance|Active, not recruiting||N/A|50|Anticipated|St. Jude Medical||4|||f||||f||||||||||2017-10-11 01:57:47.252504|2017-10-11 01:57:47.252504
NCT01798030|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-01-30|||November 2009||2009-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|||Vitamin D Retrospective Study and Role With Disease|Association of Vitamin D With Diabetes, Osteoporosis and Cardiovascular Risk|Active, not recruiting||N/A|362|Actual|Baltimore VA Medical Center|||1||f||||f||||||Samples With DNA|"     Vitamin D, IGF-1, and PTH levels will be measured in coded plasma samples belonging to the PI     and collaborating Investigators within the GRECC that are stored in our freezers (from     previously approved studies: HP-00040261,HP-00040975, HP-00041166 and HP-00041199) . The     Nutrition Obesity research center genetics core will determine Vitamin D receptor     polymorphisms on de-identified samples. No clinical information will accompany the samples.   "|No||2017-10-11 01:57:47.357581|2017-10-11 01:57:47.357581
NCT01798017|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-12-08|||November 2012||2012-11-01|March 2013|2013-03-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh|Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh|Completed||Phase 4|1738|Actual|Gynuity Health Projects||1|||f||||t||||||||||2017-10-11 01:57:47.449059|2017-10-11 01:57:47.449059
NCT01798004|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2017-02-09|2016-12-19||April 2013||2013-04-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|July 2015|Actual|2015-07-01||Interventional|||Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma|Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma|Suspended||N/A|150|Actual|Children's Oncology Group||1||CRM: 31684 - CTEP PIO requested|f||||t||||||||||2017-10-11 01:57:49.345188|2017-10-11 01:57:49.345188
NCT01797991|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-10-29|||February 2013||2013-02-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|DEXEL-RH||Comparison of Two Regimens of Dexamethasone in the Prevention of Hypersensitivity Reactions to Paclitaxel, a Pilot Study|Étude Pilote DEXEL-RH: Comparaison de Deux schémas Posologiques de DEXaméthasone en prévention Des Réactions d'Hypersensibilité au paclitaXEL|Completed||N/A|30|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 01:57:50.374893|2017-10-11 01:57:50.374893
NCT01797978|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2015-11-16|||February 2013||2013-02-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|January 2016|Anticipated|2016-01-01||Interventional|||Methylene Blue in Severe Sepsis and Septic Shock|Infusion of Methylene Blue in Severe Sepsis and Septic Shock: Randomized, Single Blinded|Recruiting||Phase 3|354|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 01:57:50.52039|2017-10-11 01:57:50.52039
NCT01797952|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2016-11-08|||November 2015||2015-11-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|mucositis||A Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation|A Randomized Double Blind Placebo Controlled Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation|Withdrawn||Phase 3|0|Actual|All India Institute of Medical Sciences, New Delhi||2||PI was away on sabbatical for 2 years.Protocol is being revised before starting the study.|f||||f||||||||||2017-10-11 01:57:51.434753|2017-10-11 01:57:51.434753
NCT01797939|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-02-22|||July 2008||2008-07-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients|Predictive Factors of Response to Proton Pump Inhibitor Treatment in Patients With Gastroesophageal Reflux Disease Symptoms|Completed||N/A|197|Actual|Seoul National University Bundang Hospital|||3||f||||f||||||||||2017-10-11 01:57:51.546289|2017-10-11 01:57:51.546289
NCT01797926|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-06-09|||May 23, 2013|Actual|2013-05-23|June 2017|2017-06-01|July 25, 2013|Actual|2013-07-25|July 25, 2013|Actual|2013-07-25||Interventional|||Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions|An Open-label, Randomised, Single Dose, Three-way Crossover, Parallel Groups Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 to Respective Reference Dosages in Healthy Adult Male and Female Subjects Under Fasting Conditions|Completed||Phase 1|102|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 01:57:51.642726|2017-10-11 01:57:51.642726
NCT01797913|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2016-02-22|||August 2008||2008-08-01|February 2016|2016-02-01||||February 2015|Actual|2015-02-01||Interventional|||The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer|The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer|Completed||Phase 2|70|Actual|Fudan University||1|||f||||||||||||||2017-10-11 01:57:51.778897|2017-10-11 01:57:51.778897
NCT01797900|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-09-09|||March 2013||2013-03-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT|Phase 2 Study of Inductive Plus Concurrent Chemoradiation Versus Concurrent Plus Adjuvant Chemoradiation for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT|Completed||Phase 2|130|Actual|Chinese Academy of Medical Sciences||2|||f||||f||||||||||2017-10-11 01:57:51.887052|2017-10-11 01:57:51.887052
NCT01797887|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-12-22|||May 2013||2013-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|VEDA||Ayurvedic Versus Conventional Counseling in Mothers With Burnout-Syndrome|Diet and Lifestyle Modification in Mothers With Burnout-Syndrome: Ayurvedic Versus Conventional Standard Counseling - A Randomized Controlled Clinical Pilot Study|Completed||N/A|40|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:57:52.045037|2017-10-11 01:57:52.045037
NCT01797874|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-05-31|||June 2013||2013-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|||Pazopanib Maintenance for SCLC|Phase II Study of Pazopanib Maintenance for SCLC|Active, not recruiting||Phase 2|97|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 01:57:52.186049|2017-10-11 01:57:52.186049
NCT01797848|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-11-21|||June 2014||2014-06-01|November 2013|2013-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|COMMAND-Asia||Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients|A Phase 3 Randomized, Double Blind, Multi-National Evaluation of Daclatasvir in Combination With Peg Interferon Alfa-2a and Ribavirin in Treatment-Naive Subjects With Chronic Hepatitis C Genotypes 1 and 4|Withdrawn||Phase 3|0|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 01:57:52.427437|2017-10-11 01:57:52.427437
NCT01797835|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-09-26|||March 2013||2013-03-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|November 2015|Actual|2015-11-01||Interventional|||Alcohol Screening in an Ethnically Diverse Sample of Adolescents in Primary Care|Alcohol Screening in an Ethnically Diverse Sample of Adolescents in Primary Care|Active, not recruiting||N/A|1573|Actual|RAND||2|||f||||t||||||||||2017-10-11 01:57:52.57375|2017-10-11 01:57:52.57375
NCT01797809|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2017-08-10|||May 11, 2013|Actual|2013-05-11|August 2017|2017-08-01|April 6, 2018|Anticipated|2018-04-06|January 31, 2018|Anticipated|2018-01-31||Observational|||Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea|Qlaira® Regulatory Post Marketing Surveillance Study in Korea|Active, not recruiting||N/A|683|Actual|Bayer|||1||f||||f||||||||||2017-10-11 01:57:52.776575|2017-10-11 01:57:52.776575
NCT01797796|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-08-19|||April 2013||2013-04-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare|A Double Blind, Randomized, Placebo-Controlled, Third-Party Open, Cross-Over Study To Examine The Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare In Healthy Volunteers|Completed||Phase 1|16|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 01:57:52.868831|2017-10-11 01:57:52.868831
NCT01797783|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2014-04-25|2014-04-25||February 2013||2013-02-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||This analysis population includes all randomized participants who were dispensed study product (79).|Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens|Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens|Completed||N/A|83|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:57:53.004947|2017-10-11 01:57:53.004947
NCT01797770|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2013-02-21|||January 2012||2012-01-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Observational|MBP||Trial on Mechanical Bowel Preparation in Laparoscopic Colorectal Surgery|A Randomised Controlled Trial On Mechanical Bowel Preparation Versus No Mechanical Bowel Preparation In Elective Laparoscopic Surgery For Left Sided Colonic Tumours|Unknown status|Recruiting|Phase 4|90|Anticipated|PVS Memorial Hospital|||1||f||||f||||||||||2017-10-11 01:57:53.697995|2017-10-11 01:57:53.697995
NCT01797757|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-21|||January 2012||2012-01-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Comparison of MAG and Fish Oil Efficacy|Comparison of the Efficacy of Monoacylglycerol (MAG) and Triacylglycerol (TAG) to Deliver Long Chain Polyunsaturated Fatty Acids (LC-PUFA) Under Malabsorption Conditions|Completed||N/A|46|Actual|Nestlé||4|||f||||f||||||||||2017-10-11 01:57:53.827856|2017-10-11 01:57:53.827856
NCT01797744|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-06-20|||February 2013||2013-02-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vestibular Rehabilitation for Strokepatients With Dizziness|Vestibular Rehabilitation for Strokepatients With Dizziness - a Randomized Controlled Trial.|Recruiting||N/A|80|Anticipated|Lund University||2|||f||||f||||||||||2017-10-11 01:57:53.951471|2017-10-11 01:57:53.951471
NCT01797731|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-07-10|2017-03-28||December 2010|Actual|2010-12-01|July 2017|2017-07-01|September 16, 2013|Actual|2013-09-16|March 2013|Actual|2013-03-01||Interventional||A sample size of 47 patients in each cohort would provide appropriate power (beta level = 0.80, alpha level = 0.05) to detect a 20% improvement in accuracy between the two groups (i.e. a 20% decrease or increase in the number of “outliers”).|Conventional Alignment System Versus Surgical Navigation System in Total Knee Arthroplasty|Conventional Tibial Extramedullary Alignment System Versus a Hand-Held, Surgical Navigation System for Tibial Component Placement in Total Knee Arthroplasty: A Randomized, Controlled Trial|Completed||N/A|100|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 01:57:54.064241|2017-10-11 01:57:54.064241
NCT01797718|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-03-20|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|March 20, 2017|Actual|2017-03-20||Interventional|CDGP||Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment|Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment|Active, not recruiting||Phase 2/Phase 3|35|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 01:57:54.416793|2017-10-11 01:57:54.416793
NCT01797705|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-05-07|2015-04-10||January 2013||2013-01-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Subjects completing the study with evaluable results|Revised Algorithm for Next Generation DeVilbiss Healthcare AutoAdjust Continuous Positive Airway Pressure (CPAP)|Revised Algorithm for Next Generation DeVilbiss AutoAdjust CPAP|Completed||N/A|33|Actual|DeVilbiss Healthcare LLC||1|||f||||f||||||||||2017-10-11 01:57:54.574529|2017-10-11 01:57:54.574529
NCT01797692|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-03-03|||January 2013||2013-01-01|July 2013|2013-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|PROGE||Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study|Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study|Completed||N/A|74|Anticipated|Centre Francois Baclesse||1|||f||||f||||||||||2017-10-11 01:57:54.781881|2017-10-11 01:57:54.781881
NCT01797679|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-21|2013-09-30|||March 2013||2013-03-01|September 2013|2013-09-01|March 2017|Anticipated|2017-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Study of Cartilage Relaxometry and Physical Activity in Osteoarthritis|Efficacy of Strength and Aerobic Exercise on the Articular Cartilage of Patients With Mild and Moderate Knee Osteoarthritis Measured by T2 and T1 Rho MR Imaging - A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|University Hospital, Akershus||3|||f||||t||||||||||2017-10-11 01:57:54.887275|2017-10-11 01:57:54.887275
NCT01797666|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-02-20||||||February 2013|2013-02-01||||September 2008|Actual|2008-09-01||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride Tablets Under Fasting Conditions|An Open Label, Randomized, 2-Period, 2-Treatment, 2-Sequence, Crossover, Single-Dose Bioequivalence Study of Pioglitazone Hydrochloride Tablet 45mg [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Actos® (Pioglitazone Hydrochloride) Tablet 45mg [Reference Formulation, Takeda Pharmaceuticals America, Inc.] in Healthy Human Volunteers Under Fasting Conditions.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 01:57:54.999505|2017-10-11 01:57:54.999505
NCT01797653|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-12-20|||February 2013||2013-02-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Randomized-controlled Trial (RCT) on CPAP-withdrawal and Microvascular Function in OSA|The Effects of CPAP-withdrawal on Microvascular Function in Patients With Obstructive Sleep Apnea: A Randomized-controlled Trial|Completed||N/A|45|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 01:57:55.078794|2017-10-11 01:57:55.078794
NCT01797640|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-07-08|||October 2012||2012-10-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Intramedullary Nailing of Tibia Fractures|Intramedullary Nailing of Tibia Fractures in the Presence of Medial or Posterior Malleolar Fractures|Completed||N/A|90|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 01:57:55.195501|2017-10-11 01:57:55.195501
NCT01797627|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-11-18|||August 2011||2011-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|VINOH||Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus|Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus (VINOH)|Active, not recruiting||N/A|62|Anticipated|University of Utah|||1||f||||f||||||||No||2017-10-11 01:57:55.277653|2017-10-11 01:57:55.277653
NCT01797614|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-02-20|||January 2012||2012-01-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Observational|IAP_SBT||Intra-abdominal Pressures During the Spontaneous Breathing Trial|Measuring the Change of Intra-abdominal Pressures of the Intensive Care Unit Patients During the Spontaneous Breathing Trial|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 01:57:55.381537|2017-10-11 01:57:55.381537
NCT01797601|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-12-02|||February 2013||2013-02-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application|Insulinsensitivität Des Menschlichen Zentralnervensystems: Kernspintomographische Untersuchung Mit Intranasaler Gabe Von Insulin|Completed||N/A|48|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-11 01:57:55.480911|2017-10-11 01:57:55.480911
NCT01797588|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-01-02|||March 2013||2013-03-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pain After Total Knee Arthroplasty: A Trial Examining Combined Adductor-canal Nerve Block and Periarticular Infiltration Versus Adductor Canal Nerve Block Versus Periarticular Infiltration|Pain After Total Knee Arthroplasty: A Randomized Controlled Trial Examining the Effectiveness of a Combined Adductor-canal Peripheral Nerve Block With Periarticular Infiltration Versus Adductor-canal Nerve Block Alone Versus Periarticular Infiltration Alone.|Completed||Phase 4|156|Actual|North York General Hospital||3|||f||||f||||||||||2017-10-11 01:57:55.598828|2017-10-11 01:57:55.598828
NCT01797575|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-04-26|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|SMRI-Bipolar||N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder|A Double-blind Randomized Placebo-controlled Study of Aspirin and N-acetyl Cysteine as Adjunctive Treatments for Bipolar Disorder Patients (SMRI 11T-009)|Completed||Phase 2|38|Actual|The University of Texas Health Science Center, Houston||4|||f||||f||||||||||2017-10-11 01:57:55.732699|2017-10-11 01:57:55.732699
NCT01797562|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-09-22|||December 2012||2012-12-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents|Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)|Unknown status|Recruiting|Phase 4|100|Anticipated|Allerderm||1|||f||||f||||||||||2017-10-11 01:57:55.917137|2017-10-11 01:57:55.917137
NCT01797549|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-12-30|||January 2013||2013-01-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01|2 Years|Observational [Patient Registry]|||Detection of Hemodynamic Changes in TBI Population With Functional Near Infrared Spectroscopy|Detection of Hemodynamic Changes in TBI Population With Functional Near Infrared Spectroscopy|Recruiting||N/A|50|Anticipated|Uniformed Services University of the Health Sciences|||2||f||||f||||||||||2017-10-11 01:57:56.05209|2017-10-11 01:57:56.05209
NCT01797536|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-09-28|2016-09-28||March 2013||2013-03-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009)|A Three-Part, Open-Label, Single-Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-8742|Completed||Phase 1|31|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 01:57:56.166337|2017-10-11 01:57:56.166337
NCT01797523|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-06-20|||October 2013|Actual|2013-10-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma|A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma|Active, not recruiting||Phase 2|62|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:57:56.714368|2017-10-11 01:57:56.714368
NCT01797510|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-08-01|||February 2013||2013-02-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Feasibility Study for a Web Based Health Coaching Program|Mayo-Sessions Clinical Trial|Completed||N/A|80|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 01:57:56.822091|2017-10-11 01:57:56.822091
NCT01797497|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-07-15|||March 2013||2013-03-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|P3RC||Intervention to Increase Parent-provider Communication During Referrals|Parent-Provider Partnerships for Referral Communication|Completed||N/A|97|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 01:57:56.88593|2017-10-11 01:57:56.88593
NCT01797289|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-01-22|||February 2012||2012-02-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PESY||Prevalence of Pulmonary Embolism in Patients With Syncope|The Prevalence of Pulmonarym Embolism in Patients With the First Episode of Syncope|Completed||N/A|600|Actual|University of Padova||1|||f||||t||||||||||2017-10-11 01:58:01.986496|2017-10-11 01:58:01.986496
NCT01797471|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-12-14|||March 2013||2013-03-01|December 2016|2016-12-01||||April 2018|Anticipated|2018-04-01||Interventional|||Phase 1 Study Evaluating Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer|A Phase 1 Study for Evaluating the Safety of Lattice Extreme Ablative Dose (LEAD) Radiotherapy Followed by Standard-Dose Chemoradiation for Patients With Bulky Stage III Non-Small Cell Lung Cancer|Terminated||Phase 1|1|Actual|University of Miami||1|||f||||t||||||||||2017-10-11 01:57:57.114494|2017-10-11 01:57:57.114494
NCT01797445|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-08-22|2015-12-04|2015-07-28|March 12, 2013|Actual|2013-03-12|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|September 17, 2014|Actual|2014-09-17||Interventional||Safety Analysis Set: participants were randomized and received at least one dose of study drug|Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults|Active, not recruiting||Phase 3|872|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||t|t|f||||||||2017-10-11 01:57:57.905723|2017-10-11 01:57:57.905723
NCT01797432|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-03-31|||March 2009||2009-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional|||Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata|Safety and Efficacy of Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata|Completed||N/A|12|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-11 01:57:59.883833|2017-10-11 01:57:59.883833
NCT01797419|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-10-24|||May 2013||2013-05-01|October 2013|2013-10-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Ranging Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GS-5806 in Subjects < 24 Months of Age Hospitalized for Respiratory Syncytial Virus (RSV) Related Respiratory Infection|Withdrawn||Phase 1|0|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 01:57:59.967238|2017-10-11 01:57:59.967238
NCT01797393|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-02-21|||February 2013||2013-02-01|February 2013|2013-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||"Air AssistedWater Injection Colonoscopy in Experienced Endoscopists"|"Air AssistedWater Injection Colonoscopy in Experienced Endoscopists"|Unknown status|Recruiting|N/A|600|Anticipated|First Affiliated Hospital of Harbin Medical University||3|||f||||t||||||||||2017-10-11 01:58:00.219601|2017-10-11 01:58:00.219601
NCT01797380|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-05-17|2013-02-25||January 2008||2008-01-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional||Terminated study. Study terminated prior to interventions|A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women|A Double-Blind, Placebo-Controlled Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women|Terminated||Phase 4|5|Actual|Duke University||2||Failure to recruit.|f||||f||||||||||2017-10-11 01:58:00.837723|2017-10-11 01:58:00.837723
NCT01797367|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-01-20|||March 2010||2010-03-01|January 2017|2017-01-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)|Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)|Completed||N/A|1026|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 01:58:01.075407|2017-10-11 01:58:01.075407
NCT01797354|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2015-09-03|||July 2011||2011-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment|Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment|Completed||Phase 2|260|Anticipated|Université Libre de Bruxelles||2|||f||||t||||||||||2017-10-11 01:58:01.147397|2017-10-11 01:58:01.147397
NCT01797341|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-09-17|||June 2013||2013-06-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Prograf-Advagraf Cross Over Conversion Study|Prograf/Advagraf Conversion Study in Kidney Pancreas Transplant Recipients|Completed||Phase 3|13|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:58:01.223899|2017-10-11 01:58:01.223899
NCT01797328|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-04-24|2016-10-26||February 2013||2013-02-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional||Healthy non-obese subjects|Does Cold Provocation Increase Brown Adipose Tissue Volume?|Study of the Effects of Temperature on Amount of Brown Adipose Tissue in Humans|Completed||N/A|28|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-11 01:58:01.310571|2017-10-11 01:58:01.310571
NCT01797315|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-05-03|||March 2007||2007-03-01|February 2013|2013-02-01|June 2013|Actual|2013-06-01|April 2011|Actual|2011-04-01||Interventional|PROSKIN||Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol|Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol|Terminated||Phase 4|40|Actual|University Hospital of Berlin||2||no adequate recruitment|f||||f||||||||||2017-10-11 01:58:01.76265|2017-10-11 01:58:01.76265
NCT01797302|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-03-09|||August 2013||2013-08-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|January 2018|Anticipated|2018-01-01||Interventional|||Vitamin D and Vascular Health in Children|Vitamin D and Vascular Function in Obese Children|Recruiting||N/A|252|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 01:58:01.856086|2017-10-11 01:58:01.856086
NCT01797263|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-05-02|||August 1, 2013|Actual|2013-08-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|POYSE||Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial|Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial|Recruiting||N/A|306|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 01:58:02.160133|2017-10-11 01:58:02.160133
NCT01797250|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-12-05|||May 2013||2013-05-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly) NEO/PEDS|Neonatal and Pediatric Studies Using a Bedside Respiratory Patient Monitoring System With the Functional Patient Monitoring PCBA-1|Completed||N/A|12|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 01:58:02.255802|2017-10-11 01:58:02.255802
NCT01797237|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-02-04|||October 2012||2012-10-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||Outcome Comparison Between PFNA and InterTAN|Outcome Comparison Between PFNA and InterTAN in Intertrochanteric Fractures|Unknown status|Recruiting|Phase 4|60|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-11 01:58:02.343832|2017-10-11 01:58:02.343832
NCT01797224|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2017-03-22|||March 2012||2012-03-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Observational|||OTIS Autoimmune Diseases in Pregnancy Project|Cimzia (Certolizumab Pegol) Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project|Recruiting||N/A|300|Anticipated|University of California, San Diego|||4||f||||t||||||||||2017-10-11 01:58:02.460227|2017-10-11 01:58:02.460227
NCT01797211|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-20|||June 2010||2010-06-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|April 2011|Actual|2011-04-01||Interventional|||Mediterranean Diet and Endothelial Function|Mediterranean Diet and Endothelial Function in Obese and Overweight Patients: the Role of Olive Oil, Non Fried Fish and Nuts|Completed||Phase 4|60|Actual|University of Bari||3|||f||||f||||||||||2017-10-11 01:58:02.629363|2017-10-11 01:58:02.629363
NCT01797198|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-02-20|||April 2012||2012-04-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects|An Open Label, Drug-drug Interaction Study to Assess the Effect of Multiple Doses of Gemfibrozil on the Single Dose Pharmacokinetics of ASP3652 and to Assess the Effect of Multiple Doses of ASP3652 on the Single Dose Pharmacokinetics of Repaglinide|Completed||Phase 1|48|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 01:58:02.759381|2017-10-11 01:58:02.759381
NCT01797185|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2017-05-24|||April 4, 2013|Actual|2013-04-04|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||An Open Label and Safety Study of the Safety Of SPARC1104||Active, not recruiting||Phase 3|100|Anticipated|Sun Pharma Advanced Research Company Limited||1|||f||||f||||||||||2017-10-11 01:58:02.89067|2017-10-11 01:58:02.89067
NCT01797172|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-02-20|||October 2012||2012-10-01|February 2013|2013-02-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Is Treatment of the Intervertebral Disc More Effective at Short-term Than the Nerve Root in Patients With a Neck Hernia?|Percutaneous Cervical Nucleoplasty vs. Pulsed Radio Frequency in Patients With Contained Cervical Disc Herniation; a Double-blind Randomized Clinical Trial|Unknown status|Recruiting|N/A|38|Anticipated|St. Anna Ziekenhuis, Geldrop, Netherlands||2|||f||||f||||||||||2017-10-11 01:58:03.102428|2017-10-11 01:58:03.102428
NCT01797159|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-10-05|||February 2013||2013-02-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer|"A Phase II Trial of Hippocampal-Sparing Cranial Irradiation (PCI) for Small-Cell Lung Cancer (SCLC)"|Active, not recruiting||Phase 2|125|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 01:58:03.245805|2017-10-11 01:58:03.245805
NCT01797146|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-11-18|||February 2013||2013-02-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CARE||Effectiveness of Catheter Reminder and Evaluation Program|Effectiveness of Catheter Reminder and Evaluation (CARE) Program in Reducing the Catheter-day and Prevention of Catheter-associated Infections|Completed||N/A|874|Actual|Siriraj Hospital||2|||f||||f||||||||||2017-10-11 01:58:03.371731|2017-10-11 01:58:03.371731
NCT01797133|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2016-02-19|||February 2013||2013-02-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|DUE||A Comparative Study of ID Fellow-based VS. Pharmacist-based Antibiotic Pre-authorization|A Comparative Study of ID Fellow-based Pre-authorization VS. Pharmacist-based Pre-authorization in Reducing Antibiotic Consumptions and Hospital Expenditures|Completed||N/A|984|Anticipated|Siriraj Hospital||2|||f||||t||||||||||2017-10-11 01:58:03.469685|2017-10-11 01:58:03.469685
NCT01797120|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-09-13|||May 31, 2013|Actual|2013-05-31|September 2017|2017-09-01|September 12, 2017|Actual|2017-09-12|March 22, 2017|Actual|2017-03-22||Interventional|PrE0102||Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI|Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Fulvestrant (Faslodex) Plus Everolimus in Post-Menopausal Patients With Hormone-Receptor Positive Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy|Completed||Phase 2|131|Actual|PrECOG, LLC.||2|||f||||t|t|f|||f|||||2017-10-11 01:58:03.568807|2017-10-11 01:58:03.568807
NCT01797107|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-09-27|||March 2013||2013-03-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study to Determine the Effect of Azasite on Corneal Surface Irregularity|A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effect of Azasite on Corneal Surface Irregularity in Subjects With Meibomian Gland Dysfunction|Withdrawn||Phase 2|0|Actual|Philadelphia Eye Associates||2||Lack of enrollment|f||||t||||||||No||2017-10-11 01:58:03.75843|2017-10-11 01:58:03.75843
NCT01797068|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-11-16|||March 2013||2013-03-01|November 2016|2016-11-01||||March 2015|Actual|2015-03-01||Interventional|||Patient Navigation for Medicaid Frequent ED Users|Patient Navigation to Improve Care and Reduce Costs for High Utilizers of the Emergency Department|Completed||N/A|100|Actual|Yale University||2|||f||||f||||||||||2017-10-11 01:58:04.753557|2017-10-11 01:58:04.753557
NCT01797055|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-05-12|||December 2010||2010-12-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Apotransferrin in Atransferrinemia|Dose Escalating Study to Evaluate Pharmacokinetics, Efficacy and Safety of Apotransferrin in Atransferrinemia Patients|Recruiting||Phase 2/Phase 3|10|Anticipated|Sanquin||1|||f||||f||||||||||2017-10-11 01:58:04.856034|2017-10-11 01:58:04.856034
NCT01797042|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2014-09-26|||March 2012||2012-03-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|May 2013|Actual|2013-05-01||Interventional|||A Comparison of the Metabolic Effects of Fructose, Glucose, High Fructose Corn Syrup and Sucrose at Normal Population Consumed Levels in Adults Aged 20-60 Years Old|A Comparison of the Metabolic Effects of Fructose, Glucose, High Fructose Corn Syrup and Sucrose at Normal Population Consumed Levels on Liver and Muscle Fatty Infiltration, Insulin Resistance, Glucose, Insulin, Leptin, Ghrelin, Postprandial Triglycerides, LDL Particle Size, Uric Acid and Appetite in Adults Aged 20-60 Years Old|Completed||N/A|366|Actual|Rippe Lifestyle Institute||4|||f||||f||||||||||2017-10-11 01:58:05.002436|2017-10-11 01:58:05.002436
NCT01797029|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-05-15|2015-04-29||February 2013||2013-02-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||All participants receiving the single dose of study vaccination.|A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh|A Randomized, Double-Blind, Placebo-Controlled Trial on the Clinical Efficacy and Safety of a Single Dose of Trivalent Seasonal Live-Attenuated Influenza Vaccine(LAIV) Among Children Aged 24 Through 59 Months in Bangladesh|Completed||Phase 3|1761|Actual|PATH||2|||f||||t||||||||||2017-10-11 01:58:05.159551|2017-10-11 01:58:05.159551
NCT01797016|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2014-11-13|||January 2013||2013-01-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Platelet Leukocyte Aggregates in Acute Cardiac Syndrome vs Healthy Volunteers|Comparing Blood Count Test Measures to Flow Cytometry in Healthy Patients to Acute General Syndrome Patients|Completed||N/A|59|Actual|Ziv Hospital|||1||f||||f||||||||||2017-10-11 01:58:05.530941|2017-10-11 01:58:05.530941
NCT01797003|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-09-12|||March 2007||2007-03-01|September 2016|2016-09-01|January 2023|Anticipated|2023-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Time-dependent Functional Results Following HTO. Closing Wedge vs Opening Wedge Technique.|Time-dependent Functional Results Following HTO. Closing Wedge vs Opening Wedge Technique.|Active, not recruiting||N/A|70|Anticipated|Martina Hansen's Hospital||2|||f||||f||||||||||2017-10-11 01:58:05.606831|2017-10-11 01:58:05.606831
NCT01796990|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-04-28|||August 2011||2011-08-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Developing a Physically More Active Lifestyle Based on One's Own Values - RCT Among Sedentary Adults|Developing a Physically More Active Lifestyle Based on One's Own Values - Randomized Controlled Trial Among Sedentary Adults|Completed||N/A|136|Actual|Likes - Foundation for Sport and Health Sciences||2|||f||||f||||||||||2017-10-11 01:58:05.725504|2017-10-11 01:58:05.725504
NCT01796977|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-02-11|2015-03-26||December 2012||2012-12-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|NSM||Using A Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy|A Prospective, Multi-Center, Randomized, Open Label Controlled Trial Using a Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy|Terminated||N/A|27|Actual|Halyard Health||2||inability to enroll in this subject population|f||||f||||||||||2017-10-11 01:58:05.871301|2017-10-11 01:58:05.871301
NCT01796964|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-01-11|2016-01-11|2014-09-09|March 2013||2013-03-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|October 2013|Actual|2013-10-01||Interventional||This analysis population includes all subjects who were randomized, received at least 1 treatment, had a baseline value, and had at least 1 postbaseline measurement of the primary efficacy variable, BCVA. Subjects were analyzed according to the actual treatment received with last observation carried forward (LOCF) imputation of missing values.|Efficacy and Safety Study of ESBA1008 Versus EYLEA®|A Prospective, Randomized, Double-Masked, Multicenter, Two Arm Study Comparing the Efficacy and Safety of ESBA1008 Versus EYLEA® in Subjects With Exudative Age-Related Macular Degeneration|Completed||Phase 2|173|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 01:58:06.318205|2017-10-11 01:58:06.318205
NCT01796951|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-03-30|||February 2013|Actual|2013-02-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers|Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers|Completed||Early Phase 1|6|Actual|Vanderbilt University Medical Center||1|||f||||f|f|f||||||||2017-10-11 01:58:07.561735|2017-10-11 01:58:07.561735
NCT01796938|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2014-10-17|||June 2004||2004-06-01|February 2013|2013-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects|Open, Non-randomized, Sequential Group Comparison to Investigate the Pharmacokinetics, Safety, and Tolerability of 100 mg SPM 927 in Male and Female Subjects With Renal Impairment Including Subjects Requiring Dialysis Compared With Male and Female Healthy Subjects Following Single-dose Administration|Completed||Phase 1|40|Actual|UCB Pharma||5|||f||||f||||||||||2017-10-11 01:58:07.670201|2017-10-11 01:58:07.670201
NCT01796925|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-10-03|||February 2013||2013-02-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|THN2||Targeted Hypoglossal Neurostimulation Study #2|Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System|Completed||Phase 2/Phase 3|57|Actual|ImThera Medical, Inc.||1|||f||||f||||||||||2017-10-11 01:58:07.835803|2017-10-11 01:58:07.835803
NCT01796912|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-02-15|||February 2013||2013-02-01|February 2013|2013-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Lipoprotein Apheresis in Refractory Angina Study|Clinical Outcomes, Perfusion and Vascular Function in Patients With Refractory Angina and Raised Lipoprotein (a), Treated With Lipoprotein Apheresis|Completed||N/A|20|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 01:58:07.970196|2017-10-11 01:58:07.970196
NCT01796899|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-04-12|||January 2013||2013-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers|A Randomized, Single-center, Open-label, 5-way Crossover, Single-dose Bioavailability/Bioequivalence Comparison of Brivaracetam Oral Tablets (10 mg, 50 mg,75 mg, and 100 mg) and Brivaracetam Intravenous Bolus Injection (100 mg) in Healthy Volunteers|Completed||Phase 1|25|Actual|UCB Pharma||5|||f||||f||||||||||2017-10-11 01:58:08.070674|2017-10-11 01:58:08.070674
NCT01796886|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2014-08-29|||February 2013||2013-02-01|August 2014|2014-08-01|November 2014|Anticipated|2014-11-01|September 2014|Anticipated|2014-09-01||Interventional|||Performance Evaluation of Pupillary Reactivity in Monitoring of Brain-damaged Patients in Intensive Care|Performance Evaluation of Pupillary Reactivity in Monitoring of Brain-damaged Patients in Intensive Care|Unknown status|Active, not recruiting|N/A|90|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 01:58:08.180496|2017-10-11 01:58:08.180496
NCT01796873|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-21|||January 2012||2012-01-01|February 2013|2013-02-01|October 2013|Anticipated|2013-10-01|June 2013|Anticipated|2013-06-01||Observational|||Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention|Clopidogrel Resistance and Platelet Reactivity in Hispanic Females Undergoing Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 3|150|Anticipated|University of Arizona|||1||f||||f||||||||||2017-10-11 01:58:08.289162|2017-10-11 01:58:08.289162
NCT01796860|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-08-03|2015-05-13||September 2012||2012-09-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effectiveness of Ankle Foot Orthoses on Gait in Multiple Sclerosis|The Impact of Ankle Foot Orthosis (AFO) on Gait Recovery in Select Individuals With Multiple Sclerosis (MS)|Terminated||N/A|10|Actual|University of Texas Southwestern Medical Center||1||Modifications were made to protocol, new IRB pending|f||||t||||||||||2017-10-11 01:58:08.425405|2017-10-11 01:58:08.425405
NCT01796847|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-12-04|||December 2012||2012-12-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Actual|2014-12-01||Observational|GLUPTEN||Relationship Between PTEN and Glycemic Variability and Outcome in Critically Ill Patients|Influence of PTEN on Glycemic Variability and Clinical Outcome in the Critically Ill Patient.|Unknown status|Recruiting|N/A|20|Anticipated|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 01:58:08.732295|2017-10-11 01:58:08.732295
NCT01796834|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-20|||August 2012||2012-08-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|MDM||Managing Diabetes Mindfully Study|Managing Diabetes Mindfully Study|Completed||N/A|38|Actual|HealthPartners Institute||1|||f||||t||||||||||2017-10-11 01:58:08.814296|2017-10-11 01:58:08.814296
NCT01796821|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-06-01|||August 2014||2014-08-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)|A Double-Blind, Vehicle Controlled, Randomized, Phase II Study of SR-T100 Gel on External Genital Warts/Condyloma Acuminate (EGWs)|Active, not recruiting||Phase 2|111|Anticipated|G&E Herbal Biotechnology Co., LTD||3|||f||||f||||||||||2017-10-11 01:58:08.937473|2017-10-11 01:58:08.937473
NCT01796808|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-04-25|||March 2013|Actual|2013-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Fat Grafting for Pedal Fat Pad Atrophy|Autologous Fat Grafting for Pedal Fat Pad Atrophy|Completed||N/A|30|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 01:58:09.064325|2017-10-11 01:58:09.064325
NCT01796795|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-07-31|||June 2016||2016-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients|A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients.|Withdrawn||Phase 2|0|Actual|G&E Herbal Biotechnology Co., LTD||3||Budget issue.|f||||f||||||||||2017-10-11 01:58:09.183659|2017-10-11 01:58:09.183659
NCT01796782|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2013-02-20|||January 2013||2013-01-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||QYHJ Granules Versus Xeloda in Metastatic Pancreatic Cancer|A Prospective, Randomized, Open-label, Phase II Study of QYHJ Granules Versus Xeloda in the Second-line Treatment of Patients With Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 01:58:09.264455|2017-10-11 01:58:09.264455
NCT01796769|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-09-04|||February 2013||2013-02-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform for Improving CPAP Compliance in Low Cardiovascular Risk Sleep Apnea Patients : OPTISAS 1 Study|Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform for Improving Continuous Positive Airway Pressure (CPAP) Compliance in Low Cardiovascular Risk Sleep Apnea Patients|Unknown status|Recruiting|Phase 4|936|Anticipated|Fédération Française de Pneumologie||2|||f||||t||||||||||2017-10-11 01:58:09.344086|2017-10-11 01:58:09.344086
NCT01796756|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-01-14|||January 2013||2013-01-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Quality Improvement in Handover of General Internal Medicine In-patients|Quality Improvement in Handover of General Internal Medicine In-patients|Completed||N/A|1168|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:58:09.553492|2017-10-11 01:58:09.553492
NCT01796743|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-02-06|||February 2013||2013-02-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|T2 AMI MRI||T2 Heart Mapping in AMI Population for the Prediction of Short Term Major Adverse Cardiovascular Events|T2 Mapping of the Heart in Acute MI Population for the Prediction of Short Term Major Adverse Cardiovascular Events|Withdrawn||N/A|0|Actual|University of Arizona|||2|No patients|f||||f||||||||||2017-10-11 01:58:09.637019|2017-10-11 01:58:09.637019
NCT01796730|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-03-10|||February 2013||2013-02-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effects and Safety of Different Dose of Bambuterol on Chinese COPD Patients|A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Randomized Trial to Investigate the Efficacy and Safety of 10mg and 5mg Bambuterol Tablets Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|60|Actual|The First Affiliated Hospital of Guangzhou Medical University||3|||f||||t||||||||||2017-10-11 01:58:09.712406|2017-10-11 01:58:09.712406
NCT01796717|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-02-14|||March 2012||2012-03-01|August 2012|2012-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia|Optimizing Dosing Regimen of Piperacillin/Tazobactam, Prolonged Infusion vs. Regular Infusion, Every 6 Hours, for Nosocomial Pneumonia in ICU Caused by Susceptible Pathogens With Higher MIC|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 01:58:09.823467|2017-10-11 01:58:09.823467
NCT01796704|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-02-21|||February 2013||2013-02-01|October 2012|2012-10-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Observational|||Comparison of the Prediction Derived by the Cardiovascular Performance Reserve Index With the Clinical Evaluation|Comparison of the Prediction Derived by the Cardiovascular Performance Reserve Index (Calculated From Physiological Parameters) With the Clinical Evaluation|Unknown status|Not yet recruiting|N/A|200|Anticipated|Clalit Health Services|||1||f||||f||||||||||2017-10-11 01:58:09.982122|2017-10-11 01:58:09.982122
NCT01796691|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2013-02-24|||January 2009||2009-01-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|BOCLA-Mort||The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)|Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.|Completed||N/A|600|Actual|Ruhr University of Bochum|||2||f||||f||||||||||2017-10-11 01:58:10.066183|2017-10-11 01:58:10.066183
NCT01796678|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-07-29|||September 2000||2000-09-01|July 2013|2013-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial|Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial|Completed||Phase 2|56|Actual|Children's Hospital & Research Center Oakland||2|||f||||t||||||||||2017-10-11 01:58:10.135683|2017-10-11 01:58:10.135683
NCT01796665|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-09-23||2013-09-23|February 2012||2012-02-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris|A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, Ltd. Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel (Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5%), and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris|Completed||Phase 3|1180|Actual|Perrigo Company||3|||f||||f||||||||||2017-10-11 01:58:10.209011|2017-10-11 01:58:10.209011
NCT01796652|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-21|||November 2011||2011-11-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01|30 Days|Observational [Patient Registry]|||Home Treatment of Acute Pancreatitis|A Randomized Controlled Trial of Home Monitoring Versus Hospitalization in Mild Non-Alcoholic Acute Interstitial Pancreatitis|Completed||N/A|84|Actual|Bezmialem Vakif University|||1||f||||f||||||||||2017-10-11 01:58:10.283071|2017-10-11 01:58:10.283071
NCT01796639|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2014-06-17|||April 2012||2012-04-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|REACH||Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China|Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China|Completed||N/A|1500|Actual|Novartis|||1||f||||t||||||||||2017-10-11 01:58:10.357121|2017-10-11 01:58:10.357121
NCT01796626|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2014-08-25|||December 2012||2012-12-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Clinical Evaluation of M22 ResurFX 1565nm Module|Clinical Evaluation of M22 ResurFX 1565nm Module|Completed||N/A|36|Actual|Lumenis Ltd.||2|||f||||f||||||||||2017-10-11 01:58:10.474989|2017-10-11 01:58:10.474989
NCT01796613|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-03-10|||June 2013||2013-06-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Ring-Plus||Safety and Acceptability of Vaginal Rings That Protect Women From Unintended Pregnancy|Safety and Acceptability of Vaginal Rings That Protect Women From Unintended Pregnancy|Completed||Phase 2/Phase 3|120|Actual|Institute of Tropical Medicine, Belgium||2|||f||||t||||||||||2017-10-11 01:58:10.557759|2017-10-11 01:58:10.557759
NCT01796600|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-03-04|||July 2012||2012-07-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|FRADICOBE||Assessment of Distal Limbs Fractures With Cone-Beam CT Newtom 5G|Assessment of Distal Limbs Fractures With Cone-Beam CT Newtom 5G|Completed||N/A|43|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 01:58:10.637132|2017-10-11 01:58:10.637132
NCT01796587|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-05-07|||January 2013||2013-01-01|May 2015|2015-05-01||||March 2015|Actual|2015-03-01||Observational|||Non-Interventional Study Among Users Of LoFric Origo|Non-Interventional Study Among Users Of LoFric Origo|Completed||N/A|423|Actual|Wellspect HealthCare|||1||f||||||||||||||2017-10-11 01:58:12.466466|2017-10-11 01:58:12.466466
NCT01796574|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-03-12|||November 2012||2012-11-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Ketogenic Diet for Refractory Status Epilepticus|Feasibility and Tolerability of the Ketogenic Diet in the Treatment of Refractory Status Epilepticus in a Neurointensive Care Unit.|Completed||N/A|15|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 01:58:12.62045|2017-10-11 01:58:12.62045
NCT01796561|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-10-10|||February 2013||2013-02-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||The Effect of Olive Leaf Extract on Blood Pressure in Overweight Prehypertensives|Effect of Chronic Polyphenol-rich Olive Leaf Extract Intake on Cardiovascular Risk Markers|Completed||N/A|60|Actual|University of Reading||2|||f||||t||||||||||2017-10-11 01:58:12.73206|2017-10-11 01:58:12.73206
NCT01796548|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-10-31|2013-03-21||December 2008||2008-12-01|October 2013|2013-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|RONDO||Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity|Extended-Release Oxybutynin in the Treatment of Neurogenic Detrusor Overactivity (RONDO)|Terminated||Phase 4|17|Actual|Janssen-Cilag Ltd.,Thailand||1||Slow rate of participant's enrollment|f||||t||||||||||2017-10-11 01:58:12.821553|2017-10-11 01:58:12.821553
NCT01796535|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-03-13|||November 2012||2012-11-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01|1 Year|Observational [Patient Registry]|OptiLIF™||The PerX360º System™ Registry|An Observational, Multi Center, Non-Randomized (Single Arm) Registration of the PerX360º System™|Unknown status|Recruiting|N/A|125|Anticipated|Interventional Spine, Inc.|||1||f||||f||||||||||2017-10-11 01:58:13.195054|2017-10-11 01:58:13.195054
NCT01796522|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-07-21|||March 2013||2013-03-01|July 2015|2015-07-01|May 2013|Anticipated|2013-05-01|May 2013|Actual|2013-05-01||Interventional|UTM/2012||Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery|Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery|Withdrawn||Phase 3|0|Actual|Instituto de Investigacion Sanitaria La Fe||2||"have been published new studies that it showed the ineffectiveness of the treatments proposed   in this study."|f||||||||||||||2017-10-11 01:58:13.399952|2017-10-11 01:58:13.399952
NCT01796145|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-07-07|||February 27, 2013|Actual|2013-02-27|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Fibroscan Study in HCC|A Study to Evaluate the Impact of Liver Stiffness on Treatment Outcome of Unresectable Hepatocellular Carcinoma|Recruiting||N/A|200|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:58:18.689477|2017-10-11 01:58:18.689477
NCT01796496|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-10-03|||March 2013||2013-03-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Manipulative Therapy Techniques to Treat Chronic Low Back Pain|Short-term Effect of Manipulative Therapy Techniques in People With Chronic Low Back Pain: A Randomized Controlled Trial.|Completed||N/A|62|Actual|Universidad de Almeria||2|||f||||f||||||||||2017-10-11 01:58:13.602914|2017-10-11 01:58:13.602914
NCT01796483|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2016-07-05|||October 2012||2012-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2013|Actual|2013-06-01||Interventional|EEGDBSNAd||EEG and Pharmacological Exploration of Executive Dysfunctions Induced by STN-DBS in PD|Exploration électroencéphalographie et Pharmacologique Des Dysfonctionnements exécutifs Induits Par la Stimulation cérébrale Profonde du Noyau Sous-thalamique Dans la Maladie de Parkinson|Completed||N/A|37|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:58:13.727789|2017-10-11 01:58:13.727789
NCT01796470|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-01-20||2015-03-10|June 2013||2013-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|April 2014|Actual|2014-04-01||Interventional|||Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies|A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Combination With Idelalisib in Subjects With Relapsed or Refractory Hematologic Malignancies|Completed||Phase 2|66|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 01:58:13.834167|2017-10-11 01:58:13.834167
NCT01796457|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-08-21|||March 2013||2013-03-01|November 2016|2016-11-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B|HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B|Active, not recruiting||N/A|40|Actual|University of Pennsylvania|||1||f||||t||||||Samples Without DNA|"     Blood   "|||2017-10-11 01:58:14.010704|2017-10-11 01:58:14.010704
NCT01796444|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-20|||January 2013||2013-01-01|February 2013|2013-02-01|June 2026|Anticipated|2026-06-01|December 2025|Anticipated|2025-12-01||Interventional|Z0011-China||Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node|A Prospective Randomized Multicenter Phase III Study of Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node--the Validation of Z0011 in China|Recruiting||Phase 3|4|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||f||||||||||2017-10-11 01:58:14.122735|2017-10-11 01:58:14.122735
NCT01796431|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2013-07-24|||March 2013||2013-03-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers||Completed||Phase 1|18|Actual|St Stephens Aids Trust||1|||f||||||||||||||2017-10-11 01:58:14.26256|2017-10-11 01:58:14.26256
NCT01796418|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-12-13|||March 2013||2013-03-01|December 2013|2013-12-01||||August 2014|Anticipated|2014-08-01||Interventional|||Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy|Effect of Beraprost Sodium on Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy (BESTinDN Study)|Unknown status|Recruiting|N/A|102|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:58:14.355939|2017-10-11 01:58:14.355939
NCT01796405|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-08-24||||||August 2015|2015-08-01||||October 2017|Anticipated|2017-10-01||Interventional|||Clofarabine for Langerhans in Pedi|Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis|Withdrawn||Phase 2|0|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 01:58:14.478431|2017-10-11 01:58:14.478431
NCT01796379|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2016-01-22|||February 2013||2013-02-01|December 2015|2015-12-01|December 2035|Anticipated|2035-12-01|December 2019|Anticipated|2019-12-01||Interventional|HITTS||High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia|High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia|Recruiting||N/A|120|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:58:14.692891|2017-10-11 01:58:14.692891
NCT01796366|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-02-28|||February 21, 2013|Actual|2013-02-21|February 2017|2017-02-01|August 19, 2013|Actual|2013-08-19|August 19, 2013|Actual|2013-08-19||Interventional|||A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes|A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes|Completed||Phase 1|40|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:58:14.80995|2017-10-11 01:58:14.80995
NCT01796353|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-05-12|||February 2013||2013-02-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|November 2016|Actual|2016-11-01||Interventional|CopenHeartSF||Effects of a Comprehensive Sexual Rehabilitation Programme in Heart Patients|A Randomized Clinical Trial of a Comprehensive Sexual Rehabilitation Programme Versus Usual Care in Male Patients With Impaired Sexual Function and Ischemic Heart Disease or Implantable Cardioverter Defibrillator|Completed||N/A|154|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:58:14.916133|2017-10-11 01:58:14.916133
NCT01796340|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-10-13|||January 2014||2014-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Cue Exposure Training for Overweight Children|Cue Exposure Training for Overweight Children|Terminated||N/A|14|Actual|Maastricht University Medical Center||2||Insufficient number of participants|f||||t||||||||||2017-10-11 01:58:15.072742|2017-10-11 01:58:15.072742
NCT01795755|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-03-11|||January 2013||2013-01-01|March 2013|2013-03-01|January 2017|Anticipated|2017-01-01|January 2014|Anticipated|2014-01-01||Interventional|HAT||YATEP - The Impact of Horse Assisted Therapy (HAT) on Treatment Outcomes|The Impact of Horse Assisted Therapy (HAT) on Treatment Outcomes|Unknown status|Recruiting|N/A|60|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 01:58:24.7666|2017-10-11 01:58:24.7666
NCT01796327|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-10-06|||April 2013||2013-04-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers|A Phase 1, Single Dose, Fixed Sequence Study To Estimate The Absolute Bioavailability Of Dacomitinib (PF-00299804) By Comparing Oral To Intravenous Administration In Healthy Volunteers|Completed||Phase 1|14|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:58:15.341881|2017-10-11 01:58:15.341881
NCT01796314|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-08-24|||January 2013||2013-01-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|THERAD||Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life|Impact of a Therapeutic Educational Programme for Alzheimer's Disease Patients and Their Caregiver in Community Dwelling, on the AD Patient's Quality of Life|Unknown status|Recruiting|N/A|170|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 01:58:15.550106|2017-10-11 01:58:15.550106
NCT01796301|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-05-31||2015-12-19|January 31, 2013|Actual|2013-01-31|May 2017|2017-05-01|May 14, 2015|Actual|2015-05-14|May 14, 2015|Actual|2015-05-14||Interventional|STRUCTURE||An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women|An Open-label, Randomized, Teriparatide-controlled Study to Evaluate the Effect of Treatment With Romosozumab in Postmenopausal Women With Osteoporosis Previously Treated With Bisphosphonate Therapy|Completed||Phase 3|436|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:58:15.728918|2017-10-11 01:58:15.728918
NCT01796288|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-02-20|||October 2012||2012-10-01|October 2012|2012-10-01|October 2017|Anticipated|2017-10-01|April 2016|Anticipated|2016-04-01||Interventional|ROLE||The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment|The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment: a Randomized Controlled Phase II Clinical Trial|Unknown status|Recruiting|Phase 2|200|Anticipated|Wu Jieping Medical Foundation||2|||f||||t||||||||||2017-10-11 01:58:16.012881|2017-10-11 01:58:16.012881
NCT01796275|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2014-02-03|||August 2012||2012-08-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Happy Family Kitchen Project II|"A Happy Family Kitchen Initiative for Promoting Family Health, Happiness, and Harmony in Tsuen Wan, Kwai Chung and Tsing Yi District"|Completed||N/A|2000|Anticipated|The University of Hong Kong||3|||f||||f||||||||||2017-10-11 01:58:16.149141|2017-10-11 01:58:16.149141
NCT01796262|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-08-28|||June 2012||2012-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|DADA||The Effects of DHA on Attention Deficit and Hyperactivity Disorder|The Effects of DHA (DOCOSAHEXAENOIC ACID) on Attention Deficit and Hyperactivity Disorder|Completed||Phase 3|50|Actual|IRCCS Eugenio Medea||2|||f||||f||||||||||2017-10-11 01:58:16.283954|2017-10-11 01:58:16.283954
NCT01796249|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2013-08-26|||October 2012||2012-10-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Prediction of Immediate Postoperative Pain Using Analgesia/Nociception Index (ANI)|Prediction of Immediate Postoperative Pain Using Analgesia/Nociception Index (ANI): an Observational Study|Completed||N/A|200|Actual|Hôpital Edouard Herriot|||1||f||||t||||||||||2017-10-11 01:58:16.445402|2017-10-11 01:58:16.445402
NCT01796236|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-02-02|2015-11-18||February 2013||2013-02-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|June 2015|Actual|2015-06-01||Interventional|||Clinical and Health Economic Evaluation With a New Baha® Abutment Combined With a Minimally Invasive Surgical Technique|Clinical and Health Economic Evaluation of a New Baha® Abutment, With a Minimally Invasive Surgical Technique. An International Multicentre, Open, Randomised, Comparative, Parallel Group, Investigation. 1y Investigation, 2y Follow-up|Active, not recruiting||N/A|106|Actual|Cochlear Bone Anchored Solutions||2|||f||||f||||||||||2017-10-11 01:58:16.557836|2017-10-11 01:58:16.557836
NCT01796223|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-06-12|||December 2012|Actual|2012-12-01|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Effects of Systematic Patient Feedback on Therapy Outcome|Effects of Systematic Patient Feedback on Therapy Outcome and Dropout: A Randomized Controlled Study on Adult Out-patients at a Community Mental Health Centre.|Completed||N/A|170|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 01:58:17.994445|2017-10-11 01:58:17.994445
NCT01796210|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-06-06|||October 2012||2012-10-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Prediction of Hemodynamic Reactivity During Suspension Laryngoscopy Using Analgesia/Nociception Index (ANI)|Prediction of Hemodynamic Reactivity During Suspension Laryngoscopy Using Analgesia/Nociception Index (ANI): an Observational Study|Completed||N/A|50|Actual|Hôpital Edouard Herriot|||1||f||||t||||||||||2017-10-11 01:58:18.131401|2017-10-11 01:58:18.131401
NCT01796197|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-06-30|||March 2013||2013-03-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|June 2018|Anticipated|2018-06-01||Interventional|||Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa|Phase II Trial of Paclitaxel Combined With Trastuzumab and Pertuzumab as Pre-Operative Therapy for Inflammatory Breast Cancer|Active, not recruiting||Phase 2|23|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:58:18.222699|2017-10-11 01:58:18.222699
NCT01796184|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-05-21|||November 2012||2012-11-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|AES||Inflammation and Glycation in a General Adult Population|Inflammation and Glycation in a General Adult Population|Completed||N/A|1516|Actual|Hospital Clinico Universitario de Santiago|||1||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 01:58:18.372231|2017-10-11 01:58:18.372231
NCT01796171|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-09-13|||December 2012|Actual|2012-12-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|October 2017|Anticipated|2017-10-01||Interventional|LYMRIT-37-01||A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma|A Phase I/II Study of (177Lu)-Lilotomab (Betalutin®) Radioimmunotherapy for Treatment of Relapsed Non-Hodgkin Lymphoma.|Recruiting||Phase 1/Phase 2|77|Anticipated|Nordic Nanovector||4|||f||||t||||||||||2017-10-11 01:58:18.458895|2017-10-11 01:58:18.458895
NCT01796158|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2016-10-06|||September 2013||2013-09-01|October 2016|2016-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use|Pilot Test of Computerized MET Intervention to Reduce Adolescent Alcohol Use|Withdrawn||N/A|0|Actual|Boston Children’s Hospital||2||not funded|f||||f||||||||No||2017-10-11 01:58:18.589825|2017-10-11 01:58:18.589825
NCT01796132|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2015-07-27|||August 2012||2012-08-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications|Antidepressant Treatments During Pregnancy and Lactation: Prediction of Drug Exposure Through Breastfeeding and Evaluation of Drug Effect on the Neonatal Adaptation and the Development of the Young Child|Recruiting||Phase 4|500|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 01:58:18.806706|2017-10-11 01:58:18.806706
NCT01796119|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-02-02|||February 2013||2013-02-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Ridge Expansion in the Maxillary Aesthetic Zone Using Piezo-electric Surgery|Lateral Alveolar Ridge Expansion in the Maxillary Aesthetic Zone Using Piezo-electric Surgery and Threaded Osteotomes for Immediate Implant Placement.|Completed||N/A|10|Actual|Clinique Dentaire et d'implantologie Dr.Vinh Nguyen||2|||f||||t||||||||||2017-10-11 01:58:19.153871|2017-10-11 01:58:19.153871
NCT01796106|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-09-28|||March 2015||2015-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trial Proximal Caries Infiltration and Detection|Clinical Efficacy of Caries Infiltration (Icon) - A Randomized, Blinded and Controlled Pilot Study of Early Caries Progression Detection|Recruiting||N/A|50|Anticipated|DMG Dental Material Gesellschaft mbH||2|||f||||f||||||||||2017-10-11 01:58:19.259967|2017-10-11 01:58:19.259967
NCT01796093|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-01-30|||April 2008||2008-04-01|January 2017|2017-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01|4 Months|Observational [Patient Registry]|DIGvsIVA||Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function|Comparison of Digoxin and Ivabradine in Heart Failure With Preserved Systolic Function.|Completed||N/A|42|Actual|Cocco, Giuseppe, M.D.|||1||f||||t||||||||||2017-10-11 01:58:19.385688|2017-10-11 01:58:19.385688
NCT01796080|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-12-20|||October 2012||2012-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Simulated Obstructive Apnoea and Hypopnoea on Heart Rhythm in Patients With Paroxysmal Atrial Fibrillation|The Effect of Simulated Obstructive Apnoea and Hypopnoea on Heart Rhythm in Patients With Paroxysmal Atrial Fibrillation|Completed||N/A|45|Actual|University of Zurich||4|||f||||f||||||||||2017-10-11 01:58:19.509701|2017-10-11 01:58:19.509701
NCT01796067|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-09-18|||July 2012||2012-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Families Improving Together (FIT) for Weight Loss|Families Improving Together (FIT) for Weight Loss|Recruiting||N/A|520|Anticipated|University of South Carolina||4|||f||||t||||||||||2017-10-11 01:58:19.611694|2017-10-11 01:58:19.611694
NCT01796054|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-01-09|||February 2013||2013-02-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|SFN-Nurses||Stress Free Now, a Mind-body Reduction Program for Nurses|Effectiveness of a Mind-body Stress Reduction Program for Nurses: A Randomized Controlled Study|Completed||N/A|360|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 01:58:19.750205|2017-10-11 01:58:19.750205
NCT01796041|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-06-11|||July 2011||2011-07-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|ICG||Intraoperative Imaging of Breast Cancer With Indocyanine Green|A Phase 0/1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subject Undergoing Breast Cancer Surgery|Recruiting||Early Phase 1|10|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 01:58:19.863479|2017-10-11 01:58:19.863479
NCT01796028|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-07-25|||January 2013||2013-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|TAXOMET||Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer|A Multicentric, Randomized, Phase II Study Evaluating the Combination of METFORMIN With TAXOTERE®+Metformine Placebo Versus TAXOTERE®+Metformin for the Treatment of Metastatic Hormone-refractory Prostate Cancer.|Active, not recruiting||Phase 2|100|Actual|Centre Antoine Lacassagne||2|||f||||t||||||||||2017-10-11 01:58:19.99658|2017-10-11 01:58:19.99658
NCT01796015|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-03-01|||April 2011||2011-04-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|DENO||Intracranial Hypertension and Optic Nerve Sheath Diameter|Intracranial Hypertension Detection Using Optic Nerve Sheath Diameter Measurement in Children|Completed||N/A|230|Actual|Hospices Civils de Lyon||3|||f||||t||||||||||2017-10-11 01:58:20.136124|2017-10-11 01:58:20.136124
NCT01796002|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-03-08|||January 2013||2013-01-01|March 2017|2017-03-01|July 2024|Anticipated|2024-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma|PHASE 3 MULTI-CENTER RANDOMIZED STUDY TO COMPARE EFFICACY AND SAFETY OF ROMIDEPSIN CHOP (Ro-CHOP) VERSUS CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T-CELL LYMPHOMA|Recruiting||Phase 3|420|Anticipated|The Lymphoma Academic Research Organisation||2|||f||||t||||||||||2017-10-11 01:58:20.258827|2017-10-11 01:58:20.258827
NCT01795989|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-02-01|||November 2011||2011-11-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of Specially Designed Pediatric MR Coils on Clinical Scanners|Novel Coils for Pediatric Musculoskeletal MRI|Active, not recruiting||N/A|45|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 01:58:20.765666|2017-10-11 01:58:20.765666
NCT01795976|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-02-06|||October 2014||2014-10-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|ATTACK-OG||NY-ESO-1 T Cells in OG Cancer|A Phase II Trial to Assess the Activity of NY-ESO-1 Targeted T Cells in Advanced Oesophagogastric Cancer|Active, not recruiting||Phase 2|28|Anticipated|The Christie NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 01:58:20.864018|2017-10-11 01:58:20.864018
NCT01795963|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-19|||June 2009||2009-06-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||ePREP for Community Couples|ePREP for Community Couples|Completed||N/A|104|Actual|Brigham Young University||2|||f||||f||||||||||2017-10-11 01:58:20.99664|2017-10-11 01:58:20.99664
NCT01795950|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-02-15|||April 2013||2013-04-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)|A Phase I Safety and Pharmacodynamic Study of Intravenous Infusion of PLX-PAD Cells in Patients With PAH|Terminated||Phase 1|6|Actual|United Therapeutics||3|||f||||t||||||||||2017-10-11 01:58:21.10402|2017-10-11 01:58:21.10402
NCT01795937|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-07-03|2015-07-03||February 2013||2013-02-01|July 2015|2015-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||"The itraconazole part of this trial was done open-label with a fixed-sequence, 2-period design (treatment seq. A_B).
The statins part was done open-label with a fixed-sequence, 2-period design. Subjects in the statins part were assigned to 1 of the 2 possible treatment sequences: treatment seq. C_D or E_F.
Both parts were performed independently."|Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin|Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin in Healthy Male and Female Subjects (Open-label, Fixed-sequence)|Completed||Phase 1|51|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:58:21.270933|2017-10-11 01:58:21.270933
NCT01795924|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-07-08|||January 2013||2013-01-01|February 2013|2013-02-01|March 2015|Anticipated|2015-03-01|September 2014|Anticipated|2014-09-01||Interventional|AML/MDS||Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome|An Open-Label, Phase 1/2 Study of PD-616 and Low-dose Cytarabine in Patients With Untreated or Relapsed/Refractory Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)|Unknown status|Recruiting|Phase 1/Phase 2|33|Anticipated|Biosuccess Biotech Co., Ltd.||1|||f||||t||||||||||2017-10-11 01:58:22.118308|2017-10-11 01:58:22.118308
NCT01795911|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-09-23||2015-09-23|March 2013||2013-03-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|D-LITE||Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin|A Phase 2B, Randomized Study to Evaluate the Safety and Efficacy of Pegylated Interferon Lambda (BMS-914143) Administered With Ribavirin Plus a Single Direct Antiviral Agent (BMS-790052 or BMS-650032) Versus Pegasys Administered With Ribavirin (Part A) and of Pegylated Interferon Lambda (BMS-914143) Administered With or Without Ribavirin Plus 2 Direct Antiviral Agents (BMS-790052 and BMS-650032) (Part B) in Chronic Hepatitis C Genotype-1 Treatment naïve Subjects|Completed||Phase 2|165|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 01:58:22.255243|2017-10-11 01:58:22.255243
NCT01795898|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-06-10|2013-03-18||January 2009||2009-01-01|June 2013|2013-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||An Efficacy and Safety Study of Fentanyl Transdermal Patch in Filipino Participants With Osteoarthritis and Chronic Low Back Pain|Efficacy, Safety and Quality of Life Outcome of Fentanyl Transdermal Patch (Durogesic-D-Trans) Among Filipino Patients With Osteoarthritis and Chronic Low Back Pain|Completed||Phase 4|237|Actual|Janssen Pharmaceutica||1|||f||||f||||||||||2017-10-11 01:58:22.413602|2017-10-11 01:58:22.413602
NCT01795885|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-07-11|||November 2012||2012-11-01|July 2017|2017-07-01|March 13, 2013|Actual|2013-03-13|March 13, 2013|Actual|2013-03-13||Interventional|||"Trial of the Effect of 16 and Pregnant on Teen Girls' Attitudes About Pregnancy"|"Can 16 & Pregnant Change Teens' Attitudes About Teen Pregnancy? A Randomized Controlled Trial"|Completed||N/A|153|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 01:58:23.072607|2017-10-11 01:58:23.072607
NCT01795872|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2015-07-24|||September 2013||2013-09-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis|BENEFIT 11 a Long-term Follow-up Study of the BENEFIT (Betaferon/Betaseron in Newly Emerging Multiple Sclerosis for Initial Treatment, 304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to Further Evaluate the Progress of Patients With First Demyelinating Event Suggestive of Multiple Sclerosis|Completed||Phase 4|278|Actual|Bayer||1|||f||||f||||||||||2017-10-11 01:58:23.191487|2017-10-11 01:58:23.191487
NCT01795859|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-20|2017-08-22|2017-05-05|2015-06-24|August 5, 2013|Actual|2013-08-05|August 2017|2017-08-01|December 5, 2014|Actual|2014-12-05|December 5, 2014|Actual|2014-12-05||Interventional|First-HD||First Time Use of SD-809 in Huntington Disease|A Randomized Double-Blind, Placebo-Controlled Study of SD-809 Extended Release for the Treatment of Chorea Associated With Huntington Disease|Completed||Phase 3|90|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 01:58:23.519385|2017-10-11 01:58:23.519385
NCT01795833|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2017-03-08|||June 2013|Actual|2013-06-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Diabetes Prevention Using SMS Technology|A Pragmatic and Scaleable Strategy Using Mobile Technology to Promote Sustained Lifestyle Changes to Prevent Type 2 Diabetes in India and the UK|Active, not recruiting||N/A|2025|Actual|Imperial College London||2|||f||||t||||||||No||2017-10-11 01:58:24.278283|2017-10-11 01:58:24.278283
NCT01795820|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-02-18|||November 2012||2012-11-01|February 2013|2013-02-01||||January 2013|Actual|2013-01-01||Interventional|SHIFT-OVER||Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor|Platelet Aggregation During Pharmacological Shift From Clopidogrel to Ticagrelor in Patients With Acute Coronary Syndrome|Completed||N/A|50|Actual|University Magna Graecia||2|||f||||||||||||||2017-10-11 01:58:24.389057|2017-10-11 01:58:24.389057
NCT01795807|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2013-02-19|||May 2013||2013-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:58:24.468967|2017-10-11 01:58:24.468967
NCT01795794|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-26|||April 2013||2013-04-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC||Unknown status|Not yet recruiting|Phase 4|12|Anticipated|Soroka University Medical Center||1|||f||||f||||||||||2017-10-11 01:58:24.513322|2017-10-11 01:58:24.513322
NCT01795781|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-04-30|||April 2012||2012-04-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Assays for and Reversal of New Anticoagulants|Development of Anticoagulant Assays for New Anticoagulants and Their Reversibility in Vitro|Completed||N/A|30|Actual|Royal Perth Hospital|||1||f||||f||||||||||2017-10-11 01:58:24.580182|2017-10-11 01:58:24.580182
NCT01795768|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-03-14|||September 2012||2012-09-01|March 2013|2013-03-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|FGFR||Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours|Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours|Unknown status|Recruiting|Phase 2|48|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 01:58:24.658887|2017-10-11 01:58:24.658887
NCT01795742|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2013-02-18|||August 2012||2012-08-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer|Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer in the Treatment of Mild to Moderate Asthma in El Salvador|Completed||Phase 2|110|Actual|Marquette University||2|||f||||f||||||||||2017-10-11 01:58:24.855868|2017-10-11 01:58:24.855868
NCT01795729|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-19|2015-10-13|||February 2013||2013-02-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|ARCHER||Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event Reduction|Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event Reduction: THE ARCHER TRIAL|Terminated||Phase 3|6|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 01:58:24.932127|2017-10-11 01:58:24.932127
NCT01795716|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-05-16|2014-03-16||September 2012||2012-09-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body|Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body|Completed||Phase 1|21|Actual|Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd||2|||f||||t||||||||||2017-10-11 01:58:25.046207|2017-10-11 01:58:25.046207
NCT01795703|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2015-11-03|||June 2012||2012-06-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel|A Phase II Study of JNJ-212082 (Abiraterone Acetate) in Metastatic Castration-Resistant Prostate Cancer Patients Who Have Received Docetaxel-based Chemotherapy|Completed||Phase 2|47|Actual|Janssen Research & Development, LLC||1|||f||||t||||||||||2017-10-11 01:58:25.310409|2017-10-11 01:58:25.310409
NCT01795690|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-02-26|||December 2011||2011-12-01|December 2014|2014-12-01|February 2016|Actual|2016-02-01|September 2013|Actual|2013-09-01||Observational|TAR||Clinical Tumor Anemia Registry (TAR)|Clinical Registry Describing Treatment Reality of Patients With Cancer-(Therapy)-Induced Anemia|Completed||N/A|1018|Actual|iOMEDICO AG|||1||f||||f||||||||No||2017-10-11 01:58:25.443585|2017-10-11 01:58:25.443585
NCT01795677|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-03-20|||December 2012||2012-12-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 8, 2017|Actual|2017-03-08||Interventional|||JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis|JAK2 Inhibitors RUXOLITINIB in Patients With High or Intermediate Risk Primary or Secondary Myelofibrosis Eligible for Allogeneic Stem Cell Transplantation: a Prospective Multicentric Phase II Study|Active, not recruiting||Phase 2|78|Actual|French Innovative Leukemia Organisation||1|||f||||t||||||||No||2017-10-11 01:58:25.520835|2017-10-11 01:58:25.520835
NCT01795664|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-09-18|||March 2013||2013-03-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Compare the Effects of Seretide® Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients|A Double Blind, Double Dummy, Randomized, Two Way Cross-over Study to Compare the Effects of Seretide® Evohaler (Supplied by Allen & Hanburys, UK) and a Generic Salmeterol/Fluticasone HFA pMDI (Manufactured by Cipla Ltd, India) on Functional Respiratory Imaging Parameters in Asthmatic Patients.|Completed||Phase 3|16|Actual|FLUIDDA nv||2|||f||||f||||||||||2017-10-11 01:58:25.61933|2017-10-11 01:58:25.61933
NCT01795651|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-10-08|||February 2013||2013-02-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|T-REX 2||Identification of Take Home Message in Lecture Based Learning|Identification of Take Home Message in Lecture Based Learning: a Randomize Controlled Trial|Completed||N/A|77|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 01:58:25.734763|2017-10-11 01:58:25.734763
NCT01795625|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-02-18|||August 2012||2012-08-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||OneTouch® Verio™Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in China|A Multi-centre, Open Clinical Evaluation to Determine Professional Clinical Accuracy Comparing the OneTouch® Verio™Pro+ Blood Glucose Results With the YSI 2300 Analyzer.|Completed||N/A|301|Actual|Johnson & Johnson Medical, China|||1||f||||t||||||||||2017-10-11 01:58:25.908745|2017-10-11 01:58:25.908745
NCT01795612|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2016-08-19|||March 2013||2013-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|July 2016|Actual|2016-07-01||Interventional|APAC||Adapted Physical Activity Effect on Aerobic Function and Fatigue at Home in Patients With Breast Cancer Treated in Adjuvant or Neoadjuvant Phase|Adapted Physical Activity Effect on Aerobic Function and Fatigue at Home in Patients With Breast Cancer Treated in Adjuvant or Neoadjuvant Phase|Recruiting||N/A|90|Anticipated|University Hospital, Limoges||3|||f||||f||||||||||2017-10-11 01:58:25.967858|2017-10-11 01:58:25.967858
NCT01795599|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-08-29|||May 2013||2013-05-01|August 2014|2014-08-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01||Interventional|||Cervical Preparation for Surgical Abortion at 12-14 Weeks: a Prospective, Randomized, Evaluator-blinded, Multicenter, Controlled Comparison Between Mifepristone, Misoprostol and Their Combination|Cervical Preparation for Surgical Abortion at 12-14 Weeks: a Prospective, Randomized, Evaluator-blinded, Multicenter, Controlled Comparison Between Mifepristone, Misoprostol and Their Combination|Unknown status|Recruiting|Phase 3|198|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-11 01:58:26.04874|2017-10-11 01:58:26.04874
NCT01795586|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-05-22|||February 6, 2013|Actual|2013-02-06|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|February 24, 2015|Actual|2015-02-24||Interventional|||A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients|A Phase I Dose Escalation Study of Eribulin in Combination With Weekly Carboplatin for the Treatment of Metastatic Breast Cancer|Active, not recruiting||Phase 1|19|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f|||f|||||2017-10-11 01:58:26.131537|2017-10-11 01:58:26.131537
NCT01795573|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-07-28|||June 24, 2014|Actual|2014-06-24|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease|Phase I Trial of Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease|Recruiting||Phase 1|48|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 01:58:26.21793|2017-10-11 01:58:26.21793
NCT01795560|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-02-19|||February 2013||2013-02-01|February 2013|2013-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||Follow up by US Following Hospitalization With Periappendicular Abscess Refusing to be Operated on Within a Few Weeks.|US Follow-up After Appendicitis Attack.|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 01:58:26.461919|2017-10-11 01:58:26.461919
NCT01795547|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-02-08|2015-09-17||February 2013||2013-02-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Demographic data is based on all enrolled subjects, which were also all randomized|Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia|A 28-week, Randomised, Open-label Study Evaluating the Effectiveness of Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia|Completed||Phase 3|295|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 01:58:26.54882|2017-10-11 01:58:26.54882
NCT01795534|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-06-20|2014-06-16||February 2013||2013-02-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Includes groups randomized to receive beetroot shot first and placebo first.|Beetroot Juice as a Potential Ergogenic Aid During Exercise in Hypoxia|Beetroot Juice as a Potential Ergogenic Aid During Exercise in Hypoxia|Completed||N/A|10|Actual|Bangor University||2|||f||||f||||||||||2017-10-11 01:58:27.274587|2017-10-11 01:58:27.274587
NCT01795521|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-10-29|||August 2015||2015-08-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|LungTech||LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC|LungTech Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC: A Phase II Study in Preparation for a Randomized Phase III Trial|Recruiting||Phase 2|150|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||t||||||||||2017-10-11 01:58:27.530902|2017-10-11 01:58:27.530902
NCT01795508|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-08-15|||January 2013||2013-01-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|November 2015|Anticipated|2015-11-01||Interventional|PMTO||Parent Management Training, Oregon|The Effect of Parent Management Training, Oregon, in Denmark|Unknown status|Recruiting|N/A|200|Anticipated|The Danish National Centre For Social Research||2|||f||||f||||||||||2017-10-11 01:58:27.658972|2017-10-11 01:58:27.658972
NCT01795495|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2016-11-28|||September 2013||2013-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Methadone vs Magnesium in Spinal Fusion|Analgesia Following Posterior Spinal Fusion: Methadone vs Magnesium|Completed||Phase 2|63|Actual|Nationwide Children's Hospital||3|||f||||t||||||||||2017-10-11 01:58:27.765478|2017-10-11 01:58:27.765478
NCT01795482|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-12-15|||January 2013||2013-01-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|THER-6||Preoperative Patient Warming for Prevention of Perioperative Hypothermia in Major Abdominal Surgery|The Effect of Preoperative Patient Warming in the Prevention of Perioperative Hypothermia in Major Abdominal Surgery Under Combined General/Epidural Anaesthesia|Completed||N/A|99|Actual|University of Schleswig-Holstein||3|||f||||f||||||||||2017-10-11 01:58:27.879111|2017-10-11 01:58:27.879111
NCT01795469|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-01-28|||February 2013||2013-02-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients|Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients|Completed||N/A|20|Actual|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-11 01:58:28.003059|2017-10-11 01:58:28.003059
NCT01795456|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-01-26|||August 2010|Actual|2010-08-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis|Contrast Enhanced Ultrasound for Assessment of Carotid Artery Neovascularization as a Marker of Disease Activity in Takayasu's Arteritis and Giant Cell Arteritis|Completed||N/A|7|Actual|The Cleveland Clinic|||1||f||||f||||||||No||2017-10-11 01:58:28.096855|2017-10-11 01:58:28.096855
NCT01795443|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-03-25|||April 2013||2013-04-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|Vibrioception||Lumbar Proprioception in Lower Back Pain Patients Versus Healthy Subjects : a Comparative Study on the Effects of Low- and High-frequency Muscle Vibrations|Lumbar Proprioception in Lower Back Pain Patients Versus Healthy Subjects : a Comparative Study on the Effects of Low- and High-frequency Muscle Vibrations|Completed||N/A|24|Actual|Centre Hospitalier Universitaire de Nīmes||12|||f||||f||||||||||2017-10-11 01:58:28.200472|2017-10-11 01:58:28.200472
NCT01795430|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-01-07|||July 2013||2013-07-01|January 2015|2015-01-01||||March 2018|Anticipated|2018-03-01||Interventional|||Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma|A Pilot Study of Whole-body MRI-guided Intensity Modulated Radiation Therapy Combined With Systemic Chemotherapy Followed by High-Dose Chemotherapy With Busulfan, Melphalan and Topotecan and Stem Cell Rescue in Patients With Poor Risk Ewing's Sarcoma|Withdrawn||N/A|0|Actual|City of Hope Medical Center||1||No participants enrolled.|f||||t||||||||||2017-10-11 01:58:28.389133|2017-10-11 01:58:28.389133
NCT01795404|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-17|2013-02-17|||June 2013||2013-06-01|February 2013|2013-02-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|IBSR||A Randomized Controlled Trial of Inquiry Based Stress Reduction (IBSR) Program for Cancer Survivors.|A Randomized Controlled Trial of Inquiry Based Stress Reduction (IBSR) Program for Cancer Survivors - Effects on Quality of Life, Psychological Measures,Physical Symptoms, and Biological Measurements.|Unknown status|Not yet recruiting|Phase 2|300|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 01:58:28.596904|2017-10-11 01:58:28.596904
NCT01795391|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-01-20|||October 2012||2012-10-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|Advanced||Comparison of Two New Generations Dressings in Intensive Care Unit|Comparison Between Two New Generation Dressings in the Prevention of Intravascular Catheter Related Complications in Intensive Care Units|Completed||N/A|685|Actual|University Hospital, Grenoble|||2||f||||t||||||||||2017-10-11 01:58:28.667454|2017-10-11 01:58:28.667454
NCT01795378|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-12-29|||February 2013||2013-02-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|DNKI-II||Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation|HLA-Haploidentical Hematopoietic Cell Transplantation and Subsequent Donor Natural Killer Cell Infusion in Refractory Acute Leukemia - A Phase 1-2a STUDY|Completed||Phase 1/Phase 2|56|Actual|Asan Medical Center||1|||f||||t||||||||||2017-10-11 01:58:28.73938|2017-10-11 01:58:28.73938
NCT01795365|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-08-08|||December 2012||2012-12-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer||Active, not recruiting||N/A|100|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 01:58:28.810933|2017-10-11 01:58:28.810933
NCT01795352|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-10-29|||March 2013||2013-03-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|Ca_Pulmon||Retrospective Study in a NSCLC M+ p|Observational Retrospective Study to Describe the Management of Advanced or Metastatic EGFR (Epidermal Growth Factor Receptor) Mutated Non-small Cell Lung Cancer Patients in Spain|Completed||N/A|187|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 01:58:28.886917|2017-10-11 01:58:28.886917
NCT01795339|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-04-02|||March 2013||2013-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Part, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Plasma and Cerebrospinal Fluid in Healthy Male and Non-Fertile Female Elderly Volunteers and in Mild-to-Moderate Alzheimer Disease Patients|Completed||Phase 1|47|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 01:58:28.972246|2017-10-11 01:58:28.972246
NCT01795326|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-01-27|||June 2013||2013-06-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Physician Survey on Monitoring of Patients Treated With Quetiapine|Assessment of Physician Behavior Regarding Metabolic Monitoring of Patients Treated With SEROQUEL® (Quetiapine Fumarate) Tablets and SEROQUEL® (Quetiapine Fumarate) Extended Release Tablets in Selected Countries in the EU|Completed||N/A|800|Actual|AstraZeneca|||8||f||||f||||||||||2017-10-11 01:58:29.0589|2017-10-11 01:58:29.0589
NCT01795313|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-03-29|||August 2012||2012-08-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|February 2019|Anticipated|2019-02-01||Interventional|||Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod|Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod|Recruiting||N/A|24|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 01:58:29.151793|2017-10-11 01:58:29.151793
NCT01795300|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-02-18|||March 2013||2013-03-01|February 2013|2013-02-01|February 2016|Anticipated|2016-02-01|February 2015|Anticipated|2015-02-01||Interventional|PINOCCHIO||Randomized Comparison of Proton and Carbon Ion Radiotherapy With Advanced Photon Radiotherapy in Skull Base Meningiomas: The PINOCCHIO Trial.|Randomized Comparison of Proton and Carbon Ion Radiotherapy With Advanced Photon Radiotherapy in Skull Base Meningiomas: The PINOCCHIO Trial.|Unknown status|Not yet recruiting|Phase 1/Phase 2|80|Anticipated|University Hospital Heidelberg||4|||f||||t||||||||||2017-10-11 01:58:29.245088|2017-10-11 01:58:29.245088
NCT01795287|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-12-29|||March 2012||2012-03-01|December 2014|2014-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety of Spinal Anesthesia in Patients With Tibial Shaft Fracture|Safety of Spinal Anesthesia in Patients With Tibial Shaft Fracture: A Single-center Randomized, Controlled Trial.|Unknown status|Recruiting|N/A|50|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-11 01:58:29.376431|2017-10-11 01:58:29.376431
NCT01795274|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-02-19|||April 2013||2013-04-01|February 2013|2013-02-01|April 2015|Anticipated|2015-04-01|January 2015|Anticipated|2015-01-01||Interventional|PHOENIX-01||Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial|Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial|Unknown status|Not yet recruiting|Phase 1|33|Anticipated|University Hospital Heidelberg||1|||f||||t||||||||||2017-10-11 01:58:29.481227|2017-10-11 01:58:29.481227
NCT01795261|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2015-11-30|||September 2012||2012-09-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|HBI||Healthy Beginning Initiative|Comparative Effectiveness of Congregation and Clinic Based Approaches to Prevention of Mother to Child Transmission of HIV|Active, not recruiting||N/A|5400|Anticipated|University of Nevada, Reno|||2||f||||t||||||||||2017-10-11 01:58:29.55323|2017-10-11 01:58:29.55323
NCT01795248|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-09-14|||July 2012||2012-07-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes|The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Gestational Diabetes Mellitus|Active, not recruiting||Phase 4|105|Actual|University Hospital, Gentofte, Copenhagen||3|||f||||f||||||||||2017-10-11 01:58:29.629915|2017-10-11 01:58:29.629915
NCT01795235|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-02-19|||December 2012||2012-12-01|February 2013|2013-02-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones|Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones|Unknown status|Recruiting|N/A|6|Anticipated|University of Virginia||4|||f||||f||||||||||2017-10-11 01:58:29.747978|2017-10-11 01:58:29.747978
NCT01795222|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-12-02|||March 2012||2012-03-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|Pedsed-I||Midazolam Efficacy for Sedating Preschoolers Undergoing Dental Treatment|A Randomised Controlled Trial of Pediatric Sedation for Dental Treatment Using Oral Midazolam or Placebo|Completed||Phase 4|18|Actual|Universidade Federal de Goias||2|||f||||t||||||||||2017-10-11 01:58:29.850326|2017-10-11 01:58:29.850326
NCT01795209|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-11-17|||January 2013||2013-01-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|RVOFV||Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision|Phase 4 Study of Ranibizumab for the Treatment of Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Initial Fair Visual Acuity|Active, not recruiting||Phase 4|19|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 01:58:29.93917|2017-10-11 01:58:29.93917
NCT01795196|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2014-12-23|||May 2011||2011-05-01|December 2014|2014-12-01||||June 2016|Anticipated|2016-06-01||Observational|IPI||Integrated Pulmonary Index (IPI) as a Determinate of Weaning Success and/or Failure in the Pediatric Population|The Use of Integrated Pulmonary Index (IPI) as a Determinate of Weaning Success and/or Failure in the Pediatric Population|Unknown status|Recruiting|N/A|100|Anticipated|Rush University Medical Center|||1||f||||f||||||||||2017-10-11 01:58:30.058123|2017-10-11 01:58:30.058123
NCT01795183|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2015-01-21|||November 2012||2012-11-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ESCAPE||Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia|The Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia - A Prospective Open-Label Multicenter Study|Completed||Phase 4|316|Actual|Sanofi||1|||f||||t||||||||||2017-10-11 01:58:30.135528|2017-10-11 01:58:30.135528
NCT01795170|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2014-09-26|||April 2013||2013-04-01|September 2014|2014-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|NOEL||Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients|Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine|Withdrawn||N/A|0|Actual|University of British Columbia|||2|The study couldn't be initiated as we did not secure funding.|f||||f||||||||||2017-10-11 01:58:30.208598|2017-10-11 01:58:30.208598
NCT01795157|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2017-09-20|||September 2009|Actual|2009-09-01|September 2017|2017-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|COMBAT||Computer Based Assessment and Treatment|Computer Based Assessment and Treatment|Completed||N/A|255|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 01:58:32.105913|2017-10-11 01:58:32.105913
NCT01795144|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-04-06|||January 2014||2014-01-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Incretin Regulation of Insulin Secretion in Monogenic Diabetes|Incretin Regulation of Insulin Secretion in Monogenic Diabetes|Completed||Phase 1|10|Actual|University of Chicago||2|||f||||f||||||||No|We do not plan to share data with other researchers.|2017-10-11 01:58:32.190727|2017-10-11 01:58:32.190727
NCT01795131|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2014-04-02|||February 2010||2010-02-01|July 2009|2009-07-01|December 2013|Actual|2013-12-01|June 2012|Actual|2012-06-01||Interventional|||Vitamin B12 Supplementation During Pregnancy|Role of Vitamin B12 Supplementation During Pregnancy and Postpartum to Reduce Nutritional Anemia and Improve Immunity in Bangladeshi Women and Their Infants|Completed||Phase 2/Phase 3|120|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-11 01:58:32.293949|2017-10-11 01:58:32.293949
NCT01795118|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2013-02-17|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:58:32.394133|2017-10-11 01:58:32.394133
NCT01795105|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-17|||June 2012||2012-06-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Observational|||ABF Tourette's Disorder PMS|"Post-Marketing Surveillance of Safety and Efficacy of Abilify® Tablets in Korean Patients With Tourette's Disorder Under the New Drug Re-Examination"|Unknown status|Recruiting|N/A|600|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.|||1||f||||t||||||||||2017-10-11 01:58:32.439396|2017-10-11 01:58:32.439396
NCT01795092|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-18|2013-02-19|||February 2012||2012-02-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study Assessing the Impact of Dermatology Consultation in Patients Presenting With Possible Cellulitis|A Randomized-controlled Study to Assess the Impact of Dermatology Consultations on Reducing Admissions for Patients Presenting to Internal Medicine Clinics for Possible Cellulitis|Completed||N/A|29|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 01:58:32.518899|2017-10-11 01:58:32.518899
NCT01795079|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-03-17|||January 2013||2013-01-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury|Boston-Harvard Burn Injury Model System: Cortical Modulation With Transcranial Direct Current Stimulation (tDCS) for Neuropathic Symptoms Following Burn Injury|Recruiting||N/A|60|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||t||||||||||2017-10-11 01:58:32.600326|2017-10-11 01:58:32.600326
NCT01795066|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2014-05-26|||March 2013||2013-03-01|May 2014|2014-05-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Endoscopic Ultrasound-guided Fine Needle Biopsy With 25-gauge Biopsy Needles for Solid Pancreatic Masses||Unknown status|Recruiting|N/A|59|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 01:58:32.691989|2017-10-11 01:58:32.691989
NCT01795053|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-03-14|||February 2012||2012-02-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Effects of Playtraining in ADHD Preschoolers on ADHD Symptoms and Play Persistence and Intensity|Randomized Controlled Trial to Evalualte Effects of Playtraining as Manualized in THOP, a Modulized German ADHD Manual, in 3 to 6 Year Old Children With a Diagnosis of ADHD on ADHD Symptoms and Play Persistence and Intensity|Recruiting||N/A|60|Anticipated|University of Cologne||2|||f||||t||||||||||2017-10-11 01:58:32.771064|2017-10-11 01:58:32.771064
NCT01795040|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2017-03-14|||September 2010||2010-09-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy of Omega-3/Omega-6 Fatty Acids in Pre-school Children at Risk for ADHD|Efficacy of a Supplementary Balanced Diet With Omega-3/ Omega-6 Fatty Acids Among 3-6 Year Olds With Symptoms of ADHD|Recruiting||N/A|40|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-11 01:58:32.849798|2017-10-11 01:58:32.849798
NCT01795027|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-10-23|||September 2011||2011-09-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|November 2016|Anticipated|2016-11-01||Interventional|CAPITAL||Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer|A Prospective,Multicentral,Open-label,Randomized,Controlled,Phase III Clinical Trial to Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer|Active, not recruiting||Phase 3|724|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 01:58:33.071978|2017-10-11 01:58:33.071978
NCT01795001|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-05-30|||October 2012||2012-10-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy|The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy|Recruiting||N/A|330|Anticipated|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||Samples With DNA|"     Non-interventional study on corneal endothelium, anterior eye chamber fluid and     paraffin-embedded corneal tissue, using molecular techniques to identify and characterise the     molecular players involved in the pathogenesis of FECD.   "|Yes|We will make the microarray and RT-qPCR data publically available through NCBI's Gene Expression Omnibus (GEO), upon publication of our findings.|2017-10-11 01:58:33.311162|2017-10-11 01:58:33.311162
NCT01794988|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-19|||July 2010||2010-07-01|February 2013|2013-02-01||||June 2015|Anticipated|2015-06-01||Interventional|||Can Therapy Alter CNS Processing of Chronic Pain: A Longitudinal Study|Can Therapy Alter CNS Processing of Chronic Pain: A Longitudinal Study|Unknown status|Recruiting|N/A|120|Anticipated|University of Vermont||4|||f||||f||||||||||2017-10-11 01:58:33.417808|2017-10-11 01:58:33.417808
NCT01794975|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-15|||August 2012||2012-08-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|AIMI2||Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline|Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline - a PET Study in Healthy Human Subjects|Completed||Phase 1|8|Actual|University of Turku||3|||f||||t||||||||||2017-10-11 01:58:33.514423|2017-10-11 01:58:33.514423
NCT01794962|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2013-02-16|||October 2012||2012-10-01|February 2013|2013-02-01|October 2014|Anticipated|2014-10-01|October 2013|Anticipated|2013-10-01||Interventional|||"Cognitive Functional Therapy vs. Manual Therapy for Non-specific Low Back Pain"|"Classification Based Cognitive Functional Therapy vs. Manual Therapy for a Subgroup of Patients With Chronic NSLBP, Classified as Having a Flexion Pattern"|Unknown status|Recruiting|N/A|30|Anticipated|Spine Centre of Southern Denmark||2|||f||||f||||||||||2017-10-11 01:58:33.613151|2017-10-11 01:58:33.613151
NCT01794949|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-04-06|2017-04-06||September 2013|Actual|2013-09-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|OFDI-DM|Individuals who consented to participate in the study and met all eligibility criteria.|Optical Frequency Domain Imaging (OFDI) and Vascular Healing After Stent Placement|Optical Frequency Domain Imaging (OFDI) Determined Stent Strut Coverage and Plaque Morphology After RESOLUTE Stent Placement in Non-Insulin Dependent Diabetics Presenting With Acute Coronary Syndrome (ACS)|Completed||N/A|8|Actual|Emory University|Due to low enrollment there were not enough participants to provide 80% power for the comparison between the study arms, therefore, statistical analyses were not performed.|2|||f||||t|f|t|f|f||||Undecided||2017-10-11 01:58:33.712863|2017-10-11 01:58:33.712863
NCT01794936|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2016-10-12|2016-03-23||August 2011||2011-08-01|October 2016|2016-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery|VTI Doppler Probe For Robotic Surgery|Terminated||N/A|9|Actual|Columbia University||2||PI left the institution|f||||t||||||||No||2017-10-11 01:58:34.033121|2017-10-11 01:58:34.033121
NCT01794923|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-04-11|||May 2013||2013-05-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Topical Ibuprofen for Delayed Onset Mulscle Soreness|Placebo-controlled, Double-blind Evaluation of the Efficacy and Safety of Ibuprofen 5% Topical Gel for the Treatment of Delayed-onset Muscle Soreness of the Elbow Flexor Muscles|Completed||Phase 3|205|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 01:58:34.216977|2017-10-11 01:58:34.216977
NCT01794910|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-02-19|||February 2010||2010-02-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|PFMT||A Randomized Controlled Trial Comparing the Effect of Pelvic Floor Muscle Training|A Randomized Controlled Trial Comparing the Effect of Pelvic Floor Muscle Training on Improving Muscle Strength of Women After Vaginal or Cesarean Delivery|Completed||N/A|297|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 01:58:34.313424|2017-10-11 01:58:34.313424
NCT01794897|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-10-25|||February 2013||2013-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia|Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia|Completed||Phase 4|134|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 01:58:34.398739|2017-10-11 01:58:34.398739
NCT01794884|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2014-05-27|||January 2013||2013-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery|Intravenous Supplementation of Glutamine Preoperatively for Cardiac Function and Recovery Improvement in Adult Accepting Cardiosurgery: A Randomized, Double-Blinded, Placebo-Controlled Trial|Completed||Phase 2|33|Actual|Southeast University, China||2|||f||||f||||||||||2017-10-11 01:58:34.501434|2017-10-11 01:58:34.501434
NCT01794871|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2013-02-20|||May 2012||2012-05-01|February 2013|2013-02-01|August 2013|Anticipated|2013-08-01|March 2013|Anticipated|2013-03-01||Observational|||The Histological Analysis in Renal Transplantation Patients With Deterioration of Graft Function||Unknown status|Recruiting|N/A|100|Anticipated|Shanghai Zhongshan Hospital|||1||f||||f||||||Samples Without DNA|"     graft biopsy after kidney transplantation   "|||2017-10-11 01:58:34.5894|2017-10-11 01:58:34.5894
NCT01794858|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-03-10|||June 2012||2012-06-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Therapeutic Hypothermia for Severe Acute Pancreatitis|"Therapeutic Hypothermia for Severe Acute Pancreatitis: A Clinical Model for Suspended Inflammation"|Withdrawn||Phase 2|0|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 01:58:34.657141|2017-10-11 01:58:34.657141
NCT01794845|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-03-31|2017-02-08||June 3, 2013|Actual|2013-06-03|March 2017|2017-03-01|June 7, 2016|Actual|2016-06-07|June 7, 2016|Actual|2016-06-07||Interventional|||Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma|Phase II Trial Using Erbitux+ Taxotere With Low Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma|Terminated||Phase 2|5|Actual|University of Miami|Data analyzed for 4 out of 5 study participants due to 1 study participant withdrawing prior to receiving study therapy.|1||Early termination due to lack of efficacy (overall response)|f||||t||||||||No||2017-10-11 01:58:34.733911|2017-10-11 01:58:34.733911
NCT01794091|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-15|||August 2013||2013-08-01|February 2013|2013-02-01||||August 2017|Anticipated|2017-08-01||Interventional|||Detection of Diffuse Scar in Patients With Diabetes|Comprehensive Stress-Perfusion Cardiac MRI Assessment of Diabetic Cardiomyopathy: Prognostic Role of the Fibrotic Index|Unknown status|Not yet recruiting|Phase 1|50|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 01:58:43.55083|2017-10-11 01:58:43.55083
NCT01794832|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2014-04-02|||February 2010||2010-02-01|April 2014|2014-04-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01|1 Year|Observational [Patient Registry]|SAS||Severe Aortic Stenosis in Patients Referred for Valve Surgery|A Prospective Longitudinal Study of Severe Aortic Stenosis in Elderly and Outcome of Aortic Surgery.|Unknown status|Recruiting|N/A|500|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Serum, myocardial biopsi   "|||2017-10-11 01:58:35.300547|2017-10-11 01:58:35.300547
NCT01794819|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-16|2013-02-16|||January 2010||2010-01-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Usefulness of C-reactive Protein Testing in Acute Cough|The Usefulness of Point-of-care-testing for C-reactive Protein in Lower Respiratory Tract Infection or Acute Cough|Completed||N/A|179|Actual|Northern State Medical University||1|||f||||f||||||||||2017-10-11 01:58:35.475011|2017-10-11 01:58:35.475011
NCT01794806|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-07-08|2017-03-01||March 2013||2013-03-01|July 2017|2017-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy of Socket Grafting for Alveolar Ridge Preservation|Efficacy of Socket Grafting for Alveolar Ridge Preservation: A Randomized Controlled Trial|Completed||N/A|59|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 01:58:35.616135|2017-10-11 01:58:35.616135
NCT01794793|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-12-30|||December 2012||2012-12-01|December 2016|2016-12-01|July 2024|Anticipated|2024-07-01|July 2024|Anticipated|2024-07-01||Interventional|||Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.|An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment|Recruiting||Phase 4|400|Anticipated|Novartis||1|||f||||f||||||||||2017-10-11 01:58:36.014349|2017-10-11 01:58:36.014349
NCT01794767|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-10-28|||January 2013||2013-01-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|August 2014|Actual|2014-08-01||Interventional|||Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children|Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children|Suspended||Phase 4|52|Anticipated|University of Florence||2||difficult recruiting|f||||f||||||||||2017-10-11 01:58:36.492935|2017-10-11 01:58:36.492935
NCT01794754|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-08-04|||April 2013|Actual|2013-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|June 2017|Actual|2017-06-01||Interventional|||Occupational Therapy and Surgery in Carpometacarpal Osteoarthritis|May Occupational Therapy Delay the Need for Surgery in Carpometacarpal Osteoarthritis: A Randomised Controlled Trial.|Active, not recruiting||N/A|180|Actual|National Resource Center for Rehabilitation in Rheumatology||2|||f||||f|f|f||||||||2017-10-11 01:58:36.626076|2017-10-11 01:58:36.626076
NCT01794741|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2015-03-22|2015-03-22||February 2013||2013-02-01|March 2015|2015-03-01||||November 2013|Actual|2013-11-01||Interventional|||3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis|Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis|Completed||Phase 3|405|Actual|Meda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 01:58:36.774743|2017-10-11 01:58:36.774743
NCT01794728|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-11-02|||July 2012||2012-07-01|November 2015|2015-11-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|HELP-HF||How the Elderly Live With Pain in Heart Failure|How the Elderly Live With Pain in Heart Failure|Completed||N/A|56|Actual|Thomas Jefferson University|||1||f||||f||||||||||2017-10-11 01:58:37.203975|2017-10-11 01:58:37.203975
NCT01794715|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2014-01-13|||February 2013||2013-02-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Ultrasound by Nurses in Heart Failure Patients|Is Routine Ultrasound Examination Performed by Nurses Useful in Heart Failure Patients at a Outpatient Clinic|Completed||N/A|62|Actual|Levanger Hospital||2|||f||||t||||||||||2017-10-11 01:58:37.301919|2017-10-11 01:58:37.301919
NCT01794702|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-05-19|||February 20, 2013|Actual|2013-02-20|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia|Phase I/II Study of Decitabine (DAC) Followed by Clofarabine, Idarubicin, and Cytarabine (CIA) in Acute Leukemia|Active, not recruiting||Phase 1/Phase 2|66|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 01:58:37.403308|2017-10-11 01:58:37.403308
NCT01794689|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-03-10|||May 2013||2013-05-01|March 2014|2014-03-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|ESP2||Mechanisms of Sleep Disruption Hyperalgesia|Mechanisms of Sleep Disruption Hyperalgesia|Recruiting||N/A|80|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:58:37.546162|2017-10-11 01:58:37.546162
NCT01794676|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-06-15|||March 2013||2013-03-01|June 2017|2017-06-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Observational|MEN1||Genetic Evaluation of Families With Endocrine Cancers|A Pilot Study of Genetic Evaluation of Families With Endocrine Cancers|Completed||N/A|9|Actual|Jersey Shore University Medical Center|||3||f||||t||||||Samples With DNA|"     Approximately 10 ml of blood will be drawn from each participant. Tumor samples will be     obtained from any prior surgeries, if available.   "|No||2017-10-11 01:58:37.678934|2017-10-11 01:58:37.678934
NCT01794663|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-02-15||2017-02-10|October 2012||2012-10-01|February 2017|2017-02-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function|A Three-Part, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Sequential Adaptive, Phase II Study to Evaluate the Safety, Tolerability and Efficacy of OPN-305, a Humanised Monoclonal Antibody That Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function|Completed||Phase 2|252|Actual|Opsona Therapeutics Ltd.||2|||f||||t||||||||||2017-10-11 01:58:37.799568|2017-10-11 01:58:37.799568
NCT01794650|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-11-14|||March 2013||2013-03-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Guidelines for Post-exercise Dietary Intake in T1DM|The Metabolic and Glycaemic Responses to Changes in the Glycaemic Index of the Meal Consumed After Performing Evening Exercise in Type 1 Diabetes Mellitus|Completed||N/A|10|Actual|Northumbria University||1|||f||||t||||||||||2017-10-11 01:58:38.312028|2017-10-11 01:58:38.312028
NCT01794637|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-10-01|||February 2013||2013-02-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|1 Day|Observational [Patient Registry]|||Study of Peripheral Tissue Oxygenation in End-stage Liver Disease Patients During Liver Transplantation|Study of Peripheral Microcirculatory Dysfunction in End-stage Liver Disease Patients During Liver Transplantation Using Near Infrared Spectroscopy|Withdrawn||N/A|0|Actual|Lawson Health Research Institute|||1|"Disposables required for the measurements in short supply and not provided by the company /   supplier"|f||||t||||||||||2017-10-11 01:58:38.463699|2017-10-11 01:58:38.463699
NCT01794624|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-08-08|||April 2013||2013-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|TMD||Biobehavioral Pain Management in TMD|Biobehavioral Pain Management in TMD|Recruiting||N/A|300|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 01:58:38.602496|2017-10-11 01:58:38.602496
NCT01794611|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-04-01|||February 2013||2013-02-01|February 2013|2013-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Different Types Of Laryngoscopes During Routine Intubation in Adult Patients|Comparison Of C-MAC Videolaryngoscopy, Kingsvision Videolaryngoscopy and Macintosh Laryngoscopy During Routine Intubation in Adult Patients|Completed||N/A|200|Actual|Istanbul University||1|||f||||t||||||||||2017-10-11 01:58:38.77081|2017-10-11 01:58:38.77081
NCT01794598|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-09-19|||May 2004||2004-05-01|February 2013|2013-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Preliminary Study Examining Heart Failure Patients Responses to Depression Education|HF-ACTION Depression Education Substudy|Terminated||N/A|270|Actual|Duke University||2||Terminated|f||||f||||||||||2017-10-11 01:58:38.867921|2017-10-11 01:58:38.867921
NCT01794585|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-01-30|||April 2013||2013-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Virtual Reality (VR) Treatment for Balance Problems in Traumatic Brain Injury (TBI)|Home-Based Virtual Reality (VR) Treatment for Chronic Balance Problems in Adults With Traumatic Brain Injury|Recruiting||N/A|66|Anticipated|Craig Hospital||2|||f||||f||||||||||2017-10-11 01:58:38.977192|2017-10-11 01:58:38.977192
NCT01794572|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-08-30|||January 2013||2013-01-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|April 2017|Anticipated|2017-04-01||Interventional|TOMMY||Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse|Phase 1-2 Study of the Combination of Escalated Total Bone Marrow Irradiation (TBMI) by Helicoidal Tomotherapy and a Fixed High-dose Melphalan (140 mg/m²) Followed by Peripheral Stem Cell Rescue (PSC) in First Relapsed Multiple Myeloma.|Recruiting||Phase 1/Phase 2|44|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||t||||||||No||2017-10-11 01:58:39.095804|2017-10-11 01:58:39.095804
NCT01794559|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-03-10|||March 2013||2013-03-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|||Study to Evaluate the Safety and Efficacy of PEER Interactive Versus Treatment as Usual in Subjects With a Primary Diagnosis of Depression|A Prospective, Double Blind, Randomized, Multicenter Study to Evaluate the Utility, Safety, and Efficacy of Using PEER Interactive to Inform the Prescription of Medications to Patients With a Primary Diagnosis of a Depressive Disorder Versus Treatment as Usual.|Unknown status|Recruiting|Phase 2/Phase 3|1922|Anticipated|CNS Response||2|||f||||t||||||||||2017-10-11 01:58:39.310092|2017-10-11 01:58:39.310092
NCT01794546|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2015-07-27|||February 2013||2013-02-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Integrated Care for Pediatric Obesity Using Telehealth|Integrated Care for Pediatric Obesity Using Telehealth|Completed||N/A|40|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 01:58:39.488573|2017-10-11 01:58:39.488573
NCT01794533|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-02-16|||October 2012||2012-10-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Fentanyl on the Rate of Anesthesia|Analgesic Efficacy of a Combination of Fentanyl and Lidocaine for Maxillary Infiltration in Teeth With Irreversible Pulpitis|Completed||Phase 2|64|Actual|Islamic Azad University, Tehran||2|||f||||t||||||||||2017-10-11 01:58:39.640436|2017-10-11 01:58:39.640436
NCT01794520|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-08-24|||October 18, 2012||2012-10-18|August 2017|2017-08-01|December 26, 2018|Anticipated|2018-12-26|December 26, 2018|Anticipated|2018-12-26||Interventional|||Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma|A Phase I Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 1|84|Anticipated|AbbVie||3|||f||||f||||||||||2017-10-11 01:58:39.784556|2017-10-11 01:58:39.784556
NCT01794507|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-07-17|||November 26, 2012||2012-11-26|July 2017|2017-07-01|May 15, 2018|Anticipated|2018-05-15|May 15, 2018|Anticipated|2018-05-15||Interventional|||A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy|A Phase 1b Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Relapsed or Refractory Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Their Standard Therapy|Active, not recruiting||Phase 1|66|Anticipated|AbbVie||2|||f||||f||||||||||2017-10-11 01:58:39.917471|2017-10-11 01:58:39.917471
NCT01794494|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2015-05-18|||November 2011||2011-11-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01|2 Years|Observational [Patient Registry]|PROVENCE||Prospective Observation Study of Cost Effectiveness of Interventions for Critical Ischemia|Prospective Observation Study of Cost Effectiveness of Interventions for Critical Ischemia|Unknown status|Active, not recruiting|N/A|250|Anticipated|Sahlgrenska University Hospital, Sweden|||2||f||||f||||||||||2017-10-11 01:58:40.100518|2017-10-11 01:58:40.100518
NCT01794481|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-05-18|||January 2010||2010-01-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy|Benefits of Resistance Exercise Training in Locally Advanced Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy|Completed||N/A|24|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 01:58:40.216147|2017-10-11 01:58:40.216147
NCT01794468|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-15|||June 2003||2003-06-01|February 2013|2013-02-01|July 2005|Actual|2005-07-01|April 2005|Actual|2005-04-01||Interventional|MDBF-CIP||A New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study|A New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study|Completed||N/A|11|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 01:58:40.316742|2017-10-11 01:58:40.316742
NCT01794455|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-08-26|2016-07-18||May 2013||2013-05-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression|Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression|Terminated||Phase 4|1|Actual|Vanderbilt University|Study was ended early due to difficulty with subject recruitment. MRI data could not be obtained on that one individual due to MRI contraindications.|2||Enrollment difficulties|f||||f||||||||||2017-10-11 01:58:40.410301|2017-10-11 01:58:40.410301
NCT01794442|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-05-28|||January 2013||2013-01-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins|Correlation Between Retinal Metabolism and the Observation of a Visible Retinal Spontaneous Venous Pulse|Unknown status|Recruiting|N/A|120|Anticipated|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||||||2017-10-11 01:58:40.711316|2017-10-11 01:58:40.711316
NCT01794429|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-06-23|||February 2013||2013-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|TAO||Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue|Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue|Completed||Phase 3|45|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 01:58:40.798963|2017-10-11 01:58:40.798963
NCT01794416|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-03-24|||May 2011||2011-05-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Thoracoscopic Versus Endocardial Ablation in Patient With Paroxysmal AF After Failed Initial Endocardial Ablation|Thoracoscopic Ablation Versus Endocardial Ablation in Patient With Paroxysmal Atrial Fibrillation After Failed Initial Endocardial Ablation|Completed||Phase 2|50|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 01:58:40.894442|2017-10-11 01:58:40.894442
NCT01794403|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-08-31|||April 4, 2013|Actual|2013-04-04|August 2017|2017-08-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|HEAT||Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer|A Randomized Study of Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer|Recruiting||N/A|456|Anticipated|University of Miami||2|||f||||t|f|t|f|||||||2017-10-11 01:58:41.000394|2017-10-11 01:58:41.000394
NCT01794390|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-10-25|||September 2013||2013-09-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01|1 Month|Observational [Patient Registry]|HI-TEC||Handling Inhalers - Technique Error Comparison (HI-TEC)|Critical Errors in Pulmojet and Other Devices|Completed||N/A|431|Actual|Research in Real-Life Ltd|||2||f||||f||||||||||2017-10-11 01:58:41.151963|2017-10-11 01:58:41.151963
NCT01794377|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-07-24|||February 2013||2013-02-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|OBELIX||Influence of Muscle Strength on the Energy Cost of Walking in Obese Subjects|Influence of Muscle Strength on the Energy Cost of Walking in Obese Subjects|Completed||N/A|59|Actual|Centre Hospitalier Universitaire de la Réunion||2|||f||||f||||||||||2017-10-11 01:58:41.242311|2017-10-11 01:58:41.242311
NCT01794364|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-04-01|||January 2013||2013-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects|A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo-Controlled, Single Dose Escalating Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-06291874 After Administration Under Fasted And Fed Conditions In Healthy Adult Subjects|Completed||Phase 1|8|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:58:41.320913|2017-10-11 01:58:41.320913
NCT01794351|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-15|||October 2012||2012-10-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Cognitive Effects of 500mg Trans-resveratrol|Effects of Trans-resveratrol on Cognitive Performance in Healthy, Young Humans: a Double-blind, Placebo-controlled, Crossover Investigation.|Completed||N/A|50|Actual|Northumbria University||2|||f||||f||||||||||2017-10-11 01:58:41.399853|2017-10-11 01:58:41.399853
NCT01794338|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-02-12|||November 2012||2012-11-01|February 2016|2016-02-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients|A Randomized, Prospective, Double Blind Clinical Trial of Non-cross-linked Porcine Dermis vs. Bioabsorbable Synthetic Mesh for the Repair of Abdominal Wall Defects in At-risk Patients|Recruiting||N/A|96|Anticipated|Carolinas Healthcare System||2|||f||||t||||||||||2017-10-11 01:58:41.497311|2017-10-11 01:58:41.497311
NCT01794325|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-09-16|||February 2013||2013-02-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|EXPERT||Transradial and Transfemoral Coronary Angiography by EXPERienced operaTors|Transradial and Transfemoral Approach by EXPERienced Operators in Daily rouTine (EXPERT): a Randomized, Non-inferiority Trial|Completed||N/A|300|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 01:58:41.590581|2017-10-11 01:58:41.590581
NCT01794312|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-11-09|||January 2013||2013-01-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer|Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer|Recruiting||Phase 3|124|Anticipated|Laboratoires Thea||2|||f||||t||||||||||2017-10-11 01:58:41.672471|2017-10-11 01:58:41.672471
NCT01794299|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-08-16||2017-08-16|March 2013||2013-03-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|June 2016|Actual|2016-06-01||Interventional|||Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor|An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of ATIR, Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy, Who Received a CD34-selected Hematopoietic Stem Cell Transplantation From a Haploidentical Donor|Active, not recruiting||Phase 2|31|Actual|Kiadis Pharma||1|||f||||t||||||||||2017-10-11 01:58:41.75201|2017-10-11 01:58:41.75201
NCT01794286|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-02-15|||January 2010||2010-01-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ImmProve||Improving Childhood Immunization|Improving Childhood Immunization Compliance Using Electronic Health Records|Completed||N/A|107|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:58:41.848819|2017-10-11 01:58:41.848819
NCT01794273|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2013-02-15|||July 2012||2012-07-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|VP-hTA-XCar||Compared Efficacy and Tolerance of Two Vasopressors Used to Treat Preoperative Hypotension During Carotid Surgery|Compared Efficacy and Tolerance of Two Vasopressors Used to Treat Preoperative Hypotension During Carotid Surgery. Prospective Randomised Controlled and Single Centre Trial|Unknown status|Recruiting|Phase 4|120|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 01:58:41.923381|2017-10-11 01:58:41.923381
NCT01794260|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-02-14|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy and Safety of Topical Essential Oil Extracted From Zingiber Cassumunar Rokb in Osteoarthritis|Efficacy and Safety of Topical Preparation of Essential Oil Extracted From Zingiber Cassumunar Rokb in Patients With Osteoarthritis|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-11 01:58:42.208462|2017-10-11 01:58:42.208462
NCT01794247|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2014-03-07|||April 2013||2013-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|MAGLIDIT||Intrathecal Magnesium for Same-day-surgery|Intrathecal Magnesium Associated to Lidocaine Decreases the Incidence of the Transitory Neurologic Syndrome Following Same-day-surgery|Terminated||Phase 3|21|Actual|Hospital General de Ciudad Real||2||low recruitment rate|f||||t||||||||||2017-10-11 01:58:42.306563|2017-10-11 01:58:42.306563
NCT01794234|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2016-11-01|||August 2012||2012-08-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues|Efficacy and Safety of Peginterferon Alfa-2a (40 KD) in Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment With Nucleoside (Nucleotide) Analogues - an Observational Study in Real-life Clinical Practice|Terminated||N/A|44|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:58:42.41398|2017-10-11 01:58:42.41398
NCT01794221|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-01-06|||November 2012||2012-11-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Circglue||The Role of 2-octyl Cyanoacrylate in Prevention of Recurrent Adhesions After Circumcision|The Role of 2-octyl Cyanoacrylate in Prevention of Recurrent Adhesions After Circumcision|Active, not recruiting||N/A|422|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||No||2017-10-11 01:58:42.515657|2017-10-11 01:58:42.515657
NCT01794208|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2014-06-23|||January 2013||2013-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®|A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX™ in Comparison With 150 IU Gonal-f® in Women Undergoing ICSI Treatment|Completed||Phase 2|240|Anticipated|Glycotope GmbH||6|||f||||f||||||||||2017-10-11 01:58:42.604975|2017-10-11 01:58:42.604975
NCT01794195|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2014-06-30|||February 2013||2013-02-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Role of Mesocorticolimbic Pathway in Apathy of Patients With Parkinson's Disease. - Study Using Diffusion Tensor Imaging and Fibres Tracking|Role of Mesocorticolimbic Pathway in Apathy of Patients With Parkinson's Disease. - Study Using Diffusion Tensor Imaging and Fibres Tracking|Completed||N/A|63|Actual|University Hospital, Clermont-Ferrand||3|||f||||||||||||||2017-10-11 01:58:42.702475|2017-10-11 01:58:42.702475
NCT01794182|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-05-31|||May 2013||2013-05-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|August 2015|Anticipated|2015-08-01||Interventional|GAMES-RP||Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals|A Randomized, Multi-center, Prospective, Double Blind, Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema|Unknown status|Active, not recruiting|Phase 2|83|Actual|Remedy Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 01:58:42.783101|2017-10-11 01:58:42.783101
NCT01794169|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-09-19|||March 2013||2013-03-01|September 2015|2015-09-01|March 2018|Anticipated|2018-03-01|September 2015|Actual|2015-09-01||Interventional|||Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML|Azacitidine Compared to Conventional Chemotherapy in Consolidation of Elderly Patients (65 Years or Older) With AML in First Complete Remission|Terminated||Phase 2|130|Anticipated|Karolinska University Hospital||2||Poor recruitment|f||||t||||||||||2017-10-11 01:58:42.907381|2017-10-11 01:58:42.907381
NCT01794156|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-07-20|||September 2012||2012-09-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|May 2017|Actual|2017-05-01||Interventional|||Evaluation of a Cognitive Therapy (Inference-based-therapy) for the Treatment of Obsessional Compulsive Disorder|Evaluation of a Cognitive Therapy (Inference-based-therapy) for the Treatment of Obsessional Compulsive Disorder|Active, not recruiting||N/A|240|Anticipated|Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine||3|||f||||f||||||||||2017-10-11 01:58:42.999703|2017-10-11 01:58:42.999703
NCT01794130|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-02-15|||July 2011||2011-07-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||The Incidence of Subclinical High-altitude Pulmonary Oedema at High Altitude||Completed||N/A|24|Actual|Institute of Mountain Emergency Medicine|||1||f||||t||||||Samples With DNA|"     blood samples   "|||2017-10-11 01:58:43.299863|2017-10-11 01:58:43.299863
NCT01794117|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-08-04|||January 23, 2013||2013-01-23|July 31, 2017|2017-07-31|December 31, 2020|Anticipated|2020-12-31|May 31, 2019|Anticipated|2019-05-31||Interventional|||Anakinra for Inflammatory Pustular Skin Diseases|A Phase 2 Study of Anakinra in Inflammatory Pustular Dermatoses: Evaluation of Therapeutic Efficacy and Validation of Pathogenic Mechanisms|Recruiting||Phase 2|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:58:43.367186|2017-10-11 01:58:43.367186
NCT01794104|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-09-12|||February 7, 2013||2013-02-07|June 27, 2017|2017-06-27|May 19, 2016|Actual|2016-05-19|May 19, 2016|Actual|2016-05-19||Interventional|||Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas|A Phase I Trial of Weekly Indenoisoquinoline LMP400 in Adults With Relapsed Solid Tumors and Lymphomas|Completed||Phase 1|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 01:58:43.464412|2017-10-11 01:58:43.464412
NCT01794078|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2015-11-11|||September 2013||2013-09-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|GQ02||A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude|A Randomized, 4-Sequence, Double-Blind Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude|Completed||Phase 1|92|Actual|Duke University||4|||f||||||||||||||2017-10-11 01:58:43.636048|2017-10-11 01:58:43.636048
NCT01794065|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-08-08|||October 2012||2012-10-01|August 2014|2014-08-01||||January 2015|Anticipated|2015-01-01||Observational|||The Promus Element Rewards Study|The Promus Element Rewards Study|Unknown status|Active, not recruiting|N/A|500|Anticipated|Medstar Health Research Institute|||5||f||||f||||||||||2017-10-11 01:58:43.749206|2017-10-11 01:58:43.749206
NCT01794052|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-08-05|||December 2012||2012-12-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|m-Power Heart||To Develop a High Quality Health Care Delivery Model for the Management of Hypertension and Diabetes at CHCs and District Hospitals of Himachal Pradesh.|m-Power Heart Project|Completed||N/A|6797|Actual|Centre for Chronic Disease Control, India||1|||f||||f||||||||||2017-10-11 01:58:43.816431|2017-10-11 01:58:43.816431
NCT01794039|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-11-17|||March 2014||2014-03-01|January 2016|2016-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide|Randomized Phase 2 Trial of Retreatment With Pomalidomide or Lenalidomide With Dexamethasone for Patients With Relapsed Myeloma|Completed||Phase 2|9|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 01:58:43.910273|2017-10-11 01:58:43.910273
NCT01794026|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-15|2017-02-28|||March 2013||2013-03-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Diffusion Weighted Magnetic Resonance Imaging for Preoperative Staging in Gastric Adenocarcinoma Patients|Use of Diffusion Weighted Magnetic Resonance Imaging to Stage Gastric Adenocarcinoma Patients Preoperatively|Completed||Early Phase 1|30|Actual|Bezmialem Vakif University||1|||f||||f||||||||||2017-10-11 01:58:44.062395|2017-10-11 01:58:44.062395
NCT01794013|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-02-23|||March 2013||2013-03-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|March 2017|Anticipated|2017-03-01||Interventional|RCT/DD||DIR/ Floortime™ Parent Training Intervention for the Children With Developmental Disabilities|A Randomized Controlled Trial of DIR/ Floortime™ Parent Training Intervention for the Children With Developmental Disabilities|Recruiting||N/A|64|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-11 01:58:44.142255|2017-10-11 01:58:44.142255
NCT01794000|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-06-15|2016-06-15||April 2013||2013-04-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional||All randomized participants.|A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)|A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease.|Terminated||Phase 3|341|Actual|Eli Lilly and Company|The study was stopped following Submission Database Lock, the topline information indicated that the primary and secondary efficacy endpoints were not met.|2||The study is being terminated for lack of efficacy.|f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 01:58:44.347696|2017-10-11 01:58:44.347696
NCT01793987|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-02-14|||May 2013||2013-05-01|February 2013|2013-02-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Coblation in Endoscopic Sinus Surgery|The Effect of Coblation on Blood Loss in Endoscopic Sinus Surgery: A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|22|Anticipated|Western University, Canada||2|||f||||f||||||||||2017-10-11 01:58:46.203282|2017-10-11 01:58:46.203282
NCT01793974|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-04-12|||July 2011||2011-07-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|November 2015|Actual|2015-11-01||Observational|LADA||Genetics of Latent Autoimmune Diabetes in Adults|A Study of the Genetic Causes of Latent Autoimmune Diabetes in Adults|Completed||N/A|205|Actual|Children's Hospital of Philadelphia|||2||f||||f||||||Samples With DNA|"     Whole blood, plasma, serum   "|||2017-10-11 01:58:46.292802|2017-10-11 01:58:46.292802
NCT01793961|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-02-15|||February 2013||2013-02-01|February 2013|2013-02-01||||July 2014|Anticipated|2014-07-01||Interventional|||Effects of Chronic Intake of Cannabis on Contrast Sensitivity|Effects of Chronic Intake of Cannabis on Contrast Sensitivity|Unknown status|Not yet recruiting|N/A|108|Anticipated|University Hospital, Strasbourg, France||3|||f||||||||||||||2017-10-11 01:58:46.368885|2017-10-11 01:58:46.368885
NCT01793948|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-07-27|||April 16, 2013|Actual|2013-04-16|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer|A Double Blind Prospective Study of Metformin vs. Placebo in Overweight or Obese Post-menopausal Women at Elevated Risk for Breast Cancer|Active, not recruiting||N/A|24|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 01:58:46.458747|2017-10-11 01:58:46.458747
NCT01793922|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-07-26|||October 2013||2013-10-01|July 2016|2016-07-01|January 2023|Anticipated|2023-01-01|January 2018|Anticipated|2018-01-01||Interventional|||POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)|A Prospective Randomized Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM) as Treatment of Idiopathic Achalasia|Recruiting||N/A|150|Anticipated|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 01:58:46.810228|2017-10-11 01:58:46.810228
NCT01793909|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-08-29|||June 2012||2012-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Type 2 Diabetes and Exercise Function in Single Leg Exercises|Role of Vascular Function: Oxygen Delivery vs Oxygen Utilization in the Exercise Impairment in Type 2 Diabetes|Recruiting||N/A|45|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 01:58:46.926868|2017-10-11 01:58:46.926868
NCT01793896|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-10-24|||July 2013||2013-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Beneficial Effects of Exercise and Healthy Diets on Muscle and Adipose Tissue|Mitochondrial Biogenesis, Reduction of Muscle Oxidative Damage and Improvement in Adipose Tissue Functional Profile, Account for the Beneficial Effects of Exercise and Healthy Diets|Terminated||N/A|115|Anticipated|University of Chile||4||"Serious difficulties for patient recruitment    to recruit patients"|f||||t||||||||||2017-10-11 01:58:47.055739|2017-10-11 01:58:47.055739
NCT01793883|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-08-31|2017-07-31|2015-09-17|May 2013||2013-05-01|August 2017|2017-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Igloo|Intent-to-treat population - all subjects who provided informed consent for this study and who had been randomized to the study drug|Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza|A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Arm Study to Investigate the Efficacy and Safety of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Symptomatic Influenza A or B Infection|Completed||Phase 2|639|Actual|Aviragen Therapeutics||3|||f||||t||||||||||2017-10-11 01:58:47.222105|2017-10-11 01:58:47.222105
NCT01793870|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-06-09|||January 15, 2013|Actual|2013-01-15|June 2017|2017-06-01|June 17, 2013|Actual|2013-06-17|June 17, 2013|Actual|2013-06-17||Interventional|||A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies|A Four Way Crossover Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies|Completed||Phase 1|17|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 01:58:48.374145|2017-10-11 01:58:48.374145
NCT01793857|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-12-03|||March 2013||2013-03-01|September 2015|2015-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama|Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media in Children Aged 6 Months to Less Than 30 Months in Panama|Completed||N/A|1330|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 01:58:48.482672|2017-10-11 01:58:48.482672
NCT01793844|ClinicalTrials.gov processed this data on October 10, 2017|2008-12-24|2015-12-10|||January 2008||2008-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients|A Prospective , Multicenter, Randomized Phase III Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients|Recruiting||N/A|732|Anticipated|Sun Yat-sen University|||3||f||||t||||||||||2017-10-11 01:58:48.627425|2017-10-11 01:58:48.627425
NCT01793831|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2014-11-21|||November 2012||2012-11-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases|Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Crohn&Apos;s Diseases in Ileum and Colon|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|The Second Hospital of Nanjing Medical University||2|||f||||t||||||||||2017-10-11 01:58:48.721231|2017-10-11 01:58:48.721231
NCT01793818|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-02-09|||February 2013||2013-02-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|EVATAT||Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein|Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein|Active, not recruiting||Phase 1/Phase 2|50|Actual|BIOSANTECH||4|||f||||t||||||||Yes|Data base (HIV RNA, CD4, CD8, HIV DNA, Tat immune response) and statistical analysis|2017-10-11 01:58:48.841556|2017-10-11 01:58:48.841556
NCT01793805|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-01-19|||February 2013||2013-02-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01|2 Years|Observational [Patient Registry]|||NSABP Patient Registry and Biospecimen Profiling Repository|NSABP Patient Registry and Biospecimen Profiling Repository|Recruiting||N/A|2000|Anticipated|NSABP Foundation Inc|||1||f||||f||||||Samples With DNA|"     Tissue blocks from the primary tumor site and an uninvolved margin of resection (normal     tissue).   "|||2017-10-11 01:58:48.944901|2017-10-11 01:58:48.944901
NCT01793792|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-01-10|||July 2013||2013-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|LVIS||Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support)|Pivotal Study of the Microvention, Inc Neurovascular Self-Expanding Retrievable Stent System LVIS|Completed||Phase 3|166|Actual|Microvention-Terumo, Inc.||1|||f||||t||||||||||2017-10-11 01:58:49.117821|2017-10-11 01:58:49.117821
NCT01793779|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-07-31|||December 2012||2012-12-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness|Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness in Experienced Resistance Trained Individuals.|Completed||N/A|40|Actual|Metabolic Technologies Inc.||4|||f||||f||||||||||2017-10-11 01:58:49.22721|2017-10-11 01:58:49.22721
NCT01793766|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-10-27|||May 2013||2013-05-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Non-invasive Brain Modulation for Weight Maintenance|Neurobehavioral Contribution to Weight Loss Maintenance: an Interdisciplinary Experimental Study With Noninvasive Brain Modulation|Terminated||Phase 1|13|Actual|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-11 01:58:49.308847|2017-10-11 01:58:49.308847
NCT01793753|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-09-12|||October 2012||2012-10-01|September 2016|2016-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Effect of Propofol on Internal Anal Sphincter Pressure During ARM||Completed||N/A|20|Actual|Massachusetts General Hospital|||1||f||||||||||||||2017-10-11 01:58:49.380154|2017-10-11 01:58:49.380154
NCT01793740|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-08-19|||October 2012||2012-10-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Cognitive Rehabilitation in Sickle Cell Disease|Cognitive Rehabilitation of Children With Sickle Cell Disease: A Pilot Study|Completed||N/A|18|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:58:49.446766|2017-10-11 01:58:49.446766
NCT01793727|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-12-02|||July 2011||2011-07-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Infant Glidescope® Learning Curve|Learning Curve of the Infant Glidescope® Cobalt Video Laryngoscope in Anesthesiology Residents|Completed||N/A|100|Actual|The Hospital for Sick Children||1|||f||||t||||||||||2017-10-11 01:58:49.561262|2017-10-11 01:58:49.561262
NCT01792401|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-13|||January 2012||2012-01-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Probiotics in Enteral Feeding in Critically Ill Patients|Probiotics in Enteral Feeding in Critically Ill Patients|Completed||Phase 2|49|Actual|University of Malaya||2|||f||||f||||||||||2017-10-11 01:59:08.183673|2017-10-11 01:59:08.183673
NCT01793714|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-09-22|||January 21, 2014|Actual|2014-01-21|September 2016|2016-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31|1 Day|Observational [Patient Registry]|MALTA||Presurgical Language Mapping With fMRI: Comparison of BOLD and fASL Techniques|Presurgical Language Mapping With fMRI: Comparison of BOLD and fASL Techniques|Recruiting||N/A|40|Anticipated|Rennes University Hospital|||1||f||||t||||||||||2017-10-11 01:58:49.624477|2017-10-11 01:58:49.624477
NCT01793701|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-08-25|||July 2010||2010-07-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2016|Actual|2016-04-01||Interventional|DEPICT||Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer|A Phase I/II, Multi-centre Dose Escalation Study of Simultaneous Boost Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer|Active, not recruiting||Phase 1/Phase 2|22|Actual|Queen Mary University of London||1|||f||||f||||||||||2017-10-11 01:58:49.727255|2017-10-11 01:58:49.727255
NCT01793688|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-03-15|2016-11-28||March 12, 2013|Actual|2013-03-12|March 2017|2017-03-01|January 27, 2016|Actual|2016-01-27|January 27, 2016|Actual|2016-01-27||Observational||A total 986 subjects were registered in this study. Of the 986 subjects, 982 subjects CRFs were collected and included in the study.Of the 982 participants, 2 participants were excluded from the baseline analysis due to a protocol violation.|Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration ‐|Special Use-result Surveillance Of Unasyn-s (Kit) For Intravenous Use - A Surveillance On High-dose (>6 G Daily) Administration For Pneumonia, Lung Abscess And Peritonitis ‐|Completed||N/A|982|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:58:49.852485|2017-10-11 01:58:49.852485
NCT01793675|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-04-27|||April 2003||2003-04-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Observational|||Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome|Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome|Completed||N/A|116|Actual|Peking University People's Hospital|||1||f||||||||||||||2017-10-11 01:58:50.199268|2017-10-11 01:58:50.199268
NCT01793662|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-04-03|||February 2013||2013-02-01|April 2017|2017-04-01|January 2023|Anticipated|2023-01-01|January 2019|Anticipated|2019-01-01||Interventional|NLAST||Norwegian Laparoscopic Aortic Surgery Trial|Norwegian Laparoscopic Aortic Surgery Trial|Recruiting||N/A|126|Anticipated|Oslo University Hospital||2|||f||||f||||||||Undecided||2017-10-11 01:58:50.287796|2017-10-11 01:58:50.287796
NCT01793649|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-03-19|||October 2012||2012-10-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Cross-Over, Vehicle-Controlled, Single-Dose Study To Characterize The Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) In Healthy Subjects|Terminated||Phase 1|7|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 01:58:50.378645|2017-10-11 01:58:50.378645
NCT01793636|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-06-23|||February 2013||2013-02-01|June 2014|2014-06-01|November 2015|Anticipated|2015-11-01|May 2014|Actual|2014-05-01||Interventional|ZEBRA||A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer|An Open Label, Randomised Phase II Study, Comparing AZD2014 Versus Everolimus With Advanced Metastatic Renal Cancer and Progression on VEGF Targeted Therapy|Terminated||Phase 2|49|Actual|Queen Mary University of London||2||Inferior efficacy of study drug in renal indication.|f||||t||||||||||2017-10-11 01:58:50.469278|2017-10-11 01:58:50.469278
NCT01793623|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-07-21|||February 2012||2012-02-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery and Tissue Banking|Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery and Tissue Banking|Active, not recruiting||N/A|300|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"     (1) myocardial tissue (2) DNA   "|||2017-10-11 01:58:52.361655|2017-10-11 01:58:52.361655
NCT01793610|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-06-07|||April 2013||2013-04-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|February 2017|Actual|2017-02-01||Interventional|||Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD|A Randomized, Double-Blind, Dose Response Phase 2 Pilot Study of Manualized MDMA-Assisted Psychotherapy in Subjects With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)|Completed||Phase 2|27|Actual|Multidisciplinary Association for Psychedelic Studies||3|||f||||f||||||||||2017-10-11 01:58:52.442876|2017-10-11 01:58:52.442876
NCT01793597|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-09-20|||May 2013||2013-05-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Platelet Reactivity After CABG|Platelet Activation, Reactivity, and Inflammation After Coronary Bypass Surgery In Patients Treated With Ticagrelor or Clopidogrel|Completed||N/A|18|Actual|University of Vermont|||2||f||||f||||||Samples Without DNA|"     Platelets and leukocytes will be evaluated acutely. Plasma will be stored for cytokine and     chemokine analysis.   "|||2017-10-11 01:58:52.648582|2017-10-11 01:58:52.648582
NCT01793584|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2016-05-24|||February 2013||2013-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Surgical Success After Laparoscopic vs Abdominal Hysterectomy|Randomized Trial of Laparoscopic Versus Abdominal Hysterectomy for Benign Indications and Impact on Surgical Success|Recruiting||Phase 4|75|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 01:58:52.72985|2017-10-11 01:58:52.72985
NCT01793571|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-02-14|||September 2012||2012-09-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Pilot Study on the Effectiveness of a TAP-block for Inguinal Hernia Repair|A Pilot Study on the Effectiveness of the Echoguided Transversus Abdominis Plane Block During Inguinal Hernia Repair Surgery|Unknown status|Active, not recruiting|N/A|30|Actual|Westfriesgasthuis||2|||f||||f||||||||||2017-10-11 01:58:52.829206|2017-10-11 01:58:52.829206
NCT01793558|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-05-11|||February 2013||2013-02-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|THER5||Incidence and Prevention of Hypothermia in Newborns Bonding During Caesarean Section|Study That Evaluates the Incidence and Possibilities for Prevention of Hypothermia in Newborns Bonding During Caesarean Section|Completed||N/A|40|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-11 01:58:52.931238|2017-10-11 01:58:52.931238
NCT01793545|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-06-30|||February 10, 2013||2013-02-10|October 28, 2016|2016-10-28|December 1, 2017|Anticipated|2017-12-01|November 1, 2017|Anticipated|2017-11-01||Observational|||Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples|Methylation Markers for Natural History and Early Detection of Endometrial Cancer|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:58:53.02986|2017-10-11 01:58:53.02986
NCT01793532|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-06-30|||January 31, 2013||2013-01-31|July 28, 2016|2016-07-28|June 8, 2016|Actual|2016-06-08|June 8, 2016|Actual|2016-06-08||Observational|||Study of [11C]DPA-713 for Temporal Lobe Epilepsy|Assessment of [11C]DPA-713 in Temporal Lobe Epilepsy|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:58:53.108809|2017-10-11 01:58:53.108809
NCT01793519|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-11-04|||January 2013||2013-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|STARA||Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis|Stopping Tumor Necrosis Factor-Alpha Inhibitors in Rheumatoid Arthritis (STARA) Clinical Trial|Recruiting||Phase 4|290|Anticipated|Georgetown University||2|||f||||t||||||||Undecided||2017-10-11 01:58:53.191455|2017-10-11 01:58:53.191455
NCT01793506|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-01-27|||April 2016||2016-04-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|September 2016|Anticipated|2016-09-01||Observational|||Novel Testing Procedures|Novel Testing Procedures for Detection of Primary Humoral Immunodeficiency|Withdrawn||N/A|0|Actual|Medical College of Wisconsin|||1|Never funded or completed|f||||f||||||||||2017-10-11 01:58:53.459083|2017-10-11 01:58:53.459083
NCT01793493|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-08-14|||March 2011||2011-03-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|Allena-Mente||Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia (Allena-Mente).|Effects of Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia: a Randomized Controlled Trial (Allena-Mente).|Completed||Phase 2|121|Actual|Fondazione Golgi Cenci||2|||f||||t||||||||||2017-10-11 01:58:53.537712|2017-10-11 01:58:53.537712
NCT01793480|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-02-15|||December 2011||2011-12-01|February 2013|2013-02-01||||September 2013|Anticipated|2013-09-01||Interventional|EQUIMETH2||Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.|Phase IIIb Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.|Unknown status|Recruiting|Phase 3|146|Anticipated|Laboratoires Bouchara-Recordati||2|||f||||f||||||||||2017-10-11 01:58:53.668225|2017-10-11 01:58:53.668225
NCT01793467|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-08-14|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Transplantation and the Use of Raltegravir in HIV-Infected Patients|Solid Organ Transplantation and the Use of Raltegravir in HIV-Infected Patients: An Observational Study of Pharmacokinetics, Safety, Tolerability and Efficacy|Completed||N/A|17|Actual|Duke University|||1||f||||f||||||||||2017-10-11 01:58:53.78533|2017-10-11 01:58:53.78533
NCT01793454|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-04-08|||February 2013||2013-02-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Hyperoxic Oxidative Stress During Abdominal Surgery|Comparing the Effect of Hyperoxic and Conventional Fraction of Inspired Oxygen on Oxidative Stress During Abdominal Surgery.|Completed||N/A|40|Actual|Istanbul University||2|||f||||t||||||||||2017-10-11 01:58:53.862553|2017-10-11 01:58:53.862553
NCT01793441|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-02-02|||September 2013||2013-09-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)|A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)|Completed||Phase 2|223|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:58:53.954286|2017-10-11 01:58:53.954286
NCT01793428|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-04-02|||August 2011||2011-08-01|April 2015|2015-04-01||||February 2013|Actual|2013-02-01||Observational|||Capillary Lactate and Transfusion Needs|Predictive Abilities for Transfusion Needs of Capillary Lactate Measure in Emergency for Injured Normotensive Patients|Completed||N/A|120|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-11 01:58:54.166041|2017-10-11 01:58:54.166041
NCT01793415|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-02-14|||February 2013||2013-02-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)|Phase 1 + 2a Proof of Concept Study of Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|PharmaLundensis AB||2|||f||||f||||||||||2017-10-11 01:58:54.238444|2017-10-11 01:58:54.238444
NCT01793402|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-04-17|||October 2010||2010-10-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|||Vitamin D Status and the Adequacy of Vitamin D Intake in Early Preterm Infants|Adequacy of Vitamin D Intake and Vitamin D Status in Early Preterm Infants|Completed||N/A|120|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 01:58:54.326713|2017-10-11 01:58:54.326713
NCT01793389|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-08-14|||January 2010||2010-01-01|August 2013|2013-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Platelet Rich Fibrin in the Treatment of Localized Gingival Recessions|Platelet Rich Fibrin in the Treatment of Localized Gingival Recessions: Split-mouth Randomized Clinical Trial|Completed||N/A|22|Actual|Ege University||2|||f||||f||||||||||2017-10-11 01:58:54.391452|2017-10-11 01:58:54.391452
NCT01793376|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-03-11|||February 2013||2013-02-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|February 2016|Anticipated|2016-02-01||Observational|||Development of Niv Score of Capsule Endoscopy in Patients With Crohn's (CECDAIic)|Development of Niv Score of Capsule Endoscopy in Patients With Crohn's (CECDAIic)|Unknown status|Active, not recruiting|N/A|30|Anticipated|Given Imaging Ltd.|||1||f||||f||||||||||2017-10-11 01:58:54.467278|2017-10-11 01:58:54.467278
NCT01793363|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-07-23|||August 2012||2012-08-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|TRAWELUS||Tracheostomy and Weaning From Mechanical Ventilation : Evaluation of the Lung Ultrasound Score|Tracheostomy and Weaning From Mechanical Ventilation : Evaluation of the Lung Ultrasound Score|Completed||N/A|60|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 01:58:54.517424|2017-10-11 01:58:54.517424
NCT01793350|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-02-24|||June 2013||2013-06-01|February 2013|2013-02-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral Neuropathy|A Combined Phase 1 + 2 Clinical Trial Evaluating the Safety and Efficacy of BC-DN-01 in the Treatment of Painful Diabetic Peripheral Neuropathy|Withdrawn||Phase 1/Phase 2|0|Actual|BioChemics, Inc.||2|||f||||t||||||||||2017-10-11 01:58:54.590184|2017-10-11 01:58:54.590184
NCT01790581|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-07-06|2014-12-04||January 2013||2013-01-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Balance Training vs. Balance Training w/ STARS|Balance Training vs. Balance Training w/ STARS|Completed||N/A|24|Actual|University of North Carolina, Charlotte||2|||f||||f||||||||||2017-10-11 01:59:37.661534|2017-10-11 01:59:37.661534
NCT01793337|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-02-14|||September 2012||2012-09-01|February 2013|2013-02-01||||October 2012|Actual|2012-10-01||Interventional|||Core Body Temperature Measurement During Hot and Cold Environmental Exposure|Tympanic and Frontal Versus Oesophageal Core Temperature Reading During Hot and Cold Environmental Exposure|Completed||N/A|32|Actual|Institute of Mountain Emergency Medicine||2|||f||||||||||||||2017-10-11 01:58:54.675423|2017-10-11 01:58:54.675423
NCT01793324|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2014-01-27|||April 2012||2012-04-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||EMR Data to Assess Monitoring of Patients Treated With Quetiapine|Objective Assessment of Metabolic Monitoring in Patients Treated With Seroquel® or Seroquel® XR/Quetiapine Fumarate: Use of IMS Disease Analyzer to Assess Physician Behaviour in the UK and Germany|Completed||N/A|6153|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 01:58:54.808149|2017-10-11 01:58:54.808149
NCT01793298|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2015-02-09|||March 2013||2013-03-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|||Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of ASM-024 Administered by Dry Powder Inhalation to Healthy Subjects and Subjects With Stable Moderate Asthma|Terminated||Phase 1/Phase 2|55|Actual|Asmacure Ltée||5||Lack of efficacy|f||||f||||||||||2017-10-11 01:58:55.114522|2017-10-11 01:58:55.114522
NCT01793285|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-02-14|2013-02-14||December 2010||2010-12-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|RELOADET||An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial|Retrospective, Multicentric, National, Observational Study, to Follow-up the Patients Who Participated in the Loadet Study (RELOADET Study)|Completed||N/A|85|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:58:55.216168|2017-10-11 01:58:55.216168
NCT01793272|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-02-14|||October 2010||2010-10-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|April 2011|Actual|2011-04-01||Interventional|||Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males|Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males With Mild and Moderate Asthenozoospermia: Randomized Controlled Prospective Crossover Study|Completed||N/A|120|Actual|Adam International Hospital||1|||f||||t||||||||||2017-10-11 01:58:55.821253|2017-10-11 01:58:55.821253
NCT01793259|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-07-12|||July 2012||2012-07-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)|An Open-label, Randomized, Two-period Cross-over Study of Repeated Subcutaneous Injections of Methotrexate 50mg/ml Solution Either by a Pre-filled Syringe (Reference) or by a Disposable Pre-filled Pen (Test) to Assess Patient's Preference and Self-injection Experience and to Compare the Local Tolerability in Patients With Active Rheumatoid Arthritis|Completed||Phase 3|120|Actual|medac GmbH||2|||f||||f||||||||||2017-10-11 01:58:55.898671|2017-10-11 01:58:55.898671
NCT01793246|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-08-28|||February 2013||2013-02-01|August 2017|2017-08-01|December 24, 2016|Actual|2016-12-24|December 24, 2016|Actual|2016-12-24||Observational|BREATH||Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung|Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy: Discrete Pulmonary Lesions and Acute Rejection in Transplanted Lungs|Completed||N/A|99|Actual|Mauna Kea Technologies|||2||f||||f||||||||||2017-10-11 01:58:55.989918|2017-10-11 01:58:55.989918
NCT01793233|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-05-05|||June 2013||2013-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas|Longitudinal Assessment of Ovarian Reserve in Adolescents With Lymphoma|Recruiting||N/A|205|Anticipated|Children's Oncology Group|||1||f||||t||||||Samples With DNA|"     blood   "|||2017-10-11 01:58:56.141431|2017-10-11 01:58:56.141431
NCT01793207|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-05-04|||December 2012||2012-12-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population|Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population|Completed||N/A|316|Actual|Cairo University|||4||f||||f||||||Samples With DNA|"     10cc blood sample and tissue biopsies from colorectal lesions when present.   "|||2017-10-11 01:58:56.623102|2017-10-11 01:58:56.623102
NCT01793194|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2013-02-26|||February 2012||2012-02-01|February 2013|2013-02-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Interventional|||Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings|Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings: A Randomized Pilot Study|Unknown status|Recruiting|Phase 4|80|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:58:56.69258|2017-10-11 01:58:56.69258
NCT01793181|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2016-11-23|||January 2013||2013-01-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Observational|||Vitamin D Levels in Patients With Central Retinal Vein Occlusion- a Prospective Controlled Study|Vitamin D Levels in Patients With Central Retinal Vein Occlusion- a Prospective Controlled Study|Completed||N/A|216|Actual|St. Erik Eye Hospital|||2||f||||f||||||Samples Without DNA|"     Blood sample of vitamin D   "|||2017-10-11 01:58:56.786221|2017-10-11 01:58:56.786221
NCT01793168|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-09-28|||July 2010||2010-07-01|September 2016|2016-09-01|December 2100|Anticipated|2100-12-01|December 2100|Anticipated|2100-12-01|100 Years|Observational [Patient Registry]|CoRDS||Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford|Coordination of Rare Diseases at Sanford|Recruiting||N/A|20000|Anticipated|Sanford Health|||1||f||||f||||||None Retained|"     Biospecimen collection capability anticipated in 2014.   "|||2017-10-11 01:58:56.871606|2017-10-11 01:58:56.871606
NCT01793155|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-01-19|||November 2012||2012-11-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|||Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial|Respiratory Muscle Strength, Functional Capacity and Subjective Outcome - Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial|Completed||Phase 2|70|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-10-11 01:58:57.552736|2017-10-11 01:58:57.552736
NCT01793142|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-09-28|||October 24, 2013|Actual|2013-10-24|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Observational|||Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice|Post Marketing Surveillance For General Drug Use To Assess The Safety And Efficacy Profile Of Viviant In Usual Practice.|Completed||N/A|3411|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:58:57.835723|2017-10-11 01:58:57.835723
NCT01793129|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-06-19|||May 2015||2015-05-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Preemie Hypothermia for Neonatal Encephalopathy|A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.|Recruiting||Phase 2/Phase 3|168|Anticipated|NICHD Neonatal Research Network||2|||f||||t|f|t|f|||||Yes|NIH has had a long-standing policy to share and make available to the public the results and accomplishments of the activities that it funds. The NRN plans to share de-identified data after final publication in an NIH supported data repository such as the NICHD Data and Specimen Hub (https://dash.nichd.nih.gov)|2017-10-11 01:58:58.205719|2017-10-11 01:58:58.205719
NCT01793116|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-07-21|||March 2012||2012-03-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01|11 Weeks|Observational [Patient Registry]|||Generic Database of Moderate Preterm Infants|Time Limited Observational Study of the Moderately Preterm Infant (29 0/7 - 33 6/7 Weeks)|Completed||N/A|7057|Actual|NICHD Neonatal Research Network|||1||f||||f||||||||||2017-10-11 01:58:58.481498|2017-10-11 01:58:58.481498
NCT01793103|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2016-07-18|||March 2003||2003-03-01|July 2016|2016-07-01|March 2028|Anticipated|2028-03-01|March 2028|Anticipated|2028-03-01|15 Years|Observational [Patient Registry]|BRASS||Brigham and Women's Rheumatoid Arthritis Sequential Study|Brigham and Women's Rheumatoid Arthritis Sequential Study|Recruiting||N/A|1600|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"     whole blood, serum, DNA   "|||2017-10-11 01:58:58.640761|2017-10-11 01:58:58.640761
NCT01793090|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-04-22|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|July 2013|Actual|2013-07-01||Interventional|||EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment|Phase 2, Double-Blind, Placebo Controlled Clinical Trial of EPI-743 in Subjects With Cobalamin C Defect|Completed||Phase 2|30|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||f||||||||||2017-10-11 01:58:58.742877|2017-10-11 01:58:58.742877
NCT01793077|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2014-01-10|||December 2011||2011-12-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|TREMODI||Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients|Phase IV, Non-interventional, Prospective, Open Label, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients|Completed||N/A|259|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 01:58:58.88644|2017-10-11 01:58:58.88644
NCT01793064|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2014-01-13|||June 2010||2010-06-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||An Adaptive Physical Activity Intervention for Overweight Adults|An Adaptive Physical Activity Intervention for Overweight Adults: A Randomized Controlled Trial|Completed||N/A|20|Actual|Arizona State University||2|||f||||f||||||||||2017-10-11 01:58:59.040883|2017-10-11 01:58:59.040883
NCT01793051|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-07-18|||March 2013|Actual|2013-03-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma|A Phase II Randomized Study of the Efficacy of Minocycline vs. Placebo to Reduce Symptom Burden During Maintenance Therapy for Multiple Myeloma|Active, not recruiting||Phase 2|88|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 01:58:59.139143|2017-10-11 01:58:59.139143
NCT01793038|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2013-03-05|||March 2013||2013-03-01|March 2013|2013-03-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women|Clomiphene Citrate Plus HPuFSH Versus Letrozole Plus HPuFSH in Clomid Resistant Infertile PCOS Women|Unknown status|Recruiting|N/A|160|Anticipated|Mansoura Integrated Fertility Center||2|||f||||f||||||||||2017-10-11 01:58:59.266179|2017-10-11 01:58:59.266179
NCT01793025|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2017-08-28|||September 2012||2012-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ATAC-AML-01||Mismatched Donor Cells to Treat Acute Myeloid Leukemia|Adoptive Transfer of Alloreactive Cells to Treat Patients With Poor-Prognosis Acute Myeloid Leukemia-01|Recruiting||Phase 1|12|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||||||||||||2017-10-11 01:58:59.412041|2017-10-11 01:58:59.412041
NCT01793012|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2015-03-30|||March 2013||2013-03-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|DRAK||Drug Monitoring of Antibiotics in Critical Care Patients|Drug Monitoring of Antibiotics in Critical Care Patients|Completed||N/A|6|Actual|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||||2017-10-11 01:58:59.552586|2017-10-11 01:58:59.552586
NCT01792999|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-03-10|||May 2012||2012-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:58:59.649134|2017-10-11 01:58:59.649134
NCT01792986|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-02-10|2016-12-09||February 2013||2013-02-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Fasting II Study|Preparatory Study to Determine Which Risk Markers May be Reduced by Fasting and Should be Evaluated in a Future Randomized Trial|Completed||N/A|12|Actual|Intermountain Health Care, Inc.||1|||f||||f||||||||||2017-10-11 01:58:59.698797|2017-10-11 01:58:59.698797
NCT01792973|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-03-20|||February 2012|Actual|2012-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PapilloV||HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study|HPV Infection and Cervical Lesions in HIV Infected Women in Thailand|Completed||N/A|829|Actual|Institut de Recherche pour le Developpement|||1||f||||t||||||Samples With DNA|"     Cervical secretions   "|||2017-10-11 01:58:59.988448|2017-10-11 01:58:59.988448
NCT01792960|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-02-17|||February 2013||2013-02-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01|2 Years|Observational [Patient Registry]|||Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy||Completed||N/A|99|Actual|Yonsei University|||1||f||||t||||||Samples With DNA|"     serum, whole blood, DNA   "|||2017-10-11 01:59:00.144879|2017-10-11 01:59:00.144879
NCT01792947|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2013-02-13|||June 2012||2012-06-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Percutaneous Electroneurostimulation of Dermatome T6 for Appetite Reduction and Weight Loss in Morbidly Obese Patients|Percutaneous Electroneurostimulation of Dermatome T6 for Appetite Reduction and Weight Loss in Morbidly Obese Patients|Completed||N/A|60|Actual|Hospital General Universitario Elche||2|||f||||t||||||||||2017-10-11 01:59:00.215115|2017-10-11 01:59:00.215115
NCT01792934|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-07-31|||May 2013|Actual|2013-05-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|ORCHESTRA||Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases|A Randomized Multicenter Clinical Trial for Patient With Multi-organ, Colorectal Cancer Metastases Comparing the Combination of Chemotherapy and Maximal Tumor Debulking Versus Chemotherapy Alone.|Recruiting||N/A|478|Anticipated|VU University Medical Center||2|||f||||t||||||||||2017-10-11 01:59:00.301733|2017-10-11 01:59:00.301733
NCT01792921|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2013-02-14|||April 2013||2013-04-01|February 2013|2013-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Effectiveness of a Cognitive-functional (Cog-Fun) Intervention for Children With ADHD|COG FUN Intervention for ADHD|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 01:59:00.609404|2017-10-11 01:59:00.609404
NCT01792908|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-02-14|||October 2011||2011-10-01|February 2013|2013-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Kinesio Tape Effects on Ankle Proprioception|Has Kinesio Tape Effects on Ankle Proprioception? A Randomized Clinical Trial|Completed||N/A|73|Actual|University Rovira i Virgili||2|||f||||t||||||||||2017-10-11 01:59:00.692871|2017-10-11 01:59:00.692871
NCT01792895|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-10-21|||January 2011||2011-01-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|CNP||Different Types of Manual Therapy Techniques in Patients With Chronic Neck Pain|Is Better the One Type of Manual Therapy Than Others for to Treat the Patients With Chronic Neck Pain? : A Randomized Clinical Trial|Completed||N/A|61|Actual|Universidad Rey Juan Carlos||3|||f||||t||||||||||2017-10-11 01:59:00.782985|2017-10-11 01:59:00.782985
NCT01792882|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-09-12|||February 2013||2013-02-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|GBCPRT0008||Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples|Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples|Enrolling by invitation||N/A|100|Actual|Global BioClinical|||1||f||||f||||||Samples With DNA|"     Surplus Surgical Tissues      Tissue procurement will involve the collection of tissues snap frozen in liquid nitrogen.     Tissues will include tumors and histologically normal (uninvolved) areas (>2cm from tumor) of     tissue. A tumor tissue sample is required; a normal tissue sample should be provided if     available.      Individual samples will be collected in weights (sizes) approximately 100-200 mg or larger.     Research tissues sample collection will only be performed on surplus (discard) tissues not     required for patient diagnosis and will never interfere with clinical diagnosis.      Blood Samples      Blood samples will be collected from consented subjects prior to surgery and will involve the     collection of up to 20 ml of whole blood into appropriate blood collection tubes and freezing     them.   "|||2017-10-11 01:59:00.877867|2017-10-11 01:59:00.877867
NCT01792869|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-07-08|||February 2013||2013-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:59:00.945841|2017-10-11 01:59:00.945841
NCT01792856|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-14|||February 2013||2013-02-01|February 2013|2013-02-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01||Interventional|||Coaching Intervention for Patients With Early Psychosis|Randomized Controlled Trial on Recovery-oriented Coaching Intervention for Patients With Early Psychosis|Unknown status|Not yet recruiting|N/A|140|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 01:59:00.992213|2017-10-11 01:59:00.992213
NCT01792843|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-02-01|||January 2013||2013-01-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|CogPhenoPark||Cognitive Phenotypes in Parkinson's Disease|Cognitive Phenotypes in Parkinson's Disease: Anatomical and Functional Correlates|Completed||N/A|158|Actual|University Hospital, Lille|||1||f||||t|f|f||||||No||2017-10-11 01:59:01.233661|2017-10-11 01:59:01.233661
NCT01792830|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-09-29|2015-05-11||October 2012||2012-10-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|CABG-D/C||Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients|Prospective Study Aim to Determine the Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Cardiac Surgery Patients With Perioperative Hyperglycemia|Completed||Phase 3|175|Actual|Emory University|The study had participants from other states who lived more than 50 miles away from the hospitals and did not return for their post-operative care or 12 week follow up. Some subjects preferred to complete follow ups via phone and no blood was drawn.|7|||f||||t||||||||||2017-10-11 01:59:01.334128|2017-10-11 01:59:01.334128
NCT01792804|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-03-14|||December 2013||2013-12-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|SABATO||Staphylococcus Aureus Bacteremia Antibiotic Treatment Options|Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection|Recruiting||Phase 3|430|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-10-11 01:59:02.451828|2017-10-11 01:59:02.451828
NCT01792791|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-12-16|||October 2012||2012-10-01|August 2015|2015-08-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Post-traumatic Arthritis Associated With Joint Injury|Assessment of Biomarkers Associated With Joint Injury and Subsequent Post-Traumatic Arthritis|Completed||N/A|20|Actual|Duke University|||1||f||||f||||||||||2017-10-11 01:59:02.781958|2017-10-11 01:59:02.781958
NCT01792778|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-05-25|||February 2013||2013-02-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|RIGHT IV||RIGHT IV Pilot Study|Post-Market Study Comparing the Clinical Performance Two Blood Control Safety Peripheral Intravenous Catheters: A Pilot Study|Completed||N/A|40|Actual|Smiths Medical, ASD, Inc.||2|||f||||f||||||||||2017-10-11 01:59:02.887267|2017-10-11 01:59:02.887267
NCT01792765|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-02-09|||October 2011||2011-10-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|August 2013|Actual|2013-08-01||Interventional|||Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach|Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach|Completed||N/A|50|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 01:59:02.996823|2017-10-11 01:59:02.996823
NCT01792752|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-07-02|||December 2014||2014-12-01|July 2015|2015-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico|Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico|Unknown status|Recruiting|N/A|400|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-11 01:59:03.11743|2017-10-11 01:59:03.11743
NCT01792739|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-02-13|||November 2010||2010-11-01|February 2013|2013-02-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||Lactobacillus Preparation on the Incidence of Diarrhea|The Impact of Lactobacillus Preparation on the Incidence of Diarrhea in Intensive Care Unit-admitted Patients : Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|124|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:59:03.298692|2017-10-11 01:59:03.298692
NCT01792726|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-08-15|||June 2013||2013-06-01|August 2016|2016-08-01|April 2022|Anticipated|2022-04-01|January 2022|Anticipated|2022-01-01||Interventional|TARGIT-B||A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.|An International Randomised Controlled Trial to Compare Targeted Intra-operative Radiotherapy Boost With Conventional External Beam Radiotherapy Boost After Lumpectomy for Breast Cancer in Women With a High Risk of Local Recurrence.|Recruiting||N/A|1796|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 01:59:03.446113|2017-10-11 01:59:03.446113
NCT01792713|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-05-19|||February 2013||2013-02-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis|Randomisierte, Doppelblinde, Plazebo-kontrollierte Prüfung Zum Nachweis Der Wirksamkeit Und Der Lokalen Verträglichkeit Einer 2%Igen Sertaconazol-Crème Bei Patienten Mit Atopischer Dermatitis (Abridged)|Completed||Phase 2|70|Actual|Spirig Pharma Ltd.||2|||f||||f||||||||||2017-10-11 01:59:03.701758|2017-10-11 01:59:03.701758
NCT01792700|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-02-14|||January 2003||2003-01-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy||Completed||Phase 4|648|Actual|Seoul National University Bundang Hospital||2|||f||||||||||||||2017-10-11 01:59:03.807349|2017-10-11 01:59:03.807349
NCT01792687|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-05-26|||February 5, 2013|Actual|2013-02-05|May 2017|2017-05-01|December 12, 2017|Anticipated|2017-12-12|May 10, 2014|Actual|2014-05-10||Interventional|||Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate|Phase Ib, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN-509 in Combination With Abiraterone Acetate in Patients With Metastatic Castrate Resistant Prostate Cancer (CRPC)|Active, not recruiting||Phase 1|6|Actual|Aragon Pharmaceuticals, Inc.||1|||f||||f||f||||||||2017-10-11 01:59:03.917584|2017-10-11 01:59:03.917584
NCT01792674|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2015-12-17|||April 2013||2013-04-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||'In Situ Simulation' Versus 'Off Site Simulation' in Obstetric Emergencies|A Randomised Educational Feasibility Trial: 'In Situ Simulation' Versus 'Off Site Simulation' in Obstetric Emergencies and the Effect on Knowledge, Safety-attitudes, Team Performance, Stress, and Motivation|Completed||N/A|97|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 01:59:04.087275|2017-10-11 01:59:04.087275
NCT01792661|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-04-27|||February 2012||2012-02-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|CKD||Navigating the Challenges of Chronic Kidney Disease|Navigating the Challenges of Chronic Kidney Disease|Completed||N/A|209|Actual|The Cleveland Clinic||4|||f||||t||||||||No||2017-10-11 01:59:04.230317|2017-10-11 01:59:04.230317
NCT01792648|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-08-01|||April 2013||2013-04-01|November 2015|2015-11-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|||Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome|Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome|Completed||N/A|24|Actual|Children's Hospital & Research Center Oakland||3|||f||||f||||||||||2017-10-11 01:59:04.387085|2017-10-11 01:59:04.387085
NCT01792635|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-12-22|2016-01-11||December 2012||2012-12-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus|A 6-week Phase 2a Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Assess Safety, Tolerability And Pharmacodynamics Of Oral Pf-05175157 As Monotherapy In Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 2|19|Actual|Pfizer|Part B of the study was terminated due to the safety issue. Due to the low number of participants who completed the study, there are no conclusions for PK or PD in Part B. The prioritization of Part A endpoints was done by inputs from team.|2||The study was terminated prematurely on 16 May 2014 due to a safety concern.|f||||f||||||||||2017-10-11 01:59:04.590805|2017-10-11 01:59:04.590805
NCT01792622|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-07-31|||July 2013||2013-07-01|July 2013|2013-07-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|PROPAH||Patient Reported Outcomes in Pulmonary Arterial Hypertension|Patient Reported Outcomes in Pulmonary Arterial Hypertension|Withdrawn||N/A|0|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 01:59:05.520019|2017-10-11 01:59:05.520019
NCT01792609|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-05-13|||January 2013||2013-01-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|MIMOCT||Min Implants Max Outcomes Clinical Trial|Minimize Implants Maximize Outcomes (MIMO) Clinical Trial|Recruiting||N/A|200|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-11 01:59:05.613635|2017-10-11 01:59:05.613635
NCT01792596|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-01-06|||October 2012||2012-10-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Satiety Effects of Protein and Fiber Added to Pasta|Satiety Effects of Protein and Fiber Added to Pasta|Completed||N/A|36|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-11 01:59:06.036322|2017-10-11 01:59:06.036322
NCT01792570|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-03-29|||September 2014||2014-09-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||DRV/r + RPV QD: Efficacy and Toxicity Reduction|Strategic Study of Dual-therapy With Darunavir/Ritonavir and Rilpivirine QD Versus Triple-therapy in Patients With Suppressed Viral Load: Virological Efficacy and Evaluation of Non-HIV Related Morbidity.|Recruiting||Phase 3|132|Anticipated|ASST Fatebenefratelli Sacco||2|||f||||f||||||||Yes||2017-10-11 01:59:06.268959|2017-10-11 01:59:06.268959
NCT01792557|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-03-21|||March 2013||2013-03-01|March 2014|2014-03-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Crystallized Phenol Versus Transposition Flaps for Treatment of Pilonidal Disease: A Prospective Study|Crystallized Phenol Application Versus Transposition Flaps for Treatment of Sacrococcygeal Pilonidal Disease: A Prospective Randomized Study|Active, not recruiting||N/A|200|Anticipated|S.B. Konya Education and Research Hospital||4|||f||||f||||||||||2017-10-11 01:59:06.515952|2017-10-11 01:59:06.515952
NCT01792544|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-04-26|||July 2011||2011-07-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|November 2013|Actual|2013-11-01||Interventional|||Clinical Reminders in Test Reports to Improve Guideline Compliance||Completed||N/A|1706|Actual|VA Palo Alto Health Care System||2|||f||||f||||||||||2017-10-11 01:59:06.645131|2017-10-11 01:59:06.645131
NCT01792531|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-08-29|||January 2013||2013-01-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|April 2016|Actual|2016-04-01||Interventional|M&L||The More & Less Study: A Trial Testing Different Treatment Approaches to Obesity in Preschoolers|The More & Less Study: A Randomized Controlled Trial Testing Different Treatment Approaches to Obesity in Preschoolers|Active, not recruiting||N/A|177|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 01:59:06.7175|2017-10-11 01:59:06.7175
NCT01792518|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-14|2017-01-13|2016-11-08||February 2013||2013-02-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional||Treated Set (TS) - including all patients treated with at least one dose of randomised trial medication.|MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin|A Phase IIIb, Multicenter, Multinational, Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Glycemic and Renal Efficacy of Once Daily Administration of Linagliptin 5 mg for 24 Weeks in Type 2 Diabetes Patients, With Micro- or Macroalbuminuria (30-3000mg/g Creatinine) on Top of Current Treatment With Angiotensin ConvEnzyme Inhibitor or Angiotensin Receptor Blocker - MARLINA (Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin)|Completed||Phase 3|360|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 01:59:06.834568|2017-10-11 01:59:06.834568
NCT01792505|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2017-04-19|||October 2009||2009-10-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|November 14, 2014|Actual|2014-11-14||Interventional|||Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma|A Phase I Trial of Surgical Resection Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate With Imiquimod for Patients With Malignant Glioma|Completed||Phase 1|71|Actual|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-10-11 01:59:07.493742|2017-10-11 01:59:07.493742
NCT01792492|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-03-28|||June 2009||2009-06-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|March 2010|Actual|2010-03-01||Observational|||The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study|The Role of an Optical Probe in the Detection of Thyroid Cancer and Normal Thyroid Tissue in a Thyroidectomy Specimen: A Pilot Study|Completed||N/A|50|Actual|Boston Medical Center|||1||f||||f||||||||No||2017-10-11 01:59:07.590725|2017-10-11 01:59:07.590725
NCT01792479|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-04-14|||April 2013||2013-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer|An Open Label, Multicenter, Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|64|Actual|BIND Therapeutics||2|||f||||||||||||||2017-10-11 01:59:07.675124|2017-10-11 01:59:07.675124
NCT01792466|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-07-17|||February 2013||2013-02-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||RCT of the Double Wire Technique for Sphincterotomy|A Randomized Controlled Trial of the Double Wire Technique With or Without Transpancreatic Sphincterotomy for Difficult Common Bile Duct Cannulation|Terminated||N/A|16|Actual|Mayo Clinic||2||Inadequate recruitment|f||||f||||||||||2017-10-11 01:59:07.794705|2017-10-11 01:59:07.794705
NCT01792453|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-07-03|||February 2013||2013-02-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||240 mL Water Drink Study|MRI Quantification of Gastric and Small Bowel Liquid Volumes Before and After Ingestion of the Standard Oral Solid Delivery 240 mL Water Drink|Completed||N/A|12|Actual|University of Nottingham||1|||f||||f||||||||||2017-10-11 01:59:07.875795|2017-10-11 01:59:07.875795
NCT01792440|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-02-19|||September 2009||2009-09-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|July 2010|Actual|2010-07-01||Observational|||The Sputum Colour Chart as a Predictor of Lung Inflammation and Proteolysis in Non-cystic Fibrosis Bronchiectasis|The Sputum Colour Chart as a Predictor of Lung Inflammation, Proteolysis and Damage in Non-cystic Fibrosis Bronchiectasis|Completed||N/A|80|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||Samples With DNA|"     induced sputum cells   "|||2017-10-11 01:59:07.968957|2017-10-11 01:59:07.968957
NCT01792427|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-02-18|||June 2006||2006-06-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Observational|||Mortality in Non-cystic Fibrosis Bronchiectasis|Mortality in Non-cystic Fibrosis Bronchiectasis: a Long-term Cohort Analysis|Completed||N/A|253|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 01:59:08.045261|2017-10-11 01:59:08.045261
NCT01792414|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-02-01|||January 2013||2013-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Transcranial Electrical Stimulation (TES) for the Treatment of Depression.||Completed||N/A|70|Actual|The University of New South Wales||2|||f||||t||||||||||2017-10-11 01:59:08.111377|2017-10-11 01:59:08.111377
NCT01780363|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-29|||January 2011||2011-01-01|January 2011|2011-01-01||||December 2011|Actual|2011-12-01||Observational|||MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE||Completed||N/A|||Cukurova University|||2||f||||||||||||||2017-10-11 02:02:45.193648|2017-10-11 02:02:45.193648
NCT01792388|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2014-07-21|||December 2011||2011-12-01|July 2014|2014-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|VIP||Vitd and Barrier Function in IBD|Vitamin D and Its Effects on Inflammation and Intestinal Permeability in Crohn's Disease in Remission|Completed||Phase 4|30|Actual|University of Dublin, Trinity College||2|||f||||f||||||||||2017-10-11 01:59:08.284134|2017-10-11 01:59:08.284134
NCT01792375|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2016-10-12|||February 2013||2013-02-01|October 2016|2016-10-01||||February 2017|Anticipated|2017-02-01||Interventional|||Concurrent Membrane Sweeping With Dinoprostone Versus Dinoprostone in Labor Induction of Nulliparas at Term With an Unfavorable Cervix||Recruiting||N/A|192|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 01:59:08.3801|2017-10-11 01:59:08.3801
NCT01792362|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-05-05|||October 2012||2012-10-01|November 2012|2012-11-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation of Anti-mullerian Hormone(AMH) Levels as a Predictive Factor of Response to Weight Loss Treatment in Obese Infertile Women With Poly Cystic Ovary(PCOS)|Comparing the Basal Anti-mullerian Hormone Levels Between Responders and Non-responders to Weight Loss Diet in Obese Infertile Women With PCOS Population|Completed||Phase 3|60|Anticipated|Royan Institute||1|||f||||||||||||||2017-10-11 01:59:08.472049|2017-10-11 01:59:08.472049
NCT01792349|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-02-14|||February 2013||2013-02-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Increasing Physical Activity in Stroke Survivors Using STARFISH|Increasing Physical Activity in Stroke Survivors Using STARFISH, an Interactive Mobile Phone Application: a Feasibility Study|Unknown status|Recruiting|N/A|24|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 01:59:08.564918|2017-10-11 01:59:08.564918
NCT01792336|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-07-11|||January 23, 2013||2013-01-23|June 9, 2017|2017-06-09|June 16, 2018|Anticipated|2018-06-16|June 16, 2018|Anticipated|2018-06-16||Observational|||Transcranial Magnetic Stimulation for Focal Hand Dystonia|Gamma Frequency Transcranial Magnetic Stimulation in Dystonia|Recruiting||N/A|62|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 01:59:08.681979|2017-10-11 01:59:08.681979
NCT01792323|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2014-02-25|||August 2011||2011-08-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|November 2011|Actual|2011-11-01||Interventional|||Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations|Subcutaneous Insulin Absorption Following Bolus Administrations With an Insulin Pump - Comparison of Bolus Administrations With Different Bolus Durations|Completed||Phase 1|20|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-11 01:59:08.770001|2017-10-11 01:59:08.770001
NCT01792310|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2016-12-05|||May 2013||2013-05-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Phase 1/2A Study of Minerval in Adult Patients With Advanced Solid Tumours|A Phase 1/2A Dose Escalation Study of 2-hydroxyoleic Acid (2-OHOA; Minerval®) in Adult Patients With Advanced Solid Tumours Including Malignant Glioma|Completed||Phase 1/Phase 2|54|Actual|Lipopharma Therapeutics SL||9|||f||||f||||||||||2017-10-11 01:59:08.852772|2017-10-11 01:59:08.852772
NCT01792297|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-05-02|||December 2012||2012-12-01|May 2017|2017-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||The Effect of Bovine Colostrum Supplementation in Older Adults|The Effect of Bovine Colostrum Supplementation in Older Adults|Completed||N/A|40|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 01:59:08.994931|2017-10-11 01:59:08.994931
NCT01792284|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2014-11-25||2014-09-29|February 2013||2013-02-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|IMAGINE 7||A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus|A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study|Completed||Phase 3|167|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 01:59:09.136336|2017-10-11 01:59:09.136336
NCT01792271|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-06-22|||February 2013||2013-02-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis|Novel Therapies for Muco-Obstructive Lung Diseases: Sustained Effects of Hypertonic Saline on Mucociliary Clearance and Clinical Tolerability in Subjects With Chronic Bronchitis|Completed||N/A|25|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-11 01:59:09.297313|2017-10-11 01:59:09.297313
NCT01792258|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-02-02|||June 2012||2012-06-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|February 2016|Anticipated|2016-02-01||Observational|||Procedures and Follow-up of Percutaneous Tracheostomy in Intensive Care Unit|Procedures, Complications and Follow-up of Percutaneous Tracheostomies in Intensive Care Unit|Recruiting||N/A|200|Anticipated|University of Genova|||1||f||||t||||||||||2017-10-11 01:59:09.417902|2017-10-11 01:59:09.417902
NCT01792245|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-06-30|||February 2013||2013-02-01|June 2015|2015-06-01||||December 2015|Anticipated|2015-12-01||Interventional|||Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand|Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand: A Prospective Randomized, Single-blinded Controlled Clinical Trial|Unknown status|Recruiting|Phase 2|30|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:59:09.547444|2017-10-11 01:59:09.547444
NCT01792232|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-09-27|||October 2011||2011-10-01|September 2017|2017-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effects of Co-Exposure to Air Pollution and Allergen|Effect of Exposure to Allergens and Air Pollution on Lung Function and Immunity|Completed||N/A|18|Actual|University of British Columbia||4|||f||||f||||||||||2017-10-11 01:59:09.668259|2017-10-11 01:59:09.668259
NCT01792219|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-02-12|||January 2013||2013-01-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|IPCIHC||Interprofessional Collaboration in Health Care and Outcomes in Nursing Homes|The Effectiveness of Learning to Collaborate Interprofessionally on Healthcare Processes and Outcomes in Nursing Homes: a Cluster Randomized Controlled Trial in Primary Care.|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Universiteit Antwerpen||1|||f||||t||||||||||2017-10-11 01:59:09.798052|2017-10-11 01:59:09.798052
NCT01792206|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2013-02-12|||September 2009||2009-09-01|February 2013|2013-02-01|February 2013|Anticipated|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease|EFFECT OF PARICALCITOL (ZEMPLAR) ON ENDOTHELIAL FUNCTION AND INFLAMMATION IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE|Unknown status|Active, not recruiting|N/A|60|Actual|Scott and White Hospital & Clinic||2|||f||||f||||||||||2017-10-11 01:59:09.909855|2017-10-11 01:59:09.909855
NCT01792193|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-03-16|||January 2013||2013-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy Controls|Quantitative Analysis of Gut-derived Neuropeptides in Cerebrospinal Fluid (CSF) of Patients With Parkinson's Disease and Healthy Controls|Completed||N/A|40|Actual|Saarland University|||2||f||||f||||||Samples Without DNA|"     CSF and serum samples   "|||2017-10-11 01:59:10.079315|2017-10-11 01:59:10.079315
NCT01792180|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-01-21|||January 2013||2013-01-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|SSS||The Senior Step Study How Elderly Help Themselves Maximally Forward|The Senior Step Study: How Elderly Help Themselves Maximally Forward|Unknown status|Recruiting|N/A|150|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 01:59:10.161308|2017-10-11 01:59:10.161308
NCT01792167|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2014-03-17|||September 2009||2009-09-01|March 2014|2014-03-01|October 2014|Anticipated|2014-10-01|June 2013|Actual|2013-06-01||Interventional|SSTP||Multi-Site Evaluation of Second Step|Multi-site Evaluation of Second Step: Student Success Through Prevention (Second Step - SSTP) in Preventing Bullying and Sexual Violence|Unknown status|Active, not recruiting|N/A|4089|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-11 01:59:10.301743|2017-10-11 01:59:10.301743
NCT01792154|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-12|||August 2012||2012-08-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Measuring Corneal Cells With Specular Microscopy|Specular Photomicrograpic Assessment of the Effect of Anti-VEGF Intravitreal Injections on Corneal Thickness and Endothelial Cell Density and Morphology|Completed||N/A|30|Actual|Retina Institute of Hawaii|||1||f||||f||||||||||2017-10-11 01:59:10.395036|2017-10-11 01:59:10.395036
NCT01792141|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-12|||January 2011||2011-01-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|||Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser Treatment|The Use of Fluorescein-Indocyanine Green Angiography in Patients With Diabetic Macular Edema to Identify Areas of Increased Leakage and Provide Targeted Focal Laser Treatment.|Completed||N/A|50|Actual|Retina Institute of Hawaii|||1||f||||f||||||||||2017-10-11 01:59:10.484383|2017-10-11 01:59:10.484383
NCT01792115|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-09-12|||January 25, 2013||2013-01-25|August 29, 2017|2017-08-29|August 1, 2019|Anticipated|2019-08-01|August 1, 2019|Anticipated|2019-08-01||Interventional|||Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E|Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E|Active, not recruiting||Phase 2|38|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 01:59:10.732573|2017-10-11 01:59:10.732573
NCT01792102|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-02-27|||April 2013||2013-04-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple Myeloma|A Phase 1/2 Study of Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Patients With Progressive Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|38|Anticipated|Oncotherapeutics||1|||f||||f||||||||||2017-10-11 01:59:10.87817|2017-10-11 01:59:10.87817
NCT01792089|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2014-06-03|||February 2013||2013-02-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|FIDNL||Fructose-induced Intestinal de Novo Lipogenesis|Measure of Intestinal Lipogenesis in Healthy Volunteers and Obese Subjects Before and After Gastroplasty: Modulation by Glucose and Fructose|Completed||N/A|24|Actual|University of Lausanne|||3||f||||f||||||||||2017-10-11 01:59:11.036429|2017-10-11 01:59:11.036429
NCT01792063|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-04-18|||February 2013||2013-02-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Two Different Preparations of Sevoflurane in Induction|A Randomized Clinical Trial on the Efficiency, Hemodynamic Effects and Patient Comfort of Two Different Preparations of Sevoflurane After Vital Capacity Rapid Inhalation Induction|Completed||Phase 4|200|Anticipated|Istanbul University||2|||f||||t||||||||||2017-10-11 01:59:11.141831|2017-10-11 01:59:11.141831
NCT01792050|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-03-14|||February 2013||2013-02-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer|A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination With a Taxane Chemotherapy in Metastatic Breast Cancer|Active, not recruiting||Phase 2|169|Actual|NewLink Genetics Corporation||4|||f||||t||||||||||2017-10-11 01:59:11.268428|2017-10-11 01:59:11.268428
NCT01792037|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-08-23|||December 2012||2012-12-01|February 2013|2013-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Single Dose of Etomidate and Adrenal Cortex|the Effect of Single Dose of Etomidate Used During Emergency Intubation on Hemodynamics and Adrenal Cortex: a Randomized Clinical Trial|Completed||Phase 4|90|Actual|Istanbul University||3|||f||||t||||||||||2017-10-11 01:59:11.561175|2017-10-11 01:59:11.561175
NCT01792024|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-09-07|||January 28, 2013|Actual|2013-01-28|September 2017|2017-09-01|September 16, 2015|Actual|2015-09-16|September 16, 2015|Actual|2015-09-16||Interventional|||MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer|PHASE II EVALUATION OF MR-GUIDED LASERINDUCED INTERSTITIAL THERMAL THERAPY (LITT) FOR PROSTATE CANCER|Completed||N/A|27|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 01:59:11.703398|2017-10-11 01:59:11.703398
NCT01792011|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-13|||October 2012||2012-10-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Accuracy of the Pleth Variability Index to Predict Fluid Responsiveness in Liver Transplantation|Accuracy and Utility of the Pleth Variability Index as a Predictor of Fluid Responsiveness During the Dissection and Anhepatic Phase of Liver Transplantation|Completed||Phase 4|25|Actual|Inonu University||1|||f||||t||||||||||2017-10-11 01:59:11.828307|2017-10-11 01:59:11.828307
NCT01791998|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2014-10-14|||August 2012||2012-08-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer|A Pilot Study to Evaluate Magnet Resonance Thermal Imageguided Interstital Thermal Therapy for Focal Ablation of Breast Cancer|Withdrawn||N/A|0|Actual|University of Chicago||1||Funding was time sensitive and expired. No subjects enrolled.|f||||f||||||||||2017-10-11 01:59:11.955446|2017-10-11 01:59:11.955446
NCT01791660|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2013-02-12|||August 2012||2012-08-01|February 2013|2013-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Targeted Fat Reduction of Pseudogynecomastia in the Male Breast Using the ZELTIQ Coolsculpting System|Targeted Fat Reduction of Pseudogynecomastia in the Male Breast Using the ZELTIQ Coolsculpting System|Unknown status|Recruiting|N/A|12|Anticipated|Dermatology, Laser & Vein Specialists of the Carolinas||1|||f||||f||||||||||2017-10-11 01:59:18.938693|2017-10-11 01:59:18.938693
NCT01791985|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-04-04|||July 2012||2012-07-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|November 2016|Actual|2016-11-01||Interventional|RADICAL||AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)|A Single Arm Phase IIa Study (With Combination SRI) to Assess the Safety & Efficacy of AZD4547 in Combination With Either Anastrozole or Letrozole in ER+ Breast Cancer Patients Who Have Progressed on Treatment With Anastrozole or Letrozole|Active, not recruiting||Phase 1/Phase 2|56|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 01:59:12.083643|2017-10-11 01:59:12.083643
NCT01791972|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-05-21|2015-05-01|2014-05-08|March 2013||2013-03-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional||Randomized participants|Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)|A Single-Dose Study to Assess the Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)|Completed||Phase 3|38|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 01:59:12.244115|2017-10-11 01:59:12.244115
NCT01791959|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-12|||March 2012||2012-03-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis|The Effects of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis|Completed||Phase 2/Phase 3|54|Actual|National Nutrition and Food Technology Institute||2|||f||||t||||||||||2017-10-11 01:59:12.769804|2017-10-11 01:59:12.769804
NCT01791946|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-01-12|||January 2013||2013-01-01|October 2015|2015-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Binocular Treatment of Amblyopia Before and After Strabismus Surgery|Binocular Treatment of Amblyopia Before and After Strabismus Surgery|Completed||N/A|22|Actual|Massachusetts Eye and Ear Infirmary||3|||f||||f||||||||No|We do not [plan on sharing IPD with other researchers.|2017-10-11 01:59:12.859566|2017-10-11 01:59:12.859566
NCT01791933|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-10-29|||February 2013||2013-02-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||The Evaluation of the Effectiveness of CAM Treatments for Lumbar and Cervical Spine Pain Patients Due to Spinal Disease|The Evaluation of the Effectiveness of CAM Treatments for Lumbar and Cervical Spine Pain Patients Due to Spinal Disease : Prospective, Observational Study|Completed||N/A|111|Actual|Jaseng Hospital of Korean Medicine|||1||f||||t||||||||||2017-10-11 01:59:12.963337|2017-10-11 01:59:12.963337
NCT01791920|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-02-13|||August 2011||2011-08-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines|"Double-blinded, Randomized, Active Control Comparative, Multicenter-designed, Phase III Clinical Trial to Evaluate the Safety and Efficacy for Improvement of Glabellar Lines of Botulax® Compared to Botox Inj. in Patients With Moderate to Severe Glabellar Lines"|Completed||Phase 3|262|Actual|Hugel||2|||f||||f||||||||||2017-10-11 01:59:13.084235|2017-10-11 01:59:13.084235
NCT01791907|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-12-19|||February 2013||2013-02-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Structured Nutrition Education in Type 1 Diabetes|Effect of Structured Education in Advanced Carbohydrate Counting or Healthy Food Choices With Low Glycemic Index in Type 1 Diabetes|Active, not recruiting||N/A|216|Anticipated|Göteborg University||3|||f||||||||||||||2017-10-11 01:59:13.181992|2017-10-11 01:59:13.181992
NCT01791894|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-10-31|2016-04-27||April 2013||2013-04-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2013|Actual|2013-11-01||Interventional|ATO|5 patients with BCC who are not eligible for curative loco-regional treatment and have either progressed on, did not tolerate, unwilling to try or ineligible for investigational smoothened antagonist such as GDC 0449, XL 139 (BMS 833923), IPI- 926, LDE225 and PF-04449913 and fit the inclusion/exclusion criteria|Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma|An Open-label, Biomarker Study of Arsenic Trioxide for the Treatment of Patients With Basal Cell Carcinoma|Completed||N/A|5|Actual|Stanford University||1|||f||||t||||||||Yes|Results will be submitted to scientific journal for publication and shared at scientific meetings|2017-10-11 01:59:13.287107|2017-10-11 01:59:13.287107
NCT01791881|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-02-13|||April 2008||2008-04-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||"Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of Hugeltox Inj. in Essential Blepharospasm"|"Double-blinded, Randomized, Active Control Comparative, Parallel-designed, Phase III Clinical Trial: Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of Hugeltox Inj. In Essential Blepharospasm Running Parallel With Phase I Study"|Completed||Phase 3|172|Actual|Hugel||2|||f||||f||||||||||2017-10-11 01:59:13.519913|2017-10-11 01:59:13.519913
NCT01791868|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2016-11-21|||February 2013||2013-02-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01||Interventional|VALSE||Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.|Randomized and Multicenter Study Assessing the Efficacy of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Yes||2017-10-11 01:59:13.615123|2017-10-11 01:59:13.615123
NCT01791855|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-10-17|||May 2013||2013-05-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||PF-04634817 Renal Impairment Study|A Phase 1, Single Dose, Open-Label Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04634817|Completed||Phase 1|26|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 01:59:13.707962|2017-10-11 01:59:13.707962
NCT01791842|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-03-14|||February 2013||2013-02-01|March 2013|2013-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|TOCIDYS||TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE|TREATMENT OF FIBROUS DYSPLASIA OF BONE WITH TOCILIZUMAB AMONG PATIENTS WHO DO NOT RESPOND TO BISPHOSPHONATES. THE TOCIDYS TRIAL.|Unknown status|Recruiting|Phase 2|12|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 01:59:13.795167|2017-10-11 01:59:13.795167
NCT01791647|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2013-02-12|||June 2011||2011-06-01|February 2013|2013-02-01||||December 2012|Actual|2012-12-01||Interventional|||Myo-inositol Versus Metformin in Obese Women With Polycystic Ovary Syndrome|Myo-inositol Versus Metformin: Effects of Six Months Treatment on Clinical, Endocrine and Metabolic Features in Obese Women With Polycystic Ovary Syndrome|Unknown status|Recruiting|N/A|40|Anticipated|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-11 01:59:19.057054|2017-10-11 01:59:19.057054
NCT01791829|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-06-26|||July 2013||2013-07-01|June 2017|2017-06-01|July 2023|Anticipated|2023-07-01|March 2023|Anticipated|2023-03-01||Observational|LUMINA||A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer|A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer|Active, not recruiting||N/A|500|Actual|Ontario Clinical Oncology Group (OCOG)|||1||f||||t||||||Samples With DNA|"     Specimens will be used to determine Ki67 status by IHC and subsequent testing for DNA/RNA.   "|||2017-10-11 01:59:13.888608|2017-10-11 01:59:13.888608
NCT01791816|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-08-14|||February 2013||2013-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Mechanisms of Vasovagal Syncope|Mechanisms of Vasovagal Syncope|Recruiting||Early Phase 1|90|Anticipated|New York Medical College||1|||f||||t||||||||||2017-10-11 01:59:14.008845|2017-10-11 01:59:14.008845
NCT01791803|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-05-17|2014-04-16||January 2006||2006-01-01|May 2017|2017-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|STOPP|patients included in analysis were less than numbers recruited in groups because some patients were eliminated due to severity of illness including mortality and one developed psychosis, thus became eligible. All patients that were lost to follow up were considered to be smokers for analysis.|Smoking Cessation After Hospitalization for a Cardiopulmonary Illness|Smoking Cessation Treatment of CardioPulmonary Hospitalized Patients|Completed||N/A|164|Actual|North Shore Medical Center|Comparing two vastly different modalities such as hypnosis and NRT represented a randomizing challenge, as participants and researchers could not be blinded to interventions.|4|||f||||f||||||||Yes|published in: Complementary Therapies in Medicine 2014: 22: 1-8.|2017-10-11 01:59:14.123315|2017-10-11 01:59:14.123315
NCT01791790|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2017-07-04|||January 2013||2013-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Elderly Healthy Subjects|Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Elderly Healthy Subjects|Active, not recruiting||N/A|22|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 01:59:14.831195|2017-10-11 01:59:14.831195
NCT01791777|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-06-06|||September 2010||2010-09-01|June 2017|2017-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effectiveness and Cost-effectiveness of Coaching Models to Promote Implementation of an Evidence-based Parenting Program|Effectiveness and Cost-effectiveness of Coaching Models to Promote Implementation of an Evidence-based Parenting Program|Completed||N/A|147|Actual|Georgia State University||2|||f||||f||||||||No|There is not a plan to make individual participant data available.|2017-10-11 01:59:14.919844|2017-10-11 01:59:14.919844
NCT01791764|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-12|||November 2010||2010-11-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01|15 Days|Observational [Patient Registry]|||Hospital Mortality in Patients Submitted to Pharmacoinvasive Strategy With Tenecteplase (TNK)|Hospital Mortality After ST Segment Elevation Acute Myocardial Infarction Submitted to Pharmacoinvasive Strategy With Tenecteplase (TNK): Analysis of 398 Patients.|Completed||N/A|368|Actual|Federal University of São Paulo|||1||f||||t||||||||||2017-10-11 01:59:15.071542|2017-10-11 01:59:15.071542
NCT01791751|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-02-12|||June 2012||2012-06-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|CLOFA||Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles|Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in Agonist Triggered GnRH Antagonist in Vitro Fertilization Cycles. Phase IV, Single-centre, Open-label, Controlled Clinical Trial.|Completed||Phase 4|10|Actual|Fundació Privada Eugin||2|||f||||f||||||||||2017-10-11 01:59:15.177736|2017-10-11 01:59:15.177736
NCT01791738|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-07-09|||January 2011||2011-01-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Acetabular Shell Positioning Using Patient Specific Instruments|Comparison of Acetabular Shell Position Using Patient Specific Instruments vs. Standard Surgical Instruments: A Randomized Clinical Trial|Completed||Phase 1|36|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 01:59:15.293514|2017-10-11 01:59:15.293514
NCT01791725|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-12-22|2015-09-03||September 2013||2013-09-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DS201||A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia|A 4-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2a Safety and PK Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia|Completed||Phase 2|23|Actual|Transition Therapeutics Ireland Limited||3|||f||||f||||||||||2017-10-11 01:59:15.43345|2017-10-11 01:59:15.43345
NCT01791712|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-02-12|||January 2010||2010-01-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy of Online Hemodiafiltrationlysis in Cytokine Removal|Enhanced Vascular Endothelial Growth Factor and Pro-inflammatory Cytokine Clearances With On-line Hemodiafiltration Versus High-flux Hemodialysis in Sepsis-related Acute Kidney Injury Patients|Completed||N/A|28|Actual|Chulalongkorn University||2|||f||||f||||||||||2017-10-11 01:59:18.492358|2017-10-11 01:59:18.492358
NCT01791699|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2014-05-04|||August 2012||2012-08-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|||Moxonidine for Prevention of Post-ablation AFib Recurrences|Pharmacologic Suppression of Central Sympathetic Activity for Prevention of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation (MOXAF)|Completed||Phase 4|150|Anticipated|G.Gennimatas General Hospital||2|||f||||t||||||||||2017-10-11 01:59:18.602662|2017-10-11 01:59:18.602662
NCT01791686|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-03-06|||January 2013||2013-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease|A Pilot, Open-label, Multicenter Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease|Terminated||Phase 1|1|Actual|Celldex Therapeutics||1||"Portfolio prioritization due to slow enrollment and variable spectrum of potential complement   abnormalities in DDD patients."|f||||t||||||||||2017-10-11 01:59:18.741446|2017-10-11 01:59:18.741446
NCT01791673|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2015-06-15|||November 2012||2012-11-01|February 2013|2013-02-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional|||Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients|Efficacy and Safety of Circular Cyclocoagulation Using High Intensity Focused Ultrasound With EYEOP1 Device in Glaucoma Patients. Prospective Multicenter Clinical Trial.|Completed||N/A|30|Actual|EyeTechCare||1|||f||||t||||||||||2017-10-11 01:59:18.826551|2017-10-11 01:59:18.826551
NCT01791634|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-12|||April 2007||2007-04-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|January 2011|Actual|2011-01-01||Interventional|Hallux valgus||Prospective, Multi-Center Clinical Evaluation of the Open Wedge Osteotomy and Low Profile Plate & Screw (LPS) System Compared to the Proximal Chevron Osteotomy for the Treatment of Hallux Valgus With an Increased Intermetatarsal Angle|Prospective, Randomized, Multi-Center Clinical Evaluation of the Open Wedge Osteotomy and Low Profile Plate & Screw (LPS) System Compared to the Proximal Chevron Osteotomy for the Treatment of Hallux Valgus With an Increased Intermetatarsal Angle|Completed||N/A|75|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 01:59:19.148562|2017-10-11 01:59:19.148562
NCT01791621|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-07-17|||January 2013||2013-01-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|FAST||The Diagnostic Predictability of Food Allergy Testing|The Diagnostic Predictability of Food Allergy Testing in Individuals With Irritable Bowel Syndrome (IBS): A Comparison Between Various Laboratory Methods and an Elimination Diet. (The FAST Study)|Completed||N/A|4|Actual|The Canadian College of Naturopathic Medicine||1|||f||||f||||||||||2017-10-11 01:59:19.441994|2017-10-11 01:59:19.441994
NCT01791608|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-13|2013-02-13|||March 2012||2012-03-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|ZAZO||Zinc Sulphate vs. Zinc Amino Acid Chelate|Effect of Zinc Sulphate and Zinc Amino Acid Chelate in Prevention Acute Diarrhea and Acute Respiratory Infection, Medellín 2012|Completed||Phase 4|360|Actual|CES University||3|||f||||f||||||||||2017-10-11 01:59:19.546725|2017-10-11 01:59:19.546725
NCT01791595|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-04-13|||February 2013||2013-02-01|April 2016|2016-04-01||||November 2017|Anticipated|2017-11-01||Interventional|||A Phase I Trial of AZD3965 in Patients With Advanced Cancer|A Cancer Research United Kingdom Phase I Trial of AZD3965, a Monocarboxylate Transporter 1 Inhibitor (MCT1) in Patients With Advanced Cancer|Recruiting||Phase 1|64|Anticipated|Cancer Research UK|||||f||||f||||||||||2017-10-11 01:59:19.678572|2017-10-11 01:59:19.678572
NCT01791582|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-12-05|||October 2012||2012-10-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Pulse Oximetry- Evaluating Resp Rate- PCBA-1|Respiration Rate Parameter Studies in Healthy Volunteers Using a Bedside Respiratory Patient Monitoring System With the Multi-Functional Patient Monitoring PCBA-1|Completed||N/A|27|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 01:59:19.791847|2017-10-11 01:59:19.791847
NCT01791569|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-12-05|||September 2012||2012-09-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Pulse Oximetry- Evaluating Sensor Off- PCBA-1|Sensor Off Studies Using a Bedside Respiratory Patient Monitoring System With the Multi-Functional Patient Monitoring PCBA-1|Completed||N/A|20|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 01:59:19.867918|2017-10-11 01:59:19.867918
NCT01791556|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-11|||January 2010||2010-01-01|February 2013|2013-02-01|August 2014|Anticipated|2014-08-01|August 2012|Actual|2012-08-01||Interventional|CLADE||Clinic-based ART Diagnostic Evaluation|Clinic-based ART Diagnostic Evaluation|Unknown status|Active, not recruiting|N/A|820|Actual|Walter Reed Army Institute of Research (WRAIR)||2|||f||||t||||||||||2017-10-11 01:59:19.930027|2017-10-11 01:59:19.930027
NCT01791543|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-07-17|||September 2016||2016-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia|Early Feasibility Study of Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation|Recruiting||N/A|50|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 01:59:20.061774|2017-10-11 01:59:20.061774
NCT01791530|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-08-04|||September 2013||2013-09-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Observational|TAVeM||International Multicenter Study of Ventilator Associated Tracheobronchitis.|International Multicenter Study of Ventilator Associated Tracheobronchitis.|Completed||N/A|3000|Actual|Corporacion Parc Tauli|||1||f||||f||||||||||2017-10-11 01:59:20.193773|2017-10-11 01:59:20.193773
NCT01791504|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2013-12-03|||March 2013||2013-03-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Clinical Trial Comparing Standard Wound Closure Techniques Versus TissuGlu® Surgical Adhesive|A Clinical Investigation for a Randomized Study Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques Plus TissuGlu® and No Drains (Test) During Abdominoplasty|Completed||Phase 2/Phase 3|130|Actual|Cohera Medical, Inc.||2|||f||||f||||||||||2017-10-11 01:59:20.484828|2017-10-11 01:59:20.484828
NCT01791491|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-06-23|2017-05-31||May 9, 2013|Actual|2013-05-09|June 2017|2017-06-01|December 6, 2016|Actual|2016-12-06|December 6, 2016|Actual|2016-12-06||Interventional|||Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients|A Phase 2 Multi-Center, Randomized Conversion Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belatacept Administered to Pediatric Subjects With a Stable Renal Transplant|Completed||Phase 2|16|Actual|Bristol-Myers Squibb||1|||f||||t|t|f||||||||2017-10-11 01:59:20.625077|2017-10-11 01:59:20.625077
NCT01791478|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-07-10|||April 2013||2013-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer|A Phase Ib Trial of BYL719 (an α-Specific PI3K Inhibitor) in Combination With Endocrine Therapy in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer|Active, not recruiting||Phase 1|46|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-11 01:59:21.10436|2017-10-11 01:59:21.10436
NCT01791465|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-01-20|2016-05-05||March 2013||2013-03-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults|Pilot Study of Extended-release Exenatide to Improve Glucose Control and Reduce Systemic Inflammation in Diabetic, HIV-infected Adults on Antiretroviral Therapy|Terminated||Phase 4|6|Actual|Vanderbilt University Medical Center|Trial terminated after only 6 individuals enrolled due to lack of interest in participation from patients and expiration of funding. Results are not considered reliable due to low number of observations|1||This study was terminated after 6 patients due to loss of funding|f||||f||||||||No|Individual participant data is protected by HIPPA and Vanderbilt University research regulations. Summary de-identified data is available if requested|2017-10-11 01:59:21.243088|2017-10-11 01:59:21.243088
NCT01791452|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2013-02-13||||||February 2013|2013-02-01||||February 2014|Anticipated|2014-02-01||Observational|||Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study||Unknown status|Not yet recruiting|N/A|||Ziv Hospital|||1||f||||||||||||||2017-10-11 01:59:21.943148|2017-10-11 01:59:21.943148
NCT01791439|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2013-02-13|||January 2013||2013-01-01|February 2013|2013-02-01||||April 2013|Anticipated|2013-04-01||Interventional|||Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese|Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese.|Unknown status|Recruiting|N/A|24|Anticipated|Royal Victoria Hospital, Canada||2|||f||||f||||||||||2017-10-11 01:59:22.021055|2017-10-11 01:59:22.021055
NCT01791426|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-10-10|||May 2013||2013-05-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye|A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye|Withdrawn||N/A|0|Actual|Bausch & Lomb Incorporated||2||Adjustment of company focus due to acquision by Valeant Pharmaceuticals|f||||f||||||||||2017-10-11 01:59:22.104277|2017-10-11 01:59:22.104277
NCT01791413|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2013-08-23|2013-06-18||March 2012||2012-03-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Lost follow up total 6 patients|Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas||Completed||Phase 1/Phase 2|40|Actual|Mahidol University|Small sample size|2|||f||||t||||||||||2017-10-11 01:59:22.199052|2017-10-11 01:59:22.199052
NCT01791400|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-10|2013-02-13|||July 2009||2009-07-01|February 2013|2013-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache|Study of Effects of Metoclopramide Versus Sumatriptan on Migraine Headache|Completed||Phase 2|124|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 01:59:22.473276|2017-10-11 01:59:22.473276
NCT01791387|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-02-01|||March 2012||2012-03-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|DILIGENCE-1||1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC|Dovitinib In 1st-Line Renal Cell Carcinoma, an Investigation Into Tumour GENe Status and Correlation With Efficacy - 1st Exploratory Study|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Auckland District Health Board||1|||f||||t||||||||||2017-10-11 01:59:22.564153|2017-10-11 01:59:22.564153
NCT01791374|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-02-26|||November 2012||2012-11-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|August 2013|Actual|2013-08-01||Interventional|||Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ|A Multicenter, Phase 1/1b, Open Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Rilotumumab in Japanese Subjects|Completed||Phase 1|21|Actual|Amgen||2|||f||||f||||||||||2017-10-11 01:59:22.698187|2017-10-11 01:59:22.698187
NCT01791361|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-10-23|||September 2012||2012-09-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe|Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe|Completed||N/A|439|Actual|Amgen|||3||f||||f||||||||||2017-10-11 01:59:22.820836|2017-10-11 01:59:22.820836
NCT01791348|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-12-03|||March 2013||2013-03-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||"The Test-retest Effect of the d2 Test of Attention."|"The Test-retest Effect of the d2 Test of Attention - a Test for Concentration and Performance."|Completed||N/A|40|Actual|Herlev Hospital||1|||f||||t||||||||||2017-10-11 01:59:23.079368|2017-10-11 01:59:23.079368
NCT01791335|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-06-09|||October 2012||2012-10-01|June 2015|2015-06-01||||January 2016|Anticipated|2016-01-01||Observational|||NIV and Glottis-diaphragm Synchrony|Effect of Noninvasive Ventilation on the Synchrony of the Upper Airways and Inspiration.|Unknown status|Recruiting|N/A|10|Anticipated|University Medical Center Nijmegen|||1||f||||f||||||||||2017-10-11 01:59:23.149403|2017-10-11 01:59:23.149403
NCT01791322|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-10-06|||January 2014||2014-01-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||NovellusDx Tissue Collection Protocol|An Observational Study to Assess the Oncogenic Status of Colorectal Cancer Patients That Have Undergone Surgery|Unknown status|Recruiting|N/A|35|Anticipated|NovellusDx|||1||f||||f||||||Samples Without DNA|"     pathology samples of tissue   "|||2017-10-11 01:59:23.219891|2017-10-11 01:59:23.219891
NCT01791309|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-01-04|||January 2013||2013-01-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer|A Pilot Study of Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer|Completed||Phase 1|16|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 01:59:23.293336|2017-10-11 01:59:23.293336
NCT01791296|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-03-15|||January 2011|Actual|2011-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|SKY-DEX||Does Nightly Dexmedetomidine Improve Sleep and Reduce Delirium in ICU Patients?|The Effect of a Dexmedetomidine-focussed Sleep Protocol* on Delirium Incidence and Healthcare Costs in Critically Ill Patients: A Prospective Randomized, Double-blind, Pilot Study.|Completed||Phase 4|100|Actual|Maisonneuve-Rosemont Hospital||2|||f||||t||||||||||2017-10-11 01:59:23.386972|2017-10-11 01:59:23.386972
NCT01791283|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-02-12|||August 2012||2012-08-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|FourComp||Real-time Comparison of Left Ventricular Strokevolume Measurement by Four Different Methods|Real-time Comparison of Left Ventricular Strokevolume Measurement by Four Different Methods|Completed||N/A|20|Actual|University Hospital, Linkoeping|||1||f||||t||||||||||2017-10-11 01:59:23.496652|2017-10-11 01:59:23.496652
NCT01791270|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-06-20|||February 2010||2010-02-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|OSAS||Obstructive Sleep Apnea (OSA), Hypertension , β1 Subunit of Maxi-k+ Channel and Cardiovascular Risk|Expression of Maxi-k+ Channel β1 Subunit in Peripheral Leukocytes, Blood Pressure Values and the Presence of Endothelial Dysfunction in Patients With Obstructive Sleep Apnea|Completed||N/A|80|Actual|Sociedad Española de Neumología y Cirugía Torácica|||2||f||||f||||||Samples Without DNA|"     Periferical blood   "|||2017-10-11 01:59:23.571372|2017-10-11 01:59:23.571372
NCT00000121|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||March 1984||1984-03-01|September 2009|2009-09-01|May 1989|Actual|1989-05-01|||||Interventional|||The Prism Adaptation Study (PAS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.030674|2017-10-11 04:17:30.030674
NCT01791257|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2014-04-07|||February 2013||2013-02-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01|3 Months|Observational [Patient Registry]|||MicroRNA Diagnostics in Subarachnoid Hemorrhage|MicroRNA Expression in Cerebrospinal Fluid From Patients Suffering Subarachnoid Hemorrhage With and Without Delayed Cerebral Ischemia|Completed||N/A|50|Actual|Rigshospitalet, Denmark|||3||f||||t||||||Samples With DNA|"     Group 1+2: Cerebrospinal fluid 1-2 ml a day for 8 days drawn in each patient from external     ventricular drain Gropu 3: Cerebrospinal fluid 2 ml drawn from patients undergoing spinal     anesthesia before injection of local anesthetic.   "|||2017-10-11 01:59:23.653124|2017-10-11 01:59:23.653124
NCT01791244|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-07-21|2017-04-19||February 28, 2013|Actual|2013-02-28|July 2017|2017-07-01|February 29, 2016|Actual|2016-02-29|February 29, 2016|Actual|2016-02-29||Interventional|RebiQoL|The Intent-to-Treat (ITT) population included all subjects randomized into the trial and have completed at least 1 post-baseline assessment of the questionnaires.|A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device|A Phase IV Multicenter Randomized Study to Assess the Impact of a Patient Support Program (MinSupport Plus) on Health Related Quality of Life (HRQoL) and Adherence in Patients With Relapsing Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart Device|Completed||Phase 4|93|Actual|Merck KGaA||2|||f||||||||||||||2017-10-11 01:59:23.809721|2017-10-11 01:59:23.809721
NCT01791231|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-06-28|||August 2007||2007-08-01|June 2016|2016-06-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||A Study to Investigate the Absorption, Metabolism, and Excretion of Canagliflozin (JNJ-28431754) in Healthy Male Volunteers|An Open-Label Study to Investigate the Absorption, Metabolism, and Excretion of JNJ-28431754 in Healthy Male Subjects Following a Single Oral Dose Administration of 14C-JNJ-28431754|Completed||Phase 1|6|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 01:59:25.012384|2017-10-11 01:59:25.012384
NCT01791218|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2015-08-19|||November 2012||2012-11-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|December 2015|Anticipated|2015-12-01||Interventional|FIN-PVI||Surgical Pulmonary Vein Isolation Efficiency Study|Concomitant Pulmonary Vein Isolation in Treatment of Paroxysmal Atrial Fibrillation Patients Undergoing Elective Coronary Artery Bypass Grafting and Aortic Valve Replacement for Aortic Stenosis: a Prospective Study|Terminated||N/A|2|Actual|Kuopio University Hospital||2||Not enough patients for study arms|f||||t||||||||||2017-10-11 01:59:25.151143|2017-10-11 01:59:25.151143
NCT01791205|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-11-14|2016-06-30||May 2013||2013-05-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational||Analysis population included all enrolled participants.|ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis|A Multi-Center Observational Study on the Use of Biologic Drugs as Monotherapy or Combination With DMARDs in Patients With Rheumatoid Arthritis in Italian Clinical Practice (ARMONIA)|Completed||N/A|304|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-11 01:59:25.35221|2017-10-11 01:59:25.35221
NCT01791192|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-04-19|||November 2013||2013-11-01|April 2014|2014-04-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Study of FTY720 in Patients With Uveitis|A Multicenter, Randomized, Active-controlled Study to Assess the Safety, Tolerability, and Efficacy of FTY720 in Patients With Acute, Noninfectious Intermediate, Posterior and Pan Uveitis|Withdrawn||Phase 2|0|Actual|Novartis||2|||f||||f||||||||||2017-10-11 01:59:27.465563|2017-10-11 01:59:27.465563
NCT01791179|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-05-09|||February 2013||2013-02-01|April 2017|2017-04-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|CADRE||Carolina Alcohol and Drug Resources|Carolina Alcohol and Drug Resources|Active, not recruiting||N/A|||Duke University||1|||f||||t||||||||||2017-10-11 01:59:27.592271|2017-10-11 01:59:27.592271
NCT01791166|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-09-09|||February 2011||2011-02-01|September 2016|2016-09-01|July 2014|Actual|2014-07-01|October 2013|Actual|2013-10-01||Interventional|RHUM-TP||Immuno-humoral Rejection Markers in Pulmonary Transplant|Humoral Rejection - Diagnostic Markers in Pulmonary Transplant.|Completed||N/A|53|Actual|Hopital Foch||1|||f||||f||||||||No||2017-10-11 01:59:27.692124|2017-10-11 01:59:27.692124
NCT01791153|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-04-10|2017-04-10||July 22, 2013|Actual|2013-07-22|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 11, 2016|Actual|2016-04-11||Interventional||Safety Population included all participants who received at least one administration of study drug and provided at least one post-dose safety assessment.|An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)|A Phase III, Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Assess the Efficacy and Safety of Tocilizumab in Subjects With Giant Cell Arteritis|Active, not recruiting||Phase 3|251|Actual|Hoffmann-La Roche||5|||f||||t||||||||||2017-10-11 01:59:27.82086|2017-10-11 01:59:27.82086
NCT01791140|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-11-01|||March 2011||2011-03-01|November 2016|2016-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer|Program for Assessment of Activity and Safety of 1st-line Bevacizumab (Avastin) Therapy in Elderly Patients With Metastatic Colorectal Cancer (BEVERLY-C Study)|Completed||N/A|3|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:59:30.05744|2017-10-11 01:59:30.05744
NCT01791127|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-09-27|||January 2013||2013-01-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01|5 Years|Observational [Patient Registry]|SIELLO||Safety and Performance Study of the Siello S Pacing Lead||Active, not recruiting||N/A|1758|Actual|Biotronik, Inc.|||1||f||||t||||||||||2017-10-11 01:59:30.129136|2017-10-11 01:59:30.129136
NCT01791114|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-12-20|||January 2012||2012-01-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||The Effect of Brown Adipose Tissue Activation on Insulin Sensitivity in Humans||Recruiting||N/A|60|Anticipated|The University of Texas Medical Branch, Galveston||4|||f||||f||||||||||2017-10-11 01:59:30.300845|2017-10-11 01:59:30.300845
NCT01791101|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-08-31|||September 2013||2013-09-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|ITP0511||Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.|Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.|Recruiting||Phase 2|40|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-11 01:59:30.436351|2017-10-11 01:59:30.436351
NCT01629836|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2015-05-05|||June 2012||2012-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:48:07.081108|2017-10-11 02:48:07.081108
NCT01791088|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-07-13|||June 2012||2012-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery|A Pharmacodynamic Study of Sirolimus in Older Children and Adults With Advanced Solid Malignancies|Active, not recruiting||Phase 1|50|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 01:59:30.626405|2017-10-11 01:59:30.626405
NCT01791075|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-13|||January 2012||2012-01-01|February 2013|2013-02-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Comparing Endoglide to Endoserter for DSAEK Graft Insertion|Prospective Randomized Study Comparing Endothelial Cell Loss Using the Tan EndoGlide With the Endoserter for Insertion of the Donor Graft in Descemets Stripping Endothelial Keratoplasty (DSAEK)|Unknown status|Recruiting|N/A|42|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:59:30.746907|2017-10-11 01:59:30.746907
NCT01791062|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-11-18|||February 2014||2014-02-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Efficacy Study of HYTOP® in the Treatment of Focal Chondral Defects.|Safety and Efficacy of a Novel, Cell-free Cartilage Repair Construct in the Treatment of Focal Chondral Defects Involving the Femoro-tibial Compartment of the Knee Joint.|Completed||N/A|2|Actual|TRB Chemedica AG||1|||f||||f||||||||||2017-10-11 01:59:30.832461|2017-10-11 01:59:30.832461
NCT01791049|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-12-03|||April 2013||2013-04-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||TD-1607 SAD Study in Healthy Subjects|A Randomized, Double−Blind, Placebo−Controlled, Single Ascending Dose (SAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TD-1607, a Glycopeptide−Cephalosporin Heterodimer Gram−Positive Antibiotic, in Healthy Subjects|Completed||Phase 1|64|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-10-11 01:59:31.072165|2017-10-11 01:59:31.072165
NCT01791036|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-03-02|||May 2013||2013-05-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Adductor Canal Block In Anterior Cruciate Ligament (ACL) Repair|Postoperative Analgesia Produced by Adductor Canal (Distal Femoral Artery Compartment) Block Is Not Inferior to Femoral Nerve Block In Outpatient Arthroscopic Anterior Cruciate Ligament Repair|Completed||N/A|100|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:59:31.16086|2017-10-11 01:59:31.16086
NCT01791023|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-02-09|||March 2011||2011-03-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Stress Reactivity of Physical Stressor on Depression|The Effect of Acute Exercise on Reactivity and Recovery of Cortisol and DHEAS Levels in Depressive and Healthy Older Adults.|Completed||N/A|80|Actual|Universidade Federal do Rio de Janeiro||1|||f||||t||||||||||2017-10-11 01:59:31.251823|2017-10-11 01:59:31.251823
NCT01791010|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-09|||January 2012||2012-01-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Inspiratory Muscle Training in Elders|Respiratory Muscle Training in the Elderly: a Strategy for Preservation of Inspiratory and Expiratory Pressures Impacting on Mobility and Thickness of the Diaphragm.|Completed||N/A|22|Actual|Universidade Federal de Pernambuco||2|||f||||f||||||||||2017-10-11 01:59:31.343354|2017-10-11 01:59:31.343354
NCT01790997|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2014-06-03|||May 2012||2012-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke|The Role of DLBS1033 in Evaluating Bleeding Profile and Clinical Outcome in Patients With Acute Ischemic Stroke: Comparison With Aspirin and Clopidogrel|Completed||Phase 3|126|Actual|Dexa Medica Group||3|||f||||f||||||||||2017-10-11 01:59:31.480117|2017-10-11 01:59:31.480117
NCT01790984|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-11|||April 2009||2009-04-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|August 2011|Actual|2011-08-01||Interventional|CHOT||How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?|How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype?|Completed||N/A|27|Actual|University of Surrey||2|||f||||f||||||||||2017-10-11 01:59:31.632803|2017-10-11 01:59:31.632803
NCT01790971|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-10-27|||September 2012||2012-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Spinal Morphine for Patients With Obstructive Sleep Apnea|Low Dose Spinal Morphine for Patients With Obstructive Sleep Apnea (OSA) Undergoing Total Hip Arthroplasty (THA)|Recruiting||N/A|40|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 01:59:31.768039|2017-10-11 01:59:31.768039
NCT01790958|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-11|||June 2012||2012-06-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Microcurrent Stimulation to Treat Macular Degeneration|An Observational, Multi-Center Phase 1 Study of the Safety and Effectiveness of Frequency Specific Microcurrent Stimulation as an Alternative Treatment for Retinal Diseases|Completed||N/A|50|Actual|Retina Institute of Hawaii|||1||f||||f||||||||||2017-10-11 01:59:31.891074|2017-10-11 01:59:31.891074
NCT01790945|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-02-12|||February 2013||2013-02-01|February 2013|2013-02-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Observational|DIVER||Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography|Diabetic Macular Edema and Diabetic Retinopathy Identification by Screening (Telemed) With Verified Automated Retinal Photography|Unknown status|Not yet recruiting|N/A|500|Anticipated|Retina Institute of Hawaii|||1||f||||f||||||||||2017-10-11 01:59:31.985042|2017-10-11 01:59:31.985042
NCT01790932|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-10-02|||February 2013||2013-02-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||BKM120 For Triple Negative Breast Cancer|A Phase II Trial of BKM120 in Patients With Triple Negative Metastatic Breast Cancer|Active, not recruiting||Phase 2|110|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 01:59:32.073785|2017-10-11 01:59:32.073785
NCT01790919|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-09-16|||February 2013||2013-02-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Improving Depression Outcome by Enhancing Memory for Cognitive Therapy|Improving Depression Outcome by Enhancing Memory for Cognitive Therapy|Completed||Phase 2|48|Actual|University of California, Berkeley||2|||f||||t||||||||||2017-10-11 01:59:32.160846|2017-10-11 01:59:32.160846
NCT01790906|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-02-09|||January 2013||2013-01-01|February 2013|2013-02-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|RSD4CHF||Renal Sympathetic Denervation for Patients With Chronic Heart Failure|Safety and Effectiveness Study of Percutaneous Catheter-base Renal Sympathetic Denervation for Patients With Chronic Heart Failure|Unknown status|Recruiting|N/A|200|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 01:59:32.258132|2017-10-11 01:59:32.258132
NCT01790893|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-06-13|||March 2013||2013-03-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|HANDLE||Treatment for Presumed Ocular Histoplasmosis|Intravitreal Aflibercept Injection for the Treatment of cHoroidAl Neovascularization seconDary to Presumed ocuLar Histoplasmosis syndromE.(the HANDLE Study)|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Retina Associates of Kentucky||2|||f||||f||||||||||2017-10-11 01:59:32.364438|2017-10-11 01:59:32.364438
NCT01790880|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-05-12|||February 2013||2013-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Enhancing Written Communication in Persons With Aphasia|Enhancing Written Communication in Persons With Aphasia: A Clinical Trial|Active, not recruiting||N/A|50|Actual|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 01:59:32.491666|2017-10-11 01:59:32.491666
NCT01789775|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2014-10-14|2014-10-14||December 2012||2012-12-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea||Completed||Phase 3|114|Actual|Galderma R&D||2|||f||||||||||||||2017-10-11 01:59:32.599872|2017-10-11 01:59:32.599872
NCT01789762|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-09-06|||May 2013||2013-05-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|EFFIPAP||Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process|Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process|Completed||Phase 4|842|Actual|Etablissement Français du Sang||3|||f||||t||||||||Undecided||2017-10-11 01:59:32.950102|2017-10-11 01:59:32.950102
NCT01789749|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-08-13|||July 2013||2013-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|October 2016|Anticipated|2016-10-01||Interventional|SCAR||Soft Coagulation for the Prevention of Adenoma Recurrence|Soft Coagulation for the Prevention of Adenoma Recurrence After Endoscopic Mucosal Resection (EMR) of Large Sessile Colonic Polyps: A Multicentre, Randomized Trial.|Active, not recruiting||N/A|411|Actual|Western Sydney Local Health District||2|||f||||t||||||||||2017-10-11 01:59:33.095532|2017-10-11 01:59:33.095532
NCT01789736|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2014-02-17||2014-02-17|February 2013||2013-02-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days|A Study Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components|Completed||Phase 2|234|Actual|Aerie Pharmaceuticals||3|||f||||f||||||||||2017-10-11 01:59:33.207953|2017-10-11 01:59:33.207953
NCT01789723|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-07-23|||March 2013||2013-03-01|July 2013|2013-07-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn|An Open Label, Multicenter, Dose Finding, Phase 1 Study of Fusilev® (Levoleucovorin) to Prevent or Reduce Mucositis in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Receiving Folotyn® (Pralatrexate)|Withdrawn||Phase 1|0|Actual|Spectrum Pharmaceuticals, Inc||5|||f||||f||||||||||2017-10-11 01:59:33.379833|2017-10-11 01:59:33.379833
NCT01790867|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-12-05|||May 2013||2013-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 01:59:33.47668|2017-10-11 01:59:33.47668
NCT01790854|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-07-28|||November 2012||2012-11-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|BLESS||BLeeding Events and Maintenance DoSe of PraSugrel|Bless Study (BLeeding Events and Maintenance DoSe of PraSugrel)|Terminated||Phase 4|195|Actual|Careggi Hospital||2||Low events rate. Scarce economical resources|f||||t||||||||||2017-10-11 01:59:33.51967|2017-10-11 01:59:33.51967
NCT01790841|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2016-04-18|||February 2013||2013-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Observational|||DF4 Master Study (Safety and Efficacy Study)|Master Study of the BIOTRONIK DF4 System|Completed||N/A|240|Actual|Biotronik SE & Co. KG|||2||f||||f||||||||||2017-10-11 01:59:33.612033|2017-10-11 01:59:33.612033
NCT01790828|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-07-21|2015-07-21||February 2014||2014-02-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational||All enrolled participants|Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A|Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha 'Registered' In Subjects With Hemophilia A|Completed||N/A|42|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:59:33.706838|2017-10-11 01:59:33.706838
NCT01790815|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2013-12-08|||August 2011||2011-08-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|MUAC||Mothers Understand And Can do it - Mid Upper Arm Circumference Screening for Malnutrition Performed by Mothers|Mothers Understand And Can do it - Mid Upper Arm Circumference Screening for Malnutrition Performed by Mothers of Children < 5 Years Old|Completed||N/A|300|Actual|Alliance for International Medical Action|||1||f||||f||||||||||2017-10-11 01:59:34.383293|2017-10-11 01:59:34.383293
NCT01790802|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-12|2017-08-14|||November 2011||2011-11-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|LEAD||Laser Intervention in Early Age-Related Macular Degeneration Study|A Multi-centre, Randomized Trial Into the Safety and Efficacy of Nanosecond Microsurgical Laser Intervention in Early Age-related Macular Degeneration|Active, not recruiting||N/A|292|Actual|Center for Eye Research Australia||2|||f||||t||||||||||2017-10-11 01:59:34.454472|2017-10-11 01:59:34.454472
NCT01790789|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-07-31|||February 2013||2013-02-01|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Stress Reduction in Ovarian Cancer|Stress Reduction During Primary Adjuvant Chemotherapy for Ovarian Cancer|Active, not recruiting||N/A|41|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 01:59:34.53275|2017-10-11 01:59:34.53275
NCT01790776|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-06-02|||February 2013||2013-02-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SONO-URETHRA||Diagnosis of Urethral Stricture With Sono-urethrography vs Conventional Urethrography (SONO-URETHRA)|Diagnosis of Urethral Stricture With Sono-urethrography vs Conventional Urethrography: Evaluation of the Diagnostic Value and Evaluation of the Reduction of the Radiation Dose With Sono-urethrography (SONO-URETHRA)|Unknown status|Recruiting|Phase 3|150|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 01:59:34.617594|2017-10-11 01:59:34.617594
NCT01790763|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-05-12|||April 2015||2015-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Compare the Efficacy of Mepilex and Keramatrix in Second Degree Burn Wounds|Prospective,Randomized, Parallel Study to Compare the Efficacy of Mepilex and Keramatrix in Promoting Healing of Second Degree Burn Wounds|Withdrawn||Phase 2/Phase 3|0|Actual|The University of Texas Medical Branch, Galveston||2||Due to lack of funding from the sponsor this study is being withdrawn.|f||||t||||||||||2017-10-11 01:59:34.723359|2017-10-11 01:59:34.723359
NCT01790750|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-03-05|2014-01-15||February 2013||2013-02-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Pocket Echocardiography System (PES) for Detection of PDA in Neonates|Pocket Echocardiography System (PES) for Detection of Patent Ductus Arteriosus (PDA) in Neonates|Completed||N/A|50|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 01:59:34.806392|2017-10-11 01:59:34.806392
NCT01790737|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-08-07|||January 2013||2013-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FMG-MM02||First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02|A Prospective Phase II Study to Assess Immunophenotypic Remission After 3-drug Induction Followed by Randomized Stem Cell Mobilization, Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|80|Anticipated|Kuopio University Hospital||2|||f||||t||||||||||2017-10-11 01:59:34.979911|2017-10-11 01:59:34.979911
NCT01790724|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-02-21|||January 2013||2013-01-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|REWinD||Regulating Efficacy and Wellness in Diabetes|Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes|Completed||N/A|125|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||||2017-10-11 01:59:35.111005|2017-10-11 01:59:35.111005
NCT01790711|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2014-11-21|||October 2012||2012-10-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Fecal Microbiota Transplantation on Type 2 Diabetes Mellitus|The Efficiency of Fecal Microbiota Transplantation on Type 2 Diabetes Mellitus|Unknown status|Enrolling by invitation|Phase 2/Phase 3|30|Anticipated|The Second Hospital of Nanjing Medical University||1|||f||||t||||||||||2017-10-11 01:59:35.278787|2017-10-11 01:59:35.278787
NCT01790698|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-08-16|||January 2013||2013-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01|3 Months|Observational [Patient Registry]|INFECT||Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).|Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures That Dictate Severity of Tissue Infection|Recruiting||N/A|500|Anticipated|Karolinska Institutet|||1||f||||f||||||Samples With DNA|"     Bacterial isolates, whole blood, plasma, tissue   "|||2017-10-11 01:59:35.392606|2017-10-11 01:59:35.392606
NCT01790685|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-04-02|2015-01-07||February 2013||2013-02-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ORVO||Ozurdex for Retinal Vein Occlusion Study (ORVO Study)|Ozurdex for Retinal Vein Occlusion Study (ORVO Study)|Completed||Phase 2/Phase 3|40|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 01:59:35.548245|2017-10-11 01:59:35.548245
NCT01790672|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-07-23|||May 2011||2011-05-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Contribution of Wine Components on Hydroxytyrosol Body Concentrations and Biological Effects|Hydroxytyrosol as an Endogenous and Natural Antioxidant: Modulation by Alcohol Intake. Substudy 2. To Establish the Contribution of Wine Components on Hydroxytyrosol Body Concentrations and Biological Effects|Completed||Phase 1|40|Actual|Parc de Salut Mar||4|||f||||f||||||||||2017-10-11 01:59:35.830829|2017-10-11 01:59:35.830829
NCT01790659|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-07-19|2016-10-11||May 2013||2013-05-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama|A Randomized, Double-blind, Pivotal Phase 3 Study of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Alone Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama|Completed||Phase 3|399|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-10-11 01:59:35.970687|2017-10-11 01:59:35.970687
NCT01790646|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-12|||September 2012||2012-09-01|February 2013|2013-02-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Learning and Performance of Glidescope® Videolaryngoscope Intubation|"Learning and Performance of Glidescope® Videolaryngoscope Intubation in Anesthesiologists Trained in Direct Laryngoscopy: a in Vivo Study"|Unknown status|Recruiting|N/A|600|Anticipated|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta|||1||f||||t||||||||||2017-10-11 01:59:36.893906|2017-10-11 01:59:36.893906
NCT01790633|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-10-19|2016-08-25||February 2013||2013-02-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|OPTISCREEN-III||Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests|Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests As a Tool for Screening and Access to Care Among At-Risk Populations|Completed||N/A|327|Actual|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba|Single-center pilot study, possibly reducing generalizability; small number of participants and infected individuals may have decreased power to detect differences in linkage-to-care; not all rapid tests were approved for routine use in France.|2|||f||||t||||||||Yes|Data will be shared under the following conditions: (1) interested parties must submit a request for data access to the principal investigator and (2) the request is approved by the Scientific Committee.|2017-10-11 01:59:36.991135|2017-10-11 01:59:36.991135
NCT01790620|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-08-08|||May 2013||2013-05-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|August 2017|Actual|2017-08-01||Interventional|||Impact of CVVHD With Increased Adsorption Membranes in Septic Acute Kidney Injury|Impact of a Continuous Dialysis Technique Associated With Increased Adsorption Membranes in Severe Septic Patients With Acute Kidney Injury.|Recruiting||N/A|100|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 01:59:37.293355|2017-10-11 01:59:37.293355
NCT01790607|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-12-02|||February 2013||2013-02-01|December 2013|2013-12-01||||November 2013|Actual|2013-11-01||Interventional|||An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment|An Open-label, Single-dose,Intravenous Administration Study to Compare the Pharmacokinetics and Safety of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment With Matching Healthy Subjects|Completed||Phase 1|20|Actual|Ono Pharmaceutical Co. Ltd||5|||f||||f||||||||||2017-10-11 01:59:37.437071|2017-10-11 01:59:37.437071
NCT01790568|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-07-03|||December 2014||2014-12-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2017|Actual|2017-01-01||Interventional|||Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant|Pilot Trial of Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft Versus Host Disease Following Unrelated Donor Allogeneic Transplant|Active, not recruiting||Phase 2|38|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 01:59:38.125454|2017-10-11 01:59:38.125454
NCT01790555|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-10-22|||July 2013||2013-07-01|February 2013|2013-02-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Interventional|NamiSur||Perioperative Δ9-THC for Postsurgical Pain|The Analgesic Efficacy of Perioperative Δ9-THC (Namisol®) in Patients Undergoing Major Abdominal Surgery: A Randomized, Double Blinded, Placebo-controlled, Parallel Design|Unknown status|Recruiting|Phase 2|40|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-11 01:59:38.25617|2017-10-11 01:59:38.25617
NCT01790542|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-05-27|||December 2012||2012-12-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Infant Feeding||Assessment of Complementary Feeding of Canadian Infants|Assessment of Complementary Feeding of Canadian Infants|Completed||N/A|87|Actual|University of Manitoba||3|||f||||f||||||||||2017-10-11 01:59:38.379405|2017-10-11 01:59:38.379405
NCT01790529|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-09-28|||February 2013||2013-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2015|Actual|2015-07-01||Interventional|||Randomized Controlled Trial to Evaluate the Optimal Timing of Surgical Antimicrobial Prophylaxis|Randomized Controlled Trial to Evaluate the Optimal Timing of Surgical Antimicrobial Prophylaxis|Completed||Phase 4|5000|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 01:59:38.487928|2017-10-11 01:59:38.487928
NCT01790516|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2014-09-26|2014-06-03||May 2012||2012-05-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional||male, caucasian, adult over 18|Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer|A Pilot Prospective Clinical Trial to Use Pharmacogenetics (PGx) to Select Erbitux or Cisplatin to Treat Head and Neck Cancer|Terminated||N/A|2|Actual|Georgetown University||2||low accruals--2 patients were enrolled in over a year|f||||t||||||||||2017-10-11 01:59:38.587462|2017-10-11 01:59:38.587462
NCT01790503|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-09-20|||August 2013||2013-08-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma|An Open Label Phase 1b/2 Study of Orally Administered PLX3397 in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma|Active, not recruiting||Phase 1/Phase 2|65|Anticipated|Plexxikon||4|||f||||t||||||||||2017-10-11 01:59:38.912033|2017-10-11 01:59:38.912033
NCT01790490|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-06-13|2013-10-31||February 2011||2011-02-01|October 2013|2013-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Glutamatergic Modulation of Cocaine-related Deficits|The Effect of Ketamine on Reducing Cue Reactivity in Cocaine Users|Completed||Phase 2|8|Actual|New York State Psychiatric Institute||3|||f||||t||||||||||2017-10-11 01:59:39.039066|2017-10-11 01:59:39.039066
NCT01790477|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-04-05|||November 2012||2012-11-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Auricular Acupuncture for The Treatment of Post-Tonsillectomy Pain|Auricular Acupuncture for The Treatment of Post-Tonsillectomy Pain|Completed||N/A|134|Actual|United States Naval Medical Center, San Diego||2|||f||||t||||||||No||2017-10-11 01:59:39.33443|2017-10-11 01:59:39.33443
NCT01790464|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-09-15|||April 2012||2012-04-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Interventional|||Glossopharyngeal Nerve Block for Awake Intubation|Glossopharyngeal Nerve Blockade for Awake Videolaryngoscopy Assisted Endotracheal Intubation in the Morbidly Obese|Completed||N/A|24|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 01:59:39.402748|2017-10-11 01:59:39.402748
NCT01790451|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-02-19|||August 2013||2013-08-01|August 2014|2014-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans|The Safety and Efficacy of Irreversible Electroporation for the Ablation of Prostate Cancer Assessed by Procedural Related Side Effects and Post Prostatectomy Histology: A Prospective Human In-Vivo Study.|Completed||Phase 1|16|Actual|Clinical Research Office of the Endourological Society||2|||f||||t||||||||||2017-10-11 01:59:39.472228|2017-10-11 01:59:39.472228
NCT01790438|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-09-29||2014-09-29|March 2013||2013-03-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|IMAGINE 6||A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes|A Comparison of LY2605541 Versus Human Insulin NPH as Basal Insulin Treatment in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With 2 or More Oral Antihyperglycemic Medications: An Open-Label, Randomized Study|Completed||Phase 3|630|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 01:59:39.560771|2017-10-11 01:59:39.560771
NCT01790425|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-06-26|||August 2011|Actual|2011-08-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Randomized Controlled Trial Comparing Water vs. Air Method for Performing Colonoscopy in Adult Female Subjects|Randomized Controlled Trial Comparing Water vs. Air Method for Performing Colonoscopy in Adult Female Subjects|Completed||N/A|200|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 01:59:41.444785|2017-10-11 01:59:41.444785
NCT01790412|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-11|||February 2009||2009-02-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Gestational Diabetes: the Prevention|Gestational Diabetes. The Rol of Exercise in the Prevention|Completed||N/A|257|Actual|Technical University of Madrid||2|||f||||t||||||||||2017-10-11 01:59:41.535804|2017-10-11 01:59:41.535804
NCT01790399|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2014-03-05|||January 2013||2013-01-01|August 2013|2013-08-01|July 2014|Anticipated|2014-07-01|February 2014|Actual|2014-02-01||Interventional|SENTIMAG||IDENTIFICATION OF SENTINEL NODE(S) IN BREAST CANCER|IDENTIFICATION OF SENTINEL NODE(S) BY SENTIMAG® /SIENNA+ IN BREAST CANCER: FEASIBILITY STUDY|Unknown status|Active, not recruiting|N/A|115|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||||2017-10-11 01:59:41.611512|2017-10-11 01:59:41.611512
NCT01790386|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-12-16|||January 2013||2013-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Equivalency Study of the TEG and CORA Hemostasis Systems|Equivalency Study of the CORA(R) and TEG(R) 5000 Systems|Completed||N/A|465|Actual|Coramed Technologies LLC|||2||f||||f||||||||||2017-10-11 01:59:41.698643|2017-10-11 01:59:41.698643
NCT01629238|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-10-07|||October 2010||2010-10-01|October 2016|2016-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Characteristics of Plant Sterols Consumers in France||Completed||N/A|780|Actual|Danone Research|||2||f||||f||||||||||2017-10-11 02:48:18.883638|2017-10-11 02:48:18.883638
NCT01790373|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-07-19|||February 2013||2013-02-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence|Suubi+Adherence: Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence|Active, not recruiting||N/A|702|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:59:41.780353|2017-10-11 01:59:41.780353
NCT01790360|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-07-28|||July 2011||2011-07-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|September 2016|Actual|2016-09-01||Interventional|STAR||Seek, Test, and Retain. Linkages for Black HIV+, Substance-Using MSM|Seek, Test, and Retain. Linkages for Black HIV+, Substance-Using Men Who Have Sex With Men.|Active, not recruiting||N/A|1930|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 01:59:41.85965|2017-10-11 01:59:41.85965
NCT01790347|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-03-13|||September 2007||2007-09-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Physical Exercise Controls Gestational Weight Gain|The Role of a Supervised Physical Exercise Program as a Alternative on the Control of Maternal Gestational Weight Gain|Completed||N/A|2350|Actual|Technical University of Madrid||2|||f||||t||||||||||2017-10-11 01:59:41.939271|2017-10-11 01:59:41.939271
NCT01790334|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2013-08-28|||February 2013||2013-02-01|February 2013|2013-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|1 Day|Observational [Patient Registry]|USG-IJV||Effects of Different Modes of Ventilation and Head Position on Size of Vena Jugular Interna|Comparing the Size of the Vena Jugular Interna Under Spontaneous Ventilation and Different Mechanical Ventilation Modes When Head is in Neutral and 30 Degree Lateral Position:Clinical Trial|Completed||N/A|30|Actual|Istanbul University|||3||f||||f||||||||||2017-10-11 01:59:42.014219|2017-10-11 01:59:42.014219
NCT01790321|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-05-09|||February 2013||2013-02-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Water-based Zinc Efficacy Trial in Beninese Shool Children|Efficacy Study of Water as Fortification Vehicle for Zinc for Improving Zinc Status in Primary Schools Children in the Municipality of Natitingou, North of Benin.|Completed||N/A|278|Actual|Swiss Federal Institute of Technology||3|||f||||t||||||||||2017-10-11 01:59:42.089049|2017-10-11 01:59:42.089049
NCT01790308|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-11|||February 2013||2013-02-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function|Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function in Newly-diagnosed Type 2 Diabetic Patients|Unknown status|Enrolling by invitation|Phase 4|100|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 01:59:42.170285|2017-10-11 01:59:42.170285
NCT01790295|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-01-16|||February 2013||2013-02-01|January 2017|2017-01-01|February 2021|Anticipated|2021-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Ruxolitinib Prior to Transplant in Patients With Myelofibrosis|Exploring the Potential of Dual Kinase JAK 1/2 Inhibitor Ruxolitinib (INC424) With Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis|Active, not recruiting||Phase 2|21|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 01:59:42.415761|2017-10-11 01:59:42.415761
NCT01790282|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-12|||March 2013||2013-03-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|March 2014|Anticipated|2014-03-01||Interventional|||Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT|Is E2 Luteal Support in High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Cycle Outcome ? A Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|200|Anticipated|Mansoura Integrated Fertility Center||2|||f||||t||||||||||2017-10-11 01:59:42.567197|2017-10-11 01:59:42.567197
NCT01790269|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-08-01|||September 2013||2013-09-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod|Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod: a Monocentric, Prospective, One Year, Baseline-to-treatment, Open-label Single Group Pilot Trial|Recruiting||N/A|40|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 01:59:42.69515|2017-10-11 01:59:42.69515
NCT01790256|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-05-05||2015-02-02|January 2013||2013-01-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Comparison of Two Temperatures to Treat Insomnia|A Multi-center Prospective, Blinded, Randomized Crossover Study to Compare the Cerêve Sleep System at Two Different Temperatures in Primary Insomnia Patients|Completed||N/A|144|Actual|Cereve, Inc.||2|||f||||t||||||||||2017-10-11 01:59:42.792897|2017-10-11 01:59:42.792897
NCT01790243|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-03-30|||February 2013||2013-02-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||LEVANT 2 Safety Registry|A Prospective, Multicenter, Registry of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries (LEVANT 2 Safety Registry)|Active, not recruiting||N/A|34|Actual|C. R. Bard||1|||f||||f||||||||||2017-10-11 01:59:42.891096|2017-10-11 01:59:42.891096
NCT01790230|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-09-01|||January 2013||2013-01-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||LifeSeal™ Preliminary Study in Subjects Undergoing Low Anterior Resection|LifeSeal™ Preliminary Study in Subjects Undergoing Low Anterior Resection|Completed||N/A|10|Actual|LifeBond Ltd.||2|||f||||||||||||||2017-10-11 01:59:42.983928|2017-10-11 01:59:42.983928
NCT01790217|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)|GERMAN TARCEVA NON-INTERVENTIONAL STUDY in 1st Line Treatment of NSCLC EGFR Mutation Positive Patients|Completed||N/A|52|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:59:43.091034|2017-10-11 01:59:43.091034
NCT01790204|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-03-19|||February 2012||2012-02-01|November 2013|2013-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of the Effects of PEITC on Oral Cells With Mutant p53||Completed||Phase 1/Phase 2|55|Actual|Georgetown University||1|||f||||f||||||||||2017-10-11 01:59:43.176336|2017-10-11 01:59:43.176336
NCT01790191|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-13|||October 2010||2010-10-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Interventional|T221_HabEat||Comparison of Effect of Repeated Exposure, Flavor-Flavor and Flavor-Nutrient Learning on Vegetable Acceptance in Infants|Comparison of the Effect of Repeated Exposure, Flavor-Flavor Learning and Flavor-Nutrient Learning on Vegetable Acceptance in Weaning Age Infants|Completed||N/A|100|Actual|Centre des Sciences du Goût et de l'Alimentation||3|||f||||t||||||||||2017-10-11 01:59:43.276991|2017-10-11 01:59:43.276991
NCT01790178|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-11-14|2016-08-01||February 2013||2013-02-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ultrasound in Muscle Biopsy|Outcomes of Ultrasound-guided Versus Blind Core Muscle Biopsy|Completed||N/A|40|Actual|Duke University||2|||f||||f||||||||||2017-10-11 01:59:43.441783|2017-10-11 01:59:43.441783
NCT01790152|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2016-10-24|||August 2013||2013-08-01|October 2016|2016-10-01||||January 2019|Anticipated|2019-01-01||Observational|HEART||Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment|Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy|Recruiting||N/A|420|Anticipated|Children's Oncology Group|||1||f||||||||||||||2017-10-11 01:59:43.944049|2017-10-11 01:59:43.944049
NCT01790139|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-03-24|||February 2013||2013-02-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic Bubbles|Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic Bubbles|Completed||N/A|84|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 01:59:44.483741|2017-10-11 01:59:44.483741
NCT01790126|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-08-17|||March 4, 2013|Actual|2013-03-04|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer|The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer|Active, not recruiting||Phase 2|90|Actual|Aragon Pharmaceuticals, Inc.||3|||f||||f||f||||||||2017-10-11 01:59:44.57864|2017-10-11 01:59:44.57864
NCT01790113|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2017-08-18|||January 2013||2013-01-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Arthrex Eclipse™ Shoulder Prosthesis|A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease|Recruiting||N/A|350|Anticipated|Arthrex, Inc.||2|||f||||f||||||||||2017-10-11 01:59:44.702317|2017-10-11 01:59:44.702317
NCT01790100|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2014-06-23|||February 2013||2013-02-01|November 2013|2013-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C|A Randomized, Phase 2a, Partially-Blind, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C|Completed||Phase 2|20|Actual|Alios Biopharma Inc.||2|||f||||f||||||||||2017-10-11 01:59:44.899939|2017-10-11 01:59:44.899939
NCT01790087|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-05-18|||February 2013||2013-02-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||ANX-188 Thorough QT/QTc Study in Healthy Volunteers|A Four Period, Four-Arm, Crossover Design, Randomized, Placebo and Active Controlled Study for the Evaluation of the Effect of Therapeutic and Supratherapeutic Single-Dose ANX-188 on the QT/QTc Intervals in Healthy Volunteers|Completed||Phase 1|72|Actual|Mast Therapeutics, Inc.||4|||f||||t||||||||||2017-10-11 01:59:45.008127|2017-10-11 01:59:45.008127
NCT01790074|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2013-02-12|||October 2010||2010-10-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Trigger Point Therapy in Cervicogenic Headache|MANUAL TREATMENT OF ACTIVE TRIGGER POINTS IN THE STERNOCLEIDOMASTOID MUSCLE IN PATIENTS WITH CERVICOGENIC HEADACHE: A PILOT RANDOMIZED CLINICAL TRIAL|Completed||N/A|20|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 01:59:45.12438|2017-10-11 01:59:45.12438
NCT01790061|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2014-11-21|||November 2012||2012-11-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||Standardized Fecal Microbiota Transplantation for Ulcerative Colitis|Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation in Patients With Moderate to Severe Ulcerative Colitis|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|The Second Hospital of Nanjing Medical University||2|||f||||t||||||||||2017-10-11 01:59:45.215877|2017-10-11 01:59:45.215877
NCT01790048|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-08|||February 2013||2013-02-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|June 2013|Anticipated|2013-06-01||Interventional|||Whey Permeate Study|Comparison of a Novel Ready-to-use Supplementary Food (RUSF) With Whey Permeate to Standard Peanut/Soy RUSF for the Treatment of Moderate Acute Malnutrition in Rural Malawian Children: a Randomised, Double-blinded, Clinical Effectiveness Trial|Unknown status|Recruiting|N/A|1800|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 01:59:45.333974|2017-10-11 01:59:45.333974
NCT01790035|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-08-02|||August 19, 2014|Actual|2014-08-19|August 2017|2017-08-01|December 31, 2023|Anticipated|2023-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|LGG||Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer|A Phase I and Randomized Controlled Phase II Trial of the Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer|Recruiting||Phase 1/Phase 2|120|Anticipated|Washington University School of Medicine||3|||f||||t|t|f||||||||2017-10-11 01:59:45.458987|2017-10-11 01:59:45.458987
NCT01790022|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2013-02-09|||July 2012||2012-07-01|February 2013|2013-02-01||||March 2013|Anticipated|2013-03-01||Interventional|METALL||Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL)|Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL) - a 12-week, Prospective, Open-label, Pilot Study|Unknown status|Active, not recruiting|Phase 2|20|Actual|Saratov State Medical University||1|||f||||||||||||||2017-10-11 01:59:45.581478|2017-10-11 01:59:45.581478
NCT01790009|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-08|||February 2011||2011-02-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Influence of Age on the Absorption and Metabolism of Cocoa Flavanols|Influence of Age on the Absorption and Metabolism of Cocoa Flavanols|Completed||Phase 1|40|Actual|University of Reading||3|||f||||f||||||||||2017-10-11 01:59:45.665649|2017-10-11 01:59:45.665649
NCT01789996|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2017-08-15|||June 2010||2010-06-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||The Six Minute Walk Test: Influence of Instruction on Results|Alternative Instruction in Six Minute Walk Test (6MWT)|Completed||N/A|45|Actual|Inova Health Care Services||2|||f||||f||||||||||2017-10-11 01:59:45.758347|2017-10-11 01:59:45.758347
NCT01789983|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-07-26|||October 2012||2012-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2014|Actual|2014-09-01||Observational|WWE||Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy|Feasibility of an Evidence-based Walking Program in a Sample of Cancer Patients >60 Years of Age Undergoing Cytotoxic Chemotherapy|Active, not recruiting||N/A|29|Actual|UNC Lineberger Comprehensive Cancer Center|||3||f||||t||||||Samples Without DNA|"     Whole Blood Sample   "|||2017-10-11 01:59:45.857409|2017-10-11 01:59:45.857409
NCT01789970|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-06-02|2017-02-19|2015-03-23|March 2013||2013-03-01|June 2017|2017-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Intent to treat population|Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 30 to 90 mg Every 12 Hours for Relief of Moderate to Severe Pain in Patients With Chronic Low Back Pain Who Require Opioid Treatment for an Extended Period of Time|Completed||Phase 3|625|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 01:59:46.00277|2017-10-11 01:59:46.00277
NCT01789957|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-11|2015-02-23|||September 2002||2002-09-01|January 2015|2015-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Extension Study for 2993-112|An Open-Label Extension Study of Protocol 2993-112 to Examine the Long-Term Effect on Glucose Control (HbA1c) and Safety and Tolerability of AC2993 Given Two Times a Day to Subjects Treated With Metformin Alone|Completed||Phase 3|225|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 01:59:47.525776|2017-10-11 01:59:47.525776
NCT01789944|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-05-19|||January 2013||2013-01-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Parent Partnership Project|Peer Counseling in Family-Based Pediatric Overweight Treatment|Completed||N/A|34|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 01:59:48.054085|2017-10-11 01:59:48.054085
NCT01789931|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-05-07|||December 2014||2014-12-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|lifebeam||"Examination of a New Non Invasive Sensor Lifebeam During HTT in Protective Clothing"|"Examination of a New Non Invasive Sensor Lifebeam During HTT (Heat Tolerance Test) in Protective Clothing"|Unknown status|Not yet recruiting|N/A|10|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 01:59:48.14713|2017-10-11 01:59:48.14713
NCT01789918|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-04-04|||February 2013||2013-02-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|ACHIEVE||TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE)|TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation|Active, not recruiting||N/A|96|Actual|ReCor Medical, Inc.||1|||f||||f||||||||||2017-10-11 01:59:48.238814|2017-10-11 01:59:48.238814
NCT01789905|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-09-01|||April 15, 2013|Actual|2013-04-15|September 2017|2017-09-01|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Observational|TIGER||Tygacil Drug Use Investigation|Tygacil Drug Use Investigation (Tigecycline Evaluation Study For Safety And Effectiveness In Patient Infected With Multi-drug Resistance.)|Completed||N/A|116|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 01:59:48.35225|2017-10-11 01:59:48.35225
NCT01789892|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-08|||June 2011||2011-06-01|February 2013|2013-02-01||||January 2013|Actual|2013-01-01||Interventional|||Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer|FDG PET/CT: Reducing False Positive Mediastinal Uptake by Premedicating With Methylprednisolone|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center||1||no patient accrual|f||||t||||||||||2017-10-11 01:59:48.436028|2017-10-11 01:59:48.436028
NCT01789879|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-03-31|||June 2013||2013-06-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy|A Pharmacokinetic Evaluation of Levonorgestrel Implant and Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in HIV-infected Ugandan Women|Completed||Phase 2|60|Actual|University of Nebraska||3|||f||||f||||||||No||2017-10-11 01:59:48.534111|2017-10-11 01:59:48.534111
NCT01789866|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-04-14|||September 2012||2012-09-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||DHA & Lutein and fMRI Brain Mapping in Healthy Children|Dynamic Roles of Dietary Docosahexaenoic Acid (DHA) and Lutein in Brain Function in Healthy Children|Completed||N/A|62|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 01:59:48.646418|2017-10-11 01:59:48.646418
NCT01789853|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-09-08|||October 2008||2008-10-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|VIEWS||Very Intensive Early Walking in Stroke|Improving the Delivery of Intensive Gait Training in the Clinical Setting to Augment Community Ambulation|Completed||N/A|56|Actual|Shirley Ryan AbilityLab||2|||f||||t||||||||||2017-10-11 01:59:48.726254|2017-10-11 01:59:48.726254
NCT01789840|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-06-30|||July 2013||2013-07-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|June 2017|Actual|2017-06-01||Interventional|||Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia|Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia|Active, not recruiting||Phase 3|186|Anticipated|Merit Medical Systems, Inc.||2|||f||||t||||||||||2017-10-11 01:59:48.816092|2017-10-11 01:59:48.816092
NCT01789827|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-05-23|||March 2014|Actual|2014-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy|Interleukin-2 Imaging as a Guide to Cancer Immunotherapy (Ipilimumab or Pembrolizumab) in Advanced Melanoma: A Pilot Study|Active, not recruiting||N/A|12|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 01:59:48.930414|2017-10-11 01:59:48.930414
NCT01789814|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-03-31|2015-12-03||July 2013||2013-07-01|March 2017|2017-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation|The Effect of Prasugrel as Compared to Clopidogrel on Platelet Function Immediately Following the Termination of Intravenous Bivalirudin in Patients Undergoing Percutaneous Coronary and Structural Cardiac Intervention|Completed||Phase 4|24|Actual|Tufts Medical Center||2|||f||||f||||||||||2017-10-11 01:59:49.03982|2017-10-11 01:59:49.03982
NCT01789801|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-09|2016-06-16|||February 2014||2014-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|ECHO-PARDIF||A Randomized Study Evaluating the Role of Ultra-sound Guidance When Drawing Radial Arterial Blood Samples|A Randomized Study Evaluating the Role of Ultra-sound Guidance When Drawing Radial Arterial Blood Samples|Completed||N/A|74|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 01:59:49.455099|2017-10-11 01:59:49.455099
NCT01789788|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-11-01|||March 2013||2013-03-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus|A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO6811135 in Patients With Type 2 Diabetes Mellitus.|Completed||Phase 1|56|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 01:59:49.543496|2017-10-11 01:59:49.543496
NCT01789710|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-06-10|||January 2013||2013-01-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Contingency Management for Smoking Cessation in Homeless Smokers|Contingency Management for Smoking Cessation in Homeless Smokers|Completed||N/A|25|Actual|Duke University||1|||f||||f||||||||||2017-10-11 01:59:49.621907|2017-10-11 01:59:49.621907
NCT01789697|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-05-26|||September 2012||2012-09-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Text Message Study|Using Mobile Phone Text Messaging and E-mailing to Decrease Anxiety, Pain, Follow-up Visits and Improve Reporting of Surgical Site Infection After Spine Surgery: A Double-Blind Randomized Trial|Completed||N/A|194|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 01:59:49.701804|2017-10-11 01:59:49.701804
NCT01789684|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-07-10|||February 2014||2014-02-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|SCUSF 1102||Cluster Randomized Trial Comparing Interventions to Enhance Genetic Counseling Among Breast Cancer Patients|A Cluster Randomized Controlled Trial Comparing Interventions to Enhance Utilization of Genetics Services Among Breast Cancer Patients|Recruiting||N/A|3780|Anticipated|University of South Florida||2|||f||||t||||||||||2017-10-11 01:59:49.774588|2017-10-11 01:59:49.774588
NCT01789671|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-05-19|||September 2012||2012-09-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|EPICH||Peer Counseling in Family-Based Treatment for Childhood Obesity|Peer Counseling in Family-Based Treatment for Childhood Obesity|Completed||N/A|33|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 01:59:50.003707|2017-10-11 01:59:50.003707
NCT01789658|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-10-26|||October 2012||2012-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Cryotherapy for Prevention of Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation|A Randomized Controlled Trial of Cryotherapy for Prevention and Reduction of Severity of Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation.|Completed||N/A|53|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 01:59:50.137677|2017-10-11 01:59:50.137677
NCT01789645|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-08-16|||February 2013||2013-02-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Interventional|||Physical Therapy in Carpal Tunnel Syndrome|Efficacy of Conservative Versus Surgical Therapy for Carpal Tunnel Syndrome: a Randomised Clinical Trial|Completed||N/A|120|Actual|Universidad Rey Juan Carlos||2|||f||||t||||||||||2017-10-11 01:59:50.27793|2017-10-11 01:59:50.27793
NCT01789632|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-02-20|||January 2013||2013-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|IMPROVE||Impact of Platelet Rich Plasma Over Alternative Therapies in Patients With Lateral Epicondylitis|Impact of Platelet Rich Plasma Over Alternative Therapies With Lateral Epicondylitis (IMPROVE): A Multicenter, Randomized Trial Comparing Autologous Whole Blood vs. Dry Needle Tendon Fenestration of Pain and Quality of Life in Patients With Lateral Epicondylitis.|Active, not recruiting||Phase 2|20|Anticipated|University of Michigan||4|||f||||t||||||||No||2017-10-11 01:59:50.379992|2017-10-11 01:59:50.379992
NCT01789619|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-05-28|||October 2012||2012-10-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients|Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients|Completed||Phase 2|9|Actual|UMC Utrecht|||1||f||||f||||||||||2017-10-11 01:59:50.512936|2017-10-11 01:59:50.512936
NCT01789606|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-07-24|2017-07-24|2014-07-25|September 24, 2012|Actual|2012-09-24|July 2017|2017-07-01|June 3, 2013|Actual|2013-06-03|June 3, 2013|Actual|2013-06-03||Interventional||Analysis population included all the participants who were randomized in the study.|Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet|Ibuprofen 600 Mg Immediate Release/Extended Release (IR/ER) Caplet Self-selection, Safety And Compliance Study|Completed||Phase 3|1083|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 01:59:50.653768|2017-10-11 01:59:50.653768
NCT01789593|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-06-11|||January 2013||2013-01-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes|A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes|Completed||Phase 1|29|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:59:51.326159|2017-10-11 01:59:51.326159
NCT01789580|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-01-28|||February 2013||2013-02-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|MOD&JEU||MOD&JEU: Moderators of Online Gambling, How Effective?|Moderators of Online Gambling, How Effective? Experimental, Controlled and Randomized Study.|Recruiting||N/A|485|Anticipated|Nantes University Hospital||5|||f||||||||||||||2017-10-11 01:59:51.425361|2017-10-11 01:59:51.425361
NCT01789554|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-09-10|||October 2012||2012-10-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|RUMBA||The Use of Mobile Phones in Out of Hospital Cardiac Arrest to Increase Bystander CPR|The Response to Urgent Mobile Message for Bystander Activation (RUMBA) Trial - The Use of Mobile Phone Positioning for Dispatch of Bystanders to Out of Hospital Cardiac Arrest.|Completed||N/A|600|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 01:59:51.663122|2017-10-11 01:59:51.663122
NCT01789541|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-01-19|||February 2013||2013-02-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Observational|TABLAS||Is a Low Thyreotropin Level Predictive of Recurrent Arrhythmia After Catheter Ablative Surgery?|Observational Prospective Case-control Study on Prevalence and Impact of Subclinical Hyperthyroidism in Patients Undergoing Atrial Fibrillation Ablation|Completed||N/A|327|Actual|Karolinska Institutet|||2||f||||f||||||||||2017-10-11 01:59:51.780637|2017-10-11 01:59:51.780637
NCT01789528|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-09-01|||August 2013||2013-08-01|September 2017|2017-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers|A Phase 1, Open-label, Multiple-dose, Single Centre Study to Investigate the Effect of Administration of CAZ-AVI and CXL on the Intestinal Flora of Healthy Volunteers.|Completed||Phase 1|48|Actual|Pfizer||1|||f||||||||||||||2017-10-11 01:59:51.882184|2017-10-11 01:59:51.882184
NCT01789515|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2014-03-11|||May 2012||2012-05-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Defunctioning Stoma and Postoperative Morbidity|Diverting Stoma and Postoperative Morbidity After Low Anterior Resection for Rectal Cancer Within an Enhanced Recovery After Surgery,ERAS, Program|Completed||N/A|287|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 01:59:52.015821|2017-10-11 01:59:52.015821
NCT01789502|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-08-02|||January 2012||2012-01-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Comparison Between Fully Covered Metal Stents and Plastic Stents in Preoperative Biliary Drainage|Are Fully Covered Metal Stents Superior to Plastic Stents for Preoperative Biliary Decompression in Malignant Distal Bile Duct Obstruction?|Completed||N/A|86|Actual|Inje University||2|||f||||t||||||||||2017-10-11 01:59:52.1416|2017-10-11 01:59:52.1416
NCT01789489|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-09-22|||July 2010||2010-07-01|September 2016|2016-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||3D Ultrasound - Based Hysteroscopy Versus Virtual Hysteroscopy|Contribution of 3D Sonohysterography and Virtual Hysteroscopy in Exploration of the Uterine Cavity in Comparison to the Diagnostic Hysteroscopy.|Terminated||N/A|3|Actual|Hopital Foch||2||recruitment difficulties|f||||f||||||||||2017-10-11 01:59:52.286582|2017-10-11 01:59:52.286582
NCT01789476|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-04-14|2015-03-30||May 2013||2013-05-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Safety population|A Phase 2 Study to Evaluate Analgesic Effect of IV CR845 For Pain Following Bunionectomy Surgery|A Single-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of CR845 Dosed in Patients With Pain Following Bunionectomy Surgery|Completed||Phase 2|51|Actual|Cara Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 01:59:52.402026|2017-10-11 01:59:52.402026
NCT01789463|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-04-19|||April 2010||2010-04-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Physiotherapy and Capsulitis|Physiotherapy Versus Self Rehabilitation After Shoulder Dilatation for Primary Idiopathic Capsulitis|Terminated||N/A|10|Actual|Hopital Foch||2||recruitment difficulties|f||||f||||||||||2017-10-11 01:59:52.985051|2017-10-11 01:59:52.985051
NCT01789450|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-04-26|||June 2013||2013-06-01|April 2013|2013-04-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Nipple-Areola Complex Sensitivity After the Section of Periareolar Dermis in Breast Reduction||Unknown status|Not yet recruiting|N/A|50|Anticipated|Universidade Federal de Pernambuco||1|||f||||t||||||||||2017-10-11 01:59:53.075465|2017-10-11 01:59:53.075465
NCT01789437|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-02-08|||June 2011||2011-06-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|||Diameters and Wall-to-lumen Ratio of Retinal Arterioles in Patients With Retinal Vein Occlusion.|Diameters and Wall-to-lumen Ratio of Retinal Arterioles in Patients With Retinal Vein Occlusion.|Completed||N/A|30|Actual|Università degli Studi di Brescia||1|||f||||t||||||||||2017-10-11 01:59:53.1858|2017-10-11 01:59:53.1858
NCT01789424|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-03-13|||May 2012||2012-05-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|SwallSed||Valuation of Swallowing in Patient Sedated for Gastroenteric Endoscopic Procedure|Valuation of Airway Protection (Swalling) in Patient Sedated for Gastroenteric Endoscopic Procedure|Completed||N/A|80|Actual|Ospedale San Raffaele|||1||f||||f||||||||||2017-10-11 01:59:53.300011|2017-10-11 01:59:53.300011
NCT01789411|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-11|||November 2008||2008-11-01|February 2013|2013-02-01||||December 2013|Anticipated|2013-12-01||Observational|AtheroRemoIVUS||The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound Study|The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound Study|Unknown status|Active, not recruiting|N/A|800|Anticipated|Erasmus Medical Center|||1||f||||f||||||Samples With DNA|"     Arterial blood samples   "|||2017-10-11 01:59:53.405931|2017-10-11 01:59:53.405931
NCT01789398|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-11-17|||September 2012||2012-09-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|HARMONY IV||Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)|Double Blind Randomized Study to Assess the Efficacy of BF2.649 Compared to Placebo in add-on to Sodium Oxybate in the Treatment of Narcoleptic Patients With Residual Excessive Daytime Sleepiness (EDS) During 8 Weeks|Completed||Phase 3|51|Actual|Bioprojet||2|||f||||f||||||||||2017-10-11 01:59:53.533052|2017-10-11 01:59:53.533052
NCT01789385|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-02|2014-05-19|||February 2013||2013-02-01|February 2013|2013-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Anesthesia for Deep Brain Stimulation|Anesthesia for Deep Brain Stimulation for the Treatment of Parkinsons Disease|Completed||Phase 4|26|Actual|Diskapi Teaching and Research Hospital||1|||f||||f||||||||||2017-10-11 01:59:53.657002|2017-10-11 01:59:53.657002
NCT01789372|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-11|||December 2009||2009-12-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation|Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation|Completed||N/A|80|Actual|Danderyd Hospital|||1||f||||t||||||||||2017-10-11 01:59:53.77829|2017-10-11 01:59:53.77829
NCT01789359|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-08|||November 2012||2012-11-01|October 2012|2012-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Urinary Excretion of Anthocyanins During Long Term Blueberry Feeding|Urinary Excretion of Anthocyanins During Long Term Blueberry Feeding|Completed||N/A|17|Actual|Atlantic Food and Horticulture Research Center||1|||f||||f||||||||||2017-10-11 01:59:53.851539|2017-10-11 01:59:53.851539
NCT01789346|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-07-25|||February 2013||2013-02-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Interventional|||Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars||Completed||Phase 4|20|Actual|Cutera Inc.||2|||f||||f||||||||||2017-10-11 01:59:53.931267|2017-10-11 01:59:53.931267
NCT01789333|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-09-27|||August 2010||2010-08-01|September 2017|2017-09-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Interventional|||Higher Irradiance in Keratoconus Ectasia|Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross- Linking at Higher Irradiances in Patients With Keratoconus or Ectasia|Recruiting||N/A|30|Anticipated|Columbia University||1|||f||||f||||||||||2017-10-11 01:59:54.023444|2017-10-11 01:59:54.023444
NCT01789320|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-07-25||2016-07-25|February 2013||2013-02-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis|Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis|Completed||Phase 1/Phase 2|11|Actual|Clearside Biomedical, Inc.||1|||f||||f||||||||||2017-10-11 01:59:54.12943|2017-10-11 01:59:54.12943
NCT01789307|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-07-03|||January 2013||2013-01-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Lactose, Sucrose & Corn Syrup Tolerance|Lactose: A Unique Carbohydrate Enabling Homeostatic Regulation of Blood Glucose & Insulin|Completed||N/A|16|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 01:59:54.235341|2017-10-11 01:59:54.235341
NCT01789294|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-08|||November 2008||2008-11-01|November 2008|2008-11-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Interventional|||Clinical Management of Childhood Intestinal Lymphoid Nodular Hyperplasia|CLINICAL MANAGEMENT OF CHILDHOOD INTESTINAL LYMPHOID NODULAR HYPERPLASIA: A RANDOMIZED CONTROLLED CLINICAL TRIAL.|Unknown status|Recruiting|Phase 4|270|Anticipated|Azienda Policlinico Umberto I||3|||f||||t||||||||||2017-10-11 01:59:54.308505|2017-10-11 01:59:54.308505
NCT01789281|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-12-04|||May 2013||2013-05-01|December 2016|2016-12-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|||Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.|An Open-label, Multi-center Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study and Are Judged by the Investigator to Benefit From Continued Everolimus Treatment|Recruiting||Phase 4|52|Anticipated|Novartis||1|||f||||||||||||||2017-10-11 01:59:54.417903|2017-10-11 01:59:54.417903
NCT01789268|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-09-14|||March 27, 2013|Actual|2013-03-27|April 5, 2017|2017-04-05|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||Impact of Respiratory Pathogens in Infants|Impact of Respiratory Virus Infections and Bacterial Microbiome Shifts on Lymphocyte and Respiratory Function in Infants Born Prematurely or Full Term|Active, not recruiting||N/A|267|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||f|t|f|f|f|||||2017-10-11 01:59:54.739143|2017-10-11 01:59:54.739143
NCT01789255|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-10-13|2015-08-26||June 2013||2013-06-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies|A Pilot Trial of Vorinostat Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease Following Unrelated Donor Hematopoietic Stem Cell Transplantation|Completed||Phase 2|12|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 01:59:54.885966|2017-10-11 01:59:54.885966
NCT01789242|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-09-18|||February 2013||2013-02-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|December 2016|Actual|2016-12-01||Interventional|||A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis|A Phase I Dose Escalation Study of Carfilzomib in Patients With Previously-Treated Systemic Light-Chain (AL) Amyloidosis|Completed||Phase 1|32|Actual|Academic Myeloma Consortium||1|||f||||f||||||||||2017-10-11 01:59:55.321714|2017-10-11 01:59:55.321714
NCT01789229|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-09-28|||September 2003||2003-09-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Tumor Bank for Tissue Samples|Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology|Unknown status|Recruiting|N/A|10000|Anticipated|Medical University of Vienna|||3||f||||t||||||Samples With DNA|"     Universal tumor bank   "|||2017-10-11 01:59:55.470213|2017-10-11 01:59:55.470213
NCT01789203|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-03-15|||January 2013||2013-01-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Ciprofloxacin for Prevention of BK Infection|Ciprofloxacin for Prevention of BK Infection in Renal Transplant Recipients|Recruiting||Phase 4|180|Anticipated|The Methodist Hospital System||2|||f||||f||||||||||2017-10-11 01:59:55.89814|2017-10-11 01:59:55.89814
NCT01789190|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-07|||January 2011||2011-01-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01|24 Months|Observational [Patient Registry]|Honeymoon||Regular Physical Exercise Extends Honeymoon Phase in Type 1 Diabetes Subjects|Observational Study: Regular Physical Exercise Extends Honeymoon Phase in Type 1 Diabetes Subjects|Terminated||N/A|19|Actual|University Hospital A Coruña|||2|The study has concluded normally|f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:59:56.067701|2017-10-11 01:59:56.067701
NCT01789177|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-03-05|||January 2013||2013-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Use of Disposable Spirometer for Recovery of Pulmonary Function|Use of Disposable Spirometer for Recovery of Pulmonary Function by Peak Expiratory Flow Measurement Following Exploratory Laparotomy|Completed||N/A|150|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 01:59:56.177066|2017-10-11 01:59:56.177066
NCT01789164|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-12-30|||January 2013||2013-01-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Observational|||Measure of Cerebrovascular Dysfunction After TBI With fNIRS|Measure of Cerebrovascular Dysfunction After Truamatic Brain Injury With Functional Near Infrared Spectroscopy|Recruiting||N/A|100|Anticipated|Uniformed Services University of the Health Sciences|||2||f||||f||||||||||2017-10-11 01:59:56.29809|2017-10-11 01:59:56.29809
NCT01789151|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-10-27||||||October 2016|2016-10-01||||||||Expanded Access|||99m-Technetium- Glucosamine in Arthritis|99mTc-labelled D-Glucosamine in the Evaluation of Disease Activity in Patients With Degenerative and Inflammatory Rheumatic Conditions|No longer available||N/A|||University of Sydney|||||f||||||||||||||2017-10-11 01:59:56.398032|2017-10-11 01:59:56.398032
NCT01789138|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-02-08|2015-12-31||January 2013||2013-01-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Adherence Support Intervention for Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in Estonia|Randomized Controlled Trial of Situated Optimal Adherence Intervention Estonia (sOAI Estonia) Among Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in Estonia|Completed||N/A|519|Actual|University of Tartu||2|||f||||f||||||||Undecided|Currently considering.|2017-10-11 01:59:56.502258|2017-10-11 01:59:56.502258
NCT01789125|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-07-27|||March 2012||2012-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|START||Smoking Termination / Anxiety Reduction Treatment (ST/ART)|Augmenting Smoking Cessation With Transdiagnostic CBT for Smokers With Anxiety|Completed||Phase 1|74|Actual|University of Houston||2|||f||||t||||||||||2017-10-11 01:59:56.940463|2017-10-11 01:59:56.940463
NCT01789112|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-09-22|||May 2012||2012-05-01|September 2015|2015-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||Acute Neurotrophic Effects of a Non Excitatory Cardial Stimulation by Optimizer III System in Patients With Heart Failure|Acute Neurotrophic Effects of a Non Excitatory Cardial Stimulation by Optimizer III System in Patients With Heart Failure|Unknown status|Recruiting|N/A|40|Anticipated|RWTH Aachen University||1|||f||||||||||||||2017-10-11 01:59:57.038468|2017-10-11 01:59:57.038468
NCT01789099|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-03-31|||February 2013||2013-02-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|UV1-hTERT2012L||A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.|A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.|Active, not recruiting||Phase 1/Phase 2|18|Actual|Ultimovacs AS||1|||f||||t||||||||||2017-10-11 01:59:57.135482|2017-10-11 01:59:57.135482
NCT01789086|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-12-21|||February 2013||2013-02-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years|A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years|Completed||Phase 1|21|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 01:59:57.238605|2017-10-11 01:59:57.238605
NCT01789073|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-12-20|||February 2013||2013-02-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay|Randomized, Controlled Trial Investigating the Effect of Preoperative Oral Immunonutrition on Complications and Length of Hospital Stay After Elective Surgery for Pancreatic Cancer|Completed||N/A|35|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 01:59:57.338313|2017-10-11 01:59:57.338313
NCT01789060|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-02-07|||December 2012||2012-12-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||p-AKT Expression on Clinical Outcomes in Malignant Lymphoma|The Impact of Activated p-AKT Expression on Clinical Outcomes in Malignant Lymphoma : A Clinicopathological Study|Completed||N/A|262|Actual|Samsung Medical Center|||1||f||||f||||||Samples Without DNA|"     paraffin-embedded biopsy specimen or unstained slides for immunostaining of p-AKT   "|||2017-10-11 01:59:57.426534|2017-10-11 01:59:57.426534
NCT01789034|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-11|||June 2011||2011-06-01|February 2013|2013-02-01|June 2013|Anticipated|2013-06-01|February 2013|Actual|2013-02-01||Observational|||Difficult Intubation With Glidescope Video Laryngoscope|Incidence and Predictors of Difficult Intubation Adopting an Institutional Algorithm Glidescope Based: a Cohort Study|Unknown status|Recruiting|N/A|2600|Anticipated|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta|||1||f||||f||||||||||2017-10-11 01:59:57.603338|2017-10-11 01:59:57.603338
NCT01789021|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2015-06-17|||February 2013||2013-02-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|IDT-1206-BA||Analytical Performance Evaluation of Blood Glucose Monitoring Systems- Investigator Sponsored Contour® XT Comparator Study - Ulm Germany|Analytical Performance Evaluation of Blood Glucose Monitoring Systems|Completed||N/A|120|Anticipated|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm|||||f||||||||||||||2017-10-11 01:59:57.678436|2017-10-11 01:59:57.678436
NCT01789008|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-06-30|||February 2013|Actual|2013-02-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|FIBR-OH||Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.|Interest of Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Didease in Alcoholic Patients in Weaning.|Active, not recruiting||N/A|300|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 01:59:57.74951|2017-10-11 01:59:57.74951
NCT01788995|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-09-07|||October 15, 2012|Actual|2012-10-15|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|||BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer|A Non-interventional Trial With Avastin as Front-line Treatment for Ovarian Cancer|Active, not recruiting||N/A|63|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 01:59:57.860262|2017-10-11 01:59:57.860262
NCT01788982|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2016-10-11|||May 2014||2014-05-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||Nintedanib(BIBF1120) in Thyroid Cancer|A Phase II Study Exploring the Safety and Efficacy of Nintedanib (BIBF1120) as Second Line Therapy for Patients With Either Differentiated or Medullary Thyroid Cancer Progressing After First Line Therapy.|Recruiting||Phase 2|143|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 01:59:57.942335|2017-10-11 01:59:57.942335
NCT01788969|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-12-26|||June 2005||2005-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Serotonergic Modulation of Motor Function in Subacute and Chronic SCI|Serotonergic Modulation of Motor Function in Subacute and Chronic SCI|Active, not recruiting||Phase 1|42|Actual|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 01:59:58.106036|2017-10-11 01:59:58.106036
NCT01435434|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2014-03-03||||||March 2014|2014-03-01||||||||Interventional|||Mononucleotide Autologous Stem Cells and Demineralized Bone Matrix in the Treatment of Non Union/Delayed Fractures||Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 03:49:45.269682|2017-10-11 03:49:45.269682
NCT01788956|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-09-25|||October 2014||2014-10-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Comparison of Central Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous Catheter|Correlation of Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter vs Central Venous Oxygen Saturation, Measured by a CO-Oximeter.|Unknown status|Active, not recruiting|N/A|40|Anticipated|Mespere Lifesciences Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 01:59:58.195041|2017-10-11 01:59:58.195041
NCT01788930|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-09-27|||February 2013||2013-02-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|July 2017|Actual|2017-07-01||Interventional|AREAS||Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients|Obstructive Sleep Apnea and Aspirin Resistance in Type-2 Diabetic Patients|Recruiting||N/A|286|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 01:59:58.355861|2017-10-11 01:59:58.355861
NCT01788917|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-07|||September 2009||2009-09-01|February 2013|2013-02-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Effects of Supplementation With Linseed Oil on Blood Lipids in Vegetarians|Effects of Supplementation With Linseed Oil on Blood Lipids and Fatty Acid Profile in Plasma and Erythrocyte Lipids in Vegetarians|Completed||N/A|10|Actual|University of Jena||1|||f||||f||||||||||2017-10-11 01:59:58.467171|2017-10-11 01:59:58.467171
NCT01788904|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-12-11|||February 2013||2013-02-01|December 2013|2013-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|FARAMIS||Plasma i-FABP as Predictor for Irreversible Bowel Ischemia|Plasma i-FABP as Predictor for Irreversible Bowel Ischemia After Interventional Re-vascularization in Patients With Acute Mesenteric Ischemia|Unknown status|Recruiting|N/A|24|Anticipated|University Hospital Regensburg|||1||f||||f||||||Samples With DNA|"     Blood plasma, blood serum, EDTA blood   "|||2017-10-11 01:59:58.539946|2017-10-11 01:59:58.539946
NCT01788891|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-05-09|||January 2011||2011-01-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|TASER-P||Second-line Therapy|TASER-Pediatrics: Prospective Monitoring of Second-line Antiretroviral Therapy Failure and Resistance in Children|Completed||N/A|300|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||f||||||Samples Without DNA|"     Blood and hair will be used for therapeutic drug monitoring (TDM). Blood drawn at every visit     will be used to assess CD4 count, viral load, and other basic chemistry test panel. If     necessary, drug resistant tests will also be carried out on the blood samples.   "|||2017-10-11 01:59:58.634785|2017-10-11 01:59:58.634785
NCT01788878|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-07-25|||February 2014||2014-02-01|July 2016|2016-07-01|May 2018|Anticipated|2018-05-01|August 2016|Anticipated|2016-08-01||Interventional|CARDEL||Cancer of the Upper Aero-digestive Tract and Socio-professional Future|Cancer of the Upper Aero-digestive Tract and Socio-professional Future|Active, not recruiting||N/A|46|Actual|Centre Oscar Lambret||1|||f||||f||||||||No||2017-10-11 02:00:00.352041|2017-10-11 02:00:00.352041
NCT01788865|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-02-07|||June 2012||2012-06-01|February 2013|2013-02-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|UVENTA||Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral Obstruction|Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA™) in Ureteral Obstruction: Prospective, Multi-center, Open Label Study|Unknown status|Recruiting|Phase 4|92|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 02:00:00.458132|2017-10-11 02:00:00.458132
NCT01788852|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-03-30|||December 2010||2010-12-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||HPV in Adolescents|Prevalence of HPV and Intraepithelial Neoplasia Biomarkers in Adolescents|Completed||N/A|27|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||3||f||||f||||||Samples With DNA|"     Cervical and anal pap smears specimens will be used for HPV typing. Blood will be collected     for STI and immune response to HPV/HIV testing   "|||2017-10-11 02:00:00.561113|2017-10-11 02:00:00.561113
NCT01788839|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-03-13|||February 2013||2013-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma|Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma|Recruiting||N/A|400|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples Without DNA|"     blood draw   "|||2017-10-11 02:00:00.649441|2017-10-11 02:00:00.649441
NCT01788800|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-05-15|||January 2009||2009-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Physical Activity and Cognitive Behavioural Therapy in Panic Disorder|The Influence of Physical Activity on the Effect of Cognitive Behavioural Therapy, Neurobiological Parameters and Information Processing in Patients With Panic Disorder With/Without Agoraphobia|Completed||N/A|46|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:00:00.938124|2017-10-11 02:00:00.938124
NCT01788787|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-07-07|||April 2013|Actual|2013-04-01|July 2017|2017-07-01|April 2049|Anticipated|2049-04-01|April 2049|Anticipated|2049-04-01||Observational|||Ask Advise Connect (AAC) Harris Heath CPRIT|Implementation of an Automated EMR System to Connect Smokers in a Safety Net Healthcare System With Smoking Cessation Treatment|Active, not recruiting||N/A|5212|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||Samples With DNA|"     Saliva sample to test for cotinine.   "|||2017-10-11 02:00:01.023957|2017-10-11 02:00:01.023957
NCT01788774|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-10-06|||April 2013||2013-04-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PRISMA-1||Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths|Phase I, Open-Label, Randomized, Parallel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of One Intramuscular Injection of Risperidone ISM® at Different Dose Strengths in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|36|Actual|Rovi Pharmaceuticals Laboratories||3|||f||||t||||||||||2017-10-11 02:00:01.279074|2017-10-11 02:00:01.279074
NCT01788761|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-04-10|||July 2012||2012-07-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effects of Probiotic Supplementation on Extremely Low Birthweight Infants|The Effects of Probiotic Supplementation on Extremely Low Birthweight Infants|Enrolling by invitation||N/A|150|Anticipated|Rockford Memorial Hospital||2|||f||||f||||||||No||2017-10-11 02:00:01.455599|2017-10-11 02:00:01.455599
NCT01788748|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-12-30|||February 2013||2013-02-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation of Fractional Bipolar Radiofrequency for the Treatment of Striae|Evaluation of Fractional Bipolar Radiofrequency, and Bipolar Radiofrequency Potentiated by Infrared, in Monotherapy or Combined, for the Treatment of Striae|Completed||N/A|22|Actual|Candela France||3|||f||||f||||||||||2017-10-11 02:00:01.670409|2017-10-11 02:00:01.670409
NCT01788735|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2013-02-08|||December 2011||2011-12-01|February 2013|2013-02-01|October 2014|Anticipated|2014-10-01|December 2013|Anticipated|2013-12-01||Observational|||Unexplained Infertility Among Asthmatic and Atopic Patients|Unexplained Infertility Among Asthmatic and Atopic Patients|Unknown status|Recruiting|N/A|396|Anticipated|Bispebjerg Hospital|||1||f||||t||||||Samples Without DNA|"     whole blod, serum   "|||2017-10-11 02:00:01.893308|2017-10-11 02:00:01.893308
NCT01788722|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-09-19|||July 19, 2013|Actual|2013-07-19|September 2017|2017-09-01|August 11, 2017|Actual|2017-08-11|August 11, 2017|Actual|2017-08-11||Observational|||Regulatory Post Marketing Surveillance Study in Korea|Visanne® (Dienogest 2mg) Regulatory Post Marketing Surveillance Study in Korea|Completed||N/A|3223|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:00:02.06681|2017-10-11 02:00:02.06681
NCT01788709|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2014-06-23|||January 2013||2013-01-01|January 2013|2013-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||PEG-Electrolyte Solution (FORTRANS®) With Mentholyptus Drops (Halls®) Versus Reduced Volume Ascorbic Acid Supplemented PEG-Electrolyte (MoviPrep®) in Colonoscopy Preparation|PEG-Electrolyte Solution (FORTRANS®) With Mentholyptus Drops (Halls®) Versus Reduced Volume Ascorbic Acid Supplemented PEG-Electrolyte (MoviPrep®) in Colonoscopy Preparation: A Randomised Controlled Study|Completed||Phase 4|200|Actual|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-11 02:00:02.197077|2017-10-11 02:00:02.197077
NCT01788696|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-06-11|||June 2012||2012-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects|Assessment of the Effect of Treatment Pathways, Adherence, and Treatment Efficacy in Parkinson's Disease Subjects Randomized to SPECT Imaging of the Dopamine Transporter (Ioflupane I123 Injection)|Completed||Phase 1|20|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:00:02.354574|2017-10-11 02:00:02.354574
NCT01788683|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-12-19|||February 2013||2013-02-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears|A Randomized Controlled Trial of Regenexx™ SD Versus Exercise Therapy for Treatment of Non-retracted Supraspinatus Tendon Tears|Recruiting||N/A|50|Anticipated|Regenerative Sciences, LLC||2|||f||||f||||||||No||2017-10-11 02:00:02.527359|2017-10-11 02:00:02.527359
NCT01788670|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-07|||May 2009||2009-05-01|February 2013|2013-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Relevance of the Ethanol Dose in the Generation of Endogenous Hydroxytyrosol|Hydroxytyrosol as an Endogenous and Natural Antioxidant: Modulation by Alcohol Intake. Substudy 1. Evaluating the Relevance of the Ethanol Dose in the Generation of Endogenous Hydroxytyrosol (DOPET).|Completed||Phase 1|24|Actual|Parc de Salut Mar||3|||f||||f||||||||||2017-10-11 02:00:02.707782|2017-10-11 02:00:02.707782
NCT01788657|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-07|||March 2013||2013-03-01|February 2013|2013-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|KONRAD||iCBT for Depression - Standard Versus Condensed Treatment Material|Internet-based Cognitive Behavior Therapy for Depression With Standard Treatment Material Compared to a Condensed Version|Unknown status|Not yet recruiting|N/A|300|Anticipated|Örebro County Council||2|||f||||f||||||||||2017-10-11 02:00:02.852982|2017-10-11 02:00:02.852982
NCT01788644|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-08-15|||February 2013|Actual|2013-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Observational|Nurture||Early Child Care and Risk of Obesity|Nurture: Early Child Care and Risk of Obesity|Active, not recruiting||N/A|1000|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"     saliva, fecal   "|||2017-10-11 02:00:02.997679|2017-10-11 02:00:02.997679
NCT01788618|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2017-07-27|||July 2012||2012-07-01|August 2015|2015-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||"Cancer and Disorders of Cognitive Functions and Quality of Life: Cognitive Rehabilitation in Patients Suffering From Cancer and Treated With Chemotherapy"|"Cancer and Disorders of Cognitive Functions and Quality of Life: Cognitive Rehabilitation in Patients Suffering From Cancer and Treated With Chemotherapy"|Completed||N/A|168|Actual|Centre Francois Baclesse||3|||f||||f||||||||||2017-10-11 02:00:03.315793|2017-10-11 02:00:03.315793
NCT01788605|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-12-05|||August 2014||2014-08-01|December 2014|2014-12-01|February 2015|Anticipated|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation|Prospective, Single-arm Phase 2 Trial to Evaluate Efficacy and Safety of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation for Hematologic Malignancies|Unknown status|Recruiting|Phase 2|65|Anticipated|The Catholic University of Korea||1|||f||||f||||||||||2017-10-11 02:00:03.447285|2017-10-11 02:00:03.447285
NCT01788592|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-08|2014-12-08|||January 2003||2003-01-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01|1 Year|Observational [Patient Registry]|||Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)|Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice|Completed||N/A|5097|Actual|Asan Medical Center|||1||f||||f||||||||||2017-10-11 02:00:03.5549|2017-10-11 02:00:03.5549
NCT01788579|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-02-26|||March 2012||2012-03-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|WINGS||Women Initiating New Goals of Safety|Project WINGS: Women Initiating New Goals of Safety|Completed||Phase 1|209|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 02:00:03.65046|2017-10-11 02:00:03.65046
NCT01788566|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-05-20|2015-12-21|2014-09-29|March 2013||2013-03-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|August 2014|Actual|2014-08-01||Interventional|||A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer|A Single-Arm, Multicenter, Open-Label, Phase 2 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|61|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:00:03.792051|2017-10-11 02:00:03.792051
NCT01788553|ClinicalTrials.gov processed this data on October 10, 2017|2009-07-06|2013-02-08|||March 2006||2006-03-01|July 2009|2009-07-01|March 2007|Actual|2007-03-01|||||Observational|||Study Of Remission In Patients Treated For Generalized Anxiety Disorder|An Observational Study of Remission in Patients Treated for Generalized Anxiety Disorder in Primary and Specialized Care in Belgium.|Completed||N/A|750|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||t||||||||||2017-10-11 02:00:04.965824|2017-10-11 02:00:04.965824
NCT01788540|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-05-31|||February 2013||2013-02-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Intralipid for Recurrent Miscarriage|The Role of Intralipid in Natural Killer Cell Positive Cases With Recurrent Miscarriages Undergoing IVF/ICSI Cycles: a Double Blind Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|300|Anticipated|Woman's Health University Hospital, Egypt||2|||f||||f||||||||||2017-10-11 02:00:05.081131|2017-10-11 02:00:05.081131
NCT01788527|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-07-14|||March 2013||2013-03-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CONCEPTT||Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial|Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial|Completed||N/A|325|Actual|Mount Sinai Hospital, Canada||2|||f||||t||||||||||2017-10-11 02:00:05.19173|2017-10-11 02:00:05.19173
NCT01788514|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-05-27|||January 2013||2013-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Combining Entertainment & Influenza Education for Pediatric Patients|Combining Entertainment & Education Into an Age Appropriate Intervention Geared Toward Increasing Influenza Vaccination of Pediatric Patients in Underserved Communities|Completed||N/A|51|Actual|Winthrop University Hospital||1|||f||||f||||||||||2017-10-11 02:00:05.410807|2017-10-11 02:00:05.410807
NCT01788501|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2017-03-20|||November 2011|Actual|2011-11-01|March 2017|2017-03-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|||Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease|Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease in Paediatric Patients|Completed||Phase 2/Phase 3|50|Actual|Seoul National University Hospital||2|||f||||f||||||||No||2017-10-11 02:00:05.532074|2017-10-11 02:00:05.532074
NCT01788488|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-06-21|||February 2013||2013-02-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Procalcitonin Use in Pneumonia Patients in the Critical Care Setting|Impact of Measuring Serum Procalcitonin Levels on Duration of Antimicrobial Therapy in Critical Care Patients With Suspected Pneumonia|Completed||N/A|134|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:00:05.688236|2017-10-11 02:00:05.688236
NCT01788475|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-09-01|||December 2012||2012-12-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery|A Randomized, Pilot Study of the Efficacy and Safety of Ozurdex Steroid Implants in Post-Vitrectomized Eyes in Patients With Diabetic Macular Edema|Withdrawn||N/A|0|Actual|Lahey Clinic||3||Unable to recruit study participants, study withdrawn by Investigator|f||||f||||||||||2017-10-11 02:00:05.827803|2017-10-11 02:00:05.827803
NCT01788462|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-03-02|||May 2012||2012-05-01|March 2017|2017-03-01||||January 2020|Anticipated|2020-01-01||Observational|||Egrifta Replacement and Sleep Disordered Breathing|Egrifta Replacement and Sleep Disordered Breathing|Withdrawn||N/A|0|Actual|Johns Hopkins University|||1|Lack of funding.|f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 02:00:05.952004|2017-10-11 02:00:05.952004
NCT01788449|ClinicalTrials.gov processed this data on October 10, 2017|2009-08-06|2013-02-12|||May 2005||2005-05-01|February 2013|2013-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance|Association of Antibiotic Measures and Control of Bacterial Resistance|Completed||N/A|335|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-10-11 02:00:06.053663|2017-10-11 02:00:06.053663
NCT01788436|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-06-16|||November 2012||2012-11-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy Volunteers|An Exploratory Study to Measure and Contrast Implicit and Explicit Learning Performance in Patients With Stable Schizophrenia and Young and Elderly Healthy Subjects|Completed||Early Phase 1|51|Actual|Janssen Research & Development, LLC||3|||f||||f||||||||||2017-10-11 02:00:06.119073|2017-10-11 02:00:06.119073
NCT01788423|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-06-08|||November 2012||2012-11-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluating Hearing Aid Service Delivery Models|Evaluating Hearing Aid Service Delivery Models|Recruiting||N/A|180|Anticipated|Indiana University||4|||f||||t||||||||Undecided||2017-10-11 02:00:06.202842|2017-10-11 02:00:06.202842
NCT01788410|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-07-21|||May 2013||2013-05-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Observational|||MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine|MRI-Guided Cryoablation of Head, Neck and Spine Nerves and Facets Using the Advanced Multimodality Image Guided Operating(AMIGO) Suite|Recruiting||N/A|50|Anticipated|Brigham and Women's Hospital|||1||f||||t||||||||Undecided||2017-10-11 02:00:06.288457|2017-10-11 02:00:06.288457
NCT01788397|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-01-11|||September 2010||2010-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Comprehensive Rehabilitation at Beitostølen Healthsports Centre|Effect of Comprehensive Rehabilitation at Beitostølen Healthsports Centre. A Randomized Study.|Completed||N/A|247|Actual|Beitostølen Health Sports Center||2|||f||||t||||||||||2017-10-11 02:00:06.396262|2017-10-11 02:00:06.396262
NCT01787812|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-07-02|||July 2011||2011-07-01|July 2013|2013-07-01||||December 2014|Anticipated|2014-12-01|5 Years|Observational [Patient Registry]|CJRR||California Joint Replacement Registry|California Joint Replacement Registry|Unknown status|Recruiting|N/A|2500|Anticipated|California Joint Replacement Registry|||1||f||||f||||||||||2017-10-11 02:00:20.810232|2017-10-11 02:00:20.810232
NCT01788384|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-02-07|||July 2012||2012-07-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris|A Multicenter, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel and Acanya® 1.2%/2.5% and Both Active Treatments to Vehicle Control for Treating Acne Vulgaris|Completed||Phase 3|708|Actual|Watson Laboratories, Inc.||3|||f||||f||||||||||2017-10-11 02:00:06.475727|2017-10-11 02:00:06.475727
NCT01788371|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-07-29|||March 2009||2009-03-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus|Nucleoside Analogue in Late Preganancy to Prevent Vertical Transmission of Hepatitis B Virus|Completed||Phase 4|700|Actual|Beijing YouAn Hospital||3|||f||||f||||||||||2017-10-11 02:00:06.569605|2017-10-11 02:00:06.569605
NCT01788358|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2015-09-24|2015-07-21|2015-06-04|February 2013||2013-02-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension|Multicenter, Open-Label, Long-Term Safety and Efficacy Study of the Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Adult Subjects With Moderate to Severe Essential Hypertension|Completed||Phase 3|508|Actual|Bayer||1|||f||||f||||||||||2017-10-11 02:00:06.800319|2017-10-11 02:00:06.800319
NCT01788345|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2013-02-07|||February 2013||2013-02-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|Boussignac||Prospective Trial of the Bilevel Positive Airway Pressure (by Boussignac) in Emergency Department of Non-invasive Patients Presenting With Acute Hypercapnic Respiratory Failure|Prospective Trial of the Bilevel Positive Airway Pressure (by Boussignac) in Emergency Department of Non-invasive Patients Presenting With Acute Hypercapnic Respiratory Failure|Unknown status|Active, not recruiting|N/A|44|Anticipated|Vygon GmbH & Co. KG||1|||f||||f||||||||||2017-10-11 02:00:07.449929|2017-10-11 02:00:07.449929
NCT01788332|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2014-07-04|||January 2014||2014-01-01|July 2014|2014-07-01||||May 2015|Anticipated|2015-05-01||Interventional|PIN||Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)|A Randomised Phase II Trial of Olaparib Maintenance Versus Placebo Monotherapy in Patients With Chemosensitive Advanced Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|114|Anticipated|Velindre NHS Trust||2|||f||||t||||||||||2017-10-11 02:00:07.54132|2017-10-11 02:00:07.54132
NCT01788319|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2015-06-22|||February 2013||2013-02-01|February 2013|2013-02-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)|Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) in Open Angle Glaucoma Patients|Completed||N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 02:00:07.652264|2017-10-11 02:00:07.652264
NCT01788306|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-11-01|||January 2013||2013-01-01|November 2016|2016-11-01|April 2021|Anticipated|2021-04-01|April 2019|Anticipated|2019-04-01||Interventional|OOPEN||Project OOPEN: Opioid Overdose Prevention, Education and Intervention|A Trial to Prevent Opioid Overdose: E.D. Based Intervention & Take-home Naloxone|Active, not recruiting||Phase 4|518|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 02:00:07.731131|2017-10-11 02:00:07.731131
NCT01788293|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-26|||February 2013||2013-02-01|February 2013|2013-02-01|February 2015|Anticipated|2015-02-01|March 2013|Anticipated|2013-03-01||Interventional|||Fluid Management Based on Pleth Variability Index (PVI) Monitoring During High-risk Surgery|Fluid Management Based on Pleth Variability Index (PVI) Monitoring During High-risk Surgery|Unknown status|Recruiting|N/A|70|Anticipated|Hospital Regional de Presidente Prudente||2|||f||||t||||||||||2017-10-11 02:00:07.852061|2017-10-11 02:00:07.852061
NCT01788280|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-09-05|||January 2018|Anticipated|2018-01-01|September 2017|2017-09-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab|Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab|Not yet recruiting||Phase 2|30|Anticipated|University of Utah||1|||f||||t|t|f||||||||2017-10-11 02:00:07.961793|2017-10-11 02:00:07.961793
NCT01788267|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-05-26|||January 2013||2013-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Bone Microarchitecture in Young Cystic Fibrosis Patients|Evaluation of the Bone Microarchitecture in a Young Cystic Fibrosis Patients Using High-Resolution Peripheral Quantitative Computed Tomography|Completed||N/A|38|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:00:08.064772|2017-10-11 02:00:08.064772
NCT01788254|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2015-05-26|||January 2012||2012-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|IKP243||Open Label Study for the Functional Characterization of Drug Metabolism and Transport|Open Label Study for the Functional Characterization of Drug Metabolism and Transport|Completed||Phase 1|144|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-11 02:00:08.166444|2017-10-11 02:00:08.166444
NCT01788241|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2015-10-06|||January 2009||2009-01-01|October 2015|2015-10-01|April 2025|Anticipated|2025-04-01|April 2015|Actual|2015-04-01||Observational|TWIST||TweeSteden Mild Stenosis Study|A Psycho-biochemical Perspective on Non-significant Coronary Artery Disease: a Prospective Cohort Study of Classic and Novel Risk Markers.|Active, not recruiting||N/A|547|Actual|University of Tilburg|||1||f||||f||||||Samples With DNA|"     Serum, DNA, leukocyte differentiation, high-sensitive C-reactive protein, fibrinogen   "|||2017-10-11 02:00:08.330687|2017-10-11 02:00:08.330687
NCT01788228|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-04-07|2015-03-26||March 2013||2013-03-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure|Safety and Tolerability of GSK 1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure|Completed||Phase 3|50|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:00:08.48378|2017-10-11 02:00:08.48378
NCT01788215|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-12-09|2015-10-23||November 2010||2010-11-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MI-PCOS||Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome|The Use of an MMP Inhibitor, Doxycycline, to Reduce Ovarian Androgen Production and Restore Normal Cycling in Women With Polycystic Ovarian Syndrome|Completed||Phase 3|10|Actual|University of Rochester|This study was underpowered due to reduced enrollment. Targeted enrollment was 40 and actual enrollment was 10.|2|||f||||t||||||||||2017-10-11 02:00:09.096082|2017-10-11 02:00:09.096082
NCT01788202|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-09-06|||January 2013||2013-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Patients With Positive Urine Cocaine Metabolites Undergoing General Anesthesia|An Observational, Prospective Study in Patients With Positive Urine Cocaine Metabolites Undergoing Surgery for General Anesthesia|Terminated||N/A|2|Actual|Rutgers, The State University of New Jersey|||1|unable to enroll patients|f||||f||||||||No||2017-10-11 02:00:09.593919|2017-10-11 02:00:09.593919
NCT01788189|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-11-08|||January 2013||2013-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|LeMLAR||Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas|Lenalidomide in Conjunction With Methotrexate, Leucovorin, Cytarabine and Rituximab for the Treatment of Relapsed or Refractory CD20-positive Aggressive Lymphomas: an Open-label, Multicenter Phase I/II Trial|Recruiting||Phase 1/Phase 2|44|Anticipated|University Hospital, Essen||1|||f||||f||||||||||2017-10-11 02:00:09.666773|2017-10-11 02:00:09.666773
NCT01788176|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-02-08|||December 2013||2013-12-01|February 2013|2013-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|Aclasta||The Use of Zoledronic Acid to Complex Regional Pain Syndrome|Phase 2 Study - The Use of a Single 5 mg Dose of Zoledronic Acid in Complex Regional Pain Syndrome Patient.|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 02:00:09.77528|2017-10-11 02:00:09.77528
NCT01788163|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-05-16|2015-10-30||February 27, 2013|Actual|2013-02-27|May 2017|2017-05-01|June 20, 2016|Actual|2016-06-20|August 25, 2014|Actual|2014-08-25||Interventional|IGNITE||Asia Pacific and Russia Diagnostic Study for EGFR Testing|A Diagnostic Study to Determine the Prevalence of EGFR Mutations in Asian and Russian Patients With Advanced NSCLC of Adenocarcinoma and Non-adenocarcinoma Histologies|Completed||N/A|3500|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 02:00:10.023538|2017-10-11 02:00:10.023538
NCT01788150|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-06-14|||January 2013||2013-01-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2014|Actual|2014-05-01||Interventional|DIRECT II||Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System|Direct Implantation of Rapamycin-Eluting Stents With Bio-Erodible Drug Carrier Technology Utilizing the Second Generation Svelte Drug-Eluting Coronary Stent Integrated Delivery System (IDS)|Active, not recruiting||N/A|159|Actual|Svelte Medical Systems, Inc.||2|||f||||t||||||||||2017-10-11 02:00:14.296903|2017-10-11 02:00:14.296903
NCT01788137|ClinicalTrials.gov processed this data on October 10, 2017|2008-12-24|2015-12-10|||January 2008||2008-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients|A Prospective , Multicenter, RandomizedPhase III Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients|Recruiting||Phase 3|380|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 02:00:14.454991|2017-10-11 02:00:14.454991
NCT01788124|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-02-07|||July 2012||2012-07-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|GYN||A Prospective Trial Comparing Metal to Plastic Speculums for Patient Comfort|A Randomized Prospective Trial Comparing Metal to Plastic Speculums for Patient Comfort|Completed||N/A|160|Actual|St. John Health System, Michigan|||2||f||||f||||||||||2017-10-11 02:00:14.588701|2017-10-11 02:00:14.588701
NCT01788111|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-04-30|||January 2013||2013-01-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Occurrence, Diagnosis and Treatment of Neck and Back Pain in Helicopter Pilots.|Occurrence, Diagnosis and Treatment of Neck and Back Pain in Helicopter Pilots.|Active, not recruiting||N/A|325|Anticipated|Helse Stavanger HF||2|||f||||t||||||||||2017-10-11 02:00:14.6856|2017-10-11 02:00:14.6856
NCT01788098|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2013-02-07|||October 2009||2009-10-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|RASGENAS||Genetics and Mechanisms of Rheumatoid Arthritis|Rheumatoid Arthritis Susceptibility Genes in Austrian and Slovak Population|Completed||N/A|790|Actual|Slovak Academy of Sciences|||2||f||||f||||||Samples With DNA|"     frozen immune cells frozen serum frozen DNA   "|||2017-10-11 02:00:14.807078|2017-10-11 02:00:14.807078
NCT01788085|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-03-10|||August 2013||2013-08-01|March 2014|2014-03-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance (Encore)|RD-41 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance|Withdrawn||N/A|0|Actual|Given Imaging Ltd.||1|||f||||f||||||||||2017-10-11 02:00:14.936862|2017-10-11 02:00:14.936862
NCT01788072|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-03-17|||June 2014||2014-06-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|INOXT||INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders|INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders (ASD)|Active, not recruiting||Phase 2|70|Actual|Anagnostou, Evdokia, M.D.||2|||f||||t||||||||No||2017-10-11 02:00:15.235519|2017-10-11 02:00:15.235519
NCT01788046|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2017-02-07|2017-02-07|2015-03-17|March 2013||2013-03-01|August 2016|2016-08-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis|A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis|Completed||Phase 3|515|Actual|Amgen||2|||f||||t||||||||||2017-10-11 02:00:15.511991|2017-10-11 02:00:15.511991
NCT01788033|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2014-02-10|||September 2009||2009-09-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|LATE STAGE||Effects of XOMA 052 on Insulin Production in Type 1 Diabetes|A Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well-controlled Type 1 Diabetes|Completed||Phase 2|22|Actual|University of Zurich||2|||f||||t||||||||||2017-10-11 02:00:17.357048|2017-10-11 02:00:17.357048
NCT01787058|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2015-03-11|||January 2013||2013-01-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Evaluation of the Dubai Cares WASH in School Initiative|Monitoring and Evaluation Framework of the Dubai Cares' WASH in School Initiative|Completed||N/A|10308|Actual|Emory University|||2||f||||f||||||||||2017-10-11 02:00:36.167353|2017-10-11 02:00:36.167353
NCT01788020|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2015-05-27|||November 2013||2013-11-01|May 2015|2015-05-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia|Efficacy of First Line Dexamethasone, Rituximab and Cyclophosphamide (DRC) +/- Bortezomib for Patients With Waldenström's Macroglobulinemia|Recruiting||Phase 3|380|Anticipated|University of Ulm||2|||f||||t||||||||||2017-10-11 02:00:17.488362|2017-10-11 02:00:17.488362
NCT01788007|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-01-19|||January 2013||2013-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.|A Randomized, Double Blind, Placebo Controlled, Parallel Design, Multiple Site, Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.|Completed||Phase 1|443|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 02:00:17.610925|2017-10-11 02:00:17.610925
NCT01787994|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-06-14|||December 2012||2012-12-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|MazF||Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy|A Phase I, Open Label, Dual Cohort, Single Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Autologous CD4 T Cells Modified With a Retroviral Vector Expressing the MazF Endoribonuclease Gene in Patients With HIV|Active, not recruiting||Phase 1|10|Actual|University of Pennsylvania||2|||f||||t||f||||||||2017-10-11 02:00:17.69527|2017-10-11 02:00:17.69527
NCT01787981|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-07-03|||January 2013||2013-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:00:17.993914|2017-10-11 02:00:17.993914
NCT01787968|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2016-11-15|||April 2011||2011-04-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Congenital Transmission of Lineages I and II of Trypanosoma Cruzi|Congenital Transmission of Lineages I and II of Trypanosoma Cruzi|Completed||N/A|28348|Actual|Tulane University|||1||f||||f||||||Samples With DNA|"     Plasma, blood with guanidine, dry spots on filter papers   "|||2017-10-11 02:00:18.813531|2017-10-11 02:00:18.813531
NCT01787955|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-02-24|||February 2013||2013-02-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Impact of Braun Anastomosis on Reduction in Delayed Gastric Emptying Following Pancreaticoduodenectomy||Completed||N/A|60|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:00:18.940006|2017-10-11 02:00:18.940006
NCT01787942|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-07|2014-08-15|||January 2013||2013-01-01|February 2013|2013-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Investigating Abnormal Lipid Layer Thickness in Blepharoplasty Patients|Investigating Abnormal Lipid Layer Thickness and Other Objective Dry Eye Parameters in Patients Seeking Blepharoplasty, and How They Change After Blepharoplasty|Completed||N/A|60|Actual|Singapore National Eye Centre||2|||f||||f||||||||||2017-10-11 02:00:19.045144|2017-10-11 02:00:19.045144
NCT01787929|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-08-31|||February 7, 2016|Actual|2016-02-07|August 2017|2017-08-01|February 7, 2019|Anticipated|2019-02-07|February 7, 2018|Anticipated|2018-02-07||Interventional|PIH||Displaced Femoral Neck Fracture in Elderly Patient. Should Cement be Used for Hip Hemiarthroplasty ?|Cemented Versus Uncemented Hemiarthroplasty for Displaced Femoral Neck Fracture in Elderly Patient : a Randomized Prospective Trial|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 02:00:19.152126|2017-10-11 02:00:19.152126
NCT01787903|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-07-25|||February 2013||2013-02-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|INCONTROL||The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA|The Effects of Real-time Continuous Glucose Monitoring on Glycemia and Quality of Life in Patients With Type 1 Diabetes Mellitus and Impaired Hypoglycemia Awareness|Completed||N/A|52|Actual|VU University Medical Center||2|||f||||f||||||||||2017-10-11 02:00:19.369534|2017-10-11 02:00:19.369534
NCT01787877|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-06|||February 2013||2013-02-01|February 2013|2013-02-01||||August 2013|Anticipated|2013-08-01||Observational|||Inflammatory Biomarkers as Tool in Diagnosis and Management of Patients With Ischemic Stroke|Inflammatory Biomarkers as Additional Tool to Neuroimaging in the Diagnosis and Management of Patients With Ischemic Stroke|Unknown status|Not yet recruiting|N/A|50|Anticipated|Ziv Hospital|||1||f||||f||||||||||2017-10-11 02:00:19.49147|2017-10-11 02:00:19.49147
NCT01787864|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-05-15|||February 2013||2013-02-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Prevalence of Dysplasia of the Gastric Cardia|Prevalence of Dysplasia of the Gastric Cardia|Completed||N/A|170|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"     Esophageal and gastric cardia biospies   "|No|No plans to share data|2017-10-11 02:00:19.619147|2017-10-11 02:00:19.619147
NCT01787851|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-08|||February 2013||2013-02-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|ACETO-TCA||Study of the Acute Effects of Triheptanoin in Heart Failure|Assessment of the Clinical Effects of Triheptanoin Oil to Target Cardiac Anaplerosis in Congestive Heart Failure- Acute Study|Unknown status|Recruiting|Phase 1/Phase 2|24|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 02:00:19.755811|2017-10-11 02:00:19.755811
NCT01787838|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-07-17|2014-05-21||January 2013||2013-01-01|July 2017|2017-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||All patients greater than 18 years of age, chronic diseases, smoker seen in presurgical testing center|Improving Pneumococcal Vaccination Rates in an Ambulatory Pre-surgical Testing Setting|A Quality Improvement Study to Improve Pneumococcal Vaccination Rates Through Targeted Health Education for Patients in an Ambulatory Pre-surgical Testing Setting|Completed||N/A|2509|Actual|Carilion Clinic||1|||f||||f||||||||||2017-10-11 02:00:19.849643|2017-10-11 02:00:19.849643
NCT01787825|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-03-31|2016-11-30||May 2012||2012-05-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|April 2015|Actual|2015-04-01||Interventional|||Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease|Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease|Completed||N/A|121|Actual|Capso Vision, Inc.||2|||f||||f||||||||No||2017-10-11 02:00:20.335435|2017-10-11 02:00:20.335435
NCT01787799|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-02-18|2016-01-06||March 2013||2013-03-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|EVOLVE II QCA|Subjects greater than or equal to 18 years of age with symptomatic coronary artery disease with objective evidence of ischemia or silent ischemia. Subjects received the SYNERGY stent system for treatment of atherosclerotic lesion(s) less than or equal to 34mm in length and between 2.25mm and 4.0mm in diameter, both by visual estimate.|EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)|EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System) for the Treatment of Atherosclerotic Lesion(s)|Completed||Phase 3|100|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 02:00:20.916818|2017-10-11 02:00:20.916818
NCT01787786|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-12-01||||||December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Observational|OPTIMIZE||Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels|Defining and Predicting the Ideal Infliximab Pharmacokinetic Profile Associated With Treatment Efficacy in Patients With Inflammatory Bowel Disease|Withdrawn||N/A|0|Actual|University of Western Ontario, Canada|||1|Unable to align the study questions with a complementary trial|f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 02:00:21.529329|2017-10-11 02:00:21.529329
NCT01787773|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-06-26|||March 2013||2013-03-01|June 2014|2014-06-01|April 2017|Anticipated|2017-04-01|April 2015|Anticipated|2015-04-01||Interventional|VERITAS||VERITAS: An Evaluation of the Veniti Vidi Retrievable Inferior Vena Cava Filter System in Patients at Risk for Pulmonary Embolism|VERITAS: An Evaluation of the Veniti Vidi Retrievable Inferior Vena Cava Filter System in Patients at Risk for Pulmonary Embolism|Unknown status|Active, not recruiting|N/A|150|Anticipated|Veniti||1|||f||||f||||||||||2017-10-11 02:00:21.619409|2017-10-11 02:00:21.619409
NCT01787760|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-05-04|2015-07-01||April 2007||2007-04-01|May 2016|2016-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||Baseline summary was conducted on all randomized subjects.|Controlling Myopia Progression With Soft Contact Lenses|Controlling Myopia Progression With Soft Contact Lenses|Completed||N/A|221|Actual|Johnson & Johnson Vision Care, Inc.||3|||f||||t||||||||||2017-10-11 02:00:21.71604|2017-10-11 02:00:21.71604
NCT01787747|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-06-24|||October 2012||2012-10-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers|A Phase 1, Single-center, Randomized, Double-blind, Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Doses of AVP-786 (Deuterated Dextromethorphan) in Healthy Volunteers|Completed||Phase 1|48|Actual|Avanir Pharmaceuticals||5|||f||||f||||||||||2017-10-11 02:00:22.167943|2017-10-11 02:00:22.167943
NCT01787721|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-12-22|||February 2013||2013-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Manipulation of the Ankle Joint on Gait|Effect of Manipulation of the Tibiotalar Joint on Gait|Terminated||N/A|2|Actual|University of Bridgeport||2||Unable to recruit more than 2 subjects|f||||f||||||||||2017-10-11 02:00:22.268299|2017-10-11 02:00:22.268299
NCT01787708|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2015-06-30|||February 2013||2013-02-01|June 2015|2015-06-01||||December 2015|Anticipated|2015-12-01||Interventional|||Efficacy of Red Light in Vitiligo|Efficacy of Red Light in Vitiligo: A Prospective, Single-Blind Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|16|Anticipated|University of British Columbia||4|||f||||f||||||||||2017-10-11 02:00:22.347836|2017-10-11 02:00:22.347836
NCT01787695|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2015-06-30|||February 2013||2013-02-01|June 2015|2015-06-01||||December 2015|Anticipated|2015-12-01||Interventional|||UVA 1 Phototherapy for Vitiligo||Unknown status|Recruiting|Phase 2|16|Anticipated|University of British Columbia||2|||f||||||||||||||2017-10-11 02:00:22.436108|2017-10-11 02:00:22.436108
NCT01787682|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-08-31|||December 2012||2012-12-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Nutritional and Functional Changes in Heart Failure and COPD|Metabolic and Functional Changes in Relation to Nutritional Status in Chronic Heart Failure and Chronic Obstructive Pulmonary Disorder|Recruiting||N/A|150|Anticipated|Texas A&M University||1|||f||||f||||||||||2017-10-11 02:00:22.527272|2017-10-11 02:00:22.527272
NCT01787669|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-12-05|||June 2013||2013-06-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|SwitchDMO||Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema|A Multicentre Clinical Trial of Switching Between Intravitreal Bevacizumab (Avastin®) and Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema (SwitchDMO)|Recruiting||Phase 2|50|Anticipated|University of Sydney||2|||f||||f||||||||||2017-10-11 02:00:22.636939|2017-10-11 02:00:22.636939
NCT01787656|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-10-25|||January 2013||2013-01-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus|A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus|Active, not recruiting||N/A|438|Actual|University of South Alabama|||1||f||||f||||||Samples With DNA|"     De-idetified samples of gynecologic fluid, mucus, and blood   "|||2017-10-11 02:00:22.782724|2017-10-11 02:00:22.782724
NCT01787643|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-08-10|||January 2013||2013-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|||Standing Behavior After Installation of Height-Adjustable Desks|Adoption of Standing Behavior After Installation of Height-Adjustable Desks|Completed||N/A|14|Actual|USDA Grand Forks Human Nutrition Research Center||1|||f||||f||||||||||2017-10-11 02:00:22.893053|2017-10-11 02:00:22.893053
NCT01787630|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-11-03|||January 2010||2010-01-01|November 2016|2016-11-01|March 2021|Anticipated|2021-03-01|March 2016|Actual|2016-03-01||Interventional|NoHarm||To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During Radiotherapy|Initiating Phase II-III Study to Evaluate the Technique and Effects of Separating the Prostate From the Rectum With Hyaluronic Acid During Radiotherapy|Active, not recruiting||Phase 2/Phase 3|81|Actual|Umeå University||1|||f||||f||||||||||2017-10-11 02:00:22.996639|2017-10-11 02:00:22.996639
NCT01787617|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-05-02|||December 2012||2012-12-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|July 2015|Actual|2015-07-01||Interventional|ARTIIS||Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men|Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men|Active, not recruiting||N/A|113|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 02:00:23.121827|2017-10-11 02:00:23.121827
NCT00172445|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-06||||||June 2004|2004-06-01||||||||Interventional|||Clinical Studies of Kikuchi's Disease||Withdrawn||N/A|0|Actual|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.865276|2017-10-11 05:25:55.865276
NCT01787591|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-09-30|2016-03-24||April 2013||2013-04-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome|Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome|Completed||N/A|21|Actual|Ohio State University||4|||f||||t||||||||Yes|Data will be shared when it becomes available|2017-10-11 02:00:23.379038|2017-10-11 02:00:23.379038
NCT01787578|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-02-12|||April 2013||2013-04-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|September 2013|Anticipated|2013-09-01||Interventional|||Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)|A Prospective Safety, Tolerance, Pharmacodynamics and Pharmacokinetics Study of Sobetirome in Male Subjects Diagnosed With X-linked Adrenoleukodystrophy (X-ALD)|Withdrawn||Phase 1|0|Actual|Oregon Health and Science University||1||revisions to original study protocol underway|f||||t||||||||||2017-10-11 02:00:24.129429|2017-10-11 02:00:24.129429
NCT01787565|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-04-04|||January 2013||2013-01-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland|Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland|Terminated||N/A|86|Actual|Pfizer|||2|See termination reason in detailed description.|f||||f||||||||||2017-10-11 02:00:24.224703|2017-10-11 02:00:24.224703
NCT01787552|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-07-24|||May 8, 2013|Actual|2013-05-08|July 2017|2017-07-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF|A Phase Ib/II, Open-label, Multi-center, Dose-finding Study to Assess the Safety and Efficacy of the Oral Combination of LDE225 and INC424 (Ruxolitinib) in Patients With Myelofibrosis|Active, not recruiting||Phase 1/Phase 2|50|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-11 02:00:24.34801|2017-10-11 02:00:24.34801
NCT01787539|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-06|||February 2013||2013-02-01|February 2013|2013-02-01|February 2022|Anticipated|2022-02-01|February 2017|Anticipated|2017-02-01||Interventional|STOPEROPCHEM||The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer|The Role of Postoperative Chemotherapy Cycles in the Combined Modality Therapy of Gastric Cancer With Perioperative Chemotherapy and Surgery in Pathological Responders|Recruiting||Phase 2/Phase 3|180|Anticipated|Medical University of Lublin||2|||f||||t||||||||||2017-10-11 02:00:24.480565|2017-10-11 02:00:24.480565
NCT01787526|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-10-05|||June 2014||2014-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|IronWoMan||Intravenous High Dose Iron in Blood Donors|High Dose Intravenous Iron in Blood Donors With Iron Deficiency: a Randomized, Controlled Trial|Completed||Phase 3|176|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 02:00:24.589731|2017-10-11 02:00:24.589731
NCT01787513|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2014-08-10|||February 2013||2013-02-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Cognitive Bias Modification (CBM) Via Imagery and Internet Cognitive Behavioural Therapy (iCBT) for Depression|A Randomised Controlled Trial Comparing Internet Based Cognitive Behavioural Therapy for Major Depressive Disorder Plus a Cognitive Bias Modification Intervention (OxIGen)on Symptoms of Depression and Negative Interpretation Bias.|Completed||N/A|121|Actual|St Vincent's Hospital, Sydney||2|||f||||t||||||||||2017-10-11 02:00:24.682714|2017-10-11 02:00:24.682714
NCT01787500|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-09-19|||February 15, 2013|Actual|2013-02-15|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Vemurafenib, Cetuximab, and Irinotecan in Advanced Solid Cancers|A Phase I Trial of Vemurafenib in Combination With Cetuximab and Irinotecan in Patients With BRAF V600 Mutant Advanced Solid Malignancies|Active, not recruiting||Phase 1|47|Actual|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-11 02:00:24.772261|2017-10-11 02:00:24.772261
NCT01787487|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-05-02|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Evaluation of Ruxolitinib And Azacytidine Combination as a Therapy For Patients With Myelofibrosis And Myelodysplastic Syndrome/ Myeloproliferative Neoplasm|Evaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic Syndrome/ Myeloproliferative Neoplasm|Recruiting||Phase 2|125|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 02:00:24.98344|2017-10-11 02:00:24.98344
NCT01787474|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-03-06|||May 19, 2014|Actual|2014-05-19|March 2017|2017-03-01|May 1, 2021|Anticipated|2021-05-01|May 1, 2021|Anticipated|2021-05-01||Interventional|||IL-21-Expanded NK Cells for Induction of Acute Myeloid Leukemia (AML)|A Phase I/II Clinical Trial Testing the Safety and Feasibility of IL-21-Expanded Natural Killer Cells for the Induction of Relapsed/Refractory Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:00:25.174296|2017-10-11 02:00:25.174296
NCT01787461|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-03-05|2015-03-05||January 2013||2013-01-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Safety analysis set included all participants who received at least one dose of the study treatments.|A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure|Randomized, Double-blind, Placebo Controlled Trial Assessing The Effects Of An Oral Dietary Supplement Containing Marine And Plant Extracts On Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin|Completed||Phase 4|194|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:00:25.418722|2017-10-11 02:00:25.418722
NCT01787448|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2013-02-27|||January 2013||2013-01-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||RIPT of Ibuprofen Topical Gel|Repeat-insult Patch Test (Ript) of Ibuprofen 5% Topical Gel in Human Volunteers|Completed||Phase 1|234|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:00:27.255901|2017-10-11 02:00:27.255901
NCT01787435|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-04-03|||June 2012||2012-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Acid-suppressing Drugs Pregnancy Asthma Offspring Study|A Cohort Study on the Association Between Acid-suppressing Drugs in Pregnancy and Asthma in the Offspring|Completed||N/A|10116|Actual|AstraZeneca|||3||f||||f||||||||||2017-10-11 02:00:27.363736|2017-10-11 02:00:27.363736
NCT01787422|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-06|||February 2013||2013-02-01|February 2013|2013-02-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Comparison of Telemedicine Versus Traditional Practice in a University Health Center|Comparison of Telemedicine Versus Traditional Practice in a University Health Center|Unknown status|Not yet recruiting|N/A|40|Anticipated|Arizona State University||2|||f||||t||||||||||2017-10-11 02:00:27.45528|2017-10-11 02:00:27.45528
NCT01787409|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-07-06|||March 2013||2013-03-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency|Effect of Vitamin D Replacement on Tumor Response and Survival Parameters for Vitamin D Insufficient Patients With Cancer|Recruiting||N/A|713|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:00:27.548836|2017-10-11 02:00:27.548836
NCT01787396|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-04-01|||April 2013||2013-04-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d|A Multicenter, Randomized, Active-controlled, Parallel Group, Double-blind, Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d Compared With Either Monotherapy in Treatment naïve Patients With Type 2 Diabetes|Completed||Phase 3|433|Actual|LG Life Sciences||3|||f||||||||||||||2017-10-11 02:00:27.682861|2017-10-11 02:00:27.682861
NCT01787383|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-05-06|2014-12-18||February 2013||2013-02-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities|A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities|Completed||Phase 3|200|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 02:00:27.785754|2017-10-11 02:00:27.785754
NCT01787370|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-09-04|||September 2009||2009-09-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01|2 Years|Observational [Patient Registry]|||Mainz Registry of Flow-mediated Constriction|Mainz Registry of Flow-mediated Constriction|Recruiting||N/A|1000|Anticipated|Johannes Gutenberg University Mainz|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 02:00:28.503803|2017-10-11 02:00:28.503803
NCT01787357|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-06-28|||June 2008||2008-06-01|June 2016|2016-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)|A Randomized, Double-Blind, Double-Dummy, Placebo- and Positive-Controlled, Four-Way Crossover Study Evaluating ECG Intervals in Healthy Adults Receiving a Single, Oral Dose of JNJ-28431754 at Therapeutic and Supra-Therapeutic Doses|Completed||Phase 1|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||f||||||||||2017-10-11 02:00:28.60043|2017-10-11 02:00:28.60043
NCT01787344|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-05-01|||March 2012||2012-03-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||"Phase III Clinical Trial of Botulax® to Treat Children With Cerebral Palsy"|"Double-blinded, Randomized, Active Control Comparative, Multicenter-designed, Phase III Clinical Trial to Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Children With Cerebral Palsy"|Completed||Phase 3|144|Actual|Hugel||2|||f||||t||||||||||2017-10-11 02:00:28.720751|2017-10-11 02:00:28.720751
NCT01787331|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-06-09|||November 2013||2013-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase II Study of Itraconazole in Biochemical Relapse|Hedgehog Inhibition as a Non-Castrating Approach to Hormone Sensitive Prostate Cancer: A Phase II Study of Itraconazole in Biochemical Relapse|Active, not recruiting||Phase 2|21|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:00:28.823766|2017-10-11 02:00:28.823766
NCT01787318|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-04-13|||January 2013||2013-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|September 2014|Actual|2014-09-01||Interventional|IPCL||Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes|Effect of the Insupatch on Automated Closed-loop Glucose Control in Type 1 Diabetes|Completed||Early Phase 1|10|Actual|Yale University||2|||f||||t||||||||||2017-10-11 02:00:28.934403|2017-10-11 02:00:28.934403
NCT01787305|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2017-06-27|||February 2013||2013-02-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2017|Actual|2017-01-01||Observational|||Pilot Study of Gut Commensals in Antiphospholipid Syndrome|Longitudinal Study of the Fecal Microbiome in Persistently Anti-β2 Glycoprotein-I Positive Individuals and Patients With Antiphospholipid Syndrome|Active, not recruiting||N/A|16|Anticipated|Yale University|||1||f||||t||||||Samples With DNA|"     Whole Blood Serum Stool DNA?   "|||2017-10-11 02:00:29.07571|2017-10-11 02:00:29.07571
NCT01787292|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-07-24|||January 14, 2013|Actual|2013-01-14|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|EIAMD||Effects of Exercise Intervention on Aging-related Motor Decline|Effects of Exercise Intervention on Aging-related Motor Decline (AGING)|Recruiting||N/A|40|Anticipated|VA Office of Research and Development||4|||f||||f|f|f|||f|||||2017-10-11 02:00:29.187123|2017-10-11 02:00:29.187123
NCT01787279|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-06-10|2016-06-10||January 2006||2006-01-01|June 2016|2016-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional||Safety analysis population included all the participants who received at least one dose of study medication and have one subsequent post baseline safety assessment|An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B|Expanded Access Programme of PEGASYS® (Peg Interferon Alpha-2a 40KD) in Patients With HBe-Ag-negative Chronic Hepatitis B|Completed||Phase 4|59|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:00:29.331948|2017-10-11 02:00:29.331948
NCT01787266|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-07|||January 2013||2013-01-01|February 2013|2013-02-01||||December 2014|Anticipated|2014-12-01||Observational|||Symptoms and Function During and After Pregnancy|Symptoms and Function During and After Pregnancy|Unknown status|Recruiting|N/A|800|Anticipated|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 02:00:29.61378|2017-10-11 02:00:29.61378
NCT01787253|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-15|2013-02-06|||November 2010||2010-11-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|March 2014|Anticipated|2014-03-01||Observational|||Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)|Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)|Unknown status|Recruiting|N/A|125|Anticipated|Örebro University, Sweden|||4||f||||f||||||Samples With DNA|"     Biopsies and blood   "|||2017-10-11 02:00:29.73831|2017-10-11 02:00:29.73831
NCT01787240|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-04-18|2017-03-02||November 2012|Actual|2012-11-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Neurobiological Bases of Placebo Response in Major Depressive Disorder|Neurobiological Bases of Placebo Response in Major Depressive Disorder|Terminated||Phase 4|20|Actual|Massachusetts General Hospital||2||Recruitment difficulties|f||||t||||||||No||2017-10-11 02:00:29.830055|2017-10-11 02:00:29.830055
NCT01787227|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-03-01|||January 2015||2015-01-01|March 2016|2016-03-01||||September 2015|Actual|2015-09-01||Observational|||A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel|A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection|Completed||N/A|1500|Actual|Luminex Molecular Diagnostics|||2||f||||f||||||Samples With DNA|"     Nasopharyngeal swab   "|||2017-10-11 02:00:30.248136|2017-10-11 02:00:30.248136
NCT01787214|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2014-03-17|||June 2013||2013-06-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Walnuts and Glucose Variability|The Effect of Walnuts on Glucose Variability in Adults With Type-2 Diabetes Mellitus: a Dose-response Metabolic Feeding Study|Terminated||N/A|18|Actual|Loma Linda University||3||Funding withdrawn|f||||t||||||||||2017-10-11 02:00:32.174881|2017-10-11 02:00:32.174881
NCT01787188|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-03-09|2015-02-06||February 2013||2013-02-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Subjects in this population received at least 1 dose of study drug and were analyzed according to treatment received, not treatment randomized. One subject who entered the study in the placebo group withdrew before receiving study drug. One subject who was randomized to meloxicam 5 mg received meloxicam 10 mg and was analyzed in that group|Study of Meloxicam Capsules to Treat Osteoarthritis Pain|A Phase 3, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy, and Safety Study of Meloxicam SoluMatrix™ Capsules in Patients With Pain Due to Osteoarthritis of the Knee or Hip|Completed||Phase 3|403|Actual|Iroko Pharmaceuticals, LLC||3|||f||||f||||||||||2017-10-11 02:00:32.29998|2017-10-11 02:00:32.29998
NCT01787175|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-05-17|2014-01-03||October 2007||2007-10-01|May 2016|2016-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|IMM|Half of the providers were assigned to use the new Integrated Medication Manager (intervention) during the simulation. The other half were assigned to use VA's CPRS (standard EHR). Providers were randomly assigned which system to use.|VA Integrated Medication Manager|Veterans Affairs Integrated Medication Manager|Completed||N/A|58|Actual|University of Utah|We were not able to evaluate a system-wide deployment of the resulting graphical user interface (GUI) (IMM) in terms of patient outcomes (Aim 3). We were unable to conduct Aim 3, which would have evaluated IMM in a cluster-randomized trial.|2|||f||||f||||||||||2017-10-11 02:00:34.809164|2017-10-11 02:00:34.809164
NCT01787162|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-09-07|||July 2012||2012-07-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases|Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases|Completed||N/A|43|Actual|Medical University of Graz|||1||f||||t||||||Samples With DNA|"     Samples with DNA will be retained for later examinations at the Biobank, in case that the     patient agrees (extra patient information).      The blood samples are taken only during routine tests.   "|||2017-10-11 02:00:35.15573|2017-10-11 02:00:35.15573
NCT01787149|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-04-26|||September 2013||2013-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis|Active, not recruiting||Phase 3|98|Anticipated|TSH Biopharm Corporation Limited||2|||f||||t||||||||||2017-10-11 02:00:35.228903|2017-10-11 02:00:35.228903
NCT01787136|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-10-17||||||October 2016|2016-10-01||||||||Expanded Access|DAOFTPWA||Dextromethorphan Added on for the Patients With ADHD|Dextromethorphan Added on Methylphenidate in the Treatment of the Patients With ADHD|Available||N/A|||Tri-Service General Hospital|||||f||||||||||||||2017-10-11 02:00:35.414406|2017-10-11 02:00:35.414406
NCT01787123|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-06|||June 2013||2013-06-01|February 2013|2013-02-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|CESAR||Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage|Randomized, Double-blind, Placebo-controlled Pilot Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage|Unknown status|Not yet recruiting|Phase 2/Phase 3|50|Anticipated|Kwong Wah Hospital||2|||f||||t||||||||||2017-10-11 02:00:35.483801|2017-10-11 02:00:35.483801
NCT01787110|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-03-01|||April 2013||2013-04-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|March 6, 2017|Anticipated|2017-03-06||Interventional|DETO2X-AMI||An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction|DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry|Active, not recruiting||Phase 3|6650|Anticipated|Karolinska Institutet||2|||f||||f||||||||No||2017-10-11 02:00:35.638208|2017-10-11 02:00:35.638208
NCT01787084|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-04-25|||April 2013||2013-04-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|Inop AA||Alternative Access Approaches for Transcatheter Aortic Valve Replace (TAVR) in Inoperable Patients With Aortic Stenosis|Transcatheter Valve Therapy (TVT) Registry Assessment of Alternative Access Approaches for Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis|Completed||N/A|8|Actual|The Society of Thoracic Surgeons|||1||f||||f||||||||||2017-10-11 02:00:35.966263|2017-10-11 02:00:35.966263
NCT01787071|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2014-08-19|||April 2013||2013-04-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|FENICE||Fluid Challenges in Intensive Care|How do we Administer Fluids in the ICU?|Completed||N/A|2304|Actual|European Society of Intensive Care Medicine|||1||f||||f||||||||||2017-10-11 02:00:36.071929|2017-10-11 02:00:36.071929
NCT01787045|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-11-16|||February 2013||2013-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|EARTH-ICU||Early Physical Therapy in Patients With Sepsis|Effect of Early Physical Activity on Skeletal Muscle Signaling Pathways Controlling Protein Turnover in Patients With Sepsis.|Terminated||N/A|29|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 02:00:36.29241|2017-10-11 02:00:36.29241
NCT01787032|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-01-25|2016-11-23||January 2013||2013-01-01|January 2017|2017-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Treated Set (TS): The ‘treated set’ (full analysis set population in the sense of ICH-E9) included all subjects who received at least one dose of trial drug; the safety analysis was based on the treated set.|Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects|Relative Bioavailability of Single Oral Dose of BI 113608 When Administered Alone or in Combination With Multiple Oral Doses of Ketoconazole or Voriconazole in Healthy Male Subjects (an Open-label, Randomised, Three-period Cross-over Trial)|Completed||Phase 1|20|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:00:36.415213|2017-10-11 02:00:36.415213
NCT01787019|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-05-12|||January 2013||2013-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Initiation of Oral Feeding at 30 Versus 33 Weeks Postmenstrual Age||Completed||Phase 2/Phase 3|66|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 02:00:37.100265|2017-10-11 02:00:37.100265
NCT01787006|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-12-19|||September 2011||2011-09-01|December 2014|2014-12-01||||September 2016|Anticipated|2016-09-01||Interventional|||Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer|Definitive Radiochemotherapy With 5-FU / Cisplatin Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer: a Phase II Study|Unknown status|Recruiting|Phase 2|134|Anticipated|University of Schleswig-Holstein||2|||f||||t||||||||||2017-10-11 02:00:37.171678|2017-10-11 02:00:37.171678
NCT01786993|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-08-08|2016-04-15||April 2013||2013-04-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|April 2015|Actual|2015-04-01||Interventional|MPP IDE|A total of 381 subjects were randomized at 3 months, of whom 180 were in the BiV arm and 201 were in the MPP arm.|MultiPoint Pacing IDE Study|MultiPoint Pacing IDE Study|Active, not recruiting||Phase 3|506|Actual|St. Jude Medical||2|||f||||f||||||||Yes|The study results will be presented at HRS Late-Breaking Clincial Trials Session in May, 2016|2017-10-11 02:00:37.303344|2017-10-11 02:00:37.303344
NCT01786980|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-03-30|||October 2012||2012-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene|The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene|Completed||N/A|300|Actual|Eastern Hepatobiliary Surgery Hospital|||1||f||||t||||||||||2017-10-11 02:00:38.104946|2017-10-11 02:00:38.104946
NCT01786967|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-06-26|||September 2012||2012-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|URGE||Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)|Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly|Active, not recruiting||Phase 3|66|Actual|University of North Carolina, Chapel Hill||1|||f||||f|t|f||||||No||2017-10-11 02:00:38.173843|2017-10-11 02:00:38.173843
NCT01786954|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-04-20|2016-01-20||October 2012||2012-10-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||iCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery|A Comparative Study of Icare Rebound Tonometry With Other Tonometry Modalities in Patients Following Vitreoretinal Surgery.|Completed||N/A|68|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:00:38.265107|2017-10-11 02:00:38.265107
NCT01786941|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-10-15|||June 2012||2012-06-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|BCAAM-PD||Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes|Regulation of Branched-chain Amino Acid Metabolism in Pre-Diabetes: Responses to Exercise Training and Gastric Bypass Surgery|Completed||N/A|132|Actual|Duke University||3|||f||||||||||||||2017-10-11 02:00:38.512942|2017-10-11 02:00:38.512942
NCT01786928|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2013-02-05|||April 2009||2009-04-01|February 2013|2013-02-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|RECOPD||The Role of Resistance Exercise in Chronic Obstructive Pulmonary Disease Exacerbation|Impact of Resistance Training During Hospitalization in COPD Patients: a Randomized and Controlled Trial|Completed||N/A|34|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:00:38.620388|2017-10-11 02:00:38.620388
NCT01786915|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-03-31|||February 2013||2013-02-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days|Phase 1 Randomized, Double-Blind, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Repeat Administration (7 Days) of Ascending Oral Doses of Bendavia in Healthy Volunteers|Completed||Phase 1|30|Actual|Stealth BioTherapeutics Inc.||3|||f||||f||||||||||2017-10-11 02:00:38.758671|2017-10-11 02:00:38.758671
NCT01786902|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2015-05-11|2014-11-20||February 2012||2012-02-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature|Open, Multi-Center, Controlled, Randomized Phase III Clinical Trial to Evaluate the Efficacy and Safety of DA-3002(Recombinant Humn Growth Hormone)Treatment in Children With Idiopathic Short Stature|Completed||Phase 3|70|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:00:38.884828|2017-10-11 02:00:38.884828
NCT01786889|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-07-28|||June 2013||2013-06-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Interventional|ANGIHE||Identification, Molecular Epidemiology Angiosarcoma of the Liver France|Identification, Molecular Epidemiology Angiosarcoma of the Liver France|Active, not recruiting||N/A|9|Actual|Centre Oscar Lambret||1|||f||||f||||||||No||2017-10-11 02:00:39.290982|2017-10-11 02:00:39.290982
NCT01786876|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-04-25|2014-02-10||February 2013||2013-02-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in Volunteers|A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C]SPD557 Following a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|6|Actual|Shire||1|||f||||f||||||||||2017-10-11 02:00:39.428771|2017-10-11 02:00:39.428771
NCT01786863|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-11-30|||February 2013||2013-02-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Frequency of Residual Neuromuscular Blockade in the Pediatric Population||Terminated||N/A|5|Actual|Nationwide Children's Hospital|||1|PI returned to her home country of Japan|f||||f||||||||||2017-10-11 02:00:39.791862|2017-10-11 02:00:39.791862
NCT01786850|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-06-17||||||June 2014|2014-06-01||||||||Expanded Access|||Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer|Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer: Phase II Study for Pain Palliation and Local Tumor Control|Available||N/A|||University of Roma La Sapienza|||||f||||||||||||||2017-10-11 02:00:39.875893|2017-10-11 02:00:39.875893
NCT01786837|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-02-02|||December 2012||2012-12-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation|A Prospective Trial to Study Whether Functional Magnetic Stimulation Enhances Gastrointestinal Motility in Patients With Chronic Constipation|Withdrawn||N/A|0|Actual|The Cleveland Clinic||2||Lack of enrollment|f||||f||||||||||2017-10-11 02:00:39.949475|2017-10-11 02:00:39.949475
NCT01786824|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-03-21|||December 2014||2014-12-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|CinBiCarn||Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration|Preventing Nephropathy Induced by Iodinated Contrast Media in Patients With Renal Impairment: a Randomized Trial Evaluating the Effectiveness of Two Hydration Strategies and L-carnitine Administration|Terminated||Phase 3|9|Actual|Centre Hospitalier Universitaire de Nīmes||4||"Patient pathway has become infeasible due to pressure for shorter hospital stays. Not enough   inclusions."|f||||t||||||||||2017-10-11 02:00:40.059313|2017-10-11 02:00:40.059313
NCT01786811|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-05-10|||June 2012|Actual|2012-06-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Serious Illness Communication Project|Serious Illness Communication Project|Completed||N/A|994|Actual|Dana-Farber Cancer Institute||3|||f||||f||||||||||2017-10-11 02:00:40.20838|2017-10-11 02:00:40.20838
NCT01786798|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-02-09|||February 2013||2013-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding|Role of Transvaginal Ultrasonography in Evaluating Premenopausal Women Aged More Than 35 Years With Abnormal Uterine Bleeding|Recruiting||N/A|560|Anticipated|Chulalongkorn University||1|||f||||f||||||||||2017-10-11 02:00:40.291139|2017-10-11 02:00:40.291139
NCT01786785|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-10-03|||February 2012||2012-02-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Optical Measurement of Cerebral Hemodynamics in Children With Acute Arterial Ischemic Stroke|Optical Measurement of Cerebral Hemodynamics in Children With Acute Arterial Ischemic Stroke: A Pilot Study|Recruiting||N/A|74|Anticipated|Children's Hospital of Philadelphia|||2||f||||f||||||||||2017-10-11 02:00:40.394406|2017-10-11 02:00:40.394406
NCT01786772|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-11-17|||November 2012||2012-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neuromuscular Consequences of Knee Arthroscopy|Neuromuscular Consequences of Knee Arthroscopy|Recruiting||N/A|60|Anticipated|Creighton University||2|||f||||f||||||||||2017-10-11 02:00:40.477668|2017-10-11 02:00:40.477668
NCT01786759|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-06|||October 2012||2012-10-01|February 2013|2013-02-01|July 2013|Anticipated|2013-07-01|May 2013|Anticipated|2013-05-01||Interventional|||Hepatic Function and Bile Acid in Preterm Infants Receiving Parenteral Lipids Emulsion|Hepatic Function and Bile Acid in Preterm Infants Receiving Parenteral Lipids Emulsion|Unknown status|Recruiting|Phase 4|100|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||||2017-10-11 02:00:40.576747|2017-10-11 02:00:40.576747
NCT01786746|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-07|||June 2007||2007-06-01|February 2013|2013-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Adapting Cognitive Behavioral Therapy (CBT) for Chinese Americans|Cognitive Behavioral Therapy (CBT)|Completed||N/A|61|Actual|Claremont McKenna College||1|||f||||t||||||||||2017-10-11 02:00:40.816148|2017-10-11 02:00:40.816148
NCT01786733|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-05-02|||March 2013||2013-03-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|March 2016|Actual|2016-03-01||Interventional|||Behavioral Activation - From Inpatient to Outpatient Services|Psychotherapy in the Transition From Acute Psychiatric Inpatient Wards to Outpatient Services - A Randomized Controlled Trial of Behavioral Activation vs. Supportive Therapy|Completed||N/A|64|Actual|Uppsala University||2|||f||||t||||||||||2017-10-11 02:00:40.920171|2017-10-11 02:00:40.920171
NCT01786720|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-04-30|||October 2012||2012-10-01|April 2014|2014-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||Analysis of the Time Taken to Triple Therapy (NOVARTIS)|Analysis of the Time Taken for Newly Diagnosed COPD Patients to be Prescribed Triple Therapy|Unknown status|Active, not recruiting|N/A|20154|Actual|Research in Real-Life Ltd|||3||f||||f||||||||||2017-10-11 02:00:41.052419|2017-10-11 02:00:41.052419
NCT01786707|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-06-29|2013-12-20||July 2009||2009-07-01|June 2017|2017-06-01|March 2013|Actual|2013-03-01|March 2011|Actual|2011-03-01||Interventional|HOT||Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus|Phase 2 Study of Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|2|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 02:00:41.162452|2017-10-11 02:00:41.162452
NCT01786694|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-01-31|||October 2013||2013-10-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|MTM-COLON-I||Feasibility of Microdialysis by Laparoscopy|Feasibility of Microdialysis by Laparoscopy|Completed||Phase 3|11|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||t||||||||||2017-10-11 02:00:41.443736|2017-10-11 02:00:41.443736
NCT01786681|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-07|||August 2011||2011-08-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Use of Positive Pressure in Morbidly Obese Patients Undergoing Reduction Stomach Surgery|Use of Positive Pressure in Morbidly Obese Patients Undergoing Gastroplasty|Completed||N/A|40|Actual|Universidade Metodista de Piracicaba||4|||f||||||||||||||2017-10-11 02:00:41.55689|2017-10-11 02:00:41.55689
NCT01786668|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-05-04|2016-03-15||April 2013||2013-04-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Safety population - included participants who received at least 1 dose of study medication|Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis|A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)|Completed||Phase 2|208|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:00:41.820386|2017-10-11 02:00:41.820386
NCT01786655|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2016-02-16|||May 2013||2013-05-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Safety Study of Long-Acting Local Anesthetic|Neosaxitoxin (NeoSTX) Alone and in Combination With Bupivacaine as Prolonged Duration Local Anesthetics: A Phase I Investigator-initiated Dose Escalation Study|Completed||Phase 1|105|Actual|Boston Children’s Hospital||4|||f||||t||||||||||2017-10-11 02:00:45.601509|2017-10-11 02:00:45.601509
NCT01786642|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-06|||February 2013||2013-02-01|February 2013|2013-02-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Observational|||Assessment of the Efficacy of Tracheal Oxygen Administration During Bronchoscopy - a Phase II Trial|Assessment of the Efficacy of Tracheal Oxygen Administration During Bronchoscopy - a Phase II Trial.|Unknown status|Recruiting|N/A|40|Anticipated|Katholieke Universiteit Leuven|||2||f||||f||||||||||2017-10-11 02:00:45.725443|2017-10-11 02:00:45.725443
NCT01786629|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2014-08-06|2014-07-14||December 2012||2012-12-01|August 2014|2014-08-01||||May 2013|Actual|2013-05-01||Interventional||Baseline Participants represents the population that was dispensed a preparation and took any portion of the preparation.|BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects|BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects|Completed||Phase 4|338|Actual|Braintree Laboratories||2|||f||||f||||||||||2017-10-11 02:00:45.845563|2017-10-11 02:00:45.845563
NCT01786616|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-02-06|||January 2005||2005-01-01|February 2013|2013-02-01||||April 2010|Actual|2010-04-01||Observational|||Polymorphism of beta2-adrenoceptor and Regular Use of Formoterol in Asthma|Polymorphism of beta2-adrenoceptor and Regular Use of Formoterol in Asthma: Preliminary Results|Completed||N/A|30|Actual|Catholic University, Italy|||1||f||||f||||||Samples With DNA|"     white cells   "|||2017-10-11 02:00:46.155852|2017-10-11 02:00:46.155852
NCT01786603|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-12|||September 2012||2012-09-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)|Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis|Active, not recruiting||Phase 2|80|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 02:00:46.239659|2017-10-11 02:00:46.239659
NCT01786590|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-12-28|||February 2013||2013-02-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)|Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)|Recruiting||N/A|150|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 02:00:46.380938|2017-10-11 02:00:46.380938
NCT01786577|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-01-06|||March 2013||2013-03-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|POCD||Study To Analyze Memory/Thinking Problems In Older Adults After Surgery|Neuroimaging Biomarkers for Post-Operative Cognitive Decline in Older Adults|Recruiting||N/A|160|Anticipated|University of Florida||2|||f||||t||||||||||2017-10-11 02:00:46.463047|2017-10-11 02:00:46.463047
NCT01786564|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-05-24|||October 2012||2012-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Home Sleep and Circadian Phase: Mediators of Diabetes Risk|Home Sleep and Circadian Phase: Mediators of Diabetes Risk|Recruiting||N/A|200|Anticipated|Northwestern University|||1||f|||||f|f||||||||2017-10-11 02:00:46.556803|2017-10-11 02:00:46.556803
NCT01786551|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-04-11|2017-04-11||March 2010||2010-03-01|April 2017|2017-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||The baseline analysis population included all participants who completed the study and had glucose data available.|Effect of Eplerenone on Postprandial Inflammatory Response in Healthy Adults|Effect of Eplerenone on Postprandial Inflammatory Response in Healthy Adults|Completed||N/A|16|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:00:46.649105|2017-10-11 02:00:46.649105
NCT01786538|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-03-12|||June 2013||2013-06-01|March 2013|2013-03-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines|Randomized Phase III Study of Oxaliplatin, Fluorouracil and Leucovorin (FOLFOX) With or Without Regorafenib in Patients With Metastatic Colorectal Cancer Progressed After First-line Irinotecan Plus Fluoropyrimidines|Withdrawn||Phase 3|0|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:00:47.014288|2017-10-11 02:00:47.014288
NCT01786525|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-07-11|||June 2013||2013-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||House Calls and Decision Support: Improving Access to Live Donor Transplantation|House Calls and Web-based Decision Support: Improving Access to Live Donor Kidney Transplantation|Recruiting||N/A|150|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||f||||||||||2017-10-11 02:00:47.117237|2017-10-11 02:00:47.117237
NCT01786512|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-08-14||2016-03-07|February 26, 2013|Actual|2013-02-26|August 2017|2017-08-01|August 19, 2015|Actual|2015-08-19|July 22, 2015|Actual|2015-07-22||Interventional|COSMIC-HF||COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.|A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction|Completed||Phase 2|544|Actual|Amgen||2|||f||||t||||||||||2017-10-11 02:00:47.267811|2017-10-11 02:00:47.267811
NCT01786499|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-11-30|||June 2013||2013-06-01|November 2016|2016-11-01||||December 2013|Anticipated|2013-12-01||Interventional|||The Effect of Relaxation Response on Provider Burnout||Withdrawn||N/A|0|Actual|Allina Health System||1|||f||||f||||||||||2017-10-11 02:00:47.588705|2017-10-11 02:00:47.588705
NCT01786486|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-09-19|||August 2009||2009-08-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01|4 Years|Observational [Patient Registry]|ACPR||AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol||Completed||N/A|204|Actual|St. Jude Medical|||1||f||||t||||||||Yes|Manuscript has been submitted to Euro Intervention Sept 2016|2017-10-11 02:00:47.66256|2017-10-11 02:00:47.66256
NCT01786473|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-06|||December 2012||2012-12-01|February 2013|2013-02-01||||December 2014|Anticipated|2014-12-01||Interventional|||Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism|A Multi-center, Double Blind, Randomized, Placebo Controlled Study of Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism|Unknown status|Recruiting|Phase 3|240|Anticipated|Laboratoires Besins International||2|||f||||f||||||||||2017-10-11 02:00:47.756208|2017-10-11 02:00:47.756208
NCT01786460|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2017-01-30|||January 2011||2011-01-01|January 2017|2017-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Brain Injury Biomarkers in the General Population||Completed||N/A|800|Actual|Banyan Biomarkers, Inc|||1||f||||f||||||Samples Without DNA|"     Whole blood, serum, plasma   "|||2017-10-11 02:00:47.839121|2017-10-11 02:00:47.839121
NCT01782625|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-05-24|||January 2013||2013-01-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Hypercapnia: Cognitive Effects and Monitoring|Hypercapnia: Cognitive Effects and Monitoring|Completed||N/A|58|Actual|Duke University||4|||f||||f||||||||||2017-10-11 02:02:00.154502|2017-10-11 02:02:00.154502
NCT01786447|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-06|2013-02-08|||April 2010||2010-04-01|February 2013|2013-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI||Terminated||N/A|111|Actual|Banyan Biomarkers, Inc|||2||f||||f||||||Samples Without DNA|"     Whole blood, serum, plasma   "|||2017-10-11 02:00:47.937717|2017-10-11 02:00:47.937717
NCT01786434|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-12-14|||January 2013||2013-01-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|FEKOL||Fentanyl in Colonoscopy|Routine Versus on Demand Administration of Fentanyl in Colonoscopy: A Multi-centre Randomized Controlled Trial|Active, not recruiting||N/A|119|Actual|Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-11 02:00:48.028393|2017-10-11 02:00:48.028393
NCT01786421|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-02-05||||||February 2013|2013-02-01||||December 2005|Actual|2005-12-01||Observational|||Diurnal Triglyceridemia in Relation to Alcohol Intake|Observational Study of Diurnal Triglyceridemia in Relation to Alcohol Intake|Completed||N/A|273|Actual|Sint Franciscus Gasthuis|||1||f||||f||||||||||2017-10-11 02:00:48.479339|2017-10-11 02:00:48.479339
NCT01786408|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2014-11-24|||March 2013||2013-03-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate|A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick Using the SAFE-T-FILL Capillary Blood Collection System|Withdrawn||N/A|0|Actual|Seventh Sense Biosystems||2|||f||||f||||||||||2017-10-11 02:00:48.550415|2017-10-11 02:00:48.550415
NCT01786395|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-01-27|||March 2013||2013-03-01|March 2013|2013-03-01||||April 2015|Actual|2015-04-01||Interventional|||Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa|Phase III Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period|Terminated||Phase 3|202|Actual|R-Tech Ueno, Ltd.||2|||f||||f||||||||||2017-10-11 02:00:48.634738|2017-10-11 02:00:48.634738
NCT01786382|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-03-22|||February 2013||2013-02-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole|A Phase 1, Open-Label Study to Evaluate the Potential Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole, and Potentially Telaprevir, in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Presidio Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 02:00:48.774889|2017-10-11 02:00:48.774889
NCT01786369|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-04-13|||February 2013||2013-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.|Determination of Adherence in Patients Admitted to a Psychiatric Unit for Decompensated Psychosis: an Analysis of Serum Levels of Antipsychotics.|Completed||N/A|106|Actual|Northwell Health|||1||f||||f||||||||||2017-10-11 02:00:48.861038|2017-10-11 02:00:48.861038
NCT01786356|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-05|||March 2008||2008-03-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two IOLs: Hoya iMics Y-60H vs. Bausch&Lomb MI60 (MIMI)||Completed||N/A|60|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 02:00:48.948866|2017-10-11 02:00:48.948866
NCT01786343|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-07-06|||February 2013|Actual|2013-02-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)|A Randomized Phase II Study of Two Schedules of Decitabine for Frontline Therapy of Older or Unfit Patients With Acute Myeloid Leukemia (AML)|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 02:00:49.024815|2017-10-11 02:00:49.024815
NCT01786330|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-03-10|2016-02-09||February 2013||2013-02-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Do Elastic Abdominal Binders Reduce Post Operative Pain and Blood Loss?|Do Elastic Abdominal Binders Reduce Post Operative Pain and Blood Loss?|Completed||N/A|60|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 02:00:49.122868|2017-10-11 02:00:49.122868
NCT01786317|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-07-21|||January 2013||2013-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Anal Motor Function in Fecal Incontinence|Measure of Ano-rectal Motility in Fecal Incontinence|Completed||N/A|60|Actual|University Hospital, Rouen|||2||f||||f||||||||||2017-10-11 02:00:49.60263|2017-10-11 02:00:49.60263
NCT01786304|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-12-06|||January 2013||2013-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|ENS-3||Effect of Sacral Nerve Stimulation on Enteric Nervous System|Effect of Sacral Nerve Stimulation on Enteric Nervous System|Completed||N/A|37|Actual|University Hospital, Rouen|||1||f||||f||||||Samples Without DNA|"     colonic biopsies   "|||2017-10-11 02:00:49.698992|2017-10-11 02:00:49.698992
NCT01786291|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-06|||May 2010||2010-05-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||PAP Therapy Sleep Apnea and Exercise|Effects of Positive Airway Pressure Therapy on Exercise Parameters in Obstructive Sleep Apnea|Completed||N/A|65|Actual|University of Gaziantep|||2||f||||f||||||||||2017-10-11 02:00:49.787827|2017-10-11 02:00:49.787827
NCT01786278|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-05|||February 2013||2013-02-01|February 2013|2013-02-01|December 2017|Anticipated|2017-12-01|February 2016|Anticipated|2016-02-01||Interventional|BRASTEGAC||Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer|The Comparison of Value of Brachytherapy and Endoscopic Stenting With SEMS in Palliative Treatment of Dysphagia Resulting From Adenocarcinoma of the Esophago-Gastric Junction|Recruiting||Phase 2/Phase 3|80|Anticipated|Medical University of Lublin||2|||f||||t||||||||||2017-10-11 02:00:49.874791|2017-10-11 02:00:49.874791
NCT01786265|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-03-24|||February 2013|Actual|2013-02-01|March 2017|2017-03-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone|A Randomized Study of Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone in Patients With Prostate Cancer Who Have PSA Progression After Prostatectomy and/or Radiotherapy|Active, not recruiting||Phase 2|200|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 02:00:50.06511|2017-10-11 02:00:50.06511
NCT01786252|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-01-05|2016-03-22||January 2013||2013-01-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of hCG on Receptivity of the Human Endometrium|The Effect of hCG on the Human Endometrium|Completed||Phase 4|15|Actual|Michigan State University||2|||f||||f||||||||No||2017-10-11 02:00:50.216183|2017-10-11 02:00:50.216183
NCT01786239|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-01-30|2016-09-12||May 2013||2013-05-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Omega-3 Dietary Supplements in Schizophrenia|Detecting Which Patients With Schizophrenia Will Improve With Omega-3 Treatment|Completed||N/A|50|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 02:00:50.684468|2017-10-11 02:00:50.684468
NCT01786226|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-09-04|||March 2010||2010-03-01|September 2014|2014-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Mifepristone to Treat Uterine Fibroids|Treatment of Uterine Myoma With 2.5 or 5 mg Mifepristone Daily During 3 Months With 9 Months Post-treatment Follow-up. Randomized Clinical Trial.|Terminated||Phase 2/Phase 3|220|Actual|Mediterranea Medica S. L.||2|||f||||t||||||||||2017-10-11 02:00:51.0335|2017-10-11 02:00:51.0335
NCT01786213|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-02-05|||February 2013||2013-02-01|February 2013|2013-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|TraCo||Training Effects in Colonoscopy|The Impact of Training Effects on Quality Indicators in Colonoscopy: a Retrospective Study.|Completed||N/A|3500|Anticipated|Technische Universität München|||10||f||||f||||||Samples Without DNA|"     Histological findings are recorded   "|||2017-10-11 02:00:51.131848|2017-10-11 02:00:51.131848
NCT01786200|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-02-05|||February 2013||2013-02-01|February 2013|2013-02-01||||December 2014|Anticipated|2014-12-01||Interventional|||Physiological Effects of Altering Cancer-related Inflammation|Pilot Study to Investigate the Physiological Effects Associated With Down-regulation of Host-tumour Inflammatory Responses in Colon Cancer|Unknown status|Not yet recruiting|N/A|60|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f||||||||||2017-10-11 02:00:51.203815|2017-10-11 02:00:51.203815
NCT01786187|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-01-11|||January 2013||2013-01-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|SES||The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer|Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience|Completed||Phase 1/Phase 2|74|Actual|Michigan State University||2|||f||||f||||||||||2017-10-11 02:00:51.311687|2017-10-11 02:00:51.311687
NCT01786174|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-06-02|2015-10-23||August 2013||2013-08-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|September 2014|Actual|2014-09-01||Interventional|||Gilenya in Amyotrophic Lateral Sclerosis (ALS)|Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod in Patients With Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|30|Actual|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-11 02:00:51.421884|2017-10-11 02:00:51.421884
NCT01786161|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-05-05|2017-03-27||September 2013||2013-09-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CIV||Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients|Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients|Terminated||Phase 4|44|Actual|Massachusetts General Hospital||2||slow recruitment|f||||f||||||||Undecided||2017-10-11 02:00:52.324563|2017-10-11 02:00:52.324563
NCT01786148|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-07-27|||June 2014||2014-06-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|April 19, 2017|Actual|2017-04-19||Interventional|MFH||Music for Health Project|An Audio Music Self-Management Program to Improve ART Adherence in Rural GA|Completed||N/A|149|Actual|Emory University||2|||f||||f||||||||||2017-10-11 02:00:52.584646|2017-10-11 02:00:52.584646
NCT01786135|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-06-29|||February 2013||2013-02-01|June 2017|2017-06-01|February 16, 2017|Actual|2017-02-16|August 2015|Actual|2015-08-01||Interventional|||A Safety Study of SGN-CD19A for B-Cell Lymphoma|A Phase 1, Open-Label, Dose-Escalation Study of SGN-CD19A in Patients With Relapsed or Refractory B-Lineage Non-Hodgkin Lymphoma|Completed||Phase 1|64|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-10-11 02:00:52.681454|2017-10-11 02:00:52.681454
NCT01786122|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-07-22|||April 2013||2013-04-01|July 2014|2014-07-01|December 2015|Anticipated|2015-12-01|January 2015|Anticipated|2015-01-01||Interventional|EFICANCER||Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients|PHYSICAL EXERCISE TO IMPROVE THE QUALITY OF LIFE OF CANCER PATIENTS DURING TREATMENT PROCESS: EFICANCER STUDY|Unknown status|Recruiting|N/A|250|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-11 02:00:52.78079|2017-10-11 02:00:52.78079
NCT01786109|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-03-13|2013-02-08||September 2009||2009-09-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome|Study on the Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor and Sensory Functions in Patients With Diarrhea-Predominant Irritable Bowel Syndrome|Completed||Phase 2|75|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 02:00:52.879596|2017-10-11 02:00:52.879596
NCT01786096|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-06-29|||February 2013||2013-02-01|June 2017|2017-06-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|||A Safety Study of SGN-CD19A for Leukemia and Lymphoma|A Phase 1, Open-Label, Dose-Escalation Study of SGN-CD19A in Patients With B-Lineage Acute Lymphoblastic Leukemia and Highly Aggressive Lymphomas|Completed||Phase 1|92|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-10-11 02:00:53.468854|2017-10-11 02:00:53.468854
NCT01786083|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-07|||September 2007||2007-09-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|September 2009|Actual|2009-09-01||Interventional|||Caring for Family Caregivers:a Research-action Study|Depression and Anxiety Symptoms Reduction and Perceived Wellbeing Improvement in Female Primary Caregivers of Chronically Ill Patients by the Application of Problem Solving Technique by Primary Health Care Nurses|Completed||N/A|122|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 02:00:53.608241|2017-10-11 02:00:53.608241
NCT01786070|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-02|2013-02-05|||March 2011||2011-03-01|February 2013|2013-02-01||||March 2014|Anticipated|2014-03-01||Interventional|||Effect of Nebulized Budesonide on Preventing Postextubation Complications in Critically Patients||Unknown status|Recruiting|N/A|70|Anticipated|Isfahan University of Medical Sciences||2|||f||||||||||||||2017-10-11 02:00:53.702753|2017-10-11 02:00:53.702753
NCT01786057|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-05|||November 2012||2012-11-01|February 2013|2013-02-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Interventional|||Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis|The Effect of Extracorporeal Shock Wave Therapy (ESWT)of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis|Unknown status|Enrolling by invitation|Phase 2/Phase 3|48|Anticipated|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:00:53.78775|2017-10-11 02:00:53.78775
NCT01786044|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-03-21|||March 2014||2014-03-01|March 2014|2014-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||"The Impact of a Serious Game on Improving Patient's Medication Knowledge"|"The Impact of a Serious Game on Improving Patient's Medication Knowledge"|Completed||N/A|850|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:00:53.881675|2017-10-11 02:00:53.881675
NCT01786031|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-02-05|||December 2012||2012-12-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|PETRUS||Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program|Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program|Completed||N/A|55|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 02:00:53.953446|2017-10-11 02:00:53.953446
NCT01786018|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-07-07|||February 2013||2013-02-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|TBF||Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas|Allogeneic Transplantation After a Conditioning With Thiotepa, Busulfan and Fludarabin for the Treatment of Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas: a Phase II Multi-Center Trial|Unknown status|Recruiting|Phase 2|42|Anticipated|Azienda Ospedaliera San Giovanni Battista||1|||f||||f||||||||||2017-10-11 02:00:54.024408|2017-10-11 02:00:54.024408
NCT01786005|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-11-05|||February 2013||2013-02-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|ANTMS||Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity|Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity|Unknown status|Recruiting|Phase 4|60|Anticipated|Russian Academy of Medical Sciences||4|||f||||t||||||||||2017-10-11 02:00:54.161487|2017-10-11 02:00:54.161487
NCT01785992|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2015-03-23|||October 2012||2012-10-01|March 2014|2014-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|IRIS||A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.|A Phase II Study to Assess the Safety and Efficacy of the Steroid Sulfa-tase Inhibitor Irosustat When Added to an Aromatase Inhibitor in ER Positive Locally Advanced or Metastatic Breast Cancer Patients.|Completed||Phase 2|27|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 02:00:54.280511|2017-10-11 02:00:54.280511
NCT01785979|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-11-12|||January 2016||2016-01-01|November 2015|2015-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|LiHMS||Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly|Prednisone Plus Chloroquine Versus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly in Papua New Guinea: a Randomized Open-label Trial|Withdrawn||Phase 3|0|Actual|Lihir Medical Centre||2||Lack of funding|f||||f||||||||||2017-10-11 02:00:54.402249|2017-10-11 02:00:54.402249
NCT01785966|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2015-03-02|||August 2013||2013-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|CHECKLIST-ICU||Checklist During Multidisciplinary Visits for Reduction of Mortality in Intensive Care Units|Checklist During Multidisciplinary Daily Visits and Clinician Prompting for Reduction of Mortality in Intensive Care Units: A Cluster Randomized Trial|Completed||N/A|13637|Actual|Hospital do Coracao||2|||f||||t||||||||||2017-10-11 02:00:54.506825|2017-10-11 02:00:54.506825
NCT01785953|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-06|||February 2013||2013-02-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Observational|AML||Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia|CONVENTIONAL AND EXPERIMENTAL CHEMOTHERAPY WITH ALLOGENEIC TRANSPLANT IN YOUNG PATIENTS WITH ACUTE MYELOID LEUKAEMIA|Unknown status|Recruiting|N/A|300|Anticipated|Azienda Ospedaliera San Giovanni Battista|||1||f||||f||||||||||2017-10-11 02:00:54.614356|2017-10-11 02:00:54.614356
NCT01785940|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-02-11|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Continuous Interscalene Block for Same Day Discharge Following Total Shoulder Arthroplasty|Evaluation of Ultrasound Guided Continuous Interscalene Block for Same Day Discharge Following Total Shoulder Arthroplasty - An Open Label Feasibility Study|Completed||N/A|10|Actual|Lawson Health Research Institute||1|||f||||f||||||||No||2017-10-11 02:00:54.692154|2017-10-11 02:00:54.692154
NCT01785914|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-05|||February 2013||2013-02-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Observational|ALL||Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.|Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.|Unknown status|Recruiting|N/A|100|Anticipated|Azienda Ospedaliera San Giovanni Battista|||1||f||||f||||||||||2017-10-11 02:00:54.883192|2017-10-11 02:00:54.883192
NCT01785901|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-08-17|||May 2013||2013-05-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China|The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China|Completed||N/A|1502|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:00:54.965368|2017-10-11 02:00:54.965368
NCT01785888|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-09-19|||April 2013||2013-04-01|September 2016|2016-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|ASSESS||Europe-Japan Diagnostic Study for EGFR Testing|A Diagnostic Study of European and Japanese Advanced NSCLC Patients to Evaluate Suitable Sample Types for EGFR Testing,|Completed||N/A|1311|Actual|AstraZeneca|||1||f||||f||||||Samples With DNA|"     Tumour samples (biopsy or citology) Blood (plasma) samples   "|||2017-10-11 02:00:55.103108|2017-10-11 02:00:55.103108
NCT01785875|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-02-07|2017-02-07|2015-12-19|July 2013||2013-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis|A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis|Completed||Phase 3|891|Actual|Amgen||1|||f||||t||||||||||2017-10-11 02:00:55.376675|2017-10-11 02:00:55.376675
NCT01785862|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-06-26|||February 2013||2013-02-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Ibuprofen Lozenge in Acute Sore Throat Pain|Study of Efficacy and Safety of V0498 Versus Placebo in Acute Sore Throat Pain.|Completed||Phase 3|427|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 02:01:00.503378|2017-10-11 02:01:00.503378
NCT01785849|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-02-07|2017-02-07|2015-04-09|March 2013||2013-03-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis|A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis|Completed||Phase 3|508|Actual|Amgen||2|||f||||t||||||||||2017-10-11 02:01:00.655647|2017-10-11 02:01:00.655647
NCT01785836|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-22|||March 2013||2013-03-01|February 2013|2013-02-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris||Withdrawn||Phase 1|0|Actual|Allergan||4||"Study was never initiated due to company decision. No study subjects were ever enrolled or   dosed."|f||||f||||||||||2017-10-11 02:01:04.356972|2017-10-11 02:01:04.356972
NCT01785823|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-06|||April 2012||2012-04-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|||Fentanyl Background Infusion for Acute Postoperative Pain|The Efficacy of the Time-scheduled Decremental Continuous Infusion of Fentanyl for Postoperative Patient-controlled Analgesia After Total Intravenous Anesthesia|Completed||N/A|99|Actual|Ajou University School of Medicine||3|||f||||t||||||||||2017-10-11 02:01:04.452429|2017-10-11 02:01:04.452429
NCT01785810|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-07-18|||February 2013||2013-02-01|January 2016|2016-01-01||||January 2016|Actual|2016-01-01||Interventional|||Phase II Maraviroc for GVHD Prevention|A Phase II Study to Assess the Efficacy of Maraviroc, a CCR5-Antagonist in Prophylaxis of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Undergoing Reduced-Intensity Allogeneic Stem-Cell Transplantation From Unrelated Donors|Active, not recruiting||Phase 2|37|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 02:01:04.545871|2017-10-11 02:01:04.545871
NCT01785797|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-06|||June 2013||2013-06-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||The Effect of Subdural Drain Placement After Burr Hole Evacuation of Chronic Subdural Haematomas on Recurrence: a Prospective Randomised-controlled Multi-centre Study|The Effect of Subdural Drain Placement After Burr Hole Evacuation of Chronic Subdural Haematomas on Recurrence: a Prospective Randomised-controlled Multi-centre Study|Unknown status|Not yet recruiting|Phase 3|260|Anticipated|Kwong Wah Hospital||2|||f||||t||||||||||2017-10-11 02:01:04.750099|2017-10-11 02:01:04.750099
NCT01785784|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-02-05|||November 2010||2010-11-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Interventional|rhGM-CSF||Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn|Phase IV Clinical Trial of rhGM-CSF Hydro-gel for Topical Application on Deep 2nd Partial Thickness Burn|Completed||Phase 4|2510|Actual|GeneScience Pharmaceuticals Co., Ltd.||1|||f||||t||||||||||2017-10-11 02:01:04.849926|2017-10-11 02:01:04.849926
NCT01785771|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-06-26|||May 2013||2013-05-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c|An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c|Active, not recruiting||Phase 3|100|Anticipated|Intarcia Therapeutics||1|||f||||||||||||||2017-10-11 02:01:04.943204|2017-10-11 02:01:04.943204
NCT01785758|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2013-02-05|||October 2011||2011-10-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy and Safety of Sugammadex in Renal Diseased Patients|Efficacy and Safety of Sugammadex (Bridion™) in the Reversal of Profound Rocuronium-induced Neuromuscular Blockade in Patients With End-stage Renal Failure: Comparison With Healthy Patients|Completed||Phase 4|40|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 02:01:05.17519|2017-10-11 02:01:05.17519
NCT01785745|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-05|||July 2012||2012-07-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Interventional|||Study of Neurocognitive Therapeutic Exercise in the Shoulder Impingement Syndrome in Comparison With Traditional Therapeutic Exercise|Evaluation of the Effectiveness of Neurocognitive Therapeutic Exercise in Pain Control and Functional Recovery of the Shoulder Impingement Syndrome in Comparison With Traditional Therapeutic Exercise|Completed||N/A|60|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 02:01:05.269862|2017-10-11 02:01:05.269862
NCT01785732|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-08|||January 2013||2013-01-01|February 2013|2013-02-01|January 2016|Anticipated|2016-01-01|January 2014|Anticipated|2014-01-01||Interventional|RENSYMPIS||Renal Sympathetic Denervation and Insulin Sensitivity (RENSYMPIS Study)||Unknown status|Recruiting|N/A|60|Anticipated|The Hospital District of Satakunta||2|||f||||t||||||||||2017-10-11 02:01:05.365327|2017-10-11 02:01:05.365327
NCT01785719|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2015-06-01|||January 2013||2013-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Ultrasound Characterization of Ovarian Morphology During Weight Loss in Women With Polycystic Ovary Syndrome (PCOS)|Ultrasound Characterization of Follicle Dynamics During Weight Loss|Completed||N/A|22|Actual|Cornell University||1|||f||||f||||||||||2017-10-11 02:01:05.450705|2017-10-11 02:01:05.450705
NCT01785706|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-06-11|||March 2007||2007-03-01|June 2015|2015-06-01||||April 2015|Actual|2015-04-01|20 Years|Observational [Patient Registry]|||COPD Research Registry||Completed||N/A|50000|Anticipated|COPD Foundation|||1||f||||||||||||||2017-10-11 02:01:05.539566|2017-10-11 02:01:05.539566
NCT01785693|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-02-05|||February 2013||2013-02-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|BLOC-FEMPOP||Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream|Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream.|Unknown status|Not yet recruiting|Phase 4|48|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:01:05.615263|2017-10-11 02:01:05.615263
NCT01785680|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-02-04|||January 2013||2013-01-01|February 2013|2013-02-01|January 2014|Anticipated|2014-01-01|June 2013|Anticipated|2013-06-01||Interventional|||Moderate Acute Malnutrition (MAM) and Severe Acute Malnutrition (SAM) in Sierra Leone|Conducting Research on Moderate Acute Malnutrition in Humanitarian Emergencies Integrated Management of MAM and SAM in Sierra Leone With Ready to Use Theraputic Foods (RUTF)|Unknown status|Recruiting|N/A|1800|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:01:05.720475|2017-10-11 02:01:05.720475
NCT01785667|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2014-07-29|||January 2011||2011-01-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|November 2011|Actual|2011-11-01|16 Years|Observational [Patient Registry]|DCPD1987||Incidence of Retinopathy and Associated Risk Factors in Children and Young Adults With Type 1 Diabetes in Denmark|Incidence of Retinopathy and Associated Risk Factors in Children and Young Adults With Type 1 Diabetes in Denmark|Completed||N/A|132|Actual|Odense University Hospital|||1||f||||f||||||Samples With DNA|"     buffy coat, whole blood, urine   "|||2017-10-11 02:01:05.837651|2017-10-11 02:01:05.837651
NCT01785654|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-05|||March 2013||2013-03-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Observational|REVECOL||Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU|Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU|Unknown status|Not yet recruiting|N/A|400|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 02:01:05.919934|2017-10-11 02:01:05.919934
NCT01785641|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-02-06|||December 2012||2012-12-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients|Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients|Unknown status|Recruiting|N/A|300|Anticipated|Chulalongkorn University||4|||f||||t||||||||||2017-10-11 02:01:06.009753|2017-10-11 02:01:06.009753
NCT01785628|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-08-20|2013-05-13||August 2010||2010-08-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||The Impact of Pharmacological and Electric Modulation of NMDA Pathway on the Cognitive Flexibility and Volitional Movement Preparation in Patients With Parkinson's Disease||Completed||N/A|30|Actual|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 02:01:06.130006|2017-10-11 02:01:06.130006
NCT01785615|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-04-25|2013-09-03||November 2004||2004-11-01|April 2017|2017-04-01|May 2013|Actual|2013-05-01|December 2011|Actual|2011-12-01||Interventional|PINK||Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin|Interactions of Thrombogenic, Lipogenic, and Inflammatory Markers in Women With the Metabolic Syndrome - Effect of Atorvastatin|Completed||Phase 1/Phase 2|116|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 02:01:06.792238|2017-10-11 02:01:06.792238
NCT01785602|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-11-11|2015-11-11||June 2013||2013-06-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study Evaluating Efficacy and Safety of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis|Completed||Phase 2|103|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:01:07.847602|2017-10-11 02:01:07.847602
NCT01785589|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-05-27|||May 2012||2012-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CameraCZT||Validation of Myocardial Perfusion Imaging|Stress Thallium-201/Rest Technetium-99m Sequential Dual Isotope High-Speed Myocardial Perfusion Imaging Validation Versus Invasive Coronary Angiography|Completed||Phase 4|220|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 02:01:08.20857|2017-10-11 02:01:08.20857
NCT01785576|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-01-30|||March 2013||2013-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CoupleCare||Couple-Based Intervention for Patients With Head and Neck Cancer and Their Partners|Couple-Based Intervention for Patients With Head and Neck Cancer and Their Partners|Completed||N/A|20|Actual|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||||2017-10-11 02:01:08.3119|2017-10-11 02:01:08.3119
NCT01785563|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-04-20|||February 2013||2013-02-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Nasal Noninvasive NAVA in the Very Low Birth Weight Infant|Nasal Noninvasive NAVA Provides Ventilation in the Very Low Birth Weight Infant|Recruiting||N/A|60|Anticipated|University of Iowa||1|||f||||f||||||||||2017-10-11 02:01:08.43534|2017-10-11 02:01:08.43534
NCT01785550|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-03-10|||February 2013||2013-02-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Neuromuscular Ultrasound in ALS|Ultrasonography in Amyotrophic Lateral Sclerosis as a Predictor of Disease Progression and Tool in Diagnosis: a Pilot Study|Completed||N/A|40|Actual|Duke University|||2||f||||f||||||||||2017-10-11 02:01:08.591434|2017-10-11 02:01:08.591434
NCT01785537|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-05-02|||October 2013||2013-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study|Multicentric 5-year Follow-up Study to Assess the Efficacy of E-cigarettes as a Tool for Smoking Cessation and to Compare the Risk of Smoking-related Diseases Among Electronic and Traditional Cigarette Smokers, and Smokers of Both.|Active, not recruiting||N/A|1050|Anticipated|Università degli Studi 'G. d'Annunzio' Chieti e Pescara|||3||f||||t||||||||||2017-10-11 02:01:08.678321|2017-10-11 02:01:08.678321
NCT01785524|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-07-26|2015-11-25||February 2013||2013-02-01|July 2017|2017-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|DM+PAD||Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD|Dietary Nitrate to Augment Exercise Training Benefits in Subjects With Type II Diabetes (DM) and Peripheral Arterial Disease (PAD)|Completed||Phase 2|18|Actual|Duke University|The largest limitation to the study was the evolving knowledge on conversion rates of oral inorganic nitrate to nitrite. We found a good deal of unexpected inter and intra-subject variation in conversion rates.|2|||f||||f||||||||||2017-10-11 02:01:08.796549|2017-10-11 02:01:08.796549
NCT01785511|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2013-02-19|||March 2012||2012-03-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Does Ultraviolet Irradiation Reduce Platelet Reactivity and Improve Coronary Microvascular Function in Man?|Does Ultraviolet Irradiation Reduce Platelet Reactivity and Improve Coronary Microvascular Function in Man?|Completed||N/A|12|Actual|University of Edinburgh||2|||f||||t||||||||||2017-10-11 02:01:09.133075|2017-10-11 02:01:09.133075
NCT01785498|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2015-02-10|||January 2012||2012-01-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|ReACH||Healthy Lifestyles for Children With Complex Heart Problems|Healthy Lifestyles for Children With Complex Heart Problems|Completed||N/A|64|Actual|Children's Hospital of Eastern Ontario||2|||f||||f||||||||||2017-10-11 02:01:09.213154|2017-10-11 02:01:09.213154
NCT01785485|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-06|||February 2013||2013-02-01|February 2013|2013-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|IMPACT||IMPACT - Integrative Medicine PrimAry Care Trial|IMPACT: Integrative Medicine PrimAry Care Trial: A Comparative Effectiveness Study of an Integrative Primary Care Clinic|Unknown status|Not yet recruiting|N/A|500|Anticipated|University of Arizona|||1||f||||f||||||||||2017-10-11 02:01:09.302485|2017-10-11 02:01:09.302485
NCT01785472|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-11-08|2015-08-06||April 2013||2013-04-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Full Analysis Set (FAS): All patients who were randomized. Patients were analyzed according to the treatment they were assigned to at the randomization. However, patients who were not qualified for randomization and were inadvertently randomized into the study were excluded from the FAS, provided these patients did not receive study drug|Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension|A Multi-center, Randomized, Double-blind, Active-controlled, 8-week Study to Evaluate the Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Patients With Essential Hypertension|Completed||Phase 3|1438|Actual|Novartis||3|||f||||t||||||||||2017-10-11 02:01:09.573807|2017-10-11 02:01:09.573807
NCT01785459|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2016-08-16|||October 2013||2013-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Bupivacaine for Benign Headache in the ED|Treatment of Benign Headache in the Emergency Department Population With Lower Cervical Paraspinous Bupivacaine Injections Versus Anti-Emetic Treatment in the Emergency Department Population: Randomized Prospective Control Trial|Terminated||Phase 2|24|Actual|Carolinas Healthcare System||2||Unable to enroll adequate number of patients.|f||||f||||||||||2017-10-11 02:01:11.062237|2017-10-11 02:01:11.062237
NCT01785446|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-02-06|||November 2012||2012-11-01|February 2013|2013-02-01||||February 2013|Anticipated|2013-02-01||Interventional|||Study of Cisatracurium and Sufentanil Consumption Using a Closed Loop Computer Control Infusion System|Effect of Dexmedetomidine on Cisatracurium Infusion and Sufentanil Consumption and Its Variations in Different Age Groups, Using a Closed Loop Computer Controlled System.|Unknown status|Recruiting|N/A|150|Anticipated|Tianjin Medical University General Hospital||4|||f||||t||||||||||2017-10-11 02:01:11.154963|2017-10-11 02:01:11.154963
NCT01785433|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2014-08-07||2013-08-27|January 2013||2013-01-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Open-Label, Repeat Dosing, Four-Period Crossover Study to Compare the Pharmacokinetics, Efficacy and Safety of Tiotropium Bromide Delivered Via Breath Actuated Inhaler (BAI), SPIRIVA® HandiHaler® and Respimat® Soft Mist™ Inhaler (SMI) in Subjects With COPD|Completed||Phase 1/Phase 2|36|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-10-11 02:01:11.259034|2017-10-11 02:01:11.259034
NCT01785420|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-10-18|||May 2013||2013-05-01|October 2016|2016-10-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Pre Operative Trastuzumab in Operable Breast Cancer|A Phase III Double Blind Randomized Placebo Controlled Study of Trastuzumab as Short Duration Preoperative Therapy in Patients With HER2-neu Positive Operable Breast Cancer|Recruiting||Phase 3|1100|Anticipated|Tata Memorial Hospital||2|||f||||f||||||||||2017-10-11 02:01:11.362798|2017-10-11 02:01:11.362798
NCT01785407|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-11-08|||February 2013||2013-02-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation|Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation|Completed||N/A|25|Actual|Swiss Federal Institute of Technology||4|||f||||f||||||||||2017-10-11 02:01:11.462926|2017-10-11 02:01:11.462926
NCT01785394|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-06|||February 2012||2012-02-01|February 2013|2013-02-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|POLET||POLlinosis and Exhaled Breath Temperature|Changes in Exhaled Breath Temperature During the Pollen Season in Subjects With Allergic Rhinoconjunctivitis Sensitized to Grasses and Effect of Sublingual Immunotherapy|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Association Asthma, Bulgaria||2|||f||||t||||||||||2017-10-11 02:01:11.574407|2017-10-11 02:01:11.574407
NCT01785381|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-05|||December 2012||2012-12-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|March 2013|Anticipated|2013-03-01||Interventional|||RCT: Added Value of Coordinator for the Management of Hip Fracture Patients|Randomized Controlled Trial: Added Value of Coordinator for the Management of Hip Fracture Patients in a Network of Public Hospitals in Brussels.|Unknown status|Recruiting|N/A|128|Anticipated|Centre Hospitalier Universitaire Saint Pierre||2|||f||||f||||||||||2017-10-11 02:01:11.662991|2017-10-11 02:01:11.662991
NCT01785368|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-03-25|||October 2013||2013-10-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|RIU||Referral Guidelines for Imaging Exams: Impact on Exam Relevance and Associated Delays|Implementing Referral Guidelines for Imaging Exams Requested Via the Emergency Department: Impact on Exam Relevance and Associated Delays|Completed||N/A|8549|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 02:01:11.78346|2017-10-11 02:01:11.78346
NCT01785355|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-01-14|||September 2012||2012-09-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|PAROHEM||The Impact Of Periodontal Disease Treatment On The General Health Status In Chronic Haemodialyzed Patients|Periodontal Disease, Inflammation, Nutritional Status And Anaemia Response To Erythropoietin In Chronic Haemodialyzed Patients - The Impact Of Treatment For Periodontal Disease|Unknown status|Recruiting|N/A|30|Anticipated|Anemia Working Group Romania||1|||f||||t||||||||||2017-10-11 02:01:11.886054|2017-10-11 02:01:11.886054
NCT01785342|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2017-03-27|||January 2013||2013-01-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules|Detection of Early Lung Cancer Among Military Personnel Study 1 (DECAMP-1): Diagnosis and Surveillance of Indeterminate Pulmonary Nodules|Recruiting||N/A|500|Anticipated|Boston University|||1||f||||t|f|f||||Samples With DNA|"     Blood, Urine, Sputum, Nasal brushing, Buccal scraping, Bronchial Biopsy, Bronchial brushing,     lung tissue   "|Undecided||2017-10-11 02:01:11.978763|2017-10-11 02:01:11.978763
NCT01785329|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-08-16|||February 2013||2013-02-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects|A Randomized Study of the Relative Bioavailability, Pharmacodynamics, Safety of SAR236553 (REGN727) After Single Subcutaneous Administration at 3 Different Injection Sites in Healthy Subjects|Completed||Phase 1|60|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:01:12.134646|2017-10-11 02:01:12.134646
NCT01785316|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-04-24|||June 2013||2013-06-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|SCANDIUM||The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases|The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases|Recruiting||Phase 3|78|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-11 02:01:12.213481|2017-10-11 02:01:12.213481
NCT01785303|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-09-14|||February 2013||2013-02-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|MATRICS||Multidisciplinary Approach to the Treatment of Insomnia and Comorbid Sleep Apnea|Multidisciplinary Treatment for Obstructive Sleep Apnea and Insomnia|Recruiting||N/A|140|Anticipated|Northwestern University||3|||f||||t||||||||||2017-10-11 02:01:12.319072|2017-10-11 02:01:12.319072
NCT01785290|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-04-13|||June 2013|Actual|2013-06-01|December 2015|2015-12-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|REDUCE||pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for Delirium|Prophylactic Haloperidol Use for Delirium in ICU Patients; a Randomized Placebo-controlled Double-blind Multicentre Trial|Completed||Phase 4|1800|Actual|Radboud University||3|||f||||t||||||||Undecided||2017-10-11 02:01:12.420851|2017-10-11 02:01:12.420851
NCT01785277|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-06|||January 2013||2013-01-01|February 2013|2013-02-01||||January 2014|Anticipated|2014-01-01||Observational|||Validation of a Translation Into Spanish (Mexico) of the Spinal Cord Independence Measure III|Validation of a Translation Into Spanish (Mexico) of the Spinal Cord Independence Measure III|Unknown status|Recruiting|N/A|100|Anticipated|American British Cowdray Medical Center|||1||f||||f||||||||||2017-10-11 02:01:12.538489|2017-10-11 02:01:12.538489
NCT01785264|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-01-25|||February 2013||2013-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment Results After Acute Rupture of the Achilles Tendon.|Non-operative Treatment of Acute Achilles Tendon Ruptures Versus Open and Mini-invasive Surgery: A Prospective Randomized Trial.|Recruiting||N/A|480|Anticipated|University Hospital, Akershus||3|||f||||t||||||||No||2017-10-11 02:01:12.797048|2017-10-11 02:01:12.797048
NCT01785251|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-04|||June 2011||2011-06-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Neuromuscular Electrical Stimulation Following Total Hip Arthroplasty|Haemodynamic Performance of Neuromuscular Electrical Stimulation (NMES) During Recovery From Total Hip Arthroplasty|Completed||N/A|11|Actual|National University of Ireland, Galway, Ireland||1|||f||||f||||||||||2017-10-11 02:01:12.974848|2017-10-11 02:01:12.974848
NCT01785238|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2014-10-15|||February 2013||2013-02-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|IRENEO||Nephronic Reduction After Neonatal Acute Renal Failure in Preterm|Renal Prognosis of Former Preterm Infants 3 to 10 Years After Neonatal Acute Renal Failure|Completed||N/A|75|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 02:01:13.089521|2017-10-11 02:01:13.089521
NCT01785225|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-05|||February 2013||2013-02-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Ultrasound-guided Blood Sampling With a Sterile and Dry Puncture Area|Ultrasound-guided Blood Sampling With a Sterile and Dry Puncture Area|Unknown status|Recruiting|N/A|10|Anticipated|Aarhus University Hospital||1|||f||||t||||||||||2017-10-11 02:01:13.222641|2017-10-11 02:01:13.222641
NCT01785212|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-04-06|||March 2013||2013-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver|The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver|Completed||N/A|40|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:01:13.335822|2017-10-11 02:01:13.335822
NCT01785199|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-10-08|||October 2013||2013-10-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effects of Head Elevation by a Bed on Sleep-disordered Breathing|Effects of Head Elevation by an Adjustable Bed on Sleep-disordered Breathing|Unknown status|Recruiting|Phase 1|60|Anticipated|Mackay Memorial Hospital||4|||f||||t||||||||||2017-10-11 02:01:13.439487|2017-10-11 02:01:13.439487
NCT01785186|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-08-22|2017-08-22||April 2013||2013-04-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design|A Multiple Arm, Multiple Stage, Phase 2, OL, Randomized, Controlled Trial to Evaluate 4 Treatment Regimens of SQ109, Increased Doses of Rifampicin, and Moxifloxacin in Adults With Newly Diagnosed, Smear-positive Pulmonary Tuberculosis|Completed||Phase 2|365|Actual|Ludwig-Maximilians - University of Munich||5|||f||||t||||||||||2017-10-11 02:01:13.612905|2017-10-11 02:01:13.612905
NCT01785173|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2013-02-06|||October 2012||2012-10-01|February 2013|2013-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Endoscopic-guided Versus Cotton-tipped Applicator Gauze Pledgetting for Nasal Anesthesia Before Transnasal Endoscopy|A Randomized Study Comparing Endoscopic-guided Gauze Pledgetting and Cotton-tipped Applicator Packing for Nasal Anesthesia Before Transnasal Endoscopy|Unknown status|Recruiting|N/A|242|Anticipated|Buddhist Tzu Chi General Hospital||2|||f||||f||||||||||2017-10-11 02:01:16.026646|2017-10-11 02:01:16.026646
NCT01785160|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-07-03|2015-07-03||February 2013||2013-02-01|July 2015|2015-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||The total number of participants N analysed for baseline characteristics is not same as the number of participants enrolled as one subject was not treated after being enrolled|Investigation of Faldaprevir Effect on Pharmacokinetics of Raltegravir|Investigation of Faldaprevir Effect on Steady State Pharmacokinetics of Raltegravir in Healthy Male and Female Volunteers (an Open-label Trial With Two Periods in a Fixed Sequence)|Completed||Phase 1|25|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:01:16.140085|2017-10-11 02:01:16.140085
NCT01785147|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2015-01-20|||February 2013||2013-02-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety of BP1.4979 in Smoking Cessation|Randomized Placebo Controlled Trial Assessing the Efficacy and Safety of BP1.4979 in Smoking Cessation|Completed||Phase 2|219|Actual|Bioprojet||4|||f||||t||||||||||2017-10-11 02:01:16.389143|2017-10-11 02:01:16.389143
NCT01785134|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-09-28|2014-09-19||May 2006||2006-05-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|DEOSH||Effects of Different Surgical Methods to Treat Obesity|Metabolic Effects of Different Surgical Methods to Treat Obesity|Completed||N/A|81|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:01:16.483379|2017-10-11 02:01:16.483379
NCT01785121|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-08-22|||January 2013||2013-01-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|HF-Wii||Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming|Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming (HF-Wii) A Randomized Controlled Trial|Active, not recruiting||N/A|605|Actual|Linkoeping University||2|||f||||t||||||||||2017-10-11 02:01:16.807564|2017-10-11 02:01:16.807564
NCT01785108|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-08-22|||February 2013||2013-02-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen|Pilot Trial to Preserve Residual Insulin Secretion in Children and Adolescents With Recent Onset Type 1 Diabetes by Using GAD-antigen (Diamyd) Therapy in Combination With Vitamin D and Ibuprofen|Completed||Phase 2|60|Actual|Linkoeping University||4|||f||||f||||||||||2017-10-11 02:01:16.906604|2017-10-11 02:01:16.906604
NCT01785095|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-12-19|2015-02-12||March 2013||2013-03-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional||All the subjects that started the stimulation.|Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles|Prospective, Open-label, Uncontrolled Clinical Trial Evaluating Multiple Controlled Ovarian Hyperstimulation Cycles in Oocyte Donor, to Assess the Immunogenicity of FSH-IBSA|Completed||Phase 3|41|Actual|IBSA Institut Biochimique SA||1|||f||||f||||||||||2017-10-11 02:01:17.171638|2017-10-11 02:01:17.171638
NCT01785082|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-10-10|||January 2013||2013-01-01|October 2013|2013-10-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|||Fast-track LiveR: Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test|Prospective, Randomized, Controlled, Multi-centric, Phase III Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test|Unknown status|Recruiting|Phase 3|120|Anticipated|Humedics GmbH||2|||f||||f||||||||||2017-10-11 02:01:17.426066|2017-10-11 02:01:17.426066
NCT01785069|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-04-25|||December 2012||2012-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:01:17.57173|2017-10-11 02:01:17.57173
NCT01785056|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-01-30|||April 2013||2013-04-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||IVIG Treatment in Systemic Sclerosis|A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of Intravenous Immunoglobulin Treatment in Patients With Systemic Sclerosis|Active, not recruiting||N/A|24|Anticipated|Georgetown University||2|||f||||t||||||||||2017-10-11 02:01:17.623673|2017-10-11 02:01:17.623673
NCT01785043|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-09-14|||March 2013||2013-03-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|LAED001||Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users|Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users: A Randomized, Open-label, Parallel-group and Active Controlled Trial|Completed||Phase 4|13|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||t||||||||||2017-10-11 02:01:17.77783|2017-10-11 02:01:17.77783
NCT01785030|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-02-27|||February 2013||2013-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nitrous Oxide Vasodilation Healthy Adult Volunteers|Peripheral Vasodilation in Healthy Adult Volunteers Receiving 50% Nitrous Oxide|Terminated||Phase 1|7|Actual|Columbia University||1||Poor enrollment|f||||t||||||||||2017-10-11 02:01:17.892445|2017-10-11 02:01:17.892445
NCT01785017|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-01-04|||January 2013||2013-01-01|February 2013|2013-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|AsthmaSCAMP||The Effects of a Standardized Management Plan on Children With Critical Asthma|The Effects of a Standardized Clinical Assessment Management Plan (SCAMP) on Clinical Outcomes in Children With Critical Asthma|Completed||N/A|273|Actual|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-11 02:01:17.966367|2017-10-11 02:01:17.966367
NCT01785004|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-02-03|||July 2012||2012-07-01|February 2017|2017-02-01|July 2020|Anticipated|2020-07-01|July 2019|Anticipated|2019-07-01||Interventional|VITAL||Vitamin D and Omega-3 Adiposity Trial (VITAL Adiposity)|Interrelationship of Vitamin D Supplementation, Adiposity and CVD Risk Factors in a Randomized Clinical Trial|Enrolling by invitation||N/A|600|Anticipated|Brigham and Women's Hospital||4|||f||||f||||||||||2017-10-11 02:01:18.045747|2017-10-11 02:01:18.045747
NCT01784991|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-06-24|||December 2011||2011-12-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study of Respiratory Depression When Using a Hydromorphone Pain Protocol|"Does a 1 Plus 1 Hydromorphone Pain Protocol Have a Similar Rate of Respiratory Depression to Physician Discretion Protocol in a Geriatric Population With Moderate to Severe Pain?"|Terminated||N/A|116|Actual|Albert Einstein Healthcare Network||2||difficulty in recruiting|f||||t||||||||||2017-10-11 02:01:18.146697|2017-10-11 02:01:18.146697
NCT01784978|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-09-29|||February 12, 2013|Actual|2013-02-12|September 2017|2017-09-01|May 8, 2017|Actual|2017-05-08|May 8, 2017|Actual|2017-05-08||Interventional|SUNRISES||Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer|Randomized ph. II Study to Explore Efficacy and Feasibility of Upfront Rotations Between SUNitinib and Everolimus vs Sequential Treatment of 1st lIne Sunitinib & 2nd Line EverolimuS Until Progression in Pats Met. Clear Cell Renal Cancer|Terminated||Phase 2|41|Actual|Associació per a la Recerca Oncologica, Spain||2||Lack of recruitment|f||||t||||||||||2017-10-11 02:01:18.240685|2017-10-11 02:01:18.240685
NCT01784965|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-03-15|2016-03-14||December 2009||2009-12-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.|Addition of a Glucagon-like Peptide-1 to a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and Cardiovascular Disease.|Completed||Phase 3|69|Actual|Stanford University|Major limitation: the experimental groups were relatively small. In addition, 31% of individuals randomized to liraglutide discontinued participation. Other studies suggest tolerance of GLP-1 receptor agonists may vary by population characteristics.|2|||f||||f||||||||No||2017-10-11 02:01:18.378073|2017-10-11 02:01:18.378073
NCT01784952|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2013-02-05|||January 2012||2012-01-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Consumption of Whole Grains and Legumes Modulates the Genetic Effect of the APOA5 -1131C Variant||Completed||N/A|200|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 02:01:19.273276|2017-10-11 02:01:19.273276
NCT01784939|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-07-23|||February 2013||2013-02-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|HEPFER||HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis|HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis|Completed||N/A|31|Actual|Rennes University Hospital|||1||f||||f||||||Samples Without DNA|"     Hepcidin serum ferritin serum transferrin serum iron serum   "|||2017-10-11 02:01:19.38894|2017-10-11 02:01:19.38894
NCT01784913|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-03-31|||February 2013||2013-02-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|UV1/hTERT2012P||A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer|A Phase I/IIA Study of UV1 Vaccination in Patients With Hormone-sensitive Metastatic Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|21|Anticipated|Ultimovacs AS||1|||f||||t||||||||||2017-10-11 02:01:19.60749|2017-10-11 02:01:19.60749
NCT01784900|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-01-25|||November 2012||2012-11-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|IIPOP||Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab|Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab. A Randomized Phase II Trial.|Terminated||Phase 2|26|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 02:01:19.72444|2017-10-11 02:01:19.72444
NCT01784887|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-05-30|||January 2013||2013-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Clinical and Mechanistic Demonstration of a Bioelectric Dressing System for Non-healing Wound Management: A Phase II Trial|Clinical and Mechanistic Demonstration of a Bioelectric Dressing System for Non-healing Wound Management: A Phase II Randomized Trial|Terminated||Phase 1/Phase 2|2|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2||Did not have study population to continue|f||||t||||||||No|no data|2017-10-11 02:01:19.854489|2017-10-11 02:01:19.854489
NCT01784874|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-01-16||2014-12-05|February 2013||2013-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|April 2014|Actual|2014-04-01||Interventional|||Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use|Immunogenicity of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Human Diploid Cell Vaccine, Imovax® Rabies in Pre-exposure Use in Healthy Adults|Completed||Phase 2|410|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:01:19.981284|2017-10-11 02:01:19.981284
NCT01784861|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-07-17|||May 3, 2013|Actual|2013-05-03|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors|A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors|Active, not recruiting||Phase 1/Phase 2|23|Actual|Washington University School of Medicine||9|||f||||t|t|f||||||||2017-10-11 02:01:20.125662|2017-10-11 02:01:20.125662
NCT01784848|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-09-19|||May 2013|Actual|2013-05-01|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2017|Actual|2017-05-01||Interventional|GATEWAY||GAstric Bypass to Treat obEse Patients With steAdy hYpertension|Phase 3 Randomized Controlled Trial Evaluating the Effect of Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) on Hypertension Medication Reduction, Blood Pressure Levels and Others Cardiovascular Risk Factors.|Active, not recruiting||N/A|100|Actual|Hospital do Coracao||2|||f||||f||||||||||2017-10-11 02:01:20.27497|2017-10-11 02:01:20.27497
NCT01784835|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-02-04|||October 2010||2010-10-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Early Exposure to OMT Prevents Long LOS||Completed||N/A|113|Actual|European Institute for Evidence Based Osteopathic Medicine||2|||f||||||||||||||2017-10-11 02:01:20.615682|2017-10-11 02:01:20.615682
NCT01784822|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-06-14|||February 2013||2013-02-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair|Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair|Completed||N/A|63|Actual|Cook Group Incorporated|||1||f||||||f||||||||2017-10-11 02:01:20.691444|2017-10-11 02:01:20.691444
NCT01784809|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2014-02-25|||November 2009||2009-11-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|Project WORTH||The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders|Multimedia HIV/STI Prevention for Drug-Involved Female Offenders|Completed||Phase 2|306|Actual|Columbia University||3|||f||||f||||||||||2017-10-11 02:01:20.787398|2017-10-11 02:01:20.787398
NCT01784796|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-07-07|||July 1, 2013|Actual|2013-07-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|July 1, 2017|Actual|2017-07-01||Interventional|||Mindful Hearts Study|Mindfulness Based Stress Reduction for Women at Risk for Cardiovascular Disease|Active, not recruiting||N/A|138|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 02:01:20.90581|2017-10-11 02:01:20.90581
NCT01784783|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-02-24|||September 2013||2013-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|HOPE||Home-based Partner Education and Testing (HOPE) Study|HIV Testing and Educating Male Partners to Improve Maternal and Infant Outcomes: Home-based Partner Education and Testing (HOPE) Study|Completed||N/A|601|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 02:01:21.006509|2017-10-11 02:01:21.006509
NCT01784757|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-09-22|||March 2013||2013-03-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|August 2013|Actual|2013-08-01||Interventional|ARAFOR||Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer|A Bioavailability Study of ODM-201 Formulations With a Safety and Tolerability Extension Component in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer|Active, not recruiting||Phase 1|30|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-11 02:01:21.231227|2017-10-11 02:01:21.231227
NCT01784744|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-01-22|||November 2012||2012-11-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|||Hyperthermia and the Amelioration of Autism Symptoms|Hyperthermia and the Amelioration of Autism Symptoms|Completed||N/A|15|Actual|Montefiore Medical Center|||2||f||||f||||||Samples With DNA|"     Buccal samples collected for DNA and RNA extraction.   "|||2017-10-11 02:01:21.320588|2017-10-11 02:01:21.320588
NCT01784731|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-03-11|||March 2013||2013-03-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||User Charges for General Practitioner Services in Denmark|Brugerbetaling i Almen Praksis (In Danish: User Charges for General Practitioner Services)|Completed||N/A|400|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 02:01:21.398492|2017-10-11 02:01:21.398492
NCT01784718|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-02-04||||||February 2013|2013-02-01||||||||Expanded Access|||Buphenyl Therapy for Byler's Disease|Compassionate Use of Buphenyl® in the Treatment of Byler's Disease|No longer available||N/A|||University of Pittsburgh|||||||||||||||||||2017-10-11 02:01:21.47011|2017-10-11 02:01:21.47011
NCT01784705|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-06-27|||January 2013||2013-01-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|SAD3||Transcranial Bright Light Therapy in Seasonal Affective Disorder (SAD)|Transcranial Bright Light Therapy in Seasonal Affective Disorder (SAD)- a Randomized Placebo-controlled Trial|Completed||N/A|60|Actual|University of Oulu||2|||f||||||||||||||2017-10-11 02:01:21.62992|2017-10-11 02:01:21.62992
NCT01784692|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-05-24|||April 2013||2013-04-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals|Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals|Completed||N/A|21|Actual|University of Mississippi Medical Center||4|||f||||||||||||||2017-10-11 02:01:21.756741|2017-10-11 02:01:21.756741
NCT01784679|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-10-24|||March 2013||2013-03-01|October 2016|2016-10-01|February 2028|Anticipated|2028-02-01|February 2020|Anticipated|2020-02-01|15 Years|Observational [Patient Registry]|||GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)|GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)|Recruiting||N/A|200|Anticipated|Ultragenyx Pharmaceutical Inc|||2||f||||f||||||||||2017-10-11 02:01:21.864857|2017-10-11 02:01:21.864857
NCT01784666|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-04-18|2016-11-30||February 2013||2013-02-01|April 2017|2017-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|Isradipine||Adjunctive Isradipine for the Treatment of Bipolar Depression|Adjunctive Isradipine for the Treatment of Bipolar Depression|Terminated||Phase 2|2|Actual|Massachusetts General Hospital|The study was terminated early by the investigator because delays in study initiation and insufficient recruitment. Our statisticians have advised that this analysis is uninformative.|3||Lack of Enrollment|f||||t||||||||||2017-10-11 02:01:22.012687|2017-10-11 02:01:22.012687
NCT01784653|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2017-04-10|||October 2013||2013-10-01|April 2017|2017-04-01||||January 2017|Anticipated|2017-01-01||Interventional|||Trial of Computerized MET for Adolescent Substance Use|Randomized Controlled Trial of Computerized MET for Adolescent Substance Use|Withdrawn||Phase 1|0|Actual|Boston Children’s Hospital||3||No funding obtained.|f||||f||||||||||2017-10-11 02:01:22.362694|2017-10-11 02:01:22.362694
NCT01784640|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-05|2016-11-08|||January 2014||2014-01-01|March 2016|2016-03-01||||January 2018|Anticipated|2018-01-01||Interventional|||Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer|A Phase IB Dose-Escalation Study of Pemetrexed and AUY922 in Previously-Treated Patients With Metastatic Non-Squamous, Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1|13|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:01:22.461392|2017-10-11 02:01:22.461392
NCT01784627|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-10-06|||January 2015||2015-01-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Trial of Computerized SBI to Reduce Teen Alcohol Use|Randomized Controlled Trial of Computerized SBI to Reduce Teen Alcohol Use|Withdrawn||Phase 1|0|Actual|Boston Children’s Hospital||2||No funding|f||||f||||||||No||2017-10-11 02:01:22.579689|2017-10-11 02:01:22.579689
NCT01784614|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2015-12-22|2015-12-22||September 2009||2009-09-01|December 2015|2015-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||All randomized participants.|A Study of LY2624803 in Japanese Participants With Transient Insomnia|Pharmacodynamics and Pharmacokinetics of Single Doses of LY2624803 in a 5-hour Phase Advance Model of Transient Insomnia in Healthy Japanese Subjects|Completed||Phase 1|24|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 02:01:22.710662|2017-10-11 02:01:22.710662
NCT01784601|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-02-11|||December 2016|Actual|2016-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Incidence of Hemidiaphragmatic Palsy After Interscalene Block|Incidence of Hemidiaphragmatic Palsy After Single Shot Interscalene Block for Pain Relief in Shoulder Surgery|Recruiting||N/A|200|Anticipated|Lawson Health Research Institute|||2||f||||t||||||||||2017-10-11 02:01:23.503858|2017-10-11 02:01:23.503858
NCT01784588|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-12-21|||June 2013||2013-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Solyx||Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence|A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence|Active, not recruiting||N/A|278|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 02:01:23.645567|2017-10-11 02:01:23.645567
NCT01784575|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2015-01-27|||May 2013||2013-05-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|IDEAS||Increasing Use of Publicly Reported Pediatric Quality Data|IDEAS for a Healthy Baby: Reducing Disparities in Consumer Use of Publicly Reported Quality Data|Completed||N/A|746|Actual|Baystate Medical Center||2|||f||||f||||||||||2017-10-11 02:01:23.77885|2017-10-11 02:01:23.77885
NCT01784562|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2016-01-05||||||January 2016|2016-01-01||||||||Expanded Access|EAS||Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|An Open-label Phase IIIb Study of Riociguat in Patients With In-operable CTEPH, or Recurrent or Persisting PH After Surgical Treatment Who Are Not Satisfactorily Treated and Cannot Participate in Any Other CTEPH Trial|No longer available||N/A|||Bayer|||||||||||||||||||2017-10-11 02:01:23.875224|2017-10-11 02:01:23.875224
NCT01784549|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-02|2014-11-23|||July 2012||2012-07-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|CONTEST||Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease|A Multi-center Phase II Randomized Study of Customized Neoadjuvant Therapy Versus Standard Chemotherapy in Non-small Cell Lung Cancer (NSLC) Patients With Resectable Stage IIIA (N2) Disease (CONTEST-TRIAL)|Unknown status|Recruiting|Phase 2|168|Anticipated|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||2|||f||||t||||||||||2017-10-11 02:01:24.1528|2017-10-11 02:01:24.1528
NCT01784536|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-04|2013-04-16|||January 2013||2013-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|DDI||Open Label Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 in Healthy Volunteers|Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 (CYP) 1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A, N-Acetyltransferase-2, and Xanthine Oxidase Activities in Healthy Adults Using the Cooperstown 5 + 1 Cocktail|Completed||Phase 1|16|Actual|The Medicines Company||1|||f||||f||||||||||2017-10-11 02:01:24.252093|2017-10-11 02:01:24.252093
NCT01784523|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2017-03-20|||February 2013||2013-02-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients|A Prospective Randomized Controlled Trial of Hydroxychloroquine in the Primary Thrombosis Prophylaxis of aPL Positive But Thrombosis-free Patients.|Terminated||Phase 3|1000|Anticipated|Hospital for Special Surgery, New York||2||"low recruitment rate exacerbated by manufacturing shortage and price increase of   hydroxychloroquine."|f||||t||||||||||2017-10-11 02:01:24.325398|2017-10-11 02:01:24.325398
NCT01784510|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-02|2013-02-05||||||February 2013|2013-02-01||||January 2013|Actual|2013-01-01||Interventional|||Two or Six cm From Pylorus at Laparoscopic Sleeve Gastrectomy||Completed||N/A|73|Actual|Mansoura University||2|||f||||||||||||||2017-10-11 02:01:24.410658|2017-10-11 02:01:24.410658
NCT01784497|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-02|2014-10-12|||January 2013||2013-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation||Completed||N/A|35|Actual|Ain Shams University|||1||f||||t||||||||||2017-10-11 02:01:24.482609|2017-10-11 02:01:24.482609
NCT01784484|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-02-03|||February 2013||2013-02-01|February 2013|2013-02-01||||January 2014|Anticipated|2014-01-01||Observational|||Screening for Liver Fibrosis by Using Non-invasive Methods ( Fibro Scan) in Patients With Elevated Liver Enzymes|Screening for Liver Fibrosis by Using Non-invasive Methods ( Fibro Scan) in Patients With Elevated Liver Enzymes|Unknown status|Not yet recruiting|N/A|||Ziv Hospital|||1||f||||t||||||||||2017-10-11 02:01:24.553578|2017-10-11 02:01:24.553578
NCT01784471|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-02-20|||November 2012||2012-11-01|February 2017|2017-02-01|March 14, 2013|Actual|2013-03-14|February 2013|Actual|2013-02-01||Interventional|MF||Open-label Pilot Study to Assess the Use of Magic Foot™ in the Improvment of Parameters in Subject With Foot Symptoms|A Pilot Study to Assess the Use of the Magic Foot in the Improvement of Subjective and Objective Parameters in Subjects With Foot Symptoms as a Result of Diabetes or Peripheral Vascular Disease.|Completed||N/A|34|Actual|Yaffa Golan, Ltd.||1|||f||||f||||||||||2017-10-11 02:01:24.799926|2017-10-11 02:01:24.799926
NCT01784458|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2013-02-03|||March 2009||2009-03-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01|2 Months|Observational [Patient Registry]|||Clinical Significance of Intra-abdominal Hypertension in Surgical Patients With Severe Sepsis|Observational Study of Relationship Between Intra-abdominal Hypertension and Severe Sepsis in Surgical Patients|Completed||N/A|46|Actual|University of Ulsan|||1||f||||f||||||||||2017-10-11 02:01:24.873824|2017-10-11 02:01:24.873824
NCT01784445|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2015-04-06|||June 2013||2013-06-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Post ERCP Pancreatitis Prevention in Average Risk Patients|Diclophenac Potassium Versus Ceftazidime for Reduction of Post ERCP Pancreatitis in Average Risk Patients-double Blind, Randomised Controlled Trial|Completed||Phase 4|124|Actual|University Hospital Rijeka||2|||f||||f||||||||||2017-10-11 02:01:24.946936|2017-10-11 02:01:24.946936
NCT01784432|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-15|2013-02-03|||January 2011||2011-01-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Low-level Laser Therapy on Global Gene Expression of Young Males Submitted to Physical Strength Training|Effects of Low-level Laser Therapy on Global Gene Expression of Young Males Submitted to Physical Strength Training|Completed||N/A|30|Actual|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-11 02:01:25.059268|2017-10-11 02:01:25.059268
NCT01784419|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2014-10-17|||October 2013||2013-10-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients|Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients|Unknown status|Recruiting|N/A|30|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:01:25.196226|2017-10-11 02:01:25.196226
NCT01784406|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-03|2016-01-14|||January 2013||2013-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PESU||Person-centred Support for Women After Treatment for Gynaecological Cancer|Person-centred Support for Women in the Follow-up Period After Surgical Treatment for Gynaecological Cancer - a Randomised Controlled Trial|Completed||N/A|165|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:01:25.32886|2017-10-11 02:01:25.32886
NCT01784393|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-02-03|||May 2004||2004-05-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Chemoradiation for Bone Metastasis|Chemoradiation With Capecitabine for Palliation of Pain From Bone Metastasis|Completed||Phase 2|29|Actual|Rabin Medical Center||1|||f||||t||||||||||2017-10-11 02:01:25.424025|2017-10-11 02:01:25.424025
NCT01784380|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-02-02|||October 2006||2006-10-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||The Potential Biochemical Diagnosis Criteria and Therapeutic Effect Indexes: Sex Hormone Binding Globulin Levels and Free Androgen Index in Blood of Patients With Polycystic Ovary Syndrome||Completed||N/A|1159|Actual|Zhongshan Bo Ai Hospital|||3||f||||||||||||||2017-10-11 02:01:25.506943|2017-10-11 02:01:25.506943
NCT01784367|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-06-16|||December 2012||2012-12-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ECLAIR||Extracorporeal Lung Assist to Avoid Intubation in Patients Failing NIV for Hypercapnic ARF|Extracorporeal Lung Assist to Avoid Intubation in Patients Failing Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure|Completed||N/A|30|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||t|f|f||||||No||2017-10-11 02:01:25.594402|2017-10-11 02:01:25.594402
NCT01784354|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-06-10|||January 2013||2013-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Acupressure for the Treatment of Raynaud's Phenomenon|Acupressure in Raynaud's Phenomenon- A Pilot Study.|Completed||N/A|23|Actual|University of Michigan||3|||f||||||||||||||2017-10-11 02:01:25.688111|2017-10-11 02:01:25.688111
NCT01784159|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-04-02|||June 2013||2013-06-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|March 2018|Anticipated|2018-03-01||Interventional|||Aspirin for Treatment of Severe Sepsis|Phase 2 Study of Aspirin Administration for Patients With Severe Sepsis and Septic Shock|Active, not recruiting||Phase 2|150|Anticipated|Federal University of São Paulo||2|||f||||f||||||||Undecided|undecided|2017-10-11 02:01:27.449458|2017-10-11 02:01:27.449458
NCT01784341|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-03-26|||August 2011||2011-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01|6 Months|Observational [Patient Registry]|||Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?|Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?|Completed||N/A|10|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"     Saliva Samples   "|||2017-10-11 02:01:25.883083|2017-10-11 02:01:25.883083
NCT01784328|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-07-04|||March 2013||2013-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Peristeen Bowel Irrigation System in Cauda Equina|The Use of the Peristeen Bowel Irrigation System for People With Cauda Equina Syndrome|Completed||N/A|12|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 02:01:25.977144|2017-10-11 02:01:25.977144
NCT01784315|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2013-11-21|||March 2013||2013-03-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01|12 Months|Observational [Patient Registry]|BCAPES||Parasitic Clearance and Recurrence Rates Among Patients With Vivax Malaria|PARASITIC CLEARANCE AND RECURRENCE RATES AMONG PATIENTS WITH VIVAX MALARIA ON CHLOROQUINE AND PRIMAQUINE THERAPY|Unknown status|Recruiting|N/A|50|Anticipated|Ministry of Health, Bhutan|||1||f||||f||||||Samples With DNA|"     Filter blot paper will be retained to study the whole genome of P.vivax malaria in Bhutan.   "|||2017-10-11 02:01:26.09718|2017-10-11 02:01:26.09718
NCT01784302|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-02-24|||April 2014||2014-04-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Effect of Antacids and Multivitamins on Raltegravir|A 3 Arm, 5 Phase Study to Determine the Effect of Divalent and Monovalent Metal Containing Antacids and Multivitamins on the Pharmacokinetics of Raltegravir in Healthy Volunteers|Completed||Phase 1|15|Actual|University of Liverpool||3|||f||||t||||||||||2017-10-11 02:01:26.234568|2017-10-11 02:01:26.234568
NCT01784289|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-02-01|||June 2010||2010-06-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|IL-7norm||Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity|Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophies According to Fat Mass and Glucose Metabolism|Completed||N/A|126|Actual|University Hospital, Lille|||4||f||||f||||||Samples With DNA|"     Wholeblood and tissue bank   "|No||2017-10-11 02:01:26.333927|2017-10-11 02:01:26.333927
NCT01784276|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-02|||September 2010||2010-09-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Dental Fear Among Children With Autism Spectrum Disorders|A PILOT AND FEASIBILITY STUDY OF ELECTRONIC SCREEN MEDIA TO REDUCE DENTAL FEAR AMONG CHILDREN WITH AUTISM SPECTRUM DISORDER|Completed||N/A|80|Actual|Boston Children’s Hospital||4|||f||||f||||||||||2017-10-11 02:01:26.466421|2017-10-11 02:01:26.466421
NCT01784263|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-05-17|||March 2012||2012-03-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|February 2017|Actual|2017-02-01||Interventional|SEBASTIEN||Schema, Emotion, and Behavior Therapy for Children|Treatment of Autism Symptoms in Children (TASC): Initial RCT With Active Control|Active, not recruiting||N/A|70||University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:01:26.579451|2017-10-11 02:01:26.579451
NCT01784250|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-02-02|||August 2012||2012-08-01|February 2013|2013-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Efficacy of Clonidine and Propranolol in Dentistry (AAA)|Efficacy of Clonidine and Propranolol Versus Placebo for the Control of Anxiety During Surgical Procedures in Dentistry|Unknown status|Recruiting|Phase 2|60|Anticipated|CES University||3|||f||||t||||||||||2017-10-11 02:01:26.684081|2017-10-11 02:01:26.684081
NCT01784237|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-02-02|||September 2012||2012-09-01|February 2013|2013-02-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||A Novel Anterior Rhinoscopic Scoring Scale to Predict Nasal Insertability Before Transnasal Endoscopy|Comparison Between an Anterior Rhinoscopic Scoring Scale With the Sniff Test to Predict Nasal Insertability Before Transnasal Endoscopy: A Prospective, Randomized, Controlled Study|Unknown status|Recruiting|N/A|233|Anticipated|Buddhist Tzu Chi General Hospital||2|||f||||f||||||||||2017-10-11 02:01:26.818984|2017-10-11 02:01:26.818984
NCT01784224|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2014-06-12|||January 2013||2013-01-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Comparison of the Blom Low Profile Voice Inner Cannula and the Passy-Muir One-Way Tracheotomy Tube Speaking Valve on Voice Production, Speech Intelligibility, and Biomechanical Swallowing Behavior|A Comparison of the Blom Low Profile Voice Inner Cannula and the Passy-Muir One-Way Tracheotomy Tube Speaking Valve on Voice Production, Speech Intelligibility, and Biomechanical Swallowing Behavior|Completed||N/A|30|Actual|Yale University||1|||f||||f||||||||||2017-10-11 02:01:26.909001|2017-10-11 02:01:26.909001
NCT01784211|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-11-27|||February 2013||2013-02-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes|The Pharmacokinetic and Pharmacodynamic Intra-subject Variability of LY2605541 and the Effect of Exercise on LY2605541 Pharmacokinetics in Patients With Type 1 Diabetes Mellitus|Completed||Phase 1|76|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 02:01:26.997964|2017-10-11 02:01:26.997964
NCT01784198|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-07-13|||April 2011||2011-04-01|July 2017|2017-07-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Determination of Protein Requirements in Pregnancy|Determination of Protein Requirements in Healthy Pregnant Women Using Indicator Amino Acid Oxidation Technique|Completed||N/A|20|Actual|University of British Columbia||1|||f||||t||||||||||2017-10-11 02:01:27.117975|2017-10-11 02:01:27.117975
NCT01784185|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2014-01-10|||January 2013||2013-01-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|February 2014|Anticipated|2014-02-01||Interventional|VB/EBUS-TBNA||Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling|Development and Evaluation of Clinical Utility of Virtual Bronchoscopy (VB)-Based System for Bronchoscopic Navigation, Mediastinal Mapping and Transbronchial Aspiration of Mediastinal Lesions.|Unknown status|Recruiting|N/A|60|Anticipated|Medical University of Warsaw||1|||f||||f||||||||||2017-10-11 02:01:27.215386|2017-10-11 02:01:27.215386
NCT01784146|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-02-01|||June 2009||2009-06-01|December 2012|2012-12-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Plethysmography Opto-electronic and Asthma|Analysis of the Distribution of Pulmonary Ventilation After Nebulization by Heliox Associated With Positive Expiratory Pressure in Patients Asthmatics Stable.|Completed||N/A|27|Actual|Universidade Federal de Pernambuco||4|||f||||t||||||||||2017-10-11 02:01:27.572637|2017-10-11 02:01:27.572637
NCT01784133|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2015-05-01||2015-05-01|March 2013||2013-03-01|May 2015|2015-05-01||||March 2014|Actual|2014-03-01||Interventional|||A Twelve Week Safety and Efficacy Study in Rosacea|A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea|Completed||Phase 2|240|Actual|Cutanea Life Sciences, Inc.||4|||f||||f||||||||||2017-10-11 02:01:27.677291|2017-10-11 02:01:27.677291
NCT01784120|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-02-09|||January 2011||2011-01-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer|A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer|Recruiting||Phase 2|48|Anticipated|Gachon University Gil Medical Center||1|||f||||||||||||||2017-10-11 02:01:27.782703|2017-10-11 02:01:27.782703
NCT01784107|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-02-09|||July 2011||2011-07-01|February 2016|2016-02-01||||July 2018|Anticipated|2018-07-01||Interventional|||A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer|A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|45|Anticipated|Gachon University Gil Medical Center||1|||f||||||||||||||2017-10-11 02:01:27.858233|2017-10-11 02:01:27.858233
NCT01784094|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-12-29|||January 2013||2013-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Connective Tissue Motion Measure 2||Completed||N/A|195|Actual|Stromatec, Inc.|||2||f||||t||||||||||2017-10-11 02:01:27.943314|2017-10-11 02:01:27.943314
NCT01784081|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-06-08|||April 2014||2014-04-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|iPC3||Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer|iPC3 - Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer|Withdrawn||N/A|0|Actual|Sidney Kimmel Comprehensive Cancer Center|||1|study was closed by PI due to no accrual|f||||t||||||||Undecided||2017-10-11 02:01:28.009197|2017-10-11 02:01:28.009197
NCT01784068|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-10-04|||March 4, 2013|Actual|2013-03-04|October 2017|2017-10-01|January 29, 2020|Anticipated|2020-01-29|January 29, 2020|Anticipated|2020-01-29||Interventional|ENESTFreedom||Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients|A Single-arm, Multicenter, Nilotinib Treatment-free Remission Study in Patients With BCR-ABL1 Positive Chronic Myelogenous Leukemia in Chronic Phase Who Have Achieved Durable Minimal Residual Disease (MRD) Status on First Line Nilotinib Treatment.|Active, not recruiting||Phase 2|222|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 02:01:28.111237|2017-10-11 02:01:28.111237
NCT01784042|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-05-05|||March 2013||2013-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue|Effect of Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue and Systemic Biomarkers of Breast Cancer Risk|Withdrawn||Early Phase 1|0|Actual|Milton S. Hershey Medical Center||4||No funding|f||||t||||||||||2017-10-11 02:01:28.672686|2017-10-11 02:01:28.672686
NCT01784029|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2015-05-06|||February 2013||2013-02-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Treatment Study of Vitamin D Deficiency in Adolescents|Comparison of Two Standard High-dose Treatment Regimens for Vitamin D Deficiency in Minority Adolescents: Associations of Vitamin D Repletion With Changes in Markers of Musculoskeletal, Cardiometabolic, and Immune Function|Completed||Phase 4|183|Actual|Montefiore Medical Center||3|||f||||t||||||||||2017-10-11 02:01:28.776641|2017-10-11 02:01:28.776641
NCT01784016|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-05-22|||January 2014||2014-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers|Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers|Withdrawn||Phase 1|0|Actual|Mclean Hospital||2||Technical complications.|f||||||||||||||2017-10-11 02:01:28.876376|2017-10-11 02:01:28.876376
NCT01784003|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-11-08|||June 2012||2012-06-01|November 2016|2016-11-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|||Characterizing Ankle Function During Sloped Locomotion for Prosthesis Development|Characterizing Ankle Function During Sloped Locomotion for Prosthesis Development|Recruiting||N/A|60|Anticipated|VA Eastern Colorado Health Care System|||2||f||||||||||||||2017-10-11 02:01:28.971237|2017-10-11 02:01:28.971237
NCT01783990|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-09-23|||October 2012||2012-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|BABY HUG||Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol|Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol|Active, not recruiting||N/A|158|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||2||f||||t||||||Samples With DNA|"     Stored blood and urine   "|||2017-10-11 02:01:29.078921|2017-10-11 02:01:29.078921
NCT01783977|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-03-31|||April 2013||2013-04-01|March 2017|2017-03-01||||September 2014|Actual|2014-09-01||Interventional|||Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults|A Phase 1 Clinical Trial to Evaluate Safety and to Compare the Immunogenicity of 3 DNA Vaccine Prime Schedules Followed by a NYVAC Vaccine Boost in Healthy, HIV-1 Uninfected Adult Participants|Active, not recruiting||Phase 1|209|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||t||||||||||2017-10-11 02:01:29.185191|2017-10-11 02:01:29.185191
NCT01783964|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-08-27|||February 2013||2013-02-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Elacytarabine Mass Balance Study in Healthy Volunteers|An Open-Label, Single-Dose Study Designed to Assess the Mass Balance Recovery of an Intravenous Microdose of [14C]-Elacytarabine in Healthy Male Subjects|Completed||Phase 1|6|Actual|Clavis Pharma||1|||f||||f||||||||||2017-10-11 02:01:29.3219|2017-10-11 02:01:29.3219
NCT01783951|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-02-03|||February 2013||2013-02-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Capital Medical University||1|||f||||f||||||||||2017-10-11 02:01:29.401904|2017-10-11 02:01:29.401904
NCT01783938|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-10-03|2016-03-11||April 17, 2013|Actual|2013-04-17|October 2017|2017-10-01|April 19, 2018|Anticipated|2018-04-19|April 3, 2015|Actual|2015-04-03||Interventional||All treated participants; All participants who received at least one dose of any study therapy.|Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma (CheckMate 064)|An Open-Label, Randomized, Phase 2 Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma|Active, not recruiting||Phase 2|177|Actual|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-11 02:01:29.529061|2017-10-11 02:01:29.529061
NCT01783925|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-09-26|||April 29, 2014|Actual|2014-04-29|September 2017|2017-09-01|March 18, 2019|Anticipated|2019-03-18|November 30, 2018|Anticipated|2018-11-30||Observational|||Eylea Post Marketing Surveillance(PMS)|Eylea Post Marketing Surveillance|Recruiting||N/A|3600|Anticipated|Bayer|||1||f||||f|f|f||||||||2017-10-11 02:01:33.072189|2017-10-11 02:01:33.072189
NCT01783912|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-01-29|2015-12-21||December 2012||2012-12-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Helping Those With Mental Illness Quit Smoking|Preparing Those With Significant and Persistent Mental Illness to Quit Smoking|Completed||Phase 4|270|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 02:01:33.193021|2017-10-11 02:01:33.193021
NCT01783899|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2014-12-25|||January 2013||2013-01-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Clinical Evaluation of Hemospray in Hemostasis of Active Variceal Bleeding|Clinical Evaluation of Hemospray in Hemostasis of Active Variceal Bleeding|Completed||N/A|30|Actual|Theodor Bilharz Research Institute||1|||f||||f||||||||||2017-10-11 02:01:33.473321|2017-10-11 02:01:33.473321
NCT01783886|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-04-08|2016-03-06||February 2013||2013-02-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|VIVID EAST||Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement|A Randomized, Double Masked, Active Controlled, Phase III Study of the Efficacy and Safety of Repeated Doses of Intravitreal VEGF Trap Eye in Subjects With Diabetic Macular Edema|Completed||Phase 3|381|Actual|Bayer||3|||f||||t||||||||||2017-10-11 02:01:33.708218|2017-10-11 02:01:33.708218
NCT01783873|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-09-07|||September 2012||2012-09-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|||Comparative Study of Pathophysiological Mechanisms and Bronchial Response in Occupational Asthma to Wheat Flour and Quaternary Ammonium Compounds During Standardized Bronchial Provocation Tests|Comparative Study of Pathophysiological Mechanisms and Bronchial Response in Occupational Asthma to Wheat Flour and Quaternary Ammonium Compounds During Standardized Bronchial Provocation Tests|Recruiting||N/A|60|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 02:01:34.901565|2017-10-11 02:01:34.901565
NCT01783860|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-12-28|2013-07-16||January 2013||2013-01-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Oral Azithromycin Versus Doxycycline in Posterior Blepharitis|Study of the Effect of Oral Azithromycin on Posterior Blepharitis|Completed||Phase 2|100|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:01:35.029789|2017-10-11 02:01:35.029789
NCT01783834|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-02-10|||February 2008||2008-02-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients|Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-small Cell Lung Cancer|Completed||Phase 2|95|Actual|Gachon University Gil Medical Center||2|||f||||||||||||||2017-10-11 02:01:35.589144|2017-10-11 02:01:35.589144
NCT01783821|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-07-22|2016-06-08||July 2013||2013-07-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|LIPS-B|Only participants who completed the study were included in the baseline analysis.|LIPS-B: Lung Injury Prevention Study With Budesonide and Beta|LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Agonist (Formoterol)|Completed||Phase 2|61|Actual|Mayo Clinic||2|||f||||t||||||||No||2017-10-11 02:01:35.680565|2017-10-11 02:01:35.680565
NCT01783808|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-05-09|||November 2012|Actual|2012-11-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Intervention Study to Investigate Supplemental Oxygen in COPD|Effects on Exercise Capacity, Physical Activity and Quality of Life Using Ambulatory Oxygen in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Desaturate Only During Exercise|Recruiting||N/A|144|Anticipated|Uppsala University||2|||f||||f||||||||||2017-10-11 02:01:36.212007|2017-10-11 02:01:36.212007
NCT01783795|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-06-19|||August 2012|Actual|2012-08-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Dent Disease Mutation Genotyping|Screening for Dent Disease Mutations in Patients With Proteinuria|Recruiting||N/A|180|Anticipated|Mayo Clinic||1|||f||||t||||||||No||2017-10-11 02:01:36.326189|2017-10-11 02:01:36.326189
NCT01783782|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2013-02-04|||November 2005||2005-11-01|November 2005|2005-11-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|PREP-CE||Small Bowel Cleansing for Capsule Endoscopy in Pediatric Patients|SMALL BOWEL CLEANSING FOR CAPSULE ENDOSCOPY IN PEDIATRIC PATIENTS: A PROSPECTIVE RANDOMIZED SINGLE-BLINDED STUDY|Unknown status|Recruiting|Phase 4|200|Anticipated|Azienda Policlinico Umberto I||5|||f||||t||||||||||2017-10-11 02:01:36.439135|2017-10-11 02:01:36.439135
NCT01783769|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-08-09|||March 2013||2013-03-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|BRITE||Evaluating the Impact That Personnel Traffic Through the Operating Room Has on Surgical Site Infections|Barrow Randomized O.R. Traffic Trial|Completed||N/A|1944|Actual|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||f||||||||||2017-10-11 02:01:36.548508|2017-10-11 02:01:36.548508
NCT01783574|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2017-02-28|||August 2013||2013-08-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|January 2017|Actual|2017-01-01||Interventional|||Testosterone Antidepressant Augmentation in Women|Collaborative Study: Testosterone Antidepressant Augmentation in Women|Active, not recruiting||N/A|100|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:01:40.323765|2017-10-11 02:01:40.323765
NCT01783756|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-03-21|||June 2013||2013-06-01|September 2016|2016-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis|Phase 1b/2 Single-arm Trial Evaluating the Combination of Lapatinib, Everolimus and Capecitabine for the Treatment of Patients With HER2-positive Metastatic Breast Cancer With CNS Progression After Trastuzumab|Active, not recruiting||Phase 1/Phase 2|9|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:01:36.632719|2017-10-11 02:01:36.632719
NCT01783730|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2016-09-02|2016-09-02||February 2013||2013-02-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational||Participants who received adalimumab treatment|Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents|Special Investigation in Japanese Rheumatoid Arthritis Patients Who Have no Previous Use of DMARDs and Biological Agents|Completed||N/A|163|Actual|AbbVie|||1||f||||f||||||||No||2017-10-11 02:01:36.850449|2017-10-11 02:01:36.850449
NCT01783717|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2013-10-20|||December 2012||2012-12-01|October 2013|2013-10-01|July 2015|Anticipated|2015-07-01|January 2015|Anticipated|2015-01-01||Interventional|||Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage|Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage|Unknown status|Recruiting|N/A|10|Anticipated|Huashan Hospital||1|||f||||t||||||||||2017-10-11 02:01:37.290258|2017-10-11 02:01:37.290258
NCT01783704|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-09-12|||June 10, 2013|Actual|2013-06-10|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|CAP||Improving Community Ambulation After Hip Fracture|Improving Community Ambulation After Hip Fracture|Active, not recruiting||N/A|210|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 02:01:37.398019|2017-10-11 02:01:37.398019
NCT01783691|ClinicalTrials.gov processed this data on October 10, 2017|2013-02-01|2015-06-25|||February 2013||2013-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)|A Single Ascending Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Biologic Activity of Intravenous NKTT120 in Adults With Stable Sickle Cell Disease|Completed||Phase 1|21|Actual|NKT Therapeutics||1|||f||||f||||||||||2017-10-11 02:01:37.553502|2017-10-11 02:01:37.553502
NCT01783678|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2015-04-15|2015-04-15||January 2013||2013-01-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug|A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults|A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects|Completed||Phase 3|275|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 02:01:37.677075|2017-10-11 02:01:37.677075
NCT01783665|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-02-08|||August 2012||2012-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Effect of Aerobic Exercise on Cognitive Function and Sleep Quality in Individuals With Multiple Sclerosis|The Effect of Aerobic Exercise on Cognitive Function and Sleep Quality in Individuals With Multiple Sclerosis|Completed||N/A|28|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 02:01:39.332608|2017-10-11 02:01:39.332608
NCT01783652|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2014-07-10|||January 2013||2013-01-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Adapted and Translated, Adolescent Depression, Internet Intervention|Adaptation of a U.S. Internet Tool to Prevent Depression and Addiction in Hong Kong Adolescents|Unknown status|Active, not recruiting|N/A|138|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:01:39.545723|2017-10-11 02:01:39.545723
NCT01783639|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2017-06-29|2015-06-08||February 2013||2013-02-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|December 2013|Actual|2013-12-01||Interventional|WISE||Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting|The WISE Study is a Pivotal Study Evaluating the Safety and Performance of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting|Completed||N/A|120|Actual|Gardia Medical||1|||f||||t||||||||||2017-10-11 02:01:39.651519|2017-10-11 02:01:39.651519
NCT01783626|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-05-05|||October 2012||2012-10-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +)|Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +) - A Prospective, Monocenter, Open and Non-randomized Pilot Study|Completed||N/A|6|Actual|Baxter Healthcare Corporation||4|||f||||f||||||||||2017-10-11 02:01:39.931792|2017-10-11 02:01:39.931792
NCT01783613|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-04-25|||October 2011||2011-10-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis|Study of the Eficacy of Long-term Suplementation With Docosahexaenoic Acid on Pulmonary, Sistemic and Intestinal Inflammation in Patients With Cystic Fibrosis|Completed||N/A|96|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||f||||||||||2017-10-11 02:01:40.021667|2017-10-11 02:01:40.021667
NCT01783600|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-08-10|||January 2013||2013-01-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions|NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions|Completed||Phase 4|100|Actual|Flanders Medical Research Program||1|||f||||t||||||||||2017-10-11 02:01:40.104289|2017-10-11 02:01:40.104289
NCT01783587|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-08-08|||February 2013||2013-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer|Phase I Study of Afatinib With Postoperative Radiation Therapy for Intermediate and High Risk Squamous Cancer of the Head and Neck (SCCHN)|Recruiting||Phase 1|38|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 02:01:40.194561|2017-10-11 02:01:40.194561
NCT01783561|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-07-05|2015-11-18||October 2013||2013-10-01|July 2017|2017-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|EARLYCAFFEINE||Early Versus Routine Caffeine Administration in Extremely Preterm Neonates|Early Versus Routine Caffeine Administration in Extremely Preterm Neonates|Completed||Phase 4|21|Actual|Sharp HealthCare||2|||f||||t||||||||||2017-10-11 02:01:40.447004|2017-10-11 02:01:40.447004
NCT01783548|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2015-09-11|2015-07-27|2014-05-08|January 2013||2013-01-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Intent to treat population which included all randomized participants.|Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR|Completed||Phase 3|547|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 02:01:40.780135|2017-10-11 02:01:40.780135
NCT01783535|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-03-30|||June 19, 2013|Actual|2013-06-19|October 2016|2016-10-01|June 30, 2022|Anticipated|2022-06-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma|Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma|Recruiting||Phase 2|155|Anticipated|St. Jude Children's Research Hospital||4|||f||||f|t|f||||||||2017-10-11 02:01:41.444143|2017-10-11 02:01:41.444143
NCT01783509|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-07-18|||November 2011||2011-11-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01|20 Years|Observational [Patient Registry]|||Limb Girdle Muscular Dystrophy (LGMD) Natural History|Longitudinal Assessment and Genetic Understanding of Limb-Girdle Muscular Dystrophy|Completed||N/A|13|Actual|Carolinas Healthcare System|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 02:01:41.708802|2017-10-11 02:01:41.708802
NCT01783496|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-05-08|2014-11-07||January 2013||2013-01-01|May 2017|2017-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Thermage CPT for Treatment of Facial and Neck Laxity|Clinical Comparison of the Thermage CPT™ System's Framed and Pattern Tips for Treatment of Facial and Neck Laxity|Completed||N/A|50|Actual|Valeant Pharmaceuticals||6|||f||||f||||||||||2017-10-11 02:01:41.790867|2017-10-11 02:01:41.790867
NCT01783483|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-08-07|2016-12-16||January 2013||2013-01-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|June 2015|Actual|2015-06-01||Interventional|SB||An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery|An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery: A Prospective, Randomized Trial|Completed||N/A|236|Actual|Zimmer Biomet|At closing of this study, only 2 prospective RCTs have been conducted that compare RPF with WC. Because both were done with first and second generation devices from the same manufacturer, conclusions on the class effect of RPF systems cannot be made.|2|||f||||f||||||||||2017-10-11 02:01:42.644171|2017-10-11 02:01:42.644171
NCT01783470|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-05-02|2017-03-09||February 2013||2013-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue|Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue|Active, not recruiting||Phase 2|15|Actual|Beth Israel Deaconess Medical Center||1|||f||||t||||||||No||2017-10-11 02:01:43.554877|2017-10-11 02:01:43.554877
NCT01783457|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-01-25|||January 2011||2011-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||e-Learning & Development of an Evidence-based Psychoeducational Programme for First Episode Psychosis|e-Learning & Development of an Evidence-based Psychoeducational Programme for First Episode Psychosis|Completed||N/A|177|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 02:01:43.945014|2017-10-11 02:01:43.945014
NCT01783431|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-10-01|||October 2012||2012-10-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells|A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic and/or Unresectable Melanoma|Terminated||Phase 1|1|Actual|Medical University of South Carolina||1||The study was terminated early due to low accrual.|f||||t||||||||||2017-10-11 02:01:44.37629|2017-10-11 02:01:44.37629
NCT01783418|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-12-07|2015-09-24||August 2012||2012-08-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Mindfulness-based Intervention for Teenagers With Cancer|A Randomized, Wait-list Controlled Clinical Trial: the Effects of a Mindfulness-based Intervention on Quality of Life, Sleep and Mood in Adolescents With Cancer.|Completed||N/A|15|Actual|St. Justine's Hospital|"Major recruitment and retention issues leading to very small number of subjects recruited and analyzed.
Small sample leading to underpowered study and uninterpretable data"|2|||f||||f||||||||||2017-10-11 02:01:44.47218|2017-10-11 02:01:44.47218
NCT01783405|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-06-07|||February 2013||2013-02-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Cardiovascular Disease in FH Heterozygous|Cardiovascular Disease in FH Heterozygous|Unknown status|Recruiting|N/A|1100|Anticipated|Sociedad Española de Arteriosclerosis|||2||f||||t||||||||||2017-10-11 02:01:44.916419|2017-10-11 02:01:44.916419
NCT01783392|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-05-21|||March 2013||2013-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|PESTOB||Peripheral Electrical Stimulation for the Treatment of Overactive Bladder|Peripheral Electrical Stimulation for the Treatment of Overactive Bladder|Completed||N/A|29|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||3|||f||||||||||||||2017-10-11 02:01:45.025935|2017-10-11 02:01:45.025935
NCT01783379|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-04-29|||January 2013||2013-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|MIMIC||Pharmacokinetics of Micafungin in Patients Intensive Care Unit|Pharmacokinetics of Micafungin (Mycamine ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates|Completed||N/A|20|Actual|Radboud University|||1||f||||f||||||Samples Without DNA|"     blood samples for pharmacokinietic analysis will be collected   "|||2017-10-11 02:01:45.117472|2017-10-11 02:01:45.117472
NCT01783366|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-02-03|||January 2013||2013-01-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Nasogastric Tube Insertion Using Cook Airway Exchange Catheter in Anesthetized Patients|Nasogastric Tube Insertion Using Cook Airway Exchange Catheter in Anesthetized Patients|Unknown status|Recruiting|N/A|100|Anticipated|Pusan National University Hospital||2|||f||||f||||||||||2017-10-11 02:01:45.218133|2017-10-11 02:01:45.218133
NCT01783353|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-11-13|||January 2013||2013-01-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial|Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 2/Phase 3|28|Actual|Philippine Dermatological Society||2|||f||||f||||||||||2017-10-11 02:01:45.311908|2017-10-11 02:01:45.311908
NCT01783340|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2014-11-12|||April 2013||2013-04-01|November 2014|2014-11-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Interventional|MMV||Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis|Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis|Withdrawn||Phase 1/Phase 2|0|Actual|Radboud University||3||No funding|f||||t||||||||||2017-10-11 02:01:45.400087|2017-10-11 02:01:45.400087
NCT01783327|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-01-06|||July 2012||2012-07-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|TeensConnect||Teens-Connect: Preventive Psycho-education for Transitioning Teens With Diabetes|Teens-Connect: Preventive Psycho-education for Transitioning Teens With Diabetes|Completed||N/A|124|Actual|Yale University||2|||f||||t||||||||||2017-10-11 02:01:45.504715|2017-10-11 02:01:45.504715
NCT01783314|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-01-31|||December 2010||2010-12-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium|Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium|Unknown status|Recruiting|Phase 4|40|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 02:01:45.611351|2017-10-11 02:01:45.611351
NCT01783301|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-01-31|||October 2011||2011-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study|A Phase IV, Open-label 2 Arm Trial to Compare the Efficacy and Safety of a Pre-defined Dose of GONAL-f® Based on Antral Follicle Count [Follicles ≥2mm - <11mm]), or AMH for Ovarian Stimulation in Subjects Undergoing Assisted Reproductive Technology (ART) Treatment.|Completed||Phase 4|348|Actual|Vietnam National University||2|||f||||f||||||||||2017-10-11 02:01:45.746316|2017-10-11 02:01:45.746316
NCT01783288|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-04-03|||February 2013||2013-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening|Aldosterone and Sodium Regulation in Postural Tachycardia Syndrome - Screening Protocol|Active, not recruiting||N/A|110|Anticipated|Vanderbilt University Medical Center||1|||f||||f||||||||||2017-10-11 02:01:45.851598|2017-10-11 02:01:45.851598
NCT01783275|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-02-20|||February 2013||2013-02-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Effect of Exercise on Hepatic Glucose Metabolism|The Effect of Exercise on Hepatic Glucose Metabolism in Type 2 Diabetes Mellitus|Completed||N/A|20|Actual|Vanderbilt University Medical Center||2|||f||||f|f|f||||||No||2017-10-11 02:01:45.955323|2017-10-11 02:01:45.955323
NCT01783262|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-31|||December 2009||2009-12-01|January 2013|2013-01-01||||June 2011|Actual|2011-06-01||Interventional|||The Role of Extracorporeal Shock Wave Therapy in the Treatment of Trapezial-Metacarpal Osteoarthritis. A Double Blind Randomized Controlled Study.|The Role of Extracorporeal Shock Wave Therapy in the Treatment of Trapezial-Metacarpal Osteoarthritis.|Completed||N/A|||University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 02:01:46.042162|2017-10-11 02:01:46.042162
NCT01783249|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2013-01-31|||November 2011||2011-11-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Influence of Exercise on Anemia in MDS Patients|The Influence of Exercise on Anemia in MDS Patients|Withdrawn||Phase 1/Phase 2|0|Actual|University of Rochester||2||We were unable to find patients that fit the eligibility criteria.|f||||t||||||||||2017-10-11 02:01:46.118709|2017-10-11 02:01:46.118709
NCT01783236|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-03-31|2017-02-03||June 2013||2013-06-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery|A Double-blind, Randomized, Placebo-controlled Study to Compare the Effectiveness of IV Acetaminophen Administered Intra-operatively in Reducing the Use of Opiates to Treat Post-operative Pain|Completed||Phase 4|16|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||No|There is no plan to share IPD|2017-10-11 02:01:46.190917|2017-10-11 02:01:46.190917
NCT01783223|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-03-02|||November 2012||2012-11-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Prevalence of Chronic Inebriates to the Emergency Department and Suitability for Sobering House Services|Prevalence of Chronic Inebriates to the Emergency Department and Suitability for Sobering House Services|Active, not recruiting||N/A|1000|Anticipated|Minneapolis Medical Research Foundation|||1||f||||f||||||||||2017-10-11 02:01:46.515427|2017-10-11 02:01:46.515427
NCT01783210|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-05-12|||October 2012||2012-10-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|TLC||Pregnancy Complications in Women With BMI>25 kg/m2 Enrolled in a Healthy Lifestyle and Eating Habits Program|Pregnancy Complications in Women With BMI>25 kg/m2 Enrolled in a Healthy Lifestyle and Eating Habits Program: a Randomized Controlled Trial.|Unknown status|Recruiting|N/A|400|Anticipated|University of Modena and Reggio Emilia||2|||f||||t||||||||||2017-10-11 02:01:46.598582|2017-10-11 02:01:46.598582
NCT01782820|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-01|||December 2011||2011-12-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium||Completed||N/A|108|Actual|Kreiskrankenhaus Dormagen|||3||f||||f||||||||||2017-10-11 02:01:54.779669|2017-10-11 02:01:54.779669
NCT01783197|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-09-11|||January 30, 2013|Actual|2013-01-30|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC|A Phase Ib Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC Who Are Receiving Standard Chemotherapy Regimens.|Active, not recruiting||Phase 1|39|Actual|Canadian Cancer Trials Group||3|||f||||f||||||||||2017-10-11 02:01:46.705699|2017-10-11 02:01:46.705699
NCT01783184|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-03-02|||June 2012||2012-06-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2013|Actual|2013-10-01||Observational|||Study of Abdominal Aortic Stent Grafts in the Treatment of Infrarenal Abdominal Aortic Aneurysms|Study of Abdominal Aortic Stent Grafts in the Treatment of Infrarenal Abdominal Aortic Aneurysms|Active, not recruiting||N/A|180|Anticipated|Vascutek Ltd.|||1||f||||f||||||||Undecided||2017-10-11 02:01:46.80382|2017-10-11 02:01:46.80382
NCT01783171|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-08-21|||January 15, 2013|Actual|2013-01-15|August 2017|2017-08-01|July 12, 2016|Actual|2016-07-12|July 12, 2016|Actual|2016-07-12||Interventional|||Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery|A Phase I Trial of Dinaciclib (SCH727965) and MK-2206 in Metastatic Pancreatic Cancer With an Expansion Cohort in Advanced Pancreatic Cancer|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 02:01:46.939113|2017-10-11 02:01:46.939113
NCT01783158|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-31|||January 2004||2004-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|HNSCC||Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma|Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma in Patients With Squamous Cell Carcinomas of the Head and Neck?|Completed||N/A|132|Actual|University Hospital Ostrava|||1||f||||f||||||||||2017-10-11 02:01:47.089328|2017-10-11 02:01:47.089328
NCT01783145|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2017-06-01|||October 2012||2012-10-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|SCFU-TC||Shared Care Follow-up After Chemotherapy for Testicular Cancer|Shared Care Follow-up After Chemotherapy for Testicular Cancer|Active, not recruiting||N/A|163|Actual|University Medical Center Groningen|||1||f||||f||||||Samples With DNA|"     whole blood, serum, plasma   "|||2017-10-11 02:01:47.16645|2017-10-11 02:01:47.16645
NCT01783132|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-31|||December 2012||2012-12-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|OCTAGEN||Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home|Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home|Unknown status|Recruiting|Phase 4|200|Anticipated|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-11 02:01:47.233945|2017-10-11 02:01:47.233945
NCT01783119|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-01|||August 2012||2012-08-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|AVIUC||Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis|Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis|Unknown status|Recruiting|Early Phase 1|60|Anticipated|National Institute of Medical Sciences and Nutrition, Salvador Zubiran||2|||f||||t||||||||||2017-10-11 02:01:47.428309|2017-10-11 02:01:47.428309
NCT01783106|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2014-06-26|||January 2013||2013-01-01|June 2014|2014-06-01||||December 2015|Anticipated|2015-12-01||Interventional|APRiCCOT||Antibiotics and Hydroxychloroquine in Crohn's|A Pilot Randomised Study to Compare Combination Antibiotic Therapy (Ciprofloxacin, Doxycycline and Hydroxychloroquine) With Standard Therapy (Budesonide) in the Treatment of Active Crohn's Disease|Unknown status|Recruiting|Phase 2|100|Anticipated|Royal Liverpool University Hospital||2|||f||||t||||||||||2017-10-11 02:01:47.552442|2017-10-11 02:01:47.552442
NCT01783093|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2013-01-31|||December 2009||2009-12-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia|An Evaluation of Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Patients With Sickle Cell Anemia: A Retrospective Data Review|Completed||N/A|209|Actual|Ohio State University|||1||f||||f||||||||||2017-10-11 02:01:47.69104|2017-10-11 02:01:47.69104
NCT01783080|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-04-04|2017-01-05||June 2010||2010-06-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning|Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning|Completed||N/A|16|Actual|New York State Psychiatric Institute|This was a small open treatment study, without a comparator group and with limited followup. Findings of this pilot study should be replicated in a larger prospective trial with a randomized design, and with longer followup.|1|||f||||t||||||||No||2017-10-11 02:01:47.775086|2017-10-11 02:01:47.775086
NCT01783067|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-04-26|||February 2011||2011-02-01|April 2016|2016-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Zinc and Iron Bioavailability From Biofortified Pearl Millet|Zinc and Iron Bioavailability From Bio-fortified Pearl Millet|Completed||N/A|44|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:01:48.16131|2017-10-11 02:01:48.16131
NCT01783054|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-02-08|2015-10-07||July 2012||2012-07-01|October 2015|2015-10-01||||October 2015|Actual|2015-10-01||Interventional|||Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas|Pilot Study of Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery for Patients With Localized, Resectable Adenocarcinoma of the Pancreas|Terminated||Early Phase 1|2|Actual|Medical University of South Carolina||1||Study terminated due to low accrual|f||||t||||||||||2017-10-11 02:01:48.291658|2017-10-11 02:01:48.291658
NCT01783041|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-09-21|||January 2013||2013-01-01|September 2015|2015-09-01|August 2020|Anticipated|2020-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants|A Double-Blind, Controlled, Randomized Clinical Trial of the Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants|Recruiting||Phase 2/Phase 3|150|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 02:01:48.737264|2017-10-11 02:01:48.737264
NCT01783028|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2014-05-08|||March 2008||2008-03-01|May 2014|2014-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|HomeBase||Home-Based Asthma Support and Education for Adults|Home-Based Asthma Support and Education for Adults|Completed||N/A|366|Actual|Public Health - Seattle and King County||2|||f||||f||||||||||2017-10-11 02:01:48.871846|2017-10-11 02:01:48.871846
NCT01783015|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2015-12-01|2015-05-12||September 2013||2013-09-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|SERUM||Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate|A Randomized, Double-blind, Placebo-controlled Study Of The Safety And Efficacy Of Etanercept In Subjects With Rheumatoid Arthritis Who Have Had An Inadequate Response To Adalimumab Or Infliximab Plus Methotrexate|Terminated||Phase 4|16|Actual|Pfizer|This study was prematurely terminated on June 25, 2014. This termination was due to delays in achieving the enrolment target and not due to any safety concerns. No statistical analyses were done since there were a small number of participants.|4||This study was prematurely terminated on June 25, 2014 due to lack of enrollment.|f||||f||||||||||2017-10-11 02:01:48.990732|2017-10-11 02:01:48.990732
NCT01783002|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-09-16|||May 2014||2014-05-01|September 2015|2015-09-01|July 2018|Anticipated|2018-07-01|March 2018|Anticipated|2018-03-01||Interventional|||11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues|Pre-operative Parathyroid Imaging: a Comparison of 11C-Methionine PET, 18F-FDG PET AND SPEC-CT for the Detection of Hyperfunctional Parathyroid Tissues|Recruiting||Phase 2|50|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 02:01:49.915457|2017-10-11 02:01:49.915457
NCT01782989|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-08-23|||February 2013||2013-02-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|TOGA||Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)|A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration|Recruiting||Phase 2/Phase 3|286|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 02:01:50.053895|2017-10-11 02:01:50.053895
NCT01782976|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-09-03|||June 2013||2013-06-01|September 2013|2013-09-01||||June 2017|Anticipated|2017-06-01||Interventional|||Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)|A Phase II Trial of Cilengitide Plus Bevacizumab in Patients With Recurrent Glioblastoma|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 02:01:50.333764|2017-10-11 02:01:50.333764
NCT01782963|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-02-17|||March 2013||2013-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RVD Lite||Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)|A Phase II Study of Modified Lenalidomide, Bortezomib and Dexamethasone for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|53|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:01:50.411779|2017-10-11 02:01:50.411779
NCT01782950|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-04-10|||February 2013||2013-02-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|SOUTH||Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes|Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes in HIV-tuberculosis Co-infected Ugandan Adults|Unknown status|Recruiting|Phase 4|400|Anticipated|Makerere University||1|||f||||t||||||||||2017-10-11 02:01:50.502724|2017-10-11 02:01:50.502724
NCT01782937|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2015-02-12|||February 2013||2013-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis|A Long-Term Study of KHK4827 in Subjects With Pustular Psoriasis (Generalized) and Psoriatic Erythroderma|Completed||Phase 3|30|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-11 02:01:50.602337|2017-10-11 02:01:50.602337
NCT01782924|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2015-02-12|||March 2013||2013-03-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Phase 3 Clinical Study of KHK4827|An Extension Study in Subjects With Plaque Psoriasis|Completed||Phase 3|145|Actual|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||||2017-10-11 02:01:50.686677|2017-10-11 02:01:50.686677
NCT01782911|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-01-31|||February 2013||2013-02-01|January 2013|2013-01-01||||April 2013|Anticipated|2013-04-01||Interventional|RES-IVF||Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS Patients|Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS Patients Undergoing IVF Treatment.|Unknown status|Not yet recruiting|Phase 3|70|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||t||||||||||2017-10-11 02:01:50.767331|2017-10-11 02:01:50.767331
NCT01782898|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-10-05|2016-02-04||January 2013||2013-01-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Intraoperative Esmolol to Improve Postoperative Quality of Recovery and Pain After Ambulatory Surgery|The Effect of Intraoperative Esmolol to Improve Postoperative Quality of Recovery and Pain After Ambulatory Surgery|Completed||N/A|70|Actual|Northwestern University||2|||f||||f||||||||No||2017-10-11 02:01:50.941396|2017-10-11 02:01:50.941396
NCT01782885|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2015-10-19|2015-09-21||May 2013||2013-05-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Comparison of Acetaminophen and PRP Therapy for Knee OA|Comparison of Acetaminophen and Platelet-rich Plasma Therapy for the Treatment of Knee Osteoarthritis.|Completed||N/A|543|Actual|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||f||||||||||2017-10-11 02:01:51.33496|2017-10-11 02:01:51.33496
NCT01782872|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-04-12|2016-02-11||October 2012||2012-10-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Analgesia After Total Shoulder Arthroplasty|Analgesia After Total Shoulder Arthroplasty|Completed||Phase 4|80|Actual|Hospital for Special Surgery, New York||4|||f||||t||||||||||2017-10-11 02:01:51.843978|2017-10-11 02:01:51.843978
NCT01782859|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-11-07|2016-04-04||October 2012||2012-10-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery|Effect of Steroids Given Over 24 Hours on Cytokine Release, Urinary Desmosine Level and Thrombogenic Markers in Patients Undergoing Unilateral Total Hip Replacement|Completed||N/A|40|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-11 02:01:52.245444|2017-10-11 02:01:52.245444
NCT01782846|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-04-19|||March 2011||2011-03-01|April 2016|2016-04-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|Trama-Code||Trama-Code (Two Analgesics-comparative Study)|Double Blind-randomized Study Comparing the Efficacy of Two Analgesia (Ixprim® and Dafalgan-Codeine®) , in the Emergency Unit.|Completed||Phase 4|803|Actual|Hopital Foch||2|||f||||||||||||||2017-10-11 02:01:52.582839|2017-10-11 02:01:52.582839
NCT01782833|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-01-31|||January 2013||2013-01-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|PLT SR PMOS||Pletaal SR Post Marketing Observational Study|A Prospective, Post Marketing Observational Study to Evaluate the Safety of Pletaal® SR Capsule|Unknown status|Not yet recruiting|N/A|3000|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.|||1||f||||||||||||||2017-10-11 02:01:52.64407|2017-10-11 02:01:52.64407
NCT01782794|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-01-31|||May 2009||2009-05-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|PopCorn||Acceptability of Hepatitis B Vaccination in General Population|Measurement of the Changes in Hepatitis B Immunization Coverage in Infants, and the Acceptability Thereof, Before Reimbursement, Then During the Three Years After Reimbursement of InfanrixHexa® in France, Among the General Population|Completed||N/A|2413|Actual|GlaxoSmithKline|||2||f||||t||||||||||2017-10-11 02:01:54.954753|2017-10-11 02:01:54.954753
NCT01782781|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-01-19|||November 2012||2012-11-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|LIA||Local Infiltration Analgesia After Abdominal Hysterectomy|Local Infiltration Analgesia After Abdominal Hysterectomy|Completed||Phase 3|60|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 02:01:55.038905|2017-10-11 02:01:55.038905
NCT01782768|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-19|2016-12-03|||January 2013||2013-01-01|December 2016|2016-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Comparative Effects of Different Noninvasive Ventilation Mode on Neural Respiratory Drive in Recovering AECOPD Patients|Comparative Effects of Noninvasive Proportional Assist and Pressure Support Ventilation on Neural Respiratory Drive in Recovering Acute Exacerbation of Chronic Obstructive Pulmonary Disease(AECOPD) Patients|Completed||N/A|20|Actual|The First Affiliated Hospital of Guangzhou Medical University||1|||f||||t||||||||||2017-10-11 02:01:55.139333|2017-10-11 02:01:55.139333
NCT01782755|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-03-16|||October 2013||2013-10-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|PROSPECT||Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial|Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial|Completed||Phase 2|150|Actual|McMaster University||2|||f||||f||||||||No||2017-10-11 02:01:55.219498|2017-10-11 02:01:55.219498
NCT01782742|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-02-10|2016-02-10||February 2013||2013-02-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|BEAT-AD||Bexarotene Amyloid Treatment for Alzheimer's Disease|A Double Blind Placebo Controlled Randomized Study to Evaluate the Efficacy and Safety of Bexarotene in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|20|Actual|The Cleveland Clinic|Sample size of this trial is small. There was 1 participant withdrawal due to adverse event. Primary outcome measures were completed by all 20 participants as anticipated.|2|||f||||t||||||||||2017-10-11 02:01:55.349752|2017-10-11 02:01:55.349752
NCT01782716|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-02-01|||January 2012||2012-01-01|December 2011|2011-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Effect of Different Scoring Systems on Mortality Rates and Length of Hospitalization in Cardiac Surgery Patients|Effect of Different Scoring Systems on Mortality Rates and Length of Hospitalization in Cardiac Surgery Patients|Completed||N/A|438|Actual|Cumhuriyet University Hospital|||2||f||||t||||||||||2017-10-11 02:01:56.369793|2017-10-11 02:01:56.369793
NCT01782703|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-09-08|||January 2013|Actual|2013-01-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis|Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis|Recruiting||N/A|500|Anticipated|Northwestern University|||3||f||||f||||||Samples With DNA|"     We have retained whole blood and tissue samples (skin and cheek swabs)   "|||2017-10-11 02:01:56.432839|2017-10-11 02:01:56.432839
NCT01782677|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-10-14|||December 2012||2012-12-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bilateral Surgical Resection of Carotid Bodies in Patients With Systolic Heart Failure|Bilateral Surgical Resection of Carotid Bodies in Patients With Systolic Heart Failure|Completed||N/A|5|Actual|Noblewell||1|||f||||t||||||||||2017-10-11 02:01:56.599522|2017-10-11 02:01:56.599522
NCT01782664|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-04-21|2017-01-30||March 1, 2013||2013-03-01|January 2017|2017-01-01|March 24, 2014|Actual|2014-03-24|March 1, 2014|Actual|2014-03-01||Interventional|||A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis|A Multi-centre, Randomised, Double-blind, Placebo-controlled, Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis|Completed||Phase 2|68|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:01:56.763437|2017-10-11 02:01:56.763437
NCT01782651|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2015-08-06|||August 2014||2014-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients|Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 02:01:59.971584|2017-10-11 02:01:59.971584
NCT01782638|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-01-31|||September 2012||2012-09-01|January 2013|2013-01-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Effect of Deep Brain Stimulation on Gait of Patients With Parkinson's Disease Depending on Electrode Location in Subthalamic Area|Effect of Deep Brain Stimulation on Gait of Patients With Parkinson's Disease Depending on Electrode Location in Subthalamic Area.|Unknown status|Recruiting|Phase 4|40|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:02:00.067578|2017-10-11 02:02:00.067578
NCT01782612|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-03-11|||March 2013||2013-03-01|March 2013|2013-03-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||The Assessments of the Postoperative Recovery on Elderly Patients Received General Anesthesia or Peripheral Nerve Blocks|Comparison of Peripheral Nerve Blocks With General Anesthesia on Elderly Patients Undergoing Total Hip Replacement (THR) by Assessing the Postoperative Recovery and Delirium|Unknown status|Recruiting|N/A|100|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 02:02:00.245163|2017-10-11 02:02:00.245163
NCT01782599|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-12-19|||January 2013||2013-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Electronic Cigarettes and Reactivity to Smoking Cues|Electronic Cigarettes and Reactivity to Smoking Cues|Recruiting||N/A|125|Anticipated|Mclean Hospital||1|||f||||f||||||||||2017-10-11 02:02:00.349378|2017-10-11 02:02:00.349378
NCT01782586|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-06-06|||February 2013||2013-02-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Validation of Gene Expression Markers of Renal Allograft Functional Decline|Multicenter Validation of Gene Expression Markers of Renal Allograft Functional Decline (GEN-04)|Active, not recruiting||N/A|480|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     biopsy & blood on 480 conventional kidney transplant participants   "|||2017-10-11 02:02:00.538086|2017-10-11 02:02:00.538086
NCT01782573|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-31|||October 2011||2011-10-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients|The Efficacy of Pre - Disinfection Skin Scrub With 4% Chlorhexidine Gluconate in Preventing Surgical Site Infections for Patients With Hepatectomy|Completed||Phase 4|100|Actual|Changhua Christian Hospital||2|||f||||f||||||||||2017-10-11 02:02:00.622822|2017-10-11 02:02:00.622822
NCT01782560|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-07-28|||February 2013||2013-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Laryngomalacia Study|Improving Care For Infants With Laryngomalacia: A Pilot Randomized Controlled Trial of Omeprazole Versus Placebo|Withdrawn||Phase 1|0|Actual|Children's & Women's Health Centre of British Columbia||2||Unable to recruit a sufficient amount of subjects|f||||f||||||||||2017-10-11 02:02:00.73406|2017-10-11 02:02:00.73406
NCT01782547|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-08-12|||June 2013||2013-06-01|August 2016|2016-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Telehealth Intervention for Youth With T1DM|Telehealth Intervention for Youth With Type 1 Diabetes|Completed||N/A|32|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 02:02:00.844367|2017-10-11 02:02:00.844367
NCT01782534|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-02-22|||August 2002||2002-08-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Logistic Regression of Risk Factor for the 5-year Mortality of Aortic Dissection|Logistic Regression of Risk Factor for the 5-year Mortality of Aortic Dissection|Completed||N/A|111|Actual|Central South University|||1||f||||t||||||||||2017-10-11 02:02:00.936912|2017-10-11 02:02:00.936912
NCT01782521|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-02-01|||March 2013||2013-03-01|February 2013|2013-02-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Is a Primer Needed for Orthodontic Bonding? A Multi-centre Trial|Is a Primer Needed for Orthodontic Bonding? A Multi-centre RCT|Unknown status|Not yet recruiting|N/A|156|Anticipated|Bradford Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:02:00.998346|2017-10-11 02:02:00.998346
NCT01782508|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2013-01-31|||August 2012||2012-08-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma|A Phase II Randomized Study of Imatinib Versus High Dose Interferon as Adjuvant Therapy in KIT-mutated Patients With Resected Melanoma|Unknown status|Recruiting|Phase 2|40|Anticipated|Beijing Cancer Hospital||2|||f||||t||||||||||2017-10-11 02:02:01.090815|2017-10-11 02:02:01.090815
NCT01782482|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2014-04-25|2014-02-18||February 2013||2013-02-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||The analysis population includes all randomized participants who satisfied specific Inclusion/Exclusion Criteria, did not sleep overnight in study lenses, and used only the habitual lens care during the study (552).|A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers|A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers|Completed||N/A|574|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:02:01.343151|2017-10-11 02:02:01.343151
NCT01782469|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2015-07-02|2015-07-02||October 2012||2012-10-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational||All enrolled participants|Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population|A Prospective, Multi-center Study in Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population|Terminated||N/A|16|Actual|AbbVie|||1|Study stopped due to low enrollment|f||||f||||||||||2017-10-11 02:02:01.61266|2017-10-11 02:02:01.61266
NCT01782456|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-05-30|||March 2013||2013-03-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Tolerance of an Oral Nutritional Supplement(ONS)|Tolerance of an Oral Nutritional Supplement(ONS)With a New Protein Blend in Healthy Children|Completed||N/A|25|Actual|Abbott Nutrition||1|||f||||f||||||||||2017-10-11 02:02:01.883218|2017-10-11 02:02:01.883218
NCT01782443|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-08-03|||February 2013||2013-02-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors|Phase II Study of Ziv-aflibercept in Patients With Advanced, Progressive Carcinoid Tumors|Recruiting||Phase 2|43|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 02:02:01.959413|2017-10-11 02:02:01.959413
NCT01782248|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-01-30|||February 2013||2013-02-01|January 2013|2013-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Self-consciousness in Dementia|Self-consciousness in Dementia|Unknown status|Not yet recruiting|Early Phase 1|65|Anticipated|University Hospital, Strasbourg, France||3|||f||||||||||||||2017-10-11 02:02:07.534914|2017-10-11 02:02:07.534914
NCT01782430|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2016-06-24|||April 2015||2015-04-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|PREONIV||PREoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation|PREoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation|Recruiting||Phase 2/Phase 3|132|Anticipated|University Hospital, Clermont-Ferrand||3|||f||||||||||||||2017-10-11 02:02:02.048975|2017-10-11 02:02:02.048975
NCT01782417|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2015-10-11|||February 2013||2013-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PRIMO-Latino||Pilot Testing a Patient and Provider Intervention for Managing Osteoarthritis in Hispanic Adults.|Pilot Testing a Patient and Provider Intervention for Managing Osteoarthritis in Hispanic Adults.|Completed||N/A|16|Actual|Duke University||1|||f||||f||||||||||2017-10-11 02:02:02.319873|2017-10-11 02:02:02.319873
NCT01782404|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2015-08-11|||January 2013||2013-01-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine|Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine|Completed||N/A|50|Actual|Wellspect HealthCare||1|||f||||||||||||||2017-10-11 02:02:02.395747|2017-10-11 02:02:02.395747
NCT01782391|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-12-20|||April 2013||2013-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Patients With Mild Cognitive Impairments|Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Patients With Mild Cognitive Impairments(MCI)|Recruiting||N/A|22|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 02:02:02.466249|2017-10-11 02:02:02.466249
NCT01782378|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-07-11|||December 1, 2014|Actual|2014-12-01|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|September 30, 2017|Anticipated|2017-09-30||Interventional|LED Treat GWVI||Scalp Application of Red and Near-Infrared Light, From Light-Emitting Diodes (LED) to Improve Thinking and Memory in Veterans With Gulf War Illnesses|Transcranial, Light-Emitting Diode (LED) Therapy to Improve Cognition in GWVI|Recruiting||Phase 2|160|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 02:02:02.565186|2017-10-11 02:02:02.565186
NCT01782365|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-07-04|||April 2013||2013-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|||Effects of Brain Stimulation During a Daytime Nap on Memory Consolidation in Patients With Mild Cognitive Impairment|Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Slow Wave Sleep of a Daytime Nap in Patients With Mild Cognitive Impairment(MCI)|Active, not recruiting||N/A|16|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 02:02:02.672674|2017-10-11 02:02:02.672674
NCT01782352|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-01-30|||July 2010||2010-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)|Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)|Active, not recruiting||N/A|25875|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:02:02.755509|2017-10-11 02:02:02.755509
NCT01782339|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2017-08-30|||July 2012||2012-07-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|GAMMA||A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis|A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis|Recruiting||Phase 2|43|Anticipated|Barts & The London NHS Trust||1|||f||||t||||||||||2017-10-11 02:02:02.84603|2017-10-11 02:02:02.84603
NCT01782326|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-05-05|2016-05-04||July 2013||2013-07-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)|A 52-week Treatment, Multi-center, Randomized, Double-blind, Double Dummy, Parallel-group, Active Controlled Study to Compare the Effect of QVA149 (Indacaterol Maleate / Glycopyrronium Bromide) With Salmeterol/Fluticasone on the Rate of Exacerbations in Subjects With Moderate to Very Severe COPD. (FLAME).|Completed||Phase 3|3362|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:02:03.097352|2017-10-11 02:02:03.097352
NCT01782313|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-03-27|||February 2013||2013-02-01|March 2017|2017-03-01||||January 2018|Anticipated|2018-01-01||Interventional|||A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas|A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas|Active, not recruiting||Phase 2|54|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 02:02:06.988143|2017-10-11 02:02:06.988143
NCT01782300|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-06-12|||January 2013||2013-01-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|March 2015|Actual|2015-03-01||Interventional|||Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart|A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003|Completed||Phase 1|48|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 02:02:07.084907|2017-10-11 02:02:07.084907
NCT01782261|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-10-10|||February 2012||2012-02-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Incretin Effect on the Immunological Phenotype|Pilot Study on Incretin Effect on the Immunological Phenotype in Healthy Subjects and in Type 1 Diabetic Subjects|Completed||Phase 2|15|Actual|Medical University of Graz||2|||f||||t||||||||No||2017-10-11 02:02:07.445199|2017-10-11 02:02:07.445199
NCT01779973|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-04-02|||February 2013||2013-02-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|RODISC||Remote Observed Dosing to Increase Suboxone Compliance||Completed||Early Phase 1|9|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 02:02:48.499013|2017-10-11 02:02:48.499013
NCT01782235|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-03-11|||July 2013||2013-07-01|March 2014|2014-03-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|ETAP||Efficacy of Tocilizumab in Primary Sjögren's Syndrome.|A Randomized, Double-blind, Parallel, Placebo-controlled Trial to Evaluate the Efficacy of Tocilizumab for the Treatment of Primary Sjögren's Syndrome.|Unknown status|Recruiting|Phase 2/Phase 3|110|Anticipated|University Hospital, Strasbourg, France||2|||f||||||||||||||2017-10-11 02:02:07.616819|2017-10-11 02:02:07.616819
NCT01782222|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2015-07-13|2014-12-15||February 2013||2013-02-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|BRIGHT|The Baseline Analysis Population refers to the Safety Set (SS). The SS included all randomized subjects who received at least 1 dose of study medication.|Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy|A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 3-Arm, Phase 4 Study To Evaluate The Efficacy Of Rotigotine On Parkinson's Disease-Associated Apathy, Motor Symptoms, And Mood|Completed||Phase 4|122|Actual|UCB Pharma||3|||f||||f||||||||||2017-10-11 02:02:07.724978|2017-10-11 02:02:07.724978
NCT01782209|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-07-25|||June 2014||2014-06-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients|Natural History of Infection Caused by BK Virus (and Other Opportunistic Viral Pathogens) in Renal Transplant Recipients|Recruiting||N/A|450|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"     Whole blood samples will be processed for serum and then evaluated for BK virus DNA   "|||2017-10-11 02:02:08.704676|2017-10-11 02:02:08.704676
NCT01782196|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-07-02|||October 2012||2012-10-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|U366||A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy|A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy|Terminated||N/A|13|Actual|ConvaTec Inc.||2||Leakage|f||||||||||||||2017-10-11 02:02:08.82056|2017-10-11 02:02:08.82056
NCT01782183|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-01-26|||September 2016||2016-09-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|thermography||Thermographic Characteristics of Sore Throat by Thermographic Camera|Thermographic Characteristics of Sore Throat by Thermographic Camera|Not yet recruiting||N/A|100|Anticipated|Clalit Health Services||1|||f||||f||||||||||2017-10-11 02:02:08.904466|2017-10-11 02:02:08.904466
NCT01782170|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-08-13|||February 2013||2013-02-01|August 2013|2013-08-01|May 2014|Anticipated|2014-05-01|January 2014|Anticipated|2014-01-01||Interventional|||Efficacy of Iocide Oral Rinse Against Gingival Inflammation|Phase II Study: Evaluate Efficacy of Iocide Oral Rinse in a Human Clinical Trial of Gingival Inflammation and Investigate Effects on Biological Markers Indicative of Systemic Disease|Unknown status|Recruiting|Phase 2|76|Anticipated|Biomedical Development Corporation||2|||f||||f||||||||||2017-10-11 02:02:09.00193|2017-10-11 02:02:09.00193
NCT01782157|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-12-09|||January 2013||2013-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CASAS/HH||Smart Environment Technology for Longitudinal Behavior Analysis and Intervention|Smart Environment Technology for Longitudinal Behavior Analysis and Intervention|Recruiting||N/A|42|Anticipated|Washington State University|||2||f||||f||||||||||2017-10-11 02:02:09.127727|2017-10-11 02:02:09.127727
NCT01782144|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-01-30|||January 2011||2011-01-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|WLF||Effects of Weight Loss on Foot Structure and Function in Obese Adults: A Pilot Study|Effect of Weight Loss on Foot Structure and Function in Obese Adults: A Pilot Study|Completed||N/A|41|Actual|Temple University||2|||f||||f||||||||||2017-10-11 02:02:09.228061|2017-10-11 02:02:09.228061
NCT01782131|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-09-27|||September 25, 2013|Actual|2013-09-25|September 2017|2017-09-01|July 16, 2019|Anticipated|2019-07-16|April 19, 2019|Anticipated|2019-04-19||Interventional|||A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)|A Phase 3 Randomized Study of the Efficacy and Safety of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults and Adolescents (Phase 3; Protocol No. MK-5592-069)|Recruiting||Phase 3|600|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 02:02:09.316004|2017-10-11 02:02:09.316004
NCT01782118|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-10-30|||February 2013||2013-02-01|October 2013|2013-10-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||LGG for Prevention of Infectious Complications During PPI Treatment in Children|Effectiveness of Lactobacillus GG in the Prevention of Gastrointestinal and Respiratory Tract Infections in Children With Gastroesophageal Reflux Disease Treated With Proton Pump Inhibitors: Randomized Double - Blind Placebo, Controlled Trial.|Unknown status|Recruiting|Phase 4|120|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 02:02:09.712704|2017-10-11 02:02:09.712704
NCT01782105|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-12-10|||December 2011||2011-12-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Intervention to Promote Changes of Healthy Lifestyle (Physical Activity and Nutrition) During Gestation|Intervention en Changement Des Habitudes de Vie Par l'Activité Physique et un Support Nutritionnel Durant la Grossesse en Estrie|Completed||N/A|16|Actual|Université de Sherbrooke||2|||f||||t||||||||||2017-10-11 02:02:09.825251|2017-10-11 02:02:09.825251
NCT01782092|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-04-19|||August 2012||2012-08-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Activator and Type II Diabetics|Effect of Activator Methods Technique on Lowering A1c Levels in Type II Diabetics|Completed||N/A|5|Actual|Life University|||1||f||||f||||||||||2017-10-11 02:02:09.934785|2017-10-11 02:02:09.934785
NCT01782079|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-03-22|||January 2013||2013-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||L. Brevis CD2 Strain Persistence in Oral Cavity|Assessment of Probiotic Lactobacillus Brevis CD2 Strain Persistence in Oral Cavity. A Pilot Study|Completed||N/A|12|Actual|University of Roma La Sapienza||1|||f||||f||||||||||2017-10-11 02:02:10.004658|2017-10-11 02:02:10.004658
NCT01782066|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-10-28|||January 2013||2013-01-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines|Dose Finding and Reactogenicity of Reduced-dose Intradermal Administration of Two Quadrivalent Meningococcal Conjugate Vaccines (Menveo® and Nimenrix®) in Healthy Adults (MENID-1).|Completed||Phase 1/Phase 2|12|Actual|Leiden University Medical Center||2|||f||||t||||||||||2017-10-11 02:02:10.080441|2017-10-11 02:02:10.080441
NCT01782053|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-12-01|||January 2013||2013-01-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Communicating Smoking Risks Through Graphic Warning Labels|Communicating Smoking Risks Through Graphic Warning Labels|Completed||Phase 3|245|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-11 02:02:10.170211|2017-10-11 02:02:10.170211
NCT01782040|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-01-30|||January 2011||2011-01-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|September 2011|Actual|2011-09-01||Interventional|||Auriculotherapy in the Cares to the Premenstrual Syndrome|Auriculotherapy in the Cares to the Premenstrual Syndrome: Randomized Clinical Trial|Completed||Phase 2|40|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:02:10.26154|2017-10-11 02:02:10.26154
NCT01782027|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-07-25|||October 2012||2012-10-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Mendelian Reverse Cholesterol Transport Study|A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL Metabolism|Suspended||N/A|30|Anticipated|University of Pennsylvania||1||Lack of funding|f||||f||||||||||2017-10-11 02:02:10.343162|2017-10-11 02:02:10.343162
NCT01782014|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2016-01-28|||February 2013||2013-02-01|September 2014|2014-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Comparison of Adenoma Detection Rate Among Water, Carbon Dioxide and Air Methods of Minimal Sedation Colonoscopy|Water Infusion and Carbon Dioxide Insufflation Versus Air Insufflation Versus Air Insufflation Techniques in Screening Colonoscopies in the United States: A Comparative Study Evaluating Safety, Efficacy and Adenoma Detection Rate (ADR)|Terminated||Phase 3|450|Anticipated|Loma Linda University||3|||f||||t||||||||||2017-10-11 02:02:10.456239|2017-10-11 02:02:10.456239
NCT01782001|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2013-01-30|||March 2009||2009-03-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Evaluation of Vitamin A and Zinc Supplementation on Malarial Morbidity|Evaluation of the Impact of Vitamin A and Zinc Supplementation on Malarial Morbidity in Ghana|Completed||Phase 3|200|Actual|Kintampo Health Research Centre, Ghana||2|||f||||t||||||||||2017-10-11 02:02:10.564229|2017-10-11 02:02:10.564229
NCT01781975|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-06-20|||January 2014|Actual|2014-01-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|May 2017|Actual|2017-05-01||Interventional|||Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus|Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-Onset Type 1 Diabetes Mellitus|Active, not recruiting||Phase 2|67|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:02:10.899433|2017-10-11 02:02:10.899433
NCT01781962|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-07-30|2014-06-16||January 2013||2013-01-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension||Terminated||N/A|206|Actual|Allergan|||1|Study terminated due to corporate decision.|f||||f||||||||||2017-10-11 02:02:11.048871|2017-10-11 02:02:11.048871
NCT01781949|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-06-13|||April 2014||2014-04-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|January 2016|Actual|2016-01-01||Interventional|HIV TESTED||The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial|Effectiveness of Rapid HIV Screening Methods in Urban Emergency Departments|Active, not recruiting||N/A|76235|Actual|Denver Health and Hospital Authority||3|||f||||f||||||||Yes|The final research dataset resulting from this project will be made available to other investigators who wish to perform secondary analyses in this content area. The final dataset will include demographic and self-reported behavioral risk information as collected as a part of the Denver HIV Risk Score (DHRS) and the Behavioral Risk Screening Tool (BRST), as well as results of rapid HIV testing, if performed. Because HIV infection is a reportable disease, identifying information will be collected. While the final dataset will be stripped of identifiers prior to release for sharing, we believe that there remains a possibility of deductive disclosure of subjects with unusual characteristics. Thus, we will make data and associated documentation available to users only under a data-use agreement (DUA).|2017-10-11 02:02:11.380267|2017-10-11 02:02:11.380267
NCT01781936|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-04-27|||June 2012||2012-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Iluvien||Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis|Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis|Active, not recruiting||Phase 1|18|Anticipated|Duke University||1|||f||||f||||||||||2017-10-11 02:02:11.507695|2017-10-11 02:02:11.507695
NCT01781923|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-08-06|||October 2010||2010-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Cognitive Remediation in 22q11DS|A Remediation Program for Children at High-Risk of Schizophrenia: 22q11.2 Deletion Syndrome|Completed||N/A|38|Actual|Duke University||2|||f||||t||||||||||2017-10-11 02:02:11.644578|2017-10-11 02:02:11.644578
NCT01781910|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-01-31|||September 2011||2011-09-01|January 2013|2013-01-01||||November 2012|Actual|2012-11-01||Interventional|||Branched Chain Amino Acid Plus Glucose Supplement Reduces Exercise-Induced Delayed Onset Muscle Soreness in College Females|The Effects of Branched Chain Amino Acid and Nutrient Supplementation on Exercise-Induced Delayed Onset Muscle Soreness in College Females|Completed||N/A|20|Actual|University of Vermont||2|||f||||f||||||||||2017-10-11 02:02:11.769494|2017-10-11 02:02:11.769494
NCT01781897|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-03-17|||February 2013||2013-02-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Electroacupuncture for the Treatment of Functional Constipation|A Randomized Controlled Trial of Acupuncture to Treat Functional Constipation|Unknown status|Recruiting|Phase 1|243|Anticipated|Huazhong University of Science and Technology||3|||f||||t||||||||||2017-10-11 02:02:11.854356|2017-10-11 02:02:11.854356
NCT01781884|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-12|2013-01-31|||January 2013||2013-01-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects Of Gamma Aminobutyric Acid On The Progression Of New Onset Juvenile Type 1 Diabetes|Effects Of Gamma Aminobutyric Acid On The Progression Of New Onset Juvenile|Unknown status|Recruiting|N/A|60|Anticipated|Huashan Hospital||3|||f||||t||||||||||2017-10-11 02:02:11.980291|2017-10-11 02:02:11.980291
NCT01781871|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-10-04|||January 2013||2013-01-01|October 2017|2017-10-01|October 4, 2017|Actual|2017-10-04|October 4, 2017|Actual|2017-10-04||Interventional|SOT13||Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients|Immunogenicity of Repeated Dose 13-valent Pneumococcal Conjugate Vaccine Compared to the Existing Recommended Protocol of Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients|Completed||Phase 4|182|Actual|Helsinki University Central Hospital||4|||f||||t||||||||||2017-10-11 02:02:12.104538|2017-10-11 02:02:12.104538
NCT01781858|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2016-06-13|||January 2008||2008-01-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Observational|SCOPE||Study on the Clinical Course Of Pulmonary Embolism|Study on the Clinical Course Of Pulmonary Embolism|Completed||N/A|700|Actual|University of Padua|||1||f||||f||||||||||2017-10-11 02:02:12.215025|2017-10-11 02:02:12.215025
NCT01781845|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2015-05-29|||November 2012||2012-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Hydronephrosis ARFI Study|Evaluation of Ultrasound Acoustic Radiation Force Impulse (ARFI)Shear Wave Velocity Imaging (SVI)in the Characterization of Pediatric Hydronephrosis|Completed||N/A|41|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 02:02:12.316123|2017-10-11 02:02:12.316123
NCT01781819|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-05-29|||October 2012||2012-10-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|||(ARFI) Shear Velocity Imaging of the Kidneys in Pediatric Patients|Ultrasound Based Acoustic Radiation Force Impulse (ARFI)Shear Wave Velocity Imaging (SVI)of the Kidneys in Pediatric Patients With Vesicoureteral Reflux|Withdrawn||N/A|0|Actual|University of Michigan||1||PI leaving institution|f||||t||||||||||2017-10-11 02:02:12.511395|2017-10-11 02:02:12.511395
NCT01781806|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-08-24|2017-08-24||May 2013||2013-05-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PATH-PrEP||A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services|A Pilot Demonstration Project to Operationalize Pre-exposure Prophylaxis as Part of Combination HIV Prevention Among MSM and Transgender Women in Los Angeles County|Completed||Phase 4|301|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:02:12.606442|2017-10-11 02:02:12.606442
NCT01781793|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-10-11|||September 2013||2013-09-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|Dyspnea_ILD||Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease|Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease|Completed||N/A|20|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:02:13.291834|2017-10-11 02:02:13.291834
NCT01781780|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2014-02-16|||January 2013||2013-01-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study of the Effectiveness of Breakfast Recommendations On Reducing Body Weight|Randomized Controlled Trial of Breakfast Recommendations on Weight: A Multi-Site Effectiveness Trial|Completed||N/A|309|Actual|University of Alabama at Birmingham||3|||f||||f||||||||||2017-10-11 02:02:13.396634|2017-10-11 02:02:13.396634
NCT01781767|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2013-01-30|||January 2013||2013-01-01|January 2013|2013-01-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|Thyroid cancer||Changes in Metabolic Status in Patients With Total Thyroidectomy||Unknown status|Recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"     Whole blood for UCP2 mRNA   "|||2017-10-11 02:02:13.493285|2017-10-11 02:02:13.493285
NCT01781754|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-30|||January 2013||2013-01-01|January 2013|2013-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|Diabetes||Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients|Changes in UCP2 mRNA in T2DM Patients|Unknown status|Recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"     Whole blood for UCP2 mRNA   "|||2017-10-11 02:02:13.582988|2017-10-11 02:02:13.582988
NCT01781741|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-07-24|||March 6, 2013|Actual|2013-03-06|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2015|Actual|2015-11-30||Interventional|||Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer|A Pilot Study of Stereotactic Body Radiation Therapy (SBRT) After TEMLA With or Without Minimally Invasive Surgery for Stage III and Stage IV (Oligometastatic) Non-small Cell Lung Cancer|Active, not recruiting||Early Phase 1|10|Actual|Roswell Park Cancer Institute||1|||f||||t|t|f||||||||2017-10-11 02:02:13.689394|2017-10-11 02:02:13.689394
NCT01781728|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-02-10|||January 2013||2013-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma|Phase II Study to Evaluate Stereotactic Body Radiation Therapy For Palliative Management of Unresectable Recurrent or Residual Pancreatic or Periampullary Adenocarcinoma Adenocarcinoma|Recruiting||Phase 2|120|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:02:13.772749|2017-10-11 02:02:13.772749
NCT01781715|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-30|||September 2011||2011-09-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|ZES for STEMI||Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI|Multivessel Stenting and Staged Revascularization for ST-elevation Myocardial Infarction Patients With Resolute Integrity Stents|Unknown status|Recruiting|Phase 4|120|Anticipated|Russian Academy of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:02:13.90171|2017-10-11 02:02:13.90171
NCT01781689|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2015-03-31|||October 2012||2012-10-01|March 2015|2015-03-01||||July 2016|Anticipated|2016-07-01||Interventional|||The Relationship Between Motor Cortex Oxygenation and Motor Function Recovery in Stroke Patients|The Relationship Between Motor Cortex Oxygenation and Motor Function Recovery in Stroke Patients|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Kaohsiung Veterans General Hospital.||3|||f||||f||||||||||2017-10-11 02:02:14.104167|2017-10-11 02:02:14.104167
NCT01781676|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-05-13|||January 2012||2012-01-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01|14 Days|Observational [Patient Registry]|||Safety Study of Kudiezi(Yueanxin,a Chinese Medicine Injection)Used in Hospitals in China|Registry Study Intensive Hospital Monitoring Protocol of Kudiezi Injection ( Yueanxin ) 's Clinical Safety|Unknown status|Active, not recruiting|N/A|30000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t||||||||||2017-10-11 02:02:14.203911|2017-10-11 02:02:14.203911
NCT01781663|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-01-29|||February 2013||2013-02-01|July 2013|2013-07-01||||June 2014|Anticipated|2014-06-01||Interventional|||Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)||Unknown status|Recruiting|Phase 4|56|Anticipated|Kamedis Ltd.||2|||f||||||||||||||2017-10-11 02:02:14.276343|2017-10-11 02:02:14.276343
NCT01781650|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-01-14|||March 2013||2013-03-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in Diagnostic Patients|A Randomized, Controlled Trial Comparing Air Insufflation, Water Immersion and Water Exchange During on Demand Sedation Colonoscopy in Diagnostic Patients|Completed||N/A|288|Actual|Presidio Ospedaliero Santa Barbara||3|||f||||f||||||||||2017-10-11 02:02:14.38063|2017-10-11 02:02:14.38063
NCT01781637|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-05-02|2017-03-23||January 2013||2013-01-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2015|Actual|2015-10-01||Interventional|PRROTECT||Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial|Phase 2 Study of Omalizumab in Oral Peanut Desensitization|Active, not recruiting||Phase 1/Phase 2|36|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 02:02:14.669258|2017-10-11 02:02:14.669258
NCT01781624|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-31|2013-01-31|||October 2012||2012-10-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of an Oral Nutritional Supplement|Evaluation of an Oral Nutritional Supplement With a New Protein Blend|Completed||N/A|25|Actual|Abbott Nutrition||1|||f||||f||||||||||2017-10-11 02:02:14.974126|2017-10-11 02:02:14.974126
NCT01781611|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-09-15|||February 2013||2013-02-01|September 2017|2017-09-01|February 2020|Anticipated|2020-02-01|February 2019|Anticipated|2019-02-01||Interventional|DARE||Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)|Dipyridamole Assessment for Flare Reduction in SLE|Recruiting||N/A|50|Anticipated|Oklahoma Medical Research Foundation||2|||f||||t||||||||||2017-10-11 02:02:15.083383|2017-10-11 02:02:15.083383
NCT01781598|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-01-30|||September 2011||2011-09-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Patient-specific Instruments as a Standard Procedure in Total Knee Arthroplasty|Patient-specific Instruments as a Standard Procedure in Total Knee Arthroplasty: Logistics, Learning Curve, and Postoperative Radiological Results in 70 Patients|Completed||N/A|73|Actual|Orthopedic Clinic Gersthof|||1||f||||f||||||||||2017-10-11 02:02:15.215043|2017-10-11 02:02:15.215043
NCT01781585|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-04-11|||August 2011||2011-08-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|NSARF||The Hemodynamic Effects During Sustained Low-efficiency Dialysis Versus Continuous Veno-venous Hemofiltration for Patients With Intracranial Hypertension in a Cross Over Study|The Hemodynamic Effects During Sustained Low-efficiency Dialysis Versus Continuous Veno-venous Hemofiltration for Patients With Intracranial Hypertension in a Cross Over Study (NSARF)|Withdrawn||N/A|0|Actual|National Taiwan University Hospital|||2|Inclusion criteria difficulties to receive the case, it is taken off the case to apply|f||||f||||||||||2017-10-11 02:02:15.305235|2017-10-11 02:02:15.305235
NCT01781572|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-09-29|||June 2013||2013-06-01|September 2017|2017-09-01|November 30, 2018|Anticipated|2018-11-30|October 2018|Anticipated|2018-10-01||Interventional|||A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma|A Phase Ib/II, Multicenter, Open Label, Study of LEE011 in Combination With MEK162 in Adult Patients With NRAS Mutant Melanoma|Active, not recruiting||Phase 1/Phase 2|80|Anticipated|Array BioPharma||2|||f||||f||||||||||2017-10-11 02:02:15.400011|2017-10-11 02:02:15.400011
NCT01781559|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-12-11|||October 2012||2012-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Bioefficacy of Phenolic Acids|Effect of Phenolic Acids on the Human Vasculature|Completed||N/A|14|Actual|Nestlé||3|||f||||f||||||||||2017-10-11 02:02:15.553825|2017-10-11 02:02:15.553825
NCT01781546|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-12-03|||May 2013||2013-05-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|DEBUT||Drug-Eluting Balloon in Stable and Unstable Angina|Drug-Eluting Balloon in Stable and Unstable Angina: a Randomized Controlled Non-inferiority Trial|Unknown status|Recruiting|N/A|600|Anticipated|North Karelia Central Hospital||2|||f||||f||||||||||2017-10-11 02:02:15.732726|2017-10-11 02:02:15.732726
NCT01781533|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-03-17|||January 2013||2013-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study to Test Software Algorithm for Insulin Therapy and New Glucose Sensor|An Open, Single-centre, Non-controlled Feasibility Study Using a Software-algorithm Based Insulin Therapy to Control Blood Glucose in Type 1 Diabetic Patients|Completed||N/A|20|Actual|Medical University of Graz||1|||f||||t||||||||||2017-10-11 02:02:15.941126|2017-10-11 02:02:15.941126
NCT01781520|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2017-02-03|||January 2013||2013-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer||Recruiting||Phase 1/Phase 2|30|Anticipated|Capital Medical University||1|||f||||f||||||||||2017-10-11 02:02:16.040939|2017-10-11 02:02:16.040939
NCT01781507|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-08-30|||June 2011||2011-06-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study of Bronchodilation Effects of Cetirizine|Assessment of Bronchodilatory Effects of Cetirizine in Adults With Concomitant Allergic Rhinitis and Mild Asthma as Measured by Impulse Oscillometry.|Completed||Phase 4|21|Actual|California Allergy and Asthma Medical Group, Inc.||2|||f||||f||||||||||2017-10-11 02:02:16.156894|2017-10-11 02:02:16.156894
NCT01781494|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-11-26|||January 2014||2014-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Immobilization Versus Immediate Motion After Anterior Submuscular Ulnar Nerve Transposition|Immobilization Versus Immediate Motion After Anterior Submuscular Ulnar Nerve Transposition: Affect on Flexor-pronator Integrity|Withdrawn||N/A|0|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:02:16.268098|2017-10-11 02:02:16.268098
NCT01780350|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-02-12|2015-02-12||April 2012||2012-04-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Assessment of the Implementation of the ResQGARD® Impedance Threshold Device by the San Antonio Fire Department||Completed||Phase 4|200|Actual|Advanced Circulatory Systems||1|||f||||f||||||||||2017-10-11 02:02:45.262098|2017-10-11 02:02:45.262098
NCT01781481|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-07-22|2016-07-15||April 2010||2010-04-01|July 2016|2016-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational||Children and youth (ages of 8-17) followed in the IBD Clinic at the Children's Hospital of Eastern ONtario with confirmed diagnoses of IBD (Crohn's disease or ulcererative colitis).|The Pediatric Intermed: A New Clinical Decision Making Tool|The Pediatric Intermed: A New Clinical Decision Making Tool for Proactive Evaluation of Psychosocial Stress in Children With Inflammatory Bowel Disease|Completed||N/A|148|Actual|Children's Hospital of Eastern Ontario|||1||f||||f||||||||No||2017-10-11 02:02:16.428511|2017-10-11 02:02:16.428511
NCT01781468|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-09-29|||June 2013||2013-06-01|September 2017|2017-09-01||||May 2020|Anticipated|2020-05-01||Interventional|||Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma|A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma|Recruiting||Phase 3|330|Anticipated|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 02:02:18.569198|2017-10-11 02:02:18.569198
NCT01781455|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-07-11|||February 2012||2012-02-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of BBI503 in Adult Patients With Advanced Solid Tumors|A Phase I Clinical Study of BBI503 in Adult Patients With Advanced Solid Tumors|Recruiting||Phase 1/Phase 2|350|Anticipated|Boston Biomedical, Inc||1|||f||||f||||||||||2017-10-11 02:02:21.879367|2017-10-11 02:02:21.879367
NCT01781442|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2013-04-30|||June 2013||2013-06-01|April 2013|2013-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||A Post Marketing Surveillance As Required By Philippine Food And Drug Administration|An Open Label, Non-interventional Study Of The Safety Of Temsirolimus Injection (Torisel) In The Treatment Of Advanced Renal Cell Carcinoma In Filipino Adult Patients: A Post Marketing Surveillance Study|Withdrawn||Phase 4|0|Actual|Pfizer|||1||f||||t||||||||||2017-10-11 02:02:23.294093|2017-10-11 02:02:23.294093
NCT01781429|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-01-04|||March 2013||2013-03-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies|Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies|Active, not recruiting||Phase 1/Phase 2|125|Anticipated|BioMed Valley Discoveries, Inc||1|||f||||t||||||||||2017-10-11 02:02:23.381644|2017-10-11 02:02:23.381644
NCT01781416|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-30|2014-05-19|||November 2013||2013-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|PERCEPTION||Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk|Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk|Completed||N/A|799|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:02:23.470554|2017-10-11 02:02:23.470554
NCT01781403|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-06-30|2016-05-17||May 2013||2013-05-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer|Preoperative Chemoradiation With Capecitabine Plus Temozolomide in Patients With Locally Advanced Resectable Rectal Cancer: Phase I Study|Active, not recruiting||Phase 1|22|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 02:02:23.575338|2017-10-11 02:02:23.575338
NCT01781390|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-09-14|||December 2012||2012-12-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|AMICI||Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in MyoCardial Infarction|A Prospective, DB, Randomized, Placebo-controlled Clinical Trial of IC Infusion of Mesenchymal Precursor Cells (MPC) in the Treatment of Patients With ST-elevation Myocardial Infarction|Active, not recruiting||Phase 2|105|Actual|Mesoblast, Ltd.||3|||f||||t||||||||||2017-10-11 02:02:23.923681|2017-10-11 02:02:23.923681
NCT01781377|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-12-15|||February 2008||2008-02-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Prophylactic Subhypnotic Propofol for Nausea and Vomiting During for Cesarean Section Under Subarachnoid Anesthesia.|Randomized Controlled Trial of Prophylactic Subhypnotic Propofol vs Metoclopramide and in Combination Therapy for the Prevention of Nausea and Vomiting During Subarachnoid Anesthesia for Cesarean Section.|Completed||Phase 4|112|Anticipated|G. d'Annunzio University||4|||f||||f||||||||||2017-10-11 02:02:24.008487|2017-10-11 02:02:24.008487
NCT01781364|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-12-15|||January 2012||2012-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Neuroplasticity-oriented Cognitive Intervention in Early Onset and First Admission Schizophrenia|Neuroplasticity-oriented Cognitive Intervention in Early Onset and First Admission Schizophrenia|Completed||N/A|20|Actual|University of Konstanz||1|||f||||t||||||||||2017-10-11 02:02:24.105388|2017-10-11 02:02:24.105388
NCT01781351|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-09-23|||March 2013||2013-03-01|September 2014|2014-09-01||||March 2015|Anticipated|2015-03-01||Interventional|||Neuromuscular Control of the Ankle With External Support||Unknown status|Active, not recruiting|N/A|50|Anticipated|University Hospital Heidelberg||1|||f||||f||||||||||2017-10-11 02:02:24.267889|2017-10-11 02:02:24.267889
NCT01781338|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-05-18|||May 2012||2012-05-01|May 2015|2015-05-01||||April 2020|Anticipated|2020-04-01||Interventional|ADAPT||Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer|Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer|Recruiting||Phase 2/Phase 3|4936|Anticipated|West German Study Group||1|||f||||t||||||||||2017-10-11 02:02:24.42437|2017-10-11 02:02:24.42437
NCT01781325|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-12-08|||January 2015||2015-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Patient Self Monitoring of Physical Therapy Exercise|Patient Self Monitoring to Transfer Physical Therapy Exercise From Clinic to Home|Withdrawn||N/A|0|Actual|University of Washington||2||Grant ended before study could be initiated|f||||f||||||||||2017-10-11 02:02:24.519771|2017-10-11 02:02:24.519771
NCT01781312|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-01-29|||January 2013||2013-01-01|January 2013|2013-01-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|||Probiotics in IgA Nephropathy|Proof-of-concept Study of Efficacy and Safety of Dietary Supplementation With Probiotics in IgAN Patients|Unknown status|Not yet recruiting|N/A|20|Anticipated|Uppsala University Hospital||2|||f||||f||||||||||2017-10-11 02:02:24.603532|2017-10-11 02:02:24.603532
NCT01780922|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-06-04|2014-04-22||July 2010||2010-07-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Effect of a Single Dose of Cranberry Beverage on Inflammation and Oxidative Stress|Acute Bioavailability of Cranberry Polyphenols After A Single Dose In Healthy Adults and Its Antioxidative and Anti-Inflammatory Action|Completed||N/A|12|Actual|Washington State University||3|||f||||f||||||||||2017-10-11 02:02:31.74272|2017-10-11 02:02:31.74272
NCT01781299|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-05-10|2017-01-27||September 2012||2012-09-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU|Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU|Completed||Phase 4|9|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:02:24.73304|2017-10-11 02:02:24.73304
NCT01781273|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-04-20|||February 2013||2013-02-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|OH-MedDrive||MedDrive's Responsiveness to Alcohol|MedDrive's Responsiveness to Different Blood Alcohol Concentrations and Concurrent Validity Against Performances on a Driving Simulator; a Phase I, Randomised, Double Blind, Placebo, Dose Response Validation Trial|Completed||N/A|21|Actual|University of Lausanne||4|||f||||f||||||||||2017-10-11 02:02:25.326373|2017-10-11 02:02:25.326373
NCT01781260|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-12-01|||May 2014||2014-05-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Observational|PLiF||Effect of Prone Position on Liver Blood Flow and Function|The Effect of Prone Positioning During Anaesthesia on Liver Blood Flow and Function|Recruiting||N/A|21|Anticipated|University of Nottingham|||1||f||||f||||||||||2017-10-11 02:02:25.452557|2017-10-11 02:02:25.452557
NCT01781247|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-01-06|||January 2013||2013-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MI-SPRINT||Myocardial Infarction - Stress Prevention Intervention|MI-SPRINT (Myocardial Infarction - Stress PRevention INTervention): A Randomized Controlled Minimal Early Behavioral Intervention Trial to Reduce the Development of Posttraumatic Stress Caused by Acute Myocardial Infarction|Terminated||N/A|190|Actual|University Hospital Inselspital, Berne||2||Population of eligible patients smaller than anticipated|f||||t||||||||||2017-10-11 02:02:25.549903|2017-10-11 02:02:25.549903
NCT01781234|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-07-27|||August 2013||2013-08-01|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome||Recruiting||Phase 2|70|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-10-11 02:02:25.662945|2017-10-11 02:02:25.662945
NCT01781221|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-29|||February 2013||2013-02-01|January 2013|2013-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Sinus Floor Elevation Using Separately Two Different Xenografts - A Prospective Randomized Clinical Trial||Not yet recruiting||N/A|44|Anticipated|University Hospital of Cologne||2|||f||||||||||||||2017-10-11 02:02:25.739009|2017-10-11 02:02:25.739009
NCT01781208|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-08-29|2016-04-26||November 2012||2012-11-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Children undergoing percutaneous core needle liver biopsy|Ultrasound Based Acoustic Radiation Force Impulse Imaging|Ultrasound Based Acoustic Radiation Force Impulse, Shear Wave Velocity Imaging in Pediatric Patients Undergoing Liver Biopsy|Completed||N/A|62|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-11 02:02:25.806066|2017-10-11 02:02:25.806066
NCT01781195|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-05-27|||February 2013||2013-02-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Observational|IMUTECT||Delayed CNI-based Immunosuppression With Advagraf After MELD-based Liver Transplantation|Effect of Delayed CNI-based Immunosuppression With Advagraf on Liver Function After MELD-based Liver Transplantation|Unknown status|Recruiting|N/A|50|Anticipated|Heidelberg University|||1||f||||f||||||Samples Without DNA|"     Blood: HLA-DR status   "|||2017-10-11 02:02:25.982376|2017-10-11 02:02:25.982376
NCT01781182|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-05-02|||February 2013|Actual|2013-02-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|||Infant Antibiotic Resistance and Implications for Therapeutic Decision-making|Infant Antibiotic Resistance and Implications for Therapeutic Decision-making|Completed||N/A|352|Actual|University Hospitals Cleveland Medical Center|||1||f||||f||||||Samples With DNA|"     specific cultured antibiotic resistant organisms of interest Stool specimens Stool DNA   "|||2017-10-11 02:02:26.062368|2017-10-11 02:02:26.062368
NCT01781169|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-09-27|2013-05-29||April 2011||2011-04-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Vitamin D Supplementation to Obese Chinese Males|Health Effect of Oral Vitamin D Supplementation on Obese Chinese Males|Completed||N/A|43|Actual|Shenzhen Center for Chronic Disease Control|The numbers of participants in both the obese group and normal-weight group were small.|2|||f||||t||||||||||2017-10-11 02:02:26.122673|2017-10-11 02:02:26.122673
NCT01781156|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2015-03-14|||August 2012||2012-08-01|November 2014|2014-11-01|June 2018|Anticipated|2018-06-01|February 2017|Anticipated|2017-02-01||Observational|||Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients|Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients|Recruiting||N/A|50|Anticipated|Shanghai 10th People's Hospital|||1||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 02:02:26.437173|2017-10-11 02:02:26.437173
NCT01781143|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-06-02|||January 2012||2012-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SOET||Self-operated Endo-vaginal Telemonitoring (SOET), an Economic and Patient-empowered Method for Ovarian Stimulation for In-vitro Fertilization (IVF)|Self-operated Endo-vaginal Telemonitoring (SOET), an Economic and Patient-empowered Method for Ovarian Stimulation for In-vitro Fertilization (IVF).|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 02:02:26.603147|2017-10-11 02:02:26.603147
NCT01781130|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-05-15|||January 2013||2013-01-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Steroid Injection Which is Added to Percutaneous Trigger Finger Release: a Double-blinded Randomized Controlled Trial.||Completed||N/A|112|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:02:26.704911|2017-10-11 02:02:26.704911
NCT01781117|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-02-12|||February 2013||2013-02-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia|Prognostic Value of the Urinary Nerve Growth Factor (NGF) in the Patients With Benign Prostatic Hyperplasia (BPH) Who Undergo Holmium Laser Enucleation of the Prostate (HoLEP)|Unknown status|Recruiting|N/A|130|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 02:02:26.785943|2017-10-11 02:02:26.785943
NCT01781104|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-09-21||2014-11-06|March 2013||2013-03-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation|A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of RM-131 Administered to Patients With Chronic Constipation|Completed||Phase 2|48|Actual|Motus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 02:02:26.890455|2017-10-11 02:02:26.890455
NCT01781091|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-05-11|||December 2012||2012-12-01|May 2017|2017-05-01|January 30, 2015|Actual|2015-01-30|December 2013|Actual|2013-12-01||Interventional|S4||S4 :Trial Of Fully Closed-Loop Ventilation In ICU.|S4 :RANDOMIZED CONTROLLED TRIAL OF FULLY CLOSED-LOOP VENTILATION IN ICU.|Completed||Phase 3|60|Actual|Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer||2|||f||||f||||||||||2017-10-11 02:02:26.977058|2017-10-11 02:02:26.977058
NCT01781078|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-04-07|2017-04-07||February 2013||2013-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|October 2014|Actual|2014-10-01||Interventional|SAMURAI||ImageReady(TM) MR Conditional Pacing System Clinical Study|ImageReady(TM) MR Conditional Pacing System Clinical Study|Active, not recruiting||N/A|363|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-11 02:02:27.083011|2017-10-11 02:02:27.083011
NCT01781065|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-07-12|||March 2008||2008-03-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|February 2009|Actual|2009-02-01||Interventional|||The Effects of Transcranial Direct Current Stimulation on Central Pain in Patients With Spinal Cord Injury|The Analgesic Effect of Transcranial Direct Current Stimulation Over the Primary Motor Cortex on Central Neuropathic Pain Patients With Spinal Cord Injury|Completed||Phase 2|16|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-10-11 02:02:28.218464|2017-10-11 02:02:28.218464
NCT01781052|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-02-09|||September 2013||2013-09-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Observational|DAILY||Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients|DAILY: Observational Description of Compliance for the Daily Ventavis® Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients|Completed||N/A|17|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:02:28.319833|2017-10-11 02:02:28.319833
NCT01781039|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-11-23|||January 2013||2013-01-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|January 2019|Anticipated|2019-01-01||Observational|||Investigation of Anatomical Correlates of Speech Discrimination||Recruiting||N/A|100|Anticipated|Steward St. Elizabeth's Medical Center of Boston, Inc.|||1||f||||t||||||||||2017-10-11 02:02:28.409284|2017-10-11 02:02:28.409284
NCT01781026|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-01-30|2015-03-10||April 2013||2013-04-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases|A Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases, Whose Tumors Harbor B-raf Mutations|Completed||Phase 2|2|Actual|Yale University||1|||f||||t||||||||||2017-10-11 02:02:28.50643|2017-10-11 02:02:28.50643
NCT01781013|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-12-03|||June 2010||2010-06-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|DCAT||Diabetes-Depression Care-management Adoption Trial|Care Management Technology to Facilitate Depression Care in Safety Net Diabetes Clinics|Completed||N/A|1485|Actual|University of Southern California||3|||f||||t||||||||||2017-10-11 02:02:28.66845|2017-10-11 02:02:28.66845
NCT01781000|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-11-03|||December 2011||2011-12-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Cerebral Reorganization in Schizophrenia|Training-induced Cerebral Reorganization in Schizophrenia|Completed||N/A|80|Actual|University of Konstanz||3|||f||||f||||||||||2017-10-11 02:02:28.811995|2017-10-11 02:02:28.811995
NCT01780987|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-05-16|2016-01-20||January 2013||2013-01-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||All participants including one participant who was assigned to the UFH/Warfarin group and withdrew from the study prior to receiving any study medication.|AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients|Active-control, Multicenter, Randomized, Open-label, Safety And Efficacy Study Evaluating The Use Of Apixaban In The Treatment Of Symptomatic Deep Vein Thrombosis And Pulmonary Embolism In Japanese|Completed||Phase 3|80|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 02:02:28.923051|2017-10-11 02:02:28.923051
NCT01780974|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-02-22|2016-12-20||April 2013||2013-04-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention|Pilot Study: Lipoic Acid and Omega-3 Fatty Acid for Alzheimer's Disease Prevention|Completed||Phase 1/Phase 2|42|Actual|Oregon Health and Science University|No Omega-3 only or lipoic acid only arm; not excluding over-the-counter medications and supplements|2|||f||||t||||||||Undecided||2017-10-11 02:02:29.70132|2017-10-11 02:02:29.70132
NCT01780961|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-29|||January 2011||2011-01-01|January 2013|2013-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01|5 Years|Observational [Patient Registry]|ESBX||Esophageal Cancer Tissue Banking|Prospective Collection of Health Information and Biospecimens in Esophageal Cancer|Unknown status|Recruiting|N/A|250|Anticipated|Washington University School of Medicine|||1||f||||f||||||Samples With DNA|"     peripheral blood and Esophageal Tissue   "|||2017-10-11 02:02:30.430192|2017-10-11 02:02:30.430192
NCT01780948|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-02-07|||September 2012||2012-09-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pharmacokinetic of Everolimus and Atorvastatin Co-administration|Drug Interaction and Pharmacokinetic Assessment of Everolimus When Coadministered With Atorvastatin in Renal Transplantation Recipient|Completed||N/A|18|Actual|Chulalongkorn University||2|||f||||f||||||||||2017-10-11 02:02:30.517142|2017-10-11 02:02:30.517142
NCT01780935|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-07-04|2016-07-08||June 3, 2013|Actual|2013-06-03|July 2017|2017-07-01|July 9, 2015|Actual|2015-07-09|July 9, 2015|Actual|2015-07-09||Interventional|OCTAVE||Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration|A 24-month, Phase IIIb, Randomized, Double-masked, Multicenter Study Assessing the Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration|Completed||Phase 3|671|Actual|Novartis|Use of optical coherence tomography guided therapy in the treatment of neovascular age related macular degeneration became standard of care by HA & Ophth. community during the time this trial was conducted.Novartis terminated this trial.|2|||f||||f|f|f||||||||2017-10-11 02:02:30.66869|2017-10-11 02:02:30.66869
NCT01780909|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-01-28|||February 2013||2013-02-01|January 2014|2014-01-01|December 2017|Anticipated|2017-12-01|December 2013|Actual|2013-12-01||Interventional|||The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit|The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit. Evaluatie Van de Gastrointestinale Transit Aan de Hand Van de Niet-absorbeerbare Merker Paromomycine Sulfaat (Dutch Translation)|Recruiting||N/A|10|Anticipated|Katholieke Universiteit Leuven||4|||f||||f||||||||||2017-10-11 02:02:32.69392|2017-10-11 02:02:32.69392
NCT01780896|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-30|||February 2013||2013-02-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Observational|||Relationship Between Vestibular Function and Topographic Memory|The Relationship Between Vestibular Function and Topographic Memory|Unknown status|Not yet recruiting|N/A|50|Anticipated|Biomedical Development Corporation|||1||f||||f||||||||||2017-10-11 02:02:32.913749|2017-10-11 02:02:32.913749
NCT01780883|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-09-04|||February 2013||2013-02-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|MELADOSE||Melatonin Dose-effect Relation in Childhood Autism|Melatonin Dose-effect Relation in Childhood Autism|Completed||Phase 2|34|Actual|Rennes University Hospital||4|||f||||t||||||||||2017-10-11 02:02:32.999699|2017-10-11 02:02:32.999699
NCT01780870|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-05-01|2017-01-06||September 2012||2012-09-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional||Due to enrolling problems, no subjects were enrolled to the control group. All the subjects were enrolled to the weight loss group|Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss|Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss|Completed||N/A|5|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||No||2017-10-11 02:02:33.119124|2017-10-11 02:02:33.119124
NCT01780857|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-07-09|||June 2013||2013-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|PPP||Immune Signature of Palmoplantar Pustulosis|The Immune Signature of Palmoplantar Pustulosis|Completed||N/A|30|Anticipated|Baylor Research Institute|||2||f||||||||||Samples With DNA|"     Blood and tissue samples. Blood from PPP patients. Skin biopsies from affected palms and     soles.   "|||2017-10-11 02:02:33.466588|2017-10-11 02:02:33.466588
NCT01780844|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-04-20||2016-08-16|March 5, 2013|Actual|2013-03-05|April 2017|2017-04-01|January 27, 2017|Actual|2017-01-27|June 30, 2014|Actual|2014-06-30||Interventional|||A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients|A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients|Completed||Phase 2|149|Actual|Astellas Pharma Inc||3|||f||||t||||||||Undecided||2017-10-11 02:02:33.574884|2017-10-11 02:02:33.574884
NCT01780831|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-08-21|||July 2013||2013-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection|A Phase I Trial to Evaluate the Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Neonates at Risk of Acquiring HIV-1 Infection|Recruiting||Phase 1|50|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 02:02:33.815124|2017-10-11 02:02:33.815124
NCT01780818|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-01-14|||March 2013||2013-03-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in CRC Screening|A Randomized, Controlled Trial Comparing Air Insufflation, Water Immersion and Water Exchange During on Demand Sedation Colonoscopy in CRC Screening Patients|Completed||N/A|288|Actual|Presidio Ospedaliero Santa Barbara||3|||f||||f||||||||||2017-10-11 02:02:34.11489|2017-10-11 02:02:34.11489
NCT01780805|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-04-25|||January 2013||2013-01-01|January 2016|2016-01-01|October 2016|Actual|2016-10-01|November 2015|Actual|2015-11-01||Observational|YANAS-2||Second Young Adult Naturalistic Alcohol Study|Second Young Adult Naturalistic Alcohol Study (YANAS-2)|Completed||N/A|69|Actual|Yale University|||1||f||||t||||||||||2017-10-11 02:02:34.795973|2017-10-11 02:02:34.795973
NCT01780792|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-04-05|||August 2011||2011-08-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|August 2015|Actual|2015-08-01||Interventional|||Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis|Examining the Effects of Dance, Dance Revolution on Mobility, Brain Plasticity and Cognition in Individuals With Multiple Sclerosis|Completed||N/A|30|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 02:02:34.905127|2017-10-11 02:02:34.905127
NCT01780779|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-28|||June 2009||2009-06-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Observational|FUBEO||Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults|Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults|Unknown status|Recruiting|N/A|25|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-11 02:02:35.081715|2017-10-11 02:02:35.081715
NCT01780766|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2013-01-28|||September 2008||2008-09-01|January 2013|2013-01-01|September 2014|Anticipated|2014-09-01|March 2013|Anticipated|2013-03-01||Observational|||Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging|Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI: What is the Added Value of Diffusion Weighted Imaging in Diagnosis and Follow-up|Unknown status|Recruiting|N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-11 02:02:35.253818|2017-10-11 02:02:35.253818
NCT01780753|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-02-12|||December 2012||2012-12-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Primaquine Pharmacokinetics in Lactating Women and Their Infants|A Study of the Pharmacokinetics of Primaquine in Lactating Women and Breastfed Infants for the Radical Treatment of Uncomplicated Maternal P. Vivax|Completed||Phase 1|20|Actual|University of Oxford||1|||f||||f||||||||||2017-10-11 02:02:35.360345|2017-10-11 02:02:35.360345
NCT01780740|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2014-08-06|||January 2012||2012-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|STARR||Statin Therapy In Atrial Refractoriness and Reperfusion Injury|Prevention of Atrial Oxidative Stress and Electrical Remodelling in Patients Undergoing Cardiac Surgery: Randomised Placebo-controlled Trial of Perioperative High-dose Atorvastatin|Completed||Phase 4|80|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 02:02:35.472026|2017-10-11 02:02:35.472026
NCT01780376|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-06-18|||January 2013||2013-01-01|June 2015|2015-06-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|LVIRMA||Latency of Vibration-Induced Reflex Muscle Activity|Latency of Whole-Body Vibration Induced Reflex Muscle Activity|Completed||N/A|20|Actual|Bagcilar Training and Research Hospital||1|||f||||f||||||||||2017-10-11 02:02:43.207283|2017-10-11 02:02:43.207283
NCT01780727|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-07-05|||September 2014||2014-09-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|May 2018|Anticipated|2018-05-01||Interventional|||Echo-guided Hemodynamic Management Strategy in Elderly Patients Undergoing Noncardiac Surgery|Echocardiography-guided Hemodynamic (EGHEM) Management Strategy to Improve Clinical Outcomes for Elderly Patients With Left Ventricular Diastolic Dysfunction (LVDD) Undergoing Non-cardiac Surgery|Recruiting||N/A|120|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-10-11 02:02:35.623035|2017-10-11 02:02:35.623035
NCT01780714|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-29|||June 2012||2012-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|ZRHX-EX-01||Exploratory THS 2.1 Biomarkers of Exposure Study|A Single-center, Open-label, Randomized, Controlled, 2-arm Parallel Group Study to Evaluate the Exposure to Selected Smoke Constituents in Smoking, But Otherwise Healthy Subjects Switching From Conventional Cigarettes to the Tobacco Heating System (THS) 2.1|Completed||N/A|42|Actual|Philip Morris Products S.A.||2|||f||||f||||||||||2017-10-11 02:02:35.727196|2017-10-11 02:02:35.727196
NCT01780701|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-04-25|||January 2013||2013-01-01|November 2016|2016-11-01|March 2017|Actual|2017-03-01|January 2016|Actual|2016-01-01||Observational|MRSI+RRP||Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer|Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer|Completed||N/A|66|Actual|OHSU Knight Cancer Institute|||2||f||||f||||||Samples Without DNA|"     Blood, Urine, Prostatic fluid and Prostatectomy tissue   "|||2017-10-11 02:02:35.886033|2017-10-11 02:02:35.886033
NCT01780688|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-06-18|||May 2012||2012-05-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Exploratory THS 2.1 Nicotine Pharmacokinetics and Safety Study|A Single-center, Open-label, Randomized, Controlled, Crossover Study to Explore the Nicotine Pharmacokinetic Profile and Safety of Tobacco Heating System (THS) 2.1 Compared to Conventional Cigarettes Following Single and ad Libitum Use in Smoking, But Otherwise Healthy Subjects.|Completed||N/A|190|Actual|Philip Morris Products S.A.||2|||f||||f||||||||||2017-10-11 02:02:36.012828|2017-10-11 02:02:36.012828
NCT01780675|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-09-26|||April 2013||2013-04-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|November 30, 2017|Anticipated|2017-11-30||Interventional|HA-PCI||Hippocampus Avoidance PCI vs PCI|Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance in SCLC a Randomized Phase III Trial|Recruiting||Phase 3|168|Anticipated|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-11 02:02:36.148596|2017-10-11 02:02:36.148596
NCT01780649|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-31|||October 2008||2008-10-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|PHRC-IMSI||Evaluation of IMSI to Treat Male Infertility|Evaluation of the Efficiency and Indications of IMSI in Comparison With ICSI in Case of Male Infertility|Completed||N/A|255|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 02:02:37.574779|2017-10-11 02:02:37.574779
NCT01780636|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-28|||January 2013||2013-01-01|January 2013|2013-01-01|July 2014|Anticipated|2014-07-01|January 2014|Anticipated|2014-01-01||Interventional|||Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome|Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|University of California, Irvine||1|||f||||t||||||||||2017-10-11 02:02:37.686996|2017-10-11 02:02:37.686996
NCT01780623|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-04-06|||January 2013||2013-01-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|LITE||An Investigation of Light Therapy for Cancer-related Fatigue (The LITE Study)|A Randomized Controlled Trial of Light Therapy on Biomarkers, Sleep/Wake Activity, and Quality of Life in Individuals With Post-treatment Cancer-related Fatigue|Completed||N/A|88|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 02:02:37.802464|2017-10-11 02:02:37.802464
NCT01780610|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-03-31|||January 2012||2012-01-01|March 2013|2013-03-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles|The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles|Unknown status|Recruiting|N/A|670|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 02:02:37.937563|2017-10-11 02:02:37.937563
NCT01780597|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-02-03|||February 2013||2013-02-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||Assessment of Hearts Deemed Unsuitable for Transplant With the Aim of Expanding the Donor Heart Pool.|Ex Vivo Assessment of Human Hearts Deemed Unsuitable for Cardiac Transplant With the Ultimate Aim of Increasing the Number of Hearts Available for Transplant for Cardiac Failure Patients.|Unknown status|Not yet recruiting|N/A|17|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f||||||Samples With DNA|"     Myocardial biopsies, serum samples.   "|||2017-10-11 02:02:38.046092|2017-10-11 02:02:38.046092
NCT01780584|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-02-02|2013-02-02||April 2010||2010-04-01|February 2013|2013-02-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional||One subject in in oral T3 low dose group with hypertension due to unrecognized coarctation and one subject in oral T3 high dose group with inability to attain enteral feeds were withdrawn from the treatment protocol. Therefore there were 43 subjects included in the final analysis.|Can Oral T3 Normalize Thyroid Hormone Levels Following Cardiopulmonary Bypass in Children?|Oral Triiodothyronine Normalizes T3 Levels After Surgery For Pediatric Congenital Heart Disease|Completed||Phase 2|45|Actual|National Cardiovascular Center Harapan Kita Hospital Indonesia|The lack of power to detect differences in clinical outcomes. There was also insufficient power to detect potentially subtle adverse effects of T3 supplementation.|3|||f||||t||||||||||2017-10-11 02:02:38.356522|2017-10-11 02:02:38.356522
NCT01780571|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2013-01-29|||May 2009||2009-05-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||CPAP/PSV Preoxygenation in Obese Patients|Continuous Positive Airway Pressure/Pressure Support Preoxygenation of Morbidly Obese Patients|Completed||N/A|44|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:02:39.171973|2017-10-11 02:02:39.171973
NCT01780558|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-03-31|||January 2010||2010-01-01|March 2013|2013-03-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||A Study:the Different Outcomes Between Natural Cycle and Hormone Replacement Cycle in FET|A Randomized Controlled Study:the Different Outcomes Between Natural Cycle and Hormon Replacement Cycle in FET|Unknown status|Recruiting|N/A|600|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 02:02:39.291266|2017-10-11 02:02:39.291266
NCT01780545|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-10-04|||April 2013||2013-04-01|October 2017|2017-10-01|October 2017|Actual|2017-10-01|October 2017|Actual|2017-10-01||Interventional|||Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer|The Borealis-2 Clinical Trial: A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination With OGX-427 in Patients With Relapsed or Refractory Metastatic Urothelial Carcinoma After Receiving a Platinum-containing Regimen: Hoosier Cancer Research Network GU12-160|Completed||Phase 2|200|Anticipated|Hoosier Cancer Research Network||2|||f||||t||||||||||2017-10-11 02:02:39.48444|2017-10-11 02:02:39.48444
NCT01780532|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-01-27|||September 2014||2014-09-01|January 2017|2017-01-01|March 2016|Anticipated|2016-03-01|September 2015|Anticipated|2015-09-01||Interventional|||Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study|Pilot Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study|Withdrawn||N/A|0|Actual|Stanford University||1||Insufficient resources|f||||t||||||||||2017-10-11 02:02:39.734877|2017-10-11 02:02:39.734877
NCT01780519|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-11-09|||January 2013||2013-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms|The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms|Completed||Phase 1|57|Actual|Mayo Clinic||5|||f||||f||||||||||2017-10-11 02:02:39.857005|2017-10-11 02:02:39.857005
NCT01780506|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-08-18|2015-12-04|2014-06-24|December 26, 2012|Actual|2012-12-26|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|August 26, 2014|Actual|2014-08-26||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug.|Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults|A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults|Active, not recruiting||Phase 3|872|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||t|t|f||||||||2017-10-11 02:02:40.089399|2017-10-11 02:02:40.089399
NCT01780493|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-30|||March 2004||2004-03-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|February 2008|Actual|2008-02-01||Interventional|||The Long Term Follow-Up Results Of The Direct Nipple Ureteroneocystostomy Technique|The Long Term Follow-Up Results Of The Direct Nipple Ureteroneocystostomy Technique: A Prospective Study|Completed||N/A|19|Actual|TC Erciyes University||1|||f||||||||||||||2017-10-11 02:02:42.280722|2017-10-11 02:02:42.280722
NCT01780480|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2014-12-16|||January 2013||2013-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Dynamic Combination Therapy on Chinese Herbal Granules to Improve the Symptoms in Convalescent Phase of Ischemic Stroke|Dynamic Combination Therapy on Chinese Herbal Granules Based on Differentiation of Syndrome (Zhenghou)of Traditional Chinese Medicine to Improve the Symptoms in the Convalescent Phase of Ischemic Stroke: a Pilot Study|Completed||N/A|120|Actual|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 02:02:42.35248|2017-10-11 02:02:42.35248
NCT01780467|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-01-29|||March 2013||2013-03-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients|Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients.|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:02:42.446279|2017-10-11 02:02:42.446279
NCT01780454|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-04-20|||March 2013||2013-03-01|April 2017|2017-04-01||||October 2018|Anticipated|2018-10-01||Interventional|||Renal Allograft Tolerance Through Mixed Chimerism|Renal Allograft Tolerance Through Mixed Chimerism|Active, not recruiting||Phase 1/Phase 2|2|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 02:02:42.542859|2017-10-11 02:02:42.542859
NCT01780441|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-01-27|||January 2013|Actual|2013-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Observational|||Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)|Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants With Tuberous Sclerosis Complex (TSC)|Active, not recruiting||N/A|166|Actual|Boston Children’s Hospital|||1||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-11 02:02:42.628335|2017-10-11 02:02:42.628335
NCT01780428|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-11-02||2016-11-02|January 2013||2013-01-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|October 2013|Actual|2013-10-01||Interventional|||Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain|A Double-Blind, Randomized, Placebo-Controlled, Multiple-dose Multi-Center Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain|Completed||Phase 3|460|Actual|Charleston Laboratories, Inc||3|||f||||||||||||||2017-10-11 02:02:42.708401|2017-10-11 02:02:42.708401
NCT01780415|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-01-30|||January 2013||2013-01-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Genomic DNA in Human Blastocoele Fluid||Active, not recruiting||N/A|35|Actual|Cervesi Hospital, Cattolica, Italy|||1||f||||t||||||||||2017-10-11 02:02:42.791714|2017-10-11 02:02:42.791714
NCT01780402|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-10-05|||March 2012||2012-03-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Comparison of Hand Feeding Techniques for Persons With Dementia|Comparison of Hand Feeding Techniques for Persons With Dementia Living in the Nursing Home|Completed||N/A|30|Actual|Duke University||1|||f||||t||||||||Undecided||2017-10-11 02:02:42.864557|2017-10-11 02:02:42.864557
NCT01780389|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2015-01-20|2013-06-18||October 2010||2010-10-01|January 2015|2015-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||5 patients enrolled, 4 completed, 1 terminated due to adverse event.|Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)|Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)|Completed||Phase 4|5|Actual|Duke University|Limitations include this was a small open label pilot study.|1|||f||||f||||||||||2017-10-11 02:02:42.975867|2017-10-11 02:02:42.975867
NCT01780337|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-06-21|2016-05-09||January 2013||2013-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Oxytocin Effects on Cardiac Electrophysiology|Pilot Study of Intranasal Oxytocin and Cardiac Electrophysiology in Humans|Completed||Early Phase 1|12|Actual|Columbia University||2|||f||||t||||||||No||2017-10-11 02:02:45.427523|2017-10-11 02:02:45.427523
NCT01780324|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-03-28|2015-11-25||January 2013||2013-01-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||Lidocaine Analgesia for Urethral Catheterization in Children|Randomized Clinical Trial of Lidocaine Analgesia for Urethral Catheterization in Children|Completed||N/A|80|Actual|Seattle Children's Hospital||2|||f||||f||||||||No||2017-10-11 02:02:45.667115|2017-10-11 02:02:45.667115
NCT01780311|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-30|||January 2013||2013-01-01|January 2013|2013-01-01||||January 2014|Anticipated|2014-01-01||Interventional|AVATAR||Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias||Unknown status|Recruiting|Phase 4|||Ospedale San Donato||2|||f||||f||||||||||2017-10-11 02:02:45.89433|2017-10-11 02:02:45.89433
NCT01780285|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2016-06-28|||June 2013||2013-06-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|January 2015|Actual|2015-01-01||Interventional|GIANT||Laparoscopic Repair of Giant Hiatal Hernias With Nitinol-framed Lightweight Polytetrafluoroethylene Mesh|Prospective Randomized Phase III Study of Laparoscopic Repair of Giant Hiatal Hernias With Nitinol-framed Lightweight Polytetrafluoroethylene Mesh|Active, not recruiting||Phase 3|50|Anticipated|Odessa National Medical University||2|||f||||f||||||||||2017-10-11 02:02:46.060764|2017-10-11 02:02:46.060764
NCT01780272|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-01-20|||January 2013||2013-01-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes|A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes|Completed||Phase 1|26|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:02:46.275972|2017-10-11 02:02:46.275972
NCT01780259|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-08-06|||December 2012||2012-12-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants|A Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Subjects|Completed||Phase 1|58|Actual|Janssen Research & Development, LLC||7|||f||||f||||||||||2017-10-11 02:02:46.360769|2017-10-11 02:02:46.360769
NCT01780246|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-03-30|||January 2013||2013-01-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1 (NCT01494701)|An Open-label Study to Assess the Safety and Tolerability of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1|Completed||Phase 1|18|Actual|Biogen||1|||t||||t||||||||||2017-10-11 02:02:46.463164|2017-10-11 02:02:46.463164
NCT01780233|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-01-28|||April 2007||2007-04-01|January 2013|2013-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)|A Single-dose Crossover Study of Fentanyl Sublingual Spray 400 Mcg Versus Actiq® 400 Mcg Versus Fentanyl Citrate Injection (iv) 100 Mcg Under Fasted Conditions|Completed||Phase 1|40|Actual|INSYS Therapeutics Inc||3|||f||||f||||||||||2017-10-11 02:02:46.565021|2017-10-11 02:02:46.565021
NCT01780220|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-29|||December 2012||2012-12-01|January 2013|2013-01-01|January 2018|Anticipated|2018-01-01|January 2015|Anticipated|2015-01-01||Interventional|CARLHA||Safety and Efficacy of Radiotherapy Combined With a 6-month LH-RH Agonist and Abiraterone Hormone Therapy Treatment in Biochemically-relapsing Prostate Cancer Following Surgery||Recruiting||Phase 1/Phase 2|43|Anticipated|UNICANCER||1|||f||||t||||||||||2017-10-11 02:02:46.676231|2017-10-11 02:02:46.676231
NCT01780207|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2014-12-29||||||December 2014|2014-12-01||||May 2014|Actual|2014-05-01||Interventional|||Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea|Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea|Completed||N/A|||University Hospital Inselspital, Berne||2|||f||||||||||||||2017-10-11 02:02:46.765449|2017-10-11 02:02:46.765449
NCT01780194|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-11-27|||December 2012||2012-12-01|November 2013|2013-11-01||||February 2013|Actual|2013-02-01||Observational|||Lumbar Fusion Compared With Conservative Treatment in Patients With Chronic Low Back Pain: a Meta-analysis||Completed||N/A|666|Actual|Turku University Hospital|||2||f||||||||||||||2017-10-11 02:02:46.836874|2017-10-11 02:02:46.836874
NCT01780181|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-10-14|||December 2012||2012-12-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Observational|||Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer|Randomized Double-blind Controlled Clinical Study of Chemotherapy Combined With or Without Traditional Chinese Medicine on Survival Affect of Elderly Patients With Advanced Non-small-cell Lung Cancer|Completed||N/A|82|Actual|Shanghai University of Traditional Chinese Medicine|||2||f||||f||||||||No||2017-10-11 02:02:46.890687|2017-10-11 02:02:46.890687
NCT01780168|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-08-08|||December 21, 2012||2012-12-21|August 4, 2017|2017-08-04|December 1, 2022|Anticipated|2022-12-01|December 1, 2017|Anticipated|2017-12-01||Observational|||The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism|The NIH Mini Study: Metabolism, Infection and Immunity in Inborn Errors of Metabolism|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:02:46.992268|2017-10-11 02:02:46.992268
NCT01780155|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-06-30|||November 15, 2012||2012-11-15|February 9, 2017|2017-02-09|July 15, 2018|Anticipated|2018-07-15|July 15, 2018|Anticipated|2018-07-15||Observational|||Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity|Candidate Genes Associated With Susceptibility to Bronchopulmonary Dysplasia and Retinopathy of Prematurity|Recruiting||N/A|3600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:02:47.095844|2017-10-11 02:02:47.095844
NCT01780142|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-10-03|||January 4, 2013||2013-01-04|September 28, 2017|2017-09-28|October 1, 2032|Anticipated|2032-10-01|October 1, 2032|Anticipated|2032-10-01||Observational|||Longitudinal Observational Study of Severe Asthma|Longitudinal Observational Study of Severe Asthma|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:02:47.178933|2017-10-11 02:02:47.178933
NCT01780129|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-29|||February 2013||2013-02-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|PIST||Polydatin Injectable (HW6) for Shock Treatment|A Randomized, Double-Blind, Placebo Controlled, Parallel Group Multi-Center Phase II Clinical Study to Evaluate the Efficacy and Safety of HW6 in the Treatment of Traumatic/Hemorrhagic Shock and Septic Shock|Unknown status|Not yet recruiting|Phase 2|240|Anticipated|Neptunus Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 02:02:47.254523|2017-10-11 02:02:47.254523
NCT01780116|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-02-17|||May 2013||2013-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness of Adherence Therapy for Schizophrenia|An Evaluation of the Effectiveness of Adherence Therapy for Schizophrenia: A Randomized Controlled Trial|Completed||Phase 1/Phase 2|134|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 02:02:47.345475|2017-10-11 02:02:47.345475
NCT01780103|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-01-29|||January 2013||2013-01-01|January 2013|2013-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Sonographic Follow up in Newborns Diagnosed With Prenatal Hydronephrosis|Sonographic Follow up in Newborns Diagnosed With Prenatal Hydronephrosis|Unknown status|Not yet recruiting|N/A|143|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 02:02:47.43246|2017-10-11 02:02:47.43246
NCT01780090|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-01-28|||September 2012||2012-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Handheld Technology for Speech Development in Students With Autism|Handheld Technology for Speech Development in Students With Autism Spectrum Disorders (ASDs)|Completed||N/A|40|Actual|Yale University||1|||f||||f||||||||||2017-10-11 02:02:47.48076|2017-10-11 02:02:47.48076
NCT01780077|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-12-02|||December 2012||2012-12-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109|A Phase 1 Single Center, Randomized, Double-Blind, Ascending, Multi-Dose, Within-Subject Controlled Study of RXI-109 for the Treatment of Incision Scars Made in the Abdominal Skin of Healthy Subjects|Completed||Phase 1|15|Actual|RXi Pharmaceuticals, Corp.||2|||f||||t||||||||||2017-10-11 02:02:47.553245|2017-10-11 02:02:47.553245
NCT01780064|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-07-28|||February 2013||2013-02-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|APAPI||Psychosocial Support to Facilitate the Return to Employment of Women With Breast Cancer|Active Early Individualized Psychosocial Accompaniment to Facilitate the Return to Employment of Women With Breast Cancer|Active, not recruiting||N/A|128|Actual|Centre Oscar Lambret||2|||f||||f||||||||No||2017-10-11 02:02:47.634176|2017-10-11 02:02:47.634176
NCT01780051|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2013-05-14|||March 2013||2013-03-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components|An Open-label, Randomized, Single-dose, 2-way Crossover Trial to Compare the Pharmacokinetics of Repaglinide2mg and MetforminHCl 500mg Complex to Combination Preparation of Repaglinide 2mg and MetforminHCl 500mg in Healthy Male Volunteers.|Completed||Phase 1|48|Actual|Dalim BioTech Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:02:47.7228|2017-10-11 02:02:47.7228
NCT01780038|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-28|||October 2012||2012-10-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Interventional|||Smokers' Response to Nicotine Dependence Genotyping|Smokers' Response to Nicotine Dependence Genotyping|Unknown status|Recruiting|N/A|150|Anticipated|University of Nebraska||2|||f||||f||||||||||2017-10-11 02:02:47.827946|2017-10-11 02:02:47.827946
NCT01780025|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-01-30|||April 2012||2012-04-01|January 2013|2013-01-01|October 2014|Anticipated|2014-10-01|May 2014|Anticipated|2014-05-01||Observational|||Objective Measures in Implantable Hearing Devices|Clinical Trial on Objective Measures in Implantable Hearing Devices for Subjects With Mixed Hearing Loss.|Unknown status|Enrolling by invitation|N/A|10|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 02:02:48.140604|2017-10-11 02:02:48.140604
NCT01780012|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-08-02|||March 2012||2012-03-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PREVOST||Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper Limb|Secondary Prevention of Osteoporosis in Women Over 50 Years Old After Low Intensity Fracture of the Upper Limb: Evaluation of an Intervention Focused on the Patient.|Completed||N/A|436|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:02:48.228643|2017-10-11 02:02:48.228643
NCT01779999|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-02-08|||June 2010||2010-06-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|October 2010|Actual|2010-10-01||Observational|||Early Detection of PICC-related Deep Vein Thrombosis by US Surveillance: an Effective Approach for Secondary Prevention?|Observational Study With Ultrasonographic Screening for Early Detection of PICC-related DVT, Results of Early Beginning of Anticoagulant Treatment|Completed||N/A|150|Actual|University of Turin, Italy|||1||f||||f||||||||||2017-10-11 02:02:48.327924|2017-10-11 02:02:48.327924
NCT01779986|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-01-29|||January 2013||2013-01-01|January 2013|2013-01-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|CTAS-MCAS||Comparison of the Evaluation of CAD by CT AngioScan and Coronary Angiogram|Comparison of the Evaluation of CAD by CT AngioScan and Coronary Angiogram in Patient as Part of Preoperative Evaluation in Ascending Aorta Replacement Surgery Patients.|Unknown status|Recruiting|N/A|100|Anticipated|Université de Sherbrooke|||1||f||||f||||||||||2017-10-11 02:02:48.413005|2017-10-11 02:02:48.413005
NCT01779960|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-06-09|||January 2013||2013-01-01|June 2015|2015-06-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01|6 Months|Observational [Patient Registry]|||Summer-Winter Variability in the Level of Physical Activity in Daily Life in Brazilian and Belgian Patients With COPD|Understanding in Depth the Physical Inactivity of Patients With COPD: Comparison of the Summer-Winter Variability in the Level of Physical Activity in Daily Life in Brazilian and Belgian Patients|Unknown status|Recruiting|N/A|40|Anticipated|Universidade Estadual de Londrina|||2||f||||f||||||||||2017-10-11 02:02:48.590369|2017-10-11 02:02:48.590369
NCT01779947|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-06-25||2014-06-25|March 2012||2012-03-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo|An Investigator-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, USP 10 mcg and Vagifem® (Estradiol Vaginal Tablets) 10 mcg and Compare Both Active Treatments to a Placebo Control in Female Subjects With Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy Associated With Menopause|Completed||Phase 3|519|Actual|Amneal Pharmaceuticals, LLC||3|||f||||f||||||||||2017-10-11 02:02:48.738993|2017-10-11 02:02:48.738993
NCT01779921|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-01-11|||October 2005||2005-10-01|January 2017|2017-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|F7CONDEF||Treatment of Congenital Factor VII Deficiency|Treatment of Congenital Factor VII Deficiency. A Prospective Observational Study|Completed||N/A|163|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples Without DNA|"     Plasma for assaying of inhibiting antibodies to FVII. All samples, which are analysed at the     local hospital laboratory, are to be stored and destroyed according to local rules. Inhibitor     samples analysed at the central laboratory will be stored until data validation has taken     place at the end of the study after which the samples will be destroyed.   "|||2017-10-11 02:02:48.929499|2017-10-11 02:02:48.929499
NCT01779908|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-02-02|||January 2013||2013-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|VIDIR||Role of Vitamin D in the Prevention and Treatment of Diseases Associated With Insulin Resistance|Role of Vitamin D in the Prevention and Treatment of Diseases Associated With Insulin Resistance|Active, not recruiting||N/A|130|Anticipated|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 02:02:49.120854|2017-10-11 02:02:49.120854
NCT01779895|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-04-08|||December 2012||2012-12-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|||Probiotic Administration and Perennial Allergic Rhinitis|Effect of Probiotic Lactobacillus Paracasei NCC2461 on House Dust Mite Allergy|Completed||N/A|64|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-11 02:02:49.261458|2017-10-11 02:02:49.261458
NCT01779882|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-08-02|||January 2013||2013-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT|Cyclophosphamide-Busulfan Versus Busulfan-Cyclophosphamide as Conditioning Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia: a Prospective Randomized Study to Assess Liver Toxicity|Recruiting||N/A|65|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 02:02:49.360169|2017-10-11 02:02:49.360169
NCT01779869|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-05-10|||January 2013||2013-01-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PET/MR-P||Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson|Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson|Completed||Phase 4|16|Actual|Washington University School of Medicine||1|||f||||f||||||||No|Analyzed data will be shared with other researchers after publication of manuscript.|2017-10-11 02:02:49.55111|2017-10-11 02:02:49.55111
NCT01779856|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2015-09-09|||January 2013||2013-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|MiD||Study the Characteristics of Cardiac Related Events in Hemodialysis Patients|Monitoring in Dialysis|Completed||N/A|81|Actual|Medtronic Corporate Technologies and New Ventures||1|||f||||t||||||||||2017-10-11 02:02:49.669239|2017-10-11 02:02:49.669239
NCT01779843|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-02-15|||April 2013||2013-04-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01||Interventional|||Alisertib for Acute Myeloid Leukemia|A Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With 7+3 Induction Chemotherapy in Patients With Acute Myeloid Leukemia|Completed||Phase 1|22|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:02:49.778536|2017-10-11 02:02:49.778536
NCT01779830|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-28|||May 2008||2008-05-01|January 2013|2013-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study of LY2624803 in Participants With Transient Insomnia|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Crossover Study of Single Doses of LY2624803 in a 5-hour Phase Advance Model of Transient Insomnia in Healthy Subjects|Completed||Phase 1|32|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 02:02:49.878701|2017-10-11 02:02:49.878701
NCT01779817|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-04-17|||February 2013||2013-02-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|EDIEMHYPER||Assessment of Intellectual, Psychological and Behavioural Developments Between 6 and 9 Years of the Children Born to Hyperthyroid Mothers During Their Pregnancy|Assessment of Intellectual, Psychological and Behavioural Developments Between 6 and 9 Years of the Children Born to Hyperthyroid Mothers During Pregnancy|Unknown status|Recruiting|Phase 4|252|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-11 02:02:49.973384|2017-10-11 02:02:49.973384
NCT01779804|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-09-07|||January 2013||2013-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Observational|OFAR||Triage-Based Application of OFAR on the Number of Radiographs Ordered|The Effect of Triage-Based Application of the Ottawa Ankle and Foot Rules (OAR/OFR) on the Number of Radiographs Ordered: A Pilot Study|Completed||N/A|60|Actual|Lehigh Valley Hospital|||1||f||||t||||||||No|No plan to share IPD, just publish the study results.|2017-10-11 02:02:50.097801|2017-10-11 02:02:50.097801
NCT01779791|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-07-14|||April 17, 2013|Actual|2013-04-17|July 2017|2017-07-01|May 18, 2016|Actual|2016-05-18|May 18, 2016|Actual|2016-05-18||Interventional|||A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma|An Open-Label, Multicenter, Single-Arm, Phase 2 Study of PCI-32765 (Ibrutinib) in Subjects With Refractory Follicular Lymphoma|Completed||Phase 2|110|Actual|Janssen Research & Development, LLC||1|||f||||t|t|f||||||||2017-10-11 02:02:50.187097|2017-10-11 02:02:50.187097
NCT01777880|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-06-30|||October 2013||2013-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:03:16.720239|2017-10-11 02:03:16.720239
NCT01779778|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-07-29|||April 2012||2012-04-01|July 2016|2016-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure|The Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure|Completed||N/A|40|Actual|University of Colorado, Denver|||1||f||||f||||||||No||2017-10-11 02:02:50.387922|2017-10-11 02:02:50.387922
NCT01779765|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-03-26|||January 2013||2013-01-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS)|The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome- a Double Blind, Placebo - Controlled, Randomized Study|Unknown status|Recruiting|Phase 4|130|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 02:02:50.454722|2017-10-11 02:02:50.454722
NCT01779752|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-01-28|||January 2013||2013-01-01|January 2013|2013-01-01||||January 2016|Anticipated|2016-01-01||Observational|CoVest||Vestibular Cortex and TMS|Functional Organisation of the Vestibular Cortical Pathways in Human: Transcranial Magnetic Stimulation (TMS) Approach|Unknown status|Not yet recruiting|N/A|40|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-10-11 02:02:50.535897|2017-10-11 02:02:50.535897
NCT01779739|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-04-03|||July 2012||2012-07-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|February 2017|Actual|2017-02-01||Interventional|FaVR||Evaluating Sexual Function After Vaginal Repair With Perineorrhaphy|Evaluating Sexual Function After Vaginal Repair With Perineorrhaphy|Active, not recruiting||N/A|66|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 02:02:50.590361|2017-10-11 02:02:50.590361
NCT01779726|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-12-02|||January 2012||2012-01-01|August 2013|2013-08-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional|||Efficiency of Diagnostic Strategy for Fast Track Lung Cancer Diagnosis|Efficiency of Diagnostic Strategy for Fast Track Lung Cancer Diagnosis. A Randomised Controlled Trial.|Completed||N/A|331|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:02:50.793519|2017-10-11 02:02:50.793519
NCT01779713|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-04-24|||January 2013||2013-01-01|January 2013|2013-01-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage|Discovery of the Risk Factors Associated to the Development of Vasospasm Following a Sub-arachnoid Aneurismal Hemorrhage Via Genomic Studies Including Genetic and Transcriptomic|Recruiting||N/A|200|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:02:50.883219|2017-10-11 02:02:50.883219
NCT01779687|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-06-12|||March 2013||2013-03-01|June 2015|2015-06-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|AVIATOR||Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.|Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin (AVIATOR).|Completed||Phase 1|24|Actual|Radboud University||3|||f||||f||||||||||2017-10-11 02:02:51.065277|2017-10-11 02:02:51.065277
NCT01779674|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-01-07|||August 2011||2011-08-01|January 2014|2014-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Atrial Fibrillation/Sinus Rhythm Before and After Cardioversion||Completed||N/A|25|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 02:02:51.162137|2017-10-11 02:02:51.162137
NCT01779661|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2014-02-12|||April 2013||2013-04-01|February 2014|2014-02-01||||August 2015|Anticipated|2015-08-01||Interventional|IA-NPI||Infant Aquatics Neurodevelopment Premature Infants|The Effect of Infant Aquatics for Neurodevelopment of Premature Infants|Unknown status|Recruiting|N/A|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:02:51.221498|2017-10-11 02:02:51.221498
NCT01779648|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2013-04-24|2013-02-23||March 2012||2012-03-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis|The Influence of the Different Ways of Pneumatic Compression on Clinical and Physiologic Efficacies in Preventing Deep Vein Thrombosis: a Randomised Comparative Study|Completed||N/A|54|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:02:51.340989|2017-10-11 02:02:51.340989
NCT01779635|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2017-05-25|||August 2013|Actual|2013-08-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CARROM||Efficacy and Safety of Heparin-grafted Membrane for CRRT|Continuous Renal Replacement Therapy With Anticoagulation-free Regimen in Bleeding-risk Patients Using oXiris Membrane - CARROM Study|Completed||N/A|20|Actual|National University Hospital, Singapore||2|||f||||t||||||||No||2017-10-11 02:02:51.961093|2017-10-11 02:02:51.961093
NCT01779622|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-27|2014-09-29|||June 2013||2013-06-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers|Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin|Completed||N/A|24|Actual|Lund University||1|||f||||t||||||||||2017-10-11 02:02:52.061088|2017-10-11 02:02:52.061088
NCT01779609|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-05-04|||April 2010||2010-04-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||ET-blockade and Exercise-induced Vascular Adaptations in T2DM|Effect of a Dual ET(Endothelin)-Blocker on Exercise Induced Vascular Adaptations in Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 4|19|Actual|Radboud University||3|||f||||f||||||||||2017-10-11 02:02:52.139276|2017-10-11 02:02:52.139276
NCT01779596|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-05-03|||May 2011||2011-05-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||ET-blockade and Exercise Induced Blood Flow in T2DM|Effect of a Dual ET-blocker on Exercise Induced Blood Flow and Endothelial Function in T2DM|Completed||Phase 4|22|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 02:02:52.230661|2017-10-11 02:02:52.230661
NCT01779583|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2015-03-24|||January 2013||2013-01-01|March 2015|2015-03-01||||January 2016|Anticipated|2016-01-01||Observational|EXO-PPP||"Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients (EXO-PPP Study)"|"Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients: A Prospective Observational Study (EXO-PPP Study)"|Unknown status|Recruiting|N/A|80|Anticipated|Hospital Miguel Servet|||2||f||||f||||||Samples With DNA|"     -  Serum        -  Tumor tissue   "|||2017-10-11 02:02:52.318127|2017-10-11 02:02:52.318127
NCT01779570|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2016-07-25|||February 2013||2013-02-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections|Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections|Completed||Phase 4|68|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:02:52.429408|2017-10-11 02:02:52.429408
NCT01779557|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-29|2017-06-13|||February 2013||2013-02-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|SEED||Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate|The Prospective, Randomized, Parallel, Controlled, Multi-center Clinical Study of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate|Recruiting||Phase 4|750|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 02:02:52.540434|2017-10-11 02:02:52.540434
NCT01779544|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-02-22|||January 2013||2013-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Rehabilitation After Lumbar Disc Surgery: Exercise Therapy and Brief Educational Intervention|Rehabilitation After Lumbar Surgery|Active, not recruiting||N/A|80|Anticipated|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 02:02:52.663365|2017-10-11 02:02:52.663365
NCT01779531|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-01-28|||January 2013||2013-01-01|January 2013|2013-01-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Observational|||Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients|A Phase III，Randomized ，Multi-center Clinical Trail to Compare the Outcomes of XT and XEC Adjuvant Chemotherapy Protocol in HER-negative Luminal B Breast Cancer Patients Who Reached Pathologic Response After XT Neoadjuvant Chemotherapy|Unknown status|Not yet recruiting|N/A|640|Anticipated|Guangdong Academy of Medical Sciences|||1||f||||t||||||Samples Without DNA|"     tissue，whole blood   "|||2017-10-11 02:02:52.748833|2017-10-11 02:02:52.748833
NCT01779518|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2014-01-15||||||January 2014|2014-01-01||||||||Expanded Access|||Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C|An Expanded Access Phase 2 Study of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon for 24 Weeks in Subjects Who Have Undergone Liver Transplantation and Who Have Aggressive, Recurrent Hepatitis C Infection|Approved for marketing||N/A|||Gilead Sciences|||||||||||||||||||2017-10-11 02:02:52.852751|2017-10-11 02:02:52.852751
NCT01779505|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2014-01-06|||January 2013||2013-01-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults|A Randomized, Open-Label, Multi-Arm, Dose Escalation, Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GI-13020; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing Hepatitis B Virus X, Surface and Core Antigens, at Various Dose Levels and Regimens in Healthy Adults.|Completed||Phase 1|60|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-11 02:02:52.952695|2017-10-11 02:02:52.952695
NCT01779492|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-11-11|||April 2013||2013-04-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers|A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers|Completed||Phase 1|24|Actual|GL Pharm Tech Corporation||2|||f||||f||||||||||2017-10-11 02:02:53.04539|2017-10-11 02:02:53.04539
NCT01779479|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-07-31|||February 2013||2013-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)|Randomized, Open-label, Phase II Study Comparing the Efficacy and the Safety of Cabazitaxel Versus Weekly Paclitaxel Given as Neo-adjuvant Treatment in Patients With Operable Triple Negative or Luminal B/HER2 Normal Breast Cancer (GENEVIEVE)|Completed||Phase 2|333|Actual|German Breast Group||2|||f||||t||||||||||2017-10-11 02:02:53.165683|2017-10-11 02:02:53.165683
NCT01779466|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-04-24|||April 2013||2013-04-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DAISS||Daytime Impact Sleep Study|A Double-blind, Randomised, Parallel-group Trial Investigating Sleep Behaviour and Daytime Performance in Nocturia Patients Treated With Desmopressin Orally Disintegrating Tablets as Compared to Placebo|Terminated||Phase 2|5|Actual|Ferring Pharmaceuticals||3||Terminated due to lack of eligible patients|f||||f||||||||||2017-10-11 02:02:53.303802|2017-10-11 02:02:53.303802
NCT01779453|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-08-27||2015-08-13|December 2012||2012-12-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia|A Placebo-Controlled, Randomized, Double-Blind, Parallel Group, Drug Interaction Study to Evaluate the Safety, Tolerability and Effect on Atorvastatin Pharmacokinetics of ETC-1002 Added to Atorvastatin 10 mg/Day in Subjects With Hypercholesterolemia|Completed||Phase 2|58|Actual|Esperion Therapeutics||2|||f||||f||||||||||2017-10-11 02:02:53.408825|2017-10-11 02:02:53.408825
NCT01779440|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-08-17|||January 2013||2013-01-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|April 2015|Actual|2015-04-01||Interventional|||Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness|Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness|Unknown status|Active, not recruiting|N/A|110|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 02:02:53.506825|2017-10-11 02:02:53.506825
NCT01779427|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-03-07|||January 2013||2013-01-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|AIM||Attention Intervention Management|Rehabilitation Research and Training Center for Traumatic Brain Injury Interventions--Attention Intervention Management|Withdrawn||N/A|0|Actual|Children's Hospital Medical Center, Cincinnati||2||"Based on data from pilot study, the PI and program officer have determined that this study was   not feasible."|f||||f||||||||||2017-10-11 02:02:53.618791|2017-10-11 02:02:53.618791
NCT01779414|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-07-28|||February 2013||2013-02-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|STAT-ED||STAT-ED: Suicidal Teens Accessing Treatment After an Emergency Department Visit|STAT-ED: Suicidal Teens Accessing Treatment After an Emergency Department Visit|Completed||N/A|169|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 02:02:53.71228|2017-10-11 02:02:53.71228
NCT00000122|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||September 1985||1985-09-01|September 2009|2009-09-01|June 1988|Actual|1988-06-01|||||Interventional|||Fluorouracil Filtering Surgery Study (FFSS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.088988|2017-10-11 04:17:30.088988
NCT01779401|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-07-18|||September 2012||2012-09-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|CREATIVE||Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients|Investigator Initiated Prospective Study to Investigate the Best Anti-platelet Treatment in High Thrombotic Risk PCI Patients.|Completed||N/A|1078|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||3|||f||||t||||||||||2017-10-11 02:02:53.800652|2017-10-11 02:02:53.800652
NCT01779388|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-08-09|||January 2013||2013-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary Nodules|Role of Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary Nodules of Indeterminate Nature. A Prospective Study by the European Lung Cancer Working Party.|Recruiting||Phase 2|120|Anticipated|European Lung Cancer Working Party||2|||f||||f||||||||Undecided||2017-10-11 02:02:53.906319|2017-10-11 02:02:53.906319
NCT01779375|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-09-26|||June 2013|Actual|2013-06-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|July 2017|Actual|2017-07-01||Interventional|RISE Peds||RISE Pediatric Medication Study|Restoring Insulin Secretion Pediatric Medication Study|Active, not recruiting||Phase 3|91|Actual|RISE Study Group||2|||f||||t|t|f|||t|||||2017-10-11 02:02:54.024001|2017-10-11 02:02:54.024001
NCT01779362|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2017-04-03|||April 2013||2013-04-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|November 2017|Anticipated|2017-11-01||Interventional|RISE Adult||RISE Adult Medication Study|Restoring Insulin Secretion Adult Medication Study|Recruiting||Phase 3|255|Anticipated|RISE Study Group||4|||f||||t||||||||Yes|A de-identified dataset will be made available through the NIDDK repository within 2 years after the final participant visit. Data can be obtained from the NIDDK repository.|2017-10-11 02:02:54.382922|2017-10-11 02:02:54.382922
NCT01779349|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-10-30|||July 2013||2013-07-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||"Bladder Outlet Obstruction Observation Using Dynamic Urine Vibration Holter"|"Bladder Outlet Obstruction Observation Using Dynamic Urine Vibration Holter With Correlation to Pressure Flow Study and Uroflowmetry."|Suspended||N/A|45|Anticipated|P. Square Medical Ltd||1||sensor calibration and other R&D activities|f||||t||||||||||2017-10-11 02:02:54.550331|2017-10-11 02:02:54.550331
NCT01779336|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-09-26|||December 2012||2012-12-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors|An Open Label Multicentre Phase 1 Study of Oral IGF-1R Inhibitor PL225B in Subjects With Advanced Refractory Solid Tumors.|Suspended||Phase 1|70|Anticipated|Piramal Enterprises Limited||1||Sponsor decision not related to patient safety|f||||f||||||||||2017-10-11 02:02:54.640596|2017-10-11 02:02:54.640596
NCT01779323|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-11-04|||March 2012||2012-03-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling|Prospective Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling|Completed||N/A|34|Actual|Duke University|||1||f||||f||||||||||2017-10-11 02:02:54.751518|2017-10-11 02:02:54.751518
NCT01779310|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-07-22|||November 2012||2012-11-01|July 2017|2017-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01|2 Months|Observational [Patient Registry]|||Clinical Pathway for Alzheimer's Disease in China (CPAD)|Clinical Pathway for Alzheimer's Disease in China (CPAD): A 8-week Multi-center Registry Study to Investigate AD Diagnostic Pattern in Chinese Local Real Clinical Practice|Completed||N/A|1024|Actual|Peking University|||1||f||||t||||||||||2017-10-11 02:02:54.851223|2017-10-11 02:02:54.851223
NCT01779297|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-28|||October 2007||2007-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|January 2008|Actual|2008-01-01||Observational|NIWIs||New Integrated Weaning Indexes|New Integrated Weaning Indexes From Mechanical Ventilation: A Prospective Clinical Trial|Completed||N/A|1175|Actual|Baqiyatallah Medical Sciences University|||1||f||||t||||||||||2017-10-11 02:02:55.022107|2017-10-11 02:02:55.022107
NCT01779284|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-05-09|||January 2012||2012-01-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy|24-Hour Efficacy of Travoprost/Timolol Benzalkonium Chloride BAK Free Compared With Latanoprost/Timolol Fixed Combination Therapy in Subjects With Open-Angle Glaucoma Insufficiently Controlled With Latanoprost Monotherapy|Completed||Phase 4|42|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-11 02:02:55.104335|2017-10-11 02:02:55.104335
NCT01779271|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-10-07|||January 2013||2013-01-01|October 2016|2016-10-01||||March 2016|Actual|2016-03-01||Interventional|||Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection||Completed||Phase 3|183|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 02:02:55.2179|2017-10-11 02:02:55.2179
NCT01779258|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-02-18|||February 2013||2013-02-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Emollients in the Management of Atopic Dermatitis|Emollients in the Management of Atopic Dermatitis in Children: Prevention of Flares.|Completed||Phase 3|347|Actual|Pierre Fabre Medicament||3|||f||||f||||||||||2017-10-11 02:02:55.340127|2017-10-11 02:02:55.340127
NCT01779245|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-09-04|||October 2012||2012-10-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effect of High-calcium Intake on Substrate Metabolism During Exercise|The Impact of a Calcium Supplementation on Lipid Metabolism During Exercise.|Completed||N/A|13|Actual|Northumbria University||2|||f||||f||||||||||2017-10-11 02:02:55.494358|2017-10-11 02:02:55.494358
NCT01779232|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-04-25|||October 2012||2012-10-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Danazol Treatment in Endometriosis Women Before IVF|Treatment With Danazol Before Controlled Ovarian Hyperstimulation in Women With Endometriosis Undergoing IVF|Completed||Phase 4|150|Actual|Centre for Endocrinology and Reproductive Medicine, Italy||2|||f||||t||||||||||2017-10-11 02:02:55.602923|2017-10-11 02:02:55.602923
NCT01779219|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-01-17|2015-06-03||June 2009||2009-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Intraoperative MRI-guidance in Frameless Stereotactic Biopsies|The Safety and Effectiveness of Low Field Intraoperative MRI-guidance in Frameless Stereotactic Biopsies of Brain Tumours - a Prospective Randomized Trial|Terminated||N/A|42|Actual|Wroclaw Medical University||2||Primary investigator has changed his employee and the country of residence.|f||||f||||||||||2017-10-11 02:02:55.712187|2017-10-11 02:02:55.712187
NCT01779206|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-05-18|||May 2012||2012-05-01|May 2015|2015-05-01||||August 2015|Anticipated|2015-08-01||Interventional|ADAPT||ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer|Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer|Unknown status|Recruiting|Phase 2/Phase 3|4936|Anticipated|West German Study Group||2|||f||||t||||||||||2017-10-11 02:02:56.351973|2017-10-11 02:02:56.351973
NCT01779193|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2015-04-26|||June 2012||2012-06-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Probiotics Capsule as Supplemental Therapy for Group B Streptococci Infection and Vaginitis During Pregnancy|A Double-blind,Randomized,Parallel,Placebo-controlled Study of Probiotics Capsule as Supplemental Therapy for Group B Streptococci Infection and Vaginitis During Pregnancy|Unknown status|Recruiting|Phase 4|200|Anticipated|National Cheng-Kung University Hospital||3|||f||||t||||||||||2017-10-11 02:02:56.472334|2017-10-11 02:02:56.472334
NCT01779180|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-11-14|||January 2013||2013-01-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|November 2013|Actual|2013-11-01||Observational|||Vitamin A Supplementation at Birth and Atopy in Childhood|The Effect of Vitamin A Supplementation at Birth on the Development of Atopy in Childhood: Long-term Follow-up of a Randomised Placebo-controlled Trial|Unknown status|Active, not recruiting|N/A|2000|Anticipated|Bandim Health Project|||1||f||||f||||||||||2017-10-11 02:02:56.600776|2017-10-11 02:02:56.600776
NCT01779167|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-04-25|2017-02-23||June 2012||2012-06-01|April 2017|2017-04-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|THRiL for WM||Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia|A Phase 2 Trial of Daily Alternating Thalidomide and Lenalidomide Plus Rituximab (ThRiL) for Patients With Previously Treated Waldenstrom Macroglobulinemia|Terminated||Phase 2|4|Actual|Weill Medical College of Cornell University||1||Slow Accrual|f||||t||||||||||2017-10-11 02:02:56.713875|2017-10-11 02:02:56.713875
NCT01779154|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2016-06-16|||January 2013||2013-01-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01|21 Years|Observational [Patient Registry]|||Eosinophilic Gastrointestinal Disorders Patient Registry|Eosinophilic Gastrointestinal Disorders Patient Registry|Withdrawn||N/A|0|Actual|Arkansas Children's Hospital Research Institute|||1|funding not available|f||||f||||||||||2017-10-11 02:02:56.961744|2017-10-11 02:02:56.961744
NCT01779141|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2014-10-15|||May 2013||2013-05-01|October 2014|2014-10-01|May 2017|Anticipated|2017-05-01|February 2017|Anticipated|2017-02-01|22 Months|Observational [Patient Registry]|||Orchestra Pregnancy Observational Study in Poland|A Multi-center Observational Study During Pregnancy for Women With T1DM Treated With the Paradigm Insulin Pumps Donated by the 'Wielka Orkiestra Świątecznej Pomocy' Foundation in Poland|Unknown status|Recruiting|N/A|350|Anticipated|Medtronic Poland Spółka z ograniczoną odpowiedzialnością|||1||f||||f||||||None Retained|"     Whole blood, serum, urine samples as required in routine practice before, during and after     pregnancy in women with Type 1 Diabetes Mellitus   "|||2017-10-11 02:02:57.050449|2017-10-11 02:02:57.050449
NCT01779128|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-01-28|||March 2013||2013-03-01|January 2013|2013-01-01||||March 2015|Anticipated|2015-03-01||Interventional|||PET-CT vs. Integrated MR-PET Scanning of GYN Cancers|Comparing Preoperative PET-CT With Integrated MR-PET Scanning of Gynecologic Cancers|Unknown status|Not yet recruiting|Early Phase 1|100|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:02:57.278687|2017-10-11 02:02:57.278687
NCT01779115|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-01-30|||January 1998||1998-01-01|January 2013|2013-01-01||||December 2100|Anticipated|2100-12-01|1 Month|Observational [Patient Registry]|||Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel|Computerized Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel|Enrolling by invitation||N/A|126000|Anticipated|Maccabi Healthcare Services, Israel|||1||f||||t||||||||||2017-10-11 02:02:57.388335|2017-10-11 02:02:57.388335
NCT01779102|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-04-16|||October 2013||2013-10-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|TESEC-07||Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses|A Phase II/III Trial Investigating if Concomitant Injections of the Diagnostic Agents C-Tb and 2 T.U Tuberculin PPD RT 23 SSI Affect the Induration Responses in Combination With a Safety Assessment of C-Tb|Completed||Phase 2/Phase 3|456|Actual|Statens Serum Institut||3|||f||||t||||||||||2017-10-11 02:02:57.47214|2017-10-11 02:02:57.47214
NCT01779076|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-28|2013-06-24|||February 2013||2013-02-01|June 2013|2013-06-01||||June 2013|Actual|2013-06-01||Interventional|||Oxygen Level and Safe Emergence From Anesthesia|Emergence From General Anesthesia With Laryngeal Mask Airway and Increased End-expiratory Pressure Using 30% Oxygen is as Safe as With 100% Oxygen But Reduces the Area of Post Operative Atelectasis.|Completed||N/A|59|Actual|Landstinget Västmanland||2|||f||||f||||||||||2017-10-11 02:02:57.699771|2017-10-11 02:02:57.699771
NCT01779063|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-04-07|||January 2013||2013-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Promoting Adherence to Lymphedema Self-care|Promoting Adherence to Lymphedema Self-care in Breast Cancer Survivors|Completed||N/A|160|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 02:02:57.791389|2017-10-11 02:02:57.791389
NCT01779050|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-01-26|||December 19, 2013||2013-12-19|January 2017|2017-01-01|October 31, 2019|Anticipated|2019-10-31|October 31, 2019|Anticipated|2019-10-31||Interventional|||Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells|A Phase II Randomized Trial Evaluating the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Bone Marrow Disseminated Tumor Cells|Active, not recruiting||Phase 2|7|Actual|Washington University School of Medicine||2|||f||||t|t|f||||||No||2017-10-11 02:02:57.887793|2017-10-11 02:02:57.887793
NCT01779037|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-10-26|||January 2001||2001-01-01|October 2016|2016-10-01||||December 2050|Anticipated|2050-12-01|1 Day|Observational [Patient Registry]|||IRF-PAI Functional Outcomes Data(With FIM Instrument Variables)|IRF-PAI Functional Outcomes Data(With FIM Instrument Variables)|Active, not recruiting||N/A|||Uniform Data System for Medical Rehabilitation|||1||f||||t||||||||||2017-10-11 02:02:58.02652|2017-10-11 02:02:58.02652
NCT01779024|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-06-30|||December 13, 2012||2012-12-13|June 1, 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers|Effects of Ghrelin on Alcohol Administration in Non-Treatment Seeking Heavy Drinkers|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:02:58.102986|2017-10-11 02:02:58.102986
NCT01779011|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2013-01-28|||January 2011||2011-01-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|SuTra²||Monitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult Contexts|Suivi et Traitement du Traumatisme Des Membres en Cas d'Afflux Massif de blessés Dans Les Contextes Difficiles|Completed||N/A|305|Actual|Alliance for International Medical Action|||2||f||||f||||||||||2017-10-11 02:02:58.197743|2017-10-11 02:02:58.197743
NCT01778998|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-02-07|||February 2012||2012-02-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|INCISIONS||Impact of Incision Size and Architecture on Wound Stability and Astigmatism in Cataract Surgery: an Exploratory Study|Impact of Incision Size and Architecture on Wound Stability and Astigmatism in Cataract Surgery: an Exploratory Study|Completed||N/A|68|Actual|Vienna Institute for Research in Ocular Surgery||4|||f||||t||||||||||2017-10-11 02:02:58.274603|2017-10-11 02:02:58.274603
NCT01778985|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2014-09-18|2014-05-20||December 2012||2012-12-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|PET||Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor|Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor|Completed||Phase 4|30|Actual|University of Texas Southwestern Medical Center|4 patients nonadherent to study protocol in the Premarin arm.|2|||f||||f||||||||||2017-10-11 02:02:58.383664|2017-10-11 02:02:58.383664
NCT01778972|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-05-09|||November 2012||2012-11-01|June 2015|2015-06-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||Fall Prevention for Old Community-dwelling People|Fall Prevention for Old Community-dwelling People in Uppsala, Västerås and Sörmland|Active, not recruiting||N/A|420|Anticipated|Uppsala University||3|||f||||f||||||||No||2017-10-11 02:02:59.29451|2017-10-11 02:02:59.29451
NCT01778959|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-25|||February 2012||2012-02-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|IFIS||Methods to Manage Intra-operative Floppy-iris Syndrome and Poor Pupil Dilation in Cataract Surgery|Methods to Manage Intra-operative Floppy-iris Syndrome and Poor Pupil Dilation in Cataract Surgery: an Exploratory Study|Unknown status|Recruiting|N/A|80|Anticipated|Vienna Institute for Research in Ocular Surgery||4|||f||||t||||||||||2017-10-11 02:02:59.399327|2017-10-11 02:02:59.399327
NCT01778946|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-06-22|||April 2013||2013-04-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||Nicotine Treatment of Cognitive Decline in Down Syndrome|Nicotinic Treatment of Age-Related Cognitive Decline in Down Syndrome: An Open Label Pilot Trial|Recruiting||Phase 1/Phase 2|15|Anticipated|Vanderbilt University Medical Center||1|||f||||f||||||||Undecided||2017-10-11 02:02:59.515764|2017-10-11 02:02:59.515764
NCT01778933|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-06-11|||May 2013||2013-05-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17)|A Pilot and Feasibility Study Of The Imaging Potential Of EC17 In Subjects Undergoing Surgery Presenting With Renal Nodules|Recruiting||Early Phase 1|10|Anticipated|University of Pennsylvania||1|||f||||||||||||||2017-10-11 02:02:59.637742|2017-10-11 02:02:59.637742
NCT01778920|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-05-16|||April 2012||2012-04-01|December 2015|2015-12-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)|Intraoperative Imaging of Pulmonary Adenocarcinoma|Completed||Phase 1|48|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 02:02:59.734061|2017-10-11 02:02:59.734061
NCT01778907|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-08-15|||February 2013|Actual|2013-02-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|May 2017|Actual|2017-05-01||Interventional|CYSCE||Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE)|Effects and Cost-Effectiveness of Pharmacogenetic Screening Among Elderly Starters With Antidepressants: A Pragmatic Randomized Controlled Trial|Completed||Phase 4|202|Actual|University of Groningen||3|||f||||f||||||||||2017-10-11 02:02:59.82789|2017-10-11 02:02:59.82789
NCT01778894|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-11-03|||September 2013||2013-09-01|November 2016|2016-11-01||||February 2018|Anticipated|2018-02-01||Observational|||Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart|Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart|Recruiting||N/A|40|Anticipated|University of Nebraska|||2||f||||t||||||||||2017-10-11 02:02:59.973388|2017-10-11 02:02:59.973388
NCT01778881|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-10-24|||March 2013||2013-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|Bruxism||Physical Therapy Interventions Relative to Dental Treatment in Individuals With Bruxism|Effectiveness of Physical Therapy Interventions, Relative to Dental Treatment in Individuals With Bruxism: a Randomized Clinical Trial|Active, not recruiting||N/A|72|Anticipated|University of Sao Paulo General Hospital||4|||f||||t||||||||No||2017-10-11 02:03:00.108866|2017-10-11 02:03:00.108866
NCT01778868|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-01-28|||August 2009||2009-08-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Observational|ENDORUP||Environmental Chemicals and Their Role in Obesity|"Endocrine Disrupting Environmental Chemicals: From Accumulation to Their Role in the Global Neuro-endocrine Epidemic of Obesity and Its Metabolic Consequences"|Unknown status|Active, not recruiting|N/A|203|Actual|University Hospital, Antwerp|||2||f||||f||||||Samples With DNA|"     Blood samples Urinary samples Fat samples   "|||2017-10-11 02:03:00.251751|2017-10-11 02:03:00.251751
NCT01778855|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-03-01|2017-01-11||February 2013||2013-02-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|HASTIER||Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization|An Ancillary Imaging Study to the Intravascular Cooling in the Treatment of Stroke 2 (ICTuS 2) Trial, an NIH-funded Project on the Safety and Efficacy of Hypothermia Combined With Thrombolysis|Terminated||Phase 2/Phase 3|6|Actual|University of California, Los Angeles|Early termination of ancillary study leading to small numbers of subjects analyzed.|2|||f||||t||||||||||2017-10-11 02:03:00.841904|2017-10-11 02:03:00.841904
NCT01778842|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-01-24|||March 2013||2013-03-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|RESET ELDERLY||Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome|PhaRmacodynamic Effect of Antiplatelet Agents in Elderly Patients: Standard Clopidogrel Versus prasugrEl Low Dose Therapy.|Unknown status|Not yet recruiting|Phase 3|68|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 02:03:01.292858|2017-10-11 02:03:01.292858
NCT01778829|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-01-28|||December 2011||2011-12-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Interventional|VNINS||Non Invasive Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants.|Nasal Intermittent Mandatory Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants of the NEOCOSUR Network.|Unknown status|Recruiting|Phase 3|220|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||t||||||||||2017-10-11 02:03:01.38812|2017-10-11 02:03:01.38812
NCT01778816|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-25|||January 2009||2009-01-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|July 2009|Actual|2009-07-01||Observational|||Calf Muscle Atrophy After Achilles Tendon Rupture. A Clinical-Radiological-Biomechanical Multicenter Study.||Completed||N/A|52|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 02:03:01.484326|2017-10-11 02:03:01.484326
NCT01778803|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-05-15|||February 26, 2013|Actual|2013-02-26|January 2017|2017-01-01|February 23, 2015|Actual|2015-02-23|February 23, 2015|Actual|2015-02-23||Interventional|||Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer|A Phase I/Ib Study of Paclitaxel in Combination With VS-6063, a Focal Adhesion Kinase Inhibitor, in Subjects With Advanced Ovarian Cancer|Completed||Phase 1|22|Actual|Verastem, Inc.||1|||f||||t||||||||||2017-10-11 02:03:01.547483|2017-10-11 02:03:01.547483
NCT01778790|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2014-08-21|||August 2013||2013-08-01|August 2014|2014-08-01|August 2015|Anticipated|2015-08-01|March 2015|Anticipated|2015-03-01||Interventional|FORESEEII||Deep Brain Stimulation of the Superolateral Branch of the Medial Forebrain Bundle (slMFB) for the Treatment of Refractory Major Depression|Assessment of Efficacy, Safety and Effects on Quality of Life of Deep Brain Stimulation to the Medial Forebrain Bundle in Patients With Treatment Resistant Major Depression (FORESEE II: FOREbrain Stimulation dEprEssion)|Unknown status|Active, not recruiting|Phase 2|12|Anticipated|University Hospital, Bonn||2|||f||||t||||||||||2017-10-11 02:03:01.651241|2017-10-11 02:03:01.651241
NCT01778777|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-10-04|||September 2013||2013-09-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Study of Univers® Revers Shoulder Prosthesis|Safety, Function and Quality of Life in Patient With Rotator Cuff Tear Arthropathy Treated With the Univers® Revers Shoulder Prosthesis|Active, not recruiting||N/A|166|Anticipated|Schulthess Klinik||1|||f||||t||||||||||2017-10-11 02:03:01.733871|2017-10-11 02:03:01.733871
NCT01778764|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-07-07|||October 2014||2014-10-01|July 2016|2016-07-01||||December 2019|Anticipated|2019-12-01||Observational|||Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases|A Comparison of Overall Survival Post-CyberKnife Radiosurgery Treatment of Patients With 1-3 Versus 4 or More Brain Metastases|Recruiting||Phase 1|1000|Anticipated|Stanford University|||2||f||||||||||||||2017-10-11 02:03:01.81961|2017-10-11 02:03:01.81961
NCT01778751|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-12-16|2015-11-03||December 2013||2013-12-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ACDC||Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes|Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes|Completed||Early Phase 1|50|Actual|VA Office of Research and Development|"Single-center pilot study
Small, male Veteran population with type 2 diabetes
Uses VA-specific infrastructure, findings may not translate to other settings."|2|||f||||f||||||||||2017-10-11 02:03:01.921446|2017-10-11 02:03:01.921446
NCT01778738|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-05-30|||January 2013||2013-01-01|May 2017|2017-05-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Interventional|OSEBERG||Type 2 Diabetes After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Randomised Single Centre Study|Glycaemia, Insulin Secretion and Action in Morbidly Obese Subjects With Type 2 Diabetes After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: A Randomised Single Centre Study|Recruiting||N/A|120|Anticipated|Sykehuset i Vestfold HF||3|||f||||f||||||||Undecided||2017-10-11 02:03:02.484068|2017-10-11 02:03:02.484068
NCT01778725|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2013-01-25|||January 2013||2013-01-01|January 2013|2013-01-01||||August 2015|Anticipated|2015-08-01||Observational|||Early Identification of Brain Insult in Chorioamnionitis|S100B as a Marker for Fetal Brain Injury in Premature Rupture of Membranes|Unknown status|Not yet recruiting|N/A|90|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 02:03:02.576208|2017-10-11 02:03:02.576208
NCT01778712|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-04-25|||April 2012||2012-04-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Developing an Intervention to Prevent Visceral Adipose Tissue Accumulation|Developing an Intervention to Prevent Visceral Adipose Tissue Accumulation in Premenopausal Women: WISHfit Phase 2|Completed||N/A|71|Actual|Rush University Medical Center||1|||f||||t||||||||||2017-10-11 02:03:02.688246|2017-10-11 02:03:02.688246
NCT01778699|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2014-02-19|||February 2013||2013-02-01|February 2014|2014-02-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|||Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2).|Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2). A Randomized Double Blind Interventional Study.|Unknown status|Recruiting|Phase 4|440|Anticipated|Università degli Studi di Sassari||2|||f||||t||||||||||2017-10-11 02:03:02.777087|2017-10-11 02:03:02.777087
NCT01778686|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-10-28|||January 2013||2013-01-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors|Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors|Completed||N/A|24|Actual|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-10-11 02:03:02.87306|2017-10-11 02:03:02.87306
NCT01778673|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-01-24|||October 2009||2009-10-01|January 2013|2013-01-01||||September 2011|Actual|2011-09-01||Observational|||Cortical Comminution and Intra-articular Involvement in Distal Radius Fractures Can Predict Radiological Outcome. A Prospective Multicenter Study||Completed||N/A|||Sundsvall Hospital|||2||f||||||||||||||2017-10-11 02:03:02.984574|2017-10-11 02:03:02.984574
NCT01778660|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-04-04|||February 2013||2013-02-01|January 2013|2013-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|FIT||Standard Versus Mnemonic Counseling for Fecal Incontinence|Standard Versus Mnemonic Counseling for Fecal Incontinence: a Pilot Randomised Control Trial|Completed||N/A|90|Actual|University of New Mexico||2|||f||||f||||||||||2017-10-11 02:03:03.066901|2017-10-11 02:03:03.066901
NCT01778647|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-30|2013-10-23|||December 2009||2009-12-01|October 2013|2013-10-01||||July 2010|Actual|2010-07-01||Interventional|||Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD|Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD|Terminated||Phase 4|15|Actual|Maimonides Medical Center||2||Co-Investigators left the Institution.|f||||t||||||||||2017-10-11 02:03:03.158209|2017-10-11 02:03:03.158209
NCT01778634|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-06-23|||July 2013||2013-07-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2016|Actual|2016-12-01||Interventional|AZIPIII||Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants|A Phase IIb Randomized, Placebo-controlled, Double-blind Trial of Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants|Active, not recruiting||Phase 2|121|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 02:03:03.271505|2017-10-11 02:03:03.271505
NCT01778621|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-25|||March 2011||2011-03-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Follicular Phase Acupuncture on Anti-Mullerian Hormone in Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF And The Effect on Assisted Reproduction Outcome|Acupuncture Treatment Versus Non-acupuncture During IVF|Completed||N/A|81|Actual|Huazhong University of Science and Technology||2|||f||||f||||||||||2017-10-11 02:03:03.39065|2017-10-11 02:03:03.39065
NCT01778608|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-05-25|||January 2012||2012-01-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Feasability Test of a Handset Device to Detect Levels of Sedation and Loss of Consciousness|Feasibility Test of a Handset Device to Detect Sedation Levels and Loss of Consciousness During Propofol Administration|Completed||N/A|20|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-11 02:03:03.464819|2017-10-11 02:03:03.464819
NCT01778595|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2017-06-30|||January 8, 2013||2013-01-08|September 21, 2016|2016-09-21|September 21, 2016|Actual|2016-09-21|December 9, 2015|Actual|2015-12-09||Observational|||Colon Cancer Study of Fecal Samples in Shanghai, China|Pilot Study of the Fecal Microbiome in the Shanghai Population|Completed||N/A|700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:03:03.524648|2017-10-11 02:03:03.524648
NCT01778582|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2017-10-05|||November 15, 2012||2012-11-15|September 18, 2015|2015-09-18|October 8, 2013|Actual|2013-10-08|October 1, 2013|Actual|2013-10-01||Observational|||Perspective-taking, and Examining the Clinical Trial Informed Consent Process|Perspective-taking, and Examining the Clinical Trial Informed Consent Process|Completed||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:03:05.414047|2017-10-11 02:03:05.414047
NCT01778569|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2017-09-21|||January 9, 2013||2013-01-09|September 14, 2017|2017-09-14|December 31, 2030|Anticipated|2030-12-31|June 30, 2022|Anticipated|2022-06-30||Observational|||The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)|Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic Disease (PACI) Initiative|Recruiting||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:03:05.477199|2017-10-11 02:03:05.477199
NCT01778543|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2017-09-21|||December 13, 2012||2012-12-13|September 18, 2017|2017-09-18|December 3, 2018|Anticipated|2018-12-03|December 3, 2018|Anticipated|2018-12-03||Observational|||Genetics of Uveal Coloboma|Genetics of Uveal Coloboma|Recruiting||N/A|240|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:03:05.664507|2017-10-11 02:03:05.664507
NCT01778530|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2015-10-06|2014-04-10||December 2012||2012-12-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||TRC105 for Recurrent Glioblastoma|A Phase 2 Study of TRC105 in Patients With Recurrent Glioblastoma (GBM)|Terminated||Phase 2|2|Actual|National Institutes of Health Clinical Center (CC)||1||Study was terminated due to poor accrual.|f||||f||||||||||2017-10-11 02:03:05.742747|2017-10-11 02:03:05.742747
NCT01778517|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2017-06-30|||December 11, 2012||2012-12-11|July 23, 2015|2015-07-23|July 23, 2015|Actual|2015-07-23|July 23, 2015|Actual|2015-07-23||Interventional|||Treatment of Functional Movement Disorders With Psychotherapy|Treatment of Functional Movement Disorders With Psychotherapy|Completed||N/A|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:03:05.983089|2017-10-11 02:03:05.983089
NCT01778504|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2017-06-30|||November 14, 2012||2012-11-14|March 2, 2017|2017-03-02|July 6, 2020|Anticipated|2020-07-06|July 6, 2020|Anticipated|2020-07-06||Observational|||Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders|Diagnosis and Treatment of Childhood-onset Behavioral Disorders, Neuropsychiatric Disorders and Neurodevelopmental Disorders|Recruiting||N/A|3500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:03:06.067482|2017-10-11 02:03:06.067482
NCT01778491|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2017-06-30|||November 5, 2012||2012-11-05|September 29, 2015|2015-09-29|September 29, 2015|Actual|2015-09-29|September 29, 2015|Actual|2015-09-29||Observational|||AMD Phenotype and Genotype Study|AMD Phenotype and Genotype Study (APGS)|Completed||N/A|49|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:03:06.144388|2017-10-11 02:03:06.144388
NCT01778478|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2017-10-05|||November 7, 2012||2012-11-07|August 31, 2017|2017-08-31|August 25, 2016|Actual|2016-08-25|August 25, 2016|Actual|2016-08-25||Observational|||A Pilot Study to Extend the K-SADS-PL to Adolescents and Young Adults|Pilot Study to Extend the K-SADS-PL to Adolescents and Young Adults|Completed||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:03:06.263946|2017-10-11 02:03:06.263946
NCT01778465|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-26|2015-03-01|||May 2013||2013-05-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease|Effect of Low Dietary Salicylate on Biochemical Markers of Aspirin Exacerbated Respiratory Disease|Completed||N/A|14|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:03:06.45101|2017-10-11 02:03:06.45101
NCT01778452|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-02-14|||November 2009||2009-11-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Endometrial Genomic Profile in Endometrial Priming|Profile Study of Genomics Endometrial Expression After Gonadotropin-releasing Hormone Agonist Administration and GnRH in Endometrial Priming.|Completed||N/A|6|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||3|||f||||f||||||||||2017-10-11 02:03:06.554741|2017-10-11 02:03:06.554741
NCT01778439|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-02-10|||February 2013||2013-02-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors|A Phase 1 Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors|Completed||Phase 1|48|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:03:06.64093|2017-10-11 02:03:06.64093
NCT01778413|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-09-01|||May 2013||2013-05-01|May 2013|2013-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|A-TRI-WEEK||Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine|Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine|Completed||Phase 4|60|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 02:03:06.814336|2017-10-11 02:03:06.814336
NCT01778400|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-11-07|||February 2013||2013-02-01|November 2013|2013-11-01|January 2014|Anticipated|2014-01-01|May 2013|Actual|2013-05-01||Interventional|||RFA (Radiofrequency Ablation) Versus EA (Ethanol Ablation) for Predominantly Cystic Thyroid Nodules|Single Session Treatment of RFA Versus EA for Predominantly Cystic Thyroid Nodules: A Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:03:06.910567|2017-10-11 02:03:06.910567
NCT01778387|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-01-25|||January 2005||2005-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2008|Actual|2008-12-01||Interventional|||Cost- Effectiveness and Cost-utility of Laparoscopic Versus Open Repair of Ventral Hernia|Cost- Effectiveness and Cost-utility of Laparoscopic Versus Open Repair of Ventral Hernia: Randomized Clinical Trial|Completed||Phase 4|130|Actual|Fundación Andaluza Beturia para la Investigación en Salud||2|||f||||t||||||||||2017-10-11 02:03:06.998944|2017-10-11 02:03:06.998944
NCT01778374|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-25|||September 2012||2012-09-01|January 2013|2013-01-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|M-BRiHT||Mater-Bronx Rapid HIV Testing Project.|Mater _Bronx Rapid HIV Testing Project. Prospective Randomised Trial of Recruitment Methods in Implementation of a HIV Screening Programme in the Emergency Department.|Unknown status|Recruiting|N/A|17000|Anticipated|University College Dublin||2|||f||||t||||||||||2017-10-11 02:03:07.079691|2017-10-11 02:03:07.079691
NCT01778361|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-11-29|||February 2011||2011-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|UPBEAT||HIV UPBEAT: Understanding the Pathology of Bone Disease in HIV-infected Patients.|HIV UPBEAT: Understanding the Pathology of Bone Disease in HIV-infected. A Prospective Cohort Study of HIV-infected Patients and HIV-negative Subjects.|Recruiting||N/A|500|Anticipated|University College Dublin|||2||f||||f||||||Samples With DNA|"     serum, plasma, buffy coat, urine   "|||2017-10-11 02:03:07.215421|2017-10-11 02:03:07.215421
NCT01778348|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-02-28|||December 2013||2013-12-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|APCam08||Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting|An Open-label, Three-centre, Randomised, Two-period, Crossover Study to Assess the Efficacy, Safety and Utility of Overnight Closed-loop in Comparison With CGM Alone in the Home Setting in Children and Adolescents With Type 1 Diabetes|Completed||Phase 2|29|Actual|University of Cambridge||2|||f||||t||||||||||2017-10-11 02:03:07.331683|2017-10-11 02:03:07.331683
NCT01778335|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-03-20|||January 2013||2013-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|ESCAPE||Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke|Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times (ESCAPE) Trial|Terminated||Phase 3|316|Actual|University of Calgary||2||On DSMB advice, trial recruitment has been halted for efficacy. F/U continues.|f||||t||||||||||2017-10-11 02:03:07.471663|2017-10-11 02:03:07.471663
NCT01778322|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-02-24|||December 2011||2011-12-01|February 2016|2016-02-01|June 2020|Anticipated|2020-06-01|December 2015|Actual|2015-12-01||Observational|WEBCAST||WEB Clinical Assessment of IntraSaccular Aneurysm Therapy|WEB Clinical Assessment of IntraSaccular Aneurysm Therapy|Active, not recruiting||N/A|100|Anticipated|Sequent Medical, Inc|||1||f||||f||||||||||2017-10-11 02:03:07.579532|2017-10-11 02:03:07.579532
NCT01778309|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-01-25|||January 2010||2010-01-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|September 2011|Actual|2011-09-01||Interventional|||NAC Supplementation and Skeletal Muscle Performance|Effects of NAC Supplementation on Skeletal Muscle Performance Following Aseptic Injury Induced by Exercise|Completed||N/A|20|Actual|Democritus University of Thrace||1|||f||||t||||||||||2017-10-11 02:03:07.708711|2017-10-11 02:03:07.708711
NCT01778296|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-10-23|2013-06-03||January 2008||2008-01-01|May 2012|2012-05-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Interventional||The participants with a follow-up period ≥18 months were included for this Baseline Measure.|Repair of Soft Tissue Defect of the Finger Using the Heterodigital Neurocutaneous Island Flap||Completed||N/A|12|Actual|The Second Hospital of Tangshan|The samples of our study are small, and the results may change as our experience grows.|1|||f||||t||||||||||2017-10-11 02:03:07.826118|2017-10-11 02:03:07.826118
NCT01778283|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-02-12|||October 2012||2012-10-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration|Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration|Completed||Phase 4|22|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-10-11 02:03:08.002661|2017-10-11 02:03:08.002661
NCT01778270|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-04-15|||October 2011||2011-10-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Not Invasive Monitoring of Pleural Drainage|Not Invasive Monitoring of Pleural Drainage|Completed||N/A|50|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 02:03:08.079881|2017-10-11 02:03:08.079881
NCT01778257|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-01-25|||October 2011||2011-10-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy and Safety of Mate Extracts on Decrement of Body and Abdominal Fat in Obese Subjects|Mate Extract Supplementation Reduces Body and Abdominal Fat in Obese Korean Subjects|Completed||Phase 2|30|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:03:08.160195|2017-10-11 02:03:08.160195
NCT01778244|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-19|2013-01-25|||November 2008||2008-11-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Metformin for Treatment of Antipsychotic-induced Dyslipidemia|Metformin for Treatment of Antipsychotic-induced Dyslipidemia: a Randomized, Double-blind Study|Completed||Phase 4|162|Actual|Central South University||2|||f||||t||||||||||2017-10-11 02:03:08.36451|2017-10-11 02:03:08.36451
NCT01778231|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-28|||March 2011||2011-03-01|January 2013|2013-01-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation|Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation|Unknown status|Recruiting|N/A|100|Anticipated|Queen's University, Belfast||2|||f||||f||||||||||2017-10-11 02:03:08.452205|2017-10-11 02:03:08.452205
NCT01778218|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-07-10|||January 2013||2013-01-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD)|A Single Center Pilot Study to Establish the 99mTc-EC-DG Imaging Protocol to Evaluate the Presence and Severity of Coronary Artery Disease|Completed||Phase 2|2|Actual|Cell>Point LLC||1|||f||||t||||||||||2017-10-11 02:03:08.556371|2017-10-11 02:03:08.556371
NCT01778205|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-04-21|||January 2005||2005-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Reus-Tarragona Birth Cohort Study of Early Development and Ageing.|Phase 1 Study of the Effect of Maternal Nutritional Status on Placental Vascular Function, Fetal Growth and Intrauterine Growth Retardation.|Recruiting||N/A|800|Anticipated|Institut Investigacio Sanitaria Pere Virgili|||1||f||||t||||||Samples With DNA|"     Plasma Serum Leukocytes Placenta   "|||2017-10-11 02:03:08.652359|2017-10-11 02:03:08.652359
NCT01778192|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-29|||July 2012||2012-07-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate|A Randomized Prospective Trial Comparing Different Regimens of Polyethylene Glycol-based Lavage and Sodium Picosulphate With Magnesium Citrate in the Preparation of Patients for Colonoscopy|Completed||Phase 3|200|Actual|Korea University Anam Hospital||4|||f||||t||||||||||2017-10-11 02:03:08.767962|2017-10-11 02:03:08.767962
NCT01778179|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-07-19|||April 2011||2011-04-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Fixed Triple Combination Cream for Solar Lentigines Associated to Cryotherapy|Safety and Efficacy of a Triple Combination Cream as Adjuvant Treatment of Solar Lentigines With Cryotherapy.|Completed||N/A|50|Actual|Brazilan Center for Studies in Dermatology||2|||f||||f||||||||||2017-10-11 02:03:08.880009|2017-10-11 02:03:08.880009
NCT01778166|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-30|||February 2013||2013-02-01|January 2013|2013-01-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|ISEEN||Gastrointestinal Postoperative Early Enteral Nutrition: Immuno-enhanced Versus Standard Early Enteral Nutrition|Immuno-enhanced Versus Standard Early Enteral Nutrition Use in Gastrointestinal Postoperative Patients|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 02:03:08.981203|2017-10-11 02:03:08.981203
NCT01778153|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-11-23|||January 2012||2012-01-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Equinox Personal Coaching Versus Self-Directed Exercise|Effectiveness of Equinox Fitness Club's Personal Coaching Method Versus Self-Directed Exercise Training on Increasing Lean Body Mass in Men Aged 30-44 Years of Age|Completed||N/A|43|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:03:09.083047|2017-10-11 02:03:09.083047
NCT01778140|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2013-02-05|||January 2012||2012-01-01|February 2013|2013-02-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|||Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder System|Randomized Controlled Trial: Comparing Effects of Patient-Specific Versus Non-Patient-Specific Computerized Reminder System to Reduce Contrast-Induced Nephropathy|Unknown status|Active, not recruiting|N/A|90|Anticipated|Taipei Medical University||3|||f||||t||||||||||2017-10-11 02:03:09.171509|2017-10-11 02:03:09.171509
NCT01778127|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-05-05|2015-04-14||February 2013||2013-02-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer|A Randomized Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer|Completed||N/A|105|Actual|St. Jude Children's Research Hospital||3|||f||||f||||||||||2017-10-11 02:03:09.294559|2017-10-11 02:03:09.294559
NCT01778114|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-03-27|||December 2006||2006-12-01|March 2017|2017-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Availability of Vitamin D in Orange Juice|Bioavailability of Vitamin D2 and Vitamin D3 in Supplements Compared to Vitamin D3 and Vitamin D2 in Fortified Orange Juice|Completed||N/A|86|Actual|Boston University||5|||f||||f||||||||No||2017-10-11 02:03:10.735417|2017-10-11 02:03:10.735417
NCT01778101|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2013-09-11|||January 2013||2013-01-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Lansoprazole in Preterm Infants With Reflux|A Pilot Study - Lansoprazole in Preterm Infants With Gastroesophageal Reflux|Completed||Phase 2|5|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 02:03:10.85271|2017-10-11 02:03:10.85271
NCT01778088|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-02-24|||May 2014||2014-05-01|February 2014|2014-02-01|January 2015|Anticipated|2015-01-01|June 2014|Anticipated|2014-06-01||Interventional|||Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma|A Phase 2a, Multi-Center, Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma|Withdrawn||Phase 2|0|Actual|Cellectar Biosciences, Inc.||1|||f||||f||||||||||2017-10-11 02:03:10.939089|2017-10-11 02:03:10.939089
NCT01778075|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-02-07|||December 2012||2012-12-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition|A Single Dose, Open-Label, Randomized, Two-Way Crossover Pivotal Study to Assess the Bioequivalence of a New ULTRACET ER Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition|Completed||Phase 1|56|Actual|Janssen Korea, Ltd., Korea||2|||f||||f||||||||||2017-10-11 02:03:11.031905|2017-10-11 02:03:11.031905
NCT01778062|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-10-01|2015-08-18||February 2013||2013-02-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|INFINITY||Indacaterol EfectIveness In COPD Patients With Tuberculosis History|A Phase Ⅲb, Multicenter, Double-blind, Randomized, Controlled Trial, to Assess the Efficacy and Safety of Indacaterol (150㎍ o.d.) vs. Placebo, in Patients With Moderate-to-severe COPD With Destroyed Lung by Tuberculosis|Completed||Phase 3|136|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:03:11.152473|2017-10-11 02:03:11.152473
NCT01774890|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-08-09|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2015|Actual|2015-01-01||Observational|||ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease||Completed||N/A|35|Actual|Hadassah Medical Organization|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 02:04:18.81828|2017-10-11 02:04:18.81828
NCT01778049|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-03-04|2016-03-04||January 2013||2013-01-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||The open-label treated set (OLTS) was used for the open label treatment period. This analysis set consisted of all patients who received at least 1 dose of open-label treatment during the trial.|Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes|A Phase III, Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Linagliptin 5 mg Compared to Placebo, Administered as Oral Fixed Dose Combination With Empagliflozin 10 mg or 25 mg for 24 Weeks, in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control After 16 Weeks of Treatment With Empagliflozin 10 mg or 25 mg on Metformin Background Therapy|Completed||Phase 3|708|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-10-11 02:03:11.738191|2017-10-11 02:03:11.738191
NCT01778036|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-03-23|||January 2013|Actual|2013-01-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Neck Motion and Motor Control in Chronic Neck Pain and Associations With Clinical Symptoms|Neck Motion and Motor Control in Chronic Neck Pain and Associations With Clinical Symptoms|Completed||N/A|84|Actual|Norwegian University of Science and Technology|||1||f||||f|f|f||||||||2017-10-11 02:03:13.398568|2017-10-11 02:03:13.398568
NCT01778023|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-05-04|2015-12-17||January 17, 2013|Actual|2013-01-17|May 2017|2017-05-01|December 17, 2014|Actual|2014-12-17|December 17, 2014|Actual|2014-12-17||Interventional|||Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature|A 12-month, Open-labelled, Randomised, Parallel-group, Multi-centre, Interventional Trial to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone (hGH) (Norditropin® Nordilet®) Therapy on Height Velocity (Ht-V) in Patients With Idiopathic Short Stature in Korea|Completed||Phase 3|54|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:03:13.563352|2017-10-11 02:03:13.563352
NCT01777984|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2013-01-24|||December 2009||2009-12-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Observational|||Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration|Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration|Unknown status|Active, not recruiting|N/A|100|Anticipated|Rudolf Foundation Clinic|||1||f||||f||||||||||2017-10-11 02:03:14.562222|2017-10-11 02:03:14.562222
NCT01777971|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2015-08-03|||July 2012||2012-07-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis|The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis|Withdrawn||N/A|0|Actual|New York University School of Medicine|||1||f||||f||||||||||2017-10-11 02:03:14.649926|2017-10-11 02:03:14.649926
NCT01777958|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-09-13|||June 14, 2013||2013-06-14|September 2017|2017-09-01|December 15, 2020|Anticipated|2020-12-15|December 15, 2020|Anticipated|2020-12-15||Observational|||HELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin Therapy|Noninterventional Study - Advanced HER2-positive Breast Cancer (Metastatic or Locally Recurrent, Inoperable): First-Line Treatment With PERJETA After Adjuvant Herceptin Therapy (HELENA)|Active, not recruiting||N/A|135|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:03:14.750047|2017-10-11 02:03:14.750047
NCT01777945|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-07-12|2016-04-12||December 2012||2012-12-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational||All participants were female.|XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer|Program for Assessment of Capecitabine (Xeloda) Plus Docetaxel First-line Therapies in HER2-negative Metastatic Breast Cancer (XEBRA Study)|Completed||N/A|46|Actual|Hoffmann-La Roche|||1||f||||f||||||||||2017-10-11 02:03:14.871072|2017-10-11 02:03:14.871072
NCT01777932|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-01-07|2016-01-07||December 2007||2007-12-01|January 2016|2016-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer|A Multicenter, Single-arm, Observational Study Describing the Clinical Benefits of Bevacizumab (Avastin) Treatment in Patients With Metastatic Breast Cancer (AVAREG Study)|Completed||N/A|220|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:03:15.572398|2017-10-11 02:03:15.572398
NCT01777919|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-10-14|||January 2017||2017-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|GLIODIS||Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform|A PHASE II CLINICAL TRIAL FOR THE EVALUATION OF THE EFFICACY OF DISULFIRAM/COPPER COMBINATION AS AN ADJUVANT AND CONCURRENT CHEMOTHERAPY IN THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORM|Not yet recruiting||Phase 2|32|Anticipated|Olympion Medical Center||1|||f||||t||||||||||2017-10-11 02:03:16.315911|2017-10-11 02:03:16.315911
NCT01777906|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-03-24|||February 2013||2013-02-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|dexamethasone||Study of the Efficacy of Topical Nasal Steroids Patients With Nasal Polyps|Comparison of Topical Nasal Steroids in Postoperative Sinus Patients With Nasal Polyps|Completed||N/A|40|Actual|Loma Linda University|||2||f||||t||||||||||2017-10-11 02:03:16.449824|2017-10-11 02:03:16.449824
NCT01777893|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-05-31|||June 2013||2013-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PREVIEW||Effect of Diet and Physical Activity on Incidence of Type 2 Diabetes|PREVention of Diabetes Through Lifestyle Intervention and Population Studies in Europe and Around the World|Active, not recruiting||N/A|2500|Anticipated|University of Copenhagen||4|||f||||t||||||||||2017-10-11 02:03:16.568384|2017-10-11 02:03:16.568384
NCT01777867|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-02-16|||December 2012|Actual|2012-12-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Cough Reflex Sensitivity and Bronchial Hyper-responsiveness|Pilot Studies Evaluating Cough Reflex Sensitivity and Bronchial Hyper-responsiveness: The Road to Cough and Wheeze in Patients With Gastroesophageal Reflux.|Completed||N/A|24|Actual|Mayo Clinic|||3||f||||f|f|f||||||No||2017-10-11 02:03:16.761434|2017-10-11 02:03:16.761434
NCT01777854|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2016-02-09|||January 2013||2013-01-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Anti-reflux Control to Decrease Post Tonsillectomy Pain|Anti-reflux Control to Decrease Post Tonsillectomy Pain|Terminated||Phase 4|6|Actual|Genesys Regional Medical Center||2||Lack of patient interest in the study.|f||||f||||||||||2017-10-11 02:03:16.870924|2017-10-11 02:03:16.870924
NCT01777841|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-01-28|||February 2012||2012-02-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Mayo Clinic Health Connection Discovery Trial|Clinical Pilot:myCare|Completed||N/A|250|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:03:16.960297|2017-10-11 02:03:16.960297
NCT01777828|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-02-12|||February 2013||2013-02-01|February 2015|2015-02-01|February 2034|Anticipated|2034-02-01|February 2033|Anticipated|2033-02-01|5 Years|Observational [Patient Registry]|FRANCE-TAVI||Registry of Aortic Valve Bioprostheses Established by Catheter|Registry of Aortic Valve Bioprostheses Established by Catheter|Recruiting||N/A|5000|Anticipated|French Cardiology Society|||1||f||||f||||||||||2017-10-11 02:03:17.027761|2017-10-11 02:03:17.027761
NCT01777815|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-09-23|||October 2009||2009-10-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|October 2012|Actual|2012-10-01||Interventional|TACT||Safety and Performance Study of the NeoChord Device|Safety and Performance Study of the NeoChord Suturing Device in Subjects With Degenerative Mitral Valve Disease; Diagnosed With Severe Mitral Regurgitation|Completed||N/A|30|Actual|NeoChord||1|||f||||t||||||||||2017-10-11 02:03:17.105685|2017-10-11 02:03:17.105685
NCT01777802|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-08-23|||January 2013||2013-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Observational|SBRT||Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy|Observational Study of Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy|Recruiting||N/A|130|Anticipated|Mayo Clinic|||4||f||||f||||||Samples Without DNA|"     Whole Blood   "|||2017-10-11 02:03:17.210609|2017-10-11 02:03:17.210609
NCT01777789|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-02-08|||December 2012||2012-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||The Role of Mid-Life Adiposity in Functional Brain Connectivity|The Role of Mid-Life Adiposity in Functional Brain Connectivity|Terminated||N/A|60|Actual|Medical College of Wisconsin|||1|This is a basic research study with no clinical data to report|f||||f||||||Samples With DNA|"     Blood draw   "|||2017-10-11 02:03:17.322745|2017-10-11 02:03:17.322745
NCT01777776|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-07-27|2016-04-13|2016-02-11|July 2013||2013-07-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Baseline data is comprised of the Full Analysis Set (FAS), which is all patients who received at least one dose of LGX818 or LEE011.|Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.|A Phase Ib/II, Multicenter, Study of LEE011 in Combination With LGX818 in Adult Patients With BRAF Mutant Melanoma.|Terminated||Phase 1/Phase 2|28|Actual|Array BioPharma|Study recruitment was halted on 07-Aug-2014 during the Phase Ib part of the study. The Phase II part of the study was not performed. Early termination of the study was not due to any safety concerns.|4||Study was withdrawn due to scientific and business considerations.|f||||f||||||||||2017-10-11 02:03:17.448357|2017-10-11 02:03:17.448357
NCT01777763|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2017-03-09|2013-02-20||June 2009||2009-06-01|March 2017|2017-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)|Pharmacokinetics and Safety of Solid Oral Posaconazole (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05615)|Completed||Phase 1|230|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:03:20.054047|2017-10-11 02:03:20.054047
NCT01777750|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-03-21|||February 2013||2013-02-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|STATIM||Cooling in Myocardial Infarction|Strategic Target Temperature Management in Myocardial Infarction|Active, not recruiting||N/A|120|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:03:21.501761|2017-10-11 02:03:21.501761
NCT01777737|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2015-03-17|||June 2013||2013-06-01|March 2015|2015-03-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|TriSulfa-FPI||Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole|Pilot Study Phase III to Evaluate the Efficacy and Safety of Trimethoprim-sulfamethoxazole in the Treatment of Idiopathic Pulmonary Fibrosis|Unknown status|Recruiting|Phase 3|56|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f||||||||||2017-10-11 02:03:21.620857|2017-10-11 02:03:21.620857
NCT01777724|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-07-16|||January 2013||2013-01-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|HAPPY||Evaluation of a Parenting and Stress Management Programmme|Evaluation of a Parenting and Stress Management Programme: An Exploratory Randomised Controlled Trial of Triple P-Positive Parenting Program and Stress Control|Terminated||N/A|14|Actual|Medical Research Council||2||"The study was terminated due to time constraints and the withdrawal of Stress Control from the   NHS Greater Glasgow and Clyde services."|f||||f||||||||||2017-10-11 02:03:21.795171|2017-10-11 02:03:21.795171
NCT01777711|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-09-25|||October 2012||2012-10-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Exploring Beliefs and Behaviors About Weight Loss in Couples|Exploring Beliefs and Behaviors About Weight Loss in Couples|Completed||N/A|140|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:03:21.936182|2017-10-11 02:03:21.936182
NCT01777698|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-06-07|||April 2012||2012-04-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|August 2015|Actual|2015-08-01||Observational|||Body Composition Analysis in Patients Undergoing Chemoembolization|Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.|Completed||N/A|21|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||t||||||||||2017-10-11 02:03:22.080734|2017-10-11 02:03:22.080734
NCT01777685|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-01-28|||January 2013||2013-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|SUL||Therapeutic Drug Monitoring and Pharmacokinetic Compartmental Analysis of Sulpiride After Oral Administration to Healthy Volunteers|Therapeutic Drug Monitoring and Pharmacokinetic Compartmental Analysis of Sulpiride|Completed||N/A|16|Actual|Damanhour University||1|||f||||t||||||||||2017-10-11 02:03:22.162521|2017-10-11 02:03:22.162521
NCT01777672|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-02-07|||October 2012||2012-10-01|February 2017|2017-02-01||||June 2016|Actual|2016-06-01||Interventional|||Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia|Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia (OD). A Randomized Controlled Trial.|Completed||Phase 2|100|Actual|Hospital de Mataró||4|||f||||||||||||||2017-10-11 02:03:22.255174|2017-10-11 02:03:22.255174
NCT01777659|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-11-07|||March 2013||2013-03-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|TEBCABG||Transcutaneous Electrical Nerve Stimulation Improves Vascular Conductance After Coronary Artery Bypass Graft Surgery|Transcutaneous Electrical Nerve Stimulation Improves Vascular Conductance After Coronary Artery Bypass Graft Surgery|Completed||N/A|38|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 02:03:22.391448|2017-10-11 02:03:22.391448
NCT01777646|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-02-04|||December 2012||2012-12-01|January 2014|2014-01-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Phase IIa, Open Label, Dose-escalating Clinical Study to Evaluate the Safety, Tolerability and Therapeutic Effects of Transplantation of Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS).|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-10-11 02:03:22.523247|2017-10-11 02:03:22.523247
NCT01777633|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2015-04-19|||February 2013||2013-02-01|December 2012|2012-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children|Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children|Completed||Phase 1/Phase 2|15|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 02:03:22.641801|2017-10-11 02:03:22.641801
NCT01777620|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2014-05-02|2014-05-02||January 2013||2013-01-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional||Baseline measures are based on the Per-Protocol population that included all randomized participants who received study treatment and had at least one post-baseline efficacy assessment and no major protocol deviations.|A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides||Completed||Phase 4|125|Actual|Allergan||2|||f||||f||||||||||2017-10-11 02:03:22.783822|2017-10-11 02:03:22.783822
NCT01777607|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-25|2013-05-11|||May 2013||2013-05-01|May 2013|2013-05-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||The Use of Impella RP Support System in Patients With Right Heart Failure|The Use of Impella RP Support System in Patients With Right Heart Failure: A Clinical and Probable Benefit Study|Unknown status|Recruiting|N/A|30|Anticipated|Abiomed Inc.||1|||f||||t||||||||||2017-10-11 02:03:23.43674|2017-10-11 02:03:23.43674
NCT01777594|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-08-18||2016-08-18|January 2013||2013-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|G-202-003||Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma|A Phase II, Multicenter, Single-Arm Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib for Adult Patients With Progressive Advanced Hepatocellular Carcinoma|Completed||Phase 2|25|Actual|GenSpera, Inc.||1|||f||||f||||||||No||2017-10-11 02:03:23.562507|2017-10-11 02:03:23.562507
NCT01777581|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2014-07-14|2013-09-20||March 2010||2010-03-01|April 2014|2014-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||Two subjects were screened/consented but not assigned to either arm patient. These two patients are reflected as one that would have been assigned to each arm. These subjects were did not receive inerventons|Milnacipran for Lumbosacral Radicular Pain|A Ten-Week, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of Milnacipran for Radicular Pain Associated With Lumbosacral Disk Disease|Completed||Phase 4|13|Actual|Duke University||2|||f||||t||||||||||2017-10-11 02:03:23.696062|2017-10-11 02:03:23.696062
NCT01777568|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-03-14|||November 2012||2012-11-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Supplemental Oxygen in Colorectal Surgery: A Quality Improvement Project||Recruiting||N/A|5017|Anticipated|The Cleveland Clinic|||2||f||||f||||||||No||2017-10-11 02:03:24.216244|2017-10-11 02:03:24.216244
NCT01777555|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-05-04||2015-05-04|April 2013||2013-04-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes|A Phase 2b, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Inhaled CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)|Completed||Phase 2|89|Actual|Acorda Therapeutics||2|||f||||f||||||||||2017-10-11 02:03:24.33177|2017-10-11 02:03:24.33177
NCT01777542|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-11-30|||January 2013||2013-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Interventional|||Treatment of Rett Syndrome With Recombinant Human IGF-1|Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)|Completed||Phase 2|30|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 02:03:24.479258|2017-10-11 02:03:24.479258
NCT01777529|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-07-07|||October 2012||2012-10-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|MMR||Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations|Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella), Single Dose and Multidose Presentations in Children 12 to 23 Months of Age.|Completed||Phase 4|240|Actual|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||2|||f||||t||||||||||2017-10-11 02:03:24.609115|2017-10-11 02:03:24.609115
NCT01777178|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-06-24|||January 2013||2013-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Comparison of Standard Versus Low Bicarbonate Hemodialysis|Intradialytic Acid-base Changes and Organic Anion Production With Standard Versus Low Bicarbonate Hemodialysis|Completed||Phase 1|10|Actual|Albert Einstein College of Medicine, Inc.||1|||f||||f||||||||||2017-10-11 02:03:35.88101|2017-10-11 02:03:35.88101
NCT01777516|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-24|||December 2012||2012-12-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|In_vitro_PAT||In Vitro Interaction Between Ticagrelor and Its Active Metabolite and Their Effects on Salicylic Acid|In Vitro Study to Evaluate the Pharmacodynamic Interaction Between Ticagrelor and Its Active Metabolite (AR-C124910XX) and Their Effects on the Pharmacodynamics of Salicylic Acid : Concentration-antiplatelet Effect Relationships|Completed||N/A|24|Actual|Asan Medical Center|||1||f||||f||||||Samples With DNA|"     Plasma and white blood cells   "|||2017-10-11 02:03:24.715188|2017-10-11 02:03:24.715188
NCT01777503|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-10-19|||November 2012||2012-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||The Elderly ACS II Trial|Phase IV: A Comparison of Reduced-dose Prasugrel and Clopidogrel in Elderly Patients With Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention (PCI)|Recruiting||Phase 4|2000|Anticipated|Arcispedale Santa Maria Nuova-IRCCS||2|||f||||t||||||||||2017-10-11 02:03:24.801131|2017-10-11 02:03:24.801131
NCT01777490|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-08-15|||February 5, 2014|Actual|2014-02-05|August 2017|2017-08-01|December 29, 2017|Anticipated|2017-12-29|January 10, 2017|Actual|2017-01-10||Interventional|HI-FIVES||Helping Invested Families Improve Veterans Experiences Study|Helping Invested Families Improve Veterans Experiences Study (HI-FIVES)|Active, not recruiting||N/A|240|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 02:03:24.92884|2017-10-11 02:03:24.92884
NCT01777477|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-09-21|||July 2012||2012-07-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Adjuvant Effect of Chloroquine on Gemcitabine|Gemcitabine Combined With Chloroquine in Patients With Metastatic or Unresectable Pancreatic Cancer. A Dose Finding Single Center Phase I Study|Completed||Phase 1|9|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 02:03:25.058677|2017-10-11 02:03:25.058677
NCT01777464|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-12-02|||November 2012||2012-11-01|September 2014|2014-09-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||Role of the Central Nervous System in Allergic Rhinitis|Role of the Central Nervous System in Allergic Rhinitis: Activation of Different Brain Regions After a Nasal Histamine Provocation in Healthy and Allergic Patients|Terminated||N/A|14|Actual|Universitaire Ziekenhuizen Leuven||2||analysing images ongoing|f||||f||||||||||2017-10-11 02:03:25.165193|2017-10-11 02:03:25.165193
NCT01777451|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-23|||December 2010||2010-12-01|January 2013|2013-01-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Observational|NEFIMAR||Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis|Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis|Unknown status|Recruiting|N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 02:03:25.254823|2017-10-11 02:03:25.254823
NCT01777438|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-10-24|2013-08-14||December 2012||2012-12-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy|Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy|Completed||N/A|434|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-11 02:03:25.49053|2017-10-11 02:03:25.49053
NCT01777425|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2014-01-17|2013-08-14||December 2012||2012-12-01|December 2014|2014-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Long-term Control in Rhinosinusitis After Functional Endoscopic Sinus Surgery (FESS)|Long-term Control in Rhinosinusitis After FESS: Cross-sectional Observational Study on Control in Rhinosinusitis at a Mean Interval of 3 Years After FESS|Completed||N/A|389|Actual|Universitaire Ziekenhuizen Leuven|patients had to fill in the questionnaire at home, with no help of an expert||1||f||||f||||||||||2017-10-11 02:03:25.893675|2017-10-11 02:03:25.893675
NCT01777412|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-08-01|2015-05-13||June 2013||2013-06-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations|An Open-label Phase 1b Study of Avastin® (Bevacizumab) for the Treatment of Acute Optic Neuritis and/or Transverse Myelitis in Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD).|Completed||Phase 1|10|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 02:03:26.181775|2017-10-11 02:03:26.181775
NCT01777386|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-01-25|||June 2009||2009-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Perforator Artery Changes During Suprafascial Pre-expansion of the Perforator Flaps||Completed||N/A|14|Actual|Istanbul University||2|||f||||||||||||||2017-10-11 02:03:26.431714|2017-10-11 02:03:26.431714
NCT01777373|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-04-09|||August 2012||2012-08-01|December 2014|2014-12-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Observational|VACFI||Conducting Airways in Lung Fibrosis (VACFI)|Conducting Airways in Lung Fibrosis|Completed||N/A|141|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||||||2017-10-11 02:03:26.503923|2017-10-11 02:03:26.503923
NCT01777360|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-02-27|||December 2012|Actual|2012-12-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|ASMATHERM||Bicentric Prospective Study, Evaluating Bronchial THERMOPLASTY in a Patient Presenting Severe Uncontrolled Asthma|Bicentric Prospective Study, Evaluating Bronchial THERMOPLASTY in a Patient Presenting Severe Uncontrolled Asthma|Active, not recruiting||Phase 3|46|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||Undecided||2017-10-11 02:03:28.39259|2017-10-11 02:03:28.39259
NCT01777334|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-11-18|2014-04-24||January 2013||2013-01-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD.|A Multicenter, Trial Comparing the Efficacy and Safety of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily With Tiotropium 18 mcg Once Daily Over 24 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|905|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:03:28.732141|2017-10-11 02:03:28.732141
NCT01777321|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-04-24|2016-11-08|2013-12-05|June 17, 2013||2013-06-17|April 2017|2017-04-01|November 11, 2014|Actual|2014-11-11|October 10, 2013|Actual|2013-10-10||Interventional|||Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years|Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Versus Intramuscularly in Adults Aged 50 Years or Older|Completed||Phase 3|60|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:03:29.698703|2017-10-11 02:03:29.698703
NCT01777282|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-03-30|2015-09-14||February 23, 2013|Actual|2013-02-23|March 2017|2017-03-01|January 27, 2015|Actual|2015-01-27|January 27, 2015|Actual|2015-01-27||Interventional|||A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus|A 52-Week, Open-Label, Multicenter Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Monotherapy of Oral Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|374|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:03:31.207193|2017-10-11 02:03:31.207193
NCT01777269|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-08-28|2016-11-15||February 18, 2013||2013-02-18|August 2017|2017-08-01|April 5, 2016|Actual|2016-04-05|April 5, 2016|Actual|2016-04-05||Interventional|||Prospective Sexual Function Study for BPH Subjects|A Prospective Study of Sexual Function in Sexually Active Men Treated for BPH|Completed||Phase 4|489|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:03:32.346157|2017-10-11 02:03:32.346157
NCT01777243|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-05-05|||May 13, 2013|Actual|2013-05-13|May 2017|2017-05-01|December 22, 2015|Actual|2015-12-22|December 22, 2015|Actual|2015-12-22||Interventional|||A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis|A Single Dose First in Human Study of GSK2398852 Co-Administered With GSK2315698 in Patients With Systemic Amyloidosis|Completed||Phase 1|25|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 02:03:34.060348|2017-10-11 02:03:34.060348
NCT01777230|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2014-12-17|||April 2013||2013-04-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||The Value of Preoperative Sentinel Lymph Node Mapping by Pelvic MR Lymphangiography and SPECT-CT in Cervical Cancer|The Value of Preoperative Sentinel Lymph Node Mapping by Pelvic MR Lymphangiography and SPECT-CT in Cervical Cancer|Withdrawn||N/A|0|Actual|UMC Utrecht|||1|Unable to get required research materials|f||||f||||||None Retained|"     no biospecimens are to be retained.   "|||2017-10-11 02:03:34.162435|2017-10-11 02:03:34.162435
NCT01777217|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2015-01-08|2014-10-10||February 2013||2013-02-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate|A Pilot Study to Assess the Safety and Efficacy of Solifenacin (VESIcare) for Improving Urinary and Bladder Functions in Patients Undergoing Radiation Therapy of the Prostate|Terminated||Phase 4|8|Actual|Advanced Research Network|Early termination leading to small numbers of subjects analyzed.|2||Terminated|f||||t||||||||||2017-10-11 02:03:34.252848|2017-10-11 02:03:34.252848
NCT01777204|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-23|||January 2011||2011-01-01|January 2013|2013-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01|5 Years|Observational [Patient Registry]|||Gastrointestinal Transit and Motility in Renal Transplant Recipients|Non-invasive Assessment of Gastrointestinal Transit and Motility in Renal Transplant Recipients Employing a Biomagnetic Technique|Unknown status|Recruiting|N/A|20|Anticipated|Universidade Estadual de Ciências da Saúde de Alagoas|||7||f||||t||||||||||2017-10-11 02:03:34.515767|2017-10-11 02:03:34.515767
NCT01777191|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-09-13|2016-04-20|2014-09-29|March 2013||2013-03-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|UNCOVER-A||Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis|Pharmacokinetic Evaluations of Ixekizumab Following Subcutaneous Administration Using Prefilled Syringe or Auto-Injector in Patients With Moderate-to-Severe Plaque Psoriasis|Completed||Phase 3|204|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 02:03:34.630393|2017-10-11 02:03:34.630393
NCT01777165|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2015-03-30||2015-03-06|February 2013||2013-02-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery|A Phase 2b, Randomized, Double-Blind,Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery|Completed||Phase 2|240|Actual|AbbVie||4|||f||||t||||||||||2017-10-11 02:03:35.967143|2017-10-11 02:03:35.967143
NCT01777152|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-06-30|||January 2013||2013-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|ECHELON-2||ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas|A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in the Frontline Treatment of Patients With CD30-positive Mature T-cell Lymphomas|Active, not recruiting||Phase 3|452|Actual|Seattle Genetics, Inc.||2|||f||||f||||||||||2017-10-11 02:03:36.170985|2017-10-11 02:03:36.170985
NCT01777126|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-07-16|2013-02-07||January 2009||2009-01-01|January 2011|2011-01-01|November 2012|Actual|2012-11-01|April 2011|Actual|2011-04-01||Interventional|ONP||Oral Nutrition After Regular Radical Cystectomy|A Simple Oral Nutrition Protocol Reduces Length of Stay in Patients With Regular Radical Cystectomy|Completed||Phase 4|94|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 02:03:36.892829|2017-10-11 02:03:36.892829
NCT01777113|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-09-09|||October 2013||2013-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||High Intensity Interval Training in Chronic Stroke Patients|The Effects of a High Intensity Gait Training in Improving Oxygen Consumption in Chronic Stroke Patients: a Randomized Control Study.|Recruiting||N/A|100|Anticipated|Universita di Verona||3|||f||||t||||||||No||2017-10-11 02:03:37.668955|2017-10-11 02:03:37.668955
NCT01777100|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2015-05-26|||July 2012||2012-07-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|SAIRA||Sufentanil for Anesthesia Induction in Continuous Remifentanil Anesthesia|Phase IV Study of Postoperative Analgesic Efficacy and Safety of Anesthesia Induction With Single Dose Sufentanil for Open Abdominal Surgery Under Continuous Remifentanil Anesthesia Versus Total Intravenous Remifentanil Anesthesia|Completed||Phase 4|40|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:03:37.80373|2017-10-11 02:03:37.80373
NCT01777087|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-06-22|||January 2013||2013-01-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Functional Brain Imaging of Pain Phenotype and Genotype|Brain Imaging of Pain Phenotype and Genotype With Novel Scanning Techniques|Completed||N/A|15|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 02:03:37.914996|2017-10-11 02:03:37.914996
NCT01777074|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2013-01-31|||November 2009||2009-11-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|PRALINE||Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians|Measurement of the Changes in Acceptability of Hepatitis B Immunization Among General Practitioners and Open-care Paediatricians|Completed||N/A|474|Actual|GlaxoSmithKline|||2||f||||t||||||||||2017-10-11 02:03:38.069599|2017-10-11 02:03:38.069599
NCT01777048|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-06-23|||April 2013||2013-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Omega-3 Fatty Acids Supplementation in ADHD|Augmenting the Effects of Methylphenidate: A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids Supplementation in Children With Attention Deficit Hyperactivity Disorder|Terminated||Phase 3|8|Actual|University Hospital, Basel, Switzerland||2||Low recruitment numbers|f||||t||||||||||2017-10-11 02:03:39.284094|2017-10-11 02:03:39.284094
NCT01777035|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-02-08|||July 2011||2011-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Mobilization in the ICU|Early Mobilization in the ICU|Recruiting||N/A|200|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 02:03:39.364562|2017-10-11 02:03:39.364562
NCT01777022|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-05-02|||January 13, 2013|Actual|2013-01-13|November 2016|2016-11-01|September 30, 2017|Anticipated|2017-09-30|December 31, 2016|Actual|2016-12-31||Interventional|AFFIRM||Promoting Awareness Fetal Movements to Reduce Fetal Mortality Stillbirth, a Stepped Wedge Cluster Randomised Trial.|Promoting Awareness Fetal Movements and Focussing Interventions Reduce Fetal Mortality Stillbirth, a Stepped Wedge Cluster Randomised Trial.|Active, not recruiting||N/A|430830|Actual|University of Edinburgh||2|||f||||t||||||||||2017-10-11 02:03:39.462373|2017-10-11 02:03:39.462373
NCT01777009|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-25|||March 2009||2009-03-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Effect of Patellar Eversion on Functional Outcomes in Primary Total Knee Arthroplasty|A Randomized, Controlled, Prospective Study Evaluating the Effect of Patellar Eversion on Functional Outcomes in Primary Total Knee Arthroplasty.|Completed||N/A|120|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 02:03:39.635749|2017-10-11 02:03:39.635749
NCT01776996|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-04-04||||||April 2017|2017-04-01||||||||Expanded Access|||An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc|An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc|No longer available||N/A|||ViiV Healthcare|||||f||t||||||||||||2017-10-11 02:03:39.746272|2017-10-11 02:03:39.746272
NCT01776970|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-03-07|||January 2013||2013-01-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CANALS||Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease|A Fase II, Randomized, Double-Blind, Placebo-Controlled, Multicentre Study for the Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease Patients|Completed||Phase 2/Phase 3|60|Actual|Ospedale San Raffaele||2|||f||||t||||||||||2017-10-11 02:03:39.960665|2017-10-11 02:03:39.960665
NCT01776957|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-02-01|||July 2012||2012-07-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Post Abortion IUD & Recurrent Abortion 2005-2006|Preventing Repeat Abortion: Is the Immediate Insertion of Intrauterine Devices Post-abortion a Cost-effective Option Associated With Fewer Repeat Abortions? Findings From 2005-2006 Data|Completed||N/A|1308|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 02:03:40.106287|2017-10-11 02:03:40.106287
NCT01776944|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-07-13|||May 2012||2012-05-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Observational|CalVal||Resting Energy Expenditure Using a Handheld Calorimeter|Validating a Handheld Indirect Calorimeter in Overweight and Obese Pediatric Population|Completed||N/A|75|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 02:03:40.206994|2017-10-11 02:03:40.206994
NCT01776931|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-07-13|||January 2012||2012-01-01|July 2017|2017-07-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Determination of Lysine Requirements in Pregnancy|Determination of Lysine Requirements in Healthy Pregnant Women Using the Indicator Amino Acid Oxidation Technique|Completed||N/A|20|Actual|University of British Columbia||1|||f||||t||||||||||2017-10-11 02:03:40.280415|2017-10-11 02:03:40.280415
NCT01776918|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-07-13|||February 2012||2012-02-01|July 2017|2017-07-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Observational|||Energy Requirements in Mitochondrial Disease|Energy Requirements in Metabolic and Mitochondrial Disease|Completed||N/A|23|Actual|University of British Columbia|||2||f||||f||||||||||2017-10-11 02:03:40.365523|2017-10-11 02:03:40.365523
NCT01776905|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-08-30|||February 2013||2013-02-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||In Vivo Real-time Detection of Circulating Melanoma Cells|In Vivo Real-time Detection of Circulating Melanoma Cells|Recruiting||N/A|75|Anticipated|University of Arkansas|||3||f||||f||||||||||2017-10-11 02:03:40.448425|2017-10-11 02:03:40.448425
NCT01776892|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2014-04-04|||May 2013||2013-05-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease|Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease|Withdrawn||Phase 3|0|Actual|University of Alberta||3|||f||||f||||||||||2017-10-11 02:03:40.53286|2017-10-11 02:03:40.53286
NCT01776879|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-01-23|||February 2013||2013-02-01|January 2013|2013-01-01|November 2014|Anticipated|2014-11-01|November 2013|Anticipated|2013-11-01||Observational|||Speech Intelligibility of Patients With P D Compared to First Degree Relatives of P D Patients|Speech Intelligibility of Patients With Parkinsons Disease at Different Stages of the Disease Compared to First Degree Relatives of Parkinson's Disease Patients|Unknown status|Not yet recruiting|N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center|||3||f||||f||||||||||2017-10-11 02:03:40.640455|2017-10-11 02:03:40.640455
NCT01776866|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-06-27|||January 2013||2013-01-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Image Content Analysis of Dural-axis Rotational Versus Standard Coronary Angiography|Comparison of Image Content Assessment Between Dural-axis Rotational and Standard Coronary Angiography|Completed||N/A|70|Actual|General Hospital of Chinese Armed Police Forces||1|||f||||t||||||||||2017-10-11 02:03:40.715713|2017-10-11 02:03:40.715713
NCT01776853|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-05-12|||January 2013||2013-01-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|FABS||Fructose and Fructans in Irritabla Bowel Syndrome|Fructose and Fructans and Irritable Bowel Syndrome: MRI Study of Underlying Mechanisms|Completed||N/A|69|Actual|University of Nottingham||3|||f||||f||||||||No||2017-10-11 02:03:40.814139|2017-10-11 02:03:40.814139
NCT01776840|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-08-25|||May 16, 2013|Actual|2013-05-16|August 2017|2017-08-01|October 12, 2021|Anticipated|2021-10-12|March 28, 2018|Anticipated|2018-03-28||Interventional|||A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma|A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination With Bendamustine and Rituximab (BR) in Subjects With Newly Diagnosed Mantle Cell Lymphoma|Active, not recruiting||Phase 3|524|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 02:03:40.940272|2017-10-11 02:03:40.940272
NCT01776827|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-05-10|||May 2012||2012-05-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Observational|||Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital|Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital|Completed||N/A|69|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 02:03:41.53163|2017-10-11 02:03:41.53163
NCT01776814|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-01-25|||February 2013||2013-02-01|January 2013|2013-01-01||||February 2013|Anticipated|2013-02-01||Observational|||Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in Korea||Unknown status|Not yet recruiting|N/A|100|Anticipated|Gachon University Gil Medical Center|||1||f||||t||||||||||2017-10-11 02:03:41.597485|2017-10-11 02:03:41.597485
NCT01776801|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-02-22|||January 2009||2009-01-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|CESNA||Assessment of Autonomic Neuronal Changes During Moderate Rise of Intracranial Pressure in Human|Assessment of Autonomic Neuronal Changes During Moderate Rise of Intracranial Pressure in Human|Completed||N/A|10|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-11 02:03:41.67259|2017-10-11 02:03:41.67259
NCT01776788|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2015-03-08|||August 2012||2012-08-01|January 2013|2013-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients|Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy on β-cell Function and Glycemic Remission Rate in Newly Diagnosed Type 2 Diabetic Patients|Completed||Phase 4|156|Actual|The First Affiliated Hospital of Xiamen University||2|||f||||t||||||||||2017-10-11 02:03:41.753093|2017-10-11 02:03:41.753093
NCT01776775|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2016-08-15|||January 2016||2016-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|INSAB||The Effect of Postoperative Abdominal Binder to Improve Outcomes After Incisional Hernia Repair|The Effect of Postoperative Abdominal Binder to Reduce Seroma Formation and Improve Early Clinical Outcome After Incisional Hernia Repair.|Withdrawn||N/A|0|Actual|Hvidovre University Hospital||2||due to lack of finace|f||||f||||||||||2017-10-11 02:03:41.945132|2017-10-11 02:03:41.945132
NCT01776762|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2014-01-30|||March 2013||2013-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Nutritional Intervention in a Cross-sector Model for the Rehabilitation of Geriatric Patients|Effect of Nutritional Intervention in a Cross-sector Model for the Rehabilitation of Undernourished Geriatric Medical Patients: a Randomized Controlled Trial.|Completed||N/A|72|Actual|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 02:03:42.051897|2017-10-11 02:03:42.051897
NCT01776749|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-04-08|||December 2011||2011-12-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|October 2014|Actual|2014-10-01||Interventional|SubQ||Subcutaneous Stimulation as Add on Therapy to SCS toTreat Low Back Pain in FBSS|Subcutaneous Stimulation as Add on Therapy to Spinal Cord Stimulation (SCS) to Treat Low Back Pain in Failed Back Surgery Syndrome (FBSS) (SubQ Study)|Unknown status|Active, not recruiting|N/A|100|Actual|SubQ||3|||f||||t||||||||||2017-10-11 02:03:42.131856|2017-10-11 02:03:42.131856
NCT01776736|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-08-10|||July 1, 2012|Actual|2012-07-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Safety and Efficacy of Posture Correction Girdle for Adolescent With Early Scoliosis|Study of Posture Correction Girdle of Adolescents With Early Scoliosis|Enrolling by invitation||Phase 1|20|Anticipated|The Hong Kong Polytechnic University||1|||f||||t||||||||||2017-10-11 02:03:42.251393|2017-10-11 02:03:42.251393
NCT01776723|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-05-23|||February 20, 2013|Actual|2013-02-20|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib|A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML) and Cataloging the Molecular Consequences of JAK2 Inhibition in Chronic Myelomonocytic Leukemia: A Correlative Study Identifying Targetable CMML Sub-Clones by Leveraging GM-CSF Dependent pSTAT Hypersensitivity|Active, not recruiting||Phase 1/Phase 2|50|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|t|f||||||||2017-10-11 02:03:42.369192|2017-10-11 02:03:42.369192
NCT01776710|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-05-05|||April 2013|Actual|2013-04-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|SEDRIC||Structured EDucation for Rehabilitation in Intermittent Claudication|Development and Piloting of a Pragmatic Structured Education Programme That Promotes Walking in Patients With Intermittent Claudication|Completed||N/A|51|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:03:42.52249|2017-10-11 02:03:42.52249
NCT01776697|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-23|||March 2012||2012-03-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects|A Randomized, Open-labeled, Comparative 3-way Crossover Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects|Completed||Phase 1|||Daewon Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 02:03:42.667042|2017-10-11 02:03:42.667042
NCT01776684|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-25|||June 2012||2012-06-01|January 2013|2013-01-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis|Detection of Resistance Genes From Serially Collected Plasma DNA in Non-small Cell Lung Cancer Patients Harboring EGFR Activating Mutation Who Are Being Treated With EGFR TKIs|Unknown status|Recruiting|N/A|200|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 02:03:42.769627|2017-10-11 02:03:42.769627
NCT01776671|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-09-13|||February 2013||2013-02-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Once Daily Gabapentin in the Treatment of Post Amputation Pain|Efficacy of Once Daily Gastroretentive Gabapentin (Gralise) in the Treatment of Post Amputation Pain|Active, not recruiting||Phase 3|16|Actual|Chicago Anesthesia Pain Specialists||1|||f||||f||||||||||2017-10-11 02:03:42.888735|2017-10-11 02:03:42.888735
NCT01776658|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2015-05-22|||November 2012||2012-11-01|May 2015|2015-05-01||||April 2015|Actual|2015-04-01||Interventional|||Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain||Completed||Phase 1/Phase 2|60|Actual|Sylentis, S.A.||2|||f||||||||||||||2017-10-11 02:03:42.992517|2017-10-11 02:03:42.992517
NCT01776645|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-10-24|2013-07-31||January 2013||2013-01-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Compassion Training and Pain||Completed||N/A|56|Actual|Stanford University||1|||f||||||||||||||2017-10-11 02:03:43.130318|2017-10-11 02:03:43.130318
NCT01776632|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-05-08|||May 11, 2011|Actual|2011-05-11|May 2017|2017-05-01|December 21, 2015|Actual|2015-12-21|December 21, 2015|Actual|2015-12-21||Interventional|||Promoting Physical Activity in Churchgoing Latinas|Promoting Physical Activity in Churchgoing Latinas: Fe en Acción (Faith in Action)|Completed||N/A|436|Actual|San Diego State University||2|||f||||t||||||||||2017-10-11 02:03:43.521736|2017-10-11 02:03:43.521736
NCT01776619|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-12-02|||April 2013||2013-04-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Safety and Tolerability Study of Multiple Doses of PF-06305591|A Double Blind (3rd Party Open) Randomized, Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics of Repeat Doses PF-06305591 Combined With a Cross-over Relative Bioavailability and Food Effect Evaluation After Single Dose of PF-06305591 in Healthy Young Subjects|Completed||Phase 1|43|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 02:03:43.634052|2017-10-11 02:03:43.634052
NCT01776606|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2014-04-14||2013-08-09|December 2012||2012-12-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|RADIANT||Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines||Completed||Phase 3|247|Actual|Revance Therapeutics, Inc.||2|||f||||||||||||||2017-10-11 02:03:43.739986|2017-10-11 02:03:43.739986
NCT01776593|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-01-23|||April 2012||2012-04-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||The Best Parameter of Bladder Diary Correlates With the Volume at Strong Desire to Void of Filling Cystometry|The Best Parameter of Bladder Diary Correlates With the Volume at Strong Desire to Void of Filling Cystometry|Completed||N/A|900|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 02:03:43.823375|2017-10-11 02:03:43.823375
NCT01776580|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-01-24|||July 2011||2011-07-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Association of Pelvic Organ Prolapse Severity and Urinary Symptoms and Sexual Function|The Association of Pelvic Organ Prolapse Severity and Urinary Symptoms and Sexual Function|Recruiting||N/A|1000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 02:03:43.911366|2017-10-11 02:03:43.911366
NCT01776567|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-11|2014-08-02|||July 2012||2012-07-01|August 2014|2014-08-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|APPOSE||Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms|Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms.|Unknown status|Recruiting|Phase 4|60|Anticipated|Northern Hospital, Australia||2|||f||||t||||||||||2017-10-11 02:03:44.025836|2017-10-11 02:03:44.025836
NCT01776554|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-20|2015-04-02|2015-04-02||January 2013||2013-01-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children|A Phase II, Randomized, Observer-Blind, Multi-Center, Study to Evaluate Safety, Tolerability and Immunogenicity of an Adjuvanted Cell Culture-Derived H5N1 Subunit Influenza Virus Vaccine at Two Different Formulations in Healthy Pediatric Subjects.|Completed||Phase 2|662|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:03:44.190835|2017-10-11 02:03:44.190835
NCT01776541|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-20|2015-01-20|2015-01-20||January 2013||2013-01-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults|A Phase II, Randomized, Observer-Blind,Multi-Center, Study to Evaluate Safety, Tolerability and Immunogenicity of an Adjuvanted Cell Culture-Derived H5N1 Subunit Influenza Virus Vaccine at Two Different Formulations in Healthy Adult Subjects.|Completed||Phase 2|979|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:03:45.411195|2017-10-11 02:03:45.411195
NCT01776528|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-12-30|||January 2013||2013-01-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants|A Phase 1 Randomized, Double Blind, Placebo Controlled, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of NGM282 in Healthy Adult Participants|Completed||Phase 1|119|Actual|NGM Biopharmaceuticals, Inc||12|||f||||t||||||||||2017-10-11 02:03:46.193589|2017-10-11 02:03:46.193589
NCT01776515|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-01-23|||January 2012||2012-01-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients|A Randomized, Double-blind, Active-controlled, Parallel, Multicenter Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients|Completed||Phase 1|||Daewon Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 02:03:46.316257|2017-10-11 02:03:46.316257
NCT01776502|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2013-01-23|||December 2007||2007-12-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Observational|||Evaluation of Non Specific Symptoms and Quality of Life Before and After Surgery for Mild Primary Hyperparathyroidism|A Prospective, Non Randomized, Open, Multicenter Trial to Evaluate Non Specific Symptoms and Quality of Life (SF 36) Before and After Surgery for Mild Primary Hyperparathyroidism|Completed||N/A|116|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 02:03:46.394505|2017-10-11 02:03:46.394505
NCT01776489|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-12-09|||December 2011||2011-12-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy|The Role of Sphingosine-1-phosphate in Food Allergy - Biomarker for Disease Severity and Anaphylaxis Outcome|Recruiting||N/A|70|Anticipated|Medical University of Vienna|||2||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 02:03:46.47074|2017-10-11 02:03:46.47074
NCT01776476|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-01-22|||February 2013||2013-02-01|January 2013|2013-01-01|February 2014|Anticipated|2014-02-01|July 2013|Anticipated|2013-07-01||Interventional|GLND Trauma||A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma|A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma|Unknown status|Not yet recruiting|Phase 2|24|Anticipated|Ziegler, Thomas R., M.D.||2|||f||||f||||||||||2017-10-11 02:03:46.574213|2017-10-11 02:03:46.574213
NCT01776463|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-09-30|||January 2013||2013-01-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||A Healthy Subject Study With Z-360 and Placebo|A Single Centre, Randomized, Double-blind, Ascending Dose, Placebo-controlled, and Food Effect Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Z-360 and Placebo in Healthy Subjects|Completed||Phase 1|43|Actual|Zeria Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:03:46.689379|2017-10-11 02:03:46.689379
NCT01776450|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2014-12-31|||November 2012||2012-11-01|December 2014|2014-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Expanded Access|||Compassionate Use of the Incraft® AAA Stent Graft System|Compassionate Use of the Incraft® AAA Stent Graft System|Available||N/A|||Cordis Corporation|||||f||||f||||||||||2017-10-11 02:03:46.776204|2017-10-11 02:03:46.776204
NCT01776437|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-07-26|||February 2013||2013-02-01|July 2017|2017-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers|A Phase 1 Food Effect Study of BMN 673 Administered to Healthy Adult Male Volunteers|Completed||Phase 1|18|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:03:46.855698|2017-10-11 02:03:46.855698
NCT01776424|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-24|2017-09-24|||February 28, 2013|Actual|2013-02-28|September 2017|2017-09-01|March 31, 2018|Anticipated|2018-03-31|July 21, 2017|Actual|2017-07-21||Interventional|COMPASS||Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease|A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).|Active, not recruiting||Phase 3|27395|Actual|Bayer||3|||f||||t|t|f||||||||2017-10-11 02:03:48.799908|2017-10-11 02:03:48.799908
NCT01776411|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-05-09|||January 2013||2013-01-01|May 2017|2017-05-01|April 26, 2017|Actual|2017-04-26|March 2016|Actual|2016-03-01||Interventional|||Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients|Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients|Completed||Phase 1/Phase 2|49|Anticipated|Mundipharma K.K.||1|||f||||f||||||||||2017-10-11 02:03:50.375522|2017-10-11 02:03:50.375522
NCT01776398|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-05-23|||September 2012||2012-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies|Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies|Recruiting||N/A|2000|Anticipated|Weill Medical College of Cornell University|||4||f||||t||||||Samples With DNA|"     Specimens collected may include blood, urine and airway samples (nasal, airway brushing,     biopsy and/or washings) from consenting subjects. Subjects will include both individuals     diagnosed with lung disease and healthy control subjects.   "|Undecided||2017-10-11 02:03:50.500206|2017-10-11 02:03:50.500206
NCT01776385|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-01-23|||February 2012||2012-02-01|November 2012|2012-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma|Detection and Characterization of Circulating Tumor Cells in Patients With Malignant Pleural Mesothelioma: Towards a New Phase in the Understanding of the Natural History of This Cancer?|Unknown status|Recruiting|N/A|45|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 02:03:50.590511|2017-10-11 02:03:50.590511
NCT01776372|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2014-05-12|||January 2013||2013-01-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Comparison of Pleural Drainage Systems on Reducing Pleural Effusion Formation Following Lung Resection|Effect of the Use of a Digital Pleural Drainage System on Reducing Pleural Effusion Formation Following Lung Resection|Completed||N/A|103|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 02:03:50.681542|2017-10-11 02:03:50.681542
NCT01776359|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-06-06|||February 2013||2013-02-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|RIPPED||Effects of High Protein Intake With Intense Exercise and Energy Deficit|Effects of High Protein Intake With Intense Exercise and Energy Deficit|Completed||N/A|40|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 02:03:50.767475|2017-10-11 02:03:50.767475
NCT01776346|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-23|||January 2011||2011-01-01|January 2013|2013-01-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01|5 Years|Observational [Patient Registry]|BPR||Barrett's Esophagus Patient Registry|Barrett's Esophagus Patient Registry|Recruiting||N/A|750|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples With DNA|"     Serum (from whole blood), plasma (from whole blood), tissue   "|||2017-10-11 02:03:50.859486|2017-10-11 02:03:50.859486
NCT01776333|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-23|||January 2013||2013-01-01|January 2013|2013-01-01||||December 2015|Anticipated|2015-12-01||Interventional|VIDEO||A Randomized Controlled Trial of a Video Decision Aid in the ICU|Video Images of Disease for Ethical Outcomes|Unknown status|Not yet recruiting|N/A|150|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:03:50.940384|2017-10-11 02:03:50.940384
NCT01776320|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2014-03-03|||December 2013||2013-12-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction|A Phase 4, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction.|Withdrawn||Phase 4|0|Actual|Lawson Health Research Institute||1||No medication|f||||f||||||||||2017-10-11 02:03:51.037874|2017-10-11 02:03:51.037874
NCT01776307|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-07-11|||March 2012||2012-03-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer|A Phase II Clinical Study of BBI608 in Adult Patients With Advanced Colorectal Cancer|Recruiting||Phase 2|150|Anticipated|Boston Biomedical, Inc||3|||f||||f||||||||||2017-10-11 02:03:51.132726|2017-10-11 02:03:51.132726
NCT01776294|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2013-01-23|||March 2009||2009-03-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|||Prehypertension Among Medical Students in Visakhapatnam and Association With Cardiovascular Risk Factors|Prevalence of Prehypertension Among Medical Students and Association With Cardiovascular Risk Factors|Completed||N/A|275|Actual|Andhra Medical College|||2||f||||t||||||||||2017-10-11 02:03:51.447514|2017-10-11 02:03:51.447514
NCT01776281|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-25|||March 2012||2012-03-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|KMC||Effects of Kangaroo Mother Care Among Low Birth Weight (LBW) and Preterm Infants|Effects of Kangaroo Mother Care Among LBW and Preterm Infants:A Randomized Control Trial in Karachi|Completed||Phase 2|82|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-11 02:03:51.545341|2017-10-11 02:03:51.545341
NCT01776268|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-06-30|2017-04-03||February 2013|Actual|2013-02-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Colostrum on Mucosal Immunity in Very Low Birth Weight (VLBWs) Premature Infants|Effect of Colostrum on Innate Mucosal Immunity in Very Premature Infants|Completed||N/A|99|Actual|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 02:03:51.675366|2017-10-11 02:03:51.675366
NCT01776255|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-10-26|||January 2013||2013-01-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|HCSF2||Healthy Children, Strong Families: American Indian Communities Preventing Obesity|Healthy Children, Strong Families: American Indian Communities Preventing Obesity|Active, not recruiting||N/A|900|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 02:03:52.254731|2017-10-11 02:03:52.254731
NCT01776242|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-03-21|||September 2010||2010-09-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01|24 Months|Observational [Patient Registry]|BOLD||Back Pain Outcomes Using Longitudinal Data (BOLD)|Back Pain Outcomes Using Longitudinal Data (BOLD) Registry and Repository|Completed||N/A|5239|Actual|University of Washington|||1||f||||t||||||||||2017-10-11 02:03:52.381116|2017-10-11 02:03:52.381116
NCT01776229|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-05-05|||October 2012||2012-10-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ERRT-C||Exposure, Relaxation, & Rescripting Therapy-Child|Exposure, Relaxation, & Rescripting Therapy-Child|Completed||N/A|24|Actual|University of Tulsa||2|||f||||f||||||||||2017-10-11 02:03:52.489509|2017-10-11 02:03:52.489509
NCT01776216|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2014-02-06|||August 2011||2011-08-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|PLAT||Impact of Dairy Consumption on Hypertension: a Clinical Study|Impact of Dairy Consumption on Hypertension: a Clinical Study.|Completed||N/A|80|Actual|Laval University||2|||f||||f||||||||||2017-10-11 02:03:52.601596|2017-10-11 02:03:52.601596
NCT01776203|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2015-03-10|||January 2012||2012-01-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist|Initiation of Medical Menopause With Depot Leuprolide Acetate vs Depot Leuprolide Acetate Plus Medroxyprogesterone Acetate: A Pilot Randomized|Terminated||Phase 4|8|Actual|Kaiser Permanente||2||Inadequate enrollment|f||||f||||||||||2017-10-11 02:03:52.704684|2017-10-11 02:03:52.704684
NCT01776190|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-05-10|||September 2012||2012-09-01|May 2016|2016-05-01||||September 2017|Anticipated|2017-09-01||Interventional|||Low-dose UVA1 Radiation in Cutaneous Lupus Patients|Low-dose UVA1 Radiation in Cutaneous Lupus Patients|Recruiting||N/A|15|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 02:03:52.797913|2017-10-11 02:03:52.797913
NCT01776177|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2013-01-23|||September 2012||2012-09-01|January 2013|2013-01-01|August 2013|Anticipated|2013-08-01|March 2013|Anticipated|2013-03-01||Observational|The Reality||The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy|A REAL-LIFE RETROSPECTIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND IMPACT OF LONG-TERM TREATMENT WITH OMALIZUMAB WITH EMPHASIS ON MARKERS OF RESPONSE IN A CLINICAL PRACTICE IN APPROXIMATELY 240 PATIENTS WITH MODERATE-TO-SEVERE ALLERGIC ASTHMA|Unknown status|Active, not recruiting|N/A|240|Anticipated|Allergy & Asthma Research Center, San Antonio, TX|||2||f||||f||||||||||2017-10-11 02:03:52.910654|2017-10-11 02:03:52.910654
NCT01776164|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-04-18|||January 2013||2013-01-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia|Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia|Enrolling by invitation||N/A|32|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||||||2017-10-11 02:03:52.996316|2017-10-11 02:03:52.996316
NCT01776151|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-11-30|||November 2009||2009-11-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)|Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)|Completed||N/A|337|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     Citrated plasma is collected at each study visit and stored at a central lab for future     assessment of changes in plasma markers of thrombosis and fibrinolysis.   "|||2017-10-11 02:03:53.075582|2017-10-11 02:03:53.075582
NCT01776138|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-07-17|||April 2012||2012-04-01|July 2016|2016-07-01|April 2021|Anticipated|2021-04-01|April 2020|Anticipated|2020-04-01||Observational|PORCH||Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer|PORCH: A Registry of Prospective Outcomes of Radical Cystectomy With or Without Chemotherapy|Recruiting||N/A|150|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"     Whole blood samples   "|||2017-10-11 02:03:53.171235|2017-10-11 02:03:53.171235
NCT01776125|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-05-12|||August 2010||2010-08-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Genetic Evaluation of NF1 and Scoliosis Patients|Genetic Evaluation for the Scoliosis Gene(s) in Patients With Neurofibromatosis 1 and Scoliosis|Completed||N/A|59|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||None Retained|"     Participants will be asked to give us a swab (a long Q-tip) of the inside of your cheek     (inside your mouth) for genetic testing. This should take no more than 10 seconds. It will     not hurt. The swab kit will be provided by Axial Biotech Inc. It will include a     self-addressed stamped envelope to mail the swab back to Axial Biotech Inc. Participatns     existing x-rays will be reviewed as part of this study as well. We will review participant's     medical record to look at what treatments have been executed during the course of     participation. Once the individual agrees to participate in this project their private health     information will be sent to Axial Biotech Inc., the company that will be doing the genetic     testing.   "|No||2017-10-11 02:03:53.269453|2017-10-11 02:03:53.269453
NCT01776112|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2015-05-26|||January 2011||2011-01-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|EXERCISE-II||Enhancing Synaptic Plasticity and Cognition in Schizophrenia|Enhancing Synaptic Plasticity and Cognition by Physical Exercise and Cognitive Training in Schizophrenia: A Randomised Controlled Trial|Completed||N/A|66|Actual|University Medical Center Goettingen||3|||f||||f||||||||||2017-10-11 02:03:53.346032|2017-10-11 02:03:53.346032
NCT01776099|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-11-21|||November 2012||2012-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|DiNA-S DiNA-F||Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes|Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes|Recruiting||N/A|60|Anticipated|German Institute of Human Nutrition||4|||f||||f||||||||||2017-10-11 02:03:53.427716|2017-10-11 02:03:53.427716
NCT01776086|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-07-09|||January 2013||2013-01-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||Neuropsychological Testing Using Mobile Devices|Neuropsychological Testing Using Mobile Devices|Withdrawn||N/A|0|Actual|Englewood Hospital and Medical Center||1||no subjects agreed to participate|f||||f||||||||||2017-10-11 02:03:53.507392|2017-10-11 02:03:53.507392
NCT01776073|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-11-03|||January 2013||2013-01-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of a Patient Navigation System to Reduce Time to Waitlisting for Potential Kidney Transplant Recipients|Evaluation of a Patient Navigation System to Reduce Time to Waitlisting for Potential Kidney Transplant Recipients|Active, not recruiting||N/A|800|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 02:03:53.576075|2017-10-11 02:03:53.576075
NCT01776060|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-02-24|||January 2013||2013-01-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study|Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study|Active, not recruiting||N/A|100|Anticipated|Duke University|||1||f||||t||||||Samples With DNA|"     Blood (RNA/DNA), serum, plasma, urine   "|||2017-10-11 02:03:53.659631|2017-10-11 02:03:53.659631
NCT01775852|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-05-23|2015-06-04||August 2010||2010-08-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|May 2012|Actual|2012-05-01||Interventional|ACT-IM||Brief Behavioral Intervention for Comorbid Migraine and Depression|Brief, Behavioral Intervention of ACT & Illness Management for Comorbid Migraine and Depression|Completed||N/A|45|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 02:03:56.449746|2017-10-11 02:03:56.449746
NCT01776047|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-23|||July 2012||2012-07-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers|A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers|Completed||Phase 1|51|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:03:53.738137|2017-10-11 02:03:53.738137
NCT01776034|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-07-12|||January 2013||2013-01-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Health Promotion and Wellness Program for Stroke Survivors|Examining the Efficacy of a SystemCHANGE™ Weight Management Intervention in Stroke Survivors|Recruiting||Phase 1|45|Anticipated|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 02:03:53.896801|2017-10-11 02:03:53.896801
NCT01776021|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2015-04-24|||January 2013||2013-01-01|November 2013|2013-11-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections|Completed||N/A|330|Actual|Ocean Spray Cranberries, Inc.||2|||f||||f||||||||||2017-10-11 02:03:54.146779|2017-10-11 02:03:54.146779
NCT01775995|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-04-11|2014-11-26||January 2013||2013-01-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Meditation-CBT for Opioid-treated Chronic Low Back Pain|Randomized Controlled Trial of Mindfulness Meditation and Cognitive Behavioral Therapy Intervention for Opioid-treated Chronic Low Back Pain|Completed||Phase 1/Phase 2|35|Actual|University of Wisconsin, Madison|Lack of blinding of study staff to group status (except the statistician who was blinded during initial primary analyses); conducting most study related activities by the same core group of research staff may have introduced bias and placebo effect.|2|||f||||f||||||||||2017-10-11 02:03:54.503199|2017-10-11 02:03:54.503199
NCT01775982|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-01-31|||April 2014||2014-04-01|January 2017|2017-01-01|February 2, 2016|Actual|2016-02-02|February 2, 2016|Actual|2016-02-02||Observational|||Validation of a French Version of the Confusion Assessment Method (CAM)|Validation of a French Version of the Confusion Assessment Method (CAM): a Diagnostic Tool for Acute Confusion Among the Elderly|Completed||N/A|102|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 02:03:55.551264|2017-10-11 02:03:55.551264
NCT01775969|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-10-24|||May 2011||2011-05-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Modality on Discharge Instruction in Patients Receiving Outpatient Antibiotic Prescriptions From the Emergency Department|Effect of Modality on Discharge Instruction in Patients Receiving Outpatient Antibiotic Prescriptions From the Emergency Department|Completed||N/A|2874|Actual|Minneapolis Medical Research Foundation||3|||f||||||||||||||2017-10-11 02:03:55.664044|2017-10-11 02:03:55.664044
NCT01775956|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-07-24|||December 2003||2003-12-01|July 2013|2013-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|||A Retrospective Review of a Comprehensive Cohort of Septic Shock: Assessment of Critical Determinants of Outcome|A Retrospective Review of a Comprehensive Cohort of Septic Shock: Assessment of Critical Determinants of Outcome|Recruiting||N/A|10000|Anticipated|University of Manitoba|||1||f||||f||||||||||2017-10-11 02:03:55.74641|2017-10-11 02:03:55.74641
NCT01775930|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-12-05|||October 2013||2013-10-01|December 2016|2016-12-01||||October 2019|Anticipated|2019-10-01||Interventional|||Carfilzomib in Refractory Renal Cell Carcinoma (RCC)|Phase II Study of Carfilzomib in Patients With Refractory Renal Cell Carcinoma|Active, not recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:03:55.880105|2017-10-11 02:03:55.880105
NCT01775917|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2014-06-01|||January 2013||2013-01-01|June 2014|2014-06-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01|6 Weeks|Observational [Patient Registry]|||The Role of Uterine Artery Doppler Parameters in the Management of Retained Products of Conception.|The Role of Uterine Artery Doppler Parameters in the Management of Retained Products of Conception.|Unknown status|Recruiting|N/A|200|Anticipated|Carmel Medical Center|||1||f||||t||||||||||2017-10-11 02:03:55.959772|2017-10-11 02:03:55.959772
NCT01775904|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-05-23|||February 2013||2013-02-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of Two Dosage Forms of LY2886721 in Healthy Participants|A Comparison Study of Capsule and Orally Disintegrating Tablet and to Determine the Effect of Food and Water on the Pharmacokinetics of LY2886721 in Healthy Subjects|Completed||Phase 1|30|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 02:03:56.023556|2017-10-11 02:03:56.023556
NCT01775891|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-02-23|||July 2012||2012-07-01|February 2013|2013-02-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation|Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation Compared With Other Class IC Anti-arrhythmic Drugs|Unknown status|Recruiting|N/A|245|Anticipated|Korea University||2|||f||||t||||||||||2017-10-11 02:03:56.097355|2017-10-11 02:03:56.097355
NCT01775839|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-06-08|||January 2013||2013-01-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin|Clinical Trial to Evaluate the Influence of Genotype of Drug Metabolizing Enzyme or Transporter and Drug-drug Interactions of Aspirin Co-administration on the PK/PD of Clopidogrel and PK of Digoxin in Healthy Volunteers|Completed||Phase 4|24|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:03:56.738973|2017-10-11 02:03:56.738973
NCT01775826|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-05-11|||March 2013||2013-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|iWatch||Validating Machine -Learned Classifiers of Sedentary Behavior and Physical Activity|Validating Machine -Learned Classifiers of Sedentary Behavior and Physical Activity|Completed||N/A|225|Actual|University of California, San Diego|||3||f||||f||||||||||2017-10-11 02:03:56.827204|2017-10-11 02:03:56.827204
NCT01775813|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-04-14|||June 2011||2011-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|HIP||The Health Influences of Puberty (HIP) Study|Combined Influence of Puberty and Obesity on Insulin Resistance in Adolescents|Active, not recruiting||Phase 4|77|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:03:56.895979|2017-10-11 02:03:56.895979
NCT01775800|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-02-26|||January 2013||2013-01-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Treatment Modification to Reduce Symptom Burden in Hemodialysis|Treatment Modification and Symptom Burden in High-Risk Dialysis Patients|Completed||N/A|16|Actual|The Rogosin Institute||2|||f||||f||||||||||2017-10-11 02:03:57.00398|2017-10-11 02:03:57.00398
NCT01775774|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-05-02|2015-12-18||July 2013||2013-07-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Interventional|START||Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome|A Phase 1 Multi-center Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome|Completed||Phase 1|9|Actual|University of California, San Francisco||1|||f||||t||||||||No||2017-10-11 02:03:57.178015|2017-10-11 02:03:57.178015
NCT01775761|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-05-20|||January 2013||2013-01-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)|A Randomized, Placebo- And Positive-Controlled Cross-Over Study To Evaluate The Effect Of Tafamidis On The QTC Interval In Healthy Volunteers|Completed||Phase 1|42|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:03:58.451285|2017-10-11 02:03:58.451285
NCT01775748|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-03-08|||January 1, 2013|Actual|2013-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 30, 2015|Actual|2015-07-30||Interventional|||Effect of Concord Grape Juice on Endothelial Function|Effect Of Concord Grape Juice On Endothelial Function In Obese And Overweight Individuals Over Age 50|Active, not recruiting||N/A|60|Anticipated|Boston University||2|||f||||f|f|f||||||No||2017-10-11 02:03:58.559946|2017-10-11 02:03:58.559946
NCT01775735|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-07-01|||January 2013||2013-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|September 2016|Anticipated|2016-09-01||Interventional|OPTIMISE||Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE|Occipital Nerve Stimulation (ONS) for Migraine OPTIMISE|Active, not recruiting||N/A|180|Anticipated|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 02:03:58.672707|2017-10-11 02:03:58.672707
NCT01775709|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-02-08|||July 2012||2012-07-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of a New Biocompatible Pressure Equalizing Tube|Evaluation of a New Biocompatible Pressure Equalizing Tube|Withdrawn||N/A|0|Actual|University of California, Irvine||1||no participants enrolled|f||||t||||||||||2017-10-11 02:03:58.898636|2017-10-11 02:03:58.898636
NCT01775696|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-09-19|||December 8, 2011|Actual|2011-12-08|September 2017|2017-09-01|September 21, 2017|Anticipated|2017-09-21|September 21, 2017|Anticipated|2017-09-21||Observational|IMABio3||Central and Systemic Inflammation in Alzheimer's Disease|The Role of Central and Systemic Inflammation and Aβ-specific Immune Responses in Early AD|Active, not recruiting||N/A|125|Actual|Assistance Publique - Hôpitaux de Paris|||5||f||||f||||||Samples With DNA|"     blood   "|||2017-10-11 02:03:58.981064|2017-10-11 02:03:58.981064
NCT01775683|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2013-01-22|||January 2013||2013-01-01|January 2013|2013-01-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||Can we Predict Chronic Homelessness?|A Case-control Study to Determine Whether a Screening Measure of Executive Dysfunction, the Quick EXIT, is Predictive of Chronic Homelessness|Unknown status|Not yet recruiting|N/A|60|Anticipated|Ottawa Hospital Research Institute|||2||f||||f||||||||||2017-10-11 02:03:59.100288|2017-10-11 02:03:59.100288
NCT01775670|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-04-06|2016-01-13||February 2013||2013-02-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Off-the-Shelf Splints Versus Occupational Therapy Splints for Treatment of Trapeziometacarpal Arthrosis|Off-the-Shelf Splints Versus Occupational Therapy Splints for Treatment of Trapeziometacarpal Arthrosis|Terminated||N/A|4|Actual|Massachusetts General Hospital||2||"Due to the principal investigator leaving the institution and slow enrollment, we have decided   to close the study prior to study completion"|f||||f||||||||||2017-10-11 02:03:59.206792|2017-10-11 02:03:59.206792
NCT01775657|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-06-09|||January 2013||2013-01-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|May 2014|Actual|2014-05-01||Interventional|DiVA Phase II||Digital Versus Analog Pleural Drainage Following Pulmonary Resection|Digital Versus Analog Pleural Drainage Following Pulmonary Resection|Active, not recruiting||N/A|176|Actual|Ottawa Hospital Research Institute||4|||f||||t||||||||Undecided||2017-10-11 02:03:59.67155|2017-10-11 02:03:59.67155
NCT01775085|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-12-13|||January 2013||2013-01-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Group Interventions for Breast Cancer Survivors|Development of Group Interventions for Breast Cancer Survivors|Active, not recruiting||N/A|104|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:04:12.150993|2017-10-11 02:04:12.150993
NCT01775644|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-08-30|||December 17, 2012|Actual|2012-12-17|August 2017|2017-08-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|||An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)|Avastin ® First Line and Where Applicable Beyond First Progression With Metastatic Colorectal Carcinoma|Active, not recruiting||N/A|3003|Actual|Hoffmann-La Roche|||1||f|||||t|f||||||||2017-10-11 02:03:59.763516|2017-10-11 02:03:59.763516
NCT01775631|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-03-29|||March 2013||2013-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma|A Phase 1b, Open-label, Multicenter Study of Urelumab (BMS-663513) in Combination With Rituximab in Subjects With Relapsed/Refractory B-cell Malignancies|Completed||Phase 1|47|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 02:03:59.869863|2017-10-11 02:03:59.869863
NCT01775618|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2017-09-21|||May 29, 2013|Actual|2013-05-29|September 2017|2017-09-01|February 17, 2020|Anticipated|2020-02-17|March 19, 2015|Actual|2015-03-19||Interventional|||Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A|A Multi-center, Phase III, Non-controlled, Open-label Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of BAY94-9027 for Prophylaxis and Treatment of Bleeding in Previously Treated Children (Age <12 Years) With Severe Hemophilia A|Active, not recruiting||Phase 3|73|Actual|Bayer||2|||f||||t|t|f||||||||2017-10-11 02:04:00.006979|2017-10-11 02:04:00.006979
NCT01775605|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-05-13|||November 2013||2013-11-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Study of Use of Synera for Pain During Local Skin Infiltration With Lidocaine Before Epidural Placement|Randomized Study of the Use of Synera for Pain Relief During Local Lidocaine Needle Skin Infiltration for Epidural Placement in Subjects Undergoing Elective Cesarean Section.|Withdrawn||Phase 4|0|Actual|Northwell Health||3||No participants enrolled|f||||f||||||||||2017-10-11 02:04:00.310106|2017-10-11 02:04:00.310106
NCT01775592|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-25|||September 2012||2012-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Plasmodium Falciparum Artemisinin Resistance Vietnam|Monitoring the Efficacy of Dihydroartemisinin - Piperaquine in Patients With Uncomplicated Falciparum Malaria in Traleng Commune, Central Vietnam|Completed||Phase 4|95|Actual|National Institute of Malariology, Parasitology and Entomology, Vietnam||1|||f||||t||||||||||2017-10-11 02:04:00.390137|2017-10-11 02:04:00.390137
NCT01775579|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-08-22|||January 2013||2013-01-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium|Randomized, Open Label, Multiple-Dose, 6-sequence, 3-period, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium in Healthy Male Subjects|Completed||Phase 1|36|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 02:04:00.489415|2017-10-11 02:04:00.489415
NCT01775566|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-12-23|||March 2013||2013-03-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Clinical Trial to Compare the Pharmacokinetics and Safety of Eperisone HCl SR Tablet 75mg and Myonal Tablet 50mg|A Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of Eperisone HCl SR Tablet 75mg and Myonal Tablet 50mgafter Oral Administration in Healthy Male Subjects.|Completed||N/A|27|Actual|Navipharm Corporation|||1||f||||t||||||Samples With DNA|"     plasma   "|||2017-10-11 02:04:00.576299|2017-10-11 02:04:00.576299
NCT01775553|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-05-24|2017-05-24||September 2013||2013-09-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib|Recapturing Disease Response: A Phase II Study of High Dose Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma Who Have Progressed on Standard Dose Carfilzomib|Completed||Phase 2|13|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 02:04:00.688732|2017-10-11 02:04:00.688732
NCT01775540|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-01-22|||May 2012||2012-05-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Systane Ultra Versus Maxidex Versus Saline|Study to Evaluate the Ocular Surface Healing Action of the Artificial Tear Systane ULTRA Using Both Positive (Maxidex) and Negative (Saline Solution) Controls|Completed||N/A|36|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||f||||||||||2017-10-11 02:04:01.350711|2017-10-11 02:04:01.350711
NCT01775527|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-08-19|||February 2013||2013-02-01|November 2012|2012-11-01|June 2016|Actual|2016-06-01|February 2014|Actual|2014-02-01||Interventional|NIDOCIGA||IgA Nephropathy, Lymphocyte Homing and IgA Class Switch|IgA Nephropathy, Lymphocyte Homing and IgA Class Switch|Completed||N/A|72|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-10-11 02:04:01.496311|2017-10-11 02:04:01.496311
NCT01775514|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-11-01|||October 2012||2012-10-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics|"Occurrence Rate of Non-Small Cell Lung, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey & Diagnosis and Treatment Characteristics Turkish Non-Small Cell Lung-Colon-Gastric-Breast (CGB) Cancer and Malignant Melanoma Study"|Completed||N/A|32277|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:04:01.592319|2017-10-11 02:04:01.592319
NCT01775501|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-01-31|||January 2013|Actual|2013-01-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Sorafenib + mFOLFOX for Hepatocellular Carcinoma|Phase II Trial of Sorafenib in Combination With Modified FOLFOX in Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 2|40|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:04:01.757144|2017-10-11 02:04:01.757144
NCT01775488|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-08-17|||June 2013||2013-06-01|August 2015|2015-08-01||||June 2014|Anticipated|2014-06-01||Interventional|||Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)|Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)|Withdrawn||N/A|0|Actual|HistoSonics, Inc.||1||Poor enrollment|f||||||||||||||2017-10-11 02:04:01.913646|2017-10-11 02:04:01.913646
NCT01775475|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2016-09-29|||September 2016||2016-09-01|June 2016|2016-06-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma|Randomized, Phase II Trial of CHOP vs. Oral Chemotherapy With Concomitant Antiretroviral Therapy in Patients With HIV-Associated Lymphoma in Sub-Saharan Africa|Recruiting||Phase 2|90|Anticipated|AIDS Malignancy Consortium||2|||f||||t||||||||||2017-10-11 02:04:01.995034|2017-10-11 02:04:01.995034
NCT01775449|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-07-10|||February 2, 2013|Actual|2013-02-02|July 2016|2016-07-01|January 6, 2015|Actual|2015-01-06|January 6, 2015|Actual|2015-01-06||Interventional|NEUROXAPOL||Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet|Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet|Completed||Phase 3|80|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:04:02.311605|2017-10-11 02:04:02.311605
NCT01775436|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-08-30|||October 13, 2013|Actual|2013-10-13|August 2017|2017-08-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|FACE||Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care|Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care|Completed||N/A|444|Actual|Children's Research Institute||2|||f||||t||||||||||2017-10-11 02:04:02.502416|2017-10-11 02:04:02.502416
NCT01775423|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-10-13|||March 2009||2009-03-01|October 2015|2015-10-01||||December 2015|Anticipated|2015-12-01||Interventional|||A Study of BBI608 in Adult Patients With Advanced Malignancies|A Phase I Clinical Study of BBI608 in Adult Patients With Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1/Phase 2|90|Anticipated|Boston Biomedical, Inc||1|||f||||f||||||||||2017-10-11 02:04:02.765628|2017-10-11 02:04:02.765628
NCT01775410|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2014-09-11|||February 2013||2013-02-01|September 2014|2014-09-01|September 2014|Anticipated|2014-09-01|August 2013|Actual|2013-08-01||Interventional|COMBINE||OptiCal COherence ToMography ABoard InformiNg AtherEctomy|A Non-randomized, Multi-center Feasibility Trial of the Avinger Wolverine System, an Atherectomy Device That Provides Directional Visualization and Imaging While Removing Plaque in Diseased Lower Extremity Arteries|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Avinger, Inc.||1|||f||||f||||||||||2017-10-11 02:04:02.903442|2017-10-11 02:04:02.903442
NCT01775397|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-06-02|||November 2012||2012-11-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|FREEDOM||A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System|A Phase IIIb/IV Randomized, Controlled, Double-blind, Double-dummy, Parallel Group Study to Compare the Efficacy of Fidaxomicin to Vancomycin in the Sustained Clinical Cure of Clostridium Difficile Infection in Adults Receiving Immunosuppressive Therapy|Terminated||Phase 4|12|Actual|Astellas Pharma Inc||2||Study terminated due to difficulty in enrollment|f||||t||||||||||2017-10-11 02:04:03.022513|2017-10-11 02:04:03.022513
NCT01775384|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-22|||April 2012||2012-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Polyphenols, Exercise, and Metabolomics|Influence of a Polyphenol-enriched Protein Powder on Exercise-induced Inflammation and Oxidative Stress in Athletes: a Metabolomics Approach|Completed||N/A|34|Actual|Appalachian State University||2|||f||||t||||||||||2017-10-11 02:04:03.224509|2017-10-11 02:04:03.224509
NCT01775371|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-05-16|||April 2013||2013-04-01|January 2013|2013-01-01||||||||Interventional|||Effectiveness and Feasibility of Patient Controlled Analgesia in the ED|Effectiveness and Feasibility of Patient Controlled Analgesia in the ED|Unknown status|Enrolling by invitation|N/A|750|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 02:04:03.342264|2017-10-11 02:04:03.342264
NCT01775358|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-05-29|||January 2013||2013-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Phase 1 Safety Study of ALRN-5281 in Healthy Subjects|A Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety and Tolerability of ALRN-5281 Administered by Subcutaneous Injection in Healthy Adult Volunteers|Completed||Phase 1|33|Actual|Aileron Therapeutics||6|||f||||f||||||||||2017-10-11 02:04:03.483773|2017-10-11 02:04:03.483773
NCT01775345|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-03-14|||January 2013||2013-01-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|MENFIS||Assessment of Different Rehabilitation Treatments After a Partial Removal of the Meniscus|Assessment of Different Treatments of Muscle Strengthening in Post-meniscectomy Knee.|Unknown status|Recruiting|Phase 2|81|Anticipated|University Rovira i Virgili||3|||f||||t||||||||||2017-10-11 02:04:03.599835|2017-10-11 02:04:03.599835
NCT01775332|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2015-07-30|||February 2014||2014-02-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools|Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools|Unknown status|Recruiting|N/A|60|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 02:04:03.736356|2017-10-11 02:04:03.736356
NCT01775319|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-04-13|||February 2013||2013-02-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of Human Zinc Absorption From Wheat-based Meals|Evaluation of Human Zinc Absorption From Wheat-based Meals|Completed||N/A|54|Actual|Swiss Federal Institute of Technology||3|||f||||f||||||||||2017-10-11 02:04:03.871966|2017-10-11 02:04:03.871966
NCT01775306|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-01-07|||October 2011||2011-10-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Not Invasive Monitoring at Cardiac Recompensation||Completed||N/A|49|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 02:04:03.995488|2017-10-11 02:04:03.995488
NCT01775293|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-01-06|||January 2013||2013-01-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety in Nasolabial Fold After Rhytidectomy Using Non-absorbable Mesh|A Multi Center, Non-comparative Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety After Rhytidectomy Using Non-absorbable Mesh(RPM)|Completed||N/A|28|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 02:04:04.092013|2017-10-11 02:04:04.092013
NCT01775280|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2015-06-08|||October 2012||2012-10-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|RESRAD||Response of Hepatic Tumors to Radioembolization|Radiologic, Histologic and Immunologic Response to Radioembolization of Hepatic Tumors|Withdrawn||Phase 2|0|Actual|University of Zurich||1||Lack of enrollment|f||||f||||||||||2017-10-11 02:04:04.192514|2017-10-11 02:04:04.192514
NCT01775267|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2015-06-08|||November 2012||2012-11-01|June 2015|2015-06-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|ALPPS||ALLPS VERSUS PVO Randomized Controlled Trial|ASSOCIATING LIVER PARTITION WITH PORTAL VEIN LIGATION FOR STAGED HEPATECTOMY (ALPPS) Versus Conventional Portal Vein Occlusion (PVO) for Resection of Liver Tumors Unresectable in One Step - a Randomized Controlled Trial|Terminated||Phase 2|7|Actual|University of Zurich||2||Study stopped due to safety concerns in both study arms|f||||t||||||||||2017-10-11 02:04:04.310144|2017-10-11 02:04:04.310144
NCT01775254|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-23|2013-01-31|||January 2013||2013-01-01|January 2013|2013-01-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Observational|||The Inland Northwest Colon Cancer Survivor's Study|Self Reported Changes in Quality of Life, Sexual Function, Peripheral Neuropathy, and Demands of Illness, Following Curative Resection and Adjuvant FOLFOX Chemotherapy in Colon Cancer Survivors|Unknown status|Recruiting|N/A|60|Anticipated|Washington State University|||3||f||||f||||||||||2017-10-11 02:04:04.409799|2017-10-11 02:04:04.409799
NCT01775241|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-01-07|||October 2011||2011-10-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Sleep Apnoea Syndrome Without Chronic Heart Failure|Sleep Apnoea Syndrome Without Chronic Heart Failure|Completed||N/A|26|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-10-11 02:04:04.556053|2017-10-11 02:04:04.556053
NCT01775228|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2013-01-23|||November 2006||2006-11-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|||Effect of Peer Support Intervention on Early Recovery Outcomes Post Coronary Artery Bypass Graft Surgery|The Effect of a Professionally-guided Telephone Peer Support Intervention on|Completed||N/A|185|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 02:04:04.638758|2017-10-11 02:04:04.638758
NCT01775215|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-11-27|||January 2013||2013-01-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Observational|AIm-AS||A Comparison of Advanced Imaging Techniques in Aortic Stenosis|A Comparative Study of Advanced Imaging Techniques in Predicting the Clinical Outcome in Aortic Stenosis|Withdrawn||N/A|0|Actual|Royal Brompton & Harefield NHS Foundation Trust|||2|Abandoned|f||||f||||||Samples Without DNA|"     Blood serum sample.   "|||2017-10-11 02:04:04.75409|2017-10-11 02:04:04.75409
NCT01775202|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-23|||January 2013||2013-01-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Observational|||Cognitive Changes After Fast-track Colon Surgery||Unknown status|Recruiting|N/A|200|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 02:04:04.859677|2017-10-11 02:04:04.859677
NCT01775189|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-04-17|2016-10-06||February 2013||2013-02-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Safety analysis set included all participants who received at least 1 dose of study drug, beginning with the naloxone challenge phase.|A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted|A Randomized, Double-blind, Placebo Controlled, Single-dose, 4-way Crossover Study To Determine The Relative Abuse Potential Of Alo-02 (Oxycodone Hydrochloride And Naltrexone Hydrochloride Extended Release Capsules) Compared To Oxycodone Immediate Release, And Placebo When Administered Intranasally To Non-dependent, Recreational Opioid Users.|Completed||Phase 1|45|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:04:05.089653|2017-10-11 02:04:05.089653
NCT01775176|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-01-27|||May 2012||2012-05-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PULSE-A||Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & Adipose|Effect of Weight and Insulin Sensitivity on Reproductive Function in Polycystic Ovary Syndrome: Studies in Skeletal Muscle and Adipose Tissue 'PULSE Ancillary Study'|Completed||Phase 3|16|Actual|Pennington Biomedical Research Center||4|||f||||f||||||||||2017-10-11 02:04:10.290024|2017-10-11 02:04:10.290024
NCT01775163|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-08-16|||December 2010||2010-12-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Effect of Exercise-Induced Weight Loss on Energy Metabolism|E-MECHANIC Ancillary Study: Effect of Exercise-Induced Weight Loss on Energy Metabolism|Completed||N/A|54|Actual|Pennington Biomedical Research Center|||3||f||||f||||||||||2017-10-11 02:04:10.422446|2017-10-11 02:04:10.422446
NCT01775150|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-22|||October 2011||2011-10-01|January 2013|2013-01-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|||Saving Mother and Baby With Text Messaging|Using Mobile Phone Text Messaging to Reduce Maternal and Infant Deaths in Remote Rural Areas in China|Unknown status|Active, not recruiting|N/A|5646|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 02:04:10.533298|2017-10-11 02:04:10.533298
NCT01775137|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2015-11-05|2015-07-28||February 2013||2013-02-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Ext. Long-term Safety Study in CF Patients: Single Arm TIP|A 48 Week Extension to CTBM100C2401, a Single Arm, Open-label, Multicenter, Phase IV Extension Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis Who Completed Participation in CTBM100C2401.|Completed||Phase 4|45|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:04:10.681102|2017-10-11 02:04:10.681102
NCT01775111|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-01-21|||January 2012||2012-01-01|January 2013|2013-01-01||||December 2013|Anticipated|2013-12-01||Interventional|||Influence of Strength Training and Protein Supplementation on Fitness of Institutionalized Elderly|Influence of Strength Training and Nutritional Supplementation on Physical Performance and Well-being of Older People in Pensioner Homes|Unknown status|Recruiting|N/A|120|Anticipated|University of Vienna||3|||f||||f||||||||||2017-10-11 02:04:11.978092|2017-10-11 02:04:11.978092
NCT01775098|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-05-10||||||May 2017|2017-05-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Allopurinol in Acute Gout|Allopurinol in Acute Gout The Title Will Not be Change as the Study as Been Closed.|Withdrawn||N/A|0|Actual|Université de Sherbrooke||2||because of a lack of funding|f||||t||||||||||2017-10-11 02:04:12.081606|2017-10-11 02:04:12.081606
NCT00000123|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||January 1978||1978-01-01|September 2009|2009-09-01|February 1979|Actual|1979-02-01|||||Interventional|||The Berkeley Orthokeratology Study||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.153757|2017-10-11 04:17:30.153757
NCT01775072|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-09-11|||January 2013||2013-01-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Genomic Profiling in Cancer Patients|Genomic Profiling in Cancer Patients|Recruiting||N/A|200|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     tissue, blood, saliva or nail clippings   "|||2017-10-11 02:04:12.245278|2017-10-11 02:04:12.245278
NCT01775059|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-02-04|||March 2013||2013-03-01|January 2013|2013-01-01||||July 2013|Anticipated|2013-07-01||Interventional|||Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4||Unknown status|Not yet recruiting|N/A|50|Anticipated|Medtronic Diabetes R&D Denmark||1|||f||||||||||||||2017-10-11 02:04:12.392672|2017-10-11 02:04:12.392672
NCT01775046|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-01-03|||March 2013||2013-03-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|November 2021|Anticipated|2021-11-01||Observational|||Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases (VALIANT CAPTIVIA France)|Post-market Study on Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases|Active, not recruiting||N/A|160|Actual|Medtronic Endovascular|||1||f||||f||||||||||2017-10-11 02:04:12.493498|2017-10-11 02:04:12.493498
NCT01775033|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-10-25|||June 2012||2012-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|OUTREACH||Regionalized Pediatric Emergency Care in Rural Pennsylvania|Regionalized Pediatric Emergency Care in Rural Pennsylvania: the Optimizing Utilization and Rural Emergency Access for Children Study|Completed||N/A|5000|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 02:04:12.779411|2017-10-11 02:04:12.779411
NCT01775020|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-01-28|||October 2003||2003-10-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2004|Actual|2004-05-01||Interventional|||Dose-response Study of Arginine Supplementation in Severe Sepsis|Arginine and Nitric Oxide (NO) Metabolism in Sepsis; Dose-response Study on the Effect of L-arginine Supplementation on NO Metabolism and Gastric Perfusion in Severe Septic Patients.|Completed||Early Phase 1|8|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 02:04:12.910924|2017-10-11 02:04:12.910924
NCT01775007|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-22|||March 2011||2011-03-01|January 2013|2013-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|Brillouin I||A Pilot Study to Test the Safety and Feasibility of a Brillouin Ocular Analyzer|A Pilot Study to Test the Safety and Feasibility of a Brillouin Ocular Analyzer|Unknown status|Recruiting|Early Phase 1|10|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 02:04:13.006458|2017-10-11 02:04:13.006458
NCT01774994|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-23|||November 2004||2004-11-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|January 2005|Actual|2005-01-01||Interventional|||Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers|Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers|Completed||N/A|33|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 02:04:13.128485|2017-10-11 02:04:13.128485
NCT01774981|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-09-07|2017-07-14|2015-12-23|March 2013||2013-03-01|September 2017|2017-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||All randomized participants who received at least one dose of study drug.|Study of LY3016859 in Participants With Diabetic Nephropathy|Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients|Completed||Phase 1/Phase 2|60|Actual|Eli Lilly and Company||8|||f||||f||||||||||2017-10-11 02:04:13.283712|2017-10-11 02:04:13.283712
NCT01774968|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2015-09-03|2015-04-24||February 2013||2013-02-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||All randomized participants.|Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes|Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial|Completed||Phase 4|325|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:04:16.454791|2017-10-11 02:04:16.454791
NCT01774955|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-08-19|||February 2012||2012-02-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01|12 Months|Observational [Patient Registry]|GRAPE||The GReek AntiPlatElet (GRAPE) Registry: A Multicenter Observational Prospective Investigation of Antiplatelet Treatment in Patients With Acute Coronary Syndrome Subjected to Percutaneous Coronary Intervention|The GReek AntiPlatElet (GRAPE) Registry: A Multicenter Observational Prospective Investigation of Antiplatelet Treatment in Patients With Acute Coronary Syndrome Subjected to Percutaneous Coronary Intervention|Completed||N/A|2047|Actual|University of Patras|||1||f||||f||||||||||2017-10-11 02:04:17.913571|2017-10-11 02:04:17.913571
NCT01774929|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-04-11|2013-02-13||October 2008||2008-10-01|April 2013|2013-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Participants With Osteoarthritis|Evaluation of Efficacy and Safety of TTS-Fentanyl in Moderate to Severe Pain in Osteoarthritis Patients|Completed||Phase 4|35|Actual|Janssen-Cilag Ltd.,Thailand||1|||f||||f||||||||||2017-10-11 02:04:18.129963|2017-10-11 02:04:18.129963
NCT01774916|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-08-29|||January 2013||2013-01-01|August 2014|2014-08-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|||Identification of Genetic and Cellular Markers Associated With Vascular Endothelial Modifications in Cutaneous Arteriovenous Malformations|Identification of Genetic and Cellular Markers Associated With Vascular Endothelial Modifications in Cutaneous Arteriovenous Malformations|Unknown status|Recruiting|N/A|50|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 02:04:18.367915|2017-10-11 02:04:18.367915
NCT01774903|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2013-02-18|2013-02-18||August 2008||2008-08-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Severe Chronic Low Back Pain|Evaluation Study of Efficacy and Safety of TTS-Fentanyl in Severe Chronic Low Back Pain|Completed||Phase 4|45|Actual|Janssen-Cilag Ltd.,Thailand||1|||f||||f||||||||||2017-10-11 02:04:18.473606|2017-10-11 02:04:18.473606
NCT00000124|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-06-01|||November 1986||1986-11-01|June 2002|2002-06-01||||||||Interventional|||Collaborative Ocular Melanoma Study (COMS)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.22424|2017-10-11 04:17:30.22424
NCT01774877|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-12-17|||July 2013||2013-07-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||A Clinical Study of Xin'an Medicine in the Treatment of Bi Syndrome|Efficacy and Safety of Xinfeng Capsule in the Treatment of Rheumatoid Arthritis (RA):A Randomized, Double-blind, Double-dummy, Multi-center Trial|Completed||N/A|304|Actual|The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 02:04:18.910202|2017-10-11 02:04:18.910202
NCT01774864|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-23|||April 2011||2011-04-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction|Phase 3 Study to Evaluate the Efficacy and Safety of Once-a-day Dosing of Udenafil in the Treatment of Erectile Dysfunction|Completed||Phase 3|349|Actual|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:04:19.02118|2017-10-11 02:04:19.02118
NCT01774851|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-06-19|2017-05-10||January 2013||2013-01-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach|Randomized, Open Label, Phase 2 Study of MM-111 and Paclitaxel With Trastuzumab in Patients With HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach Who Have Failed Front Line Metastatic or Locally Advanced Therapy|Terminated||Phase 2|84|Actual|Merrimack Pharmaceuticals|Following the recommendation of the data monitoring committee, this study was terminated prior to enrollment being completed due to lack of efficacy.|2||DSMB recommendation due to lack of efficacy. There were no safety signals.|f||||t||||||||||2017-10-11 02:04:19.29815|2017-10-11 02:04:19.29815
NCT01774838|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-06-10|||October 2014||2014-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome|Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome|Completed||Phase 3|49|Actual|University of Cologne||2|||f||||f||||||||||2017-10-11 02:04:20.95641|2017-10-11 02:04:20.95641
NCT01774825|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2015-03-25|||January 2013||2013-01-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||IQP-CL-101 in IBS Management|Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate the Safety and Efficacy of IQP-CL-101 in the Symptomatic Improvement of Irritable Bowel Syndrome (IBS)|Completed||Phase 3|100|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-11 02:04:21.110183|2017-10-11 02:04:21.110183
NCT01774812|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-08-29|||January 2013||2013-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|VITAH||Vitamin D and Cardiac Autonomic Tone in Hemodialysis|Vitamin D Supplementation and Cardiac Autonomic Tone in Hemodialysis Patients: A Blinded, Randomized-controlled Trial|Completed||Phase 2|56|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 02:04:21.247803|2017-10-11 02:04:21.247803
NCT01774799|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-08-07|||March 2013||2013-03-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|EVINCE||Educational Video to Improve Nursing Home Care in End-stage Dementia|Educational Video to Improve Nursing Home Care in End-stage Dementia|Completed||N/A|804|Actual|Hebrew Rehabilitation Center, Boston||2|||f||||t||||||||||2017-10-11 02:04:21.376244|2017-10-11 02:04:21.376244
NCT01774786|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-08-06|||June 10, 2013|Actual|2013-06-10|August 2017|2017-08-01|December 15, 2021|Anticipated|2021-12-15|December 9, 2016|Actual|2016-12-09||Interventional|||A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer||Active, not recruiting||Phase 3|780|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-11 02:04:21.557407|2017-10-11 02:04:21.557407
NCT01774773|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2014-01-31|||January 2013||2013-01-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet (Study E5501-J081-015)|A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet|Completed||Phase 1|15|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-11 02:04:22.093112|2017-10-11 02:04:22.093112
NCT01774760|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-10-20|||March 2013||2013-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer|Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer|Completed||Phase 2|10|Actual|Turku University Hospital||1|||f||||||||||||||2017-10-11 02:04:22.204367|2017-10-11 02:04:22.204367
NCT01774747|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-06-17|||December 2012||2012-12-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|MAD||A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Oral Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of DSP-1053 in Healthy Subjects and in Subjects With Major Depressive Disorder|Terminated||Phase 1|47|Actual|Sunovion||2||This program was terminated for financial reasons|f||||f||||||||||2017-10-11 02:04:22.306567|2017-10-11 02:04:22.306567
NCT01774734|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-11-24|||September 2011||2011-09-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Combined Neck Strength Exerciser Plus Physiotherapy to Treatment Chronic Neck Pain|Effect of Combined Neck Strength Exerciser Plus Physiotherapy in Treatment of Patients With Chronic Neck Pain|Completed||N/A|80|Actual|Shin Kong Wu Ho-Su Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:04:22.417573|2017-10-11 02:04:22.417573
NCT01774721|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-04-24|||April 2013||2013-04-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|July 2016|Actual|2016-07-01||Interventional|ARCHER 1050||ARCHER-1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.|ARCHER 1050: A Randomized, Open Label Phase 3 Efficacy and Safety Study Of Dacomitinib (PF-00299804) Vs. Gefitinib For The First-Line Treatment Of Locally Advanced or Metastatic NSCLC In Subjects With EGFR Activating Mutations|Active, not recruiting||Phase 3|440|Anticipated|SFJ Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 02:04:22.533696|2017-10-11 02:04:22.533696
NCT01774708|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2014-01-06|||December 2012||2012-12-01|January 2014|2014-01-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|BEDEXIT||Predict Near Future Initiation of Bed Exit|Predict Near Future Initiation of Bed Exit to Prompt Effective Intervention to Avoid Nighttime Falls With Pattern-recognition Algorithms Using Unobtrusive Monitoring of Movement and Vital Signs|Unknown status|Active, not recruiting|N/A|60|Anticipated|Atlanta VA Medical Center|||1||f||||t||||||||||2017-10-11 02:04:22.998834|2017-10-11 02:04:22.998834
NCT01774695|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-21|||June 2011||2011-06-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|IBS||Physical Activity in IBS - a Long Term Follow up|An Intervention to Improve Physical Activity in IBS Patients Has Long Term Positive Effects|Completed||N/A|39|Actual|Sahlgrenska University Hospital, Sweden||1|||f||||||||||||||2017-10-11 02:04:23.070846|2017-10-11 02:04:23.070846
NCT01774682|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-04-25|||January 2013||2013-01-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|MARCHOBESE||Kinematics of Obese Patients Perambulation|Does the Sleeve Gastrectomy Improve the Kinematics of Obese Patients Perambulation ?|Completed||Phase 3|99|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 02:04:23.15906|2017-10-11 02:04:23.15906
NCT01774669|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-04-06|||January 2013||2013-01-01|November 2015|2015-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|YouGrabber||Effectiveness Study on a Virtual Reality Based Training System for Stroke Patients|Effectiveness of the YouGrabber System Using Virtual Reality in Stroke Rehabilitation: a Single Blinded, Randomised Controlled Multi-centre Trial|Completed||Phase 3|54|Actual|Reha Rheinfelden||2|||f||||f||||||||||2017-10-11 02:04:23.254163|2017-10-11 02:04:23.254163
NCT01774656|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-04-25|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RESTAGE-HF||Remission From Stage D Heart Failure|Remission From Stage D Heart Failure (RESTAGE-HF)|Recruiting||Phase 4|40|Anticipated|University of Louisville||1|||f||||f||||||||||2017-10-11 02:04:23.378651|2017-10-11 02:04:23.378651
NCT01774643|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-04-28|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|April 2015|Actual|2015-04-01||Observational|||A Study of Pancreatic Cancer in Xenografts From Liver Metastases|A Feasibility Study Of Developing Murine Primary Xenografts From Biopsies Of Liver Metastases In Patients With Advanced Pancreatic Cancer|Active, not recruiting||N/A|31|Actual|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     Tumor tissue   "|||2017-10-11 02:04:23.533002|2017-10-11 02:04:23.533002
NCT01774630|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-08-19|||April 2013||2013-04-01|August 2016|2016-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|Nilo Post-STIM||Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)|Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)|Recruiting||Phase 2|70|Anticipated|University Hospital, Bordeaux||1|||f||||t||||||||||2017-10-11 02:04:23.631121|2017-10-11 02:04:23.631121
NCT01774617|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-02-22|||February 2013||2013-02-01|February 2013|2013-02-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Comparative Analysis of Different Tests to Evaluate Prognosis of Patients on Liver Transplant Waiting List|Comparative Analysis of Indocyanine Green Clearance Test, Model for End Stage Liver Disease(MELD)Score, MELD-Na Score, Transient Elastography and Hepatic Venous Pressure Gradient to Evaluate Prognosis of Patients on Liver Transplant Waiting List|Unknown status|Recruiting|N/A|100|Anticipated|Universidade Federal do Rio de Janeiro||1|||f||||f||||||||||2017-10-11 02:04:23.964938|2017-10-11 02:04:23.964938
NCT01774604|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-09-28|2016-07-29||January 2013||2013-01-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All patient randomized to receive rectal indomethacin or placebo|Rectal Indomethacin to Prevent Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis|Rectal Indomethacin to Prevent Post-ERCP Pancreatitis|Terminated||Phase 3|449|Actual|Dartmouth-Hitchcock Medical Center|The study was terminated due to indomethacin's lack of efficacy after 449 patients had been enrolled. Thus the study may be underpowered to draw conclusions about the role of indomethacin in preventing post ERCP pancreatitis|2||Futility|f||||t||||||||||2017-10-11 02:04:24.079189|2017-10-11 02:04:24.079189
NCT01774578|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-02-07|||February 2013||2013-02-01|February 2017|2017-02-01||||February 2017|Anticipated|2017-02-01||Interventional|||Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer|An Open-label, Randomized Phase IIB/III Active Control Study of Second-line Tergenpumatucel-L (Hyper-Acute(R)-Lung ) Immunotherapy Versus Docetaxel in Progressive or Relapsed Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2/Phase 3|135|Actual|NewLink Genetics Corporation||3|||f||||t||||||||||2017-10-11 02:04:25.370146|2017-10-11 02:04:25.370146
NCT01774565|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-03-08|||August 2016||2016-08-01|March 2017|2017-03-01||||June 2018|Anticipated|2018-06-01||Interventional|ANGIE02||Closed-loop Insulin Delivery in the General Ward|An Open-label, Randomised, Parallel Design Study to Assess the Efficacy and Safety of Automated Closed-loop Glucose Control in Comparison With Conventional Treatment in Insulin Treated Type 2 Diabetes|Recruiting||Phase 2/Phase 3|150|Anticipated|University of Cambridge||2|||f||||f||||||||||2017-10-11 02:04:25.542785|2017-10-11 02:04:25.542785
NCT01774552|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-02-08|||December 2012||2012-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Evaluate the Port-wine Stain Birthmark Treatment Before and After Pulsed Dye Laser Treatment|A Pilot Study of Photo Acoustic Microscopy and Optical Coherence Tomography Imaging Technologies to Evaluate the Port-wine Stain Birthmark Treatment Before and After Pulsed Dye Laser Treatment.|Recruiting||N/A|30|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-11 02:04:25.675545|2017-10-11 02:04:25.675545
NCT01774539|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2016-06-10|||November 2014||2014-11-01|June 2016|2016-06-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Diffusion MRI and Growth Plate Injuries: Pilot Study|Diffusion MRI as a Prognostic Tool in Growth Plate Injuries: A Pilot Study to Assess Feasibility|Recruiting||N/A|10|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 02:04:25.772198|2017-10-11 02:04:25.772198
NCT01774526|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2013-01-21|||December 2010||2010-12-01|December 2012|2012-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Molecular Epidemiology of Lung Adenocarcinoma in Multi-ethnic Asian Phenotype|Molecular Epidemiology of Lung Adenocarcinoma in Multi-ethnic Asian Phenotype|Unknown status|Recruiting|N/A|40|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 02:04:25.877284|2017-10-11 02:04:25.877284
NCT00000148|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-06-02|||April 1988||1988-04-01|October 2003|2003-10-01||||||||Interventional|||Advanced Glaucoma Intervention Study (AGIS)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.401725|2017-10-11 04:17:33.401725
NCT01774513|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2013-01-22|||January 2013||2013-01-01|January 2013|2013-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||EUS-guided Procore-biopsy in Diagnosing Autoimmune Pancreatitis||Unknown status|Recruiting|N/A|16|Anticipated|Technische Universität München||1|||f||||f||||||||||2017-10-11 02:04:25.966185|2017-10-11 02:04:25.966185
NCT01774500|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2014-03-26|||January 2013||2013-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01|1 Month|Observational [Patient Registry]|BISTRO||Biomarkers In Seizure To Predict Recurrence and Severe Outcomes|Study of Prognosis Value of Protein S100Beta and Copeptine in Seizure in the Emergency Department|Completed||N/A|300|Anticipated|Bistro Study Group|||1||f||||||||||Samples Without DNA|"     2 5ml serum sample for proteine S100Beta and copeptine analysis   "|||2017-10-11 02:04:26.060365|2017-10-11 02:04:26.060365
NCT01774487|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-22|2017-09-12|||January 2013||2013-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Pentoxifylline Therapy in Biliary Atresia|A Phase II Trial of Pentoxifylline in Newly-Diagnosed Biliary Atresia|Recruiting||Phase 2|60|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 02:04:26.139929|2017-10-11 02:04:26.139929
NCT01774474|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-04-13|||July 10, 2013|Actual|2013-07-10|May 2016|2016-05-01|November 4, 2016|Actual|2016-11-04|November 4, 2016|Actual|2016-11-04||Interventional|PREMED||PRevention of Macular EDema After Cataract Surgery|PRevention of Macular EDema After Cataract Surgery|Completed||Phase 3|1127|Actual|Maastricht University Medical Center||7|||f||||t||||||||||2017-10-11 02:04:26.261671|2017-10-11 02:04:26.261671
NCT01774461|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-03-18|||March 2013||2013-03-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Ischemic Preconditioning in Endurance Athletes|Influence of Remote Ischemic Preconditioning on Cardiac Function After Endurance Exercise|Completed||N/A|29|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:04:26.421015|2017-10-11 02:04:26.421015
NCT01774448|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-04-02|||August 2013||2013-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|MBCT_AD||Mindfulness Research Program: Designed to Enhance Wellbeing in People Living With Dementia and Their Spouses|The Efficacy of Mindfulness-Based Cognitive Therapy (MBCT) to Improve Depression Symptoms and Quality of Life in Individuals With Dementia and Their Caregivers: A Pilot Study|Completed||N/A|36|Actual|Lakehead University||2|||f||||f||||||||||2017-10-11 02:04:26.483908|2017-10-11 02:04:26.483908
NCT01774435|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-10-30|||October 2012||2012-10-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant|A Phase 1, Open-Label, Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH) Risperidone When Risperidone is Administered From a Polyurethane Implant|Completed||Phase 1|35|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:04:26.568853|2017-10-11 02:04:26.568853
NCT01774422|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-01-21|||January 2013||2013-01-01|January 2013|2013-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|DECAP CO2||Use of the Medical Device DECAP CO2 for the Treatment of Hypercapnic Respiratory Distress in Patients Under Noninvasive Ventilation|Use of the Medical Device DECAP CO2 for the Treatment of Hypercapnic Respiratory Distress in Patients Under Noninvasive Ventilation|Unknown status|Not yet recruiting|Phase 2|32|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:04:26.640674|2017-10-11 02:04:26.640674
NCT01774409|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-04-04|||February 2013||2013-02-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|July 2017|Anticipated|2017-07-01||Interventional|PROFILER||Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer|Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer|Recruiting||N/A|2000|Anticipated|Centre Leon Berard||1|||f||||f||||||||||2017-10-11 02:04:26.981852|2017-10-11 02:04:26.981852
NCT01774396|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2015-02-24|||January 2013||2013-01-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid In Hands Rejuvenation|Clinical Trial On The Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid (Emervel® Volume Lidocaine, Emervel® Deep Lidocaine And Emervel® Touch) In Hands Rejuvenation|Completed||Phase 4|30|Actual|Brazilan Center for Studies in Dermatology||2|||f||||f||||||||||2017-10-11 02:04:27.153199|2017-10-11 02:04:27.153199
NCT01774383|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2014-01-29|||August 2012||2012-08-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Investigating the Pathophysiological Roles of Cortical, Sub-thalamic Nuclear and Pedunculo-pontine Nuclear Oscillation in Movement Termination of Parkinson Disease Patients||Completed||N/A|3|Actual|China Medical University Hospital|||1||f||||t||||||||||2017-10-11 02:04:27.26248|2017-10-11 02:04:27.26248
NCT01774370|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-06-27|||January 14, 2013|Actual|2013-01-14|June 2017|2017-06-01|February 17, 2017|Actual|2017-02-17|February 17, 2017|Actual|2017-02-17||Observational|||SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea|A Regulatory Requirement Non-interventional Study to Monitor the Safety and Effectiveness of Pradaxa (Dabigatran Etexilate Mesilate, 110 mg or 150 mg b.i.d.) in Korean Patients With Non-valvular Atrial Fibrillation(SPARK: Safety Study of Pradaxa in AF Patients by Regulatory Requirement of Korea)|Completed||N/A|3187|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 02:04:27.328732|2017-10-11 02:04:27.328732
NCT01774357|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2016-11-03|||January 2013||2013-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01|2 Years|Observational [Patient Registry]|MATRIX||Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems|Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems|Active, not recruiting||N/A|2058|Actual|Biotronik SE & Co. KG|||1||f||||f||||||||No||2017-10-11 02:04:27.429266|2017-10-11 02:04:27.429266
NCT01774344|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-21|2017-09-26|2017-02-09||May 14, 2013|Actual|2013-05-14|September 2017|2017-09-01|February 28, 2018|Anticipated|2018-02-28|February 29, 2016|Actual|2016-02-29||Interventional|RESORCE||Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma|A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Study of Regorafenib in Patients With Hepatocellular Carcinoma (HCC) After Sorafenib|Active, not recruiting||Phase 3|573|Actual|Bayer|Decimal places were automatically truncated if last decimal equals zero.|2|||f||||t|t|f||||||||2017-10-11 02:04:27.581204|2017-10-11 02:04:27.581204
NCT01766232|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2015-02-17|||April 2009||2009-04-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|LDRS||Lacrimal Drainage Resistance Study|Lacrimal Drainage Resistance Study|Completed||N/A|40|Actual|The Cleveland Clinic|||2||f||||f||||||||||2017-10-11 02:06:39.851064|2017-10-11 02:06:39.851064
NCT01774331|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-09-12|||November 2012||2012-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|GOOD-SHEPARD||Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)|Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)|Recruiting||N/A|1500|Anticipated|AxelaCare Health Solutions, LLC|||1||f||||f||||||||||2017-10-11 02:04:29.688798|2017-10-11 02:04:29.688798
NCT01774318|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-01-20|||February 2012||2012-02-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|SWC||Early Development of Sleep-wake Cycles in Premature Infants and Its Impact on Neurodevelopmental Outcome|Early Development of Sleep-wake Cycles in Premature Infants and Its Impact on Neurodevelopmental Outcome|Unknown status|Recruiting|N/A|60|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 02:04:29.78852|2017-10-11 02:04:29.78852
NCT01774305|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2014-01-13|2013-06-17||December 2012||2012-12-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional||A patient in group Dexmedetomidine was not completed this study due to changed surgery plan. (Intubated time prolonged more than 3 hours)|Effect of Single-dose Dexmedetomidine on Airway Reflex in Adult With Oral Intubation After Thyroidectomy|Effect of Single-dose Dexmedetomidine on Airway Reflex in Adult With Oral Intubation After Thyroidectomy|Completed||Phase 4|141|Actual|Yonsei University||2|||f||||||||||||||2017-10-11 02:04:29.905313|2017-10-11 02:04:29.905313
NCT01774292|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-10-29|||January 2013||2013-01-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Intracuff Alkalinized Lidocaine on Coughing Incidence at Extubation|Evaluation of the Effect of Intracuff Alkalinized Lidocaine on Coughing Incidence at Extubation in Surgeries Without Nitrous Oxide Lasting More Than 2 Hours|Completed||Phase 4|80|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 02:04:30.27018|2017-10-11 02:04:30.27018
NCT01774279|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-11-07|||June 2013||2013-06-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01|12 Months|Observational [Patient Registry]|iNATT||interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT)|interNational Anaplastic Thyroid Cancer Tissue Bank and Database (NATT).|Recruiting||N/A|350|Anticipated|Velindre NHS Trust|||1||f||||f||||||Samples With DNA|"     Anaplastic thyroid cancer tissue blocks and slides. EDTA blood sample   "|||2017-10-11 02:04:30.375903|2017-10-11 02:04:30.375903
NCT01774266|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-19|2013-05-30|||September 2012||2012-09-01|May 2013|2013-05-01|March 2014|Anticipated|2014-03-01|December 2012|Actual|2012-12-01||Observational|DEMRAC||Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer|Screening and Triage Test for Early Detection of Gastric Cancer|Unknown status|Recruiting|N/A|3000|Anticipated|Pontificia Universidad Catolica de Chile|||1||f||||t||||||Samples With DNA|"     Blood and biopsy samples are collected   "|||2017-10-11 02:04:30.507358|2017-10-11 02:04:30.507358
NCT01774253|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-01-13|2016-05-10||May 2013||2013-05-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma|A Phase II, Open-label, Multi-center Study of Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma.|Terminated||Phase 2|9|Actual|Spectrum Health Hospitals||1||Lack of enrollment and commercial availability of drug|f||||t||||||||||2017-10-11 02:04:30.635536|2017-10-11 02:04:30.635536
NCT01774240|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2013-01-20|||April 2012||2012-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Incidence, Severity and Treatment of Delirium in Cardiac Surgery Patients: A Before-after Study|Incidence, Severity and Treatment of Delirium in Cardiac Surgery Patients: A Before-after Study|Completed||N/A|230|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:04:30.943555|2017-10-11 02:04:30.943555
NCT01774227|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-08-08|||May 2013||2013-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||the Pops-titration Versus the Slow-coagulation Cyclophotocoagulation in Treatment of Refractory Glaucoma|A Randomized Trial of the Pops-titration Versus the Slow-coagulation Energy Delivery Technique on the Outcome of Diode Laser Transcleral Cyclophotocoagulation in Treatment of Refractory Glaucoma With Dark Iris|Recruiting||N/A|90|Anticipated|Prince of Songkla University||2|||f||||t||||||||||2017-10-11 02:04:31.040266|2017-10-11 02:04:31.040266
NCT01774214|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-19|2013-10-26|||April 2013||2013-04-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PFFT2||Pediatric Fast Fluid Trial 2|Rapid Pediatric Fluid Resuscitation: a Randomized Controlled Trial Comparing the Efficiency of Two Provider-Endorsed Manual Fluid Resuscitation Techniques|Completed||N/A|16|Actual|McMaster Children's Hospital||2|||f||||f||||||||||2017-10-11 02:04:31.1431|2017-10-11 02:04:31.1431
NCT01774201|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-01-16|||September 2012||2012-09-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Respiratory Function and Walking Capacity in Multiple Sclerosis|Respiratory Function and Walking Capacity in Multiple Sclerosis|Completed||N/A|50|Actual|Region Örebro County||2|||f||||f||||||||No||2017-10-11 02:04:31.42901|2017-10-11 02:04:31.42901
NCT01774162|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-01-22|||September 2011||2011-09-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration|Endoscopic Ultrasound Guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration.|Completed||N/A|57|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 02:04:31.714884|2017-10-11 02:04:31.714884
NCT00000149|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||October 1993||1993-10-01|June 2002|2002-06-01||||||||Interventional|||Collaborative Initial Glaucoma Treatment Study (CIGTS)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.597037|2017-10-11 04:17:33.597037
NCT01774149|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-08-17|2015-06-16||March 2013||2013-03-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|MDDC||Model Driven Diabetes Care|Data Driven Feedback as a Method to Improve Glycaemic Control in Type 1 Diabetes|Completed||N/A|30|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 02:04:31.919521|2017-10-11 02:04:31.919521
NCT01774136|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-20|2013-01-20|||April 2012||2012-04-01|January 2013|2013-01-01|March 2014|Anticipated|2014-03-01|January 2014|Anticipated|2014-01-01||Interventional|||Effectiveness of an HIV-adapted IMCI Training and Supervision Programme for Community Health Workers|The Effectiveness of an HIV-adapted IMCI Training and Supervision Programme of Community Caregivers to Support Interventions That Will Reduce MTCT and Improve Delivery of Other Essential Newborn and Child Survival Interventions|Unknown status|Recruiting|N/A|3840|Anticipated|University of KwaZulu||2|||f||||f||||||||||2017-10-11 02:04:32.326542|2017-10-11 02:04:32.326542
NCT01774123|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-05-30|||August 2012||2012-08-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Optical Coherence Tomography in Multiple Sclerosis Patients|Optical Coherence Tomography in Multiple Sclerosis Patients|Completed||N/A|78|Actual|The Cleveland Clinic|||3||f||||f||||||||||2017-10-11 02:04:32.452084|2017-10-11 02:04:32.452084
NCT01774110|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-09-01|2015-05-13||August 2012||2012-08-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ESTT||Evaluation of Early Standardized Task-Specific Training (ESTT)|Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke|Terminated||N/A|12|Actual|University of Texas Southwestern Medical Center||1||Very limited enrollment|f||||f||||||||||2017-10-11 02:04:32.562995|2017-10-11 02:04:32.562995
NCT01774097|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-03-10|2017-01-03||June 2013|Actual|2013-06-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|August 2016|Actual|2016-08-01||Interventional|PACE|Information for 4 participants is not available due to patient withdrawal from the study.|Patients With Intermittent Claudication Injected With ALDH Bright Cells|Clinical and MR Imaging Assessments in Patients With Intermittent Claudication Following Injection of Bone Marrow Derived ALDH Bright Cells|Completed||Phase 2|82|Actual|The University of Texas Health Science Center, Houston|Small sample size. Only follow up to 6 months. Limitation in the cell dose.|2|||f||||t||||||||||2017-10-11 02:04:32.99726|2017-10-11 02:04:32.99726
NCT01774084|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-20|2014-06-03|2014-04-06||January 2012||2012-01-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Insulin Sensitivity and Beta Cell Function After Carbohydrate Loading in Hip Replacement Surgery|Insulin Sensitivity and Beta Cell Function After Carbohydrate Loading in Hip Replacement Surgery: A Randomised Doubled-blinded Control Study|Completed||Phase 4|23|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:04:33.923387|2017-10-11 02:04:33.923387
NCT01774071|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-02-24|||January 2013||2013-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer|A Phase I/II Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|27|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:04:34.269022|2017-10-11 02:04:34.269022
NCT01774058|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-05-14|||October 2012||2012-10-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|ILOFLOW||The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation|The Intraoperative Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation in Diabetics and Non-diabetics: Implication for Outcome-prediction and Perioperative Therapy|Recruiting||Phase 2|100|Anticipated|Wilhelminenspital Vienna||1|||f||||f||||||||||2017-10-11 02:04:34.420767|2017-10-11 02:04:34.420767
NCT01774045|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-20|2014-09-17|2014-02-21||November 2012||2012-11-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||One subject administrated with 380mg PDC-1421 lost baseline values of hematology and blood chemistry due to hemolysis and the problem never happens again after the nurse corrected her method of drawing blood. We reported this situation to DSMB and they suggested the remaining data to be included in ITT data set and agreed to enroll new subjects.|A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression|A Dose Escalation Phase I Study of PDC-1421 Capsule to Evaluate the Safety in Healthy Volunteers|Completed||Phase 1|30|Actual|BioLite, Inc.||2|||f||||t||||||||||2017-10-11 02:04:34.606467|2017-10-11 02:04:34.606467
NCT01774032|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-10-07|||March 2013||2013-03-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older|An Open-Label Phase 3 Study to Assess Immunogenicity and Safety of a Vero Cell-Derived Whole Virus H5N1 Influenza Vaccine in a Japanese Elderly Population Aged 65 Years and Older|Completed||Phase 3|91|Actual|Nanotherapeutics, Inc.||1|||f||||t||||||||||2017-10-11 02:04:35.045766|2017-10-11 02:04:35.045766
NCT01774019|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-03-20|||February 2013||2013-02-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Interventional|||Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer|Randomized Multi-Center Study Comparing No Drainage to Preoperative Biliary Drainage Using Metal Stents in Patients With Resectable Pancreatic or Periampullary Cancer|Recruiting||Phase 4|294|Anticipated|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 02:04:35.164094|2017-10-11 02:04:35.164094
NCT01774006|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-09-01|||September 2012||2012-09-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Observational|GroupCulture||Comparison of Individual Culture and Group Culture of Preimplantation Embryos in Human IVF Treatments|Comparison of Individual Culture and Group Culture of Preimplantation Embryos in Human IVF Treatments|Completed||N/A|532|Actual|Semmelweis University|||2||f||||f||||||||||2017-10-11 02:04:35.325367|2017-10-11 02:04:35.325367
NCT01773993|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-09-18|||February 2013|Actual|2013-02-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|||Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)|Special Investigation Of Pregabalin For Fibromyalgia|Completed||N/A|600|Anticipated|Pfizer|||1||f||||f|f|f||||||||2017-10-11 02:04:35.41914|2017-10-11 02:04:35.41914
NCT01773980|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-05-20|||August 2013||2013-08-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening|Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening|Completed||N/A|1570|Actual|OHSU Knight Cancer Institute|||4||f||||f||||||||||2017-10-11 02:04:35.50753|2017-10-11 02:04:35.50753
NCT01769625|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-08-08|||January 2009||2009-01-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Changes in Biomarkers Using Prostaglandin Inhibitors|Prostaglandin Inhibition to Prevent Breast Cancer|Completed||Phase 1/Phase 2|31|Actual|Hartford Hospital||3|||f||||f||||||||||2017-10-11 02:05:37.596689|2017-10-11 02:05:37.596689
NCT01773967|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-12-08|||July 2014||2014-07-01|December 2014|2014-12-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis|Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis|Recruiting||Phase 2/Phase 3|900|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:04:35.625869|2017-10-11 02:04:35.625869
NCT01773941|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-04-24|||January 2013||2013-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:04:35.889421|2017-10-11 02:04:35.889421
NCT01773915|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2014-01-13|||December 2012||2012-12-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|January 2014|Actual|2014-01-01||Observational|||New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study|New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study|Unknown status|Recruiting|N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||Samples Without DNA|"     Urine, blood and saliva in Biobank   "|||2017-10-11 02:04:36.264307|2017-10-11 02:04:36.264307
NCT01773902|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-05-10|||October 2012||2012-10-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|December 2014|Actual|2014-12-01||Interventional|||Protein for Premies|High Versus Standard Dose Protein for Very Preterm Infants|Active, not recruiting||N/A|60|Anticipated|University Hospital Tuebingen||3|||f||||f||||||||||2017-10-11 02:04:36.357511|2017-10-11 02:04:36.357511
NCT01773889|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-05-08|2013-05-08||June 2009||2009-06-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer|A Phase II Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2a to Treat Epithelial Ovarian Cancer FIGO Stage III or Stage IV, or Extraovarian Peritoneal Carcinoma, or Fallopian Tube Carcinoma Failing Ineligible for First-Line Therapy (OCR 09-01)|Terminated||Phase 2|2|Actual|The University of Texas Health Science Center at San Antonio||1||Lack of funding|f||||t||||||||||2017-10-11 02:04:36.451154|2017-10-11 02:04:36.451154
NCT01773876|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-03-23|||July 2012||2012-07-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|EMPIRICUS||Empirical Antifungal Treatment in ICUS|Micafungin Versus Placebo in the Nosocomial Sepsis in Patients Multi-colonized With Candida, Randomized Controlled Trial|Completed||Phase 3|260|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 02:04:36.652385|2017-10-11 02:04:36.652385
NCT01773863|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-11-27|||October 2011||2011-10-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Observational|||MACCE in Hospitalized Patients With Community-acquired Pneumonia|Major Adverse Cardiac and Cerebrovascular Events in Hospitalized Patients With Community-acquired Pneumonia|Recruiting||N/A|500|Anticipated|University of Roma La Sapienza|||1||f||||t||||||Samples Without DNA|"     Plasma, serum and urine samples   "|||2017-10-11 02:04:36.817281|2017-10-11 02:04:36.817281
NCT01773850|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-04-28|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions|Comparison of Carbon Nanotube X-ray Stationary Digital Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions.|Recruiting||N/A|100|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-11 02:04:36.939076|2017-10-11 02:04:36.939076
NCT01773837|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-05-08|||January 2012||2012-01-01|August 2013|2013-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Trial to Evaluate Short-term Efficacy of Palliative Methylphenidate in Asthenia in Advanced Cancer Patients|Double-blind, Placebo-controlled, Multicenter Randomized Clinical Trial to Evaluate Short-term Efficacy of Palliative Treatment With Methylphenidate in Asthenia in Advanced Cancer Patients|Terminated||Phase 3|100|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2||Slow accrual. 100 patients included|f||||f||||||||Undecided||2017-10-11 02:04:37.059155|2017-10-11 02:04:37.059155
NCT01773824|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-05-11|||October 2013||2013-10-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Routine Prescription Feedback and Peer Comparison to Lower Antibiotic Prescriptions in Primary Care|Routine Prescription Feedback and Peer Comparison to Lower Antibiotic Prescriptions in Primary Care - a Pragmatic Randomised Controlled Trial|Completed||N/A|2900|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 02:04:37.176197|2017-10-11 02:04:37.176197
NCT01773811|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2014-05-14|||February 2012||2012-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD|Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD|Completed||N/A|49|Actual|University of Mississippi, Oxford||3|||f||||f||||||||||2017-10-11 02:04:37.288278|2017-10-11 02:04:37.288278
NCT01773798|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-03-04|||January 2013||2013-01-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes|Completed||Phase 1|33|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-10-11 02:04:37.393646|2017-10-11 02:04:37.393646
NCT01765140|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2017-01-23||||||January 2017|2017-01-01||||||||Expanded Access|||Treatment Use of 3,4-Diaminopyridine|Treatment Use of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenia Gravis|Available||N/A|||Duke University|||||||||||||||||||2017-10-11 02:07:04.750554|2017-10-11 02:07:04.750554
NCT01773785|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-07-20|||April 2013||2013-04-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer|Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer|Terminated||Phase 2|30|Actual|Spectrum Pharmaceuticals, Inc||1||"The study completed the first phase and did not meet efficacy end point to enter into the   randomized phase."|f||||f||||||||||2017-10-11 02:04:37.50259|2017-10-11 02:04:37.50259
NCT01773772|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-02-23|||June 2003||2003-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|January 2012|Actual|2012-01-01||Interventional|JCM017||Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls|Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls (JCM017)|Active, not recruiting||Phase 1|24|Anticipated|University of Virginia||2|||f||||f|t|f||||||Undecided|We do not have current plans to share IPD|2017-10-11 02:04:37.610701|2017-10-11 02:04:37.610701
NCT01773759|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2017-04-12|||September 2011||2011-09-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|IPiCC||Immunization Protection in Child Care (IPiCC) Project|Strategies to Improve Vaccination Coverage in Child Care Centers and Preschools|Completed||N/A|107|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 02:04:37.72218|2017-10-11 02:04:37.72218
NCT01773746|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-05-18|||August 2013||2013-08-01|May 2015|2015-05-01|March 2018|Anticipated|2018-03-01|March 2016|Anticipated|2016-03-01||Interventional|PRESOX||Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants|The Premature Infants Resuscitated With Oxygen or Air (PRESOX) Trial|Recruiting||N/A|1260|Anticipated|Sharp HealthCare||2|||f||||t||||||||||2017-10-11 02:04:37.851259|2017-10-11 02:04:37.851259
NCT01773720|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-18|||October 2011||2011-10-01|January 2013|2013-01-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||Reliability of Cardiac Output Monitoring Based on Uncalibrated Pulse Contour Analysis|Evaluation of Reliability of Cardiac Output Monitoring Based on Uncalibrated Pulse Contour Analysis During Off-pump Coronary Artery Bypass Grafting|Unknown status|Recruiting|N/A|40|Anticipated|Northern State Medical University|||1||f||||f||||||None Retained|"     No biospecimens are to be retained.   "|||2017-10-11 02:04:40.307597|2017-10-11 02:04:40.307597
NCT01773707|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-12-12|||March 2013||2013-03-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1|CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes|Recruiting||Phase 2|206|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 02:04:40.401056|2017-10-11 02:04:40.401056
NCT01773694|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-05-17|||March 2013||2013-03-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Impact of Early Post-Operative Water Exposure on Complications of Cutaneous Surgeries|Impact of Early Post-Operative Water Exposure on Complications of Cutaneous Surgeries|Recruiting||N/A|914|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||No||2017-10-11 02:04:40.584075|2017-10-11 02:04:40.584075
NCT01773681|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-05-12|||October 2013||2013-10-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|January 2018|Anticipated|2018-01-01||Observational|NIMRA||Novel Imaging Markers for Rheumatoid Arthritis|Novel Imaging Markers for Rheumatoid Arthritis|Active, not recruiting||N/A|40|Anticipated|University of California, San Francisco|||1||f|||||t|f||||Samples Without DNA|"     blood sample will be collected and stored at Mary Nakamura's lab at the SF VAMC for future     studies.   "|||2017-10-11 02:04:40.693472|2017-10-11 02:04:40.693472
NCT01773668|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-02-04|||November 2012||2012-11-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Feasibility Study - Integrated Sensor and Infusion Set. Trial III|FEASIBILITY STUDY TO ASSESS PERFORMANCE OF THE INTEGRATED SENSOR AND INFUSION SET. WITH HIGH INSULIN NEED USERS (TRIAL III)|Completed||N/A|17|Actual|Medtronic Diabetes R&D Denmark||1|||f||||||||||||||2017-10-11 02:04:40.778347|2017-10-11 02:04:40.778347
NCT01773655|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-07-03|||January 2013||2013-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Clinical and Histopathologic Characteristics of BAP1 Mutations|Clinical and Histopathologic Characteristics of BAP1 Mutations|Recruiting||N/A|460|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     tissue specimens blood or saliva sample   "|||2017-10-11 02:04:40.855446|2017-10-11 02:04:40.855446
NCT01773642|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-04-26|||August 2013|Actual|2013-08-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Pediatric HIV Disclosure Intervention|Comparative Effectiveness of Pediatric HIV Disclosure Interventions in Uganda|Completed||N/A|600|Actual|University of Connecticut||2|||f||||f||||||||||2017-10-11 02:04:40.957665|2017-10-11 02:04:40.957665
NCT01773629|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-01-29|||September 2010||2010-09-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CMPD||Care Managers for Perinatal Depression (CMPD)|Care Managers for Perinatal Depression (CMPD)|Completed||N/A|194|Actual|Lancaster General Hospital||2|||f||||f||||||||||2017-10-11 02:04:41.212853|2017-10-11 02:04:41.212853
NCT01773616|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-06-30|||April 2015|Actual|2015-04-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|RITUXILUP||Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis|Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis|Suspended||Phase 3|24|Actual|Imperial College London||2||"Study assessments for patients recruited continuing per protocol so patients receive a minimum   of 6 months follow up. No safety concerns have been raised."|f||||t||||||||||2017-10-11 02:04:41.33222|2017-10-11 02:04:41.33222
NCT01773603|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2013-01-18|||December 2011||2011-12-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Blastocyst Culture Using Time-lapse in Good Prognosis IVF Patients and Elective Single Embryo Transfer|Blastocyst Culture Using Time-lapse in Good Prognosis IVF Patients and Elective Single Embryo Transfer|Terminated||N/A|64|Actual|Memorial Sisli Hospital, Istanbul||2||No statistical difference observed for outcomes.|f||||f||||||||||2017-10-11 02:04:41.54442|2017-10-11 02:04:41.54442
NCT01773590|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-02-15|||February 2013||2013-02-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||Mechanisms of Interplay Between Allergy and Viruses in Asthma|Mechanisms of Interplay Between Allergy and Viruses in Asthma: A Human Model of Rhinovirus Induced Acute Asthma Exacerbations|Completed||N/A|43|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 02:04:41.632447|2017-10-11 02:04:41.632447
NCT01773577|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-01-17|||January 2010||2010-01-01|March 2012|2012-03-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Observational|HEAL5||The Effect of Interoperable Health IT on Efficiency in Ambulatory Practices|The Effect of Interoperable Health IT on Efficiency in Ambulatory Practices|Completed||N/A|53|Actual|University of Rochester|||1||f||||f||||||||||2017-10-11 02:04:41.72312|2017-10-11 02:04:41.72312
NCT01773564|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-06-14|||October 2012||2012-10-01|June 2016|2016-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|ADVANCED||Comparison of Two New Generation Dressings in Intensive Care (ADVANCED)|Comparison Between Two Types of Semipermeable Dressings of New Generation in the Prevention of Intravascular Catheters Related Complications in Intensive Care.|Completed||N/A|628|Actual|University Hospital, Grenoble||2|||f||||t||||||||No||2017-10-11 02:04:41.795641|2017-10-11 02:04:41.795641
NCT01773551|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-02-08|||April 2012||2012-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Development of a Quantitative Tissue Optical Index of Breast Density For Prediction of Hormone Therapy Response|Development of a Quantitative Tissue Optical Index of Breast Density|Recruiting||N/A|36|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-11 02:04:41.893302|2017-10-11 02:04:41.893302
NCT01773538|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-02-22|||January 2013||2013-01-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement|Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement|Completed||N/A|136|Actual|Hospital of South West Jutland||2|||f||||t||||||||||2017-10-11 02:04:42.021888|2017-10-11 02:04:42.021888
NCT01773525|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-08-23|||January 2013||2013-01-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Testing NOTSSdk in the Clinical Setting||Completed||N/A|15|Anticipated|Herlev Hospital|||1||f||||f||||||||||2017-10-11 02:04:42.112973|2017-10-11 02:04:42.112973
NCT01773512|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-01-18|||June 2012||2012-06-01|January 2013|2013-01-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|PREDICT||The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques|The Prediction of Extent and Risk Profile of Coronary Atherosclerosis (Examined by Intravascular Ultrasound, Virtual Histology and Optical Coherence Tomography) and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques.|Unknown status|Recruiting|Phase 4|60|Anticipated|General University Hospital, Prague||1|||f||||f||||||||||2017-10-11 02:04:42.165303|2017-10-11 02:04:42.165303
NCT01773499|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-03-18|||January 2013||2013-01-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Observational|||Sonographic Features of Cellulitis and Failure of Therapy|Sonographic Features of Cellulitis and Failure of Therapy|Terminated||N/A|3|Actual|University of Massachusetts, Worcester|||1|Unable to enroll significant number of patients.|f||||f||||||||||2017-10-11 02:04:42.257005|2017-10-11 02:04:42.257005
NCT01773486|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-01-28|||June 2015||2015-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EHIS||Effects of Hesperidin on Insulin Sensitivity|An Exploratory Study to Evaluate the Ability of the Citrus Polyphenol Hesperidin to Improve Insulin Sensitivity in Healthy Subjects and to Ameliorate Insulin Resistance in Obese Subjects|Withdrawn||Phase 2|0|Actual|University of Maryland||2||Not funded|f||||t||||||||||2017-10-11 02:04:42.318941|2017-10-11 02:04:42.318941
NCT01773473|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-05-04|2015-05-04||January 2013||2013-01-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CLASSIFY|All randomized participants.|Comparison of Insulin Mix25 Versus Mix50|Comparison Between Low Mixed Insulin and Mid Mixed Insulin AS Starter Insulin For Patients With TYpe 2 Diabetes Mellitus (CLASSIFY Study)|Completed||Phase 4|403|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:04:42.451161|2017-10-11 02:04:42.451161
NCT01773460|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-02-09|||July 2013||2013-07-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|Evelyn||Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane|A Multicenter Randomized, Double Blind, Placebo- Controlled, Phase II Study to Compare Endocrine Treatment Alone Versus Endocrine Treatment With Everolimus in Patients With HR+/HER2- Metastatic Breast Cancer and Progression After Previous Treatment With Exemestane and Everolimus|Terminated||Phase 3|3|Actual|German Breast Group||2||Study was stopped terminated early due to low recruitment.|f||||t||||||||||2017-10-11 02:04:43.624068|2017-10-11 02:04:43.624068
NCT01773447|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-03-29|||August 2011||2011-08-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Set-back Suture Versus Traditional Vertical Mattress Suture|Comparing Wound Eversion and Clinical Outcomes in Surgical Wound Repair With Subcuticular Set-back Versus Traditional Vertical Mattress Suturing Techniques|Completed||N/A|47|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-10-11 02:04:43.726964|2017-10-11 02:04:43.726964
NCT01773434|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-11-08|||December 2012||2012-12-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||A Phase 1 Study of MORAb-004 in Patients With Solid Tumor (Study: MORAb-004-J081-103)|A Phase 1 Study of MORAb-004 in Patients With Solid Tumor|Completed||Phase 1|46|Actual|Eisai Inc.||1|||f||||f||||||||||2017-10-11 02:04:43.806937|2017-10-11 02:04:43.806937
NCT01773421|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-03-13|||July 8, 2011|Actual|2011-07-08|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|April 30, 2014|Actual|2014-04-30||Interventional|||An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820 to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subjects With Unresectable Solid Tumors|An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820, to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subjects With Unresectable Solid Tumors|Active, not recruiting||Phase 1|41|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 02:04:43.891481|2017-10-11 02:04:43.891481
NCT01773213|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-07-11|||December 2012||2012-12-01|January 2013|2013-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Detrusor Contraction During the Ice-water-test|Is the Detrusor Contraction During the Ice-water-test Provoked by the Ice Water or the Rapid Bladder Filling? A Randomized, Double-blind Clinical Trial|Completed||N/A|40|Actual|Balgrist University Hospital||1|||f||||f||||||||||2017-10-11 02:04:46.119678|2017-10-11 02:04:46.119678
NCT01773408|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-01-24|||February 2013||2013-02-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia|A Multi-Center, Open-Label, Phase 1/1b Study of Escalating Doses of RO5503781 Administered Orally as 1) a Single Agent, 2) In Combination With Cytarabine, or 3) With Cytarabine and Anthracycline and 4) Assessing PK and Safety of New Optimized Formulation of RO5503781 With Cytarabine in Patients With Acute Myelogenous Leukemia (AML)|Completed||Phase 1|122|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 02:04:43.984242|2017-10-11 02:04:43.984242
NCT01773395|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-07-18|||January 2013||2013-01-01|July 2017|2017-07-01|January 2033|Anticipated|2033-01-01|July 2019|Anticipated|2019-07-01||Interventional|||GVAX vs. Placebo for MDS/AML After Allo HSCT|A Randomized Placebo-controlled Phase II Trial of Irradiated, Adenovirus Vector Transferred GM-CSF Secreting Autologous Leukemia Cell Vaccination (GVAX) Versus Placebo Vaccination in Patients With Advanced MDS/AML After Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|152|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 02:04:44.13888|2017-10-11 02:04:44.13888
NCT01773382|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-01-18|||October 2012||2012-10-01|January 2013|2013-01-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Interventional|WeightPro||The Effects of Weight Reduction in IgA Nephropathy|The Effects of Weight Reduction in Chronic Proteinuric IgA Nephropathy|Unknown status|Recruiting|N/A|30|Anticipated|Chulalongkorn University||2|||f||||f||||||||||2017-10-11 02:04:44.273391|2017-10-11 02:04:44.273391
NCT01773369|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-05-23|||November 2012||2012-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intensive Motor Training After Perinatal Stroke to Enhance Walking|Intensive Motor Training After Perinatal Stroke to Enhance Walking|Recruiting||N/A|100|Anticipated|University of Alberta||4|||f||||t||||||||Undecided||2017-10-11 02:04:44.373087|2017-10-11 02:04:44.373087
NCT01773356|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-09-24|||January 2011||2011-01-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Dihydrocapsiate on Energy Expenditure in Women|Randomized, Controlled, Parallel Trial to Evaluate the Effects of Dihydrocapsiate on Energy Expenditure in Women|Completed||N/A|126|Actual|University of Georgia||2|||f||||f||||||||||2017-10-11 02:04:44.490188|2017-10-11 02:04:44.490188
NCT01773343|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-18|||November 2011||2011-11-01|January 2013|2013-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals|Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals. A Randomized Controlled Trial With Blinded Response Evaluations|Unknown status|Active, not recruiting|N/A|12|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:04:44.598026|2017-10-11 02:04:44.598026
NCT01773330|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-01-21|||October 2013||2013-10-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|HRM||High Resolution Manometry for Swallowing|High Resolution Manometry: Optimizing the Swallow Protocol|Terminated||Phase 1|71|Actual|University of Florida||1||Study has been halted per PI and IRB recommendation|f||||f||||||||||2017-10-11 02:04:44.673812|2017-10-11 02:04:44.673812
NCT01773317|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-08-16|||August 2011||2011-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Can Neuromuscular Training Alter Movement Patterns|Can Neuromuscular Training Alter Movement Patterns After Anterior Cruciate Ligament Injury?|Active, not recruiting||Early Phase 1|80|Anticipated|University of Delaware||2|||f||||f||||||||||2017-10-11 02:04:44.776705|2017-10-11 02:04:44.776705
NCT01773304|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-03-22|||December 2012||2012-12-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|MEDA||Acute Effects of Dairy and Meat Proteins on Bone Metabolism and Metabolic Profile|Acute Effects of Dairy and Meat Proteins on Bone Metabolism and Metabolic Profile in Urine and Plasma in Overweight Adults|Completed||N/A|17|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:04:44.856569|2017-10-11 02:04:44.856569
NCT01773291|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-12-22|2015-08-25||January 2013||2013-01-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Adjuvant Acupuncture for Severe Head Injury|Adjuvant Acupuncture Therapy in Patients With Severe Head Injury: a Randomized Controlled Trial|Completed||N/A|24|Actual|Chang Gung Memorial Hospital|Inclusion criteria leading to small numbers (24/583 in 2.5 years) of subjects analyzed.|3|||f||||t||||||||||2017-10-11 02:04:44.940405|2017-10-11 02:04:44.940405
NCT01773278|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-08-25|||December 2008||2008-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)|Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)|Recruiting||Phase 2|100|Anticipated|University of Colorado, Denver||3|||f||||f|t|f||||||||2017-10-11 02:04:45.236577|2017-10-11 02:04:45.236577
NCT01773265|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2017-07-25|||February 2013||2013-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:04:45.349207|2017-10-11 02:04:45.349207
NCT01773252|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-11-10|||November 2012||2012-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|PFO Detection||Right to Left Cardiac Shunt Detection|A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound|Terminated||Phase 3|141|Actual|Cardiox Corporation||1||Business decision to perform a market withdrawal of the product|f||||f||||||||||2017-10-11 02:04:45.556958|2017-10-11 02:04:45.556958
NCT01773239|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-09-29|||May 2012||2012-05-01|September 2016|2016-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|TARA||Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia|Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia -Targeted Affective Remediation Approach (TARA)|Completed||N/A|16|Actual|Posit Science Corporation||1|||f||||f||||||||||2017-10-11 02:04:45.685744|2017-10-11 02:04:45.685744
NCT01773226|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-01-25|2016-03-22||March 2013||2013-03-01|April 2014|2014-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||"Evaluation of Intra-articular Injection of Autologous Protein Solution (APS(TM)) for the Treatment of Osteoarthritis (OA)"|"A Prospective Single-Center Clinical Study of a Single Intra-Articular Injection of Autologous Protein Solution (APS(TM)) in Patients With Osteoarthritis (OA) of the Knee"|Completed||N/A|11|Actual|Zimmer Biomet|"Small sample size
Unblinded observational study"|1|||f||||f||||||||No||2017-10-11 02:04:45.80265|2017-10-11 02:04:45.80265
NCT01773200|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-03-29|||March 2013||2013-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|EVAPROPEC||Prognostic Value of Circulating Endothelial Progenitor Cells in Aneurysmal Subarachnoid Hemorrhage|Prognostic Value of Circulating Endothelial Progenitor Cells in Aneurysmal Subarachnoid Hemorrhage (Evaluation de l'intérêt Pronostic Des progéniteurs endothéliaux Circulants Dans l'hémorragie Sous-arachnoïdienne Par Rupture d'anévrysme cérébral)|Recruiting||N/A|92|Anticipated|Centre Hospitalier Universitaire de Besancon|||1||f||||f||||||||||2017-10-11 02:04:46.198724|2017-10-11 02:04:46.198724
NCT01773187|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-12-15|||December 2012||2012-12-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|January 2015|Actual|2015-01-01||Interventional|||Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis|A Randomized Controlled Phase 3 Study of Oral Pacritinib Versus Best Available Therapy in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis|Terminated||Phase 3|327|Actual|CTI BioPharma||2|||f||||t||||||||||2017-10-11 02:04:46.315418|2017-10-11 02:04:46.315418
NCT01773174|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2015-10-23|||January 2013||2013-01-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age|Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89|Withdrawn||Phase 2|0|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:04:46.64998|2017-10-11 02:04:46.64998
NCT01773161|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-05-30|||February 2011||2011-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Cerebral Palsy Hip Health Related Quality of Life|Health Related Quality of Life in Patients With Cerebral Palsy Undergoing Surgery for Dislocating Hips|Active, not recruiting||N/A|24|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 02:04:46.766773|2017-10-11 02:04:46.766773
NCT01773148|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-02-23|||December 2012||2012-12-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|ASPEN||Access Safety and Efficacy Post Endovascular Intervention|AXERA Access Safety and Efficacy Post Endovascular INtervention|Unknown status|Active, not recruiting|N/A|240|Anticipated|Arstasis, Inc.||1|||f||||t||||||||||2017-10-11 02:04:46.883781|2017-10-11 02:04:46.883781
NCT01773135|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-02-21|2014-02-21||January 2013||2013-01-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01|9 Weeks|Observational [Patient Registry]|PTL||Maternal Serum Level of ACTH as a Predictive Marker of Preterm Labor in Patients With Threatened Preterm Labor|Maternal Serum Level of ACTH as a Predictive Marker of Preterm Labor in Patients With Threatened Preterm Labor|Completed||N/A|262|Actual|Ain Shams Maternity Hospital|It's the different time of day that blood sampling was carried out, although this reflects normal clinical practice, blood samples were collected at the time of admission to hospital regardless of the time of day, rather than diurnal pattern of ACTH.||2||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 02:04:47.009231|2017-10-11 02:04:47.009231
NCT01773122|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2014-02-11|2014-02-11||January 2013||2013-01-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris||Completed||Phase 1|77|Actual|Allergan||4|||f||||f||||||||||2017-10-11 02:04:47.273576|2017-10-11 02:04:47.273576
NCT01773109|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-18|2016-07-18|||January 2013||2013-01-01|July 2016|2016-07-01||||January 2016|Actual|2016-01-01||Interventional|||Etirinotecan Pegol (NKTR-102) in NSCLC|Phase 2 Study of Etirinotecan Pegol (NKTR-102) in the Treatment of Patients With Metastatic and Recurrent Non-Small Cell Lung Cancer (NSCLC) After Failure of 2nd Line Treatment|Active, not recruiting||Phase 2|43|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 02:04:47.768919|2017-10-11 02:04:47.768919
NCT01773083|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-01-30|||October 2013||2013-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Interventional|Hepburn||Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma|Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin Versus Placebo in Burn Patients With Inhalation Trauma (Hepburn)|Terminated||Phase 3|13|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2||"insufficient recruitment of patients and high costs associated with the purchase and blinding   of study medication"|f||||t||||||||||2017-10-11 02:04:47.943768|2017-10-11 02:04:47.943768
NCT01773057|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2015-05-06|||April 2013||2013-04-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|May 2014|Actual|2014-05-01||Interventional|NHGDoc||Effects of 'NHGDoc' on Quality of Care|Effects of the Computerized Decision Support System 'NHGDoc' on Quality of Care: a Cluster Randomized Controlled Trial|Unknown status|Active, not recruiting|Early Phase 1|120|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 02:04:48.316729|2017-10-11 02:04:48.316729
NCT01773044|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-01-17|||September 2012||2012-09-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pain on Injection of Propofol: a Comparison of Lidocaine and Alkalinized Lidocaine||Completed||Phase 4|300|Actual|Inonu University||2|||f||||f||||||||||2017-10-11 02:04:48.511165|2017-10-11 02:04:48.511165
NCT01773031|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-12-28|||January 2013||2013-01-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography|Pancreatic Duct Evaluation in Autoimmune Pancreatitis: Intraindividual Comparison of MR Pancreatography at 3.0 T and 1.5 T|Completed||N/A|30|Actual|Asan Medical Center|||1||f||||f||||||||||2017-10-11 02:04:48.591912|2017-10-11 02:04:48.591912
NCT01773018|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-05-31|||February 2012||2012-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|HMPL-504||Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors|A Phase I, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of HMPL-504 in Patients With Advanced Solid Tumors|Completed||Phase 1|47|Actual|Hutchison Medipharma Limited||1|||f||||f||||||||No||2017-10-11 02:04:48.675531|2017-10-11 02:04:48.675531
NCT01772992|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-09-26|||June 2014||2014-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|CVCTPLUS||CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence|CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence|Recruiting||N/A|800|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-11 02:04:48.866039|2017-10-11 02:04:48.866039
NCT01772979|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2013-01-17|||June 2011||2011-06-01|December 2012|2012-12-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|MITO15||Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer|Phase II Study With Trabectedin (Yondelis®) in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Advanced Ovarian Cancer Patients|Unknown status|Recruiting|Phase 2|100|Anticipated|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-11 02:04:48.972228|2017-10-11 02:04:48.972228
NCT01772966|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-10-27|||February 2013||2013-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Chiropractic Manual Therapy and Neck Pain|Generalizing a Valid Control Manipulation to a Multiple Operator, Longitudinal Randomized Controlled Study for Chronic Neck Pain|Completed||N/A|319|Actual|Canadian Memorial Chiropractic College||2|||f||||t||||||||||2017-10-11 02:04:49.0675|2017-10-11 02:04:49.0675
NCT01772953|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-10-10|||September 2013||2013-09-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT|A Phase II Study of Treosulfan/Fludarabine/Low Dose Total Body Irradiation as a Preparative Regimen for Children With AML/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation|Completed||Phase 2|40|Actual|Center for International Blood and Marrow Transplant Research||1|||f||||t||||||||||2017-10-11 02:04:49.166141|2017-10-11 02:04:49.166141
NCT01772940|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-08-22|||December 2008||2008-12-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting|Nevirapine vs Ritonavir-boosted Lopinavir in ART HIV-infected Adults in a Resource-limited Setting; a Randomized, Multicenter, Parallel Group Study|Completed||Phase 4|425|Actual|Centre Hospitalier Universitaire Saint Pierre||4|||f||||t||||||||||2017-10-11 02:04:49.32385|2017-10-11 02:04:49.32385
NCT01772927|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-01-17|||January 2013||2013-01-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|May 2013|Anticipated|2013-05-01||Observational|BAXTERULG2||Clinical Tolerance of Numeta 13%|Use of Parenteral Nutrition in Premature Infants Weighing Less Than 1500 g Using Numeta G13% From the First Day of Life. A Prospective, Open-labeled Study on Intakes and Nutritional Markers.|Unknown status|Not yet recruiting|N/A|30|Anticipated|University Hospital of Liege|||1||f||||f||||||||||2017-10-11 02:04:49.439538|2017-10-11 02:04:49.439538
NCT01772914|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2014-05-19|||February 2013||2013-02-01|January 2013|2013-01-01|February 2014|Actual|2014-02-01|June 2013|Actual|2013-06-01||Observational|CoMeal||Copeptin Changes After Food Intake|Copeptin During a Standardized Oral Glucose Tolerance Test and a Mixed Meal Tolerance Test|Completed||N/A|30|Actual|University Hospital, Basel, Switzerland|||1||f||||f|||||||"     Serum EDTA   "|||2017-10-11 02:04:49.534751|2017-10-11 02:04:49.534751
NCT01772901|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-10-07|||October 2013||2013-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Brief Influenza Vaccine Education to Pregnant Women|A Randomized Controlled Trial of a Brief Educational Intervention to Increase Uptake of Influenza Vaccine Among Pregnant Women|Completed||N/A|321|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:04:49.608223|2017-10-11 02:04:49.608223
NCT01772888|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-05-10|||October 2012||2012-10-01|May 2016|2016-05-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|||Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients?|Chewing Efficiency Measured by a Two Colour Chewing Gum Test: a Marker of Insufficient Nutritional Intakes and Percutaneous Gastrostomy (PEG) Necessity in ALS Patients?|Recruiting||N/A|25|Anticipated|University Hospital, Geneva|||2||f||||f||||||||||2017-10-11 02:04:49.721122|2017-10-11 02:04:49.721122
NCT01772875|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-01-18|||March 2013||2013-03-01|January 2013|2013-01-01|August 2014|Anticipated|2014-08-01|March 2014|Anticipated|2014-03-01||Interventional|||Bladder Lavage as Decontamination Method for Asymptomatic Bacteriuria With Uropathogens in Catheterized Patients|Pilot Study to Evaluate the Efficacy of Antiseptic Bladder Lavage Versus Pulsatile Lavage With Physiologic Serum in Catheterized Patients With Asymptomatic Bacteriuria With Uropathogens.|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|National Multiple Sclerosis Center||4|||f||||t||||||||||2017-10-11 02:04:49.832561|2017-10-11 02:04:49.832561
NCT01772862|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-02-06|||January 2013||2013-01-01|February 2013|2013-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|RESPECT||Rehabilitation Including Social and Physical Activity in Children and Teenagers With Cancer|Rehabilitation Including Social and Education in Children and Teenagers With Cancer|Recruiting||N/A|240|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:04:49.973372|2017-10-11 02:04:49.973372
NCT01772849|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-02-06|||January 2013||2013-01-01|February 2013|2013-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|RESPECT-EDU||Rehabilitation Including Social Activity and Education in Children and Teenagers With Cancer|Rehabilitation Including Social Activity and Education in Children and Teenagers With Cancer|Recruiting||N/A|240|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:04:50.091085|2017-10-11 02:04:50.091085
NCT01763697|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-05-28|||March 2013||2013-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Taste Acuity and Caloric Intake After Acute Morphine Administration|Taste Acuity and Caloric Intake After Acute Morphine Administration|Completed||N/A|36|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-10-11 02:07:57.136741|2017-10-11 02:07:57.136741
NCT01772836|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-07-09|||March 2013||2013-03-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination in Healthy Adult Subjects.|Completed||Phase 1|30|Anticipated|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||4|||f||||f||||||||||2017-10-11 02:04:50.221567|2017-10-11 02:04:50.221567
NCT01772810|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-09-06|||August 2014|Actual|2014-08-01|September 2017|2017-09-01|December 2022|Anticipated|2022-12-01|July 2018|Anticipated|2018-07-01||Interventional|SCI||Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI|A Phase 1, Open-label, Single-site, Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI|Recruiting||Phase 1|8|Anticipated|Neuralstem Inc.||1|||f||||t||||||||||2017-10-11 02:04:50.485703|2017-10-11 02:04:50.485703
NCT01772797|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-09-21|||June 2013||2013-06-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer|A Phase Ib, Open-label, Dose Escalation Study of LDK378 and AUY922 in Patients With ALK-rearranged Non-small Cell Lung Cancer|Completed||Phase 1|22|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:04:50.611217|2017-10-11 02:04:50.611217
NCT01772784|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-01-17|||June 2012||2012-06-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Phenolic Acids on Endothelial Function||Completed||N/A|24|Actual|Nestlé||4|||f||||t||||||||||2017-10-11 02:04:50.767129|2017-10-11 02:04:50.767129
NCT01772771|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-08-25|||March 2012|Actual|2012-03-01|August 2017|2017-08-01|March 2032|Anticipated|2032-03-01|March 2032|Anticipated|2032-03-01||Observational|||Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program|Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program|Recruiting||N/A|8000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     Blood drawn once during a scheduled visit. Buccal swab or saliva sample may be collected     during a scheduled visit for patients with hematologic or other disease.   "|||2017-10-11 02:04:50.866099|2017-10-11 02:04:50.866099
NCT01772758|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-08-08|||August 2011||2011-08-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Cystic Fibrosis and Endothelial Function: At Rest and During Exercise|Influence of Cystic Fibrosis on Vascular Endothelial Function at Rest and During Exercise|Completed||Phase 2|36|Actual|Augusta University||2|||f||||f||||||||Yes||2017-10-11 02:04:50.986237|2017-10-11 02:04:50.986237
NCT01772745|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-01-17|||January 2010||2010-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Comparison of Single Incision Laparoscopic Cholecystectomy and Three Port Laparoscopic Cholecystectomy|The Comparison of Single Incision Laparoscopic Cholecystectomy and Three Port Laparoscopic Cholecystectomy|Completed||N/A|100|Actual|Maltepe University||2|||f||||t||||||||||2017-10-11 02:04:51.103986|2017-10-11 02:04:51.103986
NCT01772732|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-04-07|||December 2012||2012-12-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC|Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 1|30|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:04:51.212046|2017-10-11 02:04:51.212046
NCT01772719|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-02-09|||August 2012||2012-08-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid|Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid|Terminated||N/A|7|Actual|James Graham Brown Cancer Center||1||Principal Investigator left institution-study not continued|f||||t||||||||||2017-10-11 02:04:51.333608|2017-10-11 02:04:51.333608
NCT01772706|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-01-17|||October 2008||2008-10-01|January 2013|2013-01-01||||March 2019|Anticipated|2019-03-01||Interventional|LaserMucite||Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer|A Randomized, Double Blind, Controlled, Multi-center, Phase III Study to Assess Efficacy of Low Level Diode Laser (100 MW, 658 Nm), in the Prevention and Treatment of Radiochemotherapy-induced Mucositis in Head and Neck Cancer.|Recruiting||Phase 3|100|Anticipated|Institut Cancerologie de l'Ouest||2|||f||||f||||||||||2017-10-11 02:04:51.453167|2017-10-11 02:04:51.453167
NCT01772693|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-05-17|||September 2012||2012-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease|A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease.|Active, not recruiting||N/A|27|Actual|InSightec||2|||f||||f||||||||||2017-10-11 02:04:51.601354|2017-10-11 02:04:51.601354
NCT01772680|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-11-25|||November 2012||2012-11-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Zinc and Diabetes in Patients With Thalassemia: a Pilot Study|Zinc and Diabetes in Patients With Thalassemia: a Pilot Study|Completed||Phase 1|40|Actual|Children's Hospital & Research Center Oakland||1|||f||||t||||||||||2017-10-11 02:04:51.718404|2017-10-11 02:04:51.718404
NCT01772667|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-11-22|||October 2013||2013-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Interventional|||Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis|Long Term Effects of a 3-week Inpatient Pulmonary Rehabilitation Program in Patients With Idiopathic Pulmonary Fibrosis|Completed||N/A|51|Anticipated|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 02:04:51.815385|2017-10-11 02:04:51.815385
NCT01772654|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-03-04|2015-02-17||January 2013||2013-01-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy|Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy|Completed||N/A|73|Actual|Mayo Clinic|Small sample size.|2|||f||||f||||||||||2017-10-11 02:04:51.909559|2017-10-11 02:04:51.909559
NCT01772641|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-03-14|||December 2012||2012-12-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation|A Combination of Scheduled Reduced Smoking With Varenicline to Enhance Cessation|Terminated||Phase 4|32|Actual|Icahn School of Medicine at Mount Sinai||4||difficulty recruiting and retaining participants|f||||t||||||||||2017-10-11 02:04:52.181377|2017-10-11 02:04:52.181377
NCT01772628|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-03-01|||January 2010||2010-01-01|March 2013|2013-03-01|March 2014|Anticipated|2014-03-01|September 2012|Actual|2012-09-01||Interventional|PREPARE||Parenting Styles and Parent-Offspring Communication on Sexuality Issues|Promoting Parent-Child Communication on Selected Sexual and Reproductive Health Issues Among Young Secondary School Adolescents in Kampala and Wakiso Districts|Unknown status|Active, not recruiting|N/A|1700|Anticipated|Makerere University||2|||f||||||||||||||2017-10-11 02:04:52.296888|2017-10-11 02:04:52.296888
NCT01772615|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-08-09|||May 2011||2011-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle|Active Ulcerative Colitis; Placebo Controlled Treatment Trial With Ciprofloxacin and E. Coli Nissle|Completed||Phase 4|100|Actual|Hvidovre University Hospital||4|||f||||t||||||||||2017-10-11 02:04:52.416493|2017-10-11 02:04:52.416493
NCT01772602|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-08-08|||October 2010||2010-10-01|July 2015|2015-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||The National Amyotrophic Lateral Sclerosis Registry|The National Amyotrophic Lateral Sclerosis Registry|Recruiting||N/A|13000|Anticipated|Centers for Disease Control and Prevention|||1||f||||f||||||||||2017-10-11 02:04:52.522095|2017-10-11 02:04:52.522095
NCT01772589|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-02-17||||||February 2015|2015-02-01||||February 2015|Actual|2015-02-01||Interventional|||Effect of Cutting Blades for Total Knee Arthroplasty on Implant Migration|Effect of Cutting Blades for Total Knee Arthroplasty on Implant Migration. A Randomized Controlled Study With Radiostereometric Analysis|Withdrawn||N/A|0|Actual|Nova Scotia Health Authority||2||Comparator sawblade no longer available|f||||f||||||||||2017-10-11 02:04:52.636123|2017-10-11 02:04:52.636123
NCT01772576|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-06-02|2017-04-12||October 2012||2012-10-01|April 2016|2016-04-01|August 2016|Actual|2016-08-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Performance Study of the Reliance 4-Front Lead|RELIANCE 4-FRONT™ Active Fixation Defibrillation Lead Post Market Clinical Follow-Up (PMCF) Study|Completed||N/A|167|Actual|Boston Scientific Corporation|Sample size was rather small and power of the study is only 80%.|1|||f||||f|f|t|t|f|t|||No||2017-10-11 02:04:52.948092|2017-10-11 02:04:52.948092
NCT01772563|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-09-21|||February 4, 2013|Actual|2013-02-04|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|May 30, 2014|Actual|2014-05-30||Interventional|||Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours|An Open-label Fixed Sequence Trial to Investigate the Potential Drug-drug Interaction of Intravenous Volasertib Co-administered With a P-gp and CYP3A4 Inhibitor (Itraconazole p.o.) in Patients With Various Solid Tumours|Active, not recruiting||Phase 1|28|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:04:53.683673|2017-10-11 02:04:53.683673
NCT01772550|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2014-04-08|2014-02-11||January 2013||2013-01-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|ARCTR05||Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans|A Randomized Controlled Study to Determine Whether Smaller Gauge Fenestrated Catheters Are as Effective as Larger Gauge Non-fenestrated Catheters for Use in IV Contrast Enhanced CT Scans|Completed||N/A|238|Actual|Becton, Dickinson and Company||3|||f||||f||||||||||2017-10-11 02:04:53.802449|2017-10-11 02:04:53.802449
NCT01772537|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-03-02|2016-09-20||May 2012||2012-05-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Effects of Anesthesia on Patients Undergoing Surgery for Repair of a Thoracoabdominal Aneurysm.|The Effect of Anesthesia on Potential Cerebrospinal Fluid (CSF) and Serum Markers of Alzheimer's Disease.|Terminated||N/A|14|Actual|Johns Hopkins University||3||The data did not show clear results|f||||f||||||||No||2017-10-11 02:04:54.491428|2017-10-11 02:04:54.491428
NCT01772524|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-01-06|||January 2013||2013-01-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Safety, Efficacy and Pharmacokinetics of ALD403|A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines|Completed||Phase 1|163|Actual|Alder Biopharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:04:54.950907|2017-10-11 02:04:54.950907
NCT01772511|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-01-26|||March 2012||2012-03-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?|BrUOG 274: Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?|Completed||N/A|50|Actual|Brown University|||1||f||||t||||||||||2017-10-11 02:04:55.107996|2017-10-11 02:04:55.107996
NCT01772498|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-05-05|||January 2013||2013-01-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|August 2015|Anticipated|2015-08-01||Interventional|||HRV Biofeedback for Brain Tumour Survivors|Heart Rate Variability Biofeedback for Psychologically Distressed Brain Tumour Survivors|Suspended||N/A|15|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 02:04:55.213552|2017-10-11 02:04:55.213552
NCT01772485|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-05-06|||January 2013||2013-01-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Online Neuroplasticity Training for Remediation of ADHD in Adolescent Children (ONTRAC)|Double Blind Randomized Controlled Trial Evaluation of a Novel Brain Plasticity-based Training Program for the Remediation of Cognitive Deficits in Adolescents With ADHD in New Delhi, India|Completed||N/A|31|Actual|Posit Science Corporation||2|||f||||t||||||||||2017-10-11 02:04:55.309436|2017-10-11 02:04:55.309436
NCT01771965|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-07-14|2017-07-14||October 2014||2014-10-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line|Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line|Completed||N/A|19|Actual|VA Office of Research and Development||2|||f||||f|f|f||||||||2017-10-11 02:05:06.645311|2017-10-11 02:05:06.645311
NCT01772459|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2014-06-20|||August 2010||2010-08-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|P vs I||Paper vs. Internet|Internet-administered Adolescent Scoliosis Questionnaires Compared With Traditional Pencil and Paper Versions: a Randomized Crossover Design|Completed||N/A|139|Actual|University of British Columbia|||4||f||||f||||||||||2017-10-11 02:04:58.115262|2017-10-11 02:04:58.115262
NCT01772433|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-17|||January 2013||2013-01-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||Olive Oil Phonophoresis and Chronic Low Back|The Effect of Olive Oil Phonophoresis on Chronic Low Back Pain in Female Athletes: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|60|Anticipated|Ardabil University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:04:58.297659|2017-10-11 02:04:58.297659
NCT01772420|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-01-14|||October 2012||2012-10-01|January 2016|2016-01-01||||October 2017|Anticipated|2017-10-01||Interventional|||Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome|Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome (MDS)|Recruiting||Phase 2|60|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 02:04:58.429917|2017-10-11 02:04:58.429917
NCT01772407|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-04-13|||September 2009||2009-09-01|May 2016|2016-05-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|CHIRCOL||Laparoscopic Surgery Equivalent to Open Surgery in Right Colon Cancer Surgery?|Right Colon Cancer: Laparoscopic Surgery Versus Open Surgery, Costs, Mortality, Morbidity and Quality of Life|Completed||N/A|142|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||No||2017-10-11 02:04:58.767188|2017-10-11 02:04:58.767188
NCT01772394|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-01-13|||October 2012||2012-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Interventional|TreCogAM||Cognitive Remediation Therapy in Anorexia Nervosa|Cognitive Remediation Therapy Effectiveness in Anorexia Nervosa: a Multicenter Randomized Clinical Study|Completed||N/A|120|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:04:58.8886|2017-10-11 02:04:58.8886
NCT01772381|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2013-01-18|||March 2010||2010-03-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term Fetus|Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean|Completed||N/A|600|Actual|Ain Shams Maternity Hospital||1|||f||||t||||||||||2017-10-11 02:04:59.058598|2017-10-11 02:04:59.058598
NCT01772368|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-05-10|2017-02-28|2015-03-19|January 2013||2013-01-01|May 2017|2017-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Intent-to-Treat population|Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects|A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma|Completed||Phase 2|72|Actual|Teva Pharmaceutical Industries||6|||f||||f||||||||||2017-10-11 02:04:59.203065|2017-10-11 02:04:59.203065
NCT01772355|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-01-17|||October 2008||2008-10-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness and Possible Complications of Core Needle Biopsy of Orbital Tumors||Unknown status|Recruiting|N/A|75|Anticipated|The S.N. Fyodorov Eye Microsurgery State Institution||1|||f||||||||||||||2017-10-11 02:05:00.409951|2017-10-11 02:05:00.409951
NCT01772342|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-01-23|||March 2009||2009-03-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Effects of an Air Purifying Device (PureNight) on Sleep Quality in Obstructive Lung Disease|Effects of a Novel Purifying Device (PureNight) on Sleep Quality in Chronic Obstructive Pulmonary Disease|Completed||N/A|50|Actual|VA New York Harbor Healthcare System||1|||f||||f||||||||||2017-10-11 02:05:00.499595|2017-10-11 02:05:00.499595
NCT01772329|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-11-08|||January 2013||2013-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CT_TKA||Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects|Preoperative Cognitive Therapy for Improving Health Outcomes After Total Knee Replacement in High-risk Catastrophizing Subjects|Recruiting||N/A|80|Anticipated|Rush University Medical Center||4|||f||||f||||||||Undecided|No plan to share data as of yet but may be willing to.|2017-10-11 02:05:00.590669|2017-10-11 02:05:00.590669
NCT01772316|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-09-29|2016-07-18||December 2012||2012-12-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis|A Multicenter, Open-label, Long-term Extension Study of WA22762 and NA25220 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|47|Actual|Hoffmann-La Roche||1|||f||||t||||||||||2017-10-11 02:05:00.703552|2017-10-11 02:05:00.703552
NCT01771952|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2014-12-04|||March 2010||2010-03-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Randomized Evaluation of the Efficacy of Synvisc-One® for the Treatment of Patellofemoral Chondromalacia|Prospective, Randomized, Double Blind Evaluation of the Efficacy of a Single Dose of Synvisc-One® (6.0 cc) for the Treatment of Patellofemoral Chondromalacia|Unknown status|Recruiting|N/A|100|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-11 02:05:06.937109|2017-10-11 02:05:06.937109
NCT01772303|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-04-03|||January 2013||2013-01-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|H2H||Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds|An Open-Label, Prospective, Multicenter Study to Assess the Safety and Efficacy of HO/03/03 10-40 Micro Gram (Wound Size Dependence) Applied Topically for up to 24 Weeks in Subjects With Various Etiologies of Hard-to-Heal Wounds|Unknown status|Recruiting|Early Phase 1|100|Anticipated|HealOr||1|||f||||f||||||||||2017-10-11 02:05:01.303725|2017-10-11 02:05:01.303725
NCT01772290|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-11-01|||February 2013||2013-02-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of Vismodegib|A Clinical Drug-Drug Interaction Study to Evaluate the Effect of a Proton Pump Inhibitor, a Combined P-gp/CYP3A4 Inhibitor, and a CYP2C9 Inhibitor on the Pharmacokinetics of Vismodegib|Completed||Phase 1|92|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 02:05:01.489834|2017-10-11 02:05:01.489834
NCT01772277|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-02-12|||December 2012||2012-12-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis|Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis|Completed||N/A|400|Anticipated|Wenzhou Medical University|||2||f||||t||||||||||2017-10-11 02:05:01.625304|2017-10-11 02:05:01.625304
NCT01772264|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-05-08|||January 2013||2013-01-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Safety And Tolerability Study Of BID Titration Scheme With PF-05089771|An Investigator And Subject Blinded, Sponsor Open, Randomized, Placebo Controlled, Multiple Dose Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-05089771 In Healthy Subjects|Completed||Phase 1|40|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:05:01.76587|2017-10-11 02:05:01.76587
NCT01772251|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-10-27|||February 2013||2013-02-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study|A Single-Center, Multiple-dose, Randomized, Cross-Over, Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacodynamics, Safety, and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study|Completed||Phase 1/Phase 2|10|Actual|Oshadi Drug Administration||1|||f||||f||||||||||2017-10-11 02:05:01.85006|2017-10-11 02:05:01.85006
NCT01772238|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-08-02|||March 22, 2011|Actual|2011-03-22|August 2017|2017-08-01|March 30, 2011|Actual|2011-03-30|March 30, 2011|Actual|2011-03-30||Interventional|||Bioequivalence Study of an Amoxicillin-Clavulanic|Bioequivalence Study of an Amoxicillin-Clavulanic Acid Suspension Preparation. Cross-over, Randomized, Single Dose, Two Treatments, Two Periods and Two Sequences Trial in Fasting Conditions|Completed||Phase 1|35|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:05:01.96058|2017-10-11 02:05:01.96058
NCT01772225|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2014-03-27|||September 2013||2013-09-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|LuCaBIS||NSCLC Burden of Illness Study|A Burden-of Illness Study in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-10-11 02:05:02.066955|2017-10-11 02:05:02.066955
NCT01772212|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-06-21|||February 24, 2011|Actual|2011-02-24|June 2017|2017-06-01|March 15, 2011|Actual|2011-03-15|March 15, 2011|Actual|2011-03-15||Interventional|||Bioequivalence Study for Terbinafine 250 mg|Bioequivalence Study Between Two Medications for the Oral Administration of Terbinafine 250 mg in Oral Solids in Healthy Volunteers|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:05:02.162577|2017-10-11 02:05:02.162577
NCT01772186|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2013-10-22|||February 2013||2013-02-01|October 2013|2013-10-01||||July 2014|Anticipated|2014-07-01||Interventional|||Freezing of Gait Correction and Fall Prevention: Developing a Real-time Somatosensory Stimulation System|Freezing of Gait Correction and Fall Prevention in People With Parkinson's Disease: Developing and Application of a Real-time Somatosensory Stimulation System|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:05:02.47281|2017-10-11 02:05:02.47281
NCT01772173|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-05-04|||February 1, 2013|Actual|2013-02-01|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|February 1, 2016|Actual|2016-02-01||Observational|||Retinal Vessel Measurements as Clinically Useful Predictors in Veterans|Retinal Vessel Measurements as Clinically Useful Predictors in Veterans|Completed||N/A|800|Actual|VA Office of Research and Development|||1||f||||f|f|f|||f|None Retained|"     Retinal images - vessel parameters   "|No||2017-10-11 02:05:02.582921|2017-10-11 02:05:02.582921
NCT01772160|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-08-17|||February 26, 2013|Actual|2013-02-26|August 2017|2017-08-01|October 5, 2016|Actual|2016-10-05|October 5, 2016|Actual|2016-10-05||Observational|||Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy|Population Based Surveillance to Estimate the Burden of Herpes Zoster and Post-herpetic Neuralgia in Italy|Completed||N/A|395|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 02:05:02.678036|2017-10-11 02:05:02.678036
NCT01772147|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-03-21|2014-03-13||January 2013||2013-01-01|March 2017|2017-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.|A Multicenter, Randomized, Double-blind, Parallelgroup Study to Evaluate the Efficacy and Safety of the Addition of Umeclidinium Bromide Inhalation Powder (62.5mcg) Once-daily to Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily, Umeclidinium Bromide Inhalation Powder (125mcg) Once-daily to Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily Versus Placebo to Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily Over 12 Weeks in Subjects With COPD.|Completed||Phase 3|608|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:05:02.931844|2017-10-11 02:05:02.931844
NCT01772134|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2016-11-18|2014-03-06||January 2013||2013-01-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks|A Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of the Addition of Umeclidinium Bromide (62.5mcg) Once-daily to Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily, Umeclidinium Bromide (125mcg) Once-daily to Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily Versus Placebo to Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily Over 12 Weeks With COPD|Completed||Phase 3|617|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:05:03.98779|2017-10-11 02:05:03.98779
NCT01772121|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-07-07|||May 2012||2012-05-01|July 2015|2015-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India|Prevalence of Host and Viral Genotypes in Patients With Chronic Hepatitis B and Hepatitis C Infection in India|Completed||N/A|1000|Actual|Gilead Sciences|||2||f||||f||||||Samples With DNA|"     A portion of the blood drawn at the study visits will be frozen and stored. Stored blood     samples may be used by the Sponsor or its research partners for HCV/HBV     genotyping/phenotyping assays (as applicable) or their development or for retesting the     amount of HCV/HBV in the blood. At the conclusion of this study, these samples may be     retained in storage by Gilead Sciences or a designee for a period up to 10 years   "|||2017-10-11 02:05:04.907854|2017-10-11 02:05:04.907854
NCT01772095|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2014-08-18|||February 2013||2013-02-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|ADVANCE||ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE|A 6 Months, Prospective, Open-label, Observational, Non-interventional Clinical Trial to Examine the Efficacy and Safety of Donepezil (Dementis®) Administration in Patients With Dementia.|Completed||N/A|389|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 02:05:05.408754|2017-10-11 02:05:05.408754
NCT01772082|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-03-10|||April 30, 2012|Actual|2012-04-30|March 2017|2017-03-01|February 2, 2017|Actual|2017-02-02|January 6, 2016|Actual|2016-01-06||Interventional|||Use of Internet Mediated Walking Program and Pedometer in COPD|Randomized Study of Use of Internet Mediated Walking Program and Pedometer in COPD|Completed||N/A|114|Actual|VA Boston Healthcare System||2|||f||||f||||||||||2017-10-11 02:05:05.546894|2017-10-11 02:05:05.546894
NCT01772069|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2017-01-31|||January 2013||2013-01-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Observational|||Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus:Focusing on Fibromyalgia||Completed||N/A|300|Anticipated|The Catholic University of Korea|||1||f||||f||||||||||2017-10-11 02:05:05.644178|2017-10-11 02:05:05.644178
NCT01772056|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-01-08|||December 2009||2009-12-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children|Randomised Controlled, Double Blind Trial of Topical Twice Weekly Fluticasone Propionate Maintenance Treatment to Reduce Risk of Relapse in Mild or Moderate Atopic Dermatitis in Children|Terminated||Phase 3|54|Actual|University of Valencia||2||"Patient recruitment is very slow, economic grant has ended and the number of patients is enough   according to sample size (22 children/ arm)."|f||||f||||||||||2017-10-11 02:05:05.712522|2017-10-11 02:05:05.712522
NCT01772043|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-17|2015-07-27|||September 2012||2012-09-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping||Unknown status|Active, not recruiting|N/A|53|Actual|Cooperative International Neuromuscular Research Group|||1||f||||t||||||Samples With DNA|"     Blood samples with DNA Skin samples Muscle samples (optional)   "|||2017-10-11 02:05:05.862237|2017-10-11 02:05:05.862237
NCT01772030|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-05-09|||January 2013||2013-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Atrial Fibrillation Recurrence After Cryoballoon Ablation|Mechanisms and Patterns of Atrial Fibrillation Recurrence After Cryoballoon Ablation|Active, not recruiting||N/A|30|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 02:05:05.963916|2017-10-11 02:05:05.963916
NCT01772017|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-11-22|||October 2012||2012-10-01|November 2015|2015-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|OPEN||A Trial to Evaluate a Device for the Treatment of OSA and Snoring|A Multi Center, Open Label Study to Evaluate a Tongue Advancement Retainer Device in the Treatment of Subjects With Obstructive Sleep Apnea and Snoring (OPEN Trial)|Terminated||N/A|15|Actual|Sleepy, Inc||1||Sponsor decided to discontinue study for business reasons.|f||||t||||||||||2017-10-11 02:05:06.049889|2017-10-11 02:05:06.049889
NCT01772004|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-09-13|||January 31, 2013|Actual|2013-01-31|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)|A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications|Recruiting||Phase 1|1756|Anticipated|EMD Serono||1|||f||||t||||||||||2017-10-11 02:05:06.124868|2017-10-11 02:05:06.124868
NCT01771991|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-01-11|2015-04-09||August 2012||2012-08-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Sodermix||Study of Topical Superoxide Dismutase to Treat Radiation Induced Fibrosis|Topical Superoxide Dismutase For the Treatment of Radiation Induced Fibrosis in the Head and Neck Cancer Patient|Completed||N/A|74|Actual|Sanford Health||2|||f||||t||||||||||2017-10-11 02:05:06.248053|2017-10-11 02:05:06.248053
NCT01771978|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2013-01-16|||June 2002||2002-06-01|February 2008|2008-02-01||||February 2008|Actual|2008-02-01||Interventional|||Ischaemia-réperfusion During the Coronary Surgery With Beating Heart|Effects of Diltiazem and/or N-Acétylcystéine Versus Placebo on hémodynamiques and Biological Repercussions of the Ischaemia-réperfusion During the Coronary Surgery With Beating Heart|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|University Hospital, Strasbourg, France||4|||f||||f||||||||||2017-10-11 02:05:06.529382|2017-10-11 02:05:06.529382
NCT01771939|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-01-16|||October 2006||2006-10-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|November 2006|Actual|2006-11-01||Interventional|||Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes|Morphologic and Functional Results After Phacoemulsification and 25 Gauge Vitrectomy Versus Phacoemulsification Only in Eyes Affected by Idiopathic Epiretinal Membranes|Completed||N/A|60|Actual|University of Turin, Italy||2|||f||||t||||||||||2017-10-11 02:05:07.164105|2017-10-11 02:05:07.164105
NCT01771926|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-06-03|||February 2013||2013-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2015|Actual|2015-05-01||Interventional|||Lifestyle Modification and Potato Consumption|Lifestyle Modification and Potato Consumption|Completed||N/A|107|Actual|USDA Grand Forks Human Nutrition Research Center||3|||f||||t||||||||No||2017-10-11 02:05:07.26803|2017-10-11 02:05:07.26803
NCT01771913|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-07-30|2015-06-25||March 2012||2012-03-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|September 2014|Actual|2014-09-01||Interventional|||Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts|Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts for Refinements of Reconstructed Breasts|Completed||Phase 2|20|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:05:07.361693|2017-10-11 02:05:07.361693
NCT01771900|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2013-01-16|||April 2005||2005-04-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|HEART Camp||Heart Failure Exercise And Resistance Training Camp (HEART Camp)|Heart Failure Exercise and Resistance Training CAMP|Completed||N/A|42|Actual|University of Nebraska||2|||f||||t||||||||||2017-10-11 02:05:07.763271|2017-10-11 02:05:07.763271
NCT01771887|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-12-03|||February 2013||2013-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Education Program for Lebanese Diabetic T2 in Their Behavior of Auto Managing, of Self-efficacy and Adhesion|Assessing the Effects of Education Program for Lebanese Diabetic Type 2 in Their Behavior of Auto Managing Their Sense of Self-efficacy and on Their Adhesion Therapy|Completed||N/A|108|Actual|Université de Montréal||1|||f||||f||||||||||2017-10-11 02:05:07.912787|2017-10-11 02:05:07.912787
NCT01771874|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-01-20|||January 2013||2013-01-01|January 2016|2016-01-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|||Influence of Bupropion on the Effects of MDMA|Influence of Bupropion on the Effects of MDMA|Completed||Phase 1|16|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 02:05:08.032751|2017-10-11 02:05:08.032751
NCT01771861|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-10-27|||February 2013||2013-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01|1 Month|Observational [Patient Registry]|||Evaluation of Trauma Team Activation Criteria|Evaluation of a University Hospital Trauma Team Activation Protocol: a Prospective Cohort Study|Completed||N/A|324|Actual|University Hospital of North Norway|||1||f||||f||||||||||2017-10-11 02:05:08.161188|2017-10-11 02:05:08.161188
NCT01771848|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-03-31|||December 2012||2012-12-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults|A Study to Optimize Controlled Human Malarial Infection by Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults|Completed||Phase 1|36|Actual|Sanaria Inc.||6|||f||||t||||||||||2017-10-11 02:05:08.257296|2017-10-11 02:05:08.257296
NCT01771835|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2013-01-16|||August 2011||2011-08-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Observational|||Retinal Venous Pressure and ET-1 in Patients With Diabetes Mellitus|Measurement of Retinal Venous Pressure and Endothelin-1 in Patients With Diabetes Mellitus|Completed||N/A|20|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 02:05:08.37872|2017-10-11 02:05:08.37872
NCT01771822|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2013-02-27|||January 2013||2013-01-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Ibuprofen 5% Topical Gel CIPT|Cumulative Irritancy Patch Test (Cipt) of Ibuprofen 5% Topical Gel in Human Volunteers|Completed||Phase 1|50|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:05:08.472731|2017-10-11 02:05:08.472731
NCT01771809|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-03-16|||March 2013||2013-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|TURANDOT II||Long-Term Safety Of PF-00547659 In Ulcerative Colitis|A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)|Active, not recruiting||Phase 2|270|Anticipated|Shire||3|||f||||t|t|f||||||Undecided||2017-10-11 02:05:08.598121|2017-10-11 02:05:08.598121
NCT01771796|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-02-15|||November 2012||2012-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|EMITOR||Training Effects Following Resection Surgery in Patients With Lung Cancer|Training Effects Following Resection Surgery in Patients With Lung Cancer|Completed||N/A|48|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 02:05:08.929264|2017-10-11 02:05:08.929264
NCT01771783|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-05-08|||November 2012||2012-11-01|May 2013|2013-05-01||||April 2013|Actual|2013-04-01||Interventional|RAS||RAS-Peptide-Profile Study in Healthy Male Subjects|Single-center, Randomized, Open-label, 3-way Crossover Study to Characterize the RAS-peptide-profile After Single and Repeated Oral Administration of Different RAS-inhibitors in Healthy Male Subjects|Completed||Phase 1|12|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-11 02:05:09.034894|2017-10-11 02:05:09.034894
NCT01771770|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-12-10|||December 2011||2011-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|||Measurement of Retinal Venous Pressure in Chronic Low-oxygen Environment|Measurement of the Retinal Venous Pressure (RVP) Under Conditions of Chronically Reduced Ambient Pressure and Oxygen Partial Pressure (Field Study)|Completed||N/A|40|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 02:05:09.190996|2017-10-11 02:05:09.190996
NCT01771757|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2014-07-18|||December 2011||2011-12-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Observational|||Measurement of Retinal Venous Pressure Under Short-term Low-oxygen Environment|Measurement of Retinal Venous Pressure (Retinal Venous Pressure RVP) Under Conditions of Reduced Ambient Pressure and Oxygen Partial Pressure|Completed||N/A|24|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 02:05:09.290959|2017-10-11 02:05:09.290959
NCT01771744|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-01-16|||January 2000||2000-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2010|Actual|2010-12-01||Observational|||Revisional Versus Primary Roux-en-Y Gastric Bypass: a Case Matched Analysis|Revisional Versus Primary Roux-en-Y Gastric Bypass: a Case Matched Analysis|Completed||N/A|96|Actual|University Hospital, Basel, Switzerland|||2||f||||f||||||||||2017-10-11 02:05:09.359495|2017-10-11 02:05:09.359495
NCT01771731|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-07-07|||August 2014||2014-08-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|May 2017|Actual|2017-05-01||Interventional|Cannabis-SCD||Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease|Cannabinoid-Based Therapy and Approaches to Quantify Pain in Sickle Cell Disease|Active, not recruiting||Phase 1/Phase 2|34|Actual|University of California, San Francisco||2|||f||||||||||||||2017-10-11 02:05:09.450609|2017-10-11 02:05:09.450609
NCT01771718|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-08-23|||April 2012||2012-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy|Non-invasive Skin Imaging Using Multiphoton Microscopy|Withdrawn||N/A|0|Actual|University of California, Irvine|||1|Not a clinical trial study|f||||f||||||||||2017-10-11 02:05:09.565564|2017-10-11 02:05:09.565564
NCT01771705|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-05-20|||April 2013||2013-04-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients|NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients|Active, not recruiting||N/A|40|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:05:09.657152|2017-10-11 02:05:09.657152
NCT01771692|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-10-25|||January 2013||2013-01-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||A Randomised Clinical Trial: Conventional Ligation vs Figure of 8|A Study Into the Effects of Different Ligation Techniques on Orthodontic Mandibular Incisor Alignment|Completed||N/A|120|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-11 02:05:09.76704|2017-10-11 02:05:09.76704
NCT01771679|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-10-13|||July 2015||2015-07-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging|A Phase I/II, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects for Cutaneous Photoaging|Suspended||Phase 1/Phase 2|29|Anticipated|Stemedica Cell Technologies, Inc.||1|||f||||t||||||||||2017-10-11 02:05:09.864212|2017-10-11 02:05:09.864212
NCT01771653|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-01-15|||September 2011||2011-09-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection|Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection|Completed||N/A|37|Actual|Southern Illinois University|||2||f||||f||||||||||2017-10-11 02:05:10.092124|2017-10-11 02:05:10.092124
NCT01771640|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-12-31|||August 2013||2013-08-01|May 2012|2012-05-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS|Intrathecal Transplantation of Autologous Bone Marrow Derived Mesenchymal Stem Cell in Patients With ALS|Completed||Phase 1|8|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 02:05:10.174493|2017-10-11 02:05:10.174493
NCT01771627|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-10-05|||October 22, 2012|Actual|2012-10-22|October 2017|2017-10-01|August 28, 2015|Actual|2015-08-28|September 28, 2014|Actual|2014-09-28||Interventional|||Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers|Pilot Study of Varenicline vs. Nicotine Patch Delivered by a Telephone Quitline to Promote Smoking Cessation|Completed||N/A|300|Actual|Roswell Park Cancer Institute||2|||f||||f||||||||||2017-10-11 02:05:10.254258|2017-10-11 02:05:10.254258
NCT01771614|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-12-02|||July 2015||2015-07-01|December 2014|2014-12-01||||December 2015|Anticipated|2015-12-01||Interventional|||Acute Exercise and Glucotoxicity||Unknown status|Not yet recruiting|N/A|16|Anticipated|Rigshospitalet, Denmark||4|||f||||f||||||||||2017-10-11 02:05:10.350245|2017-10-11 02:05:10.350245
NCT01771601|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-09-30|||January 2013||2013-01-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Cerebral Oximetry in Newborns - Comparing INVOS 5100c and OxyPrem vs. 1.2|Cerebral Oximetry in Newborns - Comparing INVOS 5100c and OxyPrem vs. 1.2's Absolute Values, Sensitivity for Low Oxygen Levels and Reproducibility|Completed||N/A|24|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 02:05:10.454885|2017-10-11 02:05:10.454885
NCT01771588|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-05-04|||April 2011||2011-04-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Human Milk Fortifier - Growth Evaluation|Evaluation of Growth of Pre-Term Infants Fed a Human Milk Fortifier|Completed||N/A|186|Actual|Nestlé||3|||f||||t||||||||||2017-10-11 02:05:10.517167|2017-10-11 02:05:10.517167
NCT01771575|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-08-17|||July 2013||2013-07-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||The Use of the PoNS™ Device in the Treatment of Blunt and Blast Induced Vestibular Disorders|The Use of the PoNS™ Device in the Treatment of Blunt and Blast Induced Vestibular Disorders|Withdrawn||N/A|0|Actual|United States Naval Medical Center, San Diego||2||No funding received|f||||f||||||||No||2017-10-11 02:05:10.610199|2017-10-11 02:05:10.610199
NCT01771562|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-05-19|||April 2013||2013-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01|3 Years|Observational [Patient Registry]|||Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent|Assessment of Risk Factors of Nutritional and Metabolic Disorders in Children and Adolescent Receiving or Not Antiretroviral Treatment : Growing up With HIV in Senegal|Completed||N/A|330|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||f||||||Samples With DNA|"     Plasma, blood cells and urine samples to be retained   "|||2017-10-11 02:05:10.691736|2017-10-11 02:05:10.691736
NCT01771549|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-03-24|||January 2013||2013-01-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|||Kinetics of Troponin and BNP in Breast Cancer Chemotherapy With Adriamycin and Trastuzumab|Pilot Study of the Kinetics of High Sensitivity Troponin and Brain Natriuretic Peptide in Breast Cancer Chemotherapy With Adriamycin and Trastuzumab|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Mayo Clinic|||2||f||||f||||||Samples Without DNA|"     Whole blood 10 ml per draw, yielding 5 ml of serum. After testing, the remaining serum will     be stored.   "|||2017-10-11 02:05:10.78838|2017-10-11 02:05:10.78838
NCT01771536|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2016-03-18|||November 2012||2012-11-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease|The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease|Completed||N/A|132|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 02:05:10.871193|2017-10-11 02:05:10.871193
NCT01771523|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-01-16|||January 2010||2010-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Is the Use of Drain for Thyroid Surgery Realistic?|Is the Use of Drain for Thyroid Surgery Realistic?|Completed||N/A|400|Actual|Maltepe University||2|||f||||t||||||||||2017-10-11 02:05:10.949915|2017-10-11 02:05:10.949915
NCT01771497|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-01-12|||July 2010||2010-07-01|March 2015|2015-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring|Koning Breast CT (KBCT)-Guided Neoadjuvant Treatment of Breast Cancer Monitoring Phase I Trial|Completed||N/A|12|Actual|Koning Corporation|||1||f||||t||||||||||2017-10-11 02:05:11.033469|2017-10-11 02:05:11.033469
NCT01771484|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-01-16|||December 2012||2012-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||High Sodium Diet and External Abdominal Compression in POTS|Clinical Efficacy of High-Sodium Diet and External Abdominal Compression in the Treatment of Orthostatic Intolerance in POTS|Terminated||Phase 1|13|Actual|Vanderbilt University Medical Center||2||Not enough volunteer recruited before funding could be secured.|f||||t||||||||||2017-10-11 02:05:11.240967|2017-10-11 02:05:11.240967
NCT01771471|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-08-29|||November 2012||2012-11-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||A Study Comparing the Safety and Effectiveness of Cartilage Cell Injected Into the Lumbar Disc as Compared to a Placebo|A Phase II, Randomized, Double Blind, Placebo Controlled Study Evaluating the Treatment of Degenerative Lumbar Discs With Allogeneic Cultured Chondrocytes|Terminated||Phase 2|44|Actual|ISTO Technologies, Inc.||2||Change in clinical strategy|f||||t||||||||||2017-10-11 02:05:11.365392|2017-10-11 02:05:11.365392
NCT01771458|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-07-12|||October 2012||2012-10-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|SHIVA||A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer|A Randomized Proof-of-concept Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer.|Active, not recruiting||Phase 2|742|Actual|Institut Curie||2|||f||||t||||||||||2017-10-11 02:05:11.520922|2017-10-11 02:05:11.520922
NCT01771445|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-01-07|||December 2011||2011-12-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|MUSIL||Role of Interleukin-1 in the Regulation of Muscle Derived Interleukin-6 During Exercise|Role of Interleukin-1 in the Regulation of Muscle Derived Interleukin-6 During Exercise|Completed||N/A|18|Actual|University of Zurich||2|||f||||||||||||||2017-10-11 02:05:11.692225|2017-10-11 02:05:11.692225
NCT01771432|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-06-19|||January 2013||2013-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|BAC01||Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria|Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria. A Prospective Randomized Study.|Unknown status|Recruiting|N/A|200|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 02:05:11.806737|2017-10-11 02:05:11.806737
NCT01771406|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-01-15|||February 2013||2013-02-01|August 2012|2012-08-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|NEBOSA||CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients.|Effects of Continuous Positive Airway Pressure (CPAP) and Nebivolol Treatment on Arterial Blood Pressure and Endothelial Function in Hypertensive OSA Patients.|Unknown status|Not yet recruiting|Phase 4|36|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 02:05:12.094859|2017-10-11 02:05:12.094859
NCT01771393|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2013-08-02|||July 2012||2012-07-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ARCOBE||Cone-beam vs Multidetector Computed Tomography (CT) for Arthrography of the Wrist, Ankle, Elbow and Knee|Performance of Cone-beam Computed Tomography (CT) Compared to Multidetector CT for Arthrography of the Wrist, Ankle, Elbow and Knee|Completed||N/A|69|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:05:12.238828|2017-10-11 02:05:12.238828
NCT01771380|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-09-18|||February 2013||2013-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Observational|||Measurement of the Free Fraction of 25-hydroxyvitamin D in Serum|Measurement of the Free Fraction of 25-hydroxyvitamin D in Serum|Completed||N/A|78|Actual|University of Tromso|||1||f||||f||||||||||2017-10-11 02:05:12.345584|2017-10-11 02:05:12.345584
NCT01771367|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-02-12|||January 2013||2013-01-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|||Training Study to Characterize Biomarkers to Flu Vaccines|"A Clinical Study to Generate an Exploratory Training Set of Data Characterising Clinical Events, Physiological and Metabolic Responses, and Innate and Adaptive Immune Responses Following a Single Intramuscular Immunisation With Either Fluad or Agrippal Influenza Vaccines or Saline Placebo in Healthy Adults."|Completed||N/A|49|Actual|University of Surrey||3|||f||||f||||||||||2017-10-11 02:05:12.44131|2017-10-11 02:05:12.44131
NCT01771354|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-02-12|||February 2013||2013-02-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Training Study to Characterise Biomarkers to the Engerix B Vaccine|"Clinical Study to Generate Exploratory Training Data Characterising Clinical Events, Physiological & Metabolic Responses, & Innate & Adaptive Immune Responses Following 1st & 3rd of 3 IM Immunisations With Engerix B HepB Vaccine or Placebo in Healthy Adults With no Pre-existing Immunity to HepB"|Completed||N/A|24|Actual|University of Surrey||2|||f||||f||||||||||2017-10-11 02:05:12.579064|2017-10-11 02:05:12.579064
NCT01771341|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-01-21|||February 2012||2012-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SYNCHRONY||Evaluation of Synchrony in the Post-operative Patient|Evaluation of Synchrony in the Post-operative Patient (NAVA vs Pressure Support)|Completed||N/A|29|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:05:12.698126|2017-10-11 02:05:12.698126
NCT01771328|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-12-20|||February 2013||2013-02-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|CAH||Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia|Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia|Recruiting||Phase 2|20|Anticipated|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 02:05:12.82495|2017-10-11 02:05:12.82495
NCT01771315|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-06-02|||January 2013||2013-01-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|NFTKA||Nurse Led Follow-up After Total Knee Arthroplasty|Nurse Led Follow-up After Total Knee Arthroplasty - a Randomized Trial|Completed||N/A|117|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 02:05:12.99785|2017-10-11 02:05:12.99785
NCT01771302|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-23|||January 2013||2013-01-01|January 2013|2013-01-01|January 2015|Anticipated|2015-01-01|July 2014|Anticipated|2014-07-01||Interventional|||Efficiency of PRGF-Endoret in Combination With a Bone Graft in Lateral Sinus Floor Elevation|Randomized Clinical Trial on the Efficiency of PRGF-Endoret in Combination With a Bone Graft in Lateral Sinus Floor Elevation|Unknown status|Recruiting|N/A|12|Anticipated|Fundación Eduardo Anitua||2|||f||||f||||||||||2017-10-11 02:05:13.135301|2017-10-11 02:05:13.135301
NCT01771289|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-09-25|||January 2013||2013-01-01|September 2016|2016-09-01||||January 2017|Anticipated|2017-01-01||Interventional|||Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC|Phase II Trial of Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC|Recruiting||Phase 2|50|Anticipated|Peking University People's Hospital||1|||f||||f||||||||||2017-10-11 02:05:13.315507|2017-10-11 02:05:13.315507
NCT01771263|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-08-23|||February 2013||2013-02-01|August 2014|2014-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|iControl-RP||Closed-loop Control of Anesthesia: Controlled Delivery of Remifentanil and Propofol|Closed-loop Control of Anesthesia: Controlled Delivery of Remifentanil and Propofol|Completed||N/A|150|Actual|Fraser Health||1|||f||||f||||||||||2017-10-11 02:05:13.592532|2017-10-11 02:05:13.592532
NCT01771250|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-12-17|||October 2013||2013-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of LY2605541 and Glargine on Fats in Participants With Type 1 Diabetes|Assessment of the Effects of LY2605541 on Triglyceride Metabolism, Compared to Insulin Glargine, in Patients With Type 1 Diabetes Mellitus|Completed||Phase 1|15|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:05:13.752057|2017-10-11 02:05:13.752057
NCT01771237|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-10-10|||July 2007||2007-07-01|October 2016|2016-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||HIV Prevention Among Vulnerable Male Youth|Feasibility and Acceptability Trial of Behavioral Group-based HIV Prevention Intervention for Young Men Who Have Sex With Men (YMSM).|Completed||N/A|121|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 02:05:13.860133|2017-10-11 02:05:13.860133
NCT01771224|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-01-16|||January 2013||2013-01-01|January 2012|2012-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|FAUC||Effect of FAn-7 in UC Activity|Effect of Palmitoleic Acid (FAn-7) on Expression of HNF4γ and Ulcerative Colitis (UC) Activity|Unknown status|Recruiting|Early Phase 1|20|Anticipated|National Institute of Medical Sciences and Nutrition, Salvador Zubiran||2|||f||||t||||||||||2017-10-11 02:05:13.970377|2017-10-11 02:05:13.970377
NCT01771211|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-08-20|||December 2012||2012-12-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|STIMCI||Impact of Transcranial Direct Current Stimulation on Language Functions in Mild Cognitive Impairment|Impact of Transcranial Direct Current Stimulation on Language Functions in Mild Cognitive Impairment: A Proof-of-principle Study and Neural Correlates|Completed||N/A|18|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:05:14.094569|2017-10-11 02:05:14.094569
NCT01771198|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-07-09|||August 2012||2012-08-01|August 2012|2012-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal Treatment|Preliminary Evaluation of SIMVASTATIN as an Alternative Anti-inflammatory Agent in Chronic Rhinosinusitis Refractory to Conventional Medical and Surgical Treatment|Terminated||Phase 2|7|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1||Lack of efficacy with one month of treatement|f||||f||||||||||2017-10-11 02:05:14.192177|2017-10-11 02:05:14.192177
NCT01771185|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-01-17|||October 2012||2012-10-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Metabolic Effects of Gastrointestinal Surgery in T2DM|Metabolic Effects of Duodenal-jejunal Bypass Surgery in Non Morbidly Obese Subjects With Type 2 Diabetes|Unknown status|Active, not recruiting|N/A|24|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:05:14.2869|2017-10-11 02:05:14.2869
NCT01771172|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-10-10|2016-10-10||May 2013||2013-05-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|ASQ||Acute Subcutaneous Defibrillation||Completed||N/A|50|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-10-11 02:05:14.3644|2017-10-11 02:05:14.3644
NCT01771159|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-05-10|||May 2017||2017-05-01|May 2016|2016-05-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|TBC||Tissue Bonding Cystostomy(TBC)|Tissue Bonding Cystostomy(TBC)|Not yet recruiting||Phase 1|10|Anticipated|Uro-Research, LLC||1|||f||||f||||||||||2017-10-11 02:05:14.533463|2017-10-11 02:05:14.533463
NCT01771146|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-01-30|||October 2012||2012-10-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer|A Prospective Evaluation of Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancreas Cancer (Baylor University Medical Center and Texas Oncology Experience)|Active, not recruiting||N/A|30|Anticipated|Baylor Research Institute||1|||f||||f||||||||Undecided||2017-10-11 02:05:14.610696|2017-10-11 02:05:14.610696
NCT01770756|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-07-30|||August 2012||2012-08-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||FSU Hypertension Self-Care Training Study|Improving the Willpower-based Self-care for Hypertension|Unknown status|Active, not recruiting|N/A|40|Anticipated|Florida State University||2|||f||||f||||||||||2017-10-11 02:05:21.280521|2017-10-11 02:05:21.280521
NCT01771133|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-10-26|||January 2013||2013-01-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PEARLS||Pregnancy and EARly Lifestyle Improvement Study|Pregnancy and EARly Lifestyle Improvement Study|Terminated||N/A|31|Actual|University of Puerto Rico||2||"recruiting or enrolling participants has halted prematurely by Life-Moms Consortium and will   not resume; participants are no longer being examined or treated."|f||||t||||||||||2017-10-11 02:05:14.697682|2017-10-11 02:05:14.697682
NCT01771120|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-10-30|||October 2012||2012-10-01|November 2012|2012-11-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Observational|ICAR||Control and Burden of Asthma and Rhinitis|Control and Burden of Asthma and Rhinitis|Completed||N/A|858|Actual|Universidade do Porto|||4||f||||f||||||Samples With DNA|"     Serum will be retained.   "|||2017-10-11 02:05:14.852968|2017-10-11 02:05:14.852968
NCT01771107|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-09-12|||March 7, 2013|Actual|2013-03-07|September 2017|2017-09-01||||June 12, 2018|Anticipated|2018-06-12||Interventional|||Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma|A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma|Recruiting||Phase 1/Phase 2|70|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 02:05:14.959023|2017-10-11 02:05:14.959023
NCT01771094|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-15|||February 2012||2012-02-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Effect of Sweetness of the Beverage in Thirst Sensation|Effect of Sweetness of the Beverage in Thirst Sensation|Completed||N/A|27|Actual|Universidade do Porto||3|||f||||f||||||||||2017-10-11 02:05:15.209773|2017-10-11 02:05:15.209773
NCT01771081|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-10-27|||April 2013||2013-04-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Observational|POLARIS||Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy|POLARIS: A Non-interventional Study in Patients With Diabetic Macular Edema (DME) With Central Involvement to Assess the Effectiveness of Existing Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment Regimens|Completed||N/A|911|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:05:15.295986|2017-10-11 02:05:15.295986
NCT01771068|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-17|||April 2012||2012-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Trial of a Parenting Discussion Group in Panama, Central America||Completed||N/A|108|Actual|University of Manchester||2|||f||||t||||||||||2017-10-11 02:05:15.388037|2017-10-11 02:05:15.388037
NCT01771042|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-16|||April 2013||2013-04-01|January 2013|2013-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Effects of Weight Loss on Neuroadrenergic Function|Neuroadrenergic Dysfunction Along the Diabetes Continuum: Benefits of Weight Loss Within Different Strata of Metabolic Risk|Unknown status|Not yet recruiting|N/A|120|Anticipated|Baker Heart Research Institute||4|||f||||f||||||||||2017-10-11 02:05:17.47137|2017-10-11 02:05:17.47137
NCT01771029|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-12-11|||February 2013||2013-02-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01|1 Day|Observational [Patient Registry]|||Technical Evaluation of Brahms PCT Direct|Technical Evaluation of a Whole Blood Rapid Test Measuring Procalcitonin (BRAHMS PCT Direct)|Completed||N/A|150|Actual|University Hospital, Basel, Switzerland|||1||f||||t||||||||||2017-10-11 02:05:17.650245|2017-10-11 02:05:17.650245
NCT01771016|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-01-15|||January 2006||2006-01-01|January 2013|2013-01-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Observational|||Emergency Contraception - User's Profile|Emergency Contraception - Observational Study of User's Profile|Completed||N/A|729|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 02:05:17.729196|2017-10-11 02:05:17.729196
NCT01771003|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-12-09|||October 2012||2012-10-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy|The Effect of Remote Ischemic Preconditioning in Partial Nephrectomy|Terminated||N/A|21|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 02:05:17.808804|2017-10-11 02:05:17.808804
NCT01770990|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-07-13|||September 2012||2012-09-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Tel-PT||Trial of Telephone-based Psychotherapy for Depression With and Without Adjunctive Supportive Mail|Randomized Trial of Telephone-Based Psychotherapy for Depression With and Without Adjunctive Supportive Mail|Completed||N/A|59|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 02:05:17.878267|2017-10-11 02:05:17.878267
NCT01770977|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-15|2013-01-15|||May 2012||2012-05-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Phototherapy by Light-emitting Diode Therapy (LEDT) on Clinical, Biochemical and Biomechanical of Muscle Performance in Athletes|Effects of Phototherapy by Light-emitting Diode Therapy (LEDT) on Clinical, Biochemical and Biomechanical of Muscle Performance in Athletes|Completed||N/A|45|Actual|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-11 02:05:17.959534|2017-10-11 02:05:17.959534
NCT01770964|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-01-16|||December 2012||2012-12-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy|Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)|Unknown status|Recruiting|Phase 4|90|Anticipated|Analgesic Solutions||4|||f||||f||||||||||2017-10-11 02:05:18.049788|2017-10-11 02:05:18.049788
NCT01770951|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-01-16|||August 2009||2009-08-01|August 2009|2009-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)|A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)|Completed||N/A|30|Actual|Alexion Pharmaceuticals|||1||f||||||||||||||2017-10-11 02:05:18.18488|2017-10-11 02:05:18.18488
NCT01770054|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-03-07|||January 2013||2013-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01|2 Months|Observational [Patient Registry]|||Prevalence of Metabolic Syndrome in Atahualpa|Evaluation of the Prevalence of Metabolic Syndrome in Atahualpa Residents Aged 40 Years or More.|Completed||N/A|517|Actual|Hospital Clínica Kennedy|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 02:05:33.75368|2017-10-11 02:05:33.75368
NCT01770938|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-15|2014-09-19|||May 2012||2012-05-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Phototherapy by Low-level Light-emitting Diode Therapy (LEDT) on Clinical, Biochemical, Biomechanical, Histologic and Genetic Responses of Muscle Performance of Young Males Submitted to Physical Strength Training|Effects of Phototherapy by Low-level Light-emitting Diode Therapy (LEDT) on Clinical, Biochemical, Biomechanical, Histologic and Genetic Responses of Muscle Performance of Young Males Submitted to Physical Strength Training|Completed||N/A|32|Actual|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-11 02:05:18.299747|2017-10-11 02:05:18.299747
NCT01770925|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-16|||January 2013||2013-01-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Nasal Continuous Positive Airway Pressure (n-CPAP) Versus Nasal Bilevel Positive Airway Pressure (n-BiPAP) for RDS|Non-invasive Ventilation for RDS: a Randomized, Cotrolled Trial to Compare CPAP by Nasal Bipap|Unknown status|Not yet recruiting|N/A|120|Anticipated|Ain Shams University||3|||f||||t||||||||||2017-10-11 02:05:18.52879|2017-10-11 02:05:18.52879
NCT01770912|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-12-14|||March 2013||2013-03-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Efficacy of Steroid Supplementation After TMJ Rinsing for Pain Management|A Randomized, Double-Blind Study of the Efficacy of Steroid Supplementation After Temporomandibular Joint Arthrocentesis|Recruiting||Phase 2|36|Anticipated|University of Florida|||2||f||||f||||||||No||2017-10-11 02:05:18.642285|2017-10-11 02:05:18.642285
NCT01770899|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-02-22|||January 2013||2013-01-01|February 2013|2013-02-01||||December 2013|Anticipated|2013-12-01||Interventional|||Evaluation Montelukast in the Treatment of Status Asthmaticus|A Prospective Analysis of the Use of Oral Montelukast in Children With Status Asthmaticus|Unknown status|Recruiting|N/A|100|Anticipated|Advocate Center for Pediatric Research||2|||f||||t||||||||||2017-10-11 02:05:18.815156|2017-10-11 02:05:18.815156
NCT01770886|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-07-16|||January 2013||2013-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|UE2343||A Phase I Study of Oral UE2343 in Healthy Subjects|A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral UE2343 in Healthy Subjects|Completed||Phase 1|48|Actual|University of Edinburgh||2|||f||||f||||||||||2017-10-11 02:05:18.947813|2017-10-11 02:05:18.947813
NCT01770873|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2017-08-17|||October 2013||2013-10-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|TC2||A Multi-Center Randomized Controlled Trial of Mentoring to Prevent Youth Violence|Take Charge 2- A Multi-Center Randomized Trial of Mentoring to Prevent Youth Violence: Incorporating New Communication and Information Technology|Active, not recruiting||N/A|188|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:05:19.039667|2017-10-11 02:05:19.039667
NCT01770860|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-07-31|2014-05-13||January 2013||2013-01-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Test of Different Kinds of Bandages on Healing of Wounds|An Assessment of QuiltVent™ Pad Technology on the Healing of Induced Dermabrasion Wounds|Completed||N/A|46|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||5|||f||||f||||||||||2017-10-11 02:05:19.168847|2017-10-11 02:05:19.168847
NCT01770847|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-03-04|||November 2012||2012-11-01|March 2013|2013-03-01||||December 2013|Anticipated|2013-12-01||Observational|||Arterial Stiffness in Chronic Kidney Disease|Diurnal Variations in Arterial Stiffness in Patients With Chronic Kidney Disease and Healthy Age Matched Controls|Unknown status|Recruiting|N/A|50|Anticipated|University of Edinburgh|||2||f||||t||||||||||2017-10-11 02:05:19.958946|2017-10-11 02:05:19.958946
NCT01770834|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-11-01|||April 2013||2013-04-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis|A Prospective, Non-interventional Multi-center Observational Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis in Routine Practice|Recruiting||N/A|100|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:05:20.070339|2017-10-11 02:05:20.070339
NCT01770821|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-03-22|||February 2013||2013-02-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|February 2016|Anticipated|2016-02-01||Interventional|REHAB||Rehabilitation After Intensive Care|REHABILITATION AFTER INTENSIVE CARE What Effect Does Physiotherapy and Proteinrich Sip Drink Have on Physical Performance, Bodycomposition, Bodyweight and Quality of Life?|Unknown status|Not yet recruiting|N/A|100|Anticipated|Haukeland University Hospital||4|||f||||f||||||||||2017-10-11 02:05:20.644653|2017-10-11 02:05:20.644653
NCT01770808|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2013-01-17|||May 2011||2011-05-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Determine if Aquamin (as AquaCal and AquaPT) Improves Digestive Discomfort|A Randomised, Double-blind, Placebo-controlled Study to Determine if Aquamin (as AquaCal and AquaPT) Improves Digestive Discomfort in Healthy Subjects|Completed||N/A|60|Actual|University College Cork||3|||f||||t||||||||||2017-10-11 02:05:20.765539|2017-10-11 02:05:20.765539
NCT01770795|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2013-01-16|||January 2011||2011-01-01|January 2013|2013-01-01||||October 2012|Actual|2012-10-01||Interventional|||A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer|A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer|Completed||Phase 2|45|Actual|Gachon University Gil Medical Center||1|||f||||||||||||||2017-10-11 02:05:20.928593|2017-10-11 02:05:20.928593
NCT01770769|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-07-26|||February 2012||2012-02-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Undisplaced Femoral Neck Fractures in the Elderly: A Trial Comparing Internal Fixation to Hemiarthroplasty|Undisplaced Femoral Neck Fractures in Patients Aged 70 Years and Older: A Multicentre Randomised Controlled Trial Comparing Internal Fixation to Hemiarthroplasty|Active, not recruiting||N/A|220|Actual|University Hospital, Akershus||2|||f||||t||||||||Undecided|Data planned published in English in a peer-reviewed medical journal|2017-10-11 02:05:21.143957|2017-10-11 02:05:21.143957
NCT01717547|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-05-12|||June 2012|Actual|2012-06-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Strength and Awareness in Action|Strength and Awareness in Action|Completed||N/A|42|Actual|VA Eastern Colorado Health Care System||1|||f||||f||||||||||2017-10-11 02:21:08.982194|2017-10-11 02:21:08.982194
NCT01770743|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-02-06|2015-02-06||January 2013||2013-01-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional||Intent-to-treat Population|A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels|A Phase 2, Randomized, Parallel-Group, Active-Controlled, Double-Blind Study to Evaluate the Safety and Immunogenicity of AV7909 for Post-Exposure Prophylaxis of Anthrax Using Three Immunization Schedules and Two Dose Levels in Healthy Adult Volunteers|Completed||Phase 2|168|Actual|Emergent BioSolutions|A few events collected in e-diary were downgraded (severe to moderate) on verification by the PI but were unable to be corrected in subjects' e-diary data: headache & fatigue/tenderness in 2 subjects each; muscle ache & pain & AML in 1 subject each.|5|||f||||t||||||||||2017-10-11 02:05:21.5434|2017-10-11 02:05:21.5434
NCT01770730|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-06-01|||January 2013||2013-01-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|LAMRCT||A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients|A Randomized Controlled Trial to Evaluate the Impact of Using a Point-of-care Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients in Resource-poor Settings|Completed||N/A|2618|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-11 02:05:23.434248|2017-10-11 02:05:23.434248
NCT01770717|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-02-08|||August 2012||2012-08-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Assessment of the Potential for Pressure Ulcer Formation|Assessment of the Potential for Pressure Ulcer Formation Using a New Optical Imaging Technology: Spatial Frequency Domain Imaging|Recruiting||N/A|175|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-11 02:05:23.566699|2017-10-11 02:05:23.566699
NCT01770704|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-04-06|||February 2013||2013-02-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Observation Study of the Clinical Management of Bipolar Disorder|Chinese Observation Study of the Clinical Management of Bipolar Disorder|Completed||N/A|520|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:05:23.699124|2017-10-11 02:05:23.699124
NCT01770691|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2015-01-15|2014-05-13||September 2007||2007-09-01|January 2015|2015-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence|Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence|Completed||N/A|7|Actual|Assuta Hospital Systems||1|||f||||f||||||||||2017-10-11 02:05:23.823414|2017-10-11 02:05:23.823414
NCT01770678|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-01-17|||August 2010||2010-08-01|June 2012|2012-06-01||||April 2012|Actual|2012-04-01||Interventional|HCPCIMT||A Trial Comparing Two Methods of CIMT in the Hemiplegic Child|Randomised Controlled Trial to Compare Two Methods of Constraint Induced Movement Therapy to Improve Functional Ability in the Affected Upper Limb in Pre-school Children With Hemiplegic Cerebral Palsy|Completed||Phase 2|62|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-11 02:05:24.041153|2017-10-11 02:05:24.041153
NCT01770665|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2016-09-14|||June 2012||2012-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|January 2015|Actual|2015-01-01|1 Year|Observational [Patient Registry]|MiCK Assay||Validation of the MiCK Assay|Mayo Clinic Validation of the MiCK Assay|Terminated||N/A|21|Actual|DiaTech Oncology|||2|Assay being revised and re-validated.|f||||t||||||Samples With DNA|"     Human cancerous tumor.   "|||2017-10-11 02:05:24.137657|2017-10-11 02:05:24.137657
NCT01770652|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-08-25|2014-07-18||January 2013||2013-01-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment|An Open-label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox in Subjects With Impaired Renal Function and Healthy Volunteers|Completed||Phase 4|32|Actual|ApoPharma||4|||f||||f||||||||||2017-10-11 02:05:24.229226|2017-10-11 02:05:24.229226
NCT01770639|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-16|2014-06-24|||January 2013||2013-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||A Retrospective Study to Assess the Outcome After Surgical Reconstruction of the Midfoot With the Midfoot Fusion Bolt in Patients With Neuroarthropathy|A Retrospective Study to Assess the Outcome After Surgical Reconstruction of the Midfoot With the Midfoot Fusion Bolt in Patients With Neuroarthropathy|Completed||N/A|47|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 02:05:25.519891|2017-10-11 02:05:25.519891
NCT01770626|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-10-25|||April 2011||2011-04-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|July 2013|Actual|2013-07-01||Interventional|BEAM||A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients|A Pilot Study to Determine the Effectiveness of Bioelectrical Impedance Analysis as a Clinical Assessment Tool of Nutrition Status in Glioblastoma Multiforme Patients (The BEAM Study [BIA Effectiveness as Assessment Tool for Glioblastoma Multiforme (GBM) Patients])|Completed||Early Phase 1|40|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 02:05:25.620458|2017-10-11 02:05:25.620458
NCT01770613|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-04-25|||February 2013||2013-02-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)|A PHASE IIa, DOUBLE-BLINDED, MULTI-CENTER, RANDOMIZED STUDY TO ASSESS THE SAFETY,TOLERABILITY, AND PRELIMINARY EFFICACY OF A SINGLE INTRAVENOUS DOSE OF ALLOGENEIC MESENCHYMAL BONE MARROW CELLS TO SUBJECTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)|Withdrawn||Phase 2|0|Actual|Stemedica Cell Technologies, Inc.||2||Corporate business decision, may consider different subject population|f||||t||||||||||2017-10-11 02:05:25.73542|2017-10-11 02:05:25.73542
NCT01770600|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-05-26|||April 2010||2010-04-01|May 2015|2015-05-01||||September 2013|Actual|2013-09-01||Interventional|||Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression|Assessment and Treatment of Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression.|Withdrawn||N/A|0|Actual|University of Alabama at Birmingham||2||never initiated, did different study|f||||f||||||||||2017-10-11 02:05:25.873027|2017-10-11 02:05:25.873027
NCT01770587|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-11-21|||May 2013||2013-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Sleep-Oriented Intervention for Suicidal Behaviors|A Sleep-Oriented Intervention for Suicidal Behaviors|Recruiting||N/A|50|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 02:05:26.004461|2017-10-11 02:05:26.004461
NCT01770041|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-10-15|||February 2013||2013-02-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|PETALS||Paracetamol Metabolism After Liver Surgery|Observational Study Assessing Cytochrome P450 Dependant Paracetamol Metabolites Following Liver Resection.|Completed||N/A|42|Actual|University of Edinburgh|||1||f||||t||||||Samples Without DNA|"     Urine and blood   "|||2017-10-11 02:05:33.859582|2017-10-11 02:05:33.859582
NCT01770574|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-08-08|||February 2013||2013-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||New Bone Grafting Technique in Paediatric Foot Surgery. Validation of Outcome Measures|Structural HATCP Graft vs Tricortical Iliac Crest Autograft in Paediatric Calcaneal Lengthening Osteotomies: Interim Results From a Randomised Controlled Noninferiority Study|Terminated||N/A|12|Actual|University of Aarhus||2||Interim results showed that the HATCP material was not non-inferior to the AUTO graft.|f||||f||||||||||2017-10-11 02:05:26.097372|2017-10-11 02:05:26.097372
NCT01770561|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2013-02-04|||October 2012||2012-10-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Feasibility Study of an Integrated Sensor and Infusion Set|Feasibility Study to Assess Performance of an Integrated Sensor and Infusion Set. TRIAL II|Completed||N/A|20|Actual|Medtronic Diabetes R&D Denmark||1|||f||||t||||||||||2017-10-11 02:05:26.200713|2017-10-11 02:05:26.200713
NCT01770548|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-01-13|||January 2009||2009-01-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|January 2011|Actual|2011-01-01||Interventional|NMDA-Autism||Neurophysiological Molecular and Developmental Analysis of the Glutamate Synapse in Autism|Autism and Glutamatergic Synapse : Research of Genetic Mutations and Identification of Clinical and Neurophysiological Markers.|Completed||N/A|497|Actual|University Hospital, Tours||4|||f||||f||||||||||2017-10-11 02:05:26.290679|2017-10-11 02:05:26.290679
NCT01770535|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-15|||November 2012||2012-11-01|January 2013|2013-01-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Observational|OXO-PCR-01||Oxford Ovarian Cancer Predict Chemotherapy Response 01|A Single-Centre Prospective Phase 0 Translational Study for Predicting Response of High Grade Serous Ovarian Cancers to Paclitaxel Chemotherapy|Unknown status|Recruiting|N/A|35|Anticipated|University of Oxford|||1||f||||t||||||Samples With DNA|"     Ovarian cancer biopsy tissue samples Eyebrow hair follicles Blood samples Surgical tissue     samples   "|||2017-10-11 02:05:26.424441|2017-10-11 02:05:26.424441
NCT01770522|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-05-15|||January 2013||2013-01-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|MAGIC||Managing Weight in Pregnancy|A Longitudinal Study Exploring Factors Influencing Weight Gain During Pregnancy and Subsequent Weight Loss and Retention up to One Year Postpartum|Completed||N/A|368|Actual|University of Nottingham|||1||f||||f||||||||No|Currently there is no plan to share data with other researchers, only publications|2017-10-11 02:05:26.52502|2017-10-11 02:05:26.52502
NCT01770509|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2016-11-14|2015-05-17||February 2013||2013-02-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Effect of the Cosmetic Cream NMBM on Leg Ulcers - a Pilot Study|A Randomized, Parallel Group, Controlled Study to Assess the Efficacy and Safety of NMBM in the Treatment of Subjects With a Post-cellulitis and Venous Leg Ulcer|Completed||Phase 1/Phase 2|30|Actual|M.D. Lederman Consulting Ltd||2|||f||||f||||||||Undecided||2017-10-11 02:05:26.604661|2017-10-11 02:05:26.604661
NCT01770496|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-16|||October 2007||2007-10-01|January 2013|2013-01-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||Age-Specific Strategies for Immunization Reminders and Recalls||Completed||N/A|10175|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 02:05:26.962525|2017-10-11 02:05:26.962525
NCT01770483|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-09-15|2013-03-07||July 2011||2011-07-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|HEP-C-FM||The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients|The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients|Completed||Phase 4|66|Actual|Services Institute of Medical Sciences, Pakistan||2|||f||||f||||||||||2017-10-11 02:05:27.057172|2017-10-11 02:05:27.057172
NCT01770470|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-08-19|||April 2010||2010-04-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Observational|||Chitosan Chewing Gum Study in Dialysis Patients|A Pilot Study of Dietary Chitosan Chewing Gum in Dialysis Patients|Completed||N/A|15|Actual|University of Maryland|||1||f||||f||||||||||2017-10-11 02:05:27.447456|2017-10-11 02:05:27.447456
NCT01770457|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-07-24|||April 2006||2006-04-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|February 2014|Anticipated|2014-02-01||Observational|||Cytokine Response in Septic Shock|Cytokine Response in Septic Shock|Unknown status|Recruiting|N/A|325|Anticipated|University of Manitoba|||1||f||||f||||||Samples Without DNA|"     Serum samples will be collected at specific time points. Initial time point determined by     start of Vasopressors Then sequential serum samples will be drawn from patients to examine a     broad range of cytokine responses (TNF, IL-1, IL-6, MIF, LIF, HMGB1, etc)   "|||2017-10-11 02:05:27.552266|2017-10-11 02:05:27.552266
NCT01770444|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-11-01|||December 2012||2012-12-01|November 2015|2015-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Low-Dose Coronary Computed Tomographic Angiography for Early Triage of Acute Chest Pain|Safety and Efficacy of Implementing Low-Dose Coronary Computed Tomographic Angiography for Early Triage of Acute Chest Pain in Emergency Department|Completed||N/A|681|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:05:27.653671|2017-10-11 02:05:27.653671
NCT01770431|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2017-05-05|2017-01-02||August 2011||2011-08-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy|A Multicenter, Randomized, Paralleled Control Clinical Study Investigating Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy|Completed||Phase 4|1044|Actual|Qidong Gaitianli Medicines Co., Ltd||2|||f||||t||||||||Undecided||2017-10-11 02:05:27.791587|2017-10-11 02:05:27.791587
NCT01770418|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-07-10|||March 2013||2013-03-01|July 2017|2017-07-01||||January 2038|Anticipated|2038-01-01||Interventional|||A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer|A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|61|Anticipated|Proton Collaborative Group||1|||f||||t||||||||||2017-10-11 02:05:28.15947|2017-10-11 02:05:28.15947
NCT01770405|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-08-28|||September 2013||2013-09-01|August 2017|2017-08-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21|1 Year|Observational [Patient Registry]|US-nCLE||Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract|Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract|Completed||N/A|40|Actual|Mauna Kea Technologies|||1||f||||f||||||||||2017-10-11 02:05:28.299046|2017-10-11 02:05:28.299046
NCT00000150|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||January 1999||1999-01-01|September 2009|2009-09-01|September 2001||2001-09-01|||||Interventional|||Submacular Surgery Trials (SST)|Submacular Surgery Trials (SST)|Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.664725|2017-10-11 04:17:33.664725
NCT01770392|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-11-26|2014-11-14||January 2013||2013-01-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||The treated set (TS) consists of all subjects who took at least one dose of study medication.|Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin|Relative Bioavailability of a Single Oral Dose of Nintedanib Given Alone and in Combination With Multiple Oral Doses of Rifampicin in Healthy Male Volunteers (an Open-label, Two-period, Fixed Sequence Phase I Trial)|Completed||Phase 1|26|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:05:28.528146|2017-10-11 02:05:28.528146
NCT01770379|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-06-09|2016-05-03||October 2012||2012-10-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|REASSURE2||Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.|A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate the Efficacy at 24 Weeks and to Assess the Long Term Efficacy, Safety, Tolerability and Usability up to 5 Years in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNFα Agents|Terminated||Phase 3|242|Actual|Novartis|The study was terminated early due to the decision (unrelated to safety) to discontinue the clinical development program for secukinumab in Rheumatoid Arthritis, with last patient last visit (LPLV) on 11-May-2015.|3|||f||||t||||||||||2017-10-11 02:05:28.891173|2017-10-11 02:05:28.891173
NCT01770366|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-03-01|2015-03-01||January 2013||2013-01-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Virtual Support Pilot Program for Weight Loss Surgery Patients|A Virtual Support Pilot Program for Weight Loss Surgery Patients Leveraging Wireless Goal-tracking Technologies|Completed||Phase 1/Phase 2|10|Actual|Baystate Medical Center||2|||f||||f||||||||||2017-10-11 02:05:29.880069|2017-10-11 02:05:29.880069
NCT01770353|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-09-29|||November 2012||2012-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment|A Phase I Study in Patients Treated With MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment|Recruiting||Phase 1|45|Anticipated|Ipsen||2|||f||||f|t|||||||||2017-10-11 02:05:30.142899|2017-10-11 02:05:30.142899
NCT01770340|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-11-09|||January 2011||2011-01-01|November 2015|2015-11-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial|Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial|Recruiting||Phase 4|60|Anticipated|Kantonsspital Winterthur KSW||2|||f||||t||||||||||2017-10-11 02:05:30.301493|2017-10-11 02:05:30.301493
NCT01770327|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-18|||June 2012||2012-06-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Influence of Different Sugary Beverages on Thirst Sensation|Influence of Different Sugary Beverages on Thirst Sensation|Completed||N/A|32|Actual|Universidade do Porto||4|||f||||f||||||||||2017-10-11 02:05:30.474323|2017-10-11 02:05:30.474323
NCT01770314|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2014-04-21|2013-09-30||September 2012||2012-09-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional|||Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.|Medication Safety Pilot Study|Completed||Phase 2|176|Actual|Inflexxion, Inc.||2|||f||||t||||||||||2017-10-11 02:05:30.585542|2017-10-11 02:05:30.585542
NCT01770301|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-03-14|||February 2013|Actual|2013-02-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|December 2017|Anticipated|2017-12-01||Interventional|ALIENOR||Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)|A Randomized, Open Label, Phase II Trial of Bevacizumab Plus Weekly Paclitaxel Followed by Bevacizumab Monotherapy Maintenance Versus Weekly Paclitaxel Followed by Observation in Patients With Relapsed Ovarian Sex-cord Stromal Tumours|Active, not recruiting||Phase 2|60|Actual|ARCAGY/ GINECO GROUP||2|||f||||t||||||||||2017-10-11 02:05:30.911687|2017-10-11 02:05:30.911687
NCT01770288|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-15|||February 2013||2013-02-01|January 2013|2013-01-01|April 2013|Anticipated|2013-04-01|February 2013|Anticipated|2013-02-01||Interventional|||Psychophysical Aspects of Maximal Anaerobic Performance|Psychophysical Aspects of Maximal Anaerobic Performance|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hillel Yaffe Medical Center||1|||f||||||||||||||2017-10-11 02:05:31.018314|2017-10-11 02:05:31.018314
NCT01770275|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-11-17|||April 2008||2008-04-01|November 2014|2014-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||UICC Classification of Esophageal Cancer|An Attempt at Validation of the Seventh Edition of the Classification by the International Union Against Cancer for Esophageal Carcinoma|Completed||N/A|605|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-11 02:05:31.108892|2017-10-11 02:05:31.108892
NCT01770262|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2016-01-04|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Development of Non-invasive Method for Quantifying Vitamin D Levels in the Body Using Spectroscopy||Withdrawn||N/A|0|Actual|Hadassah Medical Organization|||2||f||||||||||Samples Without DNA|"     Blood samples for quantification of vitamin D levels   "|||2017-10-11 02:05:31.189293|2017-10-11 02:05:31.189293
NCT01770249|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-06-16|||June 2012||2012-06-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|POEM||Evaluation of a Novel Endoscopic Treatment for Achalasia|Evaluation of a Novel Endoscopic Treatment for Achalasia: Per-oral Endoscopic Esophagomyotomy (POEM)|Completed||N/A|10|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-10-11 02:05:31.284942|2017-10-11 02:05:31.284942
NCT01770236|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-12-19|||January 2013||2013-01-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pain Control After Minimally Invasive Coronary Artery Bypass Grafting|Optimal Method of Pain Control After Minimally Invasive Coronary Artery Bypass Grafting|Terminated||Phase 4|41|Actual|Gundersen Lutheran Medical Foundation||2||Study medication no longer available at institution|f||||f||||||||||2017-10-11 02:05:31.37839|2017-10-11 02:05:31.37839
NCT01769638|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-01-16|||September 2011||2011-09-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Safety and Pharmacokinetic Comparison of Sildenafil ODF and FCT Formulations in Healthy Korean Volunteers||Completed||Phase 1|115|Actual|Seoul Pharma Co., Ltd.||2|||f||||||||||||||2017-10-11 02:05:37.51165|2017-10-11 02:05:37.51165
NCT01770223|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-03-17|||January 2014||2014-01-01|March 2017|2017-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)|An Open Label Study Assessing SVR and Viral Resistance Profile With Boceprevir Plus PEG-IFN Plus Ribavirin Triple Therapy in HCV-1 Infected Patients With Insulin Resistance Who Have Failed PEG-IFN Plus Ribavirin Dual Therapy|Withdrawn||Phase 4|0|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 02:05:31.497637|2017-10-11 02:05:31.497637
NCT01770210|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2014-08-18|||February 2013||2013-02-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|EKVASIS||Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events|A Multicenter, Open-label, 30-week Observational Clinical Study to Examine the Progress of Patients After Leaving the Cardiology Clinic or Unit Due to Acute Cardiovascular Event.|Completed||N/A|670|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 02:05:31.614314|2017-10-11 02:05:31.614314
NCT01770197|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-12-09|||January 2008||2008-01-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01|24 Weeks|Observational [Patient Registry]|||Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window|The Feasibility and Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window in China|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Wuhan General Hospital of Guangzhou Military Command|||2||f||||t||||||||||2017-10-11 02:05:31.879958|2017-10-11 02:05:31.879958
NCT01770184|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-04-27|||January 2013||2013-01-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Clinical Effectiveness of Self-Management Education Post-Mild Stroke|Clinical Effectiveness of Self-Management Education Post-Mild Stroke|Completed||N/A|70|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 02:05:31.972596|2017-10-11 02:05:31.972596
NCT01770171|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-01-15|||April 2012||2012-04-01|December 2012|2012-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MITOBEVAEND2||Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer|A Randomized Phase II Trial of Carboplatin-Paclitaxel Compared to Carboplatin-Paclitaxel-Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer|Recruiting||Phase 2|108|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 02:05:32.070132|2017-10-11 02:05:32.070132
NCT01770158|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-01-14|||October 2012||2012-10-01|January 2013|2013-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)|Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)|Unknown status|Recruiting|N/A|60|Anticipated|University of Ulm|||1||f||||f||||||||||2017-10-11 02:05:32.200885|2017-10-11 02:05:32.200885
NCT01770145|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-03-27|2015-06-29||December 2012||2012-12-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|AM IMPAKT||Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)|A Phase 4, Open-Label, Efficacy and Safety Study of Apokyn® for Rapid and Reliable Improvement of Motor Symptoms in Parkinson Disease Subjects With Delayed Onset of L-Dopa Action|Completed||Phase 4|127|Actual|US WorldMeds LLC|Full analysis set (n=88) included patients who completed 5/7 days of diary entries in APO treatment period. The gastroparesis sub-study to assess prevalence and severity of gastroparesis was not analyzed because there were too few subjects enrolled.|1|||f||||f||||||||||2017-10-11 02:05:32.385353|2017-10-11 02:05:32.385353
NCT01770132|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-07-28|||April 19, 2013|Actual|2013-04-19|July 2017|2017-07-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer|Open-label, Single-center, Non-randomized, Phase I, Dose-ranging Study of Endoscopic Ultrasound (EUS) Guided Photodynamic Therapy (PDT) With Photofrin® in Locally Advanced Pancreatic Cancer|Active, not recruiting||Phase 1|12|Anticipated|Indiana University||1|||f||||t||||||||||2017-10-11 02:05:32.993158|2017-10-11 02:05:32.993158
NCT01770119|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-12-29|||April 2013||2013-04-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|MMRinOLT||Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients|Induction and Maintenance of Immunity Against Measles in Pediatric Orthotopic Liver Transplantation Recipients: a Prospective Nationwide Study in Switzerland|Recruiting||Phase 4|90|Anticipated|University Hospital, Geneva||1|||f||||t||||||||Undecided||2017-10-11 02:05:33.122833|2017-10-11 02:05:33.122833
NCT01770106|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2014-09-10|||December 2012||2012-12-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||RA Denosumab on Bone Microstructure Study|Comparison of the Effect of Denosumab and Alendronate on Bone Density and Microarchitecture in Rheumatoid Arthritis Females With Low Bone Mass: A Randomized Controlled Trial|Completed||Phase 4|40|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:05:33.242104|2017-10-11 02:05:33.242104
NCT01770093|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-15|||February 2013||2013-02-01|January 2013|2013-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|||Preferences of Parents for Pediatric Inpatient Ward Physicians' Attire||Unknown status|Not yet recruiting|N/A|400|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 02:05:33.390965|2017-10-11 02:05:33.390965
NCT01770080|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-12-29|||February 2013||2013-02-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|CAS/B/016611||Efficacy of Euminz® for Tension-Type Headache|Efficacy and Safety of Euminz® (10% Ethanolic Solution of Peppermint Oil for Topical Use) Compared to Placebo in Patients With Episodic Tension-type Headache (ETTH); Phase IV Clinical Trial|Completed||Phase 4|211|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 02:05:33.489574|2017-10-11 02:05:33.489574
NCT01770067|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-16|||February 2013||2013-02-01|January 2013|2013-01-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Prophylactic Treatment of High-Risk Patients With Cardiovascular Implantable Electronic Devices (CIED)With Continuous In-Situ Ultra High-Dose Antibiotics (CITA) Under Regulated Negative Pressure-Assisted Wound Therapy (RNPT)||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 02:05:33.639233|2017-10-11 02:05:33.639233
NCT00000151|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-09-01|||December 1979||1979-12-01|October 2003|2003-10-01||||||||Interventional|||Early Treatment Diabetic Retinopathy Study (ETDRS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.716865|2017-10-11 04:17:33.716865
NCT01770028|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-12-19|||January 2013||2013-01-01|December 2015|2015-12-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01|19 Months|Observational [Patient Registry]|||Ripple Effect of Lifestyle Intervention During Pregnancy on Partners' Weight|Ripple Effect of Lifestyle Intervention During Pregnancy on Partners' Weight|Active, not recruiting||N/A|384|Anticipated|California Polytechnic State University-San Luis Obispo|||2||f||||t||||||||||2017-10-11 02:05:33.966218|2017-10-11 02:05:33.966218
NCT01770015|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-01-02|||November 2011||2011-11-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|CBF et PAVMt||Bronchial Colonization With Fungi and Late Respiratory Acquired Pneumonia|Study of the Impact of Bronchial Colonization With Fungi in the Occurrence of Late Ventilator Acquired Pneumonia|Completed||N/A|213|Actual|University Hospital, Grenoble||1|||f||||t||||||||No||2017-10-11 02:05:34.081539|2017-10-11 02:05:34.081539
NCT01770002|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-04-15|||January 2012||2012-01-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|||Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?|Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?|Completed||N/A|50|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 02:05:34.195356|2017-10-11 02:05:34.195356
NCT01769989|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-05-24|||February 2009||2009-02-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Electrodermabrasion Compared to Dermabrasion|Evaluation of the Safety and Efficacy of Electrodermabrasion in Improving the Appearance of Scars That Result From Dermatologic Surgery Compared to Treatment With Dermabrasion|Completed||N/A|33|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 02:05:34.30448|2017-10-11 02:05:34.30448
NCT01769976|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-11-30|||January 2013||2013-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PREFER||Effects of Periodic Fasting Versus Daily Energy Restriction on Metabolic Health|Effects of Periodic Fasting Versus Daily Energy Restriction on Metabolic Health|Completed||N/A|88|Actual|University of Adelaide||4|||f||||t||||||||||2017-10-11 02:05:34.393879|2017-10-11 02:05:34.393879
NCT01769963|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-03-28|||April 2012||2012-04-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Advanced Glycation End-products, Inflammation and Vascular Health in Chronic Kidney Disease|Advanced Glycation End-products, Inflammation and Vascular Health in Chronic Kidney Disease|Completed||N/A|23|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-11 02:05:34.52034|2017-10-11 02:05:34.52034
NCT01769950|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-15|||January 2013||2013-01-01|January 2013|2013-01-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|ChoPEN||Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate Cancer|Evaluation of the Incidence of Choline-PET Detected Nodal Metastases Among Newly Diagnosed Prostate Cancer Patients With Presumed Absence of Nodal and Distant Metastases.|Unknown status|Recruiting|N/A|120|Anticipated|Bangalore Institute of Oncology||1|||f||||t||||||||||2017-10-11 02:05:34.609315|2017-10-11 02:05:34.609315
NCT01769937|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-07-22|||October 2012||2012-10-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ACTH||Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus|A Single-site, Investigator Initiated Open-Label Trial of H.P. Acthar Gel (Repository Corticotropin Injection)an Adrenocorticotropic Hormone (ACTH) Analogue in Subjects With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)|Completed||Phase 4|10|Actual|Fiechtner, Justus J., M.D., P.C.||1|||f||||f||||||||||2017-10-11 02:05:34.716447|2017-10-11 02:05:34.716447
NCT01769924|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-15|||February 2013||2013-02-01|January 2013|2013-01-01||||February 2015|Anticipated|2015-02-01||Observational|||A Prospective UK Multicentre Study of Kidney Donors|Effect of A Reduction in Glomerular Filtration Rate After Nephrectomy on Arterial Stiffness (EARNEST)|Unknown status|Not yet recruiting|N/A|880|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||2||f||||t||||||Samples With DNA|"     Urine, serum and plasma.   "|||2017-10-11 02:05:34.810542|2017-10-11 02:05:34.810542
NCT01769911|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-05-06|||February 2015||2015-02-01|May 2015|2015-05-01||||February 2019|Anticipated|2019-02-01||Interventional|||Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma|AUTOLOGOUS TRANSPLANTATION AND STEM CELL BASED-GENE THERAPY FOR THE TREATMENT OF HIV-ASSOCIATED LYMPHOMA|Withdrawn||N/A|0|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 02:05:34.917378|2017-10-11 02:05:34.917378
NCT01769898|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-03-10|||July 2013||2013-07-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis|The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis|Completed||Phase 4|50|Actual|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 02:05:35.107316|2017-10-11 02:05:35.107316
NCT01769885|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-04-10|||March 14, 2013|Actual|2013-03-14|April 2017|2017-04-01|December 2, 2013|Actual|2013-12-02|June 14, 2013|Actual|2013-06-14||Interventional|||Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer|A Pilot Clinical Trial of Neoadjuvant Tivozanib in Localized Renal Cell Carcinoma|Withdrawn||N/A|0|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 02:05:35.260016|2017-10-11 02:05:35.260016
NCT01769872|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-08-01|||January 2013||2013-01-01|August 2016|2016-08-01||||January 2016|Actual|2016-01-01||Interventional|||Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury|Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury|Completed||Phase 1/Phase 2|15|Actual|Biostar||1|||f||||||||||||||2017-10-11 02:05:35.380398|2017-10-11 02:05:35.380398
NCT01769859|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-10-03|||January 2013||2013-01-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01|10 Years|Observational [Patient Registry]|||Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood Disorders|Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood Disorders|Terminated||N/A|396|Actual|University Hospitals Cleveland Medical Center|||1||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 02:05:35.514104|2017-10-11 02:05:35.514104
NCT01769846|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-07-27|||March 2013||2013-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||The Impact of Early Mobilization Protocol in Patients in the ICU|The Impact of Early Mobilization Protocol in Patients in the ICU of the University Hospital of Santa Maria.|Recruiting||N/A|38|Anticipated|Universidade Federal de Santa Maria||2|||f||||f||||||||||2017-10-11 02:05:35.589191|2017-10-11 02:05:35.589191
NCT01769833|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-11-03|||May 2013||2013-05-01|November 2014|2014-11-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Interventional|||HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance|HBsAg Decline and HBeAg Seroconversion Following 48 Weeks Peg-interferon-α Treatment in Patients With e Antigen Positive Chronic Hepatitis B After Nucleoside Analogue Maintenance Therapy Compared to Continuing Nucleoside Analogue Treatment|Unknown status|Active, not recruiting|Phase 3|144|Anticipated|Pusan National University Hospital||2|||f||||t||||||||||2017-10-11 02:05:35.696377|2017-10-11 02:05:35.696377
NCT01769820|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-07-20|||January 2013||2013-01-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|dexFEM||Dexamethasone for Excessive Menstruation|Developmental Clinical Studies - Reversing Endometrial Glucocorticoid Deficiency in Heavy Menstrual Bleeding|Recruiting||Phase 2|128|Anticipated|University of Edinburgh||2|||f||||t||||||||||2017-10-11 02:05:35.843042|2017-10-11 02:05:35.843042
NCT01769807|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2013-01-16|||July 2004||2004-07-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|SABIO||Efficacy Study of CPAP on Nitrate and Norepinephrine Levels in Severe and Mild-moderate Sleep Apnea (SABIO)|Effects of CPAP on Nitrate and Norepinephrine Levels in Severe and Mild-moderate Sleep Apnea|Completed||N/A|67|Actual|University of Lisbon||1|||f||||f||||||||||2017-10-11 02:05:35.993202|2017-10-11 02:05:35.993202
NCT01769794|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2013-01-16|||June 2011||2011-06-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study||Completed||N/A|288|Actual|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 02:05:36.126071|2017-10-11 02:05:36.126071
NCT01769781|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2016-04-25|||January 2013||2013-01-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence|Treatment of Patients With Endometriosis Recurrence With Aromatase Inhibitor (Anastrazole) Plus GnRH-agonist (Luprolide).|Completed||Phase 4|70|Actual|Centre for Endocrinology and Reproductive Medicine, Italy||2|||f||||t||||||||||2017-10-11 02:05:36.282686|2017-10-11 02:05:36.282686
NCT01769768|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2017-02-03|||April 2013||2013-04-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients|A Phase Ib, Multi-center, Two Parallel Group, Open-label, Drug-drug Interaction Study to Assess the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients With Advanced Solid Tumors|Completed||Phase 1|114|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:05:36.390451|2017-10-11 02:05:36.390451
NCT01769755|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2015-08-17|||March 2013||2013-03-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease|A Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease|Completed||Phase 1|14|Actual|Celgene||2|||f||||t||||||||||2017-10-11 02:05:36.539399|2017-10-11 02:05:36.539399
NCT01769742|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-12-01|||February 2013||2013-02-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Early Mobility Bundle to Prevent Hospital Acquired Pneumonia (HAP) in Medical Inpatients|Use of Early Mobilisation to Reduce Incidence of Hospital Acquired Pneumonia in Medical Inpatients|Completed||N/A|1178|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-11 02:05:36.644075|2017-10-11 02:05:36.644075
NCT01769729|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-15|2014-12-04|||December 2012||2012-12-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PEPP - RCT||Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial|Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial|Completed||N/A|30|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-11 02:05:36.735429|2017-10-11 02:05:36.735429
NCT01769703|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-10-29|||February 2012||2012-02-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|DATAS||Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke|Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke|Completed||Phase 2|53|Actual|University of Alberta||1|||f||||t||||||||||2017-10-11 02:05:36.951482|2017-10-11 02:05:36.951482
NCT01769690|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-04-05|||December 2012||2012-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Low Frequency STN DBS on Sleep and Vigilance in Parkinson's Disease (PD) Patients|The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients|Active, not recruiting||N/A|20|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-11 02:05:37.04815|2017-10-11 02:05:37.04815
NCT01769677|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-03-19|||January 2013||2013-01-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet|A Randomized, Open-Label, 2-Period, Crossover Study to Assess the Bioequivalence of Two 45-mg and One 90-mg Hydrocodone Bitartrate Extended-Release Tablet|Completed||Phase 1|54|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 02:05:37.14986|2017-10-11 02:05:37.14986
NCT01769664|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2014-01-19|||September 2012||2012-09-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris|A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Taro Pharmaceuticals Inc.) to Duac® Topical Gel Clindamycin 1%/Benzoyl Peroxide 5% (Stiefel) in the Treatment of Acne Vulgaris|Completed||Phase 1|650|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 02:05:37.286112|2017-10-11 02:05:37.286112
NCT01769651|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-02-16|||March 2015||2015-03-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|CLiPID||Clinician-patient Interaction During Addiction Consultation|Clinician-patient Interaction During Addiction Consultation and Drug Overdose Risk|Unknown status|Not yet recruiting|N/A|16|Anticipated|University of St Andrews|||1||f||||t||||||||||2017-10-11 02:05:37.386725|2017-10-11 02:05:37.386725
NCT01769612|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-04-06|2017-02-13||January 2013||2013-01-01|April 2017|2017-04-01|April 2014|Actual|2014-04-01|August 2013|Actual|2013-08-01||Observational|CL Detect™||Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia|Evaluation of a Diagnostic Device, CL Detect Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia|Completed||N/A|168|Actual|U.S. Army Medical Research and Materiel Command|||1||f||||f|f|||||||Undecided||2017-10-11 02:05:37.880847|2017-10-11 02:05:37.880847
NCT01769599|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-01-14|||January 2013||2013-01-01|January 2013|2013-01-01|April 2014|Anticipated|2014-04-01|January 2014|Anticipated|2014-01-01||Observational|||Comparison of Initial Treatment in With Laser Grid in Diabetic Macular Edema to Intra Vitreal Avastin Injections||Unknown status|Recruiting|N/A|60|Anticipated|Ziv Hospital|||2||f||||||||||||||2017-10-11 02:05:38.184714|2017-10-11 02:05:38.184714
NCT01769586|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-12-19|2016-07-11||February 2013||2013-02-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Interventional|||"Randomized Trial of Diphenhydramine Versus Continued Midazolam in Difficult-to-sedate Patients Undergoing Colonoscopy"|"Randomized Trial of Diphenhydramine Versus Continued Midazolam in Difficult-to-sedate Patients Undergoing Colonoscopy"|Completed||N/A|200|Actual|VA Connecticut Healthcare System||2|||f||||f||||||||||2017-10-11 02:05:38.268976|2017-10-11 02:05:38.268976
NCT01769573|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-06-28|||July 2013||2013-07-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|November 2016|Actual|2016-11-01||Interventional|UWI-02||A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers|A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers|Active, not recruiting||Phase 1|36|Actual|University of Wisconsin, Madison||5|||f||||t||||||||Yes||2017-10-11 02:05:38.530183|2017-10-11 02:05:38.530183
NCT01769560|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-07-21|||January 2013||2013-01-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||MeFirst: A Tailored Intervention to HPV Vaccine Decision Making|MeFirst: A Tailored Intervention to HPV Vaccine Decision Making|Completed||N/A|661|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 02:05:38.65947|2017-10-11 02:05:38.65947
NCT01769547|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-09-16|||March 2013||2013-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|DOVE-M||A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy|A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy|Terminated||Phase 2|12|Actual|Ontario Clinical Oncology Group (OCOG)||1||Stage 1 accrual completed. Study did not proceed to Stage 2 accrual.|f||||t||||||||||2017-10-11 02:05:38.747911|2017-10-11 02:05:38.747911
NCT01769534|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-04-13|||June 2012||2012-06-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|5 Years|Observational [Patient Registry]|||Registry and Fluid Banking of Pancreatic Cystic Lesions|Prospective Registry and Cystic Fluid Banking for Patients Undergoing EUS-FNA for the Evaluation of Pancreatic Cystic Lesions.|Terminated||N/A|107|Actual|University of Oklahoma|||1|Administratively inactivated|f||||f||||||Samples Without DNA|"     Pancreatic cyst fluid   "|||2017-10-11 02:05:38.875039|2017-10-11 02:05:38.875039
NCT01769521|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-11-16|||October 2012||2012-10-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG|A Single Center, Prospective, Open Label Study Assessing the Relationship Between the 24-hour Intraocular Pressure Pattern as Determined by Sensimed Triggerfish® and the 24-hour Blood Pressure Pattern in Patients With Primary Open Angle Glaucoma|Completed||N/A|20|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 02:05:38.94686|2017-10-11 02:05:38.94686
NCT01769508|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-05-10|2016-03-25||February 2013||2013-02-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Interventional||All enrolled and treated patients|Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer|A Phase II Study With Lead-in Safety Cohort of 5-Fluorouracil, Oxaliplatin and Lapatinib in Combination With Radiation Therapy as Neoadjuvant Treatment for Patients With Localized HER2 Positive Esophagogastric Adenocarcinomas|Terminated||Phase 2|12|Actual|SCRI Development Innovations, LLC|Trial closed early due to slow accrual|1||Study closed due to slow accrual.|f||||f||||||||||2017-10-11 02:05:39.06844|2017-10-11 02:05:39.06844
NCT01769495|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-04-13|||August 2013||2013-08-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Can a Rapid 2 Day Followup After Discharge From the ED Reduce Readmissions and Death for Patients 75 Years and Older?|A Randomized Trial of the Effect of a Geriatrics Appointment Within 2-3 Days of Discharge From the Emergency Department(ED) in Reducing ED and Hospital Readmissions for Patients 75 Years of Age and Older.|Completed||N/A|26|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:05:39.58047|2017-10-11 02:05:39.58047
NCT01769482|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-03-24|||December 2011||2011-12-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|UMPIRE||Understanding of Chest Pain in Microvascular Disease Proved by Cardiac Magnetic Resonance Image|Understanding of Chest Pain in Microvascular Disease Proved by Cardiac Magnetic Resonance Image|Unknown status|Recruiting|Phase 4|70|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:05:39.685013|2017-10-11 02:05:39.685013
NCT01769352|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-08-18|2017-04-17||August 2012||2012-08-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|TEMPEST||Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)|Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)|Completed||Phase 2/Phase 3|42|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:05:46.263767|2017-10-11 02:05:46.263767
NCT01769339|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-02-18|2013-02-18||January 2009||2009-01-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis|Effectiveness and Safety of Daktacort Feminine Care Cream in the Treatment of Vulvar Candidiasis|Completed||Phase 4|115|Actual|Janssen Pharmaceutica|Data was not collected for pruritus symptom assessment by visual analog scale outcome measure as only few participants had pruritus after 1-hour of study drug application.|1|||f||||f||||||||||2017-10-11 02:05:47.067782|2017-10-11 02:05:47.067782
NCT01769157|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-12-02|||August 2012||2012-08-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effects of L-carnitine on Hypothyroidism|Single-center, Randomized, Double-Blinded, Comparative Study of the Effectiveness of L-carnitine in Patients'Fatigue Degree Changing With Hypothyroidism Who Take Levothyroxine|Completed||Phase 4|60|Actual|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-11 02:05:52.299541|2017-10-11 02:05:52.299541
NCT01769443|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-10-14|2015-10-13||June 2013||2013-06-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||All enrolled|Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation|A Prospective, Randomized, Multicenter, Two-Parallel Arm Study Evaluating the Overall Efficacy and Safety of Desensitization Therapy on Selected Patients Awaiting Heart Transplantation|Terminated||Phase 2|2|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Study was terminated by the study sponsor, with agreement from the investigators. Reason: very slow rate of accrual and inability to meet the accrual goal within the funding period. (N=2 enrolled. Aim was 80 participants).|2||Inability to enroll within funding period|f||||t||||||||||2017-10-11 02:05:40.135866|2017-10-11 02:05:40.135866
NCT01769430|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2014-01-28|||December 2012||2012-12-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|EMIT||Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza|Evaluating Modes of Influenza Transmission Work Package 1: Observational Study of Community Acquired Influenza|Completed||N/A|178|Actual|University of Maryland|||1||f||||f||||||Samples With DNA|"     viral cultures, viral RNA, viral cDNA, NP swabs, exhaled breath particles   "|||2017-10-11 02:05:40.778307|2017-10-11 02:05:40.778307
NCT01769417|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2014-07-23|||January 2013||2013-01-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjects|A Phase 1, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Extended Half-Life Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin, in Healthy Adult Subjects|Completed||Phase 1|85|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 02:05:40.866297|2017-10-11 02:05:40.866297
NCT01769404|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-12-16|||February 2013||2013-02-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes|Evaluation of the Counter-Regulatory Response to Hypoglycaemia Following LY2605541 Administration Compared to Insulin Glargine in Patients With Type 1 Diabetes Mellitus|Completed||Phase 1|15|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:05:40.945249|2017-10-11 02:05:40.945249
NCT01769391|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-06-01|2016-03-31|2015-05-08|January 2013||2013-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|April 2015|Actual|2015-04-01||Interventional|||A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer|A Randomized, Multicenter, Open-Label, Phase 2 Study of Paclitaxel-Carboplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Paclitaxel-Carboplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|167|Actual|Eli Lilly and Company||2|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 02:05:41.072573|2017-10-11 02:05:41.072573
NCT01769378|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-12-18|2015-09-14||January 2013||2013-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|AWARD-8|Intent to treat (ITT) population: all randomized participants who received at least one dose of study drug.|Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)|A Randomized, Parallel-Arm, Double-Blinded Study Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Patients With Type 2 Diabetes Mellitus on Sulfonylurea Therapy (AWARD-8: Assessment of Weekly AdministRation of LY2189265 in Diabetes - 8)|Completed||Phase 3|300|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:05:44.794679|2017-10-11 02:05:44.794679
NCT01769365|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-09-06|2015-09-06||July 2010||2010-07-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection|Comparison of 7-day Triple, 10-day Sequential, and 7-day Concomitant Therapies for Helicobacter Pylori Infection in Taiwan|Completed||Phase 4|307|Actual|Kaohsiung Veterans General Hospital.|The trial was performed in a single country|3|||f||||t||||||||||2017-10-11 02:05:45.907036|2017-10-11 02:05:45.907036
NCT01761994|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2013-01-03|||September 2007||2007-09-01|January 2013|2013-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy||Completed||Phase 4|66|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:08:23.974641|2017-10-11 02:08:23.974641
NCT01769326|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-06-05|2017-02-15||September 2012||2012-09-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional||"There were 40 participants enrolled in the study, however 7 of them did not complete the study. We listed the 7 and their reasons of not completing study in section participant flow overview."|Influence of Timing on Motor Learning|Influence of Timing on Motor Learning|Completed||N/A|40|Actual|University of California, Irvine||4|||f||||f||||||||||2017-10-11 02:05:47.343395|2017-10-11 02:05:47.343395
NCT01769313|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2014-10-30|||January 2013||2013-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract Surgery|A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract Surgery|Completed||Phase 4|30|Actual|Technolas Perfect Vision GmbH||2|||f||||f||||||||||2017-10-11 02:05:47.976737|2017-10-11 02:05:47.976737
NCT01769300|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-11|||January 2013||2013-01-01|January 2013|2013-01-01|August 2014|Anticipated|2014-08-01|August 2013|Anticipated|2013-08-01||Interventional|ePROS||Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder|Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder|Unknown status|Enrolling by invitation|N/A|450|Anticipated|American Academy of Pediatrics||2|||f||||f||||||||||2017-10-11 02:05:48.073504|2017-10-11 02:05:48.073504
NCT01769287|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-09-18|||January 2013||2013-01-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|AfMAZE EP||EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensity Focused Ultrasound|EP Study at >1 Year to Evaluate the Presence of Conduction Block Across the Cinch Line in Patients Who Have Received Left Atrial Ablation Using High Intensity Focused Ultrasound(HIFU)|Completed||N/A|20|Actual|Plymouth Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 02:05:48.157443|2017-10-11 02:05:48.157443
NCT01769274|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2013-07-30||2013-07-30|October 2012||2012-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|IEM||Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia|A Randomized, Double Blind Third Party Open Placebo-Controlled Exploratory Study To Evaluate The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia|Completed||Phase 2|5|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:05:48.235774|2017-10-11 02:05:48.235774
NCT01769261|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-07-31|||February 2013||2013-02-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|SENTIPAT||Sentinel Patients: Value of an Information System Collecting Patient's Own Report on His Healthcare Management|Sentinel Patients : Value of an Information System Collecting Patient's Own Report on His Healthcare Management. Application to the Detection of Adverse Events After Hospital Discharge.|Completed||N/A|2090|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 02:05:48.52202|2017-10-11 02:05:48.52202
NCT01769248|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-06-15|2015-03-05||September 2012||2012-09-01|June 2017|2017-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|MUCIN||Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle|Randomized Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle|Completed||N/A|140|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 02:05:48.643793|2017-10-11 02:05:48.643793
NCT01769235|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-05-03|||November 2012||2012-11-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris|A Multicenter, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Taro Pharmaceutical Inc.'s Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% to the Reference Listed Acanya® (Clindamycin Phosphate and Benzoyl Peroxide)Gel, 1.2%/2.5% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris|Completed||Phase 1|1215|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 02:05:48.999995|2017-10-11 02:05:48.999995
NCT01769222|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-01-12|2017-01-12||February 2013||2013-02-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|November 2014|Actual|2014-11-01||Interventional|||Ipilimumab and Local Radiation Therapy in Treating Patients With Recurrent Melanoma, Non-Hodgkin Lymphoma, Colon, or Rectal Cancer|A PHASE I/II STUDY OF INTRATUMORAL INJECTION OF IPILIMUMAB IN COMBINATION WITH LOCAL RADIATION IN MELANOMA, NON-HODGKIN LYMPHOMA AND COLORECTAL CARCINOMA|Terminated||Phase 1/Phase 2|3|Actual|Stanford University||2||Planned Future Study|f||||f||||||||||2017-10-11 02:05:49.142581|2017-10-11 02:05:49.142581
NCT01769209|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-03-28|||March 2013||2013-03-01|March 2017|2017-03-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|Phase II Study of Subcutaneous Bortezomib in Combination With Chemotherapy in Relapsed/Refractory Adult Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 2|18|Actual|Stanford University||1|||f||||||||||||||2017-10-11 02:05:49.654431|2017-10-11 02:05:49.654431
NCT01769196|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-04-28|2017-02-22||January 31, 2013|Actual|2013-01-31|April 2017|2017-04-01|February 23, 2016|Actual|2016-02-23|February 23, 2016|Actual|2016-02-23||Interventional|RAINIER|Intent-to-Treat (ITT) Analysis Set included all participants who were randomized into the study, and were analyzed according to treatment randomized.|Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Terminated||Phase 2|544|Actual|Gilead Sciences||2||The Study was terminated due to lack of efficacy.|f||||t|t|f||||||||2017-10-11 02:05:49.861501|2017-10-11 02:05:49.861501
NCT01769183|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-02-09|||February 2013||2013-02-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Squalamine for the Treatment in Proliferative Diabetic Retinopathy|Topical Squalamine in the Treatment of Retinal Neovascularization From Proliferative Diabetic Retinopathy|Completed||Phase 2|6|Actual|Elman Retina Group||1|||f||||f||||||||||2017-10-11 02:05:52.051636|2017-10-11 02:05:52.051636
NCT01769170|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-11-10|||August 2013||2013-08-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||A Study of the Safety and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study of the Safety, Tolerability, and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients|Completed||Phase 3|458|Actual|Chimerix||2|||f||||t||||||||||2017-10-11 02:05:52.129346|2017-10-11 02:05:52.129346
NCT01769144|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-02-20|||January 2013||2013-01-01|January 2013|2013-01-01|April 2014|Anticipated|2014-04-01|July 2013|Anticipated|2013-07-01||Interventional|||Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh|Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh---A Randomised Controlled Trial|Unknown status|Recruiting|N/A|70|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||f||||||||||2017-10-11 02:05:52.387757|2017-10-11 02:05:52.387757
NCT01769131|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-08-02|||September 2012||2012-09-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|OB39||A Comparison of Two Instruments for Stabilization of the Cervix During Office Procedures|A Comparison of Two Instruments for Stabilization of the Cervix During Office Procedures|Completed||N/A|81|Actual|Carilion Clinic|||2||f||||f||||||||||2017-10-11 02:05:52.529171|2017-10-11 02:05:52.529171
NCT01769118|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-05-06|||January 2013||2013-01-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||The Influences of Caffeine on Heart Rate Variability of Preterm Infants|The Influences of Caffeine on HRV of Preterm Infants|Completed||N/A|25|Actual|Rambam Health Care Campus|||1||f||||t||||||||||2017-10-11 02:05:52.599665|2017-10-11 02:05:52.599665
NCT01769105|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2014-10-06|2014-09-01||April 2012||2012-04-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Comparison of Lipiflow®-Treatment and a Standard Lid Hygiene Regime|Prospective, Randomized, Controlled Comparison of an Automated Thermal Pulsation Treatment (Lipiflow ®) and a Standard Lid Hygiene Regime|Completed||N/A|40|Actual|Heinrich-Heine University, Duesseldorf|For further information please have a look at Finis et al: Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial.Ocul Surf. 2014 Apr;12(2):146-54.|2|||f||||f||||||||||2017-10-11 02:05:52.680204|2017-10-11 02:05:52.680204
NCT01769092|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-09-08|||January 2013||2013-01-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders|Double Blind Placebo Controlled Trial of Anticonvulsant Effects of n-3 PUFAs in Human Subjects With Epilepsy|Active, not recruiting||Phase 2/Phase 3|30|Anticipated|The Canadian College of Naturopathic Medicine||2|||f||||t||||||||Yes|Findings will be shared with participants upon request. Results will be disseminated at epilepsy conferences.|2017-10-11 02:05:53.123338|2017-10-11 02:05:53.123338
NCT01769079|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2014-01-02|||September 2009||2009-09-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Clinical Impact of the Withdrawal of Nitrate in Patients With Stable Angina|Withdrawal of Nitrate in Patients With Stable Angina - Multicenter Clinical Trial|Completed||Phase 4|95|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 02:05:53.238988|2017-10-11 02:05:53.238988
NCT01769066|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-02-22|||December 2009||2009-12-01|February 2016|2016-02-01||||February 2014|Actual|2014-02-01||Interventional|||Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC|Random Open Exploratory Clinical Research of Sequential Gefitinib With Pemetrexed/Platinum Compare With Pemetrexed/Platinum Treatment for Advanced Non-small Cell Lung Cancer Exploratory Clinical Research|Completed||Phase 2/Phase 3|117|Actual|Fudan University||2|||f||||||||||||||2017-10-11 02:05:53.332019|2017-10-11 02:05:53.332019
NCT01769053|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-08-24|||January 2013||2013-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|ViPS||Variable Pressure Support Trial|International Multicenter Randomized Controlled Open Trial on Variable vs. Non-Variable Pressure Support for Weaning From Mechanical Ventilation|Recruiting||N/A|228|Anticipated|Technische Universität Dresden||2|||f||||f||||||||||2017-10-11 02:05:53.415529|2017-10-11 02:05:53.415529
NCT01769040|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-01-18|||November 2012||2012-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis|Intestinal Decontamination With Rifaximin. Effects on the Inflammatory and Circulatory State in Patients With Cirrhosis and Ascites - A Randomised Controlled Clinical Study|Completed||Phase 4|54|Actual|Copenhagen University Hospital, Hvidovre||2|||f||||t||||||||||2017-10-11 02:05:53.507834|2017-10-11 02:05:53.507834
NCT01769027|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2013-01-15|||June 2013||2013-06-01|January 2013|2013-01-01|June 2016|Anticipated|2016-06-01|December 2013|Anticipated|2013-12-01||Interventional|ATIVPANDAS||Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS|Antibiotic Treatment and Intravenous Immunoglobulin Double-blind, Randomized, Placebo-controlled Trial for PANDAS|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|CNS Onlus||2|||f||||f||||||||||2017-10-11 02:05:53.60185|2017-10-11 02:05:53.60185
NCT01769014|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-01-15|||January 2013||2013-01-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|April 2013|Anticipated|2013-04-01||Observational|||Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder|In the Cantons Graubunden and Glarus as Well as in the Principality of Liechtenstein: Influence of Intensive Outpatient Treatment of People With Schizophrenia and Schizoaffective Disorder on Quality of Life and Adherence|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Psychiatrische Dienste Graubuenden|||1||f||||t||||||||||2017-10-11 02:05:53.707522|2017-10-11 02:05:53.707522
NCT01769001|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2015-12-08|||March 2013||2013-03-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||An Extension of a Phase 1/2, Open Label, Dose Ranging Study of PRX-102 in Adult Fabry Patients|An Extension of Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 38 Weeks to Adult Fabry Patients|Enrolling by invitation||Phase 1/Phase 2|18|Anticipated|Protalix||3|||f||||f||||||||||2017-10-11 02:05:53.77921|2017-10-11 02:05:53.77921
NCT01768988|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-10-04|||August 2012||2012-08-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PANPAIN/1||Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study|Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study|Terminated||Phase 4|20|Actual|Parc de Salut Mar||2||"Change of PI. Former PI changed from Research Center and Promoter obliged unexpectedly to   change the PI."|f||||f||||||||||2017-10-11 02:05:53.892205|2017-10-11 02:05:53.892205
NCT01768793|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-08-02|||October 2012||2012-10-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|May 2016|Actual|2016-05-01||Interventional|LIFE-Moms||Weight Management in Obese Pregnant Underserved African American Women|Weight Management in Obese Pregnant Underserved African American Women|Active, not recruiting||N/A|267|Actual|Washington University School of Medicine||2|||f||||t|f|f||||||||2017-10-11 02:05:55.512087|2017-10-11 02:05:55.512087
NCT01768975|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2014-09-25||2014-09-10|January 2013||2013-01-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee|Randomized, Double-Blind, Vehicle-Controlled, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy|Completed||Phase 2|79|Actual|Olatec Industries LLC||2|||f||||f||||||||||2017-10-11 02:05:53.971534|2017-10-11 02:05:53.971534
NCT01768962|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-12-14|||April 2014||2014-04-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel|A Phase 1 Crossover Trial Evaluating the Pharmacokinetics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women|Completed||Phase 1|14|Actual|CONRAD||2|||f||||t||||||||||2017-10-11 02:05:54.107462|2017-10-11 02:05:54.107462
NCT01768949|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2017-01-30|||February 2013||2013-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|RV STAR||Echocardiography Predictive of the Inefficacy and/or of the Unsafeness of Recruitment Maneuvers in Patients With Acute Respiratory Distress Syndrome.|Identification of Echocardiographic Criteria Predictive of the Inefficacy and/or the Unsafeness of Recruitment Maneuvers in Patients Suffering From Acute Respiratory Distress Syndrome|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-11 02:05:54.210969|2017-10-11 02:05:54.210969
NCT01768936|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-15|||January 2009||2009-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|||Procalcitonin Ratio's Impact on the Decision Upon On-demand Relaparotomy in Septic Peritonitis|Procalcitonin Ratio's Impact on the Decision Upon On-demand Relaparotomy in Septic Peritonitis|Completed||N/A|234|Actual|CHIR-Net|||2||f||||||||||||||2017-10-11 02:05:54.313149|2017-10-11 02:05:54.313149
NCT01768923|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-07-18|||October 2012||2012-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early RA Vascular Randomised Controlled Study|Effect of Treat-to-target Strategies Aiming at Remission Compared With Minimal Disease Activity on Arterial Stiffness in Early Rheumatoid Arthritis - a Randomised Controlled Study|Recruiting||N/A|120|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:05:54.374899|2017-10-11 02:05:54.374899
NCT01768910|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-12-04|||December 2011||2011-12-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|2011-0346||Supraspinal Control of Lower Urinary Tract Function in Healthy Controls & Patients With Bladder Dysfunction|The Bladder and the Brain - Investigation of the Supraspinal Neural Control of Lower Urinary Tract Function in Healthy Subjects and Patients With Neurogenic and Non-neurogenic Bladder Dysfunction Using Advanced Neuroimaging Techniques|Unknown status|Recruiting|N/A|96|Anticipated|University of Zurich||5|||f||||f||||||||||2017-10-11 02:05:54.461009|2017-10-11 02:05:54.461009
NCT01768897|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-07-31|||January 2013|Actual|2013-01-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|An Open Label, Dose-Escalation Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given With High Dose Cytarabine and Mitoxantrone in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)|Completed||Phase 1|67|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 02:05:54.565653|2017-10-11 02:05:54.565653
NCT01768884|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2016-05-03|||January 2013||2013-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With Bronchiolitis|Phase IIa Prospective, Double Blind, Randomized Single-Center, Evaluation of the Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis|Completed||Phase 1/Phase 2|43|Actual|Advanced Inhalation Therapies Ltd||2|||f||||f||||||||||2017-10-11 02:05:54.658452|2017-10-11 02:05:54.658452
NCT01768871|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-01-26|||January 2013||2013-01-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|July 2015|Actual|2015-07-01||Observational|||Evaluation of the VEGA Knee System® Range of Motion|Prospective, Long-Term, Multi-Center Study on the Efficacy of the VEGA System® for Total Knee Arthroplasty.|Terminated||N/A|7|Actual|Aesculap Implant Systems|||1|low enrollment|f||||f||||||||||2017-10-11 02:05:54.730779|2017-10-11 02:05:54.730779
NCT01768858|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2017-07-17|||February 5, 2013||2013-02-05|July 2017|2017-07-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Observational|Adherence||Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice|Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice|Active, not recruiting||N/A|140|Anticipated|AbbVie|||1||f||||f||||||||||2017-10-11 02:05:54.949049|2017-10-11 02:05:54.949049
NCT01768845|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-02-09|||February 2009||2009-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Unrelated Umbilical Cord Blood (UBC)Transplantation|Unrelated Umbilical Cord Blood (UCB) Transplantation|Recruiting||N/A|40|Anticipated|West Virginia University||1|||f||||t||||||||No||2017-10-11 02:05:55.090057|2017-10-11 02:05:55.090057
NCT01768832|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-05-08|||February 2013||2013-02-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms|Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms|Active, not recruiting||N/A|114|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 02:05:55.224121|2017-10-11 02:05:55.224121
NCT01768819|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-12|2013-01-22|||January 2008||2008-01-01|January 2013|2013-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Multimodal Physical Activity for the Elderly|The Effects of an Elderly-specific Multimodal Physical Activity Program: a Controlled Clinical Trial|Completed||N/A|46|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-10-11 02:05:55.331009|2017-10-11 02:05:55.331009
NCT01768780|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-02-17|||December 2012||2012-12-01|February 2014|2014-02-01|November 2014|Anticipated|2014-11-01|August 2014|Anticipated|2014-08-01||Interventional|||Efficacy of Peripheral Nerve Stimulator in Assessing Sensory Nerve Block Level of Spinal Anesthesia||Unknown status|Active, not recruiting|N/A|58|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 02:05:55.607049|2017-10-11 02:05:55.607049
NCT01768767|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2013-11-27|||January 2013||2013-01-01|November 2013|2013-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Trial of Ketamine and Lithium Therapy in Bipolar Depression|Novel Approach of Combined Lithium-Ketamine Therapy in Bipolar Depression: To Preserve Efficacy and Minimize Adverse Effects|Withdrawn||Phase 2|0|Actual|Yale University||3|||f||||f||||||||||2017-10-11 02:05:55.684318|2017-10-11 02:05:55.684318
NCT01768754|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2013-03-08|||July 2012||2012-07-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Observational|||Walking Speeds in Patients With Chronic Obstructive Pulmonary Disease|Repeatability and Utility of the Usual and Fast Walking Speeds in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|29|Actual|West Park Healthcare Centre|||1||f||||f||||||||||2017-10-11 02:05:55.783883|2017-10-11 02:05:55.783883
NCT01768741|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2015-11-16|||December 2012||2012-12-01|November 2015|2015-11-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma|A Randomized Controlled Trial of Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma|Recruiting||N/A|500|Anticipated|Sir Run Run Shaw Hospital||2|||f||||||||||||||2017-10-11 02:05:55.887276|2017-10-11 02:05:55.887276
NCT01768728|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-11-16|||December 2012||2012-12-01|November 2015|2015-11-01||||September 2015|Actual|2015-09-01||Interventional|||Laparoscopic Versus Open Left Hemihepatectomy for Liver Benign Lesions|A Randomized Controlled Trial of Acute Surgical Trauma and Stress Response of Laparoscopic Versus Open Left Hemihepatectomy for Liver Benign Lesions|Completed||N/A|60|Actual|Sir Run Run Shaw Hospital||2|||f||||||||||||||2017-10-11 02:05:56.005197|2017-10-11 02:05:56.005197
NCT01768715|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2014-06-02|||January 2013||2013-01-01|June 2014|2014-06-01|December 2017|Anticipated|2017-12-01|December 2014|Anticipated|2014-12-01||Observational|SETH-HA||Liver Transplantation in Alcoholic Hepatitis|Applicability of Liver Transplantation in Alcoholic Hepatitis|Suspended||N/A|40|Anticipated|Sociedad Española de Trasplante Hepático|||3|Low rate of recruitment (only one patient up to May 2014)|f||||f||||||||||2017-10-11 02:05:56.093346|2017-10-11 02:05:56.093346
NCT01768702|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-05-18|||November 2012||2012-11-01|May 2015|2015-05-01|July 2017|Anticipated|2017-07-01|April 2016|Anticipated|2016-04-01||Interventional|CHART-1||Safety and Efficacy of Autologous Cardiopoietic Cells for Treatment of Ischemic Heart Failure.|Efficacy and Safety of Bone Marrow-derived Mesenchymal Cardiopoietic Cells (C3BS-CQR-1) for the Treatment of Chronic Advanced Ischemic Heart Failure.|Unknown status|Active, not recruiting|Phase 3|240|Anticipated|Celyad (formerly named Cardio3 BioSciences)||2|||f||||t||||||||||2017-10-11 02:05:56.222191|2017-10-11 02:05:56.222191
NCT01768689|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-06-05|||October 2013|Actual|2013-10-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|TAKE-IT||Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia|The Effect of Active Adherence-Encouraging Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - A Prospective Observational Multicenter Study (TAKE-IT)|Completed||N/A|58|Actual|Rabin Medical Center||2|||f||||f||||||||No||2017-10-11 02:05:56.372894|2017-10-11 02:05:56.372894
NCT01768676|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-11-05|2015-10-07||December 2012||2012-12-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Safety population|Study Evaluating the Effects of Avanafil on Semen Parameters|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Clinical Trial of the Effect of Avanafil (STENDRA™) on Spermatogenesis in Healthy Adult Males and Adult Males With Mild Erectile Dysfunction|Completed||Phase 4|181|Actual|VIVUS, Inc.||2|||f||||f||||||||||2017-10-11 02:05:56.508027|2017-10-11 02:05:56.508027
NCT01768663|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-11-14|||January 2013||2013-01-01|November 2013|2013-11-01||||September 2013|Actual|2013-09-01||Interventional|||A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects|A Phase 1, Open-Label Study to Examine the Effect of Ciprofloxacin, Itraconazole, and Rifampin on the Pharmacokinetics of Lumacaftor in Combination With Ivacaftor in Healthy Adult Subjects|Completed||Phase 1|80|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||f||||||||||2017-10-11 02:05:57.349918|2017-10-11 02:05:57.349918
NCT01768650|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-10-01|||June 2014|Actual|2014-06-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|July 2017|Actual|2017-07-01||Interventional|STOP||Structured Treatment of Pain (STOP) Study|Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain Following Traumatic Brain Injury|Completed||N/A|231|Actual|University of Washington||2|||f||||f|f|f||||||||2017-10-11 02:05:57.461124|2017-10-11 02:05:57.461124
NCT01768637|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-11|||January 2013||2013-01-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|WiCKDonASA||Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study|Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin|Unknown status|Recruiting|Phase 1|36|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 02:05:57.564133|2017-10-11 02:05:57.564133
NCT01768624|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-10-24|||October 2012||2012-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Observational|||PINOT Follow-up Study in End-stage Kidney Disease|Patient Information About Options for Treatment (PINOT) Follow up Study: Answering Important Questions in Home Dialysis and Conservative Care.|Completed||N/A|721|Actual|University of Sydney|||1||f||||f||||||||||2017-10-11 02:05:57.679045|2017-10-11 02:05:57.679045
NCT01768611|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2013-01-15|||October 2004||2004-10-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||SLC2A1 Variants and Diabetic Nephropathy|Association of Single Nucleotide Polymorphisms in the Gene Coding GLUT-1 and Diabetic Nephropathy in Brazilian Patients With Type 1 Diabetes Mellitus|Completed||N/A|449|Actual|University of Sao Paulo General Hospital|||3||f||||t||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 02:05:57.791866|2017-10-11 02:05:57.791866
NCT01768598|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-05-19|||June 2010|Actual|2010-06-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Risk Taking and Fracture Study|An Investigation Into Risk Taking Behaviour, Bone Microstructure and Fracture Between the Sexes: What Underpins Fracture in Boys Compared to Girls During Growth?|Completed||N/A|319|Actual|University of British Columbia|||4||f||||f||||||||||2017-10-11 02:05:57.870598|2017-10-11 02:05:57.870598
NCT01768585|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-14|||December 2012||2012-12-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease|A Randomised, Placebo Controlled, Double Blind, Cross-over, Single Center Clinical Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease|Unknown status|Recruiting|Phase 4|50|Anticipated|University Hospital, Saarland||2|||f||||f||||||||||2017-10-11 02:05:57.967406|2017-10-11 02:05:57.967406
NCT01768572|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-06-23|2017-05-23|2015-10-07|March 2013||2013-03-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)|A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF Antagonists|Completed||Phase 3|202|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 02:05:58.120397|2017-10-11 02:05:58.120397
NCT01768559|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-11-04|2016-08-22|2015-12-02|January 2013||2013-01-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|GetGoal-Duo-2||Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients|A Randomized, Open-label, Active-controlled, 3-arm Parallel-group, 26-week Study Comparing the Efficacy and Safety of Lixisenatide to That of Insulin Glulisine Once Daily and Insulin Glulisine Three Times Daily in Patients With Type 2 Diabetes Insufficiently Controlled With Insulin Glargine With or Without Metformin|Completed||Phase 3|894|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:05:59.553531|2017-10-11 02:05:59.553531
NCT01768546|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-12-17|||February 2012||2012-02-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|May 2013|Actual|2013-05-01||Interventional|Project NOT ME||Evaluation of Video On-Demand Programming to Prevent Type 2 Diabetes in Adults|Evaluation of Video On-Demand Programming to Prevent Type 2 Diabetes in Adults|Completed||N/A|306|Actual|UnitedHealth Group||2|||f||||f||||||||||2017-10-11 02:06:01.511636|2017-10-11 02:06:01.511636
NCT01768533|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2013-01-11|||September 2009||2009-09-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|TIDE||Pediatric Behavioral Informatics to Prevent Cancer|Pediatric Behavioral Informatics to Prevent Cancer|Completed||N/A|305|Actual|University of Massachusetts, Boston|||1||f||||f||||||||||2017-10-11 02:06:01.625755|2017-10-11 02:06:01.625755
NCT01768520|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-01-14|||July 2012||2012-07-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee|For 12 Weeks, the Multi-center, Randomized, Double-blinded, Clinical Study to Evaluate the Efficacy and Safety of Entelon Tab. 150mg Compared With Celebrex Capsule in Patients With Osteoarthritis of Knee (Phase III)|Unknown status|Recruiting|Phase 3|336|Anticipated|Hanlim Pharm. Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:06:01.736485|2017-10-11 02:06:01.736485
NCT01768507|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2016-09-14|||March 2011||2011-03-01|September 2016|2016-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|REVAHS||Reresveratrol Administered to Healthy Male Subjects|The Effects of the Dietary Supplement Trans-resveratrol on Heme Oxygenase-1 (HO-1) and Sirtuins Expression in PBMCs in Healthy Male Subjects: A Pilot Study.|Completed||N/A|10|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 02:06:01.838325|2017-10-11 02:06:01.838325
NCT01768494|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-12-11|||March 2013||2013-03-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|TRIAGE||Optimizing Triage and Hospitalisation In Adult General Medical Emergency Patients: the TRIAGE Study|Optimizing Triage and Hospitalisation In Adult General Medical Emergency Patients: the TRIAGE Study|Completed||N/A|7000|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     Left over blood samples of routinely collect blood tubes on admission will be asserved and     aliquoted for later batch analysis of blood biomarkers (bio-bank)   "|||2017-10-11 02:06:01.929239|2017-10-11 02:06:01.929239
NCT01768481|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-11|||January 2004||2004-01-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Intima Media Thickness Regression in Dyslipidemic Teenagers|Intervention précoce Sur Les Indices d'athérogénèse Des Adolescents à Risque|Completed||Phase 3|16|Actual|Université de Montréal||2|||f||||f||||||||||2017-10-11 02:06:02.024958|2017-10-11 02:06:02.024958
NCT01768468|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-10-11|||October 2012||2012-10-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients|Double Blinded, Randomized, Active Drug Comparative, Multi-center, Phase IV Clinical Study to Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients|Completed||Phase 4|124|Actual|PMG Pharm Co., Ltd||2|||f||||t||||||||||2017-10-11 02:06:02.147099|2017-10-11 02:06:02.147099
NCT01768455|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2013-04-22|||February 2013||2013-02-01|April 2013|2013-04-01||||April 2013|Actual|2013-04-01||Interventional|||Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects|A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Gemigliptin and Glimepiride in Healthy Male Subjects|Completed||Phase 1|27|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-11 02:06:02.285653|2017-10-11 02:06:02.285653
NCT01768442|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-10-04|||September 2011|Actual|2011-09-01|October 2017|2017-10-01|December 2020|Anticipated|2020-12-01|April 2018|Anticipated|2018-04-01||Observational|||MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043)|GCC1043: Magnetic Resonance Imaging for Evaluating Tumor and Node Response and Normal Tissue Function to Concurrent Chemotherapy and Radiation Therapy in Head and Neck Cancer|Active, not recruiting||N/A|30|Actual|University of Maryland|||1||f||||t||||||||||2017-10-11 02:06:02.365513|2017-10-11 02:06:02.365513
NCT01768429|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2014-12-02|||October 2012||2012-10-01|December 2014|2014-12-01||||June 2014|Actual|2014-06-01||Interventional|||The Effect of n-3 Fatty Acids and Fish on Glucose and Lipid Metabolism in Subjects With Impaired Glucose Metabolism|The Effect of n-3 Fatty Acids and Fish on Glucose and Lipid Metabolism in Subjects With Impaired Glucose Metabolism|Completed||N/A|79|Actual|University of Eastern Finland||4|||f||||f||||||||||2017-10-11 02:06:02.444264|2017-10-11 02:06:02.444264
NCT01768234|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-09-29|||January 2013||2013-01-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Dehydration Among School Children- Mali|Cognitive Effects of Drinking Water and Improving Hydration Status Among Schoolchildren|Completed||N/A|120|Actual|Emory University||2|||f||||f||||||||||2017-10-11 02:06:07.762756|2017-10-11 02:06:07.762756
NCT01768416|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-06-02|||March 2013||2013-03-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|BISSOPS||Measuring Depth of Unconsciousness at the End of Life Using Bispectral Index (BIS)|Measuring Depth of Unconsciousness at the End of Life: the Reliability of the BIS Monitoring as an Assessment Tool Versus Sedation Scales|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Ghent|||1||f||||f||||||||||2017-10-11 02:06:02.561645|2017-10-11 02:06:02.561645
NCT01768403|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-01-14|||September 2010||2010-09-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|CEPHEUS||Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia|Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia|Completed||N/A|1236|Actual|AstraZeneca|||1||f||||||||||Samples Without DNA|"     Whole blood serum   "|||2017-10-11 02:06:02.708587|2017-10-11 02:06:02.708587
NCT01768390|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-01-11|||January 2008||2008-01-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Caries-preventive Effect of a Dentifrice Containing 5,000 Ppm Fluoride in Orthodontic Patients|Caries-preventive Effectiveness of a Dentifrice Containing 5.000 Ppm Fluoride - a Randomized Controlled Trial in Adolescents With Fixed Orthodontic Appliances|Completed||Phase 4|500|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:06:02.836036|2017-10-11 02:06:02.836036
NCT01768377|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2013-01-14|||November 2012||2012-11-01|January 2013|2013-01-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Comparison of Intubation With Nerve Block and With Sedation in Awake Patients|Comparison of in Intubation With Nerve Block and Intubation With Sedation in Awake Patients in Terms of Efficacy, Complications and Physician's Satisfaction|Unknown status|Recruiting|Phase 3|70|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:06:02.930531|2017-10-11 02:06:02.930531
NCT01768364|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-14|2013-01-14|||January 2013||2013-01-01|January 2013|2013-01-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||Antibiotic Prophylaxis When Removing Ureteric Stent After Stone Surgery||Unknown status|Not yet recruiting|N/A|124|Anticipated|University Hospital, Akershus||2|||f||||f||||||||||2017-10-11 02:06:03.026067|2017-10-11 02:06:03.026067
NCT01768351|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-13|2014-07-29|||October 2010||2010-10-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|March 2011|Actual|2011-03-01||Interventional|||Paricalcitol Effect on Anemia in CKD|Direct Effect of Paricalcitol on Anemia in Chronic Kidney Disease|Completed||Phase 4|60|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 02:06:03.115369|2017-10-11 02:06:03.115369
NCT01768338|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-04-19|||February 2013||2013-02-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|March 2016|Actual|2016-03-01||Interventional|||Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma|A Phase I Study of Recombinant Human Interleukin-18 (SB-485232) in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma|Active, not recruiting||Phase 1|9|Actual|Indiana University||1|||f||||t||||||||No||2017-10-11 02:06:03.198528|2017-10-11 02:06:03.198528
NCT01768325|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-02-28|2015-07-23||January 2012||2012-01-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional||78 participants competed the study.|Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)|Evaluation of a New EUS-guided Needle (ProCore) Comparing to Conventional EUS-TCB Needle (Quick-Core); A Prospective Randomized, Controlled Multi-center Study.|Completed||N/A|85|Actual|Indiana University||2|||f||||t||||||||No||2017-10-11 02:06:03.291247|2017-10-11 02:06:03.291247
NCT01768312|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-01-11|||March 2012||2012-03-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|May 2012|Actual|2012-05-01||Interventional|Cyclosporine||Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group|A Multicenter, Randomized, Double-blind Phase Ⅲ Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group 12 Weeks After Treatment in Moderate to Severe Dry Eye Disease|Unknown status|Recruiting|Phase 3|86|Anticipated|Hanlim Pharm. Co., Ltd.||2|||f||||||||||||||2017-10-11 02:06:03.632704|2017-10-11 02:06:03.632704
NCT01768299|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2014-05-12|||February 2013||2013-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)|Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks): A Double-blind Randomized-controlled Trial|Completed||Phase 4|504|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-11 02:06:03.742726|2017-10-11 02:06:03.742726
NCT01768286|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-11-21|2014-11-21||January 2013||2013-01-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|ION-2|Safety Analysis Set: participants were randomized and received at least one dose of study drug. Participants failed a previous HCV treatment regimen consisting of pegylated interferon alfa-2a (Pegasys) or pegylated interferon alfa-2b (Pegintron) plus ribavirin (RBV), with or without a protease inhibitor (PI).|Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection|A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5885 Fixed-Dose Combination ± Ribavirin for 12 and 24 Weeks in Treatment-Experienced Subjects With Chronic Genotype 1 HCV Infection|Completed||Phase 3|441|Actual|Gilead Sciences||4|||f||||t||||||||||2017-10-11 02:06:05.882272|2017-10-11 02:06:05.882272
NCT01768273|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-01-12|||December 2009||2009-12-01|August 2015|2015-08-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam|A Phase 1, Open-label, Multi-Dose Study to Assess Pharmacokinetic Interaction Between PA-824 and Midazolam|Completed||Phase 1|14|Actual|Global Alliance for TB Drug Development||1|||f||||f||||||||||2017-10-11 02:06:07.453698|2017-10-11 02:06:07.453698
NCT01768260|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-03-29|||December 2012||2012-12-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|AION||Effect of EECP on Anterior Ischemic Optic Neuropathy|Study of the Effect of EECP on Anterior Ischemic Optic Neuropathy|Recruiting||N/A|40|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t|f|f||||||No||2017-10-11 02:06:07.54718|2017-10-11 02:06:07.54718
NCT01768247|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-12|2013-01-16|||January 2012||2012-01-01|January 2013|2013-01-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)|HCG Priming for Thin Endometrium in IVF|Unknown status|Active, not recruiting|Phase 4|15|Anticipated|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-11 02:06:07.679842|2017-10-11 02:06:07.679842
NCT01717339|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-09-25|||November 2012||2012-11-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Sleep Apnea and Vascular Function|Sleep Apnea and Vascular Function|Recruiting||N/A|60|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:21:12.597832|2017-10-11 02:21:12.597832
NCT01768221|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-07-22|||January 2013||2013-01-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2013|Actual|2013-12-01||Interventional|||Caregiver Outlook: An Evidence-based Intervention for the Chaplain Toolkit|Caregiver Outlook: An Evidence-based Intervention for the Chaplain Toolkit|Active, not recruiting||N/A|33|Actual|Duke University||1|||f||||f||||||||||2017-10-11 02:06:07.848817|2017-10-11 02:06:07.848817
NCT01768208|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-06-12|||October 2012||2012-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients||Active, not recruiting||Phase 4|569|Actual|Shanghai Jiao Tong University School of Medicine||1|||f||||||||||||||2017-10-11 02:06:07.934944|2017-10-11 02:06:07.934944
NCT01768195|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-01-08|||January 2013||2013-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy|Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy|Recruiting||Phase 4|80|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 02:06:08.018153|2017-10-11 02:06:08.018153
NCT01768182|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-24|||August 2009||2009-08-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Folinic Acid and Vascular Reactivity in HIV|Short-term Folinic Acid Supplementation Improves Vascular Reactivity in HIV-infected Individuals: a Randomized Trial|Completed||N/A|30|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 02:06:08.17589|2017-10-11 02:06:08.17589
NCT01768169|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2013-01-11|||April 2012||2012-04-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Observational|||Study of Metabolic Syndrome Use Omega-3 Fatty Acids and Low Fat Meal|Phase 2 Study of Metabolic Syndrome Use Omega-3 Fatty Acids and Low Fat Meal Replacements|Unknown status|Recruiting|N/A|200|Anticipated|Taipei Medical University Hospital|||1||f||||t||||||||||2017-10-11 02:06:08.26945|2017-10-11 02:06:08.26945
NCT01768156|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-03-02|||January 2011||2011-01-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|July 2015|Anticipated|2015-07-01||Interventional|Meta-Four||Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer|Determination of the Prognostic and Predictive Value of the New Marker HE4 in Metastatic Ovarian Cancer Monitoring|Unknown status|Recruiting|N/A|100|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-10-11 02:06:08.36464|2017-10-11 02:06:08.36464
NCT01768143|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-08-19|||January 2013||2013-01-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Observational|NAPSAT||Assessment of NAPS Performance.|A Reliable and Valid Assessment of Nurse Administered Propofol Sedation (NAPS) Performance.|Completed||N/A|12|Actual|Copenhagen University Hospital at Herlev|||2||f||||f||||||||||2017-10-11 02:06:08.453792|2017-10-11 02:06:08.453792
NCT01768130|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-02-27|||April 2011||2011-04-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Variability in Thermal Thresholds in Patients With Persistent Pain After Open Inguinal Herniotomy|Variability in Thermal Thresholds in Patients With Persistent Pain After Open Inguinal Herniotomy|Completed||N/A|21|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 02:06:08.566079|2017-10-11 02:06:08.566079
NCT01768117|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-02-23|2015-02-23||February 2013||2013-02-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|B1971042||Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age|A Single-arm, Open-label Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers >=18 To < =65 Years Of Age|Completed||Phase 2|13|Actual|Pfizer|Results of immunogenicity endpoints were reported in ''number'' and not in ''proportion'' as per team's input.|1|||f||||t||||||||||2017-10-11 02:06:08.633377|2017-10-11 02:06:08.633377
NCT01768104|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-11|||December 2011||2011-12-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors|Endoscopic Submucosal Tunnel Dissection Versus Video-assisted Thoracoscopic Surgery for Upper Gastrointestinal Submucosal Tumors: a Prospective Randomized Controlled Trial|Unknown status|Recruiting|N/A|200|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||f||||||||||2017-10-11 02:06:08.884414|2017-10-11 02:06:08.884414
NCT01768091|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-11|||December 2011||2011-12-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||POEM vs. Pneumatic Dilation for Esophageal Achalasia|Peroral Endoscopic Myotomy Versus Pneumatic Dilation for Esophageal Achalasia: a Prospective Randomized Controlled Trial|Unknown status|Recruiting|N/A|200|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||f||||||||||2017-10-11 02:06:09.128179|2017-10-11 02:06:09.128179
NCT01768078|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-14|||September 2008||2008-09-01|January 2013|2013-01-01||||September 2013|Anticipated|2013-09-01||Interventional|Endophtalmitis||Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis|Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.|Unknown status|Recruiting|Phase 3|130|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||t||||||||||2017-10-11 02:06:09.25061|2017-10-11 02:06:09.25061
NCT01768065|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-06-18|||July 2012||2012-07-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Nasal Expiratory Positive Airway Pressure for the Treatment of Pediatric Obstructive Sleep Apnea Syndrome|Nasal Expiratory Positive Airway Pressure for the Treatment of Pediatric Obstructive Sleep Apnea Syndrome|Completed||Early Phase 1|15|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 02:06:09.395873|2017-10-11 02:06:09.395873
NCT01768052|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-05-01|||June 2013||2013-06-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Functional Brain Imaging Study of Response to Repetitive TMS (rTMS) Treatment of Major Depression|Multimodal Functional Brain Imaging Study of Response to Repetitive TMS (rTMS) Treatment of Major Depression|Unknown status|Recruiting|N/A|40|Anticipated|Mclean Hospital|||1||f||||f||||||||||2017-10-11 02:06:09.494134|2017-10-11 02:06:09.494134
NCT01768039|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-11|||March 2013||2013-03-01|January 2013|2013-01-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|MSVit||Vitamine D in Multiple Sclerosis|Randomised Double Blind Placebo-controlled Trial of Vitamine D Supplement in Multiple Sclerosis|Unknown status|Not yet recruiting|Phase 3|240|Anticipated|Mazandaran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:06:09.602422|2017-10-11 02:06:09.602422
NCT00000152|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||April 1982||1982-04-01|September 2001|2001-09-01||||||||Interventional|||Randomized Trial of Beta-Carotene and Macular Degeneration||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.791991|2017-10-11 04:17:33.791991
NCT01768026|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-05-20|||February 2013||2013-02-01|February 2013|2013-02-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa|A Prospective, Longitudinal Assessment of Disease Severity in Subjects With Dystrophic Epidermolysis Bullosa (DEB)|Withdrawn||N/A|0|Actual|Lotus Tissue Repair, Inc.|||1||f||||f||||||||||2017-10-11 02:06:09.700856|2017-10-11 02:06:09.700856
NCT01768013|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-05-13|2013-11-08||July 2012||2012-07-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris||Completed||Phase 1/Phase 2|13|Actual|LEO Pharma||1|||f||||||||||||||2017-10-11 02:06:09.798828|2017-10-11 02:06:09.798828
NCT01768000|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-02-01|2015-09-22||January 2013||2013-01-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Baseline Analysis includes all participants recruited into the study that completed the entire baseline assessment.|The Family Cognitive Adaptation Training Manual: A Test of Effectiveness|The Family CAT (Cognitive Adaptation Training Manual): A Test of Effectiveness|Completed||N/A|40|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-11 02:06:10.327976|2017-10-11 02:06:10.327976
NCT01767987|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-08-16|2014-09-09||November 2012||2012-11-01|August 2017|2017-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Ranolazine Cardioprotection in PCI|Ranolazine Cardioprotection in PCI|Terminated||Phase 2|6|Actual|Kettering Health Network||2||Sponsor terminated study due to lack of enrollment|f||||f||||||||||2017-10-11 02:06:11.284219|2017-10-11 02:06:11.284219
NCT01767961|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-08-08|||September 2013|Actual|2013-09-01|August 2017|2017-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer|A Pilot Study Assessing Swallowing Function After Transoral Robotic Surgery (TORS) for Head and Neck Cancer|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||1||Unable to secure funding.|f||||f|f|f||||||||2017-10-11 02:06:11.903666|2017-10-11 02:06:11.903666
NCT01767948|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-10-06|||December 2012||2012-12-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Evaluate the Pharmacokinetics of PCI-32765 in Participants With Varying Degrees of Hepatic Impairment|An Open-Label, Multicenter, Pharmacokinetic Study of PCI-32765 in Subjects With Varying Degrees of Hepatic Impairment|Completed||Phase 1|30|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-11 02:06:12.018289|2017-10-11 02:06:12.018289
NCT01767935|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-05-23|||July 2014||2014-07-01|May 2016|2016-05-01||||December 2014|Actual|2014-12-01||Interventional|||Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases|A Pilot Study of The Tandem Treatment of Painful Osseous Metastases With Cryoablation Followed by Radiation Therapy|Terminated||N/A|1|Actual|Wake Forest University Health Sciences||1||Slow Accruals|f||||f||||||||||2017-10-11 02:06:12.160674|2017-10-11 02:06:12.160674
NCT01767922|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-17|||September 2008||2008-09-01|January 2013|2013-01-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|Ex Stress II||Multicentre, Double-blind Study Versus Placebo on Impact and Safety of Extramel® 140 IU on Perceived Stress, Physical and Intellectual Fatigue, Pain Perception if Present, and the Impact on the Quality of Life|Multicentre, Double-blind Study Versus Placebo on the Impact and Safety of the Daily Administration of Extramel® 140 IU for 12 Weeks on Perceived Stress, Physical and Intellectual Fatigue, Pain Perception, if Present, and the Impact on the Quality of Life of 70 Subjects Included, of Which 60 That Can be Evaluated|Completed||Phase 3|61|Actual|Bionov||2|||f||||f||||||||||2017-10-11 02:06:12.490599|2017-10-11 02:06:12.490599
NCT01767896|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-09-27|||October 2012||2012-10-01|September 2017|2017-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine|Phase III Study of ASP7374 －Approved Egg-derived Vaccine Controlled, Double-blind, Parallel Group Study in Elderly Subjects|Completed||Phase 3|1020|Actual|UMN Pharma Inc.||2|||f||||f||||||||||2017-10-11 02:06:12.846909|2017-10-11 02:06:12.846909
NCT01767883|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-02-13|||July 2011||2011-07-01|February 2014|2014-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Improving Evidence-Based Primary Care for Chronic Kidney Disease|Improving Evidence-Based Primary Care for Chronic Kidney Disease|Unknown status|Recruiting|N/A|27000|Anticipated|American Academy of Family Physicians||2|||f||||t||||||||||2017-10-11 02:06:12.961101|2017-10-11 02:06:12.961101
NCT01767870|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-01-10|||August 2012||2012-08-01|January 2013|2013-01-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|FITS||Efficacy Combined Fecal Immunochemical Test-Sigmoidoscopy for the Detection of Advanced Colorectal Neoplasia|Efficacy and Cost-effectiveness of Colonoscopy vs. Combined Fecal Immunochemical Test-Sigmoidoscopy for the Detection of Advanced Colorectal Neoplasia (eCOLO-FITS): A Randomized Multicenter Trial|Unknown status|Recruiting|Phase 4|5282|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:06:13.105054|2017-10-11 02:06:13.105054
NCT01767857|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-08-25|||March 2013||2013-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|XCITE||A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer|Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer|Terminated||Phase 3|643|Actual|XBiotech, Inc.||2||The study crossed the prospective futility boundary of primary endpoint|f||||t||||||||||2017-10-11 02:06:13.28182|2017-10-11 02:06:13.28182
NCT01767831|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-04-24|||March 2013||2013-03-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Evaluation of a Simulation-Based Educational Tool for Personalized Feedback in Insulin Therapy Management|Evaluation of a Simulation-Based Educational Tool for Personalized Feedback in Insulin Therapy Management|Terminated||N/A|15|Actual|University of Virginia|||2|"study team will review the collected data and make any necessary changes to the educational   tool."|f||||f||||||||||2017-10-11 02:06:13.833793|2017-10-11 02:06:13.833793
NCT01767818|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-12-28|||November 2012||2012-11-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Observational|PDBP||Parkinson's Disease Biomarker Program|Longitudinal, Single-center Prospective Study to Assess Progression of Clinical Features and Biologic Markers of Parkinson's Disease Subjects of Varying Levels of Disease Severity|Active, not recruiting||N/A|240|Anticipated|University of Texas Southwestern Medical Center|||3||f||||f||||||Samples With DNA|"     Blood specimen collection from all enrolled patients and cerebrospinal fluid (CSF) from     patients who have provided additional and optional consent to CSF collection.   "|||2017-10-11 02:06:13.937572|2017-10-11 02:06:13.937572
NCT01767805|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-10|||June 2009||2009-06-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|||Impact of Culture Conditions on the Embryo Quality||Completed||N/A|790|Actual|University Hospital, Gasthuisberg||2|||f||||f||||||||||2017-10-11 02:06:14.017152|2017-10-11 02:06:14.017152
NCT01767792|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-05-03|||May 2013||2013-05-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas|Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation|Active, not recruiting||Phase 2|22|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 02:06:14.116102|2017-10-11 02:06:14.116102
NCT01767779|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-01-09|||September 2012||2012-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC|Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC|Active, not recruiting||N/A|40|Anticipated|University of Alabama at Birmingham|||2||f||||f||||||Samples With DNA|"     A single venous blood sample will be drawn from the child and parents/family guardian for     future research studies and future genetic testing   "|||2017-10-11 02:06:14.246196|2017-10-11 02:06:14.246196
NCT01767753|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-11-16|||November 2012||2012-11-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty|A Prospective, Observational, Open Label Study to Assess the 24-hour IOP Fluctuation Pattern Recorded With SENSIMED Triggerfish® in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty|Completed||N/A|23|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 02:06:14.444563|2017-10-11 02:06:14.444563
NCT01767740|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-10-04|||February 2013||2013-02-01|October 2017|2017-10-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Pilot Study of the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff|Two-Arm, Single Blind, Randomized Pilot Study on the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff|Completed||N/A|82|Actual|Smith & Nephew, Inc.||2|||f||||t||||||||||2017-10-11 02:06:14.5293|2017-10-11 02:06:14.5293
NCT01767727|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-11|||March 2008||2008-03-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|August 2011|Actual|2011-08-01||Interventional|||Repair of Multiple Finger Defects Using the Dorsal Homodigital Island Flaps||Completed||N/A|12|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 02:06:14.640741|2017-10-11 02:06:14.640741
NCT01767714|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2014-12-08|||April 2013||2013-04-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of Plerixafor (0.24 mg/kg) Plus G CSF (10 µg/kg) Versus G CSF (10 µg/kg) Plus Placebo to Mobilize and Collect ≥5 × 106 CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation|Completed||Phase 3|100|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:06:14.905932|2017-10-11 02:06:14.905932
NCT01767701|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-05-24|2016-09-22||April 2013||2013-04-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|INSPIRE||Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis|A Phase II Baseline Versus Treatment Study to Determine the Efficacy of Raltegravir (Isentress) in Preventing Progression of Relapsing Remitting Multiple Sclerosis as Determined by Gadolinium-enhanced MRI|Completed||Phase 2|23|Actual|Queen Mary University of London||1|||f||||t||||||||||2017-10-11 02:06:15.063922|2017-10-11 02:06:15.063922
NCT01767688|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-06-01|2015-09-29||January 16, 2013|Actual|2013-01-16|June 2017|2017-06-01|March 7, 2013|Actual|2013-03-07|March 1, 2013|Actual|2013-03-01||Interventional|||A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)|An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-3102 in Patients With Impaired Hepatic Function|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:06:15.529139|2017-10-11 02:06:15.529139
NCT01763684|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-04-14|||September 2012||2012-09-01|April 2016|2016-04-01|June 2024|Anticipated|2024-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Oxford Signature vs. Conventional Global Study|A Global Comparison of Signature Guides and Conventional Instrumentation in the Oxford Partial Knee|Recruiting||N/A|440|Anticipated|Zimmer Biomet||2|||f||||f||||||||||2017-10-11 02:07:57.240593|2017-10-11 02:07:57.240593
NCT01767675|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-09-11|||January 8, 2013||2013-01-08|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Randomized Study: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Recruiting||Phase 2|98|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:06:15.976148|2017-10-11 02:06:15.976148
NCT01767662|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-11|||May 2011||2011-05-01|January 2013|2013-01-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Interventional|||Effectiveness of Parents' Manipulation in Newborn With Talipes Calcaneus|Natural History and Effectiveness of Parents' Manipulation in Newborn With Talipes Calcaneovalgus,a Randomized Controlled Trial|Unknown status|Recruiting|N/A|160|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 02:06:16.151557|2017-10-11 02:06:16.151557
NCT01767649|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2014-12-19|||November 2010||2010-11-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Observational|TROPHY||Inflammatory Signature of Human Chorionic Cells|Inflammatory Signature of Chorionic Cells as Markers of Premature Labor|Completed||N/A|24|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     Cord blood, placenta and maternal blood   "|||2017-10-11 02:06:16.24442|2017-10-11 02:06:16.24442
NCT01767636|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-09-07|||May 16, 2013|Actual|2013-05-16|March 2017|2017-03-01|May 16, 2018|Anticipated|2018-05-16|May 16, 2018|Anticipated|2018-05-16||Interventional|||Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer|A Phase II Efficacy Trial of Pazopanib in Non-clear Cell Metastatic Renal Cell Cancer (mRCC) PINCR|Recruiting||Phase 2|39|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:06:16.34259|2017-10-11 02:06:16.34259
NCT01767623|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2017-07-05|||August 20, 2013|Actual|2013-08-20|June 2017|2017-06-01|July 14, 2017|Anticipated|2017-07-14|November 26, 2015|Actual|2015-11-26||Interventional|||A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants|An Open Label, Phase I Study to Evaluate the Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation Positive Cancer Patients|Active, not recruiting||Phase 1|8|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:06:16.498751|2017-10-11 02:06:16.498751
NCT01767610|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2013-01-14|||January 2013||2013-01-01|January 2013|2013-01-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin|Open-label, Randomized, Repeated Dosing Crossover Study to Evaluate the Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin in Healthy Adult Subjects|Unknown status|Recruiting|Phase 1|24|Anticipated|Hanlim Pharm. Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:06:16.627584|2017-10-11 02:06:16.627584
NCT01767597|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-10-21|2016-08-26||February 2012||2012-02-01|October 2016|2016-10-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Interventional|OPTISCREEN-B|All participants completing their intervention.|Application of HBV Rapid Tests as a Tool for Wide-Use Screening|Is the Combination of Screening Algorithms and Use of Hepatitis B Rapid Tests Useful in Optimizing the Screening and Prevention of Hepatitis B?|Completed||N/A|1000|Actual|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba|Low prevalence of HBV infection; individuals with barriers to healthcare were underrepresented; Quick Profile anti-HBsAb rapid test unable to confirm nonimmunized status; intervention had same-day blood draws, which is not done in routine practice.|2|||f||||t||||||||Yes|Data will be shared upon official request by interested parties. All requests are subject to approval by the Scientific Committee.|2017-10-11 02:06:16.741816|2017-10-11 02:06:16.741816
NCT01767584|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-07-05|||April 6, 2009|Actual|2009-04-06|July 2017|2017-07-01|April 14, 2009|Actual|2009-04-14|April 14, 2009|Actual|2009-04-14||Interventional|||Bioequivalence Study of Cephalexin Tablets 1g|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparations Containing 1 g of Cephalexin (GlaxoSmithKline México, S.A. de C.V. vs. Keflex® 1g, Eli Lilly y Compañía de México, S.A. de C.V.) in Fasting Healthy Volunteers.|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:06:17.078944|2017-10-11 02:06:17.078944
NCT01767571|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-06-02|||January 30, 2011|Actual|2011-01-30|June 2017|2017-06-01|February 8, 2011|Actual|2011-02-08|February 8, 2011|Actual|2011-02-08||Interventional|||Bioequivalence Study of Cephalexin Suspension 250|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparation of Cephalexin 250 mg/5mL (Ceporex®, GlaxoSmithKline México, S.A. de C.V. vs. Keflex® , Eli Lilly y Compañía de México, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:06:17.16453|2017-10-11 02:06:17.16453
NCT01767558|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-07-30|||January 2013||2013-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD)|Phased RF Evaluation of Acute Pulmonary Vein Isolation in Paroxysmal AF With New GENius UI and PVAC GOLD|Completed||N/A|56|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||f||||||||||2017-10-11 02:06:17.246652|2017-10-11 02:06:17.246652
NCT01767545|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2013-01-10|||September 2010||2010-09-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Interventional|||Dexamethasone-implant for the Treatment of RVO|Twelve Months Experience With a Dexamethasone-implant for the Treatment of Macular Edema Associated With Retinal Vein Occlusion|Completed||Phase 4|64|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 02:06:17.353566|2017-10-11 02:06:17.353566
NCT01767532|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-06-21|||January 30, 2011|Actual|2011-01-30|June 2017|2017-06-01|February 8, 2011|Actual|2011-02-08|February 8, 2011|Actual|2011-02-08||Interventional|||Bioequivalence Study of Cephalexin Suspension 125|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparation of Cephalexin 125 mg/ 5 ml (Ceporex® GlaxoSmithKline México, S.A. de C.V. vs. Keflex®, Eli Lilly y Compañía de México, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:06:17.432832|2017-10-11 02:06:17.432832
NCT01767519|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2016-06-02|2015-10-21||March 2013||2013-03-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|||A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence||Completed||Phase 3|356|Actual|Allergan||3|||f||||f||||||||||2017-10-11 02:06:17.534285|2017-10-11 02:06:17.534285
NCT01767493|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-06-05|||November 2012||2012-11-01|June 2013|2013-06-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients|An Open-label, Non-randomized Study to Evaluate the Feasibility of [18F]Florbetapir Positron Emission Tomography (PET) for Assessment of Demyelination in Patients With Relapsing Remitting Multiple Sclerosis|Unknown status|Recruiting|N/A|18|Anticipated|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-10-11 02:06:18.37778|2017-10-11 02:06:18.37778
NCT01767480|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-07-20|||January 2013||2013-01-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|RT||Effects of Intensive Robot-assisted Therapy in Patients With Subacute Stroke|Effects and Mechanisms of Intensive Robot-Assisted Therapy in Patients With Subacute Stroke: Outcomes in Brain/Movement Reorganization, Sensorimotor and Daily Functions, and Physiological Markers.|Completed||N/A|32|Actual|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-11 02:06:18.464715|2017-10-11 02:06:18.464715
NCT01767467|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-04-21|2017-01-05||March 1, 2013||2013-03-01|March 2017|2017-03-01|January 6, 2017|Actual|2017-01-06|January 7, 2016|Actual|2016-01-07||Interventional|||Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers|Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged 18 Years and Older With Haematologic Malignancies|Completed||Phase 3|568|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:06:18.618168|2017-10-11 02:06:18.618168
NCT01767454|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-07-20|||February 12, 2013||2013-02-12|July 2017|2017-07-01|September 1, 2015|Actual|2015-09-01|September 1, 2015|Actual|2015-09-01||Interventional|||Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma|Phase 1 Study of the BRAF Inhibitor Dabrafenib +/- MEK Inhibitor Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma|Completed||Phase 1|38|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 02:06:20.28143|2017-10-11 02:06:20.28143
NCT01767441|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-11|2015-03-17|||February 2013||2013-02-01|August 2012|2012-08-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|BASMEAL||Bariatric Surgeries and Glucose Homeostasis During a Mixed Meal Test|Effects of Bariatric Surgeries on Glucose Homeostasis and Its Determinants During a Mixed Meal Tolerance Test|Unknown status|Recruiting|N/A|64|Anticipated|Azienda Ospedaliera Universitaria Integrata Verona|||4||f||||t||||||Samples Without DNA|"     serum, plasma   "|||2017-10-11 02:06:20.420671|2017-10-11 02:06:20.420671
NCT01767428|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2013-01-10|||April 2010||2010-04-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Pharmacokinetic Study to Compare Two Formulations of Paracetamol|A Pharmacokinetic Study to Evaluate the Rate and Extent of Absorption of Paracetamol From Two Formulations in an Indian Population.|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:06:20.540003|2017-10-11 02:06:20.540003
NCT01767415|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-01-12|||March 2012||2012-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection|Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection|Recruiting||Phase 1/Phase 2|30|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-10-11 02:06:20.620254|2017-10-11 02:06:20.620254
NCT01767402|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-10|||October 2003||2003-10-01|January 2013|2013-01-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults|A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine Without or With Adjuvant, Administered at 2 Different Concentrations According to a 0-2 Month Schedule, in Healthy Adults|Completed||Phase 1|150|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-10-11 02:06:20.724914|2017-10-11 02:06:20.724914
NCT01767389|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2014-07-31|||September 2012||2012-09-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Glucagon-like Peptide (GLP) Utilization and Safety|Glucagon-like Peptide-1 (GLP-1) Agonists: Treatment Utilization Patterns and Risk of Acute Pancreatitis|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 02:06:20.845997|2017-10-11 02:06:20.845997
NCT01767376|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-08-03|2017-08-03|2014-05-29|January 10, 2013|Actual|2013-01-10|August 2017|2017-08-01|January 16, 2014|Actual|2014-01-16|January 16, 2014|Actual|2014-01-16||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age|Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Healthy Adolescents and Young Adults Between 11 and 25 Years of Age|Completed||Phase 3|692|Actual|GlaxoSmithKline|Due to late availability of the serology results, only safety results were posted by the initial due date.|3|||f|||||t|f|||t|||||2017-10-11 02:06:20.991221|2017-10-11 02:06:20.991221
NCT01767363|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-11-08|||November 2012||2012-11-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||WEUSKOP5723: Prostate Cancer Study|Prostate Cancer in Benign Prostatic Hyperplasia (BPH) Patients|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 02:06:22.589586|2017-10-11 02:06:22.589586
NCT01767350|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-12-14|||February 2013||2013-02-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Determinants of Immunosuppressive Dose Requirements in Children After Solid Organ Transplantation|Study Aimed at Determining the Relation Between the Administered Dose and Exposure to Immunosuppressive Medication in Children After Solid Organ Transplantation|Completed||N/A|60|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     tube of whole blood (8 ml) to be processed for DNA extraction and storage   "|||2017-10-11 02:06:22.825663|2017-10-11 02:06:22.825663
NCT01669278|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-09-14||||||September 2016|2016-09-01||||||||Interventional|||Evaluation of Office-Based Sheathed Flexible Nasopharyngoscopy|Evaluation of Office-Based Sheathed Flexible Nasopharyngoscopy: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 02:36:17.032414|2017-10-11 02:36:17.032414
NCT01767337|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-07-31|||December 2012||2012-12-01|July 2017|2017-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intracutaneous Delivery of Varied Dose Volumes of Saline|Exploratory Evaluation of Healthy Subjects Receiving Varied Dose Volumes of Saline Delivered by a Non-Significant Risk Investigational Device Utilizing a Micro-Needle Array|Completed||N/A|24|Actual|FluGen Inc||3|||f||||t||||||||||2017-10-11 02:06:22.927515|2017-10-11 02:06:22.927515
NCT01767324|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-07-31|||December 2012||2012-12-01|July 2017|2017-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Site Selection for Intracutaneous Saline Delivery|Exploratory Evaluation of Injection Sites in Healthy Subjects Receiving Saline Delivered by a Non-Significant Risk Investigational Device Utilizing a Micro-Needle Array|Completed||N/A|12|Actual|FluGen Inc||3|||f||||t||||||||||2017-10-11 02:06:23.003153|2017-10-11 02:06:23.003153
NCT01767311|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-09-18|||December 2012|Actual|2012-12-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease|A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease|Active, not recruiting||Phase 2|856|Actual|Eisai Inc.||5|||f||||t||||||||||2017-10-11 02:06:23.094722|2017-10-11 02:06:23.094722
NCT01767298|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-10|||October 2012||2012-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PKVH PART II||Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)|Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, Four-Period Crossover Study in Healthy Egyptian Male Volunteers (PART II)|Completed||N/A|24|Actual|Damanhour University||4|||f||||t||||||||||2017-10-11 02:06:23.356357|2017-10-11 02:06:23.356357
NCT01767285|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-01-13|2016-03-30||January 2013||2013-01-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Immediate vs. Delayed Postpartum Etonogestrel Implant|A Randomized Controlled Trial of Immediate Postpartum Etonogestrel Implant Versus Six-week Postpartum Etonogestrel Implant: A Pilot Study|Completed||Phase 4|60|Actual|Duke University||2|||f||||t||||||||||2017-10-11 02:06:23.435768|2017-10-11 02:06:23.435768
NCT01767272|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2013-01-10|||December 2012||2012-12-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|DPF||Dose Proportionality of Fexofenadine in Healthy Human Egyptian Volunteers|Dose Proportionality of Fexofenadine|Completed||N/A|25|Actual|Damanhour University||5|||f||||t||||||||||2017-10-11 02:06:23.780882|2017-10-11 02:06:23.780882
NCT01767259|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-12|||October 2012||2012-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PKVH||Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide|Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide: An Open-Label, Randomized, Four-Period Crossover Study in Healthy Egyptian Male Volunteers|Completed||N/A|24|Actual|Damanhour University||4|||f||||t||||||||||2017-10-11 02:06:23.865246|2017-10-11 02:06:23.865246
NCT01767246|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-07-02|||January 2013||2013-01-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|PFSAlgorithm||The Evaluation of a Novel Treatment Algorithm for Patients With Patellofemoral Syndrome|The Evaluation of a Novel Treatment Algorithm for Patients With Patellofemoral Syndrome: A Pilot Study|Completed||N/A|30|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 02:06:23.974049|2017-10-11 02:06:23.974049
NCT01767233|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-11|||January 2011||2011-01-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|ERPNEC||Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis|Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis: a Prospective Randomized Controlled Multicenter Study|Unknown status|Recruiting|N/A|80|Anticipated|University of Oulu||1|||f||||t||||||||||2017-10-11 02:06:24.075734|2017-10-11 02:06:24.075734
NCT01767220|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-01-29|||November 2012||2012-11-01|January 2013|2013-01-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|VTeee||Endo- and Epicardial vs. Endocardial Ablation of Ventricular Tachycardia in Patients With Cardiac Disease|Primary Endo- and Epicardial vs. Endocardial Ablation of Sustained Ventricular Tachycardia in Patients With Underlying Cardiac Disease (VTeee)|Unknown status|Recruiting|N/A|40|Anticipated|University of Rostock||2|||f||||f||||||||||2017-10-11 02:06:24.168069|2017-10-11 02:06:24.168069
NCT01767207|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-07-11|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Mental Health and Cognitive Dysfunction: A Multicenter Study at Pediatric Rehabilitation Clinics in North Norway|Mental Health and Cognitive Dysfunction: A Multicenter Study at Pediatric Rehabilitation Clinics in North Norway|Completed||N/A|365|Actual|University Hospital of North Norway|||1||f||||f||||||||||2017-10-11 02:06:26.068789|2017-10-11 02:06:26.068789
NCT01767194|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-10-02|||February 12, 2013|Actual|2013-02-12|June 2017|2017-06-01|February 28, 2019|Anticipated|2019-02-28|February 28, 2019|Anticipated|2019-02-28||Interventional|||Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma|A Phase II Randomized Trial of Irinotecan/Temozolomide With Temsirolimus (NSC# 683864) or Chimeric 14.18 Antibody (Ch14.18) (NSC# 764038) in Children With Refractory, Relapsed or Progressive Neuroblastoma|Suspended||Phase 2|74|Anticipated|National Cancer Institute (NCI)||2||Other - Completion of Accrual Goal|f||||f||||||||||2017-10-11 02:06:26.187784|2017-10-11 02:06:26.187784
NCT01767181|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-08-02|||February 2013||2013-02-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Light and Exercise in Night-shift Workers|Effects of Timed Intensive Light Therapy or Timed Physical Exercise on Markers of Central and Peripheral Circadian Rhythm and on Cardiometabolic Function in Night Shift Workers|Completed||N/A|154|Actual|Universitätsklinikum Hamburg-Eppendorf||4|||f||||f||||||||||2017-10-11 02:06:26.767118|2017-10-11 02:06:26.767118
NCT01767168|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-07-29|||May 2011||2011-05-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2015|Actual|2015-04-01||Observational|PREDO||Study to Test the Value of a Pain Modulation Test in Predicting Persistent Postoperative Pain After Breast Cancer Surgery|Trial of Diagnostic Accuracy for the Prediction of Persistent Postoperative Pain After Breast Cancer Surgery Using a Conditioned Pain Modulation Test|Completed||N/A|200|Actual|University Hospital, Geneva|||1||f||||f||||||Samples With DNA|"     venous blood sample   "|||2017-10-11 02:06:26.90008|2017-10-11 02:06:26.90008
NCT00000153|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||December 1984||1984-12-01|October 1999|1999-10-01||||||||Interventional|||Krypton-Argon Regression of Neovascularization Study (KARNS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.851257|2017-10-11 04:17:33.851257
NCT01767155|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-02-09|||April 2013|Actual|2013-04-01|February 2017|2017-02-01|January 30, 2017|Actual|2017-01-30|January 30, 2017|Actual|2017-01-30||Interventional|ZoptEC||Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer|Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.|Completed||Phase 3|512|Actual|AEterna Zentaris||2|||f||||t||||||||||2017-10-11 02:06:27.024037|2017-10-11 02:06:27.024037
NCT01767142|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-06-20|||January 2013||2013-01-01|January 2013|2013-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Feasibility Study of a Belt Applicator|Feasibility Study of a Belt Applicator for Non-Invasive Fat Reduction in the Outer Thigh|Completed||N/A|40|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 02:06:27.321781|2017-10-11 02:06:27.321781
NCT01767129|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-06-22|||July 2013||2013-07-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|LID in PD||Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients|A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients.|Completed||Phase 2|14|Actual|Avanir Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:06:27.407052|2017-10-11 02:06:27.407052
NCT01767116|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-08-19|2014-12-23||December 2012||2012-12-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional|PEARL-III|All randomized participants who received at least 1 dose of study drug|A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection|A Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in Treatment-Naive Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection (PEARL-III)|Completed||Phase 3|419|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 02:06:27.657865|2017-10-11 02:06:27.657865
NCT01767103|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-09-03|2014-09-03||January 2013||2013-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers|An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox® in Subjects With Impaired Hepatic Function and Healthy Volunteers|Completed||Phase 4|21|Actual|ApoPharma||3|||f||||f||||||||||2017-10-11 02:06:28.199907|2017-10-11 02:06:28.199907
NCT01767090|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-08-12|||December 2012||2012-12-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain|A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Assess the Efficacy, Safety, and Dose-Response Relationship of ASP1707 in Subjects With Endometriosis Associated Pelvic Pain for 12 Weeks, Followed by a 12-Week Double-blind Extension Without Placebo Control, Including a 24-Week Open-Label Leuprorelin Acetate Treatment Group for Bone Mineral Density Assessment|Completed||Phase 2|912|Actual|Astellas Pharma Inc||6|||f||||t||||||||||2017-10-11 02:06:28.958516|2017-10-11 02:06:28.958516
NCT01767077|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2013-09-23|||February 2013||2013-02-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|MFGM||Role of Milk Fat Globule Membranes in Dairy Foods: Health Effects in Humans|Role of Milk Fat Globule Membranes in Dairy Foods: Health Effects in Humans|Completed||N/A|52|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 02:06:29.316747|2017-10-11 02:06:29.316747
NCT01767064|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-07-05|2017-03-30||February 2012||2012-02-01|July 2017|2017-07-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional||Clinicians|Nudging Guideline-concordant Antibiotic Prescribing Using Public Commitments|Nudging Guideline-concordant Antibiotic Prescribing Using Public Commitments|Completed||N/A|14|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 02:06:29.444424|2017-10-11 02:06:29.444424
NCT01767051|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-02-19|||November 2012||2012-11-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|CHOPS||Children Follow-up of PCOS Women|Children Follow-up of PCOS Women.Cardiovascular Health in Offspring of PCOS Mothers|Completed||N/A|74|Actual|UMC Utrecht|||2||f||||t||||||Samples Without DNA|"     saliva, serum, plasma   "|||2017-10-11 02:06:29.856921|2017-10-11 02:06:29.856921
NCT01767038|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-10|||November 2011||2011-11-01|January 2013|2013-01-01||||November 2014|Anticipated|2014-11-01||Interventional|DOREFA||DOREFA (Retinal Detachment: Function and Anatomy)|Study of Anatomical and Functional Recovery Following Retinal Detachment: Identify Correlations Between Visual Acuity and SD-OCT and Microperimetry Findings.|Unknown status|Recruiting|N/A|120|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||t||||||||||2017-10-11 02:06:29.937308|2017-10-11 02:06:29.937308
NCT01767025|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-16|||November 2012||2012-11-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Influence of Oxytocin on Automatic Imitation Behaviour in Healthy Adults||Completed||Phase 3|60|Actual|University Ghent||2|||f||||f||||||||||2017-10-11 02:06:30.096479|2017-10-11 02:06:30.096479
NCT01767012|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-09|||August 2010||2010-08-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|POL||Aqueous Flare of a Hydrophobic Acrylic Single-piece Open-loop IOL With Modified Material Surface Properties|Aqueous Flare of a Hydrophobic Acrylic Single-piece Open-loop IOL With Modified Material Surface Properties|Completed||Phase 4|40|Actual|Vienna Institute for Research in Ocular Surgery||2|||f||||||||||||||2017-10-11 02:06:30.209635|2017-10-11 02:06:30.209635
NCT01766999|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-01-09|||August 2008||2008-08-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|May 2009|Actual|2009-05-01||Observational|||Methemoglobinemia After Liposuction - Diagnostic by Pulse Oximetry and Blood Gas Analysis.|Methemoglobinemia After Liposuction Under Tumescent Local Anesthesia - Timecourse and Diagnostics by Pulse Oximetry and Blood Gas Analysis.|Completed||N/A|133|Actual|University of Schleswig-Holstein|||1||f||||f||||||||||2017-10-11 02:06:30.310691|2017-10-11 02:06:30.310691
NCT01766986|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-11-17|||January 2008||2008-01-01|November 2014|2014-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction|Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction|Completed||N/A|130|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-11 02:06:30.376201|2017-10-11 02:06:30.376201
NCT01766973|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-10|||April 2013||2013-04-01|January 2013|2013-01-01|April 2018|Anticipated|2018-04-01|April 2014|Anticipated|2014-04-01||Observational|||Decoding Chronic Pain With fMRI|Observational Study to Determine Abnormalities in Resting State fMRI in Chronic Back Pain.|Not yet recruiting||N/A|100|Anticipated|University of Cambridge|||2||f||||f||||||||||2017-10-11 02:06:30.452718|2017-10-11 02:06:30.452718
NCT01766960|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-03-02|||November 2012||2012-11-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease|Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease.|Completed||Phase 1|22|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:06:30.543899|2017-10-11 02:06:30.543899
NCT01766947|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-05-12|||November 2012||2012-11-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy|A Prospective, Open Label Study to Assess the 24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Primary Open Angle Glaucoma Before and After Deep Sclerectomy|Withdrawn||N/A|0|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 02:06:30.632428|2017-10-11 02:06:30.632428
NCT01766934|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-10-24|||May 2011||2011-05-01|October 2016|2016-10-01|August 2024|Anticipated|2024-08-01|August 2024|Anticipated|2024-08-01||Observational|SMART||Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors|Non-interventional, Prospective, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Healthy Unrelated Stem Cell Donors Undergoing Peripheral Blood Progenitor Cell Mobilization|Active, not recruiting||N/A|245|Actual|Sandoz|||1||f||||f||||||||Undecided||2017-10-11 02:06:30.709713|2017-10-11 02:06:30.709713
NCT01766921|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2015-07-14|2015-05-05||January 2013||2013-01-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional||Analysis was done on All Enrolled population.|Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects|A Phase II, Randomized, Observer-Blind, Multi-Center, Study to Evaluate Safety, Tolerability and Immunogenicity of an Adjuvanted Cell Culture-Derived H5N1 Subunit Influenza Virus Vaccine at Two Different Formulations in Healthy Elderly Subjects.|Completed||Phase 2|1393|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:06:30.816698|2017-10-11 02:06:30.816698
NCT01766908|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-12-15|||December 2012||2012-12-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|CordClamp||Optimal Timing of Cord Clamping in Preterm Pregnancy Following Vaginal or Cesarean Delivery|Timing of Umbilical Cord Clamping After Vaginal or Cesarean Preterm Birth|Completed||N/A|72|Actual|University of Mississippi Medical Center||3|||f||||f||||||||||2017-10-11 02:06:32.04158|2017-10-11 02:06:32.04158
NCT01766895|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2017-08-18|||January 2011|Actual|2011-01-01|August 2017|2017-08-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|||Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan|Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan|Recruiting||N/A|1600|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||Samples With DNA|"     host factors ssociated with viral hepatitis   "|||2017-10-11 02:06:32.137279|2017-10-11 02:06:32.137279
NCT01766882|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-07-14|||September 2012||2012-09-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|VSBP||Volume,Sodium and Blood Pressure Management in HD|Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial|Completed||N/A|50|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 02:06:32.251719|2017-10-11 02:06:32.251719
NCT01766869|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-06-07|||April 2015||2015-04-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|GCC 1261||Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS|Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS and Machine Learning to Better Manage the Disease|Withdrawn||N/A|0|Actual|University of Maryland|||1|No participants enrolled|f||||t||||||||||2017-10-11 02:06:32.354487|2017-10-11 02:06:32.354487
NCT01766856|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-01-10|||November 2012||2012-11-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Eustachian Tube Function and Myringoplasty/Tympanoplasty|Eustachian Tube Function as a Predictor of Myringoplasty/Tympanoplasty Outcome|Recruiting||N/A|120|Anticipated|University of Pittsburgh|||1||f||||f||||||||No||2017-10-11 02:06:32.422391|2017-10-11 02:06:32.422391
NCT01766843|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-01-02|||January 2013||2013-01-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus|Bioequivalence Study Comparing Two Salmeterol/Fluticasone Propionate Dry Powder Inhalers, SF Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|50|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-10-11 02:06:32.526924|2017-10-11 02:06:32.526924
NCT01766830|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-10-26|||January 2013||2013-01-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|October 2014|Actual|2014-10-01||Interventional|||Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)|Evaluation of Rapid Diagnostic Tests (RDT) in Association With Clinical and Laboratory Predictors for the Diagnosis of Neglected Tropical Diseases (NTD) in Patients Presenting With Persistent Fever (≥1 Week) in Cambodia, Nepal, Democratic Republic of the Congo and Sudan|Completed||N/A|1927|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-10-11 02:06:32.626501|2017-10-11 02:06:32.626501
NCT01766817|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-03-22||2017-03-22|January 2013||2013-01-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis|Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis|Completed||Phase 2|80|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-10-11 02:06:32.885553|2017-10-11 02:06:32.885553
NCT01766804|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-10-03|||March 2013||2013-03-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|CALL||Effect of Bovine Colostrum on Toxicity and Inflammatory Responses|Effect of Bovine Colostrum on Toxicity and Inflammatory Responses During Treatment of Childhood Acute Lymphoblastic Leukaemia|Recruiting||N/A|60|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-11 02:06:33.135272|2017-10-11 02:06:33.135272
NCT01766791|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-03-20|||January 2013||2013-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Resistance Exercise, Muscle Mass, Strength and Body Composition|Effects of Resistance Exercise on Muscle Mass, Strength, Body Composition and Heart in Men 30-50 Years Old.|Completed||Phase 3|120|Actual|University of Erlangen-Nürnberg Medical School||4|||f||||t||||||||||2017-10-11 02:06:33.265054|2017-10-11 02:06:33.265054
NCT01766778|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-04-07|2017-02-23||May 13, 2013|Actual|2013-05-13|April 2017|2017-04-01|October 22, 2015|Actual|2015-10-22|October 22, 2015|Actual|2015-10-22||Interventional||Intent to treat (ITT) included all randomized patients who received at least one dose of study medication.|Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin|A Local Phase IV, Multicenter, Open-label Study to Evaluate Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin|Completed||Phase 4|117|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:06:33.388028|2017-10-11 02:06:33.388028
NCT01766765|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-10|||April 2013||2013-04-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||Early Jejunostomy Nutrition Minimizes Time to Chemotherapy|Fast-track Surgery Recovery Program With Early Jejunostomy Nutrition Protocol Minimizes Time to Adjuvant Chemotherapy in Patients Undergoing Laparoscopic Gastrectomy for Gastric Cancer|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 02:06:33.828008|2017-10-11 02:06:33.828008
NCT01766752|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2013-04-09|||November 2012||2012-11-01|January 2013|2013-01-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management|An Open, Single-centre, Non-controlled Feasibility Study of the Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management in Non-critically Ill Patients With Type 2 Diabetes at the General Ward|Completed||Phase 3|30|Actual|Medical University of Graz||2|||f||||||||||||||2017-10-11 02:06:33.9357|2017-10-11 02:06:33.9357
NCT01766739|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-01-27|||January 2013||2013-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma|Phase I Study of Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma|Active, not recruiting||Phase 1|18|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:06:34.012917|2017-10-11 02:06:34.012917
NCT01766726|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-03-15|||December 2012||2012-12-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|Quad||Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients|Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients|Completed||N/A|33|Actual|Massachusetts General Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma, serum.   "|||2017-10-11 02:06:34.098428|2017-10-11 02:06:34.098428
NCT01766713|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-12-10|2014-12-10||January 2013||2013-01-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis|Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis|Completed||Phase 2|50|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 02:06:34.177028|2017-10-11 02:06:34.177028
NCT01766700|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2015-05-27|||September 2012||2012-09-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|||The Role of No-Calorie Beverages Within a Weight Loss Program|The Role of No-Calorie Sweetened Beverages Within a Weight Loss Behavior Change Program and During Subsequent Weight Maintenance|Completed||N/A|308|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:06:34.392647|2017-10-11 02:06:34.392647
NCT01766687|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-08-24|||April 2013||2013-04-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|WIT||Impact of Increased Water Intake in Chronic Kidney Disease|A Randomized Controlled Trial of Increased Water Intake in Chronic Kidney Disease|Completed||N/A|822|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 02:06:34.488842|2017-10-11 02:06:34.488842
NCT01766674|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-10-25|||February 2013||2013-02-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|May 2016|Actual|2016-05-01||Interventional|SCOR||Specialized Centers of Research (SCOR)on Sex Differences - Kyphosis Study|Specialized Centers of Research (SCOR) Kyphosis Study|Active, not recruiting||N/A|112|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:06:34.585049|2017-10-11 02:06:34.585049
NCT01766661|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-02-28|||January 2013||2013-01-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|June 2018|Anticipated|2018-06-01||Interventional|TURNBULL-BCN||Prospective Multicenter Randomized Controlled Trial On Two-Stage Turnbull-Cutait Coloanal Anastomosis For Rectal|Prospective Multicenter Randomized Controlled Trial Comparing Postoperative Complications and Quality of Life in Low Rectal Cancer Surgery Between Coloanal Anastomosis and Lateral Ileostomy Versus Two-Stage Turnbull-Cutait Coloanal Anastomosis|Recruiting||N/A|92|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 02:06:34.687293|2017-10-11 02:06:34.687293
NCT01766648|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-09-29|||December 2013||2013-12-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|FCL||Far Cortical Locking Versus Standard Constructs for Distal Femur Fractures|A Multicentre, Randomized Trial of Far Cortical Locking Versus Standard Constructs for Acute, Displaced Fractures of the Distal Femur Treated With Locked Plate Fixation|Recruiting||N/A|130|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 02:06:34.793157|2017-10-11 02:06:34.793157
NCT01766622|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-06-30|||November 30, 2012||2012-11-30|July 24, 2013|2013-07-24|July 24, 2013|Actual|2013-07-24|July 24, 2013|Actual|2013-07-24||Interventional|||18F-CP18 Imaging Studies for Cancer Treatment With Birinapant|A Pilot Study of [18F]-CP18 PET/CT Imaging in Patients With Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer Therapy Receiving Birinapant, a SMAC Mimetic Therapy|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:06:34.904034|2017-10-11 02:06:34.904034
NCT01766609|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-06-30|||January 2013||2013-01-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01||Interventional|||Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo|Efficacy and Safety of Intralesional Triamcinolone Acetonide in Vitiligo: A Prospective, Double-Blind Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|18|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:06:34.990947|2017-10-11 02:06:34.990947
NCT01766414|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2014-11-27|||September 2013||2013-09-01|November 2014|2014-11-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|VECTORII||In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II|In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - A Randomized Controlled Pilot Study|Completed||Phase 3|20|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 02:06:37.301147|2017-10-11 02:06:37.301147
NCT01766596|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-08-31|||October 2009||2009-10-01|August 2016|2016-08-01||||October 2013|Actual|2013-10-01||Interventional|3C||Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort)|Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort): Seek Correlations Between Signs of Neurological and Vascular Degeneration and Signs of Ocular Aging|Active, not recruiting||N/A|3000|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||||||||||||2017-10-11 02:06:35.12435|2017-10-11 02:06:35.12435
NCT01766583|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-07-11|||February 2013||2013-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|November 2014|Actual|2014-11-01||Interventional|CLEAR||A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell Lymphoma|A PHASE IB STUDY OF THE BTKi CC-292 COMBINED WITH LENALIDOMIDE IN ADULTS PATIENTS WITH RELAPSED/REFRACTORY B-CELL LYMPHOMA|Active, not recruiting||Phase 1|18|Actual|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-11 02:06:35.1973|2017-10-11 02:06:35.1973
NCT01766570|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-09-01|||March 2012||2012-03-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Interventional|||Beneficial Effects of a Polyphenol Enriched Beverage on Type 2 Diabetes Prevention and on Cardiovascular Risk Profile of Men and Women With Insulin Resistance.|Beneficial Effects of a Polyphenol Enriched Beverage on Type 2 Diabetes Prevention and on Cardiovascular Risk Profile of Men and Women With Insulin Resistance.|Completed||N/A|60|Actual|Laval University||2|||f||||f||||||||||2017-10-11 02:06:35.310268|2017-10-11 02:06:35.310268
NCT01766557|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-02-06|||August 2010||2010-08-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|PCOS||Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome.|Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome.|Completed||N/A|9|Actual|Laval University||2|||f||||f||||||||||2017-10-11 02:06:35.433245|2017-10-11 02:06:35.433245
NCT01766544|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-01-09|||September 2009||2009-09-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Asthma & COPD Guideline Implementation|Asthma and COPD Guideline Implementation: Lessons Learned on Recruitment of Primary Care Physicians to a Knowledge Translation Study|Terminated||Early Phase 1|92|Actual|Laval University||2||Insufficient recruitment of physicians to participate to the study.|f||||f||||||||||2017-10-11 02:06:35.543751|2017-10-11 02:06:35.543751
NCT01766531|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-11-28|||June 2012||2012-06-01|November 2014|2014-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|IMPREA||Evaluation of Nutritional Status in ICU : Interest for the Measurement of Body Composition by Body Bioelectrical Impedance and Comparison With Several Methods|Evaluation of Nutritional Status in ICU : Interest for the Measurement of Body Composition by Body Bioelectrical Impedance and Comparison With Several Methods|Completed||Phase 4|200|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 02:06:35.655461|2017-10-11 02:06:35.655461
NCT01766518|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-11-06|||November 2009||2009-11-01|November 2013|2013-11-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Interventional|||The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)|Open Label, Multicenter, Non-comparative Study to Evaluate the Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients.|Unknown status|Recruiting|Phase 4|120|Anticipated|Chong Kun Dang Pharmaceutical||1|||f||||f||||||||||2017-10-11 02:06:35.750538|2017-10-11 02:06:35.750538
NCT01766505|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-03-12|||June 2012||2012-06-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)|Randomized, Open-label, Phase 4 Study to Evaluate Efficacy and Safety of Candesartan and Losartan in the Patients With Hypertension and Heart Failure.|Terminated||Phase 4|32|Actual|Chong Kun Dang Pharmaceutical||2||lack of the subjects|f||||f||||||||||2017-10-11 02:06:35.879566|2017-10-11 02:06:35.879566
NCT01766492|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-01-26|||December 2012||2012-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PR-PROS||Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery|Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)|Active, not recruiting||N/A|200|Anticipated|Georgetown University|||1||f||||f||||||||No|NO individual data will be made available|2017-10-11 02:06:35.999222|2017-10-11 02:06:35.999222
NCT01766479|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2013-01-10|||May 2009||2009-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|September 2011|Actual|2011-09-01||Interventional|||Non-cathartic Computed Tomographic Colonography to Screen Subjects With a Family History of Colorectal Cancer|Non-cathartic Computed Tomographic Colonography to Screen for Colorectal Neoplasia in Subjects With a Family History of Colorectal Cancer|Completed||N/A|844|Actual|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-10-11 02:06:36.085341|2017-10-11 02:06:36.085341
NCT01766466|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-04-18|2013-04-23||January 2013||2013-01-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Cangrelor Ticagrelor Transition Study|A Study of the Transition From Cangrelor to Ticagrelor, and Ticagrelor to Cangrelor in Patients With Coronary Artery Disease|Completed||Phase 2|12|Actual|The Medicines Company||4|||f||||f||||||||||2017-10-11 02:06:36.164994|2017-10-11 02:06:36.164994
NCT01766453|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2015-05-18|||April 2013||2013-04-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|SAYET||South Asian Yoga and Exercise Trial|Utility of a Culturally Relevant or a Standard Exercise Program to Reduce Visceral Adipose Tissue and Cardiovascular Disease Risk in Abdominally Obese Postmenopausal South Asian Women|Completed||N/A|75|Actual|Simon Fraser University||3|||f||||f||||||||||2017-10-11 02:06:36.774295|2017-10-11 02:06:36.774295
NCT01766440|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-04-19|2017-02-15||March 2013||2013-03-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis|Pharmacokinetics and Pharmacodynamics of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 14 Days Under Conditions of Maximal Use in Pediatric Subjects (2 to 12 Years of Age) With Plaque Psoriasis|Completed||Phase 4|18|Actual|Galderma|Study was terminated early due to slow enrollment.|1|||f||||f||||||||||2017-10-11 02:06:36.899079|2017-10-11 02:06:36.899079
NCT01766427|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-12-19|||October 2012||2012-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Electroacupuncture for Hypertension Patients With Chronic Kidney Disease|Electroacupuncture for Hypertension Patients With Chronic Kidney Disease|Completed||N/A|90|Anticipated|Shanghai University of Traditional Chinese Medicine|||3||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 02:06:37.21327|2017-10-11 02:06:37.21327
NCT01766401|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-02-27||2015-02-27|January 2013||2013-01-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|VLZ-MD-06||Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder|A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder|Completed||Phase 3|402|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 02:06:37.409927|2017-10-11 02:06:37.409927
NCT01766388|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-07-07|||December 2012||2012-12-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia|Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Armenia|Completed||N/A|120|Actual|Gynuity Health Projects|||1||f||||f||||||||||2017-10-11 02:06:37.575746|2017-10-11 02:06:37.575746
NCT01766375|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-09|||August 2012||2012-08-01|January 2013|2013-01-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|IDBUCY||the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient|A Multi-center, Open, Randomized-control Study to Compare the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient|Unknown status|Recruiting|Phase 3|200|Anticipated|Guangxi Medical University||2|||f||||f||||||||||2017-10-11 02:06:37.661206|2017-10-11 02:06:37.661206
NCT01766362|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2013-01-10|||October 2011||2011-10-01|January 2013|2013-01-01||||October 2013|Anticipated|2013-10-01||Interventional|Pascal||Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.|Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.|Unknown status|Recruiting|Phase 3|90|Anticipated|Centre Hospitalier Universitaire Dijon||2|||f||||t||||||||||2017-10-11 02:06:37.779258|2017-10-11 02:06:37.779258
NCT01766349|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-02-03|||September 2011||2011-09-01|January 2013|2013-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer Patients|Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Primary Esophagus Cancer|Completed||N/A|100|Anticipated|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 02:06:37.889734|2017-10-11 02:06:37.889734
NCT01766336|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-05-17|2016-04-07||January 2013||2013-01-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease|A 36-Week Safety Extension Study of Oral ELND005 for Treatment of Agitation and Aggression in Patients With Moderate to Severe Alzheimer's Disease|Terminated||Phase 2|296|Actual|Transition Therapeutics Ireland Limited||2|||f||||f||||||||||2017-10-11 02:06:37.995736|2017-10-11 02:06:37.995736
NCT01766323|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-10|||September 2012||2012-09-01|January 2013|2013-01-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Interventional|||Palliative Morphine With or Without Concurrent Modafinil|Prospective Randomized Study Evaluating the Effects of Modafinil in Patients Receiving Oral Morphine for Pain Palliation|Unknown status|Recruiting|Phase 3|200|Anticipated|Dr. Rajendra Prasad Government Medical College||2|||f||||t||||||||||2017-10-11 02:06:38.671449|2017-10-11 02:06:38.671449
NCT01766310|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-11-16|2014-08-10||December 2012||2012-12-01|November 2015|2015-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||mean and SD|Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children|Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children: a Randomized Double Blinded Placebo Controlled Trial|Completed||Phase 4|50|Actual|Queen Sirikit National Institute of Child Health||2|||f||||f||||||||||2017-10-11 02:06:38.825342|2017-10-11 02:06:38.825342
NCT01766297|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2017-06-20|||February 2013||2013-02-01|June 2017|2017-06-01|January 2030|Anticipated|2030-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer|Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer|Recruiting||Phase 2|42|Anticipated|Proton Collaborative Group||1|||f||||t||||||||||2017-10-11 02:06:39.219207|2017-10-11 02:06:39.219207
NCT01766271|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-11-06|||October 2012||2012-10-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|||GENErating Behavior Change, An Integrative Health Coaching and Genetic Risk Testing Pilot|GENErating Change, An Integrative Health Coaching and Genetic Risk Testing Pilot in Primary Care: A Multidisciplinary Approach to Personalized Medicine Targeting CHD Risk|Completed||N/A|31|Actual|Duke University||4|||f||||f||||||||||2017-10-11 02:06:39.526935|2017-10-11 02:06:39.526935
NCT01766258|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2013-11-20|||May 2011||2011-05-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|PARPOC||Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations|Efficacy and Safety of ODM-101 Compared to a Standard Combination (Stalevo®); a Randomised, Double-blind, Crossover, Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations|Completed||Phase 2|117|Actual|Orion Corporation, Orion Pharma||3|||f||||f||||||||||2017-10-11 02:06:39.644578|2017-10-11 02:06:39.644578
NCT01766245|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2014-06-24|||December 2012||2012-12-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes|A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes|Completed||Phase 1|28|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:06:39.746924|2017-10-11 02:06:39.746924
NCT00000154|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||October 1976||1976-10-01|October 1999|1999-10-01||||||||Interventional|||Diabetic Retinopathy Vitrectomy Study (DRVS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.910032|2017-10-11 04:17:33.910032
NCT01766219|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2017-08-14|||May 2013||2013-05-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery|A Pilot Open-Label Clinical Trial of CPI-613 in Patients With Advanced Bile Duct Cancers|Recruiting||Phase 1/Phase 2|13|Anticipated|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 02:06:39.961381|2017-10-11 02:06:39.961381
NCT01766206|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-09-28|||March 1, 2013||2013-03-01|September 2017|2017-09-01|February 15, 2018|Anticipated|2018-02-15|February 15, 2018|Anticipated|2018-02-15||Interventional|||Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea|A Multicenter Post Marketing Surveillance Study to Monitor the Safety of Novartis Meningococcal ACWY Conjugate Vaccine(MenACWY-CRM) Administered According to the Prescribing Information to Healthy Subjects From 2 Months to 55 Years of Age in the Republic of South Korea.|Recruiting||Phase 4|3960|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 02:06:40.093799|2017-10-11 02:06:40.093799
NCT01766193|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-02-16|||August 2012||2012-08-01|February 2017|2017-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|uropro||Delivery Method and Risk for Urogenital Prolapse 15-20 Years Later|Delivery Method and Risk for Urogenital Prolapse 15-20 Years Later|Completed||N/A|1641|Actual|Norwegian University of Science and Technology|||4||f||||f||||||||||2017-10-11 02:06:40.369439|2017-10-11 02:06:40.369439
NCT01766180|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-04-19|||January 2013||2013-01-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|CCIRF-II||Cerebrovascular and Cognitive Improvement by Resveratrol (resVida) and Fruitflow-II (CCIRF-II)|Association Between Fruitflow-II Treatment (Alone or in Combination With Resveratrol) and Changes in Cerebral Blood Flow, Fitness and Cognitive Function in Adults With Memory Complaints|Unknown status|Recruiting|N/A|80|Anticipated|Neurolgy Institute for Brain Health and Fitness||4|||f||||t||||||||||2017-10-11 02:06:40.49144|2017-10-11 02:06:40.49144
NCT01766167|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2017-01-25|||February 2013||2013-02-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Clinical Pharmacology Study of MP-424|Clinical Pharmacology Study of MP-424 in Healthy Male Adult Volunteers (Single- and Multiple-Dose Study)|Completed||Phase 1|26|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 02:06:40.60165|2017-10-11 02:06:40.60165
NCT01766154|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2014-03-25|||January 2013||2013-01-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function|A Pharmacokinetic, Pharmacodynamic, and Safety Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Normal Renal Function and Subjects With Moderate-to-Severe Renal Impairment With Non-Dialysis-Dependent Renal Insufficiency (NDDRI)|Completed||Phase 1|25|Actual|Medicure||3|||f||||f||||||||||2017-10-11 02:06:40.700026|2017-10-11 02:06:40.700026
NCT01766141|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-03-08|||April 2012||2012-04-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Effects of Spinal Manipulative Treatment on Inflammatory Markers in Low Back Pain Patients|Changes in Inflammatory Cytokine Levels in Response to Spinal Manipulative Treatment of Low Back Patients: A Single-blind Pilot Clinical Trial.|Recruiting||N/A|60|Anticipated|Canadian Memorial Chiropractic College||3|||f||||t||||||||||2017-10-11 02:06:40.793346|2017-10-11 02:06:40.793346
NCT01766128|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-09|||February 2013||2013-02-01|January 2013|2013-01-01|April 2014|Anticipated|2014-04-01|February 2014|Anticipated|2014-02-01||Interventional|ZONIST||Study of Zonisamide in Early Parkinson Disease|Randomized Double Blind Placebo-controlled Study of Zonisamide Effectiveness in Early Parkinson Disease|Unknown status|Not yet recruiting|Phase 2/Phase 3|60|Anticipated|Mazandaran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:06:40.897912|2017-10-11 02:06:40.897912
NCT01766115|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-08-12|||April 2013||2013-04-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers|Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:06:41.144351|2017-10-11 02:06:41.144351
NCT01766102|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-07-25|2017-06-02||January 2013||2013-01-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Intra-operative Digital vs. Standard Mammography|A Comparison of Intra-Operative Digital Specimen Mammography to Standard Specimen Mammography|Completed||Phase 4|72|Actual|Massachusetts General Hospital||2|||f||||t||t|f|f||||||2017-10-11 02:06:41.281193|2017-10-11 02:06:41.281193
NCT01766089|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-01-19|||January 2013|Actual|2013-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery|Comparison Between Dexmedetomidine and Remifentanil on the Maternal Responses to Tracheal Intubation in Severe Pre-eclamptic Patients During Caesarean Delivery|Completed||Phase 2|50|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 02:06:41.857874|2017-10-11 02:06:41.857874
NCT01766076|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-05-20|2014-07-17||January 2013||2013-01-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Atorvastatin for HAART Suboptimal Responders|Use of Atorvastatin as Adjuvant Therapy Among Suboptimal Responders to Antiretroviral Therapy in an African Cohort of HAART-treated Adults: A Randomised Controlled Trial|Completed||Phase 3|30|Actual|Makerere University||2|||f||||t||||||||||2017-10-11 02:06:42.019111|2017-10-11 02:06:42.019111
NCT01766063|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-03-24|||December 6, 2012|Actual|2012-12-06|March 2017|2017-03-01|March 14, 2017|Actual|2017-03-14|January 9, 2017|Actual|2017-01-09||Observational|BetaSleep||Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon|BETASLEEP - SLEEP Quality and Functional Health Status, Fatigue, Comorbidities and Therapeutic Algorithms Among BETAferon® Treated MS Patients|Completed||N/A|138|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:06:42.47276|2017-10-11 02:06:42.47276
NCT01766050|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2014-05-27|2014-04-28||January 2013||2013-01-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||All participants who received study drug.|Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers|"An Open-label, Single-sequence Study of the Effect of Belatacept on the Pharmacokinetics of Caffeine, Losartan, Omeprazole, Dextromethorphan, and Midazolam Administered as Inje Cocktail in Healthy Subjects"|Completed||Phase 4|45|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 02:06:42.658357|2017-10-11 02:06:42.658357
NCT00005376|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|November 2001|2001-11-01|August 1998|Actual|1998-08-01|||||Observational|||Premature Birth and Its Sequelae in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.458464|2017-10-11 04:28:04.458464
NCT01766037|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-01-04|2016-07-13||November 2012||2012-11-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2015|Actual|2015-06-01||Interventional|PATHWAY|All enrolled subjects|Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study|Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study|Active, not recruiting||N/A|171|Actual|Aspire Bariatrics, Inc.||2|||f||||t||||||||No|No individual participant data will be shared.|2017-10-11 02:06:45.059956|2017-10-11 02:06:45.059956
NCT01766024|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-10|2016-03-30|2015-02-02||February 2013||2013-02-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers|International Multicenter Randomized Double-blind Crossover Study of Pharmacokinetics, Pharmacodynamics and Tolerability of BCD-033 (CJSC BIOCAD, Russia) and Rebif® (Merck Serono S.p.А., Italy) After Single Subcutaneous Administration to Healthy Volunteers|Completed||Phase 1|32|Actual|Biocad||2|||f||||f||||||||||2017-10-11 02:06:45.954668|2017-10-11 02:06:45.954668
NCT01766011|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-03-02|||November 2012||2012-11-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital|Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital|Completed||Phase 2/Phase 3|28|Actual|Abbott Nutrition||1|||f||||t||||||||||2017-10-11 02:06:46.340819|2017-10-11 02:06:46.340819
NCT01765998|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-10|||February 2013||2013-02-01|January 2013|2013-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease)|The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) and Markers of Inflammation|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|The Baruch Padeh Medical Center, Poriya||2|||f||||t||||||||||2017-10-11 02:06:46.439718|2017-10-11 02:06:46.439718
NCT01765985|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2015-01-13|||September 2011||2011-09-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Treatment of Palmoplantar Psoriasis With Low Doses Interferential Current|Treatment of Palmoplantar Psoriasis With Low Doses Interferential Current|Completed||Phase 2/Phase 3|36|Actual|Association Niçoise Pour la Recherche En Dermatologie||2|||f||||f||||||||||2017-10-11 02:06:48.494683|2017-10-11 02:06:48.494683
NCT01765972|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-07-19|2016-06-10||December 2012||2012-12-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||All subjects that were dispensed a study lens.|Open Eye Corneal Swelling With Daily Disposable Contact Lenses and no Lens Wear||Completed||N/A|39|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||f||||||||||2017-10-11 02:06:48.601699|2017-10-11 02:06:48.601699
NCT01765959|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-05-27|||December 2012||2012-12-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|NADA||Auricular Acupuncture and Cognitive Behavioral Therapy Treatment for Insomnia|"Auricular Acupuncture and Cognitive Behavioral Therapy in the Context of Insomnia and Low Dose Dependence of Benzodiazepine-like Drugs and Other Sleep Medicine With Addiction Risk"|Completed||N/A|60|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 02:06:48.884953|2017-10-11 02:06:48.884953
NCT01765946|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-03-12|||June 2010||2010-06-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Metformin and Longevity Genes in Prediabetes|Effects of Metformin on Longevity Gene Expression and Inflammation and Prediabetic Individuals. A Placebo-controlled Trial|Completed||Phase 4|38|Actual|University of Padova||2|||f||||f||||||||||2017-10-11 02:06:48.988226|2017-10-11 02:06:48.988226
NCT01765933|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-08|||April 2012||2012-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Pharmacokinetic Effects of Oral DMAA|Pharmacokinetic and Physiological Effects of Oral DMAA Administration|Completed||N/A|8|Actual|University of Memphis||1|||f||||f||||||||||2017-10-11 02:06:49.090187|2017-10-11 02:06:49.090187
NCT01765920|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-02-07|||December 2012||2012-12-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Trial of Safety and Clinical Efficiency of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adult Patients|Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Safety and Clinical Efficiency of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adult Patients|Completed||Phase 3|282|Actual|Materia Medica Holding||2|||f||||f||||||||||2017-10-11 02:06:49.172545|2017-10-11 02:06:49.172545
NCT01765907|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-04-15|||December 2012||2012-12-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU)|Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU).|Completed||Phase 1|3|Actual|Theraclion||1|||f||||f||||||||||2017-10-11 02:06:49.276209|2017-10-11 02:06:49.276209
NCT01765894|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2014-02-21|||October 2012||2012-10-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|DIEGO||Influence of Moderate Exercise on Blood Glucose in Type 2 Diabetics and Healthy Controls|Influence of Moderate Exercise on Blood Glucose in Type 2 Diabetics and Healthy Controls.|Completed||N/A|24|Actual|University of Copenhagen|||3||f||||t||||||Samples With DNA|"     whole blood and plasma   "|||2017-10-11 02:06:49.358229|2017-10-11 02:06:49.358229
NCT01765881|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-04-26|||September 2012||2012-09-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|CYTOPRO||Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2|Comparison Between 25 µg Vaginal Misoprostol Versus Slow Release Pessary Prostaglandin-E2 (PGE2) : Could we Use Low Dose Vaginal Misoprostol as a First Line Treatment for Induction of Labor ?|Completed||Phase 2|1700|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-11 02:06:49.556245|2017-10-11 02:06:49.556245
NCT01765868|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-08|||September 2007||2007-09-01|January 2013|2013-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers|A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers.|Completed||Phase 1|8|Actual|Portola Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:06:49.768986|2017-10-11 02:06:49.768986
NCT01765855|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-08|||September 2007||2007-09-01|December 2012|2012-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects|AN OPEN-LABEL, SINGLE-DOSE, MASS-BALANCE STUDY TO ASSESS THE DISPOSITION OF 14C-LABELED PRT054021 IN HEALTHY MALE SUBJECTS|Completed||Phase 1|5|Actual|Portola Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:06:49.844609|2017-10-11 02:06:49.844609
NCT01765842|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-07-09|||November 2012||2012-11-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|November 2014|Actual|2014-11-01||Interventional|RITULUP||Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy|Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy Resistant to Conventional Treatments.|Terminated||Phase 3|9|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2||The recruitment period has finished without reaching sample size|f||||f||||||||||2017-10-11 02:06:49.917884|2017-10-11 02:06:49.917884
NCT01765829|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2014-12-04|||November 2012||2012-11-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|NONSTOP||Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis|Randomized Multicentric Open-label Phase III Clinical Trial to Evaluate the Efficacy of Continual Treatment Versus Discontinuation Based in the Presence of Prodromes in a First Episode of Non-affective Psychosis.|Unknown status|Recruiting|Phase 3|104|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||t||||||||||2017-10-11 02:06:50.063597|2017-10-11 02:06:50.063597
NCT01765816|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-01-27|||August 2012||2012-08-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|||Generation 100: Blood Volume and Cardiac Function in Healthy Aging|Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study|Completed||N/A|25|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-10-11 02:06:50.306034|2017-10-11 02:06:50.306034
NCT01765803|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-03-15|2015-06-19||June 2013||2013-06-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells|A Single Institution Feasibility Study to Assess Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells|Terminated||Early Phase 1|6|Actual|New Mexico Cancer Care Alliance||1||Primary objective not met after planned interim analysis|f||||t||||||||||2017-10-11 02:06:50.408331|2017-10-11 02:06:50.408331
NCT01765790|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-09-13|||June 2012||2012-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors|A Phase 1 Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-MIF Antibody in Subjects With Malignant Solid Tumors|Completed||Phase 1|68|Actual|Baxalta US Inc.||2|||f||||f||||||||||2017-10-11 02:06:50.620978|2017-10-11 02:06:50.620978
NCT01765777|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-01-19|||June 2011||2011-06-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain|Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain|Recruiting||N/A|48|Anticipated|New York Institute of Technology||4|||f||||f||||||||||2017-10-11 02:06:50.738778|2017-10-11 02:06:50.738778
NCT01765764|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-01-16|2015-01-16||March 2013||2013-03-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Bimatoprost for the Treatment of Eyebrow Hypotrichosis||Completed||Phase 3|357|Actual|Allergan||3|||f||||f||||||||||2017-10-11 02:06:50.902203|2017-10-11 02:06:50.902203
NCT01765738|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-09|||February 2013||2013-02-01|January 2013|2013-01-01|July 2014|Anticipated|2014-07-01|January 2014|Anticipated|2014-01-01||Interventional|||Comparison of an Antibiotic Impregnated PICC Catheter Versus a Regular PICC Catheter in a Tertiary Care Setting|Randomized Double Blind Comparison of an Antibiotic Impregnated PICC Catheter Versus a Regular PICC Catheter in a Tertiary Care Setting|Unknown status|Not yet recruiting|Phase 2|200|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 02:06:51.450991|2017-10-11 02:06:51.450991
NCT01765712|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-08-10|||December 2012|Actual|2012-12-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||The Effect of Platelet Rich Plasma (PRP) on Post Operative Pain in Anterior Cruciate Ligament Reconstruction|"Effect of Intraoperative Application of Autologous PRP on Post Operative Morbidity in ACL Reconstruction Using Autologous Bone Patellar Tendon Bone Graft Harvest"|Completed||Phase 4|50|Anticipated|Northwell Health||2|||f||||t||||||||||2017-10-11 02:06:51.653518|2017-10-11 02:06:51.653518
NCT01765699|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2015-10-07|||February 2012||2012-02-01|October 2015|2015-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Predicting Poor Outcomes After Primary Knee Arthroplasty|Predicting Poor Outcomes After Primary Knee Arthroplasty|Completed||N/A|1300|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 02:06:51.768696|2017-10-11 02:06:51.768696
NCT01765686|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-05-19|||December 2012||2012-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery|Randomized Controlled Trial Comparing the Utility of an Ultrasonic Coagulating Device (UCSD) With Electrothermal Bipolar Vessel Sealer (EBVS) in Thyroid Surgery.|Completed||N/A|100|Actual|National Cancer Centre, Singapore||2|||f||||f||||||||||2017-10-11 02:06:51.916556|2017-10-11 02:06:51.916556
NCT01761981|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-12-16|||June 2012||2012-06-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Institutional Registry of Haemorrhagic Hereditary Telangiectasia|Institutional Registry of Haemorrhagic Hereditary Telangiectasia|Recruiting||N/A|250|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 02:08:24.101691|2017-10-11 02:08:24.101691
NCT01765660|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-08|||January 2013||2013-01-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease|Mesenchymal Stem Cells From Third-party Donors for Treatment of Refractory Chronic Graft-versus-host Disease|Unknown status|Recruiting|Phase 2|60|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 02:06:52.260302|2017-10-11 02:06:52.260302
NCT01765647|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-04-20|||May 2014||2014-05-01|May 2015|2015-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Oral AGY for Celiac Disease|Use of an Orally Administered Antibody to Gluten to Prevent the Recurrence of Symptoms and Laboratory Parameters in Persons With Celiac Disease (Gluten Sensitive Enteropathy)|Completed||Phase 1|10|Anticipated|Igy Inc.||1|||f||||f||||||||||2017-10-11 02:06:52.408327|2017-10-11 02:06:52.408327
NCT01765634|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-08|||January 2013||2013-01-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease|Mesenchymal Stem Cells From Third-party Donors for Treatment of Refractory Acute Graft-versus-host Disease|Unknown status|Recruiting|Phase 2|40|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 02:06:52.500302|2017-10-11 02:06:52.500302
NCT01765621|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-10-20|||January 2013||2013-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|DDI+||Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions|Clinical and Economic Impact of a Web Based, Electronic Medical Record Interfaced Electronic Decision Support System Incorporating Pharmacogenetic Evaluation for Physicians Intended, Mainly for Drug-drug Interaction. A Controlled Study in an Ambulatory Health Maintenance Organization Population|Completed||N/A|973|Actual|Leumit Health Services||2|||f||||f||||||||||2017-10-11 02:06:52.629861|2017-10-11 02:06:52.629861
NCT01765608|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-02-19|||March 2010||2010-03-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients|A 1 Month Randomized Placebo Controlled, Double Blind Trial With a 5 Month Open Extension Phase to Explore the Efficacy of Zonisamide on Apnea/Hypopnea Index in Overweight/Obese Sleep Apnea Patients.|Completed||Phase 2|50|Actual|Göteborg University||3|||f||||t||||||||||2017-10-11 02:06:52.720762|2017-10-11 02:06:52.720762
NCT01765595|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2014-10-20|||January 2013||2013-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|DDI+||Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions||Completed||N/A|715|Actual|Leumit Health Services||2|||f||||||||||||||2017-10-11 02:06:52.847502|2017-10-11 02:06:52.847502
NCT01765582|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-08-18|2017-06-02||January 23, 2013|Actual|2013-01-23|August 2017|2017-08-01|March 14, 2016|Actual|2016-03-14|March 14, 2016|Actual|2016-03-14||Interventional|STEAM|Intent to Treat (ITT) population was defined as all randomized participants regardless of whether they received any dose of study treatment.|Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer|Steam (Sequencing Triplet With Avastin and Maintenance): FOLFOXIRI/Bevacizumab Regimens (Concurrent and Sequential) vs. FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer|Terminated||Phase 2|280|Actual|Hoffmann-La Roche|This trial was terminated on 12 November 2015, because the primary objective was not met.|3|||f|||||t|f||||||||2017-10-11 02:06:52.980417|2017-10-11 02:06:52.980417
NCT01765569|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-08-24|2015-07-14||July 2013||2013-07-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma|A Phase I, Open-Label, Multicenter, 3-Period, Fixed-Sequence Study To Investigate The Effect Of Vemurafenib On The Pharmacokinetics Of A Single Dose Of Digoxin In Patients With BRAFV600 Mutation-Positive Metastatic Malignancy|Completed||Phase 1|29|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:06:55.075036|2017-10-11 02:06:55.075036
NCT01765556|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-11-01|||October 2013||2013-10-01|November 2016|2016-11-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma|A Phase I, Open-Label, Multicenter, Three-Period, One-Sequence Study To Investigate The Effect Of Ketoconazole On The Pharmacokinetics Of A Single Oral Dose Of 960 Mg Of Vemurafenib|Withdrawn||Phase 1|0|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:06:55.55932|2017-10-11 02:06:55.55932
NCT01765543|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2016-10-21|2016-10-21||July 2013||2013-07-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||The intent-to-treat (ITT) population included all participants who were enrolled in the study.|A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)|A Phase I, Open-Label, Multicenter, Three-Period, One-Sequence Study to Investigate the Effect of Rifampin on the Pharmacokinetics of a Single Oral Dose of 960 mg of Vemurafenib|Completed||Phase 1|27|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:06:55.74226|2017-10-11 02:06:55.74226
NCT01765530|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2017-04-13|2016-10-26||September 2012||2012-09-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy Study of a Novel Device to Clean the Endotracheal Tube|Endotracheal Tubes Cleaned With a Novel Mechanism for Secretions Removal|Completed||N/A|74|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:06:56.23149|2017-10-11 02:06:56.23149
NCT01765517|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-08-29|||October 2013||2013-10-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Study to Explore the Effects of Probiotics on Endotoxin Levels in Type 2 Diabetes Mellitus Patients|A 26-week, Randomized, Double-blind, Placebo-controlled Study to Explore the Effects of Probiotics on Endotoxin Levels in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||N/A|83|Actual|King Saud University||2|||f||||t||||||||||2017-10-11 02:06:56.524778|2017-10-11 02:06:56.524778
NCT01765504|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-08-17|||February 2013||2013-02-01|August 2017|2017-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Pilot Study of the Feasibility of Multicenter NIRS Data Collection and Interventions for Desaturation in Cardiac Surgery|Pilot Study of the Feasibility of Multicenter NIRS Data Collection and Interventions for Desaturation in Cardiac Surgery|Completed||N/A|18|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 02:06:56.624663|2017-10-11 02:06:56.624663
NCT01765491|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-01-08|||August 2012||2012-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Comparison of Two Methods of Bowel Preparation for Colonoscopy in Hospitalized Patients|Comparison of Morning-only With Split-dose Polyethylene Glycol for Colonoscopy Preparation in Hospitalized Patients: A Randomized Controlled Non-Inferiority Study|Completed||N/A|120|Actual|John H. Stroger Hospital||2|||f||||f||||||||||2017-10-11 02:06:56.704175|2017-10-11 02:06:56.704175
NCT01765478|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-05-15|||January 2013||2013-01-01|November 2012|2012-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers|A Phase1 Study, to Determine the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Single and Multiple Doses of Orally Administered HM71224 in Healthy, Adult Male Volunteers|Completed||Phase 1|62|Anticipated|Hanmi Pharmaceutical Company Limited||11|||f||||f||||||||||2017-10-11 02:06:56.797692|2017-10-11 02:06:56.797692
NCT01765465|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-11-16|2014-10-15||January 2013||2013-01-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Rowachol on Prevention of Postcholecystectomy Syndrome|Effect of Rowachol on Prevention of Postcholecystectomy Syndrome After Laparoscopic Cholecystectomy|Completed||Phase 4|138|Actual|DongGuk University||2|||f||||t||||||||||2017-10-11 02:06:56.911726|2017-10-11 02:06:56.911726
NCT01765452|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-05-09|||October 2012||2012-10-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone|Multi-center, Randomized, Open Study for Comparison of Efficacy and Safety of Plavix With Astrix and Closone in Patients With Post-Percutaneous Coronary Artery Intervention|Completed||Phase 4|285|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 02:06:57.193512|2017-10-11 02:06:57.193512
NCT01765439|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-07-25|||February 2014||2014-02-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease|The Effect of VSL#3 (Original De Simone Formulation) Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease|Recruiting||N/A|80|Anticipated|Charles University, Czech Republic||4|||f||||f||||||||||2017-10-11 02:06:57.289093|2017-10-11 02:06:57.289093
NCT01765426|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-08-03|2016-11-04||February 15, 2013|Actual|2013-02-15|August 2017|2017-08-01|June 26, 2014|Actual|2014-06-26|June 26, 2014|Actual|2014-06-26||Interventional||Baseline analysis population included all randomized participants.|Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector|Phase 1b, Partial-Blind, Parallel Group, Randomized Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine (DENVax) Administered Intradermally Using Needle or a Needle-Free PharmaJet® Injector in Healthy Adults|Completed||Phase 1|67|Actual|Takeda||4|||f||||t||||||||||2017-10-11 02:06:57.483198|2017-10-11 02:06:57.483198
NCT01765413|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-02-12|||September 2013||2013-09-01|September 2013|2013-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines|"A Clinical Study to Generate an Exploratory Training Set of Data Characterising Clinical Events, Physiological and Metabolic Responses, and Innate and Adaptive Immune Responses Following a Single Subcutaneous Immunisation With Either Varilrix Varicella-zoster Vaccine, Stamaril Yellow Fever Vaccine or Saline Placebo in Healthy Adults With Evidence of Pre-existing Immunity to Varicella-zoster and no Existing Immunity to Yellow Fever."|Completed||N/A|48|Actual|University of Surrey||3|||f||||f||||||||||2017-10-11 02:06:59.741603|2017-10-11 02:06:59.741603
NCT01765400|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-09-28|||February 2013|Actual|2013-02-01|September 2017|2017-09-01|December 28, 2015|Actual|2015-12-28|December 1, 2015|Actual|2015-12-01||Interventional|||Platelet Inhibition in Patients With Systolic Heart Failure|Platelet Reactivity With Clopidogrel Versus Prasugrel in Patients With Systolic Heart Failure|Completed||Phase 4|30|Actual|University of Nebraska||2|||f||||t||||||||||2017-10-11 02:06:59.837763|2017-10-11 02:06:59.837763
NCT01765387|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-03-24|||February 2012||2012-02-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Spa Effects After Exercise|SPA THERAPY AS RECOVERY PROCEDURE AFTER EXERCISE: A PRAGMATIC CONTROLLED TRIAL|Completed||N/A|34|Actual|University of Malaga||2|||f||||f||||||||||2017-10-11 02:06:59.934256|2017-10-11 02:06:59.934256
NCT01765374|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-01-21|||February 2011||2011-02-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|SEWORRA||Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis|Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis|Completed||Phase 4|30|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 02:07:00.072995|2017-10-11 02:07:00.072995
NCT01765361|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-01-31|||September 2012||2012-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2015|Actual|2015-01-01||Observational|||Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)|Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)|Completed||N/A|16|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 02:07:00.299986|2017-10-11 02:07:00.299986
NCT01765348|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2013-01-08|||March 2012||2012-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Evaluating Treatment Efficacy of Two Syntactic Treatment Procedures for Children With Specific Language Impairment (SLI): A Randomized Controlled Trial|Evaluating Treatment Efficacy of Two Syntactic Treatment Procedures for Children With Specific Language Impairment (SLI): A Randomized Controlled Trial|Completed||N/A|52|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:07:00.394291|2017-10-11 02:07:00.394291
NCT01765335|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-07-06|||January 2013||2013-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Heart Failure Re-admission Risk Estimation Using NICaS System With Comparison to Serum BNP Levels|Heart Failure Re-admission Risk Estimation Using NICaS System With Comparison to Serum BNP Levels|Completed||N/A|20|Actual|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 02:07:00.532432|2017-10-11 02:07:00.532432
NCT01765322|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2013-11-25|||November 2013||2013-11-01|November 2013|2013-11-01|July 2015|Anticipated|2015-07-01|January 2015|Anticipated|2015-01-01||Interventional|||The Effect of Laser-assisted Zona Thinning on the Implantation Rate in the Women of Advanced Age|Center of Assisted Reproductive Technology|Unknown status|Recruiting|N/A|150|Anticipated|Shanxi Provincial Maternity and Children's Hospital||2|||f||||t||||||||||2017-10-11 02:07:00.647109|2017-10-11 02:07:00.647109
NCT01765309|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-10|||March 2009||2009-03-01|March 2012|2012-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders|A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders|Completed||N/A|23|Actual|University of Colorado, Denver||1|||f||||f||||||||||2017-10-11 02:07:00.759501|2017-10-11 02:07:00.759501
NCT01765283|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2015-05-16|||March 2012||2012-03-01|January 2014|2014-01-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|HEP001||Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)|A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Promethera HepaStem in Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) Paediatric Patients.|Completed||Phase 1/Phase 2|20|Actual|Promethera Biosciences||3|||f||||t||||||||||2017-10-11 02:07:01.063499|2017-10-11 02:07:01.063499
NCT01765270|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-05-07|2015-04-23||March 2013||2013-03-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|MAPSS|Modified intent-to-treat (mITT) population: all subjects randomized who received at least one dose of study drug (Saxagliptin or placebo) before CABG surgery and underwent a CABG, as randomized.|Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery|Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Terminated||Phase 4|12|Actual|Duke University|Early termination leading to small numbers of subject analyzed.|2||The study was stopped due to poor enrollment.|f||||f||||||||||2017-10-11 02:07:01.193731|2017-10-11 02:07:01.193731
NCT01765257|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-09|||June 2013||2013-06-01|January 2013|2013-01-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study|Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study.|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:07:01.754861|2017-10-11 02:07:01.754861
NCT01765244|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-09-19|||January 2014||2014-01-01|March 2016|2016-03-01|September 2019|Anticipated|2019-09-01|January 2019|Anticipated|2019-01-01||Interventional|||Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment|Multicenter Clinical Trial to Evaluate the Safety and Feasibility of an Allogeneic Tissue Engineered Drug (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers Refractory to Conventional Treatment|Recruiting||Phase 1/Phase 2|20|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||t||||||||||2017-10-11 02:07:01.899712|2017-10-11 02:07:01.899712
NCT01765231|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-09|2017-01-08|||January 2013||2013-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma|Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma|Recruiting||Phase 4|190|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 02:07:02.04633|2017-10-11 02:07:02.04633
NCT01765218|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-06-19|||February 2013||2013-02-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy|TOPIRAMATE AS AN ADJUVANT TO THERAPEUTIC HYPOTHERMIA FOR INFANTS WITH HYPOXIC ISCHEMIC ENCEPHALOPATHY|Completed||Phase 1/Phase 2|13|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 02:07:02.227267|2017-10-11 02:07:02.227267
NCT01765205|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-03-13|||March 2010||2010-03-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Newborn Screening for Critical Congenital Heart Disease|The Efficacy of Newborn Screening for Critical Congenital Heart Disease|Completed||Early Phase 1|20|Actual|University of Florida|||2||f||||f||||||||||2017-10-11 02:07:02.319511|2017-10-11 02:07:02.319511
NCT01765192|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2016-12-02|2015-06-12||February 2013||2013-02-01|September 2016|2016-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Full analysis set: All randomized participants, analyzed according to the randomized treatment.|Roflumilast Plus Montelukast in Adults With Severe Asthma|A Phase 2, Randomized, Double-Blind, 4-week Crossover Trial to Investigate the Effect of a Once-Daily Combination of 500 µg Roflumilast Plus 10 mg Montelukast vs 10 mg Montelukast Alone on Pulmonary Function, Asthma Symptoms, and Inflammatory Markers in Subjects With Severe Asthma Not Adequately Controlled With a Combination of at Least Medium Dose Inhaled Corticosteroids and Long-Acting Beta Agonists Maintenance Therapy|Completed||Phase 2|64|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 02:07:02.415276|2017-10-11 02:07:02.415276
NCT01765179|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-08-22|2017-08-22||January 2013||2013-01-01|August 2017|2017-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Safety Analysis Set|Safety and Efficacy Trial of Testosterone Undecanoate|Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men|Completed||Phase 3|144|Actual|Clarus Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 02:07:03.020031|2017-10-11 02:07:03.020031
NCT01765166|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2013-01-08|||January 2010||2010-01-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|January 2011|Actual|2011-01-01||Interventional|SSGRIN-PG||Parent Treatment for Child Social Adjustment|Continuing the Research and Development of Parent Treatment for Child Social Adjustment|Completed||N/A|240|Actual|Duke University||4|||f||||f||||||||||2017-10-11 02:07:03.34993|2017-10-11 02:07:03.34993
NCT01765153|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-03-21|2017-01-16||March 2008||2008-03-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Precision Versus Endurance Training to Improve Walking After Chronic Incomplete SCI|Precision Versus Endurance Training to Improve Walking After Chronic Incomplete SCI|Completed||N/A|21|Actual|University of Alberta|"Participants were a sample of convenience, likely the most highly motivated due to the time commitment.
Sample size was small.
4 participants were less than 1 year post injury and may have had spontaneous recovery."|2|||f||||t||||||||||2017-10-11 02:07:03.483011|2017-10-11 02:07:03.483011
NCT01765127|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-10-27|||January 2012||2012-01-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Observational|||An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)|An Observational Post-Authorization Modified Prescription-Event Monitoring Safety Study to Monitor the Safety and Utilization of Asenapine (Sycrest) in the Primary Care Setting in England|Recruiting||N/A|5000|Anticipated|Drug Safety Research Unit, Southampton, UK|||1||f||||f||||||||||2017-10-11 02:07:04.829667|2017-10-11 02:07:04.829667
NCT01765114|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-08-04|||February 2013||2013-02-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes|A Phase II Open-label, Intra-individual Controlled, Single-center Study to Investigate the Efficacy, Safety and Tolerability of a Polyethylene Glycol-formulation and the Viral Shedding in Patients Suffering From Genital Herpes|Terminated||Phase 2|8|Actual|Devirex AG||1||insufficient patient recruitment|f||||f||||||||||2017-10-11 02:07:05.002975|2017-10-11 02:07:05.002975
NCT01765101|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-01-09|||January 2013||2013-01-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Therapeutic Effects of Insoles on Patients With Knee Osteoarthritis|Therapeutic Effects of Ready-made Full-length Lateral Wedged Insoles and Customized Full-length Lateral Wedged Insoles on Patients With Knee Osteoarthritis : a Double Blind, Randomized Controlled Study|Unknown status|Not yet recruiting|Phase 3|90|Anticipated|Taipei Medical University||2|||f||||f||||||||||2017-10-11 02:07:05.100818|2017-10-11 02:07:05.100818
NCT01765088|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-12-10|||September 2012||2012-09-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas|A Phase III Trial on Adjuvant Standard Temozolomide Chemotherapy With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas|Recruiting||Phase 3|300|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 02:07:05.239169|2017-10-11 02:07:05.239169
NCT01765075|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2014-03-03|||April 2013||2013-04-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|STARLIGHT||Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment|Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment|Completed||N/A|25|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 02:07:05.363688|2017-10-11 02:07:05.363688
NCT01765062|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-01-08|||July 2008||2008-07-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|September 2008|Actual|2008-09-01||Observational|ERM||One Year Skeletal and Dental Arch Changes Following Rapid Maxillary Expansion Treatment in Children|One Year Skeletal and Dental Arch Changes Following Rapid Maxillary Expansion Treatment in Children|Completed||N/A|14|Actual|State University of Maringá|||3||f||||f||||||||||2017-10-11 02:07:05.442354|2017-10-11 02:07:05.442354
NCT01765049|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-11-18|||January 2013||2013-01-01|June 2015|2015-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01|5 Years|Observational [Patient Registry]|DEAR||Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor|Prospective Study Analyzing Value of Breast Density Change Predicting ENdocrine Therapy Response in Postmenopausal Women Taking Adjuvant ARomatase Inhibitor|Recruiting||N/A|411|Anticipated|Seoul National University Hospital|||1||f||||t||||||Samples With DNA|"     Postoperatively collected specimen (normal and cancer tissue) Preoperatively collected blood     sample   "|||2017-10-11 02:07:05.518428|2017-10-11 02:07:05.518428
NCT01765036|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-09|||July 2009||2009-07-01|January 2013|2013-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma|Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma: Results of the First Multicenter Prospective Study With Intra- and Interobserver Concordances Evaluation|Completed||N/A|100|Actual|Société Française d'Endoscopie Digestive||1|||f||||t||||||||||2017-10-11 02:07:05.626822|2017-10-11 02:07:05.626822
NCT01765023|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-04-07|||October 2012||2012-10-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects|An Open-label, Fixed-sequence Study to Evaluate Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects|Completed||Phase 1|80|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 02:07:05.782578|2017-10-11 02:07:05.782578
NCT01765010|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-08|||January 2013||2013-01-01|January 2013|2013-01-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels|Comparisons of the Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels|Unknown status|Recruiting|Phase 4|88|Anticipated|Seoul National University Hospital||4|||f||||t||||||||||2017-10-11 02:07:05.913917|2017-10-11 02:07:05.913917
NCT01764997|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-06-28|2017-05-23|2015-10-07|April 2013||2013-04-01|June 2017|2017-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|RA-COMPARE|All participants who included in open label run-in period, randomized treatment and sub-study.|An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate|A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX|Terminated||Phase 3|776|Actual|Sanofi|The study was prematurely terminated due to small number of participants entering randomization.|5||Due to small number of participants entering randomization. Not a safety issue.|f||||t||||||||||2017-10-11 02:07:06.164533|2017-10-11 02:07:06.164533
NCT01764984|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-02-02|||November 2005||2005-11-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|September 2009|Actual|2009-09-01||Interventional|||Bone Mineral Density Changes Under Two Tibial Components in Total Knee Arthroplasty|Randomized Clinical Evaluation of Bone Mineral Density Changes Under Non-cemented Trabecular Metal Tibial Component and Cemented Titanium Controls.|Completed||Phase 4|65|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 02:07:08.209471|2017-10-11 02:07:08.209471
NCT01764971|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2013-01-08|||March 2013||2013-03-01|January 2013|2013-01-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01|6 Months|Observational [Patient Registry]|||Cerebral Dysfunction in Chronic ITPwith High Risk of Serious Bleeding Excluding Intracranial Hemorrhage.|Cerebral Dysfunction in Chronic ITP With High Risk of Serious Bleeding Excluding Intracranial Hemorrhage.|Unknown status|Not yet recruiting|N/A|100|Anticipated|Ain Shams University|||2||f||||t||||||||||2017-10-11 02:07:08.322432|2017-10-11 02:07:08.322432
NCT01764958|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-07-07|||April 2012||2012-04-01|April 2012|2012-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01|12 Months|Observational [Patient Registry]|||Association Between Mother-Infant Attunement During Interaction and the Quality of General Movements|Association Between Mother-Infant Attunement During Interaction and the Quality of General Movements and Motor Development of Preterm Infants|Completed||N/A|61|Actual|Assuta Hospital Systems|||1||f||||t||||||||||2017-10-11 02:07:08.432997|2017-10-11 02:07:08.432997
NCT01764945|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-07-03|2015-07-03||January 2013||2013-01-01|July 2015|2015-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||This trial was an open-label study consisting of two (40mg and 120mg Faldaprevir) 4-way crossover groups. All subjects were to receive 4 treatments: either treatments A, B, C, and D (20 subjects) or treatments E, F, G, and H (36 subjects). Subjects were randomised to 1 of the 4 treatment sequences for each dose group to be tested in a 1:1:1:1 ratio|Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions|Relative Bioavailability of BI 201335 (Capsule) Compared to Three Different Oral Solutions of BI 201335 Following Oral Administration in Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Four-way Crossover Study)|Completed||Phase 1|56|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:07:08.695432|2017-10-11 02:07:08.695432
NCT01764932|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-09-13|||December 2011||2011-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Accuracy of the Thoracic Epidural Catheter Insertion Confirmed by Fluoroscopic Imaging|Determining the Accuracy of Thoracic Epidural Continuous Catheter Insertion With Confirmatory Fluoroscopic Imaging|Active, not recruiting||N/A|60|Actual|Chicago Anesthesia Pain Specialists||1|||f||||||||||||||2017-10-11 02:07:09.722773|2017-10-11 02:07:09.722773
NCT01764919|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-04-06|2016-01-11||April 2013||2013-04-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Interventional|||[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection|Exploration of the Use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection.|Terminated||Phase 2|4|Actual|BioMed Valley Discoveries, Inc||1||No correlation between FIAU uptake and bone biopsy results.|f||||f||||||||||2017-10-11 02:07:09.82419|2017-10-11 02:07:09.82419
NCT01764906|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-04-21|||March 2013||2013-03-01|January 2013|2013-01-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||The Clinical Study of Novosis in Posterolateral Fusion|The Clinical Study to Evaluate the Efficacy and Safety of Novosis in Posterolateral Fusion|Unknown status|Enrolling by invitation|N/A|90|Anticipated|BioAlpha Inc.||2|||f||||f||||||||||2017-10-11 02:07:10.148242|2017-10-11 02:07:10.148242
NCT01764880|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-12-01|||November 2012||2012-11-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||SST0001 (Roneparstat) in Advanced Multiple Myeloma|Phase I Dose Finding Study Assessing Safety and Tolerability of SST0001 in Advanced Multiple Myeloma.|Completed||Phase 1|19|Actual|Sigma Tau Research Switzerland SA||1|||f||||f||||||||||2017-10-11 02:07:10.316169|2017-10-11 02:07:10.316169
NCT01764867|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2013-01-08|||June 2012||2012-06-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|AGTs-MDD||Algorithm Guided Treatment Strategies for Major Depressive Disorder|Algorithm Guided Treatment Strategies for Major Depressive Disorder|Unknown status|Recruiting|Phase 4|1080|Anticipated|Shanghai Mental Health Center||2|||f||||f||||||||||2017-10-11 02:07:10.425342|2017-10-11 02:07:10.425342
NCT01764854|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2014-02-25|||January 2013||2013-01-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel Design Study to Evaluate the Pharmacodynamics, Safety, and Tolerability of AZD1722 in End-Stage Renal Disease Patients on Hemodialysis|Completed||Phase 2|88|Actual|Ardelyx||2|||f||||f||||||||||2017-10-11 02:07:10.578263|2017-10-11 02:07:10.578263
NCT01764841|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-06-11|2017-02-22||May 2, 2013|Actual|2013-05-02|June 2017|2017-06-01|March 9, 2016|Actual|2016-03-09|March 9, 2016|Actual|2016-03-09||Interventional|RESPIRE 1||Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)|Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.|Completed||Phase 3|416|Actual|Bayer||4|||f||||t|t|f||||||||2017-10-11 02:07:10.69101|2017-10-11 02:07:10.69101
NCT01764828|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-03-11|||February 2013||2013-02-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||BAY86-9766 Plus Gemcitabine Phase I Study in Asian|A Multi-center, Phase Ib Study of MEK (Mitogen Activated Protein Kinase/ERK Kinase) Inhibitor BAY86-9766 Plus Gemcitabine in Asian Patients With Advanced or Refractory Solid Tumors|Completed||Phase 1|23|Actual|Bayer||1|||f||||f||||||||||2017-10-11 02:07:15.038987|2017-10-11 02:07:15.038987
NCT01764815|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2017-06-30|||December 2012||2012-12-01|June 2017|2017-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) Leads|Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation Leads for the Treatment of Movement Disorders|Completed||N/A|13|Actual|Aleva Neurotherapeutics SA||1|||f||||f||||||||||2017-10-11 02:07:15.154974|2017-10-11 02:07:15.154974
NCT01764802|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-04-12|||October 2010||2010-10-01|April 2017|2017-04-01||||August 2018|Anticipated|2018-08-01||Interventional|||Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer|Psychosexual Intervention for Gynecologic and Breast Cancer Patients|Recruiting||Phase 2|100|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:07:15.24678|2017-10-11 02:07:15.24678
NCT01667822|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-10-14|||August 2012||2012-08-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Cognitive Behavioral Therapy, Guided Self Help Versus Individual Therapy||Completed||Phase 3|396|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:36:46.994042|2017-10-11 02:36:46.994042
NCT01764789|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2015-10-08|||October 2010||2010-10-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer|A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence|Completed||N/A|39|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:07:15.398506|2017-10-11 02:07:15.398506
NCT01764776|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-06-06|||March 2013||2013-03-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Hepatic Impairment on LDE225..|A Phase I, Open Label, Multi-center, Single Dose Study to Evaluate the Pharmacokinetics of LDE225 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function.|Completed||Phase 1|33|Actual|Novartis||1|||f||||||||||||||2017-10-11 02:07:15.704582|2017-10-11 02:07:15.704582
NCT01764763|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-07|||October 2010||2010-10-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Intraoperative Epiaortic Scanning for Preventing Early Stroke After Off-pump Coronary Artery Bypass||Completed||N/A|2292|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 02:07:15.810797|2017-10-11 02:07:15.810797
NCT01764750|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-07-09|||January 2013||2013-01-01|July 2015|2015-07-01||||July 2016|Anticipated|2016-07-01||Interventional|||Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics|A Prospective Dose-Escalation Trial of the Pharmacokinetics and Preliminary Safety of Intrasite Lyophilized Vancomycin to Prevent Wound Infections in Instrumented Spinal Surgery|Suspended||Phase 1|40|Anticipated|Washington University School of Medicine||4||awaiting FDA approval for next dose group|f||||t||||||||||2017-10-11 02:07:15.8757|2017-10-11 02:07:15.8757
NCT01764737|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-02-05|||December 2012||2012-12-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of Intravenous VX15/2503 In Patients With Multiple Sclerosis|Completed||Phase 1|50|Actual|Vaccinex Inc.||2|||f||||f||||||||||2017-10-11 02:07:15.992645|2017-10-11 02:07:15.992645
NCT01764724|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-09|||September 2011||2011-09-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Attitudes and Understanding of Sodium Claims on Food Labels|Consumer Attitudes and Understanding of Low Sodium Claims on Food: An Analysis of Healthy and Hypertensive Individuals|Completed||N/A|987|Actual|University of Toronto|||1||f||||f||||||||||2017-10-11 02:07:16.117209|2017-10-11 02:07:16.117209
NCT01764711|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-04-03|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)|Aldosterone and Sodium Regulation in Postural Tachycardia Syndrome Participating in the Dietary Salt in Orthostatic Tachycardia Study.|Active, not recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center||1|||f||||||||||||||2017-10-11 02:07:16.199991|2017-10-11 02:07:16.199991
NCT01764698|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-05-11|||November 2013||2013-11-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Delivery of Anxiety Disorder Treatment in Addictions Centers|Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders|Active, not recruiting||N/A|98|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:07:16.278832|2017-10-11 02:07:16.278832
NCT01764685|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-02-16|2015-08-07||January 2013||2013-01-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers|Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers|Terminated||Phase 2|4|Actual|University of Pennsylvania|We closed our enrollment before meeting recruitment goals, due to difficulties with recruitment. We didn't analyze our data, due to a sample size of 4, that were all randomized to placebo group and only 3 of the 4 completed the study procedures.|2||We terminated the study due to problems recruiting alcoholic subjects with HIV.|f||||f||||||||||2017-10-11 02:07:16.373806|2017-10-11 02:07:16.373806
NCT01764672|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2014-02-24|||April 2013||2013-04-01|February 2014|2014-02-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Effect of Methylphenidate on Connectivity|Effects of Methylphenidate on Resting State Connectivity in Healthy Controls and in Adults With Attention Deficit Hyperactivity Disorder.|Withdrawn||Phase 4|0|Actual|UMC Utrecht||2|||f||||f||||||||||2017-10-11 02:07:16.599078|2017-10-11 02:07:16.599078
NCT01764646|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-05-12|||September 2012||2012-09-01|May 2017|2017-05-01|September 2025|Anticipated|2025-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Hypofractionated Radiation Therapy in Prostate Cancer|Stereotactic Body Radiation Therapy for cT1c - cT3a Prostate Cancer With a Low Risk of Nodal Metastases (≤ 20%, Roach Index): a Novalis Circle Phase II Prospective Randomized Trial|Active, not recruiting||N/A|170|Actual|University Hospital, Geneva||2|||f||||t||||||||Undecided|No plan to share participant data for now|2017-10-11 02:07:16.778819|2017-10-11 02:07:16.778819
NCT01764633|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-08|2017-06-19||2017-06-19|February 2013||2013-02-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|FOURIER||Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk|A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab (AMG 145) is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease|Completed||Phase 3|27564|Actual|Amgen||2|||f||||t||||||||||2017-10-11 02:07:17.269354|2017-10-11 02:07:17.269354
NCT01764620|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-03-30|||May 2012||2012-05-01|March 2013|2013-03-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Interventional|||Effects of Muscle Fatigue and a Taping Technique on Shoulder Motion of Athletes|Effects of Muscle Fatigue and Scapular Taping on Shoulder Kinematics of Overhead Athletes|Unknown status|Recruiting|N/A|20|Anticipated|Universidade Federal de Sao Carlos||3|||f||||t||||||||||2017-10-11 02:07:20.74598|2017-10-11 02:07:20.74598
NCT01761409|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-03|||January 2000||2000-01-01|January 2013|2013-01-01||||January 2013|Anticipated|2013-01-01||Observational|||Epidemiological Analysis on Endometrial Cancer in Guangdong Province of China|Epidemiological Analysis on Endometrial Cancer.|Unknown status|Active, not recruiting|N/A|10000|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||||||2017-10-11 02:08:30.583506|2017-10-11 02:08:30.583506
NCT01764607|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-03-13|2015-02-17||April 2013||2013-04-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma|A Phase II Study of Sirolimus in Renal Transplant Patients Diagnosed With New or Recurrent Squamous Cell Skin Carcinoma Currently on Calcineurin-based Immunosuppression.|Terminated||Phase 2|1|Actual|University of Florida||1||Poor accrual|f||||t||||||||||2017-10-11 02:07:20.833134|2017-10-11 02:07:20.833134
NCT01764594|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-07-14|||January 2013||2013-01-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus|A Multicenter, Investigator- and Subject-Blind, Randomized, Placebo-Controlled, Parallel-Group, Repeat-Dose Study to Evaluate the Effect of CDP7657 in Subjects With Active Systemic Lupus Erythematosus|Completed||Phase 1|24|Actual|UCB Pharma||2|||f||||t||||||||||2017-10-11 02:07:21.027467|2017-10-11 02:07:21.027467
NCT01764581|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-07|||July 2008||2008-07-01|October 2010|2010-10-01|March 2012|Actual|2012-03-01|October 2010|Actual|2010-10-01||Interventional|||Randomized Controlled Trial of ImmuKnow in Liver Transplantation|Randomized Controlled Interventional Trial of Immunosuppression Modification Based on the Cylex™ ImmuKnow® Assay in Adult Liver Transplant Recipients|Completed||N/A|206|Actual|University of Bologna||2|||f||||t||||||||||2017-10-11 02:07:21.882455|2017-10-11 02:07:21.882455
NCT01764568|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-23|||January 2013||2013-01-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|MCT||Contrasting Group Therapy Methods for Psychosis|Functional Brain Networks Underlying Non-pharmaceutical Interventions for Psychosis.|Recruiting||N/A|225|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-10-11 02:07:21.979636|2017-10-11 02:07:21.979636
NCT01764555|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-01-07|||December 2012||2012-12-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|APAP||Pharmacokinetics of Acetaminophen in Morbidly Obese Patients|Pharmacokinetics of Intravenous Acetaminophen and Its Metabolites in Morbidly Obese Patients|Unknown status|Recruiting|Phase 4|28|Anticipated|St. Antonius Hospital||2|||f||||||||||||||2017-10-11 02:07:22.118667|2017-10-11 02:07:22.118667
NCT01764542|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-04-18|||February 2010||2010-02-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors|Critical Assessment of Routine Surveillance of Asymptomatic Patients With Ulcerative Colitis With Ileal Pouch-anal Anastomosis and Risk Factors for Dysplasia - is There a Rationale?|Completed||N/A|56|Actual|Sahlgrenska University Hospital, Sweden||1|||f||||f||||||||||2017-10-11 02:07:22.374916|2017-10-11 02:07:22.374916
NCT01764529|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-09-07|||July 2009||2009-07-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01|5 Years|Observational [Patient Registry]|||Modifiers of Disease Severity in Cerebral Cavernous Malformations|Modifiers of Disease Severity and Progression in Cerebral Cavernous Malformations|Recruiting||N/A|800|Anticipated|University of New Mexico|||1||f||||f||||||Samples With DNA|"     We collect and store saliva as well as whole blood for DNA and RNA extraction. Brain     cavernous malformation tissue will be collected and banked as available.   "|||2017-10-11 02:07:22.489878|2017-10-11 02:07:22.489878
NCT01764516|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-05|||November 2011||2011-11-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01|1 Week|Observational [Patient Registry]|||Study on Serum Zinc and Selenium Levels in Epileptic Patients|Arak University of Medical Sciences , Ministry of Health and Education,I.R.Iran|Completed||N/A|40|Actual|Arak University of Medical Sciences|||6||f||||t||||||None Retained|"     Serum were analysis for zinc and selenium   "|||2017-10-11 02:07:22.656682|2017-10-11 02:07:22.656682
NCT01764503|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-03-11|||September 2003||2003-09-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01|3 Years|Observational [Patient Registry]|||Endoscopic Papillectomy for Early Ampullary Tumors: Long-term Results of the First Large Multicenter Prospective Study|to Evaluate the Long-term Results of Endoscopic Papillectomy (EP)|Completed||N/A|93|Actual|Société Française d'Endoscopie Digestive|||1||f||||f||||||||||2017-10-11 02:07:22.759212|2017-10-11 02:07:22.759212
NCT01764490|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2014-06-26|||January 2013||2013-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Observational|INCREMENT||Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study|Impact of Specific Antimicrobials and Minimal Inhibitory Concentration(MIC) Values on the Outcome of Bloodstream Infections Due to ESBL or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study|Completed||N/A|1344|Actual|Spanish Network for Research in Infectious Diseases|||1||f||||t||||||||||2017-10-11 02:07:22.838121|2017-10-11 02:07:22.838121
NCT01764477|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-08-16|||April 2013||2013-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma|Phase Ib Multicenter, Cohort Dose Escalation Trial to Determine the Safety, Tolerance and Preliminary Antineoplastic Activity of Gemcitabine Administered in Combination With Continuous Intravenous Doses of PRI-724, a CBP/ β- Catenin Inhibitor, to Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Eligible for Second-Line Therapy After Failing First-Line Therapy With FOLFIRINOX (or FOLFOX)|Completed||Phase 1|20|Actual|Prism Pharma Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:07:22.952986|2017-10-11 02:07:22.952986
NCT01764464|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-03-24|||December 2012||2012-12-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|GRASSP||GRASSP: Gralise® for Spine Surgery Pain|Gralise® for Spine Surgery Pain (GRASSP): A Partially Enriched, Placebo Controlled, Randomized, Double Blind, Cross-Over Trial of Gralise® for the Treatment of Post Laminectomy Pain Syndrome|Recruiting||Phase 4|50|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-11 02:07:23.100355|2017-10-11 02:07:23.100355
NCT01764451|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-04-07|||March 2012||2012-03-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins|Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins|Completed||Early Phase 1|12|Actual|University of New Mexico||2|||f||||f||||||||||2017-10-11 02:07:23.220528|2017-10-11 02:07:23.220528
NCT01764087|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-05-15|||December 2012||2012-12-01|March 2014|2014-03-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors|An Open-label Phase I/II Study of KX2-391 in Combination With Paclitaxel in Patients With Advanced Solid Tumors|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Hanmi Pharmaceutical Company Limited||1|||f||||f||||||||||2017-10-11 02:07:28.640051|2017-10-11 02:07:28.640051
NCT01764438|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2013-01-03|||August 2012||2012-08-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01|1 Year|Observational [Patient Registry]|PrimovistMRI||Utility Study of Primovist-MRI on HCC Staging|The Incidence of Change in BCLC Stage by add-on Primovist-enhanced MRI During Initial Staging Work-up in HCC Patients Who Can be Candidates for Curative Treatment by Liver Dynamic CT: A Prospective Multicenter Study|Unknown status|Recruiting|N/A|174|Anticipated|Inha University Hospital|||1||f||||f||||||||||2017-10-11 02:07:23.31632|2017-10-11 02:07:23.31632
NCT01764425|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-07-08|||May 2012||2012-05-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects|A Phase I, Randomized, Double-blind, Placebo-controlled Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight and/or Obese Subjects|Terminated||Phase 1|32|Actual|Piramal Enterprises Limited||2|||f||||f||||||||||2017-10-11 02:07:23.603713|2017-10-11 02:07:23.603713
NCT01764412|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-03-27|||March 2013||2013-03-01|August 2014|2014-08-01|February 2015|Actual|2015-02-01|March 2014|Actual|2014-03-01||Observational|HEPMEN||Study of Serum Hepcidin Rate Variations During Menstrual Cycle|Study of Serum Hepcidin Rate Variations During Menstrual Cycle|Completed||N/A|147|Actual|Rennes University Hospital|||1||f||||f||||||Samples Without DNA|"     Hepcidin Serum iron Transfferin saturation Serum transfferin Serum ferritin   "|||2017-10-11 02:07:23.753699|2017-10-11 02:07:23.753699
NCT01764399|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-12-12|||March 2013||2013-03-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Care4U: Self Management Intervention for Older Adult Caregivers||Completed||N/A|6|Actual|University of Nebraska||2|||f||||f||||||||||2017-10-11 02:07:23.905226|2017-10-11 02:07:23.905226
NCT01764386|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-11-30|2015-09-07||February 2013||2013-02-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Baseline analysis was based on the Intent-to-Treat (ITT) population which comprised all subjects randomized to NB + CLI who received at least 1 dose of study medication and all subjects randomly assigned to Usual Care who received their baseline lifestyle intervention program instruction.|Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects|A Multicenter, Randomized, Open-Label, Controlled, Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects (The Ignite Study)|Completed||Phase 3|242|Actual|Orexigen Therapeutics, Inc||2|||f||||f||||||||||2017-10-11 02:07:24.067832|2017-10-11 02:07:24.067832
NCT01764373|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-09-26|||June 2012||2012-06-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Pilot Study of Exercise and Peripheral Nerve Function in People With Diabetes - ENRGy2 Addendum|Pilot Study of Exercise and Peripheral Nerve Function in People With Diabetes - Exercise and Neuropathy Research Group v.2 (ENRGy2) Addendum|Completed||N/A|19|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 02:07:25.122509|2017-10-11 02:07:25.122509
NCT01764360|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-07-13|||February 2013||2013-02-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|SIKO||Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe|Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe (SIKO)|Completed||N/A|1024|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 02:07:25.206925|2017-10-11 02:07:25.206925
NCT01764347|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2014-01-27|||November 2010||2010-11-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate Cancer|Accuracy of Targeted Biopsies Using MRI-TRUS Fusion Guidance: Pilot Study on Ex Vivo Radical Prostatectomy Specimens|Completed||N/A|24|Actual|University of Southern California||1|||f||||t||||||||||2017-10-11 02:07:25.282125|2017-10-11 02:07:25.282125
NCT01764334|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2017-06-10|||October 2011||2011-10-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2014|Actual|2014-06-01||Interventional|FAMOUS NSTEMI||Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes|A Developmental Clinical Study of Management Guided by Coronary Angiography Combined With Fractional Flow Reserve (FFR) Measurement Versus Management Guided by Coronary Angiography Alone(Standard Care) in Patients With Non-ST Elevation MI.|Active, not recruiting||Phase 4|350|Actual|NHS National Waiting Times Centre Board||2|||f||||t||||||||Yes|Data sharing for the purposes of collaborative research is possible pending regulatory approval and institutional data sharing agreements.|2017-10-11 02:07:25.374587|2017-10-11 02:07:25.374587
NCT01764321|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-10-05|||December 2012||2012-12-01|October 2017|2017-10-01|October 23, 2020|Anticipated|2020-10-23|October 23, 2020|Anticipated|2020-10-23||Observational|NexT||Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors|A Multi-center, Noninterventional Study With Certolizumab Pegol in Comparison With Any Other Subcutaneous TNF Inhibitor in Two Parallel Groups in Biologic Naive Patients With Rheumatoid Arthritis|Recruiting||N/A|1700|Anticipated|UCB Pharma|||2||f||||f||||||||||2017-10-11 02:07:25.558246|2017-10-11 02:07:25.558246
NCT01764308|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-10-27|||January 2013||2013-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|Omega-3||Effects of Omega-3 Fatty Acid Supplementation in Acne Patients|Omega-3 Fatty Acid Supplementation in Acne Patients|Recruiting||Phase 3|90|Anticipated|University of California, Los Angeles||2|||f||||f||||||||Undecided||2017-10-11 02:07:26.269412|2017-10-11 02:07:26.269412
NCT01764295|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2013-08-22|||September 2012||2012-09-01|January 2013|2013-01-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Clinical Study for Patients With Hypertension Associated With Dyslipidemia|Multi-institutional, Randomized, Double-Blind, Placebo-Control, Factorial Design, 4-arms, 8 Week Administration, Phase 3 Clinical Study for Patients With Hypertension Associated With Dyslipidemia|Completed||Phase 3|150|Anticipated|Daewoong Pharmaceutical Co. LTD.||4|||f||||f||||||||||2017-10-11 02:07:26.5434|2017-10-11 02:07:26.5434
NCT01764282|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2017-08-24|||January 1, 2012|Actual|2012-01-01|August 2017|2017-08-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission|A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission|Completed||N/A|11096|Actual|National Center for AIDS/STD Control and Prevention, China CDC||2|||f||||t||||||||||2017-10-11 02:07:26.690514|2017-10-11 02:07:26.690514
NCT01764269|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-06-22|||January 2013||2013-01-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014|Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014|Completed||N/A|656|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 02:07:26.828645|2017-10-11 02:07:26.828645
NCT01764256|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-12-22|||December 2012||2012-12-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine|A Phase 1 Double Blinded, Randomized, Placebo-controlled Dose Escalation Study to Examine the Safety, Reactogenicity, Tolerability and Immunogenicity of the P2-VP8 Subunit Rotavirus Vaccine in Healthy Adult Volunteers|Completed||Phase 1|48|Actual|PATH||2|||f||||t||||||||||2017-10-11 02:07:26.962515|2017-10-11 02:07:26.962515
NCT01764243|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2015-09-24|||November 2012||2012-11-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Efficacy of MT-4666|A Double-Blind, Placebo-Controlled Phase2 Study of MT-4666 in Patients With Mild to Moderate Probable Alzheimer's Disease.|Completed||Phase 2|450|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-10-11 02:07:27.095489|2017-10-11 02:07:27.095489
NCT01764230|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2013-01-07|||January 2004||2004-01-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|July 2007|Actual|2007-07-01||Interventional|OVARONKO||Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients|Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients|Completed||N/A|72|Actual|Masaryk University||2|||f||||f||||||||||2017-10-11 02:07:27.228339|2017-10-11 02:07:27.228339
NCT01764217|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-03-29|||July 2006||2006-07-01|March 2016|2016-03-01|January 2013|Actual|2013-01-01|July 2006|Actual|2006-07-01||Observational|||Prediction of Clinical Response and Outcome in Uterine Cervix Cancer|Predicting Clinical Response and Outcome After Definitive Irradiation With MRI-Guided Adaptive Brachytherapy in Uterine Cervix Cancer|Completed||N/A|100|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-10-11 02:07:27.33101|2017-10-11 02:07:27.33101
NCT01764204|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-10-09|||January 2013||2013-01-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Observational|||Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years|Intensive Hospital-based Adverse Drug Reaction Monitoring Study On Patients Treated By Qingkailing Injection In The Next Two Years|Recruiting||N/A|30000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||||||||Samples With DNA|"     whole blood of the patient with severe adverse drug reactions   "|||2017-10-11 02:07:27.458251|2017-10-11 02:07:27.458251
NCT01764191|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-12-28||||||December 2016|2016-12-01||||||||Expanded Access|||18F-FDG PET Imaging in Cardiac Sarcoidosis|[18 F]-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography (PET) in Cardiac Sarcoidosis|No longer available||N/A|||British Columbia Cancer Agency|||||f||||||||||||||2017-10-11 02:07:27.706933|2017-10-11 02:07:27.706933
NCT01764178|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2017-03-08|||January 22, 2013|Actual|2013-01-22|March 2017|2017-03-01|December 27, 2013|Actual|2013-12-27|March 15, 2013|Actual|2013-03-15||Interventional|||Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects|A Single Dose, Sequence-randomized, Open-label, 2x2 Crossover Study to Compare Pharmacokinetics Between Pitavastatn and Valsartan Co-administration and Livalo Complex Product in Healthy Male Subjects|Completed||Phase 1|52|Actual|JW Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:07:27.796409|2017-10-11 02:07:27.796409
NCT01764165|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-16|2016-10-04|||August 2012||2012-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Pathogenesis and Outcomes of Sleep Disordered Breathing in Chronic Obstructive Pulmonary Disease (COPD)|Pathogenesis and Outcomes of Sleep Disordered Breathing in COPD|Completed||N/A|52|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:07:27.923907|2017-10-11 02:07:27.923907
NCT01764152|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-01-07|||December 2012||2012-12-01|December 2012|2012-12-01|May 2013|Anticipated|2013-05-01|April 2013|Anticipated|2013-04-01||Interventional|FLUVAC EV-02||Clinical Trial to Assess the Influenza Vaccination (FLUVAC 02)|Efficiency in Population of Influenza Vaccination for Seasonal 2012-2013 for Flu Prevention of the Hospitalized Adults: an Observational Study|Unknown status|Recruiting|N/A|500|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 02:07:28.036526|2017-10-11 02:07:28.036526
NCT01764139|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-03-15|||March 2013||2013-03-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Vitamin D Levels In Patients Who Has Normal to Grade 2 Knee Arthroscopy Changes|Vitamin D Levels In Patients Who Has Normal to Grade 2 Knee Arthroscopy Changes or Who Did Not Improve Symptoms Following Minor Knee Arthroscopic Procedures|Terminated||N/A|2|Actual|Mid Essex Hospital NHS Trust|||1|Lack of patients with recruitment criteria|f||||t||||||||||2017-10-11 02:07:28.171925|2017-10-11 02:07:28.171925
NCT01764126|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-07-09|||September 2011||2011-09-01|January 2013|2013-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PPR02||Pneumococcal Protein Vaccine Safety and Immunogenicity Trial|Safety and Immunogenicity of Pneumococcal Protein Vaccine (PPrV) in Healthy Adults, Toddlers and Infants in Bangladesh|Completed||Phase 1|280|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-11 02:07:28.272412|2017-10-11 02:07:28.272412
NCT01764113|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-01-21|||December 2012||2012-12-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Mindful Eating on Body Mass Index in Obese Adolescents|Effect of Mindful Eating on Body Mass Index and Cardiovascular Risk Markers in Obese Adolescents: A Pilot Randomized Clinical Trial|Completed||Phase 3|21|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:07:28.404576|2017-10-11 02:07:28.404576
NCT01764100|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-05|2013-01-07|||September 2009||2009-09-01|January 2013|2013-01-01|September 2013|Anticipated|2013-09-01|May 2013|Anticipated|2013-05-01||Interventional|MSC-GvHD||Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD)|Mesenchymal Stromal Cells (MSC) for the Treatment of Severe (Grade II-IV) Steroid-resistant Graft Versus Host Disease (GVHD): a Phase I Trial|Unknown status|Recruiting|Phase 1|10|Anticipated|Azienda Ospedaliera San Gerardo di Monza||1|||f||||f||||||||||2017-10-11 02:07:28.508779|2017-10-11 02:07:28.508779
NCT01764074|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-03-15|||January 2013||2013-01-01|March 2016|2016-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Brief Sleep Intervention for Bipolar Disorder|Brief Sleep Intervention for Suicide in Bipolar Disorder|Active, not recruiting||N/A|60|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:07:28.801214|2017-10-11 02:07:28.801214
NCT01764061|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-10-09|||January 2013||2013-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Clinical Investigational Protocol for 2 RBC Single Unit Recovery on MCS®+ 8150 Using LN832 Disposable Sets (US)|Clinical Investigational Protocol for 2 RBC Single Unit Recovery on MCS®+ 8150 Using LN832 Disposable Sets (US)|Completed||N/A|60|Actual|Haemonetics Corporation|||1||f||||f||||||||||2017-10-11 02:07:28.923896|2017-10-11 02:07:28.923896
NCT01764048|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-01-07|||November 2012||2012-11-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||To Compare the Efficacy and Patient's Satisfaction From Pain Management of Women After Cesarean Section by Pain Relievers' Administration in Fix Protocol Compared to Protocol Following Demand||Completed||N/A|214|Actual|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-11 02:07:29.010344|2017-10-11 02:07:29.010344
NCT01764035|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-06-22|||February 2013||2013-02-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder|The Effects of Mindfulness on Disrupted Sleep in Bipolar Disorder|Completed||N/A|48|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:07:29.108129|2017-10-11 02:07:29.108129
NCT01764022|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-10-24|2016-03-30||October 2012||2012-10-01|August 2016|2016-08-01|October 2016|Actual|2016-10-01|March 2015|Actual|2015-03-01||Interventional||Data obtained in population for efficacy analisys are reported.|A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2-Positive Metastatic Breast Cancer Patients|International Multicenter Randomized Double Blind Phase III Clinical Trial Comparing Safety and Efficacy of BCD-022 (CJSC BIOCAD, Russia) Used With Paclitaxel to Herceptin® (F. Hoffmann-La Roche Ltd, Switzerland) Used With Paclitaxel in the First-line Treatment of HER2-positive Metastatic Breast Cancer Patients|Completed||Phase 3|126|Actual|Biocad||2|||f||||f||||||||||2017-10-11 02:07:29.240063|2017-10-11 02:07:29.240063
NCT01764009|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-09-10|||June 2012||2012-06-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|AIMM||Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma|Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma: an Open-label Phase I/II Clinical Trial - The AIMM Study (AMEP In Metastatic Melanoma)|Withdrawn||Phase 1/Phase 2|0|Actual|Onxeo||1||Study stopped due to low enrolment rate.|f||||t||||||||||2017-10-11 02:07:30.402789|2017-10-11 02:07:30.402789
NCT01763996|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-03-10|2016-03-10||May 2013||2013-05-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional||All participants|The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina|The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Subjects With Chronic Stable Angina: A Phase 4 Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study|Completed||Phase 4|30|Actual|Takeda||2|||f||||f||||||||||2017-10-11 02:07:30.521742|2017-10-11 02:07:30.521742
NCT01763983|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2016-10-14|||January 2013||2013-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Effects of Cognitive Behavioural Therapy and Exercise on Stress and Cognitive Deficits in Multiple Sclerosis|A Randomized Controlled Trial Testing the Additive Benefits of CBT and Exercise For Psychological Stress and Cognitive Dysfunction in MS|Completed||N/A|173|Actual|Sunnybrook Health Sciences Centre||3|||f||||t||||||||||2017-10-11 02:07:31.078407|2017-10-11 02:07:31.078407
NCT01763970|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-05-27|||November 2013||2013-11-01|May 2015|2015-05-01||||November 2017|Anticipated|2017-11-01||Interventional|||Stereotactic Radiation Therapy for Pediatric Sarcomas|A Phase II Study of Hyperfractionated Stereotactic Radiotherapy in the Treatment of Metastatic Pediatric Sarcomas of Bony Sites|Recruiting||Phase 2|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:07:31.318249|2017-10-11 02:07:31.318249
NCT01763957|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2013-10-10|||March 2013||2013-03-01|December 2012|2012-12-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Paula Method Compared to Pelvic Floor Muscle Training (PFMT), for Urinary Stress Incontinence|The Effectiveness of Circular Muscle Exercise (the Paula Method) as Compared to Pelvic Floor Muscle Training (PFMT), for Urinary Stress Incontinence (SUI) in Menopausal Women: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 02:07:31.554769|2017-10-11 02:07:31.554769
NCT01763944|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-08-21|||January 2013||2013-01-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|CAPS2||Carbohydrate Restriction and Prostate Cancer Growth|A Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men With A Rising PSA After Failed Primary Therapy for Prostate Cancer|Recruiting||N/A|60|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 02:07:31.690939|2017-10-11 02:07:31.690939
NCT01763931|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-09-12|||January 2013||2013-01-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||DIG-HIF1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer|Digoxin as a Novel Inhibitor of Global Hypoxia Inducible Factor-1α (HIF-1α) Expression & Downstream Targets in Breast Cancer: DIG-HIF1 Pharmacodynamic Trial|Active, not recruiting||Phase 2|64|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 02:07:31.858096|2017-10-11 02:07:31.858096
NCT01763918|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-02-07|2015-09-02|2014-05-02|February 2013||2013-02-01|February 2017|2017-02-01||||November 2013|Actual|2013-11-01||Interventional|RUTHERFORD-2||Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Subjects With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|331|Actual|Amgen||4|||f||||t||||||||||2017-10-11 02:07:32.016394|2017-10-11 02:07:32.016394
NCT01763905|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-11-18|2015-09-02|2014-05-02|January 2013||2013-01-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|GAUSS-2||Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2|A Double-blind, Randomized, Multicenter Study to Evaluate Safety and Efficacy of AMG 145, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor|Completed||Phase 3|307|Actual|Amgen||4|||f||||t||||||||||2017-10-11 02:07:35.148037|2017-10-11 02:07:35.148037
NCT01763892|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-10-19|||December 2012||2012-12-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Physiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)|Physiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)|Completed||N/A|60|Actual|Duke University|||1||f||||f||||||Samples With DNA|"     Apolipoprotein E (apo-E) genotype/SNPs Endothelin 1 genotype/SNPs   "|||2017-10-11 02:07:37.697573|2017-10-11 02:07:37.697573
NCT01763879|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2013-07-24|||April 2012||2012-04-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Pressure-controlled vs Volume Controlled Ventilation on RV Function During OLV|Right Ventricular Function During One-lung Ventilation: The Effects of Pressure Controlled and Volume Controlled Ventilation|Completed||Phase 3|28|Actual|Dammam University||2|||f||||t||||||||||2017-10-11 02:07:39.803261|2017-10-11 02:07:39.803261
NCT01763866|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-11-18|2015-09-01|2014-05-02|January 2013||2013-01-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|LAPLACE-2||LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2|A Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia|Completed||Phase 3|2067|Actual|Amgen||24|||f||||t||||||||||2017-10-11 02:07:40.484486|2017-10-11 02:07:40.484486
NCT01763853|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-07-28|||December 2012||2012-12-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|IROCA||Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)|Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)|Recruiting||Phase 4|70|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:07:53.027814|2017-10-11 02:07:53.027814
NCT01763840|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-01-30|||April 2013||2013-04-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Contrast Enhanced Ultrasound for Evaluation of Pediatric Abdominal Trauma|Contrast Enhanced Ultrasound for Evaluation of Pediatric Abdominal Trauma|Completed||Phase 1|18|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-11 02:07:53.127754|2017-10-11 02:07:53.127754
NCT01763827|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-11-25|2015-08-28|2014-05-06|January 2013||2013-01-01|November 2015|2015-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|MENDEL-2||Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2|A Double-blind, Randomized, Placebo and Ezetimibe-controlled, Multicenter Study to Evaluate Safety and Efficacy of Lipid Lowering Monotherapy With AMG 145 in Subjects With a 10-Year Framingham Risk Score of 10% or Less|Completed||Phase 3|615|Actual|Amgen||6|||f||||t||||||||||2017-10-11 02:07:53.252193|2017-10-11 02:07:53.252193
NCT01763814|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-09-13|||December 2011||2011-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Three Different Approaches for Ultrasound Guided Femoral Nerve Block for Patients Undergoing Total Knee Arthroplasty|A Randomized, Single Blind Study of the Efficacy and Safety of Three Different Approaches for Ultrasound Guided Femoral Nerve Block for Patients Undergoing Total Knee Arthroplasty|Active, not recruiting||N/A|120|Anticipated|Chicago Anesthesia Pain Specialists||3|||f||||||||||||||2017-10-11 02:07:55.924528|2017-10-11 02:07:55.924528
NCT01763801|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-07|||July 2011||2011-07-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Optimization of EKG Method for Long Term Central Venous Catheter Tip Placement|P-max or P-submax? This is the Question! A Prospective Randomized Search of the Most Reliable ECG Landmark for a Long Term Central Venous Catheter.|Completed||Phase 4|326|Actual|Campus Bio-Medico University||2|||f||||t||||||||||2017-10-11 02:07:56.30008|2017-10-11 02:07:56.30008
NCT01763788|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-07-05|||May 2013||2013-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)|An Open-Label, Multicenter, Phase 1b/2 Study to Evaluate Necitumumab in Combination With Gemcitabine and Cisplatin in the First-Line Treatment of Patients With Advanced (Stage IV) Squamous Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1/Phase 2|192|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:07:56.386822|2017-10-11 02:07:56.386822
NCT01763775|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-07|||October 2012||2012-10-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|BS-BT||Clinical Trial of Transtek Body Fat Analyzer (GBF-1251-B & Other 3 Models)|Verify the Functions and Efficiency of Transtek (Trade Mark) Body Fat Analyzer, GBF-1251-B, BF-1255-B, BF-1256-B, and GBF-1257-B|Completed||N/A|50|Actual|BTS International||2|||f||||f||||||||||2017-10-11 02:07:56.517065|2017-10-11 02:07:56.517065
NCT01763762|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2014-11-19|||January 2013||2013-01-01|September 2013|2013-09-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||A Comparison of Electrical Pudendal Nerve Stimulation and Pelvic Floor Muscle Training for Female Stress Incontinence|A Comparison of the Efficacy of Electrical Pudendal Nerve Stimulation to Pelvic Floor Muscle Training With Transvaginal Electrical Stimulation in Treating Female Stress Incontinence|Completed||N/A|42|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-11 02:07:56.606035|2017-10-11 02:07:56.606035
NCT01763749|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-02-28|||October 2012||2012-10-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin|Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin in Korean Patients With Coronary Artery Disease (a Single-center, Randomized, Open-label Clinical Trial)|Completed||Phase 4|91|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-11 02:07:56.69125|2017-10-11 02:07:56.69125
NCT01763736|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-10-20|||December 2012||2012-12-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MUSIC||Medical Use of Song In Critical Care (MUSIC)|Medical Use of Song In Critical Care (MUSIC)|Terminated||N/A|52|Actual|Brigham and Women's Hospital||1||slow enrollment|f||||f||||||||||2017-10-11 02:07:56.78057|2017-10-11 02:07:56.78057
NCT01763723|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-07-30|||April 2012||2012-04-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Pigment-Tan-Safety Study of a Light-based Home Device for Hair Removal in Adult Subjects||Completed||N/A|21|Actual|Bispebjerg Hospital||1|||f||||||||||||||2017-10-11 02:07:56.850179|2017-10-11 02:07:56.850179
NCT01763710|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-03-28|||December 2012||2012-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|neurabrax||Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer|Neurotoxicity Characterization Phase II Randomized Study of Nab-paclitaxel Versus Conventional Paclitaxel as First-line Therapy of Metastatic HER2-negative Breast Cancer.|Completed||Phase 2|60|Actual|Asociación Oncosur||4|||f||||f||||||||||2017-10-11 02:07:56.919261|2017-10-11 02:07:56.919261
NCT01763671|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2017-09-19|||May 2013||2013-05-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|December 2015|Actual|2015-12-01||Interventional|Ultimate||Paclitaxel-bevacizumab in Advanced Lung Cancer|Phase III Study Comparing the Efficacy of Paclitaxel-bevacizumab With Docetaxel in 2nd or 3rd Line of Treatment of Non Squamous Non Small Cells Lung Cancer|Completed||Phase 3|164|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||t||||||||||2017-10-11 02:07:57.384765|2017-10-11 02:07:57.384765
NCT01763658|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-08|||March 2013||2013-03-01|January 2013|2013-01-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|ITP||Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia|Evaluation of Oxidant Status in Patients With Immune Thrombocytopenia (ITP) and the Role of an Adjuvant Antioxidant Therapy|Unknown status|Not yet recruiting|Phase 2/Phase 3|100|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 02:07:57.612678|2017-10-11 02:07:57.612678
NCT01763645|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2016-08-31|2016-03-30||October 2012||2012-10-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional||Patients who received at least 1 dose of study drug.|A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer|International Multicenter Randomized Double Blind Phase III Trial Comparing Safety and Efficacy of BCD-021 (CJSC BIOCAD, Russia) and Paclitaxel + Carboplatin to Avastin® (F. Hoffmann-La Roche Ltd, Switzerland) and Paclitaxel + Carboplatin in Inoperable or Advanced Non-squamous Non-small-cell Lung Cancer (NSCLC) Patients|Active, not recruiting||Phase 3|138|Actual|Biocad||2|||f||||f||||||||||2017-10-11 02:07:57.748671|2017-10-11 02:07:57.748671
NCT01763632|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-10-25|||January 2013||2013-01-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants|Development of Transcutaneous Bilirubin Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants: a Multicenter Study in China|Completed||N/A|19601|Actual|Nanjing Medical University|||1||f||||t||||||||||2017-10-11 02:07:58.35184|2017-10-11 02:07:58.35184
NCT01763619|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-07-28|||February 2013||2013-02-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Freedom® Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease|Freedom® Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease|Active, not recruiting||N/A|50|Anticipated|AxioMed Spine Corporation||1|||f||||f||||||||||2017-10-11 02:07:58.49398|2017-10-11 02:07:58.49398
NCT01763606|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-10-03|||December 2012||2012-12-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Enoxaparin Versus Aspirin in Patients With Cancer and Stroke|A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke|Active, not recruiting||N/A|20|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:07:58.578385|2017-10-11 02:07:58.578385
NCT01763593|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2013-04-29|||March 2013||2013-03-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Observational|Aurosleek||Safety and Surgical Performance Study of Aurosleek Surgical Blades|A Prospective, Open Label, Observational Study To Evaluate The Safety And Surgical Performance Of Surgical Blade (Aurosleek) In Cataract Patients|Unknown status|Recruiting|N/A|35|Anticipated|Aurolab|||1||f||||f||||||||||2017-10-11 02:07:58.692013|2017-10-11 02:07:58.692013
NCT01763580|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-09-12|||July 16, 2012|Actual|2012-07-16|September 2017|2017-09-01|August 21, 2017|Actual|2017-08-21|May 2, 2017|Actual|2017-05-02||Interventional|T-OPTIMUM||A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome|Open-Label, Randomized, Comparative, Multi-Center Clinical Trial on the Therapeutic Effect of Tacrolimus (Prograf Cap.®) in Combination With Low-Dose Corticosteroid Compared With High-Dose Corticosteroid Alone in Patients With Minimal-Change Nephrotic Syndrome (MCNS)|Completed||Phase 4|144|Actual|Astellas Pharma Inc||2|||f||||f|f|f||||||||2017-10-11 02:07:58.781395|2017-10-11 02:07:58.781395
NCT01763567|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-05-05|2014-10-14||March 2012||2012-03-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Observational|MAHI||Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS)|A Multi-Phased, Multi-Center Study to Evaluate Safety and Device Performance of the Medtronic Hospital Glucose Management System (HGMS) in Critically Ill Adult Patients|Completed||N/A|19|Actual|Medtronic Diabetes|||1||f||||f||||||||||2017-10-11 02:07:58.896715|2017-10-11 02:07:58.896715
NCT01763554|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-03-14|||October 2012||2012-10-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and July 31, 2012|Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and July 31, 2012|Active, not recruiting||N/A|69|Anticipated|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 02:07:59.344915|2017-10-11 02:07:59.344915
NCT01763541|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-03-01|||June 2014||2014-06-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading|Gonadal Steroid Regulation of the Natriuretic Peptide System|Withdrawn||Early Phase 1|0|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:07:59.42186|2017-10-11 02:07:59.42186
NCT01763528|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-01-08|||January 2011||2011-01-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women|High Protein Diet , CRP and CVD Risk Factors|Completed||Phase 3|63|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:07:59.531398|2017-10-11 02:07:59.531398
NCT01763515|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-08|||October 2012||2012-10-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Interventional|||Laterally Wedged Insoles for Patients With Knee Osteoarthritis|The Effects of Laterally Wedged Insoles on Symptoms Reduction of Patients With Knee Osteoarthritis|Unknown status|Enrolling by invitation|Phase 2/Phase 3|120|Anticipated|Isfahan University of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:07:59.604314|2017-10-11 02:07:59.604314
NCT01763502|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-04|||August 2010||2010-08-01|January 2013|2013-01-01||||May 2012|Actual|2012-05-01||Interventional|||The Impact of Cash and Food Transfers Linked to Preschool Enrollment on Child Nutrition and Cognitive Outcomes|The Impact of Cash and Food Transfers Linked to Preschool Enrollment on Child Nutrition and Cognitive Outcomes|Completed||N/A|2561|Actual|International Food Policy Research Institute||3|||f||||||||||||||2017-10-11 02:07:59.679818|2017-10-11 02:07:59.679818
NCT01763489|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-01-21|||January 2015||2015-01-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|ASTA||ASSIST Tool and Surgical Randomized Controlled Trial Applicability|Impact of a Graphical Tool on the Reader's Interpretation of Surgical RCT Applicability In the Field of Digestive Cancer|Unknown status|Not yet recruiting|N/A|130|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:07:59.759069|2017-10-11 02:07:59.759069
NCT01763476|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-07-05|||January 2013||2013-01-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|ADCAT||Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions|Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions|Recruiting||N/A|80|Anticipated|Herz-Zentrums Bad Krozingen||2|||f||||t||||||||||2017-10-11 02:07:59.832241|2017-10-11 02:07:59.832241
NCT01763463|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-03-09|||July 2012||2012-07-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects|WEUSKOP6416: Evaluating Serious Pneumonia in Subjects With Chronic Obstructive Pulmonary Disease (COPD) to Inform Risk Minimization: A Retrospective Observational Study|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 02:07:59.926669|2017-10-11 02:07:59.926669
NCT01763450|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-28|||September 2012||2012-09-01|September 2012|2012-09-01|September 2014|Anticipated|2014-09-01|May 2013|Anticipated|2013-05-01||Interventional|||Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer|LIAONING CANCER HOSPITAL&INSTITUTE|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Liaoning Tumor Hospital & Institute||1|||f||||f||||||||||2017-10-11 02:08:00.020866|2017-10-11 02:08:00.020866
NCT01763437|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2017-01-10|||March 2014||2014-03-01|January 2017|2017-01-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|TET||Intralesional Tetracycline Injection in the Treatment of Chalazia|Intralesional Tetracycline Injection in the Treatment of Chalazia|Withdrawn||Early Phase 1|0|Actual|The Cleveland Clinic||2||Investigator left the institution|f||||f||||||||||2017-10-11 02:08:00.110302|2017-10-11 02:08:00.110302
NCT01763424|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-05|||July 2011||2011-07-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Nicotinamide in the Treatment of Psoriasis|Evaluation of Topical Nicotinamide in Combination With Calcipotriol Compared With Calcipotriol Alone for the Treatment of Mild to Moderate Psoriasis.|Completed||Phase 2/Phase 3|66|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:08:00.214155|2017-10-11 02:08:00.214155
NCT01763411|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2016-02-21|||January 2008||2008-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|February 2016|Anticipated|2016-02-01||Observational|ETDRS||Visual Performance of Pseudophakic Patient With Different Intraocular Lenses|Visual Performance of Pseudophakic Patient With Different Intraocular Lenses|Active, not recruiting||N/A|80|Actual|Hospital Oftalmologico de Brasilia|||6||f||||t||||||||||2017-10-11 02:08:01.011854|2017-10-11 02:08:01.011854
NCT01763398|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-10-30|||September 2011||2011-09-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study||Completed||N/A|500|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 02:08:01.1256|2017-10-11 02:08:01.1256
NCT01763385|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2014-12-22|||November 2012||2012-11-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|TRACTS||Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases|Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases: A Prospective Multicenter Trial(TRACTS)|Unknown status|Recruiting|Phase 2|210|Anticipated|Wu Jieping Medical Foundation||2|||f||||t||||||||||2017-10-11 02:08:01.20493|2017-10-11 02:08:01.20493
NCT01763372|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-08-12|||September 2012||2012-09-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Functional Implications of Arthroscopic Iliopsoas Release|Functional Implications of Arthroscopic Iliopsoas Release|Completed||N/A|36|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 02:08:01.355403|2017-10-11 02:08:01.355403
NCT01763359|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-02-24|||April 2012||2012-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Hip Strength and Nerve Palsy After the Modified Stoppa Approach to Acetabular Fracture Reduction and Fixation|Decreased Hip Adductor Strength and Obturator Nerve Palsy After the Modified Stoppa Approach to Acetabular Fracture Reduction and Fixation: Is Retraction to Blame?|Enrolling by invitation||N/A|60|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 02:08:01.429882|2017-10-11 02:08:01.429882
NCT01763346|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-08-26|||June 2013||2013-06-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|BetaFat||Beta Cell Restoration Through Fat Mitigation|Beta Cell Restoration Through Fat Mitigation|Active, not recruiting||N/A|88|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 02:08:01.51632|2017-10-11 02:08:01.51632
NCT01763333|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-07|2015-07-06|||January 2013||2013-01-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1026706 in Healthy Male Volunteers in a Partially Randomised, Single-blind, Placebo-controlled Trial, and Investigation of Relative Bioavailability of BI 1026706 (Open-label, Randomised, Four-way Cross-over)|Completed||Phase 1|80|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:08:01.639729|2017-10-11 02:08:01.639729
NCT01763320|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2016-12-25|||March 2014||2014-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|CASSISS||China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis|China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): a New, Prospective, Multi-center, Randomized Controlled Trial in China|Recruiting||Phase 3|380|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t||||||||||2017-10-11 02:08:01.766876|2017-10-11 02:08:01.766876
NCT01763307|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2013-01-07|||January 2013||2013-01-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Interventional|EGFRI||A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI|A Phase II Randomized, Double Blind, Placebo Study to Evaluate the Efficacy of Vitamin K1 Cream Treatment Compared to Placebo for the Prevention of Papulo-pustular Rash in Metastatic Colorectal Patients Receiving First Line EGFRI Treatment.|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 02:08:01.909662|2017-10-11 02:08:01.909662
NCT01763294|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-04-05|||February 2012||2012-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|December 2012|Actual|2012-12-01||Interventional|||A Controlled Clinical Trial of Cathodal Transcranial Direct Current Stimulation in Patients With Refractory Epilepsy|A Controlled Clinical Trial of Cathodal Transcranial Direct Current Stimulation in Patients With Refractory Epilepsy|Completed||Phase 2|28|Actual|El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez||5|||f||||t||||||||||2017-10-11 02:08:02.04322|2017-10-11 02:08:02.04322
NCT01763281|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-02-05|||October 2012||2012-10-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Imaging the Effect of Experimental Stress on Small and Large Bowel Water During Fructose Absorption|Imaging the Effect of Experimental Stress on Small and Large Bowel Water During Fructose Absorption|Completed||Phase 4|20|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-11 02:08:02.203313|2017-10-11 02:08:02.203313
NCT01763268|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-05|||September 2012||2012-09-01|January 2013|2013-01-01|August 2015|Anticipated|2015-08-01|January 2015|Anticipated|2015-01-01||Interventional|||Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants||Unknown status|Recruiting|Phase 2/Phase 3|200|Anticipated|Queen Sirikit National Institute of Child Health||1|||f||||||||||||||2017-10-11 02:08:02.333008|2017-10-11 02:08:02.333008
NCT01763255|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2014-04-24|||April 2012||2012-04-01|January 2011|2011-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Multiple Transplantation of Bone Marrow Derived CD133 Cell in Cerebral Palsy|The Safety of Multiple Intrathecal Injection of Bone Marrow Derived CD133 Cells in Patients With Cerebral Palsy|Completed||Phase 1/Phase 2|8|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 02:08:02.46292|2017-10-11 02:08:02.46292
NCT01763242|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-06|||December 2011||2011-12-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|EMAN-Anaemia||Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease|EMAN-Anaemia: An Open Labelled Randomised Control Trial of the Synchronized Electronic MANagement of Anaemia in Chronic Kidney Disease (CKD) Compared to Usual Care Anaemia Management|Completed||Phase 4|102|Actual|Western Health, Australia||2|||f||||f||||||||||2017-10-11 02:08:02.589882|2017-10-11 02:08:02.589882
NCT01763229|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2014-05-12|||January 2012||2012-01-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Practical Use of Transthoracic Echocardiography for Obtaining an Optimal Depth of Internal Jugular Venous Catheters in Infants||Completed||N/A|108|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 02:08:02.726793|2017-10-11 02:08:02.726793
NCT01763216|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-04-26|||February 2013||2013-02-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|November 2016|Actual|2016-11-01||Interventional|||Improving Mood in Assisted Living Settings|Improving Mood in Assisted Living Settings Using a Cognitive Training Intervention|Active, not recruiting||N/A|300|Anticipated|University of Iowa||2|||f||||f||||||||||2017-10-11 02:08:02.79964|2017-10-11 02:08:02.79964
NCT01763203|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-11-20|||September 2013||2013-09-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|SUCCEED||The SUCCEED Trial of Secondary Stroke Prevention|Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: the SUCCEED Trial|Enrolling by invitation||N/A|500|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:08:02.964346|2017-10-11 02:08:02.964346
NCT01763190|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-05-12|||November 2012||2012-11-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment|An Open-label Pharmacokinetic and Tolerability Study of SAR302503 Given as a Single 300 mg Dose in Subjects With Mild, Moderate and Severe Renal Impairment, and in Matched Subjects With Normal Renal Function|Completed||Phase 1|36|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:08:03.096166|2017-10-11 02:08:03.096166
NCT01763177|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-11-15|||January 2013||2013-01-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|POST||Use of Oxygen Nebulizer for Preventing Post-operative Sore Throat|Use of Oxygen Nebulizer for Preventing Post-operative Sore Throat|Completed||N/A|1036|Actual|Prince of Songkla University||2|||f||||t||||||||||2017-10-11 02:08:03.186007|2017-10-11 02:08:03.186007
NCT01763164|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-03-29||2016-09-30|July 2013||2013-07-01|March 2017|2017-03-01|March 1, 2018|Anticipated|2018-03-01|December 2015|Actual|2015-12-01||Interventional|||Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma|A Randomized Phase III, Open Label, Multicenter, Two-arm Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Patients With Advanced Unresectable or Metastatic NRAS Mutation-positive Melanoma|Active, not recruiting||Phase 3|402|Actual|Array BioPharma||2|||f||||t||||||||||2017-10-11 02:08:03.30073|2017-10-11 02:08:03.30073
NCT01763151|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-08|||September 2010||2010-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism|Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism|Completed||Phase 4|55|Actual|Vienna Institute for Research in Ocular Surgery||2|||f||||||||||||||2017-10-11 02:08:03.898364|2017-10-11 02:08:03.898364
NCT01763138|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-06|||June 2012||2012-06-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Educational Intervention in Mothers for Prevention of Caries in Their Children|Effect of Educational Intervention in Mothers for Prevention of Caries in Their Children, A Randomized Controlled Trial|Completed||N/A|126|Actual|University of the Punjab||3|||f||||t||||||||||2017-10-11 02:08:03.977452|2017-10-11 02:08:03.977452
NCT01763125|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-09-28|||November 2003||2003-11-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Tumor Bank for Blood Samples|Establishment of a Blood Sample Bank in the Field of Gynaecological Oncology.|Unknown status|Recruiting|N/A|10000|Anticipated|Medical University of Vienna|||3||f||||f||||||Samples With DNA|"     Universal tumor bank   "|||2017-10-11 02:08:04.060878|2017-10-11 02:08:04.060878
NCT01763112|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-03-30|||January 2013||2013-01-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|GALILEO-PAH||Training With Whole Body Vibration Device in Patients With PAH|Influence of Training With Whole Body Vibration Device (Galileo) on Quality of Life (QoL), Exercise Capacity, as Well as on the Effects of Muscle Power and Muscle Function in Patients With Pulmonal Arterial Hypertension (PAH). (GALILEO PAH)|Unknown status|Active, not recruiting|N/A|20|Actual|Klinikum der Universität Köln||2|||f||||f||||||||||2017-10-11 02:08:04.194088|2017-10-11 02:08:04.194088
NCT01763099|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-15|||January 2013||2013-01-01|January 2013|2013-01-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure|Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure Following Autologous Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|60|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 02:08:04.273334|2017-10-11 02:08:04.273334
NCT01763086|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-05|2013-01-15|||January 2013||2013-01-01|January 2013|2013-01-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant|Mesenchymal Stem Cells From Third-party Donors for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|60|Anticipated|Nanfang Hospital of Southern Medical University||1|||f||||t||||||||||2017-10-11 02:08:04.385284|2017-10-11 02:08:04.385284
NCT01763073|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-01-31|||January 2013||2013-01-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|March 2014|Actual|2014-03-01||Observational|||Beliefs and Practice Intentions of Future Ob/Gyn Residents Regarding Reproductive Healthcare|Beliefs and Practice Intentions of Future Ob/Gyn Residents Regarding Reproductive Healthcare|Active, not recruiting||N/A|80|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||||2017-10-11 02:08:04.473368|2017-10-11 02:08:04.473368
NCT01763060|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-11-20|||October 2012||2012-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Long Term Follow up of Patients Who Were Treated With Extracorporeal Membrane Oxygenation for Pandemic Influenza A/H1N1 Induced Severe Respiratory Failure||Completed||N/A|7|Actual|Karolinska University Hospital|||1||f||||f||||||||||2017-10-11 02:08:04.526864|2017-10-11 02:08:04.526864
NCT01763047|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-05-03|2016-03-01||November 2012||2012-11-01|May 2016|2016-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||All randomized subjects that were dispensed at least one study lens.|Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population||Completed||N/A|298|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 02:08:04.619323|2017-10-11 02:08:04.619323
NCT01763034|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2013-04-22|||February 2013||2013-02-01|April 2013|2013-04-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Limb Ischemic Preconditioning for Prevention of Contrast Media Induced Nephropathy in Diabetic Kidney Patient|Limb Ischemic Preconditioning for Prevention of Contrast Media Induced Nephropathy in Diabetic Kidney Patient|Unknown status|Recruiting|N/A|200|Anticipated|Ramathibodi Hospital||1|||f||||t||||||||||2017-10-11 02:08:05.310564|2017-10-11 02:08:05.310564
NCT01763021|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-04-16|||December 2012||2012-12-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy Participants|An Open-Label, Sequential Design Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy Subjects|Completed||Phase 1|18|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 02:08:05.406195|2017-10-11 02:08:05.406195
NCT01763008|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-08-06|||November 2009||2009-11-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections|A Post-Marketing Surveillance Study on the Safety and Effectiveness of Doripenem Among Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections|Completed||Phase 4|170|Actual|Janssen Pharmaceutica|||1||f||||f||||||||||2017-10-11 02:08:05.528817|2017-10-11 02:08:05.528817
NCT01762995|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-04-18|||December 2012||2012-12-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects|A Phase I, Open Label, Randomized, Four-Period Crossover Study to Evaluate the Effects of Calcium Carbonate 1200 mg and Ferrous Fumarate 324 mg on Pharmacokinetics of Dolutegravir 50 mg in Healthy Adult Subjects|Completed||Phase 1|24|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 02:08:05.665542|2017-10-11 02:08:05.665542
NCT01762982|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-12-05|2013-07-25||February 2012||2012-02-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Patch Test of Benzalkonium Chloride Disinfectant Spray|A Single Centre, Examiner-blind Human Patch Test of Bactroban Disinfectant Liquid on Normal Skin|Completed||N/A|36|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:08:05.807916|2017-10-11 02:08:05.807916
NCT01762969|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-07|||January 2013||2013-01-01|January 2013|2013-01-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Treatment Modification Based on Early Assessment of CML Patients|Modification of Imatinib to Other Tyrosine Kinase Inhibitors Dependent on 3-months Molecular Response of CML Patients|Recruiting||Phase 2|300|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 02:08:06.345178|2017-10-11 02:08:06.345178
NCT01762956|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-01-26|||July 2015||2015-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled Trial|Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled Trial|Terminated||N/A|25|Actual|University of Sao Paulo||2||Unobtainable sample size|f||||f||||||||||2017-10-11 02:08:06.432442|2017-10-11 02:08:06.432442
NCT00000155|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||June 1995||1995-06-01|November 2001|2001-11-01||||||||Observational|||The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study||Unknown status|Active, not recruiting|N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.96513|2017-10-11 04:17:33.96513
NCT01762917|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-01-07|||September 2007||2007-09-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing|Influence of Bag Volume Variation in Inert Gas Rebreathing Pulmonary Blood Flow Measurements on the Reproducibility in Patients With Pulmonary Diseases|Completed||N/A|45|Actual|Universitätsmedizin Mannheim|||3||f||||f||||||||||2017-10-11 02:08:06.684229|2017-10-11 02:08:06.684229
NCT01762904|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-06-01|2014-06-01||January 2013||2013-01-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional|||Residual Effect of Chlorhexidine-alcohol Compared to Triclosan-alcohol|Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70% Compared to Triclosan 1% / Isopropyl Alcohol 70%|Completed||Phase 3|135|Actual|Universidad de Guanajuato||1|||f||||f||||||||||2017-10-11 02:08:06.746827|2017-10-11 02:08:06.746827
NCT01762891|ClinicalTrials.gov processed this data on October 10, 2017|2009-09-24|2013-01-06|||March 2003||2003-03-01|January 2013|2013-01-01|September 2009|Actual|2009-09-01|July 2006|Actual|2006-07-01||Interventional|CI(R)CA||CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen|CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen. A Prospective Double-blind, Placebo Controlled Study.|Completed||N/A|22|Actual|Hospital Universitario Pedro Ernesto||1|||f||||f||||||||||2017-10-11 02:08:06.977301|2017-10-11 02:08:06.977301
NCT01762878|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-07-10|||January 9, 2013|Actual|2013-01-09|July 2017|2017-07-01|October 21, 2013|Actual|2013-10-21|October 21, 2013|Actual|2013-10-21||Interventional|||A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects|A Single-Centre, Double-Blind, Placebo Controlled Two Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2269557 as a Dry Powder in Healthy Subjects Who Smoke Cigarettes|Completed||Phase 1|45|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 02:08:07.252793|2017-10-11 02:08:07.252793
NCT01762865|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-06|2013-01-07|||April 2012||2012-04-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Observational|||Acute Bronchitis in Korea:Associated Microorganisms and Clnincal Findings.|Acute Bronchitis in Korea:Associated Microorganisms and Clnincal Findings.|Unknown status|Recruiting|N/A|300|Anticipated|Hallym University Medical Center|||1||f||||||||||Samples Without DNA|"     Sputum specimens for microbiologic tests   "|||2017-10-11 02:08:07.356043|2017-10-11 02:08:07.356043
NCT01762852|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-03-21|||April 2013||2013-04-01|March 2017|2017-03-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy|BEL114674: A 2 Year Study of Efficacy and Safety of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||2||"Withdrawn due to difficulties in to recruiting due to competing studies, changing treatment   practices, unavailability of eligible study population"|f||||t||||||||||2017-10-11 02:08:07.449581|2017-10-11 02:08:07.449581
NCT01762826|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2013-01-04|||September 2012||2012-09-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|April 2013|Anticipated|2013-04-01||Observational|||Myo-inositol, D-chiro-inositol, and D-chiro/Myo-inositol in Gestational Diabetes|Adverse Obstetric Outcomes in Gestational Diabetes Mellitus and Inositol Stereoisomears|Unknown status|Enrolling by invitation|N/A|120|Actual|G. d'Annunzio University|||4||f||||f||||||||||2017-10-11 02:08:07.781508|2017-10-11 02:08:07.781508
NCT01762813|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-03-30|||August 2012||2012-08-01|March 2017|2017-03-01|December 2027|Anticipated|2027-12-01|December 2027|Anticipated|2027-12-01||Observational|ACROBATICC||Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer|Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer|Recruiting||N/A|850|Anticipated|Helse Stavanger HF|||1||f||||f||||||Samples With DNA|"     Blood, whole blood, plasma, cancer tissue, normal tissue   "|Undecided|Raw data may be provided given appropriate consent and approval for anonymous database sharing|2017-10-11 02:08:07.914629|2017-10-11 02:08:07.914629
NCT01762800|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-09-23|2016-05-02||February 2013||2013-02-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||406 participants were randomized into the study, however 405 participant received study mediciation and comprised the modified Intent to Treat (mITT) Population.|Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg|Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg|Completed||Phase 4|407|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:08:08.082358|2017-10-11 02:08:08.082358
NCT01762787|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-27|||August 17, 2010|Actual|2010-08-17|June 2017|2017-06-01|January 14, 2011|Actual|2011-01-14|January 14, 2011|Actual|2011-01-14||Interventional|||Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers|A Randomised, Single Blind, Placebo-Controlled, Cross-over, Phase 1 Methodology Study to Validate the Cantharidin Blister Model in Healthy Male Volunteers|Completed||Phase 1|40|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 02:08:12.514342|2017-10-11 02:08:12.514342
NCT01762774|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-05-05|||January 16, 2013|Actual|2013-01-16|May 2017|2017-05-01|May 1, 2014|Actual|2014-05-01|May 1, 2014|Actual|2014-05-01||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers|A Single-centre, Randomised, Double-blind, Placebo-controlled, Escalating Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers|Completed||Phase 1|56|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:08:12.630903|2017-10-11 02:08:12.630903
NCT01657708|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-02|||August 2012||2012-08-01|August 2012|2012-08-01||||August 2014|Anticipated|2014-08-01||Interventional|||Implementation of Shared Decision Making Model in Psychiatric Rehabilitation Setting||Unknown status|Not yet recruiting|N/A|140|Anticipated|Shalvata Mental Health Center||1|||f||||||||||||||2017-10-11 02:39:49.617697|2017-10-11 02:39:49.617697
NCT01762761|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-06-27|2015-01-19||February 18, 2013|Actual|2013-02-18|June 2017|2017-06-01|January 31, 2018|Anticipated|2018-01-31|June 5, 2014|Actual|2014-06-05||Interventional|||Eltrombopag Phase III Study In Chinese Chronic ITP Patients|A Multicenter, Randomized, Double-Blind and Open-label Phase III Study To Compare The Efficacy And Safety Of Eltrombopag With Placebo In Chinese Chronic ITP Patients|Active, not recruiting||Phase 3|155|Actual|Novartis||2|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 02:08:12.916463|2017-10-11 02:08:12.916463
NCT01762748|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-08|||January 2011||2011-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant|Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant|Completed||Phase 2|18|Actual|Federal University of Minas Gerais||1|||f||||f||||||||||2017-10-11 02:08:14.658538|2017-10-11 02:08:14.658538
NCT01762735|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-02-10|||February 2013||2013-02-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Water Injection Colonoscopy vs Air Insufflation Colonoscopy in Training the Beginners|Water Injection Colonoscopy vs Air Insufflation Colonoscopy in Training the Beginners|Unknown status|Recruiting|N/A|300|Anticipated|First Affiliated Hospital of Harbin Medical University||2|||f||||t||||||||||2017-10-11 02:08:14.770284|2017-10-11 02:08:14.770284
NCT01762722|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2013-03-06|2013-03-06||September 2009||2009-09-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|June 2010|Actual|2010-06-01||Interventional|Nonin4||Nonin 4 Wavelength Cerebral Oximeter Study|Calibration and Validation of the 4 Wavelength Nonin Non-invasive Cerebral Oxygen Saturation Oximeter and Cerebral Sensor|Completed||N/A|23|Actual|Duke University||1|||f||||f||||||||||2017-10-11 02:08:14.879753|2017-10-11 02:08:14.879753
NCT01762709|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2013-07-24|||April 2012||2012-04-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Low Tidal Volume and EVLWI During OLV|Effects of Different Tidal Volumes on Extravascular Lung Water Content During One-lung Ventilation for Video-assisted Thoracoscopic Surgery: Dammam University Experience|Completed||Phase 1|39|Actual|Dammam University||3|||f||||t||||||||||2017-10-11 02:08:15.166604|2017-10-11 02:08:15.166604
NCT01762696|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-12-09|||May 2013||2013-05-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|MOMENT||A Real-time, Contextual Intervention Using Mobile Technology to Reduce Marijuana Use in Youth|A Real-time, Contextual Intervention Using PDAs to Reduce Marijuana Use in Youth|Completed||N/A|70|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 02:08:15.354144|2017-10-11 02:08:15.354144
NCT01762683|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-01-07|||April 2012||2012-04-01|January 2013|2013-01-01||||November 2013|Anticipated|2013-11-01||Interventional|ObeDi||Influence of Preconceptional Obesity on the Myometrial Cells Differentiation Toward a Contractyl Phenotype|Study of Role of Mononuclear Cells of Maternal Peripheric Blood in Human Myometrial Primar Cell Lines Differentiation Toward a Contratyl Phenotype: Influence of Preconceptional Obesity|Unknown status|Recruiting|N/A|40|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||f||||||||||2017-10-11 02:08:15.448256|2017-10-11 02:08:15.448256
NCT01762670|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-02-02|||February 2013||2013-02-01|July 2013|2013-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||GoldenCareTM for the Treatment of Bacterial Vaginosis|An Open-Label, Randomized Study to Determine the Safety and Efficacy of GoldenCareTM for the Treatment of Bacterial Vaginosis|Terminated||Phase 1/Phase 2|8|Actual|CDA Research Group, Inc.||2||Company decided to stop study for reasons other than safety|f||||f||||||||||2017-10-11 02:08:15.533672|2017-10-11 02:08:15.533672
NCT01762657|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-04-17|||September 2014||2014-09-01|April 2016|2016-04-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|IIT||The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes|A Phase 3, Randomized, Double-Blind, Multinational, Placebo-Controlled Study to Evaluate the Safety and Efficacy in Diminishing Insulin Requirements Utilizing Oral Cyclosporine With Oral Lansoprazole in Children and Adults With Existing Type 1 Diabetes Mellitus|Withdrawn||Phase 3|0|Actual|Perle Bioscience, Inc.||2||Study stopped prior to Patient Enrollment|f||||f||||||||||2017-10-11 02:08:15.634898|2017-10-11 02:08:15.634898
NCT01762644|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-04-15|||August 2015||2015-08-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|IIT||The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients|A Phase IIB/III Multicenter Randomized Trial to Evaluate the Combination of Low-Dose Cyclosporine and Omeprazole Versus Omeprazole Alone in Participants With New Onset Type 1 Diabetes.|Withdrawn||Phase 3|0|Actual|Perle Bioscience, Inc.||2||This study was withdrawn prior to enrollment.|f||||f||||||||||2017-10-11 02:08:15.730569|2017-10-11 02:08:15.730569
NCT01762618|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-07-08|||January 2012||2012-01-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|EMOCUIDA||Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients|Experimental Study of the Impact of a Structured Psychological Intervention Based on Group Therapy for Caregivers of Alzheimer's Patients.|Completed||N/A|83|Actual|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation||2|||f||||f||||||||||2017-10-11 02:08:15.912281|2017-10-11 02:08:15.912281
NCT01762605|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-03-13|||March 2010||2010-03-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Treatment of Distal Radius Buckle Fractures||Terminated||N/A|11|Actual|Wake Forest University Health Sciences||2||inadequate enrollment|f||||f||||||||||2017-10-11 02:08:16.00573|2017-10-11 02:08:16.00573
NCT01762007|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-01-03|||November 2012||2012-11-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||The Change of the Detrusor Thickness After Hypospadias Repair - Comparison With the Normal Control Group||Unknown status|Recruiting|N/A|56|Anticipated|Yonsei University|||4||f||||f||||||||||2017-10-11 02:08:23.849423|2017-10-11 02:08:23.849423
NCT01762592|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-12-14|||June 2017||2017-06-01|December 2015|2015-12-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|||REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT|A Study of Iodine (124I) Girentuximab PET/CT Scan for the Detection of Clear Cell Renal Cell Carcinoma in Patients With Indeterminate cT1 Renal Masses|Not yet recruiting||Phase 3|350|Anticipated|Wilex||1|||f||||f||||||||||2017-10-11 02:08:16.086114|2017-10-11 02:08:16.086114
NCT01762579|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-03-30|||January 2012|Actual|2012-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Bio-markers of Not-celiac Wheat Sensitivity|Not-celiac Wheat Sensitivity (NCWS) in Patients With Irritable Bowel Syndrome. Randomized Double-Blind Placebo-Controlled Trial (Wheat vs Placebo) for Bio-markers Identification of NCWS and Understanding Its Pathogenetic Mechanisms.|Recruiting||N/A|40|Anticipated|University of Palermo||2|||f||||t||||||||No||2017-10-11 02:08:16.211507|2017-10-11 02:08:16.211507
NCT01762566|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2014-09-14|||January 2012||2012-01-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Bioelectrical Impedance Analysis of Not-celiac Wheat Sensitivity Patients|Randomized Double-Blind Placebo-Controlled Trial (Wheat vs Placebo) in Wheat Sensitive Patients for Evaluation of Bio-Markers of a Single Referred Symptom (Bloating & Swelling)|Completed||N/A|30|Actual|University of Palermo||2|||f||||t||||||||||2017-10-11 02:08:16.353351|2017-10-11 02:08:16.353351
NCT01762553|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-02-16|||May 2011||2011-05-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||TEA for Families and Children: A Randomized Intervention Trial|TEA (Together for Empowerment Activities)for Families and Children: A Randomized Intervention Trial|Completed||N/A|1533|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:08:16.47901|2017-10-11 02:08:16.47901
NCT01762540|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-01-07|||January 2013||2013-01-01|January 2013|2013-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Glucocorticoid Induced Whole Body Catabolisme|Glucocorticoid Induced Inhibition of IGF-I Activity: Exploring Underlying Mechanisms.|Completed||Phase 2|19|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 02:08:16.578656|2017-10-11 02:08:16.578656
NCT01762527|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-05-20|||October 2012||2012-10-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|October 2016|Anticipated|2016-10-01||Interventional|plan selection||Adaptive Radiotherapy Using Plan Selection for Bladder Cancer|Adaptive Radiotherapy Using Plan Selection for Bladder Cancer: A Phase II Trial|Active, not recruiting||Phase 2|65|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-10-11 02:08:16.702728|2017-10-11 02:08:16.702728
NCT01762514|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2017-07-11|||January 2013||2013-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens|A Multi-institutional, Randomized Parallel Controlled, Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Amifostine Every-other-day Regimen and Everyday Regimen From Monday to Friday|Recruiting||Phase 2|360|Anticipated|Sun Yat-sen University||6|||f||||t||||||||||2017-10-11 02:08:16.82935|2017-10-11 02:08:16.82935
NCT01762501|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-11-19|2015-11-19||December 2012||2012-12-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Azilsartan Circadian and Sleep Pressure|Azilsartan Circadian and Sleep Pressure - the 1st Study|Completed||N/A|957|Actual|Sogo Rinsho Médéfi Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:08:17.01645|2017-10-11 02:08:17.01645
NCT01762488|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-05-20|||January 2013||2013-01-01|May 2016|2016-05-01||||February 2016|Actual|2016-02-01||Interventional|ReSET-2||Renal Denervation in Treatment Resistant Hypertension|Renal Denervation in Treatment Resistant Hypertension, a Double-blind Randomized Controlled Trial|Terminated||Phase 3|8|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 02:08:17.692289|2017-10-11 02:08:17.692289
NCT01762475|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-12-30|||January 2013||2013-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury.|Sildenafil for the Treatment of Cerebrovascular Dysfunction During the Chronic Stage After Traumatic Brain Injury.|Completed||Phase 2|59|Actual|Uniformed Services University of the Health Sciences||3|||f||||f||||||||||2017-10-11 02:08:17.792978|2017-10-11 02:08:17.792978
NCT01762462|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-08-28|||December 2012||2012-12-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment|An Open-label, Pharmacokinetic and Tolerability Study of SAR302503 Given as a Single 300 mg Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function|Completed||Phase 1|17|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:08:17.907042|2017-10-11 02:08:17.907042
NCT01762449|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2014-01-22|||July 2012||2012-07-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Observational|||Morbidity and Mortality Follow Up for the Scleroderma Lung Study|Morbidity and Mortality Follow Up of Participants of the Scleroderma Lung Study 1|Completed||N/A|158|Actual|Duke University|||2||f||||f||||||||||2017-10-11 02:08:18.001354|2017-10-11 02:08:18.001354
NCT01762436|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-01-07|||November 2010||2010-11-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Bisoprolol and Atenolol on Sympathetic Nervous Activity and Central Aortic Pressure in Patients With Essential Hypertension|A Randomized Controlled Study: Effects of Bisoprolol and Atenolol on Sympathetic Nervous Activity and Central Aortic Pressure in Patients With Essential Hypertension|Completed||Phase 4|109|Actual|Ruijin Hospital||2|||f||||f||||||||||2017-10-11 02:08:18.29199|2017-10-11 02:08:18.29199
NCT01762423|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-02-19|||December 2012||2012-12-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|PEMF||PEMF Effects on Pain After Abdominal Body Contouring|PEMF Effects on Pain After Abdominal Body Contouring|Withdrawn||Phase 4|0|Actual|University of Pittsburgh||2||Funding issues.|f||||t||||||||||2017-10-11 02:08:18.396689|2017-10-11 02:08:18.396689
NCT01762410|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-09-26|||September 2012||2012-09-01|September 2014|2014-09-01|March 2016|Anticipated|2016-03-01|November 2015|Anticipated|2015-11-01||Interventional|||Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors|An Open Label Multicentric Phase 1 Study of Oral PI3K/mTOR Inhibitor P7170 in Patients With Advanced Refractory Solid Tumors.|Suspended||Phase 1|60|Anticipated|Piramal Enterprises Limited||1||Sponsor decision not related to patient safety|f||||f||||||||||2017-10-11 02:08:18.502507|2017-10-11 02:08:18.502507
NCT01629225|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-11-17|||July 2013||2013-07-01|June 2013|2013-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||GRK4 Polymorphisms Blood Pressure Response to Candesartan||Unknown status|Recruiting|Phase 4|500|Anticipated|Third Military Medical University||1|||f||||t||||||||||2017-10-11 02:48:18.959907|2017-10-11 02:48:18.959907
NCT01762397|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-05-29|||December 2012||2012-12-01|May 2014|2014-05-01||||May 2013|Actual|2013-05-01||Interventional|||A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers|A Randomized, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers|Completed||Phase 1|37|Anticipated|PharmaKing||1|||f||||||||||||||2017-10-11 02:08:18.596934|2017-10-11 02:08:18.596934
NCT01762384|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2013-01-04|||December 2012||2012-12-01|December 2012|2012-12-01|December 2017|Anticipated|2017-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Laparoscopic Sacral Colpopexy Versus Modified Total Pelvic Floor Reconstructive Surgery for Apical Prolapse Stage III-IV|Nationwide Multicenter Randomized Prospective Study to Compare Laparoscopic Sacral Colpopexy and Modified Total Pelvic Floor Reconstructive Surgery With Mesh for Apical Prolapse Stage III-IV|Recruiting||N/A|100|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 02:08:18.684122|2017-10-11 02:08:18.684122
NCT01762371|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2015-05-04|||December 2012||2012-12-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|January 2013|Actual|2013-01-01||Interventional|||Khalifa Acute Effects|Interdisciplinary Evaluation of Acute Effects From Khalifa's Therapy at Patients With Fully Ruptured Anterior Cruciate Ligament (ACL).|Completed||N/A|10|Anticipated|Medical University of Graz||1|||f||||t||||||||||2017-10-11 02:08:18.823984|2017-10-11 02:08:18.823984
NCT01762358|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-01-04|||June 2005||2005-06-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Interventional|||Khalifa Effectiveness Study|Effectiveness of a Non-invasive Therapy for Treating Fully Ruptured Anterior Cruciate Ligaments in the Knee by Using MRI, Functional Tests and Scores: A Randomized Controlled Trial|Completed||N/A|30|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-11 02:08:18.909917|2017-10-11 02:08:18.909917
NCT01762345|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-02-23|2016-01-15||December 2012||2012-12-01|February 2016|2016-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence|A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence|Completed||N/A|148|Actual|Procter and Gamble||1|||f||||f||||||||||2017-10-11 02:08:19.018205|2017-10-11 02:08:19.018205
NCT01762332|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2017-08-29|||January 2013||2013-01-01|May 2015|2015-05-01|May 25, 2014|Actual|2014-05-25|May 2014|Actual|2014-05-01||Interventional|||Clinical Validation of Medasense Pain Response Index (PRI)|Validation of Medasense Non-invasive Nociception Monitor During Surgery and Postoperative Recovery.|Completed||N/A|78|Actual|Medasense Biometrics Ltd||3|||f||||t||||||||||2017-10-11 02:08:19.286776|2017-10-11 02:08:19.286776
NCT01762319|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-01-04|||November 2012||2012-11-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Cervical Ripening Before Endometrial Biopsy in Abnormal Uterine Bleeding Using Sublingual Misoprostol|Cervical Ripening Before Endometrial Biopsy in Abnormal Uterine Bleeding (AUB) Using Sublingual Misoprostol 200 Mcg: A Randomized, Double Blind, Placebo-controlled Trial|Unknown status|Recruiting|N/A|52|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 02:08:19.398459|2017-10-11 02:08:19.398459
NCT01762306|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-01-04|||November 2012||2012-11-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Efficacy of Diclofenac on Pain During Endometrial Sampling|Efficacy for Acute Pain Alleviation of 50 mg Diclofenac 1 Hour Prior to Endometrial Sampling in Cases of Abnormal Uterine Bleeding|Unknown status|Recruiting|N/A|90|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 02:08:19.508491|2017-10-11 02:08:19.508491
NCT01762293|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2013-01-04|||April 2012||2012-04-01|January 2013|2013-01-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Interventional|||A Study of Famitinib in Patients With Advanced Colorectal Cancer|A Randomized, Placebo-controlled, Double-blind, Multicenter, Phase IIb Study of Famitinib as Third Line Treatment in Patients With Advanced Colorectal Cancer|Unknown status|Recruiting|Phase 2|150|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-11 02:08:19.63613|2017-10-11 02:08:19.63613
NCT01762280|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2013-01-04|||June 2009||2009-06-01|January 2013|2013-01-01||||January 2013|Anticipated|2013-01-01||Interventional|||A Phase I Study of Famitinib Malate in Patients With Solid Tumor|A Phase I Study of Famitinib Malate in Patients With Solid Tumor|Unknown status|Active, not recruiting|Phase 1|29|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||||2017-10-11 02:08:19.777888|2017-10-11 02:08:19.777888
NCT01762267|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2013-01-04|||January 2011||2011-01-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Effects of DASH Diet on Corticosteroids Medication Use|Phase 3 Study of Beneficiary Effects of Dietary Approaches to Stop Hypertension (DASH) on the Metabolic Aeffects of Corticosteroids Medications Use|Completed||Phase 3|62|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:08:19.906295|2017-10-11 02:08:19.906295
NCT01762254|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-01-04|||June 2009||2009-06-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Prospective Randomized Trial of Incisionless Versus Conventional Laparoscopic Colectomy for Left-sided Colonic Tumors|Prospective Randomized Trial of Incisionless Versus Conventional Laparoscopic Colectomy for Left-sided Colonic Tumors|Completed||N/A|70|Actual|Pamela Youde Nethersole Eastern Hospital||2|||f||||f||||||||||2017-10-11 02:08:20.008071|2017-10-11 02:08:20.008071
NCT01762241|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-08-09|||February 2015|Actual|2015-02-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Xbox Kinect Training in Men With Prostate Cancer|Xbox Kinect Training in Men With Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy|Active, not recruiting||N/A|46|Actual|Hospitalsenheden Vest||2|||f||||f||||||||||2017-10-11 02:08:20.153284|2017-10-11 02:08:20.153284
NCT01762228|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-03-17|||November 2012||2012-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy of Two Interventions Increasing Sensory Stimulus in Elderly Patients With Oropharyngeal Dysphagia|Randomized Controled Clinical Study to Evaluate the Efficacy of the Increase of the Sensorial Stimuli as a Therapeutic Strategy for the Treatment of Elderly Patients With Oropharyngeal Dysphagia.|Completed||N/A|28|Actual|Hospital de Mataró||2|||f||||t||||||||||2017-10-11 02:08:20.254741|2017-10-11 02:08:20.254741
NCT01762215|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-04|||October 2012||2012-10-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|POEM||Policy on Optimal Epilepsy Management|Policy on Optimized Epilepsy Management: The Use of an Online Social Media Platform to Collect Patient-Entered Data in the Veteran Population|Unknown status|Recruiting|N/A|200|Anticipated|Northern California Institute of Research and Education||1|||f||||f||||||||||2017-10-11 02:08:20.377012|2017-10-11 02:08:20.377012
NCT01762202|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-08-31|||November 2013||2013-11-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2015|Actual|2015-11-01||Interventional|CLL0911||Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.|Phase 2 Multicenter, Study to Assess the Efficacy and the Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab (FCO2) Chemoimmunotherapy in Young (≤65 Yrs) Patients With Chronic Lymphocytic Leukemia (CLL).|Active, not recruiting||Phase 2|80|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-11 02:08:20.530666|2017-10-11 02:08:20.530666
NCT01762189|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-10-25|||January 2013||2013-01-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants|Multicenter Prospective Study on the Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants|Completed||N/A|13157|Actual|Nanjing Medical University|||1||f||||t||||||||||2017-10-11 02:08:20.730012|2017-10-11 02:08:20.730012
NCT01762176|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2017-07-18|||October 2012||2012-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early RA MRI Early Intensive Treatment Study|Effect of Early Intensive Treatment in Chinese Patients With Recent-onset Rheumatoid Arthritis|Recruiting||N/A|200|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:08:20.896352|2017-10-11 02:08:20.896352
NCT01762163|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-04|2016-10-11|||October 2013||2013-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke|Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke With Qi Deficiency and Blood Stasis Syndrome: a Multicenter, Randomized,Double-blind，Placebo- and Active-controlled Adaptive Study|Completed||Phase 4|622|Actual|China Academy of Chinese Medical Sciences||3|||f||||t||||||||||2017-10-11 02:08:21.035029|2017-10-11 02:08:21.035029
NCT01762150|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2017-05-07|||June 2011||2011-06-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|||Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma|Sorafenib Combined With Cisplatin and Gemcitabine for the Treatment of Patients With Advanced Renal Collecting Duct Carcinoma:A Pilot, Open Study|Active, not recruiting||Phase 2|26|Anticipated|Beijing Cancer Hospital||1|||f||||t||||||||Undecided||2017-10-11 02:08:21.250199|2017-10-11 02:08:21.250199
NCT01762137|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2015-10-01|||February 2013||2013-02-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|LARGE||LARGE Aneurysm Randomized Trial: Flow Diversion Versus Traditional Endovascular Coiling Therapy|LARGE Aneurysm Randomized Trial: Flow Diversion Versus Traditional Endovascular Coiling Therapy|Recruiting||Phase 4|316|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 02:08:21.384185|2017-10-11 02:08:21.384185
NCT01762124|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-04-20|||October 2012|Actual|2012-10-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)|Native Outflow Tract Transcatheter Pulmonary Valve Research Clinical Study|Active, not recruiting||N/A|20|Actual|Medtronic Cardiovascular||1|||f||||t||||||||No||2017-10-11 02:08:22.072956|2017-10-11 02:08:22.072956
NCT01762111|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-07-24|||December 2012||2012-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||AMH and Pregnancy Rate by Age During Stimulate In-Vitro Fertilization Protocol|AMH and Pregnancy Rate by Age During Stimulate In-Vitro Fertilization Protocol|Suspended||N/A|918|Anticipated|OVO R & D|||1||f||||t||||||||||2017-10-11 02:08:22.187162|2017-10-11 02:08:22.187162
NCT01762098|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-07-24|||November 2012||2012-11-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|March 2014|Actual|2014-03-01||Observational|||Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization|Prevalence of Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization|Completed||N/A|100|Actual|OVO R & D|||2||f||||t||||||||||2017-10-11 02:08:22.264852|2017-10-11 02:08:22.264852
NCT01762085|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-06-25|||June 2013||2013-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|DURA||Nerve Decompression for Ulcer Recurrence Avoidance (DURA)|A Prospective Study of Recurrence Risk in Diabetic Foot Ulceration After Nerve Decompression|Unknown status|Recruiting|N/A|120|Anticipated|Association of Extremity Nerve Surgeons||2|||f||||f||||||||||2017-10-11 02:08:22.362894|2017-10-11 02:08:22.362894
NCT01762072|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-03|||January 2013||2013-01-01|January 2013|2013-01-01||||March 2013|Anticipated|2013-03-01||Interventional|||Effect of Vitamin B12 and n-3 Polyunsaturated Fatty Acids on Plasma Homocysteine||Unknown status|Not yet recruiting|N/A|30|Anticipated|Zhejiang University||3|||f||||t||||||||||2017-10-11 02:08:22.530432|2017-10-11 02:08:22.530432
NCT01762059|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-06-21|2015-09-10||January 2013||2013-01-01|June 2017|2017-06-01|June 2014|Actual|2014-06-01|October 2013|Actual|2013-10-01||Interventional|||Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas|The Beacon Hill Study: Feasibility of Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas|Completed||N/A|32|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:08:22.911572|2017-10-11 02:08:22.911572
NCT01762046|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2017-01-11|||January 2008||2008-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SUGAR-MGH||Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans|Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans|Active, not recruiting||Phase 1|1000|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:08:23.469948|2017-10-11 02:08:23.469948
NCT01762033|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-01-18|||February 2013||2013-02-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma|A Multi-Center, Open-Label, Single-Arm, Phase 2 Study of ASONEP™ (Sonepcizumab/LT1009) Administered as a Single Agent to Subjects With Refractory Renal Cell Carcinoma|Terminated||Phase 2|40|Actual|Lpath, Inc.||1|||f||||f||||||||||2017-10-11 02:08:23.591335|2017-10-11 02:08:23.591335
NCT01762020|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-03-06|||January 2013||2013-01-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation|Phase III Randomized Pair Comparison of a Barrier Film vs. Standard Skin Care in Preventing Radiation Dermatitis in Women With Breast Cancer Receiving Adjuvant Radiation Therapy|Completed||Phase 3|56|Actual|Lawson Health Research Institute||2|||f||||t||||||||Yes|Release as requested and via publication access notification|2017-10-11 02:08:23.740419|2017-10-11 02:08:23.740419
NCT01761968|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-09-20|||March 2013||2013-03-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms|Long-term Study Evaluating the Effect of Givinostat in Patients With JAK2V617F Positive Chronic Myeloproliferative Neoplasms|Recruiting||Phase 2|90|Anticipated|Italfarmaco||1|||f||||f||||||||||2017-10-11 02:08:24.217302|2017-10-11 02:08:24.217302
NCT01761955|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2013-01-09|||February 2009||2009-02-01|December 2008|2008-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Metabolic Health Benefits of Dairy Protein|Metabolic Health Benefits of Dairy Protein|Completed||Phase 1|21|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-11 02:08:24.478501|2017-10-11 02:08:24.478501
NCT01761929|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-09-19|||March 2013||2013-03-01|September 2017|2017-09-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|||5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases|A Phase II Study on the Toxicity and Efficacy of a Normal Tissue Tolerance Adapted, 5 Fraction Stereotactic Body Radiation Therapy (SBRT) Regimen, for Extra-Cranial Oligometastases|Recruiting||Phase 2|170|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 02:08:24.706296|2017-10-11 02:08:24.706296
NCT01761916|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2013-07-25|||January 2013||2013-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|CLONCAP||Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure|Randomized Clinical Trial for Effectiveness of Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure|Completed||Phase 4|90|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||t||||||||||2017-10-11 02:08:24.82488|2017-10-11 02:08:24.82488
NCT01761903|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-12-05|||May 2012||2012-05-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|||Functional Connectivity in Primary Focal Dystonia|Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia|Recruiting||N/A|60|Anticipated|University of Colorado, Denver|||2||f||||f||||||||||2017-10-11 02:08:24.924952|2017-10-11 02:08:24.924952
NCT01761890|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-08-31|||January 2014|Actual|2014-01-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Observational|CML1113||Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib|Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib. An Observational Multicentric Study.|Recruiting||N/A|133|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||||2017-10-11 02:08:25.075829|2017-10-11 02:08:25.075829
NCT01761877|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2017-04-24|||December 2012||2012-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||NSAID Effects on Clinical and Imaging Breast Biomarkers|NSAID Effects on Clinical and Imaging Breast Biomarkers|Recruiting||Phase 2|175|Anticipated|Stony Brook University||2|||f||||t||||||||||2017-10-11 02:08:25.497198|2017-10-11 02:08:25.497198
NCT01761864|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-02-14|||February 2013||2013-02-01|February 2014|2014-02-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||The Effect of Industry-independent Visits to Primary Care Physicians on Medication Prescribing for Pain Relief in Chronic Joint Pain.|The Effect of Academic Detailing on Prescribing of Analgesics in Primary Care: a Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|4000|Anticipated|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-11 02:08:25.653043|2017-10-11 02:08:25.653043
NCT01761851|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-04|||March 2010||2010-03-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Observational|||Resting Energy Expenditure in Patients on the Waiting List for Liver Transplantation|Metabolic and Nutritional Assessment in Patients on the Waiting List for Liver Transplantation|Completed||N/A|80|Actual|Federal University of Minas Gerais|||1||f||||t||||||||||2017-10-11 02:08:25.736795|2017-10-11 02:08:25.736795
NCT01761838|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-08-09|||January 2013||2013-01-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Underlying Mechanism of Spinal Manipulative Therapy and the Effect of Pain on Physical Outcome Measures|The Underlying Mechanism of Spinal Manipulative Therapy and the Effect of Pain on Physical Outcome Measures|Completed||N/A|103|Actual|University of Alberta||3|||f||||f||||||||||2017-10-11 02:08:25.823317|2017-10-11 02:08:25.823317
NCT01761825|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2013-01-03|||December 2012||2012-12-01|January 2013|2013-01-01||||February 2013|Anticipated|2013-02-01||Interventional|||The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome|"The Effect of Funny Channel Blocker Ivabradine on Patients With Postural Tachycardia Syndrome."|Unknown status|Enrolling by invitation|Phase 2|20|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 02:08:25.956641|2017-10-11 02:08:25.956641
NCT01761812|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-10-17|||September 2012||2012-09-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods|Determining the Extent and Grade of Prostate Cancer Using MR Elastography, Diffusion Weighted Imaging, and Dynamic Contrast Enhanced MRI With Gadofosveset|Terminated||N/A|5|Actual|Sunnybrook Health Sciences Centre||1||Inadequate accrual|f||||f||||||||||2017-10-11 02:08:26.040522|2017-10-11 02:08:26.040522
NCT01761799|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-10-30|||December 2012||2012-12-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|February 2014|Actual|2014-02-01||Interventional|||Protecting Pregnant Women From Infectious Diseases|"Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive P3 Intervention Package Within Obstetric Practices in Georgia"|Completed||N/A|330|Actual|Emory University||2|||f||||f||||||||||2017-10-11 02:08:26.139104|2017-10-11 02:08:26.139104
NCT01761786|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-09-07|||June 2011|Actual|2011-06-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics)|Cost-effectiveness of CYP2C19 Genotype Guided Treatment With Antiplatelet Drugs in Patients With ST-segment-elevation Myocardial Infarction Undergoing Immediate PCI With Stent Implantation: Optimization of Treatment (POPular Genetics).|Recruiting||Phase 4|2700|Anticipated|St. Antonius Hospital||2|||f||||t||||||||||2017-10-11 02:08:26.299061|2017-10-11 02:08:26.299061
NCT01761773|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2014-09-19|||December 2012||2012-12-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|April 2013|Actual|2013-04-01||Interventional|||A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function|A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function|Completed||Phase 1|32|Actual|Exelixis||4|||f||||t||||||||||2017-10-11 02:08:26.494185|2017-10-11 02:08:26.494185
NCT01761760|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-09-26|||May 8, 2017|Actual|2017-05-08|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Videogame-based Incentives for Smoking Cessation|Game-based Contingency Management for Smoking Cessation|Active, not recruiting||N/A|100|Anticipated|Rowan University||2|||f||||f|f|f||||||||2017-10-11 02:08:26.589562|2017-10-11 02:08:26.589562
NCT01761747|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-12-13|2014-11-15||January 2013||2013-01-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Ponatinib for Squamous Cell Lung and Head and Neck Cancers|Phase II Study of Ponatinib in Advanced Lung and Head and Neck Cancers With FGFR Kinase Alterations|Terminated||Phase 2/Phase 3|3|Actual|Dana-Farber Cancer Institute||1||FDA hold and toxicity associated with study drug|f||||t||||||||||2017-10-11 02:08:26.716902|2017-10-11 02:08:26.716902
NCT01761734|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2014-06-22|||January 2013||2013-01-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Pilot Text Message for Influenza Vaccination|Pilot Study of Text Message Reminders for Flu Vaccine For Adults|Completed||N/A|1000|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 02:08:27.055993|2017-10-11 02:08:27.055993
NCT01761721|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-02-02|||January 2013||2013-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01|4 Months|Observational [Patient Registry]|RALH||Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics|Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics|Completed||N/A|139|Actual|Copenhagen University Hospital at Herlev|||1||f||||f||||||||||2017-10-11 02:08:27.134194|2017-10-11 02:08:27.134194
NCT01761708|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-03|||March 2012||2012-03-01|January 2013|2013-01-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01|12 Months|Observational [Patient Registry]|Re-SITUP||Case-control Study of Mesh-infection After a Size Tailored Hernia Repair With C-Qur V-Patch|Case-control Study of Mesh-infection After a Size Tailored Hernia Repair With C-Qur V-Patch|Unknown status|Active, not recruiting|N/A|57|Actual|Algemeen Ziekenhuis Maria Middelares|||1||f||||f||||||||||2017-10-11 02:08:27.219605|2017-10-11 02:08:27.219605
NCT01761695|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-05-22|||January 2013||2013-01-01|May 2016|2016-05-01|December 2047|Anticipated|2047-12-01|December 2047|Anticipated|2047-12-01|30 Years|Observational [Patient Registry]|||Chronic Myelod Leukemia Registry at Asan Medical Center|Prospective Observational Cohort Registry for Patients With Chronic Myeloid Leukemia at Asan Medical Center|Terminated||N/A|100|Actual|Asan Medical Center|||4|"The PI resigned the institute. The rest investigators at the institute decided to terminate the   study."|f||||f||||||Samples With DNA|"     Bone marrow aspirate or peripheral blood (for its mononuclear cells) will be collected,     processed, and cryopreserved for future analysis of DNA or cell culture. Acquisition of     biospecimens will be proceeded if patient agree with the informed consent for donation of     biospecimen to 'Asan Medical Center Biomaterial Resource Banking Center'. This registry data     will be used as a basic demographic and clinical information for the biospecimens.   "|||2017-10-11 02:08:27.368712|2017-10-11 02:08:27.368712
NCT01761682|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-05-22|||January 2013||2013-01-01|May 2016|2016-05-01|December 2047|Anticipated|2047-12-01|December 2047|Anticipated|2047-12-01|10 Years|Observational [Patient Registry]|||Acute Lymphoblastic Leukemia Registry at Asan Medical Center|Prospective Observational Cohort Registry for Patients With Acute Lymphoblastic Leukemia at Asan Medical Center|Terminated||N/A|200|Actual|Asan Medical Center|||3|"The PI resigned the institute, and the rest investigators at the institute decided to terminate   the study."|f||||f||||||Samples With DNA|"     Bone marrow aspirate or peripheral blood (for its mononuclear cells) will be collected,     processed, and cryopreserved for future analysis of DNA or cell culture. Acquisition of     biospecimens will be proceeded if patient agree with the informed consent for donation of     biospecimen to 'Asan Medical Center Biomaterial Resource Banking Center'. This registry data     will be used as a basic demographic and clinical information for the biospecimens.   "|||2017-10-11 02:08:27.465846|2017-10-11 02:08:27.465846
NCT01761669|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-11-02|||April 2013||2013-04-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01|3 Months|Observational [Patient Registry]|||Does Deficiency in Vitamin D Induced Hypercoagulation or Thrombin Generation||Completed||N/A|400|Actual|HaEmek Medical Center, Israel|||1||f||||t||||||||||2017-10-11 02:08:27.585729|2017-10-11 02:08:27.585729
NCT01761656|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-07|||December 2012||2012-12-01|January 2013|2013-01-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|ARMYDA-IMR||Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR|Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR|Unknown status|Recruiting|Phase 2|180|Anticipated|Central South University||2|||f||||t||||||||||2017-10-11 02:08:27.692325|2017-10-11 02:08:27.692325
NCT01761643|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-02-24|||January 2013||2013-01-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|April 2016|Actual|2016-04-01||Interventional|||CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM|CCTG 595: A Multicenter, Randomized Study of Text Messaging to Improve Adherence to PrEP in Risky MSM|Active, not recruiting||Phase 4|398|Actual|California Collaborative Treatment Group||2|||f||||f||||||||||2017-10-11 02:08:27.801516|2017-10-11 02:08:27.801516
NCT01761630|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-06-28|||December 2012||2012-12-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SARPIII-AMSA||The Severe Asthma Research Program III-Boston Clinical Site|ALXR/FPR Mediated Signaling in Severe Asthma (AMSA)-The Severe Asthma Research Program (SARP) III|Active, not recruiting||N/A|100|Anticipated|Brigham and Women's Hospital|||3||f||||t||||||Samples With DNA|"     CBC/Diff, Total IgE, Serum, Plasma, DNA, RNA Urine EBC Sputum: Supernatant, Cell Pellet     Bronch: BAl, Bronchial Brushings, Bronchial Biopsy   "|||2017-10-11 02:08:28.130203|2017-10-11 02:08:28.130203
NCT01761617|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-01-16|||September 2011||2011-09-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|YLBP2||Yoga Dosing Study for Chronic Low Back Pain|Yoga Dosing Study for Chronic Low Back Pain in a Predominantly Low-Income Minority Population|Completed||Phase 1|96|Actual|Boston Medical Center||2|||f||||t||||||||||2017-10-11 02:08:28.245496|2017-10-11 02:08:28.245496
NCT01761604|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-09-13|||December 2011||2011-12-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||A Nasal Applicator for the Treatment of Trigeminal Neuralgia|The Use of Tx360™ Nasal Applicator for Sphenopalatine Ganglion Block in the Treatment of Trigeminal Neuralgia|Completed||N/A|10|Actual|Chicago Anesthesia Pain Specialists||1|||f||||f||||||||||2017-10-11 02:08:28.366723|2017-10-11 02:08:28.366723
NCT01761591|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-08-25|||December 2012||2012-12-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ACES||Acrobat Coronary Stent System Effectiveness European Study|Acrobat Coronary Stent System Effectiveness European Study (European Multicenter Effectiveness Randomized Study of Svelte Medical Systems Acrobat Stent on a Wire Compared to Other BMS PCI in de Novo Coronary Lesions) ACES Trial|Terminated||N/A|300|Anticipated|Svelte Medical Systems Europe||2||Difficulty to identify eligible patients: 8 centers contributed 54 patients in 6 months.|f||||f||||||||||2017-10-11 02:08:28.465429|2017-10-11 02:08:28.465429
NCT01761578|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-01-13|||June 2012||2012-06-01|January 2015|2015-01-01||||June 2013|Actual|2013-06-01||Interventional|||ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent|First in Man Safety Evaluation of the ART18Z Bioresorbable Stent for the Treatment of Single de Novo Lesion of a Native Coronary Artery.|Completed||N/A|30|Actual|Arterial Remodeling Technologies||1|||f||||t||||||||||2017-10-11 02:08:28.608985|2017-10-11 02:08:28.608985
NCT01761565|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-09-16|2014-12-15||January 2013||2013-01-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||One patient was withdrawn after Period 1 due to non-compliance|Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab|Single- and Multiple-Dose Pharmacokinetics of Sublingual Sufentanil NanoTab® PCA System (Zalviso™) in Healthy Subjects|Completed||Phase 1|40|Actual|AcelRx Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:08:28.735786|2017-10-11 02:08:28.735786
NCT01761552|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-09-08|||August 2013||2013-08-01|September 2012|2012-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients|A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients.|Unknown status|Recruiting|Phase 4|130|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 02:08:29.107069|2017-10-11 02:08:29.107069
NCT01761539|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-07-31|||April 2013||2013-04-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Moderate Versus Aggressive Fluids for Acute Pancreatitis|Moderate Versus Aggressive Fluid Therapy in Patient With Mild to Moderate Acute Pancratitis|Completed||N/A|60|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 02:08:29.242386|2017-10-11 02:08:29.242386
NCT01761526|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2014-10-17|||October 2002||2002-10-01|January 2013|2013-01-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects|Parallel Group Trial to Evaluate the Pharmacokinetics and Safety / Tolerability of Single-Dose Treatment With Rotigotine Continuous Delivery System (10 cm2 / 4.5 mg) in Japanese and Caucasian Healthy Subjects|Completed||Phase 1|50|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 02:08:29.389914|2017-10-11 02:08:29.389914
NCT01761513|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-04-14|||November 2012||2012-11-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|||YH4808 Postprandial PK/PD Study in Healthy Subjects|A Randomized,Open Label,Active-controlled, Multiple Dosing and Crossover Clinical Trial to Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of YH4808 After Postprandial Oral Administration in Healthy Volunteers|Completed||Phase 1|21|Actual|Yuhan Corporation||4|||f||||f||||||||||2017-10-11 02:08:29.59638|2017-10-11 02:08:29.59638
NCT01761500|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-01-03|||March 1998||1998-03-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|January 2008|Actual|2008-01-01||Interventional|||Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's Lymphoma||Completed||Phase 2|200|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 02:08:29.733423|2017-10-11 02:08:29.733423
NCT01761487|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-03|||January 2013||2013-01-01|October 2012|2012-10-01||||February 2014|Anticipated|2014-02-01||Interventional|||SDD for Eradicating CRKP Carriage|SELECTIVE DIGESTIVE DECONTAMINATION USING ORAL GENTAMICIN AND ORAL POLYMYXIN E FOR ERADICATION OF CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE CARRIAGE IN HOSPITALIZED PATIENTS|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Soroka University Medical Center||1|||f||||||||||||||2017-10-11 02:08:29.845167|2017-10-11 02:08:29.845167
NCT01761474|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-03-17|||December 2012||2012-12-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Observational|||CO2 Versus O2 Insufflation During ERCP Depending on Sedation Protocols|Carbon Dioxide Insufflations vs. Air Insufflation in Therapeutic ERCP: A Randomized Double-blind Comparative Study Depending on Sedation Methods|Completed||N/A|210|Actual|Soon Chun Hyang University|||4||f||||f||||||||||2017-10-11 02:08:29.933078|2017-10-11 02:08:29.933078
NCT01761461|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-02-15|||February 6, 2013|Actual|2013-02-06|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|January 2019|Anticipated|2019-01-01||Interventional|ARTIST-II||Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial||Recruiting||Phase 3|900|Anticipated|Samsung Medical Center||3|||f||||t||||||||||2017-10-11 02:08:30.029111|2017-10-11 02:08:30.029111
NCT01761448|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-11-26|||February 2012||2012-02-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|GEx||Heart Cycle GEx (Guided- Exercise- Main Trial)|Guided Exercise (GEx) for CAD Patients|Completed||N/A|37|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 02:08:30.150232|2017-10-11 02:08:30.150232
NCT01761435|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-04-30|||October 2012||2012-10-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|TraNsgripe||Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination|Randomized, Comparative and Prospective Clinical Trial Evaluating Efficacy and Safety of a Dose of Seasonal Flu Vaccine Compared to Two Doses of Vaccine for Prevention of Influenza in Solid Organ Transplant Recipients|Completed||Phase 3|499|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||f||||||||||2017-10-11 02:08:30.305506|2017-10-11 02:08:30.305506
NCT01761422|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2014-01-23|||July 2012||2012-07-01|January 2014|2014-01-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Observational|||Myocardial Inflammation in Systemic Lupus Erythematosus|Myocardial Inflammation in Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|40|Anticipated|Ohio State University|||1||f||||t||||||||||2017-10-11 02:08:30.475678|2017-10-11 02:08:30.475678
NCT01761396|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-03-23|||July 2012|Actual|2012-07-01|February 2015|2015-02-01|December 2018|Anticipated|2018-12-01|August 2017|Anticipated|2017-08-01||Interventional|STARS||School-based Treatment of Anxiety Research Study (STARS)|Modular CBT for Reducing Anxiety and Improving Educational Outcomes|Active, not recruiting||N/A|216|Actual|UConn Health||2|||f||||t||||||||||2017-10-11 02:08:30.69954|2017-10-11 02:08:30.69954
NCT01761383|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-02-11|||June 2012||2012-06-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia|Nintendo Wii and Schizophrenia. A Pilot Study.|Completed||N/A|5|Actual|Queen's University||1|||f||||f||||||||No||2017-10-11 02:08:30.829673|2017-10-11 02:08:30.829673
NCT01761370|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2013-01-03|||November 2005||2005-11-01|October 2011|2011-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)|Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)|Completed||N/A|21|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 02:08:30.95532|2017-10-11 02:08:30.95532
NCT01761357|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2015-09-22|||January 2013||2013-01-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TAVIQUAL||Burden Comorbidities and Transcatheter Aortic Valve Implantation|Impact of Burden of Comorbidities on Health Related Quality of Life Six Months After Transcatheter Aortic Valve Implantation in Patients Aged 75 Years and Older.|Completed||N/A|150|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 02:08:31.055693|2017-10-11 02:08:31.055693
NCT01761344|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-08-28|||January 2013||2013-01-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Intraoperative Analysis of Cortisol During Adrenal Vein Sampling|Intraoperative Analysis of Cortisol During Adrenal Vein Catheterization and Sampling in Patients With Primary Hyperaldosteronism.|Completed||N/A|21|Actual|Haukeland University Hospital||1|||f||||f||||||||||2017-10-11 02:08:31.154851|2017-10-11 02:08:31.154851
NCT01761331|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2016-06-25|||January 2013||2013-01-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ACU-COL||Acupuncture in Infantile Colic - a Three Armed Randomized Multi Center Trial (ACU-COL)|Acupuncture in Infantile Colic - a Three Armed Randomized Multi Center Trial Comparing Acupuncture in a Standardized Point, Acupuncture in Individually Chosen Points and no Acupuncture|Completed||Phase 2/Phase 3|147|Actual|Lund University||3|||f||||f||||||||No||2017-10-11 02:08:31.23285|2017-10-11 02:08:31.23285
NCT01761318|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-05-04|||November 2013||2013-11-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|MAGNA VICTORIA||Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients|Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus|Completed||Phase 4|50|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-11 02:08:31.350567|2017-10-11 02:08:31.350567
NCT01761305|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2016-08-30|||January 2013||2013-01-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|January 2019|Anticipated|2019-01-01||Interventional|CONTRAIS||Trial on Three Treatments for Scoliosis|CONTRAIS: CONservative TReatment for Adolescent Idiopathic Scoliosis. A Randomised Controlled Trial|Recruiting||N/A|135|Anticipated|Karolinska Institutet||3|||f||||t||||||||Undecided||2017-10-11 02:08:31.535994|2017-10-11 02:08:31.535994
NCT01761292|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-03-01|||May 2013||2013-05-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|December 2014|Actual|2014-12-01||Interventional|||A 2-Part Study to Assess the Safety and Tolerability, pk, Effects on Histology and Some Clinical Parameters of Givinostat in Ambulant Children With DMD|A Two-Part Study to Assess the Safety and Tolerability, Pharmacokinetics, and Effects on Histology and Different Clinical Parameters of Givinostat in Ambulant Children With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 1/Phase 2|20|Actual|Italfarmaco||1|||f||||f||||||||||2017-10-11 02:08:31.764704|2017-10-11 02:08:31.764704
NCT01761279|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-02-25|2013-01-07||May 2011||2011-05-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|HiSCOPE||High Definition Endoscopy With i-Scan for Small Colonic Polyp Evaluation: The HiScope Study|A Prospective Single-blind Observational Cohort Study of High Definition White Light Endoscopy and i-Scan Image Enhancement for the Characterisation of Small Colonic Polyps|Completed||N/A|84|Actual|Portsmouth Hospitals NHS Trust|Single centre study. Single endoscopist.||1||f||||f||||||||||2017-10-11 02:08:31.888652|2017-10-11 02:08:31.888652
NCT01761266|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-07-18|||March 14, 2013|Actual|2013-03-14|June 2017|2017-06-01|December 15, 2017|Anticipated|2017-12-15|November 13, 2016|Actual|2016-11-13||Interventional|||A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma|A Multicenter, Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma|Active, not recruiting||Phase 3|954|Actual|Eisai Inc.||2|||f||||t||||||||||2017-10-11 02:08:32.210899|2017-10-11 02:08:32.210899
NCT01761253|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-02-17|||June 2006||2006-06-01|February 2017|2017-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Assessing Costs & Cost-variability Among Enrollees of Health Insurance Programs Utilizing Charlson's Comorbidity Index and Administrative Databases|Assessing Costs & Cost-variability Among Enrollees of Health Insurance Programs Utilizing Charlson's Comorbidity Index and Administrative Databases|Completed||N/A|241000|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-10-11 02:08:34.375471|2017-10-11 02:08:34.375471
NCT01761240|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-09-28|||June 2013||2013-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|||Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC|A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies|Completed||Phase 1|27|Actual|Morphotek||1|||f||||t||||||||||2017-10-11 02:08:34.456932|2017-10-11 02:08:34.456932
NCT01761227|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-06-02|||September 2012||2012-09-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia|The Safety and Efficacy of Fufangdanshen Tablets in Treatment of Mild to Moderate Vascular Dementia: a 24-week, Double Blind, Randomized, Parallel,Placebo Controlled Trial.|Unknown status|Active, not recruiting|Phase 2|240|Anticipated|Dongzhimen Hospital, Beijing||2|||f||||t||||||||||2017-10-11 02:08:34.565531|2017-10-11 02:08:34.565531
NCT01761214|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2016-08-08|||September 2012||2012-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BISER||Bacteriology and Inflammation in Bronchiectasis|Bacteriology and Sputum and Systemic Inflammation in Steady-state, Acute Exacerbation and Recovery of Bronchiectasis|Recruiting||N/A|80|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||f||||||||||2017-10-11 02:08:34.66692|2017-10-11 02:08:34.66692
NCT01761201|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2014-08-05|||January 2012||2012-01-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|FLISH-ILT||"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients."|"A Prospective, Randomized, Comparative Clinical Trial of the Efficacy and Safety of Levofloxacin Versus Isoniazid in the Treatment of Latent Tuberculosis Infection in Liver Transplant Patients."|Terminated||Phase 3|68|Actual|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2||Recruitment rythm not sufficent to reach the simple size needed.|f||||f||||||||||2017-10-11 02:08:34.95907|2017-10-11 02:08:34.95907
NCT01761188|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2013-06-22|||June 2013||2013-06-01|June 2013|2013-06-01|January 2015|Anticipated|2015-01-01|July 2014|Anticipated|2014-07-01||Interventional|STABLE-SR||the Study of STABLE_SR for Persistent Atrial Fibrillation|The Study of CPVI Plus Electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm (STABLE-SR) for the Treatment of Persistent Atrial Fibrillation|Unknown status|Recruiting|N/A|220|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 02:08:35.185582|2017-10-11 02:08:35.185582
NCT01761175|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2017-04-25|2014-03-28||September 2012||2012-09-01|April 2017|2017-04-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional||Considering a rate of complete sensory block of 90% for the infraclavicular block and a noninferiority margin of 10%, a sample size of 224 patients was needed to evaluate the noninferiority of the axillary block in comparison to the infraclavicular block at 30 minutes, with a power of 80% and an alpha error of 5% (one-sided hypothesis).|Comparison of Ultrasound-Guided Infraclavicular Block and Ultrasound-Guided Axillary Block|Comparison of Ultrasound-Guided Single Injection Infraclavicular Block or Ultrasound-Guided Double Injection Axillary Block : A Non-inferiority Randomized Trial|Completed||N/A|224|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 02:08:35.307888|2017-10-11 02:08:35.307888
NCT01761162|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-12-20|2014-10-28||February 2013||2013-02-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Observational|||ProMRI Study of the Entovis Pacemaker System||Completed||N/A|229|Actual|Biotronik, Inc.|||1||f||||t||||||||||2017-10-11 02:08:36.028731|2017-10-11 02:08:36.028731
NCT01761149|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2013-01-03|||December 2012||2012-12-01|January 2013|2013-01-01||||March 2013|Anticipated|2013-03-01||Interventional|||Effect of Higher Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy|Comparison of Different Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy: a Prospective, Double-blinded Randomized Control Trial|Unknown status|Recruiting|Phase 4|60|Anticipated|Central South University||2|||f||||t||||||||||2017-10-11 02:08:36.339583|2017-10-11 02:08:36.339583
NCT01761136|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-03-27|||November 2011||2011-11-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site|Phase 4 Study of Haemophilus Influenzae Type b Vaccine in Different Injection Site|Completed||Phase 4|680|Actual|Beijing Center for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 02:08:36.447758|2017-10-11 02:08:36.447758
NCT01761123|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-12-08|||January 2013||2013-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ICC H1||Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum|An Open Label Phase I Substudy to Evaluate the Safety and Ability to Enhance Immunogenicity of VXA-A1.1 by Delivery Directly to the Ileum Using the InteliSite Companion Capsule in Healthy Adult Males|Completed||Phase 1|37|Actual|Vaxart||1|||f||||f||||||||||2017-10-11 02:08:36.549449|2017-10-11 02:08:36.549449
NCT01761110|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-06-24|||December 2012||2012-12-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pilot Test of a Community-based Buprenorphine Treatment Intervention|Development of a Community-based Buprenorphine Treatment Intervention|Completed||N/A|77|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 02:08:36.676019|2017-10-11 02:08:36.676019
NCT01761097|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-03|2013-01-04|||January 2013||2013-01-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Endocuff Adenoma Detection Rate Pilot Study|A Pilot Study to Assess the Role for Endocuff© Assisted Colonoscopy in the Detection of Colonic Cancer and Polyps|Unknown status|Recruiting|N/A|300|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:08:36.847074|2017-10-11 02:08:36.847074
NCT01761084|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-03-14|||January 2013||2013-01-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|December 2016|Actual|2016-12-01||Interventional|B3E||Build Better Bones With Exercise|Build Better Bones With Exercise: A Pilot Randomized Controlled Trial of Exercise in Women With Osteoporotic Vertebral Fracture|Active, not recruiting||N/A|139|Anticipated|University of Waterloo||2|||f||||t||||||||||2017-10-11 02:08:36.947906|2017-10-11 02:08:36.947906
NCT01761071|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2013-01-02|||January 2012||2012-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Time Serial Analysis on Preemptive Analgesia of Preoperative Topical Diclofenac and Ketorolac in Photorefractive Keratectomy(PRK)||Completed||Phase 3|94|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:08:37.065998|2017-10-11 02:08:37.065998
NCT01761058|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-07-01|||December 2012||2012-12-01|July 2013|2013-07-01|May 2017|Anticipated|2017-05-01|January 2017|Anticipated|2017-01-01||Observational|SARP3||Severe Asthma Research Program - University of Virginia|The Severe Asthma Research Program at University of Virginia - Airway Redox Biochemistry as a Determinant of Asthma Phenotype During Adolescence|Unknown status|Recruiting|N/A|100|Anticipated|University of Virginia|||2||f||||t|||||||"     Blood: CBC/DIFF, total IgE, Serum, plasma, DNA, RNA, sputum, urine, exhaled breath condensate   "|||2017-10-11 02:08:37.167306|2017-10-11 02:08:37.167306
NCT01761045|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-02-07|||July 2010||2010-07-01|February 2013|2013-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effect of Monosodium L-Glutamate (MSG) and Nucleic Acid (IMP) on Satiety and Food Intake|A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Study of Monosodium L-Glutamate (MSG) and Nucleic Acid (IMP) to Evaluate the Effects on Satiety and Food Intakes at the Next Meal in Healthy Adults|Completed||N/A|80|Actual|Ajinomoto Co., Inc.||3|||f||||f||||||||||2017-10-11 02:08:37.296677|2017-10-11 02:08:37.296677
NCT01761032|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-09-10|||January 2013||2013-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|GOLDEN||Gauging Of Light Dependent Experiences Through Neuroimaging (GOLDEN)|Dopamine Response to Ultraviolet Light in Frequent and Infrequent Tanners|Completed||N/A|22|Actual|University of Texas Southwestern Medical Center|||2||f||||t||||||||||2017-10-11 02:08:37.378845|2017-10-11 02:08:37.378845
NCT01761019|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-08-01|2015-09-17||January 2013||2013-01-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy|A Preliminary, Open Label, Single-arm Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy|Completed||Phase 4|8|Actual|University of Pittsburgh|The greatest limitation of this study was the small sample size. Other study limitations include the open label, non-randomized design and absence of a placebo arm.|1|||f||||t||||||||||2017-10-11 02:08:37.477657|2017-10-11 02:08:37.477657
NCT01761006|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-05-02|||March 2013||2013-03-01|May 2017|2017-05-01|September 23, 2014|Actual|2014-09-23|September 23, 2014|Actual|2014-09-23||Observational|||Evaluation of FeNO During and Following Acute COPD Exacerbation|A Single-Center Exploratory Study to Evaluate FeNO Using the NIOX MINO® Device in COPD Patients Aged ≥40 Years During and Following Recovery From an Acute COPD Exacerbation|Terminated||N/A|10|Actual|Wake Forest University Health Sciences|||1|"Study was activated initially. However, the necessary resources were not available to complete   the research."|f||||f|f|f||||||||2017-10-11 02:08:37.704038|2017-10-11 02:08:37.704038
NCT01760993|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-05-01|2014-05-01||February 2013||2013-02-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized|Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia|A Phase 3, Long-term, Open-label, Multicenter, 52-week, Flexible-dose Safety Study of SPD489 as Adjunctive Treatment to Established Maintenance Doses of Antipsychotic Medications on Negative Symptoms in Clinically Stable Adults Who Have Persistent Predominant Negative Symptoms of Schizophrenia|Terminated||Phase 3|2|Actual|Shire|Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized|1||"Study was discontinued due to non-safety related business prioritization decisions. No subjects   were randomized."|f||||t||||||||||2017-10-11 02:08:37.830838|2017-10-11 02:08:37.830838
NCT01760980|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-05-27|||November 2012||2012-11-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects||Suspended||Phase 1|90|Actual|Actavis Inc.||2||Development halted by management|f||||||||||||||2017-10-11 02:08:38.164457|2017-10-11 02:08:38.164457
NCT01760967|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2017-02-25|||January 2013||2013-01-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|DESIRE||Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial|Effect of Dexmedetomidine on Mortality, Duration of Mechanical Ventilation and Multi-organ Function in Sepsis Patients Under Lighter Sedation by Randomized Control Trial|Completed||Phase 4|203|Actual|Wakayama Medical University||2|||f||||t||||||||||2017-10-11 02:08:38.3033|2017-10-11 02:08:38.3033
NCT01760954|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-06-28||2016-05-05|December 2012||2012-12-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|May 2015|Actual|2015-05-01||Interventional|||Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain|Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain|Completed||Phase 3|507|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 02:08:38.478646|2017-10-11 02:08:38.478646
NCT01760941|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-01-29|2015-12-18||March 2013||2013-03-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients|Feasibility of a Compassionate Same-Day Evaluation and Delivery of Single Fraction Radiotherapy for Palliation of Symptomatic Bony Metastasis in Hospice Patients|Terminated||N/A|1|Actual|Virginia Commonwealth University|No data analysis or outcome measures for one participant enrolled and zero participants analyzed. Early suspension and termination due to slow accrual from Protocol Review and Monitoring Committee.|1||Slow accrual|f||||t||||||||||2017-10-11 02:08:39.074631|2017-10-11 02:08:39.074631
NCT01760928|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-01-02|||January 2009||2009-01-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|January 2010|Actual|2010-01-01||Observational|||Guidance of Patients With Asthma During Preparation and During Expedition to the Aconcagua Mountain|Guidance of Patients With Asthma During Preparation and During Expedition to the Aconcagua Mountain|Completed||N/A|18|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     induced sputum cells and peripheral blood sample   "|||2017-10-11 02:08:39.418436|2017-10-11 02:08:39.418436
NCT01760915|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2017-06-28|||December 2012||2012-12-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||University of Wisconsin Severe Asthma Research Program III|Severe Asthma Research Program (SARP) - University of Wisconsin|Active, not recruiting||N/A|120|Anticipated|University of Wisconsin, Madison|||3||f||||t||||||Samples With DNA|"     whole blood, serum, plasma, DNA, RNA, sputum, urine, bronchial tissue, bronchoalveolar     lavage, bronchial brushings, exhaled breath condensate   "|Undecided||2017-10-11 02:08:39.520721|2017-10-11 02:08:39.520721
NCT01760902|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-12-07|||March 2010||2010-03-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|CCTT||Diet & Activity Community Trial: High-Risk Inflammation|Diet & Activity Community Trial: High-Risk Inflammation|Completed||N/A|438|Actual|University of South Carolina||1|||f||||t||||||||||2017-10-11 02:08:39.645348|2017-10-11 02:08:39.645348
NCT01760733|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-12-22|||December 2012||2012-12-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2016|Actual|2016-12-01||Observational|QUESTION65||Improved Selection of Elderly (> 65 Years) for Kidney Transplantation|Improved Selection of Elderly (> 65 Years) for Kidney Transplantation|Active, not recruiting||N/A|280|Actual|Sykehuset Telemark|||1||f||||f||||||||Undecided||2017-10-11 02:08:41.779285|2017-10-11 02:08:41.779285
NCT01760720|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-07-24|||March 2012||2012-03-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Methadone Maintenance Treatment (MMT) Care for HIV Prevention|Methadone Maintenance Treatment (MMT) Care for HIV Prevention: A Randomized Controlled Trial (MMT2)|Completed||N/A|2866|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:08:41.847633|2017-10-11 02:08:41.847633
NCT01760889|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-05-01|2014-05-01||February 2013||2013-02-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized|SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia|A Phase 3 Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, 26-week, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 Low Dose Range (40mg, 80mg, 100mg) and High Dose Range (120mg, 140mg, 160mg) as Adjunctive Treatment to Established Maintenance Doses of Antipsychotic Medications on Negative Symptoms in Clinically Stable Adults Who Have Persistent Predominant Negative Symptoms of Schizophrenia|Terminated||Phase 3|1|Actual|Shire|Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized|3||"Study was discontinued due to non-safety related business prioritization decisions. No subjects   were randomized"|f||||t||||||||||2017-10-11 02:08:39.77054|2017-10-11 02:08:39.77054
NCT01760876|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-06-30|2015-05-27||December 2012||2012-12-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||All patients with coronary disease requiring stent implantation (BioFreedom) stent with (1)successful (evaluable) baseline OCT obtained, (2) 1 to 5 months 2nd OCT follow-up, and (3) 9 months 3rd OCT follow-up. 4 patients withdrew (1 renal failure, 1 emotionally unstable,1 died from fall and 1 withdrew due to personal reasons).|Evaluation of HealinG of Polymer-Free Biomlimus A9-Coated Stent by Optical Coherence Tomography (EGO-BIOFREEDOM)|Evaluation of Healing the Biofreedom Stent Study|Completed||N/A|106|Actual|The University of Hong Kong|2 patients had difficult guiding-catheter engagement for optimal baseline OCT imaging with lots of blood-displacement artifacts; obtaining good future OCT assessments were impossible and were excluded from the study (replaced by another 2 patients).|1|||f||||t||||||||||2017-10-11 02:08:40.278783|2017-10-11 02:08:40.278783
NCT01760863|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-03-08|||July 2011||2011-07-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Oral Antibiotics After 2-Stage Revision for Infected Total Hip Arthroplasty and Total Knee Arthroplasty|The Utility of Oral Antibiotic Therapy Following 2-stage Revision Arthroplasty for Infected Prosthetic Hips and Knees|Recruiting||N/A|200|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 02:08:40.583236|2017-10-11 02:08:40.583236
NCT01760850|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-07-21|||June 2007||2007-06-01|July 2015|2015-07-01|April 2015||2015-04-01|May 2012|Actual|2012-05-01||Interventional|||Breast and Cervical Cancer Educational Intervention for Latinas in Western New York|Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York|Completed||N/A|959|Actual|Roswell Park Cancer Institute||2|||f||||f||||||||||2017-10-11 02:08:40.709051|2017-10-11 02:08:40.709051
NCT01760837|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2015-12-10|||February 2013||2013-02-01|November 2012|2012-11-01|November 2015|Actual|2015-11-01|February 2014|Actual|2014-02-01||Interventional|||Oral Immunotherapy With Baked Milk Products for Patients Allergic to Cow's Milk - A Multicenter Study|Oral Immunotherapy With Baked Milk Products for Patients Allergic to Cow's Milk - A Multicenter Study|Completed||N/A|75|Actual|Wolfson Medical Center||1|||f||||f||||||||||2017-10-11 02:08:40.803109|2017-10-11 02:08:40.803109
NCT01760824|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2013-01-02|||May 2011||2011-05-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication|Ten Days Quadruple Versus Sequential Therapy as Empirical First and Second Line Treatment for Helicobacter Pylori Eradication: a Randomized Crossover Trial|Completed||N/A|391|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:08:40.876417|2017-10-11 02:08:40.876417
NCT01760811|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-02|||January 2013||2013-01-01|January 2013|2013-01-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT|CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment Followed by 6 Weeks of Cetuximab+RT Post Surgery in Locally Advanced Squamous Cell Carcinoma of the Tongue ; A NEW PARADIGM OF TREATMENT|Not yet recruiting||Phase 1/Phase 2|25|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-11 02:08:40.993863|2017-10-11 02:08:40.993863
NCT01760798|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2014-04-15|||January 2012||2012-01-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis|To Compare Efficacy of Weekly Versus Daily Teriparatide in the Management of Postmenopausal Osteoporosis|Unknown status|Recruiting|N/A|20|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 02:08:41.102113|2017-10-11 02:08:41.102113
NCT01760785|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-07-11|2016-03-28||September 2008||2008-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|August 2014|Actual|2014-08-01||Interventional|||Valproate for Mood Swings and Alcohol Use Following Head Injury|A Double Blind Trial of Divalproex Sodium for Affective Lability and Alcohol Use Following Traumatic Brain Injury|Completed||N/A|50|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 02:08:41.206893|2017-10-11 02:08:41.206893
NCT01760772|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2013-01-02|||February 2013||2013-02-01|November 2012|2012-11-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Effect of GLP-1 on Postprandial Lipid Metabolism|The Role of GLP-1 in Lipid Metabolism in Healthy Subjects and in Subjects After Bariatric Surgery|Unknown status|Not yet recruiting|N/A|42|Anticipated|University of Cincinnati||3|||f||||t||||||||||2017-10-11 02:08:41.462143|2017-10-11 02:08:41.462143
NCT01760759|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-06-23|||November 2012|Actual|2012-11-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus|Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus|Recruiting||N/A|165|Anticipated|UConn Health||3|||f||||t||||||||||2017-10-11 02:08:41.588841|2017-10-11 02:08:41.588841
NCT01760746|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-04-15|||July 2012||2012-07-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|October 2013|Actual|2013-10-01||Observational|Humour||Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis|A Randomized, Multi-Centre, Double-Masked, Study to Compare Inflammatory Protein Changes in Aqueous Humour of Subjects Treated With Bevacizumab (Avastin) vs Ranibizumab (Lucentis) Pre-Vitrectomy for Proliferative Diabetic Retinopathy|Completed||N/A|30|Actual|University of British Columbia|||1||f||||f||||||Samples Without DNA|"     Aqueous humour   "|||2017-10-11 02:08:41.696666|2017-10-11 02:08:41.696666
NCT01759433|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-12-28|||December 2012||2012-12-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Reference Intervals for Sonoclot Analysis in Chinese|Reference Ranges for Sonoclot Analysis in Chinese|Completed||N/A|135|Actual|Wuhan Asia Heart Hospital|||1||f||||t||||||None Retained|"     2.7 mL citrated blood.   "|||2017-10-11 02:08:56.274507|2017-10-11 02:08:56.274507
NCT01760707|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-03|||November 2002||2002-11-01|November 2012|2012-11-01|May 2003|Actual|2003-05-01|April 2003|Actual|2003-04-01||Interventional|||Exercise Capability and Training Effects in Diabetic Patients With Neuropathy|Exercise Capability and Training Effects in Diabetic Patients With Neuropathy|Completed||N/A|22|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:08:41.929095|2017-10-11 02:08:41.929095
NCT01760694|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2014-08-13|||January 2013||2013-01-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer|Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer|Terminated||N/A|6|Actual|Southwestern Regional Medical Center||2||Lack of enrollment|f||||t||||||||||2017-10-11 02:08:42.019797|2017-10-11 02:08:42.019797
NCT01760681|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-01-02|||January 2013||2013-01-01|June 2012|2012-06-01||||January 2014|Anticipated|2014-01-01||Interventional|||A Randomized Sham-Controlled Study of H-Coil Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Late-Life Depression||Unknown status|Not yet recruiting|N/A|60|Anticipated|Shalvata Mental Health Center||2|||f||||||||||||||2017-10-11 02:08:42.106535|2017-10-11 02:08:42.106535
NCT01760668|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-05-23|||February 2013||2013-02-01|June 2015|2015-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome|Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome|Completed||N/A|5|Actual|University of Aarhus|||4||f||||f||||||Samples With DNA|"     Aortic tissue      Blood Serum   "|||2017-10-11 02:08:42.189385|2017-10-11 02:08:42.189385
NCT01760655|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-10-19|||December 2012||2012-12-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies|A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Hematologic Malignancies|Recruiting||Phase 2|50|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 02:08:42.289796|2017-10-11 02:08:42.289796
NCT01760642|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2014-05-23|||December 2012||2012-12-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity|Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity in Female Subjects Using Metabolomics|Completed||Phase 1|16|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 02:08:42.593775|2017-10-11 02:08:42.593775
NCT01760629|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2015-02-20|||April 2013||2013-04-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|HELIX-I||Hypothermia for Encephalopathy in Low Income Countries-Feasibilty|Hypothermia for Encephalopathy in Low Income Countries-Feasibility|Completed||N/A|62|Actual|Thayyil, Sudhin||1|||f||||t||||||||||2017-10-11 02:08:42.688783|2017-10-11 02:08:42.688783
NCT01760616|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-04-07|||August 2011||2011-08-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy|A Prospective, Multicenter, Open-labeled, Parallel -Controlled Clinical Study Investigating Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy|Enrolling by invitation||Phase 4|1680|Anticipated|Qidong Gaitianli Medicines Co., Ltd||2|||f||||t||||||||Undecided||2017-10-11 02:08:42.783833|2017-10-11 02:08:42.783833
NCT01760603|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2013-01-02|||December 2012||2012-12-01|December 2012|2012-12-01|December 2017|Anticipated|2017-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Ischia Spinous Fascia Fixation Surgery for Pelvic Organ Prolapse|A Prospective,Multicenter Pilot Study to Evaluate the Clinical Performance of the Ischia Spinous Fascia Fixation Surgery for Pelvic Organ Prolapse.|Recruiting||N/A|75|Anticipated|Peking Union Medical College Hospital||1|||f||||f||||||||||2017-10-11 02:08:42.87667|2017-10-11 02:08:42.87667
NCT01760590|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2013-01-02|||December 2012||2012-12-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Effects of Thoracic Spine Manipulation in Individuals With Non-traumatic Cervical Pain|The Effects of Thoracic Spine Manipulation and Mobilization in Individuals With Nontraumatic Cervical Pain|Unknown status|Recruiting|N/A|100|Anticipated|Keystone Rehabilitation Systems||2|||f||||t||||||||||2017-10-11 02:08:42.988142|2017-10-11 02:08:42.988142
NCT01760577|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2013-01-03|||May 2010||2010-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis|Comparing Effects of Intraarticular Botulinum Toxin A Versus Hyaluronate Plus Rehabilitation Exercise in Patients With Unilateral Ankle Osteoarthritis|Completed||N/A|70|Actual|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-11 02:08:43.093258|2017-10-11 02:08:43.093258
NCT01760564|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-03|||January 2008||2008-01-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Application of Miglustat in Patients With Niemann-Pick Type C|Application of Miglustat in Patients With Niemann-Pick Type C|Completed||Phase 3|5|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 02:08:43.200527|2017-10-11 02:08:43.200527
NCT01760551|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-03|||December 2010||2010-12-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Correlation Between the American Medical Association Guides to the Evaluation of Permanent Impairment and the Medical Outcomes Study 36-Item Short Form|Correlation Between the American Medical Association Guides to the Evaluation of Permanent Impairment and the Medical Outcomes Study 36-Item Short Form.|Completed||N/A|250|Actual|JointResearch|||2||f||||f||||||||||2017-10-11 02:08:43.294373|2017-10-11 02:08:43.294373
NCT01760538|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-03|||August 2001||2001-08-01|November 2012|2012-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Study on Heart Rate Variability in Cardiac Transplant Recipients With Exercise and After Exercise Training|Study on Heart Rate Variability in Cardiac Transplant Recipients With Exercise and After Exercise Training|Completed||N/A|30|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:08:43.376686|2017-10-11 02:08:43.376686
NCT01760525|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-09-08|||March 20, 2013|Actual|2013-03-20|September 2017|2017-09-01|June 17, 2018|Anticipated|2018-06-17|June 17, 2018|Anticipated|2018-06-17||Interventional|CCGM097X2101||A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors|A Phase I, Open-label, Multi-center, Dose Escalation Study of Oral CGM097, a p53/HDM2-interaction Inhibitor, in Adult Patients With Selected Advanced Solid Tumors|Active, not recruiting||Phase 1|51|Actual|Novartis||2|||f||||f|t|f||||||||2017-10-11 02:08:43.477601|2017-10-11 02:08:43.477601
NCT01760512|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-12-09|||November 2012||2012-11-01|May 2015|2015-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Clinical and Health Economic Impact of Robot-assisted Surgery vs Conventional Laparoscopy : the Case of Gastric Bypass|Prospective, Single-blind, Randomized, Non-inferiority, and Controlled Study of Clinical and Health Economic Impact of Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery: the Case of Gastric Bypass|Completed||N/A|118|Anticipated|IHU Strasbourg||2|||f||||f||||||||||2017-10-11 02:08:43.57577|2017-10-11 02:08:43.57577
NCT01760499|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-04-18|||January 24, 2013||2013-01-24|April 2017|2017-04-01|April 2017|Actual|2017-04-01|December 29, 2015|Actual|2015-12-29||Interventional|||Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study|Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study|Completed||Phase 1|15|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 02:08:43.692523|2017-10-11 02:08:43.692523
NCT01760486|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-01-11|||January 2013||2013-01-01|December 2013|2013-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SHARE||State-wide Health Approach to Increase Reach and Effectiveness: Study 3|Using a State-wide Initiative to Disseminate Effective Behavioral Weight Loss Strategies|Completed||N/A|300|Anticipated|The Miriam Hospital||3|||f||||f||||||||||2017-10-11 02:08:43.781891|2017-10-11 02:08:43.781891
NCT01760473|ClinicalTrials.gov processed this data on October 10, 2017|2009-05-01|2017-08-07|2016-10-11||May 2009||2009-05-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone|Reinforcing Effects of Intranasal Buprenorphine Versus Buprenorphine/Naloxone in Buprenorphine-maintained Intranasal Drug Users|Completed||Phase 3|27|Actual|New York State Psychiatric Institute||9|||f||||f||||||||||2017-10-11 02:08:43.869431|2017-10-11 02:08:43.869431
NCT01760460|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-05-31|||March 14, 2013|Actual|2013-03-14|May 2017|2017-05-01|March 4, 2015|Actual|2015-03-04|March 4, 2015|Actual|2015-03-04||Interventional|||A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)|A Multicenter, 24-Week, Double-Blind, Randomized, Placebo-Controlled, Phase III Study With 28-Week Open Labeled Extension Period to Assess the Efficacy and Safety of MK-0859 When Added to Ongoing Statin Therapy With or Without Other Lipid Modifying Medication(s) in Japanese Patients With Dyslipidemia|Completed||Phase 3|307|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:08:44.229516|2017-10-11 02:08:44.229516
NCT01760434|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2016-01-05|||January 2013||2013-01-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Long-Term Outcome Following the Treatment of Pediatric Scoliosis|Prospective Study: Long-Term Pulmonary Function, Health-Related Quality of Life, and Sagittal Plane Alignment Following the Treatment of Pediatric Scoliosis|Completed||N/A|66|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:08:44.575324|2017-10-11 02:08:44.575324
NCT01760421|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-04-22|||October 2011||2011-10-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of Hydroxychloroquine Treatment in Hashimoto's Thyroiditis|The Effect of Hydroxychloroquine Treatment in Hashimoto's Thyroiditis|Completed||N/A|40|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 02:08:44.662543|2017-10-11 02:08:44.662543
NCT01760408|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2016-10-12|||February 2011||2011-02-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01|5 Years|Observational [Patient Registry]|||Sustain, A.S.P.E.N. HPN Registry 2011|SustainTM,LLC: A.S.P.E.N.'s National Patient Registry for Nutrition Care- Home Parenteral Nutrition|Completed||N/A|1600|Actual|Sustain, LLC of the American Society for Parenteral and Enteral Nutrition|||2||f||||t||||||||||2017-10-11 02:08:44.748992|2017-10-11 02:08:44.748992
NCT01760395|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2015-10-11|||January 2002||2002-01-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Observational|||Complications in Inguinal Hernia Surgery|Complications in Inguinal Hernia Surgery - a Nationwide Registry Study|Completed||N/A|335|Actual|North Karelia Central Hospital|||1||f||||f||||||||||2017-10-11 02:08:44.854508|2017-10-11 02:08:44.854508
NCT01760382|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2015-03-25|||January 2011||2011-01-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01|1 Year|Observational [Patient Registry]|RENOVAMI||REgister of Myocardial Infarction Patients Treated by the NOVAra STE-MI Network|REgister of Myocardial Infarction Patients Treated by the NOVAra STE-MI Network|Unknown status|Recruiting|N/A|700|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita|||2||f||||f||||||||||2017-10-11 02:08:44.938815|2017-10-11 02:08:44.938815
NCT01760369|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-11-13|||October 2012||2012-10-01|January 2013|2013-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|NIRS||Study of the: Effect of Head Rotation in Prone Position on Regional Cerebral Oxygen Saturation.|Observation Study of the: Effect of Head Rotation in Prone Position on Regional Cerebral Oxygen Saturation (rSO2) in Anesthetized Patients.|Completed||N/A|52|Actual|Glostrup University Hospital, Copenhagen|||1||f||||f||||||||||2017-10-11 02:08:45.069236|2017-10-11 02:08:45.069236
NCT01760356|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2016-10-07|||May 2011||2011-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|February 2015|Actual|2015-02-01|12 Months|Observational [Patient Registry]|3PIGREF||Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients|Study of Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Relationships of Anticalcineurin Drugs: Tacrolimus and Cyclosporin in Liver Transplant Recipients.|Active, not recruiting||N/A|141|Actual|UDA Centro Nacional Hepato-Bilio-Pancreático|||5||f||||f||||||Samples With DNA|"     Samples from whole blood: PBMC,DNA, RNA   "|Yes|Through scientific publications and congresses|2017-10-11 02:08:45.134289|2017-10-11 02:08:45.134289
NCT01760343|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2013-04-04|||January 2013||2013-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor|A Randomized, Double-blind, Single-center, Cross-over Study to Evaluate the Safety, Bioavailability and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor Administered Intravenously|Completed||Phase 1|16|Actual|CSL Behring||2|||f||||||||||||||2017-10-11 02:08:45.247718|2017-10-11 02:08:45.247718
NCT01760330|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-03-04|||December 2015||2015-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||IV Acetaminophen in Children Undergoing Palatoplasty|A Prospective, Double-Blinded, Randomized Comparison of Intravenous Acetaminophen Versus Placebo in Children Undergoing Palatoplasty|Withdrawn||Phase 2|0|Actual|Nationwide Children's Hospital||2||Unable to obtain funding|f||||f||||||||||2017-10-11 02:08:45.356268|2017-10-11 02:08:45.356268
NCT01760317|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-02-03|||August 2010||2010-08-01|February 2015|2015-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Two Different Approaches During Fluoroscopically Guided Interlaminar Lumbar Epidural Steroid Injection|Midline vs Lateral Parasagittal Approach During Fluoroscopically Guided Interlaminar Lumbar Epidural Steroid Injection: the Role of Concordant Pressure Paresthesia in Determing Outcome.|Completed||N/A|106|Actual|Chicago Anesthesia Pain Specialists||2|||f||||f||||||||||2017-10-11 02:08:45.449832|2017-10-11 02:08:45.449832
NCT01760304|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-05-18|2016-12-09||January 2012||2012-01-01|May 2017|2017-05-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|AZCO||Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo|Evaluation of Changes in Cardiac Function in COPD Patients With Resting Hyperinflation After Administration of Budesonide/Formoterol (Symbicort®) Compared With Placebo|Terminated||Phase 4|5|Actual|Brigham and Women's Hospital||2||Sponsor decided to stop the study due to expiration of blinded placebo .|f||||f||||||||No||2017-10-11 02:08:45.565503|2017-10-11 02:08:45.565503
NCT01760291|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-06-13|||September 2012||2012-09-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|CAP2||Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology|Continued Access to PREVAIL (CAP2)- WATCHMAN Left Atrial Appendage (LAA) Closure Technology|Active, not recruiting||N/A|578|Actual|Boston Scientific Corporation||1|||f||||t||||||||No||2017-10-11 02:08:45.947291|2017-10-11 02:08:45.947291
NCT01760278|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2013-01-03|||December 2012||2012-12-01|January 2013|2013-01-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Interventional|Embryoscope||Assessment of Implantation Potential of Embryos by Time-lapse Technology|Assessment of Implantation Potential of Embryos Cultured by Time-lapse Technology (Embryoscope) Before Transfer in In-vitro Fertilization (IVF) / Intracytoplasmic Sperm Injection (ICSI) Cycles: A Randomized Control Study.|Unknown status|Active, not recruiting|Phase 4|200|Anticipated|Bloom IVF and Fertility Centre||2|||f||||t||||||||||2017-10-11 02:08:46.032056|2017-10-11 02:08:46.032056
NCT01760265|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2013-01-25|||January 2013||2013-01-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|DARK||"DARK STUDY DysbetalipoproteinemiA and atheRoma Risk"|Dysbetalipoproteinemia and Atheroma Risk : Assessment of Cardiovascular Risk in Dysbetalipoproteinemic Patients|Unknown status|Recruiting|N/A|50|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"     Lipid, apo E genotype when is necessary to complete the phenotype   "|||2017-10-11 02:08:46.136688|2017-10-11 02:08:46.136688
NCT01760252|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-01-10|||December 2011||2011-12-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol|Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Resectable, Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Protocol|Recruiting||Phase 2|20|Anticipated|Beth Israel Medical Center||1|||f||||f||||||||||2017-10-11 02:08:46.212882|2017-10-11 02:08:46.212882
NCT01760239|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-02|2017-06-09|||April 2014||2014-04-01|June 2017|2017-06-01|April 16, 2017|Actual|2017-04-16|April 16, 2016|Actual|2016-04-16||Interventional|||EHR-Based Clinical Decision Support to Improve BP Management in Adolescents|EHR-Based Clinical Decision Support to Improve BP Management in Adolescents|Completed||N/A|529|Actual|HealthPartners Institute||2|||f||||t||||||||||2017-10-11 02:08:46.312542|2017-10-11 02:08:46.312542
NCT01760226|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-07-12|||January 2013||2013-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|August 26, 2016|Actual|2016-08-26||Interventional|DA-EPOCH-R||Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies|Use of Dose Adjusted EPOCH-R in the Treatment of Childhood Mature B Cell Malignancies|Completed||N/A|4|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 02:08:46.408019|2017-10-11 02:08:46.408019
NCT01760213|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-05-22|||January 2013||2013-01-01|December 2012|2012-12-01|August 2015|Anticipated|2015-08-01|January 2015|Anticipated|2015-01-01||Interventional|||Brief Internet Based Treatment for PTSD|Internet Based Treatment Using Virtual Reality in the Prevention of PTSD|Unknown status|Not yet recruiting|N/A|900|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 02:08:46.68888|2017-10-11 02:08:46.68888
NCT01760200|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2013-01-02|||August 2012||2012-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Drug Eluting Balloon Versus Drug Eluting Stent in PCI|Drug Eluting Balloon Versus Drug Eluting Stent in Coronary Artery Disease PCI: Insights From a Meta-analysis of 1462 Patients|Completed||N/A|1462|Actual|Azienda Ospedaliero Universitaria Maggiore della Carita|||2||f||||f||||||||||2017-10-11 02:08:46.798513|2017-10-11 02:08:46.798513
NCT01760174|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-05-11|||January 2016||2016-01-01|May 2015|2015-05-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparing the Effect of TAP-catheter and Epidural Catheter on Postoperative Pain After Open Gynecologic Surgery|A Randomized Double Blind Trial Comparing the Effect of Transversus Abdominal Plane-catheter and Epidural Catheter on Postoperative Pain After Open Gynecologic Surgery|Withdrawn||N/A|0|Actual|Aalborg Universitetshospital||2||Because of logistic and practical reasons.|f||||f||||||||||2017-10-11 02:08:47.025641|2017-10-11 02:08:47.025641
NCT01760161|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-05-11|||April 2014||2014-04-01|May 2015|2015-05-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery|A Randomised, Double-blind Study to Evaluate the Effect of Bilateral Dual Transversus Abdominis Plane Block on Postoperative Pain and Plasma Concentration of Ropivacaine After Robotic Assisted Laparoscopic Surgery|Terminated||N/A|80|Anticipated|Aalborg Universitetshospital||2||No signal on pain-score|f||||f||||||||||2017-10-11 02:08:47.134161|2017-10-11 02:08:47.134161
NCT01760148|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-08|2013-01-01|||July 2012||2012-07-01|January 2013|2013-01-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Observational|sIFN-pred2||Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)|Study of Parameters of Early Hepatitis C Virus Dynamics for Predicting the Outcome of Standard Interferon Therapy With Chinese Cohort (Second Phase)|Unknown status|Recruiting|N/A|300|Anticipated|First Hospital of Jilin University|||1||f||||t||||||Samples With DNA|"     Blood serum,Peripheral blood mononuclear cells (PBMC)   "|||2017-10-11 02:08:47.232457|2017-10-11 02:08:47.232457
NCT01760135|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-01-03|||November 2012||2012-11-01|January 2013|2013-01-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Nutritional Requirement for the Severe Trauma Patients|Nutritional Requirement for the Severe Trauma Patients|Unknown status|Recruiting|Phase 3|61|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:08:47.38092|2017-10-11 02:08:47.38092
NCT01760122|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2015-08-28|||March 2013||2013-03-01|March 2015|2015-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B|A Phase 3, Randomized, Multi-center, Active-controlled, Open-label Study to Evaluate the Efficacy and Safety of Peginterferon Alfa-2b (40kD, Y Shape) in Chinese Chronic Hepatitis B Patients.|Completed||Phase 3|820|Actual|Xiamen Amoytop Biotech Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:08:47.492824|2017-10-11 02:08:47.492824
NCT01760109|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2012-12-30|||July 2011||2011-07-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|PIP-SBT||Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection|Phase IV Study on Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection|Unknown status|Recruiting|Phase 4|2000|Anticipated|Xiangbei Welman Pharmaceutical Co., Ltd||1|||f||||t||||||||||2017-10-11 02:08:47.70107|2017-10-11 02:08:47.70107
NCT01760096|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2013-01-01|||January 2013||2013-01-01|January 2013|2013-01-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)|Phase II Study of the Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Institute of Hematology & Blood Diseases Hospital||3|||f||||t||||||||||2017-10-11 02:08:47.812175|2017-10-11 02:08:47.812175
NCT01760083|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2016-08-29|||March 2012||2012-03-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|March 2017|Anticipated|2017-03-01||Interventional|EuroCTO||A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions|A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions|Active, not recruiting||N/A|450|Actual|Euro CTO Club||2|||f||||t||||||||||2017-10-11 02:08:47.93331|2017-10-11 02:08:47.93331
NCT01760070|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2015-01-22|||December 2012||2012-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Comparison of O-type Hybrid Knife and IT Knife in ESD|Comparison of O-type Hybrid Knife and IT Knife in Endoscopic Submucosal Dissection for Upper Gastrointestinal Neoplasms: a Prospective Randomized Controlled Trial|Completed||N/A|78|Actual|Xijing Hospital of Digestive Diseases||2|||f||||t||||||||||2017-10-11 02:08:48.122095|2017-10-11 02:08:48.122095
NCT01760057|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2015-05-27|||January 2013||2013-01-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|February 2014|Actual|2014-02-01||Interventional|TuNexo||Evaluating the Effect of a Novel Web-based Intervention to Increase HIV Testing in Men Who Have Sex With Men|Randomized Controlled Trial to Evaluate the Effect of a Novel Web-based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Lima-Peru|Completed||N/A|400|Actual|Universidad Peruana Cayetano Heredia||2|||f||||f||||||||||2017-10-11 02:08:48.25761|2017-10-11 02:08:48.25761
NCT01760044|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2017-05-19|||January 2013||2013-01-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Noninvasive Assessment of Tissue Perfusion Status in Critically Ill Pediatric Patients|Noninvasive Assessment of Tissue Perfusion Status in Critically Ill Pediatric Patients|Completed||N/A|46|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 02:08:48.37828|2017-10-11 02:08:48.37828
NCT01760031|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2012-12-28|||July 2012||2012-07-01|December 2012|2012-12-01|January 2013|Anticipated|2013-01-01|December 2012|Actual|2012-12-01||Observational|RenProLong||Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy|Remote Preconditioning for Contrast-Induced Acute Kidney Injury: Long-Term Follow up (RenPro Longterm)|Unknown status|Active, not recruiting|N/A|81|Anticipated|University of Cologne|||1||f||||t||||||||||2017-10-11 02:08:48.476315|2017-10-11 02:08:48.476315
NCT01760018|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2014-02-17|||December 2012||2012-12-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparison Between Propofol-remifentanil Total Intravenous Anesthesia and Desflurane-remifentanil Balanced Anesthesia With Regard to Post-anesthetic Functional Recovery Measured With QoR-40||Completed||N/A|76|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:08:48.6045|2017-10-11 02:08:48.6045
NCT01760005|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2017-10-04|||December 2012||2012-12-01|October 2017|2017-10-01|December 2023|Anticipated|2023-12-01|September 2023|Anticipated|2023-09-01||Interventional|DIAN-TU||Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.|A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease|Recruiting||Phase 2/Phase 3|438|Anticipated|Washington University School of Medicine||6|||f||||t||||||||||2017-10-11 02:08:48.721134|2017-10-11 02:08:48.721134
NCT01759992|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2014-03-18|||January 2013||2013-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Effects and Costs of Respiratory Muscle Training in Institutionalized Elderly People|Determination of the Effects and Costs of Respiratory Muscle Training in Institutionalized Elderly People With Functional Impairment: A Randomized Controlled Trial|Completed||N/A|45|Actual|University of Valencia||2|||f||||f||||||||||2017-10-11 02:08:48.962353|2017-10-11 02:08:48.962353
NCT01558817|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-07-23|||February 2012||2012-02-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|||Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation With Informed Assent||Completed||N/A|29|Actual|University of Vermont||2|||f||||t||||||||||2017-10-11 03:09:58.367977|2017-10-11 03:09:58.367977
NCT01759979|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2017-03-30|||January 2013||2013-01-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Laser Versus Mechanical Lithotripsy of Bile Duct Stones|Randomized Trial of Combination of Cholangioscopic Guided Laser Lithotripsy and Conventional Mechanical Versus Conventional Mechanical Methods for the Endoscopic Removal of Large Bile Duct Stones|Completed||N/A|60|Actual|University of Southern California||2|||f||||t||||||||Undecided||2017-10-11 02:08:49.057604|2017-10-11 02:08:49.057604
NCT01759966|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2016-04-08|||January 2013||2013-01-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|March 2016|Actual|2016-03-01||Observational|AccHeart||Autonomic Cardiovascular Control After Heart Transplantation|Autonomic Cardiovascular Control After Heart Transplantation|Active, not recruiting||N/A|100|Actual|Oslo University Hospital|||2||f||||f||||||Samples With DNA|"     1. Blood samples for analyses of: genomic DNA, RNA-transcription in whole blood, cytokines,          cathecholamines, other blood biomarkers        2. Urine samples for analyses of: catecholamines, cortisol, other urine biomarkers        3. Saliva samples for analyses of: cortisol        4. Heart biopsy specimen for analyses of: acute and chronic rejection (routine surveillence          procedure)   "|||2017-10-11 02:08:49.162093|2017-10-11 02:08:49.162093
NCT01759953|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-12-04|||July 2014||2014-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Educational Efficacy Assessment of a Serious Game to Teach Insulin Therapy to Primary Care Physicians|Randomized Controlled Trial to Assess the Educational Efficacy of a Serious Game for Teaching Insulin Therapy to Primary Care Physicians|Completed||N/A|170|Actual|Universidade Estadual de Londrina||2|||f||||t||||||||||2017-10-11 02:08:49.264893|2017-10-11 02:08:49.264893
NCT01759940|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2014-03-15|||November 2012||2012-11-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Influence of the Concentration of the Local Anesthetic Ropivacaine on the Quality of a Ultrasound Guided Intermediate Cervical Block.|Influence of the Concentration of the Local Anesthetic Ropivacaine on the Quality of a Ultrasound Guided Block of the Regio Collis Lateralis for Carotid Endarterectomy: a Prospective, Randomized and Controlled Trail|Completed||Phase 4|46|Actual|Salzburger Landeskliniken||2|||f||||f||||||||||2017-10-11 02:08:49.385715|2017-10-11 02:08:49.385715
NCT01759927|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2015-12-02|||February 2013||2013-02-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Investigating the Effectiveness of Exercise Coaching on the Physical Activity Behavior of Physically Inactive Employees.|Investigating the Effectiveness of Exercise Coaching on the Physical Activity Behavior of Physically Inactive Employees in a Company in Flanders: a Randomized Control Trial.|Completed||N/A|301|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 02:08:49.486458|2017-10-11 02:08:49.486458
NCT01759914|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2014-03-06|||September 2012||2012-09-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Ocular Pressure in Steroid-treated Dermatology Patients|Intraocular Pressure in Corticosteroid-treated Dermatology Patients|Terminated||N/A|25|Actual|University Hospitals Coventry and Warwickshire NHS Trust|||2|Unable to recruit sufficient number of subjects in required timeline.|f||||f||||||||||2017-10-11 02:08:49.578081|2017-10-11 02:08:49.578081
NCT01759901|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2015-02-02|||January 2013||2013-01-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma|Open Liver Resection With or Without Vascular Inflow Occlusion for Hepatocellular Carcinoma: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|100|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:08:49.675282|2017-10-11 02:08:49.675282
NCT01759888|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2015-01-23|||August 2011||2011-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism|From Mouse Models to Patients: Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism|Completed||Phase 2|49|Actual|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-10-11 02:08:49.790829|2017-10-11 02:08:49.790829
NCT01759875|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2015-04-24|||January 2013||2013-01-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effects of Gastric pH on the Pharmacokinetics of Atazanavir|Effects of Gastric pH on the Pharmacokinetics of Atazanavir in Healthy Volunteers|Completed||Phase 1|8|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-10-11 02:08:49.888032|2017-10-11 02:08:49.888032
NCT01759862|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2014-06-30|||November 2012||2012-11-01|June 2014|2014-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|RTphylline||Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant|Perioperative Aminophylline to Improve High Risk Renal Graft Outcome- a Double Blinded, Placebo Controlled, Randomized Clinical Trial|Unknown status|Recruiting|N/A|50|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 02:08:50.022721|2017-10-11 02:08:50.022721
NCT01759849|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-07-10|||November 2012||2012-11-01|July 2017|2017-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Effect of in Vitro Blocking the Common Beta Chain on Cell Viability in Asthma|Effect of in Vitro Blocking the Common Beta Chain on the Function of Blood, Bone Marrow and Sputum Cells Collected From Asthmatic Donors.|Completed||N/A|10|Actual|Hamilton Health Sciences Corporation|||1||f||||f|f|f||||Samples Without DNA|"     Blood, bone marrow and induced sputum.   "|||2017-10-11 02:08:50.220007|2017-10-11 02:08:50.220007
NCT01759836|ClinicalTrials.gov processed this data on October 10, 2017|2013-01-01|2013-01-09|||October 2012||2012-10-01|January 2013|2013-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer|A Randomized Double Blind, Placebo-controlled Study Determining the Role of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer|Unknown status|Recruiting|Phase 2|354|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:08:50.363377|2017-10-11 02:08:50.363377
NCT01759823|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2015-10-24|||December 2012||2012-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||Bone Marrow Derived Stem Cell Transplantation in T2DM|Efficacy and Safety of Autologous Bone Marrow Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2/Phase 3|30|Actual|Postgraduate Institute of Medical Education and Research||3|||f||||t||||||||||2017-10-11 02:08:50.541346|2017-10-11 02:08:50.541346
NCT01512316|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-01-13||||||December 2011|2011-12-01||||||||Interventional|||Exploring Learning and Unlearning of Fear|The Effect of D-cycloserine on Fear Learning and Extinction|Unknown status|Not yet recruiting|N/A|90|Anticipated|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||||2017-10-11 03:23:50.457056|2017-10-11 03:23:50.457056
NCT01759797|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2016-07-02|||January 2013||2013-01-01|May 2012|2012-05-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS|Safety of Intravenous Transplantation of Bone Marrow Derived Mesenchymal Stem Cell in Patients With ALS|Completed||Phase 1|6|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 02:08:50.835732|2017-10-11 02:08:50.835732
NCT01759784|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2015-12-31|||March 2014||2014-03-01|May 2012|2012-05-01||||March 2017|Anticipated|2017-03-01||Interventional|||Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS|Safety of Intraventricular Injection of Bone Marrow Derived Mesenchymal Stem Cell in Patients With ALS|Withdrawn||Phase 1|0|Actual|Royan Institute||1||The stereotaxis can be threatful for the patients because of respiratory insufficiency|f||||t||||||||||2017-10-11 02:08:50.950874|2017-10-11 02:08:50.950874
NCT01759771|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2017-09-08|||January 3, 2013|Actual|2013-01-03|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|VD3 PCa||Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial|Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial|Recruiting||Phase 2|136|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-11 02:08:51.07101|2017-10-11 02:08:51.07101
NCT01759758|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2016-01-12|||December 2012||2012-12-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Randomized Trial Comparing Conventional Plaster and Thermoplastic Splints to Treat Pediatric Boxer's Fractures|Conventional Plaster Versus Thermoplastic Splint for the Treatment of a Pediatric Metacarpal Neck Fracture: a Randomized Trial|Completed||N/A|40|Actual|IWK Health Centre||2|||f||||f||||||||||2017-10-11 02:08:51.199571|2017-10-11 02:08:51.199571
NCT01759745|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2014-06-29|||December 2014||2014-12-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm|The Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm- a Pilot Study.|Unknown status|Not yet recruiting|N/A|40|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 02:08:51.355003|2017-10-11 02:08:51.355003
NCT01759732|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-30|2012-12-30|||September 2012||2012-09-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia|Haploidentical Stem Cell Transplantation With Fixed Dose of T Cells After in Vitro T Cell Depletion Using CD3 Monoclonal Antibody for Children With Acquired Severe Aplastic Anemia|Unknown status|Recruiting|Phase 2|10|Anticipated|Asan Medical Center||1|||f||||||||||||||2017-10-11 02:08:53.196387|2017-10-11 02:08:53.196387
NCT01759719|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2015-03-25|||January 2012||2012-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01|1 Year|Observational [Patient Registry]|PROMETEUS||Novara Registry of Platinum-Chromium Platform Stents|Novara Platinum CROMium Everolimus EluTing StEnt SpontaneoUs RegiStry|Unknown status|Recruiting|N/A|500|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita|||1||f||||f||||||||||2017-10-11 02:08:53.332215|2017-10-11 02:08:53.332215
NCT01759706|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2014-12-03|||October 2010||2010-10-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy|Safety and Feasibility Study of an Enhanced Recovery After Surgery Protocol in Patients Undergoing Elective Pancreaticoduodenectomy.|Completed||N/A|123|Actual|Università Vita-Salute San Raffaele||2|||f||||t||||||||||2017-10-11 02:08:53.459592|2017-10-11 02:08:53.459592
NCT01759693|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-02|||February 2013||2013-02-01|December 2012|2012-12-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Observational|||Platelet Activation in Chronic Inflammatory Skin Diseases||Unknown status|Not yet recruiting|N/A|80|Anticipated|Meir Medical Center|||2||f||||f||||||||||2017-10-11 02:08:53.584283|2017-10-11 02:08:53.584283
NCT01759680|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-01-02|||January 2012||2012-01-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Effects of 3 Months of Controlled Whole Body Vibrations on the Risk of Falls Among Nursing Home Residents|Effects of 3 Months of Controlled Whole Body Vibrations With Low Exposure Period on the Risk of Falls Among Nursing Home Residents|Completed||N/A|62|Actual|University Hospital of Liege||2|||f||||t||||||||||2017-10-11 02:08:53.664537|2017-10-11 02:08:53.664537
NCT01759667|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2012-12-27|||August 2012||2012-08-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|DIT RYGB||DIT After RYGB - A Prospective Study|Diet-induced Thermogenesis After Roux-en-Y Gastric Bypass - A Prospective Study|Completed||N/A|13|Actual|Gastrocirurgia, Brazil||1|||f||||f||||||||||2017-10-11 02:08:53.739851|2017-10-11 02:08:53.739851
NCT01759654|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-27|||October 2012||2012-10-01|December 2012|2012-12-01|January 2013|Anticipated|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects||Unknown status|Recruiting|Phase 3|120|Anticipated|Adimmune Corporation||1|||f||||f||||||||||2017-10-11 02:08:53.834873|2017-10-11 02:08:53.834873
NCT01759641|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2012-12-24|||January 2011||2011-01-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|September 2011|Actual|2011-09-01||Observational|SOGLIA||Observational Study to Assess Oxygen Saturation Predictive Power Related to Intradialytic Acute Hypotension|Italian Group of Study on the Role of Oxygen Saturation as a Potential Surrogate Marker of Intradialytic Cardiovascular Instability|Completed||N/A|51|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||f||||||||||2017-10-11 02:08:53.925339|2017-10-11 02:08:53.925339
NCT01759628|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-06-12|||April 2012||2012-04-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease|The Effect of Helicobacter Pylori Eradication on Liver Function Tests in Subjects With Non-alcoholic Fatty Liver Disease|Completed||Phase 2|100|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:08:54.012284|2017-10-11 02:08:54.012284
NCT01759420|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2014-06-24|2014-05-23||December 2012||2012-12-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Ondansetron and the QT Interval In Adult Emergency Department Patients|Ondansetron and the QT Interval In Adult Emergency Department Patients|Completed||N/A|28|Actual|C.R.Darnall Army Medical Center|||1||f||||f||||||||||2017-10-11 02:08:56.405541|2017-10-11 02:08:56.405541
NCT01759615|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2012-12-31|||April 2006||2006-04-01|December 2012|2012-12-01|April 2007|Actual|2007-04-01|February 2007|Actual|2007-02-01||Interventional|AREDF||Early Versus Late Initiation of Feeding in Preterm Newborns With Prenatal AREDF in Umbilical Artery|A Randomized Clinical Trial on Comparison of Early Versus Late Initiation of Feeding in Preterm Small for Gestation Infants Below 35 Weeks Gestation With Prenatal Absent or Reversal of End Diastolic Flow (AREDF) in Umbilical Artery|Completed||N/A|60|Actual|Lady Hardinge Medical College||2|||f||||t||||||||||2017-10-11 02:08:54.109186|2017-10-11 02:08:54.109186
NCT01759602|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2014-07-17|2014-05-28||January 2013||2013-01-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation|Phase 1b Study of C1-esterase Inhibitor (Cinryze) With Standard of Care for Acute Treatment of Neuromyelitis Optica Exacerbations|Completed||Phase 1|10|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 02:08:54.319073|2017-10-11 02:08:54.319073
NCT01759589|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2012-12-31|||January 2011||2011-01-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Three Anaesthesic Method in Electroconvulsive Theraphy|Sevoflurane Alone and Propofol With or Without Remifentanil in Electroconvulsive Therapy|Completed||Phase 4|39|Actual|Inonu University||3|||f||||t||||||||||2017-10-11 02:08:54.566818|2017-10-11 02:08:54.566818
NCT01759576|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2013-05-27|||March 2008||2008-03-01|May 2013|2013-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function|An Open-Label, Single-Dose Study to Evaluate JNJ-28431754 Pharmacokinetics, Pharmacodynamics and Safety in Non-Diabetic Subjects With Varying Degrees of Renal Function|Completed||Phase 1|40|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||5|||f||||f||||||||||2017-10-11 02:08:54.67522|2017-10-11 02:08:54.67522
NCT01759563|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2013-01-02|||July 2012||2012-07-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|OCCTAVI-I||Oxygenation of the Cerebrum and Cooling During TAVI - Part I|Safety and Feasibility Study of Nasopharyngeal Cooling (RhinoChill Device) During Transcutaneous Aortic Valve Implantation|Completed||Phase 3|6|Actual|Hasselt University||1|||f||||f||||||||||2017-10-11 02:08:54.800323|2017-10-11 02:08:54.800323
NCT01759550|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2015-06-09|||September 2011||2011-09-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip|Prospective Case-Series of LigaSure Advance Pistol Grip and LigaSure Blunt Tip in Gastric Procedures|Terminated||N/A|51|Actual|Duke University|||1|The Sponsor terminated the study.|f||||t||||||||||2017-10-11 02:08:54.898986|2017-10-11 02:08:54.898986
NCT01759537|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-31|2015-08-20|||September 2012||2012-09-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study to Evaluate Bone and Gum Dimension Changes Around Dental Implants Placed in Different Positions in Bone.|Evaluation of Changes of Hard and Soft Tissues After Epi-crestal and Sub-crestal Placement of Ankylos Dental Implants.|Unknown status|Active, not recruiting|N/A|48|Anticipated|Dentsply International||2|||f||||f||||||||||2017-10-11 02:08:54.976177|2017-10-11 02:08:54.976177
NCT01759524|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2013-11-17|||October 2011||2011-10-01|November 2013|2013-11-01||||January 2013|Actual|2013-01-01||Interventional|||To Compare lidocaine2%/Clonidine in Combination, With Bupivacaine 0.5 % Alone in Equal Volumes for Combined Sciatic-saphenous Nerve Block in Terms of Selectivity of Blockade|To Compare lidocaine2%/Clonidine in Combination With Bupivacaine 0.5 % Alone in Equal Volumes for Combined Sciatic-saphenous Nerve Block in Terms of Selectivity of Blockade|Completed||Phase 4|30|Actual|Cork University Hospital||2|||f||||f||||||||||2017-10-11 02:08:55.099862|2017-10-11 02:08:55.099862
NCT01759511|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-02-17|2017-02-17||October 18, 2012|Actual|2012-10-18|February 2017|2017-02-01|February 19, 2016|Actual|2016-02-19|February 19, 2016|Actual|2016-02-19||Interventional|ATLAS|Safety Analysis Set: all participants who received at least 1 dose of study drug|Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF)|A Phase 2, Long-Term Safety Study of GS-6624 in Adult Subjects With Idiopathic Pulmonary Fibrosis (IPF)|Terminated||Phase 2|34|Actual|Gilead Sciences||1||The Study was terminated due to lack of efficacy.|f||||f|t|f||||||||2017-10-11 02:08:55.225661|2017-10-11 02:08:55.225661
NCT01759498|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2013-09-27|||December 2012||2012-12-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||The Effects of Hydrogen-rich Formulation for Treatment of Sport-related Soft Tissue Injuries||Completed||Phase 2|36|Actual|Center for Health, Exercise and Sport Sciences, Serbia||3|||f||||t||||||||||2017-10-11 02:08:55.767108|2017-10-11 02:08:55.767108
NCT01759485|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-04-12|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|September 2016|Actual|2016-09-01||Interventional|||Vitamin D for Schizophrenia|Vitamin D Supplementation as Adjunct to Clozapine-treated Chronic Schizophrenia Patients|Completed||N/A|47|Actual|Geha Mental Health Center||2|||f||||f||||||||||2017-10-11 02:08:55.868319|2017-10-11 02:08:55.868319
NCT01759472|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2013-01-06|||September 2012||2012-09-01|January 2013|2013-01-01||||September 2013|Anticipated|2013-09-01||Observational|||Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Provocation Test|Effect of Montelukast on Leukotriene Sensitive Asthma Detected by LTD4 Bronchial Provocation Test|Unknown status|Recruiting|N/A|60|Anticipated|Guangzhou Institute of Respiratory Disease|||2||f||||t||||||||||2017-10-11 02:08:55.975463|2017-10-11 02:08:55.975463
NCT01759446|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-04-07|||February 2013||2013-02-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users|A Single-center, Randomized, Double-blind, Active- and Placebo Controlled, 5-way Crossover Study Assessing the Abuse Potential of Intranasally Administered VYCAVERT Tablets in Non-dependent Recreational Opioid Users.|Completed||Phase 2|40|Actual|Acura Pharmaceuticals Inc.||5|||f||||f||||||||||2017-10-11 02:08:56.181477|2017-10-11 02:08:56.181477
NCT01758861|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-31|||July 2011||2011-07-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Erythropoietin on the Incidence of Acute Kidney Injury Following Complex Valvular Heart Surgery||Completed||Phase 2|98|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:09:04.924711|2017-10-11 02:09:04.924711
NCT01759407|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-29|2017-03-01|||May 2013||2013-05-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Femoral Nerve Block for Femur Fracture Repair in Pediatrics|A Prospective, Double-blinded, Randomized Comparison of Ultrasound-guided Femoral Nerve Block With Lateral Femoral Cutaneous Nerve Block Versus Standard Anesthetic Management for Traumatic Femur Fracture Repair in the Pediatric Population|Terminated||Phase 2|19|Actual|Nationwide Children's Hospital||2||Interim analysis showed no significant difference between study arms.|f||||f||||||||||2017-10-11 02:08:56.743593|2017-10-11 02:08:56.743593
NCT01759394|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2013-10-30|||October 2012||2012-10-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal|A Randomized, Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal|Completed||Phase 1|36|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 02:08:56.849915|2017-10-11 02:08:56.849915
NCT01759381|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2015-06-30|2015-06-25||December 2012||2012-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Incisional Negative Pressure Wound Therapy|The Efficacy of Negative Pressure Wound Therapy (NPWT) in the Postoperative Management of Complex Spinal Surgeries: A Randomized Outcomes Study.|Terminated||N/A|19|Actual|Duke University||2||PI leaving institution|f||||f||||||||||2017-10-11 02:08:57.373551|2017-10-11 02:08:57.373551
NCT01759368|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-09-15|2014-08-07||October 2010||2010-10-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Heart at Home- a Self-care Study|Heart at Home- Remote Patient Monitoring in the Care of Heart Failure Patients|Completed||N/A|94|Actual|VTT Technical Research Centre of Finland||2|||f||||f||||||||||2017-10-11 02:08:57.663507|2017-10-11 02:08:57.663507
NCT01759355|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-05-02|||October 2012||2012-10-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|November 2014|Actual|2014-11-01||Observational|||Hybrid PET/MR in the Therapy of Cervical Cancer|Hybrid PET/MR in the Therapy of Cervical Cancer: A Pilot Study|Active, not recruiting||N/A|18|Actual|UNC Lineberger Comprehensive Cancer Center|||2||f||||t||||||||||2017-10-11 02:08:58.152672|2017-10-11 02:08:58.152672
NCT01759342|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-06-27|||April 2008||2008-04-01|December 2012|2012-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Comprehensive Exercise Training Program During Hospitalization for an Acute CF Exacerbation|The Efficacy of a Standardized Exercise Protocol in Inpatient Care of Patients With Cystic Fibrosis|Completed||N/A|23|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 02:08:58.276089|2017-10-11 02:08:58.276089
NCT01759329|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2012-12-28|||January 2011||2011-01-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|DüsselKaffee||Health Effects of Coffee Consumption|Health Effects of Coffee Consumption|Completed||N/A|118|Actual|West German Center of Diabetes and Health||2|||f||||f||||||||||2017-10-11 02:08:58.375576|2017-10-11 02:08:58.375576
NCT01759316|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-10-25|||December 2012||2012-12-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Heliox in Preterm Infants With Respiratory Distress Syndrome|Nasal Intermittent Positive Pressure Ventilation and Mechanical Ventilation With Heliox in Preterm Infants With Respiratory Distress Syndrome|Completed||N/A|36|Actual|Third Military Medical University||2|||f||||t||||||||||2017-10-11 02:08:58.511844|2017-10-11 02:08:58.511844
NCT01759303|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-09-26|||April 2013||2013-04-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung|A Phase II Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung|Active, not recruiting||Phase 2|35|Anticipated|Vector Oncology||1|||f||||f||||||||||2017-10-11 02:08:58.617566|2017-10-11 02:08:58.617566
NCT01759290|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-08-26|2016-08-26||January 2013||2013-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01|1 Year|Observational [Patient Registry]|||ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.|ABSORB FIRST Registry: An International Post-market Registry of Patients With de Novo Lesions in Previously Untreated Vessels Treated With Absorb Bioresorbable Vascular Scaffold (Absorb BVS).|Completed||N/A|1800|Actual|Abbott Vascular|||1||f||||f||||||||||2017-10-11 02:08:58.78266|2017-10-11 02:08:58.78266
NCT01759277|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-01-22|||December 2012||2012-12-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Femoral Versus Adductor Canal Continuous Peripheral Nerve Blocks for Knee Arthroplasty|Femoral Versus Adductor Canal Continuous Peripheral Nerve Blocks for Knee Arthroplasty|Completed||Phase 4|150|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 02:09:00.455876|2017-10-11 02:09:00.455876
NCT01759264|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2015-06-12|2015-05-26||January 2013||2013-01-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|FAIR|Safety Analysis Set (SAS): Participants who received at least one dose of study drug.|An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)|An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience|Completed||N/A|101|Actual|AbbVie|||1||f||||f||||||Samples Without DNA|"     Stool   "|||2017-10-11 02:09:00.563417|2017-10-11 02:09:00.563417
NCT01759251|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-28|2015-02-12|2015-02-12||January 2013||2013-01-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|VIRTUOSO|Patients with vestibular vertigo of known or unknown origin, and for whom the physician has decided to prescribe 48 mg of Betaserc® in accordance with locally approved label.|Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice|Post-marketing Observational Program of Betaserc® (Betahistine Dihydrochloride) to Evaluate Effectiveness in Patients With Vestibular Vertigo in Routine Practice|Completed||N/A|309|Actual|Abbott|4 patients had a treatment exposure of 30 days. No subgroup analyses were performed as the majority of patients had 60 days treatment with Betaserc®.||1||f||||f||||||||||2017-10-11 02:09:00.882725|2017-10-11 02:09:00.882725
NCT01759238|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2015-02-04|||May 2013||2013-05-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|OLGA||Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer|Capecitabine and Bevacizumab With Radiotherapy After 3-6 Months Chemotherapy for Patients With Oligometastatic Colorectal Cancer (OLGA Trial)|Terminated||Phase 2|1|Actual|Universitätsklinikum Hamburg-Eppendorf||1||slow accrual|f||||t||||||||||2017-10-11 02:09:01.200499|2017-10-11 02:09:01.200499
NCT01759225|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2012-12-27|||January 1998||1998-01-01|December 2012|2012-12-01||||December 2100|Anticipated|2100-12-01|1 Month|Observational [Patient Registry]|CVD Registry||Registry of Cardiovascular Disease Patients|Computerized Registry of Cardiovascular Disease Patients|Enrolling by invitation||N/A|110000|Anticipated|Maccabi Healthcare Services, Israel|||1||f||||||||||||||2017-10-11 02:09:01.314602|2017-10-11 02:09:01.314602
NCT01759212|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-11-27|||October 2012||2012-10-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.|Safety and Efficacy of Intramyocardial Implantation of Allogeneic Mesenchymal Stem Cells in Patients With End-stage Heart Failure Undergoing Left Ventricular Assist Device Implantation|Unknown status|Recruiting|Phase 2/Phase 3|5|Anticipated|AHEPA University Hospital||1|||f||||f||||||||||2017-10-11 02:09:01.438585|2017-10-11 02:09:01.438585
NCT01759199|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-11-28|||September 2012||2012-09-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|STEPPER||The Six-minute Stepper Test as an Outcome Measure of Exercise Tolerance During Pulmonary Rehabilitation in With Chronic Obstructive Pulmonary Disease (COPD) Patients(STEPPER)?|The Six-minute Stepper Test : Marker of Exercise Tolerance's Evolution During Pulmonary Rehabilitation in Patients With COPD ?|Completed||N/A|72|Actual|University Hospital, Brest||1|||f||||f||||||||||2017-10-11 02:09:01.563462|2017-10-11 02:09:01.563462
NCT01759186|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-07-17|||December 2012||2012-12-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|SARP3||Airway Redox and Gender Determinants in Severe Asthma|Severe Asthma Research Program|Active, not recruiting||N/A|300|Anticipated|The Cleveland Clinic|||1||f||||t||||||||||2017-10-11 02:09:01.674654|2017-10-11 02:09:01.674654
NCT01759173|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-04-08|||September 2012||2012-09-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|||Evaluate the Effectiveness of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion|Evaluate the Effectiveness of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in the College Age Athletes|Completed||N/A|234|Actual|ElMindA Ltd|||1||f||||f||||||||||2017-10-11 02:09:01.81207|2017-10-11 02:09:01.81207
NCT01759160|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-03-21|2013-01-16||December 2012||2012-12-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|TCI||Hemodynamic Responses During Induction: Comparison of Marsh and Schnider Pharmacokinetic Models|Hemodynamic Responses During Induction: Comparison of Marsh and Schnider Pharmacokinetic Models in Propofol Plasma Target-controlled Infusion|Completed||N/A|60|Actual|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 02:09:01.898401|2017-10-11 02:09:01.898401
NCT01759147|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2012-12-23|||January 2011||2011-01-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|January 2013|Anticipated|2013-01-01||Interventional|||Clinical Outcome of Coracoclavicular Ligament Repair Using Autogenous Gracilis Tendon in Endobutton System.|Case Series to Evaluate Clinical Outcome of Coracoclavicular Ligament Repair Using Autogenous Gracilis Tendon in Endobutton System.|Unknown status|Active, not recruiting|N/A|10|Actual|Helsingborgs Hospital||1|||f||||f||||||||||2017-10-11 02:09:02.248275|2017-10-11 02:09:02.248275
NCT01759134|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2013-10-24|||January 2013||2013-01-01|December 2012|2012-12-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Comparison of Post-Discharge Growth of Premature Infants Using Two Different Formulas|Comparison of Post-Discharge Growth of Premature Infants Using Two Different Formulas|Terminated||Phase 4|30|Anticipated|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-10-11 02:09:02.332795|2017-10-11 02:09:02.332795
NCT01759108|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2012-12-23|||December 2012||2012-12-01|December 2012|2012-12-01||||March 2013|Anticipated|2013-03-01||Interventional|||Rebamipide for the Treatment of Xerostomia in sjögren Syndrome||Unknown status|Recruiting|N/A|55|Anticipated|Faculty of Medicine, University of Alexandria||2|||f||||t||||||||||2017-10-11 02:09:02.51261|2017-10-11 02:09:02.51261
NCT01759095|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-04-08|||January 2013||2013-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Multidrug Blister Pack Study|Electronic Multidrug Blister Packs to Improve Clinical and Humanistic Outcomes in Patients After Hospital Discharge|Terminated||N/A|11|Actual|University Hospital, Basel, Switzerland||2||Difficulties with patient recruitement|f||||f||||||||||2017-10-11 02:09:02.622452|2017-10-11 02:09:02.622452
NCT01759082|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2013-01-01|||September 2012||2012-09-01|December 2012|2012-12-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Observational|TALDI||The Angioma's Treatment Evaluation With Laser Doppler Imaging (LDI)|The Angioma's Treatment Evaluation With Laser Doppler Imaging (LDI)|Unknown status|Enrolling by invitation|N/A|20|Anticipated|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 02:09:02.727672|2017-10-11 02:09:02.727672
NCT01759069|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2014-01-17|||September 2012||2012-09-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||RCT: Effectiveness of a Microscope During Dental Root Apical Surgery|The Effectiveness of a Microscope During Apical Surgery; a Prospective Randomized Controlled Clinical Trial.|Unknown status|Recruiting|N/A|190|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 02:09:02.783327|2017-10-11 02:09:02.783327
NCT01759056|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2014-03-04|||February 2013||2013-02-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis|A Multicenter, Double-Blind, Placebo-Controlled, Ascending-Dose, Repeat-Dose Safety and Pharmacokinetic Investigation of a Delayed-Release, Enteric-Coated Capsule Formulation of AVX 470 [Anti-TNF (Tumor Necrosis Factor) Globulin (Bovine)] in Patients With Active Ulcerative Colitis|Completed||Phase 1|33|Actual|Avaxia Biologics, Incorporated||2|||f||||t||||||||||2017-10-11 02:09:02.867749|2017-10-11 02:09:02.867749
NCT01758848|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-22|2012-12-27|||September 2010||2010-09-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|June 2011|Actual|2011-06-01||Observational|||Physical Therapy for Overactive Bladder|Physical Therapy for Overactive Bladder|Terminated||N/A|155|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:09:05.027548|2017-10-11 02:09:05.027548
NCT01759043|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2016-01-15|||December 2012||2012-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|April 2014|Actual|2014-04-01||Interventional|RAPID||Safety and Feasibility of Using a Single Transradial Guiding Catheter for Primary PCI|Safety and Feasibility of Using a Single Transradial Guiding Catheter for Both Left and Right Coronary Angiography and Intervention in Patients With ST-segment Myocardial Infarction(RAPID)|Completed||N/A|360|Actual|Beijing Luhe Hospital||2|||f||||f||||||||||2017-10-11 02:09:02.983506|2017-10-11 02:09:02.983506
NCT01759030|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-03-24|||December 2012||2012-12-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|BIORA||Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis|Double Blind Randomized Clinical Study Evaluating Efficacy and Safety of BCD-020 and MabThera in Patients With Rheumatoid Arthritis Who Had an Inadequate Response or Intolerance to Other DMARDs Including One or More TNF Inhibitor Therapies|Completed||Phase 3|181|Actual|Biocad||2|||f||||f||||||||||2017-10-11 02:09:03.0753|2017-10-11 02:09:03.0753
NCT01759017|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-07-20|||December 2012||2012-12-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease|Molecular Imaging to Predict Response to Infliximab Therapy in Patients With Crohn's Disease|Terminated||N/A|8|Actual|Brigham and Women's Hospital|||2|slow enrollment|f||||f||||||||||2017-10-11 02:09:03.405039|2017-10-11 02:09:03.405039
NCT01759004|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-12-04|||December 2012||2012-12-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Physical Condition in Lipedema and Obesity|Muscle Strength and Physical Fitness in Patients With Lipedema and Obesity: a Prospective Cross-sectional Pilot Study|Completed||N/A|40|Actual|Nij Smellinghe Hosptial||2|||f||||f||||||||||2017-10-11 02:09:03.49393|2017-10-11 02:09:03.49393
NCT01758991|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2016-10-25|||January 2013||2013-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|iSWAT||Improving SWAllowing After Stroke With Transcranial Direct Current Stimulation|Therapeutic Impact of tDCS on Dysphagia in the Acute Phase of Stroke / Impact thérapeutique de la tDCS Sur la Dysphagie en Phase Aigue de l'Accident Vasculaire cérébral|Recruiting||Phase 1/Phase 2|100|Anticipated|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-10-11 02:09:03.596459|2017-10-11 02:09:03.596459
NCT01758978|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2013-03-19|||December 2012||2012-12-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet|A Randomized, Open-Label, 2-Period, Crossover Study to Assess the Bioequivalence of Two 30-mg and One 60-mg Hydrocodone Bitartrate Extended-Release Tablet|Completed||Phase 1|54|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 02:09:03.693649|2017-10-11 02:09:03.693649
NCT01758965|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2014-05-12|||December 2012||2012-12-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Surgicel® Fibrillar for Delayed Bleeding After ESD|Surgicel® (Fibrillar) for Preventing Delayed Bleeding After ESD in Stomach: A Prospective Randomized Study|Completed||N/A|146|Actual|Soonchunhyang University Hospital||2|||f||||f||||||||||2017-10-11 02:09:03.778148|2017-10-11 02:09:03.778148
NCT01758952|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2013-11-06|||March 2012||2012-03-01|November 2013|2013-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01|1 Month|Observational [Patient Registry]|POSIC||Incidence and Risk Factors of Peri-operative Stroke in Non-cardiac,Non-neurosurgical Surgeries|Multi-center Prospective Investigation of Incidence and Risk Factors of Peri-operative Stroke in Non-cardiac,Non-neurosurgical Surgeries and Practicability of NIHSS in Screening Peri-operative Strokes|Unknown status|Recruiting|N/A|10000|Anticipated|Chinese Medical Association|||6||f||||f||||||Samples With DNA|"     whole blood, serum, white cells   "|||2017-10-11 02:09:03.855748|2017-10-11 02:09:03.855748
NCT01758939|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2013-04-15|||January 2011||2011-01-01|April 2013|2013-04-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01|18 Months|Observational [Patient Registry]|||Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients|Phase 4 Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Genotype IV Infected Egyptian Patients|Unknown status|Recruiting|N/A|100000|Anticipated|Cairo University|||1||f||||t||||||||||2017-10-11 02:09:03.98082|2017-10-11 02:09:03.98082
NCT01758926|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2012-12-27|||December 2012||2012-12-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||Association Between Inflammatory Activities and Gap Density|Association Between Inflammatory Activities and Epithelial Gap Density in Inflammatory Bowel Disease|Unknown status|Recruiting|N/A|50|Anticipated|Shandong University|||2||f||||t||||||Samples With DNA|"     Observational Study Model: Case-Control   "|||2017-10-11 02:09:04.104482|2017-10-11 02:09:04.104482
NCT01758913|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2013-01-01|||February 2007||2007-02-01|December 2012|2012-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants|Pharmacological Closure of Patent Ductus Arteriosus in Extreme Low Birth Weight Infants. A Comparison of Efficacy, Side Effects and Outcomes Between Indomethacin and Ibuprofen|Completed||N/A|110|Actual|Taipei Medical University Hospital||1|||f||||f||||||||||2017-10-11 02:09:04.187245|2017-10-11 02:09:04.187245
NCT01758900|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-10-13|2016-04-26||July 2011||2011-07-01|October 2016|2016-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||CO2 Versus Air Insufflation for Single-balloon Enteroscopy|CO2 Versus Air Insufflation for Single-balloon Enteroscopy: a Randomized, Controlled Trial|Completed||Phase 4|214|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||No||2017-10-11 02:09:04.296896|2017-10-11 02:09:04.296896
NCT01758887|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2016-10-12|||December 2012||2012-12-01|October 2016|2016-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Antipsychotic Discontinuation in High-risk Subjects|Antipsychotic Discontinuation in High-risk Subjects|Withdrawn||N/A|0|Actual|Seoul National University Hospital|||2|administrative reason|f||||f||||||||No||2017-10-11 02:09:04.756749|2017-10-11 02:09:04.756749
NCT01758874|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-12-27|||September 2006||2006-09-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2007|Actual|2007-04-01||Interventional|CLI-PH||Study to Explore the Effect of Lowering Blood Viscosity in Patients With Treatment-resistant Critical Limb Ischemia|Phase 2 Study to Explore the Effect of Lowering Blood Viscosity in Patients With Treatment-resistant Critical Limb Ischemia|Completed||Phase 2|20|Actual|Seoul Veterans Hospital||2|||f||||f||||||||||2017-10-11 02:09:04.836448|2017-10-11 02:09:04.836448
NCT00000156|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-06-02|||July 1995||1995-07-01|October 2003|2003-10-01||||||||Interventional|||The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:34.038865|2017-10-11 04:17:34.038865
NCT01758835|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2016-09-09|||October 2012||2012-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||PRCT-study of Different Non-operative Treatment Protocols of ER-stress Negative Weber-B Unimalleolar Ankle Fractures.|Evaluation of Different Non-operative Treatment Protocols of ER-stress Negative Weber-B Unimalleolar Ankle Fractures. A Prospective Randomized Multicenter Trial.|Active, not recruiting||N/A|246|Anticipated|University of Oulu||3|||f||||t||||||||No||2017-10-11 02:09:05.103426|2017-10-11 02:09:05.103426
NCT01758822|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-07-09|||May 2012||2012-05-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|ETMAS||Role of Endotracheal Suction on the Occurrence of Meconium Aspiration Syndrome in Non-vigorous Meconium Stained Babies|Role of Endotracheal Suction on the Occurrence of Meconium Aspiration Syndrome in Non-vigorous Meconium Stained Neonates- A Randomized Controlled Trial|Completed||N/A|175|Actual|Lady Hardinge Medical College||2|||f||||t||||||||||2017-10-11 02:09:05.198971|2017-10-11 02:09:05.198971
NCT01758809|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2012-12-25|||December 2010||2010-12-01|December 2012|2012-12-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Pain Control of Thoracoscopic Major Pulmonary Resection|Pain Control of Thoracoscopic Major Pulmonary Resection: Is Pre-emptive Local Bupivacaine Injection Able to Replace the Intravenous Patient Controlled Analgesia?|Completed||N/A|86|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 02:09:05.288736|2017-10-11 02:09:05.288736
NCT01758796|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2016-11-01|||February 2012||2012-02-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of Operative Versus Non-operative Treatment of ER-stress Positive Ankle Fractures|A Prospective Randomized Study of Operative Versus Non-operative Treatment of ER-stress Positive Weber-B Unimalleolar Fractures.|Recruiting||N/A|126|Anticipated|University of Oulu||2|||f||||t||||||||Undecided||2017-10-11 02:09:05.372371|2017-10-11 02:09:05.372371
NCT01758783|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2013-01-03|||June 2012||2012-06-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Therapy of Radiation Enteritis With Glutamine|the Efficacy of Glutamine in the Therapy of Radiation Enteritis Among Patients Treated With Radiation of Abdomen and Pelvis.|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Nanjing University School of Medicine||2|||f||||t||||||||||2017-10-11 02:09:05.470816|2017-10-11 02:09:05.470816
NCT01758770|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2017-02-02|||October 2012|Actual|2012-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|CASH||China Action on Spine and Hip Status|Multi Center Survey on Spine and Hip Status in Chinese Population Using Quantitative Computed Tomography (QCT)|Recruiting||N/A|5000|Anticipated|Beijing Jishuitan Hospital|||1||f||||t|f|f||||||No||2017-10-11 02:09:05.539933|2017-10-11 02:09:05.539933
NCT01758757|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2012-12-31|||September 2007||2007-09-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Interventional|||Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy|Comparison of Small-gauge and Conventional Vitrectomy for Proliferative Diabetic Retinopathy|Completed||N/A|347|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 02:09:05.631962|2017-10-11 02:09:05.631962
NCT01758744|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-07-18|||December 2012||2012-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|TAPIT-1||Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1|TAPIT-1: Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1|Completed||Phase 1|10|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 02:09:05.7181|2017-10-11 02:09:05.7181
NCT01758731|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2017-07-17|||October 22, 2012|Actual|2012-10-22|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History|Phase I Trial of Olaparib (AZD2281) in Combination With C225 and Radiation Therapy in Patients With Locally Advanced, Stage IVA-B Squamous Cell Carcinomas of the Head/Neck With Heavy Smoking Histories|Active, not recruiting||Phase 1|16|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 02:09:05.804502|2017-10-11 02:09:05.804502
NCT01758718|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2012-12-27|||April 2007||2007-04-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Interventional|||Eyelash Line Resection for Entropion Associated With Down's Syndrome|Eyelash Line Resection for Entropion Associated With Down's Syndrome|Completed||N/A|24|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 02:09:05.893446|2017-10-11 02:09:05.893446
NCT01758705|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2016-11-26|||February 2013||2013-02-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Post Marketing Observational Study on Venezuelan Patients With Psoriasis|Observational Study; Clinical Effectiveness and Impact on Patient Reported Outcomes in Venezuelan Patients With Psoriasis After 16 Weeks of ADA Therapy|Withdrawn||N/A|0|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 02:09:05.971828|2017-10-11 02:09:05.971828
NCT01758692|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2017-01-13|||July 2012||2012-07-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|||Measurement of Autonomic Cardiovascular Integrity in Persons With SCI|Measurement of Autonomic Cardiovascular Integrity in Persons With SCI|Recruiting||N/A|100|Anticipated|James J. Peters Veterans Affairs Medical Center|||2||f||||f||||||Samples Without DNA|"     Two catecholamine samples are collected either pre/post tilt (in the ICU) or positional shift     (in the autonomics lab). Samples are collected once for individuals participants in the     non-invasive testing only subgroup, twice for individuals participating in the ambulatory     training subgroup, and on all 4 visits for individuals participating in the main group.   "|||2017-10-11 02:09:06.045515|2017-10-11 02:09:06.045515
NCT01758679|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-02-14|||January 2012||2012-01-01|August 2012|2012-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma|A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Relapse and Metastasis of Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|120|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t||||||||||2017-10-11 02:09:06.13653|2017-10-11 02:09:06.13653
NCT01758666|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-12-21|||September 2012||2012-09-01|December 2012|2012-12-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy||Unknown status|Active, not recruiting|N/A|40|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||||||||||||2017-10-11 02:09:06.216668|2017-10-11 02:09:06.216668
NCT01758653|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2016-10-04|||February 2012||2012-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Carbon Monoxide Blood and DNA Biorepository|Carbon Monoxide Blood and DNA Repository|Enrolling by invitation||N/A|300|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||Samples With DNA|"     Blood for plasma, serum, and DNA sequestration   "|||2017-10-11 02:09:06.278675|2017-10-11 02:09:06.278675
NCT01758640|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2013-01-25|||February 2010||2010-02-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin Therapy|Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin Therapy Throughout Pregnancy In Patients With Mechanical Heart Valves Prosthesis|Completed||Phase 3|200|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 02:09:06.370863|2017-10-11 02:09:06.370863
NCT01758627|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2014-02-17|||December 2012||2012-12-01|February 2014|2014-02-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|||The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease||Unknown status|Recruiting|N/A|44|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:09:06.47906|2017-10-11 02:09:06.47906
NCT01758614|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2012-12-31|||December 2012||2012-12-01|December 2012|2012-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|CMOSS||The Carotid and Middle Cerebral Artery Occlusion Surgery Study|The Carotid and Middle Cerebral Artery Occlusion Surgery Study|Recruiting||Phase 3|330|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t||||||||||2017-10-11 02:09:06.567072|2017-10-11 02:09:06.567072
NCT01758601|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2017-03-06|||January 2010||2010-01-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|December 2011|Actual|2011-12-01||Interventional|||White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study|Estudio de intervención Nutricional Para la evaluación de Los Beneficios Sobre la Salud Derivados Del Consumo de Merluza en población Con Alto Riesgo Cardiovascular.|Completed||Phase 3|273|Actual|Hospital Universitario Ramon y Cajal||2|||f||||f||||||||||2017-10-11 02:09:06.707262|2017-10-11 02:09:06.707262
NCT01758588|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2016-05-19|||January 2013||2013-01-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis|Phase II Randomized Controlled Trial of Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis|Active, not recruiting||Phase 2|6|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 02:09:06.820091|2017-10-11 02:09:06.820091
NCT01758575|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-04-06|||November 2012||2012-11-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Clinical Evaluation of the Underlying Mechanisms of Targeted Therapy Related Toxicities|Clinical Evaluation of the Underlying Mechanisms of Targeted Therapy Related Toxicities|Terminated||N/A|8|Actual|VU University Medical Center|||5||f||||f||||||Samples With DNA|"     Blood samples and blind biopsies of the oral mucosa, skin and colon mucosa will be taken     pre-treatment and after 4 weeks of treatment.   "|||2017-10-11 02:09:06.918606|2017-10-11 02:09:06.918606
NCT01758562|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2014-08-14|||January 2013||2013-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Caphosol® Versus State-of-the-art Mouthcare in Patients With Allogeneic Stem Cell Transplantation: a Randomized Controlled Study About the Efficacy of the Mouth Rinse Caphosol®||Completed||N/A|72|Actual|University of Zurich||2|||f||||t||||||||||2017-10-11 02:09:06.992475|2017-10-11 02:09:06.992475
NCT01758549|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2014-06-29|||July 2012||2012-07-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis|Feasibility Study of a Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis|Completed||N/A|62|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 02:09:07.077636|2017-10-11 02:09:07.077636
NCT01758536|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2013-01-18|||December 2012||2012-12-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|HTZZP-INF||Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke|A Phase IV, Double Blind, Placebo-controlled, Randomized, Multi-Center Study to Evaluate the Efficacy of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke|Unknown status|Recruiting|Phase 4|1100|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-11 02:09:07.183519|2017-10-11 02:09:07.183519
NCT01758523|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2017-06-20|||January 2013||2013-01-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Dutasteride Treatment for the Reduction of Heavy Drinking in Men|Dutasteride Treatment for the Reduction of Heavy Drinking|Active, not recruiting||Phase 4|160|Anticipated|UConn Health||2|||f||||f||||||||||2017-10-11 02:09:07.315183|2017-10-11 02:09:07.315183
NCT01758510|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-12-27|||December 2012||2012-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis|"An Open-label, Phase 1 Trial for Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell(HYNR-CS-Allo Inj) Treatment in Amyotrophic Lateral Sclerosis(ALS)"|Active, not recruiting||Phase 1|6|Anticipated|Hanyang University Seoul Hospital||1|||f||||t||||||||||2017-10-11 02:09:07.412742|2017-10-11 02:09:07.412742
NCT01758497|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-12-28|||October 2010||2010-10-01|December 2016|2016-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|FICB||Fascia Iliaca Compartment Block For Analgesia After Total Hip Arthroplasty|Fascia Iliaca Compartment Block For Analgesia After Total Hip Arthroplasty; A Randomized Double Blind, Placebo-Controlled Trial|Completed||N/A|32|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||t||||||||||2017-10-11 02:09:07.671543|2017-10-11 02:09:07.671543
NCT01758484|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2016-02-29|||April 2013||2013-04-01|February 2016|2016-02-01||||November 2014|Actual|2014-11-01||Interventional|||Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant|FEASIBILITY OF IMPLEMENTING PRE-TRANSPLANT EVALUATION BY THE SUPPORTIVE CARE TEAM FOR PATIENTS UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES|Completed||N/A|20|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 02:09:07.817033|2017-10-11 02:09:07.817033
NCT01758471|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2012-12-24|||December 2012||2012-12-01|December 2012|2012-12-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes|An Open-label, Randomized , Phase 4 Study to Compare the Different Efficacies of α-glucosidase Inhibitor and Sulfonylurea on Improvement of Intestinal Microbiome and Serum Incretins in Patients With Type 2 Diabetes|Unknown status|Recruiting|Phase 4|160|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 02:09:07.941486|2017-10-11 02:09:07.941486
NCT01758458|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2017-04-17||2017-03-03|February 2013||2013-02-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma|Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma|Terminated||Phase 1/Phase 2|4|Actual|Fred Hutchinson Cancer Research Center||1||A Phase I/II study (NCT01758458) is now recruiting|f||||t||||||||||2017-10-11 02:09:08.066818|2017-10-11 02:09:08.066818
NCT01758445|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-07-10|||February 2013||2013-02-01|July 2017|2017-07-01|January 2030|Anticipated|2030-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Proton Radiation for Stage II/III Breast Cancer|Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Patients With Stage II/III,Loco-Regional, Non-Metastatic Breast Cancer Requiring Whole Breast or Chest Wall Irradiation With Lymph Node Irradiation|Recruiting||Phase 2|220|Anticipated|Proton Collaborative Group||1|||f||||t||||||||||2017-10-11 02:09:08.219648|2017-10-11 02:09:08.219648
NCT01758432|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-09-26||2017-09-19|December 2012||2012-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests|A Randomized, Double-Blind, Vehicle-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously Administered PRT064445 After Dosing to Steady State With One of Four Direct/Indirect fXa Inhibitors in Healthy Volunteers|Completed||Phase 2|54|Actual|Portola Pharmaceuticals||2|||f||||t||||||||||2017-10-11 02:09:08.38413|2017-10-11 02:09:08.38413
NCT01758419|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2014-05-06|||December 2012||2012-12-01|July 2013|2013-07-01|November 2015|Anticipated|2015-11-01|December 2014|Anticipated|2014-12-01||Observational|||The Role of Myocardial SPECT in Evaluation of Irradiation-induced Changes.|The Role of Myocardial SPECT in Evaluation of Irradiation-induced Changes With Myocardial Perfusion, Cardiac Function, Metabolism and Clinical Prognosis.|Unknown status|Recruiting|N/A|60|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||Samples Without DNA|"     Venous blood sampling   "|||2017-10-11 02:09:08.483366|2017-10-11 02:09:08.483366
NCT01758406|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2015-12-03|||December 2013||2013-12-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Transplantation of Autologous Cardiac Stem Cells in Ischemic Heart Failure|Therapeutic Outcome of Intracoronary Transplantation of Autologous Cardiac Stem Cells in Patients With Ischemic Heart Failure: Randomized Double Blind Clinical Trial|Recruiting||Phase 2|50|Anticipated|Royan Institute||2|||f||||t||||||||||2017-10-11 02:09:08.594184|2017-10-11 02:09:08.594184
NCT01758380|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2013-10-16|||January 2013||2013-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|STEADFAST||Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan|A Double Blind, Double Dummy, Randomised, Multi-centre Study to Assess the Tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan|Completed||Phase 4|557|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:09:08.846661|2017-10-11 02:09:08.846661
NCT01758367|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2016-08-29|||December 2012||2012-12-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation||Recruiting||Phase 1/Phase 2|30|Anticipated|Chinese PLA General Hospital||1|||f||||||||||||||2017-10-11 02:09:09.123878|2017-10-11 02:09:09.123878
NCT01758354|ClinicalTrials.gov processed this data on October 10, 2017|2008-07-09|2012-12-26|||September 2005||2005-09-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Newborn Screening Assay of Pompe's Disease|Newborn Screening Assay of Pompe's Disease|Completed||N/A|236536|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 02:09:09.269065|2017-10-11 02:09:09.269065
NCT01758341|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-01-22|||December 2012||2012-12-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Radiofrequency Ablation for Malignant Biliary Obstruction|Endoscopic Radiofrequency Ablation for Malignant Biliary Obstruction|Completed||Phase 4|58|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 02:09:09.356163|2017-10-11 02:09:09.356163
NCT01758328|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2017-04-05|||December 2012|Actual|2012-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma|A Phase I Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1|29|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:09:09.458515|2017-10-11 02:09:09.458515
NCT01758315|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-24|||July 2010||2010-07-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|PROMISES||Proactive Reduction of Outpatient Malpractice: Increasing Safety, Efficiency, and Satisfaction|Medical Malpractice and Patient Safety Proposal|Unknown status|Enrolling by invitation|N/A|213|Actual|Massachusetts Department of Health||2|||f||||t||||||||||2017-10-11 02:09:09.565718|2017-10-11 02:09:09.565718
NCT01758302|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2012-12-26|||January 2012||2012-01-01|December 2012|2012-12-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||A Pilot Laboratory Study Investigating How Physical Tasks and Hunger Affect Taste Perception|A Pilot Laboratory Study Investigating How Physical Tasks and Hunger Affect Taste Perception|Unknown status|Recruiting|N/A|120|Anticipated|The Miriam Hospital||4|||f||||f||||||||||2017-10-11 02:09:09.661376|2017-10-11 02:09:09.661376
NCT01758289|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-27|2014-11-07|2014-11-07||January 2013||2013-01-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients|A Prospective, Multicenter, Six-Month Study on the Effectiveness, Safety and Impact on Health Related Quality of Life (HRQoL) and Depression Symptoms of Paricalcitol Administered to Venezuelan Patients With Chronic Kidney Disease (Stage V) Who Are on Hemodialysis|Terminated||N/A|105|Actual|AbbVie|||1|Changes in country regulation|f||||f||||||||||2017-10-11 02:09:09.791937|2017-10-11 02:09:09.791937
NCT01758276|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2012-12-31|||January 2013||2013-01-01|December 2012|2012-12-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Obstetric Complications in Women Who Smoke During Pregnancy|Obstetric Complications in Women Who Smoke During Pregnancy|Unknown status|Not yet recruiting|N/A|21000|Anticipated|Hillel Yaffe Medical Center|||2||f||||f||||||||||2017-10-11 02:09:10.298602|2017-10-11 02:09:10.298602
NCT01758263|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2012-12-26|||October 2012||2012-10-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|December 2012|Anticipated|2012-12-01||Observational|||Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment|Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment: A Retrospective Database Analysis|Unknown status|Active, not recruiting|N/A|3000|Anticipated|Forest Laboratories|||1||f||||f||||||||||2017-10-11 02:09:10.37405|2017-10-11 02:09:10.37405
NCT01758250|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2017-05-02|||February 2013||2013-02-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Microvascular and Fibrosis Imaging Study|Mechanistic Study: Non-Invasive Cutaneous Microvascular and Fibrosis Imaging of Patients With Systemic Sclerosis, Sickle Cell Disease and Chronic Graft-Versus-Host Disease (GVHD) Compared to Healthy Subjects|Recruiting||N/A|220|Anticipated|Duke University|||6||f||||f||||||||||2017-10-11 02:09:10.468243|2017-10-11 02:09:10.468243
NCT01758237|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-02-11|||January 2008||2008-01-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Dysphotopsia Following Laser Peripheral Iridotomy|Incidence of Visual Symptom Following Laser (Nd:YAG ) Peripheral Iridotomy (LPI) in Relation to Position of LPI|Completed||N/A|214|Actual|Credit Valley EyeCare||2|||f||||f||||||||||2017-10-11 02:09:10.580585|2017-10-11 02:09:10.580585
NCT01758224|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-08-02|||September 2012||2012-09-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Expiratory Muscle Conditioning in Multiple Sclerosis Using Magnetic Stimulation|Cleveland Clinic Research Program: Expiratory Muscle Conditioning Using Functional Magnetic Stimulation for Patients With Multiple Sclerosis|Completed||N/A|4|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-11 02:09:10.663295|2017-10-11 02:09:10.663295
NCT01758211|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-26|2013-03-01|||January 2013||2013-01-01|March 2013|2013-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|FMRINAVMS||Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation Surgery|Blood Oxygen Level Dependent fMRI Navigation for Function Protection in Intracranial Arteriovenous Malformation Surgery: a Multicenter Prospective Randomized Controlled Single Blind Clinical Trial|Unknown status|Recruiting|Phase 3|600|Anticipated|Beijing Tiantan Hospital||2|||f||||t||||||||||2017-10-11 02:09:10.74061|2017-10-11 02:09:10.74061
NCT01758198|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-05-12|||April 11, 2013|Actual|2013-04-11|May 2017|2017-05-01|December 26, 2016|Actual|2016-12-26|December 26, 2016|Actual|2016-12-26||Interventional|||Abatacept Post-marketing Clinical Study in Japan|A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy With Methotrexate vs. Methotrexate Alone in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate|Completed||Phase 4|405|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 02:09:10.836548|2017-10-11 02:09:10.836548
NCT01758185|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-03-27|||August 2011||2011-08-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|November 2011|Actual|2011-11-01||Interventional|||Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine|Phase 4 Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine|Completed||Phase 4|3308|Actual|Beijing Center for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 02:09:11.099847|2017-10-11 02:09:11.099847
NCT01758172|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2013-01-01|||October 2009||2009-10-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|October 2010|Actual|2010-10-01||Interventional|||Comparison of Hemodynamic Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy|Comparison of Hemodynamic and Clinical Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy|Completed||Phase 3|100|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:09:11.182011|2017-10-11 02:09:11.182011
NCT01758159|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-09-29|||February 2013||2013-02-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|August 2013|Actual|2013-08-01||Interventional|CFR||Effect of CFR and Iron Supplementation on Iron Status and Gut Microbiota of 1-2 Years Old Myanmar Children|The Effect of Optimized Local Food-based Complementary Feeding With or Without Iron Supplementation on Iron Status and Gut Microbiota of 1-2 Years Old Myanmar Children|Unknown status|Active, not recruiting|Phase 3|433|Actual|SEAMEO Regional Centre for Food and Nutrition||4|||f||||t||||||||||2017-10-11 02:09:11.247694|2017-10-11 02:09:11.247694
NCT01758146|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2015-02-09|||January 2012||2012-01-01|February 2015|2015-02-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors|Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors in Postmenopausal Patients With Early Breast Cancer|Unknown status|Recruiting|Phase 3|360|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 02:09:11.337208|2017-10-11 02:09:11.337208
NCT01758133|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2012-12-24|||January 2013||2013-01-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||Influence of Medical Clown Activity on Milk Production of Mothers of Premature Infants||Unknown status|Not yet recruiting|N/A|60|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-10-11 02:09:11.420714|2017-10-11 02:09:11.420714
NCT01758120|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-07-12|||December 2012||2012-12-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|TOPplus-IgAN||Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy|A Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy|Active, not recruiting||Phase 4|135|Actual|Guangdong General Hospital||2|||f||||t||||||||||2017-10-11 02:09:11.489609|2017-10-11 02:09:11.489609
NCT01758107|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-25|2015-02-01|||August 2010||2010-08-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|August 2013|Actual|2013-08-01||Interventional|||Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients|Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients|Unknown status|Recruiting|Phase 4|30|Anticipated|Chulalongkorn University||2|||f||||t||||||||||2017-10-11 02:09:13.371685|2017-10-11 02:09:13.371685
NCT01758094|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2013-01-01|||January 2008||2008-01-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism||Completed||N/A|25|Actual|Gulhane School of Medicine|||1||f||||t||||||||||2017-10-11 02:09:13.453253|2017-10-11 02:09:13.453253
NCT01758081|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-24|2016-12-20|||July 2010||2010-07-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)|Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18|Active, not recruiting||N/A|25874|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:09:13.539267|2017-10-11 02:09:13.539267
NCT01758068|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2012-12-23|||November 2005||2005-11-01|December 2012|2012-12-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|TEWL||Effect of Twice Daily Application of Coconut Oil in Reducing Water Loss From Skin of Premature Babies in First Week of Life|Effect of Topical Oil Application on Trans-Epidermal Water Loss in Preterm Infants - A Randomized Clinical Trail|Completed||N/A|74|Actual|Lady Hardinge Medical College||2|||f||||t||||||||||2017-10-11 02:09:13.656924|2017-10-11 02:09:13.656924
NCT01758055|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2012-12-23|||December 2012||2012-12-01|November 2012|2012-11-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients|Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells Derived Bone Marrow in Patients With Emphysema|Unknown status|Not yet recruiting|Phase 1|12|Anticipated|Masih Daneshvari Hospital||1|||f||||t||||||||||2017-10-11 02:09:13.756684|2017-10-11 02:09:13.756684
NCT01758042|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-03-21|||November 2012||2012-11-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|July 2019|Anticipated|2019-07-01||Interventional|BMT||Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders|Combined Haploidentical Reduced Intensity Bone Marrow and Kidney Transplantation for Patients With Chronic Kidney Disease and Advanced Hematological Disorders|Recruiting||N/A|10|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:09:13.909508|2017-10-11 02:09:13.909508
NCT01758029|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2012-12-23|||January 2013||2013-01-01|December 2012|2012-12-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Testosterone Undecanoate and Quality of Life of Men and Spouses|Satisfaction and Quality of Life of Men and Spouses of Hypogonadal Men Treated With Injectable Testosterone Undecanoate|Unknown status|Not yet recruiting|N/A|80|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 02:09:14.051974|2017-10-11 02:09:14.051974
NCT01758016|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-23|2015-10-06|||November 2012||2012-11-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Haptoglobin and Diabetes Complications in Pregnancy|Haptoglobin and Diabetes Complications in Pregnancy|Unknown status|Recruiting|N/A|400|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples With DNA|"     Serum   "|||2017-10-11 02:09:14.167682|2017-10-11 02:09:14.167682
NCT01758003|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2014-04-04|||October 2012||2012-10-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Physical Activity in Healthy Over 40s|Patterns of Physical Activity in a Healthy Population Aged Over 40 Years Old|Completed||N/A|30|Actual|University of Ulster|||1||f||||f||||||||||2017-10-11 02:09:14.288075|2017-10-11 02:09:14.288075
NCT01757990|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2013-01-12|||March 2012||2012-03-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Stevia Rebaudiana Extracts on Different Variables Related to Caries: an in Vitro and in Vivo Evaluation.|A Comparative Clinical Evaluation of the Effect of Stevia Rebaudiana Extracts and Sucrose on Dental Plaque pH (Stephan Curve Trend) Using a Microtouch Electrode in Healthy Volunteers. A Phase II Study.|Completed||Phase 2|20|Actual|Università degli Studi di Sassari||3|||f||||f||||||||||2017-10-11 02:09:14.37881|2017-10-11 02:09:14.37881
NCT01757977|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2013-03-15|||August 2012||2012-08-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Comparison of the Performance of Standard Double Lumen Tubes With Vivasight DL™ Double Lumen Tubes for Lung Isolation in Patients Undergoing Thoracic Surgery|A Comparison of the Performance of Standard Double Lumen Tubes With Vivasight DL™ Double Lumen Tubes for Lung Isolation in Patients Undergoing Thoracic Surgery|Completed||N/A|25|Actual|University College Hospital Galway||2|||f||||f||||||||||2017-10-11 02:09:14.662838|2017-10-11 02:09:14.662838
NCT01757964|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2017-04-25|2015-11-16||December 2012||2012-12-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|October 2013|Actual|2013-10-01||Interventional|||Bacteriotherapy in Pediatric Inflammatory Bowel Disease|Bacteriotherapy in Pediatric Inflammatory Bowel Disease|Completed||Phase 1|13|Actual|Seattle Children's Hospital||1|||f||||t||||||||||2017-10-11 02:09:14.767402|2017-10-11 02:09:14.767402
NCT01757951|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2012-12-21|||February 2012||2012-02-01|December 2012|2012-12-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Unimalleolar Versus Bimalleolar Fixation in Bi- or Trimalleolar Ankle Fracture|Unimalleolar Versus Bimalleolar Fixation in Bi- or Trimalleolar Ankle Fracture - A Randomized Clinical Trial|Unknown status|Recruiting|N/A|126|Anticipated|University of Oulu||2|||f||||t||||||||||2017-10-11 02:09:14.998572|2017-10-11 02:09:14.998572
NCT01757938|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2012-12-28|||April 2011||2011-04-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Randomized Control Trial of Shang Ring Versus Forceps-guided Adult Male Circumcision in Southwestern Uganda.|Shang Ring Versus Forceps-guided Adult Male Circumcision: a Randomized Controlled Effectiveness Study in Southwestern Uganda.|Completed||N/A|138|Actual|Mbarara University of Science and Technology||2|||f||||f||||||||||2017-10-11 02:09:15.124113|2017-10-11 02:09:15.124113
NCT01757925|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2012-12-28|||August 2011||2011-08-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of a Commercial Gaming Impact in a Childhood Obesity Intervention|Evaluation of a Commercial Gaming Impact in a Childhood Obesity Intervention|Completed||Phase 4|77|Actual|UnitedHealth Group||2|||f||||f||||||||||2017-10-11 02:09:15.261723|2017-10-11 02:09:15.261723
NCT01757912|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2012-12-28|||February 2011||2011-02-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|CP||Effect of Body Position Changes on Endotracheal Tube Cuff Pressure in Ventilated Critically Ill Patients|Effect of Body Position Changes on Endotracheal Tube Cuff Pressure in Ventilated Critically Ill Patients.|Completed||N/A|12|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 02:09:15.392239|2017-10-11 02:09:15.392239
NCT01757899|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2016-10-24|||February 2014||2014-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|PEDALI||Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children|Phase II, Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Evaluate the Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children|Recruiting||Phase 2|30|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-11 02:09:15.483632|2017-10-11 02:09:15.483632
NCT01757886|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-22|2012-12-22|||November 2012||2012-11-01|December 2012|2012-12-01|November 2013|Anticipated|2013-11-01|November 2012|Actual|2012-11-01|12 Months|Observational [Patient Registry]|ARTERIA||inflAmmatory maRkers in Blood and Thrombus Aspirated From Patients With acutE myocaRdial Infarction With St-segment elevAtion||Unknown status|Recruiting|N/A|100|Anticipated|Fundación Canaria Rafael Clavijo para la Investigación Biomédica|||1||f||||||||||||||2017-10-11 02:09:15.612289|2017-10-11 02:09:15.612289
NCT01757873|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-12-11|||December 2012||2012-12-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|PHN||Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Z160 in Subjects With Postherpetic Neuralgia|Completed||Phase 2|144|Actual|Zalicus||2|||f||||t||||||||||2017-10-11 02:09:15.731496|2017-10-11 02:09:15.731496
NCT01757860|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-28|||September 2011||2011-09-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|CARD-024||Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CARD-024 (1α-Hydroxy-Vitamin-D5) in Healthy Subjects|Completed||Phase 1|34|Actual|Cardiavent Inc.||2|||f||||t||||||||||2017-10-11 02:09:15.92278|2017-10-11 02:09:15.92278
NCT01757847|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-10-06|2016-08-10||January 2013||2013-01-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Acceptance-based Group Intervention for Binge Eating|Acceptance-based Group Intervention for Binge Eating|Completed||N/A|90|Actual|VA Office of Research and Development||2|||f||||f||||||||No|Individual participant data is not available for data sharing but aggregate data may be available by contacting the PI.|2017-10-11 02:09:16.019865|2017-10-11 02:09:16.019865
NCT01757834|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-05-26|||November 2012||2012-11-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules|Efficacy of Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules|Unknown status|Enrolling by invitation|N/A|175|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 02:09:16.50977|2017-10-11 02:09:16.50977
NCT01757808|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-03-02|||August 2011||2011-08-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension|A Phase I Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension|Completed||Phase 1|12|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 02:09:16.961367|2017-10-11 02:09:16.961367
NCT01757795|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2012-12-28|||March 2013||2013-03-01|December 2012|2012-12-01|July 2014|Anticipated|2014-07-01|March 2014|Anticipated|2014-03-01||Interventional|||Safety, Tolerability and Pharmacokinetics of SP-8203|A Phase I Single-Center, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8203|Unknown status|Not yet recruiting|Phase 1|80|Anticipated|Shin Poong Pharmaceutical Co. Ltd.||2|||f||||f||||||||||2017-10-11 02:09:17.084194|2017-10-11 02:09:17.084194
NCT01757782|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-06-24|||December 2011||2011-12-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns|Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns: A Randomized Placebo Controlled Trial|Completed||Phase 4|96|Actual|Sir Takhtasinhji General Hospital||2|||f||||f||||||||||2017-10-11 02:09:17.210784|2017-10-11 02:09:17.210784
NCT01757769|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2014-04-28|||May 2011||2011-05-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01||Interventional|SiRE||Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia|Effectiveness and Safety of Silodosin in the Treatment of LUTS in Patients With Benign Prostatic Hyperplasia: a European Phase IV Clinical Study. The Silodosin in Real-life Evaluation Study|Completed||Phase 4|1036|Actual|Recordati Industria Chimica e Farmaceutica S.p.A.||1|||f||||f||||||||||2017-10-11 02:09:17.318744|2017-10-11 02:09:17.318744
NCT01757756|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-12-21|||October 2012||2012-10-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects|A Phase 1 Placebo-Controlled Study To Assess The Safety, Tolerability, Pharmacokinetics And Effect On Midazolam Pharmacokinetics Of Multiple Oral Doses Of PF-05175157 In Otherwise Healthy Overweight And Obese Subjects|Completed||Phase 1|12|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 02:09:17.436664|2017-10-11 02:09:17.436664
NCT01757743|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-04-08|||February 2013||2013-02-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Fluid Balance During Closure of Atrial Septal Defect|Protein Distribution and Colloid Osmotic Pressure in Children With Volume and Pressure Loading Due to Congenital Heart Defects|Completed||N/A|41|Actual|Oslo University Hospital|||2||f||||f||||||Samples Without DNA|"     Interstitial fluid Serum   "|Undecided||2017-10-11 02:09:17.572189|2017-10-11 02:09:17.572189
NCT01757730|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-09-26|||March 2012||2012-03-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|MRE||Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues|Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues|Recruiting||N/A|500|Anticipated|Ohio State University|||2||f||||t||||||||||2017-10-11 02:09:17.667021|2017-10-11 02:09:17.667021
NCT01757717|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-07-25|||January 2013||2013-01-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis|A Pilot Study of Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis|Completed||N/A|3|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:09:17.817056|2017-10-11 02:09:17.817056
NCT00000157|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||April 1982||1982-04-01|September 2009|2009-09-01|January 1988|Actual|1988-01-01|||||Interventional|||Randomized Trial of Aspirin and Cataracts in U.S. Physicians||Terminated||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:34.10364|2017-10-11 04:17:34.10364
NCT01757704|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2014-01-11|2013-10-08||September 2012||2012-09-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional||Only participants that did not fulfill intraoperative exclusion criteria continued throughout the study according to the study protocol and were included in baseline data analysis.|Factors Responsible for the Effectiveness of the Lund De-airing Technique|Factors Responsible for the Effectiveness of the Lund Technique for De-airing Following Open Left Heart Surgery.|Completed||N/A|20|Actual|Lund University|This study is a small single center study. Though randomized and controlled, the surgeon and anesthesiologist were not blinded to which arm a participant belonged to during the course of surgery.|2|||f||||f||||||||||2017-10-11 02:09:17.937411|2017-10-11 02:09:17.937411
NCT01757691|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-04-16|2015-04-16||August 2013||2013-08-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)|A 48-week, Double-blind, Randomized, Multi-center, Parallel-group Study Comparing Structural Changes in the Retina and Evolution of Visual Function After Immediate Versus Delayed Treatment With Fingolimod in Patients With Acute Demyelinating Optic Neuritis|Terminated||Phase 2|2|Actual|Novartis||2||"Discontinuation of this study was based on Novartis decision to discontinue development of   fingolimod for the treatment of ADON"|f||||t||||||||||2017-10-11 02:09:18.45273|2017-10-11 02:09:18.45273
NCT01757665|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-07-21|||December 2012||2012-12-01|July 2017|2017-07-01|February 2026|Anticipated|2026-02-01|August 2018|Anticipated|2018-08-01||Interventional|COMMENCE||ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)|ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000A and 11000M) With a New Tissue Treatment Platform (COMMENCE)|Active, not recruiting||N/A|777|Actual|Edwards Lifesciences||1|||f||||t||||||||||2017-10-11 02:09:18.859584|2017-10-11 02:09:18.859584
NCT01757639|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-09-19|||December 14, 2012|Actual|2012-12-14|September 2017|2017-09-01||||December 31, 2016|Actual|2016-12-31||Interventional|||Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia|A Phase 1 Study of Ipilimumab in Relapsed and Refractory High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia With Minimal Residual Disease|Active, not recruiting||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 02:09:19.053793|2017-10-11 02:09:19.053793
NCT01757626|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-02-06|||December 2012||2012-12-01|February 2017|2017-02-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma|Phase I/II Study of Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma|Recruiting||Phase 1/Phase 2|224|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:09:19.192609|2017-10-11 02:09:19.192609
NCT01757613|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-05-13|||December 2012||2012-12-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis|Three-armed, Randomized, Double-blind Dose-finding Trial on Efficiency and Safety of AK 3012 in 3 Different Concentrations in Patients With Actinic Keratosis Olsen Grade I/II|Completed||Phase 2|150|Anticipated|Dolorgiet GmbH & Co. KG||3|||f||||f||||||||||2017-10-11 02:09:19.315667|2017-10-11 02:09:19.315667
NCT01757600|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-21|||August 2010||2010-08-01|December 2012|2012-12-01||||November 2010|Actual|2010-11-01||Observational|||Microperimetry and Optical Coherence Tomography (OCT) in Idiopathic Macular Hole|Long-term Anatomical and Functional Outcomes of Idiopathic Macular Hole Surgery. The Yield of Spectral-domain OCT Combined With Microperimetry.|Completed||N/A|23|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||||||||||||2017-10-11 02:09:19.435974|2017-10-11 02:09:19.435974
NCT01757587|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2015-07-29|||December 2011||2011-12-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Galvus (Vildagliptin) vs Placebo in Combination With Metformin and Insulin|Evaluation of Galvus (Vildagliptin) Efficacy Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled by Metformin and Basal Insulin, This One Having Been Properly Titrated.|Completed||Phase 4|39|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||||2017-10-11 02:09:19.524981|2017-10-11 02:09:19.524981
NCT01757574|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-05-17|||November 2012|Actual|2012-11-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)|An Open-Label Trial of Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)|Withdrawn||Phase 4|0|Actual|Johns Hopkins University||1||"At the request of the global principal investigator, no subjects were enrolled in this study at   any site."|f||||t||||||||||2017-10-11 02:09:19.633081|2017-10-11 02:09:19.633081
NCT01757561|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-08-18|2015-03-23||December 2012||2012-12-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|||The Difference in Cerebral Oxygenation Between Propofol and Sevoflurane|The Difference in Cerebral Oxygenation Between Propofol and Sevoflurane|Completed||N/A|144|Actual|First Affiliated Hospital, Sun Yat-Sen University|||4||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 02:09:19.803604|2017-10-11 02:09:19.803604
NCT01757548|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2012-12-28|||December 2012||2012-12-01|December 2012|2012-12-01|November 2020|Anticipated|2020-11-01|November 2014|Anticipated|2014-11-01||Interventional|||The Effect and Prognosis of Different Operations on Varicocele - a Single-center Clinical Study|The Effect and Prognosis of Different Operations on Varicocele - a Single-center Clinical Study|Active, not recruiting||N/A|1000|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 02:09:20.45438|2017-10-11 02:09:20.45438
NCT01757340|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-03-24|||September 2012|Actual|2012-09-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Calorie Restriction With Leucine Supplementation|Calorie Restriction With Leucine Supplementation in Postmenopausal Women|Completed||N/A|43|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 02:09:24.709663|2017-10-11 02:09:24.709663
NCT01757535|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-10-02|||April 24, 2013|Actual|2013-04-24|October 2017|2017-10-01|April 30, 2019|Anticipated|2019-04-30|January 31, 2019|Anticipated|2019-01-31||Interventional|QUAZAR AML-001||Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission|A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Compare Efficacy and Safety of Oral Azacitidine Plus Best-supportive Care Versus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission|Recruiting||Phase 3|460|Anticipated|Celgene||2|||f||||t||||||||||2017-10-11 02:09:20.602885|2017-10-11 02:09:20.602885
NCT01757522|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-03-14|||January 2013||2013-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|STRAIN||Detection of Right Ventricular Dysfunction by 2D Strain During Acute Respiratory Distress Syndrom (ARDS)|Detection of Right Ventricular Dysfunction by 2D Strain During Acute Respiratory Distress Syndrom (ARDS)|Recruiting||N/A|290|Anticipated|University Hospital, Grenoble|||3||f||||f||||||Samples Without DNA|"     Plasmatic levels of NT proBNP and pre pro endothelin are monitored in ARDS group to determine     whether these biomarkers can help detect right ventricular dysfunction.   "|||2017-10-11 02:09:21.204244|2017-10-11 02:09:21.204244
NCT01757509|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2013-08-25|||December 2012||2012-12-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Randomized Controlled Feasibility Trial to Determine the Effectiveness of Set Dancing for People With Parkinson's Disease|A Randomized Controlled Feasibility Trial to Determine the Effectiveness of Set Dancing for People With Parkinson's Disease|Completed||N/A|24|Actual|University of Limerick||2|||f||||f||||||||||2017-10-11 02:09:21.321408|2017-10-11 02:09:21.321408
NCT01757496|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-11-30|||September 2012||2012-09-01|November 2015|2015-11-01||||December 2017|Anticipated|2017-12-01||Interventional|||Cough Assist in Bronchiolitis|Cough Assist in RSV-bronchiolitis|Active, not recruiting||N/A|20|Anticipated|University Hospital, Antwerp||2|||f||||f||||||||||2017-10-11 02:09:21.416236|2017-10-11 02:09:21.416236
NCT01757483|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-12-08|||November 2012||2012-11-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Canadian Ticagrelor Survey|Effectiveness of Risk Minimisation Interventions for Ticagrelor in Canada|Completed||N/A|244|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:09:21.555749|2017-10-11 02:09:21.555749
NCT01757470|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-08-30|||June 2012||2012-06-01|August 2016|2016-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Vandetanib Risk Minimisation Effectiveness|Effectiveness of Risk Minimisation Interventions for Vandetanib in Canada|Completed||N/A|12|Actual|Sanofi|||2||f||||f||||||||||2017-10-11 02:09:23.042189|2017-10-11 02:09:23.042189
NCT01757457|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2012-12-28|||April 2006||2006-04-01|December 2012|2012-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention|Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention.(Molecole di Adesione Nella Sindrome Coronarica Acuta|Completed||Phase 4|89|Actual|Azienda Ospedaliero Universitaria Maggiore della Carita||2|||f||||t||||||||||2017-10-11 02:09:23.148658|2017-10-11 02:09:23.148658
NCT01757444|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2015-07-02|||June 2013||2013-06-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Non Invasive Ventilation : Efficacy of a New Ventilatory Mode in Patients With OHS|Clinical Benefits and Tolerance to a New Ventilatory Mode in Patients With Obesity Hypoventilation Syndrome (OHS).|Unknown status|Recruiting|N/A|60|Anticipated|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche||2|||f||||t||||||||||2017-10-11 02:09:23.259593|2017-10-11 02:09:23.259593
NCT01757431|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-03-09|||May 16, 2012|Actual|2012-05-16|March 2017|2017-03-01|September 25, 2013|Actual|2013-09-25|September 24, 2013|Actual|2013-09-24||Interventional|||The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)||Completed||Phase 2|2|Actual|Alexion Pharmaceuticals||1|||f||||||||||||||2017-10-11 02:09:23.410493|2017-10-11 02:09:23.410493
NCT01757418|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-09-20|||November 2008||2008-11-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|September 2019|Anticipated|2019-09-01||Interventional|||Intravenous Gammaglobulin for Sickle Cell Pain Crises|Phase 1-2 Trial of Gamunex (Intravenous Gammaglobulin) for Sickle Cell Acute Pain|Recruiting||Phase 1/Phase 2|94|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 02:09:23.496543|2017-10-11 02:09:23.496543
NCT01757405|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2016-11-02|2016-08-31|2015-11-18|February 2013||2013-02-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen|A PHASE 3, PROSPECTIVE, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE SAFETY AND EFFICACY OF RECOMBINANT ACTIVATED FVII BI (rFVIIa BI) IN THE TREATMENT OF ACUTE BLEEDING EPISODES PER AN ON-DEMAND REGIMEN IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS|Completed||Phase 3|40|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-10-11 02:09:23.65151|2017-10-11 02:09:23.65151
NCT01757392|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2016-10-03|||September 2012||2012-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Candin Safety & Efficacy Study for the Treatment of Warts|Study of the Safety and Effectiveness of Candin for the Treatment of Common Warts|Active, not recruiting||Phase 2|39|Actual|Nielsen BioSciences, Inc.||1|||f||||f||||||||||2017-10-11 02:09:24.173669|2017-10-11 02:09:24.173669
NCT01757379|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2015-01-13|||April 2011||2011-04-01|January 2015|2015-01-01||||April 2012|Actual|2012-04-01||Interventional|||Determination of the Bioavailability of Short Chain Fatty Acids in Healthy Humans|Evaluation of the Bioavailability and Production of Short Chain Fatty Acids in the Colon. A Stable Isotope Study in Healthy Humans.|Completed||N/A|12|Actual|Katholieke Universiteit Leuven||4|||f||||f||||||||||2017-10-11 02:09:24.39877|2017-10-11 02:09:24.39877
NCT01757366|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2014-03-30|||December 2012||2012-12-01|December 2012|2012-12-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer|Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|100|Anticipated|Hebei Tumor Hospital||2|||f||||t||||||||||2017-10-11 02:09:24.49325|2017-10-11 02:09:24.49325
NCT01757353|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-02-26|||December 2012||2012-12-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Detroit Area Study of College Student Lifestyles||Completed||N/A|181|Actual|Wayne State University||3|||f||||||||||||||2017-10-11 02:09:24.587113|2017-10-11 02:09:24.587113
NCT01757327|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-04-24|||April 2014||2014-04-01|April 2015|2015-04-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Interventional|||LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer|A Randomized Placebo-Controlled Phase II Trial Evaluating the Effect of Hedgehog Inhibitor LDE225 on Bone Marrow Disseminated Tumor Cells in Women With Early Stage Estrogen Receptor Negative and HER2 Negative Breast Cancer|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||2||Poor accrual|f||||f||||||||||2017-10-11 02:09:24.794538|2017-10-11 02:09:24.794538
NCT01757314|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-09-27|||October 2012||2012-10-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Comparing Palpation Guided and Ultrasound Guided Arterial Line Placement|A Prospective Study Comparing Palpation Guided and Ultrasound Guided Arterial Catheter Placement by Anesthesiology Residents in Training|Terminated||N/A|4|Actual|Rutgers, The State University of New Jersey|||2|already several publications in the literature|f||||f||||||||||2017-10-11 02:09:24.893721|2017-10-11 02:09:24.893721
NCT01757301|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-08-17|||January 2, 2014|Actual|2014-01-02|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|July 31, 2017|Actual|2017-07-31||Interventional|CAMMPS||Comprehensive vs. Assisted Management of Mood and Pain Symptoms|Comprehensive vs. Assisted Management of Mood and Pain Symptoms (CAMMPS) Trial|Active, not recruiting||N/A|300|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 02:09:24.995552|2017-10-11 02:09:24.995552
NCT01757288|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-07-14|||March 2013||2013-03-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC|A RANDOMIZED PHASE I/II STUDY OF NAB-PACLITAXEL, OR PACLITAXEL, PLUS CARBOPLATIN WITH CONCURRENT RADIATION THERAPY FOLLoWED BY CONSOLIDATION IN PATIENTS WITH FAVORABLE PROGNOSIS INOPERABLE STAGE IIIA/B NON-SMALL CELL LUNG CANCER (NSCLC)|Recruiting||Phase 1/Phase 2|98|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 02:09:25.108747|2017-10-11 02:09:25.108747
NCT01757275|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2016-02-09|2015-12-16||February 2013||2013-02-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Among 222 randomised patients, 215 patients received iv treatment: 108 patients in the esomeprazole treatment group and 107 patients in the cimetidine treatment group.|High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer|A Multi-center, Randomised, Double-blind, Parallel-group Phase III Study to Assess High Dose Esomeprazole Na i.v. Treatment (Bolus Infusion of 80 mg Followed by a Continuous Infusion of 8 mg Per Hour Administered for 72 Hours) for Prevention of Rebleeding|Completed||Phase 3|239|Actual|AstraZeneca|No hypothesis testing was performed in this study and, as such, no formal statistical comparisons were made. Two patients who were initially randomised to receive cimetidine treatment actually received esomeprazole treatment.|2|||f||||||||||||||2017-10-11 02:09:25.270448|2017-10-11 02:09:25.270448
NCT01757262|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2013-05-10|||January 2013||2013-01-01|May 2013|2013-05-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patient|Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patients With Coronary Heart Disease: A Randomized, Open Label, Crossover Study|Withdrawn||Phase 3|0|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:09:26.119082|2017-10-11 02:09:26.119082
NCT01757249|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-11-11|||January 2013||2013-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Pituitary Down-regulation Before IVF for Women With Endometriosis|A Single Centre Open-label Randomised Controlled Trial of Long Term Pituitary Down-regulation Before in Vitro Fertilisation for Women With Endometriosis: a Pilot Study|Terminated||Phase 4|5|Actual|University of Oxford||2||Unable to recruit sufficient participants|f||||f||||||||||2017-10-11 02:09:26.208081|2017-10-11 02:09:26.208081
NCT01757236|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-05-27|||October 2012||2012-10-01|May 2014|2014-05-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|LIZ-BONE||Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection|Prospective,Randomized,Open Label,European Multicenter Study of the Efficacy of the Linezolid-rifampin Combination Versus Standard of Care in the Treatment of Gram-positive.|Unknown status|Recruiting|Phase 2|100|Anticipated|University Hospital, Tours||3|||f||||t||||||||||2017-10-11 02:09:26.314796|2017-10-11 02:09:26.314796
NCT01757223|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-05-23|||December 2018|Anticipated|2018-12-01|May 2017|2017-05-01|October 2030|Anticipated|2030-10-01|October 2030|Anticipated|2030-10-01||Interventional|||Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery|Phase I/II Study, Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector Expressing a cDNA/Genomic Hybrid of Human Vascular Endothelial Growth Factor to the Ischemic Myocardium...|Not yet recruiting||Phase 1/Phase 2|41|Anticipated|Weill Medical College of Cornell University||5|||f||||t|t|f||||||No||2017-10-11 02:09:26.511738|2017-10-11 02:09:26.511738
NCT01757210|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2013-08-21|||September 2012||2012-09-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients|A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients|Completed||N/A|20|Actual|West Virginia University Healthcare|||1||f||||t||||||||||2017-10-11 02:09:26.620366|2017-10-11 02:09:26.620366
NCT01757197|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-08-03|2017-04-28||November 7, 2013|Actual|2013-11-07|August 2017|2017-08-01|June 17, 2014|Actual|2014-06-17|June 17, 2014|Actual|2014-06-17||Interventional||Race (NIH/OMB)|Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)|Tocilizumab (an Anti-human IL-6 Receptor Monoclonal Antibody) as a First Line Therapy for Patients With Glucocorticoid-refractory Acute Graft vs. Host Disease (aGVHD) After Allogeneic Hematopoetic Stem Cell Transplant (HSCT), a Phase II Study.|Terminated||Phase 2|2|Actual|Weill Medical College of Cornell University||1||Slow accrual|f||||t||||||||||2017-10-11 02:09:26.728771|2017-10-11 02:09:26.728771
NCT01757184|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-02-13|2016-01-14||January 2013||2013-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||A Multicenter Study of SBC-102 (Sebelipase Alfa) in Patients With Lysosomal Acid Lipase Deficiency/ ARISE (Acid Lipase Replacement Investigating Safety and Efficacy)|A Multicenter, Randomized, Placebo-Controlled Study of SBC-102 in Patients With Lysosomal Acid Lipase Deficiency|Active, not recruiting||Phase 3|66|Actual|Alexion Pharmaceuticals||2|||f||||t||||||||||2017-10-11 02:09:27.018302|2017-10-11 02:09:27.018302
NCT01757171|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-02-28|||December 2012|Actual|2012-12-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|July 2016|Actual|2016-07-01||Interventional|||Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma|An Open-Labeled, Multicenter Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma|Active, not recruiting||Phase 2|85|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-11 02:09:28.095643|2017-10-11 02:09:28.095643
NCT01757158|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-01-26|||February 2012||2012-02-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2014|Actual|2014-06-01||Interventional|||Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients|Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients Who Are Not Candidates for Lobectomy or Patients With High Risk of Local Recurrence|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||No|There is no plan to share any individual participant data for this trial as it has not accrued any patients and is now closed.|2017-10-11 02:09:28.22074|2017-10-11 02:09:28.22074
NCT01757145|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2015-06-18|||January 2013||2013-01-01|February 2013|2013-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation|Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation|Unknown status|Recruiting|Phase 2|20|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-11 02:09:28.527371|2017-10-11 02:09:28.527371
NCT01757132|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-10-27|||August 2010||2010-08-01|October 2016|2016-10-01|December 2028|Anticipated|2028-12-01|December 2023|Anticipated|2023-12-01||Interventional|PAS-01||Post-Approval Study of the Implantable Miniature Telescope|Post-approval Study of VisionCare's Implantable Miniature Telescope (by Dr. Isaac Lipshitz) in Patients With Bilateral Severe to Profound Central Vision Impairment Assoc. With End-stage Age-related Macular Degeneration|Enrolling by invitation||N/A|770|Anticipated|VisionCare, Inc.||1|||f||||f||||||||||2017-10-11 02:09:28.656254|2017-10-11 02:09:28.656254
NCT01757119|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-04-14|||January 2013||2013-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia|Study of the Pharmacokinetics of Serum Iron After Single Oral Administration of Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia|Completed||Phase 1|55|Actual|Pierre Fabre Medicament||1|||f||||||||||||||2017-10-11 02:09:28.815518|2017-10-11 02:09:28.815518
NCT01757106|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2014-03-24|||December 2012||2012-12-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Xenon in Off-pump Coronary Artery Bypass Graft Surgery|The Safety and Feasibility of Administering Xenon to Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery: a Pilot Study|Completed||Phase 2|42|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 02:09:28.904639|2017-10-11 02:09:28.904639
NCT01757093|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2014-11-25|||June 2012||2012-06-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Evaluation of Oxygen Consumption and Energy Expenditure During Spontaneous Breathing Trial.|Evaluation of Oxygen Consumption and Energy Expenditure During Spontaneous Breathing Trial - A Randomized Crossover Controled Trial.|Completed||N/A|40|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:09:29.005541|2017-10-11 02:09:29.005541
NCT01757080|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-20|||January 2012||2012-01-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Cardiorespiratory Performance in Diabetic Elderly||Completed||N/A|40|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 02:09:29.113882|2017-10-11 02:09:29.113882
NCT01757067|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-06-20|||January 2013||2013-01-01|June 2017|2017-06-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|EVAC-HF||Early Elimination of Premature Ventricular Contractions in Heart Failure|EVAC-HF is a Prospective, Multi-center, Randomized Study to Compare the Effects on LV Systolic Function Following Radiofrequency Catheter Ablation of Frequent Premature Ventricular Contraction With Optimized Medical Therapy Alone.|Terminated||N/A|3|Actual|University of Maryland||2||Unable to recruit sufficient participants|f||||t||||||||No|"n|A"|2017-10-11 02:09:29.209848|2017-10-11 02:09:29.209848
NCT01757054|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-10-29|||February 2013||2013-02-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|LGG BB-12||Fecal Recovery of the Probiotic Bacteria Lactobacillus Rhamnosus GG (LGG) and Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) in Healthy Humans Following Daily Consumption of a Probiotic Supplement|Randomized, Two Arm, Parallel Group, Open Label, Single Center Prospective Study of the Fecal Recovery of Lactobacillus Rhamnosus GG (LGG) and Bifidobacterium Animalis Subspecies Lactis (BB-12) in Healthy Humans Following Daily Consumption of ProNutrients Probiotic Powder Sachet|Completed||Phase 4|27|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:09:29.317271|2017-10-11 02:09:29.317271
NCT01757041|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2014-12-18|||September 2011||2011-09-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|GBS||The Clinical and Molecular Epidemiology of Streptococcus Agalactiae Colonisation on the Kenyan Coast|The Clinical and Molecular Epidemiology of Streptococcus Agalactiae (Group B Streptococcus)Maternal Colonisation and Association With Adverse Perinatal Outcomes|Completed||N/A|7967|Actual|University of Oxford|||1||f||||f||||||||||2017-10-11 02:09:29.414461|2017-10-11 02:09:29.414461
NCT01757028|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2014-12-18|||January 2010||2010-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|KIPMAT||Risk Factors for Severe Morbidity and Mortality in Mothers and Neonates|Risk Factors for Severe Morbidity and Mortality in Mothers and Neonates|Unknown status|Recruiting|N/A|4600|Anticipated|University of Oxford|||1||f||||f||||||Samples With DNA|"     Cord blood Maternal blood   "|||2017-10-11 02:09:29.493576|2017-10-11 02:09:29.493576
NCT01757015|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-04-19|||April 2013||2013-04-01|August 2013|2013-08-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|GLOW8||Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS|A 26-week Multi-center Randomized Double-blind Study to Compare Efficacy and Safety of NVA237 Versus Placebo as an add-on to Maintenance Therapy With Fixed-dose Combination Salmeterol/Fluticasone Propionate in COPD Patients With Moderate to Severe Airflow Limitation|Withdrawn||Phase 3|0|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:09:29.566042|2017-10-11 02:09:29.566042
NCT01757002|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-08-08|||March 2013||2013-03-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|May 2015|Actual|2015-05-01||Interventional|PCC||Web-Based and Tailored Asthma Management Intervention (Puff City) in Teens With Asthma Attending Urban Clinics|Pragmatic Randomized Controlled Trial of the Web-Based Asthma Management Intervention (Puff City) in Teens With Asthma Attending Urban Clinics|Completed||N/A|266|Actual|Henry Ford Health System||2|||f||||t||||||||||2017-10-11 02:09:29.639697|2017-10-11 02:09:29.639697
NCT01756989|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2014-05-07|||January 2005||2005-01-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors|ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors|Completed||Phase 2|50|Anticipated|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-11 02:09:29.727126|2017-10-11 02:09:29.727126
NCT01756976|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-09-17|2013-09-17||December 2012||2012-12-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Clinical Evaluation of the OrthoPAT Advance System|Clinical Evaluation of the OrthoPAT Advance System|Completed||N/A|84|Actual|Haemonetics Corporation|||2||f||||f||||||||||2017-10-11 02:09:29.814126|2017-10-11 02:09:29.814126
NCT01756963|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-12-14|||November 2012||2012-11-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|||Diet and Disease Activity in Patients With Inflammatory Bowel Disease|Diet and Disease Activity in Patients With Inflammatory Bowel Disease|Recruiting||N/A|600|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-11 02:09:30.057214|2017-10-11 02:09:30.057214
NCT01756950|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2013-12-18|||January 2013||2013-01-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses|A Phase I, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CR8020, a Monoclonal Antibody Against Influenza A Viruses, Following Single-Dose and Repeat-Dose Intravenous Administration|Completed||Phase 1|64|Actual|Crucell Holland BV||12|||f||||t||||||||||2017-10-11 02:09:30.145862|2017-10-11 02:09:30.145862
NCT01756937|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-03-24|||January 2013||2013-01-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|October 2016|Actual|2016-10-01||Interventional|ABSOLUTE-R||Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee|A Six-month, Multi Center, Randomizied, Double Blind, Parallel-group,Placebo Controlled Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee|Completed||Phase 4|287|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:09:30.264719|2017-10-11 02:09:30.264719
NCT01756924|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-11-18||2014-11-06|December 2012||2012-12-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection||Terminated||Phase 2|14|Actual|Cempra Inc||2||"This study has been terminated; alternative study designs are being considered. Fusidic acid   remains available under an Expanded Access Protocol."|f||||f||||||||||2017-10-11 02:09:30.4131|2017-10-11 02:09:30.4131
NCT01756911|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-04-11|||March 2010||2010-03-01|April 2014|2014-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|STRATO||Evaluation of the Safety and Efficacy of the Multilayer Stent|Evaluation du Stent Multicouches Dans le Traitement Des anévrismes de l'Aorte Thoraco-abdominale|Completed||N/A|23|Actual|Cardiatis||1|||f||||t||||||||||2017-10-11 02:09:30.547006|2017-10-11 02:09:30.547006
NCT01756898|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-10-19||2014-06-03|December 2012||2012-12-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis|A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis|Completed||Phase 2|370|Actual|Daiichi Sankyo, Inc.||4|||f||||f||||||||||2017-10-11 02:09:30.669561|2017-10-11 02:09:30.669561
NCT01756885|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-04-28|||January 2013||2013-01-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Extended Varenicline Treatment for Smoking Among Cancer Patients|Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial|Recruiting||Phase 3|400|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 02:09:30.853704|2017-10-11 02:09:30.853704
NCT01756872|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-05-10|||June 2012||2012-06-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Clinical Measures of Ovarian Reserve in Predicting IVF Success|Determining the Accuracy of Clinical Measures of Ovarian Reserve in Predicting Successful In Vitro Fertilisation (IVF)Treatment.|Completed||N/A|204|Actual|University of Oxford|||1||f||||f||||||||||2017-10-11 02:09:30.973351|2017-10-11 02:09:30.973351
NCT01756859|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-01-14|||January 2013||2013-01-01|January 2014|2014-01-01||||June 2014|Anticipated|2014-06-01||Observational|MRQuee||MRI in Portal Hypertension|Quantitative Magnetic Resonance Imaging (MRI) Techniques in the Evaluation and Estimation of Portal Hypertension|Unknown status|Recruiting|N/A|49|Anticipated|University of Nottingham|||1||f||||f||||||Samples Without DNA|"     Blood, urine and stool samples.   "|||2017-10-11 02:09:31.056529|2017-10-11 02:09:31.056529
NCT01756833|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-03-15|||May 2013|Actual|2013-05-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|February 2019|Anticipated|2019-02-01||Interventional|N-TA^3CT||Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial|Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA^3CT)|Active, not recruiting||Phase 2|261|Actual|University of Maryland||2|||f||||t||||||||Yes||2017-10-11 02:09:31.292756|2017-10-11 02:09:31.292756
NCT01756820|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-05-10|||January 2013||2013-01-01|May 2016|2016-05-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|CTS-HV||Single-portal Endoscopic Carpal Tunnel Release Versus Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial|Single-portal Endoscopic Carpal Tunnel Release vs Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial.|Withdrawn||Phase 2|0|Actual|University of Ioannina||2||The principal investigator of the study relocated to another institution.|f||||f||||||||||2017-10-11 02:09:31.436751|2017-10-11 02:09:31.436751
NCT01756807|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-10-21|||December 2012||2012-12-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||EGO-COMBO Angiographic Extension Study|Evaluation of Endothelial ProGenitor Cell Capture Sirolimus-Eluting Stent by Optical Coherence Tomography: the COMBO Stent Angiographic Extension Study (EGO-COMBO Angiographic Extension Study)|Completed||N/A|41|Actual|The University of Hong Kong||1|||f||||t||||||||||2017-10-11 02:09:31.530751|2017-10-11 02:09:31.530751
NCT01756794|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-01-17|||December 2012||2012-12-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|QuickTrans||Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment|Validation of an Accelerated Procedure of Selection in Early Liver Transplantation for Severe Alcoholic Hepatitis Not Responding to Medical Treatment QuickTransHAA.|Active, not recruiting||N/A|263|Anticipated|University Hospital, Lille||2|||f||||f||||||||No||2017-10-11 02:09:31.628403|2017-10-11 02:09:31.628403
NCT01756781|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-10-06|||May 2013||2013-05-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.|A Phase 1 Randomized, Open-Label, 2-Sequence, 2-Period Crossover Study Of The Effect Of Multiple Doses Of PD-0332991 On Midazolam Pharmacokinetics In Healthy Women of Non-Childbearing Potential|Completed||Phase 1|26|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:09:31.786192|2017-10-11 02:09:31.786192
NCT01756768|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-12-16|||January 2013||2013-01-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Single-Radiolabeled Dose Mass Balance Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] Palbociclib (PD-0332991) In Healthy Male Volunteers|A Phase One Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] PD-0332991 In Healthy Male Volunteers|Completed||Phase 1|6|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 02:09:31.879254|2017-10-11 02:09:31.879254
NCT01756755|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-02-04|||December 2012||2012-12-01|February 2015|2015-02-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Endotoxin Adsorber Hemoperfusion and Microcirculation|The Effect of Endotoxin Adsorber Hemoperfusion on the Microcirculation in Patients With Severe Sepsis and Septic Shock|Unknown status|Recruiting|Phase 4|40|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:09:31.966747|2017-10-11 02:09:31.966747
NCT01756729|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-02-29|||December 2012||2012-12-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Post-approval Study of NovoTTF-100A in Recurrent GBM Patients|A Prospective, Non-randomized, Concurrent Control, Open Label, Post-approval Study of NovoTTF-100A in Recurrent GBM Patient|Terminated||Phase 4|13|Actual|NovoCure Ltd.||2||Amendment of Study Protocol|f||||f||||||||Undecided||2017-10-11 02:09:32.16057|2017-10-11 02:09:32.16057
NCT01756716|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-02-05|||December 2012||2012-12-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR|A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect on Urine Albumin-to-Creatinine Ratio (UACR), Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of MT-3995 as Add-on Therapy to ACE-I or ARB in Type II Diabetic Nephropathy Subjects With Albuminuria and an eGFR ≥30-<60 mL/Min/1.73m^2|Completed||Phase 2|49|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||||||||||||2017-10-11 02:09:32.334468|2017-10-11 02:09:32.334468
NCT01756703|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-02-05|||November 2012||2012-11-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria|A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect on Urine Albumin-to-Creatinine Ratio (UACR), Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of MT-3995 as Add-on Therapy to ACE-I or ARB in Type II Diabetic Nephropathy Subjects With Albuminuria and an eGFR ≥60 mL/Min/1.73m^2|Completed||Phase 2|67|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||||||||||||2017-10-11 02:09:32.651195|2017-10-11 02:09:32.651195
NCT01756690|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-01-27|||October 2011||2011-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2014|Actual|2014-10-01||Observational|||Predicting Lung Injury From Transfusion in Patients With Liver Disease|Endogenous Heparinoid Interference With Coagulation on Thromboelastogram as a Predictive Biomarker for Transfusion Related Acute Lung Injury (TRALI)|Terminated||N/A|16|Actual|University of Colorado, Denver|||1|Recruitment|f||||t||||||||||2017-10-11 02:09:32.849478|2017-10-11 02:09:32.849478
NCT01756651|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-05-10|||February 2013|Actual|2013-02-01|May 2017|2017-05-01|May 10, 2016|Actual|2016-05-10|May 10, 2016|Actual|2016-05-10||Interventional|||Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures|A Prospective Study Comparing the Efficacy and Safety of 100 mcg and 200 mcg of Intranasal Fentanyl Pectin Spray as an Analgesic in Adult Males Undergoing Outpatient Cystoscopic Procedures|Completed||Phase 1|20|Actual|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-10-11 02:09:33.04096|2017-10-11 02:09:33.04096
NCT01756638|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-10-30|||June 2012||2012-06-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer|A Phase II Study of JNJ-212082 (Abiraterone Acetate) in Metastatic Castration Resistant Prostate Cancer Patients Who Are Chemotherapy-Naïve|Completed||Phase 2|48|Actual|Janssen Research & Development, LLC||1|||f||||t||||||||||2017-10-11 02:09:33.21246|2017-10-11 02:09:33.21246
NCT01756625|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2012-12-20|||January 2010||2010-01-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|March 2012|Actual|2012-03-01||Observational|||PREMIUM, Observational Study|Factors Impacting on Efficacy and Compliance to Cetuximab Treatment in First Line WT KRAS Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|N/A|500|Actual|Institut Sainte Catherine|||1||f||||f||||||||||2017-10-11 02:09:33.413713|2017-10-11 02:09:33.413713
NCT00000158|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||February 1979||1979-02-01|June 2002|2002-06-01||||||||Interventional|||Macular Photocoagulation Study (MPS)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:34.158857|2017-10-11 04:17:34.158857
NCT01756612|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-07-12|||November 21, 2012|Actual|2012-11-21|July 2017|2017-07-01|March 25, 2015|Actual|2015-03-25|March 25, 2015|Actual|2015-03-25||Observational|||A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)|A Non-interventional Study to Assess the Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Patients Not in Dialysis Treated With Mircera®|Completed||N/A|551|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:09:33.536338|2017-10-11 02:09:33.536338
NCT01756599|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-10-16|||December 2012||2012-12-01|September 2015|2015-09-01|July 2023|Anticipated|2023-07-01|December 2022|Anticipated|2022-12-01||Interventional|||Multi-centre Prospective Cohort of Childhood Leukaemia: Determinants of Health and Quality of Life of the Patients After Treatment for an Acute Leukaemia During Childhood or Adolescence - LEA|Multi-centre Prospective Cohort of Childhood Leukaemia: Determinants of Health and Quality of Life of the Patients After Treatment for an Acute Leukaemia During Childhood or Adolescence - LEA|Recruiting||N/A|2900|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:09:33.947952|2017-10-11 02:09:33.947952
NCT01756586|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-05-24|2016-06-16||February 2013||2013-02-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Dexamethasone and Lower Extremity Block Duration||Terminated||Phase 4|4|Actual|University of Chicago||2||no logistical support to carry out the study fairly|f||||f||||||||||2017-10-11 02:09:34.052589|2017-10-11 02:09:34.052589
NCT01756547|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2012-12-26|||January 2013||2013-01-01|December 2012|2012-12-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|PRENECAL||Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature|Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature.|Unknown status|Not yet recruiting|Phase 3|74|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 02:09:34.557561|2017-10-11 02:09:34.557561
NCT01756534|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2012-12-26|||January 2011||2011-01-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|March 2013|Anticipated|2013-03-01||Interventional|||Oxidized Cellulose Hemostatic Agent in Thyroid Surgery: a Prospective Randomized Controlled Study|The Effectiveness of an Oxidized Cellulose Patch Hemostatic Agent in Thyroid Surgery: a Prospective Randomized Controlled Study|Unknown status|Active, not recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-11 02:09:34.706882|2017-10-11 02:09:34.706882
NCT01756521|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-04-25|||January 2013||2013-01-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||A Study Study to Investigate the Effect on QT/QTc Interval of Moxifloxacin After a Single Dose in Healthy Male Subjects|A Multi-center, Randomized, Open-label, Placebo-controlled, 3-way Crossover Study to Investigate the Effect on QT/QTc Interval of Moxifloxacin After a Single Dose in Healthy Male Subjects|Completed||Phase 1|39|Actual|Seoul National University Hospital||3|||f||||||||||||||2017-10-11 02:09:34.794475|2017-10-11 02:09:34.794475
NCT01756508|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-04-04|||March 2013||2013-03-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury|Study of Eculizumab for Prevention and Treatment Reperfusion Injury in Kidney Transplantation.|Recruiting||Phase 2|40|Anticipated|Russian Academy of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:09:34.885869|2017-10-11 02:09:34.885869
NCT01756495|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-06-06|||January 10, 2013|Actual|2013-01-10|June 2017|2017-06-01|April 23, 2013|Actual|2013-04-23|April 23, 2013|Actual|2013-04-23||Interventional|||A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin|A Single Center Phase 1 Double Blind Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects|Completed||Phase 1|56|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:09:34.994818|2017-10-11 02:09:34.994818
NCT01756482|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-08-03||2014-01-02|November 2012||2012-11-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Challenge||Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)|Phase 2a Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV-A Memphis 37b Strain)|Completed||Phase 2|140|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 02:09:35.117071|2017-10-11 02:09:35.117071
NCT01756469|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-01-08|||March 2011||2011-03-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|October 2012|Actual|2012-10-01||Interventional|||Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, Kenya|Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, Kenya|Completed||N/A|818|Actual|FHI 360||2|||f||||f||||||||||2017-10-11 02:09:35.214002|2017-10-11 02:09:35.214002
NCT01756456|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-02-06|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|April 2015|Actual|2015-04-01||Interventional|REPARO||Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.|An 8-week Phase I/II, Multicenter, Randomized, Double-masked, Vehicle Controlled Parallel Group Study With a 48 or 56 Week Follow-up Period to Evaluate the Safety and Efficacy of Two Doses (10 µg/ml and 20 µg/ml) of Recombinant Human Nerve Growth Factor Eye Drops Solution Versus Vehicle in Patients With Stage 2 and 3 of Neurotrophic Keratitis|Completed||Phase 1/Phase 2|174|Actual|Dompé Farmaceutici S.p.A||3|||f||||t||||||||||2017-10-11 02:09:35.330766|2017-10-11 02:09:35.330766
NCT01492634|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2014-02-27|||November 2011||2011-11-01|December 2011|2011-12-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Optimizing Fluid Status|Clinical Investigation Plan Optimizing Fluid Status|Completed||N/A|56|Actual|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-11 03:29:33.248481|2017-10-11 03:29:33.248481
NCT01756443|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-12-06|||August 2011||2011-08-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Sciatic Nerve Block for Ankle/Foot Surgeries. A Comparison Between a Premixed Solution of Lidocaine Plus Bupivacaine and Consecutive Infiltration of Lidocaine and Bupivacaine|Sciatic Nerve Block for Ankle/Foot Surgeries. A Comparison Between a Premixed Solution of Lidocaine Plus Bupivacaine and Consecutive Infiltration of Lidocaine and Bupivacaine. A Double Blinded Randomised Controlled Prospective Study|Completed||Phase 4|40|Actual|Cork University Hospital||2|||f||||f||||||||||2017-10-11 02:09:35.587119|2017-10-11 02:09:35.587119
NCT01756430|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-01-13|||December 2012||2012-12-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension|A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension|Completed||Phase 3|238|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:09:35.673311|2017-10-11 02:09:35.673311
NCT01756417|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-06-28|||October 2007||2007-10-01|June 2016|2016-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy Volunteers|An Open-Label, Fixed Sequence, Single and Multiple Dose Study in Male and Female Subjects to Investigate the Potential for Pharmacokinetic and Pharmacodynamic Interaction Between Metformin and JNJ-28431754|Completed||Phase 1|18|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 02:09:35.800415|2017-10-11 02:09:35.800415
NCT01756404|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-06-28|||June 2007||2007-06-01|June 2016|2016-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers|A Double-Blind, Randomized, Placebo-Controlled, Sequential Cohort Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of JNJ-28431754 in Otherwise Healthy Obese Male and Female Subjects|Completed||Phase 1|80|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||5|||f||||f||||||||||2017-10-11 02:09:35.90948|2017-10-11 02:09:35.90948
NCT01756391|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-12-04|2014-11-22||March 2008||2008-03-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|SICAS-1||Allergens in Inner-City Schools and Childhood Asthma|Allergens in Inner-City Schools and Childhood Asthma|Completed||N/A|351|Actual|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-11 02:09:36.055189|2017-10-11 02:09:36.055189
NCT01756378|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2012-12-20|||March 2011||2011-03-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Mulligan'Mobilization With Movement on Pain, Disability and Range of Motion in Patients With Knee Osteoarthritis|Effect of Mulligan'Mobilization With Movement on Pain, Disability and Range of Motion in Patients With Knee Osteoarthritis|Completed||N/A|30|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 02:09:36.261988|2017-10-11 02:09:36.261988
NCT01756365|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-02-24|||December 2012||2012-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CECA||Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency|Autologous Cultured Corneal Epithelium ( Culture d'épithélium cornéen Autologue CECA) for the Treatment of Unilateral Corneal Lesions Associated With Limbal Stem Cell Deficiency|Recruiting||Phase 1/Phase 2|15|Anticipated|CHU de Quebec-Universite Laval||1|||f||||||||||||||2017-10-11 02:09:36.358552|2017-10-11 02:09:36.358552
NCT01756352|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-08-28|||February 2013||2013-02-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||FET-PET for Evaluation of Response of Recurrent GBM to Avastin|"Assessment of the Utility of the Radiotracer FETin PET Imaging of Recurrent Glioblastoma Multiforme (GBM): Monitoring Early Response to Antiangiogenic Therapy"|Active, not recruiting||Phase 2|30|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:09:36.438862|2017-10-11 02:09:36.438862
NCT01756339|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-03-01||2014-11-06|December 2012||2012-12-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|SOLITAIRE-ORAL||Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia|A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in the Treatment of Adult Patients With Community-Acquired Bacterial Pneumonia|Completed||Phase 3|860|Actual|Cempra Inc||2|||f||||t||||||||||2017-10-11 02:09:36.545523|2017-10-11 02:09:36.545523
NCT01756326|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2013-11-22|||June 2012||2012-06-01|November 2013|2013-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase 2b/3 Study on Autologous Osteoblastic Cells Implantation in Hypotrophic Non-Union Fractures|A Pivotal Phase 2b/3, Multicentre, Randomised, Open, Controlled Study on the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB®) Implantation in Non-Infected Hypotrophic Non-Union Fractures|Unknown status|Recruiting|Phase 2/Phase 3|176|Anticipated|Bone Therapeutics S.A||2|||f||||t||||||||||2017-10-11 02:09:38.922326|2017-10-11 02:09:38.922326
NCT01756313|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-07-25|||May 2012||2012-05-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Optimizing Uptake of Methylaminolevulinat With Fractional Ablative Laser Technique||Completed||Phase 4|12|Actual|Bispebjerg Hospital||1|||f||||t||||||||||2017-10-11 02:09:39.172475|2017-10-11 02:09:39.172475
NCT01756300|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2015-10-15|2015-07-27||December 2012||2012-12-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|November 2013|Actual|2013-11-01||Interventional||All treated subjects who underwent the renal sympathetic denervation procedure.|RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension|A Prospective, Multi‐Center, Non‐Randomized Feasibility Study of Catheter‐Based Renal Denervation to Treat Resistant Hypertension (RENABLATE- EC12-02)|Completed||Phase 1|35|Actual|Biosense Webster, Inc.||1|||f||||t||||||||||2017-10-11 02:09:39.2907|2017-10-11 02:09:39.2907
NCT01756287|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2014-06-17|||August 2012||2012-08-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy of Chinese Ocular Exercise on Visual Acuity and Ocular Accommodation in Myopic Teenager|A Randomized Controlled Trial to Alter Ocular Accommodation in Myopic Teenager With Chinese Ocular Exercise|Completed||N/A|190|Actual|Beijing Tongren Hospital||3|||f||||t||||||||||2017-10-11 02:09:39.939707|2017-10-11 02:09:39.939707
NCT01450839|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2012-05-30|||September 2011||2011-09-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||E2022 Patch Formulation Multiple Dose Study|E2022 Patch Formulation Multiple Dose Phase I Study|Completed||Phase 1|16|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 03:44:18.297085|2017-10-11 03:44:18.297085
NCT01756274|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2016-12-30|2014-02-28||December 2012||2012-12-01|December 2016|2016-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Of 217 blood samples from 162 neonates 211(217-6) were included in data analysis. Two samples could not be used because they had been taken from sources that had not been specified in the protocol. Four samples had no reference method results due to laboratory errors.|Evaluation of Blood Glucose Monitoring Systems With Blood Samples From Neonates|Performance of Three Bayer Blood Glucose Monitoring Systems With Blood Samples From Neonates|Completed||N/A|162|Actual|Ascensia Diabetes Care||1|||f||||f||||||||No||2017-10-11 02:09:40.03963|2017-10-11 02:09:40.03963
NCT01756261|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-08-11|||January 11, 2013|Actual|2013-01-11|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|July 20, 2016|Actual|2016-07-20||Observational|||EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan|Special Drug Use Investigation of EYLEA for Quality of Life|Active, not recruiting||N/A|757|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:09:40.328385|2017-10-11 02:09:40.328385
NCT01756248|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-08-21|||December 26, 2012|Actual|2012-12-26|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan|Special Drug Use Investigation of EYLEA for AMD|Active, not recruiting||N/A|4017|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:09:40.433985|2017-10-11 02:09:40.433985
NCT01756235|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-20|2017-01-17|2016-10-26||December 2012||2012-12-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|PACE|Baseline analyses accounts for main analysis set (MAS) population (all participants who received at least 1 dose of study drug).|Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice|Physical ACtivity in patiEnts With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (PACE)|Completed||N/A|462|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 02:09:40.551762|2017-10-11 02:09:40.551762
NCT01756222|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-06-22|||April 2010||2010-04-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|30 Years|Observational [Patient Registry]|BAV||Bicuspid Aortic Valve (BAV) Registry|Bicuspid Aortic Valve and Ascending Aortic Aneurysm Registry|Recruiting||N/A|500|Anticipated|University of Michigan|||1||f||||t||||||Samples With DNA|"     Blood   "|Undecided||2017-10-11 02:09:41.672525|2017-10-11 02:09:41.672525
NCT01756183|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2012-12-19|||September 2011||2011-09-01|December 2012|2012-12-01|December 2016|Anticipated|2016-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer|Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Creating the Operation Chance in the Patients With Unresectable Gastric Cancer|Unknown status|Recruiting|Phase 2|60|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-11 02:09:41.950483|2017-10-11 02:09:41.950483
NCT01756170|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-04-27|||January 2011||2011-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients|Phase III Randomized Trial of Comparing Chemoradiotherapy vs. Radiotherapy Alone in Lymph Node Negative Patients With Early-Stage Cervical Cancer Following Radical Hysterectomy|Recruiting||Phase 3|200|Anticipated|Wenzhou Medical University||2|||f||||f||||||||||2017-10-11 02:09:42.06452|2017-10-11 02:09:42.06452
NCT01756157|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2015-05-29|2015-05-29|2015-02-19|December 2012||2012-12-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional||Intent-to-treat safety (ITT-S) population included all participants who received any amount of study drug.|Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks|A Phase 2, Randomized, Double-Blind, Multicenter, Dose-Ranging, Crossover Study to Evaluate the Safety and Efficacy of Subcutaneous Administration of CINRYZE® (C1 Esterase Inhibitor [Human]) With Recombinant Human Hyaluronidase (rHuPH20) for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema|Completed||Phase 2|47|Actual|Shire|Results of efficacy endpoints (time to first angioedema attack, effects of C1 inhibitor and C4 levels on clinical outcome during treatment period) were not reported due to early termination of the study but later completed for safety data.|2|||f||||f||||||||||2017-10-11 02:09:42.206266|2017-10-11 02:09:42.206266
NCT01756144|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-05-26|||July 2015||2015-07-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport|rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport|Unknown status|Not yet recruiting|N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 02:09:42.671208|2017-10-11 02:09:42.671208
NCT01756131|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-05-16|||September 2010||2010-09-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects|An Observer- and Subject-Blinded, Randomized, Placebo-Controlled, Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects|Completed||Phase 1|72|Actual|ViiV Healthcare||9|||f||||f||||||||||2017-10-11 02:09:42.749806|2017-10-11 02:09:42.749806
NCT01756118|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-08-16|||June 2012||2012-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia|A Phase I, Dose-finding Study of the Oral, Dual Phosphatidylinositol 3(PI3)-Kinase / Mammilian Target of Rapamycin (mTOR) Inhibitor BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia|Active, not recruiting||Phase 1|23|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||||2017-10-11 02:09:42.873377|2017-10-11 02:09:42.873377
NCT01756105|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-09-07|||June 2012|Actual|2012-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women|Gestational Diabetes in Non Obese Women and Metformine|Active, not recruiting||Phase 2|84|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 02:09:42.964005|2017-10-11 02:09:42.964005
NCT01756092|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-10-19|||July 2011||2011-07-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Treatment of Benign Breast Deformities and Post-Segmental Mastectomy Breast Deformities With Autologous Fat Grafting (AFT)|Treatment of Benign Breast Deformities and Post-Segmental Mastectomy Breast Deformities With Autologous Fat Grafting (AFT)|Withdrawn||N/A|0|Actual|University of Pittsburgh||1||Because funding was not secured, the study was never initiated. 0 subjects enrolled|f||||t||||||||||2017-10-11 02:09:43.064456|2017-10-11 02:09:43.064456
NCT01756079|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-02-24|2016-09-29||February 2013||2013-02-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||All participants who received PegIFN-2b + RBV during the Lead-in Period|A Study to Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)|A Multi-centre Single-arm Study to Evaluate the Efficacy and Safety of BOCEPREVIR 44 Weeks in Addition to Standard of Care (SOC) in Previously Treatment Failure (Relapser, Non-responders, Both Partial and Null) Patients With Chronic Hepatitis C Genotype 1 (G1) and Cirrhosis (F4 Metavir). (MK-3034-105)|Completed||Phase 4|58|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:09:43.181139|2017-10-11 02:09:43.181139
NCT01756066|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-12-18|||January 2013||2013-01-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||A Test of Different Degrees of Cost Sharing on Program Uptake and Attendance|A Test of Different Degrees of Cost Sharing on Program Uptake and Attendance|Completed||N/A|1239|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 02:09:43.683852|2017-10-11 02:09:43.683852
NCT01756053|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2014-10-23|2014-09-23||March 2013||2013-03-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effects of ABT-089 on Smoking Abstinence Symptoms and Reward|A Pilot Feasibility Study of the Effects of ABT-089 on Smoking Abstinence Symptoms and Reward|Terminated||Phase 2|17|Actual|University of Pennsylvania|The study was terminated early due to the results of an interim futility analysis.|2||Trial discontinued based on the results of an interim futility analysis.|f||||t||||||||||2017-10-11 02:09:43.806485|2017-10-11 02:09:43.806485
NCT01756040|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-06-23|||February 2013||2013-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|IPPI||Intestinal Permeability in Preterm Infants|Gut Permeability in Very Low Birth Weight Infants|Active, not recruiting||Phase 1|50|Anticipated|University of Maryland||1|||f||||t||||||||||2017-10-11 02:09:44.309241|2017-10-11 02:09:44.309241
NCT01756027|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-11-18|||November 2012||2012-11-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|||Feasibility Study: Ulthera System for the Treatment of Rosacea|Feasibility Study: Evaluation of the Effectiveness and Safety of the Ulthera® System for Treatment of Erythematotelangiectatic Rosacea|Completed||N/A|12|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-11 02:09:44.423434|2017-10-11 02:09:44.423434
NCT01756014|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2012-12-21|||January 2012||2012-01-01|December 2012|2012-12-01||||December 2012|Anticipated|2012-12-01||Observational|BRAIN-HF||Brain Function and Perfusion in Patients With Heart Failure|Brain Function and Perfusion in Patients With Heart Failure|Unknown status|Recruiting|N/A|45|Anticipated|University Medical Center Groningen|||3||f||||f||||||||||2017-10-11 02:09:44.529107|2017-10-11 02:09:44.529107
NCT01756001|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-05-08|||February 2015||2015-02-01|May 2017|2017-05-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Observational|||GlowCaps Adherence Randomized Control Trial|Using Behavioral Economics to Promote Medication Adherence and Habit Formation|Completed||N/A|119|Actual|University of Pennsylvania|||4||f||||f|f|f||||||No|Individual participant data will not be made available to other researchers. All data will be de-identified, aggregated, and summarized.|2017-10-11 02:09:44.638018|2017-10-11 02:09:44.638018
NCT01755988|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-01-04|||September 2013||2013-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effectiveness of a Website and Telemonitoring in Patients With Heart Failure.|Effectiveness of an Interactive Web-based Platform and a Disease Specific Information Website in Patients With Heart Failure: a 3-arm Randomised Trial.|Completed||N/A|450|Actual|UMC Utrecht||3|||f||||f||||||||||2017-10-11 02:09:44.774059|2017-10-11 02:09:44.774059
NCT01755975|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-09-21|||December 2012||2012-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma|A Phase Ib/IIa Study of Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma|Active, not recruiting||Phase 1/Phase 2|62|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:09:44.916125|2017-10-11 02:09:44.916125
NCT01755962|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2012-12-19|||April 2012||2012-04-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|GET FIT||Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity|Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity|Unknown status|Recruiting|N/A|160|Anticipated|University of California, Los Angeles||4|||f||||f||||||||||2017-10-11 02:09:45.041063|2017-10-11 02:09:45.041063
NCT01755949|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-03-24|||March 2013||2013-03-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Colchicine and CRP in Atrial Fibrillation and AF Ablation|Impact and Time Course of Colchicine Therapy on C-reactive Protein Elevation in Chronic Atrial Fibrillation (AF) and Post AF Ablation|Unknown status|Recruiting|Phase 2|60|Anticipated|Mayo Clinic||6|||f||||f||||||||||2017-10-11 02:09:45.18939|2017-10-11 02:09:45.18939
NCT01755936|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-08-29|||January 2012||2012-01-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||The Role of Myocardial Fibrosis in Patients With Aortic Stenosis|The Role of Myocardial Fibrosis in Patients With Aortic Stenosis|Recruiting||N/A|240|Anticipated|University of Edinburgh|||2||f||||t||||||Samples Without DNA|"     Full blood count and renal panel will be measured.   "|||2017-10-11 02:09:45.305948|2017-10-11 02:09:45.305948
NCT01755923|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-19|||December 2012||2012-12-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC|A Phase Ⅱ Randomized Controlled Trial to Compare Gefitinib With Docetaxel as Second-line Therapy for Advanced or Metastatic Non-squamous NSCLC Patients With Wild-type EGFR|Unknown status|Recruiting|Phase 2|60|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 02:09:45.418836|2017-10-11 02:09:45.418836
NCT01755910|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2014-07-09|||December 2014||2014-12-01|July 2014|2014-07-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Observational|||Effect of Thoracic Paravertebral Block on Heart Rate Variability (HRV)|Effect of Thoracic Paravertebral Block on the Autonomous System as Measured by Heart Rate Variability (HRV)|Unknown status|Not yet recruiting|N/A|100|Anticipated|Larissa University Hospital|||2||f||||f||||||||||2017-10-11 02:09:45.577446|2017-10-11 02:09:45.577446
NCT01755884|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-03-19|||August 2009||2009-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Oral Desensitization to Wheat in School Aged Children|Oral Desensitization to Wheat in Children Over 6 Years of Age With Wheat Allergy|Completed||N/A|100|Actual|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-11 02:09:45.806336|2017-10-11 02:09:45.806336
NCT01755871|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-06-08|||January 2013||2013-01-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|BiobankII||Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis|The Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis|Terminated||Phase 4|8|Actual|Heinrich-Heine University, Duesseldorf||1||lack of recruitment|f||||f||||||||||2017-10-11 02:09:45.923685|2017-10-11 02:09:45.923685
NCT01755858|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-06-03|||December 2012||2012-12-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|EVOLVE||Study to Assess the Effects of Intravenous Bendavia in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA)|A Phase 2a, Randomized, Placebo-controlled, Single Center Trial to Evaluate the Impact of Intravenous Bendavia™ (MTP-131) on Ischemia Reperfusion Injury in Atherosclerotic Renal Artery Stenosis in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA)|Terminated||Phase 1/Phase 2|17|Actual|Stealth BioTherapeutics Inc.||2|||f||||f||||||||||2017-10-11 02:09:46.017227|2017-10-11 02:09:46.017227
NCT01755845|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-04-27|||January 2011||2011-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients|Phase III Randomized Study of Concurrent Paclitaxel/Cisplatin Chemotherapy and Radiotherapy With or Without Consolidation Chemotherapy in High-Risk Patients With Early-Stage Cervical Cancer Following Radical Hysterectomy|Recruiting||Phase 3|300|Anticipated|Wenzhou Medical University||2|||f||||t||||||||||2017-10-11 02:09:46.139204|2017-10-11 02:09:46.139204
NCT01755832|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2015-01-08|||September 2012||2012-09-01|December 2012|2012-12-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Observational|||Heated Pool Exercise Groups for Patients With Rheumatic Diseases|Better Everyday-life With Heated Pool Exercise Groups for Patients With Inflammatory Rheumatic Diseases|Completed||N/A|36|Actual|National Resource Center for Rehabilitation in Rheumatology|||1||f||||f||||||||||2017-10-11 02:09:46.28865|2017-10-11 02:09:46.28865
NCT01755819|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-01-15|||January 2013||2013-01-01|January 2013|2013-01-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Outcome and Tunnel Widening After ACL Reconstruction: Comparison of Aperture and Cortical Fixation|Clinical Outcome and Tunnel Widening After Hamstring Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Computed Tomography - Based Trial Comparing Aperture With Cortical Fixation|Unknown status|Recruiting|N/A|60|Anticipated|Medical University Innsbruck||2|||f||||t||||||||||2017-10-11 02:09:46.389824|2017-10-11 02:09:46.389824
NCT01755806|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-21|||January 2012||2012-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||Comparison of Aortic Root Dimension Changes During Cardiac Cycle Between the Patients With and Without Aortic Valve Calcification Using ECG-gated 64-slice and Dual-source 256-slice Computed Tomography Scanners: Results of a Multicenter Study||Completed||N/A|104|Actual|Modarres Hospital|||2||f||||f||||||||||2017-10-11 02:09:46.485845|2017-10-11 02:09:46.485845
NCT01755780|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2014-07-09|||December 2012||2012-12-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|January 2015|Anticipated|2015-01-01||Observational|||Effect of the Side of Interscalene Block on Bradycardia and Hypotension in Beach Chair Position|The Effect of the Side of Interscalene Block on the Occurrence of Bradycardia and Hypotension During Shoulder Surgery in the Beach Chair Position|Unknown status|Recruiting|N/A|50|Anticipated|Larissa University Hospital|||2||f||||f||||||||||2017-10-11 02:09:46.556711|2017-10-11 02:09:46.556711
NCT01755767|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-06-07|||December 2012||2012-12-01|June 2017|2017-06-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|METIV-HCC||Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy|A Phase 3, Randomized, Double-Blind Study of Tivantinib (ARQ 197) in Subjects With MET Diagnostic-High Inoperable Hepatocellular Carcinoma Treated With One Prior Systemic Therapy|Completed||Phase 3|383|Actual|Daiichi Sankyo, Inc.||3|||f||||t||||||||||2017-10-11 02:09:46.67031|2017-10-11 02:09:46.67031
NCT01755754|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-09-26|||August 2013||2013-08-01|September 2017|2017-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring|A Multicenter, Open-label, Randomized, Two-period, Crossover Non-inferiority Trial to Assess the Functionality of Female Condoms With a Silicone Elastomer Vaginal Ring|Completed||Phase 1|160|Actual|International Partnership for Microbicides, Inc.||2|||f||||f|t|||||||||2017-10-11 02:09:47.191187|2017-10-11 02:09:47.191187
NCT01755741|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-09-07|||February 2013||2013-02-01|September 2017|2017-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng|A Multicenter, Open-Label, Randomized, Two-Period, Crossover Non-inferiority Trial to Assess the Functionality of Male Condoms With a Silicone Elastomer Vaginal Ring|Completed||Phase 2|70|Actual|International Partnership for Microbicides, Inc.||2|||f||||f|t|f||||||||2017-10-11 02:09:47.3136|2017-10-11 02:09:47.3136
NCT01755728|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2017-02-22|||January 2013||2013-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants|Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants|Recruiting||Phase 3|20|Anticipated|Hillel Yaffe Medical Center||5|||f||||f||||||||No||2017-10-11 02:09:47.431863|2017-10-11 02:09:47.431863
NCT01755715|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-08-16|||January 2013||2013-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Immediate Versus Later Insertion of IUD After Medical Termination of Pregnancy|Immediate Versus Later Insertion of IUD After Medical Termination of Pregnancy|Active, not recruiting||N/A|300|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 02:09:47.597013|2017-10-11 02:09:47.597013
NCT01755702|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-03-12|2014-01-16||July 2009||2009-07-01|November 2014|2014-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Paracetamol With Caffeine to Treat Episodic Tension Type Headache|A Study to Assess the Efficacy of Paracetamol Taken in Combination With Caffeine for the Treatment of Episodic Tension Type Headache|Terminated||Phase 2/Phase 3|66|Actual|GlaxoSmithKline||4||"Study was terminated due to unforeseen difficulties with subject recruitment. No safety issues   were identified in the study with this new formulation."|f||||f||||||||||2017-10-11 02:09:47.700444|2017-10-11 02:09:47.700444
NCT01755676|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-01-25|||September 2016|Actual|2016-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults|A Prospective Study, Parallel, Double-blind, Multicenter for Evaluation of Efficacy of Orlistat 60 mg as Adjuvant Treatment of Obesity in Adults|Recruiting||Phase 3|570|Anticipated|EMS||2|||f||||t|f|f||||||||2017-10-11 02:09:48.937111|2017-10-11 02:09:48.937111
NCT01755663|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2014-10-27|||December 2014||2014-12-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|IMAGE||Comparison of Efficacy of Ivabradine Versus Metoprolol|Comparison of Efficacy and Safety of Ivabradine Versus Metoprolol for Controlling Heart Rate Prior to 640-Slice Computed Tomographic Angiography in Elective Patients|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Phramongkutklao College of Medicine and Hospital||2|||f||||t||||||||||2017-10-11 02:09:49.072933|2017-10-11 02:09:49.072933
NCT01755650|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2012-12-19|||October 2011||2011-10-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|January 2013|Anticipated|2013-01-01||Interventional|||Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies|A Phase 0 Exploratory Microdosing Study of S-(3-18Ffluoropropyl)Homocysteine Hydrochloride; 18FFPM Using PET/CT in Patients With a Variety of Malignancies.|Unknown status|Recruiting|Early Phase 1|20|Anticipated|Cooperative Research Centre for Biomedical Imaging Development||2|||f||||t||||||||||2017-10-11 02:09:49.21457|2017-10-11 02:09:49.21457
NCT01755637|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-07-11|2013-03-21||April 2012||2012-04-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population|A Single-dose, Two-centre, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Two Kinds of AlbendazoleTablet Formulations in Healthy Chinese Adult Males|Completed||Phase 1|56|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:09:49.338954|2017-10-11 02:09:49.338954
NCT01755624|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-09-20|||January 2013||2013-01-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)|A Phase II Randomized Study of TTField Therapy (150 kHz) Versus Supportive Care in Non-small Cell Lung Cancer Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment|Active, not recruiting||Phase 2|18|Actual|NovoCure Ltd.||2|||f||||f||||||||||2017-10-11 02:09:49.811593|2017-10-11 02:09:49.811593
NCT01755611|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-06-21|||June 17, 2011|Actual|2011-06-17|June 2017|2017-06-01|June 25, 2011|Actual|2011-06-25|June 25, 2011|Actual|2011-06-25||Interventional|||Bioequivalence Minocycline Bioequivalence|Bioequivalence Study Between Two Medications for Oral Administration of Minocycline in 100 mg Oral Solids in Healthy Volunteers|Completed||Phase 1|25|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:09:49.94533|2017-10-11 02:09:49.94533
NCT01755598|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-06-15|||August 19, 2014|Actual|2014-08-19|June 2017|2017-06-01|October 22, 2018|Anticipated|2018-10-22|October 22, 2018|Anticipated|2018-10-22||Interventional|||Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults|Efficacy of GSK Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 Against TB Disease, in Adults Living in a TB Endemic Region|Active, not recruiting||Phase 2|3506|Anticipated|GlaxoSmithKline||2|||f|||||f|f||||||||2017-10-11 02:09:50.075972|2017-10-11 02:09:50.075972
NCT01755585|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2014-01-19|||July 2011||2011-07-01|January 2014|2014-01-01||||December 2015|Anticipated|2015-12-01||Observational|||Irradiation Modulates the Pharmacokinetics of Anticancer Drugs||Unknown status|Enrolling by invitation|N/A|40|Anticipated|Far Eastern Memorial Hospital|||2||f||||||||||Samples With DNA|"     whole blood collection   "|||2017-10-11 02:09:50.221029|2017-10-11 02:09:50.221029
NCT00000159|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||August 1983||1983-08-01|October 1999|1999-10-01||||||||Interventional|||Sorbinil Retinopathy Trial (SRT)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:34.233407|2017-10-11 04:17:34.233407
NCT01755559|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-11-26|||June 2013||2013-06-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger|Efficacy of Artesunate-amodiaquine, Dihydroartemisinin-piperaquine and Artemether-lumefantrine Combination Therapies for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Aged 6 to 59 Months in Maradi, Niger 2012-13|Completed||Phase 4|663|Actual|Epicentre||3|||f||||f||||||||||2017-10-11 02:09:50.434582|2017-10-11 02:09:50.434582
NCT01755546|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-01-12|||December 2012||2012-12-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Long-term Open-Label Safety Study to Evaluate EN3409|A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time|Completed||Phase 3|554|Actual|BioDelivery Sciences International||1|||f||||f||||||||||2017-10-11 02:09:50.553697|2017-10-11 02:09:50.553697
NCT01755533|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-21|2017-04-18|||February 2008||2008-02-01|April 2017|2017-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Adaptation Processes in School-Based Substance Abuse Programs|Adaptation Processes in School-Based Substance Abuse Programs|Completed||N/A|2827|Actual|Penn State University||3|||f||||f||||||||||2017-10-11 02:09:50.762111|2017-10-11 02:09:50.762111
NCT01755520|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-06-23|||April 2013||2013-04-01|June 2016|2016-06-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Interventional|TiCAB||Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG|A Randomized, Parallel Group, Double-Blind Study of Ticagrelor Compared With Aspirin for Prevention of Vascular Events in Patients Undergoing Coronary Artery Bypass Graft Operation TiCAB- Ticagrelor in CABG|Recruiting||Phase 3|3850|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||Undecided||2017-10-11 02:09:50.863572|2017-10-11 02:09:50.863572
NCT01755507|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-08-02|||December 2012||2012-12-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|NUC-3||Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis|Double-blind,Randomized, Placebo-controlled, Phase II Dose-finding Study Comparing Different Doses of Norursodeoxycholic Acid Capsules With Placebo in the Treatment of Primary Sclerosing Cholangitis|Completed||Phase 2|159|Actual|Dr. Falk Pharma GmbH||4|||f||||f||||||||||2017-10-11 02:09:51.336353|2017-10-11 02:09:51.336353
NCT01755494|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-12-12|||February 2013||2013-02-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|SAXA||A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration|A Single-centre, Randomized, Open-label, Two-period, Cross-over, Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration of the Individual Components in Two Cohorts of Healthy Chinese Subjects Under Fed Conditions|Completed||Phase 1|64|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:09:51.457708|2017-10-11 02:09:51.457708
NCT01755481|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-01-25|||December 2012||2012-12-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate|Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate|Recruiting||N/A|800|Anticipated|Arla Foods||2|||f||||f||||||||||2017-10-11 02:09:51.619633|2017-10-11 02:09:51.619633
NCT01755468|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-03-22|||April 2013||2013-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)|A Randomized Controlled Trial to Evaluate Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes: REmission Studies Evaluating Type 2 DM - Intermittent Insulin Therapy (RESET-IT Pilot Study)|Active, not recruiting||Phase 3|24|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-10-11 02:09:51.71128|2017-10-11 02:09:51.71128
NCT01755455|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-02-07|2013-12-31||June 2011||2011-06-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis|Iron Supplementation for the Hypoferremic Anemia of Cystic Fibrosis|Completed||N/A|22|Actual|Dartmouth-Hitchcock Medical Center|The power to detect changes in Akron PES was 42%; 160 subjects would be needed to ensure that exacerbation risk was lower for ferrous sulfate with 80% power and p <0.05.|2|||f||||f||||||||||2017-10-11 02:09:51.828251|2017-10-11 02:09:51.828251
NCT01755442|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-04-19|||November 2012||2012-11-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects|A Phase 1, Double-blind, Randomized, 2-Way Crossover, Placebo-controlled Study to Investigate the Effect of AMG 151 on 24-hour Ambulatory Blood Pressure and Glucose Levels in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 1|5|Actual|Amgen||2||Amgen determined no further need for this study.|f||||f||||||||||2017-10-11 02:09:52.153413|2017-10-11 02:09:52.153413
NCT01755429|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-21|||May 2012||2012-05-01|February 2012|2012-02-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Observational|||To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients|A Research Study to Describe the Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS). An Assessment of Two Case Studies|Completed||N/A|2|Actual|Alexion Pharmaceuticals|||1||f||||f||||||||||2017-10-11 02:09:52.259092|2017-10-11 02:09:52.259092
NCT01755416|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-06-22|||January 2013||2013-01-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting|Phase 1 Study of Medtronic Closed Loop Device With ePID Algorithm and Enlite Sensors on Adjuvant Therapy With Insulin and Liraglutide to Minimize Post-prandial Hyperglycemia|Completed||Phase 1|15|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 02:09:52.330908|2017-10-11 02:09:52.330908
NCT01755403|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-05-25|||December 2012||2012-12-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|CINEBENZ||Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease|Population Pharmacokinetics in Benznidazole-treated Adults With Chronic Chagas Disease. Benznidazole Pharmacokinetics and Adverse Reactions Relationship.|Completed||Phase 4|52|Actual|Barcelona Centre for International Health Research||1|||f||||f||||||||||2017-10-11 02:09:52.441298|2017-10-11 02:09:52.441298
NCT01751841|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-01-12|||May 2012||2012-05-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Observational|||Outcome Analysis for Minimally Invasive Spine Surgery|Outcome Analysis for Minimally Invasive Spine Surgery|Recruiting||N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-10-11 02:10:56.907366|2017-10-11 02:10:56.907366
NCT01755390|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-21|||October 1999||1999-10-01|December 2012|2012-12-01|October 2002|Actual|2002-10-01|August 2002|Actual|2002-08-01||Interventional|||A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors|A Phase I Dose Finding Study of XRP6258 Administered as a Weekly 1-hour Intravenous Infusion to Patients With Advanced Solid Tumors|Completed||Phase 1|42|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:09:52.516525|2017-10-11 02:09:52.516525
NCT01755377|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-08-19|||December 2012||2012-12-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Observational|BIOMARCHA||New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease|Evolution of Serologic Biomarkers and Diastolic Function and Segmentary Contractility Determined by Echocardiography After Treatment in Chagas Diseases|Completed||N/A|63|Actual|Barcelona Centre for International Health Research|||2||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:09:52.605494|2017-10-11 02:09:52.605494
NCT01755364|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-19|||November 2012||2012-11-01|December 2012|2012-12-01|February 2013|Anticipated|2013-02-01|January 2013|Anticipated|2013-01-01||Interventional|||A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old||Unknown status|Recruiting|Phase 3|120|Anticipated|Adimmune Corporation||1|||f||||f||||||||||2017-10-11 02:09:52.672778|2017-10-11 02:09:52.672778
NCT01755351|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-01-02|||December 2011||2011-12-01|January 2013|2013-01-01||||December 2012|Actual|2012-12-01|1 Year|Observational [Patient Registry]|||Comparative Study About the Influence of Diabetes Diatress and Depression on Treatment Adherence in Chinese Type 2 Diabetes Patients||Completed||N/A|200|Actual|Shandong Provincial Hospital|||1||f||||||||||||||2017-10-11 02:09:52.74615|2017-10-11 02:09:52.74615
NCT01755338|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-05-31|||December 2012||2012-12-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Effect of Steroids on Cerebral Inflammation and Neuronal Damage After Surgical Aortic Valve Replacement|Effect of Steroids on Cerebrospinal Fluid Markers of Inflammation and Neuronal Damage After Surgical Aortic Valve Replacement|Completed||N/A|30|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-11 02:09:52.819306|2017-10-11 02:09:52.819306
NCT01755325|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-08-02|||November 2012||2012-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+|Phase III Study of Compound Realgar Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult Patients With Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|Enrolling by invitation||Phase 3|680|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-11 02:09:52.914444|2017-10-11 02:09:52.914444
NCT01755312|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-08-26|||June 2013||2013-06-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes|The Effect of Medication Reminder Technology on Medication Adherence and Hypertension|Terminated||N/A|28|Actual|Purdue University||2||Research site no longer available|f||||f||||||||||2017-10-11 02:09:53.0261|2017-10-11 02:09:53.0261
NCT01755299|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-07-06|||December 2012||2012-12-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels|"Efficacy of 5-hour Energy®, 5-Hour Energy Decaf®, and Caffeine for Perceived Energy and Wakefulness"|Completed||N/A|48|Actual|ProMedica Health System||4|||f||||t||||||||||2017-10-11 02:09:53.116222|2017-10-11 02:09:53.116222
NCT01755286|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-06-17|||December 2012||2012-12-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement|A Prospective, Randomized, Double-Blind, Placebo- and Sham-Controlled, Multicenter, Phase 1b Study of OTO-201 Given as a Single Intratympanic Injection for Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement|Completed||Phase 1|83|Actual|Otonomy, Inc.||4|||f||||t||||||||||2017-10-11 02:09:53.213608|2017-10-11 02:09:53.213608
NCT01755273|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-10-04|||January 2013||2013-01-01|October 2016|2016-10-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effect of More Distal Enteral Bypass After Pancreaticoduodenectomy: A Prospective Multicenter Randomized Clinical Trial|Compare More Distal Enteral Bypass With Standard Enteral Bypass in the Remission of Glucose Metabolism for Patients With Diabetes or Impaired Fasting Glucose After Pancreaticoduodenectomy: A Prospective Multicenter Randomized Clinical Trial|Recruiting||N/A|90|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 02:09:53.319254|2017-10-11 02:09:53.319254
NCT01755247|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-01-10|||November 2012||2012-11-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers|A Phase One, Single-Center, Open-Label, Randomized, Parllel Group, 3 Day Study Evaluating the Safety and Cutaneous Toleraility of NVN10000 Topical Gel in Healthy Volunteers|Completed||Phase 1|15|Actual|Novan, Inc.||3|||f||||f||||||||||2017-10-11 02:09:53.534598|2017-10-11 02:09:53.534598
NCT01755234|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-02-18|2015-06-19||November 2012||2012-11-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Propofol Versus Sevoflurane Recovery After Gynecological Surgery|The Effects of Propofol vs. Sevoflurane Administered During Anesthesia Maintenance on Early and Late Recovery After Gynecological Surgery|Completed||Phase 4|90|Actual|Northwestern University|"We only studied patients undergoing outpatient laparoscopic gynecological surgery, therefore, our results cannot be generalizable to other surgical procedures.
We also administered remifentanil which is has been linked to hyperalgesia."|2|||f||||f||||||||No||2017-10-11 02:09:53.635678|2017-10-11 02:09:53.635678
NCT01755208|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-04-11|||November 21, 2012|Actual|2012-11-21|April 2017|2017-04-01|November 21, 2019|Anticipated|2019-11-21|November 21, 2018|Anticipated|2018-11-21||Interventional|||Light-Scattering Spectroscopy for Detection of Breast Cancer|Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study|Recruiting||N/A|110|Anticipated|University of Southern California||1|||f||||t|f|f||||||||2017-10-11 02:09:54.134729|2017-10-11 02:09:54.134729
NCT01755182|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-05-05|||July 2013||2013-07-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|LOTUS||Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors|Randomized Phase 3 Trial Evaluating the Efficacy of Locoregional Treatment With Transarterial Embolization (TAE) for Liver Metastases, in Combination With Pharmacotherapy, in Patients With Neuroendocrine Tumor and Inoperable Liver Metastasis.|Terminated||Phase 3|1|Actual|National Cancer Institute, Naples||2||difficulty enrollment, no patients received treatment|f||||f||||||||||2017-10-11 02:09:54.367663|2017-10-11 02:09:54.367663
NCT01755169|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-11-28|2016-11-28||January 2013||2013-01-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|KiCK Pain||Ketamine in Chronic Kid's (KiCK) Pain|Ketamine in Chronic Kid's (KiCK) Pain|Terminated||Phase 2|7|Actual|Medical University of South Carolina||4||Inability to enroll sufficient patients|f||||t||||||||No|Only aggregate data will be shared.|2017-10-11 02:09:54.511026|2017-10-11 02:09:54.511026
NCT01755156|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-08-29|2017-01-30||January 11, 2013|Actual|2013-01-11|August 2017|2017-08-01|March 16, 2016|Actual|2016-03-16|March 16, 2016|Actual|2016-03-16||Interventional|||A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of MK-3102 to Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy|Completed||Phase 3|402|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 02:09:54.896977|2017-10-11 02:09:54.896977
NCT01755143|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-06-22|2015-06-22||December 2012||2012-12-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Evaluation of Approved Pacing Lead (Model 5076) for Use in MRI Environment|CapSureFix® Novus Model 5076 Lead MRI Study|Completed||N/A|266|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f||||||||||2017-10-11 02:09:55.997292|2017-10-11 02:09:55.997292
NCT01755130|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-11-15|||May 2014||2014-05-01|November 2016|2016-11-01||||May 2019|Anticipated|2019-05-01||Interventional|||LOUIS-3D Breast Study|Multimode Laser Optoacoustic Ultrasonic Tomography System for Breast Cancer Care|Active, not recruiting||N/A|96|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:09:57.169723|2017-10-11 02:09:57.169723
NCT01755117|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-04-27|||December 2012||2012-12-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Ultrasound Guided Obturator Nerve Block for Total Knee Replacement (TKR)|Comparison of Posterior Lumbar Plexus Block Plus Sciatic Nerve Block With Sciatic Plus Femoral Plus Obturator Nerve Block for Total Knee Replacement (TKR)|Unknown status|Recruiting|N/A|100|Anticipated|Larissa University Hospital||2|||f||||f||||||||||2017-10-11 02:09:57.310287|2017-10-11 02:09:57.310287
NCT01755104|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-03-06|||January 2013||2013-01-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effect of Stablor on Visceral Fat Loss in Patients With a Metabolic Syndrome|A Randomized Double-blind Placebo Controlled Trial on the Effect of Stablor™ on the Abdominal Visceral Fat Mass Loss in Patients With a Metabolic Syndrome|Completed||N/A|118|Actual|Laboratoires Nutrition et Cardiometabolisme||2|||f||||f||||||||||2017-10-11 02:09:57.459695|2017-10-11 02:09:57.459695
NCT01755091|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-05-24|||December 2012||2012-12-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|June 2016|Actual|2016-06-01||Interventional|PACE||Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea|Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial|Completed||Phase 2|78|Actual|University of Illinois at Chicago||3|||f||||t||||||||||2017-10-11 02:09:57.557553|2017-10-11 02:09:57.557553
NCT01755078|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2014-08-04|||June 2007||2007-06-01|December 2012|2012-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients|Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients|Completed||Phase 4|166|Actual|Chugai Pharma Taiwan||2|||f||||f||||||||||2017-10-11 02:09:57.691474|2017-10-11 02:09:57.691474
NCT01755065|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-04-16|||December 2012||2012-12-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Clinical Meaning of Visual Analog Scales(VAS) for Teenage Pediatric Patients Undergoing Laparoscopic Surgical Procedures|Clinical Meaning of Visual Analog Scales (VAS) for Teenage Pediatric Patients Undergoing Laparoscopic Surgical Procedures|Unknown status|Recruiting|N/A|206|Anticipated|Children's Hospital of Pittsburgh|||1||f||||||||||||||2017-10-11 02:09:57.810074|2017-10-11 02:09:57.810074
NCT01755052|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-01-23|||January 2013||2013-01-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SILVER-AMI||SILVER-AMI: Outcomes in Older Persons With Heart Attacks|SILVER-AMI: Risk Stratification in Older Persons With Acute Myocardial Infarction|Active, not recruiting||N/A|3100|Anticipated|Yale University|||1||f||||f||||||||||2017-10-11 02:09:57.93549|2017-10-11 02:09:57.93549
NCT01755039|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-12-18|||January 2009||2009-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Course and Complications of Invasive Out-of-hospital Ventilation|Verlauf Und Respiratorische Zwischenfälle Bei Patienten Mit außerklinischer Beatmung|Completed||N/A|59|Actual|Wissenschaftliches Institut Bethanien e.V|||1||f||||||||||||||2017-10-11 02:09:58.263557|2017-10-11 02:09:58.263557
NCT01755026|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2013-06-12|2013-06-12||November 2010||2010-11-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|July 2011|Actual|2011-07-01||Interventional|||Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery|Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery Receiving Two Differing Doses of Pre-operative Cefazolin.|Completed||Phase 4|23|Actual|West Virginia University||2|||f||||f||||||||||2017-10-11 02:09:58.350669|2017-10-11 02:09:58.350669
NCT01755013|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-02-16|||February 2012||2012-02-01|February 2017|2017-02-01|March 22, 2018|Anticipated|2018-03-22|January 22, 2018|Anticipated|2018-01-22||Interventional|||Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma|Open-label Observational Study of Plastic Cylindrical Fiber Optic Diffuser (Pioneer Optics) in Photodynamic Therapy for the Management of Cholangiocarcinoma.|Recruiting||Phase 2/Phase 3|55|Anticipated|Weill Medical College of Cornell University||1|||f||||f|f|f||||||No|No sharing of IPD|2017-10-11 02:09:58.683591|2017-10-11 02:09:58.683591
NCT01755000|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-08-30|||December 2012||2012-12-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings|A Pilot Feasibility Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings|Completed||N/A|69|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-10-11 02:09:58.804404|2017-10-11 02:09:58.804404
NCT01754987|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-01-31|||September 2012||2012-09-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective|Phase I/II Study of Intravenous Ascorbic Acid in Treatment of Metastatic Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|5|Actual|Thomas Jefferson University||2|||f||||t||||||||No||2017-10-11 02:09:58.923321|2017-10-11 02:09:58.923321
NCT01754974|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-01-27|||March 2013||2013-03-01|December 2013|2013-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|BASIS||Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C|A Double-Blinded, Randomized Control Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a, Each in Combination With Ribavirin, in the Treatment of Naive Genotype 1 Chronic Hepatitis C Subjects|Completed||Phase 3|40|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 02:09:59.049048|2017-10-11 02:09:59.049048
NCT01754961|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2012-12-18|||November 2011||2011-11-01|December 2012|2012-12-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Interventional|||Effects of Vitamin D on Inflammation in Liver Disease|Effects of Vitamin D on Inflammation in Liver Disease|Unknown status|Recruiting|Phase 2|24|Anticipated|Veterans Medical Research Foundation||2|||f||||f||||||||||2017-10-11 02:09:59.206838|2017-10-11 02:09:59.206838
NCT01754948|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2012-12-20|||July 2012||2012-07-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|EHF||Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic Children|Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic Children|Unknown status|Recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 02:09:59.314174|2017-10-11 02:09:59.314174
NCT01754935|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-04-30||2015-03-06|January 2013||2013-01-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of VX-509 Using Magnetic Resonance Imaging and Arthroscopic Biopsies in Subjects With Active Rheumatoid Arthritis on Stable Disease-Modifying Antirheumatic Drugs|Completed||Phase 2|43|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||f||||||||||2017-10-11 02:09:59.413166|2017-10-11 02:09:59.413166
NCT01754922|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-01-10|2016-07-18||November 2013||2013-11-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Observational|AirHzds||Effects of Deployment Exposures on Cardiopulmonary and Autonomic Function|Effects of Deployment Exposures on Cardiopulmonary and Autonomic Function|Completed||N/A|50|Actual|VA Office of Research and Development|||2||f||||t||||||None Retained|"     No biospecimens will be collected   "|||2017-10-11 02:09:59.58632|2017-10-11 02:09:59.58632
NCT01754909|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-08-04|||November 1, 2013|Actual|2013-11-01|August 2017|2017-08-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Interventional|||Mitigation of Radiation Pneumonitis and Fibrosis|Mitigation of Radiation Pneumonitis and Fibrosis|Recruiting||Phase 2|200|Anticipated|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-11 02:09:59.953424|2017-10-11 02:09:59.953424
NCT01754896|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-12-19|||April 2012||2012-04-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Pilot Evaluation of Fecal Immunologic Test (FIT) in Ontario|Pilot Evaluation of Fecal Immunologic Test (FIT) in Ontario|Completed||N/A|28|Actual|Sunnybrook Health Sciences Centre||4|||f||||f||||||||||2017-10-11 02:10:00.079801|2017-10-11 02:10:00.079801
NCT01754883|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-01-05|||January 2011||2011-01-01|December 2012|2012-12-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study|Lithium Augmentation for Hyperarousal Symptoms of Traumatic Stress Disorder: Pilot Study|Withdrawn||Phase 1|0|Actual|VA Eastern Colorado Health Care System||1|||f||||f||||||||||2017-10-11 02:10:00.199401|2017-10-11 02:10:00.199401
NCT01754870|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-07-22|||November 2013||2013-11-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)|HO11415: Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)|Withdrawn||Phase 2|0|Actual|University of Wisconsin, Madison||1||slow accrual|f||||t||||||||||2017-10-11 02:10:00.282517|2017-10-11 02:10:00.282517
NCT01754857|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-10-02|||November 2013||2013-11-01|October 2017|2017-10-01|November 2021|Anticipated|2021-11-01|June 2019|Anticipated|2019-06-01||Interventional|||Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL|Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab and Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)|Recruiting||Phase 2|32|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 02:10:00.374236|2017-10-11 02:10:00.374236
NCT01754844|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2015-04-01|||January 2013||2013-01-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects|A Double-blind Placebo-controlled, Randomised, Single Centre, First Time in Man Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Inhaled Doses of AZD7624 in Healthy Subjects|Completed||Phase 1|57|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:10:00.559411|2017-10-11 02:10:00.559411
NCT01754818|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-02-05|||November 2012||2012-11-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)|Phase 1 Randomized, Double-blind, Placebo-controlled Study of The Safety, Tolerability and Pharmacokinetics of Single, Ascending Oral Doses Of Bendavia in Healthy Volunteers|Completed||Phase 1|30|Actual|Stealth BioTherapeutics Inc.||4|||f||||t||||||||||2017-10-11 02:10:00.71611|2017-10-11 02:10:00.71611
NCT01754805|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2012-12-19|||February 2010||2010-02-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis|A Phase 1b, Open-Label, Single Sequence, Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid Arthritis|Completed||Phase 1|15|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:10:00.826736|2017-10-11 02:10:00.826736
NCT01754792|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2014-10-27|||January 2012||2012-01-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Pinitol on Hidrocarbonated Metabolism Parameters in Diabetic, Impaired and Normal Fasting Glucose Subjects|A Randomized, Double-blind, Placebo-controlled Study on the Influence of Pinitol on Carbohydrate, Lipid and Inflammatory Parameters, Endothelial Function and Oxidative Stress in Diabetic, Impaired and Normal Fasting Glucose Subjects|Completed||N/A|120|Actual|University of Valencia||3|||f||||f||||||||||2017-10-11 02:10:00.9112|2017-10-11 02:10:00.9112
NCT01754779|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-10-27|||July 2012||2012-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Treatment for Calcium Phosphate Kidney Stone Disease|Pharmacological Therapy for Calcium Phosphate Urolithiasis|Recruiting||Phase 2|50|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-10-11 02:10:01.00476|2017-10-11 02:10:01.00476
NCT01754766|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2013-12-17|2013-12-17||October 2012||2012-10-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||AGN-229666 for the Treatment of Allergic Conjunctivitis||Completed||Phase 2|90|Actual|Allergan||3|||f||||f||||||||||2017-10-11 02:10:01.097969|2017-10-11 02:10:01.097969
NCT01754753|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-05-12|||June 2012||2012-06-01|May 2016|2016-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|PLINY||Putting Life in Years (PLINY): Telephone Friendship Groups Research Study|Evaluation of the Effectiveness and Cost Effectiveness of an Intervention to Promote Mental Wellbeing in Community Living Older People.|Terminated||N/A|157|Actual|University of Sheffield||2||Due to lack of volunteer facilitators to deliver the intervention|f||||t||||||||||2017-10-11 02:10:01.425019|2017-10-11 02:10:01.425019
NCT01754740|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-18|||January 2010||2010-01-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|BMS||The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study|The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study|Completed||N/A|38|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 02:10:03.935928|2017-10-11 02:10:03.935928
NCT01754727|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2017-01-17|2016-10-26||December 2012||2012-12-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|IDEA|Baseline analyses accounts for main analysis set (MAS) population (all participants who received at least 1 dose of study drug).|Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice|Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice|Completed||N/A|452|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 02:10:04.100512|2017-10-11 02:10:04.100512
NCT01754714|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-19|2016-01-22|2015-10-02||December 2012||2012-12-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|EXPO||Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group|Open-label, Randomized, Parallel-Group, Exploratory Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Steatohepatitis (NASH) and Non-treated Matched Healthy Volunteers as Control Group|Completed||Phase 3|108|Actual|Abbott||4|||f||||t||||||||||2017-10-11 02:10:04.708219|2017-10-11 02:10:04.708219
NCT01754701|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-11-25|||June 2013||2013-06-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe Malaria|Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe Malaria|Completed||N/A|100|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 02:10:06.516829|2017-10-11 02:10:06.516829
NCT01754675|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2012-12-20|||May 2012||2012-05-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Cardiovascular Effects of a Soccer Match in Viewers With With Coronary Artery Disease|Cardiovascular Effects of a Soccer Match in Viewers With With Coronary Artery Disease|Completed||Phase 2|17|Actual|Instituto de Cardiologia de Santa Catarina||2|||f||||f||||||||||2017-10-11 02:10:06.738304|2017-10-11 02:10:06.738304
NCT01754662|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-11-19|||October 2011||2011-10-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Combining Cocoa and Soy in Type 2 Diabetes|A Pilot Study Investigating the Effects of the Combined Effects of Cocoa and Soy Polyphenols in a Soy Protein Matrix on Insulin Resistance and Cardiovascular Disease Risk in Type 2 Diabetes - A Randomised Placebo-Controlled Double-Blind Parallel Study|Completed||N/A|84|Actual|Hull and East Yorkshire Hospitals NHS Trust||5|||f||||f||||||||||2017-10-11 02:10:06.832144|2017-10-11 02:10:06.832144
NCT01754649|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-06-03|||January 2013||2013-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Use of Misoprostol in Case of Insertion Failure of Intrauterine Contraceptives|Assessment of Use of Misoprostol to Facilitate the Insertion of Intrauterine Contraceptives After Failure of Insertion. A Randomized Double-blind Clinical Trial|Completed||Phase 4|102|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 02:10:06.961994|2017-10-11 02:10:06.961994
NCT00000160|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-06-01|||January 1972||1972-01-01|October 2003|2003-10-01||||||||Interventional|||Diabetic Retinopathy Study (DRS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:34.290318|2017-10-11 04:17:34.290318
NCT01754636|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-04-13|||November 2012|Actual|2012-11-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|SAGE||Inclusion of Elderly Patients With Colorectal Cancer in Clinical Trials|Elderly Patients With Colorectal Cancer in Clinical Trials: Factors Associated With Non Inclusion|Completed||N/A|707|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-11 02:10:07.049604|2017-10-11 02:10:07.049604
NCT01754623|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-08-06|2015-06-17||February 2013||2013-02-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional||All participants|GTX-RT in Borderline Resectable Pancreatic Cancer|Validation of a Radiation Response Signature in Borderline Resectable Pancreatic Cancer Patients Treated With Induction Chemotherapy Followed by Stereotactic Body Radiation Therapy (SBRT)|Terminated||Phase 2|9|Actual|H. Lee Moffitt Cancer Center and Research Institute|The study only accrued 9 (of planned 35) participants. It was not possible to collect adequate pre-treatment tissue for radiosensitivity index (RSI) analysis, pre-treatment. The study was terminated before planned completion.|1||Lack of pre-treatment tissue to make the study plan feasible.|f||||f||||||||||2017-10-11 02:10:07.161839|2017-10-11 02:10:07.161839
NCT01754610|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-04-19|||February 2006||2006-02-01|April 2017|2017-04-01|September 30, 2021|Anticipated|2021-09-30|September 30, 2021|Anticipated|2021-09-30||Observational|SFCR||Strengthening Family Coping Resources Open Trials|Strengthening Family Coping Resources Open Trials|Recruiting||N/A|500|Anticipated|University of Maryland|||1||f||||t||||||||||2017-10-11 02:10:07.739036|2017-10-11 02:10:07.739036
NCT01754597|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2015-11-25|||September 2009||2009-09-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PEPNATB||Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines|Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines. Pilot Study in Patients Operated on for Breast Cancer. Monocentric Study Feasibility.|Completed||N/A|56|Actual|Institut Bergonié||1|||f||||t||||||||||2017-10-11 02:10:07.903398|2017-10-11 02:10:07.903398
NCT01754584|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-06|2012-12-20|||January 2009||2009-01-01|November 2012|2012-11-01||||||||Observational|||The Effect and Mechanism of Hyaluronan on the Mucociliary Differentiation of Human Respiratory Epithelial Cells|The Effect and Mechanism of Hyaluronan on the Mucociliary Differentiation of Human Respiratory Epithelial Cells|Unknown status|Not yet recruiting|N/A|||Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 02:10:08.002329|2017-10-11 02:10:08.002329
NCT01754571|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-12-20|||July 2012||2012-07-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||CBT in Patients With Medication Overuse Headache|Cognitive Behavior Therapy in Patients With Medication Overuse|Unknown status|Recruiting|Early Phase 1|60|Anticipated|Far Eastern Memorial Hospital||1|||f||||t||||||||||2017-10-11 02:10:08.075409|2017-10-11 02:10:08.075409
NCT01754558|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2014-05-01|||May 2012||2012-05-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||One Year Outcome Using the Ajust System for Treatment of Urinary Stress Incontinence||Completed||N/A|500|Anticipated|Zealand University Hospital||2|||f||||||||||||||2017-10-11 02:10:08.167726|2017-10-11 02:10:08.167726
NCT01754545|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-18|||September 2012||2012-09-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura|Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura|Withdrawn||Phase 4|0|Actual|St. Olavs Hospital||2||altered situation in study population; not enough patients meeting enrollment criteria|f||||t||||||||||2017-10-11 02:10:08.267565|2017-10-11 02:10:08.267565
NCT01754532|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-11-18|||January 2013||2013-01-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|June 2015|Anticipated|2015-06-01||Observational|||Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels||Unknown status|Recruiting|N/A|40|Anticipated|Shalvata Mental Health Center|||1||f||||f||||||Samples Without DNA|"     10mg of posterior vertex hair   "|||2017-10-11 02:10:08.37309|2017-10-11 02:10:08.37309
NCT01754519|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2017-06-07|2017-05-15||May 2013||2013-05-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||All treated and eligible patients|Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery|Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer|Terminated||Phase 2|1|Actual|Roswell Park Cancer Institute|The study was terminated early by the IRB due to the fact that an IDE (Investigational Device Exemption) was never submitted. No outcome measure data was collected.|1||IDE not submitted|f||||t||||||||||2017-10-11 02:10:08.498899|2017-10-11 02:10:08.498899
NCT01754506|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-10-14|||January 2013||2013-01-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers|Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers|Completed||N/A|41|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 02:10:08.85444|2017-10-11 02:10:08.85444
NCT01754493|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-11-03|2016-09-06||December 2008||2008-12-01|December 2012|2012-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|IBS-MDD||Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression|Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression|Completed||Phase 4|17|Actual|New York State Psychiatric Institute|Study limitations include the lack of placebo control, modest sample size, single ethnic group, and high attrition rate.|1|||f||||f||||||||No||2017-10-11 02:10:09.001438|2017-10-11 02:10:09.001438
NCT01754480|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2016-12-16|2016-12-16||March 2013||2013-03-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries|A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Parenchymous Tissue Open Surgeries|Completed||Phase 3|325|Actual|Grifols Biologicals Inc.||2|||f||||f||||||||||2017-10-11 02:10:09.5463|2017-10-11 02:10:09.5463
NCT01754467|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-04-26|2017-01-25||February 2013||2013-02-01|April 2017|2017-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||NEAT! Technology to Increase Breaks in Sedentary Behavior in Adults With Diabetes|NEAT! Technology to Increase Breaks in Sedentary Behavior in Adults With Diabetes|Completed||N/A|9|Actual|Northwestern University||1|||f||||f||||||||||2017-10-11 02:10:10.441876|2017-10-11 02:10:10.441876
NCT01754454|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-11|2016-04-07|||December 2012||2012-12-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease|Open-Label, Single-Center, Self Control, Phase Ⅰ/Ⅱ Clinical Trial to Evaluate the Safety and the Efficacy of Umbilical Cord-derived Mesenchymal Stem Cells in Patients With Acute Graft-versus-host Disease|Enrolling by invitation||Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-11 02:10:10.917552|2017-10-11 02:10:10.917552
NCT01754441|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-08-21|||May 2008||2008-05-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Mechanisms of Cell Death in Spinal Muscular Atrophy|Mechanisms of Cell Death in Spinal Muscular Atrophy|Enrolling by invitation||N/A|50|Anticipated|Nemours Children's Clinic|||1||f||||f||||||Samples With DNA|"     Skin biopsy specimens   "|||2017-10-11 02:10:11.032727|2017-10-11 02:10:11.032727
NCT01754428|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-08-19|||November 2012||2012-11-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age|A Multi-Center, Outpatient, Surveillance Study of Respiratory Syncytial Virus (RSV) Infection and Respiratory Syncytial Virus-related Hospitalizations Among Subjects < 24 Months of Age With a Medically Attended Respiratory Tract Infection|Completed||N/A|2432|Actual|Gilead Sciences|||1||f||||f||||||Samples Without DNA|"     Nasal swabs   "|||2017-10-11 02:10:11.136072|2017-10-11 02:10:11.136072
NCT01754415|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2013-11-13|||February 2010||2010-02-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|February 2011|Actual|2011-02-01||Interventional|||Evaluation of Exercise Benefits to Promote Health Aging Among Chronically Ill Geriatrics in a Community|Evaluation of Exercise Benefits to Promote Health Aging Among Chronically Ill Geriatrics in a Community.|Completed||N/A|160|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:10:11.291492|2017-10-11 02:10:11.291492
NCT01754402|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-06-22|2016-12-12||January 7, 2013|Actual|2013-01-07|June 2017|2017-06-01|January 1, 2023|Anticipated|2023-01-01|December 6, 2016|Actual|2016-12-06||Interventional||Subjects who received drug|Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma|A Phase I-II Study of the Combination of Bendamustine and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|56|Actual|Duke University||3|||f||||f|t|f||||||||2017-10-11 02:10:11.447154|2017-10-11 02:10:11.447154
NCT01754389|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-06-20|2017-05-22||January 2013||2013-01-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|May 2016|Actual|2016-05-01||Interventional|||Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant|A 3-Arm Randomized Phase II Study of Standard-of-Care vs. Bortezomib Based Graft-Versus-Host Disease Regimen for Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Patients Lacking HLA-matched Related Donors|Completed||Phase 2|138|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-11 02:10:13.079954|2017-10-11 02:10:13.079954
NCT01754376|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2017-03-14|2017-01-18||January 2013||2013-01-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|February 2015|Actual|2015-02-01||Interventional|||Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma|COMBAT 1: A Phase II Trial of Combined BRAF-Targeted Therapy and Immunotherapy for Melanoma|Terminated||Phase 2|6|Actual|Massachusetts General Hospital|The protocol terminated early due to a dramatic change in the treatment landscape for treating BRAF mutant melanoma (e.g. one BRAF/MEK inhibitor combination and two anti-PD1 antibodies were approved by the FDA while this study was open).|1||changes in available treatments for melanoma|f||||t||||||||Yes|All raw analytic data on tumor and blood samples will be shared, upon acceptance of manuscript.|2017-10-11 02:10:13.686934|2017-10-11 02:10:13.686934
NCT01754363|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-04-24|||February 2013||2013-02-01|April 2017|2017-04-01|February 2030|Anticipated|2030-02-01|February 2030|Anticipated|2030-02-01||Interventional|||Survivorship of Attune Primary Total Knee Prosthesis|Short, Medium and Long Term Survivorship of Attune Primary Knee Prosthesis|Active, not recruiting||N/A|1232|Actual|DePuy International||1|||f||||f||||||||||2017-10-11 02:10:14.062701|2017-10-11 02:10:14.062701
NCT01754350|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-03-21|||May 2013||2013-05-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|ERGO2||Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma|Calorie-restricted, Ketogenic Diet and Transient Fasting vs. Standard Nutrition During Reirradiation for Patients With Recurrent Glioblastoma: the ERGO2 Study|Recruiting||N/A|50|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 02:10:14.217771|2017-10-11 02:10:14.217771
NCT01754337|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2014-07-03|||December 2012||2012-12-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 Diabetes|An Open-label, Randomized, Three-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Conventional Pump Therapy in Regulating Glucose Levels During 24 Hours in Adults and Adolescents With Type 1 Diabetes|Completed||Phase 2|30|Anticipated|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-11 02:10:14.355234|2017-10-11 02:10:14.355234
NCT01754324|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-06-12|||December 2012||2012-12-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome|The Utility and Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome in Neonates|Completed||Phase 1|20|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 02:10:14.716173|2017-10-11 02:10:14.716173
NCT01754311|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2012-12-18|||February 2013||2013-02-01|December 2012|2012-12-01|August 2013|Anticipated|2013-08-01|February 2013|Anticipated|2013-02-01||Observational|HAMIL28B||Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1|Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1|Unknown status|Not yet recruiting|N/A|165|Anticipated|University Hospital Center of Martinique|||2||f||||f||||||||||2017-10-11 02:10:14.849815|2017-10-11 02:10:14.849815
NCT01754298|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2016-12-01|||November 2012||2012-11-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of Two Surgical Drilling Techniques to Treat Juvenile Osteochondritis Dissecans of the Knee|Retro Versus Trans Articular Drilling for Juvenile Osteochondritis Dissecans of the Knee: A Multicenter, Randomized Controlled Trial|Recruiting||N/A|58|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 02:10:14.967209|2017-10-11 02:10:14.967209
NCT00000161|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||August 1993||1993-08-01|September 2001|2001-09-01||||||||Interventional|||Randomized Trials of Vitamin Supplements and Eye Disease||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:34.355994|2017-10-11 04:17:34.355994
NCT01754285|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-07-28|||November 2012||2012-11-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea|A Randomized, Double-Blind, Double Dummy, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of LF-PB 10 mg, 20 mg, and 30 mg to Treat Lymphorrhea Post Axillary Dissection in Breast Cancer|Completed||Phase 2|114|Actual|Chemi S.p.A.||4|||f||||f||||||||||2017-10-11 02:10:15.197|2017-10-11 02:10:15.197
NCT01754272|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-18|||January 2012||2012-01-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||A Non-Interventional Follow-Up to the VELOUR Study - Translational Research|A Non-Interventional Follow-Up to the VELOUR Study (Multicentre International Study of Aflibercept Versus Placebo in Combination With FOLFIRI for Metastatic Colorectal Cancer) - Translational Research|Unknown status|Active, not recruiting|N/A|1226|Actual|Katholieke Universiteit Leuven|||2||f||||f||||||Samples With DNA|"     Archived FFPE (Formaldehyde fixed paraffin-embedded) primary tumour colorectal cancer tissues     Archived FFPE (Formaldehyde fixed paraffin-embedded) metastatic tumour tissue Archived     residual blood samples (plasma, serum) collected in the frame of the VELOUR trial   "|||2017-10-11 02:10:15.366858|2017-10-11 02:10:15.366858
NCT01754259|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-06-26|2017-03-23||April 2013||2013-04-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|RAND-CFR||Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD|Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Patients With Diabetes and Suspected or Known Coronary Artery Disease|Completed||Phase 3|47|Actual|Brigham and Women's Hospital|The limitations for our study include a relatively small cohort size of 47 patients, that our mechanistic trial was not designed to assess clinical outcomes and that our experimental design allowed for inclusion of patients with non-obstructive CAD.|2|||f||||t||||||||No||2017-10-11 02:10:15.509798|2017-10-11 02:10:15.509798
NCT01754246|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-07-29|||December 2012||2012-12-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluation of the 755nm Alexandrite Laser for Skin Toning and Epidermal Pigmented Lesions in Asian Skin Types||Completed||N/A|20|Actual|Cynosure, Inc.||2|||f||||f||||||||||2017-10-11 02:10:15.890877|2017-10-11 02:10:15.890877
NCT01754233|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-07-29|||December 2012||2012-12-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of the 755nm Alexandrite for the Treatment of Epidermal and Dermal Pigmented Lesions||Completed||N/A|6|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 02:10:15.971145|2017-10-11 02:10:15.971145
NCT01754220|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2012-12-18|||March 2012||2012-03-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Open-label Study of the Effects of Montelukast in Patients With Chronic Cough|The Effects of Alvokast (Montelukast) in Patients With Chronic Cough|Completed||Phase 4|14|Actual|Association Asthma, Bulgaria||1|||f||||t||||||||||2017-10-11 02:10:16.039847|2017-10-11 02:10:16.039847
NCT01754207|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-02-07|||December 2011||2011-12-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos|Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos|Completed||N/A|20|Actual|Cynosure, Inc.||2|||f||||f||||||||||2017-10-11 02:10:16.125702|2017-10-11 02:10:16.125702
NCT01754194|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-04-12|2016-08-03||April 2012||2012-04-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|September 2013|Actual|2013-09-01||Observational|OPTIMIZE||Clinical and Economic Outcomes in Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Surgery|An Observational Study in Morbidly Obese Patients to Evaluate Laparoscopic Gastric Sleeve Resections and Roux-en-Y Gastric Bypass Surgery in Clinical and Health-Economic Terms|Completed||N/A|293|Actual|Medtronic - MITG|||2||f||||f||||||||||2017-10-11 02:10:16.203666|2017-10-11 02:10:16.203666
NCT01754181|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-10-24|||March 2013||2013-03-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|DiabeloopWP6-0||Initial Testing of the Diabeloop Algorithm in T1D Patients on Pump Therapy Over the Prandial Period and Physical Activity.|Development of the Glycemic Control Algorithm, in Prandial and Physical Effort Situations.|Completed||Phase 3|18|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||||2017-10-11 02:10:16.748844|2017-10-11 02:10:16.748844
NCT01754168|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-05-02|||February 2013||2013-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Amyloid Beta and Cognition in Parkinson Disease|The Role of Amyloid Beta in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study|Active, not recruiting||N/A|44|Actual|University of Michigan|||1||f||||f||||||Samples With DNA|"     Saliva samples with DNA   "|||2017-10-11 02:10:16.831273|2017-10-11 02:10:16.831273
NCT01754155|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-08-23|||January 2013||2013-01-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Prospective Radiostereometric Analysis and Clinical Evaluation of the Zimmer® Continuum® Acetabular Cup With Vitamin E Stabilized Polyethylene|A Prospective Radiostereometric Analysis and Clinical Evaluation of the Zimmer® Continuum® Acetabular Cup With Vitamin E Stabilized Polyethylene|Recruiting||N/A|55|Anticipated|Central DuPage Hospital||1|||f||||||||||||||2017-10-11 02:10:16.919776|2017-10-11 02:10:16.919776
NCT01754142|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-08-07|||November 24, 2012|Actual|2012-11-24|August 2017|2017-08-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Observational|||Korean Post-marketing Surveillance for Kombiglyze XR®|Kombiglyze XR (Saxagliptin + Metformin XR Fixed Dose Combination) Regulatory Postmarketing Surveillance|Completed||N/A|755|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:10:17.029817|2017-10-11 02:10:17.029817
NCT01754116|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2014-04-17|||January 2013||2013-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects|A Single-Center Randomized, Open-Label, Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 LAP in Healthy Adult Subjects.|Completed||Phase 1|43|Actual|ViiV Healthcare||5|||f||||f||||||||||2017-10-11 02:10:17.38371|2017-10-11 02:10:17.38371
NCT01421771|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-01-04|||October 2011||2011-10-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|BID||Blood Pressure in Dialysis Patients|Blood Pressure in Dialysis Patients (BID Study)|Completed||N/A|126|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-11 03:54:02.231393|2017-10-11 03:54:02.231393
NCT01754103|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2012-12-17|||January 2012||2012-01-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Neuroplasticity in Blind Subjects After Repetitive Tactile Stimulation|Neuroplasticity in Blind Subjects After Repetitive Tactile Stimulation|Unknown status|Recruiting|N/A|24|Anticipated|Universidad Complutense de Madrid||1|||f||||f||||||||||2017-10-11 02:10:17.524748|2017-10-11 02:10:17.524748
NCT01754090|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-09-07|||April 2011||2011-04-01|September 2017|2017-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Testing the Efficacy of an Online Alcohol Intervention|"Digital Therapy: Evaluation of the Fully Automated Alcohol Intervention Balance."|Completed||N/A|244|Actual|University of Oslo||2|||f||||f||||||||||2017-10-11 02:10:17.662841|2017-10-11 02:10:17.662841
NCT01754077|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-09-04|||September 2010||2010-09-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|TMW||Thirty Million Words Project: A Feasibility Trial|Thirty Million Words Project: A Feasibility Trial|Completed||N/A|40|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 02:10:17.782804|2017-10-11 02:10:17.782804
NCT01754064|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-10-06|||November 2007||2007-11-01|October 2015|2015-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||St. Jude Medical Product Longevity and Performance (SCORE) Registry|St. Jude Medical Product Longevity and Performance (SCORE) Registry|Active, not recruiting||N/A|10957|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 02:10:17.918096|2017-10-11 02:10:17.918096
NCT01754051|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-09-26|||January 2013||2013-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|1 Year|Observational [Patient Registry]|VOLCAN||A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System in France|VOLCAN: A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System in France|Recruiting||N/A|200|Anticipated|Penumbra Inc.|||1||f||||f||||||||||2017-10-11 02:10:18.264689|2017-10-11 02:10:18.264689
NCT01754038|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-09-02|||August 2013||2013-08-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|PRIMIER||Registry for Integrative Medicine Interventions Effectiveness|Patients Receiving Integrative Medicine Interventions Effectiveness Registry|Recruiting||N/A|10000|Anticipated|BraveNet|||1||f||||f||||||||||2017-10-11 02:10:18.368327|2017-10-11 02:10:18.368327
NCT01754025|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-08-10|||December 2012||2012-12-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|INHERIT||INHERIT EGFR - Studying Germline EGFR Mutations|INHERIT EGFR - INvestigating HEreditary RIsk From T790M: A Multi-Centered Study to Identify and Characterize Individuals Carrying Germline EGFR Mutations|Recruiting||N/A|100|Anticipated|Dana-Farber Cancer Institute|||3||f||||f||||||Samples With DNA|"     tumor tissue   "|||2017-10-11 02:10:18.577445|2017-10-11 02:10:18.577445
NCT01754012|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2016-02-17|||April 2012||2012-04-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|NU-AGE||European Project on Nutrition in Elderly People|New Dietary Strategies Addressing the Specific Needs of Elderly Population for an Healthy Aging in Europe|Completed||N/A|1190|Actual|University of Bologna||2|||f||||f||||||||||2017-10-11 02:10:18.745637|2017-10-11 02:10:18.745637
NCT01753999|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-08-03|||December 2012||2012-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Obstructive Sleep Apnea in World Trade Center Responders|Obstructive Sleep Apnea in WTC Responders: Role of Nasal Pathology|Active, not recruiting||N/A|440|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 02:10:18.912368|2017-10-11 02:10:18.912368
NCT01753986|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-19|||December 2012||2012-12-01|December 2012|2012-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Alcohol Use and Relationships - III|Impact of Brief Substance Use Intervention on Substance Use and Intimate Partner Violence|Recruiting||Phase 2|500|Anticipated|The University of Tennessee, Knoxville||2|||f||||f||||||||||2017-10-11 02:10:19.053849|2017-10-11 02:10:19.053849
NCT01753973|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2015-12-15|||January 2013||2013-01-01|June 2014|2014-06-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|||Assessing the Prevalence of Metabolic Syndrome in Renal Transplantation|Assessing the Prevalence of Metabolic Syndrome in Renal Transplantation|Completed||N/A|200|Actual|University of Sao Paulo General Hospital|||1||f||||t||||||||||2017-10-11 02:10:19.148905|2017-10-11 02:10:19.148905
NCT01753960|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2013-01-01|||January 2013||2013-01-01|January 2013|2013-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Surgical Blood Management Using Noninvasive and Continuous Hemoglobin Monitoring(NACHO)|Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management (NACHO) - Matched-pair Cluster-randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||f||||||||||2017-10-11 02:10:19.220332|2017-10-11 02:10:19.220332
NCT01753947|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-17|||January 2008||2008-01-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Individualized Deliberate Practice on a Virtual Reality Simulator|Individualized Deliberate Practice on a Virtual Reality Simulator Improves Technical Performance of Surgical Novices in the Operating Room: A Randomized Controlled Trial|Completed||N/A|16|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 02:10:19.354067|2017-10-11 02:10:19.354067
NCT01753934|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2016-04-13|||May 2011||2011-05-01|April 2016|2016-04-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Diabetic Ketoacidosis and Its Impact on the Brain|Diabetic Ketoacidosis and Its Impact on Neurocognition|Recruiting||N/A|120|Anticipated|Stanford University|||1||f||||f||||||None Retained|"     There is no intervention. All subjects with DM and controls get neurocognitive testing and an     MRI of the brain. We want to see if the scores are different but no changes in therapy will     be done.   "|||2017-10-11 02:10:19.462503|2017-10-11 02:10:19.462503
NCT01753921|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2016-04-13|||November 2011||2011-11-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|December 2016|Anticipated|2016-12-01||Observational|||Evaluation of a Non-invasive Brain Compliance Measurement Device|Evaluation of a Non-invasive Brain Compliance Measurement Device|Recruiting||N/A|30|Anticipated|Stanford University|||2||f||||f||||||||||2017-10-11 02:10:19.571409|2017-10-11 02:10:19.571409
NCT01753908|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-08-30|||May 21, 2013|Actual|2013-05-21|August 2017|2017-08-01|August 20, 2019|Anticipated|2019-08-20|August 20, 2018|Anticipated|2018-08-20||Interventional|||Broccoli Sprout Extract in Treating Patients With Breast Cancer|A Pilot Study of Broccoli Sprout Extract in Patients With Breast Cancer|Recruiting||N/A|50|Anticipated|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-11 02:10:19.719645|2017-10-11 02:10:19.719645
NCT01753895|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-05-05|||December 2012||2012-12-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Mercury Versus Automated Blood Pressure Monitoring|Comparison of Manual Blood Pressure Monitoring Using a Mercury Sphygmomanometer to an Automated Blood Pressure Instrument in a Research Setting|Completed||N/A|156|Actual|Rockefeller University|||1||f||||f||||||||||2017-10-11 02:10:19.889121|2017-10-11 02:10:19.889121
NCT01753882|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-06-14|||February 2012||2012-02-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)|Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury|Active, not recruiting||Phase 1|88|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 02:10:19.988713|2017-10-11 02:10:19.988713
NCT01753869|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-07-18|||December 2012||2012-12-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic Fibrosis|Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic Fibrosis|Terminated||N/A|14|Actual|Belfast Health and Social Care Trust||2||Challenges with recruitment|f||||f||||||||No||2017-10-11 02:10:20.12375|2017-10-11 02:10:20.12375
NCT01753856|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2015-09-11|2015-06-09||January 2013||2013-01-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Randomized participants who received at least 1 dose of study drug (teriparatide or denosumab).|Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis|Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis|Completed||Phase 4|69|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:10:20.320561|2017-10-11 02:10:20.320561
NCT01753843|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-07-04|||July 2012||2012-07-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Brief Delay in Cord Clamping and Neurobehaviour in Preterms|A Randomised Controlled Trial to Evaluate the Role of Brief Delay in Cord Clamping in Preterm Neonates (34-36weeks) on Short Term Neurodevelopmental Outcome|Completed||N/A|120|Actual|Lady Hardinge Medical College||2|||f||||f||||||||||2017-10-11 02:10:22.770654|2017-10-11 02:10:22.770654
NCT01753830|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-07-15||2016-07-15|December 2012||2012-12-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis|A Multi Center, Randomized, Double Blind, Saline Controlled Study of a Single Injection of Durolane® Versus a Single Injection of Phosphate Buffered Saline (PBS) to Treat Pain Associated With Osteoarthritis of the Knee|Terminated||N/A|75|Actual|Q-Med AB||2||Study terminated early due to decision by sponsor|f||||t||||||||||2017-10-11 02:10:23.644825|2017-10-11 02:10:23.644825
NCT01753817|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2012-12-26|||January 2013||2013-01-01|December 2012|2012-12-01|January 2015|Anticipated|2015-01-01|July 2014|Anticipated|2014-07-01||Observational|||Assessment of Radial Artery Patency Following Catheterization With a 7F Sheath|Observational Study of Radial Artery Patency Following Catheterization With a 7F Sheath|Unknown status|Not yet recruiting|N/A|200|Anticipated|Jaffe, Ronen, M.D.|||1||f||||f||||||||||2017-10-11 02:10:23.79141|2017-10-11 02:10:23.79141
NCT01753804|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-10-27|||September 2012||2012-09-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.|A Prospective Natural History Study of Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy.|Terminated||N/A|269|Actual|BioMarin Pharmaceutical|||1||f||||f||||||Samples Without DNA|"     Blood sampling at 4 time points (first visit then once a year). Urinalysis sampling at 4 time     points (first visit then once a year).   "|||2017-10-11 02:10:23.8842|2017-10-11 02:10:23.8842
NCT01753791|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-09-24|||November 2012||2012-11-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults|A Phase 1, Dose Expansion Of A Within-cohort, Randomized, Double-blind, Third-party Open, Placebo-controlled, Single-and Multiple-dose Escalation Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of Pf-06473871 In Normal Healthy Adults|Completed||Phase 1|32|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:10:24.122236|2017-10-11 02:10:24.122236
NCT01753778|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-01-27|||November 2012||2012-11-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Study Evaluating Treatment of Forefoot Pain Related to Nerve Entrapment Using the Cryo-Touch III Device|A Prospective Non-Randomized Unblinded Study Evaluating Treatment of Forefoot Pain Related to Nerve Entrapment Using the Cryo-Touch III Device|Completed||N/A|7|Actual|MyoScience, Inc||1|||f||||f||||||||||2017-10-11 02:10:24.256168|2017-10-11 02:10:24.256168
NCT01753765|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-10-19|||October 2012||2012-10-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|||Study Evaluating the Treatment of Occipital Neuralgia|A Prospective Non-Randomized Unblinded Study Evaluating the Treatment of Occipital Neuralgia With the Cryo-Touch III Device|Completed||N/A|26|Actual|MyoScience, Inc||1|||f||||t||||||||||2017-10-11 02:10:24.38991|2017-10-11 02:10:24.38991
NCT01753752|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-04-04|||September 2012||2012-09-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation||Completed||Phase 2|32|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:10:24.528592|2017-10-11 02:10:24.528592
NCT01753739|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2014-07-30||2014-04-04|January 2013||2013-01-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)|A Dose-Ranging Study to Evaluate the Safety and Efficacy of Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR) in Subjects With a Demonstrated History of Mountain Cedar Pollen Allergic Sensitivity|Completed||Phase 2|613|Actual|Bausch & Lomb Incorporated||5|||f||||f||||||||||2017-10-11 02:10:24.616243|2017-10-11 02:10:24.616243
NCT01753726|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-10-30|||June 2012||2012-06-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Diaphragm Stretching Increases Spine and Thoracic Mobility|Diaphragm Stretching Technique Increases Spine Mobility and Thoracic Movement: a Randomized Controlled Trial|Completed||N/A|80|Actual|Universidad de Granada||2|||f||||t||||||||Undecided||2017-10-11 02:10:24.708734|2017-10-11 02:10:24.708734
NCT00000162|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||July 1977||1977-07-01|October 1999|1999-10-01||||||||Interventional|||Branch Vein Occlusion Study||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:34.428193|2017-10-11 04:17:34.428193
NCT01753713|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2017-07-07|2017-04-14||December 20, 2012|Actual|2012-12-20|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|January 28, 2015|Actual|2015-01-28||Interventional|||Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma|Phase II Study of TKI258 (Dovitinib) in Patients With Recurrent or Progressive Glioblastoma Who Have Progressed With or Without Anti-Angiogenic Therapy (Including Anti-VEGF Therapy)|Active, not recruiting||Phase 2|33|Actual|Case Comprehensive Cancer Center||2|||f||||t|t|f||||||||2017-10-11 02:10:24.862807|2017-10-11 02:10:24.862807
NCT01753700|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-17|||December 2012||2012-12-01|December 2012|2012-12-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|UHT||Effect of UHT Treated Milk on Blolipid Profile|Effect of UHT Treated Milk on Blolipid Profile|Unknown status|Recruiting|N/A|20|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:10:26.133234|2017-10-11 02:10:26.133234
NCT01753687|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-11-26|||September 2011||2011-09-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Correlation of Different Signs for Assessment of Dry Eye Syndrome|Correlation of Different Signs for Assessment of Dry Eye Syndrome|Completed||N/A|50|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 02:10:26.249732|2017-10-11 02:10:26.249732
NCT01753674|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2015-05-27|||January 2013||2013-01-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome|The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome|Terminated||Phase 1|13|Actual|University of Connecticut||2||non-compliance issues|f||||t||||||||||2017-10-11 02:10:26.362063|2017-10-11 02:10:26.362063
NCT01753661|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-06-02|||June 2012||2012-06-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|ASPIRE||Project ASPIRE Efficacy Pilot: Achieving Superior Parental Involvement for Rehabilitative Excellence|A Parent-Directed, Multimedia Early Intervention Tool to Improve Outcomes in Underserved Children Who Are Deaf or Hard-of-Hearing|Completed||N/A|41|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 02:10:26.482231|2017-10-11 02:10:26.482231
NCT01753648|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-12-01|||January 2015||2015-01-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy|Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy|Recruiting||N/A|60|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:10:26.610351|2017-10-11 02:10:26.610351
NCT01753635|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2013-03-15|||November 2012||2012-11-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparison of the Baska Mask Airway to a Single-use LMA Device in Low-risk Female Patients|Comparison of the Baska Mask Airway to a Single-use LMA Device in Low-risk Female Patients|Completed||N/A|150|Actual|University College Hospital Galway||2|||f||||f||||||||||2017-10-11 02:10:26.754191|2017-10-11 02:10:26.754191
NCT01753622|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2014-11-13|||October 2009||2009-10-01|December 2012|2012-12-01|November 2015|Anticipated|2015-11-01|January 2013|Actual|2013-01-01||Interventional|||Physical Exercise Program in Obese and Overweight Pregnant Women|Effect of a Supervised Exercise Program in Obese and Overweight Pregnant Women on Outcomes and Level of Depression. A Randomized Controlled Trial|Unknown status|Recruiting|N/A|150|Anticipated|Technical University of Madrid||2|||f||||t||||||||||2017-10-11 02:10:26.864195|2017-10-11 02:10:26.864195
NCT01753609|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-17|||January 2013||2013-01-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Interventional|||Safety and Performance Evaluation of Tulip Device in Healthy Overweight and Obese Volunteers|"Safety and Performance Evaluation of TrimWeight Device - an Intragastric Auto-inflating & Degradable Balloon in a Swallow-able Capsule (the Device), for Enhancing Satiety and Satiation in Healthy Over Weight and Obese Volunteers"|Unknown status|Not yet recruiting|N/A|8|Anticipated|Tulip Medical Ltd.||1|||f||||t||||||||||2017-10-11 02:10:27.002524|2017-10-11 02:10:27.002524
NCT01753596|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2014-11-13|||December 2014||2014-12-01|November 2014|2014-11-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease|Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease|Withdrawn||Phase 3|0|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:10:27.266729|2017-10-11 02:10:27.266729
NCT01753583|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-11-30|||July 2013||2013-07-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||High-resolution Imaging of Corneal Lesions With Optical Coherence Tomography (OCT) - A Pilot Study|High-resolution Imaging of Corneal Lesions With Optical Coherence Tomography (OCT) - A Pilot Study|Recruiting||N/A|20|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:10:27.366094|2017-10-11 02:10:27.366094
NCT01753557|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-08-09|2016-06-14||December 2012||2012-12-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C|A Phase 3 Study of MP-424 in Combination With PEG-IFN Alfa-2a and RBV, in Subjects With Genotype 1 Hepatitis C, Who Are Treatment-Naïve or Relapsed After Previous Treatment|Completed||Phase 3|54|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 02:10:27.621723|2017-10-11 02:10:27.621723
NCT01753544|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2015-11-16|||October 2012||2012-10-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Endoscopic Submucosal Dissection Using a Thulium Laser|Endoscopic Submucosal Dissection Using a Thulium Laser: Preliminary Results of a New Method for Treatment of Gastric Epithelial Neoplasia|Completed||N/A|10|Actual|Soonchunhyang University Hospital|||1||f||||t||||||Samples Without DNA|"     ESD specimen will be examined by a experienced pathologist.   "|||2017-10-11 02:10:28.236379|2017-10-11 02:10:28.236379
NCT01753531|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2013-06-20|||November 2012||2012-11-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Observational|||Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B|A Multicenter Performance Evaluation for the Ultra Influenza A&B Test Using Nasal Swabs|Completed||N/A|677|Actual|Sekisui Diagnostics, LLC|||1||f||||t||||||Samples With DNA|"     Nasal swab specimens   "|||2017-10-11 02:10:28.310514|2017-10-11 02:10:28.310514
NCT01753518|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-04-14|2015-03-26||November 2012||2012-11-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional||Intention-to-Treat Analysis|A Clinical Trial of Subcuticular Staples Versus Subcuticular Suture for Cesarean Section Skin Closure|A Randomized Clinical Trial of Subcuticular Staples Versus Subcuticular Suture for Cesarean Section Skin Closure|Completed||N/A|220|Actual|Mayo Clinic|The data are limited by the lack of diversity, and there may be racial or genetic differences in wound healing confounding the results. This trial was not powered for postoperative wound complications.|2|||f||||f||||||||||2017-10-11 02:10:28.402582|2017-10-11 02:10:28.402582
NCT01753505|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2014-02-17|||January 2013||2013-01-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Clinical Significance of 64-slice Multidetector Coronary CT Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Renal Transplant Recipients||Unknown status|Recruiting|N/A|160|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 02:10:29.144392|2017-10-11 02:10:29.144392
NCT01753492|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-05-22|||August 2013||2013-08-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||Trabeculectomy With Ologen|Trabeculectomy With Ologen-Pilot|Terminated||N/A|7|Actual|Maastricht University Medical Center||1||The results were disappointing.|f||||f||||||||||2017-10-11 02:10:31.182397|2017-10-11 02:10:31.182397
NCT01753479|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-03-03|||January 2013|Actual|2013-01-01|March 2017|2017-03-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Spectroscopy From Duodenum|Duodenal Spectroscopy Study for Cancer Diagnosis|Completed||N/A|445|Actual|Olympus Corporation||1|||f||||t||||||||||2017-10-11 02:10:31.308375|2017-10-11 02:10:31.308375
NCT01753466|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2013-04-19|||October 2012||2012-10-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|WIT||The Water Intake Trial: Pilot Phase|The Water Intake Trial: Pilot Phase|Completed||Phase 3|33|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:10:31.455304|2017-10-11 02:10:31.455304
NCT01753453|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-10-06|||June 2013||2013-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells|A Pilot, Exploratory, Randomized, Phase 2 Safety Study Evaluating Tumor Cell (Plasma Cell) Mobilization and Apheresis Product Contamination in Plerixafor Plus Non-pegylated G-CSF Mobilized Patients and in Non-pegylated G-CSF Alone Mobilized Patients|Completed||Phase 2|23|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:10:31.552268|2017-10-11 02:10:31.552268
NCT01753440|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-18|2013-11-27|||November 2012||2012-11-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy|Study on the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Implantation Combined With Bypass Grafting in Patients With Coronary Artery Disease and Ischemic Cardiomyopathy.|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|AHEPA University Hospital||1|||f||||f||||||||||2017-10-11 02:10:31.682832|2017-10-11 02:10:31.682832
NCT01753427|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-06-14|||December 2012||2012-12-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Perception of Symptom Variability in COPD|Perception of Symptom Variability in Chinese COPD Patients|Completed||N/A|1058|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:10:31.822998|2017-10-11 02:10:31.822998
NCT01753414|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-12-30|||December 2012||2012-12-01|December 2016|2016-12-01||||January 2021|Anticipated|2021-01-01||Interventional|POSTILV||Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC|POSTILV: A RANDOMIZED PHASE II TRIAL IN PATIENTS WITH OPERABLE STAGE I NON-SMALL CELL LUNG CANCER: RADICAL RESECTION VERSUS ABLATIVE STEREOTACTIC RADIOTHERAPY - This is a Limited Participation Study.|Recruiting||Phase 2|76|Anticipated|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 02:10:31.947193|2017-10-11 02:10:31.947193
NCT01753401|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-11-23|||December 2012||2012-12-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease|A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease|Active, not recruiting||Phase 4|36|Anticipated|Mallinckrodt||4|||f||||f||||||||||2017-10-11 02:10:32.07566|2017-10-11 02:10:32.07566
NCT01753388|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-09-26|||December 2012||2012-12-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety and Performance of the Penumbra Liberty Stent in the Treatment of Wide-Neck, Saccular, Intracranial Aneurysms|Safety and Performance of the Penumbra Liberty Stent in the Treatment of Wide-Neck, Saccular, Intracranial Aneurysms|Active, not recruiting||Phase 2|40|Anticipated|Penumbra Inc.||1|||f||||t||||||||||2017-10-11 02:10:32.404021|2017-10-11 02:10:32.404021
NCT01753375|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-17|||January 2013||2013-01-01|December 2012|2012-12-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Interventional|||Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis|Role of Vitamin D on the Relapse Rate of Multiple Sclerosis|Unknown status|Not yet recruiting|Phase 2|200|Anticipated|King Saud University||2|||f||||t||||||||||2017-10-11 02:10:32.53618|2017-10-11 02:10:32.53618
NCT01753362|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-02-08|||December 2012||2012-12-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Liraglutide In Overweight Patients With Type 1 Diabetes|LIRAGLUTIDE IN OVERWEIGHT PATIENTS WITH TYPE 1 DIABETES|Recruiting||Phase 3|84|Anticipated|University at Buffalo||2|||f||||t||||||||||2017-10-11 02:10:32.692171|2017-10-11 02:10:32.692171
NCT01753349|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-08-28|||December 2012|Actual|2012-12-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|INTEREST_INCD2||Phase IV-Cervical Dystonia-INTEREST IN CD2|An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact|Active, not recruiting||N/A|1050|Actual|Ipsen|||1||f||||f||||||||||2017-10-11 02:10:32.907739|2017-10-11 02:10:32.907739
NCT01753336|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-03-23|2017-01-12||March 2013||2013-03-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||The safety population included all subjects who received at least 1 dose of study treatment, regardless of the amount of study treatment administered, and who had at least 1 safety record post-treatment or attended a post-treatment visit.|Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia|A Phase IIIb, Prospective, Multicentre, Open-Label Extension Study To Assess Long Term Safety And Effectiveness Of Dysport® Using 2 mL Dilution In Adults With Cervical Dystonia|Completed||Phase 3|112|Actual|Ipsen||1|||f||||f||||||||||2017-10-11 02:10:33.41619|2017-10-11 02:10:33.41619
NCT01753323|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2015-10-01|2015-07-23||March 2013||2013-03-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection|A Proof-of-concept, Open Label Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection|Completed||Phase 2|43|Actual|Novartis||3|||f||||f||||||||||2017-10-11 02:10:34.452855|2017-10-11 02:10:34.452855
NCT01753310|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-01-26|2016-11-08||January 2013||2013-01-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional||The baseline characteristics are presented for the Intent to Treat (ITT) Population which consisted of all randomised subjects.|Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.|A Phase 3b, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.|Completed||Phase 3|134|Actual|Ipsen||2|||f||||f||||||||||2017-10-11 02:10:35.450549|2017-10-11 02:10:35.450549
NCT01753297|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-07-25|||December 2012||2012-12-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|PRIORITI||A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.|A Multicentric, Multinational (China and Russia), Randomised, Open, Controlled Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients|Active, not recruiting||Phase 4|226|Anticipated|Ipsen||2|||f||||f||||||||||2017-10-11 02:10:36.326583|2017-10-11 02:10:36.326583
NCT01753284|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-09-27|||January 2013||2013-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||First Episode Psychosis and Pathway to Care in Nordland|Patients and Carers Experiences With First Episode Psychosis and Pathway to Care in Nordland: A Qualitative Study|Active, not recruiting||N/A|40|Anticipated|Nordlandssykehuset HF|||1||f||||f||||||||||2017-10-11 02:10:36.64077|2017-10-11 02:10:36.64077
NCT01753271|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2015-08-19|||September 2012||2012-09-01|August 2015|2015-08-01||||June 2015|Actual|2015-06-01||Interventional|||Subacute Effects of Spinal Mobilization to Treat Subacromial Impingement|Subacute Effects of Cervicothoracic Spinal Manipulation in Addition to Shoulder Manual Therapy Plus Exercise Intervention in Individuals With Subacromial Impingement Syndrome: a Randomized, Controlled Clinical Trial Pilot Study|Completed||N/A|20|Actual|High Point University||2|||f||||f||||||||||2017-10-11 02:10:36.710099|2017-10-11 02:10:36.710099
NCT01753258|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-10-10|||January 2013||2013-01-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Outcomes of Delivery in Patients With Dyspareunia|Outcomes of Delivery in Patients With Dyspareunia- A Prospective Study|Completed||N/A|173|Actual|Hadassah Medical Organization|||3||f||||f||||||||||2017-10-11 02:10:36.812518|2017-10-11 02:10:36.812518
NCT01753245|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2014-03-12|||December 2012||2012-12-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Observational|||Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.|CARDIOVASCULAR RISK FACTORS IN A SPANISH POPULATION OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS VULGARIS, WITH OR WITHOUT ARTHRITIS, TREATED WITH ANTI-TNF IN REAL CLINICAL PRACTICE. ANALYSIS OF THE INFLUENCE OF METABOLIC SYNDROME ON TREATMENT EFFICACY.|Unknown status|Active, not recruiting|N/A|300|Anticipated|Hospital Universitario Reina Sofia|||2||f||||f||||||Samples With DNA|"     whole blood, serum, plasma.   "|||2017-10-11 02:10:36.940538|2017-10-11 02:10:36.940538
NCT01753232|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-09-03|||May 2012||2012-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Observational|LINET||Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter|Non-interventional Study: Safety and Efficacy of the DALI LDL-adsorber and MONET-lipoprotein Filter|Completed||N/A|108|Actual|Fresenius Medical Care Deutschland GmbH|||2||f||||f||||||||||2017-10-11 02:10:37.096284|2017-10-11 02:10:37.096284
NCT01753219|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2015-08-17|||March 2013||2013-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Interventional|Onli||Onstep Versus Lichtenstein, the Onli Trial.|Effect of Suture for Mesh Fixation on Pain and Other Complications in Patients Undergoing Inguinal Hernia Repair: a Double-blind, Randomized Study Comparing the Lichtenstein With the Onstep Technique - the ONLI Trial.|Completed||N/A|290|Actual|Herlev Hospital||2|||f||||f||||||||||2017-10-11 02:10:37.270866|2017-10-11 02:10:37.270866
NCT01753206|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2015-01-14|||February 2013||2013-02-01|January 2014|2014-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|Teveten_RH||Observational Study to Investigate Resistant Hypertension Prevalence in Korean General Hospitals|Observational Study to Investigate Resistant Hypertension Prevalence Among the Hypertensive Patients Who Have Been Treated in Korean General Hospitals|Completed||N/A|1579|Actual|Handok Pharmaceuticals Co., Ltd.|||1||f||||f||||||||||2017-10-11 02:10:37.420728|2017-10-11 02:10:37.420728
NCT01753193|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-10-04|||March 28, 2013|Actual|2013-03-28|September 2017|2017-09-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults|A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of MEDI-546 in Adults With Systemic Lupus Erythematosus|Active, not recruiting||Phase 2|218|Actual|MedImmune LLC||1|||f||||f||||||||||2017-10-11 02:10:37.514763|2017-10-11 02:10:37.514763
NCT01753180|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-07-07|||April 2014||2014-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|TOSCA-5||Total Occlusion Study in Coronary Arteries - 5|A 2-stage Study to Evaluate Single Doses of MZ-004 at Different Dose Levels in Patients With Chronic Total Occlusions. Stage 1: Open Label Training Stage. Stage 2: Double-blind, Randomized, Placebo-Controlled Stage|Completed||Phase 2|76|Actual|Matrizyme Pharma Corporation||2|||f||||t||||||||||2017-10-11 02:10:37.743362|2017-10-11 02:10:37.743362
NCT01753167|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-03-07||2017-03-07|December 14, 2012|Actual|2012-12-14|March 2017|2017-03-01|October 15, 2014|Actual|2014-10-15|October 15, 2014|Actual|2014-10-15||Interventional|||A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients|A Phase II Randomized, Double-blind, Placebo-controlled Trial of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-risk Kidney Allograft Recipients|Completed||Phase 2|122|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 02:10:37.86122|2017-10-11 02:10:37.86122
NCT01753154|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2016-04-29|||July 2011||2011-07-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis|The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis|Completed||Phase 4|25|Actual|Fresenius Medical Care Deutschland GmbH||2|||f||||f||||||||||2017-10-11 02:10:38.032081|2017-10-11 02:10:38.032081
NCT01753141|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2013-09-25|||January 2008||2008-01-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|STAMP||Smoking Treatment and Anxiety Management Program|Smoking Treatment and Anxiety Management Program|Completed||N/A|378|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 02:10:38.160449|2017-10-11 02:10:38.160449
NCT01753128|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2014-08-15|||December 2012||2012-12-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn|Efficacy of Imipramine for Treatment of Patients With Esophageal|Completed||Phase 3|83|Actual|Mahidol University||1|||f||||f||||||||||2017-10-11 02:10:38.260812|2017-10-11 02:10:38.260812
NCT01753115|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-11-18|2014-10-22||December 2012||2012-12-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Intent to treat population: all subjects who were randomized.|Ciprofloxacin BioThrax Co-Administration Study|A Study of The Effects of Co-Administering Ciprofloxacin and BioThrax on the Pharmacokinetics of Ciprofloxacin in Healthy Adults|Completed||Phase 2|154|Actual|Emergent BioSolutions||3|||f||||f||||||||||2017-10-11 02:10:38.361323|2017-10-11 02:10:38.361323
NCT01753102|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2015-05-19|||November 2012||2012-11-01|December 2012|2012-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety Of Spil's Estradiol Vaginal Tablet|EFFICACY AND SAFETY OF SPIL'S ESTRADIOL VAGINAL TABLET, 10 MCG ESTRADIOL IN SUBJECTS WITH VULVAR AND VAGINAL ATROPHY: A RANDOMIZED, OBSERVER BLIND, PARALLEL GROUPS, ACTIVE AND PLACEBO CONTROLLED, CLINICAL ENDPOINT BIOEQUIVALENCE STUDY|Terminated||Phase 3|49|Actual|Sun Pharmaceutical Industries Limited||3||Slow recruitment|f||||f||||||||||2017-10-11 02:10:38.855955|2017-10-11 02:10:38.855955
NCT01753089|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-01-04|||June 2013||2013-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Dendritic Cell Activating Scaffold in Melanoma|A Phase I Trial of a Dendritic Cell Activating Scaffold Incorporating Autologous Melanoma Cell Lysate (WDVAX) in Metastatic Melanoma Patients|Recruiting||Phase 1|25|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 02:10:38.966602|2017-10-11 02:10:38.966602
NCT01753076|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-04-18|2016-12-01|2015-05-28|December 1, 2012||2012-12-01|February 2017|2017-02-01|January 22, 2015|Actual|2015-01-22|November 1, 2014|Actual|2014-11-01||Interventional||One participant who did not receive any study drug was excluded from the intent-to-treat (ITT) population.|Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis|Study NOG112264, a Phase II Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis|Completed||Phase 2|304|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 02:10:39.149146|2017-10-11 02:10:39.149146
NCT01753063|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2013-12-16|||January 2013||2013-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Managing Patient Expectations in Pediatric Weight Management|Managing Expectations in Pediatric Weight Management: A Pilot Study in Focus on a Fitter Future III Hospitals|Completed||N/A|405|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-11 02:10:40.643766|2017-10-11 02:10:40.643766
NCT01753050|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-07-25|||December 2012||2012-12-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|HipHop||HIP Surgery - Hemodynamic Optimization Project|A Quality Improvement Project for Goal-directed Intraoperative Hemodynamic Optimization in Patients Redo Hip Surgery|Recruiting||N/A|390|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 02:10:40.792779|2017-10-11 02:10:40.792779
NCT01753037|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2013-11-14|||December 2006||2006-12-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Effects of Androgen Administration on Inflammation in Normal Women|Effects of Oral Androgen Administration on Hyperglycemia-Induced Inflammation in Lean Reproductive-Age Women|Completed||N/A|25|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:10:40.896646|2017-10-11 02:10:40.896646
NCT01753024|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2013-09-28|||January 2012||2012-01-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01|2 Weeks|Observational [Patient Registry]|||Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Supplementation in Critically Ill Adult Patients|The Incidence of Pancreatic Exocrine Insufficiency and the Benefits of Pancreatic Enzyme Supplementation in Critically Ill Adult Patients|Unknown status|Recruiting|N/A|1200|Anticipated|Shanghai 10th People's Hospital|||8||f||||t||||||Samples Without DNA|"     Blood samples: lactate, hemoglobin, total bilirubin, trypsin, Vit D, etc. Stool samples: 24h     fecal fat; fetal elastase-1; Fecal chymotrypsin. Nutrition status: BMI, weight loss,     biomarkers such as albumin and prealbumin, etc.      Radiological assessments: MRCP & CT scanning.   "|||2017-10-11 02:10:40.995368|2017-10-11 02:10:40.995368
NCT01753011|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-17|||May 2007||2007-05-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Urethral Length and TOT (Transobturator Tape) Positioning|Prospective, Observational Study: Can Pelvic Floor Ultrasound Help to Optimize TOT (Transobturator Tape) Positioning?|Completed||N/A|123|Actual|Cantonal Hospital, Frauenfeld|||1||f||||t||||||||||2017-10-11 02:10:41.155248|2017-10-11 02:10:41.155248
NCT01752998|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-09-15|||September 2012||2012-09-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|BupPain||Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings|Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings|Completed||N/A|28|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-11 02:10:41.244947|2017-10-11 02:10:41.244947
NCT01752049|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-05-17|||May 2013||2013-05-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept|Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept|Recruiting||N/A|10|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||Undecided||2017-10-11 02:10:53.041368|2017-10-11 02:10:53.041368
NCT01752985|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-03-22||2017-03-22|March 2013||2013-03-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease|A Double-Blind, Placebo-Controlled, Randomized, Two-stage, Parallel-Group, Adaptive Design Phase 2a Study to Evaluate the Effects of BMS-813160 in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease (DKD) Who Have Residual Macroalbuminuria Despite Treatment With an Inhibitor of the Renin-Angiotensin System|Completed||Phase 2|89|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 02:10:41.361662|2017-10-11 02:10:41.361662
NCT01752972|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-17|||April 2011||2011-04-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic|Effect of Spirulina on the Levels of Zinc, Vitamin E and Linoleic Acid in the Palm Skin Extracts of People With Prolonged Exposure to Arsenic|Completed||N/A|30|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||3|||f||||f||||||||||2017-10-11 02:10:41.588873|2017-10-11 02:10:41.588873
NCT01752959|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-17|||July 2012||2012-07-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||A Comparison of Esmolol and Remifentanil to Reduce Blood Loss|A Randomized Comparison of Esmolol and Remifentanil on Intraoperative Bleeding and Surgical Field Conditionsin Nasal Surgery|Unknown status|Recruiting|Phase 4|60|Anticipated|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-11 02:10:41.688325|2017-10-11 02:10:41.688325
NCT01752946|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-15|2012-12-19|||October 2012||2012-10-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|RSCMI-VII||A Registry Study of Shuxuening Injection Used in Hospitals in China|A Registry Study of Shuxuening (a Chinese Medicine Injection) Used in Hospitals in China|Unknown status|Active, not recruiting|N/A|30000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t||||||||||2017-10-11 02:10:41.82126|2017-10-11 02:10:41.82126
NCT01752933|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2017-01-24||2017-01-24|December 2012||2012-12-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)|A Phase 2 Study of SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Subjects Who Failed Prior Treatment With Sorafenib|Completed||Phase 2|51|Actual|Astex Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:10:41.912207|2017-10-11 02:10:41.912207
NCT01752907|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-12-06|2015-12-06||January 2013||2013-01-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|VINE|The full analysis set included all randomized participants who received primary prophylaxis (cycle 1 administration) with pegfilgrastim.|Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim|Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim|Completed||Phase 2|304|Actual|Amgen||2|||f||||f||||||||||2017-10-11 02:10:42.241747|2017-10-11 02:10:42.241747
NCT01752894|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-02-26|||January 2013||2013-01-01|February 2015|2015-02-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|DETECT-OCT||DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)||Recruiting||N/A|1100|Anticipated|Yonsei University||6|||f||||f||||||||||2017-10-11 02:10:43.466394|2017-10-11 02:10:43.466394
NCT01752881|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2012-12-17|||August 2012||2012-08-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects|Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects|Completed||Phase 4|130|Actual|Adimmune Corporation||1|||f||||f||||||||||2017-10-11 02:10:43.587888|2017-10-11 02:10:43.587888
NCT01752868|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2012-12-14|||May 2011||2011-05-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Can Fish Oil and Phytochemical Supplements Mimic Anti-Aging Effects of Calorie Restriction?|Can Fish Oil and Phytochemical Supplements Mimic Anti-Aging Effects of Calorie Restriction?|Completed||N/A|56|Actual|Washington University School of Medicine||2|||f||||||||||||||2017-10-11 02:10:43.68133|2017-10-11 02:10:43.68133
NCT01752855|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-17|2014-10-22|2014-10-22||December 2012||2012-12-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||All participants who received at least 1 dose of study drug|Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab|A Phase 2b, Multicenter, Open-Label Study in Rheumatoid Arthritis Subjects Who Completed Preceding Study M13-390 With Adalimumab|Completed||Phase 2|88|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 02:10:43.771667|2017-10-11 02:10:43.771667
NCT01752842|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-04-05|||March 2013||2013-03-01|April 2017|2017-04-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Interventional|||Lipid Biomarkers for Diabetic Heart Disease|Lipid Biomarkers for Diabetic Heart Disease|Recruiting||N/A|104|Anticipated|Washington University School of Medicine||2|||f||||t||||||||No||2017-10-11 02:10:44.190691|2017-10-11 02:10:44.190691
NCT01752829|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-18|||January 2013||2013-01-01|December 2012|2012-12-01||||January 2016|Anticipated|2016-01-01|3 Years|Observational [Patient Registry]|||Post-marketing Surveillance Study of A.M.I. Protector Adjustable Gastric Band|A Single-arm, Observational, Post-marketing Study to Evaluate the Effects of the A.M.I. Protector Adjustable Gastric Band on Weight Loss, Co-morbidities, Adverse Events and Other Clinical Characteristics.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Weight to Go Ltd|||1||f||||f||||||||||2017-10-11 02:10:44.304018|2017-10-11 02:10:44.304018
NCT01752816|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2013-08-14|||January 2012||2012-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Does Aerobic Training Followed by Resistance Training Enhance Aerobic Capacity in Seniors|Does Aerobic Training Followed by Resistance Training Enhance Aerobic Capacity in Seniors? A Randomized Controlled Trial.|Completed||Phase 2|33|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 02:10:44.410483|2017-10-11 02:10:44.410483
NCT01752803|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2014-09-30|||December 2012||2012-12-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|July 2013|Actual|2013-07-01||Interventional|||RCT Examining Effects of Probiotics in T2DM Individuals|A Double-blind, Randomized Placebo-controlled Parallel Group Study of Probiotics as an Adjuvant Therapy for Individuals With Type 2 Diabetes Mellitus|Unknown status|Recruiting|N/A|100|Anticipated|Universiti Kebangsaan Malaysia Medical Centre||2|||f||||f||||||||||2017-10-11 02:10:44.508075|2017-10-11 02:10:44.508075
NCT01752790|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-03-05|||December 2012||2012-12-01|March 2013|2013-03-01|December 2015|Anticipated|2015-12-01|January 2014|Anticipated|2014-01-01||Interventional|||Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease|Efficacy and Safety of Infliximab as First-line Therapy in Pediatric Crohn's Disease: a Randomized, Controlled, Open-label Trial|Withdrawn||Phase 4|0|Actual|University of Roma La Sapienza||2||"The study will be part of a European multicenter trial (Infliximab Top-down Study in Kids with   Crohn's disease)"|f||||f||||||||||2017-10-11 02:10:44.617048|2017-10-11 02:10:44.617048
NCT01752777|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2017-05-27|||February 2012||2012-02-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Behavioral Intervention to Enhance HIV Test/Treat|Behavioral Intervention to Enhance HIV Test/Treat|Active, not recruiting||N/A|500|Actual|University of Connecticut||2|||f||||t||||||||||2017-10-11 02:10:44.739548|2017-10-11 02:10:44.739548
NCT01752764|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-01-27|||April 2013||2013-04-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Assessment of the Relative Increase in Bioavailability of (Non-) Nutrients From a Mixed Salad by Adding Fat Containing Dressing|Assessment of the Relative Increase in Bioavailability of (Non-) Nutrients From a Mixed Salad by Adding Fat Containing Dressing|Completed||N/A|12|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-11 02:10:44.835076|2017-10-11 02:10:44.835076
NCT01752751|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-05-15|||November 2012||2012-11-01|May 2017|2017-05-01|July 10, 2018|Anticipated|2018-07-10|May 2015|Actual|2015-05-01||Observational|||Predicting Tolerance to Radiation Therapy in Older Adults With Cancer|Predicting Tolerance to Radiation Therapy in Older Adults With Cancer: A Prospective Blinded Study of the Comprehensive Geriatric Assessment|Active, not recruiting||N/A|50|Actual|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:10:44.938847|2017-10-11 02:10:44.938847
NCT01752738|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-05-03|||December 2013||2013-12-01|May 2016|2016-05-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Intestinal Transport of Microbial Metabolites in Chronic Kidney Disease|The Influence of Chronic Kidney Disease on Intestinal Transport of Gut Microbial Metabolites|Active, not recruiting||N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"     Serum, plasma, urine, faeces   "|||2017-10-11 02:10:45.060884|2017-10-11 02:10:45.060884
NCT01752725|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-14|||October 2011||2011-10-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Comparison of BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy (LASH)|Comparison of BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy (LASH): A Prospective, Controlled, Randomized, Non-inferiority in Vivo Human Study.|Completed||N/A|30|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-11 02:10:45.162996|2017-10-11 02:10:45.162996
NCT01752699|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-03-14|||January 1998||1998-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|NPH||Methadone in Post-Herpetic Neuralgia Pain|Methadone in Post-Herpetic Neuralgia Pain|Completed||Phase 3|10|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:10:45.420918|2017-10-11 02:10:45.420918
NCT01752686|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-12-21|||March 2013||2013-03-01|December 2012|2012-12-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer|A Phase III Trial of Carboplatin as Adjuvant Chemotherapy Versus Observation in Triple Negative Breast Cancer With Pathologic Residual Cancer After Neoadjuvant Chemotherapy: POST-Neo Adjuvant Study|Not yet recruiting||Phase 3|587|Anticipated|Severance Hospital||2|||f||||t||||||||||2017-10-11 02:10:45.526953|2017-10-11 02:10:45.526953
NCT01752673|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-14|||March 2011||2011-03-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Visualization of Uncertainty in Clinical Diagnostic Reasoning for Pulmonary Embolism|The Visualization of Uncertainty in Clinical Diagnostic Reasoning for Pulmonary Embolism: a Randomized Controlled Trial.|Completed||N/A|30|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 02:10:45.656725|2017-10-11 02:10:45.656725
NCT01752660|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-07-17|||October 2012||2012-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||Exercise in Severely Disabled Patients With MS|Endurance Training in Severely Disabled Patients With MS - a Feasibility Study|Completed||Phase 1|12|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:10:45.827714|2017-10-11 02:10:45.827714
NCT01752647|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-09-26|||November 2012||2012-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||CT Screening For Lung Cancer in High Risk Patients: the Russian Study.|Cohort Study of Low Dose Computed Tomography for Lung Cancer Screening in Asymptomatic High-risk Patients.|Completed||Phase 2|369|Actual|Petrov Research Institute of Oncology||1|||f||||f||||||||||2017-10-11 02:10:45.930749|2017-10-11 02:10:45.930749
NCT01752634|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-02-07|||April 2013||2013-04-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|FUTURE 2||Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis|A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate the Efficacy at 24 Weeks and to Assess the Long Term Efficacy, Safety and Tolerability up to 5 Years in Patients With Active Psoriatic Arthritis|Active, not recruiting||Phase 3|399|Actual|Novartis||4|||f||||||||||||||2017-10-11 02:10:46.055132|2017-10-11 02:10:46.055132
NCT01752621|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-12-05|||February 2013||2013-02-01|December 2014|2014-12-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Epidemiology of Acromegaly in Denmark 1991-2010|Incidence and Late Prognosis of Acromegaly in Denmark From 1991 - 2010: Twenty Years of Medical Treatment|Unknown status|Active, not recruiting|N/A|500|Anticipated|University of Aarhus|||2||f||||t||||||||||2017-10-11 02:10:46.318428|2017-10-11 02:10:46.318428
NCT01752608|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2015-10-12|||October 2012||2012-10-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder|A Randomized, Comparator-Controlled, Two-Arm, Parallel Group Study to Determine the Safety and Efficacy of eCBT Mood®, a Handheld, Computerized, Electronic Cognitive Behavioral Therapy Application, in Patients With Major Depressive Disorder|Withdrawn||N/A|0|Actual|MindApps||2||Lack of enrollment|f||||f||||||||||2017-10-11 02:10:46.412695|2017-10-11 02:10:46.412695
NCT01752595|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2013-11-25|||November 2012||2012-11-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|MAINTAIN||The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment|The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment Study|Unknown status|Active, not recruiting|N/A|35|Anticipated|Toronto Rehabilitation Institute||3|||f||||||||||||||2017-10-11 02:10:46.518853|2017-10-11 02:10:46.518853
NCT01752582|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-03-10|||December 2012||2012-12-01|March 2016|2016-03-01||||December 2014|Actual|2014-12-01||Interventional|||BuMA OCT Study(A Comparative Evaluation of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)|BuMA OCT Study(A Comparative Evaluation of BuMA Stent and of EXCEL Stent in Terms of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)|Completed||N/A|80|Actual|Sino Medical Sciences Technology Inc.||2|||f||||t||||||||||2017-10-11 02:10:46.63439|2017-10-11 02:10:46.63439
NCT01752569|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2014-09-18|||June 2012||2012-06-01|September 2014|2014-09-01|February 2016|Anticipated|2016-02-01|June 2015|Anticipated|2015-06-01||Interventional|SCART||A Study of Selumetinib in Patients With Kaposi's Sarcoma|Phase I/II Study of Oral MEK Inhibitor Selumetinib (AZD6244 Hyd-Sulphate) in Combination With Highly Active Anti-Retroviral Therapy (HAART) in AIDS-associated Kaposi's Sarcoma (KS).|Unknown status|Recruiting|Phase 1/Phase 2|29|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 02:10:46.743461|2017-10-11 02:10:46.743461
NCT01752556|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-02-06|||May 2012||2012-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2015|Actual|2015-06-01||Interventional|HRP-M||Cost-effectiveness of Home Respiratory Polygraphy|Non-inferiority Randomized Control Trial About Efficacy and Cost-effectiveness of Home Respiratory Polygraphy Management in Sleep Apneas/Hypopneas Syndrome|Completed||Phase 3|440|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||f||||||||||2017-10-11 02:10:47.07322|2017-10-11 02:10:47.07322
NCT01752543|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-06-16|||December 2013||2013-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients|Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients|Completed||Phase 4|20|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 02:10:47.184178|2017-10-11 02:10:47.184178
NCT01752530|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-04-26|||February 2013|Actual|2013-02-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|October 2015|Actual|2015-10-01||Interventional|||Cognitive Training in Children With Attention Deficit/ Hyperactivity Disorder (ADHD)|A Study of the Efficacy of Computerized Cognitive Training on Cognitive Function, Symptoms and Functional Outcome in Children With ADHD.|Completed||N/A|70|Actual|Region Syddanmark||2|||f||||f||||||||||2017-10-11 02:10:47.302397|2017-10-11 02:10:47.302397
NCT01752517|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-14|||December 2012||2012-12-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|||Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer|A Phase Ⅱ Single-arm Clinical Trial to Investigate the Efficacy and Safety of Vinorelbine-ifosfamide Regimen as Third-line Treatment in Refractory or Recurrent Extensive Small Cell Lung Cancer Patients|Unknown status|Recruiting|N/A|60|Anticipated|Peking Union Medical College Hospital|||1||f||||f||||||||||2017-10-11 02:10:47.410709|2017-10-11 02:10:47.410709
NCT01752504|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-02-27|||November 2011||2011-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention|Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention|Completed||N/A|650|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 02:10:47.529216|2017-10-11 02:10:47.529216
NCT01752491|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-04-20|||April 2013||2013-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|November 2015|Actual|2015-11-01||Interventional|||A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme|A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme|Active, not recruiting||Phase 1|13|Actual|University of Iowa||6|||f||||t||||||||Yes|Data will be shared on clinicaltrials.gov as well as through an NIH/NCI approved data sharing plan in compliance with subject's consent to sharing.|2017-10-11 02:10:47.627802|2017-10-11 02:10:47.627802
NCT01752478|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-05-18|||January 2013||2013-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01|6 Months|Observational [Patient Registry]|||Preoperative and Intraoperative Factors Related to the Development of Ptosis After Retinal Surgery|Preoperative and Intraoperative Factors Related to the Development of Ptosis After Retinal Surgery|Completed||N/A|50|Actual|University of California, San Francisco|||1||f||||t||||||||||2017-10-11 02:10:47.804443|2017-10-11 02:10:47.804443
NCT01752465|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-11-30|||January 2016||2016-01-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders?|Is Health Coaching a Useful Clinical Tool to Facilitate Healthy Lifestyle Change and Improve Metabolic Health in People With Psychotic Illness?|Enrolling by invitation||N/A|40|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:10:47.920557|2017-10-11 02:10:47.920557
NCT01752452|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-14|||January 2009||2009-01-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01|2 Years|Observational [Patient Registry]|||Effect of Ulnar Styloid Fracture on the Outcome of Distal Radial Fractures Treated With External Fixation||Completed||N/A|106|Actual|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|||1||f||||t||||||||||2017-10-11 02:10:48.068451|2017-10-11 02:10:48.068451
NCT01752439|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-14|||February 2013||2013-02-01|December 2012|2012-12-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache|Randomized Double-Blind Sham-Controlled Study of the Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache Patients|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Mediterranean Neurological Institute||3|||f||||t||||||||||2017-10-11 02:10:48.151708|2017-10-11 02:10:48.151708
NCT01752426|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-03-30|||December 2012|Actual|2012-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL|A Pilot Study to Determine the Effects of the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:10:48.252315|2017-10-11 02:10:48.252315
NCT01752413|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-01-17|||December 2012||2012-12-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Iron Depletion and Replacement in Blood Donors|Iron Depletion and Replacement in Blood Donors|Unknown status|Recruiting|N/A|1000|Anticipated|Memorial Blood Centers, Minnesota||2|||f||||f||||||||||2017-10-11 02:10:48.383429|2017-10-11 02:10:48.383429
NCT01752400|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-04-12|||January 2013||2013-01-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|June 2017|Anticipated|2017-06-01||Interventional|||AUY922 for Advanced ALK-positive NSCLC|A Phase II Open-Label Trial of AUY922, an HSP90 Inhibitor, in Patients With ALK-Rearranged Advanced Non-Small Cell Lung Cancer and Acquired Resistance to Prior ALK Tyrosine Kinase Inhibition|Active, not recruiting||Phase 2|6|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:10:48.494584|2017-10-11 02:10:48.494584
NCT01752387|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2015-06-11|||June 2006||2006-06-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Observational|||The Management of Sportsman's Groin Hernia in Professional and Amateur Soccer Players|A Study, Based on Medical Record and Questionnaire, Investigate the Management of Sportsman's Groin Hernia in Professional and Amateur Soccer Players -Results of the Follow-up in Our Department and a Comparison the Medical Literature|Completed||N/A|246|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-11 02:10:48.606367|2017-10-11 02:10:48.606367
NCT01752374|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2015-08-28|||December 2011||2011-12-01|August 2015|2015-08-01||||March 2013|Actual|2013-03-01||Observational|||Palonestron, Granisetron and Ramosetron for Prevention of Postoperative Nasea and Voming After Laparoscopic Abdominal Surgery||Completed||N/A|90|Actual|Gachon University Gil Medical Center|||3||f||||f||||||||||2017-10-11 02:10:48.665975|2017-10-11 02:10:48.665975
NCT01752361|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-01-06|||April 2013||2013-04-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|April 2014|Anticipated|2014-04-01||Observational|||Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit|Gastrointestinal Transit Times and Motility in Patients Suffering From Severe Ulcerative Colitis Obtained by Motilis-3D-transit|Unknown status|Recruiting|N/A|20|Anticipated|University of Aarhus|||1||f||||t||||||||||2017-10-11 02:10:48.742647|2017-10-11 02:10:48.742647
NCT01752348|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-11-24|||February 2013||2013-02-01|July 2013|2013-07-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||Effects of Free Fatty Acids and 3-hydroxybutyrate on Protein, Glucose, Lipid Metabolism and Intracellular Signals.|Effects of Free Fatty Acids and 3-hydroxybutyrate on Protein, Glucose, Lipid Metabolism and Intracellular Signals; a Study on Muscle Wasting and Metabolism During Acute Inflammation and Potential Anabolic Mechanisms.|Completed||N/A|10|Actual|University of Aarhus||4|||f||||t||||||||||2017-10-11 02:10:48.839435|2017-10-11 02:10:48.839435
NCT01752335|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-02-07|||December 2011||2011-12-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|TOCRIVAR||Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis|Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis|Active, not recruiting||Phase 4|28|Anticipated|Hospital Universitario de Canarias||1|||f||||f||||||||||2017-10-11 02:10:48.938527|2017-10-11 02:10:48.938527
NCT01752322|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-07-05|||October 2012||2012-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain|Efficacy and Safety of Lidocaine 5% Medicated Plaster in Localized Chronic Post-operative Neuropathic Pain|Completed||Phase 3|444|Actual|Grünenthal GmbH||2|||f||||f||||||||||2017-10-11 02:10:49.040195|2017-10-11 02:10:49.040195
NCT01752309|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-11-18|||June 2010||2010-06-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|EVA||The Predictive Value of Ultrasound in Early Rheumatoid Arthritis|The Predictive Value of Ultrasound in Early Rheumatoid Arthritis|Completed||N/A|150|Actual|Erasmus Medical Center|||1||f||||f||||||||||2017-10-11 02:10:49.209882|2017-10-11 02:10:49.209882
NCT01752296|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-12-02|||July 2012||2012-07-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|MAP||Psychological Concomitants of Morquio Syndrome (The MAP Study)|Psychological Concomitants of Morquio Syndrome|Completed||N/A|20|Actual|Emory University|||1||f||||t||||||||||2017-10-11 02:10:49.285903|2017-10-11 02:10:49.285903
NCT01752283|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-12-18|||January 2010||2010-01-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Video-assisted Thyroid Surgery and Hypnosis in Thyroid Surgery|Combination of Video-assisted Thyroid Surgery and Hypnosis as a Complete Minimally Invasive Approach: a Comparative Pilot Study|Completed||N/A|130|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 02:10:49.344921|2017-10-11 02:10:49.344921
NCT01752270|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-16|||December 2012||2012-12-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome|The Effect of Diane-35 Pretreatment on Endocrine and Clinical Profile for Patients With Polycystic Ovary Syndrome Undergoing In-vitro Fertilization|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-11 02:10:49.436874|2017-10-11 02:10:49.436874
NCT01752257|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-03-06|||July 2012||2012-07-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||EF5 in Melanoma Patients|Pilot Study to Characterize the HRHV Axis in the Microenvironment of Melanoma in Patients Undergoing Isolated Limb Infusion or Hypothermic Isolated Limb Perfusion With Melphalan|Completed||Phase 1|15|Actual|Duke University||1|||f||||f||||||||||2017-10-11 02:10:49.514528|2017-10-11 02:10:49.514528
NCT01752036|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-10-05|||March 2013||2013-03-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Radiotherapy for Solid Tumor Spine Metastases|Phase II Study of Post-Operative Stereotactic Radiosurgery for Solid Tumor Spine Metastases|Active, not recruiting||Phase 2|35|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:10:53.365272|2017-10-11 02:10:53.365272
NCT01752244|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2012-12-24|||January 2012||2012-01-01|December 2012|2012-12-01|January 2013|Anticipated|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Assessing the Effects of Alfacalcidol Intake on Expression of Involed Gene in Metabolism in Obese Subjects|Assessing the Effects of Supplementary Alfacalcidol Intake on Peroxisome Proliferator-activated Receptor-coactivator-1α, Vitamin D Receptor and Peroxisome Proliferator-activated Receptor Gamma Gene Expression in Obese Subjects|Unknown status|Recruiting|N/A|94|Anticipated|Tehran University of Medical Sciences||2|||f||||||||||||||2017-10-11 02:10:49.57791|2017-10-11 02:10:49.57791
NCT01752231|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-09-06|||July 23, 2013|Actual|2013-07-23|September 2017|2017-09-01|August 29, 2017|Actual|2017-08-29|August 29, 2017|Actual|2017-08-29||Interventional|||Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring|Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring|Terminated||N/A|1|Actual|City of Hope Medical Center||1||Feasibility issues.|f||||t||||||||||2017-10-11 02:10:49.67321|2017-10-11 02:10:49.67321
NCT01752218|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-05-21|||January 2013||2013-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Address Precision and Refractive Predictability of Femtosecond Laser-assisted Astigmatic Keratotomy Following the Cataract Surgery|A Single Centre Study to Address Precision and Refractive Predictability of Femtosecond Laser-assisted Astigmatic Keratotomy Following the Cataract Surgery|Completed||N/A|43|Actual|Technolas Perfect Vision GmbH||1|||f||||f||||||||||2017-10-11 02:10:49.747491|2017-10-11 02:10:49.747491
NCT01752205|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-16|2012-12-16|||November 2012||2012-11-01|December 2012|2012-12-01|November 2014|Anticipated|2014-11-01|May 2014|Anticipated|2014-05-01||Interventional|ESCC-307PLAH||Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma|A Randomized Phase III Study: Paclitaxel Plus Radiation Therapy With or Without Erlotinib in Treating Patients With Esophageal Squamous Carcinoma|Unknown status|Recruiting|Phase 3|120|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-11 02:10:49.820406|2017-10-11 02:10:49.820406
NCT01752192|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-12-29|||December 2012||2012-12-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Teledi@log||Teledi@Log - Tele-rehabilitation of Heart Patients|Tele-rehabilitation of Heart Patients|Completed||N/A|151|Actual|Aalborg University||2|||f||||t||||||||||2017-10-11 02:10:49.946139|2017-10-11 02:10:49.946139
NCT01752179|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2013-02-28|||May 2011||2011-05-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|KT||Kinesio Taping Technique and Trigger Point|The Effect of Kinesio Taping Technique on Trigger Point of Piriformis Muscle|Completed||N/A|50|Actual|University of Social Welfare and Rehabilitation Science||2|||f||||t||||||||||2017-10-11 02:10:50.04919|2017-10-11 02:10:50.04919
NCT01752166|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-05-23|||July 2013||2013-07-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|direcT2||Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)|Prospective Collection and Testing of Un-Spiked and Candida-Spiked Fresh Whole Blood Specimens From Patients Who Have Been Referred For a Diagnostic Blood Culture|Completed||N/A|1500|Anticipated|T2 Biosystems|||1||f||||f||||||Samples With DNA|"     Whole blood specimens   "|||2017-10-11 02:10:50.124283|2017-10-11 02:10:50.124283
NCT01752153|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-12-18|||June 2012||2012-06-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major||Completed||Phase 1|25|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:10:50.203768|2017-10-11 02:10:50.203768
NCT01752140|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-15|||January 2009||2009-01-01|December 2012|2012-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme|A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme|Completed||N/A|463|Actual|Hospital de Santa Maria, Portugal||2|||f||||f||||||||||2017-10-11 02:10:50.276085|2017-10-11 02:10:50.276085
NCT01752127|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2012-12-18|||July 2011||2011-07-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|COPERES||COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease|Study for Investigate the Effectiveness and Safety of Resolute Integrity or Xience Prime in Diabetes or Small Vessels Lesion Patients|Unknown status|Recruiting|Phase 3|600|Anticipated|Chonbuk National University Hospital||2|||f||||||||||||||2017-10-11 02:10:50.35258|2017-10-11 02:10:50.35258
NCT01752114|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-08-29|||October 2012||2012-10-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Early Diagnosis of Pulmonary Nodules|Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12|Active, not recruiting||N/A|684|Actual|Integrated Diagnostics|||1||f||||f||||||Samples With DNA|"     Blood samples   "|No||2017-10-11 02:10:50.445911|2017-10-11 02:10:50.445911
NCT01752101|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-01-07|||October 2012||2012-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Identification of a Plasma Proteomic Signature for Lung Cancer|Identification of a Plasma Proteomic Signature for Lung Cancer|Completed||N/A|475|Actual|Integrated Diagnostics|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 02:10:50.574139|2017-10-11 02:10:50.574139
NCT01752088|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2012-12-18|||June 2012||2012-06-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|June 2013|Anticipated|2013-06-01|2 Years|Observational [Patient Registry]|||Repair of Subscapularis Tear :Clinical Results and MRI Analysis|Arthroscopic Repair of Subscapularis Tear :Clinical Results and MRI Analysis|Unknown status|Recruiting|N/A|60|Anticipated|Peking University Third Hospital|||1||f||||t||||||||||2017-10-11 02:10:52.520111|2017-10-11 02:10:52.520111
NCT01752075|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-02-11|||January 2011||2011-01-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01|2 Years|Observational [Patient Registry]|||A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan|A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan|Completed||N/A|100|Actual|Celgene|||1||f||||f||||||||||2017-10-11 02:10:52.59502|2017-10-11 02:10:52.59502
NCT01752062|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-02-21|||May 2013||2013-05-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|CML1012||Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors|Observational Study of Conception/Pregnancy in Adult Patients With Chronic Myeloid Leukemia (CML) Treated With Tyrosine Kinase Inhibitors|Recruiting||N/A|45|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||No||2017-10-11 02:10:52.7007|2017-10-11 02:10:52.7007
NCT01752023|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-07-28|2017-03-06||March 2013||2013-03-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|April 2014|Actual|2014-04-01||Interventional|NA_00067809||A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.|A Randomized Phase II Study of SUBATM-itraconazole With Cisplatin/Gemcitabine in Patients With Previously Untreated Metastatic Squamous Non-Small Cell Lung Cancer.|Terminated||Phase 2|3|Actual|Sidney Kimmel Comprehensive Cancer Center||2||Low Accrual|f||||t||||||||||2017-10-11 02:10:53.470604|2017-10-11 02:10:53.470604
NCT01752010|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-05-18|||May 2010||2010-05-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Comparing Acupuncture, BioModulator, and Transcutaneous Electrical Nerve Stimulation for Symptomatic Treatment of Chronic Pain.|A Randomized Study Comparing the Tennant BioModulator to Transcutaneous Electrical Nerve Stimulation (TENS) and Traditional Chinese Acupuncture for the Symptomatic Treatment of Chronic Pain Among Injured Service Members.|Completed||N/A|98|Actual|Samueli Institute for Information Biology||3|||f||||t||||||||||2017-10-11 02:10:53.877197|2017-10-11 02:10:53.877197
NCT01751997|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-10-18|||January 2013||2013-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors|The Comparison of Transplantation From Family-mismatched/Haploidentical Donors With Matched Unrelated Donors in Adult Patients With Acute Myeloid Leukemia|Recruiting||Phase 3|116|Anticipated|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-11 02:10:53.992089|2017-10-11 02:10:53.992089
NCT01751984|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-08-27||2015-08-13|October 2012||2012-10-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of the Efficacy and Safety of ETC-1002 in Subjects With Statin Intolerance|A Placebo-Controlled, Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of ETC-1002 in Subjects With Hypercholesterolemia and a History of Statin Intolerance|Completed||Phase 2|56|Actual|Esperion Therapeutics||2|||f||||f||||||||||2017-10-11 02:10:54.106388|2017-10-11 02:10:54.106388
NCT01751958|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-14|||July 2011||2011-07-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||Radiation Exposure in Spine Intervention Under Angiography|Phase 3 Study of Evaluate Radiation Exposure and Procedure Times for Continuous Fluoroscopic Monitoring During Lumbar ESI|Completed||Phase 3|1000|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-10-11 02:10:54.330939|2017-10-11 02:10:54.330939
NCT01751945|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-06-08|||November 2012||2012-11-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EmONC||Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project|Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project.|Completed||N/A|12000|Actual|Aga Khan University||2|||f||||t||||||||Yes||2017-10-11 02:10:54.418196|2017-10-11 02:10:54.418196
NCT01751932|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-12-13|||January 2013||2013-01-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|SPACE2||Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems|Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems|Completed||N/A|24|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||t||||||||||2017-10-11 02:10:54.505458|2017-10-11 02:10:54.505458
NCT01751919|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-09-29|||May 2012||2012-05-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)|A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400 mg (1 Tablet) and Glivec Film-coated Tablet 100 mg (4 Tablets) After Oral Administration in Healthy Male Subjects (Phase I)|Completed||Phase 1|37|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:10:54.60891|2017-10-11 02:10:54.60891
NCT01751893|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-02-10|||December 2014||2014-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Testing the Effectiveness of Henna on Managing PPE|A Randomized Double-blind, Placebo-controlled Study of the Effects of Lawsonia Inermis on Palmar-Plantar Erythrodysesthesia Induced by Capecitabine and/or Pegylated Liposomal Doxorubicin|Recruiting||N/A|80|Anticipated|Cyprus University of Technology||2|||f||||t||||||||||2017-10-11 02:10:55.819491|2017-10-11 02:10:55.819491
NCT01751880|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-13|||June 2012||2012-06-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Interventional|||Safety, Feasibility and Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Pilot Study||Unknown status|Recruiting|N/A|28|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 02:10:55.918891|2017-10-11 02:10:55.918891
NCT01751867|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-04-01|2013-06-24||August 2009||2009-08-01|April 2016|2016-04-01|April 2013|Actual|2013-04-01|May 2011|Actual|2011-05-01||Interventional||Randomized analysis set included all randomized participants, regardless of whether having received any treatment, or whether having any post-baseline efficacy data.|An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome|An Open-label, Multi-center, Phase IIIb Study for Decitabine in Patients With Myelodysplastic Syndrome (MDS)|Completed||Phase 3|135|Actual|Xian-Janssen Pharmaceutical Ltd.||2|||f||||f||||||||||2017-10-11 02:10:56.027954|2017-10-11 02:10:56.027954
NCT01751854|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-12-26|||December 2004||2004-12-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Enhanced Motor Recovery Using Serotonergic Agents in Stroke|Enhanced Motor Recovery Using Serotonergic Agents in Stroke|Completed||Phase 1|30|Actual|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 02:10:56.793202|2017-10-11 02:10:56.793202
NCT00000163|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||December 1997||1997-12-01|September 2009|2009-09-01|July 2000||2000-07-01|||||Observational|||Congenital Esotropia Observational Study (CEOS)||Completed||N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:34.487183|2017-10-11 04:17:34.487183
NCT01751828|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-07-30|||December 2012||2012-12-01|July 2013|2013-07-01||||August 2013|Anticipated|2013-08-01||Interventional|||Late-life Depression and Cerebral Perfusion|Late-life Depression and Cerebral Perfusion|Withdrawn||N/A|0|Actual|Vanderbilt University||1||This was an initial unfunded pilot project stopped after similar studies were funded.|f||||f||||||||||2017-10-11 02:10:57.01095|2017-10-11 02:10:57.01095
NCT01751815|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-02-10|||October 2012||2012-10-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Acu-TENS for Pain Relief During Colonoscopy|The Application of Transcutaneous Electric Nerve Stimulation on Acupoints (Acu-TENS) for Pain Relief During Colonoscopy: a Prospective, Randomized, Placebo-controlled Study|Completed||Phase 3|135|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:10:57.15422|2017-10-11 02:10:57.15422
NCT01751802|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-10-05|2015-10-05||December 2012||2012-12-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease|An Outpatient Phase 3 Efficacy Study of Ecopipam (PSYRX 101) in the Symptomatic Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease|Terminated||Phase 3|9|Actual|Psyadon Pharma||2||Study terminated for commercial reasons|f||||t||||||||||2017-10-11 02:10:57.353729|2017-10-11 02:10:57.353729
NCT01751789|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-07-17|||October 2012||2012-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Linking Opioid Dependent Patients From Inpatient Detoxification to Primary Care|Linking Opioid Dependent Patients From Inpatient Detoxification to Primary Care|Recruiting||N/A|370|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-10-11 02:10:57.846333|2017-10-11 02:10:57.846333
NCT01751776|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-05-10|||December 2012||2012-12-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy|A Randomised, Double-blind, Placebo-controlled Trial for Establishing Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Efficacy of Multiple Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy|Completed||Phase 1|107|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:10:57.962421|2017-10-11 02:10:57.962421
NCT01751763|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-09-22|||July 9, 2013|Actual|2013-07-09|September 2017|2017-09-01|September 8, 2017|Actual|2017-09-08|December 31, 2016|Actual|2016-12-31||Observational|SECURE||Sorafenib for Residue Disease After Resection With Curative Intent|Investigations of Sorafenib for HCC Patients Who Have Residue Disease After Resection With Curative Intent|Completed||N/A|106|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:10:58.179775|2017-10-11 02:10:58.179775
NCT01751750|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-05-23|||September 2011||2011-09-01|May 2017|2017-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Grape Polyphenol Kinetics in Humans||Completed||N/A|16|Actual|USDA Beltsville Human Nutrition Research Center||1|||f||||f||||||||No||2017-10-11 02:10:58.306082|2017-10-11 02:10:58.306082
NCT01751737|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-11-18|||November 2012||2012-11-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Choline PET/CT and MRI for Targeted Prostate Biopsy|Investigation of the Magnitude of Uptake, Retention, and Spatial Distribution Pattern of 18F-Choline in Comparison With MRI and Histology Obtained From Prostate Cancer Biopsies|Active, not recruiting||N/A|63|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-11 02:10:58.401115|2017-10-11 02:10:58.401115
NCT01751724|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-05-17|2017-02-28||December 2012||2012-12-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Caffeine to Reduce Mechanical Ventilation in Preterm Infants|Use of Caffeine to Reduce Length of Mechanical Ventilation in Preterm Infants|Terminated||N/A|87|Actual|University of Miami||2||Safety|f||||t||||||||||2017-10-11 02:10:58.552909|2017-10-11 02:10:58.552909
NCT01751698|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-09-12|||January 2013||2013-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|June 2017|Actual|2017-06-01||Interventional|AIM-ASD||Adaptive Interventions for Minimally Verbal Children With ASD in the Community|Adaptive Interventions for Minimally Verbal Children With ASD in the Community|Active, not recruiting||N/A|192|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:10:59.104856|2017-10-11 02:10:59.104856
NCT01751685|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-10-25|||February 2013||2013-02-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|July 2016|Actual|2016-07-01||Interventional|sheaf||Study of Hyperkyphosis, Exercise and Function-SHEAF|Study of Hyperkyphosis, Exercise and Function-SHEAF|Active, not recruiting||N/A|99|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:10:59.218983|2017-10-11 02:10:59.218983
NCT01751672|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-06-15|||June 2012||2012-06-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Integrating Substance Abuse Assessment & Intervention in Primary Care Settings|Integrating Substance Abuse Assessment & Intervention in Primary Care Settings|Completed||N/A|600|Actual|Treatment Research Institute||2|||f||||t||||||||||2017-10-11 02:10:59.30981|2017-10-11 02:10:59.30981
NCT01751659|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-02-27|||September 2012||2012-09-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention|Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention|Completed||N/A|62|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||||||2017-10-11 02:10:59.401527|2017-10-11 02:10:59.401527
NCT01751646|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-07-01|||October 2012||2012-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART|A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 50,000 IU Every 4 Weeks to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in Youth With HIV Infection Being Treated With Tenofovir-Containing Combination Antiretroviral Therapy|Completed||N/A|214|Actual|Westat||2|||f||||t||||||||||2017-10-11 02:10:59.475394|2017-10-11 02:10:59.475394
NCT01751633|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-08-22|||January 2013||2013-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Observational|FA3||Spine FA3 - a Prospective, International, Multicenter Cohort Study on Treatment of of AO A3 Thoracolumbar Fractures|Comparison of Surgical Versus Conservative Treatment of AO Type A3 Thoracolumbar Fractures Without Neurological Deficits Prospective, International, Multicenter Cohort Study|Terminated||N/A|38|Actual|AO Clinical Investigation and Documentation|||2|Administrative reason. Lack of funding.|f||||f||||||||||2017-10-11 02:10:59.633834|2017-10-11 02:10:59.633834
NCT01751620|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-02-27|||January 2013||2013-01-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care|Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care|Completed||N/A|167|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:10:59.741847|2017-10-11 02:10:59.741847
NCT01751607|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-09-04|||December 2012||2012-12-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2013|Actual|2013-08-01||Observational|DECAF||Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)|Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)|Completed||Phase 3|400|Actual|Texas Cardiac Arrhythmia Research Foundation|||1||f||||f||||||Samples With DNA|"     Blood samples will be collected from which DNA would be extracted for SNP analysis   "|||2017-10-11 02:10:59.824834|2017-10-11 02:10:59.824834
NCT01751594|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-07-28|||April 2012||2012-04-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men|Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men|Completed||N/A|92|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:10:59.893543|2017-10-11 02:10:59.893543
NCT01751581|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2013-08-01|||November 2011||2011-11-01|December 2011|2011-12-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Sleep Restriction and Energy Expenditure|The Effect of Sleep Reduction on Daily Energy Expenditure, Thermic Effect of Food, and Substrate Oxidation in Overweight Women|Completed||N/A|10|Anticipated|St. Luke's-Roosevelt Hospital Center||2|||f||||f||||||||||2017-10-11 02:10:59.992409|2017-10-11 02:10:59.992409
NCT01751568|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-05-08|||May 2014||2014-05-01|May 2017|2017-05-01||||May 2019|Anticipated|2019-05-01||Interventional|||Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Infants and Children Infected With HIV and TB|Phase I/II Dose-Finding, Safety, Tolerance, and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-Infected and TB Co-Infected Infants and Children|Recruiting||Phase 1/Phase 2|108|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-11 02:11:00.085285|2017-10-11 02:11:00.085285
NCT01751555|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2013-06-27|||February 2011||2011-02-01|December 2010|2010-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection|A Single-Arm Study Evaluating the Efficay and Safety of Tenofovir DF,Lamivudine and Efavirenz in Adults With HIV/HBV Coinfection|Completed||Phase 4|100|Actual|National Center for AIDS/STD Control and Prevention, China CDC||1|||f||||t||||||||||2017-10-11 02:11:00.310659|2017-10-11 02:11:00.310659
NCT01751542|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-13|||August 2012||2012-08-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Mindfulness and Acceptance Group Therapy for Substance Use|Mindfulness and Acceptance Group Therapy for Substance Use|Unknown status|Recruiting|Phase 2|150|Anticipated|The University of Tennessee, Knoxville||2|||f||||f||||||||||2017-10-11 02:11:00.424754|2017-10-11 02:11:00.424754
NCT01751529|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-03-15|||May 2013||2013-05-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer|LCCC 1219: A Prospective Pilot Study Evaluating Renal Lesions Through Contrast-enhanced US in Patients With Renal Cancer and in Those With a Risk Factor for Renal Malignancy|Completed||Early Phase 1|48|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:11:00.512018|2017-10-11 02:11:00.512018
NCT01751516|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-05-02|||October 2012||2012-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|August 2014|Actual|2014-08-01||Observational|||PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study|PET/MRI as a Predictor for Response to Preoperative Radiation Therapy and Chemotherapy in Resectable Rectal Cancer: a Pilot Study.|Active, not recruiting||N/A|8|Actual|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 02:11:00.61183|2017-10-11 02:11:00.61183
NCT01751503|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-05-19|||March 2013||2013-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer|Prospective Randomized Controlled Trial Comparing Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer.|Recruiting||N/A|52|Anticipated|Royal National Orthopaedic Hospital NHS Trust||2|||f||||f||||||||||2017-10-11 02:11:00.686886|2017-10-11 02:11:00.686886
NCT01751490|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-06-12|||February 2013||2013-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effectiveness of Surgery for Atraumatic Shoulder Instability|Does Surgery Followed by Physiotherapy Improve Short and Long Term Outcomes for Patients With Atraumatic Shoulder Instability Compared With Physiotherapy Alone?|Recruiting||N/A|140|Anticipated|Royal National Orthopaedic Hospital NHS Trust||2|||f||||t||||||||||2017-10-11 02:11:00.805429|2017-10-11 02:11:00.805429
NCT01751477|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2015-04-20|||September 2010||2010-09-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|||Infloran® for Prevention of Necrotizing Enterocolitis|Oral Probiotics (Infloran®) for Prevention of Necrotizing Enterocolitis in Very Low Birth Weight Infants|Completed||N/A|463|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 02:11:00.920856|2017-10-11 02:11:00.920856
NCT01751464|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-07-04|||November 2012||2012-11-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A WrapAround Case Management Program for Youth Injured by Violence|A WrapAround Case Management Program for Youth Injured by Violence: A Feasibility Study|Completed||N/A|8|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 02:11:01.005998|2017-10-11 02:11:01.005998
NCT01751451|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2017-04-05|||December 2012||2012-12-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy|A Phase 2, Randomized, 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy|Active, not recruiting||Phase 2|122|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-11 02:11:01.114731|2017-10-11 02:11:01.114731
NCT01751438|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-12-28|||March 2013||2013-03-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|||Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)|A Prospective, Multi-Institutional, Randomized, Phase II Trial of Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) of the Primary Tumor in Metastatic (M1) Prostate Cancer (PC)|Recruiting||Phase 2|180|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 02:11:01.275533|2017-10-11 02:11:01.275533
NCT01751425|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2016-12-05|||July 2013||2013-07-01|December 2016|2016-12-01||||July 2019|Anticipated|2019-07-01||Interventional|||Ruxolitinib for Chronic Myeloid Leukemia (CML) With Minimal Residual Disease (MRD)|Phase I-II Study of Ruxolitinib (INCB18424) for Patients With Chronic Myeloid Leukemia (CML) With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors|Recruiting||Phase 1/Phase 2|48|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:11:01.39285|2017-10-11 02:11:01.39285
NCT01751399|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-14|2014-01-17|||December 2012||2012-12-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Single Dose Study of LY2605541 in Participants With Liver Impairment|A Single Dose Pharmacokinetic Study of LY2605541 in Subjects With Hepatic Impairment|Completed||Phase 1|60|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 02:11:01.616473|2017-10-11 02:11:01.616473
NCT01751386|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-08-18|2017-07-17||December 3, 2012||2012-12-03|July 17, 2017|2017-07-17|August 17, 2016|Actual|2016-08-17|August 17, 2016|Actual|2016-08-17||Interventional|||Baclofen for Treating Anxiety and Alcoholism|A Double-Blind, Placebo-Controlled, Randomized Human Laboratory Pilot Study of Baclofen in Anxious Alcoholics|Completed||Phase 2|39|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f|t|f|||t|||||2017-10-11 02:11:01.720359|2017-10-11 02:11:01.720359
NCT01751373|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-05-19|||May 2011||2011-05-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Assessment and Management of Post-Stroke Spasticity With Botulinum Toxin-A|Novel Assessment and Treatment Approaches for Detecting and Facilitating Functional Improvements in Post-Stroke Spasticity With Botulinum Toxin-A|Completed||N/A|16|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 02:11:02.210402|2017-10-11 02:11:02.210402
NCT01751360|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-11-05|||April 2013||2013-04-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||SYR-472 Open-label Study||Completed||Phase 3|14|Actual|Takeda||1|||f||||f||||||||||2017-10-11 02:11:02.324531|2017-10-11 02:11:02.324531
NCT01751347|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-12-10|||February 2013||2013-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Bupivacaine Versus Lidocaine Local Anesthesia|Bupivacaine Versus Lidocaine Local Anesthesia in Elective Outpatient Hand Surgery: A Randomized Controlled Trial|Completed||Phase 4|135|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:11:02.402673|2017-10-11 02:11:02.402673
NCT01751334|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-13|||September 2005||2005-09-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2006|Actual|2006-08-01||Interventional|||Comparison of the Tibiofemoral Rotational Alignment After Mobile and Fixed Bearing Total Knee Arthroplasty|Comparison of the Tibiofemoral Rotational Alignment After Mobile and Fixed Bearing Total Knee Arthroplasty|Completed||Phase 4|80|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:11:02.507711|2017-10-11 02:11:02.507711
NCT01751321|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-13|||May 2013||2013-05-01|December 2012|2012-12-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||Glucose Variability With DPP-4 Inhibition|Glucose Variability With DPP-4 Inhibition|Unknown status|Not yet recruiting|N/A|50|Anticipated|Research Clinical Centre of the Russian Railways, JSC||1|||f||||f||||||||||2017-10-11 02:11:02.599438|2017-10-11 02:11:02.599438
NCT01751308|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-06-28|2016-06-28||February 2013||2013-02-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|July 2015|Actual|2015-07-01||Interventional||All treated (AT)/safety population was defined as all registered participants who actually received at least 1 dose or part of a dose of the investigational medicinal product (IMP).|Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors|A Phase 1-2 Dose Finding, Safety and Efficacy Study of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Tumors of the Central Nervous System|Completed||Phase 1/Phase 2|39|Actual|Sanofi||5|||f||||f||||||||||2017-10-11 02:11:02.744605|2017-10-11 02:11:02.744605
NCT01751295|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-13|||December 2012||2012-12-01|December 2012|2012-12-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Statin and Post-interventional Coronary Microcirculation Dysfunction|Effect of Statin on the Post-interventional Coronary Microcirculation Dysfunction|Unknown status|Active, not recruiting|N/A|84|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:11:04.674633|2017-10-11 02:11:04.674633
NCT01751282|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-10-03|||June 2010||2010-06-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds|A Randomized, Double-Blind, Controlled Study to Evaluate the Effectiveness of the Use of Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) in Fibrin in the Treatment of Chronic Wounds|Terminated||Phase 1|5|Actual|Roger Williams Medical Center||3||Left Institution where study was approved|f||||t||||||||||2017-10-11 02:11:04.788281|2017-10-11 02:11:04.788281
NCT01751269|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-07-22|||December 2012||2012-12-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects.|Completed||Phase 1|80|Actual|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||2|||f||||f||||||||||2017-10-11 02:11:04.900005|2017-10-11 02:11:04.900005
NCT01751256|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-14|||June 2010||2010-06-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|KTcesar||Additional Effect of Wound Infiltration After Cesarean Section With Optimal Standard Analgesia|Levobupivacaine Continuous Wound Infiltration and Optimal Standard Analgesia Versus Optimal Standard Analgesia Alone After Cesarean Section.|Completed||Phase 4|68|Actual|Poissy-Saint Germain Hospital||2|||f||||f||||||||||2017-10-11 02:11:04.995689|2017-10-11 02:11:04.995689
NCT01751243|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-09-20|||January 2013||2013-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies|Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies.|Recruiting||Phase 1/Phase 2|20|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||6|||f||||t||||||||||2017-10-11 02:11:05.312889|2017-10-11 02:11:05.312889
NCT01751217|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-08-17|||February 2012||2012-02-01|August 2017|2017-08-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|RAFT||Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents|Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents|Completed||N/A|90|Actual|Oregon Research Institute||3|||f||||f||||||||||2017-10-11 02:11:05.650671|2017-10-11 02:11:05.650671
NCT01751204|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-03-26|||November 2012||2012-11-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Comparison of Absorbability Between Calcium Tablet and Calcium Ion Water|A Randomized, Double-blind, Crossover Study to Compare the Absorbability Between Calcium Tablet and Calcium Ion Water|Completed||N/A|10|Anticipated|Hiroshima University||3|||f||||f||||||||||2017-10-11 02:11:05.767725|2017-10-11 02:11:05.767725
NCT01751191|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2012-12-13|||August 2011||2011-08-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||HVPG for Rebleeding Risk Stratification|Study Protocol: Observational Cohort Study to Improve Rebleeding Risk Stratification for Patients With Cirrhosis and Portal Hypertension on Non-selective Beta-blockers|Completed||N/A|338|Actual|Hospital Clinic of Barcelona|||3||f||||f||||||||||2017-10-11 02:11:05.912549|2017-10-11 02:11:05.912549
NCT01751178|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2014-07-03|2014-05-01||October 2012||2012-10-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||An Efficacy Study of Chlorhexidine Mouthwashes|Clinical Study to Evaluate the Efficacy of Chlorhexidine Mouthwashes|Completed||Phase 4|324|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:11:06.052335|2017-10-11 02:11:06.052335
NCT01751165|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-02-13|2016-11-08|2015-03-12|March 2013||2013-03-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional|||Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older|Open-label Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged 50 Years or Older|Completed||Phase 3|354|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 02:11:06.916679|2017-10-11 02:11:06.916679
NCT01751152|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-03-30||2017-03-30|February 2013||2013-02-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease|A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease|Completed||Phase 2|53|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:11:08.571355|2017-10-11 02:11:08.571355
NCT01751139|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-08-07|||February 18, 2014||2014-02-18|August 2017|2017-08-01|March 21, 2021|Anticipated|2021-03-21|March 21, 2021|Anticipated|2021-03-21||Interventional|||An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil|An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Endemic Regions of Brazil|Recruiting||N/A|3600|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 02:11:08.750403|2017-10-11 02:11:08.750403
NCT01751126|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-10-04|||March 2013||2013-03-01|October 2017|2017-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis|A Multicenter, Randomized, Double-Masked, 3 Parallel Arms, Placebo Controlled Study to Assess the Efficacy and Safety of NOVA22007 1mg/mL (Ciclosporin/Cyclosporine) Eye Drops, Emulsion Administered in Paediatric Patients With Active Severe Vernal Keratoconjunctivitis With Severe Keratitis|Completed||Phase 3|169|Actual|Santen SAS||3|||f||||t||||||||||2017-10-11 02:11:08.901553|2017-10-11 02:11:08.901553
NCT01751113|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-01-25|2014-07-10||February 2013||2013-02-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|SCO116572||A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects|A Randomised, Double-blind, Double Dummy, 3 Way Cross-over Study Evaluating the Effects of ADOAIR 50/250mcg Twice Daily Plus Tiotropium Bromide 18mcg Once Daily Compared With the Individual Treatments (Tiotropium Bromide 18mcg Alone and ADOAIR 50/250mcg Alone) in the Treatment of Japanese Subjects With COPD|Completed||Phase 4|53|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:11:09.18304|2017-10-11 02:11:09.18304
NCT01751100|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-05-07|||July 2013||2013-07-01|May 2015|2015-05-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies|Building Bridges: Addressing HIV Stigma in At-Risk Groups in Community Pharmacies|Withdrawn||N/A|0|Actual|North Bronx Healthcare Network||2||We did not receive proper funding to complete this study.|f||||f||||||||||2017-10-11 02:11:10.694274|2017-10-11 02:11:10.694274
NCT01751087|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-01-27|2015-09-02||January 2013||2013-01-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Cervical Preparation Before Dilation and Evacuation|Cervical Preparation Before Dilation and Evacuation in the Second Trimester: A Multicenter Randomized Trial Comparing Osmotic Dilators Alone to Dilators Plus Adjunctive Misoprostol or Adjunctive Mifepristone.|Completed||N/A|300|Actual|Planned Parenthood League of Massachusetts|Limitations include inadequate sample size to measure complications as a primary outcome and reliance on outcomes that measure efficacy of the cervical preparation rather than its direct effect on overall safety.|3|||f||||t||||||||||2017-10-11 02:11:10.827148|2017-10-11 02:11:10.827148
NCT01751074|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-07-24|||December 17, 2012|Actual|2012-12-17|July 2017|2017-07-01|March 14, 2013|Actual|2013-03-14|March 14, 2013|Actual|2013-03-14||Interventional|||To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers|A Two-Part, Open-label, Sequential, Double Cohort, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Rosuvastatin When Co Administered With Darapladib in Healthy Adult Subjects|Completed||Phase 1|18|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:11:11.707462|2017-10-11 02:11:11.707462
NCT01751061|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-03-17|||January 2013|Actual|2013-01-01|March 2017|2017-03-01|January 6, 2017|Actual|2017-01-06|May 3, 2016|Actual|2016-05-03||Interventional|||Improving Decision Making for Patients With Prolonged Mechanical Ventilation|Improving Decision Making for Patients With Prolonged Mechanical Ventilation|Completed||N/A|421|Actual|Duke University||2|||f||||t||||||||||2017-10-11 02:11:11.871804|2017-10-11 02:11:11.871804
NCT01751048|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-12-29|||March 2013||2013-03-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine|A Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the Vaccine Candidates LEISH-F3 + GLA-SE, LEISH-F3 + MPL-SE, and LEISH-F3 + SE in Healthy Adult Subjects|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 02:11:12.047257|2017-10-11 02:11:12.047257
NCT01751035|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-10-01|||November 2012||2012-11-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|RRFT||Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD|Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD|Recruiting||N/A|250|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 02:11:12.169727|2017-10-11 02:11:12.169727
NCT01751022|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-10-12|2016-02-29||December 2012||2012-12-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Subjects with an attempted Attain Performa LV Lead implant|Attain Performa(TM) Quadripolar Lead Study|Attain Performa(TM) Quadripolar Lead Study|Completed||N/A|1202|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-10-11 02:11:12.454941|2017-10-11 02:11:12.454941
NCT01751009|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-12-14|||January 2010||2010-01-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|vitapool||Effects of Fortified Complementary Foods on Vitamin A Status and Body Pool Size in Ghanaian Infants.|A Randomised Controlled Home-based Trial of the Effects of Fortified Complementary Foods on Vitamin A Status and Body Pool Size in Ghanaian Infants.|Completed||N/A|93|Actual|Kintampo Health Research Centre, Ghana||2|||f||||f||||||||||2017-10-11 02:11:19.096235|2017-10-11 02:11:19.096235
NCT01750996|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2016-09-01|||October 2011||2011-10-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Fin-Can||Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive Behavior|Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive Behavior|Completed||Phase 1/Phase 2|464|Actual|IWK Health Centre||2|||f||||f||||||||No|Aggregate summary data would be made available but not individual data.|2017-10-11 02:11:19.194366|2017-10-11 02:11:19.194366
NCT01750983|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-07-07|||March 2013|Actual|2013-03-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Ipilimumab and Lenalidomide in Advanced Cancer|A Phase I Trial of Ipilimumab (Anti CTLA- 4 Antibody) in Combination With Lenalidomide (IMiD) in Patients With Advanced Malignancies|Active, not recruiting||Phase 1|101|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:11:19.308594|2017-10-11 02:11:19.308594
NCT01750970|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-09-20|||November 2009||2009-11-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Endoscopic Resection of Bladder Tumors|Endoscopic Resection of High Grade(TA, T1, Cis)Non-muscle Invasive Bladder Tumors: Modification of Usual Management of This Resection by Using the Blue Light and Evaluation of the Outcome: Should we Maintain the Dogma of Second Endoscopic Resection as a Principle?|Completed||N/A|68|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 02:11:19.44521|2017-10-11 02:11:19.44521
NCT01750957|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-08-09||2016-08-09|February 2013||2013-02-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of RO4917523 in Pediatric Patients With Fragile X Syndrome|A Randomized, Parallel Group, Double-Blind, Placebo-Controlled, Safety and Exploratory Efficacy and Pharmacokinetic, Study of RO4917523 in Pediatric Patients With Fragile X Syndrome|Completed||Phase 2|47|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 02:11:19.539609|2017-10-11 02:11:19.539609
NCT01750944|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-03-25|||July 2013||2013-07-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|IPSO FACTO||Measurement of a Systolic Pressure Index at the Toe After a Walking Test|Validation of the Measurement of a Systolic Pressure Index at the Toe (IPSO) After a Walking Test|Completed||N/A|50|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 02:11:19.688221|2017-10-11 02:11:19.688221
NCT01750931|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-04-18|2017-02-02||September 12, 2013|Actual|2013-09-12|April 2017|2017-04-01|October 1, 2013|Actual|2013-10-01|October 1, 2013|Actual|2013-10-01||Interventional|BA/BE: 250/12||This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.|AN OPEN LABEL, BALANCED, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, CROSSOVER, SINGLE ORAL DOSE, BIOEQUIVALENCE STUDY OF MELOXICAM GSK 15 MG TABLETS MANUFACTURED BY SAVIPHARM J.S.C, VIETNAM AND MOBIC® 15 MG TABLETS OF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG BINGER STR.173, 5521 INGELHEIM AM RHEIN, GERMANY, IN HEALTHY, ADULT, HUMAN MALE SUBJECTS UNDER FED CONDITION.|Completed||N/A|28|Actual|GlaxoSmithKline||2|||f||||f|f|f||||||||2017-10-11 02:11:19.944721|2017-10-11 02:11:19.944721
NCT01750918|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-08-31|||December 19, 2012|Actual|2012-12-19|August 2017|2017-08-01|March 31, 2018|Anticipated|2018-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)|An Open-Label, Four-Part, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of the MEK Inhibitor GSK1120212, BRAF Inhibitor GSK2118436 and the Anti-EGFR Antibody Panitumumab in Combination in Subjects With BRAF-mutation V600E Positive Colorectal Cancer and in Subjects With CRC With Secondary Resistance to Prior Anti-EGFR Therapy|Active, not recruiting||Phase 2|170|Anticipated|Novartis||9|||f||||f|t|f||||||||2017-10-11 02:11:20.359092|2017-10-11 02:11:20.359092
NCT01750528|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-06-08|||September 2012||2012-09-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Prevalence and Progression of Periodontitis in Ankylosing Spondylitis|The Prevalence and the Progression of Periodontitis in Ankylosing Spondylitis (AS) Patients Versus Non-AS Population|Completed||N/A|168|Actual|Seoul National University Hospital|||2||f||||f||||||||||2017-10-11 02:11:25.028521|2017-10-11 02:11:25.028521
NCT01750905|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-08-29|||April 2013||2013-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Interventional|||Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients|A Phase I, Randomized, Double-blind, Placebo-controlled, Crossover Study Evaluating The Safety, Hemodynamic And Neurohumoral Effects of a Novel Chimeric Peptide, CD-NP, in Patients With Left Ventricular Assist|Completed||Phase 1|14|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 02:11:20.548469|2017-10-11 02:11:20.548469
NCT01750892|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2015-02-02|||October 2012||2012-10-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Primary Care Transition Study|Transition From Pediatric to Adult Services: A Primary Care Based Model for Patients With Chronic Conditions|Completed||N/A|43|Actual|Children's Hospital of Philadelphia||4|||f||||t||||||||||2017-10-11 02:11:20.644433|2017-10-11 02:11:20.644433
NCT01750879|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-07-07|||May 2013||2013-05-01|July 2017|2017-07-01|July 11, 2017|Anticipated|2017-07-11|July 11, 2017|Anticipated|2017-07-11||Interventional|PNOIT2||Tolerance Following Peanut Oral Immunotherapy|Clinical Desensitization and Tolerance Following Peanut Oral Immunotherapy and Subsequent Allergen Avoidance|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:11:20.754452|2017-10-11 02:11:20.754452
NCT01750866|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-10-15|||February 2013||2013-02-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer|Efficacy and Toxicity of Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer With Progression After Treatment With Docetaxel|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||1||No accrual|f||||t||||||||||2017-10-11 02:11:20.862311|2017-10-11 02:11:20.862311
NCT01750853|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2013-07-25|||January 2013||2013-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study of LY3045697 in Healthy Participants|A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3045697 After Single Oral Dosing in Healthy Subjects|Completed||Phase 1|27|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 02:11:20.963147|2017-10-11 02:11:20.963147
NCT01750840|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-06-16|2016-03-09||October 2012||2012-10-01|June 2017|2017-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01|12 Months|Observational [Patient Registry]|||A Clinical Registry to Collect Patient Outcome Date for the BIOMET® Stimulator Systems|A Clinical Registry to Collect Patient Outcome Data for the BIOMET® EBI Bone Healing System, BIOMET® OrthoPak® Non-invasive Bone Growth Stimulator System, and the BIOMET® SpinalPak® Non-Invasive Spine Fusion Stimulator System|Terminated||N/A|8|Actual|Zimmer Biomet|||1|Slow enrollment and poor patient follow-up following enrollment|f||||f||||||||Undecided||2017-10-11 02:11:21.256672|2017-10-11 02:11:21.256672
NCT01750827|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-13|||September 2004||2004-09-01|December 2012|2012-12-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Study to Assess the Effect of SB 659032 on Platelet Function|A Single Dose Study to Assess the Effect of Non-Bioenhanced, Non-Enteric Coated, Freebase SB-659032 on Platelet Function in Healthy Adult Subjects|Completed||Phase 1|14|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 02:11:21.46659|2017-10-11 02:11:21.46659
NCT01750814|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-01-14|||June 2013||2013-06-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults|A Phase III, Randomized, Double-blind, Multi-center Study to Compare the Immunological Efficacy and Safety of GC3102C With GC FLU Inj. Administered Intramuscularly in Healthy Adults|Completed||Phase 3|400|Actual|Green Cross Corporation||2|||f||||f||||||||||2017-10-11 02:11:21.542377|2017-10-11 02:11:21.542377
NCT01750801|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-12-13|||February 2013||2013-02-01|December 2012|2012-12-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01||Interventional|PRO||Efficacy of a Mouthwash Containing Propolis|Clinical Evidence Efficacy of a Mouthwash Containing Propolis for the Control of Plaque and Gingivitis: Phase III, Randomized, Double-blind Comparison With Mouthwash Chlorhexidine Base.|Unknown status|Not yet recruiting|Phase 3|2|Anticipated|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-11 02:11:21.612286|2017-10-11 02:11:21.612286
NCT01750788|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-09-20|||January 13, 2013|Actual|2013-01-13|September 2017|2017-09-01|October 12, 2015|Actual|2015-10-12|October 12, 2015|Actual|2015-10-12||Observational|XANAP||Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia|Xarelto® on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Asia: A Non-interventional Study|Completed||N/A|2297|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:11:21.719133|2017-10-11 02:11:21.719133
NCT01750775|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-13|||August 2012||2012-08-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|SS-SBVPT||Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions|Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Multi-center,Randomized, Double-blind, Placebo-controlled Clinical Study|Unknown status|Enrolling by invitation|Phase 4|330|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 02:11:21.865864|2017-10-11 02:11:21.865864
NCT01750762|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-04-14|||December 2012||2012-12-01|April 2017|2017-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Lenalidomide After Allo Transplant|Phase I Study of Lenalidomide to Augment Anti-Tumor Immunity Following Allogeneic Transplantation|Terminated||Phase 1|1|Actual|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-11 02:11:21.965987|2017-10-11 02:11:21.965987
NCT01750749|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-03-02|||May 2011||2011-05-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Cell Therapy for Venous Leg Ulcers Pilot Study|Autologous Bone Marrow Derived Cells in the Treatment of Venous Leg Ulcers Pilot Study|Completed||Phase 1|4|Actual|Hospital de Clínicas Dr. Manuel Quintela||1|||f||||f||||||||||2017-10-11 02:11:22.059576|2017-10-11 02:11:22.059576
NCT01750736|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2015-02-10|||November 2011||2011-11-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Manual Therapy and Augmented Exercise for Neck Pain|The Use of a Home Exercise Program to Augment a Manual Therapy Intervention: a Randomized Controlled Trial|Completed||N/A|72|Actual|Des Moines University||2|||f||||f||||||||||2017-10-11 02:11:22.249586|2017-10-11 02:11:22.249586
NCT01750723|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-07-08|||December 2012||2012-12-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow|Basic Research on Acetazolamide´s Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow in a Humane Experimental Headache Model|Completed||N/A|12|Actual|Danish Headache Center||2|||f||||f||||||||||2017-10-11 02:11:22.383406|2017-10-11 02:11:22.383406
NCT01750710|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2012-12-13|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|CCA1||Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A|Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A|Unknown status|Not yet recruiting|N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 02:11:22.533042|2017-10-11 02:11:22.533042
NCT01750697|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2017-09-06|||May 23, 2013|Actual|2013-05-23|September 2017|2017-09-01|May 16, 2018|Anticipated|2018-05-16|May 16, 2018|Anticipated|2018-05-16||Interventional|||A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis|A Phase IIA, International, Multicenter, Open-label, Uncontrolled Study to Evaluate The Safety And Pharmacokinetics of 4 × 375 mg/m2 Intravenous Rituximab in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis|Active, not recruiting||Phase 2|25|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:11:22.662686|2017-10-11 02:11:22.662686
NCT01750684|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-13|2016-05-06|2016-05-06||July 2013||2013-07-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|AC105|Safety Population|A Study of AC105 in Patients With Acute Traumatic Spinal Cord Injury|A Phase 2 Double-blind, Randomized, Placebo-controlled Study to Determine the Safety, Tolerability and Potential Activity of AC105 Following a Regimen of 6 Doses Over 30 Hours in Patients With Acute Traumatic Spinal Cord Injury (SCI) as Compared to Patients Treated With Placebo.|Completed||Phase 2|15|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-10-11 02:11:22.852712|2017-10-11 02:11:22.852712
NCT01750671|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2012-12-13|||December 2012||2012-12-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Observational|FEEDING||Influence Of Nutritional Status Of Patients In The Intensive Care Output On Long Term Fate|Influence Of Nutritional Status Of Patients In The Intensive Care Output On Long Term Fate|Unknown status|Not yet recruiting|N/A|680|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 02:11:23.361223|2017-10-11 02:11:23.361223
NCT01750658|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-12-13|||September 2006||2006-09-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|ECOS||Study of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations In Spain|ECOS: A Study of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations In Spain (o Estudio de Las Exacerbaciones de la EPOC en España)|Completed||N/A|99|Actual|Cimera|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 02:11:24.053378|2017-10-11 02:11:24.053378
NCT01750645|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-13|||July 2012||2012-07-01|December 2012|2012-12-01|January 2013|Anticipated|2013-01-01|October 2012|Actual|2012-10-01||Observational|||Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic Review|Management of the Idiopathic Overactive Bladder With Intradetrusor Injection of Type-A Botulinum Toxin: Systematic Review of the Literature|Unknown status|Active, not recruiting|N/A|||Clínica Infantil Colsubsidio|||2||f||||f||||||||||2017-10-11 02:11:24.16717|2017-10-11 02:11:24.16717
NCT01750632|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2016-10-03|||August 2010||2010-08-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Subcapsular Orchiectomy in Men With Klinefelter Syndrome||Completed||N/A|14|Actual|Odense University Hospital||1|||f||||t||||||||||2017-10-11 02:11:24.258085|2017-10-11 02:11:24.258085
NCT01750619|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-08-23|||July 2011||2011-07-01|August 2016|2016-08-01||||January 2020|Anticipated|2020-01-01||Observational|||Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions|Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions|Recruiting||N/A|1000|Anticipated|California Pacific Medical Center Research Institute|||3||f||||f||||||||||2017-10-11 02:11:24.353279|2017-10-11 02:11:24.353279
NCT01750606|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-08-03|||October 2012||2012-10-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|MoM_MRI||An MRI Investigation of Soft Tissues in Total Hip Arthroplasty|An MRI Investigation of Soft Tissues in Total Hip Arthroplasty|Active, not recruiting||N/A|436|Anticipated|Zimmer Biomet|||6||f||||||||||||Undecided||2017-10-11 02:11:24.44084|2017-10-11 02:11:24.44084
NCT01750593|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2013-11-27|||April 2013||2013-04-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Radiofrequency Ablation in Thyroid Nodules|Efficacy of Radiofrequency Ablation in Thyroid Nodules|Unknown status|Recruiting|N/A|40|Anticipated|Bezmialem Vakif University||1|||f||||f||||||||||2017-10-11 02:11:24.53677|2017-10-11 02:11:24.53677
NCT01750580|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2015-07-20|||December 2012||2012-12-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor|A Phase 1 Study of BMS-986015, an Anti-KIR Monoclonal Antibody, Administered With Ipilimumab, an Anti-CTLA4 Monoclonal Antibody, in Subjects With Select Advanced Solid Tumors|Completed||Phase 1|22|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 02:11:24.633871|2017-10-11 02:11:24.633871
NCT01750567|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-03-16|||October 2012||2012-10-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL|A Phase II Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia and Untreated CLL Patients With Genomic Deletion 11q|Recruiting||Phase 2|53|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 02:11:24.751034|2017-10-11 02:11:24.751034
NCT01750554|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-04-09|||December 2012||2012-12-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Influence of a Bupivacaine Digital Nerve Block Using Rev G.|The Influence of a Bupivacaine Digital Nerve Block With the New Continuous Sensor (Rev G) on the Accuracy of SpHb Monitoring.|Completed||N/A|19|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:11:24.848959|2017-10-11 02:11:24.848959
NCT01750515|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-12-12|||January 2013||2013-01-01|December 2012|2012-12-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Acupuncture as an Adjunctive Treatment for Hepatitis C Patients|Acupuncture as an Adjunctive Treatment for Hepatitis C Patients|Unknown status|Not yet recruiting|N/A|||Ziv Hospital||2|||f||||t||||||||||2017-10-11 02:11:25.321649|2017-10-11 02:11:25.321649
NCT01750502|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2015-02-17|2013-11-07||May 2012||2012-05-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||The Clinical Diagnosis Meaning of MIF in Coronary Heart Disease|MIF Gene Polymorphism in Coronary Heart Disease：Clinical Meaning|Completed||N/A|256|Actual|Wenzhou Medical University|There are some limitations to this research. First, the sample size was relative small. Second,no participants were retrospectively analyzed.||2||f||||f||||||Samples Without DNA|"     The biospecimen is blood that taken from cubital vein.   "|||2017-10-11 02:11:25.438031|2017-10-11 02:11:25.438031
NCT01750489|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2014-05-09|||August 2011||2011-08-01|May 2014|2014-05-01||||November 2012|Actual|2012-11-01||Interventional|||Muscle Dysfunction in Patients With Chronic Obstructive Lung Disease (COPD): the Role of Sympathetic Activation|Skeletal and Respiratory Muscle Dysfunction in Patients With COPD: the Role of Sympathetic Activation|Completed||N/A|||University Medical Center Goettingen||3|||f||||f||||||||||2017-10-11 02:11:25.815971|2017-10-11 02:11:25.815971
NCT01750476|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2014-01-05|||December 2012||2012-12-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Observational|||Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives|Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives|Terminated||N/A|7|Actual|Ohio State University|||3|PI and lab have re-located study to The Ohio State University|f||||f||||||||||2017-10-11 02:11:25.908286|2017-10-11 02:11:25.908286
NCT01750463|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-12-01|||January 2013||2013-01-01|December 2014|2014-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children|Verifying the Accuracy of the Masimo Pronto Non-Invasive Hemoglobin (Hb) Monitor and Associated Rainbow Probes Compared to Measured Laboratory Values in Critically Ill Pediatric Patients|Completed||N/A|65|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 02:11:25.987466|2017-10-11 02:11:25.987466
NCT01750450|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-04-30|||February 2013||2013-02-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Observational|||"Validation of Peripheral Pressure Volume Loops and Ultrasound-derived Cardiac Power by Comparison With Invasive Left Ventricular Pressure Volume Loops"||Completed||N/A|65|Actual|University of Virginia|||1||f||||f||||||||||2017-10-11 02:11:26.075962|2017-10-11 02:11:26.075962
NCT01750437|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-07-08|||January 2013||2013-01-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|||Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)|Randomized, Double-blind, Active-controlled, Multi-center Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)|Completed||Phase 2|149|Actual|Yuhan Corporation||5|||f||||f||||||||||2017-10-11 02:11:26.142037|2017-10-11 02:11:26.142037
NCT01750424|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-09-02|||November 2012||2012-11-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||3-D Imaging Assessment of Scar Formation and Would Healing in Fat Grafted vs Non-Fat Grafted Facial Reconstruction Wound Sites|3-D Imaging Assessment of Scar Formation and Would Healing in Fat Grafted vs Non-Fat Grafted Facial Reconstruction Wound Sites|Withdrawn||Phase 1/Phase 2|0|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:11:26.338284|2017-10-11 02:11:26.338284
NCT01750411|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-09-27|||December 2012||2012-12-01|September 2017|2017-09-01|March 1, 2018|Anticipated|2018-03-01|March 1, 2018|Anticipated|2018-03-01||Observational|SARP3||Severe Asthma Research Program - Wake Forest University|The Severe Asthma Research Program at Wake Forest University - Longitudinal Phenomics and Genetics of Severe Asthma.|Active, not recruiting||N/A|700|Anticipated|Wake Forest University Health Sciences|||1||f||||t|f|f||||Samples With DNA|"     Blood: CBC/Diff, Total IgE, Serum, Plasma, DNA, RNA Urine EBC Sputum: Supernatant, Cell     Pellet Bronch: BAl, Bronchial Brushings, Bronchial Biopsy   "|||2017-10-11 02:11:26.43607|2017-10-11 02:11:26.43607
NCT01750398|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-10-10|2016-06-29||January 2013||2013-01-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|BAT||Bipolar Androgen-based Therapy for Prostate Cancer (BAT)|A Phase II Study of Bipolar Androgen-based Therapy for Men With Androgen Ablation NaÃ-ve Recurrent Prostate Cancer|Completed||Phase 2|33|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||No||2017-10-11 02:11:26.531896|2017-10-11 02:11:26.531896
NCT01750385|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-12-12|||October 2012||2012-10-01|December 2012|2012-12-01|August 2013|Anticipated|2013-08-01|April 2013|Anticipated|2013-04-01||Interventional|||Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia|Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia|Unknown status|Active, not recruiting|N/A|60|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-11 02:11:26.92|2017-10-11 02:11:26.92
NCT01750372|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-05-17|||April 2010||2010-04-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||A Client-Based Outcome System for Individuals With Lower Limb Amputation|A Client-Based Outcome System for Individuals With Lower Limb Amputation|Completed||N/A|1572|Actual|University of Washington|||1||f||||f||||||||||2017-10-11 02:11:26.996065|2017-10-11 02:11:26.996065
NCT01750359|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-02-06|||August 2010||2010-08-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy and Safety Curcumin in Depression|The Efficacy and Safety of Adjunctive Curcumin for Treatment of Depression: A Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 4|40|Actual|Beersheva Mental Health Center||2|||f||||t||||||||||2017-10-11 02:11:27.0829|2017-10-11 02:11:27.0829
NCT01750346|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-09-22|2016-06-01||November 2012||2012-11-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Acetyl Hexapeptide-8 for Blepharospasm|Placebo Controlled Double Blind Study of Acetyl Hexapeptide-8 in Treatment of Blepharospasm|Terminated||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 02:11:27.184074|2017-10-11 02:11:27.184074
NCT01750320|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-01-12|||August 2012||2012-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:11:27.814046|2017-10-11 02:11:27.814046
NCT01750307|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-17|||September 2012||2012-09-01|December 2012|2012-12-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|OCEAN||The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)|The Relationship of Essential Fatty Acids to Cognitive Electrophysiological and Behavioural Function in Adults With Attention Deficit Hyperactivity Disorder and Controls|Unknown status|Recruiting|N/A|80|Anticipated|King's College London||2|||f||||t||||||||||2017-10-11 02:11:27.861712|2017-10-11 02:11:27.861712
NCT01750294|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-05-10|2016-04-06||August 2012||2012-08-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Participants who completed the two-week run-in and enrolled in the study are included in the baseline analysis.|A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD||Completed||Phase 4|14|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 02:11:27.971948|2017-10-11 02:11:27.971948
NCT01750281|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-06-21|2017-01-13||December 18, 2012|Actual|2012-12-18|June 2017|2017-06-01|December 29, 2017|Anticipated|2017-12-29|January 27, 2016|Actual|2016-01-27||Interventional|SELECT-2||Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.|A Phase II, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy and Safety of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Combination With Docetaxel, Compared With Placebo in Combination With Docetaxel, in Patients Receiving Second Line Treatment for Locally Advanced or Metastatic Non Small Cell Lung Cancer (Stage IIIB - IV)|Active, not recruiting||Phase 2|212|Actual|AstraZeneca||3|||f||||t||||||||||2017-10-11 02:11:28.290252|2017-10-11 02:11:28.290252
NCT01750268|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-12-04|||November 2012||2012-11-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|VAT||Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI||Completed||Phase 4|32|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:11:30.809053|2017-10-11 02:11:30.809053
NCT01750255|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-07-27|2016-02-24||November 2011||2011-11-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional|EMDADER-TABI||Effect of Pharmaceutical Care in Patients With Bipolar I Disorder (BD I)|Effect of Pharmaceutical Care in Patients With Bipolar I Disorder at St John of God Clinic. Randomized Trial.|Completed||N/A|92|Actual|Universidad de Antioquia|There was no “placebo” treatment, the study patients were not blinded to treatment assignment and both groups (were seen by the same pharmacist, who was responsible for collecting the measurements).|2|||f||||f||||||||Undecided||2017-10-11 02:11:31.040524|2017-10-11 02:11:31.040524
NCT01750242|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-09-10|2014-03-21||November 2012||2012-11-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Observational|DBS|Per protocol|Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study|OPTIVISE Map Concordance Study in DBS for Parkinson's Disease|Completed||N/A|20|Actual|MedtronicNeuro|||1||f||||f||||||||||2017-10-11 02:11:31.507783|2017-10-11 02:11:31.507783
NCT01750216|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1|An Observational Study of Peginterferon-alfa-2a (Pegasys) and Ribavirin (Copegus) on Predictive Values of RVR on Sustained Virological Response (SVR) in Different Stage of Liver Fibrosis in Treatment-naïve Patients With Genotype 1 Chronic Hepatitis C|Completed||N/A|196|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:11:31.812843|2017-10-11 02:11:31.812843
NCT01750203|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-19|||December 2012||2012-12-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay|Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay|Completed||N/A|135|Actual|Systagenix Wound Management|||1||f||||t||||||None Retained|"     Swabs will be tested on day on collection. Test is destructive. No swabs will be retained.   "|||2017-10-11 02:11:31.92498|2017-10-11 02:11:31.92498
NCT01750190|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-02-24|||November 2012||2012-11-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis|A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis|Recruiting||Phase 3|900|Anticipated|FibroGen||2|||f||||t||||||||Yes||2017-10-11 02:11:32.03169|2017-10-11 02:11:32.03169
NCT01750177|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-13|||June 2011||2011-06-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Sedentary Screen Time Activities on Food Intake|Effect of Sedentary Screen Time Activities Before a Meal on Food Intake in Girls|Completed||N/A|31|Actual|Ryerson University||4|||f||||t||||||||||2017-10-11 02:11:32.495728|2017-10-11 02:11:32.495728
NCT01750164|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-05-08|||December 2013||2013-12-01|December 2013|2013-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Patient Derived Breast Cancer Xenografts|Patient Derived Breast Cancer Xenografts|Terminated||N/A|1|Actual|Dartmouth-Hitchcock Medical Center|||1|discontinued funding|f||||t||||||Samples With DNA|"     whole blood and tumor tissue samples as well as DNA that has been extracted from both blood     and tiisue will be stored.   "|||2017-10-11 02:11:32.585022|2017-10-11 02:11:32.585022
NCT01750151|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-07-20|||July 2011||2011-07-01|July 2014|2014-07-01||||June 2014|Actual|2014-06-01||Interventional|||Video Game Playing on Lunch-time Food Intake in Children|The Effect of Sedentary Video Game Playing Before a Mixed Meal on Subjective Appetite and Satiety Signals From a Glucose Preload in Normal Weight and Overweight/Obese Boys|Completed||N/A|16|Actual|Ryerson University||4|||f||||t||||||||||2017-10-11 02:11:32.654881|2017-10-11 02:11:32.654881
NCT01750138|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-12|||June 2011||2011-06-01|December 2012|2012-12-01||||June 2014|Anticipated|2014-06-01||Interventional|||SNE1725: Can Oral Glutamine Facilitate Early Return of Gut Function|Can Preoperative Oral Glutamine Facilitate Earlier Return of Gut Function in Patients Undergoing Colorectal Surgery. A Prospective Randomized Trial.|Unknown status|Recruiting|N/A|206|Anticipated|Scarborough General Hospital||2|||f||||t||||||||||2017-10-11 02:11:32.747338|2017-10-11 02:11:32.747338
NCT01750125|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-04-30|||December 2012||2012-12-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Validation of Pulse Wave Doppler Demodulation Algorithm for the Continuous, Non-invasive Measurement of Blood Flow Velocity||Completed||N/A|10|Actual|University of Virginia|||1||f||||f||||||||||2017-10-11 02:11:32.831958|2017-10-11 02:11:32.831958
NCT01750112|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-05-08|||December 2012||2012-12-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Treatment of Pectus Excavatum Deformity Using Macrolane Filler|An Open Non Comparative Multicenter Prospective Study to Evaluate Efficacy and Safety of Macrolane VRF20 in Treatment of Pectus Excavatum|Completed||N/A|23|Actual|Q-Med AB||1|||f||||f||||||||||2017-10-11 02:11:32.9008|2017-10-11 02:11:32.9008
NCT01750099|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-05-23|||February 2013||2013-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Pain Relief Effects on Length of Labor|A Randomized Single-blinded Trial of Combined Spinal-Epidural Versus Continuous Epidural Analgesia|Completed||N/A|202|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 02:11:32.997847|2017-10-11 02:11:32.997847
NCT01750086|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-02-22|2016-11-30||January 2013||2013-01-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption|Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption|Completed||Phase 4|27|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:11:33.088112|2017-10-11 02:11:33.088112
NCT01750073|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-12|||December 2012||2012-12-01|December 2012|2012-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Stage I-III Breast Cancer|A Phase II Study of Neoadjuvant Chemotherapy With and Without Trastuzumab in Patients With Breast Cancer|Recruiting||Phase 2|125|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-11 02:11:33.31776|2017-10-11 02:11:33.31776
NCT01750060|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-04-17|||December 2012||2012-12-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).|Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).|Completed||Phase 1|54|Actual|Incline Therapeutics, Inc.||5|||f||||f||||||||||2017-10-11 02:11:33.465375|2017-10-11 02:11:33.465375
NCT01750034|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-09-02|||June 2015||2015-06-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Best Method of Burn Wound Care: A Prospective Randomized Trial|Best Method of Burn Wound Care: A Prospective Randomized Trial|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||2||Feasibility issues|f||||t||||||||||2017-10-11 02:11:33.615502|2017-10-11 02:11:33.615502
NCT01750021|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-07-13|||December 2012||2012-12-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Interventional|FATFUNC||Effects of Fat and Carbohydrates in Obese Men|Comparison of Two Weight Reducing Diets in Obese Men|Completed||N/A|40|Actual|Haukeland University Hospital||2|||f||||f||||||||||2017-10-11 02:11:33.705708|2017-10-11 02:11:33.705708
NCT01750008|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-06-30|||November 2012||2012-11-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2013|Actual|2013-09-01||Interventional|LUSTOR||Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions|The LUSTOR (Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions)Trial|Active, not recruiting||N/A|50|Anticipated|Acessa Health, Inc.||2|||f||||t||||||||||2017-10-11 02:11:34.049879|2017-10-11 02:11:34.049879
NCT01749995|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2015-03-05|||November 2012||2012-11-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|PROACTIVE||Prospective Validation of the Use of the Freund Clock Drawing Test to Screen for Cognitive Dysfunction in Cancer Patients Undergoing Comprehensive Geriatric Assessment|Prospective Validation of the Use of the Freund Clock Drawing Test (CDT) to Screen for Cognitive Dysfunction in Cancer Patients Undergoing Comprehensive Geriatric Assessment (CGA)|Completed||N/A|200|Actual|General Hospital Groeninge|||1||f||||||||||||||2017-10-11 02:11:34.170036|2017-10-11 02:11:34.170036
NCT01749982|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-08-14|2014-08-14||December 2012||2012-12-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|March 2013|Actual|2013-03-01||Interventional|CABS||A Preliminary Study of Choline and Betaine Supplementation Among Adults Exposed to Arsenic in Bangladesh|A Pilot Study of Choline and Betaine Supplementation in Arsenic-exposed Individuals in Bangladesh|Completed||Phase 4|60|Actual|Columbia University|This is a pilot study that is not powered to detect statistically significant effects. The results given here are descriptive.|4|||f||||f||||||||||2017-10-11 02:11:34.24645|2017-10-11 02:11:34.24645
NCT01749969|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-09-21|||February 6, 2013|Actual|2013-02-06|September 2017|2017-09-01|May 15, 2019|Anticipated|2019-05-15|May 15, 2019|Anticipated|2019-05-15||Interventional|||SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients|A Phase 1b Study of SAR650984 (Anti-CD38 mAb) in Combination With Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 1|60|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-11 02:11:34.889609|2017-10-11 02:11:34.889609
NCT01749956|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-12-13|2016-10-14||January 2013||2013-01-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All enrolled patients|5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer|A Phase II Study of 5-Fluorouracil (5-FU), Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients With Stage II/III Rectal Cancer|Completed||Phase 2|39|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 02:11:35.061249|2017-10-11 02:11:35.061249
NCT01749943|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-08-20|||July 2012||2012-07-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|HHD||Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis|Validation of a Hand-Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics|Completed||N/A|21|Actual|Brown, Theodore R., M.D., MPH|||3||f||||f||||||||||2017-10-11 02:11:35.66824|2017-10-11 02:11:35.66824
NCT01749930|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2015-11-10|||January 2013||2013-01-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|LUNAR||Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension|A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|421|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 02:11:35.755037|2017-10-11 02:11:35.755037
NCT01749917|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-11-01|||December 2012||2012-12-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Exercise Intervention and Dexterity in Parkinson|Therapeutic Intervention in Motor Disorders in Parkinson.|Completed||N/A|60|Actual|Universidad de Granada||2|||f||||t||||||||Undecided||2017-10-11 02:11:35.884252|2017-10-11 02:11:35.884252
NCT01749904|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2015-11-10|||January 2013||2013-01-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|APOLLO||Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension|A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension.|Completed||Phase 3|421|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 02:11:36.015166|2017-10-11 02:11:36.015166
NCT01749891|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-12|||March 2012||2012-03-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration|A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Allegro Ophthalmics, LLC||3|||f||||t||||||||||2017-10-11 02:11:36.150733|2017-10-11 02:11:36.150733
NCT01749878|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-05-10|||December 2012||2012-12-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Study to Assess the Safety and Tolerability of Single Doses of REGN1500||Completed||Phase 1|99|Actual|Regeneron Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:11:36.311043|2017-10-11 02:11:36.311043
NCT01749865|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-04-13|||October 2008||2008-10-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||CIK Treatment for HCC Patient Underwent Radical Resection|A Randomized Controlled Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients With Hepatocellular Carcinoma Who Underwent Radical Resection|Completed||Phase 3|200|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 02:11:36.423464|2017-10-11 02:11:36.423464
NCT01749852|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2014-10-20|||January 2013||2013-01-01|May 2013|2013-05-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Polyphenol-rich Dark Chocolate on Body Weight in Overweight and Obese Adults|Effect of Polyphenol-rich Dark Chocolate on Body Weight in Overweight and Obese Adults: A Pilot Study|Completed||N/A|14|Actual|Queen Margaret University||2|||f||||f||||||||||2017-10-11 02:11:36.525209|2017-10-11 02:11:36.525209
NCT01749839|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-12|||December 2012||2012-12-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||Pain Relief by Platelet-rich Plasma (PRP) Treatment||Unknown status|Active, not recruiting|N/A|25|Anticipated|Saint Bernard Mission University|||1||f||||t||||||||||2017-10-11 02:11:36.646119|2017-10-11 02:11:36.646119
NCT01749813|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-05-28|||April 2012||2012-04-01|May 2015|2015-05-01|May 2015|Anticipated|2015-05-01|May 2015|Actual|2015-05-01||Observational|SCD||Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease|Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease|Unknown status|Active, not recruiting|N/A|120|Anticipated|Stanford University|||1||f||||f||||||Samples With DNA|"     Blood and stool   "|||2017-10-11 02:11:36.81831|2017-10-11 02:11:36.81831
NCT01749800|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2017-04-30|2017-03-19||July 2011||2011-07-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors|Combining Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors With Attentional Deficits|Terminated||N/A|7|Actual|Spaulding Rehabilitation Hospital||3||Lack of funding|f||||f||||||||No||2017-10-11 02:11:36.916539|2017-10-11 02:11:36.916539
NCT01749787|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-12-18|||November 2012||2012-11-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|SPARTA||Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis|A Phase Ib Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose Escalation, Safety and Tolerability Study of PRTX-100 in Combination With Methotrexate or Leflunomide in Patients With Active Rheumatoid Arthritis|Completed||Phase 1|61|Actual|Protalex, Inc.||7|||f||||t||||||||||2017-10-11 02:11:37.429979|2017-10-11 02:11:37.429979
NCT01749774|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2014-10-15|||December 2012||2012-12-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Physical Activity and Testicular Cancer|Physical Activity and Testicular Cancer - a Pilot Study: Feasibility and Effects of a Program Including Information, Counseling and a Physical Activity Program for Patients With Testicular Cancer During and After Chemotherapy|Completed||N/A|13|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 02:11:37.571698|2017-10-11 02:11:37.571698
NCT01749761|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-06-14|||January 2013||2013-01-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|BP-RIDH||Blood Pressure Guided Biofeedback on Hemodialysis and the Reduction of IntraDialytic Hypotension|Blood Pressure Guided Biofeedback on Hemodialysis and the Reduction of IntraDialytic Hypotensive Episodes: A Randomized Cross Over Trial|Completed||N/A|25|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 02:11:37.674182|2017-10-11 02:11:37.674182
NCT01749748|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2016-02-01|||July 2008||2008-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|||The Study of Breast MRI Screening and Proton Magnetic Resonance Spectroscopy|The Study of Breast MRI Screening and Proton Magnetic Resonance Spectroscopy|Completed||N/A|270|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 02:11:37.77872|2017-10-11 02:11:37.77872
NCT01749735|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-03-30|2015-03-09||July 2011||2011-07-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) and Motor Training for Traumatic Brain Injury (TBI) Survivors|The Effect of Transcranial Direct Current Stimulation Combined With Functional Task Training on Motor Recovery in Traumatic Brain Injury Survivors|Terminated||N/A|2|Actual|Spaulding Rehabilitation Hospital|Patient 1 did not finish study (stopped in follow up week 2). Patient 2 missed 2 training sessions. Both patients received the intervention (tDCS group) according to the confidential patient log. There was no control group available for comparison.|2||The study was terminated because of lack of funding.|f||||f||||||||No||2017-10-11 02:11:37.876128|2017-10-11 02:11:37.876128
NCT01749722|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-11|2013-07-29|||November 2012||2012-11-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy|Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy|Completed||N/A|50|Actual|Smart Medical Systems Ltd.||1|||f||||f||||||||||2017-10-11 02:11:38.167959|2017-10-11 02:11:38.167959
NCT01749709|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-06-24|||December 2012||2012-12-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|MUKU2||Music Listening and Stroke Recovery|Effect of Cognitive Stimulation on Recovery After Stroke|Unknown status|Recruiting|N/A|60|Anticipated|Turku University Hospital||3|||f||||f||||||||||2017-10-11 02:11:38.248903|2017-10-11 02:11:38.248903
NCT01749696|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-05-08|||November 2009||2009-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|September 2012|Actual|2012-09-01||Observational|||Alterations in Connective Tissue in Patients With or Without Pelvic Organ Prolapse|Alterations in Connective Tissue in Patients With or Without Pelvic Organ Prolapse.|Completed||N/A|78|Actual|Turku University Hospital|||2||f||||||||||||||2017-10-11 02:11:38.535184|2017-10-11 02:11:38.535184
NCT01749683|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-04-18|||August 2011||2011-08-01|April 2016|2016-04-01||||August 2017|Anticipated|2017-08-01||Observational|GEMyCE 1||Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction|Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction|Recruiting||N/A|100|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-10-11 02:11:38.626047|2017-10-11 02:11:38.626047
NCT01749670|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-11-25|||January 2013||2013-01-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder|Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder|Completed||N/A|45|Actual|State University of New York - Upstate Medical University|||2||f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 02:11:38.690885|2017-10-11 02:11:38.690885
NCT01749657|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-11-19|||September 2012||2012-09-01|November 2014|2014-11-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Kinematic and Kinetic Effects of Orthotic Devices for Subjects With Stage II Posterior Tibial Tendon Dysfunction|Kinematic and Kinetic Effects of Orthotic Devices for Subjects With Stage II Posterior Tibial Tendon Dysfunction|Unknown status|Recruiting|N/A|60|Anticipated|State University of New York - Upstate Medical University||4|||f||||f||||||||||2017-10-11 02:11:38.771334|2017-10-11 02:11:38.771334
NCT01749644|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2012-12-15|||January 2013||2013-01-01|December 2012|2012-12-01|January 2015|Anticipated|2015-01-01|June 2014|Anticipated|2014-06-01||Observational|||Switching From Tobramycin Inhalation Treatment to Tobramycin Inhaler Treatment: The Effect on CF Patients' Adherence and Quality of Life||Unknown status|Not yet recruiting|N/A|40|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 02:11:38.886067|2017-10-11 02:11:38.886067
NCT01749631|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-02-02|2016-02-02||December 2012||2012-12-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational||Per protocol population: all participants prescribed sevoflurane due to an anticipated difficulty in intubation during surgery and who met the study’s inclusion/exclusion criteria.|Investigation of the Effectiveness of Sevoflurane Anaesthesia in Difficult to Intubate Egyptian Patients|A Prospective, Open-label, Multicenter, Post Marketing, Observational Study to Investigate the Effectiveness of Sevoflurane Anaesthesia in Difficult to Intubate Egyptian Patients|Completed||N/A|97|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 02:11:38.962108|2017-10-11 02:11:38.962108
NCT01749618|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-04-05|||November 2012||2012-11-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|Metrix II||Closing the Gap in Care in Seronegative Inflammatory Arthritis|Closing the Gap in Care in Seronegative Inflammatory Arthritis: From Identification to Implementation of Treating to Target: A Randomized Trial of Feedback, Education, and Behavioural Change|Completed||N/A|40|Actual|Pope Research Corporation||2|||f||||f||||||||||2017-10-11 02:11:39.171781|2017-10-11 02:11:39.171781
NCT01749605|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-05-02|2017-03-16||October 2010||2010-10-01|May 2017|2017-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department||Completed||Phase 4|35|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 02:11:39.265434|2017-10-11 02:11:39.265434
NCT01749592|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-07-04|||December 2012||2012-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Single-sided Deafness and Cochlear Implants|Hemispheric Dominance in Single-sided Postlingual Deafness and Changes / Plasticity Induced by Cochlear Implants|Active, not recruiting||N/A|20|Anticipated|University of Zurich||1|||f||||t|f|f||||||||2017-10-11 02:11:39.562195|2017-10-11 02:11:39.562195
NCT01749579|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-11|||May 2012||2012-05-01|December 2012|2012-12-01|February 2013|Anticipated|2013-02-01|January 2013|Anticipated|2013-01-01||Interventional|||Comparison of Propofol-fentanyl and Midazolam-fentanyl for Conscious Sedation|Comparison of Propofol-fentanyl and Midazolam-fentanyl for Conscious Sedation in Painful Procedures|Unknown status|Recruiting|Phase 4|60|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:11:39.632916|2017-10-11 02:11:39.632916
NCT01749566|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-07-08|||December 2012||2012-12-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MVC-PREP||Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women|Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women|Completed||Phase 1|31|Actual|Emory University||3|||f||||f||||||||||2017-10-11 02:11:39.727471|2017-10-11 02:11:39.727471
NCT01749553|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-01-22|||October 2011||2011-10-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Effectiveness of an 8-week Posterior Shoulder Stretching Program on Varsity-level Overhead Athletes|Effectiveness of an 8-week Posterior Shoulder Stretch Program on Varsity-level Overhead Athletes|Completed||N/A|37|Actual|Shoulder & Upper Extremity Research Group of Edmonton||2|||f||||f||||||||||2017-10-11 02:11:39.803434|2017-10-11 02:11:39.803434
NCT01749540|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-12-13|||February 2013||2013-02-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study to Evaluate the Effects of ACE-536 in Patients With Beta-thalassemia|A Phase 2, Open-Label, Ascending Dose Study to Evaluate the Effects of ACE-536 in Patients With Beta-Thalassemia Intermedia|Completed||Phase 2|64|Actual|Acceleron Pharma, Inc.||1|||f||||f||||||||||2017-10-11 02:11:39.872563|2017-10-11 02:11:39.872563
NCT01749527|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-12|||March 2006||2006-03-01|December 2012|2012-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Does Patient Activity Level Affect 24-Hour Pad Test Results in Stress-Incontinent Women|Does Patient Activity Level Affect 24-Hour Pad Test Results in Stress-Incontinent Women?|Completed||N/A|30|Actual|St George Hospital, Australia||1|||f||||f||||||||||2017-10-11 02:11:39.959632|2017-10-11 02:11:39.959632
NCT01749514|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-09-26|||January 2013||2013-01-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|||Study of ACE-536 for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)|A Phase 2, Open Label, Ascending Dose Study of ACE-536 for the Treatment of Anemia in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)|Recruiting||Phase 2|128|Anticipated|Acceleron Pharma, Inc.||1|||f||||f||||||||||2017-10-11 02:11:40.039355|2017-10-11 02:11:40.039355
NCT01749501|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-12-13|2015-06-02||January 2011||2011-01-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Premedication for Non-Emergency Endotracheal Intubation In the NICU|Premedication for Non-Emergency Endotracheal Intubation In the NICU|Completed||Phase 4|45|Actual|William Beaumont Hospitals||2|||f||||t||||||||||2017-10-11 02:11:40.156257|2017-10-11 02:11:40.156257
NCT01749488|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-08-02|||October 2015||2015-10-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|NutriSave||The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care|The Impact of Involving a Dietitian in the Implementation of Expert Recommendations Concerning Nutrition During Intensive Care on Energy Balance|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes||2||The intervention becomes obsolete for participating centres pending regulatories.|f||||f||||||||||2017-10-11 02:11:42.404737|2017-10-11 02:11:42.404737
NCT01749475|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-02-27|||June 2010||2010-06-01|February 2013|2013-02-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Observational|||Hypnosis vs Midazolam for Sedation for TEE|Hypnosis for Sedation in Transesophageal Echocardiography: Comparison With Midazolam|Completed||N/A|98|Actual|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||2||f||||f||||||||||2017-10-11 02:11:42.598876|2017-10-11 02:11:42.598876
NCT01749462|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2016-02-09|||February 2013||2013-02-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Oxis 9mcg Turbuhaler Clinical Experience Investigation|Oxis 9mcg Turbuhaler Clinical Experience Investigation|Completed||N/A|398|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:11:42.684894|2017-10-11 02:11:42.684894
NCT01749449|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-12|||January 2005||2005-01-01|January 2007|2007-01-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|3v6||Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body Fat During Weight Maintenance and Weight Loss|Increased Protein Intake and Meal Frequency Reduces Abdominal Fat and Increases Postprandial Thermogenesis During Energy Balance and Energy Deficit|Completed||N/A|30|Actual|Skidmore College||3|||f||||t||||||||||2017-10-11 02:11:42.838237|2017-10-11 02:11:42.838237
NCT01749436|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2013-09-12|||April 2013||2013-04-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Role of Lung Ultrasound Imaging for Intraoperative Monitoring of Atelectasis During Laparoscopic Surgery|Role of Lung Ultrasound Imaging for Intraoperative Monitoring of Atelectasis During Laparoscopic Surgery|Completed||N/A|30|Actual|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-10-11 02:11:42.916631|2017-10-11 02:11:42.916631
NCT01749423|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2014-01-31|||November 2012||2012-11-01|January 2014|2014-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines||Withdrawn||N/A|0|Actual|Allergan|||1|Company decision due to enrollment challenges.|f||||f||||||||||2017-10-11 02:11:42.993869|2017-10-11 02:11:42.993869
NCT01749410|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-12|2015-08-10|2015-08-10||May 2013||2013-05-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines||Completed||N/A|33|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:11:43.065109|2017-10-11 02:11:43.065109
NCT01749397|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-06-30|||December 7, 2012|Actual|2012-12-07|May 2017|2017-05-01||||June 30, 2017|Anticipated|2017-06-30||Interventional|||Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer|A Phase I Trial of the Combination of the PARP Inhibitor ABT-888 With Intraperitoneal Floxuridine (FUDR) in Epithelial Ovarian, Primary Peritoneal and Fallopian Tube Cancers|Recruiting||Phase 1|102|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:11:43.382162|2017-10-11 02:11:43.382162
NCT01749371|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-05-10|||February 2013||2013-02-01|May 2016|2016-05-01||||September 2016|Anticipated|2016-09-01||Interventional|||Vitamin E Supplementation in Burned Patients|Vitamin E Supplementation in Burned Patients|Recruiting||Phase 2/Phase 3|42|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 02:11:43.727202|2017-10-11 02:11:43.727202
NCT01749358|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-04-04|||March 2012||2012-03-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|DOSE||Dose Optimization for Stroke Evaluation|Optimizing the Dose of Rehabilitation After Stroke.|Completed||Phase 1|60|Actual|University of Southern California||4|||f||||f||||||||||2017-10-11 02:11:43.885063|2017-10-11 02:11:43.885063
NCT01749345|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-11|||July 2012||2012-07-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Social Determinants of Health in Diabetes Outcomes|Social Determinants of Health as Explanatory Factors for Ethnic Disparities in Diabetes Outcomes|Unknown status|Recruiting|N/A|600|Anticipated|Medical University of South Carolina|||1||f||||||||||||||2017-10-11 02:11:44.015713|2017-10-11 02:11:44.015713
NCT01749332|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-07-17|||December 2012|Actual|2012-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections|A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections|Active, not recruiting||N/A|117|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:11:44.126316|2017-10-11 02:11:44.126316
NCT01749319|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-08-04|||January 2013||2013-01-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Oral and IV Baclofen in Adult Volunteers|Prevention of Baclofen Withdrawal Syndrome: Two-Way Crossover Study of Oral and Intravenous Baclofen in Healthy Adult Volunteers|Completed||Phase 1|12|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 02:11:44.235922|2017-10-11 02:11:44.235922
NCT01749293|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-05-26|||August 2012||2012-08-01|May 2015|2015-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation|Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation for Patients With Hematologic Malignancies|Terminated||Phase 2|2|Actual|University of Illinois at Chicago||1||The protocol design is being reconfigured in order to open a new study.|f||||t||||||||||2017-10-11 02:11:44.436087|2017-10-11 02:11:44.436087
NCT01749280|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-12-11|||March 2011||2011-03-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Magnetic Resonance Imaging To Predict Outcomes In Aortic Aneurysms|Efficacy of Magnetic Resonance Imaging Using Ultrasmall Superparamagnetic Particles of Iron Oxide to Predict Clinical Outcome in Patients Under Surveillance for Abdominal Aortic Aneurysms|Terminated||N/A|16|Actual|University of Edinburgh|||1|"Study being continued as a multi centre MA3RS study.The patients will be followed up under   MA3RS and AAA PET."|f||||f||||||||||2017-10-11 02:11:44.53525|2017-10-11 02:11:44.53525
NCT01749267|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-11|||September 2010||2010-09-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|DSR||Digital Subtraction Radiography Evaluation of SMART Restoration With Partial Caries Removal in Primary Teeth|Clinical and Digital Subtraction Radiography Evaluation of Partial Caries Removal in Primary Teeth|Completed||N/A|38|Actual|Mahidol University||1|||f||||f||||||||||2017-10-11 02:11:44.632413|2017-10-11 02:11:44.632413
NCT01749254|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-12-11|||February 2012||2012-02-01|December 2012|2012-12-01||||February 2013|Anticipated|2013-02-01||Observational|||Novel Imaging Approaches To Identify Unstable Coronary Plaques|Novel Imaging Approaches To Identify Unstable Coronary Plaques|Unknown status|Recruiting|N/A|80|Anticipated|University of Edinburgh|||2||f||||f||||||||||2017-10-11 02:11:44.742491|2017-10-11 02:11:44.742491
NCT01749241|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2012-12-11|||September 2012||2012-09-01|December 2012|2012-12-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy of Loteprednol Ointment Following Eyelid Surgery|Loteprednol Etabonate Ophthalmic Ointment vs. Soothe Night Time Ointment for Inflammation Following Eyelid Surgery|Unknown status|Recruiting|N/A|100|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 02:11:44.847731|2017-10-11 02:11:44.847731
NCT01749228|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-12|||October 2012||2012-10-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition|An Open Label, Balanced, Randomized, Single-dose, Two-treatment, Two-sequence, Two-period, Crossover, Oral Bioequivalence Study of Etodolac Capsules USP 300 mg of Ipca Laboratories Limited, India and Etodolac Capsules USP 300mg of Taro Pharmaceutical Industries Ltd., USA in Healthy, Adult, Human Subjects Under Fed Condition.|Completed||Phase 1|36|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:11:44.939903|2017-10-11 02:11:44.939903
NCT01749215|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2016-10-25|||February 2013||2013-02-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|TAP2||A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD|A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD|Recruiting||Phase 4|150|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:11:45.073315|2017-10-11 02:11:45.073315
NCT01749202|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-12-11|||August 2010||2010-08-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||Effects of Stearidonic Acid-Containing Foods on Eicosapentaenoic Acid Levels in Red Blood Cells and Omega-3 Index||Completed||N/A|126|Actual|Solae, LLC||3|||f||||t||||||||||2017-10-11 02:11:45.344402|2017-10-11 02:11:45.344402
NCT01749189|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-06-03|||July 2012||2012-07-01|June 2014|2014-06-01|June 2015|Anticipated|2015-06-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength|A Randomized, Controlled Double Blind Longitudinal Study: Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength|Unknown status|Active, not recruiting|N/A|60|Anticipated|Solae, LLC||3|||f||||f||||||||||2017-10-11 02:11:45.450906|2017-10-11 02:11:45.450906
NCT01749176|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-11-17|||October 2012||2012-10-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Dulce Digital-Project Dulce 2.0 Texting Study|Dulce Digital-Project Dulce 2.0 Texting Study in High Risk Latinos With Diabetes|Completed||N/A|126|Actual|Scripps Whittier Diabetes Institute||2|||f||||t||||||||||2017-10-11 02:11:45.551316|2017-10-11 02:11:45.551316
NCT01749163|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-12-02|||September 2012||2012-09-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Hyperglycemia and the Extra-pancreatic Effect of Incretins|Determining the Extra-pancreatic Effects of Incretin Hormones During Euglycemic and Hyperglycemic Pancreatic Clamps|Completed||N/A|20|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-11 02:11:45.663377|2017-10-11 02:11:45.663377
NCT01748968|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2015-12-11|||September 2012||2012-09-01|December 2012|2012-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence|Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence|Completed||N/A|20|Actual|VA Eastern Colorado Health Care System|||1||f||||t||||||||||2017-10-11 02:11:47.424543|2017-10-11 02:11:47.424543
NCT01749150|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-11-01|||April 2013||2013-04-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis|STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND ANTIVIRAL ACTIVITY OF RITONAVIR-BOOSTED DANOPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS OF ASIAN ORIGIN WHO HAVE CHRONIC HEPATITIS C GENOTYPE 1 WITH OR WITHOUT COMPENSATED CIRRHOSIS|Completed||Phase 2|61|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:11:45.765104|2017-10-11 02:11:45.765104
NCT01749137|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-11-06||2014-11-06|December 2012||2012-12-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|March 2013|Actual|2013-03-01||Interventional|||Phase 2 Study to Evaluate Safety and Efficacy of Rm-493 in Obese Patients|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM 493, a Melanocortin 4 Receptor (MC4R) Agonist in Obese Patients|Completed||Phase 2|70|Actual|Rhythm Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:11:45.90959|2017-10-11 02:11:45.90959
NCT01749124|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-05-16|||December 2012||2012-12-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|MCC||My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness|"My Coach Connect: Pilot Under the Partnered Research Center for Quality Care, RHINO 2008-0132"|Active, not recruiting||N/A|160|Anticipated|RAND||1|||f||||f||||||||Undecided||2017-10-11 02:11:46.03463|2017-10-11 02:11:46.03463
NCT01749111|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-03-02|||December 2012||2012-12-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|CICLODECH||Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis|Randomized Study to Compare Post Bone Marrow Transplant Cyclophosphamide With the Combination of Methotrexate Plus Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis|Terminated||Phase 3|3|Actual|Hospital Israelita Albert Einstein||2||Lack of accrual|f||||f||||||||||2017-10-11 02:11:46.157967|2017-10-11 02:11:46.157967
NCT01749098|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-03-07|||December 2012||2012-12-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers|A Randomized, Subject And Investigator Blinded, Sponsor Open Placebo Controlled, 2 Way, Crossover Phase 1b Study To Examine The Effects Of PF-04958242 On Ketamine Induced Cognitive Impairment In Healthy Male Volunteers|Completed||Phase 1|29|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 02:11:46.283054|2017-10-11 02:11:46.283054
NCT01749085|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2013-04-08|||December 2012||2012-12-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels|A Phase 1, Open Label Study In Healthy Subjects To Estimate The Effect Of Food And The Drug-Drug Interaction Potential Of Ketoconazole On PF-04449913 Pharmacokinetics|Completed||Phase 1|14|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:11:46.406365|2017-10-11 02:11:46.406365
NCT01749072|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-12|||December 2012||2012-12-01|December 2012|2012-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients|A Phase Ⅱ Randomized Clinical Trial Comparing Vinorelbine-ifosfamide With Gefitinib as Third-line Treatment in Advanced EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients|Recruiting||Phase 2|120|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 02:11:46.517335|2017-10-11 02:11:46.517335
NCT01749059|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-12-16|||June 2012||2012-06-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|CCHD||The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease|The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease|Completed||N/A|6147|Actual|Mednax Center for Research, Education and Quality|||1||f||||f||||||||||2017-10-11 02:11:46.653675|2017-10-11 02:11:46.653675
NCT01749046|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-05-10|||March 2012||2012-03-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures|Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety and Tolerability of a Fixed Dose of Remegal as Adjunctive Therapy in Patients With Partial Seizures|Completed||Phase 3|224|Actual|Valexfarm||2|||f||||t||||||||||2017-10-11 02:11:46.748302|2017-10-11 02:11:46.748302
NCT01749020|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-11-19|||March 2012||2012-03-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Polyphenol-rich Dark Chocolate on Insulin Sensitivity in Normal Weight and Overweight Adults|Effect of Polyphenol-rich Dark Chocolate on Insulin Sensitivity in Normal Weight and Overweight Adults|Completed||N/A|61|Actual|Queen Margaret University||2|||f||||f||||||||||2017-10-11 02:11:46.984751|2017-10-11 02:11:46.984751
NCT01749007|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-05-12|||November 2012||2012-11-01|December 2012|2012-12-01|January 2017|Actual|2017-01-01|August 2016|Actual|2016-08-01||Observational|||Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS|Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS|Completed||N/A|50|Actual|VA Eastern Colorado Health Care System|||1||f||||f||||||||||2017-10-11 02:11:47.106156|2017-10-11 02:11:47.106156
NCT01748994|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-04-06|||February 2011||2011-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Apple/Pear||Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women|Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women|Completed||N/A|49|Actual|Pennington Biomedical Research Center||2|||f||||t||||||||||2017-10-11 02:11:47.21232|2017-10-11 02:11:47.21232
NCT01748981|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-06-16|||November 2010||2010-11-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|FALC||Fitness, Activity and Lung Cancer Study|Cardiorespiratory Fitness and Effect of Training After Lung Cancer Surgery. A Randomized Controlled Trial|Enrolling by invitation||N/A|80|Anticipated|Oslo University Hospital||2|||f||||t||||||||No||2017-10-11 02:11:47.315516|2017-10-11 02:11:47.315516
NCT00000514|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-14|||June 1984||1984-06-01|January 2005|2005-01-01|October 1996||1996-10-01|||||Interventional|||Systolic Hypertension in the Elderly Program (SHEP)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:58.835236|2017-10-11 04:18:58.835236
NCT01748955|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-02-14|2017-02-14||June 2010||2010-06-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study|SSRI Versus Bupropion in High-Risk Major Depressive Disorder|Completed||Phase 4|15|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 02:11:47.518381|2017-10-11 02:11:47.518381
NCT01748942|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-08-10|2017-05-08||December 2012||2012-12-01|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|July 2016|Actual|2016-07-01||Interventional|||Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer|A Randomized, Placebo Controlled, Double Blinded Study of Corticosteroid Treatment for the Reduction of Postoperative Pain Following Transoral Robotic Surgery|Active, not recruiting||N/A|76|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-10-11 02:11:47.865095|2017-10-11 02:11:47.865095
NCT01748929|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-08-28|||February 24, 2014|Actual|2014-02-24|August 2017|2017-08-01|September 16, 2016|Actual|2016-09-16|February 13, 2015|Actual|2015-02-13||Interventional|||Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth|Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth|Completed||Phase 4|1010|Actual|McGill University Health Center||2|||f||||t||||||||||2017-10-11 02:11:48.769026|2017-10-11 02:11:48.769026
NCT01748916|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-05-19|2014-10-15||June 2011||2011-06-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|November 2011|Actual|2011-11-01||Interventional|||Comparison of Carotenoid Bioavailability From Fresh Papaya, Tomato and Carrot|Evaluation of the Effect of the Consumption of Papaya, Tomato, and Carrot on the Bioavailability of Carotenoids|Active, not recruiting||N/A|16|Actual|Ohio State University||6|||f||||t||||||||||2017-10-11 02:11:48.880705|2017-10-11 02:11:48.880705
NCT01748903|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-12-13|||February 2013||2013-02-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|TARGET||TARGET Intracranial Aneurysm Coiling Registry|TARGET Intracranial Aneurysm Coiling Registry: A Prospective Clinical Efficacy and Safety Study of Stryker Target® 360°, Target® Helical, and 2nd Generation Target® Nano Coils|Recruiting||Phase 4|150|Anticipated|Mercy Health, Ohio||1|||f||||t||||||||||2017-10-11 02:11:49.146945|2017-10-11 02:11:49.146945
NCT01748890|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2014-04-17|2014-04-17||December 2009||2009-12-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy|A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy|Terminated||N/A|4|Actual|Massachusetts General Hospital||1||Insufficient recruitment|f||||t||||||||||2017-10-11 02:11:49.283836|2017-10-11 02:11:49.283836
NCT01748877|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-06-18|||January 2013||2013-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia|A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)|Completed||Phase 2|188|Actual|NeurAxon Inc.||2|||f||||f||||||||||2017-10-11 02:11:49.43818|2017-10-11 02:11:49.43818
NCT01748864|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2014-07-28|||April 2013||2013-04-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers|A Single-Center Phase I Clinical Study to Evaluate The Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers|Completed||Phase 1|23|Actual|Endocyte||1|||f||||||||||||||2017-10-11 02:11:49.601834|2017-10-11 02:11:49.601834
NCT01748851|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2014-11-02|||December 2012||2012-12-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)|A Phase III Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Capecitabine and Oxaliplatin (XELOX) in Comparison to the Combination Therapy of Fluorouracil/Folinic Acid and Oxaliplatin (FOLFOX) in Patients With AGC|Terminated||Phase 3|42|Actual|Dong-A University Hospital||2||Poor enrollment of patients|f||||t||||||||||2017-10-11 02:11:49.686753|2017-10-11 02:11:49.686753
NCT01748838|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2013-09-09|||December 2012||2012-12-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Phase 1 Study Assessing the Safety and Tolerability of CTX-4430|A Phase I Randomised, Double-Blind, Placebo-Controlled, Ascending Single & Repeat-Dose Study of Safety, Tolerability & Pharmacokinetics of CTX-4430 When Administered Orally to Healthy Adult Subjects|Completed||Phase 1|96|Actual|Celtaxsys, Inc.||4|||f||||t||||||||||2017-10-11 02:11:49.788559|2017-10-11 02:11:49.788559
NCT01748825|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-09-12|||November 14, 2012||2012-11-14|August 15, 2017|2017-08-15|September 21, 2018|Anticipated|2018-09-21|December 31, 2017|Anticipated|2017-12-31||Interventional|||AZD1775 for Advanced Solid Tumors|A Phase I Study of Single-agent AZD1775 (MK-1775), a Wee1 Inhibitor, in Patients With Advanced Refractory Solid Tumors|Recruiting||Phase 1|72|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 02:11:49.903781|2017-10-11 02:11:49.903781
NCT01748812|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-06-30|||November 16, 2012||2012-11-16|July 7, 2015|2015-07-07|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)|Open-label Dose-titration Study of the Tolerability and Efficacy of Cinacalcet to Treat Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia|Terminated||Phase 1|1|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:11:50.004471|2017-10-11 02:11:50.004471
NCT01748799|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2015-12-30|2015-08-14||February 2013||2013-02-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Fixed or Self-Titrated Dosages of Sativex on Cannabis Users|Effects of Fixed or Self-Titrated Dosages of Sativex on Cannabis Users|Completed||N/A|16|Actual|Centre for Addiction and Mental Health|The main limitation is the small sample size. Also our study did not include experimental conditions containing THC alone and CBD alone for comparison. The short duration of the experimental condition is also a limitation.|8|||f||||f||||||||||2017-10-11 02:11:50.10303|2017-10-11 02:11:50.10303
NCT01748786|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-02-19|||January 2011||2011-01-01|February 2016|2016-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|EGIFT||Online Mindfulness Training Versus Health Education for Fibromyalgia|Emotional Resilience in Fibromyalgia: A Pilot Study of Web-based Treatment|Completed||N/A|94|Actual|Arizona State University||2|||f||||f||||||||||2017-10-11 02:11:51.114084|2017-10-11 02:11:51.114084
NCT01748201|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2013-09-09|||November 2012||2012-11-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Viscosupplementation in Patients With Hemophilic Arthropathy|Viscosupplementation in Patients With Hemophilic Arthropathy|Completed||Phase 4|13|Actual|University of Sao Paulo General Hospital||1|||f||||t||||||||||2017-10-11 02:11:57.447005|2017-10-11 02:11:57.447005
NCT01748773|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-08-17|||January 29, 2013|Actual|2013-01-29|August 2017|2017-08-01|June 15, 2017|Actual|2017-06-15|August 21, 2015|Actual|2015-08-21||Interventional|TOXAG||A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer|Safety and Tolerability of Oxaliplatin-Capecitabine-Trastuzumab Combination and Chemoradiotherapy in Operated Patients With HER-2 Positive Gastric or Gastroesophageal Junction Adenocarcinoma: Phase II Study, TOXAG [ML25574]|Completed||Phase 2|35|Actual|Hoffmann-La Roche||1|||f||||t||||||||||2017-10-11 02:11:51.225989|2017-10-11 02:11:51.225989
NCT01748760|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-11-17|2016-02-03||October 2012||2012-10-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CLASP-A||Coping Long Term With Attempted Suicide - Adolescents|Coping Long Term With Attempted Suicide - Adolescents|Completed||N/A|50|Actual|Brown University||2|||f||||t||||||||Yes|Please contact PI for data.|2017-10-11 02:11:51.362168|2017-10-11 02:11:51.362168
NCT01748747|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-03-21|||October 2012|Actual|2012-10-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery|Peptide Vaccine With Resiquimod as an Immune Modulator for Patients With Resected Melanoma: A Pilot Study|Active, not recruiting||N/A|36|Anticipated|Mayo Clinic||3|||f||||t||||||||||2017-10-11 02:11:51.722277|2017-10-11 02:11:51.722277
NCT01748734|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-06-02|||March 2011||2011-03-01|June 2015|2015-06-01||||March 2011|Actual|2011-03-01||Interventional|||Cognitive Therapy in Reducing Depression in Patients With Cancer|An Examination of Cognitive Therapy for Depression in Cancer Patients.|Completed||Phase 2|25|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:11:51.824672|2017-10-11 02:11:51.824672
NCT01748721|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-01-07|||November 2013||2013-11-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma|Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors|Completed||Phase 1|27|Actual|Morphotek||1|||f||||t||||||||||2017-10-11 02:11:51.927563|2017-10-11 02:11:51.927563
NCT01748708|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2016-09-26|||January 2017||2017-01-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Evaluating the Efficacy of Magnetic Seizure Therapy in Treatment Resistant Depression.|Evaluating the Efficacy of Magnetic Seizure Therapy in Treatment Resistant Depression.|Not yet recruiting||N/A|200|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 02:11:52.078261|2017-10-11 02:11:52.078261
NCT01748695|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2017-04-10|2016-12-21||June 2013||2013-06-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury|A Phase IIa, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over Study Evaluating the Safety, Tolerability and Efficacy of V158866 in Central Neuropathic Pain Following Spinal Cord Injury|Completed||Phase 2|25|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 02:11:52.197483|2017-10-11 02:11:52.197483
NCT01748682|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-10|||January 2011||2011-01-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Very Low Calorie Liquid Diet for Pre op Patients|Use of Very Low Calorie Liquid Diet in the Preoperative Phase of Bariatric Surgery|Completed||N/A|104|Actual|Gastrocirurgia, Brazil||2|||f||||f||||||||||2017-10-11 02:11:52.628403|2017-10-11 02:11:52.628403
NCT01748669|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2012-12-11|||October 2011||2011-10-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis|Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis|Completed||Phase 2|60|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||3|||f||||f||||||||||2017-10-11 02:11:52.767101|2017-10-11 02:11:52.767101
NCT01748656|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-11|2014-03-13|||January 2013||2013-01-01|December 2012|2012-12-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|CIBLE||Target Volume in Noninvasive Positive Pressure Ventilation|Comparison of Two Noninvasive Positive Pressure Ventilation Devices Using Target Volume Modes in Obesity Hypoventilation Syndrome (OHS): A Pilot Randomized Crossover Controlled Trial|Completed||N/A|12|Actual|AGIR à Dom||2|||f||||f||||||||||2017-10-11 02:11:52.877328|2017-10-11 02:11:52.877328
NCT01748643|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-04-24|2017-03-13||April 2013||2013-04-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|CURES||CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity|Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity in Patients Undergoing Laparoscopic Gastric Bypass Surgery|Completed||Phase 4|60|Actual|Ziekenhuis Oost-Limburg||2|||f||||f||||||||||2017-10-11 02:11:53.005824|2017-10-11 02:11:53.005824
NCT01748630|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-12-11|||February 2012||2012-02-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Dexmedetomidine on the Postoperative Experience in Children|Pain, Fentanyl Consumption, and Delirium in Children After Scoliosis Surgery: Dexmedetomidine Versus Midazolam|Completed||Phase 4|42|Actual|Inonu University||2|||f||||f||||||||||2017-10-11 02:11:53.519101|2017-10-11 02:11:53.519101
NCT01748617|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-08-27|||December 2012||2012-12-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Potential for Pomegranate Juice to Ameliorate Endothelial Dysfunction||Completed||N/A|12|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 02:11:53.62453|2017-10-11 02:11:53.62453
NCT01748604|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-16|||February 2004||2004-02-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|January 2010|Actual|2010-01-01||Interventional|||Physical Therapies in the Decongestive Treatment of Lymphedema|Physical Therapies in the Decongestive Treatment of Lymphedema: A Multicenter, Randomized, Controlled Study.|Completed||N/A|194|Actual|Hospital Universitario La Fe||3|||f||||t||||||||||2017-10-11 02:11:53.717721|2017-10-11 02:11:53.717721
NCT01748591|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-12-21|||May 2012||2012-05-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice|A Study of PICOPREP in Patients Needing to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery|Terminated||N/A|3324|Actual|Ferring Pharmaceuticals|||1|Terminated due to problems enrolling adequate number of patients.|f||||f||||||||||2017-10-11 02:11:53.867895|2017-10-11 02:11:53.867895
NCT00006403|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2016-05-12|||July 2000||2000-07-01|March 2005|2005-03-01|June 2004|Actual|2004-06-01|||||Observational|||Inflammation: Correlates and Prognosis in Framingham||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:30:18.561992|2017-10-11 04:30:18.561992
NCT01748578|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-05-06|||November 2012||2012-11-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|EBI-005-1||Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects|A Phase 1, Double-Masked, Placebo-Controlled, Dose Escalating Study of the Safety, Tolerability, and Pharmacokinetics of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects|Completed||Phase 1|16|Actual|Eleven Biotherapeutics||2|||f||||f||||||||||2017-10-11 02:11:54.013371|2017-10-11 02:11:54.013371
NCT01748565|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-08-18|||May 2012||2012-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|GRP||Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia|Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia|Completed||N/A|260|Actual|Duke University|||1||f||||t||||||Samples With DNA|"     urine specimens and saliva with DNA   "|||2017-10-11 02:11:54.145285|2017-10-11 02:11:54.145285
NCT01748552|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-08-22|||December 2012||2012-12-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study of LY2922083 in Healthy Participants and Participants With Diabetes|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of LY2922083 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|36|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 02:11:54.243542|2017-10-11 02:11:54.243542
NCT01748539|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-09-03|||December 2012||2012-12-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Phase 2 Clinical Study of KHK4827|A Randomized, Double-blind, Placebo-controlled Parallel Group Study in Subjects With Plaque Psoriasis|Completed||Phase 2|140|Anticipated|Kyowa Hakko Kirin Co., Ltd||4|||f||||f||||||||||2017-10-11 02:11:54.344744|2017-10-11 02:11:54.344744
NCT01748526|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-07-15|||August 2008||2008-08-01|July 2016|2016-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin (JNJ-28431754) in Healthy Indian Volunteers|A Single-Dose, Open-Label, Randomized, Two-Way, Cross-Over Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-28431754 in Healthy Indian Subjects|Completed||Phase 1|16|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 02:11:54.443519|2017-10-11 02:11:54.443519
NCT01748513|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-04-28|||March 2011||2011-03-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Volume-challenge in Morbid Obesity|Morbid Obesity and Optimization of Preoperative Fluid Therapy|Completed||N/A|34|Actual|Umeå University|||1||f||||f||||||||||2017-10-11 02:11:54.558903|2017-10-11 02:11:54.558903
NCT01748500|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-04-28|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Interventional|||Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer|Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer - a Single Arm Phase II Clinical Trial With a Predefined Reference Group (PANDORA)|Active, not recruiting||Phase 2|32|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 02:11:54.668706|2017-10-11 02:11:54.668706
NCT01748487|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-11-30|||December 2012||2012-12-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Effect of Intravitreal Ozurdex on DME After Cataract Surgery|A Pilot Study of the Effect of Intravitreal Dexamethasone Implant (700 Micrograms) on Diabetic Macular Edema After Cataract Surgery|Completed||Phase 3|24|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 02:11:54.763836|2017-10-11 02:11:54.763836
NCT01748474|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-08-11|||December 2012||2012-12-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|ExOx-CPET||Effect of Short-term Oxygen During CPET in Pulmonary Hypertension|Effect of Short-term Oxygen Therapy on Cardiopulmonary Exercise Capacity in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension|Completed||Phase 2|20|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 02:11:54.846034|2017-10-11 02:11:54.846034
NCT01748461|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2014-08-04|||May 2013||2013-05-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Objective Assessment and Promotion of Physical Activity in Elderly||Completed||N/A|105|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||||||||||||2017-10-11 02:11:54.930948|2017-10-11 02:11:54.930948
NCT01748448|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-09-14|||December 2012||2012-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ViDMe||Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome|Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome|Recruiting||Phase 3|500|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 02:11:55.025494|2017-10-11 02:11:55.025494
NCT01748435|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2012-12-10|||February 2013||2013-02-01|December 2012|2012-12-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Observational|||Pre-emptive Analgesia With Qutenza in Lower Limb Amputation|The Role of Pre-emptive Analgesia With Qutenza (Topical Capsaicin 8%) in Preventing Neuropathic Pain Following Lower Limb Amputation: a Pilot Randomised Controlled Study|Unknown status|Not yet recruiting|N/A|30|Anticipated|NHS Greater Glasgow and Clyde|||1||f||||f||||||||||2017-10-11 02:11:55.211691|2017-10-11 02:11:55.211691
NCT01748422|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-11-09|||November 2015||2015-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Qutenza (Topical Capsaicin 8%) for Painful Arteriovenous Fistulae|The Role of Qutenza (Topical Capsaicin 8%) in Treating Neuropathic Pain From Arteriovenous Fistulae in Patients With End Stage Renal Failure|Recruiting||N/A|20|Anticipated|NHS Greater Glasgow and Clyde|||1||f||||f||||||||Undecided||2017-10-11 02:11:55.311711|2017-10-11 02:11:55.311711
NCT01748409|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-10-04|||February 2013||2013-02-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SYNAPark||Physiopathological Study of Autonomic Failure in Parkinson's Disease|Physiopathological Study of Autonomic Failure in Parkinson's Disease : a Monocentric Study|Completed||N/A|47|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 02:11:55.419424|2017-10-11 02:11:55.419424
NCT01748396|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2013-02-14|||July 2012||2012-07-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol|Effect of Phosphate Binders on FGF-23 During Calcitriol Administration in CKD Stage 3 Patients|Completed||Phase 4|30|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:11:55.507667|2017-10-11 02:11:55.507667
NCT01748188|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2014-05-27|||January 2012||2012-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|DOFIS||The Effectiveness of Dexketoprofen on Shoulder Pain Using Different Physiotherapy Treatments|Valuation of the Dexketoprofen Effectiveness on Subacromial Syndrome With Different Physiotherapy Treatments.|Completed||Phase 2|99|Actual|University Rovira i Virgili||3|||f||||t||||||||||2017-10-11 02:11:57.560334|2017-10-11 02:11:57.560334
NCT01748370|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-01-04|||December 2012||2012-12-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Vitamin D Treatment and Hypogonadism in Men|A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Effects of Vitamin D Supplementation on Androgen Levels in Hypogonadal Men|Recruiting||Phase 4|200|Anticipated|Medical University of Graz||4|||f||||t||||||||||2017-10-11 02:11:55.732683|2017-10-11 02:11:55.732683
NCT01748357|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2014-11-05|||December 2012||2012-12-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Siemens VOC TB Pilot Study|Pattern Recognition of Volatile Organic Compounds (VOC) in Exhaled Breath for the Diagnosis of Pulmonary Tuberculosis|Completed||N/A|60|Anticipated|Research Center Borstel|||3||f||||f||||||Samples Without DNA|"     Volatile compounds from exhaled breath   "|||2017-10-11 02:11:55.856403|2017-10-11 02:11:55.856403
NCT01748344|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-04-14|||November 2012||2012-11-01|September 2012|2012-09-01||||February 2014|Actual|2014-02-01||Interventional|||Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis|A Randomised, Placebo Controlled, Four Period Crossover Study to Evaluate the Efficacy, Safety of Oral Repeat Doses of ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis in the Vienna Challenge Chamber.|Completed||Phase 2|58|Actual|Ono Pharmaceutical Co. Ltd||4|||f||||f||||||||||2017-10-11 02:11:55.935527|2017-10-11 02:11:55.935527
NCT01748331|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-10-26|||November 2012||2012-11-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|Decongest||The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia|The Significance of the Vasopressin System of the Hemodynamics, Water Balance and Prognosis in Chronic Heart Failure|Unknown status|Recruiting|N/A|40|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:11:56.03517|2017-10-11 02:11:56.03517
NCT01748318|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-05-06|||March 2013||2013-03-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||New Mexico Honey Wound Treatment Research Study|New Mexico Honey Wound Treatment Research Study|Recruiting||Phase 2|60|Anticipated|Rankin, R. Stephen, M.D.||2|||f||||f||||||||Yes||2017-10-11 02:11:56.251833|2017-10-11 02:11:56.251833
NCT01748305|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-10-22|||December 2012||2012-12-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Moderate-to-vigorous Physical Activity for Glycemic Control in Patients With Gestational Diabetes Mellitus|Moderate-to-vigorous Physical Activity for Glycemic Control in Patients With Gestational Diabetes Mellitus: a Pilot Study|Terminated||N/A|14|Actual|Oregon Health and Science University||1||Recruitment issues.|f||||f||||||||||2017-10-11 02:11:56.341849|2017-10-11 02:11:56.341849
NCT01748279|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2013-04-21|||December 2012||2012-12-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effects of Atorvastatin Treatment in COPD Patients|The Effects of Atorvastatin Treatment in COPD Patients|Completed||Phase 4|18|Actual|Medical University of Bialystok||2|||f||||t||||||||||2017-10-11 02:11:56.556363|2017-10-11 02:11:56.556363
NCT01748266|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-11|||April 2010||2010-04-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Microcirculation of the Thenar Eminence|Interest of the Measure of the StO2 to Estimate the Microcirculatory Disturbances Following Cardiac Surgery With Cardiopulmonary Bypass|Completed||N/A|40|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 02:11:56.649671|2017-10-11 02:11:56.649671
NCT01748253|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2013-05-20|||November 2012||2012-11-01|May 2013|2013-05-01||||October 2013|Anticipated|2013-10-01||Interventional|ACROBAT||ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)|ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing|Unknown status|Recruiting|N/A|80|Anticipated|Acrobat Trial Group||2|||f||||||||||||||2017-10-11 02:11:56.723098|2017-10-11 02:11:56.723098
NCT01748227|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-04-27|2014-12-11||January 2013||2013-01-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|IMPPRESS||IMproving Pain Using Peer RE-inforced Self-management Skills|Improving Pain Using Peer RE-inforced Self-management Skills (IMPPRESS)|Completed||N/A|20|Actual|VA Office of Research and Development|This was a pilot study to examine feasibility and preliminary effectiveness of peer support for veterans with chronic pain. Because of the small sample size and pretest/posttest design of the study, results should be interpreted with caution.|1|||f||||f||||||||||2017-10-11 02:11:57.080201|2017-10-11 02:11:57.080201
NCT01748214|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-10|||November 2008||2008-11-01|December 2012|2012-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Premature Infant Exposure to Noise Generated by Respiratory Support|Premature Infant Exposure to Noise Generated by Respiratory Support|Completed||N/A|28|Actual|University of Virginia|||2||f||||f||||||||||2017-10-11 02:11:57.346667|2017-10-11 02:11:57.346667
NCT01748175|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-07-21|||January 2013||2013-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Interventional|SARPIII||Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma|Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma|Active, not recruiting||N/A|700|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 02:11:57.696395|2017-10-11 02:11:57.696395
NCT01748149|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-01-12|||February 2014||2014-02-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Vemurafenib in Children With Recurrent/Refractory BRAFV600E-mutant Gliomas|PNOC-002: Safety, Phase 0, and Pilot Efficacy Study of Vemurafenib, an Oral Inhibitor of BRAFV600E, in Children and Young Adults With Recurrent/Refractory BRAFV600E- or BRAF Ins T Mutant Brain Tumors|Recruiting||Early Phase 1|54|Anticipated|University of California, San Francisco||1|||f||||t||||||||No||2017-10-11 02:11:57.918222|2017-10-11 02:11:57.918222
NCT01748136|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-10-12|||January 2006||2006-01-01|October 2016|2016-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|NA_00036809||Screening for Lung Cancer in the HIV Patient|Screening for Lung Cancer in the HIV Patient|Completed||N/A|200|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 02:11:58.231537|2017-10-11 02:11:58.231537
NCT01748123|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-08-15|||August 2016||2016-08-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network|Creating an Active Collaborative Network of Comparative Effectiveness Researchers: A Randomized Study of Initial Diuretic Therapy for Hypertension.|Withdrawn||Phase 4|0|Actual|Johns Hopkins University||2||Slow enrollment|f||||f||||||||||2017-10-11 02:11:58.31489|2017-10-11 02:11:58.31489
NCT01748110|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-01-25|||December 2012||2012-12-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|HIM-UP||Health Interventions in Men Undergoing Radical Prostatectomy|Health Interventions in Men Undergoing Radical Prostatectomy- A Randomized Controlled Clinical Trial|Withdrawn||N/A|0|Actual|Johns Hopkins University||5||Funding could not be secured|f||||f||||||||||2017-10-11 02:11:58.437691|2017-10-11 02:11:58.437691
NCT01748097|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2012-12-30|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|IVBICONCOL||Intravenous Bicarbonate To Verify The Correct Position of IV Catheters in Oncological Patients Oncological Patients Receiving Chemotherapy|Phase III Study to Assess the Utility of a New Innovative Technique Using Intravenous Bicarbonate to Verify the Correct Position of Patients Scheduled for Intravenous Bicarbonate|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:11:58.612382|2017-10-11 02:11:58.612382
NCT01748084|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-06-27|||April 2013||2013-04-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|RECOVER||Rituximab in Systemic Sclerosis|Evaluation of Rituximab in Systemic Sclerosis Associated Polyarthritis|Active, not recruiting||Phase 2/Phase 3|22|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:11:58.721789|2017-10-11 02:11:58.721789
NCT01748071|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2013-09-22|2013-05-30||June 2012||2012-06-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Observational|||The Realtime Detection for Individual Variation of Analgesic ：A Comparison of Sufentanil vs Fentanyl|Study of Analgesic Effect and Individual Sensitivity Differences of Opioid Analgesics|Completed||N/A|120|Actual|Huazhong University of Science and Technology|Because 3 patients couldn't maintain the SPO2 at 90% and 1 patient was at deep sedation, 4 subject patients were not analysed in the final results. These patients were performed as a routine intravenous anesthetic induction.||3||f||||t||||||||||2017-10-11 02:11:58.866498|2017-10-11 02:11:58.866498
NCT01748058|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-04-25|||January 2013||2013-01-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Active Video Games to Promote Physical Activity in Children With Cancer|Active Video Games to Promote Physical Activity, Motor Performance and Quality of Life in Children With Cancer: an Intervention Study With 2-year Follow-up|Active, not recruiting||N/A|36|Actual|Turku University Hospital||2|||f||||||||||||||2017-10-11 02:11:59.327745|2017-10-11 02:11:59.327745
NCT01748045|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-06-20|2016-06-17||March 2013||2013-03-01|June 2017|2017-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants|The Use of Inhaled Nitric Oxide to Improve Respiratory Outcomes in Late Preterm Infants|Terminated||Phase 2/Phase 3|3|Actual|Tufts Medical Center||2||Enrollenment has been suspended due to poor enrollment|f||||t||||||||||2017-10-11 02:11:59.423348|2017-10-11 02:11:59.423348
NCT01748032|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-04-06|||August 2012||2012-08-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Short-term Cognitive Training in Late-life Depression|The Effects of Short-term Cognitive Training on Cognition and Mood Symptoms in Late-life Depression: A Pilot Study|Terminated||N/A|6|Actual|Rotman Research Institute at Baycrest||2||Low Recruitment|f||||||||||||||2017-10-11 02:11:59.884497|2017-10-11 02:11:59.884497
NCT01748019|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-12-10|||June 2007||2007-06-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||ST1968 Intravenous (Weekly) in Solid Tumors|Phase I Dose Finding and Pharmacokinetic Study of the Intravenous Camptothecin ST1968 in Patients With Solid Tumors|Completed||Phase 1|62|Actual|sigma-tau i.f.r. S.p.A.||1|||f||||f||||||||||2017-10-11 02:11:59.972674|2017-10-11 02:11:59.972674
NCT01748006|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-10-26|||June 2012||2012-06-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure|The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure|Unknown status|Recruiting|Early Phase 1|30|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples Without DNA|"     Blood and urine analyses   "|||2017-10-11 02:12:00.064954|2017-10-11 02:12:00.064954
NCT01747993|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2014-10-01|||January 2013||2013-01-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|TAMSU||Tamsulosin for Urinary Retention in Hospitalized Older Women|Tamsulosin to Facilitate Early Catheter Removal After Urinary Retention in Older Women Hospitalized for an Acute Medical Condition|Terminated||Phase 3|34|Actual|Assistance Publique - Hôpitaux de Paris||2||low inclusion|f||||f||||||||||2017-10-11 02:12:00.153224|2017-10-11 02:12:00.153224
NCT01747980|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-04-04|||March 2013||2013-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Safety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease Patients|An Exploratory, Open-label Study to Evaluate the Safety of PRX-112 and Pharmacokinetics of Oral prGCD (Plant Recombinant Human Glucocerebrosidase) in Gaucher Patients|Completed||Phase 1|16|Actual|Protalix||1|||f||||f||||||||||2017-10-11 02:12:00.378844|2017-10-11 02:12:00.378844
NCT01747967|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-07-31|||November 15, 2011|Actual|2011-11-15|July 2016|2016-07-01|May 30, 2017|Actual|2017-05-30|May 30, 2017|Actual|2017-05-30||Interventional|IMMADIAB||Immune Biomarkers of Residual Beta-cell Mass in Type 1 Diabetes|Immune Biomarkers of Residual Beta-cell Mass in Type 1 Diabetes|Completed||N/A|156|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 02:12:00.482811|2017-10-11 02:12:00.482811
NCT01747954|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2012-12-19|||March 2010||2010-03-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||Effects of Physiotherapy in Hemodynamics and Childrens Respiratory Mechanics|Respiratory Mechanics and Hemodynamics in Children With Respiratory Failure: Comparison of Two Techniques of Respiratory Physiotherapy|Terminated||N/A|12|Actual|Federal University of Uberlandia||2||Terminated|f||||f||||||||||2017-10-11 02:12:00.589413|2017-10-11 02:12:00.589413
NCT01747941|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2013-05-22|||November 2012||2012-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects|A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Crossover Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects|Completed||Phase 1|30|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:12:00.675254|2017-10-11 02:12:00.675254
NCT01747928|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-04-01|2014-04-01||March 2013||2013-03-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Users Study Of The Caverject Delivery System|A Representative Users Study Of The Operating Characteristics Of The Caverject Delivery System|Completed||Early Phase 1|48|Actual|Pfizer|For outcome measure 7, the endpoint was originally the comments provided as part of the PAT. As clinicaltrials.gov do not support textual results, the number of participants who provided comments to any questions on the PAT are reported instead.|1|||f||||f||||||||||2017-10-11 02:12:00.825234|2017-10-11 02:12:00.825234
NCT01747915|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-10-02|||April 3, 2013|Actual|2013-04-03|October 2017|2017-10-01|March 19, 2019|Anticipated|2019-03-19|March 19, 2019|Anticipated|2019-03-19||Interventional|||A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.|A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin As Adjunctive Therapy In Pediatric And Adult Subjects With Primary Generalized Tonic-clonic Seizures - Protocol A0081105|Recruiting||Phase 3|168|Anticipated|Pfizer||3|||f||||t|t|f||||||||2017-10-11 02:12:05.499557|2017-10-11 02:12:05.499557
NCT01747902|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-09-18|||January 2013||2013-01-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|BicepsTvsT||Biceps Tenodesis Versus Tenotomy|Biceps Tenodesis Versus Tenotomy in the Treatment of Lesions of the Long Head of Biceps Brachii: a Randomized Controlled Trial|Active, not recruiting||N/A|112|Actual|Panam Clinic||2|||f||||f||||||||||2017-10-11 02:12:06.190437|2017-10-11 02:12:06.190437
NCT01747889|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-03-28|||January 2013||2013-01-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Objective and Subjective Outcomes of an Electronic Chest Drainage System|Objective and Subjective Outcomes of an Electronic Chest Drainage System Versus Traditional Devices: a Randomized Comparison|Completed||N/A|400|Actual|Ospedali Riuniti Ancona||2|||f||||||||||||||2017-10-11 02:12:06.292715|2017-10-11 02:12:06.292715
NCT01747876|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-08-09|||May 28, 2013|Actual|2013-05-28|August 2017|2017-08-01|June 29, 2017|Actual|2017-06-29|June 29, 2017|Actual|2017-06-29||Interventional|||Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma|A Phase I, Multi-center, Open-label Study of LEE011 in Patients With Malignant Rhabdoid Tumors and Neuroblastoma|Completed||Phase 1|32|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 02:12:06.370688|2017-10-11 02:12:06.370688
NCT01747863|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-09-21|||December 2012||2012-12-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|December 2015|Actual|2015-12-01||Observational|PRIME||Prospective Research in Infants With Mild Encephalopathy|Prospective Research in Infants With Mild Encephalopathy: the PRIME Study.|Completed||N/A|63|Actual|McGill University Health Center|||1||f||||f||||||||||2017-10-11 02:12:06.492079|2017-10-11 02:12:06.492079
NCT01747850|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-08-14|2017-01-18||March 2013||2013-03-01|July 2017|2017-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence|Sativex Associated With Behavioral-relapse Prevention Strategy as Treatment for Cannabis Dependence|Completed||Phase 2|45|Actual|Centre for Addiction and Mental Health||3|||f||||t||||||||||2017-10-11 02:12:06.620922|2017-10-11 02:12:06.620922
NCT01747837|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-06-28|||October 2012||2012-10-01|June 2017|2017-06-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|RESCUE||REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients|REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients|Recruiting||N/A|462|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-11 02:12:07.183971|2017-10-11 02:12:07.183971
NCT01747824|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-12-22|||December 2012||2012-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|Agitation||Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department|Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department|Completed||N/A|1322|Actual|Minneapolis Medical Research Foundation|||2||f||||t||||||||||2017-10-11 02:12:07.324563|2017-10-11 02:12:07.324563
NCT01747811|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-05-01|2015-11-30||December 2010||2010-12-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Bright Light Therapy in Mild Traumatic Brain Injury|Effects of Bright Light Therapy of Sleep, Cognition, Brain Function, and Neurochemistry in Mild Traumatic Brain Injury|Completed||N/A|32|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 02:12:07.492655|2017-10-11 02:12:07.492655
NCT01747798|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-12-20|||November 2012||2012-11-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Interventional|||Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Pilot Trial to Evaluate the Feasibility Auranofin (Ridaura®) for Asymptomatic Patients With First-Recurrence Epithelial Ovarian Cancer|Active, not recruiting||N/A|10|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:12:08.024512|2017-10-11 02:12:08.024512
NCT01747785|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-05-13|||June 2012||2012-06-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|X-HF-SPECKLE||Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction|Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction: Speckle Tracking Echocardiography - One Piece of the Puzzle.|Terminated||N/A|21|Actual|Mayo Clinic|||2|Study stopped for administrative reasons.|f||||f||||||||No||2017-10-11 02:12:08.106124|2017-10-11 02:12:08.106124
NCT01747772|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-05-12|2017-03-23||February 2010|Actual|2010-02-01|May 2017|2017-05-01|February 14, 2014|Actual|2014-02-14|February 14, 2014|Actual|2014-02-14||Interventional||The analysis population included all participants who completed the study and had adequate shear-wave sonoelastography (SWE) and liver biopsy data. 16 participants were excluded: 9 discontinued and 7 had inadequate SWE or biopsy data.|Sonoelastography: Ultrasound Method to Measure Liver Fibrosis|Evaluate the Utility of Shear Wave Sonoelastography as a Tool to Measure Liver Fibrosis Grade|Completed||N/A|180|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:12:08.200706|2017-10-11 02:12:08.200706
NCT01747759|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2012-12-11|||November 2010||2010-11-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|August 2011|Actual|2011-08-01||Interventional|EPOP||Evaluation of a Preoperative Education in Total Knee Arthroplasty||Completed||N/A|44|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:12:08.386812|2017-10-11 02:12:08.386812
NCT01747746|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-02-02|||October 2012||2012-10-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ARC||Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study|Anticoagulation With Rivaroxaban in Post Cardioversion Patients|Completed||Phase 4|33|Actual|John H. Stroger Hospital||2|||f||||t||||||||||2017-10-11 02:12:08.473263|2017-10-11 02:12:08.473263
NCT01747733|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-02-18|||December 2013||2013-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Assessment of Sedation During Endoscopy|Assessment of Sedation During Endoscopy, a Prospective Validation Study|Completed||N/A|200|Actual|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-11 02:12:08.579398|2017-10-11 02:12:08.579398
NCT01747720|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-05-23|||October 2012||2012-10-01|May 2017|2017-05-01|May 17, 2017|Actual|2017-05-17|May 2017|Actual|2017-05-01||Interventional|EVIDENSE||Vitamin D and Mammographic Breast Density|A Randomized Double-blind Placebo-controlled Trial of the Effect of Vitamin D Supplementation on Breast Density in Premenopausal Women|Completed||N/A|405|Actual|CHU de Quebec-Universite Laval||4|||f||||t||||||||No|We will not share IPD. Results of the study are published in Cancer Epidemiology, Biomarkers and Prevention.|2017-10-11 02:12:08.663824|2017-10-11 02:12:08.663824
NCT01747707|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2012-12-10|||September 2012||2012-09-01|December 2012|2012-12-01|May 2014|Anticipated|2014-05-01|September 2013|Anticipated|2013-09-01||Interventional|||Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer|Phase II Clinical Trial of Cisplatin,Docetaxel and S-1 as First Line Chemotherapy for Advanced Gastric and Gastroesophageal Junction Cancer|Unknown status|Recruiting|Phase 2|40|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:12:08.761343|2017-10-11 02:12:08.761343
NCT01747694|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2012-12-10|||December 2012||2012-12-01|October 2012|2012-10-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Interventional|||Respiratory Muscle Exercise Training in COPD Patients|The Effectiveness of Multi-respiratory Muscle Training on Respiratory Function in Patients With COPD|Unknown status|Recruiting|N/A|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-11 02:12:08.880886|2017-10-11 02:12:08.880886
NCT01747681|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-01-26|||December 2012||2012-12-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Observational|||Results at 10 to 14 Years After Microfracture in the Knee|Results at 10 to 14 Years After Microfracture in Articular Cartilage Defects in the Knee|Completed||N/A|110|Actual|Bergen Orthopedic Study Group|||1||f||||f||||||||||2017-10-11 02:12:08.969651|2017-10-11 02:12:08.969651
NCT01747668|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2013-05-30|||November 2012||2012-11-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Lactation Fortification Study|Impact of Nutrient Supplementation on Breast Milk Levels of Lactating Women|Completed||Phase 3|89|Actual|Abbott Nutrition||3|||f||||f||||||||||2017-10-11 02:12:09.057989|2017-10-11 02:12:09.057989
NCT01747655|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-10-06|2016-07-21||February 2013||2013-02-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|MONOTREAT|All subjects in the MAS|A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study|A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study - MONOTREAT|Completed||N/A|64|Actual|AbbVie|Results for the SoC group should be interpreted with care due to the small number of patients. Also, when comparing the SoC and Duodopa groups one should be aware that patients of the SoC group may have had Duodopa treatment before returning to SoC.||2||f||||f||||||||||2017-10-11 02:12:09.234062|2017-10-11 02:12:09.234062
NCT01747642|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-11|||December 2012||2012-12-01|December 2012|2012-12-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma|Study to Evaluate Safety and Therapeutic Efficacy of a Combination Therapy of 'Oncoxin', a Nutritional Supplement and Surafenib, a Multikinase Inhibitor in Patients With Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Clinical Research Organization, Dhaka, Bangladesh||3|||f||||f||||||||||2017-10-11 02:12:09.9968|2017-10-11 02:12:09.9968
NCT01747629|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2015-05-28|2015-05-02|2014-05-08|December 2012||2012-12-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional||Randomized analysis set|Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics|A 12-week Comparison of the Efficacy and Safety and Steady-State Pharmacokinetics of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma|Completed||Phase 3|160|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 02:12:10.236743|2017-10-11 02:12:10.236743
NCT01747616|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-10|||July 2011||2011-07-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|November 2011|Actual|2011-11-01||Interventional|||Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses|Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses|Completed||Phase 1|48|Actual|Medical University of Vienna||4|||f||||t||||||||||2017-10-11 02:12:11.387866|2017-10-11 02:12:11.387866
NCT01747603|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-04-07|||May 2013||2013-05-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|GROWNDUP||The GROWNDUP Study of Late Preterm Births|The GROWNDUP Study: Pilot to Assess the Feasibility of an RCT for Promoting Growth, Nutrition and Development Through a Specialized Late Preterm Clinic|Unknown status|Active, not recruiting|N/A|100|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 02:12:11.484917|2017-10-11 02:12:11.484917
NCT01747590|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-10|||July 2011||2011-07-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T|Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T|Unknown status|Recruiting|Early Phase 1|12|Anticipated|Mclean Hospital||1|||f||||f||||||||||2017-10-11 02:12:11.577048|2017-10-11 02:12:11.577048
NCT01747577|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2015-12-18|||December 2012||2012-12-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|POST-TURP||Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)|A Randomized, Double-blind, Placebo-controlled, Parallel-group, and Phase IV Study of Efficacy and Safety of Solifenacin Succinate in Patients With Overactive Bladder After TURP or PVP|Completed||Phase 4|68|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 02:12:11.70384|2017-10-11 02:12:11.70384
NCT01747564|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2012-12-10|||August 2012||2012-08-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects|A Study to Evaluate Pharmacokinetics of Mirabegron After Single and Multiple Oral Administration to Healthy Non-elderly Male and Female Chinese Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:12:11.838375|2017-10-11 02:12:11.838375
NCT01747551|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-05-09|||September 2013||2013-09-01|May 2016|2016-05-01||||September 2016|Anticipated|2016-09-01||Interventional|||FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer|Randomized, Double-Blind, Placebo Controlled Phase II Study of FOLFOX +/- Ziv-Aflibercept in Patients With Advanced Esophageal and Gastric Cancer|Active, not recruiting||Phase 2|64|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 02:12:11.970512|2017-10-11 02:12:11.970512
NCT01747538|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-07-11|||October 2012||2012-10-01|July 2016|2016-07-01||||June 2016|Actual|2016-06-01||Interventional|EYEGUARD™-C||Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment|A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment|Terminated||Phase 3|281|Actual|XOMA (US) LLC||3|||f||||f||||||||||2017-10-11 02:12:12.109796|2017-10-11 02:12:12.109796
NCT01747525|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-08-22|||October 2011||2011-10-01|August 2016|2016-08-01||||October 2013|Anticipated|2013-10-01||Observational|LUNAR||Near-Infrared Spectroscopy and Ultrasound Investigation of Coronary Artery Plaque|Lipiscan and Ultrasound Interrogation of Atherosclerotic Coronary Arteries (LUNAR)|Withdrawn||N/A|0|Actual|William Beaumont Hospitals|||1|It was decided not to proceed with the study at this time.|f||||f||||||||Undecided||2017-10-11 02:12:12.525243|2017-10-11 02:12:12.525243
NCT01747512|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2016-03-10|||January 2013||2013-01-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)|A Phase II/III Study of Cyclotron-produced Tc-99m Pertechnetate (C-PERT) Efficacy and Safety in Patients With Conformed and Suspected Thyroid Cancer or Head and Neck Cancer|Recruiting||Phase 2|115|Anticipated|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-10-11 02:12:12.625485|2017-10-11 02:12:12.625485
NCT01747499|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-07-21|||April 15, 2013||2013-04-15|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|April 15, 2018|Anticipated|2018-04-15||Interventional|||Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation|Phase I/II Trial of Intravenous Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation|Recruiting||Phase 1/Phase 2|64|Anticipated|Washington University School of Medicine||5|||f||||t|t|f||||||||2017-10-11 02:12:12.742922|2017-10-11 02:12:12.742922
NCT01747486|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-10|2017-08-09|||December 2012||2012-12-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||CD19 Redirected Autologous T Cells|Dose Optimization Trial of Autologous T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (CART-19) in Patients With Relapsed or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 2|61|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 02:12:12.895123|2017-10-11 02:12:12.895123
NCT01747473|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-12-05|||November 2012||2012-11-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Pulse Oximetry_Performance During Severe Signal Interference - PCBA-1 (Printed Circuit Board Assembly)|Controlled Acute Hypoxia Studies Comparing Pulse Oximetry to Arterial Blood Samples During Motion in Healthy, Well-perfused Subjects With the Functional Monitoring PCBA-1|Completed||N/A|17|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 02:12:12.97888|2017-10-11 02:12:12.97888
NCT01747460|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-12-05|||September 2012||2012-09-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly)|Controlled Acute Hypoxia Studies Using a Bedside Respiratory Patient Monitoring System With the Functional Patient Monitoring PCBA-1|Completed||N/A|25|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 02:12:13.054571|2017-10-11 02:12:13.054571
NCT01747447|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-03-14|||August 2012||2012-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VITAL||VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture|VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture|Active, not recruiting||N/A|773|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:12:13.130445|2017-10-11 02:12:13.130445
NCT01747434|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-07|||January 2010||2010-01-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Complaints and Presumptive Diagnosis in a Danish Emergency Department||Completed||N/A|10070|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 02:12:13.237375|2017-10-11 02:12:13.237375
NCT01747421|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-07|||March 2009||2009-03-01|December 2012|2012-12-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Observational|||Validation of a High-risk Versus Low-risk Referral Model in Suspected Acute Coronary Syndrome||Completed||N/A|495|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 02:12:13.29336|2017-10-11 02:12:13.29336
NCT01747408|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-12-10|||June 2006||2006-06-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|July 2010|Actual|2010-07-01||Interventional|ALISAH||Treatment of Subarachnoid Hemorrhage With Human Albumin|Treatment of Subarachnoid Hemorrhage With Human Albumin|Terminated||Phase 1|47|Actual|Baylor College of Medicine||1||The study met the pre-specified criteria for stopping the trial|f||||t||||||||||2017-10-11 02:12:13.356809|2017-10-11 02:12:13.356809
NCT01747395|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-05-03|||August 2012||2012-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Interventional|||Exercise Training Associated With Inspiratory Muscle Training in Heart Failure|Effects of Aerobic Exercise Training Associated With Inspiratory Muscle Training in Patients With Heart Failure|Recruiting||N/A|40|Anticipated|University of Sao Paulo General Hospital||4|||f||||t||||||||Undecided||2017-10-11 02:12:13.459534|2017-10-11 02:12:13.459534
NCT01747382|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2017-04-27|||April 2012||2012-04-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2015|Actual|2015-09-01||Expanded Access|||Renal Denervation for Treatment of Resistant Hypertension in Patients With Chronic Kidney Disease|Catheter-based Renal Sympathetic Nerve Ablation for Treatment-resistant Hypertension in Patients With Chronic Kidney Disease|No longer available||N/A|||Singapore General Hospital||||Symplicity HTN-3 trial showed no benefit, hence trial was terminated|f||||||||||||||2017-10-11 02:12:13.799093|2017-10-11 02:12:13.799093
NCT01747369|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2017-03-03|||April 2010|Actual|2010-04-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013||Recruiting||N/A|2000|Anticipated|Agence de Médecine Préventive, France|||1||f||||f||||||Samples With DNA|"     Whole blood, cerebro-spinal fluid, nasal aspirate   "|||2017-10-11 02:12:13.870145|2017-10-11 02:12:13.870145
NCT01747356|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2015-11-13|||February 2013||2013-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|RESOLUTE-DM||Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions|Study of Resolute Coronary Stent System in Treating Diabetic Coronary Lesions|Completed||N/A|1000|Actual|Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||||2017-10-11 02:12:13.971176|2017-10-11 02:12:13.971176
NCT01747343|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2014-08-21|2014-07-08||November 2012||2012-11-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Toilet Training Toddlers and Preschoolers|Changing the Number of Accidents, Percentage of Appropriate Eliminations, and Number of Self-Initiations Across Toddlers and Preschoolers|Completed||N/A|4|Actual|University of Kansas||1|||f||||f||||||||||2017-10-11 02:12:14.076176|2017-10-11 02:12:14.076176
NCT01747330|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2014-06-13|2013-12-23||June 2012||2012-06-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency|An Open Label, Multicenter Study Evaluating Safety and Tolerability of Creon Micro in Pediatric Subjects From at Least One Month to Less Than Four Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|Completed||Phase 3|40|Actual|Abbott||1|||f||||f||||||||||2017-10-11 02:12:14.29513|2017-10-11 02:12:14.29513
NCT01747317|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2012-12-10|||December 2012||2012-12-01|December 2012|2012-12-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Interventional|PERFECT||Diagnostic Performance of Noninvasive Fractional Flow Reserve From Computed Tomography|Individual-Patient-Data Pooled-Analysis of Diagnostic Accuracy of Noninvasive Fractional Flow Reserve From Anatomic CT Angiography|Unknown status|Active, not recruiting|Phase 4|300|Anticipated|Shanghai 10th People's Hospital||1|||f||||t||||||||||2017-10-11 02:12:14.615976|2017-10-11 02:12:14.615976
NCT01747304|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-10-27|||July 2012||2012-07-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Evaluation of IVA (SE Femur Scans) to Identify Incomplete AFFs|Evaluation of Dual Energy X-ray Absorptiometry Scanners in the Identification of Atypical Femur Fractures - A Validation Study|Recruiting||N/A|500|Anticipated|University Health Network, Toronto|||3||f||||f||||||||||2017-10-11 02:12:14.739071|2017-10-11 02:12:14.739071
NCT01747291|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-11-28|||June 2009||2009-06-01|November 2016|2016-11-01||||December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|||Atypical Fracture Cohort Study|Atypical Femur Fracture Ontario Cohort Registry|Recruiting||N/A|300|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 02:12:14.846183|2017-10-11 02:12:14.846183
NCT01747278|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2012-12-09|||August 2012||2012-08-01|December 2012|2012-12-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Interventional|||Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients|The Safety and Effectiveness of Trimethoprim/Sulfamethoxazole as Pneumocystis Carinii Pneumonia (PCP) Prophylaxis in Patients With Connective Tissue Diseases|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 02:12:14.95004|2017-10-11 02:12:14.95004
NCT01747265|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2012-12-10|||January 2013||2013-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:12:15.079301|2017-10-11 02:12:15.079301
NCT01747252|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-09|2013-05-01|||August 2012||2012-08-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||Pharmacokinetics of Resveratrol Comprising Products|Randomized Three-way Cross-over Comparative Pharmacokinetic Study of Resveratrol Comprising Products in Fasting Healthy Subjects|Completed||N/A|15|Actual|Fruitura Bioscience Ltd.||3|||f||||f||||||||||2017-10-11 02:12:15.132542|2017-10-11 02:12:15.132542
NCT01747239|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-12-03|||January 2013||2013-01-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Cabazitaxel in Platinum Refractory Ovarian Cancer|Cabazitaxel in Platinum Refractory Ovarian Cancer. A Phase II Trial|Terminated||Phase 2|4|Actual|Vejle Hospital||1||Too low inclusion rate. Only 4 patients included over 16 months|f||||t||||||||||2017-10-11 02:12:15.233583|2017-10-11 02:12:15.233583
NCT01747226|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2012-12-10|||March 2013||2013-03-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01||Interventional|MR2012||Effect of Mouth Rinses in Oral Malodor|Masking and Therapeutic Effect of Different Mouth Rinses in Patients With Oral Malodor.|Unknown status|Not yet recruiting|N/A|96|Anticipated|Universitaire Ziekenhuizen Leuven||4|||f||||t||||||||||2017-10-11 02:12:15.348203|2017-10-11 02:12:15.348203
NCT01747031|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-10|||December 2012||2012-12-01|December 2012|2012-12-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|iFRCT||Determination of Instantaneous Wave-Free Ratio by Computed Tomography|Diagnostic Performance of Instantaneous Wave-Free Ratio From Computed Tomography|Unknown status|Active, not recruiting|N/A|100|Anticipated|Shanghai 10th People's Hospital||1|||f||||t||||||||||2017-10-11 02:12:17.123868|2017-10-11 02:12:17.123868
NCT01747213|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2017-10-05|||November 15, 2012||2012-11-15|July 17, 2017|2017-07-17|July 3, 2018|Anticipated|2018-07-03|July 1, 2018|Anticipated|2018-07-01||Interventional|||Bisnorcymserine in Healthy Adult Volunteers|Phase I, Double-Blind, Placebo-Controlled, Ascending, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of Bisnorcymserine (BNC), a Highly Selective Inhibitor of Butyrylcholinesterase, in Healthy Adult Volunteers|Recruiting||Phase 1|200|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:12:15.523763|2017-10-11 02:12:15.523763
NCT01747200|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2017-06-30|||November 16, 2012||2012-11-16|January 26, 2017|2017-01-26|January 26, 2017|Actual|2017-01-26|January 26, 2017|Actual|2017-01-26||Interventional|||Effects of Transcranial Magnetic Stimulation on Object Recognition|Modulating Behavior in Humans by Entrainment With Rhythmic Transcranial Magnetic Stimulation|Completed||N/A|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:12:15.649886|2017-10-11 02:12:15.649886
NCT01747187|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-12-10|||October 2012||2012-10-01|December 2012|2012-12-01|April 2015|Anticipated|2015-04-01|October 2014|Anticipated|2014-10-01||Observational|Septic Heart||Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and Outcome|Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and Outcome.|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Linkoeping|||1||f||||f||||||||||2017-10-11 02:12:15.755906|2017-10-11 02:12:15.755906
NCT01747174|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-06-15|||October 2011||2011-10-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|REFLO-STEMI||REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction|Randomized Controlled Trial Comparing Intracoronary Administration of Adenosine or Sodium Nitroprusside to Control for Attenuation of Microvascular Obstruction During Primary Percutaneous Coronary Intervention|Completed||Phase 2|247|Actual|University Hospitals, Leicester||3|||f||||t||||||||||2017-10-11 02:12:15.88912|2017-10-11 02:12:15.88912
NCT01747161|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-12-04|||January 2013||2013-01-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|VVS-01||Infiltration of the Vestibulum Vaginae With Botulin Toxin in Patients With Localized Provoked Vulvodynia|Randomized Placebo Controlled Double Blind Study: Efficacy and Safety of Infiltration of the Vestibulum Vaginae With Botulin Toxin in Patients With Localized Provoked Vulvodynia.|Unknown status|Recruiting|Phase 2|50|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 02:12:16.045496|2017-10-11 02:12:16.045496
NCT01747148|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2017-07-13|||November 14, 2012||2012-11-14|July 12, 2017|2017-07-12|June 29, 2016|Actual|2016-06-29|June 29, 2016|Actual|2016-06-29||Interventional|||Testing the AVI-7100 Flu Drug in Healthy Volunteers|A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects|Completed||Phase 1|66|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:12:16.14948|2017-10-11 02:12:16.14948
NCT01747135|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2017-04-18|||January 2013||2013-01-01|October 2016|2016-10-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease|Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease|Completed||Phase 1|14|Actual|Vtesse Inc.||1|||f||||||||||||Yes|Publish in peer reviewed journal|2017-10-11 02:12:16.235577|2017-10-11 02:12:16.235577
NCT01747122|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2014-10-13|||December 2012||2012-12-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|LIVER 2||The Effects of Local Infiltration Versus Epidural Following Liver Resection 2|A Randomised Trial of Peri-operative Nerve Block and Continuous Infusion of Local Anaesthetic Via Wound Catheter Versus Epidural in Patients Undergoing Open Liver Resection.|Completed||N/A|97|Actual|University of Edinburgh||2|||f||||t||||||||||2017-10-11 02:12:16.347006|2017-10-11 02:12:16.347006
NCT01747109|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-12-09|||November 2012||2012-11-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|PREOXYFLOW||Benefits of Optiflow® Device for Preoxygenation Before Intubation in Acute Hypoxemic Respiratory Failure : The PREOXYFLOW Study|A Prospective, Multicenter, Randomized, Controlled, Parallel-group, Open Label Trial Evaluating Benefits of Nasal High Flow Therapy (HFT) in Preoxygenation Before Tracheal Intubation in Acute Hypoxemic Respiratory Failure|Completed||N/A|122|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 02:12:16.445595|2017-10-11 02:12:16.445595
NCT01747096|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-07-28|||November 2012||2012-11-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|68-DOTANOC-GEP||TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors|Diagnostic, Prospective, Comparative, Multicentric Study of the PET / CT With 68Ga-DOTANOC Versus Conventional Imaging Procedures (octréoscan ® Scintigraphy and CT / MRI) in the Assessment of in Gastroenteropancreatic Neuroendocrine Tumors|Completed||N/A|130|Anticipated|Nantes University Hospital|||||f||||f||||||||||2017-10-11 02:12:16.555494|2017-10-11 02:12:16.555494
NCT01747083|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-10-22|||January 2013||2013-01-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)|A Randomized, Open Label, Single Dose, Crossover Study to Investigate Food-effect Bioavailability of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)Under Fed and Fasting Conditions in Healthy Male Volunteers|Completed||Phase 1|24|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-11 02:12:16.649687|2017-10-11 02:12:16.649687
NCT01747070|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-08-17|||March 2014||2014-03-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Cranial Stimulation and Acupuncture on Pain, Functional Capability and Cerebral Function in Osteoarthritis|Effect of Transcranial Direct Current Stimulation and Electro Acupuncture in Pain, Functional Capability and Cortical Excitability in Patients With Osteoarthritis.|Completed||N/A|60|Actual|Hospital de Clinicas de Porto Alegre||4|||f||||t||||||||||2017-10-11 02:12:16.749707|2017-10-11 02:12:16.749707
NCT01747057|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2014-02-12|||March 2013||2013-03-01|February 2014|2014-02-01|May 2015|Anticipated|2015-05-01|February 2015|Anticipated|2015-02-01||Interventional|||Monitoring Resuscitation in Severe Sepsis and Septic Shock|Monitoring Resuscitation in Severe Sepsis and Septic Shock|Unknown status|Recruiting|N/A|952|Anticipated|Corporacion Parc Tauli||2|||f||||t||||||||||2017-10-11 02:12:16.870929|2017-10-11 02:12:16.870929
NCT01747044|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-07-04|||April 2013||2013-04-01|July 2014|2014-07-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Prospective Study of the Influence of the Diffuse Noxious Inhibitory Controls of the Pain on the Efficacy of Milnacipran in Fibromyalgia Therapy||Unknown status|Recruiting|Phase 2|48|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:12:17.000979|2017-10-11 02:12:17.000979
NCT01747018|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-08|2012-12-10|||February 2011||2011-02-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Platelet Rich Plasma Injection for Knee Pain|Intra-articular Injections of Platelet-rich Plasma in Patients With Knee Pain of Articular Cartilage Origin (Degenerative Chondropathy and Early OA).|Completed||Phase 1/Phase 2|44|Actual|The Catholic University of Korea||1|||f||||t||||||||||2017-10-11 02:12:17.238069|2017-10-11 02:12:17.238069
NCT01747005|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-11-16|||June 2012||2012-06-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|GERAS||Effect of Enhanced Recovery After Surgery (ERAS) on Inflammatory Response After Planned Abdominal Hysterectomy|Effect of Enhanced Recovery After Surgery (ERAS) on Inflammatory Response After Planned Abdominal Hysterectomy: A Prospective Randomized Clinical Trial.|Recruiting||N/A|80|Anticipated|Samoilova Maternity Home|||2||f||||||||||Samples Without DNA|"     serum   "|||2017-10-11 02:12:17.327473|2017-10-11 02:12:17.327473
NCT01746992|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-11-24|||September 2012||2012-09-01|November 2013|2013-11-01|December 2018|Anticipated|2018-12-01|September 2015|Anticipated|2015-09-01||Interventional|||CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma|An Open-label,Multicenter Randomised Study of CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for the New Diagnosed Young Patients With T Cell Non-hodgkin Lymphoma|Recruiting||Phase 4|200|Anticipated|Ruijin Hospital||2|||f||||t||||||||||2017-10-11 02:12:17.425077|2017-10-11 02:12:17.425077
NCT01746966|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2014-05-04|||December 2012||2012-12-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Observational|||Anterior Shoulder US - a New Access|US Investigation of Gleno-humeral Joint by Anterior Access With Measurement of Rotator Interval in Patients With Rheumatoid Arthritis and Healthy Controls|Unknown status|Recruiting|N/A|40|Anticipated|Rambam Health Care Campus|||2||f||||f||||||||||2017-10-11 02:12:17.662427|2017-10-11 02:12:17.662427
NCT01746953|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-10|||May 2005||2005-05-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Observational|||The Effect of Red Blood Cells Transfusion in Trauma Patients|The Effect of Red Blood Cells Transfusion in Trauma Patients: A Risk Stratified Analysis|Completed||N/A|20211|Actual|Progress|||1||f||||f||||||||||2017-10-11 02:12:17.760561|2017-10-11 02:12:17.760561
NCT01746940|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-04-06|2016-05-31||March 2014||2014-03-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||The analysis of baseline characteristics includes all enrolled subjects.|Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia|A Phase III Investigation of Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia for Diagnostic Procedures and Surgeries on or Through Accessible Mucous Membranes of the Nasal Cavities.|Terminated||Phase 3|159|Actual|Lannett Company, Inc.||3||Trial operational issues.|f||||f||||||||||2017-10-11 02:12:17.828785|2017-10-11 02:12:17.828785
NCT01746927|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-12-02|||February 2012||2012-02-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|CP||Does the Position of the Esophageal Entrance Determine the Cricoid Force Necessary to Occlude the Esophageal Lumen|Does the Position of the Esophageal Entrance Determine the Cricoid Force Necessary to Occlude the Esophageal Lumen?|Unknown status|Recruiting|N/A|80|Anticipated|Procare Riaya Hospital|||1||f||||f||||||||||2017-10-11 02:12:18.632243|2017-10-11 02:12:18.632243
NCT01746914|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-03-29|||January 2013||2013-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|July 2014|Actual|2014-07-01||Observational|||Morphofunctional Lung Analysis by PET and CT After Lung Transplantation|Morphofunctional Lung Analysis by Positron Emission Tomography and Computed Tomography After Lung Transplantation|Completed||N/A|30|Actual|Policlinico Hospital|||1||f||||f||||||||Undecided||2017-10-11 02:12:18.765879|2017-10-11 02:12:18.765879
NCT01746888|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2013-11-06|||August 2011||2011-08-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Expanding Antimicrobial Stewardship|Expanding Antimicrobial Stewardship|Completed||N/A|437|Actual|Ohio State University|||1||f||||f||||||||||2017-10-11 02:12:19.087276|2017-10-11 02:12:19.087276
NCT01746875|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2015-09-14|||February 2014||2014-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes|Pigment Epithelium Detachment - a Prospective Clinical Study. PED-study.|Terminated||N/A|9|Actual|Norwegian University of Science and Technology||2||treatment effects not as desired|f||||t||||||||||2017-10-11 02:12:19.157448|2017-10-11 02:12:19.157448
NCT01746862|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-08-24|2016-08-24||December 2012||2012-12-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional||Safety analysis set (SAS) included all randomized subjects who received at least 1 dose of planned trial treatment and had follow-up safety data. SAS also included the safety data for all subjects during non-treatment (the first 6 months after enrollment) period who belonged to control group.|A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)|A Randomized, Open-label, Two-arm Parallel Group, No Treatment Group-controlled, Multicenter Phase III Study to Evaluate the Safety and Efficacy of Saizen® 0.067 mg/kg/Day Subcutaneous Injection in Children With Idiopathic Short Stature|Completed||Phase 3|90|Actual|Merck KGaA||2|||f||||||||||||||2017-10-11 02:12:19.307836|2017-10-11 02:12:19.307836
NCT01746849|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-05-18|||December 2012||2012-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation|A Phase II Study of Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|120|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:12:20.13265|2017-10-11 02:12:20.13265
NCT01746836|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-07-07|||January 2013|Actual|2013-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Ponatinib as Second Line Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib, Dasatinib or Nilotinib|Ponatinib as Second Line Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib, Dasatinib or Nilotinib|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:12:20.303273|2017-10-11 02:12:20.303273
NCT01746823|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2014-03-05|||April 2013||2013-04-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01|6 Months|Observational [Patient Registry]|||Identification and Validation of Functional Biomarkers for Keratoconus|Identification of Disease Progression Specific Biomarkers and Their Pharmacologic Modulation for Keratoconus.|Unknown status|Recruiting|N/A|200|Anticipated|Narayana Nethralaya|||1||f||||f||||||Samples Without DNA|"     Tear samples and discarded epithelium from Keratoplasty surgeries.   "|||2017-10-11 02:12:20.42841|2017-10-11 02:12:20.42841
NCT01746810|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-09-15|||July 2012|Actual|2012-07-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|October 2015|Actual|2015-10-01||Interventional|||IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors|IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Lung Tumors Larger Than 3 cm: Phase I Dose Escalation and Pilot Study With Companion Biomarker Analysis|Terminated||Phase 1|1|Actual|New Mexico Cancer Care Alliance||1||Closed study as requested by PI due to lack of accruals|f||||t||||||||||2017-10-11 02:12:20.546166|2017-10-11 02:12:20.546166
NCT01746797|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-06-08|||October 2012||2012-10-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|June 2016|Actual|2016-06-01||Observational|START||Symptom Tracking in Assisted Reproductive Technologies|Symptom Tracking in Women With a History of Depression Going Through Infertility Treatment.|Active, not recruiting||N/A|60|Anticipated|Massachusetts General Hospital|||2||f||||||||||Samples With DNA|"     samples obtained with permission from participant and stored for future proteomic research   "|||2017-10-11 02:12:20.664301|2017-10-11 02:12:20.664301
NCT01746784|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-11-21|2014-11-17||February 2014||2014-02-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|SNO-1||Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of N6022 to Evaluate Safety and Pharmacokinetics in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation (SNO1)|Completed||Phase 1|66|Actual|Nivalis Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 02:12:20.78289|2017-10-11 02:12:20.78289
NCT01746771|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-03-01|||November 2012||2012-11-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer|A Phase I-II Study to Assess the Safety, Efficacy and Pharmacokinetic Profile of HM781-36B Combined With Paclitaxel and Trastuzumab in Patients With HER-2 Positive Advanced Gastric Cancer|Completed||Phase 1/Phase 2|44|Actual|Hanmi Pharmaceutical Company Limited||1|||f||||f||||||||||2017-10-11 02:12:21.915751|2017-10-11 02:12:21.915751
NCT01746758|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-07|||August 2012||2012-08-01|May 2012|2012-05-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|SMS4Health||Mobile Phone Text Messaging Referral|Establishing a Community Referral System to Improve Uptake of Adolescent Sexual Reproductive Health Services in Mwanza, Tanzania|Unknown status|Recruiting|N/A|700|Anticipated|Liverpool School of Tropical Medicine||2|||f||||t||||||||||2017-10-11 02:12:22.011732|2017-10-11 02:12:22.011732
NCT01746745|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-03-14|||January 2013||2013-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of LY2940680 in Healthy Participants|Disposition of [14C]-LY2940680 Following Oral Administration in Healthy Subjects|Completed||Phase 1|8|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:12:22.11752|2017-10-11 02:12:22.11752
NCT01746732|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2013-06-18|||December 2012||2012-12-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of Evacetrapib in Healthy Female Participants|Effects of Evacetrapib (LY2484595) on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Subjects|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:12:22.19591|2017-10-11 02:12:22.19591
NCT01746719|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-07|||October 2012||2012-10-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition|An Open Label, Balanced, Randomized, Single-dose, Two-treatment, Two-sequence, Two-period, Crossover, Oral Bioequivalence Study of Etodolac Capsules USP 300 mg of Ipca Laboratories Limited, India and Etodolac Capsules USP 300mg of Taro Pharmaceutical Industries Ltd., USA in Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|36|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:12:22.285165|2017-10-11 02:12:22.285165
NCT01746706|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-04-13|||October 2011||2011-10-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|November 2015|Actual|2015-11-01||Interventional|||Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).|Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease?|Active, not recruiting||N/A|80|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 02:12:22.366929|2017-10-11 02:12:22.366929
NCT01746693|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-11-29|||February 2014||2014-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neurovascular Coupling in Subjects With Amblyopia|Neurovascular Coupling in Subjects With Amblyopia|Recruiting||N/A|60|Anticipated|Medical University of Vienna||3|||f||||t||||||||||2017-10-11 02:12:22.496113|2017-10-11 02:12:22.496113
NCT00000196|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-06-02|||January 1993||1993-01-01|September 2013|2013-09-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 5 - 5|Neurobiology of Opioid Dependence: 5|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-10-11 04:17:38.256461|2017-10-11 04:17:38.256461
NCT01746680|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-08-09|||August 2012||2012-08-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|TIARA||Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis|Phase IV STudy of Tacrobell in Active Rheumatoid Arthritis|Completed||Phase 4|111|Actual|Chong Kun Dang Pharmaceutical||1|||f||||t||||||||||2017-10-11 02:12:22.614715|2017-10-11 02:12:22.614715
NCT01746667|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-02-28|||February 2012||2012-02-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Virtual Reality Exposure Therapy Versus Exposure in Vivo for Social Phobia||Completed||N/A|70|Anticipated|VU University of Amsterdam||3|||f||||f||||||||||2017-10-11 02:12:22.706398|2017-10-11 02:12:22.706398
NCT01746654|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-03-04|||December 2012||2012-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients|A Randomized Double-Blind Placebo-Controlled Study to Determine Safety of P128 Applied to Nares of Healthy Volunteers and Safety And Efficacy of Any Patient Including Chronic Kidney Disease Patients Who Are Nasal Carriers of S.Aureus.|Completed||Phase 1/Phase 2|74|Actual|GangaGen, Inc.||4|||f||||t||||||||||2017-10-11 02:12:22.816555|2017-10-11 02:12:22.816555
NCT01746641|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-12-08|||January 2010||2010-01-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Remifentanil Versus Propofol for TCI Sedation of Patients Undergoing Gastrointestinal Endoscopic Procedures|Remifentanil Versus Propofol With Target Controlled Infusion Effect Site for the Sedation of Patients During Gastrointestinal Endoscopic Procedures: Randomized Controlled Trial|Terminated||Phase 4|69|Actual|Fundación Universitaria de Ciencias de la Salud||2||Occurrence of severe respiratory depression in the remifentanil group.|f||||t||||||||||2017-10-11 02:12:22.931357|2017-10-11 02:12:22.931357
NCT01746628|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-01-20|||December 2012||2012-12-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Intrauterine Use of FloSeal: Is it Safe and Useful?|Intrauterine Use of FloSeal: Is it Safe and Useful?|Completed||N/A|14|Actual|David L Zisow MD LLC||2|||f||||f||||||||||2017-10-11 02:12:23.029462|2017-10-11 02:12:23.029462
NCT01746615|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-12-01|||January 2015||2015-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects|Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects|Recruiting||N/A|60|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:12:23.112281|2017-10-11 02:12:23.112281
NCT01746602|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2016-12-01|||July 2011||2011-07-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy Subjects|Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy Subjects|Terminated||Phase 3|38|Actual|Medical University of Vienna||6|||f||||t||||||||||2017-10-11 02:12:23.217302|2017-10-11 02:12:23.217302
NCT01746576|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-04-15|||September 2012||2012-09-01|December 2012|2012-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Use of Near Infrared Spectroscopy to Measure Intracranial ScvO2||Completed||N/A|20|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-11 02:12:23.390341|2017-10-11 02:12:23.390341
NCT01746563|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-07|||May 2011||2011-05-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy|Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Treatment-Naive Proliferative Diabetic Retinopathy|Completed||Phase 1/Phase 2|30|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:12:25.787554|2017-10-11 02:12:25.787554
NCT01746550|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-03-22|||December 2012||2012-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Reliable||A Safety and Effectiveness Study of the MD-12-001 Stent in the Treatment of Superficial Femoral Artery or Popliteal Artery Blockages in Japanese Patients|A Single Arm Clinical Trial in Japan for Reconstruction of Obstructive Lesions of the Superficial Femoral Artery or Proximal Popliteal Artery by Bard LifeStent.|Active, not recruiting||N/A|70|Anticipated|C. R. Bard||1|||f||||f||||||||||2017-10-11 02:12:25.998576|2017-10-11 02:12:25.998576
NCT01746537|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2017-01-10|||June 2012||2012-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|ATAC||Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography|Automated Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography|Recruiting||N/A|1500|Anticipated|The Cleveland Clinic|||1||f||||f||||||||||2017-10-11 02:12:26.113407|2017-10-11 02:12:26.113407
NCT01746524|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-04-24|||November 1, 2012|Actual|2012-11-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|September 29, 2017|Anticipated|2017-09-29||Interventional|10004||Prospective, Multiconfiguration Study to Assess Functional Performance of Primary Total Knee Arthroplasty System|Prospective, Single Arm Multiconfiguration Investigation to Assess Functional Performance of Attune™ Primary Total Knee Arthroplasty System|Active, not recruiting||N/A|1138|Actual|DePuy Orthopaedics||1|||f||||f||||||||||2017-10-11 02:12:26.197264|2017-10-11 02:12:26.197264
NCT01746511|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-11-04|2015-09-16||July 2012||2012-07-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Demographic data, including age at start of phototherapy, was incomplete, missing for one infant in each study group.|Glycerin Suppositories to Reduce Jaundice in Premature Infants|The Use of Glycerin Suppositories to Reduce Hyperbilirubinemia in Premature Infants Requiring Phototherapy|Completed||N/A|79|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 02:12:26.349327|2017-10-11 02:12:26.349327
NCT01746498|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-12-14|||June 2011||2011-06-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients||Completed||N/A|33|Actual|Assiut University||3|||f||||f||||||||||2017-10-11 02:12:26.896833|2017-10-11 02:12:26.896833
NCT00000241|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||February 1994||1994-02-01|October 2016|2016-10-01|May 1996||1996-05-01|||||Interventional|||Flupenthixol Decanoate in Methamphetamine Smoking - 1|Flupenthixol Decanoate in Methamphetamine Smoking|Completed||Phase 2|58||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:18:25.910316|2017-10-11 04:18:25.910316
NCT01746485|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-12-10|||July 2012||2012-07-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Three Times Daily Dosing of UT-15C|A PK Evaluation of Three Times Daily Dosing of UT-15C SR Tablets in Healthy Subjects|Completed||Phase 1|19|Actual|United Therapeutics||1|||f||||f||||||||||2017-10-11 02:12:27.126412|2017-10-11 02:12:27.126412
NCT01746472|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-03-14|||December 2012||2012-12-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|||Study of the Diffusion of a Smoking Cessation Application Through an Online Network|Online Social Networks for Dissemination of Smoking Cessation Interventions|Completed||N/A|11413|Actual|Truth Initiative||12|||f||||t||||||||||2017-10-11 02:12:27.229447|2017-10-11 02:12:27.229447
NCT01746459|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-08-04|||February 2013||2013-02-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|START||Sustaining Transfers Through Affordable Research Translation (START)|Sustaining Transfers Through Affordable Research Translation (START): Knowledge Translation Interventions to Support the Uptake of Innovations in Continuing Care Settings|Completed||N/A|1158|Actual|University of Alberta||4|||f||||t||||||||||2017-10-11 02:12:27.383772|2017-10-11 02:12:27.383772
NCT01746433|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2015-03-25|||November 2013||2013-11-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|L'ERGONOME||"Mobility of Elderly Patients When Using the l'Ergonome Mobility Device"|"Evaluation of the Mobility of Elderly Patients (> 65 Years) When Using the l'Ergonome Mobility Device: a Randomized, Monocentric Study"|Completed||N/A|37|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 02:12:27.619906|2017-10-11 02:12:27.619906
NCT01746420|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2012-12-10|||December 2012||2012-12-01|December 2012|2012-12-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis|A Phase II Randomized, Single Ascending Dose, Double-blinded, Placebo Controlled, Multi-center Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis|Unknown status|Recruiting|Phase 2|100|Anticipated|BioMimetic Therapeutics||5|||f||||t||||||||||2017-10-11 02:12:27.73278|2017-10-11 02:12:27.73278
NCT01746407|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-07|2015-12-28|||December 2012||2012-12-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|EMOS||Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis|Observational Study to Procure Human Specimens for Use in the Diagnosis and Management of Sepsis and Other Related Conditions|Completed||N/A|872|Actual|Abbott Diagnostics Division|||1||f||||f||||||Samples Without DNA|"     Plasma and serum samples stored @ -70C.   "|||2017-10-11 02:12:27.858167|2017-10-11 02:12:27.858167
NCT01746394|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-10-24|||January 2013||2013-01-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Delta Healthy Sprouts: Intervention to Promote Maternal Weight Control and Reduce Childhood Obesity in the MS Delta|Delta Healthy Sprouts: A Randomized Trial to Determine the Comparative Efficacy of Two Maternal, Infant, and Early Childhood Home Visiting Programs on Maternal Weight Control and Childhood Obesity in the Mississippi Delta|Completed||N/A|82|Actual|USDA, Delta Human Nutrition Research Program||2|||f||||f||||||||||2017-10-11 02:12:27.921724|2017-10-11 02:12:27.921724
NCT01746381|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-01-12|||February 2014||2014-02-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode|Initiation of Long-term Home Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode During a Daytime Trial|Recruiting||N/A|30|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 02:12:28.019592|2017-10-11 02:12:28.019592
NCT01746368|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-05-26|2015-03-26||April 2013||2013-04-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|EADCRAV|The number of participants for analysis was 50 - the full sample size.|Enabling Advance Directive Completion|Enabling Advance Directive Completion by Rural Alabama Veterans: A Pilot Study|Completed||N/A|50|Actual|VA Office of Research and Development|The local Institutional Review Board directed that the advance directive completion and satisfaction data for one participant randomized to the Nurse-Supported Advance Care Planning Intervention be excluded from analysis.|2|||f||||t||||||||||2017-10-11 02:12:28.149386|2017-10-11 02:12:28.149386
NCT01746355|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-04-24|||March 2011||2011-03-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|December 2012|Actual|2012-12-01||Interventional|EMTr-AFP||Assessment and Treatment Patients With Atypical Facial Pain Trough Repetitive Transcranial Magnetic Stimulation|Assessment and Treatment Patients With Atypical Facial Pain Trough Repetitive Transcranial Magnetic Stimulation|Completed||N/A|40|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:12:28.604465|2017-10-11 02:12:28.604465
NCT01746342|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-09-18|||February 2013||2013-02-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|SAMSPAP||Sleep Apnea in Multiple Sclerosis Positive Airway Pressure Trial|A Randomized, Controlled, Clinical Trial of Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea-Hypopnea in Multiple Sclerosis|Recruiting||N/A|65|Anticipated|McGill University||2|||f||||f||||||||||2017-10-11 02:12:28.677165|2017-10-11 02:12:28.677165
NCT01746329|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-08-02|||December 2012||2012-12-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Tea-beetroot-venous Occlusion Plethysmography|Exploratory Study on the Effect of Nutritional Intervention on Postprandial Skeletal Muscle Microcirculation in Obese Subjects|Completed||N/A|18|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-11 02:12:28.772209|2017-10-11 02:12:28.772209
NCT01746303|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-05-25|||January 2010||2010-01-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline|Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline|Completed||N/A|94|Actual|University of Cincinnati||4|||f||||t||||||||||2017-10-11 02:12:28.85832|2017-10-11 02:12:28.85832
NCT01746290|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-11-24|||January 2013||2013-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||The PulsePoint Randomized Controlled Trial|The PulsePoint Smartphone Application: Recruiting Bystanders to Provide Basic Life Support for Victims of Out-of-Hospital Cardiac Arrest|Withdrawn||N/A|0|Actual|Queen's University||2||The intervention (PulsePoint application) could not be implemented in Toronto as planned|f||||f||||||||||2017-10-11 02:12:28.9715|2017-10-11 02:12:28.9715
NCT01746277|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-07|||October 2012||2012-10-01|December 2012|2012-12-01|June 2016|Anticipated|2016-06-01|October 2015|Anticipated|2015-10-01||Interventional|||Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy|A Phase Ⅱ Randomized Controlled Trial to Compare Chemotherapy Sequenced by EGFR-TKIs and Chemotherapy Combined With EGFR-TKIs for Advanced or Metastatic NSCLC Patients Failed to EGFR-TKIs Therapy|Unknown status|Recruiting|Phase 2|60|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 02:12:29.053853|2017-10-11 02:12:29.053853
NCT01746264|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-03-30|2016-01-25||November 2012||2012-11-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents|Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents|Completed||Phase 1|19|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:12:29.32106|2017-10-11 02:12:29.32106
NCT01746251|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-09-19|||January 2013||2013-01-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation|Randomized Phase II Study Comparing Concise Versus Prolonged Afatinib as Adjuvant Therapy for Patients With Resected Stage I-III NSCLC With EGFR Mutation|Active, not recruiting||Phase 2|92|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:12:29.858943|2017-10-11 02:12:29.858943
NCT01746238|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-08-24|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|May 2016|Actual|2016-05-01||Interventional|||Bevacizumab/Doxorubicin/Radiation for Sarcoma|Phase I Trial of Bevacizumab, Metronomic Doxorubicin and Radiation Therapy for Resectable Soft Tissue Sarcoma|Active, not recruiting||Phase 1|14|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:12:29.97077|2017-10-11 02:12:29.97077
NCT01746225|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-05-29|||April 2013||2013-04-01|May 2017|2017-05-01|April 2023|Anticipated|2023-04-01|May 2016|Actual|2016-05-01||Interventional|SNAP||Schedules of Nab-Paclitaxel in Metastatic Breast Cancer|A Randomized Phase II Study Evaluating Different Schedules of Nab-Paclitaxel in Metastatic Breast Cancer (SNAP Trial)|Active, not recruiting||Phase 2|258|Actual|International Breast Cancer Study Group||3|||f||||t||||||||||2017-10-11 02:12:30.111773|2017-10-11 02:12:30.111773
NCT01746212|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-06|||December 2012||2012-12-01|December 2012|2012-12-01|May 2015|Anticipated|2015-05-01|March 2015|Anticipated|2015-03-01||Observational|InQu||Outcomes of Degenerative Disc Disease Patients Treated With an Anterior-Only Fusion Using InQu Bone Graft|Outcomes of Patients With Lumbar Degenerative Disc Disease Treated Operatively With an Anterior-Only Approach Using InQu Bone Graft Extender and Substitute|Unknown status|Recruiting|N/A|60|Anticipated|Kansas Joint and Spine Institute|||1||f||||f||||||||||2017-10-11 02:12:30.329053|2017-10-11 02:12:30.329053
NCT01746199|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-11-14|||December 2013||2013-12-01|December 2012|2012-12-01||||October 2015|Anticipated|2015-10-01||Interventional|MACOMBA||Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum|Comparative Study of Efficacy of Two Antifolates Prophylactic Strategies Against Malaria in HIV Positive Pregnant Women (MACOMBA Study)|Unknown status|Not yet recruiting|Phase 3|300|Anticipated|Institut Pasteur||2|||f||||t||||||||||2017-10-11 02:12:30.480293|2017-10-11 02:12:30.480293
NCT01746186|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-05-10|||October 2010||2010-10-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||The Energy Balance Study||Completed||N/A|400|Actual|University of South Carolina|||1||f||||||||||||||2017-10-11 02:12:30.594606|2017-10-11 02:12:30.594606
NCT01746173|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-01-11|2016-10-04||February 2013||2013-02-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||The analysis dataset is comprised of all enrolled patients.|CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma|A Phase II Study of CHOEP Induction Followed by Gemcitabine/Busulfan/Melphalan Autologous Stem Cell Transplantation for Patients With Newly Diagnosed T-Cell Lymphoma|Terminated||Phase 2|5|Actual|Dana-Farber Cancer Institute|The trial closed early due to poor accrual. The small sample size precludes definitive conclusions.|1||Slow accrual and futility|f||||t||||||||No||2017-10-11 02:12:30.69167|2017-10-11 02:12:30.69167
NCT01746160|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2013-09-09|||December 2012||2012-12-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Longitudinal Follow-up After C1 Implant Stabilization Values|A Short-term Longitudinal Follow-up After C1 Implant Stability Values.|Unknown status|Recruiting|N/A|10|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 02:12:31.053878|2017-10-11 02:12:31.053878
NCT01746147|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-12-12|||December 2012||2012-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Observational|ALLIVE||Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial|Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in MDS or AML Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial|Completed||N/A|134|Actual|GWT-TUD GmbH|||1||f||||f||||||||||2017-10-11 02:12:31.180951|2017-10-11 02:12:31.180951
NCT01746134|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-11-01|||December 2012||2012-12-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||The Management of Schizophrenia in Clinical Practice (MOSAIC)|A Prospective, Non-Interventional Registry of Diverse Patients With Schizophrenia Across the Disease Spectrum in Usual Care Settings: Course of Disease, Treatments, and Burden of Illness|Completed||N/A|557|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 02:12:31.294049|2017-10-11 02:12:31.294049
NCT01746121|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-02-04|||November 2009||2009-11-01|February 2013|2013-02-01||||March 2013|Anticipated|2013-03-01||Observational|||Amelogenesis Imperfecta|Clinical and Molecular Study of Amelogenesis Imperfecta|Unknown status|Recruiting|N/A|600|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||Samples With DNA|"     saliva   "|||2017-10-11 02:12:31.476435|2017-10-11 02:12:31.476435
NCT01746108|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-02-10|2016-11-08|2015-10-08|June 2013||2013-06-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection|Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection|Completed||Phase 3|52|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-10-11 02:12:31.64919|2017-10-11 02:12:31.64919
NCT01746095|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-12-05|||March 2013||2013-03-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients|A Phase 2, Randomized, Double Blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients|Completed||Phase 2|87|Actual|Savara Inc.||2|||f||||t||||||||||2017-10-11 02:12:33.103045|2017-10-11 02:12:33.103045
NCT01746082|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-01-27||2014-01-27|January 2013||2013-01-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations|A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine|Completed||Phase 2|211|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 02:12:33.289699|2017-10-11 02:12:33.289699
NCT01746056|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-08-04|||December 2012||2012-12-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Comparative Study of Occlusive Heat Patch in the Treatment of Warts|A Comparative Study of Occlusive Heat Patch Vs. No Treatment in the Treatment of Verruca|Active, not recruiting||N/A|20|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 02:12:33.486438|2017-10-11 02:12:33.486438
NCT01746043|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-01-17|||February 2013||2013-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer|A Randomized Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer|Completed||Phase 2|22|Actual|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-10-11 02:12:33.578335|2017-10-11 02:12:33.578335
NCT01746030|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-11-19|||September 2012||2012-09-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Observational|||Geriatric Assessments in Senior Adults With Multiple Myeloma|Pilot Study of Geriatric Assessments in Senior Adults With Multiple Myeloma|Completed||N/A|42|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 02:12:33.704859|2017-10-11 02:12:33.704859
NCT01746004|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2013-02-14|||January 2013||2013-01-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study of LY2157299 Monohydrate in Healthy Volunteers|Disposition of [14C]-LY2157299 Monohydrate Following Oral Administration in Healthy Subjects|Completed||Phase 1|8|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:12:33.898318|2017-10-11 02:12:33.898318
NCT01745991|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-09-13|||December 2012||2012-12-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01|5 Years|Observational [Patient Registry]|CoSRCT||Trail to Investigate the Effectiveness of CoSeal in Reducing Adhesions Following the Kasai Hepatoportoenterostomy for Biliary Atresia|Randomised Control Trial to Investigate the Effectiveness of CoSeal® Surgical Sealant in Reducing Intra-abdominal Adhesions Following the Kasai Hepatoportoenterostomy for Biliary Atresia.|Recruiting||N/A|126|Anticipated|The Leeds Teaching Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 02:12:33.998522|2017-10-11 02:12:33.998522
NCT01745978|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-07|||December 2012||2012-12-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Compare the Knob-tipped Knife With the Needle Knife in Difficult Biliary Cannulation|The Efficacy and Safety of Precut Papillotomy Using the Knob-tipped Knife and Needle Knife in Difficult Biliary Cannulation: a Randomized-controlled Trial.|Unknown status|Recruiting|Phase 3|50|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-10-11 02:12:34.097169|2017-10-11 02:12:34.097169
NCT01745965|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-06-18|||November 2012||2012-11-01|June 2015|2015-06-01|October 2020|Anticipated|2020-10-01|February 2015|Actual|2015-02-01||Interventional|ADAPT; T-DM1||A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.|A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.|Active, not recruiting||Phase 2|380|Anticipated|West German Study Group||3|||f||||t||||||||||2017-10-11 02:12:34.742732|2017-10-11 02:12:34.742732
NCT01745952|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-03-23|2015-12-15||November 2012||2012-11-01|January 2015|2015-01-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)|Multimodal Image-guided Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Refractory Partial Epilepsy.|Completed||N/A|11|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||No||2017-10-11 02:12:34.880391|2017-10-11 02:12:34.880391
NCT01745939|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-11-03|||November 2012||2012-11-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Manipulation Effects on Abdominal Muscles|The Immmediate Effects of Thrust Joint Manipulation on the Resting and Contraction Thickness of Transversus Abdominis in Subjects With Low Back Pain|Completed||N/A|12|Actual|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-11 02:12:35.420063|2017-10-11 02:12:35.420063
NCT01745926|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2012-12-10|||April 2013||2013-04-01|December 2012|2012-12-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01|6 Months|Observational [Patient Registry]|||Implementation of LUCAS 2 in Helicopter Rescue in South Tyrol|Implementation of LUCAS 2 in Helicopter Rescue in South Tyrol|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Institute of Mountain Emergency Medicine|||1||f||||t||||||||||2017-10-11 02:12:35.521039|2017-10-11 02:12:35.521039
NCT01745913|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-08-03|2017-03-02||October 26, 2012|Actual|2012-10-26|August 2017|2017-08-01|April 29, 2015|Actual|2015-04-29|April 29, 2015|Actual|2015-04-29||Interventional|||Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies|A Randomized Study of Combined Haplo-identical Umbilical Cord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies|Terminated||Phase 2|2|Actual|Weill Medical College of Cornell University||2||Slow accrual|f||||t||||||||||2017-10-11 02:12:35.769424|2017-10-11 02:12:35.769424
NCT01745900|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-06|||December 2012||2012-12-01|December 2012|2012-12-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||Evaluation and Comparison of Noninvasive Blood Glucose Concentrations|An Evaluation and Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References|Unknown status|Recruiting|N/A|125|Anticipated|VeraLight, Inc.|||1||f||||f||||||||||2017-10-11 02:12:36.229435|2017-10-11 02:12:36.229435
NCT01745887|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-08-13|||November 2012||2012-11-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|EBI||A Multi-Center Study Subjects With Dry Eye Syndrome|A Multi-Center, Double Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of EBI-005 Ophthalmic Solution Versus Placebo in Subjects With Dry Eye Syndrome|Completed||Phase 1|74|Actual|Eleven Biotherapeutics||3|||f||||f||||||||||2017-10-11 02:12:36.33353|2017-10-11 02:12:36.33353
NCT01745874|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2012-12-07|||October 2012||2012-10-01|December 2012|2012-12-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Observational|||Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative Staging|Diagnostic Value of Whole-Body MRI Compared to FDG-PET-CT for Rectal Cancer Preoperative Staging, Before and After Neoadjuvant Treatment|Unknown status|Recruiting|N/A|20|Anticipated|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 02:12:36.429768|2017-10-11 02:12:36.429768
NCT01745861|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2012-12-07|||June 2010||2010-06-01|December 2012|2012-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Effects Of Fish Oil Emulsion On Severe Acute Pancreatitis Patients|Randomised Controlled Trial On The Effects Of Parenteral Fish Oil Emulsion In Patients With Severe Acute Pancreatitis|Completed||Phase 2|44|Actual|University Hospitals, Leicester||2|||f||||f||||||||||2017-10-11 02:12:36.510563|2017-10-11 02:12:36.510563
NCT01745848|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-07-27|2017-06-05||February 2013||2013-02-01|July 2017|2017-07-01|June 30, 2016|Actual|2016-06-30|June 2016|Actual|2016-06-01||Interventional|||Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD|Effect of Roflumilast on Systemic Markers of Bone Metabolism and Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|26|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 02:12:36.619887|2017-10-11 02:12:36.619887
NCT01745835|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-05-03|||January 2013||2013-01-01|May 2013|2013-05-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation|Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation for Colonoscopy|Unknown status|Recruiting|Phase 3|196|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:12:37.521872|2017-10-11 02:12:37.521872
NCT01745822|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-08-16|||January 2013||2013-01-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|December 2016|Actual|2016-12-01||Interventional|iTAP||Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand|Phase 3, Randomized Clinical Trial to Assess the Efficacy and Safety of Tenofovir in Hepatitis B Virus Infected, s and e Antigen Positive, Pregnant Women to Prevent Perinatal Transmission Despite Infant Passive-active HBV Immunization.|Active, not recruiting||Phase 3|328|Anticipated|Institut de Recherche pour le Developpement||2|||f||||t||||||||||2017-10-11 02:12:37.626011|2017-10-11 02:12:37.626011
NCT01745809|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2015-05-28|||January 2013||2013-01-01|October 2011|2011-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Bronchoscopy Study for Severe Asthma|An Exploratory Study to Obtain Functional and Transcriptional/Translational Profiling of Cells From Bronchial Lavages and Brushings in Severe Asthmatics and Healthy Control Subjects|Withdrawn||N/A|0|Actual|University of Pennsylvania|||2|Contractual issues|f||||t||||||||||2017-10-11 02:12:37.794826|2017-10-11 02:12:37.794826
NCT01745796|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-12-01|||January 2013||2013-01-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|PYO GEN||Impact of the Contamination Mode on the Clinical Evolution During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia (PYO GEN)|Impact of the Contamination Mode on the Clinical Evolution During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia|Recruiting||N/A|180|Anticipated|University Hospital, Grenoble|||1||f||||f||||||Samples Without DNA|"     In order to achieve an antibiogram according to conventional methods and PCR genotyping Rep     (DiversiLab ®) to assess the clonality of bacterial populations, there will be taken 5     different isolated colonies (possibly diluted)from each clinical sample of bronchial     secretion, selected according to morphological criteria or randomly if no visible differences     are noted.   "|||2017-10-11 02:12:37.899385|2017-10-11 02:12:37.899385
NCT01745783|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-09-20|||January 2013||2013-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis|Clinical Trial Phase I / II Multicenter, Randomized, Crossover, Double-blind Evaluation of the Safety and Feasibility of Systemic Therapy With Mesenchymal Cells Derived From Autologous Bone Marrow in Patients With Multiple Sclerosis|Recruiting||Phase 1/Phase 2|30|Anticipated|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||t||||||||||2017-10-11 02:12:37.989133|2017-10-11 02:12:37.989133
NCT01745770|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-05-30|||January 2013||2013-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)|Double-blind, Double-dummy, Randomised, Multi-centre, Comparative Phase III Clinical Study on the Efficacy and Tolerability of an 8 Week Oral Treatment With Three Times Daily 1000 mg Mesalazine Versus Three Times Daily 2x500 mg Mesalazine in Patients With Active Ulcerative Colitis|Completed||Phase 3|306|Actual|Dr. Falk Pharma GmbH||2|||f||||t||||||||||2017-10-11 02:12:38.12758|2017-10-11 02:12:38.12758
NCT01745406|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-08-06|||January 2013||2013-01-01|April 2013|2013-04-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Observational|NEWS||Benefits of the Involvement of Nurses in Meetings Between Physicians and the Families of Patients in the ICU.|Benefits of the Involvement of Nurses in Meetings Between Physicians and the Families of Patients in the ICU.|Completed||N/A|100|Actual|Groupe Hospitalier Paris Saint Joseph|||2||f||||t||||||||||2017-10-11 02:12:41.909404|2017-10-11 02:12:41.909404
NCT01745757|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-08-05|||June 2012||2012-06-01|August 2014|2014-08-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|COMET||Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer|Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab (AVASTIN ®) in Combination With Weekly Paclitaxel Chemotherapy in First Line Treatment Patients With Metastatic Breast Cancer|Unknown status|Recruiting|N/A|510|Anticipated|UNICANCER|||1||f||||f||||||||||2017-10-11 02:12:38.244383|2017-10-11 02:12:38.244383
NCT01745744|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-09-19|||February 2011||2011-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2013|Actual|2013-07-01||Interventional|||Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.|Clinical Trial Phase I / II, Multicentre, Open, Randomized Study of the Use of Mesenchymal Stem Cells From Adipose Tissue (CeTMAd) as Cell Regeneration Therapy in Critical Chronic Ischemic Syndrome of Lower Limb in Nondiabetic Patients.|Active, not recruiting||Phase 2|33|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||3|||f||||t||||||||||2017-10-11 02:12:38.460453|2017-10-11 02:12:38.460453
NCT01745731|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-12-11|||March 2011||2011-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration|Clinical Trial Phase II Multicenter Open Randomized Trial of the Therapeutic Use of Cells Intraportal Infusion of Autologous Bone Marrow Mononuclear as Enhancing Liver Regeneration Prior to Performing Extended Hepatic Resection.|Completed||Phase 2|13|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||2|||f||||t||||||||||2017-10-11 02:12:38.589434|2017-10-11 02:12:38.589434
NCT01745718|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-09-22|||October 2012||2012-10-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer|Targeted Biopsies and the Role of Cytological Imprints for Diagnosis of Prostate Cancer|Withdrawn||N/A|0|Actual|Oslo University Hospital||1||The study was stopped for technical reasons|f||||f||||||||||2017-10-11 02:12:38.697694|2017-10-11 02:12:38.697694
NCT01745705|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2013-06-17|||April 2011||2011-04-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Cervical Spine Manipulation Affects on Balance and Proprioception|Immediate Effects of Cervical Spine Manipulation on Balance and Joint Proprioception in Healthy Individuals|Completed||N/A|45|Actual|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-11 02:12:38.825638|2017-10-11 02:12:38.825638
NCT01745692|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-10-23|||December 2012||2012-12-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|PISTE||Pragmatic Ischaemic Stroke Thrombectomy Evaluation|A Randomised Controlled Clinical Trial of Adjunctive Mechanical Thrombectomy Compared With Intravenous Thrombolysis in Patients With Acute Ischaemic Stroke Due to an Occluded Major Intracranial Vessel.|Terminated||N/A|65|Actual|NHS Greater Glasgow and Clyde||2||"IDMC decision - recommended on basis of results from other relevant clinical trials, there were   not safety concerns"|f||||t||||||||||2017-10-11 02:12:38.971884|2017-10-11 02:12:38.971884
NCT01745679|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-10-04|||December 2012||2012-12-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pharmacological Study of High Doses of Ceftriaxone in Meningitidis|Therapeutic Monitoring of Ceftriaxone, Prescribed at High Doses, in the Treatment of Meningitis and Others Neurological Infections.|Completed||Phase 4|198|Actual|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 02:12:39.117294|2017-10-11 02:12:39.117294
NCT01745666|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-10-04|||May 2012||2012-05-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|QT long||Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients|Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients With KCNQ1 or KCNH2 Mutation Without Long QT Interval in Rest ECG|Recruiting||N/A|130|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 02:12:39.246511|2017-10-11 02:12:39.246511
NCT01745653|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-02-04|||April 2011||2011-04-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Ortholaser||Effect of Low Level Laser Therapy on Pain Occurring After Insertion of an Orthodontic Device|"Monocentric, Randomized, Single Blinded Study Designed to Evaluate the Effect of Low Level Laser Therapy on Pain Occurring After Insertion of an Orthodontic Device : the Quadhelix"|Completed||N/A|69|Actual|Nantes University Hospital||3|||f||||f||||||||||2017-10-11 02:12:39.426201|2017-10-11 02:12:39.426201
NCT01745640|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-12-03|||January 2012||2012-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IFM2010-02||Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)|A Multicenter Open Label Phase II Study of Pomalidomide and Dexamethasone in Progressive Relapsed or Refractory Multiple Myeloma Patients With Deletion 17p or Translocation (4;14) Adverse Karyotypic Abnormalities-IFM2010-02|Completed||Phase 2|63|Actual|University Hospital, Lille||1|||f||||t||||||||||2017-10-11 02:12:39.542247|2017-10-11 02:12:39.542247
NCT01745627|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-02-07|||October 2011||2011-10-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||755nm Alex Laser for Treatment of Pigmented and Vascular Lesions and Scars||Completed||N/A|43|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 02:12:39.711094|2017-10-11 02:12:39.711094
NCT01745614|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-06-09|||July 18, 2010|Actual|2010-07-18|June 2017|2017-06-01|July 26, 2010|Actual|2010-07-26|July 26, 2010|Actual|2010-07-26||Interventional|||Bioequivalence Study of Nimesulide 100 mg Tablets|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparations Containing Nimesulide 100 mg(Eskaflam®, GlaxoSmithKline México, S.A. de C.V. vs. Mesulid®, Producto de Roche, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:12:39.786609|2017-10-11 02:12:39.786609
NCT01745601|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-06-14|||May 4, 2010|Actual|2010-05-04|June 2017|2017-06-01|May 19, 2010|Actual|2010-05-19|May 19, 2010|Actual|2010-05-19||Interventional|||Bioequivalence Study of Escitalopram Tablets 10 mg|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparations in Tablets Containing Escitalopram 10 mg (Product From GlaxoSmithKline México, S.A. de C.V. vs. Lexapro® 10mg, Lundbeck México, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:12:39.877643|2017-10-11 02:12:39.877643
NCT01745588|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-12-16|||December 2012||2012-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma|Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma: A Phase 2 Open-Label Randomized Study by Tristate Consortium|Active, not recruiting||Phase 2|23|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:12:39.992164|2017-10-11 02:12:39.992164
NCT01745575|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-06-19|||March 28, 2010|Actual|2010-03-28|June 2017|2017-06-01|April 5, 2010|Actual|2010-04-05|April 5, 2010|Actual|2010-04-05||Interventional|||Bioequivalence Trial of Alprazolam 2 mg Tablets|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Trial With Single Dosageof Two Oral Preparations Containing 2 mg of Alprazolam (Zamoprax GlaxoSmithKline México, S.A. de C.V. vs. Tafil 2.0 mg, Pharmacia &Upjohn, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:12:40.150574|2017-10-11 02:12:40.150574
NCT01745562|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-06-12|||December 7, 2010|Actual|2010-12-07|June 2017|2017-06-01|December 17, 2010|Actual|2010-12-17|December 17, 2010|Actual|2010-12-17||Interventional|||Bioequivalence Trial of Alprazolam 0.5 mg Tablets|Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparations of Alprazolam 0.5 mg Alprazolam (Zamoprax GlaxoSmithKline México, S.A. de C.V. vs. Tafil 0.5mg, Pharmacia &Upjohn, S.A. de C.V.) in Fasting Healthy Volunteers|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:12:40.247811|2017-10-11 02:12:40.247811
NCT01745549|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-03-17|||December 2012||2012-12-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|AGO01||Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm.|Efficacy, Safety and Satisfaction of the New Pen Needle 33G x 4 mm 33G x 4 mm: Cross-over Randomized Controlled Clinical Trial. Studio AGO 01|Completed||N/A|87|Actual|Consorzio Mario Negri Sud||2|||f||||f||||||||||2017-10-11 02:12:40.347604|2017-10-11 02:12:40.347604
NCT01745536|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2016-03-07|||November 2012||2012-11-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Closed Vitrification of Oocytes|"Impact of a Closed System in Donor Oocyte Vitrification"|Withdrawn||N/A|0|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||2||NO RECRUITMENT|f||||f||||||||||2017-10-11 02:12:40.462193|2017-10-11 02:12:40.462193
NCT01745523|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-03-09|||November 2012||2012-11-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||Use of a Synthetic Macromolecule (Hydroxypropyl Cellulose ) and Trehalose as Additives for Oocyte Vitrification|"Impact of Using Hydroxypropyl Cellulose (HPC) and Trehalose for Oocyte Vitrification in an Ovum Donation Program"|Completed||N/A|440|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-10-11 02:12:40.558498|2017-10-11 02:12:40.558498
NCT01745510|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2017-01-12|||October 2012||2012-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates|Efficacy of Enteral Administration of the Docosahexaenoic Acid on Necrotizing Enterocolitis, Cytokines and Hospital Stay in Preterm Neonates|Enrolling by invitation||Phase 2|306|Anticipated|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||Undecided||2017-10-11 02:12:40.655693|2017-10-11 02:12:40.655693
NCT01745497|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-06-29|||December 2012||2012-12-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder|Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder|Completed||Phase 2|24|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 02:12:40.988127|2017-10-11 02:12:40.988127
NCT01745484|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2015-07-06|||June 2012||2012-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation|Role of SPECT in Radiotherapy Treatment Planning and Toxicity Evaluation for the Patients With Stage I-III NSCLC: a Randomized Phase II Trial|Completed||N/A|71|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 02:12:41.148414|2017-10-11 02:12:41.148414
NCT01745458|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-06|||July 2005||2005-07-01|December 2012|2012-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||SB-659032 Platelet Aggregation Study|A Double Blind Study to Evaluate Effects of Repeat Doses of SB-659032 on Platelet Aggregation in Healthy Volunteers|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:12:41.428136|2017-10-11 02:12:41.428136
NCT01745445|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-05-15|||January 2012||2012-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|SCLC||Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC)|Phase ⅡClinical Trial of Randomized Concurrent Chemoradiotherapy or Radiotherapy Alone for Local-advanced Small Cell Lung Cancer After Induced Chemotherapy|Recruiting||Phase 2|30|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t||||||||Undecided||2017-10-11 02:12:41.545607|2017-10-11 02:12:41.545607
NCT01745432|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-07-03|||August 2012||2012-08-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|ADBEE||Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological Surgery|Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological Surgery|Completed||Phase 1|30|Anticipated|Terumo Europe N.V.||2|||f||||t||||||||||2017-10-11 02:12:41.661069|2017-10-11 02:12:41.661069
NCT01745419|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-07-27|||January 2013||2013-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|January 2015|Actual|2015-01-01||Observational|||Prevalence of Different Haptoglobin Phenotypes in Patients With COPD- Frequent Exacerbators Versus Non Exacerbators|Prevalence of Different Haptoglobin Phenotypes in Patients With COPD- Frequent Exacerbators Versus Non Exacerbators|Completed||N/A|105|Actual|Carmel Medical Center|||2||f||||f||||||Samples Without DNA|"     3 ml of Serum will be collected from each patient   "|||2017-10-11 02:12:41.799267|2017-10-11 02:12:41.799267
NCT01745393|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-08-29|||March 2012||2012-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|KiSS||Kids Safe and Smokefree (KiSS)|Pediatrician Advice, Family Counseling & SHS Reduction for Underserved Children|Completed||N/A|325|Anticipated|Temple University||2|||f||||t||||||||||2017-10-11 02:12:42.020413|2017-10-11 02:12:42.020413
NCT01745380|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-12-05|2016-09-28|2015-05-15|February 2013||2013-02-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults|A Phase 3, Multi-Center, Randomized, Double-Blind, Parallel-Groups Clinical Trial Comparing the Efficacy and Safety of Intranasally Administered Kovacaine Mist to Placebo for Anesthetizing Maxillary Teeth in Adults|Completed||Phase 3|150|Actual|St. Renatus, LLC||2|||f||||f||||||||Undecided||2017-10-11 02:12:42.189293|2017-10-11 02:12:42.189293
NCT01745354|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-11-17|||August 2012||2012-08-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)|Intratumoral Injection of an Immunostimulatory CpG, SD-101, Combined With Local Radiation for the Treatment of Recurrent or Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation|Terminated||Phase 1|6|Actual|Stanford University||1||Accrual issues - Slow accrual|f||||t||||||||||2017-10-11 02:12:43.547347|2017-10-11 02:12:43.547347
NCT01745341|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-12-02|||August 2012||2012-08-01|December 2015|2015-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Rates of Apnea in Patients Undergoing Vitreoretinal Surgery|Rates of Apnea in Patients Undergoing Vitreoretinal Surgery|Completed||N/A|113|Actual|Stanford University|||1||f||||||||||||||2017-10-11 02:12:43.64858|2017-10-11 02:12:43.64858
NCT01745328|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2012-12-07|||January 2009||2009-01-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Interventional|||Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine|Study on Treatment of Recurrent Urinary Tract Infection by Traditional Chinese Medicine|Unknown status|Recruiting|N/A|150|Anticipated|Beijing Institute of Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 02:12:43.733292|2017-10-11 02:12:43.733292
NCT01745315|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2013-01-29|||February 2013||2013-02-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Comparison of Perioperative Outcomes of Three Different Instruments in Total Laparoscopic Hysterectomy|Comparison of the Use of LigaSure, Halo PKS Cutting Forceps and Enseal Tissue Sealer in Total Laparoscopic Hysterectomy: a Randomised Trial.|Unknown status|Not yet recruiting|N/A|45|Anticipated|Adana Numune Training and Research Hospital||3|||f||||t||||||||||2017-10-11 02:12:43.926785|2017-10-11 02:12:43.926785
NCT01745302|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-07-12|||November 2011||2011-11-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma|Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma: a Randomized Double-blind Controlled Clinical Trial|Enrolling by invitation||N/A|470|Anticipated|Shanghai University of Traditional Chinese Medicine|||2||f||||t||||||||Undecided||2017-10-11 02:12:44.08441|2017-10-11 02:12:44.08441
NCT01745289|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-06-01|||October 2010||2010-10-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|LATTE||Long-term Anastrozole Versus Tamoxifen Treatment Effects|Long-term Anastrozole Versus Tamoxifen Treatment Effects (LATTE)|Completed||N/A|78|Actual|American Cancer Society, Inc.|||1||f||||f||||||||||2017-10-11 02:12:44.201574|2017-10-11 02:12:44.201574
NCT01745276|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-12-07|||April 2011||2011-04-01|May 2012|2012-05-01|February 2013|Anticipated|2013-02-01|November 2012|Actual|2012-11-01||Interventional|PFX||Evaluation of Bisphosphonate Coated Pins for Extern Fixation in Tibia Osteotomy|Evaluation of Bisphosphonate Coated Pins for Extern Fixation in Tibia Osteotomy|Unknown status|Active, not recruiting|Phase 3|30|Anticipated|Region Skane||1|||f||||t||||||||||2017-10-11 02:12:44.288587|2017-10-11 02:12:44.288587
NCT01745263|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-06-10|||December 2012||2012-12-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|DO-HEALTH||DO-HEALTH / Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial|Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial (Acronym: DO-HEALTH)|Active, not recruiting||Phase 3|2159|Actual|University of Zurich||8|||f||||t||||||||||2017-10-11 02:12:44.450758|2017-10-11 02:12:44.450758
NCT01745250|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-01-12|||December 2012||2012-12-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy of Lip Injections With Emervel Lips and Juvederm Ultra Smile|A Randomised, Evaluator-blinded, Comparative Study of the Safety and Efficacy of Lip Injections With Emervel Lips and Juvederm Ultra Smile|Completed||N/A|40|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-11 02:12:44.707982|2017-10-11 02:12:44.707982
NCT01745237|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-01-24|||September 2002|Actual|2002-09-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01|10 Years|Observational [Patient Registry]|||Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis|Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis|Recruiting||N/A|400|Anticipated|Duke University|||1||f||||f||||||||||2017-10-11 02:12:44.831024|2017-10-11 02:12:44.831024
NCT01745224|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-02-07|||July 2012||2012-07-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma||Completed||N/A|10|Actual|Cynosure, Inc.||2|||f||||f||||||||||2017-10-11 02:12:44.947711|2017-10-11 02:12:44.947711
NCT01745211|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-04-09|||January 2012||2012-01-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||755nm Alex Laser for Treatment of Stretch Marks||Completed||N/A|45|Actual|Cynosure, Inc.||2|||f||||f||||||||||2017-10-11 02:12:45.055413|2017-10-11 02:12:45.055413
NCT01745198|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-04-27|||December 2012||2012-12-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Observational|||Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements|Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Related Disorders|Completed||N/A|121|Actual|Pamlab, Inc.|||2||f||||f||||||Samples With DNA|"     A single blood draw for approximately 6-10 mL of blood will be performed for the total plasma     homocysteine measurement and genetic studies.   "|||2017-10-11 02:12:45.151194|2017-10-11 02:12:45.151194
NCT01745185|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-04-03|||June 2012|Actual|2012-06-01|April 2017|2017-04-01|August 7, 2016|Actual|2016-08-07|April 7, 2015|Actual|2015-04-07||Observational|||Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta|Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta|Completed||N/A|30|Anticipated|O & O Alpan LLC|||2||f||||f||||||Samples With DNA|"     Blood, Urine   "|||2017-10-11 02:12:45.255543|2017-10-11 02:12:45.255543
NCT01745172|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-10-14|||January 2013||2013-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Carotid Body Removal for the Treatment of Resistant Hypertension|Carotid Body Removal for the Treatment of Chronic Diseases Characterized by Excessive Central Sympathetic Activity Including Resistant Hypertension: a Pilot Study.|Completed||N/A|4|Actual|Noblewell||1|||f||||t||||||||Yes||2017-10-11 02:12:45.329931|2017-10-11 02:12:45.329931
NCT01745159|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-08-04|||September 2012||2012-09-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis|Proactive Treatment With Tacrolimus Ointment in Children With Moderate/Severe Atopic Dermatitis: A Randomized, Multicenter, Open-label Study|Completed||Phase 4|125|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:12:45.398696|2017-10-11 02:12:45.398696
NCT01745146|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-01-06|||September 2012||2012-09-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|ASMT||Anger Self-Management in Traumatic Brain Injury|Anger Self-Management in Post-Acute Traumatic Brain Injury: Clinical Trial|Completed||N/A|90|Actual|Albert Einstein Healthcare Network||2|||f||||f||||||||Undecided||2017-10-11 02:12:47.472916|2017-10-11 02:12:47.472916
NCT01745133|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-11-15|2016-08-18||January 2013||2013-01-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis|Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis|Completed||Phase 4|63|Actual|Derm Research, PLLC|small population|3|||f||||f||||||||||2017-10-11 02:12:47.583418|2017-10-11 02:12:47.583418
NCT01745120|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-05-12|||August 2013||2013-08-01|May 2017|2017-05-01||||March 2018|Anticipated|2018-03-01||Interventional|||A Study Evaluating the Safety and Efficacy of the LentiGlobin® BB305 Drug Product in Beta-Thalassemia Major Subjects|A Phase 1/2 Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects With β-Thalassemia Major by Transplantation of Autologous CD34+ Cells Transduced Ex Vivo With a Lentiviral β-A(T87Q)-Globin Vector (LentiGlobin® BB305 Drug Product)|Active, not recruiting||Phase 1/Phase 2|18|Actual|bluebird bio||1|||f||||t||||||||||2017-10-11 02:12:47.989985|2017-10-11 02:12:47.989985
NCT01745107|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-07-30|||November 2012||2012-11-01|July 2016|2016-07-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|IMRT||Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;|Phase Ⅲ Study of Prophylactic Postoperative Intensity Modulated Radiation Therapy in Stage T2-3N0M0 Disease of Thoracic Esophageal Squamous Cell Carcinoma;|Recruiting||Phase 3|240|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:12:48.100231|2017-10-11 02:12:48.100231
NCT01745094|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-02-14|||October 2012||2012-10-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients|Post-Marketing Clinical Study of Mirabegron -Add-on Therapy With Mirabegron in Patients With Overactive Bladder Under Treatment With Solifenacin-|Completed||Phase 4|223|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:12:48.230971|2017-10-11 02:12:48.230971
NCT01745081|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2012-12-06|||September 2012||2012-09-01|December 2012|2012-12-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies|Comparison of the Efficacy Between 20% Mannitol and 3% Hypertonic Saline, Given as a Bolus at the Beginning of Elective Supratentorial Craniotomy for Tumor Resection, in Favoring Cerebral Relaxation Evaluated by a Sub-dural Intracranial Pressure Measurement.|Unknown status|Recruiting|Phase 4|80|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 02:12:48.334199|2017-10-11 02:12:48.334199
NCT01745068|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-11-23|||January 2013||2013-01-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|November 2016|Actual|2016-11-01||Interventional|OPTI-FRAC||Partnership for Applied Research in Fracture Prevention Programs for the Elderly|Partnership for Applied Research in Fracture Prevention Programs for the Elderly|Active, not recruiting||N/A|631|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 02:12:48.424002|2017-10-11 02:12:48.424002
NCT01745055|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-01-29|2012-12-06||April 2005||2005-04-01|January 2013|2013-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Co-Administration Of Methotrexate And CP-690,550|A Phase 1, Open Label Study Of The Pharmacokinetics Of Multiple Doses Of Oral CP-690,550 And Single Doses Of Oral Methotrexate In Rheumatoid Arthritis Subjects|Completed||Phase 1|12|Actual|Pfizer|Results were summarized for Ae(0-12) instead of planned Ae(0-24), as CP-690,550 was administered every 12 hours.|1|||f||||f||||||||||2017-10-11 02:12:48.732971|2017-10-11 02:12:48.732971
NCT01745042|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-05|||September 2009||2009-09-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Anthropometric, Metabolic, Cardiovascular and Symptomatic Profile in Postmenopausal Women|Impact of Fat Distribution on Metabolic, Cardiovascular and Symptomatic Aspects in Postmenopausal Women|Completed||N/A|45|Actual|University of Sao Paulo|||2||f||||t||||||||||2017-10-11 02:12:49.358583|2017-10-11 02:12:49.358583
NCT01745029|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-01-06|||April 2013||2013-04-01|January 2014|2014-01-01|March 2015|Anticipated|2015-03-01|April 2014|Anticipated|2014-04-01||Observational|||Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit|Gastrointestinal Motility in Patients Suffering From Severe Ulcerative Colitis Obtained by Motilis-3D-transit|Unknown status|Recruiting|N/A|20|Anticipated|University of Aarhus|||1||f||||t||||||||||2017-10-11 02:12:49.469699|2017-10-11 02:12:49.469699
NCT01745016|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2013-04-29|||January 2013||2013-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Beta-Alanine on Heart Rate Response|The Effect of 28 Days of Beta-alanine Supplementation on the Physical Working Capacity at Heart Rate Threshold (PWCHRT)|Completed||N/A|35|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:12:49.571312|2017-10-11 02:12:49.571312
NCT01745003|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-12-01|||March 2012||2012-03-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Direct Transcranial Current Stimulation on Central Neural Pain Processing in Fibromyalgia|Effects of Direct Transcranial Current Stimulation on Central Neural Pain Processing in Fibromyalgia|Completed||Phase 1/Phase 2|13|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 02:12:49.659524|2017-10-11 02:12:49.659524
NCT01744990|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-07|||October 2012||2012-10-01|December 2012|2012-12-01|January 2016|Anticipated|2016-01-01|December 2013|Anticipated|2013-12-01||Interventional|ProNut||Tree Nuts Allergies: Does a Single Nut Allergy Necessitate the Dietary Eviction of Other Tree Nuts?|Tree Nuts Allergies: Does a Single Nut Allergy Necessitate the Dietary Eviction?|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-10-11 02:12:49.745066|2017-10-11 02:12:49.745066
NCT01744977|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-04-12|2016-03-11||December 2012||2012-12-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|MWV_CAPS||Cholesterol Medication Packaging Study|Evaluate the Efficacy, Perceptions and Cost of an Innovative Cholesterol Packaging|Completed||N/A|240|Actual|Durham VA Medical Center||2|||f||||f||||||||||2017-10-11 02:12:49.883687|2017-10-11 02:12:49.883687
NCT01744964|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-09-15|||July 2009||2009-07-01|September 2016|2016-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Apomorphine Effects on Experimental Pain|Alterations in the Ability to Tolerate Experimental Pain by Apomorphine and Its Association With a Dopamine Transporter Polymorphism|Completed||Early Phase 1|105|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 02:12:50.34421|2017-10-11 02:12:50.34421
NCT01744951|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-10-25|||October 2012||2012-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ADAPT||Adoption-specific Treatment Prevention Pilot Trial|Evaluate the Adoption-specific Prevention Treatment Program (ADAPT)|Recruiting||Phase 1|60|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:12:50.484592|2017-10-11 02:12:50.484592
NCT01744938|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-12-21|||September 2012||2012-09-01|May 2012|2012-05-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice|Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice: A Phase III, Randomized, Controlled, Single Center Study.|Unknown status|Enrolling by invitation|Phase 3|136|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 02:12:50.600227|2017-10-11 02:12:50.600227
NCT01744925|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-02-06|||October 2012||2012-10-01|August 2012|2012-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR|An Open-label,Randomized,Controlled Study to Evaluate the Safety and Efficacy for Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR|Recruiting||Phase 2|60|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 02:12:50.67613|2017-10-11 02:12:50.67613
NCT01744899|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-12-05|||January 2012||2012-01-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Soleus H-Reflex in Different Sitting Postures|The Influence of Different Sitting Postures on Soleus H-Reflex in Normal Subjects|Completed||N/A|30|Actual|Texas Woman's University|||2||f||||f||||||||||2017-10-11 02:12:51.059172|2017-10-11 02:12:51.059172
NCT01744886|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2014-10-16|||December 2012||2012-12-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Oxygen Saturation During Different Intraoperative Positions|A Comparison of Oxygen Saturation Between Lateral Decubitus Lung Surgery and Port Access Procedures in Dorsal Decubitus|Terminated||N/A|29|Actual|Onze Lieve Vrouw Hospital||2||Inacceptable oxygen saturation values in one study group|f||||f||||||||||2017-10-11 02:12:51.182807|2017-10-11 02:12:51.182807
NCT01744873|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2012-12-06|||August 2012||2012-08-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg of With Zebeta® 10 mg in Normal, Healthy, Adult, Human Subjects Under Fed Condition.|Completed||Phase 1|24|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:12:51.294939|2017-10-11 02:12:51.294939
NCT01744860|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2016-02-25|2016-01-21||December 2012||2012-12-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational||Biological samples were analysed rather than samples|Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples|Evaluation of Concordance Between the Methods Used in INCa Platforms and the Cobas® 4800 BRAF V600 Mutation Test for Detection of BRAF V600 Mutations in Melanoma in Real Life Setting|Completed||N/A|420|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-11 02:12:51.431173|2017-10-11 02:12:51.431173
NCT01744847|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-12-06|||January 2005||2005-01-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Multi-center Study|DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Randomized Multi-center Study|Completed||Phase 4|111|Actual|Soon Chun Hyang University||2|||f||||t||||||||||2017-10-11 02:12:52.193275|2017-10-11 02:12:52.193275
NCT01744834|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-06|2017-08-09|||December 2012||2012-12-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|April 2015|Actual|2015-04-01||Observational|LeAD||Learning in Young Adults as Predictor for the Development of Alcohol Use Disorders|Learning in Young Adults as Predictor for the Development of Alcohol Use Disorders|Active, not recruiting||N/A|201|Actual|Technische Universität Dresden|||1||f||||f||||||Samples With DNA|"     Bloodsample are taken for genetic analysis   "|||2017-10-11 02:12:52.312903|2017-10-11 02:12:52.312903
NCT01744821|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-07-01|2015-03-17||October 2012||2012-10-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional||With a total of 80 patients (40 per arm), assuming a Type I error rate of 5% and a power of 80, an effect size of 0.63 may be detected between patients exposed to Vitamin D supplementation and those not exposed.|Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer|A Randomized Controlled Pilot Trial of Vitamin D3 Replacement of Placebo Followed by Bilateral Salpingo-Oophorectomy for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer.|Terminated||N/A|7|Actual|Northwestern University|Low accrual led to this pilot study closing early. Accrual barriers included the 4-week minimum treatment time frame and narrow eligibility criteria. Small numbers prohibit meaningful analysis. Study provides important insights to recruitment.|2||Inability to recruit study subjects|f||||||||||||||2017-10-11 02:12:52.419124|2017-10-11 02:12:52.419124
NCT01744808|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2014-04-02|||February 2013||2013-02-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020|A Phase 1 Study To Investigate the Pharmacokinetics of SR Formulations; and the Food Effect, Safety, Tolerance, Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020 In Young Healthy Subjects|Completed||Phase 1|54|Actual|Euthymics BioScience, Inc.||5|||f||||f||||||||||2017-10-11 02:12:52.983801|2017-10-11 02:12:52.983801
NCT01744795|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-06-17|||December 2012||2012-12-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||CardioQ vs Thermodilution Measurements of Cardiac Output|Comparison of CardioQ and Pulmonary Artery Thermodilution Derived Cardiac Output Measurements|Completed||N/A|25|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 02:12:53.083849|2017-10-11 02:12:53.083849
NCT01744782|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-04-11|||December 19, 2012|Actual|2012-12-19|April 2017|2017-04-01|December 13, 2016|Actual|2016-12-13|December 13, 2016|Actual|2016-12-13||Interventional|||Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis|An Open-Label, Safety and Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naïve Patients With Cystinosis|Completed||Phase 3|17|Actual|Horizon Pharma USA, Inc.||1|||||||f||||||||||2017-10-11 02:12:53.171931|2017-10-11 02:12:53.171931
NCT01744769|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2012-12-06|||July 2012||2012-07-01|December 2012|2012-12-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer|Effects of Thyroid Hormone Withdrawal on Metabolic and Cardiovascular Parameters During Radioactive Iodine Therapy in Differentiated Thyroid Cancer|Unknown status|Recruiting|N/A|80|Anticipated|Konkuk University Medical Center|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 02:12:53.287818|2017-10-11 02:12:53.287818
NCT01744756|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2012-12-06|||February 2012||2012-02-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|BRP||Subconjunctival Bevacizumab and Recurrent Pterygium|Interventional Trial of Subconjunctival Bevacizumab in Recurrent Pterygium|Completed||Phase 2/Phase 3|36|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-10-11 02:12:53.391519|2017-10-11 02:12:53.391519
NCT01744730|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-11-21|2016-02-10||June 2013||2013-06-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CLIN01||Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile|Safety and Pharmacokinetics of Multiple-Dose Intravenous and Oral Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile (NICHD): CLIN01|Completed||Phase 1|22|Actual|Duke University|Data from 3 different studies was included to increase the robustness of the population PK model developed and leverage all available clindamycin PK data.|4|||f||||t||||||||||2017-10-11 02:12:53.599045|2017-10-11 02:12:53.599045
NCT01744717|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2016-09-16|||November 2012||2012-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Observational|ESCID-MQ||"Validation of Escala de Conductas Indicadoras de Dolor ESCID Scale for Measuring Pain in Critically Ill Patients"|"Estudio multicéntrico de Validez y Fiabilidad de la Escala de Conductas Indicadoras de Dolor ESCID Para Medir el Dolor en Pacientes críticos, no Comunicativos y Sometidos a ventilación mecánica"|Completed||N/A|286|Actual|Puerta de Hierro University Hospital|||1||f||||f||||||||Undecided||2017-10-11 02:12:54.57615|2017-10-11 02:12:54.57615
NCT01744691|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-01-09|2015-05-21||January 2013||2013-01-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|June 2014|Actual|2014-06-01||Interventional||One hundred forty-five subjects were enrolled and 144 subjects received at least 1 dose of PCI-32765 and constitute the all treated population and the safety analysis set.|A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion|An Open-label, Single Arm, Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma With 17p Deletion (RESONATE™-17)|Completed||Phase 2|145|Actual|Pharmacyclics LLC.||1|||f||||f||||||||No||2017-10-11 02:12:55.144869|2017-10-11 02:12:55.144869
NCT01744678|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2012-12-05|||September 2012||2012-09-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Fatigue Countermeasure Program in Operational Flight Controllers|Experimental Trial of Fatigue Countermeasure Program in Operational Flight Controllers|Completed||N/A|20|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:12:56.038742|2017-10-11 02:12:56.038742
NCT00197899|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-12|||March 2004||2004-03-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Low-Dose Endotoxemia and the Acute Phase Response||Unknown status|Active, not recruiting|N/A|||Herlev Hospital|||||f||||||||||||||2017-10-11 05:33:38.951095|2017-10-11 05:33:38.951095
NCT01744665|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-02-06|||August 12, 2013|Actual|2013-08-12|February 2017|2017-02-01|December 31, 2021|Anticipated|2021-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|ENESTgoal||Safety and Efficacy of CML Patients Who Switch to Nilotinib and Stop Treatment After Achieving and Sustaining MR4.5.|A Phase II Randomized, Multicenter Study of Treatment-free Remission in Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Patients Who Achieve and Sustain MR4.5 After Switching to Nilotinib|Active, not recruiting||Phase 2|59|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:12:56.173194|2017-10-11 02:12:56.173194
NCT01744652|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-09-28|||March 2013|Actual|2013-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Dasatinib and Crizotinib in Advanced Cancer|A Phase I Trial of Dasatinib in Combination With Crizotinib in Patients With Advanced Malignancies|Active, not recruiting||Phase 1|62|Actual|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 02:12:56.404822|2017-10-11 02:12:56.404822
NCT01744639|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-06-07|||December 2012||2012-12-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|||Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation|Analysis of Body Composition by Bioelectrical Impedance in Patients With Hepatocellular Carcinoma (HCC) Undergoing Treatment Radioablation|Withdrawn||N/A|0|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||1||Unable to find patients|f||||f||||||||||2017-10-11 02:12:56.53532|2017-10-11 02:12:56.53532
NCT01744626|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-04-18|||December 2012||2012-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|A Phase 1b, Multi-center, Open Label, Study to Determine the Safety and Activity of CC-292 in Combination With Rituximab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma.|Completed||Phase 1|40|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 02:12:56.625217|2017-10-11 02:12:56.625217
NCT01744613|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2013-01-11|||January 2010||2010-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01|12 Months|Observational [Patient Registry]|PRECLOP||High on Treatment Platelet Reactivity Following Peripheral Endovascular Procedures|Clinical Impact of High on Treatment Platelet Reactivity Following Peripheral Endovascular Procedures. The PRECLOP Study (Platelet REsponsiveness to CLOpidogrel Treatment After Peripheral Angioplasty or Stenting)|Completed||N/A|100|Actual|University of Patras|||2||f||||f||||||||||2017-10-11 02:12:56.74489|2017-10-11 02:12:56.74489
NCT01744600|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2014-12-19|||February 2013||2013-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Music Therapy in Methodist Homes: a Study Investigating the Impact of a Music Therapy Programme|Music Therapy in Methodist Homes: a Cluster Randomised Controlled Trial Including Mixed Methods Analysis Investigating the Efficacy of the Impact of a Music Therapy Programme on Caring for People With Dementia Who Have Behavioural Symptoms.|Completed||N/A|27|Actual|Methodist Homes for the Aged||2|||f||||f||||||||||2017-10-11 02:12:56.85229|2017-10-11 02:12:56.85229
NCT01744587|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-11-08|||April 2013||2013-04-01|October 2013|2013-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|NPC||Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients|Study of Epstein-Barr Virus Reactivation and the Effect of Dietary Supplement Epigallocatechin Gallate (EGCG) on Virus Reactivation in Remission Patients With Nasopharyngeal Carcinoma - A Randomized Trial|Recruiting||Phase 2/Phase 3|352|Anticipated|National Health Research Institutes, Taiwan||2|||f||||t||||||||||2017-10-11 02:12:56.950902|2017-10-11 02:12:56.950902
NCT01744574|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-07-27|||December 2012||2012-12-01|July 2017|2017-07-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Interventional|||Sex Differences, Hormones & Smoking Cessation|Sex Differences & Progesterone: Association With Impulsivity and Smoking Cessation|Completed||N/A|312|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 02:12:57.087002|2017-10-11 02:12:57.087002
NCT01744561|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-09-07|||July 2014||2014-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|ACTIVATE-CF||Effects of a Partially Supervised Conditioning Program in CF|Effects of a Partially Supervised Conditioning Program in CF: an International Multi-centre, Randomized Controlled Trial|Recruiting||N/A|292|Anticipated|Wuerzburg University Hospital||2|||f||||t|f|f||||||||2017-10-11 02:12:57.193127|2017-10-11 02:12:57.193127
NCT01744548|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2013-01-22|||December 2012||2012-12-01|January 2013|2013-01-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|||A Pilot Trial Of Transdiagnostic Cognitive Behavioural Therapy (tCBT) For Depression And Anxiety In Older People|A Pilot Randomised Controlled Trial (RCT) Examining The Feasibility, Acceptability And Efficacy Of Transdiagnostic Cognitive Behavioural Therapy (tCBT) For Depression And Anxiety In Older People.|Unknown status|Recruiting|N/A|22|Anticipated|King's College London||2|||f||||||||||||||2017-10-11 02:12:57.479583|2017-10-11 02:12:57.479583
NCT01744535|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2012-12-06|||March 2011||2011-03-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||"Pilot Trial of My Meal Mate (MMM), a Smartphone Application for Weight Loss"|"Pilot Trial of My Meal Mate (MMM), a Smartphone Application Designed to Facilitate Weight Loss."|Completed||Phase 2|128|Actual|University of Leeds||3|||f||||f||||||||||2017-10-11 02:12:57.595416|2017-10-11 02:12:57.595416
NCT01744522|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-04-10|||September 2012||2012-09-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|ZoHir||Leech Therapy for Postherpetic Neuralgia|Pilot Study on the Influence of Leech Therapy on Pain and Sensory Processing in Patients With Postherpetic Neuralgia|Terminated||N/A|6|Actual|Universität Duisburg-Essen|||1|We were not able to recruit enough patients for this study within a given time frame.|f||||f||||||||||2017-10-11 02:12:57.701081|2017-10-11 02:12:57.701081
NCT01744509|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-05|||March 2011||2011-03-01|December 2012|2012-12-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||PillCam Colon Capsule 2® (PCC2) in the Setting of Colorectal Cancer Screening Program|PillCam Colon Capsule 2® (PCC2) in the Setting of Colorectal Cancer Screening (CRC) Program: Comparison With a New Integrated Reference Standard|Unknown status|Recruiting|N/A|35|Anticipated|Valduce Hospital||1|||f||||f||||||||||2017-10-11 02:12:57.804914|2017-10-11 02:12:57.804914
NCT01744314|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-03-22|||November 2012||2012-11-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma|Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma: A Randomized Prospective Double-blinded Study.|Recruiting||N/A|150|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:13:02.32334|2017-10-11 02:13:02.32334
NCT01744496|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-04-09|2014-11-24||November 2012||2012-11-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|DOLORES|The Baseline Analysis Population refers to the Safety Set (SS). The SS includes all randomized subjects who received at least 1 dose of study medication.|Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain|A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 2-Arm Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain|Completed||Phase 4|68|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 02:12:57.909111|2017-10-11 02:12:57.909111
NCT01744483|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-05-11|2016-10-31||December 2012||2012-12-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|PreVent|Figures do not include inadvertent enrollments (IRB excluded, Not admitted to ICU or Routed to OSH)|Endotracheal Tubes for Prevention of Ventilator-associated Pneumonia|Pilot Trial of Tubes to Prevent Ventilator-Associated Pneumonia (PreVent)|Completed||N/A|117|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 02:12:58.661407|2017-10-11 02:12:58.661407
NCT01744470|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-04-07|||May 2012||2012-05-01|April 2014|2014-04-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|ADEQUATE||Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)|Efficacy and Safety Outcome of Two Different Targets of Advagraf® Trough Levels Between 4 Months and 12 Months After Transplantation Among de Novo Renal Transplant Recipients.|Unknown status|Active, not recruiting|Phase 4|286|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 02:12:59.007934|2017-10-11 02:12:59.007934
NCT01744457|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2012-12-05|||February 2011||2011-02-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy Subjects|Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy Subjects|Completed||N/A|40|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:12:59.15639|2017-10-11 02:12:59.15639
NCT01744444|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-12-17|||November 2012||2012-11-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis||Completed||Phase 2|10|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:12:59.264598|2017-10-11 02:12:59.264598
NCT01744431|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-12-15|||December 2012||2012-12-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01|1 Day|Observational [Patient Registry]|||Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients||Completed||N/A|400|Actual|HaEmek Medical Center, Israel|||1||f||||t||||||||||2017-10-11 02:12:59.36473|2017-10-11 02:12:59.36473
NCT01744418|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-02-13|||December 2012||2012-12-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2016|Actual|2016-04-01||Interventional|||Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRD|A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease|Active, not recruiting||N/A|40|Actual|Humacyte, Inc.||1|||f||||t||||||||No||2017-10-11 02:12:59.438901|2017-10-11 02:12:59.438901
NCT01744405|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-03-17|||December 2012||2012-12-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2013|Actual|2013-12-01||Observational|LACTNFX||Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease|Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease|Completed||N/A|12|Actual|Hospital de Niños R. Gutierrez de Buenos Aires|||1||f||||f||||||Samples Without DNA|"     breastmilk; plasma   "|||2017-10-11 02:12:59.529471|2017-10-11 02:12:59.529471
NCT01744392|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-10-22|2015-09-10||February 2013||2013-02-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Medication Adherence With Polyglot Meducation|Evaluate Changes in Medication Adherence and Patient Perspective of Polyglot Systems, Inc's Meducation Technology|Completed||N/A|23|Actual|Durham VA Medical Center||1|||f||||f||||||||||2017-10-11 02:12:59.61392|2017-10-11 02:12:59.61392
NCT01744379|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-06-18|||December 2012||2012-12-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Single and Multiple Dose Study in Japanese|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of Lesinurad in Healthy Male Japanese Subjects|Completed||Phase 1|40|Actual|Ardea Biosciences, Inc.||5|||f||||f||||||||||2017-10-11 02:13:00.104315|2017-10-11 02:13:00.104315
NCT01744366|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2015-06-22|||January 2013||2013-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|PANDA||One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population|An Open-label, Multi-centre, Randomised, Parallel-group Trial, Comparing Efficacy and Safety of Degarelix One-month Dosing Regimen With Goserelin in Chinese Patients With Prostate Cancer Requiring Androgen Ablation Therapy|Completed||Phase 3|285|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:13:00.242408|2017-10-11 02:13:00.242408
NCT01744353|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-03-11|2015-05-06||November 2012||2012-11-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Interventional|278||BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study|BrUOG 278:FOLFOX-A For Pancreatic Cancer :A Brown University Oncology Research Group Study|Completed||Phase 1|35|Actual|Brown University||3|||f||||t||||||||||2017-10-11 02:13:00.813523|2017-10-11 02:13:00.813523
NCT01744340|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-03-11|2016-01-12||May 2012||2012-05-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer|A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer With an Expansion Cohort For Head and Neck Cancer: A Brown University Oncology Research Group Study|Completed||Phase 1/Phase 2|23|Actual|Brown University||2|||f||||t||||||||||2017-10-11 02:13:01.419516|2017-10-11 02:13:01.419516
NCT01744327|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2013-05-27|||December 2012||2012-12-01|May 2013|2013-05-01||||December 2013|Anticipated|2013-12-01||Observational|||TL1A Expression in Psoriatic Skin|An Exploratory Study Investigating TL1A Expression in Psoriatic Skin and Serum and Monocytes Capacity to Produce TL1A|Unknown status|Active, not recruiting|N/A|20|Anticipated|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-11 02:13:02.203167|2017-10-11 02:13:02.203167
NCT01744301|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2016-09-08|||March 2013||2013-03-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Acid Suppressing Drug Seizure Epidemiology Study|A Cohort Study With a Nested Case Control Analysis on the Association Between Acid-suppressing Drugs and Seizures Using THIN Database in the UK|Completed||N/A|8605|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 02:13:02.433883|2017-10-11 02:13:02.433883
NCT01744288|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2014-04-23|||December 2012||2012-12-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets|A Open Label, Randomized, Crossover and Potential Parallel, Single Dose Study of Ticagrelor 180 mg and Acetylsalicylic Acid (ASA) in Healthy Volunteers Followed by Autologous in Vivo Platelet Transfusion to Determine the Effects of Platelet Supplementation on the Reversibility of Platelet Inhibition|Completed||Phase 1|258|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 02:13:02.534638|2017-10-11 02:13:02.534638
NCT01744275|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-02-25|||July 2013||2013-07-01|February 2014|2014-02-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01||Interventional|HOPE-Epilepsy||HOPE-Epilepsy Trial|High Dose Omega 3 Fatty Acids Supplementation in Patients With Epilepsy : The HOPE-Epilepsy Trial|Suspended||Phase 2/Phase 3|370|Anticipated|Hospital do Coracao||2||Lack of funding|f||||t||||||||||2017-10-11 02:13:02.631018|2017-10-11 02:13:02.631018
NCT01744262|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-08-16|||May 2011||2011-05-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Comparison of Totally Intravenous and Inhalation Anesthesia for Intraocular Pressure During Robot-Assisted Laparoscopic Radical Prostatectomy||Completed||N/A|66|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 02:13:02.715341|2017-10-11 02:13:02.715341
NCT01744249|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-08-23|||November 2011|Actual|2011-11-01|August 2017|2017-08-01|October 2020|Anticipated|2020-10-01|November 2019|Anticipated|2019-11-01||Interventional|||Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas|A Phase II/III Randomized Double-blind Study of Sandostatin LAR in Combination With Axitinib Versus Sandostatin LAR With Placebo in Patients With Advanced G1-G2 Neuroendocrine Tumours (WHO 2010) of Non-pancreatic Origin|Recruiting||Phase 2/Phase 3|253|Anticipated|Grupo Espanol de Tumores Neuroendocrinos||2|||f||||f||||||||||2017-10-11 02:13:02.791526|2017-10-11 02:13:02.791526
NCT01744236|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-12-08|||April 2013||2013-04-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies|A Phase IV, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Effect of 12-week Treatment With the Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) Liraglutide or Dipeptidyl Peptidase-4 Inhibitor (DPP-4i) Sitagliptin on the Cardiovascular, Renal and Gastrointestinal System in Insulin-naïve Patients With Type 2 Diabetes (T2DM).|Completed||Phase 4|70|Actual|VU University Medical Center||7|||f||||f||||||||||2017-10-11 02:13:02.987556|2017-10-11 02:13:02.987556
NCT01744223|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-05|2017-03-27|||March 2013||2013-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant|A Phase 1/2 Dose Escalation Study Evaluating Safety and Feasibility of BPX-501 T Cells After Partially Mismatched, Related, T Cell-Depleted HSCT (Hematopoietic Stem Cell Transplant)|Recruiting||Phase 1/Phase 2|36|Anticipated|Bellicum Pharmaceuticals||1|||f||||f||||||||Undecided||2017-10-11 02:13:03.091742|2017-10-11 02:13:03.091742
NCT01744210|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2014-06-24|||September 2012||2012-09-01|August 2012|2012-08-01|July 2015|Anticipated|2015-07-01|April 2015|Anticipated|2015-04-01||Observational|||Evaluation of Blood Flow Patterns in Lung Blood Vessels Using Ultrasound Technique in Patients With Congestive Heart Failure|Evaluation of Pulmonary Blood Flow Patterns Using Transthoracic Doppler in Patients With Congestive Heart Failure|Withdrawn||N/A|0|Actual|Echosense Ltd.|||1|Decided not tostart study because of unavailability of staff|f||||f||||||||||2017-10-11 02:13:03.292136|2017-10-11 02:13:03.292136
NCT01744197|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-10-14|2016-01-20||January 2013||2013-01-01|October 2016|2016-10-01|November 2013|Actual|2013-11-01|February 2013|Actual|2013-02-01||Interventional||ITT population|Synera Venipuncture Pain|Effect of Synera in Reducing Pain Associated With Venipuncture and Superficial Dermatologic Procedures|Completed||Phase 2|61|Actual|US Oncology Research||2|||f||||f||||||||||2017-10-11 02:13:03.499789|2017-10-11 02:13:03.499789
NCT01744184|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-04-11|||May 2013||2013-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||A Single-centre Study of Entonox Versus Midazolam Sedation in Gastroscopy|A Single-centre, Randomised Controlled Study of Entonox Versus Midazolam Sedation in Gastroscopy.|Suspended||Phase 4|200|Anticipated|The Royal Bournemouth Hospital||2||Resource issues|f||||t||||||||||2017-10-11 02:13:03.902288|2017-10-11 02:13:03.902288
NCT01744171|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-09-21|||March 26, 2013|Actual|2013-03-26|September 2017|2017-09-01|June 13, 2018|Anticipated|2018-06-13|November 13, 2017|Anticipated|2017-11-13||Interventional|||Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma|A Phase I Trial of a Recombinant Human hsp110-gp100 Chaperone Complex Vaccine for Advanced Stage IIIB/C or IV Melanoma|Recruiting||Phase 1|20|Anticipated|Roswell Park Cancer Institute||1|||f||||f||||||||||2017-10-11 02:13:04.009066|2017-10-11 02:13:04.009066
NCT01744158|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-12-04|||March 2011||2011-03-01|December 2012|2012-12-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Observational|HypE-CP||Exploring Hypertonia in Children With Cerebral Palsy|Exploring Hypertonia in Children With Cerebral Palsy- a Population-based Approach.|Unknown status|Recruiting|N/A|300|Anticipated|Women's and Children's Hospital, Australia|||1||f||||f||||||||||2017-10-11 02:13:04.171445|2017-10-11 02:13:04.171445
NCT01744145|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-12-04|||August 2012||2012-08-01|December 2012|2012-12-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|EPICC||Effect of Exercise and Education After Pneumonia|Early Pneumonia Intervention to Prevent Chronic Complications in Patients Age 40 and Above|Unknown status|Recruiting|N/A|120|Anticipated|Winthrop University Hospital||4|||f||||f||||||||||2017-10-11 02:13:04.29144|2017-10-11 02:13:04.29144
NCT01744132|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-11-19|||October 2012||2012-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes|Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes|Completed||N/A|3000|Actual|Wills Eye||2|||f||||t||||||||No||2017-10-11 02:13:04.416975|2017-10-11 02:13:04.416975
NCT01744119|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2016-05-23|||April 2005||2005-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Vascutek Anaconda™ Abdominal Aortic Aneurysm (AAA) Post-Market Surveillance Registry|Vascutek Anaconda™ Stent Graft System for Infra-Renal Abdominal Aortic Aneurysm Repair|Terminated||N/A|318|Actual|Vascutek Ltd.|||1||f||||||||||||||2017-10-11 02:13:04.561856|2017-10-11 02:13:04.561856
NCT01744106|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-04-20|||November 2012||2012-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold|A Multicenter, Randomized, Placebo-Controlled Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold|Completed||Phase 3|565|Actual|Perrigo Company||2|||f||||f||||||||||2017-10-11 02:13:04.753517|2017-10-11 02:13:04.753517
NCT01744093|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-10-31|||January 2014||2014-01-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Doxycycline for COPD in HIV-Infected Patients|Doxycycline for COPD in HIV-Infected Patients|Recruiting||N/A|30|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||Undecided||2017-10-11 02:13:04.924236|2017-10-11 02:13:04.924236
NCT01744080|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-04-03|||January 2014||2014-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|RC-IS||Rotator Cuff Injury to Surgery|Effect of Surgical Wait Times on Outcomes of Rotator Cuff Surgery|Withdrawn||N/A|0|Actual|Panam Clinic||2||Logistic issues could not be resolved - study closed without any patients recruited|f||||f||||||||||2017-10-11 02:13:05.115046|2017-10-11 02:13:05.115046
NCT01744067|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-12-06|||November 2013||2013-11-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ORENTRA||The Effects of Omega-3 Fatty Acids in Renal Transplantation|The Effects of n-3 Polyunsaturated Fatty Acids on Renal and Cardiovascular Risk Markers in Renal Transplant Recipients: a Randomized Double Blinded Placebo Controlled Intervention Study.|Completed||Phase 4|132|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 02:13:05.279551|2017-10-11 02:13:05.279551
NCT01744054|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-04-27|||October 25, 2012|Actual|2012-10-25|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization|Pilot Study of Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization|Recruiting||Phase 1|80|Anticipated|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||No||2017-10-11 02:13:05.47067|2017-10-11 02:13:05.47067
NCT01744041|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-03-07|||November 2012||2012-11-01|March 2017|2017-03-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Mommy-Baby Treatment for Perinatal Depression|Perinatal Depression: Dyadic-IPT to Improve Health of Mother and Baby|Completed||N/A|42|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:13:05.608606|2017-10-11 02:13:05.608606
NCT01744028|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-02-06|||June 2012||2012-06-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PREMIERE||Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool.|A 52-week Multi-center Randomized Trial to Evaluate Remote Patient Monitoring Using the EXACT Patient-reported Outcome Tool on Reduction of Hospitalizations From Exacerbations in Patients With Chronic Obstructive Pulmonary Disease as Compared to Those Managed by Usual Care|Completed||Phase 1|118|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:13:05.766754|2017-10-11 02:13:05.766754
NCT01744015|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2013-07-09|||April 2013||2013-04-01|December 2012|2012-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Influence of Patient-Informed Choice in a Novel Treatment Model for LBP|Influence of Patient-Informed Choice in a Novel Treatment Model for LBP: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Walsh University||2||We did not receive funding|f||||f||||||||||2017-10-11 02:13:05.931221|2017-10-11 02:13:05.931221
NCT01744002|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2013-07-09|||December 2011||2011-12-01|December 2012|2012-12-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Neck Mobs and Impingement|The Addition of Cervical Unilateral Posterior Anterior Mobilization (UPA) in the Treatment of Patients With Shoulder Impingement Syndrome: A Randomized Clinical Trial|Completed||Phase 2|68|Actual|Walsh University||2|||f||||f||||||||||2017-10-11 02:13:06.059631|2017-10-11 02:13:06.059631
NCT01743989|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-03-21|||April 15, 2013|Actual|2013-04-15|March 2017|2017-03-01|May 4, 2020|Anticipated|2020-05-04|May 4, 2020|Anticipated|2020-05-04||Interventional|ENESTPath||A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.|A Prospective, Randomized, Open Label, Two Arm Phase III Study to Evaluate Treatment Free Remission (TFR) Rate in Patients With Philadelphia-positive CML After Two Different Durations of Consolidation Treatment With Nilotinib 300mg BID.|Recruiting||Phase 3|1058|Anticipated|Novartis||2|||f||||t||||||||||2017-10-11 02:13:06.258527|2017-10-11 02:13:06.258527
NCT01743976|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-01-29|||December 2012||2012-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain|Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain|Active, not recruiting||Phase 4|33|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 02:13:07.030193|2017-10-11 02:13:07.030193
NCT01743963|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-06-05|2015-03-27||December 2012||2012-12-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|CDA-GID||Intervention to Increase Screening for Glucocorticoid Induced Diabetes|Intervention to Increase Screening for Glucocorticoid Induced Diabetes|Completed||N/A|38|Actual|VA Eastern Colorado Health Care System||2|||f||||f||||||||||2017-10-11 02:13:07.133927|2017-10-11 02:13:07.133927
NCT01743950|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-09-19|||December 2012||2012-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab|A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab|Recruiting||Phase 2|80|Anticipated|University of Wisconsin, Madison||4|||f||||t||||||||||2017-10-11 02:13:09.333849|2017-10-11 02:13:09.333849
NCT01743937|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-11-01|||January 2013||2013-01-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ETCH||A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans|A Randomized, Controlled, Open Label Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans|Recruiting||Phase 4|50|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 02:13:09.511346|2017-10-11 02:13:09.511346
NCT01743924|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-12-04|||July 2011||2011-07-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Bioavailability of Chemopreventive and Nutritional Compounds in Broccoli|Bioavailability of Bioactive Compounds in Broccoli|Completed||Early Phase 1|7|Actual|Universidad Politécnica de Cartagena||2|||f||||t||||||||||2017-10-11 02:13:09.63104|2017-10-11 02:13:09.63104
NCT01743911|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-12-04|||September 2010||2010-09-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Tadalafil Effects in Left Ventricle Diastolic Dysfunction in Resistant Hypertensive Patients|Phosphodiesterase-5 Inhibitor (Tadalafil) Two Weeks Administration Period Effects in Left Ventricle Diastolic Dysfunction and BNP Levels in Resistant Hypertensive Patients|Completed||N/A|20|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 02:13:09.727683|2017-10-11 02:13:09.727683
NCT01743898|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2014-08-01|||October 2012||2012-10-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|March 2013|Actual|2013-03-01||Observational|||A Prospective Pharmacodynamic Study of Rivaroxaban|A Prospective Pharmacodynamic Study of Rivaroxaban Using Peak and Trough Coagulation Test Results in Patients on Therapeutic Doses of Rivaroxaban|Completed||N/A|65|Anticipated|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-11 02:13:09.826826|2017-10-11 02:13:09.826826
NCT01743885|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-05-31|||November 2012||2012-11-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma|Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma|Terminated||Phase 3|55|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 02:13:09.926119|2017-10-11 02:13:09.926119
NCT01743872|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-06-15|||September 2012||2012-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|OPTIMISE||Optical Imaging Measurement of Intravascular Solution Efficacy Trial|Optical Imaging Measurement of Intravascular Solution Efficacy Trial|Completed||Phase 1/Phase 2|26|Actual|University Hospitals Cleveland Medical Center||3|||f||||t||||||||||2017-10-11 02:13:10.064664|2017-10-11 02:13:10.064664
NCT01743859|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-06-08|||December 6, 2012|Actual|2012-12-06|June 2017|2017-06-01|August 3, 2016|Actual|2016-08-03|April 27, 2016|Actual|2016-04-27||Interventional|||Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia|Sequential Treatment With Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia|Completed||Phase 2|37|Actual|University of Colorado, Denver||3|||f||||t||||||||No||2017-10-11 02:13:10.179741|2017-10-11 02:13:10.179741
NCT01743846|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-12-05|||January 2014||2014-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||CNAP Accuracy Dependent on Hemodynamic Variables|Accuracy of Continuous Non-invasive Arterial Pressure (CNAP) With Invasive Measurements Dependent on Cardiac Function, Vascular Resistance and Volume Status|Completed||N/A|50|Actual|University of Schleswig-Holstein|||1||f||||f||||||||||2017-10-11 02:13:10.288385|2017-10-11 02:13:10.288385
NCT01743833|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-04-24|||June 2011||2011-06-01|April 2017|2017-04-01|December 5, 2012|Actual|2012-12-05|December 5, 2012|Actual|2012-12-05||Interventional|||Effects of Thoracic Orthopedic Manual Therapy and Biopsychosocial Variables on Signs of Shoulder Impingement|Effects of Thoracic Orthopedic Manual Therapy and Biopsychosocial Variables on Signs of Shoulder Impingement: A Randomized Clinical Trial|Completed||N/A|97|Actual|UConn Health||4|||f||||f||||||||||2017-10-11 02:13:10.358515|2017-10-11 02:13:10.358515
NCT01743820|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-01-16|||September 2013||2013-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase2a Primaquine Dose Escalation Study|Phase 2a Dose Escalation Study of the Efficacy, Safety, and Pharmacokinetics of Low Dose Primaquine for Gametocytocidal Activity Against P. Falciparum in Sub-Saharan Africa and South East Asia|Completed||Phase 2|81|Actual|University of California, San Francisco||5|||f||||t||||||||||2017-10-11 02:13:10.544021|2017-10-11 02:13:10.544021
NCT01743807|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-11-22|||November 2012||2012-11-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia|A Phase I Study of GNKG168 in Pediatric Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (IND#113600)|Terminated||Phase 1|4|Actual|Therapeutic Advances in Childhood Leukemia Consortium||4||"SBI Biotech who provided the drug for this study has decided to no longer support the study or   GNKG168."|f||||t||||||||||2017-10-11 02:13:10.762921|2017-10-11 02:13:10.762921
NCT01743794|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-12-05|||January 2011||2011-01-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|January 2011|Actual|2011-01-01||Interventional|||Continuous Wound Infusion in Lumbar or Thoracic Surgery|Efficacy of Continuous Wound Infusion in Major Lumbar and Thoracic Spine Surgery : A Randomised, Double-blinded, Placebo-controlled Study|Completed||Phase 2/Phase 3|60|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 02:13:10.936821|2017-10-11 02:13:10.936821
NCT01743781|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-01-03|||July 2013||2013-07-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Uptake of Comprehensive Eye Examination Trial|The Impact of Multimedia Education on Uptake of Comprehensive Eye Examination in Rural Southern China:A Randomized, Controlled Trial|Completed||N/A|459|Actual|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 02:13:11.031954|2017-10-11 02:13:11.031954
NCT01743768|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-05-19|||December 2012||2012-12-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)|Clinical Study to Investigate Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of Multiple Doses of the Human GATA-3-specific DNAzyme Solution SB010 in Patients With Mild Allergic Asthma. A Randomised, Double-blind, Parallel, Multicentre, Phase-IIa Study|Completed||Phase 2|38|Actual|Sterna Biologicals GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 02:13:11.117606|2017-10-11 02:13:11.117606
NCT01743755|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-10-24|||December 2012||2012-12-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Santeon-CAP; Dexamethasone in Community-acquired Pneumonia|Santeon-CAP; Dexamethasone in Community-acquired Pneumonia.|Recruiting||Phase 4|600|Anticipated|St. Antonius Hospital||2|||f||||t||||||||||2017-10-11 02:13:11.248377|2017-10-11 02:13:11.248377
NCT01743742|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2014-08-22|||May 2013||2013-05-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Single High Dose Vitamin C, E in Severe Birth Asphyxia|Single High Dose Vitamin E and Vitamin C in Hypoxic Ischemic Encephalopathy (Following Birth Asphyxia)in Newborns|Completed||Phase 4|95|Actual|Sir Takhtasinhji General Hospital||1|||f||||f||||||||||2017-10-11 02:13:11.39737|2017-10-11 02:13:11.39737
NCT01743729|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-01-05|2016-08-09|2014-01-15|December 2012||2012-12-01|January 2017|2017-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Randomized population.|A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye|A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)|Completed||Phase 3|720|Actual|Shire||2|||f||||f||||||||||2017-10-11 02:13:11.504641|2017-10-11 02:13:11.504641
NCT01743716|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-03-14|||April 2013||2013-04-01|March 2016|2016-03-01||||June 2018|Anticipated|2018-06-01||Observational|||Genetic and Neural Predictors of Adolescent Depression|Towards Identification of Genetic and Neural Predictors of Adolescent Depression|Recruiting||N/A|100|Anticipated|Mclean Hospital|||4||f||||f||||||Samples With DNA|"     Adolescent participants will provide a saliva sample for DNA analysis.   "|||2017-10-11 02:13:11.836565|2017-10-11 02:13:11.836565
NCT01743703|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2012-12-04|||August 2011||2011-08-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|PEDIMA||Utility of Whole-body MRI in the Detection of Traumatic Injuries of Undetermined Origin in Children|Utility of Whole-body MRI (STIR and Diffusion Weighted) in the Detection of Traumatic Injuries of Undetermined Origin in Children|Unknown status|Recruiting|N/A|200|Anticipated|Rennes University Hospital||1|||f||||||||||||||2017-10-11 02:13:11.934038|2017-10-11 02:13:11.934038
NCT01743690|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-12-10|||March 2012||2012-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus|The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus|Completed||N/A|25|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-11 02:13:12.017208|2017-10-11 02:13:12.017208
NCT01743664|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-12-06|||May 2010||2010-05-01|December 2012|2012-12-01|February 2014|Anticipated|2014-02-01|March 2013|Anticipated|2013-03-01||Interventional|||The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis|The Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Patients With Post Traumatic Stress Disorder in Multiple Sclerosis. A Randomized Controlled Trial.|Unknown status|Recruiting|Phase 3|60|Anticipated|San Luigi Gonzaga Hospital||2|||f||||f||||||||||2017-10-11 02:13:12.203279|2017-10-11 02:13:12.203279
NCT01743651|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2014-05-27|||November 2012||2012-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis|A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis|Completed||Phase 3|353|Actual|Osmotica Pharmaceutical US LLC||3|||f||||t||||||||||2017-10-11 02:13:12.45975|2017-10-11 02:13:12.45975
NCT01743638|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-04-09|||April 2012||2012-04-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||MR-Guided Laser Ablation of Prostate Bed Recurrences|Technical Success, Safety, and Short-term Efficacy for MR-Guided Laser Ablation of Prostate Bed Recurrences|Withdrawn||N/A|0|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:13:12.669254|2017-10-11 02:13:12.669254
NCT01743625|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-10-18||2014-10-10|November 2012||2012-11-01|October 2016|2016-10-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain|A Phase 3 Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Evaluation of the Safety and Analgesic Efficacy of COV155 Tablets in Moderate to Severe Post-Operative Bunionectomy Pain Followed by an Open-Label Extension|Completed||Phase 3|406|Actual|Mallinckrodt||2|||f||||f||||||||||2017-10-11 02:13:12.749854|2017-10-11 02:13:12.749854
NCT01743612|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-06-01|||January 2012||2012-01-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|SPECIES||Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.|Laser SPEckle Contrast Imaging Interest in dEtection of Cutaneous Microvascular Dysfunction in Systemic Sclerosis.|Completed||N/A|101|Actual|University Hospital, Grenoble||3|||f||||f||||||||||2017-10-11 02:13:12.841994|2017-10-11 02:13:12.841994
NCT01743599|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-10-03|||February 2008||2008-02-01|October 2016|2016-10-01||||April 2011|Actual|2011-04-01||Observational|||Retrograde Ejaculation and Sexual Dysfunction in Men With Diabetes Mellitus||Completed||N/A|45|Actual|Odense University Hospital|||2||f||||||||||||||2017-10-11 02:13:12.95429|2017-10-11 02:13:12.95429
NCT01743586|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-16|2012-12-04|||August 2010||2010-08-01|November 2012|2012-11-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Respiratory Muscle Function Changes and Effects of Chest Physiotherapy Education Interventionin Advanced Lung Cancer|The Impact of Changes in Respiratory Muscle Function on Dyspnea, Functional Capacity, and Quality of Life in Patients With Advanced Lung Cancer & the Effects of Chest Physiotherapy Education Intervention|Unknown status|Active, not recruiting|N/A|102|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 02:13:13.060471|2017-10-11 02:13:13.060471
NCT01743573|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-12-05|||March 2009||2009-03-01|December 2012|2012-12-01||||March 2011|Actual|2011-03-01||Interventional|||Effects on Physical Fitness, Immunity, and Quality of Life of Yoga Training in Breast Cancer Survivors.|Effects on Physical Fitness, Immunity, and Quality of Life of Yoga Training in Breast Cancer Survivors.|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:13:13.186853|2017-10-11 02:13:13.186853
NCT01743547|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-11-05|||November 2012||2012-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study|THE EFFECTS OF YOGA ON QUALITY OF LIFE AMONG A POPULATION OF OVARIAN/ FALLOPIAN TUBE/ PRIMARY PERITONEAL CANCER PATIENTS RECEIVING CHEMOTHERAPY: A FEASIBILITY STUDY|Terminated||N/A|25|Actual|Northwestern University||2||"The investigators concluded that it is not feasible due to the lack of participation and   difficulty in recruiting patients."|f||||||||||||||2017-10-11 02:13:13.392629|2017-10-11 02:13:13.392629
NCT01743534|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2016-08-19|||July 2011||2011-07-01|May 2011|2011-05-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Observational|PRAXALIM||Conservation of Praxis in the Food and Alzheimer Disease|Impact of the Shape of Plates on the Conservation of Praxis in the Food at the Old Persons Suffering From Severe Insanities of Chap Alzheimer or Mixed in Institution.|Completed||N/A|32|Actual|University Hospital, Limoges|||1||f||||f||||||||||2017-10-11 02:13:13.468793|2017-10-11 02:13:13.468793
NCT01743521|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-02-28|2016-08-28||January 2013||2013-01-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|DARE-C||DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)|Direct Acting Antiviral (DAA) Based Therapy for Recently Acquired Hepatitis C|Completed||Phase 4|14|Actual|Kirby Institute||3|||f||||t||||||||No||2017-10-11 02:13:13.557796|2017-10-11 02:13:13.557796
NCT01743508|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-08-15|||April 2012||2012-04-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Misoprostol Treatment of Incomplete Abortion by Midwives and Physicians in Uganda|Misoprostol Treatment of Incomplete Abortion by Midwives and Physicians. A Randomized Control Trial in Uganda|Completed||N/A|731|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:13:14.27593|2017-10-11 02:13:14.27593
NCT01743495|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-03-01|||September 2012||2012-09-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|August 2017|Anticipated|2017-08-01||Interventional|CAPABLE500||CAPABLE for Frail Dually Eligible Older Adults|CAPABLE for Frail Dually Eligible Older Adults|Active, not recruiting||N/A|500|Anticipated|Johns Hopkins University||1|||f||||t||||||||No||2017-10-11 02:13:14.364473|2017-10-11 02:13:14.364473
NCT01743482|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-04|||January 2013||2013-01-01|December 2012|2012-12-01|April 2015|Anticipated|2015-04-01|January 2015|Anticipated|2015-01-01||Interventional|Pazotest-01||Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors|Phase II Study of Single-agent Pazopanib (Votrient®) for Patients With Relapsed or Refractory Germ-cell Tumors (GCT).|Unknown status|Not yet recruiting|Phase 2|43|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t||||||||||2017-10-11 02:13:14.44678|2017-10-11 02:13:14.44678
NCT01743456|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-05-13|||January 2011||2011-01-01|December 2012|2012-12-01|February 2015|Actual|2015-02-01|April 2014|Actual|2014-04-01||Interventional|||Depth of Anaesthesia and Postoperative Cognitive Decline in Patients Undergoing Heart Surgery|Effect of Depth of Anaesthesia on Postoperative Cognitive Decline in Patients Undergoing Coronary Artery Bypass Graft Surgery - a Prospectively Randomized Controlled Study|Completed||N/A|88|Actual|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-11 02:13:14.678142|2017-10-11 02:13:14.678142
NCT01743443|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2012-12-04|||March 2009||2009-03-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|CSK||Corneal Sensitivity Cross-linking Keratoconus|Corneal Sensitivity Changes Following Cross-linking for Progressive Lower Stage Keratoconus|Completed||Phase 2/Phase 3|19|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-10-11 02:13:14.754207|2017-10-11 02:13:14.754207
NCT01743430|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-12-05|||November 2008||2008-11-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|telerehab||Development of Smart Holistic Telerehabilitation System: An Application of Stroke Patients- 3 Years Study|1. Telerehabilitation on Balance in Subacute Stroke; 2.Telerehabilitation on Balance and Daily Activities in Chronic Stroke; 3. Telerehabilitation on Quality of Life in Chronic Stroke; 4. Telerehabilitation on Satisfaction in Stroke|Completed||Phase 2|80|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:13:14.843325|2017-10-11 02:13:14.843325
NCT01743417|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-05-19|||April 2011|Actual|2011-04-01|May 2017|2017-05-01|August 23, 2016|Actual|2016-08-23|August 23, 2016|Actual|2016-08-23||Interventional|CM_CCRT||Computerized Cognitive Rehabilitation in Children After Severe Malaria|Computerized Cognitive Rehabilitation in Children After Severe Malaria|Completed||N/A|300|Actual|Makerere University||3|||f||||f||||||||No||2017-10-11 02:13:14.923682|2017-10-11 02:13:14.923682
NCT01743404|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2012-12-04|||September 2007||2007-09-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|February 2013|Anticipated|2013-02-01||Interventional|||Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis|Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis|Unknown status|Recruiting|Phase 2|300|Anticipated|Institute for Atherosclerosis Research, Russia||2|||f||||t||||||||||2017-10-11 02:13:15.135858|2017-10-11 02:13:15.135858
NCT01743391|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2016-04-21|||January 2013||2013-01-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Hysteroscopy Before in Vitro Fertilization - Does it Improve the Outcome?||Recruiting||N/A|300|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 02:13:15.224701|2017-10-11 02:13:15.224701
NCT01743378|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-08-28|||February 2011||2011-02-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Ultrasound Guided Transversus Abdominis Plane Block With Ropivacaine vs Placebo for Abdominal Hysterectomy: a Double-blinded, Randomized Clinical Trial|Ultrasound Guided Transversus Abdominis Plane Block With Ropivacaine vs Placebo for Abdominal Hysterectomy: a Double-blinded, Randomized Clinical Trial|Completed||N/A|48|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 02:13:15.322969|2017-10-11 02:13:15.322969
NCT01743352|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-10-01|||March 2013||2013-03-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Observational|||Comparison of Ultrafast Echo With Echotracking|Protocole ULTRAFAST - ECHOTRACKING : Remodelage pariétal et rigidité artérielle Chez l'Hypertendu : Nouvelle étude de Leur Relation Utilisant l'élastographie Par Ultrafast-écho et la séparation Intima/média Par écho-tracking|Completed||N/A|57|Actual|French Cardiology Society|||2||f||||f||||||||||2017-10-11 02:13:15.554097|2017-10-11 02:13:15.554097
NCT01743339|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-04-25|||January 2013||2013-01-01|August 2016|2016-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress|A Randomized Controlled Trial of CBT for Insomnia in Patients With PTSD and Depression|Completed||N/A|110|Actual|University of Rochester||2|||f||||t||||||||Undecided|To be determined.|2017-10-11 02:13:15.638892|2017-10-11 02:13:15.638892
NCT01743326|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-01-15|||November 2012||2012-11-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||RFD Versus Cervical Medial Branch Blocks in Chronic Degenerative Neck Pain|Percutaneous Radiofrequency Denervation of the Cervical Facet Joints Compared With Cervical Medial Branch Block of the Facet Joints for Patients With Chronic Degenerative Neck Pain : A Prospective Randomized Clinical Study|Unknown status|Recruiting|N/A|84|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 02:13:15.739295|2017-10-11 02:13:15.739295
NCT01743313|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2017-08-05|||April 2012||2012-04-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|August 2012|Actual|2012-08-01||Observational|HyTe-2||Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement|Hyperglycemia in Joint Replacement Recipients: Glucose Metabolism Disorders and Metabolic Syndrome in Osteoarthritis Patients Before and After Primary Hip and Knee Replacement|Suspended||N/A|155|Actual|Coxa, Hospital for Joint Replacement|||1|Primary researcher not able to continue research at the moment.|f||||f||||||Samples Without DNA|"     Plasma samples (one per patient).   "|||2017-10-11 02:13:15.857277|2017-10-11 02:13:15.857277
NCT01743300|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-12-18|||July 2007||2007-07-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients|The Influence of Genotype/Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib (Sutent, SU011248) in Patient With Imatinib Resistant Gastrointestinal Stromal Cell Tumor (GIST) or Metastatic Renal Cell Carcinoma|Completed||Phase 1|15|Actual|Leiden University Medical Center||2|||f||||t||||||||||2017-10-11 02:13:15.960589|2017-10-11 02:13:15.960589
NCT01743287|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-04-29|||December 2012||2012-12-01|July 2014|2014-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ABSOLUTE-OS||The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee|A Six-month, Multi Center, Randomized, Double Blind, Parallel-group, Placebo Controlled Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee|Completed||Phase 4|234|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:13:16.063491|2017-10-11 02:13:16.063491
NCT01743274|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2016-08-04|||October 2012||2012-10-01|March 2015|2015-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|DOCTORS||Does Optical Coherence Tomography Optimise Results of Stenting|Does Optical Coherence Tomography Optimise Results of Stenting: The DOCTORS Study|Unknown status|Active, not recruiting|N/A|230|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-11 02:13:16.195294|2017-10-11 02:13:16.195294
NCT01743261|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-12-05|||January 2007||2007-01-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2010|Actual|2010-01-01||Interventional|||Cost/Utility Ratio in the Management of Patients With Acquired Severe Brain Injury|Cost/Utility Ratio in the Management of Patients With Acquired Severe Brain Injury: Comparison Between a Programme of In-hospital Graded Intensity Rehabilitation and Usual Care.|Completed||N/A|249|Actual|Fondazione Don Carlo Gnocchi Onlus||2|||f||||f||||||||||2017-10-11 02:13:16.307722|2017-10-11 02:13:16.307722
NCT01743248|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2012-12-04|||August 2012||2012-08-01|December 2012|2012-12-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Observational|||Vestibular Schwannoma and Psychological Factors|Evaluation of the Influence of Psychological Factors on Balance Control Compensation After Vestibular Schwannoma Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Central Hospital, Nancy, France|||1||f||||t||||||||||2017-10-11 02:13:16.383973|2017-10-11 02:13:16.383973
NCT01743235|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-03-28|||July 2012||2012-07-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems|A Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Investigate the Safety and Efficacy of Lybridos in the Domestic Setting in Healthy Female Subjects With Hypoactive Sexual Desire Disorder and Maladaptive Activity of Sexual Inhibitory Mechanisms|Completed||Phase 2|207|Actual|Emotional Brain NY Inc.||7|||f||||f||||||||||2017-10-11 02:13:16.465823|2017-10-11 02:13:16.465823
NCT01743222|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2013-03-05|||January 2012||2012-01-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Intralymphatic eASC Administration in Healthy Volunteers|Cx621-0101 Phase I Clinical Trial in Healthy Volunteers to Evaluate the Feasibility and Safety of the Intralymphatic Administration Technique of Expanded Allogeneic Adipose-derived Stem Cells (eASCs)|Completed||Phase 1|10|Actual|Cellerix||2|||f||||f||||||||||2017-10-11 02:13:16.57668|2017-10-11 02:13:16.57668
NCT01743209|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-09-05|||December 2012||2012-12-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|EPIPARA||Descriptive Epidemiology Study for Patients With Paraphilia Sex Offenders and Receiving Androgen Antagonists|A Retrospective Non-interventional Descriptive Epidemiology Study for Patients With Paraphilia Sex Offenders Receiving Androgen Antagonists Treatment|Completed||N/A|213|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-11 02:13:16.652603|2017-10-11 02:13:16.652603
NCT01743196|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-10-20|||May 2012||2012-05-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|August 2012|Actual|2012-08-01||Observational|||Folate Metabolism in Normal Weight and Obese Women of Child-bearing Age|Pilot Study of Folate Pharmacokinetics in Normal Weight and Obese Women of Child-bearing Age|Completed||N/A|32|Actual|University of Georgia|||2||f||||f||||||Samples With DNA|"     Buffy Coat Serum samples Plasma samples   "|||2017-10-11 02:13:16.72586|2017-10-11 02:13:16.72586
NCT01743183|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2012-12-04|||September 2012||2012-09-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness|Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness|Completed||N/A|4|Actual|Universidade Federal do Rio Grande do Norte||1|||f||||t||||||||||2017-10-11 02:13:16.800952|2017-10-11 02:13:16.800952
NCT01743170|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-07-18|||November 2017|Anticipated|2017-11-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|LAPTOHP||Telemonitoring of Hypertensive Patients|Leuven Academic Programme for Telemonitoring of Hypertensive Patients|Not yet recruiting||N/A|240|Anticipated|Katholieke Universiteit Leuven||2|||f||||f|f|f||||||||2017-10-11 02:13:16.8766|2017-10-11 02:13:16.8766
NCT01743131|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-01-24|||February 2013||2013-02-01|January 2017|2017-01-01|February 2023|Anticipated|2023-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Abatacept as GVHD Prophylaxis Phase 2|Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial|Recruiting||Phase 2|180|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 02:13:17.227261|2017-10-11 02:13:17.227261
NCT01743118|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2013-07-16|||March 2013||2013-03-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris|Phase Ib, Two-centre, Randomised, Observer-blind, Placebo- and Comparator Controlled Trial to Evaluate the Safety, Tolerability and Antipsoriatic Efficacy of Three Strengths of a Topical SPS4251 Formulation in a Psoriasis Plaque Test|Completed||Phase 1|24|Actual|Circassia Limited||1|||f||||f||||||||||2017-10-11 02:13:17.400765|2017-10-11 02:13:17.400765
NCT01743105|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-03-25|||August 2013||2013-08-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|EDDRA-Repro||Reproductibility of TM-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the ER|Reproductibility of Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the Emergency Room|Completed||N/A|26|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-11 02:13:17.501034|2017-10-11 02:13:17.501034
NCT01743092|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-03-10|2015-10-14||November 2012||2012-11-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|November 2014|Actual|2014-11-01||Interventional|||Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment|Meeting the Unique Treatment Needs of Female Gamblers: A Workbook and Webinar Effectiveness Pilot Study|Completed||N/A|59|Actual|Centre for Addiction and Mental Health|The samples were recruited by advertisements and thus were not a true random sample of the population.|2|||f||||f||||||||||2017-10-11 02:13:17.603913|2017-10-11 02:13:17.603913
NCT01743079|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2013-07-29|||January 2009||2009-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B|The Efficacy and Safety of Telbivudine and Lamivudine Use in Highly Viremic Mothers to Prevent Hepatitis B Transmission|Completed||Phase 4|700|Actual|Beijing YouAn Hospital||3|||f||||t||||||||||2017-10-11 02:13:17.906304|2017-10-11 02:13:17.906304
NCT01743066|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2012-12-04|||October 2010||2010-10-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Vitamin E Level in Buccal Cells of Arsenicosis Patients|Vitamin E Level in Buccal Cells of Arsenicosis Patients Following Vitamin E Supplementation|Completed||N/A|60|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||3|||f||||f||||||||||2017-10-11 02:13:18.01952|2017-10-11 02:13:18.01952
NCT01743053|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2016-06-07|||January 2013||2013-01-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers||Completed||Phase 4|52|Actual|Avita Medical||2|||f||||f||||||||||2017-10-11 02:13:18.110462|2017-10-11 02:13:18.110462
NCT01743027|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-07-18|2014-07-18||January 2013||2013-01-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||This analysis population includes all randomized participants.|Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis|Phase 3, Efficacy and Safety Study of AL-4943A Ophthalmic Solution, 0.77% in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model|Completed||Phase 3|902|Actual|Alcon Research||4|||f||||f||||||||||2017-10-11 02:13:18.617776|2017-10-11 02:13:18.617776
NCT01743014|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-12-04|||July 2012||2012-07-01|November 2012|2012-11-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy|A Prospective, Randomized, Two Period, With an Intermediate Wash Out Period, Cross-over Study to Compare the Effects of Either Combined Therapy With Ramipril and Clopidogrel or Ramipril Monotherapy on Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Patients With Type 2 Diabetes and Diabetic Nephropathy|Unknown status|Recruiting|Phase 4|60|Anticipated|AHEPA University Hospital||2|||f||||t||||||||||2017-10-11 02:13:19.498651|2017-10-11 02:13:19.498651
NCT01743001|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2016-12-21|||May 2013||2013-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|MAESTRO||Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome|A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 3 Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome|Completed||Phase 3|220|Actual|Actelion||2|||f||||t||||||||||2017-10-11 02:13:19.645705|2017-10-11 02:13:19.645705
NCT01742988|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2016-11-22|||December 2012||2012-12-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Patients With Lymphoma or Multiple Myeloma|Phase I Open Label, Multi-center, Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered CUDC-907, a PI3K and HDAC Inhibitor, in Subjects With Refractory or Relapsed Lymphoma or Multiple Myeloma|Recruiting||Phase 1|138|Anticipated|Curis, Inc.||10|||f||||f||||||||||2017-10-11 02:13:19.901604|2017-10-11 02:13:19.901604
NCT01742975|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-08-25|||November 2011||2011-11-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|April 2015|Actual|2015-04-01||Interventional|Ifabond||Efficacy Study of Ifabond in Breast Cancer Surgery|A Randomized Study Evaluating the Efficacy of the Synthetic Adhesive Solution Ifabond, in Reducing Seroma Formation Post Surgery in Breast Cancer Patients, When Used in Partial Mastectomy With or Without Axillary Lymph Node Dissection|Completed||N/A|104|Actual|Hôpital Européen Marseille||2|||f||||f||||||||||2017-10-11 02:13:20.050843|2017-10-11 02:13:20.050843
NCT01742962|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-07-01|||December 2012||2012-12-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Observational|||Prevalence of Neglected Side Effects to Radical Prostatectomy|Prevalence of Neglected Side Effects to Radical Prostatectomy|Completed||N/A|396|Actual|Copenhagen University Hospital at Herlev|||1||f||||f||||||||||2017-10-11 02:13:20.156174|2017-10-11 02:13:20.156174
NCT01742936|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-07-25|2016-05-02||February 2013||2013-02-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Point of Care Testing in Pediatric Patients Undergoing Major Surgery|Point of Care Testing for Coagulation Function Versus Standard Laboratory Testing in Pediatric Patients Undergoing Major Surgery|Completed||N/A|100|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 02:13:20.376508|2017-10-11 02:13:20.376508
NCT01742923|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-11-17|||December 2012||2012-12-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Tailored Intervention to Improve Medication Adherence in Patients With Hypertension|Pharmacist Intervention Programme in Secondary Care to Improve Medication Adherence in Patients With Hypertension|Completed||N/A|532|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 02:13:20.647394|2017-10-11 02:13:20.647394
NCT01742910|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-04|||April 2008||2008-04-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|June 2011|Actual|2011-06-01||Interventional|||Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two Microincision IOLs: Tecnis ZCB00 and Acrysof SA60AT||Completed||N/A|54|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 02:13:20.747807|2017-10-11 02:13:20.747807
NCT01742897|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-05-29|2013-01-21||August 2008||2008-08-01|May 2013|2013-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety Study of Transdermal Therapeutic System (TTS) Fentanyl in Participants With Osteoarthritis Knee Pain|Evaluation of Efficacy and Safety of TTS-Fentanyl in Moderate to Severe Pain From Knee Osteoarthritis|Completed||Phase 4|35|Actual|Janssen-Cilag Ltd.,Thailand||1|||f||||f||||||||||2017-10-11 02:13:20.83616|2017-10-11 02:13:20.83616
NCT01742884|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-01-07|||December 2012||2012-12-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz|Evaluation of the Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz|Completed||Phase 4|50|Actual|Instituto Universitario de Oftalmobiología Aplicada||2|||f||||f||||||||||2017-10-11 02:13:21.036332|2017-10-11 02:13:21.036332
NCT01742871|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2012-12-04|||August 2012||2012-08-01|December 2012|2012-12-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Nutritional Status of Patients Victims of Haemorragic Accidents With Antivitamins K|Nutritional Status of Patients Victims of Haemorragic Accidents With Antivitamins K|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-11 02:13:21.141104|2017-10-11 02:13:21.141104
NCT01742858|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-03-31|||February 2013||2013-02-01|March 2016|2016-03-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Normative Data of Brain Network Activation|Establishment of Normative Data of Brain Network Activation Analysis (BNA) Using Evoked Response Potentials, in Adolescents and Young Adults|Withdrawn||N/A|0|Actual|ElMindA Ltd|||3|The study was halted due to logistical reasons.|f||||f||||||||||2017-10-11 02:13:21.234366|2017-10-11 02:13:21.234366
NCT01742845|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-03|||April 2011||2011-04-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|CERVECHO||Ultrasound-guided Intermediate Cervical Block Versus Superficial Cervical Block for Carotid Endarterectomy (CERVECHO)|Ultrasound-guided Intermediate Cervical Block Versus Superficial Cervical Block for Carotid : a Randomised Controlled Trial|Completed||N/A|86|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-10-11 02:13:21.314483|2017-10-11 02:13:21.314483
NCT01742832|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-04-19|2017-03-07||May 2013||2013-05-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Double-Blind Treatment of Major Depressive Disorder With Vilazodone|Double-Blind Switch Study of Vilazodone in the Treatment of Major Depressive Disorder Following Partial Response to or Inability to Tolerate a Generic SSRI|Completed||Phase 2|79|Actual|University of Chicago|The sample size was likely too small to make comments about predictors of outcome and generally the study was under-powered, which would make differences difficult to detect. The study design enrolled only non-responders into the double-blind phase.|2|||f||||t||||||||||2017-10-11 02:13:21.421183|2017-10-11 02:13:21.421183
NCT01742819|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-12-04|||May 2012||2012-05-01|December 2015|2015-12-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|AGPS||Advanced Glaucoma Progression Study|Detection of Glaucoma Progression Study With Macular OCT Imaging|Active, not recruiting||N/A|150|Anticipated|University of California, Los Angeles|||1||f||||f||||||||||2017-10-11 02:13:21.773973|2017-10-11 02:13:21.773973
NCT01742806|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-12-03|||October 2012||2012-10-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Interventional|||Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer|Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer: Multicenter Prospective Randomized Comparison Study|Unknown status|Recruiting|N/A|120|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 02:13:21.863657|2017-10-11 02:13:21.863657
NCT01742065|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-10-03|||January 2013||2013-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|STOPCRC||Strategies and Opportunities to Stop Colon Cancer in Priority Populations|Strategies and Opportunities to Stop Colon Cancer in Priority Populations|Recruiting||N/A|20000|Anticipated|Kaiser Permanente||2|||f||||t|f|f||||||||2017-10-11 02:13:32.917821|2017-10-11 02:13:32.917821
NCT01742793|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-02-26|||October 2012||2012-10-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|RID||An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)|An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)|Terminated||Phase 1/Phase 2|12|Actual|Yale University||2|||f||||t||||||||||2017-10-11 02:13:22.014527|2017-10-11 02:13:22.014527
NCT01742767|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-04|||November 2012||2012-11-01|December 2012|2012-12-01|April 2015|Anticipated|2015-04-01|May 2014|Anticipated|2014-05-01||Interventional|PemSplitCisp||Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC|Randomized Phase II Trial of Three-weekly Cisplatinum and Pemetrexed Versus Split-dose d1 and d8 Cisplatinum and Pemetrexed In Advanced and Inoperable Non-squamous Non-small-cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|||Universität Duisburg-Essen||2|||f||||t||||||||||2017-10-11 02:13:22.296126|2017-10-11 02:13:22.296126
NCT01742754|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-11-11|||October 2012||2012-10-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Fecal Microbiota Transplantation for Ulcerative Colitis|Evaluation of Durability of Fecal Microbiota Transplantation in Patients With Mild to Moderate Ulcerative Colitis|Terminated||N/A|7|Actual|University of Washington||1||IND required by the FDA for all future FMTs.|f||||f||||||||||2017-10-11 02:13:22.4071|2017-10-11 02:13:22.4071
NCT01742741|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2013-09-06|||May 2013||2013-05-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (France)|Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (France)|Completed||N/A|5|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 02:13:22.499462|2017-10-11 02:13:22.499462
NCT01742728|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-12-03|||May 2009||2009-05-01|December 2012|2012-12-01|March 2015|Anticipated|2015-03-01|March 2012|Actual|2012-03-01||Observational|||Nagasaki and Tokushima|Oxidative Stress in Community-dwelling Adults|Unknown status|Recruiting|N/A|2000|Anticipated|University of Tokushima|||3||f||||||||||||||2017-10-11 02:13:22.613674|2017-10-11 02:13:22.613674
NCT01742715|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-12-02|||December 2012||2012-12-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Three Methods for Best PEEP Determination Compared With PEEP Determination Guided by Adult Respiratory Distress Syndrome (ARDS) Network|Three Methods for Best PEEP Determination Compared With PEEP Determination Guided by Adult Respiratory Distress Syndrome (ARDS) Network, a Crossover Study.|Unknown status|Not yet recruiting|N/A|20|Anticipated|Wolfson Medical Center||3|||f||||f||||||||||2017-10-11 02:13:22.720576|2017-10-11 02:13:22.720576
NCT01742702|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-05-02|||May 25, 2006|Actual|2006-05-25|May 2017|2017-05-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|DYNAMIC||HaemoDYNAMICs in Primary and Secondary Hypertension|Non-Invasive HaemoDYNAMICs in Primary and Secondary Hypertension: the DYNAMIC-study|Recruiting||N/A|2000|Anticipated|University of Tampere|||7||f||||f||||||Samples With DNA|"     Whole blood, serum, urine   "|Undecided||2017-10-11 02:13:22.837971|2017-10-11 02:13:22.837971
NCT01742689|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-04|||March 2012||2012-03-01|December 2012|2012-12-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic|Assessment of Analgesic Efficacy of Intranasal Desmopressin in the Treatment of Acute Pain in Patients With Renal Colic|Unknown status|Recruiting|Phase 3|88|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:13:22.98827|2017-10-11 02:13:22.98827
NCT01742676|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-08-04|||April 2011||2011-04-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|SINGLE||A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients|A Single Center, Open-label, Randomized Pilot Study to Evaluate the Safety and Efficacy of Modified-release Tacrolimus, ADVAGRAF®, Versus Those of Twice-daily Tacrolimus, PROGRAF®, in Stable Renal Recipients (SINGLE)|Completed||Phase 4|100|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:13:23.120059|2017-10-11 02:13:23.120059
NCT01742663|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2014-01-19|||October 2012||2012-10-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis|A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Diclofenac Sodium Gel 3% (Taro Pharmaceuticals Inc.) to Solaraze® (Diclofenac Sodium) Gel 3% (Fougera Pharms) in the Treatment of Actinic Keratosis.|Completed||Phase 1|435|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 02:13:23.280741|2017-10-11 02:13:23.280741
NCT01742650|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-05-13|||July 2010||2010-07-01|May 2016|2016-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Screw Versus Tightrope Syndesmotic Injury Fixation in Weber C Ankle Fractures|Screw Versus Tightrope Syndesmotic Injury Fixation in Weber C Ankle Fractures. A Prospective Randomized Study.|Completed||N/A|38|Actual|University of Oulu||2|||f||||f||||||||No||2017-10-11 02:13:23.465343|2017-10-11 02:13:23.465343
NCT01742637|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-05-03|||October 2012||2012-10-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris|A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% (Taro Pharmaceuticals Inc.) to Epiduo® (Galderma Laboratories, L.P., Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%) and Both Active Treatments to a Placebo in the Treatment of Acne Vulgaris.|Completed||Phase 1|2008|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 02:13:23.593828|2017-10-11 02:13:23.593828
NCT01741298|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-30|||March 2008||2008-03-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|CHARMS||Biobehavioral Bases & Management of Metabolic Syndrome (CHARMS)|Biobehavioral Bases & Management of Metabolic Syndrome|Completed||N/A|112|Actual|University of Miami||1|||f||||f||||||||||2017-10-11 02:13:47.770074|2017-10-11 02:13:47.770074
NCT01742624|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-10-08|||April 2012||2012-04-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|AdProCISE||Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation|Multicenter, Open-label, Parallel Clinical Investigation of the Safety and Efficacy of Advagraf® (Extended Release Tacrolimus) vs. Prograf® (Tacrolimus) in de Novo Kidney Recipients 1 Month After Kidney Transplantation|Completed||Phase 4|60|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:13:23.738206|2017-10-11 02:13:23.738206
NCT01742611|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2015-06-08|||March 2013||2013-03-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis|ASP1585 Phase 3 Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis|Completed||Phase 3|105|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:13:23.856411|2017-10-11 02:13:23.856411
NCT01742598|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-03-09|||December 2015||2015-12-01|December 2015|2015-12-01|November 2020|Anticipated|2020-11-01|July 2016|Anticipated|2016-07-01||Interventional|Portico TA EU||Assessment of St Jude Medical Portico Re-sheathable Transapical Aortic Valve System||Withdrawn||N/A|0|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 02:13:23.984011|2017-10-11 02:13:23.984011
NCT01742585|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2014-07-15|||October 2012||2012-10-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis|ASP1585 Phase 3 Randomized Double Blind Placebo-controlled Study in Chronic Kidney Disease (CKD) Patients With Hyperphosphatemia Not on Dialysis|Completed||Phase 3|163|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:13:24.100128|2017-10-11 02:13:24.100128
NCT01742572|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-09-18|||November 2012||2012-11-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|New DIETs||New DIETs: New Dietary Interventions Enhancing the Treatment for Weight Loss|NEW Dietary Interventions to Enhance the Treatments for Weight Loss (NEW DIETs for Weight Loss Study)|Completed||Phase 1|63|Actual|University of South Carolina||5|||f||||f||||||||||2017-10-11 02:13:25.200703|2017-10-11 02:13:25.200703
NCT01742559|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-12-02|||January 2009||2009-01-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|||The Anesthetic Effect of Anterior Middle Superior Alveolar Technique|The Anesthetic Effect of Anterior Middle Superior Alveolar Technique (AMSA) for Non-surgical Periodontal Procedures: a Randomized Controlled Clinical Study|Completed||N/A|30|Actual|State University of Maringá||2|||f||||t||||||||||2017-10-11 02:13:25.363997|2017-10-11 02:13:25.363997
NCT01742546|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2013-02-21|||June 2012||2012-06-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|MPS||Effectiveness of Ultrasound Combine TENS in Treatment of Upper Trapezius Myofascial Pain|Effectiveness of Ultrasound Combine Transcutaneous Electrical Nerve Stimulation (TENS) in Treatment of Upper Trapezius Myofascial Pain: a Randomized Controlled Trial|Completed||N/A|40|Actual|Sirindhorn National Medical Rehabilitation Centre||2|||f||||t||||||||||2017-10-11 02:13:25.537546|2017-10-11 02:13:25.537546
NCT01742533|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-12-02|||March 2012||2012-03-01|December 2012|2012-12-01|March 2014|Anticipated|2014-03-01|June 2013|Anticipated|2013-06-01||Interventional|||Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure|A Phase Ι/Π Study of Human Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Hormone Replacement Therapy in Patients With Premature Ovarian Failure|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Shenzhen Beike Bio-Technology Co., Ltd.||4|||f||||t||||||||||2017-10-11 02:13:25.710176|2017-10-11 02:13:25.710176
NCT01742520|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2013-06-09|||January 2013||2013-01-01|June 2013|2013-06-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Neurodevelopmental Outcomes of Preterm Infants Treated for Pain Management With Repeated Doses of Sucrose 24%|Its an Interventional Study That Will Evaluate the Effect of Different Doses of Sucrose 24% on Neurodevelopmental Outcome of Preterm Infants|Unknown status|Recruiting|N/A|90|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:13:25.892268|2017-10-11 02:13:25.892268
NCT01742507|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-07-24|||April 2012||2012-04-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|OCT-ORION||A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study|A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study|Completed||Phase 4|60|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:13:26.063454|2017-10-11 02:13:26.063454
NCT01742494|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-12-02|||August 2011||2011-08-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Comparison Study of Conventional POEM and Hybrid POEM for Esophageal Achalasia|Peroral Endoscopic Myotomy for Esophageal Achalasia: Randomized Comparison of Water-Jet Assisted Versus Conventional Dissection Technique|Unknown status|Recruiting|N/A|100|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-11 02:13:26.227197|2017-10-11 02:13:26.227197
NCT01742481|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-05-10|||August 2010||2010-08-01|May 2016|2016-05-01|November 2012|Actual|2012-11-01|March 2011|Actual|2011-03-01||Interventional|SPEAC||Study to Education Childhood Cancer Survivors About Survivorship Care|Childhood Cancer Survivor Program to Empower Action in Care|Completed||N/A|50|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 02:13:26.400467|2017-10-11 02:13:26.400467
NCT01742468|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-10-06|||February 2013||2013-02-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Intervention With Long-chain n-3 Polyunsaturated Fatty Acids From Microalgae Oil in Patients With Rheumatoid Arthritis|Intervention With Products Enriched With Long Chain n-3 Polyunsaturated Fatty Acids (n-3 LC-PUFA) From Microalgae Oil in Patients With Rheumatoid Arthritis - Influence on Disease Activity and Inflammation Status|Completed||N/A|38|Actual|University of Jena||2|||f||||t||||||||||2017-10-11 02:13:26.508879|2017-10-11 02:13:26.508879
NCT01742455|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-06-17|||February 2010||2010-02-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Assessment of Natural Bypasses in the Lower Limb|Quantitative Assessment of the Peripheral Artery Collateral Circulation in Patients With and Without Coronary Artery Disease (Pilot Study)|Completed||N/A|30|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||Samples Without DNA|"     Blood samples (routine)   "|||2017-10-11 02:13:26.636659|2017-10-11 02:13:26.636659
NCT00000515|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||July 1984||1984-07-01|February 2005|2005-02-01|September 1992|Actual|1992-09-01|||||Interventional|||Randomized Trial of Dietary Intervention Therapy in Obese Hypertensives (DITOH)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:58.953732|2017-10-11 04:18:58.953732
NCT01742442|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-11-07|||January 2013||2013-01-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2015|Actual|2015-04-01||Observational|||Cancer in the Elderly: Prevalence and Impact of Age Related Problems|Cancer in the Elderly: Prevalence and Impact of Age Related Problems. A Prospective Observational Study|Active, not recruiting||N/A|300|Anticipated|Sykehuset Innlandet HF|||1||f||||f||||||Samples Without DNA|"     Blood samples (serum and EDTA blood) for analysis of inflammatory markers. Dependent on the     study results and results from other studies that may emerge during the study conduct,     analyses of other markers of ageing may also be conducted   "|||2017-10-11 02:13:26.731151|2017-10-11 02:13:26.731151
NCT01742429|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2014-08-28|||November 2012||2012-11-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Levoﬂoxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection||Completed||Phase 4|200|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 02:13:26.856165|2017-10-11 02:13:26.856165
NCT01742416|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2014-12-19|||November 2012||2012-11-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Ultrasound Assisted Arterial Cannulation in Small Children|Ultrasound Assisted Arterial Cannulation in Small Children - To See or Not to See?|Completed||N/A|40|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 02:13:26.974637|2017-10-11 02:13:26.974637
NCT01742403|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2017-05-01|||January 2013||2013-01-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|KIM Gating||Continuous Monitoring of Prostate Position During Radiotherapy|Phase I Feasibility Study of Prostate Cancer Radiotherapy Gating Using kV Intrafraction Monitoring (KIM)|Recruiting||N/A|100|Anticipated|Royal North Shore Hospital||1|||f||||f||||||||Yes|With other ethics approved centres using annonymised data.|2017-10-11 02:13:27.084821|2017-10-11 02:13:27.084821
NCT01742390|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2013-03-13|||February 2013||2013-02-01|March 2013|2013-03-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders||Unknown status|Recruiting|Phase 4|120|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 02:13:27.186603|2017-10-11 02:13:27.186603
NCT01742377|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2015-04-11|||February 2010||2010-02-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|MCE||Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients|i-Scan Endoscopy in the Detection of Minimal Change Esophagitis in Dyspeptic Patients With or Without Gastroesophageal Reflux Disease by Gerd Q Questionnaire and by 24 Hour pH Monitoring.|Completed||N/A|174|Actual|Prince of Songkla University|||3||f||||t||||||||||2017-10-11 02:13:27.284679|2017-10-11 02:13:27.284679
NCT01742364|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-12-15|2016-04-06||December 2012||2012-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Infants (n=66) and Adults (n=30)|Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe|A Randomized Clinical Trial in Adults and Newborns to Compare the Safety, Reactogenicity and Immunogenicity of BCG Administration Via a Disposable Syringe Jet Injector (DSJI) to BCG Administration Via Syringe and Needle|Completed||N/A|96|Actual|PATH||2|||f||||t||||||||No||2017-10-11 02:13:27.406766|2017-10-11 02:13:27.406766
NCT01742351|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2013-05-02|||January 2013||2013-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Internet-based Cognitive Behaviour Therapy (CBT) for Persons Diagnosed With Bipolar II|Internet-based Cognitive Behaviour Therapy for Persons Diagnosed With Bipolar II - a Pilot Study|Completed||N/A|7|Actual|Örebro County Council||1|||f||||f||||||||||2017-10-11 02:13:28.068375|2017-10-11 02:13:28.068375
NCT01742338|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-09-29|||May 2012||2012-05-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|DOSE||Dose of Corticosteroids in COPD|Determining Optimal Dose of Corticosteroids in COPD Exacerbations: A Pilot Study|Recruiting||Phase 4|125|Anticipated|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 02:13:28.127894|2017-10-11 02:13:28.127894
NCT01742325|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-12-03|||January 2010||2010-01-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||The Effect of Walking Intervention on Sleep Related Symptom Distress in Pediatric Oncology Patients|The Effect of Walking Intervention on Sleep Related Symptom Distress in Pediatric Oncology Patients|Unknown status|Recruiting|N/A|55|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 02:13:28.223977|2017-10-11 02:13:28.223977
NCT01742312|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-02-17|||October 2011||2011-10-01|February 2016|2016-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|Oeso-Chemo||Effects of Chemotherapy on Muscle Mass and Exercise Performance in Patients With Oesophageal Cancer.|Effect of Neoadjuvant Chemotherapy on Muscle Mass and Peri-operative Cardiorespiratory Performance in Patients Undergoing Oesophageal Cancer- a Pilot Study|Completed||N/A|25|Actual|University of Nottingham|||1||f||||t||||||Samples Without DNA|"     blood tests for serum albumin and total protien levels.   "|||2017-10-11 02:13:28.303911|2017-10-11 02:13:28.303911
NCT01742299|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-05-15|||March 26, 2013|Actual|2013-03-26|May 2017|2017-05-01|June 21, 2024|Anticipated|2024-06-21|June 21, 2024|Anticipated|2024-06-21||Interventional|||Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator|An Open Label, Multi-center Imatinib Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Imatinib Study and Are Judged by the Investigator to Benefit From Continued Imatinib Treatment|Active, not recruiting||Phase 4|152|Actual|Novartis||1|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 02:13:28.446364|2017-10-11 02:13:28.446364
NCT01742260|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-06-07|||July 2013||2013-07-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Cranial Reconstruction Using Mesenchymal Stromal Cells and Resorbable Biomaterials|A Pilot Study to Demonstrate Safety and Feasibility of Cranial Reconstruction Using Mesenchymal Stromal Cells and Resorbable Biomaterials|Recruiting||Phase 1|10|Anticipated|Royal Perth Hospital||1|||f||||t||||||||||2017-10-11 02:13:28.936784|2017-10-11 02:13:28.936784
NCT01742247|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-03-29|||September 2012||2012-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|||Assessment of Needs of Moisturizers After Various Laser Treatments|Phase 4 Study of Assessment of Needs of Moisturizers After Various Laser Treatment|Completed||Phase 4|20|Actual|Pusan National University Hospital||1|||f||||f||||||||||2017-10-11 02:13:29.011441|2017-10-11 02:13:29.011441
NCT01742234|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-03-23|||August 2008||2008-08-01|March 2017|2017-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||RELIVE Informed Consent Study|Renal and Lung Living Donors Evaluation (RELIVE) Informed Consent Study|Completed||N/A|624|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 02:13:29.10269|2017-10-11 02:13:29.10269
NCT01742221|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2013-04-25|||August 2012||2012-08-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure|A Phase 1b, Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HemaMax™ (rHuIL-12) in Healthy Subjects|Completed||Phase 1|60|Actual|Neumedicines Inc.||2|||f||||t||||||||||2017-10-11 02:13:31.192917|2017-10-11 02:13:31.192917
NCT01742208|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-01-28||2015-01-14|February 2013||2013-02-01|January 2015|2015-01-01||||January 2014|Actual|2014-01-01||Interventional|||Safety and Efficacy of LX4211 in Patients With Inadequately Controlled Type 1 Diabetes Mellitus|A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of LX4211 in Patients With Inadequately Controlled Type 1 Diabetes Mellitus|Completed||Phase 2|36|Actual|Lexicon Pharmaceuticals||3|||f||||||||||||||2017-10-11 02:13:31.306508|2017-10-11 02:13:31.306508
NCT01742195|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-09-10|||November 2012||2012-11-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Comparison of Patient Comfort With the Nasal and Oral Insertion of the Endobronchial Ultrasound Bronchoscope|Randomized Study Comparing the Oral and Nasal Routes for Linear Endobronchial Ultrasound|Completed||N/A|220|Actual|Laval University||2|||f||||f||||||||||2017-10-11 02:13:31.410392|2017-10-11 02:13:31.410392
NCT01742182|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-03-22|||June 2012||2012-06-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease|Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease|Recruiting||N/A|80|Anticipated|Massachusetts General Hospital||4|||f||||f||||||||||2017-10-11 02:13:31.512966|2017-10-11 02:13:31.512966
NCT01742169|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-01-06|||January 2013||2013-01-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Improving Rates of Colorectal Cancer Screening Among Never Screened Patients|Center for Advancing Equity in Clinical Preventive Services Project 1B: Improving Rates of Colorectal Cancer Screening Among Never Screened Patients|Completed||N/A|420|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 02:13:31.609372|2017-10-11 02:13:31.609372
NCT01742156|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-04-05|||January 2013||2013-01-01|April 2017|2017-04-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Observational|||Single Blind Randomized Study to Determine the Sensitivity and Specificity of 2 Non-invasive Markers of Early Coronary Disease||Terminated||N/A|10|Actual|McGill University Health Center|||2|inadequate number of recruita|f||||f||||||||||2017-10-11 02:13:31.690545|2017-10-11 02:13:31.690545
NCT01742143|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-02-01|||November 2012||2012-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Impact of ICCAN on Cancer Treatment Completion and Quality of Life|A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life|Active, not recruiting||N/A|158|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 02:13:31.773525|2017-10-11 02:13:31.773525
NCT01742130|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2013-11-05|||January 2011||2011-01-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Early Hydration in Acute Myocardial Infarction|Early Hydration in Acute Myocardial Infarction: Sodium Bicarbonate Versus Saline for the Prevention on Contrast-induced Acute Kidney Injury|Completed||Phase 4|300|Actual|Ospedale Misericordia e Dolce||2|||f||||t||||||||||2017-10-11 02:13:31.881973|2017-10-11 02:13:31.881973
NCT01742104|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-04-17|||March 2012||2012-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Observational|||Multicentric Observational Study on Quality of Life in Glaucoma|Multicentric Observational Clinical Study on Quality of Life in Patients With Glaucoma in Italy|Completed||N/A|3226|Actual|Mario Negri Institute for Pharmacological Research|||1||f||||f||||||||||2017-10-11 02:13:32.452489|2017-10-11 02:13:32.452489
NCT00000516|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-14|||July 1985||1985-07-01|April 2012|2012-04-01|May 1990|Actual|1990-05-01|||||Interventional|||Studies of Left Ventricular Dysfunction (SOLVD)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:59.028973|2017-10-11 04:18:59.028973
NCT01742052|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2016-09-12|||January 2013||2013-01-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Dose-finding Study of MT-1303|A Phase II, Multicentre, Randomised, Double-blind,Parallel Group, Placebo-controlled, Dose-finding Study to Evaluate the Safety and Efficacy of Three Different Oral Doses of MT-1303 Administered for a Period of 24 Weeks in Subjects With Relapsing-remitting Multiple Sclerosis|Completed||Phase 2|415|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||t||||||||||2017-10-11 02:13:33.133382|2017-10-11 02:13:33.133382
NCT01742039|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-12-03|||July 2008||2008-07-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Prevention of Postoperative Atrial Fibrillation|A New Therapeutic Strategy to Reduce the Incidence of Postoperative Atrial Fibrillation|Completed||N/A|160|Actual|George Washington University|||4||f||||||||||||||2017-10-11 02:13:33.337931|2017-10-11 02:13:33.337931
NCT01742026|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-12-03|||February 2011||2011-02-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|||||Observational|||Aspergillus PCR Early Detection in High Risk Oncohematological Patients|ADVANCE THERAPY ASPERGILLOSIS INVASIVE IN PATIENTS HIGH RISK ONCOHEMATOLOGICAL PCR USING FOR EARLY DETECTION OF ASPERGILLUS|Unknown status|Active, not recruiting|Phase 4|225|Actual|Grupo Espanol de trasplantes hematopoyeticos y terapia celular|||1||f||||f||||||||||2017-10-11 02:13:33.432194|2017-10-11 02:13:33.432194
NCT01742013|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-09-24|||January 2013||2013-01-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients|Randomized, Double-blinded, Placebo-controlled, Multicenter Investigator Initiated Clinical Study to Explore the Efficacy and Safety of GCJBP Laennec Inj.(Human Placenta Hydrolysate) 4ml Per Day 3 Times Per Week for 6 Weeks in the Chronic Fatigue Patients With Chronic Fatigue Syndrome or Idiopathic Chronic Fatigue|Completed||Phase 3|78|Actual|Kangbuk Samsung Hospital||2|||f||||f||||||||||2017-10-11 02:13:33.569639|2017-10-11 02:13:33.569639
NCT01742000|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2012-12-04|||January 2007||2007-01-01|September 2012|2012-09-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|PEARS-POST||Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women|Double-blinded Placebo-controlled Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women|Completed||Phase 3|180|Actual|Institute for Atherosclerosis Research, Russia||2|||f||||t||||||||||2017-10-11 02:13:33.715855|2017-10-11 02:13:33.715855
NCT01741987|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-02-14|||October 2008||2008-10-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|October 2012|Actual|2012-10-01||Interventional|||Osmoprotective Containing Lubricants in Dysfunctional Tear Syndrome and Post Refractive Surgery Patients|An Effectiveness of Osmoprotective Containing Lubricants in Dysfunctional Tear Syndrome (DTS) and Post Refractive Surgery Patients|Completed||N/A|100|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 02:13:33.801356|2017-10-11 02:13:33.801356
NCT01741974|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2012-12-04|||October 2005||2005-10-01|January 2012|2012-01-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|PEARS||Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women|Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women|Completed||Phase 3|340|Actual|Institute for Atherosclerosis Research, Russia||2|||f||||t||||||||||2017-10-11 02:13:33.922765|2017-10-11 02:13:33.922765
NCT01741961|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-12-03|||June 2006||2006-06-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Long Term Outcome After Ahmed Glaucoma Valve|4-year Follow-up After Ahmed Glaucoma Valve Implantation for Lowering Intraocular Pressure in Different Types of Glaucoma|Completed||N/A|214|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 02:13:34.027642|2017-10-11 02:13:34.027642
NCT01741948|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2015-02-09|||January 2012||2012-01-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Hormonal Contraceptive Use and the Risk of Provoked Vestibulodynia|Hormonal Contraceptive Use and the Risk of Provoked Vestibulodynia- A Prospective Study|Withdrawn||N/A|0|Actual|Clalit Health Services|||1|the study has never started. my grant request was denied.|f||||f||||||Samples Without DNA|"     Peripheral blood cells will be extracted from all blood samples. mRNA will be purified from     all samples. The mRNA will be divided to aliquots and will be frozen in -80°C until further     processing after all cohort samples have been collected.      mRNAs will be purified from whole blood using the QIAamp RNA purification kit (Quiagen     Germany). A DNase I (Qiagen) digestion step is included in order to eliminate genomic DNA.      Serum will be collected from all blood samples. It will will be frozen in -70°C until further     processing after all cohort samples have been collected.   "|||2017-10-11 02:13:34.141291|2017-10-11 02:13:34.141291
NCT01741935|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2013-10-30|||November 2012||2012-11-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|CTC-Actiwise||Continuous Monitoring of Patients With Chronic Obstructive Pulmonary Disease|Is COPD Patient Mobility in Combination With Other Parameters a Sensitive Measure and Predictive Indicator for Early Detection of Exacerbations in COPD?|Completed||N/A|25|Actual|CareTelCom AB|||1||f||||f||||||||||2017-10-11 02:13:34.253852|2017-10-11 02:13:34.253852
NCT01741922|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-02-02|||December 2012|Actual|2012-12-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|TAHPS||Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients|Effectiveness of the Timing of the Administration of Aspirin in Hypertensive Patients Treated With Low Doses of Acetyl Salicylic Acid for Secondary Prevention - TAHPS|Completed||Phase 3|230|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 02:13:34.619698|2017-10-11 02:13:34.619698
NCT01741909|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2016-08-30|||December 2012||2012-12-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Reducing Cost of Azythromycin by Transferring From IV to Oral Therapy|Can the Cost of Azythromycin in be Reduced in Hospitalized Patients With Community Acquired Pneumonia by Quick Transfer From Intravenous to Oral Therapy?|Withdrawn||N/A|0|Actual|HaEmek Medical Center, Israel||1||Due to recruiting issues|f||||f||||||||||2017-10-11 02:13:34.76821|2017-10-11 02:13:34.76821
NCT01741896|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2013-09-12|||November 2012||2012-11-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CT RIPC CIN||Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?|Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?|Completed||N/A|100|Actual|Mid Western Regional Hospital, Ireland||2|||f||||||||||||||2017-10-11 02:13:34.863053|2017-10-11 02:13:34.863053
NCT01741883|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-04|2017-09-24|||November 2012||2012-11-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|December 2015|Actual|2015-12-01||Interventional|||Side Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients|Clinical Application of Nocebo Research: Optimizing Expectations of Breast Cancer Patients to Prevent Nocebo Side Effects and Decrease of Quality of Life During Adjuvant Endocrine Therapy (DFG, NE 1635/2-1)|Active, not recruiting||N/A|165|Anticipated|Philipps University Marburg Medical Center||3|||f||||f||||||||||2017-10-11 02:13:34.970542|2017-10-11 02:13:34.970542
NCT01741870|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2012-12-03|||April 2011||2011-04-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||A Need-based Nutritional Intervention in Nursing Home Residents|The Effectiveness of a Need-based Nutritional Intervention Strategy to Improve the Nutritional Status of Elderly Nursing Home Residents|Completed||N/A|92|Actual|Asia University||2|||f||||t||||||||||2017-10-11 02:13:35.123307|2017-10-11 02:13:35.123307
NCT01741857|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-11-01|||January 2012||2012-01-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus|Phase I/II: Umbilical Cord Derived Mesenchymal Stem Cells Transplantation For Active And Refractory Systemic Lupus Erythematosus|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||1|||f||||t||||||||||2017-10-11 02:13:35.250507|2017-10-11 02:13:35.250507
NCT01741844|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-03-31|||September 2012||2012-09-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence|Regulatory Post Marketing Surveillance of Intelence Tablet|Completed||Phase 4|57|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 02:13:35.397308|2017-10-11 02:13:35.397308
NCT01741831|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-12-02|||July 2012||2012-07-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista|Regulatory Post Marketing Surveillance of Prezista 400mg Tablet|Completed||Phase 4|225|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 02:13:35.506186|2017-10-11 02:13:35.506186
NCT01741818|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-03|||April 2011||2011-04-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Observational|||The Cutoff Point for Caval Index and Its Correlation With Central Venous Pressure and Plasma Lactate Level for Assessing Patients in Hypovolemic Hemorrhagic States||Completed||N/A|106|Actual|Isfahan University of Medical Sciences|||1||f||||t||||||||||2017-10-11 02:13:35.60801|2017-10-11 02:13:35.60801
NCT01741805|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2016-07-28|||December 2012||2012-12-01|July 2016|2016-07-01|April 2014|Anticipated|2014-04-01|November 2013|Actual|2013-11-01||Observational|||The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa|The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa.|Withdrawn||N/A|0|Actual|Carmel Medical Center|||1|Slow recruitment of patients|f||||f||||||||No||2017-10-11 02:13:35.738569|2017-10-11 02:13:35.738569
NCT01741792|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-11-09|2015-06-26||July 2012||2012-07-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|July 2014|Actual|2014-07-01||Interventional|||Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)|An Open Label, Multicenter, Exploratory Phase 2 Study to Evaluate the Efficacy and Safety of the Bispecific T-Cell Engager (BiTE®) Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Completed||Phase 2|25|Actual|Amgen Research (Munich) GmbH||1|||f||||t||||||||||2017-10-11 02:13:36.07977|2017-10-11 02:13:36.07977
NCT01741779|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-03|||September 2011||2011-09-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function|The Effect of Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function in Obese Postmenopausal Women|Completed||N/A|60|Actual|Florida State University||4|||f||||f||||||||||2017-10-11 02:13:39.839713|2017-10-11 02:13:39.839713
NCT01741766|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-04|||May 2011||2011-05-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Effects of Stretching Training on Arterial Function and Autonomic Control|The Effects of 8 Weeks of Stretching Training on Arterial Stiffness, Wave Reflection, Endothelial Function and Cardiac Autonomic Control.|Completed||N/A|30|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 02:13:39.943969|2017-10-11 02:13:39.943969
NCT01741753|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-01-25|||November 2012||2012-11-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||BKM120+Abiraterone Acetate for Metastatic CRPC|Phase Ib Study of BKM120 Combined With Abiraterone Acetate for Docetaxel-pretreated, Castrate-resistant, Metastatic Prostate Cancer|Terminated||Phase 1|4|Actual|Dana-Farber Cancer Institute||1||"Due to continued slow accrual the supllier of BKM120 requested that we cease further   enrollment."|f||||t||||||||||2017-10-11 02:13:40.072099|2017-10-11 02:13:40.072099
NCT01741740|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2012-12-21|||January 2000||2000-01-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2005|Actual|2005-01-01||Observational|||Chronic Complaints After Small Umbilical Hernia Repair|High Incidence of Chronic Complaints and Recurrence 5 Years After Simple Sutured Umbilical Hernia Repair|Completed||N/A|295|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 02:13:40.204402|2017-10-11 02:13:40.204402
NCT01741727|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-02-07|||October 2012||2012-10-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of ABT-414 in Subjects With Solid Tumors|A Phase 1/2 Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-414 in Subjects With Advanced Solid Tumors Likely to Over-Express the Epidermal Growth Factor Receptor (EGFR)|Completed||Phase 1|57|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 02:13:40.285012|2017-10-11 02:13:40.285012
NCT01741714|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-02|2015-12-30|||February 2013||2013-02-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine|Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine? A Randomized Controlled Clinical Trial|Completed||Phase 3|104|Actual|University Hospital, Akershus||3|||f||||t||||||||||2017-10-11 02:13:40.401089|2017-10-11 02:13:40.401089
NCT01741701|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2016-02-18|2016-01-18||December 2012||2012-12-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Pilot Study of Oxaloacetate in Subjects With Treated PD|A Pilot Double-Blind, Parallel Group, Placebo Controlled Study of Oxaloacetate in Subjects With Treated Parkinson's Disease (PD)|Completed||Phase 2/Phase 3|33|Actual|University of Kansas Medical Center||2|||f||||f||||||||No||2017-10-11 02:13:40.704972|2017-10-11 02:13:40.704972
NCT01741688|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-06-27|2015-07-23||October 26, 2012|Actual|2012-10-26|June 2017|2017-06-01|March 6, 2014|Actual|2014-03-06|March 6, 2014|Actual|2014-03-06||Observational|||An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis|A Multi-National, Multi-Center Non-Interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab|Completed||N/A|16|Actual|Hoffmann-La Roche|||1||f||||f||||||||||2017-10-11 02:13:41.37082|2017-10-11 02:13:41.37082
NCT01741675|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-02-26|||November 2012||2012-11-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Monetary Incentive on Survey Response for Vulnerable Children and Youth|The Effect of Monetary Incentive on Survey Response for Vulnerable Children and Youth|Completed||N/A|270|Actual|The Danish National Centre For Social Research||2|||f||||t||||||||||2017-10-11 02:13:41.916656|2017-10-11 02:13:41.916656
NCT01741662|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-11-16|||July 2013||2013-07-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|LEA-PsyCog||Prevalence of Psychocognitive Impairments in Adolescents Surviving Childhood Leukemia : LEA-PsyCog|Prevalence of Psychocognitive Impairments in Adolescents Surviving Childhood Leukemia : LEA-PsyCog|Recruiting||N/A|170|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:13:42.021558|2017-10-11 02:13:42.021558
NCT01741649|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2013-05-16|||October 2012||2012-10-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection After Cesarean Section|Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection in Patients After Cesarean Section. Randomized, Controlled Trial.|Completed||N/A|800|Actual|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-11 02:13:42.130595|2017-10-11 02:13:42.130595
NCT01741636|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2013-12-16|||January 2013||2013-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer|Survivorship Care Planning in Colorectal and Lung Cancer: A Feasibility Study|Completed||N/A|30|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 02:13:42.256145|2017-10-11 02:13:42.256145
NCT01741623|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-01|2012-12-01|||August 2012||2012-08-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg of With Zebeta® 10 mg in Normal, Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|24|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:13:42.383055|2017-10-11 02:13:42.383055
NCT01741610|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-01-14|||October 2008||2008-10-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|August 2011|Actual|2011-08-01||Interventional|||Fluid Coloading and the Incidence of Hypotension|Rapid Fluid Administration and the Incidence of Hypotension Induced by Spinal Anaesthesia and Ephedrine Requirement: the Effect of Crystalloid Versus Colloid Coloading|Completed||Phase 4|90|Actual|Cukurova University||3|||f||||f||||||||||2017-10-11 02:13:42.524708|2017-10-11 02:13:42.524708
NCT01741597|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2014-05-28|||July 2014||2014-07-01|May 2014|2014-05-01||||July 2016|Anticipated|2016-07-01||Interventional|||Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung|A First Time in Human Phase I Imaging Study of iRGD in Patients With Advanced Breast and Pancreas Cancer|Withdrawn||Phase 1|0|Actual|City of Hope Medical Center||1||PI chose to close the study|f||||t||||||||||2017-10-11 02:13:42.650531|2017-10-11 02:13:42.650531
NCT01741584|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2016-03-15|||December 2010||2010-12-01|March 2016|2016-03-01||||September 2014|Actual|2014-09-01||Interventional|||Effects of Physical Activity on the Brain in Parkinson's Disease (PD)||Completed||N/A|20|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:13:42.770825|2017-10-11 02:13:42.770825
NCT01741571|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-03-23|||October 2012||2012-10-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Trial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques|Randomized Controlled Trial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques|Unknown status|Recruiting|N/A|50|Anticipated|American University of Beirut Medical Center||1|||f||||f||||||||||2017-10-11 02:13:42.867901|2017-10-11 02:13:42.867901
NCT01741558|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2013-04-05|||April 2013||2013-04-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|TETHYS||The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)|The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS: Randomized Double-blind, Placebo-controlled Trial (TETHYS Trial)|Unknown status|Not yet recruiting|Phase 2|80|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||t||||||||||2017-10-11 02:13:43.209046|2017-10-11 02:13:43.209046
NCT01741545|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-03-02||2017-03-02|March 2013||2013-03-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|MAGNITUDE||Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia|A Phase 3 Study Evaluating the Safety and Efficacy of Lambda/Ribavirin/Daclatasvir in Subjects With Chronic HCV Infection and Underlying Hemophilia Who Are Treatment Naïve or Are Prior Relapsers to Peginterferon Alfa-2a/Ribavirin|Completed||Phase 3|51|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 02:13:43.377207|2017-10-11 02:13:43.377207
NCT01741532|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2017-03-22|||December 2012||2012-12-01|April 2016|2016-04-01|January 11, 2017|Actual|2017-01-11|October 7, 2016|Actual|2016-10-07||Interventional|||A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)|A Randomized, Double-blind, Placebo-controlled Trial of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)|Completed||Phase 3|89|Actual|ApoPharma||2|||f||||t||||||||||2017-10-11 02:13:43.567266|2017-10-11 02:13:43.567266
NCT01741519|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2015-04-17|||December 2012||2012-12-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers|A Single Centre Prospective, Randomized, Double Blind, Crossover, Pharmacokinetic, Safety and Tolerability Study to Compare Long-term Infusion Administration of LDLL600 Against Esmolol in Healthy Volunteers.|Completed||Phase 1|14|Actual|AOP Orphan Pharmaceuticals AG||2|||f||||f||||||||||2017-10-11 02:13:43.698734|2017-10-11 02:13:43.698734
NCT01741506|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2015-06-22|||March 2013||2013-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|COPPVATS||Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer|Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer - A Randomized, Controlled Trial|Completed||Phase 4|116|Actual|Aarhus University Hospital||3|||f||||t||||||||||2017-10-11 02:13:43.81847|2017-10-11 02:13:43.81847
NCT01741493|ClinicalTrials.gov processed this data on October 10, 2017|2012-12-03|2014-01-03|||November 2012||2012-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494|A Study in Healthy Adult Volunteers and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability, and Pharmacokinetics After Multiple Dosing of ABT-494|Completed||Phase 1|67|Actual|AbbVie||4|||f||||f||||||||||2017-10-11 02:13:43.923018|2017-10-11 02:13:43.923018
NCT01741467|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-10-18|||May 2012||2012-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|CGM PreDM||The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes|The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes|Completed||N/A|110|Actual|Walter Reed National Military Medical Center||1|||f||||t||||||||||2017-10-11 02:13:44.327282|2017-10-11 02:13:44.327282
NCT01741454|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-09-28|||November 2012||2012-11-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction|Combination Versus Monotherapy With Alpha Blocker and Anticholinergics to Relieve Urinary Stent Symptoms|Active, not recruiting||Phase 4|106|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 02:13:44.490741|2017-10-11 02:13:44.490741
NCT01741441|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2012-11-30|||June 2002||2002-06-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2007|Actual|2007-06-01||Observational|||Laparoscopic Total Fundoplication for Duodenogastroesophageal Reflux|Study of Prognostic Factors for Long Term Results of Total Laparoscopic Fundoplication for Weakly Acidic or Mixed Reflux|Completed||N/A|188|Actual|University of Turin, Italy|||1||f||||f||||||||||2017-10-11 02:13:44.649225|2017-10-11 02:13:44.649225
NCT01741428|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-03-16|||November 2012||2012-11-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|HeartLift||"Hjerteloeftet (HeartLift). Interaction For Preventing Cardiovascular Disease"|"Hjerteloeftet. Early Interventions to Promote Physical Activity, Dietary Lifestyle Changes and Optimal Medication for Cardiovascular Risk Factor Reduction in Over 3 Years Follow-up."|Active, not recruiting||N/A|800|Anticipated|LHL Helse||4|||f||||t||||||||||2017-10-11 02:13:44.80978|2017-10-11 02:13:44.80978
NCT01741415|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-05-02|||May 2013||2013-05-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Distress Tolerance Treatment for Substance Users|Distress Tolerance Treatment for Substance Users|Recruiting||Phase 2|325|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-11 02:13:44.953271|2017-10-11 02:13:44.953271
NCT01741402|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-04-11|||February 2010||2010-02-01|November 2012|2012-11-01|February 2014|Actual|2014-02-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Training in a Virtual Environment in Healthy Elderly|Effects of Training in a Virtual Environment on the Performance of Gait, Postural Control and Executive Functions in Healthy Elderly|Completed||N/A|32|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 02:13:45.09832|2017-10-11 02:13:45.09832
NCT01741376|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-05-13|||November 2012||2012-11-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Progesterone and Atomoxetine for Cocaine Cessation|Progesterone and Atomoxetine for Cocaine Cessation|Terminated||N/A|150|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Cocaine use is no longer a substance of abuse in our geographic location|f||||t||||||||No||2017-10-11 02:13:45.296111|2017-10-11 02:13:45.296111
NCT01741350|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2014-01-10|2013-11-20||September 2006||2006-09-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|May 2011|Actual|2011-05-01||Interventional||Only participants who completed all 5 time points on drug-risk reduction knowledge and personal motivation for safer drug use were included in the analysis (i.e., 95 participants for the intervention group and 90 participants for the control group). For all other variables, the participants analyzed for the two groups were 97 and 92, respectively.|Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users|Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users|Completed||N/A|304|Actual|University of Connecticut|The drug-risk reducing effects of methadone may have restricted our ability to detect intervention effects on drug-related outcomes. Participants may have also been reluctant to report HIV risk related behaviors.|2|||f||||t||||||||||2017-10-11 02:13:45.590238|2017-10-11 02:13:45.590238
NCT01741337|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2017-02-01|||January 29, 2013|Actual|2013-01-29|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||PAC-IC-SAS Pilot Study - Central Sleep Apneas Syndrome and Ventricular Function|Central Sleep Apneas Syndrome and Ventricular Function in Patients With Heart Failure, After Coronary Artery Bypass Graft Surgery or Other Coronary Reperfusion|Completed||N/A|10|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 02:13:47.107777|2017-10-11 02:13:47.107777
NCT01741324|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-10-31|||November 2012||2012-11-01|October 2016|2016-10-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|Dvisum||Comparing Different Amounts of Vitamin D Supplementation to Preschool Children Living in Northern and Southern Sweden||Completed||N/A|220|Actual|Umeå University||10|||f||||f||||||||||2017-10-11 02:13:47.193967|2017-10-11 02:13:47.193967
NCT01741311|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-09-12|||September 2012||2012-09-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Secondary HIV Prevention and Adherence Among HIV-infected Drug Users|Secondary HIV Prevention and Adherence Among HIV-infected Drug Users|Recruiting||N/A|256|Anticipated|University of Connecticut||2|||f||||t||||||||||2017-10-11 02:13:47.569439|2017-10-11 02:13:47.569439
NCT01741285|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-08-25|||April 2013||2013-04-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|OLiVIA||Effects of QVAR in Smokers With Asthma|Effects Of Extra-fine Particle HFA-becLomethasone (HFA-QVAR) Versus Course Particle Treatment In Smokers and Ex-smokers With Asthma|Completed||Phase 4|40|Actual|University Medical Center Groningen||3|||f||||t||||||||||2017-10-11 02:13:47.868899|2017-10-11 02:13:47.868899
NCT01741272|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-03-03|2015-02-12||September 2003||2003-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional||No significant differences in baseline characteristics. Mean age: Group A 54.9(35;78), Group B 55.4(38;86). Males (%): Group A 58(63), Group B 57(58.8).|Early Mobilization Following Mini-Open Rotator Cuff Repair|Early Mobilization Following Mini-Open Rotator Cuff Repair: A Randomized Clinical Trial|Completed||Phase 4|189|Actual|Shoulder & Upper Extremity Research Group of Edmonton||2|||f||||f||||||||||2017-10-11 02:13:48.019066|2017-10-11 02:13:48.019066
NCT01741246|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-06-26|||September 2011||2011-09-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging|Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging|Completed||N/A|78|Actual|University of California, San Francisco|||3||f||||f||||||||||2017-10-11 02:13:48.756011|2017-10-11 02:13:48.756011
NCT01741233|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-07-31|||November 2012||2012-11-01|December 2012|2012-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|VitDgen||The Genetics Behind Vitamin D Status (VitDgen)|The Genetics Behind Vitamin D Status (VitDgen)|Completed||N/A|102|Actual|Technical University of Denmark||1|||f||||||||||||||2017-10-11 02:13:49.020738|2017-10-11 02:13:49.020738
NCT01741220|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-04-04|||February 2015||2015-02-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|REMEDIA||Resilience and Mentoring in German-speaking Intensive Care Providers and Anesthesiologists|Resilience and Mentoring in German-speaking Intensive Care Providers and Anesthesiologists|Completed||N/A|92|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-11 02:13:49.119302|2017-10-11 02:13:49.119302
NCT01741194|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-05-16|||March 2013||2013-03-01|May 2017|2017-05-01|April 14, 2017|Actual|2017-04-14|October 24, 2016|Actual|2016-10-24||Interventional|NOURISH-AD||AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext|A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension|Completed||Phase 2/Phase 3|418|Actual|Accera, Inc.||2|||f||||t||||||||||2017-10-11 02:14:56.010428|2017-10-11 02:14:56.010428
NCT01741181|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2014-11-17|||September 2012||2012-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|DIMENSION||Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2|Vitamin D Supplementation in Patients With Diabetes Mellitus Type 2 and Low 25(OH)D Concentrations: Does it Help to Improve Endothelial Function-The DIMENSION TRIAL|Completed||Phase 4|64|Actual|Tan Tock Seng Hospital||2|||f||||t||||||||||2017-10-11 02:14:56.260867|2017-10-11 02:14:56.260867
NCT01741168|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-30|||June 2005||2005-06-01|November 2012|2012-11-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|||Brace Versus No Brace for the Treatment of Thoracolumbar Burst Fractures Without Neurologic Injury|TLSO Versus No Orthosis for the Treatment of Thoracolumbar Burst Fractures Without Neurologic Injury: A Multicenter Prospective Randomized Equivalence Trial|Completed||N/A|97|Actual|The London Spine Centre||2|||f||||f||||||||||2017-10-11 02:14:56.662648|2017-10-11 02:14:56.662648
NCT01741155|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-07-20|||May 2013||2013-05-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)|A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy|Terminated||Phase 2|34|Actual|Spectrum Pharmaceuticals, Inc||2||The study did not meet efficacy end point and did not enroll patients in the randomized phase.|f||||f||||||||||2017-10-11 02:14:56.773042|2017-10-11 02:14:56.773042
NCT01741142|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-10-04|||January 2012||2012-01-01|October 2013|2013-10-01|August 2015|Anticipated|2015-08-01|October 2013|Anticipated|2013-10-01||Interventional|||Efficacy and Safety Study of ABT-436 in Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ABT-436 in Major Depressive Disorder|Terminated||Phase 2|19|Actual|AbbVie||3||Decision based on strategic determination; not safety.|f||||t||||||||||2017-10-11 02:14:56.897801|2017-10-11 02:14:56.897801
NCT01741129|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-03-07|||November 2012||2012-11-01|January 2013|2013-01-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Effectiveness of Nasal CPAP and Nasal IMV in Early Rescue Surfactant Treatment in Preterm Infants||Completed||Phase 4|200|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-11 02:14:57.034154|2017-10-11 02:14:57.034154
NCT01741116|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-11-30|||November 2012||2012-11-01|November 2012|2012-11-01|June 2016|Anticipated|2016-06-01|October 2014|Anticipated|2014-10-01||Interventional|||Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer|A Phase II Study of TKI258 in Patients With Castration-resistant Prostate Cancer|Unknown status|Recruiting|Phase 2|44|Anticipated|Korean Cancer Study Group||1|||f||||t||||||||||2017-10-11 02:14:57.129594|2017-10-11 02:14:57.129594
NCT01741103|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-11-30|||June 2011||2011-06-01|June 2012|2012-06-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Sitagliptin in Type I Diabetic Patients|Effect of Sitagliptin on Glycemic Control, Post-prandial Glucagon, and Inflammation in Type 1 Diabetics|Unknown status|Recruiting|N/A|36|Anticipated|Kaleida Health||2|||f||||f||||||||||2017-10-11 02:14:57.230803|2017-10-11 02:14:57.230803
NCT01741090|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2012-12-07|||September 2009||2009-09-01|December 2012|2012-12-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Interventional|||The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis|The Evaluation of Effectiveness and Safety for New Therapy With Bone Marrow Derived Autologous Mesenchymal Stem Cell for Hepatic Failure Caused by Alcoholic Liver Cirrhosis|Unknown status|Recruiting|Phase 2|12|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 02:14:57.32684|2017-10-11 02:14:57.32684
NCT01741077|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-12-03|||May 2008||2008-05-01|December 2013|2013-12-01|April 2010|Actual|2010-04-01|October 2008|Actual|2008-10-01||Observational|||The Effect of Folic Acid Supplementation and Pregnancy on the Folate Forms in Red Blood Cells|The Effect of Folic Acid Supplementation and Pregnancy on the Folate Forms in Red Blood Cells|Completed||N/A|32|Actual|The Hospital for Sick Children|||4||f||||f||||||||||2017-10-11 02:14:57.436771|2017-10-11 02:14:57.436771
NCT01741064|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-12-03|||February 2012||2012-02-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|SHPT-RT||Morbidity Related to Secondary Hyperparathyroidism After Renal Transplantation|Secondary Hyperparathyroidism Related Vascular and Bone Morbidity After Renal Transplantation - a 6 Year Follow up Retrospective Cohort Study.|Completed||N/A|257|Actual|Skane University Hospital|||3||f||||f||||||||||2017-10-11 02:14:57.512294|2017-10-11 02:14:57.512294
NCT01741051|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-12-01|||January 2014||2014-01-01|April 2015|2015-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted Community|A Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted Community|Completed||N/A|540|Actual|Simon Fraser University||2|||f||||f||||||||||2017-10-11 02:14:57.583759|2017-10-11 02:14:57.583759
NCT01741038|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2016-08-07|||December 2017||2017-12-01|August 2016|2016-08-01|October 2020|Anticipated|2020-10-01|December 2019|Anticipated|2019-12-01||Interventional|||AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer|A Phase II/III, Randomized, Open Label, Controlled, Two Arm Study Comparing Overall Survival of AlloStim® Combined With Cryoablation to a Physician's Choice Combined With Cryoablation in 3rd Line Treatment for Metastatic Colorectal Cancer|Not yet recruiting||Phase 2/Phase 3|450|Anticipated|Immunovative Therapies, Ltd.||2|||f||||t||||||||No||2017-10-11 02:14:57.661103|2017-10-11 02:14:57.661103
NCT01741025|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-09-30|||June 2013||2013-06-01|September 2017|2017-09-01|September 24, 2017|Actual|2017-09-24|December 15, 2015|Actual|2015-12-15||Interventional|iMIA||iFuse Implant System® Minimally Invasive Arthrodesis|A Multicenter Randomized Controlled Post-market Clinical Follow-up Trial Comparing the Effectiveness and Safety of the iFuse Implant System® Versus Conservative Management for Patients With Chronic, Disabling SI Joint Pain.|Completed||N/A|103|Actual|SI-BONE, Inc.||2|||f||||f||||||||||2017-10-11 02:14:57.768709|2017-10-11 02:14:57.768709
NCT01740999|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-04-15|||June 2012||2012-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Silicone Arthroplasty vs. Arthrodesis in the Distal Interphalangeal Joint|Functional Outcome in Silicone Arthroplasty Compared to Arthrodesis Screws in Patients With Osteoarthritis in the Distal Interphalangeal Joint|Terminated||N/A|49|Actual|Schulthess Klinik||2||"Non achievement of the estimated sample size of the group silicone arthroplasty in a reasonable   recruitment time."|f||||||||||||||2017-10-11 02:14:57.941844|2017-10-11 02:14:57.941844
NCT01740986|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-11-13|||November 2012||2012-11-01|January 2015|2015-01-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Efficacy of SA09012 in Asthma|Double Blinded, Randomized, Placebo Controlled, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients|Completed||Phase 2|225|Actual|SamA Pharmaceutical Co., Ltd||3|||f||||||||||||||2017-10-11 02:14:58.014745|2017-10-11 02:14:58.014745
NCT01740973|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-02-11|||April 2014||2014-04-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|UMBI-SILS||Risk of Umbilical Trocar-site Hernia After SILC Cholecystectomy Versus Conventional Cholecystectomy|Risk of Umbilical Trocar-site Hernia After SILC Versus Conventional Laparoscopic Cholecystectomy|Completed||N/A|699|Actual|Hvidovre University Hospital|||2||f||||f||||||||||2017-10-11 02:14:58.35054|2017-10-11 02:14:58.35054
NCT01740960|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-01-06|||August 2012||2012-08-01|July 2012|2012-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|THC||Safety and Tolerability of Namisol in the Elderly|Safety and Tolerability of Oral Namisol®, a Tablet Containing Delta-9-Tetrahydrocannabinol, in Elderly Subjects: A Randomized Controlled Trial|Completed||Phase 1|12|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 02:14:58.42744|2017-10-11 02:14:58.42744
NCT01740947|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-11-30|||January 2013||2013-01-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|January 2018|Anticipated|2018-01-01||Interventional|SELECT||Does Administration of Antibiotics in Patients Undergoing Surgery for Colorectal Cancer Result in Less Complications and Better Prognosis?|Perioperative Selective Decontamination of the Digestive Tract (SDD) in Elective Colorectal Cancer Patients: a Multicenter Randomized Clinical Trial|Recruiting||Phase 4|762|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-10-11 02:14:58.522562|2017-10-11 02:14:58.522562
NCT01740934|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-10-29|||November 2012||2012-11-01|October 2015|2015-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea|An Eight-Week, Multi-Site, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Trial to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Subjects With Rosacea Followed by an Open-Label Extension|Completed||N/A|117|Actual|Rock Creek Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:14:58.644491|2017-10-11 02:14:58.644491
NCT01740921|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-02-16|||January 2011||2011-01-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|GLP-1ADDS||GLP-1 and Microvascular Function in Type 2 Diabetes|Does Glucagon-like Polypeptide 1 Improve Vascular Function and Inflammation?|Completed||N/A|39|Actual|Royal Devon and Exeter NHS Foundation Trust||3|||f||||f||||||||||2017-10-11 02:14:58.753995|2017-10-11 02:14:58.753995
NCT00000517|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-04-09|||July 1985||1985-07-01|April 2014|2014-04-01|June 1991|Actual|1991-06-01|June 1991|Actual|1991-06-01||Interventional|||Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)||Completed||Phase 3|||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 04:18:59.144382|2017-10-11 04:18:59.144382
NCT01740908|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-11-30|||December 2012||2012-12-01|November 2012|2012-11-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Observational|||Stem Cell Quantification In Peripheral Blood After Hyperbaric Oxygen Therapy Treatments|Pilot Study for the Detection of Stem/Progenitor Cell Up-regulation Using Aldagen BRIGHT Technology in Peripheral Blood After Hyperbaric Oxygen Therapy (HBOT) Treatment|Unknown status|Enrolling by invitation|N/A|8|Anticipated|Restorix Research Institute, LLLP|||2||f||||t||||||||||2017-10-11 02:14:58.858957|2017-10-11 02:14:58.858957
NCT01740895|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-08-05|||December 2012||2012-12-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|ADVISEII||ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II|A Prospective, Observational, Non-randomized, Double Blind, Global, Multi-center Registry With an Adaptive Design, Investigating the Diagnostic Utility of Instantaneous Wave-free Ratio™ (iFR®) in Assessing Coronary Stenosis Relevance.|Completed||N/A|818|Actual|Volcano Corporation|||1||f||||f||||||||||2017-10-11 02:14:58.9469|2017-10-11 02:14:58.9469
NCT01740882|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2014-04-24|||November 2013||2013-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|ABSTACK||Risk of Recurrence After Incisional Hernia Repair With Mesh Fixation With Absorbable Versus Non-absorbable Tacks|Risk of Recurrence After Incisional Hernia Repair With Mesh Fixation With Absorbable Versus Non-absorbable Tacks|Completed||N/A|816|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 02:14:59.102447|2017-10-11 02:14:59.102447
NCT01740869|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2015-06-03|||November 2012||2012-11-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|Autism||Autologous Bone Marrow Stem Cells for Children With Autism Spectrum Disorders|Autologous Bone Marrow Stem Cells for Children With Autism Spectrum Disorders|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||t||||||||||2017-10-11 02:14:59.190822|2017-10-11 02:14:59.190822
NCT01740856|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-04-10|||January 2011||2011-01-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|Three-Cath||Clinical Trial to Assess the Safety of Reducing the Time of Bed Rest After Cardiac Catheterization|Randomized Clinical Trial to Assess the Safety of Reducing the Time of Bed Rest Within Five to Three Hours After Diagnostic Cardiac Catheterization With a 6F Sheath|Completed||N/A|730|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 02:14:59.313165|2017-10-11 02:14:59.313165
NCT01740843|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-02-24|||August 2012||2012-08-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of tDCS on Motor Performance and Cortical Excitability||Completed||N/A|30|Actual|Hasselt University||3|||f||||f||||||||||2017-10-11 02:14:59.401272|2017-10-11 02:14:59.401272
NCT01740830|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-06-01|||June 2012||2012-06-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Effect of Anodal tDCS on Motor Learning in Multiple Sclerosis||Completed||N/A|31|Actual|Hasselt University||2|||f||||f||||||||||2017-10-11 02:14:59.480555|2017-10-11 02:14:59.480555
NCT01740817|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-12-18|2015-06-30||January 2008||2008-01-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling|A Randomized, Crossover Study to Evaluate the Effect of Lipid Infusion on TLR4 Signaling and Insulin Resistance in Human Muscle|Completed||N/A|12|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 02:14:59.552147|2017-10-11 02:14:59.552147
NCT01740804|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-12-02|||November 2012||2012-11-01|September 2015|2015-09-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Observational|POLICE||Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC|A Prospective Observational Study on the Dynamic Changes of CTC Enumeration in Advanced NSCLC With 1st Line Chemotherapy|Completed||N/A|180|Actual|Guangdong Association of Clinical Trials|||1||f||||t||||||Samples With DNA|"     The DNA sample will be rtetained for molecular analysis such as EGFR, KRAS, etc.   "|||2017-10-11 02:14:59.781077|2017-10-11 02:14:59.781077
NCT01740791|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-03-06|||November 2012||2012-11-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-5816 in Subjects With Chronic HCV Infection|Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-5816 in Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 1|94|Actual|Gilead Sciences||12|||f||||f||||||||||2017-10-11 02:14:59.871094|2017-10-11 02:14:59.871094
NCT01740778|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-11-30|||August 2009||2009-08-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Lancing Device Comparison Study|Lancing Device Comparison Study|Completed||N/A|200|Actual|Facet Technologies|||4||f||||t||||||||||2017-10-11 02:14:59.991748|2017-10-11 02:14:59.991748
NCT01740765|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2012-11-29|||May 2012||2012-05-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Energy Expenditure and Substrate Utilization During Acute Under- and Over-feeding|Energy Expenditure and Substrate Utilization During Acute Under- and Over-feeding|Completed||N/A|7|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 02:15:00.088084|2017-10-11 02:15:00.088084
NCT01740752|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-07-21|||July 2012||2012-07-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|UCAN2||UCAN2: Uniting Couples in the Treatment of Anorexia Nervosa|Enhancing Treatment for Adult Anorexia With a Couple-Based Approach|Active, not recruiting||N/A|60|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 02:15:00.15926|2017-10-11 02:15:00.15926
NCT01740739|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2013-06-13|||November 2012||2012-11-01|June 2013|2013-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|Cardiac-CV||Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors|Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors (Cardiac-CV)|Suspended||N/A|60|Anticipated|Epic Research & Diagnostics, Inc.|||1|Evaluating cohort for value|f||||f||||||||||2017-10-11 02:15:00.282945|2017-10-11 02:15:00.282945
NCT01740726|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-03-26|2015-03-26||January 2013||2013-01-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Baseline analysis is only for the subject that completed the study.|Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression|Randomized Trial of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Major Depression|Terminated||N/A|3|Actual|Emory University||2||Lack of success with recruitment|f||||t||||||||||2017-10-11 02:15:00.385594|2017-10-11 02:15:00.385594
NCT01740713|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-11-11|2016-03-04||December 2012||2012-12-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|DEEP-1||Pharmacokinetic Study of Deferiprone in Paediatric Patients|Multi-centre, Oral Single Dose Experimental and Modelling Study to Evaluate the Pharmacokinetics of Deferiprone in Patients Aged From 1 Month to Less Than 6 Years of Age Affected by Transfusion-dependent Haemoglobinopathies.|Completed||Phase 2|23|Actual|Consorzio per Valutazioni Biologiche e Farmacologiche||3|||f||||f||||||||Undecided||2017-10-11 02:15:00.747365|2017-10-11 02:15:00.747365
NCT01740700|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-02-15|||January 2013||2013-01-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|June 2015|Actual|2015-06-01||Interventional|||Zenith® p-Branch® OTS Multicenter Study|Zenith® p-Branch® Multicenter Study|Active, not recruiting||N/A|30|Actual|Cook Group Incorporated||1|||f|||||f|t|t|f||||||2017-10-11 02:15:01.415323|2017-10-11 02:15:01.415323
NCT01740674|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-12-04|||December 2012||2012-12-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Does Internet Data Collection Improve Cohort Retention?|Is Internet Data Collection Superior to Traditional Methods in Retaining Participants in Longitudinal Research?|Completed||N/A|301|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 02:15:01.797771|2017-10-11 02:15:01.797771
NCT01740661|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-04-15|||November 2012||2012-11-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Cryotherapy and Joint Biomechanics During Running|Effects of Cryotherapy on Lower Extremity Joint Biomechanics During Running in Healthy Adults|Completed||N/A|26|Actual|University of Calgary||2|||f||||||||||||||2017-10-11 02:15:01.926689|2017-10-11 02:15:01.926689
NCT01740648|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-10-05|||November 26, 2012|Actual|2012-11-26|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer|A Phase I Trial of MEK Inhibitor Trametinib in Combination With Neoadjuvant 5-Fluorouracil Chemoradiation in the Treatment of KRAS, BRAF, and NRAS-MUTANT Rectal Cancers|Active, not recruiting||Phase 1|19|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:15:02.055526|2017-10-11 02:15:02.055526
NCT01740635|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-05-18|||March 2013||2013-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||EPIC WheelS Feasibility Study|Enhancing Participation In the Community by Improving Wheelchair Skills (EPIC WheelS): A Feasibility Study|Active, not recruiting||N/A|20|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:15:02.211893|2017-10-11 02:15:02.211893
NCT01740622|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-01-31|||October 2012||2012-10-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|H3C||Healthy Homes Healthy Children (H3C)|Healthy Homes Healthy Children (H3C)|Active, not recruiting||N/A|520|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 02:15:02.325314|2017-10-11 02:15:02.325314
NCT01740609|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-06-17|||November 2012||2012-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers|A Phase 1 Study To Evaluate The Safety, Tolerability, Immunogenicity, Pharmacokinetics And Pharmacodynamics Of Escalating Doses Of Pf-06342674 (RN168) In Healthy Volunteers|Completed||Phase 1|80|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:15:02.41736|2017-10-11 02:15:02.41736
NCT01740596|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-05-16|||November 2012||2012-11-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|COUNTER HF||C-Pulse® System: A Heart Assist Device Clinical Study|C-Pulse Heart Assist Device pivOtal stUdy treatiNg paTients With modERate to Severe Heart Failure C-Pulse® System: A Heart Assist Device Pivotal IDE Study|Active, not recruiting||Phase 3|38|Actual|Sunshine Heart Inc.||2|||f||||t||||||||||2017-10-11 02:15:02.56671|2017-10-11 02:15:02.56671
NCT01740583|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-10-13|||November 2012||2012-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|January 2017|Anticipated|2017-01-01||Interventional|ALIGN||Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation|A Feasibility Study of the Mitralign Annuloplasty System for the Treatment of Chronic Functional Mitral Valve Regurgitation|Active, not recruiting||N/A|50|Anticipated|Mitralign, Inc.||1|||f||||t||||||||||2017-10-11 02:15:02.705411|2017-10-11 02:15:02.705411
NCT01740570|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-03-07|||April 2013||2013-04-01|March 2013|2013-03-01||||April 2017|Anticipated|2017-04-01||Interventional|||Phase I/II Cabazitaxel for Recurrent Malignant Glioma|Phase I/II Trial of Cabazitaxel in Adult Patients With Recurrent Malignant Glioma|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:15:02.800672|2017-10-11 02:15:02.800672
NCT01740557|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-10-05|||January 28, 2015|Actual|2015-01-28|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Study of Lymphodepletion Plus Adoptive Cell Transfer With T-Cells Transduced With CXCR2 and NGFR Followed by High Dose Interleukin-2 in Patients With Metastatic Melanoma|A Pilot Study of Lymphodepletion Plus Adoptive Cell Transfer With T-Cells Transduced With CXCR2 and NGFR Followed by High Dose Interleukin-2 in Patients With Metastatic Melanoma|Recruiting||Phase 1/Phase 2|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:15:02.894197|2017-10-11 02:15:02.894197
NCT01740544|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-06-12|||October 2012||2012-10-01|June 2017|2017-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|KMS-Neglect 2||Computerised Assessment of Visual Neglect Symptoms in Peripersonal Space|Computerised Assessment of Visual Neglect Symptoms in Peripersonal Space|Completed||N/A|16|Actual|Charite University, Berlin, Germany||4|||f||||f||||||||||2017-10-11 02:15:03.014135|2017-10-11 02:15:03.014135
NCT01740531|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-12-01|||December 2012||2012-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion|A Randomized Controlled Study to Evaluate Efficacy and Safety of S 303 Treated Red Blood Cells (RBC) in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion|Active, not recruiting||Phase 3|86|Actual|Cerus Corporation||2|||f||||f||||||||||2017-10-11 02:15:03.101898|2017-10-11 02:15:03.101898
NCT01740518|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-11-30|||March 2012||2012-03-01|November 2012|2012-11-01||||December 2012|Anticipated|2012-12-01||Observational|||Comparison of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy|Randomized Controlled Trial of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy|Unknown status|Enrolling by invitation|N/A|360|Anticipated|Kangbuk Samsung Hospital|||2||f||||t||||||||||2017-10-11 02:15:03.246097|2017-10-11 02:15:03.246097
NCT01740505|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2015-01-19|||January 2013||2013-01-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|HealthySteps||HealthySteps: Exercise for Older Adults With Mobility Limitation|HealthySteps: A Pilot Randomized Controlled Trial of Exercise to Improve Walking Energetics, Fatigue, and Activity in Older Adults With Mobility Limitation|Completed||N/A|72|Actual|Simon Fraser University||3|||f||||f||||||||||2017-10-11 02:15:03.327537|2017-10-11 02:15:03.327537
NCT01740492|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2015-10-30|||September 2012||2012-09-01|September 2012|2012-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Low Dose Ketamine for Management of Acute Severe Pain in the Emergency Department|Low Dose Ketamine for Management of Acute Severe Pain in the Emergency Department|Completed||Phase 1|75|Actual|Rhode Island Hospital||3|||f||||t||||||||||2017-10-11 02:15:03.417311|2017-10-11 02:15:03.417311
NCT01740479|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-03-23|||December 2012||2012-12-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|COMPLETE||Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Primary PCI for STEMI|Randomized Comparative Effectiveness Study of Complete vs Culprit-only Revascularization Strategies to Treat Multi-vessel Disease After Primary Percutaneous Coronary Intervention (PCI) for ST-segment Elevation Myocardial (STEMI) Infarction|Recruiting||N/A|3900|Anticipated|Population Health Research Institute||2|||f||||t||||||||||2017-10-11 02:15:03.522203|2017-10-11 02:15:03.522203
NCT01740466|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2012-12-06|||March 2012||2012-03-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01|6 Months|Observational [Patient Registry]|EPP||Epidemiological Profile of Ophthalmological Care in the Public Service in Brazil|Epidemiological Profile of Ophthalmological Care in the Public Service in Brazil|Completed||N/A|1670|Actual|Instituto de Olhos de Goiania|||1||f||||t||||||||||2017-10-11 02:15:03.633819|2017-10-11 02:15:03.633819
NCT01740453|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-01-16|||January 2012||2012-01-01|January 2015|2015-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|KTBIS||Effect of Interscalene Block on Ventilatory Function|Interscalene Block on Ventilatory Function After Shoulder Surgery : Evaluation of Single or Continuous Injection|Completed||Phase 4|70|Actual|Pierre and Marie Curie University||2|||f||||t||||||||||2017-10-11 02:15:03.720235|2017-10-11 02:15:03.720235
NCT01740440|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-05-30|2014-07-17||November 2012||2012-11-01|May 2016|2016-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of a Transcutaneous Electrical Nerve Stimulation (TENS) Device on Overall Facial Appearance|Effect of a Transcutaneous Electrical Nerve Stimulation (TENS) Device on Overall Facial Appearance|Completed||Phase 4|30|Actual|Bio-Medical Research, Ltd.||1|||f||||f||||||||No||2017-10-11 02:15:03.822831|2017-10-11 02:15:03.822831
NCT01740427|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-08-22|2016-10-21||February 22, 2013|Actual|2013-02-22|August 2017|2017-08-01|November 15, 2018|Anticipated|2018-11-15|February 26, 2016|Actual|2016-02-26||Interventional||The intent-to-treat (ITT) population included all participants who were randomized, with study drug assignment designated according to initial randomization, regardless of whether participants received study drug or received a different drug from that to which they were randomized.|A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)|A Randomized, Multicenter, Double-blind Phase 3 Study Of Pd-0332991 (Oral Cdk 4/6 Inhibitor) Plus Letrozole Versus Placebo Plus Letrozole For The Treatment Of Postmenopausal Women With Er (+), Her2 (-) Breast Cancer Who Have Not Received Any Prior Systemic Anti Cancer Treatment For Advanced Disease|Active, not recruiting||Phase 3|666|Actual|Pfizer|For Overall Survival: The patients continue to be followed for survival and the final OS analysis will be performed when 390 deaths have been reported. OS should not be reported at this time because the OS data is still being followed.|2|||f||||t||||||||||2017-10-11 02:15:06.48506|2017-10-11 02:15:06.48506
NCT01740414|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-07-17|2017-06-13||November 2012||2012-11-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|December 2015|Actual|2015-12-01||Interventional||This was a within-subjects design, however, these numbers denote participant who began with Active (MN-166) maintenance, and those who began under Placebo maintenance.|Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers|Effects of Ibudilast (MN-166, Formerly AV411), a Glial Activation Inhibitor, on Oxycodone Self-administration in Opioid Abusers|Completed||Phase 2|28|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 02:15:10.48198|2017-10-11 02:15:10.48198
NCT01740401|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-03-15|2017-03-15||October 2012||2012-10-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma|Phase II Study of CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma|Terminated||Phase 2|10|Actual|Icahn School of Medicine at Mount Sinai||1||Primary Endpoint not met|f||||t||||||||||2017-10-11 02:15:10.997473|2017-10-11 02:15:10.997473
NCT01740388|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2014-09-17|2014-09-11||February 2013||2013-02-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis|A Study to Evaluate the Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% BID Compared to Vehicle in the Treatment of Bacterial Conjunctivitis|Terminated||Phase 3|136|Actual|Bausch & Lomb Incorporated||2||Strategic business decision|f||||f||||||||||2017-10-11 02:15:11.297924|2017-10-11 02:15:11.297924
NCT01740375|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-08-26|||November 2012||2012-11-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ESOPRESSO||Role of Esophagectomy in Complete Responders to CCRT|A Randomized Phase III Trial on the Role of Esophagectomy in Complete Responders to Preoperative Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus|Terminated||Phase 3|486|Anticipated|Asan Medical Center||2||slow recruitment|f||||t||||||||||2017-10-11 02:15:11.918733|2017-10-11 02:15:11.918733
NCT01740362|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-12-03|2012-12-03||October 2003||2003-10-01|December 2012|2012-12-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function|Phase 1, Open-Label Study To Evaluate Single Dose Pharmacokinetics, Safety And Tolerability Of CP-690,550 In Patients With Impaired Renal Function|Completed||Phase 1|24|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:15:12.017319|2017-10-11 02:15:12.017319
NCT01740349|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-07-10|||August 2012||2012-08-01|November 2012|2012-11-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Observational|||Evaluation Of The Pillcam™ Colon Capsule Endoscopy (Pcce-2) In Pediatric Ulcerative Colitis|EVALUATION OF THE PILLCAM™ COLON CAPSULE ENDOSCOPY (PCCE) IN PEDIATRIC ULCERATIVE COLITIS|Completed||N/A|30|Actual|Azienda Policlinico Umberto I|||1||f||||t||||||||||2017-10-11 02:15:12.410544|2017-10-11 02:15:12.410544
NCT01740336|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-04-21|||February 6, 2013|Actual|2013-02-06|April 2017|2017-04-01|December 10, 2015|Actual|2015-12-10|October 20, 2015|Actual|2015-10-20||Interventional|||A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer|A Phase II, Randomized Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 2|183|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 02:15:12.597077|2017-10-11 02:15:12.597077
NCT01740323|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-07-03|||May 2015||2015-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy|Meriva for Treatment-induced Inflammation and Fatigue in Women With Breast Cancer|Recruiting||Phase 2|22|Anticipated|Emory University||2|||f||||t|t|f||||||||2017-10-11 02:15:12.858453|2017-10-11 02:15:12.858453
NCT01740310|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-03-06|||July 2012||2012-07-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Vaccine Acceptance in Pregnant Minority Women|Vaccine Acceptance in Pregnant Minority Women|Completed||N/A|121|Actual|Emory University||3|||f||||f||||||||||2017-10-11 02:15:12.981959|2017-10-11 02:15:12.981959
NCT01740284|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-02-07|||September 2008||2008-09-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|GT-19||A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine|A Phase III Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis|Completed||Phase 3|46|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-10-11 02:15:15.127525|2017-10-11 02:15:15.127525
NCT01740271|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-10-01|||December 2012||2012-12-01|October 2014|2014-10-01|June 2025|Anticipated|2025-06-01|June 2015|Anticipated|2015-06-01||Interventional|||A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients|Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy|Recruiting||Phase 2|48|Anticipated|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 02:15:15.207746|2017-10-11 02:15:15.207746
NCT01740258|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-01-27|||January 2013||2013-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|BBP||Bevacizumab Beyond Progression (BBP)|Phase II Trial of Bevacizumab, Radiation Therapy and Temodar Followed by Bevacizumab and Temodar With Continuation of Bevacizumab Beyond Progression (BBP-Bevacizumab Beyond Progression)|Active, not recruiting||Phase 2|68|Anticipated|Duke University||1|||f||||t||||||||||2017-10-11 02:15:15.287657|2017-10-11 02:15:15.287657
NCT01740245|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-11-30||||||June 2012|2012-06-01||||||||Interventional|||Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine||Completed||Phase 4|||AGUNCO Obstetrics and Gynecology Centre||2|||f||||||||||||||2017-10-11 02:15:15.480767|2017-10-11 02:15:15.480767
NCT01740232|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2015-01-14|||November 2012||2012-11-01|January 2015|2015-01-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Can a Simple Trephination Increase the Heeling Potential for All-inside Meniscal Repair in the Vascular Zone?|A Simple Trephination Increase the Heeling Potential for All-inside Meniscal Repair in the Vascular Zone|Unknown status|Recruiting|N/A|100|Anticipated|Amager Hospital||2|||f||||t||||||||||2017-10-11 02:15:15.558112|2017-10-11 02:15:15.558112
NCT01740219|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-08-21|||September 2011||2011-09-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|CRUZA||Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches|Promoting the Utilization of Cancer Early Detection Methods Among Latinos in Church: a Faith-based Approach|Unknown status|Enrolling by invitation|N/A|348|Anticipated|Dana-Farber Cancer Institute||2|||f||||f||||||||||2017-10-11 02:15:15.659595|2017-10-11 02:15:15.659595
NCT01740206|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-08-28|2017-07-14||November 2012||2012-11-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)||Completed||N/A|50|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 02:15:15.749998|2017-10-11 02:15:15.749998
NCT01740193|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-01-30|||August 2012||2012-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Comparison of Two Different Pain Management Techniques in Pediatric Patients Undergoing a Hernia Repair|Randomized Prospective Comparison of Analgesic Efficacy of Surgeon Performed IIlioinguinal/Iliohypogastric Blockade With Ultrasound-Guided TAP Blockade in Pediatric Patients Undergoing Unilateral Herniorrhaphy on an Outpatient Basis|Enrolling by invitation||N/A|126|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 02:15:16.028907|2017-10-11 02:15:16.028907
NCT01740180|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-10-24|||March 2015||2015-03-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01|3 Years|Observational [Patient Registry]|||Cortico-saving Treatments Proposed for CLIPPERS: a First Cohort|Cortico-saving Treatments Proposed for CLIPPERS (Chronic Lymphocytic Inflammation With Pontine Perivascular Responsive to Steroids): a First Cohort|Recruiting||N/A|15|Anticipated|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 02:15:16.143675|2017-10-11 02:15:16.143675
NCT01740167|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-11-30|||November 2012||2012-11-01|November 2012|2012-11-01|October 2015|Anticipated|2015-10-01|October 2013|Anticipated|2013-10-01||Interventional|HPMI||Health Promotion on Young Adults With High Risk Disability for Mental Health|Health Promotion on Young Adults With High Risk Disability for Mental Health: Development and Evaluation of the Screen Prevention Model|Unknown status|Active, not recruiting|N/A|200|Anticipated|China Medical University Hospital||1|||f||||f||||||||||2017-10-11 02:15:16.29705|2017-10-11 02:15:16.29705
NCT01740154|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-08-12|||September 2012||2012-09-01|August 2015|2015-08-01||||March 2014|Actual|2014-03-01||Interventional|||Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer|Exploration of the Neuromuscular Mechanisms Associated With Sunitinib Related Fatigue|Terminated||N/A|13|Actual|Case Comprehensive Cancer Center||1||Slow Accrual|f||||t||||||||||2017-10-11 02:15:16.370128|2017-10-11 02:15:16.370128
NCT01740141|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-04-05|||November 2012||2012-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Interventional|||Plexus Brachialis Block. Better to do by Start Than by End of Surgery?|Plexus Brachialis Block. Better to do by Start Than by End of Surgery?|Completed||N/A|52|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 02:15:16.444832|2017-10-11 02:15:16.444832
NCT01740128|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-08-11|||January 1, 2013|Actual|2013-01-01|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|November 30, 2016|Actual|2016-11-30||Interventional|||Multimodal Exercises to Improve Leg Function After Spinal Cord Injury|A Hebbian Approach to Regaining Control of Spared Circuits in Spinal Cord Injury|Active, not recruiting||N/A|75|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 02:15:16.521583|2017-10-11 02:15:16.521583
NCT01740115|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2016-09-08|||November 2012||2012-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Observational|||Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort|Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort|Completed||N/A|250|Actual|Boston Medical Center|||1||f||||t||||||Samples With DNA|"     We are storing serum and plasma for future use. We are also storing dried blood spots.   "|||2017-10-11 02:15:16.620785|2017-10-11 02:15:16.620785
NCT01740102|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-08-03|||August 2012||2012-08-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|||Clinical Value of Remote Ischemic Preconditioning|Does Remote Ischemic Preconditioning Reduce the Incidence of Postoperative Atrial Fibrillation in Patient Undergoing Coronary Artery Bypass Graft Surgery?|Completed||N/A|92|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 02:15:16.695043|2017-10-11 02:15:16.695043
NCT01740089|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2015-07-22|2015-03-01||November 2011||2011-11-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|July 2012|Actual|2012-07-01||Interventional||During randomization, patients were stratified by gender, age, viral load, and HCV genotype. The mITT-analysis included all randomized patients received at least one dose of investigational products, who were not withdrawn from the study at its beginning due to serious violations of the inclusion/non-inclusion criteria.|Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C|Multicenter Open-label Randomized Prospective Clinical Study of Efficacy and Safety of Algeron (Cepeginterferon Alfa-2b) in Comparison With PegIntron (Peginterferon Alfa-2b) in the Combined Treatment of Chronic Hepatitis C|Completed||Phase 2/Phase 3|150|Actual|Biocad||3|||f||||f||||||||||2017-10-11 02:15:16.801908|2017-10-11 02:15:16.801908
NCT01740076|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2017-03-29|||September 2001||2001-09-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|July 2004|Actual|2004-07-01||Interventional|||Soy Nuts and Cardiovascular Risk in Postmenopausal Women|Effect of Soy Nuts on Blood Pressure, Lipids and Inflammation in Postmenopausal Women|Completed||N/A|84|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 02:15:17.50518|2017-10-11 02:15:17.50518
NCT01740063|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-07-11|||November 2012||2012-11-01|July 2013|2013-07-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza|Randomized, Double-blind, Placebo-controlled Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza.|Unknown status|Active, not recruiting|Phase 2|372|Anticipated|Ansun Biopharma, Inc.||3|||f||||t||||||||||2017-10-11 02:15:17.580784|2017-10-11 02:15:17.580784
NCT01740050|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-29|||January 2013||2013-01-01|November 2012|2012-11-01||||January 2015|Anticipated|2015-01-01||Interventional|||Weight-loss and Gut-brain Interactions|Effect of Different Weight-loss Methods on Gut-brain Interactions|Unknown status|Not yet recruiting|N/A|45|Anticipated|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 02:15:17.665417|2017-10-11 02:15:17.665417
NCT01740024|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2014-05-21|||November 2012||2012-11-01|November 2012|2012-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Biological Potency of the Cat Epithelial Allergenic Extracts|An Open-label, Multicentre Study Comparing the Biological Potency of the Native, Depigmented and Depigmented Polymerized Cat Epithelial Allergenic Extracts.|Completed||Phase 2|35|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 02:15:17.96105|2017-10-11 02:15:17.96105
NCT01740011|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2014-09-05|||January 2013||2013-01-01|January 2014|2014-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|AirSeal||Prospective Randomized Trial on Comparison of Standard- Carbon Dioxide Pressure Pneumoperitoneum Insufflators Versus AirSeal|A Prospective Randomized Trial on Comparison of Standard- Carbon Dioxide Pressure Pneumoperitoneum Insufflators Versus AirSeal|Completed||N/A|182|Anticipated|Krankenhaus Barmherzige Schwestern Linz||2|||f||||f||||||||||2017-10-11 02:15:18.03144|2017-10-11 02:15:18.03144
NCT01739998|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-29|||January 2011||2011-01-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|NOBO||Health Benefits of Functional Oil (Mega 3 Fatty Acids From Fish Oil) on Obese People|Randomized, Double-blind, Controlled Study to Evaluate the Efficacy of Omega 3 Fatty Acids on Different Inflammatory Markers in Obese Subjects With Dietary Intervention for Weight Lost|Completed||Phase 4|52|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-11 02:15:18.110854|2017-10-11 02:15:18.110854
NCT01739985|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2014-07-25|||December 2010||2010-12-01|August 2013|2013-08-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|VPOP2||Postoperative Vomiting in Children: Comparison Tri - Versus bi -Prophylaxis|Postoperative Vomiting in Children: Evaluation of the Addition of Droperidol to Conventional Bi-prophylaxis|Completed||N/A|322|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:15:18.187431|2017-10-11 02:15:18.187431
NCT00000518|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-01-19|||July 1985||1985-07-01|January 2016|2016-01-01|December 1992||1992-12-01|||||Interventional|||Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)||Completed||Phase 3|||University of Utah|||||f||||||||||||||2017-10-11 04:18:59.241533|2017-10-11 04:18:59.241533
NCT01739959|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-11-28|||September 2000||2000-09-01|November 2012|2012-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Exploratory Study of Raised Serum Lactate as a Marker of Necrotizing Fasciitis|Raised Serum Lactate as a Marker of Necrotizing Fasciitis; a Consecutive Prospective Review.|Completed||N/A|53|Actual|National Health Service, United Kingdom|||2||f||||f||||||||||2017-10-11 02:15:18.420691|2017-10-11 02:15:18.420691
NCT01739946|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-07-27|||October 2012||2012-10-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Observational|||Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.|Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.|Completed||N/A|30|Actual|William Beaumont Hospitals|||2||f||||f||||||||||2017-10-11 02:15:18.491865|2017-10-11 02:15:18.491865
NCT01739933|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-01|||August 2012||2012-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|MENDSII||The MENDSII Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure|Altering Sedation Paradigms to Improve Brain Injury and Survival in Severe Sepsis|Recruiting||Phase 3|420|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 02:15:18.59342|2017-10-11 02:15:18.59342
NCT01739920|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-01-23|||May 2011|Actual|2011-05-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora|Comparative Efficacy of Two Different Regimens of Povidone-iodine 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora|Completed||Phase 4|124|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:15:18.903707|2017-10-11 02:15:18.903707
NCT01739907|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-06-12|||January 2012||2012-01-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional|||Iron-fortified Flavoured Skimmed Milk With or Without Vitamin D in Iron Deficient Women||Completed||N/A|109|Actual|National Research Council, Spain||2|||f||||f||||||||||2017-10-11 02:15:19.001274|2017-10-11 02:15:19.001274
NCT01739894|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2016-06-06|||January 2013||2013-01-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|November 2017|Anticipated|2017-11-01||Interventional|||Feasibility Study of Intraperitoneal Paclitaxel|Feasibility Study of Intraperitoneal Paclitaxel With Oxaliplatin and Capecitabine in Patients With Advanced Gastric Cancer|Recruiting||Phase 2|20|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-11 02:15:19.093671|2017-10-11 02:15:19.093671
NCT01739881|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-11-28|||April 2011||2011-04-01|July 2012|2012-07-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Evaluating the Pulmonary Nodule With Imaging and Biomarkers|Evaluating the Pulmonary Nodule With Imaging and Biomarkers|Unknown status|Recruiting|N/A|60|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 02:15:19.196923|2017-10-11 02:15:19.196923
NCT01739868|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2015-04-15|||April 2011||2011-04-01|April 2015|2015-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|DECODIAB||Screening and Understanding of the Pre-diabetes: DECODIAB|Screening and Understanding of the Pre-diabetes: DECODIAB|Active, not recruiting||N/A|103|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 02:15:19.292423|2017-10-11 02:15:19.292423
NCT01739855|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2014-08-22|||November 2012||2012-11-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|BABS||Bone Metabolism After Laparoscopic Gastric Bypass Surgery (BABS)|Phase 2 Study of Patients Undergoing Bariatric Surgery (Laparoscopic Gastric Bypass) and Evaluation of Bone Metabolism With/Without Vitamin D/Calcium Supplementation|Completed||Phase 2|160|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:15:19.374985|2017-10-11 02:15:19.374985
NCT01739842|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-10-26|||November 2012||2012-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Interventional|Kudzu MRS||Kudzu Effects on Brain Ethanol Levels: Proton Spectroscopy Assessment|Kudzu Effects on Brain Ethanol Levels: Proton Spectroscopy Assessment|Withdrawn||Phase 2/Phase 3|0|Actual|Mclean Hospital||2||Funding was not received for this study.|f||||f||||||||||2017-10-11 02:15:19.457218|2017-10-11 02:15:19.457218
NCT01739829|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-08-17|||August 2011||2011-08-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus|A Phase I/IIa Open-label Investigation of the Safety and Effectiveness of DIABECELL® [Immunoprotected (Alginate-Encapsulated) Porcine Islets for Xenotransplantation] in Patients With Type 1 Diabetes Mellitus|Completed||Phase 1/Phase 2|8|Actual|Living Cell Technologies||2|||f||||t||||||||||2017-10-11 02:15:19.558726|2017-10-11 02:15:19.558726
NCT01739816|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-04-08|||June 2012||2012-06-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|evalPMC||Polymedication Check - a Randomised Controlled Trial|Polymedication Check - Evaluation of the Impact of Community Pharmacy Based Medication Review on Medicines Use and Humanistic Outcomes|Completed||N/A|450|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-11 02:15:19.668564|2017-10-11 02:15:19.668564
NCT01739803|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-12-20|2013-07-29||January 2010||2010-01-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|September 2012|Actual|2012-09-01||Interventional|||Behavioral Contract Adherence Intervention|Behavioral Contract Intervention to Improve Adherence Among Renal Transplant Recipients|Completed||N/A|150|Actual|University of Tennessee|Did not include attention control group. Did not employ multiple study pharmacists to perform intervention. Limitations of pharmacy refill records: accuracy may be affected by dosage changes, do not indicate if drug actually consumed as prescribed.|2|||f||||t||||||||||2017-10-11 02:15:19.833698|2017-10-11 02:15:19.833698
NCT01739790|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-08-15|2017-06-06||January 2013||2013-01-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||N-Acetylcysteine for Patients With COPD and Chronic Bronchitis|Effects of High-Dose N-Acetylcysteine on Respiratory Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis: A Randomized, Placebo-Controlled Trial-3|Terminated||N/A|51|Actual|University of Minnesota - Clinical and Translational Science Institute||2||PI discretion|f||||t||||||||||2017-10-11 02:15:20.371643|2017-10-11 02:15:20.371643
NCT01739777|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-06-02|||December 2012||2012-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|RIMECARD||Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy|Phase 1 Randomized-Double Blind Clinical Trial of Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells Transplantation in Heart Failure on Patients With Cardiopathy in Dilated Stage, of Different Etiology|Completed||Phase 1/Phase 2|30|Actual|Universidad Los Andes, Chile||2|||f||||t||||||||||2017-10-11 02:15:20.787238|2017-10-11 02:15:20.787238
NCT01739751|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2012-12-03|||January 2011||2011-01-01|November 2012|2012-11-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Interventional|||Physical Activity Enhancement Using Pedometers in COPD|Effect of a Program of Physical Activity Enhancement Using Pedometers in Chronic Obstructive Pulmonary Disease|Unknown status|Active, not recruiting|N/A|90|Actual|University of Chile||2|||f||||f||||||||||2017-10-11 02:15:21.366279|2017-10-11 02:15:21.366279
NCT01739738|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-02-24|||December 2012||2012-12-01|February 2015|2015-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||The Impact of Ureteral Stents on Peristalsis|The Impact of Ureteral Stents on Peristalsis|Withdrawn||N/A|0|Actual|University of British Columbia|||2|Study did not start|f||||f||||||||||2017-10-11 02:15:21.475496|2017-10-11 02:15:21.475496
NCT01739725|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-03-01|||December 2012||2012-12-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study Evaluating the Helical Ureteral Stent|A Prospective Multicenter Clinical Trial to Evaluate the Comfort of the Percuflex Helical Ureteral Stent|Completed||N/A|17|Actual|University of British Columbia||1|||f||||t||||||||No||2017-10-11 02:15:21.560837|2017-10-11 02:15:21.560837
NCT01739712|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2016-11-17|||October 2012||2012-10-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Sleep Intervention for Youth With Type 1 Diabetes|Students With Diabetes: Does Optimizing Sleep Promote Classroom, Behavioral, and Disease-Related Improvement|Completed||N/A|114|Actual|University of Arizona||2|||f||||f||||||||Yes|Upon request.|2017-10-11 02:15:21.663554|2017-10-11 02:15:21.663554
NCT01739686|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-07-28|||August 2012|Actual|2012-08-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CASA||Collaborative Care to Alleviate Symptoms and Adjust to Illness in Chronic Heart Failure (CASA) Trial|Collaborative Care to Alleviate Symptoms and Adjust to Illness in Chronic Heart Failure (CASA) Trial|Completed||N/A|317|Actual|Denver Research Institute||2|||f||||t||||||||||2017-10-11 02:15:21.86996|2017-10-11 02:15:21.86996
NCT01739673|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-02-01|||August 2011||2011-08-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis|Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis|Completed||N/A|1000|Anticipated|Cxlusa||1|||f||||f||||||||||2017-10-11 02:15:21.959815|2017-10-11 02:15:21.959815
NCT01739660|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-10-24|||December 2012||2012-12-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis|A Phase 1, Single Site, Open-Label Study to Assess the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis|Completed||Phase 1|12|Actual|Savient Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:15:22.063305|2017-10-11 02:15:22.063305
NCT01739647|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-30|2013-08-26|||December 2012||2012-12-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 Including an Open-Label Food Effect Group in Healthy Male and Non-Fertile Female Volunteers|Completed||Phase 1|72|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:15:22.16528|2017-10-11 02:15:22.16528
NCT01739634|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2012-11-29|||November 2012||2012-11-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer|The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Salient Pharmaceuticals Incorporated||1|||f||||t||||||||||2017-10-11 02:15:22.262693|2017-10-11 02:15:22.262693
NCT01739621|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2014-04-15|||September 2012||2012-09-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200|A Phase 2, Multi-Center, Extension Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200|Completed||Phase 2|40|Anticipated|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 02:15:22.392686|2017-10-11 02:15:22.392686
NCT01739608|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-11-29|||December 2010||2010-12-01|November 2012|2012-11-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|Proteus||Participation and Detection Rate Diagnostic of a Colorectal Cancer Screening Program: CT Colonography vs. Flexible Sigmoidoscopy|Assessment of the Participation Rate and the Diagnostic Accuracy of a Colorectal Cancer Screening Program: CT Colonography Versus Flexible Sigmoidoscopy. Evaluation of a New Model Based on Telediagnosis|Unknown status|Recruiting|Phase 4|20000|Anticipated|Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte||2|||f||||t||||||||||2017-10-11 02:15:22.479943|2017-10-11 02:15:22.479943
NCT01739595|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-05-07|2014-06-26||November 2012||2012-11-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Safety population|Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism|A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration|Completed||Phase 3|181|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-10-11 02:15:22.61098|2017-10-11 02:15:22.61098
NCT01739582|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2014-04-15|||November 2012||2012-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism|An Open Label, 6 Month Phase III Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism|Completed||Phase 3|300|Anticipated|Repros Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 02:15:23.22636|2017-10-11 02:15:23.22636
NCT01739569|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2013-01-22|||August 2012||2012-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Healthy Lunch and Snack Meal on Reaction Time and Well-being of Physicians and Nursing Staff (Go-No-Go)|Long-term Effect of Healthy Lunch and Snack Meal on Reaction Time and Well-being: A Randomised Controlled Intervention in Physicians and Nursing Staff.|Completed||N/A|60|Actual|Copenhagen University Hospital at Herlev||2|||f||||f||||||||||2017-10-11 02:15:23.319203|2017-10-11 02:15:23.319203
NCT01739556|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-02-10|||June 2015||2015-06-01|February 2017|2017-02-01|October 2019|Anticipated|2019-10-01|June 2019|Anticipated|2019-06-01||Interventional|PLATFORM||On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction|On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction (PLATFORM)|Recruiting||Phase 3|632|Anticipated|Clinical Centre of Serbia||2|||f||||t||||||||||2017-10-11 02:15:23.425063|2017-10-11 02:15:23.425063
NCT01739543|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-03-14|||April 2012||2012-04-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer|A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer|Completed||N/A|102|Actual|Plexus Biomedical, Inc.||2|||f||||f||||||||||2017-10-11 02:15:23.570343|2017-10-11 02:15:23.570343
NCT01739530|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-12-03|||March 2009||2009-03-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Safety of Repaircell in Healthy Volunteers|Phase I Study to Evaluate Safety of Repaircell in Healthy Volunteers|Completed||Phase 1|5|Actual|Anterogen Co., Ltd.||1|||f||||||||||||||2017-10-11 02:15:23.664242|2017-10-11 02:15:23.664242
NCT01739517|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-11-29|||March 2009||2009-03-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease|Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease|Unknown status|Recruiting|Phase 2|20|Anticipated|Amarnath, Rathna, M.D.||1|||f||||t||||||||||2017-10-11 02:15:23.74848|2017-10-11 02:15:23.74848
NCT01739504|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-09-19|||March 2014||2014-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Autologous Adipose-Derived Stromal Cells Delivered Intra-articularly in Patients With Osteoarthritis.|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intra- Articularly in Patients With Osteoarthritis|Recruiting||Phase 1/Phase 2|100|Anticipated|Ageless Regenerative Institute||1|||f||||f||||||||Undecided||2017-10-11 02:15:23.854186|2017-10-11 02:15:23.854186
NCT01739491|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-11-30|||October 2014||2014-10-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||A Study of Safety and Effectiveness of Bendamustine Hydrochloride in Adult Filipino Patients With Chronic Lymphocytic Leukemia|A Post-Marketing Surveillance Study on the Safety And Effectiveness of Bendamustine Hydrochloride Among Adult Filipino Patients With Chronic Lymphocytic Leukemia|Withdrawn||Phase 4|0|Actual|Janssen Pharmaceutica|||1|The study is cancelled. FDA Circular 2013-004 mandates that PMSs like this are not required|f||||f||||||||||2017-10-11 02:15:23.964273|2017-10-11 02:15:23.964273
NCT01739478|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2012-12-02||||||December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|January 2015|Anticipated|2015-01-01||Interventional|PPAC||Packing of Perianal Abscess Cavities Trial: A Randomised Multicentre Trial Comparing Packing With Non-packing of the Abscess Cavity|Packing of Perianal Abscess Cavities (PPAC) Trial: A Randomised Multicentre Trial Comparing Packing With Non-packing of the Abscess Cavity|Unknown status|Not yet recruiting|N/A|300|Anticipated|North Western Research Collaborative||2|||f||||||||||||||2017-10-11 02:15:24.071768|2017-10-11 02:15:24.071768
NCT01739465|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-02-25|||November 2012||2012-11-01|February 2013|2013-02-01||||December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma|A Randomized Controlled Trial Comparing Endoscopic Biliary Radiofrequency Ablation With Photodynamic Therapy for Inoperable Cholangiocarcinoma|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|Guangzhou Medical University||3|||f||||||||||||||2017-10-11 02:15:24.163459|2017-10-11 02:15:24.163459
NCT01739452|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2015-04-08|||January 2013||2013-01-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Observational|SPRESAS||Spanish Registry of Erythropoietic Stimulating Agents Study|National Registry of Patients Diagnosed With Low-risk Myelodysplastic Syndromes According to the Criteria of the WHO / French-American-British Classification System (FAB) and IPSS and Treated With Erythropoietic Agents.|Completed||N/A|722|Actual|Grupo Español de Síndromes Mielodisplásicos|||2||f||||f||||||||||2017-10-11 02:15:24.272465|2017-10-11 02:15:24.272465
NCT01739439|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-09-08|||May 2013|Actual|2013-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery|RT-054: A Phase I Study of Neoadjuvant Hypofractionated Chemoradiation Plus Radiosurgical Boost for Patients With Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer|Active, not recruiting||Phase 1|6|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 02:15:24.357819|2017-10-11 02:15:24.357819
NCT01739426|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-10-21|||March 2013||2013-03-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ZENKER LS||Evaluation of Endoscopic Treatment of Zenker's Diverticulum Using LigaSure|Evaluation of Endoscopic Treatment of Zenker's Diverticulum Using the LigaSure Thermal Vessel Sealing System|Completed||N/A|10|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||t||||||||||2017-10-11 02:15:24.45519|2017-10-11 02:15:24.45519
NCT01739400|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-09-05|||September 1, 2013|Actual|2013-09-01|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|MAESTRO-OL||Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome|Long Term, Single-arm, Open-label Extension Study of Protocol AC-055-305 to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome|Active, not recruiting||Phase 3|220|Anticipated|Actelion||1|||f||||t|t|f||||||||2017-10-11 02:15:24.670857|2017-10-11 02:15:24.670857
NCT01739387|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-06-27|||November 2012||2012-11-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)|A Randomised, Open-label, Cross-over Study of Flutiform® BAI and Flutiform® pMDI Devices in Adolescents and Adult Subjects With Persistent Asthma or Chronic Obstructive Pulmonary Disease (COPD) to Assess Patient Handling.|Completed||N/A|332|Actual|Mundipharma Research Limited|||2||f||||f||||||||||2017-10-11 02:15:24.87001|2017-10-11 02:15:24.87001
NCT01739374|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2015-06-17|||May 2013||2013-05-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Reduced Pelvic Floor Mesh Implants|Phase 2-3 Study of Efficacy and Safety of Reduced Pelvic Floor Mesh Implants|Completed||Phase 2/Phase 3|100|Actual|Western Galilee Hospital-Nahariya||1|||f||||f||||||||||2017-10-11 02:15:24.99594|2017-10-11 02:15:24.99594
NCT01739361|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-03-19|2015-03-11||April 2013||2013-04-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ACROSS||Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis|Phase IIa Randomized Controlled Trial of Acetaminophen for the Reduction of Oxidative Stress in Severe Sepsis|Completed||Phase 2|44|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 02:15:25.10444|2017-10-11 02:15:25.10444
NCT01739348|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-04-25|||November 30, 2012|Actual|2012-11-30|April 2017|2017-04-01|April 14, 2017|Actual|2017-04-14|April 14, 2017|Actual|2017-04-14||Interventional|EPOCH||An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)|A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 With a Long Term Double-Blind Extension in Subjects With Mild to Moderate Alzheimer's Disease (Protocol No. MK-8931-017-10)(Also Known as SCH 900931, P07738)|Terminated||Phase 2/Phase 3|2210|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-10-11 02:15:25.339717|2017-10-11 02:15:25.339717
NCT01739322|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2013-11-08|||November 2012||2012-11-01|March 2013|2013-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Biological Standardization of Platanus Acerifolia Allergen Extract|Biological Standardization of Platanus Acerifolia Allergen Extract to Determine the Biological Activity in HEP Units.|Completed||Phase 2|36|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 02:15:25.540762|2017-10-11 02:15:25.540762
NCT01739309|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-29|2017-03-08||2015-12-23|March 2013||2013-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|September 2015|Actual|2015-09-01||Interventional|||Study of LY2835219 for Mantle Cell Lymphoma|Phase 2 Study of a CDK4/6 Inhibitor for Patients With Relapsed or Refractory Mantle Cell Lymphoma|Active, not recruiting||Phase 2|20|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:15:25.649115|2017-10-11 02:15:25.649115
NCT01739296|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2013-09-10|||June 2011||2011-06-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|||Lateral Wedge Insole With Subtalar Strapping for Knee Osteoarthritis|Lateral Wedge Insole With Subtalar Strapping for Knee Osteoarthritis: a Randomized Clinical Trial|Completed||N/A|58|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 02:15:25.780196|2017-10-11 02:15:25.780196
NCT01739283|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2015-07-10|||July 2012||2012-07-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|||GIP and GLP-1 in Type 1 Diabetes||Completed||N/A|10|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-10-11 02:15:26.610541|2017-10-11 02:15:26.610541
NCT01739270|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2015-07-28|||October 2012||2012-10-01|July 2015|2015-07-01||||January 2013|Actual|2013-01-01||Interventional|||Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia|Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia After Supraclavicular Brachial Plexus Blockade|Unknown status|Active, not recruiting|N/A|55|Anticipated|University Hospital Dubrava||2|||f||||f||||||||||2017-10-11 02:15:26.70443|2017-10-11 02:15:26.70443
NCT01739257|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-05-25|||August 2012||2012-08-01|May 2017|2017-05-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Use of Theater to Invoke Empathy and Reduce Bias in Medical Students||Completed||N/A|129|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 02:15:26.809446|2017-10-11 02:15:26.809446
NCT01739244|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-06-07|||July 2012||2012-07-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma|Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma|Completed||Phase 2|80|Actual|Sylentis, S.A.||4|||f||||f||||||||||2017-10-11 02:15:26.98001|2017-10-11 02:15:26.98001
NCT01739218|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-08-15|||February 1, 2013|Actual|2013-02-01|August 2017|2017-08-01|August 17, 2016|Actual|2016-08-17|August 17, 2016|Actual|2016-08-17||Interventional|ANTHALYA||A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable|A Randomized, Open-Label, Phase II Study Assessing the Efficacy and the Safety of Bevacizumab in Neoadjuvant Therapy in Patients With FIGO Stage IIIC/IV Ovarian, Tubal or Peritoneal Adenocarcinoma, Initially Unresectable|Completed||Phase 2|99|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 02:15:27.195413|2017-10-11 02:15:27.195413
NCT01739205|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-30|||January 2008||2008-01-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|CALM-D||Biobehavioral Bases & Management of Type 2 Diabetes|Biobehavioral Bases & Management of Type 2 Diabetes|Completed||N/A|114|Actual|University of Miami||1|||f||||f||||||||||2017-10-11 02:15:27.339458|2017-10-11 02:15:27.339458
NCT01739192|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-10-02|||January 2013||2013-01-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence||Recruiting||Early Phase 1|48|Anticipated|University of Kentucky||3|||f||||t||||||||||2017-10-11 02:15:27.416079|2017-10-11 02:15:27.416079
NCT01739179|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-12-17|||March 2007||2007-03-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Observational|||Keyhole Surgery for the Positioning of the Distal Catheter in Ventricular Peritoneal Shunt Placement|Laparoscopically Assisted Ventriculoperitoneal Shunt Placement: A Prospective, Randomized Two-arm Study|Completed||N/A|120|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-11 02:15:27.519425|2017-10-11 02:15:27.519425
NCT01739166|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-12-02|||October 2010||2010-10-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||QI Study of a Practice Facilitator's Impact in Working With Clinics on Improving Dental, Lead & Obesity Measures for Children|Child Healthcare Excellence Center - A University-Practice-Public Partnership (CHEC-UPPP)|Completed||N/A|30|Actual|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-11 02:15:27.637742|2017-10-11 02:15:27.637742
NCT01739153|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-11-20|||January 2013||2013-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|August 2013|Actual|2013-08-01||Interventional|ECCA||Effect of Cheese on Cardiovascular Risk|Effect of Cheese on Cardiovascular Risk|Completed||N/A|19|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 02:15:27.737253|2017-10-11 02:15:27.737253
NCT01739140|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-08-18|||December 2012||2012-12-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|July 2013|Actual|2013-07-01||Interventional|YoMA||Yoga for Chronic Low Back Pain and Its Mechanism of Action (YoMA)|Yoga for Chronic Low Back Pain and Its Mechanism of Action (YoMA)|Unknown status|Active, not recruiting|N/A|24|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 02:15:29.283941|2017-10-11 02:15:29.283941
NCT01739127|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-05-24|||November 2012||2012-11-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|CALM||Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI|A Longitudinal Comparison of Aripiprazole vs. Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI|Completed||N/A|83|Actual|University of British Columbia|||3||f||||f||||||Samples With DNA|"     Participants will be offered the option of taking part in an optional biobanking component of     the main study. Six milliliters of whole blood samples will be collected and stored at -80     degrees Celsius for genotyping to determine if certain genetic polymorphisms predispose     individuals to gain weight while taking antipsychotic medications.   "|||2017-10-11 02:15:29.388157|2017-10-11 02:15:29.388157
NCT01739114|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-03-13|||May 2013||2013-05-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Assessment of Lung Aeration at Birth|Sustained Inflations to Achieve Lung Aeration at Birth - a Randomized Control Trial|Completed||N/A|186|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 02:15:29.513265|2017-10-11 02:15:29.513265
NCT01739101|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-12-12|||March 2012||2012-03-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Reproductive Life Plan in Midwifery Counseling|The Reproductive Life Plan in Midwifery Counseling|Completed||N/A|299|Actual|Uppsala University||3|||f||||t||||||||||2017-10-11 02:15:29.646471|2017-10-11 02:15:29.646471
NCT01739088|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-03-23|||March 2013||2013-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|PREP||Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery|Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery|Active, not recruiting||N/A|53|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 02:15:29.737964|2017-10-11 02:15:29.737964
NCT01739075|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-05-30|||March 2012||2012-03-01|August 2013|2013-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Assessment of Coronary Stenoses Using Coronary CT-angiography and Non-invasive Fractional Flow Reserve Measurement.|Assessment of the Functional Significance of Coronary Stenoses Using Coronary CT-angiography and Non-invasive Fractional Flow Reserve Measurement.|Completed||N/A|64|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 02:15:29.838797|2017-10-11 02:15:29.838797
NCT01739062|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-04-10|||February 2013||2013-02-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|ProCaRis||The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice|Prostate Cancer Risk Assessment Using Genetic Markers in General Practice|Recruiting||N/A|4500|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 02:15:29.922172|2017-10-11 02:15:29.922172
NCT01739049|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-05-01|||November 2012||2012-11-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|October 2013|Actual|2013-10-01||Interventional|||Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese|The Influence of Appetite-Related Central and Gut Hormones in Modulating Binge Eating Behaviour in Obese and Overweight Healthy Subjects|Completed||Phase 4|42|Actual|Universiti Kebangsaan Malaysia Medical Centre||2|||f||||f||||||||No||2017-10-11 02:15:30.026483|2017-10-11 02:15:30.026483
NCT01739036|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-11-08|||January 2013||2013-01-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1|A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1|Completed||Phase 1/Phase 2|48|Actual|University of Oxford||4|||f||||f||||||||||2017-10-11 02:15:30.120215|2017-10-11 02:15:30.120215
NCT01739023|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-09-25|||November 2012||2012-11-01|September 2017|2017-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute SCI|The Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute Spinal Cord Injury (SCI)|Completed||Phase 1|9|Actual|University of Miami||1|||t||||t||||||||||2017-10-11 02:15:30.220795|2017-10-11 02:15:30.220795
NCT01739010|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-01-27|||January 2007||2007-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Hypothermia Following Acute Spinal Cord Injury|Efficacy of Intravenously Instituted Hypothermia Treatment in Improving Functional Outcomes in Patients Following Acute Spinal Cord Injury|Recruiting||N/A|100|Anticipated|University of Miami|||1||f||||t||||||||No||2017-10-11 02:15:30.418814|2017-10-11 02:15:30.418814
NCT01738997|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-11-29|||December 2003||2003-12-01|November 2012|2012-11-01||||December 2006|Actual|2006-12-01||Interventional|||Endoscopical Dilation of Benign Esophageal Strictures|Endoscopical Dilation of Benign Esophageal Strictures - a Randomized, Clinical Trial, Comparing Two Different Inflation Times.|Completed||N/A|20|Actual|University Hospital, Umeå||2|||f||||f||||||||||2017-10-11 02:15:30.492753|2017-10-11 02:15:30.492753
NCT01738984|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-03-11|2015-06-23||December 2012||2012-12-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MamaMove||A Home Exercise Program for Women With Infants & Young Children|A Home Exercise Program for Women With Infants & Young Children|Completed||Phase 3|499|Actual|University of Hawaii||2|||f||||t||||||||||2017-10-11 02:15:30.59815|2017-10-11 02:15:30.59815
NCT01738971|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2014-08-01|2014-06-23||April 2012||2012-04-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Baseline analysis conducted on all participants successfully contacted for telephone follow-up at 6-8weeks post enrollment to study. no baseline analysis possible on those recruited in pharmacy but lost to follow-up.|Initiating Contraception After Emergency Contraception From Pharmacy|Pharmacy Based Interventions for Initiating Effective Contraception Following the Use of Emergency Contraception : a Feasibility Study|Completed||N/A|168|Actual|University of Edinburgh|"Loss to follow-up relatively high. Self-reporting of primary outcome measure (contraceptive method at time of follow-up). Would have been preferable to be able to validate this.
Pharmacists unable to record demographic data of those not recruited."|3|||f||||f||||||||||2017-10-11 02:15:31.037002|2017-10-11 02:15:31.037002
NCT01738958|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2014-12-02|||September 2012||2012-09-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Lozenges Containing Probiotic Lactobacilli on Enamel Demineralization Assed by QLF|Effect of Lozenges Containing Probiotic Lactobacilli on Enamel Demineralization Assed by QLF|Completed||N/A|66|Actual|University of Copenhagen||2|||f||||||||||||||2017-10-11 02:15:31.451984|2017-10-11 02:15:31.451984
NCT01738945|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-11-29|||February 2008||2008-02-01|February 2008|2008-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose||Completed||Phase 4|32|Actual|Gulhane School of Medicine||1|||f||||||||||||||2017-10-11 02:15:31.531055|2017-10-11 02:15:31.531055
NCT01738932|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-11-29|||December 2006||2006-12-01|November 2012|2012-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Genetic Polymorphisms of Mannan-binding Lectin (MBL)and Serum Levels of MBL in Patients With Endometriosis|Genetic Polymorphisms of Mannan-binding Lectin (MBL) and Serum Levels of MBL in Patients With Endometriosis|Completed||N/A|100|Actual|University of Aarhus|||2||f||||f||||||Samples With DNA|"     Serum, EDTA blood   "|||2017-10-11 02:15:31.630961|2017-10-11 02:15:31.630961
NCT01738919|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-09-15|2016-04-01||April 2011||2011-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|May 2015|Actual|2015-05-01||Interventional|Ishiguro||Extension Block Technique Versus Splinting in Mallet Finger Fracture.|Ishiguro Extension Block Technique Versus Splinting in the Treatment of Mallet Finger Fracture. A Randomized Controlled Trial.|Completed||N/A|32|Actual|University of Aarhus||2|||f||||f||||||||No||2017-10-11 02:15:31.722657|2017-10-11 02:15:31.722657
NCT01738906|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-01-02|||October 2012||2012-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of Alcohol on Food Reward|The Effect of Moderate Alcohol Consumption on Subsequent Food Reward|Completed||N/A|24|Actual|TNO||6|||f||||f||||||||||2017-10-11 02:15:32.092118|2017-10-11 02:15:32.092118
NCT01738893|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-19|||January 14, 2011|Actual|2011-01-14|June 2017|2017-06-01|January 22, 2011|Actual|2011-01-22|January 22, 2011|Actual|2011-01-22||Interventional|||Bioequivalence Study of 300 mg Gabapentin|Bioequivalence Study Between Two Medications for Administration of Oral Gabapentin in 300 mg Capsules in Healthy Volunteers|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:15:32.241406|2017-10-11 02:15:32.241406
NCT01738880|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2015-01-26|||December 2012||2012-12-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Goal-directed Fluid Therapy Based on Stroke Volume Variation on Metabolic Acidosis in Patients Undergoing Brain Tumor Surgery||Completed||N/A|50|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:15:32.343338|2017-10-11 02:15:32.343338
NCT01738867|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-05-09|||December 12, 2012|Actual|2012-12-12|May 2017|2017-05-01|May 27, 2014|Actual|2014-05-27|May 27, 2014|Actual|2014-05-27||Interventional|||To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers|A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers|Completed||Phase 1|56|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:15:32.576087|2017-10-11 02:15:32.576087
NCT01738854|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2014-04-06|||November 2012||2012-11-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||The Comparison of Airway Sealing With the Laryngeal Mask Airway (LMA) Supreme at Different Intracuff Pressure in Children||Completed||N/A|36|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 02:15:32.730788|2017-10-11 02:15:32.730788
NCT01738672|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2014-11-07|||February 2012||2012-02-01|November 2014|2014-11-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Inhaled Nitrous Oxide and Labor Analgesia|Inhaled Nitrous Oxide and Labor Analgesia|Suspended||Phase 2|100|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 02:15:35.37829|2017-10-11 02:15:35.37829
NCT01738841|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-07-18|||August 2013||2013-08-01|July 2013|2013-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines|Post-marketing Surveillance Study of GSK Biologicals' Live, Attenuated Measles, Mumps, Rubella and Varicella Vaccine, Priorix-Tetra, Following a Single Vaccine Dose Given According to Local Prescribing Information in the Philippines|Withdrawn||N/A|0|Actual|GlaxoSmithKline|||1|"Local authorities no longer require routine PMS studies; GSK does not believe the study would   add meaningfully to the safety data already available for MMRV."|f||||||||||||||2017-10-11 02:15:32.856114|2017-10-11 02:15:32.856114
NCT01738828|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-02-08|||December 2012||2012-12-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|May 2014|Actual|2014-05-01||Observational|GLOBAL||GLOBAL Clinical Study|Genetic Loci and the Burden of Atherosclerotic Lesions|Active, not recruiting||N/A|10000|Anticipated|Global Genomics Group, LLC|||2||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, buffy coat and RNA PAXgene   "|||2017-10-11 02:15:32.98785|2017-10-11 02:15:32.98785
NCT01738815|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-12-12|||December 2011||2011-12-01|December 2012|2012-12-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer|Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer|Unknown status|Recruiting|Early Phase 1|50|Anticipated|State University of New York - Upstate Medical University||1|||f||||t||||||||||2017-10-11 02:15:33.170323|2017-10-11 02:15:33.170323
NCT01738802|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-04-27|||January 2012||2012-01-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PMC||The Effects of Micronutrients in Combination With Usual Care in Type 2 Diabetes|The Effects of Micronutrients in Combination With Usual Care in Type 2 Diabetes|Completed||N/A|111|Actual|Walter Reed National Military Medical Center||2|||f||||t||||||||||2017-10-11 02:15:33.266497|2017-10-11 02:15:33.266497
NCT01738789|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-07-25|||March 2013||2013-03-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|EURAD||EURAD-MR Classification : European Multicenter Study|"European Multicenter Validation of an ADNEXMR SCORING System for Characterizing Adnexal Masses: EURAD-MR Classification"|Active, not recruiting||N/A|1340|Actual|Société d'Imagerie de la Femme|||1||f||||f||||||||||2017-10-11 02:15:33.374713|2017-10-11 02:15:33.374713
NCT01738776|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-30|||September 2009||2009-09-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Nutritional Risk Factors for Hip Fracture: a Case Control Study|Nutritional Risk Factors for Hip Fracture: a Case Control Study|Completed||N/A|184|Actual|Oslo University Hospital|||2||f||||f||||||Samples With DNA|"     For vitamin and hormone analysis serum was collected For some vitamin analysis EDTA blood was     collected For RNA analysis fullblood was collected   "|||2017-10-11 02:15:33.487304|2017-10-11 02:15:33.487304
NCT01738763|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-11-27|||July 2011||2011-07-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Effects of Different Doses of Pinitol on Carbohydrate Metabolism Parameters in Healthy Subjects|Effects of Different Doses of Pinitol on Carbohydrate Metabolism Parameters in Healthy Subjects: a Randomized Cross-over Placebo-controlled Study|Completed||N/A|30|Actual|University of Valencia||3|||f||||f||||||||||2017-10-11 02:15:33.563725|2017-10-11 02:15:33.563725
NCT01738750|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2014-04-16|2014-01-08||July 2012||2012-07-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Age, Gender|Laparoscopic Versus Open Appendectomy? Let the Patient Decide|Laparoscopic Versus Open Appendectomy? Let the Patient Decide|Completed||N/A|100|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 02:15:33.65492|2017-10-11 02:15:33.65492
NCT01738737|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-11-06|2015-09-17||December 2012||2012-12-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||There was no statistically significant difference between groups at baseline (p> 0.05).|Low-level Laser Therapy and Static Stretching in Knee Osteoarthritis.|Effect of Low-level Laser Therapy (904 nm) and Static Stretching in Patients With Knee Osteoarthritis: Randomised Controlled Trial.|Completed||N/A|145|Actual|University of Sao Paulo General Hospital||5|||f||||f||||||||||2017-10-11 02:15:33.920911|2017-10-11 02:15:33.920911
NCT01738724|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2012-11-27|||January 2013||2013-01-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin|Abnormal Uterine Bleeding in Women With Uterine Leiomyomas: Open Randomized Clinical Trial Of Non Inferiority Between Oral Dienogest, Oral Desogestrel and Subcutaneous Goserelin|Unknown status|Not yet recruiting|Phase 4|63|Anticipated|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 02:15:34.491193|2017-10-11 02:15:34.491193
NCT01738711|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-12-11|||December 2012||2012-12-01|December 2012|2012-12-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients|Does Cognitive Behavioural Therapy (CBT) Delivered by a Respiratory Nurse Reduce Anxiety and the Impact of Cough and Breathlessness on Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF)?|Unknown status|Not yet recruiting|N/A|30|Anticipated|Royal Victoria Infirmary||2|||f||||f||||||||||2017-10-11 02:15:34.595729|2017-10-11 02:15:34.595729
NCT01738698|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2014-05-01|2014-05-01||November 2012||2012-11-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized|Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia|A Phase 3 Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, 12-week, Forced-dose Titration Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 40mg, 100mg, or 160mg as Adjunctive Treatment to Established Maintenance Doses of Antipsychotic Medications on Negative Symptoms in Clinically Stable Adults Who Have Persistent Predominant Negative Symptoms of Schizophrenia|Terminated||Phase 3|4|Actual|Shire|Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized|4||"Study was discontinued due to non-safety related business prioritization decisions. No subjects   were randomized."|f||||t||||||||||2017-10-11 02:15:34.738876|2017-10-11 02:15:34.738876
NCT01738685|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-11-11|||December 2012||2012-12-01|November 2016|2016-11-01|December 2015|Anticipated|2015-12-01|June 2014|Anticipated|2014-06-01||Interventional|Relief||Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy|Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy.|Withdrawn||N/A|0|Actual|University of Pittsburgh||2||No funding.|f||||f||||||||||2017-10-11 02:15:35.305928|2017-10-11 02:15:35.305928
NCT01738659|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-11-27|||October 2008||2008-10-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|December 2010|Actual|2010-12-01||Interventional|||Estimated Echocardiographic Pulmonary Capillary Wedge Pressure in Heart Failure|Moderate Versus Low Sodium Diet Intake Effects on Estimated Echocardiographic Pulmonary Capillary Wedge Pressure During 12 Months of Follow up in Compensated Heart Failure Patients.|Completed||Phase 4|143|Actual|University of Palermo||1|||f||||f||||||||||2017-10-11 02:15:35.460871|2017-10-11 02:15:35.460871
NCT01738646|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-01-20|2015-09-30||January 2013||2013-01-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|December 2014|Actual|2014-12-01||Interventional|||Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients|Phase II Study of Bevacizumab and Vorinostat for Recurrent WHO Grade IV Malignant Glioma Patients|Completed||Phase 2|48|Actual|Duke University||1|||f||||t||||||||||2017-10-11 02:15:35.546457|2017-10-11 02:15:35.546457
NCT01738633|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2017-04-11|||January 2013||2013-01-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Quality of Life After Esophagectomy for Cancer - Step 2|Quality of Life After Esophagectomy for Cancer - Step 2|Recruiting||N/A|128|Anticipated|University of Padova||4|||f||||f||||||||||2017-10-11 02:15:35.972835|2017-10-11 02:15:35.972835
NCT01738620|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2017-04-11|||January 2013||2013-01-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Quality of Life After Esophagectomy for Cancer - Step 1|Quality of Life After Esophagectomy for Cancer - QOLEC1|Terminated||N/A|74|Actual|University of Padova||4||"In October 2015 ICU's setting completely changed from an open concept 8-beds unit to a single   bed isolated room."|f||||f||||||||||2017-10-11 02:15:36.078302|2017-10-11 02:15:36.078302
NCT01738607|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-10-29|||April 2004||2004-04-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|June 2007|Actual|2007-06-01||Interventional|||Dietary Fiber for Fecal Incontinence|The Impact of Fiber Fermentation on Fecal Incontinence|Completed||N/A|206|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||t||||||||||2017-10-11 02:15:36.187589|2017-10-11 02:15:36.187589
NCT01738594|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-11-10|||January 2013||2013-01-01|November 2015|2015-11-01||||October 2016|Anticipated|2016-10-01||Interventional|||Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma|A Randomized Phase I Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma|Recruiting||Phase 1|48|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-11 02:15:36.321083|2017-10-11 02:15:36.321083
NCT01738581|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2016-12-30|2015-05-19||November 2011||2011-11-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|DSS||rTMS and Retraining in Focal Hand Dystonia|Effectiveness of rTMS and Retraining in the Treatment of Focal Hand Dystonia|Completed||Phase 1/Phase 2|9|Actual|University of Minnesota - Clinical and Translational Science Institute|Small sample size may have underpowered the study. The high variance seen in our single subject analysis is not unusual as a current conundrum in neuromodulation is the variable response between subjects to many different types of neuromodulation.|2|||f||||t||||||||No||2017-10-11 02:15:36.441284|2017-10-11 02:15:36.441284
NCT01738568|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-07-18|||October 2012||2012-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Effects of Aging and Aerobic Exercise Training on Brain Glucose Metabolism|Effect of Aging and Aerobic Exercise Training on Brain Glucose Metabolism|Active, not recruiting||N/A|40|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:15:36.824556|2017-10-11 02:15:36.824556
NCT01738555|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-03-27|||April 2013||2013-04-01|March 2013|2013-03-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects|An Open-label, 36-week Extension Study on Amdoxovir at 500 mg Bid or 300 mg Bid in Combination With Zidovudine and Lopinavir/Ritonavir in HIV-1 Treatment-experienced Subjects With M184I/V Mutation in Addition to 0-2 Confirmed Thymidine Analog Mutations.|Withdrawn||Phase 2|0|Actual|RFS Pharma, LLC||2|||f||||f||||||||||2017-10-11 02:15:36.891319|2017-10-11 02:15:36.891319
NCT01738542|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-11-28|||April 2009||2009-04-01|November 2012|2012-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|CLAU||Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease|CLAU Test Results (CLinical Assessment And Endothelin fUnction Assessment After Endothelin Receptor Antagonist) : Randomized Controlled Clinical Trial of Bosentan for Intermittent Claudication in Peripheral Arterial Disease|Completed||N/A|30|Actual|Hospital Universitario Getafe||2|||f||||t||||||||||2017-10-11 02:15:36.98606|2017-10-11 02:15:36.98606
NCT01738529|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2015-02-17|||November 2012||2012-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||Characterization of Crohn's Disease at Confocal Laser Endomicroscopy (CLE) and Related to Disease Activity|Characterization of Crohn's Disease at Confocal Laser Endomicroscopy and Related to Disease Activity|Completed||N/A|36|Anticipated|Herlev Hospital||2|||f||||t||||||||||2017-10-11 02:15:37.078139|2017-10-11 02:15:37.078139
NCT01738516|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-10-04|||February 2013||2013-02-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|conneXion||Contribution of High Resolution EEG Functional Connectivity Measures to Presurgical Evaluation of Patients With Intractable Epilepsy|Contribution of High Resolution EEG Functional Connectivity Measures to Presurgical Evaluation of Patients With Intractable Epilepsy|Completed||N/A|44|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 02:15:37.170928|2017-10-11 02:15:37.170928
NCT01738503|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-12-28||2015-05-15|September 2012||2012-09-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects|Open-Label, Multicenter, Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, Efficacy Markers, and Opioid Receptor Availability of Subcutaneous Injections of Depot Buprenorphine in Treatment Seeking Opioid-Dependent Subjects|Completed||Phase 2|124|Actual|Indivior Inc.||6|||f||||f||||||||||2017-10-11 02:15:37.259498|2017-10-11 02:15:37.259498
NCT01738490|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-08-31|||June 2012||2012-06-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|June 2014|Actual|2014-06-01||Interventional|||Long-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant|Long-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant|Completed||N/A|59|Actual|Oticon Medical||2|||f||||f||||||||||2017-10-11 02:15:37.399027|2017-10-11 02:15:37.399027
NCT01737931|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2014-03-26|2014-02-09||August 2012||2012-08-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject|An Open-Label Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject|Completed||Phase 1|120|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:15:44.016762|2017-10-11 02:15:44.016762
NCT01738464|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-03-13|||June 2012||2012-06-01|March 2017|2017-03-01|March 8, 2018|Anticipated|2018-03-08|March 7, 2018|Anticipated|2018-03-07||Observational|||Microbiomes of Pelvic Pain|Microbiomes of Pelvic Pain|Recruiting||N/A|300|Anticipated|Northwestern University|||3||f||||f||||||Samples With DNA|"     Stool specimen, Blood/Serum specimen, Urine specimen   "|||2017-10-11 02:15:37.690918|2017-10-11 02:15:37.690918
NCT01738451|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-08-27|||January 2013||2013-01-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors|A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study|Completed||Phase 1|44|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 02:15:37.805025|2017-10-11 02:15:37.805025
NCT01738438|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-10-24|2016-05-27||February 2013||2013-02-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||The analysis dataset is comprised of all treated patients.|Cabozantinib for Metastatic Triple Negative BrCa|A Phase II Study of XL184 (Cabozantinib) for Metastatic Triple-Negative Breast Cancer|Completed||Phase 2|35|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 02:15:38.007317|2017-10-11 02:15:38.007317
NCT01738425|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-07-17|||November 2012||2012-11-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||A Clinical Phase I Study on GIC-1001 in Healthy Volunteers|A Double-Blind, Placebo Controlled, Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of GIC-1001 in Normal Healthy Volunteers|Completed||Phase 1|80|Actual|gicare Pharma Inc.||2|||f||||t||||||||||2017-10-11 02:15:38.34322|2017-10-11 02:15:38.34322
NCT01738412|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-11-29||||||November 2012|2012-11-01||||||||Observational|||Validation of an Electroencephalograph Based Algorithm for Detection of Onset and Deterioration of Acute Ischemic Stroke by Comparison to NIHSS|Validation of an Electroencephalograph Based Algorithm for Detection of Onset and Deterioration of Acute Ischemic Stroke by Comparison to NIHSS.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Neurokeeper Technologies|||1||f||||f||||||||||2017-10-11 02:15:38.45317|2017-10-11 02:15:38.45317
NCT01738399|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-04-21|||April 2012||2012-04-01|March 2012|2012-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|COMETH||Coffee and Metabolic Health Outcomes|Influence of Coffee Consumption on Insulin Sensitivity in Overweight and Insulin Resistant Subjects.|Completed||N/A|128|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 02:15:38.662754|2017-10-11 02:15:38.662754
NCT01738386|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-10-05|||June 13, 2012||2012-06-13|February 24, 2016|2016-02-24|February 24, 2016||2016-02-24|||||Observational|||Living With Frontotemporal Dementia|Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual|Terminated||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:15:38.755182|2017-10-11 02:15:38.755182
NCT01738373|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-03-19|||December 2011||2011-12-01|March 2015|2015-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation|Investigator Centers Will Be All French Hematology Centers Performing Autologous Transplantation and Prescribing Mozobil in Hematopoietic Stem Cell Mobilization Willing to Participate In This Study|Completed||Phase 4|262|Actual|Sanofi|||1||f||||t||||||||||2017-10-11 02:15:38.838225|2017-10-11 02:15:38.838225
NCT01738360|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-01-05|||July 2013||2013-07-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|LUPSENIC||Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)|Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE)|Terminated||Phase 2|11|Actual|Nantes University Hospital||1||Difficulty of inclusions and a sufficient number of relevant clinical information|f||||||||||||||2017-10-11 02:15:38.922854|2017-10-11 02:15:38.922854
NCT01738347|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-02-23|||April 2013||2013-04-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).|Assess Safety, Bio-distribution, and Radiation Dosimetry, and Optimize the Imaging Protocol of GEH120714 (18F) Injection, a Marker of Microglial Activation, in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS)|Completed||Phase 1|30|Anticipated|GE Healthcare||1|||f||||t||||||||||2017-10-11 02:15:39.060387|2017-10-11 02:15:39.060387
NCT01738321|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-02-13|2015-02-24||January 2013||2013-01-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||Changes in Intracuff Pressure of a Cuffed Endotracheal Tube During Prolonged Surgical Procedures.||Completed||N/A|63|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 02:15:39.23025|2017-10-11 02:15:39.23025
NCT01738308|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-07-28|||September 2013||2013-09-01|July 2016|2016-07-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|||The Effects of Healing Touch on Post Operative Pediatric Patients|Investigating the Effect of Healing Touch on Post-Operative Recovery of Pediatric Tonsillectomies and Adenoidectomies Patients Ages 3 & 4|Recruiting||N/A|240|Anticipated|Children's Hospital Medical Center, Cincinnati||3|||f||||f||||||||||2017-10-11 02:15:39.493335|2017-10-11 02:15:39.493335
NCT01738295|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-06-01|||January 2013||2013-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|||Donepezil Effect on Visual Attention and Training|Donepezil Effect on Visual Attention and Perceptual Training in Healthy Young Adults|Completed||N/A|20|Actual|Université de Montréal||2|||f||||t||||||||||2017-10-11 02:15:39.661233|2017-10-11 02:15:39.661233
NCT01738282|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-07-29|||December 2012||2012-12-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ALPADIR||Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients|A Randomized, Multicentric, Double Blind Study to Assess the Efficacy of Xylka® (Baclofen) at the Target Dosage of 180mg/Day Compared to Placebo, for Maintenance of Abstinence in Alcohol Dependent Patients|Completed||Phase 3|316|Anticipated|Ethypharm||2|||f||||t||||||||||2017-10-11 02:15:39.781543|2017-10-11 02:15:39.781543
NCT01738269|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2013-07-30|||November 2012||2012-11-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Elecsys HE4 Chinese Reference Value Study|A Multi-center Reference Value Study of Elecsys HE4 in Chinese Population|Completed||N/A|2351|Actual|Chinese PLA General Hospital|||3||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 02:15:39.960255|2017-10-11 02:15:39.960255
NCT01738256|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2014-02-07|||August 2012||2012-08-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study of Effectiveness of Different Lifestyle Interventions for Health and Wellbeing|Applicability and Efficiency of Different Approaches in Lifestyle Interventions - Lifestyle Management and Changes in Everyday Life|Completed||N/A|339|Actual|University of Jyvaskyla||4|||f||||f||||||||||2017-10-11 02:15:40.045723|2017-10-11 02:15:40.045723
NCT01738243|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2016-05-10|||December 2013||2013-12-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|HALR||Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease|Phase IV Study of Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease|Recruiting||Phase 4|40|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:15:40.16687|2017-10-11 02:15:40.16687
NCT01738230|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2013-08-06|||October 2012||2012-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:15:40.262911|2017-10-11 02:15:40.262911
NCT01738217|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-07-07|||April 2013||2013-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|HEPATOFLUO||Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery|Evaluation, for Patients Requiring a Liver Cancer Surgery, of the Use of Fluorescence Imaging Device: Faisability and Efficiency of Lesional and/or Anatomical Marking|Completed||Phase 1/Phase 2|48|Actual|Centre Leon Berard||1|||f||||t||||||||||2017-10-11 02:15:40.306671|2017-10-11 02:15:40.306671
NCT01738204|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-21|||November 2012||2012-11-01|June 2017|2017-06-01|January 2030|Anticipated|2030-01-01|January 2030|Anticipated|2030-01-01||Observational|||The Women's Health Study: From Adolescence to Adulthood|The Women's Health Study: From Adolescence to Adulthood Sponsored by the Boston Center for Endometriosis.|Recruiting||N/A|2000|Anticipated|Boston Children’s Hospital|||2||f||||f||||||Samples With DNA|"     urine, saliva, blood, tissue, peritoneal fluid   "|||2017-10-11 02:15:40.429758|2017-10-11 02:15:40.429758
NCT01738178|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-03-21|||April 2014||2014-04-01|March 2017|2017-03-01|December 1, 2016|Actual|2016-12-01|May 1, 2016|Actual|2016-05-01||Interventional|||Caffeine as a Therapy for Parkinson's Disease|Caffeine as a Therapeutic Agent in Parkinson's Disease|Completed||Phase 3|119|Actual|McGill University Health Center||2|||f||||t||||||||||2017-10-11 02:15:40.609781|2017-10-11 02:15:40.609781
NCT01738165|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-06-13|||December 2012||2012-12-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|April 2017|Actual|2017-04-01||Interventional|SOAR||Study of the KineSpring® System to Evaluate Symptom Relief in Patients With Medial Knee Osteoarthritis|Prospective, Multi-Center, Pilot Study to Evaluate Symptom Relief in Patients With Medial Knee Osteoarthritis (OA) Treated With the KineSpring® Knee Implant for Load Reduction|Active, not recruiting||N/A|83|Actual|Moximed||1|||f||||t||||||||Undecided||2017-10-11 02:15:40.729996|2017-10-11 02:15:40.729996
NCT01738152|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-09-25|||November 2012||2012-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health|A Single-Arm Clinical Trial Investigating the Feasibility of a Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health|Recruiting||N/A|60|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:15:40.859393|2017-10-11 02:15:40.859393
NCT01738139|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2017-07-10|||February 2013|Actual|2013-02-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Ipilimumab and Imatinib Mesylate in Advanced Cancer|A Phase I Trial of Ipilimumab (Immunotherapy) and Imatinib Mesylate (c-Kit Inhibitor) in Patients With Advanced Malignancies|Recruiting||Phase 1|96|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-11 02:15:40.970565|2017-10-11 02:15:40.970565
NCT01738126|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-09-13|||May 2009||2009-05-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Observational|||fMRI and DTI of Cerebellar Responses to Pain in the Human Trigeminal System||Completed||N/A|43|Actual|Mclean Hospital|||1||f||||f||||||||||2017-10-11 02:15:41.094067|2017-10-11 02:15:41.094067
NCT01738113|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2016-07-26|||July 2014||2014-07-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Open Versus Closed Kinetic Chain Exercises in Tibial Distraction Osteogenesis by Ilizarov's METHOD|Open Versus Closed Kinetic Chain Exercises in Tibial Distraction Osteogenesis by Ilizarov's METHOD|Completed||Phase 2|10|Actual|Cairo University||2|||f||||f||||||||Undecided||2017-10-11 02:15:41.175582|2017-10-11 02:15:41.175582
NCT01738100|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2016-07-04|||September 2012||2012-09-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention|Effects of Ticagrelor and Intracoronary Morphine on Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 2|100|Anticipated|Samsung Medical Center||4|||f||||f||||||||||2017-10-11 02:15:41.288854|2017-10-11 02:15:41.288854
NCT01737736|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-07-17|||June 2013||2013-06-01|July 2013|2013-07-01||||||||Observational|||Validation of Neurokeeper's Algorithm on Patients Undergoing Carotid Endarterectomy||Unknown status|Recruiting|N/A|||Neurokeeper Technologies|||1||f||||f||||||||||2017-10-11 02:15:48.491987|2017-10-11 02:15:48.491987
NCT01738087|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-03-28|||November 2012||2012-11-01|March 2017|2017-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder|A Phase II, Monocentric, Open, Randomized, 6-way Cross-over Clinical Pharmacology Study to Evaluate the Lung Bioavailability of BDP/B17MP and Formoterol and the Total Systemic Exposure Across Two Different Strengths of CHF 1535 NEXThaler Dry Powder Inhaler (Fixed Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate 100/6 mcg and 200 mcg) Administered With and Without Activated Charcoal in Adult Asthmatic Patients.|Completed||Phase 2|30|Actual|Chiesi Farmaceutici S.p.A.||6|||f||||f||||||||||2017-10-11 02:15:41.404597|2017-10-11 02:15:41.404597
NCT01738074|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-11-28|||August 2012||2012-08-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine||Unknown status|Active, not recruiting|Phase 3|10020|Actual|Center for Disease Control and Prevention, Henan Province||2|||f||||||||||||||2017-10-11 02:15:41.535175|2017-10-11 02:15:41.535175
NCT01738061|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2012-11-29|||January 2010||2010-01-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||A Multidimensional Lifestyle Intervention to Reduce the Risk of Metabolic Disorders in Older Workers in Taiwan|A Multidimensional Lifestyle Intervention to Reduce the Risk of Metabolic Disorders in Older Workers in Taiwan|Completed||N/A|108|Actual|Asia University||2|||f||||t||||||||||2017-10-11 02:15:41.613472|2017-10-11 02:15:41.613472
NCT01738048|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-29|||January 2008||2008-01-01|November 2012|2012-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Persistent Pain After Reconstruction Following Mastectomy|Persistent Pain After Reconstruction Following Mastectomy|Completed||N/A|1352|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-11 02:15:41.685004|2017-10-11 02:15:41.685004
NCT01738035|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2015-09-23|||December 2012||2012-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|NEFIGAN||The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease|A Multicentre, Interventional Treatment, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Different Doses of Nefecon in Primary IgA Nephropathy Patients at Risk of End-stage Renal Disease|Completed||Phase 2|150|Actual|Pharmalink AB||3|||f||||t||||||||||2017-10-11 02:15:41.787211|2017-10-11 02:15:41.787211
NCT01738022|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-09-25|||December 2012||2012-12-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C|Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study C|Unknown status|Recruiting|N/A|20|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:15:41.999172|2017-10-11 02:15:41.999172
NCT01738009|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-09-25|||December 2012||2012-12-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B|Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B|Unknown status|Recruiting|N/A|40|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:15:42.103539|2017-10-11 02:15:42.103539
NCT01737996|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-03-10|2016-01-21||November 2012||2012-11-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||The study comprised 2 trial parts: a multiple rising dose part (Part 1) followed by a combined treatment part (Part 2). The multiple rising dose part was performed in an open-label, non-randomised, non-placebocontrolled manner with 2 dose groups. The combined treatment part was conducted open-label in 1 treatment group.|Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID and Multiple Doses of BI 207127 Combined With Faldaprevir in Healthy Male and Female Subjects|An Open-label, Multiple Dose Study to Assess Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID Administered Orally for 9 Days (Part 1) and Multiple Doses of BI 207127 Combined With Faldaprevir Administered Orally for 16 Days (Part 2) in Healthy Male and Female Subjects|Completed||Phase 1|32|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:15:42.216942|2017-10-11 02:15:42.216942
NCT01737983|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-11-28|||May 2009||2009-05-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Lactobacillus Reuteri in Cystic Fibrosis|Lactobacillus Reuteri Reduces Pulmonary Exacerbations and Upper Respiratory Tract Infections in CF Patients With Mild-to-moderate Lung Disease. LR Administration Might Have a Beneficial Effect on the Disease Course of Cystic Fibrosis.|Completed||Phase 4|61|Actual|Azienda Policlinico Umberto I||2|||f||||t||||||||||2017-10-11 02:15:43.207109|2017-10-11 02:15:43.207109
NCT01737957|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2012-11-28|||November 2012||2012-11-01|November 2012|2012-11-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Safety and Efficacy of Low-Fluence PRP for PDR|Safety and Efficacy of Single-session, Low-fluence Panretinal Photocoagulation (PRP) for Proliferative Diabetic Retinopathy (PDR)|Unknown status|Recruiting|N/A|60|Anticipated|Asociación para Evitar la Ceguera en México||2|||f||||t||||||||||2017-10-11 02:15:43.372027|2017-10-11 02:15:43.372027
NCT01737944|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-01-08|2013-01-25||January 2011||2011-01-01|January 2014|2014-01-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional||38 subjects were randomized to a treatment sequence. Two subjects discontinued prior to receiving the first study drug dose. Safety Population = 36 subjects who received study drug and completed all study visits. All 36 subjects were included in Pharmacokinetic Population. No discontinuations after first study drug dose.|Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration|Exposure, Safety and Local Tolerance Study Comparing 3 Routes of Methotrexate (MTX) Administration: Vibex-MTX Device, Subcutaneous (SC)and Intramuscular (IM) in Adult Subjects With Rheumatoid Arthritis|Completed||Phase 1/Phase 2|38|Actual|Antares Pharma Inc.||4|||f||||f||||||||||2017-10-11 02:15:43.473951|2017-10-11 02:15:43.473951
NCT01737723|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-27|||August 2011||2011-08-01|November 2012|2012-11-01||||||||Observational|||Electroencephalograph for Detection of Acute Ischemic Stroke|Collecting Data for an Electroencephalograph Based Algorithm for Detection of Onset and Deterioration of Acute Ischemic Stroke by Comparison to NIHSS|Unknown status|Recruiting|N/A|20|Anticipated|Neurokeeper Technologies|||1||f||||f||||||||||2017-10-11 02:15:48.581332|2017-10-11 02:15:48.581332
NCT01737918|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-28|2015-04-06|||January 2013||2013-01-01|April 2015|2015-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|URGE-II||Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa|Phase 1/2 Study of the Effect of TOT or Solifenacin After Cesa or Vasa on Urge Urinary Incontinence|Recruiting||Phase 1/Phase 2|120|Anticipated|Klinikum der Universität Köln||2|||f||||t||||||||||2017-10-11 02:15:44.532408|2017-10-11 02:15:44.532408
NCT01737905|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-02-11||2016-02-11|October 2012||2012-10-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma|Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)|Completed||Phase 3|28|Actual|Amphastar Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:15:44.629707|2017-10-11 02:15:44.629707
NCT01737892|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-02-18||2013-07-10|November 2012||2012-11-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults|Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults (A Randomized, Evaluator-Blind, Single-Dose, Two Arm, Crossover, PK Study in Healthy Volunteers)|Terminated||Phase 1/Phase 2|21|Actual|Amphastar Pharmaceuticals, Inc.||2||unable to validate analytical method|f||||f||||||||||2017-10-11 02:15:44.741346|2017-10-11 02:15:44.741346
NCT01737879|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-03-14|2014-03-14||October 2012||2012-10-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis|Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Subjects Receiving Hemodialysis|Terminated||Phase 4|41|Actual|Amgen||1||"Terminated: Test article, Omontys, was recalled from the market; Enrollment has halted   prematurely and will not resume; participants are no longer being treated"|f||||f||||||||||2017-10-11 02:15:44.85861|2017-10-11 02:15:44.85861
NCT01737866|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2013-08-09|||November 2012||2012-11-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency|An Open-label, Single-dose Study of the Safety, Tolerability, and Pharmacokinetics of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency and Effect of Hemodialysis on AMG 423 Pharmacokinetics|Completed||Phase 1|13|Actual|Amgen||6|||f||||f||||||||||2017-10-11 02:15:45.174747|2017-10-11 02:15:45.174747
NCT01737853|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-11-29|||February 2011||2011-02-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|February 2011|Actual|2011-02-01||Observational|||Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)|Comparison of Efficacy and Tolerability Between 2fixed Combinations for Treating Mexican Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: Ganforti vs Krytantek.A Phase IV,Examiner-masked Cross-over Multicenter Clinical Trial|Completed||N/A|90|Actual|Allergan S.A. DE C.V..|||2||f||||f||||||||||2017-10-11 02:15:45.30791|2017-10-11 02:15:45.30791
NCT01737840|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2015-06-27|2015-03-16||October 2012||2012-10-01|June 2015|2015-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparison of Pantoprazole and Ranitidine in Dyspepsia|Intravenous Pantoprazole vs Ranitidine in Dyspepsia in Emergency Department: A Randomized Controlled Trial.|Completed||Phase 4|66|Actual|Akdeniz University||2|||f||||f||||||||||2017-10-11 02:15:45.403914|2017-10-11 02:15:45.403914
NCT01737827|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-08-08|||March 25, 2013|Actual|2013-03-25|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|January 1, 2018|Anticipated|2018-01-01||Interventional|||Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.|A Phase II, Open Label, Single Arm, Multicenter Study of INC280 Administered Orally in Adults With Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 2|39|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:15:45.670329|2017-10-11 02:15:45.670329
NCT01737814|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-10-26|||May 2013||2013-05-01|October 2016|2016-10-01||||February 2016|Actual|2016-02-01||Interventional|EPIC||Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)|Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis|Completed||Phase 3|388|Actual|Mast Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 02:15:45.792478|2017-10-11 02:15:45.792478
NCT01737801|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2012-11-29|||February 2008||2008-02-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|January 2012|Actual|2012-01-01||Interventional|||Time to Perform Lung Function Test in Cystic Fibrosis|Time to Perform Lung Function Test in Cystic Fibrosis After Chest Physiotherapy.|Completed||N/A|24|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 02:15:47.351781|2017-10-11 02:15:47.351781
NCT01737788|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2012-11-29|||August 2006||2006-08-01|November 2012|2012-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Cervical Occlusion for the Prevention of Preterm Birth|Randomised Trial of Cervical Cerclage With and Without Occlusion for the Prevention of Preterm Birth in Women Suspected for Cervical Insufficiency|Terminated||N/A|309|Actual|Hvidovre University Hospital||2||Due to slow recruitment and an interim analysis showing no benefit of occlusion.|f||||t||||||||||2017-10-11 02:15:47.42949|2017-10-11 02:15:47.42949
NCT01737775|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-08-07|||October 2012||2012-10-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|Under the Dome||Comparative Ultrasonic Study of Post Operative Diaphragmatic Dysfunction in Abdominal and Head and Neck Surgery|Comparative Ultrasonic Study of Post Operative Diaphragmatic Dysfunction in Abdominal and Head and Neck Surgery|Completed||N/A|43|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-11 02:15:47.547893|2017-10-11 02:15:47.547893
NCT01737762|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-06-27|2017-06-27||November 2012||2012-11-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2|A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2|Completed||Phase 3|155|Actual|Healthpoint|The trial was terminated due to the failure of the Phase 3 study|2|||f||||t||||||||Yes|Results summaries have been sent to each site for distribution to participants|2017-10-11 02:15:47.639696|2017-10-11 02:15:47.639696
NCT01737749|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-27||||||November 2012|2012-11-01||||||||Observational|||Validation of Neurokeeper's Algorithm on Patients Undergoing Cardiac Surgery.||Unknown status|Not yet recruiting|N/A|||Neurokeeper Technologies|||1||f||||f||||||||||2017-10-11 02:15:48.384337|2017-10-11 02:15:48.384337
NCT01737710|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-02-27|2016-11-08||October 2012||2012-10-01|February 2017|2017-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study|A Randomized Open Label Mechanistic Study in Atopic Dermatitis to Assess the Immunogenicity of Fluzone® Intradermal and Intramuscular Vaccines|Completed||N/A|368|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||f||||||||||2017-10-11 02:15:48.714025|2017-10-11 02:15:48.714025
NCT01737684|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-05-16|2016-05-16||January 2013||2013-01-01|May 2016|2016-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||All Enrolled Participants|A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013)|A Two-Part, Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 02:15:50.09497|2017-10-11 02:15:50.09497
NCT01737671|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-04-03|||December 2012|Actual|2012-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study|Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study|Active, not recruiting||Early Phase 1|12|Anticipated|M.D. Anderson Cancer Center||1|||f||||t|t|f||||||||2017-10-11 02:15:50.408767|2017-10-11 02:15:50.408767
NCT01737658|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-01-06|||December 2012||2012-12-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Insulin Resistance and Cognitive Dysfunction in Obese Adolescents: Pilot Study|Insulin Resistance and Cognitive Dysfunction in Obese Adolescents: Pilot Study|Completed||N/A|56|Actual|Winthrop University Hospital||2|||f||||f||||||||||2017-10-11 02:15:50.522575|2017-10-11 02:15:50.522575
NCT01737645|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-07-16|||August 2012||2012-08-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients|A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients|Terminated||N/A|4|Actual|William Beaumont Hospitals|||2|Difficulty in enrolling subjects.|f||||t||||||||||2017-10-11 02:15:50.596461|2017-10-11 02:15:50.596461
NCT01737632|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-11-26|||August 2000||2000-08-01|November 2012|2012-11-01|June 2010|Actual|2010-06-01|June 2008|Actual|2008-06-01||Interventional|ART||Family-based and Adolescent Residential Drug Treatment|Family-Based Versus Adolescent Residential Drug Treatment|Completed||N/A|113|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 02:15:50.662393|2017-10-11 02:15:50.662393
NCT01737619|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-11-10|||April 2013||2013-04-01|November 2016|2016-11-01||||April 2019|Anticipated|2019-04-01||Interventional|||Prospective Evaluation of Lymph Node Metastasis at the Time of Surgical Staging for High Risk Endometrial Cancer|Prospective Evaluation of Lymph Node Metastasis at the Time of Surgical Staging for High Risk Endometrial Cancer|Active, not recruiting||N/A|150|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:15:50.744541|2017-10-11 02:15:50.744541
NCT01737606|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2013-09-27|||September 2012||2012-09-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|COSTUM||Ultrasonic Explorations of Cerebral Tissue Motions - Influence of Aging|Ultrasonic Explorations of Cerebral Tissue Motions - Influence of Aging|Completed||N/A|53|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-11 02:15:50.825062|2017-10-11 02:15:50.825062
NCT01737593|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-08-30|2015-06-11||November 2012||2012-11-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?|Can Acetaminophen PO Given 1-2 Hours Before Bilateral Myringotomy Tube (BMT) Placement Reduce Emergence Agitation (EA) in Children After General Sevoflurane Anesthesia?|Terminated||Phase 4|108|Actual|University of California, Los Angeles||3||Interim analysis revealed a negative effect.|f||||t||||||||No||2017-10-11 02:15:50.92744|2017-10-11 02:15:50.92744
NCT01737580|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2013-08-27|||April 2013||2013-04-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists|Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists|Completed||Phase 1|59|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 02:15:51.335291|2017-10-11 02:15:51.335291
NCT01737567|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-12-15|||February 2014||2014-02-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|WLEvB-NBI||Comparison Between White Light Endoscopy and Bright Narrow Band Imaging in Diagnosis Colonic Adenomas.|A Randomised Comparison Between White Light Endoscopy (WLE) and Bright Narrow Band Imaging (B-NBI) in the Diagnosis of Colonic Adenomas in Asymptomatic Subjects Undergoing Screening Colonoscopy.|Recruiting||N/A|1000|Anticipated|Western Sydney Local Health District||2|||f||||t||||||||||2017-10-11 02:15:51.423229|2017-10-11 02:15:51.423229
NCT01737554|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-12-20|||December 2012||2012-12-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents|Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents: A Feasibility Study|Completed||N/A|10|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 02:15:51.506528|2017-10-11 02:15:51.506528
NCT01737541|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-08-20|||November 2012||2012-11-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|FMRICH||Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage|Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage (FMRICH): a Randomised Placebo-controlled Trial|Terminated||Phase 3|32|Actual|Universidad Autónoma de Aguascalientes||2||Study recruitment was suspended due to lack of funding|f||||t||||||||||2017-10-11 02:15:51.59219|2017-10-11 02:15:51.59219
NCT01737528|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-06-29|||June 2012||2012-06-01|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2018|Anticipated|2018-06-01|30 Days|Observational [Patient Registry]|TVTR||STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)|Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry (STS/ACC TVT Registry).|Recruiting||N/A|16000|Anticipated|The Society of Thoracic Surgeons|||1||f||||t||||||||||2017-10-11 02:15:51.697512|2017-10-11 02:15:51.697512
NCT01737515|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-27|||November 2008||2008-11-01|November 2012|2012-11-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Observational|||Investigation of Waist Circumference and Waist/Hip Ratio as a Predictive Risk Factor for Morbidity and Mortality After Colorectal Surgery|Investigation of Waist Circumference and Waist/Hip Ratio as a Predictive Risk Factor for Morbidity and Mortality After Colorectal Surgery|Completed||N/A|1415|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-10-11 02:15:51.791709|2017-10-11 02:15:51.791709
NCT01737502|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-08-28|||November 2012||2012-11-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer|A Phase I-II Trial of Combined PKCι and mTOR Inhibition for Patients With Advanced or Recurrent Lung Cancer (NSCLC and SCLC) Without Standard Treatment Options|Recruiting||Phase 1/Phase 2|47|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:15:51.862269|2017-10-11 02:15:51.862269
NCT01737489|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-09-07|||October 2012||2012-10-01|September 2017|2017-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||"Title: Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods"|"Title: Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods"|Completed||N/A|17|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 02:15:51.969584|2017-10-11 02:15:51.969584
NCT01737476|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-11-26|||November 2012||2012-11-01|November 2012|2012-11-01||||August 2015|Anticipated|2015-08-01||Interventional|||Trial to Evaluate the Efficacy of the HLPFC Coil Deep Transcranial Magnetic Stimulation System in Treating Attention Deficit and Hyperactivity Disorder (ADHD) in Adults||Unknown status|Not yet recruiting|N/A|60|Anticipated|Soroka University Medical Center||5|||f||||||||||||||2017-10-11 02:15:52.041803|2017-10-11 02:15:52.041803
NCT01737463|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2012-12-01|||March 2010||2010-03-01|December 2012|2012-12-01|October 2014|Anticipated|2014-10-01|October 2013|Anticipated|2013-10-01||Interventional|PDS||Prophylactic Pancreatic Duct Stent Placement After ESP of Major Papillary Tumors; Prospective, Randomized Study|Prophylactic Pancreatic Duct Stent Placement After Endoscopic Snare Papillectomy of Duodenal Major Papillary Tumors; Prospective, Randomized, Controlled Study|Unknown status|Enrolling by invitation|Phase 4|100|Anticipated|Soonchunhyang University Hospital||2|||f||||f||||||||||2017-10-11 02:15:52.121585|2017-10-11 02:15:52.121585
NCT01737450|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-07-25|||January 2013||2013-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|March 2018|Anticipated|2018-03-01||Interventional|PIK-ORL||Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive|A Phase II, Multicenter Trial Aiming to Evaluate the Clinical Interest of a Monotherapy With BKM120 , a Phosphoinositide 3-kinase (PI3K) Inhibitor in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive Under Platin and Cetuximab-based Chemotherapy|Recruiting||Phase 2|70|Anticipated|Centre Leon Berard||1|||f||||t||||||||||2017-10-11 02:15:52.19769|2017-10-11 02:15:52.19769
NCT01737437|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-11-26|||October 2012||2012-10-01|November 2012|2012-11-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Effect of Lidocaine Sprayed on Hemodynamics During Endotracheal Intubation|Effect of Lidocaine Sprayed on Direct Laryngoscopy and Trachea on Hemodynamics During Endotracheal Intubation|Unknown status|Recruiting|N/A|80|Anticipated|Seoul National University Hospital||4|||f||||f||||||||||2017-10-11 02:15:52.344796|2017-10-11 02:15:52.344796
NCT01737424|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-03-13|||December 2012||2012-12-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects|A Dose Blocked-randomized, Double-blind, Placebo-controlled, Single Dosing and Dose-escalation Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects|Completed||Phase 1|89|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 02:15:52.522825|2017-10-11 02:15:52.522825
NCT01737411|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-04-06|||January 2013||2013-01-01|April 2015|2015-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|URGE-I||Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women|Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women|Recruiting||Phase 1/Phase 2|120|Anticipated|Klinikum der Universität Köln||2|||f||||t||||||||||2017-10-11 02:15:52.592489|2017-10-11 02:15:52.592489
NCT01737398|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-03-23|||December 2012||2012-12-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|||Efficacy and Safety of IONIS-TTR Rx in Familial Amyloid Polyneuropathy|A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy|Active, not recruiting||Phase 3|172|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 02:15:52.712891|2017-10-11 02:15:52.712891
NCT01737385|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-28|||May 2012||2012-05-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Examination of Microcirculation of the Caput Humeri After Proximal Humerus Fracture|Intraoperative Examination of Microcirculation of the Caput Humeri After Traumatic Proximal Humerus Fracturation.|Completed||N/A|25|Actual|RWTH Aachen University|||4||f||||t||||||||||2017-10-11 02:15:52.890035|2017-10-11 02:15:52.890035
NCT01737372|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-11-08|||November 2012||2012-11-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis|A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis|Completed||N/A|49|Actual|Rocky Mountain MS Research Group, LLC|||3||f||||f||||||Samples Without DNA|"     Cerebrospinal fluid and blood may be stored for future immunological, cell product and     microRNA testing related to the primary outcome of the this study.   "|No||2017-10-11 02:15:52.979591|2017-10-11 02:15:52.979591
NCT01737359|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-11-04|||December 2012||2012-12-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.|A Phase IIa, Randomized, Double-blind, Active-controlled, 12-week Study of Amdoxovir (Two Doses) Versus Tenofovir DF, in Combination With Zidovudine in HIV-1 Treatment-experienced Subjects With M184I/V Mutation in Addition to 0-2 Confirmed Thymidine Analog Mutations.|Terminated||Phase 2|2|Actual|RFS Pharma, LLC||3|||f||||f||||||||||2017-10-11 02:15:53.062792|2017-10-11 02:15:53.062792
NCT01736618|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-09-14|||March 12, 2013|Actual|2013-03-12|September 2017|2017-09-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|||S-ICD® System Post Approval Study|S-ICD® System Post Approval Study|Active, not recruiting||N/A|1766|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 02:16:03.90782|2017-10-11 02:16:03.90782
NCT01737346|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-30|||October 2012||2012-10-01|November 2012|2012-11-01|April 2014|Anticipated|2014-04-01|September 2013|Anticipated|2013-09-01||Interventional|||Procarbazine and Lomustine in Recurrent Glioblastoma|Phase 2 Clinical Trial of PC(Procarbazine-CCNU) Chemotherapy in Patients With Recurrent or Resistant Glioblastoma With Methylated MGMT|Unknown status|Recruiting|Phase 2|52|Anticipated|Incheon St.Mary's Hospital||1|||f||||t||||||||||2017-10-11 02:15:53.165601|2017-10-11 02:15:53.165601
NCT01737333|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-09-27|||October 2012||2012-10-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Multidetector Computed Tomography (MDCT) Tailored Protocol|A Multicenter, Multinational, Randomized Study of Standard vs. Patient-Adapted Protocols in Multidetector Computed Tomography (MDCT) of the Chest, Abdomen, Liver or Aorta|Completed||N/A|1493|Actual|Bracco Diagnostics, Inc|||1||f||||f||||||||||2017-10-11 02:15:53.257207|2017-10-11 02:15:53.257207
NCT01737320|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-08-24|||January 2013||2013-01-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia|Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia - a Randomized Controlled Trial|Recruiting||N/A|600|Anticipated|Rabin Medical Center||2|||f||||||||||||||2017-10-11 02:15:53.31669|2017-10-11 02:15:53.31669
NCT01737307|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-27|||March 2011||2011-03-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy|Effect of Fluoride Varnish and CPP-ACP Paste on Oral and Salivary Symptoms of Patients Under Chemotherapy: A Double-blind Clinical Trial|Completed||Phase 2|30|Actual|Azad University of Medical Sciences||3|||f||||t||||||||||2017-10-11 02:15:53.423235|2017-10-11 02:15:53.423235
NCT01737294|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2014-10-03|||February 2012||2012-02-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|ASCEND||Observation of the Use of QUTENZA™ in Standard Clinical Practice|The Use of QUTENZA™ in Standard Clinical Practice: a Phase IV, Multicentre, European Non-interventional Study|Completed||N/A|429|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 02:15:53.512494|2017-10-11 02:15:53.512494
NCT01737281|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-06-28|||July 1, 2014|Actual|2014-07-01|June 2017|2017-06-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|PROMH||Proactive Outreach for Smokers in VA Mental Health|Proactive Outreach for Smokers in VA Mental Health|Active, not recruiting||N/A|6400|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-11 02:15:53.703981|2017-10-11 02:15:53.703981
NCT01737255|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-09-12|||October 2012||2012-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Observational|SIGNIFY||Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome|Magnetic Resonance Imaging Screening In Li Fraumeni Syndrome: An Exploratory Whole Body MRI Study|Active, not recruiting||N/A|88|Actual|Institute of Cancer Research, United Kingdom|||2||f||||f||||||||||2017-10-11 02:15:53.92927|2017-10-11 02:15:53.92927
NCT01737242|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-09-12|||January 1993||1993-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|UKGPCS||UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies|UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies|Recruiting||N/A|26000|Anticipated|Institute of Cancer Research, United Kingdom|||1||f||||t||||||Samples With DNA|"     Whole blood, Prostate Tissue   "|||2017-10-11 02:15:54.011876|2017-10-11 02:15:54.011876
NCT01737216|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-12-28|||November 2012||2012-11-01|November 2012|2012-11-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer||Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Hebei Tumor Hospital||2|||f||||||||||||||2017-10-11 02:15:54.173264|2017-10-11 02:15:54.173264
NCT01737203|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-11-26|||August 2012||2012-08-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil|Phase 1, Open-Label, Randomized, Single-Dose, 3-Way Crossover Study Assessing Bioequivalence Of Sildenafil 50 Mg Orally-Disintegrating Tablet With Or Without Water To Viagra® 50 Mg Oral Tablet With Water Under Fasted Condition|Completed||Phase 1|53|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:15:54.258128|2017-10-11 02:15:54.258128
NCT01737190|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-11-28|||December 2012||2012-12-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||PEEP Guided by Esophageal Balloon Measurement and Its Effect on Recruitment Maneuver|PEEP Guided by Esophageal Balloon Measurement and Its Effect on Recruitment Maneuver|Unknown status|Not yet recruiting|N/A|20|Anticipated|Wolfson Medical Center||1|||f||||f||||||||||2017-10-11 02:15:54.35268|2017-10-11 02:15:54.35268
NCT01737177|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-09-06|||April 2012||2012-04-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|July 2014|Actual|2014-07-01||Interventional|R2-B||Bendamustine/Lenalidomide/Rituximab: Combination as a Second-Line Therapy for 1st Relapsed-Refractory MCL|Bendamustine, Lenalidomide and Rituximab (R2-B) Combination as a Second-Line Therapy for First Relapsed-Refractory Mantle Cell Lymphomas: A Phase II Study|Active, not recruiting||Phase 2|42|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-11 02:15:54.433515|2017-10-11 02:15:54.433515
NCT01737164|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-02-17|||September 2010||2010-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Age on Glucose and Lipid Metabolism|Effect of Age on Glucose and Lipid Metabolism|Completed||N/A|44|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 02:15:54.601185|2017-10-11 02:15:54.601185
NCT01728623|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-01-15|||September 2012||2012-09-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||A Study of E7080 in Subjects With Advanced Thyroid Cancer|A Phase 2 Study of E7080 in Subjects With Advanced Thyroid Cancer|Completed||Phase 2|37|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 02:18:08.544184|2017-10-11 02:18:08.544184
NCT01737151|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-09-14|||March 8, 2013||2013-03-08|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer|Study of 4-Fraction Split-Course Stereotactic Ablative Radiation Therapy of the Treatment of Patients With Low and Intermediate Risk Adenocarcinoma of the Prostate|Active, not recruiting||N/A|19|Actual|Virginia Commonwealth University||2|||f||||t|f|f||||||||2017-10-11 02:15:54.687462|2017-10-11 02:15:54.687462
NCT01737138|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2012-11-30|||November 2012||2012-11-01|November 2012|2012-11-01|April 2018|Anticipated|2018-04-01|August 2017|Anticipated|2017-08-01||Interventional|RSD4CKD||Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension|Safety and Effectiveness Study of Percutaneous Catheter-based Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension|Recruiting||N/A|100|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 02:15:54.76819|2017-10-11 02:15:54.76819
NCT01737125|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-07-02|||December 2012||2012-12-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Morphological Study of Distal Tibio-fibular Joint on MRI|Morphological Study of Distal Tibio-fibular Joint by Static MRI, Dynamics of Movement and Effort in Spatial High Resolution. Clinical Implication|Completed||N/A|15|Actual|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 02:15:54.87689|2017-10-11 02:15:54.87689
NCT01737112|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-04-05|||February 2011||2011-02-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TcRGDLC||99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients|Safety and Diagnostic Performance of 99mTc-3PRGD2 SPECT/CT in Evaluation of Lung Cancer Patients|Recruiting||Early Phase 1|100|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-11 02:15:54.958415|2017-10-11 02:15:54.958415
NCT01737099|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-04-24|||November 2012||2012-11-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|DHA-O||Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia||Completed||N/A|93|Actual|DSM Nutritional Products, Inc.||3|||f||||f||||||||||2017-10-11 02:15:55.155464|2017-10-11 02:15:55.155464
NCT01737086|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-10-31|||December 2012||2012-12-01|October 2016|2016-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|Profat||Comparing the Efficacy of Two Oral Rehydration Solutions, With or Without the Probiotic Lactobacillus Reuteri DSM 17938 and Zinc, on the Duration and Severity of Acute Gastroenteritis in 6 - 36 Months Old Children in Out-patient Care|Comparing the Efficacy of Two Oral Rehydration Solutions, With or Without the Probiotic Lactobacillus Reuteri DSM 17938 and Zinc, on the Duration and Severity of Acute Gastroenteritis in 6 - 36 Months Old Children in Out-patient Care|Terminated||Phase 2/Phase 3|14|Actual|Umeå University||2||Terminated due to lack of eligible patients.|f||||f||||||||||2017-10-11 02:15:55.237322|2017-10-11 02:15:55.237322
NCT01737073|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-05-09|||April 1, 2017|Actual|2017-04-01|May 2017|2017-05-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Interventional|COMPACT||Comprehensive Opioid Management in Patient Aligned Care Teams|Comprehensive Opioid Management in Patient Aligned Care Teams (COMPACT)|Withdrawn||N/A|0|Actual|VA Office of Research and Development||4||"This study was unable to overcome IT and contracting barriers which prevented the study's data   collection system from being implemented."|f||||t|f|f|||f|||No||2017-10-11 02:15:55.326707|2017-10-11 02:15:55.326707
NCT01737060|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-08-19|||January 1, 2013|Actual|2013-01-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 1, 2017|Actual|2017-06-01||Interventional|DELPHI||Displaced Proximal Humeral Fractures: Delta Prothesis or Philos Plate?|Clinical Investigation for Fractures of the Proximal Humerus in Elderly Patients. A Randomized Study of Two Surgical Treatments: Reverse Total Shoulder Arthroplasty Versus Angular Stable Device Philos|Active, not recruiting||N/A|125|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 02:15:55.426115|2017-10-11 02:15:55.426115
NCT01737047|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-01-13|||April 2013||2013-04-01|December 2016|2016-12-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Observational|POPPY||A Prospective, Observational Study to Examine the Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'|A Prospective, Observational Study to Examine the Effects of Ageing on the Clinical Outcomes of People Living With HIV in England and Ireland|Active, not recruiting||N/A|1376|Actual|Imperial College London|||3||f||||t||||||Samples With DNA|"     Blood for storage Blood (serum and plasma,) and urine samples will be collected at visits 1     and 3 stored for subsequent projects of the potential pathogenic mechanisms underlying     age-related diseases. This will include assessment of vitamin-D and PTH and probably DNA     analysis.   "|||2017-10-11 02:15:55.526431|2017-10-11 02:15:55.526431
NCT01737034|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-11-29|||January 2011||2011-01-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Low Glycemic Index Diet as Prevention of the Catch-up Fat Phenomenon|Ätiologie, Pathophysiologie Und Prävention Einer überschießenden Körperfettzunahme Nach Gewichtsreduktion - Vermeidung Des JoJo-Effektes in Der Behandlung Von Übergewicht|Completed||N/A|32|Actual|University of Kiel||4|||f||||f||||||||||2017-10-11 02:15:55.622139|2017-10-11 02:15:55.622139
NCT01737021|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2015-04-24|2015-04-24||November 2012||2012-11-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Improving Outcomes After PICU Admission: A Pilot Study|A Psycho-educational Intervention to Improve Family Mental Health and Child Educational Outcomes Following Admission to PICU: A Pilot Study|Completed||N/A|31|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 02:15:55.700671|2017-10-11 02:15:55.700671
NCT01737008|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-06-09|||January 2013||2013-01-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck|Phase I Trial of Dacomitinib Concomitant With Radiotherapy With and Without Cisplatin in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|12|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 02:15:55.897651|2017-10-11 02:15:55.897651
NCT01736982|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-02-16|||October 2012||2012-10-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Contingency Management for Smoking Cessation in the Homeless|Contingency Management for Smoking Cessation in the Homeless|Completed||N/A|70|Actual|UConn Health||2|||f||||t|f|f||||||||2017-10-11 02:15:56.083442|2017-10-11 02:15:56.083442
NCT01736969|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2012-11-30|||August 2012||2012-08-01|November 2012|2012-11-01||||March 2013|Anticipated|2013-03-01||Interventional|||A Substantial Equivalence Study of RD04723 and Predicate Device|Microcyn Scar Management HydroGel, K103163 vs. Kelo-cote® Scar Gel for the Management of Hypertrophic or Keloid Scars|Unknown status|Active, not recruiting|N/A|40|Anticipated|Oculus Innovative Sciences, Inc.||2|||f||||f||||||||||2017-10-11 02:15:56.163588|2017-10-11 02:15:56.163588
NCT01736956|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-10-24|||October 2012||2012-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome|Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome|Recruiting||Phase 1/Phase 2|30|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:15:56.246482|2017-10-11 02:15:56.246482
NCT01736943|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-01-19|||December 2012||2012-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia|Phase II Trial of the Combination of Subcutaneous (SQ) Bortezomib and Pegylated Liposomal Doxorubicin (PLD or Doxil or LipoDox) for the Treatment of Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML)|Recruiting||Phase 2|30|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-11 02:15:56.331137|2017-10-11 02:15:56.331137
NCT01736930|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-08-26|2013-08-07||January 2012||2012-01-01|August 2016|2016-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|PSO1|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|An Outpatient Pump Shutoff Pilot Feasibility and Safety Study|Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Safety Study|Completed||Phase 2|20|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-11 02:15:56.457128|2017-10-11 02:15:56.457128
NCT01736917|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-04-18|2016-03-01||January 2013||2013-01-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional||64 participants were consented and treated per protocol. 1 participant listed in participant flow experienced an adverse event during infusion and was immediately taken off study. His baseline characteristics are not included in this table.|Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors|Phase II Study of Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Patients With Germ Cell Tumors Undergoing 5 Day Cisplatin-based Chemotherapy: Hoosier Oncology Group Study QL12-153|Completed||Phase 2|65|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-10-11 02:15:57.056191|2017-10-11 02:15:57.056191
NCT01736904|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-26|||May 2012||2012-05-01|November 2012|2012-11-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients|A Multicenter, Randomized Phase II Study of Weekly XELIRI Regimen Versus FOLFIRI in the Treatment of Advanced Colorectal Cancer Patients|Unknown status|Recruiting|Phase 2|100|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 02:15:57.619178|2017-10-11 02:15:57.619178
NCT01736891|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-09-12|||November 2011||2011-11-01|November 2012|2012-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations|Evaluation for the Efficacy,Tolerability,and Safety of Rasagiline in Levodopa-treated PD Patients With Motor Fluctuations: A Multicenter, Double Blind, Randomized, Placebo-Controlled Group Study (China)|Completed||Phase 3|268|Actual|Chongqing Fortune Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:15:57.731989|2017-10-11 02:15:57.731989
NCT01736878|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2013-05-16|||October 2012||2012-10-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|SUMMIT||Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma|Randomized Double-blind Placebo Controlled Phase II Study to Evaluate the Efficacy and Safety of Sorafenib Treatment in Patients With Advanced (Recurrent, Persistent and/or Metastasizing) Medullary Thyroid Carcinoma|Withdrawn||Phase 2|0|Actual|Eanm Research Ltd||2||Study was withdrawn due to unanticipated hassle in patient recruitment.|f||||t||||||||||2017-10-11 02:15:57.863049|2017-10-11 02:15:57.863049
NCT01736865|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-06-08|||December 2012||2012-12-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|DDM2||Vitamin D for Established Type 2 Diabetes (DDM2)|Vitamin D for Established Type 2 Diabetes (DDM2)|Completed||Phase 2/Phase 3|124|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-10-11 02:15:57.942791|2017-10-11 02:15:57.942791
NCT01736852|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-06-30|||November 2012||2012-11-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Evaluation of CRB in PROM Patients|Randomized Study to Compare the Cook Cervical Ripening Balloon Plus Pitocin to Pitocin Alone in PROM Patients|Recruiting||N/A|200|Anticipated|Cook Group Incorporated||2|||f||||||||||||||2017-10-11 02:15:58.027385|2017-10-11 02:15:58.027385
NCT01736839|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-09-26|||November 2012||2012-11-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution|Ultrasensitive Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine for Inhalation Solution|Recruiting||N/A|30|Anticipated|National Jewish Health|||1||f||||||||||||||2017-10-11 02:15:58.106749|2017-10-11 02:15:58.106749
NCT01736826|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-10-24|||June 2015||2015-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Free DNA and Nucleosome Concentrations in Pathological Pregnancies|Comparative Study of Plasma Free DNA and Nucleosome Concentrations: Pathological Versus Normal Pregnancies|Recruiting||N/A|180|Anticipated|Centre Hospitalier Universitaire de Nīmes|||5||f||||f||||||Samples Without DNA|"     At each visit a total of 36 ml of blood will be drawn (5 x EDTA tube = 5 x 4.5ml; 2 x CTAD     tube = 2 x 4.5 ml and 1 dry tube = 4.5 ml).      Tubes will be rapidly conditioned and samples stored at -80°C. After analysis, remaining     samples will be stored in the Nîmes University Hospital Biological Collections.   "|||2017-10-11 02:15:58.192123|2017-10-11 02:15:58.192123
NCT01736813|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-03-20|||November 2012||2012-11-01|July 2014|2014-07-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Observational|MARACON||CCR5-blockade in Metastatic Colorectal Cancer|Treatment of Advanced Colorectal Cancer Patients With Hepatic Liver Metastases Using the CCR5-Antagonist Maraviroc (Phase I Maracon Trial)|Completed||N/A|12|Actual|National Center for Tumor Diseases, Heidelberg|||1||f||||f||||||Samples With DNA|"     Biopsies, Serum and DNA   "|||2017-10-11 02:15:58.40797|2017-10-11 02:15:58.40797
NCT00000519|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-06-25|||July 1982||1982-07-01|June 2013|2013-06-01||||||||Interventional|||Exercise Training and Plasma Lipoproteins in Man||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-10-11 04:18:59.368754|2017-10-11 04:18:59.368754
NCT01736800|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-09-15|||March 2007|Actual|2007-03-01|September 2017|2017-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors|Phase II Trial of Chemotherapy With Temozolomide in Combination With Topotecan for Central Nervous System (CNS) Metastasis of Solid Tumors|Withdrawn||Phase 2|0|Actual|The Methodist Hospital System||1||No enrollment and PI requested study termination per IRB system.|f||||t||||||||||2017-10-11 02:15:58.601772|2017-10-11 02:15:58.601772
NCT01736787|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-11-26|||September 2012||2012-09-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:15:58.694401|2017-10-11 02:15:58.694401
NCT01736774|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-01-26|||December 2012||2012-12-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Exercise and Manipulative Therapy for Older Persons With Headache|A Randomized Controlled Trial of Exercise and Manipulative Therapy for Older Persons With Frequent Intermittent Headaches Associated With Neck Pain and Impairment|Completed||N/A|65|Actual|Chiang Mai University||2|||f||||f||||||||||2017-10-11 02:15:58.770326|2017-10-11 02:15:58.770326
NCT01736761|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-06-14|||December 2012||2012-12-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.|A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.|Completed||Phase 4|36|Actual|St Stephens Aids Trust||1|||f||||||||||||||2017-10-11 02:15:58.862538|2017-10-11 02:15:58.862538
NCT01736748|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-07-11|||January 2015||2015-01-01|July 2013|2013-07-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|CIRCUIT||Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors|Implementing Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors|Not yet recruiting||N/A|100|Anticipated|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 02:15:58.937539|2017-10-11 02:15:58.937539
NCT01736735|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-03-03|||January 2013||2013-01-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|STEPWISE||Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects|A Phase 2b, Randomized, Double-Blind, Multi-center Study Comparing Cross-linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects|Unknown status|Recruiting|Phase 2|270|Anticipated|Sorbent Therapeutics||2|||f||||t||||||||||2017-10-11 02:15:59.031749|2017-10-11 02:15:59.031749
NCT01736709|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-05-27|||November 2012||2012-11-01|November 2012|2012-11-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine|A Single-centered, Open-labeled, Phase 4 Study of 2012-2013 Trivalent Seasonal Influenza Vaccine|Completed||Phase 4|202|Actual|Sinovac Biotech Co., Ltd||1|||f||||t||||||||||2017-10-11 02:15:59.219681|2017-10-11 02:15:59.219681
NCT01736696|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-01-16|2012-12-06||November 2002||2002-11-01|January 2013|2013-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis|Phase 1, Investigator-Blind, Subject-Blind, Sponsor-Open, Placebo-Controlled, Two-Week, Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of CP-690,550|Completed||Phase 1|59|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 02:15:59.380961|2017-10-11 02:15:59.380961
NCT01736683|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-04-26|||November 28, 2012|Actual|2012-11-28|April 2017|2017-04-01|July 24, 2018|Anticipated|2018-07-24|August 25, 2015|Actual|2015-08-25||Interventional|||Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)|An Open-label, Randomized, Phase 2, Parallel, Dose-Ranging, Multicenter Study of Sotatercept for the Treatment of Patients With Anemia and Low or Intermediate-1 Risk Myelodysplastic Syndromes or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)|Active, not recruiting||Phase 2|74|Actual|Celgene||6|||f||||f||||||||||2017-10-11 02:16:03.07117|2017-10-11 02:16:03.07117
NCT01736670|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-12-03|||April 2012||2012-04-01|December 2012|2012-12-01||||May 2012|Actual|2012-05-01||Interventional|||An Investigator-Initiated Study to Assess the Cooling Effect of Triamcinolone Acetonide Aerosol When Used for Steroid-Responsive Dermatoses|An Investigator-Initiated Study to Assess the Cooling Effect of Triamcinolone Acetonide Aerosol When Used for Steroid-Responsive Dermatoses|Completed||N/A|30|Actual|Patel, Rita Vikram, M.D.||3|||f||||t||||||||||2017-10-11 02:16:03.308582|2017-10-11 02:16:03.308582
NCT01736657|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-07-10|2013-08-22||November 2012||2012-11-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ESSENTIAL|"Seventy-two patients were in safety analysis and 60 patients (evaluable popluation) were analyzed in the efficacy analysis. The 12 patients not in the efficacy analysis were lead-in patients and the RBCX procedures were conducted as the last phase in Operator training on the device."|Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients|Evaluation of the Spectra Optia Apheresis Red Blood Cell Exchange Protocol in Patients With Sickle Cell Disease.|Completed||N/A|73|Actual|Terumo BCT||1|||f||||f||||||||||2017-10-11 02:16:03.414147|2017-10-11 02:16:03.414147
NCT01736644|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-03-13|||October 2012||2012-10-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Bipolar Sealer Aquamantys Use in Total Knee Replacement|A Prospective Randomized Control Trial to Compare the Aquamantys System With Standard Electrocautery in Reducing Blood Loss in Primary Total Knee Arthroplasty|Unknown status|Active, not recruiting|Phase 4|112|Anticipated|Medtronic Surgical Technologies||2|||f||||f||||||||||2017-10-11 02:16:03.698774|2017-10-11 02:16:03.698774
NCT01736631|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-06-20|||March 2013||2013-03-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder|Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder: A Pilot Study|Recruiting||N/A|20|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 02:16:03.796797|2017-10-11 02:16:03.796797
NCT01736605|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-04-06|||January 2013||2013-01-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Tissue Reconstruction|The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Autologous Tissue Reconstruction - A Pilot Study|Completed||N/A|40|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:16:04.157098|2017-10-11 02:16:04.157098
NCT01736592|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-07-11|||December 14, 2012|Actual|2012-12-14|July 2017|2017-07-01|March 15, 2034|Anticipated|2034-03-15|March 15, 2034|Anticipated|2034-03-15||Interventional|||A Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration|An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration|Enrolling by invitation||Phase 1/Phase 2|28|Anticipated|Sanofi||1|||f||||t||||||||||2017-10-11 02:16:04.247194|2017-10-11 02:16:04.247194
NCT01736579|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-11-28|2016-07-13||November 2012||2012-11-01|October 2016|2016-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Long-Term Study of IGIV, 10% in Alzheimer´s Disease|A Study of the Long-Term Safety and Efficacy of Immune Globulin Intravenous (Human), 10% Solution (IGIV, 10%) in Mild to Moderate Alzheimer´s Disease|Terminated||Phase 3|6|Actual|Baxalta US Inc.|This study was an extension of study 160701 and was stopped early due to lack of evidence of clinical benefit of IGIV treatment in Alzheimer's Disease patients in Baxalta study 160701. Summary tables available for safety data only.|2||"The study was terminated because the first Phase 3 did not demonstrate efficacy on the   co-primary endpoints. The known safety profile remained unchanged."|f||||t||||||||||2017-10-11 02:16:04.348827|2017-10-11 02:16:04.348827
NCT01736566|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-12-28|||December 2011||2011-12-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare|The MedSeq Project Pilot Study: Integrating Whole Genome Sequencing Into the Practice of Clinical Medicine|Enrolling by invitation||N/A|220|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 02:16:04.791794|2017-10-11 02:16:04.791794
NCT01736540|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-03-14|2016-05-28||February 2013||2013-02-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)|An Epidemiological Study to Assess the Prevalence of Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)|Completed||Phase 4|243|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:16:05.15136|2017-10-11 02:16:05.15136
NCT01736527|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2013-08-27|2013-08-27||January 2013||2013-01-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation|Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% at 6, 9, 12, and 24 Hours Following a Single Instillation in Healthy Volunteers|Completed||Phase 1|12|Actual|Bausch & Lomb Incorporated|All 12 subjects were exposed to a single dose of LE Gel.|1|||f||||f||||||||||2017-10-11 02:16:06.74428|2017-10-11 02:16:06.74428
NCT01736514|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2014-10-28|||March 2011||2011-03-01|October 2014|2014-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout|A Randomized, Open Label, Multicenter, Allopurinol- Controlled Study to Assess the Safety and Efficacy of Oral Febuxostat in Patients With Gout|Completed||Phase 3|109|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:16:06.95351|2017-10-11 02:16:06.95351
NCT01736501|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-07-11|||June 2012||2012-06-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|September 2014|Actual|2014-09-01||Interventional|BabySeq||Surveying Parents About Genome Screening of Newborns|Surveying Parents About Genome Screening of Newborns|Active, not recruiting||N/A|1101|Actual|Brigham and Women's Hospital||4|||f||||f||||||||||2017-10-11 02:16:07.234723|2017-10-11 02:16:07.234723
NCT01736488|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-09-21|||October 2012||2012-10-01|September 2016|2016-09-01||||June 2016|Actual|2016-06-01||Interventional|||Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients|A Randomized, Double-Blind, Phase IV Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients|Completed||Phase 4|25|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||||||||||||2017-10-11 02:16:07.314899|2017-10-11 02:16:07.314899
NCT01736475|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-07-22|2016-03-04|2015-10-14|January 2013||2013-01-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||All Study Participants|Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)|A Phase 2/3, Multi-Center, Open Label Study of Efficacy, Safety, and Pharmacokinetics of PEGylated Recombinant Factor VIII (BAX 855) Administered for Prophylaxis and Treatment of Bleeding in Previously Treated Patients With Severe Hemophilia A|Completed||Phase 2/Phase 3|159|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-10-11 02:16:07.456256|2017-10-11 02:16:07.456256
NCT01736462|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-11-22|||February 2013||2013-02-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 Days|An Open-Label Study to Evaluate 3 Month Corneal Endothelial Cell Density Changes in Healthy Subjects When Mapracorat Ophthalmic Suspension, 3%, is Administered 4 Times Daily for 14 Days|Completed||Phase 1|61|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 02:16:09.261146|2017-10-11 02:16:09.261146
NCT01736449|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-26|||April 2011||2011-04-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management|Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management|Completed||Phase 4|31|Actual|Arrowhead Regional Medical Center||2|||f||||f||||||||||2017-10-11 02:16:09.344822|2017-10-11 02:16:09.344822
NCT01736436|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2016-08-23|||January 2013||2013-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|APG101 in MDS||APG101 in Myelodysplastic Syndrome|APG101 in Transfusion-Dependent Patients With Low or Intermediate Risk Myelodysplastic Syndrome|Completed||Phase 1|20|Actual|Apogenix GmbH||1|||f||||f||||||||||2017-10-11 02:16:09.453066|2017-10-11 02:16:09.453066
NCT01736423|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2015-10-09|||September 2012||2012-09-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome|A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome|Completed||Phase 3|151|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:16:09.534774|2017-10-11 02:16:09.534774
NCT01736410|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-06-14|||May 2010||2010-05-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer|A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer|Completed||Phase 2|30|Anticipated|National Cancer Centre, Singapore||2|||f||||f||||||||||2017-10-11 02:16:09.622977|2017-10-11 02:16:09.622977
NCT01736384|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-03-02|||February 2009||2009-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Can Genetic Markers Predict Weight Loss After Gastric By-pass Surgery|Can Genetic Changes Predict Weight Loss and Outcome After Bariatric Surgery and Can it Related to Virus Infection and Function of Liver and Adipose Tissue as Well as Lipid and Protein Profiles.|Active, not recruiting||N/A|2000|Actual|Karolinska Institutet|||1||f||||f||||||Samples With DNA|"     Tissue biopies, liver and subcutaneous and omental fat Whole blood EDTA-plasma Serum   "|||2017-10-11 02:16:09.855843|2017-10-11 02:16:09.855843
NCT01736358|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-11-28|||October 2012||2012-10-01|November 2012|2012-11-01||||October 2013|Anticipated|2013-10-01||Interventional|||The Use of Intranasal Ketoralac for Pain Management|Evaluating Post-operative Pain Management Efficacy of Intra Nasal Ketorolac in Ambulatory Urological Surgeries-A Randomized Double-blinded Placebo Controlled Study|Unknown status|Recruiting|Phase 4|100|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 02:16:10.041672|2017-10-11 02:16:10.041672
NCT01736345|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2015-11-23|||November 2012||2012-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study|A Study of the Communication of Genetic Test Results by Telephone: a Multi-center Study|Completed||N/A|289|Actual|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-11 02:16:10.253635|2017-10-11 02:16:10.253635
NCT01736332|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-10-05|||July 19, 2012||2012-07-19|March 19, 2014|2014-03-19|January 31, 2014|Actual|2014-01-31|January 31, 2014|Actual|2014-01-31||Interventional|||Factors Affecting Methamphetamine and Opiates Drug Testing|Evidence-Based Drug Policy and Legislation: Amphetamines and Opiates in Blood, Oral Fluid and Urine Following Intranasal l-Methamphetamine and Oral Poppy Seeds|Completed||Phase 1|36|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:16:10.356903|2017-10-11 02:16:10.356903
NCT01736319|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-06-30|||June 26, 2012||2012-06-26|April 6, 2016|2016-04-06|April 6, 2016||2016-04-06|||||Observational|||Artemisinin-resistant Malaria in Cambodia|Artemisinin-resistant Plasmodium Falciparum Malaria in Cambodia|Completed||N/A|860|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:16:10.466414|2017-10-11 02:16:10.466414
NCT01736306|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-06-30|||July 19, 2012||2012-07-19|April 6, 2017|2017-04-06||||||||Observational|||Biomarkers for Breast Cancer Risk in African American Women|Epigenetics and Breast Cancer Risk in African American Women|Completed||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:16:10.558864|2017-10-11 02:16:10.558864
NCT01736293|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-10-05|||September 2, 2012||2012-09-02|September 20, 2017|2017-09-20||||||||Observational|||Natural History of Eye Diseases Related to ABCA4 Mutations|Natural History of ABCA4-Related Retinopathies|Recruiting||N/A|70|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:16:10.657371|2017-10-11 02:16:10.657371
NCT01736280|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-06-30|||August 29, 2012||2012-08-29|April 28, 2017|2017-04-28||||||||Observational|||Evaluating and Treating Potential Research Participants With Digestive Disorders|Evaluation and Treatment Protocol for Potential Research Participants With Digestive Disorders|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:16:10.743732|2017-10-11 02:16:10.743732
NCT01736267|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-10-03|||November 2012||2012-11-01|October 2017|2017-10-01|November 2022|Anticipated|2022-11-01|November 2022|Anticipated|2022-11-01||Interventional|||Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects|Study of Nucleus 24 and ABI541 Auditory Brainstem Implants (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects|Recruiting||N/A|10|Anticipated|Massachusetts Eye and Ear Infirmary||1|||f||||f||||||||||2017-10-11 02:16:10.824529|2017-10-11 02:16:10.824529
NCT00000520|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-12|||July 1985||1985-07-01|April 2012|2012-04-01|November 1989|Actual|1989-11-01|||||Interventional|||Prevention of Coronary Aneurysms in Kawasaki Syndrome||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:59.465924|2017-10-11 04:18:59.465924
NCT01736254|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2013-02-14|||December 2012||2012-12-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study of Evacetrapib in Healthy Participants|Effect of Gemfibrozil on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 02:16:10.948487|2017-10-11 02:16:10.948487
NCT01736228|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-03-15|||November 2012||2012-11-01|October 2013|2013-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus|A Phase IIb Open-label Investigation of the Safety and Efficacy of DIABECELL [Immunoprotected (Alginate-Encapsulated) Porcine Islets for Xenotransplantation] in Patients With Type 1 Diabetes Mellitus|Completed||Phase 2|14|Actual|Living Cell Technologies||1|||f||||t||||||||||2017-10-11 02:16:11.177661|2017-10-11 02:16:11.177661
NCT01736215|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-03-28|2013-03-29||November 2010||2010-11-01|March 2014|2014-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational||Number of participants analyzed for this baseline characteristic included all the participants who received erythropoietin treatment and had sufficient data to perform statistical evaluation.|An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy|Prediction of Response to Erythropoietin Treatment in Cancer Related Anemia Patients Receiving Chemotherapy|Terminated||Phase 4|33|Actual|Janssen-Cilag Ltd.,Thailand|||1|This study was terminated regarding to slow enrollment.|f||||f||||||Samples Without DNA|"     Blood samples will be collected for hematological analysis.   "|||2017-10-11 02:16:11.284506|2017-10-11 02:16:11.284506
NCT01736202|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-11-26|||March 2012||2012-03-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|FLAME||Acute Effects of an Oral Fat Load on Skeletal Muscle and Hepatic Insulin Sensitivity|Acute Effects of an Oral Fat Load on Skeletal Muscle and Hepatic Insulin Sensitivity (FLAME-study)|Unknown status|Recruiting|Phase 4|20|Anticipated|German Diabetes Center||3|||f||||t||||||||||2017-10-11 02:16:11.701502|2017-10-11 02:16:11.701502
NCT01736189|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2017-07-17|||September 14, 2012||2012-09-14|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Special Investigation in Patients With Rheumatoid Arthritis (Combo Study; Adalimumab With High Dose Methotrexate)|Special Investigation in Patients With Rheumatoid Arthritis (Combo Study : Adalimumab With High Dose MTX)|Active, not recruiting||N/A|350|Anticipated|AbbVie|||1||f||||||||||||||2017-10-11 02:16:11.847007|2017-10-11 02:16:11.847007
NCT01736176|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-27|2016-12-16|2016-12-16||March 2013||2013-03-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease|An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa-Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease|Completed||Phase 3|39|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 02:16:13.757319|2017-10-11 02:16:13.757319
NCT01736163|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-03-19|||May 2012||2012-05-01|March 2015|2015-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours|A Retrospective, Non-interventional Study of Patients With T4 Tumours Comparing the Thyroid Remnant Ablation Success Following Thyrogen and 131I Administration Versus Thyroid Hormone Withdrawal and 131I Administration|Completed||Phase 4|144|Actual|Sanofi|||2||f||||f||||||||||2017-10-11 02:16:15.090272|2017-10-11 02:16:15.090272
NCT01736150|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-03-19|||March 2010||2010-03-01|March 2015|2015-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis|A Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study of Sevelamer Carbonate in CKD Patients on Hemodialysis|Completed||Phase 3|205|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:16:15.186451|2017-10-11 02:16:15.186451
NCT01736137|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-08-05|||November 2011||2011-11-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Evaluation of the Six Minute Walk Test and Other Instruments in Heart Failure|Evaluation of the Six Minute Walk Test, Heart Rate Variability and Quality of Life in Heart Failure Patients on Beta-blocker Treatment|Completed||N/A|17|Actual|Federal University of Uberlandia|||2||f||||f||||||||||2017-10-11 02:16:15.384847|2017-10-11 02:16:15.384847
NCT01736124|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-05-22|||April 7, 2015|Actual|2015-04-07|May 2017|2017-05-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|CCT_DEV||CCT for Diabetic Elderly Veterans|Computerized Cognitive Training to Improve Cognition in Diabetic Elderly Veterans|Recruiting||N/A|400|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||No||2017-10-11 02:16:15.483586|2017-10-11 02:16:15.483586
NCT01736111|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-11-09|||October 2012||2012-10-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Text Messaging for Weight Loss|Text Messaging for Weight Loss in Primary Care Patients|Completed||N/A|91|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 02:16:15.586507|2017-10-11 02:16:15.586507
NCT01736098|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-12-01|||August 2012||2012-08-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Energy Flux Study|Evaluation of Energy Balance at High vs. Low Energy Flux - Energy Flux Study|Completed||N/A|81|Actual|University of South Carolina||3|||f||||t||||||||||2017-10-11 02:16:15.670383|2017-10-11 02:16:15.670383
NCT01736085|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-10-27|||April 2013||2013-04-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Providing Free Nicotine Patches to Quitline Smokers|Distribution of Voucher vs. Direct Mailing of Nicotine Patches to Quitline Smokers|Completed||Phase 3|3710|Actual|University of California, San Diego||6|||f||||f||||||||||2017-10-11 02:16:15.763873|2017-10-11 02:16:15.763873
NCT01735708|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-11-10|||November 2012||2012-11-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|HIVPASS||Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings|Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings|Completed||N/A|23|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-11 02:16:20.280228|2017-10-11 02:16:20.280228
NCT01736072|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-11-30|||December 2011||2011-12-01|November 2015|2015-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|ROLARR||RObotic Versus LAparoscopic Resection for Rectal Cancer|RObotic Versus LAparoscopic Resection for Rectal Cancer An International, Multicentre, Prospective, Randomised, Controlled, Unblinded, Parallel-group Trial of Robotic-assisted Versus Laparoscopic Surgery for Treatment of Rectal Cancer.|Active, not recruiting||N/A|520|Actual|University of California, Irvine||2|||f||||t||||||||||2017-10-11 02:16:15.876908|2017-10-11 02:16:15.876908
NCT01736059|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-02-14|||July 2012||2012-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy|A Pilot Clinical Trial of the Feasibility and Safety of Intravitreal Autologous Adult Bone Marrow Stem Cells in Treating Eyes With Vision Loss From Retinopathy|Enrolling by invitation||Phase 1|15|Anticipated|University of California, Davis||1|||f||||f||||||||Yes|Once study is completed, the study findings will be published in peer reviewed publication for public access.|2017-10-11 02:16:16.01821|2017-10-11 02:16:16.01821
NCT01736046|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2015-07-30|||December 2012||2012-12-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|||Comparison of Standard and Low Dose CT Enterography for Crohn's Disease|Effects of CT Reconstruction Algorithm on the Quantitative Assessment of Crohn's Disease: A Comparison of Standard and Low Dose CT Enterography|Completed||N/A|163|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 02:16:16.101018|2017-10-11 02:16:16.101018
NCT01736033|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2014-05-13|||February 2012||2012-02-01|May 2014|2014-05-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|ABSOLUTE||Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients|A Multicenter, Randomized, Double-blind, Clinical Study to Investigate the Efficacy and Safety of Treatment With Tamsulosin 0.2mg Mono and Tamsulosin 0.2mg, Finasteride 5mg Combination Therapy in Patients With LUTS/BPH|Unknown status|Active, not recruiting|Phase 4|545|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:16.178352|2017-10-11 02:16:16.178352
NCT01736020|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-10-12|||September 2009||2009-09-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Developing Anesthesia as Post Traumatic Stress Disorder (PTSD) Therapy|Developing Anesthesia as PTSD Therapy|Active, not recruiting||Phase 1|293|Actual|Southern California Institute for Research and Education||5|||f||||t||||||||||2017-10-11 02:16:16.315084|2017-10-11 02:16:16.315084
NCT01736007|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-10-29|||August 2012||2012-08-01|October 2014|2014-10-01|August 2014|Anticipated|2014-08-01|June 2013|Anticipated|2013-06-01||Interventional|||Childhood Alopecia Areata Study Using the 308-nm Excimer Laser|Childhood Alopecia Areata Study: Part 1: Feasibility of the 308-nm Excimer Laser in Treatment of Patch Type Alopecia Areata in Pediatric Patients|Withdrawn||N/A|0|Actual|Phoenix Children's Hospital||2||was not able to recruit participants|f||||f||||||||||2017-10-11 02:16:16.425566|2017-10-11 02:16:16.425566
NCT01735994|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2016-09-07|||November 2012||2012-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|FAB||Efficacy of the Female Athlete Body Project (FAB)|Healthy Weight Intervention in Female Athletes: A Randomized Controlled Trial|Active, not recruiting||N/A|481|Actual|Pennington Biomedical Research Center||2|||f||||t||||||||No||2017-10-11 02:16:16.502431|2017-10-11 02:16:16.502431
NCT01735981|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2012-11-21|||June 2008||2008-06-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|November 2010|Actual|2010-11-01||Interventional|||The Effect of Video Game Exercise on Dynamic Balance and Gait in Individuals With Huntington's Disease|The Effect of Video Game Biofeedback Modulated Exercise (ViBE)on Dynamic Balance and Gait in Individuals With Huntington's Disease|Completed||N/A|24|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 02:16:16.597989|2017-10-11 02:16:16.597989
NCT01735968|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-09-12|||February 27, 2013|Actual|2013-02-27|September 2017|2017-09-01|December 28, 2018|Anticipated|2018-12-28|December 28, 2018|Anticipated|2018-12-28||Interventional|||A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients|A Dose-finding Phase Ib Multicenter Study of Imatinib in Combination With the Oral Phosphatidyl-inositol 3-kinase (PI3K) Inhibitor BYL719 in Patients With Gastrointestinal Stromal Tumor (GIST) Who Failed Prior Therapy With Imatinib and Sunitinib|Active, not recruiting||Phase 1|56|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:16:16.694475|2017-10-11 02:16:16.694475
NCT01735955|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-10-03|||March 29, 2013|Actual|2013-03-29|October 2017|2017-10-01|December 18, 2023|Anticipated|2023-12-18|December 18, 2023|Anticipated|2023-12-18||Interventional|||Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study|An Open Label, Multi-center Nilotinib Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Nilotinib Study and Are Judged by the Investigator to Benefit From Continued Nilotinib Treatment|Recruiting||Phase 4|300|Anticipated|Novartis||1|||f||||f|t|f||||||||2017-10-11 02:16:16.89655|2017-10-11 02:16:16.89655
NCT01735942|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-06-27|||October 2012||2012-10-01|June 2016|2016-06-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions|A Comparison of Ingenol Mebutate and Cryotherapy for Treatment of Actinic Keratoses.|Withdrawn||Early Phase 1|0|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 02:16:17.101759|2017-10-11 02:16:17.101759
NCT01735929|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-06-27|||March 2016||2016-03-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Combination of Ultrasound Treatment and Neck Liposuction for Skin Tightening|Evaluating the Combined Skin Tightening Benefit of Non-Invasive Ultrasound Treatment and Neck Liposuction|Withdrawn||N/A|0|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 02:16:17.189577|2017-10-11 02:16:17.189577
NCT01735916|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-10-01|2014-09-12||December 2012||2012-12-01|October 2014|2014-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MIRACLE EF||MIRACLE EF Clinical Study|MIRACLE EF Clinical Study|Terminated||N/A|44|Actual|Medtronic Cardiac Rhythm and Heart Failure||2||The study was terminated early due to low enrollment.|f||||t||||||||||2017-10-11 02:16:17.306377|2017-10-11 02:16:17.306377
NCT01735903|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-08-08|||November 2012||2012-11-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Observational|OMNIFICENT||Objective Measures of Nerve Integrity, Posture, Gait and Blood Flow, After Nerve Decompression|Objective Measures of Nerve Integrity, Posture, Gait and Blood Flow, After Nerve Decompression In diabetiC Neuropathy PatiENTs|Recruiting||N/A|40|Anticipated|Foot Surgery Center of Northern Colorado|||1||f||||t||||||||Undecided||2017-10-11 02:16:18.386042|2017-10-11 02:16:18.386042
NCT01735890|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2013-09-11|||September 2012||2012-09-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet|A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet After a Single Oral Administration in Healthy Male Volunteers|Completed||Phase 1|48|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 02:16:18.475923|2017-10-11 02:16:18.475923
NCT01735877|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-05-24|2013-12-10||January 2011||2011-01-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|MUST||Effectiveness of Mirror Therapy in Stroke Patients With Unilateral Neglect - A Randomized Controlled Trial|Effectiveness of Mirror Therapy in Stroke Patients With Unilateral Neglect - A Randomized Controlled Trial|Completed||Phase 3|48|Actual|Christian Medical College and Hospital, Ludhiana, India||2|||f||||f||||||||||2017-10-11 02:16:18.57503|2017-10-11 02:16:18.57503
NCT01735864|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-11-26|||November 2012||2012-11-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment|Evaluation of the Efficacy and Safety of Indigo Naturalis Extract in Oil in the Topical Therapy of Psoriasis Vulgaris: Dosage Determination|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Chang Gung Memorial Hospital||4|||f||||t||||||||||2017-10-11 02:16:19.206672|2017-10-11 02:16:19.206672
NCT01735851|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-08-31|||December 2012||2012-12-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Bilateral Thoracic Paravertebral Block to Thoracic Epidural Analgesia for Post Operative Analgesia in Patients Undergoing Abdominal Surgery|Comparison of Bilateral Thoracic Paravertebral Block to Thoracic Epidural Analgesia for Post Operative Analgesia in Patients Undergoing Abdominal Surgery - A Randomized Open Label Study|Completed||Phase 4|70|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:16:19.324187|2017-10-11 02:16:19.324187
NCT01735838|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-01-27|||June 2012||2012-06-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Observational|||Intrathoracic Bloodvolume Measurement by Contrast Enhanced Ultrasound: Validation of the Technique and Evaluation as a Measurement of Response to Cardiac Resynchronization Therapy: a Pilot Study|Intrathoracic Bloodvolume Measurement by Contrast Enhanced Ultrasound: Validation of the Technique and Evaluation as a Measurement of Response to Cardiac Resynchronization Therapy: a Pilot Study|Completed||N/A|20|Actual|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||||2017-10-11 02:16:19.422592|2017-10-11 02:16:19.422592
NCT01735825|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-08-23|||January 2012||2012-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|July 2015|Actual|2015-07-01||Interventional|TIS||Treatment of Coronary In-Stent Restenosis|Prospective Randomised Study Comparing Efficacy of Treatment Coronary In-stent Restenosis Using Drug Eluting Paclitaxel-coated Balloon and Drug Eluting Stent With Everolimus.|Active, not recruiting||Phase 4|120|Anticipated|University Hospital Ostrava||3|||f||||t||||||||||2017-10-11 02:16:19.488386|2017-10-11 02:16:19.488386
NCT01735812|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-02-05|||December 2012||2012-12-01|November 2012|2012-11-01||||December 2015|Anticipated|2015-12-01||Interventional|UFREEZE-01||Laparoscopic Cryoablation of Uterine Fibroids|Cryoablation of Symptomatic Uterine Fibroids Using the IceSense3™ System in a Percutaneous Laparoscopic-assisted Approach|Unknown status|Recruiting|N/A|30|Anticipated|IceCure Medical Ltd.||1|||f||||f||||||||||2017-10-11 02:16:19.58785|2017-10-11 02:16:19.58785
NCT01735799|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2012-11-27|||November 2012||2012-11-01|November 2012|2012-11-01||||||||Observational|||THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS||Unknown status|Not yet recruiting|N/A|||Ziv Hospital|||1||f||||||||||||||2017-10-11 02:16:19.690516|2017-10-11 02:16:19.690516
NCT01735786|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2012-11-27|||April 2010||2010-04-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Observational|||EndoClot for Preventing Rebleeding After Endoscopic Mucosal Resection (EMR)|EndoClotTM Absorbable Polysaccharide Hemostat for Preventing Rbleeding After Endoscopic Mucosal Resection (EMR)|Completed||N/A|164|Actual|Xijing Hospital of Digestive Diseases|||2||f||||t||||||||||2017-10-11 02:16:19.775356|2017-10-11 02:16:19.775356
NCT01735773|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2012-11-27|||January 2010||2010-01-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Role of Prohepcidin in Uremic Patients|The Relationship of Prohepcidin Levels With Anemia and Inflammatory Markers in Non-diabetic Uremic Patients: A Controlled Study|Completed||N/A|25|Actual|Haseki Training and Research Hospital|||4||f||||f||||||||||2017-10-11 02:16:19.890949|2017-10-11 02:16:19.890949
NCT01735760|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2013-11-23|||November 2012||2012-11-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Ultrasound Examination Versus Palpation to Locate the Cricothyroid Membrane|Comparison of Ultrasound Examination and Palpation to Locate the Cricothyroid Membrane - a Randomized Study|Completed||N/A|44|Anticipated|Rigshospitalet, Denmark|||2||f||||||||||||||2017-10-11 02:16:19.959251|2017-10-11 02:16:19.959251
NCT01735747|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-03-11|||June 2008||2008-06-01|March 2013|2013-03-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma|Phase Ⅱ Trial of Temozolomide Plus Concurrent Whole-Brain Radiation Followed by TNV Regimen as Adjuvant Therapy for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma (PCNSL)|Unknown status|Active, not recruiting|Phase 2|16|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||t||||||||||2017-10-11 02:16:20.033361|2017-10-11 02:16:20.033361
NCT01735734|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2012-11-25|||February 2013||2013-02-01|November 2012|2012-11-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Observational|||Assessing the Effects of Air-cooling on Capillary Malformations|An Observational Study as to the Effects of Cutaneous Air-cooling on Blood Vessel Diameter in Capillary Malformations|Unknown status|Not yet recruiting|N/A|35|Anticipated|National Health Service, United Kingdom|||1||f||||f||||||||||2017-10-11 02:16:20.126127|2017-10-11 02:16:20.126127
NCT01735721|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2015-04-07|||March 2009||2009-03-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Comparative Study of Algipore and Decalcified Freeze-dried Bone Allograft in Open Maxillary Sinus Augmentation|Comparative Study of Algipore and Decalcified Freeze-dried Bone Allograft in Open Maxillary Sinus Elevation Using Piezoelectric Surgery|Completed||Phase 2|10|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:16:20.203033|2017-10-11 02:16:20.203033
NCT00207974|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-11-16||||||September 2005|2005-09-01||||||||Interventional|||Pharmacokinetic Study of Marine Active in Health Men||Unknown status|Active, not recruiting|Phase 1|||China Medical University Hospital|||||f||||||||||||||2017-10-11 05:34:47.102108|2017-10-11 05:34:47.102108
NCT01735695|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2013-04-28|||December 2012||2012-12-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Observational|||Performance Evaluation Study for a New Meconium Detection Test|Performance Evaluation Study for a New Meconium Detection Test|Unknown status|Recruiting|N/A|100|Anticipated|Laniado Hospital|||1||f||||f||||||||||2017-10-11 02:16:20.363459|2017-10-11 02:16:20.363459
NCT01735682|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-05-29|||November 2012||2012-11-01|May 2014|2014-05-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Interventional|||Whole Body Vibration Exercise Training for Institutionalized Elderly|The Effects of Whole Body Vibration Exercise Training on Physical Functioning and Falls in Institutionalized Elderly: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|68|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-11 02:16:20.426712|2017-10-11 02:16:20.426712
NCT01735669|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-02-14|||July 2012||2012-07-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|April 2013|Actual|2013-04-01||Interventional|REMIVER||Open Randomized Controlled Trial to Evaluate the Efficacy and Safety of Remifentanil Versus Nitrous Oxide in External Cephalic Version at Term in Singleton Pregnancy in Breech Presentation|Open Randomized Controlled Trial to Evaluate the Efficacy and Safety of Remifentanil Versus Nitrous Oxide in External Cephalic Version at Term in Singleton Pregnancy in Breech Presentation|Completed||Phase 3|120|Actual|Hospital de Cruces||2|||f||||f||||||||||2017-10-11 02:16:20.527398|2017-10-11 02:16:20.527398
NCT01735656|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2016-02-01|||March 2014||2014-03-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting for True Bifurcation Lesions|Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting in the Treatment of True Bifurcation Lesions: a Multicenter, Noninferior, Randomized, Controlled Trial (the DK Culotte-I Study)|Recruiting||N/A|328|Anticipated|Fujian Medical University||2|||f||||t||||||||||2017-10-11 02:16:20.614806|2017-10-11 02:16:20.614806
NCT01735643|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-27|||January 2011||2011-01-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients|"Spielend zu Mehr Bewegung - Lebensstilintervention Durch Das Interaktive Video-spiel Wii Fit Plus Bei Personen Mit Typ-2-Diabetes Mellitus"|Completed||Early Phase 1|220|Actual|West German Center of Diabetes and Health||2|||f||||t||||||||||2017-10-11 02:16:20.79455|2017-10-11 02:16:20.79455
NCT01735630|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-25|2016-07-06|2016-04-07||November 2012||2012-11-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Efficacy and Safety Study of Oral ELND005 for Treatment of Agitation and Aggression in Patients With Moderate to Severe Alzheimer's Disease|Completed||Phase 2|350|Actual|Transition Therapeutics Ireland Limited||2|||f||||f||||||||||2017-10-11 02:16:20.926937|2017-10-11 02:16:20.926937
NCT01735617|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-04-11|2015-06-25||December 2012||2012-12-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All treated subjects|Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH|A Phase 2 Pilot Study to Characterize and Examine the Pharmacokinetics and Disease Bio-marker Response of Chronocort® in Adults With Congenital Adrenal Hyperplasia|Completed||Phase 2|16|Actual|Diurnal Limited||1|||f||||f||||||||No||2017-10-11 02:16:22.102959|2017-10-11 02:16:22.102959
NCT01735604|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2015-09-27|||January 2013||2013-01-01|September 2015|2015-09-01|October 2018|Anticipated|2018-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy|Pilot Study of Redirected Autologous T Cells Transduced to Express A CD20-Specific Chimeric Immunoreceptor in Patient With Chemotherapy Resistant or Refractory CD20+ Leukemia and Lymphoma|Recruiting||Phase 1/Phase 2|50|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 02:16:22.860808|2017-10-11 02:16:22.860808
NCT01735591|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2016-07-28|||November 2012||2012-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation|An Attempt to Optimize the Results of Liver Transplantation With Administration of Probiotics.|Completed||N/A|55|Actual|Medical University of Warsaw||2|||f||||t||||||||||2017-10-11 02:16:22.958267|2017-10-11 02:16:22.958267
NCT01735578|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2015-05-01|||October 2012||2012-10-01|December 2014|2014-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis|Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis|Completed||N/A|52|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 02:16:23.053558|2017-10-11 02:16:23.053558
NCT01735565|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-08-09|||June 2012||2012-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|March 2014|Actual|2014-03-01||Observational|||Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant|Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant|Completed||N/A|23|Actual|University of Utah|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:16:23.133822|2017-10-11 02:16:23.133822
NCT01735552|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2015-05-01|||June 2012||2012-06-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates|Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates.|Terminated||N/A|12|Actual|University of Utah|||1|Unable to recruit participants|f||||f||||||||||2017-10-11 02:16:23.209357|2017-10-11 02:16:23.209357
NCT01735539|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2014-01-16|||December 2011||2011-12-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Ajinomoto1A||Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance With Age; the Role of Amino Acids in Modulating Muscle Metabolism|Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People; The Role of Essential Amino Acids in Modulating Muscle Protein Metabolism; Bolus vs. Pulse Feeding Strategies and the Ability of Arginine to Rejuvenate Microvascular Responsiveness.|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Nottingham||5|||f||||t||||||||||2017-10-11 02:16:23.29742|2017-10-11 02:16:23.29742
NCT01734980|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-11-25|||February 2011||2011-02-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Endobronchial Ultrasound Transbronchial Needle Aspiration Using Needle Suction Versus No Suction|Comparison Of Cytologic Accuracy Of Endobronchial Ultrasound Transbronchial Needle Aspiration Using Needle Suction Versus No Suction|Completed||N/A|30|Actual|Northwell Health||1|||f||||f||||||||||2017-10-11 02:16:32.989912|2017-10-11 02:16:32.989912
NCT01735526|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2014-09-21|||October 2012||2012-10-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|DLNO/DLCO||Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide After Hematopoietic Stem-cell Transplantation|Changes in Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide After Allogeneic Versus Autologous Hematopoietic Stem-cell Transplantation|Completed||N/A|40|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|||1||f||||t||||||||||2017-10-11 02:16:23.385035|2017-10-11 02:16:23.385035
NCT01735513|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-05-11|||July 2012||2012-07-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|April 2014|Actual|2014-04-01||Interventional|TAo-EmbolX||Intraprocedural Intraaortic Embolic Protection With the EmbolX Device in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation|Intraprocedural Intraaortic Embolic Protection With the EmbolX Device in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation: a Randomized-controlled Trial|Completed||N/A|30|Actual|University Hospital, Essen||2|||f||||f||||||||||2017-10-11 02:16:23.457418|2017-10-11 02:16:23.457418
NCT01735500|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2014-12-06|||February 2010||2010-02-01|December 2014|2014-12-01||||November 2011|Actual|2011-11-01||Observational|||hsTnT After Elective Coronary Angiography|Rise of hscTnT After Elective Coronary Angiography Without Coronary Intervention|Completed||N/A|545|Actual|University Hospital Heidelberg|||2||f||||||||||||||2017-10-11 02:16:23.527852|2017-10-11 02:16:23.527852
NCT01735487|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2012-12-17|||September 2012||2012-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|CogEcig||CogEcig: Cognitive Functioning and Electronic Cigarette|Electronic Cigarette and Cognitive Functioning: (CogEcig)|Completed||N/A|20|Actual|Universita degli Studi di Catania||5|||f||||f||||||||||2017-10-11 02:16:23.587325|2017-10-11 02:16:23.587325
NCT01735474|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-11-02|||November 2012||2012-11-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Results of Manual Therapy on Pulmonary Parameters|Manual Therapy Results on Pulmonary Function and Musculoskeletal Movement|Suspended||N/A|60|Actual|Universidad de Granada||2||Sample size was not completed|f||||t||||||||Undecided||2017-10-11 02:16:23.676246|2017-10-11 02:16:23.676246
NCT01735461|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-04-06|||December 2012||2012-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Calcium Supplements Strategy for Kidney Stones Prevention in Crohn's Patients|Oral Calcium Supplementation, a Strategy to Reduce Kidney Stones in Crohn's Patients Living With a Small Bowel Resection|Recruiting||N/A|40|Anticipated|University of British Columbia||1|||f||||t||||||||No||2017-10-11 02:16:23.772794|2017-10-11 02:16:23.772794
NCT01735448|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2017-04-06|||March 2013||2013-03-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Improving Health for Aboriginal People Through Tobacco Related Research|Advancing the Understanding of Barriers and Facilitators for Tobacco Prevention, Cessation Treatments, Doctor Visits for Related Illnesses and Health Research for Aboriginal Australians|Completed||N/A|16|Actual|The Queen Elizabeth Hospital|||13||f||||t||||||||Yes|Available on request|2017-10-11 02:16:23.862083|2017-10-11 02:16:23.862083
NCT01735435|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2012-11-27|||May 2010||2010-05-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|TICACOSiGP||Tight Caloric Balance in Geriatric Patients|Tight Caloric Balance in Geriatric Patients After Hip Fracture.|Completed||N/A|50|Actual|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 02:16:23.9804|2017-10-11 02:16:23.9804
NCT01735422|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2014-02-03|||December 1999||1999-12-01|February 2014|2014-02-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women|A Phase II, Single Center, Open, Randomized, Parallel Group, Dose Finding Study to Assess the Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH), Compared With Urinary Human Chorionic Gonadotrophin (u-hCG), in Inducing Ovulation in Infertile Women Undergoing Stimulation of Follicular Development With Recombinant Human Follicle Stimulating Hormone (Gonal F®).|Completed||Phase 2|67|Actual|Merck KGaA||6|||f||||f||||||||||2017-10-11 02:16:24.068873|2017-10-11 02:16:24.068873
NCT01735409|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2014-01-25|||November 2012||2012-11-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|ABX-DDP-Dose||Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma|A Single Center Phase IIa Study of Nanoparticle Albumin-bound Paclitaxel in Combination With Cisplatin in Advanced Nasopharyngeal Carcinoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|69|Anticipated|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 02:16:24.16634|2017-10-11 02:16:24.16634
NCT01735396|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2017-04-04|2017-04-04||December 2012||2012-12-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Abiraterone Acetate Trial in African American Prostate Cancer Patients|A Pilot Study of Abiraterone Acetate in African American/Black Patients With Castration Resistant Prostate Cancer|Terminated||Phase 2|11|Actual|Icahn School of Medicine at Mount Sinai||1||poor accrual|f||||t||||||||||2017-10-11 02:16:24.248503|2017-10-11 02:16:24.248503
NCT01735383|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-30|||May 2012||2012-05-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition|An Open Label, Balanced, Randomized, Single-dose, Two-treatment, Two-sequence, Two-period, Crossover, Oral Bioequivalence Study of Etodolac Tablets USP 500mg of Ipca Laboratories Limited, India and Etodolac Tablets USP 500mg of Taro Pharmaceutical Industries Ltd., USA in Healthy, Adult, Human Subjects Under Fed Condition.|Completed||Phase 1|36|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:16:24.486487|2017-10-11 02:16:24.486487
NCT01735370|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2012-11-30|||May 2012||2012-05-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition|An Open Label, Balanced, Randomized, Single-dose, Two-treatment, Two-sequence, Two-period, Crossover, Oral Bioequivalence Study of Etodolac Tablets USP 500mg of Ipca Laboratories Limited, India and Etodolac Tablets USP 500mg of Taro Pharmaceutical Industries Ltd., USA in Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|36|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:16:24.563126|2017-10-11 02:16:24.563126
NCT01735357|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-11-27|||June 2009||2009-06-01|November 2012|2012-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Differential Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Platelet, Endothelial and Vascular Function|Investigation Into Incorporation of (n-3) Polyunsaturated Fatty Acids Into Erythrocyte Membranes and Clearance, and Effects on Platelet Function, Arterial Function and Endothelial Repair|Completed||N/A|48|Actual|King's College London||3|||f||||f||||||||||2017-10-11 02:16:24.662282|2017-10-11 02:16:24.662282
NCT01735344|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-30|||June 2012||2012-06-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition|A Randomized, Balanced, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study of Lisinopril Tablets 40 mg With Zestril® (Lisinopril) 40 mg Tablets in Normal, Healthy, Adult, Male and Female Human Subjects Under Fed Conditions.|Completed||Phase 1|40|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:16:24.751041|2017-10-11 02:16:24.751041
NCT01735331|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-08-06|||November 2012||2012-11-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Vascular Endothelial Growth Factor Levels at Hysteroscopic Biopsies Which Taken From Recurrent Pregnancy Loss|Vascular Endothelial Growth Factor Levels at Hysteroscopic Biopsies Which Taken From Recurrent Pregnancy Loss|Completed||N/A|30|Actual|Bagcilar Training and Research Hospital|||2||f||||f||||||||||2017-10-11 02:16:24.819246|2017-10-11 02:16:24.819246
NCT01735318|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-30|||June 2012||2012-06-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition|A Randomized, Balanced, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study of Lisinopril Tablets 40 mg With Zestril® (Lisinopril) 40 mg Tablets in Normal, Healthy, Adult, Male and Female Human Subjects Under Fasting Conditions.|Completed||Phase 1|40|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:16:25.013055|2017-10-11 02:16:25.013055
NCT01735305|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-12-10|||November 2012||2012-11-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|OPT-CAD||Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease|Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease|Completed||N/A|14032|Actual|Shenyang Northern Hospital|||1||f||||t||||||||||2017-10-11 02:16:25.10593|2017-10-11 02:16:25.10593
NCT01735292|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2012-11-23|||January 2013||2013-01-01|November 2012|2012-11-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|Timer||Safety of the Automatic Respiration Transfer System- Timer|Safety of the Automatic Respiration Transfer System- Timer|Unknown status|Not yet recruiting|N/A|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 02:16:25.464269|2017-10-11 02:16:25.464269
NCT01735266|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-09-11|||May 2013||2013-05-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Left-colon WEC May Reduce Insertion Time Compared With Whole-colon WEC.|Comparative Efficacy of Whole-colon Water Exchange, Left-colon Water Exchange and Air Methods of Colonoscopy on Cecum Intubation in Unsedated Outpatients - - - a Prospective, Randomized Controlled Trail|Completed||N/A|300|Actual|Fourth Military Medical University||3|||f||||t||||||||||2017-10-11 02:16:25.707731|2017-10-11 02:16:25.707731
NCT01735253|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2012-11-27|||December 2009||2009-12-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|December 2011|Actual|2011-12-01||Interventional|T2DM||Prospective Observatonal Study for Effect of Duodenojejunal Bypass and Gastric Bypass on T2DM Patients|Metabolic Surgery for Type 2 Diabetes|Completed||N/A|20|Actual|Inha University Hospital||1|||f||||t||||||||||2017-10-11 02:16:25.859636|2017-10-11 02:16:25.859636
NCT01735240|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-06-24|||December 2012||2012-12-01|June 2015|2015-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.|An Open-label, Fixed-sequence, Single-centre Phase I Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of AZD5069 After Oral Administration of a Single Dose AZD5069 to Healthy Male Volunteers|Completed||Phase 1|15|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 02:16:25.964085|2017-10-11 02:16:25.964085
NCT01735227|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-27|||November 2012||2012-11-01|November 2012|2012-11-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)|Single-center Randomized Controlled Study of Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Randomized Controlled Trials|Unknown status|Not yet recruiting|Phase 4|620|Anticipated|Shenyang Northern Hospital||2|||f||||t||||||||||2017-10-11 02:16:26.07429|2017-10-11 02:16:26.07429
NCT01735214|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-05-20|2015-04-10||March 2013||2013-03-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments||Completed||N/A|358|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:16:26.185571|2017-10-11 02:16:26.185571
NCT01735201|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2014-05-02|2014-05-02||December 2012||2012-12-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||AGN-199201 for the Treatment of Erythema With Rosacea||Completed||Phase 2|357|Actual|Allergan||8|||f||||f||||||||||2017-10-11 02:16:27.318107|2017-10-11 02:16:27.318107
NCT01735188|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2016-07-18|||August 2013||2013-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|November 2015|Actual|2015-11-01||Observational|||A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies|A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies|Completed||N/A|65|Actual|Alexion Pharmaceuticals|||2||f||||f||||||Samples With DNA|"     Plasma, urine, whole blood   "|||2017-10-11 02:16:28.279046|2017-10-11 02:16:28.279046
NCT01735175|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-06-29|2017-03-28||June 2012||2012-06-01|June 2017|2017-06-01|February 2014|Actual|2014-02-01|May 2013|Actual|2013-05-01||Interventional|PROTECT-1||Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®|A Randomized, Double-blind, Parallel-group, Multi-center Phase 3 Comparative Study Investigating Efficacy and Safety of LA-EP2006 and Neulasta® in Breast Cancer Patients Treated With Myelosuppressive Chemotherapy|Completed||Phase 3|316|Actual|Sandoz||2|||f||||t||||||||Undecided||2017-10-11 02:16:28.438501|2017-10-11 02:16:28.438501
NCT01734967|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-08-13|||November 2012||2012-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Needle-based Confocal Endomicroscopy Examination of Pancreatic Masse|Needle-based Confocal Endomicroscopy Examination of Pancreatic Masses|Recruiting||N/A|50|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-10-11 02:16:33.065215|2017-10-11 02:16:33.065215
NCT01735162|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-02-02|||October 2012||2012-10-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|May 2013|Actual|2013-05-01||Observational|AKI-CHERUB||Study of the Prediction of Acute Kidney Injury in Children Using Risk Stratification and Biomarkers|Prospective Study of Acute Kidney Injury in Critically Ill Children Predicted by Renal Angina and Urinary Biomarkers|Completed||N/A|184|Actual|Children's Hospital Medical Center, Cincinnati|||3||f||||t||||||Samples Without DNA|"     Urinary samples, intended for discard so waiver of consent obtained. Urine samples spun and     frozen at -80C. Samples to be run for biomarker ELISA kits.   "|||2017-10-11 02:16:29.459361|2017-10-11 02:16:29.459361
NCT01735149|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2012-11-27|||November 2012||2012-11-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:29.531882|2017-10-11 02:16:29.531882
NCT01735136|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2012-11-27|||November 2012||2012-11-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:29.616104|2017-10-11 02:16:29.616104
NCT01735123|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-24|2017-02-24|||January 2013||2013-01-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|EDIA||Early Dietary Intervention and Later Signs of Beta-Cell Autoimmunity|Early Dietary Intervention and Later Signs of Beta-Cell Autoimmunity: Potential Mechanisms|Completed||N/A|87|Actual|Helsinki University||2|||f||||t||||||||||2017-10-11 02:16:29.708083|2017-10-11 02:16:29.708083
NCT01735110|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-12-11|||March 2013||2013-03-01|December 2013|2013-12-01|March 2018|Anticipated|2018-03-01|March 2014|Anticipated|2014-03-01||Interventional|PREPARE||PREPARE：Assessing the Safety and Efficacy of Radial Versus Femoral Approach PCI|A Prospective, Multicenter, Randomized Trial Assessing the Safety and Efficacy of PCI Via Radial Versus Femoral Approach in Patients With Left Main and/or Three-Vessel Disease|Withdrawn||N/A|0|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-11 02:16:31.296788|2017-10-11 02:16:31.296788
NCT01735097|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-05-02|||January 2013||2013-01-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis|A Double-blind, Randomized, Placebo-controlled Trial of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis|Completed||N/A|40|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||f||||||||||2017-10-11 02:16:31.395783|2017-10-11 02:16:31.395783
NCT01735084|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-09-22|||December 2012||2012-12-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PREV-IX_B||Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life|Pneumococcal Conjugate Vaccine (PCV) Schedules for the Northern Territory (NT): Randomised Controlled Trial of Booster Vaccines to Broaden and Strengthen Protection From Invasive and Mucosal Infections.|Enrolling by invitation||Phase 4|270|Anticipated|Menzies School of Health Research||2|||f||||t||||||||||2017-10-11 02:16:31.480648|2017-10-11 02:16:31.480648
NCT01735071|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-06-22|||July 2013||2013-07-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Interventional|||Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer|Multicenter, Randomized, Non-comparative, Open-label Phase II Trial on the Efficacy and Safety of the Combination of Bevacizumab and Trabectedin With or Without Carboplatin in Adult Women With Platinum Partially Sensitive Recurring Ovarian Cancer.|Recruiting||Phase 2|74|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-11 02:16:31.575321|2017-10-11 02:16:31.575321
NCT01735058|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2012-12-01|||February 2012||2012-02-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in Rotator Cuff Disease|Evaluating the Efficacy of Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in the Treatment of Rotator Cuff Disease|Unknown status|Recruiting|Phase 2/Phase 3|48|Anticipated|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:16:31.698925|2017-10-11 02:16:31.698925
NCT01735045|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-11-25|||May 2010||2010-05-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||LSH Silicone Hydrogel Soft Hydrophilic Contact Lens for Daily Wear|LSH Silicone Hydrogel Soft Hydrophilic Contact Lens for Daily Wear|Completed||Phase 3|76|Actual|Szabocsik and Associates, Inc.||2|||f||||t||||||||||2017-10-11 02:16:31.783837|2017-10-11 02:16:31.783837
NCT01735032|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-11-29|||October 2012||2012-10-01|October 2012|2012-10-01|May 2016|Anticipated|2016-05-01|November 2012|Anticipated|2012-11-01||Observational|EPIMAGE||Multimodal Imaging in Pre-surgical Evaluation of Epilepsy|Contribution of Multimodal Imaging (MRI, PET, MEG) in Pre-surgical Evaluation of Drug-resistant Focal Epilepsy|Unknown status|Recruiting|N/A|140|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||||||2017-10-11 02:16:31.860857|2017-10-11 02:16:31.860857
NCT01735019|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2013-09-17|||November 2012||2012-11-01|November 2012|2012-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Estimating EC95 of Remifentanil for Cough Prevention During Emergence From Total Intravenous Anesthesia With Propofol and Remifentanil in Patients Undergoing Transsphenoidal Hypophysectomy||Completed||N/A|40|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 02:16:31.92275|2017-10-11 02:16:31.92275
NCT01735006|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2017-06-27|||November 2012||2012-11-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine|A Phase III Multicenter, Randomized, Double-Blind, Placebo(Hepatitis E Vaccine)Controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant(E.Coli)Human Papillomavirus Bivalent Vaccine in Healthy Women|Active, not recruiting||Phase 3|6000|Anticipated|Xiamen University||2|||f||||t||||||||||2017-10-11 02:16:31.984872|2017-10-11 02:16:31.984872
NCT01734993|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-10-05|2016-10-05||October 2012||2012-10-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Safety population included all participants who received at least one dose of study medication.|A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).|A Multicenter, Open-Label Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|11|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:16:32.193843|2017-10-11 02:16:32.193843
NCT01734954|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-10|2013-04-17|||April 2013||2013-04-01|April 2013|2013-04-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Comparison of Two Techniques of Sciatic Nerve Block With Levobupivacaine 0.5% in Orthopedic Surgery|Comparison of Two Techniques of Ultrasound-guided Sciatic Nerve Block Using Levobupivacaine 0.5% in Orthopedic Surgery at the Hospital Pablo Tobon Uribe - Clínica CES, 2013, Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|66|Anticipated|CES University||2|||f||||f||||||||||2017-10-11 02:16:33.170055|2017-10-11 02:16:33.170055
NCT01734941|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-01-31|||April 2014||2014-04-01|April 2014|2014-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|TSO||TSO in Pediatric Autistic Spectrum Disorders|A Phase 2 Randomized Three-Arm Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of 16 Weeks of Treatment With Trichuris Suis Ova (TSO) Therapy in Pediatric Patients Ages 6 to 17 With Autism|Terminated||Phase 2|9|Actual|Hadassah Medical Organization||3||"Well tolerated but failed to demonstrate significant activity. So it did not meet its primary   endpoint or key secondary endpoints."|f||||t||||||||||2017-10-11 02:16:33.309802|2017-10-11 02:16:33.309802
NCT01734928|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2017-09-28|||January 7, 2013|Actual|2013-01-07|September 2017|2017-09-01|April 24, 2022|Anticipated|2022-04-24|May 30, 2018|Anticipated|2018-05-30||Interventional|OPTIMISMM||Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma|A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide, Bortezomib and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 3|559|Actual|Celgene||2|||f||||t||||||||||2017-10-11 02:16:33.429924|2017-10-11 02:16:33.429924
NCT01734915|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2016-09-23|||November 2012||2012-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Detecting EGFR T790M Mutations From Circulating Tumor Cells|Detecting EGFR T790M Mutations From Circulating Tumor Cells|Completed||N/A|40|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     Circulating Tumor Cells (CTCs)   "|||2017-10-11 02:16:34.098737|2017-10-11 02:16:34.098737
NCT01734902|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-23|2013-06-13|||November 2012||2012-11-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers|Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide, Following Oral Administration in Healthy Male and Female Volunteers (an Open-label, Randomised, Single Dose, Two-way Crossover, Phase I Study)|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:16:34.186036|2017-10-11 02:16:34.186036
NCT01734889|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2014-10-31|2014-01-21||October 2012||2012-10-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Taste and Palatability of Orfadin Suspension|Taste and Palatability of Orfadin Suspension. An Open, Non-controlled 3 Day Study in Pediatric Patients With Hereditary Tyrosinemia Type 1 Treated With Orfadin.|Completed||Phase 1|18|Actual|Swedish Orphan Biovitrum||1|||f||||f||||||||||2017-10-11 02:16:34.261762|2017-10-11 02:16:34.261762
NCT01734876|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-11|2012-11-27|||September 2004||2004-09-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Tactile Touch on Chronic Pain in Parkinson´s Disease|Short and Long-term Effects of Tactile Touch on Salivary Cortisol Concentrations in Parkinson's Disease.|Completed||N/A|45|Actual|FUTURUM, Academy of Health and Science||2|||f||||t||||||||||2017-10-11 02:16:34.503586|2017-10-11 02:16:34.503586
NCT01734863|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-01-11|||September 2012||2012-09-01|November 2012|2012-11-01|December 2022|Anticipated|2022-12-01|September 2022|Anticipated|2022-09-01||Interventional|||Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients|Post-operative Radiotherapy Randomization in Poor Responders Ewing's Sarcoma Patients|Withdrawn||Phase 3|0|Actual|Children's Cancer Hospital Egypt 57357||2|||f||||t||||||||||2017-10-11 02:16:34.604137|2017-10-11 02:16:34.604137
NCT01734850|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-11-28|||April 2013||2013-04-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection|An Adaptive Phase I/II Study of the Safety of CD4+ T Lymphocytes and CD34+ Hematopoietic Stem/Progenitor Cells Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct, With and Without Conditioning With Busulfan in HIV-1 Infected Adults Previously Exposed to ART|Active, not recruiting||Phase 1/Phase 2|12|Actual|Calimmune, Inc.||3|||f||||t||||||||||2017-10-11 02:16:34.69056|2017-10-11 02:16:34.69056
NCT01734837|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-09-08|||October 2011||2011-10-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Observational|TICAP||TICAP - Titanium Clips for Appendiceal Stump Closure|Prospective Multicenter Observational Study (Registry) on the Aesculap DS Titanium Ligation Clips for Appendiceal Stump Closure.|Completed||N/A|390|Actual|Aesculap AG|||1||f||||f||||||||||2017-10-11 02:16:34.802178|2017-10-11 02:16:34.802178
NCT01734824|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-02|2015-09-22|||May 2012||2012-05-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo|Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo|Suspended||Phase 4|90|Anticipated|Medical University of Vienna||4||no patients randomized|f||||t||||||||||2017-10-11 02:16:34.885287|2017-10-11 02:16:34.885287
NCT01734811|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2015-12-22|||October 2012||2012-10-01|December 2015|2015-12-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|MV130||Efficacy and Safety Evaluation in Recurrent Bronchospasms|Randomized Double-blind Placebo-controlled, Parallel, Single Centre Clinical Trial of Sublingual Bacterial Vaccine in Children With Recurrent Bronchospasm for the Evaluation of Efficacy, Security and Clinical Impact.|Active, not recruiting||Phase 3|120|Actual|Inmunotek S.L.||2|||f||||f||||||||||2017-10-11 02:16:34.978514|2017-10-11 02:16:34.978514
NCT01734798|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2012-11-22|||December 2002||2002-12-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|January 2008|Actual|2008-01-01||Interventional|||Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer|Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer|Completed||Phase 3|198|Actual|Cairo University||3|||f||||t||||||||||2017-10-11 02:16:35.095708|2017-10-11 02:16:35.095708
NCT01734603|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-06-24|||October 2011||2011-10-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|ARTEX||Intensive Rehabilitation in Peripheral Arterial Disease With Claudication: Effects of a Treadmill Training With Active Recovery|Randomized, Monocentric and Multidisciplinary Study of the Effects of an Intensive Rehabilitation by Interval Training With Active Recovery in Peripheral Arterial Disease With Claudication|Completed||Phase 3|40|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 02:16:37.64846|2017-10-11 02:16:37.64846
NCT01734785|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-06-09|2016-03-17||January 2013||2013-01-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||The treated set (TS) consisted of all patients who were randomised and treated with at least 1 dose of study drug during the double-blind part of the trial.|Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes|A Phase III, Randomised, Double-blind, Parallel Group, 24 Week Study to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg and 25 mg Compared to Placebo, All Administered as Oral Fixed Dose Combinations With Linagliptin 5 mg, in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control After 16 Weeks Treatment With Linagliptin 5 mg Once Daily on Metformin Background Therapy.|Completed||Phase 3|607|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:16:35.205261|2017-10-11 02:16:35.205261
NCT01734772|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-04-02|2014-04-02||November 2012||2012-11-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Treated Set which includes all subjects who were documented to have received at least 1 dose of trial medication.|Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor|Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor Under Steady State Conditions in Healthy Male Subjects|Completed||Phase 1|48|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:16:36.206726|2017-10-11 02:16:36.206726
NCT01734759|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2013-10-18|||November 2012||2012-11-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits|Influence of Medication Palatability on Prescribing Habits of Pediatric Prescribers|Completed||Phase 1|50|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:16:36.5203|2017-10-11 02:16:36.5203
NCT01734733|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2016-02-09|||July 2013||2013-07-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease|A Phase I/IIa, Open-label Investigation of the Safety and Clinical Effects of NTCELL [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease|Completed||Phase 1/Phase 2|4|Actual|Living Cell Technologies||1|||f||||t||||||||||2017-10-11 02:16:36.671417|2017-10-11 02:16:36.671417
NCT01734720|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2013-08-28|||May 2005||2005-05-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Common Bile Duct Stones - Natural History and Interventions|Common Bile Duct Stones - Natural History and Interventions : Data From the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangio Pancreatography (ERCP) (GallRiks)|Completed||N/A|3828|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 02:16:36.747389|2017-10-11 02:16:36.747389
NCT01734707|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2012-11-21|||January 2004||2004-01-01|January 2005|2005-01-01|October 2005|Actual|2005-10-01|January 2005|Actual|2005-01-01||Interventional|||Atherosclerosis Monitoring and Atherogenicity Reduction Study||Completed||Phase 3|300|Actual|Institute for Atherosclerosis Research, Russia||2|||f||||||||||||||2017-10-11 02:16:36.797267|2017-10-11 02:16:36.797267
NCT01734694|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-07-08|||October 2011||2011-10-01|July 2013|2013-07-01||||September 2013|Anticipated|2013-09-01||Interventional|STOP-NT||Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients|Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients|Terminated||Phase 4|100|Actual|Henry Ford Health System||2||"Independent biostatistician recommended early termination of the trial due to low probability   of success."|f||||||||||||||2017-10-11 02:16:36.878938|2017-10-11 02:16:36.878938
NCT01734681|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2014-02-16|||May 2013||2013-05-01|February 2013|2013-02-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer|An Open-Label, Single-Arm, Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer|Withdrawn||Phase 2|0|Actual|GenSpera, Inc.||1|||f||||f||||||||||2017-10-11 02:16:36.965266|2017-10-11 02:16:36.965266
NCT01734668|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-02-05|||March 2012||2012-03-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Sofia RSV FIA Field Study|Sofia RSV FIA Field Study|Completed||N/A|2468|Actual|Quidel Corporation|||1||f||||f||||||||||2017-10-11 02:16:37.052866|2017-10-11 02:16:37.052866
NCT01734655|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-06-22|2015-07-20||November 2012||2012-11-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|MEQ|All participants were pregnant women between the ages of 18-40 with a self-reported pre-pregnancy BMI between 25 and 40. All women had a singleton pregnancy and were otherwise healthy.|Study of the Validity of Using the MEQ to Measure Mindful Eating in Pregnant Women|Qualitative Evaluation of the Mindful Eating Questionnaire (MEQ) in Pregnant Women|Completed||N/A|40|Actual|Pennington Biomedical Research Center|||1||f||||t||||||||Undecided||2017-10-11 02:16:37.146717|2017-10-11 02:16:37.146717
NCT01734642|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-28|||January 2013||2013-01-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Observational|OSME||Observational Study to Reduce Medication Errors|A Regional Project to Reduce Adverse Drug Reactions Due to Medication Errors in Hospital|Unknown status|Not yet recruiting|N/A|8000|Anticipated|Universita di Verona|||1||f||||t||||||||||2017-10-11 02:16:37.416381|2017-10-11 02:16:37.416381
NCT01734629|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-12-02|||April 2011||2011-04-01|November 2013|2013-11-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Pulmonary Disease in Patients Referred for Coronary CT|Pulmonary Disease in Patients Referred for Coronary CT and Association Between Spirometric Abnormalities and Coronary Calcium Score.|Completed||N/A|205|Actual|University of Sao Paulo General Hospital|||1||f||||t||||||Samples Without DNA|"     Blood Samples   "|||2017-10-11 02:16:37.499283|2017-10-11 02:16:37.499283
NCT01734616|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-27|||September 2009||2009-09-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|Dunhill01||Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People|Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People|Completed||N/A|50|Actual|University of Nottingham||5|||f||||f||||||||||2017-10-11 02:16:37.562448|2017-10-11 02:16:37.562448
NCT00000544|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-11-04|||August 1993||1993-08-01|October 2005|2005-10-01|July 1997|Actual|1997-07-01|||||Interventional|||Dietary Approaches to Stop Hypertension (DASH)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:03.074144|2017-10-11 04:19:03.074144
NCT01734590|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2013-06-18|||November 2012||2012-11-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Different Flour Compositions in a Carbohydrate-based Food on Rate of Exogenous Glucose Appearance in Blood|The Effect of Different Flour Compositions in a Carbohydrate-based Food on Rate of Exogenous Glucose Appearance in Blood.|Completed||N/A|12|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-11 02:16:37.755486|2017-10-11 02:16:37.755486
NCT01734577|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2013-06-17|||August 2012||2012-08-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Dry Needling Multifidus on Thickness of Transversus Abdominis in Healthy Individuals|The Effect of Trigger Point Dry Needling to the Multifidus Muscle on Resting and Contracted Thickness of Transversus Abdominis in Healthy Subjects|Completed||N/A|60|Actual|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-11 02:16:37.944763|2017-10-11 02:16:37.944763
NCT01734564|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-04-10|||November 2012||2012-11-01|May 2016|2016-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors|Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors|Completed||Phase 2|15|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||t||||||||||2017-10-11 02:16:38.026755|2017-10-11 02:16:38.026755
NCT01734551|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-08-11|2016-09-23||September 2011||2011-09-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NAS||NAS Treatment - Opiate Versus Non-Opiate|Pharmacological Treatment of Neonatal Abstinence Syndrome: Opiate Versus Non-Opiate|Completed||Phase 4|31|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-11 02:16:38.105939|2017-10-11 02:16:38.105939
NCT01734538|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-26|||November 2012||2012-11-01|November 2012|2012-11-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Effect of 12 wk of Omega-3 FA Supplementation on Metabolic and Physical Health Parameters in Older Adults|Effects of 12 Weeks of Omega-3 Fatty Acid Supplementation on Metabolic and Physical Health Parameters in Older Adults|Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Guelph||2|||f||||||||||||||2017-10-11 02:16:38.447381|2017-10-11 02:16:38.447381
NCT01734512|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-05-08|||November 2012||2012-11-01|May 2017|2017-05-01|November 2022|Anticipated|2022-11-01|March 2019|Anticipated|2019-03-01||Interventional|||PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children|PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children|Recruiting||Phase 2|65|Anticipated|University of California, San Francisco||1|||f||||t||||||||No||2017-10-11 02:16:38.62808|2017-10-11 02:16:38.62808
NCT01734499|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-04-19|||October 2012||2012-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CCIP||The Change Cycle Intervention for Improving Quality of Life in Breast Cancer Survivors|The Change Cycle Intervention for Improving Quality of Life in Breast Cancer Survivors|Completed||N/A|120|Actual|Texas Tech University Health Sciences Center||2|||f||||f||||||||No||2017-10-11 02:16:38.804253|2017-10-11 02:16:38.804253
NCT01734486|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-02-27|||September 23, 1996|Actual|1996-09-23|February 2017|2017-02-01|May 21, 2003|Actual|2003-05-21|May 21, 2003|Actual|2003-05-21||Interventional|||Growth Response in Girls With Turner Syndrome|Growth Response in Girls With Turner Syndrome During a Three-year GH Treatment Comparing Two Dose Regimens. Identification of Predictive Factors of Growth Response|Completed||Phase 4|31|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:16:38.924122|2017-10-11 02:16:38.924122
NCT01734473|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-04-17|||November 2012||2012-11-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)|Casein Protein and Leucine Supplementation to Induce Anabolism in COPD Patients and Healthy Elderly|Active, not recruiting||N/A|36|Actual|Texas A&M University||5|||f||||f||||||||||2017-10-11 02:16:39.051392|2017-10-11 02:16:39.051392
NCT01734460|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-26|||January 2013||2013-01-01|August 2012|2012-08-01||||December 2016|Anticipated|2016-12-01||Observational|||Maternal Sleep Disordered Breathing and Fetal Growth||Unknown status|Not yet recruiting|N/A|230|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||||||||||||2017-10-11 02:16:39.184021|2017-10-11 02:16:39.184021
NCT01734447|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-02-27|||April 30, 2000|Actual|2000-04-30|February 2017|2017-02-01|April 30, 2003|Actual|2003-04-30|April 30, 2003|Actual|2003-04-30||Interventional|||Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation|Discontinued Administration (6 Months a Year) of Growth Hormone to Children With Very Short Stature and Having Suffered From Intrauterine Growth Retardation: Safety and Effect on Growth of Long-term Therapy|Completed||Phase 4|57|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 02:16:39.260068|2017-10-11 02:16:39.260068
NCT01734421|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-26|||January 2013||2013-01-01|November 2012|2012-11-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|TOBB_STOP||Efficacy of a Mobile Application in the Smoking Cessation Among Young People|Efficacacy of a Mobile Application in the Smoking Cessation Among Young Poeple: Cluster Randomized Trial|Unknown status|Not yet recruiting|N/A|604|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||||||||||||2017-10-11 02:16:39.432242|2017-10-11 02:16:39.432242
NCT01734408|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2013-10-21|||November 2012||2012-11-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children|A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children|Completed||Phase 2|773|Actual|Jiangsu Province Centers for Disease Control and Prevention||8|||f||||f||||||||||2017-10-11 02:16:39.550223|2017-10-11 02:16:39.550223
NCT01703884|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-07-29|||August 2012||2012-08-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|AQUAMOD||ANC & Malaria Diagnostic in Pregnancy|Improved Quality of ANC and Diagnostic Services for Malaria in Pregnancy|Completed||Phase 4|5254|Actual|Centre Muraz||2|||f||||f||||||||||2017-10-11 02:25:33.436993|2017-10-11 02:25:33.436993
NCT01734395|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2013-08-02|2013-04-15||March 2007||2007-03-01|August 2013|2013-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational||Baseline characteristics were determined in Full Analysis Set (FAS) population. Out of 1,882 enrolled participants, 1,393 participants were included in the FAS and 489 participants were excluded due to violation of the inclusion/exclusion criteria.|A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease|An Observational, Multi-Center Study to Demonstrate That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease|Completed||Phase 4|1882|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 02:16:39.674321|2017-10-11 02:16:39.674321
NCT01734382|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-09-27|||June 10, 2013|Actual|2013-06-10|September 2017|2017-09-01|September 7, 2019|Anticipated|2019-09-07|September 7, 2019|Anticipated|2019-09-07||Interventional|||A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)|A Phase IV Study to Evaluate Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis (SJIA) Who Experience Laboratory Abnormalities During Treatment With Tocilizumab|Recruiting||Phase 4|65|Anticipated|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 02:16:39.97017|2017-10-11 02:16:39.97017
NCT01734369|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2017-10-04|||October 13, 2012||2012-10-13|September 15, 2017|2017-09-15|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Observational|||Environmental Risk Factors for Myositis in Military Personnel|Environmental Risk Factors for the Development of Myositis in Military Personnel|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:16:40.131931|2017-10-11 02:16:40.131931
NCT01734356|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2014-11-06|||November 2011||2011-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Diag-iPS||Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells|Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells|Terminated||N/A|20|Anticipated|Nantes University Hospital||3|||f||||||||||||||2017-10-11 02:16:40.211553|2017-10-11 02:16:40.211553
NCT01734343|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-22|||January 2009||2009-01-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|MIPHY||Posterior Capsule Opacification Development With Two Different Intraocular Lenses|Posterior Capsule Opacification Development and Frequency of Nd:YAG Treatment of Two Microincision IOLs: Hoya iMics Y-60H vs. PhysIOL microAY|Completed||N/A|65|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 02:16:40.289759|2017-10-11 02:16:40.289759
NCT01734330|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-26|||July 2010||2010-07-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Cognitive Behaviour Therapy and Nicotine Replacement to Increase Tobacco Cessation|Efficacy of Cognitive Behaviour Therapy Associated to Nicotine Replacement in Tobacco Cessation: a Randomised Open Label Clinical Trial|Completed||N/A|200|Actual|Hospital do Coracao||2|||f||||f||||||||||2017-10-11 02:16:40.372231|2017-10-11 02:16:40.372231
NCT01734317|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-02-03|2014-01-22||October 2012||2012-10-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||An Open Single-centre Investigation Evaluating Efficacy in Second Degree Partial Thickness Burns Using a Silicone Contact Layer Containing Silver.|An Open, Non Controled, Single-centre, Clinical Investigation to Evaluate Efficacy in Second Degree (Superficial, Deep or Mixed) Partial Thickness Burns When Using a Soft Silicone Wound Contact Ayer Containing Silver.|Completed||N/A|10|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 02:16:40.45494|2017-10-11 02:16:40.45494
NCT01734304|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2016-09-09|||September 2013||2013-09-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|May 2017|Anticipated|2017-05-01||Interventional|||DC Vaccination for Postremission Therapy in AML|Active Immunotherapy of Patients With Acute Myeloid Leukemia Using Autologous Dendritic Cells Transfected With RNA Encoding Leukemia-associated Antigens|Recruiting||Phase 1/Phase 2|20|Anticipated|Ludwig-Maximilians - University of Munich||1|||f||||t||||||||Undecided||2017-10-11 02:16:40.66161|2017-10-11 02:16:40.66161
NCT01734291|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-04-03|||October 1, 2012|Actual|2012-10-01|April 2017|2017-04-01|October 9, 2016|Actual|2016-10-09|June 20, 2016|Actual|2016-06-20||Interventional|||Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression|Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression: A Randomized Controlled Trial|Completed||N/A|49|Actual|Nagoya City University||2|||f||||f||||||||||2017-10-11 02:16:40.769162|2017-10-11 02:16:40.769162
NCT01734278|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2016-10-27|||October 2012||2012-10-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|September 2016|Actual|2016-09-01||Observational|OBSERVA||Observational Post-Authorisation Safety Study of Asenapine (Sycrest)|An Observational Post-Authorisation Safety Specialist Cohort Monitoring Study (SCEM) to Monitor the Safety and Utilisation of Asenapine (Sycrest) in the Mental Health Trust Setting in England|Active, not recruiting||N/A|1000|Actual|Drug Safety Research Unit, Southampton, UK|||1||f||||f||||||||||2017-10-11 02:16:40.843046|2017-10-11 02:16:40.843046
NCT01734265|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2014-01-28|||November 2012||2012-11-01|November 2012|2012-11-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).|Prospective, Open Uncontrolled Study to Evaluate the Safety of Depigoid With Two Pollen Combinations (Grasses/Olea and Grasses/Parietaria)2000DPP/ml in Patients With Allergic Rhinitis or Rhinoconjunctivitis With or Without Seasonal Asthma.|Completed||Phase 2|63|Actual|Laboratorios Leti, S.L.||2|||f||||f||||||||||2017-10-11 02:16:40.924203|2017-10-11 02:16:40.924203
NCT01734252|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-04-16|||June 2012||2012-06-01|April 2015|2015-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||Argatroban in Critically Ill Patients With Heparin Resistance|A Pilot Trial to Assess the Efficacy of Argatroban (Argatra®) in Critically Ill Patients With Heparin Resistance|Unknown status|Recruiting|Phase 2|44|Anticipated|Medical University Innsbruck||2|||f||||t||||||||||2017-10-11 02:16:41.009364|2017-10-11 02:16:41.009364
NCT01734057|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-04-18|||July 2012||2012-07-01|November 2012|2012-11-01|October 2013|Anticipated|2013-10-01|July 2013|Anticipated|2013-07-01||Interventional|||Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)|A Multicentre Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)|Withdrawn||Phase 3|0|Actual|Shandong University||2||No eligible patient was enrolled.|f||||t||||||||||2017-10-11 02:16:42.879329|2017-10-11 02:16:42.879329
NCT01734239|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-03-13|2014-08-26||June 2013||2013-06-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)|A Phase III, Open-Label Clinical Trial to Study the Safety and Immunogenicity of V110 in Subjects 50 Years of Age and Older and in Subjects 2 to 49 Years of Age at Increased Risk for Pneumococcal Disease, From the Russian Population|Completed||Phase 3|102|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:16:41.205303|2017-10-11 02:16:41.205303
NCT01734226|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-26|||August 2012||2012-08-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy and Safety of Prunus Mume Extract on Improvement of Constipation||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:41.554882|2017-10-11 02:16:41.554882
NCT01734213|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-26|||May 2012||2012-05-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy and Safety of Eriobotyra Japonica Lindley Extract on Improvement of Cognitive Function||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:41.631346|2017-10-11 02:16:41.631346
NCT01734200|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2015-07-13|||November 2012||2012-11-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy and Safety of Eriobotyra Japonica Lindley Extract on Improvement of Cognitive Function|Efficacy and Safety of Eriobotyra Japonica Lindley Extract on Improvement of Cognitive Function: a 12 Week, Randomized Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 2/Phase 3|80|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:41.705131|2017-10-11 02:16:41.705131
NCT01734187|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-22|2012-11-26|||January 2012||2012-01-01|November 2012|2012-11-01|November 2012|Anticipated|2012-11-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy and Safety of Fermented Cinnamon Vine Powder on Decrement of Body Fat||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:41.776787|2017-10-11 02:16:41.776787
NCT01734174|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-06-13|||September 2012||2012-09-01|June 2013|2013-06-01||||August 2014|Anticipated|2014-08-01||Observational|||Left Ventricular Volume and Ejection Fraction: Validation of Real Time 3 Dimensional Transesophageal Echocardiography|Left Ventricular Volume and Ejection Fraction: Validation of Real Time 3 Dimensional Transesophageal Echocardiography|Unknown status|Recruiting|N/A|150|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-10-11 02:16:41.861363|2017-10-11 02:16:41.861363
NCT01734161|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-02-28|2017-02-28||November 2012||2012-11-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Interventional|||Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections|A Prospective, Randomized, Double-Blinded Study to Evaluate the Efficacy of Intravenous Dexamethasone for Nausea Prophylaxis Prior to Duramorph and Bupivacaine Spinal Anesthesia for Scheduled Cesarean Section|Completed||Phase 4|122|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||No|No plan to share IPD|2017-10-11 02:16:41.946506|2017-10-11 02:16:41.946506
NCT01734148|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-11-17|||September 2011||2011-09-01|November 2014|2014-11-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||The RELAX TO SLEEP Study|The RELAX TO SLEEP Study: A Pilot Randomized Controlled Trial|Completed||N/A|48|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 02:16:42.174451|2017-10-11 02:16:42.174451
NCT01734135|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-04-26|||October 2010||2010-10-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2013|Actual|2013-09-01||Interventional|||Provider Notification for High B-type Natriuretic Peptide Values|Trial of Provider Notification for Patients With High B-type Natriuretic Peptide and no Imaging to Identify Unsuspected Heart Failure.|Completed||N/A|115|Actual|VA Palo Alto Health Care System||2|||f||||f||||||||||2017-10-11 02:16:42.268655|2017-10-11 02:16:42.268655
NCT01734122|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-10-31|||November 2012||2012-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|||Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor|Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor|Recruiting||N/A|30|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-10-11 02:16:42.348684|2017-10-11 02:16:42.348684
NCT01734109|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-27|||December 2012||2012-12-01|November 2012|2012-11-01|March 2014|Anticipated|2014-03-01|September 2013|Anticipated|2013-09-01||Interventional|||Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers.|A 12-week, Single Site, Randomized Controlled Trial to Compare the Efficacy of Quantum NPWT With and Without Simultaneous Irrigation Versus Standard of Care on Reduction of the Volume of Stage III/IV Pressure Ulcers.|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|Innovative Therapies, Inc.||3|||f||||f||||||||||2017-10-11 02:16:42.431177|2017-10-11 02:16:42.431177
NCT01734096|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-05-23|||May 2009||2009-05-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2013|Actual|2013-04-01||Interventional|||Renal Response to Lower Body Negative Pressure in Pre-hypertensive States|Effect of Lower Body Negative Pressure and Angiotensin II Receptor Blockade on Renal Hemodynamic, Neuro-hormonal and Tubular Response in Pre-hypertensive States: a Randomized Controlled Trial.|Completed||Phase 4|78|Actual|Centre Hospitalier Universitaire Vaudois||4|||f||||f||||||||||2017-10-11 02:16:42.528141|2017-10-11 02:16:42.528141
NCT01734083|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-26|||November 2012||2012-11-01|November 2012|2012-11-01|July 2015|Anticipated|2015-07-01|January 2015|Anticipated|2015-01-01||Interventional|||Whole Body Vibration Exercise for Elderly With Cognitive Impairments|The Effects of Whole Body Vibration Exercise Training on Physical Functioning and Falls in Community-dwelling Elderly With Cognitive Impairments|Unknown status|Recruiting|N/A|66|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 02:16:42.652927|2017-10-11 02:16:42.652927
NCT01734070|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-02-07|||May 2003||2003-05-01|February 2013|2013-02-01|September 2004|Actual|2004-09-01|September 2003|Actual|2003-09-01||Interventional|||Role of Cherry Consumption in Reducing Risk Factors for Chronic Inflammatory Diseases|Role of Cherry Consumption in Reducing Risk Factors for Human Chronic Inflammatory Diseases|Completed||N/A|20|Actual|USDA, Western Human Nutrition Research Center||1|||f||||f||||||||||2017-10-11 02:16:42.787066|2017-10-11 02:16:42.787066
NCT01732016|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-06-22|||January 2013||2013-01-01|June 2017|2017-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Camera Oximeter: A Calibration Study|The Camera Oximeter: A Calibration Study|Completed||N/A|20|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 02:17:18.339339|2017-10-11 02:17:18.339339
NCT01734044|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-04-18|||July 2012||2012-07-01|November 2012|2012-11-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP|A Multicentre Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)|Completed||Phase 3|158|Actual|Shandong University||2|||f||||t||||||||||2017-10-11 02:16:42.985419|2017-10-11 02:16:42.985419
NCT01734018|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B|A Multicenter, Prospective, Non-Interventional Study Evaluating Response Parameters During and After Therapy With PEGASYS (Peginterferon Alfa-2a 40KD) in Subjects With HBeAg Positive or HBeAg Negative Chronic Hepatitis B|Completed||N/A|50|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:16:43.078149|2017-10-11 02:16:43.078149
NCT01734005|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-26|||September 2012||2012-09-01|November 2012|2012-11-01|March 2013|Anticipated|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy and Safety of Red Ginseng on Decrement of Body Fat||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:43.157043|2017-10-11 02:16:43.157043
NCT01733992|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-07-31|||November 2012||2012-11-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease|A Phase 1, Single Center, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Pharmacokinetics, Tolerability and Safety Study of R932348 Ophthalmic Solution in Patients With Mild to Moderate Keratoconjunctivitis Sicca|Completed||Phase 1|36|Actual|Rigel Pharmaceuticals||4|||f||||f||||||||||2017-10-11 02:16:43.232627|2017-10-11 02:16:43.232627
NCT01733979|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-11-26|||February 2012||2012-02-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy and Safety of Heme-Iron Polypeptide on Improvement of Anemia||Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|Chonbuk National University Hospital||4|||f||||t||||||||||2017-10-11 02:16:43.322852|2017-10-11 02:16:43.322852
NCT01733966|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-21|||May 2010||2010-05-01|March 2010|2010-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|DIVA||A Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among Adults|A Third Phase, Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among Adults|Terminated||Phase 3|100|Actual|Quanta Medical||2||difficulties to recruit patients who suffer from this pathology|f||||t||||||||||2017-10-11 02:16:43.405833|2017-10-11 02:16:43.405833
NCT01733953|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-10-28|2016-04-11||November 2012||2012-11-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Statin Therapy in Young Adult Survivors of Childhood Cancer|Pilot Study of Statin Therapy in Young Adult Survivors of Childhood Cancer|Completed||Phase 2|27|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No|At this time we have no plan to share the IPD.|2017-10-11 02:16:43.484889|2017-10-11 02:16:43.484889
NCT01733940|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-27|||September 2012||2012-09-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Interventional|EAC-UCI||Efficacy of Tegaderm-CHG® Dressing vs. Tegaderm-IV® Dressing|"Efficacy of Tegaderm-CHG® Dressing vs. Tegaderm-IV® Dressing in the Reduction of Central Catheter Colonization in Patients of the Intensive Care Unit of the University Gómez Ulla Hospital."|Unknown status|Recruiting|Phase 4|398|Anticipated|Hospital Central de la Defensa Gómez Ulla||2|||f||||t||||||||||2017-10-11 02:16:43.799489|2017-10-11 02:16:43.799489
NCT01733927|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2012-11-26|||May 2010||2010-05-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|November 2010|Actual|2010-11-01||Interventional|||An Evaluation of a Rapid Test for HIV|An Evaluation of an Oral Rapid Test for HIV|Completed||Phase 3|497|Actual|Pontificia Universidad Catolica de Chile||1|||f||||f||||||||||2017-10-11 02:16:43.881415|2017-10-11 02:16:43.881415
NCT01733914|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2015-04-12|||September 2011||2011-09-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain|Phase II Study of Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain|Completed||Phase 2|80|Actual|Peking University||2|||f||||f||||||||||2017-10-11 02:16:43.954939|2017-10-11 02:16:43.954939
NCT01733901|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-11-21|||November 2012||2012-11-01|November 2012|2012-11-01|July 2015|Anticipated|2015-07-01|November 2014|Anticipated|2014-11-01||Interventional|RSD4CHD2PRE||Renal Sympathetic Denervation as Secondary Prevention for Patients After Percutaneous Coronary Intervention.|Safety and Effectiveness Study of Percutaneous Catheter-based Renal Sympathetic Denervation as a Method of Secondary Prevention for Patients After Percutaneous Coronary Intervention.|Unknown status|Recruiting|N/A|600|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 02:16:44.040509|2017-10-11 02:16:44.040509
NCT01733888|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-06-20|||July 2013||2013-07-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||Resin Infiltration and Resin Infiltration With Bleaching in Improving the Esthetics for Fluorosis Stains|Evaluating the Effect of Resin Infiltration and Resin Infiltration With Bleaching in Improving the Esthetics for Non Pitted Fluorosis Stains in Indian Population|Completed||N/A|80|Anticipated|DMG Dental Material Gesellschaft mbH||4|||f||||f||||||||||2017-10-11 02:16:44.146718|2017-10-11 02:16:44.146718
NCT01733875|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2013-10-23|||November 2012||2012-11-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects|A Phase 1, Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of CC-220 and to Explore the Effect of Food on the Bioavailability of CC-220 in Healthy Subjects|Completed||Phase 1|65|Actual|Celgene||9|||f||||f||||||||||2017-10-11 02:16:44.235694|2017-10-11 02:16:44.235694
NCT01733862|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-02-17|||November 2012||2012-11-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis|A Study to Assess the Impact of Rotavirus Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis (RV GE) in Japan|Completed||N/A|5394|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 02:16:44.334033|2017-10-11 02:16:44.334033
NCT01733849|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-01-16|||December 2012||2012-12-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia|An Observational Study to Estimate the Disease Burden of Rotavirus Gastroenteritis in Infants/Children Less Than Five Years of Age in Primary Care Settings, in Bulgaria and Latvia|Completed||N/A|1266|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-10-11 02:16:44.420707|2017-10-11 02:16:44.420707
NCT01733836|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-05-23|||January 2013||2013-01-01|May 2013|2013-05-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Prostate Cancer Active Surveillance Metformin Trial|A Randomized Double Blind Placebo Controlled Single Institution Phase 2 Study of Metformin in Patients Undergoing Active Surveillance for Prostate Cancer.|Withdrawn||Phase 2|0|Actual|University Health Network, Toronto||2||"The reason for this decision is that this study is being merged with a larger multi-centre   study using the same agent in the same population."|f||||t||||||||||2017-10-11 02:16:44.586842|2017-10-11 02:16:44.586842
NCT01733823|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-07-26|||January 2013||2013-01-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole|Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole for Patients With Stage III-IV p16 Negative Squamous Cell Cancer (SCC) of the Larynx, Pharynx and Oral Cavity|Completed||Phase 1/Phase 2|31|Actual|Danish Head and Neck Cancer Group||4|||f||||f||||||||||2017-10-11 02:16:44.651734|2017-10-11 02:16:44.651734
NCT01733810|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-08-01|||February 2013||2013-02-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis|The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis|Active, not recruiting||N/A|15|Anticipated|Dallas VA Medical Center||1|||f||||f||||||||||2017-10-11 02:16:44.729316|2017-10-11 02:16:44.729316
NCT01733797|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2015-09-30|||December 2012||2012-12-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients|Randomised Pilot Study of Therabite® Versus Wooden Spatula in the Amelioration of Trismus in Head and Neck Cancer Patients. (Trismus Trial)|Completed||Phase 2|71|Actual|The Christie NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:16:44.921545|2017-10-11 02:16:44.921545
NCT01733784|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-09-25|||December 2012||2012-12-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D|Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D|Unknown status|Recruiting|N/A|40|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:16:45.049265|2017-10-11 02:16:45.049265
NCT01733771|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-01-13|||April 2010||2010-04-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|||The Effect of Complementary Medicine (CAM) Treatments on Common Symptoms in Hospitalized Patients|Patient Reported Outcomes Following Complementary Medicine Treatments in Hospitalized Patients|Recruiting||N/A|2000|Anticipated|Bnai Zion Medical Center|||2||f||||f||||||||||2017-10-11 02:16:45.141377|2017-10-11 02:16:45.141377
NCT01733758|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2016-08-12|2015-04-02||February 2013||2013-02-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional||Baseline characteristics are presented for the Safety Population.|A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Monotherapy Study to Determine the Efficacy and Safety of 2 Dose Levels of Albiglutide in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|494|Actual|GlaxoSmithKline||4|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:16:45.268695|2017-10-11 02:16:45.268695
NCT01733745|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-07-02|2014-06-02||February 2013||2013-02-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|M-12-077|This reporting group includes all subjects who were enrolled and received at least one of the study treatments.|SYSTANE® Family - Meibomian Deficiency|SYSTANE® Family Efficacy in Meibomian Gland Functionality for Lipid Deficient Evaporative Dry Eye Subjects|Completed||N/A|26|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:16:46.68843|2017-10-11 02:16:46.68843
NCT01733732|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-10-31|2014-10-29||March 2013||2013-03-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||This analysis group includes all randomized subjects.|SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers|Study to Evaluate the Efficacy of SYSTANE® BALANCE in Reducing Symptoms and Inflammatory Biomarker Expression of HLA-DR and Tear Film Cytokines in Dry Eye Subjects With Lipid Deficiency|Completed||N/A|54|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:16:46.999587|2017-10-11 02:16:46.999587
NCT01733719|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-03-10|||February 2013||2013-02-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|BRIDE||Barrett&Apos;s Intervention for Dysplasia by Endoscopy|BRIDE (Barrett&Apos;s Randomised Intervention for Dysplasia by Endoscopy) - a Feasibility Study|Completed||N/A|76|Actual|University Hospitals, Leicester||2|||f||||t||||||||Undecided||2017-10-11 02:16:47.521326|2017-10-11 02:16:47.521326
NCT01733706|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-02-07|||June 2011||2011-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Early Smoking Reduction or Cessation by Means of no Nicotine Electronic Cigarette Added to Standard Counselling.|Evaluation of Early Smoking Reduction or Cessation by Means of no Nicotine Electronic Cigarette Added to Standard Counselling.|Completed||N/A|75|Actual|European Institute of Oncology||2|||f||||f||||||||||2017-10-11 02:16:47.605522|2017-10-11 02:16:47.605522
NCT01733693|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-07-05|||January 2013||2013-01-01|August 2016|2016-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|NEO||Neurocognitive Effects of Opiate Agonist Treatment|Neurocognitive Effects of Opiate Agonist Treatment|Completed||Phase 4|135|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 02:16:47.679548|2017-10-11 02:16:47.679548
NCT01703871|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-08|||September 2012||2012-09-01|September 2012|2012-09-01||||||||Observational|||Music During Diagnostic Hysteroscopy||Unknown status|Active, not recruiting|N/A|200|Anticipated|Campus Bio-Medico University|||1||f||||f||||||||||2017-10-11 02:25:33.5563|2017-10-11 02:25:33.5563
NCT01733667|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2013-06-03|||December 2011||2011-12-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|MISTY||A Prospective, Randomized, Multi-Center Evaluation of MediENT® Middle Turbinate Implant Versus MeroPack®, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery|A Prospective, Randomized, Multi-Center Evaluation of MediENT® Middle Turbinate Implant Versus MeroPack®, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery|Completed||N/A|60|Actual|ENTrigue Surgical, Inc.||2|||f||||f||||||||||2017-10-11 02:16:47.881217|2017-10-11 02:16:47.881217
NCT01733654|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-09-10|||September 2012||2012-09-01|September 2013|2013-09-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder|A Multi-center Randomized Double-blind Placebo-controlled Parallel-group Study to Investigate Efficacy and Safety of RO4995819 vs Placebo, as Adjunct Therapy in Patients w/Major Depressive Disorder|Withdrawn||Phase 2|0|Actual|Stanford University||4|||f||||t||||||||||2017-10-11 02:16:47.957989|2017-10-11 02:16:47.957989
NCT01733641|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-12-10|||September 2011||2011-09-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Test-Retest Reliability in DETECT|Test-Retest Psychometrics of a Novel Neuropsychological Assessment Tool: Reliability Measures for DETECT|Terminated||N/A|44|Actual|Emory University|||1|Limited eligible sample size for study outcomes|f||||f||||||||||2017-10-11 02:16:48.025883|2017-10-11 02:16:48.025883
NCT01733628|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-05-18|||November 2012||2012-11-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|December 2013|Actual|2013-12-01||Observational|BRECOL||Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Metastatic Colorectal Cancer|Evaluation Study of Hypertension as a Predictor of Efficacy Bevacizumab (BV) in Combination With Chemotherapy (CT) in Metastatic Colorectal Cancer (MCC) and Metastatic Breast Cancer (MBC).|Unknown status|Recruiting|N/A|137|Anticipated|Spanish Breast Cancer Research Group|||1||f||||f||||||Samples With DNA|"     Blood samples (serum or plasma) Tissue samples   "|||2017-10-11 02:16:48.070694|2017-10-11 02:16:48.070694
NCT01733615|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2014-09-02|||June 2012||2012-06-01|September 2014|2014-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA|Discovering New Biomarkers for Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA (MPSIVA)|Terminated||N/A|3|Actual|Emory University|||1|Original PI relocated to another institution|f||||f||||||Samples Without DNA|"     Frozen urine   "|||2017-10-11 02:16:48.156801|2017-10-11 02:16:48.156801
NCT01733602|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2017-08-07|||November 2012||2012-11-01|August 2017|2017-08-01||||November 2016|Actual|2016-11-01||Interventional|||tDCS to Enhance Cognitive Training in Schizophrenia|Does Transcranial Direct Current Stimulation (tDCS) Enhance Outcomes From Computerised Cognitive Remediation in Patients With Schizophrenia?|Completed||Phase 1/Phase 2|52|Anticipated|The University of New South Wales||2|||f||||||||||||||2017-10-11 02:16:48.230837|2017-10-11 02:16:48.230837
NCT01733589|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-07-11|||November 2012|Actual|2012-11-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC|Multicenter Phase I/II Clinical Trial of Recombinant Human Endostatin Continued Pumping Into Vein Combining With Concurrent Chemo-Radiotherapy in the Patients With Unresectable Stage III Non-small-Cell Lung Cancer|Completed||Phase 1/Phase 2|73|Actual|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-11 02:16:48.289441|2017-10-11 02:16:48.289441
NCT01733576|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-26|2015-07-21||||||July 2015|2015-07-01||||March 2014|Actual|2014-03-01||Interventional|||High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning|Enhancing Verbal Learning and Memory Using High-Definition Transcranial Direct Current Stimulation (HD-tDCS)|Completed||Early Phase 1|16|Actual|The University of New South Wales||4|||f||||f||||||||||2017-10-11 02:16:48.375064|2017-10-11 02:16:48.375064
NCT01733563|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2016-05-10|||April 2013||2013-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Sugar Sweetened Beverages (SSB)- Effects on Metabolism|Effects of Carbohydrate Containing Diets on Lipid Metabolism & Fatty Acid Oxidation in Healthy Young Men - a Randomized, Double-Blinded Study.|Completed||N/A|96|Actual|University of Zurich||4|||f||||f||||||||||2017-10-11 02:16:48.439751|2017-10-11 02:16:48.439751
NCT01733550|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-27|||November 2012||2012-11-01|September 2012|2012-09-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Observational|||ICare Self-tonometry - A Head-to-head Comparison to the Gold Standard Goldmann Tonometer|ICare Self-tonometry - A Head-to-head Comparison to the Gold Standard Goldmann Tonometer|Unknown status|Not yet recruiting|N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 02:16:49.883011|2017-10-11 02:16:49.883011
NCT01733537|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2013-08-06|||February 2013||2013-02-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Improving Motorcycle Taxi Driver Visibility in Tanzania|Improving Motorcycle Taxi Driver Visibility in Tanzania—A Cluster Randomized Controlled Trial|Completed||N/A|180|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:16:49.975832|2017-10-11 02:16:49.975832
NCT01733524|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-06-01|||October 2012||2012-10-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pet Ownership and Glucose Control in Type 1 Diabetes|Impact of Pet Ownership on Glycemic Control in Youth With Type 1 Diabetes|Completed||N/A|29|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 02:16:50.057015|2017-10-11 02:16:50.057015
NCT01733511|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2012-11-20|||February 2011||2011-02-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|||the Patients Journey Through Surgical Admission Ward Versus Emergency Department||Completed||N/A|109|Actual|University of Southern Denmark|||2||f||||f||||||||||2017-10-11 02:16:50.138462|2017-10-11 02:16:50.138462
NCT01733485|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-07-05|||October 2011||2011-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|September 2016|Actual|2016-09-01||Interventional|EFADA||Electrophilic Fatty Acid Derivatives in Asthma|Electrophilic Fatty Acid Derivatives in Asthma|Completed||Phase 1|50|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 02:16:50.187462|2017-10-11 02:16:50.187462
NCT01733459|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-21|2017-05-02|||March 2013||2013-03-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)|The Role of DLBS3233 in the Management of Polycystic Ovary Syndrome (PCOS)|Recruiting||Phase 3|124|Anticipated|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 02:16:50.341195|2017-10-11 02:16:50.341195
NCT01733446|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-08-17|||September 2012||2012-09-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|RIP03||A Study of the Effect of Arterial Carbon Dioxide Tension on the Recovery of Spontaneous Respiration|A Study of the Effect of Arterial Carbon Dioxide Tension on the Recovery of Spontaneous Respiration With Respiratory Inductance Plethysmography (RIP) During High Frequency Jet Ventilation (HFJV) Under General Anesthesia|Recruiting||N/A|50|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 02:16:50.455468|2017-10-11 02:16:50.455468
NCT01733433|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2014-12-04|||October 2012||2012-10-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|February 2015|Anticipated|2015-02-01||Interventional|CAI||Influence of Taping on Postural Control in Subjects With Chronic Ankle Instability|Influence of Taping on Postural Control in Subjects With Chronic Ankle Instability (CAI).|Unknown status|Recruiting|N/A|30|Anticipated|University Ghent||1|||f||||f||||||||||2017-10-11 02:16:50.531373|2017-10-11 02:16:50.531373
NCT01733420|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2014-12-04|||October 2011||2011-10-01|December 2014|2014-12-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||Biodentine Versus White MTA Pulpotomy|The Clinical and Radiographic Efficacy of Biodentine™ and White Mineral Trioxide Aggregate in Deciduous Molar Pulpotomy - a Randomized Control Trial|Unknown status|Recruiting|Phase 3|75|Anticipated|University Ghent||3|||f||||f||||||||||2017-10-11 02:16:50.61163|2017-10-11 02:16:50.61163
NCT01733407|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-07-12|||September 2013||2013-09-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|May 2017|Actual|2017-05-01||Interventional|||L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of L-Serine in Subjects With Hereditary Sensory Neuropathy Type 1|Completed||Phase 1/Phase 2|18|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:16:50.805923|2017-10-11 02:16:50.805923
NCT01733394|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-07-18|||December 12, 2012|Actual|2012-12-12|July 2017|2017-07-01|September 26, 2016|Actual|2016-09-26|September 26, 2016|Actual|2016-09-26||Interventional|||Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)|Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)|Completed||Phase 4|54|Actual|University of Cincinnati||3|||f||||t||||||||||2017-10-11 02:16:50.920542|2017-10-11 02:16:50.920542
NCT01733381|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-02-04|||November 2012||2012-11-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Effects of Barefoot Running vs. in Shoes on Physiology and Mood|An Examination of the Differential Effects of Running Minimally Shod vs. in Shoes on Physiology and Emotional States Relevant to Major Depression.|Completed||N/A|22|Actual|University of Arizona|||2||f||||f||||||||||2017-10-11 02:16:51.031893|2017-10-11 02:16:51.031893
NCT01733355|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2013-07-18|||July 2012||2012-07-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807|A Phase 0, Open Label, Non-randomized, Multi-center Exploratory and Safety Study of [F-18]T807|Terminated||Early Phase 1|11|Actual|Avid Radiopharmaceuticals||1||Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals.|f||||f||||||||||2017-10-11 02:16:51.174184|2017-10-11 02:16:51.174184
NCT01733342|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-12-02|||November 2012||2012-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SiCDIP||Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport|Single-center Randomized Trial for Comparison of Performance Between Domestic and Imported Chemoport|Completed||Phase 4|176|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:16:51.250064|2017-10-11 02:16:51.250064
NCT01733329|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-02-12|2013-12-14||February 2008||2008-02-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage|Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage in Women With Risk Factors for Uterine Atony|Completed||Phase 4|123|Actual|Hospital Universitario Dr. Jose E. Gonzalez|"Technical problems with blood loss measurement leading to blood transfusion before receiving hematocrit result.
Small number of patients fulfill inclusion criteria."|2|||f||||t||||||||||2017-10-11 02:16:51.33717|2017-10-11 02:16:51.33717
NCT01733316|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-07-26|2017-04-10||January 13, 2013|Actual|2013-01-13|July 2017|2017-07-01|July 10, 2017|Actual|2017-07-10|February 2015|Actual|2015-02-01||Interventional|||Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis|A Long-Term, Open-Label, Safety, Tolerability and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Patients With Cystinosis|Completed||Phase 3|41|Actual|Horizon Pharma USA, Inc.||2|||f||||f||||||||||2017-10-11 02:16:51.67383|2017-10-11 02:16:51.67383
NCT01733303|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-11-20|||January 2010||2010-01-01|November 2012|2012-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Fracture and Fall Prevention in Elderly With Osteoporosis|Fracture and Fall Prevention in Elderly With Osteoporosis|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 02:16:52.764309|2017-10-11 02:16:52.764309
NCT01733290|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-03-07|||October 2012|Actual|2012-10-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding|Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding - A Multicenter Study, Randomized, Double-Blind, Placebo Control|Completed||Phase 2|70|Actual|Buddhist Tzu Chi General Hospital||2|||f||||f||||||||||2017-10-11 02:16:52.840466|2017-10-11 02:16:52.840466
NCT00000545|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-28|||September 1993||1993-09-01|December 2005|2005-12-01|July 2002|Actual|2002-07-01|||||Interventional|||PATHWAYS--FULL SCALE STUDY|PATHWAYS--FULL SCALE STUDY|Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:03.181322|2017-10-11 04:19:03.181322
NCT01733277|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-05-30|2014-02-07||January 2013||2013-01-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Observational|||Osteoarthritis Structural Changes Assessed by Magnetic Resonance Imaging and Neuropathic Pain in Knee Osteoarthritis|A Cross-sectional Study to Explore the Osteoarthritis Structural Changes Assessed by MRI That Are Biomarkers of Neuropathic Pain in Knee Osteoarthritis|Completed||N/A|50|Actual|ArthroLab Inc.|||2||f||||f||||||||||2017-10-11 02:16:52.958668|2017-10-11 02:16:52.958668
NCT01732315|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-08-13|||October 2012||2012-10-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Adolescent Vaccination Reminder Study|Adolescent Vaccination Reminders Using Email|Completed||N/A|3783|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:16:53.226135|2017-10-11 02:16:53.226135
NCT01732302|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2013-10-18|||November 2012||2012-11-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients|Educational Intervention to Reduce Drug-related Hospitalizations and Visits in Emergency Departments in Elderly Primary Health Care Patients - a Cluster-randomized Controlled Trial|Completed||N/A|69|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:16:53.302987|2017-10-11 02:16:53.302987
NCT01732289|ClinicalTrials.gov processed this data on October 10, 2017|2008-09-01|2012-11-21|||August 2008||2008-08-01|November 2012|2012-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|ARHL||Genetic Study of Age Related Hearing Loss|Genetic Study of Age Related Hearing Loss|Completed||Early Phase 1|1000|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 02:16:53.396976|2017-10-11 02:16:53.396976
NCT01732276|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2012-11-30|||January 2013||2013-01-01|November 2012|2012-11-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Interventional|||The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer|Phase Ⅱ Study of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|Jiangmen Central Hospital||1|||f||||t||||||||||2017-10-11 02:16:53.469912|2017-10-11 02:16:53.469912
NCT01732263|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2014-04-16|2014-04-16||December 2012||2012-12-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function|A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (SPD602) in Subjects With Hepatic Impairment Compared to Matched Healthy Subjects|Completed||Phase 1|44|Actual|Shire||4|||f||||f||||||||||2017-10-11 02:16:53.549158|2017-10-11 02:16:53.549158
NCT01732250|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-04-10|||March 2013|Actual|2013-03-01|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|January 31, 2017|Actual|2017-01-31||Interventional|||Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem|Multicenter Open-label RCT to Compare Colistin Alone vs. Colistin Plus Meropenem|Completed||Phase 4|406|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 02:16:53.987576|2017-10-11 02:16:53.987576
NCT01732237|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2013-09-09|||August 2012||2012-08-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants|A Single Dose Study to Investigate the Pharmacokinetics of an Oral Microdose of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Subjects|Completed||Phase 1|18|Actual|Janssen-Cilag International NV||3|||f||||f||||||||||2017-10-11 02:16:54.094301|2017-10-11 02:16:54.094301
NCT01732224|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-03-22|||November 2012||2012-11-01|November 2012|2012-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B|A Prospective Randomized Controlled Study to Compare the Efficacy of Combined Tenofovir Plus Telbuvidine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B.|Completed||N/A|69|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 02:16:54.171467|2017-10-11 02:16:54.171467
NCT01732211|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2015-10-30||2015-10-30|March 2013||2013-03-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis|A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Group, 20-week Safety, Tolerability, And Efficacy Study Of Pd 0360324 In Adult Subjects With Chronic Pulmonary Sarcoidosis|Terminated||Phase 2|1|Actual|Pfizer||2||See termination reason in detailed description.|f||||t||||||||||2017-10-11 02:16:54.246334|2017-10-11 02:16:54.246334
NCT01732198|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2013-09-20|||March 2013||2013-03-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|January 2014|Anticipated|2014-01-01||Interventional|||A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers|A Phase 2, Multicenter, Randomized, Double-Blind, Immunogenicity, Reactogenicity, and Safety Study of NU300 Booster Dose Compared to ActHIB®, Both Co-administered With Prevnar 13® at 12-15 Months of Age, in Healthy Toddlers Who Have Received a Primary Series of a Licensed Hib Vaccine and Prevnar 13®|Unknown status|Active, not recruiting|Phase 2|220|Anticipated|Nuron Biotech Inc.||2|||f||||t||||||||||2017-10-11 02:16:54.335428|2017-10-11 02:16:54.335428
NCT01733264|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-10-23|||December 2012||2012-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:16:54.402691|2017-10-11 02:16:54.402691
NCT01733251|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-10-23|||December 2012||2012-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:16:54.435802|2017-10-11 02:16:54.435802
NCT01733238|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-01-16|||November 2012||2012-11-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma|PNT2258-02: A Pilot Phase II Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|13|Actual|Sierra Oncology, Inc.||1|||f||||f||||||||||2017-10-11 02:16:54.471065|2017-10-11 02:16:54.471065
NCT01733199|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-04-26|||October 2012||2012-10-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|May 2016|Anticipated|2016-05-01||Interventional|PARKADD||Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles|Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles.|Recruiting||Phase 4|250|Anticipated|Nantes University Hospital||3|||f||||||||||||||2017-10-11 02:16:54.608419|2017-10-11 02:16:54.608419
NCT01733186|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-04-18|||January 7, 2013|Actual|2013-01-07|April 2017|2017-04-01|June 27, 2017|Anticipated|2017-06-27|June 27, 2017|Anticipated|2017-06-27||Interventional|||Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects|Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects: A Phase I/IIa Clinical Trial in Patients With Focal, Full-thickness Grade 3-4 Articular Cartilage Defects of the Knee|Active, not recruiting||Phase 1/Phase 2|12|Actual|Medipost Co Ltd.||1|||f||||t||||||||Undecided||2017-10-11 02:16:54.698566|2017-10-11 02:16:54.698566
NCT01733173|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-09-07|||November 2012||2012-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Functional Imaging of Cerebellar Mutism Syndrome|Pilot Study: Functional Imaging of Cerebellar Mutism Syndrome|Recruiting||N/A|10|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 02:16:54.767901|2017-10-11 02:16:54.767901
NCT01733160|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-07-19|||November 2013||2013-11-01|July 2017|2017-07-01|August 15, 2017|Anticipated|2017-08-15|August 15, 2017|Anticipated|2017-08-15||Observational|SPRINT-AF||Stroke Prevention and Rhythm Interventions in Atrial Fibrillation|SPRINT-AF: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation|Active, not recruiting||N/A|2499|Actual|Canadian Collaborative Research Network|||1||f||||f||||||||||2017-10-11 02:16:54.93213|2017-10-11 02:16:54.93213
NCT01733147|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-03-31|||November 2012||2012-11-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids|Modulation of Esophageal Inflammation in Barrett&Apos;s Esophagus by Omega-3 Fatty Acids, a Double Blind Placebo Controlled Randomized Pilot Study|Recruiting||Phase 4|80|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:16:55.005338|2017-10-11 02:16:55.005338
NCT01733134|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-01-17|||January 2013||2013-01-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|ACTIVATE||Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)|Acute Heart Failure With High Copeptin Levels Treated With Tolvaptan Targets Increased AVP Activation for Treatment Efficacy|Unknown status|Not yet recruiting|Phase 3|350|Anticipated|Maisel, Alan, M.D.||2|||f||||t||||||||||2017-10-11 02:16:55.098362|2017-10-11 02:16:55.098362
NCT01733121|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-07-11|2017-05-11|2014-11-20|December 2012||2012-12-01|July 2017|2017-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Safety analysis set (all randomized subjects who received at least one dose of study drug).|NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia|Completed||Phase 2|102|Actual|Neurocrine Biosciences||2|||f||||f||||||||||2017-10-11 02:16:55.185501|2017-10-11 02:16:55.185501
NCT01733108|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-12-11|||July 2008||2008-07-01|December 2012|2012-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers|An Open-Label Drug-Drug Interaction Study in Healthy Subjects to Explore the Effects of Multiple Doses of JNJ-28431754 on the Pharmacokinetics and Safety of Single Doses of Glyburide|Completed||Phase 1|29|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 02:16:55.681827|2017-10-11 02:16:55.681827
NCT01733095|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-06-16|||July 2012||2012-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Ambrisentan for Treatment of Portopulmonary Hypertension|Ambrisentan for Treatment of Portopulmonary Hypertension (PoPH): a Pilot Study|Withdrawn||Phase 1/Phase 2|0|Actual|Medical University of Graz||1||slow recruitment|f||||f||||||||||2017-10-11 02:16:55.759412|2017-10-11 02:16:55.759412
NCT01733082|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-11-01|||November 2012||2012-11-01|November 2016|2016-11-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|||The Mycophenolate Pregnancy Registry|The Mycophenolate Pregnancy Registry|Recruiting||N/A|500|Anticipated|Genentech, Inc.|||1||f||||||||||||||2017-10-11 02:16:55.834784|2017-10-11 02:16:55.834784
NCT01733069|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2013-11-26|2013-03-07||November 2010||2010-11-01|November 2013|2013-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational||Symptomatic and asymptomatic men (n=549) and women (n=1313) enrolled from seven geographically and ethnically diverse US clinical sites, including obstetrics and gynecology, family planning, public health, and STD clinics.|Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System|Clinical Evaluation of the APTIMA® COMBO 2®Assay Using the PANTHER™ System|Completed||N/A|1912|Actual|Gen-Probe, Incorporated|||1||f||||f||||||Samples With DNA|"     4 specimens will be collected from each female subject in the following order: 1 first-catch     urine specimen, 1 vaginal swab specimen (patient or clinician-collected), 1 cervical specimen     (using a broomlike collection device or a brush/spatula combination), and 1 endocervical swab     specimen. An additional cervical specimen may be collected from female subjects for other     clinical trial purposes or research studies. Up to 2 specimens will be collected from each     male subject in the following order: 1 urethral swab specimen and 1 first-catch urine     specimen   "|||2017-10-11 02:16:55.923128|2017-10-11 02:16:55.923128
NCT01733056|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-06-19|2013-07-16||January 2011||2011-01-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression|Characterization of Immune Response to Vaccination in Patients Receiving Single-Drug Immunosuppressive Therapy|Completed||N/A|43|Actual|Emory University||3|||f||||f||||||||||2017-10-11 02:16:56.21098|2017-10-11 02:16:56.21098
NCT01733043|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-03-02|||March 2015||2015-03-01|March 2015|2015-03-01|November 2015|Anticipated|2015-11-01|May 2015|Anticipated|2015-05-01||Interventional|||Sedative Effects in Obstructive Sleep Apnea|Dexmedetomidine for Sedation in Individuals With Obstructive Sleep Apnea|Withdrawn||Phase 2/Phase 3|0|Actual|Duke University||2||Failure to secure funding|f||||f||||||||||2017-10-11 02:16:56.514981|2017-10-11 02:16:56.514981
NCT01733030|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-05-01|||January 2013||2013-01-01|May 2017|2017-05-01|October 1, 2015|Actual|2015-10-01|October 1, 2015|Actual|2015-10-01||Observational|DCS||The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear Healthy Controls.|The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear in Healthy Controls.|Completed||N/A|56|Actual|University of Minnesota - Clinical and Translational Science Institute|||3||f||||f||||||||||2017-10-11 02:16:56.586897|2017-10-11 02:16:56.586897
NCT01733017|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-03-15|||November 2011||2011-11-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|NIHFT||Nutrition Intervention to Decrease Symptoms in Patients With Heart Failure|Nutrition Intervention to Reduce Symptoms in Patients With Advanced Heart Failure|Completed||Phase 2|150|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 02:16:56.672026|2017-10-11 02:16:56.672026
NCT01733004|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-08-03|||November 2012||2012-11-01|August 2016|2016-08-01||||January 2016|Actual|2016-01-01||Interventional|||A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors|A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors|Completed||Phase 1|42|Actual|Merrimack Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:16:56.764024|2017-10-11 02:16:56.764024
NCT01732991|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2015-08-31|||September 2012||2012-09-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PROPIL||Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound|Assessing the Impact of the Prostatic Photo-vaporization (PVP) With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound|Completed||N/A|12|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-11 02:16:56.844823|2017-10-11 02:16:56.844823
NCT01732978|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2015-01-28|||September 2012||2012-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|BABIES_CRY||Are Parents Privileged Listeners Their Baby ?|Are Parents Privileged Listeners Their Baby ?|Completed||N/A|24|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-10-11 02:16:56.918766|2017-10-11 02:16:56.918766
NCT01732965|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-02-22|||March 2013||2013-03-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||NB-UVB and PUVA Vitiligo Study|Prospective Open Parallel Right to Left Bilateral Study Comparing Narrowband Ultraviolet B Alone Versus Narrowband Ultraviolet B and Psoralen Plus Ultraviolet A for the Treatment of Vitiligo|Completed||Phase 4|10|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-10-11 02:16:56.981659|2017-10-11 02:16:56.981659
NCT01732952|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2012-11-23|||February 2012||2012-02-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|April 2012|Actual|2012-04-01||Observational|DYSIS-China||Dyslipidemia International Survey-China|Dyslipidemia International Survey - China|Unknown status|Recruiting|N/A|25000|Anticipated|Chinese Society of Cardiology|||1||f||||t||||||||||2017-10-11 02:16:57.056409|2017-10-11 02:16:57.056409
NCT01732939|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2014-02-17|||May 2012||2012-05-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|December 2013|Actual|2013-12-01||Observational|||Phase II Study of Neoadjuvant Chemotherapy Regimen Choice in Breast Cancer||Unknown status|Recruiting|Phase 2|60|Anticipated|Hospital Affiliated to Military Medical Science, Beijing|||2||f||||f||||||||||2017-10-11 02:16:57.130198|2017-10-11 02:16:57.130198
NCT01732926|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-03-30|2017-03-30||January 2, 2013|Actual|2013-01-02|March 2017|2017-03-01|May 17, 2016|Actual|2016-05-17|May 17, 2016|Actual|2016-05-17||Interventional|Bridalveil|The Intent to Treat (ITT) Analysis Set: all participants who were randomized regardless of whether they received any study treatment|Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas|Terminated||Phase 3|475|Actual|Gilead Sciences|Due to the early termination of the study, efficacy data were not available for all participants, and therefore the prespecified analyses were not conducted.|2|||f||||t|t|f||||||||2017-10-11 02:16:57.25481|2017-10-11 02:16:57.25481
NCT01732913|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-03-30|2017-03-30||January 16, 2013|Actual|2013-01-16|March 2017|2017-03-01|May 18, 2016|Actual|2016-05-18|May 18, 2016|Actual|2016-05-18||Interventional|Yosemite|Intent-to-Treat (ITT) Analysis Set: all participants who were randomized regardless of whether they received any study treatment|Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas|Terminated||Phase 3|295|Actual|Gilead Sciences|Due to the early termination of the study, efficacy data were not available for all participants, and therefore the prespecified analyses were not conducted.|2|||f||||t|t|f||||||||2017-10-11 02:16:59.350887|2017-10-11 02:16:59.350887
NCT01732900|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-07-11|||February 2013||2013-02-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Gene Expression in Cumulus Cells to Predict Pregnancy|The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.|Completed||N/A|133|Actual|Gema Diagnostics||2|||f||||f||||||||||2017-10-11 02:17:00.882652|2017-10-11 02:17:00.882652
NCT01732887|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-01-31|||January 2013||2013-01-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Evaluating Short-term Effects of Computerized Brain Fitness Exercises in Adult Cochlear Implant and/or Hearing Aid Users|Evaluating Short-term Effects of Home-based Computerized Multi-domain Cognitive Training in Adult Cochlear Implant and/or Hearing Aid Users: A Prospective Randomized Intervention Study|Terminated||N/A|12|Actual|Nova Scotia Health Authority||2||We were not able to recruit enough participants during the funding period.|f||||f||||||||||2017-10-11 02:17:00.990713|2017-10-11 02:17:00.990713
NCT01732874|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-02-13|||November 2012||2012-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DHA-1||DHA-1 for Lactating Mothers|Docosahexaenoic Acid Supplementation of Mothers to Improve Preterm Infant Nutrition and Immune Homeostasis|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 02:17:01.093375|2017-10-11 02:17:01.093375
NCT01732861|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-02-28|||December 28, 2012|Actual|2012-12-28|February 2017|2017-02-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma|A MULTICENTER, PHASE 1B, OPEN-LABEL STUDY TO DETERMINE THE SAFETY AND ACTIVITY OF CC-292 IN COMBINATION WITH LENALIDOMIDE IN SUBJECTS WITH RELAPSED AND/OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA / SMALL LYMPHOCYTIC LYMPHOMA|Active, not recruiting||Phase 1|20|Actual|Celgene||1|||f||||f||||||||||2017-10-11 02:17:01.185111|2017-10-11 02:17:01.185111
NCT01732848|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2014-08-13|||November 2012||2012-11-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)|A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)|Completed||N/A|113|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 02:17:01.312155|2017-10-11 02:17:01.312155
NCT01732835|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2017-01-30|2016-10-06||December 2012||2012-12-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|June 2014|Actual|2014-06-01||Interventional||Participants with implanted device|The HAART 300 Annuloplasty Ring Trial Extended Safety and Performance|The HAART 300 Annuloplasty Ring Extended Safety and Performance Trial Used in Surgical Repair of the Aortic Valve|Completed||N/A|68|Actual|Biostable Science & Engineering||1|||f||||t||||||||Undecided||2017-10-11 02:17:01.469582|2017-10-11 02:17:01.469582
NCT01732809|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2012-11-28|||January 2011||2011-01-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|ABO ONA||Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses|FIELDS OF EFFECTS OF TWO COMMERCIAL PREPARATIONS OF BOTULINUM TOXIN TYPE A AT EQUAL LABELED UNIT DOSES|Completed||Phase 4|20|Actual|Brazilan Center for Studies in Dermatology||2|||f||||f||||||||||2017-10-11 02:17:04.226231|2017-10-11 02:17:04.226231
NCT01732796|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-03-17|2016-01-21|2014-06-25|December 2012||2012-12-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||The baseline characteristics were carried out on an intent-to-treat basis including all randomized patients who were dispensed study medication and were documented to have taken at least one dose of study medication (FAS).|IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1|A Phase III, Randomized, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination With Faldaprevir and Ribavirin in Treatment-Naive Patients With Chronic Genotype 1 HCV Infection|Completed||Phase 3|470|Actual|Boehringer Ingelheim|BI stopped the further development of DBV, per protocol amendment the Follow-up period was reduced to 24 weeks for patients who achieved SVR12, and to 48 weeks for SVR12 non-responders provided they had not started an alternative HCV treatment.|3|||f||||||||||||||2017-10-11 02:17:04.368388|2017-10-11 02:17:04.368388
NCT01732783|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-12-07|||December 2012||2012-12-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients|Prospective Observational Cohort Study to Describe the Use of Vectibix® in Combination With Chemotherapy in Routine Clinical Practice for Patients With Wild-type RAS Metastatic Colorectal Cancer|Completed||Phase 4|242|Actual|Amgen|||1||f||||f||||||||||2017-10-11 02:17:05.480338|2017-10-11 02:17:05.480338
NCT01732770|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-20|2016-01-28|2015-12-09||November 2012||2012-11-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis|A Randomized Double-blind Study to Evaluate the Safety and Efficacy of Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates|Completed||Phase 4|643|Actual|Amgen||2|||f||||f||||||||||2017-10-11 02:17:05.578787|2017-10-11 02:17:05.578787
NCT01732757|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2013-11-27|2013-11-27||November 2012||2012-11-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis||Completed||Phase 4|157|Actual|Allergan||3|||f||||f||||||||||2017-10-11 02:17:06.553691|2017-10-11 02:17:06.553691
NCT01732744|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-11-19|||March 2008||2008-03-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|ACBSFCD||A Castor Bean Solution for Cleaning Dentures|A Castor Bean Solution Reduces Complete Denture Biofilm|Completed||N/A|50|Actual|University of Sao Paulo||4|||f||||f||||||||||2017-10-11 02:17:07.25816|2017-10-11 02:17:07.25816
NCT01732731|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-11-23|||April 2009||2009-04-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Intensive Locomotor Treadmill Training on Gross Motor Function in Young Children With Neuromotor Impairment|Effects of Intensive Locomotor Treadmill Training on Gross Motor Function in Young Children With Neuromotor Impairment|Completed||N/A|12|Actual|University of the Pacific||2|||f||||f||||||||||2017-10-11 02:17:07.345296|2017-10-11 02:17:07.345296
NCT01732718|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2016-11-02|||September 2013||2013-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ENDO||Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease|The Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease (in the Grant Entitled: Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy)|Enrolling by invitation||Phase 2|19|Anticipated|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 02:17:07.416717|2017-10-11 02:17:07.416717
NCT01732705|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-12-30|||September 2012||2012-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|HIT_T2DM||High Intensity Interval Training (HIT) in Patients With Type 2 Diabetes|Effect of High Intensity Interval Training (HIT) on Insulin Sensitivity in Patients With Type 2 Diabetes|Completed||N/A|20|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-11 02:17:07.547795|2017-10-11 02:17:07.547795
NCT01732692|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2014-04-16|2014-04-05||November 2012||2012-11-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation|Multicenter Endoscopist-blinded Randomized Parallel-group Comparative Study to Assess Efficacy, Safety and Tolerance of Morning-only Dosing Compared to Control Split-dosing With Nocturnal Pause in MOVIPREP® Bowel Preparation Prior to Colonoscopy|Completed||Phase 3|140|Actual|Takeda||2|||f||||f||||||||||2017-10-11 02:17:07.6463|2017-10-11 02:17:07.6463
NCT00257413|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-21|2005-11-21||||||December 2003|2003-12-01||||||||Interventional|||Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension||Completed||N/A|||Zhejiang University|||||f||||||||||||||2017-10-11 05:52:00.546478|2017-10-11 05:52:00.546478
NCT01732679|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-04-24|||September 2012||2012-09-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|December 2014|Actual|2014-12-01||Observational|SINs||Sunnaas International Network´s Stroke Study|A Prospective Multicenter Study of Stroke Rehabilitation in Seven Countries: Norway, China, USA, Russia, Israel, Palestine, and Sweden.|Completed||N/A|230|Actual|Sunnaas Rehabilitation Hospital|||1||f||||t||||||||||2017-10-11 02:17:08.260546|2017-10-11 02:17:08.260546
NCT01732666|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2014-02-17|||May 2012||2012-05-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Nefopam on Remifentanil Induced Postoperative Hyperalgesia||Completed||N/A|25|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 02:17:08.382198|2017-10-11 02:17:08.382198
NCT01732653|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-04-17|||November 2012||2012-11-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|VTIME||A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults|V-TIME: A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults, Patients With Parkinson's Disease and Individuals With Mild Cognitive Impairments|Completed||N/A|302|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-11 02:17:08.473589|2017-10-11 02:17:08.473589
NCT01732627|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-11-11||2013-11-11|November 2012||2012-11-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older|Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older|Completed||Phase 2|301|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:17:08.714955|2017-10-11 02:17:08.714955
NCT01732614|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-03-19|||August 2012||2012-08-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|Topcon EM||Topcon Endpoint Management|Safety Assessment and Therapeutic Effect of Non-damaging Patterned Scanning Laser Phototherapy in Patients With Diffuse Diabetic Macular Edema|Completed||N/A|10|Actual|Retinal Consultants of Arizona||1|||f||||f||||||||||2017-10-11 02:17:08.839583|2017-10-11 02:17:08.839583
NCT01732601|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-07-31|||September 1, 2012|Actual|2012-09-01|July 2017|2017-07-01|June 1, 2018|Anticipated|2018-06-01|October 1, 2017|Anticipated|2017-10-01||Interventional|INVEST||Intensive Outpatient Services for Teens|Intensive Outpatient Protocol for High Risk Suicidal Teens|Active, not recruiting||Phase 1|140|Actual|Brown University||2|||f||||t||||||||||2017-10-11 02:17:08.918594|2017-10-11 02:17:08.918594
NCT01732588|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-02-17|2014-03-07||November 2012||2012-11-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||cross over design so each regimen is represented in each sequence once|A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route|Three Way Randomised CrossOver Study in Healthy Subjects to Compare the Relative Bioavailability of Nanoparticulate OZ439 Delivered Via the Enterion™ Capsule to the Proximal Small Bowel With Orally Administered OZ439 as PIB Suspension and Orally Administered Nanoparticulate|Completed||Phase 1|11|Actual|Medicines for Malaria Venture||3|||f||||f||||||||||2017-10-11 02:17:09.005237|2017-10-11 02:17:09.005237
NCT01732575|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-08-24|||October 2008||2008-10-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|February 2012|Actual|2012-02-01||Interventional|||Enrichment of Day Centers in Community-based Psychiatry|Effectiveness of an Intervention Tailored for Day Centers for People With Psychiatric Disabilities|Completed||N/A|107|Actual|Lund University||2|||f||||f||||||||||2017-10-11 02:17:09.351994|2017-10-11 02:17:09.351994
NCT01732562|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-08-08|||April 2013||2013-04-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Trial to Establish Realistic Patient Expectations of Total Knee Replacement|A Randomized Controlled Trial to Establish Realistic Patient Expectations of Total Knee Arthroplasty|Completed||N/A|416|Actual|Lawson Health Research Institute||2|||f||||f||||||||No||2017-10-11 02:17:09.41146|2017-10-11 02:17:09.41146
NCT01732549|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-08-09|2016-04-29||January 2013||2013-01-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional||ITT population: All randomised patients. Patients were allocated to the treatment they were randomised to. Patients randomised that have been actually dead before randomisation were not retained in the intention to treat (ITT) population|A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy|A Randomised, Double-Blind, Placebo-Controlled Proof Of Concept Study Of Maintenance Therapy With Tasquinimod In Patients With Metastatic Castrate-Resistant Prostate Cancer Who Are Not Progressing After A First Line Docetaxel Based Chemotherapy|Terminated||Phase 2|144|Actual|Ipsen|The study was terminated early due to the stop of the project as decided by sponsor. The trial included number of planned patients & number of events(PFS)were met to draw conclusions. Only follow-up of patients were discontinued earlier than planned.|2||Development of tasquinimod in prostate cancer discontinued|f||||t||||||||||2017-10-11 02:17:09.518758|2017-10-11 02:17:09.518758
NCT01732536|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-03-19||2015-03-05|January 2013||2013-01-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional|RESOLVE||Safety and Efficacy of a Steroid-Releasing Sinus Implant for Recurrent Sinus Obstruction|A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing S8 Sinus Implant Used in Post-Sinus Surgery Patients With Recurrent Sinus Obstruction|Completed||Phase 2/Phase 3|100|Actual|Intersect ENT||2|||f||||t||||||||No|No plan|2017-10-11 02:17:12.220472|2017-10-11 02:17:12.220472
NCT01732523|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2016-11-14|||October 2012||2012-10-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Predictive Value of Neovascularization Within Asymptomatic Carotis Stenosis on CEUS|Predictive Value of Carotid Lesion Neovascularization Detected by Contrast-enhanced Ultrasound (CEUS) in Patients With Asymptomatic Carotid Stenosis|Recruiting||N/A|240|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 02:17:12.488894|2017-10-11 02:17:12.488894
NCT01726751|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-04-17|||August 2005||2005-08-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Spinal Cord Stimulation for Pain Relief in Irritable Bowel Syndrome|Spinal Cord Stimulation in the Irritable Bowel Syndrome - a Randomized Cross-over Trial|Completed||Phase 1/Phase 2|10|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 02:18:38.964405|2017-10-11 02:18:38.964405
NCT01732510|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-05-02|2016-02-26||December 2012||2012-12-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003)|A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis|Terminated||Phase 1|65|Actual|Merck Sharp & Dohme Corp.||7||The study was prematurely stopped due to business reasons.|f||||f||||||||||2017-10-11 02:17:12.637146|2017-10-11 02:17:12.637146
NCT01732497|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-03-30|||September 2012||2012-09-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Prospective Study of Axillary Hair Loss in Patients Treated With the miraDry System|A Prospective Study of Axillary Hair Loss in Patients Treated With the miraDry System|Completed||N/A|56|Actual|Miramar Labs||1|||f||||f||||||||No||2017-10-11 02:17:14.674731|2017-10-11 02:17:14.674731
NCT01732484|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2013-04-30|2013-02-04||August 2009||2009-08-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|May 2010|Actual|2010-05-01||Interventional|||Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two Microincision IOLs: Hoya iMics NY-60 vs Acrysof SN60WF||Completed||N/A|100|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 02:17:14.746283|2017-10-11 02:17:14.746283
NCT01732471|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2014-07-25|2014-06-24||November 2012||2012-11-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Intention to Treat (ITT) population included all participants who had efficacy assessment result from at least 1 visit except for the inclusion visit.|Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria|A Phase III Non-comparative Open-label Clinical Study to Evaluate the Response to and Safety of Kuvan (Sapropterin Dihydrochloride) After 6 Weeks of Treatment in Patients of 4 to 18 Years of Age With Phenylketonuria Who Have Elevated Blood Phenylalanine Levels|Completed||Phase 3|90|Actual|Merck KGaA||1|||f||||f||||||||||2017-10-11 02:17:14.924694|2017-10-11 02:17:14.924694
NCT01732458|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-08-04|2017-08-04||February 12, 2013|Actual|2013-02-12|August 2017|2017-08-01|September 26, 2016|Actual|2016-09-26|September 26, 2016|Actual|2016-09-26||Interventional||All Participants as Treated (APaT) population; all randomized participants who received at least 1 dose of study treatment.|A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)|A Phase IIb, Partially-Blinded, Randomized, Active Comparator-Controlled Study to Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Aprepitant in Pediatric Patients for the Prevention of Post Operative Nausea and Vomiting|Completed||Phase 2|229|Actual|Merck Sharp & Dohme Corp.||4|||f||||f|t|f||||||||2017-10-11 02:17:15.259381|2017-10-11 02:17:15.259381
NCT01732432|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2015-03-31|||October 2012||2012-10-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Observational|EAOC||Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)|Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) - Epidemiological and Molecular Pathological Aspects|Withdrawn||N/A|0|Actual|University Hospital, Basel, Switzerland|||1||f||||t||||||||||2017-10-11 02:17:16.397601|2017-10-11 02:17:16.397601
NCT01732419|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-03-15|||January 2013||2013-01-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|FIT@Home||Homebased Training With Telemonitoring Guidance in Low to Moderate Risk Patients Entering Cardiac Rehabilitation|Effects of Homebased Training With Telemonitoring Guidance in Low to Moderate Risk Patients Entering Cardiac Rehabilitation|Completed||N/A|90|Actual|Maxima Medical Center||2|||f||||f||||||||||2017-10-11 02:17:16.451084|2017-10-11 02:17:16.451084
NCT01732406|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-03-01|||January 2013||2013-01-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|March 2017|Actual|2017-03-01||Observational|||Acromegaly Treatment Quality of Life Study|Effect of Growth Hormone Receptor Antagonism and Somatostatin Analog Administration on Quality of Life|Active, not recruiting||N/A|134|Actual|Massachusetts General Hospital|||3||f||||f||||||Samples Without DNA|"     Plasma and blood serum   "|||2017-10-11 02:17:16.528774|2017-10-11 02:17:16.528774
NCT01732393|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2012-12-04|||January 2010||2010-01-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Quercetin in Prevention and Treatment of Oral Mucositis|Effect of Quercetin in Prevention and Treatment of Chemotherapy Induced Oral Mucositis in Blood Dyscrasias|Completed||Phase 1/Phase 2|20|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:17:16.59251|2017-10-11 02:17:16.59251
NCT01732380|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-19|||July 2012||2012-07-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer|A Multicenter Randomized Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer|Unknown status|Recruiting|Phase 2|108|Anticipated|The First People's Hospital of Lianyungang||2|||f||||f||||||||||2017-10-11 02:17:16.680031|2017-10-11 02:17:16.680031
NCT01732367|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-10-27|||November 2012||2012-11-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA|Randomized Trial of Tenofovir Versus Lamivudine Plus Adefovir in Lamivudine Plus Adefovir Treated Lamivudine-resistant Chronic Hepatitis B Patients With Undetectable Hepatitis B Virus DNA.|Completed||Phase 4|171|Actual|Keimyung University Dongsan Medical Center||2|||f||||t||||||||||2017-10-11 02:17:16.781148|2017-10-11 02:17:16.781148
NCT01732341|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-04-19|||May 2013||2013-05-01|November 2015|2015-11-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Interventional|APPOSITION V||Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction|APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction|Terminated||Phase 3|318|Actual|Stentys||2||Decision to discontinue patient follow-up at 2 years.|f||||t||||||||||2017-10-11 02:17:16.953561|2017-10-11 02:17:16.953561
NCT01732328|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2012-11-21|||July 2009||2009-07-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|June 2012|Actual|2012-06-01||Interventional|||Effect of Calcium Plus Vitamin D Supplementation on Adolescent Mother and Infant Bone Health|Calcium Plus Vitamin D Supplementation During Pregnancy of Adolescent Mothers: Effects on Maternal and Infant Bone Mass, Calcium and Bone Metabolism and Breast Milk Composition|Unknown status|Active, not recruiting|N/A|76|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 02:17:17.040228|2017-10-11 02:17:17.040228
NCT01732185|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2015-12-15|||October 2012||2012-10-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|December 2015|Actual|2015-12-01||Interventional|MAKP||Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations|Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations|Active, not recruiting||N/A|45|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 02:17:17.203202|2017-10-11 02:17:17.203202
NCT01732172|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2016-07-05|||June 2012||2012-06-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|April 2016|Actual|2016-04-01||Interventional|URIS||Chronic Inflammatory Condition of the Male Genital Tract|Study of the Prevalence of a Chronic Inflammatory Condition of the Male Genital Tract at a Distance and Urethritis Following.|Active, not recruiting||N/A|113|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:17:17.284651|2017-10-11 02:17:17.284651
NCT01732159|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2015-04-20|||November 2012||2012-11-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|AMBUPROG||Impact of a Checklist on the Rate of Late Cancellation in Ambulatory Surgery|Impact of a Checklist on the Rate of Late Cancellation in Ambulatory Surgery|Completed||N/A|4093|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:17:17.365642|2017-10-11 02:17:17.365642
NCT01732146|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2015-08-18|||March 2013||2013-03-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|Neurepo||Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy|Phase III Study of Efficacy of High Dose Erythropoietin to Prevent Hypoxic-ischemic Encephalopathy Sequelae in Term Newborn|Active, not recruiting||Phase 3|120|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:17:17.452566|2017-10-11 02:17:17.452566
NCT01732133|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-04-10|||April 2013|Actual|2013-04-01|April 2017|2017-04-01|January 22, 2016|Actual|2016-01-22|January 22, 2016|Actual|2016-01-22||Interventional|NEXFIN-CESAR||Evaluation of NEXFIN During Cesarean Delivery to Detect Hypotension|Evaluation of the System NEXFIN for Continuous and Non-invasive Measure of the Blood Pressure During Cesarean Delivery Practised Under Spinal Anesthesia|Completed||N/A|171|Actual|Hopital Foch||1|||f||||f||||||||||2017-10-11 02:17:17.53919|2017-10-11 02:17:17.53919
NCT01732120|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-10-03|||November 2012||2012-11-01|October 2017|2017-10-01|June 30, 2020|Anticipated|2020-06-30|May 31, 2017|Actual|2017-05-31||Interventional|||Off Clamp Randomization|Evaluation of the Off-Clamp Robot-Assisted Partial Nephrectomy Technique in the Management of Renal Tumors|Active, not recruiting||N/A|73|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:17:17.605556|2017-10-11 02:17:17.605556
NCT01732107|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-08-21|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression|A Phase II Trial of Dovitinib in Bacillus Calmette-Guerin(BCG) Refractory Urothelial Carcinoma Patients With Tumor Fibroblast Growth Factor Receptor 3(FGFR3) Mutations or Over-expression: Hoosier Cancer Research Network GU12-157|Active, not recruiting||Phase 2|50|Anticipated|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-10-11 02:17:17.73319|2017-10-11 02:17:17.73319
NCT01732094|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2013-05-07|||July 2012||2012-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders|Phase II Study of Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders|Completed||Phase 2|57|Actual|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-11 02:17:17.846586|2017-10-11 02:17:17.846586
NCT01732081|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2012-11-16|||January 2011||2011-01-01|November 2012|2012-11-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|||"Real-life Cohort of Patients With Chronic Hepatitis B Virus Infection"|Hepatitis B Cohort: Predictive Factors of the Outcome of Chronic Hepatitis B Virus Infection|Recruiting||N/A|3000|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 02:17:17.940095|2017-10-11 02:17:17.940095
NCT01732068|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2013-05-07|||July 2012||2012-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol|Phase II Study for the Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol|Completed||Phase 2|51|Actual|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-11 02:17:18.016961|2017-10-11 02:17:18.016961
NCT01732055|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-01-13|||November 2012||2012-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Partner-Assisted Interpersonal Psychotherapy or Antidepressant Medication for Antenatal Depression|Partner-Assisted Interpersonal Psychotherapy or Antidepressant Medication for Antenatal Depression|Terminated||Phase 1/Phase 2|2|Actual|University of North Carolina, Chapel Hill||2||Study ended because recruitment goals unmet and further funding unlikely|f||||f||||||||||2017-10-11 02:17:18.096037|2017-10-11 02:17:18.096037
NCT01732042|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2013-12-10|||November 2011||2011-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|||Retinal Venous Pressure (RVP) in Normals|Retinal Venous Pressure (RVP) in Normals|Completed||N/A|200|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 02:17:18.202094|2017-10-11 02:17:18.202094
NCT01732029|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-06-22|||January 2013||2013-01-01|June 2017|2017-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Calibration and Evaluation of an Audio Pulse Oximeter Sensor (AudioOx) at Ascent and Descent From Simulated Altitude|Calibration and Evaluation of an Audio Pulse Oximeter Sensor (AudioOx) at Ascent and Descent From Simulated Altitude|Completed||N/A|20|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 02:17:18.262249|2017-10-11 02:17:18.262249
NCT01732003|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2012-11-27|||November 2011||2011-11-01|November 2012|2012-11-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||The Effect of Omega-3 Fatty Acid Supplementation on Skeletal Muscle Membrane Composition and Cellular Metabolism|The Effect of Omega-3 Fatty Acid Supplementation on Skeletal Muscle Plasma and Mitochondrial Membrane Composition and Cellular Metabolism|Unknown status|Recruiting|N/A|24|Anticipated|University of Guelph||2|||f||||f||||||||||2017-10-11 02:17:18.435453|2017-10-11 02:17:18.435453
NCT01731990|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2017-08-29|2017-07-21||October 30, 2012|Actual|2012-10-30|July 2017|2017-07-01|August 4, 2016|Actual|2016-08-04|August 4, 2016|Actual|2016-08-04||Interventional||safety analysis set: All patients that received any study drug were included in the safety analysis set|Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.|Terminated||Phase 2|38|Actual|Novartis|Study was terminated after the third interim analysis based on result from primary outcome analysis.|2||The study got terminated based on result from primary endpoint analysis|f||||f|t|f||||||||2017-10-11 02:17:18.586315|2017-10-11 02:17:18.586315
NCT01731977|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2016-01-02|||July 2012||2012-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Strengths-Based Family Psychoeducation for Youth Psychosis|Effectiveness of the Strengths-Based Family Psychoeducation for Youth Psychosis: Randomized Controlled Trial|Completed||N/A|74|Actual|Nagoya City University||2|||f||||f||||||||||2017-10-11 02:17:19.283716|2017-10-11 02:17:19.283716
NCT01731964|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-12-10|||November 2012||2012-11-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration|Pilot Study of WA-NG Telescope Prosthesis in Patients With Central Vision Impairment Associated With End-stage Age-related Macular Degeneration|Withdrawn||N/A|0|Actual|VisionCare, Inc.||1||No participants enrolled|f||||f||||||||||2017-10-11 02:17:19.360546|2017-10-11 02:17:19.360546
NCT01731951|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2017-06-16|||October 31, 2012|Actual|2012-10-31|June 2017|2017-06-01|January 16, 2019|Anticipated|2019-01-16|January 16, 2019|Anticipated|2019-01-16||Interventional|||Imetelstat Sodium in Treating Patients With Primary or Secondary Myelofibrosis|A Pilot Open-Label Study of the Efficacy and Safety of Imetelstat (GRN163L) in Myelofibrosis and Other Myeloid Malignancies|Active, not recruiting||Phase 2|81|Actual|Janssen Research & Development, LLC||6|||f||||t||f||||||||2017-10-11 02:17:19.429036|2017-10-11 02:17:19.429036
NCT01731938|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-01-03|2016-11-02||November 2012||2012-11-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries|A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Soft Tissue Open Surgeries|Completed||Phase 3|327|Actual|Grifols Biologicals Inc.||2|||f||||f||||||||||2017-10-11 02:17:19.53642|2017-10-11 02:17:19.53642
NCT01731925|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-01-30|||January 7, 2013|Actual|2013-01-07|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SUNLAND||A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors|A RANDOMIZED PHASE II DOUBLE-BLIND TRIAL OF SUNITINIB VERSUS PLACEBO IN COMBINATION WITH LANREOTIDE IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC MIDGUT CARCINOID TUMORS|Active, not recruiting||Phase 2|44|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2|||f||||t||||||||||2017-10-11 02:17:20.265736|2017-10-11 02:17:20.265736
NCT01731899|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2014-05-06|||June 2010||2010-06-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Observational|||Agomelatine in Depressed Patients With Fibromyalgia|Observational Study Evaluating the Efficacy and Tolerability of Agomelatine in the Treatment of Depressed Patients With Fibromyalgia|Completed||N/A|27|Actual|Universidad de Granada|||1||f||||f||||||||||2017-10-11 02:17:20.567194|2017-10-11 02:17:20.567194
NCT01731886|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-06-16|||September 2012|Actual|2012-09-01|June 2017|2017-06-01|April 11, 2017|Actual|2017-04-11|April 11, 2017|Actual|2017-04-11||Interventional|||Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma|A Randomized Clinical Trial of Lenalidomide (CC-5013) and Dexamethasone With and Without Autologous Peripheral Blood Stem Cell Transplant in Patients With Newly Diagnosed Multiple Myeloma|Completed||Phase 4|12|Actual|Columbia University||2|||f||||t|t|f|||f|||Undecided||2017-10-11 02:17:20.646055|2017-10-11 02:17:20.646055
NCT01731873|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2017-07-28|||May 22, 2011|Actual|2011-05-22|July 2017|2017-07-01|May 21, 2021|Anticipated|2021-05-21|May 21, 2021|Anticipated|2021-05-21||Observational|||Patient Controlled Analgesia Pharmacogenetic Study|Non-Interventional Pharmacogenetic Study of Patient / Proxy Controlled Analgesia in Children Undergoing Surgery|Enrolling by invitation||N/A|650|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||Samples With DNA|"     A database/ repository will be constructed for future research, analysis, and recruitment.     De-identified study participants' genetic information, their responses to pain and pain     medications, and side-effects will be included in a study database. Blood specimens will be     included in the repository for exploring potentially important SNPs and biomarkers in future.     No patient identifiers will be included in the database, and there will be a confidential     (access limited to investigators only) code or link between the database and other     information about the participant.   "|||2017-10-11 02:17:20.735232|2017-10-11 02:17:20.735232
NCT01731665|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2016-07-11|||December 2012||2012-12-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.|Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.|Recruiting||N/A|2000|Anticipated|Asan Medical Center|||1||f||||f||||||||No||2017-10-11 02:17:22.155106|2017-10-11 02:17:22.155106
NCT01731847|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2012-11-18|||February 2007||2007-02-01|November 2012|2012-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Combined NMES,FEES and Traditional Swallowing Rehabilitation in the Treatment of Stroke-related Dysphagia|Combined Neuromuscular Electrical Stimulation (NMES) With Fiberoptic Endoscopic Evaluation of Swallowing (FEES) and Traditional Swallowing Rehabilitation in the Treatment of Stroke-related Dysphagia|Completed||N/A|32|Actual|Kaohsiung Veterans General Hospital.||1|||f||||f||||||||||2017-10-11 02:17:20.914459|2017-10-11 02:17:20.914459
NCT01731821|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-10|2014-12-02|||October 2012||2012-10-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy|A Prospective Randomized Clinical Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy: Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy|Completed||Phase 3|308|Actual|Fudan University||2|||f||||f||||||||||2017-10-11 02:17:21.135237|2017-10-11 02:17:21.135237
NCT01731808|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-03-03|||October 2010||2010-10-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Outpatient Nurse Managed Counseling Program for Patients With Diabetic Foot Ulceration: a Pilot Study|Outpatient Nurse Managed Counseling Program for Patients With Diabetic Foot Ulceration: a Pilot Study|Completed||N/A|19|Actual|Zurich University of Applied Sciences||2|||f||||t||||||||||2017-10-11 02:17:21.217419|2017-10-11 02:17:21.217419
NCT01731795|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-18|2017-07-25|||April 2013||2013-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DEXA-ARDS||Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome|A Comparative, Randomised Controlled Trial for Evaluating the Efficacy of Dexamethasone in the Treatment of Patients With Acute Respiratory Distress Syndrome|Recruiting||Phase 4|314|Anticipated|Dr. Negrin University Hospital||2|||f||||t||||||||||2017-10-11 02:17:21.294904|2017-10-11 02:17:21.294904
NCT01731782|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-06-03|||July 2012||2012-07-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|TAP Block||Evaluation of a TAP Block Given During Laparoscopic Colorectal Surgery to Help Control Pain|Evaluation of a TAP Block as Part of an Enhanced Recovery Pathway in Laparoscopic Colorectal Surgery: A Prospective, Randomized, Double-blinded Multi-institution Trial|Completed||N/A|79|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 02:17:21.390207|2017-10-11 02:17:21.390207
NCT01731769|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2012-11-19|||January 2013||2013-01-01|November 2012|2012-11-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|||Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure|Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure--- a Randomized Control Clinical Trial|Unknown status|Not yet recruiting|N/A|50|Anticipated|Changhai Hospital||2|||f||||f||||||||||2017-10-11 02:17:21.5046|2017-10-11 02:17:21.5046
NCT01731756|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-05-02|||January 2013||2013-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis|Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis: Randomized, Double Blind, Placebo-controlled Trial|Completed||N/A|50|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||2|||f||||f||||||||||2017-10-11 02:17:21.576389|2017-10-11 02:17:21.576389
NCT01731743|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2013-12-18|||January 2012||2012-01-01|December 2013|2013-12-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses||Unknown status|Active, not recruiting|N/A|120|Anticipated|Carl Zeiss Meditec AG||1|||f||||f||||||||||2017-10-11 02:17:21.65346|2017-10-11 02:17:21.65346
NCT01731730|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-19|2015-01-14||2015-01-14|January 2013||2013-01-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery|Study to Evaluate the Safety & Efficacy of a Single Intrathecal Pre-Operative Administration of AYX1 Injection at Two Dose Levels Compared to Placebo in Patients Undergoing Unilateral Total Knee Arthroplasty (TKA)|Completed||Phase 2|102|Actual|Adynxx, Inc.||3|||f||||t||||||||||2017-10-11 02:17:21.714271|2017-10-11 02:17:21.714271
NCT01731717|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-07-10|||September 2012||2012-09-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|SCM||Cluster Randomized Trial of Stepped Care Intervention vs. Treatment as Usual for Patients With Depression|Effektivität Und Effizienz Von Behandlungspfaden für Patienten Mit Depressiven Erkrankungen: Stepped Care Als Ansatz für Ein Leitliniengerechtes Und Integriertes Versorgungsmanagement|Completed||N/A|737|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 02:17:21.805526|2017-10-11 02:17:21.805526
NCT01731704|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-03-10|||December 2012||2012-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|October 26, 2015|Actual|2015-10-26||Interventional|NAGKC 12-01||Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases|A Randomized Controlled Study Of Neurocognitive Outcomes In Patients With Five Or More Brain Metastases Treated With Radiosurgery Or Whole-Brain Radiotherapy|Withdrawn||N/A|0|Actual|University of California, San Francisco||2||Insufficient staff|f||||t||||||||||2017-10-11 02:17:21.911273|2017-10-11 02:17:21.911273
NCT01731678|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2017-01-27|||November 2012|Actual|2012-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TMSAD||Transcranial Magnetic Stimulation for Adolescent Depression|Transcranial Magnetic Stimulation for Adolescent Depression|Active, not recruiting||N/A|42|Actual|University of Calgary||1|||f||||f||||||||||2017-10-11 02:17:22.08328|2017-10-11 02:17:22.08328
NCT01731652|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-02-09|||February 2013||2013-02-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|||Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer|Phase II Pilot Study With TMX 101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer|Completed||Phase 2|12|Actual|Telormedix SA||1|||f||||f||||||||||2017-10-11 02:17:22.275297|2017-10-11 02:17:22.275297
NCT01731639|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2014-11-17|||January 2013||2013-01-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Motile Sperm Organelle Morphology Examination (MSOME) Influence on Intracytoplasmic Sperm Injection (ICSI) Outcomes in Infertile Couples|The Influence of Motile Sperm Organelle Morphology Examination on ICSI Outcomes|Completed||N/A|72|Actual|Sapientiae Institute||1|||f||||f||||||||||2017-10-11 02:17:22.355058|2017-10-11 02:17:22.355058
NCT01731613|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-03-31|||August 2012||2012-08-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|February 2017|Anticipated|2017-02-01||Interventional|||Adjustable Fortification of Human Milk Fed to Chinese Preterm Infants|Adjustable Fortification of Human Milk Fed to Chinese Preterm Infants|Recruiting||N/A|60|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||No||2017-10-11 02:17:22.425901|2017-10-11 02:17:22.425901
NCT01731600|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-07-28|||February 20, 2013|Actual|2013-02-20|July 2017|2017-07-01|May 11, 2018|Anticipated|2018-05-11|May 11, 2018|Anticipated|2018-05-11||Interventional|pathfinder™5||A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A|A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A|Active, not recruiting||Phase 3|68|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 02:17:22.544224|2017-10-11 02:17:22.544224
NCT01731587|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-02-27|||January 2001||2001-01-01|February 2017|2017-02-01||||||||Interventional|FINGERPRINT||Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer|Phase Ib, Single-arm, Proof-of-principle Trial Investigating the Cytokine Profile and Specific T Cell Response in Peripheral Blood of Non-small Cell Lung Cancer (NSCLC) Subjects With Unresected Stage III Disease Treated With L-BLP25|Withdrawn||Phase 1|0|Actual|Merck KGaA||1||"The objectives of this trial are no longer deemed appropriate for the clinical development of   L-BLP25 therefore this trial is withdrawn"|f||||f||||||||||2017-10-11 02:17:22.757555|2017-10-11 02:17:22.757555
NCT01731574|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-09-05|||December 2012||2012-12-01|September 2017|2017-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate|An Open-label, Randomized, Three-period Crossover Trial in Healthy HIV-negative Women to Assess the Drug-drug Interaction Between Dapivirine Vaginal Ring-004 and Miconazole Nitrate|Completed||Phase 1|36|Actual|International Partnership for Microbicides, Inc.||2|||f||||f|t|f||||||||2017-10-11 02:17:22.841124|2017-10-11 02:17:22.841124
NCT01731561|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-11-18|||November 2012||2012-11-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|April 2016|Actual|2016-04-01||Interventional|MAINRITSAN 2||Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis|MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis II|Active, not recruiting||Phase 3|166|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:17:22.925748|2017-10-11 02:17:22.925748
NCT01731548|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-01-21|||June 2002||2002-06-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer|Omitting Elective Nodal Irradiation and Irradiating Post-induction Versus Pre-induction Chemotherapy Tumor Extent for Limited-stage Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2/Phase 3|500|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-11 02:17:23.03964|2017-10-11 02:17:23.03964
NCT01731535|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2015-10-09|||November 2012||2012-11-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Observational|||Evaluation of the Risk for Radiographic and Clinical Nonunion in Patients With Previous Bisphosphonates Therapy.|Evaluation of the Risk for Radiographic and Clinical Nonunion in Patients With Previous Bisphosphonates Therapy.|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison|||1|It was a project initiated by a trainee but did not progress to subject accrual.|f||||f||||||||||2017-10-11 02:17:23.115174|2017-10-11 02:17:23.115174
NCT01731522|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-07-14|||December 2012|Actual|2012-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Eating Frequency Study||Active, not recruiting||N/A|20|Anticipated|University of Tennessee||1|||f||||f||||||||||2017-10-11 02:17:23.171211|2017-10-11 02:17:23.171211
NCT01731509|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-12-16|||June 2014||2014-06-01|November 2012|2012-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Early FETO for Severe Congenital Diaphragmatic Hernia|"Early Versus Standard Fetal Endoscopic Tracheal Occlusion for Severe Congenital Diaphragmatic Hernia - a Randomized Controlled Trial"|Unknown status|Not yet recruiting|Phase 2|70|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 02:17:23.23079|2017-10-11 02:17:23.23079
NCT01731496|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-02-05|||April 2012||2012-04-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|ICHAT||The Efficacy of Reminders to Complete HPV Series|Improving Communication and Health for Adolescents With Technology - Implementation of Immunization Strategy|Completed||N/A|749|Actual|University of Rochester||4|||f||||f||||||||||2017-10-11 02:17:23.311082|2017-10-11 02:17:23.311082
NCT01731483|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-20|||July 2012||2012-07-01|November 2012|2012-11-01||||July 2015|Anticipated|2015-07-01||Observational|||Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections|Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections.|Unknown status|Recruiting|N/A|130|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"     tissue specimens from endocarditis lesions and necrotizing fasciitis   "|||2017-10-11 02:17:23.387555|2017-10-11 02:17:23.387555
NCT01731470|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-11-13|2016-05-12||July 2012||2012-07-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)|Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)|Completed||N/A|14|Actual|William Beaumont Hospitals|This was an open-label trial without evaluation of placebo effects.|1|||f||||t||||||||No|No plan to share data|2017-10-11 02:17:23.458275|2017-10-11 02:17:23.458275
NCT00000546|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||March 1994||1994-03-01|October 2005|2005-10-01|May 2005|Actual|2005-05-01|||||Interventional|||Stress Reduction and Atherosclerotic CVD in Blacks||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:03.282249|2017-10-11 04:19:03.282249
NCT01731457|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-05-09|||April 2011||2011-04-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2014|Actual|2014-02-01||Interventional|||Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft Function|Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft Function|Completed||Phase 2|94|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 02:17:23.674912|2017-10-11 02:17:23.674912
NCT01731444|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-11-14|||December 2014||2014-12-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|May 2018|Anticipated|2018-05-01||Interventional|||Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury|Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury - A Randomized Control Trial|Recruiting||Phase 1|24|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-11 02:17:23.759323|2017-10-11 02:17:23.759323
NCT01731431|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-11-14|||January 2012||2012-01-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Interventional|INDAO||Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes|Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes|Active, not recruiting||Phase 3|914|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:17:23.843072|2017-10-11 02:17:23.843072
NCT01731418|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-04-24|||November 2012||2012-11-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||NET in Iranian Women Suffering From Post Traumatic Stress Symptoms|Efficacy of Narrative Exposure Therapy (NET) in a Sample of Iranian Women Exposed to Intimate Partner Violence (IPV)|Completed||N/A|34|Actual|University of Konstanz||2|||f||||t||||||||||2017-10-11 02:17:23.921477|2017-10-11 02:17:23.921477
NCT01731405|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-04-08|||November 2012||2012-11-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|March 2013|Actual|2013-03-01||Observational|||Consumer Understanding and Use of Medication Guides|Consumer Understanding and Use of Medication Guides|Completed||N/A|600|Actual|Northwestern University|||2||f||||t||||||||||2017-10-11 02:17:24.01344|2017-10-11 02:17:24.01344
NCT01731392|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2013-12-11|||November 2012||2012-11-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Children Immune Functions(2)|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Milk-based Formulas on Infections and Immune Functions in Healthy Children|Completed||N/A|604|Actual|Nestlé||3|||f||||f||||||||||2017-10-11 02:17:24.081415|2017-10-11 02:17:24.081415
NCT01731379|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2015-11-02|||December 2012||2012-12-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|January 2014|Actual|2014-01-01||Observational|NerveSpect||Optical Detection of Peripheral Nerve Bundles During Surgery|In Vivo Identification of Peripheral Nerve Bundles During Surgery Using Optical Spectroscopy Techniques - a Pilot Study|Completed||N/A|35|Actual|Philips Healthcare|||1||f||||t||||||||||2017-10-11 02:17:24.271656|2017-10-11 02:17:24.271656
NCT01731366|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-09-01|||August 2012||2012-08-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|February 2014|Actual|2014-02-01||Interventional|3G||The Effect of Whole Grain on Gut Microbiome and Metabolic Health|Gut, Grain and Greens (3G): The Effect of Wholegrain on Gut Microbiome and Metabolic Health|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Copenhagen||2|||f||||t||||||||||2017-10-11 02:17:24.360926|2017-10-11 02:17:24.360926
NCT01731353|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-07-15|||March 2003||2003-03-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|Fungiscope||Fungiscope - A Global Emerging Fungal Infection Registry|Fungiscope - A Global Emerging Fungal Infection Registry|Recruiting||N/A|1000|Anticipated|University of Cologne|||1||f||||f||||||Samples Without DNA|"     -  fixed tissue        -  fungal culture   "|||2017-10-11 02:17:24.480293|2017-10-11 02:17:24.480293
NCT01731340|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-05-01|||June 2012||2012-06-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Study on the Impact of Calcium on Woman's Vascular Health|The Effect of Dietary Calcium Intake as Compared to Calcium Supplementation on Vascular Health and Bone Health in Postmenopausal Women|Recruiting||Phase 4|180|Anticipated|McGill University Health Center||3|||f||||f||||||||No||2017-10-11 02:17:24.559227|2017-10-11 02:17:24.559227
NCT01731327|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-12-20|||November 2012||2012-11-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers|A Phase 1, Randomized, Open-Label, 2-Way Crossover Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of Tofacitinib Following Single Oral Dose Of MR 11 mg Compared To MR 22 mg In Healthy Volunteers|Completed||Phase 1|20|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:17:24.649811|2017-10-11 02:17:24.649811
NCT01731314|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-08-28|||January 2013||2013-01-01|June 2015|2015-06-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Learning and Memory of the Experience of Pain||Active, not recruiting||N/A|60|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 02:17:24.727265|2017-10-11 02:17:24.727265
NCT01731301|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2012-11-20|||January 2013||2013-01-01|November 2012|2012-11-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)|A Pilot Study to Treat Patients With Chronic HCV Genotype 1 and ESRD Receiving Hemodialysis and Naïve to Prior HCV Therapy With Peginterferon Alfa-2b, the Maximally Tolerated Ribavirin Dose and Boceprevir|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|Liver Institute of Virginia||1|||f||||f||||||||||2017-10-11 02:17:24.838082|2017-10-11 02:17:24.838082
NCT01731288|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-05-30|||March 2012||2012-03-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Observational|PRECIOUS||Pregnancy, Childbirth Intentions and Outcomes Under Sexual Pain|Pregnancy, Childbirth Intentions and Outcomes Under Sexual Pain|Completed||N/A|241|Actual|University of British Columbia|||2||f||||f||||||||||2017-10-11 02:17:24.961256|2017-10-11 02:17:24.961256
NCT01731275|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-02-13|||August 2012||2012-08-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects (Study E6011-J081-001)|A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects|Completed||Phase 1|64|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 02:17:25.045018|2017-10-11 02:17:25.045018
NCT01730885|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-02-04|||November 2012||2012-11-01|November 2012|2012-11-01||||January 2014|Actual|2014-01-01||Interventional|||A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 Diabetes||Completed||Phase 4|20|Anticipated|Profil Institut für Stoffwechselforschung GmbH||1|||f||||f||||||||||2017-10-11 02:17:29.103787|2017-10-11 02:17:29.103787
NCT01731262|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-20|||November 2012||2012-11-01|November 2012|2012-11-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Observational|||Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis|Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis|Unknown status|Not yet recruiting|N/A|78|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||2||f||||t||||||||||2017-10-11 02:17:25.127337|2017-10-11 02:17:25.127337
NCT01731249|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-22|||November 2010||2010-11-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis|A Randomised, Double-blind, Placebo-controlled, Multi-national, Phase IIIb Study to Assess the Sustained Clinical Effect and Safety of Sublingual Immunotherapy Administered as Birch Pollen Extract Solution at a Dose of 300 IR Once Daily to Patients Suffering From Birch Pollen-induced Rhinoconjunctivitis|Completed||Phase 3|574|Actual|Stallergenes Greer||2|||f||||t||||||||||2017-10-11 02:17:25.20431|2017-10-11 02:17:25.20431
NCT01731236|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-07-13|||July 2010||2010-07-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CARNIVAL||CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease|CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease|Enrolling by invitation||Early Phase 1|100|Anticipated|The Cleveland Clinic||5|||f||||f||||||||||2017-10-11 02:17:25.337374|2017-10-11 02:17:25.337374
NCT01731223|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-03-07|||August 2010||2010-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|Sleep Prime||Group Treatment for Insomnia in Primary Health Care|Group Treatment for Insomnia in Primary Health Care: a Randomized Controlled Trial|Active, not recruiting||N/A|165|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:17:25.455011|2017-10-11 02:17:25.455011
NCT01731210|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-20|||November 2012||2012-11-01|November 2012|2012-11-01|November 2014|Anticipated|2014-11-01|November 2013|Anticipated|2013-11-01||Interventional|LENEA||Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA)|Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation|Unknown status|Recruiting|Phase 2/Phase 3|128|Anticipated|LivaNova||1|||f||||f||||||||||2017-10-11 02:17:25.542786|2017-10-11 02:17:25.542786
NCT01731197|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-01-28|||November 2012||2012-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|||Satiating Effects of Isolated Soy Proteins|Comparison of the Satiating Effects of Differentially Processed Isolated Soy Proteins|Completed||N/A|40|Actual|Solae, LLC||4|||f||||f||||||||||2017-10-11 02:17:25.611382|2017-10-11 02:17:25.611382
NCT01731184|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2012-11-16|||November 2006||2006-11-01|November 2012|2012-11-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|Morphine-Mida||Morphine-Midazolam in Pre-hospital Traumatic Patients With Severe Acute Pain|Randomized Double-blind Placebo-controlled Trial: Administration of Morphine-Placebo vs. Morphine-Midazolam in Pre-hospital Traumatic Patients With Severe Acute Pain.|Completed||Phase 3|100|Actual|Centre Hospitalier de Cornouaille||2|||f||||f||||||||||2017-10-11 02:17:25.692646|2017-10-11 02:17:25.692646
NCT01731171|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-09-20|||November 2012|Actual|2012-11-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Probiotics to Prevent Relapse After Hospitalization for Mania|A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Mania|Completed||N/A|66|Actual|Sheppard Pratt Health System||2|||f||||t||||||||||2017-10-11 02:17:25.787633|2017-10-11 02:17:25.787633
NCT01731158|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-01-26|||October 2012||2012-10-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|BERAT||Sequential Therapy With Bevacizumab, RAd001 (Everolimus) and Tyrosinekinase Inhibitors (TKI) in Metastatic Renal Cell Carinoma (mRCC)|A Prospective, Open-label, Multicenter, Randomized Phase II Trial: Sequential Therapy With BEvacizumab, RAd001 (Everolimus) and Tyrosinekinase Inhibitors (TKI) in Metastatic Renal Cell Carcinoma (mRCC) (BERAT Study)|Active, not recruiting||Phase 2|100|Anticipated|Central European Society for Anticancer Drug Research||2|||f||||||||||||||2017-10-11 02:17:25.885111|2017-10-11 02:17:25.885111
NCT01731145|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-07-07|||August 2014||2014-08-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|SNUMAP||Assessment of Tremor Using SNUMAP Motion Sensing System|Quantitative Assessment of Tremor Using Portable Six-axis (Tri-axial Accelerometer and Tri-axial Gyroscope) Motion Sensing System|Completed||N/A|187|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 02:17:26.060678|2017-10-11 02:17:26.060678
NCT01731132|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-07-15|||July 2012||2012-07-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Observational|DIUQoL||DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.|DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.|Completed||N/A|207|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:17:26.170746|2017-10-11 02:17:26.170746
NCT01731119|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-05-18|2017-02-23||December 2012||2012-12-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents|An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents|Completed||Phase 2|9|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||No||2017-10-11 02:17:26.28439|2017-10-11 02:17:26.28439
NCT01731106|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-01-24|||June 2012||2012-06-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Cerebral Autoregulation in Non Neurological Critical Patients.|Cerebral Autoregulation in Non Neurological Critical Patients.|Recruiting||N/A|100|Anticipated|Althaia Xarxa Assistencial Universitària de Manresa|||1||f||||t||||||Samples Without DNA|"     Blood sample for biomarkers at admision, 72 hours and 7 days.   "|||2017-10-11 02:17:26.988175|2017-10-11 02:17:26.988175
NCT01730144|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2017-10-05|||November 5, 2012||2012-11-05|August 21, 2017|2017-08-21|October 7, 2013|Actual|2013-10-07|April 17, 2013|Actual|2013-04-17||Observational|||Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults|Elucidation of the Mucosal Immune Responses to Live Attenuated Influenza Vaccine In Healthy Adults|Completed||N/A|10|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:17:42.526011|2017-10-11 02:17:42.526011
NCT01731080|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-20|||January 2012||2012-01-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|Ca-Art-PXE2||Arterial Wall Calcium Load in Pseudoxanthoma Elasticum|Arterial Wall Calcium Load and Preferential Sites in Pseudoxanthoma Elasticum Versus Type 2 Diabetes and Chronic Kidney Disease.|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Angers|||3||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-11 02:17:27.143214|2017-10-11 02:17:27.143214
NCT01731067|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-09-15|||November 2012||2012-11-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|May 2013|Actual|2013-05-01||Interventional|||Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot||Completed||Phase 1|10|Anticipated|University Hospital, Geneva||4|||f||||f||||||||||2017-10-11 02:17:27.21638|2017-10-11 02:17:27.21638
NCT01731054|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2015-04-23|||June 2013||2013-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Functional MRI in Lupus Nephritis|Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis|Completed||N/A|50|Actual|Biogen|||1||f||||f||||||Samples With DNA|"     Blood Samples, Urine samples and Renal biopsy tissue samples.   "|||2017-10-11 02:17:27.294497|2017-10-11 02:17:27.294497
NCT01731041|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2015-05-26|2015-05-06||January 2013||2013-01-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||All patients had experienced an ACS and had a guideline-based indication to be on DAPT with aspirin and ticagrelor|Impact of Ticagrelor Re-load on Pharmacodynamic Profiles|Impact of Ticagrelor Re-load on Pharmacodynamic Profiles in Patients on Maintenance Ticagrelor Therapy|Completed||N/A|60|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 02:17:27.376708|2017-10-11 02:17:27.376708
NCT01731028|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2013-01-31|||January 2013||2013-01-01|January 2013|2013-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®|Non-interventional, Observational Study of the Application of Zomacton® in the Treatment of Growth Hormone Deficiency in Routine Clinical Practice|Withdrawn||N/A|0|Actual|Ferring Pharmaceuticals|||1|Change of local requirements|f||||f||||||||||2017-10-11 02:17:27.703748|2017-10-11 02:17:27.703748
NCT01731015|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-08-20|||January 2012||2012-01-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Imaging Lung Function Using Oxygen Enhanced MRI|A Pilot Study for Evaluation of Regional Lung Function in Normal Subjects and Subjects With Airway and Lung Disorders Using 1H Magnetic Resonance Imaging With Oxygen as a Contrast Agent|Completed||Phase 1|15|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:17:27.767427|2017-10-11 02:17:27.767427
NCT01731002|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-06-03||2014-02-17|November 2012||2012-11-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of Netarsudil (AR-13324) to Latanoprost in Patients With Elevated Intraocular Pressure|A Phase 2 Study Comparing the Safety and Ocular Hypotensive Efficacy of Netarsudil (AR-13324) to Latanoprost in Patients With Elevated Intraocular Pressure|Completed||Phase 2|224|Actual|Aerie Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:17:27.848919|2017-10-11 02:17:27.848919
NCT01730989|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-20|||November 2012||2012-11-01|November 2012|2012-11-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Estromineral Serena Plus and Symptomatic Menopause|Controlled Clinical Study on the Activity of the Combination of Isoflavones, Agnocastus and Magnolia Extract in Menopause|Unknown status|Not yet recruiting|N/A|300|Anticipated|Rottapharm||2|||f||||f||||||||||2017-10-11 02:17:28.093999|2017-10-11 02:17:28.093999
NCT01730976|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-09-08|||November 2012||2012-11-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Asthma in the Elderly: The Role of Vitamin D|Asthma in the Elderly: The Role of Vitamin D|Completed||Phase 3|30|Actual|Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.||1|||f||||f||||||||||2017-10-11 02:17:28.216201|2017-10-11 02:17:28.216201
NCT01730963|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-20|||January 2007||2007-01-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Observational|||Multi-Reader Multi-Case Study to Identify Uterine Contractions Recorded From Laboring and Nonlaboring Patients by Practicing Clinicians|Multi-Reader Multi-Case Study to Identify Uterine Contractions Recorded From Laboring and Nonlaboring Patients by Practicing Clinicians|Completed||N/A|30|Actual|Reproductive Research Technologies, LP|||3||f||||f||||||||||2017-10-11 02:17:28.312232|2017-10-11 02:17:28.312232
NCT01730950|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-10-11|||December 2012||2012-12-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma|RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VERSUS BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA|Active, not recruiting||Phase 2|182|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 02:17:28.403204|2017-10-11 02:17:28.403204
NCT01730937|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-10-11|||April 2013||2013-04-01|October 2016|2016-10-01||||June 2020|Anticipated|2020-06-01||Interventional|||Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer|Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma|Recruiting||Phase 3|368|Anticipated|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 02:17:28.594083|2017-10-11 02:17:28.594083
NCT01730924|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-09-28|||December 2012||2012-12-01|September 2016|2016-09-01||||December 2014|Actual|2014-12-01||Interventional|||Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data|A Randomised Study Comparing Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data. The SMART Trial|Completed||N/A|120|Anticipated|Queen Mary University of London||2|||f||||||||||||||2017-10-11 02:17:28.83524|2017-10-11 02:17:28.83524
NCT01730911|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-09-22|||August 2012||2012-08-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Quick Start Insertion of Mirena and ParaGard|Quick Start Insertion of Mirena and ParaGard Intrauterine Contraceptive Devices|Completed||N/A|230|Actual|Columbia University||4|||f||||f||||||||||2017-10-11 02:17:28.918722|2017-10-11 02:17:28.918722
NCT01730898|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2013-07-02|||November 2012||2012-11-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Lutein Absorption in Healthy Adults|Lutein Absorption in Healthy Adults|Completed||Phase 3|24|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-11 02:17:29.029419|2017-10-11 02:17:29.029419
NCT01730872|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2013-05-14|||November 2012||2012-11-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model|A Single-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of Prednisolone Sodium Phosphate Ophthalmic Solution, 1% Compared to Placebo in a Modified Conjunctival Allergen Challenge (CAC) Model|Completed||Phase 4|16|Actual|ORA, Inc.||2|||f||||f||||||||||2017-10-11 02:17:29.187305|2017-10-11 02:17:29.187305
NCT01730859|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-10|2012-11-21|||February 2011||2011-02-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||The Effect of Ankle Taping and Balance Exercises on Postural Stability|The Effect of Ankle Taping and Balance Exercises on Postural Stability Indices in Healthy Women|Completed||N/A|30|Actual|Zahedan University of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:17:30.767722|2017-10-11 02:17:30.767722
NCT01730846|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2016-11-22|||February 2013||2013-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?|Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?|Active, not recruiting||Phase 2|60|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 02:17:30.870226|2017-10-11 02:17:30.870226
NCT01730833|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-09-08|||July 17, 2013|Actual|2013-07-17|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer|Phase II Prospective Open Label Study of Pertuzumab, Trastuzumab, and Nab-Paclitaxel in Patients With HER-2 Positive Advanced Breast Cancer|Recruiting||Phase 2|65|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 02:17:30.985934|2017-10-11 02:17:30.985934
NCT01730820|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2014-09-12|||November 2012||2012-11-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Influence of Preload Dependence on the Effect of Phenylephrine on Cardiac Output|Influence of Preload Dependence on the Effect of Phenylephrine on Cardiac Output|Completed||N/A|50|Anticipated|University Hospital, Caen|||1||f||||t||||||||||2017-10-11 02:17:31.11595|2017-10-11 02:17:31.11595
NCT01730807|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-16|2017-05-02|||March 2013||2013-03-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional|MiFi-CTI||IntellaTip MiFi XP Ablation Catheter Trial|IntellaTip MiFi XP Ablation Catheters First in Human Use Trial|Completed||N/A|10|Actual|Boston Scientific Corporation||1|||f||||f|f|f||||||||2017-10-11 02:17:31.187396|2017-10-11 02:17:31.187396
NCT01730794|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-09-18|||March 2014||2014-03-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Neurally Adjusted Ventilatory Assist (NAVA) Study in Adults With Acute Respiratory Failure|A Comparative, Multicenter, Randomized, Controlled Study of Neurally Adjusted Ventilatory Assist (NAVA) vs. Conventional Lung Protective Ventilation in Patients With Acute Respiratory Failure|Recruiting||N/A|306|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:17:31.296184|2017-10-11 02:17:31.296184
NCT01730781|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-06-21|||July 2010||2010-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning|Characterization of CB1 Receptors Using [11-C]OMAR|Recruiting||N/A|100|Anticipated|Yale University|||5||f||||t||||||Samples With DNA|"     At the screening visit, genomic DNA will be extracted from whole blood, assigned a code, and     stored for analysis of group differences in the frequency of CB1R alleles and to examine the     relationship between allelic variation at the CB1R locus and [11-C] OMAR binding. In     addition, other genes or markers that may be related to brain function or to behavior may be     studied.   "|||2017-10-11 02:17:31.405146|2017-10-11 02:17:31.405146
NCT01730768|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-03-24|||September 2012||2012-09-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients|A 12 Week, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients|Completed||Phase 2|147|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:17:31.504892|2017-10-11 02:17:31.504892
NCT01730755|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-01-06||||||January 2016|2016-01-01||||||||Expanded Access|||Ruxolitinib for Chuvash Polycythemia|Ruxolitinib for Chuvash Polycythemia|Available||N/A|||Washington University School of Medicine|||||f||||||||||||||2017-10-11 02:17:31.656575|2017-10-11 02:17:31.656575
NCT01730742|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2012-11-15|||February 2012||2012-02-01|November 2012|2012-11-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|SS||Sleep Deprivation's Regulation of Immune System Function and Behavior|The Role of Sleep Deprivation in the Regulation of Immune System, Neuroendocrine Responses, and Behavioral Measures.|Unknown status|Active, not recruiting|N/A|18|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 02:17:31.869964|2017-10-11 02:17:31.869964
NCT01730729|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-12-13|||November 2012||2012-11-01|December 2016|2016-12-01||||October 2018|Anticipated|2018-10-01||Interventional|||Cabergoline in Metastatic Breast Cancer|A Pilot Phase II Trial of Cabergoline in the Treatment of Metastatic Breast Cancer|Active, not recruiting||Early Phase 1|20|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 02:17:31.987121|2017-10-11 02:17:31.987121
NCT01730716|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2015-04-16|||May 2013||2013-05-01|May 2013|2013-05-01|November 2016|Anticipated|2016-11-01|December 2015|Anticipated|2015-12-01||Interventional|||Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis|A Phase II, Open-label, Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis|Unknown status|Active, not recruiting|Phase 2|18|Anticipated|Neuralstem Inc.||1|||f||||t||||||||||2017-10-11 02:17:32.139447|2017-10-11 02:17:32.139447
NCT01730703|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-04-07|||February 2013|Actual|2013-02-01|April 2017|2017-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Why Join a Walking Program?|Why Join a Walking Program?|Completed||N/A|132|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 02:17:32.246969|2017-10-11 02:17:32.246969
NCT01730690|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-07-03|||March 2013||2013-03-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|COMBAT||Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae|Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae|Completed||N/A|527|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 02:17:32.309269|2017-10-11 02:17:32.309269
NCT01730677|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2014-03-11|||July 2012||2012-07-01|March 2014|2014-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LV||Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab|Randomized Phase II Study of Lapatinib Plus Vinorelbine Versus Vinorelbine in Patients With HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib and Trastuzumab Treatment|Recruiting||Phase 2|150|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 02:17:32.416044|2017-10-11 02:17:32.416044
NCT01730664|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-08-24|||January 26, 2017|Actual|2017-01-26|August 2017|2017-08-01|July 13, 2017|Actual|2017-07-13|July 13, 2017|Actual|2017-07-13||Interventional|||PK/PD of Ertapenem In Patients With TB|Pharmacokinetics and Pharmacodynamics of Ertapenem in Patients With Tuberculosis|Completed||Phase 2|12|Actual|University Medical Center Groningen||1|||f||||f|f|f|||f|||||2017-10-11 02:17:32.583153|2017-10-11 02:17:32.583153
NCT01730651|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-09-17|||July 2012||2012-07-01|September 2017|2017-09-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Interventional|||High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.|A Phase II Study of High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies at Initial Diagnosis.|Recruiting||N/A|55|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-11 02:17:32.718863|2017-10-11 02:17:32.718863
NCT01730638|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-01-17|||January 2013||2013-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|iTEP-CMT||ImmunoTEP for Patients With Medullary Thyroid Carcinoma.|Pharmacokinetic and Imaging Optimization Study of Pretargeted Immuno-PET Using the Anti-CEA x Anti-HSG TF2 Bispecific Antibody and 68Ga-IMP-288 Peptide in Patients With Recurrences of Medullary Thyroid Carcinoma.|Completed||Phase 1/Phase 2|25|Actual|Nantes University Hospital|||||f||||t||||||||||2017-10-11 02:17:32.849963|2017-10-11 02:17:32.849963
NCT01730625|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-11-15|||October 2010||2010-10-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Augmenting Effects of ABMT on CBT in Anxious Children: A Randomized Clinical Trial|Augmenting Effects of Attention Bias Modification Treatment on Cognitive Behavioral Therapy in Anxious Children: A Randomized Clinical Trial|Completed||N/A|119|Actual|Tel Aviv University||3|||f||||f||||||||||2017-10-11 02:17:33.002503|2017-10-11 02:17:33.002503
NCT01730612|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-01-17|||December 2012||2012-12-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|iTEPsein||ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA|Pilot Study for Optimization of Immuno-PET Pretargeted With Anti-CEA Bispecific Antibody X Anti-HSG TF2 and the Peptide IMP-288 Radiolabeled With Gallium-68 -Pharmacokinetic and Imaging for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA|Active, not recruiting||Phase 1/Phase 2|23|Actual|Nantes University Hospital|||||f||||t||||||||||2017-10-11 02:17:33.123349|2017-10-11 02:17:33.123349
NCT01730599|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-11-15|||November 2012||2012-11-01|November 2012|2012-11-01||||June 2015|Anticipated|2015-06-01||Observational|||A Longitudinal Study in Parkinson's Disease (PD) Patients|A Longitudinal 5 Years Follow up Study in Parkinson's Disease (PD) Patients Carriers of the LRRK2 Gene G2019S Mutation|Unknown status|Not yet recruiting|N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 02:17:33.213403|2017-10-11 02:17:33.213403
NCT01730586|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2016-08-12|||November 2012||2012-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas|Phase II Study of Abraxane in CIMP-High Colorectal Adenocarcinomas and Small Bowel Adenocarcinomas|Completed||Phase 2|34|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:17:33.298449|2017-10-11 02:17:33.298449
NCT01730560|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-12-23|||November 2010||2010-11-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|VISIOTRAIN||Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach|Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach|Recruiting||Phase 2|22|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:17:33.491346|2017-10-11 02:17:33.491346
NCT01730547|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-01-14|||February 2013||2013-02-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Mesenchymal Stem Cells for Multiple Sclerosis|Phase 1/2 Clinical Trial With Autologous Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:17:33.605044|2017-10-11 02:17:33.605044
NCT01730534|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-09-15|||April 25, 2013|Actual|2013-04-25|September 2017|2017-09-01|April 29, 2019|Anticipated|2019-04-29|April 29, 2019|Anticipated|2019-04-29||Interventional|DECLARE-TIMI58||Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events|Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes|Active, not recruiting||Phase 3|17276|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 02:17:33.886759|2017-10-11 02:17:33.886759
NCT01730521|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-09-12|||October 2012||2012-10-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Observational|||The Effect of a Short Term Exercise Schedule on Oral Iron Bio-availability and Iron Incorporation|The Effect of a Short Term Exercise Schedule on Oral Iron Bio-availability and Iron Incorporation|Completed||N/A|10|Actual|Swiss Federal Institute of Technology|||1||f||||f||||||Samples With DNA|"     Whole blood and serum samples   "|||2017-10-11 02:17:35.887213|2017-10-11 02:17:35.887213
NCT01730508|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-07-13|||November 20, 2012|Actual|2012-11-20|July 2017|2017-07-01|June 25, 2017|Actual|2017-06-25|June 25, 2017|Actual|2017-06-25||Observational|||An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B|A MULTICENTER, PROSPECTIVE, OBSERVATIONAL, NON-INTERVENTIONAL COHORT STUDY IN CHINESE SUBJECTS WITH HBeAg NEGATIVE CHRONIC HEPATITIS B (CHB) RECEIVING THERAPY WITH PEGINTERFERON ALFA|Completed||N/A|978|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:17:35.965935|2017-10-11 02:17:35.965935
NCT01730495|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2015-11-30|||October 2012||2012-10-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome|Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Moderate and Serious Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (CFS/ME), Including in Patients With no Clinical Response After B-lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab.|Terminated||Phase 2|4|Actual|Haukeland University Hospital||1||After inclusion of four patients, two experienced moderate worsening of symptoms|f||||f||||||||||2017-10-11 02:17:36.347259|2017-10-11 02:17:36.347259
NCT01730482|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2013-12-17|||August 2011||2011-08-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014)|A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C] AT1001 (Migalastat Hydrochloride) Following a Single Oral Administration in Healthy Volunteers (AT1001-014)|Completed||Phase 1|6|Actual|Amicus Therapeutics||1|||f||||f||||||||||2017-10-11 02:17:36.947694|2017-10-11 02:17:36.947694
NCT01730469|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-08-02|||August 2011||2011-08-01|August 2017|2017-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function|An Open-Label Study to Determine the Safety and Pharmacokinetics of AT1001 in Subjects With Impaired Renal Function and Healthy Subjects With Normal Renal Function (AT1001-015)|Completed||Phase 1|32|Actual|Amicus Therapeutics||1|||f||||f||||||||||2017-10-11 02:17:37.04014|2017-10-11 02:17:37.04014
NCT01730456|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-11-01|||October 2012||2012-10-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926|A MULTICENTER, OPEN-LABEL, SINGLE ARM, LONG TERM EXTENSION STUDY OF WA19926 TO DESCRIBE SAFETY DURING TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH EARLY, MODERATE TO SEVERE RHEUMATOID ARTHRITIS|Completed||Phase 3|13|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:17:37.164696|2017-10-11 02:17:37.164696
NCT01730443|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-12-02|||July 2011||2011-07-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Observational|BIO-ProTECT||Blood Biomarkers of Injury and Outcome in Traumatic Brain Injury|Biomarkers of Injury and Outcome in ProTECT III (BIO-ProTECT)|Terminated||N/A|576|Actual|Emory University|||2|Parent trial (ProTECT III) stopped for futility|f||||t||||||Samples Without DNA|"     with consent there will be long term storage of serum for Non-DNA testing   "|||2017-10-11 02:17:37.248931|2017-10-11 02:17:37.248931
NCT01730430|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-04-18|||July 2012||2012-07-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias|Investigation of Biomarkers of Disease State in Alzheimer's Disease and Non-AD Dementias|Completed||N/A|40|Actual|Duke University|||1||f||||f||||||Samples With DNA|"     Blood, urine and cerebral spinal fluid.   "|||2017-10-11 02:17:37.411094|2017-10-11 02:17:37.411094
NCT01730417|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2012-11-20|||November 2009||2009-11-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|mIBG||Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG|Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG-Nanodosing: the Path to Higher Sensitivity and Lower Toxicity Radiopharmaceuticals|Completed||Phase 1|12|Actual|Duke University||1|||f||||f||||||||||2017-10-11 02:17:37.496966|2017-10-11 02:17:37.496966
NCT01730404|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-03-28|||October 2012||2012-10-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients|A Randomised, Double-blind, Double-dummy, Placebo and Active-controlled, Three-way Crossover Study to Evaluate the Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI (1200 µg Daily) in Subjects With COPD|Completed||Phase 2|55|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||||2017-10-11 02:17:37.582506|2017-10-11 02:17:37.582506
NCT01730391|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-11-09|||January 2013||2013-01-01|November 2015|2015-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Neisseria Meningitidis Burden of Disease Study|Neisseria Meningitidis Burden of Disease|Completed||N/A|521|Actual|GlaxoSmithKline|||1||f||||||||||Samples Without DNA|"     Cerebrospinal Fluid (CSF) sample (collected as part of routine practice)   "|||2017-10-11 02:17:37.782997|2017-10-11 02:17:37.782997
NCT01730378|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2016-05-19|2014-12-15||December 2012||2012-12-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old|Immunogenicity and Safety of GlaxoSmithKline Biologicals' (Pre-) Pandemic Influenza Vaccine Prepandrix™ in Korean Subjects Aged 18 to 60 Years Old|Completed||Phase 4|131|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:17:37.919534|2017-10-11 02:17:37.919534
NCT01730365|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-04-08|||October 2012||2012-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Optical Detection of Malignancy During Percutaneous Interventions|Discrimination of Benign and Malignant Human Tissue During Percutaneous Interventions Using Optical Spectroscopy Techniques|Completed||N/A|104|Actual|Philips Healthcare|||1||f||||t||||||Samples Without DNA|"     Biopsies are taken from the enrolled patients and these biopsies are send to the pathology     department for histopathological analysis.   "|||2017-10-11 02:17:38.837816|2017-10-11 02:17:38.837816
NCT01730352|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-20|||October 2008||2008-10-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|May 2011|Actual|2011-05-01||Interventional|||Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients|Helicobacter Pylori Infection and Chronic Immune Thrombocytopenic Purpura in Children and Adolescents - A Randomized Controlled Trial|Completed||Phase 2/Phase 3|100|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 02:17:38.944426|2017-10-11 02:17:38.944426
NCT01730339|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-01-19|2015-10-14||December 2012||2012-12-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Modified Intent To Treat (mITT) population included all participants who were randomized and received at least 1 dose of investigational product.|Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery|A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring|Completed||Phase 2|103|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:17:39.124419|2017-10-11 02:17:39.124419
NCT00000547|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||April 1994||1994-04-01|December 2005|2005-12-01|February 2001|Actual|2001-02-01|||||Interventional|||Enalapril After Anthracycline Cardiotoxicity||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:03.362674|2017-10-11 04:19:03.362674
NCT01730326|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-15|||March 2012||2012-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|||Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack|The Comparison of the Effectiveness of Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack in Emergency Service|Completed||Phase 4|200|Actual|Pamukkale University||2|||f||||t||||||||||2017-10-11 02:17:40.847166|2017-10-11 02:17:40.847166
NCT01730313|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-11-20|||February 2013||2013-02-01|November 2012|2012-11-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda — 2012|Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda — 2012|Unknown status|Not yet recruiting|Phase 2|80|Anticipated|Centers for Disease Control and Prevention||4|||f||||t||||||||||2017-10-11 02:17:40.93465|2017-10-11 02:17:40.93465
NCT01730300|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2013-05-14|||June 2012||2012-06-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Observational|||Genitourinary Symptoms With Levonorgestrel Releasing Intrauterine Systems|Genitourinary Symptoms in Women Using Levonorgestrel Releasing Intrauterine Systems|Completed||N/A|60|Actual|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|||1||f||||t||||||||||2017-10-11 02:17:41.054483|2017-10-11 02:17:41.054483
NCT01730287|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-20|||May 2010||2010-05-01|November 2012|2012-11-01|May 2013|Anticipated|2013-05-01|December 2012|Anticipated|2012-12-01||Interventional|||Effect Of Different Lining Materials in Stepwise Excavation|Effect Of Different Lining Materials on Clinical Symptoms of Stepwise Excavation Without Re-enter: Double Blind Randomizd Clinical Trial|Unknown status|Recruiting|Phase 2|100|Anticipated|Azad University of Medical Sciences||4|||f||||t||||||||||2017-10-11 02:17:41.127029|2017-10-11 02:17:41.127029
NCT01730274|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-20|||January 2013||2013-01-01|November 2012|2012-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Cerebellum - Cognitive Outcome and Functional Connectivity|Cerebellar Tumors of Childhood - Impact on Cognition and Functional Connectivity|Unknown status|Not yet recruiting|N/A|40|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 02:17:41.242313|2017-10-11 02:17:41.242313
NCT01730261|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-10-01|||November 2012||2012-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Online Emotional Regulation Group Treatment|Online Emotional Regulation Group Treatment for Individuals With Traumatic Brain Injury (TBI)|Completed||Phase 1|147|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-11 02:17:41.393802|2017-10-11 02:17:41.393802
NCT01730248|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-07-17|||December 18, 2012|Actual|2012-12-18|July 2017|2017-07-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis|A Phase Ib, Open-label, Multi-center, Two-arm, Dose-finding Study to Assess Safety and Efficacy of the Oral Combination or INC424 (INC424) and BKM120 in Patients With Primary Myelofibrosis (PMF), Postpolycythemia Vera-myelofibrosis (PPV-MF), or Post-essential Thrombocythemia-myelofibrosis (PET-MF)|Active, not recruiting||Phase 1|63|Actual|Novartis||2|||f||||f|f|f||||||||2017-10-11 02:17:41.519587|2017-10-11 02:17:41.519587
NCT01730235|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2012-11-14|||May 2012||2012-05-01|November 2012|2012-11-01||||October 2012|Actual|2012-10-01||Observational|mymedihealth||My MediHealth: A Paradigm for Children-centered Medication Management|My MediHealth: A Paradigm for Children-centered Medication Management|Completed||N/A|115|Actual|Vanderbilt University|||2||f||||f||||||||||2017-10-11 02:17:41.689308|2017-10-11 02:17:41.689308
NCT01730222|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2017-08-31|||November 2012||2012-11-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|February 2017|Actual|2017-02-01||Interventional|PACT-19||A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma|A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma|Completed||Phase 1/Phase 2|137|Actual|IRCCS San Raffaele||2|||f||||f||||||||||2017-10-11 02:17:41.779891|2017-10-11 02:17:41.779891
NCT01730209|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-05-04|||November 2012||2012-11-01|May 2015|2015-05-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|RAPIT||Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex|Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 02:17:41.930062|2017-10-11 02:17:41.930062
NCT01730196|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-04-08|||September 2009||2009-09-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Interventional|||Lifestyle Change to Prevent Diabetes Via African-American Churches|Fit Body and Soul: A Lifestyle Intervention for Diabetes Prevention Conducted Through African American Churches|Completed||N/A|604|Actual|Augusta University||2|||f||||t||||||||||2017-10-11 02:17:42.106337|2017-10-11 02:17:42.106337
NCT01730183|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2012-11-15|||November 2012||2012-11-01|November 2012|2012-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|ABSCI||To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury|To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury (SCI)|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Max Institute of Neurosciences||1|||f||||f||||||||||2017-10-11 02:17:42.211087|2017-10-11 02:17:42.211087
NCT01730170|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-05-24|||January 2013||2013-01-01|May 2017|2017-05-01|August 2023|Anticipated|2023-08-01|August 2017|Anticipated|2017-08-01||Observational|MONEAD||Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure|Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs|Active, not recruiting||N/A|565|Actual|Emory University|||3||f||||f||||||Samples With DNA|"     Serum, cheek cells, urine   "|||2017-10-11 02:17:42.299349|2017-10-11 02:17:42.299349
NCT01730157|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-03-09|||December 2012||2012-12-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases|Pilot Study of Sequential Hepatic Radioembolization and Systemic Ipilimumab in Patients With Uveal Melanoma Metastatic to Liver|Terminated||Early Phase 1|6|Actual|Case Comprehensive Cancer Center||1||Research Cancelled|f||||t||||||||||2017-10-11 02:17:42.41742|2017-10-11 02:17:42.41742
NCT01729026|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-04-26|2016-02-23||October 2013||2013-10-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|VITAL||A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD)|A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder|Completed||Early Phase 1|19|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 02:18:03.752634|2017-10-11 02:18:03.752634
NCT01730131|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2017-09-22|||November 5, 2012||2012-11-05|September 21, 2017|2017-09-21|December 31, 2021|Anticipated|2021-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)|Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:17:42.608984|2017-10-11 02:17:42.608984
NCT01730118|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2017-10-05|||November 5, 2012||2012-11-05|September 5, 2017|2017-09-05|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing|A Phase I Study of an Adenoviral Transduced Autologous Dendritic Cell Vaccine Expressing Human HER2/Neu ECTM in Adults With Tumors With 1-3+ HER2/Neu Expression|Recruiting||Phase 1|65|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 02:17:42.720098|2017-10-11 02:17:42.720098
NCT01730105|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2017-10-05|||October 11, 2012||2012-10-11|May 15, 2017|2017-05-15|June 24, 2014|Actual|2014-06-24|June 24, 2014|Actual|2014-06-24||Observational|||Chronic Cold Exposure and Energy Metabolism in Humans|Impact of Chronic Cold Exposure on Energy Metabolism in Humans|Completed||N/A|7|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:17:42.808541|2017-10-11 02:17:42.808541
NCT01730092|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2017-09-21|||October 13, 2012||2012-10-13|September 13, 2017|2017-09-13|August 31, 2022|Anticipated|2022-08-31|August 31, 2022|Anticipated|2022-08-31||Observational|||Natural History Study of Biomarkers in Pulmonary Arterial Hypertension|A Natural History Study of Novel Biomarkers in Pulmonary Arterial Hypertension|Recruiting||N/A|270|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:17:42.872701|2017-10-11 02:17:42.872701
NCT01730079|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2017-06-30|||October 23, 2012||2012-10-23|April 11, 2017|2017-04-11|April 11, 2017|Actual|2017-04-11|April 11, 2017|Actual|2017-04-11||Observational|||Near Infrared Spectroscopy in Children With Autism and ADHD|Near Infra-Red Spectroscopy (NIRS) in Neurodevelopmental Disorders and Typically Developing Children|Terminated||N/A|42|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:17:42.963548|2017-10-11 02:17:42.963548
NCT01730066|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-10-03|||October 2012||2012-10-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Probiotics Against Pathogenic Bacteria in Advanced ENT-Surgery|Probiotics for Reduction of Pathogenic Bacteria in Connection With Advanced Surgery in the Mouth, the Oropharynx, and on the Neck|Recruiting||N/A|102|Anticipated|Region Skane||2|||f||||f||||||||||2017-10-11 02:17:43.043714|2017-10-11 02:17:43.043714
NCT01730053|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-09-29|2015-07-29|2015-01-24|November 2012||2012-11-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)|A Randomized, Double-Blind Study of the Efficacy and Safety of REGN727 Added-on to Rosuvastatin Versus Ezetimibe Added-on to Rosuvastatin Versus Rosuvastatin Dose Increase in Patients Who Are Not Controlled on Rosuvastatin|Completed||Phase 3|305|Actual|Regeneron Pharmaceuticals||6|||f||||t||||||||||2017-10-11 02:17:43.248392|2017-10-11 02:17:43.248392
NCT01730040|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-07-29|2015-07-29|2015-01-24|October 2012||2012-10-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)|A Randomized, Double-Blind Study of the Efficacy and Safety of Alirocumab Added on to Atorvastatin Versus Ezetimibe Added on to Atorvastatin Versus Atorvastatin Dose Increase Versus Switch to Rosuvastatin in Patients Who Are Not Controlled on Atorvastatin|Completed||Phase 3|355|Actual|Regeneron Pharmaceuticals||7|||f||||t||||||||||2017-10-11 02:17:45.580272|2017-10-11 02:17:45.580272
NCT01730027|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-10-02||2017-09-20|April 2013||2013-04-01|October 2017|2017-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma|A Randomised, Double Blind, Placebo-Controlled, Multi-Centre, Parallel Group Study to Evaluate the Efficacy and Safety of ADC3680 Administered Once Daily as an Add-On Therapy to Inhaled Corticosteroids and When Co-Administered With Montelukast in Subjects With Inadequately-Controlled Asthma.|Completed||Phase 2|248|Actual|Pulmagen Therapeutics||3|||f||||f||||||||||2017-10-11 02:17:48.601514|2017-10-11 02:17:48.601514
NCT01730014|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2013-07-30|||October 2012||2012-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes|A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0148-0000-0287 in Healthy Subjects and in Subjects With Type 1 Diabetes|Completed||Phase 1|70|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 02:17:48.990941|2017-10-11 02:17:48.990941
NCT01730001|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-10|2017-09-18|||January 1, 2015|Anticipated|2015-01-01|September 2017|2017-09-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|ELITE||Early Versus Late Intubation Trial in Physician Manned Emergency Medical Services|A Prospective Randomized Controlled Trial Comparing Competent EARLY-intubation to LATE-intubation in Patients With Prehospital GCS < 9 and Short Transport Time to Hospital.|Withdrawn||N/A|0|Actual|Norwegian Air Ambulance Foundation||2||Withdrawn, no patients included|f||||t||||||||||2017-10-11 02:17:49.075684|2017-10-11 02:17:49.075684
NCT01729988|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-10-14|||November 2012||2012-11-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Carotid Body Removal for the Treatment of Resistant Hypertension: a Pilot Study|Carotid Body Removal for the Treatment of Resistant Hypertension: a Pilot Study|Completed||N/A|11|Actual|Noblewell||1|||f||||t||||||||||2017-10-11 02:17:49.163338|2017-10-11 02:17:49.163338
NCT01729975|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2012-11-19|||October 2012||2012-10-01|November 2012|2012-11-01||||October 2012|Actual|2012-10-01||Observational|||Comparative Study of Specular Microscope for Cell Density, Coefficient of Variation, Hexagonality and Corneal Thickness|Comparative Study of Specular Microscopes for the Measurement of Endothelial Cell Densities, Coefficient of Variation of Endothelial Cell Area, ％Hexagonality, and Central Corneal Thickness|Completed||N/A|80|Actual|Nidek Co. LTD.|||3||f||||||||||||||2017-10-11 02:17:49.227916|2017-10-11 02:17:49.227916
NCT01729962|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-06-26|||December 2012||2012-12-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Observational|||Comparative Study of the Optical Biometer for Measurements of the Eye|Comparative Study of the Optical Biometer for the Measurements of Axial Length, Anterior Chamber Depth, Keratometry, Corneal Cylinder Axis, Corneal Thickness, White-to-White Distance, and Pupil Diameter|Completed||N/A|125|Actual|Nidek Co. LTD.|||2||f||||f||||||||||2017-10-11 02:17:49.284149|2017-10-11 02:17:49.284149
NCT01729949|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-02-06|||December 2012||2012-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Acute and Chronic Effects of Fruit Polyphenols on Chronic Disease (PPF)|A Randomized Placebo Controlled Trial to Test the Acute and Chronic Effects of Fruit Polyphenols on Postprandial Indices of Chronic Disease (PPF)|Active, not recruiting||N/A|30|Anticipated|Institute for Food Safety and Health, United States||2|||f||||f||||||||||2017-10-11 02:17:49.347717|2017-10-11 02:17:49.347717
NCT01729936|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-02-07|||June 2012||2012-06-01|February 2014|2014-02-01|December 2016|Anticipated|2016-12-01|February 2014|Anticipated|2014-02-01||Interventional|SedestActiv||SedestActiv Project: Intervention to Reduce Diary Hours of Sitting Time in Overweight and Obese Patients|Effectiveness of an Intervention to Reduce Diary Hours of Sitting Time in Overweight and Obese Patients (SEDESACTIV):Simple Randomized Controlled Trial|Unknown status|Recruiting|N/A|450|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-10-11 02:17:49.424711|2017-10-11 02:17:49.424711
NCT01729910|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-11-23|||September 2009||2009-09-01|November 2015|2015-11-01|March 2011|Actual|2011-03-01|November 2010|Actual|2010-11-01||Interventional|||Primary Care Child Obesity Intervention Targeting Parents|Primary Care Child Obesity Intervention Targeting Parents|Completed||N/A|67|Actual|East Tennessee State University||2|||f||||f||||||||||2017-10-11 02:17:49.638768|2017-10-11 02:17:49.638768
NCT01729884|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-04-09||2017-04-03|December 2012||2012-12-01|April 2017|2017-04-01||||June 2013|Actual|2013-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer|Phase II Study to Evaluate the Development of HER2/Neu (HER2)-Specific Memory T Cells After HER2 Peptide-based Vaccination in Patients With Advanced Stage Her2+ Breast Cancer|Terminated||Phase 2|3|Actual|University of Washington||1||Study ended early due to slow enrollment|f||||f||||||||||2017-10-11 02:17:49.776282|2017-10-11 02:17:49.776282
NCT01729871|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-01-23|2015-10-09||February 2013||2013-02-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|VENTURE-AF||A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy|A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation|Completed||Phase 3|253|Actual|Janssen Scientific Affairs, LLC||2|||f||||f||||||||||2017-10-11 02:17:49.869174|2017-10-11 02:17:49.869174
NCT01729858|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-08-16|||December 2008|Actual|2008-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|||Survival of Implant-Supported All-Ceramic Prostheses|Factors Influencing the Survival of Implant-Supported All-Ceramic Prostheses|Active, not recruiting||N/A|150|Actual|University of Florida|||2||f||||f||||||||||2017-10-11 02:17:52.160169|2017-10-11 02:17:52.160169
NCT01729832|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-04-12|||January 10, 2011|Actual|2011-01-10|April 2017|2017-04-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer|Intraoperative Stereotactic Image-guided Navigation of Perforators for DIEP Flap Breast Reconstruction.|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:17:52.352962|2017-10-11 02:17:52.352962
NCT01729819|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-12-17||2015-11-02|January 2013||2013-01-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women|A Multi-centre, Double-blind, Randomised Trial Investigating the Efficacy and Safety of a Combination Therapy, Desmopressin and Tolterodine, for Treatment of Overactive Bladder With Nocturia in Women|Completed||Phase 2|106|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:17:52.427628|2017-10-11 02:17:52.427628
NCT01729806|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-09-12|||November 19, 2012|Actual|2012-11-19|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma|A Phase I Study of Ipilimumab in Combination With Rituximab in Patients With Relapsed/Refractory CD20+ B-Cell Lymphoma|Active, not recruiting||Phase 1|38|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 02:17:52.536953|2017-10-11 02:17:52.536953
NCT01729793|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-26|||November 2012||2012-11-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Study to Investigate the Efficacy of Digestive Enzymes on Inflammation After a Meal|A Randomized, Double-Blind, Placebo Controlled, Cross-Over Study to Investigate the Efficacy of Digestive Enzymes on Inflammation After a Meal|Unknown status|Enrolling by invitation|N/A|30|Anticipated|National Enzyme Company||2|||f||||t||||||||||2017-10-11 02:17:52.643046|2017-10-11 02:17:52.643046
NCT01729780|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-19|||December 2012||2012-12-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Early EEG-NF Intervention for the Prevention of PTSD|Early EEG-NF Intervention for the Prevention of PTSD in First Time ACS Patients|Unknown status|Not yet recruiting|N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 02:17:52.812712|2017-10-11 02:17:52.812712
NCT01729767|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-19|||August 2011||2011-08-01|November 2012|2012-11-01||||December 2012|Anticipated|2012-12-01||Interventional|||Efficacy of Antiviral Medications in Controlling Vertigo Attacks of Patients With Meniere's Disease|Assessment of Acyclovir Efficacy Versus Placebo in Controlling Vertigo Attacks of Patients With Meniere's Disease Visited in Amiralam Hospital|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|Tehran University of Medical Sciences||2|||f||||||||||||||2017-10-11 02:17:52.904152|2017-10-11 02:17:52.904152
NCT01729754|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-11-09|||February 2013||2013-02-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)|A 52-Week, Phase 3, Randomized, Active Comparator and Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222), Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis (Protocol No. MK-3222-011)|Active, not recruiting||Phase 3|1090|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-10-11 02:17:52.991626|2017-10-11 02:17:52.991626
NCT01729741|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-19|||December 2010||2010-12-01|December 2010|2010-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Drain or no Drain After Thyroid Surgery: a Randomized Clinical Trial at Mulago Hospital|Drain or no Drain After Thyroid Surgery: a Randomized Clinical Trial at Mulago Hospital|Completed||N/A|68|Actual|Makerere University||2|||f||||t||||||||||2017-10-11 02:17:53.091675|2017-10-11 02:17:53.091675
NCT01729728|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2015-07-16|2014-09-09||November 2012||2012-11-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Number of participants that were dosed.|Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain|Open-label Evaluation of the Pharmacokinetic Profile, Safety, and Efficacy of Tapentadol Oral Solution for the Treatment of Post-surgical Pain in Children and Adolescents Aged From 2 Years to Less Than 18 Years.|Completed||Phase 2|86|Actual|Grünenthal GmbH|Another opioid may been given according to medical judgment/standard of care if the participant had persistent intolerable pain 2 hours or more after administration of tapentadol oral solution despite having received a non-opioid analgesic.|1|||f||||||||||||||2017-10-11 02:17:53.248862|2017-10-11 02:17:53.248862
NCT01729715|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-07-19|||November 2012||2012-11-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|November 2015|Actual|2015-11-01||Interventional|||Helping Young Children Sleep|Helping Young Children Sleep|Completed||N/A|240|Actual|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-11 02:17:55.72832|2017-10-11 02:17:55.72832
NCT01729702|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2014-03-25|||April 2009||2009-04-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|REEF-CMH||Neurohormonal Parameters in Hypertrophic Cardiomyopathies|Evaluation at Rest and Exercise of Clinical, Ultrasonic and Neurohormonal Parameters in Hypertrophic Cardiomyopathies|Completed||N/A|131|Actual|French Cardiology Society||1|||f||||f||||||||||2017-10-11 02:17:55.801525|2017-10-11 02:17:55.801525
NCT01729689|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-08-20|||November 2012||2012-11-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers|Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers|Completed||N/A|13|Actual|Stanford University||1|||f||||||||||||||2017-10-11 02:17:55.891551|2017-10-11 02:17:55.891551
NCT01729676|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2014-07-16|||May 2013||2013-05-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|FACT||Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation|Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation: FACT STUDY|Completed||N/A|315|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 02:17:55.976736|2017-10-11 02:17:55.976736
NCT01729663|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2015-08-31|||April 2009||2009-04-01|August 2015|2015-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients|Randomized, Comparative Phase II/III Study Between Treatment With CSF470 Vaccine (Allogeneic, Irradiated) Plus BCG and MOLGRAMOSTIN (rhGM-CSF) as Adjuvants and Interferon-alfa 2b (IFN-ALPHA), in Stages IIB, IIC and III Post Surgery Cutaneous Melanoma Patients|Recruiting||Phase 2/Phase 3|108|Anticipated|Laboratorio Pablo Cassará S.R.L.||2|||f||||t||||||||||2017-10-11 02:17:56.059173|2017-10-11 02:17:56.059173
NCT01729650|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2016-08-31|||June 2012||2012-06-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|CapiCor||Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)|Effectiveness of a Physical Activity and Diet Program, Coordinated Between Primary Care and Mental Health, to Modify Cardiovascular Risk Factors in Patients With Schizophrenia or Bipolar Disorder (CapiCor)|Completed||N/A|332|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 02:17:56.162366|2017-10-11 02:17:56.162366
NCT01729637|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2013-07-05|||July 2011||2011-07-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Observational|||SI-EVLP Study: STRESS INDEX in Lung Reconditioning|Normothermic Ex-vivo Lung Perfusion: Clinical Experience of the Pressure/Time Curve Profile Study (Stress Index)|Completed||N/A|11|Actual|University of Turin, Italy|||1||f||||f||||||||||2017-10-11 02:17:56.250827|2017-10-11 02:17:56.250827
NCT01729624|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-05-27|||September 2012||2012-09-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||PRO Development for ANCA Associated Vasculitis|A Qualitative Study Using Interviews With Patients Who Have Anti-neutrophil Cytoplasm Antibody (ANCA) Associated Vasculitis, to Develop a Patient Reported Outcome (PRO) Measure|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of Oxford|||1||f||||t||||||||||2017-10-11 02:17:56.331369|2017-10-11 02:17:56.331369
NCT01729611|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2017-04-10|||December 2013||2013-12-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension|Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension|Recruiting||N/A|140|Anticipated|The Cleveland Clinic|||2||f||||f||||||||||2017-10-11 02:17:56.404272|2017-10-11 02:17:56.404272
NCT01729585|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-15|2015-09-25|||July 2013||2013-07-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||The Effects of Massage Therapy on QOL in Youth/Young Adults With Cystic Fibrosis|The Effects of Massage Therapy on Quality of Life in Youth and Young Adults With Cystic Fibrosis: A Pilot Study|Completed||N/A|30|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 02:17:56.587436|2017-10-11 02:17:56.587436
NCT01729572|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-04-24|||January 2014||2014-01-01|April 2014|2014-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients|The Effect of add-on Tele Medicine Monitoring of Medication Adherence, on the Risk of Re-hospitalisation of Ambulatory Schizophrenic Patients. an Open, Prospective, Randomised Controled Trial|Unknown status|Recruiting|N/A|200|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 02:17:56.698829|2017-10-11 02:17:56.698829
NCT01729559|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2016-06-07|2015-07-29||November 2012||2012-11-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional||Basic demographic and clinical characteristics of trauma patients who met all inclusion criteria.|Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin|Venous Thromboembolic Prophylaxis After Major Trauma: A Randomized Controlled Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin|Completed||Phase 4|495|Actual|Scripps Health|The lack of long-term follow-up to identify VTE events among patients who were either transferred or readmitted to other facilities with VTE-related events was not performed. Published risk estimates were inaccurate for our sample size calculation.|2|||f||||t||||||||Undecided||2017-10-11 02:17:56.797176|2017-10-11 02:17:56.797176
NCT01729546|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2015-01-13|||November 2012||2012-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluating System Accuracy of Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus|Evaluating System Accuracy of Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus [Following EN ISO 15197:2003 - 7.3 System Accuracy Evaluation] Part 40 of Study IDT-2010|Completed||N/A|114|Actual|Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm|||||f||||||||||||||2017-10-11 02:17:57.198591|2017-10-11 02:17:57.198591
NCT01729533|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-11-17|||December 2012||2012-12-01|November 2014|2014-11-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||The Benefits of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) in Couples With Unexplained Infertility|The Benefits of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) in Couples With Unexplained Infertility|Withdrawn||N/A|0|Actual|Sapientiae Institute||2|||f||||f||||||||||2017-10-11 02:17:57.268602|2017-10-11 02:17:57.268602
NCT01729520|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-06-24|||November 2012||2012-11-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Descriptive Study of Knee Joint Pain During Strength Training After Total Knee Arthroplasty|Knee Joint Pain During Strength Training After Total Knee Arthroplasty: Effect of Loading and Repetitions to Failure|Completed||N/A|15|Actual|Hvidovre University Hospital||1|||f||||t||||||||||2017-10-11 02:17:57.353974|2017-10-11 02:17:57.353974
NCT01729507|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2012-11-25|||July 2012||2012-07-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||tDCS as Add on Therapy for Treatment of Tobacco Dependence by Standardized Behaviour Therapy|Transcranial Direct Current Stimulation (TDCS) as Add on Therapy for Treatment of Tobacco Dependence by Standardized Behaviour Therapy - Active and Placebo Controlled Double Blind Study|Unknown status|Recruiting|Phase 4|40|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 02:17:57.425607|2017-10-11 02:17:57.425607
NCT01729494|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-12-15|||September 2012||2012-09-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Belatacept Early Steroid Withdrawal Trial|Randomized, Open Label, Multicenter Study of Belatacept-based Early Steroid Withdrawal Regimen With Alemtuzumab or rATG Induction Compared to Tacrolimus-based Early Steroid Withdrawal Regimen With rATG Induction in Renal Transplantation|Active, not recruiting||Phase 4|316|Actual|University of Cincinnati||3|||f||||t||||||||||2017-10-11 02:17:57.531037|2017-10-11 02:17:57.531037
NCT01729481|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-07-16|||July 2012||2012-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Interventional|ML22774||Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer|Phase II Study to Evaluatate the Efficacy of Gemcitabine Plus Erlotinib for RASH-positive Patients With Metastatic Pancreatic Cancer and Friendly Risk Circumstances|Active, not recruiting||Phase 2|150|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 02:17:57.652444|2017-10-11 02:17:57.652444
NCT01729468|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-02-23|||June 27, 2012|Actual|2012-06-27|February 2017|2017-02-01|October 25, 2016|Actual|2016-10-25|October 25, 2016|Actual|2016-10-25||Interventional|PERASTUN||Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers|Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers|Completed||Phase 4|1106|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 02:17:57.771458|2017-10-11 02:17:57.771458
NCT01729455|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-01-16|||February 2013||2013-02-01|January 2017|2017-01-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01|12 Years|Observational [Patient Registry]|SABLE||Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry|A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)|Recruiting||N/A|3000|Anticipated|GlaxoSmithKline|||2||f||||t||||||||||2017-10-11 02:17:57.973078|2017-10-11 02:17:57.973078
NCT01729442|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2014-10-21|||October 2012||2012-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|IDITOP-1||Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound Elastography|Transrectal Prostate Cancer High-Intensity Focused Ultrasound Ablation: Assessment of Tissue Destruction With Shear-wave Ultrasound Elastography|Completed||N/A|30|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-11 02:17:59.195956|2017-10-11 02:17:59.195956
NCT01729429|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-04-30|||May 2010||2010-05-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||An Intervention Promoting HPV Vaccination in Safety-net Clinics|An Intervention Promoting HPV Vaccination in Safety-net Clinics|Completed||N/A|831|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 02:17:59.292657|2017-10-11 02:17:59.292657
NCT01729416|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-05-26|||February 2014||2014-02-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Prospective Randomized Controlled Trial Comparing Water and Air Colonoscopy in a Community Based Setting|Prospective Randomized Controlled Trial Comparing Water Exchange Colonoscopy and Air Colonoscopy in a Community Based Setting|Completed||N/A|178|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 02:17:59.430872|2017-10-11 02:17:59.430872
NCT01729403|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2016-11-01||2016-08-09|December 2012||2012-12-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin|A Single Centre, Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus (T2D) Who Are Inadequately Controlled With Metformin Monotherapy|Completed||Phase 2|57|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:17:59.572498|2017-10-11 02:17:59.572498
NCT01729390|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-14|||September 2010||2010-09-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Varying the Energy Density and Portion Size of the Main Course After a First-course Salad|Varying the Energy Density and Portion Size of the Main Course After a First-course Salad|Completed||N/A|53|Actual|Penn State University||6|||f||||f||||||||||2017-10-11 02:17:59.675951|2017-10-11 02:17:59.675951
NCT01729377|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-11-14|||April 2013||2013-04-01|November 2012|2012-11-01|April 2016|Anticipated|2016-04-01|April 2014|Anticipated|2014-04-01||Observational|||The Meaning of Suicidality for Older Persons With Suicidal Tendencies and Their Families||Unknown status|Not yet recruiting|N/A|45|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 02:17:59.756246|2017-10-11 02:17:59.756246
NCT01729364|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-05-20|||April 2008||2008-04-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Fluid Investigation Colloid vs Crystalloid Reg. Renal Hemodynamics and Function|Colloid vs Crystalloid Infusion Postoperative in CABG Patients Regarding Renal Hemodynamics and Function|Completed||N/A|30|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-11 02:17:59.836893|2017-10-11 02:17:59.836893
NCT01729351|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-11-14|||November 2011||2011-11-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Qvar Therapy in Smoking Asthmatics|Comparative Effectiveness of Extrafine Hydrofluoroalkane Beclometasone Versus Fluticasone and Chlorofluorocarbon Beclometasone in Smoking Asthma — a Retrospective, Real-life Observational Study in a UK Primary Care Asthma Population|Completed||N/A|7195|Actual|Research in Real-Life Ltd|||6||f||||t||||||||||2017-10-11 02:17:59.94975|2017-10-11 02:17:59.94975
NCT01729338|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-04-26|2016-12-19||December 19, 2012|Actual|2012-12-19|April 2017|2017-04-01|December 31, 2016|Actual|2016-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma|Phase II Subcutaneous VELCADE and Oral Cyclophosphamide-based Induction + Sequential VELCADE and Revlimid Maintenance for Newly Diagnosed Multiple Myeloma in Non-transplant Candidates: An Entirely Non-intravenous Regimen|Terminated||Phase 2|17|Actual|Duke University||1|||f||||t|t|f|||f|||No||2017-10-11 02:18:00.133741|2017-10-11 02:18:00.133741
NCT01729325|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-06-02|||November 2012||2012-11-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|January 2013|Actual|2013-01-01||Interventional|||Prevention of Post-Traumatic Stress Disorder in Soldiers|Prevention of Post-Traumatic Stress Disorder in Relation to Appetitive Aggression in Burundian Soldiers Deployed in a Peace-keeping Mission in Somalia|Completed||Phase 2|118|Actual|University of Konstanz||2|||f||||t||||||||||2017-10-11 02:18:01.310692|2017-10-11 02:18:01.310692
NCT01729312|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-02-24|||January 2012||2012-01-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Observational|||Female Acl Prevention Study Where we Look at Landing Techniques Pre/Post Nine Week Strenghtening Program|Pilot Study to See if There is a Improvement in Landing Techniques After a 9 Week Strenghtening Program, Which May Decrease ACL Tears in Female Athletes|Terminated||N/A|7|Actual|Henry Ford Health System|||1|Not enough participants to validate study.|f||||f|f|f||||None Retained|"     No biospecimens are taken   "|No||2017-10-11 02:18:01.391402|2017-10-11 02:18:01.391402
NCT01729299|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-04-02|||April 2013||2013-04-01|April 2013|2013-04-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Ghrelin Effect on Beta Cell Function in Health and Disease|Ghrelin Effect on Beta Cell Function in Health and Disease|Unknown status|Recruiting|N/A|30|Anticipated|University of Cincinnati||4|||f||||t||||||||||2017-10-11 02:18:01.449564|2017-10-11 02:18:01.449564
NCT01729286|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-10-14|||September 2012||2012-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Interventional|HEALED||Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix|A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers|Terminated||N/A|92|Actual|Integra LifeSciences Corporation||2|||f||||f||||||||No||2017-10-11 02:18:01.595511|2017-10-11 02:18:01.595511
NCT01729273|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2014-10-02|||July 2012||2012-07-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|VHEPOC||Vascular Health and Exercise Performance of Overweight Children|Vascular Health and Exercise Performance of Overweight Children in 12 Weeks Using Skype|Completed||N/A|20|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 02:18:01.751787|2017-10-11 02:18:01.751787
NCT01729260|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-07-28|||November 2012|Actual|2012-11-01|July 2017|2017-07-01||||September 2016|Actual|2016-09-01||Interventional|Mebendazole||Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide|Phase I Study of Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide|Completed||Phase 1|24|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:18:01.863852|2017-10-11 02:18:01.863852
NCT01729247|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2014-01-15|2013-11-27||October 2012||2012-10-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age||Completed||N/A|50|Actual|Aerocrine AB|||1||f||||f||||||||||2017-10-11 02:18:01.956013|2017-10-11 02:18:01.956013
NCT01729234|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-12-06|||October 2012||2012-10-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effects of Dietary Nitrate on Age-related Vascular Function|Effects of Dietary Nitrate Supplementation on Age-related Vascular Dysfunction|Completed||Phase 1/Phase 2|20|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 02:18:02.449171|2017-10-11 02:18:02.449171
NCT01729221|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-17|2012-11-18|||January 2010||2010-01-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|February 2013|Anticipated|2013-02-01||Observational|||Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.||Unknown status|Active, not recruiting|N/A|280|Anticipated|Cairo University|||2||f||||t||||||||||2017-10-11 02:18:02.529342|2017-10-11 02:18:02.529342
NCT01729208|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-03-02|||November 2012|Actual|2012-11-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|May 2017|Anticipated|2017-05-01||Interventional|||An Evaluation of the Effectiveness of Dual Focus Soft Contact Lenses in Slowing Mypoia Progression|A Multicentre Dispensing Clinical Evaluation of MiSight® Lenses|Active, not recruiting||N/A|300|Anticipated|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 02:18:02.598369|2017-10-11 02:18:02.598369
NCT01729195|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2014-02-14|||March 2006||2006-03-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2008|Actual|2008-01-01||Interventional|||Ankle Syndesmosis Fixation by Antibiotic Releasing Bioabsorbable Screw|An Antibiotic Releasing Bone Screw: a Randomized Clinical Trial of Patients With Weber C Type Ankle Fractures|Completed||Phase 2|17|Actual|Turku University Hospital||1|||f||||f||||||||||2017-10-11 02:18:02.674465|2017-10-11 02:18:02.674465
NCT01729182|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-06-20|||January 1, 2013|Actual|2013-01-01|June 2017|2017-06-01|March 9, 2017|Actual|2017-03-09|March 9, 2017|Actual|2017-03-09||Observational|||Nexium Capsules LDA Specific Clinical Experience Investigation|Nexium Capsules Specific Clinical Experience Investigation for Long-term Use Concerning Prevention of Recurrence of Gastric Ulcer or Duodenal Ulcer With LDA|Completed||N/A|2363|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:18:02.758255|2017-10-11 02:18:02.758255
NCT01729169|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-05-10|||June 2012||2012-06-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET|Diagnosing Cardiac Sarcoidosis Using FDG PET: Optimization|Completed||N/A|19|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 02:18:02.910328|2017-10-11 02:18:02.910328
NCT01729156|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-05-04|||January 2013||2013-01-01|May 2017|2017-05-01|May 5, 2017|Actual|2017-05-05|May 5, 2017|Actual|2017-05-05||Interventional|||Effects of Metformin on Hepatic FFA Metabolism|Effects of Metformin on Hepatic Free Fatty Acid Metabolism in Patients Diagnosed With Type 2 Diabetes: A C11 PET Study|Completed||Phase 4|36|Actual|University of Aarhus||3|||f||||t||||||||||2017-10-11 02:18:02.979989|2017-10-11 02:18:02.979989
NCT01729143|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-04-05|||April 2011||2011-04-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Impact of Black Pepper on Energy Expenditure and Substrate Utilization|A Randomized, Cross-Over Trial to Evaluate the Acute Effects of Black Pepper on Energy Expenditure and Fat Oxidation in Humans|Completed||N/A|18|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:18:03.054604|2017-10-11 02:18:03.054604
NCT01729130|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-08-24|||September 2009||2009-09-01|July 2015|2015-07-01||||September 2012|Actual|2012-09-01||Observational|||A Pilot Study to Identify the Differences in Adipose Tissue Function After Restoring Normal Glycemic Control Following Pancreas Transplantation|A Pilot Study to Identify the Differences in Adipose Tissue Function After Restoring Normal Glycemic Control Following Pancreas Transplantation|Unknown status|Active, not recruiting|N/A|15|Actual|The University of Texas Medical Branch, Galveston|||3||f||||f||||||Samples With DNA|"     adipose tissue blood samples   "|||2017-10-11 02:18:03.120475|2017-10-11 02:18:03.120475
NCT01729117|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2012-11-13|||May 2009||2009-05-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Trial of Meal Replacement at a Community Diabetes Clinic Serving a Low Socioeconomic Hispanic Population|The 1,2,3 Plan: A Randomized Controlled Trial of Meal Replacement With a Lifestyle Modification Program vs. Standard Care at a Community Diabetes Clinic Serving a Low Socioeconomic Hispanic Population|Completed||N/A|30|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 02:18:03.184181|2017-10-11 02:18:03.184181
NCT01729104|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-09-11|||April 25, 2013|Actual|2013-04-25|September 2017|2017-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma|A Phase I/II Study of Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma|Active, not recruiting||Phase 1/Phase 2|18|Actual|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-11 02:18:03.260102|2017-10-11 02:18:03.260102
NCT01729091|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-09-25|||June 2013|Actual|2013-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study of Umbilical Cord Blood-Derived Natural Killer Cells in Conjunction With High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients With Multiple Myeloma|Phase I/II Study of Umbilical Cord Blood-Derived Natural Killer Cells in Conjunction With High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients With Multiple Myeloma|Recruiting||Phase 1/Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:18:03.357581|2017-10-11 02:18:03.357581
NCT01729078|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-07-27|||October 2012||2012-10-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional|||Dietary Interventions in Prediabetes|The Effects of Dietary Supplementation on Hepatic Insulin Action and Glucose Tolerance in Pre-diabetes|Completed||N/A|48|Actual|Mayo Clinic||3|||f||||||||||||||2017-10-11 02:18:03.468718|2017-10-11 02:18:03.468718
NCT01729065|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-05-21|||January 2010||2010-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study to Assess the Efficacy of Early Physical Therapy Intervention Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer|A Randomized Study to Assess the Efficacy of Early Physical Therapy Intervention on Upper Quarter Strength and Mobility, and Reported Upper Extremity Disability and Quality of Life Measures Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer|Completed||N/A|50|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:18:03.538897|2017-10-11 02:18:03.538897
NCT01729052|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-09-18|||November 2012||2012-11-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Acupuncture for Postoperative Nausea, Vomiting and Pain in Children: The Implication of Parental Attitudes|The Effect of Acupuncture for Alleviation of Postoperative Nausea, Vomiting, and Pain in Children: The Implications of Parental Attitudes and Expectations|Completed||N/A|282|Actual|University of Tromso||2|||f||||f||||||||||2017-10-11 02:18:03.605394|2017-10-11 02:18:03.605394
NCT01729039|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-02-21|||November 1, 2012|Actual|2012-11-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|September 30, 2016|Actual|2016-09-30||Interventional|DZO||Vestibular Rehabilitation and Dizziness|Vestibular Rehabilitation and Dizziness in Geriatric Patients|Active, not recruiting||N/A|97|Anticipated|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 02:18:03.670065|2017-10-11 02:18:03.670065
NCT01729013|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-09-18|||November 2012||2012-11-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Observational|||Duration of Vitamin D Stores After Prolonged Vitamin D Substitution|Duration of Vitamin D Stores After Prolonged Vitamin D Substitution|Completed||N/A|78|Actual|University of Tromso|||2||f||||f||||||Samples Without DNA|"     blood samples and fat biopsy   "|||2017-10-11 02:18:03.974656|2017-10-11 02:18:03.974656
NCT01729000|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-04|2012-11-13|||October 2008||2008-10-01|November 2012|2012-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study to Determine if Gloving in Addition to Hand Hygiene Will Prevent Invasive Infections and Necrotizing Enterocolitis|Gloving and Handwashing to Prevent Invasive Infections in Necrotizing Enterocolitis|Completed||N/A|124|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 02:18:04.029706|2017-10-11 02:18:04.029706
NCT01728987|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2016-11-14|||August 2016||2016-08-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|||The Significance of Vitamin D Storage in Adipose Tissue|The Significance of Vitamin D Storage in Adipose Tissue|Withdrawn||Phase 2|0|Actual|University of Tromso||2||study stopped due to Financial problems|f||||f||||||||||2017-10-11 02:18:04.092391|2017-10-11 02:18:04.092391
NCT01728974|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2013-09-25|||December 2012||2012-12-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study A|Mechanisms of Pharyngeal Collapse in Sleep Apnea|Unknown status|Recruiting|N/A|20|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:18:04.155566|2017-10-11 02:18:04.155566
NCT01728961|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-05-16|||February 2012||2012-02-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy|Pharmacology of Artemisinin-Based Antimalarial Therapy Within the Context of Antiretroviral Therapy|Terminated||Phase 4|19|Anticipated|International Maternal Pediatric Adolescent AIDS Clinical Trials Group||2||Slow accrual and funding limitations.|f||||f||||||||||2017-10-11 02:18:04.221468|2017-10-11 02:18:04.221468
NCT01728948|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2016-07-28|||December 2012||2012-12-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Sorafenib in Elderly mRCC|Non-interventional Study of Effectiveness of Elderly Metastatic Renal Cell Carcinoma (mRCC) Treated With Sorafenib|Completed||Phase 4|60|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:18:04.461153|2017-10-11 02:18:04.461153
NCT01728935|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-12-29|||April 2008||2008-04-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||Tenofovir in Asian Chronic Hepatitis B Patients|Serologic and Virologic Outcomes of Tenofovir in Asian Chronic Hepatitis B Patients With Prior Nucleoside Analogue Exposure|Completed||N/A|141|Actual|The University of Hong Kong||1|||f||||||||||||||2017-10-11 02:18:04.536403|2017-10-11 02:18:04.536403
NCT01728922|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-05-01|||November 6, 2012|Actual|2012-11-06|May 2017|2017-05-01|June 5, 2016|Actual|2016-06-05|June 5, 2015|Actual|2015-06-05||Interventional|CISAVID||Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome|Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome and Healthy Control Participants. An Exploratory Double Blind Placebo Randomised Controlled Study.|Completed||Phase 1/Phase 2|64|Actual|University College Dublin||6|||f||||t|f|f|||f|||Yes|all demographic details and outcome measures may be obtained directly from the PI by e-mail|2017-10-11 02:18:04.616151|2017-10-11 02:18:04.616151
NCT01728909|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-05-10|||May 2012||2012-05-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|MOO||Methadone Oxytocin Option|The Effects of Intranasal Oxytocin on Social Cognition and Social Approach Behaviors in Opioid-dependent Patients|Completed||Early Phase 1|64|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:18:04.70824|2017-10-11 02:18:04.70824
NCT01728896|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2013-01-04|||December 2012||2012-12-01|January 2013|2013-01-01||||||||Interventional|PICTOR||Patient-Initiated and ConTrolled Oral Refeeding (PICTOR)|A Randomized Controlled Trial of Patient-Initiated and ConTrolled Oral Refeeding in Acute Pancreatitis|Unknown status|Recruiting|N/A|116|Anticipated|University of Auckland, New Zealand||2|||f||||f||||||||||2017-10-11 02:18:04.786078|2017-10-11 02:18:04.786078
NCT01728883|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-05-11|||April 2013||2013-04-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|April 2016|Actual|2016-04-01||Observational|DRAMA||Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study|Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy|Completed||N/A|60|Actual|Vital Art and Science Incorporated|||1||f||||t||||||||Yes|DME Monitoring Results presented at ARVO on May 2, 2016. Additional results planned.|2017-10-11 02:18:04.859139|2017-10-11 02:18:04.859139
NCT01728870|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-03-01|||January 2013||2013-01-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Partial Enteral Nutrition With a Unique Diet vs. Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn's Disease|Comparison of Partial Enteral Nutririon (Modulen) With a Unique Diet to Exclusive Enteral Nutrition (Modulen) for the Treatment of Pediatric Crohn's Disease. A Prospective Randomized Controlled Trial.|Recruiting||N/A|72|Anticipated|Wolfson Medical Center||2|||f||||f||||||||||2017-10-11 02:18:04.934078|2017-10-11 02:18:04.934078
NCT01728857|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-06-20|||November 2012|Actual|2012-11-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|TOPS||Tissue Optimization on Cryolipolysis Procedures for Fat Layer Reduction|The Effects of Tissue Optimization on Cryolipolysis Procedures for Fat Layer Reduction|Completed||N/A|19|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 02:18:05.038241|2017-10-11 02:18:05.038241
NCT01728844|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-11-17|||October 2012||2012-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:18:05.101323|2017-10-11 02:18:05.101323
NCT01728831|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2015-12-01|||November 2012||2012-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|May 2014|Actual|2014-05-01||Observational|NIRSTBI||Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury|Observational Study of Cerebral Tissue Oxygen Saturation During Blood Transfusion in Severe Traumatic Brain Injured Patients|Completed||N/A|20|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-11 02:18:05.135405|2017-10-11 02:18:05.135405
NCT01728818|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-07-16|||April 2013||2013-04-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2017|Actual|2017-01-01||Interventional|ACCEPT||Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours|Gemcitabine in Combination With the Oral Irreversible ErbB Inhibitor Afatinib Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer: an Explorative Randomized Phase II Trial|Active, not recruiting||Phase 2|119|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 02:18:05.194037|2017-10-11 02:18:05.194037
NCT01728805|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-04-26|||November 2012||2012-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|March 2017|Actual|2017-03-01||Interventional|||Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL|Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 (Mogamulizumab) Versus Vorinostat in Subjects With Previously Treated Cutaneous T-Cell Lymphoma|Active, not recruiting||Phase 3|372|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||2|||f||||t||||||||||2017-10-11 02:18:05.33707|2017-10-11 02:18:05.33707
NCT01728792|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-08-03|2016-08-30||January 22, 2013|Actual|2013-01-22|August 2017|2017-08-01|November 21, 2013|Actual|2013-11-21|November 1, 2013|Actual|2013-11-01||Interventional||Safety Analysis Set included all enrolled participants who received at least 1 dose of study vaccine and for whom any post-vaccination safety data has been obtained.|Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity|Impact of Subcutaneous Versus Intramuscular Administration of Inviragen's Live Attenuated Dengue Vaccine on Safety and Immunogenicity|Completed||Phase 1|80|Actual|Takeda|Due to protocol non-compliance issues, sponsor decided to only report safety data.|5|||f||||f||||||||||2017-10-11 02:18:05.628427|2017-10-11 02:18:05.628427
NCT01728779|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-06-08|||April 2013||2013-04-01|June 2016|2016-06-01||||July 2018|Anticipated|2018-07-01||Interventional|||Stereotactic Body Radiation With Nelfinavir for Oligometastases|Single-Arm Phase II Study of Stereotactic Body Radiation Therapy Concurrent With Nelfinavir for Oligometastases|Active, not recruiting||Phase 2|40|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:18:07.258226|2017-10-11 02:18:07.258226
NCT01728766|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2017-06-01|||July 2006||2006-07-01|November 2012|2012-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Breast Milk Zinc Transfer to Appropriate- and Small-for-gestational-age Bangladeshi Infants|Longitudinal Studies of Breast Milk Zinc Transfer to Appropriate- and Small-for-gestational-age, Predominantly Breast Fed, Bangladeshi Infants|Completed||N/A|76|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh|||1||f||||f||||||None Retained|"     Breast milk Plasma   "|||2017-10-11 02:18:07.343509|2017-10-11 02:18:07.343509
NCT01728753|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-09-30||2015-09-30|November 2012||2012-11-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|FAVOR||T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza|Randomized, Double Blind,Placebo-Controlled, Multicenter Study Evaluating the Safety and Pharmacokinetics of Different Dosing Regimens of Favipiravir in Healthy Adult Subjects and Adult Subjects With Uncomplicated Influenza|Completed||Phase 1/Phase 2|550|Actual|MDVI, LLC||4|||f||||t||||||||||2017-10-11 02:18:07.422636|2017-10-11 02:18:07.422636
NCT01728740|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2012-12-18|||September 2012||2012-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bioequivalence Study for Acarbose / Metformin FDC|Randomized, Non-blinded Crossover Study to Establish the Bioequivalence Between Fixed Dose Combination (FDC) and Loose Combination of Acarbose and Metformin and to Investigate the Potential for a Drug-drug Interaction Following Single Oral Dosing in Healthy Adult Male Subjects|Completed||Phase 1|40|Actual|Bayer||4|||f||||f||||||||||2017-10-11 02:18:07.550184|2017-10-11 02:18:07.550184
NCT01728727|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-13|||September 2012||2012-09-01|November 2012|2012-11-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis|Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis|Unknown status|Recruiting|Phase 1/Phase 2|240|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 02:18:07.63331|2017-10-11 02:18:07.63331
NCT01728714|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-14|2017-09-29|||May 19, 2014|Actual|2014-05-19|September 2017|2017-09-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|MINERVA||Better Diabetes Control, Quality - Educate to Achieve Compliance.|Prospective Study to Evaluate Impact of an Educational Programme About Diabetes, Comparing to Normal Clinical Practice, on Treatment Compliance and Disease Control of People With Type 2 Diabetes Followed in Primary Care Units in Portugal|Recruiting||N/A|250|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-10-11 02:18:07.713167|2017-10-11 02:18:07.713167
NCT01728701|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-05-12|||September 2012||2012-09-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis|Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis|Completed||Phase 1|30|Actual|Sanaria Inc.||4|||f||||t|t|f||||||||2017-10-11 02:18:07.787458|2017-10-11 02:18:07.787458
NCT01728688|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-13|||September 2012||2012-09-01|November 2012|2012-11-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis|Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis|Unknown status|Recruiting|Phase 1/Phase 2|240|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 02:18:07.87831|2017-10-11 02:18:07.87831
NCT01728675|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-13|||May 2012||2012-05-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Eccentric Exercise and Oxidative Stress|The Effect of Eccentric Exercise on Oxidative Stress in the Elderly|Completed||N/A|20|Actual|European University Cyprus||2|||f||||f||||||||||2017-10-11 02:18:08.163695|2017-10-11 02:18:08.163695
NCT01728662|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-11-13|||December 2012||2012-12-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Emphysematous Lung Sealant Therapy in Homogeneous Emphysema|Post Market Investigator Sponsored Study of Emphysematous Lung Sealant Therapy in Homogeneous Emphysema Using a Modified Treatment Strategy|Unknown status|Not yet recruiting|N/A|8|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 02:18:08.266796|2017-10-11 02:18:08.266796
NCT01728649|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-11-10|||February 2013||2013-02-01|November 2013|2013-11-01|June 2015|Anticipated|2015-06-01|February 2015|Anticipated|2015-02-01||Interventional|ReCCLAIM II||Reperfusion With Cooling in Cerebral Acute Ischemia II|Phase 2 Study of Mild Hypothermia in Combination With Acute Cerebral Vascular Reperfusion in the Setting of Acute Ischemic Stroke|Withdrawn||Phase 2|0|Actual|Emory University||2||unable to be funded|f||||t||||||||||2017-10-11 02:18:08.335672|2017-10-11 02:18:08.335672
NCT01728636|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-02-28|||January 2013||2013-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|TXA||The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery|The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery|Enrolling by invitation||Phase 2|170|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 02:18:08.429969|2017-10-11 02:18:08.429969
NCT01728610|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-01-25|||October 2012||2012-10-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms|Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms (IBS-2)|Completed||Phase 2|391|Actual|Danisco||3|||f||||f||||||||No||2017-10-11 02:18:08.622373|2017-10-11 02:18:08.622373
NCT01728597|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2017-08-13|||December 2011||2011-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|CMR-TECH||Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols|Optimization of Non-contrast Enhanced 1.5 Tesla and 3 Tesla Cardiac Magnetic Resonance Imaging Techniques and Acquisition of Normal Values|Recruiting||N/A|200|Anticipated|Medical University of Graz|||1||f||||t||||||||||2017-10-11 02:18:08.717419|2017-10-11 02:18:08.717419
NCT01728584|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-05-08|2015-03-12||November 28, 2012|Actual|2012-11-28|May 2017|2017-05-01|April 29, 2014|Actual|2014-04-29|April 29, 2014|Actual|2014-04-29||Interventional||All participants as randomized|A Study Comparing the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures in Participants Undergoing Laparoscopic Cholecystectomy (P07982)|Randomized, Controlled, Parallel-Group, Double-Blind Trial to Compare the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures Using a 2x2 Factorial Design in Patients Undergoing Laparoscopic Cholecystectomy (Protocol No. MK-8616-076-03 Also Known as SCH 900616, P07982)|Completed||Phase 4|127|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:18:08.820523|2017-10-11 02:18:08.820523
NCT01728571|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-01-30|||July 2010||2010-07-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|lungVITAL||LungVITamin D and OmegA-3 Trial (lungVITAL)|LungVITamin D and OmegA-3 Trial|Active, not recruiting||N/A|25875|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:18:09.982828|2017-10-11 02:18:09.982828
NCT01728558|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2016-04-12|||November 2013||2013-11-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|SPICE III RCT||Early Goal-Directed Sedation Compared With Standard Care in Mechanically Ventilated Critically Ill Patients|Early Goal-Directed Sedation Compared With Standard Care in Mechanically Ventilated Critically Ill Patients: a Prospective Multicentre Randomised Controlled Trial|Recruiting||Phase 3|4000|Anticipated|Australian and New Zealand Intensive Care Research Centre||2|||f||||t||||||||||2017-10-11 02:18:10.08567|2017-10-11 02:18:10.08567
NCT01728545|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-08-17|||April 2005|Actual|2005-04-01|August 2017|2017-08-01|April 2099|Anticipated|2099-04-01|April 2099|Anticipated|2099-04-01||Observational|||The Collection and Storage of Umbilical Cord Blood for Transplantation|The Collection and Storage of Umbilical Cord Blood for Transplantation|Recruiting||N/A|250000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f|f|f||||Samples With DNA|"     Blood samples from the umbilical cords of newborn babies, a minimum of 40 ml is needed for     processing.   "|||2017-10-11 02:18:10.329352|2017-10-11 02:18:10.329352
NCT01728532|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-11-30|||June 2012||2012-06-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PA0903||Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer|Open, Randomized Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer|Completed||N/A|26|Actual|Ascopharm Groupe Novasco||2|||f||||t||||||||||2017-10-11 02:18:10.407919|2017-10-11 02:18:10.407919
NCT01728519|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-11-13|||August 2008||2008-08-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|March 2009|Actual|2009-03-01||Interventional|AN003||Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen|Phase I/IIa Study to Assess the Safety, Immunogenicity and Efficacy of AllerT, a Combination of Peptides Derived From Bet v 1, Administered Via the Subcutaneous or Intradermal Route to Volunteers Allergic to Birch Pollen|Terminated||Phase 1/Phase 2|29|Actual|Anergis||4||Recruitment was stopped before start of the pollen season|f||||f||||||||||2017-10-11 02:18:10.493316|2017-10-11 02:18:10.493316
NCT01728506|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-05-15|||October 2012||2012-10-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|iWEB||An Internet-based Weight Loss and Exercise Intervention for Breast Cancer Survivors|An Internet-based Weight Loss and Exercise Intervention for Breast Cancer Survivors: The iWEB Program|Unknown status|Active, not recruiting|N/A|48|Anticipated|University of Vermont||1|||f||||t||||||||||2017-10-11 02:18:10.595645|2017-10-11 02:18:10.595645
NCT01728493|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-04-05|||September 2013||2013-09-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Observational|PAGODE||Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment|Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment|Completed||N/A|700|Actual|Radboud University|||3||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 02:18:10.703058|2017-10-11 02:18:10.703058
NCT01728480|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-12-10|||January 2014||2014-01-01|December 2013|2013-12-01||||October 2015|Anticipated|2015-10-01||Interventional|||Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy|A Phase I Study of CBLB502 in the Treatment of Patients With Poor Prognosis Advanced Squamous Cell Carcinomas of the Head and Neck Receiving Chemoradiotherapy|Withdrawn||Phase 1|0|Actual|Roswell Park Cancer Institute||1||Financial Sponsor requested termination|f||||t||||||||||2017-10-11 02:18:10.783488|2017-10-11 02:18:10.783488
NCT01728467|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2014-03-31|||November 2012||2012-11-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes|Phase 2 Randomised, Double-blind, Placebo-controlled, Cross-over Study for the Assessment of Glucose Metabolism Changes With RVX000222 in Individuals With Pre-diabetes|Completed||Phase 2|20|Actual|Resverlogix Corp||2|||f||||f||||||||||2017-10-11 02:18:10.900268|2017-10-11 02:18:10.900268
NCT01728454|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-07-25|||November 2012||2012-11-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis|A Phase 2, Multi-Center, Three-Arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis|Completed||Phase 2|60|Actual|Repros Therapeutics Inc.||3|||f||||t||||||||||2017-10-11 02:18:11.015557|2017-10-11 02:18:11.015557
NCT01728441|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2014-05-19|||October 2012||2012-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery|REAL PTX - Randomized Evaluation of the Zilver PTX Stent vs. Paclitaxel-Eluting Balloons for Treatment of Symptomatic Peripheral Artery Disease of the Femoropopliteal Artery|Completed||N/A|150|Actual|Provascular GmbH||2|||f||||t||||||||||2017-10-11 02:18:11.417431|2017-10-11 02:18:11.417431
NCT01728428|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2012-11-13|||February 2012||2012-02-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Observational|||A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients||Completed||N/A|1003|Actual|Peking Union Medical College Hospital|||1||f||||t||||||||||2017-10-11 02:18:11.545432|2017-10-11 02:18:11.545432
NCT01728415|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2014-09-19|||October 2012||2012-10-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|December 2014|Anticipated|2014-12-01||Interventional|OsloExDia||Effects of High-intensity Interval Training in Patients in Hemodialysis|Effects of High-intensity Interval Training in Patients in Hemodialysis|Unknown status|Recruiting|N/A|18|Anticipated|Oslo University Hospital||3|||f||||f||||||||||2017-10-11 02:18:11.626231|2017-10-11 02:18:11.626231
NCT01728402|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-05-08|||September 2008||2008-09-01|May 2017|2017-05-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||Pathogenesis of Hematologic Malignancies|Pathogenesis of Acute Leukemia, Lymphoproliferative Disorders, and Myeloproliferative Disorders|Enrolling by invitation||N/A|5000|Anticipated|OHSU Knight Cancer Institute|||1||f||||f||||||||||2017-10-11 02:18:11.720376|2017-10-11 02:18:11.720376
NCT01728389|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-07-23|||November 2012||2012-11-01|July 2013|2013-07-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Interventional|||Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies.|Efficacy and Safety of Direct Intrabone Transplantation of Peripheral Blood Haematopoietic Stem Cells Form HLA-matched Sibling Donors in Patients With Myeloid and Lymphoid Malignancies.|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||1|||f||||t||||||||||2017-10-11 02:18:11.791661|2017-10-11 02:18:11.791661
NCT01728376|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-02-23|2016-10-13||November 2012||2012-11-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Participants who received any dose of IV study medication.|Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)|A Comparative Evaluation of the Safety and Efficacy of Daptomycin Versus Standard of Care in Pediatric Subjects One - Seventeen Years of Age With Bacteremia Caused by Staphylococcus Aureus.|Completed||Phase 4|82|Actual|Cubist Pharmaceuticals LLC||6|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:18:11.934162|2017-10-11 02:18:11.934162
NCT01728363|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-06-30|||January 2013||2013-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Staph||Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)|Pharmacokinetics of Antistaphylococcal Antibiotics in Infants|Completed||Phase 1|63|Actual|Duke University||3|||f||||t||||||||||2017-10-11 02:18:14.11875|2017-10-11 02:18:14.11875
NCT01728350|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-07-20|||April 2013||2013-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Well-Being After TBI Through Structured Volunteer Activity|Improving Well-Being After TBI Through Structured Volunteer Activity|Active, not recruiting||N/A|74|Actual|Craig Hospital||2|||f||||f||||||||||2017-10-11 02:18:14.23583|2017-10-11 02:18:14.23583
NCT01728337|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2014-07-22|2013-01-28||July 2011||2011-07-01|July 2014|2014-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Phase Iv Study On Muscle Activity Of Two Commercial Preparations Of Botulinum|PHASE IV STUDY ON MUSCLE ACTIVITY OF TWO COMMERCIAL PREPARATIONS OF BOTULINUM TOXIN TYPE A ADMINISTERED TO THE UPPER THIRD OF THE FACE.|Completed||Phase 4|80|Actual|Brazilan Center for Studies in Dermatology||1|||f||||f||||||||||2017-10-11 02:18:14.339985|2017-10-11 02:18:14.339985
NCT01728324|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-01-14|2016-01-14|2014-06-25|November 2012||2012-11-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional||Full Analysis Set (FAS): This analysis set includes all randomized patients who were dispensed study medication and were documented to have taken at least one dose of any study medication, either active or placebo.|Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2|A Phase III Randomised, Partially Double-blind and Placebo-controlled Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Chronic Genotype 1 Hepatitis C Infection in an Extended Population of Treatment naïve Patients That Includes Those Ineligible to Receive Peginterferon|Completed||Phase 3|496|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:18:14.649877|2017-10-11 02:18:14.649877
NCT01728311|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-06-08|||November 21, 2012|Actual|2012-11-21|June 2017|2017-06-01|February 6, 2017|Actual|2017-02-06|June 3, 2016|Actual|2016-06-03||Interventional|||Open Label Study of BAY1082439 in Patients With Advanced Cancer|An Open-label Phase I Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY 1082439 Given Once Daily Continuously or in an Intermittent Dosing Schedule in Subjects With Advanced Malignancies|Completed||Phase 1|60|Actual|Bayer||1|||f||||f|f|f||||||||2017-10-11 02:18:15.9913|2017-10-11 02:18:15.9913
NCT01728298|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-01-20|||November 2012||2012-11-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|SUMMIT||A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy|A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy - The SUMMIT Trial|Completed||Phase 2|219|Actual|ALK-Abelló A/S||3|||f||||f||||||||||2017-10-11 02:18:16.12307|2017-10-11 02:18:16.12307
NCT01728285|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2012-11-14|||March 2007||2007-03-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|GT-17||Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis|A Multicentric Open Randomised, Cross-over Phase III Trial Assessing the Treatment Compliance With GRAZAX® in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis|Completed||Phase 3|261|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-10-11 02:18:16.2014|2017-10-11 02:18:16.2014
NCT01700101|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-08-25|||November 2012||2012-11-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||MelaFind Evaluations for Patients With Multiple Nevi|MelaFind Evaluations for Patients With Multiple Nevi|Completed||N/A|19|Actual|MELA Sciences, Inc.|||1||f||||f||||||||||2017-10-11 02:26:48.817398|2017-10-11 02:26:48.817398
NCT01728272|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-08-19|||November 2012||2012-11-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|Minimeto||Influence of CPB and Mini CPB to the Absorption of the Metoprolol|Influence of CPB and Mini CPB to the Absorption of the Metoprolol After CABG|Unknown status|Recruiting|N/A|45|Anticipated|Kuopio University Hospital||1|||f||||t||||||||||2017-10-11 02:18:16.28371|2017-10-11 02:18:16.28371
NCT01728259|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-04-05|||March 2013||2013-03-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD|Phase I Study of Pomalidomide, Bortezomib, and Dexamethasone (PVD) as First-Line Treatment of AL Amyloidosis or Light Chain Deposition Disease|Suspended||Phase 1|36|Anticipated|Barbara Ann Karmanos Cancer Institute||1||Temporarily enrollment suspension due to unknown cause of death of participant|f||||t||||||||||2017-10-11 02:18:16.363108|2017-10-11 02:18:16.363108
NCT01728246|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-02-06|2012-12-07||October 2007||2007-10-01|February 2013|2013-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||An Efficacy, Safety and Effects on Quality of Life of Tramadol/Paracetamol as Add-on Therapy in Chronic Osteoarthritis|A Randomized Controlled Trial on the Efficacy, Safety and Quality of Life Effects of Add-on Tramadol/Paracetamol Combination in Chronic Osteoarthritis|Completed||Phase 4|473|Actual|Janssen Pharmaceutica||2|||f||||f||||||||||2017-10-11 02:18:16.481878|2017-10-11 02:18:16.481878
NCT01728233|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-03-08|||June 15, 2013|Actual|2013-06-15|March 2017|2017-03-01|February 15, 2018|Anticipated|2018-02-15|October 15, 2017|Anticipated|2017-10-15||Interventional|HER-Uro01||Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis|Phase II Study of the Pan-HER Inhibitor Dacomitinib (PF-00299804) for Patients With Locally Advanced or Metastatic Squamous Cell Carcinoma of the Penis.|Recruiting||Phase 2|37|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t||||||||||2017-10-11 02:18:16.97879|2017-10-11 02:18:16.97879
NCT01728220|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2015-01-30||2015-01-30|December 2012||2012-12-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD|A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1|Completed||Phase 2|159|Actual|Bellerophon||7|||f||||f||||||||||2017-10-11 02:18:17.091353|2017-10-11 02:18:17.091353
NCT01728207|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-01-28|||March 2013||2013-03-01|January 2016|2016-01-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|||Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL|A Phase I Dose Escalation Study of Immunotherapy With IMMU-114 in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)|Recruiting||Phase 1|100|Anticipated|Immunomedics, Inc.||1|||f||||f||||||||||2017-10-11 02:18:17.317331|2017-10-11 02:18:17.317331
NCT01728194|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-02-19|||July 2012||2012-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Emotional and Cognitive Control in Late-Onset Depression|White Matter and Emotional and Cognitive Control in Late-Onset Depression|Recruiting||Phase 4|140|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-10-11 02:18:17.448347|2017-10-11 02:18:17.448347
NCT01728181|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-07-23|||November 2013||2013-11-01|July 2013|2013-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation|A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation|Withdrawn||Phase 1/Phase 2|0|Actual|University of Utah||4||Stopped before approval due to ineffective drug|f||||t||||||||||2017-10-11 02:18:17.545371|2017-10-11 02:18:17.545371
NCT01728168|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2014-02-03|||December 2012||2012-12-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Observational|||Prevalence of Food Allergies to Proteins From Different Legumes|Prevalence of Food Allergies to Proteins From Different Legumes (Lupin, Peanut, Soy, and Pea) in Atopic and Healthy Subjects|Completed||N/A|183|Actual|University of Jena|||2||f||||||||||||||2017-10-11 02:18:17.627409|2017-10-11 02:18:17.627409
NCT01728155|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-06-16|||December 2011||2011-12-01|June 2017|2017-06-01|December 2031|Anticipated|2031-12-01|December 2021|Anticipated|2021-12-01||Interventional|||European Low and Intermediate Risk Neuroblastoma Protocol|European Low and Intermediate Risk Neuroblastoma Protocol|Recruiting||Phase 3|685|Anticipated|Instituto de Investigacion Sanitaria La Fe||11|||f||||t||||||||No||2017-10-11 02:18:17.708425|2017-10-11 02:18:17.708425
NCT01728142|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-10-05|||January 2013||2013-01-01|October 2017|2017-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparison of the DANA to the ANAM in the Evaluation of Cognitive Changes After Concussion|Comparison of the Defense Automated Neurobehavioral Assessment (DANA) Brief Exam to the Automated Neuropsychological Assessment Metrics (ANAM) Battery in the Evaluation of Cognitive Changes During Concussion Recovery|Completed||N/A|118|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-10-11 02:18:18.607754|2017-10-11 02:18:18.607754
NCT01728129|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-10-05|||January 2013||2013-01-01|October 2017|2017-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||DANA Compared to MACE in Evaluation of Suspected Acute Concussion|Comparison of the Defense Automated Neurobehavioral Assessment (DANA) Tool to the Military Acute Concussion Evaluation (MACE) in the Evaluation of Suspected Acute Concussion|Completed||N/A|40|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-10-11 02:18:18.688749|2017-10-11 02:18:18.688749
NCT01728116|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-12-02|2016-06-22||December 2012||2012-12-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ENDO|mITT|Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese|A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Comparing the EndoBarrier Gastrointestinal Liner System vs. Sham for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects on Oral Anti-Diabetes Agents|Terminated||N/A|325|Actual|GI Dynamics|The ENDO Trial was stopped early due to a higher than anticipated rate of hepatic abscess (n=7).|2||Higher than anticipated rate of Hepatic abscess (N=7)|f||||t||||||||Yes||2017-10-11 02:18:18.831895|2017-10-11 02:18:18.831895
NCT01698762|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-12-14|||March 2013||2013-03-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Observational|||IADAPT-Third Phase|IADAPT-Third Phase|Active, not recruiting||N/A|828|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-10-11 02:27:08.615833|2017-10-11 02:27:08.615833
NCT01728103|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-08-14|||January 2013||2013-01-01|August 2017|2017-08-01||||July 2014|Actual|2014-07-01||Observational|||Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays|Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays|Terminated||N/A|1336|Actual|Gen-Probe, Incorporated|||1|Corporate decision to spend money on other development programs.|f||||f||||||Samples With DNA|"     urine; endocervical and vaginal swabs   "|||2017-10-11 02:18:20.76827|2017-10-11 02:18:20.76827
NCT01728090|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2012-11-16|||October 2009||2009-10-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections|Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections|Completed||Phase 4|1640|Actual|Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental||2|||f||||t||||||||||2017-10-11 02:18:20.851398|2017-10-11 02:18:20.851398
NCT01728077|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-08-02|2017-07-10||October 2012||2012-10-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional||Baseline Characteristics refer to the Safety Set, which consisted of all subjects who received at least 1 dose of study medication.|Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy|An Open-label, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Subjects Aged 16 Years or Older With Epilepsy Phase 3b|Completed||Phase 3|26|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 02:18:20.965478|2017-10-11 02:18:20.965478
NCT01728064|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2016-03-18|||December 2012||2012-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|||Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia|Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia|Completed||Phase 2|60|Anticipated|Edison Pharmaceuticals Inc||3|||f||||t||||||||||2017-10-11 02:18:21.540953|2017-10-11 02:18:21.540953
NCT01728051|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2013-10-22||||||October 2013|2013-10-01||||||||Expanded Access|||Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver|An Open Label, Expanded Access Study of Melphalan Chemosaturation With the Delcath System in Patients With Ocular and Cutaneous Melanoma Metastatic to the Liver|No longer available||N/A|||Delcath Systems Inc.|||||||||||||||||||2017-10-11 02:18:21.640842|2017-10-11 02:18:21.640842
NCT01728038|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2017-08-29|||March 2012|Actual|2012-03-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|July 2014|Actual|2014-07-01||Interventional|||Exploring a Cessation Intervention for Smokers|Exploring a Cessation Intervention for Low Income Smokers in an Emergency Setting|Completed||N/A|230|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 02:18:21.73295|2017-10-11 02:18:21.73295
NCT01728025|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-03-25|||October 2012||2012-10-01|March 2015|2015-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine||Recruiting||Phase 2|10|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||||||||||||2017-10-11 02:18:21.803228|2017-10-11 02:18:21.803228
NCT01728012|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-08-14|||November 2012||2012-11-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|||Long-term Cardiovascular Risk Following Successful Renal Transplantation|The Prevalence of Cardiovascular Risk Factors in Patients More Than 10 Years Following Successful Renal Transplant.|Completed||N/A|60|Actual|Helse Stavanger HF|||2||f||||f||||||Samples Without DNA|"     Blood and urine will be collected along with the clinical observations. Serum, plasma and     urine will be frozen for later analyses.   "|||2017-10-11 02:18:21.885288|2017-10-11 02:18:21.885288
NCT01727999|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-04-24|||July 2012|Actual|2012-07-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics|Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics|Completed||N/A|75|Actual|Stanford University|||2||f||||f||||||Samples With DNA|"     RNA and DNA will be retained   "|No||2017-10-11 02:18:21.944087|2017-10-11 02:18:21.944087
NCT01727986|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-05-04|||March 2013||2013-03-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study|Extension, Open-label, Interventional, Long-term Study to Evaluate the Safety of Tocilizumab Treatment in Patients From Brazil With Polyarticular-course Juvenile Idiopathic Arthritis Who Completed the Global Multinational Trial (WA19977)|Completed||Phase 3|11|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:18:22.047556|2017-10-11 02:18:22.047556
NCT01727973|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-12-07|||October 2012||2012-10-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy|Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy: a Prospective, Uncontrolled Pilot Study|Completed||Phase 1/Phase 2|14|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 02:18:22.144947|2017-10-11 02:18:22.144947
NCT01727960|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2012-11-12|||January 2012||2012-01-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|November 2012|Actual|2012-11-01||Observational|||The Effect of Education on Decreasing the Prevalence and Severity of Neck and Shoulder Pain||Unknown status|Recruiting|N/A|1302|Anticipated|Soonchunhyang University Hospital|||1||f||||t||||||||||2017-10-11 02:18:22.317868|2017-10-11 02:18:22.317868
NCT01727947|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2014-11-17|||January 2013||2013-01-01|November 2014|2014-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Influence of Sperm With Large Nuclear Vacuole on ICSI Outcomes|Influence of Sperm With Large Nuclear Vacuoles on the Cycles' Outcomes of Couples Couples Undergoing ICSI|Completed||N/A|200|Actual|Sapientiae Institute||1|||f||||f||||||||||2017-10-11 02:18:22.411304|2017-10-11 02:18:22.411304
NCT01727934|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2014-01-03|||November 2012||2012-11-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|January 2014|Anticipated|2014-01-01||Interventional|||Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C|A Phase 2, Open-Label, Clinical Trial of Miravirsen Sodium in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C (CHC) Virus Genotype 1 Infection|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|Santaris Pharma A/S||1|||f||||f||||||||||2017-10-11 02:18:22.475937|2017-10-11 02:18:22.475937
NCT01727921|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2016-04-27|||January 2013||2013-01-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Interventional|||Comparative Study of 22 and 25 Gauge ProCore EUS-guided Biopsy in Pancreatic Mass|Endoscopic Ultrasound-guided Fine Needle Tissue Acquisition With 22- and 25-gauge ProCore Needle in Solid Pancreatic and Peripancreatic Masses: A Prospective Comparative Study|Completed||N/A|219|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:18:22.558229|2017-10-11 02:18:22.558229
NCT01727908|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-09-26|||November 2012||2012-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|FamGaCan||Screening for Familial Gastric Cancer in First Degree Relatives|Screening for Familial Gastric Cancer in First Degree Relatives|Active, not recruiting||N/A|79|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 02:18:22.631556|2017-10-11 02:18:22.631556
NCT01727895|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2014-07-01|2014-07-01||May 2013||2013-05-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|BG||Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans|Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans, a Pilot Study|Completed||N/A|15|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 02:18:22.721394|2017-10-11 02:18:22.721394
NCT01727882|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2012-11-12|||December 2009||2009-12-01|November 2012|2012-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Automated Telephone Follow-up in the Swedish Prison and Probation Services|Automated Telephone Follow-up in the Swedish Prison and Probation Services. A Randomized Controlled Trail.|Completed||N/A|108|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 02:18:22.924395|2017-10-11 02:18:22.924395
NCT01727869|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-04-02|||October 2012||2012-10-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer||Completed||Phase 1|56|Actual|Regeneron Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:18:23.009426|2017-10-11 02:18:23.009426
NCT01727856|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-11-05|||October 2012||2012-10-01|November 2014|2014-11-01||||December 2012|Actual|2012-12-01||Observational|||Usability and Reliability of a New Physical Therapy Tool|An Evaluation of a Novel Motion Tracking Enabled Knee Physical Therapy Application With Healthy Patients to Assess Reliability and Usability|Completed||N/A|20|Actual|Reflexion Health, Inc.|||1||f||||f||||||||||2017-10-11 02:18:23.099677|2017-10-11 02:18:23.099677
NCT01727843|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2013-05-13|||April 2013||2013-04-01|May 2013|2013-05-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures|Phase III Examining the Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures: a Randomized Control Trial.|Unknown status|Recruiting|Phase 3|126|Anticipated|Queen's University||2|||f||||t||||||||||2017-10-11 02:18:23.184414|2017-10-11 02:18:23.184414
NCT01727830|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-12|||June 2012||2012-06-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Hemodilution and Coagulopathy With 3 Colloids|Influence of Hemodilution on Coagulation, pH, Platelet Function, Laboratory Values and ROTEM in Volunteers Using HES 6%, Gelatine and Balanced Gelatine and the Reversal of Coagulopathy With F XIII and Fibrinogen|Completed||Phase 4|12|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 02:18:23.267171|2017-10-11 02:18:23.267171
NCT01727817|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-09-29|||January 2013||2013-01-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (Italy)|Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy|Completed||N/A|5|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 02:18:23.335373|2017-10-11 02:18:23.335373
NCT01727804|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2012-11-12|||August 2009||2009-08-01|August 2012|2012-08-01||||November 2012|Actual|2012-11-01||Interventional|||Neodymiun:Yttrium Aluminum Garnet Laser in Caries Prevention of Primary Teeth: One-year Follow-up|Clinical Effect of Neodymiun:Yttrium Aluminum Garnet Laser in Occlusal Caries Prevention of Primary Teeth: One Year Follow up.|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 02:18:23.420205|2017-10-11 02:18:23.420205
NCT01727791|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-04-11|2016-04-11||December 2012||2012-12-01|April 2016|2016-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||The baseline analysis population included participants who received at least 1 dose of study medication.|A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women|A Multiple Dose Pharmacokinetic Open-label Study Of Pregabalin (Lyrica Registered) In Healthy Lactating Women|Completed||Phase 4|10|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 02:18:23.498294|2017-10-11 02:18:23.498294
NCT01727778|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-10-20|||October 2012||2012-10-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma|Open-label, Single-centre, Phase I, Multi-dose Escalating Study to Investigate the Safety and Preliminary Efficacy of an i.v. Infusion of the Anti-GRP78 Monoclonal IgM Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|12|Actual|Patrys Ltd.||1|||f||||t||||||||||2017-10-11 02:18:23.914957|2017-10-11 02:18:23.914957
NCT01727765|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-06-02|||February 2014||2014-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Inspiratory Muscle Training and Asthma|Inspiratory Muscle Training as a Novel Approach in the Treatment of Asthma|Completed||N/A|16|Actual|University of Portsmouth||2|||f||||f||||||||||2017-10-11 02:18:24.192842|2017-10-11 02:18:24.192842
NCT01727752|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-03-29|||October 2007||2007-10-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|FELIX||A Randomized Controlled Trial Comparing Surgical Decompression With an Interlaminar Implant in Patients With Intermittent Neurogenic Claudication Caused by Lumbar Stenosis|A Randomized Controlled Trial Comparing Surgical Decompression With an Interlaminar Implant in Patients With Intermittent Neurogenic Claudication Caused by Lumbar Stenosis|Completed||N/A|386|Actual|Paradigm Spine||2|||f||||f||||||||||2017-10-11 02:18:24.265221|2017-10-11 02:18:24.265221
NCT01727739|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-09-18|||November 2012||2012-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Tibial Tunnel Widening in Anterior Cruciate Ligament (ACL) Reconstruction-Comparing Two Bioscrews|Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews: A Prospective Randomized Clinical Trial|Active, not recruiting||N/A|80|Actual|Panam Clinic||2|||f||||f||||||||||2017-10-11 02:18:24.355072|2017-10-11 02:18:24.355072
NCT01698554|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-01-27|2015-01-27||November 2012||2012-11-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Bimatoprost in the Treatment of Eyelash Hypotrichosis||Completed||Phase 3|464|Actual|Allergan||4|||f||||f||||||||||2017-10-11 02:27:10.744982|2017-10-11 02:27:10.744982
NCT01727726|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2016-11-29|||December 2012||2012-12-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial|A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator Controlled Trial of Flexible-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial|Completed||Phase 3|2182|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||f||||||||||2017-10-11 02:18:24.428998|2017-10-11 02:18:24.428998
NCT01727713|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-09-17|2015-08-04||January 2013||2013-01-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|Completed||Phase 3|110|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 02:18:24.721226|2017-10-11 02:18:24.721226
NCT01727700|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-02-12|2015-01-09|2014-07-28|November 2012||2012-11-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|Completed||Phase 3|133|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||f||||||||||2017-10-11 02:18:25.701628|2017-10-11 02:18:25.701628
NCT01727687|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-11-12|||August 2011||2011-08-01|November 2012|2012-11-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Investigation of Road-crossing Safety Before and After Training Between Parkinson Disease Pedestrians and Older Pedestrians|An Investigation of Road Crossing Safety Before and After Training Between Parkinson Disease Pedestrians and Older Pedestrians|Unknown status|Active, not recruiting|N/A|60|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 02:18:26.326894|2017-10-11 02:18:26.326894
NCT01727674|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2012-11-12|||November 2012||2012-11-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||Exploring the Experience of Communication for Patients With Depression|Exploring the Experience of Communication for Patients With Depression|Unknown status|Not yet recruiting|N/A|12|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 02:18:26.409747|2017-10-11 02:18:26.409747
NCT01727661|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2013-03-06|||February 2012||2012-02-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Cardiopulmonary Fitness, Lung Function, Muscular Oxygen Saturation, and Quality of Life in T1DM|Cardiopulmonary Fitness, Lung Function, Muscular Oxygen Saturation, and Quality of Life in Patients With Type 1 Diabetes Mellitus|Completed||N/A|40|Actual|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 02:18:26.8982|2017-10-11 02:18:26.8982
NCT01727648|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-12-19|||August 2012||2012-08-01|December 2012|2012-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of RAT in Sequential Combination With CIT in Stroke Rehabilitation|Effects of Robot-Assisted Therapy in Sequential Combination With Constraint-Induced Therapy in Stroke Rehabilitation|Unknown status|Recruiting|N/A|92|Anticipated|National Taiwan University Hospital||4|||f||||f||||||||||2017-10-11 02:18:26.985529|2017-10-11 02:18:26.985529
NCT01727635|ClinicalTrials.gov processed this data on October 10, 2017|2009-10-21|2012-11-12|||October 2009||2009-10-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||The Long-term Effects of Body-mind-spirit Group Therapy|The Long-term Effects of Body-mind-spirit Group Therapy on Close Relationships, Sleeping Quality, Depression, Quality of Life, Meaning of Life, and Saliva Cortisol Responses in Breast Cancer Survivors and Partners|Completed||Phase 2/Phase 3|60|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 02:18:27.103379|2017-10-11 02:18:27.103379
NCT01727622|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-06-26|||August 2012||2012-08-01|June 2017|2017-06-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Arterial Spin Labeling (ASL) MRI for Cognitive Decline|Optimized Arterial Spin Labeling MRI for Cognitive Decline|Active, not recruiting||N/A|120|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 02:18:27.189309|2017-10-11 02:18:27.189309
NCT01727609|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-05-02|||February 2013||2013-02-01|May 2017|2017-05-01|January 31, 2019|Anticipated|2019-01-31|January 2019|Anticipated|2019-01-01||Interventional|SIFT||Speed of Increasing Milk Feeds Trial|A Multi-centre Randomised Controlled Trial of Two Speeds of Daily Increment of Milk Feeding in Very Preterm or Very Low Birth Weight Infants|Active, not recruiting||N/A|2804|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 02:18:27.297465|2017-10-11 02:18:27.297465
NCT01727596|ClinicalTrials.gov processed this data on October 10, 2017|2009-12-18|2012-11-15|||April 2009||2009-04-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||The Effects and Predictors of Patella Taping in the Treatment of Patellafemoral Pain Syndrome|The Effects and Predictors of Patella Taping in the Treatment of Patellafemoral Pain Syndrome|Completed||N/A|100|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 02:18:27.726034|2017-10-11 02:18:27.726034
NCT01727583|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-11-07|||September 2012||2012-09-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients|Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients|Completed||N/A|18|Actual|Nestlé||5|||f||||f||||||||||2017-10-11 02:18:27.799312|2017-10-11 02:18:27.799312
NCT01727570|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2014-11-18|||September 2012||2012-09-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Prehabilitation to Overcome the Stress of Surgery: the Role of Nutrition in Enhancing Postoperative Functional Capacity|Prehabilitation to Overcome the Stress of Surgery: the Role of Nutrition in Enhancing Postoperative Functional Capacity|Completed||N/A|60|Actual|McGill University Health Center||2|||f||||t||||||||||2017-10-11 02:18:27.892529|2017-10-11 02:18:27.892529
NCT01727557|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-03-15|||February 2012||2012-02-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Anesthetic Technique for AV Fistulae Creation||Recruiting||Phase 4|175|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-10-11 02:18:27.980823|2017-10-11 02:18:27.980823
NCT01727544|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2014-02-11|||August 2012||2012-08-01|February 2014|2014-02-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Vestibular Function Outcome After Cartilage Cap Occlusion Surgery|Objective Assessment of Vestibular Function Outcome After Cartilage Cap Occlusion Surgery for Dehiscent Superior Semicircular Canal|Withdrawn||Early Phase 1|0|Actual|Mayo Clinic||2||Changed to a retrospective chart review|f||||f||||||||||2017-10-11 02:18:28.076572|2017-10-11 02:18:28.076572
NCT01727531|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-04-07|||December 2008||2008-12-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy|IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine in Brain Metastasis Radiotherapy.|Completed||N/A|20|Actual|Main Line Health||1|||f||||f||||||||||2017-10-11 02:18:28.166861|2017-10-11 02:18:28.166861
NCT01727518|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2016-01-16|||October 2011||2011-10-01|January 2016|2016-01-01|October 2023|Anticipated|2023-10-01|May 2016|Anticipated|2016-05-01||Observational|LEAD||The Austrian LEAD (Lung hEart sociAl boDy) Study|The Austrian LEAD (Lung hEart sociAl boDy) Study|Enrolling by invitation||N/A|10000|Anticipated|LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology|||1||f||||f||||||Samples With DNA|"     Samples of urine and blood   "|||2017-10-11 02:18:28.260961|2017-10-11 02:18:28.260961
NCT01727505|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-01-10|2016-08-29||November 2012||2012-11-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Volume Guarantee Ventilation in Preterm Infants With Frequent Episodes of Hypoxemia|Volume Guarantee Ventilation in Preterm Infants With Frequent Episodes of Hypoxemia|Completed||N/A|30|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 02:18:28.446558|2017-10-11 02:18:28.446558
NCT01727492|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2013-11-05|||November 2012||2012-11-01|November 2013|2013-11-01||||||||Interventional|||Prevention of Noise-induced Damage by Use of Antioxidants||Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Antwerp||2|||f||||||||||||||2017-10-11 02:18:28.923857|2017-10-11 02:18:28.923857
NCT01727479|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-12-02|||August 2012||2012-08-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Ribose and Sport Performance|The Effect of Ribose on Performance and Recovery in Athletes|Completed||N/A|18|Actual|Laval University||2|||f||||||||||||||2017-10-11 02:18:29.046492|2017-10-11 02:18:29.046492
NCT01727466|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-11-12|||August 2006||2006-08-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Treatment for Children With Autism and Anxiety|A Randomized Trial: Group Cognitive Behavior Therapy for Children With High-Functioning Autism Spectrum Disorders and Anxiety|Completed||N/A|50|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 02:18:29.16555|2017-10-11 02:18:29.16555
NCT01727453|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-09-17|||December 2011||2011-12-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|HEPACO||Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.|Randomized Controlled Trial to Compare Treatment With Oral Anticoagulation With Antagonists of vitaminK vs Low Molecular Weight Heparin(Bemiparin) in Patients With Anticoagulation Criteria and an Episode of Gastrointestinal Bleeding.|Completed||Phase 4|40|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 02:18:29.257369|2017-10-11 02:18:29.257369
NCT01727440|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-08-23|||September 2011||2011-09-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|SA||Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment|Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment|Completed||N/A|123|Actual|Duke University|||1||f||||t||||||Samples With DNA|"     Whole blood collected in three 2-mL EDTA tubes   "|||2017-10-11 02:18:29.389403|2017-10-11 02:18:29.389403
NCT01727427|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-12-02|||November 2012||2012-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients|Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients|Recruiting||N/A|610|Anticipated|G. d'Annunzio University|||1||f||||t||||||||||2017-10-11 02:18:29.507351|2017-10-11 02:18:29.507351
NCT01727414|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-06-19|2017-04-04||June 2006||2006-06-01|June 2017|2017-06-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional||Children meeting DSM-IV criteria for ADHD-inattentive type are in the Inattentive Type Arm, while children meeting DSM-IV criteria for ADHD-combined type are in the Combined Type Arm.|Attention Deficit Disorder Medication Response Study|Medication Response in Children With Predominately Inattentive Type ADHD|Completed||Phase 4|171|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||Undecided||2017-10-11 02:18:29.814218|2017-10-11 02:18:29.814218
NCT01727401|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-12-02|||November 2012||2012-11-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|FAITH||Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia|Thromboprophylaxis With Fondaparinux of Deep Vein Thrombosis and Pulmonary Embolism in the Acutely-ill Medical Inpatients With Thrombocytopenia|Active, not recruiting||Phase 4|117|Anticipated|G. d'Annunzio University||1|||f||||t||||||||||2017-10-11 02:18:30.100239|2017-10-11 02:18:30.100239
NCT01727388|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-11-26|||November 2012||2012-11-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|RIFIONA||Informativeness to Digital Rectal Examination|Prospective Randomized Study Comparing the Results of Digital Rectal Examination in the Supine and Lateral Decubitus|Completed||Phase 3|320|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-11 02:18:30.180711|2017-10-11 02:18:30.180711
NCT01727375|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2015-10-16|||July 2013||2013-07-01|October 2015|2015-10-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|PreDeLight-ICU||Prevention of Delirium With Light in the Intensive Care Unit|Prevention of Delirium With Light in the Intensive Care Unit|Withdrawn||N/A|0|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:18:30.254483|2017-10-11 02:18:30.254483
NCT01727362|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-07-21|||October 2012||2012-10-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy|Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy- A Pragmatic Randomized Trial|Completed||N/A|140|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:18:30.330107|2017-10-11 02:18:30.330107
NCT01727349|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-01-26|||December 2011||2011-12-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DESCENDANCE||Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk|Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.|Recruiting||N/A|3000|Anticipated|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||||2017-10-11 02:18:30.41003|2017-10-11 02:18:30.41003
NCT01727336|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-07-14|||December 2012||2012-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma|A Phase 2 Randomized, Double-Blind Study of Dalantercept and Axitinib Compared to Placebo and Axitinib in Patients With Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 2|174|Anticipated|Acceleron Pharma, Inc.||2|||f||||t||||||||||2017-10-11 02:18:30.529227|2017-10-11 02:18:30.529227
NCT01727310|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2014-05-24|||November 2012||2012-11-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|PRESSEVAL||Filling Pressures of the Left Ventricle in Patients With Significant Aortic Stenosis|Filling Pressures of the Left Ventricle in Patients With Significant Aortic Stenosis: Study of Echocardiographic Parameters Compared to Invasive Evaluation|Completed||N/A|100|Anticipated|University Hospital, Limoges|||1||f||||f||||||||||2017-10-11 02:18:30.813034|2017-10-11 02:18:30.813034
NCT01727297|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-02-21|||November 13, 2012|Actual|2012-11-13|February 2017|2017-02-01|April 28, 2017|Anticipated|2017-04-28|January 13, 2017|Actual|2017-01-13||Interventional|||REVEAL AF: Incidence of AF in High Risk Patients|REVEAL AF: Incidence of AF in High Risk Patients|Active, not recruiting||N/A|450|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f|f|t|f|f|f|||No||2017-10-11 02:18:30.882129|2017-10-11 02:18:30.882129
NCT01727284|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-04-04|||November 2012||2012-11-01|April 2017|2017-04-01|January 2022|Anticipated|2022-01-01|January 2019|Anticipated|2019-01-01||Interventional|||MR-Guided Cryoablation of Prostate Bed Recurrences|Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences|Recruiting||N/A|100|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:18:31.074407|2017-10-11 02:18:31.074407
NCT01727271|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-09-18|||August 2013||2013-08-01|September 2013|2013-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)|An Open-Label, Pilot, Randomized, Multi-Center Study to Compare Efficacy and Safety of Tenofovir Monotherapy Alone With Tenofovir Monotherapy Followed by Concurrent Combination of Pegylated Interferon-Alpha-2b and Tenofovir or Tenofovir Monotherapy Followed by Sequential Therapy of Pegylated Interferon-Alpha-2b and Tenofovir in HBeAG-Positive Chronic Hepatitis B Patients With Raised ALT.|Withdrawn||Phase 4|0|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 02:18:31.181749|2017-10-11 02:18:31.181749
NCT01727258|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-06-08|2015-05-20||December 2012||2012-12-01|April 2015|2015-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Test on a New Experimental Mouth Rinse for Relieving Tooth Sensitivity|Evaluation of an Experimental Mouth Rinse Device for Relieving Dentinal Hypersensitivity|Completed||N/A|153|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-10-11 02:18:31.30399|2017-10-11 02:18:31.30399
NCT01727245|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-03-02|||November 2011||2011-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||NEFA (Non Esterified Fatty Acid) , Adipose Factors Behind Insulin Sensitivity|The Role of Adipose Tissue in Atherogenic Conditions in Man - Mechanisms and Interventions|Active, not recruiting||N/A|500|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:18:31.808229|2017-10-11 02:18:31.808229
NCT01727232|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2012-11-12|||January 2007||2007-01-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Observational|||Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia|Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia|Completed||N/A|107|Actual|Henri Mondor University Hospital|||2||f||||f||||||||||2017-10-11 02:18:31.873656|2017-10-11 02:18:31.873656
NCT01727219|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2012-11-18|||December 2012||2012-12-01|February 2011|2011-02-01|May 2013|Anticipated|2013-05-01|February 2013|Anticipated|2013-02-01||Observational|||COPD Assessment Test Can Predict Depression|COPD Assessment Test Can Predict Depression|Unknown status|Not yet recruiting|N/A|600|Anticipated|Hallym University Medical Center|||1||f||||f||||||||||2017-10-11 02:18:31.92744|2017-10-11 02:18:31.92744
NCT01727206|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-02-09|||November 2012||2012-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|||Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease|Open-label, Single-arm, Phase II, Prospective, Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease|Terminated||Phase 2|3|Actual|Ospedale San Raffaele||1|||f||||t||||||||||2017-10-11 02:18:31.985127|2017-10-11 02:18:31.985127
NCT01727193|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2012-11-16|||September 2012||2012-09-01|November 2012|2012-11-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy||Unknown status|Recruiting|Phase 3|158|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 02:18:32.055569|2017-10-11 02:18:32.055569
NCT01727180|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-03-04|2015-03-04||June 2011||2011-06-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|June 2012|Actual|2012-06-01||Observational|||Pruritus in Patients With Chronic Kidney Disease||Completed||N/A|108|Actual|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 02:18:32.146864|2017-10-11 02:18:32.146864
NCT01727167|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-05-18|2016-05-18||February 2014||2014-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional||Collected demographic and clinical characteristics are not reported to protect patient anonymity.|CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle|Effects of Low Level Carbon Monoxide Preconditioning on Human Mitochondrial Biogenesis in Aortic Valve Surgery Patients|Terminated||Phase 1/Phase 2|1|Actual|Duke University|Terminated study due to low accrual.|2||Lack of funding and low accrual.|f||||f||||||||No|Only one subject was recruited. Funding was not obtained. The study was cancelled with the Duke IRB 3/16.|2017-10-11 02:18:33.885116|2017-10-11 02:18:33.885116
NCT01727154|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-07-06|||October 2012||2012-10-01|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|PRIME||Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T|Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T|Terminated||N/A|52|Actual|Dendreon|||1|Completion of 3yr follow up|f||||f||||||Samples With DNA|"     Whole blood, serum, manufacturing samples   "|||2017-10-11 02:18:34.069143|2017-10-11 02:18:34.069143
NCT01727141|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-03-02|2015-05-26||November 2012||2012-11-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.|A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.|Completed||Phase 3|1042|Actual|Novartis||4|||f||||f||||||||||2017-10-11 02:18:34.258465|2017-10-11 02:18:34.258465
NCT01727128|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2014-04-26|||October 2011||2011-10-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Pharmacokinetic Study of BKM120 in Subjects With Hepatic Impairment|A Phase I, Multicenter, Open-label, Single-dose, Parallel Group Study to Assess the Pharmacokinetics of BKM120 in Subjects With Mild, Moderate and Severe Hepatic Impairmen|Completed||Phase 1|31|Actual|Novartis||4|||f||||f||||||||||2017-10-11 02:18:35.952003|2017-10-11 02:18:35.952003
NCT01727115|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2012-11-12|||April 2008||2008-04-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|October 2010|Actual|2010-10-01||Interventional|||Althera® Versus Nutramigen / Cow's Milk Intolerance|Comparison of Two Extensively Hydrolyzed Formulas for the Treatment of Children With Cow's Milk Intolerance|Completed||N/A|116|Actual|Nestlé||2|||f||||t||||||||||2017-10-11 02:18:36.039825|2017-10-11 02:18:36.039825
NCT01727089|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-09-04|||November 1, 2012|Actual|2012-11-01|September 2017|2017-09-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Interventional|||Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer|A Phase II Study of Bevacizumab Alone or in Combination With TRC105 for Advanced Renal Cell Cancer|Completed||Phase 2|88|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 02:18:36.24612|2017-10-11 02:18:36.24612
NCT01727076|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-09-14|||February 15, 2013|Actual|2013-02-15|September 2017|2017-09-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|||Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer|A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 02:18:36.427347|2017-10-11 02:18:36.427347
NCT01727063|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2012-11-12|||January 2006||2006-01-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|MiHeart||Cell Therapy in Severe Chronic Ischemic Heart Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Intramyocardial Injection of Autologous Bone-Marrow Cells in Patients With Severe, Chronic Ischemic Heart Disease Undergoing Coronary Bypass Surgery|Unknown status|Recruiting|Phase 2/Phase 3|200|Anticipated|Ministry of Health, Brazil||2|||f||||t||||||||||2017-10-11 02:18:36.540763|2017-10-11 02:18:36.540763
NCT01727050|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2012-11-16|||June 2007||2007-06-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Fibrin Sealant Spray Versus Mechanical Stapling in Laparoscopic Totally Extraperitoneal Hernioplasty|Randomized Prospective Trial of Fibrin Sealant Spray Versus Mechanical Stapling in Laparoscopic Totally Extraperitoneal Hernioplasty|Completed||Phase 3|129|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:18:36.628605|2017-10-11 02:18:36.628605
NCT01727037|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2012-11-19|||October 2012||2012-10-01|November 2012|2012-11-01||||September 2014|Anticipated|2014-09-01||Interventional|BIABI||Bronchoscopic Intrabullous Autologous Blood Instillation (BIABI) for Emphysema|A Feasibility and Safety Study of Bronchoscopic Intrabullous Autologous Blood Instillation for the Treatment of Severe Bullous Emphysema (BIABI Study)|Unknown status|Recruiting|Phase 2|30|Anticipated|Chelsea and Westminster NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 02:18:36.702811|2017-10-11 02:18:36.702811
NCT01727024|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-01-23|2016-11-09||April 2013||2013-04-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|INHALATOR|The analysis population contained all 140 participants who were randomized.|Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients|Study to Evaluate the Preference, Satisfaction and Correct Use of Inhalers in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|140|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:18:36.820663|2017-10-11 02:18:36.820663
NCT01727011|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-11-13|||November 2012||2012-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|June 2014|Actual|2014-06-01||Interventional|SIFEBI||Single Fraction Elderly Breast Irradiation (SiFEBI)|A Phase I-II Trial Evaluating the Toxicity of Early Breast Partial Irradiation in Patients Aged at Least of 70 Years With Breast Cancer at Low Risk of Local Recurrence|Completed||Phase 1/Phase 2|25|Anticipated|Centre Antoine Lacassagne||1|||f||||t||||||||||2017-10-11 02:18:37.192973|2017-10-11 02:18:37.192973
NCT01726998|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2014-02-17|||March 2012||2012-03-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effects of Locomotion Training With Assistance of a Robot-Driven Gait Orthosis in Hemiparetic Patients After Subacute Stroke||Completed||N/A|72|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:18:37.272638|2017-10-11 02:18:37.272638
NCT01726985|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2017-04-10|||November 2012||2012-11-01|November 2012|2012-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|HEART||Model for Heart Failure ExAcerbation Reduction Trial|"Model for Heart Failure ExAcerbation Reduction Trial - Model HEART"|Completed||N/A|230|Actual|The Cleveland Clinic|||1||f||||f||||||||No||2017-10-11 02:18:37.340479|2017-10-11 02:18:37.340479
NCT01726972|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2012-11-14|||November 2012||2012-11-01|November 2012|2012-11-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Observational|||A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty|A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty|Unknown status|Active, not recruiting|N/A|150|Anticipated|Western Orthopaedics Research and Education Foundation|||1||f||||f||||||||||2017-10-11 02:18:37.407089|2017-10-11 02:18:37.407089
NCT01726959|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2013-02-05|||December 2011||2011-12-01|February 2013|2013-02-01||||||||Observational|MRS||Prediction of Methotrexate Response - A Pilot Study||Unknown status|Recruiting|N/A|||Carolinas Healthcare System|||1||f||||||||||||||2017-10-11 02:18:37.453667|2017-10-11 02:18:37.453667
NCT01726192|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-11-13|||August 2012||2012-08-01|November 2012|2012-11-01||||January 2013|Anticipated|2013-01-01||Interventional|HLOCSTIM2||Comparison of Two Techniques for Placement of Perineural Femoral Catheters.|Comparison of Ultrasound Hydrolocalization Technique Versus Neurostimulation for Placement of Continuous Femoral Catheters.|Unknown status|Recruiting|N/A|50|Anticipated|Attikon Hospital||2|||f||||f||||||||||2017-10-11 02:18:46.31214|2017-10-11 02:18:46.31214
NCT01726946|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-03-27||2015-03-06|November 2012||2012-11-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C|A Phase 2, Multicenter, Dose-Ranging Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C|Completed||Phase 2|10|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||||||||||||2017-10-11 02:18:37.521699|2017-10-11 02:18:37.521699
NCT01726933|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2015-12-01|||November 2012||2012-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2014|Actual|2014-10-01||Interventional|||LAS41008 in Moderate to Severe Chronic Plaque Psoriasis|A Multi-center, Randomized, Double-blind, Three-arm, 16 Week, Adaptive Phase III Clinical Study to Investigate the Efficacy and Safety of LAS41008 vs LASW1835 and vs Placebo in Patients With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|839|Actual|Almirall, S.A.||3|||f||||t||||||||||2017-10-11 02:18:37.608641|2017-10-11 02:18:37.608641
NCT01726920|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-12|2016-03-15|||July 2014||2014-07-01|March 2016|2016-03-01||||December 2014|Anticipated|2014-12-01||Interventional|Copérnico||Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.|A Phase III, Multicenter, National, Open, Randomized, Parallel and Comparative Study to Evaluate the Efficacy and Safety of a Fixed-dose Combination of Naratriptan 2,5 mg + Naproxen 500 mg for the Acute Treatment of Migraine.|Withdrawn||Phase 3|0|Actual|Ache Laboratorios Farmaceuticos S.A.||3||Due to budget limitations, the company decided to withdraw this study.|f||||t||||||||||2017-10-11 02:18:37.689884|2017-10-11 02:18:37.689884
NCT01726907|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2012-11-11|||February 2012||2012-02-01|November 2012|2012-11-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||A Prospective Comparison of Robotic and Endoscopic SMG Resection Via Retroauricular Approach||Unknown status|Recruiting|N/A|40|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:18:37.759313|2017-10-11 02:18:37.759313
NCT01726894|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-06-17|||October 2013||2013-10-01|June 2014|2014-06-01||||August 2015|Anticipated|2015-08-01||Interventional|Nano||Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation|A Prospective Development Study Evaluating Focal Therapy Using Irreversible Electroporation (Nanoknife®) in Men With Localised Prostate Cancer|Unknown status|Active, not recruiting|N/A|20|Anticipated|University College London Hospitals||1|||f||||t||||||||||2017-10-11 02:18:37.897663|2017-10-11 02:18:37.897663
NCT01726881|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-01-02|||December 2012||2012-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Predicting Central Pain Among People With a Spinal Cord Injury by Evaluating Mechanisms Regulating Pain and Efficacy Testing of the TENS Apparatus|Predicting Central Pain Among People With a Spinal Cord Injury by Evaluating Mechanisms Regulating Pain and Efficacy Testing of the TENS Apparatus|Enrolling by invitation||N/A|120|Anticipated|Sheba Medical Center||3|||f||||f||||||||||2017-10-11 02:18:37.964036|2017-10-11 02:18:37.964036
NCT01726868|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-10|2016-06-30|||July 2013||2013-07-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Clinical Study to Evaluate the Efficacy of Blood Purification Therapy on Cholesterol Crystal Embolism|Clinical Study to Evaluate the Efficacy of Blood Purification Therapy on Cholesterol Crystal Embolism|Recruiting||Phase 2|35|Anticipated|Japan Community Health Care Organization Sendai Hospital||1|||f||||t||||||||||2017-10-11 02:18:38.039233|2017-10-11 02:18:38.039233
NCT01726855|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-11|2012-11-14|||January 2010||2010-01-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|September 2011|Actual|2011-09-01||Observational|||Prevention of Adhesions Following Flexor Tendon Injury Within Zone II With Vascularized Finger Dorsal Fascial Flap||Completed||N/A|1|Actual|The Second Hospital of Tangshan|||2||f||||t||||||||||2017-10-11 02:18:38.106417|2017-10-11 02:18:38.106417
NCT01726842|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2015-10-27|||October 2010||2010-10-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner|Pediatric Vision Scanner for the Eradication of Amblyopia|Completed||N/A|300|Actual|Rebiscan, Inc.|||3||f||||||||||||||2017-10-11 02:18:38.24986|2017-10-11 02:18:38.24986
NCT01726829|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-04-07|||November 2012||2012-11-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home|Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home, Pilot Study.|Completed||N/A|75|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 02:18:38.322969|2017-10-11 02:18:38.322969
NCT01726816|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-05-01|||October 2012||2012-10-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy|A Phase II, Multicenter, Randomized, Double Blind, Double-dummy, 16-week, Placebo Controlled Study to Evaluate the Efficacy and Safety of Probucol in Patients With Nephropathy Due to Type 2 Diabetes.|Completed||Phase 2|126|Actual|Korea Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:18:38.423864|2017-10-11 02:18:38.423864
NCT01726790|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-11|2012-11-11|||August 2011||2011-08-01|November 2012|2012-11-01|October 2013|Anticipated|2013-10-01|June 2013|Anticipated|2013-06-01||Observational|||Effect of Intravitreal Bevacizumab on Corneal Endothelium|Effect of Intravitreal Bevacizumab on Corneal Endothelium|Unknown status|Recruiting|N/A|37|Anticipated|Khon Kaen University|||1||f||||t||||||||||2017-10-11 02:18:38.66505|2017-10-11 02:18:38.66505
NCT01726777|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-09-15|||October 2012||2012-10-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|EVIDENCE||Effect of Vitamin D Supplementation on Glucose Tolerance in Subjects at Risk for Diabetes With Low Vitamin D.|Effect of Vitamin D Supplementation on Oral Glucose Tolerance in Subjects Exhibiting Marginal Vitamin D Status and an Increased Risk of Developing Diabetes.|Completed||Phase 2|71|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 02:18:38.752764|2017-10-11 02:18:38.752764
NCT01726764|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-12-02|||January 2013||2013-01-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|June 2013|Actual|2013-06-01||Interventional|||Interaction Between St John's Wort and Metformin?|Is There a Pharmacokinetic Interaction Between St John's Wort and Metformin?|Completed||Phase 1|20|Actual|University of Southern Denmark||1|||f||||f||||||||||2017-10-11 02:18:38.870458|2017-10-11 02:18:38.870458
NCT01726738|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-05-31|||October 2012||2012-10-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2, 2017|Actual|2017-04-02||Interventional|||LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations|LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations|Active, not recruiting||Phase 2|17|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:18:39.075125|2017-10-11 02:18:39.075125
NCT01726712|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-01-19|||November 2012||2012-11-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|NSEC||Network Supported Engagement In HIV Care|Network Supported Engagement In HIV Care|Completed||N/A|105|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 02:18:39.256068|2017-10-11 02:18:39.256068
NCT01726699|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2015-04-01|||November 2012||2012-11-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Scripps Tumorgraft Study|Scripps Tumorgraft Study|Completed||N/A|11|Actual|Scripps Translational Science Institute|||1||f||||f||||||Samples With DNA|"     Blood and tissue samples   "|||2017-10-11 02:18:39.338999|2017-10-11 02:18:39.338999
NCT01726686|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-11-24|||February 2010||2010-02-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|July 2011|Actual|2011-07-01||Interventional|||Pain Treatment After TKA With LIA and Intra-articular Continuous Infusion Pump|Evaluation of Intra-articular Continuous Infusion Pump With Ropivacaine in Addition to Local Infiltration Analgesia (LIA) in Total Knee Arthroplasty (TKA). A Placebo Controlled Randomised Trial.|Completed||Phase 4|200|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 02:18:39.414682|2017-10-11 02:18:39.414682
NCT01726673|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-06-26|||September 2012||2012-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Robots Paired With tDCS in Stroke Recovery|Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients|Recruiting||Phase 2|66|Anticipated|Northwell Health||2|||f||||f||||||||||2017-10-11 02:18:39.517208|2017-10-11 02:18:39.517208
NCT01726660|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-12-14|||December 2015||2015-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The General Use of Robots in Stroke Recovery|Pilot Study of the Effects of Protocol-Specific Robotic Arm Therapy in Stroke Recovery|Withdrawn||N/A|0|Actual|Northwell Health||4||Unfunded|f||||f||||||||||2017-10-11 02:18:39.619707|2017-10-11 02:18:39.619707
NCT01726647|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-09|||September 2008||2008-09-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|October 2009|Actual|2009-10-01||Observational|||Metabolism Associated With Abdominal Fat Mass Distribution|Metabolism Associated With Abdominal Fat Mass Distribution|Completed||N/A|40|Actual|Nestlé|||1||f||||f||||||||||2017-10-11 02:18:39.733021|2017-10-11 02:18:39.733021
NCT01726634|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-11|||March 2012||2012-03-01|November 2012|2012-11-01|May 2013|Anticipated|2013-05-01|November 2012|Anticipated|2012-11-01||Interventional|||Performance Evaluation on the Upper Limb Closed Kinetic Chain Test After Scapular Elastic Taping on Jiu Jitsu Practitioners||Unknown status|Recruiting|N/A|64|Anticipated|Federal University of São Paulo||1|||f||||||||||||||2017-10-11 02:18:39.816776|2017-10-11 02:18:39.816776
NCT01726621|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-03-17|2015-07-02||March 2013||2013-03-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||User Evaluation of the MiniMed 620G and 640G Insulin Pumps|A User Evaluation of the MiniMed® 620G and 640G Insulin Pumps and Guardian® Link Transmitter|Completed||N/A|55|Actual|Medtronic Diabetes||1|||f||||f||||||||||2017-10-11 02:18:39.923974|2017-10-11 02:18:39.923974
NCT01726608|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-11|2013-01-28|||November 2012||2012-11-01|January 2013|2013-01-01||||December 2013|Anticipated|2013-12-01||Interventional|||RFN for SIJ Disease Study|A Sham, Controlled, Randomised Trial to Investigate the Effects of Radiofrequency Neurotomy Using Simplicity III® on Patients With Sacroiliac Joint Pain.|Unknown status|Recruiting|Phase 4|30|Anticipated|Barts & The London NHS Trust||2|||f||||t||||||||||2017-10-11 02:18:40.127768|2017-10-11 02:18:40.127768
NCT01726595|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-08-26|||January 2013||2013-01-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|URHC||Ultrasound Measurement of Reactive Hyperemia in Critical Care|Ultrasound Measurement of Reactive Hyperemia in Critical Care: Prognostic and Pathophysiologic Significance|Recruiting||N/A|252|Anticipated|University of Rochester|||3||f||||f||||||Samples With DNA|"     Blood and urine specimens will be obtained within 48 hours of diagnosis of severe sepsis or     severe non-infectious systemic inflammatory response syndrome. Subsequent blood and urine     samples will be obtained 3-5 days after the first set of samples, within 48 hours of ICU     discharge, and within 48 hours of hospital discharge. Samples will analyzed immediately or     stored at -80 degrees celsius until use.   "|||2017-10-11 02:18:40.215352|2017-10-11 02:18:40.215352
NCT01726582|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-04-28|||November 2011||2011-11-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||"Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery (Personalized Medicine)"|A Prospective Phase II Trial of Molecular Profiling to Guide Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas|Active, not recruiting||Phase 2|130|Anticipated|Medical College of Wisconsin||10|||f||||t||||||||||2017-10-11 02:18:40.315502|2017-10-11 02:18:40.315502
NCT01726569|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-10|2013-04-10|||December 2012||2012-12-01|April 2013|2013-04-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Post-operative Satisfaction With Glaucoma Surgery Trial|A Randomized Trial of the Impact of Multifaceted Education on Post-operative Satisfaction With Glaucoma Surgery in Rural China|Unknown status|Active, not recruiting|N/A|356|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 02:18:40.473011|2017-10-11 02:18:40.473011
NCT01726556|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-01-09|||April 2011||2011-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|RISE||A Trial of Rigid Versus Semirigid Thoracoscopy in the Evaluation of Exudative Pleural Effusions|A Randomized Controlled Trial of Rigid Versus Semirigid Thoracoscopy in the Evaluation of Exudative Pleural Effusions|Completed||N/A|70|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 02:18:40.557755|2017-10-11 02:18:40.557755
NCT01726543|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-11-10|||February 2011||2011-02-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Glaucoma and Cataract|Comparison of Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy Combined With Phacoemulsification to Treat Glaucoma and Cataract. A Randomised, Prospective Study.|Unknown status|Recruiting|N/A|80|Anticipated|Military Institute of Medicine, Poland||2|||f||||||||||||||2017-10-11 02:18:40.654134|2017-10-11 02:18:40.654134
NCT01726530|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-10|2012-11-14|||June 2011||2011-06-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|October 2011|Actual|2011-10-01||Interventional|||Transdermal Fentanyl Patch for Postoperative Analgesia After Abdominal Surgery: a Randomized Placebo-controlled Trial|Transdermal Fentanyl Patch for Postoperative Analgesia After Abdominal Surgery: a Randomized Placebo-controlled Trial|Completed||N/A|50|Actual|Khon Kaen University||2|||f||||f||||||||||2017-10-11 02:18:40.756019|2017-10-11 02:18:40.756019
NCT01726517|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-10|2014-11-07|2014-11-07|2014-03-17|October 2012||2012-10-01|November 2014|2014-11-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional||Safety Analysis Set: participants received at least 1 dose of study drug|Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects|A Phase 2, Randomized, Open-Label Study of Sofosbuvir/GS-5885 Fixed-Dose Combination ± Ribavirin in Subjects With Chronic Genotype 1 HCV Infection|Completed||Phase 2|100|Actual|Gilead Sciences||5|||f||||f||||||||||2017-10-11 02:18:40.865225|2017-10-11 02:18:40.865225
NCT01726504|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2016-01-21|2015-09-03||October 2012||2012-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||The Efficacy and Safety Study of Electro-acupuncture for Severe Chronic Functional Constipation|The Efficacy and Safety Study of Electro-acupuncture for Severe Chronic Functional Constipation - a Multi-center, Randomized Controlled Trial|Completed||Phase 2|1075|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|The 8-week treatment and 12-week follow-up may not be long enough for EA to show its specific therapeutic effect. Efficacy of electro-acupuncture in relieving severe constipation was evaluated without classifying the types of constipation.|2|||f||||t||||||||||2017-10-11 02:18:42.280146|2017-10-11 02:18:42.280146
NCT01726491|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-10-27|||August 2012||2012-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Epigenetics and the Origin of Muscle Insulin Resistance in Humans|Epigenetics and the Origin of Muscle Insulin Resistance in Humans|Recruiting||N/A|72|Anticipated|Mayo Clinic|||3||f||||f||||||Samples With DNA|"     thigh muscle biopsies bloodsamples   "|||2017-10-11 02:18:43.158415|2017-10-11 02:18:43.158415
NCT01726478|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2012-11-09|||February 2011||2011-02-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital|Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital; Adouble Blinded Clinical Trial.|Completed||N/A|386|Actual|Makerere University||2|||f||||t||||||||||2017-10-11 02:18:43.260299|2017-10-11 02:18:43.260299
NCT01726465|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-11-09|||November 2012||2012-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|MENHIR||Methylprednisolone N Acetylcysteine in Hepatic Resections|Phase II Randomized Double Blind Trial of Methylprednisolone and N-acetylcysteine in Hepatic Resections.|Terminated||Phase 2|50|Actual|Istituto Clinico Humanitas||3||The first phase was completed|f||||f||||||||||2017-10-11 02:18:43.359678|2017-10-11 02:18:43.359678
NCT01726452|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-08-09|||August 2012||2012-08-01|August 2017|2017-08-01||||January 2024|Anticipated|2024-01-01||Interventional|||NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)|Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction|Recruiting||Phase 3|366|Anticipated|Cancer Trials Ireland||2|||f||||||||||||||2017-10-11 02:18:43.47398|2017-10-11 02:18:43.47398
NCT01726439|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-04-10|||December 2012||2012-12-01|December 2016|2016-12-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|EVOLVE||Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China|A 5-year Prospective and Observational Study to Evaluate the Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Chronic Hepatitis B (CHB) Patients Naive to NUC in Real World Practice at Hospitals in Tier 2 Cities in China (the EVOLVE Study)|Active, not recruiting||N/A|3435|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||Samples With DNA|"     Serum   "|||2017-10-11 02:18:43.694674|2017-10-11 02:18:43.694674
NCT01726426|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2014-05-02|||April 2013||2013-04-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Modulation of Anaerobic Gut Bacteria of Arsenicosis Patients by Probiotics|Modulation of Anaerobic Gut Bacteria in Palmer Arsenical Keratosis Patients by Supplementation With Probiotics|Completed||N/A|90|Actual|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||3|||f||||f||||||||||2017-10-11 02:18:43.875598|2017-10-11 02:18:43.875598
NCT01726413|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2014-10-01|||November 2012||2012-11-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).|A Phase II, 4-Week Randomised, Double-Blind, Parallel Group, Placebo Controlled Proof of Concept Study to Evaluate Efficacy, Safety and Tolerability of GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy.|Completed||Phase 2|138|Actual|Glenmark Pharmaceuticals Ltd. India||2|||f||||f||||||||||2017-10-11 02:18:43.950572|2017-10-11 02:18:43.950572
NCT01726387|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2016-09-28|||March 2013||2013-03-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SMADS||Self-Management for Anxiety, Depression and Somatoform Disorders|Self-Management Support in Primary Care|Completed||N/A|364|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||Undecided||2017-10-11 02:18:44.159566|2017-10-11 02:18:44.159566
NCT01726374|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-09-18|||February 2010||2010-02-01|September 2015|2015-09-01|August 2019|Anticipated|2019-08-01|August 2016|Anticipated|2016-08-01||Interventional|111||Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours|A Single Group Trial Evaluating One Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Tumours of the Testis (NSGCTT)|Active, not recruiting||Phase 3|236|Anticipated|Institute of Cancer Research, United Kingdom||1|||f||||t||||||||||2017-10-11 02:18:44.261418|2017-10-11 02:18:44.261418
NCT01726361|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2013-11-06|||November 2012||2012-11-01|November 2013|2013-11-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Multidimensional Treatment Foster Care for Adolescents|Multidimensional Treatment Foster Care for Adolescents|Withdrawn||Phase 4|0|Actual|The Danish National Centre For Social Research||2||We were not able to recruit families|f||||f||||||||||2017-10-11 02:18:44.395257|2017-10-11 02:18:44.395257
NCT01726348|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-11-30|||January 2014||2014-01-01|November 2015|2015-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients|A Post-Marketing Surveillance Study on the Safety and Effectiveness of Darunavir on Filipino Patients With Human Immunodeficiency Virus-Type I (HIV-1) Infection|Withdrawn||Phase 4|0|Actual|Janssen Pharmaceutica|||1|The company decided to cancel this study in conformity with PH FDA Circular 2013-004|f||||f||||||||||2017-10-11 02:18:44.478439|2017-10-11 02:18:44.478439
NCT01726335|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2014-04-10|2013-04-18||January 2006||2006-01-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia|An Open-Label Study of Oral Antipsychotics Replacement by Prolonged Release Risperidone (Risperdal Consta) in Schizophrenic Subjects With Bad Adhesion to the Treatment|Completed||Phase 4|53|Actual|Janssen-Cilag Ltd.||1|||f||||f||||||||||2017-10-11 02:18:44.566475|2017-10-11 02:18:44.566475
NCT01726322|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2016-10-05|||September 2012||2012-09-01|October 2016|2016-10-01||||September 2018|Anticipated|2018-09-01||Observational|||Anti-Mullerian Hormone Study. ICORG 10-16, V2|A Study to Determine Alteration of Anti-mullerian Hormone (AMH) Concentrations in Premenopausal Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Breast Cancer|Recruiting||N/A|250|Anticipated|Cancer Trials Ireland|||1||f||||||||||||||2017-10-11 02:18:45.034694|2017-10-11 02:18:45.034694
NCT01726309|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-08-09|||May 2011||2011-05-01|August 2017|2017-08-01||||December 2019|Anticipated|2019-12-01||Observational|||Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4|Correlation of Single Nucleotide Polymorphism (SNP) Profile of Domain III of EGFR to Skin and/or Eye Toxicity and Disease Response to Treatment With Cetuximab or Panitumumab - SNP and Cetuximab or Panitumumab Response|Recruiting||N/A|150|Anticipated|Cancer Trials Ireland|||2||f||||||||||||||2017-10-11 02:18:45.227008|2017-10-11 02:18:45.227008
NCT01726296|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2017-04-05|||January 2013||2013-01-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care|Adherence to NCCN Survivorship Care Guidelines in Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care|Completed||N/A|1440|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-11 02:18:45.382829|2017-10-11 02:18:45.382829
NCT01726283|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-08-20|||October 2011||2011-10-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia|Combined Collagen Crosslinking/Ultraviolet-A and Photorefractive Keratectomy or LASIK in Forme Fruste Keratoconus or Eyes With Potentially Elevated Risk of Ectasia|Completed||N/A|22|Anticipated|Cxlusa|||2||f||||f||||||||||2017-10-11 02:18:45.473318|2017-10-11 02:18:45.473318
NCT01726270|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2014-03-25||2014-03-25|November 2012||2012-11-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms|A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment|Completed||Phase 2|689|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:18:45.56321|2017-10-11 02:18:45.56321
NCT01726257|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-10-20|||December 2013||2013-12-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|June 2016|Actual|2016-06-01||Interventional|EVAS IDE||Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System|Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System: A Pivotal and Continued Access Study|Recruiting||N/A|429|Anticipated|Endologix||1|||f||||t||||||||||2017-10-11 02:18:45.698579|2017-10-11 02:18:45.698579
NCT01726244|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2013-03-04|||December 2012||2012-12-01|November 2012|2012-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|AUTOCUID||Self-care Program in the Prevention of Admissions of Patients|Effectiveness of an Self-care Program in the Prevention of Admissions of Patients With Hospitalizations Potentially Avoidable: Randomized Clinical Trial|Unknown status|Recruiting|N/A|144|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-11 02:18:46.022273|2017-10-11 02:18:46.022273
NCT01726231|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2013-12-24|||November 2012||2012-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Evaluation of Abdominal Wall Lifting During Laparoscopic Direct Trocar Insertion|Evaluation of Abdominal Wall Lifting During Laparoscopic Direct Trocar Insertion|Completed||N/A|40|Actual|Bagcilar Training and Research Hospital|||1||f||||f||||||||||2017-10-11 02:18:46.106549|2017-10-11 02:18:46.106549
NCT01726205|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-11-09|||October 2008||2008-10-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy||Completed||Phase 4|45|Actual|Attikon Hospital||3|||f||||f||||||||||2017-10-11 02:18:46.241607|2017-10-11 02:18:46.241607
NCT01724515|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2014-05-08|||September 2012||2012-09-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||PGC-1 and Mitochondrial Dysfunction in Diabetes|PGC-1 and Mitochondrial Dysfunction in Diabetes|Completed||N/A|16|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 02:19:10.492278|2017-10-11 02:19:10.492278
NCT01726179|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-09-28|||December 2012||2012-12-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Proximal Caries Infiltration|Efficacy of Resin Infiltration of Proximal Caries Lesions in Primary Molars: Randomized Clinical Trial|Active, not recruiting||N/A|66|Anticipated|DMG Dental Material Gesellschaft mbH||2|||f||||f||||||||||2017-10-11 02:18:46.401516|2017-10-11 02:18:46.401516
NCT01726166|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-07-24|||April 2013||2013-04-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|SPA||Suprapubic Aspiration Versus Urinary Catheterization In Neonates.|A Randomized Controlled Trial: Suprapubic Aspiration Versus Urinary Catheterization in the Neonatal Intensive Care Unit.|Terminated||N/A|49|Actual|Children's Hospital of Eastern Ontario||2||Slow recruitment over 3 yrs (n=47). No chance to reach sample size (n=~160).|f||||f||||||||||2017-10-11 02:18:46.474396|2017-10-11 02:18:46.474396
NCT01726153|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-09|||November 2012||2012-11-01|November 2012|2012-11-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||A Pilot Trial of an Individualized Web-Based Condom Use Intervention|A Pilot Randomized Control Trial (RCT) of an Individualized Condom-HIM Web-based Intervention for Condom USe Among HIV+ Gay Males|Unknown status|Recruiting|Early Phase 1|60|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 02:18:46.559993|2017-10-11 02:18:46.559993
NCT01726140|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-07-10|||April 2013||2013-04-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|CRHACS||CPAP Reduces Hypoxemia After Cardiac Surgery|CPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A Randomized Controlled Trial|Recruiting||N/A|960|Anticipated|University of Turin, Italy||2|||f||||f||||||||||2017-10-11 02:18:46.642801|2017-10-11 02:18:46.642801
NCT01726127|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-10-05|||November 2012||2012-11-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Green Vegetables and Women's Health|Effect of Cruciferous Vegetables or a Cruciferous Supplement on Urinary Estrogen Metabolites in Premenopausal Women|Completed||N/A|66|Actual|University of Wisconsin, Madison||3|||f||||f||||||||||2017-10-11 02:18:46.734592|2017-10-11 02:18:46.734592
NCT01726114|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-03-23|||June 2012||2012-06-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|Spectrum||A Clinical Study of the C8 MediSensors Optical Glucose Monitor™|A Clinical Study to Evaluate the Performance of the C8 MediSensors Optical Glucose Monitor™ During On-Site Testing and Real Time Use Monitoring|Completed||N/A|86|Actual|C8 MediSensors, Inc.||1|||f||||f||||||||||2017-10-11 02:18:46.81742|2017-10-11 02:18:46.81742
NCT01726088|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-11-09|||August 2012||2012-08-01|November 2012|2012-11-01|May 2014|Anticipated|2014-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Modafinil in the Treatment of PTSD (Posttraumatic Stress Disorder)|A Double-Blind, Placebo-Controlled Trial of Modafinil in OEF/OIF Combat Veterans With PTSD|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Biomedical Research Foundation||2|||f||||f||||||||||2017-10-11 02:18:46.905824|2017-10-11 02:18:46.905824
NCT01726075|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-01-11|||February 2013||2013-02-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|EUROCONDOR||Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy|Neurodegeneration as Early Event in Pathogenesis of Diabetic Retinopathy:Multicentric, Prospective, Ph. II-III,Random.Controlled Trial to Assess Efficacy of Neuroprotective Drugs Administered Topically to Prevent/Arrest Diabetic Retinopathy|Completed||Phase 2/Phase 3|450|Actual|BCN Peptides||3|||f||||t||||||||||2017-10-11 02:18:47.013762|2017-10-11 02:18:47.013762
NCT01726062|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-10-24|||August 2012||2012-08-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes|Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes (The Baby's Breath II Project)|Recruiting||Phase 2|396|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 02:18:47.167591|2017-10-11 02:18:47.167591
NCT01726049|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-02-20|2015-10-16||October 2011||2011-10-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH|Effects of Sildenafil on Pulmonary Arterial Pressure in Patients With Heart Failure With Preserved Ejection Fraction ( HFpEF) and Pulmonary Hypertension|Completed||Phase 3|52|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-10-11 02:18:47.261651|2017-10-11 02:18:47.261651
NCT01726023|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-09-01|2016-02-01||January 2013||2013-01-01|September 2017|2017-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|RECLAIM3|Baseline analysis population is MITT ; Randomized patients who received any amount of study therapy, excluding patients who received both study therapies. 9 patients were randomized but not treated, and one patient received doses of both treatments.|Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections|A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In Hospitalized Adults|Completed||Phase 3|486|Actual|Pfizer||2|||f||||||||||||||2017-10-11 02:18:47.828957|2017-10-11 02:18:47.828957
NCT01726010|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2012-11-08|||September 2012||2012-09-01|September 2012|2012-09-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Interventional|PRO-SET||22-G-Procore Needle for the Diagnosis of SETs of the Upper GI Tract|Endoscopic Ultrasound Guided Biopsy of Subepithelial Tumors of the Upper Gastrointestinal Tract Using the 22-G-Procore Needle|Unknown status|Recruiting|N/A|20|Anticipated|Technische Universität München||1|||f||||||||||||||2017-10-11 02:18:49.621707|2017-10-11 02:18:49.621707
NCT01725997|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-15|||November 2012||2012-11-01|November 2012|2012-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Operative or Conservative Treatment of Acute Acromioclavicular Joint Dislocation|Operative or Conservative Treatment of Acute Acromioclavicular Joint Dislocation Rockwood Grade III and V - a Prospective Randomized Study|Recruiting||N/A|120|Anticipated|St Goran's Hospital||2|||f||||f||||||||||2017-10-11 02:18:49.710746|2017-10-11 02:18:49.710746
NCT00000548|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-03-03|||March 2000||2000-03-01|March 2015|2015-03-01|February 2006|Actual|2006-02-01|||||Interventional|||Inhaled NO in Prevention of Chronic Lung Disease||Completed||Phase 3|||University of California, San Francisco|||||f||||||||||||||2017-10-11 04:19:03.566712|2017-10-11 04:19:03.566712
NCT01725984|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-06-25|2015-03-17||August 2012||2012-08-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Observational|||AMS AdVance and AdVance XP Male Sling Systems for the Treatment of Stress Urinary Incontinence Following Prostatectomy: Evaluation of Safety, Efficacy, and Quality of Life Through Retrospective Chart Review and Prospective Follow-up|AMS AdVance and AdVance XP Male Sling Systems for the Treatment of Stress Urinary Incontinence Following Prostatectomy: Evaluation of Safety, Efficacy, and Quality of Life Through Retrospective Chart Review and Prospective Follow-up|Completed||Phase 3|80|Actual|American Medical Systems|||2||f||||f||||||||||2017-10-11 02:18:49.834494|2017-10-11 02:18:49.834494
NCT01725971|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-10-21|||July 2010||2010-07-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Observational|||Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis|The Use of Forced Oscillation Technique in the Analysis of Respiratory System in Never-smoking Patients With Silicosis:Pathophysiological Study and Evaluation of Diagnostic Accuracy|Completed||N/A|67|Actual|Rio de Janeiro State University|||4||f||||f||||||||||2017-10-11 02:18:50.539741|2017-10-11 02:18:50.539741
NCT01725958|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2014-10-27|||September 2012||2012-09-01|November 2012|2012-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effects of a Nutritional Supplement Combination on Body Weight Management|A Phase IV, Open-label, Parallel Group, Single-Center Study on the Effects of a Nutritional Supplement Combination on Body Weight Management Over a 90-day Period|Completed||Phase 4|60|Actual|Pharmanex||1|||f||||t||||||||||2017-10-11 02:18:50.612434|2017-10-11 02:18:50.612434
NCT01725945|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2014-09-17|||January 2013||2013-01-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The DASH Diet for Adults With Uncontrolled Asthma|A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma|Completed||N/A|90|Actual|Palo Alto Medical Foundation||2|||f||||f||||||||||2017-10-11 02:18:50.717215|2017-10-11 02:18:50.717215
NCT01725932|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-06-16|||March 2012||2012-03-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CaCBT_SH||Randomized Controlled Trial of Cognitive Therapy Based Self Help Manual for Depression|A Multicentre Randomised Controlled Trial of Culturally Adapted CBT Based Self Help Manual for Depression in Pakistan|Completed||N/A|192|Actual|Pakistan Association of Cognitive Therapists||2|||f||||t||||||||||2017-10-11 02:18:50.885099|2017-10-11 02:18:50.885099
NCT01725919|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-07-17|||July 2012||2012-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 30, 2017|Actual|2017-06-30||Interventional|||Examining How Motor Rehabilitation Promotes Brain Reorganization Following Stroke, an MRI Study|Examining Mechanisms of Neuroplasticity Following Motor Rehabilitation in Stroke|Active, not recruiting||N/A|31|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 02:18:50.983654|2017-10-11 02:18:50.983654
NCT01725906|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-05-04|||November 2012||2012-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication|Genotypic Resistance Guided Therapy in the Treatment of Helicobacter Pylori Infection|Recruiting||Phase 4|450|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:18:51.094529|2017-10-11 02:18:51.094529
NCT01725893|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-11-13|||March 2012||2012-03-01|November 2012|2012-11-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Observational|||Percutaneous Tenotomy of the Toe Flexor Tendon is a Simple and Efficient Method in Treating Checkrein Deformity|Percutaneous Tenotomy of the Toe Flexor Tendon is a Simple and Efficient Method in Treating Checkrein Deformity|Unknown status|Recruiting|N/A|14|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:18:51.232408|2017-10-11 02:18:51.232408
NCT01725880|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2016-06-01|||November 2012||2012-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Long-Term Follow-Up of Transplanted Human Central Nervous System Stem Cells (HuCNS-SC) in Spinal Cord Trauma Subjects|Long-term Follow-up (LTFU) Study of the Phase I/II Safety and Preliminary Efficacy Investigation of Intramedullary Spinal Cord Transplantation of HuCNS-SC® in Subjects With Thoracic (T2-T11) Spinal Cord Trauma|Terminated||N/A|12|Actual|StemCells, Inc.|||1|Based on a business decision unrelated to any safety concerns.|f||||f||||||||||2017-10-11 02:18:51.333922|2017-10-11 02:18:51.333922
NCT01725867|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-30|2012-11-08|||June 2010||2010-06-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Comparing the Effect of Physical Therapy With Oral Appliance on Temporomandibular Disorder Related Myofascial Pain|Comparing the Effect of Physical Therapy With Oral Appliance on Temporomandibular Disorder Related Myofascial Pain|Completed||N/A|49|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:18:51.427814|2017-10-11 02:18:51.427814
NCT01725854|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2016-10-31|||July 2012||2012-07-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|RR||Relaxation Response Training for PTSD Prevention in US Military Personnel|"Relaxation Response (RR) Training for PTSD Prevention in Soldiers a.k.a. SPIRIT SMART (Stemming PTSD, Increasing Resilience and Impeding Trauma in Service Members: Assessing Relaxation Response Training)"|Terminated||N/A|8|Actual|William Beaumont Army Medical Center||2||Loss of staff for completion|f||||t||||||||Undecided|Study terminated|2017-10-11 02:18:51.536909|2017-10-11 02:18:51.536909
NCT01725841|ClinicalTrials.gov processed this data on October 10, 2017|2009-10-08|2012-11-08|||April 2009||2009-04-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Observational|||The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan|The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan|Completed||N/A|300|Actual|National Taiwan University Hospital|||1||f||||t||||||None Retained|"     bacterial isolates   "|||2017-10-11 02:18:51.630412|2017-10-11 02:18:51.630412
NCT01725828|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2014-11-17|||October 2012||2012-10-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Accuracy of Ultrasound of Identification of Cricothyroid Membrane.A Randomized Control Trial.|Accuracy of Ultrasound Compared to Conventional Methods of Identification of Cricothyroid Membrane in Subjects With Poorly Defined Neck Landmarks. A Randomized Control Trial.|Completed||N/A|227|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||t||||||||||2017-10-11 02:18:51.706611|2017-10-11 02:18:51.706611
NCT01725815|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-07-12|||June 2011||2011-06-01|July 2017|2017-07-01|March 31, 2017|Actual|2017-03-31|June 1, 2016|Actual|2016-06-01||Interventional|HARP||The Health Access and Recovery Peer Program|A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers|Completed||Phase 3|400|Actual|Emory University||2|||f||||t||||||||||2017-10-11 02:18:51.8329|2017-10-11 02:18:51.8329
NCT01725802|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2016-03-31|||December 2012||2012-12-01|June 2013|2013-06-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||A Phase I/IIa Study of Safety, Tolerability and Plasma Concentration of Subcutaneous Continuously-delivered Levodopa/Carbidopa Solution (ND0612) in PD Patients|A Phase I/IIa, Single Dose, Single-centre, Randomized, Crossover, Double-blind, Placebo-controlled Study Evaluating Safety, Tolerability and Levodopa Plasma Concentration Following Administration of Subcutaneous Continuously-delivered Levodopa/Carbidopa Solution (ND0612) in PD Patients|Completed||Phase 1/Phase 2|8|Actual|NeuroDerm Ltd.||2|||f||||f||||||||||2017-10-11 02:18:51.931155|2017-10-11 02:18:51.931155
NCT01725789|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2016-12-15|||November 2012||2012-11-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)|A Randomized Patient -Blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose (Ferinject®) With Placebo in Patients With Acute Isovolemic Anemia After Gastrectomy|Completed||Phase 3|454|Actual|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 02:18:52.041453|2017-10-11 02:18:52.041453
NCT01725776|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-11-08|||December 2006||2006-12-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Inhaled Milrinone in Cardiac Surgery|Pharmacokinetic and Pharmacodynamic of Inhaled Milrinone in Cardiac Surgical Patients|Completed||Phase 2|40|Actual|Montreal Heart Institute||1|||f||||f||||||||||2017-10-11 02:18:52.138929|2017-10-11 02:18:52.138929
NCT01725763|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2017-08-13|||December 2012||2012-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CMR-PH||Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension|Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension|Enrolling by invitation||N/A|150|Anticipated|Medical University of Graz||1|||f||||t||||||||||2017-10-11 02:18:52.219253|2017-10-11 02:18:52.219253
NCT01725750|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-08-10|||November 2012||2012-11-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy|Treatment of Post-TBI Fatigue With Light Therapy|Completed||Phase 2|78|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 02:18:52.286044|2017-10-11 02:18:52.286044
NCT01725737|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2013-07-14|||April 2012||2012-04-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||Placebo-Controlled Trial With GlyTI-M Among Children With Attention Deficit Hyperactivity Disorder (ADHD)|Placebo-Controlled Trial With GlyTI-M Among Children With ADHD|Completed||Phase 2|116|Actual|Mackay Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:18:52.383772|2017-10-11 02:18:52.383772
NCT01725724|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-03-27|||December 2009||2009-12-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of the Sangvia Blood Collection System on Postoperative Infections in Orthopedic Patients|Effects of the Sangvia Blood Collection System on Postoperative Infections in Orthopedic Patients|Completed||N/A|162|Actual|Haukeland University Hospital||2|||f||||f||||||||||2017-10-11 02:18:52.470861|2017-10-11 02:18:52.470861
NCT01725711|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2012-11-13|||May 1999||1999-05-01|November 2012|2012-11-01|May 2027|Anticipated|2027-05-01|May 2027|Anticipated|2027-05-01||Interventional|OPRA||Osseointegrated Prostheses for the Rehabilitation of Amputees|Osseointegrated Prostheses for the Rehabilitation of Amputees.|Active, not recruiting||N/A|51|Actual|Integrum||1|||f||||f||||||||||2017-10-11 02:18:52.693388|2017-10-11 02:18:52.693388
NCT01725698|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2012-11-08|||November 2012||2012-11-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Combined Effect of Mesenchymal Stem Cell, HA-CaSO4,BMP-2, and Implant in Inducing The Healing of Critical-Sized Bone Defect||Unknown status|Not yet recruiting|Phase 1|5|Anticipated|Indonesia University||1|||f||||||||||||||2017-10-11 02:18:52.756048|2017-10-11 02:18:52.756048
NCT01725685|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-06-07|||November 8, 2012|Actual|2012-11-08|June 2017|2017-06-01|January 2, 2013|Actual|2013-01-02|January 2, 2013|Actual|2013-01-02||Interventional|||To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI)|A Randomized, Double Blind, Single-dose, Three-period, Crossover Study to Investigate Pharmacokinetic, Safety and Tolerability of Fluticasone Furoate With Umeclidinium When Administered in Combination and as Monotherapies in Adult Healthy Volunteer Subjects|Completed||Phase 1|18|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:18:52.830415|2017-10-11 02:18:52.830415
NCT01725672|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-06-09|||September 27, 2012|Actual|2012-09-27|June 2017|2017-06-01|August 21, 2013|Actual|2013-08-21|August 21, 2013|Actual|2013-08-21||Interventional|||Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers|An Open-Label, Randomized, Single Dose, Four-way Crossover, Multi-stage Study to Determine the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations, 500 mg or 1000 mg Extended Release Metformin and 1 mg or 2 mg Extended Release Glimepiride, in Healthy Adult Male and Female Subjects in the Fed State|Terminated||Phase 1|20|Actual|GlaxoSmithKline||6||"Due to changes in EMA guidelines on modified release dosage forms (Feb 2013;   EMA/CHMP/EWP/280/96). The Part B formulation would not meet the new guidelines."|f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:18:52.940452|2017-10-11 02:18:52.940452
NCT01725659|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2012-11-09|||September 2001||2001-09-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Innovative Modalities for Restoring Upper Limb Function Post Stroke|Innovative Modalities for Restoring Upper Limb Function Post Stroke|Completed||N/A|35|Actual|Malcom Randall VA Medical Center||3|||f||||f||||||||||2017-10-11 02:18:53.048405|2017-10-11 02:18:53.048405
NCT01725646|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-05-16|||July 2011||2011-07-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients|A Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy and Safety of Omacor® in Taiwanese Hypertriglyceridemic Patients|Completed||Phase 3|253|Actual|Excelsior||3|||f||||f||||||||||2017-10-11 02:18:53.119327|2017-10-11 02:18:53.119327
NCT00000549|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-15|||August 1994||1994-08-01|December 2005|2005-12-01|July 2000|Actual|2000-07-01|||||Interventional|||Estrogen Replacement and Atherosclerosis (ERA) in Older Women||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:03.63159|2017-10-11 04:19:03.63159
NCT01725633|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-08-07|||December 2010||2010-12-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|Breast Mets||Aerobic Training in Metastatic Breast Cancer|Phase II Trial of Aerobic Training in Metastatic Breast Cancer|Active, not recruiting||N/A|27|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:18:53.212512|2017-10-11 02:18:53.212512
NCT01725620|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-01-29|||November 2012||2012-11-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|||Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®|A Randomized, Double-blind, Single-dosing, 2-way Cross-over Study to Compate the Safety and Pharmacokinetic Characteristics of LBEC0101(Etanercept) 25mg With Those of Enbrel® 25mg After Subcutaneous Injection in Healthy Male Volunteers|Completed||Phase 1|48|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-11 02:18:53.297021|2017-10-11 02:18:53.297021
NCT01725607|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2015-07-07|||January 2013||2013-01-01|October 2013|2013-10-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Postoperative Sleep Quality in Patients Undergoing Thoracic Surgery With Different Types of Anesthesia Management|Postoperative Sleep Quality in Patients Undergoing Thoracic Surgery With Different Types of Anesthesia Management|Completed||Phase 4|219|Actual|China Medical University, China||3|||f||||t||||||||||2017-10-11 02:18:53.373338|2017-10-11 02:18:53.373338
NCT01725594|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2013-07-09|||November 2012||2012-11-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003|A Two-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003 in Healthy Subjects|Completed||Phase 1|99|Actual|Catabasis Pharmaceuticals||11|||f||||f||||||||||2017-10-11 02:18:53.446407|2017-10-11 02:18:53.446407
NCT01725581|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2014-04-02|||June 2013||2013-06-01|June 2013|2013-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|PEAT||A Study to Test a New Pelvic Examination Assessment Tool|A Study to Test the Validity and Reliability of an Objective Structured Assessment of Technical Skills in Pelvic Examination|Completed||N/A|60|Actual|Birmingham Women's NHS Foundation Trust|||3||f||||f||||||||||2017-10-11 02:18:53.537912|2017-10-11 02:18:53.537912
NCT01725568|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-11-19|||November 2012||2012-11-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|BioMonitor||BioMonitor Master Study|"Master Study of the Implantable Cardiac Monitor BioMonitor"|Completed||N/A|152|Actual|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 02:18:53.605156|2017-10-11 02:18:53.605156
NCT01725555|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-04-04|||October 2012||2012-10-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors|A Randomized, Open-label, Phase I, Crossover Study to Assess the Effect of Food on the Bioavailability of AXL1717, in Patients With Advanced Malignant Tumors|Completed||Phase 1|13|Actual|Axelar AB||2|||f||||f||||||||||2017-10-11 02:18:53.682801|2017-10-11 02:18:53.682801
NCT01725542|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2014-09-05|||December 2012||2012-12-01|March 2014|2014-03-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|QUADRIH||Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders|Pilot Study to Assess the Efficacy and Tolerance to a QUadruple Therapy With Asunaprevir , Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a, in HIV-HCV Genotype 1 or 4 Coinfected Patients Previously Null Responders to a Standard Pegylated Interferon -Ribavirin Regimen|Completed||Phase 2|75|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 02:18:55.280075|2017-10-11 02:18:55.280075
NCT01725529|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-09|2015-07-15|2015-07-15||November 2012||2012-11-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of TMC435 vs. Placebo as Part of a Treatment Regimen Including Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve, Genotype 1 Hepatitis C-Infected Subjects|Completed||Phase 3|457|Actual|Janssen R&D Ireland||3|||f||||t||||||||||2017-10-11 02:18:55.375441|2017-10-11 02:18:55.375441
NCT01725516|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-13|2012-11-13||||||August 2011|2011-08-01||||||||Interventional|||Effect of Myofascial Release Technique on Reducing Symptoms in Patients With Chronic Disc Protrusion||Completed||N/A|||Shiraz University of Medical Sciences||1|||f||||t||||||||||2017-10-11 02:18:56.110162|2017-10-11 02:18:56.110162
NCT01725503|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-01-29|||January 2010||2010-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Creatine Kinetics, Synthesis From Glycine and Response to Creatine and Amino Acid Supplement in Healthy Humans|Creatine Metabolism in Humans:Effect of Creatine and Amino Acid Supplement|Completed||N/A|15|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-10-11 02:18:56.291991|2017-10-11 02:18:56.291991
NCT01725490|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-07-08|||November 2012||2012-11-01|July 2013|2013-07-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study||Unknown status|Recruiting|Phase 2|100|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-11 02:18:56.410524|2017-10-11 02:18:56.410524
NCT01725477|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-04-08|||September 2012||2012-09-01|April 2017|2017-04-01|March 9, 2015|Actual|2015-03-09|February 14, 2014|Actual|2014-02-14||Interventional|||Laparoscopic Tubal Patency Assessment||Completed||N/A|30|Actual|Pourmatroud, Elham, M.D.||2|||f||||t||||||||||2017-10-11 02:18:56.554411|2017-10-11 02:18:56.554411
NCT01725464|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2013-08-16|||November 2012||2012-11-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of Nasal Cannula During the First 2 Hours Postoperative in Patient Undergoing Thoracotomy|The Effect of Nasal Cannula During the First 2 Hours Postoperative in Patient Undergoing Thoracotomy|Completed||Phase 4|34|Actual|Mahidol University||1|||f||||f||||||||||2017-10-11 02:18:56.650261|2017-10-11 02:18:56.650261
NCT01725451|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-10-07|2014-01-17||November 2012||2012-11-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||All randomized participants who received at least 1 dose of testosterone 2% solution.|A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants|Effects of Deodorant and Antiperspirant Use and the Presence of Axillary Hair on the Absorption of Testosterone Applied as Testosterone 2% Solution|Completed||Phase 1|30|Actual|Eli Lilly and Company|Not specified.|6|||f||||f||||||||||2017-10-11 02:18:56.77875|2017-10-11 02:18:56.77875
NCT01725438|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-02-02|||June 2012||2012-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|ISETTRI21||Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells|Clinical Validation of the ISET Method for the Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Trophoblastic Cells|Active, not recruiting||N/A|150|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 02:18:58.575088|2017-10-11 02:18:58.575088
NCT01725425|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-07-14|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Portion Sizes on Mood|The Impact of Portion Size of Foods on Mood in Normal Weight Adults 18-35|Active, not recruiting||N/A|25|Anticipated|University of Tennessee||4|||f||||f||||||||||2017-10-11 02:18:58.693296|2017-10-11 02:18:58.693296
NCT01725412|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2012-11-09|||November 2012||2012-11-01|November 2012|2012-11-01||||June 2013|Anticipated|2013-06-01||Interventional|||Prevention of Renal Complications of Diabetes With Thiamine||Unknown status|Not yet recruiting|Phase 4|40|Anticipated|University of Saskatchewan||2|||f||||||||||||||2017-10-11 02:18:58.778803|2017-10-11 02:18:58.778803
NCT01725399|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-08-05|||October 2012||2012-10-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|XOndansetron||Does First Oral Intake After Emergence Predict the Incidence of Post-operative Vomiting in Children?|Randomized Controlled Trial: Does First Oral Intake After Emergence From Anesthesia Predict the Incidence of Post-operative Vomiting in Children?|Completed||N/A|183|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:18:58.884011|2017-10-11 02:18:58.884011
NCT01725386|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-08-19|2016-06-30||March 2011||2011-03-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|XEPAD|Participants eligible for analysis (received at least one dose of study medication and for whom data for at least one follow-up variable were available).|An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer|Study on Xeloda® to Document Its Use in Routine Practice in Patients With Metastatic or Advanced Breast Cancer|Completed||N/A|274|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-11 02:18:59.017607|2017-10-11 02:18:59.017607
NCT01725373|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-01-12|||January 2007||2007-01-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|May 2012|Actual|2012-05-01||Observational|ALMA||Angioplasty of Left Main - lAriboisiere Registry|Prospective Registry in Patients With Unprotected Left Main Disease Treated by Percutaneous Coronary Intervention: The ALMA (Angioplasty of Left Main - lAriboisiere) Registry|Completed||N/A|125|Actual|Hopital Lariboisière|||1||f||||f||||||||||2017-10-11 02:18:59.627338|2017-10-11 02:18:59.627338
NCT01725360|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-08-04|||January 2007||2007-01-01|August 2017|2017-08-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma|Change of Airway Hyperresponsiveness to Mannitol and Methacholine During Intensified Anti-inflammatory Treatment in Patients With Asthma.|Completed||Phase 4|17|Actual|Cantonal Hosptal, Baselland||1|||f||||t||||||||||2017-10-11 02:18:59.687101|2017-10-11 02:18:59.687101
NCT01725347|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-07-11|||February 2012|Actual|2012-02-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|May 2015|Actual|2015-05-01||Observational|||Validation of a Digital Diet Method for Use With Preschoolers|Validation of a Digital Diet Method for Use With Preschoolers|Completed||N/A|94|Actual|Baylor College of Medicine|||4||f||||t||||||Samples Without DNA|"     Urine samples are to be collected.   "|||2017-10-11 02:18:59.91083|2017-10-11 02:18:59.91083
NCT01725334|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2015-07-31|||September 2012||2012-09-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia|Deep Brain Stimulation for the Management of Treatment Refractory Negative Symptoms in Schizophrenia|Withdrawn||Phase 1|0|Actual|Centre for Addiction and Mental Health||2||No participants enrolled|f||||f||||||||||2017-10-11 02:19:00.004123|2017-10-11 02:19:00.004123
NCT01725321|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2015-05-28|||October 2012||2012-10-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Narrow Band Imaging for Diagnosis of Proximal Serrated Polyps|Colonoscopy With Narrow Band Imaging for Diagnosis of Proximal Serrated Polyps|Completed||N/A|360|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 02:19:00.097497|2017-10-11 02:19:00.097497
NCT01725308|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-02-17|2016-12-16||February 2012||2012-02-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|August 2015|Actual|2015-08-01||Interventional||Full Analysis Set (FAS), which included participants who received at least one dose of study drug and had measurements taken for at least one efficacy endpoint after start of drug treatment in Treatment Period I.|A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes|Phase II/III Study of FK949E — Placebo-controlled, Double-blind, Parallel-group Comparative Study and Open-label, Non-controlled Extension Study in Bipolar Disorder Patients With Major Depressive Episodes —|Completed||Phase 2/Phase 3|431|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 02:19:00.245764|2017-10-11 02:19:00.245764
NCT01725295|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2012-11-09|||April 2003||2003-04-01|November 2012|2012-11-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|NST||Neurostructural Integration Technique for Fibromyalgia||Completed||N/A|20|Actual|University College Dublin||2|||f||||f||||||||||2017-10-11 02:19:01.805398|2017-10-11 02:19:01.805398
NCT01725282|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-02-14|2014-08-14||December 2011||2011-12-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder|Phase II Study of FK949E -Placebo-controlled, Double-blind, Parallel-group Comparative Study in Major Depressive Disorder Patients With Lack of Response to Existing Antidepressants-|Completed||Phase 2|172|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 02:19:01.913907|2017-10-11 02:19:01.913907
NCT01725269|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-04-07|||March 2013||2013-03-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05|A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension|Terminated||Phase 2|17|Actual|Aires Pharmaceuticals, Inc.||3||Terminated early dt acquisition of Sponsor and change in corporate priorities|f||||t||||||||||2017-10-11 02:19:02.727957|2017-10-11 02:19:02.727957
NCT01724502|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2014-05-08|||September 2012||2012-09-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|PGC-1||Mitochondrial Dysfunction in Diabetes|PGC-1 and Mitochondrial Dysfunction in Diabetes, Aims 4 & 5|Completed||N/A|16|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 02:19:10.585317|2017-10-11 02:19:10.585317
NCT01725256|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-04-07|||November 2012||2012-11-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)|A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)|Terminated||Phase 2|29|Actual|Aires Pharmaceuticals, Inc.||3||Terminated early dt to acquisition of Sponsor and change in corporate priorities|f||||t||||||||||2017-10-11 02:19:03.051358|2017-10-11 02:19:03.051358
NCT01725243|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2013-05-28|||November 2012||2012-11-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Carbetocin at Cesarean Delivery for Labor Arrest|Carbetocin at Cesarean Delivery for Labor Arrest: A Dose Finding Study|Completed||N/A|40|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||8|||f||||f||||||||||2017-10-11 02:19:03.284539|2017-10-11 02:19:03.284539
NCT01725230|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-02-01|||November 2012||2012-11-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Statin DDI||Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib|An Open-label, Non-randomized, 2-Period, Fixed Sequence, Single-center Study to Assess the Pharmacokinetics of Rosuvastatin and Simvastatin in Healthy Subjects When Administered Alone and in Combination With Fostamatinib 100 mg Twice Daily|Completed||Phase 1|42|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:19:03.451816|2017-10-11 02:19:03.451816
NCT01725217|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-03-24|2014-02-03||November 2012||2012-11-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia|A Phase 3, Multi-center, Open-label Study to Evaluate Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) in Healthy Children, Adolescents and Adults in Russia|Completed||Phase 3|198|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:19:03.589292|2017-10-11 02:19:03.589292
NCT01725204|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-09-21|||September 2012|Actual|2012-09-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|NordCML007||Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia|A Safety and Efficacy Study of Adding Low Dose Pegylated IFN-alpha 2B to Standard Dose Dasatinib in Patients With Newly Diagnosed Chronic Phase Myeloid Leukemia|Completed||Phase 2|40|Actual|Norwegian University of Science and Technology||1|||f||||t|f|f||||||||2017-10-11 02:19:04.483643|2017-10-11 02:19:04.483643
NCT01725191|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2015-06-30|||October 2012||2012-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors|A Phase 1 Study of the c-Met Inhibitor, Tivantinib (ARQ 197) in Children With Relapsed or Refractory Solid Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:19:04.620544|2017-10-11 02:19:04.620544
NCT01725178|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2016-03-29|||March 2012||2012-03-01|March 2016|2016-03-01|March 2016|Anticipated|2016-03-01|December 2014|Actual|2014-12-01||Interventional|TTB||Train the Brain - Cognitive and Physical Training for Slowing Dementia|Train the Brain - Effective of Cognitive and Physical Training in Slowing Progression to Dementia: a Clinical and Experimental Study|Active, not recruiting||N/A|160|Anticipated|"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"||2|||f||||f||||||||||2017-10-11 02:19:04.792582|2017-10-11 02:19:04.792582
NCT01725165|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-09-21|||November 2012|Actual|2012-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Study Assessing the Efficacy of Local Consolidative Therapy for Non-Small Cell Lung Cancer Patients With Induced Oligometastatic Disease|A Randomized Phase II Study Assessing the Efficacy of Local Consolidative Therapy for Non-Small Cell Lung Cancer Patients With Induced Oligometastatic Disease|Active, not recruiting||Phase 2|94|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 02:19:04.887319|2017-10-11 02:19:04.887319
NCT01725152|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-03-14|||November 2012||2012-11-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Ganaxolone Treatment in Children With Fragile X Syndrome|A Controlled, Double-blind, Crossover Trial of Ganaxolone in Children With Fragile X Syndrome|Active, not recruiting||Phase 2|60|Anticipated|Marinus Pharmaceuticals||2|||f||||t||||||||||2017-10-11 02:19:05.007856|2017-10-11 02:19:05.007856
NCT01725139|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-04-19|||March 8, 2013|Actual|2013-03-08|April 2017|2017-04-01|July 12, 2016|Actual|2016-07-12|July 12, 2016|Actual|2016-07-12||Interventional|||A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|A Randomised, Placebo-controlled, Double-blind, Repeat Dose Escalation Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 1|17|Actual|GlaxoSmithKline||12|||f||||f||||||||||2017-10-11 02:19:05.131941|2017-10-11 02:19:05.131941
NCT01725113|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-01-11|||November 2012||2012-11-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|December 2013|Actual|2013-12-01||Interventional|ECRIP||Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol|A Randomized, Prospective, Cross-Over Study of Calcitriol vs. Paricalcitol in the Treatment of Mineral and Bone Disease in Hemodialysis Patients|Terminated||Phase 4|11|Actual|Winthrop University Hospital||2||Nationwide shortage of study meds in 2013 loss of funding & competing studies|f||||f||||||||||2017-10-11 02:19:05.379052|2017-10-11 02:19:05.379052
NCT01725100|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2015-03-26|||February 2013||2013-02-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies|An Open-label, Randomized, 2-treatment, 2-period, 2-way Crossover, Single-dose Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies|Completed||Phase 1|61|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:19:05.471029|2017-10-11 02:19:05.471029
NCT01725087|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-08-28|||November 2012||2012-11-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain.|Efficacy, Safety, and Tolerability of GRT6005 in Subjects With Moderate to Severe Chronic Low Back Pain.|Completed||Phase 2|1089|Actual|Grünenthal GmbH||5|||f||||||||||||||2017-10-11 02:19:05.604018|2017-10-11 02:19:05.604018
NCT01725074|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2012-11-09|||July 2011||2011-07-01|November 2012|2012-11-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|KHK ProMA||Randomized Control Trial to Evaluate Effectiveness of a Case Managment Program Regarding Psychosocial Well-being and Disease Symptoms Health for Patients With Multimorbid Coronary Heart Disease (CHD) Patients (KHK ProMA)|Koronare Herzkrankheit Projekt Mannheim|Unknown status|Active, not recruiting|N/A|320|Actual|Genossenschaft Gesundheitsprojekt Mannheim e.G||3|||f||||f||||||||||2017-10-11 02:19:05.970262|2017-10-11 02:19:05.970262
NCT01725061|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2014-12-17|||December 2009||2009-12-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|AMFAS||Study of the Function of Cells Involved in Inflammation in the Lungs of Those With Acute Lung Injury and Sepsis|Alveolar Macrophage Function in ALI and Sepsis|Completed||N/A|80|Actual|Emory University|||1||f||||f||||||Samples Without DNA|"     Plasma and bronchoalveolar lavage fluid   "|||2017-10-11 02:19:06.052579|2017-10-11 02:19:06.052579
NCT01725048|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-03-08|||January 2011||2011-01-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|May 2012|Actual|2012-05-01||Interventional|NRR||Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer|A Pilot Study to Evaluate Individualized Choice of Antidepressant in Patients With Cancer|Completed||Early Phase 1|21|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:19:06.116773|2017-10-11 02:19:06.116773
NCT01725035|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2016-04-06|||December 2010||2010-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|DNL||Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth|The Role of Hepatic De Novo Lipogenesis (DNL) in the Pathogenesis of Hepatic Steatosis in Obese Children and Adolescents|Completed||N/A|14|Actual|Yale University|||2||f||||f||||||Samples With DNA|"     Serum   "|||2017-10-11 02:19:06.218864|2017-10-11 02:19:06.218864
NCT01725022|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2017-07-25|||February 2012||2012-02-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital Care|A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital Care|Recruiting||N/A|90|Anticipated|Duke University||3|||f||||t||||||||||2017-10-11 02:19:06.349752|2017-10-11 02:19:06.349752
NCT01725009|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-03-27|||October 2012||2012-10-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males|A Single-center, Open-label, Multiple-dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Levetiracetam Administered as Intravenous Infusion in Japanese and Caucasian Healthy Male Subjects|Completed||Phase 1|32|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 02:19:06.440238|2017-10-11 02:19:06.440238
NCT01724996|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-05-26|||October 2012||2012-10-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Observational|||Usefulness of Chest Wall Tenderness as Bedside Test to Exclude Acute Coronary Syndrome in Different Demographic Groups|Usefulness of Chest Wall Tenderness as Bedside Test to Exclude Acute Coronary Syndrome in Different Demographic Groups|Completed||Phase 4|110|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 02:19:06.552181|2017-10-11 02:19:06.552181
NCT01724983|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2012-11-07|||June 2012||2012-06-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Ketamine in Bariatric Surgery|Effects of Ketamine on Recovery From Bariatric Surgery|Unknown status|Active, not recruiting|Phase 3|90|Anticipated|University of Padova||2|||f||||f||||||||||2017-10-11 02:19:06.628145|2017-10-11 02:19:06.628145
NCT01724970|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2012-11-07|||July 2012||2012-07-01|November 2012|2012-11-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Laryngeal Masks for Bariatric Surgery|A Randomized Comparative Study on Proseal LMATM and Supreme LMATM for Bariatric Surgery.|Unknown status|Recruiting|Phase 3|80|Anticipated|University of Padova||2|||f||||f||||||||||2017-10-11 02:19:06.738831|2017-10-11 02:19:06.738831
NCT01724957|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-12-01|||September 2012||2012-09-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Observational|FIESTA||FFR vs. icECG in Coronary Bifurcations|Fractional Flow Reserve Versus Intracoronary ECG for Detection of Post Stenting Ischemia in Side Branch Territory in coronAry Bifurcation Lesions|Unknown status|Recruiting|N/A|40|Anticipated|University National Heart Hospital|||1||f||||t||||||||||2017-10-11 02:19:06.862608|2017-10-11 02:19:06.862608
NCT01724944|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-08|2012-11-09|||February 2011||2011-02-01|November 2012|2012-11-01||||February 2013|Anticipated|2013-02-01||Interventional|LYANA||LYmphadenectomy After NeoAdjuvant Chemotherapy|Lymphadenectomy After Neo-Adjuvant Chemotherapy in Ovarian Neoplasm|Unknown status|Recruiting|Phase 1/Phase 2|65|Anticipated|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-11 02:19:06.946966|2017-10-11 02:19:06.946966
NCT01724931|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-05-18|||February 2013||2013-02-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis|A Phase 2 Double-Blind, Placebo-Controlled, Randomized Dose Finding Study For The Efficacy And Safety Of Aminopterin In Methotrexate-Naive Rheumatoid Arthritis|Completed||Phase 2|175|Actual|Syntrix Biosystems, Inc.||3|||f||||f||||||||||2017-10-11 02:19:07.0347|2017-10-11 02:19:07.0347
NCT01724918|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2016-09-23|||May 2013||2013-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|LIVE||Lacosamide IV and EEG/EKG (LIVE) Study|Lacosamide IV and EEG/EKG (LIVE) Study|Terminated||Phase 2|72|Actual|Lawson Health Research Institute||3||Time limitation for recruitment exceeded. 72 of 90 estimated sample recruited.|f||||f||||||||||2017-10-11 02:19:07.145207|2017-10-11 02:19:07.145207
NCT01724905|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-12-10|||May 2011||2011-05-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Weight Loss and Maintenance for Individuals With Intellectual Developmental Disabilities (IDD)|Weight Loss and Maintenance for Individuals With Intellectual Developmental Disabilities (IDD)|Completed||N/A|151|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 02:19:07.240453|2017-10-11 02:19:07.240453
NCT01724892|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-03-14|||November 2012||2012-11-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparison the Effects of Dexamethasone and Loteprednol on Epithelial Healing||Completed||Phase 4|32|Actual|Khon Kaen University||2|||f||||t||||||||||2017-10-11 02:19:07.316602|2017-10-11 02:19:07.316602
NCT01724879|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-02-10|||November 2011||2011-11-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)|Open Label Phase II Study to Evaluate the Safety of Standard Induction and Consolidation Therapy in Combination With Dasatinib in Newly Diagnosed Adult Patients With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)|Completed||Phase 2|19|Actual|Johann Wolfgang Goethe University Hospital||1|||f||||t||||||||||2017-10-11 02:19:07.403771|2017-10-11 02:19:07.403771
NCT01724866|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-05-26|||January 2013||2013-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients|Phase 2, Open-Label, Dose-Ranging Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Patients With Breast Cancer Who Are Candidates for Adjuvant and Neoadjuvant Chemotherapy With the Docetaxel + Cyclophosphamide (TC) Regimen|Completed||Phase 2|148|Actual|Spectrum Pharmaceuticals, Inc||4|||f||||f||||||||||2017-10-11 02:19:07.52815|2017-10-11 02:19:07.52815
NCT01724853|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2013-11-28|||September 2011||2011-09-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|RASSH||Outcomes of Treatment for Trapeziometacarpal Osteoarthritis|Outcomes of Treatment for Trapeziometacarpal Osteoarthritis Using a Comprehensive Core Set.|Completed||N/A|177|Actual|Schulthess Klinik||2|||f||||t||||||||||2017-10-11 02:19:07.709382|2017-10-11 02:19:07.709382
NCT01724840|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-08-19|||September 2012||2012-09-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||GraftJacket Versus Tendon Interposition for Trapeziometacarpal Osteoarthritis|Resection Suspension Arthroplasty With Interposition of GraftJacket Versus Tendon Interposition for Trapeziometacarpal Osteoarthritis: A Randomised Controlled Trial|Completed||N/A|60|Actual|Schulthess Klinik||2|||f||||f||||||||||2017-10-11 02:19:07.787044|2017-10-11 02:19:07.787044
NCT01724827|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-10-17|||September 2012||2012-09-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|CECOIA||Ceramic Versus Composite in the Treatment of Posterior Teeth by Inlays or Onlays|Ceramic Versus Composite in the Treatment by Inlays or Onlays of Posterior Teeth Affected by Tooth Substance Loss : a Multicenter Randomized Controlled Trial|Active, not recruiting||Phase 3|355|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:19:07.866105|2017-10-11 02:19:07.866105
NCT01724814|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-02-06|||January 2013||2013-01-01|February 2014|2014-02-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|HM12460A||A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A|A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A|Unknown status|Active, not recruiting|Phase 1|48|Anticipated|Hanmi Pharmaceutical Company Limited||6|||f||||f||||||||||2017-10-11 02:19:07.967906|2017-10-11 02:19:07.967906
NCT01724801|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2017-02-28|||October 14, 2012||2012-10-14|February 2017|2017-02-01|September 14, 2016|Actual|2016-09-14|June 30, 2015|Actual|2015-06-30||Interventional|BRAIN||Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer|Phase III Study of Icotinib Treat the Patient With Brain Metastasis EGFR-mutant Non Small Cell Lung Cancer Comparing With Whole Brain Radiotherapy|Completed||Phase 3|176|Actual|Guangdong Association of Clinical Trials||2|||f||||||||||||Undecided||2017-10-11 02:19:08.054481|2017-10-11 02:19:08.054481
NCT01724788|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2013-02-11|||November 2012||2012-11-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis|Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation (PRLasix® Special, Tablets 500 mg) in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis|Completed||Phase 1|12|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:19:08.138804|2017-10-11 02:19:08.138804
NCT01724775|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2016-08-17|||November 2012||2012-11-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|ESCME||Efficacy and Safety Study of Complete Mesocolic Excision for Colon Cancer|A Prospective, Non-randomized, Double-blind, Single-center Study to Evaluate Efficacy and Safety of Complete Mesocolic Excision for Colon Cancer.|Recruiting||N/A|450|Anticipated|Peking University People's Hospital|||2||f||||t||||||||No||2017-10-11 02:19:08.226014|2017-10-11 02:19:08.226014
NCT01724762|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-09|||April 2010||2010-04-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy of Nursing Orientation to Reduce the Anxiety of Patients Undergoing Bed Bath|Evaluation of the Efficacy of Nursing Orientation to Reduce the Anxiety of Patients With Acute Coronary Syndrome Undergoing Bed Bath|Completed||N/A|120|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-10-11 02:19:08.303445|2017-10-11 02:19:08.303445
NCT01724749|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-07|||November 2012||2012-11-01|November 2012|2012-11-01|December 2016|Anticipated|2016-12-01|November 2014|Anticipated|2014-11-01||Observational|CAMONA||Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT|Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT: The CAMONA Study|Unknown status|Recruiting|N/A|144|Anticipated|Odense University Hospital|||2||f||||f||||||Samples Without DNA|"     Whole blood, serum.   "|||2017-10-11 02:19:08.383158|2017-10-11 02:19:08.383158
NCT01724736|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-07-23|||November 2012||2012-11-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Gastrointestinal Microbiome|A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Fecal Bacteroidetes: Firmicutes Ratio in Pre-Diabetic Subjects.|Completed||N/A|45|Anticipated|NuMe Health||2|||f||||f||||||||||2017-10-11 02:19:08.491407|2017-10-11 02:19:08.491407
NCT01724723|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-11-07|||December 2012||2012-12-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|HBV||Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment|Prophylactic Use of Entecavir to Reduce Hepatitis Flare in Highly Viremic HBV Patients With Active Tuberculosis Receiving Anti-tuberculous Treatment|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:19:08.579318|2017-10-11 02:19:08.579318
NCT01724476|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-08-30|||December 2014|Actual|2014-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia|A Placebo-Controlled Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia|Active, not recruiting||Phase 4|200|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:19:10.746835|2017-10-11 02:19:10.746835
NCT01724710|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-11-09|||August 2012||2012-08-01|November 2012|2012-11-01||||August 2013|Anticipated|2013-08-01||Observational|||To Study the Effect of Organic Light Emitting Diodes (OLED) on Cultured Fibroblast|To Study the Effect of Organic Light Emitting Diodes (OLED) on Cultured Fibroblast|Unknown status|Recruiting|N/A|10|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples With DNA|"     Fibroblasts of Chronic ulcer and normal skin will be cultured. Fibroblast culture will be     analyzed with quantitative PCR.   "|||2017-10-11 02:19:08.687387|2017-10-11 02:19:08.687387
NCT01724697|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-07|||September 2012||2012-09-01|November 2012|2012-11-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis|Safety and Efficacy of Human Autologous Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis|Unknown status|Recruiting|Phase 1/Phase 2|240|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 02:19:08.752371|2017-10-11 02:19:08.752371
NCT01724684|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-11-07|||December 2011||2011-12-01|November 2012|2012-11-01||||December 2012|Anticipated|2012-12-01||Interventional|||Feasibility and Effectiveness of Telehealth in Patients With Chronic Obstructive Pulmonary Disease in Taiwan|Feasibility and Effectiveness of Telehealth in Patients With Chronic Obstructive Pulmonary Disease in Taiwan|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:19:08.835691|2017-10-11 02:19:08.835691
NCT01724671|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-07|||December 2012||2012-12-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline|A Case Series of Ceftaroline-treated Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline, Compared to Vancomycin-treated Patients|Unknown status|Not yet recruiting|N/A|30|Anticipated|CPL Associates|||2||f||||f||||||Samples Without DNA|"     MRSA cultures obtained retrospectively from Microbiology labs if available for patients.   "|||2017-10-11 02:19:08.908286|2017-10-11 02:19:08.908286
NCT01724632|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-05-26|||November 2012||2012-11-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||LIVE SMART: Smartphone Intervention for Weight Control||Completed||N/A|276|Actual|The Miriam Hospital||3|||f||||f||||||||||2017-10-11 02:19:09.151422|2017-10-11 02:19:09.151422
NCT01724619|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-07-28|||November 2012|Actual|2012-11-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT|Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT|Terminated||Early Phase 1|7|Actual|Wake Forest University Health Sciences||2||Study tracer can no longer be obtained at our institution|f||||f|t|f||||||||2017-10-11 02:19:09.292813|2017-10-11 02:19:09.292813
NCT01724606|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-03-02|||November 2012||2012-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)|Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM): A Phase I Study|Recruiting||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:19:09.364006|2017-10-11 02:19:09.364006
NCT01724593|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2013-11-03|||October 2012||2012-10-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Functional Recovery in Critically Ill Children|Functional Recovery in Critically Ill Children - the Wee-Cover Pilot Study|Completed||N/A|30|Actual|McMaster University|||1||f||||f||||||||||2017-10-11 02:19:09.463154|2017-10-11 02:19:09.463154
NCT01724580|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-09-20||||||September 2017|2017-09-01||||||||Expanded Access|||Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes|Compassionate Use Treatment Protocol I4V-MC-JAGA: Treatment of Conditions Expected to Benefit From JAK 1/2 Inhibition: CANDLE, CANDLE-Related Conditions, SAVI and Severe Juvenile Dermatomyositis|Available||N/A|||Eli Lilly and Company|||||||||||||||||||2017-10-11 02:19:09.523957|2017-10-11 02:19:09.523957
NCT01724567|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-08-03|||September 2011||2011-09-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CUT-IT||Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training|Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training: A Randomized Clinical Trial|Completed||N/A|70|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 02:19:09.598693|2017-10-11 02:19:09.598693
NCT01724554|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-05-21|||November 2012||2012-11-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ANDROID||Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion|A Single-center, Open-label Study Evaluating the Impact of Repeat Intravitreal Injections of Aflibercept on Capillary Non-Perfusion (CNP) in Subjects With Proliferative Retinopathy and/or Macular Edema Secondary to Proliferative Diabetic Retinopathy and Central Retinal Venous Occlusive Disease|Completed||Phase 1/Phase 2|24|Actual|Ophthalmic Consultants of Boston||2|||f||||f||||||||||2017-10-11 02:19:09.738124|2017-10-11 02:19:09.738124
NCT01724541|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-04-28|||September 2015||2015-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:19:09.818635|2017-10-11 02:19:09.818635
NCT01724528|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2014-10-27|2014-10-27||October 2012||2012-10-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|FLORENCE||Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies|Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies: a Randomized, Double Blind, Phase III Study Versus Allopurinol|Completed||Phase 3|346|Actual|Menarini Group||2|||f||||f||||||||||2017-10-11 02:19:09.879024|2017-10-11 02:19:09.879024
NCT01724463|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-03-30|||March 2013||2013-03-01|March 2015|2015-03-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|eASSIST-M||Electronic Application of a Severe Sepsis Screening Tool and Management Bundle|Application of a Severe Sepsis Electronic Health Record Integrated Screening Tool and Management Bundle Study to Improve Sepsis Related Outcomes|Recruiting||N/A|30000|Anticipated|University of Tennessee|||1||f||||f||||||||||2017-10-11 02:19:10.831274|2017-10-11 02:19:10.831274
NCT01724450|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-03-04|||June 2012||2012-06-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|Ceccy||Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity|Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity. A Randomized Double Blind Study.|Recruiting||Phase 3|200|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:19:10.930773|2017-10-11 02:19:10.930773
NCT01724437|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2012-11-08|||November 2009||2009-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2010|Actual|2010-11-01||Interventional|||Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation||Completed||N/A|102|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||||||||||||2017-10-11 02:19:11.03533|2017-10-11 02:19:11.03533
NCT01724424|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2013-05-07|||June 2012||2012-06-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|DAMSEL1||Melatonin in Healthy Volunteers|A Dose Escalation Study of Melatonin in Healthy Volunteers as a Potential Treatment for Sepsis|Completed||Phase 1|20|Actual|University of Aberdeen||4|||f||||t||||||||||2017-10-11 02:19:11.106915|2017-10-11 02:19:11.106915
NCT01724411|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-03-26|||August 2012||2012-08-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|September 2013|Actual|2013-09-01||Interventional|SATIN||Satiety Innovation- Study 793. University of Aberdeen|SATIN: Satiety Innovation, Study 1|Completed||N/A|24|Actual|University of Aberdeen||2|||f||||t||||||||||2017-10-11 02:19:11.191751|2017-10-11 02:19:11.191751
NCT01724398|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2013-02-27|||November 2012||2012-11-01|February 2013|2013-02-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure|Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Acute-on-Chronic Liver Failure Caused by Hepatitis B Virus (HBV)|Unknown status|Recruiting|Phase 1/Phase 2|120|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||4|||f||||t||||||||||2017-10-11 02:19:11.289194|2017-10-11 02:19:11.289194
NCT01724385|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-04-25|||August 2012||2012-08-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy|Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy With New Dense Vitreous Hemorrhage After Full Panretinal Photocoagulation|Completed||Phase 4|18|Actual|Khon Kaen University||1|||f||||t||||||||||2017-10-11 02:19:11.375959|2017-10-11 02:19:11.375959
NCT01724372|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-05-23|||October 2012||2012-10-01|November 2012|2012-11-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||The Role of Antidepressants or Antipsychotics in Preventing Psychosis|The Role of Antidepressants or Antipsychotics in Preventing Psychosis|Withdrawn||N/A|0|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||f||||||||||2017-10-11 02:19:11.438397|2017-10-11 02:19:11.438397
NCT01724359|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-02-04|2012-11-27||February 2008||2008-02-01|February 2013|2013-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|PERFLEX||Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia|An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia|Completed||Phase 4|95|Actual|Janssen-Cilag, S.A.||1|||f||||f||||||||||2017-10-11 02:19:11.515506|2017-10-11 02:19:11.515506
NCT01724346|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-04-03|||January 2013||2013-01-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil)|Active, not recruiting||Phase 3|232|Actual|Pharmacyclics LLC.||4|||f||||f||||||||No|We share this information with FDA and other authorities for the purposes of analyzing the study but not with other researchers|2017-10-11 02:19:11.81596|2017-10-11 02:19:11.81596
NCT01724333|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-04-28|||December 2012||2012-12-01|November 2012|2012-11-01|December 2015|Actual|2015-12-01|September 2014|Actual|2014-09-01||Observational|QLQ-OH17||International Validation of the QLQ-OH17 for Oral Health|International Validation and Testing of a Supplementary Questionnaire Module for Assessment of Oral and Dental Health in Cancer; the QLQ-OH17|Completed||N/A|585|Actual|Oslo University Hospital|||5||f||||f||||||||Yes|Phase III and Phase IV reports approved by the EORTC Quality of Life Group Executive Committee. First publication in Eur J Cancer. 2012 Sep;48(14):2203-11. doi: 10.1016/j.ejca.2012.04.003. Second publication accepted for publication in Supp Care Cancer, April 2016|2017-10-11 02:19:12.226336|2017-10-11 02:19:12.226336
NCT01724320|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2012-11-06|||February 2012||2012-02-01|November 2012|2012-11-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors|A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors|Unknown status|Recruiting|Phase 1|20|Anticipated|Oncoethix GmbH||1|||f||||f||||||||||2017-10-11 02:19:12.334481|2017-10-11 02:19:12.334481
NCT01724307|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-01-25|||September 2011||2011-09-01|January 2016|2016-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma|Stimulation of the Cervical Sympathetic Ganglion for Treatment of Asthma.|Completed||N/A|1|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 02:19:12.415585|2017-10-11 02:19:12.415585
NCT01724294|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2016-11-01|||December 2012||2012-12-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell Lymphoma|Non-interventional, Post-marketing Study to Evaluate the Correlation Between Clinical and Biological Factors and IPI as Prognostic Factors in Patients With DLBCL in First Line Treatment With R-CHOP|Terminated||N/A|113|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:19:12.478108|2017-10-11 02:19:12.478108
NCT01723553|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2015-12-18|||November 2012||2012-11-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD|Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD|Completed||Phase 1|27|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:19:23.769954|2017-10-11 02:19:23.769954
NCT01724281|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-08|||December 2012||2012-12-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Outcome of Babies With Asymetry of Lateral Brain Ventricles|Outcome of Babies With Asymetry of Lateral Brain Ventricles|Unknown status|Not yet recruiting|N/A|10|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||None Retained|"     not relevant   "|||2017-10-11 02:19:12.549793|2017-10-11 02:19:12.549793
NCT01724268|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2012-11-08|||May 2012||2012-05-01|November 2012|2012-11-01|September 2014|Anticipated|2014-09-01|May 2014|Anticipated|2014-05-01||Interventional|||Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient|Randomized Controlled Clinical Trial of Low Dose Corticosteroids vs Anti TNF Treatment in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient- a Pilot Study|Unknown status|Recruiting|Phase 3|80|Anticipated|Hamad Medical Corporation||2|||f||||t||||||||||2017-10-11 02:19:12.619787|2017-10-11 02:19:12.619787
NCT01724255|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-07-26|||January 2013||2013-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|||Optimal Time for Staple/Dressing Removal|The Influence of the Timing of Staple and Dressing Removal After Cesarean Section on the Surgical Incision Healing|Completed||N/A|1500|Actual|Hadassah Medical Organization|||5||f||||f||||||||||2017-10-11 02:19:12.713353|2017-10-11 02:19:12.713353
NCT01724242|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-07-26|||February 2013||2013-02-01|July 2015|2015-07-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Interventional|||Vaginal DHEA for Women After Breast Cancer|Vaginal DHEA to Ease Vaginal Dryness in Women With a Contraindication to Estrogen Therapy|Withdrawn||Phase 2/Phase 3|0|Actual|Hadassah Medical Organization||2||Inability to recruit patients|f||||f||||||||||2017-10-11 02:19:12.7825|2017-10-11 02:19:12.7825
NCT01724216|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-10-15|2013-10-22||October 2012||2012-10-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional||images collected|Magnetic Resonance Imaging Using Innovative Pulse Sequences|Magnetic Resonance Imaging Using Innovative Pulse Sequences|Completed||N/A|11|Actual|GE Healthcare||1|||f||||f||||||||||2017-10-11 02:19:14.474802|2017-10-11 02:19:14.474802
NCT01724203|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2013-10-10|||December 2012||2012-12-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of 12-week Probiotic Supplementation on Bacterial and Viral Infections in Infants Aged 6 to 12 Months.|Effect of 12-week Probiotic Supplementation on Bacterial and Viral Infections in Infants Aged 6 to 12 Months: a Double-blind, Randomized, Placebo-controlled Study.|Completed||N/A|192|Actual|Fonterra Research Centre||3|||f||||t||||||||||2017-10-11 02:19:14.604705|2017-10-11 02:19:14.604705
NCT01724190|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2015-06-19|||November 2012||2012-11-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 Diabetes|Effect of Vitamin D Supplementation on Rate of Partial Clinical Remission in Children and Adolescents With Type 1 Diabetes|Completed||N/A|36|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-11 02:19:14.682389|2017-10-11 02:19:14.682389
NCT01724177|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-07|2017-02-01|2015-09-04||November 2012||2012-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|November 2014|Actual|2014-11-01||Interventional||Intent to treat population consisted of all participants enrolled independent of whether they received study treatment or not.|A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma|A Phase 2, Multicenter, Single-arm, Open-label Study to Evaluate the Safety and Efficacy of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma|Active, not recruiting||Phase 2|26|Actual|Celgene||1|||f||||t||||||||||2017-10-11 02:19:14.79681|2017-10-11 02:19:14.79681
NCT01724164|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-11-08|||August 2011||2011-08-01|November 2012|2012-11-01|July 2014|Anticipated|2014-07-01|January 2014|Anticipated|2014-01-01||Interventional|||Robot- Versus Mirror-Assisted Rehabilitation in Stroke Patients|Robot- Versus Mirror-Assisted Motor Interventions in Rehabilitating Upper-Limb Motor and Muscle Performance and Daily Functions Poststroke: A Comparative Effectiveness Study|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||5|||f||||f||||||||||2017-10-11 02:19:15.556653|2017-10-11 02:19:15.556653
NCT01724151|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-25|2014-04-21|||April 2009||2009-04-01|April 2014|2014-04-01|April 2012|Actual|2012-04-01|October 2009|Actual|2009-10-01||Observational|||Effects of Exercise Training in Patients With Mild Cognitive Impairment|Effects of Exercise Training in Patients With Mild Cognitive Impairment|Completed||N/A|60|Actual|National Taiwan University Hospital|||3||f||||t||||||||||2017-10-11 02:19:15.702705|2017-10-11 02:19:15.702705
NCT01724138|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-04-19|||June 2013||2013-06-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Interventional|MACS2163||An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old|An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old|Withdrawn||Phase 4|0|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:19:15.793502|2017-10-11 02:19:15.793502
NCT01724125|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-08-03|||March 2009||2009-03-01|August 2016|2016-08-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||An Electronic Personal Health Record for Mental Health Consumers|An Electronic Personal Health Record for Mental Health Consumers|Completed||Phase 3|170|Actual|Emory University||2|||f||||f||||||||||2017-10-11 02:19:15.901896|2017-10-11 02:19:15.901896
NCT01724112|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-02-01||2014-04-14|November 2012||2012-11-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)|8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)|Completed||Phase 2|136|Actual|BlackThorn Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 02:19:16.034671|2017-10-11 02:19:16.034671
NCT01724099|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-07-19|||October 2012||2012-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|February 2015|Actual|2015-02-01||Interventional|||Evaluating the Safety and Efficacy of Euiiyin-tang on Obesity|A Double Blind, Randomized, Multicenter, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Euiiyin-tang on Obese Patients|Completed||Phase 2/Phase 3|149|Actual|Kyunghee University Medical Center||2|||f||||f||||||||||2017-10-11 02:19:16.175972|2017-10-11 02:19:16.175972
NCT01724086|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-01-08|||October 2012||2012-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus|A Phase IIa, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of a 12 Weeks Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Chronic Genotype 1 Hepatitis C Infected Patients|Completed||Phase 2|90|Actual|Janssen R&D Ireland||7|||f||||f||||||||||2017-10-11 02:19:16.309286|2017-10-11 02:19:16.309286
NCT01724073|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2014-03-04|||December 2012||2012-12-01|March 2014|2014-03-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|Instapa-WP4||Regular Consumption of Leafy Vegetable Sauces and Micro-nutrient Status of Young Children in Burkina Faso|Effect of the Regular Consumption of Leafy-vegetable Sauces, Rich in Iron, Zinc and Vitamin A, on Growth and Micro-nutrient Status of Young Children in Burkina Faso|Withdrawn||N/A|0|Actual|Institut de Recherche pour le Developpement||4||Approval denied by national ethical committee of Burkina Faso|f||||f||||||||||2017-10-11 02:19:16.50549|2017-10-11 02:19:16.50549
NCT01724060|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-11-03|||September 2012||2012-09-01|November 2016|2016-11-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|FPS||Effects of Obesity Treatments on Food Preferences and Metabolism|The Effects of Current Treatments of Obesity on Food Preferences, Gut Hormones, Bile Acids and Hepatic Glucose Output in Humans.|Recruiting||N/A|400|Anticipated|Imperial College London|||8||f||||t||||||Samples Without DNA|"     Human plasma   "|No||2017-10-11 02:19:16.608871|2017-10-11 02:19:16.608871
NCT01724047|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-09-22|||November 2012||2012-11-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|AIR-B II||Autism Intervention Research Network for Behavioral Health (AIR-B II): Deployment Into Elementary Schools|Autism Intervention Research Network for Behavioral Health (AIR-B II): Network Activity A: Conduct Research on Evidence-Based Practices.|Completed||N/A|250|Actual|Health Resources and Services Administration (HRSA)||4|||f||||f||||||||||2017-10-11 02:19:16.717844|2017-10-11 02:19:16.717844
NCT01724034|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-06|||October 2012||2012-10-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|WeanUS||Lung Ultrasound Assisting Weaning in Difficult-to-wean Patients|Daily Lung Ultrasound Assisting Weaning From Mechanical Ventilation in Difficult-to-wean Adult Patients - a Randomized Trial.|Unknown status|Recruiting|N/A|128|Anticipated|Hospital Ernesto Dornelles||2|||f||||f||||||||||2017-10-11 02:19:16.847581|2017-10-11 02:19:16.847581
NCT01724021|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-07-19|2016-05-03||December 2012||2012-12-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a|A Randomized, Open-label, Mutli-centre Study to Evaluate Patient Preference With Subcutaneous Administration of Rituximab Versus Intravenous Rituximab in Previously Untreated Patients With CD20+ Diffuse Large B-cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2, OR 3A|Completed||Phase 3|743|Actual|Hoffmann-La Roche||2|||f||||f||||||||||2017-10-11 02:19:17.041437|2017-10-11 02:19:17.041437
NCT01724008|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-07-27|||March 2012||2012-03-01|July 2015|2015-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Efficacy of a Dentifrice in Providing Relief From Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Immediate and Short Term Relief From Dentinal Hypersensitivity.|Completed||Phase 3|120|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:19:19.004367|2017-10-11 02:19:19.004367
NCT01723995|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-11-06|||February 2011||2011-02-01|October 2012|2012-10-01|July 2013|Anticipated|2013-07-01|November 2011|Actual|2011-11-01||Interventional|LTNIBF||Laser Therapy in Nipples Injured During Breastfeeding|Effect of Low-level of Laser Therapy in Nipple Trauma During Breastfeeding|Unknown status|Recruiting|N/A|66|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 02:19:19.074223|2017-10-11 02:19:19.074223
NCT01723982|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2015-06-15|||November 2012||2012-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|BASIC||Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions|A Randomised, Placebo-controlled, Double-blind, Parallel Groups, Multinational, Multicentre Trial Assessing the Effect of Barusiban Administered Subcutaneously on the Day of Transfer on Implantation and Pregnancy Rates in IVF/ICSI Patients|Completed||Phase 2|256|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:19:19.188562|2017-10-11 02:19:19.188562
NCT01723969|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-08-07|||September 2013||2013-09-01|August 2017|2017-08-01|February 2020|Anticipated|2020-02-01|December 2018|Anticipated|2018-12-01||Observational|SPECTAcolor||Screening Platform for Clinical Trials in Advanced Colorectal Cancer|"Screening Platform of the EORTC for Clinical Trials in Advanced Colorectal Cancer SPECTAcolor"|Recruiting||N/A|2600|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||t||||||Samples With DNA|"     FFPE blocks of tumour tissue   "|||2017-10-11 02:19:19.28816|2017-10-11 02:19:19.28816
NCT01723956|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-09-19|||March 2010||2010-03-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|VICAR2||Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women|Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women|Completed||N/A|166|Actual|University of Witwatersrand, South Africa||2|||f||||t||||||||||2017-10-11 02:19:19.511127|2017-10-11 02:19:19.511127
NCT01723943|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-12-29|||March 2009||2009-03-01|December 2014|2014-12-01||||December 2014|Actual|2014-12-01||Interventional|||Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients|Psychoeducation for Spouses/Partners of Women With Breast Cancer|Completed||N/A|108|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 02:19:19.613236|2017-10-11 02:19:19.613236
NCT01723930|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-07||||||November 2012|2012-11-01||||||||Observational|||Transpulmonary Gradient After Cardiac Surgery Under Cardiopulmonary Bypass|Transpulmonary Gradient of Inflammation Biomarkers and Pulmonary Vascular Resistance in Acute Respiratory Failure After Cardiac Surgery Under Cardiopulmonary Bypass|Unknown status|Not yet recruiting|N/A|30||University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 02:19:19.725112|2017-10-11 02:19:19.725112
NCT01722396|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2013-01-14|||March 2011||2011-03-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pharmacogenetics of Vitamin D Supplementation in Tuberculosis|The Pharmacogenetics of Vitamin D Supplementation in Tuberculosis|Completed||Phase 3|62|Actual|University of Birmingham||1|||f||||f||||||||||2017-10-11 02:19:39.84839|2017-10-11 02:19:39.84839
NCT01723917|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2015-01-13|||July 2012||2012-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|phytoSERM||Phytoserms for Menopause Symptoms and Age-Associated Memory Decline|Estrogen Receptor-beta phytoSERMs for Management of Menopause and Age-Associated Memory Decline|Completed||N/A|71|Actual|University of Southern California||3|||f||||t||||||||||2017-10-11 02:19:19.823449|2017-10-11 02:19:19.823449
NCT01723904|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-05-07|2014-03-11||October 2012||2012-10-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional||Baseline characteristics refer to the Safety Set. The Safety Set consists of all subjects who had at least one patch application.|A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease|An Open-Label Study to Investigate the Safety and Efficacy of Rotigotine Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease Phase 3B|Completed||Phase 3|90|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 02:19:19.906|2017-10-11 02:19:19.906
NCT01723891|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-07|||November 2012||2012-11-01|November 2012|2012-11-01||||||||Interventional|||Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers||Completed||Phase 1|24|Actual|Hyundai Pharmaceutical Co., LTD.||2|||f||||||||||||||2017-10-11 02:19:20.253351|2017-10-11 02:19:20.253351
NCT01723878|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-09-08|||December 30, 2013|Actual|2013-12-30|September 2017|2017-09-01|June 20, 2017|Actual|2017-06-20|June 20, 2017|Actual|2017-06-20||Observational|||ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating Mutations|Observational, Post-authorization, Prospective Study for Evaluating Patterns of Disease Progression in Patients With Advanced Non-small-cell Lung Carcinoma (NSCLC) Harbouring EGFR Activating Mutations Treated With Erlotinib in First Line.|Completed||N/A|144|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:19:20.335303|2017-10-11 02:19:20.335303
NCT01723865|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2014-08-04|||May 2011||2011-05-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|EFFECT||Clinical Efficacy of Remote Monitoring in the Management of Heart Failure|Clinical Efficacy of a Specifically Dedicated Remote Monitoring System in the Management of Patients With Heart Failure and ICD&CRT-D.|Completed||N/A|988|Actual|Effect Group, Italy|||2||f||||f||||||||||2017-10-11 02:19:20.510868|2017-10-11 02:19:20.510868
NCT01723852|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-04-07|||January 2013||2013-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|VIDI||Vitamin D Intervention in Infants|Vitamin D Intervention in Infants|Active, not recruiting||N/A|1000|Anticipated|Helsinki University Central Hospital||2|||f||||t||||||||||2017-10-11 02:19:20.621636|2017-10-11 02:19:20.621636
NCT01723839|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-08-09|||February 22, 2012|Actual|2012-02-22|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|January 12, 2015|Actual|2015-01-12||Interventional|FCR||Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide|Phase II Clinical Protocol for the Treatment of Patients With Previously Untreated CLL With Four or Six Cycles of Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide Followed by Lenalidomide Consolidation/ Maintenance|Active, not recruiting||Phase 2|54|Anticipated|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-11 02:19:20.711534|2017-10-11 02:19:20.711534
NCT01723826|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-07-07|||December 7, 2012|Actual|2012-12-07|July 2017|2017-07-01|February 8, 2017|Actual|2017-02-08|February 8, 2017|Actual|2017-02-08||Interventional|||A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab|A Multicenter, Open-Label, Long-Term Safety Extension of Phase II Studies ABE4869g and ABE4955g in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|360|Actual|Genentech, Inc.||1|||f|||||t|f||||||||2017-10-11 02:19:20.861165|2017-10-11 02:19:20.861165
NCT01723813|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2012-11-07|||April 2012||2012-04-01|November 2012|2012-11-01|April 2015|Anticipated|2015-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Peptide Vaccinations Plus GM-CT-01 in Melanoma|Phase I/II Study of Peptide Vaccination Associated With GM-CT-01, a Galactomannan Oligomer That Inhibits Galectin-3, in Patients With Advanced Metastatic Melanoma|Unknown status|Recruiting|Phase 1/Phase 2|12|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 02:19:21.281816|2017-10-11 02:19:21.281816
NCT01723800|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-09-16|||July 2013||2013-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer|Phase I Trial of BKM120 in Combination With Carboplatin and Pemetrexed in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|9|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 02:19:21.371475|2017-10-11 02:19:21.371475
NCT01723787|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-06-28|||March 2013||2013-03-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|||Genetic Studies in Patients and Families With Infantile Spasms|Genetic Studies in Patients and Families With Infantile Spasms|Recruiting||N/A|60|Anticipated|University of Colorado, Denver|||2||f||||f||||||Samples With DNA|"     blood, saliva, buccal cells,urine   "|||2017-10-11 02:19:21.460046|2017-10-11 02:19:21.460046
NCT01723774|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-06-26|||April 10, 2013||2013-04-10|June 2017|2017-06-01|April 30, 2025|Anticipated|2025-04-30|December 31, 2020|Anticipated|2020-12-31||Interventional|||PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer|A Phase II Trial of Neoadjuvant PD 0332991, a Cyclin-Dependent Kinase (Cdk) 4/6 Inhibitor, in Combination With Anastrozole in Women With Clinical Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer|Recruiting||Phase 2|87|Anticipated|Washington University School of Medicine||3|||f||||t|t|f||||||No||2017-10-11 02:19:21.552145|2017-10-11 02:19:21.552145
NCT01723761|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-07-01|||April 2011||2011-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|November 2013|Actual|2013-11-01||Observational|ARIA||Correlations Between Arrhythmias and Air Pollution in Patients With Pacemaker and ICD|Correlations Between Arrhythmias, Climatic Variables and Air Pollution in Patients With Pacemaker and ICD, Followed by Remote Monitoring.|Completed||N/A|473|Actual|Effect Group, Italy|||1||f||||f||||||||||2017-10-11 02:19:21.714669|2017-10-11 02:19:21.714669
NCT01723748|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-04-04|||December 2012||2012-12-01|December 2014|2014-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects|Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects|Completed||N/A|18|Actual|University of Aarhus||2|||f||||t||||||||No||2017-10-11 02:19:21.912793|2017-10-11 02:19:21.912793
NCT01723735|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-09-27|||November 2012||2012-11-01|September 2016|2016-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects|A Randomized, Partial Blind, 3 Parallel Groups Study of the Pharmacodynamic Profile of SAR236553 (REGN727) Administered as Multiple Subcutaneous Doses, Either Alone or on Top of Ezetimibe or Fenofibrate Administered as Multiple Oral Doses in Healthy Subjects|Completed||Phase 1|79|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:19:22.040079|2017-10-11 02:19:22.040079
NCT01723722|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-27|2013-11-05|2013-03-01||January 2007||2007-01-01|November 2013|2013-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|HOMENOW||Treatment of Neonatal Abstinence Syndrome|Treatment of Neonatal Abstinence Syndrome: Evaluation of Efficacy of Phenobarbital in Combination With Either Methadone or Diluted Deodorized Tincture of Opium as Stabilizing and Tapering Regiments|Completed||Phase 4|40|Actual|Eastern Maine Medical Center||2|||f||||t||||||||||2017-10-11 02:19:22.171625|2017-10-11 02:19:22.171625
NCT01723709|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-07-18|||June 2010||2010-06-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort|The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort|Completed||N/A|973|Actual|Duke University|||1||f||||t||||||Samples With DNA|"     7.5 mL PaxGene RNA collection 6 mL DNA whole blood collection 40 mL urine collection 20 mL     serum SST tube collection 16 mL plasma EDTA tube collection   "|||2017-10-11 02:19:22.47809|2017-10-11 02:19:22.47809
NCT01723696|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-09-26|||December 2012||2012-12-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|April 2016|Actual|2016-04-01||Interventional|VCSIP||Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function|Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function|Active, not recruiting||Phase 2/Phase 3|278|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 02:19:22.565472|2017-10-11 02:19:22.565472
NCT01723683|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2012-11-06|||February 2012||2012-02-01|November 2012|2012-11-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|MISTCPAP||Minimally Invasive Surfactant Therapy Followed by CPAP (MISTCPAP) in Preterm Infants With RDS|Minimally Invasive Surfactant Therapy Followed by Early CPAP (MISTCPAP) in Very Preterm Infants With RDS|Unknown status|Recruiting|Phase 2|60|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 02:19:22.676457|2017-10-11 02:19:22.676457
NCT01723670|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-02-09|||December 2012||2012-12-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|CT05||Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Multiple Dose Regimens of CHF 5074 for up to 2 Years on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment|Withdrawn||Phase 2|0|Actual|CERESPIR||3|||f||||t||||||||||2017-10-11 02:19:22.791973|2017-10-11 02:19:22.791973
NCT01723657|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-06|||October 2003||2003-10-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)|Risk Adapted Treatment for Primary AML in Adults, Based on Genetics and Minimal Residual Disease (MRD) in Patients up to the Age of 70 Years.|Completed||Phase 2|862|Actual|Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias||1|||f||||f||||||||||2017-10-11 02:19:22.899434|2017-10-11 02:19:22.899434
NCT01723644|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-05-29|||October 2012||2012-10-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|April 2015|Actual|2015-04-01||Interventional|CLINPCT||Clinical Reassessment Versus Procalcitonin in Order to Shorten Antibiotic Duration in Community-acquired Pneumonia|CLINPCT Study: Clinical Reassessment Versus Procalcitonin-guided Algorithm in Order to Reduce Antibiotic Consumption in Community-acquired Pneumonia|Completed||N/A|286|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 02:19:23.088347|2017-10-11 02:19:23.088347
NCT01723631|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-05-15|||April 2012||2012-04-01|December 2014|2014-12-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|TRAP-Myéline||Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis|Study Multicenter, Controlled, Prospective, Non-randomized Test to Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis|Terminated||N/A|189|Actual|Nantes University Hospital||7||"The number of patients achieved is sufficient to evaluate the diagnostic performance of the   test TRAP-myelin"|f||||f||||||||||2017-10-11 02:19:23.215433|2017-10-11 02:19:23.215433
NCT01723618|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2012-11-28|||November 2012||2012-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.|An Open-label, Randomised, Uncontrolled Trial Investigating the Pharmacokinetics of CRD007 After Single Dose Administration to Subjects With Abdominal Aortic Aneurysm (AAA)|Completed||Phase 1|18|Actual|RSPR Pharma AB||3|||f||||f||||||||||2017-10-11 02:19:23.349001|2017-10-11 02:19:23.349001
NCT01723605|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2013-12-28|||October 2012||2012-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Insitu Repair Versus Uterine Exeriorization During Cesarean Section|Insitu Repair Versus Uterine Exeriorization During Cesarean Section: A Randomised Controlled Trial|Completed||Phase 3|1000|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 02:19:23.4366|2017-10-11 02:19:23.4366
NCT01723592|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-06-04|||October 2012||2012-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.|The Ability of an Orally Administered Preparation of Four Lactobacillus Species to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy. A Prospective Randomized Placebo-controlled, Double-blind Trial|Completed||N/A|27|Actual|Medical University of Vienna||2|||f||||t||||||||No||2017-10-11 02:19:23.522393|2017-10-11 02:19:23.522393
NCT01723579|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2015-08-26|||July 2013||2013-07-01|August 2015|2015-08-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)|An Open-label, Multi-center Trial to Evaluate the Contraceptive Efficacy, Safety and Acceptability of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2) in Indian Women. Protocol MK-8175A-017-00|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 02:19:23.612786|2017-10-11 02:19:23.612786
NCT01723566|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2017-08-31|||July 25, 2012|Actual|2012-07-25|August 2017|2017-08-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Observational|||PANORAMA 2 Observational Study|Panorama 2 Medtronic CRDM Implantable Cardiac Device Long Term Registry|Completed||N/A|4706|Actual|Medtronic Bakken Research Center|||1||f||||f||||||||||2017-10-11 02:19:23.700947|2017-10-11 02:19:23.700947
NCT01723540|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2012-11-06|||September 2010||2010-09-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|MC-UsD||A Comparison of Laparoscopic Cholecystectomy Versus Ultrasonic Dissection Assisted Minilaparotomy Cholecystectomy|A Comparison of Ultrasonic Dissection Assisted Minilaparotomy Cholecystectomy Versus Laparoscopic Cholecystectomy; a Randomised Two-center Study.|Completed||N/A|88|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-10-11 02:19:23.861036|2017-10-11 02:19:23.861036
NCT01723527|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-12-10|||December 2012||2012-12-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin||Completed||Phase 1|1|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:19:23.929736|2017-10-11 02:19:23.929736
NCT01723514|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2014-07-24|||November 2012||2012-11-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Ascending Multiple-Doses of AMG 334 in Healthy Subjects and in Migraine Patients|Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 334 in Healthy Subjects and in Migraine Patients|Completed||Phase 1|48|Actual|Amgen||2|||f||||f||||||||||2017-10-11 02:19:24.038213|2017-10-11 02:19:24.038213
NCT01723501|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-06|2016-07-15|||November 2012||2012-11-01|July 2016|2016-07-01||||||||Interventional|CAPS||Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at Birth|Whole Body Cleansing With 0.25% Chlorhexidine at Birth for Prevention of Sepsis in Infants <1500 g: a Multi-center, Blinded, Randomized Trial|Withdrawn||Phase 2/Phase 3|0|Actual|All India Institute of Medical Sciences, New Delhi||2||The study was not started and prematurely closed.|f||||t||||||||||2017-10-11 02:19:24.126488|2017-10-11 02:19:24.126488
NCT01723488|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2013-07-18|||July 2012||2012-07-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|T808||A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808|A Phase 0, Open Label, Non-Randomized, Multi-Center, Exploratory and Safety Study of [F-18]T808|Terminated||Early Phase 1|12|Actual|Avid Radiopharmaceuticals||1||Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals.|f||||f||||||||||2017-10-11 02:19:24.236969|2017-10-11 02:19:24.236969
NCT01723475|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-08-16|||October 25, 2012|Actual|2012-10-25|August 2017|2017-08-01|December 29, 2017|Anticipated|2017-12-29|August 31, 2017|Anticipated|2017-08-31||Interventional|||First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer|An Open-label, Phase I, Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY 2010112, Given Once Daily by Subcutaneous Administration or by Continuous Intravenous Infusion, in Subjects With Castration-resistant Prostate Cancer|Active, not recruiting||Phase 1|45|Actual|Bayer||2|||f||||t||||||||||2017-10-11 02:19:24.318116|2017-10-11 02:19:24.318116
NCT01723462|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-07|||August 2008||2008-08-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||How Often Are Pharmacist Recommendations Followed by Emergency Physicians in Emergency Departments?||Completed||N/A|301|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 02:19:24.423728|2017-10-11 02:19:24.423728
NCT01723449|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-02-13|||November 2012||2012-11-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Predictors for Admission to Emergency Department More Than 48 Hours||Completed||N/A|730|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 02:19:24.486417|2017-10-11 02:19:24.486417
NCT01723436|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2015-01-27|||November 2012||2012-11-01|January 2015|2015-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effects of Repeated Decision Making Among Surrogates of Seriously Ill Patients|Pilot Study of Repeated Decision Making in Surrogates|Completed||N/A|132|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 02:19:24.553446|2017-10-11 02:19:24.553446
NCT01723423|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-07-12|||August 2011||2011-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|MROC||Mastectomy Reconstruction Outcomes Consortium (MROC) Study|Mastectomy Reconstruction Outcomes Consortium (MROC) Study|Completed||N/A|4436|Actual|University of Michigan|||8||f||||t||||||||||2017-10-11 02:19:24.654737|2017-10-11 02:19:24.654737
NCT01723410|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2015-12-10|||January 2013||2013-01-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Neural and Physiological Responses to Real-World Experiences|Neural and Physiological Responses to Real-World Experiences|Completed||N/A|70|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:19:24.941181|2017-10-11 02:19:24.941181
NCT01723397|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-11-07|2016-09-06||November 2012||2012-11-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Nasaleze on Nasal Challenge With Allergen|Effect of Nasaleze on the Early Reaction to Nasal Challenge With Allergen|Terminated||N/A|14|Actual|University of Chicago||2||Poor recruitment|f||||f||||||||||2017-10-11 02:19:25.193714|2017-10-11 02:19:25.193714
NCT01723384|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-12-12|||May 2013||2013-05-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|Project iN||Intermittent Naltrexone Among Polysubstance Users||Completed||Phase 2|30|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:19:25.464809|2017-10-11 02:19:25.464809
NCT01723371|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-12-30|||September 2012||2012-09-01|December 2015|2015-12-01||||September 2015|Actual|2015-09-01||Interventional|||Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children|Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children|Withdrawn||Phase 1/Phase 2|0|Actual|The Hospital for Sick Children||1||Due to lack of enrollment.|f||||f||||||||||2017-10-11 02:19:25.556639|2017-10-11 02:19:25.556639
NCT01723358|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2015-07-17|||September 2010||2010-09-01|July 2015|2015-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Neuromuscular Electrical Stimulation (NMES) Treatment Technique Therapy in the Management of Young Infants With Severe Dysphagia|Effectiveness of a New Neuromuscular Electrical Stimulation (NMES) Treatment Technique (VitalStim® Therapy) in the Management of Young Infants With Severe Dysphagia: a Prospective Pilot Study|Completed||Phase 2|10|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 02:19:25.629655|2017-10-11 02:19:25.629655
NCT01723345|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2013-01-26|||February 2012||2012-02-01|January 2013|2013-01-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Interventional|||Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)?||Unknown status|Recruiting|Phase 3|90|Anticipated|Shiraz University of Medical Sciences||2|||f||||||||||||||2017-10-11 02:19:25.709611|2017-10-11 02:19:25.709611
NCT01723332|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-09-16|||November 2012||2012-11-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The CHAPTER II Study - Congenital Heart Adolescents Participating in Transition Evaluation Research|The CHAPTER II Study - Congenital Heart Adolescents Participating in Transition Evaluation Research|Active, not recruiting||N/A|120|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 02:19:25.86039|2017-10-11 02:19:25.86039
NCT01723319|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-05|||November 2012||2012-11-01|November 2012|2012-11-01||||May 2013|Anticipated|2013-05-01||Interventional|||A Double Blind Randomized Controlled Evaluation of the HBLPADD-coil Transcranial Magnetic Stimulation (TMS) Device - Efficacy and Safety In Subjects With ADHD.||Unknown status|Not yet recruiting|N/A|40|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 02:19:25.946965|2017-10-11 02:19:25.946965
NCT01723306|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-06-10|||October 2012||2012-10-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|October 2016|Anticipated|2016-10-01||Interventional|||Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas|"Phase II/Pilot Study of 2nd Generation Anti-CEA Esigner T Cells in Adenocarcinomas"|Suspended||Phase 2|48|Anticipated|Roger Williams Medical Center||1||Funding|f||||t||||||||||2017-10-11 02:19:26.040562|2017-10-11 02:19:26.040562
NCT01723293|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-11-13|||March 2010||2010-03-01|August 2012|2012-08-01|June 2015|Anticipated|2015-06-01|May 2013|Actual|2013-05-01||Interventional|||Fetal Cardiovascular Response to Maternal Exercise During Third Trimester|Effect of a Specific Exercise Program During Whole Pregnancy on Fetal Heart Rate Response to Maternal Effort in Third Trimester. A Randomised Controlled Trial|Unknown status|Recruiting|N/A|160|Anticipated|Technical University of Madrid||2|||f||||t||||||||||2017-10-11 02:19:26.134778|2017-10-11 02:19:26.134778
NCT01723280|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-05|||October 2006||2006-10-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|September 2011|Actual|2011-09-01||Observational|PROXI||Supplemental Oxygen - Effect on Occurrence of Subsequent Cancer After Abdominal Surgery (Follow-up of the PROXI Trial)|Perioperative Inspiratory Oxygen Fraction - Effect on Occurrence of Subsequent Cancer After Abdominal Surgery (Follow-up of the PROXI Trial)|Completed||N/A|1386|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-11 02:19:26.240012|2017-10-11 02:19:26.240012
NCT01723267|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-04-10|||December 2012||2012-12-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Automated 3D (SonoAVC) Versus 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial|Automated 3D (SonoAVC) vs 2D Ovarian Follicles Assessment in IVF Cycles: a Randomized Controlled Trial|Completed||N/A|54|Actual|Rabin Medical Center||2|||f||||f||||||||Undecided||2017-10-11 02:19:26.336344|2017-10-11 02:19:26.336344
NCT01723254|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-05-31|2016-05-31||December 2012||2012-12-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis|A Phase 1, Randomized, Double Blinded, Placebo Controlled Study To Evaluate The Safety, Tolerability, Immunogenicity, And Exploratory Pharmacodynamic Response Of Ascending Dose Levels Of An Anti-ige Vaccine With Two Different Adjuvant Formulations (Pf-06444753 And Pf-06444752) In Generally Healthy Subjects With Allergic Rhinitis|Completed||Phase 1|190|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:19:27.065993|2017-10-11 02:19:27.065993
NCT01723241|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-01-09|||November 2012||2012-11-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Phase 1 Study of XAF5 Gel Applied to Skin of Healthy Volunteers|A Randomized, Placebo-controlled, Double-blind, Multiple-ascending-dose Study to Assess the Safety and Tolerability of XAF5 Gel Applied to the Skin of Healthy Volunteers|Completed||Phase 1|32|Actual|Topokine Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 02:19:30.110451|2017-10-11 02:19:30.110451
NCT01723228|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-02-29|2016-01-26||November 2012||2012-11-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease|A 24-Week, Multicenter, Randomized, Double-blind, Placebo-Controlled, Add-on, Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease|Completed||Phase 4|170|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 02:19:30.207092|2017-10-11 02:19:30.207092
NCT01723215|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2015-03-17|||December 2012||2012-12-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Prevention of Combat-related PTSD Using Attention Bias Modification (ABM): A Randomized Controlled Trial|Prevention of Posttraumatic Symptoms in IDF Soldiers Using Attention Bias Modification (ABM): A Randomized Controlled Trial|Completed||N/A|862|Actual|Tel Aviv University||4|||f||||f||||||||||2017-10-11 02:19:30.968507|2017-10-11 02:19:30.968507
NCT01723202|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-01-26|||November 7, 2012|Actual|2012-11-07|January 2017|2017-01-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer|A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma|Active, not recruiting||Phase 2|52|Actual|Ohio State University Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 02:19:31.066039|2017-10-11 02:19:31.066039
NCT01723189|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-11-05|||August 2012||2012-08-01|November 2012|2012-11-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Pathophysiology of Central Apnoeas in Stroke Patients|Central Apnoeas in the Course of Transient Ischemic Attack/Ischemic Stroke: Clinical, Prognostic, Pathophysiological Elements.|Unknown status|Recruiting|N/A|120|Anticipated|Ospedale Civico, Lugano|||4||f||||t||||||||||2017-10-11 02:19:31.234032|2017-10-11 02:19:31.234032
NCT01723176|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2015-09-24|||December 2012||2012-12-01|September 2015|2015-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Evaluation of Ultrasound of the Heart in Patients With Low Blood Pressure|Evaluating Critical Care Echocardiography in Patients With Cardiopulmonary Failure at the Time of Presentation|Withdrawn||N/A|0|Actual|Northwell Health|||1|study never got off the ground, no pts ever recruited|f||||f||||||||||2017-10-11 02:19:31.463855|2017-10-11 02:19:31.463855
NCT01723163|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-04-18|||November 21, 2013|Actual|2013-11-21|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|October 26, 2016|Actual|2016-10-26||Interventional|||Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers|Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers|Active, not recruiting||N/A|300|Anticipated|VA Office of Research and Development||2|||f||||f||||||||Undecided||2017-10-11 02:19:31.556752|2017-10-11 02:19:31.556752
NCT00000550|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-03-03|||August 1994||1994-08-01|March 2014|2014-03-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Rapid Early Action for Coronary Treatment (REACT)||Completed||Phase 3|||New England Research Institutes|||||f||||||||||||||2017-10-11 04:19:03.703284|2017-10-11 04:19:03.703284
NCT01723150|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-04-13|||November 5, 2013|Actual|2013-11-05|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|December 31, 2017|Anticipated|2017-12-31||Interventional|||Antibiotics for Klebsiella Liver Abscess Study|A Multi-centre Randomised Open-label Active Comparator-controlled Non-inferiority Trial Comparing Oral to Intravenous Antibiotics in the Early Management of Klebsiella Pneumoniae Liver Abscess|Recruiting||N/A|152|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-11 02:19:31.663072|2017-10-11 02:19:31.663072
NCT01723137|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-10-24|||May 2010||2010-05-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Measuring Changes in Acute Pain in the Emergency Department Using Patient Reported Scales|Measuring Changes in Acute Pain in the Emergency Department Using Patient Reported Scales|Completed||N/A|3630|Actual|Minneapolis Medical Research Foundation|||1||f||||||||||||||2017-10-11 02:19:31.816461|2017-10-11 02:19:31.816461
NCT01723124|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-09-19|||July 2012||2012-07-01|September 2016|2016-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up|Comparison of Breast Cancer Detection Rate for Prevalent Screen Low-dose Molecular Breast Imaging and Incident Biennial Screen Low-dose Molecular Breast Imaging in Women With Mammographically Dense Breasts|Terminated||N/A|228|Actual|Mayo Clinic||1||Dose specified in protocol was not adequate to achieve optimal resolution.|f||||f||||||||No||2017-10-11 02:19:31.92418|2017-10-11 02:19:31.92418
NCT01723111|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-08-19|||November 2012||2012-11-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Observational|HERMES||Impact of Dialysis Modality on Hepcidin and Iron Metabolism|A Prospective, Multicenter, Observational Study to Evaluate the Impact of Peritoneal Dialysis Compared With Hemodialysis on Iron Metabolism and Hepcidin|Completed||N/A|120|Actual|Kyungpook National University|||2||f||||f||||||Samples Without DNA|"     2 ml serum will be retained   "|||2017-10-11 02:19:32.070068|2017-10-11 02:19:32.070068
NCT01723098|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-11-13|||February 2009||2009-02-01|March 2014|2014-03-01|September 2015|Anticipated|2015-09-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Regular Exercise on Maternal Cardiovascular System During Pregnancy|Effect of Supervised Exercise Program on Cardiovascular Function and Structure in Pregnant Women. Randomized Controlled Trial|Unknown status|Recruiting|N/A|800|Anticipated|Technical University of Madrid||2|||f||||t||||||||||2017-10-11 02:19:32.212057|2017-10-11 02:19:32.212057
NCT01723085|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-07-24|||March 2012||2012-03-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Anti-Mullerian Hormone Levels Before and After an Open Myomectomy|Anti-Mullerian Hormone Levels Variations Following an Open Myomectomy|Suspended||N/A|21|Anticipated|OVO R & D|||1|It has been put on hold for the moment due to logistic problems|f||||f||||||Samples Without DNA|"     Blood samples collected to measure Anti-Mullerian hormone levels   "|||2017-10-11 02:19:32.321982|2017-10-11 02:19:32.321982
NCT01723059|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-05|||February 2012||2012-02-01|November 2012|2012-11-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection|Conventional Therapy vs Sequential Therapy for the Treatment of Helicobacter Pylori Infection|Unknown status|Recruiting|N/A|184|Anticipated|Dallas VA Medical Center||2|||f||||f||||||||||2017-10-11 02:19:32.562853|2017-10-11 02:19:32.562853
NCT01723046|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-12-10|||February 2013||2013-02-01|December 2012|2012-12-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|ARTHE||Therapeutic Effects of a New Upper Limb Robot Assisted Therapy Device for Persons After Stroke|Active Smart Wearable Orthosis Using Painted EMG Electrodes for Home Based Therapy With Augmentative Feedback|Unknown status|Not yet recruiting|N/A|10|Anticipated|Thomas More Kempen||2|||f||||f||||||||||2017-10-11 02:19:32.683518|2017-10-11 02:19:32.683518
NCT01723033|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2012-11-07|||December 2012||2012-12-01|November 2012|2012-11-01||||December 2013|Anticipated|2013-12-01||Observational|||Differences in Cognitive Performance and Brain Activity Between Patients With PTSD and OCD|Differences in Cognitive Performance and Brain Activity Between Patients With PTSD and OCD|Unknown status|Not yet recruiting|N/A|30|Anticipated|Beersheva Mental Health Center|||2||f||||t||||||||||2017-10-11 02:19:32.789389|2017-10-11 02:19:32.789389
NCT01723020|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-10-04|||December 27, 2012|Actual|2012-12-27|October 2017|2017-10-01|September 5, 2017|Actual|2017-09-05|March 15, 2017|Actual|2017-03-15||Interventional|||A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma|A Phase 1 First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 232 in Adult Subjects With Advanced Solid Tumors or Multiple Myeloma|Completed||Phase 1|107|Actual|Amgen||1|||f||||f||||||||||2017-10-11 02:19:32.868792|2017-10-11 02:19:32.868792
NCT01723007|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-11-06|||August 1999||1999-08-01|November 2012|2012-11-01|June 2001|Actual|2001-06-01|June 2000|Actual|2000-06-01||Interventional|NCTAPPLEBR||Weight Loss Associated With the Consumption of Apple|Modifications of Body Weight and Plasma Lipids With Diet Added of Fruits: Randomized Clinical Trial in Overweight Women|Completed||N/A|49|Actual|Universidade Federal do Amazonas||3|||f||||t||||||||||2017-10-11 02:19:32.975372|2017-10-11 02:19:32.975372
NCT01722994|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-02-02|2015-12-26||August 2012||2012-08-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy Sites|A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy Sites|Completed||Phase 4|97|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-10-11 02:19:33.084578|2017-10-11 02:19:33.084578
NCT01722981|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2012-11-13|||January 2013||2013-01-01|November 2012|2012-11-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Percutaneous Tracheostomy - Systematic Comparison Among Three Methods: Prospective Study|Percutaneous Tracheostomy - Systematic Comparison Among Three Methods: US-guided Tracheostomy, Bronchoscopy Guided Tracheostomy, and Direct Laryngoscopy Tracheostomy.|Unknown status|Not yet recruiting|N/A|300|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||t||||||||||2017-10-11 02:19:33.352223|2017-10-11 02:19:33.352223
NCT01722968|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-08-16|||November 2012||2012-11-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|BEVPAC||A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel|A Prospective Randomized Phase II Study to Identify Predictive Biomarkers and Mechanisms of Therapy Resistance in Patients With HER2-negative Metastatic Breast Cancer Treated With the Combination of Bevacizumab and Paclitaxel (BEVPAC).|Recruiting||Phase 2|30|Anticipated|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 02:19:33.43735|2017-10-11 02:19:33.43735
NCT01722955|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2014-11-17|||September 2012||2012-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Pre-warmed Intravenous Fluids and Monitored Anesthesia Care|Effect of Pre-warmed Intravenous Fluids on the Early Outcomes After Ambulatory Surgery Under Monitored Anesthesia Care|Completed||N/A|50|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:19:33.812337|2017-10-11 02:19:33.812337
NCT01722942|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-09-08|||October 2014||2014-10-01|September 2014|2014-09-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|CHAGASICS||Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death|CHronic Use of Amiodarone aGAinSt Implantable Cardioverter-defibrillator Therapy for Primary Prevention of Death in Patients With Chagas Cardiomyopathy Study (CHAGASICS)|Not yet recruiting||N/A|1100|Anticipated|InCor Heart Institute||2|||f||||t||||||||||2017-10-11 02:19:33.9132|2017-10-11 02:19:33.9132
NCT01722916|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-01-05|||October 2012||2012-10-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase|Pilot Study of Appropriate Dosing for Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase: A Randomized Control Clinical Trial|Active, not recruiting||Early Phase 1|5|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 02:19:34.243036|2017-10-11 02:19:34.243036
NCT01722903|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-09-12|||August 2012||2012-08-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|May 2013|Actual|2013-05-01||Observational|||Detection of CTCs in Patients Undergoing Surgery for Stage IV Colorectal Cancer|Perioperative Detection and Characterization of Circulating Tumor Cells in Patients Undergoing Colorectal Cancer Liver and Lung Metastasectomy|Completed||N/A|25|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||Samples With DNA|"     Colorectal liver and lung metastases, adjacent healthy liver and lung metastases, isolated     circulating tumor cells   "|||2017-10-11 02:19:34.303927|2017-10-11 02:19:34.303927
NCT01722890|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-10-05|||July 2012||2012-07-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Observational|||CharactHer. ICORG 12-09, V3|CharactHer: A Study of the Molecular and Cytogenetic Characteristics of HER2-positive Breast Cancers to Predict Durable Complete Response After Chemotherapy and Trastuzumab|Recruiting||N/A|150|Anticipated|Cancer Trials Ireland|||2||f||||||||||||||2017-10-11 02:19:34.370727|2017-10-11 02:19:34.370727
NCT01722877|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-03-25|2017-03-25||October 2012||2012-10-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|August 2014|Actual|2014-08-01||Interventional|JetStreamISR||JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions|Safety and Effectiveness of JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions: A Prospective Registry|Completed||N/A|29|Actual|Midwest Cardiovascular Research Foundation|This is a feasibility study that will need to be validated with larger multicenter trials.|1|||f||||f||||||||Yes|Manuscript will be published in JEVT early 2016|2017-10-11 02:19:34.449055|2017-10-11 02:19:34.449055
NCT01722864|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-10-18||2014-10-10|November 2012||2012-11-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|||Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)|An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain|Completed||Phase 3|153|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-11 02:19:34.702183|2017-10-11 02:19:34.702183
NCT01722851|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-08-09|||May 2011||2011-05-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Observational|||Circulating miRNAs. ICORG 10-11, V2|Circulating miRNAs: Novel Breast Cancer Biomarkers and Their Use for Guiding and Monitoring Response to Chemotherapy|Recruiting||N/A|122|Anticipated|Cancer Trials Ireland|||2||f||||||||||||||2017-10-11 02:19:34.843263|2017-10-11 02:19:34.843263
NCT01722838|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2015-03-31|||September 2012||2012-09-01|March 2015|2015-03-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|B-ME||Black Men Evolving Behavioral HIV Prevention Intervention for Black MSM|An Evaluation of a Locally Developed Homegrown HIV Prevention Intervention|Unknown status|Active, not recruiting|Phase 2|438|Anticipated|Loyola University Chicago||2|||f||||t||||||||||2017-10-11 02:19:34.941074|2017-10-11 02:19:34.941074
NCT01722825|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2014-06-30|||November 2012||2012-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study of LY2157299 in Japanese Participants With Cancer|Phase 1 Dose-Escalation Study of LY2157299 Monotherapy in Patients With Solid Tumors|Completed||Phase 1|12|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:19:35.013538|2017-10-11 02:19:35.013538
NCT01722812|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2013-05-02|||November 2012||2012-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Cromoglicate in Psoriasis|An Exploratory Study Evaluating the Efficacy of Cromoglicate Cream Compared to Cream Vehicle in the Treatment of Itch in Psoriasis|Completed||Phase 2|30|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 02:19:35.086813|2017-10-11 02:19:35.086813
NCT01722799|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-06-02|||December 2012|Actual|2012-12-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2017|Actual|2017-05-01||Interventional|RAMSES||Randomized Trial of Coronary Angioplasty for de Novo Lesions in sMall vesSElS With Drug Eluting Balloon.|PROSPECTIVE RANDOMIZED TRIAL Multicentric Study to Evaluate the Treatment and the Efficiency of Paclitaxel-coated Balloon IN.PACT FALCON ® in Small-vessel Coronary Stenosis.|Active, not recruiting||N/A|97|Actual|Hospital de Meixoeiro||2|||f||||t||||||||||2017-10-11 02:19:35.159909|2017-10-11 02:19:35.159909
NCT01722591|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-02-03|||January 2013||2013-01-01|February 2015|2015-02-01||||February 2014|Actual|2014-02-01||Interventional|||Safety and Efficacy Study of the Cardiapex Percutaneous Trans-apical Access and Closure System|A Prospective, Multicenter, Uncontrolled Study to Evaluate the Safety and Efficacy of the Cardiapex Percutaneous Trans-apical Access and Closure System|Terminated||N/A|38|Anticipated|Cardiapex Ltd.||1|||f||||f||||||||||2017-10-11 02:19:36.716363|2017-10-11 02:19:36.716363
NCT01722786|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2016-11-10|||April 2014||2014-04-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|RADOA||Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists|Prospective, Observational, Non-interventional Open-label Multicenter Registry Regarding the Management of Severe Bleeding and/or Urgent Interventions During Treatment With Direct Oral Anticoagulants or Vitamin K Antagonists|Recruiting||N/A|260|Anticipated|Cardioangiologisches Centrum Bethanien|||2||f||||t||||||Samples Without DNA|"     If possible, left-over from plasma samples (retention sample) should be used to perform     further analyses as drug concentrations. Retention samples of very low volume would suffice     for HPLC (information on collection method needed) to assess plasma concentrations of     anticoagulants in these patients.   "|No||2017-10-11 02:19:35.263563|2017-10-11 02:19:35.263563
NCT01722773|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2012-11-05|||April 2001||2001-04-01|November 2012|2012-11-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Trial of Non-invasive Ventilation for Stable COPD||Completed||N/A|40|Anticipated|University of Iowa||2|||f||||f||||||||||2017-10-11 02:19:35.357139|2017-10-11 02:19:35.357139
NCT01722760|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-11-05|||August 2013||2013-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Tidal Neonatal NO, Vitamins A and D, and Infant Lung Disease - The AD-ON Study|AD-ON: The Danish Study on Tidal Neonatal Nitrogen Oxide (NO) and Vitamins A and D as Possible Predictors of BPD|Completed||N/A|1500|Actual|Hillerod Hospital, Denmark|||1||f||||t||||||Samples Without DNA|"     Air samples for Nitrogen oxide NO. Maternal, cord and neonatal blood samples for vitamins A     and D.   "|||2017-10-11 02:19:35.434777|2017-10-11 02:19:35.434777
NCT01722747|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2013-03-19|||June 2009||2009-06-01|March 2013|2013-03-01||||July 2012|Actual|2012-07-01||Interventional|BSTS||Bihar School Teachers Study|Promoting Tobacco Control Among Teachers in India|Completed||N/A|945|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 02:19:35.517517|2017-10-11 02:19:35.517517
NCT01722734|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-02-03|2013-10-23||June 2011||2011-06-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|December 2011|Actual|2011-12-01||Interventional|PACT||Preserving ACTs - Text Reminders to Increase Adherence to ACT Treatment|Preserving ACTs - Text Reminders to Increase Adherence to ACT Treatment|Completed||N/A|1140|Actual|Harvard School of Public Health|Main outcome is self-reported adherence. Study was restricted to urban population with mobile phone ownership.|3|||f||||f||||||||||2017-10-11 02:19:35.599101|2017-10-11 02:19:35.599101
NCT01722721|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-11-05|||January 2012||2012-01-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Physicians Work Distribution in a Danish Emergency Department||Completed||N/A|9|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 02:19:35.897714|2017-10-11 02:19:35.897714
NCT01722708|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2017-04-02|||April 2012||2012-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies|Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies|Recruiting||N/A|230|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-10-11 02:19:35.955743|2017-10-11 02:19:35.955743
NCT01722695|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-04-04|||November 2012||2012-11-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|Revacom HD||Performance Comparison of Revaclear With Larger Dialyzer|HD Performance Comparison of Revaclear 200 and Revaclear 400 With Larger-surface Competitor Dialyzers|Completed||N/A|30|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-10-11 02:19:36.041263|2017-10-11 02:19:36.041263
NCT01722682|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-02-13|||June 2012||2012-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|IsletBOM2||Bone Marrow vs Liver as Site for Islet Transplantation|Bone Marrow vs Liver as Site for Islet Transplantation in Patients With Type 1 Diabetes: Pilot Study to Evaluate Efficacy|Active, not recruiting||Phase 1/Phase 2|12|Anticipated|Ospedale San Raffaele||2|||f||||t||||||||||2017-10-11 02:19:36.114025|2017-10-11 02:19:36.114025
NCT01722669|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-05-02|||May 2012||2012-05-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PK/PD||Quercetin PK/PD Study in Healthy Adults and Patients With Elevated Anti-phospholipid Antibodies|Pharmacokinetic and Pharmacodynamic Study of Oral Quercetin and Isoquercetin in Healthy Adults and Patients With Elevated Anti-phospholipid Antibodies|Active, not recruiting||Early Phase 1|40|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t|t|f||||||Undecided|Contact PI|2017-10-11 02:19:36.22229|2017-10-11 02:19:36.22229
NCT01722656|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-01-20|||November 2012||2012-11-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|EVEN||Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment|Open Label Study: Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment.|Completed||Phase 4|40|Actual|Southern California Desert Retina Consultants, MC||1|||f||||f||||||||||2017-10-11 02:19:36.312467|2017-10-11 02:19:36.312467
NCT01722643|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-08-02|||January 2013||2013-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 Diabetes|Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 Diabetes|Recruiting||N/A|95|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 02:19:36.404995|2017-10-11 02:19:36.404995
NCT01722630|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2012-11-05|||March 2012||2012-03-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Renal Function During Laparoscopic Surgery|Dopamine Infusion and Crystalloids Administration Improve Renal Function During Laparoscopic Surgery|Completed||N/A|60|Actual|Catholic University of the Sacred Heart||3|||f||||f||||||||||2017-10-11 02:19:36.488384|2017-10-11 02:19:36.488384
NCT01722617|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-09-22|||March 2012||2012-03-01|January 2012|2012-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|FLARE||A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.|A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.|Completed||N/A|207|Actual|Central Hospital, Nancy, France||3|||f||||f||||||||||2017-10-11 02:19:36.553465|2017-10-11 02:19:36.553465
NCT01722604|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2017-03-20||2015-03-25|January 2012||2012-01-01|March 2017|2017-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt||Completed||Phase 3|258|Actual|InnoPharma Inc.||2|||f||||f||||||||||2017-10-11 02:19:36.648235|2017-10-11 02:19:36.648235
NCT01722578|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-02-06|||December 2013||2013-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|HEAL||L-ornithine L-aspartate in Overt Hepatic Encephalopathy|Efficacy of Intravenous 'L-ornithine L-aspartate' in Reversal of Overt Acute Hepatic Encephalopathy in Patients With Liver Cirrhosis: a Prospective, Randomized, Double-blind, Placebo Controlled Trial|Completed||Phase 4|200|Actual|Dayanand Medical College and Hospital||2|||f||||t||||||||||2017-10-11 02:19:36.786573|2017-10-11 02:19:36.786573
NCT01722565|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-04|2015-09-09|||January 2012||2012-01-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection|Randomized, Controlled, Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection|Completed||Phase 4|32|Actual|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-11 02:19:36.892137|2017-10-11 02:19:36.892137
NCT01722552|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2017-03-11|2017-03-11||November 2012||2012-11-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CATS|Intervention arm baseline information|China Adherence Through Technology Study|China Adherence Through Technology Study|Completed||N/A|120|Actual|Boston University||2|||f||||f||||||||No|We have no IPD sharing plan.|2017-10-11 02:19:36.967871|2017-10-11 02:19:36.967871
NCT01722539|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2014-02-03|||November 2012||2012-11-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|PIP-IPT||Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren|Efficacy and Safety of Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine Regimens Delivered Through Intermittent Preventive Treatment in Schoolchildren of Democratic Republic of Congo: A Randomised Control Trial|Completed||Phase 3|616|Actual|Universiteit Antwerpen||3|||f||||f||||||||||2017-10-11 02:19:37.373339|2017-10-11 02:19:37.373339
NCT01722526|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-05|2015-07-29|||March 2013||2013-03-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Tolerability and Safety Study of Recombinant Human Acid Sphingomyelinase in Acid Sphingomyelinase Deficiency Patients|An Open-label, Multicenter, Ascending Dose Study of the Tolerability and Safety of Recombinant Human Acid Sphingomyelinase (rhASM) in Patients With Acid Sphingomyelinase Deficiency (ASMD)|Completed||Phase 1|5|Actual|Sanofi||1|||f||||t||||||||||2017-10-11 02:19:37.479728|2017-10-11 02:19:37.479728
NCT01722513|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2012-11-06|||November 2012||2012-11-01|November 2012|2012-11-01|February 2014|Anticipated|2014-02-01|November 2013|Anticipated|2013-11-01||Interventional|||Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy|Phase 4 Study of Alprostadil Prevent Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization|Unknown status|Active, not recruiting|Phase 4|150|Anticipated|Shanghai 10th People's Hospital||1|||f||||t||||||||||2017-10-11 02:19:37.585695|2017-10-11 02:19:37.585695
NCT01722500|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-02-04|||December 2010||2010-12-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|ISCOLE||International Study of Childhood Obesity, Lifestyle and the Environment|International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE)|Completed||N/A|7806|Actual|Pennington Biomedical Research Center|||1||f||||t||||||||No||2017-10-11 02:19:37.692131|2017-10-11 02:19:37.692131
NCT01722487|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-04-03|2016-03-31||March 2013||2013-03-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL|Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Completed||Phase 3|269|Actual|Pharmacyclics LLC.||2|||f||||f||||||||No|We share this information with FDA and other authorities for the purposes of analyzing the study but not with other researchers|2017-10-11 02:19:37.851648|2017-10-11 02:19:37.851648
NCT01722474|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-02-11|||October 2012||2012-10-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|ASI-2012||Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness.|Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness.|Terminated||N/A|15|Actual|University of Manitoba||1||Minor device modifications required, move revised device to clinical site in USA.|f||||f||||||||||2017-10-11 02:19:39.270726|2017-10-11 02:19:39.270726
NCT01722461|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2013-12-12|||November 2012||2012-11-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis|A Prospective, Multi-Center, Parallel, Randomized, Double-Blinded Study of the Efficacy and Safety of the Ulthera® System for the Treatment of Primary Axillary Hyperhidrosis|Terminated||N/A|120|Actual|Ulthera, Inc||2||Sponsor decision; unexpectedly high sham response at primary outcome time point.|f||||t||||||||||2017-10-11 02:19:39.356229|2017-10-11 02:19:39.356229
NCT01722435|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-08-05|2014-06-03||July 2011||2011-07-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational||Patients treated with methadone or levomethadone who were eligible for the study and consented to participate and qualified for treatment completion in the next 12 months.|Completion of OST - a Prospective Study|Completion of Substitution Treatment With Methadone/Levomethadone - a Prospective Study|Completed||N/A|78|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-10-11 02:19:39.520446|2017-10-11 02:19:39.520446
NCT01722422|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-11-19|||October 2012||2012-10-01|November 2012|2012-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Hyper2S||Hyperoxia and Hypertonic Saline in Septic Shock||Terminated||N/A|441|Actual|University Hospital, Angers||4|||f||||t||||||||||2017-10-11 02:19:39.701656|2017-10-11 02:19:39.701656
NCT01722409|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2015-06-23|||December 2012||2012-12-01|October 2013|2013-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Better Choice for Patients Undergoing Endovascular Coil Embolization|Sevoflurane, Laryngeal Mask Airway and Single-dose Dexmedetomidine: A Better Choice for Patients Undergoing Endovascular Coil Embolization|Completed||Phase 4|64|Actual|China Medical University, China||3|||f||||t||||||||||2017-10-11 02:19:39.780556|2017-10-11 02:19:39.780556
NCT00000551|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-24|||September 1994||1994-09-01|August 2007|2007-08-01|September 2002||2002-09-01|||||Interventional|||Activity Counseling Trial (ACT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:03.776048|2017-10-11 04:19:03.776048
NCT01722383|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-10-04|||October 2010||2010-10-01|October 2016|2016-10-01|December 2026|Anticipated|2026-12-01|December 2025|Anticipated|2025-12-01||Observational|RIISC||What Are the Determinations of Adult Progressive CKD? The Renal Impairment In Secondary Care (RIISC) Study|What Are the Determinations of Adult Progressive CKD? The Renal Impairment In Secondary Care (RIISC) Study|Active, not recruiting||N/A|932|Actual|University Hospital Birmingham NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Serum, Plasma, Urine, DNA, Saliva, Dental Plaque   "|Yes|Anonymised patient data is being shared within the remit of the ethics for this study with collaborators|2017-10-11 02:19:39.921277|2017-10-11 02:19:39.921277
NCT01722370|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-12-01|||August 2012||2012-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|OM-COPD||Ambulatory Oxygen Effects on Muscles in COPD|Can Muscle Dysfunction in COPD be Altered by Oxygenation in Patients With Intermittent Hypoxia on Exertion?|Completed||Phase 4|25|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-11 02:19:40.134944|2017-10-11 02:19:40.134944
NCT01722357|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-10-12|||November 2009||2009-11-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|July 2014|Actual|2014-07-01||Interventional|||Promoting Physical Activity Among Bariatric Surgery Patients|Promoting Physical Activity Among Bariatric Surgery Patients|Active, not recruiting||N/A|152|Actual|St. Vincent Carmel Hospital||3|||f||||f||||||||Undecided||2017-10-11 02:19:40.21428|2017-10-11 02:19:40.21428
NCT01722344|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-04-10|||October 2012||2012-10-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|July 2017|Anticipated|2017-07-01||Interventional|||Improving Work Outcome for People With Severe Mental Illness|Individual Placement and Support (IPS) Enhanced With Cognitive Remediation and Social Skills Training in Denmark: a Randomized Controlled Trial|Active, not recruiting||N/A|717|Actual|Mental Health Centre Copenhagen||3|||f||||t||||||||||2017-10-11 02:19:40.310683|2017-10-11 02:19:40.310683
NCT01722331|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-03-16|||December 2012||2012-12-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)|A 64-Week, Phase 3, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222), Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis (Protocol No. MK-3222-010)|Active, not recruiting||Phase 3|772|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 02:19:40.428605|2017-10-11 02:19:40.428605
NCT01722318|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-01-13|||November 2012||2012-11-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|CIBS||The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)|A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|Completed||Phase 2|350|Actual|Synergy Pharmaceuticals Inc.||5|||f||||f||||||||||2017-10-11 02:19:40.524998|2017-10-11 02:19:40.524998
NCT01722305|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-08-28|||April 2013||2013-04-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma|Phase I Trial of Pomalidomide for Patients With Relapsed/Refractory Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma|Suspended||Phase 1|34|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:19:40.771327|2017-10-11 02:19:40.771327
NCT01722292|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-09-30||2015-05-08|January 2013||2013-01-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of LY2940680 in Small Cell Lung Cancer|A Phase 1b/2 Double-Blind Randomized Trial of the Hedgehog/SMO Antagonist LY2940680 in Combination With Carboplatin and Etoposide Followed by LY2940680 Versus Carboplatin and Etoposide Plus Placebo Followed by Placebo in Patients With Extensive-Stage Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|26|Actual|Eli Lilly and Company||3||Change in clinical strategy.|f||||f||||||||||2017-10-11 02:19:40.898253|2017-10-11 02:19:40.898253
NCT01722279|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2012-11-02|||July 2010||2010-07-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||The Long Term Impact of Bariatric Surgery on Quality of Life|The Long Term Impact of Bariatric Surgery on Quality of Life|Completed||N/A|414|Actual|St. Vincent Carmel Hospital|||1||f||||f||||||||||2017-10-11 02:19:41.007072|2017-10-11 02:19:41.007072
NCT01722266|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-03-02|2015-02-09||November 2012||2012-11-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Liraglutide in the Treatment of Type 1 Diabetes Mellitus|Liraglutide in the Treatment of Type 1 Diabetes Mellitus|Completed||Phase 3|72|Actual|Kaleida Health|Three subjects randomized to 1.2 mg group and one subject randomized to 1.8 mg group tolerated only 0.6 mg. These 4 subjects were included in the 0.6 mg group for analysis.|4|||f||||f||||||||||2017-10-11 02:19:41.092986|2017-10-11 02:19:41.092986
NCT01722253|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-03|2015-06-04|||December 2008||2008-12-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|LFE||Postoperative Analgesia After Low Frequency Electroacupuncture|Postoperative Analgesia After Low Frequency Electroacupuncture as Adjunctive Therapy in Inguinal Hernia Surgery With Abdominal Wall Mesh Reconstruction|Completed||Early Phase 1|54|Actual|Aristotle University Of Thessaloniki|||1||f||||t||||||Samples Without DNA|"     serum, plasma   "|||2017-10-11 02:19:43.112563|2017-10-11 02:19:43.112563
NCT01722240|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-11-15|||November 2012||2012-11-01|November 2016|2016-11-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Liraglutide in Type 1 Diabetes||Recruiting||Phase 3|96|Anticipated|University at Buffalo||2|||f||||t||||||||||2017-10-11 02:19:43.182688|2017-10-11 02:19:43.182688
NCT01722227|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-02-08|||November 2012||2012-11-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|||Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes|Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes|Withdrawn||Phase 3|0|Actual|University at Buffalo||2||No Funding Received from ADA|f||||f||||||||||2017-10-11 02:19:43.255346|2017-10-11 02:19:43.255346
NCT01722214|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2016-09-08|||November 2012||2012-11-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis|Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis|Completed||Phase 4|107|Actual|Innovaderm Research Inc.||2|||f||||f||||||||No||2017-10-11 02:19:43.333028|2017-10-11 02:19:43.333028
NCT01722201|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2012-11-02|||June 2012||2012-06-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Risperidone Tablet 1 mg With Risperdal® 1 mg in Normal, Healthy, Adult, Human Subjects Under Fasting Condition|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:19:43.444296|2017-10-11 02:19:43.444296
NCT01722188|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-10-06|||August 2006||2006-08-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|OPTIMUM||Lead Registry for Optim Leads|Optim Lead Insulation Material Registry|Active, not recruiting||N/A|14124|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 02:19:43.545053|2017-10-11 02:19:43.545053
NCT01722175|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-07-21||||||July 2014|2014-07-01|January 2019|Anticipated|2019-01-01|April 2016|Anticipated|2016-04-01||Interventional|ALPPS||Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer|Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Portal Vein Occlusion (PVO) to Induce Liver Regeneration for Resection of Liver Tumors That Are Unresectable in One Step - a Randomized Controlled Trial|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||2||Safety concerns.|f||||f||||||||||2017-10-11 02:19:44.138501|2017-10-11 02:19:44.138501
NCT01722162|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-03-22|2016-12-20||April 2013||2013-04-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer|Phase II Study of Levocetirizine in Combination With Capecitabine + Bevacizumab to Overcome Resistance to Anti-angiogenic Therapy in Patients With Refractory Colorectal Cancer|Completed||Phase 2|47|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 02:19:44.240459|2017-10-11 02:19:44.240459
NCT01722149|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-05-02|||October 2014||2014-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma|Phase I Study for the Adoptive Transfer of Re-directed FAP-specific T Cells in the Pleural Effusion of Patients With Malignant Pleural Mesothelioma.|Recruiting||Phase 1|6|Anticipated|University of Zurich||1|||f||||t||||||||||2017-10-11 02:19:45.086371|2017-10-11 02:19:45.086371
NCT01722136|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-05-10|||August 2012||2012-08-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|WW||"We Walk: Impact of Exercise Dose on Health Outcomes Among Women Ages 60-75"|We Walk - Energy Expenditure and Health Outcomes in Older, Sedentary Women.|Completed||N/A|72|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-11 02:19:45.187709|2017-10-11 02:19:45.187709
NCT01722123|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-08-11|||November 2012||2012-11-01|August 2017|2017-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effects of Frequent Decision Making Among Patients With Serious Illnesses|Pilot Study of Repeated Decision Making in Patients|Completed||N/A|66|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 02:19:45.28978|2017-10-11 02:19:45.28978
NCT01722110|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2012-11-02|||April 2012||2012-04-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition|A Randomized, Balanced, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg of Ipca Laboratories Ltd., With Indomethacin Extended-Release Capsules USP 75 mg of Epic Pharma, USA, in Normal, Healthy, Adult, Male and Female Human Subjects Under Fed Conditions.|Completed||Phase 1|32|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:19:45.383502|2017-10-11 02:19:45.383502
NCT01722097|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2015-09-21|2015-08-18||November 2012||2012-11-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||Recovery After Laparoscopic Hysterectomy With Deep Neuromuscular Blockade and Low Intra-abdominal Pressure|Recovery After Laparoscopic Hysterectomy With Deep Neuromuscular Blockade and Low Intra-abdominal Pressure|Completed||Phase 4|110|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 02:19:45.465657|2017-10-11 02:19:45.465657
NCT01722084|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-12-04|||July 2011||2011-07-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|CERCA||Community-embedded Reproductive Health Care for Adolescents in Latin America.|Community-embedded Reproductive Health Care for Adolescents in Latin America (CERCA).|Completed||N/A|9625|Actual|University Ghent||2|||f||||f||||||||||2017-10-11 02:19:45.847424|2017-10-11 02:19:45.847424
NCT01722071|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-12-28|2015-04-22||October 2012||2012-10-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|September 2013|Actual|2013-09-01||Interventional||Subjects who completed Baseline Assessments prior to scanning.|Deciphering the Role of Oxytocin in Motivation: an fMRI Study|Deciphering the Role of Oxytocin in Motivation: an fMRI Study|Completed||Phase 2|20|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 02:19:45.938689|2017-10-11 02:19:45.938689
NCT01722058|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2013-11-14|||February 2013||2013-02-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||A Phase I In-Vivo Peptide Applied in the Right Colon|A Phase I In-Vivo Colon Protocol for Detection of Neoplasia in the Digestive Tract (U54)|Completed||Phase 1|25|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 02:19:46.170957|2017-10-11 02:19:46.170957
NCT01722032|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2012-11-02|||June 2010||2010-06-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|HC2||USDA Healthy Caregivers/Healthy Children: A Childhood Obesity Prevention Program|Healthy Caregivers/Healthy Children|Completed||N/A|1100|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 02:19:46.429342|2017-10-11 02:19:46.429342
NCT01721850|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2016-05-13|||December 2011||2011-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|Coco||Evaluation of Safety and Efficacy of New Infant Formula in Infantile Colic|Evaluation of the Safety and Efficacy of New Infant Formula and Its Effects on the Gastrointestinal Tolerance (Crying Time) in Infantile Colic: a Double-blind, Randomized, Controlled Intervention Study|Recruiting||N/A|174|Anticipated|HiPP GmbH & Co. Vertrieb KG||3|||f||||f||||||||||2017-10-11 02:19:48.8117|2017-10-11 02:19:48.8117
NCT01722019|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-12-04|||January 2014||2014-01-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|VNUS vs TULIP||Prospective Multicentric Trial Between Radiofrequency Ablation With VNUS Closure Fast ® and Endovenous Ablation With 1470 nm Diode Laser and Tulip Fiber ® for Treatment of Primary Venous Insufficiency.|Prospective Multicentric Randomised Trial Between Radiofrequency Ablation With VNUS Closure Fast ® and Endovenous Ablation With 1470 nm Diod Laser and Tulip Fiber ® for Treatment of Primary Venous Insufficiency.|Unknown status|Recruiting|N/A|400|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 02:19:46.500127|2017-10-11 02:19:46.500127
NCT01722006|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2013-09-04|||December 2010||2010-12-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Drug Effects on Preference and Reward|Drug Effects on Preference and Reward|Completed||N/A|103|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 02:19:46.624398|2017-10-11 02:19:46.624398
NCT01721993|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2015-03-25|||January 2013||2013-01-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women|Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01Fand T121E02F in Healthy Postmenopausal Women|Completed||Phase 1|71|Actual|Thar Pharmaceuticals, Inc||2|||f||||t||||||||||2017-10-11 02:19:46.705589|2017-10-11 02:19:46.705589
NCT01721980|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2013-02-09|||October 2012||2012-10-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects|Double-blind, Randomized, Placebo-controlled Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of GLPG0974 in Healthy Male Subjects|Completed||Phase 1|32|Actual|Galapagos NV||4|||f||||f||||||||||2017-10-11 02:19:46.769633|2017-10-11 02:19:46.769633
NCT01721967|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-01-19|2016-11-04||November 2012||2012-11-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Interventional|RHYME||Ranolazine for the Treatment of Chest Pain in HCM Patients|Ranolazine for the Treatment of Angina in Hypertrophic Cardiomyopathy Investigation|Completed||Phase 4|14|Actual|Duke University||1|||f||||t||||||||||2017-10-11 02:19:46.993653|2017-10-11 02:19:46.993653
NCT01721954|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-04-07|||February 2013||2013-02-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|FOXFIREGlobal||FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer|Assessment of Overall Survival of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First-line Treatment in Patients With Non-resectable Liver Metastases From Primary Colorectal Carcinoma in a Randomised Clinical Study|Active, not recruiting||Phase 3|200|Anticipated|Sirtex Medical||2|||f||||t||||||||Undecided||2017-10-11 02:19:47.293994|2017-10-11 02:19:47.293994
NCT01721941|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-07-03|||December 2014||2014-12-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma|A Phase I Dose Escalation Study of TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|Scripps Clinic Cancer Center||4|||f||||t||||||||||2017-10-11 02:19:47.565119|2017-10-11 02:19:47.565119
NCT01721928|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-04-23|||November 2012||2012-11-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|October 2016|Anticipated|2016-10-01||Observational|NORIDES||Norwegian Intensive Care Unit Dalteparin Effect Study|Norwegian Intensive Care Unit Dalteparin Effect Study|Recruiting||N/A|300|Anticipated|Oslo University Hospital|||2||f||||f||||||Samples With DNA|"     12 ml whole blood (10 ml for storage and 2 ml for bedside TEG analysis) will be aspirated     from the arterial or the central venous catheter for each measurement. Four measurements will     be performed in each patient, from minimum day 2 to maximum day 30 dependent on the dialysis     therapy.      Four urinary samples (each of 20 ml) will be collected from urinary catheter collection bags     at the same time as blood samples are drawn.      Blood (20 mL stored as whole blood, serum and plasma) and urine samples (20 mL) will be     collected from each patient at the same time as blood samples are drawn. The samples will be     stored at - 70°C for future analysis.   "|||2017-10-11 02:19:47.671043|2017-10-11 02:19:47.671043
NCT01721915|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-01-04|||October 2012||2012-10-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism|A Randomized, Double‐Blind, Placebo Controlled Trial to Evaluate the Effects of Vitamin D Supplementation on Metabolic and Fertility Parameters in PCOS Women|Recruiting||Phase 4|300|Anticipated|Medical University of Graz||2|||f||||f||||||||||2017-10-11 02:19:47.835416|2017-10-11 02:19:47.835416
NCT01721902|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2013-12-03|||January 2010||2010-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Stem Cell Implantation in Patients Undergoing CABG|Stem Cell Implantation in Patients Undergoing CABG|Terminated||Phase 1|23|Anticipated|Miltenyi Biotec, Inc.||2||The study was terminiated due the lack of recruitment.|f||||t||||||||||2017-10-11 02:19:48.00121|2017-10-11 02:19:48.00121
NCT01721889|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-06-10|||November 2012||2012-11-01|June 2013|2013-06-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Observational|||Radiostereometric Analysis of Spine Arthrodesis|Radiostereometric Analysis of Spine Arthrodesis|Unknown status|Recruiting|N/A|30|Anticipated|OAD Orthopaedics|||3||f||||f||||||||||2017-10-11 02:19:48.125777|2017-10-11 02:19:48.125777
NCT01721876|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-08-03||2014-10-14|January 29, 2013|Actual|2013-01-29|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|August 12, 2014|Actual|2014-08-12||Interventional|||Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)|A Phase III Randomised, Double-blind, Controlled, Parallel Group Study of Intravenous Volasertib in Combination With Subcutaneous Low-dose Cytarabine vs. Placebo + Low-dose Cytarabine in Patients >=65 Years With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy|Active, not recruiting||Phase 3|666|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:19:48.259579|2017-10-11 02:19:48.259579
NCT01721863|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-22|2012-11-02|||November 2010||2010-11-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Exercise Training in Patients With Permanent Atrial Fibrillation|Effects of Exercise Training on Endothelial Function, Heart Rate Variability, Exercise Capacity, and Quality of Life in Patients With Permanent Atrial Fibrillation|Completed||Phase 1|58|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:19:48.676673|2017-10-11 02:19:48.676673
NCT01721837|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-06-30|2014-06-30||October 2012||2012-10-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational||All patients with documented mild or moderate renal impairment and non valvular atrial fibrillation (PPS).|Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment|Use of Pradaxa® (Dabigatran Etexilate) for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Mild to Moderate Renal Impairment|Completed||N/A|4340|Actual|Boehringer Ingelheim|This non-interventional studies is conducted according to §67, section 6 German Medicines Act. The term ‚principal investigator‘ is not applicable.||1||f||||||||||||||2017-10-11 02:19:49.665403|2017-10-11 02:19:49.665403
NCT01721824|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-07-06|||October 2011||2011-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|||The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders|IPS-MA - A Randomized Clinical Trial Examining the Effect of a Modified IPS Intervention in Addition to Treatment as Usual Versus Treatment as Usual Alone for Individuals With Mood or Anxiety Disorders|Completed||N/A|326|Actual|Mental Health Centre Copenhagen||2|||f||||f||||||||No||2017-10-11 02:19:53.897408|2017-10-11 02:19:53.897408
NCT01721811|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-03-10|||October 2012||2012-10-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism|Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism|Unknown status|Recruiting|N/A|120|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-10-11 02:19:54.026093|2017-10-11 02:19:54.026093
NCT01721798|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-07-31|||November 2013|Actual|2013-11-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparison of Two IUDs Among Cape Town HIV-positive Women|Comparison of Two IUDs Among Cape Town HIV-positive Women: A Randomized Controlled Trial Assessing Safety of Registered Products in South Africa|Active, not recruiting||N/A|166|Anticipated|FHI 360||2|||f||||t||||||||||2017-10-11 02:19:54.136566|2017-10-11 02:19:54.136566
NCT01721785|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-03-21|||October 2012||2012-10-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer|Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer|Completed||N/A|307|Actual|Maastricht University Medical Center|||2||f||||f||||||||Undecided||2017-10-11 02:19:54.259186|2017-10-11 02:19:54.259186
NCT01721772|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-06-08|2015-11-20|2015-07-03|January 17, 2013|Actual|2013-01-17|June 2017|2017-06-01|February 23, 2019|Anticipated|2019-02-23|June 24, 2014|Actual|2014-06-24||Interventional|CheckMate 066|All participants randomized to receive treatment|Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma|A Phase 3, Randomized, Double-Blind Study of BMS-936558 vs Dacarbazine in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma|Active, not recruiting||Phase 3|583|Actual|Bristol-Myers Squibb|An independent data monitoring committee (DMC) found that data from a DMC-requested database lock showed clear survival benefit with nivolumab and thus recommended unblinding the study and switching patients randomized to dacarbazine to nivolumab.|2|||f||||t||||||||||2017-10-11 02:19:54.437389|2017-10-11 02:19:54.437389
NCT01721733|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-08-01|||October 2012||2012-10-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome|A Phase 2B Randomized, Placebo Controlled, Double Blind Clinical Trial of EPI-743 in Children With Leigh Syndrome|Completed||Phase 2|35|Actual|Edison Pharmaceuticals Inc||3|||f||||t||||||||Undecided||2017-10-11 02:20:00.442352|2017-10-11 02:20:00.442352
NCT01721720|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2017-06-30|||September 7, 2012||2012-09-07|March 3, 2017|2017-03-03||||||||Observational|||Genetic, Brain Structure, and Environmental Effects on ADHD|The Neurobehavioral, Environmental and Genetic Factors Impacting the Clinical Course of Attention Deficit Hyperactivity Disorder|Recruiting||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:20:00.577608|2017-10-11 02:20:00.577608
NCT01721707|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-12-10|||December 2012||2012-12-01|December 2014|2014-12-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Interventional|||Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH|Safety and Efficacy to Reduce the IOP of the Fixed Association of Latanoprost 0.005% (50 μg/mL)/ Brinzolamide 1% (10mg/mL) Drops, Compared to Latanoprost 0.005% (50 μg/mL) Drops, in Patients With Open Angle Glaucoma or Ocular Hypertension|Withdrawn||Phase 3|0|Actual|Adapt Produtos Oftalmológicos Ltda.||2||withdrawn by industry|f||||f||||||||||2017-10-11 02:20:00.690854|2017-10-11 02:20:00.690854
NCT01721694|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-02|2014-12-10|||December 2012||2012-12-01|December 2014|2014-12-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|||Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection|Association of Azithromycin 1,5%/Loteprednol 0,5% Eye Drops Versus Individual Administration of Azithromycin 1,5% and Loteprednol 0,5% in the Treatment of Ocular Inflammation and Infection|Withdrawn||Phase 3|0|Actual|Adapt Produtos Oftalmológicos Ltda.||2||withdrawn by industry|f||||f||||||||||2017-10-11 02:20:00.799134|2017-10-11 02:20:00.799134
NCT00000552|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-03-03|||September 1994||1994-09-01|March 2014|2014-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.||Completed||Phase 3|||New England Research Institutes|||||f||||||||||||||2017-10-11 04:19:03.842919|2017-10-11 04:19:03.842919
NCT01721668|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-08-03|||November 2012||2012-11-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Improving Arm and Hand Functions in Chronic Stroke (CIHR 2012-2015)|Examination of Therapeutic Intervention Methods on the Brain Recovery|Completed||N/A|29|Actual|Baycrest||2|||f||||t||||||||||2017-10-11 02:20:00.998889|2017-10-11 02:20:00.998889
NCT01721655|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-11-28|||October 2012||2012-10-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease|Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease|Recruiting||Phase 2/Phase 3|40|Anticipated|West Virginia University Healthcare||2|||f||||f||||||||||2017-10-11 02:20:01.091643|2017-10-11 02:20:01.091643
NCT01721642|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-06-26|||May 2012||2012-05-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||A Pilot Study to Evaluate the Safety and Efficacy of the Apica Access, Stabilization and Closure (ASC™) Device|A Pilot Study to Evaluate the Safety and Efficacy of the Apica Access, Stabilization and Closure (ASC™) Device During and After Transcatheter Aortic Valve Implantation (TAVI) Procedures|Completed||Phase 1/Phase 2|31|Actual|Apica Cardiovascular Limited||1|||f||||t||||||||||2017-10-11 02:20:01.210541|2017-10-11 02:20:01.210541
NCT01721629|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-04-28|||September 2012||2012-09-01|April 2017|2017-04-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|||Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants|Weaning of Nasal Continuous Positive Airway Pressure in Infants Born With a Gestational Age Under 32 Weeks: a Randomized Controlled Multicenter Trial|Completed||N/A|380|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 02:20:01.304571|2017-10-11 02:20:01.304571
NCT01721616|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2015-05-04|||November 2012||2012-11-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis|A Randomized Clinical Trial of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis|Withdrawn||Phase 4|0|Actual|University of Missouri, Kansas City||2||Poor enrollment|f||||f||||||||||2017-10-11 02:20:01.423721|2017-10-11 02:20:01.423721
NCT01721603|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-10-28|||April 2013||2013-04-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Phase 2 Prospective Trial of Dabrafenib With Stereotactic Radiosurgery in BRAFV600E Melanoma Brain Metastases|A Phase 2 Prospective Trial of Dabrafenib With Stereotactic Radiosurgery in BRAFV600E Melanoma Brain Metastases|Completed||Phase 2|2|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:20:01.524829|2017-10-11 02:20:01.524829
NCT01721590|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2015-12-21|||November 2012||2012-11-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional|Talent||Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease|Study of Tongxinluo to Improve High on Clopidogrel Platelet Reactivity in Patients With Coronary Heart Disease|Completed||Phase 4|134|Actual|Shenyang Northern Hospital||2|||f||||t||||||||||2017-10-11 02:20:01.678001|2017-10-11 02:20:01.678001
NCT01721577|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-01-08|||December 2012||2012-12-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|AXL1717||Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas|Phase I/II Clinical Trial of the Safety, Tolerability, and Anti-tumor Efficacy of the IGF-1R Inhibitor, AXL1717 (Picropodophyllin), in the Treatment of Recurrent Malignant Astrocytomas|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Rush University Medical Center||1|||f||||t||||||||||2017-10-11 02:20:01.811008|2017-10-11 02:20:01.811008
NCT01721564|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-10-18|2012-12-04||April 2006||2006-04-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|PARBO||Bosentan and Pulmonary Endothelial Function|Pulmonary Artery Remodelling With Bosentan|Completed||N/A|8|Actual|Royal Prince Alfred Hospital, Sydney, Australia||1|||f||||||||||||||2017-10-11 02:20:01.984659|2017-10-11 02:20:01.984659
NCT01721551|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-06-19|||November 2012||2012-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|StandFirm||Sleep and Training Aspects in Dialysis Fatigue - Exercise Intervention|Phase 4 Exercise Training in Aspects of Fatigue in Patients Receiving Dialysis Therapy|Completed||Phase 4|50|Actual|University of Thessaly||2|||f||||t||||||||||2017-10-11 02:20:02.159943|2017-10-11 02:20:02.159943
NCT01721538|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2012-11-02|||October 2012||2012-10-01|November 2012|2012-11-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|SCENARIO||Secondary Prevention of Stroke Through Non-drug Therapeutic Weight Reduction|Secondary Prevention of Stroke Through Participation in the Non-drug Therapeutic Weight Reduction Program: A Single-blinded Randomized Controlled Multicenter Trial|Unknown status|Recruiting|N/A|200|Anticipated|Philipps University Marburg Medical Center||2|||f||||t||||||||||2017-10-11 02:20:02.266743|2017-10-11 02:20:02.266743
NCT01721525|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-05-22|||November 2012|Actual|2012-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)|Phase I Study of Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)|Active, not recruiting||Phase 1|22|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:20:02.513569|2017-10-11 02:20:02.513569
NCT01721512|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2012-11-02|||September 2010||2010-09-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||The Growth and Development of Breast and Formula Fed Term Asian Infants|The Growth and Development of Breast and Formula Fed (Containing Synbiotics and LCPUFA) Term Asian Infants.|Completed||N/A|160|Actual|Indonesia University|||2||f||||t||||||Samples With DNA|"     Faecal samples   "|||2017-10-11 02:20:02.630202|2017-10-11 02:20:02.630202
NCT00000553|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-08|||September 1994||1994-09-01|March 2005|2005-03-01|February 2001||2001-02-01|||||Interventional|||HDL-Atherosclerosis Treatment Study (HATS)||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-10-11 04:19:03.966841|2017-10-11 04:19:03.966841
NCT01721499|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-07-28|||September 2010||2010-09-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Sync||"Decreasing Stress and Improving Self-control With Stress in Control (Sync) Training"|"Decreasing Stress and Improving Self-control With Stress in Control (Sync) Training"|Completed||Phase 1|112|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:20:02.731926|2017-10-11 02:20:02.731926
NCT01721486|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-06-06|2017-01-18||September 2012||2012-09-01|June 2017|2017-06-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional||Baseline participant number does not include 2 patients removed from study.|Acetaminophen's Efficacy For Post-operative Pain|Efficacy of IV vs Oral Administration of Acetaminophen for Pain Control Following Tonsillectomy With or Without Adenoidectomy|Completed||Phase 4|41|Actual|William Beaumont Hospitals|The number of participants in both groups are very small. Data in pain scores outcome was skewed.|2|||f||||t||||||||No||2017-10-11 02:20:02.841892|2017-10-11 02:20:02.841892
NCT01721473|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-07-19|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|BNRDVS||Brain Nicotine Receptor Density in Veteran Smokers|Nicotinic Acetylcholine Receptor Density and Veteran Cigarette Smokers|Recruiting||N/A|198|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|None Retained|"     None retained.   "|||2017-10-11 02:20:03.164859|2017-10-11 02:20:03.164859
NCT01721447|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-11-01|||June 2013||2013-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|DOLOP||Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage|The Use of Optison Echocardiography Contrast in the Detection of Left Atrial Appendage Thrombus With Transesophageal Echocardiography.|Recruiting||Phase 4|100|Anticipated|University of Utah||1|||f||||t||||||||||2017-10-11 02:20:03.345502|2017-10-11 02:20:03.345502
NCT01721434|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-06-09|||September 2012||2012-09-01|June 2015|2015-06-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Effects of Levosimendan on Diaphragm Function in Mechanically Ventilated Patients|Effects of Levosimendan on Diaphragm Function in Mechanically Ventilated Patients|Unknown status|Recruiting|Phase 2/Phase 3|42|Anticipated|University Medical Center Nijmegen||2|||f||||f||||||||||2017-10-11 02:20:03.444199|2017-10-11 02:20:03.444199
NCT01721421|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2012-11-02|||September 2011||2011-09-01|November 2012|2012-11-01|February 2015|Anticipated|2015-02-01|March 2014|Anticipated|2014-03-01||Interventional|||Effects of Extended Haemodialysis Treatment Duration in Patients With End-stage Renal Disease|Feasibility and Physiological and Nutritional Effects of Extended Treatment Duration in Patients With End-stage Renal Disease on Haemodialysis|Unknown status|Recruiting|N/A|52|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 02:20:03.533413|2017-10-11 02:20:03.533413
NCT01721395|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-10-22|||January 2013||2013-01-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents|Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents|Completed||N/A|120|Actual|Penn State University||3|||f||||t||||||||||2017-10-11 02:20:03.792711|2017-10-11 02:20:03.792711
NCT01721382|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2016-06-10|||November 2012||2012-11-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis|Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis.|Completed||Phase 1|6|Actual|Nemours Children's Clinic||1|||f||||f||||||||||2017-10-11 02:20:03.873836|2017-10-11 02:20:03.873836
NCT01721369|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-04-08|||November 2011||2011-11-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|SYNCAT||Syncope in Cataluña SYNCAT|Observational Study of the Application of the ESC2009 Syncope Guidelines in Cataluña|Completed||N/A|581|Actual|Medtronic Bakken Research Center|||1||f||||f||||||||||2017-10-11 02:20:03.949475|2017-10-11 02:20:03.949475
NCT01721356|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-01|||September 2009||2009-09-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|EQ||Neurobiological Basis of Emotional Intelligence|The Neurobiological Basis and Potential Modification of Emotional Intelligence Through Affective / Behavioral Training|Completed||N/A|70|Actual|Mclean Hospital|||1||f||||f||||||||||2017-10-11 02:20:04.00287|2017-10-11 02:20:04.00287
NCT01721343|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-03-21|||November 2012||2012-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer|MC1193: Collaborative Care to Preserve Performance in Cancer (COPE)|Suspended||N/A|516|Anticipated|Mayo Clinic||3|||f||||t||||||||||2017-10-11 02:20:04.060481|2017-10-11 02:20:04.060481
NCT01721330|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2016-04-27|2016-03-14||November 2012||2012-11-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder|A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder|Terminated||Phase 4|3|Actual|Massachusetts General Hospital|The study was terminated prior to completion due to competing studies. Therefore, only one subject in each group was analyzed.|2||Competing studies|f||||f||||||||Undecided||2017-10-11 02:20:04.178182|2017-10-11 02:20:04.178182
NCT01720966|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-11-09|||January 2013||2013-01-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|ALIVE||Adhesions After Open Versus Laparoscopic Resection of Colorectal Malignancies Detected During Liver Resection|Adhesions After Open Versus Laparoscopic Resection of Colorectal Malignancies Detected During Liver Resection|Completed||N/A|150|Actual|Radboud University|||2||f||||f||||||||||2017-10-11 02:20:16.415375|2017-10-11 02:20:16.415375
NCT01721317|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-11-18|2014-02-06||December 2012||2012-12-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures|Study PTG116878, a Dose-Optimization Study of Ezogabine/Retigabine Immediate Release Tablets Versus Placebo in the Adjunctive Treatment of Subjects With Partial-Onset Seizures|Terminated||Phase 4|6|Actual|GlaxoSmithKline||16||"After reevaluation of the benefit: risk profile of ezogabine/retigabine, GSK does not believe   the early adjunctive treatment study population is appropriate."|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:20:04.638468|2017-10-11 02:20:04.638468
NCT01721304|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-04-21|||May 2009||2009-05-01|April 2015|2015-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Decisionmaking for Abnormal Uterine Bleeding (AUB)|Decision Making Among Treatment Alternatives for Abnormal Uterine Bleeding (AUB)|Completed||N/A|380|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 02:20:05.395371|2017-10-11 02:20:05.395371
NCT01721291|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-08-26|||October 2012||2012-10-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|April 2015|Actual|2015-04-01||Interventional|||Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)|Improving Inhaler Treatment and Small Airways Assessment in Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Active, not recruiting|Phase 4|50|Actual|Imperial College London||4|||f||||f||||||||||2017-10-11 02:20:05.615887|2017-10-11 02:20:05.615887
NCT01721278|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-01-12|||October 2012||2012-10-01|September 2015|2015-09-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Observational|||Furlong Evolution® Hip Trial|A Prospective Multicentre Clinical Surveillance Study To Evaluate The Stability, Efficacy And Safety Of The Furlong Evolution® Hip Stem In Primary Total Hip Arthroplasty|Recruiting||N/A|700|Anticipated|Imperial College London|||1||f||||f||||||||||2017-10-11 02:20:05.715914|2017-10-11 02:20:05.715914
NCT01721265|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-04-15|||October 2012||2012-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals|3-Year, Observational Study to Evaluate the Durability of Sustained Viral Response and the Kinetics of Antiviral-Resistant HCV in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals|Terminated||N/A|145|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||Samples Without DNA|"     Human plasma   "|||2017-10-11 02:20:05.787942|2017-10-11 02:20:05.787942
NCT01721252|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-03-27|||December 2009||2009-12-01|March 2015|2015-03-01||||August 2013|Actual|2013-08-01||Observational|||Tarceva. ICORG 08-41|Prospective Evaluation of a Proteomic Signature Developed to Identify Patients Likely to Benefit From Erlotinib (TarcevaTM), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Used in the Treatment of Non-small Cell Lung Cancer|Completed||N/A|200|Actual|Cancer Trials Ireland|||1||f||||||||||||||2017-10-11 02:20:05.851816|2017-10-11 02:20:05.851816
NCT01721239|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-02-17|||December 1, 2012|Actual|2012-12-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|February 2016|Actual|2016-02-01||Interventional|RAPIT||Recovery and Aftercare in Post Intensive Care Therapy Patients - RAPIT Study|Recovery and Aftercare in Post Intensive Care Therapy Patients - The RAPIT Study. The Effectiveness and Experiences of a Follow-up Program for Danish Mechanically Ventilated ICU Patients: A Pragmatic Randomized Controlled Multicentre Trial.|Completed||N/A|340|Anticipated|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-10-11 02:20:05.935114|2017-10-11 02:20:05.935114
NCT01721226|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-12-20|2016-09-14||August 2013||2013-08-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|CARE+||CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)|CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)|Completed||N/A|112|Actual|George Washington University||2|||f||||t||||||||||2017-10-11 02:20:06.023092|2017-10-11 02:20:06.023092
NCT01721213|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-01-19|||September 2012||2012-09-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Trobalt™ Products Risk Survey|European Survey of Patient and Prescriber Understanding of Risks Associated With Trobalt™|Completed||N/A|1|Actual|GlaxoSmithKline|||3||f||||f||||||||||2017-10-11 02:20:06.329717|2017-10-11 02:20:06.329717
NCT01721187|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-08-04|||October 2012||2012-10-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Observational|||Satiety Effects on the Neural Valuation of Food|Functional Magnetic Resonance Imaging Study of the Valuation of Food as a Function of Satiety|Completed||N/A|60|Actual|Duke-NUS Graduate Medical School|||2||f||||f||||||None Retained|"     (NA)   "|||2017-10-11 02:20:06.519784|2017-10-11 02:20:06.519784
NCT01721174|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2016-11-16|||November 2012||2012-11-01|November 2016|2016-11-01||||November 2016|Anticipated|2016-11-01||Interventional|||Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures|A Randomized Controlled Trial of Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures.|Recruiting||Phase 2/Phase 3|116|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:20:06.624669|2017-10-11 02:20:06.624669
NCT01721161|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-05-24|2016-05-24|2015-08-21|December 2012||2012-12-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||BIIB033 In Acute Optic Neuritis (AON)|A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With First Episode of Acute Optic Neuritis|Completed||Phase 2|82|Actual|Biogen||2|||f||||t||||||||||2017-10-11 02:20:06.77859|2017-10-11 02:20:06.77859
NCT01721148|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-01-23|||October 2012||2012-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase I Multiple Ascending Dose Study of ASLAN002 in Subjects With Advanced or Metastatic Solid Tumours|A Phase I Multiple Ascending Dose Study of ASLAN002 (BMS 777607) in Subjects With Advanced or Metastatic Solid Tumours|Completed||Phase 1|39|Actual|Aslan Pharmaceuticals||1|||f||||t||||||||||2017-10-11 02:20:07.782525|2017-10-11 02:20:07.782525
NCT01720758|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-08-10|||November 2012|Actual|2012-11-01|August 2017|2017-08-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|B-RAF V600E||Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease|Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease.|Completed||N/A|20|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||Samples With DNA|"     perpheral blood   "|||2017-10-11 02:20:18.228262|2017-10-11 02:20:18.228262
NCT01721135|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2013-08-20|||September 2010||2010-09-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.|A Randomised, Placebo Controlled, Four-way Cross-over Study to Assess Cardiac Re-polarisation Following Repeat Dosing With GSK2190915 and Placebo for Five Days, With Moxifloxacin as a Positive Control, in Healthy Male and Female Subjects.|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||4||"Study was terminated due to toxicology findings after screening started but before first   subject first dose."|f||||f||||||||||2017-10-11 02:20:07.847364|2017-10-11 02:20:07.847364
NCT01721122|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2014-01-06|||May 2013||2013-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:20:07.966755|2017-10-11 02:20:07.966755
NCT01721109|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-09-06|2017-02-24|2016-08-17|December 6, 2012|Actual|2012-12-06|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|October 22, 2015|Actual|2015-10-22||Interventional||Safety Analysis Set: all participants who received at least 1 dose of study drug.|Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents|A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents|Active, not recruiting||Phase 2/Phase 3|50|Actual|Gilead Sciences||1|||f||||t|t|f||||||||2017-10-11 02:20:08.034659|2017-10-11 02:20:08.034659
NCT01721096|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-08-26|2015-07-17||October 2012||2012-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|June 2014|Actual|2014-06-01||Observational|||XIENCE PRIME Japan Post-Marketing Surveillance (PMS)|XIENCE PRIME Everolimus Eluting Coronary Stent Post Marketing Surveillance (PMS) in Japan|Active, not recruiting||N/A|536|Actual|Abbott Vascular|||2||f||||t||||||||||2017-10-11 02:20:08.697516|2017-10-11 02:20:08.697516
NCT01721083|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-07-15|||October 2012||2012-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Comparison of Two Methods of Immunization for Intramuscular Injections|Comparison of Two Methods of Immunization for Intramuscular Injections|Completed||Phase 4|511|Actual|Christiana Care Health Services||2|||f||||f||||||||||2017-10-11 02:20:10.6|2017-10-11 02:20:10.6
NCT01721070|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2016-09-30|2014-02-10||November 2012||2012-11-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics|IAP104 - Assessment of Pharmacokinetic Changes Following Concurrent Administration of Sufentanil NanoTab and Ketoconazole in Healthy Subjects|Completed||Phase 1|19|Actual|AcelRx Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:20:10.729686|2017-10-11 02:20:10.729686
NCT01721057|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2017-05-09|2017-05-01|2015-01-16|December 2012||2012-12-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|RA-BUILD|Modified Intent-to-Treat (mITT) population includes all randomized participants who received at least 1 dose of the study drug.|A Study in Moderate to Severe Rheumatoid Arthritis Participants|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis|Completed||Phase 3|684|Actual|Eli Lilly and Company||3|||f||||t||||||||Yes|Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement.|2017-10-11 02:20:11.090122|2017-10-11 02:20:11.090122
NCT01721031|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-27|2015-10-07|||October 2012||2012-10-01|October 2015|2015-10-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||DPNB for Prevention of CRDB|Comparison of Dorsal Penile Nerve Block With 0.33% Ropivacaine and Intravenous Tramadol for Prevention of Catheter-related Bladder Discomfort: Study Protocol for a Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|60|Anticipated|West China Hospital||2|||f||||t||||||||||2017-10-11 02:20:15.785737|2017-10-11 02:20:15.785737
NCT01721018|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-06-08|||October 2012||2012-10-01|June 2017|2017-06-01|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Interventional|1716-12||Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.|A Phase I/IIa Study of the Safety, Tolerability and Biological Effect of Single and Repeat Administration of the Selectively Replication-competent Herpes Simplex Virus HSV1716 Into the Tumor-bearing Pleural Cavity (Intrapleural) in Patients With Inoperable Malignant Pleural Mesothelioma.|Completed||Phase 1/Phase 2|12|Actual|Virttu Biologics Limited||1|||f||||f||||||||||2017-10-11 02:20:15.901701|2017-10-11 02:20:15.901701
NCT01721005|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-05-07|||April 2012||2012-04-01|May 2014|2014-05-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01||Interventional|LietoAF||Screening Versus Routine Practice in Detection of Atrial Fibrillation in the Elderly Population of Lieto|Screening Versus Routine Practice in Detection of Atrial Fibrillation in the Elderly Population of Lieto|Active, not recruiting||N/A|200|Actual|University of Turku||1|||f||||f||||||||||2017-10-11 02:20:16.106975|2017-10-11 02:20:16.106975
NCT01720992|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2014-02-03|||March 2012||2012-03-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Enhancing Family Well-being Project|Enhancing Family Well-being Project|Completed||N/A|2400|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:20:16.219648|2017-10-11 02:20:16.219648
NCT01720979|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-12-02|||November 2011||2011-11-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||TBI Project Amsterdam|Attention, Learning and Behaviour Following Traumatic Brain Injury in Children|Completed||N/A|90|Anticipated|VU University of Amsterdam|||1||f||||f||||||||||2017-10-11 02:20:16.318369|2017-10-11 02:20:16.318369
NCT01720953|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-07-24|||October 2012||2012-10-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|MENTAB||Neuropsychiatric Mechanisms of Change in Mentalization Based Treatment of Borderline Personality Disorder (MENTAB)|Neuropsychiatric Mechanisms of Change in Mentalization Based Treatment of Borderline Personality Disorder (MENTAB)|Terminated||N/A|100|Anticipated|Region Sjælland|||1||f||||||||||Samples With DNA|"     Whole blood samples to measure DNA methylation and BDNF serum levels. Salivary samples to     measure cortisol levels.   "|||2017-10-11 02:20:16.538522|2017-10-11 02:20:16.538522
NCT01720940|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2012-11-01|||October 2012||2012-10-01|November 2012|2012-11-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin|Reducing Nephrotoxicity of Vancomycin: A Prospective, Randomized Study of Continuous Versus Intermittent Infusion of Vancomycin|Unknown status|Recruiting|N/A|220|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 02:20:16.657454|2017-10-11 02:20:16.657454
NCT01720927|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2014-09-12|||November 2012||2012-11-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Pakistan Epidemiological Survey in Acute Pharyngitis|Pakistan Epidemiological Survey in Acute Pharyngitis|Completed||N/A|5140|Actual|Hill Park General Hospital|||1||f||||f||||||||||2017-10-11 02:20:16.786111|2017-10-11 02:20:16.786111
NCT01720914|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-12-22|||November 2012||2012-11-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Observational|IDEAS||Instruments for Delirium Assessment Regarding to Analgesia Sedation and Ventilator Status|Instruments for Delirium Assessment Regarding to Analgesia Sedation and Ventilator Status|Completed||N/A|160|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 02:20:16.878822|2017-10-11 02:20:16.878822
NCT01720901|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-05-21|||February 2013||2013-02-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy|An Open, Single-Center,Single Arm Trial to Evaluate the Efficacy and Safety of Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy|Suspended||Phase 4|20|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1||Accrual limitations|f||||t||||||||||2017-10-11 02:20:17.002455|2017-10-11 02:20:17.002455
NCT01720888|ClinicalTrials.gov processed this data on October 10, 2017|2012-11-01|2015-04-15|||July 2012||2012-07-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy|A Controlled Open Label Phase II Study Assessing the Efficacy of Intracoronary Autologous Mesenchymal Stem Cells in Patients With Ischemic Dilated Cardiomyopathy|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|National University of Malaysia||2|||f||||t||||||||||2017-10-11 02:20:17.10441|2017-10-11 02:20:17.10441
NCT01720875|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-05-24|||August 2013||2013-08-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2015|Actual|2015-08-01||Interventional|MUKfour||Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)|A Phase II Trial of Combination Treatment With Vorinostat, Bortezomib and Dexamethasone in Patients With Relapsed and Relapsed Refractory Multiple Myeloma|Active, not recruiting||Phase 2|68|Anticipated|University of Leeds||1|||f||||t||||||||||2017-10-11 02:20:17.223634|2017-10-11 02:20:17.223634
NCT01720862|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2016-01-27|||April 2012||2012-04-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Migraine and Body Composition|Migraine and Body Composition|Completed||N/A|300|Actual|Johns Hopkins University|||3||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 02:20:17.3541|2017-10-11 02:20:17.3541
NCT01720849|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-06-29|||December 2012||2012-12-01|June 2015|2015-06-01||||May 2016|Anticipated|2016-05-01||Observational|||Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis||Unknown status|Recruiting|N/A|50|Anticipated|Vestre Viken Hospital Trust|||1||f||||||||||||||2017-10-11 02:20:17.428699|2017-10-11 02:20:17.428699
NCT01720836|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-07-25|||November 2012||2012-11-01|July 2017|2017-07-01|February 2022|Anticipated|2022-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer|Study of the Immunogenicity of the MUC1 Peptide - Poly-ICLC (Polyinosinic-polycytidylic Acid Stabilized With Polylysine and Carboxymethylcellulose) OR HILTONOL™ Adjuvant Vaccine in Patients With Localized and Locally Advanced Non-Small Cell Lung Cancer|Suspended||Phase 1/Phase 2|30|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 02:20:17.512706|2017-10-11 02:20:17.512706
NCT01720823|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2016-04-04|||October 2012||2012-10-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|GETEMED||Obstructive Sleep Apnea Syndrome (OSA) and Getemed|Diagnostic Characteristics of a Home Polysomnograph for the Diagnosis of Patients With Obstructive Sleep Apnea Syndrome - A Pilot Study|Completed||N/A|62|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 02:20:17.600909|2017-10-11 02:20:17.600909
NCT01720810|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-05-28|||March 2010||2010-03-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|PANUC||Pacific Northwest Udall Center (PANUC) Clinical Core|Pacific Northwest Udall Center (PANUC) Clinical Core|Recruiting||N/A|2000|Anticipated|University of Washington|||1||f||||t||||||||||2017-10-11 02:20:17.676877|2017-10-11 02:20:17.676877
NCT01720797|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-06-02|2015-06-02||February 2013||2013-02-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Propel||Alveolar Microperforation for Inflammation-Enhanced Tooth Movement During Orthodontic Treatment|Alveolar Microperforation for Inflammation-Enhanced Tooth Movement During Orthodontic Treatment|Completed||N/A|21|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 02:20:17.744403|2017-10-11 02:20:17.744403
NCT01720784|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2014-09-01|||October 2012||2012-10-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|ALSAT||Effect of Beverages Containing Different Doses of Alginate Fibers on Appetite, Energy Intake and Glycemia|Effect of Beverages Containing Different Doses of Alginate Fibers on Appetite, Energy Intake and Glycemia|Completed||N/A|24|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 02:20:17.998244|2017-10-11 02:20:17.998244
NCT01720771|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-05-28|||February 2013||2013-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||Preventive Effect of a Probiotic Tablet on Oral Health in Preschool Children|Preventive Effect of a Probiotic Tablet on Oral Health in Preschool Children|Completed||N/A|138|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:20:18.076076|2017-10-11 02:20:18.076076
NCT01720745|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-03-27|||October 2012||2012-10-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||"Comparison of Wet Suction Technique to Contemporary Dry Suction Technique Using a 22 Gauge Needle for EUS FNA"|"Comparison of Wet Suction Technique to Contemporary Dry Suction Technique Using a 22 Gauge Needle for EUS FNA of Solid Lesions. A Randomized, Prospective, Blinded, and Controlled Trial"|Terminated||N/A|128|Actual|University of Minnesota - Clinical and Translational Science Institute|||1|PI no longer at University of Minnesota|f||||f||||||||||2017-10-11 02:20:18.352893|2017-10-11 02:20:18.352893
NCT01720732|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2014-12-01|||October 2012||2012-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Lifeline-NET (Narrative Exposure Therapy): A Short-term Treatment for Traumatized Refugees and Asylum Seekers||Completed||N/A|32|Actual|University of Konstanz||2|||f||||t||||||||||2017-10-11 02:20:18.452097|2017-10-11 02:20:18.452097
NCT01720719|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2016-02-02|||May 2013||2013-05-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease|An Randomized Open Label Trial on the Impact of 24 Weeks of Atorvastatin Therapy on Liver Fat Content and Abdominal Fat Content in Patients With Type 2 Diabetes Combined With High LDL-C and Non-alcoholic Fatty Liver Disease|Recruiting||Phase 4|120|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 02:20:18.558606|2017-10-11 02:20:18.558606
NCT01720706|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-06-01|||August 2011||2011-08-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Thermal Ablation in Larger Liver and Kidney Tumours|Thermal Ablation With a Loosely Wound Helical Coil for Radiofrequency Treatment of Large Renal and Hepatic Tumors in Patients Undergoing Partial or Total Nephrectomy or Heptectomy|Recruiting||N/A|12|Anticipated|University Health Network, Toronto||2|||f||||f|f|f||||||No||2017-10-11 02:20:18.705829|2017-10-11 02:20:18.705829
NCT01720693|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-02-10|||June 2012||2012-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy|A Pilot Study to Examine a Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy|Terminated||Phase 2|3|Actual|University Health Network, Toronto||1||Low accrual|f||||f||||||||||2017-10-11 02:20:18.796495|2017-10-11 02:20:18.796495
NCT01720680|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2013-06-27|||October 2012||2012-10-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Prospective Exploratory Study to Assess the Effects of the AlphaCore® Device in Patients With COPD|Open-label, Prospective Exploratory Study to Assess the Effects of the AlphaCore® Device on Central and Peripheral Airway Dimensions in Patients With COPD|Completed||N/A|2|Actual|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-11 02:20:18.875544|2017-10-11 02:20:18.875544
NCT01720667|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-07-05|||March 2013||2013-03-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NEOLEV2||Efficacy of Intravenous Levetiracetam in Neonatal Seizures|Efficacy of Intravenous Levetiracetam in Neonatal Seizures: A Phase 2 Randomized Blinded Controlled Study of the Efficacy of Intravenous Levetiracetam (LEV) as First Line Treatment for Neonatal Seizures|Recruiting||Phase 1/Phase 2|100|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-11 02:20:18.950427|2017-10-11 02:20:18.950427
NCT01720654|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-08-04|||August 2012||2012-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Expedited Partner Therapy for MSM in Peru|Expedited Partner Therapy as STI Control Among MSM in Peru|Completed||N/A|165|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:20:19.078236|2017-10-11 02:20:19.078236
NCT01720641|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-08-04|||August 2012||2012-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Partner Notification Strategies for MSM in Peru|Partner Notification Strategies for STI Control in Urban Peru|Completed||N/A|370|Actual|University of California, Los Angeles||4|||f||||f||||||||||2017-10-11 02:20:19.169546|2017-10-11 02:20:19.169546
NCT01720628|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-10-31|||November 2011||2011-11-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Observational|||The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease||Completed||N/A|86|Actual|Turkish Ophthalmology Society|||1||f||||t||||||Samples With DNA|"     serum   "|||2017-10-11 02:20:19.26024|2017-10-11 02:20:19.26024
NCT01720615|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-31|||January 2001||2001-01-01|October 2012|2012-10-01|April 2003|Actual|2003-04-01|November 2001|Actual|2001-11-01||Interventional|||Detection of Consciousness by EEG and Auditory Evoked Potentials|Detection of Consciousness by EEG and Auditory Evoked Potentials|Completed||Phase 4|80|Actual|Technische Universität München||1|||f||||t||||||||||2017-10-11 02:20:19.361986|2017-10-11 02:20:19.361986
NCT01720602|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2016-11-04|2014-10-30||November 2012||2012-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|March 2015|Actual|2015-03-01||Interventional|||Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy|A Pilot Study of Vorinostat to Restore Sensitivity to Aromatase Inhibitor Therapy Part B|Active, not recruiting||N/A|15|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 02:20:19.460879|2017-10-11 02:20:19.460879
NCT01720589|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-05-28|||October 2012||2012-10-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|Melt||Effect of Dietary Fat Cooking Blend on Energy Expenditure in Children|Development of Rich & Creamy Melt® Organic Cooking Blend for Oxidative Stability and Reducing Childhood Obesity|Completed||N/A|5|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||t||||||||||2017-10-11 02:20:19.729221|2017-10-11 02:20:19.729221
NCT01720576|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2013-09-10|||October 2012||2012-10-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)||Completed||Phase 1|60|Actual|Regeneron Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:20:19.848503|2017-10-11 02:20:19.848503
NCT01720563|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-11-03|||December 2012||2012-12-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy|A Phase II Double-blind and Randomized Trial Comparing Concurrent Chemoradiotherapy Plus PG2 Injection Versus Concurrent Chemoradiotherapy Plus Placebo in Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma|Terminated||Phase 2|17|Actual|PhytoHealth Corporation||2||Change study drug dosage form|f||||f||||||||||2017-10-11 02:20:19.964554|2017-10-11 02:20:19.964554
NCT00000554|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-04-03|||May 2001||2001-05-01|April 2014|2014-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Women's Ischemia Syndrome Evaluation (WISE)||Completed||Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:19:04.064604|2017-10-11 04:19:04.064604
NCT01720550|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-08-01|||November 2012|Actual|2012-11-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care|PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care|Completed||Phase 4|323|Actual|PhytoHealth Corporation||2|||f||||t||||||||||2017-10-11 02:20:20.092028|2017-10-11 02:20:20.092028
NCT01720537|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2013-11-19|||July 2012||2012-07-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects|A Phase I, Placebo-Controlled, Randomized Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Following Single, Ascending Doses Of PF-05335810 In Hypercholesterolemic Subjects, With One, Open-Label, Multiple Fixed Dosage Cohort|Completed||Phase 1|136|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 02:20:20.222645|2017-10-11 02:20:20.222645
NCT01720524|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-10-02|||August 5, 2013|Actual|2013-08-05|October 2017|2017-10-01|May 27, 2020|Anticipated|2020-05-27|April 30, 2018|Anticipated|2018-04-30||Interventional|||A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn|A Multi-centre, Randomized, Placebo-controlled, Double-blind, Two-armed, Parallel Group Study To Evaluate Efficacy And Safety Of Iv Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn (Pphn) Or Hypoxic Respiratory Failure And At Risk For Pphn, With A Long Term Follow-up Investigation Of Developmental Progress 12 And 24 Months After Completion Of Study Treatment|Recruiting||Phase 3|64|Anticipated|Pfizer||2|||f||||t||||||||||2017-10-11 02:20:20.381663|2017-10-11 02:20:20.381663
NCT01720511|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-12-17|||September 2012||2012-09-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation|Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation.|Completed||N/A|10|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 02:20:20.563115|2017-10-11 02:20:20.563115
NCT01720498|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-06-16|||October 2012||2012-10-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation Under Propofol-remifentanil Anesthesia in Elderly Patients||Completed||N/A|50|Anticipated|Severance Hospital||2|||f||||f||||||||||2017-10-11 02:20:20.638475|2017-10-11 02:20:20.638475
NCT01720472|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-02-06|||May 2012||2012-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01|2 Years|Observational [Patient Registry]|PPS||Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository|Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository|Active, not recruiting||N/A|1000|Anticipated|Duke University|||1||f||||t||||||Samples With DNA|"     Serum and plasma samples collected from MURDOCK Study enrollment visit and two year follow up     Physical Performance visit.   "|||2017-10-11 02:20:20.79169|2017-10-11 02:20:20.79169
NCT01720459|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-01|||December 2012||2012-12-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients|Effects of Micronized Trans-resveratrol Treatment on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Placebo-controlled Randomized Single-blind Study|Unknown status|Not yet recruiting|N/A|40|Anticipated|Poznan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:20:20.927294|2017-10-11 02:20:20.927294
NCT01720446|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-02-06||2016-12-13|February 2013||2013-02-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SUSTAIN™ 6||Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes|A Long-term, Randomised, Double-blind, Placebo-controlled, Multinational, Multi-centre Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes (SUSTAIN™ 6 - Long-term Outcomes)|Completed||Phase 3|3297|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 02:20:21.10071|2017-10-11 02:20:21.10071
NCT01720433|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-31|||August 2010||2010-08-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Reduction of Pain Following Laparoscopic Surgery: A Double Blind Prospective Randomized Controlled Trial|Reduction of Pain Following Laparoscopic Surgery: A Double Blind Prospective Randomized Controlled Trial.|Completed||N/A|127|Actual|Northampton General Hospital NHS Trust||2|||f||||f||||||||||2017-10-11 02:20:21.787525|2017-10-11 02:20:21.787525
NCT01720420|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-03-29|||October 2012||2012-10-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|||A Clinical Evaluation of NobelProcera Implant Bar Overdenture|A Clinical Evaluation of NobelProceraTM Implant Bar Overdenture in the Mandible or Maxilla on 4 NobelReplaceTM CC Implants|Recruiting||N/A|76|Anticipated|Nobel Biocare||2|||f||||t||||||||||2017-10-11 02:20:21.893263|2017-10-11 02:20:21.893263
NCT01720407|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-07-17|||December 2012|Actual|2012-12-01|July 2017|2017-07-01|August 2022|Anticipated|2022-08-01|August 2019|Anticipated|2019-08-01||Interventional|ImiReduc||Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face|Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face|Recruiting||Phase 3|268|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 02:20:22.062142|2017-10-11 02:20:22.062142
NCT01720394|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-08-21|||November 2013||2013-11-01|August 2014|2014-08-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert|Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert - a Multicenter Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|253|Anticipated|Medical University of Graz||2|||f||||f||||||||||2017-10-11 02:20:22.248834|2017-10-11 02:20:22.248834
NCT01720381|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2014-06-23|||July 2012||2012-07-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||OptiScanner Versus Standard Blood Glucose Monitoring|Manual vs. Automated moNitoring Accuracy of GlucosE II (MANAGE II)|Completed||N/A|98|Actual|OptiScan Biomedical Corporation|||1||f||||t||||||Samples Without DNA|"     One additional blood sample (4 ml)will be collected once a day, separated into Draw an     additional ~ 4.0 mL from the subject into a syringe once per every 24 hour period. The study     site will indicate where and at what time the sample was taken. This sample is placed into a     sodium heparin tube, labeled with the subject number and sampling time and centrifuged on a     refrigerated centrifuge. The gained plasma will be frozen at minus 70 degrees Celsius or less     and may be used for potential analysis by the Sponsor, should an analysis of outliers     indicate the potential presence of an interferent.   "|||2017-10-11 02:20:22.411573|2017-10-11 02:20:22.411573
NCT01720368|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-08-14|||October 2012||2012-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Observational|OPERA||OPERA Database - Crohn's Protocol|IBD-OPERA Database IBD OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database - Crohn's Protocol|Completed||N/A|50|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||f||||||||||2017-10-11 02:20:22.483395|2017-10-11 02:20:22.483395
NCT01720355|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2013-02-12|||August 2012||2012-08-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Pulse Oximetry- Performance During Severe Signal Interference||Completed||N/A|17|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 02:20:22.561273|2017-10-11 02:20:22.561273
NCT01720342|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-04-17|||February 2013||2013-02-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|EASE||Enable® Aortic Sutureless Bioprosthesis Evaluation|Enable® Aortic Sutureless Bioprosthesis Evaluation: A Post-market Release Non-interventional Study|Active, not recruiting||N/A|225|Actual|Medtronic Cardiovascular|||1||f||||f||||||||||2017-10-11 02:20:22.629472|2017-10-11 02:20:22.629472
NCT01720329|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-08-03|||July 2013||2013-07-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Use of Probiotics to Prevent Influenza|A Randomized Controlled Trial of Probiotics to Prevent Influenza and Other Respiratory Infections in Residents of Long-term Care Facilities: A Pilot Study|Active, not recruiting||N/A|1440|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 02:20:22.766945|2017-10-11 02:20:22.766945
NCT01720316|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-09-18|2017-04-16||December 10, 2012|Actual|2012-12-10|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders|Pilot Study of Glycine Augmentation in Carriers of a Mutation in the Gene Encoding Glycine Decarboxylase|Completed||Phase 2|2|Actual|Mclean Hospital||3|||f||||t|t|f||||||||2017-10-11 02:20:22.930253|2017-10-11 02:20:22.930253
NCT01720303|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-02-17|||September 19, 2002|Actual|2002-09-19|February 2017|2017-02-01|April 10, 2003|Actual|2003-04-10|April 10, 2003|Actual|2003-04-10||Interventional|||Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes|A Multi-centre, Open, Randomised, Parallel, Controlled Trial to Compare the Efficacy and Safety of Repaglinide Combined With Bedtime Insulin With Insulin Alone in Type 2 Diabetic Subjects Inadequately Controlled With Sulphonylurea ± Biguanide Therapy|Completed||Phase 4|159|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:20:24.356932|2017-10-11 02:20:24.356932
NCT01720290|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-02-17|||July 25, 2002|Actual|2002-07-25|February 2017|2017-02-01|February 25, 2003|Actual|2003-02-25|February 25, 2003|Actual|2003-02-25||Interventional|||Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes|A 3-month, Open-label, Randomized, Multi-center Study of Repaglinide in Combination With Metformin as Compared to Metformin or Repaglinide Given as Monotherapy for the Treatment of Type 2 Diabetes.|Completed||Phase 4|150|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 02:20:24.484582|2017-10-11 02:20:24.484582
NCT01720264|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-04-10|||November 2, 2012|Actual|2012-11-02|April 2017|2017-04-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant|A Multicenter Phase II Trial of Inhibition of CD26 Peptidase Using Sitagliptin to Enhance Engraftment After Umbilical Cord Blood Transplantation for Adults With Hematological Malignancies|Active, not recruiting||Phase 2|19|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 02:20:24.779428|2017-10-11 02:20:24.779428
NCT01720251|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-03-30|2015-03-20||October 2012||2012-10-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||In AllerT low dose group, one patient has been randomized but not treated explaining the difference beween baseline participants number and participant flow|Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy|Phase IIb Study to Assess the Efficacy, Safety and Tolerability of Two Dosing Regimens of AllerT in Comparison to Placebo in Adult Subjects Allergic to Birch Pollen|Completed||Phase 2|240|Actual|Anergis||3|||f||||f||||||||||2017-10-11 02:20:24.911527|2017-10-11 02:20:24.911527
NCT01720238|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2015-07-27|||March 2012||2012-03-01|July 2015|2015-07-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01||Observational|||Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis|Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis|Active, not recruiting||N/A|621|Actual|Beijing Friendship Hospital|||2||f||||t||||||Samples With DNA|"     serum,plasma and DNA   "|||2017-10-11 02:20:25.368402|2017-10-11 02:20:25.368402
NCT01720225|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2017-02-23|||November 2012|Actual|2012-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk|Phase II Randomized Study of Lower Doses of Decitabine (DAC; 20 mg/m2 IV Daily for 3 Days Every Month) Versus Azacitidine (AZA; 75 mg/m2 SC/IV Daily for 3 Days Every Month) in Myelodysplastic Syndrome (MDS) Patients With Low and Intermediate-1 Risk Disease|Active, not recruiting||Phase 2|120|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 02:20:25.517586|2017-10-11 02:20:25.517586
NCT01720212|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-10-31|||May 2012||2012-05-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers|An Open-Label, Single and Multiple Dose Study to Assess the Safety and Pharmacokinetics of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers|Completed||Phase 1|24|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:20:25.651568|2017-10-11 02:20:25.651568
NCT01720199|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2014-01-18|||November 2012||2012-11-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|DDS||A School-based Prevention Intervention to Promote Wellbeing in Preadolescents|Diario Della Salute (DDS), a School-based Prevention Intervention to Promote Well-being for Grade 7 Students (12-13 Years)|Completed||N/A|2630|Actual|Azienda Sanitaria Locale CN2 Alba-Bra||2|||f||||f||||||||||2017-10-11 02:20:25.759787|2017-10-11 02:20:25.759787
NCT01720186|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-10-08|||May 2013||2013-05-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|SPI COHERENCE||Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer|Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer|Terminated||N/A|46|Actual|Institut Claudius Regaud||2|||f||||f||||||||||2017-10-11 02:20:25.896905|2017-10-11 02:20:25.896905
NCT01720160|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-07-19||2016-08-30|November 2012||2012-11-01|July 2017|2017-07-01|January 2021|Anticipated|2021-01-01|May 2015|Actual|2015-05-01||Interventional|||Barostim HOPE4HF (Hope for Heart Failure) Study|Barostim HOPE4HF Study|Active, not recruiting||N/A|98|Actual|CVRx, Inc.||2|||f||||t||||||||||2017-10-11 02:20:26.256124|2017-10-11 02:20:26.256124
NCT01720147|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-07-05|||July 2012||2012-07-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Quercetin in Children With Fanconi Anemia; a Pilot Study|Quercetin in Children With Fanconi Anemia; a Pilot Study|Recruiting||Phase 1|32|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 02:20:26.40239|2017-10-11 02:20:26.40239
NCT01720134|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-03-29|||September 2010||2010-09-01|March 2017|2017-03-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|||The Impact of Legally Enforced Embryo Transfer Policy (Belgian Law 2003) on Cumulative Delivery Rate.||Completed||N/A|1258|Actual|Katholieke Universiteit Leuven|||2||f||||||||||||||2017-10-11 02:20:26.512013|2017-10-11 02:20:26.512013
NCT01720121|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-31|||April 2009||2009-04-01|October 2012|2012-10-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Digital Videos Disc and Printed Guidelines and Improve the Knowledge of Patients Undergoing Cardiac Catheterization|Digital Videos Disc and Printed Guidelines and Improve the Knowledge of Patients Undergoing Cardiac Catheterization|Completed||N/A|150|Actual|Instituto de Cardiologia do Rio Grande do Sul||3|||f||||f||||||||||2017-10-11 02:20:26.589482|2017-10-11 02:20:26.589482
NCT01720108|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-07-31|||February 24, 2013|Actual|2013-02-24|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|EPCAT II||Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty|Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty|Active, not recruiting||Phase 3|3426|Actual|Nova Scotia Health Authority||2|||f||||t||||||||||2017-10-11 02:20:26.674129|2017-10-11 02:20:26.674129
NCT01720095|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-08-06|||October 2009||2009-10-01|October 2012|2012-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis|A 1 Year Randomized, Controlled, Open-Label Study of the Impact of Flexible Doses of Niacin (NIASPAN) as an Adjunct to Antipsychotic Medication in the Treatment of First Episode Psychosis|Completed||Phase 3|22|Actual|Nova Scotia Health Authority||3|||f||||f||||||||||2017-10-11 02:20:27.519312|2017-10-11 02:20:27.519312
NCT01720082|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-31|2012-11-02|||March 2013||2013-03-01|November 2012|2012-11-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|AMUSING||Laparoscopic Appendectomy by Multi-port vs Single Port.|Randomized Controlled Trial Comparing Single Incision Laparoscopic Appendectomy Versus Standard Three Port Appendectomy in a Selected Cohort of Patients|Unknown status|Not yet recruiting|Phase 3|300|Anticipated|Associazione Chirurghi Ospedalieri Italiani||2|||f||||f||||||||||2017-10-11 02:20:27.613245|2017-10-11 02:20:27.613245
NCT01720069|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-09-11||2014-09-11|October 2012||2012-10-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma|A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.|Completed||Phase 2/Phase 3|197|Actual|Vectura Limited||3|||f||||||||||||||2017-10-11 02:20:27.714764|2017-10-11 02:20:27.714764
NCT01720056|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-06-09|||October 2012||2012-10-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Verapamil vs Steroid to Prevent Keloid Recurrence|Assessment of Verapamil as an Adjunct for Prevention of Keloid Recurrence After Surgical Removal|Terminated||Phase 4|14|Actual|The University of Western Australia||2||Objective of study achieved after interim analysis.|f||||t||||||||||2017-10-11 02:20:27.914715|2017-10-11 02:20:27.914715
NCT01720043|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-08-04|2017-05-17||July 2013||2013-07-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|April 2015|Actual|2015-04-01||Interventional|||Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients|Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients|Terminated||Phase 2|8|Actual|University of Utah||1||Slow Accrual|f||||t||||||||||2017-10-11 02:20:27.99989|2017-10-11 02:20:27.99989
NCT01720030|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-09-26|||September 2016||2016-09-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|LAKIS||Levosimendan in Acute Kidney Injury Study|Prospective, Randomized, Monocenter, Double Blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Levosimendan in Intensive Care Patients With Acute Kidney Injury|Active, not recruiting||Phase 2/Phase 3|68|Actual|VieCuri Medical Centre||2|||f||||t||||||||||2017-10-11 02:20:28.553435|2017-10-11 02:20:28.553435
NCT01720017|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-09-30|||October 2012||2012-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Impact of Manikin Training on Airtraq Avant Learning Curve in Predicted Difficult Airways|The Impact of Airway Manikin Training on the Airtraq Avant and Wireless Monitor System Learning Curve in Airways With Predictors for Difficult Intubation|Terminated||N/A|30|Actual|University of Wisconsin, Madison||2||"Difficulty was encountered with the subjects completing their required 20 intubations in   patients with at least one predictor of difficult intubation."|f||||f||||||||||2017-10-11 02:20:28.641285|2017-10-11 02:20:28.641285
NCT01720004|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-30|||October 2010||2010-10-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|LPT2||A Pilot Randomized Controlled Trial of Repeated Hands-and-Knees Positioning During Labour|Repeated Hands-and-Knees Positioning During Labour: A Pilot Randomized Controlled Trial|Completed||Phase 1|30|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 02:20:28.734729|2017-10-11 02:20:28.734729
NCT01719991|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2014-12-01|||November 2012||2012-11-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|V1SAGES||Vulnerable Patients in Primary Care: Nurse Case Management and Self-management Support|Pragmatic Evaluation of Case Management and Self-management Support for Vulnerable People With Chronic Diseases in Primary Care|Completed||N/A|247|Actual|Université de Sherbrooke||2|||f||||t||||||||||2017-10-11 02:20:28.843821|2017-10-11 02:20:28.843821
NCT01719978|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-31|||October 2007||2007-10-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|October 2007|Actual|2007-10-01||Interventional|||Hemodynamic and Electrocardiographic Effects of Hyaluronidase Associated With Local Anaesthetics|"Hemodynamic and Electrocardiographic Effects of Hyaluronidase Associated With Local Anaesthetics: a Double-blind Split-mouth Controlled Trial."|Completed||Phase 4|20|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:20:28.942651|2017-10-11 02:20:28.942651
NCT01719965|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-08-27|||October 2012||2012-10-01|August 2013|2013-08-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Evaluation of Tak Community Advisory Board|Evaluation of the Tak Province Community Ethics Community Advisory Board: Interviews and Focus Group Discussions|Unknown status|Recruiting|N/A|45|Anticipated|University of Oxford|||5||f||||f||||||||||2017-10-11 02:20:29.108983|2017-10-11 02:20:29.108983
NCT01719952|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2015-02-26|||January 2012||2012-01-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin|Comparison of Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin in Women Undergoing Elective Caesarean Section: A Double-blinded Randomised Clinical Trial|Completed||N/A|50|Actual|Universiti Kebangsaan Malaysia Medical Centre||2|||f||||t||||||||||2017-10-11 02:20:29.216507|2017-10-11 02:20:29.216507
NCT01719926|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-08-15|||September 2012||2012-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|PIFA||Phase I Platinum Based Chemotherapy Plus Indomethacin|Phase I Study Evaluating Indomethacin in Combination With Platinum-based Chemotherapy|Completed||Phase 1|13|Actual|UMC Utrecht||2|||f||||f||||||||||2017-10-11 02:20:29.311909|2017-10-11 02:20:29.311909
NCT01719913|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2013-12-04|||October 2012||2012-10-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|3G||The Effect of Gluten on Gut Microbiome and Metabolic Health.|Gut, Grain and Greens (3G): The Effect of Gluten on Gut Microbiome and Metabolic Health.|Completed||N/A|60|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 02:20:29.44375|2017-10-11 02:20:29.44375
NCT01719900|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-06-14|||October 2012||2012-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 2013|Actual|2013-05-01||Interventional|||Evaluation of Pulse Fibre Supplementation on Obesity and the Metabolic Syndrome|Evaluation of Pulse Fibre Supplementation in Obesity and the Metabolic Syndrome: Generating Evidence in Support of Health Claims|Active, not recruiting||N/A|60|Anticipated|University of Calgary||2|||f||||t||||||||Undecided||2017-10-11 02:20:29.536384|2017-10-11 02:20:29.536384
NCT01719887|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2017-05-28|||October 2012||2012-10-01|May 2017|2017-05-01|October 2025|Anticipated|2025-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Effectiveness and Cost-effectiveness of Surgical Treatment of Humeral Shaft Fractures. Randomized Controlled Trial|Effectiveness and Cost-effectiveness of Surgical Treatment of Humeral Shaft Fractures. Randomized Controlled Trial.|Recruiting||N/A|80|Anticipated|Töölö Hospital||2|||f||||f||||||||||2017-10-11 02:20:29.649883|2017-10-11 02:20:29.649883
NCT01719861|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-03-02|2017-01-12||October 2012||2012-10-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors|A Phase 2a Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors|Terminated||Phase 2|6|Actual|Stanford University|This study had to be terminated early because patients with small cell lung cancer were not able to tolerate clinically relevant doses of desipramine, and no clinical activity was observed in the first enrolled patients.|1||Lack of efficacy|f||||t||||||||No||2017-10-11 02:20:29.954363|2017-10-11 02:20:29.954363
NCT01719848|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-04-16|||August 2012||2012-08-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Evaluation of Clinical Airway Assessments With a Gray Zone Approach|Evaluation of Clinical Airway Assessments for Predicting Difficult Laryngoscopy Using a Gray Zone Approach|Completed||N/A|200|Anticipated|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 02:20:30.421661|2017-10-11 02:20:30.421661
NCT01719835|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-10-30|||March 2012||2012-03-01|October 2012|2012-10-01|August 2022|Anticipated|2022-08-01|March 2017|Anticipated|2017-03-01||Interventional|CHEMO-T||CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study|CHEMO-T: Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (CHOP) Versus Gemcitabine, Cisplatin and Methyl Prednisolone (GEM-P) in the First Line Treatment Of T-cell Lymphoma,a Multicentre Randomised Phase II Study|Recruiting||Phase 2|186|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:20:30.5023|2017-10-11 02:20:30.5023
NCT00000555|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||August 1996||1996-08-01|August 2005|2005-08-01|May 2003|Actual|2003-05-01|||||Interventional|||Women's Angiographic Vitamin and Estrogen Trial (WAVE)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.182352|2017-10-11 04:19:04.182352
NCT01719822|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-05-12|||July 2012||2012-07-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease|Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease|Completed||N/A|155|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:20:30.619197|2017-10-11 02:20:30.619197
NCT01719809|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-04-11|||October 2012||2012-10-01|April 2017|2017-04-01|June 1, 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation|A Prospective Evaluation of the Effect of Training on Eye Drop Administration in Glaucoma Subjects Who Have Difficulties Properly Instilling Eye Drops|Terminated||N/A|18|Actual|Robin, Alan L., M.D.|||1|Enrollment Goals not met|f||||t||||||||||2017-10-11 02:20:30.701545|2017-10-11 02:20:30.701545
NCT01719796|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-30|||October 2012||2012-10-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|KTAP||Effect of TAP Block on Ventilatory Function Following Abdominal Surgery|Assessment of the Ventilatory Effects of Transverse Abdominal Plan Regional Analgesia Following Abdominal Surgery.|Unknown status|Recruiting|Phase 2|60|Anticipated|Pierre and Marie Curie University||2|||f||||f||||||||||2017-10-11 02:20:30.782357|2017-10-11 02:20:30.782357
NCT01719783|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2016-12-22|||September 2012||2012-09-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine|Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/Turkey/Turkey/05/133 (H5N2) Influenza Vaccine|Completed||Phase 1|40|Actual|PATH||2|||f||||t||||||||||2017-10-11 02:20:30.877574|2017-10-11 02:20:30.877574
NCT01719770|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2015-04-30|||November 2010||2010-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|October 2013|Actual|2013-10-01||Interventional|RELAX||Skeletal Muscle Paralysis in Hypothermic Patients After Cardiac Arrest|Requirement of Skeletal Muscle Paralysis in Hypothermic Patients After Cardiac Arrest - a Pilot Study|Completed||Phase 3|60|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:20:30.956868|2017-10-11 02:20:30.956868
NCT01719757|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-07-11|2016-06-01||July 2012||2012-07-01|July 2016|2016-07-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|PROBE|Safety set|PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain|A 4-week, Open Label, Multi-center, Prospective, Single-arm, Non-interventional Phase IV Study to Evaluate the Efficacy of Targin for the Treatment of Korean Patients With Cancer Pain Under Conditions of Daily Practice|Completed||Phase 4|359|Actual|Mundipharma Korea Ltd||1|||f||||f||||||||No||2017-10-11 02:20:31.068831|2017-10-11 02:20:31.068831
NCT01719731|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-09-23|||July 2013||2013-07-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Psychoeducation of Borderline Patients|Psychoeducation of Borderline Patients|Completed||N/A|80|Actual|Mclean Hospital||2|||f||||t||||||||||2017-10-11 02:20:31.634753|2017-10-11 02:20:31.634753
NCT01719718|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-12-04|||October 2012||2012-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|CLOSURE||The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair|The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair.|Unknown status|Recruiting|N/A|132|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 02:20:31.728146|2017-10-11 02:20:31.728146
NCT01719705|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2015-07-29|||November 2012||2012-11-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Pregabalin on Post-cesarean Pain|Efficacy of Preoperative Pregabalin on the Post-caesarean Pain; a Dose-response Study|Completed||Phase 1|135|Actual|Mansoura University||3|||f||||t||||||||||2017-10-11 02:20:31.849559|2017-10-11 02:20:31.849559
NCT01719692|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-05-15|||August 2012||2012-08-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|October 2015|Actual|2015-10-01||Interventional|ITP||Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia|Prospective Multi-center Randomized Controlled Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia|Completed||N/A|100|Actual|Institute of Hematology & Blood Diseases Hospital||2|||f||||t||||||||||2017-10-11 02:20:31.950968|2017-10-11 02:20:31.950968
NCT01719679|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-12-31|||August 2010||2010-08-01|September 2012|2012-09-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||School Located Adolescent Vaccination Study|Examination of the Effectiveness of Adolescent Vaccines Given in Schools|Completed||N/A|2000|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:20:32.029796|2017-10-11 02:20:32.029796
NCT01719666|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-05-22|||November 2011|Actual|2011-11-01|May 2017|2017-05-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Medial Patellofemoral Ligament Reconstruction With or Without Lateral Retinaculum Release|Randomized Control Trial on Lateral Retinaculum Release in MPFL Reconstruction|Recruiting||N/A|140|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:20:32.105775|2017-10-11 02:20:32.105775
NCT01719653|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2017-03-23|2017-03-23||October 2012||2012-10-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Comparison of 5 Low Volume Bowel Preparations|A Randomized Comparison of Five Low Volume Bowel Preparations for Colonoscopy|Completed||Phase 4|1079|Actual|Gastroenterology Services, Ltd.||5|||f||||t||||||||||2017-10-11 02:20:32.181456|2017-10-11 02:20:32.181456
NCT01719640|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2017-09-20|||January 2011|Actual|2011-01-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|January 2014|Actual|2014-01-01||Interventional|||UCMSC and BMMNC in Type 2 Diabetes Mellitus|Umbilical Cord Mesenchymal Stem Cell and Autologous Bone Marrow Mononuclear Cell Infusion in Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|30|Actual|Fuzhou General Hospital||3|||f||||t|f|f||||||||2017-10-11 02:20:32.631393|2017-10-11 02:20:32.631393
NCT01719627|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-03-04|||October 2012||2012-10-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|May 2014|Actual|2014-05-01||Interventional|||First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers|PILOT STUDY OF PROTECTION AGAINST ex Vivo HIV INFECTION IN RECTAL MUCOSA IN HEALTHY VOLUNTEERS AFTER ADMINISTRATION OF MARAVIROC|Completed||Phase 1|10|Actual|Fundacio Lluita Contra la SIDA||3|||f||||f||||||||||2017-10-11 02:20:32.774896|2017-10-11 02:20:32.774896
NCT01719614|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-03-05|||October 2012||2012-10-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants|A Phase I, Open-Label Study in Healthy Subjects to Explore the Potential for a Pharmacokinetic Interaction Between Steady-State Rilpivirine and a Single Dose Of Metformin|Completed||Phase 1|20|Actual|Janssen R&D Ireland||1|||f||||f||||||||||2017-10-11 02:20:32.970411|2017-10-11 02:20:32.970411
NCT01719601|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-09-25|||October 2014||2014-10-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain|A Post-Marketing Surveillance (PMS) Study on the Safety and Effectiveness of Immediate Release Tapentadol Hydrochloride Among Adult Filipino Patients With Moderate to Severe Acute Non-Cancer Pain|Withdrawn||Phase 4|0|Actual|Janssen Pharmaceutica|||1|The company decided to cancel this study in conformity with PH FDA Circular 2013-004|f||||f||||||||||2017-10-11 02:20:33.157785|2017-10-11 02:20:33.157785
NCT01719588|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-11-30|||October 2014||2014-10-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain|A Post-Marketing Surveillance (PMS) Study on the Safety and Effectiveness of Prolonged Release Tapentadol Hydrochloride Among Adult Filipino Patients With Moderate To Severe Chronic Non-Cancer Pain|Withdrawn||Phase 4|0|Actual|Janssen Pharmaceutica|||1|The company decided to cancel this study in conformity with PH FDA Circular 2013-004|f||||f||||||||||2017-10-11 02:20:33.297739|2017-10-11 02:20:33.297739
NCT01719575|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2013-08-13|||March 2012||2012-03-01|August 2013|2013-08-01||||November 2012|Actual|2012-11-01||Interventional|DA-9701||Clinical Trial of Motilitone on Gastric Motor Function in Healthy Volunteers|A Double-blind, Randomized, Two-way, Cross-over Study for Evaluating Motilitone on Gastric Motor Function in Healthy Volunteers|Completed||Phase 4|30|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:20:33.404212|2017-10-11 02:20:33.404212
NCT01719562|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-08-14|||January 2013||2013-01-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy|Early Imaging Detection of Cardiovascular Injury After Cancer|Recruiting||N/A|150|Anticipated|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 02:20:33.51658|2017-10-11 02:20:33.51658
NCT01719549|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-07-13|||September 2012|Actual|2012-09-01|July 2017|2017-07-01|November 2016|Actual|2016-11-01|February 2016|Actual|2016-02-01||Interventional|||Dovitinib for Gastric Cancer With FGFR2 Amplification|A Phase II Trial of Dovitinib Monotherapy as Salvage Treatment in Patients With Metastatic or Unresectable Gastric Cancer Harboring FGFR2(Fibroblast Growth Factor Receptor 2) Amplification After Failure of First or Second Line Chemotherapy|Completed||Phase 2|19|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 02:20:33.628842|2017-10-11 02:20:33.628842
NCT01719536|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-09-28|||December 2012||2012-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|Convince||Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma Patients|Conmana Versus Pemetrexed-based First-line Induction and Maintenance Chemotherapy in Advanced Lung Adenocarcinoma With EGFR-mutation|Active, not recruiting||Phase 3|296|Actual|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 02:20:33.75428|2017-10-11 02:20:33.75428
NCT01719523|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-03-04|||October 2012||2012-10-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Open-Trial of EPI-743 for Adults With Tourette Syndrome|Open-Trial of EPI-743 for Adults With Tourette Syndrome|Completed||Phase 1|10|Actual|Yale University||1|||f||||f||||||||||2017-10-11 02:20:33.984035|2017-10-11 02:20:33.984035
NCT01719510|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2016-06-27|||November 2012||2012-11-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|June 2016|Actual|2016-06-01||Interventional|Col-Strepto B||Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningitis|Study of the Digestive Colonization of the Newborn Children by the Streptococcus of the Group B|Active, not recruiting||N/A|949|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 02:20:34.092242|2017-10-11 02:20:34.092242
NCT01719497|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-04-24|||June 2009||2009-06-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2015|Actual|2015-06-01||Observational|||Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET|Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET|Active, not recruiting||N/A|120|Anticipated|Yale University|||4||f||||t||||||||||2017-10-11 02:20:34.186608|2017-10-11 02:20:34.186608
NCT01719484|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-04-24|||May 2008||2008-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2015|Actual|2015-05-01||Observational|||fMRI of Stress in Obesity|Functional Magnetic Resonance Imaging of Stress in Obesity|Active, not recruiting||N/A|60|Anticipated|Yale University|||2||f||||t||||||||||2017-10-11 02:20:34.275834|2017-10-11 02:20:34.275834
NCT01719471|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-12-12|||February 2008||2008-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|February 2013|Actual|2013-02-01||Observational|||fMRI of Stress in Smoking Behavior|fMRI of Stress in Smoking Behavior|Withdrawn||N/A|0|Actual|Yale University|||2|No subjects enrolled|f||||t||||||||||2017-10-11 02:20:34.385288|2017-10-11 02:20:34.385288
NCT01719458|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-04-24|||July 2007||2007-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2012|Actual|2012-07-01||Observational|||Norepinephrine Transporter Imaging in Addiction Disorders|Norepinephrine Transporter Imaging in Addiction Disorders|Active, not recruiting||N/A|72|Anticipated|Yale University|||3||f||||t||||||||||2017-10-11 02:20:34.487223|2017-10-11 02:20:34.487223
NCT01719445|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2016-01-15|||October 2012||2012-10-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|FPP||The Food Phone Project|Remote Food Photography for the Real-time Measurement of Children's Food Intake|Completed||N/A|53|Actual|Pennington Biomedical Research Center|||1||f||||t||||||Samples Without DNA|"     Urine collection as part DLW procedure.   "|||2017-10-11 02:20:34.616419|2017-10-11 02:20:34.616419
NCT01719432|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-10-31|||October 2012||2012-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Effect of Body Mass on Filgrastim Pharmacokinetics|Effect of Body Mass on Filgrastim Pharmacokinetics|Recruiting||N/A|30|Anticipated|West Virginia University|||2||f||||t||||||||||2017-10-11 02:20:34.713954|2017-10-11 02:20:34.713954
NCT00000556|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-24|||March 1995||1995-03-01|November 2005|2005-11-01|September 2002||2002-09-01|||||Interventional|||Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.27247|2017-10-11 04:19:04.27247
NCT01719419|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-12-17|||March 2012||2012-03-01|December 2015|2015-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects|The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects: A Pilot Study|Withdrawn||N/A|0|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 02:20:34.854931|2017-10-11 02:20:34.854931
NCT01719406|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-10-14|||November 2012||2012-11-01|January 2013|2013-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|PEN||The OHSU Pregnancy Exercise & Nutrition (PEN) Program|Randomized Control Pilot of a Behavior-based Exercise and Diet Intervention to Reduce Risk Factors for Gestational Diabetes Among Otherwise Healthy Pregnant Women.|Completed||N/A|30|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 02:20:34.959344|2017-10-11 02:20:34.959344
NCT01719393|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-10-31|||November 2012||2012-11-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Observational|||Pulse Spectrum Analysis in Adult Asthmatics: Correlation With Lung Function, Asthma Control Exhaled Nitric Oxide and Metabolites in Exhaled Breath Condensate|Pulse Spectrum Analysis in Adult Asthmatics: Correlation With Lung Function, Asthma Control Exhaled Nitric Oxide and Metabolites in Exhaled Breath|Unknown status|Not yet recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Exhaled brath condensate   "|||2017-10-11 02:20:35.055734|2017-10-11 02:20:35.055734
NCT01719380|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-07-21||2017-07-17|November 2012||2012-11-01|July 2017|2017-07-01|March 1, 2018|Anticipated|2018-03-01|October 31, 2015|Actual|2015-10-31||Interventional|||Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer|A Phase lb/II Multi-center, Open-label, Dose Escalation Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in Patients With BRAF Mutant Metastatic Colorectal Cancer|Active, not recruiting||Phase 1/Phase 2|150|Anticipated|Array BioPharma||2|||f||||||||||||||2017-10-11 02:20:35.191333|2017-10-11 02:20:35.191333
NCT01719367|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-10-31|||January 2013||2013-01-01|December 2015|2015-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation|Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation|Completed||N/A|41|Actual|Vanderbilt University||1|||f||||f||||||||||2017-10-11 02:20:35.393361|2017-10-11 02:20:35.393361
NCT01719354|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-02-12|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Aftercare in the Community Health Center|Aftercare in the Community Health Center - a Venue for Identifying and Coordinating Community Services|Completed||N/A|41|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 02:20:35.498979|2017-10-11 02:20:35.498979
NCT01719341|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2013-12-10|||September 2012||2012-09-01|December 2013|2013-12-01||||June 2014|Anticipated|2014-06-01||Observational|||Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia||Unknown status|Recruiting|N/A|21|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 02:20:35.600983|2017-10-11 02:20:35.600983
NCT01719328|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2013-10-23|||February 2007||2007-02-01|October 2013|2013-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Vinayasa Yoga and Mood|The Effects of Vinayasa Yoga on Mood and Stress|Completed||N/A|19|Actual|The Miriam Hospital||1|||f||||f||||||||||2017-10-11 02:20:35.699208|2017-10-11 02:20:35.699208
NCT01719315|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-05-12|||November 2012||2012-11-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Neurophysiologic Correlates of Hypersomnia|Neurophysiologic Correlates of Hypersomnia: a High Density EEG Investigation|Recruiting||N/A|240|Anticipated|University of Wisconsin, Madison|||8||f||||f||||||||||2017-10-11 02:20:35.787771|2017-10-11 02:20:35.787771
NCT01719289|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-31|||March 2011||2011-03-01|October 2012|2012-10-01|September 2014|Anticipated|2014-09-01|November 2013|Anticipated|2013-11-01||Interventional|PROGRAVIDA||Efficacy of a Program for the Management of Depression in Pregnant Women in Primary Care in São Paulo, Brazil|Cluster Randomised Controlled Trial of a Primary-care Based Intervention to Improve Depressive Symptoms of Pregnant Women in Sao Paulo, Brazil|Unknown status|Recruiting|N/A|600|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 02:20:36.039036|2017-10-11 02:20:36.039036
NCT01719276|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-06-13|||February 2013||2013-02-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|January 2014|Actual|2014-01-01||Interventional|||Graded Activity Versus Supervised Exercises in Patients With Chronic Non-specific Low Back Pain|EFFECT OF COGNITIVE-BEHAVIORAL THERAPY AND EXERCISE VERSUS SUPERVISED EXERCISE PROGRAM IN PATIENTS WITH CHRONIC PAIN LUMBAR NO SPECIFIC: RANDOMIZED CONTROLLED TRIAL|Unknown status|Active, not recruiting|N/A|66|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:20:36.163959|2017-10-11 02:20:36.163959
NCT01719263|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-10-27|||June 2013||2013-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study|Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study|Completed||N/A|69|Actual|Uptake Medical Corp||2|||f||||f||||||||||2017-10-11 02:20:36.285031|2017-10-11 02:20:36.285031
NCT01719250|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-03-24|||December 2012|Actual|2012-12-01|December 2016|2016-12-01|March 22, 2017|Actual|2017-03-22|September 16, 2016|Actual|2016-09-16||Interventional|||Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma|A Pilot Study of the PI3K Inhibitor BKM120 in Patients With Relapsed Lymphoma|Completed||N/A|7|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:20:36.417717|2017-10-11 02:20:36.417717
NCT01719237|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-31|||August 2009||2009-08-01|October 2012|2012-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture|Double Blinded Randomized Control Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture|Completed||Phase 4|60|Actual|University of New Mexico||2|||f||||f||||||||||2017-10-11 02:20:36.52419|2017-10-11 02:20:36.52419
NCT01719211|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-02-10|||January 1999||1999-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|MVP||Genetic Basis of Mitral Valve Prolapse|Genetic Basis of Mitral Valve Prolapse|Recruiting||N/A|1500|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     DNA   "|||2017-10-11 02:20:36.716972|2017-10-11 02:20:36.716972
NCT01719198|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-11-12|||October 2012||2012-10-01|November 2012|2012-11-01||||March 2013|Anticipated|2013-03-01||Observational|||Usefulness of Calprotectin for Colon Adenoma Screening|Usefulness of Fecal Calprotectin for Screening Colon Adenoma in Korean Population|Unknown status|Recruiting|N/A|500|Anticipated|Konkuk University Medical Center|||1||f||||f||||||Samples Without DNA|"     stool specimen   "|||2017-10-11 02:20:36.877917|2017-10-11 02:20:36.877917
NCT01719185|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2015-08-11|||September 2012||2012-09-01|August 2015|2015-08-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||The Effect of Phentermine and B12 on Weight Loss Among Obese Patients|A Pilot Study to Assess Whether the Combination of Phentermine and B12 Has a Significant Effect on Weight Loss Among an Obese Study Population|Completed||Early Phase 1|22|Actual|East Carolina University||2|||f||||t||||||||||2017-10-11 02:20:36.973493|2017-10-11 02:20:36.973493
NCT01719172|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2014-01-17|2014-01-17||September 2012||2012-09-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional||Baseline demographic and clinical characteristics are summarized by descriptive statistics for continuous variables, and frequencies and percentages for categorical variables. These analyses were performed on the Treated Population.|A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue|A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue|Completed||N/A|30|Actual|Medtronic - MITG||1|||f||||t||||||||||2017-10-11 02:20:37.08805|2017-10-11 02:20:37.08805
NCT01719159|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-11-18|||November 2009||2009-11-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|ITT-PMS||Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis|Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis|Completed||Phase 2|23|Actual|Umeå University||1|||f||||f||||||||Undecided|IPD will be shared upon request from the researcher or scientific journals|2017-10-11 02:20:37.439382|2017-10-11 02:20:37.439382
NCT01719146|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-12-06|||January 2013||2013-01-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease|Computational Approach to Personalized Anemia Management|Active, not recruiting||N/A|120|Anticipated|University of Louisville|||3||f||||f||||||Samples Without DNA|"     Blood, serum will be extracted and frozen for further analysis. Serum will be retained for up     to 60 days.   "|Undecided||2017-10-11 02:20:37.528752|2017-10-11 02:20:37.528752
NCT01719133|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2012-10-31|||February 2008||2008-02-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen|Détermination de la réactivité cutanée de Volontaires Allergiques au Pollen de Bouleau Contre Des Peptides dérivés de Bet v 1|Completed||Phase 1|20|Actual|Anergis||1|||f||||f||||||||||2017-10-11 02:20:37.652884|2017-10-11 02:20:37.652884
NCT01719120|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-05-12|||August 2012||2012-08-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|April 2014|Actual|2014-04-01||Interventional|||Internet-Based Cognitive-Behavioral Therapy for Insomnia|Internet-Based Self-Help Cognitive-Behavioral Therapy for Insomnia (CBTI): A Randomized Controlled Trial|Completed||N/A|312|Actual|The University of Hong Kong||3|||f||||f||||||||||2017-10-11 02:20:37.769414|2017-10-11 02:20:37.769414
NCT01719107|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2016-02-20|||November 2012||2012-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy of Dietary Supplementation With Lactobacilllus Reuteri DSM 17938 on Functional Abdominal Pain (FAP) in Children|Efficacy of Dietary Supplementation With Lactobacilllus Reuteri DSM 17938 on Functional Abdominal Pain (FAP) in Children|Completed||N/A|54|Actual|Aghia Sophia Children's Hospital of Athens||2|||f||||t||||||||||2017-10-11 02:20:37.856914|2017-10-11 02:20:37.856914
NCT01719094|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-04-17|||August 2012||2012-08-01|April 2017|2017-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||RITHM - Resonance Imaging Trial for Heart Biomarkers in Adolescent/Young (AYA) Cancer Survivors|RITHM - Resonance Imaging Trial for Heart Biomarkers in Adolescent/Young (AYA) Cancer Survivors|Completed||N/A|101|Actual|Wake Forest University Health Sciences|||3||f||||f|f|f||||||||2017-10-11 02:20:39.511927|2017-10-11 02:20:39.511927
NCT01719081|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-12-21|||January 2012||2012-01-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Sacroiliac Joint Injection: Comparison of Xray Versus Ultrasound|Ultrasound for Sacroiliac Joint Injection: Evaluation of the Efficacy of Two Image-Guided Techniques for Sacroiliac Joint Injection|Completed||N/A|40|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 02:20:39.586864|2017-10-11 02:20:39.586864
NCT01719068|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2012-10-30|||October 2012||2012-10-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Observational|||Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos|Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos|Unknown status|Recruiting|N/A|200|Anticipated|British Columbia Cancer Agency|||1||f||||f||||||||||2017-10-11 02:20:39.673226|2017-10-11 02:20:39.673226
NCT01719055|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2017-09-18|||May 2013||2013-05-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Observational|RELIEF||RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain|A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain|Recruiting||N/A|4800|Anticipated|Boston Scientific Corporation|||2||f||||f||||||||||2017-10-11 02:20:39.757111|2017-10-11 02:20:39.757111
NCT01719042|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-04-02|||January 2013||2013-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|ITT-MAC||Improving Tolerance of Treatment of Pulmonary MAC Infections|Improving Tolerance of Treatment of Pulmonary Mycobacterium Avium Complex Infections|Withdrawn||Phase 2|0|Actual|University of Florida||2||No recruitment was achievable|f||||f||||||||||2017-10-11 02:20:39.859938|2017-10-11 02:20:39.859938
NCT01719029|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-06-08|||August 2007||2007-08-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Role of Macronutrient Diet Composition and Infant Metabolic Outcomes in Gestational Diabetes|Role of Macronutrient Diet Composition on Maternal and Infant Metabolic Outcomes in Gestational Diabetes|Completed||N/A|35|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:20:39.949877|2017-10-11 02:20:39.949877
NCT01719016|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-05-12|||August 2010||2010-08-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics|Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics|Active, not recruiting||N/A|68|Anticipated|University of Cincinnati|||1||f||||f||||||||Undecided||2017-10-11 02:20:40.059024|2017-10-11 02:20:40.059024
NCT01719003|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-30|2016-01-22|2015-11-23||October 2012||2012-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional||Full analysis set (FAS): FAS comprised all randomised patients treated with at least 1 dose of trial medication, with a baseline and at least 1 on-treatment HbA1c assessment.|Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes|A 24-week Phase III Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Twice Daily Oral Administration of Empagliflozin + Metformin Compared With the Individual Components of Empagliflozin or Metformin in Drug Naive Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|1413|Actual|Boehringer Ingelheim||9|||f||||||||||||||2017-10-11 02:20:40.187111|2017-10-11 02:20:40.187111
NCT01718990|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-10-24|||October 2012||2012-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis|Prospective, Longitudinal Cohort Trial of Patients With Idiopathic Pulmonary Fibrosis (IPF) and Healthy Control Patients. Clinical Data, Blood, and Bronchiolavage (BAL) Fluid Will be Collected Over 12 Months.|Recruiting||N/A|120|Anticipated|University of California, San Francisco|||2||f||||t||||||Samples With DNA|"     Serum, plasma, Bronchiolavage (BAL) supernatant, and BAL cell pellets   "|||2017-10-11 02:20:41.941071|2017-10-11 02:20:41.941071
NCT01718977|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-05-01|||January 2013||2013-01-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|CHOICES||Cardiovascular Health/Outcomes: Improvements Created by Exercise and Eduction in SCI (CHOICES)|Cardiovascular Health/Outcomes: Improvements Created by Exercise and Eduction in SCI (CHOICES)|Recruiting||N/A|20|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 02:20:42.037888|2017-10-11 02:20:42.037888
NCT01718964|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2013-10-29|||November 2012||2012-11-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Ghost-Basel||Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel)|Acute Effects of Cortisol on Heroin Craving in Opioid Dependence|Completed||Phase 2|30|Actual|University of Basel||2|||f||||t||||||||||2017-10-11 02:20:42.309971|2017-10-11 02:20:42.309971
NCT01718951|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-05-11|||August 2012||2012-08-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial|Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Randomized Controlled Trial|Completed||Phase 4|30|Actual|Tuen Mun Hospital||2|||f||||f||||||||||2017-10-11 02:20:42.430144|2017-10-11 02:20:42.430144
NCT01718938|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-05-11|||December 2012||2012-12-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis|A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase 2 Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis|Completed||Phase 2|34|Actual|Theravance Biopharma R & D, Inc.||4|||f||||f||||||||||2017-10-11 02:20:42.547174|2017-10-11 02:20:42.547174
NCT01718925|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-10-14|||October 2012||2012-10-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||25-hydroxyvitamin D and Fatigue: The VITALITY Study|Vitamin D, Fatigue and Patient Reported Outcome (PRO) in Chronic Somatic and Functional Disorders.|Completed||N/A|614|Actual|Ostfold Hospital Trust|||4||f||||f||||||||||2017-10-11 02:20:42.734302|2017-10-11 02:20:42.734302
NCT01718912|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-03-29|||November 2013||2013-11-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|PDT||Periodontal Disease Treatment of a Physically Challenged Population|The Effect of an Antibiotic-antifungal Rinse on Periodontal Disease|Completed||N/A|11|Actual|Oravital Inc||1|||f||||f||||||||No||2017-10-11 02:20:42.849|2017-10-11 02:20:42.849
NCT01718899|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-09-26|||November 2012||2012-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma|A Phase 1/2a Dose Escalation Study of PVX-410, a Multi-Peptide Cancer Vaccine, in Patients With Smoldering Multiple Myeloma|Completed||Phase 1|22|Actual|OncoPep, Inc.||3|||f||||t||||||||||2017-10-11 02:20:42.968515|2017-10-11 02:20:42.968515
NCT01718886|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-29|||January 2012||2012-01-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||European Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss|Feasibility Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss|Completed||N/A|17|Actual|Obalon Therapeutics, Inc.|||1||f||||f||||||||||2017-10-11 02:20:43.075855|2017-10-11 02:20:43.075855
NCT01718873|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-03-28|||May 2012||2012-05-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|OBELICS||Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer|Randomized Phase 3 Study on the Optimization of Bevacizumab With mFOLFOX/mOXXEL in the Treatment of Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 3|230|Actual|National Cancer Institute, Naples||2|||f||||f||||||||||2017-10-11 02:20:43.169396|2017-10-11 02:20:43.169396
NCT01718860|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-05-01|||April 2011||2011-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|February 2014|Actual|2014-02-01||Observational|||Effects of Postoperative Residual Paralysis on Hospital Costs|Effects of Postoperative Residual Paralysis on Costs of Hospital Care, Length of Hospitalization and Intensive Care Unit Admission Rate|Active, not recruiting||N/A|3000|Anticipated|Massachusetts General Hospital|||2||f||||f||||||||No||2017-10-11 02:20:43.271514|2017-10-11 02:20:43.271514
NCT00000557|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-12|||September 1995||1995-09-01|January 2008|2008-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.381688|2017-10-11 04:19:04.381688
NCT01718847|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-08-13|||January 2013||2013-01-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|NSCLC||NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors|Phase II Exploratory Trial to Evaluate the Efficacy and Safety of NOV120101 (Poziotinib) in Lung Adenocarcinoma Patients With Acquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors|Completed||Phase 2|40|Actual|National OncoVenture||1|||f||||t||||||||||2017-10-11 02:20:43.394179|2017-10-11 02:20:43.394179
NCT01718834|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-10-30|||March 2011||2011-03-01|October 2012|2012-10-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|CENV3||Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection|Safety and Efficacy of a Novel Candidate Peptide Vaccine Against HCV Infection in Healthy Volunteers and in Treated (Non-responders/ Responders) Chronic HCV Patients. Clinical Trials Phases I and II|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|National Liver Institute, Egypt||2|||f||||t||||||||||2017-10-11 02:20:43.536164|2017-10-11 02:20:43.536164
NCT01718821|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2014-09-24|||September 2012||2012-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Observational|||Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients|Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients|Completed||N/A|50|Actual|National Cheng Kung University|||1||f||||f||||||||||2017-10-11 02:20:43.652063|2017-10-11 02:20:43.652063
NCT01718808|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-01-23|||November 2012|Actual|2012-11-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2015|Actual|2015-12-01||Interventional|||Cetuximab for Elderly Patients With mCRC|Cetuximab Monotherapy and Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With KRAS- and BRAF Wild-type Metastatic Colorectal Cancer. A Multicenter Phase II Trial|Terminated||Phase 2|24|Actual|Swiss Group for Clinical Cancer Research||2||"FU for 3 years from randomization as initially planned is stopped as we do not expect any   changes to the endpoints in the future after one year of FU."|f||||f||||||||No||2017-10-11 02:20:43.759403|2017-10-11 02:20:43.759403
NCT01718795|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-03-23|||September 2012||2012-09-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Prehospital Laryngeal Tube vs. Bag-Valve Mask Ventilation Used by Paramedics During CPR|Prehospital Laryngeal Tube vs. Bag-Valve Mask Ventilation Used by Paramedics During CPR- A Prospective, Controlled, Randomised, Multi-center Trial|Terminated||Phase 4|78|Actual|Medical University Innsbruck||2||Recruiting too slow, down to 1-0 patients per month|f||||f||||||||Yes||2017-10-11 02:20:43.912874|2017-10-11 02:20:43.912874
NCT01718782|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-05-14|||March 2013||2013-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Laryngeal Mask Ambu Aura Once vs. Supreme in Children|Ventilation With Laryngeal Mask Ambu Aura Once vs. Supreme in Children|Withdrawn||N/A|0|Actual|Medical University Innsbruck||2||Other studies with the same protocol have already published.|f||||t||||||||||2017-10-11 02:20:44.015369|2017-10-11 02:20:44.015369
NCT01718769|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-04-26|||October 2012||2012-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Interventional|STAMP2||Validation of the STAMP Screening Tool For Pediatric Nutritional Risk|Validation of the STAMP Screening Tool For Pediatric Nutritional Risk To Be Used in the Ambulatory Setting.|Completed||N/A|60|Actual|Meir Medical Center||2|||f||||f||||||||||2017-10-11 02:20:44.117597|2017-10-11 02:20:44.117597
NCT01718756|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2015-03-15|||June 2013||2013-06-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Continuous Lornoxicam Infusion for Orthopaedic Surgery|Efficacy of Continuous Intravenous Infusion vs. Scheduled Dosing of Lornoxicam on Patient Controlled Morphine Consumption After Orthopaedic Surgery: A Comparative Placebo Study|Unknown status|Recruiting|Phase 1/Phase 2|96|Anticipated|Mansoura University||3|||f||||t||||||||||2017-10-11 02:20:44.205085|2017-10-11 02:20:44.205085
NCT01718743|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-03-06|||December 2012|Actual|2012-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||MLN 9708 With Lenalidomide as Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma Patients|Phase II Study of the Combination of MLN 9708 With Lenalidomide as Maintenance Therapy Post Autologous Stem Cell Transplant in Patients With Multiple Myeloma|Active, not recruiting||Phase 2|88|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:20:44.3349|2017-10-11 02:20:44.3349
NCT01718730|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-04-20|||October 2012||2012-10-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Cortical Excitability and Inhibition in MDD|Cortical Excitability and Inhibition in Children and Adolescents With Major Depressive Disorder|Active, not recruiting||N/A|200|Anticipated|Mayo Clinic|||4||f||||f||||||||Undecided||2017-10-11 02:20:44.446148|2017-10-11 02:20:44.446148
NCT01718717|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2014-07-09|||December 2014||2014-12-01|July 2014|2014-07-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Effect of Thoracic Epidural Analgesia for Thoracotomy on the Occurrence of AF|Effect of Thoracic Epidural Analgesia for Thoracic Surgery on Arrhythiogenesis|Unknown status|Not yet recruiting|N/A|50|Anticipated|Larissa University Hospital||2|||f||||f||||||||||2017-10-11 02:20:44.683313|2017-10-11 02:20:44.683313
NCT01718704|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-09-29|||April 2013|Actual|2013-04-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Viberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-Prostatectomy|Study of Non-Invasive Viberect® Penile Vibratory Stimulation Regimen to Enhance Recovery of Erectile Function/Rigidity and Urinary Control/Continence After Nerve Sparing Radical Prostatectomy (RP) for Clinically Localized Prostate Cancer.|Recruiting||N/A|105|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:20:44.803427|2017-10-11 02:20:44.803427
NCT01718691|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-03-24|2015-06-19||November 2011||2011-11-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Of the 70 subjects enrolled, one who did not receive the investigational product was excluded. Therefore, the total number of Baseline Participants is 69.|Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma|Phase II Clinical Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B-cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma (Multicenter, Open-label).|Completed||Phase 2|70|Actual|SymBio Pharmaceuticals||1|||f||||||||||||||2017-10-11 02:20:45.145186|2017-10-11 02:20:45.145186
NCT01718678|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2012-10-30|||May 2012||2012-05-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Melatonin on Multiple Sclerosis Related Fatigue|Study of Melatonin in Treatment of Fatigue in Multiple Sclerosis|Completed||Phase 2|44|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:20:46.978349|2017-10-11 02:20:46.978349
NCT01718652|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-11-22|||February 2011||2011-02-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy Volunteers|An Open-Label, Single Sequence Study to Assess the Effect of a Single Dose of Cyclosporine on the Steady-State Pharmacokinetics of JNJ-28431754 (Canagliflozin) in Healthy Adult Subjects|Completed||Phase 1|18|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 02:20:47.087159|2017-10-11 02:20:47.087159
NCT01718639|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2013-03-07|||October 2012||2012-10-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn|Randomized, Controlled, Single-blind, Three-way Crossover Clinical Investigation to Evaluate Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn|Completed||Phase 4|41|Actual|InQpharm Group||3|||f||||f||||||||||2017-10-11 02:20:47.198695|2017-10-11 02:20:47.198695
NCT01718626|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2012-11-05|||October 2012||2012-10-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer||Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Hebei Tumor Hospital||2|||f||||||||||||||2017-10-11 02:20:47.296931|2017-10-11 02:20:47.296931
NCT01718613|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-05-18|||November 2012||2012-11-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|March 2014|Actual|2014-03-01||Interventional|VANCS II||Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients|Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients|Unknown status|Active, not recruiting|Phase 3|250|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||||||||||||2017-10-11 02:20:47.417126|2017-10-11 02:20:47.417126
NCT01718600|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-04-02|||June 2011||2011-06-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions||Unknown status|Recruiting|N/A|200|Anticipated|Stanford University|||1||f||||t||||||||||2017-10-11 02:20:47.506237|2017-10-11 02:20:47.506237
NCT01718587|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2012-10-30|||November 2012||2012-11-01|October 2012|2012-10-01|July 2014|Anticipated|2014-07-01|May 2013|Anticipated|2013-05-01||Interventional|||Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients|Difference in Efficacy Between Umbilical Cord Mesenchyma Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|General Hospital of Chinese Armed Police Forces||2|||f||||t||||||||||2017-10-11 02:20:47.603713|2017-10-11 02:20:47.603713
NCT01718574|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2014-09-05|||February 2013||2013-02-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bibliotherapy for Patients With Cancer|Feasibility, Acceptability and Efficacy of Bibliotherapy for Patients With Cancer: a Randomized Control Trial|Completed||N/A|89|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 02:20:47.737482|2017-10-11 02:20:47.737482
NCT01718561|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-02-07|||October 2012||2012-10-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|DIFFICAIR||"The Difficult Airway Management Trial: The DIFFICAIR-Trial"|Incidence of Unanticipated Difficult Airway Using an Objective Airway Score Versus a Standard Clinical Airway Assessment, The DIFFICAIR Trial - A Cluster-randomized Clinical Trial on 28 Anaesthesia Departments With 70,000 Patients Registered in the Danish Anaesthesia Database|Completed||N/A|76058|Actual|Hillerod Hospital, Denmark||2|||f||||f||||||||||2017-10-11 02:20:47.823936|2017-10-11 02:20:47.823936
NCT01718548|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-29|||December 2012||2012-12-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Effects of Cordyceps Sinensis and Lingzhi on Cardiovascular Fitness and Cognitive Function||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 02:20:48.038353|2017-10-11 02:20:48.038353
NCT01718535|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2013-05-28|2013-02-07||September 2012||2012-09-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing|Method Comparison Study of the Spartan FRX CYP2C19 *2, *3, and *17 Genotyping System|Completed||N/A|327|Actual|Spartan Bioscience Inc.|||1||f||||t||||||||||2017-10-11 02:20:48.214897|2017-10-11 02:20:48.214897
NCT01718509|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-11-03|2014-07-17||November 2012||2012-11-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||The Safety Analysis Set defined as all randomized subjects who took at least 1 dose of investigational product and had at least 1 post-baseline safety assessment. 11 subjects from Site 015, 12 subjects had not been treated, and 1 subject had been treated but did not have any safety follow-up assessments were excluded from the Safety Analysis Set.|SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder|The SPD489-344, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder|Completed||Phase 3|390|Actual|Shire||2|||f||||f||||||||||2017-10-11 02:20:49.013419|2017-10-11 02:20:49.013419
NCT01718496|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-09-22|||July 2014||2014-07-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Morphine, Dyspnea, Exercise and COPD|Physiological Mechanisms of Dyspnea Relief and Improved Exercise Tolerance After Treatment With Oral Morphine in Patients With Advanced Chronic Obstructive Pulmonary Disease (COPD).|Unknown status|Recruiting|Phase 3|20|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-11 02:20:50.052972|2017-10-11 02:20:50.052972
NCT01718483|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-11-03|2014-03-18||November 2012||2012-11-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Safety Analysis Set was used for Baseline Measures. The Safety Analysis Set was defined as all randomized participants who took at least 1 dose of investigational product and who had at least 1 post-baseline safety assessment completed. Four participants did not receive investigational product, therefore n=379.|SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder|The SPD489-343, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder|Completed||Phase 3|383|Actual|Shire||2|||f||||f||||||||||2017-10-11 02:20:50.201389|2017-10-11 02:20:50.201389
NCT01718470|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-30|||July 2011||2011-07-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Proseal Laryngeal Mask Airway or Endotracheal Tube for Emergence From Neuroanesthesia|Proseal Laryngeal Mask Airway Attenuates Systemic and Cerebral Hemodynamic Response During Awakening of Neurosurgical Patients|Completed||N/A|42|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 02:20:51.131216|2017-10-11 02:20:51.131216
NCT01718457|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-06-30|||December 2012||2012-12-01|June 2014|2014-06-01|January 2018|Anticipated|2018-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Endobarrier Treatment in Obese Subjects With T2DM|Endobarrier Treatment in Obese Subjects With T2DM|Active, not recruiting||Phase 4|45|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 02:20:51.263384|2017-10-11 02:20:51.263384
NCT01718444|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-12-07|||March 2015||2015-03-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|March 2017|Anticipated|2017-03-01||Interventional|||Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)|Optimizing Fertility Treatment in Women With Polycystic Ovary Syndrome (PCOS) - A Randomized Controlled Trial: The Role of Progestin-induced Endometrial Shedding in PCOS (PIES in PCOS)|Recruiting||N/A|170|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 02:20:51.349363|2017-10-11 02:20:51.349363
NCT01718431|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-05-07|||October 2010||2010-10-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Prebiotics as a Means to Modulate Gut Fermentation, Metabolism, Appetite and Cognition|Prebiotics as Means to Modulate Colonic Events, With the Purpose to Increase Beneficial Effects on Metabolism, Satiety and Cognition.|Completed||Early Phase 1|40|Actual|Lund University||2|||f||||f||||||||||2017-10-11 02:20:51.501064|2017-10-11 02:20:51.501064
NCT01718418|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-05-07|||September 2012||2012-09-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Role of Colonic Events on Metabolism and Appetite Control: A Synbiotic Approach|Prebiotics and Probiotics as Means to Modulate Colonic Events, With Specific Focus on Metabolism and Satiety|Completed||Early Phase 1|21|Actual|Lund University||3|||f||||f||||||||||2017-10-11 02:20:51.567515|2017-10-11 02:20:51.567515
NCT01718405|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-29|||November 2012||2012-11-01|October 2012|2012-10-01|November 2017|Anticipated|2017-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Genetic Polymorphism as Moderator of the Effect of an Acute Bout of Exercise on Cognitive Function||Not yet recruiting||N/A|150|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 02:20:51.629221|2017-10-11 02:20:51.629221
NCT01718392|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-11-22|||March 2011||2011-03-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional|||Rehabilitation in Multiple Sclerosis: Influence of Exercise on Development of Insulin Resistance, Muscle Power and Aerobic Capacity||Completed||N/A|45|Actual|Hasselt University||2|||f||||t||||||||||2017-10-11 02:20:51.686006|2017-10-11 02:20:51.686006
NCT01718379|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-11-07|||July 2010||2010-07-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|November 2012|Actual|2012-11-01||Interventional|||Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.|A Phase II Study Evaluating the Efficacy/Safety of Lenalidomide With or Without Epoetin Beta in Transfusion-dependent ESA-resistant Patients With IPSS Low- and Intermediate-1 Risk Myelodysplastic Syndromes Without Chromosome 5 Abnormality.|Completed||Phase 2|132|Actual|Groupe Francophone des Myelodysplasies||2|||f||||f||||||||No||2017-10-11 02:20:51.760034|2017-10-11 02:20:51.760034
NCT01718366|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-07-11|||February 2013|Actual|2013-02-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|GFM-EXVD-AZA||A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS|Phase I-II Study of Association of Deferasirox, Vitamin D and Azacytidine as Treatment of High Risk MDS (IPSS Int-2 and High)|Recruiting||Phase 1/Phase 2|50|Anticipated|Groupe Francophone des Myelodysplasies||2|||f||||t||||||||||2017-10-11 02:20:51.91475|2017-10-11 02:20:51.91475
NCT01718340|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2014-05-25|||June 2012||2012-06-01|May 2014|2014-05-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|MetRPL||Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia|Phase 4 Study of Effectiveness of Metformin in Patients With Unexplained Recurrent Miscarriages|Unknown status|Recruiting|Phase 4|396|Anticipated|Woman's Health University Hospital, Egypt||1|||f||||t||||||||||2017-10-11 02:20:52.253552|2017-10-11 02:20:52.253552
NCT01718327|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-01-30|||September 1, 2011|Actual|2011-09-01|January 2017|2017-01-01|November 17, 2016|Actual|2016-11-17|November 17, 2016|Actual|2016-11-17||Interventional|SUN-CK||A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma|A Phase II Open-label Single Arm Study of Sunitinib in Patients With Advanced Cholangiocarcinoma|Completed||Phase 2|53|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||f||||||||||2017-10-11 02:20:52.362605|2017-10-11 02:20:52.362605
NCT01718314|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-30|||March 2008||2008-03-01|October 2012|2012-10-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy|Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Pain Relief in Office Hysteroscopy: A Randomized, Double Blind, Placebo-Controlled Trial|Completed||N/A|138|Actual|Dr. Sami Ulus Children's Hospital||2|||f||||f||||||||||2017-10-11 02:20:52.458566|2017-10-11 02:20:52.458566
NCT01718288|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-10-29|||November 2006||2006-11-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|March 2011|Actual|2011-03-01||Interventional|2bPILOT||Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)|Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb), Unsuitable or Suitable to Surgical Revascularization / Endovascular With Reference to the Change of Pain-free Walking Distance and Other Endpoints|Completed||Phase 4|150|Actual|Fadoi Foundation, Italy||4|||f||||t||||||||||2017-10-11 02:20:52.643128|2017-10-11 02:20:52.643128
NCT01718275|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2016-08-18|||October 2012||2012-10-01|August 2016|2016-08-01|February 2024|Anticipated|2024-02-01|February 2014|Actual|2014-02-01||Observational|||Non-operative Management of Early Appendicitis in Children|Non-operative Management of Early Appendicitis in Children|Active, not recruiting||N/A|102|Actual|Nationwide Children's Hospital|||2||f||||f||||||||No||2017-10-11 02:20:52.761767|2017-10-11 02:20:52.761767
NCT01718262|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-11-14|||April 2010||2010-04-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|||||Observational|||Study Measuring Total Plasma Ropivacaine Levels During Continuous Peripheral Nerve Catheter Infusion|Study Measuring Total Plasma Ropivacaine Levels During Continuous Peripheral Nerve Catheter Infusion|Completed||N/A|49|Actual|Defense and Veterans Center for Integrative Pain Management|||1||f||||f||||||Samples Without DNA|"     The plasma ropivacaine samples will be assayed at the Department of Research Programs     Laboratory (DRP) at WRNMMC. Once the whole blood sample has been centrifuged, the plasma will     be removed with a glass pipette, placed in a storage container. The blood samples will be     labeled with a non sequential serial number and will not include the time of the blood draw.     This will blind the DRP laboratory to the patient's identity and timing of the blood draw.   "|||2017-10-11 02:20:52.836828|2017-10-11 02:20:52.836828
NCT01718249|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2013-10-11|||April 2012||2012-04-01|October 2013|2013-10-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|Post-coma DBS||Study of Conscious Behavior Under Low-frequency Deep Brain Stimulation in Chronic and Severe Post-coma Disorders of Consciousness|Study of Conscious Behavior Under Low-frequency Deep Brain Stimulation in Chronic and Severe Post-coma Disorders of Consciousness|Unknown status|Recruiting|N/A|4|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 02:20:52.903496|2017-10-11 02:20:52.903496
NCT01718236|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-07-22|||September 2012||2012-09-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|RocSugIO||Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section|Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section|Completed||Phase 4|500|Actual|Brno University Hospital||2|||f||||t||||||||||2017-10-11 02:20:52.991332|2017-10-11 02:20:52.991332
NCT01718223|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-09-02|||December 2013||2013-12-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer|A Pilot Study of Interstitial Photodynamic Therapy for Recurrent Squamous Cell Carcinoma of the Oropharynx and Oral Cavity|Withdrawn||N/A|0|Actual|Roswell Park Cancer Institute||1||implementation issues|f||||t||||||||||2017-10-11 02:20:53.090484|2017-10-11 02:20:53.090484
NCT01718210|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-04-25|||December 2012||2012-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure|GM-CSF Supplemented Medium for IVF Embryo Growth in Patients With Recurrent Implantation Failure|Completed||Phase 4|100|Actual|Centre for Endocrinology and Reproductive Medicine, Italy||2|||f||||t||||||||||2017-10-11 02:20:53.189726|2017-10-11 02:20:53.189726
NCT01718197|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-27|2016-06-01|||November 2012||2012-11-01|June 2016|2016-06-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Observational|SARP||Severe Asthma Research Program (SARP)- San Francisco Clinical Site|Clinical and Molecular Phenotypes of Severe Asthma|Active, not recruiting||N/A|749|Anticipated|University of California, San Francisco|||3||f||||t||||||Samples With DNA|"     Blood: CBC/Diff, Total IgE, Serum, Plasma, DNA, RNA Urine EBC Sputum: Supernatant, Cell     Pellet Bronchoscopy: BAL, Bronchial Brushings, Bronchial Biopsy   "|||2017-10-11 02:20:53.285118|2017-10-11 02:20:53.285118
NCT01718184|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-29|||October 2012||2012-10-01|July 2012|2012-07-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Interventional|||Piggyback Sulcoflex Toric IOL for Correcting Refractive Error Following Corneal Transplantation||Unknown status|Recruiting|N/A|25|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-11 02:20:53.368112|2017-10-11 02:20:53.368112
NCT01718171|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-29|||January 2011||2011-01-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Observational|||Inflammatory Response in Appendicitis|Progression of the Systemic Inflammatory Response in Patients With Appendicitis|Completed||N/A|183|Actual|Cirujanos la Serena|||1||f||||f||||||||||2017-10-11 02:20:53.493988|2017-10-11 02:20:53.493988
NCT01718158|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-09-23||2015-09-23|January 2013||2013-01-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|STRUCTURE||Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy|A Phase 3 Evaluation of Daclatasvir in Combination With Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination With Peginterferon Alfa-2a and RBV in Patients With Chronic Hepatitis C Genotype 1b Who Are Treatment naïve or Prior Relapsers to Alfa/RBV Therapy (the STRUCTURE Study)|Completed||Phase 3|444|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 02:20:53.580915|2017-10-11 02:20:53.580915
NCT01718145|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2015-09-23||2015-09-23|November 2012||2012-11-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects|A Phase 3, Comparative Study of Asunaprevir and Daclatasvir (DUAL) Combination Therapy Versus Telaprevir Therapy in Japanese Genotype 1b Chronic Hepatitis C IFN Eligible-naive Subjects With a Single Arm Assessment of DUAL Therapy in IFN-therapy Relapsers|Completed||Phase 3|258|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 02:20:53.867181|2017-10-11 02:20:53.867181
NCT01718132|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-27|2012-10-30|||January 2009||2009-01-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Observational|||Reduction of Postoperative Pain, Nausea and Vomiting|Reduction of Postoperative Pain, Nausea and Vomiting|Completed||N/A|16309|Actual|Triemli Hospital|||1||f||||f||||||||||2017-10-11 02:20:54.116855|2017-10-11 02:20:54.116855
NCT01718119|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2013-08-12|||February 2012||2012-02-01|August 2013|2013-08-01||||February 2013|Actual|2013-02-01||Interventional|DA-3803||Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel|Phase III Clinical Trial Comparing the Efficacy and Safety of DA-3803(Recombinant Human Chorionic Gonadotrophin) and Ovidrel for Inducting Final Follicular Maturation and Early Luteinization in Women Undergoing Ovulation|Completed||Phase 3|180|Actual|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:20:54.16743|2017-10-11 02:20:54.16743
NCT01718106|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-27|2015-03-25|||March 2014||2014-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|ROCCO||Single Long vs Two Short Overlapping Bioabsorbable Polymer DES|Randomized Study to Evaluate Segmental Late Loss Comparing Two PCI Strategies Using a Long Stent vs 2 Shorter Stents to Treat Long or Tandem Coronary Stenosis.|Unknown status|Recruiting|N/A|300|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita||2|||f||||t||||||||||2017-10-11 02:20:54.260321|2017-10-11 02:20:54.260321
NCT01718093|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-04-21|||October 2012|Actual|2012-10-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes|A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes Mellitus|Completed||Phase 4|21|Actual|Baylor College of Medicine||3|||f||||t||||||||No||2017-10-11 02:20:54.49065|2017-10-11 02:20:54.49065
NCT01718080|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2017-04-21|||October 2012|Actual|2012-10-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Observational|||The Effects of Puberty and Weight on Sugar Metabolism in Children|The Role of Puberty and Insulin Resistance in the Development of Hyperglucagonemia|Completed||N/A|83|Actual|Baylor College of Medicine|||4||f||||f|f|f||||Samples Without DNA|"     plasma   "|No||2017-10-11 02:20:54.606822|2017-10-11 02:20:54.606822
NCT01718067|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2014-12-09|||January 2013||2013-01-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy of Vakum Technology in Patients With Chronic Hypersecretion|Efficacy of Vakum Technology in Patients With Chronic Hypersecretion.|Unknown status|Recruiting|N/A|100|Anticipated|Villa Pineta Hospital||2|||f||||f||||||||||2017-10-11 02:20:54.708182|2017-10-11 02:20:54.708182
NCT01718054|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-07-26|||August 2012||2012-08-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|V-FIT||Vascular Function Intervention Trial in Sickle Cell Disease|Development of a Ready-to-use Nutraceutical Food for Patients With Sickle Cell Disease (SCD): Testing of Vascular Support Components|Active, not recruiting||Phase 2/Phase 3|120|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 02:20:54.846709|2017-10-11 02:20:54.846709
NCT01718041|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-08-05|||October 2012||2012-10-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|VERTICAL||Versartis Trial in Children to Assess Long-Acting Growth Hormone|A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months|Completed||Phase 1/Phase 2|64|Actual|Versartis Inc.||1|||f||||f||||||||||2017-10-11 02:20:54.985038|2017-10-11 02:20:54.985038
NCT01718028|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2013-11-15|2013-11-15||September 2012||2012-09-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects|The Effect of SYSTANE® BALANCE on Non-Invasive Tear Film Break Up Time (NITFBUT) in Dry Eye Subjects With Lipid Deficiency Following 30 Days of Use|Completed||N/A|51|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:20:55.175919|2017-10-11 02:20:55.175919
NCT01718015|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2012-10-29|||November 2012||2012-11-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy|Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy|Unknown status|Not yet recruiting|N/A|70|Anticipated|Aarhus University Hospital|||5||f||||t||||||Samples With DNA|"     Cerebrospinal fluid, plasma and serum   "|||2017-10-11 02:20:55.549392|2017-10-11 02:20:55.549392
NCT01718002|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2012-11-08|||November 2011||2011-11-01|November 2012|2012-11-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Effect of the Use of Simulation (Video) on the Oral Hygiene|Effect of the Use of Simulation (Video) on the Oral Hygiene of People Undergoing Chemotherapy|Unknown status|Active, not recruiting|N/A|24|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 02:20:55.672388|2017-10-11 02:20:55.672388
NCT01717989|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-11-25|2013-11-25||June 2010||2010-06-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|STEPPS™||Study to Evaluate the Prospective Payment System|Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations|Completed||N/A|2248|Actual|Amgen|||1||f||||f||||||||||2017-10-11 02:20:55.804883|2017-10-11 02:20:55.804883
NCT01717976|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-06-22|2017-03-30||December 2013||2013-12-01|June 2017|2017-06-01|November 2016|Actual|2016-11-01|March 2016|Actual|2016-03-01||Interventional|DISPO ED||Discharge Information and Support for Patients Receiving Outpatient Care in the Emergency Department|Discharge Information & Support for Patients Receiving Outpatient Care in the ED|Completed||N/A|513|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 02:20:57.065972|2017-10-11 02:20:57.065972
NCT01717963|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2016-03-22|||October 2012||2012-10-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|NTX-SBX||Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway|Optimal Prevention of Overdose Deaths and Opioid Relapse Following Discharge: A Multi-Center RCT of Naltrexone Versus Buprenorphine in Norway|Active, not recruiting||Phase 3|166|Actual|University of Oslo||2|||f||||f||||||||||2017-10-11 02:20:57.502461|2017-10-11 02:20:57.502461
NCT01717950|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-05-30|||September 2013||2013-09-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of Na-APR-1 (M74)/Alhydrogel® in Healthy Adults|Completed||Phase 1|40|Actual|Baylor College of Medicine||6|||f||||t||||||||||2017-10-11 02:20:57.618276|2017-10-11 02:20:57.618276
NCT01717937|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2014-09-03|||February 2013||2013-02-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|PVOCT||Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging|Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in the Imaging of Retinovascular Disease|Terminated||N/A|10|Actual|University of California, San Francisco|||1|insufficient enrollment|f||||f||||||||||2017-10-11 02:20:57.705528|2017-10-11 02:20:57.705528
NCT01717924|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-03-02|||October 2012|Actual|2012-10-01|March 2017|2017-03-01|April 2024|Anticipated|2024-04-01|April 2021|Anticipated|2021-04-01||Interventional|ADCI002||Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma|Multicenter Randomized Controlled Trial to Evaluate the Strategy of Primary Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma (ADCI002 Study)|Recruiting||N/A|314|Anticipated|University Hospital, Lille||2|||f||||t||||||||||2017-10-11 02:20:57.807394|2017-10-11 02:20:57.807394
NCT01717911|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2012-10-28|||September 2010||2010-09-01|July 2010|2010-07-01|December 2018|Anticipated|2018-12-01|December 2013|Anticipated|2013-12-01||Interventional|||ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia|ß-Cell Function and Glycemic Control of Basal Insulin, Metformin or Sitagliptin in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia|Recruiting||Phase 4|160|Anticipated|Taipei Veterans General Hospital, Taiwan||3|||f||||f||||||||||2017-10-11 02:20:57.89442|2017-10-11 02:20:57.89442
NCT01717898|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-07-25|||January 31, 2013|Actual|2013-01-31|July 2017|2017-07-01|August 29, 2016|Actual|2016-08-29|September 3, 2013|Actual|2013-09-03||Interventional|||A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer|A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer|Terminated||Phase 1/Phase 2|6|Actual|University of California, San Francisco||1||Dose limiting toxicities on lowest dose level|f||||t||||||||||2017-10-11 02:20:57.993006|2017-10-11 02:20:57.993006
NCT01717885|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-10-26|||August 2012||2012-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Observational|||Antimalarial Pharmacology in Children and Pregnant Women in Uganda|Antimalarial Pharmacology in HIV Infected and Uninfected Children and Pregnant Women in Uganda|Completed||N/A|473|Actual|University of California, San Francisco|||9||f||||f||||||Samples With DNA|"     Samples are for drug level measurements,parasite density. RNA samples are for host     transcriptional and molecular markers of resistance. Samples are also retained for future use     including possible genetic testing for drug metabolism variants   "|Undecided||2017-10-11 02:20:58.108337|2017-10-11 02:20:58.108337
NCT01717872|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2017-02-10|2014-08-08||October 2012||2012-10-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparing the Laryngoscopy View Using Miller and Macintosh Laryngoscopy Blades in Infants Under Two Years of Age|Comparing the Laryngoscopy View Using Miller and Macintosh Laryngoscopy Blades in Infants Under Two Years of Age|Completed||N/A|50|Actual|State University of New York at Buffalo||2|||f||||f||||||||No||2017-10-11 02:20:58.199263|2017-10-11 02:20:58.199263
NCT01717859|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-05-23|||September 2014||2014-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|RASTS||Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab|Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab|Completed||Phase 4|53|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 02:20:58.503784|2017-10-11 02:20:58.503784
NCT01717846|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-05-09|||December 2012||2012-12-01|May 2016|2016-05-01|November 2014|Anticipated|2014-11-01|November 2013|Anticipated|2013-11-01||Interventional|RA||Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis|In Vivo Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and Antigen Presenting (APC) Cells in Rheumatoid Arthritis|Withdrawn||Phase 4|0|Actual|University of California, Los Angeles||2||The PI has left UCLA and we do not plan to pursue this study.|f||||f||||||||||2017-10-11 02:20:58.586039|2017-10-11 02:20:58.586039
NCT01717833|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2015-06-17|||November 2010||2010-11-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||The Role of NEMS for Post ICU Rehabilitation|The Role of Neuromuscular Electrical Stimulation as a Tool for Post ICU Rehabilitation|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|University of Athens||2|||f||||f||||||||||2017-10-11 02:20:58.716696|2017-10-11 02:20:58.716696
NCT01717820|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-10-30|||April 2012||2012-04-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Effect of Whole-grape Powder on Body Composition, Fat and Bone Serum Biomarkers in Postmenopausal Women|The Effect of Whole-grape Powder on Body Composition, Fat, and Bone Serum Biomarkers in Postmenopausal Women|Completed||N/A|40|Actual|Texas Woman's University||1|||f||||t||||||||||2017-10-11 02:21:00.373187|2017-10-11 02:21:00.373187
NCT01717807|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2012-10-28|||April 2013||2013-04-01|October 2012|2012-10-01||||April 2014|Anticipated|2014-04-01||Observational|EGFR; PET/CT||C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).||Unknown status|Not yet recruiting|N/A|30|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-10-11 02:21:00.565152|2017-10-11 02:21:00.565152
NCT01717794|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2012-11-05|||October 2012||2012-10-01|November 2012|2012-11-01||||October 2014|Anticipated|2014-10-01||Interventional|Thunder Endom||Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer|Prospective Randomized Trial on Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Endometrial Cancer FIGO Stage IB-II: Thunderbeat Technology Versus Standard Bipolar Electro-surgery.|Unknown status|Recruiting|N/A|36|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 02:21:00.65652|2017-10-11 02:21:00.65652
NCT01717781|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-28|2012-11-05|||October 2012||2012-10-01|November 2012|2012-11-01||||October 2014|Anticipated|2014-10-01||Interventional|Thunder Cervix||Thunderbeat Technology vs Standard Bipolar Electro Surgery in Laparoscopic Radical Hysterectomy and Pelvic Lymphadenectomy for Cervical Cancer|Prospective Randomized Trial on Laparoscopic Radical Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Early Stage Cervical Cancer (FIGO Stages IA2-IB1-IIA<2cm) and Advanced Stage Cervical Cancer (FIGO Stages IB2-IIA>2 Cm-IIB) Submitted to NACT With Complete Clinical Response: Thunderbeat Technology Versus Standard Bipolar Electro Surgery|Unknown status|Recruiting|N/A|26|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 02:21:00.763719|2017-10-11 02:21:00.763719
NCT01717768|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-12-14|2015-08-14||October 2012||2012-10-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Oral Testosterone for the Treatment of Hypogonadism|A Phase 2, Randomized, Double-blind, Dose Response Study of Oral Testosterone in Subjects With Hypogonadism|Completed||Phase 2|130|Actual|TesoRx Pharma, LLC||10|||f||||f||||||||||2017-10-11 02:21:00.907965|2017-10-11 02:21:00.907965
NCT01717755|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-11-17|||October 2011||2011-10-01|November 2015|2015-11-01|October 2017|Anticipated|2017-10-01|January 2017|Anticipated|2017-01-01||Interventional|BASICS||Basilar Artery International Cooperation Study|Basilar Artery International Cooperation Study|Recruiting||Phase 3|750|Anticipated|St. Antonius Hospital||2|||f||||t||||||||||2017-10-11 02:21:03.075795|2017-10-11 02:21:03.075795
NCT01717742|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-02-13|||December 2012||2012-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)|Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)|Recruiting||Phase 3|92|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 02:21:03.281424|2017-10-11 02:21:03.281424
NCT01717729|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-26|||January 2000||2000-01-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Hepatocellular Carcinoma Treated With Iodine-125 Implantation|Hepatocellular Carcinoma Treated With Radiofrequency Ablation With or Without Iodine-125 Implantation: A Prospective Study|Completed||Phase 3|136|Actual|The Second People's Hospital of GuangDong Province||2|||f||||t||||||||||2017-10-11 02:21:03.429429|2017-10-11 02:21:03.429429
NCT01717716|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-10-26|||June 2011||2011-06-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Sugars-containing Beverage and Food Intake in Children|Role of Sugars in Solution on Subjective Appetite and Short-term Food Intake in Normal Weight 9-14 Year Old Boys|Completed||N/A|15|Actual|Ryerson University||4|||f||||t||||||||||2017-10-11 02:21:03.506492|2017-10-11 02:21:03.506492
NCT01717703|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-10-29|||January 2010||2010-01-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Sugars-sweetened Commercial Beverages on Short-term Food Intake|Effect of Sugars-Sweetened Commercial Beverages on Short-Term Food Intake Regulation in Normal Weight and Overweight/Obese 9-14 Year Old Boys and Girls|Completed||N/A|55|Actual|Ryerson University||4|||f||||f||||||||||2017-10-11 02:21:03.601479|2017-10-11 02:21:03.601479
NCT01717690|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-02-20|||August 2013||2013-08-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of 2% Chlorhexidine Gluconate-Impregnated Bath Cloths to Prevent MRSA Colonization in Complex Continuing Care|Randomized Controlled Clinical Trial of 2% Chlorhexidine Gluconate-Impregnated Bath Cloths to Prevent MRSA Colonization on Complex Continuing Care Units of Baycrest Hospital|Completed||Phase 4|122|Actual|Baycrest||2|||f||||f||||||||||2017-10-11 02:21:03.687986|2017-10-11 02:21:03.687986
NCT01717677|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-02-07|||October 2012||2012-10-01|February 2017|2017-02-01|December 2030|Anticipated|2030-12-01|December 2029|Anticipated|2029-12-01||Interventional|PREFERE||"Evaluation of Four Treatment Modalities in Prostate Cancer With Low or Early Intermediate Risk"|"Preference Based Randomized Trial for Evaluation of Four Treatment Modalities in Prostate Cancer With Low or Early Intermediate Risk"|Active, not recruiting||N/A|7600|Anticipated|Association of Urogenital Oncology (AUO)||4|||f||||t||||||||||2017-10-11 02:21:03.783066|2017-10-11 02:21:03.783066
NCT01717664|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-07-27|||June 2013||2013-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|CEASE-MS||Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)|A Phase IIa Proof of Concept Study to Assess the Efficacy and Safety of Fixed Dose Combination RHB-104 as Add-On Therapy to Interferon Beta-1a in Patients Treated for Relapsing Remitting Multiple Sclerosis|Completed||Phase 2|18|Actual|RedHill Biopharma Limited||1|||f||||f||||||||||2017-10-11 02:21:03.902292|2017-10-11 02:21:03.902292
NCT01717651|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-01-15|||December 2011||2011-12-01|January 2016|2016-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Muscle Atrophy in Patients With Severe Sepsis|Muscle Atrophy in Patients With Severe Sepsis|Terminated||N/A|25|Actual|Ohio State University|||1|slow accrual made study completion unfeasible|f||||f||||||||||2017-10-11 02:21:04.026162|2017-10-11 02:21:04.026162
NCT01717638|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-12-29|2014-10-01||November 2012||2012-11-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional||Anaysis was done on the all enrolled population, ie, all subjects who have signed an informed consent, undergone screening procedure(s) and were randomized.|Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1|A Phase 3, Open Label, Multi-Center, Extension Study to Assess Antibody Persistence and Response to a Third or Fifth Dose of Novartis Meningococcal B Recombinant Vaccine in 4-Year-Old Children Who Previously Participated in Study V72P12E1|Completed||Phase 3|805|Actual|Novartis||13|||f||||f||||||||||2017-10-11 02:21:04.300064|2017-10-11 02:21:04.300064
NCT01717625|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-02-09|||November 2011||2011-11-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|BPD||The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia|The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia|Completed||Phase 2|72|Actual|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-11 02:21:08.201924|2017-10-11 02:21:08.201924
NCT01717612|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2012-11-02|||October 2012||2012-10-01|November 2012|2012-11-01||||April 2016|Anticipated|2016-04-01||Interventional|||A Prospective, Randomized Trial of Histoacryl Injection Versus Thrombin in the Control of Acute Gastric Variceal Bleeding|A Prospective, Randomized Trial of Histoacryl Injection Versus Thrombin in the Control of Acute Gastric Variceal Bleeding|Unknown status|Recruiting|Phase 3|62|Anticipated|National Science Council, Taiwan||2|||f||||f||||||||||2017-10-11 02:21:08.32436|2017-10-11 02:21:08.32436
NCT01717599|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2012-10-29|||August 2012||2012-08-01|October 2012|2012-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis||Unknown status|Recruiting|N/A|380|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:21:08.441025|2017-10-11 02:21:08.441025
NCT01717586|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-09-08|||August 2012||2012-08-01|July 2017|2017-07-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Pravastatin for Prevention of Preeclampsia|Pravastatin for the Prevention of Preeclampsia in High-Risk Women: A Phase I Pilot Study|Recruiting||Phase 1|40|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 02:21:08.561302|2017-10-11 02:21:08.561302
NCT01717573|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-06-10|||March 2012||2012-03-01|June 2017|2017-06-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||Deferred Stent Trial in STEMI|Randomised Controlled Study to Assess Whether Deferred Stenting in Acute STEMI Patients Might Reduce the Incidence of No-reflow Versus Conventional Treatment With Immediate Stenting|Completed||N/A|101|Actual|NHS National Waiting Times Centre Board||2|||f||||t||||||||||2017-10-11 02:21:08.746379|2017-10-11 02:21:08.746379
NCT01717560|ClinicalTrials.gov processed this data on October 10, 2017|2008-04-29|2012-10-25|||February 2005||2005-02-01|October 2012|2012-10-01|December 2020|Anticipated|2020-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Hepatitis C Treatment in Underserved Populations|Hepatitis C Treatment in Underserved Populations|Enrolling by invitation||N/A|30|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 02:21:08.88149|2017-10-11 02:21:08.88149
NCT01717534|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2013-08-26|||October 2012||2012-10-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Children Immune Functions|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Heat-treated Lactobacilli on Infections and Immune Status in Healthy Children|Completed||N/A|374|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 02:21:09.064918|2017-10-11 02:21:09.064918
NCT01717508|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-03-14|||October 2012||2012-10-01|March 2016|2016-03-01||||June 2018|Anticipated|2018-06-01||Interventional|||Neural Components Underlying the Treatment of Adolescent Depression|Examination of the Neural Components Underlying the Treatment of Adolescent Major Depression|Recruiting||N/A|112|Anticipated|Mclean Hospital||2|||f||||f||||||||||2017-10-11 02:21:09.222895|2017-10-11 02:21:09.222895
NCT01717495|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-30|2013-05-04|||April 2013||2013-04-01|May 2013|2013-05-01|April 2016|Anticipated|2016-04-01|April 2014|Anticipated|2014-04-01||Observational|||Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures|Thromboembolic Complications Associated With Pacemaker or Implantable Cardioverter-Defibrillator Procedures: a Prospective Registry|Unknown status|Recruiting|N/A|1|Anticipated|University of Sao Paulo|||2||f||||t||||||Samples Without DNA|"     Blood Fibrinogen, D Dimer, Antithrombin, Prothrombin fragment 1 +2, thromboxane B, Platelets,     Plasminogen   "|||2017-10-11 02:21:09.303264|2017-10-11 02:21:09.303264
NCT01717482|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-03-01|||October 2012||2012-10-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer|A Pilot Study of Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|100|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:21:09.403683|2017-10-11 02:21:09.403683
NCT01717469|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-30|2012-11-05|||June 2012||2012-06-01|November 2012|2012-11-01|June 2017|Anticipated|2017-06-01|June 2015|Anticipated|2015-06-01||Interventional|SAFE-LVPACE||Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias|Randomized Clinical Study to Assess the Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias|Unknown status|Recruiting|Phase 4|12|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:21:09.509842|2017-10-11 02:21:09.509842
NCT01717456|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-15|2017-02-16|2016-05-16||January 2013||2013-01-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|FIX|The baseline analysis population is limited to patients who were randomized after referral to Home Health Care.|Educational-Medical-Behavioral Treatment of Fecal Incontinence|Conservative Treatment of Fecal Incontinence: Community-Based Effectiveness Trial|Terminated||N/A|31|Actual|University of North Carolina, Chapel Hill|Early termination leading to small numbers of subjects analyzed.|2||Low enrollment led sponsor to terminate study early.|f||||f||||||||No|Insufficient data to be analyzed by an outside investigator.|2017-10-11 02:21:09.671418|2017-10-11 02:21:09.671418
NCT01717443|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-10-24|||February 2012||2012-02-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Observational|||Genital HPV Infections Before and After Renal Transplantation|The Incidence, Prevalence and Genotype of Genital Human Papillomavirus Infections in Females Before and After Renal Transplantation|Completed||N/A|65|Actual|University Medical Center Nijmegen|||1||f||||f||||||||||2017-10-11 02:21:11.070587|2017-10-11 02:21:11.070587
NCT01717430|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-12-10|||October 2012||2012-10-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|||Metabolic and Endocrine Effects of Repeated Epidural and Sacroiliac Joint Corticosteroid Injections|Repeated Epidural and Sacroiliac Joint Glucocorticoid Injections and Their Effect on Hypothalamic-Pituitary-Adrenal Axis Suppression and Metabolic Status|Unknown status|Recruiting|N/A|126|Anticipated|University of Manitoba|||1||f||||f||||||||||2017-10-11 02:21:11.2865|2017-10-11 02:21:11.2865
NCT01717417|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2013-12-09|||September 2011||2011-09-01|December 2013|2013-12-01||||December 2013|Anticipated|2013-12-01||Observational|||Three Dimensional Movement Analysis of Maxillary Impacted Canine: a Randomized Clincial Trial|Three Dimensional Movement Analysis of Maxillary Impacted Canine Using TADs: a Randomized Clinical Trial|Unknown status|Recruiting|N/A|20|Anticipated|University of Genova|||1||f||||f||||||||||2017-10-11 02:21:11.392261|2017-10-11 02:21:11.392261
NCT01717404|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2013-09-30|||October 2012||2012-10-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)|Effects of Mexiletine on Colonic Transit in a Patient With a Known SCN5A A997T Mutation|Completed||Phase 1|1|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:21:11.464791|2017-10-11 02:21:11.464791
NCT01717391|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-08-01|2017-06-30||October 2012||2012-10-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|February 2016|Actual|2016-02-01||Interventional|||[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers|Improving Pelvic Cancer Patient Chemoradiotherapy Outcomes With FLT PET Imaging|Completed||Phase 2|36|Actual|University of Iowa||1|||f||||t|t|f||||||||2017-10-11 02:21:11.556736|2017-10-11 02:21:11.556736
NCT01717378|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-03-09|||March 2012||2012-03-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01|4 Years|Observational [Patient Registry]|||UCSF Research Participant Registry|Facilitating Enrollment Into UCSF Clinical Studies Via a Volunteer Research Participant Registry|Terminated||N/A|1541|Actual|University of California, San Francisco|||1|"This is a voluntary registry formerly managed by a unit within CTSI that was disbanded in 2013.   The registry has been dormant since that time."|f||||f||||||||||2017-10-11 02:21:12.362246|2017-10-11 02:21:12.362246
NCT01717352|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-01-03|||September 2012||2012-09-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Sleep Plus Eating Routines for Weight Loss|Increasing Sleep Duration: A Novel Approach to Weight Control. Study 5-Randomized Trial of Sleep Plus Eating Routines as An Approach to Prepare Participants for Weight Loss|Completed||Phase 2|90|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 02:21:12.503418|2017-10-11 02:21:12.503418
NCT01717326|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-03-01|2016-02-16||February 2013||2013-02-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|C-WORTHy|Full Analysis Set (FAS); all randomized participants who received ≥1 dose of study treatment.|A Study of the Combination Regimen Grazoprevir (MK-5172) and Elbasvir (MK-8742) ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)|A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin (RBV) in Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 2|573|Actual|Merck Sharp & Dohme Corp.||20|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:21:12.77478|2017-10-11 02:21:12.77478
NCT01717313|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2016-06-10|2016-05-09||December 2012||2012-12-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)|A Multicenter, Phase III, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of MK-3102 Monotherapy in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control|Completed||Phase 3|329|Actual|Merck Sharp & Dohme Corp.|Care must be taken in the interpretation of the results in this study as the non-protocol-specified prohibited use of metformin among a number of participants may have impacted the safety and efficacy results disproportionally among study arms.|2|||f||||t||||||||||2017-10-11 02:21:17.461952|2017-10-11 02:21:17.461952
NCT01717300|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-04-13|||November 6, 2012|Actual|2012-11-06|April 2017|2017-04-01|October 29, 2014|Actual|2014-10-29|October 29, 2014|Actual|2014-10-29||Interventional|||A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021)|A 24-Week, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Statin Therapy With or Without Other Lipid Modifying Medication(s) in Patients With Hypercholesterolemia or Low HDL-C|Completed||Phase 3|459|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 02:21:18.214765|2017-10-11 02:21:18.214765
NCT01717287|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-02-14|2014-06-30||November 2012||2012-11-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)|A Phase II, Multicenter, Open-Label, Noncomparative Study of Raltegravir (MK-0518) in Two Oral Formulations in Combination With Other Antiretroviral Agents to Evaluate the Safety, Tolerability, and Antiretroviral Activity in HIV-1 Infected Russian Children and Adolescents|Completed||Phase 2|32|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:21:18.317645|2017-10-11 02:21:18.317645
NCT01717274|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2016-04-13|||November 2012||2012-11-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|HSI||Hot Saline Irrigation Study|Hot Saline Irrigation vs Room Temperature Saline Irrigation in the Control of Intraoperative Bleeding During Functional Endoscopic Sinus Surgery (FESS)|Completed||N/A|60|Actual|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 02:21:18.697501|2017-10-11 02:21:18.697501
NCT01717261|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-04-23|||August 2012||2012-08-01|April 2015|2015-04-01|May 2019|Anticipated|2019-05-01|May 2016|Anticipated|2016-05-01||Interventional|SPORT||Single Pre-Operative Radiation Therapy (SPORT) for Low Risk Breast Cancer||Recruiting||Phase 1|10|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||||2017-10-11 02:21:18.77247|2017-10-11 02:21:18.77247
NCT01717248|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2013-06-19|||January 2013||2013-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety Study of GCS-100 to Treat Chronic Kidney Disease|A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease|Completed||Phase 1|29|Actual|La Jolla Pharmaceutical Company||1|||f||||f||||||||||2017-10-11 02:21:18.844966|2017-10-11 02:21:18.844966
NCT01717235|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2012-10-26|||September 2008||2008-09-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions|AN OPEN LABEL, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, CROSSOVER, BIOEQUIVALENCE STUDY OF ROPINIROLE HYDROCHLORIDE CR 2mg TABLETS OF LUPIN LIMITED, INDIA, COMPARING WITH THAT OF REQUIP XL OF GLAXOSMITHKLINE RESEARCH TRIANGLE PARK, IN HEALTHY ADULT MALE SUBJECTS|Completed||Phase 1|12|Actual|Lupin Ltd.||2|||f||||t||||||||||2017-10-11 02:21:18.924939|2017-10-11 02:21:18.924939
NCT01717222|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-29|||December 2011||2011-12-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy|Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy - A Randomized Clinical Trial|Completed||Phase 4|50|Actual|Jawaharlal Institute of Postgraduate Medical Education & Research||2|||f||||t||||||||||2017-10-11 02:21:18.995737|2017-10-11 02:21:18.995737
NCT01717196|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-10-26|||October 2012||2012-10-01|October 2012|2012-10-01||||October 2012|Actual|2012-10-01||Interventional|expect fna||Diagnostic Accuracy of FNA: is Aspiration- Related?|Diagnostic Accuracy of FNA (Fine Needle Aspiration) on Solid Pancreatic Lesions: is Aspiration- Related?|Unknown status|Active, not recruiting|N/A|100|Anticipated|The Mediterranean Institute for Transplantation and Advanced Specialized Therapies||1|||f||||t||||||||||2017-10-11 02:21:19.374107|2017-10-11 02:21:19.374107
NCT01717183|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-04-10|||April 2013||2013-04-01|April 2014|2014-04-01||||||||Interventional|||Assessment of the Efficacy and Safety of a New Wound Dressing in the Local Treatment of Diabetic Foot Ulcers|Assessment of the Efficacy and Safety of a New Wound Dressing in the Local Treatment of Diabetic Foot Ulcers: a Prospective, Randomised, Controlled, Double-blind, European Multicentre Clinical Trial|Unknown status|Recruiting|N/A|||Laboratoires URGO||2|||f||||||||||||||2017-10-11 02:21:19.452907|2017-10-11 02:21:19.452907
NCT01717170|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-04-26|||March 2013||2013-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|STOP-Uveitis||Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study|Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study|Active, not recruiting||Phase 1/Phase 2|36|Anticipated|University of Nebraska||2|||f||||f||||||||||2017-10-11 02:21:19.53495|2017-10-11 02:21:19.53495
NCT01717157|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-03-05|||August 2012||2012-08-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Volunteers|An Open-Label, Randomized, 4-Way Crossover Study to Assess the Relative Bioavailability of 4 New Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Subjects|Completed||Phase 1|32|Actual|Janssen Research & Development, LLC||8|||f||||||||||||||2017-10-11 02:21:19.61002|2017-10-11 02:21:19.61002
NCT01717144|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-05-10|||December 2008||2008-12-01|May 2017|2017-05-01|April 2011|Actual|2011-04-01|December 2008|Actual|2008-12-01||Interventional|ETPARK||Education in Therapy of Parkinson's Disease|EVALUATION OF A THERAPEUTIC EDUCATION PROGRAMME IN PARKINSON'S DISEASE|Completed||N/A|120|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 02:21:19.999802|2017-10-11 02:21:19.999802
NCT01717131|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-08-29|||July 2012||2012-07-01|August 2016|2016-08-01|July 2025|Anticipated|2025-07-01|July 2025|Anticipated|2025-07-01||Interventional|||Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node|A Non Inferiority Randomized Multicenter Phase III Trial of Axillary Node Dissection Versus no Axillary Node Dissection in Case of Positive Sentinel Lymph Node in Invasive Breast Cancer|Recruiting||Phase 3|3000|Anticipated|Institut Paoli-Calmettes||2|||f||||f||||||||||2017-10-11 02:21:20.070143|2017-10-11 02:21:20.070143
NCT01717118|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-03-26|||November 2009||2009-11-01|March 2015|2015-03-01|December 2017|Anticipated|2017-12-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico|Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico|Active, not recruiting||Phase 4|2000|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||f||||||||||2017-10-11 02:21:20.156078|2017-10-11 02:21:20.156078
NCT01717105|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2012-11-05|||March 2011||2011-03-01|November 2012|2012-11-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Observational|||Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients|Observational Post-authorization Prospective Study to Characterize the Incidence of Epidermal Growth Factor Receptor (EGFR) Mutation Positive and Advanced Non-small Cell Lung Cancer Patients and Their Clinical Management in Galicia|Unknown status|Active, not recruiting|N/A|225|Anticipated|Grupo Gallego de Cancer de Pulmon|||1||f||||t||||||None Retained|"     Tumor tissue Plasma samples   "|||2017-10-11 02:21:20.239525|2017-10-11 02:21:20.239525
NCT01717092|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2014-02-26|||October 2012||2012-10-01|February 2014|2014-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China||Unknown status|Recruiting|N/A|400|Anticipated|Fourth Military Medical University|||1||f||||t||||||||||2017-10-11 02:21:20.324959|2017-10-11 02:21:20.324959
NCT01717079|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-12-06|||May 2013||2013-05-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|STIMOREX||rTMS and Body Shape Perception|Effect of Transcranial Magnetic Stimulation on Disturbance of Body Shape Perception in Patients With Anorexia Nervosa|Recruiting||N/A|54|Anticipated|University Hospital, Rouen||2|||f||||||||||||||2017-10-11 02:21:20.401332|2017-10-11 02:21:20.401332
NCT01717066|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2016-03-30|||April 2012||2012-04-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|Rg3||the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma|A Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Study to Evaluate the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma|Completed||N/A|480|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 02:21:20.521652|2017-10-11 02:21:20.521652
NCT01717053|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2017-09-18|||January 17, 2014|Actual|2014-01-17|September 2017|2017-09-01|August 2021|Anticipated|2021-08-01|August 24, 2017|Actual|2017-08-24||Interventional|||Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer|A Phase II Trial of Abiraterone Acetate, Radiotherapy and Short-Term Androgen Deprivation in Men With Unfavorable Risk Localized Prostate Cancer|Active, not recruiting||Phase 2|37|Actual|Duke University||1|||f||||f||||||||||2017-10-11 02:21:20.629731|2017-10-11 02:21:20.629731
NCT01717040|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-11-30|2016-09-19||September 2012||2012-09-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Pioglitazone for the Treatment of Bipolar Depression|Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression|Terminated||Phase 4|37|Actual|University Hospitals Cleveland Medical Center||2||The study ended early due to budgetary issues|f||||t||||||||No||2017-10-11 02:21:20.804236|2017-10-11 02:21:20.804236
NCT01717027|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-08-28|||November 2012||2012-11-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers|Open Label, Single Dose, Randomized, Crossover Study To Evaluate The Pharmacokinetics And Relative Bioavailability Of Oxycodone Following Oral Administration Of 40 Mg Doses Of PF 00345439 Taken Whole Under Fed Conditions And After Chewing Under Fasted Conditions In Healthy Volunteers|Completed||Phase 1|19|Actual|Pain Therapeutics||4|||f||||f||||||||||2017-10-11 02:21:21.285126|2017-10-11 02:21:21.285126
NCT01717014|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-02-13|2015-02-13||May 2013||2013-05-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Radial Reload Open LAR Case Series|Evaluating the Radial Reload Stapler With Tri-Staple TM Technology During Open Low Anterior Resection for Rectal Cancer: A Prospective Multicenter Case Series|Terminated||N/A|8|Actual|Medtronic - MITG||1|||f||||f||||||||||2017-10-11 02:21:21.399109|2017-10-11 02:21:21.399109
NCT01717001|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2016-07-25|||August 2012||2012-08-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Observational|||Comparison of Knee Kinematics for Subjects Implanted With Either a ConforMIS or Traditional Knee Implant|In Vivo Determination & Comparison of Knee Kinematics for Subjects Implanted With Either a Personalized ConforMIS or Traditional Knee Implant|Recruiting||N/A|100|Anticipated|ConforMIS, Inc.|||2||f||||f||||||||No||2017-10-11 02:21:21.754963|2017-10-11 02:21:21.754963
NCT01716988|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-01-11|||October 2012||2012-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Observational|||Pharmacokinetics of Micafungin in Critically Ill Patients|Pharmacokinetics of Micafungin in Critically Ill Patients With Invasive Candidiasis|Completed||N/A|19|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-11 02:21:21.901301|2017-10-11 02:21:21.901301
NCT01716975|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-05-02|||October 2012||2012-10-01|June 2015|2015-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy|A Randomized, Double-blind, Placebo-controlled, Parallel, 26-Week, Phase 3 Study of 2 Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo as an Adjunctive Pro-cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy|Completed||Phase 3|767|Actual|FORUM Pharmaceuticals Inc||3|||f||||f||||||||||2017-10-11 02:21:22.009071|2017-10-11 02:21:22.009071
NCT01716949|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-08-09|||September 2012||2012-09-01|August 2017|2017-08-01|June 2023|Anticipated|2023-06-01|June 2022|Anticipated|2022-06-01||Interventional|HyRec||Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer|Multi-institutional Phase I/II Study: Neoadjuvant Chemoradiation With 5-FU (or Capecitabine) and Oxaliplatin Combined With Deep Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer|Recruiting||Phase 1/Phase 2|59|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-10-11 02:21:22.499069|2017-10-11 02:21:22.499069
NCT01716936|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-08-13|||July 2012||2012-07-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System|A Retrospective Multicenter Review of Early Onset Spinal Deformity Patients That Underwent Either a Primary or Revision Spinal Bracing Procedure With the Ellipse Technologies MAGEC Spinal Bracing and Distraction System|Completed||N/A|54|Actual|Ellipse Technologies, Inc.|||1||f||||f||||||||||2017-10-11 02:21:22.689312|2017-10-11 02:21:22.689312
NCT01716923|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-08-24|||April 2013||2013-04-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia|A Randomized Controlled Double-Blind Phase 3 Study to Assess Characteristics of S 303 Treated RBC Components and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia|Completed||Phase 3|81|Actual|Cerus Corporation||2|||f||||f||||||||||2017-10-11 02:21:22.820803|2017-10-11 02:21:22.820803
NCT01716910|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-29|||March 2011||2011-03-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effect of Synbiotic on Composition of Human Gut Microbiota and Production of Short and Branched-chain Fatty Acids||Completed||Early Phase 1|18|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:21:22.933393|2017-10-11 02:21:22.933393
NCT01716897|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2013-05-20|||October 2012||2012-10-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption|A Randomized, Open-label, 3-treatment Crossover Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption in Healthy Caucasian Male Adults|Completed||Phase 1|18|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-11 02:21:23.009061|2017-10-11 02:21:23.009061
NCT01716884|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2012-10-26|||December 2011||2011-12-01|October 2012|2012-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|||China STEMI-PCI Program|China STEMI-PCI Program|Unknown status|Recruiting|N/A|4000|Anticipated|Peking University First Hospital|||1||f||||t||||||||||2017-10-11 02:21:23.089685|2017-10-11 02:21:23.089685
NCT01716871|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-10-26|||September 2011||2011-09-01|October 2012|2012-10-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Interventional|TUNEMAS||The Using of NEurocryostimulation in Military Ankle Sprains|COMPARAISON D'EFFICACITÉ ENTRE LA CRYOTHÉRAPIE GAZEUSE HYPERBARE ET LA CRYOTHÉRAPIE CONVENTIONNELLE DANS LE TRAITEMENT DES ENTORSES EXTERNES DE LA CHEVILLE Étude randomisée auprès d'Une Population de Militaires|Unknown status|Recruiting|N/A|190|Anticipated|Direction Centrale du Service de Santé des Armées||2|||f||||f||||||||||2017-10-11 02:21:23.159875|2017-10-11 02:21:23.159875
NCT01716858|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-07-28|||October 2012||2012-10-01|October 2012|2012-10-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|||An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia|Sulforaphane-rich Broccoli Sprout Extract for Schizophrenia|Completed||Phase 2|10|Anticipated|Chiba University||1|||f||||t||||||||||2017-10-11 02:21:23.25277|2017-10-11 02:21:23.25277
NCT01716845|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2014-12-15|||October 2012||2012-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|SAGA||SynapDx Autism Gene Expression Analysis Study|SynapDx Autism Spectrum Disorder Gene Expression Analysis Study|Completed||N/A|660|Anticipated|SynapDx|||4||f||||f||||||Samples With DNA|"     DNA, RNA   "|||2017-10-11 02:21:23.331535|2017-10-11 02:21:23.331535
NCT01716832|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-29|||March 2011||2011-03-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Walking for Stress Reduction|Effectiveness of Mindfulness Walking on Stress Reduction|Completed||N/A|74|Actual|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 02:21:23.402414|2017-10-11 02:21:23.402414
NCT01716819|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2015-08-21|||November 2012||2012-11-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|R2C2-II||Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity|Role of the Renin Angiotensin Aldosterone System and Remodeling of the Matrix Cardiac Extra Cellular in the Mechanisms of Transition to Heart Failure in Abdominal Obesity: Prospective Longitudinal Study R2C2 II|Completed||N/A|101|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-10-11 02:21:23.468445|2017-10-11 02:21:23.468445
NCT01716078|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2016-01-28|||November 2011||2011-11-01|January 2016|2016-01-01||||September 2014|Actual|2014-09-01||Observational|||The Effect of Brachial Plexus Nerve Block on Distal Peripheral Nerve Conduction|The Effect of Brachial Plexus Nerve Block on Distal Peripheral Nerve Conduction|Withdrawn||N/A|0|Actual|Defense and Veterans Center for Integrative Pain Management|||1||f||||f||||||||||2017-10-11 02:21:40.073996|2017-10-11 02:21:40.073996
NCT01716806|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-09-01|||October 2012||2012-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)|A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) in Adults Age 60 and Above|Recruiting||Phase 2|100|Anticipated|Seattle Genetics, Inc.||4|||f||||f||||||||||2017-10-11 02:21:23.581315|2017-10-11 02:21:23.581315
NCT01716793|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-10-31|||September 1998||1998-09-01|October 2012|2012-10-01|November 2003|Actual|2003-11-01|September 1998|Actual|1998-09-01||Interventional|||Risk-adapted Therapy for Adult Acute Myeloid Leukemia.|Risk Adapted Treatment for Primary AML in Adults up to the Age of 60 Years.|Completed||Phase 2|354|Actual|Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias||1|||f||||t||||||||||2017-10-11 02:21:24.011497|2017-10-11 02:21:24.011497
NCT01716780|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-10-25|||January 2011||2011-01-01|October 2012|2012-10-01|October 2012|Anticipated|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Pain: Screen and Treat|Towards a Pain Free Hospital: Effect and Cost Effectiveness of Routine Screening and Treatment for Pain in Head and Neck Oncology Outpatients|Unknown status|Active, not recruiting|Phase 3|156|Actual|Royal Marsden NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:21:24.143104|2017-10-11 02:21:24.143104
NCT01716767|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2013-06-27|||December 2012||2012-12-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|IRMA||Acute Effect of Topical Menthol on Carpal Tunnel Syndrome|Acute Effect of Topical Menthol on Pain Symptoms in Slaughterhouse Workers With Symptoms of Carpal Tunnel Syndrome: Randomized Controlled Trial|Completed||N/A|10|Actual|National Research Centre for the Working Environment, Denmark||2|||f||||f||||||||||2017-10-11 02:21:24.225513|2017-10-11 02:21:24.225513
NCT01716754|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-08-07|2017-01-18||December 2012||2012-12-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Baseline characteristics were based on the FAS.|Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma|A Multi-center, Randomized, Double-blind, Placebo and Active-controlled Study With Exploratory Dose-ranging to Investigate the Efficacy and Safety of 16 Weeks Treatment With Subcutaneous (s.c.) QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists|Completed||Phase 2|471|Actual|Novartis||14|||f||||f||||||||||2017-10-11 02:21:24.367756|2017-10-11 02:21:24.367756
NCT01716741|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2012-10-26|||August 2012||2012-08-01|August 2012|2012-08-01||||August 2014|Anticipated|2014-08-01||Interventional|||Identification of Undiagnosed Gaucher Disease|Identification of Undiagnosed Gaucher Disease|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:21:25.91554|2017-10-11 02:21:25.91554
NCT01716728|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-26|2013-08-10|||August 2012||2012-08-01|August 2013|2013-08-01||||August 2014|Anticipated|2014-08-01||Interventional|||Identification of Undiagnosed Lysosomal Acid Lipase Deficiency|Identification of Undiagnosed Lysosomal Acid Lipase Deficiency|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 02:21:26.012317|2017-10-11 02:21:26.012317
NCT01716702|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2014-03-13|||November 2012||2012-11-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer|A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer|Unknown status|Recruiting|N/A|48|Anticipated|Nova Scotia Health Authority||2|||f||||t||||||||||2017-10-11 02:21:26.674854|2017-10-11 02:21:26.674854
NCT01716689|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2017-03-27|||June 2012|Actual|2012-06-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas|Phase II Clinical Study of Metronomic Oral Cyclophosphamide in Elderly and/or Pre-treated Patients With Advanced Sarcomas|Completed||Phase 2|24|Actual|National Cancer Centre, Singapore||1|||f||||f||||||||||2017-10-11 02:21:26.791031|2017-10-11 02:21:26.791031
NCT01716676|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-29|2014-12-08||||||October 2012|2012-10-01||||September 2014|Actual|2014-09-01||Interventional|||Telemedicine in Sleep Breathing Disorders: a Multicenter Study.||Completed||N/A|||Hospital Clinic of Barcelona||2|||f||||||||||||||2017-10-11 02:21:26.855821|2017-10-11 02:21:26.855821
NCT01716663|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2014-11-24|2014-11-24||October 2012||2012-10-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|IUAF|Enrolled|CARTO® 3 System and Real Time Intracardiac Ultrasound|CARTO® 3 System and Real Time Intracardiac Ultrasound for Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal AF: Acute Procedural Outcomes Study|Completed||N/A|234|Actual|Biosense Webster, Inc.|||1||f||||f||||||||||2017-10-11 02:21:26.934974|2017-10-11 02:21:26.934974
NCT01716650|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-04-10|||October 2012||2012-10-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||A Pilot Study to Evaluate the Contribution of the Saphenous Nerve in Ankle Pain of Patients With Degenerative Joint Disease of the Ankle|A Pilot Study to Evaluate the Contribution of the Saphenous Nerve in Ankle Pain of Patients With Degenerative Joint Disease of the Ankle|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Mayo Clinic|||1||f||||t||||||||||2017-10-11 02:21:27.872569|2017-10-11 02:21:27.872569
NCT01716637|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-05-10|||February 2010||2010-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|October 2015|Actual|2015-10-01||Interventional|||Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease|Open Label,Crossover,Pilot Study to Assess the Efficacy & Safety of Perispinal Admin.of Etanercept(Enbrel®) in Comb.w/Nutritional Supplements vs. Nutritional Supplements Alone in Subj. w/Mild to Mod. Alzheimer's Disease Receiving Std. Care.|Completed||Phase 1|12|Anticipated|Life Extension Foundation Inc.||2|||f||||f||||||||||2017-10-11 02:21:27.95734|2017-10-11 02:21:27.95734
NCT01716624|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-10-25|||May 2011||2011-05-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder|A Pilot Study Comparing the Effects of Botulinum Toxin A and Standard Oxybutynin Therapy as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder|Completed||Phase 3|20|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:21:28.097443|2017-10-11 02:21:28.097443
NCT01716611|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-29|||November 2012||2012-11-01|October 2012|2012-10-01|February 2014|Anticipated|2014-02-01|January 2014|Anticipated|2014-01-01||Interventional|TONIC||Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites|Efficacy and Safety Study of Tolvaptan for Liver Cirrhotic Patients With Hyponatremia and Ascites: A Multi-center, Randomized, Double-blind, Placebo-controlled 4-weeks Clinical Trial|Unknown status|Not yet recruiting|Phase 4|105|Anticipated|Konkuk University Medical Center||2|||f||||t||||||||||2017-10-11 02:21:28.20123|2017-10-11 02:21:28.20123
NCT01716598|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-09-22|||October 2012||2012-10-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|May 2014|Actual|2014-05-01||Interventional|IPS-II||Evaluation of the IPS System for TLD Therapy in Patients With COPD|IPS-II Study: Evaluation of the Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation (TLD) Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) - A Pilot Study.|Completed||Phase 1|15|Actual|Nuvaira, Inc.||1|||f||||t||||||||||2017-10-11 02:21:28.325436|2017-10-11 02:21:28.325436
NCT01716585|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2015-10-09|2014-12-23||November 2012||2012-11-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional||Safety population: all randomized participants who received at least 1 dose of blinded study drug|A Study to Evaluate Chronic Hepatitis C Infection|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered With Ribavirin (RBV) in Treatment-Naïve Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (SAPPHIRE-I)|Completed||Phase 3|636|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 02:21:28.42714|2017-10-11 02:21:28.42714
NCT01716572|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-10-07|||February 2012||2012-02-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopy in Patients With Upper Gastrointestinal Bleeding|Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopic Examination in Patients With Upper Gastrointestinal Bleeding. A Prospective Randomized Trial.|Unknown status|Active, not recruiting|Phase 3|122|Anticipated|Hospital Universitari de Bellvitge||2|||f||||f||||||||||2017-10-11 02:21:30.693735|2017-10-11 02:21:30.693735
NCT01716559|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-08-16|2016-01-11||August 2010||2010-08-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational||The Total population included all participants who met the inclusion and exclusion criteria and received at least one dose of study medication.|An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid Malignancy|Multicenter, Observational Study to Evaluate NeoRecormon Treatment in Anemic Patients Suffering From Non-myeloid Malignancy Receiving Chemotherapy|Completed||N/A|160|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:21:30.805646|2017-10-11 02:21:30.805646
NCT01716546|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-10-07|||July 2011||2011-07-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer|Phase I/II, Multicenter, Single-Arm Clinical Trial of Panitumumab in Combination With Cisplatin, Fluourouracil and Docetaxel (DCF) in Locally Advanced or Metastatic Cancer of the Stomach and Gastro-oesophageal Junction.|Terminated||Phase 1/Phase 2|51|Actual|Hellenic Oncology Research Group||1||Not reached the primary endpoint target according to the statistical design|f||||f||||||||||2017-10-11 02:21:31.09609|2017-10-11 02:21:31.09609
NCT01716533|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-01-16|||February 2013||2013-02-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)|A Serological Study in Adult Subjects With Clostridium Difficile Infection|Completed||N/A|57|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:21:31.220524|2017-10-11 02:21:31.220524
NCT01716520|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-11-18|2013-12-19||October 2012||2012-10-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg|A Randomized, Double-Blind, 3-Way, Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|182|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:21:31.489362|2017-10-11 02:21:31.489362
NCT01716507|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-12-09|||April 2008||2008-04-01|December 2016|2016-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||23 Gauge and 20 Gauge Vitrectomy for Rhegmatogenous Retinal Detachments|A Prospective, Randomized Study Comparing 23-gauge and 20-gauge Pars Plana Vitrectomy for Repair of Pseudophakic Rhegmatogenous Retinal Detachments|Completed||N/A|46|Actual|Wills Eye||2|||f||||f||||||||No||2017-10-11 02:21:32.190756|2017-10-11 02:21:32.190756
NCT01716494|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-06-23|||October 2012|Actual|2012-10-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|WU SARPIII||Washington University Severe Asthma Research Program III|Severe Asthma Research Program (SARP)-Washington University|Active, not recruiting||N/A|121|Actual|Washington University School of Medicine|||3||f||||t||||||Samples With DNA|"     whole blood, serum, plasma, DNA, RNA, sputum, urine, bronchial tissue, bronchoalveolar     lavage, bronchial brushings, exhaled breath condensate   "|||2017-10-11 02:21:32.326342|2017-10-11 02:21:32.326342
NCT01716481|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-04-24|||November 2012||2012-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|STARTING-2||The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study|Intravenous Administration of Autoserum-cultured Autologous Mesenchymal Stem Cells in Ischemic Stroke: A Single Center, Randomized, Open Label, Prospective, Phase 3 Study|Recruiting||Phase 3|60|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:21:32.42554|2017-10-11 02:21:32.42554
NCT01716468|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2016-04-09|2016-02-09||October 2012||2012-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Ketogenic Diet in Advanced Cancer|A Low-Carbohydrate Diet for Advanced or Metastatic Cancer|Completed||N/A|17|Actual|VA Pittsburgh Healthcare System||1|||f||||f||||||||||2017-10-11 02:21:32.553057|2017-10-11 02:21:32.553057
NCT01716455|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2014-01-02|2014-01-02||November 2012||2012-11-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function|A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function|Completed||Phase 1|66|Actual|Shire||6|||f||||f||||||||||2017-10-11 02:21:32.799382|2017-10-11 02:21:32.799382
NCT01716442|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2012-10-26|||August 2012||2012-08-01|October 2012|2012-10-01|November 2013|Anticipated|2013-11-01|September 2013|Anticipated|2013-09-01||Interventional|RTX2012||Rituximab Trial for Pediatric Nephrotic Syndrome|A Multi-center Randomized Controlled Trial of Rituximab for Refractory Nephrotic Syndrome in Children|Unknown status|Recruiting|Phase 2/Phase 3|88|Anticipated|Seoul National University Childrens Hospital||3|||f||||f||||||||||2017-10-11 02:21:33.396835|2017-10-11 02:21:33.396835
NCT01716429|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2013-09-19|||October 2012||2012-10-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|HER Health||Healthy Eating for Reproductive Health: Greenville|Healthy Eating for Reproductive Health: Greenville|Withdrawn||Phase 1|0|Actual|University of South Carolina||2||No participants were recruited over the course of the study time period|f||||f||||||||||2017-10-11 02:21:33.473589|2017-10-11 02:21:33.473589
NCT01716416|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-06-26|||May 31, 2013||2013-05-31|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|July 31, 2015|Actual|2015-07-31||Interventional|HNSCC||Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)|A Phase I Trial of Pazopanib Suspension Plus Cetuximab in Patients With Incurable Head and Neck Squamous Cell Carcinoma|Active, not recruiting||Phase 1|32|Actual|Washington University School of Medicine||5|||f||||t|t|f||||||No||2017-10-11 02:21:33.57694|2017-10-11 02:21:33.57694
NCT01716403|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-01-12|||October 2012||2012-10-01|January 2017|2017-01-01||||October 2014|Actual|2014-10-01||Observational|Ribatela||Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy|Influence of Telaprevir Exposure on the Severe Anemia Induced by Ribavirin/Pegylated Interferon/Telaprevir Tri-therapy in HCV Infected Patients|Terminated||N/A|8|Actual|University Hospital, Grenoble|||1||f||||f||||||Samples With DNA|"     plasma   "|||2017-10-11 02:21:33.696833|2017-10-11 02:21:33.696833
NCT01716390|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2012-10-26|||January 2011||2011-01-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Lipid-lowering Effect of Plant Stanol Drink|The Effect of Plant Stanol Drink on Serum Lipids in Comparison to Placebo in Subjects With Mildly to Moderately Elevated Serum Cholesterol Concentrations|Completed||N/A|56|Actual|Raisio Group||2|||f||||f||||||||||2017-10-11 02:21:33.891864|2017-10-11 02:21:33.891864
NCT01716377|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-04-12|||October 2012||2012-10-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|HELP||Healing With Venlafaxine After Injury (HELP)|Healing With Venlafaxine After Injury: A Randomized Clinical Trial of Venlafaxine Following Motor Vehicle Collision|Completed||Phase 2|20|Actual|Rhode Island Hospital||2|||f||||t||||||||No||2017-10-11 02:21:34.090826|2017-10-11 02:21:34.090826
NCT01716364|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2012-12-03|||January 2010||2010-01-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome|A Phase I Study Investigating Safety Immunological Effects of Peripheral Blood T Lymphocytes Transduced With Anti LewisY Chimeric Receptor Gene in LewisY Positive Myeloma, Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome|Unknown status|Active, not recruiting|Phase 1|6|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-11 02:21:34.235345|2017-10-11 02:21:34.235345
NCT01716351|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-24|||August 2007||2007-08-01|October 2012|2012-10-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||The Efficacy of Adapted Yoga in Managing Psychosocial Risk in Implantable Cardioverter Defibrillator (ICD) Patients|The Efficacy of Adapted Yoga in Managing Psychosocial Risk in Implantable Cardioverter Defibrillator (ICD) Patients|Completed||N/A|55|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:21:34.330103|2017-10-11 02:21:34.330103
NCT01716338|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-09-15|||January 2013||2013-01-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Glyburide Healthy Volunteer Study|Glyburide Healthy Volunteer Study|Completed||Phase 1|21|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:21:34.443955|2017-10-11 02:21:34.443955
NCT01716325|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-24|||February 2012||2012-02-01|October 2012|2012-10-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|||E-support for Healthcare Processes - WEIGHT LOSS|E-support for Healthcare Processes - WEIGHT LOSS|Unknown status|Recruiting|N/A|60|Anticipated|University of Primorska||2|||f||||f||||||||||2017-10-11 02:21:34.561835|2017-10-11 02:21:34.561835
NCT01716312|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-10-05|||October 2, 2012||2012-10-02|August 24, 2017|2017-08-24|August 24, 2017|Actual|2017-08-24|August 24, 2017|Actual|2017-08-24||Interventional|||Omalizumab for Lupus|A Phase 1b, Randomized, Double-Blind, Placebo Controlled Study With an Open Label Extension to Evaluate the Safety and Tolerability of Omalizumab, A Humanized IgG1 Monoclonal Antibody in Patients With Lupus (STOP LUPUS)|Completed||Phase 1|17|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:21:34.680686|2017-10-11 02:21:34.680686
NCT01716299|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2014-01-20|||December 2010||2010-12-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|July 2011|Actual|2011-07-01||Observational|||Comparison of HIV Testing Algorithms|Comparison of HIV Testing Algorithms in Two Sites in Ethiopia|Completed||N/A|495|Actual|Medecins Sans Frontieres, Netherlands|||1||f||||f||||||||||2017-10-11 02:21:34.780049|2017-10-11 02:21:34.780049
NCT01716286|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-05-10|||February 2012||2012-02-01|May 2016|2016-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Neural Correlates of an Olive Oil Essence||Completed||N/A|11|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-11 02:21:34.857712|2017-10-11 02:21:34.857712
NCT01716273|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-26|||June 2011||2011-06-01|October 2012|2012-10-01|October 2014|Anticipated|2014-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Use of White Granulated Sugar on Wounds|A Randomised Controlled Trial to Investigate the Clinical and Cost-effectiveness of White Granulated Sugar Dressing Compared With Standard Treatment in the Management of Exudating Wounds With Parallel Economic Evaluation|Unknown status|Recruiting|N/A|108|Anticipated|University Hospital Birmingham||2|||f||||f||||||||||2017-10-11 02:21:34.953371|2017-10-11 02:21:34.953371
NCT01716260|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-05-26|||January 2013||2013-01-01|April 2015|2015-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in Bhutan|Parasitic Clearance and Recurrence Rates Among Patients With Vivax Malaria on Chloroquine and Primaquine Therapy|Completed||N/A|24|Actual|Menzies School of Health Research|||1||f||||t||||||||||2017-10-11 02:21:35.086608|2017-10-11 02:21:35.086608
NCT01715909|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-10-02|||January 22, 2014|Actual|2014-01-22|October 2017|2017-10-01|May 26, 2018|Anticipated|2018-05-26|May 26, 2018|Anticipated|2018-05-26||Interventional|||A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection||Recruiting||Phase 1|20|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:21:42.590314|2017-10-11 02:21:42.590314
NCT01716247|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-06-06|||October 2012||2012-10-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer|Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer|Active, not recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:21:35.178591|2017-10-11 02:21:35.178591
NCT01716234|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-03-31|2016-03-15||April 17, 2008|Actual|2008-04-17|March 2017|2017-03-01|April 1, 2015|Actual|2015-04-01|April 1, 2015|Actual|2015-04-01||Interventional|||A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)|Phase 1B Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children With Neutropenia (P03579)|Terminated||Phase 1|142|Actual|Merck Sharp & Dohme Corp.|Only 1 participant was enrolled in the POS 12 TID 3 months to <2 years group, limiting conclusions that may be drawn for pharmacokinetics or safety.|7||"Study was terminated early (10 July 2015) based on preliminary analysis of pharmacokinetic   data."|f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:21:35.342745|2017-10-11 02:21:35.342745
NCT01716221|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-07-27|2016-03-11||October 2012||2012-10-01|July 2016|2016-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia|An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia|Completed||Phase 4|1|Actual|University of Colorado, Denver||4|||f||||||||||||||2017-10-11 02:21:37.548925|2017-10-11 02:21:37.548925
NCT01716208|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-07-05|||January 2013||2013-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma|Phase II Trial of Ofatumumab and Fresh Frozen Plasma in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 2|12|Actual|University of California, Davis||1|||f||||t||||||||||2017-10-11 02:21:37.867411|2017-10-11 02:21:37.867411
NCT01716195|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-05-01|||October 2012||2012-10-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|May 2015|Actual|2015-05-01||Interventional|||Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer|Phase II Trial Of Induction Chemotherapy Followed By Attenuated Chemoradiotherapy For Locally Advanced Head And Neck Squamous Cell Carcinoma Associated With Human Papillomavirus (HPV)|Active, not recruiting||Phase 2|50|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-10-11 02:21:38.118154|2017-10-11 02:21:38.118154
NCT01716182|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2014-07-08|||June 2012||2012-06-01|July 2014|2014-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|RAMP||RAMP Study: A Study Comparing Two Lumbar Fusion Procedures|RAMP Study: A Prospective Randomized Study Comparing Two Lumbar Fusion Procedures|Terminated||N/A|200|Anticipated|Baxano Surgical, Inc.|||2|Slow enrollment|f||||f||||||||||2017-10-11 02:21:38.237294|2017-10-11 02:21:38.237294
NCT01716169|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-04-01|2015-05-22||October 2012||2012-10-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care|Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care|Completed||N/A|10|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 02:21:38.365948|2017-10-11 02:21:38.365948
NCT01716156|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-02-24|2016-02-03||January 2013||2013-01-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||A Study of Different Durations of Treatment With Grazoprevir (MK-5172) in Combination With Ribavirin in Participants With Chronic Hepatitis C (MK-5172-039)|A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of MK-5172 in Combination With Ribavirin (RBV) in Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 2|26|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:21:38.627354|2017-10-11 02:21:38.627354
NCT01716143|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-10-25|||March 2010||2010-03-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation to Treat Chronic Atrial Fibrillation|Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation in the Treatment of Persistent and Long-standing Atrial Fibrillation|Unknown status|Recruiting|N/A|87|Anticipated|The First Affiliated Hospital with Nanjing Medical University||1|||f||||||||||||||2017-10-11 02:21:39.41528|2017-10-11 02:21:39.41528
NCT01716130|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-24|||October 2011||2011-10-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators|Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators|Completed||N/A|249|Actual|Touro University, California|||3||f||||t||||||||||2017-10-11 02:21:39.51132|2017-10-11 02:21:39.51132
NCT01716117|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-07-26|||October 2012||2012-10-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|July 28, 2017|Anticipated|2017-07-28||Interventional|SCENT||Safety and Effectiveness of an Intracranial Aneurysm Embolization System for Treating Large or Giant Wide Neck Aneurysms|The Surpass Intracranial Aneurysm Embolization System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms (SCENT Trial)|Active, not recruiting||N/A|180|Actual|Stryker Neurovascular||1|||f||||t||t|t|f||||||2017-10-11 02:21:39.604936|2017-10-11 02:21:39.604936
NCT01716091|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-01-06|||November 2012||2012-11-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Observational|||The Effect of Saline Irrigation in the Peritoneal Cavity at Cesarean Delivery|The Effect of Saline Irrigation in the Peritoneal Cavity at Cesarean Delivery on Maternal Morbidity and Gastrointestinal System Outcome|Completed||N/A|430|Actual|Istanbul Bakirkoy Maternity and Children Diseases Hospital|||1||f||||f||||||||||2017-10-11 02:21:39.941349|2017-10-11 02:21:39.941349
NCT01716065|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-04-29|||June 2012||2012-06-01|April 2014|2014-04-01||||May 2013|Actual|2013-05-01||Observational|CTC||Regional Anesthesia Versus General Anesthesia on Circulating Tumor Cells (CTC)|Impact of Regional Anesthesia Versus General Anesthesia on Immune Modulation and Clearance of Circulating Tumor Cells (CTC) in Subjects Undergoing Surgery for Primary Nonmetastatic Breast Cancer|Completed||N/A|12|Actual|Defense and Veterans Center for Integrative Pain Management|||1||f||||f||||||Samples Without DNA|"     Samples collected for CTC analysis (2 tubes of 8ml of blood) will be drawn at 4 time points:     pre-operative (at least 24 hours before surgery), immediate prior to surgery, 12-24 hours     post-operative, and 5-7 days post-operative.   "|||2017-10-11 02:21:40.156284|2017-10-11 02:21:40.156284
NCT01716052|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2015-12-01|2015-01-13||July 2012||2012-07-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Two sided significance level of 0.05 and a statistical power of 0.90 with 187 patients in both the placebo and the ibuprofen group..|Women's Mammography Study To Improve Comfort During Mammography|Women's Mammography Study Attempting to Improve the Comfort During Screening Mammography CTRC#11-45|Terminated||N/A|2|Actual|The University of Texas Health Science Center at San Antonio||2||Lack of funding.|f||||f||||||||||2017-10-11 02:21:40.265334|2017-10-11 02:21:40.265334
NCT01716039|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-03-21|||June 2013||2013-06-01|June 2015|2015-06-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|||Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)|A Study to Evaluate the Pharmacokinetics of Adalimumab in Combination With Methotrexate for the Treatment of Patients With Ulcerative Colitis|Enrolling by invitation||Phase 4|100|Anticipated|Western University, Canada||3|||f||||f||||||||||2017-10-11 02:21:40.567248|2017-10-11 02:21:40.567248
NCT01716026|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-03-27|||October 2012||2012-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BENEMCOR||Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia|Establishment of the Initial Protocol With Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization Associated With High Myopia:3 vs 1.|Active, not recruiting||Phase 3|110|Anticipated|Instituto Universitario de Oftalmobiología Aplicada||2|||f||||f||||||||||2017-10-11 02:21:40.675584|2017-10-11 02:21:40.675584
NCT01716013|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2016-11-17|2016-09-28||September 2012||2012-09-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional||Intent-to-treat (ITT) population|Safety and Efficacy Study of BondEase to Treat Traumatic Lacerations and Surgical Incisions|A Multi-Center, Prospective, Open-label, Randomized Study of the Safety and Efficacy of BondEase™ Topical Skin Adhesive for the Closure of Traumatic Lacerations and Surgical Incisions|Completed||N/A|162|Actual|OptMed, Inc.||2|||f||||t||||||||||2017-10-11 02:21:40.853523|2017-10-11 02:21:40.853523
NCT01716000|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2014-07-23|||January 2013||2013-01-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Optical Imaging and User Perception Study of Vaginal Gel|Optical Imaging and User Perception Study of Vaginal Gel|Completed||N/A|56|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:21:41.565813|2017-10-11 02:21:41.565813
NCT01715987|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-09-05|||October 2012||2012-10-01|June 2015|2015-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment|A Prospective and Open-Label Study of the Effect on Proximal Tubular Function in Asian-American Patients Receiving Tenofovir Disoproxil Fumarate (TDF) or Entecavir (ETV) for HBV Treatment|Terminated||N/A|48|Actual|New Discovery LLC|||2||f||||f||||||Samples With DNA|"     Blood Urine   "|||2017-10-11 02:21:41.657318|2017-10-11 02:21:41.657318
NCT01715974|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-04-25|||December 2012||2012-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Use of G-CSF Treatment in Recurrent Implantation Failure|Administration of G-CSF in Women With Recurrent Implantation Failure in IVF Cycles|Completed||Phase 3|140|Actual|Centre for Endocrinology and Reproductive Medicine, Italy||2|||f||||t||||||||||2017-10-11 02:21:41.756784|2017-10-11 02:21:41.756784
NCT01715961|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-10-04|||January 2012||2012-01-01|July 2016|2016-07-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|SARCOPENIE||Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma|Multicentric Prospective Study to Assess the Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma|Completed||N/A|98|Actual|Centre Henri Becquerel||1|||f||||t||||||||No||2017-10-11 02:21:41.831053|2017-10-11 02:21:41.831053
NCT01715948|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-03-07|2015-09-09||January 2013||2013-01-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Comparison Between Wireless CROS and Bone-anchored Hearing Devices for Single-Sided Deafness: A Pilot Study|A Comparison Between Wireless CROS and Bone-anchored Hearing Devices for Single-Sided Deafness: A Pilot Study|Completed||N/A|9|Actual|Nova Scotia Health Authority|The sample size was small and included only one male. The trial period of two weeks was short and may not have provided enough time for participants to adjust to the new CROS. The long-term benefit of both hearing devices needs to be assessed.|2|||f||||f||||||||Yes||2017-10-11 02:21:41.94591|2017-10-11 02:21:41.94591
NCT01715935|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-08-18|||June 2012||2012-06-01|February 2016|2016-02-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Interventional|NEORAD||Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus|A Comparison of Blood and Tissue Biomarkers Before and After Nephrectomy in the First-line Setting With Everolimus in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma|Completed||Phase 2|25|Actual|Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie||1|||f||||f||||||||No||2017-10-11 02:21:42.256301|2017-10-11 02:21:42.256301
NCT01715922|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-07-11|||May 2012||2012-05-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2015|Actual|2015-09-01||Interventional|Flucocrypto||Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa|Prospective Pilot Study to Evaluate a Standardized Management of Cryptococcal Meningitis in Patients Infected With HIV in Sub-Saharan Africa Involving an Initial Combination Therapy With Fluconazole and Flucytosine in High Doses, Complemented by Repeat Lumbar Punctures|Active, not recruiting||Phase 2/Phase 3|41|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 02:21:42.431805|2017-10-11 02:21:42.431805
NCT01713192|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-11-16|||January 2013||2013-01-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Registry for Perioperative Data in Patients Undergoing Cardiac Surgery||Completed||N/A|300|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 02:22:24.795579|2017-10-11 02:22:24.795579
NCT01715896|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-09-12|2016-03-08||March 2013||2013-03-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional||The modified intent to treat (mITT) population analysis set included all participants in the treatment group corresponding to their randomized treatment group.|A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis|A Phase 2 Exploratory Study of Mavrilimumab Versus Anti-tumor Necrosis Factor in Subjects With Rheumatoid Arthritis|Completed||Phase 2|215|Actual|MedImmune LLC|Non-compartmental analyses was not performed for pharmacokinetics parameters due to limited sampling schedule.|2|||f||||t||||||||||2017-10-11 02:21:42.839388|2017-10-11 02:21:42.839388
NCT01715883|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-08-21|||October 2011||2011-10-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction|Sodium Nitrite Administration at the Time of Lung Organ Procurement and Transplantation to Minimize the Risk of Pulmonary Graft Dysfunction|Terminated||Phase 2|3|Actual|University of Pittsburgh||1||Lack of support staff|f||||t||||||||||2017-10-11 02:21:44.26724|2017-10-11 02:21:44.26724
NCT01715870|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-10-07|||December 2012||2012-12-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Life Style and Food Habits Questionnaire in the Portuguese Population Aged 55 or More|Life Style and Food Habits Questionnaire in the Portuguese Population Aged 55 or More.|Completed||N/A|2000|Actual|Association for Innovation and Biomedical Research on Light and Image|||1||f||||f||||||||||2017-10-11 02:21:44.389824|2017-10-11 02:21:44.389824
NCT01715857|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-02|2014-08-15|2014-07-23||July 2012||2012-07-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Clinical Practice of Inhalation Anesthesia With Sevoflurane in China|A Multicenter Registry on the Clinical Practice of Inhalation Anesthesia With Sevoflurane in China|Completed||N/A|4100|Actual|AbbVie|||1||f||||||||||||||2017-10-11 02:21:44.495879|2017-10-11 02:21:44.495879
NCT01715844|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-06-29|||September 7, 2013|Actual|2013-09-07|June 2017|2017-06-01|June 1, 2017|Actual|2017-06-01|June 1, 2016|Actual|2016-06-01||Interventional|SANDIA||L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics|L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics|Completed||Phase 1|10|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:21:44.942043|2017-10-11 02:21:44.942043
NCT01715831|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-05-19|2017-05-19||January 15, 2013|Actual|2013-01-15|May 2017|2017-05-01|June 6, 2016|Actual|2016-06-06|June 6, 2016|Actual|2016-06-06||Interventional|RITACT|Intention to treat (ITT) population included all participants who received at least one dose of tocilizumab during the study.|A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488|A Multicenter, Open-Label, Single-Arm Extension Study to Describe the Safety of Tocilizumab Treatment In Brazilian Patients With DMARDs Refractory Rheumatoid Arthritis Which Completed Studies ML21530 and MA21488 and Presenting an Indication of Maintaining the Tocilizumab Treatment|Completed||Phase 4|26|Actual|Hoffmann-La Roche||1|||f|||||t|f|||t|||||2017-10-11 02:21:45.086003|2017-10-11 02:21:45.086003
NCT01715818|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-11-01|||December 2012||2012-12-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities|A PHASE 3B STUDY TO EVALUATE THE POTENTIAL OF ALEGLITAZAR TO REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH STABLE CARDIOVASCULAR DISEASE AND GLUCOSE ABNORMALITIES|Completed||Phase 3|1999|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:21:45.979967|2017-10-11 02:21:45.979967
NCT01715805|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-06-07|||November 2012||2012-11-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)|A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)|Active, not recruiting||Phase 3|1100|Anticipated|Forest Laboratories||2|||f||||f||||||||||2017-10-11 02:21:47.108013|2017-10-11 02:21:47.108013
NCT01715792|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2014-02-06|||October 2012||2012-10-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK|Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in the United Kingdom|Completed||N/A|587|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 02:21:47.451099|2017-10-11 02:21:47.451099
NCT01715779|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-04-06|||August 2012||2012-08-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies|An Observational Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies|Completed||N/A|22|Actual|Novartis|||1||f||||f||||||||||2017-10-11 02:21:47.532988|2017-10-11 02:21:47.532988
NCT01715766|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-03-23|||January 2012||2012-01-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2013|Actual|2013-10-01||Observational|VIPER||VIPER: Veterans Integrated Pain Evaluation Research|VIPER: Veterans Integrated Pain Evaluation Research- Molecular Subtypes of Chronic Pain Syndromes|Active, not recruiting||N/A|124|Actual|Defense and Veterans Center for Integrative Pain Management|||1||f||||f||||||Samples With DNA|"     Blood draw will consist of, two BD™ P100 tubes (2x8.5mL=17mL) where the plasma will be     separated by centrifuge then placed in a -80ºC freezer. Two RNA tubes (2 x 2.5mL=5mL) and one     DNA tube (8.5mL) will be place first, in a -20ºC freezer for 24-36 hours then moved to a     -80ºC freezer. All the blood samples will remain in a -80ºC freezer at the Department of     Clinical Investigation(DCI) laboratory until they are sent to Duke University after every 8     subjects.   "|||2017-10-11 02:21:47.611331|2017-10-11 02:21:47.611331
NCT01715753|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-06-19|||September 2012||2012-09-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MEASUR-UP||Measuring Eating, Activity and Strength: Understanding the Response -Using Protein|Does Enhanced Protein Intake Preserve Function and Lean Muscle Mass During Weight Reduction in Frail, Obese Older Adults?|Completed||N/A|71|Actual|Duke University||2|||f||||t||||||||||2017-10-11 02:21:47.683368|2017-10-11 02:21:47.683368
NCT01715727|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-08-03|||July 2012||2012-07-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Diagnosis of Parkinson's Disease Using Diffusion Magnetic Resonance Imaging|Diagnosis of Parkinson's Disease Using Diffusion Magnetic Resonance Imaging|Completed||N/A|284|Actual|Chang Gung Memorial Hospital|||5||f||||t||||||||||2017-10-11 02:21:47.895955|2017-10-11 02:21:47.895955
NCT01715714|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-05-11|||October 2012||2012-10-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|StaRT-CABG||Statin Recapture Therapy Before Coronary Artery Bypass Grafting|Statin Recapture Therapy Before Coronary Artery Bypass Grafting|Recruiting||Phase 4|2630|Anticipated|University of Cologne||2|||f||||t||||||||||2017-10-11 02:21:47.982585|2017-10-11 02:21:47.982585
NCT01715701|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2014-06-05|||January 2013||2013-01-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy of Paravertebral Nerve Blockade to Reduce Pain Following Thoracoscopy|Efficacy of Multilevel Thoracic Paravertebral Nerve Blockade to Reduce Postoperative Pain Following Video-assisted Thoracic Surgery|Completed||N/A|60|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||3|||f||||f||||||||||2017-10-11 02:21:48.155758|2017-10-11 02:21:48.155758
NCT01715688|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-01-28|||January 2013||2013-01-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy of Alkalinized Lidocaine in the Endotracheal Tube Cuff on the Incidence of Coughing During Emergence|Efficacy of Endotracheal Tube Cuffs Pre-filled With Alkalinized Lidocaine Compared to Endotracheal Tube Cuffs Filled With Saline on the Incidence of Coughing During Emergence of Anesthesia.|Completed||N/A|200|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 02:21:48.277013|2017-10-11 02:21:48.277013
NCT01715675|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2014-01-09|||October 2010||2010-10-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Plant Stanols on Immune Function in Asthma Patients|The Effect of Plant Stanols on the Immune Function of Asthma Patients|Completed||N/A|61|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:21:48.50689|2017-10-11 02:21:48.50689
NCT01715662|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-12-02|||January 2013||2013-01-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|February 2014|Actual|2014-02-01||Interventional|||A Pilot RCT to Investigate the Use of a Home-based Nintendo Wii Program for Rehabilitation in Older Adults With Lower Limb Amputation|WiiHOME-AMPS: A Pilot Randomized Controlled Trial to Investigate the Use of a Home-based Nintendo Wii Program for Rehabilitation in Older Adults With a Unilateral Transtibial or Transfemoral Amputation|Completed||N/A|28|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:21:48.593171|2017-10-11 02:21:48.593171
NCT01715649|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2014-11-17|||November 2012||2012-11-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes|Evaluation of a Telehealth Intervention Combining Structured Self-Monitoring of Blood Glucose and Nurse Care Coordination Among People With Type 2 Diabetes Noninsulin-Treated|Completed||N/A|90|Actual|Sutter Health||2|||f||||t||||||||||2017-10-11 02:21:48.704536|2017-10-11 02:21:48.704536
NCT01715636|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2015-01-08|||December 2012||2012-12-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|EPEP||Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men.|Safety, Tolerability, and Adherence to Co-formulated Emtricitabine-rilpivirine-tenofovir Used as HIV Nonoccupational Post Exposure Prophylaxis in Men Who Have Sex With Men (EPEP)|Completed||Phase 4|100|Actual|St Vincent's Hospital, Sydney||1|||f||||f||||||||||2017-10-11 02:21:48.788959|2017-10-11 02:21:48.788959
NCT01715623|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-10-06|||October 2012||2012-10-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|April 2013|Actual|2013-04-01||Observational|PRIERR||Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.|Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.|Completed||N/A|486|Actual|University Hospital, Limoges|||4||f||||f||||||Samples Without DNA|"     We previously showed that both antibody class switching (from IgM to IgG, IgA or IgE) and     antibody secretion are controlled by a polymorphic 3' regulatory region (3'RR) of the     immunoglobulin heavy chain (IgH) locus   "|||2017-10-11 02:21:48.87659|2017-10-11 02:21:48.87659
NCT01715610|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-10-24|||June 2012||2012-06-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|PTA||Assessing the Necessity of Prescribing Antibiotics (Clavulin or Clindamycin Versus Placebo) Post-peritonsillar Abscess Drainage|Comparing Post-drainage Treatment of Peritonsillar Abscesses With Antibiotics (Clavulin or Clindamycin) to Treating With Placebo - a Double-blinded Randomized Control Trial|Unknown status|Recruiting|N/A|120|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:21:48.953647|2017-10-11 02:21:48.953647
NCT01715597|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-12-24|||December 2012||2012-12-01|December 2013|2013-12-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma|Placebo-controlled,Doubled,Randomized Trial Evaluating the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women Undergoing Laparoscopic Myomectomy|Unknown status|Recruiting|Phase 3|50|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:21:49.069392|2017-10-11 02:21:49.069392
NCT01715584|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-08-22|||July 2012||2012-07-01|August 2017|2017-08-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics|Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics? - A Pilot Study. Optional Deoxyribo-Nucleic Acid Donation for the Study of Hypertension.|Recruiting||Phase 4|80|Anticipated|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-11 02:21:49.165019|2017-10-11 02:21:49.165019
NCT01715571|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2017-09-29|||March 2013|Actual|2013-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessment of Penile Vibratory Stimulation Using the Viberect in Men With Mild-Moderate and No Erectile Dysfunction|Clinical and Physiological Assessment of Noninvasive Penile Afferent Vibratory Stimulation of Both Surfaces of the Penis Using the Viberect® Device in Men With Mild to Moderate and No Erectile Dysfunction.|Recruiting||N/A|50|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:21:49.286753|2017-10-11 02:21:49.286753
NCT01713179|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-08-29|||August 2011||2011-08-01|August 2016|2016-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effects of Oral Mucolytics on Tear Film and Ocular Surface||Completed||Phase 1/Phase 2|20|Actual|Hallym University Kangnam Sacred Heart Hospital||2|||f||||f||||||||||2017-10-11 02:22:24.869981|2017-10-11 02:22:24.869981
NCT01715558|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-05-08|||February 2013||2013-02-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|OPTI-MIND 2||Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications OPTI-MIND 2|Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications|Completed||N/A|514|Actual|Boston Scientific Corporation|||2||f||||f||||||||||2017-10-11 02:21:49.383663|2017-10-11 02:21:49.383663
NCT01715545|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-25|||January 2011||2011-01-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Observational|Availability||Availability of Poor Quality Embryos|Availability of Poor Quality Embryos in Frozen-thawed Embryo Transfer Cycles|Completed||N/A|481|Actual|The Second Affiliated Hospital of Kunming Medical University|||2||f||||f||||||||||2017-10-11 02:21:49.557031|2017-10-11 02:21:49.557031
NCT01715532|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-12-16|||July 2012||2012-07-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase|Phase II Study of Huachansu for Treatment of Advanced Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase|Recruiting||Phase 2|120|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 02:21:49.651859|2017-10-11 02:21:49.651859
NCT01715519|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-04-24|||October 2012||2012-10-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Vilazodone for the Treatment of Posttraumatic Stress Disorder|A Double-blind, Placebo-controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder|Completed||Phase 4|59|Actual|Southern California Institute for Research and Education||2|||f||||t||||||||No||2017-10-11 02:21:49.75548|2017-10-11 02:21:49.75548
NCT01715506|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2016-07-22|||August 2011||2011-08-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|MEDCED||Continuing Education in Nursing Home Dementia Care|Modeling and Evaluating Evidence Based Continuing Education in Nursing Home Dementia Care|Completed||N/A|274|Actual|Bergen University College||1|||f||||t||||||||||2017-10-11 02:21:49.861113|2017-10-11 02:21:49.861113
NCT01715493|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-07-17|||October 2012||2012-10-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom|Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom: a Randomised Placebo-controlled Study|Completed||Phase 4|48|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 02:21:51.539471|2017-10-11 02:21:51.539471
NCT01715480|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-05-27|||March 2012||2012-03-01|February 2015|2015-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|BSH||Effect of Broccoli Sprouts Homogenate on SS RBC|Physiological Effect of Sulforaphane Obtained From Broccoli Sprouts Homogenates (BSH) on the HbF and Anti-oxidative Capacity of Human Sickle Red Blood Cells (SS RBC)|Completed||N/A|21|Actual|Duke University||1|||f||||t||||||||||2017-10-11 02:21:51.660154|2017-10-11 02:21:51.660154
NCT01715467|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-06-12|||September 2012||2012-09-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|CORRECT||CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment|Community Registry Study Evaluating Dupuytren's Contracture Treatment. A Prospective, Observational, Longitudinal, Multicenter Study of the Treatment Patterns and Outcomes in Patients With Dupuytren's Contracture.|Completed||N/A|162|Actual|Endo Pharmaceuticals|||1||f||||f||||||||||2017-10-11 02:21:51.755335|2017-10-11 02:21:51.755335
NCT01715454|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-04-17|||October 2013||2013-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:21:51.876599|2017-10-11 02:21:51.876599
NCT01715441|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-03-02|||September 2012||2012-09-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|NEXIRI2||Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors|A Randomized Phase II Trial Assessing Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors After Failure of All Drugs Known to be Effective|Unknown status|Recruiting|Phase 2|160|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||3|||f||||t||||||||||2017-10-11 02:21:51.927459|2017-10-11 02:21:51.927459
NCT01715428|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-06-02|||June 2012||2012-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Liraglutide and Cardio-Metabolic Risk Markers|Effects of Liraglutide on Cardio-Metabolic Risk Markers|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|University of Palermo|||1||f||||f||||||Samples With DNA|"     serum and plasma samples   "|||2017-10-11 02:21:52.069218|2017-10-11 02:21:52.069218
NCT01715415|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2015-10-23|2014-12-23||November 2012||2012-11-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|November 2013|Actual|2013-11-01||Interventional||Safety population: all randomized participants who received at least 1 dose of blinded study drug.|A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered With Ribavirin (RBV) in Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (SAPPHIRE-II)|Completed||Phase 3|395|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 02:21:52.168134|2017-10-11 02:21:52.168134
NCT01715402|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-02-03|||September 2012|Actual|2012-09-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Optimization of Health Expenditure in Liver Surgery|Optimization of Health Expenditure in Major Surgery: Impact of a Mixed, Clinical and Ethnographic Approach in the Model of Liver Surgery|Enrolling by invitation||N/A|3000|Anticipated|Centre Hospitalier Universitaire, Amiens|||1||f||||f||||||||||2017-10-11 02:21:53.906354|2017-10-11 02:21:53.906354
NCT01715389|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-06-26|||November 2012||2012-11-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of a Shared Decision Making Portal for Pediatric Asthma|Evaluation of a Shared Decision Making Portal for Pediatric Asthma|Completed||N/A|81|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 02:21:54.022298|2017-10-11 02:21:54.022298
NCT01715376|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2012-10-26|||April 2012||2012-04-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Observational|||Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events|Prospective Cohort Study on Integrated Treatment by Traditional Chinese and Western Medicine of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina|Unknown status|Active, not recruiting|N/A|2|Anticipated|Changchun University of Chinese Medicine|||2||f||||t||||||||||2017-10-11 02:21:54.119045|2017-10-11 02:21:54.119045
NCT01715363|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-02-09|||July 2012||2012-07-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PRIMM||Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer|Feasibility of an Immediate Preoperative Chemotherapy Before Resection of Colorectal Cancer and Research of Gene Expressions Changes Induced in the Tumor, Predictive of Chemotherapy Efficiency|Terminated||Phase 2|3|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1||Recruitment difficulties|f||||f||||||||||2017-10-11 02:21:54.209019|2017-10-11 02:21:54.209019
NCT01715350|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-04-15|||May 2012||2012-05-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional|ADD||Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease|A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease: Double-Blind, Randomized Between Placebo Control Group and Dose Groups, Parallel-Design, Multicenter Study|Completed||Phase 2|151|Actual|Purimed Co., Ltd.||3|||f||||t||||||||||2017-10-11 02:21:54.310141|2017-10-11 02:21:54.310141
NCT01715337|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2014-04-14|||February 2010||2010-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Rehabilitation on Muscle Fibre Composition and Capillaries in Chronic Obstructive Pulmonary Disease (COPD) Patients|Effects of Pulmonary Rehabilitation on Muscle Fibre Composition and Capillaries in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|20|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||1|||f||||f||||||||||2017-10-11 02:21:54.544352|2017-10-11 02:21:54.544352
NCT01715324|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-07-24|||June 25, 2014|Actual|2014-06-25|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Adjuvant Growth Therapy in in Vitro Fertilization|Adjuvant Growth Therapy in in Vitro Fertilization: A Randomized Control Trial|Recruiting||Phase 4|528|Anticipated|OVO R & D||2|||f||||t||||||||||2017-10-11 02:21:54.644325|2017-10-11 02:21:54.644325
NCT01715311|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-04-19|||November 2012||2012-11-01|February 2013|2013-02-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|INITIATE||Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control|A Randomized, Double-blind Placebo-controlled Study to Compare the Efficacy of Indacaterol With That of Placebo in Patients With COPD Who Have Not Previously Received Maintenance COPD Medication, Using Blinded Tiotropium as Active Control|Withdrawn||Phase 4|0|Actual|Novartis||3||withdrawn prior to patient recruitment|f||||f||||||||||2017-10-11 02:21:54.780387|2017-10-11 02:21:54.780387
NCT01715298|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-03-09|2014-12-17||November 2012||2012-11-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||NVA237 BID Versus Placebo Twelve-week Efficacy Study|A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients|Completed||Phase 3|432|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:21:54.908926|2017-10-11 02:21:54.908926
NCT01715285|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-09-21|||February 12, 2013|Actual|2013-02-12|September 2017|2017-09-01|August 3, 2021|Anticipated|2021-08-03|July 10, 2018|Anticipated|2018-07-10||Interventional|||A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)|A Randomized, Double-blind, Comparative Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Subjects With High-Risk, Metastatic Hormone-naive Prostate Cancer (mHNPC)|Active, not recruiting||Phase 3|1209|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 02:21:56.055827|2017-10-11 02:21:56.055827
NCT01715272|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2013-02-27|||October 2012||2012-10-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compared With Fleet Enema|A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compared With Fleet Enema|Completed||Phase 1|60|Actual|Norgine||2|||f||||f||||||||||2017-10-11 02:21:56.739863|2017-10-11 02:21:56.739863
NCT01715259|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-11-16|||August 2009||2009-08-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function|A Phase 1 Single Dose Open-Label Reduced/Staged Pharmacokinetic Study of Abiraterone Acetate in Male Subjects With Impaired Renal Function Compared to Matched Control Subjects With Normal Renal Function|Completed||Phase 1|16|Actual|Cougar Biotechnology, Inc.||1|||f||||f||||||||||2017-10-11 02:21:56.868125|2017-10-11 02:21:56.868125
NCT01715246|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-09-10|||October 2012||2012-10-01|July 2014|2014-07-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Clinical Safety of a New Infant Starter Formula Containing 2 Human Milk Oligosaccharides (HMOs)|Clinical Safety of a New Infant Starter Formula Containing 2 Human Milk Oligosaccharides (HMOs)|Completed||N/A|176|Anticipated|Nestlé||3|||f||||f||||||||||2017-10-11 02:21:56.99721|2017-10-11 02:21:56.99721
NCT01715233|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-10-10|||October 2012||2012-10-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Phase II Study Investigating Checkpoint With Forkhead and Ring Finger Domains (CHFR) Methylation Status In Patients With Metastatic Esophageal, Gastroesophageal And Gastric Cancer|A Phase II Study Investigating CHFR Methylation Status As A Biomarker For Taxane Sensitivity Using Modified Docetaxel, Cisplatin and 5 Flourouracil In Patients With Metastatic Esophageal, Gastroesophageal And Gastric Cancer.|Recruiting||Phase 2|127|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:21:57.115679|2017-10-11 02:21:57.115679
NCT01715220|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-09-27|||October 2014||2014-10-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of Suspected Cholelithiasis With Nitroglycerin|Treatment of Suspected Cholelithiasis With Nitroglycerin: a Randomized, Prospective Double-blind Trial|Recruiting||Phase 2|62|Anticipated|United States Naval Medical Center, San Diego||2|||f||||t||||||||||2017-10-11 02:21:57.247371|2017-10-11 02:21:57.247371
NCT01715207|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-05-03|2016-11-21||June 2010||2010-06-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Comparison of Aliskiren vs Negative Controls on Aortic Stiffness in Patients With MFS|Comparison Study of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol|Completed||Phase 3|30|Actual|Samsung Medical Center||2|||f||||f||||||||No|to contact the principal investigator|2017-10-11 02:21:57.388578|2017-10-11 02:21:57.388578
NCT01715194|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-07-25|||December 2012||2012-12-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Telemedicine to Enhance Adherence to CPAP Therapy in Patients With OSAS|Telemedicine to Enhance Adherence to Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea Syndrome; a Randomized Placebo-controlled Prospective Study|Completed||N/A|240|Actual|Cantonal Hospital of St. Gallen||2|||f||||f||||||||No||2017-10-11 02:21:57.737638|2017-10-11 02:21:57.737638
NCT01715181|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-04-13|||January 2013||2013-01-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Interventional|VALID||Volunteers Adding Life in Dementia: VALID|A Cluster-Randomized Controlled Trial Evaluating the Effects of a Volunteer-Led Nonpharmacological Intervention to Reduce Neuropsychiatric Symptoms of Dementia in Long-Term Care Residents|Completed||N/A|75|Actual|Queen's University||2|||f||||f||||||||||2017-10-11 02:21:57.837245|2017-10-11 02:21:57.837245
NCT01715168|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-01-13|||October 2012||2012-10-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer|A Phase 1, Single-blind, Randomized, Two-way, Crossover Bioequivalence Study of Intravenously Administered ATI 0918 in Patients With Ovarian Cancer That Has Progressed or Recurred After Platinum-based Chemotherapy|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|Azaya Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 02:21:57.927455|2017-10-11 02:21:57.927455
NCT01715155|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-08-21|||December 2012||2012-12-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study|A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria|Completed||N/A|171|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:21:58.032395|2017-10-11 02:21:58.032395
NCT01715142|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-24|||December 2012||2012-12-01|October 2012|2012-10-01|September 2015|Anticipated|2015-09-01|June 2014|Anticipated|2014-06-01||Interventional|NEOPAX-001||Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer|Evaluation of Tumoral Perfusion Modification by Dynamic Imaging After Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Patients With Potentially Operable, Locally Advanced or Metastatic Pancreatic Adenocarcinoma|Unknown status|Not yet recruiting|Early Phase 1|31|Anticipated|Erasme University Hospital||1|||f||||f||||||||||2017-10-11 02:21:58.121495|2017-10-11 02:21:58.121495
NCT01715129|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-09-23|2015-07-17||January 2013||2013-01-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|DKP 3M SC||Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer|A Phase III Single Arm Study to Evaluate the Efficacy, Safety and Local Tolerability of a Subcutaneous 3-month Formulation of Triptorelin Pamoate (11.25 mg) in Patients With Locally Advanced or Metastatic Prostate Cancer|Completed||Phase 3|126|Actual|Ipsen||1|||f||||f||||||||||2017-10-11 02:21:58.234913|2017-10-11 02:21:58.234913
NCT01715116|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2013-04-16|||April 2013||2013-04-01|April 2013|2013-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|ENHANCED-ICD||ENHANCED Device Programming to Reduce Therapies and Improve Quality of Life in Implantable Cardioverter Defibrillator (ICD) Patients|ENHANCED Device Programming to Reduce Therapies and Improve Quality of Life in Implantable Cardioverter Defibrillator Patients: A Prospective, Single-arm Safety Monitoring Study (ENHANCED-ICD Study)|Unknown status|Recruiting|N/A|60|Anticipated|UMC Utrecht||1|||f||||t||||||||||2017-10-11 02:21:58.874437|2017-10-11 02:21:58.874437
NCT01715103|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-06-30|||July 2013||2013-07-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|MUCOVAC||Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women|Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women|Terminated||N/A|14|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2||Results of primary outcome are not satisfactory in terms of RNA quality|f||||t||||||||||2017-10-11 02:21:58.973704|2017-10-11 02:21:58.973704
NCT01715090|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2014-11-19|||December 2012||2012-12-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Web-based Insulin Titration - An Efficacy Study|Web-based Insulin Titration: Improving Diabetes Care in the Netherlands. An Efficacy Study.|Completed||N/A|73|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||||2017-10-11 02:21:59.081524|2017-10-11 02:21:59.081524
NCT01715077|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-06-21|||October 2012||2012-10-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Ipilimumab in the Immune System|A Correlative Study of Melanoma Tumor-Infiltrating Lymphocytes (TILs) and Response to Ipilimumab|Active, not recruiting||N/A|4|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 02:21:59.17641|2017-10-11 02:21:59.17641
NCT01715064|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-01-12|2013-05-24||July 2012||2012-07-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients|Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients|Completed||Phase 2/Phase 3|36|Actual|University of Guelph-Humber||2|||f||||f||||||||||2017-10-11 02:21:59.265062|2017-10-11 02:21:59.265062
NCT01715051|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-02-05|||February 2014||2014-02-01|February 2014|2014-02-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|STED-CD||D-Serine for Cocaine Dependence Pilot|A Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of D-Serine for Cocaine Dependence|Withdrawn||Phase 2|0|Actual|University of Cincinnati||2||Funding was not received|f||||f||||||||||2017-10-11 02:21:59.545446|2017-10-11 02:21:59.545446
NCT01715038|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-05-24|||October 2011||2011-10-01|May 2017|2017-05-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|RDNS||Effectiveness of LNS and MNP Supplements to Prevent Malnutrition in Women and Their Children in Bangladesh|Home-fortification Approaches for the Prevention of Malnutrition in Pregnant and Lactating Women and Their Children in Bangladesh: Program Effectiveness Study|Completed||N/A|4011|Actual|University of California, Davis||4|||f||||f||||||||||2017-10-11 02:21:59.69127|2017-10-11 02:21:59.69127
NCT01715012|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-11-29||2016-11-29|October 2012||2012-10-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Study of ACCS (Amnion-derived Cellular Cytokine Solution) in Diabetic Subjects With Deep Burns Managed With Skin Grafts|A Phase 2a Randomized, Double Blind, Placebo Controlled, Single-center Study of ACCS (Amnion-derived Cellular Cytokine Solution) Spray in Diabetic Subjects With Deep Burns Managed With Meshed Skin Grafts.|Terminated||Phase 2|1|Actual|Noveome Biotherapeutics, formerly Stemnion||2||Enrollment futility|f||||t||||||||No||2017-10-11 02:21:59.994102|2017-10-11 02:21:59.994102
NCT01714999|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2014-04-14|||April 2014||2014-04-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Treatment of Acute Traumatic Laceration of the Olecranon and Prepatellar Bursa|A Prospective Evaluation of the Current Treatment Regime for Acute Traumatic Laceration of the Olecranon and Prepatellar Bursa|Unknown status|Recruiting|N/A|100|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 02:22:00.079876|2017-10-11 02:22:00.079876
NCT01714986|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2016-04-06|||March 2009||2009-03-01|April 2016|2016-04-01|December 2024|Anticipated|2024-12-01|December 2023|Anticipated|2023-12-01||Interventional|ALEXIDIAB||Psychological Variables and Hyperglycemia in Diabetes Mellitus|Psychological Impact, Metabolic Control, Biological Stress Markers in Diabetes: Intervention With Affect School and Basal Body Awareness|Enrolling by invitation||N/A|150|Anticipated|Lund University||2|||f||||f||||||||||2017-10-11 02:22:00.191168|2017-10-11 02:22:00.191168
NCT01714973|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-01-14|||October 2012||2012-10-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Study of Amnion-derived Cellular Cytokine Solution (ACCS) Versus Saline in Treating Skin Irritation From Radiation|Phase I Randomized, Blinded Safety and Efficacy Trial of Amnion-derived Cellular Cytokine Solution (ACCS) Versus Saline Sprayed on the Breast of Women Undergoing Radiation Therapy for Breast Cancer After Surgical Removal of the Tumor|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|Noveome Biotherapeutics, formerly Stemnion||1|||f||||t||||||||||2017-10-11 02:22:00.276199|2017-10-11 02:22:00.276199
NCT01714960|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2014-01-28|||October 2012||2012-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients|Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients|Completed||Phase 1|70|Actual|Merz Pharmaceuticals GmbH||4|||f||||f||||||||||2017-10-11 02:22:00.350696|2017-10-11 02:22:00.350696
NCT01714947|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-09-03|||January 2013||2013-01-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib|Mass Balance, Pharmacokinetics, and Metabolism of [14C]-Alisertib in Patients With Advanced Solid Tumors or Lymphomas|Completed||Phase 1|3|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:22:00.439424|2017-10-11 02:22:00.439424
NCT01714934|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-10-25|||January 2013||2013-01-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|||The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis|Study of Pepsin Levels in the Broncho-Alveolar-Lavage Fluid of Patients With Idiopathic Pulmonary Fibrosis|Unknown status|Not yet recruiting|N/A|40|Anticipated|Sheba Medical Center|||2||f||||f|||||||"     BAL broncho alveolar lavage at bronchoscopy   "|||2017-10-11 02:22:00.519272|2017-10-11 02:22:00.519272
NCT01714908|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-02-04|||December 14, 2012|Actual|2012-12-14|February 2017|2017-02-01|October 20, 2018|Anticipated|2018-10-20|August 20, 2018|Anticipated|2018-08-20||Interventional|RECEL||Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21|A Multicenter, Randomized, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Erlotinib Versus Etoposide Plus Cisplatin With Concurrent Radiotherapy in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) With Activating Mutation of Epidermal Growth Factor Receptor (EGFR) in Exon 19 or 21|Active, not recruiting||Phase 2|100|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||t||||||||||2017-10-11 02:22:00.633452|2017-10-11 02:22:00.633452
NCT01714895|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-24|||October 2011||2011-10-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose Monitoring|New Strategies for Automated Glycaemic Control: the Issue of Continuous Glucose Monitoring Accuracy Under Hypoglycaemic Conditions|Completed||N/A|14|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||||2017-10-11 02:22:00.762654|2017-10-11 02:22:00.762654
NCT01714882|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2015-11-05|||October 2012||2012-10-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Stress Management for Couples Undergoing In Vitro Fertilization (IVF)|Stress Management for Couples With Infertility Undergoing In Vitro Fertilization (IVF)|Completed||Phase 2|60|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:22:00.840726|2017-10-11 02:22:00.840726
NCT01714869|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2013-11-22|||November 2012||2012-11-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|EMBARK VA||Exploring Massage Benefits for Arthritis of the Knee for VA Healthcare Users|Multisite RCT Investigating the Efficacy of Massage in Osteoarthritis for VA Healthcare Users|Completed||N/A|25|Actual|Duke University||1|||f||||t||||||||||2017-10-11 02:22:00.936177|2017-10-11 02:22:00.936177
NCT01714856|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2012-10-25|||September 2008||2008-09-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions|AN OPEN LABEL, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, CROSSOVER, BIOEQUIVALENCE STUDY OF ROPINIROLE HYDROCHLORIDE CR 2mg TABLETS OF LUPIN LIMITED, INDIA, COMPARING WITH THAT OF REQUIP XL OF GLAXOSMITHKLINE RESEARCH TRIANGLE PARK, IN HEALTHY ADULT MALE SUBJECTS|Completed||Phase 1|12|Actual|Lupin Ltd.||2|||f||||t||||||||||2017-10-11 02:22:01.013165|2017-10-11 02:22:01.013165
NCT01714843|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2014-04-29|||August 2012||2012-08-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome|Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Constipation-predominant Irritable Bowel Syndrome|Completed||Phase 2|559|Actual|Astellas Pharma Inc||5|||f||||f||||||||||2017-10-11 02:22:01.11316|2017-10-11 02:22:01.11316
NCT01714830|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2012-10-23|||August 2011||2011-08-01|October 2012|2012-10-01||||November 2012|Anticipated|2012-11-01||Interventional|||Efficacy of Extracorporal Shock Wave Therapy in Patient With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain Syndrome|The Efficacy of Extracorporal Shock Wave Therapy on Symptoms Relief in Patients With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain Syndrome|Unknown status|Active, not recruiting|N/A|20|Anticipated|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:22:01.218894|2017-10-11 02:22:01.218894
NCT01714817|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-08-16|||January 22, 2013|Actual|2013-01-22|August 2017|2017-08-01|May 18, 2018|Anticipated|2018-05-18|November 21, 2016|Actual|2016-11-21||Interventional|||Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BMS-188667 (Abatacept) or Placebo on a Background of Mycophenolate Mofetil and Corticosteroids in the Treatment of Subjects With Active Class III or IV Lupus Nephritis|Active, not recruiting||Phase 3|695|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-11 02:22:01.311483|2017-10-11 02:22:01.311483
NCT01714804|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-11-28|||August 2012||2012-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Efficacy and Safety of Integra Accell Evo3 DBM in Instrumented Lumbar Spine Fusion|Efficacy and Safety of Integra Accell Evo3 Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion|Completed||N/A|30|Actual|SeaSpine, Inc.||1|||f||||f||||||||||2017-10-11 02:22:01.787255|2017-10-11 02:22:01.787255
NCT01714791|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-01-23|||January 2010||2010-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OSTinCARE||Effects of Osteopathic Treatment on Pulmonary Function After Coronary Artery Bypass Graft Surgery|Effect of Osteopathy on Pulmonary Function in Patients After Coronary Artery Bypass Graft Surgery: a Randomized Controlled Trial|Terminated||N/A|112|Actual|Hartcentrum Hasselt||2||"Lack of new inclusions due to a significant change in surgery technique. An endoscopic   a-traumatic coronary artery bypass (endo-ACAB) approach is now used."|f||||f||||||||||2017-10-11 02:22:01.870078|2017-10-11 02:22:01.870078
NCT01714778|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2014-03-12|||February 2013||2013-02-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Observational|TADEUS||Toxins and Delivery in e-Cigarette Users|Electronic Cigarettes: Potential Toxicant (Acrolein) and Nicotine Delivery in Users|Completed||N/A|40|Actual|Queen Mary University of London|||1||f||||f||||||Samples Without DNA|"     Urine is collected for analysis of a metabolite of acrolein (3-HPMA_.      Blood is collected for analysis of nicotine.   "|||2017-10-11 02:22:01.992721|2017-10-11 02:22:01.992721
NCT01714765|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-11-11|||April 2011||2011-04-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|DEVELOP||Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer|A Phase I Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer|Completed||Phase 1|17|Actual|Queen Mary University of London||1|||f||||||||||||||2017-10-11 02:22:02.064893|2017-10-11 02:22:02.064893
NCT01714752|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2013-09-27|||December 2012||2012-12-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|PREFFORT||Evaluation of Left Ventricular Filling Pressures During Exercise|Evaluation of Left Ventricular Filling Pressures During Exercise: Comparative Study, Catheterization Versus Echocardiography|Completed||N/A|60|Actual|French Cardiology Society||1|||f||||f||||||||||2017-10-11 02:22:02.149325|2017-10-11 02:22:02.149325
NCT01714739|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-10-02|||October 7, 2012|Actual|2012-10-07|September 2017|2017-09-01|February 16, 2021|Anticipated|2021-02-16|July 14, 2019|Anticipated|2019-07-14||Interventional|||A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors|A Phase 1/2 Study of the Combination of Lirilumab (Anti-KIR) Plus Nivolumab (Anti-PD-1) or Lirilumab Plus Nivolumab and Ipilimumab in Advanced Refractory Solid Tumors|Recruiting||Phase 1/Phase 2|650|Anticipated|Bristol-Myers Squibb||4|||f||||f|t|f||||||||2017-10-11 02:22:02.235722|2017-10-11 02:22:02.235722
NCT01714726|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-05-09||2017-04-19|February 1, 2013|Actual|2013-02-01|May 2017|2017-05-01|December 14, 2016|Actual|2016-12-14|May 20, 2014|Actual|2014-05-20||Interventional|||Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.|A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy|Completed||Phase 2|174|Actual|Allergan||3|||f||||t|t|f||||||||2017-10-11 02:22:02.496555|2017-10-11 02:22:02.496555
NCT01714713|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-05-02|||June 2013||2013-06-01|September 2015|2015-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy|A Multicenter 26-Week Extension Study to Evaluate the Safety and Clinical Effects of Prolonged Exposure to Two Doses of EVP-6124, an Alpha-7 Nicotinic Acetylcholine Receptor Agonist, as an Adjunctive Pro-cognitive Treatment in Subjects With Schizophrenia on Chronic Stable Atypical Antipsychotic Therapy|Completed||Phase 3|830|Actual|FORUM Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-11 02:22:02.723872|2017-10-11 02:22:02.723872
NCT01714700|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-09-09|||August 2006||2006-08-01|September 2014|2014-09-01|May 2007|Actual|2007-05-01|March 2007|Actual|2007-03-01||Interventional|||Interactive Effects of an Isocaloric High-protein Diet and Resistance Exercise in Untrained Overweight Young Men|Interactive Effects of an Isocaloric High-protein Diet and Resistance Exercise on Body Composition, Ghrelin, and Metabolic and Hormonal Parameters in Untrained Overweight Young Men|Completed||N/A|18|Actual|Pusan National University Yangsan Hospital||2|||f||||t||||||||||2017-10-11 02:22:03.085395|2017-10-11 02:22:03.085395
NCT01714687|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2017-06-29|||October 1, 2012|Actual|2012-10-01|June 2017|2017-06-01|April 1, 2016|Actual|2016-04-01|October 1, 2015|Actual|2015-10-01||Interventional|CABERNET||Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients (CABERNET)|Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients: A Randomized Controlled Study (CABERNET)|Completed||N/A|59|Actual|Acclarent||2|||f||||f|f|t|f|||||Yes|Publication planned in the future|2017-10-11 02:22:03.208467|2017-10-11 02:22:03.208467
NCT01714674|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2012-10-31|||October 2012||2012-10-01|October 2012|2012-10-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|NO troponin||Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes|The Impact of Dietary Nitrate Supplementation on Exercise-induced Cardiac Troponin T Release in Type 2 Diabetic Patients|Unknown status|Recruiting|N/A|10|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:22:03.344199|2017-10-11 02:22:03.344199
NCT01714661|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-05-02|||October 2012||2012-10-01|June 2015|2015-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy|A Randomized, Double-blind, Placebo-controlled, Parallel, 26-Week, Phase 3 Study of 2 Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo as an Adjunctive Pro-cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy|Completed||Phase 3|753|Actual|FORUM Pharmaceuticals Inc||3|||f||||f||||||||||2017-10-11 02:22:03.460486|2017-10-11 02:22:03.460486
NCT01714648|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2015-08-03|||November 2012||2012-11-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?|An Uncontrolled, Open-label Feasibility Study to Demonstrate That a GnRH Agonist (Decapeptyl) Can be Safely Administered to Trigger Final Oocyte Maturation in High Responder Patients to Mitigate the Risk of OHSS|Terminated||Phase 4|6|Actual|Elisha Hospital||1||"Terminated: recruiting or enrolling participants has halted prematurely and will not resume;   participants are no longer being examined or treated"|f||||f||||||||||2017-10-11 02:22:03.708299|2017-10-11 02:22:03.708299
NCT01714635|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-24|2015-02-26|2015-01-09||November 2012||2012-11-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|October 2013|Actual|2013-10-01||Interventional|||Clinical Investigation of Expanded Designs of a Multifocal IOL|Clinical Investigation of Expanded Designs of the Tecnis® Multifocal 1-Piece IOL|Completed||Phase 1|445|Actual|Abbott Medical Optics||3|||f||||f||||||||||2017-10-11 02:22:03.808808|2017-10-11 02:22:03.808808
NCT01714622|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-02-17|||October 2012||2012-10-01|February 2014|2014-02-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance||Unknown status|Recruiting|N/A|270|Anticipated|Yonsei University|||3||f||||f||||||||||2017-10-11 02:22:04.248983|2017-10-11 02:22:04.248983
NCT01714609|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-11-03|2015-11-03||August 2011||2011-08-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|||Pilot Study of Effect of Sorafenib on Portal Pressure|A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization|Completed||Phase 2|10|Actual|Yale University||2|||f||||t||||||||||2017-10-11 02:22:04.524295|2017-10-11 02:22:04.524295
NCT01714596|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-03-16|||September 2012||2012-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|POvIV||A Prospective Randomized Trial to Assess PO Versus IV Antibiotics for the Treatment of Post-op Wound Infection After Extremity Fractures|A Prospective Randomized Trial to Assess PO Versus IV Antibiotics for the Treatment of Post-op Wound Infection After Extremity Fractures (POvIV)|Recruiting||N/A|264|Anticipated|Major Extremity Trauma Research Consortium||2|||f||||t||||||||||2017-10-11 02:22:04.870847|2017-10-11 02:22:04.870847
NCT01714583|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-25|||April 2011||2011-04-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With Acute Respiratory Distress Syndrome (ARDS) Managed on a Fluid Protocol|The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With ARDS Managed on a Fluid Protocol: A Secondary Analysis of a Prospective Trial|Completed||N/A|367|Actual|Yale University|||2||f||||f||||||||||2017-10-11 02:22:04.984779|2017-10-11 02:22:04.984779
NCT01714570|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2014-04-16|||November 2012||2012-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia|A Prospective, Randomized, Open Label Study of Piperacillin/Tazobactam Versus Imipenem/Cilastin for Empirical Therapy of Febrile Patients With Neutropenia After Hematopoietic Stem Cell Transplantation|Completed||N/A|123|Actual|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 02:22:05.098836|2017-10-11 02:22:05.098836
NCT01714557|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-10-25|||September 2012||2012-09-01|October 2012|2012-10-01|November 2014|Anticipated|2014-11-01|September 2014|Anticipated|2014-09-01||Interventional|||Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation|Piperacillin/Tazobactam for Prophylaxis in Patients of Neutropenia After Hematopoietic Stem Cell Transplantation - A Pilot Study|Unknown status|Not yet recruiting|N/A|150|Anticipated|Chinese PLA General Hospital||3|||f||||f||||||||||2017-10-11 02:22:05.222409|2017-10-11 02:22:05.222409
NCT01714544|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2014-06-25|2014-06-25||October 2012||2012-10-01|June 2014|2014-06-01||||March 2013|Actual|2013-03-01||Interventional|||Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis|An Open-Label, Multicenter Study of the Efficacy of Cloderm® Cream (Clocortolone Pivalate, 0.1%) in the Treatment of Moderate Plaque Psoriasis for 28 Days|Completed||Phase 4|60|Actual|Promius Pharma, LLC||1|||f||||f||||||||||2017-10-11 02:22:05.356225|2017-10-11 02:22:05.356225
NCT01714531|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-04-21|||January 2013||2013-01-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|GMT||Improving Outcomes After Traumatic Injury: A Goal Management Approach|Improving Trauma Outcomes: A Goal Management Approach|Completed||N/A|91|Actual|Vanderbilt University Medical Center||3|||f||||f||||||||||2017-10-11 02:22:05.630933|2017-10-11 02:22:05.630933
NCT01714518|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-01-05|||October 2012||2012-10-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung Diseases|Cryobiopsy vs. VATS: Efficiency and Safety in the Diagnosis of Interstitial Lung Diseases|Recruiting||N/A|30|Anticipated|Wissenschaftliches Institut Bethanien e.V|||1||f||||f||||||||||2017-10-11 02:22:05.737938|2017-10-11 02:22:05.737938
NCT01714505|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2014-09-05|2014-08-08||October 2012||2012-10-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy|Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy|Completed||N/A|20|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 02:22:05.850902|2017-10-11 02:22:05.850902
NCT01714492|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2014-01-21|2013-05-23||April 2012||2012-04-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|Sigma MB TKA||Mechanics Analysis of Patients Having a Sigma Mobile Bearing TKA|In Vivo Mechanics Analysis of Patients Having a Sigma Mobile Bearing TKA|Completed||N/A|8|Actual|The University of Tennessee, Knoxville|Small study population; only one specific type of mobile bearing implant was analyzed; no definitive way to quantitatively measure level of wear on various implants to determine if there was any influence on the kinematic performance.||1||f||||f||||||||||2017-10-11 02:22:06.152387|2017-10-11 02:22:06.152387
NCT01714479|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-07-19|||October 2012||2012-10-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Skeletal Muscle Response to Amino Acids and Load Carriage Exercise|Skeletal Muscle and Physical Performance Responses to Leucine-Enriched Nutrition Supplementation During Load Carriage|Completed||N/A|40|Actual|United States Army Research Institute of Environmental Medicine||4|||f||||f||||||||||2017-10-11 02:22:06.442908|2017-10-11 02:22:06.442908
NCT01714466|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2014-11-19|||October 2012||2012-10-01|November 2014|2014-11-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy|Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy|Completed||Phase 2|240|Actual|Norgine||8|||f||||f||||||||||2017-10-11 02:22:06.522781|2017-10-11 02:22:06.522781
NCT01714440|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-06-02|||August 2012||2012-08-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Genomics of Kidney Transplantation|Genomics of Kidney Transplantation|Completed||N/A|1552|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:22:06.609485|2017-10-11 02:22:06.609485
NCT01714427|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2013-04-23|||July 2011||2011-07-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Validation of a Lung Inflammation Model in Healthy Volunteers by Radiological Tools and Glucocorticoid Treatment|Validation of a Lung Inflammation Model in Healthy Volunteers by Radiological Tools and Glucocorticoid Treatment|Completed||N/A|36|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:22:06.696467|2017-10-11 02:22:06.696467
NCT01714414|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-25|2017-04-27|||December 2012||2012-12-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|June 2014|Actual|2014-06-01||Interventional|FATI-01||A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen|A Prospective, Multicenter, Open, Randomized Phase 2a Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen After 24 Weeks of Treatment in ART naïve, Non Subtype B HIV-1 Infected Individuals From Tanzania and Ivory Coast|Completed||Phase 2|120|Actual|Ludwig-Maximilians - University of Munich||4|||f||||t||||||||||2017-10-11 02:22:06.775774|2017-10-11 02:22:06.775774
NCT01714401|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-10-24|||March 2012||2012-03-01|October 2012|2012-10-01||||April 2013|Anticipated|2013-04-01||Interventional|||Nebulized Bronchodilatators and Cardiac Repolarization|The Development of Procedures to Optimalize the Intensive Care Units Patients Clinical Condition. Evaluation of Influence of Nebulized Bronchodilatatory Drugs on Cardiac Repolarization|Unknown status|Recruiting|N/A|75|Anticipated|Medical University of Gdansk||3|||f||||||||||||||2017-10-11 02:22:06.876191|2017-10-11 02:22:06.876191
NCT01714388|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2015-09-30|||May 2010||2010-05-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Vagotonic Effect of Remifentanil and Autonomic Nervous System Activity.|Vagotonic Effect of Remifentanil in Reference to Sympathetic or Parasympathetic Predominance of Autonomic Nervous System.|Completed||Phase 4|70|Actual|Medical University of Gdansk||1|||f||||f||||||||||2017-10-11 02:22:06.956002|2017-10-11 02:22:06.956002
NCT01714375|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-08-20|||July 2007||2007-07-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|DEMON||Daily Exposure Monitoring to Prevent Hearing Loss|Daily Exposure Monitoring of Noise Study|Unknown status|Recruiting|Phase 2|800|Anticipated|Yale University||3|||f||||f||||||||||2017-10-11 02:22:07.020331|2017-10-11 02:22:07.020331
NCT01714362|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2017-03-21|||April 2009||2009-04-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Autonomic Nervous System Activity and Oculocardiac Reflex.|Prediction of Oculocardiac Reflex in Relationship to Autonomic Nervous System Activity, Mesured With the Use of ECG HRV Analysis.|Recruiting||N/A|60|Anticipated|Medical University of Gdansk|||1||f||||f||||||||||2017-10-11 02:22:07.10159|2017-10-11 02:22:07.10159
NCT01714349|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-09-21|||October 2012||2012-10-01|September 2016|2016-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Nerve Transfer After Spinal Cord Injuries|Restoring Hand Function Using Nerve Transfers in Persons With Spinal Cord Injury|Recruiting||N/A|20|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 02:22:07.205076|2017-10-11 02:22:07.205076
NCT01714336|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-04-08|2016-04-08||September 2012||2012-09-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery?|Is Tranexamic Acid Effective in Limiting Transfusion After Hip Replacement for Femoral Neck Fracture: A Randomized Controlled Trial|Completed||Phase 4|138|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 02:22:07.304835|2017-10-11 02:22:07.304835
NCT01714310|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2016-11-03|||January 2013||2013-01-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation|Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation|Completed||Phase 2|39|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:22:07.718206|2017-10-11 02:22:07.718206
NCT01714297|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-12-07|||January 2008||2008-01-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|June 2008|Actual|2008-06-01||Interventional|||Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)|A Prospective Randomized, Double Blind Study to Evaluate Safety and Effect With Pre Versus Postoperative Start of Thromboprophylaxis With Dalteparin|Completed||Phase 4|80|Actual|Martina Hansen's Hospital||2|||f||||f||||||||||2017-10-11 02:22:07.807125|2017-10-11 02:22:07.807125
NCT01714284|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2013-02-21|||February 2011||2011-02-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy Study of Dietary Intervention and Weight Loss in Improving Psoriasis|Multicenter Randomized Clinical Study Evaluating the Efficacy of Dietary Intervention and Weight Loss in Improving Psoriasis|Completed||N/A|303|Actual|Centro Studi Gised||2|||f||||f||||||||||2017-10-11 02:22:07.884279|2017-10-11 02:22:07.884279
NCT01714271|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2012-10-24|||October 2010||2010-10-01|October 2012|2012-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Promotora-based Latino Family CVD Risk Reduction|Promotora-based Latino Family CVD Risk Reduction: Remaking the Home Environment|Unknown status|Recruiting|Phase 2|240|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:22:09.368276|2017-10-11 02:22:09.368276
NCT01714258|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-12-05|||September 2011||2011-09-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||A Non Invasive Estimation of Cardiac Output in Mechanically Ventilated Patients|A Non Invasive Estimation of Cardiac Output in Mechanically Ventilated Patients: a Prolonged Expiration Method|Completed||N/A|35|Actual|Campus Bio-Medico University||1|||f||||t||||||||||2017-10-11 02:22:09.470636|2017-10-11 02:22:09.470636
NCT01714245|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-07-10|||November 2012||2012-11-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|CLeaN||A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients|A Multicenter, Prospective Study to Evaluate CLn® BodyWash As An Adjunctive Therapy in Pediatric Subjects With Moderate to Severe, Staphylococcus Aureus Colonized Atopic Dermatitis|Completed||N/A|50|Actual|TopMD Skin Care, Inc.|||1||f||||f||||||||||2017-10-11 02:22:09.550565|2017-10-11 02:22:09.550565
NCT01714232|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-01-29|2013-11-08||October 2012||2012-10-01|January 2016|2016-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of Blood Glucose Meter Systems|Evaluation of Blood Glucose Meter Systems - Contour® PLUS Study|Completed||N/A|106|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 02:22:09.630551|2017-10-11 02:22:09.630551
NCT01714219|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2014-09-25|||October 2012||2012-10-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy|Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy: Prospective, Single-blinded, Randomized Controlled Trial|Completed||N/A|100|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:22:09.879916|2017-10-11 02:22:09.879916
NCT01714206|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-11-16|||June 2009||2009-06-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.|An Open-Label, 2-Period, Crossover Study to Evaluate the Effects of Multiple Doses of JNJ-28431754 on the Pharmacokinetics of Multiple Doses of Digoxin in Healthy Subjects.|Completed||Phase 1|18|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 02:22:09.988422|2017-10-11 02:22:09.988422
NCT01714193|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-11-16|||February 2008||2008-02-01|November 2012|2012-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers|An Open-label Drug-Drug Interaction Study in Healthy Female Subjects to Explore the Effects of Multiple Doses of JNJ-28431754 on the Pharmacokinetics and Safety of Single Doses of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel|Completed||Phase 1|30|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 02:22:10.092982|2017-10-11 02:22:10.092982
NCT01714180|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-06-02|||October 2012||2012-10-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Observational|||Effect of Body Mass on Acyclovir Pharmacokinetics|Effect of Body Mass on Acyclovir Pharmacokinetics|Completed||N/A|14|Actual|West Virginia University|||2||f||||t||||||||||2017-10-11 02:22:10.201369|2017-10-11 02:22:10.201369
NCT01714167|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-06-04|||June 2012||2012-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke|Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Treatment of Chronic Stroke|Unknown status|Recruiting|Phase 1|30|Anticipated|Wenzhou Medical University||2|||f||||t||||||||||2017-10-11 02:22:10.294318|2017-10-11 02:22:10.294318
NCT01714154|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2016-11-01|||November 2012||2012-11-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy Controls|A Multi Center, Sequential, Open-Label, Multiple-Dose Study of Setrobuvir (STV) Alone and With Co-Administration of Ritonavir-boosted Danoprevir to Evaluate the Safety, Tolerability and Pharmacokinetics of STV, DNV, and Ritonavir (RTV) in Subjects With Mild Hepatic Impairment Compared to Healthy Controls|Completed||Phase 1|18|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:22:10.544245|2017-10-11 02:22:10.544245
NCT01714141|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2016-10-31|||December 2011||2011-12-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Multi-Component Technology Intervention for Minority Emerging Adults With Asthma|Multi-Component Technology Intervention for Minority Emerging Adults With Asthma|Completed||N/A|48|Actual|Wayne State University||2|||f||||t||||||||||2017-10-11 02:22:10.661245|2017-10-11 02:22:10.661245
NCT01714128|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-02-05|||June 2013||2013-06-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|January 2015|Anticipated|2015-01-01||Interventional|||FES-PET for Patients Treated on NCI Protocol 8762|Positron Emission Tomography (PET) With 18F-Fluoroestradiol (FES) as a Predictor of Response in Patients With Breast Cancer Scheduled to be Treated With MK-2206 in Combination With Either an Aromatase Inhibitor or Fulvestrant on NCI Protocol 8762|Withdrawn||N/A|0|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 02:22:10.776418|2017-10-11 02:22:10.776418
NCT01714115|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-08-07||||||August 2017|2017-08-01||||||||Expanded Access|||Use of Eylea for the Treatment of an Optic Nerve Hemangioma|Use of Eylea for the Treatment of an Optic Nerve Hemangioma|No longer available||N/A|||Vitreous -Retina- Macula Consultants of New York|||||||||||||||||||2017-10-11 02:22:10.885955|2017-10-11 02:22:10.885955
NCT01714102|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-07-10|||October 2012||2012-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|August 2015|Actual|2015-08-01||Interventional|||Resveratrol and the Metabolic Syndrome|The Effects of Trans-Resveratrol (RSV) on Insulin Resistance, Inflammation, and the Metabolic Syndrome: A Placebo Controlled, Double-Blind Study.|Active, not recruiting||Phase 2|28|Actual|Rockefeller University||2|||f||||f||||||||||2017-10-11 02:22:10.949351|2017-10-11 02:22:10.949351
NCT01714089|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-04-05||||||April 2016|2016-04-01||||||||Interventional|||Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis|A Phase II Study Evaluating RNS60 Compared to Interferon Beta-1a (Avonex) for the Treatment of Relapsing Remitting Multiple Sclerosis|Withdrawn||Phase 2|0|Actual|Revalesio Corporation||3|||f||||||||||||||2017-10-11 02:22:11.047497|2017-10-11 02:22:11.047497
NCT01714076|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-10-21|||November 2012||2012-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Observational|||Co-infections in Children Hospitalised for Bronchiolitis|Co-infections in Children Hospitalised for Bronchiolitis: Incidence, Clinical Symptoms and Influence of Cohort Isolation|Completed||N/A|172|Actual|Princess Amalia Children's Clinic|||1||f||||f||||||Samples Without DNA|"     sputum tested for viral agents by PCR-techniques   "|||2017-10-11 02:22:11.167165|2017-10-11 02:22:11.167165
NCT01714063|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-04-21|||December 2012||2012-12-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use|Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use|Unknown status|Recruiting|N/A|40|Anticipated|Philips Respironics|||2||f||||f||||||||||2017-10-11 02:22:11.266099|2017-10-11 02:22:11.266099
NCT01714050|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-02-24|||July 2008||2008-07-01|February 2014|2014-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD Recurrence|Cognitive-behavioral Therapy vs. Light Therapy for Preventing Seasonal Affective Disorder Recurrence|Unknown status|Active, not recruiting|Phase 2/Phase 3|160|Anticipated|University of Vermont||2|||f||||f||||||||||2017-10-11 02:22:11.349201|2017-10-11 02:22:11.349201
NCT01714037|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2015-04-07|||August 2012||2012-08-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|HALO||A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]|A Phase I-II Evaluation of the Safety and Efficacy of the Oral HSP90 Inhibitor Debio 0932 in Combination With Standard of Care in first-and Second-line Therapy of Patients With Stage IIIb or IV Non-small Cell Lung Cancer-the HALO Study (HSP90 Inhibition And Lung Cancer Outcomes)|Terminated||Phase 1|82|Actual|Debiopharm International SA||3|||f||||f||||||||||2017-10-11 02:22:11.451297|2017-10-11 02:22:11.451297
NCT01714011|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2012-11-26|||May 2009||2009-05-01|November 2012|2012-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome|Randomized Controlled Trial of The Safety and Efficacy of Aripiprazole VS Ziprasidone in Schizophrenic Patients With Metabolic Syndrome and Diabetes Mellitus.|Completed||Phase 4|175|Actual|University of Malaya||2|||f||||f||||||||||2017-10-11 02:22:12.086448|2017-10-11 02:22:12.086448
NCT01713998|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-01-06|2013-06-19||September 2011||2011-09-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Treatment of the Face and Neck With Lower Ulthera System Energy Settings|Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck With Lower Energy Settings|Completed||N/A|47|Actual|Ulthera, Inc||3|||f||||f||||||||||2017-10-11 02:22:12.206106|2017-10-11 02:22:12.206106
NCT01713985|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-09-09|||September 2012||2012-09-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck|Feasibility Study: Evaluation of the Ulthera® System vs Thermage® for Lifting and Tightening of the Full Face and Neck|Completed||N/A|20|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-11 02:22:12.936193|2017-10-11 02:22:12.936193
NCT01713972|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-05-08|||November 19, 2012|Actual|2012-11-19|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|July 30, 2016|Actual|2016-07-30||Interventional|||Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors|A Phase I Trial of Dabrafenib (BRAFi) and Pazopanib in Patients With BRAF-mutated Advanced Malignant Tumors|Active, not recruiting||Phase 1|56|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:22:13.087711|2017-10-11 02:22:13.087711
NCT01713959|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-06-27|||August 2011||2011-08-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis|Feasibility Study: Evaluation of the Safety and Efficacy of the Ulthera® System for the Treatment of Axillary Hyperhidrosis|Completed||N/A|15|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-11 02:22:13.281555|2017-10-11 02:22:13.281555
NCT01713946|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-10-05|||April 29, 2013|Actual|2013-04-29|October 2017|2017-10-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|EXIST-3||A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures|A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures|Active, not recruiting||Phase 3|370|Actual|Novartis||3|||f||||t|t|f||||||||2017-10-11 02:22:13.42913|2017-10-11 02:22:13.42913
NCT01713933|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-04-25|2014-01-13||June 2011||2011-06-01|April 2014|2014-04-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional||Three subjects excluded due to subject withdrawal. One subject excluded from results analyses as an outlier, with a high Body Mass Index (BMI) and substantial weight gain during the study period.|Evaluation of the Ulthera® System for Treatment of the Brachia|Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Brachia|Completed||N/A|37|Actual|Ulthera, Inc|- Poor subject selection (high BMI with large volume arms enrolled rather than subjects with laxity and wrinkled skin)|1|||f||||f||||||||||2017-10-11 02:22:13.801643|2017-10-11 02:22:13.801643
NCT01713920|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-11-06|||April 2010||2010-04-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|EARTH||Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM|Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to Angiotensin Receptor Blocker(ARB) monoTHerapy Using 24h ABPM.|Completed||Phase 4|68|Actual|The Catholic University of Korea||1|||f||||t||||||||||2017-10-11 02:22:14.325932|2017-10-11 02:22:14.325932
NCT00000601|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||July 1995||1995-07-01|February 2005|2005-02-01|June 2000|Actual|2000-06-01|||||Interventional|||Postmenopausal Hormone Therapy in Unstable Angina||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.19615|2017-10-11 04:19:08.19615
NCT01713907|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-02-27|||June 2011||2011-06-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Evaluation of the Ulthera® System for Treatment of the Face and Neck|Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Facial Tissue and Improvement in Jawline Definition and Submental Skin Laxity|Terminated||N/A|15|Actual|Ulthera, Inc||1||Inadequate study staff to appropriately manage trial.|f||||f||||||||||2017-10-11 02:22:14.425135|2017-10-11 02:22:14.425135
NCT01713894|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-09-11|||May 2013||2013-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Decision Aid - Extreme Prematurity|Utility of a Clinically Relevant Decision Aid, for Parents Facing Extremely Premature Delivery|Recruiting||N/A|300|Anticipated|Christiana Care Health Services||2|||f||||f||||||||||2017-10-11 02:22:14.539102|2017-10-11 02:22:14.539102
NCT01713881|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2014-03-19|||August 2012||2012-08-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|December 2013|Actual|2013-12-01||Observational|||Effect of a Tracking Program on Colon Adenoma Surveillance and Adherence to Guideline Recommendations|Effect of a Tracking Program on Colon Adenoma Surveillance and Adherence to Guideline Recommendations|Unknown status|Active, not recruiting|N/A|500|Anticipated|United States Department of Defense|||2||f||||f||||||||||2017-10-11 02:22:14.65019|2017-10-11 02:22:14.65019
NCT01713868|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-05-01|||March 2015||2015-03-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|SMART||Social Media And Risk-reduction Training for Infant Care Practices (SMART)|Social Media And Risk-reduction Training for Infant Care Practices (SMART)|Active, not recruiting||N/A|1600|Actual|University of Virginia||4|||f||||t||||||||No||2017-10-11 02:22:14.723336|2017-10-11 02:22:14.723336
NCT01713855|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-24|||October 2004||2004-10-01|October 2012|2012-10-01|March 2006|Actual|2006-03-01|||||Interventional|||Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura|Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)|Completed||N/A|10|Actual|Neufeld, Ellis J, MD, PhD|||||f||||f||||||||||2017-10-11 02:22:14.812033|2017-10-11 02:22:14.812033
NCT01713842|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-02-10|||July 2012||2012-07-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|TENOR||Tocilizumab Effect iN pOlymyalgia Rheumatica|Phase II Open 24 Weeks Study to Evaluate Effect and Safety of Tocilizumab as the First Line Therapy in Subjects With Polymyalgia Rheumatica (PMR)|Completed||Phase 2|21|Actual|University Hospital, Brest||1|||f||||t||||||||||2017-10-11 02:22:14.920734|2017-10-11 02:22:14.920734
NCT01713829|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-01-10|||October 2012||2012-10-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Interventional|||Cranberry Consumption Improves γδ T Cell Function|Cranberry Consumption Improves γδ T Cell Function|Completed||N/A|52|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 02:22:15.006908|2017-10-11 02:22:15.006908
NCT01713816|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-10-25|||June 2013||2013-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||Human Brain Antioxidants During Oxidative Stress|Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress|Recruiting||N/A|86|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 02:22:15.110215|2017-10-11 02:22:15.110215
NCT01713803|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-05-02||||||May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects|Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects|Withdrawn||Phase 3|0|Actual|BioDelivery Sciences International||2||FDA did not require a clinical trial for indication.|f||||f||||||||||2017-10-11 02:22:15.189586|2017-10-11 02:22:15.189586
NCT01713790|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2015-07-22|||October 2012||2012-10-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Innovative Training Methods for Frail Elderly in the Training Gain Stage|Effects of Whole Body Vibration With Stochastic Resonance and Exergames in the Elderly in Need of Care: Effects on Physical Functional Performance|Completed||N/A|40|Actual|Bern University of Applied Sciences||1|||f||||f||||||||||2017-10-11 02:22:15.255743|2017-10-11 02:22:15.255743
NCT01713764|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2013-12-24|||October 2012||2012-10-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|SUCCEED||A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics|A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics|Completed||Phase 2|34|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:22:15.467846|2017-10-11 02:22:15.467846
NCT01713751|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2012-10-24|||March 2012||2012-03-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Surgical Site Infection Rates in Obese Patients After Cesarean Delivery|Surgical Site Infection Rates of Two Different Skin Closure Methods Used in Obese Patients After Cesarean Delivery|Completed||N/A|500|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 02:22:15.617223|2017-10-11 02:22:15.617223
NCT01713738|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-11-08|||May 2003||2003-05-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)|Open Label, Phase I/II Trial of Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura (ITP)in Children and Adolescents|Completed||Phase 1/Phase 2|36|Actual|Neufeld, Ellis J, MD, PhD||1|||f||||t||||||||||2017-10-11 02:22:15.775069|2017-10-11 02:22:15.775069
NCT01713725|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-02-04|||March 2012||2012-03-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|February 2016|Actual|2016-02-01||Interventional|||Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria|Multicenter, Double- Blinded, Placebo- Controlled, Randomized, Cross-over (2x2) Clinical Trial, to Assess Efficacy and Safety of a New Indication for Omalizumab (Xolair®, Novartis) in Autoimmune and no Autoimmune Chronic Urticaria.|Enrolling by invitation||Phase 2|20|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||f||||||||||2017-10-11 02:22:15.889035|2017-10-11 02:22:15.889035
NCT00000602|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-09-15|||April 1994||1994-04-01|October 2005|2005-10-01|March 1997|Actual|1997-03-01|||||Interventional|||Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.262773|2017-10-11 04:19:08.262773
NCT01713712|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2013-04-18|||December 2012||2012-12-01|April 2013|2013-04-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Access to Nutritional Services and the Effect on Maternal Weight Gain|Ease of Access to Nutritional Services and the Effect on Maternal Weight in an Obese Urban Population|Unknown status|Recruiting|N/A|120|Anticipated|Abington Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:22:16.00878|2017-10-11 02:22:16.00878
NCT01713699|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-10-22|||September 2012||2012-09-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|||Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases|Determining the Sensitivity and Specificity of Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases|Unknown status|Recruiting|N/A|100|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-11 02:22:16.116315|2017-10-11 02:22:16.116315
NCT01713686|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-03-02|2015-01-20||October 2012||2012-10-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Evaluation of the Ulthera System for the Treatment of the Decolletage|Prospective, Multi-center, Pivotal Trial Evaluating the Safety and Effectiveness of the Ulthera® System for Improvement in Lines and Wrinkles of the Décolletage|Completed||N/A|129|Actual|Ulthera, Inc||1|||f||||t||||||||||2017-10-11 02:22:16.255646|2017-10-11 02:22:16.255646
NCT01713673|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-06-28|||December 2011||2011-12-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|June 2012|Actual|2012-06-01||Interventional|||Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis|Feasibility Study: A Prospective, Parallel, Randomized, Sham-controlled, Blinded Pilot Trial of the Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis|Completed||N/A|20|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-11 02:22:16.635254|2017-10-11 02:22:16.635254
NCT01713660|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-06-04|2013-04-05||November 2012||2012-11-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Corneal Incisions With the IntraLase iFS Femtosecond Laser System|A MULTI-CENTER PROSPECTIVE STUDY TO EVALUATE THE USE OF THE INTRALASE iFS™ FEMTOSECOND LASER SYSTEM TO CREATE CLEAR CORNEAL INCISIONS AND PARACENTESIS INCISIONS FOR CATARACT SURGERY|Completed||N/A|37|Actual|Abbott Medical Optics||1|||f||||f||||||||||2017-10-11 02:22:16.761005|2017-10-11 02:22:16.761005
NCT01713647|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2013-07-24|||October 2012||2012-10-01|October 2012|2012-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions|Comparative, Randomized,, Single Dose, Open-label, Crossover Bioequivalence Study of LOSANET AM PLUS 10mg/100mg/12.5 mg Tablets (One Tablet) of (PHARMALINE, Lebanon) Versus NORVASC 10mg Tablets (One Tablet) of (Pfizer Canada Inc., Kirkland (Quebec)) and HYZAAR 100mg/12.5 Tablets (One Tablet) of (Merck Sharp & Dohme, Quimica de Puerto Rico, Inc, Road 2 Km. 60.3, Sabana Hoyos, Arecibo, PR 00688 for Merck Sharp & Dohme B.V. Haarlem, The Netherlands) in Healthy Subjects Under Fasting Conditions.|Completed||Phase 1|39|Actual|Pharmaceutical Research Unit, Jordan||2|||f||||||||||||||2017-10-11 02:22:16.962215|2017-10-11 02:22:16.962215
NCT01713634|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-11-13|||January 2009||2009-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ProK||Dietary Intake Modifications to Protect Against Changes in Bone Metabolism|Dietary Intake Can Predict and Protect Against Changes in Bone Metabolism During Spaceflight and Recovery|Completed||N/A|17|Actual|National Aeronautics and Space Administration (NASA)||2|||f||||f||||||||||2017-10-11 02:22:17.041739|2017-10-11 02:22:17.041739
NCT01713621|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-03-17|2016-12-19||March 2013||2013-03-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||"Analysed:
Safety population: 25 patients Intent to Treat population: 23 patients Per Protocol population: 22 patients
Pharmacokinetic (PK) population:
Noncompartmental PK Analysis:19 patients Population PK Analysis: 22 patients"|OZ439 PhIIa Study in Plasmodium Falciparum: Extended Observation|The Extended Observation Over a Period of 28 Days of the Effects of Single Doses of OZ439 on the Recrudescence of Plasmodium Falciparum Malaria - a PhIIa, Open Label Study in Adult Patients|Completed||Phase 2|25|Actual|Medicines for Malaria Venture||2|||f||||f||||||||No||2017-10-11 02:22:17.158959|2017-10-11 02:22:17.158959
NCT01713608|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-03-12|2015-03-12||November 2012||2012-11-01|March 2015|2015-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||34 subjects were enrolled with all 34 completing the study.|A Dose-escalation Study to Investigate Safety and Toleration of OZ439|A Randomised, Placebo-controlled, Dose-escalation Study to Investigate Safety and Toleration of OZ439 OD for 3 Days to Healthy Male and Female Volunteers|Completed||Phase 1|34|Actual|Medicines for Malaria Venture||3|||f||||f||||||||||2017-10-11 02:22:17.637921|2017-10-11 02:22:17.637921
NCT01713595|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2015-08-14|||October 2013||2013-10-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety Study of Inhaled Saline in Acute Lung Injury|Inhaled Hypertonic Saline for the Treatment of Acute Lung Injury|Withdrawn||Phase 1|0|Actual|Mayo Clinic||1||difficult getting subjects|f||||f||||||||||2017-10-11 02:22:18.335761|2017-10-11 02:22:18.335761
NCT01713582|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-02-23|||December 2012||2012-12-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||A Phase I, Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/MK-8628 in Hematologic Malignancies (MK-8628-001)|A Phase I, Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/MK-8628 in Hematologic Malignancies|Completed||Phase 1|141|Actual|Oncoethix GmbH||2|||f||||t||||||||||2017-10-11 02:22:18.445348|2017-10-11 02:22:18.445348
NCT01713569|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-11-01|||October 2012||2012-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Feasibility Study: Histological Characterization After Treatment With the Ulthera® System|Feasibility Study: Histological Characterization of Dermal and Subdermal Thermal Coagulation Points in Rhytidectomy Patients After Treatment With the Ulthera® System|Terminated||N/A|2|Actual|Ulthera, Inc||6||Slow subject enrollment; study to be obtained is no longer required.|f||||f||||||||||2017-10-11 02:22:18.551608|2017-10-11 02:22:18.551608
NCT01713556|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-02-21|||November 2012||2012-11-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|May 2017|Anticipated|2017-05-01||Interventional|REDUCTRAUMA2||Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol : a Multisite Trial|Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol : a Multisite Trial|Recruiting||Phase 2|56|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 02:22:18.677223|2017-10-11 02:22:18.677223
NCT00000603|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-12|||September 1996||1996-09-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cord Blood Stem Cell Transplantation Study (COBLT)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.318332|2017-10-11 04:19:08.318332
NCT01713543|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-09-04|||December 2012||2012-12-01|September 2015|2015-09-01||||April 2015|Actual|2015-04-01||Interventional|||Community-based Falls Prevention Program for the Elderly|Multifactorial, Evidence-based Program of Screening, Risk Modification and Physical Therapy to Prevent Falls Among Vulnerable Elderly Recently Discharged From Hospital to the Community.|Completed||N/A|354|Actual|National University, Singapore||2|||f||||f||||||||||2017-10-11 02:22:18.796342|2017-10-11 02:22:18.796342
NCT01713530|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-02-09|2015-10-16|2014-01-24|February 2013||2013-02-01|February 2017|2017-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||The full analysis set (FAS) included all randomised subjects. The statistical evaluation of the FAS followed the intention-to-treat (ITT) principle and subjects contributed to the evaluation “as randomised”.|A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin|A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin|Completed||Phase 3|274|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:22:18.903257|2017-10-11 02:22:18.903257
NCT01713517|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-10-25|||April 2011||2011-04-01|October 2012|2012-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Impact of Insecticide Resistance on Vector Control|Impact of Insecticide Resistance in Anopheles Arabiensis on the Effectiveness of Malaria Vector Control in Sudan|Unknown status|Recruiting|Phase 4|28000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 02:22:19.628979|2017-10-11 02:22:19.628979
NCT01713504|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-05-17|||June 29, 2010|Actual|2010-06-29|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SHE||Identification of New Markers in the Hypereosinophilic Syndrome|Identification of New Markers in the Hypereosinophilic Syndrome|Active, not recruiting||N/A|41|Actual|University Hospital, Lille||3|||f||||f|f|f||||||No||2017-10-11 02:22:19.760149|2017-10-11 02:22:19.760149
NCT01713491|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-10-26|||November 2011||2011-11-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|OPHELIE-COG||Pre-stroke Cognitive Status and Thrombolytic Therapy|Influence of the Pre-existing Cognitive Status on the Outcome in Patients Treated by Thrombolytic Therapy for Acute Cerebral Ischaemia|Completed||N/A|205|Actual|University Hospital, Lille|||3||f||||t||||||||No||2017-10-11 02:22:19.843547|2017-10-11 02:22:19.843547
NCT01713478|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-02-03|||December 2011||2011-12-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CIRRHECHO||Subclinical Myocardial Dysfunction in Patients With Hepatic Cirrhosis|An Integrated Approach of Subclinical Myocardial Dysfunction in Patients With Hepatic Cirrhosis: Echocardiography, Specific Biomarkers, and Vascular Assessment|Completed||N/A|100|Actual|Carol Davila University of Medicine and Pharmacy||2|||f||||f||||||||||2017-10-11 02:22:20.002751|2017-10-11 02:22:20.002751
NCT01713465|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-10-23|||March 2012||2012-03-01|October 2012|2012-10-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Interventional|||Use of Computers to Prevent Metabolic Syndrome|An Innovative Informatics Platform to Deliver a Multidimensional Intervention to Prevent and Manage Metabolic Syndrome|Unknown status|Recruiting|N/A|750|Anticipated|Asian Institute of Public Health||1|||f||||t||||||||||2017-10-11 02:22:20.16189|2017-10-11 02:22:20.16189
NCT01713452|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2014-05-19|||December 2008||2008-12-01|May 2014|2014-05-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||A Randomized Trial of Ostomy Closure Techniques|A Randomized Trial of Ostomy Closure Techniques: An Outcomes Evaluation of Primary Closure Versus Pursestring Closure|Completed||N/A|125|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 02:22:20.289302|2017-10-11 02:22:20.289302
NCT01713439|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-06-07|||December 1997||1997-12-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|January 2001|Actual|2001-01-01||Interventional|CYCHEALL||Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL|Phase 1 Study of Chemokine and Cytokine Gene Modified Allogeneic Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using a Retroviral Vector (CYCHEALL)|Completed||Phase 1|32|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 02:22:20.429701|2017-10-11 02:22:20.429701
NCT01713426|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-01-07|||July 2012||2012-07-01|January 2016|2016-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ELEVATE||A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment|Qutenza Versus Pregabalin in Subjects With Peripheral Neuropathic Pain: an Open-label, Randomized, Multicenter, Non-inferiority Efficacy and Tolerability Study|Completed||Phase 4|568|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 02:22:20.609456|2017-10-11 02:22:20.609456
NCT01713413|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-04-14|||February 2012||2012-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases|Effects of an Oxymizer Versus Conventional Nasal Cannula on Endurance Time in Patients With Chronic Obstructive Pulmonary Disease IV (COPD) or Interstitial Lung Disease (ILD)|Completed||N/A|67|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 02:22:21.093721|2017-10-11 02:22:21.093721
NCT01713400|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-08-16|2015-07-15||February 25, 2013|Actual|2013-02-25|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|October 27, 2014|Actual|2014-10-27||Interventional|Ustekinumab|All participating recipients|Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease|Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation|Active, not recruiting||Phase 2|54|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-10-11 02:22:21.235955|2017-10-11 02:22:21.235955
NCT01713166|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2016-06-15|||March 2013||2013-03-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Colloid and Crystalloid on the Microcirculatory Alterations During Off-pump Coronary Artery Bypass Surgery||Completed||N/A|120|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:22:24.951248|2017-10-11 02:22:24.951248
NCT01713374|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2015-03-31|||October 2012||2012-10-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|PAN||Physiological Assessment of the Endothelium - Circadian Rhythm and Role of the Sympathetic Nervous System|Studies on the Physiological Meaning of Flow-mediated Constriction, Flow-mediated Dilatation and Vasomotion/Flowmotion: Circadian Variability and Role of the Sympathetic Nervous System.|Completed||N/A|40|Actual|Johannes Gutenberg University Mainz||4|||f||||f||||||||||2017-10-11 02:22:21.887224|2017-10-11 02:22:21.887224
NCT01713361|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2014-08-25|||October 2012||2012-10-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty|An Open-label, Randomized, Active Comparator-Controlled, Adaptive Parallel-group Phase 2 Study to Assess the Safety and Efficacy of Multiple Doses of ISIS 416858 Administered Subcutaneously to Patients Undergoing Total Knee Arthroplasty|Completed||Phase 2|315|Actual|Ionis Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-11 02:22:22.030415|2017-10-11 02:22:22.030415
NCT01713348|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-02-04|2015-02-26||October 2012||2012-10-01|February 2016|2016-02-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|SIGN||Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes|Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes|Completed||Phase 4|105|Actual|Abbott Diabetes Care||2|||f||||f||||||||||2017-10-11 02:22:22.261521|2017-10-11 02:22:22.261521
NCT01713335|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-04-24|||October 2012||2012-10-01|October 2012|2012-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|Pro-BPCO||Proteasis Evaluation in COPD|Proteasis Evaluation in COPD|Unknown status|Recruiting|N/A|120|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples Without DNA|"     Sputum   "|||2017-10-11 02:22:23.005659|2017-10-11 02:22:23.005659
NCT01713322|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2012-12-21|||November 2012||2012-11-01|December 2012|2012-12-01||||September 2013|Anticipated|2013-09-01||Interventional|||Testing Educational Materials in a Paediatric Setting|Testing Educational Materials About Immunizations in a Paediatric Setting|Unknown status|Recruiting|Phase 3|160|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-11 02:22:23.100302|2017-10-11 02:22:23.100302
NCT01713309|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2012-10-25|||January 1996||1996-01-01|October 2012|2012-10-01|September 1998|Actual|1998-09-01|June 1998|Actual|1998-06-01||Interventional|HBP-Neupogen||Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)|Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With Granulocyte Colony-stimulating Factor (Filgrastim)|Completed||Phase 2/Phase 3|59|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 02:22:23.195126|2017-10-11 02:22:23.195126
NCT01713296|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2015-10-07|||November 2011||2011-11-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Pazopanib in Relapsed and Refractory Small Cell Lung Cancer|A Phase II Trial of Pazopanib, in Relapsed and Refractory Small Cell Lung Cancer (SCLC)|Completed||Phase 2|58|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-10-11 02:22:23.285442|2017-10-11 02:22:23.285442
NCT01713283|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-11-18|2014-11-18||October 2012||2012-10-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug|Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection|A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 HCV Infection|Completed||Phase 2|60|Actual|Gilead Sciences||2|||t||||f||||||||||2017-10-11 02:22:23.406936|2017-10-11 02:22:23.406936
NCT01713270|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2013-07-04|||July 2012||2012-07-01|July 2013|2013-07-01|July 2015|Anticipated|2015-07-01|October 2014|Anticipated|2014-10-01||Interventional|RSDforAF||Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation|Safety and Effectiveness Study of Percutaneous Catheter-based Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation|Unknown status|Recruiting|N/A|200|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 02:22:24.038772|2017-10-11 02:22:24.038772
NCT01713257|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-10-22|||January 2011||2011-01-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|ROSIED||Study of Arginine Free IED in Critically Ill Patients.|A Comparative Randomized Controlled Study of Arginine Free Immunoenhancing Diet and Isocaloric, Isonitrogenous Formula in Critically Ill Patients|Completed||Phase 4|172|Actual|Thai Otsuka Pharmaceutical Co.,Ltd.||2|||f||||t||||||||||2017-10-11 02:22:24.249731|2017-10-11 02:22:24.249731
NCT01713244|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2015-11-19|||October 2012||2012-10-01|November 2015|2015-11-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma|A Randomized Controlled Trial of Radiofrequency Ablation Assisted Hepatectomy and Hepatectomy Alone in the Treatment of Advanced Hepatocellular Carcinoma|Recruiting||N/A|150|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 02:22:24.349377|2017-10-11 02:22:24.349377
NCT01713231|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2014-09-08|||September 2012||2012-09-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|March 2013|Actual|2013-03-01||Interventional|||Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta|Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta|Completed||Phase 4|60|Actual|Shriners Hospitals for Children||2|||f||||t||||||||||2017-10-11 02:22:24.452477|2017-10-11 02:22:24.452477
NCT01713218|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-22|||December 2012||2012-12-01|October 2012|2012-10-01|December 2016|Anticipated|2016-12-01|June 2014|Anticipated|2014-06-01||Interventional|NEOPACHI-001||Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer|Evaluation of Tumoral Perfusion Modification by Dynamic Imaging After Neoadjuvant Chemotherapy Combining Gemcitabine and a Hedgehog Inhibitor (Vismodegib) in Patients With Resectable Pancreatic Adenocarcinoma|Unknown status|Not yet recruiting|Early Phase 1|21|Anticipated|Erasme University Hospital||1|||f||||f||||||||||2017-10-11 02:22:24.542983|2017-10-11 02:22:24.542983
NCT01713205|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-22|||October 2012||2012-10-01|October 2012|2012-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|PSCAT||Prediction Study of Complications After Severe Trauma|Identifying Severe Trauma Patients at High Risk of Post-traumatic Complications|Unknown status|Recruiting|N/A|2000|Anticipated|Daping Hospital and the Research Institute of Surgery of the Third Military Medical University|||1||f||||t||||||Samples With DNA|"     whole blood, serum, white cells, urine and tissue   "|||2017-10-11 02:22:24.662347|2017-10-11 02:22:24.662347
NCT01713153|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-02-24|||June 2012||2012-06-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in Senegal|Preventing Postpartum Hemorrhage: Examining Two Strategies for PPH Prevention in Communities: Misoprostol and Oxytocin Uniject in Senegal|Completed||N/A|1365|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 02:22:25.053496|2017-10-11 02:22:25.053496
NCT01713140|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2013-06-24|||October 2012||2012-10-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Experimental Study of Strength Training to Activate the Quadriceps Muscle After Total Knee Arthroplasty|Central (CNS) Activation of the Quadriceps Muscle During Strength Training With Repetitions to Contraction Failure After Total Knee Arthroplasty|Completed||N/A|20|Actual|Copenhagen University Hospital, Hvidovre||1|||f||||t||||||||||2017-10-11 02:22:25.165528|2017-10-11 02:22:25.165528
NCT01713127|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-11-18|||August 2012||2012-08-01|October 2012|2012-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Remifentanil in Ventilated Preterm Infants|Efficacy and Safety of Remifentanil in Preterm Infants Who Require Ventilator Support|Terminated||Phase 1/Phase 2|12|Actual|Seoul National University Hospital||2||declined enrollment|f||||t||||||||||2017-10-11 02:22:25.250986|2017-10-11 02:22:25.250986
NCT01713114|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2012-10-22|||October 2012||2012-10-01|October 2012|2012-10-01||||August 2013|Anticipated|2013-08-01||Interventional|||Effects of a Variety of Meals on Satiety|A Randomized, Controlled Crossover Trial to Assess the Effects of Varying Meals on Satiety|Unknown status|Recruiting|N/A|38|Anticipated|The Hillshire Brands Company||4|||f||||||||||||||2017-10-11 02:22:25.358424|2017-10-11 02:22:25.358424
NCT01713101|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-05-14|||October 2012||2012-10-01|May 2014|2014-05-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|TAUGIB||Tranexamic Acid for Upper Gastrointestinal Bleeding|Early Administration of Intravenous Tranexamic Acid for Upper Gastrointestinal Bleeding Prior to Endoscopy|Unknown status|Recruiting|Phase 3|414|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 02:22:25.460568|2017-10-11 02:22:25.460568
NCT01713088|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-23|||November 2003||2003-11-01|October 2012|2012-10-01|February 2014|Anticipated|2014-02-01|September 2010|Actual|2010-09-01||Interventional|||A Trial of Multisystemic Therapy in UK a Statutory Therapeutic Intervention for Young Offenders||Unknown status|Active, not recruiting|N/A|108|Actual|The Brandon Centre, London||2|||f||||t||||||||||2017-10-11 02:22:25.573233|2017-10-11 02:22:25.573233
NCT01713075|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-10-27|||November 2012||2012-11-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients|Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for COPD Patients|Completed||N/A|1183|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:22:25.662185|2017-10-11 02:22:25.662185
NCT01713062|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-03-20|||January 2012||2012-01-01|March 2017|2017-03-01|April 2030|Anticipated|2030-04-01|April 2015|Actual|2015-04-01||Observational|VITAS||Longterm-Evaluation of Vitelene® Against Standard|Randomised Prospective Multicenter Longterm-Evaluation of the Survival Rate of the Implant, Wear and Periprosthetic Osteolysis of Highly Cross-linked Polyethylene With and Without Addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X)|Active, not recruiting||N/A|400|Actual|Aesculap AG|||2||f||||f||||||||||2017-10-11 02:22:25.915675|2017-10-11 02:22:25.915675
NCT01713049|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2012-10-23|||August 2010||2010-08-01|August 2010|2010-08-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound|Use of 18F-FLT Positron Emission Tomography to Evaluate the Suspicious Findings on Mammography and Breast Ultrasound: A Pilot Study|Unknown status|Recruiting|N/A|70|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 02:22:26.053416|2017-10-11 02:22:26.053416
NCT01713036|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-07-06|2016-07-19||November 30, 2012|Actual|2012-11-30|July 2017|2017-07-01|July 31, 2014|Actual|2014-07-31|July 31, 2014|Actual|2014-07-31||Interventional||Safety analysis set included all subjects who received at least one administration of trial medication and had at least one subsequent safety assessment.|Oral Bioavailability and Mass Balance Trial With Pimasertib|A Phase I, Open-Label, Single Center Trial to Investigate the Mass Balance, Metabolite Profile and Oral Bioavailability of Pimasertib in Cancer Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|6|Actual|Merck KGaA||1|||f||||f||||||||||2017-10-11 02:22:26.171302|2017-10-11 02:22:26.171302
NCT01713023|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-04-14|||March 2013||2013-03-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Interventional|TAS1R2||Fructose and Glucose and TAS1R2 in Type 1 Diabetes|Effect of Fructose and Glucose and TAS1R2 in Glucose, Triglycerides, Uremia, Oxidative Stress, Feelings Related to Food Intake of Individuals With Type 1 Diabetes|Completed||N/A|16|Actual|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-11 02:22:26.833969|2017-10-11 02:22:26.833969
NCT01712984|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-04-20|2013-12-15||October 2012||2012-10-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years|Immunogenicity and Safety Trial of Quadrivalent Influenza Vaccine Administered by Intradermal Route in Adult Subjects Aged 18 Through 64 Years|Completed||Phase 3|3360|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:22:27.214287|2017-10-11 02:22:27.214287
NCT01712594|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-05-10|||May 2013||2013-05-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight Period|Feasibility and Safety of a Closed Loop Insulin Delivery System (Aka AAGC) With an Artificially Induced Calibration Error During the Overnight Period|Completed||N/A|9|Actual|Medtronic Diabetes||2|||f||||f|f|t|t||t|||No||2017-10-11 02:22:35.712586|2017-10-11 02:22:35.712586
NCT01712971|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2013-09-16|||November 2012||2012-11-01|September 2013|2013-09-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Observational|||Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery|Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Randomized Trial on Standard Open Versus Minimally Invasive Surgery|Withdrawn||N/A|0|Actual|University Hospital, Gasthuisberg|||2||f||||f||||||||||2017-10-11 02:22:28.942009|2017-10-11 02:22:28.942009
NCT01712958|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2012-10-23|||November 2012||2012-11-01|October 2012|2012-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|CRC||Quantifying Micro RNA Levels of Colon|Quantifying Micro RNA Levels to Obtain a Micro RNA Signature of Colon Tumor Phenotypes and Sub Phenotypes|Unknown status|Not yet recruiting|N/A|100|Anticipated|Meir Medical Center|||1||f||||t|||||||"     human colon and rectal tumors, tumor adjacent and normal tissues   "|||2017-10-11 02:22:29.042134|2017-10-11 02:22:29.042134
NCT01712945|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-23|||June 2012||2012-06-01|October 2012|2012-10-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Interventional|CAM-THY||Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis|Keratinocyte Growth Factor - Promoting Thymic Reconstitution and Preventing Autoimmunity After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis|Unknown status|Recruiting|Phase 1/Phase 2|86|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:22:30.843076|2017-10-11 02:22:30.843076
NCT01712919|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-03-21|||May 2010||2010-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)|IMRT With Concurrent Chemotherapy and Cetuximab Against Locoregionally Advanced NPC: a Phase 1 Study|Completed||Phase 1/Phase 2|61|Actual|Jiangsu Cancer Institute & Hospital||1|||f||||t||||||||||2017-10-11 02:22:30.953251|2017-10-11 02:22:30.953251
NCT01712906|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-04-26|||October 2012||2012-10-01|October 2012|2012-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children|A Phase II Clinical Trial for Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children|Completed||Phase 1|300|Actual|Chinese Academy of Medical Sciences||18|||f||||t||||||||||2017-10-11 02:22:31.043194|2017-10-11 02:22:31.043194
NCT01712893|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2017-08-24|||June 2009||2009-06-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer|A Phase III,Randomized,Open Label Study Comparing Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa up to 2-3 Years for ≤ 45 Year Old Pre-menopausal Hormone Receptor-positive Breast Cancer|Completed||Phase 3|216|Actual|Fudan University||2|||f||||t||||||||||2017-10-11 02:22:31.154417|2017-10-11 02:22:31.154417
NCT01712880|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2013-11-05|||October 2012||2012-10-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Treatment of Acute Periprosthetic Total Hip Arthroplasty Infections|The Treatment of the Acute Periprosthetic Hip Infection After Uncemented Total Hip Arthroplasty: A Randomized Study Comparing Open Debridement Component Retention (ODCR) With Modular Exchange Versus One Stage Exchange Arthroplasty|Withdrawn||N/A|0|Actual|OrthoCarolina Research Institute, Inc.||2||The study was not feasible.|f||||t||||||||||2017-10-11 02:22:31.226906|2017-10-11 02:22:31.226906
NCT01712867|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-08-06|||October 2012||2012-10-01|September 2012|2012-09-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels|The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels in Hypertriglyceridemia Patients: A Double-blind, Randomized, Noninferiority Trial|Unknown status|Active, not recruiting|Phase 4|206|Anticipated|Enzymotec||2|||f||||||||||||||2017-10-11 02:22:31.305987|2017-10-11 02:22:31.305987
NCT01712854|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-21|2016-07-22|2016-03-23||March 2012||2012-03-01|July 2016|2016-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Symbicort on the Ventilatory Kinematics|Investigating the Effects of Symbicort on the Ventilatory Kinematics in Patients With Obstructive Disease With Optoelectronic Plethysmography|Terminated||Phase 4|9|Actual|Columbia University||2||Closed by study sponsor; PI left the institution; responsible party changed to Columbia|f||||f||||||||||2017-10-11 02:22:31.388292|2017-10-11 02:22:31.388292
NCT01712841|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2015-04-21|||October 2012||2012-10-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|NEAMD||Non-exudative Age-related Macular Degeneration|A Prospective Study Examining Patients With Non-exudative Age-related Macular Degeneration (NEAMD) of Different Severity|Unknown status|Recruiting|N/A|20|Anticipated|Oregon Health and Science University|||3||f||||||||||||||2017-10-11 02:22:31.573357|2017-10-11 02:22:31.573357
NCT01712828|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2016-03-29|||October 2012||2012-10-01|March 2016|2016-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males|A Phase 1, Open-Label, Two-Part, Fixed-Sequence Crossover Study to Evaluate the Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Male Subjects|Completed||Phase 1|31|Actual|Celgene Corporation||2|||f||||f||||||||||2017-10-11 02:22:31.674484|2017-10-11 02:22:31.674484
NCT01712815|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-04-08|||November 22, 2013|Actual|2013-11-22|April 2017|2017-04-01|November 22, 2018|Anticipated|2018-11-22|November 22, 2017|Anticipated|2017-11-22||Interventional|||PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer|Development of an In Vivo Cell Proliferation Marker for PET Assessment of Chemotherapeutic Response in Cancer|Suspended||N/A|25|Anticipated|University of Southern California||1||lack of drug|f||||t||||||||||2017-10-11 02:22:32.002807|2017-10-11 02:22:32.002807
NCT01712802|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-03-27|||December 2012|Actual|2012-12-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|DAG||Multicenter Study of Denture Adhesive|Multicenter Randomized Clinical Study of Denture Adhesive to Establish the Guideline|Completed||N/A|200|Actual|Nihon University||3|||f||||f||||||||||2017-10-11 02:22:32.113271|2017-10-11 02:22:32.113271
NCT01712581|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-09-05|||August 2012||2012-08-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|HeartMS||Heart Map Study -Determination of Myocardial Relaxation Times Values in Healthy Volunters|Determination of Myocardial Relaxation Times Values in Healthy Volunters|Completed||N/A|175|Actual|University Hospital, Rouen||1|||f||||t||||||||||2017-10-11 02:22:35.836761|2017-10-11 02:22:35.836761
NCT01712789|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-22|2017-09-28|||November 6, 2012|Actual|2012-11-06|September 2017|2017-09-01|December 11, 2019|Anticipated|2019-12-11|December 11, 2019|Anticipated|2019-12-11||Interventional|STRATUS||Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma|A Multicenter, Single-arm, Open-label Study With Pomalidomide in Combination With Low Dose Dexamethasone in Subjects With Refractory or Relapsed and Refractory Multiple Myeloma|Active, not recruiting||Phase 3|682|Actual|Celgene||1|||f||||t||||||||||2017-10-11 02:22:32.235413|2017-10-11 02:22:32.235413
NCT01712776|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-01-16|2014-01-09||April 2011||2011-04-01|January 2017|2017-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||pain after spray with placebo or vapocoolant|Vapocoolant (Pain Ease) Use for Venipuncture|Prospective, Randomized, Blinded,Comparative Efficacy and Safety Trial of Vapocoolant (Pain Ease Medium Stream) for Venipuncture|Completed||Phase 4|100|Actual|The Cleveland Clinic|This study enrolled only adults. No pediatric patients were enrolled. However, an earlier study by Farion KJ et al in CMAJ in 2008 found that the use of a vapocoolant (pain-ease) significantly decreased the pain of intravenous cannulation in children|2|||f||||t||||||||No||2017-10-11 02:22:32.570782|2017-10-11 02:22:32.570782
NCT01712763|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-04-25|||November 2012||2012-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Degarelix in the Treatment of Endometriosis Recurrence|Treatment With Long Acting GnRH Antagonist Degarelix in Women With Endometriosis Recurrence|Completed||Phase 3|100|Actual|Centre for Endocrinology and Reproductive Medicine, Italy||2|||f||||t||||||||||2017-10-11 02:22:32.883466|2017-10-11 02:22:32.883466
NCT01712750|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-23|2012-10-25|||February 2011||2011-02-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|||||Observational|||Near-Infrared Spectroscopic (NIRS) Tissue Oxygen Saturation and the Vascular Occlusion Test in Cardiac Surgery Patients||Completed||N/A|13|Actual|London Health Sciences Centre|||1||f||||f||||||||||2017-10-11 02:22:32.97806|2017-10-11 02:22:32.97806
NCT01712737|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2012-10-25|||January 2011||2011-01-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||The Effects of Ad Libitum Pre-Meal Raisin Snack on Satiety and Food Intake in Children|The Effects of Ad Libitum Pre-Meal Raisin Snack on Satiety and Food Intake in Children|Completed||N/A|26|Actual|University of Toronto||4|||f||||f||||||||||2017-10-11 02:22:33.043319|2017-10-11 02:22:33.043319
NCT01712724|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2016-10-31|||March 2013||2013-03-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|TRI-RAvA||Effects of Combined Resistance and Aerobic Training vs Aerobic Training on Cognition and Mobility Following Stroke|Effects of Combined Resistance and Aerobic Training vs Aerobic Training on Cognition and Mobility Following Stroke|Completed||N/A|72|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 02:22:33.113384|2017-10-11 02:22:33.113384
NCT01712711|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2013-03-21|2013-03-21||September 2012||2012-09-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease|The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Diabetic Subjects With Non-alcoholic Fatty Liver Disease|Completed||Phase 2|40|Actual|Tehran University of Medical Sciences|No limitation existed.|2|||f||||f||||||||||2017-10-11 02:22:33.198757|2017-10-11 02:22:33.198757
NCT01712698|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-02-03|||January 2014||2014-01-01|February 2014|2014-02-01|June 2017|Anticipated|2017-06-01|January 2016|Anticipated|2016-01-01||Observational|||Diffusion Tensor Imaging to Assess the Functional Outcomes of Adults With Cervical Spinal Cord Injuries|Diffusion Tensor MRI to Assess Subacute Functional Outcomes in Patients With Acute Cervical Spinal Cord Injuries|Unknown status|Recruiting|N/A|20|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 02:22:33.509418|2017-10-11 02:22:33.509418
NCT01712685|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2017-01-10|2014-07-31||October 2012||2012-10-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Imaging Studies of Kidney Cancer Using 18F-VM4-037|PET Imaging Of Renal Cell Carcinoma With 18F-VM4-037: A Phase II Pilot Study For Detection Of Disease And Correlation With VHL Mutation Status|Terminated||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)|Study was closed to accrual because imaging agent was no longer available.|1||Study was closed to accrual because imaging agent was no longer available.|f||||f||||||||No||2017-10-11 02:22:33.771607|2017-10-11 02:22:33.771607
NCT01712672|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2017-06-30|||October 9, 2012||2012-10-09|May 9, 2017|2017-05-09|January 7, 2016|Actual|2016-01-07|January 7, 2016|Actual|2016-01-07||Observational|||Bacterial Arrangement on the Teeth|Bacterial Arrangement in Supragingival Biofilms|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:22:34.958253|2017-10-11 02:22:34.958253
NCT01712646|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2017-07-06|||October 5, 2012||2012-10-05|June 20, 2016|2016-06-20||||June 20, 2016|Actual|2016-06-20||Interventional|||Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia|The Use of Daily, Intranasal Oxytocin for the Treatment of Childhood-Onset Schizophrenia (COS), a Randomized Double-Blind Trial|Terminated||Phase 1/Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:22:35.266213|2017-10-11 02:22:35.266213
NCT01712568|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-22|||September 2008||2008-09-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets|AN OPEN LABEL, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, CROSSOVER, BIOEQUIVALENCE STUDY OF ROPINIROLE HYDROCHLORIDE CR 2mg TABLETS OF LUPIN LIMITED, INDIA, COMPARING WITH THAT OF REQUIP XL OF GLAXOSMITHKLINE RESEARCH TRIANGLE PARK, IN HEALTHY ADULT MALE SUBJECTS|Completed||Phase 1|12|Actual|Lupin Ltd.||2|||f||||t||||||||||2017-10-11 02:22:35.938788|2017-10-11 02:22:35.938788
NCT01712555|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2017-03-08|||December 2011||2011-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets|Autologous Fat Grafting to Anophthalmic Sockets With PRP (Platelet Rich Plasma) Using a Closed Cannula Technique|Recruiting||N/A|10|Anticipated|Fox, Donald Munro, M.D., P.C.||1|||f||||t||||||||||2017-10-11 02:22:36.031769|2017-10-11 02:22:36.031769
NCT01712542|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-20|2013-06-01|||October 2012||2012-10-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Curcumin Bioavailability in Glioblastoma Patients|Measurement of Intratumoral Concentration of the Nontoxic Natural Compound Curcumin in Glioblastoma Patients|Completed||Early Phase 1|15|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||Samples Without DNA|"     Tumor tissue   "|||2017-10-11 02:22:36.172457|2017-10-11 02:22:36.172457
NCT01712516|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-07-13|2015-05-27||December 2012||2012-12-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation|A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation|Completed||Phase 3|1001|Actual|Novartis||4|||f||||f||||||||||2017-10-11 02:22:36.408751|2017-10-11 02:22:36.408751
NCT01712503|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-22|||January 2013||2013-01-01|October 2012|2012-10-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||A Trial of Toric Versus Non-toric Intraocular Lenses in Phacoemulsification Cataract Surgery||Unknown status|Not yet recruiting|N/A|190|Anticipated|Western Sussex Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 02:22:38.769083|2017-10-11 02:22:38.769083
NCT01712490|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-07-31|||November 1, 2012|Actual|2012-11-01|July 2017|2017-07-01|March 1, 2020|Anticipated|2020-03-01|April 20, 2017|Actual|2017-04-20||Interventional|||Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma|A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma|Active, not recruiting||Phase 3|1334|Actual|Takeda||2|||f||||t||||||||||2017-10-11 02:22:38.88394|2017-10-11 02:22:38.88394
NCT01712477|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-19|||November 2011||2011-11-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||A Comparison of Propofol Versus Midazolam to Sedate Critically Brain Injury; Measurement of Cytokine Response and Assessment of Function|Propofol Versus Midazolam for Sedation in Mechanically Ventilated Critically Ill Patients Who Presented With Traumatic Brain Injury: Cytokine Response and Neuropsychological Assessment (IRRC#1201M)|Unknown status|Recruiting|Phase 4|30|Anticipated|Michigan State University||2|||f||||f||||||||||2017-10-11 02:22:39.542685|2017-10-11 02:22:39.542685
NCT01712464|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-09-22|||April 2012||2012-04-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Modulation of Reinforcement Learning|Modulation of Reinforcement Learning and Neuronal Activation in Ventral Stratum by Oxytocin - a Pilot Study at Autism Spectrum Disorder|Completed||N/A|46|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 02:22:39.641953|2017-10-11 02:22:39.641953
NCT01712451|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-03-05||2015-03-05|August 2011||2011-08-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|LIPO-102-CL-11||Dose-ranging Study|Dose-ranging Study of the Safety and Efficacy of Fluticasone Propionate and Salmeterol Xinafoate in Healthy Patients With Abdominal Contour Defects|Completed||Phase 2|200|Actual|Neothetics, Inc||5|||f||||f||||||||||2017-10-11 02:22:39.720746|2017-10-11 02:22:39.720746
NCT01712438|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-10-19|||February 2013||2013-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Human-cl-rhFVIII in Previously Untreated Patients|Immunogenicity, Efficacy and Safety of Treatment With Human-cl-rhFVIII in Previously Untreated Patients With Severe Hemophilia A|Active, not recruiting||Phase 3|110|Actual|Octapharma||1|||f||||t||||||||||2017-10-11 02:22:39.851695|2017-10-11 02:22:39.851695
NCT01712425|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-04-28|||October 2012||2012-10-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals|Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals With Early Viral Suppression After Initiation of Antiretroviral Therapy (HAART)|Completed||Phase 1|48|Actual|IrsiCaixa||4|||f||||f||||||||||2017-10-11 02:22:40.059113|2017-10-11 02:22:40.059113
NCT01712412|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2014-03-18|||October 2012||2012-10-01|July 2013|2013-07-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Phase 2a Study of IW-9179 to Treat Functional Dyspepsia||Terminated||Phase 2|10|Actual|Ironwood Pharmaceuticals, Inc.||2||Slow enrollment|f||||f||||||||||2017-10-11 02:22:40.155147|2017-10-11 02:22:40.155147
NCT01712230|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-07-17|||October 2012||2012-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|FAME||Females, Aging, Metabolism, and Exercise|Bioenergetic and Metabolic Consequences of the Loss of Ovarian Function in Women|Active, not recruiting||N/A|132|Anticipated|University of Colorado, Denver||3|||f||||f||||||||||2017-10-11 02:22:44.366369|2017-10-11 02:22:44.366369
NCT01671215|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-04-14|||August 2012||2012-08-01|April 2012|2012-04-01||||August 2014|Actual|2014-08-01||Observational|||Endometrial and Myometrial Changes, With and Without Fibroids|Endometrial and Myometrial Changes, With and Without Fibroids|Withdrawn||N/A|0|Actual|Meir Medical Center|||1|no enrollment|f||||f||||||||||2017-10-11 02:35:49.037269|2017-10-11 02:35:49.037269
NCT01712399|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-05-30|2017-02-28||January 28, 2013||2013-01-28|May 2017|2017-05-01|December 30, 2015|Actual|2015-12-30|December 30, 2015|Actual|2015-12-30||Interventional||The As-treated Population included participants who received at least one dose of mavrilimumab 100 mg every 2 weeks (Q2W).|A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis|An Open-label Extension Study to Evaluate the Long-term Safety of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis|Terminated||Phase 2|409|Actual|MedImmune LLC|The study was terminated after approximately 3 years due to future clinical development plans, including ethical considerations.|1||"The study was terminated after approximately 3 years due to future clinical development plans,   including ethical considerations."|f||||t||||||||||2017-10-11 02:22:40.30389|2017-10-11 02:22:40.30389
NCT01712386|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-10-02|||November 2012||2012-11-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Nitrate, Chronic Obstructive Pulmonary Disease (COPD) and Exercise|The Effects of Dietary Nitrate Supplementation on the Oxygen Cost of Moderate-Intensity Exercise and Functional Capacity in Mild-Moderate COPD Patients|Completed||N/A|13|Actual|NIHR Exeter Clinical Research Facility||1|||f||||f||||||||||2017-10-11 02:22:41.604294|2017-10-11 02:22:41.604294
NCT01712373|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-22|||December 2010||2010-12-01|October 2012|2012-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Ginseng in Treatment of Fatigue in Multiple Sclerosis|Study of Ginseng in Treatment of Fatigue in Multiple Sclerosis|Completed||Phase 2|60|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:22:41.705075|2017-10-11 02:22:41.705075
NCT01712360|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-06-03|2016-04-14||October 2012||2012-10-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Safety Analysis Set which is the subset of subjects who have been exposed to the study medication at least once|Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis|An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of NAFT-500 in Pediatric Subjects With Tinea Cruris and Tinea Pedis and NAFT-600 in Pediatric Subjects With Tinea Pedis|Completed||Phase 4|56|Actual|Merz Pharmaceuticals, LLC||4|||f||||f||||||||No||2017-10-11 02:22:41.927995|2017-10-11 02:22:41.927995
NCT01712347|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-07-01|||October 2012||2012-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer|AN OPEN-LABEL, MULTICENTER, NON-INTERVENTION, OBSERVATIONAL STUDY TO ASSESS THE EFFECT OF FIRST LINE BEVACIZUMAB TREATMENT WITH FLUOROPYRIMIDINE-BASED CHEMOTHERAPY (CTX) IN PATIENTS WITH METASTATIC COLORECTAL CANCER|Completed||N/A|351|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:22:42.753735|2017-10-11 02:22:42.753735
NCT01712334|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2014-03-31|2014-03-27||December 2012||2012-12-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Baseline measures were based on the modified Intent-to-Treat (mITT) population that included all participants randomized with both baseline and endpoint Forced Expiratory Volume in 1 second (FEV1) values for both treatment periods.|A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis|A Phase IV Multicenter, Randomized, Open Label, Two-Period, Crossover Study in Patients With Cystic Fibrosis to Evaluate the Comparable Efficacy and Safety of Pulmozyme Delivered by the eRapid Nebulizer System|Completed||Phase 4|99|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 02:22:42.873504|2017-10-11 02:22:42.873504
NCT01712308|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-06-07|||February 2013|Actual|2013-02-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Sotatercept (ACE-011) in Subjects With Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) and Anemia|A Phase-2, Prospective, Open-Label Study to Determine the Safety and Efficacy of Sotatercept (ACE-011) in Subjects With Myeloproliferative Neoplasm (MPN) -Associated Myelofibrosis and Anemia|Recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-11 02:22:43.249689|2017-10-11 02:22:43.249689
NCT01712295|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-22|||November 2011||2011-11-01|October 2012|2012-10-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts|New Formulation of Salicylate to Improve Treatment of Common Skin Warts|Unknown status|Recruiting|Phase 4|100|Anticipated|Grossman, Michael, D.P.M.||2|||f||||f||||||||||2017-10-11 02:22:43.360694|2017-10-11 02:22:43.360694
NCT01712282|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-03-13|||December 2012||2012-12-01|March 2013|2013-03-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|||Physical Activity Immediately After Acute Cerebral Ischemia 3|Physical Activity Immediately After Acute Cerebral Ischemia: Too Little or Too Much|Unknown status|Recruiting|N/A|20|Anticipated|Hillerod Hospital, Denmark||1|||f||||f||||||||||2017-10-11 02:22:43.457162|2017-10-11 02:22:43.457162
NCT01712269|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-02-28|||October 2012||2012-10-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Assessment of Sleep Apnea and Its Causes Before and After Weight Loss Surgery|Understanding the Role Obesity Plays in the Pathogenesis of Obstructive Sleep Apnea|Terminated||N/A|10|Actual|Brigham and Women's Hospital||1||PI and main Co-I (Dr Edwards) relocated locations|f||||f||||||||No||2017-10-11 02:22:43.538358|2017-10-11 02:22:43.538358
NCT01712256|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-01-11|2017-01-11||December 2012||2012-12-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Re-boost||Re-boosting of HIV-1 Infected Subjects With Vacc-4x|Re-boosting of Subjects Previously Included in the CT BI-Vacc-4x 2007/1 Study. An Open, Multicenter, Immunogenicity, Follow-up Re-boosting Study With Vacc-4x in Subjects Infected With HIV-1 Who Have Maintained an Adequate Response to ART|Completed||Phase 2|33|Actual|Bionor Immuno AS||1|||f||||t||||||||No|Participants have not provided informed consent for their anonymized individual data to be made available beyond that described in the patient information sheet.|2017-10-11 02:22:43.643033|2017-10-11 02:22:43.643033
NCT01712243|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Light to Maximize Vision, Minimize Insomnia|Toileting at Night in Older Adults: Light to Maximize Vision, Minimize Insomnia|Completed||N/A|29|Actual|VA Palo Alto Health Care System||3|||f||||f||||||||||2017-10-11 02:22:44.130786|2017-10-11 02:22:44.130786
NCT01712217|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-03-14|||October 2012||2012-10-01|March 2017|2017-03-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Interventional|||A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib|A Study of HSP90 Inhibitor AT13387 Alone and in Combination With Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1/Phase 2|228|Anticipated|Astex Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:22:44.463282|2017-10-11 02:22:44.463282
NCT01712204|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2014-11-24|2014-11-24||January 2013||2013-01-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||A total of 82 subjects were randomized and received at least one dose of study medication (the Intent-to-Treat [ITT] Population). The ITT Population was used for baseline/demographic, disposition, and safety summaries. The ITT Population was the primary analysis set for efficacy analyses.|A Proof-of-Concept Study of AC-201 to Prevent Gout Flares|A Randomized, Double-Blind, Placebo-Controlled Trial Of AC-201 In Subjects With Gout Initiating Urate-Lowering Therapy|Completed||Phase 2|82|Actual|TWi Biotechnology, Inc.||2|||f||||f||||||||||2017-10-11 02:22:44.67487|2017-10-11 02:22:44.67487
NCT01712191|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-01-24|||January 2011||2011-01-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant|Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant|Active, not recruiting||N/A|150|Anticipated|Active Implants||1|||f||||t||||||||||2017-10-11 02:22:44.942296|2017-10-11 02:22:44.942296
NCT01712178|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2014-06-10|2014-05-07||June 2012||2012-06-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety|Study to Assess the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of a New Adalimumab Formulation in Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|100|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 02:22:45.13715|2017-10-11 02:22:45.13715
NCT01712165|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2013-10-10|||June 2013||2013-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Micronutrient-supplemented Milk Study in Women of Childbearing Age|Micronutrient-supplemented Milk Study in Women of Childbearing Age|Completed||N/A|70|Actual|Fonterra Research Centre||2|||f||||f||||||||||2017-10-11 02:22:45.654288|2017-10-11 02:22:45.654288
NCT01712152|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-10-03|||October 2012||2012-10-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|April 2014|Actual|2014-04-01||Observational|||Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-study||Completed||N/A|20|Actual|Hospital Rudolfstiftung|||1||f||||||||||||||2017-10-11 02:22:45.75493|2017-10-11 02:22:45.75493
NCT01712139|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-19|||September 2007||2007-09-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan / Hydrochlorothiazide 300/25 mg Tablets Under Fasting Conditions|Completed||N/A|37|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:22:45.82982|2017-10-11 02:22:45.82982
NCT01712126|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-19|||September 2007||2007-09-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan / Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions|Completed||N/A|40|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:22:45.919894|2017-10-11 02:22:45.919894
NCT01712113|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-19|||August 2007||2007-08-01|October 2012|2012-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan Tablets Under Fasting Conditions|Completed||N/A|33|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:22:46.020714|2017-10-11 02:22:46.020714
NCT01712100|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-19|||August 2007||2007-08-01|October 2012|2012-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Irbesartan Tablets Under Fed Conditions|Completed||N/A|34|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:22:46.113479|2017-10-11 02:22:46.113479
NCT01712087|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-02-08|||October 2012||2012-10-01|February 2016|2016-02-01|July 2020|Anticipated|2020-07-01|February 2020|Anticipated|2020-02-01||Observational|||Long-term Surveillance of the MedStream Programmable Infusion System|Long-term Surveillance of the MedStream Programmable Infusion System for the Intrathecal Infusion of Baclofen in the Treatment of Spasticity|Terminated||N/A|2|Actual|Codman & Shurtleff|||1|Lack of enrollment|f||||t||||||||||2017-10-11 02:22:46.219144|2017-10-11 02:22:46.219144
NCT01712074|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2017-01-30|2016-08-26||November 2012||2012-11-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||One (1) of participant randomized but not treated appeared under placebo run-in including his/her discontinued and safety information|Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil|A Randomized, 18-week, Placebo-controlled, Double-blind, Parallel Group Study Of The Safety And Efficacy Of Pf-05212377 (Sam-760) In Subjects With Mild-to-moderate Alzheimer's Disease With Existing Neuropsychiatric Symptoms On A Stable Daily Dose Of Donepezil|Terminated||Phase 2|186|Actual|Pfizer||2||"The study was terminated October 23, 2015 as pre-specified, interim analysis futility criteria   were met. The termination was not due to safety concerns."|f||||t||||||||||2017-10-11 02:22:46.374326|2017-10-11 02:22:46.374326
NCT01712061|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-09-22|2015-09-22||December 2012||2012-12-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study To Evaluate The Efficacy And Safety Of Once-daily Administration Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) In Adults With Type 2 Diabetes And Overt Nephropathy|Completed||Phase 2|226|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:22:47.509375|2017-10-11 02:22:47.509375
NCT01712048|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-08-23|||September 2012||2012-09-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|IvU||Submucosal Injection EMR vs. Underwater EMR for Colorectal Polyps|Submucosal Injection Assisted Endoscopic Resection vs. Underwater EMR for Large Sessile Colorectal Polyps|Recruiting||N/A|320|Anticipated|California Pacific Medical Center Research Institute||2|||f||||f||||||||||2017-10-11 02:22:49.260126|2017-10-11 02:22:49.260126
NCT01712035|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-04-21|||October 2012||2012-10-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|NVAMD||Neovascular Age-related Macular Degeneration|OCT Evaluation of Treated and Untreated Choroidal Neovascular Membranes in Age-Related Macular Degeneration|Unknown status|Active, not recruiting|N/A|15|Anticipated|Oregon Health and Science University|||2||f||||||||||||||2017-10-11 02:22:49.366225|2017-10-11 02:22:49.366225
NCT01712022|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2014-09-09|||October 2012||2012-10-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Evaluation of Corneal Epithelial Thickness Mapping|Evaluation of Corneal Epithelial Thickness Mapping|Completed||N/A|88|Actual|Optovue|||3||f||||f||||||||||2017-10-11 02:22:49.445652|2017-10-11 02:22:49.445652
NCT01712009|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-02-09|2016-02-09||November 2012||2012-11-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|NOLAN|Full analysis set included all participants based on the randomization treatment group who received primary prophylaxis with pegfilgrastim.|NOLAN: Naproxen or Loratadine and Neulasta|Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim|Completed||Phase 2|600|Actual|Amgen||3|||f||||f||||||||||2017-10-11 02:22:49.580109|2017-10-11 02:22:49.580109
NCT01711996|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-22|||August 2012||2012-08-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|August 2012|Actual|2012-08-01||Observational|||The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction Patients||Unknown status|Recruiting|N/A|60|Anticipated|Yonsei University|||3||f||||f||||||||||2017-10-11 02:22:51.410118|2017-10-11 02:22:51.410118
NCT01711983|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-01-16|||October 2012||2012-10-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects|GORE® Septal Occluder Clinical Study: A Study to Evaluate Safety and Efficacy in the Treatment of Transcatheter Closure of Ostium Secundum Atrial Septal Defects (ASDs)|Active, not recruiting||N/A|400|Anticipated|W.L.Gore & Associates||1|||f||||t||||||||No||2017-10-11 02:22:51.481771|2017-10-11 02:22:51.481771
NCT01711970|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-08-17|||November 2012||2012-11-01|August 2016|2016-08-01||||January 2017|Anticipated|2017-01-01||Interventional|||A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian Cancer|A Phase I/II Trial of Multiple Dose VB-111 and Weekly Paclitaxel for the Treatment of Recurrent Platinum-Resistant Müllerian Cancer|Active, not recruiting||Phase 1/Phase 2|38|Anticipated|Vascular Biogenics Ltd. operating as VBL Therapeutics||1|||f||||t||||||||||2017-10-11 02:22:51.55426|2017-10-11 02:22:51.55426
NCT01711957|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-23|||January 2008||2008-01-01|October 2012|2012-10-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation|The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation|Unknown status|Enrolling by invitation|N/A|250|Anticipated|University of Zurich|||1||f||||t||||||||||2017-10-11 02:22:51.622301|2017-10-11 02:22:51.622301
NCT01711944|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-29|2017-01-06|||July 2012||2012-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Online Problem Solving Skills Training|Online Implementation of Problem Solving Skills Training for Mothers of Newly Diagnosed Childhood Cancer Patients|Recruiting||N/A|620|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 02:22:51.706915|2017-10-11 02:22:51.706915
NCT01711931|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-05-27|||October 2012||2012-10-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EVERBIOII||Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents|Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents|Completed||Phase 4|240|Actual|University of Freiburg||3|||f||||t||||||||||2017-10-11 02:22:51.816523|2017-10-11 02:22:51.816523
NCT01711918|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-10-24|2016-10-24||July 2012||2012-07-01|October 2016|2016-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis|Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis|Completed||N/A|9|Actual|University of Iowa||1|||f||||f||||||||||2017-10-11 02:22:51.909257|2017-10-11 02:22:51.909257
NCT01711905|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-04-19|||November 2012||2012-11-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Study on the Effects of a Recommendation Based Supply of Vitamin D3 in Healthy Volunteers|Study on the Effects of a Recommendation Based Supply of Vitamin D3 in Healthy Volunteers - a Randomized Trail|Completed||N/A|107|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||t||||||||||2017-10-11 02:22:52.140343|2017-10-11 02:22:52.140343
NCT01711892|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-04-16|||March 2012||2012-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy|A Randomized Controlled Clinical Trial on the Effects of Recreational Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: The FC Prostate Study|Completed||N/A|57|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 02:22:52.239182|2017-10-11 02:22:52.239182
NCT01711866|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-02-25|2014-02-25||September 2012||2012-09-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Baseline characteristics refer to the Safety Set. The Safety Set consists of all subjects who had at least one patch application.|A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease|An Open-Label, Multicenter, Multinational Study to Assess the Feasibility of Switching Therapy From Pramipexole or Ropinirole to the Rotigotine Transdermal System and Its Effect on Motor and Non-Motor Symptoms in Subjects With Advanced Idiopathic Parkinson's Disease Phase 4|Completed||Phase 4|87|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 02:22:52.415267|2017-10-11 02:22:52.415267
NCT01711164|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-11-28|||January 2014||2014-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Observational|||The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis|The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis|Completed||N/A|106|Actual|University Health Network, Toronto|||2||f||||t||||||||||2017-10-11 02:23:07.7773|2017-10-11 02:23:07.7773
NCT01711853|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2015-01-09|2014-12-19||October 2012||2012-10-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Treated set (TS) which included all patients who had taken at least 1 dose of trial medication.|Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.|An Exploratory Study to Investigate the Pharmacokinetics and Effects of DABIgatran Etexilate in Patients With Stable Severe RENAL Disease: DabiRenal|Completed||Phase 1|19|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:22:54.198741|2017-10-11 02:22:54.198741
NCT01711840|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-07-15|||November 2012||2012-11-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy|Symbicort Turbuhaler 30/60 Clinical Experience Investigation for Treatment With Symbicort as Maintenance Therapy and as Needed in Response to Symptoms|Completed||N/A|2409|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:22:54.399663|2017-10-11 02:22:54.399663
NCT01711827|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2012-10-19|||February 2012||2012-02-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects|A Phase 1, Open-label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects|Completed||Phase 1|21|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:22:54.547401|2017-10-11 02:22:54.547401
NCT01711814|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-19|2016-06-22|||September 2012||2012-09-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study|A Phase 2, Open-Label, Non-Comparative, Multi-Center Extension Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study|Completed||Phase 2|611|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-11 02:22:54.644269|2017-10-11 02:22:54.644269
NCT01711801|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-11-01|||October 2012||2012-10-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers|A Single-Center, Randomized, Investigator/Subject-Blind, Adaptive Single-Ascending Dose, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including the Effect of Food), and Pharmacodynamics of RO5545965 Following Oral Administration in Healthy Subjects.|Completed||Phase 1|53|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 02:22:54.921192|2017-10-11 02:22:54.921192
NCT01711788|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-10-03|||November 2012||2012-11-01|October 2017|2017-10-01|October 3, 2017|Actual|2017-10-03|October 3, 2017|Actual|2017-10-03||Interventional|||Intrabone Infusion of Umbilical Cord Blood Stem Cells|A New Approach to Improve Long-term Hematopoietic Recovery After Allogeneic Umbilical Cord Blood Transplantation in Children - Intrabone Infusion of Umbilical Cord Blood Stem Cells|Completed||Phase 2|15|Actual|St. Justine's Hospital||1|||f||||t||||||||||2017-10-11 02:22:55.004255|2017-10-11 02:22:55.004255
NCT01711775|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-11-01|||November 2012||2012-11-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers|A Single-center, Non-randomized, Open-label Study to Assess the Pharmacokinetics of Aleglitazar (RO0728804) After Administration of Single and Multiple Oral Doses of 150 µg Tablet in Healthy Chinese Subjects|Completed||Phase 1|16|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:22:55.09876|2017-10-11 02:22:55.09876
NCT01711762|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-11-01|||September 2012||2012-09-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers|A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0973 Following Single Oral Dose Administration in Healthy Male Subjects|Completed||Phase 1|6|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 02:22:55.183283|2017-10-11 02:22:55.183283
NCT01711749|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-06-19|||February 25, 2013|Actual|2013-02-25|June 2017|2017-06-01|March 13, 2013|Actual|2013-03-13|March 13, 2013|Actual|2013-03-13||Interventional|||Rosuvastatin Calcium Bioequivalence Study - Fast|Study of Bioequivalence Between Two Formulations of 20 mg Rosuvastatin Calcium Tablets, Administered Under Fasting to Healthy Volunteers of Both Genders, Being the Test Formulation Manufactured by Laboratorios Phoenix S.A.I.C.F/Argentina for GlaxoSmithKline Brasil Ltda. and the Reference Formulation (Crestor®) Commercialized by AstraZeneca do Brasil Ltda.|Completed||Phase 1|60|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:22:55.258494|2017-10-11 02:22:55.258494
NCT01711736|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-09-22|2014-02-20||November 2012||2012-11-01|September 2016|2016-09-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age|Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) When Administered in Children|Completed||Phase 3|606|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:22:55.400142|2017-10-11 02:22:55.400142
NCT01711723|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-07-24|||October 29, 2012|Actual|2012-10-29|July 2017|2017-07-01|March 25, 2013|Actual|2013-03-25|March 25, 2013|Actual|2013-03-25||Interventional|||A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment|An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and in Subjects With Severe Renal Impairment|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:22:56.164301|2017-10-11 02:22:56.164301
NCT01711710|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-07-12|||October 2010||2010-10-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|October 2014|Actual|2014-10-01||Interventional|||Clinical Trial to Evaluate the Safety and Efficacy of Breast Implant|Clinical Trial to Evaluate the Safety and Efficacy of Cohesive Silicone Gel-Filled Breast Implant (CoSBI) in Women Aged 22 and Over With Breast Reconstruction or Augmentation Mammoplasty.|Active, not recruiting||N/A|103|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 02:22:56.277715|2017-10-11 02:22:56.277715
NCT01711151|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-17|||November 2012||2012-11-01|October 2012|2012-10-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Observational|||Interstitial Lung Disease Questionnaire|Questionnaire Study for Patients With Interstitial Lung Disease|Unknown status|Not yet recruiting|N/A|304|Anticipated|University of East Anglia|||4||f||||f||||||||||2017-10-11 02:23:07.857729|2017-10-11 02:23:07.857729
NCT01711697|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-02-13|||September 2012||2012-09-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Suspended||Phase 1|24|Anticipated|Emory University||1||Toxicity assessment|f||||t||||||||||2017-10-11 02:22:56.375307|2017-10-11 02:22:56.375307
NCT01711684|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-09-06|||October 16, 2012|Actual|2012-10-16|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|June 22, 2015|Actual|2015-06-22||Interventional|||Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)|An Open Label Study Employing the Topical Immunomodulator Diphenylcyclopropenone in a Stabilized Gel to Treat Cutaneous Metastases|Active, not recruiting||Phase 1|13|Anticipated|Rockefeller University||1|||f||||f||||||||||2017-10-11 02:22:56.57506|2017-10-11 02:22:56.57506
NCT01711671|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-03-08|||May 2013||2013-05-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|A Pilot Study of DKN-01 and Lenalidomide (Revlimid®)/Dexamethasone Versus Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|8|Actual|Leap Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 02:22:56.66687|2017-10-11 02:22:56.66687
NCT01711658|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-07-19|||March 18, 2013|Actual|2013-03-18|July 2017|2017-07-01|March 31, 2023|Anticipated|2023-03-31|March 31, 2020|Anticipated|2020-03-31||Interventional|TRYHARD||TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.|TRYHARD: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb®) for Non-HPV Locally Advanced Head and Neck Cancer With Concurrent Chemoradiation|Active, not recruiting||Phase 2|142|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 02:22:56.799488|2017-10-11 02:22:56.799488
NCT01711645|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-03-23|2016-11-23||October 26, 2012|Actual|2012-10-26|April 8, 2015|2015-04-08|August 28, 2015|Actual|2015-08-28|August 28, 2015|Actual|2015-08-28||Interventional|||Tdap Vaccine in Post-Partum Women|Phase IV, Open Label Trial to Evaluate Immunogenicity of Tdap Vaccine in Post-Partum Women to Optimize Vaccination Schedule for Women Who May Have a Subsequent Child|Completed||Phase 4|55|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f|||||t|f|||f|||||2017-10-11 02:22:56.98314|2017-10-11 02:22:56.98314
NCT01711632|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-09-18|||October 2012|Actual|2012-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia|A Phase II Study of the BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia|Active, not recruiting||Phase 2|36|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:22:57.951682|2017-10-11 02:22:57.951682
NCT01711606|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-03-02|||March 2013||2013-03-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|EXPLAIN||EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes|EXPLAIN - FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes|Terminated||N/A|75|Actual|Novartis|||1||f||||||||||||||2017-10-11 02:22:58.185806|2017-10-11 02:22:58.185806
NCT01711593|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-09-14|||January 2013||2013-01-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MGH-002||Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma|Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma|Completed||Phase 1|43|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:22:58.262277|2017-10-11 02:22:58.262277
NCT01711580|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2015-05-11|||March 2013||2013-03-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Observational|||Re-irradiation of High Grade Gliomas: a Quality of Life Study|Re-irradiation of High Grade Gliomas: a Quality of Life Study|Withdrawn||N/A|0|Actual|Maastricht Radiation Oncology|||1|Another study was commenced for this patient group|f||||t||||||||||2017-10-11 02:22:58.369082|2017-10-11 02:22:58.369082
NCT01711567|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2016-11-08|||April 2013||2013-04-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|December 2015|Actual|2015-12-01||Interventional|STEEP||Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir|Switching to Tenofovir Disoproxil Fumarate vs. Continuing Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response During Entecavir Therapy: STEEP Study|Completed||Phase 4|60|Actual|Korea University||2|||f||||t||||||||||2017-10-11 02:22:58.486221|2017-10-11 02:22:58.486221
NCT01711554|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-09-07|||February 4, 2013|Actual|2013-02-04|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma|A Phase I Study of Lenalidomide and Anti-GD2 Mab Ch14.18 +/- Isotretinoin in Patients With Refractory/Recurrent Neuroblastoma|Suspended||Phase 1|62|Anticipated|National Cancer Institute (NCI)||1||Scheduled interim monitoring|f||||f||||||||||2017-10-11 02:22:58.58763|2017-10-11 02:22:58.58763
NCT01710631|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-18|||February 2001||2001-02-01|October 2012|2012-10-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia|A Randomized, Double-Blind, Placebo-Controlled and Open-Label Twelve Month Study of the Safety of (S)-Zopiclone in Adult Subjects With Insomnia|Completed||Phase 3|791|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 02:23:15.447003|2017-10-11 02:23:15.447003
NCT01711528|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-09-04|||December 19, 2012|Actual|2012-12-19|August 2017|2017-08-01||||June 30, 2016|Actual|2016-06-30||Interventional|||Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma|Phase 1 Clinical Trial of a Novel CDK Inhibitor Dinaciclib (SCH 727965) in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma|Active, not recruiting||Phase 1|41|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 02:22:58.915609|2017-10-11 02:22:58.915609
NCT01711515|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-09-28|||October 1, 2012|Actual|2012-10-01|April 2017|2017-04-01||||March 9, 2017|Actual|2017-03-09||Interventional|||Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer|A Phase I Trial of Sequential Ipilimumab After Chemoradiation for the Primary Treatment of Patients With Locally Advanced Cervical Cancer Stages IB2/IIA With Positive Para-Aortic Lymph Nodes Only and Stage IIB/IIIB/IVA With Positive Lymph Nodes|Active, not recruiting||Phase 1|34|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 02:22:59.231441|2017-10-11 02:22:59.231441
NCT01711502|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-01-29|||January 2013||2013-01-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Epidemiology and Management of Metastatic Breast Cancer|Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A Retrospective Cohort Study|Completed||N/A|128|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:22:59.409463|2017-10-11 02:22:59.409463
NCT01711489|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-18|||March 2012||2012-03-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult Subjects|A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:22:59.525436|2017-10-11 02:22:59.525436
NCT01711476|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-01-20|||October 2012||2012-10-01|January 2013|2013-01-01|January 2013|Anticipated|2013-01-01|January 2013|Actual|2013-01-01||Interventional|MealTimePCOS||Meal Timing on Glucose and Hyperandrogenism in PCOS Women|Influence of Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome|Unknown status|Recruiting|N/A|60|Anticipated|Hospital de Clinicas Caracas||2|||f||||t||||||||||2017-10-11 02:22:59.614171|2017-10-11 02:22:59.614171
NCT01711463|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-07-24|||December 5, 2012|Actual|2012-12-05|July 2017|2017-07-01|June 4, 2013|Actual|2013-06-04|June 4, 2013|Actual|2013-06-04||Interventional|||Relovair PD PK in Chinese Healthy Subjects|A Randomized, Double-blind, Placebo-controlled, Four-way Crossover Study to Evaluate and Compare the Pharmacodynamics and Pharmacokinetics of Fluticasone Furoate /Vilanterol in Different Dose Combination (50/25mcg, 100/25mcg and 200/25mcg) After Single and Repeat Dose Administration From a Novel Dry Powder Device in Healthy Chinese Subjects|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:22:59.727016|2017-10-11 02:22:59.727016
NCT01711450|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2016-03-22|||December 2012||2012-12-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Success of Paravertebral Blocks in Analgesia for Interventional Hepatic Procedures|Randomised Double Blind Controlled Study of the Effectiveness of Paravertebral Nerve Block in Decreasing Analgesia Requirements and Improving Patient Experience During Interventional Hepatic Procedures.|Withdrawn||N/A|0|Actual|McGill University Health Center||2||"Institutional Ethics Board concern regarding sham procedure, requiring modifications that are   not feasible within the man-power limitations of our institution."|f||||f||||||||No||2017-10-11 02:22:59.836291|2017-10-11 02:22:59.836291
NCT01711437|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-11-05|||January 2011||2011-01-01|October 2012|2012-10-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Different Bowel Preparations for Colonoscopy In Children|EFFICACY, TOLERABILITY, AND SAFETY OF DIFFERENT BOWEL PREPARATIONS FOR COLONOSCOPY IN CHILDREN|Unknown status|Recruiting|Phase 4|400|Anticipated|Azienda Policlinico Umberto I||4|||f||||t||||||||||2017-10-11 02:22:59.929902|2017-10-11 02:22:59.929902
NCT01711424|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2014-01-29|2014-01-29||September 2012||2012-09-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease||Completed||N/A|1209|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:23:00.067725|2017-10-11 02:23:00.067725
NCT01711411|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2013-11-25|||November 2012||2012-11-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Observational Study of Male Circumcision Using PrePex Device|Prospective Observational Study of Male Circumcision Using the PrePex Device in Routine Clinical Settings in Kenya|Completed||Phase 4|427|Actual|FHI 360|||1||f||||f||||||||||2017-10-11 02:23:01.007369|2017-10-11 02:23:01.007369
NCT01711398|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-02-11|||July 2012||2012-07-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|IP N02||Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors|A Non-randomized, Open-label, Multi-centric Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Repeated Intravenous IPP-204106N Administrations in Adult Patients With Advanced Solid Tumors|Completed||Phase 1/Phase 2|15|Actual|Elro Pharma||1|||f||||t||||||||||2017-10-11 02:23:01.118761|2017-10-11 02:23:01.118761
NCT01711385|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-18|||April 2009||2009-04-01|October 2012|2012-10-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Undiagnosed Diabetes in a Dental Setting|Screening for Undiagnosed Diabetes in a Dental Setting - A New Paradigm for Dental Practice|Unknown status|Active, not recruiting|N/A|101|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 02:23:01.249327|2017-10-11 02:23:01.249327
NCT01711359|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2017-07-14|2017-03-10|2015-05-08|November 2012||2012-11-01|July 2017|2017-07-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|RA-BEGIN|Modified Intent-to-Treat (mITT) population includes all randomized participants who received at least 1 dose of the study drug.|A Study in Participants With Moderate to Severe Rheumatoid Arthritis|A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had Limited or No Treatment With Disease-Modifying Antirheumatic Drugs|Completed||Phase 3|588|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-10-11 02:23:01.669126|2017-10-11 02:23:01.669126
NCT01711346|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-12-03||2015-09-14|October 2012||2012-10-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|S303 RBC||A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells|A Randomized, Controlled, Single-Blind, 2-Period Crossover Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells|Completed||Phase 2|42|Actual|Cerus Corporation||2|||f||||f||||||||||2017-10-11 02:23:05.321044|2017-10-11 02:23:05.321044
NCT01711333|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-18|2012-10-23|||October 2012||2012-10-01|October 2012|2012-10-01|April 2015|Anticipated|2015-04-01|September 2014|Anticipated|2014-09-01||Interventional|||A Multicenter, Therapeutic Used Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease||Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:23:05.414118|2017-10-11 02:23:05.414118
NCT01711320|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2013-03-16|||September 2012||2012-09-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Omeprazole on Metformin|Effect of Omeprazole, an OCT Inhibitor, on the Pharmacodynamics and Pharmacokinetics of Metformin, Involved the Mechanism of Attenuating AMPK Phosphorylation|Completed||Phase 1|20|Actual|Xijing Hospital||2|||f||||t||||||||||2017-10-11 02:23:05.517197|2017-10-11 02:23:05.517197
NCT01711307|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-08-10|||October 2012||2012-10-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|AchillesRCT||Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon|Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon: A Multi-centered Randomized Control Trial Using Standardized Objective and Subjective Outcome Measurement to Determine Rerupture Rate.|Recruiting||N/A|220|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 02:23:05.628533|2017-10-11 02:23:05.628533
NCT01711294|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-08-03|||January 8, 2013|Actual|2013-01-08|August 2017|2017-08-01|July 7, 2017|Actual|2017-07-07|July 7, 2017|Actual|2017-07-07||Interventional|||Evaluation of PCLs Using Three EUS-FNA Needles|A Multicenter, Prospective, Randomized Study on Endosonographic Evaluation of Pancreatic Cystic Lesions Using 22 G, 19 G, and Flexible 19 G Fine Needle Aspiration|Completed||Phase 4|250|Actual|Boston Scientific Corporation||3|||f||||f||||||||||2017-10-11 02:23:05.759117|2017-10-11 02:23:05.759117
NCT01711281|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-07-14|||October 2012||2012-10-01|July 2015|2015-07-01||||June 2015|Actual|2015-06-01||Interventional|BIODetectHFII||Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement|Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement|Completed||Phase 4|68|Actual|Biotronik SE & Co. KG||1|||f||||f||||||||||2017-10-11 02:23:05.88313|2017-10-11 02:23:05.88313
NCT01711268|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-05-13|||May 2012||2012-05-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|CRESTO||Sunitinib Drug Levels and Outcomes in Kidney Cancer|Correlating Renal Cell Cancer Treatment Efficacy With Sunitinib Therapeutic Levels and Outcomes|Unknown status|Recruiting|Phase 2|35|Anticipated|Western Sydney Local Health District|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:23:06.017546|2017-10-11 02:23:06.017546
NCT01711255|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-07-27|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Evaluation of Coagulation in Multiple Sclerosis|A Cross-Sectional Study of Coagulation in Multiple Sclerosis|Completed||N/A|69|Actual|Bastyr University|||2||f||||f||||||Samples With DNA|"     Six (6) whole blood vials of 10ml each will be collected from each subject. Three (3) will be     stored for future use. Three will be used immediately for coagulation analysis using     Sonoclot.   "|||2017-10-11 02:23:06.097913|2017-10-11 02:23:06.097913
NCT01711242|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2016-04-27|||January 2012||2012-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma|Phase III Randomized Trial of Adjuvant XELOX Chemotherapy and XELOX With Concurrent Capecitabine and Radiotherapy for Gastric Adenocarcinoma With D2 Dissection|Recruiting||Phase 3|300|Anticipated|Wenzhou Medical University||2|||f||||||||||||||2017-10-11 02:23:06.186653|2017-10-11 02:23:06.186653
NCT01711229|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-01-27|||December 2015||2015-12-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Equality Study of Ofirmev vs Oral Acetaminophen|Prospective Randomized Equivalence Trial Comparing the Analgesic Efficacy of Ofirmev® Compared to a 1.5 Gram Dose of Oral Acetaminophen for Arthroscopic Rotator Cuff Repair|Unknown status|Not yet recruiting|Phase 4|114|Anticipated|Babiash, Kimberly H., M.D.||2|||f||||f||||||||||2017-10-11 02:23:06.300372|2017-10-11 02:23:06.300372
NCT01711216|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2015-11-23|2015-06-09||August 2012||2012-08-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational||Full Analysis Set (FAS): All eligible patients who received at least 1 dose of program drug and at most 6 treatment cycles|Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine Clinical Practice in Russia, Ukraine, Kazakhstan and Uzbekistan|A Post-Marketing, Prospective, Multicenter, Observational Program: Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine Clinical Practice in Russia, Ukraine, Kazakhstan and Uzbekistan|Completed||N/A|999|Actual|Abbott|Follow up period was limited to 6 months of observation. Pregnancy incidence was not the aim of research, however, spontaneous pregnancies were observed in 56 (5.6%) patients following standard dosages of dydrogesterone for irregular cycle treatment.||1||f||||f||||||||||2017-10-11 02:23:06.596017|2017-10-11 02:23:06.596017
NCT01711203|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-01-18|||October 2012||2012-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||The Addition of a Pilates Program for Short-Term Improvements in Patients With Spondylolysis or Spondylolisthesis|The Addition of a Pilates Program for Short-Term Improvements in Self Report and Physical Functions With Patients With Spondylolysis or Spondylolisthesis: A Randomized Clinical Trial|Completed||N/A|25|Actual|Walsh University||2|||f||||f||||||||||2017-10-11 02:23:07.289088|2017-10-11 02:23:07.289088
NCT01711190|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2013-06-22|||January 2012||2012-01-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||Astigmatism Post-trabeculectomy|The Effect of Trabeculectomy on Astigmatism.|Completed||N/A|52|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 02:23:07.386518|2017-10-11 02:23:07.386518
NCT01711177|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-06-16|2016-06-16||October 2012||2012-10-01|June 2016|2016-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma|Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma|Completed||N/A|14|Actual|Université de Montréal||3|||f||||t||||||||||2017-10-11 02:23:07.471908|2017-10-11 02:23:07.471908
NCT01711138|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-04-07|||October 2012||2012-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|ASAP-Jr||An Intervention Study to Assess the Role of the Built Environment on Physical Activity and Active Transportation to School in Children and Youth|Active Streets, Active People - Junior: An Integrated Community Partnership to Enhance Physical Activity and Active Transport to School in Children and Youth|Unknown status|Recruiting|N/A|998|Anticipated|University of British Columbia|||2||f||||f||||||||||2017-10-11 02:23:07.941359|2017-10-11 02:23:07.941359
NCT01711125|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-08-07|||March 2013||2013-03-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|BacALD||Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease|Exploring the Efficacy and Biobehavioural Basis of Baclofen in the Treatment of Alcoholic Liver Disease|Completed||Phase 3|104|Actual|South West Sydney Local Health District||3|||f||||t|f|f|||f|||||2017-10-11 02:23:08.025534|2017-10-11 02:23:08.025534
NCT01711112|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-05-14|||August 2010||2010-08-01|October 2012|2012-10-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional|||Salvage Docetaxel for Pretreated Urothelial Cancer|A Phase II Study of Salvage Docetaxel in Patients With Advanced Urothelial Cancer Failed to Prior Chemotherapy|Completed||Phase 2|31|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 02:23:08.406374|2017-10-11 02:23:08.406374
NCT01711099|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-10-24|||October 2012||2012-10-01|October 2012|2012-10-01||||September 2013|Anticipated|2013-09-01||Interventional|ANGEL||Efficacy of Extracorporeal Shockwave Myocardial Revascularization|Hungarian Study on the Efficacy of Extracorporeal Shockwave Myocardial Revascularization in Patients With Therapy-refracter Angina Pectoris|Unknown status|Recruiting|N/A|14|Anticipated|Salus Ltd.||1|||f||||||||||||||2017-10-11 02:23:08.489818|2017-10-11 02:23:08.489818
NCT01711086|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2012-10-17|||October 2012||2012-10-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Safety and Efficacy of the Inspiromatic Inhaler in Comparison to the Aerolizer Inhaler When Delivering Formoterol|Double Blind Placebo Controlled Trial Checking the Safety and Efficacy of the Inspiromatic Inhaler in Comparison to the Aerolizer Inhaler When Delivering Formoterol|Unknown status|Not yet recruiting|Phase 1/Phase 2|30|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 02:23:08.605897|2017-10-11 02:23:08.605897
NCT01711073|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-01-23|||October 2012||2012-10-01|January 2013|2013-01-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease|Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease|Unknown status|Recruiting|Phase 1|15|Anticipated|Proteonomix, Inc.||1|||f||||t||||||||||2017-10-11 02:23:08.698276|2017-10-11 02:23:08.698276
NCT01711060|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-10-10|||December 2010||2010-12-01|October 2016|2016-10-01||||January 2014|Actual|2014-01-01||Interventional|||A Comparison of Balloon Catheter Versus Ocytocin for Cervical Ripening on Scarred Uterus With Unfavorable Cervix||Completed||N/A|204|Actual|Poitiers University Hospital||2|||f||||||||||||||2017-10-11 02:23:08.783089|2017-10-11 02:23:08.783089
NCT01711034|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-04-01|||June 2012||2012-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer|A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer|Completed||Phase 1|145|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||No||2017-10-11 02:23:08.969995|2017-10-11 02:23:08.969995
NCT01711021|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-10-14||2014-04-01|October 2012||2012-10-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System Compared to Placebo in Children & Adolescents With ADHD|A Randomized, Double-Blind, Placebo-Controlled, Crossover, Laboratory Classroom Study to Evaluate the Safety and Efficacy of d-Amphetamine Transdermal Drug Delivery System (d-ATS) Compared to Placebo in Children and Adolescents With ADHD|Completed||Phase 2|106|Actual|Noven Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:23:09.063076|2017-10-11 02:23:09.063076
NCT01711008|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2013-04-30|||September 2012||2012-09-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Breakfast Size Prior to Morning Exercise on Cognition, Mood and Appetite in Habitually Active Women|The Effect of Breakfast Size Prior to Morning Exercise on Cognition, Mood and Appetite Later in the Day in Habitually Active Women|Completed||N/A|24|Actual|Northumbria University||3|||f||||f||||||||||2017-10-11 02:23:09.155162|2017-10-11 02:23:09.155162
NCT01710982|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2012-10-17|||February 2012||2012-02-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Evaluate the Safety of TZP-101 (IV Ulimorelin) Administered Post-Operatively in Patients Who Have Undergone Partial Bowel Resection|A Multicentre, Randomised, Double-blind, Placebo-Controlled Study to Evaluate the Safety of TZP-101 (IV Ulimorelin) Administered Post-Operatively in Patients Who Have Undergone Partial Bowel Resection|Completed||Phase 3|27|Actual|Norgine||2|||f||||||||||||||2017-10-11 02:23:09.436854|2017-10-11 02:23:09.436854
NCT01710969|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-01-10|||September 2008||2008-09-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Individual and Group Intervention Formats With Aggressive Children|Individual and Group Intervention Formats With Aggressive Children|Completed||N/A|360|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 02:23:09.525749|2017-10-11 02:23:09.525749
NCT01710956|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-10-17|||March 2011||2011-03-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer|Randomized Phase II Study of Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|84|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 02:23:09.610662|2017-10-11 02:23:09.610662
NCT01710943|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-10-17|||September 2010||2010-09-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|Web CBT||Web-based CBT for Recent Veterans Experiencing Problems With Trauma Symptoms or Alcohol/Drug Use|Web-based CBT for Substance Misusing and PTSD Symptomatic OEF/OIF Veterans|Unknown status|Recruiting|Phase 1/Phase 2|216|Anticipated|National Development and Research Institutes, Inc.||2|||f||||f||||||||||2017-10-11 02:23:09.737453|2017-10-11 02:23:09.737453
NCT01710930|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2016-02-19|||July 2012||2012-07-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Protocol TARC-ABPA|Interest of TARC Serum Marker for Follow-up of Patients With Allergic Broncho-Pulmonary Aspergillosis (ABPA), Excluding Cystic Fibrosis|Active, not recruiting||N/A|29|Actual|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 02:23:09.869889|2017-10-11 02:23:09.869889
NCT01710917|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-11-11|||September 2012||2012-09-01|November 2013|2013-11-01|January 2014|Anticipated|2014-01-01|November 2013|Anticipated|2013-11-01||Observational|||A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment|The Efficacy of Targinact® Treatment With Respect to Quality of Life (Overall Health Assessment) in Chronic Severe Pain Patients Compared to Previous Analgesic Treatment: a Non-interventional, Observational Study.|Unknown status|Recruiting|Phase 4|1800|Anticipated|Mundipharma CVA|||1||f||||||||||||||2017-10-11 02:23:09.977088|2017-10-11 02:23:09.977088
NCT01710904|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-04-07|||September 2012||2012-09-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Observational|||A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain|The Evaluation of Targinact® in Daily Practice, With Regards to Pain Relief and Constipation, in Chronic Severe Pain Patients Compared to Previous Prolonged Release Oxycodone Treatment: a Non-interventional, Observational Study.|Completed||N/A|68|Actual|Mundipharma CVA|||1||f||||||||||||||2017-10-11 02:23:10.097878|2017-10-11 02:23:10.097878
NCT01710878|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2013-11-24|||February 2008||2008-02-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|SYNERGY||Performance and Safety of a Second Generation Antimicrobial Graft in Abdominal Position|Multicenter Clinical Study Assessing the Performance and the Safety of the Second Generation Antimicrobial Graft in Abdominal Position|Completed||N/A|60|Actual|Maquet Cardiovascular||1|||f||||f||||||||||2017-10-11 02:23:10.331532|2017-10-11 02:23:10.331532
NCT01710865|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-10-18|||January 2013||2013-01-01|October 2012|2012-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Two Sealant Materials Over 5 Years|Evidence Based Effectiveness of Pit and Fissure Sealants Applied By Students and Paediatric Dentists After (Three) Five Years.|Not yet recruiting||N/A|400|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 02:23:10.47136|2017-10-11 02:23:10.47136
NCT01710852|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-08-24|||October 2012||2012-10-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|ASET||Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation|A Phase 2 Study to Assess the Antiarrhythmic and Symptomatic Effect of the Second Generation Antisense Oligonucleotide ISIS 329993 Targeting CRP in Patients With Paroxysmal Atrial Fibrillation|Completed||Phase 2|7|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 02:23:10.594955|2017-10-11 02:23:10.594955
NCT01710839|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-08-08|2017-02-22||October 2012||2012-10-01|August 2017|2017-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|WAVE||Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion|A Phase IV Open Label Trial of the Safety, Tolerability and Efficacy of 0.5mg Ranibizumab Intravitreal Injections Combined With Wide Field Angiography Guided Panretinal Photocoagulation vs. 0.5mg Ranibizumab Intravitreal Injection Monotherapy in Subjects With Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Who Incompletely Respond to at Least 2 Consecutive Intravitreal Injections in the Past 4 Months.|Completed||Phase 4|30|Actual|Greater Houston Retina Research||2|||f||||f||||||||||2017-10-11 02:23:10.724973|2017-10-11 02:23:10.724973
NCT01710826|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2014-03-17|||October 2012||2012-10-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy Volunteers|A Single-center, Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending 14-day Repeated Oral Doses of Genz-682452 in Healthy Male and Female Subjects|Completed||Phase 1|36|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:23:11.418909|2017-10-11 02:23:11.418909
NCT01710813|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-06-07|||March 20, 2015||2015-03-20|June 2017|2017-06-01|April 2021|Anticipated|2021-04-01|March 2021|Anticipated|2021-03-01|4 Years|Observational [Patient Registry]|||Alglucosidase Alfa Pompe Safety Sub-Registry|A Prospective Safety Sub-Registry to Assess Anaphylaxis and Severe Allergic Reactions, and Severe Cutaneous and Systemic Immune Complex Mediated Reactions With Alglucosidase Alfa Treatment|Recruiting||N/A|100|Anticipated|Sanofi|||1||f||||t||||||||||2017-10-11 02:23:11.52249|2017-10-11 02:23:11.52249
NCT01710267|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-03-31|||March 2013||2013-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Observational|RivaMoS2||Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)|Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)|Completed||N/A|20|Actual|Luzerner Kantonsspital|||1||f||||t||||||Samples Without DNA|"     Plasma samples for coagulation assays   "|||2017-10-11 02:23:28.458012|2017-10-11 02:23:28.458012
NCT01710800|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-01-08|2012-10-24||September 2008||2008-09-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy|Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy|Completed||N/A|41|Actual|Walter Reed National Military Medical Center|Single center study. Relatively small number of patients studied, although recruitment goal reached.|2|||f||||t||||||||||2017-10-11 02:23:11.684561|2017-10-11 02:23:11.684561
NCT01710787|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-07-28|2016-10-06|2015-05-15|October 2012||2012-10-01|July 2017|2017-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Adults|A Phase III, Multi-Center, Randomized, Double-Blind, Parallel-Groups Clinical Trial Comparing the Efficacy and Safety of Intranasally Administered Kovacaine Mist to Tetracaine Alone and to Placebo for Anesthetizing Maxillary Teeth in Adults|Completed||Phase 3|110|Actual|St. Renatus, LLC||3|||f||||f||||||||||2017-10-11 02:23:11.919326|2017-10-11 02:23:11.919326
NCT01710774|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-05-22|||May 2012|Actual|2012-05-01|May 2017|2017-05-01|October 2019|Anticipated|2019-10-01|February 2017|Actual|2017-02-01||Interventional|DiaFOTo||Telemedicine Follow-up in Primary Health Care for Diabetes-related Foot Ulcers|Effect of Telemedicine Follow-up Care in Primary Health Care Versus Traditional Follow-up in Specialist Health Care on the Healing Time for Diabetes-related Foot Ulcers - a Cluster-randomized Controlled Trial|Active, not recruiting||N/A|276|Anticipated|Helse Stavanger HF||2|||f||||f||||||||No||2017-10-11 02:23:13.003766|2017-10-11 02:23:13.003766
NCT01710748|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-11-05|||October 2012||2012-10-01|November 2013|2013-11-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Interventional|RESERVOIR||Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic Patients|Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic Patients (RESERVOIR) Trial|Unknown status|Active, not recruiting|Phase 3|112|Anticipated|Spanish Society of Cardiology||2|||f||||f||||||||||2017-10-11 02:23:13.176376|2017-10-11 02:23:13.176376
NCT01710735|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-18|||April 2011||2011-04-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||Skeletal Muscle Contractility, Self-reported Pain and Tissue Sensitivity in Females With Neck/Shoulder Pain and Trapezius MFTrPs|Skeletal Muscle Contractility, Self-reported Pain and Tissue Sensitivity in Females With Neck/Shoulder Pain and Upper Trapezius Myofascial Trigger Points- a Randomized Intervention Study|Completed||N/A|80|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 02:23:13.277507|2017-10-11 02:23:13.277507
NCT01710722|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-12-17|||February 2001||2001-02-01|December 2015|2015-12-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man|The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man|Completed||N/A|45|Actual|Pennington Biomedical Research Center||3|||f||||f||||||||||2017-10-11 02:23:13.356534|2017-10-11 02:23:13.356534
NCT01710709|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-05-04|||November 2012||2012-11-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|ATLAS||Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder|A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder|Completed||Phase 3|748|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t||||||||||2017-10-11 02:23:13.462066|2017-10-11 02:23:13.462066
NCT01710696|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-02-27|||July 23, 1998|Actual|1998-07-23|February 2017|2017-02-01|July 26, 2004|Actual|2004-07-26|July 26, 2004|Actual|2004-07-26||Interventional|||Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome|Induction of Puberty With 17-Beta Estradiol in Girls With Turner Syndrome. An Open Randomized Trial|Completed||Phase 3|50|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:23:13.865567|2017-10-11 02:23:13.865567
NCT01710683|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-05-27||||||May 2015|2015-05-01||||||||Observational|||Early Mobilisation Following Discectomy|Early Mobilisation Following Discectomy|Withdrawn||N/A|0|Actual|Northern Orthopaedic Division, Denmark|||2|No participants were enrolled.|f||||f||||||||||2017-10-11 02:23:14.017352|2017-10-11 02:23:14.017352
NCT01710670|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-12-10|||September 2012||2012-09-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects|A Double-blind, Randomized, Placebo-controlled, Three-way Crossover Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects.|Completed||Phase 1|18|Actual|UCB Pharma||3|||f||||f||||||||||2017-10-11 02:23:14.119491|2017-10-11 02:23:14.119491
NCT01710657|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-07-28|2015-01-22||September 2012||2012-09-01|July 2017|2017-07-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional||The Baseline Characteristics refer to the Safety Set (SS) which was defined as all enrolled subjects who took at least 1 dose of Lacosamide.|A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Japanese and Chinese Adults With Uncontrolled Partial-Onset Seizures With or Without Secondary Generalization|Completed||Phase 3|548|Actual|UCB Pharma||3|||f||||f||||||||||2017-10-11 02:23:14.241377|2017-10-11 02:23:14.241377
NCT01710644|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2016-06-03||2016-04-04|May 2013||2013-05-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis|A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis|Completed||Phase 1/Phase 2|35|Actual|Nordmark Arzneimittel GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 02:23:15.334201|2017-10-11 02:23:15.334201
NCT01710618|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-02-14|||July 2011||2011-07-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|SEXI||SEXI: Sciatic Expression and Identification of Differential Proteins in Traumatized Versus Nontraumatized Nerves|SEXI: Sciatic Expression and Identification of Differential Proteins in Traumatized Versus Non-traumatized Nerves|Active, not recruiting||N/A|100|Anticipated|Defense and Veterans Center for Integrative Pain Management|||1||f||||f||||||Samples Without DNA|"     sciatic nerve specimen will be obtained   "|No||2017-10-11 02:23:15.529129|2017-10-11 02:23:15.529129
NCT01710605|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-07-11|||February 2012||2012-02-01|July 2016|2016-07-01||||September 2018|Anticipated|2018-09-01||Interventional|||Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers|Randomized Trial to Evaluate the Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers.|Recruiting||Phase 3|819|Anticipated|Institut Curie||2|||f||||f||||||||||2017-10-11 02:23:15.593318|2017-10-11 02:23:15.593318
NCT01710592|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-01-08|||May 2007||2007-05-01|January 2013|2013-01-01||||December 2012|Actual|2012-12-01||Interventional|ELECT||A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer|A Randomised Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer|Completed||Phase 2|35|Actual|Cancer Trials Ireland||2|||f||||f||||||||||2017-10-11 02:23:15.722711|2017-10-11 02:23:15.722711
NCT01710579|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2015-05-06|||September 2012||2012-09-01|September 2012|2012-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|NOMAD||Normal Values in Ano-rectal 3D High Resolution Manometry|Ano-rectal 3D High Resolution Manometry: Normal Values and Comparison With Ultrasound Examination in Healthy Volunteers, Patients With Fecal Incontinence and Patients With Constipation|Completed||N/A|127|Actual|Hospices Civils de Lyon||3|||f||||t||||||||||2017-10-11 02:23:15.813887|2017-10-11 02:23:15.813887
NCT01710566|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-02-12|||July 2013||2013-07-01|February 2016|2016-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities|Preventing Postpartum Hemorrhage: Examining Two Strategies for PPH Prevention in Communities: Misoprostol and Oxytocin in Uniject®|Withdrawn||Phase 3|0|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 02:23:15.894475|2017-10-11 02:23:15.894475
NCT01710527|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-04-25|2017-04-25||May 9, 2012|Actual|2012-05-09|April 2017|2017-04-01|May 18, 2012|Actual|2012-05-18|May 18, 2012|Actual|2012-05-18||Interventional|BA/BE 173/11||BE Study of Metformin GSK 500mg|AN OPEN LABEL, BALANCED, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, CROSSOVER, SINGLE ORAL DOSE, BIOEQUIVALENCE STUDY OF METFORMIN 500 MG TABLETS MANUFACTURED BY SAVIPHARM J.S.C, VIETNAM AND GLUCOPHAGE® 500 MG TABLETS MANUFACTURED BY MERCK SANTE S.A.S.2, RUE DU PRESSOIR VERT-45400 SEMOY-FRANCE AND BE REGISTERED IN VIETNAM IN HEALTHY, ADULT, HUMAN MALE SUBJECTS UNDER FASTING CONDITION|Completed||Phase 2|32|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:23:16.146805|2017-10-11 02:23:16.146805
NCT01710514|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-08-29|2014-07-11||October 2012||2012-10-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Full Analysis Set (FAS) population|A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment|A Multi-Center, Randomized, Open-Label, Parallel Group Study of FE 999913 Vaginal Tablet 100 mg in Japanese Female Patients Undergoing Fertility Treatment [In Vitro Fertilization/Embryo Transfer (IVF-ET)]|Completed||Phase 3|108|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:23:16.734931|2017-10-11 02:23:16.734931
NCT01710501|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-03-01|2016-02-03||December 2012||2012-12-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)|A Phase II Randomized, Dose Ranging, Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Different Doses of MK-5172 When Administered Concomitantly With Peginterferon Alfa-2b and Ribavirin in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 2|87|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:23:17.512338|2017-10-11 02:23:17.512338
NCT01710488|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-01-11|||May 2009||2009-05-01|October 2012|2012-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|FLOR||Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD|A Randomized, Controlled, Single-blind, Parallel-group Comparison Between Levofloxacin and Prulifloxacin, in Patients With Acute Exacerbation of COPD Unresponsive to Other Antibiotics and Admitted to the Internal Medicine|Completed||Phase 4|258|Actual|Fadoi Foundation, Italy||2|||f||||t||||||||||2017-10-11 02:23:18.531351|2017-10-11 02:23:18.531351
NCT01710462|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-07-23|||August 2013||2013-08-01|October 2012|2012-10-01||||||||Interventional|PANDA||Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease||Withdrawn||Phase 3|0|Actual|Eurofarma Laboratorios S.A.||2||Change of company's strategy|f||||f||||||||||2017-10-11 02:23:18.728358|2017-10-11 02:23:18.728358
NCT01710449|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-12-05|||September 2009||2009-09-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen|Evaluation of Regional Ventilation in Normal Subjects and Subjects With Airway and Lung Disorders (COPD, Asthma, Emphysema, Small Airway Disease and Cystic Fibrosis) Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen.|Completed||Phase 1|44|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:23:18.852493|2017-10-11 02:23:18.852493
NCT01710436|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-05-16|||October 2012||2012-10-01|May 2013|2013-05-01||||November 2013|Anticipated|2013-11-01||Observational|RDPAC||Relationship Between Dosage of Clopidogrel and Platelet Aggregation in Chinese With Different Genotype||Unknown status|Active, not recruiting|N/A|880|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||4||f||||t||||||||||2017-10-11 02:23:18.977887|2017-10-11 02:23:18.977887
NCT01710423|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-02-04|||November 2012||2012-11-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||Peer-mentored Cooking Classes for Parents of Toddlers: Do Families Cook More and Eat Healthier After the Intervention?|Improving Home Food Preparation Practices Among Families With Young Children: A Peer Mentoring Intervention|Completed||N/A|47|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 02:23:19.083991|2017-10-11 02:23:19.083991
NCT01710410|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-06-09|||October 2016||2016-10-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|tDCS||Transcranial Direct Current Stimulation in a Smoking Cessation Trial|Pilot Study of Transcranial Direct Current Stimulation (tDCS) as a Smoking Cessation Treatment for Nicotine Dependent Smokers|Withdrawn||Phase 2|0|Actual|Centre for Addiction and Mental Health||3||Funding|f||||f||||||||||2017-10-11 02:23:19.19295|2017-10-11 02:23:19.19295
NCT01710397|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-06-25|||May 2013||2013-05-01|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|July 2015|Actual|2015-07-01||Interventional|RapIT||Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)|Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)|Active, not recruiting||N/A|463|Actual|Boston University||4|||f||||f||||||||Yes|Data will be made publicly available in the Dryad repository (http://www. datadryad.org/) after the protocol has been closed (anticipated closure June 2018).|2017-10-11 02:23:19.340118|2017-10-11 02:23:19.340118
NCT01710384|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-17|||November 2012||2012-11-01|October 2012|2012-10-01|November 2015|Anticipated|2015-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Effect of Antenatal Corticosteroids in Late Preterm||Unknown status|Not yet recruiting|Phase 2|200|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-11 02:23:19.453143|2017-10-11 02:23:19.453143
NCT01710371|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-11-12|||December 2012||2012-12-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls|Quantitative PET Imaging of Pancreatic Beta-Cell Mass in Healthy Overweight/Obese Subjects, Subjects With Prediabetes, and Type 2 Diabetes Patients With 18F-FP-DTBZ (18F-AV-133)|Completed||Phase 1|40|Actual|Avid Radiopharmaceuticals||2|||f||||f||||||||||2017-10-11 02:23:19.542342|2017-10-11 02:23:19.542342
NCT01710358|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-07-14|2017-03-10|2015-05-08|October 2012||2012-10-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|RA-BEAM|Modified Intent-to-Treat (mITT) population: all randomized participants who received at least 1 dose of study drug.|A Study in Moderate to Severe Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy|Completed||Phase 3|1307|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-10-11 02:23:19.879385|2017-10-11 02:23:19.879385
NCT01710345|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-01-23|2014-12-15||October 2012||2012-10-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy||Completed||Phase 2|101|Actual|AcelRx Pharmaceuticals, Inc.||3|||f||||||||||||||2017-10-11 02:23:26.766708|2017-10-11 02:23:26.766708
NCT01710332|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-05-22|2017-02-22||October 2012||2012-10-01|May 2017|2017-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|CONTAIN||The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy|Intravitreal Aflibercept Injection for Persistent Central Serous Chorioretinopathy: A Prospective Pilot Study|Completed||Phase 2|12|Actual|Wills Eye||2|||f||||f||||||||No||2017-10-11 02:23:27.338779|2017-10-11 02:23:27.338779
NCT01710319|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-06-02|||September 2012||2012-09-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Observational|MechLungCa||Mechanisms of Immunosurveillance for Lung Cancer|Mechanisms of Immunosurveillance for Lung Cancer|Unknown status|Recruiting|N/A|160|Anticipated|Washington University School of Medicine|||4||f||||f||||||Samples Without DNA|"     A blood draw will be obtained from patients in order to complete flow cytometry to analyze     NK-specific markers to determine NK cell abundance and phenotypic expression. Obtain an     optional blood draw on pts at least 30 days from the initial draw if transient confounders     (viral infections or leukemoid reactions-a benign transient post-viral increase in WBCs)     noted that could affect the NK Cell's behavior and interfere with the results.   "|||2017-10-11 02:23:28.049639|2017-10-11 02:23:28.049639
NCT01710293|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-05-10|||January 27, 2017|Actual|2017-01-27|May 2017|2017-05-01|January 27, 2017|Actual|2017-01-27|January 27, 2017|Actual|2017-01-27||Interventional|PACT CREATE 3||Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis|Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis|Withdrawn||N/A|0|Actual|VA Office of Research and Development||2||Unable to obtain data needed to run the RCT; project never began recruitment|f||||t|f|f|||f|||No||2017-10-11 02:23:28.27065|2017-10-11 02:23:28.27065
NCT01710280|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-18|||May 2011||2011-05-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Palmitic Acid in the Sn-2 Position of Triacylglycerols and Postprandial Lipemia||Completed||N/A|11|Actual|King's College London||2|||f||||f||||||||||2017-10-11 02:23:28.370903|2017-10-11 02:23:28.370903
NCT01710228|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-12-28|||July 2013||2013-07-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ATP||Alternative Treatment Paradigm for Natalizumab Trial|Alternative Treatment Paradigm for Natalizumab Trial|Withdrawn||Phase 2|0|Actual|University of Texas Southwestern Medical Center||2||sponsor stopped|f||||t||||||||||2017-10-11 02:23:28.639941|2017-10-11 02:23:28.639941
NCT01710215|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-07-26|||April 2013||2013-04-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies|Parkland-UT Southwestern PROSPR Center: Colon Cancer Screening in a Safety Net: Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies|Completed||N/A|5999|Actual|University of Texas Southwestern Medical Center||3|||f||||f||||||||||2017-10-11 02:23:28.729195|2017-10-11 02:23:28.729195
NCT01710202|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-03-18|||October 2012||2012-10-01|August 2013|2013-08-01|November 2014|Actual|2014-11-01|December 2013|Actual|2013-12-01||Observational|5-HTTLPR||Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration|Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration|Completed||N/A|120|Actual|University of Texas at Austin|||2||f||||t||||||Samples With DNA|"     Saliva   "|||2017-10-11 02:23:28.829606|2017-10-11 02:23:28.829606
NCT01710189|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-12-02|||October 2012||2012-10-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CRC306||Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac|Phase 4 Clinical Trial of Cervico-vaginal Immune Responses Following Three Right Deltoid or Right Thigh Intramuscular Immunisations With TicoVac (Tick Borne Encephalitis Virus [TBEV]) Vaccine in Adult Female Participants|Completed||Phase 4|40|Actual|University of Surrey||2|||f||||f||||||||||2017-10-11 02:23:28.939179|2017-10-11 02:23:28.939179
NCT01710176|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-03-01|||June 1, 2011|Actual|2011-06-01|March 2016|2016-03-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy|Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy|Recruiting||Phase 3|350|Anticipated|Italian Sarcoma Group||2|||f||||t||||||||||2017-10-11 02:23:29.035166|2017-10-11 02:23:29.035166
NCT01710163|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-28|2012-10-16|||June 2012||2012-06-01|October 2012|2012-10-01|June 2015|Anticipated|2015-06-01|June 2013|Anticipated|2013-06-01||Interventional|ARIQUELI||Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients|ARIQUELI: Potentiation of Quetiapine Treatment in Bipolar 1 Nonresponders Patients With Lithium or Aripiprazole|Unknown status|Recruiting|Phase 4|50|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:23:29.288293|2017-10-11 02:23:29.288293
NCT01710150|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-04-28|||November 2012||2012-11-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|REDUCE AF||Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical Flutter|Randomized Trial Comparing Long Term Occurrence of Atrial Arrhythmias Including Atrial Fibrillation (AF) and Thromboembolic Complications in Patients With Typical Atrial Flutter (AFLT) Undergoing Cavo-tricuspid Isthmus (CTI) Ablation Alone Versus CTI Ablation Combined With Pulmonary Vein Isolation (PVI).|Withdrawn||N/A|0|Actual|University of Pennsylvania||2||Lack of enrollment|f||||t||||||||||2017-10-11 02:23:29.386541|2017-10-11 02:23:29.386541
NCT01710137|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-04-28|||October 2012||2012-10-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Varenicline for Nicotine Dependence Among Those With HIV/AIDS|A Placebo Controlled Trial of Varenicline for Smoking Among Those With HIV/AIDS|Recruiting||Phase 3|350|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 02:23:29.468578|2017-10-11 02:23:29.468578
NCT01710124|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-06-09|||January 2013||2013-01-01|September 2012|2012-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Buy 1 Get 1: Role of Grocery Coupons in Promoting Obesogenic Home Food Environments and Eating Behaviors|Buy 1 Get 1: Role of Grocery Coupons in Promoting Obesogenic Home Food|Completed||N/A|54|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 02:23:29.594036|2017-10-11 02:23:29.594036
NCT01710111|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-01-14|||January 2013||2013-01-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|EMIT||Evaluating Modes of Influenza Transmission|Evaluating Modes of Influenza Transmission Using a Human Challenge Model|Completed||N/A|127|Actual|University of Nottingham||2|||f||||t||||||||||2017-10-11 02:23:29.76972|2017-10-11 02:23:29.76972
NCT01710098|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-16|||June 2012||2012-06-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Treatment of Prostate Cancer With Firmagon®|"Effectiveness and Safety as Well as Adherence of the S3 Guidelines for the Treatment of Prostate Cancer in the Treatment of Patients of Patients With Firmagon®"|Unknown status|Recruiting|N/A|100|Anticipated|United Clinic Management GmbH|||1||f||||f||||||||||2017-10-11 02:23:29.876505|2017-10-11 02:23:29.876505
NCT01710085|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2012-10-16|||August 2012||2012-08-01|October 2012|2012-10-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|||Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients|Diagnostic Value of Diffusion Weighted Imaging in Detection of Recurrent Disease in Cervical and Endometrial Cancer Treated With Curative Surgery|Unknown status|Recruiting|N/A|100|Anticipated|Uludag University||1|||f||||f||||||||||2017-10-11 02:23:29.974116|2017-10-11 02:23:29.974116
NCT01710072|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-05-28|||August 2011||2011-08-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Aspirin Attenuates Inflammation in Human Cerebral Aneurysms|Aspirin as a Promising Agent to Attenuate Inflammation in the Wall of Human Cerebral Aneurysms|Completed||Phase 1|11|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 02:23:30.122635|2017-10-11 02:23:30.122635
NCT01710059|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2014-02-10|||December 2012||2012-12-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ADEPT4||Using Mobile Phones to Improve Adherence to Inhaled Steroids|Refined ADEPT: Human Augmentics for Sustained Wellbeing|Completed||N/A|12|Actual|Rush University Medical Center||1|||f||||f||||||||||2017-10-11 02:23:30.206878|2017-10-11 02:23:30.206878
NCT01710033|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-11-26|2012-11-26||September 2003||2003-09-01|November 2012|2012-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Study Of CP-690,550 In Stable Kidney Transplant Patients|Phase 1, Placebo-controlled, Randomized, Sequential, Parallel-group, Dose Escalation Study to Evaluate 28-day Multiple Dose Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CP-690,550 in Stable Renal Allograft Recipients|Completed||Phase 1|28|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:23:31.377958|2017-10-11 02:23:31.377958
NCT01710020|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-11-19|2012-11-19||February 2003||2003-02-01|November 2012|2012-11-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease|Phase 1, Open-Label Study Of The Pharmacokinetics, Non-Renal Clearance And Dialyzability Of CP-690,550 In Subjects With End-Stage Renal Disease Undergoing Hemodialysis|Completed||Phase 1|12|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 02:23:32.695511|2017-10-11 02:23:32.695511
NCT01710007|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2013-06-14|||November 2011||2011-11-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia|A Prospective, Double-blind, Randomized, Parallel, Multiple-center Study to Compare the Efficacy and Safety of 1PC002 and Atorvastatin in Taiwanese Patients With Hypercholesterolemia|Completed||Phase 3|202|Actual|Orient Pharma Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:23:33.260833|2017-10-11 02:23:33.260833
NCT01709994|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2012-10-17|||May 2010||2010-05-01|October 2012|2012-10-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients|Effect of Aspirin in Primary Prevention of Cardiovascular Risk in Patients With Chronic Kidney Disease (AASER Study)|Unknown status|Recruiting|Phase 3|97|Anticipated|Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales||2|||f||||f||||||||||2017-10-11 02:23:33.415116|2017-10-11 02:23:33.415116
NCT01709981|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-06-22|||June 2013||2013-06-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Anti-inflammatory Effects of Colchicine in PCI|Anti-inflammatory Effects of Colchicine in Patients Undergoing Percutaneous Coronary Intervention|Recruiting||Phase 4|400|Anticipated|New York University School of Medicine||2|||f||||||||||||||2017-10-11 02:23:33.563334|2017-10-11 02:23:33.563334
NCT01709968|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2017-07-18|||February 2013||2013-02-01|July 2017|2017-07-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|MgNLC||Magnesium Oxide Monohydrate for Nocturnal Leg Cramps|Magnesium Oxide Monohydrate for Nocturnal Leg Cramps (MgNLC); a Prospective, Randomized, Double Blind, Placebo Controlled Clinical Trial.|Terminated||Phase 4|94|Actual|Clalit Health Services||2||"Blinded interim analysis Recommendation, submitted April 1, 2014, was early termination for   futility."|f||||t||||||||||2017-10-11 02:23:33.807403|2017-10-11 02:23:33.807403
NCT01709955|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-10-17|||February 2011||2011-02-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Effects of Glucomannan on Weight Loss||Completed||Phase 1|43|Actual|New York Chiropractic College||2|||f||||f||||||||||2017-10-11 02:23:33.907362|2017-10-11 02:23:33.907362
NCT01709942|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2016-04-25|||November 2012||2012-11-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)|Use of Long Acting GnRH Antagonist to Prevent Ovarian HyperStimulation Syndrome (OHSS) in PCOS Women Undergoing COH for IVF|Completed||Phase 3|80|Actual|Centre for Endocrinology and Reproductive Medicine, Italy||2|||f||||t||||||||||2017-10-11 02:23:33.98012|2017-10-11 02:23:33.98012
NCT01709929|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-03-02|||October 2005||2005-10-01|March 2016|2016-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|PREDICTIVE™||Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus|A Multicentre, Open Label, Nonrandomised, Safety Study in Subjects Using Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus|Completed||Phase 3|2287|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 02:23:34.110639|2017-10-11 02:23:34.110639
NCT01709916|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2015-02-23|||November 2012||2012-11-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|IOP||Comparing Diurnal Fluctuations in Intra Ocular Pressure Measured in Same Day Versus Different Days in Glaucoma Patients|Comparing Diurnal Fluctuations in Intra Ocular Pressure Measured in Same Day Versus Different Days in Glaucoma Patients|Completed||N/A|50|Anticipated|Carmel Medical Center|||1||f||||||||||||||2017-10-11 02:23:34.202687|2017-10-11 02:23:34.202687
NCT01709903|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-03-13|2015-02-27||November 2012||2012-11-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Three patients in the Flut/Salm treatment arm: were excluded from the FAS, safety set and PPS as they were randomized in error and did not receive the study medication.|A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149|A 26-week Treatment Randomized, Double-blind, Double Dummy, Parallel-group Study to Assess the Efficacy and Safety of QVA149 (Indacaterol / Glycopyrronium Bromide) Compared to Fluticasone/Salmeterol in Patients With Moderate to Severe COPD|Completed||Phase 3|744|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:23:34.318721|2017-10-11 02:23:34.318721
NCT01709890|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-10-29|||December 2012||2012-12-01|October 2012|2012-10-01||||||||Observational|||Evaluation of a New Airway Device - the YO2(R) Catheter in Patients Under Sedation||Unknown status|Not yet recruiting|N/A|50|Anticipated|The University of Hong Kong|||1||f||||||||||||||2017-10-11 02:23:35.368302|2017-10-11 02:23:35.368302
NCT01709877|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-17|2013-06-28|||April 2013||2013-04-01|June 2013|2013-06-01|November 2014|Anticipated|2014-11-01|July 2014|Anticipated|2014-07-01||Interventional|||EndoCone Single Port Versus Conventional Multi-port Laparoscopic Approach|Randomised Non-inferiority Trial of Laparoscopic Cholecystectomy Performed With EndoCone Single Port Versus Conventional Multi-port Laparoscopic Approach Using Clinical, PROMS and Health Economic Endpoints|Unknown status|Recruiting|N/A|300|Anticipated|Azienda Ospedaliero, Universitaria Pisana||2|||f||||t||||||||||2017-10-11 02:23:35.454464|2017-10-11 02:23:35.454464
NCT01709864|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-02-12|2014-10-12||November 2012||2012-11-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||NVA237 Versus Placebo 12-week Efficacy Study|A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients|Completed||Phase 3|440|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:23:35.620874|2017-10-11 02:23:35.620874
NCT01709851|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-04-15|||November 2012||2012-11-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Observational|||Performance Study to Test the GlucoMen®Day System Using Intravascular and Subcutaneous Microdialysis in Subjects With Type 1 Diabetes|A Single-center, Open, Pilot Trial to Investigate the Performance of the GlucoMen®Day System Using Intravascular and Subcutaneous Microdialysis in Subjects With Type 1 Diabetes|Completed||N/A|12|Actual|Medical University of Graz|||2||f||||f||||||||||2017-10-11 02:23:36.64012|2017-10-11 02:23:36.64012
NCT01709838|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-09-12|||December 6, 2012|Actual|2012-12-06|September 2017|2017-09-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|THETIS||Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia|An Open Label, Multi-center, Efficacy and Safety Study of Deferasirox in Iron Overloaded Patients With Non-transfusion Dependent Thalassemia|Active, not recruiting||Phase 4|134|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:23:36.715116|2017-10-11 02:23:36.715116
NCT01709825|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-01-27|||September 2012||2012-09-01|January 2015|2015-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of Probiotics (L. Helveticus, B. Longum, and B. Bifidum) on Immune Function and Digestive Health|The Effect of Probiotics on Immune Function, and Digestive Health in Academically-stressed University Students: A Randomized, Double-blinded, Placebo-controlled Study|Completed||N/A|583|Actual|University of Florida||4|||f||||f||||||||||2017-10-11 02:23:36.836429|2017-10-11 02:23:36.836429
NCT01709812|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2014-09-29|||July 2013||2013-07-01|September 2014|2014-09-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|STAY||Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMS|A 6 Months, Randomized, Multicenter, Parallel-group, Open-label Study to Evaluate the Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With Relapsing-remitting Multiple Sclerosis|Withdrawn||Phase 4|0|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:23:36.941735|2017-10-11 02:23:36.941735
NCT01709799|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-06-03|2015-06-03||January 2010||2010-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|VITAL||Village Interactive Training and Learning Study|The Village Interactive Training and Learning Study|Completed||N/A|64|Actual|University of Florida||3|||f||||f||||||||||2017-10-11 02:23:37.023976|2017-10-11 02:23:37.023976
NCT01709786|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-06-27|2015-12-14||September 2012||2012-09-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational||Adult patients (>18 years of age) with the potential for hemorrhage and who were admitted to the Surgical Intensive Care Unit of a tertiary referral, Level I verified trauma center.|Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage|Non-Invasive Hemoglobin Monitoring in the Patient With Suspected Hemorrhage|Completed||N/A|88|Actual|University of Cincinnati|||1||f||||f||||||||No||2017-10-11 02:23:37.855483|2017-10-11 02:23:37.855483
NCT01709773|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-08-07|||April 2013||2013-04-01|August 2014|2014-08-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Focal Ablation of Cervical Precancer|Focal Ablation of High-grade Cervical Intraepithelial Neoplasia|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 02:23:38.075858|2017-10-11 02:23:38.075858
NCT01709760|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-04-26|||November 2012||2012-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ENIA11||A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With Rheumatoid Arthritis|Active, not recruiting||Phase 3|91|Actual|TSH Biopharm Corporation Limited||2|||f||||t||||||||||2017-10-11 02:23:38.169432|2017-10-11 02:23:38.169432
NCT01709747|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-03-28|||June 2013||2013-06-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration|A Phase 3, Open-Label, Single-Arm Study To Assess The Safety Of Hydromorphone Hydrochloride Delivered By Intrathecal Administration|Active, not recruiting||Phase 3|350|Anticipated|Mallinckrodt||1|||f||||f||||||||||2017-10-11 02:23:38.309794|2017-10-11 02:23:38.309794
NCT01709734|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-08-08|||December 2012||2012-12-01|August 2017|2017-08-01|August 2017|Anticipated|2017-08-01|September 2016|Actual|2016-09-01||Interventional|ARMOR2||A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer|ARMOR2: A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer|Active, not recruiting||Phase 2|126|Actual|Novus Therapeutics, Inc||2|||f||||t||||||||||2017-10-11 02:23:38.417411|2017-10-11 02:23:38.417411
NCT01709721|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-03-28|||February 2013||2013-02-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration Using a Programmable Implantable Pump|A Controlled, Two-Arm, Parallel Group, Randomized Withdrawal Study to Assess the Safety and Efficacy of Hydromorphone Hydrochloride Delivered by Intrathecal Administration Using a Programmable Implantable Pump|Recruiting||Phase 3|250|Anticipated|Mallinckrodt||2|||f||||f||||||||||2017-10-11 02:23:38.595243|2017-10-11 02:23:38.595243
NCT01709708|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2014-11-12|2014-07-24||September 2012||2012-09-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|Tx360||Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine|Use of the Tx360 Nasal Applicator for Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine: A Double-blind Placebo-controlled Study|Completed||Phase 4|41|Actual|Tian Medical Inc.||2|||f||||t||||||||||2017-10-11 02:23:38.742145|2017-10-11 02:23:38.742145
NCT01709682|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2012-10-16|||November 2007||2007-11-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||A Comparison of the Drug Therapy Versus Re-Ablation|Progression of Atrial Fibrillation After a Failed Initial Ablation Procedure in Patients With Paroxysmal Atrial Fibrillation: A Randomized Comparison of the Drug Therapy Versus Re-Ablation|Completed||Phase 2|154|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-11 02:23:39.41222|2017-10-11 02:23:39.41222
NCT01709669|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-04-28|||September 2012||2012-09-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|GRACE||The Impact of Gratitude on Biology and Behavior in Persons With Heart Disease|The Impact of Gratitude on Biology and Behavior in Persons With Heart Disease|Completed||N/A|212|Actual|Massachusetts General Hospital|||1||f||||f||||||Samples Without DNA|"     Analyzed Blood Samples:      Subjects will have a blood draw for the following biological factors that are important to     cardiac health and may be modified by psychological states: Inflammation will be measured via     interleukin-6 (IL-6) and high sensitivity C-reactive protein (hsCRP), soluble intercellular     adhesion molecule-1 (sICAM-1), tumor necrosis factor alpha (TNF-α), and overall cardiac     prognosis will be assessed using N-terminal pro-brain natriuretic peptide (NT-proBNP). A     total of 15 ml/cc of blood will be drawn (this is equivalent to 3 tablespoons of blood).      Retained Blood Samples:      Given that additional, more sensitive/critical markers of cardiac outcomes may be identified     in the near future, participants will be given the option to allow us to store their blood     samples for additional biomarker analysis.   "|||2017-10-11 02:23:39.534538|2017-10-11 02:23:39.534538
NCT01709656|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-02-10|||March 2012||2012-03-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis|A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis|Completed||N/A|120|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 02:23:39.632339|2017-10-11 02:23:39.632339
NCT01709643|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-09-19|||September 2012||2012-09-01|October 2012|2012-10-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Postprandial IHL and IMCL Measured With Proton Magnetic Resonance Spectroscopy|Postprandial Intrahepactic Lipid (IHL) and Intramyocellular Lipid (IMCL) Levels Measured With Proton Magnetic Resonance Spectroscopy (1H-MRS)|Completed||N/A|9|Actual|Maastricht University Medical Center||4|||f||||f||||||||||2017-10-11 02:23:39.736856|2017-10-11 02:23:39.736856
NCT01709630|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2014-11-19|||September 2012||2012-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||PK/PD Modeling of Magnesium in the Mother and Neonate|Pharmacokinetics (PK)/Pharmacodynamics (PD) Modeling of Magnesium Sulfate In the Mother and Exposed Neonate|Completed||N/A|151|Actual|Stanford University|||2||f||||f||||||Samples Without DNA|"     Blood specimens will be obtained to test magnesium levels in the mother and neonate.   "|||2017-10-11 02:23:39.88714|2017-10-11 02:23:39.88714
NCT01709617|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2012-10-16|||November 2012||2012-11-01|October 2012|2012-10-01|January 2014|Anticipated|2014-01-01|September 2013|Anticipated|2013-09-01||Interventional|CHO-use||Carbohydrate Use During and Following Exercise|Sucrose as a Preferred Carbohydrate in Sports Nutrition|Unknown status|Not yet recruiting|N/A|17|Anticipated|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 02:23:40.005017|2017-10-11 02:23:40.005017
NCT01709604|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-06-11|||October 2012||2012-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|PQ||Role of CVVH in Patients With Acute Paraquat Poisoning|The Efficacy and Safety of Continuous Venovenous Hemofiltration in Patients With Severe Acute Paraquat Poisoning|Completed||N/A|110|Actual|Shanghai 10th People's Hospital|||2||f||||f||||||Samples Without DNA|"     Serum, Plasma, Urine,Dialysate   "|No||2017-10-11 02:23:40.114627|2017-10-11 02:23:40.114627
NCT01709591|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-10-03|||June 2011||2011-06-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of Prenatal Education on Perceptions of Epidural Acceptance|Effect of Targeted Prenatal Education on Perceptions of Epidural on Acceptance of Epidural Analgesia: a Randomized Controlled Trial|Active, not recruiting||N/A|111|Actual|Santa Clara Valley Health & Hospital System||2|||f||||f||||||||||2017-10-11 02:23:40.213367|2017-10-11 02:23:40.213367
NCT01709578|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-07-07|2017-05-23|2015-11-16|October 2012||2012-10-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)|A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists|Completed||Phase 3|546|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 02:23:40.362642|2017-10-11 02:23:40.362642
NCT01709565|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-10-16|||July 2012||2012-07-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Lactate Clearance According to the Presence of Hepatic Dysfunction|Lactate Clearance and Mortality in Patients With Severe Sepsis and Septic Shock: Comparison by Hepatic Dysfunction|Unknown status|Recruiting|N/A|245|Anticipated|Samsung Medical Center|||2||f||||t||||||Samples Without DNA|"     Interleukin-1, Interleukin-6, Interleukin-10, TNF-alfa   "|||2017-10-11 02:23:42.798356|2017-10-11 02:23:42.798356
NCT01709552|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-05-21|||March 2012||2012-03-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|B-SAFER||Brief Intervention for Substance Use and Partner Abuse Among Females in the ER|A Computer-based Intervention for Women With Substance Use and Intimate Partner Violence in the Emergency Department|Completed||N/A|40|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-10-11 02:23:42.939796|2017-10-11 02:23:42.939796
NCT01709539|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-10-10|||October 2012||2012-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CPF-DC||Clinical Evaluation of a New Cancer Diagnosis Center at Kristianstad General Hospital, Sweden|Clinical Evaluation of a New Cancer Diagnosis Center at Kristianstad General Hospital, Sweden|Recruiting||N/A|1725|Anticipated|Region Skane||2|||f||||t||||||||||2017-10-11 02:23:43.038804|2017-10-11 02:23:43.038804
NCT01709526|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-10-17|||January 2009||2009-01-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|AdolInpRehabi||How the Adolescent Inpatients Are Rehabilitated After Discharge|Prospective Study the Adolescent Inpatients Rehabilitation|Terminated||Phase 2/Phase 3|63|Actual|Kuopio University Hospital||1||Study couldn´t start due to investigator|f||||t||||||||||2017-10-11 02:23:43.153713|2017-10-11 02:23:43.153713
NCT01709513|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-07-27|2015-07-29|2015-01-24|September 2012|Actual|2012-09-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2014|Actual|2014-05-01||Interventional|||Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)|A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study to Evaluate the Efficacy and Safety of REGN727/SAR236553 in Patients With Primary Hypercholesterolemia Who Are Intolerant to Statins|Completed||Phase 3|314|Actual|Regeneron Pharmaceuticals||3|||f||||t||||||||||2017-10-11 02:23:43.300231|2017-10-11 02:23:43.300231
NCT01709500|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-09-29|2015-07-29|2015-01-24|December 2012||2012-12-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|May 2014|Actual|2014-05-01||Interventional|ODYSSEY FH II||Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of REGN727/SAR236553 in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy|Completed||Phase 3|249|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-11 02:23:44.689317|2017-10-11 02:23:44.689317
NCT01709487|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-02-23|||May 2010||2010-05-01|July 2014|2014-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy|Feasibility Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy|Completed||Phase 1/Phase 2|19|Actual|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 02:23:45.71601|2017-10-11 02:23:45.71601
NCT01709474|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-12-15|2015-10-20||June 2013||2013-06-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||The population included all subjects who were randomized to receive either Vitamin D3 6000 IU daily or 400 IU daily.|Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus|Vitamin D3 Effects on Immune Function in Pediatric Systemic Lupus Erythematosus (SLE)|Terminated||Phase 2|7|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The study terminated early due to recruitment feasibility issues. Seven subjects were enrolled and received treatment in contrast to the planned number of 78 subjects for randomization/receipt of treatment. No mechanistic analyses were performed.|2||Due to slow enrollment|f||||t||||||||||2017-10-11 02:23:45.804141|2017-10-11 02:23:45.804141
NCT01709461|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2012-10-16|||October 2012||2012-10-01|June 2012|2012-06-01||||||||Observational|||Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical Trial|Continue Providing Care for Patient Who Participated in the Adagio TVP 1012/501 Clinical Trial|Unknown status|Not yet recruiting|N/A|12|Anticipated|Rabin Medical Center|||1||f||||f||||||||||2017-10-11 02:23:46.183456|2017-10-11 02:23:46.183456
NCT01709448|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-10-16|||January 2009||2009-01-01|October 2012|2012-10-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV|Predictive Modeling of Anal Dysplasia Progression in HIV|Unknown status|Recruiting|N/A|165|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||f||||||Samples With DNA|"     Anal cytology Anal biopsies   "|||2017-10-11 02:23:46.233439|2017-10-11 02:23:46.233439
NCT01709435|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-09-12|||November 14, 2012|Actual|2012-11-14|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors|A Phase 1 Study of XL184 (Cabozantinib) in Children and Adolescents With Recurrent or Refractory Solid Tumors, Including CNS Tumors|Active, not recruiting||Phase 1|41|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 02:23:46.312701|2017-10-11 02:23:46.312701
NCT01709422|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2013-09-12|2012-11-30||June 2010||2010-06-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|ERCP||Efficacy and Safety Profiles of Combination Sedation Propofol With Midazolam and Meperidine.|Efficacy and Safety Profiles of Sedation With Propofol Combined With Intravenous Midazolam and Meperidine Versus Intravenous Midazolam and Meperidine for Ambulatory Endoscopic Retrograde-cholangiopancreatography(ERCP).|Completed||Phase 4|140|Actual|Prince of Songkla University||2|||f||||t||||||||||2017-10-11 02:23:48.103363|2017-10-11 02:23:48.103363
NCT01709396|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-01-10|||January 2012||2012-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|ED-TBI||ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS|Extended Dose - Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory Acute Leukemia And Advanced Myelodysplastic Syndrome|Suspended||Phase 2|20|Anticipated|Ottawa Hospital Research Institute||1||initial on hold due to space but now permanently suspended due to futility.|f||||t||||||||Undecided||2017-10-11 02:23:48.604391|2017-10-11 02:23:48.604391
NCT01709383|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-06-06|2016-10-27||December 2012||2012-12-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional||People with aphasia due to left hemisphere stroke|Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia|Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?|Completed||N/A|38|Actual|Georgetown University||2|||f||||f||||||||Undecided||2017-10-11 02:23:48.721311|2017-10-11 02:23:48.721311
NCT01709370|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-12-29|||February 2012||2012-02-01|October 2012|2012-10-01||||||||Interventional|||Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal Women|Phase II Neoadjuvant Study of Letrozole in Combination With PD0332991 (Oral CDK 4/6 Inhibitor) for ER Positive, HER2 Negative Breast Cancer in Postmenopausal Women|Unknown status|Recruiting|Phase 2|45|Anticipated|Organisation for Oncology and Translational Research||1|||f||||t||||||||||2017-10-11 02:23:49.505452|2017-10-11 02:23:49.505452
NCT01707784|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-05-10|||October 2012||2012-10-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2013|Actual|2013-09-01||Observational|||Effects of Stress on Glucose Tolerance During Pregnancy|Effects of Stress on Glucose Tolerance During Pregnancy|Active, not recruiting||N/A|200|Anticipated|University of Lausanne Hospitals|||2||f||||f||||||||||2017-10-11 02:24:21.617706|2017-10-11 02:24:21.617706
NCT01709357|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2012-10-16|||September 2011||2011-09-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Short and Medium-term Effects of Manual Therapy on Latent Myofascial Pain|Short and Medium-term Effects of Manual Therapy on Latent Myofascial Pain : a Comparative Study|Completed||N/A|117|Actual|Escola Superior de Tecnologia da Saúde do Porto||5|||f||||f||||||||||2017-10-11 02:23:49.622058|2017-10-11 02:23:49.622058
NCT01709344|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-08-10|||February 2013||2013-02-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|||Reducing Disability in Older Adult Cancer Survivors|A Phase I Randomized Controlled Trial of a Problem-solving Occupational Therapy Intervention for Older Adult Cancer Survivors|Active, not recruiting||N/A|73|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 02:23:49.794097|2017-10-11 02:23:49.794097
NCT01709331|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-06-02|2016-04-04||February 11, 2013|Actual|2013-02-11|June 2017|2017-06-01|April 8, 2015|Actual|2015-04-08|April 8, 2015|Actual|2015-04-08||Interventional||All participants enrolled in the combined treatment phase|A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)|A Phase III, Multi-center, Open Label, Uncontrolled Trial to Investigate the Efficacy and Safety of MK-8962 (Corifollitropin Alfa) in Combination With Human Chorionic Gonadotropin (hCG) in Inducing Increased Testicular Volume and Spermatogenesis in Adult Men With Hypogonadotropic Hypogonadism Who Remain Azoospermic When Treated With hCG Alone (Phase III; Protocol No. MK-8962-031-00 [Also Known as SCH 900962, P07937])|Completed||Phase 3|18|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 02:23:49.912572|2017-10-11 02:23:49.912572
NCT01709318|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-09-23|||December 2012||2012-12-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)|A Multicenter, Randomized, Partially-blinded, Phase IIb Dose-finding Study on Ovarian Function, Vaginal Bleeding Pattern, and Pharmacokinetics Associated With the Use of Combined Vaginal Rings Releasing 17β-estradiol Plus Three Different Doses of Either Nomegestrol Acetate or Etonogestrel in Healthy Women Aged 18-35 Years. Protocol MK-8175A/MK-8342B 012|Completed||Phase 2|666|Actual|Merck Sharp & Dohme Corp.||7|||f||||f||||||||||2017-10-11 02:23:50.212073|2017-10-11 02:23:50.212073
NCT01709305|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-05-09|2016-04-06||November 8, 2012|Actual|2012-11-08|May 2017|2017-05-01|April 17, 2015|Actual|2015-04-17|April 17, 2015|Actual|2015-04-17||Interventional||This population includes all participants who enrolled in Phase 1 and were GCP compliant.|A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)|A Multicenter, Randomized, Active-Controlled, Open-label Clinical Trial to Evaluate the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose as a Third OAHA on Top of Sitagliptin+Metformin Combination Therapy in Chinese Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|5570|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:23:50.339702|2017-10-11 02:23:50.339702
NCT01709292|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-08-17|||November 7, 2012|Actual|2012-11-07|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer|Pharmacodynamic Study of Vemurafenib in the Neoadjuvant Setting in Patients With Locally Advanced Thyroid Cancer|Active, not recruiting||Phase 2|24|Actual|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-11 02:23:51.964915|2017-10-11 02:23:51.964915
NCT01709279|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-08-15|||August 2012||2012-08-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure||Enrolling by invitation||N/A|6|Anticipated|Kanazawa University||1|||f||||f||||||||||2017-10-11 02:23:52.10112|2017-10-11 02:23:52.10112
NCT01709266|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-08-26|||August 2012||2012-08-01|August 2015|2015-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|PROTETEC||The Effect of Probiotics on E. Coli-induced Gastroenteritis|A Randomized, Placebo-controlled, Double Blind Volunteer Study Into the Effect of Probiotics on Gastroenteritis Caused by an Attenuated E. Coli.|Completed||N/A|60|Actual|NIZO Food Research||2|||f||||f||||||||||2017-10-11 02:23:52.355056|2017-10-11 02:23:52.355056
NCT01709253|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-03-27|||March 2007||2007-03-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma|Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma|Completed||N/A|117|Actual|National Cancer Center, Korea||4|||f||||f||||||||||2017-10-11 02:23:52.465049|2017-10-11 02:23:52.465049
NCT01709240|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-03-26|||January 2013||2013-01-01|October 2012|2012-10-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Evaluation of the BioWeld1 System as a Method for Surgical Incision Closure|Evaluation of the BioWeld1 System as a Method for Surgical Incision Closure|Withdrawn||Phase 2/Phase 3|0|Actual|IonMed Ltd||1||Internal decision|f||||f||||||||||2017-10-11 02:23:52.559525|2017-10-11 02:23:52.559525
NCT01709227|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-05-04|2017-01-31||October 2011||2011-10-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass|Early Renal Replacement Therapy vs. Furosemide for Neonates With Oliguria After Cardiopulmonary Bypass|Completed||N/A|73|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||Yes|De-identified patient data would be available to other researchers after publication of data at the discretion of the research team after communication with the PI|2017-10-11 02:23:52.680962|2017-10-11 02:23:52.680962
NCT01709214|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-06-03|||November 2012||2012-11-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain|A Randomized, Double-Blind, Placebo- and Active Controlled Study to Evaluate the Safety and Efficacy of GRT6005 in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee|Completed||Phase 2|619|Actual|Grünenthal GmbH||4|||f||||f||||||||||2017-10-11 02:23:53.505848|2017-10-11 02:23:53.505848
NCT01709201|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-06-19|||July 2013||2013-07-01|June 2017|2017-06-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Reducing Problematic Substance Use in Youth With Chronic Medical Conditions|Reducing Problematic Substance Use in Youth With Chronic Medical Conditions|Withdrawn||N/A|0|Actual|Boston Children’s Hospital||2||Study did not receive funding and was administratively withdrawn.|f||||f||||||||||2017-10-11 02:23:53.889336|2017-10-11 02:23:53.889336
NCT01709175|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-06-04|||November 2012||2012-11-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Strength Training Study for Survivors of Breast and Gynecologic Cancer|The Effect of Resistance Exercise Frequency in Breast and Gynecologic Cancer Survivors|Completed||N/A|20|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 02:23:54.12567|2017-10-11 02:23:54.12567
NCT01709162|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2015-10-27|2015-09-17||March 2013||2013-03-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||All participants who were randomized|Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma|A Randomized, Open-Label, Multicenter Phase II Study of Ipilimumab Retreatment Versus Chemotherapy for Subjects With Advanced Melanoma Who Progressed After Initially Achieving Disease Control With Ipilimumab Therapy|Terminated||Phase 2|31|Actual|Bristol-Myers Squibb|As planned, accrual of participants was to be completed within 21 months. However, current projections showed that 4 to 5 years were needed. The study was terminated early because the scientific objective could not be met in the predefined timeframe.|2||Discontinued early due to enrollment challenges and changes in treatment standards|f||||f||||||||||2017-10-11 02:23:54.23717|2017-10-11 02:23:54.23717
NCT01709149|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-01-05||2015-03-26|October 2012||2012-10-01|January 2017|2017-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)|A Phase IIb, Multi-National, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (BENEFIT-ALS)|Completed||Phase 2|711|Actual|Cytokinetics||2|||f||||t||||||||||2017-10-11 02:23:54.994834|2017-10-11 02:23:54.994834
NCT01709136|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-29|2016-03-21|2016-01-14||December 2005||2005-12-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|Sirolimus||Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity|Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Early Nephrotoxicity and/or Hypertension Due to Tacrolimus|Terminated||Phase 2/Phase 3|3|Actual|University of Pittsburgh|Complete follow-up failed, due to early study termination as a result of FDA black box warning (6/11/2009) about Sirolimus in liver transplant recipients (risk of thrombosis and death).|1||Sirolimus usage discontinued since black box warning|f||||t||||||||||2017-10-11 02:23:55.465217|2017-10-11 02:23:55.465217
NCT01709123|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-10-29|||August 2007||2007-08-01|October 2012|2012-10-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Effects of Micronutrient (Chromium) Supplementation on Diabetes|Ketosis, Vascular Inflammation, and Its Therapy (Chromium Supplementation) in Diabetic Patients|Unknown status|Recruiting|N/A|150|Anticipated|Louisiana State University Health Sciences Center Shreveport||2|||f||||t||||||||||2017-10-11 02:23:55.647692|2017-10-11 02:23:55.647692
NCT01709097|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2013-08-30|||June 2011||2011-06-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|C/A||Compliance/Adherence After Kidney Transplant, With or With Out Med-O-Wheel™.|Compliance/Adherence After Kidney Transplant, With or With Out an Electronic Drug Dispenser(Med-O-Wheel™), Karolinska University Hospital.|Completed||N/A|80|Actual|Karolinska University Hospital|||2||f||||t||||||||||2017-10-11 02:23:56.116677|2017-10-11 02:23:56.116677
NCT01709084|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2017-04-25|2016-10-05||October 2, 2013|Actual|2013-10-02|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|October 22, 2015|Actual|2015-10-22||Interventional|SALIF||A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment|A Phase 3b, Randomized, Open-label Clinical Study to Demonstrate Non-inferiority in Virologic Response Rates of HIV-1 RNA Suppression <400 Copies/mL of TDF/FTC/RPV Versus TDF/FTC/EFV in First-line Antiretroviral NNRTI-based Suppressed Patients. Switching At Low HIV-1 RNA Into Fixed Dose Combinations (SALIF)|Active, not recruiting||Phase 3|426|Actual|Janssen-Cilag International NV|It was an open label switch study with a significant number of patients (55%) on the Efavirenz (EFV) arm who did not switch their Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NNRTI) unlike in the Rilpivirine (RPV) arm where 100% switched.|2|||f||||t||||||||||2017-10-11 02:23:56.252428|2017-10-11 02:23:56.252428
NCT01709071|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2014-02-20|||February 2012||2012-02-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants|Double Blind Dose - Escalation, Randomized, Controlled, Phase I-II Trial to Evaluate Safety and Immunogenicity of Three Doses of Sabin-IPV and Adjuvanted Sabin-IPV in Healthy Infants|Completed||Phase 1/Phase 2|140|Actual|National Institute for Public Health and the Environment (RIVM)||7|||f||||t||||||||||2017-10-11 02:23:56.906749|2017-10-11 02:23:56.906749
NCT01709058|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2012-10-17|||August 2012||2012-08-01|October 2012|2012-10-01|August 2015|Anticipated|2015-08-01|December 2014|Anticipated|2014-12-01||Interventional|O2-O3||Study on the Effects of Oxygen-ozone Therapy on Back Pain in Subjects Aged 65 or Older|Prospective, Randomized, Single Blind Trial on the Effects of Paravertebral Intramuscular Oxygen-ozone Therapy on Back Pain in Subjects Aged 65 or Older|Unknown status|Recruiting|Phase 4|130|Anticipated|Istituto Nazionale di Ricovero e Cura per Anziani||2|||f||||f||||||||||2017-10-11 02:23:57.068496|2017-10-11 02:23:57.068496
NCT01709045|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2013-09-12|||August 2011||2011-08-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|ParisK||ParisK: Correlation of Imaging Techniques With Histology|The Assessment of the Plaque at RISK by Non-invasive (Molecular) Imaging and Modelling (ParisK): Correlation of Imaging Techniques With Histology|Unknown status|Recruiting|N/A|50|Anticipated|Maastricht University Medical Center|||1||f||||f||||||Samples Without DNA|"     Carotid plaque removed during carotid endarterectomy   "|||2017-10-11 02:23:57.17172|2017-10-11 02:23:57.17172
NCT01709019|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-03-04|||October 2012||2012-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly|A Phase I Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of an RSV-F Protein Nanoparticle Vaccine, With or Without Aluminum Adjuvant, and Co-administered With a Licensed Inactivated Influenza Vaccine, in Healthy Subjects ≥ 60 Years of Age.|Completed||Phase 1|220|Actual|Novavax||5|||f||||f||||||||||2017-10-11 02:23:57.36425|2017-10-11 02:23:57.36425
NCT01709006|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2016-08-03|||August 2012||2012-08-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase I-II Study on Treatment of Advanced Oropharynx Cancer in Elderly Population by Intensity Modulated Radiotherapy With Treatment Volume Reduction and Combination Chemotherapy|Phase I-II Study on Treatment of Advanced Oropharynx Cancer in Elderly Population by Intensity Modulated Radiotherapy With Treatment Volume Reduction and Combination Chemotherapy|Active, not recruiting||Phase 1/Phase 2|10|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 02:23:57.468374|2017-10-11 02:23:57.468374
NCT01708993|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-03-27|||October 15, 2012|Actual|2012-10-15|March 2017|2017-03-01|May 2016|Actual|2016-05-01|October 2015|Actual|2015-10-01||Interventional|||Reolysin in Patients With Previously Treated Advanced or Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy|A Randomized Phase II Study of Reolysin in Patients With Previously Treated Advanced or Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy.|Completed||Phase 2|165|Actual|Canadian Cancer Trials Group||4|||f||||t||||||||||2017-10-11 02:23:57.544175|2017-10-11 02:23:57.544175
NCT01708980|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2013-10-22|||October 2012||2012-10-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Descriptive Study of Strength Training Exercises to Activate the Muscles of the Operated Leg After Total Knee Replacement|Neuromuscular Activity of the Operated Leg During Strength Training Performed in Machines and in More Simple Forms After Total Knee Replacement|Completed||Phase 1|24|Actual|Copenhagen University Hospital, Hvidovre||1|||f||||t||||||||||2017-10-11 02:23:57.66739|2017-10-11 02:23:57.66739
NCT01708967|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2014-01-29|2013-11-09||March 2009||2009-03-01|January 2014|2014-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|RTNPMTNE||Trial of New Pretreatment Method in Transnasal Endoscopy|One-time Spray of Epinephrine (1cc) Plus 4% Lidocaine (4cc) is Sufficient Pretreatment Method for the Preparation of Transnasal Endoscopy|Completed||N/A|100|Actual|Chuncheon Sacred Heart Hospital|A limitation of this study was the small number of patients; n = 93 is insufficient to conclusively generalize the efficiency of the catheter-free method.|2|||f||||t||||||||||2017-10-11 02:23:57.792587|2017-10-11 02:23:57.792587
NCT01708954|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2016-11-30|2016-10-06||February 2013||2013-02-01|November 2016|2016-11-01||||August 2015|Actual|2015-08-01||Interventional||Eligible and treated patients|Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer|A Randomized Phase II Trial of Erlotinib, Cabozantinib, or Erlotinib Plus Cabozantinib as 2nd or 3rd Line Therapy in Patients With EGFR Wild-Type NSCLC|Active, not recruiting||Phase 2|125|Actual|National Cancer Institute (NCI)||4|||f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-10-11 02:23:58.739348|2017-10-11 02:23:58.739348
NCT01708928|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-06-27|||August 2010||2010-08-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Feasibility Study: Lifting and Tightening Neck Skin in Patients|Feasibility Study: Evaluation Of The Ulthera™ System For Obtaining Lift And Tightening Of The Neck Skin In Patients With A History Of Submentoplasty And Or Rhytidectomy Vs Patients Naïve To Submentoplasty Or Rhytidectomy - A Feasibility Study|Completed||N/A|30|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-11 02:24:02.41814|2017-10-11 02:24:02.41814
NCT01708915|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2014-05-20|2014-04-17||October 2012||2012-10-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Patients from Treated Set (TS): Patients who were randomised and who used at least 1 dose of study medication.|Nonivamide/Nicoboxil Ointment in Acute Low Back Pain|A Multi-centre, Double-blind, Randomised, Parallel Group Study to Assess the Efficacy and Safety of Multiple Doses of Topically Applied Hyperemisation-inducing Ointment (2cm Ointment Line Per Application; up to 3 Times Daily for up to 4 Days) Containing 2.5% Nicoboxil/0.4% Nonivamide Versus 2.5% Nicoboxil, 0.4% Nonivamide and Placebo in Patients 18 to 65 Years of Age With Acute Low Back Pain|Completed||Phase 3|805|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 02:24:02.544089|2017-10-11 02:24:02.544089
NCT01708902|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2015-04-08|2015-04-08||October 2012||2012-10-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Treated set (TS): all patients treated with at least 1 dose of study medication|Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients|A Phase III Randomised, Double-blind, Double-dummy, Parallel Group Study to Compare the Efficacy and Safety of Twice Daily Administration of the Fix Dose Combination of Linagliptin 2.5 mg + Metformin 500 mg, or of Linagliptin 2.5 mg + Metformin 1000 mg, With the Individual Components of Metformin (500 mg or 1000 mg, Twice Daily), and Linagliptin (5.0 mg, Once Daily) Over 24 Weeks in Treatment naïve Type 2 Diabetic Patients With Insufficient Glycaemic Control|Completed||Phase 3|876|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 02:24:03.394026|2017-10-11 02:24:03.394026
NCT01707771|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-15|||September 2008||2008-09-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||Bariatric Surgery and HDL-cholesterol|Effect of Gastric Bypass Versus Diet on Cardiovascular Risk Factors|Completed||N/A|40|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 02:24:21.718989|2017-10-11 02:24:21.718989
NCT01708889|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-16|2013-06-04|||September 2012||2012-09-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|PK||Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction|An Open-label, Single Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-914143 in Subject With Normal Renal Function and Subjects With Mild, Moderate, Severe, and End-stage Renal Dysfunction|Completed||Phase 1|43|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-10-11 02:24:05.109795|2017-10-11 02:24:05.109795
NCT01708876|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-04-07|||October 2012||2012-10-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ACT KNOW||P. Knowlesi Trial of Artesunate-mefloquine Versus Chloroquine|Artesunate-mefloquine vs Chloroquine in Patients With Acute Uncomplicated P. Knowlesi and P. Vivax Malaria: a Randomized Open Label Trial in Sabah, Malaysia|Completed||Phase 3|250|Anticipated|Menzies School of Health Research||2|||f||||f||||||||||2017-10-11 02:24:05.268813|2017-10-11 02:24:05.268813
NCT01708863|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2016-03-11|||October 2012||2012-10-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation|A PROSPECTIVE STUDY OF PATIENTS WITH HYPOPLASTIC LEFT HEART SYNDROME FOLLOWING STAGE II SURGICAL PALLIATION|Recruiting||N/A|20|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-11 02:24:05.420203|2017-10-11 02:24:05.420203
NCT01708850|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2016-09-06|||November 2012||2012-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)|A Pilot Study in Cancer Patients With Central Venous Catheter Associated Deep Vein Thrombosis in the Upper Extremity Treated With Rivaroxaban (Catheter 2)|Completed||Phase 4|70|Actual|London Health Sciences Centre||1|||f||||f||||||||||2017-10-11 02:24:05.532688|2017-10-11 02:24:05.532688
NCT01708837|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2013-05-29|||October 2012||2012-10-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction|Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction : A Multi-Center Study|Unknown status|Active, not recruiting|Phase 4|300|Anticipated|Xiangya Hospital of Central South University||2|||f||||t||||||||||2017-10-11 02:24:05.636038|2017-10-11 02:24:05.636038
NCT01708824|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-05-11|||April 2013||2013-04-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Diet and Physical Activity Intervention in CRC Survivors|The Acceptability and Feasibility of a Diet and Physical Activity Intervention to Prevent Recurrence in Colorectal Cancer Survivors: a Phase 2 Study|Recruiting||Phase 2|224|Anticipated|The University of Hong Kong||4|||f||||f||||||||No|no consent has been obtained to make individual participant data available|2017-10-11 02:24:05.728549|2017-10-11 02:24:05.728549
NCT01708811|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-10-12|||October 2012||2012-10-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Hyponatremia and Myometrium Contractility. An Invitro Study|Will Reduction in Plasma Sodium Reduce Myometrium Contractility in Humans? An Invitro Study of Pregnant Myometrium at Term.|Terminated||N/A|12|Actual|Karolinska University Hospital|||1|Few biopsies showed the expected pattern We suspect erroeneous method.|f||||f||||||None Retained|"     Biopsies of pregant myometrium   "|||2017-10-11 02:24:05.850342|2017-10-11 02:24:05.850342
NCT01708798|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-01-03|||May 2014||2014-05-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer|A Prospective Randomized Placebo-controlled Study of the Effect of Eplerenone on Left Ventricular Diastolic Function in Women Receiving Anthracycline Therapy for Breast Cancer|Terminated||Phase 2/Phase 3|44|Actual|University of British Columbia||2||Futility|f||||t||||||||No||2017-10-11 02:24:05.924563|2017-10-11 02:24:05.924563
NCT01708785|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-04-28|||October 2012||2012-10-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|iROC||Learning Theory to Improve Obesity Treatment|Learning Theory to Improve Obesity Treatment (Intervention for Regulation of Cues)|Active, not recruiting||N/A|230|Actual|University of California, San Diego||4|||f||||t||||||||No||2017-10-11 02:24:06.049488|2017-10-11 02:24:06.049488
NCT01708772|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2013-06-06|||November 2012||2012-11-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|||Serum TNF-a in Comparison to Sequential Organ Failure Assessment (SOFA) Score Monitoring in Critically Ill Patients|The Predictive Prognostic Values of Serum TNF-a in Comparison to SOFA Score Monitoring in Critically Ill Patients|Completed||N/A|90|Actual|Tanta University|||2||f||||t||||||||||2017-10-11 02:24:06.165277|2017-10-11 02:24:06.165277
NCT01708759|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-04-06|||November 2012||2012-11-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||IL8 Monitoring and Its Correlation With 251-gene Polymorphism|The Value of Admission Serum Il-8 Monitoring and the Detection of IL8 (-251 A/T) Polymorphism in Critically Ill Patients|Completed||N/A|80|Actual|Tanta University|||2||f||||t||||||||||2017-10-11 02:24:06.234475|2017-10-11 02:24:06.234475
NCT01708746|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-09-24|||November 2012||2012-11-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views||Completed||N/A|205|Actual|Verinata Health, Inc.|||2||f||||f||||||||||2017-10-11 02:24:06.296482|2017-10-11 02:24:06.296482
NCT01708733|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-05-28|||August 2012||2012-08-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function|An Evaluation of the Extract of KUAN SIN YIN on Hepatitis C: a Randomized, Double-blinded and Placebo-controlled Clinical Trial.|Completed||Phase 2/Phase 3|57|Actual|Taipei City Hospital||2|||f||||t||||||||||2017-10-11 02:24:07.90427|2017-10-11 02:24:07.90427
NCT01708720|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-02-20|||August 2011||2011-08-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|September 2011|Actual|2011-09-01||Interventional|||Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults|Safety and Immunogenicity of Sabin-IPV and Adjuvanted Sabin-IPV in Healthy Adults|Completed||Phase 1|45|Actual|National Institute for Public Health and the Environment (RIVM)||3|||f||||f||||||||||2017-10-11 02:24:07.977566|2017-10-11 02:24:07.977566
NCT00000604|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-12-11|||January 1994||1994-01-01|December 2015|2015-12-01|December 1996||1996-12-01|||||Interventional|||Influence of CPB Temperature on CABG Morbidity||Completed||Phase 2|||Baystate Medical Center|||||f||||||||||||||2017-10-11 04:19:08.393228|2017-10-11 04:19:08.393228
NCT01708707|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-06-14|||December 2012||2012-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)|A Randomized Comparison of Sublingual Buprenorphine to Morphine Sulfate in the Treatment of Neonatal Abstinence Syndrome (NAS)|Enrolling by invitation||Phase 2|64|Anticipated|Mednax Center for Research, Education and Quality||2|||f||||t||||||||||2017-10-11 02:24:08.075101|2017-10-11 02:24:08.075101
NCT01708694|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-09-26|||August 2012||2012-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|STARCH||Role of Slowly Digesible Starch on Diabetes Risk Factors|Role of Slowly Digesible Starch on Diabetes Risk Factors In Pre-diabetic People|Active, not recruiting||N/A|95|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 02:24:08.189212|2017-10-11 02:24:08.189212
NCT01708681|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-10-05|||October 2012||2012-10-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|May 2013|Actual|2013-05-01||Interventional|LeSIP||Lean Seafood Intake and Postprandial Metabolism|Ability of a Lean Seafood Diet to Modulate Postprandial Metabolism in Human-beings - a Controlled Intervention Study With Cross-over Design|Completed||N/A|27|Actual|National Institute of Nutrition and Seafood Research, Norway||2|||f||||||||||||||2017-10-11 02:24:08.263432|2017-10-11 02:24:08.263432
NCT01708668|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2015-01-14|||October 2012||2012-10-01|January 2015|2015-01-01|June 2017|Anticipated|2017-06-01|July 2015|Anticipated|2015-07-01||Interventional|EIEBFLA||The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia|The Effects of Intermittent Epidural Bolus Versus Continuous Epidural Infusion on Fever for Labor Analgesia in Primiparous Women|Unknown status|Recruiting|N/A|12000|Anticipated|Nanjing Medical University||8|||f||||t||||||||||2017-10-11 02:24:08.349866|2017-10-11 02:24:08.349866
NCT01708655|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2014-12-01|||December 2011||2011-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Sweat Evaporimeter Measurement|Evaluation of the Accuracy and Reliability of B-Adrenergic Sweat Secretion Using an Evaporimeter to Assess CFTR Function in Cystic Fibrosis|Completed||N/A|16|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 02:24:08.487938|2017-10-11 02:24:08.487938
NCT01708642|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-02-16|||November 2012||2012-11-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The Effect of Administration of Low Dose Adrenaline During Surgery on Bleeding During Hip Surgery|The Effect of Intraoperative Low Dose Adrenaline on Bleeding in Total Hip Arthroplasty - a Randomized Placebo-controlled Trial|Completed||Phase 3|106|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 02:24:08.57759|2017-10-11 02:24:08.57759
NCT01708616|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2016-11-01|||November 2012||2012-11-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Volunteers|A Single-center, Randomized, Double-blind, Two-period Crossover Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Subjects|Completed||Phase 1|24|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 02:24:09.263068|2017-10-11 02:24:09.263068
NCT01708577|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2012-11-13|||July 2011||2011-07-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||UMIC Validation Study|Ultra High Speed Mobile Information and Communication|Completed||N/A|12|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 02:24:10.269892|2017-10-11 02:24:10.269892
NCT01708564|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-07-29|||October 2012||2012-10-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|rhFVIIa||A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B|A Phase 1b, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Coagulation Factor VIIa (Recombinant) in Congenital Hemophilia A or B Patients|Completed||Phase 1|15|Actual|rEVO Biologics||3|||f||||t||||||||||2017-10-11 02:24:10.3611|2017-10-11 02:24:10.3611
NCT01708551|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-10-07|||August 2012||2012-08-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|||Histological Analysis Following Ulthera System Treatment for Hyperhidrosis|Histological Analysis and Correlation With Ultrasound Imaging to Evaluate the Safety and Effectiveness of Treating Axillary Hyperhidrosis Subjects With the Ulthera® System|Completed||N/A|59|Actual|Ulthera, Inc||5|||f||||f||||||||||2017-10-11 02:24:10.472941|2017-10-11 02:24:10.472941
NCT01708538|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-04-11|||October 2012||2012-10-01|April 2017|2017-04-01||||October 2018|Anticipated|2018-10-01||Interventional|||The Effects of Corneal Collagen Cross-linking|Phase III Study of Corneal Collagen Cross-linking Using Two Different Techniques.|Recruiting||Phase 3|30|Anticipated|Rush Eye Associates||2|||f||||t||||||||||2017-10-11 02:24:10.577835|2017-10-11 02:24:10.577835
NCT01706133|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-02-03|||June 2013||2013-06-01|February 2015|2015-02-01||||March 2014|Actual|2014-03-01||Interventional|||An Intervention for Elderly in Emergency Services|Elderly in Emergency Services: Effectiveness of an Intervention to Improve Health Outcomes|Completed||N/A|1400|Actual|Coordinación de Investigación en Salud, Mexico||1|||f||||f||||||||||2017-10-11 02:24:50.064992|2017-10-11 02:24:50.064992
NCT01708525|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-12-04|2014-06-16||August 2012||2012-08-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Both study subjects completed two weeks of heavy water tissue labeling then received Ultherapy® treatment to the pre-auricular region on one side of their face. The non-treated pre-auricular region on the contralateral side served as a control. Treated and non-treated tissue was resected at 4 weeks post Ultherapy® for analysis.|Feasibility Study: Heavy Water Tissue Labeling Protocol|Feasibility Study: Determination of the Effect of Ultherapy® Treatment on the Rate of Collagen Synthesis in Normal Skin|Completed||N/A|2|Actual|Ulthera, Inc|A limitation of this trial includes only a two subject study population due to the extremely high expense of the tissue analyses conducted. High expense precluded further research in a randomized designed trial with a broader patient population.|1|||f||||f||||||||||2017-10-11 02:24:10.670929|2017-10-11 02:24:10.670929
NCT01708512|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-09-09|||April 2012||2012-04-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and Neck|Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of Facial and Neck Skin Laxity Using a Customized, High-Density and Vectoring Treatment Approach|Completed||N/A|21|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-11 02:24:10.85571|2017-10-11 02:24:10.85571
NCT01708499|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-06-27|||March 2012||2012-03-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal Tissue|Feasibility Study: Evaluation of the Ulthera® System for Efficacious and Safe Treatment of Laxity/Crepiness and Texture of Abdominal Tissue|Completed||N/A|24|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-11 02:24:10.946251|2017-10-11 02:24:10.946251
NCT01708486|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2014-08-18|||February 2013||2013-02-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|BALLOON||BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) Study|Multicenter, Prospective, Non-interventional, Observational Study on Treatment of Asthma in Children.|Completed||N/A|35|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 02:24:11.027991|2017-10-11 02:24:11.027991
NCT01708473|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-06-27|||July 2011||2011-07-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ Treatments|Feasibility Study: Comparison Of Advil® Vs. Lortab® For Reducing Discomfort Associated With Ultherapy™ Treatment|Completed||N/A|20|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-11 02:24:11.128641|2017-10-11 02:24:11.128641
NCT01708460|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-09-09|||December 2011||2011-12-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||Feasibility Study: Ulthera Treatment of the Buttocks and Thighs|Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening the Buttocks and Thighs|Completed||N/A|31|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-11 02:24:11.21089|2017-10-11 02:24:11.21089
NCT01708447|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-06-27|||July 2011||2011-07-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment|Feasibility Study: Evaluation of the Efficacy of a Liposome-encapsulated Lidocaine Topical Anesthetic for Reducing Discomfort Associated With Ultherapy™ Treatment|Completed||N/A|16|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-11 02:24:11.290086|2017-10-11 02:24:11.290086
NCT01708434|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-06-27|||June 2011||2011-06-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Knees|Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of the Knees|Completed||N/A|30|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-11 02:24:11.374329|2017-10-11 02:24:11.374329
NCT01708421|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-10-02|||November 2012||2012-11-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Symptom Clusters in Children With Leukemia|Phenotypic and Genotypic Associations With Symptom Clusters During Childhood Leukemia Treatment|Enrolling by invitation||N/A|400|Anticipated|Duke University|||1||f||||t||||||Samples With DNA|"     A baseline CSF sample will be obtained prior to intrathecal chemotherapy. CSF biomarkers will     be obtained at the initiation of post-induction, 4 and 6 months into post-induction therapy,     and at the start of maintenance therapy.A saliva sample will be obtained for genotypic     analysis at one of the four data collection times.   "|||2017-10-11 02:24:11.450013|2017-10-11 02:24:11.450013
NCT01708408|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2017-02-06|||February 2009||2009-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|MURDOCK||The MURDOCK Study Registry and Biorepository Horizon 1.5|Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis The MURDOCK Study Registry and Biorepository Horizon 1.5|Recruiting||N/A|50000|Anticipated|Duke University|||1||f||||t||||||Samples With DNA|"     Blood, 50 mL (whole blood, plasma, serum, buffy coat, PAXgene); Urine, 36 mL   "|||2017-10-11 02:24:11.512294|2017-10-11 02:24:11.512294
NCT01708395|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2015-08-14|||October 2012||2012-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Observational|OPERA||IBD-OPERA Database, UC Protocol|IBD-OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database|Completed||N/A|50|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||f||||||||||2017-10-11 02:24:11.720023|2017-10-11 02:24:11.720023
NCT01708382|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-06-27|||September 2011||2011-09-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||Feasibility Study: Lifting and Tightening of the Elbows|Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of the Elbow Tissue - A Feasibility Study|Completed||N/A|21|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-11 02:24:11.790584|2017-10-11 02:24:11.790584
NCT01708369|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-13|2012-10-15|||February 2012||2012-02-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Alcohol Inhibits Drug Metabolism by Carboxylesterases|Inhibition of Carboxylesterase Metabolism by Ethanol|Completed||Phase 1|19|Actual|University of Tennessee||4|||f||||f||||||||||2017-10-11 02:24:11.880026|2017-10-11 02:24:11.880026
NCT01708356|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-15|||June 2010||2010-06-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|CAPaH||Cycling, Air Pollution and Health|Cycling, Air Pollution and Health|Completed||N/A|38|Actual|University of British Columbia||1|||f||||||||||||||2017-10-11 02:24:11.962044|2017-10-11 02:24:11.962044
NCT01708343|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-15|||January 2011||2011-01-01|October 2012|2012-10-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|DIMMST||Paraspinal Stimulation in Treating MPS|Paraspinal Stimulation Combined With Trigger Point Needling and Needle Rotation in Treating Myofascial Pain: Randomized Sham-controlled Clinical Trial|Unknown status|Recruiting|Phase 3|75|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||t||||||||||2017-10-11 02:24:12.03812|2017-10-11 02:24:12.03812
NCT01708330|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-07-18|||October 2012||2012-10-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Topical Lidocaine on Pain Scores During Manual Vacuum Aspiration for Nonviable Pregnancies||Completed||Phase 3|70|Actual|Bridgeport Hospital||2|||f||||f||||||||||2017-10-11 02:24:12.164743|2017-10-11 02:24:12.164743
NCT01708317|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-12-04|2012-10-17||April 2011||2011-04-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Computer-Assisted Self-Interviews and Health Screening in the Pediatric Emergency Department|The Use of Computer-Assisted Self-Interviews to Improve Adolescent and Young Adult Health Screening in the Pediatric Emergency Department|Completed||N/A|801|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 02:24:12.270057|2017-10-11 02:24:12.270057
NCT01708304|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-09-14|||November 2012||2012-11-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|RDAD||Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)|From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services|Completed||N/A|510|Actual|University of Washington||1|||f||||t||||||||||2017-10-11 02:24:12.558983|2017-10-11 02:24:12.558983
NCT01708291|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2015-10-20|2015-09-21||October 2012||2012-10-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|HEALTHY|Baseline characteristics were not collected for 3 subjects. They were excluded from the study for fighting.|HEALTHY (Health Education Adolescent Leadership Training to Help Youth) Leaders||Completed||N/A|45|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 02:24:12.741344|2017-10-11 02:24:12.741344
NCT01708278|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-10-31|2016-10-31||February 2014||2014-02-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Quercetin||Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)|Phase I Study to Determine the Safety of Quercetin in COPD Patients|Completed||Phase 1|9|Actual|University of Michigan||6|||f||||t||||||||||2017-10-11 02:24:13.19768|2017-10-11 02:24:13.19768
NCT01708265|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-11-22|||February 2013||2013-02-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|Dutch AMR||The Dutch Asymptomatic Mitral Regurgitation Trial|Dutch AMR; Early Mitral Valve Repair Versus Watchful Waiting in Asymptomatic Patients With Severe Organic Mitral Regurgitation; a Multicenter, Randomised Trial.|Terminated||N/A|12|Actual|UMC Utrecht||2||low inclusion rate|f||||t||||||||||2017-10-11 02:24:13.836992|2017-10-11 02:24:13.836992
NCT01708252|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2013-06-28|||September 2011||2011-09-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment|Feasibility Study: Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Neck in Post-Surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ultherapy™ Treatment|Completed||N/A|4|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-11 02:24:14.028573|2017-10-11 02:24:14.028573
NCT01708239|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-05-27|||October 2012||2012-10-01|May 2015|2015-05-01|January 2016|Anticipated|2016-01-01|October 2015|Anticipated|2015-10-01||Observational|||Left Rule, D-Dimer Measurement and Complete Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy.|Sequential Use of the LEFt Rule, D-dimer Measurement and Complete Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy: a Prospective Outcome Study.|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 02:24:14.148152|2017-10-11 02:24:14.148152
NCT01708226|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-01-13|||November 2012||2012-11-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|November 2013|Actual|2013-11-01||Interventional|AMPOCD||Attention Training for Childhood Obsessive Compulsive Disorder: An Open Case Series|Attention Training for Childhood Obsessive Compulsive Disorder: An Open Case Series|Completed||Phase 1|6|Actual|University of California, Los Angeles||1|||f||||t||||||||No||2017-10-11 02:24:14.248272|2017-10-11 02:24:14.248272
NCT01708213|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-12-16|2014-09-03||October 2012||2012-10-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Safety Evaluation of Aline HA, an Implanted Cross-Linked HA Device|A Multi-center, Open-label, Prospective Study of Implanted Cross-linked HA Device, Aline HA, for Soft Tissue Augmentation, to Treat Only One Anatomic Feature in up to 100 Subjects for 6 Months|Completed||N/A|72|Actual|TauTona Group||1|||f||||t||||||||||2017-10-11 02:24:14.327802|2017-10-11 02:24:14.327802
NCT01708200|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-15|||October 2012||2012-10-01|October 2012|2012-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||A Comparison of the Effectiveness of Two Types of Memory Training Programs in People With a Diagnosis of Mental Illness.|A Comparison of the Effectiveness of Two Types of Cognitive Training Interventions Administered to Individuals With a Diagnosis of a Mental Health Condition.|Unknown status|Not yet recruiting|N/A|76|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||||2017-10-11 02:24:14.53066|2017-10-11 02:24:14.53066
NCT01708187|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-09-29|2016-04-13||October 2012||2012-10-01|September 2016|2016-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Amniox||The Role of C-HAM in the Surgical Repair of Peroneal Tendons: An Infrared Thermography Model|The Role of Cryopreserved Human Amniotic Membrane in the Surgical Repair of Peroneal Tendons: An Infrared Thermography Model|Terminated||N/A|2|Actual|Orthopedic Foot and Ankle Center, Ohio|Early termination leading to only one subject completing the trial.|2||Protocol halted due to less than anticipated recruitment.|f||||f||||||||||2017-10-11 02:24:14.621367|2017-10-11 02:24:14.621367
NCT01708174|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-08-07|2017-03-31||May 6, 2013|Actual|2013-05-06|August 2017|2017-08-01|October 5, 2016|Actual|2016-10-05|October 5, 2016|Actual|2016-10-05||Interventional|||A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)|A Phase II, Multi-center, Open-label, Single-arm Study of the Efficacy and Safety of Oral LDE225 in Patients With Hh-pathway Activated Relapsed Medulloblastoma|Completed||Phase 2|22|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:24:14.947221|2017-10-11 02:24:14.947221
NCT01704443|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-05-30|||April 2008||2008-04-01|May 2017|2017-05-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|IMPROVED||Integrated Mindfulness for Provoked Vestibulodynia|Integrated Mindfulness for Provoked Vestibulodynia|Completed||N/A|97|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:25:18.680159|2017-10-11 02:25:18.680159
NCT01708161|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-07-18|||November 27, 2012|Actual|2012-11-27|July 2017|2017-07-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors|A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors|Completed||Phase 1/Phase 2|47|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 02:24:16.848742|2017-10-11 02:24:16.848742
NCT01708148|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-12-05|||September 2011||2011-09-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|March 2012|Actual|2012-03-01||Interventional|||Oral Administration of Four Lactobacillus Species Preparation to Improve the Quality of the Neovaginal Flora in Male to Female Transsexual Patients||Completed||N/A|60|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:24:16.986046|2017-10-11 02:24:16.986046
NCT01708135|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-09-15|||October 2012||2012-10-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Feasibility of Use of BariCare App in Pre-bariatric Surgery.|Feasibility and Efficacy of Engagement Modules for Pre-Bariatric Surgery Patients.|Completed||N/A|30|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:24:17.073497|2017-10-11 02:24:17.073497
NCT01708122|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-07-25|2015-07-25||May 2009||2009-05-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|March 2013|Actual|2013-03-01||Interventional|||Intranasal Fentanyl as an Analgesic for Cystoscopic Procedures|A Prospective, Randomized, Double Blind Study Comparing the Efficacy and Safety of Fentanyl Nasal Spray to Placebo as an Analgesic, in Patients Undergoing Outpatient Cystoscopic Procedures|Completed||Phase 4|71|Actual|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-10-11 02:24:17.168428|2017-10-11 02:24:17.168428
NCT01708109|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-08-31|||November 2011||2011-11-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Interventional|||Optimal Handling of Common Bile Duct Calculus, a Prospective Study|Optimal Handling of Common Bile Duct Calculus, a Prospective Randomized Study|Recruiting||N/A|200|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:24:17.467629|2017-10-11 02:24:17.467629
NCT01708096|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-03-11|||October 2009||2009-10-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Mechanisms Behind Antidiabetic Effects by Gastric By-pass|Mechanisms Behind Antidiabetic Effects by Gastric By-pass|Completed||N/A|15|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:24:17.623174|2017-10-11 02:24:17.623174
NCT01708083|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-08-21|||January 2010||2010-01-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Polymorphids an mRNA Expression in Obese Genes|Polymorphids and mRNA Expression in Genes, Significant for Developing Obesity and Typ II Diabetes in Different Types/Localisations of Fat Tissue|Completed||N/A|50|Actual|Karolinska Institutet|||3||f||||f||||||Samples With DNA|"     biopsys; Fat from oment, thigh and abdomen   "|||2017-10-11 02:24:17.739506|2017-10-11 02:24:17.739506
NCT01708070|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-09-09|||October 2012||2012-10-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Trial of Asthma Self-Management Education in Patients With Depressive Symptoms|Trial of Asthma Self-Management Education in Patients With Depressive Symptoms|Completed||N/A|66|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 02:24:17.810253|2017-10-11 02:24:17.810253
NCT01708057|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2013-12-13|2013-07-30||October 2012||2012-10-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients|A Randomised, Double-blind Placebo- and Active-controlled, Multi-centre, 6-way Cross-over, Single-dose Phase IIa Study to Investigate the Bronchodilatory and Systemic Effects of 4 Different Doses of Inhaled AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Terminated||Phase 2|3|Actual|AstraZeneca||6|||f||||||||||||||2017-10-11 02:24:17.91837|2017-10-11 02:24:17.91837
NCT01708044|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-10-17|||November 2012||2012-11-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM|A Phase 1, Randomized, Placebo-Controlled Single-Blind, Dose-Ranging, 4-Way Crossover Study to Evaluate the Effect of Different Fixed Pramlintide: Insulin Dose Ratios on Postprandial Glycemic Control in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|32|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 02:24:18.547691|2017-10-11 02:24:18.547691
NCT01708031|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-15|||October 2011||2011-10-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|April 2013|Anticipated|2013-04-01||Interventional|UNIMAP||Computerized Mental Arthimetic Task Based Human Stress Level Detection Using Physiological Signal|Computerized Mental Arthimetic Task Based Human Stress Level Detection Using Physiological Signal|Unknown status|Enrolling by invitation|N/A|300|Anticipated|Universiti Malaysia Perlis||1|||f||||t||||||||||2017-10-11 02:24:18.684755|2017-10-11 02:24:18.684755
NCT01708018|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-09-09|||July 2012||2012-07-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effects of Relaxing Hydrotherapy in Third Trimester of Pregnancy|Pilot Study: Effects of Relaxing Hydrotherapy WATSU in Third Trimester of Pregnancy, an Explorative Cohort-Study|Completed||N/A|17|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 02:24:18.809508|2017-10-11 02:24:18.809508
NCT01708005|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-15|||November 2012||2012-11-01|October 2012|2012-10-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|DIET-D||DIetary Supplements, Executive funcTions and Vitamin D (DIET-D)|DIetary Supplements, Executive funcTions and Vitamin D (DIET-D): a Double-blind Randomized Controlled Trial|Unknown status|Enrolling by invitation|Phase 2/Phase 3|160|Anticipated|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 02:24:18.947827|2017-10-11 02:24:18.947827
NCT01707992|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-05-15|||February 28, 2013|Actual|2013-02-28|May 2017|2017-05-01|April 19, 2017|Actual|2017-04-19|March 9, 2017|Actual|2017-03-09||Interventional|CONCERTO||The Efficacy, Safety, and Tolerability of Laquinimod in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)|A Multinational, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Followed by an Active Treatment Period, to Evaluate the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod (0.6 mg/d or 1.2 mg/d) in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)|Completed||Phase 3|2199|Actual|Teva Pharmaceutical Industries||3|||f||||t|t|f||||||||2017-10-11 02:24:19.067929|2017-10-11 02:24:19.067929
NCT01707979|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-10-15|||September 2012||2012-09-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|NIR||NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes|NIR (Near Infrared)- Spectroscopy and Multifrequent Impedance Spectroscopy on the Skin to Detection of Sensory and Autonomic Neuropathy Among Patients With Type 1 Diabetes|Completed||N/A|30|Actual|Steno Diabetes Center|||3||f||||t||||||||||2017-10-11 02:24:19.744304|2017-10-11 02:24:19.744304
NCT01707966|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-07-25|||September 2012||2012-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|September 2014|Actual|2014-09-01||Interventional|||Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy|Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy: a Multicenter Randomized Double-blind Placebo-controlled Phase III Trial.|Completed||Phase 3|47|Actual|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||No||2017-10-11 02:24:19.841773|2017-10-11 02:24:19.841773
NCT01707953|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2014-01-17|||October 2012||2012-10-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty|Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty - a Randomized, Placebo Controlled Trial.|Completed||Phase 3|120|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 02:24:19.991881|2017-10-11 02:24:19.991881
NCT01707940|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-15|2013-05-15|||October 2012||2012-10-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers|Relative Bioavailability of a Single Oral Dose of BI 144807 (Oral Solution) When Administered Alone or in Combination With Multiple Oral Doses of Ketoconazole (200 mg Tablet) in Healthy Male Subjects (an Open-label, Two-period, Fixed-sequence Trial)|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:24:20.098689|2017-10-11 02:24:20.098689
NCT01707927|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-10-12|||September 2012||2012-09-01|October 2014|2014-10-01|December 2022|Anticipated|2022-12-01|September 2015|Anticipated|2015-09-01||Observational|||Comparison of Two Biological Aortic Valves. Mosaic Ultra and Trifecta.||Recruiting||N/A|70|Anticipated|Oslo University Hospital|||2||f||||f||||||||||2017-10-11 02:24:20.191994|2017-10-11 02:24:20.191994
NCT01707914|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2012-12-01|||June 2012||2012-06-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver Disease|Effects of Chinese Bayberry Juice on Liver Enzymes and Plasma Antioxidant Activity in Adult Subjects With Features of Fatty Liver Disease: a Randomised Placebo-controlled Trial|Completed||N/A|44|Actual|Shaoguan University||2|||f||||t||||||||||2017-10-11 02:24:20.510862|2017-10-11 02:24:20.510862
NCT01707901|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-10-13|||December 2012||2012-12-01|October 2015|2015-10-01||||October 2014|Actual|2014-10-01||Interventional|||A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease|A Randomised, Double-blind, Placebo-controlled, Two-period Crossover Study to Investigate the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease|Completed||Phase 1|14|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 02:24:20.639898|2017-10-11 02:24:20.639898
NCT01707888|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-13|2015-01-24|||September 2014||2014-09-01|January 2015|2015-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01|3 Years|Observational [Patient Registry]|||VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer|VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung cancer-a Registry Study|Unknown status|Recruiting|Phase 3|500|Anticipated|Peking University People's Hospital|||1||f||||f||||||||||2017-10-11 02:24:20.736326|2017-10-11 02:24:20.736326
NCT01707875|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2015-06-14|||November 2012||2012-11-01|July 2012|2012-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Fetal Brain Asymmetry: in Utero and Early Neonatal Follow up||Terminated||N/A|6|Actual|HaEmek Medical Center, Israel|||1|Difficulties in recruiting|f||||f||||||||||2017-10-11 02:24:20.862998|2017-10-11 02:24:20.862998
NCT01707862|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-14|2012-10-15|||March 1997||1997-03-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Observational|SIVL||Surgery for Intravenous Leiomyomatosis|Surgical Management of Intravenous Leiomyomatosis With Intracardiac Extension: Our Experience and Outcomes|Completed||N/A|6|Actual|General Hospital of Beijing PLA Military Region|||1||f||||t||||||||||2017-10-11 02:24:20.928038|2017-10-11 02:24:20.928038
NCT01707849|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-13|2016-08-29|||October 2012||2012-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation|An Unicenter, Prospective, Randomized, Pilot Study Comparing the Effect of Everolimus-containing Versus mTOR Inhibitor Free Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation.|Completed||Phase 3|18|Actual|Hospital Vall d'Hebron||2|||f||||t||||||||||2017-10-11 02:24:21.009349|2017-10-11 02:24:21.009349
NCT01707836|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-05-08|||October 2012||2012-10-01|May 2017|2017-05-01|May 8, 2017|Actual|2017-05-08|May 8, 2017|Actual|2017-05-08||Observational|||Neurofibromatosis Type 1 Brain Tumor Genetic Risk|Genetic Variation and Risk of Pediatric Brain Cancers|Completed||N/A|176|Actual|Washington University School of Medicine|||1||f||||f||||||Samples With DNA|"     Blood or saliva samples   "|Undecided||2017-10-11 02:24:21.155532|2017-10-11 02:24:21.155532
NCT01707823|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-06-29|||October 2012||2012-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer|Prevention of Death From Adenocarcinoma of the Lung by Low Dose Aspirin|Recruiting||N/A|40|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-10-11 02:24:21.243153|2017-10-11 02:24:21.243153
NCT01707810|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2012-10-15|||October 1999||1999-10-01|October 2012|2012-10-01|October 2000|Actual|2000-10-01|September 2000|Actual|2000-09-01||Interventional|LTx-outflow||Prospective Trial Comparing Conventional Versus Piggyback Method in Venous Drainage of the Transplanted Liver|Prospective Randomized Trial Comparing the Clinical Efficiency of Conventional Versus Piggyback Method in Venous Drainage of the Transplanted Liver|Completed||N/A|32|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:24:21.361514|2017-10-11 02:24:21.361514
NCT01707797|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-06-16|||November 15, 2012|Actual|2012-11-15|June 2017|2017-06-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Observational|||Predicting Caries Risk in Underserved Toddlers in Primary Healthcare Settings|Predicting Caries Risk in Underserved Toddlers in Primary Healthcare Settings A Stratified (by Race, Ethnicity, and Medicaid Status) Study to Develop a Caries Risk Prediction Questionnaire|Completed||N/A|1326|Actual|University of Michigan|||1||f||||t||||||||||2017-10-11 02:24:21.449908|2017-10-11 02:24:21.449908
NCT00000605|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||August 1996||1996-08-01|April 2005|2005-04-01|July 2002|Actual|2002-07-01|||||Interventional|||Estrogen and Graft Atherosclerosis Research Trial (EAGER)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.478707|2017-10-11 04:19:08.478707
NCT01707758|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2013-05-15|||October 2012||2012-10-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence|Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence|Withdrawn||N/A|0|Actual|University of Kansas Medical Center|||1|Trial terminated - Nanoscale Company out of business|f||||t||||||Samples Without DNA|"     Approximately 1 tablespoon of blood will be collected from each subject.   "|||2017-10-11 02:24:21.820196|2017-10-11 02:24:21.820196
NCT01707745|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2012-10-15|||January 2010||2010-01-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.||Unknown status|Recruiting|N/A|50|Anticipated|Dubai Health Authority||1|||f||||t||||||||||2017-10-11 02:24:21.91352|2017-10-11 02:24:21.91352
NCT01707732|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2015-06-17|||November 2012||2012-11-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ITOHENOX||Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin|Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin|Completed||Phase 3|92|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 02:24:22.021358|2017-10-11 02:24:22.021358
NCT01707719|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-03-31|||June 2015||2015-06-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|September 2016|Anticipated|2016-09-01||Observational|||Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's Disease|Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Patients Affected by Alzheimer's Disease and Healthy Controls|Recruiting||N/A|50|Anticipated|Campus Bio-Medico University|||2||f||||t||||||Samples With DNA|"     Whole blood   "|No||2017-10-11 02:24:22.138032|2017-10-11 02:24:22.138032
NCT01707706|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-12-12|||January 2011||2011-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Acupuncture for Persistent Insomnia Associated With Major Depressive Disorder|A Randomized Controlled Trial of Electroacupuncture for Persistent Insomnia Symptoms Associated With Major Depressive Disorder|Completed||N/A|150|Actual|The University of Hong Kong||3|||f||||f||||||||||2017-10-11 02:24:22.299967|2017-10-11 02:24:22.299967
NCT01707693|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2015-08-13|||April 2012||2012-04-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Lifestyle Physical Activity Intervention for Older Sedentary Women|A Lifestyle Physical Activity Intervention for Older Sedentary Women|Completed||N/A|144|Actual|University of Arkansas||2|||f||||t||||||||||2017-10-11 02:24:22.435298|2017-10-11 02:24:22.435298
NCT01707680|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2012-11-01|||June 2012||2012-06-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Observational|NICEWEAN||Non-interventional Comparison of Sedatives on Weaning From Mechanical Ventilation in Intensive Care Patients|Non-interventional Comparison of Sedatives on Weaning From Mechanical Ventilation in Intensive Care Patients|Unknown status|Recruiting|N/A|250|Anticipated|Orion Corporation, Orion Pharma|||3||f||||f||||||||||2017-10-11 02:24:22.560857|2017-10-11 02:24:22.560857
NCT01707667|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-10-17|2014-10-17||January 2013||2013-01-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional||The Safety Analysis Set consisted of all randomized subjects who had taken at least 1 dose of investigational product.|Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity|An Open-label, Randomized, Crossover, Reader-blinded Study to Investigate the Effect of Prucalopride and Polyethylene Glycol 3350 on Colon Motility With Intramural Manometry in Subjects With Chronic Constipation|Completed||Phase 4|13|Actual|Shire||2|||f||||||||||||||2017-10-11 02:24:22.736228|2017-10-11 02:24:22.736228
NCT01707654|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2013-08-18|2013-06-03||July 2008||2008-07-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|May 2010|Actual|2010-05-01||Interventional|||Repair of Infective Wound Associated With Nerve Defect in the Finger Using A Bipedicled Nerve Flap||Completed||N/A|9|Actual|The Second Hospital of Tangshan||1|||f||||||||||||||2017-10-11 02:24:23.253409|2017-10-11 02:24:23.253409
NCT01707641|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-05-19|||November 2012||2012-11-01|May 2014|2014-05-01|December 2019|Anticipated|2019-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer|A Randomized Study on the Effects of Lactobacillus Brevis CD2 in the Prevention of Radio and Chemotherapy Induced Oral Mucositis in Head and Neck Cancer Patients.|Recruiting||Phase 4|140|Anticipated|S. Andrea Hospital||2|||f||||f||||||||||2017-10-11 02:24:23.516378|2017-10-11 02:24:23.516378
NCT01707628|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2014-01-30|||October 2012||2012-10-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Rituxivac||Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab|Response to Influenza Vaccination in Lymphoma Patients Treated With CHOP and Rituximab|Completed||N/A|98|Actual|St. Antonius Hospital||3|||f||||f||||||||||2017-10-11 02:24:23.636947|2017-10-11 02:24:23.636947
NCT01707615|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-10-14|||October 2006||2006-10-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|GSPE||Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use|Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Carotid Intima-media Thickness and Atherosclerotic Plaques in Clinical Use|Completed||Phase 2|287|Actual|Shandong University||2|||f||||t||||||||||2017-10-11 02:24:23.742915|2017-10-11 02:24:23.742915
NCT01707602|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2013-08-02|||October 2012||2012-10-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|FLUWAY||Routes of Immunization and Flu Immune Responses|Impact of Immunization Routes on the Immune Response to Influenza Vaccine|Completed||Phase 1/Phase 2|60|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 02:24:23.824208|2017-10-11 02:24:23.824208
NCT01707589|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2013-02-11|||May 2013||2013-05-01|February 2013|2013-02-01||||October 2014|Anticipated|2014-10-01||Interventional|||Noninvasive Monitoring of Vital Signs in Neonates||Unknown status|Not yet recruiting|Phase 2|100|Anticipated|Meir Medical Center||1|||f||||||||||||||2017-10-11 02:24:23.940908|2017-10-11 02:24:23.940908
NCT01707576|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-04-01|||February 2010||2010-02-01|January 2010|2010-01-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|DESPERADOS||Screening of Adolescent Mental Suffering|SCREENING OF ADOLESCENT MENTAL SUFFERING CONSULTANT TO EMERGENCIES, MANAGEMENT AND Later MONITORING|Completed||N/A|346|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 02:24:24.035156|2017-10-11 02:24:24.035156
NCT01664988|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-08-15|||February 2010||2010-02-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Muscular Relaxation and Breathing Technique on Blood Pressure in Pregnancy||Terminated||Phase 2/Phase 3|60|Actual|Mashhad University of Medical Sciences||3|||f||||||||||||||2017-10-11 02:37:29.371453|2017-10-11 02:37:29.371453
NCT01707563|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-11-05|||January 2009||2009-01-01|December 2010|2010-12-01|January 2012|Actual|2012-01-01|June 2011|Actual|2011-06-01||Interventional|Variarfan||Clinical Variability in Marfan Syndrome|Correlations' Study Between Variability of Expression in FBN1 Gene and Clinical Features in Marfan Patients.|Completed||N/A|160|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:24:24.141441|2017-10-11 02:24:24.141441
NCT01707550|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-11-01|||December 2009||2009-12-01|November 2016|2016-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients|Observational, Non-interventional Survey of Renal Allograft Recipients Receiving CellCept as Part of Their Immunosuppressive Protocol|Completed||N/A|414|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:24:24.425465|2017-10-11 02:24:24.425465
NCT01707537|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-02-18|||September 2012||2012-09-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|OCV||To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men|Phase I Study to Determine the Safety and Immunogenicity of Euvichol(Oral Cholera Prevention Vaccine)in Healthy Adult Men ; Open, Non-comparative Clinical Trial|Completed||Phase 1|20|Actual|EuBiologics Co.,Ltd||1|||f||||t||||||||||2017-10-11 02:24:24.512103|2017-10-11 02:24:24.512103
NCT01707524|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2015-09-22|||August 2012||2012-08-01|September 2015|2015-09-01||||May 2015|Actual|2015-05-01||Interventional|||Left Versus Right Radial Artery and Radiation Exposure in Patients With Predictors of Trans-radial Failure|Effect of Left Versus Right Radial Artery Access on Radiation Exposure in Patients With Predictors of Potential Trans-radial Access Failure|Completed||N/A|150|Anticipated|New York University School of Medicine||2|||f||||||||||||||2017-10-11 02:24:24.598252|2017-10-11 02:24:24.598252
NCT01707511|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-15|2012-10-15|||January 2012||2012-01-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|March 2012|Actual|2012-03-01||Observational|||The Investigation of the EtCO₂- PaCO₂ Relation During Laparoscopic Colon Surgery|Cohort Study on Patients Underwent Colorectal Surgery|Unknown status|Recruiting|N/A|40|Anticipated|Diskapi Teaching and Research Hospital|||1||f||||f||||||||||2017-10-11 02:24:24.697234|2017-10-11 02:24:24.697234
NCT01707498|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-04-28|||February 2013|Actual|2013-02-01|April 2017|2017-04-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|PVCRoBIK||Robust Intelligent Keyboard for Quadraplegic Patients|Clinical Evaluation of Brain-Computer Interface for Helping Communication of Quadriplegic Patients|Recruiting||N/A|20|Anticipated|Centre d'Investigation Clinique et Technologique 805||2|||f||||t||||||||||2017-10-11 02:24:24.773491|2017-10-11 02:24:24.773491
NCT01707472|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-11-17||2015-11-17|August 2012||2012-08-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis|A Phase 2a Study of an Anti-LOXL2 Monoclonal Antibody (GS-6624) in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis|Completed||Phase 2|18|Actual|Gilead Sciences||3|||f||||f||||||||||2017-10-11 02:24:24.967464|2017-10-11 02:24:24.967464
NCT01707459|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-06-17|||March 2010||2010-03-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2013|Actual|2013-08-01||Observational|||The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery|The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery|Completed||N/A|201|Actual|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     TEG-PMA and gene polymorphism analysis on blood samples   "|||2017-10-11 02:24:25.094107|2017-10-11 02:24:25.094107
NCT01707446|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-05-31|||January 2012||2012-01-01|May 2016|2016-05-01|August 2016|Actual|2016-08-01|December 2014|Actual|2014-12-01||Interventional|||Role of Cerebral Oximetry In Reducing Delirium After Complex Cardiac Surgery|Role of Cerebral Oximetry In Reducing Delirium After Complex Cardiac Surgery|Completed||N/A|250|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 02:24:25.165935|2017-10-11 02:24:25.165935
NCT01707433|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2015-07-31|||October 2012||2012-10-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease|Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease|Completed||N/A|22|Actual|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||||2017-10-11 02:24:25.267738|2017-10-11 02:24:25.267738
NCT01707420|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2016-05-20|||August 2012||2012-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Preoperative Gabapentin for Post-tonsillectomy Pain in Children|Preoperative Gabapentin for Reduction of Post-tonsillectomy Pain in Children|Completed||N/A|36|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:24:25.364276|2017-10-11 02:24:25.364276
NCT01707407|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2012-12-03|||September 2012||2012-09-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|DDI||A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects|A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects|Completed||Phase 1|32|Actual|Celgene||4|||f||||f||||||||||2017-10-11 02:24:25.541759|2017-10-11 02:24:25.541759
NCT01707394|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2017-09-14|||January 10, 2013|Actual|2013-01-10|September 2017|2017-09-01|October 30, 2017|Anticipated|2017-10-30|October 29, 2017|Anticipated|2017-10-29||Interventional|||Study to Evaluate a Single Dose of Apixaban in Pediatric Subjects at Risk for a Thrombotic Disorder|Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects at Risk for a Venous or Arterial Thrombotic Disorder|Recruiting||Phase 1|44|Anticipated|Bristol-Myers Squibb||7|||f||||t||||||||||2017-10-11 02:24:25.670363|2017-10-11 02:24:25.670363
NCT01707212|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-10-26|||October 2012||2012-10-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Prenatal Education About Infant Immunization Pain Management|A Prenatal Education Module for Parents to Improve the Use of Pain-management Strategies for Immunization in Two-month Old Infants: a Randomized Controlled Trial of Knowledge Translation|Completed||Phase 3|197|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 02:24:30.982854|2017-10-11 02:24:30.982854
NCT01707381|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-11-24|||November 2012||2012-11-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|Constellation||BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension|A Randomized, Single-Center, Open-Label, Crossover Study Comparing the Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension.|Completed||Phase 2|25|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 02:24:25.883432|2017-10-11 02:24:25.883432
NCT01707368|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-10-29|||October 2012||2012-10-01|November 2013|2013-11-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Observational|||Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation|Course of Psoriasis During Long Term Treatment With Calcipotriol Plus Betamethasone in Gel Formulation|Completed||N/A|561|Actual|LEO Pharma|||1||f||||f||||||||||2017-10-11 02:24:25.986117|2017-10-11 02:24:25.986117
NCT01707355|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2012-10-15|||March 2011||2011-03-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effectiveness of Educational Poster to Primary and Secondary Teachers Regarding Emergency Management of Dental Trauma|Effectiveness of Educational Poster to Primary and Secondary Teachers Regarding Emergency Management of Dental Trauma - A Cluster Randomised Controlled Trial|Completed||N/A|403|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:24:26.073192|2017-10-11 02:24:26.073192
NCT01707342|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2014-03-27|||October 2012||2012-10-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male Patients|A Phase I, Open-Label, Sequential, Single-Dose Study to Assess the Absolute Bioavailability and Pharmacokinetics of TMC435 Administered as Single Oral Doses of 50 mg and 150 mg and an Intravenous Microdose of 100 μg [3H]-TMC435 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Janssen R&D Ireland||1|||f||||f||||||||||2017-10-11 02:24:26.17395|2017-10-11 02:24:26.17395
NCT01707329|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-09-05|||September 2012||2012-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment|A Phase II Randomised, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Who Have Progressed After Icotinib Treatment in NSCLC|Unknown status|Recruiting|Phase 2|180|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 02:24:26.279055|2017-10-11 02:24:26.279055
NCT01707316|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-12|2013-02-18|||June 2012||2012-06-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin in Healthy Chinese Volunteers|A Double-Blind, Randomized, Placebo-Controlled, 3-Way Cross-Over Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of JNJ-28431754 (Canagliflozin) in Healthy Chinese Subjects|Completed||Phase 1|15|Actual|Janssen Research & Development, LLC||3|||f||||f||||||||||2017-10-11 02:24:26.410864|2017-10-11 02:24:26.410864
NCT01707303|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-01-23|||July 2007||2007-07-01|January 2017|2017-01-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure|Effect Of Acute Inflammatory Mediators On Duration Of Functional Limitations In Patients With Acute Respiratory Failure, A Randomized, Controlled Pilot Study of Early ICU Rehabilitation Strategies|Completed||Phase 1/Phase 2|100|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-11 02:24:26.521109|2017-10-11 02:24:26.521109
NCT01707290|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-04-03|2017-04-03||February 2013||2013-02-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|KONTINUE||Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation|A Phase 3, Two-Arm, Rollover Study to Evaluate the Safety of Long Term Ivacaftor Treatment in Subjects 6 Years of Age and Older With Cystic Fibrosis and a Non-G551D CFTR Mutation|Completed||Phase 3|125|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-11 02:24:26.719244|2017-10-11 02:24:26.719244
NCT01707277|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-02-03|||March 2011||2011-03-01|February 2016|2016-02-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||The Effects of Inspiratory Muscle Training in Patients With Heart Failure With Preserved Ejection Fraction|The Effects of Inspiratory Muscle Training in Patients With Heart Failure With Preserved Ejection Fraction|Completed||N/A|26|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||||2017-10-11 02:24:29.679637|2017-10-11 02:24:29.679637
NCT01707264|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-10-10|||April 2013||2013-04-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis|A Phase 1/2, Open Label, Dose Escalation Study of Intravenous Administration of Single Agent NEOD001 in Subjects With Light Chain (AL) Amyloidosis|Unknown status|Active, not recruiting|Phase 1/Phase 2|69|Actual|Prothena Therapeutics Ltd.||1|||f||||t||||||||||2017-10-11 02:24:29.768572|2017-10-11 02:24:29.768572
NCT01707251|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-09-02|||October 2012||2012-10-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Intravenous Ibuprofen for Laparoscopic Bariatric Surgery|Intravenous Ibuprofen for Laparoscopic Bariatric Surgery|Completed||Phase 4|100|Anticipated|Jacobi Medical Center||2|||f||||t||||||||||2017-10-11 02:24:29.88767|2017-10-11 02:24:29.88767
NCT01707238|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2014-08-25|2014-04-01||October 2012||2012-10-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional||All subjects assigned as overall study population wore both sets of lenses. Study population was randomized to wear either stenfilcon A followed by etafilcon A or etafilcon A followed by stenfilcon A.|Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact Lenses|Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact Lenses|Completed||Phase 4|100|Actual|Coopervision, Inc.||2|||f||||t||||||||||2017-10-11 02:24:30.053673|2017-10-11 02:24:30.053673
NCT01707225|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-12-07|2015-12-07||February 2013||2013-02-01|December 2016|2016-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)|Safety and Efficacy of Octreotide LAR Depot in Left Ventricular Assist Device (LVAD) Associate Gastrointestinal (GI)|Completed||Phase 1|10|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 02:24:30.739783|2017-10-11 02:24:30.739783
NCT00000606|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||December 1996||1996-12-01|April 2009|2009-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||National Emphysema Treatment Trial (NETT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.557254|2017-10-11 04:19:08.557254
NCT01707199|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-08-27|||October 2012||2012-10-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||SPK Study in Afghanistan|Efficacy and Safety of Artesunate+Sulphadoxine-Pyrimethamine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malaria Control Center Asadabad in Kunar Province of Afghanistan|Unknown status|Recruiting|N/A|100|Anticipated|University of Oxford||1|||f||||f||||||||||2017-10-11 02:24:31.070243|2017-10-11 02:24:31.070243
NCT01707186|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-05-02|||October 2012||2012-10-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2017|Anticipated|2017-06-30||Observational|PRISM||Pictorial Representation of Illness and Self Measure|Pictorial Representation of Illness and Self Measure|Active, not recruiting||N/A|220|Actual|University of Oxford|||4||f||||f||||||||||2017-10-11 02:24:31.180087|2017-10-11 02:24:31.180087
NCT01707173|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-06-01|||October 2012||2012-10-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PrAAIS||Improving the Self-Efficacy of African American Parents in Infant Supine Sleep|Improving the Self-Efficacy of African American Parents in Infant Supine Sleep|Completed||N/A|735|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 02:24:31.245181|2017-10-11 02:24:31.245181
NCT01707160|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-01-03|||November 1995||1995-11-01|January 2017|2017-01-01|December 1995|Actual|1995-12-01|December 1995|Actual|1995-12-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers|A Randomised, Double-blind 2 Way Crossover Trial to Investigate the Pharmacokinetics and Pharmacodynamics of Insulin X14 30/70 PreMix Compared to Human Insulin 30/70 PreMix in Healthy Volunteers|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:24:31.322403|2017-10-11 02:24:31.322403
NCT01707147|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-08-16|||November 16, 2012|Actual|2012-11-16|August 2017|2017-08-01|September 13, 2017|Anticipated|2017-09-13|September 13, 2017|Anticipated|2017-09-13||Observational|||A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus|A Regulatory Requirement Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus(SELINA Study)|Active, not recruiting||N/A|3000|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 02:24:31.41206|2017-10-11 02:24:31.41206
NCT01707134|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-01-03|||September 1997||1997-09-01|January 2017|2017-01-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes|An Open-labelled, Controlled, Multicentre, Multinational, Extension Study Assessing Safety and Efficacy of the Human Insulin Analogue Insulin Aspart (X14) and Human Soluble Insulin as Meal Related Insulin in a Multiple Injection Regimen in Type 1 Diabetic Subjects|Completed||Phase 3|753|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:24:31.61014|2017-10-11 02:24:31.61014
NCT01707121|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-11-18|||December 2012||2012-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Observational|||The Impact of Physical Activity on the Outcome of Surgery|The Impact of Physical Activity on the Outcome of Surgery|Completed||N/A|450|Actual|Sahlgrenska University Hospital, Sweden|||1||f||||f||||||||||2017-10-11 02:24:31.949709|2017-10-11 02:24:31.949709
NCT01707108|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-09-27|||February 2013||2013-02-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Survival and Success of MIS C1 Implants- a Field Study|Survival and Success of MIS C1 Implants- a Field Study|Active, not recruiting||N/A|120|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-11 02:24:32.063072|2017-10-11 02:24:32.063072
NCT01707095|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2014-07-03|2014-05-27||September 2012||2012-09-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord|Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord: A Randomized, Controlled Trial|Completed||N/A|84|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:24:32.172241|2017-10-11 02:24:32.172241
NCT01707082|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-07-29|||October 2012||2012-10-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|B521MAD||A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults|A Phase 1, Randomized, Placebo-Controlled, Multiple Dose Study To Evaluate The Safety, Pharmacokinetics And Pharmacodynamics Of PF-06282999 In Healthy Overweight Subjects And A Fixed-Sequence Study To Assess The Effect Of PF-06282999 On The Pharmacokinetics Of Midazolam In Healthy Subjects|Completed||Phase 1|69|Actual|Pfizer||7|||f||||f||||||||||2017-10-11 02:24:32.477238|2017-10-11 02:24:32.477238
NCT01707069|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2014-05-21|||October 2012||2012-10-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid|A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid|Completed||Phase 1|24|Actual|Immunomic Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 02:24:32.629154|2017-10-11 02:24:32.629154
NCT01707056|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2013-05-21|||September 2012||2012-09-01|May 2013|2013-05-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma|The Effect of Coffee Consumption on the Intestinal Absorption of Levothyroxine Thyroid Hormone Replacement in Patients With Thyroid Carcinoma|Unknown status|Recruiting|N/A|10|Anticipated|Washington Hospital Center||4|||f||||f||||||||||2017-10-11 02:24:32.743054|2017-10-11 02:24:32.743054
NCT01707043|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-06-08|2017-01-27||October 2012||2012-10-01|June 2017|2017-06-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|PSTaclonex||Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris|Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris|Completed||N/A|20|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-11 02:24:32.904769|2017-10-11 02:24:32.904769
NCT01707030|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-08-09|||March 1, 2015|Actual|2015-03-01|August 2017|2017-08-01|December 30, 2017|Anticipated|2017-12-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C|Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C|Recruiting||N/A|240|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 02:24:33.422534|2017-10-11 02:24:33.422534
NCT01707017|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2013-02-19|||January 2012||2012-01-01|November 2011|2011-11-01||||December 2012|Actual|2012-12-01||Interventional|||The Effects of Low- and High-intensity Resistance Exercise on Force-velocity Characteristics in Older Adults||Completed||N/A|56|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||||||||||||2017-10-11 02:24:33.534223|2017-10-11 02:24:33.534223
NCT01707004|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-09-06|||May 16, 2013|Actual|2013-05-16|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|October 30, 2017|Anticipated|2017-10-30||Interventional|||Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|Decitabine Followed by Bone Marrow Transplant and High-Dose Cyclophosphamide for the Treatment of Relapsed and Refractory Acute Myeloid Neoplasms|Active, not recruiting||Phase 2|20|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 02:24:33.613694|2017-10-11 02:24:33.613694
NCT01706991|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-12|||January 2011||2011-01-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner|MEPEDS New Device Pediatric Vision Scanner|Completed||N/A|32|Actual|Rebiscan, Inc.|||3||f||||||||||||||2017-10-11 02:24:33.747659|2017-10-11 02:24:33.747659
NCT01706978|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-10-25|||April 2012||2012-04-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Comparison of Two Adjunctive Treatments in Arthroscopic Cuff Repair|A Comparison of Two Adjunctive Treatments in Arthroscopic Cuff Repair: Soft Tissue or Bone Trephination, a Prospective Cohort Study|Active, not recruiting||N/A|90|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 02:24:33.824048|2017-10-11 02:24:33.824048
NCT01706965|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-08-14|2017-07-10||October 2012||2012-10-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Kuvan in People With Schizophrenia and Schizoaffective Disorder|6R-BH 4 in People With Schizophrenia and Schizoaffective Disorder|Completed||Phase 1/Phase 2|27|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 02:24:33.904334|2017-10-11 02:24:33.904334
NCT01706952|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-03-22|2014-08-10||December 2012||2012-12-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||23 were male, 14 were female|Comparison of Topical Vasoconstriction in Endoscopic Sinus Surgery|Comparison of Topical Vasoconstriction in Endoscopic Sinus Surgery: Cocaine Versus Adrenaline|Completed||Phase 4|45|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 02:24:34.318944|2017-10-11 02:24:34.318944
NCT01706939|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-03-21|||September 2012||2012-09-01|March 2017|2017-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer|The Quarterback Trial: A Randomized Phase III Clinical Trial Comparing Reduced and Standard Radiation Therapy Doses for Locally Advanced HPV Positive Oropharynx Cancer|Active, not recruiting||Phase 3|24|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||Undecided|randomized trial should not be shared until trial is over.|2017-10-11 02:24:34.764709|2017-10-11 02:24:34.764709
NCT01706926|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-08-03|2016-05-31||August 2012||2012-08-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional||The modified intent-to-treat (mITT) population analysis set included all participants in the treatment group corresponding to their randomized treatment group.|A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis|A Phase 2b Study to Evaluate the Efficacy and Safety of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis|Completed||Phase 2|420|Actual|MedImmune LLC|Non-compartmental analyses was not performed for pharmacokinetics parameters due to limited sampling schedule|4|||f||||t||||||||||2017-10-11 02:24:34.958588|2017-10-11 02:24:34.958588
NCT01706913|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-02-20|||October 2012||2012-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis|A Randomized Controlled Study to Assess the Impact of Dermatology Consultations on the Hospital Course of Patients Admitted for Cellulitis|Recruiting||N/A|248|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:24:39.402444|2017-10-11 02:24:39.402444
NCT01706900|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-06-28|||November 2012||2012-11-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Incubator Temperature for Culturing Human Embryos|Incubator Temperature for Culturing Human Embryos|Completed||N/A|400|Actual|Ibn Sina Hospital||2|||f||||t||||||||||2017-10-11 02:24:39.479595|2017-10-11 02:24:39.479595
NCT01706887|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-10-12|||April 2007||2007-04-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|JEU004||Genetic Determinant of Blood Pressure Sensitivity to Salt Intake|Clinical, Pharmacological and Biological Investigations of a Polymorphism of Nedd4 , a Regulatory Protein of the Epithelial Sodium Channel|Terminated||N/A|219|Actual|Assistance Publique - Hôpitaux de Paris||1||end of recruitment period was reach|f||||t||||||||||2017-10-11 02:24:39.559235|2017-10-11 02:24:39.559235
NCT01706874|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-07-31|||November 20, 2012|Actual|2012-11-20|July 2017|2017-07-01|July 26, 2017|Actual|2017-07-26|September 7, 2016|Actual|2016-09-07||Observational|BHYRRA||Effect Assessment of Periodontal Prophylaxis on Rheumatoid Arthritis Activity.|Assessment of the Effect of an Intervention (Periodontal Scaling + Mouthwash + Toothpaste) to Reduce the Load on Oral Bacterial Activity of Rheumatoid Arthritis: a Randomized Trial Nested in the Cohort ESPOIR|Completed||N/A|92|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     Biospecimen: gingival fluid      A first sampling will take place at T0 and the second at Month 12 (test end).      A bacterial sampling at 4 deepest periodontal pockets will be carried. It will quantify the 9     following bacteria:      Aggregatibacter actinomycetemcomitans Porphyromonas gingivalis Prevotella intermedia     Tannerella forsythensis Treponema denticola Peptostreptococcus micros Fusobacterium nucleatum     Eikenella corrodens Campylobacter rectus   "|||2017-10-11 02:24:39.73673|2017-10-11 02:24:39.73673
NCT01706861|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-05-24|||September 2012||2012-09-01|February 2014|2014-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|EURO KLEAR||A Post Market Study Evaluating the Safety, Device Perfomance and Possible Emergent Risks of Celotres in Preventing Recurrence in Keloid Lesions Treated Adjunctive to Surgical Excision|A Post Market Study Evaluating the Safety, Device Perfomance and Possible Emergent Risks of Celotres in Preventing Recurrence in Keloid LEsions Treated Adjunctive to suRgical Excision. PMCS: EURO-KLEAR|Completed||N/A|51|Actual|Halscion, Inc.||1|||f||||f||||||||||2017-10-11 02:24:39.832445|2017-10-11 02:24:39.832445
NCT01706848|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-05-24|||September 2012||2012-09-01|August 2013|2013-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|PMCS EURO HEAL||Celotres for Improvement in Wound Healing and Resulting Scar Consequences Following Suturing of a Wound|A Post Market Clinical Study Evaluating the Safety, Device Performance and Possible Emergent Risks of Celotres in the Improvement of Wound Healing and the Resulting Scar Consequences Following Suturing of a Wound|Completed||N/A|60|Anticipated|Halscion, Inc.||2|||f||||f||||||||||2017-10-11 02:24:39.930111|2017-10-11 02:24:39.930111
NCT01706835|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2014-12-15|||October 2012||2012-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors|An Open-Lable Phase 1 Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors|Completed||Phase 1|18|Actual|CytRx||1|||f||||f||||||||||2017-10-11 02:24:40.054965|2017-10-11 02:24:40.054965
NCT01706822|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-03-17|2015-02-13||April 2013||2013-04-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Radial Reload Laparoscopic LAR Case Series|Evaluating the Radial Reload Stapler With Tri-Staple TM Technology During Laparoscopic Low Anterior Resection for Rectal Cancer: A Prospective Multicenter Case Series|Terminated||Phase 4|8|Actual|Medtronic - MITG||1||Slow recruitment|f||||f||||||||||2017-10-11 02:24:40.140182|2017-10-11 02:24:40.140182
NCT01706809|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2014-02-04|||September 2011||2011-09-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|||Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer||Unknown status|Recruiting|N/A|30|Anticipated|Odense University Hospital|||1||f||||f||||||||||2017-10-11 02:24:40.411646|2017-10-11 02:24:40.411646
NCT01706796|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-01-23|||November 2012||2012-11-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State|A Phase 1, Open Label, Randomized, Single Dose, 5 Period Crossover Relative Bioavailability Study In Healthy Volunteers Evaluating Spray Dried Dispersion (SDD) Immediate Release (IR) PF-06273340 Tablet, Two SDD Modified Release (MR) Matrix Tablets In Comparison With PF-06273340 Oral Solution, Including Preliminary Assessment Of Food Effect|Completed||Phase 1|12|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 02:24:40.480688|2017-10-11 02:24:40.480688
NCT01706783|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-02-23|||October 12, 2012|Actual|2012-10-12|February 2017|2017-02-01|November 18, 2013|Actual|2013-11-18|November 18, 2013|Actual|2013-11-18||Interventional|||A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency|A Randomised, Open-labelled, Active-controlled, Multiple Dose, Dose Escalating, Sequential Dose Group Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Once-weekly Long-acting Growth Hormone (NNC0195-0092) Compared to Once-daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency|Completed||Phase 1|35|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:24:40.572016|2017-10-11 02:24:40.572016
NCT01706770|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2014-03-28|2013-10-22||May 2012||2012-05-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Evaluation of CooperVision Avaira Toric (Enfilcon A) Soft Contact Lens When Compared to Acuvue Advance Toric Soft Contact Lens|Evaluation of CooperVision Avaira Toric (Enfilcon A) Soft Contact Lens (Test) When Compared to Acuvue Advance Toric (Galyfilcon A) Soft Contact Lens (Control)|Completed||Phase 4|50|Actual|Coopervision, Inc.||2|||f||||t||||||||||2017-10-11 02:24:40.67047|2017-10-11 02:24:40.67047
NCT01706757|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-10-12|||December 2011||2011-12-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Assessment of Motivity in People Aged 65 to 86 Years|Assessment of Motivity in People Aged 65 to 86 Years : Comparison of a Standard Assessment Versus a Technological Solution|Unknown status|Recruiting|N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 02:24:41.065402|2017-10-11 02:24:41.065402
NCT01706744|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-12-07|||February 2010||2010-02-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Discharge Via an Intermediate Care Unit|Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study|Completed||N/A|328|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 02:24:41.141701|2017-10-11 02:24:41.141701
NCT01706731|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-12|||October 2012||2012-10-01|October 2012|2012-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|Add-CBT||Effectiveness of Buddhist Monks in Providing Cognitive Behavior Therapy|A Randomized Controlled Trial of Cognitive Behavior Therapy Provided by Buddhist Monks vs. Treatment as Usual in the Treatment of Late Life-depression|Unknown status|Not yet recruiting|N/A|62|Anticipated|Chiang Mai University||2|||f||||f||||||||||2017-10-11 02:24:41.329746|2017-10-11 02:24:41.329746
NCT01706705|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-02-13|||October 2012|Actual|2012-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study|3D Image-guided Intracavitary Brachytherapy Treatment Planning for Cervical Cancer Using a Novel Shielded Applicator|Active, not recruiting||N/A|57|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:24:41.496448|2017-10-11 02:24:41.496448
NCT01706692|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2015-11-16|||July 2011||2011-07-01|November 2015|2015-11-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|SDNTT||Swiss Dermatology Network of Targeted Therapies (SDNTT)|Long-Term Benefits and Safety of Systemic Psoriasis Therapy: Swiss Registry on the Treatment of Psoriasis With Biologics and Systemic Therapeutics|Recruiting||N/A|500|Anticipated|Swiss Dermatology Network for Targeted Therapies|||8||f||||f||||||||||2017-10-11 02:24:41.587636|2017-10-11 02:24:41.587636
NCT01706679|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-11-12|||October 2012||2012-10-01|October 2012|2012-10-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|ATX-101-11-24||Evaluation of the Effect of ATX-101 on QT/QTc Intervals|A Four-Arm, Parallel Design, Randomized, Double-Blinded, Placebo and Active Controlled Study for the Evaluation of the Effect of Maximum Therapeutic and Supratherapeutic Single-Dose ATX-101 on the QT/QTc Intervals in Healthy Volunteers|Completed||Phase 1|218|Actual|Kythera Biopharmaceuticals||4|||f||||f||||||||||2017-10-11 02:24:41.812143|2017-10-11 02:24:41.812143
NCT01706666|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-08-28|2016-04-27||December 2012|Actual|2012-12-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|July 2014|Actual|2014-07-01||Interventional|||Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant|A Phase II Randomized Study of Three Subcutaneous Bortezomib-based Consolidation Treatments for Patients Completing Induction Therapy and Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|3|Actual|Mayo Clinic||3|||f||||t||||||||||2017-10-11 02:24:41.915868|2017-10-11 02:24:41.915868
NCT01706653|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-04-17|||October 2012||2012-10-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health|Fruit Polyphenols: Maximising Knowledge of Their Metabolic Health Benefits and Practical Applications|Completed||N/A|23|Actual|King's College London||4|||f||||f||||||||||2017-10-11 02:24:42.543976|2017-10-11 02:24:42.543976
NCT01706640|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-12|||December 2012||2012-12-01|October 2012|2012-10-01|May 2014|Anticipated|2014-05-01|November 2013|Anticipated|2013-11-01||Observational|||An Open Label,Observational, Real Time Data Capturing of Usage & Outcome of Coseal|An Open- Label,Multicentre, Observational, Prospective, Real-time Data Capturing of Usage, Outcome & Physician Satisfaction of Coseal in Cardio- Vascular- Thoracic Operative and Re- Operative Procedures|Unknown status|Not yet recruiting|N/A|750|Anticipated|Medanta, The Medicity, India|||1||f||||t||||||||||2017-10-11 02:24:42.626224|2017-10-11 02:24:42.626224
NCT01706627|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2012-10-11|||August 2007||2007-08-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|MIRCIT||Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial|Melatonin In Cancer Patients Receiving Chemotherapy: A Randomized, Double Blind, Placebo, Controlled Trial|Completed||Phase 2/Phase 3|175|Actual|Khon Kaen University||3|||f||||f||||||||||2017-10-11 02:24:42.69815|2017-10-11 02:24:42.69815
NCT01706614|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-12|||April 2012||2012-04-01|October 2012|2012-10-01||||||||Observational|||Biochemical and Genetic Markers in Liver Diseases|Biochemical and Genetic Markers in Liver Diseases|Unknown status|Recruiting|N/A|500|Anticipated|University Hospital Heidelberg|||1||f||||||||||||||2017-10-11 02:24:42.790147|2017-10-11 02:24:42.790147
NCT01706601|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-03-09|||February 2011||2011-02-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Observational|||Patients With Hemorrhoids Referred to a Surgical Specialist Department|Patients With Hemorrhoids Referred to a Surgical Specialist Department|Unknown status|Active, not recruiting|N/A|800|Anticipated|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 02:24:42.868054|2017-10-11 02:24:42.868054
NCT01706588|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2014-08-28|2014-08-13||January 2013||2013-01-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|DP4||Injectable Diclofenac for the Prevention of Post-operative Dental Pain|Preliminary Evaluation of the Efficacy and Local Tolerability of Injectable Diclofenac at 5, 12.5, 25 and 50 mg/mL, Administered Locally Prior to Surgery for the Prevention of Post-operative Pain After Third Molar Surgery|Completed||Phase 2|75|Actual|IBSA Institut Biochimique SA||5|||f||||f||||||||||2017-10-11 02:24:42.957953|2017-10-11 02:24:42.957953
NCT01706575|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-12-29|2016-06-24||January 2013||2013-01-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|September 2013|Actual|2013-09-01||Interventional||Lead-in participants included all participants enrolled in lead-in period.|A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression|A Phase IIb, Open Label, Single Arm, Multicenter Study to Evaluate the Effect of 48-weeks PEG-Interferon Alfa-2a (PEG-IFN) Administration on Serum HBsAg in Chronic Hepatitis B, HBeAg-Negative, Genotype D Patients on Treatment With Nucleos(t)Ide Analogues (NAs), Showing Stable HBV DNA Suppression|Completed||Phase 2|76|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:24:43.445493|2017-10-11 02:24:43.445493
NCT01706562|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-02-18|||May 2011||2011-05-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||A Study of Empirical Antifungal Therapy With Itraconazole|Retrospective Observation of Empirical Antifungal Therapy With Itraconazole|Completed||Phase 4|138|Actual|Janssen Korea, Ltd., Korea|||1||f||||||||||||||2017-10-11 02:24:43.779577|2017-10-11 02:24:43.779577
NCT01706549|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-12-23|2014-12-19||March 2012||2012-03-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational||Patients undergone hysterectomy and reportteri to have SUFFERED from pain 6 months postoperatively and volunteered for a clinical examination.|Clinical Analysis of Pain After Hysterectomy|Chronic Pain After Hysterectomy, Qualitative Analysis of Pain and Its Impact on Quality of Life|Completed||N/A|16|Actual|Tampere University Hospital|Low participation rate. Inadequate filling of questionnaires. Time from surgery to clinical examination varied from 10 to 44 months. No preoperative quality of life measure.||1||f||||f||||||||No||2017-10-11 02:24:43.862583|2017-10-11 02:24:43.862583
NCT01706536|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-03-01||2014-05-14|October 2012||2012-10-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|GOLDEN-2||A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of EP-101 (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease: GOLDEN-2 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)|Completed||Phase 2|275|Actual|Sunovion Respiratory Development Inc.||5|||f||||f||||||||||2017-10-11 02:24:44.162108|2017-10-11 02:24:44.162108
NCT01706523|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2013-07-30|||November 2011||2011-11-01|July 2013|2013-07-01|July 2013|Anticipated|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders|An Open-Label Extension Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of STX209 (Arbaclofen) in Subjects With Autism Spectrum Disorders|Terminated||Phase 3|165|Anticipated|Seaside Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 02:24:44.308588|2017-10-11 02:24:44.308588
NCT01706510|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-05-04|||December 2012||2012-12-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients|A Single Center, Randomized, Open Label, Multiple Dose, Crossover Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients With Stable Coronary Artery Disease|Completed||Phase 4|28|Actual|Rapid City Regional Hospital, Inc||2|||f||||f||||||||||2017-10-11 02:24:44.52476|2017-10-11 02:24:44.52476
NCT01706146|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-02-23|2016-01-25||October 2012||2012-10-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|REACT COM||Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring|Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring|Completed||Phase 4|59|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 02:24:49.802908|2017-10-11 02:24:49.802908
NCT01706497|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-09-26|||October 2012||2012-10-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Predictive Value of the FORE-SIGHT™ Monitor for Hemodynamic Deterioration|Validation of the Predictive Value of the FORE-SIGHT™ Monitor for Early Detection of Hemodynamic Deterioration After Pediatric Cardiac Surgery. A Data-mining Study.|Completed||N/A|300|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-11 02:24:44.645427|2017-10-11 02:24:44.645427
NCT01706484|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2014-07-07|||September 2012||2012-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Chronic Rhinosinusitis|A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Assess Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Chronic Rhinosinusitis|Completed||Phase 3|927|Actual|Bionorica SE||3|||f||||f||||||||||2017-10-11 02:24:44.774449|2017-10-11 02:24:44.774449
NCT01706471|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-02-17|||June 2009||2009-06-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation||Completed||Phase 4|60|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:24:44.906372|2017-10-11 02:24:44.906372
NCT01706458|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-09-13|||May 2013|Actual|2013-05-01|September 2017|2017-09-01|June 12, 2021|Anticipated|2021-06-12|June 12, 2017|Actual|2017-06-12||Interventional|||Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer|Pilot Trial of Sipuleucel-T, With or Without pTVG-HP DNA Booster Vaccine, in Patients With Castrate-Resistant, Metastatic Prostate Cancer|Active, not recruiting||Phase 2|18|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 02:24:45.006826|2017-10-11 02:24:45.006826
NCT01706445|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-11|||September 2011||2011-09-01|October 2012|2012-10-01||||July 2012|Actual|2012-07-01||Interventional|||Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic Fibrosis||Completed||N/A|20|Actual|Universidad Europea de Madrid||2|||f||||t||||||||||2017-10-11 02:24:45.14196|2017-10-11 02:24:45.14196
NCT01706432|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-06-26|||June 2009||2009-06-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer|Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)|Active, not recruiting||N/A|24|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 02:24:45.225374|2017-10-11 02:24:45.225374
NCT01706419|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2014-12-16|||October 2012||2012-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|FORISCA||Fortified Rice for School Children in Cambodia|Fortified Rice for School Children in Cambodia: Effects on Micronutrient Status, Growth, Cognition and Health.|Completed||N/A|9500|Actual|Institut de Recherche pour le Developpement||5|||f||||t||||||||||2017-10-11 02:24:45.323802|2017-10-11 02:24:45.323802
NCT01706406|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-29|2017-05-30|||November 2007||2007-11-01|May 2017|2017-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|Group PED||Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase II|Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase II|Completed||N/A|98|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:24:45.419418|2017-10-11 02:24:45.419418
NCT01706393|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2013-04-18|||October 2012||2012-10-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|RTxIMprobio||Effects of Probiotics Supplementation on Intestinal Microbiome in Malignancy Pts(Get Pelvic/Abdominal Rtx)|Double Blind Placebo Controled Randomized Trial, Effects of Probiotics Supplementation on Intestinal Microbiome in Malignancy Patients Who Get Pelvic/Abdominal Radiotherapy|Unknown status|Recruiting|N/A|26|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:24:45.509954|2017-10-11 02:24:45.509954
NCT01706380|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-11|||October 2012||2012-10-01|October 2012|2012-10-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Interventional|||3M Study - Maria Malmö Mobile Telephone Study|A Randomized Controlled Trial of Interactive Voice Response With and Without Personal Feedback in the Treatment of Adolescents With Substance Use Disorders|Unknown status|Recruiting|N/A|120|Anticipated|Region Skane||2|||f||||f||||||||||2017-10-11 02:24:45.600149|2017-10-11 02:24:45.600149
NCT01706367|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-03-05|||September 2012||2012-09-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years|A Phase 1, Placebo-Controlled, Randomized, Observer-Blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Clostridium Difficile Vaccine Administered With Or Without Adjuvant, In A 3-Dose Regimen In Healthy Adults Aged 50 To 85 Years|Completed||Phase 1|192|Actual|Pfizer||6|||f||||t||||||||||2017-10-11 02:24:45.702714|2017-10-11 02:24:45.702714
NCT01706354|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-11|||October 2012||2012-10-01|October 2012|2012-10-01|October 2015|Anticipated|2015-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Local Anaesthesia vs Regional Block for Arteriovenous Fistulae|Does Regional Compared to Local Anaesthesia Influence Outcome After Arteriovenous Fistula Creation?|Unknown status|Recruiting|N/A|126|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 02:24:45.833252|2017-10-11 02:24:45.833252
NCT01706341|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-11|||October 2012||2012-10-01|October 2012|2012-10-01||||October 2013|Anticipated|2013-10-01||Interventional|||The Effect of Administering a Small Dose of Glucose During Cesarean Section|The Effect of Administering a Small Dose of Glucose on the Pregnant Women and Their Neonates During Cesarean Section|Unknown status|Recruiting|N/A|40|Anticipated|Nagoya City University||2|||f||||t||||||||||2017-10-11 02:24:45.948945|2017-10-11 02:24:45.948945
NCT01706328|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-04-18|2014-01-23||October 15, 2012|Actual|2012-10-15|April 2017|2017-04-01|June 17, 2013|Actual|2013-06-17|June 17, 2013|Actual|2013-06-17||Interventional|||A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|828|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:24:46.083595|2017-10-11 02:24:46.083595
NCT01706315|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-05-05|||October 17, 2012|Actual|2012-10-17|May 2017|2017-05-01|December 13, 2013|Actual|2013-12-13|December 13, 2013|Actual|2013-12-13||Interventional|||This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects|A Randomized, Single Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Repeat Escalating Oral Doses of GSK2140944 in Healthy Adult Subjects (BTZ116778)|Completed||Phase 1|72|Actual|GlaxoSmithKline||12|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:24:46.736992|2017-10-11 02:24:46.736992
NCT01706302|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2013-04-25|||October 2012||2012-10-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009|Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom, 1995 to 2009|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 02:24:46.871826|2017-10-11 02:24:46.871826
NCT01706289|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-12|||March 2009||2009-03-01|September 2012|2012-09-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic Neuropathy|The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic Neuropathy|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 02:24:46.951572|2017-10-11 02:24:46.951572
NCT01706276|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2013-11-19|||March 2012||2012-03-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Observational|||MASIMO Radical 7 and Laboratory Measurement||Completed||N/A|225|Actual|Huazhong University of Science and Technology|||1||f||||t||||||||||2017-10-11 02:24:47.034795|2017-10-11 02:24:47.034795
NCT01706250|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-07-19|2017-04-04||September 1, 2009||2009-09-01|April 2017|2017-04-01|January 25, 2010|Actual|2010-01-25|January 1, 2010|Actual|2010-01-01||Interventional|||U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™|U0289-401: An Evaluator Blinded, 8 Week, Split-Face Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and PROACTIV in Subjects With Acne|Completed||Phase 4|20|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:24:47.233815|2017-10-11 02:24:47.233815
NCT01706237|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2014-06-03|||May 2012||2012-05-01|June 2014|2014-06-01||||June 2014|Actual|2014-06-01||Interventional|||Visual Outcomes And Contrast Sensitivity After Myopic Wavefront-Optimized Lasik With Nexisvision Shield Or Bandage Contact Lens|Evaluation Of Visual Outcomes And Contrast Sensitivity After Myopic Wavefront-Optimized Lasik With Nexisvision Shield Or Bandage Contact Lens|Withdrawn||Phase 4|0|Actual|Durrie Vision||1||Nexis Vision was unable to provide the shields to continue with the study.|f||||f||||||||||2017-10-11 02:24:48.383075|2017-10-11 02:24:48.383075
NCT01706224|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-01-09|||November 2012||2012-11-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals|Sero-prevalence of Pertussis Antibodies and Disease Awareness Among Healthcare Professionals in Spain|Completed||N/A|757|Actual|GlaxoSmithKline|||4||f||||||||||Samples With DNA|"     Blood   "|||2017-10-11 02:24:48.472205|2017-10-11 02:24:48.472205
NCT01706211|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-12|||October 1998||1998-10-01|September 2012|2012-09-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes|A Double-blind, Placebo Controlled, Parallel Group Comparative Study to Evaluate the Efficacy and Safety of BRL 49653C With Concurrent Sulphonylurea Therapy, When Administered to Patients With Non-insulin Dependent Diabetes Mellitus.|Completed||Phase 3|77|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:24:48.575919|2017-10-11 02:24:48.575919
NCT01706198|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-03-06|||November 2012||2012-11-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma|A 12-month, Open Label, Randomised, Effectiveness Study to Evaluate Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) Inhalation Powder Delivered Once Daily Via a Novel Dry Powder Inhaler Compared With Usual Maintenance Therapy in Subjects With Asthma|Completed||Phase 3|4232|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 02:24:48.698244|2017-10-11 02:24:48.698244
NCT01706185|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2012-10-18|||January 2008||2008-01-01|October 2012|2012-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer|Analysis of the Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer|Completed||N/A|156|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 02:24:49.179251|2017-10-11 02:24:49.179251
NCT01706172|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2017-01-31|||January 2013||2013-01-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection|Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection: A Randomised Clinical Trial of Efficacy|Completed||Phase 2/Phase 3|42|Actual|Chisel Peak Medical Clinic||2|||f||||t||||||||||2017-10-11 02:24:49.271336|2017-10-11 02:24:49.271336
NCT01706159|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-09-22|2014-07-10|2013-11-07|October 2012||2012-10-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||The demographics and baseline characteristics are presented for the Full analysis set (FAS) which included all randomised and treated subjects.|A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis|A Multicenter, Randomised, Double-blind, Placebo-controlled, Multiple-dose Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis|Terminated||Phase 2|20|Actual|Novo Nordisk A/S|The trial was terminated earlier than planned as the hypothesis of a correlation between low levels of FXIII and disease activity of UC could not be confirmed.|2||Trial screening data did not support the medical hypothesis|f||||f||||||||||2017-10-11 02:24:49.385949|2017-10-11 02:24:49.385949
NCT01706120|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-03-27|||October 2012||2012-10-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|MITO16/MANGO-2||Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab|A MULTICENTER STUDY IN PATIENTS WITH STAGE III-IV EPITHELIAL OVARIAN CANCER TREATED WITH CARBOPLATIN/PACLITAXEL WITH BEVACIZUMAB: CLINICAL AND BIOLOGICAL PROGNOSTIC FACTORS|Active, not recruiting||Phase 4|400|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-10-11 02:24:50.160877|2017-10-11 02:24:50.160877
NCT01706107|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2016-01-08|||April 2012||2012-04-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Observational|COSTAN||Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants|Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Patients|Terminated||N/A|73|Actual|Biogen|||1|Due to on-going enrollment challenges|f||||f||||||||||2017-10-11 02:24:50.373179|2017-10-11 02:24:50.373179
NCT01706094|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-11|2015-12-02|||January 2013||2013-01-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|HeadPoST-Pilot||Head Position in Stroke Trial|Head Position in Stroke Trial|Completed||N/A|92|Actual|Clinica Alemana de Santiago||1|||f||||t||||||||||2017-10-11 02:24:50.459084|2017-10-11 02:24:50.459084
NCT01706081|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-08-21|||October 2012||2012-10-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Acupuncture for Chronic Lymphedema|Acupuncture for Chronic Lymphedema: A Randomized Wait-list Controlled Trial|Active, not recruiting||Phase 2|83|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:24:50.535633|2017-10-11 02:24:50.535633
NCT01706068|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-12|||November 2012||2012-11-01|October 2012|2012-10-01|May 2014|Anticipated|2014-05-01|November 2013|Anticipated|2013-11-01||Observational|||Transient ECG Changes in Patients With Acute Biliary Disease|Transient ECG Changes in Patients With Acute Biliary Disease|Unknown status|Not yet recruiting|N/A|100|Anticipated|Ziv Hospital|||1||f||||t||||||||||2017-10-11 02:24:50.610506|2017-10-11 02:24:50.610506
NCT01706055|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-03-13|||September 2012||2012-09-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Observational|INFLUENCE||Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)|Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon®|Completed||N/A|629|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:24:50.668926|2017-10-11 02:24:50.668926
NCT01706042|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-12|||February 2010||2010-02-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Effects of Legumes on Glucose Regulation|Over-night Metabolic Effects of Legumes|Completed||N/A|16|Actual|Lund University||2|||f||||||||||||||2017-10-11 02:24:50.756485|2017-10-11 02:24:50.756485
NCT01706029|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-03-08|||October 2012||2012-10-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|December 2014|Actual|2014-12-01||Observational|Douleur-PR||Pain Evaluation in Rheumatoid Arthritis|Multidimensional Evaluation of Pain in Rheumatoid Arthritis (Douleur PR)|Unknown status|Active, not recruiting|N/A|300|Anticipated|University Hospital, Limoges|||1||f||||f||||||Samples Without DNA|"     Sampling of blood for dosage of IL-6, IL-17 and IL-33 serum level   "|||2017-10-11 02:24:50.905351|2017-10-11 02:24:50.905351
NCT01706016|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-06-08|||October 2012||2012-10-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|LASERBREAST1||Local Treatment by Thermic Destruction of Primitive Breast Cancer|Local Treatment by Thermic Destruction of Primitive Breast Cancer. Phase II: Feasibility and Effectiveness, Standardization of Procedures.|Recruiting||Phase 2|30|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 02:24:50.978022|2017-10-11 02:24:50.978022
NCT01706003|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-18|||October 2012||2012-10-01|October 2012|2012-10-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Observational|||The Utility of Telemedicine in the Management of Migraine|The Utility of Telemedicine in the Management of Migraine: A Pilot Study :MK0974-071-00|Unknown status|Enrolling by invitation|N/A|46|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-11 02:24:51.060829|2017-10-11 02:24:51.060829
NCT01705990|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-08-25|||March 2013||2013-03-01|August 2015|2015-08-01||||March 2015|Actual|2015-03-01||Interventional|||Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers|A Phase I Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety and Immunogenicity of a Sendai HIV Vaccine SeV-G(NP) Given Intranasally and Ad35-GRIN Administered Intramuscularly in Prime-Boost Regimens in HIV-Uninfected, Healthy Adult Volunteers|Completed||Phase 1|65|Actual|International AIDS Vaccine Initiative||4|||f||||t||||||||||2017-10-11 02:24:51.201195|2017-10-11 02:24:51.201195
NCT01705977|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-09-25|||November 27, 2012|Actual|2012-11-27|September 2017|2017-09-01|July 20, 2022|Anticipated|2022-07-20|July 26, 2018|Anticipated|2018-07-26||Interventional|BASE||Belimumab Assessment of Safety in SLE|A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab|Active, not recruiting||Phase 4|4000|Anticipated|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 02:24:51.360485|2017-10-11 02:24:51.360485
NCT01705964|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-03-30|||June 2013||2013-06-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation|Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation|Recruiting||Phase 4|54|Anticipated|University of Louisville||2|||f||||f||||||||||2017-10-11 02:24:52.153892|2017-10-11 02:24:52.153892
NCT01705951|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-11|||April 2011||2011-04-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|START||Effect of Resistance Training on Tobacco-Related Cardiovascular Disease Risk|Effect of Resistance Training on Tobacco-Related Cardiovascular Disease Risk|Unknown status|Recruiting|N/A|100|Anticipated|University of California, Los Angeles||4|||f||||f||||||||||2017-10-11 02:24:52.298076|2017-10-11 02:24:52.298076
NCT01705938|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2013-08-15|||October 2012||2012-10-01|October 2012|2012-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects|A First In Human, Single Blind, Placebo Controlled, Randomized Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SP-333 Tablets in Healthy Adult Subjects|Completed||Phase 1|56|Actual|Synergy Pharmaceuticals Inc.||7|||f||||f||||||||||2017-10-11 02:24:52.438734|2017-10-11 02:24:52.438734
NCT01705925|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-12-16|||March 2012||2012-03-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome|Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome|Recruiting||N/A|500|Anticipated|Mednax Center for Research, Education and Quality|||1||f||||f||||||||||2017-10-11 02:24:52.550793|2017-10-11 02:24:52.550793
NCT01705912|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-11|||January 2007||2007-01-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Fall Prevention Among Community Living Elderly|Fall Prevention by Assistant Nurses Among Community Living Elderly With Risk of Falling - a Randomized Controlled Trial|Completed||N/A|148|Actual|Örebro County Council||2|||f||||f||||||||||2017-10-11 02:24:52.660245|2017-10-11 02:24:52.660245
NCT01705899|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-02-01|||November 2006||2006-11-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Islet Allotransplantation in Type 1 Diabetes|Islet Allotransplantation in Type 1 Diabetes|Enrolling by invitation||Phase 1|20|Anticipated|Ohio State University||2|||f||||t||||||||Undecided|Individual participant data for patients who agree is entered into a multi-center islet transplant data registry (no personally identifiable information will be shared). Upon completion of the study, results may also be published in a peer-reviewed journal.|2017-10-11 02:24:52.772151|2017-10-11 02:24:52.772151
NCT01705886|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-07-14|||October 2012||2012-10-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement|Clinical and Economic Comparison of Robotic Versus Manual Knee Arthroplasty|Active, not recruiting||N/A|61|Actual|Northwest Surgical Specialists, Vancouver|||1||f||||f||||||||||2017-10-11 02:24:52.916426|2017-10-11 02:24:52.916426
NCT01705873|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-11|||September 2012||2012-09-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|March 2013|Anticipated|2013-03-01||Observational|||Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen|Retrospective Analysis on the Risk of Cardiovascular (CV) Events in HIV- Infected Subjects From Latin America Treated With a Lopinavir/Ritonavir (LPV/r) Based HAART Regimen vs. an Efavirenz (EFV) Based HAART Regimen|Unknown status|Recruiting|N/A|300|Anticipated|Helios Salud|||2||f||||f||||||||||2017-10-11 02:24:53.017082|2017-10-11 02:24:53.017082
NCT01705847|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-05-16|||November 2012||2012-11-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies|A Phase 1b Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GS-9820 in Subjects With Lymphoid Malignancies|Completed||Phase 1|39|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 02:24:53.187142|2017-10-11 02:24:53.187142
NCT01705834|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2014-04-08||||||April 2014|2014-04-01||||||||Observational|||Dataglove to Measure Joint Stiffness in Patients With Arthritis|The Evaluation of a Dataglove to Measure Joint Stiffness in Patients With Arthritis|Withdrawn||N/A|0|Actual|Western Health and Social Care Trust|||1|The study protocol has been replaced with a two-glove protocol NCT02026245|f||||f||||||||||2017-10-11 02:24:53.277926|2017-10-11 02:24:53.277926
NCT01705821|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-12-08|||October 2012||2012-10-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Forces During Skull Base Surgery|Measuring Forces Applied During Skull Base Surgery|Completed||N/A|3|Actual|Vanderbilt University|||1||f||||f||||||||||2017-10-11 02:24:53.354733|2017-10-11 02:24:53.354733
NCT01705808|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2015-12-14|||September 2012||2012-09-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Administration of Protein C Concentrates in Adult Critically Ill Septic Patients|Administration of Protein C Concentrates in Adult Critically Ill Septic Patients|Terminated||Phase 3|||Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-10-11 02:24:53.453298|2017-10-11 02:24:53.453298
NCT01705795|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-02-27|||February 13, 2013|Actual|2013-02-13|February 2017|2017-02-01|January 31, 2017|Actual|2017-01-31|January 31, 2017|Actual|2017-01-31||Interventional|||Anti-IL-5 Therapy in Bullous Pemphigoid (BP)|Anti-IL-5 Therapy in Bullous Pemphigoid. Randomized, Placebo-controlled, Double-blind Study Evaluating the Effect of Anti-IL-5 Therapy in Patients With Bullous Pemphigoid.|Completed||Phase 2|32|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 02:24:53.618806|2017-10-11 02:24:53.618806
NCT01705782|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-11-11|||October 2012||2012-10-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of Amino Acid Supplement During Acute Inflammation.|Metabolic Effects of Endotoxin Induced Acute Inflammation in Healthy Young Men With and Without Supplement of Amino Acids.|Completed||N/A|8|Actual|University of Aarhus||3|||f||||t||||||||||2017-10-11 02:24:53.69597|2017-10-11 02:24:53.69597
NCT01705769|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-06-04|||October 2012||2012-10-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SAMPOORNA||Effects of Three Feeding Regimens on Recovery of Uncomplicated Severely Acute Malnourished Children|To Evaluate the Impact of Three Feeding Regimens on the Recovery of Children From Uncomplicated Severe Acute Malnutrition (SAM) in India and to Use the Evidence to Inform National Policy|Completed||N/A|911|Actual|Society for Applied Studies||3|||f||||t||||||||||2017-10-11 02:24:53.773152|2017-10-11 02:24:53.773152
NCT01705756|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-07-19|||November 2012||2012-11-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|FMF||Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever|A Randomized Placebo-Controlled Study of the Efficacy and Safety of Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever|Completed||Phase 3|25|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:24:53.890294|2017-10-11 02:24:53.890294
NCT01705743|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2014-02-03|||September 2012||2012-09-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Minimum Alveolar Concentration of Sevoflurane With Nitrous Oxide Inducing Isoelectric EEG|Minimum Alveolar Concentration of Sevoflurane With 60% Nitrous Oxide Inducing Isoelectric EEG in Mid-aged Adults|Completed||Phase 4|76|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 02:24:53.988608|2017-10-11 02:24:53.988608
NCT01705717|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-03-10|2015-01-05||June 1, 2011|Actual|2011-06-01|March 2017|2017-03-01|May 1, 2012|Actual|2012-05-01|May 1, 2012|Actual|2012-05-01||Observational|||A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C|Treatment Outcomes in the Management of Patients With Chronic Hepatitis C: A Case Study of Faculty of Medicine Vajira Hospital, University of Bangkok Metropolis|Completed||N/A|49|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:24:54.158267|2017-10-11 02:24:54.158267
NCT01705704|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-11-01|||June 2012||2012-06-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B|An Exploratory Evaluation of Interleukin 28B (IL28B) Genotype, Single Nucleotide Polymorphisms (SNP) of rs12356193, Protein and RNA Biomarkers in Serum Samples (Stored, Already Obtained From Completed Studies) From Subjects With HBe-antigen Positive or Negative Chronic Hepatitis B, Who Have Completed Therapy for Hepatitis B With Pegasys ± Lamivudine.|Completed||N/A|269|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:24:54.437121|2017-10-11 02:24:54.437121
NCT01705691|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-01-20|||September 2012||2012-09-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|March 2014|Actual|2014-03-01||Interventional|||Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer|A Phase II Randomized Clinical Trial Evaluating Neoadjuvant Chemotherapy Regimens With Weekly Paclitaxel or Eribulin Followed by Doxorubicin and Cyclophosphamide in Women With Locally Advanced HER2-Negative Breast Cancer|Completed||Phase 2|50|Actual|NSABP Foundation Inc||2|||f||||f||||||||||2017-10-11 02:24:54.559413|2017-10-11 02:24:54.559413
NCT01705678|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-10-11|||May 2009||2009-05-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|September 2010|Actual|2010-09-01||Interventional|||Investigation Into the Effects of Krill Oil vs. Fish Oil on Markers of Cardiovascular Disease|An Investigation Into the Effects of Krill Oil vs. Fish Oil on Markers of Cardiovascular Disease in Males With Metabolic Syndrome|Completed||N/A|19|Actual|Liverpool John Moores University||2|||f||||f||||||||||2017-10-11 02:24:56.248004|2017-10-11 02:24:56.248004
NCT01705665|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-22|||January 2012||2012-01-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Histopathology of the Aspirated Thrombus During Acute Myocardial Infarction||Unknown status|Recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 02:24:56.327477|2017-10-11 02:24:56.327477
NCT01705652|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-05-26|2015-03-12||July 2011||2011-07-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Nexrutine||Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients|Phase II Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients Undergoing Surgery or Radiation Therapy|Terminated||Phase 2|21|Actual|The University of Texas Health Science Center at San Antonio||2||loss of funding|f||||t||||||||||2017-10-11 02:24:56.407539|2017-10-11 02:24:56.407539
NCT01705639|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-01-03|||November 2012||2012-11-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|MELAG||Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene|Does Melatonin Treatment Affect Glucose Tolerance Among Individuals With a Variant (rs10830963) of the Melatonin Receptor 1B (MTNR1B) Gene?|Completed||Phase 3|45|Actual|Helsinki University||1|||f||||f||||||||No||2017-10-11 02:24:56.906565|2017-10-11 02:24:56.906565
NCT01705626|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-05-10|||December 2016||2016-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|TRAP2||Screening for the Transthyretin-Related Familial Amyloidotic Small Fiber Polyneuropathy|TTR-FAP Screening - Screening for the Transthyretin-Related Familial Amyloidotic Small Fiber Polyneuropathy - a International, Multicentre, Epidemiological Protocol|Recruiting||N/A|500|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the molecular genetic diagnosis of the disease TTR-FAP a sequencing of the entire TTR     gene in all study patients will be performed. Dried blood spots will be used for this     procedure.   "|Undecided||2017-10-11 02:24:57.021004|2017-10-11 02:24:57.021004
NCT01705613|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-04-10|||April 2014||2014-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Cost-effectiveness of the Treatment of Attention Deficit/Hyperactivity Disorder With Methylphenidate Immediate-release in Brazil|Cost-effectiveness of the Treatment of Attention Deficit/Hyperactivity Disorder With Methylphenidate Immediate-release in Brazil|Completed||N/A|120|Actual|Hospital de Clinicas de Porto Alegre|||1||f||||t||||||||||2017-10-11 02:24:57.111816|2017-10-11 02:24:57.111816
NCT01705600|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-10-11|||September 2012||2012-09-01|October 2012|2012-10-01||||August 2013|Anticipated|2013-08-01||Interventional|||Verbalization in Patients With Non-specific Low Back Pain and Central Sensitization|Protocol for the Evaluation of the Effects of Limiting Verbal Complaints on Pain and Pain Catastrophizing in Individuals With LBP Who Are in a State of Central Sensitization|Unknown status|Active, not recruiting|N/A|100|Anticipated|Keystone Rehabilitation Systems||1|||f||||f||||||||||2017-10-11 02:24:57.306291|2017-10-11 02:24:57.306291
NCT01705574|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-08-15|2016-02-11||October 24, 2012|Actual|2012-10-24|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|February 11, 2015|Actual|2015-02-11||Interventional|WAVES|Safety Analysis Set: participants who were randomized and received at least one dose of study drug.|Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women|A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women|Active, not recruiting||Phase 3|583|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|3|||f||||t|t|f||||||||2017-10-11 02:24:57.582823|2017-10-11 02:24:57.582823
NCT01705561|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2012-10-12|||December 2012||2012-12-01|October 2012|2012-10-01|June 2013|Anticipated|2013-06-01|||||Observational|||Evaluation of Attitudes About Fertility|Evaluation of Attitudes of Premenopausal Latin American Patients With Breast Cancer Towards the Risk of Loss Their Fertility by Chemotherapy|Unknown status|Not yet recruiting|N/A|450|Anticipated|Grupo de Estudios Clínicos Oncológicos Peruano|||1||f||||t||||||||||2017-10-11 02:24:58.798551|2017-10-11 02:24:58.798551
NCT01705548|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-07-12|||September 2012||2012-09-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis|Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Brain Metastasis|Recruiting||Phase 1|24|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 02:24:58.892563|2017-10-11 02:24:58.892563
NCT01705535|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-08-19|||October 2012||2012-10-01|July 2016|2016-07-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||The Effect of Physiotherapy for the Treatment of Fecal Incontinence.|The Effect of Physiotherapy for the Treatment of Fecal Incontinence - a Randomized, Controlled Trial.|Active, not recruiting||N/A|102|Actual|Copenhagen University Hospital, Hvidovre||2|||f||||f||||||||||2017-10-11 02:24:58.997507|2017-10-11 02:24:58.997507
NCT01705522|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-07-25|||October 2012||2012-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Observational|MAID||Multimodal Approach in IBD Patients|Multimodal Approach in IBD Patients|Recruiting||N/A|50|Anticipated|Clinical Hospital Colentina|||1||f||||f||||||Samples Without DNA|"     serum and fecal samples   "|||2017-10-11 02:24:59.113636|2017-10-11 02:24:59.113636
NCT01705509|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2017-04-05|||September 2012|Actual|2012-09-01|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|ERIC||The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)|The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)|Terminated||N/A|15|Actual|Cardiovascular Institute of the South Clinical Research Corporation||1||Study terminated due to lack of resources.|f||||f||||||||||2017-10-11 02:24:59.326801|2017-10-11 02:24:59.326801
NCT01705496|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2016-02-08|2016-01-11||August 2012||2012-08-01|February 2016|2016-02-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|PJI||[124I]FIAU PET-CT Scanning in Patients With Pain in a Prosthetic Knee or Hip Joint|Sensitivity and Specificity of [124I]FIAU PET-CT Scanning in Patients Presenting With Pain in a Prosthetic Knee or Hip Joint|Terminated||Phase 2|23|Actual|BioMed Valley Discoveries, Inc||1||"The sensitivity and specificity were not able to be assessed in this study due to the poor   image quality."|f||||f||||||||||2017-10-11 02:24:59.433815|2017-10-11 02:24:59.433815
NCT01705483|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-10|2015-08-31|||August 2012||2012-08-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies|A Phase 1, Multicenter, Open-Label, Dose Escalation Study of ASP9853 in Combination With Either Docetaxel or Paclitaxel in Subjects With Advanced Non-hematologic Malignancies|Terminated||Phase 1|21|Actual|Astellas Pharma Inc||2||"Based on the results of the Phase 1 data, the company decided not to pursue the development of   this drug at this time."|f||||f||||||||||2017-10-11 02:24:59.696337|2017-10-11 02:24:59.696337
NCT01705470|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-06-27|||October 2012||2012-10-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction||Withdrawn||N/A|0|Actual|Tel-Aviv Sourasky Medical Center||2||PI left the medical center, no replacement assigned|f||||f||||||||No||2017-10-11 02:24:59.80533|2017-10-11 02:24:59.80533
NCT01705457|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-11|||February 2010||2010-02-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|February 2013|Anticipated|2013-02-01||Interventional|RAR||Impact of Vitamin A on RAR Gene Expression in Multiple Sclerosis|Impact of Vitamin A Supplementation on RAR Gene Expression in PBMC Cells in Multiple Sclerotic Patients|Unknown status|Enrolling by invitation|Phase 4|20|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:24:59.885257|2017-10-11 02:24:59.885257
NCT01705444|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-03-30|||March 2012||2012-03-01|October 2012|2012-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SpannerQoL||The Spanner Prostatic Stent and Patient's Quality of Life|The Impact of the Temporary Stent on Parameters of Voiding Function and on the Quality of Life Among Patients With LUTS|Completed||N/A|88|Actual|Princess Al-Johara Al-Ibrahim Cancer Research Center||1|||f||||t||||||||Yes|Results will be published in per-reviewed journal|2017-10-11 02:24:59.984455|2017-10-11 02:24:59.984455
NCT01705431|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-12-10|||October 2011||2011-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|OnTrack||Students, Parents, and Teachers On Track: Intervention Development for Youth With Emotional Disturbance|Students, Parents, and Teachers On Track: Intervention Development for Youth With Emotional Disturbance|Completed||Phase 1|31|Actual|Oregon Social Learning Center||2|||f||||f||||||||||2017-10-11 02:25:00.111468|2017-10-11 02:25:00.111468
NCT01705418|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-03-08|||November 2012||2012-11-01|October 2012|2012-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|PDdicted||Behavior Addictions Improvement in Parkinson Disease's Patients Treated by Subthalamic Stimulation : Long Term Follow-up|Behavior Addictions Improvement in Parkinson Disease's Patients Treated by|Completed||N/A|69|Actual|University Hospital, Grenoble|||1||f||||f||||||||No||2017-10-11 02:25:00.239466|2017-10-11 02:25:00.239466
NCT01705405|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-10-17|||October 2012||2012-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|FEE||Merging of Endoscopic and Ultrasound Images for Laparoscopic Surgery|Merging of Endoscopic and Ultrasound Images for Laparoscopic Surgery|Terminated||N/A|2|Actual|University Hospital, Grenoble||1||due to a problem of device|f||||t||||||||||2017-10-11 02:25:00.324684|2017-10-11 02:25:00.324684
NCT01705392|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-02-23|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|February 20, 2017|Actual|2017-02-20|February 20, 2017|Actual|2017-02-20||Interventional|||Bevacizumab vs Dacarbazine in Metastatic Melanoma|A Randomized Phase II Trial Comparing Bevacizumab Monotherapy With Dacarbazine (DTIC) in Treatment of Malignant Melanoma, Focusing on Angiogenic Markers and Prevention of Hypertension.|Terminated||Phase 2|2|Actual|Haukeland University Hospital||3||Lack of financing of the study drug. Not sufficient financial support.|f||||t||||||||||2017-10-11 02:25:00.427802|2017-10-11 02:25:00.427802
NCT01705379|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-11-30|||March 2013||2013-03-01|November 2016|2016-11-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older|A Multicenter, Single Arm, Post Marketing Surveillance Study to Monitor the Safety of Novartis Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) Administered According to the Prescribing Information to Healthy Subjects 2 Years of Age and Older in the Philippines|Withdrawn||N/A|0|Actual|Novartis|||1||f||||f||||||||||2017-10-11 02:25:00.559919|2017-10-11 02:25:00.559919
NCT01705366|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-07-14|||October 2012||2012-10-01|July 2017|2017-07-01|January 2028|Anticipated|2028-01-01|December 2026|Anticipated|2026-12-01||Observational|||Clinical Outcomes of Knee Replacement|Clinical Outcomes of Joint Arthroplasty|Active, not recruiting||N/A|316|Actual|Northwest Surgical Specialists, Vancouver|||1||f||||f||||||||||2017-10-11 02:25:00.638054|2017-10-11 02:25:00.638054
NCT01705353|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-10-12|||September 2012||2012-09-01|June 2016|2016-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||The Role of HMGB-1 in Chronic Stroke|Pilot Study of the Role of HMGB-1 in Retarding Recovery in Chronic Stroke|Recruiting||N/A|100|Anticipated|Northwell Health|||1||f||||t||||||Samples With DNA|"     Whole blood, DNA, serum/serum cytokines   "|||2017-10-11 02:25:00.755397|2017-10-11 02:25:00.755397
NCT01705340|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-09-27|||September 2012||2012-09-01|September 2013|2013-09-01||||May 2013|Actual|2013-05-01||Interventional|||Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery|A Phase I Study of MK-2206 in Combination With Trastuzumab and Lapatinib in HER2-Positive Breast and Gastric Cancer|Terminated||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:25:00.845906|2017-10-11 02:25:00.845906
NCT01705327|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-10-02|||October 2012||2012-10-01|December 2013|2013-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|BioFIND||Fox Investigation for New Discovery of Biomarkers|Fox Investigation for New Discovery of Biomarkers (BioFIND)|Completed||N/A|240|Anticipated|Michael J. Fox Foundation for Parkinson's Research|||2||f||||f||||||Samples With DNA|"     Cerebrospinal Fluid (CSF), whole blood, DNA, plasma   "|||2017-10-11 02:25:00.971177|2017-10-11 02:25:00.971177
NCT01705314|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-10-24|||December 2014||2014-12-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Randomized Trial of Vitamin D to Reduce Respiratory Infection|Effect of Vitamin D3 Supplementation to Reduce Respiratory Infections in Children and Adolescents in Vietnam: A Blinded, Placebo-controlled Randomized Controlled Trial|Completed||N/A|1300|Actual|McMaster University||2|||f||||f||||||||No||2017-10-11 02:25:01.060719|2017-10-11 02:25:01.060719
NCT01705301|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-08-01|||January 2010||2010-01-01|August 2017|2017-08-01|July 27, 2017|Actual|2017-07-27|July 27, 2017|Actual|2017-07-27||Observational|||Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery|Neurotransmitter Measurements Using Wireless Instantaneous Neurotransmitter Concentration System (WINCS) During Deep Brain Stimulation Neurosurgery.|Completed||N/A|36|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 02:25:01.166212|2017-10-11 02:25:01.166212
NCT01705288|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-02-09|||January 1, 2013|Actual|2013-01-01|February 2017|2017-02-01|August 24, 2016|Actual|2016-08-24|August 24, 2016|Actual|2016-08-24||Interventional|||Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study|Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study|Completed||Early Phase 1|112|Actual|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-10-11 02:25:01.256082|2017-10-11 02:25:01.256082
NCT01705275|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-07-04|||January 2013||2013-01-01|October 2012|2012-10-01||||March 2014|Actual|2014-03-01||Interventional|||A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers|A Randomised, Double-blind, Placebo-controlled, Two-period Crossover Study to Investigate the Effect of ONO-8539 on Acid-induced Oesophageal Hypersensitivity in Healthy Male Adult Volunteers|Completed||Phase 1|20|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 02:25:01.365229|2017-10-11 02:25:01.365229
NCT01705262|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-04-03|||October 2010||2010-10-01|April 2017|2017-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Comparing Oral Preparation With Macrogol (Moviprep) and Natriumdihydrogenphosphatdihydrat (Phosphoral)||Terminated||N/A|80|Actual|Odense University Hospital|||4|Phophoral was no longer used as a preparation before coloscopies at OUH|f||||f||||||||||2017-10-11 02:25:01.473157|2017-10-11 02:25:01.473157
NCT01705249|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-02-27|||August 14, 2001|Actual|2001-08-14|February 2017|2017-02-01|June 6, 2003|Actual|2003-06-06|June 6, 2003|Actual|2003-06-06||Interventional|||Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women|Bleeding Profile With Continuous Hormone Replacement Therapy in Postmenopausal Women: A Prospective, Open, Multicenter Trial of Activelle® Treatment Following Switch From Trisekvens®|Completed||Phase 4|191|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 02:25:01.551095|2017-10-11 02:25:01.551095
NCT01705236|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-07-19|||August 20, 2012|Actual|2012-08-20|July 2017|2017-07-01|January 27, 2019|Anticipated|2019-01-27|January 27, 2019|Anticipated|2019-01-27||Interventional|PASSOS||A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®|A 3-year Multi-center Study to Describe the Long Term Changes of Optical Coherence Tomography (OCT) Parameters in Patients Under Treatment With Gilenya®|Active, not recruiting||Phase 4|87|Actual|Novartis||1|||f|||||f|f||||||||2017-10-11 02:25:01.700233|2017-10-11 02:25:01.700233
NCT01705223|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-05-05|||August 2012||2012-08-01|October 2014|2014-10-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)|Phase IIa Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)|Completed||Phase 2|150|Actual|National Center for AIDS/STD Control and Prevention, China CDC||4|||f||||t||||||||||2017-10-11 02:25:01.824935|2017-10-11 02:25:01.824935
NCT01705210|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-04-09|||May 2012||2012-05-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Functional MRI Biomarkers of Cognitive Decrements in Diabetes|Functional MRI Biomarkers of Cognitive Decrements in Diabetes|Completed||N/A|106|Actual|Maastricht University Medical Center|||3||f||||f||||||||||2017-10-11 02:25:01.951137|2017-10-11 02:25:01.951137
NCT01705197|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-03-08|||February 2012||2012-02-01|March 2017|2017-03-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|SPEED||This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.|A Double-blind, Stratified Randomization, Placebo Controlled, Parallel Group, Multicenter, Dose Escalation Study to Evaluate the Efficacy and Safety of Avanafil in Subjects With Moderate to Severe Erectile Dysfunction in Korea.|Completed||Phase 3|195|Actual|JW Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:25:02.204838|2017-10-11 02:25:02.204838
NCT01705184|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-03-08|||December 2012||2012-12-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|January 2016|Actual|2016-01-01||Interventional|BUCiL||Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.|Phase II Study Evaluating the Interest of the Re-introduction of Pemetrexed and Platinum (Cisplatin or Carboplatin) With Prolonged Angiogenic Blocking by Bevacizumab in Non Squamous Non Small Cell Lung Cancer of Advanced Stage.|Active, not recruiting||Phase 2|118|Actual|Intergroupe Francophone de Cancerologie Thoracique||1|||f||||f||||||||||2017-10-11 02:25:02.337026|2017-10-11 02:25:02.337026
NCT01705171|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2014-03-10|||December 2011||2011-12-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Observational|||Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?|Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?|Completed||N/A|20|Anticipated|Brain-Gut Research Group|||2||f||||f||||||||||2017-10-11 02:25:02.517182|2017-10-11 02:25:02.517182
NCT01705158|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-04-05|||October 2012||2012-10-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2014|Actual|2014-10-01||Interventional|MYCA||Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum|Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum|Active, not recruiting||Phase 1/Phase 2|87|Actual|ARCAGY/ GINECO GROUP||1|||f||||f||||||||||2017-10-11 02:25:02.653628|2017-10-11 02:25:02.653628
NCT01705145|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-03-09|2015-04-02||January 2013||2013-01-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Safety set included all participants who received at least 1 dose of study drug.|Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation|A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation|Completed||Phase 3|35|Actual|Vertex Pharmaceuticals Incorporated||1|||f||||t||||||||||2017-10-11 02:25:02.979696|2017-10-11 02:25:02.979696
NCT01705132|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2013-07-26|||June 2012||2012-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Observational|||Urinary Biomarkers of the Progression of Alport Kidney Disease|Urinary Biomarkers of the Progression of Alport Kidney Disease|Completed||N/A|80|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     Subjects submit first morning urine. Portion of urine retained for ASTOR repository.   "|||2017-10-11 02:25:04.577243|2017-10-11 02:25:04.577243
NCT01705119|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-12-12|||October 2012||2012-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Vertical Position on Gas Exchange in Patients With Respiratory Failure|The Effects of Vertical Position on Gas Exchange in Patients With Respiratory Failure|Recruiting||N/A|16|Anticipated|University of Chicago||1|||f||||t||||||||||2017-10-11 02:25:04.691052|2017-10-11 02:25:04.691052
NCT01705093|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-07-13|||May 2012|Actual|2012-05-01|July 2017|2017-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Effects of California Strawberries on Parameters of Cardiovascular Health|The Effects of California Strawberries on Parameters of Cardiovascular Health|Completed||Phase 2|32|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 02:25:04.902339|2017-10-11 02:25:04.902339
NCT01705080|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-03-15|||January 2013|Actual|2013-01-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|May 2017|Anticipated|2017-05-01||Observational|EnligHTN-II||IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN|IntErnational Non-randomized, Single-arm, Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN|Active, not recruiting||N/A|354|Actual|St. Jude Medical|||3||f||||t||||||||No||2017-10-11 02:25:05.005173|2017-10-11 02:25:05.005173
NCT01705067|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-02-06|||June 2012||2012-06-01|February 2017|2017-02-01|June 2024|Anticipated|2024-06-01|April 2024|Anticipated|2024-04-01||Interventional|NIMBLE||Safety and Efficacy of the Journey II BCS Total Knee System|A Retro-Prospective, Non-randomized, Consecutive Series, SIngle Cohort, Multicenter Adaptive Design Study to Evaluate the Outcomes of Total Knee Arthroplasty (TKA) Using JOURNEY™ II BCS TotaL Knee SystEm (The NIMBLE Study)|Active, not recruiting||N/A|209|Anticipated|Smith & Nephew, Inc.||1|||f||||t||||||||||2017-10-11 02:25:05.190884|2017-10-11 02:25:05.190884
NCT01705054|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-06-20|||July 2013||2013-07-01|June 2017|2017-06-01|July 22, 2015|Actual|2015-07-22|July 2015|Actual|2015-07-01||Observational|APPEAR||Angina Prevalence and Provider Evaluation of Angina Relief|Angina Prevalence and Provider Evaluation of Angina Relief|Completed||N/A|1246|Actual|Saint Luke's Health System|||1||f||||f||||||||No||2017-10-11 02:25:05.287645|2017-10-11 02:25:05.287645
NCT01705041|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-01-29|||June 2012||2012-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|DFA||Preliminary Evaluation of a Point-Of-Care Liver Function Test|Preliminary Field Evaluation of a Point-of-Care Transaminase Test|Completed||N/A|700|Actual|PATH||1|||f||||f||||||||||2017-10-11 02:25:05.363291|2017-10-11 02:25:05.363291
NCT01705015|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-10-15|||September 2012||2012-09-01|September 2012|2012-09-01||||August 2015|Anticipated|2015-08-01||Interventional|||Organ Transplantation Rehabilitation: Effect of Bedside Exercise Device and Activity Reinforcement|Organ Transplantation Rehabilitation: Effect of Bedside Exercise Device and Activity Reinforcement for Heart or Liver Transplantation Recipients in Early Postoperative Period|Unknown status|Recruiting|N/A|110|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:25:05.470899|2017-10-11 02:25:05.470899
NCT01705002|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-07-04|||October 2012||2012-10-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.|A Phase I, Dose-Escalating, Safety Study of an Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PL-MLP, PROMITIL) in Cancer Patients With Solid Tumors.|Recruiting||Phase 1|90|Anticipated|Lipomedix Pharmaceuticals Inc.||12|||f||||t||||||||||2017-10-11 02:25:05.671865|2017-10-11 02:25:05.671865
NCT00005142|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||July 1978||1978-07-01|June 2000|2000-06-01|March 1990|Actual|1990-03-01|||||Observational|||Etiology and Prevalence of Peripheral Arterial Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:32.152516|2017-10-11 04:26:32.152516
NCT01704989|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2012-10-10|||October 2012||2012-10-01|October 2012|2012-10-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|LIP||The Laser in Pseudoexfoliation (LIP) Study|A Randomised Controlled Trial to Compare the Clinical Effectiveness of Selective Laser Trabeculoplasty (SLT) Versus Topical Therapy in the Treatment of Pseudoexfoliative Glaucoma|Unknown status|Not yet recruiting|Phase 4|110|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 02:25:05.819719|2017-10-11 02:25:05.819719
NCT01704976|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2016-07-23|2014-07-12||September 2012||2012-09-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||SR-WBV Training for Frail Elderly in the Skilling up Stage|Effects of Whole Body Vibration With Stochastic Resonance and Dance Therapy in the Elderly: Effects on Physical Functional Performance|Completed||N/A|27|Actual|Bern University of Applied Sciences||2|||f||||f||||||||||2017-10-11 02:25:05.936417|2017-10-11 02:25:05.936417
NCT01704963|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-03-20|||September 12, 2012|Actual|2012-09-12|March 2017|2017-03-01|February 1, 2017|Actual|2017-02-01|November 20, 2015|Actual|2015-11-20||Interventional|||A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms|A Phase 1 Study of the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Subjects With Recurrent Mature B-Cell Neoplasms|Completed||Phase 1|15|Actual|Janssen Pharmaceutical K.K.||1|||f||||t||||||||||2017-10-11 02:25:06.320501|2017-10-11 02:25:06.320501
NCT01704950|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-02-24|||February 2013||2013-02-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|July 2014|Actual|2014-07-01||Observational|||Clinical Outcome of Defect Reconstruction Using IDRT Single Layer : Results From a Prospective Multicentric Trial|Clinical Outcome of Defect Reconstruction Using IDRT Single Layer : Results From a Prospective Multicentric Trial|Completed||N/A|52|Actual|Integra LifeSciences Services|||1||f||||f||||||||||2017-10-11 02:25:06.44472|2017-10-11 02:25:06.44472
NCT01704937|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2014-06-18|||November 2012||2012-11-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum|Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum|Completed||Phase 1|20|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:25:06.531817|2017-10-11 02:25:06.531817
NCT01704924|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-09|||October 2012||2012-10-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Prospective Observation of Wound Healing With Prevena Incision Management System|Prospective Observation of Wound Healing With Prevena Incision Management System|Unknown status|Recruiting|N/A|20|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-10-11 02:25:06.631091|2017-10-11 02:25:06.631091
NCT01704911|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-25|||October 2012||2012-10-01|October 2012|2012-10-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Evaluate the Safety And Efficacy of the Transradial Coronary in Comparison With the Transfemoral Coronary Intervention|Determination of the Transradial Versus Transfemoral Coronary Angioplasty|Unknown status|Not yet recruiting|N/A|1700|Anticipated|CCRF Consulting Co., Ltd.||2|||f||||t||||||||||2017-10-11 02:25:06.727063|2017-10-11 02:25:06.727063
NCT01704898|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-08-12|||April 2013||2013-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|efv600||Efavirenz Comparative Bioavailability|Comparative Bioavailability Study of Two Efavirenz 600 mg Formulations in Healthy Volunteers.|Completed||Phase 4|12|Actual|Center for Clinical Pharmacology Research Bdbeq S.A.||2|||f||||f||||||||||2017-10-11 02:25:06.822133|2017-10-11 02:25:06.822133
NCT01704885|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-07-30|||September 2011||2011-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer|A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer: A Pilot Study|Terminated||Early Phase 1|5|Actual|Case Comprehensive Cancer Center||2||Slow Accrual|f||||t||||||||||2017-10-11 02:25:06.92656|2017-10-11 02:25:06.92656
NCT01704872|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-11|||July 2005||2005-07-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|February 2006|Actual|2006-02-01||Interventional|||ch14.18/CHO Bridging Study|Bridging Study Using ch14.18/CHO Antibody in Children With Refractory Neuroblastoma|Completed||Phase 1|16|Actual|St. Anna Kinderkrebsforschung||1|||f||||f||||||||||2017-10-11 02:25:07.035869|2017-10-11 02:25:07.035869
NCT01704859|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2017-03-14|||July 2010||2010-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vitamin D and Omega-3 Fatty Acids (VITAL Trial): Effects on Fractures|Vitamin D and Omega-3 Fatty Acids (VITAL Trial): Effects on Fractures|Active, not recruiting||N/A|25874|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:25:07.137776|2017-10-11 02:25:07.137776
NCT01704846|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2015-07-03|2015-07-03||October 2012||2012-10-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Treated set (TS) included all subjects who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules|Assessment of Bioequivalence Between Two Different Formulations of BI 201335 NA Soft Gelatine Capsules in Healthy Male Volunteers. (an Open-label, Randomised, Single-dose, Four-period Replicated Crossover Study)|Completed||Phase 1|60|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:25:07.273904|2017-10-11 02:25:07.273904
NCT01704833|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-10-10|||September 2006||2006-09-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|September 2009|Actual|2009-09-01||Interventional|CBTp||Cognitive Behavioral Therapy for Paranoia in Schizophrenia|Cognitive Behavioral Therapy for Paranoia in Schizophrenia|Unknown status|Active, not recruiting|N/A|24|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 02:25:07.784808|2017-10-11 02:25:07.784808
NCT01704807|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-10-10|||September 2011||2011-09-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Duration of Spinal Manipulation Effects as Influenced by Orthotics|Duration of Spinal Manipulation Effects as Influenced by Orthotics|Completed||Phase 1/Phase 2|41|Actual|Logan College of Chiropractic||2|||f||||f||||||||||2017-10-11 02:25:08.045117|2017-10-11 02:25:08.045117
NCT00005143|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||July 1978||1978-07-01|March 2005|2005-03-01|February 1998||1998-02-01|||||Observational|||Stanford Five-City Multifactor Risk Reduction Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:32.230289|2017-10-11 04:26:32.230289
NCT01704794|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-04-01|||April 2013||2013-04-01|April 2013|2013-04-01|September 2014|Anticipated|2014-09-01|April 2014|Anticipated|2014-04-01||Interventional|||Quality of Life Study for Sickle Cell Patients Treated With Jobelyn (Sorghum Bicolor Extract)|Antioxidant Effect of the Extract of Jobelyn (Sorghum Bicolor) on the Quality of Life of Patients With Sickle Cell Disease|Unknown status|Recruiting|Phase 1/Phase 2|96|Anticipated|Lagos State University||3|||f||||t||||||||||2017-10-11 02:25:08.136701|2017-10-11 02:25:08.136701
NCT01704781|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-01-16|2017-01-16||September 2012||2012-09-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|IMID||Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)|A Double-blind Placebo Controlled Immunogenicity Study of Vacc-4x + Lenalidomide Versus Vacc-4x With an Initial Open-label Dose Escalation Assessment of Lenalidomide in HIV-1-infected Subjects on Antiretroviral Therapy (ART).|Completed||Phase 1/Phase 2|36|Actual|Bionor Immuno AS||3|||f||||t||||||||No|Participants have not provided informed consent for their anonymized individual data to be made available beyond that described in the patient information sheet.|2017-10-11 02:25:08.447094|2017-10-11 02:25:08.447094
NCT01704768|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-10-10|||January 2010||2010-01-01|October 2012|2012-10-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||COPE/Healthy Lifestyles for Teens: A School-Based RCT|COPE/Healthy Lifestyles for Teens: A School-Based RCT|Unknown status|Active, not recruiting|N/A|1219|Actual|Arizona State University||2|||f||||t||||||||||2017-10-11 02:25:09.815581|2017-10-11 02:25:09.815581
NCT01704755|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-09-24|2014-12-23||October 2012||2012-10-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|January 2014|Actual|2014-01-01||Interventional|TURQUOISE-II|All participants who received at least 1 dose of study drug.|A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis|A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)|Completed||Phase 3|381|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 02:25:10.010447|2017-10-11 02:25:10.010447
NCT01704742|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-11-04||||||November 2016|2016-11-01||||||||Observational|||Prospective Study of Lymphoproliferative Diseases|A Prospective Clinicopathological Cohort Study of Lymphoproliferative Diseases at Kenyatta National Hospital in Nairobi, Kenya|Withdrawn||N/A|0|Actual|West Virginia University|||1|"Protocol not considered a clinical trial for registration purposes; no subjects enrolled to   date pending further grant funding"|f||||f||||||Samples With DNA|"     Tumor tissue, blood plasma and serum upon consent and suitability of sample preparation.   "|||2017-10-11 02:25:10.833901|2017-10-11 02:25:10.833901
NCT01704729|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-10-10|||September 2012||2012-09-01|October 2012|2012-10-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|WEAR||The Children's WEAR Trial(Phase 1&2)|The Children's WEAR (Wearability and Evaluation of Adjustable Refraction) Trial(Phase 1&2)|Unknown status|Enrolling by invitation|Phase 1/Phase 2|2300|Anticipated|Sun Yat-sen University||4|||f||||t||||||||||2017-10-11 02:25:10.949991|2017-10-11 02:25:10.949991
NCT01704716|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-09-26|||February 2002||2002-02-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||High Risk Neuroblastoma Study 1.7 of SIOP-Europe (SIOPEN)|High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN)|Recruiting||Phase 3|2700|Anticipated|St. Anna Kinderkrebsforschung||10|||f||||t||||||||||2017-10-11 02:25:11.103061|2017-10-11 02:25:11.103061
NCT01704703|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-07-31|||October 2012||2012-10-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|ULTRA||Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques|Open Label Phase II Study of FOLFIRI + Panitumumab Using Ultra-selection Technology With Next Generation High Sensitivity Genotyping of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques.|Completed||Phase 2|72|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1|||f||||f||||||||||2017-10-11 02:25:11.600733|2017-10-11 02:25:11.600733
NCT01704690|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-04-05|||August 2012|Actual|2012-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer|Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer|Terminated||Phase 2/Phase 3|4|Actual|Peking University||3||The enrollment of the study is much slower than expected.|f||||t||||||||||2017-10-11 02:25:11.740377|2017-10-11 02:25:11.740377
NCT01704677|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-01-18|||September 2012||2012-09-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up|Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation in Chronic Back Pain and Localized Degenerative Disc. Long Term Follow-up of a Randomized Multicentre Trial|Completed||N/A|151|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 02:25:11.901826|2017-10-11 02:25:11.901826
NCT01704664|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-09-04|||March 2007||2007-03-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients|Prospective Study of the Effect of Perioperative Immunonutrition on the Immune Host Defense and the Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients.|Recruiting||N/A|240|Anticipated|Medical University of Bialystok||4|||f||||t||||||||||2017-10-11 02:25:12.075085|2017-10-11 02:25:12.075085
NCT01704651|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2016-08-30|2016-08-30||January 2013||2013-01-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional||Baseline characteristics are provided for the subjects who completed study follow up.|Accelerating Gastrointestinal Recovery|Accelerating Gastrointestinal Recovery in Women Undergoing Staging and/or Debulking Surgery for Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 3|146|Actual|Mayo Clinic||2|||f||||f||||||||Undecided||2017-10-11 02:25:12.227728|2017-10-11 02:25:12.227728
NCT01704638|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-08-31|||August 2008||2008-08-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes||Completed||Phase 1|14|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:25:13.063194|2017-10-11 02:25:13.063194
NCT01704625|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2012-10-10|||January 2012||2012-01-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Will the Use of Osteopathic Manipulative Treatments Help Alleviate Headache Pain|Will the Use of Osteopathic Manipulative Treatments on Patients With Headache in the Emergency Department Result in Decreased Pain on 100 Point Pain Scale?|Unknown status|Recruiting|N/A|50|Anticipated|Good Samaritan Hospital Medical Center, New York||2|||f||||f||||||||||2017-10-11 02:25:13.18133|2017-10-11 02:25:13.18133
NCT01704612|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2012-12-21|||July 2011||2011-07-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|Diabeteblock||Evaluation of Block Duration in Type 2 Diabetes Patients|Comparison of Subgluteal Sciatic Nerve Block Duration in Type-2 Diabetic and Non Diabetic Patients|Completed||Phase 4|70|Actual|Pierre and Marie Curie University||2|||f||||t||||||||||2017-10-11 02:25:13.311257|2017-10-11 02:25:13.311257
NCT01704599|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2015-01-30|2014-12-08||January 2009||2009-01-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|June 2013|Actual|2013-06-01||Interventional||5 male 3 female Adults over age 18 < or = 65 7 Adults over age 65 1|Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis|A Single-Center, Open-Label Study to Assess the Effects of the Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis Evaluated With the PASI, PGA and DLQI|Terminated||Phase 1/Phase 2|8|Actual|Wayne State University|Early termination due to high amount of combination of side effects and poor outcomes leading to small numbers of subjects analyzed.|1||side effect and poor clinical outcome|f||||t||||||||||2017-10-11 02:25:13.45713|2017-10-11 02:25:13.45713
NCT01704586|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-05-02|||May 2015||2015-05-01|May 2017|2017-05-01|November 2019|Anticipated|2019-11-01|May 2019|Anticipated|2019-05-01||Interventional|CLERAD-PROBE||I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer|Clinical Evaluation of a I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Using PROBE Design|Recruiting||N/A|340|Anticipated|University of Wuerzburg||2|||f||||t||||||||||2017-10-11 02:25:14.51204|2017-10-11 02:25:14.51204
NCT01704573|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-06-14|||October 2010||2010-10-01|June 2017|2017-06-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Observational|||Nicotinic Receptor Levels After Stopping Smoking|Nicotinic Receptor Availability in Slow and Fast Nicotine Metabolizers|Completed||N/A|20|Actual|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Two saliva samples will be collected at the medical screening session. A 6ml saliva sample     will be used for nicotine metabolite ratio (NMR) estimation, and a 2ml saliva sample for DNA     extraction (using an Oragene collection kit).   "|No||2017-10-11 02:25:14.643966|2017-10-11 02:25:14.643966
NCT01704560|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-04-27|||March 2012||2012-03-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Improving Measurement Of Parents' Understanding Of Research Permission|IMPROVING MEASUREMENT OF PARENTS' UNDERSTANDING OF RESEARCH PERMISSION|Recruiting||N/A|40|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 02:25:14.761159|2017-10-11 02:25:14.761159
NCT01704534|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-02-12|||May 2012||2012-05-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|HiTS||A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa|A Prospective Proof of Concept Study to Evaluate the Potential Efficacy of Ustekinumab in Patients With Moderate to Severe Hidradenitis Suppurativa (Acne Ectopica)|Completed||Phase 2|20|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 02:25:14.926412|2017-10-11 02:25:14.926412
NCT01704521|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2015-03-26|2015-02-03||December 2012||2012-12-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|HCV/Hemophil||Viral Kinetics in HCV Clearance in Subjects With Hemophilia|Viral Kinetic Models of HCV Clearance in Hemophiliacs With Telaprevir|Completed||Phase 1|5|Actual|University of Cincinnati||2|||f||||t||||||||||2017-10-11 02:25:15.043627|2017-10-11 02:25:15.043627
NCT01704508|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2013-12-05|||November 2012||2012-11-01|December 2013|2013-12-01|January 2015|Anticipated|2015-01-01|April 2014|Anticipated|2014-04-01||Interventional|||Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A|Efficacy and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for the Treatment of Uncomplicated Malaria in Guinea-Bissau.|Unknown status|Recruiting|Phase 4|346|Anticipated|Bandim Health Project||2|||f||||f||||||||||2017-10-11 02:25:15.593709|2017-10-11 02:25:15.593709
NCT01704495|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2016-02-01|2015-06-30||November 2012||2012-11-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|NIMBUS||A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.|A 6-month, Randomised, Double-blind, Placebo-controlled, Multi-centre, Parallel-group, Phase II Study With an Optional Safety Extension Treatment Period up to 6 Months, to Evaluate the Efficacy, Safety, and Tolerability of 3 Different Doses of AZD5069 Twice Daily as Add-on Treatment to Medium to High Dose Inhaled Corticosteroids (ICS) and Long-acting β2 Agonists (LABA), in Patients With Uncontrolled Persistent Asthma|Completed||Phase 2|1147|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 02:25:15.780741|2017-10-11 02:25:15.780741
NCT01704482|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-09|2012-10-10|||February 2011||2011-02-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement|N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement.|Completed||Phase 2|60|Actual|Assiut University||2|||f||||||||||||||2017-10-11 02:25:18.249778|2017-10-11 02:25:18.249778
NCT01704469|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-08|||March 2012||2012-03-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Comparison of the Perception of a Needle Injection Pain Between Cancer Patients Receiving Opioid Therapy Versus Opioid-naive Patients||Completed||N/A|80|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 02:25:18.331814|2017-10-11 02:25:18.331814
NCT01704456|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-05-30|||October 2012||2012-10-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|COMFORT||Integrated Mindfulness-based Cognitive Behaviour Therapy Versus Cognitive Behaviour Therapy for Provoked Vestibulodynia|Integrated Mindfulness-based Cognitive Behaviour Therapy Versus Cognitive Behaviour Therapy for Provoked Vestibulodynia|Active, not recruiting||N/A|141|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:25:18.596551|2017-10-11 02:25:18.596551
NCT01704430|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-02-06|||September 2012||2012-09-01|February 2017|2017-02-01|June 21, 2016|Actual|2016-06-21|June 21, 2016|Actual|2016-06-21||Interventional|GLADIATOR||Glutamine to Improve Outcomes in Cardiac Surgery|GLutamine Enterally After carDiac Surgery for Inflammation Attenuation and ouTcOme impRovement (GLADIATOR): A Phase II Randomized, Blinded, Placebo-Controlled Trial|Completed||N/A|60|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 02:25:18.757848|2017-10-11 02:25:18.757848
NCT01704417|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-12-15|||October 2012||2012-10-01|December 2016|2016-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine|A Trial Comparing the Effect of Exercise on Blood Glucose Between Insulin Degludec and Insulin Glargine in Subjects With Type 1 Diabetes|Completed||Phase 1|40|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:25:18.865367|2017-10-11 02:25:18.865367
NCT01704404|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-05-12|2017-01-17||December 2012||2012-12-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||7 Days of TD−4208 in Subjects With Chronic Obstructive Pulmonary Disease|A Phase 2 Study of the Pharmacodynamics, Safety and Tolerability, and Pharmacokinetics of Multiple Doses of TD−4208 for 7 Days in Subjects Diagnosed With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|62|Actual|Theravance Biopharma R & D, Inc.||7|||f||||f||||||||No||2017-10-11 02:25:18.990185|2017-10-11 02:25:18.990185
NCT01704391|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2012-10-09|||January 2012||2012-01-01|October 2012|2012-10-01||||May 2013|Anticipated|2013-05-01||Observational|||Haemodynamic Response to Aortic Surgery|Haemodynamic Response to Aortic Surgery|Unknown status|Recruiting|N/A|20|Anticipated|Sygehus Lillebaelt|||2||f||||f||||||Samples Without DNA|"     Urine samples taken from urinary catheter. Centrifuged, supernatant frozen at -80 degrees C.     Immunoassay analyzed at Roche modular P quantifying NGAL.   "|||2017-10-11 02:25:19.523721|2017-10-11 02:25:19.523721
NCT01704378|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-02-22|||April 18, 2001|Actual|2001-04-18|February 2017|2017-02-01|March 14, 2003|Actual|2003-03-14|March 14, 2003|Actual|2003-03-14||Interventional|||Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes|A Multi-National, Multi-Centre, Open-Labelled Extension Study Assessing the Long-Term Safety of Biphasic Insulin Aspart 30 in NovoMix®30 FlexPen™ in Type 2 Diabetic Patients Previously Treated in BIAsp-1236|Completed||Phase 4|89|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 02:25:19.613773|2017-10-11 02:25:19.613773
NCT01704365|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-02-05||2014-02-05|October 2012||2012-10-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||RSV-F Vaccine Dose Ranging Study in Young Women|A Phase II Randomized, Observer-Blinded, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of an RSV-F Protein Nanoparticle Vaccine, With or Without Aluminum, in Healthy Women of Child-Bearing Age|Completed||Phase 2|330|Actual|Novavax||10|||f||||f||||||||||2017-10-11 02:25:19.726237|2017-10-11 02:25:19.726237
NCT01704339|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-08|||December 2012||2012-12-01|October 2012|2012-10-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Qutenza for Critical Ischaemia in End Stage Renal Failure|The Role of Qutenza (Topical Capsaicin 8%) in Treating Neuropathic Pain From Critical Ischaemia in Patients With End-stage Renal Failure|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|NHS Greater Glasgow and Clyde||1|||f||||f||||||||||2017-10-11 02:25:19.96492|2017-10-11 02:25:19.96492
NCT01704326|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-10-09|||September 2006||2006-09-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Observational|||A Study of Patients Treated With the Journey Deuce Bicompartmental Knee System|A Prospective, Multicenter Consecutive Series Study of Patients Treated With the Journey Deuce Bicompartmental Knee System|Completed||N/A|59|Actual|Smith & Nephew, Inc.|||1||f||||f||||||||||2017-10-11 02:25:20.08241|2017-10-11 02:25:20.08241
NCT01704313|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-10|||May 2012||2012-05-01|October 2012|2012-10-01|May 2014|Anticipated|2014-05-01|August 2013|Anticipated|2013-08-01||Interventional|||A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic Fistulae|A Randonimised Trial Comparing Interrupted to Continuous Suturing Techniques in Radiocephalic Fistulae|Unknown status|Recruiting|N/A|70|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 02:25:20.174746|2017-10-11 02:25:20.174746
NCT01704300|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-10|||January 2001||2001-01-01|October 2012|2012-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|CALIBER||Body Mass Index and Initial Presentations of Cardiovascular Diseases|Body Mass Index and Initial Presentations of Cardiovascular Diseases|Completed||N/A|2240000|Actual|University College, London|||1||f||||t||||||||||2017-10-11 02:25:20.278692|2017-10-11 02:25:20.278692
NCT01704287|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-08-18|2016-10-17||November 20, 2012|Actual|2012-11-20|August 2017|2017-08-01|July 2, 2018|Anticipated|2018-07-02|November 16, 2015|Actual|2015-11-16||Interventional||The Intent-to-Treat (ITT) population consisted of all randomized participants. Participants were included in the group to which they were randomized for Baseline Characteristics.|Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (P08719/KEYNOTE-002)|Randomized, Phase II Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Patients With Advanced Melanoma (KEYNOTE 002)|Active, not recruiting||Phase 2|540|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-10-11 02:25:20.44583|2017-10-11 02:25:20.44583
NCT01704274|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2013-11-05|||April 2012||2012-04-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|GTN||GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy|A Double-Blind, Randomised, Placebo-Controlled Study of the Effect of Transdermal Nitroglycerin (Glyceryl Trinitrate; GTN) Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy|Unknown status|Recruiting|Phase 3|60|Anticipated|Queen's University||3|||f||||f||||||||||2017-10-11 02:25:26.938362|2017-10-11 02:25:26.938362
NCT01704079|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2016-08-22|2016-07-08|2015-10-22|November 2012||2012-11-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency|Completed||Phase 3|216|Actual|OPKO Health, Inc.||2|||f||||t||||||||||2017-10-11 02:25:29.911325|2017-10-11 02:25:29.911325
NCT01704261|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-06-05|2015-10-23||October 18, 2012|Actual|2012-10-18|June 2017|2017-06-01|December 23, 2014|Actual|2014-12-23|December 23, 2014|Actual|2014-12-23||Interventional|||Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)|A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Safety and Efficacy of the Addition of MK-3102 to Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin|Completed||Phase 3|307|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 02:25:27.086943|2017-10-11 02:25:27.086943
NCT01704248|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-10|||October 2012||2012-10-01|October 2012|2012-10-01|April 2013|Anticipated|2013-04-01|February 2013|Anticipated|2013-02-01||Interventional|||"The Effect of Eye Drop Guide on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients"|"The Effect of Eye Drop Guide on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients."|Unknown status|Recruiting|Phase 4|60|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 02:25:27.550306|2017-10-11 02:25:27.550306
NCT01704235|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-05-18|||November 2012||2012-11-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|November 2013|Actual|2013-11-01||Observational|||Vietnamese Women's Health Project III|Community Based Participatory Research to Understanding Symptom Perception, Preventive Care-Seeking, and Their Impact on Cervical Cancer Screening Among Vietnamese American Women|Active, not recruiting||N/A|13|Actual|OHSU Knight Cancer Institute|||1||f||||f||||||||||2017-10-11 02:25:27.656906|2017-10-11 02:25:27.656906
NCT01704222|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2013-10-31|||September 2009||2009-09-01|October 2012|2012-10-01|September 2013|Actual|2013-09-01|February 2012|Actual|2012-02-01||Observational|CrèchMV||Epidemiology of Human Cytomegalovirus Excretion in the Saliva of Children Attending Nursery in France|Epidemiology of Human Cytomegalovirus Excretion in the Saliva of Children Attending Nursery in France.|Completed||N/A|2001|Actual|University Hospital, Limoges|||1||f||||f||||||Samples With DNA|"     Direct DNA amplification, viral isolation and specific antibody measurement in saliva   "|||2017-10-11 02:25:27.729481|2017-10-11 02:25:27.729481
NCT01704209|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-09-03|||April 2013||2013-04-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Collagen Injections for the Treatment of Acne Scars and Wrinkles|Pilot Study of Autologous Fibroblast Injection for Acne Scars, Forehead Lines, Lip Lines, Horizontal Neck Lines, and Static Crow's Feet|Terminated||Phase 1|4|Actual|Northwestern University||2||"Company stopped making product for cosmetic use. All consented subjects withdrew before any   study interventions were performed."|f||||t||||||||||2017-10-11 02:25:27.791164|2017-10-11 02:25:27.791164
NCT01704196|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-04-07|2017-01-04||April 2013||2013-04-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||A Multi-Center Trial of Nepicastat for Cocaine Dependence|Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence|Completed||Phase 2|179|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 02:25:27.867027|2017-10-11 02:25:27.867027
NCT01704183|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-05-07|||December 2012||2012-12-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|FingoHRV||Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis|Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis|Completed||N/A|27|Actual|Kuopio University Hospital|||1||f||||||||||||||2017-10-11 02:25:28.239812|2017-10-11 02:25:28.239812
NCT01704170|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-04-10|||November 2012||2012-11-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Feasibility Study to Evaluate Renal Denervation Using Focused Ultrasound|A Feasibility Study: An Evaluation of Renal Denervation Using Externally Focused Therapeutic Ultrasound on Patients With Refractory Hypertension|Completed||N/A|31|Actual|Kona Medical Inc.||1|||f||||f||||||||||2017-10-11 02:25:28.385194|2017-10-11 02:25:28.385194
NCT01704157|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2014-01-27|||September 2012||2012-09-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device|A Prospective Non-Randomized Unblinded Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device|Completed||N/A|33|Actual|MyoScience, Inc||1|||f||||f||||||||||2017-10-11 02:25:28.951719|2017-10-11 02:25:28.951719
NCT01704144|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2012-10-16|||October 2012||2012-10-01|September 2012|2012-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Rifampin and Efavirenz Interactions in Older Children|Effect of Rifampin-containing Anti-TB Treatment on Efavirenz Pharmacokinetics in HIV/TB Co-infected Children Aged 3 - 14 Years|Unknown status|Recruiting|N/A|160|Anticipated|The Miriam Hospital|||1||f||||t||||||Samples With DNA|"     EDTA plasma Whole blood DNA   "|||2017-10-11 02:25:29.051184|2017-10-11 02:25:29.051184
NCT01704131|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-04-20|||November 2012|Actual|2012-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|||||Observational|LevoCorKids||Levosimendan Pharmacokinetics in Children|Pharmacokinetics of Levosimendan in Children With Acute Heart Failure|Recruiting||N/A|36|Anticipated|Leiden University Medical Center|||2||f||||f||||||||||2017-10-11 02:25:29.164481|2017-10-11 02:25:29.164481
NCT01704118|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2012-10-09|||January 2012||2012-01-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Comparison of Size 1 I-gel and ProSeal Laryngeal Mask|Is Size 1 I-gel More Effective Than Size 1 ProSeal Laryngeal Mask for Anesthetized Infants and Neonates?|Completed||N/A|50|Actual|Inonu University||2|||f||||t||||||||||2017-10-11 02:25:29.270629|2017-10-11 02:25:29.270629
NCT01704105|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-08-10|||November 2012|Actual|2012-11-01|August 2017|2017-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|WASHB-Kenya||WASH Benefits Kenya|WASH Benefits Kenya: A Cluster Randomized Controlled Trial of the Benefits of Sanitation, Water Quality, Handwashing, and Nutrition Interventions on Child Health and Development|Completed||N/A|8246|Actual|Innovations for Poverty Action||8|||f||||t||||||||||2017-10-11 02:25:29.372757|2017-10-11 02:25:29.372757
NCT01704092|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-26|||May 2012||2012-05-01|October 2012|2012-10-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Observational|||Dexmedetomidine's Cardiac and Cognitive Influence on Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery|Dexmedetomidine's Cardiac and Cognitive Influence on Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery|Unknown status|Recruiting|N/A|90|Anticipated|Huazhong University of Science and Technology|||3||f||||t||||||Samples With DNA|"     blood samples are drawn from patients recruited into the study. We planned to draw blood     samples from patients with their consent through the central line.   "|||2017-10-11 02:25:29.522532|2017-10-11 02:25:29.522532
NCT01704066|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2012-12-20|||October 2012||2012-10-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Interobserver Variation in Applying a Radiographic Definition for Acute Respiratory Distress Syndrome (ARDS)|Interobserver Variation in Applying a Radiographic Definition for ARDS: Impact of a Training Set of Berlin ARDS Definition|Completed||N/A|286|Actual|Society of Critical Care Medicine, China|||1||f||||f||||||||||2017-10-11 02:25:30.576641|2017-10-11 02:25:30.576641
NCT01704053|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-08-14|||October 2012||2012-10-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study|Monitoring The Anticoagulatory Effects of Dabigatran and Rivaroxaban On Plasmatic and Cellular Coagulation by Rotational Thrombelastometry/-Graphy and Multiple Platelet Function Analyzer|Completed||N/A|34|Actual|Johann Wolfgang Goethe University Hospital|||1||f||||t||||||||||2017-10-11 02:25:30.686599|2017-10-11 02:25:30.686599
NCT01704040|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-12-11|||October 2012||2012-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16|A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating CNTO 3157 in Healthy Normal and Asthmatic Subjects Inoculated With Human Rhinovirus Type 16|Completed||Phase 1|76|Actual|Janssen Research & Development, LLC||4|||f||||t||||||||||2017-10-11 02:25:30.755602|2017-10-11 02:25:30.755602
NCT01704027|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-09-17|||October 2012||2012-10-01|September 2014|2014-09-01||||March 2014|Actual|2014-03-01||Interventional|||Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer|Prospective Phase II Study Evaluating the Feasibility of a Conformational Pelvic and Prostatic Radiotherapy With Simultaneous Integrated Boost Modulated-intensity Arctherapy (SIB-IMAT) in Combination With Long Term Androgen Deprivation for High Risk Localized Prostate Cancer.|Terminated||Phase 2|28|Actual|Centre Georges Francois Leclerc||1||termination of the trial after interim analysis. the main criterion could not be reached|f||||f||||||||||2017-10-11 02:25:30.891144|2017-10-11 02:25:30.891144
NCT01704014|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-10|||January 2010||2010-01-01|October 2012|2012-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Intraoperative Floppy Iris Syndrome in Korean Patients Taking α1-Adrenergic Receptor Antagonists|Intraoperative Floppy Iris Syndrome in Korean Patients Taking α1-Adrenergic Receptor Antagonists|Completed||N/A|150|Actual|Samsung Medical Center|||2||f||||t||||||||||2017-10-11 02:25:31.082254|2017-10-11 02:25:31.082254
NCT01704001|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-02-13|||October 2012||2012-10-01|October 2012|2012-10-01|June 2014|Actual|2014-06-01|October 2013|Actual|2013-10-01||Interventional|||Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment|A Post-Marketing Clinical Pharmacokinetics Study of ART-123 in DIC Subjects With Renal Impairment|Completed||Phase 4|40|Anticipated|Asahi Kasei Pharma Corporation||4|||f||||||||||||||2017-10-11 02:25:31.158109|2017-10-11 02:25:31.158109
NCT01703988|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-01-20|2017-01-20|2016-05-07|October 2012||2012-10-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy|An Open-Label, Dose Escalation Study to Assess the Safety, Tolerability and Dose-Range Finding of Multiple Doses of ISIS 396443 Delivered Intrathecally to Patients With Spinal Muscular Atrophy|Completed||Phase 1/Phase 2|34|Actual|Biogen||4|||t||||t||||||||Yes||2017-10-11 02:25:31.275648|2017-10-11 02:25:31.275648
NCT01703975|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2013-06-26|||January 2013||2013-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effects of Virtual Reality Ultrasound Training in Pairs Compared to Training Alone||Completed||N/A|30|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:25:32.570818|2017-10-11 02:25:32.570818
NCT01703962|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-02-24|||March 2012||2012-03-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Observational|IDASPE||Non Invasive IDentification of Gliomas With IDH1 Mutation|Non Invasive IDentification of Gliomas With IDH1 Mutation by Free Plasmatic DNA Analysis, 2-hydroxyglutarate Dosage in the Urines and 2-hydroxyglutarate Detection by Brain SPEctro-MRI: Diagnostic and Follow-up Application (IDASPE)|Recruiting||N/A|40|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples With DNA|"     Plasma samples containing free DNA fragments Urine   "|||2017-10-11 02:25:32.684449|2017-10-11 02:25:32.684449
NCT01703949|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2017-05-01|||March 20, 2013||2013-03-20|May 2017|2017-05-01||||January 15, 2021|Anticipated|2021-01-15||Interventional|||Brentuximab Vedotin in Treating Patients With Relapsed or Refractory CD30+ Lymphoma|A Pilot Study of Weekly Brentuximab Vedotin in Patients With CD30+ Malignancies Refractory to Every ≥ 3 Week Brentuximab Vedotin|Active, not recruiting||N/A|8|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 02:25:32.807154|2017-10-11 02:25:32.807154
NCT01703936|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2012-10-08|||May 2009||2009-05-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|March 2010|Actual|2010-03-01||Interventional|||Ex-combatant Reintegration in Liberia|Evaluating a Landmine Action Ex-combatant Reintegration Program in Liberia|Completed||N/A|1330|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 02:25:32.916994|2017-10-11 02:25:32.916994
NCT01703923|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-10-30||2014-10-30|November 2012||2012-11-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough|An Exploratory, Randomized, Placebo-Controlled, Double-Blind, Crossover Study of FP01 Lozenges in Subjects With Chronic Refractory Cough|Completed||Phase 2|83|Actual|Cerecor Inc||2|||f||||f||||||||||2017-10-11 02:25:33.048471|2017-10-11 02:25:33.048471
NCT01703910|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-10-08|||November 2012||2012-11-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|November 2012|Actual|2012-11-01||Interventional|||Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic|Phase II Individualized Therapies Selection Study for Patients With Metastatic Colorectal Carcinoma According to the Genomic Expression Profile in Tumor Samples.|Completed||Phase 2|29|Actual|Centro Nacional de Investigaciones Oncologicas CARLOS III||2|||f||||t||||||||||2017-10-11 02:25:33.175153|2017-10-11 02:25:33.175153
NCT01703897|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2014-11-04|||October 2012||2012-10-01|November 2014|2014-11-01||||||||Observational|||Esophageal Manometry and Impedance Study in Obese Patients Before and During Anesthesia|Evaluation of Esophageal Pressures and Reflux in Obese Patients Before and During Anesthesia Using High-resolution Solid-state Manometry|Withdrawn||N/A|0|Actual|Örebro University, Sweden|||1||f||||f||||||||||2017-10-11 02:25:33.341922|2017-10-11 02:25:33.341922
NCT01703858|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-11-23|2016-11-23||September 2012||2012-09-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Treated Set (TS): All subjects those who received at least 1 dose of study drug were included in the in the treated set.|Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608|An Open Label, Randomised, Single Dose, 3-way Cross Over Study to Investigate Relative Bioavailability and Food Effect on Different Formulations of BI 113608 in Healthy Male Subjects, Followed by Fixed Sequence Periods Investigating Influence of Pantoprazole Coadministration and Food Effect on Pharmacokinetics of Different Formulations of BI 113608|Completed||Phase 1|15|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 02:25:33.630273|2017-10-11 02:25:33.630273
NCT01703845|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-06-19|2015-06-19||October 2012||2012-10-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Treated Set (TS) includes all randomised patients who received at least one dose of trial medication.|A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.|A Randomised, Open-label, Parallel-group Trial to Assess Pharmacokinetics and Safety of Tiotropium + Olodaterol Fixed-dose Combination (2.5 µg/ 5 µg, 5 µg/ 5 µg) Delivered by the RESPIMAT Inhaler After 3 Weeks Once Daily Treatment in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:25:34.570641|2017-10-11 02:25:34.570641
NCT01703832|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-02-09|2014-08-01||October 2012||2012-10-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|NEUPRO-OL|33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for efficacy.|Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects|Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting - an Explorative Open-Label Study in Healthy Probands|Completed||Phase 1/Phase 2|65|Actual|Biologische Heilmittel Heel GmbH||2|||f||||f||||||||||2017-10-11 02:25:35.266774|2017-10-11 02:25:35.266774
NCT01703819|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2015-02-09|2014-08-01||October 2012||2012-10-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|NEUPRO-DB|34 participants were randomized to Neurexan and 32 participants to Placebo and all randomized participants were included in the Safety Set. Two premature terminators could not be evaluated for primary efficacy, so 34 participants in the Neurexan group and 30 participants in the Placebo group formed the Full Analysis Set for analysis of efficacy.|Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects|Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting - an Explorative Double-blind Study in Healthy Probands|Completed||Phase 1/Phase 2|66|Actual|Biologische Heilmittel Heel GmbH||2|||f||||f||||||||||2017-10-11 02:25:36.353371|2017-10-11 02:25:36.353371
NCT01703806|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-08|2016-07-11|||December 2007||2007-12-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation|Early Surgery Versus Conventional Treatment for Asymptomatic Patients With Severe Degenerative Mitral Regurgitation: A Propensity Analysis|Recruiting||N/A|600|Anticipated|Asan Medical Center|||1||f||||t||||||||||2017-10-11 02:25:37.119689|2017-10-11 02:25:37.119689
NCT01703793|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2013-01-07|||September 2012||2012-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Efficacy Study in Subjects With Seborrheic Dermatitis|A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis|Completed||Phase 2|240|Actual|Medicis Global Service Corporation||3|||f||||f||||||||||2017-10-11 02:25:37.2316|2017-10-11 02:25:37.2316
NCT01703780|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-07|2016-04-25|||July 2012||2012-07-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|doublepres||The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis|The Prevalence and the Prognosis of Resistant Hypertension Ascertained With Systemic Investigation and Optimal Treatment With Antihypertensive Drugs|Active, not recruiting||N/A|9638|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital|||3||f||||||||||Samples With DNA|"     whole blood, serum, peripheral white blood cells, urine   "|||2017-10-11 02:25:37.382873|2017-10-11 02:25:37.382873
NCT01703767|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-08-10|||October 2014||2014-10-01|August 2016|2016-08-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Observational|||Gulf War 1 Veteran Healthcare Satisfaction|Gulf War 1 Veteran Patient Satisfaction With VA Primary Care: A Survey Study.|Withdrawn||N/A|0|Actual|University of Utah|||1|We did not have sufficient funds to conduct the study.|f||||f||||||||||2017-10-11 02:25:37.550174|2017-10-11 02:25:37.550174
NCT01703754|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-01-26|||March 2013||2013-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.|A Phase II Randomized, Open Label Study of Ad-RTS-hIL-12 Monotherapy or Combination With Palifosfamide in Subjects With Recurrent/Metastatic Breast Cancer and Accessible Lesions|Completed||Phase 2|12|Actual|Ziopharm||2|||f||||f||||||||||2017-10-11 02:25:37.672142|2017-10-11 02:25:37.672142
NCT01703741|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-09-19|2017-06-29|2014-10-07|December 2012||2012-12-01|September 2017|2017-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Intent-to-treat (ITT) Population consists of all subjects who received at least one dose of Investigational Medicinal Product (IMP).|A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel|A Multicenter Extension Trial to Evaluate the Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males|Completed||Phase 3|145|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:25:37.818777|2017-10-11 02:25:37.818777
NCT01703728|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-05-29|||November 2012||2012-11-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|SHOview||Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.|SHOview Observational Study. Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.|Completed||N/A|455|Actual|Ferring Pharmaceuticals|||1||f||||f||||||None Retained|"     No biological samples   "|||2017-10-11 02:25:38.49525|2017-10-11 02:25:38.49525
NCT01664052|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-07-06|2016-02-03|2014-03-05|July 2012||2012-07-01|July 2016|2016-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||ESS505 Pre-hysterectomy Protocol|ESS505 Pre-hysterectomy Protocol: Safety and Short Term Effectiveness Study|Completed||N/A|66|Actual|Bayer||2|||f||||||||||||||2017-10-11 02:37:48.742747|2017-10-11 02:37:48.742747
NCT01703715|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2014-07-14|||August 2012||2012-08-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|HOOP||Hydration and Outcome in Older Patients|Hydration and Outcome in Older Patients|Completed||N/A|200|Actual|University of Nottingham|||1||f||||t||||||Samples With DNA|"     Participants provide 5mls of whole blood on admission, at 48 hours post admission and at 3     month following discharge. This blood is to be analysed for urea, creatinine, sodium,     potassium, osmolality, full blood count as well as renin and aldosterone.   "|||2017-10-11 02:25:38.825838|2017-10-11 02:25:38.825838
NCT01703702|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-07-08|2016-04-01||October 2012||2012-10-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline|A Randomized, Multicenter, Multicountry Study to Evaluate the Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and to Evaluate the Relationship Between Florbetapir (18F) PET Scan Status and Cognitive Decline|Completed||Phase 4|641|Actual|Avid Radiopharmaceuticals||2|||f||||f||||||||||2017-10-11 02:25:38.946854|2017-10-11 02:25:38.946854
NCT01703689|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-07-18|||May 2011||2011-05-01|July 2016|2016-07-01|March 2013|Actual|2013-03-01|July 2011|Actual|2011-07-01||Interventional|IQUARE||Impact of Educational and Professional Supportive Interventions on Nursing Home Quality Indicators|Impact of Either Audit and Feedback Only or Audit and Feedback Associated to Cooperative Work Meetings Between Hospital Geriatricians and Nursing Home Staff on Quality Indicators and Health Care Practices in Nursing Homes.|Completed||N/A|8039|Actual|Agence Régionale de la Santé - Midi Pyrénées||2|||f||||f||||||||||2017-10-11 02:25:39.651923|2017-10-11 02:25:39.651923
NCT01703676|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-12|||March 2010||2010-03-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Observational|IZKF-CRA03-09||Epigenetics and Metabolic Disorders in Men With the Klinefelter Syndrome|Klinefelter Syndrome: Do the Parental Origin and Epigenetic Profile of the Supernumerary X Chromosome Determine Phenotype, Morbidity, Inflammatory Status and Cardiovascular Risk?|Completed||N/A|300|Actual|University Hospital Muenster|||4||f||||t||||||Samples With DNA|"     Blood, Testicular Tissue, Mouth Epithelium   "|||2017-10-11 02:25:40.138122|2017-10-11 02:25:40.138122
NCT01703663|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-08-19|2016-05-19||November 2012||2012-11-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All subjects who completed both nights|Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.|Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.|Completed||N/A|40|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 02:25:40.22419|2017-10-11 02:25:40.22419
NCT01703650|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2017-04-02|||November 2012||2012-11-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Observational|||Role of Perfusion CT in Pancreatic Cancer|Evaluation of Diagnostic Efficacy of Perfusion CT Using Wide Detector for Staging and Response Prediction After Chemotherapy in Pancreatic Cancer|Active, not recruiting||N/A|48|Actual|Seoul National University Hospital|||2||f||||t||||||||No||2017-10-11 02:25:40.491589|2017-10-11 02:25:40.491589
NCT01703637|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2016-03-30|||October 2012||2012-10-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin|A Multicenter, Randomized, Double-Blind Comparative Study of Efficacy，Tolerance and Safety Between Sitagliptin ,Vildagliptin and Saxagliptin After 12-week Monotherapy in Drug-naive Adult Patients With Type 2 Diabetes Mellitus|Recruiting||N/A|300|Anticipated|Qianfoshan Hospital||3|||f||||t||||||||||2017-10-11 02:25:40.614962|2017-10-11 02:25:40.614962
NCT01703624|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-03-29|||May 2013||2013-05-01|March 2016|2016-03-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease|An Investigation of the Efficacy, Tolerability and Safety of a Range of Doses of Orally Inhaled Glycopyrronium Bromide (PSX1002-GB pMDI) in Male and Female Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 2|37|Actual|Prosonix Limited||5|||f||||f||||||||||2017-10-11 02:25:40.780497|2017-10-11 02:25:40.780497
NCT01703611|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2016-02-18|||December 2012||2012-12-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|DINGS||Diabetes in India Nutrition Guidelines Study (DINGS)|Diabetes in India Nutrition Guidelines Study (DINGS)|Completed||N/A|238|Actual|Academy of Nutrition and Dietetics||2|||f||||t||||||||||2017-10-11 02:25:40.935403|2017-10-11 02:25:40.935403
NCT01703598|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-09-18|||September 2011||2011-09-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Clinical Outcomes of Deep Brain Stimulator (DBS) Electrodes Placed Using Intraoperative Computed Tomography (CT) and Frameless Stereotaxis|Clinical Outcomes of Deep Brain Stimulator Electrodes Placed Using Intraoperative Computed Tomography and Frameless Stereotaxis Versus Microelectrode Recording and Frame-based Stereotaxis|Completed||N/A|32|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-10-11 02:25:41.128145|2017-10-11 02:25:41.128145
NCT01703585|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-06-21|||October 2012||2012-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples|A Feasibility Study of Genomic Profiling Methods and Timing of Sample Collection to Evaluate Clonal Evolution and Tumor Heterogeneity|Recruiting||N/A|50|Anticipated|University Health Network, Toronto|||4||f||||f||||||Samples With DNA|"     Fresh tumor tissue   "|||2017-10-11 02:25:41.237029|2017-10-11 02:25:41.237029
NCT01703572|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-02-10|||October 2012||2012-10-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies|A Phase 1 Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies|Completed||Phase 1|24|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:25:41.351485|2017-10-11 02:25:41.351485
NCT01703559|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-10-09|||October 2011||2011-10-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Complaints|Double-masked Parallel Evaluation of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Complaints|Completed||Phase 2|60|Actual|Ocularis Pharma Inc.||3|||f||||f||||||||||2017-10-11 02:25:41.490212|2017-10-11 02:25:41.490212
NCT01703546|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-01-12|||November 2011||2011-11-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Weight Loss & Comorbidity Resolution With LAGB Alone vs. LAGB With Gastric Plication|Weight Loss & CoMorbidity Resolution With Laparoscopic Adjustable Gastric Band Alone vs. Laparoscopic Adjustable Gastric Band With Gastric Plication|Completed||N/A|420|Actual|Northwell Health||1|||f||||t||||||||||2017-10-11 02:25:41.628595|2017-10-11 02:25:41.628595
NCT01703533|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-03-27|||March 2013||2013-03-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Safety Study of NNZ-2566 in Patients With Rett Syndrome|A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation Study of NNZ-2566 in Rett Syndrome|Completed||Phase 2|67|Actual|Neuren Pharmaceuticals Limited||2|||f||||t||||||||No||2017-10-11 02:25:41.748793|2017-10-11 02:25:41.748793
NCT01703520|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-09-08|||May 1, 2011|Actual|2011-05-01|September 2017|2017-09-01|April 1, 2018|Anticipated|2018-04-01|November 1, 2017|Anticipated|2017-11-01||Observational|||Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).|Finasteride and Male Breast Cancer - A Register-Based Nested Case-Control Study in Denmark, Finland, Norway, and Sweden|Active, not recruiting||N/A|428000|Anticipated|Merck Sharp & Dohme Corp.|||4||f||||f||||||||||2017-10-11 02:25:41.886491|2017-10-11 02:25:41.886491
NCT01703507|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-10-19|||December 2012||2012-12-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma|Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases|Active, not recruiting||Phase 1|24|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 02:25:42.004967|2017-10-11 02:25:42.004967
NCT01703494|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2015-09-29|||October 2012||2012-10-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Fecal Transplant for Relapsing C. Difficile Infection|Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection|Unknown status|Active, not recruiting|Phase 2|53|Anticipated|The Miriam Hospital||2|||f||||t||||||||||2017-10-11 02:25:42.17458|2017-10-11 02:25:42.17458
NCT01703481|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-09-14|||June 15, 2012|Actual|2012-06-15|September 2017|2017-09-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma|A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects With Advanced or Refractory Solid Tumors or Lymphoma|Active, not recruiting||Phase 1|188|Actual|Janssen Research & Development, LLC||8|||f||||t||f||||||||2017-10-11 02:25:42.300146|2017-10-11 02:25:42.300146
NCT01703468|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2014-01-17|||September 2009||2009-09-01|January 2014|2014-01-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions|Completed||Phase 1|59|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:25:42.521265|2017-10-11 02:25:42.521265
NCT01703455|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2013-01-29|||September 2010||2010-09-01|January 2013|2013-01-01|January 2013|Anticipated|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Activity of Sorafenib in Salivary Gland Cancer|Sorafenib in Recurrent and/or Metastatic Salivary Gland Carcinomas: Phase II Study|Unknown status|Active, not recruiting|Phase 2|37|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t||||||||||2017-10-11 02:25:42.617851|2017-10-11 02:25:42.617851
NCT01703442|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Observational|||Intraoperative Anuric Episodes in Patients Undergoing Laparotomy|Perioperative Relevance of Intraoperative Anuric Episodes Within a Goal-directed Haemodynamic Algorithm in Patients Undergoing Laparotomy Due to Epithelial Ovarian Cancer|Withdrawn||N/A|0|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 02:25:42.892535|2017-10-11 02:25:42.892535
NCT01703429|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-07-26|||June 2012||2012-06-01|July 2017|2017-07-01|June 2040|Anticipated|2040-06-01|June 2040|Anticipated|2040-06-01||Observational|CAM Care in MS||Complementary and Alternative Care in Multiple Sclerosis|Complementary and Alternative Medicine (CAM) in Multiple Sclerosis. A Prospective Observational Study of a CAM-using Cohort|Recruiting||N/A|1000|Anticipated|Bastyr University|||1||f||||f||||||||||2017-10-11 02:25:42.979362|2017-10-11 02:25:42.979362
NCT01703416|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-04-24|||October 2012||2012-10-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|RELIEF||Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) Patients|CorRELation Between PatIent PErception of the Ability to Perform Morning Activities and Findings on Clinical Examination in COPD Patients Receiving Inhaled Combined Therapy (Corticosteroid/Long Acting ß2-agonist) - RELIEF Study|Completed||N/A|500|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:25:43.084333|2017-10-11 02:25:43.084333
NCT01703403|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-09|||May 2012||2012-05-01|October 2012|2012-10-01||||||||Observational|||Physical Therapy Management in Degenerative Lumbar Diseases and Osteoporosis|Physical Therapy Management in Degenerative Lumbar Diseases and Osteoporosis|Unknown status|Recruiting|N/A|120|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:25:43.180665|2017-10-11 02:25:43.180665
NCT01703390|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2015-03-06|||August 2012||2012-08-01|March 2015|2015-03-01||||August 2016|Anticipated|2016-08-01||Interventional|||Biomarker Directed Treatment in Metastatic Colorectal Cancer||Unknown status|Recruiting|Phase 2|30|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||2|||f||||f||||||||||2017-10-11 02:25:43.262979|2017-10-11 02:25:43.262979
NCT01703377|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2015-07-07|||April 2012||2012-04-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Effect of Constraining Joint Motions on Postural Control|Effect of Constraining Joint Motions on Postural Control|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:25:43.412447|2017-10-11 02:25:43.412447
NCT01703364|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-05-25|||June 2012||2012-06-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|||Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL|Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated Chronic Lymphocytic Leukemia (CLL) - a Dose-finding Study With Escalating Starting Dose of Lenalidomide and Concomitant Evaluation of Safety and Efficacy|Completed||Phase 1/Phase 2|12|Actual|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||||2017-10-11 02:25:43.484496|2017-10-11 02:25:43.484496
NCT01703351|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-01-01|||October 2012||2012-10-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy||Recruiting||Phase 2|96|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:25:43.58037|2017-10-11 02:25:43.58037
NCT01703338|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-09|||August 2012||2012-08-01|February 2012|2012-02-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Clinical and Biomechanics Research in Core Muscles After Lumbar Fusion Surgery|Clinical and Biomechanics Research in Core Muscles After Lumbar Fusion Surgery|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:25:43.679148|2017-10-11 02:25:43.679148
NCT01703325|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-10-07|||November 2010||2010-11-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails|Comparison of Efficacy and Safety of Psoriatic Nails Treatment Between by Intralesional 0.1%Triamcinolone Injection and Topical 0.05%Clobetasol Propionate Ointment|Completed||Phase 4|16|Actual|Mahidol University||3|||f||||t||||||||||2017-10-11 02:25:43.837628|2017-10-11 02:25:43.837628
NCT01703312|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-04-19|||November 2012||2012-11-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma|A Randomized, Double-blind, Placebo- and Comparator-controlled Study Evaluating the Effect of Multiple Doses of QGE031 Compared to Omalizumab in Asthma Induced by Allergen Bronchial Provocation|Completed||Phase 1/Phase 2|37|Actual|Novartis||3|||f||||f||||||||||2017-10-11 02:25:43.942478|2017-10-11 02:25:43.942478
NCT01703299|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2015-05-12|||October 2012||2012-10-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Observational|ERIC||Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments|Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments|Completed||N/A|35|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"     faeces, bacterial DNA   "|||2017-10-11 02:25:44.096158|2017-10-11 02:25:44.096158
NCT01703286|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-01-12|2015-01-12||October 2012||2012-10-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||TS (treated set) - included all patients who were dispensed trial medication and were documented to have taken at least 1 dose of trial drug.|Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)|Randomized, Three Period Cross Over, Double Blind, Double Dummy Study in Type 2 Diabetic Patients to Assess the Endothelial Effects of Linagliptin, Glimepiride and Placebo Therapy for 28 Days ('ENDOTHELINA')|Completed||Phase 1|42|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:25:44.227777|2017-10-11 02:25:44.227777
NCT01703273|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-09-14|||July 2012||2012-07-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|STEREO||Low-level Intervention for Adolescents With Extreme Obesity|Structured Low-level Intervention vs. Treatment as Usual Evaluated in a Randomized Controlled Trial for Adolescents With Extreme Obesity, Subproject 2|Completed||N/A|119|Actual|University of Ulm||2|||f||||t||||||||||2017-10-11 02:25:44.813361|2017-10-11 02:25:44.813361
NCT01703260|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-12-02|2015-09-21||June 2013||2013-06-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||The randomized set included all participants who were randomized.|Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis|A Randomized, Double-Blind, Controlled, Multi-Center Phase 2 Study to Evaluate the Effect of Roflumilast Plus Pioglitazone on Liver Enzymes and Liver Fat Content in Subjects With Nonalcoholic SteatoHepatitis|Terminated||Phase 2|20|Actual|AstraZeneca||3||Company decision; No safety or efficacy concerns (see detailed description)|f||||f||||||||||2017-10-11 02:25:44.965714|2017-10-11 02:25:44.965714
NCT01703247|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-09|||January 2008||2008-01-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|||Ganglionated Plexi Ablation Combined With Pulmonary Vein Isolation|Ganglionated Plexi Ablation vs Linear Ablation in Patients Undergoing Pulmonary Vein Isolation for Persistent/Longstanding Persistent Atrial Fibrillation: A Randomized Comparison|Completed||Phase 2|264|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-11 02:25:45.96501|2017-10-11 02:25:45.96501
NCT01703234|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2012-10-06|||January 2008||2008-01-01|October 2012|2012-10-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients||Completed||Phase 4|78|Actual|Gulhane School of Medicine||1|||f||||||||||||||2017-10-11 02:25:46.053544|2017-10-11 02:25:46.053544
NCT01703221|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-06-01|2015-09-29||October 24, 2012|Actual|2012-10-24|June 2017|2017-06-01|April 25, 2014|Actual|2014-04-25|April 25, 2014|Actual|2014-04-25||Interventional|||Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)|A Phase III, Multicenter, Randomized, Placebo- and Sitagliptin-controlled, Parallel-group, Double-blinded Study and Subsequent Open-label, Extension Study to Assess the Safety and Efficacy of MK-3102 in Japanese Patients With Type 2 Diabetes Mellitis Who Have Inadequate Glycemic Control on Diet/Exercise Therapy|Completed||Phase 3|414|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 02:25:46.153432|2017-10-11 02:25:46.153432
NCT01703208|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-04-05|||October 5, 2012|Actual|2012-10-05|April 2017|2017-04-01|March 22, 2017|Actual|2017-03-22|March 22, 2017|Actual|2017-03-22||Interventional|||A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 3|4202|Actual|Merck Sharp & Dohme Corp.||2||"The study was terminated for business reasons and not due to any safety or efficacy concerns   related to omarigliptin"|f||||t||||||||||2017-10-11 02:25:46.97586|2017-10-11 02:25:46.97586
NCT01703195|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-11-16|||November 2012||2012-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Interventional|||Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina|Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina|Active, not recruiting||N/A|12|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:25:47.102325|2017-10-11 02:25:47.102325
NCT01703182|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2015-09-21|||April 2011||2011-04-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Observational|TCOM||Transcutaneous Oximetry, Transcutaneous Carbon Dioxide and Supplemental Oxygen Therapy in Lower Limb Amputations|Transcutaneous Oximetry, Transcutaneous Carbon Dioxide and Supplemental Oxygen Therapy in Lower Limb Amputations - An Observational Study|Terminated||N/A|41|Actual|McMaster University|||1|Stopped due to feasibility|f||||f||||||||||2017-10-11 02:25:47.22312|2017-10-11 02:25:47.22312
NCT01703156|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-04-10|||May 2009||2009-05-01|April 2017|2017-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|LOW ACT||Low Risk Acute Coronary Syndrome|Stress Testing Versus Non-Stress Testing Based Strategy in Patients Hospitalized With Low-Risk Acute Coronary Syndromes: A Randomized, Single-Center Pilot Study|Completed||N/A|70|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-11 02:25:47.404818|2017-10-11 02:25:47.404818
NCT01703143|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2015-01-23|||May 2011||2011-05-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy|A Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy|Completed||Phase 1|14|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:25:47.498292|2017-10-11 02:25:47.498292
NCT01703130|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2014-05-29|||October 2012||2012-10-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|MEAV 95||Determining the Minimal Effective Volume (MEAV95) for Interscalene Brachial Plexus Block for Surgical Anesthesia|Determining the Minimal Effective Volume (MEAV95) for Interscalene Brachial Plexus Block for Surgical Anesthesia|Unknown status|Recruiting|Phase 4|60|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 02:25:47.604963|2017-10-11 02:25:47.604963
NCT01703117|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-09-21|||November 2013|Actual|2013-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Riluzole in Mild Alzheimer's Disease|Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Alzheimer's Disease|Recruiting||Phase 2|48|Anticipated|Rockefeller University||2|||f||||t||||||||||2017-10-11 02:25:47.736909|2017-10-11 02:25:47.736909
NCT01703104|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-05|||January 2012||2012-01-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia|The Effect of Jobelyn ( Extract of Sorghum Bicolor) on the Haematological Parameters of Patients With Sickle Cell Anaemia Disease.|Completed||Phase 1/Phase 2|150|Actual|Lagos State University||2|||f||||t||||||||||2017-10-11 02:25:47.851693|2017-10-11 02:25:47.851693
NCT01703091|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2016-12-21|2015-12-14||December 2012||2012-12-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|December 2014|Actual|2014-12-01||Interventional||All randomized participants who had received at least one dose of study drug.|A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer|A Randomized, Double-Blind, Phase 2 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy|Completed||Phase 2|197|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 02:25:47.992108|2017-10-11 02:25:47.992108
NCT01703078|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2013-04-03|||November 2012||2012-11-01|February 2013|2013-02-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis|A Phase 1 Exploratory Trial Evaluating Safety and Tolerability of Topical Administration of Different Concentrations of an Ingenol Derivative Compared to Ingenol Mebutate Gel 0.05% Applied on Two Consecutive Days to Four Separate 25cm2 Treatment Areas on the Forearms of Subjects With Actinic Keratosis (Field Therapy)|Completed||Phase 1|41|Actual|LEO Pharma||4|||f||||f||||||||||2017-10-11 02:25:48.808721|2017-10-11 02:25:48.808721
NCT01703065|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-06-14|||June 18, 2013|Actual|2013-06-18|June 2017|2017-06-01|April 1, 2019|Anticipated|2019-04-01|February 18, 2019|Anticipated|2019-02-18||Interventional|||Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer|A Pilot Study of the Effects of Cabozantinib (XL184) on Bone Turnover and the Microenvironment in Men With Non-Metastatic and Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||N/A|9|Actual|University of Washington||1|||f||||t||||||||||2017-10-11 02:25:48.890929|2017-10-11 02:25:48.890929
NCT01703052|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-10-08|||July 2011||2011-07-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)|A Placebo-controlled Double-blind Single and Repeated Ascending Dose Study to Investigate the Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers|Completed||Phase 1|74|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||t||||||||||2017-10-11 02:25:50.815856|2017-10-11 02:25:50.815856
NCT01703039|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-07-11|||January 2013||2013-01-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|May 2019|Anticipated|2019-05-01||Interventional|RAPID||Riluzole Augmentation Pilot in Depression (RAPID) Trial|Riluzole Augmentation Pilot in Depression (RAPID) Trial|Recruiting||Phase 2|120|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 02:25:50.904347|2017-10-11 02:25:50.904347
NCT01703026|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-09|||August 2009||2009-08-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|||||Observational|||Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses|Contrast Enhanced EUS Using Definity in the Evaluation of Pancreatic Cancer and Pancreatic Masses|Completed||N/A|33|Actual|Changi General Hospital|||1||f||||f||||||||||2017-10-11 02:25:51.030349|2017-10-11 02:25:51.030349
NCT01703013|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2012-10-09|||January 2013||2013-01-01|October 2012|2012-10-01||||||||Observational|||The Significance of Defensin Alpha 4 in the Pathophysiology of the Adrenal Insufficiency in Inflammatory Lung Diseases|The Significance of Defensin Alpha 4 in the Pathophysiology of the Adrenal Insufficiency in Inflammatory Lung Diseases|Unknown status|Not yet recruiting|N/A|75|Anticipated|Cantonal Hospital of St. Gallen|||1||f||||f||||||Samples With DNA|"     Blood leukocytes, serum   "|||2017-10-11 02:25:51.091427|2017-10-11 02:25:51.091427
NCT01703000|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2014-03-20|2013-12-16||November 2012||2012-11-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||"Single arm with investigational NG PROMUS Everolimus Eluting Coronary Stent System
N=100 patients, N=119 Lesions, N=127 Stents"|NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions|NG PROMUS: A Prospective, Multicenter Trial to Assess the NG PROMUS Everolimus-Eluting Platinum Chromium Coronary Stent System (NG PROMUS Stent System) for the Treatment of Atherosclerotic Lesion(s)|Completed||N/A|100|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 02:25:51.181003|2017-10-11 02:25:51.181003
NCT01702987|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-03-06|2016-01-04||October 2012||2012-10-01|February 2017|2017-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS|Evaluation of Ubiquinol on the Association of Statins and Mitochondrial Oxidative Capacity Using 31P Magnetic Resonance Imaging|Completed||N/A|22|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-10-11 02:25:52.251117|2017-10-11 02:25:52.251117
NCT01702974|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-02-04|||September 2012||2012-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|IREHIV||Immune Reconstitution in HIV Disease (IREHIV)|Immune Reconstitution in HIV Disease Using Antimicrobial Treatment With Vitamin D and Phenylbutyrate|Completed||Phase 2|279|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:25:52.528984|2017-10-11 02:25:52.528984
NCT01702961|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-05|2017-10-04|2015-08-27||June 2002||2002-06-01|October 2017|2017-10-01|August 2018|Anticipated|2018-08-01|August 2014|Actual|2014-08-01||Interventional|Rituxan+BEAM||Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease|A Current Practice Study of Rituxan in Patient Receiving BEAM Chemotherapy and Autologous Blood Stem Cell Transplantation for High Risk Lymphoma or Hodgkin's Disease|Active, not recruiting||N/A|75|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 02:25:52.651216|2017-10-11 02:25:52.651216
NCT01702948|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2017-10-04|||September 10, 2012||2012-09-10|October 3, 2017|2017-10-03|October 3, 2017||2017-10-03|||||Observational|||Studying Nicotine Addiction With Transcranial Magnetic Stimulation|Understanding the Neurocircuitry of Nicotine Addiction Using Repetitive Transcranial Magnetic Stimulation (rTMS)|Completed||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:25:52.947811|2017-10-11 02:25:52.947811
NCT01702935|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2017-10-05|||September 19, 2012||2012-09-19|September 21, 2017|2017-09-21|September 21, 2017||2017-09-21|||||Observational|||Ovarian Stem Cells From Women With Ovarian Insufficiency|Oogonial Stem Cell Isolation in Ovarian Insufficiency Patients|Completed||N/A|11|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:25:53.023934|2017-10-11 02:25:53.023934
NCT01702922|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-06|2017-10-05|||September 7, 2012||2012-09-07|February 24, 2017|2017-02-24||||||||Observational|||Relationship Stressors in Parents of Children With Cancer or Neurofibromatosis Type 1 (NF1)|Understanding the Perceived Influence of Childhood Cancer and NF1 on the Parents' Marital/Partner Relationship: A Descriptive Study|Recruiting||N/A|360|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:25:53.121543|2017-10-11 02:25:53.121543
NCT01702909|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-09-23|2017-08-14||September 2012||2012-09-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Interleukin-2 in Metastatic Kidney Cancer|Phase II Trial of Moderate Dose Bolus Interleukin-2 in Metastatic Kidney Cancer|Terminated||Phase 2|7|Actual|Western Regional Medical Center||1||PI Decision|f||||f||||||||||2017-10-11 02:25:53.244867|2017-10-11 02:25:53.244867
NCT01702883|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-03-08|||October 2012||2012-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Interventional|||The Medication Experience Study|Using an Internet Survey to Improve Patient Adherence in Chronic Disease|Active, not recruiting||N/A|186|Actual|Wake Forest University Health Sciences||4|||f||||f||||||||||2017-10-11 02:25:53.631696|2017-10-11 02:25:53.631696
NCT01702870|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2012-10-16|||November 2012||2012-11-01|October 2012|2012-10-01|November 2014|Anticipated|2014-11-01|||||Observational|||Diagnostic Accuracy of MR in Myositis|Comparison of Magnetic Resonance (MR) Imaging Against Clinical Criteria in the Diagnosis and Monitoring of Adult Idiopathic Myopathy|Unknown status|Not yet recruiting|N/A|70|Anticipated|University of Warwick|||2||f||||f||||||||||2017-10-11 02:25:53.766023|2017-10-11 02:25:53.766023
NCT01702857|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-05-22|||November 2012|Actual|2012-11-01|May 2017|2017-05-01|March 23, 2017|Actual|2017-03-23|January 20, 2017|Actual|2017-01-20||Interventional|DPIV-002||A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)|A Phase I, Randomized, Placebo-Controlled, Observer-blind, Two-dose (0-28 Day Schedule) Primary Vaccination Study of WRAIR Tetravalent Dengue Virus Purified Inactivated Vaccine (TDENV-PIV) in Healthy Adults in Puerto Rico|Completed||Phase 1|100|Actual|U.S. Army Medical Research and Materiel Command||5|||f||||t||||||||||2017-10-11 02:25:54.033197|2017-10-11 02:25:54.033197
NCT01702844|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-05-09|||October 2012||2012-10-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|||Single Arm on the Tolerability of Weekly Nab-paclitaxel|LCCC 1210 - Phase II, Multicenter, Single Arm Study of the Tolerability of Weekly Nab-paclitaxel as Second Line Treatment for Elderly Patients With Advanced Lung Cancer|Recruiting||Phase 2|42|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:25:54.174877|2017-10-11 02:25:54.174877
NCT01702831|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-09-20|||March 2013||2013-03-01|December 2016|2016-12-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|BuMelMCRN001||Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance|A Phase II Study of Busulfan & Melphalan as Conditioning Regimen for ASCT in Patients Who Received Bortezomib Based Induction for Newly Diagnosed Multiple Myeloma Followed by Lenalidomide Maintenance Until Progression.|Active, not recruiting||Phase 2|78|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 02:25:54.339274|2017-10-11 02:25:54.339274
NCT01702818|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-05-30|||February 2012||2012-02-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|MODEST||Stress Hormones, Mood and Women's Sexual Desire (MODEST)|Stress Hormones, Mood and Women's Sexual Desire (MODEST)|Completed||N/A|320|Anticipated|University of British Columbia|||2||f||||f||||||Samples Without DNA|"     saliva and fingernail and toenail samples   "|||2017-10-11 02:25:54.487159|2017-10-11 02:25:54.487159
NCT01702623|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2014-01-17|||September 2009||2009-09-01|January 2014|2014-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions|Completed||Phase 1|64|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:25:56.168061|2017-10-11 02:25:56.168061
NCT01702805|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-06-19|||December 2012|Actual|2012-12-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|TOP||Transfusion of Prematures Trial|Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?|Active, not recruiting||Phase 3|1824|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||Yes|NIH has had a long-standing policy to share and make available to the public the results and accomplishments of the activities that it funds. The NRN plans to share de-identified data after final publication in an NIH supported data repository such as the NICHD Data and Specimen Hub (https://dash.nichd.nih.gov)|2017-10-11 02:25:54.58645|2017-10-11 02:25:54.58645
NCT01702792|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-03-22|||January 2014||2014-01-01|March 2016|2016-03-01||||May 2015|Actual|2015-05-01||Interventional|||Derivation of Tumor Specific Hybridomas|Vaccination of Patients With Newly Diagnosed Glioblastoma Using Autologous Tumor Lysate and Montanide Emulsion for Derivation of Tumor Specific Hybridomas|Terminated||Phase 1|1|Actual|Dartmouth-Hitchcock Medical Center||1||Investigator is leaving dartmouth|f||||t||||||||||2017-10-11 02:25:54.752187|2017-10-11 02:25:54.752187
NCT01702779|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-11-28|||August 2011||2011-08-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|HiFloLUS||Nasal Humidified High Flow Oxygen During Weaning From Mechanical Ventilation : Ultrasonography Study||Completed||N/A|80|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:25:54.848146|2017-10-11 02:25:54.848146
NCT01702740|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-10-05|||March 2007||2007-03-01|October 2012|2012-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus|A Phase 1, Double-blind, Placebo-controlled, Multiple Intravenous, Ascending-Dose Study of CNTO 136 to Evaluate Safety and Pharmacokinetics in Subjects With Cutaneous Lupus Erythematosus and to Evaluate Safety and Pharmacokinetics in a Cohort of Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|49|Actual|Centocor Research & Development, Inc.||4|||f||||f||||||||||2017-10-11 02:25:55.135709|2017-10-11 02:25:55.135709
NCT01702727|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-11-21|||June 2012||2012-06-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|I-BiT||I-BiT - Evaluation of a Novel Binocular Treatment System (I-BiTTM) in Children With Amblyopia|Evaluation and Development of a Novel Binocular Treatment (I-BiTTM) System Using Video Clips and Interactive Games to Improve Vision in Children With Amblyopia ('Lazy Eye').|Completed||Phase 2|75|Actual|Nottingham University Hospitals NHS Trust||3|||f||||f||||||||||2017-10-11 02:25:55.263114|2017-10-11 02:25:55.263114
NCT01702714|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-11-03|||July 2014||2014-07-01|November 2016|2016-11-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease|A MULTICENTER, OPEN-LABEL PHASE IB STUDY OF RO5083945 IN COMBINATION WITH CISPLATIN AND GEMCITABINE OR CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH ADVANCED OR RECURRENT NON SMALL CELL LUNG CANCER OF SQUAMOUS HISTOLOGY WHO HAVE NOT RECEIVED PRIOR CHEMOTHERAPY FOR THE METASTATIC DISEASE.|Withdrawn||Phase 1|0|Actual|Hoffmann-La Roche||2||Project Team decision|f||||||||||||||2017-10-11 02:25:55.36401|2017-10-11 02:25:55.36401
NCT01702701|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-01-28|||January 2012||2012-01-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone|Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone|Active, not recruiting||Phase 3|100|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 02:25:55.461609|2017-10-11 02:25:55.461609
NCT01702688|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-07-11|||July 2012||2012-07-01|July 2017|2017-07-01||||||||Interventional|||Evaluation of Lysine-Specific Demethylase 1|Evaluation of Lysine-Specific Demethylase 1 As An Epigenetic Regulator of Salt Sensitive Hypertension|Withdrawn||N/A|0|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-11 02:25:55.559789|2017-10-11 02:25:55.559789
NCT01702675|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-10-27|||May 2015||2015-05-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|ACH15||Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug|Phase I, Monocentric, Double-blind, Randomized Study to Assess Tolerability, Safety and Pharmacokinetics of ACH15 After Single Dose and Multiple Doses in Healthy Male Volunteers|Terminated||Phase 1|22|Actual|Ache Laboratorios Farmaceuticos S.A.||11|||f||||t||||||||||2017-10-11 02:25:55.64445|2017-10-11 02:25:55.64445
NCT01702662|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-12-10|||August 2012||2012-08-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|Photopill||Photopill Treatment in Healthy Volunteers|The Assessment of the Photopill Capsule Treatment for Safety and Feasibility in Healthy Volunteers, a Phase 1 Trial|Completed||Phase 1|4|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-11 02:25:55.763846|2017-10-11 02:25:55.763846
NCT01702649|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-11-29|||August 2012||2012-08-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single- and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 in Healthy Adult Subjects|Completed||Phase 1|36|Actual|Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)||2|||f||||f||||||||||2017-10-11 02:25:55.85871|2017-10-11 02:25:55.85871
NCT01702636|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-06-19|||December 2012||2012-12-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|STOP-AUST||STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial|STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.|Recruiting||Phase 2|100|Anticipated|Neuroscience Trials Australia||2|||f||||t||||||||||2017-10-11 02:25:55.97622|2017-10-11 02:25:55.97622
NCT01702610|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-09-26|||December 2008||2008-12-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme||Completed||N/A|50|Actual|McGill University Health Center||1|||f||||f||||||||||2017-10-11 02:25:56.271046|2017-10-11 02:25:56.271046
NCT01702597|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-04|||October 2012||2012-10-01|October 2012|2012-10-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|WBV and ALAS||WBV and Acute Lateral Ankle Sprain|The Effect of Whole Body Vibration and Acute Unilateral Unstable Lateral Ankle Sprain - A Biphasic Randomized Controlled Trial -|Unknown status|Active, not recruiting|N/A|60|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 02:25:56.363486|2017-10-11 02:25:56.363486
NCT01702584|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-10-04|||September 2012||2012-09-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Observational|||Efficacy and Safety of StENt-assisted Treatment for CErebral Aneurysms|Efficacy and Safety of StENt-assisted Treatment for CErebral Aneurysms|Unknown status|Recruiting|N/A|1000|Anticipated|Kobe City General Hospital|||1||f||||f||||||||||2017-10-11 02:25:56.449538|2017-10-11 02:25:56.449538
NCT01702558|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-10-04|||December 31, 2014|Actual|2014-12-31|October 2017|2017-10-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)|Phase I Study of the Combination of Trastuzumab Emtansine (T-DM1) and Capecitabine in HER2-Positive Metastatic Breast Cancer and HER2-Positive Locally Advanced/Metastatic Gastric Cancer Patients, Followed by a Randomized, Open-Label Phase II Study of Trastuzumab Emtansine and Capecitabine Versus Trastuzumab Emtansine Alone in HER2-Positive Metastatic Breast Cancer|Completed||Phase 2|181|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 02:25:57.610434|2017-10-11 02:25:57.610434
NCT01702545|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-03-07|||August 2012||2012-08-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Determination of Drugs and Their Metabolites in Hospitalized Patients|Determination of Drugs and Their Metabolites in Hospitalized Patients|Recruiting||N/A|1000|Anticipated|Klinikum Nürnberg|||1||f||||f|||||||"     Blood, Plasma   "|||2017-10-11 02:25:57.916511|2017-10-11 02:25:57.916511
NCT01702532|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2013-12-12|2013-12-12||September 2012||2012-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Nicotine Mouth Film for Craving Relief.|A Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Film and Nicotine Lozenge|Completed||Phase 3|320|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:25:58.027052|2017-10-11 02:25:58.027052
NCT01702519|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2015-03-19|2013-09-05||March 2012||2012-03-01|February 2015|2015-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers|A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers|Completed||Phase 1|40|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:25:58.413497|2017-10-11 02:25:58.413497
NCT01702506|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2013-12-16|||October 2012||2012-10-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)|Phase 1 Three Period Crossover Study To Evaluate The Effect Of Food And Antacids On The Pharmacokinetics, Safety & Tolerability Of PF-299,804 In Healthy Volunteers Who Have Received PF-299,804|Completed||Phase 1|24|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:25:58.841485|2017-10-11 02:25:58.841485
NCT01702493|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-06-09|||October 30, 2012|Actual|2012-10-30|June 2017|2017-06-01|December 5, 2012|Actual|2012-12-05|December 5, 2012|Actual|2012-12-05||Interventional|||A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers|A Phase 1, Open-Label, Randomized, Controlled, Four-Period Crossover Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers|Completed||Phase 1|16|Actual|GlaxoSmithKline||7|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:25:58.981272|2017-10-11 02:25:58.981272
NCT01702480|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-05-05|||November 5, 2012|Actual|2012-11-05|May 2017|2017-05-01|July 3, 2015|Actual|2015-07-03|July 3, 2015|Actual|2015-07-03||Interventional|||Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects|Effects of Medium-Chain Triglycerides on Cognitive Function in Older Subjects With Age-Related Cognitive Decline|Completed||Phase 1|116|Actual|GlaxoSmithKline||7|||f||||f||||||||||2017-10-11 02:25:59.118479|2017-10-11 02:25:59.118479
NCT01702467|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-07-24|||October 19, 2012|Actual|2012-10-19|July 2017|2017-07-01|May 15, 2013|Actual|2013-05-15|May 15, 2013|Actual|2013-05-15||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers|A Single-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers|Completed||Phase 1|27|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:25:59.231313|2017-10-11 02:25:59.231313
NCT01702454|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-07-21|2014-06-05||October 6, 2012||2012-10-06|July 2017|2017-07-01|June 5, 2013|Actual|2013-06-05|May 6, 2013|Actual|2013-05-06||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345|Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals' Quadrivalent Seasonal Influenza Candidate Vaccine GSK2321138A, Administered to Children Who Previously Participated in Study 115345|Completed||Phase 3|470|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:25:59.519276|2017-10-11 02:25:59.519276
NCT00001933|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Nefiracetam in the Treatment of Alzheimer's Disease|Nefiracetam Therapy of Alzheimer's Type Dementia|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:51.249475|2017-10-11 04:19:51.249475
NCT01702441|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-03-09||2015-03-09|September 2012||2012-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema|Phase 1b/2a Open Label, Multiple-Ascending Dose Cohort Study to Assess the Safety, Tolerability, Pilot Efficacy, Pharmacokinetics and Pharmacodynamic Effects of 28 Day Repeat Subcutaneous Doses of AKB-9778 in Subjects With Diabetic Macular Edema|Completed||Phase 1/Phase 2|24|Actual|Aerpio Therapeutics||1|||f||||t||||||||||2017-10-11 02:26:01.946862|2017-10-11 02:26:01.946862
NCT01702415|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2015-10-19|||October 2013||2013-10-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|IZAC||Zoledronic Acid in Cystic Fibrosis|Randomised, Double Blind, Placebo Controlled Trial to Ascertain the Efficacy and Safety of Intravenous Zoledronic Acid in Adult Patients With Cystic Fibrosis.|Withdrawn||Phase 4|0|Actual|Papworth Hospital NHS Foundation Trust||2||Lack of funding|f||||t||||||||||2017-10-11 02:26:02.498705|2017-10-11 02:26:02.498705
NCT01702402|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-09-12|||June 2007||2007-06-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|September 2013|Actual|2013-09-01||Interventional|||Operations Research to Address Unmet Need for Contraception in the Postpartum Period in Sylhet District, Bangladesh|Operations Research to Address Unmet Need for Contraception in the Postpartum Period in Sylhet District, Bangladesh (Healthy Fertility Study)|Completed||N/A|6916|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 02:26:02.587918|2017-10-11 02:26:02.587918
NCT01702389|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2014-10-28|||October 2012||2012-10-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Opioid-induced Hyperalgesia After Remifentanil Infusion|Can Opioid-induced Hyperalgesia be Prevented by Gradual Dose Reduction vs. Abrupt Withdrawal of Remifentanil?|Completed||Phase 4|16|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 02:26:02.670716|2017-10-11 02:26:02.670716
NCT01702376|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-06-09|||October 3, 2012|Actual|2012-10-03|June 2017|2017-06-01|January 14, 2013|Actual|2013-01-14|January 14, 2013|Actual|2013-01-14||Interventional|||This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.|A Randomized, Placebo-Controlled, Double-Blind, Four-way Crossover Study to Assess the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers|Completed||Phase 1|52|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:26:02.776797|2017-10-11 02:26:02.776797
NCT01702363|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-11-18|2014-07-17||August 2012||2012-08-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|AC4115361||Long-term Safety Study for GSK573719 in Japanese|A 52-week, Multi-centre, Open-label Study to Evaluate the Safety and Tolerability of GSK573719 125 mcg Once-daily Via Novel Dry Powder Inhaler (nDPI) in Japanese Subjects With Chronic Obstructive Pulmonary Disease.|Completed||Phase 3|131|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:26:02.969581|2017-10-11 02:26:02.969581
NCT01702350|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-06-27|||October 21, 2011|Actual|2011-10-21|June 2017|2017-06-01|December 8, 2011|Actual|2011-12-08|December 8, 2011|Actual|2011-12-08||Interventional|Relative Bio||A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study|A Study to Evaluate the Relative Bioavailability of Five Different Oral Formulations of GSK2251052 and the Multiple-dose, Safety, Tolerability, and Pharmacokinetics of GSK2251052 With and Without Food in Male and Female, Young and Elderly Healthy Volunteers|Terminated||Phase 1|24|Actual|GlaxoSmithKline||5||"Study was terminated in March 2012 due to lack of eficacy in a seperate Phase II study in   patients."|f||||f||||||||||2017-10-11 02:26:04.294743|2017-10-11 02:26:04.294743
NCT01702337|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-10-04|||February 2010||2010-02-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine|Additional Health and Economic Impact of the Bivalent Versus the Quadrivalent HPV Vaccine in Taiwan: Results of a Prevalence-based Model|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-10-11 02:26:04.427253|2017-10-11 02:26:04.427253
NCT01702324|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-04|||October 2012||2012-10-01|October 2012|2012-10-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study|Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Fortuderm Ltd.||1|||f||||t||||||||||2017-10-11 02:26:04.547822|2017-10-11 02:26:04.547822
NCT01702311|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-07-02|2014-07-02||May 2012||2012-05-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|POC|16 subjects were not included in the data analysis for bedtime supplementation arm 13 subjects were not included in the data analysis for no bedtime supplementation arm|Point-of-Care Glucose Testing and Insulin Supplementation|Benefits of Point-of-Care Glucose Testing and Insulin Supplementation at Bedtime in Insulin Treated Patients With Type 2 Diabetes|Completed||N/A|206|Actual|Emory University||2|||f||||t||||||||||2017-10-11 02:26:04.683894|2017-10-11 02:26:04.683894
NCT01702298|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-04-06|2014-05-01||December 7, 2012|Actual|2012-12-07|April 2017|2017-04-01|May 29, 2013|Actual|2013-05-29|May 29, 2013|Actual|2013-05-29||Interventional||All participants enrolled|A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)|An Open-label Study to Assess the Safety and Tolerability of MK-0431D for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy|Completed||Phase 3|42|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 02:26:05.107192|2017-10-11 02:26:05.107192
NCT01702272|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-09-11|||January 2013||2013-01-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS|Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - Creative Testing Solutions|Completed||N/A|150000|Anticipated|Gen-Probe, Incorporated|||1||f||||f||||||||||2017-10-11 02:26:05.573765|2017-10-11 02:26:05.573765
NCT01702259|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2015-11-08|2015-07-09||October 2009||2009-10-01|November 2015|2015-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.|A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia Scanner Device (GLS) Green Diode on Reducing the Appearance of Cellulite Clinical Study Protocol.|Completed||N/A|68|Actual|Erchonia Corporation||2|||f||||f||||||||||2017-10-11 02:26:05.701606|2017-10-11 02:26:05.701606
NCT01702246|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-10-26|2016-01-15||February 2012||2012-02-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease|Phase 2 Study of Simvastatin Treatment Effects on Vaso-occlusive Pain in Sickle Cell Disease|Completed||Phase 1/Phase 2|24|Actual|Children's Hospital & Research Center Oakland||1|||f||||t||||||||No|publication|2017-10-11 02:26:06.402309|2017-10-11 02:26:06.402309
NCT01702233|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-01-27|2015-06-22||April 2013||2013-04-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|TRARO||TRARO (Traumeel® S in Rotator Cuff Syndrome)-Study|Treatment of Rotator Cuff Syndrome and Bursitis: A Double Blind, Controlled Trial to Assess the Efficacy and Safety of Traumeel® S Injection Versus Corticosteroid Injections and Versus Placebo|Completed||Phase 3|175|Actual|Biologische Heilmittel Heel GmbH||3|||f||||f||||||||Undecided||2017-10-11 02:26:06.692066|2017-10-11 02:26:06.692066
NCT01702220|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2016-01-11|||October 2012||2012-10-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||Calmer Life: Testing the Effectiveness of a Treatment for Anxiety|Calmer Life: A Randomized Controlled Trial of a Participant-Centered Treatment for Anxiety in Low-Income, Older Adults|Completed||N/A|60|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 02:26:07.806564|2017-10-11 02:26:07.806564
NCT01702207|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-01-05|||January 2013||2013-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ESTTEROD||Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk|A One-Year, Prospective, Randomized, Controlled Study Evaluating The Efficacy Of Switching From The Twice Daily Tacrolimus Formulation To The Extended Release, Once Daily Formulation To Reduce The Framingham Cardiovascular Risk Scores.|Active, not recruiting||Phase 4|75|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 02:26:07.908605|2017-10-11 02:26:07.908605
NCT01702194|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-09-03|||November 2012||2012-11-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||TD-1211 IV/Oral Mass Balance Study|A Single-Dose, Fixed-Sequence, Two-Period, Two−Treatment Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of TD−1211 Following an Intravenous Infusion and an Oral Dose of [14C]TD−1211 in Healthy Male Subjects|Completed||Phase 1|10|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-10-11 02:26:08.020896|2017-10-11 02:26:08.020896
NCT01702181|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-01-16|||August 2012||2012-08-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis|A Multiple-Dose (0.3%, 1%, and 3% [w/w]), Randomized, Blinded, Vehicle- and Active Comparator-Controlled, Sequential Dose Cohorts, Multi-Center Trial to Assess the Safety, Pharmacokinetics, and Proof-of-Concept Efficacy of Topical OPA 15406 Ointment, Applied Twice Daily for 28 Days, in Adult Subjects With Atopic Dermatitis|Completed||Phase 1|92|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||f||||||||||2017-10-11 02:26:08.197295|2017-10-11 02:26:08.197295
NCT01702168|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2015-04-07|||October 2012||2012-10-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|August 2016|Anticipated|2016-08-01||Observational|||Implementation of CPT for PTSD in Diverse Communities|Implementation of Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD) in Diverse Communities|Unknown status|Active, not recruiting|N/A|32|Actual|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-11 02:26:08.403416|2017-10-11 02:26:08.403416
NCT01702155|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-03-02|||September 2012||2012-09-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Phase I/II Study of DFP-10917 in Patients With Acute Leukemia|A Phase I/II Study of DFP 10917 Given by Continuous Infusion in Patients With Relapsed or Refractory Acute Leukemia|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|Delta-Fly Pharma, Inc.||1|||f||||||||||||||2017-10-11 02:26:08.531476|2017-10-11 02:26:08.531476
NCT01702142|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-06-10|||March 2012||2012-03-01|May 2013|2013-05-01|May 2016|Anticipated|2016-05-01|February 2015|Actual|2015-02-01||Observational|||To Test a Payer/Treatment Agency Intervention to Increase Use of Buprenorphine|To Test a Payer/Treatment Agency Intervention to Increase Use of Buprenorphine|Unknown status|Active, not recruiting|N/A|15|Anticipated|University of Wisconsin, Madison|||2||f||||t||||||None Retained|"     Biospecimens are not part of this study.   "|||2017-10-11 02:26:08.692462|2017-10-11 02:26:08.692462
NCT01702129|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2014-09-08|||January 2007||2007-01-01|September 2014|2014-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Anti-EGFR Immunoliposomes in Solid Tumors|A Phase I Study of Doxorubicin-loaded Anti-EGFR Immunoliposomes in Patients With Advanced Solid Tumors|Completed||Phase 1|26|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 02:26:08.827284|2017-10-11 02:26:08.827284
NCT01702116|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-04-23|||July 2011||2011-07-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma|Multicenter Randomized Controlled Trial, Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma|Unknown status|Recruiting|N/A|34|Anticipated|Stony Brook University||2|||f||||t||||||||||2017-10-11 02:26:08.952278|2017-10-11 02:26:08.952278
NCT01702103|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-10-04|||October 2012||2012-10-01|October 2012|2012-10-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|PHT-01-12||Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays|MULTICENTER, RANDOMIZED, DOUBLE BLIND, CONTROLLED, CLINICAL STUDY TO DEMONSTRATE THE THERAPEUTIC CLINICAL EQUIVALENCE OF TWO MOMETASONE NASAL SPRAYS IN THE RELIEF OF THE SIGNS AND SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS.|Unknown status|Not yet recruiting|Phase 3|360|Anticipated|PH&T S.p.A.||2|||f||||f||||||||||2017-10-11 02:26:09.17243|2017-10-11 02:26:09.17243
NCT01702090|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-05-20|||February 2012||2012-02-01|May 2016|2016-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients|Early Access to TMC114 in Combination With Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or TMC114-naive, Early Treatment Experienced in HIV-1 Infected Patients|Completed||Phase 4|10|Actual|Janssen-Cilag Ltd.||1|||f||||t||||||||||2017-10-11 02:26:09.312349|2017-10-11 02:26:09.312349
NCT01702077|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-09-14|||October 2012||2012-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Neurofeedback for Tourette Syndrome|Neurofeedback of Activity in the Supplementary Motor Area for Tourette Syndrome|Recruiting||N/A|30|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 02:26:09.4196|2017-10-11 02:26:09.4196
NCT01702064|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-08-18|||February 21, 2013|Actual|2013-02-21|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|October 17, 2016|Actual|2016-10-17||Interventional|||Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients|A Phase I Study of Ruxolitinib in Combination With Nilotinib in CML Patients With Evidence of Molecular Disease|Active, not recruiting||Phase 1|11|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 02:26:09.524933|2017-10-11 02:26:09.524933
NCT01702051|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-06-14|||February 2012||2012-02-01|January 2016|2016-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|AutoTx||Extending Indication for Islet Autotransplantation in Pancreatic Surgery|Autologous Pancreatic Islet Cell Transplantation for Improved Glycaemic Control After Pancreatectomy: Observational Study|Recruiting||N/A|150|Anticipated|Ospedale San Raffaele|||4||f||||t||||||Samples With DNA|"     Serum, PBMC   "|||2017-10-11 02:26:09.613589|2017-10-11 02:26:09.613589
NCT01702038|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-04|||September 2009||2009-09-01|October 2012|2012-10-01||||||||Interventional|||Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE|Rituximab in SLE: Understanding of Long-term Responses and the Impact of B Cell Depletion on T Cells|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-11 02:26:09.696946|2017-10-11 02:26:09.696946
NCT01702025|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-10-23|2014-08-21||June 2012||2012-06-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Subjects could choose to participate in multiple arms of the trial. Trial arms were separated by a 7 day wash out period following the hypoxia visit of the previous arm.|Rapid Acclimatization to Hypoxia at Altitude|Rapid Acclimatization to Hypoxia at Altitude|Completed||Phase 1/Phase 2|41|Actual|Colorado State University||4|||f||||f||||||||||2017-10-11 02:26:09.794562|2017-10-11 02:26:09.794562
NCT01702012|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-03-07|||January 2013|Actual|2013-01-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|AMDIT||Almased Multi-Center Diabetes Intervention Trial|Evaluation of Almased on Glycemic Control and Metabolic Effects in Patients With Type 2 Diabetes|Completed||N/A|240|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-11 02:26:10.433053|2017-10-11 02:26:10.433053
NCT01701999|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-04-19|2016-12-15|2016-09-26|February 2013||2013-02-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid|Phase 2b, Two-part, Open-label, Uncontrolled Study to Evaluate Safety, Tolerability, and Immunogenicity of a Single 40-µg Dose of Recombinant Botulinum Vaccine A/B (rBV A/B) for the Production of BabyBIG® in Volunteers Previously Immunized With Pentavalent Botulinum Toxoid for Occupational Protection|Completed||Phase 2|45|Actual|California Department of Public Health||1|||f||||t||||||||||2017-10-11 02:26:10.540111|2017-10-11 02:26:10.540111
NCT01701986|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-03-16|||October 25, 2012|Actual|2012-10-25|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas|Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas|Recruiting||Phase 1/Phase 2|80|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:26:11.111288|2017-10-11 02:26:11.111288
NCT01701973|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-06-27|||January 2013||2013-01-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Effect of DPP4 Inhibition on Growth Hormone Secretion|The Effect of Dipeptidyl Peptidase IV Inhibition on Growth Hormone-Mediated Vasodilation|Completed||Phase 4|43|Actual|Vanderbilt University Medical Center||3|||f||||t||||||||||2017-10-11 02:26:11.270123|2017-10-11 02:26:11.270123
NCT01701960|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2015-03-18|||November 2012||2012-11-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|February 2014|Anticipated|2014-02-01||Observational|||Effect of Local Anesthetic on Hemodynamic Measures During Nasal Surgery|Effect of Local Anesthetic on Hemodynamic Measures During Nasal Surgery|Withdrawn||N/A|0|Actual|Loma Linda University|||2|no time|f||||t||||||||||2017-10-11 02:26:11.391606|2017-10-11 02:26:11.391606
NCT01701947|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-08-22||||||August 2013|2013-08-01||||||||Expanded Access|EAP||HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency|HEMOLEVEN® Expanded Access Program for Prevention of Surgical and Postpartum Hemorrhage in Patients With Severe Inherited Factor XI Deficiency|No longer available||N/A|||Laboratoire français de Fractionnement et de Biotechnologies|||||||||||||||||||2017-10-11 02:26:11.458595|2017-10-11 02:26:11.458595
NCT01701934|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-11-10|||February 2013||2013-02-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|October 2014|Actual|2014-10-01||Interventional|RAMBO||Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease|Impact of Roflumilast on Visceral Adiposity and MetaBolic Profile in Chronic Obstructive Lung Disease: a Randomized and Controlled Trial: the RAMBO Trial.|Terminated||Phase 2|14|Actual|Laval University||2||"The recruitment of the study was prematurely stopped in July 2014 for the following reason; no   more study medication."|f||||t||||||||||2017-10-11 02:26:11.528763|2017-10-11 02:26:11.528763
NCT01701921|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-09-08|||July 2011||2011-07-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||The Effects of Pregabalin on Postoperative Pain After Cardiac Surgery|The Effects of Pregabalin on Acute and Chronic Postoperative Pain After Cardiac Surgery|Completed||Phase 2/Phase 3|94|Actual|Larissa University Hospital||3|||f||||f||||||||Undecided||2017-10-11 02:26:11.627984|2017-10-11 02:26:11.627984
NCT01701908|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-30|2012-10-05|||January 2013||2013-01-01|October 2012|2012-10-01||||December 2013|Anticipated|2013-12-01||Observational|||Postoperative Pulmonary Complications in Abdominal Surgery|Postoperative Pulmonary Complications in Major (Abdominal) Surgery: a Multicenter Study|Unknown status|Not yet recruiting|N/A|1500|Anticipated|University of Udine|||1||f||||||||||||||2017-10-11 02:26:11.719686|2017-10-11 02:26:11.719686
NCT01701895|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-11-30|||October 2012||2012-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera|CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF|Completed||N/A|33|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 02:26:13.85961|2017-10-11 02:26:13.85961
NCT01701882|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-07-24|||September 2012||2012-09-01|July 2017|2017-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine|A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine|Completed||Phase 3|40|Actual|St Stephens Aids Trust||1|||f||||||||||||||2017-10-11 02:26:13.941003|2017-10-11 02:26:13.941003
NCT01701856|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-01-21|||September 2012||2012-09-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis|Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis: A Swiss Multicenter Study Prospective, Controlled, Single-arm, Open-label, Multi-centre, Phase IV Study|Terminated||Phase 4|5|Actual|Ospedale Civico, Lugano||1||Problems to recruit the needed number of patients in the planned time|f||||t||||||||||2017-10-11 02:26:14.07959|2017-10-11 02:26:14.07959
NCT01701843|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-03-06|||October 2012||2012-10-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Cromoglicate in Mastocytosis|A Phase II Exploratory Study Evaluating the Efficacy of Topical Cromoglicate Solution Compared to Topical Solution Vehicle in the Treatment of Mastocytosis|Terminated||Phase 2|7|Actual|LEO Pharma||2||prematurely terminated because of low recruitment|f||||f||||||||||2017-10-11 02:26:14.209036|2017-10-11 02:26:14.209036
NCT01701830|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-04|||October 2012||2012-10-01|October 2012|2012-10-01|May 2013|Anticipated|2013-05-01|||||Observational|||Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease|The Relationship Between Serum Omentin-1 and IL-6 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease|Unknown status|Recruiting|N/A|85|Anticipated|Kocaeli Derince Education and Research Hospital|||2||f||||||||||||||2017-10-11 02:26:14.299429|2017-10-11 02:26:14.299429
NCT01701817|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-07-28|||February 20, 2013|Actual|2013-02-20|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|February 28, 2018|Anticipated|2018-02-28||Observational|ORBIT-AF II||Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)|Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (Orbit-AF II)|Recruiting||N/A|15000|Anticipated|Janssen Scientific Affairs, LLC|||1||f||||f||||||||||2017-10-11 02:26:14.422382|2017-10-11 02:26:14.422382
NCT01701804|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-22|2014-09-24|||September 2011||2011-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||The Effectiveness of Non-surgical Integrative Package on Failed Back Surgery Syndrome|The Effectiveness of Non-surgical Integrative Package on Failed Back Surgery Syndrome : A Multicenter, Prospective, Case Series Observational Study|Completed||N/A|120|Actual|Jaseng Hospital of Korean Medicine|||1||f||||||||||||||2017-10-11 02:26:15.106401|2017-10-11 02:26:15.106401
NCT01701791|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-02-23|||November 2012||2012-11-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|January 2016|Actual|2016-01-01||Interventional|||Telemedicine for Depression in Primary Care|The Efficacy of Telemedicine for Improving Depression Outcomes in Primary Care|Active, not recruiting||N/A|120|Actual|IRCCS Centro San Giovanni di Dio Fatebenefratelli||2|||f||||t||||||||||2017-10-11 02:26:15.198046|2017-10-11 02:26:15.198046
NCT01701778|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-05-07|||October 2012||2012-10-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children|Double-blind Randomized Controlled Trial of Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children|Completed||Phase 2|90|Anticipated|Fujian Provincial Hospital||3|||f||||t||||||||||2017-10-11 02:26:15.301854|2017-10-11 02:26:15.301854
NCT01701765|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-06|||September 2010||2010-09-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|PERDOVE||Outcomes and Discharge of Long-stay Psychiatric Patients|Epidemiological Study on Outcomes and Discharges of Psychiatric Patients Living in Italian Residential Facilities (PERDOVE)|Completed||N/A|403|Actual|IRCCS Centro San Giovanni di Dio Fatebenefratelli|||1||f||||t||||||||||2017-10-11 02:26:15.41369|2017-10-11 02:26:15.41369
NCT01701752|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-07-26|||September 2012||2012-09-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults|A Randomised, Double Blind, Double Observer Study to Assess Repeated Administration of a Single Dose of an Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Dose of a Trivalent Inactivated Influenza Virus Vaccine in Subjects 65 to 74 Years of Age.|Completed||Phase 1|120|Actual|Immune Targeting Systems Ltd||6|||f||||t||||||||||2017-10-11 02:26:15.600128|2017-10-11 02:26:15.600128
NCT01701739|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-11-01|||October 2012||2012-10-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers|An Open-label, Two-period Fixed-sequence Study to Investigate the Effect of Multiple Doses of Aleglitazar on a Single Dose of Digoxin in Healthy Subjects|Completed||Phase 1|28|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:26:15.71132|2017-10-11 02:26:15.71132
NCT01701726|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-06-19|||July 2012||2012-07-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|EAPMH||Effect of Acupuncture on Patients With Mild Hypertension|Acupuncture for Patients With Mild Hypertension: Study Protocol of an Open-label Multicenter Randomized Controlled Trial|Completed||Phase 3|400|Actual|Chengdu University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-11 02:26:15.803827|2017-10-11 02:26:15.803827
NCT01701713|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-10-05|||June 2009||2009-06-01|October 2012|2012-10-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|TDCS-aphasia||TDCS in Acute Stroke|Safety Study of Transcranial Direct Current Stimulation in Aphasia Therapy in Acute and Post-acute Stroke|Unknown status|Recruiting|N/A|100|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:26:15.904858|2017-10-11 02:26:15.904858
NCT01701700|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-07-27|||February 2013||2013-02-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|p-EVES||The Effectiveness of Portable Electronic Vision Enhancement Systems (p-EVES) for Near Vision in Visual Impairment|The Effectiveness of Portable Electronic Vision Enhancement Systems (EVES) in Comparison to Optical Magnifiers for Near Vision Activities in Visual Impairment - The p-EVES Study|Completed||N/A|100|Actual|Central Manchester University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:26:16.016772|2017-10-11 02:26:16.016772
NCT01701687|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2015-07-31|||September 2012||2012-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|BANDED||Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease|The Feasibility of Liver Biomarkers as Prognostic Markers in Decompensated Alcoholic Liver Disease|Completed||N/A|36|Actual|University of Nottingham|||1||f||||f||||||Samples Without DNA|"     Serum, plasma and urine stored at -80 degrees centigrade under written patient consent   "|||2017-10-11 02:26:16.121608|2017-10-11 02:26:16.121608
NCT01701674|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-07-10|2017-03-22||October 3, 2012||2012-10-03|March 2017|2017-03-01|April 30, 2018|Anticipated|2018-04-30|April 21, 2016|Actual|2016-04-21||Interventional||All participants (13). All evaluable participants (12) may be referenced for some outcome measures.|Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts|Co-stimulation With Ipilimumab to Enhance Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Patients With Metastatic Melanoma|Active, not recruiting||N/A|13|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 02:26:16.219529|2017-10-11 02:26:16.219529
NCT01701661|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-04|||September 2004||2004-09-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|October 2008|Actual|2008-10-01||Interventional|||Compression Therapy Versus Surgery in the Treatment of Superficial Venous Reflux|Compression Therapy Versus Surgery in the Treatment of Superficial Venous Reflux - A Randomized Controlled Trial|Completed||N/A|153|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 02:26:16.818259|2017-10-11 02:26:16.818259
NCT01701648|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-10-11|||December 2010||2010-12-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||Melanocyte Transplantation for Patients With Stable Vitiligo.|Phase I-II, Randomized, Intraindividually Placebo Controlled Clinical Trial, to Evaluate the Efficacy of Autologous Melanocyte Transplantion on Amniotic Membrane as a Substrate for Patients With Stable Vitiligo.|Completed||Phase 1/Phase 2|30|Actual|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||||2017-10-11 02:26:16.910049|2017-10-11 02:26:16.910049
NCT01701635|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-08-23|||January 2013||2013-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||SANKOFA Pediatric HIV Disclosure Intervention|"A Bioecological Pediatric HIV Disclosure Intervention in Ghana - SANKOFA"|Recruiting||N/A|756|Anticipated|Yale University||2|||f||||f||||||||||2017-10-11 02:26:16.994989|2017-10-11 02:26:16.994989
NCT01701622|ClinicalTrials.gov processed this data on October 10, 2017|2010-01-27|2013-02-08|2012-11-09||January 2010||2010-01-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study|The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study|Terminated||N/A|1|Actual|University of Mississippi Medical Center|Early termination leading to no subjects analyzed|1||unable to enroll participants|f||||f||||||||||2017-10-11 02:26:17.10086|2017-10-11 02:26:17.10086
NCT01701609|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-07-06|||January 2007||2007-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Cognitive Remediation Therapy (CRT) in Adolescents With EOS|Efficacy of a Cognitive Remediation Treatment in Adolescents With Schizophrenia Spectrum Disorders|Completed||N/A|50|Actual|Hospital Clinic of Barcelona||1|||f||||t||||||||||2017-10-11 02:26:17.29254|2017-10-11 02:26:17.29254
NCT01701596|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2014-08-18|||August 2004||2004-08-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Efficacy of Rotational Atherectomy (RA) in Coronary Dissection|Safety and Efficacy of Immediate Rotational Atherectomy in Nondilatable Calcified Lesion Complicated by Coronary Dissection (RAISE)|Completed||Phase 1/Phase 2|198|Actual|Xijing Hospital||2|||f||||t||||||||||2017-10-11 02:26:17.391081|2017-10-11 02:26:17.391081
NCT01701583|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-08-19|||April 2013||2013-04-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria|Effect of Omalizumab (Xolair) on the Basophil Proteome in Patients With Chronic Idiopathic Urticaria|Active, not recruiting||Phase 4|12|Anticipated|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 02:26:17.478044|2017-10-11 02:26:17.478044
NCT01701570|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-05-23|||April 2012||2012-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|Rxercise||Barriers to Physical Activity in People With Type 2 Diabetes|Mediators of Perceived Exercise Effort in Type 2 Diabetes - Barriers to Physical Activity|Recruiting||N/A|150|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:26:17.561989|2017-10-11 02:26:17.561989
NCT01701557|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-03|||November 2007||2007-11-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Fluid Resuscitation for Pediatric Diabetic Ketoacidosis|Fluid Resuscitation for Pediatric Diabetic Ketoacidosis|Completed||N/A|50|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:26:17.75983|2017-10-11 02:26:17.75983
NCT01701544|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-10-28|||August 2012||2012-08-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Nucleus Basalis Deep Brain Stimulation for Thinking & Memory Problems in Parkinson's.|Double Blind, Randomised, Single Centre, Crossover Pilot Trial of Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation to Improve Cognitive Deficits in Patients With Parkinson's Disease.|Completed||Phase 1/Phase 2|6|Actual|University College, London||2|||f||||t||||||||||2017-10-11 02:26:17.845395|2017-10-11 02:26:17.845395
NCT01701531|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-05-04|||October 2012||2012-10-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|RBCPF||Red Blood Cell Precursor Formulation to Determine Increased Production|An Open-Label, Pilot Study of a Red Blood Cell Precursor Formulation to Determine Increased Production in Subjects With Mild to Moderate Anemia|Withdrawn||Phase 2/Phase 3|0|Actual|Targeted Medical Pharma||1||Funding not received|f||||||||||||||2017-10-11 02:26:17.953295|2017-10-11 02:26:17.953295
NCT01701518|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-01-04|||October 2012||2012-10-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes|A Prospective Multicentre Pilot Study of the Effectiveness of an Intra-operative Intravitreal Sustained Release Dexamethasone Implant (Ozurdex®) in Vitrectomy Surgery for Epiretinal Membranes|Recruiting||N/A|15|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 02:26:18.058544|2017-10-11 02:26:18.058544
NCT01701505|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-07-28|2016-11-08|2015-05-15|October 2012||2012-10-01|July 2017|2017-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects|A Phase 2, Single-Center, Open-Label, Randomized, Parallel-Groups, Dose-Ranging Study to Assess the Efficacy and Safety of Intranasally Administered Kovacaine Mist for Anesthetizing Maxillary Teeth in Pediatric Subjects|Completed||Phase 2|48|Actual|St. Renatus, LLC||3|||f||||f||||||||||2017-10-11 02:26:18.214305|2017-10-11 02:26:18.214305
NCT01701492|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-03-31|||October 19, 2012|Actual|2012-10-19|October 2016|2016-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Cognitive, Academic and Psychosocial Functioning in Long-Term Survivors of Pediatric Stem Cell Transplantation|Cognitive, Academic and Psychosocial Functioning in Long-Term Survivors of Pediatric Stem Cell Transplantation|Recruiting||N/A|400|Anticipated|St. Jude Children's Research Hospital|||2||f||||f|f|f||||||||2017-10-11 02:26:19.849937|2017-10-11 02:26:19.849937
NCT01701479|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-05|||November 2010||2010-11-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|March 2013|Anticipated|2013-03-01||Interventional|LTI||Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)|A Phase I/II Dose Schedule Finding Study of ch14.18/CHO Continuous Infusion Combined With Subcutaneous Aldesleukin (IL-2) in Patients With Primary Refractory or Relapsed Neuroblastoma|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|St. Anna Kinderkrebsforschung||1|||f||||t||||||||||2017-10-11 02:26:19.960504|2017-10-11 02:26:19.960504
NCT01701466|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2015-05-22|||December 2011||2011-12-01|May 2015|2015-05-01||||May 2014|Actual|2014-05-01||Interventional|||Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis|A Phase II Study Designed to Evaluate the Value of Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis for Patients Undergoing External Radiation Therapy|Terminated||Phase 2|14|Actual|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||f||||||||||2017-10-11 02:26:20.179993|2017-10-11 02:26:20.179993
NCT01701453|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-03-01|||August 2012||2012-08-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|SMART-DATE||Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE)|Smart Angioplasty Research Team: Safety of 6-month Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes (SMART-DATE)|Active, not recruiting||N/A|2700|Anticipated|Samsung Medical Center||2|||f||||t||||||||Yes|After publication of first manuscript|2017-10-11 02:26:20.255411|2017-10-11 02:26:20.255411
NCT01701440|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-10|||October 2012||2012-10-01|October 2012|2012-10-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Efficacy Study for Magnetic Induction to Treat Wrinkles|Radiofrequency Magnetic Induction Device for Use In Dermatologic Procedures for the Non-Invasive Treatment of Wrinkles and Rhytides|Unknown status|Active, not recruiting|N/A|60|Anticipated|Rocky Mountain Biosystems, Inc.||1|||f||||f||||||||||2017-10-11 02:26:20.340288|2017-10-11 02:26:20.340288
NCT01701427|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-01-04|||June 2012||2012-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|HADES-1||Pain After Deep Electrical Stimulation in the Groin in Pain Free Subjects|Hyperalgesia After Deep Electrical Stimulation in Pain Free Subjects|Completed||N/A|21|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 02:26:20.403161|2017-10-11 02:26:20.403161
NCT01701414|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-02-07|2013-05-29||November 2008||2008-11-01|February 2008|2008-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|FNB|It was determined that a sample size of 17 in each arm would provide 80% power to detect at least a 33% PID. Sample size was inflated by 10% to account for attrition, missing data, and protocol violations, for a total of 19 subjects in each arm.|Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures|Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures: a Randomized Controlled Clinical Study|Completed||Phase 2|38|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-10-11 02:26:20.467596|2017-10-11 02:26:20.467596
NCT01701401|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-03-17|2015-03-17||September 2012||2012-09-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional||Safety Analysis Set: participants were randomized and received at least 1 dose of study drug.|Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV|A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5885 Fixed-Dose Combination (FDC) +/- Ribavirin for 12 and 24 Weeks in Treatment-Naive Subjects With Chronic Genotype 1 HCV Infection.|Completed||Phase 3|870|Actual|Gilead Sciences||4|||f||||t||||||||||2017-10-11 02:26:20.7817|2017-10-11 02:26:20.7817
NCT01701388|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-09-21|||May 2012||2012-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EKSO||EKSO Trial: Powered Exoskeleton for Ambulation in Subjects With Spinal Cord Injury (SCI)|Investigational Study of the Ekso Powered Exoskeleton for Ambulation in Individuals With Spinal Cord Injury (or Similar Neurological Weakness)|Active, not recruiting||N/A|40|Anticipated|Shirley Ryan AbilityLab||1|||f||||t||||||||||2017-10-11 02:26:22.856039|2017-10-11 02:26:22.856039
NCT00005144|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||August 1978||1978-08-01|April 2000|2000-04-01|June 1991|Actual|1991-06-01|||||Observational|||Coronary-Prone Behavior and Cardiovascular Reactivity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:32.371794|2017-10-11 04:26:32.371794
NCT01701375|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-08-30|2013-06-14||September 2012||2012-09-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia|A Phase I and Pharmacodynamic Trial of Timed Sequential Administration of the Cyclin Dependent Kinase 4/6 Inhibitor PD 0332991 Followed by Cytarabine Plus Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasias|Terminated||Phase 1|2|Actual|Sidney Kimmel Comprehensive Cancer Center||1||Material sponsor withdrew support|f||||t||||||||||2017-10-11 02:26:22.983233|2017-10-11 02:26:22.983233
NCT01701362|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-05-04|2016-07-20||October 2012||2012-10-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain|A Randomized Double Blind Placebo Controlled Parallel Group Study Of The Efficacy And Safety Of Pregabalin (Bid) In Subjects With Post-traumatic Peripheral Neuropathic Pain|Completed||Phase 3|542|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 02:26:23.293764|2017-10-11 02:26:23.293764
NCT01701349|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-04-30|||March 2015||2015-03-01|April 2014|2014-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|FACT2||Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Fosbretabulin Tromethamine (CA4P) in Combination With Paclitaxel and Carboplatin in Anaplastic Thyroid Carcinoma (FACT2)|Withdrawn||Phase 3|0|Actual|Mateon Therapeutics||2||Expected inability to recruit study participants in a reasonable amount of time.|f||||t||||||||||2017-10-11 02:26:25.343006|2017-10-11 02:26:25.343006
NCT01701336|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-08-28|||March 2012||2012-03-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|HCV004||Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients|Phase Ib Study to Assess the Safety and Immunogenicity of a Novel HCV Vaccine, Based on the Sequential Injection of Ad6NSmut and MVA-NSmut, Given in Combination With PEG-Interferon Alfa Plus Ribavirin for Re-treatment of Chronic Hepatitis C|Completed||Phase 1|9|Actual|ReiThera Srl||1|||f||||t||||||||||2017-10-11 02:26:25.460051|2017-10-11 02:26:25.460051
NCT01701323|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2017-06-29|||December 10, 2012|Actual|2012-12-10|June 2017|2017-06-01|August 5, 2018|Anticipated|2018-08-05|August 5, 2018|Anticipated|2018-08-05||Interventional|||Laboratory-Treated Donor Cord Blood Cell Infusion Following Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia|Pilot Study Evaluating the Use of Ex Vivo Expanded Cord Blood Progenitors as Supportive Care Following Chemotherapy (FLAG) in Patients With AML or Acute Leukemia of Ambiguous Lineage|Active, not recruiting||N/A|15|Anticipated|Fred Hutchinson Cancer Research Center||1|||||||f||||||||||2017-10-11 02:26:25.596739|2017-10-11 02:26:25.596739
NCT01701310|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-10-27|||April 2012||2012-04-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|IVICA||IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia|An Open Label Study to Determine the Efficacy of Ferric Carboxymaltose in Preoperative Colorectal Cancer Related Anaemia, and to Develop Biomarkers to Predict Response to This Treatment Strategy|Completed||Phase 4|116|Actual|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 02:26:25.806069|2017-10-11 02:26:25.806069
NCT01701297|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-10-27|||February 2012||2012-02-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||VSL#3 and Spontaneous Bacterial Peritonitis|The Effect of Probiotics on the Incidence of Spontaneous Bacterial Peritonitis in Patients With Cirrhosis and Ascites|Terminated||Phase 2|10|Actual|Nottingham University Hospitals NHS Trust||3||Unable to obtain QP release certification from the manufacturer (VSL3) for shipment of IMP|f||||t||||||||No||2017-10-11 02:26:25.944866|2017-10-11 02:26:25.944866
NCT01701284|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-10-03|||December 2012||2012-12-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|rTMSinCP||Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety|A Randomized Open-Label Pilot Trial To Evaluate The Safety And Efficacy Of Repetitive Transcranial Magnetic Stimulation In Cancer Patients With Depression And Anxiety|Recruiting||N/A|30|Anticipated|Northwestern University||2|||f||||t||||||||No||2017-10-11 02:26:26.043131|2017-10-11 02:26:26.043131
NCT01701271|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-01-20|2013-09-13||February 2001||2001-02-01|January 2016|2016-01-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|MEXISPATENT||Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females|Evaluation of the Efficacy of the Cosmetic Lotion M.P.A.F. (Mixture of Paraffin, Alcohol and Fur) MEXIS PATENT in the Treatment of Androgenetic Alopecia by Decreasing of Hair Loss and Strengthening and Thickening of Hair in Males and Females.|Completed||N/A|20|Actual|Mexis George||1|||f||||t||||||||||2017-10-11 02:26:26.184071|2017-10-11 02:26:26.184071
NCT01701258|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-12-28|||November 2012||2012-11-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||An Investigation of Early Life Stress and Depression|Early Life Stress and Depression: Molecular and Functional Imaging Approaches|Recruiting||N/A|92|Anticipated|Mclean Hospital||2|||f||||f||||||||||2017-10-11 02:26:26.431062|2017-10-11 02:26:26.431062
NCT01701245|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-03-23|2015-09-30||October 2012||2012-10-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care|A Randomized, Multicenter Study for the Prevention and Acute Treatment of Chronic Cluster Headache Using Gammacore, Versus Standard of Care.|Completed||Phase 2|97|Actual|ElectroCore LLC||2|||f||||f||||||||No|Not planned to share individual data|2017-10-11 02:26:26.598502|2017-10-11 02:26:26.598502
NCT01701232|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-09-01|||September 2011||2011-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Safety and Efficacy Study of BCD-020 in Therapy of Non-Hodgkin's Lymphoma|A Multicenter Open-label Randomized Study of BCD-020 (Rituximab, CJSC BIOCAD, Russia) Efficacy and Safety in Comparison With MabThera (F. Hoffmann-La Roche Ltd., Switzerland) in Monotherapy of CD20-positive Indolent Non-Hodgkin's Lymphoma|Recruiting||Phase 3|134|Anticipated|Biocad||2|||f||||f||||||||Undecided||2017-10-11 02:26:27.013518|2017-10-11 02:26:27.013518
NCT01700868|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-10-19|||July 2014||2014-07-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PBNI-2||Practice Based Nutrition Intervention-2|Practice Based Nutrition Intervention-2|Completed||N/A|15|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-10-11 02:26:34.45368|2017-10-11 02:26:34.45368
NCT01701219|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-07-30|||January 2013||2013-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia|A Multicenter, 2-Cohort Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia|Completed||Phase 4|56|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 02:26:27.227987|2017-10-11 02:26:27.227987
NCT01701206|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-04|2017-05-01|||July 2009||2009-07-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|HOPE||HOPE (Harnessing Online Peer Education): Using Online Social Networks for HIV Prevention and Testing|Using Online Social Networks for HIV Prevention and Testing|Completed||N/A|558|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-10-11 02:26:27.472957|2017-10-11 02:26:27.472957
NCT01701193|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-03|||October 2012||2012-10-01|October 2012|2012-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||A Phase I Study For the Reduction of Scar Tissue in Adult Females Undergoing Surgery for an Ectopic Pregnancy|A Randomized, Double-Blind, Placebo Controlled Phase I Study of an Amino Acid For the Reduction of Peritoneal Adhesions in Adult Females Undergoing a Laparoscopic Salpingostomy for the Removal of an Ectopic Pregnancy|Unknown status|Recruiting|Phase 1|38|Anticipated|AdeTherapeutics Inc.||2|||f||||t||||||||||2017-10-11 02:26:27.540049|2017-10-11 02:26:27.540049
NCT01701180|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-12-02|||August 2012||2012-08-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|ODIS||Neural Correlates of Empathogenic and Affiliative Actions of Oxytocin|Neural Correlates of the Empathogenic and Affiliative Actions of Oxytocin|Completed||Early Phase 1|23|Actual|University Hospital, Bonn||2|||f||||f||||||||||2017-10-11 02:26:27.633602|2017-10-11 02:26:27.633602
NCT01701167|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2012-10-02|||November 2012||2012-11-01|October 2012|2012-10-01||||February 2013|Anticipated|2013-02-01||Observational|||Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain|ROMAN (PCA-9000A) PET/CT System Verification|Unknown status|Not yet recruiting|N/A|30|Anticipated|Toshiba America Medical Systems, Inc.|||1||f||||f||||||||||2017-10-11 02:26:27.731835|2017-10-11 02:26:27.731835
NCT01701154|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-01-16|||December 2010||2010-12-01|October 2012|2012-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||The Effects of Respiratory Muscle Strength Training (RMST) on Inspiratory and Expiratory Muscle Strength in Adults and Children With Pompe Disease|The Effects of Respiratory Muscle Strength Training (RMST) on Inspiratory and Expiratory Muscle Strength in Adults and Children With Pompe Disease|Completed||N/A|11|Actual|Duke University|||1||f||||t||||||||||2017-10-11 02:26:27.793315|2017-10-11 02:26:27.793315
NCT01701141|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-04-06|||January 2012||2012-01-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Depression and Dopamine Transporter Function Study Using C-11 Altropane|Depression and Dopamine Transporter Function: A Positron Emission Tomography Study Using C-11 Altropane|Completed||N/A|150|Anticipated|Mclean Hospital|||2||f||||f||||||||||2017-10-11 02:26:27.868686|2017-10-11 02:26:27.868686
NCT01701128|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2012-10-03|||October 2010||2010-10-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|June 2011|Actual|2011-06-01||Interventional|||The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease|The Effect of Exercise Training on Gait and Quality of Life in Patients With Early Parkinson's Disease|Terminated||N/A|35|Actual|Laval University||3||Protocol is completed|f||||t||||||||||2017-10-11 02:26:27.943648|2017-10-11 02:26:27.943648
NCT01701115|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-10-02|2017-04-03||August 2012||2012-08-01|October 2017|2017-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|Low Dose ISB||Effect of Local Anesthetic Dose on Interscalene Block|Effect of Local Anesthetic Dose on Interscalene Block for Shoulder Arthroscopy, Patient Satisfaction and Return of Handgrip Strength|Completed||N/A|154|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 02:26:28.109916|2017-10-11 02:26:28.109916
NCT01701102|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-03-09|2016-02-11||December 2011||2011-12-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|July 2012|Actual|2012-07-01||Interventional|||Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery|Optimal Dose of Spinal Mepivacaine Combined With Fentanyl For Knee Arthroscopy|Completed||N/A|56|Actual|Hospital for Special Surgery, New York||4|||f||||f||||||||||2017-10-11 02:26:28.467302|2017-10-11 02:26:28.467302
NCT01701089|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-11-01|||September 2012||2012-09-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers|An Open-Label, Parallel Group Study to Assess the Inhibition of Brain MAO-B by RO4602522 After Repeated Dosing in Patients With Alzheimer's Disease and in Healthy Control Subjects|Completed||Phase 1|17|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:26:29.465636|2017-10-11 02:26:29.465636
NCT01701076|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-08-23|||March 2012||2012-03-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|BRd||Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma|An Open, Multicentric Phase II Trial to Evaluate the Efficacy and Safety of Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|50|Actual|Cantonal Hospital of St. Gallen||1|||f||||f||||||||||2017-10-11 02:26:29.565762|2017-10-11 02:26:29.565762
NCT01701063|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-06-07|2016-04-18||January 2013||2013-01-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Full analysis set (FAS) included all enrolled participants who received at least 1 dose of study drug.|An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus|A Two-Part, Open-Label, Single-Arm Phase 1/2 Study of Safety, Pharmacokinetics, and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Aged 3 to 17 Infected With Genotype 1 Hepatitis C Virus|Terminated||Phase 1/Phase 2|42|Actual|Vertex Pharmaceuticals Incorporated|Study was terminated early because it was determined that telaprevir/Peg-IFN/RBV regimen did not present a meaningful therapeutic treatment over existing interferon-free regimens and was unlikely to be used for participants aged 3 to 17 years.|1|||f||||t||||||||||2017-10-11 02:26:29.752454|2017-10-11 02:26:29.752454
NCT01700855|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2014-07-10|||June 2012||2012-06-01|May 2012|2012-05-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Electroacupuncture Anesthesia for Nasal Sinus Surgery and Mammaplasty|Electroacupuncture for Pain Relief in Patients With Nasal Sinus Surgery and Mammaplasty: a Randomized Controlled Study|Completed||N/A|137|Actual|Xijing Hospital||2|||f||||t||||||||||2017-10-11 02:26:34.601067|2017-10-11 02:26:34.601067
NCT01701050|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-03-07|||April 1, 2013|Actual|2013-04-01|March 2017|2017-03-01|November 10, 2016|Actual|2016-11-10|November 10, 2016|Actual|2016-11-10||Observational|COMETI P2||Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index|COMETI Phase 2: Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index|Completed||N/A|121|Actual|Janssen Diagnostics, LLC|||1||f||||f||||||Samples With DNA|"     Cartridges containing Circulating Tumor Cells (isolated by CellSearch) as well as primary     and/or metastatic tumor tissue (blocks or slides).   "|||2017-10-11 02:26:31.152504|2017-10-11 02:26:31.152504
NCT01701037|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-06-20|2017-03-10||January 2013||2013-01-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery|Biomarkers of Response and Resistance to Sequential B-RAF and MEK Targeted Therapy in a Pre-Surgical Model of Advanced, Operable Melanoma|Terminated||Phase 2|13|Actual|Vanderbilt-Ingram Cancer Center||1||PI leaving VICC, low future accrual predicted, continued funding improbable,|f||||t||||||||||2017-10-11 02:26:31.350709|2017-10-11 02:26:31.350709
NCT01701024|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-11-11|2015-01-15||October 2012||2012-10-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|ACYC||Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne|A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of ACYC and ACYC Vehicle Gel in the Treatment of Acne Vulgaris|Completed||Phase 3|498|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||Yes||2017-10-11 02:26:31.869573|2017-10-11 02:26:31.869573
NCT01701011|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-06|2016-06-28|2014-12-03||October 2010||2010-10-01|June 2016|2016-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Coping Intervention After Embryo Transfer|Study of the Effectiveness of a Coping Selfhelp Intervention for Women in the Waiting Period After an Embryo Transfer During an IVF/ISCI Treatment|Completed||N/A|377|Actual|UMC Utrecht||3|||f||||f||||||||||2017-10-11 02:26:32.460702|2017-10-11 02:26:32.460702
NCT01700998|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2014-11-01|||September 2012||2012-09-01|November 2014|2014-11-01||||October 2014|Actual|2014-10-01||Interventional|||Magnesium Replacement Therapy to Prevent Acute Renal Failure in Critically Ill Patients|Randomized Trial of Magnesium Replacement Therapy to Prevent Acute Renal Failure in Hypomagnesemic Critically Ill Patients|Completed||N/A|140|Actual|Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude||2|||f||||t||||||||||2017-10-11 02:26:32.855468|2017-10-11 02:26:32.855468
NCT01700985|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2013-11-25||2013-11-25|May 2012||2012-05-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis|A Double-Blind, Randomized, Single Center, Vehicle-Controlled, Parallel Group Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment|Completed||Phase 2|44|Actual|Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 02:26:32.934113|2017-10-11 02:26:32.934113
NCT01700972|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-03-04|||February 2013||2013-02-01|March 2014|2014-03-01|August 2014|Anticipated|2014-08-01|January 2014|Anticipated|2014-01-01||Interventional|||Feasibility and Diagnostic Accuracy of Myocardial Perfusion Imaging Using Early Imaging Protocol|Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol: A Pilot Study|Withdrawn||Phase 4|0|Actual|St. Louis University||1||The study did not recruit/no study activity occurred.|f||||t||||||||||2017-10-11 02:26:33.015803|2017-10-11 02:26:33.015803
NCT01700959|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-07-10|||February 6, 2013|Actual|2013-02-06|July 2017|2017-07-01|April 19, 2017|Actual|2017-04-19|April 19, 2017|Actual|2017-04-19||Interventional|||Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort|Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort|Completed||Phase 3|911|Actual|St. Jude Children's Research Hospital||2|||f||||t|t|f||||||||2017-10-11 02:26:33.266096|2017-10-11 02:26:33.266096
NCT01700946|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-04-17|||April 15, 2013|Actual|2013-04-15|November 2016|2016-11-01|October 31, 2021|Anticipated|2021-10-31|October 31, 2021|Anticipated|2021-10-31||Interventional|||Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma|A Phase II Study of Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma|Recruiting||Phase 2|40|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|t|t|t|f||||||2017-10-11 02:26:33.364693|2017-10-11 02:26:33.364693
NCT01700933|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-09-19|||September 2012|Actual|2012-09-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Dose-response: Exercise Therapy on Hip Osteoarthritis|Dose-response: Exercise Therapy on Hip Osteoarthritis, a Pilot Study|Completed||N/A|35|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 02:26:33.54144|2017-10-11 02:26:33.54144
NCT01700920|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-03-29|||July 2012||2012-07-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CSM/ON/2011||PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells|PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells|Completed||Phase 2|3|Actual|Red de Terapia Celular||1|||f||||t||||||||||2017-10-11 02:26:33.622504|2017-10-11 02:26:33.622504
NCT01700907|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-30|2014-11-25|2013-02-26||August 2012||2012-08-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Optimization of Desflurane in Elderly Patients|Optimization of Desflurane in Elderly Patients Compared With Sevoflurane: A Pilot Study|Completed||Phase 1/Phase 2|20|Actual|Sapporo Medical University||2|||f||||t||||||||||2017-10-11 02:26:33.703677|2017-10-11 02:26:33.703677
NCT01700894|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2013-09-17|||March 2010||2010-03-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|WWP3||Women's Walking Program|Reducing Health Disparities in African American Women: Lifestyle Physical Activity Adherence|Completed||N/A|288|Actual|Rush University Medical Center||3|||f||||t||||||||||2017-10-11 02:26:34.180626|2017-10-11 02:26:34.180626
NCT01700881|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-09-08|||October 2012||2012-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|October 2013|Actual|2013-10-01||Interventional|WCCR-ARTH2||A Nutrition Intervention for Arthritis -2|A Nutrition Intervention for Arthritis-2|Active, not recruiting||N/A|6|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-10-11 02:26:34.319545|2017-10-11 02:26:34.319545
NCT01700842|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2013-06-26|||October 2012||2012-10-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|CERBERUS||Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia|Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia|Completed||N/A|3000|Actual|AstraZeneca|||1||f||||||||||None Retained|"     Microbiological strains   "|||2017-10-11 02:26:34.717087|2017-10-11 02:26:34.717087
NCT01700829|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-08-24|||June 2012||2012-06-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|January 12, 2017|Actual|2017-01-12||Interventional|||Ketamine in the Treatment of Suicidal Depression|Ketamine vs. Midazolam: Testing Rapid Relief of Suicide Risk in Depression|Completed||Phase 4|80|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 02:26:34.810246|2017-10-11 02:26:34.810246
NCT01700816|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-05-26|2016-10-27||October 2012||2012-10-01|May 2017|2017-05-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Prevention of Delirium After Bone Marrow Transplantation|Usefulness of Bright Light Therapy in the Prevention of Delirium in Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT)|Terminated||N/A|40|Actual|Massachusetts General Hospital||2||Low incidence of delirium.|f||||t||||||||No||2017-10-11 02:26:34.971671|2017-10-11 02:26:34.971671
NCT01700803|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2012-10-03|||January 2012||2012-01-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Povidone Iodine and Cesarean Section Wound Infections|Povidone Iodine 10% Versus 7.5% Hand Scrub and Cesarean Section Wound Infections: A Randomized Trial|Completed||Phase 3|3231|Actual|Assiut University||2|||f||||t||||||||||2017-10-11 02:26:35.673252|2017-10-11 02:26:35.673252
NCT01700790|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-12-06|||January 2016||2016-01-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin|A Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir in Combination With Rifampin in HIV-1-infected Patients With Tuberculosis.|Recruiting||Phase 4|12|Anticipated|University of Miami||1|||f||||f||||||||Undecided||2017-10-11 02:26:35.7921|2017-10-11 02:26:35.7921
NCT01700777|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-01-21|||November 2010||2010-11-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Bimanual Training in Children With Hemiplegia With Lower Limb and Postural Stimulation (HABIT & Leg)|Effet de la réadaptation Sur Les déficiences, Limitations d'activité et Restriction de la Participation Des Enfants présentant Des lésions Neurologiques Non-évolutives (Infirmes Moteurs cérébraux).|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|University Hospital of Mont-Godinne||2|||f||||t||||||||||2017-10-11 02:26:35.976971|2017-10-11 02:26:35.976971
NCT01700764|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2014-10-27|||December 2012||2012-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:26:36.128554|2017-10-11 02:26:36.128554
NCT01700751|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2017-03-02|||February 25, 2013|Actual|2013-02-25|March 2017|2017-03-01|January 31, 2020|Anticipated|2020-01-31|November 11, 2015|Actual|2015-11-11||Interventional|||Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation|A Pilot Study of Brentuximab Vedotin in the Prevention of Graft-Versus-Host Disease (GVHD) After Unrelated Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 1|17|Actual|Washington University School of Medicine||5|||f||||t|t|f||||||No||2017-10-11 02:26:36.194128|2017-10-11 02:26:36.194128
NCT01700738|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2012-10-02|||November 2012||2012-11-01|October 2012|2012-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|CHADO||Evaluation of the Effects of Laying Early a Gastric Band on the Prevention of Morbid Obesity Randomized Checked Against Standard Management of Obesity in This Population.|Evaluation of the Effects of Laying Early (Between 12 and 16) a Gastric Band on the Prevention of Morbid Obesity in Late Adolescence. Randomized Checked Against Standard Management of Obesity in This Population.|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-11 02:26:36.318681|2017-10-11 02:26:36.318681
NCT01700725|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-05-23|||October 2012||2012-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|GWINIS||Gulf War Illness Nasal Irrigation Study|Nasal Irrigation for Chronic Rhinosinusitis and Fatigue in Patients With Gulf War Illness|Active, not recruiting||Phase 2|48|Actual|University of Wisconsin, Madison||3|||f||||f||||||||||2017-10-11 02:26:36.483222|2017-10-11 02:26:36.483222
NCT01700712|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2012-10-03|||December 2010||2010-12-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Acid Production in Dental Plaque After Exposure to Probiotic Bacteria||Completed||N/A|18|Actual|University of Copenhagen||2|||f||||||||||||||2017-10-11 02:26:36.59464|2017-10-11 02:26:36.59464
NCT01700699|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2012-10-20|||October 2012||2012-10-01|October 2012|2012-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Observational|||Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibitors|Impact of BRAFV600E Intratumor Heterogeneity on the Efficacy of Tyrosine Kinase Inhibitors in the Treatment of Radioiodine-resistant Thyroid Cancer|Unknown status|Recruiting|N/A|50|Anticipated|University of Salerno|||6||f||||f||||||Samples With DNA|"     Primary and metastatic tumor tissue, frozen or formaldehyde fixed-paraffin embedded from     block, genomic DNA already extracted from tumor tissue   "|||2017-10-11 02:26:36.673076|2017-10-11 02:26:36.673076
NCT01700686|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-12-16|||October 2011||2011-10-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||The Effect of Gastric Bypass Surgery on Gut Hormones Related to Bone Remodeling and Intestinal Growth.|The Effect of Gastric Bypass Surgery on Gut Hormones Related to Bone Remodeling and Intestinal Growth.|Completed||N/A|18|Actual|University of Copenhagen|||1||f||||f||||||Samples Without DNA|"     Plasma and serum samples are retained.   "|||2017-10-11 02:26:36.766595|2017-10-11 02:26:36.766595
NCT01700673|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-04-11|||June 2013|Actual|2013-06-01|April 2017|2017-04-01|October 2019|Anticipated|2019-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS|A Phase II Study of 5-Azacitidine (5AC) in Combination With Sargramostim (GM-CSF) as Maintenance Treatment, After Definitive Therapy With Either Stem Cell Transplant (SCT) or Cytarabine-based Chemotherapy, in Patients With Poor-risk Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)|Enrolling by invitation||Phase 2|75|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||f||||||||No||2017-10-11 02:26:36.862024|2017-10-11 02:26:36.862024
NCT01700660|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-03|2016-01-25|||October 2012||2012-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|RISE||Reperfusion-induced Self-antigen Excretion Following Major Liver Surgery|Reperfusion-induced Self-antigen Excretion Following Major Liver Surgery|Completed||N/A|40|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f||||||Samples With DNA|"     2 liver biopsies   "|Undecided||2017-10-11 02:26:36.953312|2017-10-11 02:26:36.953312
NCT01700647|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-09-10|||October 2012||2012-10-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Breath Testing in Early and Late Larynx Cancer|Breath Testing in Laryngeal Cancer- Comparing in Situ Cancer and Advanced Cancer|Completed||N/A|30|Actual|Royal Brisbane and Women's Hospital|||3||f||||t||||||None Retained|"     Breath test- for analysis in ENose as well as massspectroscopy gas chromatography   "|||2017-10-11 02:26:37.027507|2017-10-11 02:26:37.027507
NCT01700634|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-10-04|||September 2012||2012-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2014|Actual|2014-07-01||Observational|||fMRI Evaluation of Pain Central Sensitization Phenomena in Subjects With Knee Osteoarthritis|fMRI Evaluation of Pain Central Sensitization Phenomena in Subjects With Knee Osteoarthritis|Completed||N/A|90|Actual|Parc de Salut Mar|||3||f||||f||||||||||2017-10-11 02:26:37.108309|2017-10-11 02:26:37.108309
NCT01700621|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-05-05|||January 2013||2013-01-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Coadministration of Measles-rubella and Rotavirus Vaccines|Non-interference and Safety of Concomitant Administration of Measles-rubella and Rotavirus Vaccines at 9 Months of Age in Rural Bangladesh|Completed||Phase 4|480|Actual|PATH||2|||f||||t||||||||||2017-10-11 02:26:37.171245|2017-10-11 02:26:37.171245
NCT01700608|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-02|||September 2008||2008-09-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Prospective Observational Study on Plerixafor After Chemotherapy|Prospective Observational Study on Plerixafor After Chemotherapy|Completed||N/A|27|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||1||f||||f||||||||||2017-10-11 02:26:37.270552|2017-10-11 02:26:37.270552
NCT01700595|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-02|||September 2012||2012-09-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Preexpanded Perforator Flaps in Children|Preexpanded Perforator Flaps in Pediatric Patients|Completed||N/A|7|Actual|Istanbul University||1|||f||||f||||||||||2017-10-11 02:26:37.393169|2017-10-11 02:26:37.393169
NCT01700582|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-04-13|||April 2012||2012-04-01|April 2016|2016-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings|French National Observatory of the Patients With Non-small Cell Lung (NSCLC) Benefiting From a Molecular Test on the Hospital Platforms of Molecular Genetics.|Completed||N/A|18858|Actual|Intergroupe Francophone de Cancerologie Thoracique|||1||f||||f||||||||No||2017-10-11 02:26:37.512902|2017-10-11 02:26:37.512902
NCT01700569|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-08-30|||January 2013||2013-01-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|FOLAGLI||Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma|Phase I Study of Escalated Pharmacologic Dose, of Oral Folinic Acid in Combination With Temozolomide, According to Stupp R. Regimen, in Patients With Operated Grade-IV Astocytoma and a Non-methylated Gene Status of MGMT.|Recruiting||Phase 1|44|Anticipated|Institut Cancerologie de l'Ouest||1|||f||||t||||||||||2017-10-11 02:26:38.035195|2017-10-11 02:26:38.035195
NCT01700556|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2013-01-28|||November 2012||2012-11-01|January 2013|2013-01-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|UP-TECH||A Trial to Support Caregivers of Patients With Dementia in Italy: the UP-TECH Project|A Randomised Controlled Trial to Improve Support Services for Caregivers of Patients With Alzheimer Disease in Italy by UPgrading Quality of Care Through the Integration of Services and the Use of New TECHnologies (The UP-TECH Project)|Unknown status|Recruiting|N/A|900|Anticipated|Istituto Nazionale di Ricovero e Cura per Anziani||3|||f||||f||||||||||2017-10-11 02:26:38.187388|2017-10-11 02:26:38.187388
NCT01700543|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-08-01|||October 2012||2012-10-01|August 2017|2017-08-01|September 2024|Anticipated|2024-09-01|September 2019|Anticipated|2019-09-01||Observational|||Sidus(TM) Post Market Clinical Follow-up (PMCF) Study|Sidus(TM) Stem-Free Shoulder - A Multi-center, Prospective, Non-controlled Post Market Clinical Follow-up Study.|Active, not recruiting||N/A|160|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-11 02:26:38.333862|2017-10-11 02:26:38.333862
NCT01700530|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-01-04|2014-10-14||May 2007||2007-05-01|January 2016|2016-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||Sedentary, obese, 2/5 metabolic syndrome risk factors, males and females|Exercise, Statins, and the Metabolic Syndrome|Exercise, Statins, and the Metabolic Syndrome|Completed||N/A|121|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-10-11 02:26:38.505865|2017-10-11 02:26:38.505865
NCT01700517|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2013-03-19|2012-10-21||December 2011||2011-12-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|PAINCONTROL||Postoperatory Analgesia After Total Knee Arthroplasty|Postoperatory Analgesia After Total Knee Arthroplasty Comparing Femoral and Sciatic-femoral Block|Completed||N/A|120|Actual|Hospital Madre Teresa|The relative small sample size is one of them. Differences between groups are expected to grow as sample size increases. Despite an improvement in pain control with femoral and sciatic femoral blocks, the morphine consumption was not reduced.|3|||f||||t||||||||||2017-10-11 02:26:38.971468|2017-10-11 02:26:38.971468
NCT01700504|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-10-02|||May 2011||2011-05-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Gentamicin Lavage of the Axillary Surgical Bed After Lymph Node Dissection on Drainage Discharge Volume||Completed||Phase 3|40|Actual|Hospital General Universitario Elche||2|||f||||||||||||||2017-10-11 02:26:41.580591|2017-10-11 02:26:41.580591
NCT01700491|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2015-12-11|||October 2012||2012-10-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ParaEpi||Pilot Study: Paravertebral Analgesia vs Epidural Analgesia After Thoracotomy|Pilot Study: A Non-Inferiority Trial of the Analgesic Effect of Paravertebral Analgesia to Epidural Analgesia for the Management of Post-Operative Pain After Thoracotomy|Terminated||Phase 3|21|Actual|University of Manitoba||2||Difficulty in recruiting and maintenance of blinding necessary for the trial|f||||f||||||||||2017-10-11 02:26:41.677235|2017-10-11 02:26:41.677235
NCT01700478|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2013-02-07|||February 2005||2005-02-01|October 2012|2012-10-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy|A Trial Comparing The Use Of Rectal Plus Perivascular Vasopressin With Perivascular Vasopressin Alone To Decrease Bleeding At The Time Of Myomectomy|Completed||Phase 4|45|Actual|University Hospital of the West Indies||1|||f||||f||||||||||2017-10-11 02:26:41.778649|2017-10-11 02:26:41.778649
NCT01700465|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-12-01|||September 2012||2012-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Estimating and Predicting Hemodynamic Changes During Hemodialysis|Estimating and Predicting Hemodynamic Changes During Hemodialysis|Completed||N/A|241|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 02:26:41.870333|2017-10-11 02:26:41.870333
NCT01700452|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-07-18|||April 2012||2012-04-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Diagnostic Study for Lung Cancer Detection Test|Clinical Study of BioView Target -FISH Lung Cancer Detection Test|Completed||N/A|173|Actual|Bioview, Inc.|||1||f||||f||||||Samples Without DNA|"     sputum specimens, fixed and stained for diagnostic testing   "|No||2017-10-11 02:26:41.943428|2017-10-11 02:26:41.943428
NCT01700426|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2014-03-25|||June 2011||2011-06-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E|Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E|Completed||Phase 1|44|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:26:42.175569|2017-10-11 02:26:42.175569
NCT01700413|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-01-27|||October 2012||2012-10-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia|Treatment of di Novo Acute Myeloid Leukemia With the Combination of Increasing Doses of Idarubicin, Cytarabine and Sensitization (Priming) With G-CSF. A Phase II Prospective Study of Toxicity and Efficacy.|Completed||Phase 2|48|Actual|Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias||1|||f||||f||||||||||2017-10-11 02:26:42.319069|2017-10-11 02:26:42.319069
NCT01700400|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2014-11-21|||September 2012||2012-09-01|May 2014|2014-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer|Phase I Dose Escalation Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab in Stage IV Non-Squamous Non-Small Cell Lung Cancer|Completed||Phase 1|13|Actual|Cancer Research and Biostatistics Clinical Trials Consortium||1|||f||||f||||||||||2017-10-11 02:26:42.487308|2017-10-11 02:26:42.487308
NCT01700387|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2014-11-12|2014-10-07||October 2012||2012-10-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Only those subjects which randomized were included in the baseline analysis.|A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency|A Randomized, Pilot Study to Evaluate the Tolerability of OnabotulinumtoxinA Plus Topiramate vs. OnabotulinumtoxinA Plus Placebo and Long Term Effect of Treatment on Cognitive Efficiency and Continuation of Care|Completed||Phase 4|20|Actual|Cady, Roger, M.D.||2|||f||||t||||||||||2017-10-11 02:26:42.666688|2017-10-11 02:26:42.666688
NCT01700374|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-09-01|||August 2012||2012-08-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|FAP||Happy Mommy! Happy Baby! Study|Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response|Recruiting||N/A|1500|Anticipated|University of Pennsylvania|||2||f||||f||||||Samples Without DNA|"     -  Salivary cortisol;        -  Blood plasma Corticotropin-releasing Hormone (CRH).   "|||2017-10-11 02:26:43.176958|2017-10-11 02:26:43.176958
NCT01700361|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-05-30|||October 2012||2012-10-01|May 2017|2017-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|VESPA||Visual Erotica, EMG, and Sexual Psychophysiological Arousal (VESPA)|Visual Erotica, EMG, and Sexual Psychophysiological Arousal (VESPA)|Completed||N/A|15|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 02:26:43.30503|2017-10-11 02:26:43.30503
NCT01700348|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-05-28|2015-02-26||August 2012||2012-08-01|May 2015|2015-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Data cannot be provided for each arm separately, but only in aggregate|Philips AirFlosser Study|An Investigation of the Effects of a Oral Hygiene Regimen in Irregular Flossers on Gingivitis and Plaque|Terminated||N/A|257|Actual|Tufts University School of Dental Medicine|"Terminated by sponsor due to:
Changes in business strategy/Target completion dates not being met
Higher than anticipated screen failure rate
Higher than anticipated early termination rate
Large number of protocol deviations encountered"|2||"Study terminated by sponsor due to low accrual, and high number of protocol deviations due in   part to the impact of Hurricane Sandy on protocol compliance."|f||||f||||||||||2017-10-11 02:26:43.38641|2017-10-11 02:26:43.38641
NCT01700335|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-10-17|2016-07-26||June 2012||2012-06-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)|Phase I Clinical Trial of SyB L-1101 in Patients With Myelodysplastic Syndrome|Completed||Phase 1|9|Actual|SymBio Pharmaceuticals||1|||f||||||||||||||2017-10-11 02:26:43.613113|2017-10-11 02:26:43.613113
NCT01700322|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-09-04|||August 2012||2012-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|EST||Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study|Effects of Clopidogrel vs Prasugel vs Ticagrelor on Endothelial Function, Inflammatory and Oxidative Stress Parameters and Platelet Function in Patients Undergoing Coronary Artery Stenting. A Randomised, Prospective Study.|Completed||Phase 4|126|Actual|Johannes Gutenberg University Mainz||3|||f||||t||||||||||2017-10-11 02:26:44.107005|2017-10-11 02:26:44.107005
NCT01700309|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-04-14|||January 2012||2012-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|YFH||Young, Fit and Happy. A Web-based Intervention to Prevent Obesity in Adolescents.|Young Fit and Happy - Meaningful Physical Activity as Means to Improve Quality of Life and Prevent Weight Gain in Over-weight and Obese Adolescents. A Web-based Intervention.|Completed||N/A|120|Actual|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-11 02:26:44.192595|2017-10-11 02:26:44.192595
NCT01700296|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-04-06|||January 2013||2013-01-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|January 2015|Actual|2015-01-01||Interventional|||COPD, Inflammation and Rehabilitation|COPD, Inflammation and Rehabilitation|Completed||N/A|47|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 02:26:44.402418|2017-10-11 02:26:44.402418
NCT01700283|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2012-11-12|||October 2012||2012-10-01|October 2012|2012-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Developing Objective Fatigue Indicators in Colorectal Cancer Survivors.|Developing Objective Fatigue Indicators: Exploring the Relationships Among Fatigue, Muscle Power and Metabolomics Through Fatigue Management and Individualized Exercise Education Program in Colorectal Cancer Survivors.|Unknown status|Recruiting|N/A|306|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:26:44.482133|2017-10-11 02:26:44.482133
NCT01700270|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-11-04|||May 2013||2013-05-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CTKI258A2120||Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.|A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of the CYP1A2 Inhibitor, Fluvoxamine, on Dovitinib (TKI258) Pharmacokinetics in Patients With Advanced Solid Tumors|Completed||Phase 1|45|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:26:44.596728|2017-10-11 02:26:44.596728
NCT01700257|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-09-12|||May 2012||2012-05-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker|Different Strategies Using Autoantibodies and/or CT Scan Detection of Lung Cancer|Recruiting||Phase 2|1600|Anticipated|National Jewish Health||1|||f||||t||||||||||2017-10-11 02:26:44.717154|2017-10-11 02:26:44.717154
NCT01700244|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2013-06-25|||December 2012||2012-12-01|June 2013|2013-06-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|||Evaluation of a New Cardiac Pacemaker||Unknown status|Active, not recruiting|N/A|36|Anticipated|Nanostim, Inc.||1|||f||||t||||||||||2017-10-11 02:26:44.815277|2017-10-11 02:26:44.815277
NCT01700231|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-04-06|||October 2010||2010-10-01|April 2015|2015-04-01||||August 2013|Actual|2013-08-01||Observational|||Plasma and Hemodynamic Markers During Hepatectomy|Monitoring Plasma and Hemodynamic Markers in Patients Undergoing Liver Resection to Identify Pathophysiological Mechanisms and Predict Clinical Outcome|Completed||N/A|100|Actual|Medical University of Vienna|||1||f||||f||||||Samples With DNA|"     perioperative plasma samples   "|||2017-10-11 02:26:44.912408|2017-10-11 02:26:44.912408
NCT01700218|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-11-23|||October 2012||2012-10-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Interventional|INTENSE-HF||Integrated Telemonitoring and Nurse Support Evaluation|Integrated Telemonitoring and Nurse Support Evaluation in Heart Failure|Unknown status|Recruiting|N/A|350|Anticipated|Medical University of Graz||2|||f||||t||||||||||2017-10-11 02:26:45.000685|2017-10-11 02:26:45.000685
NCT01700205|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-06-05|||October 2012|Actual|2012-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|February 2017|Actual|2017-02-01||Interventional|GRO||"Watch Your Baby Grow Study"|Impact of Diet Composition on Energy Balance and Satiety During Infancy|Active, not recruiting||N/A|144|Anticipated|Monell Chemical Senses Center||2|||f||||f||||||||||2017-10-11 02:26:45.1559|2017-10-11 02:26:45.1559
NCT01700192|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-09-14|2017-01-11||January 2013||2013-01-01|September 2017|2017-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Baseline Characteristics refer to all randomized participants.|Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)|A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)|Completed||Phase 3|1482|Actual|ALK-Abelló A/S||2|||f||||t||||||||||2017-10-11 02:26:45.317718|2017-10-11 02:26:45.317718
NCT01700179|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-10-02|2014-09-30||September 2012||2012-09-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||The analysis population for baseline characteristics was all enrolled subjects.|Evaluation of Safety Tolerability and Antiviral Activity of ACH-0143102 Plus RBV Treatment Naive HCV GT1b Subjects|A Phase 1b, Open-label, Pilot Study to Evaluate the Safety, Tolerability and Antiviral Activity of Oral ACH-0143102 Administered in Combination With Ribavirin for 12 Weeks in Treatment Naive Subjects With Chronic Hepatitis C Virus Infection Genotype 1b.|Completed||Phase 1|8|Actual|Achillion Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:26:46.170157|2017-10-11 02:26:46.170157
NCT01700166|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-01-21|||September 2012||2012-09-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|August 2013|Actual|2013-08-01||Interventional|Pedi Stroke||Umbilical Cord Blood in the Treatment of Stroke in Children.|Safety of Autologous Human Umbilical Cord Blood in the Treatment of Stroke in Children.|Withdrawn||Phase 1|0|Actual|Memorial Hermann Health System||1||Principal Investigator relocated; Study may resume in Fl Hosp. for Children, Orlando FL|f||||t||||||||||2017-10-11 02:26:46.497176|2017-10-11 02:26:46.497176
NCT01700153|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2013-05-06|||September 2012||2012-09-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy Study of an Interactive Robot for the Rehabilitation of the Upper Limb in Children With Cerebral Palsy|Study of the Effectiveness of an Interactive Robot for the Rehabilitation of the Upper Limb in Children With Cerebral Palsy by Evaluating the 3 Fields of the ICF: A Prospective, Randomized, Controlled, Simple Blind Study.|Completed||N/A|16|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 02:26:46.605934|2017-10-11 02:26:46.605934
NCT01700140|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2014-11-11|2014-10-01||May 2011||2011-05-01|November 2014|2014-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||"Per protocol set:
Of all the randomized subjects, those who were compliant with the protocol were included in the per protocol set."|Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)|Phase II Clinical Study of SyB D-0701 for Radiotherapy Induced Nausea and Vomiting|Completed||Phase 2|189|Actual|SymBio Pharmaceuticals||3|||f||||||||||||||2017-10-11 02:26:46.794887|2017-10-11 02:26:46.794887
NCT01700127|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2013-06-25|||October 2012||2012-10-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PPIR||Predictors of Poor Immune Response to Rotavirus Vaccine in Infants|Predictors of Poor Immune Response to Rotavirus Vaccine in Infants|Completed||N/A|400|Actual|Society for Applied Studies||2|||f||||f||||||||||2017-10-11 02:26:48.598024|2017-10-11 02:26:48.598024
NCT01700114|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-03-10|||November 2012||2012-11-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Post-Approval Study of MelaFind|Post-Approval Study of MelaFind|Terminated||N/A|487|Actual|MELA Sciences, Inc.|||1|FDA withdrew requirement to complete study|f||||f||||||Samples Without DNA|"     pathology slides of biopsied tissue   "|No||2017-10-11 02:26:48.717105|2017-10-11 02:26:48.717105
NCT01700088|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-12-10|||November 2012||2012-11-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Effect of Nasal Cannulae During the First 2 Hours Postoperative in Patient Undergoing Thoracotomy|The Effect of Nasal Cannulae During the First 2 Hours Postoperative in Patient|Completed||N/A|35|Actual|Mahidol University|||1||f||||f||||||||||2017-10-11 02:26:48.882145|2017-10-11 02:26:48.882145
NCT01700075|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2012-10-03|||January 2009||2009-01-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2009|Actual|2009-12-01||Interventional|PCSAM||Physical and Chemical Study of Atherosclerosis Mechanisms|Comparative Physical and Chemical Study of the Mechanisms of Atherosclerosis With Development of Concept of Treatment and Prevention|Completed||Phase 4|97|Actual|Republican Scientific Center for Emergency Medicine||2|||f||||t||||||||||2017-10-11 02:26:48.959879|2017-10-11 02:26:48.959879
NCT01700062|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2012-10-02|||April 2007||2007-04-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Medium Calorie Parenteral Nutrition on Patients With Gastrointestinal Cancer Undergoing Surgery|Assessment the Effect of Medium-Calorie TPN on Patients With Gastrointestinal Cancer Undergoing Surgery|Completed||Phase 4|40|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:26:49.08068|2017-10-11 02:26:49.08068
NCT01700049|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-07-21|||January 14, 2013|Actual|2013-01-14|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 3, 2017|Actual|2017-07-03||Interventional|||Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes|ML28485:Phase 2B Single-site,Open-label,Nonrandomized Study Evaluating Efficacy of Oral Vismodegib in Various Histologic Subtypes (Infiltrative/Morpheaform,Nodular and Superficial)of High Risk and/or Locally Advanced Basal Cell Carcinoma|Active, not recruiting||Phase 2|28|Actual|St. Louis University||1|||f||||t||||||||||2017-10-11 02:26:49.197455|2017-10-11 02:26:49.197455
NCT01700010|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2013-01-15|||November 2012||2012-11-01|January 2013|2013-01-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer|Phase II Trial of Lapatinib and Weekly Paclitaxel for Advanced Platinum Refractory Urothelial Cancer|Withdrawn||Phase 2|0|Actual|University of Michigan Cancer Center||1||Funding issues.|f||||t||||||||||2017-10-11 02:26:49.486033|2017-10-11 02:26:49.486033
NCT01699997|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-02-23|||January 2014||2014-01-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|April 2015|Actual|2015-04-01||Interventional|||Oxytocin as Adjunctive Therapy for Schizophrenia|The Use of Oxytocin as Adjunctive Therapy for the Treatment of Schizophrenia: a Randomized, Double Blind Trial|Completed||Phase 2|32|Actual|IRCCS Centro San Giovanni di Dio Fatebenefratelli||2|||f||||t||||||||||2017-10-11 02:26:49.585531|2017-10-11 02:26:49.585531
NCT01699984|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2012-10-02|||February 2011||2011-02-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Observational|||PERDOVE ANZIANI: a Prospective Cohort Study on Older Patients|THE HOSPITALIZATION OF OLDER PATIENTS: RISK FACTORS, ADVERSE EVENTS AND OUTCOMES. A MULTICENTRE STUDY.|Completed||N/A|329|Actual|IRCCS Centro San Giovanni di Dio Fatebenefratelli|||1||f||||t||||||Samples Without DNA|"     Blood samples for the assessment of APOE genetic polymorphisms; routine lab examinations.   "|||2017-10-11 02:26:49.711601|2017-10-11 02:26:49.711601
NCT01699971|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-03|||October 2006||2006-10-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2009|Actual|2009-03-01||Interventional|||Randomized Controlled Study Comparing Three Different Techniques for Open Hernia Repair|Randomized Controlled Study Comparing Three Different Techniques for Open|Completed||N/A|160|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 02:26:49.811859|2017-10-11 02:26:49.811859
NCT01699958|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2012-10-01|||June 2011||2011-06-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Brief Outpatient Problem-solving Intervention to Promote Healthy Eating and Activity Habits in Adolescents|"A Pilot Study of the Healthy Living Study, a Randomized Controlled Trial of a Brief Outpatient Problem-solving Intervention to Promote Healthy Eating and Activity Habits in Adolescents."|Completed||N/A|50|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 02:26:49.893121|2017-10-11 02:26:49.893121
NCT01699945|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-10-28|||August 2012||2012-08-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|AMANHI||Using Ongoing Newborn Intervention Trials to Obtain Additional Data Critical to Maternal, Fetal and Newborn Health in a Harmonized Way|Using Ongoing Newborn Intervention Trials to Obtain Additional Data Critical to Maternal, Fetal and Newborn Health in a Harmonized Way: The AMANHI* Study *Alliance for Maternal and Newborn Health Improvement (AMANHI)|Completed||N/A|2258|Actual|Society for Applied Studies|||1||f||||t||||||||||2017-10-11 02:26:49.973924|2017-10-11 02:26:49.973924
NCT01699932|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-05-07|||September 2012||2012-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|LEGEND||Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled|A Multinational, Open Label, Non Comparative, 24-week Study to Evaluate the Blood Glucose Lowering Efficacy and Safety of a Fixed Dose Combination of Glimepiride and Metformin in Patients With Inadequately Controlled Type 2 Diabetes|Completed||Phase 3|167|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:26:50.126104|2017-10-11 02:26:50.126104
NCT01699919|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-10-03|||April 2011||2011-04-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Assess Analgesic Efficacy of Intravenous Lignocaine|Effect of Perioperative Systemic Lignocaine on Postoperative Pain in Patients Undergoing Elective Open Abdominal Surgeries- a Double Blinded Randomized Control Trial|Completed||Phase 4|134|Actual|Jawaharlal Institute of Postgraduate Medical Education & Research||2|||f||||f||||||||||2017-10-11 02:26:50.248874|2017-10-11 02:26:50.248874
NCT00005167|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1984||1984-07-01|April 2000|2000-04-01|December 1991|Actual|1991-12-01|||||Observational|||Diet Modification and Blood Pressure in Young People||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.102817|2017-10-11 04:26:35.102817
NCT01699906|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-11-04|||September 2012||2012-09-01|June 2013|2013-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Diet Induced Weight Loss to Reduce Inflammation in Obese Women|Diet Induced Weight Loss Reduces Inflammation and Crown-like Structures and Corrects Immune Dysfunction in Subcutaneous Adipose Tissue In Class 2-3 Obese Women: A Pilot Study|Completed||N/A|22|Actual|Rockefeller University||1|||f||||f||||||||||2017-10-11 02:26:50.352544|2017-10-11 02:26:50.352544
NCT01699893|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-05-28|||September 2012||2012-09-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|LabExMI||Genetic & Environmental Determinants Of Immune Phenotype Variance: Establishing A Path Towards Personalized Medicine|Genetic & Environmental Determinants Of Immune Phenotype Variance: Establishing A Path Towards Personalized Medicine|Completed||N/A|1012|Actual|Institut Pasteur||1|||f||||f||||||||||2017-10-11 02:26:50.46027|2017-10-11 02:26:50.46027
NCT01699880|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2014-08-11|||March 2011||2011-03-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Observational|HAPI||Efficacy of High Flow Nasal Cannula Oxygen to Reduce Desaturation During Tracheal Intubation|High Flow Nasal Cannula Oxygen for Pre and During Procedure Oxygenation During Tracheal Intubation: Comparison With High FiO2 Non Rebreathing Bag Reservoir Facemasks|Completed||N/A|101|Actual|Hôpital Louis Mourier|||2||f||||f||||||||||2017-10-11 02:26:50.554979|2017-10-11 02:26:50.554979
NCT01699867|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-12-12|2014-12-05||December 2012||2012-12-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Observational||47 patients completed the study. 1 patient was excluded from the analysis due to insufficient images in all specimens (did not meet protocol specifications).|Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)|Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)|Completed||N/A|50|Actual|Diagnostic Photonics, Inc.|||1||f||||f||||||||||2017-10-11 02:26:50.671315|2017-10-11 02:26:50.671315
NCT01699854|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2014-02-25|||August 2012||2012-08-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Capsaicin Patch 8 % for the Treatment of Persistent Pain After Inguinal Herniotomy||Terminated||Phase 3|50|Anticipated|Rigshospitalet, Denmark||2||Expiration of the placebo patch|f||||t||||||||||2017-10-11 02:26:50.854157|2017-10-11 02:26:50.854157
NCT01699841|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-11-21|||April 2012||2012-04-01|November 2014|2014-11-01||||July 2013|Actual|2013-07-01||Observational|||Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events||Unknown status|Active, not recruiting|N/A|208|Anticipated|Cornell University|||1||f||||f||||||||||2017-10-11 02:26:50.949991|2017-10-11 02:26:50.949991
NCT01699828|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-06-03|||October 2012||2012-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET|Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET|Completed||Phase 1/Phase 2|6|Actual|Centre for Addiction and Mental Health||4|||f||||f||||||||||2017-10-11 02:26:51.047226|2017-10-11 02:26:51.047226
NCT01699815|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2014-08-26|2014-08-06||October 2012||2012-10-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|TIAA||Time of Intravenous Acetaminophen Administration|Time of Intravenous Acetaminophen Administration for Total Hip Arthroplasty|Completed||Phase 4|126|Actual|Duke University||2|||f||||t||||||||||2017-10-11 02:26:51.176045|2017-10-11 02:26:51.176045
NCT01699802|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2015-05-13|||September 2012||2012-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)|Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)|Completed||N/A|12|Actual|Region Skane||1|||f||||f||||||||||2017-10-11 02:26:51.708331|2017-10-11 02:26:51.708331
NCT01699789|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-04-13|2014-05-06||January 2009||2009-01-01|April 2017|2017-04-01|May 31, 2016|Actual|2016-05-31|May 31, 2016|Actual|2016-05-31||Interventional|CPIC||Community Partners in Care is a Research Project Funded by the National Institutes of Health|CPIC is a Community Partnered Participatory Research (CPPR) Project of Community and Academic Partners Working Together to Learn the Best Way to Reduce Depression in Our Communities.|Completed||N/A|1246|Actual|RAND|Communities had history of using CPPR for depression. Response rates moderate for agencies, high for programs. Convenience samples of sites. Client retention rates lower than other QI studies. Outcomes rely on client self-report at 6-month follow-up.|2|||f||||f||||||||||2017-10-11 02:26:51.832548|2017-10-11 02:26:51.832548
NCT01699776|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-11-08|||April 2008||2008-04-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|Dig&Iva||Efficacy Study of Digoxin & Ivabradine to Treat Heart Failure|Comparison of Digoxin and Ivabradine in Heart Failure With Preserved Systolic Function. Time to Rethink About Digoxin.|Completed||Phase 4|22|Actual|Cocco, Giuseppe, M.D.||2|||f||||t||||||||||2017-10-11 02:26:53.204916|2017-10-11 02:26:53.204916
NCT01699763|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2016-01-29|2013-09-20||October 2012||2012-10-01|January 2016|2016-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Evaluation of Blood Glucose Monitoring Systems|Evaluation of Blood Glucose Meter Systems - Contour® NEXT LINK Study|Completed||N/A|112|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 02:26:53.349529|2017-10-11 02:26:53.349529
NCT01699750|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-12-03|2014-12-01||December 2012||2012-12-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||This analysis population includes all randomized and dispensed participants.|Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems|Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems|Completed||N/A|109|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:26:53.623062|2017-10-11 02:26:53.623062
NCT01699737|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2013-07-25||2013-07-25|September 2012||2012-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus|A Phase 2, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of JTT-851 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|325|Actual|Akros Pharma Inc.||5|||f||||f||||||||||2017-10-11 02:26:54.090741|2017-10-11 02:26:54.090741
NCT01699724|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2012-10-31|||September 2012||2012-09-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects|Phase 1, Open-Label, Randomized, Single-Dose, 3-Way Crossover Assessing Bioequivalence Of Zoloft ODT 50 Mg Under Fasting Condition With And Without Water To Jzoloft Tablet 50 Mg Under Fasting Condition With Water In Healthy Japanese Subjects|Completed||Phase 1|30|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:26:54.373041|2017-10-11 02:26:54.373041
NCT01699711|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-02-10|||February 2012||2012-02-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Interventional|||Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool|Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool|Completed||Phase 2|87|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 02:26:54.475461|2017-10-11 02:26:54.475461
NCT01699698|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-09-02|2015-06-30||October 2012||2012-10-01|September 2015|2015-09-01||||July 2014|Actual|2014-07-01||Interventional|||Pancreatic Juice Diagnosis From Duodenum|Pancreatic Juice Diagnosis From Duodenum|Completed||N/A|105|Actual|Olympus Corporation||1|||f||||t||||||||||2017-10-11 02:26:54.575756|2017-10-11 02:26:54.575756
NCT01699685|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-01-11|2015-06-26||November 2012||2012-11-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|SYNERGY|Demographic summary by treatment group (safety population, N = 77)|Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.|A Multicenter, Randomized, Double-blind, Single-dose Study to Assess the Effect of the QAB149 and NVA237 Combination Versus QAB149 Alone on Inspiratory Capacity in Patients With Moderate or Severe COPD.|Completed||Phase 3|79|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:26:54.919586|2017-10-11 02:26:54.919586
NCT01699672|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-01-25|||October 2012||2012-10-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Group-based or Individual Information About Disease and Treatment Plan|Cancer Patients' Knowledge and Satisfaction After Group-based or Individual Information About Their Disease and Treatment Plan|Terminated||N/A|98|Actual|Norwegian University of Science and Technology||2||Problems recruiting patients (not willing, travel time, no respons)|f||||f||||||||||2017-10-11 02:26:55.523369|2017-10-11 02:26:55.523369
NCT01699659|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-10-03|||April 2012||2012-04-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||The Efficacy & Safety of the UAS Immunotherapy Protocol|The Efficacy and Safety of the United Allergy Service (UAS) Immunotherapy Protocol|Completed||N/A|60|Actual|United Allergy Services|||1||f||||t||||||||||2017-10-11 02:26:55.627191|2017-10-11 02:26:55.627191
NCT01699646|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-10-03|||December 2005||2005-12-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|January 2011|Actual|2011-01-01||Interventional|||Cadiotocography Combined With ST-analysis Versus Cardiotocography Combined With Scalp-pH|Cardiotocography Combined With ST-analysis Versus Cardiotocography Combined With Scalp-pH in Deliveries With Abnormal CTG - A Randomised Trial|Terminated||N/A|1025|Actual|Hvidovre University Hospital||2||slow enrollment|f||||f||||||||||2017-10-11 02:26:55.703948|2017-10-11 02:26:55.703948
NCT01699633|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2012-10-11|||October 2012||2012-10-01|September 2012|2012-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Rifampin and Nevirapine Interactions in Young Children|Effect of Rifampin-containing Anti-TB Therapy on Nevirapine Plasma Pharmacokinetics in HIV/TB Co-infected Children < 3 Years Old|Unknown status|Recruiting|N/A|58|Anticipated|The Miriam Hospital|||1||f||||t||||||Samples With DNA|"     EDTA Plasma Whole blood DNA   "|||2017-10-11 02:26:55.790492|2017-10-11 02:26:55.790492
NCT01699620|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2015-01-13|||August 2012||2012-08-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional|||Comparative Study of Two Surgical Techniques for Soft Tissue Healing and Implant Stability of Cochlear BI300 Implants.|Evaluation of Soft Tissue Healing and Implant Stability of Cochlear Baha BI300 Implants Loaded From 2 Weeks Post-surgery: a Comparison Between Two Surgical Techniques.|Completed||N/A|49|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 02:26:55.89154|2017-10-11 02:26:55.89154
NCT01699607|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-12-15|2015-07-14||June 2012||2012-06-01|December 2016|2016-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|phno_amth||Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion Paradigm|Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion|Completed||N/A|10|Actual|Yale University|Preliminary data. Small subject number.|1|||f||||f||||||||No||2017-10-11 02:26:56.148606|2017-10-11 02:26:56.148606
NCT01699594|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-04-08|||October 2012||2012-10-01|October 2013|2013-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Change in Airway Responsiveness After Allergen Exposure|Allergen Induced Increase in Indirect Non-allergic Bronchial Reactivity|Completed||N/A|11|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 02:26:56.460031|2017-10-11 02:26:56.460031
NCT01699581|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-10-17|||September 2012||2012-09-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|June 2014|Actual|2014-06-01||Interventional|||Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant|Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant|Terminated||Phase 2|35|Actual|University of Kentucky||1||Research cancelled following interim analysis|f||||t||||||||||2017-10-11 02:26:56.556699|2017-10-11 02:26:56.556699
NCT01699568|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2013-02-14|||February 2012||2012-02-01|February 2013|2013-02-01||||July 2013|Anticipated|2013-07-01||Interventional|||Stability of Implants With Different Surface Treatment: Randomized Clinical Trial|Stability of Implants With Different Surface Treatment: Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|42|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:26:56.642137|2017-10-11 02:26:56.642137
NCT01699555|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-12-04|||July 2011||2011-07-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||First-in-Human Study With GNbAC1 in Healthy Volunteers|Randomized Placebo-Controlled First-in-Human Study With GNbAC1|Completed||Phase 1|33|Actual|GeNeuro Innovation SAS||2|||f||||f||||||||||2017-10-11 02:26:56.722405|2017-10-11 02:26:56.722405
NCT01699542|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2017-06-26|||April 2013||2013-04-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|September 2016|Actual|2016-09-01||Interventional|||WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture|A Multi-Center, Prospective, Randomized (RCT) Study Comparing WallFlex® Esophageal Fully Covered (FC) Metal Stent to Bougie Dilation for the Treatment of Refractory Anastomotic Esophageal Strictures|Active, not recruiting||Phase 4|44|Anticipated|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 02:26:56.801549|2017-10-11 02:26:56.801549
NCT01699529|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-10-24|||September 2012||2012-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|March 2014|Actual|2014-03-01||Interventional|||Multi-electrode Radiofrequency Renal Denervation System Feasibility Study|Multi-electrode Radiofrequency Renal Denervation System Feasibility Study|Completed||N/A|50|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-10-11 02:26:56.914674|2017-10-11 02:26:56.914674
NCT00005168|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1984||1984-08-01|May 2000|2000-05-01|December 1991|Actual|1991-12-01|||||Observational|||Hyperapo B and Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.171115|2017-10-11 04:26:35.171115
NCT01699516|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-01|||January 2008||2008-01-01|October 2012|2012-10-01||||May 2012|Actual|2012-05-01||Observational|||Non-invasive Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft-vs-Host Disease|A Prospective Study on Qualitative and Quantitative Non-invasive Evaluation of Intestinal Acute Graft-vs-host Disease by Contrast Enhanced Ultrasound Sonography|Unknown status|Recruiting|N/A|32|Anticipated|University of Pisa|||2||f||||f||||||||||2017-10-11 02:26:57.003421|2017-10-11 02:26:57.003421
NCT01699503|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-09-30|||October 2012||2012-10-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|IU-CHOICE||Indiana University Dementia Screening Trial|Indiana University Dementia Screening Trial: The IU CHOICE Study|Active, not recruiting||N/A|4000|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 02:26:57.090709|2017-10-11 02:26:57.090709
NCT01699490|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-30|2014-09-26|||August 2012||2012-08-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder|Role of Inflammation Factors and Insulin Resistance in the Pathophysiology and Treatment Response of Major Depressive Disorder|Unknown status|Recruiting|Phase 4|200|Anticipated|National Cheng-Kung University Hospital||2|||f||||t||||||||||2017-10-11 02:26:57.219171|2017-10-11 02:26:57.219171
NCT01699464|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2015-12-07||2014-02-17|October 2012||2012-10-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months|Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months|Completed||Phase 2|211|Actual|Aerie Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:26:57.518374|2017-10-11 02:26:57.518374
NCT01699451|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-30|2017-03-21|||September 2012||2012-09-01|March 2017|2017-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida|DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida|Enrolling by invitation||N/A|160|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     This study will establish a repository of stored DNA, RNA, monocyte, lymphocyte and skin     fibroblast samples from people with ALS and ALS-FTD, subjects with a family history of ALS     who do not have ALS or ALS-FTD, and subjects with no personal history of ALS or dementia, to     support future translational and basic research studies on ALS and related neurodegenerative     disorders.   "|||2017-10-11 02:26:57.645812|2017-10-11 02:26:57.645812
NCT01699438|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2017-02-23|||April 2012|Actual|2012-04-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|MIBS||Mesalazine Treatment in IBS (The MIBS Study)|Mesalazine Treatment in IBS, a Double-blind Placebo-controlled Phase II Intervention Study in Adult Patients|Completed||Phase 2|211|Actual|Göteborg University||2|||f||||t||||||||||2017-10-11 02:26:57.725658|2017-10-11 02:26:57.725658
NCT01699425|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2017-03-27|||March 2013||2013-03-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Multicentric Comparative Randomized Study of the Single-incision Sling Ajust® Versus Suburethral Transobturator Slings.|Multicentric Comparative Randomized Study of the Single-incision Sling Ajust® Versus Suburethral Transobturator Slings.|Completed||N/A|60|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||||||||||||2017-10-11 02:26:57.850176|2017-10-11 02:26:57.850176
NCT01699412|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-09-30|||August 2008||2008-08-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease|Randomized Double-blid Clinical Trial Comparing the Topical Treatment With Clobetasol and Dexamethasone for Oral Lesions of Chronic Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients|Completed||Phase 3|28|Actual|Grupo de Estudos Multicentricos em Onco-Hematologia||2|||f||||f||||||||||2017-10-11 02:26:57.984253|2017-10-11 02:26:57.984253
NCT01699399|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-30|2014-07-29|||August 2012||2012-08-01|July 2014|2014-07-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Comparing Water Exchange, Water Immersion and Air Insufflation Methods During Colonoscopy With the Option of on Demand Sedation|A Randomized, Controlled Trial Comparing Water Exchange, Water Immersion and Air Insufflation Methods During Colonoscopy With the Option of on Demand Sedation|Unknown status|Recruiting|N/A|225|Anticipated|Dalin Tzu Chi General Hospital||3|||f||||f||||||||||2017-10-11 02:26:58.120477|2017-10-11 02:26:58.120477
NCT01699386|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2012-10-02|||April 1999||1999-04-01|October 2012|2012-10-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Growth of Infants Fed an Elemental Medical Food|Growth of Infants Fed an Elemental Medical Food|Completed||Phase 3|213|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-10-11 02:26:58.256988|2017-10-11 02:26:58.256988
NCT01699373|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-30|2013-02-27|2013-02-27||April 2011||2011-04-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||A Trial on Ultrasound-assisted Spinal Anaesthesia|A Randomised Controlled Trial on Ultrasound-assisted Spinal Anaesthesia|Completed||N/A|170|Actual|Changi General Hospital|Baseline characteristics not equal|2|||f||||f||||||||||2017-10-11 02:26:58.375117|2017-10-11 02:26:58.375117
NCT01699360|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-09-30|||September 2012||2012-09-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients|The Biomarker for CYP3A-mediated Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients|Unknown status|Recruiting|Phase 4|600|Anticipated|Central South University||1|||f||||f||||||||||2017-10-11 02:26:58.635846|2017-10-11 02:26:58.635846
NCT01699347|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2013-11-28|||September 2012||2012-09-01|November 2013|2013-11-01|January 2016|Anticipated|2016-01-01|January 2014|Anticipated|2014-01-01||Interventional|OK432||Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432|Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432|Unknown status|Recruiting|Phase 4|5|Anticipated|Carmel Medical Center||1|||f||||t||||||||||2017-10-11 02:26:58.713781|2017-10-11 02:26:58.713781
NCT01699334|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-06-10|||October 2012||2012-10-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|December 2016|Anticipated|2016-12-01||Interventional|||Effectiveness of an Educational Video Following Acute Whiplash Trauma|Effectiveness of an Educational Video Following Acute Whiplash Trauma: A Randomized Controlled Trial|Recruiting||N/A|300|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 02:26:58.807582|2017-10-11 02:26:58.807582
NCT01699321|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-06-15|||July 2012||2012-07-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|September 2013|Actual|2013-09-01||Interventional|FITShop||FITShop: Promoting Physical Activity in Black Barbershops|Promoting Physical Activity in Black Barbershops|Completed||N/A|628|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 02:26:58.907907|2017-10-11 02:26:58.907907
NCT01699308|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2013-05-13|||December 2009||2009-12-01|May 2013|2013-05-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|GH||Growth Hormone and Brain Functioning After Traumatic Brain Injury|Growth Hormone and Brain Functioning After Traumatic Brain Functioning|Unknown status|Recruiting|Phase 4|15|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 02:26:58.996402|2017-10-11 02:26:58.996402
NCT01699295|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-01-09|||September 2011||2011-09-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|A+PAAC||Physical Activity and Academic Achievement Across the Curriculum (A+PAAC)|Physical Activity and Academic Achievement Across the Curriculum (A+PAAC)|Completed||N/A|584|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 02:26:59.076787|2017-10-11 02:26:59.076787
NCT01699282|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-10-01|||July 2010||2010-07-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|EDUCA||Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education|Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education.|Unknown status|Recruiting|Phase 3|186|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:26:59.161934|2017-10-11 02:26:59.161934
NCT01699269|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-07-04|||April 2012||2012-04-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|TeDi-C2||Histopathologic Evaluation of High Grade Brain Tumors by High Order Diffusion Tensor Imaging|Histopathologic Evaluation of High Grade Brain Tumors by High Order Diffusion Tensor Imaging: Peritumoral Glial Cell Infiltration Quantitative Method|Completed||N/A|10|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 02:26:59.244646|2017-10-11 02:26:59.244646
NCT01699256|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-11-29|||October 2012||2012-10-01|July 2015|2015-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Enhanced Implementation of Low Back Pain Guidelines in General Practice|Enhanced Implementation of Low Back Pain Guidelines in General Practice: A Cluster Randomized Trial|Completed||N/A|1101|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:26:59.318889|2017-10-11 02:26:59.318889
NCT01699243|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-12-01|||September 2012||2012-09-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Continuous Noninvasive Method for Estimating and Predicting Maternal and Fetal Hemodynamic Changes During Regional Anesthesia|A Continuous, Noninvasive Method for Estimating and Predicting Maternal and Fetal Hemodynamic Changes During Regional Anesthesia|Completed||N/A|19|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 02:26:59.441109|2017-10-11 02:26:59.441109
NCT01699230|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-10-01|||March 2011||2011-03-01|October 2012|2012-10-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|CORONOMEGA3||Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?|Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?|Unknown status|Recruiting|Phase 3|30|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:26:59.51864|2017-10-11 02:26:59.51864
NCT01699217|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-08-31|||June 2013|Actual|2013-06-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|CML0912||Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase|Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase. An Observational Multicentre Study of the GIMEMA CML WP.|Recruiting||N/A|120|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||||2017-10-11 02:26:59.655195|2017-10-11 02:26:59.655195
NCT01699204|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-09-27|||September 2007||2007-09-01|September 2017|2017-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Diesel Exhaust and Mechanism of Asthma|Effects of Diesel Exhaust on Airways|Completed||N/A|26|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-11 02:27:00.010924|2017-10-11 02:27:00.010924
NCT01699191|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-02|||October 2012||2012-10-01|October 2012|2012-10-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Interventional|ProCel||Probiotics for the Treatment of Irritable Bowel Syndrome in Celiac Patients||Unknown status|Not yet recruiting|N/A|120|Anticipated|University of Bari||2|||f||||f||||||||||2017-10-11 02:27:00.139935|2017-10-11 02:27:00.139935
NCT01699178|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-12-17|||August 2012||2012-08-01|December 2013|2013-12-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men|Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men|Unknown status|Active, not recruiting|Phase 4|182|Actual|Clarus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 02:27:01.957878|2017-10-11 02:27:01.957878
NCT01699165|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-04-18|||December 2012||2012-12-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)|Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis in a Double-blinded Randomized Placebo-controlled Crossover Pilot Study|Completed||N/A|24|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 02:27:02.10161|2017-10-11 02:27:02.10161
NCT01699152|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-05-05|||September 2012||2012-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|July 2015|Actual|2015-07-01||Interventional|||Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Phase 1 Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Completed||Phase 1|30|Anticipated|Tragara Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:27:02.223373|2017-10-11 02:27:02.223373
NCT01699139|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2015-02-09|||August 2012||2012-08-01|August 2012|2012-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effect of Positional Device on the Obstructive Sleep Apnea in Patients With Ischemic Stroke|The Effect of Positional Device on the Obstructive Sleep Apnea in Patients With Ischemic Stroke|Completed||N/A|13|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:27:02.361481|2017-10-11 02:27:02.361481
NCT01699126|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-10-16|||May 2010||2010-05-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|December 2012|Anticipated|2012-12-01||Interventional|||The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome|The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome|Unknown status|Recruiting|Phase 4|120|Anticipated|Chang Gung Memorial Hospital||4|||f||||t||||||||||2017-10-11 02:27:02.476284|2017-10-11 02:27:02.476284
NCT01699113|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-10-02|||August 2006||2006-08-01|September 2012|2012-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effects of YF476 and Rabeprazole on Gastric Function|Effects of YF476, a Gastrin Antagonist, and Rabeprazole, a Proton Pump Inhibitor, Alone and in Combination, on Gastric Function in Healthy Subjects|Completed||Phase 1|32|Actual|Trio Medicines Ltd.|||||f||||f||||||||||2017-10-11 02:27:02.612419|2017-10-11 02:27:02.612419
NCT01699100|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-10-02|||September 2011||2011-09-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Reduction of Plantar Pressure in Neuropathic Diabetic Foot Patients Using Insoles With Removable Pegs Design|Reduction of Plantar Pressure in Neuropathic Diabetic Foot Patients Using Offloading Technique: Insoles With Peg Assist Design|Completed||N/A|26|Actual|Taichung Veterans General Hospital||1|||f||||t||||||||||2017-10-11 02:27:02.715351|2017-10-11 02:27:02.715351
NCT01699087|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-02-27|2017-01-03||August 2012||2012-08-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||This analysis population includes all enrolled subjects who underwent PRK surgery (intent-to-treat).|A Safety and Effectiveness Study of PRK Using the ALLEGRETTO WAVE® EYE-Q Excimer Laser System|Prospective Safety and Effectiveness Study of PRK for Myopia With or Without Astigmatism Using the ALLEGRETTO WAVE® EYE-Q Excimer Laser System|Completed||N/A|176|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 02:27:02.828944|2017-10-11 02:27:02.828944
NCT01699074|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2014-04-14|||May 2013||2013-05-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|KWG||Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 Diabetes|Acute Dose Response Effects of Korean White Ginseng (Panax Ginseng C.A. Meyer) on Cardiovascular Disease Risk Factors in Individuals With Metabolic Syndrome or Type 2 Diabetes|Completed||Phase 1|30|Actual|St. Michael's Hospital, Toronto||5|||f||||||||||||||2017-10-11 02:27:03.440135|2017-10-11 02:27:03.440135
NCT01699061|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2013-09-30|||July 2012||2012-07-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Tivantinib on the QTC Interval in Cancer Subjects|A PHASE 1 SINGLE-BLIND, SINGLE-SEQUENCE STUDY ASSESSING THE EFFECT OF TIVANTINIB ON THE QTC INTERVAL IN CANCER SUBJECTS|Completed||Phase 1|38|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 02:27:03.550046|2017-10-11 02:27:03.550046
NCT01699048|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-09-27|||December 1, 2012|Actual|2012-12-01|September 2017|2017-09-01|September 16, 2017|Actual|2017-09-16|March 1, 2017|Actual|2017-03-01||Interventional|HREVS||The Comparative Effectiveness of Hybrid Revascularization (MIDCAB Then PCI) With DES Versus Multivessel DES PCI or CABG|Prospective, Single-center, Randomized Trial, Intended to Compare Three Revascularization Strategies in Patients With Multi-vessel Coronary Artery Disease|Completed||N/A|150|Actual|Russian Academy of Medical Sciences||3|||f||||f||||||||||2017-10-11 02:27:03.651645|2017-10-11 02:27:03.651645
NCT01699035|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2014-09-10|||February 2012||2012-02-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|December 2012|Actual|2012-12-01||Observational|||Survey on Return to Work After Stroke|Survivor Perspective on Critical Factors to Return to Work After Stroke|Completed||N/A|715|Actual|Shirley Ryan AbilityLab|||1||f||||f||||||||||2017-10-11 02:27:03.75561|2017-10-11 02:27:03.75561
NCT01699022|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2013-12-27|2012-12-12||June 2010||2010-06-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of Cyclofem|Pharmacokinetic and Pharmacodynamic Study of Cyclofem|Completed||Phase 1/Phase 2|17|Actual|Sun Pharmaceutical Industries Limited||1|||f||||f||||||||||2017-10-11 02:27:03.852125|2017-10-11 02:27:03.852125
NCT01699009|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-10-19|||October 2012||2012-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|WCCR-MIG2||A Nutritional Intervention for Migraines-2|A Nutritional Intervention for Migraines-2|Completed||N/A|24|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-10-11 02:27:04.194743|2017-10-11 02:27:04.194743
NCT01698996|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-03-30|||March 2013||2013-03-01|March 2015|2015-03-01||||March 2016|Anticipated|2016-03-01||Interventional|||A Randomized Blinded Trial of Abscess Management With Packing vs No Packing|A Randomized Blinded Trial of Abscess Management With Packing vs No Packing|Withdrawn||N/A|0|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:27:04.298236|2017-10-11 02:27:04.298236
NCT01698983|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-30|||June 2011||2011-06-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|||||Observational|||Ex Vivo Stimulation of Whole Blood as a Means to Determine Glucocorticoid Sensitivity to Mild-to-Moderate and Refractory Asthmatics|Ex Vivo Stimulation of Whole Blood as a Means to Determine Glucocorticoid Sensitivity to Mild-to-Moderate and Refractory Asthmatics|Terminated||N/A|14|Actual|Ohio State University|||1|data not as expected|f||||f||||||||||2017-10-11 02:27:04.408984|2017-10-11 02:27:04.408984
NCT01698970|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-12-06|||February 2004||2004-02-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2007|Actual|2007-03-01||Interventional|||Effect of the Consumption of a Probiotic Strain on the Prevention of Post-operative Recurrence in Crohn's Disease|Effect of the Consumption of a Probiotic Strain on the Prevention of Post-operative Recurrence in Crohn's Disease|Completed||N/A|122|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 02:27:04.496407|2017-10-11 02:27:04.496407
NCT01698957|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-11-21|||September 2012||2012-09-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Observational|||Maternal Uterine Artery Doppler Study|A Simple Technique to Modify Maternal Uterine Artery Perfusion.|Completed||N/A|52|Actual|Mednax Center for Research, Education and Quality|||1||f||||f||||||||||2017-10-11 02:27:04.595842|2017-10-11 02:27:04.595842
NCT01698944|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-02-23|||May 16, 2001|Actual|2001-05-16|February 2017|2017-02-01|November 18, 2002|Actual|2002-11-18|November 18, 2002|Actual|2002-11-18||Interventional|||Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency|Cardiovascular Effects on Growth Hormone Replacement Therapy in Adults With Primary or Secondary Childhood Onset Growth Hormone Deficiency|Terminated||Phase 4|7|Actual|Novo Nordisk A/S||1||The trial was prematurely terminated due to low recruitment|f||||f||||||||||2017-10-11 02:27:04.69585|2017-10-11 02:27:04.69585
NCT01698541|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2014-12-02|||February 2013||2013-02-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|GenTac||Generic Tacrolimus in the Elderly - Prograf® vs Tacni®|Generic Tacrolimus in the Elderly - Prograf® vs Tacni®|Completed||Phase 4|28|Actual|University of Oslo School of Pharmacy||2|||f||||f||||||||||2017-10-11 02:27:11.424208|2017-10-11 02:27:11.424208
NCT01698931|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-02-17|||April 26, 2002|Actual|2002-04-26|February 2017|2017-02-01|March 6, 2003|Actual|2003-03-06|March 6, 2003|Actual|2003-03-06||Interventional|||Efficacy of Repaglinide in Subjects With Type 2 Diabetes|Efficacy of Repaglinide Compared to Glyburide and Placebo on Hepatic Glucose Metabolism in Type 2 Diabetic Subjects Treated With Diet or With Antidiabetic Oral Agents. A Randomized, Open, Cross-over Single-centre Placebo-controlled Trial|Completed||Phase 4|9|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 02:27:04.781438|2017-10-11 02:27:04.781438
NCT01698918|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-06-30|||March 7, 2013|Actual|2013-03-07|June 2017|2017-06-01|June 22, 2020|Anticipated|2020-06-22|June 22, 2020|Anticipated|2020-06-22||Interventional|Bolero-4||Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer|An Open-label, Phase II, Single-arm Study of Everolimus in Combination With Letrozole in the Treatment of Postmenopausal Women With Estrogen Receptor Positive HER2 Negative Metastatic or Locally Advanced Breast Cancer|Active, not recruiting||Phase 2|202|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 02:27:04.87317|2017-10-11 02:27:04.87317
NCT01698905|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-09-22|||December 20, 2012|Actual|2012-12-20|September 2017|2017-09-01|February 1, 2020|Anticipated|2020-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|ENESTop||Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)|A Phase II, Single Arm, Open Label Study of Treatment-free Remission in Chronic Myeloid Leukemia (CML) Chronic Phase (CP) Patients After Achieving Sustained MR4.5 on Nilotinib|Active, not recruiting||Phase 2|163|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 02:27:05.247831|2017-10-11 02:27:05.247831
NCT01698892|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2015-06-05|||October 2012||2012-10-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TORSIV||Comparison of Respiratory Tolerance to I.V. Versus Sublingual Sedation During Bronchoscopy. (TORSIV)|Comparison of Respiratory Tolerance to I.V. Versus Sublingual Sedation During Bronchoscopy.|Completed||Phase 4|85|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 02:27:05.482809|2017-10-11 02:27:05.482809
NCT01698866|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-06-15|||July 2012||2012-07-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|July 2017|Anticipated|2017-07-01||Interventional|EVACC-B||Low Grade Lymphoma|Evaluation of the Immune Response After Vaccination Against Hepatitis B in Patients With Indolent Lymphoproliferative Disorders With no Treatment.|Recruiting||Phase 4|40|Anticipated|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-11 02:27:05.70774|2017-10-11 02:27:05.70774
NCT01698853|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-09-29|||October 2012||2012-10-01|September 2012|2012-09-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Observational|||Difference Between Central and Peripheral Arterial Blood Oxygen Saturation With Different CPB Strategy|The Difference Between Central and Peripheral Arterial Blood Oxygen Saturation in Patients Undergoing Cardiac Surgery With Different Cardiopulmonary Bypass Strategy|Unknown status|Not yet recruiting|N/A|60|Anticipated|Xijing Hospital|||1||f||||f||||||||||2017-10-11 02:27:05.834788|2017-10-11 02:27:05.834788
NCT01698840|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-02-15|||January 2013||2013-01-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||Effect of Vitamin D in Diets of Preterm Infants|An Evaluation of the Effects of Two Levels of Vitamin D in Infants Fed Preterm or Transitional Formula on Serum 25-Hydroxyvitamin D and Bone Status in Preterm Infants: A Double-Blind, Randomized Controlled Trial|Completed||N/A|39|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 02:27:05.937511|2017-10-11 02:27:05.937511
NCT01698827|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2012-09-29|||January 2012||2012-01-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Replacement Gastrostomy Tubes: Technical and Clinical Comparison of Five Commercial Models|Replacement Gastrostomy Tubes: Technical and Clinical Comparison of Five Commercial Models|Completed||N/A|100|Actual|University of Sao Paulo|||5||f||||f||||||||||2017-10-11 02:27:06.051276|2017-10-11 02:27:06.051276
NCT01698814|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-02-27|2014-01-21||October 2012||2012-10-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||This reporting group includes all randomized subjects who received study medication.|A Six-Week Safety Study of an Investigational Ophthalmic Solution|A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AL-4943A Ophthalmic Solution Administered Once Daily|Completed||Phase 3|518|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:27:06.171396|2017-10-11 02:27:06.171396
NCT01698801|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-10-28|2014-11-25||October 2012||2012-10-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|November 2013|Actual|2013-11-01||Interventional||The intent-to-treat (ITT) population consisted of all participants enrolled independent of whether they received study treatment or not.|A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma|A Phase 2, Multicenter, Open-label, Single Arm Study of Lenalidomide (CC-5013) in Combination With Low-dose Dexamethasone in Japanese Patients With Previously Untreated Multiple Myeloma|Active, not recruiting||Phase 2|26|Actual|Celgene Corporation||1|||f||||t||||||||||2017-10-11 02:27:06.503784|2017-10-11 02:27:06.503784
NCT01698788|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-09-29|||May 2011||2011-05-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema|Role of Intraoperative Dexamethasone Implant in Improving Outcome of Taut Posterior Hyaloid Removal in Diabetic Macular Edema|Completed||N/A|5|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 02:27:07.074664|2017-10-11 02:27:07.074664
NCT01698775|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-05-31|2017-01-03||October 2, 2012|Actual|2012-10-02|May 2017|2017-05-01|January 19, 2016|Actual|2016-01-19|January 19, 2016|Actual|2016-01-19||Interventional|||A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)|A Phase III, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of MK-3102 Versus Placebo in Subjects With Type 2 Diabetes Mellitus With Moderate or Severe Chronic Kidney Disease or Kidney Failure on Dialysis Who Have Inadequate Glycemic Control.|Completed||Phase 3|213|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 02:27:07.267773|2017-10-11 02:27:07.267773
NCT01698749|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-09-29|||December 2011||2011-12-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema|Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema|Completed||N/A|61|Actual|Postgraduate Institute of Medical Education and Research||1|||f||||f||||||||||2017-10-11 02:27:08.722957|2017-10-11 02:27:08.722957
NCT01698736|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2013-02-28|||October 2012||2012-10-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||ABO Blood Group Antibody Elimination by a Combination of Semiselective Immunoadsorption Therapy and Membrane Filtration|ABO Blood Group Antibody Elimination by a Combination of Semiselective Immunoadsorption Therapy and Membrane Filtration|Completed||N/A|14|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:27:08.821031|2017-10-11 02:27:08.821031
NCT01698723|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-04-24|||September 2012||2012-09-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|HEVRibavirin||A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus|A Double Blind Placebo Controlled Randomized Trial of Ribavirin in Patients With Acute on Chronic Liver Failure Due to Hepatitis E Virus|Recruiting||Phase 2|40|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||Yes||2017-10-11 02:27:08.916422|2017-10-11 02:27:08.916422
NCT01698710|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-05-26|2017-05-26||November 2012||2012-11-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Endoscopic Abraxane Injection Into Pancreatic Cysts|EUS Guided Injection of Albumin Bound Paclitaxel Into Pancreatic Cysts|Terminated||N/A|5|Actual|Massachusetts General Hospital||1||expiration of IRB approval|f||||t||||||||||2017-10-11 02:27:09.035165|2017-10-11 02:27:09.035165
NCT01698697|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-02-28|||September 2, 2002|Actual|2002-09-02|February 2017|2017-02-01|October 18, 2002|Actual|2002-10-18|October 18, 2002|Actual|2002-10-18||Interventional|||Comparison of Two Insulin Aspart Formulations in Healthy Volunteers|A Single Centre, Randomized, Balanced Double-blind, Cross-Over Trial Investigating the Bioequivalence of a Continuous Subcutaneous Infusion of a Marketed NovoRapid Formulation Containing 100 U/ml and a New NovoRapid Formulation Containing 200 U/ml in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:27:09.286753|2017-10-11 02:27:09.286753
NCT01698684|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-10-21|2014-10-15|2014-01-13|September 2012||2012-09-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction|A Randomized, Double-Blind, Placebo-Controlled Evaluation of Avanafil for On-Demand Treatment of Men With Erectile Dysfunction|Completed||Phase 4|440|Actual|VIVUS, Inc.||3|||f||||f||||||||||2017-10-11 02:27:09.382679|2017-10-11 02:27:09.382679
NCT01698671|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2013-11-24|||October 2012||2012-10-01|November 2013|2013-11-01|May 2014|Anticipated|2014-05-01|October 2013|Actual|2013-10-01||Interventional|||InterGard Synergy Post-Marketing Surveillance Study|InterGard Synergy Post-Marketing Surveillance Study|Unknown status|Active, not recruiting|N/A|50|Anticipated|Maquet Cardiovascular||1|||f||||f||||||||||2017-10-11 02:27:09.888186|2017-10-11 02:27:09.888186
NCT01698658|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-05-24|||October 2012||2012-10-01|May 2017|2017-05-01|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer|Clinical Data Collection for Initial Evaluation of SoftVue: a Novel Ultrasound Breast Scanner|Recruiting||N/A|100|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 02:27:09.987424|2017-10-11 02:27:09.987424
NCT01698645|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2013-07-10|||September 2012||2012-09-01|July 2013|2013-07-01||||December 2014|Anticipated|2014-12-01||Observational|Qualipec||Patient Satisfaction and Quality of Life Impact - PecFent®|A Spanish , Multicentre, Open-label, Observational Study to Assess Quality of Life and Satisfaction in Subjects Taking PecFent® for the Treatment of Breakthrough Cancer Pain (BTPc)|Unknown status|Recruiting|N/A|150|Anticipated|Archimedes Development Ltd|||1||f||||f||||||||||2017-10-11 02:27:10.120193|2017-10-11 02:27:10.120193
NCT01698632|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-05-26|||September 2012||2012-09-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|IOTA-5||International Ovarian Tumour Analysis (IOTA) Phase 5|A Multicentre Study to Examine the Short and Long Term Outcomes of the Conservative Management of Benign-looking Adnexal Masses and the Pre-operative Characterisation of Ovarian Tumours|Enrolling by invitation||N/A|200|Anticipated|University of South Florida|||1||f||||f||||||||||2017-10-11 02:27:10.204981|2017-10-11 02:27:10.204981
NCT01698619|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-10-02|||August 2012||2012-08-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Hemodynamic Changes in Altitude Adaptation|Hemodynamic Changes in Altitude Adaptation|Unknown status|Recruiting|N/A|12|Anticipated|Goethe University|||1||f||||f||||||||||2017-10-11 02:27:10.277463|2017-10-11 02:27:10.277463
NCT01698606|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-04-26|||January 2013||2013-01-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|October 2017|Anticipated|2017-10-01||Interventional|FOR HEALTH||FOR HEALTH: A Family-oriented Healthy Eating, Activity and Lifestyle Intervention for Overweight Preschool Children|FOR HEALTH: A Family-ORiented Healthy Eating, Activity and Lifestyle Training With Hands-on Experience for Overweight and Obese Preschool Children and Their Families - a Pilot Trial.|Recruiting||N/A|28|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:27:10.358119|2017-10-11 02:27:10.358119
NCT01698593|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2012-10-02|||July 2009||2009-07-01|October 2012|2012-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Bupivacaine Digital Blocks: How Long is the Pain Relief and Temperature Elevation?|Bupivacaine Digital Blocks: How Long is the Pain Relief and Temperature Elevation?|Completed||N/A|44|Actual|Lalonde, Donald H., M.D.||1|||f||||||||||||||2017-10-11 02:27:10.444975|2017-10-11 02:27:10.444975
NCT01698580|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-11-24|||January 2013||2013-01-01|November 2016|2016-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Multifactorial Falls Prevention Program - Brazil|Effectiveness of a Multifactorial Falls Prevention Program in Community-dwelling Older People When Compared to Usual Care: A Randomized, Controlled Trial|Recruiting||N/A|612|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:27:10.524205|2017-10-11 02:27:10.524205
NCT01698567|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-03-21|||July 2012||2012-07-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)|Antithrombin III Supplementation for Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass.|Terminated||Phase 1|6|Actual|University of Rochester||2||Challenges enrolling subjects in study|f||||t||||||||||2017-10-11 02:27:10.641846|2017-10-11 02:27:10.641846
NCT01698528|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-08-16|2017-04-20||October 2012||2012-10-01|August 2017|2017-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration|Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration|Completed||N/A|40|Actual|Joslin Diabetes Center||2|||f||||t||||||||||2017-10-11 02:27:11.522381|2017-10-11 02:27:11.522381
NCT01698515|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2016-08-30|||August 2012||2012-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Oral Health Assessment in Rheumatoid Arthritis and Other Autoimmune Diseases-- Anti- TNF Substudy|Oral Health Assessment in Rheumatoid Arthritis and Other Autoimmune Diseases-- Anti- TNF Substudy|Completed||N/A|20|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 02:27:11.804151|2017-10-11 02:27:11.804151
NCT01698502|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-03-24|2013-12-10||August 2012||2012-08-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Observational|EXINT2||Physical Training and the Incretin Effect|Does Physical Training Effect the Incretin Effect|Completed||N/A|21|Actual|University of Copenhagen|||2||f||||f||||||Samples Without DNA|"     Human plasma samples.   "|||2017-10-11 02:27:11.873587|2017-10-11 02:27:11.873587
NCT01698489|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-01|2017-08-16|||April 2006|Actual|2006-04-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|April 2016|Actual|2016-04-01||Observational|VLDL||The Very Large Database of Lipids (VLDL)|The Very Large Database of Lipids (VLDL): A Clinical Laboratory Big Data Project|Active, not recruiting||N/A|2859333|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 02:27:12.164955|2017-10-11 02:27:12.164955
NCT01698476|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-02-04|||September 2012||2012-09-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|IRETB||Immune Reconstitution in Tuberculosis Disease|Immune Reconstitution in Tuberculosis Disease Using Antimicrobial Treatment With Vitamin D and Phenylbutyrate|Completed||Phase 2|390|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:27:12.259372|2017-10-11 02:27:12.259372
NCT01698450|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-10-08|||November 2012||2012-11-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders|MR-Guided Functional Ultrasound-Neurosurgery for Movement Disorders|Completed||Phase 1|10|Actual|University Children's Hospital, Zurich||1|||f||||t||||||||||2017-10-11 02:27:12.462599|2017-10-11 02:27:12.462599
NCT01698437|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-06-02|||February 2011||2011-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|FUS-Tumor||Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Brain Tumors|MR-guided Ultrasound-Neurosurgery for the Treatment of Malignant Brain Tumors|Completed||Phase 1|3|Actual|University Children's Hospital, Zurich||1|||f||||t||||||||||2017-10-11 02:27:12.546547|2017-10-11 02:27:12.546547
NCT01698424|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-01-09|||June 2013||2013-06-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|||PET/CT of Skeletal Muscle Amino Acid Kinetics||Completed||N/A|12|Actual|University of California, San Francisco|||1||f||||f||||||Samples Without DNA|"     Biopsies will be taken from upper thigh, Muscle tissue   "|||2017-10-11 02:27:12.629249|2017-10-11 02:27:12.629249
NCT01698411|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-01-30|||October 2012||2012-10-01|July 2012|2012-07-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|HATS||Study of the Influence of Sleep on Hemodynamic Parameters in Patients With Sleep Disorders|Study of the Influence of Sleep on Hemodynamic Parameters in Patients With Sleep Disorders|Unknown status|Recruiting|N/A|305|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-10-11 02:27:12.702515|2017-10-11 02:27:12.702515
NCT01698398|ClinicalTrials.gov processed this data on October 10, 2017|2012-10-02|2014-02-10|||October 2012||2012-10-01|October 2012|2012-10-01||||January 2013|Actual|2013-01-01||Interventional|||The Increase Study. Effect of Incremental Versus Fixed Pump on Peak Oxygen Consumption in Heart Failure Patients Supported With a Continuous Flow Left Venticular Assist Device|The Increase Study. Effect of Incremental Versus Fixed Pump on Peak Oxygen Consumption in Heart Failure Patients Supported With a Continuous Flow Left Venticular Assist Device.|Completed||N/A|||Rigshospitalet, Denmark||1|||f||||||||||||||2017-10-11 02:27:12.785414|2017-10-11 02:27:12.785414
NCT01698385|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-01-14|||February 2008||2008-02-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|RADIEL||Prevention of Gestational Diabetes Through Lifestyle Modification|Prevention of Gestational Diabetes Through Lifestyle Modification (RADIEL) - a Randomized Controlled Multi-centre Intervention Study|Completed||Phase 2|750|Actual|Helsinki University||2|||f||||t||||||||||2017-10-11 02:27:12.882647|2017-10-11 02:27:12.882647
NCT01698372|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-11-30|||September 2012||2012-09-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Interventional|||Negative Pressure Dressing After Saphenous Vein Harvest|Negative Pressure Dressing to Decrease the Incidence of Leg Wound Complications After CABG|Completed||Phase 1|64|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 02:27:12.990705|2017-10-11 02:27:12.990705
NCT01698359|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-28|||November 2012||2012-11-01|September 2012|2012-09-01|October 2013|Anticipated|2013-10-01|July 2013|Anticipated|2013-07-01||Observational|||Evaluation of Ultrasound Probe for Use in Bladder Radiotherapy|Evaluation of Ultrasound Probe for Use in Adaptive Bladder Radiotherapy|Unknown status|Not yet recruiting|N/A|5|Anticipated|University Hospital Birmingham NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 02:27:13.120336|2017-10-11 02:27:13.120336
NCT01698346|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-05-30|||February 2012||2012-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Pertussis (Tdap) Vaccination in Pregnancy|Impact of Pertussis Vaccination in Pregnancy on Maternal Protection Offered to Young Infants|Active, not recruiting||Phase 4|100|Anticipated|Universiteit Antwerpen||2|||f||||f||||||||||2017-10-11 02:27:13.236447|2017-10-11 02:27:13.236447
NCT01698333|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2013-11-25||2013-11-25|March 2012||2012-03-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression|An Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily 122-0551 in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment|Completed||Phase 2|25|Actual|Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 02:27:13.36517|2017-10-11 02:27:13.36517
NCT01698320|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2015-08-12|2015-07-13|2014-05-08|October 2012||2012-10-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Full analysis set of randomized subjects|Safety Study of Albuterol Spiromax® in Subjects With Asthma|A Multi-Center 52-Week Study to Assess the Safety of Albuterol Spiromax® in Subjects With Asthma|Completed||Phase 3|364|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 02:27:13.475788|2017-10-11 02:27:13.475788
NCT01698307|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-07-12|||March 2014||2014-03-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|REACT2||Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy|A Cluster Randomized Controlled Trial of an Enhanced Treatment Algorithm for the Management of Crohn's Disease|Enrolling by invitation||Phase 4|1200|Anticipated|Western University, Canada||2|||f||||f||||||||||2017-10-11 02:27:14.662294|2017-10-11 02:27:14.662294
NCT01698294|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-07-20|||December 14, 2012|Actual|2012-12-14|July 2017|2017-07-01|June 9, 2018|Anticipated|2018-06-09|June 9, 2017|Actual|2017-06-09||Interventional|||Biomarkers in Post-Menopausal Women Receiving Flaxseed|A Pilot Study of the Flaxseed Effects on Hormones and Lignans: Role of Race, Genes, and Gut Microbiome|Active, not recruiting||N/A|258|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-11 02:27:14.748008|2017-10-11 02:27:14.748008
NCT01698281|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2014-01-14|||December 2012||2012-12-01|May 2013|2013-05-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer|A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.|Terminated||Phase 2|7|Actual|AEterna Zentaris||2||Poor recruitment|f||||f||||||||||2017-10-11 02:27:14.839161|2017-10-11 02:27:14.839161
NCT01698268|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-07-24|2017-01-18||February 2012||2012-02-01|July 2017|2017-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|TAP|Data not included for patients removed from study by physician|Study of Transverse Abdominis Plane (TAP) Block in Children Undergoing Hydrocelectomy and/or Hernia Repair Surgery|The Efficacy of Transverse Abdominis Plane (TAP) Block in Children Undergoing Hydrocelectomy and/or Hernia Repair|Completed||N/A|50|Actual|William Beaumont Hospitals|Of the 47 treated patients, the local infiltration was administered by 8 different surgeons while the TAP block was administered by 2 different anesthesiologists.|2|||f||||t||||||||||2017-10-11 02:27:14.945196|2017-10-11 02:27:14.945196
NCT01698255|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-02-17|||March 2012||2012-03-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ENGAGE-II||Psychotherapy for Late Life Depression|Psychotherapy for Late Life Depression|Completed||N/A|48|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-11 02:27:15.407778|2017-10-11 02:27:15.407778
NCT01698242|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-04-15|||May 2011||2011-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CHART||The Congestive Heart Failure Adherence Redesign Trial|Reduction in Hospitalizations in Low-Income Patients With Heart Failure|Completed||Phase 3|320|Actual|Rush University Medical Center||2|||f||||t||||||||||2017-10-11 02:27:15.493141|2017-10-11 02:27:15.493141
NCT01698229|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-05-03|||December 2011||2011-12-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Collection of Cerebrospinal Fluid in Healthy Children|Collection of Cerebrospinal Fluid in Healthy Children|Terminated||N/A|32|Actual|Weill Medical College of Cornell University|||1|Study interest shifted|f||||f||||||Samples Without DNA|"     5 mL of cerebrospinal fluid (CSF) will be collected in this study at one time point.   "|No||2017-10-11 02:27:15.615255|2017-10-11 02:27:15.615255
NCT01698216|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2015-12-07|||December 2011||2011-12-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Switching From Consta® to Sustenna® in Patients With Schizophrenia|Switching From Risperidone Long Acting Injection (Consta®) to Paliperidone Palmitate (Sustenna®) in Patients With Schizophrenia and Its Influence on Subjective Well-Being: A Prospective Observational Study|Completed||N/A|50|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 02:27:15.700584|2017-10-11 02:27:15.700584
NCT01698203|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2014-10-27|||October 2012||2012-10-01|October 2014|2014-10-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Continuous Wound Catheter Analgesia Associated With Intravenous Morphine PCA After Thoracotomy|Postoperative Analgesia After Thoracotomy Without Thoracic Epidural Analgesia: Continuous Wound Catheter Analgesia Associated With Intravenous Morphine Patient-Controlled-Analgesia (PCA)|Unknown status|Recruiting|Phase 4|92|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 02:27:15.797692|2017-10-11 02:27:15.797692
NCT01698190|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-11-18|||December 2011||2011-12-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions|Comparing the Overall Efficacy of Endoscopic Ultrasound Fine Needle Aspiration Versus Fine Needle Biopsy in the Diagnosis of Solid Lesions: A Multicenter, Randomized Clinical Trial|Unknown status|Recruiting|N/A|400|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-10-11 02:27:15.894386|2017-10-11 02:27:15.894386
NCT01698177|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-04-18|||October 2011||2011-10-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Optimizing Influenza Vaccination in Surgical Oncology Patients|Optimizing Influenza Vaccination in Surgical Oncology Patients|Unknown status|Recruiting|Phase 4|204|Anticipated|Stony Brook University||4|||f||||f||||||||||2017-10-11 02:27:16.01772|2017-10-11 02:27:16.01772
NCT01698164|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-09-28|||December 2008||2008-12-01|September 2012|2012-09-01||||October 2012|Anticipated|2012-10-01||Interventional|||Multi-centre Clinical Trial on Hormone Replacement Treatment in China|Multi-centre Clinical Trial on Hormone Replacement Treatment in China|Unknown status|Recruiting|Phase 4|1200|Anticipated|Peking Union Medical College Hospital||3|||f||||||||||||||2017-10-11 02:27:16.146374|2017-10-11 02:27:16.146374
NCT01698151|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-03-07|||October 2012||2012-10-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Observational|PROTECCT-M||Prognosis and Treatment of COPD in Primary Care-use of Biomarkers|Prognosis and Treatment of COPD in Primary Care-use of Biomarkers|Recruiting||N/A|2000|Anticipated|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 02:27:16.316301|2017-10-11 02:27:16.316301
NCT01698138|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-02-07|||September 2012||2012-09-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|BOT-SCI||Prevention of Bladder Dysfunction in Acute Spinal Cord Injury|Prevention of Bladder Dysfunction in Acute Spinal Cord Injury. A Double-blind, Randomized, Placebo-controlled Study to Explore the Effect of Early Treatment With Onabotulinumtoxin A on Development of Detrusor Overactivity|Recruiting||Phase 4|20|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 02:27:16.530227|2017-10-11 02:27:16.530227
NCT01698125|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-04-14|||October 2012||2012-10-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Autonomic Cardiovascular Control for Elderly Surgery Patients|Autonomic Cardiovascular Control for Elderly Surgery Patients|Terminated||N/A|3|Actual|Oslo University Hospital|||1|Practical circumstances made it too difficult to carry out as planned.|f||||f||||||Samples With DNA|"     Serum. Plasma. Saliva.   "|||2017-10-11 02:27:16.680431|2017-10-11 02:27:16.680431
NCT01698112|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-09-27|||July 2006||2006-07-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Does Flaxseed Supplementation Improve Glycemic Control in Individuals With Pre-diabetes?|Does Flaxseed Supplementation Improve Glycemic Control in Individuals With Pre-diabetes?|Completed||N/A|25|Actual|University of Colorado, Colorado Springs||3|||f||||f||||||||||2017-10-11 02:27:16.809676|2017-10-11 02:27:16.809676
NCT01698099|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-27|||May 2009||2009-05-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|August 2011|Actual|2011-08-01||Observational|||Diagnostic Accuracy of Serum Bilirubin in the Prediction of Perforated Appendicitis|Diagnostic Accuracy of Serum Bilirubin in the Prediction of Perforated Appendicitis|Completed||N/A|500|Actual|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-11 02:27:16.928842|2017-10-11 02:27:16.928842
NCT01698086|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-03-27|||October 2012||2012-10-01|March 2017|2017-03-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial)|Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most?|Active, not recruiting||N/A|88|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:27:17.004866|2017-10-11 02:27:17.004866
NCT01698073|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-01-07|||September 2012||2012-09-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|COL/AS+||Effect of a Culturally-based Intervention on Sexual Risky Behavior Among Young American Indian Adolescents|Teen Pregnancy Prevention Among Native Youth of the Northern Plains|Completed||N/A|167|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:27:17.107067|2017-10-11 02:27:17.107067
NCT01698060|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-29|2014-12-08|||September 2012||2012-09-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ICC H5||Immunogenicity of ND1.1 by Delivery Directly to the Ileum|An Open Label Phase I Substudy to Evaluate the Safety and Ability to Enhance Immunogenicity of ND1.1 by Delivery Directly to the Ileum Using the InteliSite® Companion Capsule in Healthy Adult Males|Completed||Phase 1|12|Actual|Vaxart||1|||f||||f||||||||||2017-10-11 02:27:17.195878|2017-10-11 02:27:17.195878
NCT01698047|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-05-04|||October 2012||2012-10-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|BRICH||Building Resiliency and Increasing Community Hope|Building Resiliency and Increasing Community Hope|Completed||N/A|168|Actual|University of California, Los Angeles||2|||f||||t||||||||No|There are no current plans to share a de-identified, individual participant data as a publicly available dataset due to the original funding not including resources to support this activity; however on a case-by-case basis, the PI would consider additional analyses of the data by other investigators.|2017-10-11 02:27:17.269212|2017-10-11 02:27:17.269212
NCT01698034|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2012-10-02|||September 2011||2011-09-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Volunteering and Cardiovascular Risk in Adolescents|How Volunteer Programs Affect Health and Well-being in Low-income Youth|Completed||N/A|106|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:27:17.388464|2017-10-11 02:27:17.388464
NCT01698021|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2013-06-25|||June 2013||2013-06-01|September 2012|2012-09-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Observational|QUANTUM||Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome|Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome|Unknown status|Recruiting|N/A|500|Anticipated|Université de Sherbrooke|||1||f||||f||||||||||2017-10-11 02:27:17.462799|2017-10-11 02:27:17.462799
NCT01698008|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-08-16|||December 2012|Actual|2012-12-01|August 2017|2017-08-01|September 25, 2013|Actual|2013-09-25|September 25, 2013|Actual|2013-09-25||Interventional|||Effect of Mobile Phone Telemedicine on Diabetes Care|Effect of Mobile Phone Telemedicine on Diabetes Care|Completed||N/A|5|Actual|University of Nebraska||1|||f||||t||||||||||2017-10-11 02:27:17.564687|2017-10-11 02:27:17.564687
NCT01697995|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-11-03|||January 2013||2013-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|RVuptakeLexi||Stress Induced Right Ventricular Uptake on Lexiscan Stress MPI|Diagnostic and Prognostic Value of the Stress Induced Right Ventricular Uptake on Lexiscan Stress MPI in Patients With Known or Suspected Coronary Artery Disease (CAD).|Enrolling by invitation||N/A|650|Anticipated|University of Arizona|||2||f||||f||||||||||2017-10-11 02:27:17.669583|2017-10-11 02:27:17.669583
NCT01697982|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-12-02|||September 2012||2012-09-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Pilot Study of Living With Hope Program|Living With Hope: Pilot Study of Patient-Centered Hope Intervention for Persons Receiving Palliative Care Services|Completed||N/A|19|Actual|University of Alberta||3|||f||||f||||||||||2017-10-11 02:27:17.80194|2017-10-11 02:27:17.80194
NCT01697969|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-07-30|2014-07-30||September 2012||2012-09-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||This analysis population includes all participants exposed to the test product.|Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients|Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients Pre and Post Treatment With Olopatadine HCL Ophthalmic Solution, 0.2%|Completed||Phase 4|17|Actual|Alcon Research|The lack of concurrent control made it difficult to discriminate changes caused by PATADAY® from that caused by other factors, such as observer or patient expectation. Open-labeled design increased the bias from the observer or patient expectation.|1|||f||||f||||||||||2017-10-11 02:27:17.914886|2017-10-11 02:27:17.914886
NCT01697956|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-09-10|2015-07-27|2014-05-08|October 2012||2012-10-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Per Protocol (PP) population included all data from randomized subjects obtained prior to experiencing major protocol deviations|Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 6-Week Study Designed to Investigate the Effects of BDP Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal (HPA)-Axis in Pediatric Subjects (6 to 11 Years of Age) With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|99|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 02:27:18.165775|2017-10-11 02:27:18.165775
NCT01697943|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2012-10-15|||May 2012||2012-05-01|October 2012|2012-10-01|May 2017|Anticipated|2017-05-01|May 2015|Anticipated|2015-05-01||Interventional|GCQOL02||Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total Gastrectomy|A Pilot Randomized Controlled Trial Examining the Differences of Quality of Life of Roux-En-Y Pouch Reconstruction and Conventional Roux-En-Y Reconstruction in Patients Undergoing Total Gastrectomy.|Unknown status|Recruiting|Phase 3|140|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 02:27:19.070662|2017-10-11 02:27:19.070662
NCT01697930|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-08-15|||September 2012||2012-09-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)|A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)|Recruiting||Phase 1|65|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:27:19.16771|2017-10-11 02:27:19.16771
NCT01697917|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-29|2012-10-01|||May 2012||2012-05-01|September 2012|2012-09-01|May 2017|Anticipated|2017-05-01|May 2015|Anticipated|2015-05-01||Interventional|GCQOL01||Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction|A Pilot Randomized Controlled Trial Examining the Differences of Quality of Life of Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction|Unknown status|Recruiting|Phase 3|140|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 02:27:19.262561|2017-10-11 02:27:19.262561
NCT01697904|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-10-01|||August 2010||2010-08-01|September 2012|2012-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns|Randomized Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns|Completed||N/A|88|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 02:27:19.355911|2017-10-11 02:27:19.355911
NCT01697891|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-10-01|||October 2012||2012-10-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers|Effectiveness of Acupuncture-like Transcutaneous Nerve Stimulation (ALTENS) in Improving Dysphagia and Associated Symptoms of Chemotherapy and/or Intensity Modulated Radiation Therapy (IMRT) for Head and Neck Cancers: A Pilot Study|Unknown status|Enrolling by invitation|Phase 1/Phase 2|35|Anticipated|McMaster University||1|||f||||f||||||||||2017-10-11 02:27:19.470418|2017-10-11 02:27:19.470418
NCT01697878|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-03-16|||March 2012||2012-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|July 2014|Actual|2014-07-01||Interventional|||Consequences of Obstructive Sleep Apnea on Respiratory Function Following Weight-loss Surgery|Consequences of Obstructive Sleep Apnea on Respiratory Function Following Weight-loss Surgery: A Randomized Controlled Trial|Completed||N/A|45|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:27:19.56485|2017-10-11 02:27:19.56485
NCT01697865|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-09-26|||October 2012||2012-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Reverse Shoulder Arthroplasty With or Without Concomitant Latissimus and Teres Major Transfer for Shoulder Pseudoparalysis With Teres Minor Dysfunction|Reverse Shoulder Arthroplasty With or Without Concomitant Latissimus and Teres Major Transfer for Shoulder Pseudoparalysis With Teres Minor Dysfunction: A Prospective, Randomized Investigation|Recruiting||N/A|42|Anticipated|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-11 02:27:19.674169|2017-10-11 02:27:19.674169
NCT01697839|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-03-08|||June 2012||2012-06-01|April 2015|2015-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients|Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide|Completed||N/A|110|Actual|Oncotherapeutics|||1||f||||f||||||Samples Without DNA|"     whole blood, serum, white blood cells, red blood cells   "|||2017-10-11 02:27:19.878083|2017-10-11 02:27:19.878083
NCT01697826|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-29|2012-10-01|||April 2011||2011-04-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections|A Comparative Open Labeled Clinical Study to Evaluate the Efficacy and Tolerability of Two Different Intravaginal Formulations Containing a Combination of Clindamycin and Clotrimazole in Vaginal Infections|Completed||Phase 4|73|Actual|Daswani, Bhart, M.D.||2|||f||||f||||||||||2017-10-11 02:27:19.966723|2017-10-11 02:27:19.966723
NCT01697813|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-05-14|||September 2012||2012-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:27:20.092207|2017-10-11 02:27:20.092207
NCT01697800|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2014-05-12|||September 2012||2012-09-01|May 2014|2014-05-01|September 2016|Anticipated|2016-09-01|September 2014|Anticipated|2014-09-01||Interventional|||A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract|A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract|Unknown status|Recruiting|Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:27:20.135414|2017-10-11 02:27:20.135414
NCT01697787|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-29|2015-07-29|||October 2012||2012-10-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso|Efficacy of Amodiaquine-Artesunate (ASAQ) and Artemether-Lumefantrine (AL) for the Treatment of Uncomplicated Falciparum Malaria in Nanoro, Burkina Faso|Completed||Phase 4|150|Actual|Centre Muraz||2|||f||||f||||||||||2017-10-11 02:27:20.336211|2017-10-11 02:27:20.336211
NCT01697774|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-05-14|||September 2012||2012-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:27:20.438567|2017-10-11 02:27:20.438567
NCT01697761|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2014-11-19|||September 2012||2012-09-01|September 2012|2012-09-01|November 2014|Actual|2014-11-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's Disease|Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's Disease and Its Regulation Mechanism to the Immune Homeostasis Mediated by Th17/Treg Cells|Completed||N/A|92|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-11 02:27:20.486376|2017-10-11 02:27:20.486376
NCT01697735|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-04-27|||September 2012||2012-09-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Therapeutic Effects of Statins and Berberine on the Hyperlipemia|The Therapeutic Effects of Combination of Statins With Berberine on the Patients With Hyperlipemia:a Single-center, Open Clinical Trial|Terminated||Phase 4|24|Actual|Wenzhou Medical University||2||Because of lack of participants and funds|f||||f||||||||||2017-10-11 02:27:20.588913|2017-10-11 02:27:20.588913
NCT01697722|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2012-10-03|||January 1991||1991-01-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|June 2007|Actual|2007-06-01||Observational|QvarvsCombo||Real-world Effectiveness and Cost-effectiveness of HFA-beclometasone Compared With ICS/LABA Combination Therapy|A Retrospective Evaluation of Effectiveness and Cost-effectiveness of Extrafine HFA-BDP Compared With Combination ICS/LABA Therapy in the Management of Asthma in a Representative Population of UK Primary Care Patients|Completed||N/A|815377|Actual|Research in Real-Life Ltd|||3||f||||t||||||||||2017-10-11 02:27:20.701421|2017-10-11 02:27:20.701421
NCT01697709|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-08-17|||October 1, 2012|Actual|2012-10-01|August 2017|2017-08-01|December 1, 2016|Actual|2016-12-01|December 1, 2016|Actual|2016-12-01||Interventional|QUEST||Quetiapine Pharmacotherapy for Cannabis Dependence|Quetiapine Pharmacotherapy for Cannabis Dependence|Completed||Phase 2|130|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 02:27:20.822225|2017-10-11 02:27:20.822225
NCT01697696|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-02-17|2015-11-10||October 2012||2012-10-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||The Safety set included all patients that received at least one dose of study drug and had at least one-post baseline assessment . Subjects were analyzed according to the treatment they received (if a subject incorrectly took more than one treatment, the subject was analyzed according to the treatment they were randomized to).|Long Term Safety Study of NVA237 vs QAB149 in COPD Patients|A Multi-center, Randomized, Double-blind, 52-week Study to Assess the Safety of NVA237 Compared to QAB149 in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Have Moderate to Severe Airflow Limitation|Completed||Phase 3|511|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:27:20.970552|2017-10-11 02:27:20.970552
NCT01697683|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2014-03-20|||May 2012||2012-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ProVIP||Probiotic Therapy for the Reversal of Bacterial Vaginosis in Pregnancy|Probiotic Therapy for the Reversal of Bacterial Vaginosis in Pregnancy|Completed||Phase 2|86|Actual|Mount Sinai Hospital, Canada||2|||f||||t||||||||||2017-10-11 02:27:22.422397|2017-10-11 02:27:22.422397
NCT01697670|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2012-11-02|||September 2012||2012-09-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Photodynamic Therapy for Ulcerative Colitis|"A Multicenter, Open Phase II Study to Assess the Effect and Safety of Low Dose Photodynamic Therapy in Patients With Moderate to Severe Active Distal Ulcerative Colitis"|Unknown status|Recruiting|Phase 1|7|Anticipated|University of Zurich||1|||f||||t||||||||||2017-10-11 02:27:22.494295|2017-10-11 02:27:22.494295
NCT01697657|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-01-26|||September 2001||2001-09-01|January 2017|2017-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes|A Randomised, Open Label, Cross-over, Multi-centre, Multinational Trial Comparing the Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir and NPH Insulin in Well Controlled Subjects With Type 1 Diabetes on a Basal-bolus Regimen|Completed||Phase 3|131|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:27:22.581888|2017-10-11 02:27:22.581888
NCT01697644|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-01-17|||October 1990||1990-10-01|January 2017|2017-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation|Growth Hormone Treatment of Children After Intrauterine Growth Retardation|Completed||Phase 4|75|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:27:22.697034|2017-10-11 02:27:22.697034
NCT01697631|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-02-22|||July 22, 2002|Actual|2002-07-22|February 2017|2017-02-01|April 24, 2003|Actual|2003-04-24|April 24, 2003|Actual|2003-04-24||Interventional|||Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes|Comparison of Biphasic Insulin Aspart 30 Twice Daily and Biphasic Insulin Aspart 30 Twice Daily Plus Lunchtime Injection of Insulin Aspart Treatment Efficiency in Overall Glycemic Control and Postprandial Glycemic Excursions. A Multi-center, Randomized, Open-label, Two-armed Parallel Group Trial in Subjects With Type 2 Diabetes Previously Treated With Conventional Biphasic Human Insulin 30/70|Completed||Phase 4|131|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:27:22.778466|2017-10-11 02:27:22.778466
NCT01697618|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-01-03|||April 1997||1997-04-01|January 2017|2017-01-01|November 1998|Actual|1998-11-01|November 1998|Actual|1998-11-01||Interventional|||Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes|A Randomised, Double-blind, Single Centre, Two-way Cross-over Trial Comparing the Pharmacokinetics, Pharmacodynamics and Safety of the Biphasic Insulin Aspart 30 and Insulin Mixtard 30/70 After Multiple Dosing With a Twice Daily Dose Regimen in Type 2 Diabetic Patients|Completed||Phase 2|13|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:27:22.880926|2017-10-11 02:27:22.880926
NCT01697605|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-09-29|||October 19, 2012|Actual|2012-10-19|September 2017|2017-09-01|December 7, 2017|Anticipated|2017-12-07|December 7, 2017|Anticipated|2017-12-07||Interventional|||A Phase I Study of Oral BGJ398 in Asian Patients|A Phase I Study of Oral BGJ398 in Asian Patients With Advanced Solid Tumor Having Alterations of the FGF-R Pathway|Recruiting||Phase 1|22|Anticipated|Novartis||1|||f||||f|f|f||||||||2017-10-11 02:27:22.983103|2017-10-11 02:27:22.983103
NCT01697592|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-06-05|2015-09-29||October 24, 2012|Actual|2012-10-24|June 2017|2017-06-01|May 8, 2014|Actual|2014-05-08|May 8, 2014|Actual|2014-05-08||Interventional|||Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)|A Phase III, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blinded Study and Subsequent Open-label, Extension Study to Assess the Safety and Efficacy of Addition of MK-3102 in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy and Oral Antihyperglycemic Agent Monotherapy|Completed||Phase 3|585|Actual|Merck Sharp & Dohme Corp.||10|||f||||t||||||||||2017-10-11 02:27:23.161002|2017-10-11 02:27:23.161002
NCT01697579|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-03-27|||December 13, 2012|Actual|2012-12-13|March 2017|2017-03-01|November 21, 2016|Actual|2016-11-21|November 21, 2016|Actual|2016-11-21||Interventional|||Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)|A Phase IIb, Partially-Blinded, Randomized, Active Comparator-Controlled Study to Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Fosaprepitant in Pediatric Patients for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With Emetogenic Chemotherapy Sub-title: Open-Label Cohort to Further Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Fosaprepitant in Pediatric Patients Birth to <12 Years Old|Completed||Phase 2|241|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:27:24.852864|2017-10-11 02:27:24.852864
NCT01697566|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-06-16|||May 2013|Actual|2013-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||An Endometrial Cancer Chemoprevention Study of Metformin|An Endometrial Cancer Chemoprevention Study of Metformin Versus No Treatment in Women With a Body Mass Index (BMI) >/= 30 kg.m2 and Hyperinsulinemia|Active, not recruiting||Phase 3|100|Anticipated|M.D. Anderson Cancer Center||4|||f||||f|t|f||||||||2017-10-11 02:27:25.000702|2017-10-11 02:27:25.000702
NCT01697553|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-04-01|||October 2012||2012-10-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|October 2015|Anticipated|2015-10-01||Interventional|DOMOLIM||Home-Based Technologies Coupled to Teleassistance Service in the Elderly|Home-Based Technologies Coupled to Teleassistance Service: Efficacy for Preventing Falls at Home in Frail Elderly Population Losing Autonomy|Unknown status|Recruiting|N/A|1200|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 02:27:26.860506|2017-10-11 02:27:26.860506
NCT01697540|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-04-27|||September 2012||2012-09-01|January 2017|2017-01-01||||September 2019|Anticipated|2019-09-01||Observational|||Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan|Tropical Medicine Center (TMC), Kaohsiung Medicine University Hospital (KMUH)|Recruiting||N/A|100|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||||||||||||2017-10-11 02:27:26.98676|2017-10-11 02:27:26.98676
NCT01697527|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-09-12|||November 2, 2012|Actual|2012-11-02|September 2017|2017-09-01|November 2, 2019|Anticipated|2019-11-02|November 2, 2018|Anticipated|2018-11-02||Interventional|||Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies|Adoptive Transfer of NY-ESO-1 TCR Engineered Peripheral Blood Mononuclear Cells (PBMC) After a Nonmyeloablative Conditioning Regimen, With Administration of NY-ESO-1157-165 Pulsed Dendritic Cells and Interleukin-2, in Patients With Advanced Malignancies|Recruiting||Phase 2|22|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:27:27.067746|2017-10-11 02:27:27.067746
NCT01697514|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2013-08-26|||July 2013||2013-07-01|August 2013|2013-08-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma|A Phase 1 Trial of LY2940680 in Pediatric Patients With Recurrent or Refractory Rhabdomyosarcoma or Medulloblastoma|Withdrawn||Phase 1|0|Actual|Eli Lilly and Company||2||Trial stopped early for poor accrual.|f||||f||||||||||2017-10-11 02:27:27.240216|2017-10-11 02:27:27.240216
NCT01697501|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-03-10|2015-06-10||November 8, 2012|Actual|2012-11-08|March 2017|2017-03-01|June 21, 2013|Actual|2013-06-21|June 21, 2013|Actual|2013-06-21||Interventional|||A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253|Cross-sectional Multicenter Study Evaluating the IL28B Polymorphism in Patients With HBeAg-negative Chronic Hepatitis B Treated With Pegylated Interferon Alfa-2a in the Course of Peg.Be.Liver Study|Completed||Phase 3|88|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:27:27.396532|2017-10-11 02:27:27.396532
NCT01697488|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-07-20|||February 2, 2012|Actual|2012-02-02|June 2017|2017-06-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|||An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)|Non-interventional Surveillance Study (NIS) on First-line (FL) Bevacizumab (Avastin) in Combination With Carboplatin/Paclitaxel in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Active, not recruiting||N/A|1090|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-11 02:27:28.089293|2017-10-11 02:27:28.089293
NCT01697475|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-09-27|||October 2010||2010-10-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Text-Messaging to Motivate Walking in Older African Americans|An Motivational Text Messaging Walking Program for Older African Americans|Completed||N/A|36|Actual|Georgetown University||2|||f||||f||||||||||2017-10-11 02:27:28.180571|2017-10-11 02:27:28.180571
NCT01697462|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-12-16|2015-12-16||July 2009||2009-07-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational||Baseline population included all enrolled participants.|An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)|Evaluation of Safety and Efficacy of Xeloda in Metastatic Colorectal Carcinoma|Completed||N/A|258|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:27:28.267094|2017-10-11 02:27:28.267094
NCT01697449|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-09-15|2015-09-15||March 2009||2009-03-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational||Included all participants who were enrolled in the study.|An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT)||Completed||N/A|191|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:27:28.531724|2017-10-11 02:27:28.531724
NCT01697436|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-11-01|||September 2012||2012-09-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets|A Bioequivalence Study of Ribavirin Oral Solution (RO0209963) Versus the Reference Ribavirin Tablets (Copegus) Following Oral Administration in Healthy Adult Subjects|Completed||Phase 1|40|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 02:27:28.928827|2017-10-11 02:27:28.928827
NCT01697423|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-11-09|||October 2012||2012-10-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparative Assessment of Intra-articular Knee Injections of Platelet-rich Plasma (PRP) and Hyaluronic Acid in the Treatment of Knee Osteoarthritis|Comparative Assessment of Intra-articular Knee Injections of Platelet-rich Plasma (PRP) and Hyaluronic Acid in the Treatment of Knee Osteoarthritis|Recruiting||Phase 2|80|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-10-11 02:27:29.039604|2017-10-11 02:27:29.039604
NCT01697410|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-12-25|||January 2013||2013-01-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Continuos Terlipressin Infusion in Septic Shock|A Multicenter,Prospective,Randomized,Controlled,Double Blind Study in China to Evaluate the Effect of Terlipressin in Patients With Septic Shock|Unknown status|Recruiting|N/A|1000|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 02:27:29.623088|2017-10-11 02:27:29.623088
NCT01697384|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-09-27|||April 2000||2000-04-01|September 2012|2012-09-01|October 2004|Actual|2004-10-01|August 2003|Actual|2003-08-01||Interventional|||Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer|Phase III, Open-Label Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Patients With Advanced Prostate Cancer|Completed||Phase 3|138|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:27:29.889997|2017-10-11 02:27:29.889997
NCT01697371|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-12-14|||September 2012||2012-09-01|August 2016|2016-08-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Proton Therapy in the Treatment of Liver Metastases|Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases|Recruiting||N/A|35|Anticipated|Loma Linda University||1|||f||||t||||||||No||2017-10-11 02:27:29.999082|2017-10-11 02:27:29.999082
NCT01697358|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-06-22|2017-03-10||January 8, 2013|Actual|2013-01-08|June 2017|2017-06-01|June 20, 2017|Actual|2017-06-20|March 12, 2016|Actual|2016-03-12||Interventional|PROMISE||Spinal Cord Stimulation for Predominant Low Back Pain|Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low Back Pain|Completed||Phase 4|278|Actual|MedtronicNeuro||2|||f||||f||||||||No|Data will be kept confidential by Medtronic and only be shared with study investigators following Medtronic approval of a data request form.|2017-10-11 02:27:30.156037|2017-10-11 02:27:30.156037
NCT01697345|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2013-12-18|2013-08-15||February 2013||2013-02-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional||One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy|Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy|Completed||Early Phase 1|12|Actual|Creighton University|Limitations of this pilot study included the narrow time frame for enrollment, the exclusion of surgically menopausal women under the age of 50, and symptoms of recurrent Gardnerella vaginalis.|1|||f||||f||||||||||2017-10-11 02:27:31.036009|2017-10-11 02:27:31.036009
NCT01697332|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-07-11|||January 2013|Actual|2013-01-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Functional Applications of Hyperpolarized 129Xe MRI|Functional Applications of Hyperpolarized 129Xe MRI|Terminated||Phase 1/Phase 2|1|Actual|Brigham and Women's Hospital||1||Funding ended prior to resolution of all equipment (polarizer) issues.|f||||t||||||||||2017-10-11 02:27:31.596189|2017-10-11 02:27:31.596189
NCT01697319|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-12-08|2015-10-12||August 2012||2012-08-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation|A Phase 2, Open-label, Multinational Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Who Have Limited Ambulation|Terminated||Phase 2|16|Actual|BioMarin Pharmaceutical||1|||f||||t||||||||||2017-10-11 02:27:31.709565|2017-10-11 02:27:31.709565
NCT01697306|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2012-09-27|||September 2006||2006-09-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|March 2011|Actual|2011-03-01||Interventional|||The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer|The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus-Calmette Guerin (BCG) Instillation Therapy on the Quality of Life in Non-muscle-invasive Bladder Cancer (NMIBC) Patients: Results of a Prospective, Randomised Phase II Trial.|Completed||Phase 2|120|Actual|Azienda Ospedaliera San Giovanni Battista||2|||f||||f||||||||||2017-10-11 02:27:32.417119|2017-10-11 02:27:32.417119
NCT01697293|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-01-13|||January 2012||2012-01-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Triciribine Phosphate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer|A Phase I-II Study of PTX-200 Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients With Metastatic and Locally Advanced Breast Cancer|Recruiting||Phase 1/Phase 2|56|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 02:27:32.512465|2017-10-11 02:27:32.512465
NCT01697280|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2014-01-15|||April 2012||2012-04-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Polio NID and Routine EPI Integration Trial Pakistan|Improving Routine Immunization Coverage Through Educational Messages Delivered During Polio NIDs in Pakistan: A Cluster Randomized Trial|Completed||N/A|4560|Actual|Aga Khan University||4|||f||||t||||||||||2017-10-11 02:27:32.669055|2017-10-11 02:27:32.669055
NCT01697267|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-02-21|||April 2013||2013-04-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|RITAZAREM||Rituximab Vasculitis Maintenance Study|An International, Open Label, Randomised Controlled Trial Comparing Rituximab With Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis|Active, not recruiting||Phase 3|190|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:27:32.775242|2017-10-11 02:27:32.775242
NCT01697254|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-11-16|||August 2009||2009-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01|10 Years|Observational [Patient Registry]|CARRA Registry||The CARRA Registry|The CARRA Registry|Completed||N/A|9587|Actual|Duke University|||1||f||||f||||||Samples With DNA|"     Specimens currently being collected from subjects with juvenile dermatomyositis JDM),     systemic juvenile idiopathic arthritis (sJIA), and localized scleroderma.   "|||2017-10-11 02:27:33.00279|2017-10-11 02:27:33.00279
NCT01696526|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-12-19|||October 2012||2012-10-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bioefficiency of of Conventional Fish and Vitamin D Fortified Fish|Bioefficiency of of Conventional Fish and Vitamin D Fortified Fish in Healthy Volunteers|Completed||N/A|53|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||t||||||||||2017-10-11 02:27:49.008338|2017-10-11 02:27:49.008338
NCT01697241|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2014-12-15|||March 2013||2013-03-01|December 2014|2014-12-01|September 2016|Anticipated|2016-09-01|January 2016|Anticipated|2016-01-01||Interventional|HipSPORT||Effect of Exercise as Non-surgical Treatments on Time to Total Hip Replacement Surgery|The Effect of Education and Supervised Exercise vs. Education Alone on Time to Total Hip Replacement in Patients With Hip Osteoarthritis Considered Eligible for Surgery|Unknown status|Recruiting|N/A|200|Anticipated|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 02:27:33.093526|2017-10-11 02:27:33.093526
NCT01697228|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-05-04|||October 2012|Actual|2012-10-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||The Effects of Vitamin D on Glycemic Control and Proinflammatory Markers in Adolescents With T1DM|The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.|Completed||N/A|26|Actual|Children's Hospital Los Angeles||2|||f||||t||||||||||2017-10-11 02:27:33.232707|2017-10-11 02:27:33.232707
NCT01697215|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-12-12|||April 2012||2012-04-01|December 2016|2016-12-01||||June 2012|Actual|2012-06-01||Observational|||Novel Device to Assess Endotracheal Tube Migration|Novel Device (AirWave™) to Assess Endotracheal Tube Migration.|Completed||N/A|50|Actual|The Cleveland Clinic|||1||f||||||||||||||2017-10-11 02:27:33.334289|2017-10-11 02:27:33.334289
NCT01697202|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-02-19|||November 2011||2011-11-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Fatigue in Rheumatoid Arthritis - Longitudinal Study|Fatigue in Rheumatoid Arthritis - Longitudinal Study|Completed||N/A|67|Actual|Göteborg University|||1||f||||f||||||||||2017-10-11 02:27:33.447946|2017-10-11 02:27:33.447946
NCT01697189|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-05|2012-09-28|||August 2010||2010-08-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||An Educational Intervention to Promote Safe Driving|An Educational Intervention to Promote Safe and Economic Truck Driving|Completed||N/A|54|Actual|Finnish Institute of Occupational Health||2|||f||||f||||||||||2017-10-11 02:27:33.644629|2017-10-11 02:27:33.644629
NCT01697176|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-10-21|||August 2010||2010-08-01|September 2012|2012-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|OPTION||Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques|A 1-year Prospective, Multicenter, Non-Randomized, Observational, Study to Evaluate Optimal Improvement of Vein Graft Patency Long Term by the Implementation of Novel Endoscopic Harvesting Techniques|Completed||N/A|100|Actual|Cardiopulmonary Research Science and Technology Institute|||1||f||||f||||||||||2017-10-11 02:27:33.752083|2017-10-11 02:27:33.752083
NCT01697163|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-26|||October 2012||2012-10-01|September 2012|2012-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors|Pilot Study to Identify the Mechanism of De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) in NSCLC With EGFR Mutation.|Unknown status|Not yet recruiting|N/A|155|Anticipated|Severance Hospital|||1||f||||f||||||Samples With DNA|"     DNA extracted from FFPE tissue sample   "|||2017-10-11 02:27:33.844101|2017-10-11 02:27:33.844101
NCT01697150|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-04-20|||April 2012||2012-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Outpatient Control-to-Range: System and Monitoring Testing|Systems Approach to Closed-Loop Control of Type 1 Diabetes at Home|Completed||N/A|5|Actual|William Sansum Diabetes Center||1|||f||||f||||||||||2017-10-11 02:27:33.958003|2017-10-11 02:27:33.958003
NCT01697137|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2015-02-19|||September 2012||2012-09-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|DECIDE||Patient and Physician Intervention to Increase Organ Donation|Patient and Physician Intervention to Increase Organ Donation in Primary Care Settings|Completed||N/A|916|Actual|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 02:27:34.077049|2017-10-11 02:27:34.077049
NCT01697124|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-28|||September 2007||2007-09-01|September 2012|2012-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|CIA||The Children in Action Feasibility Study|The Children in Action Feasibility Study|Completed||N/A|274|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 02:27:35.211747|2017-10-11 02:27:35.211747
NCT01697111|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-02-16|||October 2012||2012-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|||Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis|A Multi-center, Randomized, Double-blinded, Placebo-controlled, and Open-label, Active-controlled, Parallel-group Comparative Study to Assess Efficacy and Safety of an Extended Flexible Regimen of BAY 86-5300 [0.02 mg Ethinylestradiol (β-CDC) and 3 mg Drospirenone] in the Patients With Endometriosis|Completed||Phase 3|312|Actual|Bayer||3|||f||||f||||||||||2017-10-11 02:27:35.349015|2017-10-11 02:27:35.349015
NCT01697098|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2012-09-28|||January 2012||2012-01-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|PTL||Dexamethasone for Preterm Labour|Dexamethasone Dosing Interval: 12 or 24 Hours Apart? A Randomized,Clinical Trial|Completed||Phase 2|200|Actual|Assiut University||2|||f||||t||||||||||2017-10-11 02:27:35.550884|2017-10-11 02:27:35.550884
NCT01697085|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-01-27|||October 2012||2012-10-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|SBMM||Effects of Sea Buckthorn Oil on Mucous Membranes|Effects of Sea Buckthorn Oil on Mucous Membranes|Completed||N/A|116|Actual|Aromtech Ltd.||2|||f||||||||||||||2017-10-11 02:27:35.653532|2017-10-11 02:27:35.653532
NCT01697072|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-01-18||2015-10-22|October 2012||2012-10-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|November 2014|Actual|2014-11-01||Interventional|RILOMET-1||First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Rilotumumab (AMG102) With Epirubicin, Cisplatin, and Capecitabine (ECX) as First-line Therapy in Advanced MET-Positive Gastric or Gastroesophageal Junction Adenocarcinoma|Terminated||Phase 3|609|Actual|Amgen||2||"All Amgen sponsored AMG102 clinical studies were terminated following a pre-planned Data   Monitoring Committee safety review of study 20070622."|f||||t||||||||||2017-10-11 02:27:35.801396|2017-10-11 02:27:35.801396
NCT01697059|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-05-04|||September 2012||2012-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Initial Antibiotics and Delayed Appendectomy for Acute Appendicitis|Initial Antibiotics and Delayed Appendectomy for Acute Appendicitis|Completed||N/A|73|Actual|Rhode Island Hospital||1|||f||||f||||||||||2017-10-11 02:27:36.97083|2017-10-11 02:27:36.97083
NCT00005169|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1984||1984-09-01|October 2002|2002-10-01|June 2000||2000-06-01|||||Observational|||Lifestyle and Chronic Disease in College Alumni (Harvard Alumni Health Study)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.243587|2017-10-11 04:26:35.243587
NCT01697046|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-26|||November 2012||2012-11-01|September 2012|2012-09-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|PERIEP||A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection|A Pilot Study of the Safety, Acceptability, Behavior Impact, and HIV Seroincidence Among High Risk Men Who Have Sex With Men With Access to Isentress 400 mg BID + Truvada Once Daily for Peri-exposure Chemoprophylaxis for HIV Infection Chemoprophylaxis for HIV Infection|Unknown status|Not yet recruiting|Phase 3|65|Anticipated|Projeto Praça Onze||1|||f||||f||||||||||2017-10-11 02:27:37.128217|2017-10-11 02:27:37.128217
NCT01697020|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2013-11-28|||September 2012||2012-09-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions|A SINGLE CENTER, SINGLE-DOSE, OPEN-LABEL, RANDOMIZED, TWO-PERIOD CROSSOVER STUDY TO ASSESS THE BIOEQUIVALENCE OF AN ORAL MERCAPTOPURINE SUSPENSION 100 mg / 5 mL VERSUS AN ORAL MERCAPTOPURINE TABLET 50 mg (PURINETHOL®) IN AT LEAST 62 HEALTHY MALE SUBJECTS UNDER FASTING CONDITIONS|Completed||Phase 1|70|Actual|Nova Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:27:37.281914|2017-10-11 02:27:37.281914
NCT01697007|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2015-06-26|||November 2012||2012-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|TaMoVac II||A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique|A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique|Completed||Phase 2|198|Actual|Muhimbili University of Health and Allied Sciences||3|||f||||t||||||||||2017-10-11 02:27:37.458984|2017-10-11 02:27:37.458984
NCT01696994|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2016-12-28|2013-08-30||November 1993||1993-11-01|December 2016|2016-12-01||||May 2012|Actual|2012-05-01||Interventional|||Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)|Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial|Active, not recruiting||N/A|78216|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 02:27:37.626581|2017-10-11 02:27:37.626581
NCT01696981|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-07-10|2013-08-30||November 16, 1993|Actual|1993-11-16|June 2017|2017-06-01||||May 21, 2012|Actual|2012-05-21||Interventional|||Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)|Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial|Active, not recruiting||N/A|154900|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 02:27:38.499056|2017-10-11 02:27:38.499056
NCT01696968|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-09-04|2013-08-30||November 16, 1993|Actual|1993-11-16|June 2017|2017-06-01||||May 21, 2012|Actual|2012-05-21||Interventional|||Screening for Lung Cancer in Older Patients (PLCO Screening Trial)|Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial|Active, not recruiting||N/A|154901|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 02:27:39.269336|2017-10-11 02:27:39.269336
NCT01696955|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-28|2017-08-21|||August 20, 2012|Actual|2012-08-20|August 2017|2017-08-01||||May 6, 2017|Actual|2017-05-06||Interventional|||Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery|A Randomized Phase II Trial of ARQ 197 (Tivantinib)/Cetuximab Versus Cetuximab in Patients With Recurrent/Metastatic Head and Neck Cancer|Active, not recruiting||Phase 2|79|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 02:27:39.938974|2017-10-11 02:27:39.938974
NCT01696929|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-06-23|2015-08-05||September 2012||2012-09-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||An Open-Label Trial of Tocilizumab in Schizophrenia|An Open-Label Trial of Tocilizumab in Schizophrenia|Completed||Phase 1|8|Actual|Augusta University||1|||f||||f||||||||||2017-10-11 02:27:40.778827|2017-10-11 02:27:40.778827
NCT01696916|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-04-14|||March 2012||2012-03-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Development of the Partial Pressure of Carbon Dioxide During Exercise and at Night in Patients With Chronic Obstructive Pulmonary Disease (COPD) IV|Development of the Partial Pressure of Carbon Dioxide During 6-min Walking Test and at Night in Patients With Chronic Obstructive Pulmonary Disease IV|Completed||N/A|75|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||1|||f||||f||||||||||2017-10-11 02:27:41.01458|2017-10-11 02:27:41.01458
NCT01696903|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2015-03-30|||September 2011||2011-09-01|October 2013|2013-10-01|September 2015|Anticipated|2015-09-01|April 2015|Anticipated|2015-04-01||Interventional|||Evaluation of a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy|Clinical Randomized Trial Investigating a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy in Patients With a High Risk for Postoperative Pancreatic Fistula|Unknown status|Recruiting|N/A|120|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:27:41.122383|2017-10-11 02:27:41.122383
NCT01696890|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-04-06|||October 2011||2011-10-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|TEMA-HF2||Integration of Follow-up by First and Second Line Practitioners by Telemonitoring in Heart Failure.|Integration of Follow-up by First and Second Line Practitioners Facilitated by Telemonitoring Versus Stand-alone Telemonitoring in Patients With Severe Heart Failure|Terminated||Phase 2|50|Actual|Jessa Hospital||2||lack of inclusions, sudden withdrawal of study coordinator|f||||t||||||||||2017-10-11 02:27:41.278141|2017-10-11 02:27:41.278141
NCT01696877|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-09-06|||September 2012||2012-09-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer|A Neoadjuvant Immunologic Study of Androgen Deprivation Therapy Combined With a GM-CSF-secreting Allogeneic Prostate Cancer Vaccine and Low-dose Cyclophosphamide in Men With High-risk Localized Prostate Cancer Undergoing Radical Prostatectomy|Active, not recruiting||Phase 1/Phase 2|29|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:27:41.4117|2017-10-11 02:27:41.4117
NCT01695980|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-02-09|||August 2012||2012-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LMA||Laryngeal Mask Airway in Pediatric Adenotonsillectomy|Laryngeal Mask Airway in Pediatric Adenotonsillectomy|Recruiting||N/A|120|Anticipated|Eastern Virginia Medical School||2|||f||||f||||||||||2017-10-11 02:28:00.030784|2017-10-11 02:28:00.030784
NCT01696864|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-01-02|||March 2016||2016-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Remote Rehabilitation Via the Internet in Patients After a Stroke - Physical Rehabilitation Using Biofeedback Systems to Improve Upper Extremity Function|Remote Rehabilitation Via the Internet in Patients After a Stroke - Physical Rehabilitation Using Biofeedback Systems to Improve Upper Extremity Function|Withdrawn||N/A|0|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:27:41.562741|2017-10-11 02:27:41.562741
NCT01696851|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-12-28|||September 2012||2012-09-01|December 2016|2016-12-01||||September 2013|Anticipated|2013-09-01||Observational|||Physiological and Psycho-social Variables of People With a Spinal Cord Injury Participating in Competitive Rugby in Wheelchairs|Physiological and Psycho-social Variables of People With a Spinal Cord Injury|Withdrawn||N/A|0|Actual|Sheba Medical Center|||2|no more interested in this issue|f||||f||||||||||2017-10-11 02:27:41.685734|2017-10-11 02:27:41.685734
NCT01696838|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-09-02|||September 2012||2012-09-01|September 2012|2012-09-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With fMRI|Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With Functional Magnetic Resonance Imaging(fMRI)|Completed||N/A|61|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian||2|||f||||t||||||||||2017-10-11 02:27:41.778531|2017-10-11 02:27:41.778531
NCT01696825|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-12-12|||October 2012||2012-10-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Absorption of Vaginal Diazepam Using Different Delivery Systems|COMPARISON OF ABSORPTION OF VAGINAL DIAZEPAM USING DIFFERENT DELIVERY SYSTEMS|Terminated||Phase 1|3|Actual|William Beaumont Hospitals||4|||f||||t||||||||||2017-10-11 02:27:41.935858|2017-10-11 02:27:41.935858
NCT01696812|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-11-25|||November 2014||2014-11-01|November 2014|2014-11-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Web-based International Multi-Center Clinical Study for Parkinson's Disease|Web-based International Multi-Center Clinical Study for Parkinson's Disease; the Evaluation of Clinical Outcome Based on the Electrode Position Estimated From the Fused Images of Preoperative MRI and Postoperative CT After Bilateral STN DBS|Not yet recruiting||N/A|136|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 02:27:42.064227|2017-10-11 02:27:42.064227
NCT01696786|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2015-06-10|||June 2009||2009-06-01|June 2015|2015-06-01|October 2017|Anticipated|2017-10-01|October 2013|Actual|2013-10-01||Interventional|||Oocyte Cryopreservation|Oocyte Cryopreservation|Unknown status|Active, not recruiting|N/A|250|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-10-11 02:27:42.262982|2017-10-11 02:27:42.262982
NCT01696773|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-09-28|2014-10-14||October 2012||2012-10-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|September 2013|Actual|2013-09-01||Interventional|||Carotenoid and Flavonoid Absorption From Red and Tangerine-Type Tomatoes|Enhancing Bioavailability and Nutritional Quality of Processed Tomato Products|Active, not recruiting||N/A|12|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 02:27:42.376111|2017-10-11 02:27:42.376111
NCT01696760|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-06-04|2014-06-04||October 2010||2010-10-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology|Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology|Completed||N/A|12|Actual|Ohio State University Comprehensive Cancer Center|Overall patient compliance for the study was low|2|||f||||t||||||||||2017-10-11 02:27:42.781658|2017-10-11 02:27:42.781658
NCT01696747|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-09-13|||July 2012||2012-07-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Observational|GpR2||Gastroparesis Registry 2|GpR 2: Continuation of the NIDDK Gastroparesis Registry for the Characterization and Clinical Course of Gastroparesis Patients|Recruiting||N/A|500|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||3||f||||t||||||Samples With DNA|"     plasma serum DNA   "|||2017-10-11 02:27:43.399812|2017-10-11 02:27:43.399812
NCT01696734|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-12-13|||October 2012||2012-10-01|December 2016|2016-12-01||||October 2018|Anticipated|2018-10-01||Interventional|||Treatment Protocol for the Compassionate Use of Domperidone|Treatment Protocol for the Compassionate Use of Domperidone|Recruiting||Phase 3|200|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:27:43.559517|2017-10-11 02:27:43.559517
NCT01696721|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-03-02|||July 2012||2012-07-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||PPCR: Registry for Pedi Patients Treated With Proton RT|Pediatric Proton Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Proton Radiation Therapy|Recruiting||N/A|5000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:27:43.695636|2017-10-11 02:27:43.695636
NCT01696708|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-03-08|||December 6, 2012|Actual|2012-12-06|September 2012|2012-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PRO-MH2||Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease|Study of the Brain Energy Profile Evolution, Using 31Phosphorus-Nuclear Magnetic Resonance Spectroscopy, at Different Stages of Huntington Disease|Completed||N/A|50|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f|f|f||||||||2017-10-11 02:27:43.85276|2017-10-11 02:27:43.85276
NCT01696695|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-02-17|2016-09-22||July 2011||2011-07-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|AXEL|Intent to treat (ITT) population included all enrolled participants who provided evaluable data for efficacy variables.|An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer|Program for Assessment of Capecitabine (Xeloda) Based First-line Therapies in Metastatic Colorectal Cancer (AXEL Study)|Completed||N/A|882|Actual|Hoffmann-La Roche|||1||f||||f||||||||||2017-10-11 02:27:44.105986|2017-10-11 02:27:44.105986
NCT01638143|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-07-10|||November 2010||2010-11-01|July 2012|2012-07-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Bio-equivalence Study|Comparison of Bioavailability of Three Different Vitamin K2 Formulations|Completed||N/A|24|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 02:45:53.381841|2017-10-11 02:45:53.381841
NCT01696682|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2013-02-07|||September 2012||2012-09-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Optimal Width of Gastric Conduit for Minimally Invasive Esophagectomy: Wide or Narrow?|Study on the Difference of Anastomotic Leakage Ratio Between Wide and Narrow Gastric Conduit During Minimally Invasive Esophagectomy|Unknown status|Recruiting|N/A|200|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 02:27:44.719374|2017-10-11 02:27:44.719374
NCT01696669|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-08-17|||April 2010||2010-04-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults|Phase 2, Open-label, Uncontrolled, Multicenter and Prospective Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults|Unknown status|Active, not recruiting|Phase 2|43|Actual|Grupo Espanol de Investigacion en Sarcomas||1|||f||||t||||||||||2017-10-11 02:27:44.831336|2017-10-11 02:27:44.831336
NCT01696656|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-09-28|||September 2012||2012-09-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Prescription Pattern of Adjuvant Drugs and Vitamins in Patients Undergoing Long-term Home Nutritional Support for Intestinal Insufficiency|Prescription Pattern of Adjuvant Drugs and Vitamins in Patients Undergoing Long-term Home Nutritional Support for Intestinal Insufficiency|Completed||N/A|37|Actual|University of Sao Paulo|||1||f||||f||||||||||2017-10-11 02:27:44.959423|2017-10-11 02:27:44.959423
NCT01696643|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-01-05|2015-07-14||October 2012||2012-10-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional||All randomized participants who received at least 1 dose of study drug. Two participants were randomized to the Placebo Arm but were administered CB-5945 instead. As a result, these 2 participants were included in the CB-5945 Arm for analysis.|Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation|Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain|Terminated||Phase 3|1407|Actual|Cubist Pharmaceuticals LLC||2||"A review of blinded data indicates that the number of participant exposures needed to reach ICH   standards has been met"|f||||||||||||||2017-10-11 02:27:45.172354|2017-10-11 02:27:45.172354
NCT01696630|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-08-03|||October 2012||2012-10-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Xenon Combined With Intraoperative Thoracic Epidural Analgesia|Phase II Study, Randomized, Monocentric, Single-blind, Comparing the Efficacy of Xenon and Desflurane, in Association With a Thoracic Epidural Analgesia in the Maintenance Phase of a Colorectal Oncologic Surgery|Completed||Phase 2|31|Actual|Centre Leon Berard||2|||f||||t||||||||||2017-10-11 02:27:47.825091|2017-10-11 02:27:47.825091
NCT01696617|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2015-12-07|||February 2012||2012-02-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder|Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder|Recruiting||Phase 4|70|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:27:47.922954|2017-10-11 02:27:47.922954
NCT01696604|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-06-06|||September 26, 2012|Actual|2012-09-26|June 2017|2017-06-01|May 3, 2013|Actual|2013-05-03|May 3, 2013|Actual|2013-05-03||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects|A Single-center, Randomized, Blinded, Placebo-controlled Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Selective Androgen Receptor Modulator (SARM), GSK2849466, in Single and Repeat Doses, With and Without Food, in Healthy Male Subjects|Completed||Phase 1|17|Actual|GlaxoSmithKline||10|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:27:48.031881|2017-10-11 02:27:48.031881
NCT01696591|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-27|||March 2012||2012-03-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD|The Long-Term Safety and Efficacy Follow-up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD|Unknown status|Recruiting|N/A|14|Anticipated|Samsung Medical Center|||2||f||||t||||||||||2017-10-11 02:27:48.180987|2017-10-11 02:27:48.180987
NCT01696578|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-04-23|||January 2012||2012-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness of Combined Intervention Approaches in the Treatment of Affective Disorders and Chronic Pain in War Victims|Effectiveness of Combined Intervention Approaches in the Treatment of Affective Disorders and Chronic Pain in Victims of Torture and Massive Violence in Kosovo: A Randomized Controlled Trial|Completed||N/A|31|Actual|Rehabilitation and Research Centre for Torture Victims||2|||f||||t||||||||||2017-10-11 02:27:48.284236|2017-10-11 02:27:48.284236
NCT01696565|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2012-09-27|||December 2001||2001-12-01|September 2012|2012-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy|PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy|Completed||Phase 1/Phase 2|32|Actual|PhytoHealth Corporation||3|||f||||f||||||||||2017-10-11 02:27:48.398345|2017-10-11 02:27:48.398345
NCT01696552|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2017-03-27|||September 2011||2011-09-01|March 2017|2017-03-01|January 2024|Anticipated|2024-01-01|January 2014|Actual|2014-01-01||Interventional|||Patient-specific Positioning Guides (PSPG) Technique Versus Conventional Technique in Total Knee Arthroplasty|Patient-specific Positioning Guides (PSPG) Technique Versus Conventional Technique in Total Knee Arthroplasty - a Prospective Randomized Study.|Active, not recruiting||N/A|109|Anticipated|Oslo University Hospital||2|||f||||f||||||||Undecided||2017-10-11 02:27:48.506083|2017-10-11 02:27:48.506083
NCT01696539|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2012-09-27|||March 2010||2010-03-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients|Pilot Intervention Study of the Impact of Sustainable Daily Physical Activity on Health and Quality of Life in a Cohort of Men With Prostate Cancer in Sweden: Steps for PRosTAte Cancer Health and Survival (SPaRTACuS)|Completed||N/A|42|Actual|Örebro University, Sweden||2|||f||||t||||||||||2017-10-11 02:27:48.686398|2017-10-11 02:27:48.686398
NCT01685996|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-05-30|2017-04-17||September 2012||2012-09-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|1207||Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation|Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation|Completed||Phase 1/Phase 2|74|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:30:47.070009|2017-10-11 02:30:47.070009
NCT01696513|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-09-13|||September 2012||2012-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Effect of Subcision and Suction on Acne Scars|Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Subcision and Suctioning With a Microdermabrasion Device on Rolling Acne Scars|Active, not recruiting||N/A|20|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 02:27:49.124046|2017-10-11 02:27:49.124046
NCT01696500|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2014-07-01|||October 2012||2012-10-01|October 2013|2013-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.|NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.|Completed||Phase 3|10|Anticipated|Nihon Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-11 02:27:49.230655|2017-10-11 02:27:49.230655
NCT01696487|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2015-09-24|||February 2012||2012-02-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|||Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.|Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.|Completed||N/A|10|Actual|Medical University of Vienna||4|||f||||t||||||||||2017-10-11 02:27:49.323128|2017-10-11 02:27:49.323128
NCT01696461|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-06-13|||May 2013||2013-05-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor|A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients With Hematological Malignancies|Completed||Phase 2|128|Actual|Center for International Blood and Marrow Transplant Research||1|||f||||t||||||||||2017-10-11 02:27:49.604486|2017-10-11 02:27:49.604486
NCT01696448|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2014-11-10|||August 2012||2012-08-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|CAR-191||The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza|"Changes in Appetite, Weight, Body Composition, Endothelial Function and Biomarkers in Patients With the Cardiometabolic Syndrome: Comparison of a Combination of Berberine, Lipoic Acid, and Picrorhiza (CAR-191) Versus Placebo (The BANGALORE Study)"|Completed||N/A|28|Actual|Carmel Biosciences||2|||f||||f||||||||||2017-10-11 02:27:49.768551|2017-10-11 02:27:49.768551
NCT01696435|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-01-27|||July 2010||2010-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VITAL-DEP||VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL|VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL|Active, not recruiting||N/A|25875|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:27:49.886812|2017-10-11 02:27:49.886812
NCT01696422|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-07-11|||October 2013||2013-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|April 2016|Actual|2016-04-01||Interventional|||Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine|Phase II, Step-wise, Randomized, Double-blind, Controlled Clinical Trial for Safety and Immunogenicity Evaluation of a Lyophilized Formulation of Dengue 1,2,3,4 (Attenuated) Vaccine in Healthy Adults|Active, not recruiting||Phase 2|300|Actual|Butantan Institute||5|||f||||t||||||||||2017-10-11 02:27:50.014835|2017-10-11 02:27:50.014835
NCT01696409|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-04-03|||July 2009||2009-07-01|April 2017|2017-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||The Effect Of Vitamin D On Measures Of Bone Health And Gene Expression|The Effect of Vitamin D on Measures of Bone Health and Gene Expression|Completed||N/A|11|Actual|Boston University|||2||f||||f||||||Samples With DNA|"     Buffy coat has been retained from whole blood.   "|No||2017-10-11 02:27:50.154748|2017-10-11 02:27:50.154748
NCT01696396|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-06-08||2015-12-19|December 4, 2012|Actual|2012-12-04|June 2017|2017-06-01|April 20, 2018|Anticipated|2018-04-20|December 26, 2014|Actual|2014-12-26||Interventional|||AMG 181 in Subjects With Moderate to Severe Crohn's Disease|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Crohn's Disease|Active, not recruiting||Phase 2|254|Actual|Amgen||4|||f||||t||||||||||2017-10-11 02:27:50.31923|2017-10-11 02:27:50.31923
NCT01696383|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2013-02-06|||February 2013||2013-02-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia|Assessing the Efficacy of DuoTrav® (Travoprost 0.004%/Timolol 0.5% Fixed Combination), as a Replacement Therapy in Glaucoma Patients in Russia, Previously on Prior Prostaglandin Analogue or Beta-blocker Monotherapy|Withdrawn||Phase 4|0|Actual|Alcon Research||1||Management decision|f||||f||||||||||2017-10-11 02:27:50.655516|2017-10-11 02:27:50.655516
NCT01696370|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2013-02-27|||April 2012||2012-04-01|August 2011|2011-08-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Trimetazidine Therapy in Hypertrophic Cardiomyopathy|A Phase 2b Randomised, Double Blind, Placebo-controlled Trial of Trimetazidine Therapy in Patients With Non-obstructive Hypertrophic Cardiomyopathy|Unknown status|Recruiting|Phase 2|90|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 02:27:50.777564|2017-10-11 02:27:50.777564
NCT01696357|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-12-08|2014-12-02||September 2009||2009-09-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|ADAM||Automated Device for Asthma Monitoring|Developing an Automated Symptom Monitoring Device for Adolescents With Asthma|Completed||N/A|84|Actual|University of Rochester|||2||f||||t||||||||||2017-10-11 02:27:50.886304|2017-10-11 02:27:50.886304
NCT01696344|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-04-25|||May 2012||2012-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|TARGET||Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome?|Does AF Termination Without Additional Ablation Influence Outcome?|Recruiting||N/A|60|Anticipated|Texas Cardiac Arrhythmia Research Foundation|||2||f||||f|f|f||||||Undecided||2017-10-11 02:27:51.100682|2017-10-11 02:27:51.100682
NCT00001975|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-20|2017-10-05|||January 18, 2000||2000-01-18|August 3, 2017|2017-08-03||||||||Observational|||Study of Skin Tumors in Tuberous Sclerosis|Cutaneous Tumorigenesis in Patients With Tuberous Sclerosis|Recruiting||N/A|130|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.489131|2017-10-11 04:19:54.489131
NCT01696331|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2015-11-24|||September 2012||2012-09-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|January 2013|Actual|2013-01-01||Interventional|||Text Messaging for Adherence in Adolescent Liver Transplant Recipients|Impact of Text Messaging on Adherence in Adolescent Liver Transplant Patients|Active, not recruiting||N/A|42|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 02:27:51.201509|2017-10-11 02:27:51.201509
NCT01696318|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2016-01-14|||May 2012||2012-05-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Program for Cardiovascular Prevention and Randomized Clinical Trial|Management Models for Cardiovascular Risk Reduction in Primary for Brazil: Developing a Program for Cardiovascular Prevention and Randomized Clinical Trial|Completed||N/A|256|Actual|Federal University of Rio Grande do Sul||2|||f||||t||||||||||2017-10-11 02:27:51.314055|2017-10-11 02:27:51.314055
NCT01696305|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-02-27|||December 2012||2012-12-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Study for Hyalobarrier to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG After Thyroidectomy|Prospective, Randomized, Double Blind, Multicenter Study for Hyalobarrier ® to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG® After Thyroidectomy|Completed||Phase 3|198|Actual|Green Cross Corporation||2|||f||||f||||||||||2017-10-11 02:27:51.41478|2017-10-11 02:27:51.41478
NCT01696292|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-09-28|||August 2004||2004-08-01|September 2012|2012-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Evaluation of Mental Flexibility Through Language Tests in Adolescents With Frontal Brain Damage and in Healthy Children in Ages 8-17||Completed||N/A|20|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 02:27:51.57468|2017-10-11 02:27:51.57468
NCT01696279|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-01-25|||February 11, 2013||2013-02-11|January 2017|2017-01-01|July 9, 2018|Anticipated|2018-07-09|July 2, 2018|Anticipated|2018-07-02||Interventional|||A Comparison of Lanthanum Carbonate and Calcium Carbonate in Children|A 3-part Open-label Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Compare the Efficacy, Safety and Tolerability of 8 Weeks of Treatment With Lanthanum Carbonate and Calcium Carbonate Using a Crossover Design and Investigate the Efficacy and Safety of 8 Months of Treatment With Lanthanum Carbonate in Hyperphosphataemic Children and Adolescents Aged 10 Years to <18 Years With Chronic Kidney Disease on Dialysis|Recruiting||Phase 2|50|Anticipated|Shire||2|||f||||f||||||||||2017-10-11 02:27:51.674464|2017-10-11 02:27:51.674464
NCT01696266|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-09-06|||September 5, 2012|Actual|2012-09-05|September 2017|2017-09-01|December 30, 2013|Actual|2013-12-30|December 30, 2013|Actual|2013-12-30||Observational|||An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes|An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes|Completed||N/A|29304|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 02:27:51.970976|2017-10-11 02:27:51.970976
NCT01696253|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-04-19|||September 2012|Actual|2012-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|August 2014|Actual|2014-08-01||Observational|||Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study|Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study|Active, not recruiting||N/A|360|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||Samples Without DNA|"     First morning clean catch urine sample.   "|||2017-10-11 02:27:52.173177|2017-10-11 02:27:52.173177
NCT01696240|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2013-02-22|||September 2012||2012-09-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Randomized Trial of Udenafil Therapy in Patients With Mild Pulmonary Hypertension [ULTIMATE-Mild PHT]|Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Mild Pulmonary Hypertension [ULTIMATE-Mild PHT]|Unknown status|Recruiting|Phase 3|40|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:27:52.250212|2017-10-11 02:27:52.250212
NCT01696227|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-10-13|||July 2012||2012-07-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|Nissle 1917||Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children|Targeted Pathogen Replacement With Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children|Completed||N/A|50|Actual|Nationwide Children's Hospital|||1||f||||f||||||Samples Without DNA|"     Bacteria recovered from samples will be retained   "|||2017-10-11 02:27:52.368543|2017-10-11 02:27:52.368543
NCT01696214|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-10-03|2016-08-08||October 2012||2012-10-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|May 2015|Actual|2015-05-01||Interventional|SAPS|smoking asthmatics|A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial|SAPS:Smoking Asthmatics Pilot Study:|Active, not recruiting||Phase 4|20|Actual|University of California, San Diego||4|||f||||t||||||||Yes|results will be presented been publication four-minute meetings|2017-10-11 02:27:52.472498|2017-10-11 02:27:52.472498
NCT01696201|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-11-13|||October 2009||2009-10-01|September 2012|2012-09-01|June 2015|Anticipated|2015-06-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Physical Exercise Program on Outcomes and Level of Depression|Effect of a Supervised Exercise Program During Whole Pregnancy on Outcomes and Level of Depression. A Randomized Controlled Trial|Unknown status|Recruiting|N/A|160|Anticipated|Technical University of Madrid||2|||f||||t||||||||||2017-10-11 02:27:52.942263|2017-10-11 02:27:52.942263
NCT01696188|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-10-14|2015-08-04||July 2012||2012-07-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study Comparing Two Methods of Placing an Interscalene Nerve Catheter for Postoperative Pain Control in Patients Who Undergo Open Shoulder Surgery.|Comparison of In-Plane vs. Out-of-Plane Ultrasound-Guided Approach for Interscalene Nerve Catheters: a Prospective, Randomized Trial|Completed||N/A|84|Actual|Thomas Jefferson University||2|||f||||f||||||||||2017-10-11 02:27:53.071629|2017-10-11 02:27:53.071629
NCT01696175|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-09-28|||September 2012||2012-09-01|September 2017|2017-09-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|PALVOS||PICU Admission Lactate and Central Venous Oxymetry Study|Lactate Levels and Venous Oxygen Saturation in Children Admitted to a Dutch PICU|Terminated||N/A|50|Actual|Radboud University|||1|Researcher stopped activity at institution|f||||f||||||||||2017-10-11 02:27:53.352793|2017-10-11 02:27:53.352793
NCT01696162|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-15|2014-06-15|||September 2012||2012-09-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||"Conventional Home Exercise Programs Versus Electronic Home Exercise Versus Artificial Intelligence Virtual Therapy for Anterior Knee Pain"|"Conventional Home Exercise Programs Versus Electronic Home Exercise Versus Artificial Intelligence Virtual Therapy for Anterior Knee Pain: a Prospective Randomized Comparative Trial."|Completed||N/A|85|Actual|Simpletherapy||3|||f||||t||||||||||2017-10-11 02:27:53.419491|2017-10-11 02:27:53.419491
NCT01696149|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2012-09-27|||March 2010||2010-03-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Effects of High and Low Frequency TENS on Sympathetic Skin Response and Skin Temperature|The Effects of High and Low Frequency Transcutaneous Electrical Nerve Stimulation on Sympathetic Skin Response and Skin Temperature|Completed||N/A|15|Actual|Shiraz University of Medical Sciences||1|||f||||t||||||||||2017-10-11 02:27:53.505525|2017-10-11 02:27:53.505525
NCT01696136|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2015-05-27|||January 2011||2011-01-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|MYSTIC-PAF||Multi-electrode PulmonarY Vein Isolation Versus Single Tip Wide Area Catheter Ablation for Paroxysmal Atrial Fibrillation (PAF)|Multi-electrode PulmonarY Vein Isolation Versus Single Tip Wide Area Catheter Ablation for PAF a Randomized Multinational Multicenter Trial|Completed||N/A|120|Anticipated|R&D Cardiologie||2|||f||||f||||||||||2017-10-11 02:27:53.579297|2017-10-11 02:27:53.579297
NCT01696123|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2012-09-27|||January 2011||2011-01-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine||Completed||Phase 2|125|Actual|Shahid Beheshti University of Medical Sciences||1|||f||||||||||||||2017-10-11 02:27:53.648785|2017-10-11 02:27:53.648785
NCT01696110|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2014-09-30|||August 2012||2012-08-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|BRIGHT||BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial.|Bivalirudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin Undergoing Angioplasty (BRIGHT):a Randomised Controlled Trial|Completed||Phase 4|2194|Actual|Shenyang Northern Hospital||3|||f||||t||||||||||2017-10-11 02:27:53.744253|2017-10-11 02:27:53.744253
NCT01696097|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2015-08-13|||April 2012||2012-04-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|S31||The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults|The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults (S31)|Completed||N/A|19|Actual|Purdue University||1|||f||||f||||||||||2017-10-11 02:27:55.621041|2017-10-11 02:27:55.621041
NCT01696084|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-09-03|2017-09-03||November 2012||2012-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Interventional|301||Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia|Phase III, Multicenter, Randomized, Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection Versus Cytarabine and Daunorubicin in Patients 60-75 Years of Age With Untreated High Risk (Secondary) AML|Active, not recruiting||Phase 3|309|Actual|Jazz Pharmaceuticals||2|||f||||t||||||||||2017-10-11 02:27:55.725761|2017-10-11 02:27:55.725761
NCT01696071|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-07-24|2014-06-18||September 2012||2012-09-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Treated Set (TS) : All patients who were dispensed study medication and were documented as having taken at least one dose of investigational treatment.|Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication|A Randomised, Double- Blind, 2 Way Cross-over Study to Determine 24-hour FEV1-time Profile of Inhaled Tiotropium, Delivered Via the Respimat Inhaler, After 4 Weeks of Once Daily [5 mcg in the Evening (2 Actuations of 2.5 mcg)] or Twice Daily [2.5 mcg in the Morning and Evening (2 Actuations of 1.25 mcg)] Administration in Patients With Moderate Persistent Asthma.|Completed||Phase 2|98|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:27:56.982029|2017-10-11 02:27:56.982029
NCT01696058|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-11-13|2014-09-05||September 2012||2012-09-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Treated set (TS), which includes all randomized patients who receive at least one dose of double-blind study treatment.|Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®|A Randomised, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of 12 Weeks of Once Daily, Orally Inhaled, Co-administration of Olodaterol 5µg (Delivered by the Respimat® Inhaler) and Tiotropium 18µg (Delivered by the HandiHaler®) Compared to Once Daily, Orally Inhaled, Co-administration of Placebo (Delivered by the Respimat® Inhaler) and Tiotropium 18µg (Delivered by the HandiHaler®) in Patients With Chronic Obstructive Pulmonary Disease (COPD)[ANHELTO TM 2]|Completed||Phase 3|1137|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:27:57.455745|2017-10-11 02:27:57.455745
NCT01696045|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-07-31|2017-07-05||November 12, 2012|Actual|2012-11-12|July 2017|2017-07-01|July 31, 2016|Actual|2016-07-31|July 31, 2016|Actual|2016-07-31||Interventional||All treated participants|Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma|Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage IV Malignant Melanoma|Terminated||Phase 2|14|Actual|Bristol-Myers Squibb||2||Slow accrual|f||||t|t|f||||||||2017-10-11 02:27:58.655833|2017-10-11 02:27:58.655833
NCT01696032|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-01-23|||September 2012||2012-09-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|SGI-110||SGI-110 in Combination With Carboplatin in Ovarian Cancer|A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer|Completed||Phase 1/Phase 2|116|Anticipated|Astex Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:27:59.458408|2017-10-11 02:27:59.458408
NCT01696019|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2012-09-27|||July 2008||2008-07-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|SCIBHI||Randomized Trial of Exercise and Social Interaction in a Community-Based Sample of Non-Demented Chinese Elders|A Pilot Randomized Intervention Study of Physical Exercise and Social Engagement in Chinese Elders|Completed||N/A|120|Actual|University of South Florida||4|||f||||f||||||||||2017-10-11 02:27:59.579015|2017-10-11 02:27:59.579015
NCT01696006|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-09-21|||September 2012||2012-09-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|September 2018|Anticipated|2018-09-01||Observational|Perfusion CT||Perfusion CT Registry||Active, not recruiting||N/A|1059|Actual|Asan Medical Center|||1||f||||||||||||||2017-10-11 02:27:59.665127|2017-10-11 02:27:59.665127
NCT01695993|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-06-27|||November 2012|Actual|2012-11-01|June 2017|2017-06-01|May 16, 2017|Actual|2017-05-16|May 16, 2017|Actual|2017-05-16||Interventional|||Alternative Approaches for Nausea Control|Alternative Approaches for Nausea Control|Completed||N/A|242|Actual|University of Rochester||3|||f||||t||||||||No||2017-10-11 02:27:59.887051|2017-10-11 02:27:59.887051
NCT01695967|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-02-09|||August 2012||2012-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Turbinate Cauterization in Pediatric Patients With Nasal Obstruction|Turbinate Cauterization in Pediatric Patients With Nasal Obstruction A Randomized Prospective Trial|Recruiting||N/A|110|Anticipated|Eastern Virginia Medical School||2|||f||||f||||||||||2017-10-11 02:28:00.167581|2017-10-11 02:28:00.167581
NCT01695928|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2015-10-09|||September 2012||2012-09-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Shock Waves on Tooth Movement and Miniscrew Stability|Effect of Low-energy Extracorporeal Shock Waves on Orthodontic Tooth Movement and Miniscrew Stability|Completed||Phase 2/Phase 3|30|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:28:01.110786|2017-10-11 02:28:01.110786
NCT01695915|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-11-15|||September 2012||2012-09-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Diurnal Variation in Rectal Diameter|Diurnal Variation in Rectal Diameter Measured by Transabdominal Ultrasound in Healthy and Constipated Children.|Completed||N/A|30|Actual|Vejle Hospital|||2||f||||f||||||||||2017-10-11 02:28:01.274944|2017-10-11 02:28:01.274944
NCT01695902|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-09-27|||December 2007||2007-12-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|January 2010|Actual|2010-01-01||Interventional|LVS-20||Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding|A Multiple Center, Randomised, Parallel Group, Single-blind Clinical Trial, to Assess the Therapeutic Equivalence in Terms of Efficacy and Safety of Test Product (Levosert) and Reference Product (Mirena®) in Patients With Menorrhagia - Phase III (Therapeutic Equivalence).|Completed||Phase 3|280|Actual|Uteron Pharma S.A.||2|||f||||f||||||||||2017-10-11 02:28:01.387317|2017-10-11 02:28:01.387317
NCT01695889|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-03-24|||May 2012||2012-05-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|DEMA||Is There a Relationship Between Previous Exposure to General Anesthesia and the Development of Alzheimer´s Disease?|A Case-control Study of Exposure to General Anesthesia and a Diagnosis of Alzheimer´s Disease Later in Life.|Active, not recruiting||N/A|877|Actual|University Hospital, Linkoeping|||1||f||||f||||||||||2017-10-11 02:28:01.492468|2017-10-11 02:28:01.492468
NCT01695876|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2015-03-02|||October 2012||2012-10-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects||Completed||Phase 1|58|Actual|Amgen||2|||f||||||||||||||2017-10-11 02:28:01.579341|2017-10-11 02:28:01.579341
NCT01695863|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2013-03-20|||February 2012||2012-02-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep|Phase 4 of Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep|Unknown status|Active, not recruiting|Phase 4|150|Anticipated|Rush University Medical Center||2|||f||||t||||||||||2017-10-11 02:28:01.697883|2017-10-11 02:28:01.697883
NCT01695850|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-08-15|||June 2013||2013-06-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Double-blinded,Double-dummy Clinical Trial of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation|Chinese Herbal Medicine (MaZhiRenWan) for Functional Constipation: a Prospective, Double-blinded, Double-dummy, Randomized Controlled Study|Completed||Phase 2|291|Actual|Hong Kong Baptist University||3|||f||||t||||||||||2017-10-11 02:28:01.807277|2017-10-11 02:28:01.807277
NCT01695837|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2012-09-27|||July 2011||2011-07-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia||Completed||N/A|61|Actual|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-11 02:28:01.950668|2017-10-11 02:28:01.950668
NCT01695824|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2015-07-07|||December 2011||2011-12-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation|Implantation of Left Atrial Appendage Occluders Concomitantly With Catheter Ablation in Patients With Atrial Fibrillation|Completed||Phase 2|96|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 02:28:02.092053|2017-10-11 02:28:02.092053
NCT01695811|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2015-01-16|||November 2007||2007-11-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|March 2012|Actual|2012-03-01||Observational|FLAK||Femtosecond Laser-Assisted Keratoplasty|Femtosecond Laser-Assisted Keratoplasty|Completed||N/A|24|Actual|University of Michigan|||2||f||||f||||||||||2017-10-11 02:28:02.212926|2017-10-11 02:28:02.212926
NCT01695798|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2014-01-14|||October 2012||2012-10-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|MIPV||IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.|Immunogenicity of Combined Bivalent OPV and IPV Vaccines at 9 - 12 Months of Age Compared to bOPV Alone in Malnourished and Non-Malnourished Pakistani Infants.|Completed||Phase 4|840|Actual|Aga Khan University||4|||f||||t||||||||||2017-10-11 02:28:02.283383|2017-10-11 02:28:02.283383
NCT01695785|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-09-09|||June 2012||2012-06-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Perception of Physical Exertion in Healthy Weight and Obese Adolescents|Perception of Physical Exertion in Healthy Weight and Obese Adolescents: A Pilot Study|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Vermont|||2||f||||f||||||||||2017-10-11 02:28:02.43656|2017-10-11 02:28:02.43656
NCT01628406|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-05-27|||June 2012||2012-06-01|May 2016|2016-05-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|||A Patient Registry at the Neurosurgery Department|A Patient Registry at the Neurosurgery Department.|Enrolling by invitation||Phase 1|12000|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 02:48:30.168052|2017-10-11 02:48:30.168052
NCT01695772|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2017-05-11|2016-06-17||October 16, 2012|Actual|2012-10-16|May 2017|2017-05-01|May 12, 2016|Actual|2016-05-12|April 4, 2015|Actual|2015-04-04||Interventional||Intent-to-treat (ITT) population included all participants enrolled in the study.|A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer|A Multi-Center, Single-Arm, Pilot Study of 5-FU Based Doublet Chemotherapy Plus Bevacizumab as Neoadjuvant Therapy for Patients With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer|Completed||Phase 4|50|Actual|Hoffmann-La Roche||1|||f|||||t|f|||t|||||2017-10-11 02:28:02.556348|2017-10-11 02:28:02.556348
NCT01695759|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-04-06|||December 2013||2013-12-01|April 2016|2016-04-01|April 2017|Anticipated|2017-04-01|June 2016|Anticipated|2016-06-01||Interventional|||Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.|Evaluation of Clinical Efficacy and Immunogenicity of Drug Eritromax® at Blau Farmacêutica S.A. Laboratory in Relation to Drug Eprex®, Produced by Janssen-Cilag Laboratory in Participants With Secondary Anemia to Chronic Kidney Disease.|Recruiting||Phase 3|210|Anticipated|Azidus Brasil||2|||f||||t||||||||Undecided||2017-10-11 02:28:03.043823|2017-10-11 02:28:03.043823
NCT01695746|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-27|2016-04-26|2016-03-08||August 2011||2011-08-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational||Baseline characteristics were evaluated for the safety population which included all participants entered into the study.|An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia|Efficacy of Methoxy Poly-Ethylene Glycol Epoetin Beta (C.E.R.A.) for Correction of Anemia and Maintenance of the Hb Levels in CKD Patients in Stage III - IV, Not on Dialysis, Treated According to Routine Clinical Practice|Completed||N/A|108|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:28:03.264355|2017-10-11 02:28:03.264355
NCT01695733|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-12-04|||September 2011||2011-09-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy|Influenza Vaccination Response in Patients With Non-Hematological Malignancies|Terminated||Early Phase 1|21|Actual|Washington University School of Medicine||2||no longer had funding to continue|f||||f||||||||||2017-10-11 02:28:03.765283|2017-10-11 02:28:03.765283
NCT01695720|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2013-05-29|||June 2012||2012-06-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|VSI-001||Clinical Efficacy Study Comparing VisionScope Imaging (VSI) to Magnetic Resonance Imaging (MRI) in Injuries of the Knee|Trial Comparing VisionScope Imaging (VSI) With Magnetic Resonance Imaging (MRI) in the Diagnosis of Suggestive Clinical Symptoms for Meniscus and Articular Cartilage Injuries in the Knee|Completed||N/A|105|Actual|VisionScope Technologies||1|||f||||f||||||||||2017-10-11 02:28:03.879092|2017-10-11 02:28:03.879092
NCT01695707|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-12-01|||March 2013||2013-03-01|December 2014|2014-12-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients|Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients|Withdrawn||N/A|0|Actual|University of Rochester||2||Insufficient Funding.|f||||t||||||||||2017-10-11 02:28:03.997788|2017-10-11 02:28:03.997788
NCT01695694|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2014-02-17|||September 2012||2012-09-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|VHRW||Violence and HIV Risk Among Women|HIV Risk Reduction for Women Reporting Intimate Partner Violence|Completed||N/A|120|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-11 02:28:04.115417|2017-10-11 02:28:04.115417
NCT01695681|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-11-28|||October 2012||2012-10-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Screen-detected Coeliac Disease, a Population Based Study|Screen-detected Coeliac Disease. Prevalence and Impact on Gastrointestinal Symptoms and Quality of Life|Active, not recruiting||N/A|200|Anticipated|University Hospital of North Norway||1|||f||||f||||||||||2017-10-11 02:28:04.212882|2017-10-11 02:28:04.212882
NCT01695668|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2015-08-24|2015-01-16||August 2011||2011-08-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|September 2013|Actual|2013-09-01||Interventional|Lotemax_BMT||Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%|Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol|Completed||N/A|75|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 02:28:04.522135|2017-10-11 02:28:04.522135
NCT01695655|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-03-13|||November 2007||2007-11-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Observational|||Neovascularization Patterns in Corneal Graft Rejection|Neovascularization Patterns in Corneal Graft Rejection|Completed||N/A|44|Actual|University of Michigan|||1||f||||f||||||||No||2017-10-11 02:28:04.911703|2017-10-11 02:28:04.911703
NCT01695642|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-03-16|||June 2011||2011-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2013|Actual|2013-12-01||Observational|LASIK||Long-term LASIK Follow up Study|Long-term Outcomes After Laser in Situ Keratomileusis (LASIK): Mechanical Microkeratome vs Femtosecond Laser|Completed||N/A|51|Actual|University of Michigan|||2||f||||f||||||||||2017-10-11 02:28:05.007488|2017-10-11 02:28:05.007488
NCT01695629|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2015-12-03|||January 2011||2011-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy|In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy|Completed||N/A|37|Actual|University of Michigan|||2||f||||f||||||Samples Without DNA|"     Skin biopsy from leg   "|||2017-10-11 02:28:05.129158|2017-10-11 02:28:05.129158
NCT01695616|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2016-10-18|||August 2013||2013-08-01|October 2016|2016-10-01|March 2015|Anticipated|2015-03-01|August 2014|Anticipated|2014-08-01||Interventional|Monalisa||Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms|A Phase III, Multicenter, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms.|Withdrawn||Phase 3|0|Actual|Ache Laboratorios Farmaceuticos S.A.||2|||f||||t||||||||||2017-10-11 02:28:05.223745|2017-10-11 02:28:05.223745
NCT01695603|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-05-03|||March 2012||2012-03-01|May 2017|2017-05-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Comparison of a New Automated Ventilatory Mode Named Intellivent to Standard Controlled Ventilation in Brain Injured Patients|Comparison of a New Automated Ventilatory Mode Named Intellivent to Standard Controlled Ventilation in Brain Injured Patients|Completed||N/A|23|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-11 02:28:05.348063|2017-10-11 02:28:05.348063
NCT01695590|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2013-05-31|||March 2012||2012-03-01|May 2013|2013-05-01|September 2014|Anticipated|2014-09-01|March 2014|Anticipated|2014-03-01||Interventional|||Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma|Phase 1/2, Multi-center, Open Label, Dose Escalation, Safety, Efficacy and PK Study of PRLX 93936 Administered IV 3 Days a Week for 3 Weeks Followed by a 9 Day Rest Period in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Prolexys Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:28:05.471426|2017-10-11 02:28:05.471426
NCT01695577|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-01-10|||September 2012||2012-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VRTBI2012||Vestibular Rehabilitation and Balance Training After Traumatic Brain Injury|Vestibular Rehabilitation and Balance Training for Patients With Dizziness and Balance Problems After Traumatic Brain Injury.|Active, not recruiting||N/A|65|Actual|Oslo University Hospital||2|||f||||t||||||||Undecided||2017-10-11 02:28:05.64588|2017-10-11 02:28:05.64588
NCT01695564|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-01-04|||May 2012||2012-05-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|||Safety and Efficacy of Left Atrial Appendage Occlusion Devices|Comparison of Safety and Efficacy of Left Atrial Appendage Occlusion Devices|Enrolling by invitation||N/A|150|Anticipated|University of Kansas Medical Center|||2||f||||f||||||||||2017-10-11 02:28:05.768655|2017-10-11 02:28:05.768655
NCT01695551|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-01-05|||July 2012||2012-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia|Assessment of Intracardiac and Surgace Electrogram Characteristics Correlated to Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia|Completed||N/A|11|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-11 02:28:05.887212|2017-10-11 02:28:05.887212
NCT01695538|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-11-13|||December 2011||2011-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|YOGA STAR||Yoga and Rate and Duration of Inappropriate Sinus Tachycardia (IST) Episodes|The Effect of Yoga on Arrhythmia Burden and Quality of Life in Patients With Inappropriate Sinus Tachycardia|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 02:28:05.974387|2017-10-11 02:28:05.974387
NCT01695525|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-06-27|||June 2012||2012-06-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SYNC - YOGA||Influence of Yoga in Patients With Neurocardiogenic Syncope|Neurocardiogenic Syncope and the Role That Yoga Plays in People With Autonomic Dysfunction|Completed||Early Phase 1|8|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 02:28:06.0627|2017-10-11 02:28:06.0627
NCT01695512|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-05-05|||August 2012||2012-08-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients|Open, Prospective, Multicenter Trial to Evaluate the Clinical Significance of Combined Serological (Galactomannan ELISA, 1->3-β-D Glucan Assay) and Molecular (Nested Aspergillus PCR Assay, Multifungal DNA Microarray) Diagnostic Assays to Detect and Characterize Fungal Pathogens in Bronchoalveolar Lavage (BAL) and Blood Samples of Hematological High Risk Patients and to Detect Point Mutations Conferring Azole Resistance|Enrolling by invitation||N/A|200|Anticipated|Heidelberg University|||2||f||||f||||||Samples With DNA|"     Only fungal DNA is retained and investigated   "|||2017-10-11 02:28:06.142241|2017-10-11 02:28:06.142241
NCT01695499|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-05-05|||August 2012||2012-08-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Diagnostic Study of Biomarkers in BAL of ICU Patients With Lung Infiltrates|Open, Prospective, Multicenter Trial to Evaluate the Clinical Significance of Combined Serological (Galactomannan ELISA, Beta D Glucan Assay) and Molecular (Nested Aspergillus PCR Assay, Real-time qPCR Assay, Multifungal DNA Microarray) Diagnostic Assays to Detect and Characterize Fungal Pathogens in Bronchoalveolar Lavage (BAL)and Blood Samples of Intensive Care Unit Patients With Pulmonary Infiltrates|Enrolling by invitation||N/A|200|Anticipated|Heidelberg University|||2||f||||f||||||Samples With DNA|"     Only fungal DNA investigated   "|||2017-10-11 02:28:06.234521|2017-10-11 02:28:06.234521
NCT01695486|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-09-15|||October 2011||2011-10-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Sedation Monitoring During Open Muscle Biopsy in Children||Completed||N/A|30|Actual|University Hospital, Essen|||1||f||||f||||||||||2017-10-11 02:28:06.339058|2017-10-11 02:28:06.339058
NCT01695473|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-07-17|||October 2012||2012-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|February 2015|Actual|2015-02-01||Interventional|||Neoadjuvant BKM120 in High-risk Prostate Cancer|A Pharmacodynamic Study of Pre-prostatectomy BKM120 in Men With High-risk, Localized Prostate Cancer|Active, not recruiting||Phase 2|24|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:28:06.409853|2017-10-11 02:28:06.409853
NCT01695460|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2015-12-28|||September 2012||2012-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine|A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine|Completed||Phase 3|48|Actual|Aalborg University||2|||f||||t||||||||||2017-10-11 02:28:06.503779|2017-10-11 02:28:06.503779
NCT01695447|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-01-25|||January 2012||2012-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy|Randomised Controlled Trail of Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy After Pancreaticoduodenectomy|Recruiting||N/A|100|Anticipated|Zhejiang University||2|||f||||||||||||||2017-10-11 02:28:06.649249|2017-10-11 02:28:06.649249
NCT01695434|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2013-03-21|||June 2012||2012-06-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|GASWI||A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months|A Prospective, Observational, Single-blinded, Longitudinal MRI Study of Effect of Glatiramer Acetate on Iron Deposition in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months|Completed||N/A|60|Actual|University at Buffalo|||2||f||||f||||||||||2017-10-11 02:28:06.769332|2017-10-11 02:28:06.769332
NCT01695421|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-06-06|||November 2012||2012-11-01|September 2012|2012-09-01|July 2015|Anticipated|2015-07-01|July 2013|Anticipated|2013-07-01||Interventional|||The Effect of a Five Week Electrical Myostimulation Program in Chronic Diseases|Soft-hard Technologies to Assistance and Accessibility in Patients With Chronic Diseases: The Effect of a Five Week Electrical Myostimulation Program.|Unknown status|Recruiting|N/A|40|Anticipated|University of Brasilia||4|||f||||f||||||||||2017-10-11 02:28:06.881831|2017-10-11 02:28:06.881831
NCT01695408|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-07-31|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|December 2019|Anticipated|2019-12-01||Observational|INSIGHTS-IPF||Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis|Investigating Significant Health Trends in IPF (INSIGHTS-IPF). Nationwide Prospective Registry.|Recruiting||N/A|1000|Anticipated|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 02:28:07.041225|2017-10-11 02:28:07.041225
NCT01695395|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2015-02-10|||February 2012||2012-02-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Observational|MEMENTA||Mental Health Care Provision for Adults With Intellectual Disability and a Mental Disorder|Mental Health Care Provision for Adults With Mental Retardation and a Psychiatric Diagnosis|Completed||N/A|371|Actual|Technische Universität Dresden|||2||f||||t||||||||||2017-10-11 02:28:07.19302|2017-10-11 02:28:07.19302
NCT01695382|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-02-01|||August 2012|Actual|2012-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Apoyo Con Carino: Patient Navigation for Palliative Care|Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer|Completed||N/A|223|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:28:07.288576|2017-10-11 02:28:07.288576
NCT01695369|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2014-02-03|2013-11-01||August 2012||2012-08-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Subjects|Evaluation of Comfilcon A and Senofilcon A Lenses|Clinical Comfort Evaluation of Biofinity and Acuvue Oasys Lenses|Completed||Phase 4|61|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 02:28:07.390523|2017-10-11 02:28:07.390523
NCT01695356|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-12-01|||September 2012||2012-09-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma|A Double Blind Randomized Study Comparing the Ultraviolet (UV) Photoprotection With UV Plus Visible Light Photoprotection in the Treatment of Melasma.|Completed||Phase 4|68|Actual|Universidad Autonoma de San Luis Potosí||2|||f||||f||||||||||2017-10-11 02:28:07.603745|2017-10-11 02:28:07.603745
NCT01695343|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2015-01-12|||December 2012||2012-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|KB001-A||Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment|A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa|Completed||Phase 2|182|Actual|KaloBios Pharmaceuticals||2|||f||||t||||||||||2017-10-11 02:28:07.731216|2017-10-11 02:28:07.731216
NCT01695330|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-11-17|2016-11-17||May 2012||2012-05-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens|A Phase II Study of Subcutaneous (SC) Bortezomib-Regimens for Patients With Relapsed/Refractory Multiple Myeloma (MM) Failing Prior Intravenous (IV) Bortezomib-Containing Regimens|Terminated||Phase 2|5|Actual|Oncotherapeutics||1||Terminated by Sponsor of this study.|f||||t||||||||||2017-10-11 02:28:07.940954|2017-10-11 02:28:07.940954
NCT01695317|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-01-21|||April 2013||2013-04-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|ALCAR||Effect of Acetyl-L-carnitine in Migraine|Effect of Acetyl-L-carnitine in Migraine - a Randomized, Double-blind Placebo Controlled Study|Completed||Phase 4|72|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-10-11 02:28:08.131694|2017-10-11 02:28:08.131694
NCT01695304|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-26|2017-02-01|2015-09-28||January 2013||2013-01-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|August 2013|Actual|2013-08-01||Interventional|||Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya|Pilot Intervention Trial of Ceramic Water Filters to Reduce the Burden of Cryptosporidium in Household Drinking Water in Rural Kenya.|Completed||N/A|227|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||Yes|No PII will be shared with any researcher. It is possible that researchers may request access to the clean de-identified data once closed out for all aspects of the work.|2017-10-11 02:28:08.248491|2017-10-11 02:28:08.248491
NCT01695291|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-03-28|||May 2012||2012-05-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|February 2017|Actual|2017-02-01||Interventional|||Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD|A Randomized, Placebo-controlled Trial of Minocycline Added to Serotonin Reuptake Inhibitors in Pediatric OCD: Examining the Effects on Clinical Symptoms and on Brain Glutamate Levels Using MRS Imaging|Active, not recruiting||Phase 2|33|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 02:28:08.517742|2017-10-11 02:28:08.517742
NCT01695278|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2014-11-19|||September 2012||2012-09-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Interventional|C4C||A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community|Coaching for Control: A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community|Completed||Phase 3|16|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 02:28:08.636165|2017-10-11 02:28:08.636165
NCT01695265|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-10-25|||February 2012||2012-02-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|June 2012|Actual|2012-06-01||Interventional|BreatheCOPD||Feel Breathe, Restriction Device Ventilatory Nasal (COPD)|Feel Breathe, Restriction Device Ventilatory Nasal (COPD)|Completed||N/A|20|Actual|University of Cadiz||1|||f||||f||||||||||2017-10-11 02:28:08.745703|2017-10-11 02:28:08.745703
NCT01695252|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-24|||October 2012||2012-10-01|September 2012|2012-09-01|September 2014|Anticipated|2014-09-01|||||Interventional|MEMOS||Measuring and Monitoring Patient Informed Clinical Outcomes In Psychological Therapy Supervision|Measuring and Monitoring Patient Informed Clinical Outcomes In Psychological Therapy Supervision - A Stepped Wedge Cluster Randomised Controlled Trial|Unknown status|Not yet recruiting|N/A|470|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 02:28:08.840148|2017-10-11 02:28:08.840148
NCT01695239|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-09-06|2016-04-20|2015-09-03|December 2012||2012-12-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|December 2014|Actual|2014-12-01||Interventional|SPIRIT-P1||A Study of Ixekizumab in Participants With Active Psoriatic Arthritis|A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 24-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Active Psoriatic Arthritis|Active, not recruiting||Phase 3|417|Actual|Eli Lilly and Company||4|||f||||t||||||||||2017-10-11 02:28:09.17217|2017-10-11 02:28:09.17217
NCT01695226|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-09-25|||February 2004||2004-02-01|September 2012|2012-09-01||||July 2007|Actual|2007-07-01||Interventional|||Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer|Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer|Completed||Phase 2|||Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:28:11.669113|2017-10-11 02:28:11.669113
NCT01695213|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-09-25|||April 2003||2003-04-01|September 2012|2012-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||RCT Comparing the DEXA Results of the HA-Omnifit Versus the Symax Uncemented Hip Stem|A Randomized Comparative Study to Evaluate the Performance and Confirm the Safety of the Diocom Hip Syhstem in Cementless Hip Arthroplasty|Completed||Phase 4|50|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:28:11.755057|2017-10-11 02:28:11.755057
NCT01695200|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2013-04-30|||September 2011||2011-09-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Omega-3 Fatty Acids in Autism Spectrum Disorders|The Role of Omega-3 Fatty Acids in the Management of Singaporean Children With Autism Spectrum Disorders|Completed||Phase 4|60|Anticipated|National Healthcare Group, Singapore||1|||f||||f||||||||||2017-10-11 02:28:11.84587|2017-10-11 02:28:11.84587
NCT01695187|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2013-06-13|||October 2012||2012-10-01|June 2013|2013-06-01|July 2013|Anticipated|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||NB-001 Treatment of Recurrent Herpes Labialis|A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 Treatment of Recurrent Herpes Labialis|Unknown status|Active, not recruiting|Phase 3|362|Actual|NanoBio Corporation||2|||f||||t||||||||||2017-10-11 02:28:11.928691|2017-10-11 02:28:11.928691
NCT01695174|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-10-12|||August 2012||2012-08-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|PSC||A Pilot Study of Xifaxan to Treat Patients With PSC|A Pilot Study of Xifaxan in Patients With Primary Sclerosing Cholangitis|Completed||Phase 1|16|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:28:12.027397|2017-10-11 02:28:12.027397
NCT01695161|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2013-02-28|||September 2012||2012-09-01|February 2013|2013-02-01||||September 2013|Anticipated|2013-09-01||Observational|MPSORA||Non-invasive Assessment of Intraocular Pressure in MPS by Use of the Ocular Response Analyzer.|Corneal-Compensated Intraocular Pressure, Corneal Hysteresis and Corneal Resistance Factor Measurements Performed With the Ocular Response Analyzer and Their Correlation to Conventional Goldmann Applanation Tonometry.|Unknown status|Recruiting|N/A|75|Anticipated|Johannes Gutenberg University Mainz|||3||f||||f||||||||||2017-10-11 02:28:12.10673|2017-10-11 02:28:12.10673
NCT01695148|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-02-05|||August 2012||2012-08-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy of β-carotene Biofortified Maize in Reducing Vitamin A Deficiency Among Children|Efficacy of β-carotene Biofortified Maize in Improving Vitamin A Status and Reducing the Prevalence of Vitamin A Deficiency Among Children in Rural Zambia|Completed||Phase 3|1228|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-10-11 02:28:12.176508|2017-10-11 02:28:12.176508
NCT01695135|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-06-01|||August 9, 2012|Actual|2012-08-09|June 2017|2017-06-01|December 1, 2017|Anticipated|2017-12-01|June 20, 2014|Actual|2014-06-20||Interventional|||A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy|A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (JNJ-212082) Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy|Active, not recruiting||Phase 3|214|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 02:28:12.330815|2017-10-11 02:28:12.330815
NCT01695122|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-02-22|||September 2012||2012-09-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma|Efficacy Evaluation of the Combination of Valproic Acid and Standard Platinum-based Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma|Completed||Phase 2|14|Actual|Instituto do Cancer do Estado de São Paulo||1|||f||||f||||||||||2017-10-11 02:28:12.440294|2017-10-11 02:28:12.440294
NCT01695109|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2012-09-26|||November 2010||2010-11-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers|The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers|Completed||Phase 4|16|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:28:12.52774|2017-10-11 02:28:12.52774
NCT01695096|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-06-28|||October 2012||2012-10-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||High Versus Free Humidity Incubators; A Randomized Clinical Trial|High Versus Free Humidity Incubators; A Randomized Clinical Trial|Completed||N/A|284|Actual|Ibn Sina Hospital||2|||f||||t||||||||||2017-10-11 02:28:12.618877|2017-10-11 02:28:12.618877
NCT01695083|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-05-31|||October 2012||2012-10-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|FIRM||Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients|Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients|Completed||N/A|180|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     blood, liver biopsy   "|||2017-10-11 02:28:12.709653|2017-10-11 02:28:12.709653
NCT01695070|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-11-14|||September 2012||2012-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies|A Pilot Study of Maternally Administered Melatonin to Decrease the Level of Oxidative Stress in Human Pregnancies Affected by Intrauterine Growth Restriction.|Completed||Phase 4|16|Actual|Monash University||1|||f||||f||||||||||2017-10-11 02:28:12.777944|2017-10-11 02:28:12.777944
NCT01695057|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2014-01-27|||October 2012||2012-10-01|January 2014|2014-01-01|October 2015|Anticipated|2015-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer|A Pilot Clinical Trial to Evaluate the Biological Activity of HDAC (Histone Deacetylase Transferases) Inhibition on ER and PR Expression in Triple Negative Invasive Breast Cancer|Withdrawn||N/A|0|Actual|University of Southern California||1||Lack of funding|f||||t||||||||||2017-10-11 02:28:12.850979|2017-10-11 02:28:12.850979
NCT01695044|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-02-21|2016-12-28||September 2012||2012-09-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)|A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer|Completed||Phase 2|119|Actual|Progenics Pharmaceuticals, Inc.||1|||f||||t||||||||No||2017-10-11 02:28:12.960663|2017-10-11 02:28:12.960663
NCT01695031|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-03-30|||October 2012||2012-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PuffCityED||Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens|Feasibility of an ED-initiated Online Asthma Management Program for Urban Teens (Puff City-ED)|Completed||N/A|126|Actual|Henry Ford Health System||2|||f||||t||||||||||2017-10-11 02:28:15.125388|2017-10-11 02:28:15.125388
NCT01695018|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-09-24|||February 2009||2009-02-01|September 2014|2014-09-01||||March 2014|Actual|2014-03-01||Observational|||Early Diagnosis of Oral Cancer by Detecting p16 Methylation|A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Methylation|Completed||N/A|180|Actual|Peking University|||2||f||||t||||||Samples With DNA|"     Oral mucosal biopsy tissues were formalin fixed , paraffin embedded , sliced and     hematoxylin-eosin (HE) staining.   "|||2017-10-11 02:28:15.216916|2017-10-11 02:28:15.216916
NCT01695005|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-09-15|||October 2012||2012-10-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study of LY3039478 in Participants With Advanced Cancer|A Phase 1 Study of LY3039478 in Patients With Advanced or Metastatic Cancer|Recruiting||Phase 1|282|Anticipated|Eli Lilly and Company||4|||f||||f|t|f||||||||2017-10-11 02:28:15.298292|2017-10-11 02:28:15.298292
NCT01694992|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2012-09-25|||March 2012||2012-03-01|September 2012|2012-09-01|August 2015|Anticipated|2015-08-01|December 2012|Anticipated|2012-12-01||Interventional|VERIS-Brazil||Very Early Rehabilitation in Acute Ischemic Stroke|Randomized Clinical Trial of Very Early Rehabilitation Compared With Conventional Rehabilitation in Acute Ischemic Stroke in the Vascular Unit of the Hospital de Clínicas de Porto Alegre - HCPA|Unknown status|Recruiting|Phase 1/Phase 2|184|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 02:28:15.439945|2017-10-11 02:28:15.439945
NCT01694979|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-26|||February 2012||2012-02-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Pelvic Floor Activity and Breathing in Women|Effect Of Variations In Forced Expiration Effort On Pelvic Floor Activation In Asymptomatic Women|Completed||N/A|18|Actual|Kitani, Lenore, PT|||1||f||||f||||||||||2017-10-11 02:28:15.699258|2017-10-11 02:28:15.699258
NCT01694953|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-08-08|||February 2013||2013-02-01|May 2016|2016-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|NAHIM||The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)|The Rare Disease Clinical Research Network Natural History Study of MNGIE|Recruiting||N/A|10|Anticipated|Columbia University|||1||f||||f||||||||Yes|When applicable manuscript (s) will be submitted|2017-10-11 02:28:15.9264|2017-10-11 02:28:15.9264
NCT01694940|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-08-21|||December 2010||2010-12-01|August 2017|2017-08-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|NAMDC||North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)|North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)|Recruiting||N/A|1000|Anticipated|Columbia University|||1||f||||f||||||Samples With DNA|"     Any type of tissue sample can be stored in the biorepository.   "|||2017-10-11 02:28:16.035228|2017-10-11 02:28:16.035228
NCT01694927|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2013-07-02|||January 2012||2012-01-01|July 2013|2013-07-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|MSC-SCI||Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients|Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients|Unknown status|Enrolling by invitation|Phase 2|30|Anticipated|Clinica las Condes, Chile||1|||f||||f||||||||||2017-10-11 02:28:16.231122|2017-10-11 02:28:16.231122
NCT01694914|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2015-01-29|||January 2012||2012-01-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium|Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium|Completed||Phase 3|122|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-11 02:28:16.332774|2017-10-11 02:28:16.332774
NCT01694901|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-07-18|||May 2013|Actual|2013-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Observational|||Optimization of the Anesthetic Regimen Using the SmartPilot® System and Influence on Different Outcome Parameters - a Pilot Study.|Optimization of the Anesthetic Regimen Using the SmartPilot® System and Influence on Different Outcome Parameters - a Pilot Study. A Single- Center Prospective Randomized Controlled Pilot Study.|Active, not recruiting||N/A|100|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 02:28:16.494889|2017-10-11 02:28:16.494889
NCT01694888|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-25|||June 2011||2011-06-01|April 2011|2011-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Midwifery Students' Performance Before and After Teaching Fundamentals of Documentation||Completed||Phase 2/Phase 3|27|Actual|Mashhad University of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:28:16.60776|2017-10-11 02:28:16.60776
NCT01694875|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-11-12|||October 2012||2012-10-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System|Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System in Women With ASC-US Pap Test Results and in Women 30 Years of Age or Older With Negative Pap Test Results Using ThinPrep Pap Test Specimens|Completed||N/A|2200|Anticipated|Gen-Probe, Incorporated|||1||f||||f||||||||||2017-10-11 02:28:16.69813|2017-10-11 02:28:16.69813
NCT01694862|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-05-13|||January 2009||2009-01-01|May 2016|2016-05-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|Integra||Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland|Integra Initiative to Assess the Benefits and Costs of Integrating Sexual and Reproductive Health and HIV Services in Kenya and Swaziland|Completed||N/A|4763|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 02:28:16.793634|2017-10-11 02:28:16.793634
NCT01694849|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-01-13|||September 2012||2012-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|||Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)|A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).|Completed||Phase 2|270|Actual|Genfit||3|||f||||t||||||||||2017-10-11 02:28:16.938683|2017-10-11 02:28:16.938683
NCT00005170|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||December 1984||1984-12-01|April 2000|2000-04-01|February 1993|Actual|1993-02-01|||||Observational|||Ambulatory Blood Pressure and Behavior||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.331082|2017-10-11 04:26:35.331082
NCT01694836|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2014-07-11|||September 2012||2012-09-01|July 2014|2014-07-01|July 2018|Anticipated|2018-07-01|May 2018|Anticipated|2018-05-01||Interventional|||Depigoid Birch 5000 Longterm Study in Adults and Adolescents|Multicenter, Placebo-controlled, Long-term Study of Depigoid Birch 5000 in Adults and Adolescents With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma|Active, not recruiting||Phase 3|634|Actual|Leti Pharma GmbH||2|||f||||t||||||||||2017-10-11 02:28:17.240157|2017-10-11 02:28:17.240157
NCT01694823|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-28|||April 2012||2012-04-01|September 2012|2012-09-01|June 2015|Anticipated|2015-06-01|July 2013|Anticipated|2013-07-01||Interventional|CS-ACI||Safety and Efficacy Study of Cells Sheet-Autologous Chondrocyte Implantation to Treat Articular Cartilage Defects|A Prospective Open-label Multi-center Study to Demonstrate the Safety and Efficacy of Cells Sheet-Autologous Chondrocyte Implantation（CS-ACI）for the Treatment of Articular Cartilage Defects|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Fourth Military Medical University||1|||f||||t||||||||||2017-10-11 02:28:17.384072|2017-10-11 02:28:17.384072
NCT01694810|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2017-01-03|||September 2012||2012-09-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers|A Phase 1 Multiple Dose, Single-Center, Observer-Blind Parallel Group Study Evaluating Safety and Cutaneous Tolerability of NVN1000 Topical Gel in Healthy Volunteers|Completed||Phase 1|60|Actual|Novan, Inc.||4|||f||||f||||||||||2017-10-11 02:28:17.667992|2017-10-11 02:28:17.667992
NCT01694797|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-27|||January 2011||2011-01-01|November 2010|2010-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Oral Bioequivalence Study of Metoprolol Succinate Extended-Release Tablets 50 mg of Dr. Reddy's Laboratories Limited, India Comparing With That of TOPROL-XL® (Containing Metoprolol Succinate) Extended-Release Tablets 50 mg of AstraZeneca LP Wilmington, DE in Healthy, Adult, Human Subjects Under Fasting Conditions|Completed||Phase 1|48|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 02:28:17.806465|2017-10-11 02:28:17.806465
NCT01694784|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-04-15|||September 2012||2012-09-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Understanding and Discouraging Overuse of Potentially Harmful Screening Tests|Understanding and Discouraging Overuse of Potentially Harmful Screening Tests|Completed||N/A|775|Actual|University of North Carolina, Chapel Hill||4|||f||||t||||||||||2017-10-11 02:28:17.916577|2017-10-11 02:28:17.916577
NCT01694771|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-08-25|2014-07-23||September 2012||2012-09-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Treated set (TS), which includes all randomized patients who receive at least one dose of double-blind study treatment.|Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®|A Randomised, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of 12 Weeks of Once Daily, Orally Inhaled, Co-administration of Olodaterol 5µg (Delivered by the Respimat® Inhaler) and Tiotropium 18µg (Delivered by the HandiHaler®) Compared to Once Daily, Orally Inhaled, Co-administration of Placebo (Delivered by the Respimat® Inhaler) and Tiotropium 18µg (Delivered by the HandiHaler®) in Patients With Chronic Obstructive Pulmonary Disease (COPD)[ANHELTO TM 1]|Completed||Phase 3|1134|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:28:18.068114|2017-10-11 02:28:18.068114
NCT01694758|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-08-13|||November 2012||2012-11-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|OPTIMISE||OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA|OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA (OPTIMISE)|Completed||N/A|733|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:28:19.377777|2017-10-11 02:28:19.377777
NCT01694745|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2014-01-22|||October 2012||2012-10-01|February 2013|2013-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|EUROPAINsurvey||EUROpean Pain Audit In Neonates|European Survey of Sedation and Analgesia Practices for Newborns Admitted to Intensive Care Units|Completed||N/A|6489|Actual|Hôpital Armand Trousseau|||1||f||||f||||||||||2017-10-11 02:28:19.532645|2017-10-11 02:28:19.532645
NCT01694732|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-02-10|||August 2012||2012-08-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SAVE||Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease|Efficacy of Varenicline Associated With Intensive Counselling Versus Placebo of Varenicline Associated With Intensive Counselling on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD). A Multicenter Randomized Double-blind Trial|Completed||Phase 3|83|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 02:28:20.413706|2017-10-11 02:28:20.413706
NCT01694706|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-07-03|2015-07-03||September 2012||2012-09-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Treated set (TS) including all subjects who received at least 1 dose of study drug|Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir|Investigation of the Effect of Food and of Increased Gastric pH on the Relative Bioavailability of a Single Oral Dose of 240 mg Faldaprevir in an Open-label, Randomised, Three-way Cross-over Trial in Healthy Subjects|Completed||Phase 1|15|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:28:20.717418|2017-10-11 02:28:20.717418
NCT01694693|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-05-09|||January 31, 2018|Anticipated|2018-01-31|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study|Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study|Withdrawn||N/A|0|Actual|Bristol-Myers Squibb|||1|Business objectives have changed|f||||f||||||||||2017-10-11 02:28:21.364079|2017-10-11 02:28:21.364079
NCT01694316|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-01-19|||September 2012||2012-09-01|November 2016|2016-11-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Use of a Novel Neuroplasticity-based Neurobehavioral Intervention for PTSD|Use of a Novel Neuroplasticity-based Neurobehavioral Intervention for PTSD - A Nationwide, Online Study|Completed||N/A|54|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 02:28:26.14975|2017-10-11 02:28:26.14975
NCT01694680|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-25|2016-09-20|||October 2012||2012-10-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|I-TEAM||Intervention Trial in Early Age-related Macular Degeneration|Intervention Study to Assess the Effect of Daily Consumption of a Lutein-enriched-egg Beverage on Maintenance of Visual Function in Subjects With Early Signs of Age-related Macular Degeneration|Completed||N/A|120|Actual|Newtricious R&D BV||2|||f||||f||||||||||2017-10-11 02:28:21.479601|2017-10-11 02:28:21.479601
NCT01694667|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-08-17|2014-04-03||September 2012||2012-09-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder|Effectiveness of Omega-3 Fatty Acids for the Reduction of Hyperactivity in Children With Autism Spectrum Disorder|Completed||Phase 2|57|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||t||||||||No||2017-10-11 02:28:21.643793|2017-10-11 02:28:21.643793
NCT01694654|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-04-13|||September 2012||2012-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Epidemiology and Outcome of Solitary Fibrous Tumors of the Pleura.|Epidemiology and Outcome of Solitary Fibrous Tumors of the Pleura. A Multicenter Study.|Active, not recruiting||Phase 4|300|Anticipated|University of Zurich|||1||f||||t||||||Samples With DNA|"     Tumor specimen (operative resectate)   "|||2017-10-11 02:28:22.306927|2017-10-11 02:28:22.306927
NCT01694641|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-12-30|2016-11-02||July 2012||2012-07-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||161 patients were randomized. Each patient participated only once in the RCT.|"Embryo Selection by Time Lapse Monitoring for Single Embryo Transfer (SET)"|Time Lapse Embryo Monitoring Versus Standard Embryo Monitoring for Selection for Single Blastocyst Transfer|Terminated||Phase 4|161|Actual|Kaali Institute IVF Center|The downside of the study demographics is that we limited the study population to good prognosis cases therefore the conclusions can only be applied to similar patients. Stopped the study before meeting calculated sample size.|2||"A general TL algorithm with higher predicting power became available in 2015 (Petersen et al.)   and speed of recruitment was slower than expected."|f||||t||||||||No||2017-10-11 02:28:22.389403|2017-10-11 02:28:22.389403
NCT01694628|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-10-28|||September 2012||2012-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|December 2014|Actual|2014-12-01||Interventional|CLIMB||Cognitive Behavioral Therapy for COPD|Psychosocial-Behavioral Therapy for Patients With Advanced COPD and Depression|Completed||N/A|18|Actual|University of Washington||2|||f||||f||||||||No||2017-10-11 02:28:22.718318|2017-10-11 02:28:22.718318
NCT01694615|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2016-10-03|||November 2011||2011-11-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Cryoprobe Transbronchial Lung Biopsy in Lung Transplant Patients|Prospective Controlled Study of Transbronchial Cryoprobe Versus Forceps Biopsy for Acute Rejection in Lung Transplantation|Completed||N/A|30|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:28:22.79893|2017-10-11 02:28:22.79893
NCT01694602|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-07-01|||November 2012||2012-11-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|3MH-2||Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase II|Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase 2|Completed||Phase 2|8|Actual|The University of Texas Medical Branch, Galveston|||1||f||||f||||||Samples Without DNA|"     Spot urine samples.   "|||2017-10-11 02:28:22.88654|2017-10-11 02:28:22.88654
NCT01694589|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2014-12-10|||November 2012||2012-11-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer|A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer|Withdrawn||Early Phase 1|0|Actual|Rutgers, The State University of New Jersey||1||Lack of accrual|f||||f||||||||||2017-10-11 02:28:22.967771|2017-10-11 02:28:22.967771
NCT01694576|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-06-12|||September 2012||2012-09-01|June 2015|2015-06-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|||NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation|Adjuvant Chemotherapy or Not for NPC Patients Staged N2-3M0 After Concurrent Chemotherapy :a Phase Ⅱ Study|Terminated||Phase 2|10|Actual|Jiangsu Cancer Institute & Hospital||2||slow patient enrollment|f||||t||||||||||2017-10-11 02:28:23.051653|2017-10-11 02:28:23.051653
NCT01694563|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-09-14|||September 2012||2012-09-01|January 2017|2017-01-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Observational|ABLATE-PAS||ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal AF|AtriCure Synergy Ablation Lesions for Non-Paroxysmal Forms of Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery|Active, not recruiting||N/A|365|Actual|AtriCure, Inc.|||1||f||||f||||||||||2017-10-11 02:28:23.185313|2017-10-11 02:28:23.185313
NCT01694550|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-10-27|||March 2012||2012-03-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2015|Actual|2015-04-01||Observational|QT-TENDENCY||QT Interval in Patients With Pacemaker Dependency|Corrected QT Interval in Patients With Pacemaker Dependency (QT-TENDENCY-Study)|Completed||N/A|180|Anticipated|University of Magdeburg|||1||f||||t||||||None Retained|"     No biospecimen are necessary for the study and this issue is irrelevant.   "|||2017-10-11 02:28:23.466753|2017-10-11 02:28:23.466753
NCT01694537|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-05-11|||July 2012|Actual|2012-07-01|May 2017|2017-05-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers|The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers|Completed||Phase 2|21|Actual|Indonesia University||2|||f||||t||||||||No||2017-10-11 02:28:23.662818|2017-10-11 02:28:23.662818
NCT01694524|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2014-05-19|||June 2013||2013-06-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Nervous System Infections Among Patients With Febrile Seizure|Nervous System Infections Among Patients With Febrile Seizure : Retrospective Cohort Review of Consecutive Patients Admitted in 7 Pediatric Emergency Departments in Ile-de-France Between 2007 and 2011|Completed||N/A|1200|Actual|Hôpital Armand Trousseau|||1||f||||f||||||||||2017-10-11 02:28:23.813542|2017-10-11 02:28:23.813542
NCT01694511|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-02-07|||November 2009||2009-11-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Endoscopic Detection of Dysplasia in Barrett's Esophagus|High Resolution Magnifying Endoscopy and Contrast Enhanced Imaging Versus Standard White Light Endoscopy for the Detection of Dysplasia in Barrett's Esophagus. A Prospective Blinded Cross-over Study.|Completed||N/A|111|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 02:28:23.970115|2017-10-11 02:28:23.970115
NCT01694498|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-08-22|||September 2012||2012-09-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|NOC||Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men|A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial Investigating the Efficacy and Safety of Two Different Dose Levels of Desmopressin for the Treatment of Nocturia in Adult Men|Completed||Phase 2|183|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:28:24.14256|2017-10-11 02:28:24.14256
NCT01694485|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-06-21||2016-03-18|November 16, 2012|Actual|2012-11-16|June 2017|2017-06-01|April 20, 2018|Anticipated|2018-04-20|July 13, 2015|Actual|2015-07-13||Interventional|||AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis|A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis|Active, not recruiting||Phase 2|359|Actual|Amgen||5|||f||||t||||||||||2017-10-11 02:28:24.369414|2017-10-11 02:28:24.369414
NCT01694472|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2015-12-21|||July 2012||2012-07-01|September 2012|2012-09-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors|Phase 1 Study of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||||||||||||2017-10-11 02:28:24.73625|2017-10-11 02:28:24.73625
NCT01694459|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2012-09-26|||January 2010||2010-01-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|DEDICA||DEDICA (Dose of HEparin During Coronary Angioplasty) Trial|Comparison of Low-dose Heparin Versus Standard Dose Heparin During Coronary Interventions (DEDICA Trial)|Unknown status|Recruiting|Phase 4|1000|Anticipated|San Filippo Neri General Hospital||2|||f||||f||||||||||2017-10-11 02:28:24.815533|2017-10-11 02:28:24.815533
NCT01694446|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-03-06|||September 2011||2011-09-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|glucose||Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose|Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose|Completed||N/A|14|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 02:28:24.925469|2017-10-11 02:28:24.925469
NCT01694433|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2013-10-18|||February 2013||2013-02-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Interventional|||"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"|Innate Immunity in Acne Vulgaris|Unknown status|Active, not recruiting|Phase 2/Phase 3|54|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:28:25.007386|2017-10-11 02:28:25.007386
NCT01694420|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-03-14|2016-10-31||September 2012||2012-09-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|April 2016|Actual|2016-04-01||Interventional|PHI04||Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet|Treatment of Acute HIV Infection With the Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate, A Pilot Study of Response to Therapy and HIV Pathogenesis|Completed||Phase 3|33|Actual|Duke University||1|||f||||f||||||||||2017-10-11 02:28:25.128812|2017-10-11 02:28:25.128812
NCT01694407|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-03-31|||February 2013||2013-02-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine|A Phase I Clinical Trial Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine|Completed||Phase 1|48|Actual|CONRAD||4|||f||||f||||||||||2017-10-11 02:28:25.448938|2017-10-11 02:28:25.448938
NCT01694394|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2015-09-21|||December 2012||2012-12-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Observational|ASSERT-II||Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor|Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor in Patient With Cardiovascular Risk Factors (ASSERT-II)|Unknown status|Active, not recruiting|Phase 4|250|Anticipated|Population Health Research Institute|||1||f||||t||||||Samples Without DNA|"     Blood will be collected for NT-ProBNP and hs-Troponin-T   "|||2017-10-11 02:28:25.572758|2017-10-11 02:28:25.572758
NCT01694381|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-01-09|||September 2015||2015-09-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor|Phase 1 Trial of Mutant proUK, M5, and Its Inhibitor, C1-inhibitor|Suspended||N/A|50|Anticipated|TSI, LLC|||2||f||||t||||||Samples Without DNA|"     plasma samples.   "|||2017-10-11 02:28:25.714459|2017-10-11 02:28:25.714459
NCT01694368|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-10-12|||November 2011||2011-11-01|October 2016|2016-10-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|NIRS-IVUS||Intracoronary Imaging With NIRS-IVUS to Characterize Arterial Plaques|Multimodality Advanced Intracoronary Imaging With Near-infrared Spectroscopy and Intravascular Ultrasound to Characterize Coronary Artery Plaques Before and After Percutaneous Intervention|Active, not recruiting||N/A|500|Actual|Spectrum Health Hospitals|||1||f||||f||||||||No||2017-10-11 02:28:25.839402|2017-10-11 02:28:25.839402
NCT01694355|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-04-19|||September 2012||2012-09-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|October 2019|Anticipated|2019-10-01||Interventional|Vitamin D||The Impact of Severe Vitamin D Deficiency and Its Correction on Bone Mineral Density (BMD) in Postmenopausal Women||Recruiting||N/A|30|Anticipated|Soroka University Medical Center||1|||f||||f||||||||No||2017-10-11 02:28:25.935631|2017-10-11 02:28:25.935631
NCT01694342|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2012-09-26|||September 2012||2012-09-01|July 2012|2012-07-01||||||||Observational|telomereFL||Telomere Parameters in Patients With Nonalcoholic Fatty Liver|Telomere Parameters Like Telomere Length, Telomerase Expression, Telomere Capture and Aneuploidy in Patients With Nonalcoholic Fatty Liver|Unknown status|Not yet recruiting|N/A|30|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 02:28:26.008472|2017-10-11 02:28:26.008472
NCT01694329|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-03-01|||September 2012||2012-09-01|October 2015|2015-10-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|Nunavik2||Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada|Impact of Introduction of PHiD-CV (Pneumococcal Nontypeable H. Influenza Protein D-conjugate Vaccine) for Nunavik Children, Quebec, Canada|Active, not recruiting||N/A|1420|Actual|CHU de Quebec-Universite Laval|||1||f||||f||||||||||2017-10-11 02:28:26.076201|2017-10-11 02:28:26.076201
NCT01684709|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-07-31|||December 2012||2012-12-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|September 30, 2017|Anticipated|2017-09-30||Interventional|||Enhancing Informal Caregiving to Support Diabetes Self-Management|Enhancing Informal Caregiving to Support Diabetes Self-Management|Active, not recruiting||N/A|808|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 02:31:12.333924|2017-10-11 02:31:12.333924
NCT01694303|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2015-07-15|||September 2012||2012-09-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being|Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being|Completed||N/A|38|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 02:28:26.231669|2017-10-11 02:28:26.231669
NCT01694290|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-24|||August 2012||2012-08-01|September 2012|2012-09-01||||July 2013|Anticipated|2013-07-01||Interventional|||Chemical Ice Packs for Cooling Hyperthermic Patients|Randomized Controlled Trial Assessing Effectiveness of Chemical Cold Packs Used on Various Skin Surfaces for Cooling Hyperthermic Patients|Unknown status|Recruiting|N/A|10|Anticipated|Stanford University||3|||f||||t||||||||||2017-10-11 02:28:26.312371|2017-10-11 02:28:26.312371
NCT01694277|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2013-08-13|||April 2012||2012-04-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|January 2015|Anticipated|2015-01-01||Interventional|||A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib|A Prospective, Multicenter, Randomized, Open-label, Active-controlled, Two-parallel Groups, Phase 3 Study to Compare the Efficacy and Safety of Masitinib to Sunitinib in Patients With Gastrointestinal Stromal Tumor After Progression With Imatinib at 400mg as First Line Treatment|Unknown status|Recruiting|Phase 3|208|Anticipated|AB Science||2|||f||||t||||||||||2017-10-11 02:28:26.391423|2017-10-11 02:28:26.391423
NCT01694264|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-03-02|||September 1, 2012|Actual|2012-09-01|March 2017|2017-03-01|December 31, 2015|Actual|2015-12-31|August 31, 2015|Actual|2015-08-31||Interventional|||Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα|A Randomized, Double-blinded, Phase 3, Multicenter, Investigator-initiated Trial for Entecavir for Prophylaxis of Hepatitis B Virus (HBV) Reactivation in HBV Surface Antigen or Anti-HBc Positive Patients Undergoing Anti-TNFα Treatment|Terminated||Phase 3|43|Actual|Seoul National University Hospital||2||Delayed recruitment, unable to meet calculated sample size|f||||f||||||||||2017-10-11 02:28:26.488132|2017-10-11 02:28:26.488132
NCT01694251|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2012-09-23|||December 2011||2011-12-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|MVA||Mitral Valve Area Using 3-dimensional Transesophageal Echocardiography|Determination of Mitral Valve Area After Mitral Valve Repair Surgery for Mitral Stenosis Using 3-dimensional Transesophageal Echocardiography|Completed||N/A|86|Actual|Konkuk University Medical Center|||1||f||||t||||||||||2017-10-11 02:28:26.651861|2017-10-11 02:28:26.651861
NCT01694238|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-10-03|||June 2013||2013-06-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||A Randomized Trial on the Technical Aspects of Stoma Construction.|Circular, Mesh Enforced or Cruciate Incision in the Abdominal Wall Fascia for coloStomy Construction - A Randomised Trial|Recruiting||N/A|240|Anticipated|Sahlgrenska University Hospital, Sweden||3|||f||||||||||||||2017-10-11 02:28:26.725706|2017-10-11 02:28:26.725706
NCT01694225|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2016-11-21|||July 2012||2012-07-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors|Estimating the Adherence Rate of a Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors|Active, not recruiting||N/A|87|Actual|James Graham Brown Cancer Center||1|||f||||t||||||||No|no plan for public sharing of individual participant data|2017-10-11 02:28:26.901419|2017-10-11 02:28:26.901419
NCT01694212|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2017-04-19|||October 2012||2012-10-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy|Effect of Perioperative Topical Diclofenac on Intraocular Inflammation After Cataract Surgery and the Incidence of Postoperative Macular Edema in Patients With Diabetic Retinopathy|Completed||N/A|55|Actual|Eye Clinic Medic Zuljan Jukic||2|||f||||f||||||||||2017-10-11 02:28:27.058773|2017-10-11 02:28:27.058773
NCT01694199|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-03-21|2014-12-29||September 2012||2012-09-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Pulsed Radiofrequency Energy to Treat Post-Bunionectomy Pain|A Multicenter, Randomized, Sham-Controlled, Double-Blinded Study to Evaluate the Analgesic Efficacy and Safety of Pulsed Radiofrequency Energy (PRFE) in Bunionectomy Surgery for the Treatment of Post-Operative Pain|Terminated||N/A|139|Actual|Regenesis Biomedical, Inc.||2||IDMC recommendation|f||||t||||||||No||2017-10-11 02:28:27.194445|2017-10-11 02:28:27.194445
NCT01694186|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2016-12-22|||June 2013||2013-06-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert|A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye|Active, not recruiting||Phase 3|129|Actual|pSivida Corp.||2|||f||||f||||||||||2017-10-11 02:28:27.895803|2017-10-11 02:28:27.895803
NCT01694173|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-28|||December 2010||2010-12-01|September 2012|2012-09-01|February 2013|Anticipated|2013-02-01|August 2012|Actual|2012-08-01||Interventional|||Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM|Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 Diabetes Mellitus|Unknown status|Recruiting|Phase 2/Phase 3|28|Anticipated|Postgraduate Institute of Medical Education and Research||4|||f||||t||||||||||2017-10-11 02:28:28.092112|2017-10-11 02:28:28.092112
NCT01694160|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2016-03-29|||January 2013||2013-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria|Consultant in Nephrology. MD., Ph.D.|Completed||Phase 3|77|Actual|Oslo University Hospital||2|||f||||t||||||||No|Yes|2017-10-11 02:28:28.218809|2017-10-11 02:28:28.218809
NCT01694147|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2015-07-27|||July 2011||2011-07-01|September 2012|2012-09-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Observational|||EVLWI Exhibits Pulmonary and Systemic Permeability in Sepsis Related ALI/ARDS|Extravascular Lung Water Index Exhibits Pulmonary and Systemic Permeability in Patients With Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome.|Unknown status|Recruiting|N/A|60|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||Samples Without DNA|"     To measure the relationship between endothelial injury (serum TM, vWF, VEGF, TIE-2 increase     and imbalance of ANG-1/ANG-2) and vascular permeability and EVLWI in patients, 20ml     peripheral blood will be sampling retented on day 1 and day 3 after including.   "|||2017-10-11 02:28:28.308201|2017-10-11 02:28:28.308201
NCT01694134|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2016-05-31|||July 2012||2012-07-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|MODISC||Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.|Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.|Recruiting||Phase 3|40|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 02:28:28.407408|2017-10-11 02:28:28.407408
NCT01694121|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2016-03-13|||March 2013||2013-03-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|MEN Count||Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men|Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men|Recruiting||N/A|504|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-11 02:28:28.516|2017-10-11 02:28:28.516
NCT01694108|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2017-04-26|2015-12-03||September 2012||2012-09-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Baseline characteristics by allocation among the 4184 mothers in The Danish Calmette Study|Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.|Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children. A Prospective, Randomised, Clinical Trial.|Completed||Phase 4|4262|Actual|Rigshospitalet, Denmark|The allocation was planned to be stratified by sex, study site, and prematurity, however, due to a programming error the allocation was stratified only by prematurity.|2|||f||||t||||||||||2017-10-11 02:28:28.629366|2017-10-11 02:28:28.629366
NCT01694095|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-22|2015-03-23|||December 2009||2009-12-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|GAIN||Evolution and Risk Factors Associated With Geographic Atrophy Progression|Characterization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration|Completed||N/A|96|Actual|Institut de la Macula y la Retina|||1||f||||t||||||||||2017-10-11 02:28:29.823652|2017-10-11 02:28:29.823652
NCT01694082|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2014-06-12|||October 2012||2012-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Interventional|||Brief Web-Based Alcohol Reduction Intervention for Undergraduates|Randomized, Controlled Trial of a Brief, Web-Based Alcohol Reduction Intervention for Undergraduates|Completed||N/A|207|Actual|Yale University||4|||f||||f||||||||||2017-10-11 02:28:29.919928|2017-10-11 02:28:29.919928
NCT01694069|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-03-14|||September 2012||2012-09-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|March 2014|Anticipated|2014-03-01||Interventional|PIPE-CF||Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis|Continuous Infusion Piperacillin-Tazobactam for the Treatment of Pulmonary Exacerbations in Patients With Cystic Fibrosis|Terminated||Phase 4|6|Actual|West Virginia University||2||Recruitment was not sufficient to complete the study|f||||f||||||||||2017-10-11 02:28:30.005785|2017-10-11 02:28:30.005785
NCT01694056|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-01-03|||September 2012||2012-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SOY||Soy Protein Intake and the Metabolic Syndrome|Soy Protein Intake and the Metabolic Syndrome: Reducing Inflammation to Improve Insulin Resistance and Glucose Homeostasis|Completed||N/A|15|Actual|Wageningen University||2|||f||||t||||||||||2017-10-11 02:28:30.129283|2017-10-11 02:28:30.129283
NCT01694043|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-07-14|||August 2012|Actual|2012-08-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Watching a Television Show on the Liking of Snack Foods|The Effect of Perceived Healthy and Unhealthy Commercials on Intake of Perceived Healthy and Unhealthy Snack Foods in Normal Weight, College-Aged, Dietary Restrained Women|Completed||N/A|38|Actual|University of Tennessee||3|||f||||f||||||||||2017-10-11 02:28:30.289532|2017-10-11 02:28:30.289532
NCT01694030|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-24|||November 2012||2012-11-01|September 2012|2012-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of Repeated Attachment Security Priming on Depressed Mood: a Clinical Study|Effects of Repeated Attachment Security Priming on Depressed Mood: a Clinical Study|Unknown status|Not yet recruiting|Phase 1|100|Anticipated|University of Southampton||2|||f||||f||||||||||2017-10-11 02:28:30.381359|2017-10-11 02:28:30.381359
NCT01694017|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-11-20|||November 2012||2012-11-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy|Economic Evaluation of Treatment of HIV With Zidovudine/Stavudine and Tenofovir Regimen: A Cost Effectiveness Study|Completed||Phase 4|68|Actual|Tufts University||2|||f||||t||||||||||2017-10-11 02:28:30.484061|2017-10-11 02:28:30.484061
NCT01694004|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2017-01-20|||November 2012||2012-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nutrient Sensing in the Duodenum|Duodenal Lipid Sensing and Nutrient Absorption|Enrolling by invitation||Phase 1|20|Anticipated|Vanderbilt University Medical Center||1|||f||||f|t|f|||f|||Undecided||2017-10-11 02:28:30.584747|2017-10-11 02:28:30.584747
NCT01693991|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-07-09|||October 2012||2012-10-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Randomized Controlled Trial of the Meaning-Making Intervention (MMi)|Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: A Pilot Study|Completed||Phase 1|60|Actual|Jewish General Hospital||3|||f||||f||||||||||2017-10-11 02:28:30.660433|2017-10-11 02:28:30.660433
NCT01693978|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-08-30|||September 2012||2012-09-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|COPE||Contingency Outcomes in Prolonged Exposure|Incentivizing Adherence to Prolonged Exposure With Substance Users|Completed||N/A|126|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:28:30.7491|2017-10-11 02:28:30.7491
NCT01693965|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-08-29|||January 2013||2013-01-01|August 2014|2014-08-01|February 2016|Anticipated|2016-02-01|September 2015|Anticipated|2015-09-01||Interventional|||Clinical Course and Changes in the Respiratory Microbiota Based on Antibiotic Treatment in Patients With Cystic Fibrosis|Clinical Course and Changes in the Respiratory Microbiota Based on Antibiotic Treatment in Patients With Cystic Fibrosis|Unknown status|Recruiting|N/A|10|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:28:30.862925|2017-10-11 02:28:30.862925
NCT01693952|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-08-29|||May 2012||2012-05-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Sepsis in Neutropenic Patients: Autologous Stem Cell Transplantation as Model: a Transcriptomic Approach|Sepsis in Neutropenic Patients: Autologous Stem Cell Transplantation as Model: a Transcriptomic Approach.|Unknown status|Recruiting|N/A|24|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:28:30.963072|2017-10-11 02:28:30.963072
NCT01693926|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-05-10|||September 2012||2012-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Physical Activity an Stress in Children|Effect of Physical Activity an Stress in Children|Active, not recruiting||N/A|60|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-11 02:28:31.132735|2017-10-11 02:28:31.132735
NCT01693913|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2013-12-27|||October 2012||2012-10-01|December 2013|2013-12-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Cognitive-behavioral Weight Loss Treatment|Effects of a Cognitive-behavioral Weight Loss Treatment|Withdrawn||N/A|0|Actual|YMCA of Metropolitan Atlanta||2||IRB approval canceled|f||||f||||||||||2017-10-11 02:28:31.213472|2017-10-11 02:28:31.213472
NCT01693900|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-03-31|2017-01-09||August 2012||2012-08-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional||Data lost for one participant in Intra-operative FICB group leaving 24 analyzed for all measures.|Efficacy of Fascia Iliaca Block Versus Intraoperative Nerve Infiltration During Anterior Hip Replacement Surgery|Efficacy of Fascia Iliaca Block Versus Intraoperative Nerve Infiltration During Anterior Hip Replacement Surgery|Completed||N/A|50|Actual|William Beaumont Hospitals|Small sample size limited conclusions that could be drawn.|2|||f||||t|f|f|||f|||No||2017-10-11 02:28:32.954253|2017-10-11 02:28:32.954253
NCT01693887|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-12-10|||August 2012||2012-08-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|4056||Treatment Method Research of Invasive Pulmonary Fungal Infection|A Comparative Study About Empirical Therapy and Preemptive Therapy to Invasive Pulmonary Fungal Infection ICU Patients in China|Terminated||N/A|7|Actual|West China Hospital|||2|The study difficulty is more serious than expected. The budget isn't enough.|f||||t||||||||||2017-10-11 02:28:33.30814|2017-10-11 02:28:33.30814
NCT01693874|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-07-21|||October 2011||2011-10-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging|Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging|Completed||Phase 1/Phase 2|103|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:28:33.389883|2017-10-11 02:28:33.389883
NCT01693861|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-12-06|||October 2012||2012-10-01|December 2016|2016-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||"Cancersensor Chemotherapy"|Molecularly Imprinted Polymer Sensors of Modified Nucleosides for Non-invasive Monitoring of Cancer Therapy : Effect of Chemotherapy on Cancerous Proliferation Based on the Dynamic Excretion of Urinary Nucleosides.|Completed||N/A|16|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples With DNA|"     Urine and exfoliated oral mucosa cells   "|||2017-10-11 02:28:33.480711|2017-10-11 02:28:33.480711
NCT01693848|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-12-06|||September 2012||2012-09-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||"Cancersensor Metastasis Resection"|Molecularly Imprinted Polymer Sensors of Modified Nucleosides for Non-invasive Monitoring, of Cancer Therapy: Impact of Surgical Resection of Metastasis on Urinary Excretion of Modified Nucleosides.|Completed||N/A|10|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-11 02:28:33.544819|2017-10-11 02:28:33.544819
NCT01693835|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-12-06|||August 2012||2012-08-01|December 2016|2016-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||"Cancersensor: Circadian Rhythms"|Molecularly Imprinted Polymer Sensors of Modified Nucleosides for Non-invasive Monitoring of Cancer Therapy : the Circadian Rhythms of Urinary Excretion of Modified Nucleosides.|Completed||N/A|32|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||Samples With DNA|"     Saliva (exfoliated oral mucosa cells) and urine   "|||2017-10-11 02:28:33.613268|2017-10-11 02:28:33.613268
NCT01693822|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2013-04-12|||October 2012||2012-10-01|April 2013|2013-04-01|September 2016|Anticipated|2016-09-01|October 2014|Anticipated|2014-10-01||Interventional|A-PREDICT||A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy|A-PREDICT: A Phase II Study Of Axitinib In Metastatic Renal Cell Cancer in Patients Unsuitable for Nephrectomy|Unknown status|Recruiting|Phase 2|99|Anticipated|Institute of Cancer Research, United Kingdom||1|||f||||t||||||||||2017-10-11 02:28:33.701243|2017-10-11 02:28:33.701243
NCT01693809|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-09-29|||January 2012||2012-01-01|September 2012|2012-09-01|January 2013|Anticipated|2013-01-01|October 2012|Anticipated|2012-10-01||Interventional|||The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy Subjects|The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy|Unknown status|Active, not recruiting|Phase 4|25|Anticipated|Hospital do Servidor Publico Estadual||1|||f||||t||||||||||2017-10-11 02:28:33.855119|2017-10-11 02:28:33.855119
NCT01693796|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-05|2015-08-20|||March 2011||2011-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation of Thyroid Exposure to Radiation Doses During Paediatric Cardiac Catheterisations Performed for Diagnosis or the Treatment of Congenital Heart Disease|Evaluation of Thyroid Exposure to Radiation Doses During Paediatric Cardiac Catheterisations Performed for Diagnosis or the Treatment of Congenital Heart Disease|Completed||N/A|500|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:28:34.055952|2017-10-11 02:28:34.055952
NCT01693783|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-09-12|||December 3, 2012|Actual|2012-12-03|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer|A Phase 2 Study of Ipilimumab in Women With Metastatic or Recurrent HPV-Related Cervical Carcinoma of Either Squamous Cell or Adenocarcinoma Histologies|Active, not recruiting||Phase 2|44|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 02:28:34.140948|2017-10-11 02:28:34.140948
NCT01693770|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2014-06-17|||January 2011||2011-01-01|June 2014|2014-06-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Interventional|||Primary Pain Palliation in Bone Metastases Treated With Magnetic Resonance-guided Focused Ultrasound|Primary Pain Palliation and Local Tumor Control in Bone Metastases Treated With Magnetic Resonance-guided Focused Ultrasound|Unknown status|Enrolling by invitation|Phase 1/Phase 2|18|Actual|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-11 02:28:34.263766|2017-10-11 02:28:34.263766
NCT01693757|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-09-24|||January 2010||2010-01-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Observational|||Functional Outcome Anterior Cruciate Ligament Reconstruction|Comparison of Functional Outcome Measures of Anterior Cruciate Ligament Reconstruction Using Either Patellar Tendon or Hamstring Tendon Grafts and Controls in Competitive Soccer Players: A Randomized Trial|Completed||N/A|63|Actual|University of Social Welfare and Rehabilitation Science|||3||f||||t||||||||||2017-10-11 02:28:34.348536|2017-10-11 02:28:34.348536
NCT01693744|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-09-24|||October 2011||2011-10-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|||||Observational|||Pseudoexfoliation and Chronic Kidney Disease|The Relationship Between Pseudoexfoliation and Chronic Kidney Disease|Completed||N/A|358|Actual|Corum State Hospital|||3||f||||t||||||||||2017-10-11 02:28:34.424362|2017-10-11 02:28:34.424362
NCT01693731|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-05-18|||April 2012||2012-04-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Oral Health in Breast Cancer Survivors on Aromatase Inhibitors|Oral Health in Breast Cancer Survivors on Aromatase Inhibitors|Completed||N/A|300|Actual|University of Michigan|||2||f||||t||||||Samples With DNA|"     Each patient will have 5ml of blood collected at the visit. Saliva, and urine will also be     collected at the study visit.   "|||2017-10-11 02:28:34.502285|2017-10-11 02:28:34.502285
NCT01693718|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-20|2013-09-04|||March 2003||2003-03-01|September 2013|2013-09-01|September 2004|Actual|2004-09-01|September 2003|Actual|2003-09-01||Interventional|||A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer|A Multicenter Phase II Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer|Completed||Phase 2|44|Actual|University of Chicago|||||f||||t||||||||||2017-10-11 02:28:34.588733|2017-10-11 02:28:34.588733
NCT01693705|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-09-24|||October 2012||2012-10-01|September 2012|2012-09-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Observational|||Outcome Evaluation of Patients After Percutaneous Tracheostomy Due to Respiratory Failure in an Intensive Care Unit||Unknown status|Not yet recruiting|N/A|55|Anticipated|Hillel Yaffe Medical Center|||2||f||||f||||||||||2017-10-11 02:28:34.691963|2017-10-11 02:28:34.691963
NCT01693692|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2014-09-08|||November 2012||2012-11-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Phase 2 Study of TD-9855 to Treat Fibromyalgia|A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)|Completed||Phase 2|392|Actual|Theravance Biopharma Antibiotics, Inc.||3|||f||||f||||||||||2017-10-11 02:28:34.788184|2017-10-11 02:28:34.788184
NCT01693679|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-09-24|||September 2012||2012-09-01|September 2012|2012-09-01||||April 2014|Anticipated|2014-04-01||Interventional|||Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis||Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 02:28:34.960555|2017-10-11 02:28:34.960555
NCT01693666|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-09-30|||September 2012||2012-09-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)|Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)|Completed||N/A|30|Actual|St. Louis University||2|||f||||f||||||||||2017-10-11 02:28:35.097189|2017-10-11 02:28:35.097189
NCT01693640|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-01-23|||June 2012|Actual|2012-06-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome|A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Mucocutaneous Manifestations of Behcet's Syndrome|Active, not recruiting||N/A|30|Anticipated|New York University School of Medicine||1|||f||||f||||||||||2017-10-11 02:28:35.450804|2017-10-11 02:28:35.450804
NCT01693627|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-02-23|||January 2012||2012-01-01|February 2016|2016-02-01|January 2022|Anticipated|2022-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Cemented Marathon/Corail Versus Pinnacle/Corail|Cemented Marathon/Corail Versus Pinnacle/Corail. Comparison of Polyethylene Wear, Component Migration and Periprosthetic Bone Mineral Density. A Randomised Study of 48 Hips Using Radiostereometry and Dual-energy X-ray Absorptiometry|Active, not recruiting||N/A|61|Actual|Haukeland University Hospital||4|||f||||t||||||||||2017-10-11 02:28:35.536284|2017-10-11 02:28:35.536284
NCT01693614|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-09-15|||February 28, 2013|Actual|2013-02-28|September 2017|2017-09-01|July 21, 2017|Actual|2017-07-21|July 21, 2017|Actual|2017-07-21||Interventional|||Safety and Efficacy of BKM120 in Relapsed and Refractory NHL|An Open-label Phase II Study of BKM120 in Patients With Relapsed and Refractory Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma and Follicular Lymphoma|Completed||Phase 2|72|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 02:28:35.623838|2017-10-11 02:28:35.623838
NCT01693601|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-01-16|||January 2013||2013-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRIME||Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)|Panobinostat and Ruxolitinib In MyElofibrosis (PRIME STUDY) - Phase I/II Study of Combination Oral JAK2 Tyrosine Kinase Inhibitor (JAK2-TKI) and Histone Deacetylase Inhibitor (HDACI) Therapy in Patients With Myelofibrosis|Active, not recruiting||Phase 1/Phase 2|18|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 02:28:35.849986|2017-10-11 02:28:35.849986
NCT01693588|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-01-13|||October 2012||2012-10-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study of a Multimodality Pain Management Protocol on Postoperative Neurosurgical Pain|The Effect of a Multimodality Pain Management Protocol on Postoperative Neurosurgical Pain|Completed||N/A|94|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 02:28:35.941067|2017-10-11 02:28:35.941067
NCT01693575|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2015-04-15|||September 2012||2012-09-01|September 2012|2012-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Use of APX 100 Device for Small-pupil Cataract Surgery and Intraoperative Floppy-iris Syndrome|Use of APX 100 Device for Expansion of Small Pupil in Cataract Surgery and Management of Intraoperative Floppy-iris Syndrome|Completed||N/A|6|Actual|Meir Medical Center||1|||f||||f||||||||||2017-10-11 02:28:36.031532|2017-10-11 02:28:36.031532
NCT01693562|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-10-04|||August 29, 2012|Actual|2012-08-29|September 2017|2017-09-01|July 13, 2018|Anticipated|2018-07-13|June 23, 2017|Actual|2017-06-23||Interventional|||A Phase 1/2 Study to Evaluate MEDI4736|A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1/Phase 2|1022|Actual|MedImmune LLC||4|||f||||f|t|f||||||||2017-10-11 02:28:36.118903|2017-10-11 02:28:36.118903
NCT01693549|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-07-31|||September 2012||2012-09-01|July 2017|2017-07-01|July 20, 2017|Actual|2017-07-20|July 10, 2017|Actual|2017-07-10||Interventional|||Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes|Phase II Study of Cabazitaxel as 2nd Line Treatment in Patients With HER-2 Negative Metastatic Breast Cancer Previously Treated With Taxanes|Completed||Phase 2|84|Actual|Hellenic Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 02:28:36.433913|2017-10-11 02:28:36.433913
NCT01693536|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2012-09-22|||October 2008||2008-10-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|July 2009|Actual|2009-07-01||Interventional|ECOBEING||Can Primary Care Change Elderly Physical Activity and Salt Intake? An Australian Pilot Trial|Effective Change of Behaviour of the Elderly in Normal General Practice|Completed||N/A|85|Actual|Health HQ||2|||f||||f||||||||||2017-10-11 02:28:36.572975|2017-10-11 02:28:36.572975
NCT01693523|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-11-15|||January 2013||2013-01-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||Minocycline Study in Pancreatic Cancer Patients|A Randomized, Placebo Controlled-Double Blind Study of Minocycline for Reducing the Symptom Burden for Pancreatic Cancer Patients|Active, not recruiting||Phase 2|76|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 02:28:36.674117|2017-10-11 02:28:36.674117
NCT01693510|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-06-06|||July 2012||2012-07-01|June 2017|2017-06-01|June 30, 2018|Anticipated|2018-06-30|December 30, 2017|Anticipated|2017-12-30||Interventional|BHIP||Be Healthy in Pregnancy (B-HIP): A Trial to Study Nutrition and Exercise Approaches for Healthy Pregnancy|Be Healthy in Pregnancy (B-HIP): A Randomized Clinical Trial (RCT) to Study Nutrition and Exercise Approaches for Healthy Pregnancy|Recruiting||N/A|110|Anticipated|McMaster University||2|||f||||t||||||||No||2017-10-11 02:28:36.799342|2017-10-11 02:28:36.799342
NCT01693497|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2012-09-24|||September 2002||2002-09-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of Cognitive Processing Therapy (CPT) and Dialogical Exposure Therapy (DET) for Posttraumatic Stress Disorder|Comparison of a Gestalt-based Approach to PTSD Therapy With Cognitive Processing Therapy|Completed||N/A|150|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 02:28:36.928338|2017-10-11 02:28:36.928338
NCT01693484|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-05-23|2017-03-06||April 2013||2013-04-01|May 2017|2017-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures|Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures Requiring Extensile Lateral Incision|Terminated||Phase 2/Phase 3|13|Actual|Louisiana State University Health Sciences Center Shreveport||1||Resource availability|f||||f||||||||No||2017-10-11 02:28:37.021253|2017-10-11 02:28:37.021253
NCT01693471|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2013-02-27|||September 2012||2012-09-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|||Survey on the Effect of Health Related Quality of Life (QOL) Associated With Compliance of Carbocisteine in Asthma Patients|Survey on the Effect of Health Related QOL Associated With Compliance of Carbocisteine in Asthma Patients Study (SEARCH Study)|Completed||N/A|179|Actual|Kyorin Pharmaceutical Co.,Ltd|||1||f||||f||||||||||2017-10-11 02:28:37.275583|2017-10-11 02:28:37.275583
NCT01693458|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-10-16|||April 2011||2011-04-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|January 2014|Actual|2014-01-01||Interventional|||Positive Change Agents Program-Tanzania (Evaluation)|Enabling People Living With HIV/AIDS (PHA) to Serve as Change Agents for HIV Prevention|Completed||Phase 3|1046|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 02:28:37.364278|2017-10-11 02:28:37.364278
NCT01693445|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-02-18|||June 2012||2012-06-01|September 2012|2012-09-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer|Dose Finding Study of S-1, Oxaliplatin, and Irinotecan Combination Chemotherapy for Patients With Inoperable Advanced or Metastatic Gastrointestinal Cancers|Completed||Phase 1|22|Actual|Hallym University Medical Center||1|||f||||f||||||||Undecided||2017-10-11 02:28:37.468803|2017-10-11 02:28:37.468803
NCT01693432|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-08-22|||November 2011||2011-11-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Docetaxel and S-1 for Advanced Esophageal Cancer|A Phase II Study of Docetaxel and S-1 as First-line Chemotherapy in Patients With Advanced Esophageal Cancer|Recruiting||Phase 2|37|Anticipated|Hallym University Medical Center||1|||f||||f||||||||||2017-10-11 02:28:37.57555|2017-10-11 02:28:37.57555
NCT01693419|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-08-22|||August 2011||2011-08-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer|A Phase II Study of S-1 in Combination With Gemcitabine and Erlotinib in Patients With Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|37|Actual|Hallym University Medical Center||1|||f||||f||||||||||2017-10-11 02:28:37.686713|2017-10-11 02:28:37.686713
NCT01693406|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-05-08|||August 2012||2012-08-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|MIG||Breast Milk and Infant Growth Among Lean, Overweight and Diabetic Mothers|Breast Milk and Infant Growth and Body Composition Among Healthy Mothers, Obese Mothers, and Mothers With Diabetes|Recruiting||N/A|160|Anticipated|University of Colorado, Denver|||4||f||||f||||||Samples Without DNA|"     Human Milk, Plasma, Urine and Stool   "|||2017-10-11 02:28:37.790041|2017-10-11 02:28:37.790041
NCT01693393|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2015-07-27|||March 2010||2010-03-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CYPRESS||Low Dose Cyclosporin A in Primary Sjögren Syndrome|A Phase II Pilot-Study With Low-dose Sandimmun Optoral (Cyclosporin A) for the Treatment of Primary Sjögren Syndrome|Completed||Phase 2|30|Actual|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-10-11 02:28:37.88821|2017-10-11 02:28:37.88821
NCT01693380|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-24|||May 2009||2009-05-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|Xo_Gripe||Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza|Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza the in São Paulo, 2009|Completed||Phase 4|1742|Actual|Butantan Institute||2|||f||||t||||||||||2017-10-11 02:28:37.98753|2017-10-11 02:28:37.98753
NCT00001185|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1982||1982-06-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||"Study of Post-Polio Syndrome"|Post-Polio Motor Neuron Disease: Clinical, Virological, and Immunological Studies|Completed||N/A|360||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.326977|2017-10-11 04:20:08.326977
NCT01693367|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-08-04|2016-04-08||September 2012||2012-09-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Study was stopped|Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation|A Multi-Center Randomized Controlled Pilot Study of Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation|Terminated||Phase 4|5|Actual|AO Clinical Investigation and Documentation||2||The medical device has been withdrawn from the market due to technical issues.|f||||f||||||||||2017-10-11 02:28:38.098578|2017-10-11 02:28:38.098578
NCT01693354|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-01-12|||September 2012||2012-09-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|MILESTONE||Mid-HDF Randomized Controlled Study on Outcome|Mid-dilution Hemodiafiltration International Randomized Prospective Study on Incident Patients Focused on Outcome|Active, not recruiting||N/A|500|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||||2017-10-11 02:28:38.511396|2017-10-11 02:28:38.511396
NCT01693341|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2013-03-28|||October 2011||2011-10-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Caregiver-mediated Intervention Improves the Functional Ability of Home-living Chronic Stroke Patients|Caregiver-mediated Intervention in Home-living Chronic Stroke Patients|Completed||N/A|50|Actual|Asia University||2|||f||||t||||||||||2017-10-11 02:28:38.76538|2017-10-11 02:28:38.76538
NCT01693328|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2014-01-14|||September 2012||2012-09-01|January 2014|2014-01-01||||March 2014|Anticipated|2014-03-01||Observational|Qualipec||Patient Satisfaction and Quality of Life Impact - PecFent®|A French, Multicentre, Open-label, Observational Study to Assess Quality of Life and Satisfaction in Subjects Taking PecFent® for the Treatment of Breakthrough Cancer Pain (BTPc)|Unknown status|Recruiting|N/A|300|Anticipated|Archimedes Development Ltd|||1||f||||f||||||||||2017-10-11 02:28:38.869587|2017-10-11 02:28:38.869587
NCT01693315|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2013-07-16|||September 2012||2012-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma|A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma|Completed||Phase 2|82|Actual|Amakem, NV||4|||f||||f||||||||||2017-10-11 02:28:38.961919|2017-10-11 02:28:38.961919
NCT01693302|ClinicalTrials.gov processed this data on October 10, 2017|2009-09-09|2012-09-21|||August 2007||2007-08-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes|Timing of Meal Insulin Boluses to Achieve Optimal Postprandial Glycemic Control in Patients With Type 1 Diabetes|Completed||N/A|23|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-10-11 02:28:39.087584|2017-10-11 02:28:39.087584
NCT01693276|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2015-10-23|||September 2012||2012-09-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer|Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer|Terminated||Phase 1/Phase 2|3|Actual|University of Cincinnati||1||Slow accrual|f||||f||||||||||2017-10-11 02:28:39.389669|2017-10-11 02:28:39.389669
NCT01693263|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-05-03|||October 2011||2011-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|BCF||Outcome of BCF Access in Hemodialysis Patients|A Clinical and Computational Study to Improve Brachiocephalic Fistula (BCF) Outcomes|Enrolling by invitation||N/A|250|Anticipated|University of Chicago|||2||f||||f||||||Samples With DNA|"     Whole Blood Viscosity (WBV), Hematocrit, and ADMA: WBV will be measured by Brookfield     Programmable DV-II+ cone plate viscometer. ADMA will be measured by ADMA ELISA kit. The     samples will be collected every 6 months on all subjects and frozen to be run in aliquots of     50.      Cephalic Vein and Arterial Tissue Samples: During placement of BCF vein and arterial tissue     are excised during anastomosis to create the fistula. After the tissue is removed from the     vein and artery a small portion of each will be removed and collected for research from this     discarded material. The cephalic vein and arterial samples will be collected and preserved in     a tissue bank for later review by light and electron microscopy in a subsequent study.   "|||2017-10-11 02:28:39.503545|2017-10-11 02:28:39.503545
NCT01693250|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-05-09|||April 2015|Actual|2015-04-01|May 2017|2017-05-01|December 1, 2016|Actual|2016-12-01|June 1, 2016|Actual|2016-06-01||Interventional|||iStart Smart for Teens for Healthy Weight Management|Phase 1 Study of Fitbit and Apps on Healthy Weight Management in Obese Teens in Primary Care Clinics|Completed||Phase 1/Phase 2|40|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:28:39.608399|2017-10-11 02:28:39.608399
NCT01693237|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-02-25|||August 2012||2012-08-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|F-EAT||Improving Patient Outcome in Group Therapy for Eating Disorders|Feedback Versus no Feedback to Improve Patient Outcome in Group Psychotherapy for Eating Disorders: A Randomised Clinical Trial|Unknown status|Active, not recruiting|Phase 2/Phase 3|159|Actual|Psychotherapeutic Center Stolpegard||2|||f||||t||||||||||2017-10-11 02:28:39.724312|2017-10-11 02:28:39.724312
NCT01693224|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-23|2012-09-23|||April 2011||2011-04-01|September 2012|2012-09-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa|Feasibility of Using the Inverness Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in HIV-Positive TB Suspects in Cape Town, South Africa|Unknown status|Active, not recruiting|N/A|512|Actual|Tuberculosis Clinical Diagnostics Research Consortium||1|||f||||f||||||||||2017-10-11 02:28:39.828303|2017-10-11 02:28:39.828303
NCT01692639|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-03-02|||May 2013||2013-05-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Acute Acetaminophen Ingestion: Does Repeated Acetaminophen Blood Test Have an Interest?|Acute Acetaminophen Ingestion: Does Repeated Acetaminophen Blood Test Have an Interest?|Terminated||N/A|4|Actual|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 02:28:48.102786|2017-10-11 02:28:48.102786
NCT01693211|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-06-30|||September 2012||2012-09-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|1118||Prospective Evaluation of Circularity and Diameter of Femtosecond Laser Versus Manual Anterior Capsulotomy in Singapore National Eye Centre|Prospective Evaluation of Circularity and Diameter of Femtosecond Laser Versus Manual Anterior Capsulotomy in Singapore National Eye Centre|Completed||N/A|48|Actual|Technolas Perfect Vision GmbH||2|||f||||f||||||||||2017-10-11 02:28:39.968121|2017-10-11 02:28:39.968121
NCT01693198|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2012-09-23|||November 2012||2012-11-01|September 2012|2012-09-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Cyanobacteria Allergy in Lake Kineret|Cyanobacteria Allergy in Lake Kineret|Unknown status|Not yet recruiting|N/A|200|Anticipated|Meir Medical Center||1|||f||||t||||||||||2017-10-11 02:28:40.166744|2017-10-11 02:28:40.166744
NCT01693185|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-05-16|2014-02-02||December 2012||2012-12-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|remifentanil|Patients with ASA PS class 1 or 2 undergoing elective colonoscopy under monitored anesthesia care|Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy|Remifentanil Only vs. Combination Group Midazolam + Meperidine During Elective Colonoscopy|Completed||Phase 4|60|Actual|Konkuk University Medical Center||2|||f||||f||||||||||2017-10-11 02:28:40.318389|2017-10-11 02:28:40.318389
NCT01693172|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-08-27|||December 2014||2014-12-01|August 2015|2015-08-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of an Early Mobilization Program on Outcomes After Major Cancer Surgery|Effect of an Early Mobilization Program After Surgery on Functional Recovery and Clinical Complications in Patients Undergoing Major Cancer Surgey : a Randomized Controlled Trial|Unknown status|Recruiting|N/A|108|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||f||||||||||2017-10-11 02:28:40.744251|2017-10-11 02:28:40.744251
NCT01693159|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2017-09-22|||May 2011||2011-05-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|SUPPORT||Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades|Randomized Controlled Multicenter Trial to Evaluate the Effects of Ethyl-2-cyanoacrylate on Pain Intensity and Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades During Radioimmunotherapy|Recruiting||N/A|50|Anticipated|National Center for Tumor Diseases, Heidelberg||2|||f||||f||||||||||2017-10-11 02:28:40.859295|2017-10-11 02:28:40.859295
NCT01693146|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2012-09-25|||December 2011||2011-12-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|STIT-2||STIT-2: Evaluation of Safety and Efficacy of Short-time TNI® Treatment in Patients With COPD and Hypercapnia|Evaluation of Safety and Efficacy of Short-time TNI® Treatment in Patients With COPD and Hypercapnia Acute Testing of Oxygen Demand Using TNI® vs. Standard Insufflation in COPD Patients With Hypercapnia at Rest|Unknown status|Recruiting|Phase 1|30|Anticipated|Medical University Innsbruck||2|||f||||f||||||||||2017-10-11 02:28:40.96552|2017-10-11 02:28:40.96552
NCT01693133|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-02-17|||July 2012||2012-07-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers|A Multicenter, Prospective, Randomized, Controlled, Comparative Parallel Study of Dehydrated Human Amnion/Chorion Membrane (dHACM) Wound Graft in the Management of Diabetic Foot Ulcers|Recruiting||N/A|130|Anticipated|MiMedx Group, Inc.||2|||f||||t||||||||||2017-10-11 02:28:41.077088|2017-10-11 02:28:41.077088
NCT01693120|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-03-22|||November 2013||2013-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|February 7, 2017|Actual|2017-02-07||Interventional|VICTORY-AF||Evaluation of the Phased Radio Frequency Ablation System|Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation|Terminated||N/A|300|Anticipated|Medtronic Atrial Fibrillation Solutions||1||The study was stopped solely based on lower than expected enrollment rate.|f||||t||||||||No||2017-10-11 02:28:41.231042|2017-10-11 02:28:41.231042
NCT01693107|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-21|||September 2012||2012-09-01|September 2012|2012-09-01|January 2015|Anticipated|2015-01-01|December 2013|Anticipated|2013-12-01||Observational|CAFCAS||Atrial Fibrillation Force Contact Ablation Study|The Canadian Atrial Fibrillation Force Contact Ablation Study|Unknown status|Not yet recruiting|Phase 1/Phase 2|100|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-11 02:28:41.380698|2017-10-11 02:28:41.380698
NCT01693094|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-12-20|||September 2012||2012-09-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||A Randomized Trial Measuring the Effect of Decision Aids on Patients' Satisfaction, Conflict of Decision-making and Clinical Outcome||Enrolling by invitation||N/A|126|Anticipated|Massachusetts General Hospital||2|||f||||||||||||||2017-10-11 02:28:41.45256|2017-10-11 02:28:41.45256
NCT01693081|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2012-09-25|||March 2007||2007-03-01|September 2012|2012-09-01|July 2009|Actual|2009-07-01|July 2007|Actual|2007-07-01||Interventional|VR040/2/003||Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease|A Clinic-Based, Phase IIa, Double-Blind, Placebo- Controlled, Ascending-Dose, Multicentre Study of Safety, Tolerability, Efficacy and Pharmacokinetics of VR040 in Parkinson's Disease|Completed||Phase 2|47|Actual|South Glasgow University Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 02:28:41.55814|2017-10-11 02:28:41.55814
NCT01693068|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2016-02-11|||December 2012||2012-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|||Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma|A Multicenter, Open Label, Randomized Phase II Trial of the MEK Inhibitor Pimasertib or Dacarbazine in Previously Untreated Subjects With N-Ras Mutated Locally Advanced or Metastatic Malignant Cutaneous Melanoma|Completed||Phase 2|194|Actual|EMD Serono||2|||f||||||||||||||2017-10-11 02:28:41.673771|2017-10-11 02:28:41.673771
NCT01693055|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-04-04|||September 2012||2012-09-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid|Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid,Phase 4.|Completed||N/A|7|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 02:28:42.048067|2017-10-11 02:28:42.048067
NCT01693042|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-03-20|||November 2013||2013-11-01|March 2017|2017-03-01|January 2025|Anticipated|2025-01-01|November 2022|Anticipated|2022-11-01||Interventional|REPEAT||Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure|Randomized Controlled Trial to Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Total and SHFM-predicted Mortality in Patients With Chronic Post-infarction Heart Failure|Recruiting||Phase 2/Phase 3|676|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||t||||||||||2017-10-11 02:28:42.125376|2017-10-11 02:28:42.125376
NCT01693029|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-06-01|2017-04-04|2015-05-04|September 2012||2012-09-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|ACCESS||Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa|Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease|Completed||Phase 3|435|Actual|Sandoz||2|||f||||t||||||||Undecided||2017-10-11 02:28:42.279901|2017-10-11 02:28:42.279901
NCT01693016|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-03-23|||September 2012||2012-09-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Validation of Non-invasive Hemoglobin (SpHb) Measurement in Children|Validation of Non-invasive Hb-measurement (SpHb) in Children With the Masimo@ Radical 7|Completed||N/A|81|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-11 02:28:43.951793|2017-10-11 02:28:43.951793
NCT01693003|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-01-06|||March 2013||2013-03-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPD|Randomized, Open-label, Crossover Clinical Trial to Assess the Effects of Indacaterol 150 µg d.o. Compared to Tiotropium Bromide 5 µg d.o. on Dyspnea, Dynamic Pulmonary Hyperinflation and Exercise Tolerance in Patients With Moderate COPD|Completed||Phase 4|20|Actual|Irmandade Santa Casa de Misericórdia de Porto Alegre||2|||f||||f||||||||||2017-10-11 02:28:44.041181|2017-10-11 02:28:44.041181
NCT01692990|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-11-09|||October 2011||2011-10-01|September 2012|2012-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Study on the Effect of Fish Oil and Appetite|Study on the Effect of Fish Oil and Appetite|Completed||Early Phase 1|20|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:28:44.145982|2017-10-11 02:28:44.145982
NCT01692977|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-07-29|||August 2012||2012-08-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|JAZ-TOP||What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate?|Orienting Oneself in a Healing Garden: What Elements of the Design Are Used as Landmarks by Patients With Alzheimer's Disease ?|Completed||N/A|77|Actual|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-10-11 02:28:44.225417|2017-10-11 02:28:44.225417
NCT01692964|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-05-08|||October 2012||2012-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:28:44.298551|2017-10-11 02:28:44.298551
NCT01692951|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-04-06|2017-02-21||August 2012|Actual|2012-08-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer|Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer|Completed||N/A|220|Actual|The Cleveland Clinic|||4||f||||f||||||Samples Without DNA|"     Blood will be sampled for FFA metabolites   "|||2017-10-11 02:28:44.351573|2017-10-11 02:28:44.351573
NCT01692938|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-04-03|2013-07-19||October 2012||2012-10-01|April 2017|2017-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO|Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO|Completed||N/A|32|Actual|Optos, PLC.|||2||f||||f||||||||||2017-10-11 02:28:44.813251|2017-10-11 02:28:44.813251
NCT01692925|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-02-09|||December 2012||2012-12-01|February 2017|2017-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A|Multi-centre, Open-labelled Trial Investigating the Pharmacokinetics of Four Lots of Turoctocog Alfa in Subjects With Haemophilia A|Completed||Phase 1|15|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 02:28:45.107938|2017-10-11 02:28:45.107938
NCT01692912|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-04-05|||October 2012||2012-10-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|PRC-05-2011||Psoriatic Arthritis Treat to Target vs. Usual Care|A Trial of Active Psoriatic Arthritis (PsA): Randomizing to Treat to a Target vs. Usual Care|Withdrawn||N/A|0|Actual|Pope Research Corporation||2||no enrollment|f||||f||||||||||2017-10-11 02:28:45.201204|2017-10-11 02:28:45.201204
NCT01692899|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2012-09-24|||June 2011||2011-06-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|MAINTAIN||Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice|Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice|Completed||Phase 4|780|Actual|Pfizer|||3||f||||f||||||||||2017-10-11 02:28:45.288188|2017-10-11 02:28:45.288188
NCT01692873|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-06-20|||February 2012||2012-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PACAomics||Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors|Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004|Recruiting||N/A|300|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-11 02:28:45.471103|2017-10-11 02:28:45.471103
NCT01692860|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-11-03|||January 2012||2012-01-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|S28||Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults|Effects of Milk Protein Concentrate on Blood Pressure, Inflammation, Muscle Health During Weight Loss in Overweight/Obese Adults|Completed||N/A|48|Actual|Purdue University||2|||f||||f||||||||||2017-10-11 02:28:45.649373|2017-10-11 02:28:45.649373
NCT01692847|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-04-01|||October 2012||2012-10-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes|Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes (VitalCare - Guardian Version 2)|Completed||N/A|678|Actual|Philips Healthcare|||2||f||||t||||||||No||2017-10-11 02:28:45.729807|2017-10-11 02:28:45.729807
NCT00004340|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||June 1995||1995-06-01|April 2002|2002-04-01||||||||Interventional|||Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis||Completed||Phase 2|109||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.44214|2017-10-11 04:25:04.44214
NCT01692834|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2014-07-31|||June 2009||2009-06-01|July 2014|2014-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers|A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers ; An Open-label, Subject-blind, Laboratory-blind, Single-dose (5 mg/kg Infusion), Randomised, Two-period Crossover Tolerability Study Carried Out in Healthy Male and Female Subjects|Completed||Phase 1|65|Actual|NeuroVive Pharmaceutical AB||2|||f||||f||||||||||2017-10-11 02:28:45.818607|2017-10-11 02:28:45.818607
NCT01692821|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2013-01-29|||June 2012||2012-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation|Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation|Completed||Phase 4|30|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-10-11 02:28:45.924344|2017-10-11 02:28:45.924344
NCT01692808|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-11-02|||October 2012||2012-10-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Bioavailability of Vitamin D in Children and Adolescents With Crohn's Disease|Bioavailability of Vitamin D in Children and Adolescents With Crohn's Disease.|Completed||Phase 2|20|Actual|St. Justine's Hospital||5|||f||||t||||||||||2017-10-11 02:28:46.021989|2017-10-11 02:28:46.021989
NCT01692795|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-10-01|||September 2009||2009-09-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Cardiovascular Medication Use Before First Myocardial Infarction|Cardiovascular Medication Prescriptions Before First Myocardial Infarction in Patients With and Without Previously Diagnosed Atherosclerotic Disease: an Analysis of Linked Prospectively Collected Electronic Healthcare Records|Completed||N/A|17000|Actual|London School of Hygiene and Tropical Medicine|||1||f||||t||||||||||2017-10-11 02:28:46.122127|2017-10-11 02:28:46.122127
NCT01692782|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-01-09|2014-11-17||December 2012||2012-12-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional||Intent to treat population|Adult Attention Deficit Hyperactivity Disorder|A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2|341|Actual|Sunovion||3|||f||||t||||||||||2017-10-11 02:28:46.21912|2017-10-11 02:28:46.21912
NCT01692769|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-07-02|||May 2013||2013-05-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|||Trial Of Normal Saline Versus Ringer's Lactate In Paediatric Trauma Patients|Randomized Controlled Trial of Intravenous Fluid In Severely Injured Paediatric Trauma Patients: Comparison of Normal Saline Versus Ringer's Lactate|Unknown status|Recruiting|Phase 4|50|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:28:47.004267|2017-10-11 02:28:47.004267
NCT01692756|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-02-06|||March 2013||2013-03-01|February 2017|2017-02-01|February 5, 2017|Actual|2017-02-05|February 5, 2017|Actual|2017-02-05||Interventional|AAA||Early Treatment for Acute ACL Tear|Early Anti-inflammatory Treatment in Patients With Acute ACL Tear|Completed||Phase 2|48|Actual|University of Kentucky||4|||f||||t||||||||||2017-10-11 02:28:47.110196|2017-10-11 02:28:47.110196
NCT01692717|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2012-09-24|||February 2013||2013-02-01|September 2012|2012-09-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Lorsatana + Hydrochlorothiazide Produced By Lab Hypermarcas S/A. In Healthy Subjects||Unknown status|Not yet recruiting|Phase 1|90|Anticipated|Azidus Brasil||3|||f||||||||||||||2017-10-11 02:28:47.417656|2017-10-11 02:28:47.417656
NCT01692704|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-03-24|||April 2012||2012-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy|Downstaging of Unresectable Intrahepatic or Hilar Cholangiocellular Carcinoma by Selective Intra-arterial Floxuridine and Systemic Cisplatin and Gemcitabine. A Dose Finding Single Center Phase IIa Study|Completed||Phase 1/Phase 2|12|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 02:28:47.519437|2017-10-11 02:28:47.519437
NCT01692691|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-08-14|2016-01-01||August 2012||2012-08-01|August 2017|2017-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Dacarbazine and Carmustine in Metastatic Melanoma|Phase II Trial of Sequenced Chemotherapy With Dacarbazine and Carmustine With Neulasta® Support in Previously Treated Metastatic Melanoma|Terminated||Phase 2|1|Actual|Western Regional Medical Center||1||Low enrollment|f||||f||||||||||2017-10-11 02:28:47.614979|2017-10-11 02:28:47.614979
NCT01692678|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-06-01|||August 7, 2012|Actual|2012-08-07|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|March 1, 2018|Anticipated|2018-03-01||Interventional|||A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma|Multicenter, Open-label Study of YONDELIS (Trabectedin) in Subjects With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma|Active, not recruiting||Phase 3|16|Actual|Xian-Janssen Pharmaceutical Ltd.||2|||f||||f||||||||||2017-10-11 02:28:47.824059|2017-10-11 02:28:47.824059
NCT01692665|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2014-02-17|||November 2012||2012-11-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland Dysfunction||Withdrawn||N/A|0|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 02:28:47.937179|2017-10-11 02:28:47.937179
NCT01692652|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-02-17|||August 2012||2012-08-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate||Completed||N/A|98|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:28:48.01487|2017-10-11 02:28:48.01487
NCT01692626|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-01-24|2014-12-08||February 2012||2012-02-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX|1% Topical Pimecrolimus Cream for the Prevention of Rash Associated With the Use of the EGFR Antagonist, Cetuximab|Terminated||Phase 2|13|Actual|West Virginia University|Changed Status to Terminated to indicate study closed early|2||Interim analysis shows no efficacy|f||||t||||||||No||2017-10-11 02:28:48.205974|2017-10-11 02:28:48.205974
NCT01692613|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-06-02|||September 2012||2012-09-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Endomicroscopy, IBS and Food Intolerance|Confocal Endomicrosopy for the Detection of Food Intolerance in Patients With Irritable Bowel Syndrome|Completed||N/A|60|Actual|University of Schleswig-Holstein|||1||f||||t||||||Samples Without DNA|"     -  duodenal biopsies        -  duodenal fluid   "|||2017-10-11 02:28:48.480092|2017-10-11 02:28:48.480092
NCT01692600|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-05-07|||June 2012||2012-06-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients|Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients|Completed||N/A|20|Actual|University Health Network, Toronto|||2||f||||f||||||||||2017-10-11 02:28:48.555657|2017-10-11 02:28:48.555657
NCT01692587|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-10-13|||January 2011||2011-01-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Does Protein Restriction Inhibit Prostrate Cancer Growth|Does Protein Restriction Inhibit Prostrate Cancer Growth|Completed||N/A|65|Actual|Washington University School of Medicine||2|||f||||t||||||||No|Plan to publish|2017-10-11 02:28:48.703097|2017-10-11 02:28:48.703097
NCT01692574|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-08-18|||August 2012||2012-08-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|TODI||Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)|Treatment of Obesity in Depressed Individuals: A Randomized Controlled Trial|Completed||N/A|76|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-10-11 02:28:48.837338|2017-10-11 02:28:48.837338
NCT01692561|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-04-18|||August 2012||2012-08-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|April 2018|Anticipated|2018-04-01||Observational|||MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters|Study Title: Brain Transmitters/Metabolites, Magnetic Resonance Spectroscopy, and Brain Connectivity: Diagnostic Strategies to Study the Effects of Non-Pharmacologic Therapies for Dysautonomia and Chronic Nausea|Active, not recruiting||N/A|18|Anticipated|Wake Forest University Health Sciences|||4||f||||t||||||||||2017-10-11 02:28:48.999489|2017-10-11 02:28:48.999489
NCT01692548|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-05-01|||May 2012||2012-05-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Neurofeedback Intervention on the Development of ADHD in Children at Risk|Effect of Neurofeedback Intervention on the Development of ADHD in Children at Risk: a Comparative Study.|Completed||N/A|36|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 02:28:49.140049|2017-10-11 02:28:49.140049
NCT01692535|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-06-10|||January 2013||2013-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|SWIVIT I||Evaluation of Video Laryngoscopes in Difficult Airway|Multicenter Study Evaluating Video Laryngoscopes: The Swiss Video-Intubation Trial (SWIVIT I)|Completed||N/A|720|Actual|University Hospital Inselspital, Berne||6|||f||||f||||||||||2017-10-11 02:28:49.246526|2017-10-11 02:28:49.246526
NCT01692522|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-08-14|||October 2012||2012-10-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparison of the Laryngeal Mask Ambu Aura-i Versus AirQ in Children|Comparison of the Pediatric Intubation on Laryngeal Masks Ambu Aira-i and AirQ for Simulated Blind Intubation in Anesthetized Children|Completed||N/A|80|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 02:28:49.352826|2017-10-11 02:28:49.352826
NCT01692509|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-06-07|||April 2012||2012-04-01|June 2015|2015-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Non Invasive Ventilation (NIV) Related Practices, Monitoring of the NIV Treatment Effect and of the Patient's Comfort|Observation of Non Invasive Ventilation (NIV) Related Practices, Monitoring of the NIV Treatment Effect and of the Patient's Comfort During NIV|Completed||N/A|30|Actual|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 02:28:49.591517|2017-10-11 02:28:49.591517
NCT01692496|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2016-02-18|||January 2013||2013-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial|Phase II Clinical Trial of Pazopanib to Evaluate the Activity and Tolerability in Patients With Advanced and/or Metastatic Liposarcoma Who Have Relapsed Following Standard Therapies or for Whom no Standard Therapy Exists|Active, not recruiting||Phase 2|52|Actual|Grupo Espanol de Investigacion en Sarcomas||1|||f||||f||||||||||2017-10-11 02:28:49.72081|2017-10-11 02:28:49.72081
NCT01692483|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-11-30|||July 2013||2013-07-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer|Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Metastatic Advanced Prostate Cancer|Withdrawn||Phase 4|0|Actual|Janssen Pharmaceutica|||1|Sponsor determined study is not required according to PFDA Circular 2013-004|f||||f||||||||||2017-10-11 02:28:49.908953|2017-10-11 02:28:49.908953
NCT01692470|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-11-30|||June 2013||2013-06-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection|A Post-Marketing Surveillance Study on the Safety and Effectiveness of Rilpivirine Hydrochloride Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection|Withdrawn||Phase 4|0|Actual|Janssen Pharmaceutica|||1|The company decided to cancel this study in conformity with Philippines FDA Circular 2013-004|f||||f||||||||||2017-10-11 02:28:50.014949|2017-10-11 02:28:50.014949
NCT01692288|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-01-04|||September 2012||2012-09-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation of the Effectiveness of a Home Visiting Program for New Parents in New Mexico|Evaluation of the Effectiveness of the First Born® Program for New Parents in Santa Fe County, New Mexico|Completed||N/A|278|Actual|RAND||2|||f||||f||||||||||2017-10-11 02:28:53.448821|2017-10-11 02:28:53.448821
NCT01692457|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2015-11-30|||July 2013||2013-07-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis|A Post-Marketing Surveillance Study on the Safety and Effectiveness of Golimumab (Simponi) Among Adult Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis|Withdrawn||Phase 4|0|Actual|Janssen Pharmaceutica|||1|The company decided to cancel the study in conformity with Philippine FDA Circular 2013-004|f||||f||||||||||2017-10-11 02:28:50.10599|2017-10-11 02:28:50.10599
NCT01692444|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-11-12|||April 2013||2013-04-01|November 2014|2014-11-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Observational|FIBROCHIR||Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary Disease|Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|45|Anticipated|University Hospital, Bordeaux|||3||f||||f||||||Samples Without DNA|"     Lung tissue form surgery such as lobectomy or pneumonectomy,whole blood sample for fibrocytes     analysis   "|||2017-10-11 02:28:50.219744|2017-10-11 02:28:50.219744
NCT01692431|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2013-10-14|||September 2012||2012-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|FOFA||The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity|The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity|Completed||N/A|28|Actual|University of East Anglia||3|||f||||f||||||||||2017-10-11 02:28:50.478137|2017-10-11 02:28:50.478137
NCT01692418|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2016-09-28|||January 2014||2014-01-01|April 2015|2015-04-01|August 2019|Anticipated|2019-08-01|September 2018|Anticipated|2018-09-01||Interventional|PREVENTT||Preoperative Intravenous Iron to Treat Anaemia in Major Surgery|A Randomised Double-blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose With Placebo in Patients With Anaemia Undergoing Major Open Abdominal Surgery|Recruiting||Phase 3|500|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 02:28:50.605838|2017-10-11 02:28:50.605838
NCT01692405|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-20|||October 2012||2012-10-01|September 2012|2012-09-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample|Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample|Unknown status|Not yet recruiting|N/A|100|Anticipated|UC Care, Ltd.||3|||f||||f||||||||||2017-10-11 02:28:50.943583|2017-10-11 02:28:50.943583
NCT01692392|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-08-04|||September 2012||2012-09-01|September 2012|2012-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|HRQoL||Health-related Quality of Life in Patients Undergoing Surgery for Pectus Carinatum|Short and Long-term Effects of Surgical Repair of Pectus Carinatum - A Questionnaire Study of Health-related Quality of Life, Persisten Post-surgical Pain and Sensory Disturbances.|Completed||N/A|40|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-11 02:28:51.089177|2017-10-11 02:28:51.089177
NCT01692379|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-02-02|||November 2012||2012-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|REVASCAT||Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours|RandomizEd Trial of reVascularizAtion With Solitaire FR® Device Versus Best mediCal Therapy in the Treatment of Acute Stroke Due to anTerior Circulation Large Vessel Occlusion Presenting Within 8 Hours of Symptom Onset|Terminated||Phase 3|206|Actual|Fundacio Ictus Malaltia Vascular||2||Following DSMB advice after first interim analysis (n=174)|f||||t||||||||||2017-10-11 02:28:51.172714|2017-10-11 02:28:51.172714
NCT01692366|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-09-19|||November 2012||2012-11-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly|A Phase 2 Open-Label, Dose-Ranging Study of the Efficacy and Safety of Orally Administered SAR302503 in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly|Completed||Phase 2|8|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:28:51.30083|2017-10-11 02:28:51.30083
NCT01692353|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-02-15|||September 2008||2008-09-01|February 2016|2016-02-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Observational|||Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers|Evaluation of Cardiovascular Disease Biomarkers in Exclusive Smokers and Exclusive Moist Snuff Consumers|Completed||N/A|168|Actual|R.J. Reynolds Tobacco Company|||3||f||||f||||||Samples Without DNA|"     Biospecimens to be retained include: serum, plasma, and urine.   "|No||2017-10-11 02:28:51.42161|2017-10-11 02:28:51.42161
NCT01692340|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-09-04|2015-02-10||February 2012||2012-02-01|September 2015|2015-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Healthy subjects (6 males and 6 females) between the age of 21-33 yo (inclusive).|Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans|Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans.|Completed||Phase 1/Phase 2|12|Actual|Ohio State University Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 02:28:51.585882|2017-10-11 02:28:51.585882
NCT01692327|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-11-04|||September 2012||2012-09-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|December 2012|Actual|2012-12-01||Interventional|||Study About High Fat Meal and Postprandial Lipemia|Evaluating the Effect of Lipid Overload in Endothelial Function and Microvascular Reactivity in Young Obese Women|Completed||N/A|60|Actual|Rio de Janeiro State University||3|||f||||t||||||||||2017-10-11 02:28:52.299824|2017-10-11 02:28:52.299824
NCT01692314|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2012-09-24|||June 2010||2010-06-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|September 2010|Actual|2010-09-01||Interventional|||Effect of Resistance Training on Microvascular, Hemodynamic and Physical Parameters in Obese Adolescents|Effect of Resistance Training on Microvascular Reactivity, Endothelial Function, Inflammatory Markers, Body Composition, Blood Pressure, Heart Rate and Physical Fitness in Obese Adolescents|Completed||N/A|20|Actual|Rio de Janeiro State University||1|||f||||f||||||||||2017-10-11 02:28:52.473641|2017-10-11 02:28:52.473641
NCT01692301|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-03-31|2016-03-31||December 2012||2012-12-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Full analysis set - All patients who were randomized.|Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension|A Randomized, Double-blind 52-week Study to Evaluate the Safety and Efficacy of an LCZ696 Regimen Compared to an Olmesartan Regimen on Arterial Stiffness Through Assessment of Central Blood Pressure in Elderly Patients With Hypertension|Completed||Phase 2|454|Actual|Novartis||2|||f||||t||||||||||2017-10-11 02:28:52.634136|2017-10-11 02:28:52.634136
NCT01692275|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-07-05|||September 2012||2012-09-01|July 2017|2017-07-01|November 28, 2016|Actual|2016-11-28|November 28, 2016|Actual|2016-11-28||Interventional|||Assessment of Chiropractic Treatment for Low Back Pain and Smoking Cessation in Military Active Duty Personnel.|Assessment of Chiropractic Treatment for Low Back Pain and Smoking Cessation in Military Active Duty Personnel|Completed||N/A|750|Actual|RAND||2|||f||||t||||||||||2017-10-11 02:28:53.535762|2017-10-11 02:28:53.535762
NCT01692262|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-06-18|||November 2012||2012-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PYRUS||Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.|A Phase Ib Multicentre Study of AZD5363 Monotherapy to Assess Anti-Tumour Activity,Safety,Tolerability,and Pharmacokinetics in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC)(PYRUS)|Completed||Phase 1|59|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 02:28:53.765634|2017-10-11 02:28:53.765634
NCT01692249|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2012-09-24|||March 2009||2009-03-01|September 2012|2012-09-01|May 2011|Actual|2011-05-01|April 2010|Actual|2010-04-01||Interventional|ROTATHERM||Efficacy and Safety of Spa Treatment in Chronic Shoulder Pain Due to Rotator Cuff Tendinopathy|Spa Therapy in the Treatment of Chronic Shoulder Pain Due to Rotator Cuff Tendinopathy: ROTATHERM, a Large Randomized Multicentre Trial|Completed||N/A|186|Actual|Association Francaise pour la Recherche Thermale||2|||f||||t||||||||||2017-10-11 02:28:53.914454|2017-10-11 02:28:53.914454
NCT01692236|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-08-04|||September 12, 2012||2012-09-12|July 26, 2017|2017-07-26||||||||Observational|||Brain Imaging for HIV-Associated Thinking and Mood Disorders|Neurovascular Magnetic Resonance Imaging in the Assessment of HIV-Associated Neurocognitive Disorders|Recruiting||N/A|160|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:28:54.023701|2017-10-11 02:28:54.023701
NCT01692223|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-08-08|||September 2012||2012-09-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||A Safety Study Assessing the Effects of Receiving Genome Sequencing Results|Personal Genomics: A Safety Study Assessing the Effects of Receiving Genome Sequencing Results|Active, not recruiting||N/A|8|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||Samples With DNA|"     Participants will be recruited from cohorts of patients whose DNA samples are being examined     with WGS/WES as part of efforts to identify novel cancer susceptibility alleles. Participants     will be derived from the following protocols: 09-068 and 96-051.   "|||2017-10-11 02:28:54.15532|2017-10-11 02:28:54.15532
NCT01692210|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-01-05|||September 2012||2012-09-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||The Effect of Dexmedetomidine of the Immune System|The Effect of Dexmedetomidine on Immunological Parameters of Women Undergoing Breast Cancer Surgery|Completed||N/A|20|Actual|M.D. Anderson Cancer Center|||1||f||||t||||||Samples With DNA|"     15cc of blood drawn prior or at the moment of anesthesia induction and the morning after     surgery.   "|||2017-10-11 02:28:54.267033|2017-10-11 02:28:54.267033
NCT01692197|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-06-13|||February 1, 2013|Actual|2013-02-01|June 2017|2017-06-01|June 7, 2017|Actual|2017-06-07|June 7, 2017|Actual|2017-06-07||Interventional|||E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes|A Phase 2 Study of E7070, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-risk Myelodysplastic Syndromes|Completed||Phase 2|43|Actual|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 02:28:54.376879|2017-10-11 02:28:54.376879
NCT01692184|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2016-03-24|||August 2012||2012-08-01|March 2016|2016-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Pharmacokinetics of AVL-292|A Phase 1, Two-part Study to Investigate the Safety and Pharmacokinetics of AVL-292 Following Multiple Oral Doses and to Evaluate the Effect of Food on the Pharmacokinetics of AVL-292 Following a Single Oral Dose in Healthy Adult Subjects|Completed||Phase 1|54|Anticipated|Celgene Corporation||6|||f||||f||||||||||2017-10-11 02:28:54.534991|2017-10-11 02:28:54.534991
NCT01692171|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-03-03|||September 2013||2013-09-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration|Pharmacodynamics Study of Enoxalow, Produced by Blau Farmacêutica S/A, Compared to Clexane, Produced by Sanofi-Aventis Farmacêutica Ltda, in Healthy Subjects After Intravenous Administration.|Completed||Phase 1|32|Actual|Azidus Brasil||2|||f||||t||||||||Undecided||2017-10-11 02:28:54.668457|2017-10-11 02:28:54.668457
NCT01692158|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-09-24|||March 2013||2013-03-01|September 2012|2012-09-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose|Pharmacodynamics Study of Enoxalow, Produced by Blau Farmacêutica S/A, Compared to Clexane, Produced by Sanofi-Aventis Farmacêutica Ltda, in Healthy Subjects After Subcutaneous Administration.|Unknown status|Not yet recruiting|Phase 1|36|Anticipated|Azidus Brasil||2|||f||||t||||||||||2017-10-11 02:28:54.794635|2017-10-11 02:28:54.794635
NCT01692145|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2014-05-29||||||May 2014|2014-05-01||||||||Interventional|||A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes|A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes|Completed||Phase 2|||Kissei Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:28:54.917802|2017-10-11 02:28:54.917802
NCT01692132|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-11-30|||February 2013||2013-02-01|November 2015|2015-11-01|December 2014|Anticipated|2014-12-01|February 2014|Anticipated|2014-02-01||Observational|||A Post Marketing Surveillance Study on the Safety and Effectiveness of Prucalopride in the Treatment of Chronic Constipation|A Study on the Safety and Effectiveness of Prucalopride in the Treatment of Chronic Constipation|Withdrawn||Phase 4|0|Actual|Janssen Pharmaceutica|||1|The company decided to cancel this study in conformity with PH FDA Circular 2013-004|f||||f||||||||||2017-10-11 02:28:55.015068|2017-10-11 02:28:55.015068
NCT01692119|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-01-27|||October 2012|Actual|2012-10-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|PHARM-CHF||Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure|Pharmacy-based Interdisciplinary Program for Patients With Chronic Heart Failure (PHARM-CHF): A Randomized Controlled Trial|Active, not recruiting||N/A|258|Actual|Federal Union of German Associations of Pharmacists||2|||f||||t||||||||||2017-10-11 02:28:55.130455|2017-10-11 02:28:55.130455
NCT01692106|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2015-09-22|||November 2012||2012-11-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|POEM||A Clinical Study of Per Oral Endoscopic Myotomy (POEM) in Patients Suffering From Achalasia|A Clinical Study of Per Oral Endoscopic Myotomy (POEM) in Patients Suffering From Achalasia.|Completed||N/A|10|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 02:28:55.248883|2017-10-11 02:28:55.248883
NCT01692093|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2013-11-12|||September 2012||2012-09-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||KM110329 in Adult Patients With Atopic Dermatitis|KM110329 in Adult Patients With Atopic Dermatitis : a Randomised, Double-blind, Placebo-controlled, Multicenter Trial|Unknown status|Recruiting|Phase 2|66|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-11 02:28:55.34659|2017-10-11 02:28:55.34659
NCT01692080|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-08-05|||January 2010||2010-01-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Implementation of an Asthma Program to Improve Asthma Identification and Education in Children|Implementation of an Asthma Program to Improve Asthma Identification and Education in Children|Completed||N/A|231|Actual|Duquesne University|||1||f||||t||||||||||2017-10-11 02:28:55.442557|2017-10-11 02:28:55.442557
NCT01692067|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2016-08-29|||April 2009||2009-04-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|DHRMS||Deployment Health in Regular Military Women|Combat, Sexual Assault and Post-Traumatic Stress in OIF/OEF Military Women|Completed||N/A|871|Actual|Iowa City Veterans Affairs Medical Center|||4||f||||t||||||||||2017-10-11 02:28:55.52908|2017-10-11 02:28:55.52908
NCT01692054|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-05-20|||June 2012||2012-06-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Observational|RiScA||Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication|Prediction and Detection of Intermediate and Long-term Developmental Hazards in Adolescents After Alcohol Intoxication|Completed||N/A|394|Actual|Technische Universität Dresden|||2||f||||f||||||||||2017-10-11 02:28:57.259839|2017-10-11 02:28:57.259839
NCT01692041|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-09-24|||April 2012||2012-04-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|HeHe||Effect of an add-on Treatment With Ivy Leaves Dry Extract on Lung Function in Bronchial Asthma|Tolerance and Effect of an add-on Treatment With a Cough Medicine Containing Ivy Leaves Dry Extract on Lung Function in Children With Bronchial Asthma|Unknown status|Recruiting|Phase 2|30|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 02:28:57.484129|2017-10-11 02:28:57.484129
NCT01692028|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2012-09-21|||February 2012||2012-02-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|GRH-PN01||Identification of the Region of Vitamin D Responsiveness|A Novel Approach Localizes the Association of Vitamin D Status With Insulin Resistance to One Region of the 25(OH)D Continuum.|Completed||N/A|4116|Actual|Creighton University|||1||f||||f||||||||||2017-10-11 02:28:57.590987|2017-10-11 02:28:57.590987
NCT01692015|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-05-28|||April 2011||2011-04-01|September 2012|2012-09-01|September 2016|Anticipated|2016-09-01|September 2013|Actual|2013-09-01||Interventional|||Diet and Hereditary Haemorrhagic Telangiectasia|A Questionnaire Study on Diet and Hereditary Haemorrhagic Telangiectasia|Unknown status|Active, not recruiting|N/A|150|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 02:28:57.661262|2017-10-11 02:28:57.661262
NCT01692002|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-11-18|||January 2013||2013-01-01|September 2012|2012-09-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|||Oral Propionate to Treat and Prevent Diabetes|Development of Orally Administered Sodium Propionate to Treat and Prevent Diabetes|Completed||Phase 2|90|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 02:28:57.787559|2017-10-11 02:28:57.787559
NCT01691989|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-11-01|||December 2012||2012-12-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy|A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PHASE III STUDY TO ASSESS THE EFFICACY,SAFETY AND TOLERABILITY OF ALEGLITAZAR ADDED TO A SU OR ADDED TO A SU IN COMBINATION WITH MET IN PATIENTS WITH T2D INADEQUATELY CONTROLLED WITH SU MONOTHERAPY OR WITH SU + METFORMIN COMBINATION THERAPY|Completed||Phase 3|197|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:28:57.899538|2017-10-11 02:28:57.899538
NCT01691976|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-10-16|||October 2012||2012-10-01|October 2012|2012-10-01|March 2014|Anticipated|2014-03-01|September 2013|Anticipated|2013-09-01||Interventional|||Mild Cognitive Impairment in Men Following Androgen Deprivation|Mild Cognitive Impairment in Men Following Androgen Deprivation Therapy for Prostate Cancer: a Longitudinal fMRI and qEEG Pilot Study.|Unknown status|Not yet recruiting|N/A|10|Anticipated|Imperial College London||3|||f||||f||||||||||2017-10-11 02:28:58.079039|2017-10-11 02:28:58.079039
NCT01691963|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-01-27|||April 2013||2013-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Epiglottic Downfolding During Endotracheal Intubation|Epiglottic Downfolding During Endotracheal Intubation - An Alternative Technique to Improve Glottic Exposure and Facilitate Intubation?|Withdrawn||N/A|0|Actual|Catharina Ziekenhuis Eindhoven||2||"Main investigators (Pieters/van Zundert) changed institutions. Therefore, they were not able to   start the study and decided to withdraw the study for now."|f||||t||||||||||2017-10-11 02:28:58.224816|2017-10-11 02:28:58.224816
NCT01691950|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-12-11|||April 2012||2012-04-01|March 2013|2013-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Investigating Lower Limb Trauma|Investigating the Outcomes of Lower-limb Trauma Patients|Completed||N/A|30|Actual|Imperial College London|||3||f||||f||||||||||2017-10-11 02:28:58.528582|2017-10-11 02:28:58.528582
NCT01691937|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2013-08-12|||September 2012||2012-09-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Continuous Paravertebral Block on Postoperative Pain After Hepatectomy|Continuous Right Thoracic Paravertebral Block on Postoperative Pain After Right Lobe Hepatectomy|Completed||Phase 2|48|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 02:28:58.620021|2017-10-11 02:28:58.620021
NCT01691924|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-03-07|||October 2012||2012-10-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers|"Randomized, Double Blind, Placebo Controlled First In-human Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-509 in Male Healthy Volunteers"|Completed||Phase 1|56|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-11 02:28:58.743228|2017-10-11 02:28:58.743228
NCT01691911|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-06-02|||February 2012||2012-02-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|SAVES||Preconditioning Shields Against Vascular Events in Surgery|Preconditioning Shields Against Vascular Events in Surgery. A Multi-Centre Trial of Preconditioning Against Adverse Events in Major Vascular Surgery|Completed||N/A|200|Actual|Mid Western Regional Hospital, Ireland||2|||f||||t||||||||||2017-10-11 02:28:58.845898|2017-10-11 02:28:58.845898
NCT01691898|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2017-08-24|||September 26, 2012|Actual|2012-09-26|August 2017|2017-08-01|February 14, 2019|Anticipated|2019-02-14|March 28, 2017|Actual|2017-03-28||Interventional|ROMULUS||A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma|A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating the Safety and Activity of Pinatuzumab Vedotin (DCDT2980S) in Combination With Rituximab or Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab and a Non-Randomized Phase Ib/II Evaluation of Polatuzumab Vedotin in Combination With Obinutuzumab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1/Phase 2|246|Actual|Genentech, Inc.||7|||f||||||||||||||2017-10-11 02:28:58.982421|2017-10-11 02:28:58.982421
NCT01691885|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-09-26|2015-03-26||November 2012||2012-11-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||RELOVAIR® Lung Deflation Study|A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily on Cardiac Biventricular Function and Arterial Stiffness in Adults With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|45|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:28:59.254198|2017-10-11 02:28:59.254198
NCT01691872|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-11-09|||October 2012||2012-10-01|November 2015|2015-11-01|October 2012|Anticipated|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects|An Open-label, Single Centre, Parallel Group Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||2||Development plan of retigabine XR in Japan was readjusted.|f||||f||||||||||2017-10-11 02:28:59.476552|2017-10-11 02:28:59.476552
NCT01691859|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-09-28|||September 28, 2012|Actual|2012-09-28|September 2017|2017-09-01|May 31, 2017|Actual|2017-05-31|May 31, 2017|Actual|2017-05-31||Interventional|||MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects|MEA115666: A Multi-centre, Open-label, Long Term Safety Study of Mepolizumab in Asthmatic Subjects Who Participated in the MEA112997 Trial|Completed||Phase 3|347|Actual|GlaxoSmithKline||1|||t||||t|t|f||||||||2017-10-11 02:28:59.576067|2017-10-11 02:28:59.576067
NCT01691846|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-02-22||2016-08-09|October 2012||2012-10-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess the Efficacy, Safety and Tolerability of Aleglitazar Plus Metformin Combination Therapy Compared With Placebo Plus Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy|Completed||Phase 3|200|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:28:59.788994|2017-10-11 02:28:59.788994
NCT01691833|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-02-24|||February 2011||2011-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|VitD||The Effect of Hypovitaminosis D and Vitamin D Supplementation on Fracture Nonunion Rates|The Effect of Hypovitaminosis D and Vitamin D Supplementation on Fracture Nonunion Rates|Active, not recruiting||N/A|880|Anticipated|Carolinas Healthcare System||2|||f||||t||||||||||2017-10-11 02:29:00.072273|2017-10-11 02:29:00.072273
NCT01691820|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-05-24|||October 5, 2012|Actual|2012-10-05|May 2017|2017-05-01|April 8, 2017|Actual|2017-04-08|April 8, 2017|Actual|2017-04-08||Interventional|||A Study in Adolescent Females to Explore Cytomegalovirus Infection|A Study in Adolescent Females to Explore Cytomegalovirus Infection|Completed||N/A|370|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:29:00.171461|2017-10-11 02:29:00.171461
NCT01691807|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-03-25|||January 2013||2013-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma|An Open-label Phase I Drug-drug Interaction Study of Ofatumumab With Bendamustine for the Treatment of Subjects With Indolent B-cell Non-Hodgkin's Lymphoma|Completed||Phase 1|30|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:29:00.27514|2017-10-11 02:29:00.27514
NCT01691794|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-21|2017-04-06|2015-10-27||November 2012||2012-11-01|April 2017|2017-04-01|February 20, 2017|Actual|2017-02-20|October 2014|Actual|2014-10-01||Interventional||All participants who received at least 1 dose of study drug.|Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients|A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety of Atazanavir (ATV) Capsule Boosted With Ritonavir (RTV) With an Optimized NRTI Background Therapy, in HIV Infected, Antiretroviral Naive and Experienced Pediatric Subjects Greater Than or Equal to 6 Years to Less Than 18 Years|Completed||Phase 4|108|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 02:29:00.417866|2017-10-11 02:29:00.417866
NCT01691781|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-08-18|2017-06-19||October 2012|Actual|2012-10-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|RAAS-PARC||The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study|The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study|Completed||N/A|41|Actual|Brigham and Women's Hospital|This a small physiology pilot study that is open-label and non-randomized. The intervention was an ACE inhibitor, an approved therapy. Results have physiologic implications, but treatment implications are not intended.|1|||f||||t||||||||||2017-10-11 02:29:01.571206|2017-10-11 02:29:01.571206
NCT01691768|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-01-27|||October 2012||2012-10-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Interventional|||Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services|Open-Label Randomized Controlled Trial to Assess the Implementation Effectiveness and Safety of 1% Tenofovir Gel Provision Through Family Planning Services in KwaZulu-Natal, South Africa|Completed||Phase 2/Phase 3|382|Actual|Centre for the AIDS Programme of Research in South Africa||2|||f||||t||||||||||2017-10-11 02:29:02.002182|2017-10-11 02:29:02.002182
NCT01691755|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-08-09||2016-08-09|November 2012||2012-11-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess the Efficacy, Safety and Tolerability of Aleglitazar Monotherapy Compared With Placebo in Patients With Type 2 Diabetes Mellitus (T2D) Who Are Drug-Naïve to Anti-Hyperglycemic Therapy|Completed||Phase 3|196|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:29:02.1015|2017-10-11 02:29:02.1015
NCT01691742|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2017-02-14|||September 2012||2012-09-01|October 2014|2014-10-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|MVP||MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery|Double-Blind Randomized Controlled Trial of MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery in Women Receiving Routine Docusate Sodium|Completed||N/A|131|Actual|Duke University||2|||f||||t|f|f||||||||2017-10-11 02:29:02.236131|2017-10-11 02:29:02.236131
NCT01691729|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-11-13|||September 2012||2012-09-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Comparison Study of 3 Ostomy Products|A Randomized, Multicenter, Cross-Over Study Comparing the Performance of Three Ostomy Accessory Products|Unknown status|Active, not recruiting|N/A|26|Actual|ConvaTec Inc.||6|||f||||f||||||||||2017-10-11 02:29:02.338609|2017-10-11 02:29:02.338609
NCT01691716|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-02-25|||April 2012||2012-04-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|Tendoactive||The Efficacy of Tendoactive, Eccentric Training, and the Combination of Both as a Treatment of Achilles Tendinopathy|A Prospective Randomized Study Comparing the Therapeutic Effect of Tendoactive®, Eccentric Training, and a Combination of Both as a Treatment of Achilles Tendinopathy|Completed||N/A|100|Anticipated|Bioiberica||3|||f||||||||||||||2017-10-11 02:29:02.547474|2017-10-11 02:29:02.547474
NCT01691703|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2013-02-19|||August 2012||2012-08-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Combined Technique for Difficult Intubation|Combined Technique Using Videolaryngoscopy and Bonfils for a Difficult Airway Intubation|Completed||N/A|40|Actual|Catharina Ziekenhuis Eindhoven||1|||f||||f||||||||||2017-10-11 02:29:02.677764|2017-10-11 02:29:02.677764
NCT01691690|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-02-21|2016-09-07||October 2012||2012-10-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|November 2015|Actual|2015-11-01||Interventional|||Analgesic Effect of IV Acetaminophen in Tonsillectomies|Analgesic Effect of Single Dose Intravenous Acetaminophen in Pediatric Patients Undergoing Tonsillectomy|Completed||Phase 2|250|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 02:29:02.802967|2017-10-11 02:29:02.802967
NCT01691677|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-03-28|||January 2013||2013-01-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CLEAR||beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study|Multicentre, Randomized, Double-blind, Parallel Group, Placebo-Controlled Study on the Therapeutic Efficacy and Safety of Beclomethasone Dipropionate Suspension for Inhalation 800 µg Twice Daily vs. Placebo Added to Antibiotic Therapy in Patients With Acute Rhinosinusitis|Completed||Phase 3|166|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 02:29:03.242539|2017-10-11 02:29:03.242539
NCT01691664|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2017-02-03|||September 2012||2012-09-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer|Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer|Recruiting||N/A|40|Anticipated|Capital Medical University||2|||f||||f||||||||||2017-10-11 02:29:03.342977|2017-10-11 02:29:03.342977
NCT01691651|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-10-18|||September 2012||2012-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Botulinum Toxin A for the Treatment of Keratoconus|Botulinum Toxin Type A for Keratoconus|Completed||N/A|40|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 02:29:03.442904|2017-10-11 02:29:03.442904
NCT01691638|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-24|2012-09-24||||||September 2012|2012-09-01||||||||Observational|||Genetics of Periodontal Diseases in European Caucasians||Unknown status|Active, not recruiting|N/A|||University of Kiel|||2||f||||||||||||||2017-10-11 02:29:03.584704|2017-10-11 02:29:03.584704
NCT01691625|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-02-03|||September 2012||2012-09-01|February 2017|2017-02-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer|Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer|Recruiting||N/A|50|Anticipated|Capital Medical University||2|||f||||f||||||||||2017-10-11 02:29:03.657278|2017-10-11 02:29:03.657278
NCT01691612|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-06-06|2017-03-06||March 2013||2013-03-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Pin1||Role of the Isomerase Pin-1 in the Development and Treatment of Asthma|Role of the Isomerase Pin-1 in the Development and Treatment of Asthma|Completed||Phase 2|14|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 02:29:03.765972|2017-10-11 02:29:03.765972
NCT01691599|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-06-23|||August 2012||2012-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Infection Rates Following Internal Fixation of Open and Closed Tibia Fractures in India|Infection Rates Following Internal Fixation of Open and Closed Tibia Fractures in India (INFINITI): a Prospective Multi-center Observational Study.|Completed||N/A|800|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 02:29:04.049141|2017-10-11 02:29:04.049141
NCT01691586|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-05-19|||April 2013||2013-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|REMOTE-CIED||Patient Perspective on Remote Monitoring of Cardiovascular Implantable Electronic Devices|Remote Monitoring of Heart Failure Patients With Cardiovascular Implantable Electronic Device: The Patient Perspective|Active, not recruiting||N/A|600|Actual|UMC Utrecht|||2||f||||f||||||||||2017-10-11 02:29:04.151677|2017-10-11 02:29:04.151677
NCT01691573|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-24|||July 2012||2012-07-01|September 2012|2012-09-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|EUROPA||European Pediatric Catheter Ablation Registry|European Pediatric Catheter Ablation Registry|Unknown status|Recruiting|N/A|||A.O. Ospedale Papa Giovanni XXIII|||1||f||||f||||||||||2017-10-11 02:29:04.235273|2017-10-11 02:29:04.235273
NCT01691560|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2014-05-01|2014-05-01||August 2012||2012-08-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity|A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity|Completed||Phase 2|140|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:29:04.382185|2017-10-11 02:29:04.382185
NCT01691391|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-03-20|||January 2012||2012-01-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|January 2015|Actual|2015-01-01||Observational|||Treatment Optimization of Cetuximab in Patients With Metastatic Colorectal Cancer Based on Tumor Uptake of 89Zr-labeled Cetuximab Assessed by PET|Treatment Optimization of Cetuximab in Patients With Metastatic Colorectal Cancer Based on Tumor Uptake of 89Zr-labeled Cetuximab Assessed by PET|Completed||N/A|11|Actual|VU University Medical Center|||1||f||||||||||||||2017-10-11 02:29:10.796107|2017-10-11 02:29:10.796107
NCT01691547|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-07-24|||December 17, 2012|Actual|2012-12-17|July 2017|2017-07-01|March 8, 2013|Actual|2013-03-08|March 8, 2013|Actual|2013-03-08||Interventional|||A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects|A Randomized, Double-blind, Single Dose, Four Way Cross-over Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol Following Single Inhaled Doses of Umeclidinium/Vilanterol Blend + Fluticasone Furoate, Umeclidinium + Vilanterol, Fluticasone Furoate + Vilanterol and Fluticasone Furoate + Umeclidinium in Healthy Subjects|Completed||Phase 1|44|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:29:05.23359|2017-10-11 02:29:05.23359
NCT01691534|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-10-19|2016-10-19||October 2012||2012-10-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|NC-003||Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)|A Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of the Following: TMC207 Plus PA-824 Plus Pyrazinamide Plus Clofazimine, TMC207 Plus PA-824 Plus Pyrazinamide, TMC207 Plus PA-824 Plus Clofazimine Alone, TMC207 Plus Pyrazinamide Plus Clofazimine, Pyrazinamide Alone, and Clofazimine Alone; in Adult Patients With Newly Diagnosed, Smear-Positive Pulmonary Tuberculosis.|Completed||Phase 2|105|Actual|Global Alliance for TB Drug Development||7|||f||||f||||||||||2017-10-11 02:29:05.445192|2017-10-11 02:29:05.445192
NCT01691521|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-09-07|2015-11-05|2015-04-22|October 8, 2012||2012-10-08|September 2017|2017-09-01|January 18, 2014|Actual|2014-01-18|January 1, 2014|Actual|2014-01-01||Interventional|||Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma|MEA115588 A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma|Completed||Phase 3|580|Actual|GlaxoSmithKline||3|||f||||t||||||||||2017-10-11 02:29:07.338936|2017-10-11 02:29:07.338936
NCT01691508|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2017-03-21|2015-11-05|2015-04-22|October 2012||2012-10-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma|MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects With Severe Refractory Asthma|Completed||Phase 3|135|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:29:08.667698|2017-10-11 02:29:08.667698
NCT01691495|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-03-26|||October 2012||2012-10-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||ARIXTRA® Adherence in SVT Patients.|ARIXTRA® Physician Adherence to the Prescribing Information in Isolated Superficial Vein Thrombosis (SVT) Patients.|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 02:29:09.441506|2017-10-11 02:29:09.441506
NCT01691482|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2016-11-18|2013-06-12||July 2012||2012-07-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium|A 4-Week Randomized Cross-Over Study to Evaluate Daily Lung Function Following the Administration of Albuterol/Salbutamol and Ipratropium in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|56|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:29:09.540397|2017-10-11 02:29:09.540397
NCT01691469|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-09-20|||January 2011||2011-01-01|September 2012|2012-09-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fed Conditions.|Completed||Phase 1|31|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:29:10.256566|2017-10-11 02:29:10.256566
NCT01691456|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2012-09-20|||January 2011||2011-01-01|September 2012|2012-09-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fasting Conditions.|Completed||Phase 1|45|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:29:10.350514|2017-10-11 02:29:10.350514
NCT01691443|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-10-17|||April 2013||2013-04-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|TEXIGLOVE||Functional Assessment of a Vibration Feedback on the Gripping Pressure in the Territory of the Median Nerve|Preliminary Study of the Substitution of Sensory Deficits of the Hand by a Medical Device Embedded : a Functional Assessment of Vibration Feedback on the Gripping Pressure in the Territory of the Median Nerve.|Terminated||N/A|1|Actual|University Hospital, Grenoble||1||Technical problem with one of the medical device used for the study.|f||||t||||||||||2017-10-11 02:29:10.443093|2017-10-11 02:29:10.443093
NCT01691417|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-19||||||September 2012|2012-09-01||||||||Interventional|Sleeves-Bickel||Pneumatic Sleeves and Congestive Heart Failure|The Impact of Intermittent Sequential Pneumatic Compression (ISPC) Leg Sleeves on Cardiac Performance in Patients With Congestive Heart Failure|Completed||N/A|||Western Galilee Hospital-Nahariya||2|||f||||||||||||||2017-10-11 02:29:10.637328|2017-10-11 02:29:10.637328
NCT01691404|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-04-22|||September 2012||2012-09-01|November 2012|2012-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)|Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure in Untreated (Pre)Hypertensive Subjects|Completed||N/A|38|Actual|Wageningen University||3|||f||||f||||||||||2017-10-11 02:29:10.708556|2017-10-11 02:29:10.708556
NCT01690117|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2016-10-05|2016-07-01||October 2012||2012-10-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|GE-REACH||German Adaptation of REACH II|German Adaptation of Resources to Enhance Alzheimer`s Caregiver Health|Completed||N/A|92|Actual|University of Leipzig||2|||f||||f||||||||No||2017-10-11 02:29:32.744524|2017-10-11 02:29:32.744524
NCT01691378|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-05-17|||January 2012||2012-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|October 27, 2015|Actual|2015-10-27||Interventional|WtoH||Window to Hope-Evaluating a Psychological Treatment for Hopelessness Among Veterans With Traumatic Brain Injury|Window to Hope-Evaluating a Psychological Treatment for Hopelessness Among Veterans With Traumatic Brain Injury|Active, not recruiting||N/A|51|Actual|VA Eastern Colorado Health Care System||2|||f||||f||||||||||2017-10-11 02:29:10.886712|2017-10-11 02:29:10.886712
NCT01691365|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-19|||September 2008||2008-09-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Antioxidants and B Vitamins Supplements on Inflammation in Obese Diabetic Patients|Oxidative Damage and Inflammation in Obese Diabetic Emirati Subjects Supplemented With Antioxidants and B-vitamins: a Randomized Placebo-controlled Trail|Completed||Phase 4|100|Actual|United Arab Emirates University||2|||f||||f||||||||||2017-10-11 02:29:10.97697|2017-10-11 02:29:10.97697
NCT01691352|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2014-12-16|||January 2012||2012-01-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Wick vs. No Wick: Does Method of Closure Affect Rate of Wound Infection?|Prospective, Randomized Controlled Trial of Wound Management After Ostomy Closure|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta||2||lack of sufficient population for recruitment|f||||f||||||||||2017-10-11 02:29:11.057193|2017-10-11 02:29:11.057193
NCT01691339|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-08-29|2013-08-29||September 2012||2012-09-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.|Safety and Immunogenicity Among Adults of Fluzone®, Influenza Virus Vaccines 2012-2013 Formulation (Intradermal and Intramuscular Route)|Completed||Phase 4|200|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 02:29:11.155543|2017-10-11 02:29:11.155543
NCT01691326|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-03-12|2014-01-24||September 2012||2012-09-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)|Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)|Completed||Phase 4|60|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:29:12.009882|2017-10-11 02:29:12.009882
NCT01691313|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-11-18|2015-10-15||November 2012||2012-11-01|November 2015|2015-11-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|COR-ART||Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm|Randomized, Double-blind, Placebo-controlled Dose Modification Study to Evaluate the Safety and Efficacy of Single Doses of Vanoxerine for Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm|Completed||Phase 2|104|Actual|Laguna Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-11 02:29:12.581523|2017-10-11 02:29:12.581523
NCT01691300|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-11-11|||May 2011||2011-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|ACTMM||C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT|C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT for Staging and Response Assessment|Completed||N/A|30|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 02:29:13.123866|2017-10-11 02:29:13.123866
NCT01691287|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-04-30|||October 2012||2012-10-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||MICHAEL Method- Fulfilling Individual Potential to Attain Excellence - as a Tool for Improving Metabolic Control and Quality of Life Among Adolescence With Type 1 Diabetes|MICHAEL Method- Fulfilling Individual Potential to Attain Excellence - as a Tool for Improving Metabolic Control and Quality of Life Among Adolescence With Type 1 Diabetes|Completed||N/A|23|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 02:29:13.20735|2017-10-11 02:29:13.20735
NCT01691274|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-03-26|||October 2012||2012-10-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162|A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Parallel Group Dose Escalation Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of Pf-04895162 In Healthy Subjects|Completed||Phase 1|10|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:29:13.280142|2017-10-11 02:29:13.280142
NCT01691261|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-01-04|||June 2015||2015-06-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study Of Implantation Of Retinal Pigment Epithelium In Subjects With Acute Wet Age Related Macular Degeneration|Phase 1, Open-Label, Safety And Feasibility Study Of Implantation Of PF-05206388 (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE) Living Tissue Equivalent) In Subjects With Acute Wet Age Related Macular Degeneration And Recent Rapid Vision Decline|Suspended||Phase 1|10|Anticipated|Pfizer||1|||f||||t||||||||||2017-10-11 02:29:13.363106|2017-10-11 02:29:13.363106
NCT01691248|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-03-28|2016-03-11||October 10, 2012|Actual|2012-10-10|March 2017|2017-03-01|April 16, 2015|Actual|2015-04-16|March 18, 2015|Actual|2015-03-18||Interventional|DEFLECT-1|Modified Intent-to-Treat (mITT) consisting of all randomized participants undergoing hematopoietic stem cell transplantation (HSCT) who received at least 1 dose of study drug.|Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)|DEFLECT-1: A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation|Completed||Phase 3|611|Actual|Optimer Pharmaceuticals LLC||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:29:13.470751|2017-10-11 02:29:13.470751
NCT01691235|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-10-06|||September 2012||2012-09-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|SIMpill HCV||SIMpill Medication Dispensing Device in the Treatment of HCV|Evaluation of the SIMpill Medication Dispensing Device in the Treatment of Chronic Hepatitis C|Withdrawn||N/A|0|Actual|University of Chicago|||2|No subjects enrolled due to delay in device production|f||||f||||||Samples With DNA|"     A blood draw (about 1 tablespoon) if the medication is not working for a subject. This blood     draw is another way for the study team to measure adherence to the therapy. This blood draw     will be taken only once at the time HCV in the blood return to high levels. This blood draw     will measure HCV resistance.   "|||2017-10-11 02:29:14.715441|2017-10-11 02:29:14.715441
NCT01691222|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2013-07-02|||July 2012||2012-07-01|July 2013|2013-07-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Tracheostomy in ICU With a Double Lumen Endotracheal Tube|Percutaneous Tracheostomy in Intensive Care Unit With a Dedicated Double Lumen Endotracheal Tube|Unknown status|Recruiting|N/A|30|Anticipated|University of Genova||1|||f||||t||||||||||2017-10-11 02:29:14.820875|2017-10-11 02:29:14.820875
NCT01691209|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2013-08-09|||October 2013||2013-10-01|August 2013|2013-08-01|June 2014|Anticipated|2014-06-01|April 2014|Anticipated|2014-04-01||Interventional|Phoenix||Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis|An Investigator-blinded, Randomized, Monocentre, 3-arm, Active Controlled Pilot Trial to Explore the Efficacy and Safety of a Topical Medical Device in Patients With Mild to Moderate Atopic Dermatitis in an Intra-individual Comparison With a Standard Therapy (1% Hydrocortisone Cream) and Untreated Skin|Withdrawn||N/A|0|Actual|Bayer||3|||f||||f||||||||||2017-10-11 02:29:14.961547|2017-10-11 02:29:14.961547
NCT01691196|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-05-27|||September 2012||2012-09-01|May 2015|2015-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Inflammation in Peritoneal Dialysis Patients: Effect of Obesity|Inflammation in Peritoneal Dialysis Patients: Effect of Obesity|Unknown status|Recruiting|N/A|50|Anticipated|University of Illinois at Chicago|||1||f||||t||||||Samples Without DNA|"     Blood Collection: Venous blood after overnight fast will include: (1) heparinized tube (green     top) for whole blood (WB) cultures; (2) EDTA tube (lavender top) for CBC and measurement of     cytokines and adipokines, and (3) serum-separator (red top) for determination of lipid panel,     glucose, insulin, and hemoglobin A1c. Glucose and insulin will be used to calculate HOMA-IR     (index of insulin resistance).      Collection of peritoneal dialysis effluent (PDE): To minimize variability, 2.5% glucose     peritoneal dialysis (PD) solution and 4h dwell time will be used for all patients on test     day. Immediately after collection, PDE will be chilled before further processing.   "|||2017-10-11 02:29:15.082361|2017-10-11 02:29:15.082361
NCT01691183|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-09-21|||May 2012||2012-05-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Reliability of Hertel Exophthalmometer Measurements|Reliability of Hertel Exophthalmometer Measurements|Completed||N/A|85|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 02:29:15.195416|2017-10-11 02:29:15.195416
NCT01691170|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2012-09-21|||March 2008||2008-03-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|February 2011|Actual|2011-02-01||Interventional|PFPS||Comparison of Two Protocols for Patellofemoral Pain Syndrome|Quadriceps Femoris Strengthening Versus Hamstring Stretching for Patellofemoral Pain Syndrome: A Randomized Clinical Trial.|Completed||Phase 1/Phase 2|20|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-11 02:29:15.295393|2017-10-11 02:29:15.295393
NCT01691157|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2012-10-11|||September 2012||2012-09-01|October 2012|2012-10-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|EaSI||Exercise in the Physiotherapy Management of Shoulder Impingement|The Effectiveness of Exercise in the Physiotherapy Management of Subacromial Impingement Syndrome|Unknown status|Recruiting|N/A|94|Anticipated|University of Ulster||2|||f||||t||||||||||2017-10-11 02:29:15.400341|2017-10-11 02:29:15.400341
NCT01691144|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-05-11|||September 2012||2012-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project|Gynecological Cancer Survivors` Views on Follow-up After Cancer Treatment|Completed||N/A|239|Actual|University of Oslo|||2||f||||f||||||||||2017-10-11 02:29:15.54565|2017-10-11 02:29:15.54565
NCT01691131|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-09-21|||July 2011||2011-07-01|September 2012|2012-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of Two Training Protocols in Patients With Chronic Obstructive Pulmonary Disease|Effects of Two Training Protocols in Physical Activity in Daily Life and Balance in Patients With COPD: Land Versus Water|Unknown status|Recruiting|N/A|60|Anticipated|Universidade Norte do Paraná||2|||f||||f||||||||||2017-10-11 02:29:15.663536|2017-10-11 02:29:15.663536
NCT01691118|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-20|2015-12-29|||September 2012||2012-09-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|FINE||A Trial of Fimasartan for Early Diastolic Heart Failure|Fimasartan for Improvement of Diastolic Dysfunction in Hypertensive Patients|Completed||Phase 4|60|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:29:15.784607|2017-10-11 02:29:15.784607
NCT01691105|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-01-12|||August 2013||2013-08-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers|Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers|Completed||N/A|1044|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:29:15.920719|2017-10-11 02:29:15.920719
NCT01691092|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-03-10|2016-12-21||June 2012||2012-06-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||reason for discrepancy: some subjects completed baseline scan but did not continue with ketamine administration and subsequent scans.|PET Imaging of mGLuR5 With Drug Challenge|PET Imaging of mGluR5 With Drug Challenge|Completed||N/A|79|Actual|Yale University|Study lacks placebo control group Hemodynamic effects of ketamine may alter tracer delivery and washout Study lacks long-term follow up Only non-smokers studied Ketamine dose administered is higher than typical dose used for clinical purposes|1|||f||||f||||||||No||2017-10-11 02:29:16.045331|2017-10-11 02:29:16.045331
NCT01691079|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-12-01|||December 2012||2012-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|STAMINA||Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes|Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes|Completed||Phase 4|20|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:29:16.423837|2017-10-11 02:29:16.423837
NCT01691066|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2015-07-01|||September 2012||2012-09-01|July 2015|2015-07-01|September 2015|Anticipated|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder|Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder|Unknown status|Active, not recruiting|N/A|30|Anticipated|Yale University||2|||f||||||||||||||2017-10-11 02:29:16.572312|2017-10-11 02:29:16.572312
NCT01691053|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-11-02|||December 2012||2012-12-01|February 2014|2014-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|MiREnDa||Mineralocorticoid Receptor Antagonists in End Stage Renal Disease|Phase II Trial to Evaluate the Efficacy and Safety of Spironolactone in Hemodialysis Patients|Unknown status|Active, not recruiting|Phase 2|118|Actual|Wuerzburg University Hospital||2|||f||||t||||||||||2017-10-11 02:29:16.715795|2017-10-11 02:29:16.715795
NCT01691040|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2014-06-25|||September 2012||2012-09-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer|Phase IIa Study to Characterize the Effects of the Spiegelmer® NOX H94 on Anemia of Chronic Disease in Patients With Cancer|Completed||Phase 2|12|Actual|NOXXON Pharma AG||1|||f||||f||||||||||2017-10-11 02:29:16.838788|2017-10-11 02:29:16.838788
NCT01691014|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-11-01|2016-11-01||April 2013||2013-04-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational||Effectiveness analysis set (EAS) included all participants that provided at least 1 post-baseline assessment.|Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents|Formation Of Antibodies And Subsequent Prediction Of Clinical Response In Patients With Rheumatoid Arthritis Treated With Four Tnf Blocking Agents|Terminated||N/A|79|Actual|Pfizer|Due to premature termination of the study, the primary objective and few of the secondary objectives for the study were not met.||4|"The study was terminated on 10DEC2014 due to the inability to enroll the planned number of   patients. There were no safety concerns."|f||||f||||||||||2017-10-11 02:29:17.142125|2017-10-11 02:29:17.142125
NCT01691001|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-18|||August 2011||2011-08-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Dexmedetomidine on Sevoflurane Requirements and Emergence Agitation in Children Undergoing Ambulatory Surgery||Completed||N/A|40|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:29:17.98852|2017-10-11 02:29:17.98852
NCT01690975|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-09-19|||July 2012||2012-07-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Benzonatate Dose Tolerance Study|A Phase I, Randomized, Placebo-controlled, Dose Escalation Study to Assess the Tolerability of Benzonatate Following Single Dose Administration in Healthy Volunteers|Completed||Phase 1|9|Actual|Pfizer||2|||f||||||||||||||2017-10-11 02:29:18.172701|2017-10-11 02:29:18.172701
NCT01690962|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-09-02|||November 2012||2012-11-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Nutritional Intervention for Diabetic Neuropathy|A Nutritional Intervention for Diabetic Neuropathy|Completed||N/A|15|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-10-11 02:29:18.256271|2017-10-11 02:29:18.256271
NCT01690949|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-07-18|||August 2012||2012-08-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers|Single-blind Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers|Completed||Phase 1|24|Actual|Pulmatrix Inc.||3|||f||||f||||||||||2017-10-11 02:29:18.385147|2017-10-11 02:29:18.385147
NCT01690936|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-05-28|||October 2010||2010-10-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|MEAL||Metabolic Effects of Almond in the Longer-term Study|Effects of Chronic Almond Consumption at Meals or as Snacks on Appetite, Intake, Body Weight, Glycemia, Insulinemia and Lipids in Healthy Adults.|Completed||N/A|150|Actual|Purdue University||5|||f||||t||||||||||2017-10-11 02:29:18.464705|2017-10-11 02:29:18.464705
NCT01690923|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2014-10-07|2014-09-26||August 2011||2011-08-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Nasal Pillows vs. Nasal Masks at High CPAP Pressure|Nasal Pillows at High CPAP Pressure|Completed||N/A|20|Actual|ResMed|This study only included established CPAP users.|2|||f||||t||||||||||2017-10-11 02:29:18.558898|2017-10-11 02:29:18.558898
NCT01690910|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-09-19|||September 2012||2012-09-01|September 2012|2012-09-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|EMS||Effects of Mobility Devices on Nursing Compliance With Mobility Protocols|Effects of Mobility Devices on Nursing Compliance With Mobility Protocols.|Unknown status|Recruiting|N/A|40|Anticipated|Saint Joseph Mercy Health System||2|||f||||f||||||||||2017-10-11 02:29:18.737838|2017-10-11 02:29:18.737838
NCT01690897|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-05-30|||January 2013||2013-01-01|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Mindfulness-Based Treatment for Women With Sexual Interest/Desire Concerns: The MIND Group||Recruiting||N/A|64|Anticipated|University of British Columbia||2|||f||||||||||||||2017-10-11 02:29:18.833576|2017-10-11 02:29:18.833576
NCT01690884|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-01-16|||August 2012||2012-08-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake|Ticagrelor and Adenosine Uptake. Phase II Study Comparing the Effects of Ticagrelor vs Dipyridamole on Adenosine Uptake|Completed||Phase 1|28|Actual|Vanderbilt University Medical Center||3|||f||||f||||||||||2017-10-11 02:29:18.911481|2017-10-11 02:29:18.911481
NCT01690871|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2013-08-01|||September 2012||2012-09-01|August 2013|2013-08-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa|A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa|Withdrawn||Phase 2|0|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:29:18.9983|2017-10-11 02:29:18.9983
NCT01690858|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-10-14|||May 2011||2011-05-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Multicentric Prospective Study of Genetic and Physiopathology Concerning Dysregulation of Complement During Repeated Fetal Abortions|Multicentric Prospective Study of Genetic and Physiopathology Concerning Dysregulation of Complement During Repeated Fetal Abortions|Completed||N/A|60|Actual|Nantes University Hospital|||2||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-11 02:29:19.075698|2017-10-11 02:29:19.075698
NCT00004341|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||July 1995||1995-07-01|October 2003|2003-10-01||||||||Observational|||Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders||Unknown status|Active, not recruiting|N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:04.552209|2017-10-11 04:25:04.552209
NCT01690845|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2016-09-21|||June 2012||2012-06-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|MARS in HH||Molecular Adsorbent Recirculating System (MARS®) in Hypoxic Hepatitis|Molecular Adsorbent Recirculating System (MARS®) for the Treatment of Patients With Hypoxic Hepatitis - a Prospective Randomized Controlled Clinical Study|Recruiting||Phase 2|40|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:29:19.149884|2017-10-11 02:29:19.149884
NCT01690832|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2012-09-19|||September 2012||2012-09-01|September 2012|2012-09-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|FANCY||Fenoldopam for Prevention of Acute Kidney Injury|Fenoldopam for Prevention of Acute kidNey Injury in Patients With aCute coronarY Syndrome Undergoing Coronary Angiography and/or Percutaneous Coronary Intervention - The FANCY Trial|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 02:29:20.921242|2017-10-11 02:29:20.921242
NCT01690819|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-05-05|||October 2013||2013-10-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|PROLABI||Protective Ventilatory Strategy in Severe Acute Brain Injury|Protective Ventilatory Strategy in Severe Acute Brain Injury: Randomized Multi-center Controlled Trial|Recruiting||N/A|524|Anticipated|University of Turin, Italy||2|||f||||t||||||||||2017-10-11 02:29:21.022306|2017-10-11 02:29:21.022306
NCT01690806|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2012-09-25|||January 2008||2008-01-01|August 2011|2011-08-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Observational|||Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy|Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy (and Not Only) After Thyroid Surgery. A Randomized Double-blind Placebo-controlled Trial.|Completed||N/A|328|Actual|Università degli Studi dell'Aquila|||2||f||||t||||||||||2017-10-11 02:29:21.116803|2017-10-11 02:29:21.116803
NCT01690793|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-05|2015-05-27|||February 2009||2009-02-01|May 2015|2015-05-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Observational|acute asthma||Measurement of Natriuretic Hormone Peptides in Exacerbation of Asthma|Measurement of Natriuretic Hormone Peptides in Exacerbation of Asthma|Completed||N/A|30|Actual|University of South Florida|||1||f||||f||||||Samples With DNA|"     Samples of blood will be secured in the Division of Allergy/Immunology at the University of     South Florida, Joy McCann Culverhouse Airways Disease Center. All samples will be     appropriately coded to maintain confidentiality. Blood specimens will be held at minus 20     degrees Celsius. GENETICS SAMPLES ARE OPTIONAL   "|||2017-10-11 02:29:21.178909|2017-10-11 02:29:21.178909
NCT01690780|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-07-15|||September 2012||2012-09-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Oral Morphine Versus Ibuprofen|Oral Morphine Versus Ibuprofen for Post-fracture Pain Management in Children: a Randomized Controlled Study|Completed||N/A|183|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:29:21.25567|2017-10-11 02:29:21.25567
NCT01690767|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-15|2015-03-25|||December 2011||2011-12-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study to Assess the Ability of 2% Lidocaine Gel to Reduce the Discomfort of Urethral Catheterization|A Randomized Blinded Controlled Trial of 2% Lidocaine Gel Compared to Standard of Care in Children Undergoing Urethral Catheterization|Completed||Phase 2|133|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:29:21.343139|2017-10-11 02:29:21.343139
NCT01690754|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-03-18|||March 2011||2011-03-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluating the Effectiveness of Interactive SMS Reminders on TB Treatment Outcomes|Monitoring Patient Compliance With Tuberculosis Treatment Regimens|Completed||N/A|2207|Actual|Interactive Research and Development||2|||f||||f||||||||||2017-10-11 02:29:21.42104|2017-10-11 02:29:21.42104
NCT01690741|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-01-29|||December 2013|Actual|2013-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies|A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies|Recruiting||Phase 1|48|Anticipated|Immune System Key Ltd||1|||f||||t||||||||Undecided||2017-10-11 02:29:21.518066|2017-10-11 02:29:21.518066
NCT01690728|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-03-28|||October 2012|Actual|2012-10-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Physical Activity on Weight Loss and Cardiovascular Risk Factors After Gastric Bypass|Effect of Physical Activity on Weight Loss and Cardiovascular Risk Factors After Gastric Bypass|Completed||N/A|60|Actual|Hospital of South West Denmark||2|||f||||t||||||||No||2017-10-11 02:29:21.651152|2017-10-11 02:29:21.651152
NCT01690715|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-19|||July 2012||2012-07-01|September 2012|2012-09-01||||||||Observational|HSL2012-06||Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery|Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Hospital Sirio-Libanes|||1||f||||t||||||||||2017-10-11 02:29:21.826119|2017-10-11 02:29:21.826119
NCT01690702|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-07-10|||September 2012||2012-09-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|January 2020|Anticipated|2020-01-01||Interventional|GAIN-2||Study of Nab-Paclitaxel in High Risk Early Breast Cancer|Neo-/Adjuvant Phase III Trial to Compare Intense Dose-dense Chemotherapy to Tailored Dose-dense Chemotherapy in Patients With High-risk Early Breast Cancer (GAIN-2)|Active, not recruiting||Phase 3|2886|Actual|German Breast Group||2|||f||||t||||||||||2017-10-11 02:29:21.914215|2017-10-11 02:29:21.914215
NCT01690689|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-02-23|||December 2012||2012-12-01|February 2015|2015-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|Knee100||Investigation of a Customized Femoral Resurfacing Implant|Investigation of a Customized Femoral Resurfacing Implant (Episealer® Knee Condyle Device) to Assess the Safety Profile and Performance for 2 Years Post-operatively|Recruiting||N/A|26|Anticipated|Episurf Medical AB||1|||f||||t||||||||||2017-10-11 02:29:22.046681|2017-10-11 02:29:22.046681
NCT01690676|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-04-07|||August 2012||2012-08-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory Function|The Effect of an Apple Polyphenol Extract Rich in Epicatechin and Flavan-3-ol Oligomers (Evesse™ EPC) on Brachial Artery Flow-mediated Vasodilatory Function (FMD)in Volunteer Subjects|Completed||Phase 2|57|Actual|Danisco||2|||f||||f||||||||||2017-10-11 02:29:22.169467|2017-10-11 02:29:22.169467
NCT00004342|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||June 1994||1994-06-01|December 2003|2003-12-01||||||||Observational|||International Registry for Severe Chronic Neutropenia||Unknown status|Recruiting|N/A|1000||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.626304|2017-10-11 04:25:04.626304
NCT01690663|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-03-23|2016-10-21||September 2012||2012-09-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Dex Dose||Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25%|Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25% in Ultrasound Guided Supraclavicular Brachial Plexus Nerve Block, a Randomized, Placebo Controlled Prospective Clinical Trial|Completed||N/A|89|Actual|University of Pennsylvania|First, all information was collected via telephone call during the recovery period at home, during which recall may be inaccurate. Second, we did not control the intravenous dexamethasone use, which could potentially affect the analgesia duration.|4|||f||||t||||||||||2017-10-11 02:29:22.298915|2017-10-11 02:29:22.298915
NCT01690650|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2013-11-06|||September 2012||2012-09-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Neonatal Cerebral Oxygenation After Exposure to Oxygen Evaluated With the INVOS Oximeter|Oxygenation of the Neonatal Brain - a Study Using the INVOS Oximeter|Completed||N/A|33|Actual|Copenhagen University Hospital, Hvidovre||1|||f||||f||||||||||2017-10-11 02:29:22.78663|2017-10-11 02:29:22.78663
NCT01690637|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-06-30|||September 2012||2012-09-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|PECOS||Panama and El Salvador Children's Oseltamivir Study|Efficacy of Early Oseltamivir Phosphate Treatment at Hospital Admission to Reduce Severity of Illness Among Children Aged Less Than 10 Years Hospitalized With Influenza in El Salvador and Panama|Terminated||Phase 4|721|Actual|Centers for Disease Control and Prevention||2||Slower than anticipated participant accrual|f||||t||||||||||2017-10-11 02:29:22.889427|2017-10-11 02:29:22.889427
NCT01690624|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-10-02|||September 13, 2012|Actual|2012-09-13|October 2017|2017-10-01|March 25, 2019|Anticipated|2019-03-25|March 25, 2019|Anticipated|2019-03-25||Interventional|||BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients in Complete Remission With High Risk to Relapse|A Phase I, Open-label, Cohort Dose Escalation Trial With BI 836858 in Patients With Refractory or Relapsed Acute Myeloid Leukemia and Patients With Acute Myeloid Leukemia in Complete Remission With High Risk to Relapse.|Recruiting||Phase 1|63|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:29:23.026009|2017-10-11 02:29:23.026009
NCT01690611|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-04-19|||June 2011||2011-06-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Visual Feedback to Improve Balance During Walking|Sensory Treadmill to Improve of Balance During Walking|Completed||N/A|40|Actual|Temple University||2|||f||||f||||||||||2017-10-11 02:29:23.165962|2017-10-11 02:29:23.165962
NCT01690598|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-06-09|||November 2012||2012-11-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status|Veliparib (ABT888) and Topotecan (Hycamtin®) for Patients With Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer With Negative or Unknown BRCA Status|Completed||Phase 1/Phase 2|22|Actual|Vejle Hospital||1|||f||||t||||||||||2017-10-11 02:29:23.290207|2017-10-11 02:29:23.290207
NCT01690585|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-08-21|||January 2013|Actual|2013-01-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|FerHem||Efficacy of Parenteral Iron Supplementation After Gastrointestinal Bleeding in Subjects Over 65|Efficacy of Parenteral Iron Supplementation After Gastrointestinal Bleeding in Subjects Over 65|Completed||Phase 3|62|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 02:29:23.389965|2017-10-11 02:29:23.389965
NCT01690572|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-04-27|||October 2012||2012-10-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|||Drug Eluting Balloon for Prevention of Constrictive Remodeling|Drug Coated Balloon (DCB) for the Prevention of Constrictive Remodeling and Restenosis in Small Vessel Coronary Disease|Terminated||N/A|14|Actual|Herz-Zentrums Bad Krozingen||2||recruitment was not sufficient.|f||||f||||||||||2017-10-11 02:29:23.511767|2017-10-11 02:29:23.511767
NCT01690559|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2012-09-19|||April 2010||2010-04-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution||Completed||N/A|704|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:29:23.611475|2017-10-11 02:29:23.611475
NCT01690546|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-04-25|2016-02-22||September 2012||2012-09-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|BUP/NXT-VIVI||Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence|An Open Label, Flexible Dose Study of Very Low Doses of Naltrexone-Buprenorphine Transfer to Extend-Release Naltrexone (VIVITROL®) in Opioid Addiction|Completed||Phase 2|38|Actual|Duke University||1|||f||||t||||||||No||2017-10-11 02:29:23.724764|2017-10-11 02:29:23.724764
NCT01690533|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-09-16|||May 2008||2008-05-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|December 2010|Actual|2010-12-01||Observational|||Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease|Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease|Completed||N/A|497|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:29:24.217385|2017-10-11 02:29:24.217385
NCT01690520|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-09-14|||December 11, 2012|Actual|2012-12-11|September 2017|2017-09-01||||April 30, 2018|Anticipated|2018-04-30||Interventional|||Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes|Multi-center, Open-Label Randomized Study of Single or Double Myeloablative Cord Blood Transplantation With or Without Infusion of Off-The-Shelf Ex Vivo Expanded Cryopreserved Cord Blood Progenitor Cells in Patients With Hematologic Malignancies|Recruiting||Phase 2|160|Anticipated|Fred Hutchinson Cancer Research Center||2|||||||t|t|f||||||||2017-10-11 02:29:24.344647|2017-10-11 02:29:24.344647
NCT01690507|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-02-23|||November 2012||2012-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Interventional|||Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）|Phase 1/2 Study of Decitabine Combined With Modified CAG Followed by HLA Haploidentical T Cell Infusion in Treating Elderly Patients With Intermediate-high Risk Myelodysplastic Syndrome(MDS) or Acute Myeloid Leukemia(AML）|Completed||Phase 1/Phase 2|29|Actual|Chinese PLA General Hospital||1|||f||||f||||||||||2017-10-11 02:29:24.597136|2017-10-11 02:29:24.597136
NCT01690104|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-12-29|||August 2012||2012-08-01|September 2012|2012-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of PXR Activation on Blood Pressure Regulation|The Effect of PXR Activation on Blood Pressure Regulation|Completed||Phase 4|22|Actual|University of Oulu||2|||f||||f||||||||||2017-10-11 02:29:33.444536|2017-10-11 02:29:33.444536
NCT01690494|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-01-26|||June 2013||2013-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|PACT||Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders|Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders, An Effectiveness Trial|Recruiting||N/A|480|Anticipated|Columbia University||2|||f||||f|f|f||||||Undecided||2017-10-11 02:29:24.691037|2017-10-11 02:29:24.691037
NCT01690481|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-04-13|||December 2006||2006-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Effects of High and Low Blood Glucose Values on the Brain in Children With Type 1 Diabetes Mellitus|Neurocognitive and Neuroanatomical Studies in Young Children With Type 1 Diabetes Mellitus|Completed||N/A|43|Actual|Stanford University|||1||f||||f||||||||||2017-10-11 02:29:24.805563|2017-10-11 02:29:24.805563
NCT01690468|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-09-07|||September 2014||2014-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||PTX-200 and Carboplatin in Ovarian Cancer|A Phase IA/IB Trial of PTX-200 and Carboplatin in Patients With Platinum-Resistant Recurrent Ovarian Cancer|Recruiting||Phase 1/Phase 2|36|Anticipated|Prescient Therapeutics, Ltd.||1|||f||||f||||||||Undecided||2017-10-11 02:29:24.880943|2017-10-11 02:29:24.880943
NCT01690455|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice|Non-interventional Study to Assess the Efficacy of Mircera for Renal Anemia Correction in Dialysis Patients in Everyday Clinical Practice in Poland.|Completed||N/A|247|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:29:24.988379|2017-10-11 02:29:24.988379
NCT01690442|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-02-25|||May 2008||2008-05-01|February 2014|2014-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||HIV Prevention for Injecting Drug Users in Kazakhstan|Couples Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan|Completed||Phase 2|600|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 02:29:25.152643|2017-10-11 02:29:25.152643
NCT01690429|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-11-13|||June 2012||2012-06-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Arousal Analysis by Pulse Wave Amplitude in Patients With Obstructive Sleep Apnea|Arousalanalyse Mittels Pulswellenamplitude Bei Patienten Mit Obstruktiver Schlafapnoe|Completed||N/A|26|Actual|Institut für Pneumologie Hagen Ambrock eV||1|||f||||f||||||||||2017-10-11 02:29:25.267717|2017-10-11 02:29:25.267717
NCT01690416|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-05-11|||September 2012||2012-09-01|May 2015|2015-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Conventional vs Ultrasound Guided Arteria Cannulation.|Conventional vs Ultrasound Guided Arteria Cannulation|Completed||N/A|40|Actual|Aarhus University Hospital Skejby||2|||f||||f||||||||||2017-10-11 02:29:25.368753|2017-10-11 02:29:25.368753
NCT01690403|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-02-26|||December 2012||2012-12-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients|An Open-label, Non-randomized, Single Sequence, Two Periods, Four-treatment, Three Parallel Groups Pharmacokinetic Interaction Study of Repeated Oral Doses (Daily or Weekly Regimen) of Rifapentine on ATRIPLA™ (Fixed Dose Combination of Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate) Given to HIV+ Patients|Completed||Phase 1|25|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:29:25.480828|2017-10-11 02:29:25.480828
NCT01690390|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-12-26|||September 2012||2012-09-01|December 2013|2013-12-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease|An Open-label, Randomized, Multicenter, Phase II Trial to Evaluate the Safety and Efficacy of Dose Escalation of Icotinib in Advanced or Metastatic NSCLC Patients After 8 Weeks Routine Therapy Evaluated as Stable Disease|Unknown status|Recruiting|Phase 2|180|Anticipated|Betta Pharmaceuticals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 02:29:25.585201|2017-10-11 02:29:25.585201
NCT01690377|ClinicalTrials.gov processed this data on October 10, 2017|2008-02-05|2016-12-07|||February 2008||2008-02-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients|Plasmacytoid Dendritic Cells in Vaccination of Stage IV Melanoma Patients: a Phase I Study|Completed||Phase 1|30|Actual|Radboud University||1|||f||||f||||||||||2017-10-11 02:29:25.758479|2017-10-11 02:29:25.758479
NCT01690364|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2013-12-24|||July 2012||2012-07-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of the Effects of Vecuronium and Cisatracurium on Electrophysiologic Monitoring During Neurosurgery|Comparison of the Effects of Vecuronium and Cisatracurium on Electrophysiologic Monitoring During Neurosurgery|Completed||N/A|74|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 02:29:25.832344|2017-10-11 02:29:25.832344
NCT01690351|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-12-10|||September 2012||2012-09-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State|A Phase 1, Open Label, Single Dose, Bioavailability Study In Healthy Volunteers Comparing PF-05089771 TS Oral Dispersion To PF-05089771 TS Capsule|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:29:25.939444|2017-10-11 02:29:25.939444
NCT01690338|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-05-22|||October 2012||2012-10-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||A Study of Residual Curarization Incidence in China|A Perspective, Multicentre, Randomized，Blind Study of Residual Curarization Incidence in China|Unknown status|Recruiting|Phase 4|6090|Anticipated|Peking University First Hospital||3|||f||||t||||||||||2017-10-11 02:29:26.024567|2017-10-11 02:29:26.024567
NCT01690325|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-06-18|||September 2012||2012-09-01|June 2015|2015-06-01|September 2022|Anticipated|2022-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)|Molecular Imaging for Response Assessment of Bevacizumab + Docetaxel as Neoadjuvant Chemotherapy in Primary Breast Cancer|Recruiting||Phase 2|94|Anticipated|West German Study Group||2|||f||||f||||||||||2017-10-11 02:29:26.219193|2017-10-11 02:29:26.219193
NCT01690312|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-02-06|||September 2012||2012-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy|Clinical Study to Assess the Acute and Chronic Effects of a High-DHA Fish Oil on Fasting and Post-Prandial Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy.|Completed||N/A|36|Anticipated|Nutrasource Diagnostics Inc.||2|||f||||f||||||||||2017-10-11 02:29:26.488701|2017-10-11 02:29:26.488701
NCT01690299|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2017-05-12|2015-07-02||October 1, 2012|Actual|2012-10-01|May 2017|2017-05-01|April 4, 2016|Actual|2016-04-04|July 3, 2014|Actual|2014-07-03||Interventional||Randomized population includes all randomized participants.|Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis|A Phase 3B, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Double-Dummy, Study Of The Efficacy And Safety Of Apremilast (CC-10004), Etanercept, And Placebo, In Subjects With Moderate To Severe Plaque Psoriasis|Completed||Phase 3|250|Actual|Celgene||3|||f||||t||||||||||2017-10-11 02:29:26.704566|2017-10-11 02:29:26.704566
NCT01690286|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-07-15|||October 2012||2012-10-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers|An Open-Label Study to Assess the Effects of Repeated Twice-Daily Doses of Ketoconazole on the Steady-State Pharmacokinetics of JNJ-38518168 in Healthy Subjects|Completed||Phase 1|33|Actual|Janssen Research & Development, LLC||3|||f||||||||||||||2017-10-11 02:29:28.846404|2017-10-11 02:29:28.846404
NCT01690273|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2016-08-27|2016-01-27||July 2012||2012-07-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|June 2013|Actual|2013-06-01||Interventional|||Exercise Therapy Program in Ankylosing Spondylitis Patients|Effect of Two Exercise Therapy Program With and Without Elastic Resistance in Ankylosing Spondylitis Patients|Completed||N/A|55|Actual|University of Sao Paulo||3|||f||||f||||||||Yes|paper is been written|2017-10-11 02:29:29.016139|2017-10-11 02:29:29.016139
NCT01690260|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-10-04|||September 2004|Actual|2004-09-01|October 2017|2017-10-01|October 2, 2017|Actual|2017-10-02|October 2, 2017|Actual|2017-10-02||Interventional|||Parallel Study Between BMP-2 and Autologous Bone Graft After Ilizarow Treatment|Bone Morphogenetic Protein-2 Increase as Substitute for Autologous Bone Graft After Ilizarow Treatment for Arthritis and Degenerative Bones.|Completed||Phase 1|41|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 02:29:31.140846|2017-10-11 02:29:31.140846
NCT01690247|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2013-05-30|||February 2012||2012-02-01|May 2013|2013-05-01|February 2015|Anticipated|2015-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance|Human Umbilical Cord Mesenchymal Stem Cell Induce Liver Allografts Tolerance|Unknown status|Recruiting|Phase 1|50|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||||2017-10-11 02:29:31.255721|2017-10-11 02:29:31.255721
NCT01690234|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2012-09-19|||September 2009||2009-09-01|September 2012|2012-09-01|October 2014|Anticipated|2014-10-01|September 2012|Actual|2012-09-01||Interventional|TIKI||Early Coordinated Multidisciplinary Intervention to Prevent Sickness Absence and Labor Market Exclusion in Patients With Low Back Pain.|Early Coordinated Multidisciplinary Intervention to Prevent Sickness Absence and Labor Market Exclusion in Patients With Low Back Pain. A Randomized Controlled Trial|Unknown status|Recruiting|N/A|770|Anticipated|Back and Rehabilitation Center, Copenhagen||2|||f||||f||||||||||2017-10-11 02:29:31.384406|2017-10-11 02:29:31.384406
NCT01690208|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2015-08-06|||May 2012||2012-05-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|EMERALD||Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by a Diabetes Specialist Team|Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by an All-encompassing Program Led by a Diabetes Specialist Team|Recruiting||N/A|600|Anticipated|Asia Diabetes Foundation||2|||f||||t||||||||||2017-10-11 02:29:31.796762|2017-10-11 02:29:31.796762
NCT01690195|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-19|2014-03-21|||September 2012||2012-09-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease|Long-Term Safety and Tolerability of ABT-126 in Adults With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: An Open-Label Extension Study for Subjects Completing Study M11-793|Terminated||Phase 2|343|Actual|AbbVie||1||Data obtained from the M11-428 study is not critical to the continued evaluation of ABT-126.|f||||f||||||||||2017-10-11 02:29:31.900789|2017-10-11 02:29:31.900789
NCT01690182|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-12-17|||December 2010||2010-12-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||MRI Study of Stomach Volumes and Satiety|Effects of Test Meal Volume and Energy Density on Gastric Volumes and Satiety Assessed by MRI|Completed||N/A|18|Actual|University of Nottingham||3|||f||||f||||||||||2017-10-11 02:29:32.089516|2017-10-11 02:29:32.089516
NCT01690169|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-02-24|||September 14, 2012|Actual|2012-09-14|February 2017|2017-02-01|December 11, 2012|Actual|2012-12-11|December 11, 2012|Actual|2012-12-11||Interventional|||Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects|Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects|Completed||Phase 1|45|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:29:32.188831|2017-10-11 02:29:32.188831
NCT01690156|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-20|||August 2012||2012-08-01|September 2012|2012-09-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Observational|||Trial on the Effects of Ultrasound Probe Position on Ultrasound-guided Nerve Blocks|Double Blinded Randomized Control Trial on the Effects of Ultrasound Probe Position on Ultrasound-guided Nerve Blocks|Unknown status|Recruiting|N/A|62|Anticipated|University of New Mexico|||2||f||||f||||||||||2017-10-11 02:29:32.440675|2017-10-11 02:29:32.440675
NCT01690143|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-03-17|||May 2012||2012-05-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation|Phase 1/2A Study Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|58|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 02:29:32.521567|2017-10-11 02:29:32.521567
NCT01690130|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-20|||June 2009||2009-06-01|September 2012|2012-09-01||||June 2014|Anticipated|2014-06-01||Interventional|||Transcranial Magnetic Stimulation Effects on Nicotine Craving|Transcranial Magnetic Stimulation Effects on Nicotine Craving|Unknown status|Recruiting|Early Phase 1|30|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 02:29:32.612507|2017-10-11 02:29:32.612507
NCT01690091|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-03-03|||November 2012||2012-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|CARMET||Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes|Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes|Recruiting||Phase 2/Phase 3|40|Anticipated|Institute for Clinical and Experimental Medicine||2|||f||||t||||||||||2017-10-11 02:29:33.556948|2017-10-11 02:29:33.556948
NCT01690078|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-04-18|||April 2011||2011-04-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Functional Modeling of the Pediatric Airway|Predictive Modeling for Treatment of Upper Airway Obstruction in Young Children|Completed||N/A|39|Actual|University of North Carolina, Chapel Hill|||3||f||||t||||||||||2017-10-11 02:29:33.669895|2017-10-11 02:29:33.669895
NCT01690065|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-05-10|||September 2012||2012-09-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Interventional|NICE-BORA||Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML|Nilotinib Combined by Chemotherapy for Myeloid Blastic Phase of Chronic Myeloid Leukemia or Bcr-abl Positive Acute Myeloid Leukemia|Recruiting||Phase 2|46|Anticipated|Ulsan University Hospital||1|||f||||f||||||||||2017-10-11 02:29:33.761324|2017-10-11 02:29:33.761324
NCT01690052|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2014-08-05|2012-12-16||January 2009||2009-01-01|August 2014|2014-08-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva|Efficacy of Cevimeline vs. Pilocarpine in the Secretion of Saliva|Completed||N/A|15|Actual|University of Kentucky|There are limitations that affected this study. This is a pilot study with a relative low number of patients.|2|||f||||f||||||||||2017-10-11 02:29:33.915305|2017-10-11 02:29:33.915305
NCT01690039|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-11-24|||September 2012||2012-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis|Comparison of Furosemide/Fludrocortisone With Ammonium Chloride Loading Test in the Diagnosis of Incomplete dRTA in Kidney Stone Formers|Recruiting||N/A|200|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 02:29:34.164364|2017-10-11 02:29:34.164364
NCT01690026|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-05-27|||October 2012||2012-10-01|May 2015|2015-05-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Facilitating Adolescent Self-Change for Alcohol Problems||Unknown status|Recruiting|Phase 3|9400|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 02:29:34.274466|2017-10-11 02:29:34.274466
NCT01690013|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-05-31|||September 2012||2012-09-01|September 2012|2012-09-01|July 2014|Actual|2014-07-01|January 2013|Actual|2013-01-01||Observational|||Life Quality and Health in Patients With Klinefelter Syndrome|Life Quality and Health in Patients With Klinefelter Syndrome - a Questionnaire Survey|Completed||N/A|452|Actual|University of Aarhus|||2||f||||f||||||||||2017-10-11 02:29:34.379077|2017-10-11 02:29:34.379077
NCT01690000|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-03-31|2016-02-01||November 2012||2012-11-01|April 2013|2013-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|MelaOst||Treatment of Osteopenia With Melatonin|Treatment of Osteopenia With Melatonin: Effects on BMD, Muscle Strength and Quality of Life|Completed||N/A|81|Actual|University of Aarhus||3|||f||||t||||||||||2017-10-11 02:29:34.473504|2017-10-11 02:29:34.473504
NCT01689987|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-09-05|||September 2012||2012-09-01|August 2017|2017-08-01||||April 2016|Actual|2016-04-01||Interventional|||Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase I Dose Escalation Study of Hydroxychloroquine With Infusional Cyclophosphamide, Pulse Dexamethasone and Rapamycin in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|18|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 02:29:34.808723|2017-10-11 02:29:34.808723
NCT01689961|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-06-06|||November 2012||2012-11-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 30, 2017|Anticipated|2017-12-30||Interventional|BHIP||Be Healthy in Pregnancy (BHIP) With Nutrition and Exercise|Be Healthy in Pregnancy (BHIP) With Nutrition and Exercise|Recruiting||N/A|350|Anticipated|McMaster University||2|||f||||t||||||||No||2017-10-11 02:29:35.09818|2017-10-11 02:29:35.09818
NCT01689948|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-10-14|||October 2012||2012-10-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|pré MATAPA||Alzheimer Disease : Rehabilitation's Intervention at Home|Alzheimer Disease : Rehabilitation's Intervention at Home. A Preliminary Pilot Study.|Terminated||N/A|17|Actual|Nantes University Hospital||1||difficulties of recruitment|f||||f||||||||||2017-10-11 02:29:35.208175|2017-10-11 02:29:35.208175
NCT01689935|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2013-05-16|||November 2009||2009-11-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|i-PDT||Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)|A Pilot Clinical Trial To Reduce Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|Massachusetts General Hospital||5|||f||||t||||||||||2017-10-11 02:29:35.305047|2017-10-11 02:29:35.305047
NCT01689922|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-02-28|||June 2012||2012-06-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||The Effectiveness of Anti-Gravity Treadmill Training|The Effectiveness of Anti-Gravity Treadmill Training in Patients After Lumbar Microdiscectomy and Fusion Surgeries|Terminated||N/A|27|Actual|Justin Parker Neurological Institute|||2|slow enrollment|f||||f||||||||||2017-10-11 02:29:35.412969|2017-10-11 02:29:35.412969
NCT01689909|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2016-08-10|||September 2012||2012-09-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|REST-IT||Reducing Suicidal Ideation Through Insomnia Treatment|Reducing Suicidal Ideation Through Insomnia Treatment|Recruiting||Phase 4|138|Anticipated|Augusta University||2|||f||||t||||||||||2017-10-11 02:29:35.49318|2017-10-11 02:29:35.49318
NCT01689896|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-03-30|||August 2012||2012-08-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Testosterone and Pain Sensitivity|Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception in Men With Chronic Pain Syndrome|Withdrawn||Phase 4|0|Actual|Johns Hopkins University||2||Difficult to obtain placebo|f||||f||||||||||2017-10-11 02:29:35.632844|2017-10-11 02:29:35.632844
NCT01689883|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-04-20|||August 2011|Actual|2011-08-01|April 2017|2017-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Improving Recovery After Stroke Via Electrical Stimulation of Proprioceptors|Improving Recovery After Stroke Via Electrical Stimulation of Proprioceptors|Terminated||N/A|1|Actual|Spaulding Rehabilitation Hospital||1||Lack of funding|f||||f|f|f||||||No||2017-10-11 02:29:35.71589|2017-10-11 02:29:35.71589
NCT01689870|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-03-31|||March 2014||2014-03-01|March 2014|2014-03-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma|Phase 1/2 Study of the Combination of a Mouse Monoclonal Antibody to OX40 and Ipilimumab in Patients With Metastatic Melanoma|Withdrawn||Phase 1/Phase 2|0|Actual|Ludwig Institute for Cancer Research||4|||f||||f||||||||||2017-10-11 02:29:35.799108|2017-10-11 02:29:35.799108
NCT01689857|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2013-04-12|2012-12-03||October 2010||2010-10-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Clinical Trial to Evaluate the Safety and Efficacy of Scarclinic™ Thin in Surgical Scars|Phase 4 Study of Scarclinic™ Thin That Treats Surgical Scars.|Completed||N/A|40|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:29:35.897007|2017-10-11 02:29:35.897007
NCT01689844|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-08-30|||April 2012||2012-04-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|FivePlus||Randomized Trial of Tailored Dietary Advice to Lower Blood Pressure|Five Plus Nuts and Beans Trial|Completed||N/A|123|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:29:36.151945|2017-10-11 02:29:36.151945
NCT01689831|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-09-18|||May 2012||2012-05-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)|Dose Comparison Study of Tuberculin Purified Protein Derivative (PPD)With Standard Tuberculin Purified Protein Derivative.|Unknown status|Recruiting|Phase 2|168|Anticipated|JHP Pharmaceuticals LLC||2|||f||||f||||||||||2017-10-11 02:29:36.23551|2017-10-11 02:29:36.23551
NCT01689818|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-09-20|||August 2011||2011-08-01|September 2012|2012-09-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Long-term Follow-up of Functional Performance and Exercise Efficacy in Community-dwelling Elderly With Insomnia|Long-term Follow-up of Functional Performance and Exercise Efficacy in Community-dwelling Elderly With Insomnia|Unknown status|Recruiting|N/A|250|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:29:36.32048|2017-10-11 02:29:36.32048
NCT01689805|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-09-18|||June 2011||2011-06-01|September 2012|2012-09-01||||||||Observational|||Clinical Importance of Filaggrin Gene Mutation for Treatment Outcome in Atopic Dermatitis|Do Mutations in the Filaggrin Gene Have Clinical Importance for the Treatment Outcome in Atopic Dermatitis?|Unknown status|Recruiting|N/A|800|Anticipated|Helsinki University Central Hospital|||2||f||||f||||||Samples With DNA|"     Serum samples are collected to investigate if the patient has a mutation in the filaggrin     gene.   "|||2017-10-11 02:29:36.410881|2017-10-11 02:29:36.410881
NCT01689792|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-03-30|||November 2011||2011-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|||A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)|A Multi-centre, Randomised, Investigator-blinded Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)|Completed||Phase 4|398|Actual|Norgine||2|||f||||f||||||||||2017-10-11 02:29:36.649997|2017-10-11 02:29:36.649997
NCT01689779|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-08-29|2017-03-28||January 2013||2013-01-01|August 2017|2017-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||High Dose Preoperative Cholecalciferol Supplementation and Perioperative Vitamin D Status|Effect of High-dose Cholecalciferol Supplementation on Perioperative Vitamin D Status in Colorectal Surgery Patients|Completed||Phase 3|60|Actual|Massachusetts General Hospital|A small sample size and a relatively homogenous patient cohort at a major teaching hospital limit the generalizability of results.|2|||f||||t||||||||||2017-10-11 02:29:36.744567|2017-10-11 02:29:36.744567
NCT01689766|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-17|||November 2003||2003-11-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma|A Screening Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma|Completed||Phase 2|150|Actual|Endocyte||1|||f||||||||||||||2017-10-11 02:29:37.116299|2017-10-11 02:29:37.116299
NCT01689753|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-09-25|||March 2009||2009-03-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|April 2010|Actual|2010-04-01||Interventional|||Effect of the TEGO Connector in Preventing Tunneled Cuffed Hemodialysis Catheters From Dysfunction and/or Bacteremia|Prevention of Tunneled Cuffed Hemodialysis Catheter-Related Dysfunction and Bacteremia by the TEGO® Connector: A Single-Center Randomized Controlled Trial|Completed||N/A|66|Actual|Erasme University Hospital||2|||f||||f||||||||||2017-10-11 02:29:37.202449|2017-10-11 02:29:37.202449
NCT01689740|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-08-08|||October 2013||2013-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|July 2017|Actual|2017-07-01||Interventional|||Randomized, Double-blind, Active-placebo Controlled Study of MDMA-assisted Psychotherapy in People With Chronic PTSD|A Randomized, Double-Blind, Active Placebo-Controlled Phase 2 Pilot Study of MDMA-assisted Psychotherapy in People With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)|Active, not recruiting||Phase 2|10|Anticipated|Multidisciplinary Association for Psychedelic Studies||3|||f||||f||||||||||2017-10-11 02:29:37.291304|2017-10-11 02:29:37.291304
NCT01689727|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-17|||September 2002||2002-09-01|September 2012|2012-09-01||||September 2004|Actual|2004-09-01||Interventional|||Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors|A Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors|Completed||Phase 2|40|Actual|Endocyte||1|||f||||||||||||||2017-10-11 02:29:37.426407|2017-10-11 02:29:37.426407
NCT01689714|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-17|||August 2003||2003-08-01|September 2012|2012-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma|A MULTI-CENTER CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FOLATESCAN (TECHNETIUM Tc 99m EC20) IN PATIENTS WITH SUSPECTED OVARIAN CARCINOMA OR RECURRENT ENDOMETRIAL CARCINOMA|Completed||Phase 2|16|Actual|Endocyte||1|||||||t||||||||||2017-10-11 02:29:37.494887|2017-10-11 02:29:37.494887
NCT01689688|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2013-09-06|||September 2012||2012-09-01|September 2013|2013-09-01|October 2015|Anticipated|2015-10-01|September 2013|Anticipated|2013-09-01||Observational|HEAL||Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography|Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography|Unknown status|Recruiting|N/A|40|Anticipated|Kobe University|||1||f||||t||||||||||2017-10-11 02:29:37.708305|2017-10-11 02:29:37.708305
NCT01689675|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-10-04|||January 2012||2012-01-01|October 2017|2017-10-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Pain Management Following Musculoskeletal Injury|Pain Management Following Musculoskeletal Injury|Completed||N/A|200|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:29:37.793634|2017-10-11 02:29:37.793634
NCT01689662|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-17|||August 2002||2002-08-01|September 2012|2012-09-01|July 2003|Actual|2003-07-01|||||Interventional|||Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma|A Multi-center Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma|Completed||Phase 2|40|Actual|Endocyte||1|||f||||||||||||||2017-10-11 02:29:37.894557|2017-10-11 02:29:37.894557
NCT01689649|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2013-04-26|2012-10-22||May 2008||2008-05-01|April 2013|2013-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy|Open Flexible Dose Optimisation Trial Assessing Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy Who Are Treatment Naive or Have Failed One Anti-Epileptic Drug Treatment in Monotherapy|Completed||Phase 4|139|Actual|Johnson & Johnson Pte Ltd||1|||f||||f||||||||||2017-10-11 02:29:37.983236|2017-10-11 02:29:37.983236
NCT01689636|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-17|||August 2000||2000-08-01|September 2012|2012-09-01|July 2002|Actual|2002-07-01|||||Interventional|||Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients|CLINICAL STUDY OF A SINGLE-CENTER CLINICAL STUDY TO EVALUATE THE SAFETY AND BIODISTRIBUTION OF TECHNETIUM Tc 99m EC20 IN NORMAL VOLUNTEERS AND OVARIAN CANCER PATIENTS|Completed||Phase 1|8|Actual|Endocyte||1|||f||||||||||||||2017-10-11 02:29:38.372085|2017-10-11 02:29:38.372085
NCT01689623|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2013-03-01|||June 2012||2012-06-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy Participants|A Phase I, 2-Panel, Open-Label Study in Healthy Subjects to Investigate the Pharmacokinetic Interaction Between TMC435 and the HMG-CoA Reductase Inhibitors Atorvastatin and Simvastatin|Completed||Phase 1|36|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 02:29:38.461325|2017-10-11 02:29:38.461325
NCT01689610|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-05-31|||April 2012||2012-04-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Observational|Nabucco||Non-interventional Study With Nab-Paclitaxel (Abraxane®)|Nabucco - Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer|Completed||N/A|705|Actual|iOMEDICO AG|||1||f||||f||||||||||2017-10-11 02:29:38.570248|2017-10-11 02:29:38.570248
NCT01689597|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2017-09-22|||September 2012|Anticipated|2012-09-01|September 2012|2012-09-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Epidural Morphine for Analgesia After Traumatic Vaginal Delivery|Efficacy of Two Doses of Epidural Morphine for Analgesia After Traumatic Vaginal Delivery: a Randomized, Double Blinded, Placebo-controlled Pilot Study|Withdrawn||Phase 4|0|Actual|Lawson Health Research Institute||3||Withdrawn - no participants enrolled|f|||||f|f||||||||2017-10-11 02:29:38.701289|2017-10-11 02:29:38.701289
NCT01689584|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-08-23|||April 2012||2012-04-01|August 2017|2017-08-01|December 2027|Anticipated|2027-12-01|December 2022|Anticipated|2022-12-01||Interventional|COVAR||COsegregation of VARiants in the BRCA1/2 Genes|Study of Family COsegregation of VARiants in the BRCA1/2 Genes to Validate Their Use in Genetic|Recruiting||N/A|2000|Anticipated|Institut Curie||1|||f||||f||||||||||2017-10-11 02:29:38.80355|2017-10-11 02:29:38.80355
NCT01689571|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-03-28|||October 2012||2012-10-01|March 2017|2017-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|CHF6001_POC2||A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics|A Randomised, Double-blind, Placebo-controlled, Three-way Crossover Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Two Doses of Inhaled CHF6001 DPI After 9 Days of Treatment in Adult Patients With Asthma|Completed||Phase 2|36|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||||2017-10-11 02:29:39.103332|2017-10-11 02:29:39.103332
NCT01689558|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2013-03-11|||December 2011||2011-12-01|March 2013|2013-03-01|January 2017|Anticipated|2017-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer|Recombine Endostatin in Alliance With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Cancer Hospital of Guizhou Province||1|||f||||t||||||||||2017-10-11 02:29:39.214987|2017-10-11 02:29:39.214987
NCT01689545|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-06-04|||December 2007||2007-12-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU|Prevention for Positives: A Randomized Controlled Trial Among Vietnamese HIV-positive Injecting Drug Users|Completed||N/A|2175|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||t||||||||||2017-10-11 02:29:39.314145|2017-10-11 02:29:39.314145
NCT01689532|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2016-09-06|2016-07-08|2016-02-16|November 2012||2012-11-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Baseline population included all randomized participants who received study drug.|A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine|A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously as Monotherapy, in Japanese Subjects With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine|Completed||Phase 3|122|Actual|Janssen Pharmaceutical K.K.||2|||f||||t||||||||||2017-10-11 02:29:39.445549|2017-10-11 02:29:39.445549
NCT01689194|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-06-08|||February 2013||2013-02-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer|A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)|Active, not recruiting||Phase 2|53|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 02:29:51.379285|2017-10-11 02:29:51.379285
NCT01689519|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2017-09-27|2015-07-01||January 9, 2013|Actual|2013-01-09|September 2017|2017-09-01|December 31, 2019|Anticipated|2019-12-31|May 9, 2014|Actual|2014-05-09||Interventional|coBRIM|Intent-to-treat population: All randomized participants regardless of whether or not study treatment was received.|A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma|A Phase III, Double-Blind, Placebo-Controlled Study of Vemurafenib Versus Vemurafenib Plus GDC-0973 in Previously Untreated BRAF^600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma|Active, not recruiting||Phase 3|495|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:29:40.765341|2017-10-11 02:29:40.765341
NCT01689506|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-06-25|||December 2012||2012-12-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Fluid Resuscitation in Patients Suffering From Burns Injury|Prospective Randomised Controlled Open-label Explorative Multi-centre Pilot Trial of Volulyte®-Supplemented Versus Albumin-supplemented Fluid Resuscitation for Major Burns|Terminated||Phase 4|11|Actual|Fresenius Kabi||2||Study stopped due to low recruitment|f||||t||||||||||2017-10-11 02:29:43.917056|2017-10-11 02:29:43.917056
NCT01689493|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-09-17|||May 2011||2011-05-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent Implantation|Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent Implantation|Completed||N/A|800|Actual|Hôpital de la Timone||2|||f||||f||||||||||2017-10-11 02:29:44.007479|2017-10-11 02:29:44.007479
NCT01689480|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-12-08|||December 2011||2011-12-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|FSHD2||Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program.|Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With Facioscapulohumeral Dystrophy : Tolerance, Sustainability and Efficiency of Unsupervised Training Program.|Completed||N/A|15|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||No||2017-10-11 02:29:44.190393|2017-10-11 02:29:44.190393
NCT01689467|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2012-09-24|||June 2012||2012-06-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Efficacy and Safety of Fermented Velvet Antler Extract on Fatigue Recovery After Exercise||Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:29:44.292045|2017-10-11 02:29:44.292045
NCT01689454|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-17|||September 2012||2012-09-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Observational|||ISM1 Versus EmbrioGen Media for Embryo Culture With Previous Failure Implantation in ART Treatments|Prospective Randomized Controlled Trail to Assess the Efficacy of EmbryoGen Culture Medium to Improve Ongoing Pregnancy and Implantation Rates in IVF Treatments of Patients With a Previous History of Implantation Failure|Unknown status|Enrolling by invitation|Phase 3|100|Anticipated|Biogenesi|||2||f||||f||||||||||2017-10-11 02:29:44.395381|2017-10-11 02:29:44.395381
NCT01689441|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2016-08-04|2014-10-27||February 2013||2013-02-01|August 2016|2016-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis|Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis|Completed||Phase 2|67|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 02:29:44.48047|2017-10-11 02:29:44.48047
NCT01689428|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-17|||September 2012||2012-09-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Observational|||Ism1 Versus EmbryoGen Media for Embryo Culture in Previous Pregnancy Loss Cases|Prospective Randomized Controlled Trail to Assess the Efficacy of EmbryoGen Culture Medium to Improve Ongoing Pregnancy and Implantation Rates in IVF Treatments of Patients With a Previous History of Pregnancy Loss|Unknown status|Enrolling by invitation|Phase 3|100|Anticipated|Biogenesi|||2||f||||f||||||||||2017-10-11 02:29:44.782117|2017-10-11 02:29:44.782117
NCT01689415|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-07-15|||September 2012||2012-09-01|July 2014|2014-07-01|November 2014|Anticipated|2014-11-01|January 2014|Actual|2014-01-01||Observational|REHEARSE||Renal Denervation Hypertension After Stroke|Pilot Study in Renal Denervation in Patients With Stroke and Uncontrolled Hypertension|Terminated||N/A|25|Anticipated|Bispebjerg Hospital|||1|Based on results from SYMPLICITY HTN-3|f||||f||||||||||2017-10-11 02:29:44.858269|2017-10-11 02:29:44.858269
NCT01689402|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2014-07-15|||April 2012||2012-04-01|July 2014|2014-07-01||||April 2015|Anticipated|2015-04-01||Observational|||MRI for the Early Evaluation of Acute Intracerebral Hemorrhage|MRI for Early Identification of Underlying Pathology in Patients With Acute Intracerebral Hemorrhage|Unknown status|Recruiting|N/A|60|Anticipated|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-11 02:29:44.951303|2017-10-11 02:29:44.951303
NCT01689389|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-18|2015-12-14|||December 2012||2012-12-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|TBD||Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study|Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France|Completed||N/A|2292|Actual|AstraZeneca|||3||f||||f||||||||||2017-10-11 02:29:45.062841|2017-10-11 02:29:45.062841
NCT01689376|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-08-15||||||August 2016|2016-08-01||||||||Expanded Access|||Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)|Guidelines for Treatment With Regorafenib in Patients With Gastrointestinal Stromal Tumors (GIST) After Disease Progression on or Intolerance to Imatinib and Sunitinib (Managed Access Program)|No longer available||N/A|||Bayer|||||f||||||||||||||2017-10-11 02:29:45.202774|2017-10-11 02:29:45.202774
NCT01689363|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-01-18|2016-07-25||September 2012||2012-09-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|H001-A2||Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)|A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test|Completed||Phase 2|253|Actual|Amphastar Pharmaceuticals, Inc.||3|||f||||t||||||||No||2017-10-11 02:29:45.293471|2017-10-11 02:29:45.293471
NCT01689181|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-17|||June 2012||2012-06-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Observational|||Apathy in Schizophrenia|L'Apathie Dans la schizophrénie: étude Neuropsychologique et Anatomique|Unknown status|Recruiting|N/A|60|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||2||f||||f||||||||||2017-10-11 02:29:51.465584|2017-10-11 02:29:51.465584
NCT01689350|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-08-27|2014-06-10||October 2012||2012-10-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|SLE|SLE patients who met the ACR criteria and applied CPA medication were included.|A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment|Prospective Study Based on Genetic Polymorphisms Related to Individual Variations of Side Effects of Cyclophosphamide in Systemic Lupus Erythematosus Treatment|Completed||N/A|92|Actual|Sun Yat-sen University|The sample size is too small to evaluate the significance of the cyclophosphamide (CPA) medication based on genotypes. We need to enroll more SLE patients in the following study.|2|||f||||t||||||||||2017-10-11 02:29:45.941501|2017-10-11 02:29:45.941501
NCT01689337|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-01-12|2015-07-08||April 2013||2013-04-01|January 2017|2017-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Intention-to-treat (ITT) analysis set included all participants randomly allocated to treatment.|A Multicenter Trial of Sprifermin (AS902330 [Recombinant Human Fibroblast Growth Factor-18]) or Placebo After Microfracture Surgery for Cartilage Injury of the Knee|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase II Trial to Investigate the Efficacy and Safety of 30 mcg and 100 mcg AS902330 Given as One Cycle of Three Intra-articular Knee Injections Once a Week for Three Weeks as an Adjunct Treatment to Patients Following Microfracture Surgery for Cartilage Injury of the Knee.|Terminated||Phase 2|1|Actual|EMD Serono|Efficacy analysis was not performed as only one participant was enrolled in the study. The study was terminated due to low recruitment.|3||The study was discontinued due to low recruitment.|f||||f||||||||||2017-10-11 02:29:46.245002|2017-10-11 02:29:46.245002
NCT01689324|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-02-19|2013-11-07||September 2012||2012-09-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents|Immunogenicity and Safety of the Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (SP306) as a Booster in Japanese Adolescents|Completed||Phase 1/Phase 2|43|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:29:46.72999|2017-10-11 02:29:46.72999
NCT01689311|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-20|||March 2009||2009-03-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||In Vitro Myometrial Contractions in Laboring and Non-laboring Women|In Vitro Myometrial Contractions in Laboring and Non-laboring Women: Oxytocin is Superior to Other Uterotonic Agents|Completed||N/A|53|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||1|||f||||f||||||||||2017-10-11 02:29:47.147388|2017-10-11 02:29:47.147388
NCT01689298|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-17|||January 2010||2010-01-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment|Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment|Completed||N/A|20|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 02:29:47.279317|2017-10-11 02:29:47.279317
NCT01689285|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-09-02|||December 2013||2013-12-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|VALID-I||Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir|Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of VZV and HSV Infections in Children, Phase I (VALID-I)|Completed||Phase 1|16|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 02:29:47.377243|2017-10-11 02:29:47.377243
NCT01689272|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-02-10|||May 2011||2011-05-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|September 2011|Actual|2011-09-01||Interventional|||Functional Reserve Estimation of Donor Kidney|Improving of Morphological,Clinical Biochemical and Instrumental Functional Reserve Estimation of Donor Kidney|Completed||Phase 4|60|Actual|Republican Scientific Center for Emergency Medicine||1|||f||||t||||||||||2017-10-11 02:29:47.495854|2017-10-11 02:29:47.495854
NCT01689259|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-09-24|||September 2012||2012-09-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults|A Single-Dose, Open-Label, Randomized, Parallel-Design Study of the Comparative Pharmacokinetics and Safety of TNX-102 2.4 mg SL Tablets (With Phosphate) at 2.4 mg and 4.8 mg, TNX-102-A 2.4 mg SL Tablets (Without Phosphate) at 2.4 mg and Cyclobenzaprine 5 mg Oral Tablets in Healthy Adults.|Completed||Phase 1|24|Actual|Tonix Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 02:29:47.584377|2017-10-11 02:29:47.584377
NCT01689246|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2016-04-07|||January 2013||2013-01-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 3|891|Actual|TauRx Therapeutics Ltd||3|||f||||t||||||||||2017-10-11 02:29:47.713134|2017-10-11 02:29:47.713134
NCT01689233|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2016-06-15|||October 2012||2012-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease|Completed||Phase 3|800|Actual|TauRx Therapeutics Ltd||2|||f||||t||||||||||2017-10-11 02:29:48.118261|2017-10-11 02:29:48.118261
NCT01689220|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-09-03|||September 2012||2012-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|January 2014|Actual|2014-01-01||Interventional|||A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea|A Phase 1 Study of SP-02L (Darinaparsin for Injection) in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea|Completed||Phase 1|6|Actual|Solasia Pharma K.K.||1|||f||||f||||||||||2017-10-11 02:29:48.440889|2017-10-11 02:29:48.440889
NCT01689207|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-08-31|2015-12-14||September 2012||2012-09-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All randomised subjects|To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)|A Phase I, Randomised, Double-blind, 3-Part Study in Healthy Young and Elderly Subjects to Assess the Safety and Tolerability, and Investigate the Pharmacokinetics of Aztreonam and Avibactam Given Alone and in Combination (ATM-AVI)|Completed||Phase 1|222|Actual|Pfizer|No formal statistical hypothesis testing was performed. The analyses of safety, tolerability, and pharmacokinetic data were summarised descriptively including tables, listings, and graphs, as appropriate.|4|||f||||||||||||||2017-10-11 02:29:48.702763|2017-10-11 02:29:48.702763
NCT01689168|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-05-18|||March 2012||2012-03-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||Chiropractic Treatment With Counseling Versus Counseling Alone for Promoting Smoking Cessation|Chiropractic Treatment With Counseling Versus Counseling Alone for Promoting Smoking Cessation: A Randomized Clinical Trial|Terminated||Phase 1|19|Actual|Southern California University of Health Sciences||2||Funding ran out|f||||t||||||||||2017-10-11 02:29:51.53736|2017-10-11 02:29:51.53736
NCT01689155|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2016-09-25|2016-08-01||June 2011||2011-06-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|June 2015|Actual|2015-06-01||Observational||Participants age 9 months through 23 months of age receiving Menactra vaccine within the study institution following licensure of the vaccine for this age indication. KPNC databases were used; Menactra vaccine was administered according to routine clinical practice.|Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children|Post-licensure Safety Surveillance Study of Menactra® Vaccine When Administered As a 2-dose Schedule to Children 9 Months Through 23 Months of Age.|Completed||N/A|116|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 02:29:51.633729|2017-10-11 02:29:51.633729
NCT01689142|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-06-04|||September 2012||2012-09-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Interventional|EDITION JP II||Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus|A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus With a 6 Month Safety Extension Period|Completed||Phase 3|240|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:29:51.893842|2017-10-11 02:29:51.893842
NCT01689129|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-06-06|||September 2012||2012-09-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|EDITION JP I||Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus|A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period|Completed||Phase 3|243|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:29:52.167092|2017-10-11 02:29:52.167092
NCT01689116|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2013-04-09|||August 2012||2012-08-01|September 2012|2012-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers|A Blinded Randomized Parallel Trial to Define the ECG Effects of Bardoxolone Methyl Using a Clinical and a Supratherapeutic Dose Compared to Placebo and Moxifloxacin (a Positive Control) in Healthy Men and Women: A Thorough ECG Trial.|Completed||Phase 1|179|Actual|Reata Pharmaceuticals, Inc.||4|||f||||||||||||||2017-10-11 02:29:52.28938|2017-10-11 02:29:52.28938
NCT01689103|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-04-24|||August 2012||2012-08-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Therapeutic Alliances in Alcoholism Treatment||Active, not recruiting||N/A|166|Anticipated|State University of New York at Buffalo||2|||f||||t||||||||||2017-10-11 02:29:52.402929|2017-10-11 02:29:52.402929
NCT01689090|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-08-17|||November 2012||2012-11-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Diameter Changes of Retinal Vessels During Hypoxia|Diameter Changes of Retinal Vessels During Hypoxia|Unknown status|Recruiting|N/A|60|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:29:52.490932|2017-10-11 02:29:52.490932
NCT01689077|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-01-17|||January 2013||2013-01-01|December 2016|2016-12-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|TTH48||Time-differentiated Therapeutic Hypothermia|Time-differentiated Treatment With Mild Therapeutic Hypothermia Following Cardiac Arrest, a Multi Center Study.|Completed||N/A|355|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:29:52.595268|2017-10-11 02:29:52.595268
NCT01689064|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-12-01|||September 2012||2012-09-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Comparison of Surgical Approach to Endoscopic Pituitary Adenoma Resection|Comparison of the Posterior Septectomy and Stamm Approach to Endoscopic Pituitary Adenoma Resection: A Randomized, Single-blind Trial|Completed||N/A|55|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 02:29:52.712568|2017-10-11 02:29:52.712568
NCT01689051|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-01-30|||March 2012||2012-03-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus||Completed||N/A|20|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-10-11 02:29:52.810974|2017-10-11 02:29:52.810974
NCT01689038|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2013-02-13|||November 2012||2012-11-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Brain Imaging Study of F17464||Completed||Phase 1|8|Actual|Pierre Fabre Medicament||1|||f||||||||||||||2017-10-11 02:29:52.91298|2017-10-11 02:29:52.91298
NCT01689025|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-04-07|||September 2012||2012-09-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)|A Randomised, Placebo-controlled, Double-blind, Multiple-dose, Dose-escalation Trial Investigating the Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus|Terminated||Phase 1|10|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:29:52.97656|2017-10-11 02:29:52.97656
NCT01689012|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2015-03-02|||September 2012||2012-09-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Facial Exercise on the Appearance of Aging|A Pilot Study of the Efficacy of a Facial Exercise Program|Completed||N/A|27|Actual|Northwestern University||1|||f||||f||||||||||2017-10-11 02:29:53.068166|2017-10-11 02:29:53.068166
NCT01688999|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-06-30|||September 7, 2012||2012-09-07|May 12, 2017|2017-05-12|August 10, 2018|Anticipated|2018-08-10|March 14, 2018|Anticipated|2018-03-14||Interventional|||Cabozantinib for Advanced Urothelial Cancer|A Phase II Study of Cabozantinib (XL184) in Patients With Advanced/Metastatic Urothelial Carcinoma|Active, not recruiting||Phase 2|69|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 02:29:53.136358|2017-10-11 02:29:53.136358
NCT01688986|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-10-05|||August 25, 2012||2012-08-25|November 22, 2016|2016-11-22|November 22, 2016||2016-11-22|||||Observational|||Environmental Polymorphisms Registry Health and Exposures Survey|Environmental Polymorphisms Registry Health and Exposures Survey|Completed||N/A|9000|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:29:53.227958|2017-10-11 02:29:53.227958
NCT01688973|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-08-28|||August 20, 2012|Actual|2012-08-20|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|April 30, 2017|Actual|2017-04-30||Interventional|||Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery|Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination With Erlotinib in Papillary Renal Cell Carcinoma|Completed||Phase 2|65|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 02:29:53.534933|2017-10-11 02:29:53.534933
NCT01688960|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-03-16|||October 2012||2012-10-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||"Nesvacumab (REGN910/ SAR307746) and Aflibercept (Ziv-aflibercept in the U.S.) in Patients With Advanced Solid Malignancies"|A Phase 1b Study of Combined Angiogenesis Inhibition by Administering REGN910 and Aflibercept (Ziv-aflibercept) in Patients With Advanced Solid Malignancies|Completed||Phase 1|48|Actual|Regeneron Pharmaceuticals||5|||f||||f||||||||||2017-10-11 02:29:54.108117|2017-10-11 02:29:54.108117
NCT01688947|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-05-09|||September 2012||2012-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)|A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)|Completed||Phase 2|105|Actual|Purdue Pharma LP||4|||f||||f||||||||||2017-10-11 02:29:54.211245|2017-10-11 02:29:54.211245
NCT01688934|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2013-12-04|||September 2012||2012-09-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee|A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee|Completed||Phase 2|230|Actual|Purdue Pharma LP||4|||f||||t||||||||||2017-10-11 02:29:54.371993|2017-10-11 02:29:54.371993
NCT01688921|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-10-16|2014-09-15|2013-03-05|October 2012||2012-10-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|JIFI|Three subjects randomized to the PJ Stratis arm did not have properly documented informed consent and were excluded from the Full Analysis Set (FAS).|Jet Injection for Influenza|Jet Injection for Influenza: A Randomized Controlled Clinical Trial to Demonstrate Non Inferiority of Jet Injection vs. Needle and Syringe for Administration of Trivalent Inactivated Influenza Vaccine|Completed||Phase 4|1250|Actual|PharmaJet, Inc.||2|||f||||f||||||||||2017-10-11 02:29:54.522396|2017-10-11 02:29:54.522396
NCT01688908|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-10-19|||January 2012||2012-01-01|October 2015|2015-10-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|ESECC||Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)|Efficacy of Endoscopy Screening on Esophageal Cancer in a High Risk Region of Rural China: a Randomized Controlled Trial|Recruiting||N/A|32000|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 02:29:55.158945|2017-10-11 02:29:55.158945
NCT01688895|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-08-23|||July 2012||2012-07-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact|Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact|Recruiting||N/A|150|Anticipated|Icahn School of Medicine at Mount Sinai|||3||f||||t||||||Samples With DNA|"     DNA extracted from peripheral blood sample or buccal (inside cheek) sampling for DNA     analysis; whole blood in ACD anti-coagulant to establish a lymphoid cell line, red blood     cells and plasma for biochemical assays.   "|||2017-10-11 02:29:55.240938|2017-10-11 02:29:55.240938
NCT01688882|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2016-03-28|2016-03-28||January 2013||2013-01-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment|A Randomized, Double-blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of QGE031 in the Treatment of Patients With Bullous Pemphigoid With Disease Refractory to Oral Steroid Treatment|Terminated||Phase 2|20|Actual|Novartis||3||"This study was stopped after Part 1 completed and was terminated because the predefined   criteria of efficacy was not reached ( >50% better then placebo)"|f||||t||||||||||2017-10-11 02:29:55.384515|2017-10-11 02:29:55.384515
NCT01688869|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-02-09|||April 2012||2012-04-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|mTBI||Mild Traumatic Brain Injury Registry|Mild Traumatic Brain Injury Registry|Completed||N/A|40|Actual|Carolinas Healthcare System|||1||f||||t||||||Samples With DNA|"     Blood samples will be obtained in the emergency room and processed for future analysis.     Depending on the blood volume obtained, up to two citrate, two EDTA, and one Paxgene tube     will be collected.   "|||2017-10-11 02:29:56.735494|2017-10-11 02:29:56.735494
NCT01688856|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2017-08-30|||July 2012||2012-07-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Contralaterally Controlled FES of Arm & Hand for Subacute Stroke Rehabilitation|Optimizing Contralaterally Controlled FES for Acute Upper Limb Hemiplegia|Recruiting||N/A|108|Anticipated|MetroHealth Medical Center||3|||f||||f||||||||||2017-10-11 02:29:56.809916|2017-10-11 02:29:56.809916
NCT01688830|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2016-05-20|2015-11-13||September 2012||2012-09-01|May 2016|2016-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Treated Set (TS): All randomised subjects who received 1 dose of trial medication were included in the treated set|Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran Etexilate|Randomised, Double-blind, Placebo-controlled Phase I Study in Healthy Male Volunteers. to Investigate Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BI 655075 (Part 1) and to Explore the Dose of BI 655075 Effective to Reverse Dabigatran Anticoagulant Activity (Part 2)|Completed||Phase 1|157|Actual|Boehringer Ingelheim|There is only one group of subjects in study part 3 receiving active treatment. However, AE table displays the AEs occurring in different phases separately.|3|||f||||||||||||||2017-10-11 02:29:57.276761|2017-10-11 02:29:57.276761
NCT01688817|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-24|||May 2008||2008-05-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||The Magnitude of Effect of PCP Counseling on Participation Rate and Sedation Rate in Colonoscopy-based Screening Program|The Magnitude of Effect of Physician's Counseling on Participation Rate and Utilization of Sedation in Colonoscopy-based Colorectal Cancer Screening Program|Completed||N/A|600|Actual|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||f||||||||||2017-10-11 02:30:00.620784|2017-10-11 02:30:00.620784
NCT01688804|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-03-19|||February 2013||2013-02-01|September 2012|2012-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Reducing Sedentary Time in Obese Adults|A Mobile Health Approach to Reducing Sedentary Time in Bariatric Surgery Patients|Completed||N/A|60|Actual|The Miriam Hospital||1|||f||||f||||||||||2017-10-11 02:30:00.729298|2017-10-11 02:30:00.729298
NCT01688791|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2015-02-09|||December 2012||2012-12-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)|A Phase I Dose Escalation Study Evaluating Vintafolide (MK-8109) Chemotherapy Alone or in Combination in Adult Subjects With Advanced Cancers|Terminated||Phase 1|37|Actual|Endocyte||3|||f||||f||||||||||2017-10-11 02:30:00.824686|2017-10-11 02:30:00.824686
NCT01688778|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-03-27|||June 2012||2012-06-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 Diabetes|The Copenhagen Rehabilitation Trial Part 2: Telemedicine as a Means to Achieve Good Diabetes Control Among Patients With Type 2 Diabetes|Unknown status|Active, not recruiting|N/A|165|Anticipated|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 02:30:00.926777|2017-10-11 02:30:00.926777
NCT01688765|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-17|||October 2012||2012-10-01|September 2012|2012-09-01||||||||Observational|||Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis|Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis|Unknown status|Not yet recruiting|N/A|200|Anticipated|Mclean Hospital|||2||f||||f||||||||||2017-10-11 02:30:01.032418|2017-10-11 02:30:01.032418
NCT01688752|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-08-21||||||August 2014|2014-08-01||||||||Observational|||Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia|Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia, A Pilot Study|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute|||2|Funding unavailable|f||||f||||||Samples With DNA|"     Fasting blood samples will be obtained for lipids (total cholesterol, triglycerides, LDL-     cholesterol, HDL-cholesterol) insulin, glucose, inflammatory cytokines (CRP, IL-6, oxidized     LDL), leptin, adiponectin, insulin-like growth factor 1 (IGF-1), thyroid, and gonadal     function.   "|||2017-10-11 02:30:01.099967|2017-10-11 02:30:01.099967
NCT01688739|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-01-08|||March 2012||2012-03-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Ascending Single Doses of AMG 334 in Healthy Subjects and Migraine Patients|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 334 in Healthy Subjects and Migraine Patients|Completed||Phase 1|60|Actual|Amgen||2|||f||||f||||||||||2017-10-11 02:30:01.180267|2017-10-11 02:30:01.180267
NCT01688726|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-11-18|2014-11-11||December 2012||2012-12-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||This analysis population includes all randomized participants.|Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency|Evaluation of SYSTANE® BALANCE on Conjunctival Staining (CS) Visual Performance (VP) and Tear Film Kinetics (TFK) in Dry Eye Subjects With Lipid Deficiency|Completed||N/A|91|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:30:01.483411|2017-10-11 02:30:01.483411
NCT01688713|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2012-09-19|||August 2012||2012-08-01|September 2012|2012-09-01|September 2015|Anticipated|2015-09-01|February 2015|Anticipated|2015-02-01||Interventional|||Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer||Unknown status|Recruiting|Phase 2|20|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-11 02:30:02.017206|2017-10-11 02:30:02.017206
NCT01688700|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2012-09-19|||September 2012||2012-09-01|September 2012|2012-09-01|September 2017|Anticipated|2017-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma|A Prospective, Single Arm, Multicenter, Phase II Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma|Unknown status|Recruiting|Phase 2|60|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-11 02:30:02.156972|2017-10-11 02:30:02.156972
NCT01688687|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2012-09-19|||February 2012||2012-02-01|September 2012|2012-09-01||||September 2012|Actual|2012-09-01||Observational|pCLE||Conventional Biopsies vs pCLE for Diagnosis of Superficial Gastric Neoplasia|The Accuracy of Probe-based Confocal Endomicroscopy Versus Conventional Biopsies for the Diagnosis of Superficial Gastric Neoplasias|Completed||N/A|63|Actual|Soonchunhyang University Hospital|||1||f||||t||||||Samples Without DNA|"     Endscopic resection specimens of gastric neoplasia. Speciments were obtained either by     endoscopic mucosal resection or endoscopic submucosal dissection.   "|||2017-10-11 02:30:02.301019|2017-10-11 02:30:02.301019
NCT01688674|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2012-09-17|||February 2012||2012-02-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal Hypoglycemia|Dextrose Boluses Versus Dextrose Infusions by Burettes in Prevention of Hypoglycemia Among Preterms Admitted at Mulago Hospital: An Open Label Randomized Clinical Trial|Terminated||N/A|140|Actual|Makerere University||2||There was more benefit from the infusion arm compared to the bolus arm.|f||||t||||||||||2017-10-11 02:30:02.427609|2017-10-11 02:30:02.427609
NCT01688661|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2013-04-23|||August 2012||2012-08-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||The Effects of Age and Gender on the Advantage of Sniffing Position for Laryngoscopic View||Completed||N/A|200|Actual|Kyung Hee University Hospital at Gangdong|||1||f||||||||||||||2017-10-11 02:30:02.550991|2017-10-11 02:30:02.550991
NCT01688648|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-10-24|||September 2012||2012-09-01|October 2014|2014-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft|The Comparison of Antiarrhythmic and Myocardial Protective Effect Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft|Completed||N/A|160|Actual|Samsung Medical Center||4|||f||||f||||||||||2017-10-11 02:30:02.633031|2017-10-11 02:30:02.633031
NCT01688635|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2014-10-03|2014-10-03||September 2012||2012-09-01|October 2014|2014-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||All randomized participants|A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy Participants|Comparative Pharmacokinetics and Pharmacodynamics of LY2963016 and US-Approved Lantus® After Single-Dose Subcutaneous Administration to Healthy Subjects|Completed||Phase 1|91|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:30:02.765235|2017-10-11 02:30:02.765235
NCT01688622|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2012-09-20|||July 2012||2012-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Glypican4 and CTRP5 in Metabolic Syndrome and the Effect of Exercise on These Adipokines|Effects of Exercise on Glypican4,CTRP3,5 and RBP4 Levels and Circulating Levels of These Adipokines in the Subjects With or Without Metabolic Syndrome|Completed||N/A|90|Actual|Korea University||1|||f||||t||||||||||2017-10-11 02:30:03.356984|2017-10-11 02:30:03.356984
NCT01688609|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2017-08-09|2017-06-08||July 2012||2012-07-01|August 2017|2017-08-01|August 15, 2016|Actual|2016-08-15|December 2013|Actual|2013-12-01||Interventional|||Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer|Phase II Study of Lapatinib and Trastuzumab Followed by Concurrent Lapatinib, Trastuzumab, and Paclitaxel Followed by Surgery for Primary HER2-positive (HER2+) Breast Cancer|Completed||Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:30:03.44129|2017-10-11 02:30:03.44129
NCT01688583|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2013-11-20|||December 2011||2011-12-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement|The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement: Multicenter, Prospective, Open-label, Observational Study|Completed||Phase 4|410|Actual|Janssen Korea, Ltd., Korea|||1||f||||||||||||||2017-10-11 02:30:03.868025|2017-10-11 02:30:03.868025
NCT01688570|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-11-04|||August 2011||2011-08-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Mechanisms of Neuromuscular Fatigue Post Stroke|Mechanisms of Neuromuscular Fatigue Post Stroke|Completed||Early Phase 1|27|Actual|Medical College of Wisconsin||3|||f||||f||||||||||2017-10-11 02:30:03.980997|2017-10-11 02:30:03.980997
NCT01688557|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2016-10-06|||September 2012||2012-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|RCT-IC||Trial on Innovative Technologies in Colonoscopy|Prospective Randomised Trial Comparing New Technologies of Endoscopic Bowel Visualisation With Conventional Colonoscopy.|Completed||N/A|600|Actual|Jagiellonian University||2|||f||||f||||||||||2017-10-11 02:30:04.072046|2017-10-11 02:30:04.072046
NCT01688544|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-09-19|||January 2009||2009-01-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic Polymorphism|Phase 1 Study to Evaluate the Effect of CYP Polymorphism and Gender on the Pharmacokinetics and Pharmacodynamics of Ilaprazole After Multiple Dosing|Completed||Phase 1|27|Actual|Inje University||1|||f||||t||||||||||2017-10-11 02:30:04.206582|2017-10-11 02:30:04.206582
NCT01688531|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2013-09-16|||August 2012||2012-08-01|September 2013|2013-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients|A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients|Unknown status|Active, not recruiting|Phase 1|38|Actual|Galderma R&D||1|||f||||f||||||||||2017-10-11 02:30:04.303283|2017-10-11 02:30:04.303283
NCT01688518|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-17|2013-01-02|||September 2012||2012-09-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers|Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers|Completed||Phase 1|22|Actual|CRI Lifetree||2|||f||||t||||||||||2017-10-11 02:30:04.376014|2017-10-11 02:30:04.376014
NCT01688505|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-16|2012-09-19|||May 2012||2012-05-01|September 2012|2012-09-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Observational|BPV-COG||Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function|Multicenter Retrospective Study of Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function|Unknown status|Recruiting|N/A|140|Anticipated|Hallym University Medical Center|||1||f||||f||||||||||2017-10-11 02:30:04.45853|2017-10-11 02:30:04.45853
NCT01688492|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-09-07|||September 2012||2012-09-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer|A Phase 2 Study Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|57|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:30:04.555345|2017-10-11 02:30:04.555345
NCT01688479|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-15|2015-09-16|||February 2011||2011-02-01|September 2015|2015-09-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||"Trial Comparing Calendula Officinalis With Aqueous Cream Essex to Treat Skin Reactions From Radiotherapy of Breast Cancer"|"Randomized, Blinded Phase III Trial Comparing Calendula Officinalis Cream With Standard Aqueous Cream Essex for Treatment of Skin Reactions Caused by Postoperative Radiotherapy of Breast Cancer"|Completed||Phase 3|420|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 02:30:05.02444|2017-10-11 02:30:05.02444
NCT01688466|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-15|2017-07-06|||August 29, 2012||2012-08-29|May 25, 2017|2017-05-25|July 1, 2018|Anticipated|2018-07-01|March 30, 2017|Actual|2017-03-30||Interventional|||Pomalidomide for Chronic Graft-versus-Host Disease|A Randomized Phase 2 Single-Center Study of Pomalidomide for Chronic GvHD|Active, not recruiting||Phase 2|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 02:30:05.118963|2017-10-11 02:30:05.118963
NCT01688453|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-02-12|||September 2012||2012-09-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2015|Actual|2015-09-01||Interventional|PRALIMAP-INES||Overweight Management and Social Inequalities|Reduction of Inequalities in Overweight and Obesity Management Care Access Among High School Adolescents|Active, not recruiting||N/A|1689|Actual|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||t||||||||||2017-10-11 02:30:05.21492|2017-10-11 02:30:05.21492
NCT01688440|ClinicalTrials.gov processed this data on October 10, 2017|2008-05-12|2012-09-18|||June 2005||2005-06-01|September 2012|2012-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||ETCare: Safety and Preliminary Efficacy Trial|"ETCare: A Phase II, Safety and Preliminary Efficacy Trial"|Completed||Early Phase 1|10|Actual|Intermountain Health Care, Inc.||1|||f||||f||||||||||2017-10-11 02:30:05.345872|2017-10-11 02:30:05.345872
NCT01688427|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-08-17|||October 2012||2012-10-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Perinatal Nurse Home Visiting Enhanced With mHealth Technology|Perinatal Nurse Home Visiting Enhanced With mHealth Technology|Active, not recruiting||N/A|433|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:30:05.464997|2017-10-11 02:30:05.464997
NCT01688414|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-07-25|||September 2012||2012-09-01|July 2014|2014-07-01||||September 2015|Anticipated|2015-09-01||Interventional|||Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer|Utility of Fluorescence and Photoacoustic Imaging Intraoperatively to Assist With Robotic Assisted Minimally Invasive Surgery|Withdrawn||N/A|0|Actual|Stanford University||1||PI left Stanford|f||||||||||||||2017-10-11 02:30:05.541264|2017-10-11 02:30:05.541264
NCT01688401|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-03-29|||January 2013||2013-01-01|March 2017|2017-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).|Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).|Suspended||Phase 1|5|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1||Study has been placed on hold for an interim review.|f||||t||||||||||2017-10-11 02:30:05.626439|2017-10-11 02:30:05.626439
NCT01688388|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-10-14|||February 2012||2012-02-01|October 2014|2014-10-01|February 2022|Anticipated|2022-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Single Fraction Intraoperative Radiotherapy|Single Fraction Intraoperative Radiotherapy With Electrons: An Option in Breast-Conserving Operable Breast Cancer Stages 0, I and II - Prospective, Single-arm Trial|Recruiting||Phase 1/Phase 2|200|Anticipated|St. Joseph Hospital of Orange||1|||f||||f||||||||||2017-10-11 02:30:05.69975|2017-10-11 02:30:05.69975
NCT01688375|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-10-01|||December 2012||2012-12-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice|The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice After Endoscopic or Surgical Treatment|Unknown status|Not yet recruiting|Phase 2|54|Anticipated|University Clinical Centre of Kosova||1|||f||||f||||||||||2017-10-11 02:30:05.799737|2017-10-11 02:30:05.799737
NCT01688362|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-04-13|||November 2012||2012-11-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Platelet Rich Plasma vs. Corticosteroid Injection in the Treatment of Partial Rotator Cuff Tears|Platelet Rich Plasma vs. Corticosteroid Injection in the Treatment of Partial Thickness Rotator Cuff Tears. A Randomized, Prospective, Double Blinded Trial.|Terminated||Phase 1|12|Actual|University of North Carolina, Chapel Hill||2||Did not meet target enrollment deadlines.|f||||f||||||||||2017-10-11 02:30:05.932533|2017-10-11 02:30:05.932533
NCT01688349|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-03-21|||October 2012||2012-10-01|March 2017|2017-03-01|September 16, 2016|Actual|2016-09-16|September 16, 2016|Actual|2016-09-16||Interventional|LIPOCUSH||Pattern of Gene Expression in Adipose Tissue From Patients With Cushing Syndrome|Comparative Study of Subcutaneous and Visceral Adipose Tissue in Patients Affected by Cushing Syndrome Versus 2 Controls Population|Completed||N/A|90|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-10-11 02:30:06.114708|2017-10-11 02:30:06.114708
NCT01688336|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-09-07|2017-07-21||January 2012||2012-01-01|September 2017|2017-09-01|November 22, 2016|Actual|2016-11-22|August 22, 2016|Actual|2016-08-22||Interventional|||FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer|Phase II Single Arm Clinical Trial of FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer|Terminated||Phase 2|9|Actual|UNC Lineberger Comprehensive Cancer Center||1||Results unlikely to impact treatment patterns. Time to complete not justified.|f||||t||||||||||2017-10-11 02:30:06.227704|2017-10-11 02:30:06.227704
NCT01688323|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-09-11|||July 2012|Actual|2012-07-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|July 2014|Actual|2014-07-01||Observational|||Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer|Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer|Completed||N/A|3|Actual|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 02:30:06.649379|2017-10-11 02:30:06.649379
NCT01688310|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2013-06-30|2013-06-07||August 2012||2012-08-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Randomized Controlled Trial of Open Surgical vs. Minimally-invasive Voluntary Adult Male Circumcision|A Randomized Controlled Trial of Open Surgical vs. Minimally-invasive Voluntary Adult Male Circumcision|Completed||N/A|200|Actual|Universidade Católica de Moçambique||2|||f||||t||||||||||2017-10-11 02:30:06.764438|2017-10-11 02:30:06.764438
NCT01688297|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-05-11|||September 2012||2012-09-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional|||Safety Study of an Oral Vaccine to Prevent Seasonal Influenza|Randomized Phase 1 Double-Blinded Placebo Controlled Trial to Determine the Safety and Immunogenicity of an Adenoviral-Vector Based Seasonal Influenza A Vaccine and dsRNA Adjuvant Administered Orally to Healthy Volunteers|Completed||Phase 1|61|Actual|Vaxart||4|||f||||t|t|f||||||No||2017-10-11 02:30:07.228331|2017-10-11 02:30:07.228331
NCT01688284|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-09-18|||March 2010||2010-03-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Role of Uterine NK Cells and T Cell Cytokines in Recurrent Miscarriage|The Role of Uterine NK Cells and T Cell Cytokines in Recurrent Miscarriage.|Completed||N/A|500|Actual|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-11 02:30:07.321271|2017-10-11 02:30:07.321271
NCT01688271|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-10-27|||August 2012||2012-08-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Simulation-Based Training for Ultrasound-Guided Perineural Catheter Insertion|A Prospective Study to Determine the Efficacy of Simulation-based Training on Practicing Anesthesiologists' Acquisition of Ultrasound-guided Perineural Catheter Insertion Skills|Completed||N/A|32|Actual|VA Palo Alto Health Care System|||1||f||||t||||||||||2017-10-11 02:30:07.401431|2017-10-11 02:30:07.401431
NCT01688258|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-07-12|||January 2012||2012-01-01|July 2017|2017-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||New Multiplex Real-time PCR for Genital Ulcer Disease|A Prospective, Open Labeled, Multicenter, Diagnostic Study on the Detection of T. Pallidum, H. Ducreyi and HSV Type 1 and 2 From Genital, Anal and Oropharyngeal Ulcers With a New Multiplex Real-time Polymerase Chain Reaction|Completed||N/A|50|Actual|University of Zurich|||1||f||||||||||||||2017-10-11 02:30:07.501332|2017-10-11 02:30:07.501332
NCT01688245|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2015-05-26|||November 2012||2012-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|TRAC||A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults|A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults|Completed||N/A|765|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 02:30:07.563125|2017-10-11 02:30:07.563125
NCT01688232|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2016-09-01|||October 2012||2012-10-01|August 2016|2016-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|IMMUCOL||The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer|Colorectal Cancer: a Prospective Multicentric Study of the in Situ Immune Infiltrate for the Identification of the Patients at High Risk of Relapse|Active, not recruiting||N/A|459|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     The pathologist of each center will choose a tumor block containing the core of the tumor and     the invasive margin. Three tissue sections of 4 microns of this tumor block will be cut and     deposited on glass slides for the immunohistochemical analyses. Four tissue sections of 4     microns will be cut and deposited in a safe lock eppendorf tube for a DNA extraction. If     biopsies for diagnostic purpose are available in the laboratory of pathology for the same     patient, one tissue section of 4 microns of each biopsy will be cut and deposited on a glass     slide   "|||2017-10-11 02:30:07.659583|2017-10-11 02:30:07.659583
NCT01688219|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2012-09-18|||November 2005||2005-11-01|October 2007|2007-10-01|May 2008|Actual|2008-05-01|||||Observational|||Immune Response in the SAPHO Syndrome|Immune Mechanisms During SAPHO Syndrome and Treatment by Etarnecept|Completed||N/A|39|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||||||||||||2017-10-11 02:30:07.756429|2017-10-11 02:30:07.756429
NCT01688206|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-09-21|||October 31, 2012|Actual|2012-10-31|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|December 2, 2016|Actual|2016-12-02||Interventional|||A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors|An Open-label, Multi-center, Dose Escalation Phase I Study of Single Agent RO5520985 (Vanucizumab), and in Combination With Atezolizumab, Administered as an Intravenous Infusion in Patients With Locally Advanced or Metastatic Solid Tumors|Active, not recruiting||Phase 1|132|Actual|Hoffmann-La Roche||2|||f|||||f|f||||||||2017-10-11 02:30:07.834137|2017-10-11 02:30:07.834137
NCT01688193|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2013-01-04|||October 2012||2012-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male|Randomized, Open, 2-way Cross Over, Single Dose Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male|Completed||N/A|68|Actual|Hanmi Pharmaceutical Company Limited|||2||f||||f||||||||||2017-10-11 02:30:07.958357|2017-10-11 02:30:07.958357
NCT01688180|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2013-08-06|||December 2012||2012-12-01|August 2013|2013-08-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF Bronchiectasis|The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF Bronchiectasis|Unknown status|Recruiting|N/A|160|Anticipated|The First Affiliated Hospital of Guangzhou Medical University|||1||f||||t||||||||||2017-10-11 02:30:08.020801|2017-10-11 02:30:08.020801
NCT01688167|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-07-08|||January 2012||2012-01-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Increasing Availability and Acceptability of Circumcision in Zambia|Increasing Availability and Acceptability of Circumcision in Zambia|Completed||N/A|1468|Actual|University of Miami||3|||f||||f||||||||||2017-10-11 02:30:08.094826|2017-10-11 02:30:08.094826
NCT01688154|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2013-07-02|||February 2013||2013-02-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans|Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans|Completed||N/A|16|Actual|Technological Centre of Nutrition and Health, Spain||2|||f||||f||||||||||2017-10-11 02:30:08.172269|2017-10-11 02:30:08.172269
NCT01688141|ClinicalTrials.gov processed this data on October 10, 2017|2009-11-20|2015-12-07|||January 2010||2010-01-01|December 2015|2015-12-01|July 2017|Anticipated|2017-07-01|January 2014|Actual|2014-01-01||Interventional|||A Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease|A Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease|Active, not recruiting||N/A|28304|Anticipated|University Hospitals, Leicester||2|||f||||t||||||||||2017-10-11 02:30:08.257962|2017-10-11 02:30:08.257962
NCT01688128|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-04-18|||August 2012||2012-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|U-SMART||Efficacy of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART)|An Open-label, Controlled, Cross-over Trial of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART) in Mild Cognitive Impairment|Completed||Phase 3|50|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 02:30:08.352512|2017-10-11 02:30:08.352512
NCT01688115|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-10-28|||September 2012||2012-09-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Reduction of Preoperative Anxiety in Children: Clickamico Project 2nd Phase|Reduction of Preoperative Anxiety in Children: Clickamico Project 2nd Phase|Completed||N/A|40|Actual|University of Florence||2|||f||||t||||||||||2017-10-11 02:30:08.691028|2017-10-11 02:30:08.691028
NCT01688089|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2014-09-18|||September 2012||2012-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|NOCOS||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Repeated Escalating Doses of ODM-103: a Randomised, Double-blind, Placebo- and Entacapone-controlled Single Centre First-in-man Study in Healthy Volunteers.|Completed||Phase 1|67|Actual|Orion Corporation, Orion Pharma||3|||f||||t||||||||||2017-10-11 02:30:09.334307|2017-10-11 02:30:09.334307
NCT01688076|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-02-07|||January 2012||2012-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection|Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection: Impact of Muscle Contraction on Onset of Action, Efficacy, and Duration of Treatment|Active, not recruiting||N/A|25|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 02:30:09.426211|2017-10-11 02:30:09.426211
NCT01688063|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-02-07|||July 2011||2011-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Skin Elasticity Measurements of the Face and Surgical Scars Stratified by Age and Skin Type|A Pilot Study of Skin Elasticity Measurements of the Face and Surgical Scars Stratified by Age and Skin Type|Active, not recruiting||N/A|35|Actual|Northwestern University|||2||f||||t||||||||||2017-10-11 02:30:09.529583|2017-10-11 02:30:09.529583
NCT01688050|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-03-24|2015-10-15|2015-07-28|January 2013||2013-01-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|June 2014|Actual|2014-06-01||Interventional|TRANSFIX||TRANSFIX Zenith® Transection Clinical Study|TRANSFIX - Zenith® TX2® Low Profile Endovascular Graft for Blunt Thoracic Aortic Injury|Active, not recruiting||N/A|50|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 02:30:09.643021|2017-10-11 02:30:09.643021
NCT01688024|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-09-06|||September 2012||2012-09-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis|Phase 2 Study of Mitomycin C Therapy for Biliary Strictures in Patients With Primary Sclerosing Cholangitis|Recruiting||Phase 2|130|Anticipated|Li, Zhiping, M.D.||2|||f||||t||||||||||2017-10-11 02:30:10.456571|2017-10-11 02:30:10.456571
NCT01688011|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2017-05-22|||December 12, 2013||2013-12-12|May 2017|2017-05-01|December 12, 2026|Anticipated|2026-12-12|December 12, 2018|Anticipated|2018-12-12||Observational|||Connect® MDS/AML Disease Registry|Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry|Recruiting||N/A|1500|Anticipated|Celgene|||4||f||||f||||||Samples With DNA|"     Perform molecular and cellular correlative studies on blood/bone marrow and oral epithelial     cell samples.   "|||2017-10-11 02:30:10.601971|2017-10-11 02:30:10.601971
NCT01687998|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-12-12||2016-08-13|October 2012||2012-10-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|ACCELERATE||A Study of Evacetrapib in High-Risk Vascular Disease|Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High-Risk for Vascular Outcomes|Terminated||Phase 3|12092|Actual|Eli Lilly and Company||2||Study termination due to insufficient efficacy.|f||||t||||||||Yes|Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement.|2017-10-11 02:30:11.524245|2017-10-11 02:30:11.524245
NCT01687985|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-07-14||2014-07-14|August 2012||2012-08-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults|A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults|Completed||Phase 2|81|Actual|Braintree Laboratories||2|||f||||f||||||||||2017-10-11 02:30:12.930793|2017-10-11 02:30:12.930793
NCT01687959|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2015-01-27|||September 2012||2012-09-01|January 2015|2015-01-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary Pancreatitis|Prospective Randomized Clinical Study for Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary Pancreatitis|Unknown status|Active, not recruiting|Early Phase 1|60|Actual|Bezmialem Vakif University||2|||f||||f||||||||||2017-10-11 02:30:13.146719|2017-10-11 02:30:13.146719
NCT01687946|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-03-15|||June 2010||2010-06-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Observational|||Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology|Pilot Investigation on the Combined Use of Established Clinical Criteria and Systems Biology for Progressive Pulmonary Fibrosis|Completed||N/A|80|Actual|Medical University of Vienna|||3||f||||f||||||Samples With DNA|"     Transbronchial biopsies and Video-assisted throracoscopic biopsies   "|No||2017-10-11 02:30:13.226238|2017-10-11 02:30:13.226238
NCT01687933|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-09-15|||February 2011||2011-02-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||The Effect of Virtual Reality Glasses on Labor Pain|Principal Investigator|Completed||Phase 2/Phase 3|30|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:30:13.304511|2017-10-11 02:30:13.304511
NCT01687920|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2014-01-08|||September 2012||2012-09-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets|Single Center, Randomized, Open-label, 5-fold Crossover Study in Healthy Male Subjects to Investigate the Pharmacokinetic Dose Proportionality of BAY94-8862 Given as 5 Different Single Oral IR Tablet Doses (1.25, 2.5, 5.0, 7.5 and 10 mg)|Completed||Phase 1|25|Actual|Bayer||5|||f||||f||||||||||2017-10-11 02:30:13.371645|2017-10-11 02:30:13.371645
NCT01687907|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-15|||October 2009||2009-10-01|September 2012|2012-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|MUUSA||The Effects of Music on Fear of Childbirth and Outcome of Delivery|A Randomized Longitudinal Trial About the Effects of Music on Fear of Childbirth and Outcome of Delivery|Unknown status|Recruiting|N/A|800|Anticipated|Helsinki University Central Hospital||4|||f||||||||||||||2017-10-11 02:30:13.462252|2017-10-11 02:30:13.462252
NCT01687894|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-08|2017-02-23|||May 2012||2012-05-01|September 2012|2012-09-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Observational|||Vasopressin to Prevent Hypotension During Beach Chair Surgery|Clinical Trials of Vasopressin for Prevention of Hypotension During Shoulder Surgery in Beach Chair Position Under General Anesthesia|Completed||N/A|74|Actual|Chonnam National University Hospital|||4||f||||f||||||||||2017-10-11 02:30:13.574668|2017-10-11 02:30:13.574668
NCT01687881|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-12-30|||September 2012||2012-09-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option in Cervicogenic Headache|Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option in Cervicogenic Headache? A Randomized Controlled Clinical Trial.|Completed||Phase 3|19|Actual|University Hospital, Akershus||3|||f||||t||||||||||2017-10-11 02:30:13.69579|2017-10-11 02:30:13.69579
NCT01687868|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-03-04|||July 2012||2012-07-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Evaluation of Efficacy and Safety of General Anesthesia Using Dexmedetomidine With Sevoflurane in Patients Undergoing Arthroscopic Shoulder Surgery: Preliminary Study||Completed||N/A|19|Actual|Yonsei University||1|||f||||t||||||||||2017-10-11 02:30:13.815738|2017-10-11 02:30:13.815738
NCT01687855|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-18|||February 2003||2003-02-01|September 2012|2012-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Dynamic Alterations of Tongue in Sleep Apnoea Hypopnea Syndrome During Sleep|Observation of the Change in Soft Tissue in OSAH|Completed||N/A|41|Actual|Wenzhou Medical University|||2||f||||t||||||||||2017-10-11 02:30:14.125448|2017-10-11 02:30:14.125448
NCT01687842|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-07-24|||March 2013|Actual|2013-03-01|October 2016|2016-10-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Observational|COGNITUR||Social Cognition and Turner Syndrome|Social Cognition and Turner Syndrome|Completed||N/A|25|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Buccal DNA samples will be collected in the patient and her mother   "|||2017-10-11 02:30:14.207924|2017-10-11 02:30:14.207924
NCT01687829|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-02-12|||January 2013||2013-01-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Observational|||Macular Hole Surgery With and Without Internal Limiting Membrane Peeling：A Systematic Review and Meta-analysis|Macular Hole Surgery With and Without Internal Limiting Membrane Peeling：A Systematic Review and Meta-analysis|Unknown status|Recruiting|N/A|400|Anticipated|Wenzhou Medical University|||2||f||||||||||||||2017-10-11 02:30:14.284036|2017-10-11 02:30:14.284036
NCT01687816|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2012-09-13|||February 2012||2012-02-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting|Prospective, Nasal Specimen Collection Study in Patients Presenting With Influenza Like Illness and/or Acute Respiratory Infection in an Outpatient Setting|Unknown status|Active, not recruiting|N/A|300|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||Samples With DNA|"     Nasal swabs of left and right nostril   "|||2017-10-11 02:30:14.363519|2017-10-11 02:30:14.363519
NCT01687803|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-13|||October 2006||2006-10-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2009|Actual|2009-09-01||Interventional|FL52||Evaluating the Health Benefits of Physical Activity Recommendations in the Dietary Guidelines|Evaluating the Health Benefits of Physical Activity Recommendations in the Dietary Guidelines|Completed||N/A|37|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 02:30:14.441117|2017-10-11 02:30:14.441117
NCT01687790|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-07-31|2016-01-27||September 2012||2012-09-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Women scheduled for biopsy based on a suspicious mammogram and/or ultrasound. MBI results were compared to pathology.|The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease|The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease.|Completed||N/A|60|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 02:30:14.560711|2017-10-11 02:30:14.560711
NCT01687777|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-18|||May 2010||2010-05-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|msctendonrep||Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair|Treatment of Rotator Cuff Tears Using Autologous Bone Marrow Mensenchymal Stem Cell Transplantation.|Unknown status|Recruiting|Phase 2|10|Anticipated|Hospital San Carlos, Madrid||2|||f||||f||||||||||2017-10-11 02:30:14.805646|2017-10-11 02:30:14.805646
NCT01687764|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2012-09-14|||August 2011||2011-08-01|September 2012|2012-09-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children|Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children: a Randomized Clinical Trial|Unknown status|Recruiting|N/A|90|Anticipated|Hospital de Clinicas de Porto Alegre||4|||f||||||||||||||2017-10-11 02:30:14.93083|2017-10-11 02:30:14.93083
NCT01687751|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-05-22|||November 2012||2012-11-01|January 2013|2013-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients|Dexmedetomidine Compared to Midazolam for Symptom Control in Advanced Cancer Patients: A Pilot Randomized Controlled Trial (RCT)|Withdrawn||Phase 2|0|Actual|Fraser Health||2||Study design determined to be not likely feasible|f||||f||||||||||2017-10-11 02:30:15.190135|2017-10-11 02:30:15.190135
NCT01686971|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2012-09-24|||November 2012||2012-11-01|September 2012|2012-09-01|November 2013|Anticipated|2013-11-01|May 2013|Anticipated|2013-05-01||Observational|||The Needs of Cancer Survivors|The Needs of Cancer Survivors|Unknown status|Not yet recruiting|N/A|150|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 02:30:32.442514|2017-10-11 02:30:32.442514
NCT01687699|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-14|||April 2008||2008-04-01|September 2012|2012-09-01||||December 2008|Actual|2008-12-01||Interventional|||Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients||Completed||Phase 4|157|Actual|Dialysis Outcomes Heart Failure Aldactone Study Group||1|||f||||||||||||||2017-10-11 02:30:15.863742|2017-10-11 02:30:15.863742
NCT01687686|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2012-09-18|||January 2001||2001-01-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|March 2010|Actual|2010-03-01||Observational|||Differential Effects of Lipids on Cardiovascular Diseases: A CALIBER Study|Differential Effects of Total Cholesterol, Non-HDL Cholesterol and Triglycerides on Initial Presentation of Specific Cardiovascular Diseases (a CALIBER Study)|Unknown status|Active, not recruiting|N/A|175872|Actual|University College, London|||1||f||||t||||||||||2017-10-11 02:30:15.988105|2017-10-11 02:30:15.988105
NCT01687673|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-06-20|||October 5, 2012|Actual|2012-10-05|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|May 27, 2016|Actual|2016-05-27||Interventional|||Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma|Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 2|27|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:30:16.078147|2017-10-11 02:30:16.078147
NCT01687660|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2013-10-22|||September 2012||2012-09-01|May 2013|2013-05-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|AMP||Acupuncture for Migraine Prophylaxis|A Continuous Study on Abiding Effect of Acupuncture for Migraine Treatment|Unknown status|Recruiting|Phase 2/Phase 3|249|Anticipated|Chengdu University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-11 02:30:16.201225|2017-10-11 02:30:16.201225
NCT01687647|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-04-08|||September 2012||2012-09-01|April 2014|2014-04-01|December 2019|Anticipated|2019-12-01|March 2015|Anticipated|2015-03-01||Interventional|AMORCE-CBP||Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure|Interest of Morphometric Analysis of Sputum Cytology for Lung Cancer Screening in Workers Highly Exposed to Asbestos - Exploratory Analysis of Biomarkers Predictive for Lung Cancer|Enrolling by invitation||Phase 3|1000|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-11 02:30:16.32854|2017-10-11 02:30:16.32854
NCT01687634|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-05-12|||October 2012||2012-10-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Home Visiting for Low Income, Pregnant Women|Home Visiting for Low Income, Pregnant Women|Completed||N/A|203|Actual|University of California, Los Angeles||2|||f||||f||||||||Yes|Data will be be made available on the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) website.|2017-10-11 02:30:16.428347|2017-10-11 02:30:16.428347
NCT01687621|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-07-20|||September 2012||2012-09-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|OCAVS||Omphalitis Community Based Algorithm Validation Study|Omphalitis Community Based Algorithm Validation Study|Completed||N/A|1009|Actual|Boston University|||1||f||||f||||||||||2017-10-11 02:30:16.546245|2017-10-11 02:30:16.546245
NCT01687608|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2016-09-07|||September 2012||2012-09-01|September 2016|2016-09-01|November 2030|Anticipated|2030-11-01|November 2030|Anticipated|2030-11-01||Interventional|||Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B|A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adeno-associated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults With Hemophilia B|Active, not recruiting||Phase 1/Phase 2|30|Actual|Baxalta US Inc.||1|||f||||t||||||||||2017-10-11 02:30:16.633599|2017-10-11 02:30:16.633599
NCT01687595|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-01-12||2015-01-12|October 2012||2012-10-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|September 2013|Actual|2013-09-01||Interventional|||Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes|A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes|Completed||Phase 2|80|Actual|Agenus Inc.||2|||f||||t||||||||||2017-10-11 02:30:16.741037|2017-10-11 02:30:16.741037
NCT01687582|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-13|||January 2012||2012-01-01|September 2012|2012-09-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients|Clinical and Histopathological Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients|Unknown status|Recruiting|N/A|10|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-11 02:30:16.851285|2017-10-11 02:30:16.851285
NCT01687569|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2013-05-07|||September 2012||2012-09-01|May 2013|2013-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Glycaemic Responses to Cracker Snacks|Effects of Added Spice Flour on Glycaemic Responses to a Cracker Snack|Completed||N/A|27|Actual|Mondelēz International, Inc.||3|||f||||f||||||||||2017-10-11 02:30:16.945793|2017-10-11 02:30:16.945793
NCT01687556|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-23|2012-09-13|||July 2005||2005-07-01|September 2012|2012-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|EGCG||EGCG Improves Acne by Modulating Molecular Targets|Epigallocatechin-3-Gallate Improves Acne in Humans by Modulating Intracellular Molecular Targets and Inhibiting P. Acnes|Completed||N/A|35|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:30:17.018741|2017-10-11 02:30:17.018741
NCT01687543|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-10-03|||June 2012||2012-06-01|October 2017|2017-10-01|October 1, 2017|Actual|2017-10-01|June 2017|Actual|2017-06-01||Interventional|ProbiEnt||Probiotics for Reduction of Infections With Clostridium Difficile in Critically Ill Patients|Probiotics for Reduction of Colonisation With Clostridium Difficile in Antibiotic Treated Intensive Care Patients|Terminated||N/A|25|Actual|Region Skane||2||Too low inclusion rate and several sites did not comply|f||||f||||||||||2017-10-11 02:30:17.107585|2017-10-11 02:30:17.107585
NCT01687530|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2013-08-26||||||August 2013|2013-08-01||||||||Interventional|||Evaluation of the Safety and Efficacy of a Guided Bone Regeneration Membrane for the Treatment of Femoral Fractures|Randomised Controlled Trial to Evaluate the Safety Performance and Initial Efficacy of a Guided Bone Regeneration Membrane for the Treatment of Proximal (Subtrochanteric) Femoral Fractures|Unknown status|Not yet recruiting|Phase 1/Phase 2|48|Anticipated|RegeneCure, Ltd.||1|||f||||t||||||||||2017-10-11 02:30:17.230947|2017-10-11 02:30:17.230947
NCT01687517|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-14|2015-04-20|||October 2012||2012-10-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|June 2013|Actual|2013-06-01||Interventional|SARCOVAC||Efficacy and Safety of Influenza Vaccine During Sarcoidosis|Determination of the Efficacy and Safety of the Seasonal Influenza Vaccine Among Patients Suffering From Sarcoidosis.|Completed||Phase 3|190|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:30:17.468124|2017-10-11 02:30:17.468124
NCT01687504|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-10-10|||October 2012||2012-10-01|September 2012|2012-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana|Pharmacokinetics and Safety of the WHO Recommended Increased Dosages of the First-line Anti-TB Medications in Children With TB and HIV/TB Coinfection|Unknown status|Recruiting|N/A|106|Anticipated|The Miriam Hospital|||1||f||||t||||||Samples With DNA|"     EDTA plasma for analysis of drug concentrations Whole blood DNA for for genotyping of drug     metabolizing enzymes and transporters   "|||2017-10-11 02:30:17.575389|2017-10-11 02:30:17.575389
NCT01687491|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-11-02|||July 2012||2012-07-01|September 2012|2012-09-01|October 2014|Actual|2014-10-01|May 2013|Actual|2013-05-01||Interventional|AXA||Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome|Comparison of Anti-Xa Activity in the Treatment With Enoxaparin in ACS Admitted to the Emergency. Randomized Clinical Trial ENOXA ® Versus LOVENOX ®|Completed||Phase 4|179|Actual|Les Laboratoires des Médicaments Stériles||2|||f||||t||||||||||2017-10-11 02:30:17.652951|2017-10-11 02:30:17.652951
NCT01687478|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-08-23|2016-11-16||September 2012||2012-09-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||All randomized participants.|A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression|A Study to Assess the Short-Term Efficacy and Safety of Olanzapine and Fluoxetine Compared to Placebo and Fluoxetine for Nonpsychotic Treatment-Resistant Depression|Terminated||Phase 3|176|Actual|Eli Lilly and Company||2||Interim assessment: Lack of efficacy|f||||f||||||||||2017-10-11 02:30:17.763507|2017-10-11 02:30:17.763507
NCT01687465|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-01-26|||November 2012||2012-11-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|SLTRepeat||A Trial to Compare the Laser Treatment (SLT vs. ALT) in Glaucoma Patients|A Randomized Clinical Trial of Selective Laser Trabeculoplasty (SLT) in Open Angle Glaucoma Who Had Been Previously Treated With Complete SLT|Active, not recruiting||Phase 3|139|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 02:30:18.717716|2017-10-11 02:30:18.717716
NCT01687452|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-31|2014-08-29|||March 2011||2011-03-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Microparticles, Vector of Genetic Information During HIV Infection|Microparticles, Vector of Genetic Information During HIV Infection ?|Completed||N/A|15|Actual|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-11 02:30:18.81611|2017-10-11 02:30:18.81611
NCT01687439|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-09-18|||December 2008||2008-12-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)|Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer|Completed||Phase 2|15|Actual|Fudan University||1|||f||||f||||||||||2017-10-11 02:30:18.891778|2017-10-11 02:30:18.891778
NCT01687426|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-12-21|||September 2012||2012-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension|A Single-Center, Randomized, Double-Masked, Cross-Over Pilot Study Evaluating Safety and IOP Lowering Response of Brimonidine Tartrate Ophthalmic Solution Versus Vehicle in Subjects With Open Angle Glaucoma or Ocular Hypertension|Completed||Phase 1|15|Actual|Eye Therapies, LLC||2|||f||||f||||||||||2017-10-11 02:30:18.976472|2017-10-11 02:30:18.976472
NCT01687413|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-08-30|||January 10, 2013|Actual|2013-01-10|August 2017|2017-08-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|ADEPT||Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer|Adjuvant De-escalation, Extracapsular Spread, P16+, Transoral (ADEPT) Trial for Oropharynx Malignancy|Active, not recruiting||Phase 3|41|Actual|Washington University School of Medicine||2|||f||||t|t|f|||f|||||2017-10-11 02:30:19.048969|2017-10-11 02:30:19.048969
NCT01687400|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-08-18|||February 12, 2013|Actual|2013-02-12|August 2017|2017-08-01|June 23, 2018|Anticipated|2018-06-23|June 23, 2017|Actual|2017-06-23||Interventional|||Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes|Genomic Predictors of Decitabine Response in AML/MDS|Active, not recruiting||Phase 2|114|Actual|Washington University School of Medicine||1|||f||||t|t|f||||||||2017-10-11 02:30:19.142372|2017-10-11 02:30:19.142372
NCT01687387|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-03-02|||October 2012||2012-10-01|March 2017|2017-03-01|November 17, 2016|Actual|2016-11-17|November 17, 2016|Actual|2016-11-17||Interventional|EFFIKIR||Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)|Double-Blind Placebo-Controlled Randomized Phase 2 Study of IPH2102 as Maintenance Treatment in Elderly Patients With Acute Myeloid Leukemia (AML) in First Complete Remission|Completed||Phase 2|153|Actual|Innate Pharma||3|||f||||t||||||||||2017-10-11 02:30:19.227063|2017-10-11 02:30:19.227063
NCT01687374|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-09-13|||March 2012||2012-03-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Parathyroid Hormone for the Treatment of Humerus Fractures|Phase IV Study of the Effect of Parathyroid Hormone on Fractures of the Humerus|Unknown status|Recruiting|Phase 4|72|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 02:30:20.969536|2017-10-11 02:30:20.969536
NCT01687361|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-08-29|||June 2012||2012-06-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional|||Can Branched Chain Amino Acids Supplementation Reduce Muscle Damage Induced by Neuromuscular Electrical Stimulation? A Combined Functional and Metabolic Non-invasive Investigation in Healthy Humans|Can Branched Chain Amino Acids Supplementation Reduce Muscle Damage Induced by Neuromuscular Electrical Stimulation ? A Combined Functional and Metabolic Non-invasive Investigation in Healthy Humans.|Completed||N/A|20|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 02:30:21.068946|2017-10-11 02:30:21.068946
NCT01687348|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-01-22|||November 2012||2012-11-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy|Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy.|Completed||Phase 3|30|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:30:21.174338|2017-10-11 02:30:21.174338
NCT01687335|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2014-08-29|||September 2011||2011-09-01|August 2014|2014-08-01|February 2015|Anticipated|2015-02-01|September 2014|Anticipated|2014-09-01||Observational|||Impact on the Nutritional State and the Quality of Life|Conformity With European Recommendations Concerning the Nutritional Care of the Cancerous Patients Benefiting From a Treatment by Chemotherapy Impact on the Nutritional State and the Quality of Life|Unknown status|Recruiting|N/A|200|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||f||||||||||2017-10-11 02:30:21.277058|2017-10-11 02:30:21.277058
NCT01687322|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2013-03-19|||January 2013||2013-01-01|March 2013|2013-03-01||||January 2015|Anticipated|2015-01-01||Observational|||Long Term Follow-Up After Patients Underwent Total Hip Replacement||Unknown status|Active, not recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 02:30:21.397327|2017-10-11 02:30:21.397327
NCT01687309|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-06-09|||April 30, 2012|Actual|2012-04-30|June 2017|2017-06-01|July 31, 2012|Actual|2012-07-31|July 31, 2012|Actual|2012-07-31||Interventional|JAK116439||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender|A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586184 Following a Single Doseof 800mg and Repeat Oral Tablet Doses of 800mg b.d and the Effect of Food and Gender on the Pharmacokinetics of oralGSK2586184 in Healthy Subjects|Completed||Phase 1|19|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:30:21.485274|2017-10-11 02:30:21.485274
NCT01687283|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-07-17|2017-02-14||September 27, 2012||2012-09-27|April 2017|2017-04-01|November 7, 2013|Actual|2013-11-07|November 1, 2013|Actual|2013-11-01||Interventional||The analysis was performed on intent-to-treat population. This population comprised of all participants randomized to treatment and who received at least one dose of study medication. Only the participants present at the indicated time point were analyzed.|Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma|A Multicenter, Randomized, Single Blind, Active Controlled, Parallel Group Study to Determine Efficacy and Safety of Nebulized Fluticasone Propionate 1mg BID Compared With Nebulized Budesonide 2mg BID Administered for 12 Weeks in Chinese Adult and Adolescent Patients With Severe Persistent Asthma|Completed||Phase 3|316|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:30:21.809099|2017-10-11 02:30:21.809099
NCT01687270|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-12-11|2014-12-11||November 2012||2012-11-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional||Safety Analysis Set: participants were enrolled and received at least one dose of study medication.|Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant|A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of GS-7977 and Ribavirin for 24 Weeks in Subjects With Recurrent Chronic HCV Post Liver Transplant|Completed||Phase 2|40|Actual|Gilead Sciences||1|||t||||f||||||||||2017-10-11 02:30:22.849554|2017-10-11 02:30:22.849554
NCT01687257|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-08-05|2016-01-27||July 2012||2012-07-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|January 2015|Actual|2015-01-01||Interventional||Participants who were randomized and received at least 1 dose of study drug|Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation|A Phase 2, Multicenter, Open-Label, Randomized Study to Investigate the Safety and Efficacy of GS-7977 and Ribavirin Administered for 48 Weeks in Patients Infected With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation|Completed||Phase 2|50|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 02:30:23.455371|2017-10-11 02:30:23.455371
NCT01687244|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-06-23|2017-01-09||September 2012||2012-09-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer|A Phase 2, Randomized, Open Label, Parallel Arm Study to Evaluate the Safety and Efficacy of rAd-IFN/Syn3 Following Intravesical Administration in Subjects With High Grade, BCG Refractory or Relapsed Superficial Bladder Cancer|Completed||Phase 2|40|Actual|FKD Therapies Oy||2|||f||||t||||||||No|A manuscript will be published on the results of the study|2017-10-11 02:30:24.780907|2017-10-11 02:30:24.780907
NCT01687231|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-05-08|||April 2009||2009-04-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets|A Randomized Pilot Study Comparing Infection Rates in Myeloablative Allogeneic Stem Cell Transplant Patients Receiving a Non-Neutropenic Diet or a Neutropenic Diet|Completed||N/A|47|Actual|Duke University||2|||f||||t||||||||||2017-10-11 02:30:25.863791|2017-10-11 02:30:25.863791
NCT01687218|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-03-01|2016-12-07||September 25, 2013|Actual|2013-09-25|March 2017|2017-03-01|May 26, 2015|Actual|2015-05-26|May 26, 2015|Actual|2015-05-26||Interventional||Includes all participants enrolled.|Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel|A Phase 2 Randomized Sequence Open Label Expanded Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel|Completed||Phase 2|195|Actual|CONRAD||6|||f||||t||||||||||2017-10-11 02:30:25.995|2017-10-11 02:30:25.995
NCT01687205|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2015-12-14|||November 2012||2012-11-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel|Phase 1 Evaluation of the Impact of Coitus on Pharmacokinetics and Pharmacodynamics of Tenofovir 1% Gel Following Pericoital or Daily Gel Dosing|Completed||Phase 1|31|Actual|CONRAD||2|||f||||t||||||||||2017-10-11 02:30:28.542133|2017-10-11 02:30:28.542133
NCT01687192|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-07-30|||October 2012||2012-10-01|July 2015|2015-07-01|November 2016|Anticipated|2016-11-01|May 2015|Actual|2015-05-01||Interventional|PRIMAVERA||Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.|Multicenter Clinical Trial Evaluating the Immunological Response of Vaccination Against Infection by Human Papillomavirus (HPV) 6, 11, 16, 18 in Girls Receiving Immunosuppressive Therapy.|Unknown status|Active, not recruiting|Phase 2|37|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-11 02:30:28.767406|2017-10-11 02:30:28.767406
NCT01687166|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-01-31|||October 2012||2012-10-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ZERO-AF||Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation|Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation|Completed||N/A|398|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 02:30:29.030403|2017-10-11 02:30:29.030403
NCT01687140|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2012-09-13|||July 2012||2012-07-01|September 2012|2012-09-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|DCS||The Use of D-Cycloserine to Augment CBT for Pediatric OCD|The Use of D-Cycloserine to Augment Intensive Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder|Unknown status|Recruiting|Phase 2|26|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:30:29.380072|2017-10-11 02:30:29.380072
NCT01687127|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-05-01|||July 1, 2017|Anticipated|2017-07-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Impact of High-dose Folic Acid Supplementation on Pathways Linked to DNA Formation|Metabolic Consequences of High-Dose Folic Acid Supplementation on Kinetics of 1-Carbon Metabolism|Not yet recruiting||N/A|25|Anticipated|University of British Columbia||2|||f||||f|f|f||||||||2017-10-11 02:30:29.481208|2017-10-11 02:30:29.481208
NCT01687114|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-12-10|2014-11-13||September 2012||2012-09-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|March 2013|Actual|2013-03-01||Interventional|||Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products|Urinary Proanthocyanidin (PAC) A2 as a Biomarker of Compliance to Intake of Cranberry Products - A Pilot Study|Completed||N/A|5|Actual|Tufts University||1|||f||||f||||||||||2017-10-11 02:30:29.634061|2017-10-11 02:30:29.634061
NCT01687101|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-05-05|2015-02-19||May 2012||2012-05-01|May 2017|2017-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||STOPAIN in the Treatment of a Single Migraine Attack|A Study to Evaluate the Efficacy and Tolerability of STOPAIN in the Treatment of a Single Migraine Attack|Completed||N/A|32|Actual|Thomas Jefferson University||1|||f||||f||||||||||2017-10-11 02:30:30.50654|2017-10-11 02:30:30.50654
NCT01687088|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-10-21|2014-07-14||July 2011||2011-07-01|October 2014|2014-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Smell Sensitivity in Chronic Migraine: A Case-Control Study|Olfactory Acuity in Chronic Migraine: A Case-Control Study|Completed||N/A|100|Actual|Thomas Jefferson University|||2||f||||f||||||||||2017-10-11 02:30:30.781606|2017-10-11 02:30:30.781606
NCT01687075|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-06-27|||October 2012||2012-10-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||CRE8 in All Comers Patients|CRE8 in All Comers Patients|Completed||N/A|215|Actual|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||No||2017-10-11 02:30:31.090639|2017-10-11 02:30:31.090639
NCT01687062|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2013-10-11|||September 2012||2012-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2012|Actual|2012-10-01||Interventional|||Iron Absorption From Tef-injera in Women of Reproductive Age|Iron Absorption From Tef-injera in Women of Reproductive Age|Completed||N/A|40|Actual|Swiss Federal Institute of Technology||5|||f||||f||||||||||2017-10-11 02:30:31.21309|2017-10-11 02:30:31.21309
NCT01687049|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2012-11-06|||January 2013||2013-01-01|November 2012|2012-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance|A Prospective Study of Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance|Not yet recruiting||Phase 2|60|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 02:30:31.323272|2017-10-11 02:30:31.323272
NCT01687036|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-01-08|2013-07-19||September 2012||2012-09-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System|Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System|Completed||N/A|10|Actual|AFreeze GmbH||1|||f||||t||||||||||2017-10-11 02:30:31.448433|2017-10-11 02:30:31.448433
NCT01687023|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-01-03|||July 2011||2011-07-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|May 2016|Actual|2016-05-01||Observational|||A Wearable System to Monitor Tai Chi Practice|A Wearable System to Monitor Tai Chi Practice|Active, not recruiting||N/A|24|Anticipated|Spaulding Rehabilitation Hospital|||1||f||||f||||||||||2017-10-11 02:30:31.888434|2017-10-11 02:30:31.888434
NCT01687010|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2012-09-17|||March 2012||2012-03-01|August 2012|2012-08-01|October 2012|Anticipated|2012-10-01|||||Observational|||Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.||Unknown status|Recruiting|N/A|300|Anticipated|Southeast University, China|||1||f||||||||||||||2017-10-11 02:30:31.974916|2017-10-11 02:30:31.974916
NCT01686997|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-06-02|||July 2012||2012-07-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|Elegance||Effect of Long Biliopancreatic Limb RYGB on Weight Loss and Comorbidities|'Effect of Long biLiopancrEatic Limb lenGth in lAparoscopic Roux-eN-Y Gastric Bypass on Weight Loss and Comorbidities in Patients With Morbid obEsity: a Prospective Randomized Control Trial'|Completed||N/A|280|Actual|Rijnstate Hospital||4|||f||||f||||||||||2017-10-11 02:30:32.281299|2017-10-11 02:30:32.281299
NCT01686984|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-05-13|||September 2012||2012-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Influence of Inspiratory Flow Pattern on Exchange of Carbon Dioxide in Humans Without Primary Lung Disease|Influence of Inspiratory Flow Pattern on Exchange of Carbon Dioxide in Humans Without Primary Lung Disease|Completed||N/A|8|Actual|Region Skane||1|||f||||f||||||||||2017-10-11 02:30:32.374568|2017-10-11 02:30:32.374568
NCT00005171|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||December 1984||1984-12-01|June 2000|2000-06-01|March 1993|Actual|1993-03-01|||||Observational|||Cardiovascular Risk Factors in United States Adolescents and Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.417491|2017-10-11 04:26:35.417491
NCT01686958|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-11-04|||March 2013||2013-03-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|March 2014|Actual|2014-03-01||Interventional|||Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer|Phase 1 Study: A Prospective, Multi-center, Single Arm Study - Evaluation of the Safety and Feasibility of MRI-guided Transurethral Ultrasound Therapy for the Ablation of Prostate Tissue in Patients With Localized Prostate Cancer|Active, not recruiting||Phase 1|30|Anticipated|Profound Medical Inc.||1|||f||||t||||||||||2017-10-11 02:30:32.503287|2017-10-11 02:30:32.503287
NCT01686945|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-02-23|||September 19, 2012|Actual|2012-09-19|February 2017|2017-02-01|April 8, 2013|Actual|2013-04-08|April 8, 2013|Actual|2013-04-08||Interventional|||Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes|Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes|Completed||Phase 1|107|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 02:30:32.606307|2017-10-11 02:30:32.606307
NCT01686932|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-02-02|2015-08-31||November 2012||2012-11-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|CGM-VISIT||Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function|Multicentric Cross-over Trial to Assess the Glycemic Profiles on 8 Weeks of Vildagliptin and Sitagliptin Treatment, Each, in Type-2 Diabetic Patients With a Pre-existing Cardiovascular Disease Pre-treated With Insulin, Using a PROBE-design|Completed||Phase 4|51|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:30:32.736897|2017-10-11 02:30:32.736897
NCT01686919|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-01-20|||December 2012||2012-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Milk-free Diet on Weight and Irritable Bowel Syndrome in Morbid Obesity|Effect of Milk-free Diet on Weight and Irritable Bowel Syndrome in Morbid Obesity|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-10-11 02:30:33.414835|2017-10-11 02:30:33.414835
NCT01686906|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-06-02|||January 2011||2011-01-01|June 2015|2015-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Isolated Bowman Layer Graft for Reducing and Stabilizing Advanced Keratoconus|Mid-stromal Isolated Bowman Layer Graft Implantation to Reduce and Stabilize Advanced Keratoconus|Recruiting||N/A|100|Anticipated|Netherlands Institute for Innovative Ocular Surgery||1|||f||||||||||||||2017-10-11 02:30:33.50673|2017-10-11 02:30:33.50673
NCT01686893|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2012-09-18|||February 2009||2009-02-01|September 2012|2012-09-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Interventional|STIT-1||Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPD|STIT-1 Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPD|Unknown status|Recruiting|Phase 1|50|Anticipated|Medical University Innsbruck||2|||f||||f||||||||||2017-10-11 02:30:33.608475|2017-10-11 02:30:33.608475
NCT01686880|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-06-30|||September 2012||2012-09-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TRYPHON||Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver|Treatment With Yttrium90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver|Terminated||Phase 2|10|Actual|Jules Bordet Institute||1||poor recruitment and an unexpected low treatment rate|f||||f||||||||||2017-10-11 02:30:33.758606|2017-10-11 02:30:33.758606
NCT01686867|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-04-01|||April 2012||2012-04-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Feasibility Intervention Trial of Two Types of Improved Cookstoves in Three Developing Countries|Feasibility Intervention Trial of Two Types of Improved Cookstoves in Three Developing Countries|Completed||N/A|137|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 02:30:33.896177|2017-10-11 02:30:33.896177
NCT01686841|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-06-20|||September 2012|Actual|2012-09-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum Production|PILOT STUDY OF NON-INVASIVE FAT LAYER REDUCTION IN THE FLANKS OF ASIAN PATIENTS WITH THE COOLCURVE+ APPLICATOR|Completed||N/A|11|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 02:30:34.12807|2017-10-11 02:30:34.12807
NCT01686828|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-06-12|2017-02-16||June 2013||2013-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|May 2015|Actual|2015-05-01||Interventional|T-IR||T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin|Androgen-mediated Pathways in the Regulation of Insulin Sensitivity in Men|Active, not recruiting||Phase 1/Phase 2|53|Actual|University of Washington||4|||f||||t||||||||Undecided||2017-10-11 02:30:34.284905|2017-10-11 02:30:34.284905
NCT01686815|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-04-15|||October 2012||2012-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Cross-Sectional Iloperidone IVGTT|Cross-sectional Study to Compare Glucose and Lipid Metabolism in SMI Subjects Treated With Either Fanapt (Iloperidone), Zyprexa (Olanzapine), or Risperdal (Risperidone)|Unknown status|Recruiting|N/A|60|Anticipated|Massachusetts General Hospital|||3||f||||f||||||Samples Without DNA|"     Samples will be retained to test IL-6 and other inflammatory markers.   "|||2017-10-11 02:30:35.57403|2017-10-11 02:30:35.57403
NCT01686802|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-12-27|||September 2012||2012-09-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Post-operative Oral Morphine Versus Ibuprofen|Oral Morphine Versus Ibuprofen for Post-operative Pain Management in Children: a Randomized Controlled Study|Completed||Phase 2|132|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 02:30:35.699374|2017-10-11 02:30:35.699374
NCT01686620|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-07-22||2015-07-22|August 2012||2012-08-01|July 2015|2015-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)|A Randomized, Parallel Group Trial Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes Using Basal-bolus Insulin Injection Therapy|Completed||Phase 2|132|Actual|Biodel||2|||f||||f||||||||||2017-10-11 02:30:39.102387|2017-10-11 02:30:39.102387
NCT01686789|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-02-23|||January 2011||2011-01-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4|Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4|Completed||Phase 4|181|Actual|King Abdulaziz Medical City||2|||f||||t||||||||||2017-10-11 02:30:35.823159|2017-10-11 02:30:35.823159
NCT01686776|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2013-01-16|||September 2012||2012-09-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA|A Prospective Validation Study in Healthy Volunteers, Patients With Acute Inflammation and Patients Scheduled for Major Abdominal Surgery|Unknown status|Recruiting|Phase 3|48|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 02:30:35.955558|2017-10-11 02:30:35.955558
NCT01686763|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-03-15|||January 2004||2004-01-01|December 2009|2009-12-01||||December 2008|Actual|2008-12-01||Observational|||Endothelin-1 and Methabolites Concentrations in Mycrodialysis and Cerebrospinal Fluid in Subarachnoid Hemorrhage Patients||Completed||N/A|35|Actual|University of Turin, Italy|||1||f||||||||||||||2017-10-11 02:30:36.074155|2017-10-11 02:30:36.074155
NCT01686750|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-07-28|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations|A Cluster Randomized Trial of Integrated Care Centers to Improve Access to HIV Prevention, Testing, and Treatment Services Among High-Risk Vulnerable Populations in India|Completed||N/A|48272|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:30:36.152927|2017-10-11 02:30:36.152927
NCT01686737|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-02-04|||November 2012||2012-11-01|February 2013|2013-02-01|July 2014|Anticipated|2014-07-01|January 2014|Anticipated|2014-01-01||Interventional|IFaB||Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients|Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients|Withdrawn||N/A|0|Actual|Universität Duisburg-Essen||3||Recruitment problems|f||||f||||||||||2017-10-11 02:30:36.263596|2017-10-11 02:30:36.263596
NCT01686724|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-05-08|||September 2012||2012-09-01|May 2014|2014-05-01|June 2016|Anticipated|2016-06-01|November 2015|Anticipated|2015-11-01||Interventional|||Study of the Collaborative Life Skills Program|Efficacy of the Collaborative Life Skills Program|Unknown status|Recruiting|N/A|504|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:30:36.371069|2017-10-11 02:30:36.371069
NCT01686711|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-05-16|||September 2012||2012-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322|A Phase 4, Multicenter, Randomized, Double-blind, Parallel-group, Comparative Study to Evaluate the Efficacy and Safety of AD-4833 When Orally Administered Once Daily as add-on to SYR-322 Versus SYR-322 Alone in the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control Despite Treatment With SYR-322 in Addition to Diet and/or Exercise Therapy|Completed||Phase 4|207|Actual|Takeda||3|||f||||f||||||||||2017-10-11 02:30:36.480883|2017-10-11 02:30:36.480883
NCT01686698|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-05-18|||March 2013||2013-03-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With Cirrhosis|Study of the Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With Cirrhosis|Completed||Phase 4|40|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-11 02:30:36.610358|2017-10-11 02:30:36.610358
NCT01686685|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-04-19|||September 2013||2013-09-01|September 2012|2012-09-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Observational|ASD-CXCR4||Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months|Study of Correlation Between Expression of Proteins That Are Essential for Embryonic Brain Development and Neurodevelopmental Outcomes at 2 Years of Age in Premature Infants.|Recruiting||N/A|400|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples Without DNA|"     blood samples. expression of proteins or RNA will be determined from the blood.   "|||2017-10-11 02:30:36.689342|2017-10-11 02:30:36.689342
NCT01686672|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-10-17|||October 2012||2012-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2013|Actual|2013-09-01||Interventional|Be In Charge||Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis|Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis|Completed||N/A|12|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 02:30:36.774126|2017-10-11 02:30:36.774126
NCT01686659|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-11-27|||September 2012||2012-09-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|September 2016|Anticipated|2016-09-01||Interventional|NACHO||Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management|Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management|Recruiting||N/A|470|Anticipated|Society for the Advancement of Blood Management, Inc||2|||f||||t||||||||||2017-10-11 02:30:36.894251|2017-10-11 02:30:36.894251
NCT01686646|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2014-11-20|2013-08-29||November 2011||2011-11-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Two Doses of a Common Cold Treatment on Alertness|Effects of Two Doses of a Common Cold Treatment on Cognitive Function|Completed||Phase 3|240|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:30:37.198657|2017-10-11 02:30:37.198657
NCT01686633|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-11-18|2014-04-03||September 2012||2012-09-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.|A Randomized, Double-Blind, Parallel Group, Multicenter Study of Fluticasone Furoate/Vilanterol 200/25 mcg Inhalation Powder, Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, and Fluticasone Furoate 100 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents|Completed||Phase 3|1040|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:30:37.989243|2017-10-11 02:30:37.989243
NCT01686022|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-09-13|||October 2012||2012-10-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Grass Sensitisation and Allergic Rhinitis in Thai Patients|The Study of Allergens From Grass and Weed Which Are Causes of Allergic Rhinitis in Thai Patients|Completed||N/A|40|Actual|Mahidol University|||1||f||||f||||||Samples Without DNA|"     Serum   "|Undecided||2017-10-11 02:30:46.881505|2017-10-11 02:30:46.881505
NCT01686607|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-09-01|||October 1, 2012|Actual|2012-10-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|MYCOS||Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents|A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents|Active, not recruiting||N/A|40110|Actual|Astellas Pharma Inc|||2||f||||f||||||||||2017-10-11 02:30:39.264309|2017-10-11 02:30:39.264309
NCT01686594|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-01-11|||February 2013||2013-02-01|January 2017|2017-01-01|October 2022|Anticipated|2022-10-01|October 2021|Anticipated|2021-10-01||Interventional|M_PUVA_2012||PUVA Maintenance Therapy in Mycosis Fungoides|A Multi-center, Randomized Study on Oral 8-methoxypsoralen Plus UVA With or Without Maintenance Therapy in Mycosis Fungoides EORTC/ISCL Stage IA to IIB|Active, not recruiting||Phase 3|28|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 02:30:39.384237|2017-10-11 02:30:39.384237
NCT01686581|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2016-12-12|||July 2015||2015-07-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine||Completed||Phase 4|644|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:30:39.509169|2017-10-11 02:30:39.509169
NCT01686568|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-01-18|2015-06-16||December 21, 2012|Actual|2012-12-21|January 2017|2017-01-01|June 8, 2015|Actual|2015-06-08|October 30, 2014|Actual|2014-10-30||Interventional||Baseline characteristics were reported for participants who received treatment and did not withdraw from the study.|Omega-3 Fatty Acids and Insulin Sensitivity|Dietary Omega-3 Fatty Acids as a Therapeutic Strategy in Insulin Resistant Humans|Completed||Phase 3|31|Actual|Mayo Clinic||2|||f||||f|t|f||||||||2017-10-11 02:30:40.049352|2017-10-11 02:30:40.049352
NCT01686555|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-07-07|||November 2012||2012-11-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)|Assessment of the Safety, Tolerability, and Pharmacokinetics of ABT-199 After Single and Multiple Ascending Doses in Female Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 1|97|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 02:30:40.55872|2017-10-11 02:30:40.55872
NCT01686542|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2017-07-14|||June 2012|Actual|2012-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||CPVI Plus Renal Sympathetic Modification Versus CPVI Alone for AF（Atrial Fibrillation） Ablation|Circumferential Pulmonary Vein Isolation (CPVI) Plus Renal Sympathetic Modification Versus CPVI Alone for AF Ablation: a Pilot Study|Recruiting||N/A|100|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||||2017-10-11 02:30:40.697239|2017-10-11 02:30:40.697239
NCT01686529|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-12-05|||March 2010||2010-03-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Interventional|||Bevacizumab for Primary Pterygium Treatment|Conjunctival Autografting Alone or Combined With Subconjunctival Bevacizumab for Primary Pterygium Treatment.|Completed||Phase 1|49|Actual|Instituto de Oftalmología Fundación Conde de Valenciana||3|||f||||f||||||||||2017-10-11 02:30:40.808609|2017-10-11 02:30:40.808609
NCT01686516|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-17|||June 2011||2011-06-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Synaptic Plasticity Imaging With Diffusion MRI|Methodological Study of Synaptic Plasticity Imaging With Diffusion MRI|Unknown status|Recruiting|N/A|35|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-10-11 02:30:40.935681|2017-10-11 02:30:40.935681
NCT01686503|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-13|2015-01-22|2015-01-13||September 2012||2012-09-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|IDIPV||Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects|Comparison of the Immunogenicity of Various Inactivated Polio Vaccine Booster Doses by Intradermal vs. Intramuscular Routes in HIV-Infected Subjects|Completed||Phase 2|231|Actual|Eastern Virginia Medical School|Higher baseline antibody titers than expected making it more difficult to detect differences between the study groups.|4|||f||||f||||||||||2017-10-11 02:30:41.1073|2017-10-11 02:30:41.1073
NCT01686490|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-09-17|||December 2007||2007-12-01|September 2012|2012-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|AICD||LifeSkills Video Training in Patients About to Receive an Automatic Implantable Cardioverter-Defibrillator (AICD)|LifeSkills Video Training in Patients About to Receive an Automatic Implantable Cardioverter-Defibrillator|Completed||Phase 1|37|Actual|Williams LifeSkills||1|||f||||t||||||||||2017-10-11 02:30:42.122092|2017-10-11 02:30:42.122092
NCT01686477|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-08-27|||August 2013||2013-08-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|PREMFOOD||PREterM FOrmula Or Donor Breast Milk for Premature Babies|Preterm Formula or Donor Breast Milk to Make up Any Shortfall in Mother's Own Milk|Unknown status|Recruiting|N/A|66|Anticipated|Imperial College London||3|||f||||f||||||||||2017-10-11 02:30:42.234165|2017-10-11 02:30:42.234165
NCT01686464|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-09-12|||June 1998||1998-06-01|September 2012|2012-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy|A New Clinical Therapy for Bell's Palsy|Completed||N/A|882|Actual|Wenzhou Medical University||2|||f||||t||||||||||2017-10-11 02:30:42.371041|2017-10-11 02:30:42.371041
NCT01686451|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2014-04-20|2013-10-08||August 2012||2012-08-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||A total of 60 patients with dyslipidemia and moderate to low cardiovascular disease (CVD) risk were randomly assigned in an open label fashion to receive either simvastatin (n=33) 20 mg daily or xuezhikang (n=27) 600 mg twice daily. All 60 patients were included in baseline analysis.|The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin|Comparison Between XueZhiKang and Simvastatin on Fatigue: a Single-center, Randomized Clinical Trial|Completed||Phase 4|60|Actual|Wenzhou Medical University|There are some limitations to this research. First, the sample size was relative small. Second, the follow-up period was short (4 weeks).|2|||f||||f||||||||||2017-10-11 02:30:42.48638|2017-10-11 02:30:42.48638
NCT01686438|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-07-12|||April 1, 2013|Actual|2013-04-01|July 2017|2017-07-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2016|Actual|2016-11-30||Interventional|VIP||Telemedicine Management of Chronic Insomnia|Telemedicine Management of Veterans With PTSD and Chronic Insomnia|Active, not recruiting||N/A|225|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 02:30:43.393874|2017-10-11 02:30:43.393874
NCT01686009|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-02-03|||October 2012||2012-10-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|INKA||Intra-nasal Ketamine for Analgesia in the Emergency Department|Intra-nasal Ketamine for Analgesia in the Emergency Department|Completed||Phase 4|40|Actual|Lions Gate Hospital||1|||f||||f||||||||||2017-10-11 02:30:46.961868|2017-10-11 02:30:46.961868
NCT01686425|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-06-12|||July 2012||2012-07-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|PETRUS||Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary Drainage|Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary Drainage in Advanced Biliary Tract Malignancy That Failed ERCP (PETRUS Study): A Randomized Pilot Study|Unknown status|Recruiting|N/A|60|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 02:30:43.506137|2017-10-11 02:30:43.506137
NCT01686412|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-09-10|||July 2012||2012-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency|Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency in Patients With Breast and Advanced Hepatocellular Cancer.|Completed||N/A|60|Actual|Hospital Sirio-Libanes||2|||f||||t||||||||||2017-10-11 02:30:43.621981|2017-10-11 02:30:43.621981
NCT01686399|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2015-03-22|||June 2015||2015-06-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||A Sustainable Diet for Hadassah Employees Workers|A Sustainable Diet for Hadassah Employees|Unknown status|Not yet recruiting|N/A|450|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 02:30:43.715342|2017-10-11 02:30:43.715342
NCT01686386|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-04-04|||February 2010||2010-02-01|April 2013|2013-04-01|October 2013|Anticipated|2013-10-01|April 2012|Actual|2012-04-01||Interventional|||Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma|A Phase I/II Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, (BdL) for the Treatment of Patients With Relapsed Myeloma.|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Gruppo Italiano Studio Linfomi||1|||f||||f||||||||||2017-10-11 02:30:43.805725|2017-10-11 02:30:43.805725
NCT01686373|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-09-18|||April 2012||2012-04-01|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|tDCS||Brain Stimulation and Aphasia Treatment|Transcranial Direct Current Stimulation and Aphasia Treatment Outcomes|Recruiting||Phase 2|75|Anticipated|University of South Carolina||2|||f||||t||||||||||2017-10-11 02:30:43.927732|2017-10-11 02:30:43.927732
NCT01686360|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-07-20|||September 2012||2012-09-01|July 2017|2017-07-01|December 18, 2012|Actual|2012-12-18|December 18, 2012|Actual|2012-12-18||Interventional|||Communicating Objective Risk for Personalized Decision Making About Mammography|Communicating Objective Risk for Personalized Decision Making About Mammography|Completed||N/A|1560|Actual|University of Pennsylvania||8|||f||||f||||||||||2017-10-11 02:30:44.0665|2017-10-11 02:30:44.0665
NCT01686347|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-01-22|||June 2012||2012-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|epidarc||Epidural Analgesia and Troubles of Fetal Cardiaq Rythm : Effect of the Systemic Transfer of Ropivacaine and Sufentanil|Epidural Analgesia and Troubles of Fetal Cardiaq Rythm : Effect of the Systemic Transfer of Ropivacaine and Sufentanil|Completed||Phase 4|40|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 02:30:44.144356|2017-10-11 02:30:44.144356
NCT01686334|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-05-04|||October 2012||2012-10-01|May 2017|2017-05-01||||July 2024|Anticipated|2024-07-01||Interventional|WIDEA||Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission|Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial|Recruiting||Phase 2|138|Anticipated|University Hospital, Antwerp||2|||f||||||||||||||2017-10-11 02:30:44.380456|2017-10-11 02:30:44.380456
NCT01686321|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2013-02-21|||May 2012||2012-05-01|February 2013|2013-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|B-R-ENDA||Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma|"Subcutaneous Rituximab and Intravenous Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients (Slow Go) With Aggressive CD20-positive B-cell"|Unknown status|Recruiting|Phase 2|100|Anticipated|University of Göttingen||1|||f||||t||||||||||2017-10-11 02:30:44.482438|2017-10-11 02:30:44.482438
NCT01686308|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-02-09|||February 2011||2011-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CIRCAT||The Effect of Cataract on Photoentrainment of the Circadian Rhythm in Humans|The Effect of Cataract on Photoentrainment of the Circadian Rhythm in Humans|Completed||N/A|76|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-11 02:30:44.597524|2017-10-11 02:30:44.597524
NCT01686295|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-09-12|||July 2012||2012-07-01|September 2012|2012-09-01|May 2013|Anticipated|2013-05-01|April 2013|Anticipated|2013-04-01||Interventional|||24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness|A Randomized, Double -Blind,, Sham-Device-Controlled, Multicenter, 24-Week Clinical Trial to Evaluate the Safety and Effectiveness of the iRestore ™ Hair Rejuvenation System in the Treatment of Male and Female Androgeneticalopecia|Unknown status|Recruiting|N/A|100|Anticipated|Freedom Laser Therapy, Inc.||2|||f||||f||||||||||2017-10-11 02:30:44.677379|2017-10-11 02:30:44.677379
NCT01686282|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-01-12|||January 2012||2012-01-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|March 2013|Actual|2013-03-01||Interventional|||Blueberry Consumption Improves Vascular Function and Lowers Blood Pressure in Postmenopausal Women With Pre- and Stage 1-hypertension|Daily Incorporation of Blueberries Into a Diet Favorably Improves Vascular Function and Lowers Aortic Blood Pressure in Postmenopausal Women With Pre- and Stage 1-hypertension.|Completed||Phase 2|48|Actual|Florida State University||2|||f||||t||||||||||2017-10-11 02:30:44.765488|2017-10-11 02:30:44.765488
NCT01686269|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-06|2012-09-12|||March 2007||2007-03-01|January 2007|2007-01-01||||||||Interventional|||Endothelial Progenitor Cells|Mobilization of Endothelial Progenitor Cells in Patients With Coronary Artery Bypass Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Far Eastern Memorial Hospital|||||f||||t||||||||||2017-10-11 02:30:44.84898|2017-10-11 02:30:44.84898
NCT01686256|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-12|||August 2001||2001-08-01|September 2012|2012-09-01||||August 2004|Actual|2004-08-01||Interventional|||Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer|A Multi-center Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer|Completed||Phase 1|12|Actual|Endocyte||1|||f||||||||||||||2017-10-11 02:30:44.918071|2017-10-11 02:30:44.918071
NCT01686243|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-09-12|||July 2012||2012-07-01|September 2012|2012-09-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Real-time Ultrasound-guided Paramedian Epidural Access: Evaluation of a Novel In-plane Transverse View Technique||Unknown status|Recruiting|N/A|20|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 02:30:44.991121|2017-10-11 02:30:44.991121
NCT01686230|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2014-09-07|||July 2012||2012-07-01|September 2014|2014-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|ASAP||Acupuncture in Patients With Stable Angina Pectoris|Effect of Acupuncture in Patients With Stable Angina Pectoris: an Open Label, Randomized, Controlled,Multi-center Clinical Study|Unknown status|Recruiting|N/A|404|Anticipated|Chengdu University of Traditional Chinese Medicine||4|||f||||t||||||||||2017-10-11 02:30:45.073644|2017-10-11 02:30:45.073644
NCT01686217|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2015-08-31|||June 2012||2012-06-01|August 2015|2015-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K|A Phase 1, Open-Label, Randomized, Parallel Dose Group Study to Compare the Pharmacokinetic Profiles of Three Different Strengths of ASP015K Extended Release Formulation With ASP015K Immediate Release Formulation and to Evaluate Food Effect on Extended Release Strengths in Healthy Volunteers|Completed||Phase 1|30|Actual|Astellas Pharma Inc||9|||f||||f||||||||||2017-10-11 02:30:45.185467|2017-10-11 02:30:45.185467
NCT01686204|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-09-29|||September 2012||2012-09-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|September 30, 2016|Actual|2016-09-30||Interventional|||Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt|Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt|Completed||N/A|128|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-11 02:30:45.358732|2017-10-11 02:30:45.358732
NCT01686191|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-12-14|||August 2012||2012-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|||Genetic Predictors of Renal Dysfunction Following Heart Transplantation|Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation|Recruiting||N/A|300|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     Buccal cell and blood sample for genomic DNA   "|||2017-10-11 02:30:45.473851|2017-10-11 02:30:45.473851
NCT01686178|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-06-14|||September 2012||2012-09-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Countering Young Adult Tobacco Marketing in Bars|Countering Young Adult Tobacco Marketing in Bars|Active, not recruiting||N/A|25200|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:30:45.572794|2017-10-11 02:30:45.572794
NCT01686165|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-05-26|||August 31, 2012|Actual|2012-08-31|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|February 9, 2016|Actual|2016-02-09||Interventional|||Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL|A Phase II Exploratory Study of PXD-101(Belinostat) Followed by Zevalin in Patients With Relapsed Aggressive High-Risk Lymphoma|Active, not recruiting||Phase 2|5|Actual|University of Arizona||1|||f||||t||||||||||2017-10-11 02:30:45.66513|2017-10-11 02:30:45.66513
NCT01686152|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2013-12-05|||September 2012||2012-09-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis|A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis of the Face or Balding Scalp|Completed||Phase 3|589|Actual|Teva Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 02:30:45.783244|2017-10-11 02:30:45.783244
NCT01686139|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-01-26|||March 2016||2016-03-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers|Phase 1 Study: Treatment of Patients With Diabetic Foot Complications With Allogeneic Bone Marrow Derived Mesenchymal Stromal Cells (ABMD-MSC)|Not yet recruiting||Phase 1|12|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 02:30:45.918326|2017-10-11 02:30:45.918326
NCT01686126|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-03-28|||October 2012||2012-10-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|feMMe||Improving the Treatment for Women With Early Stage Cancer of the Uterus|A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients With Early Stage Cancer of the Endometrium|Recruiting||Phase 2|165|Anticipated|Queensland Centre for Gynaecological Cancer||3|||f||||t||||||||No||2017-10-11 02:30:46.05474|2017-10-11 02:30:46.05474
NCT01686113|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-11-20|||May 2012||2012-05-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Free Fatty Acids: Short Exposure Study|Free Fatty Acids: Short Exposure Study|Completed||N/A|100|Anticipated|Purdue University||2|||f||||t||||||||||2017-10-11 02:30:46.265317|2017-10-11 02:30:46.265317
NCT01686100|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-18|||June 2010||2010-06-01|September 2012|2012-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||CT-angiographic Follow up of Patients That Underwent Coronary Bypass Surgery Between 1993-1997|CT-angiographic Follow Upp of Patients That Underwent Coronary Bypass Surgery Between 1993-1997. A Randomized Longitudinal Trial.|Completed||N/A|52|Actual|Örebro County Council||2|||f||||f||||||||||2017-10-11 02:30:46.387801|2017-10-11 02:30:46.387801
NCT01686087|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-08-21|||October 2012||2012-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Interventional|||Attaining and Maintaining Wellness in Obsessive-compulsive Disorder|Attaining and Maintaining Wellness in OCD|Active, not recruiting||Phase 4|140|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 02:30:46.496751|2017-10-11 02:30:46.496751
NCT01686074|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-09-19|||September 2012||2012-09-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Motor Control in Chronic Fatigue Syndrome and Fibromyalgia|Motor Control in Chronic Fatigue Syndrome and Fibromyalgia.|Completed||N/A|90|Actual|Norwegian University of Science and Technology|||4||f||||f||||||||||2017-10-11 02:30:46.606525|2017-10-11 02:30:46.606525
NCT01686061|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-04-07|||September 2012||2012-09-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Blepharospasm Patient Survey for Patients With Blepharospasm|Blepharospasm Patient Survey: A Structured Interview Evaluating Previous and Current incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA Treatment for Patients With Blepharospasm|Completed||N/A|124|Actual|Merz Pharmaceuticals, LLC|||1||f||||f||||||||||2017-10-11 02:30:46.703676|2017-10-11 02:30:46.703676
NCT01686048|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-10-06|||April 2015||2015-04-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel||Completed||N/A|120|Anticipated|Meir Medical Center|||1||f||||||||||||||2017-10-11 02:30:46.804117|2017-10-11 02:30:46.804117
NCT01684696|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-06-15|||August 2016||2016-08-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|VILC||Virtual Intervention for Lung Cancer|Virtual Intervention for Lung Cancer|Not yet recruiting||N/A|50|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:31:12.458183|2017-10-11 02:31:12.458183
NCT01685983|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-05-26|2016-03-02||August 30, 2011|Actual|2011-08-30|May 2017|2017-05-01|November 6, 2020|Anticipated|2020-11-06|January 24, 2013|Actual|2013-01-24||Interventional|||A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer|A Phase 2 Open Label Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy.|Active, not recruiting||Phase 2|82|Actual|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-11 02:30:47.6748|2017-10-11 02:30:47.6748
NCT01685970|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-14|||September 2012||2012-09-01|September 2012|2012-09-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|SP2HP||Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy|Comparison of Using the Same-day 2 Sachets Picosulfate Versus High Volume PEG Bowel Preparation for Afternoon Colonoscopy|Unknown status|Recruiting|Phase 3|200|Anticipated|Inje University||2|||f||||t||||||||||2017-10-11 02:30:48.399247|2017-10-11 02:30:48.399247
NCT01685957|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-08-17|||October 2012|Actual|2012-10-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|OPDIOS||Optimal Dietary Treatment of Obese Adults|Optimal Dietary Treatment of Obese Adults|Completed||N/A|120|Actual|Hospitalsenheden Vest||3|||f||||f||||||||||2017-10-11 02:30:48.793642|2017-10-11 02:30:48.793642
NCT01685944|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-02-25|||August 2012||2012-08-01|February 2016|2016-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Anti-Obesity Effect of Pediococcus Pentosaceus LP28|A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Pediococcus Pentosaceus LP28 on Obesity|Completed||N/A|62|Actual|Hiroshima University||3|||f||||f||||||||||2017-10-11 02:30:48.912726|2017-10-11 02:30:48.912726
NCT01685931|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-01-25|||November 2012||2012-11-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics|Effectiveness, Safety and Tolerability of Flexibly Dosed Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics and With Acute Symptom of Schizophrenia: A 13-Week, Open-label, Single-arm, Multicenter, Prospective, Interventional Study Followed by a Naturalistic Additional 1 Year Follow up|Completed||Phase 4|617|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||||||||||2017-10-11 02:30:49.044336|2017-10-11 02:30:49.044336
NCT01685918|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-12|||April 2012||2012-04-01|September 2012|2012-09-01|August 2016|Anticipated|2016-08-01|August 2013|Anticipated|2013-08-01||Observational|||Safety and Effectiveness of Biological DMARDs in Elderly Patients With Rheumatoid Arthritis|Safety and Effectiveness of Biological DMARDs in Elderly Patients With Rheumatoid Arthritis|Unknown status|Recruiting|N/A|600|Anticipated|Hanyang University|||1||f||||f||||||||||2017-10-11 02:30:49.190298|2017-10-11 02:30:49.190298
NCT01685905|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-17|||April 2012||2012-04-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection|Evaluation of the Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Mycobacterium Tuberculosis Infection in Korean Patients With Rheumatic Diseases|Unknown status|Recruiting|N/A|2000|Anticipated|Hanyang University|||1||f||||f||||||||||2017-10-11 02:30:49.306193|2017-10-11 02:30:49.306193
NCT01685892|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-07-28|||November 29, 2012|Actual|2012-11-29|July 2017|2017-07-01|April 2, 2019|Anticipated|2019-04-02|April 2, 2019|Anticipated|2019-04-02||Interventional|||A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia|A Phase Ib Multicenter Dose-Finding and Safety Study of Venetoclax and Obinutuzumab in Patients With Relapsed or Refractory or Previously Untreated Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|82|Actual|Genentech, Inc.||6|||f||||f|t|f||||||||2017-10-11 02:30:49.4273|2017-10-11 02:30:49.4273
NCT01685879|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2014-08-28|||October 2012||2012-10-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Glycemic Response to High Amylose Rice|Glycemic Response to High Amylose Rice|Completed||N/A|18|Actual|University of Hawaii||4|||f||||f||||||||||2017-10-11 02:30:49.608427|2017-10-11 02:30:49.608427
NCT01685866|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-08-05|||October 2012||2012-10-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|3V||3V- Improve Venous Access in Pediatric Anesthesia|Difficult Venous Access in Pediatric Anesthesia: Evaluation of a New Medical Device in Multicenter Trial.|Completed||N/A|311|Actual|Fondation Ophtalmologique Adolphe de Rothschild||2|||f||||f||||||||||2017-10-11 02:30:49.742718|2017-10-11 02:30:49.742718
NCT01685853|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-18|||April 2011||2011-04-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Bowel Cleansing for Colonoscopy: Comparison Between a Same Day Low-Volume Preparation and a Conventional 4L Split One|Bowel Cleansing for Colonoscopy: Comparison Between a Same Day Low-Volume Preparation and a Conventional 4L Split One. A Randomized, Observer-blind, Parallel Group, Comparative Study.|Completed||Phase 3|164|Actual|European Institute of Oncology||2|||f||||t||||||||||2017-10-11 02:30:49.98198|2017-10-11 02:30:49.98198
NCT01685827|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-10-06|||November 2012||2012-11-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|October 2016|Anticipated|2016-10-01||Interventional|||Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2|Efficacy and Safety of Fexinidazole Compared to Nifurtimox-Eflornithine Combination Therapy (NECT) in Patients With Late-stage Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: Pivotal, Non-inferiority, Multicentre, Randomised, Open-label Study|Active, not recruiting||Phase 2/Phase 3|394|Actual|Drugs for Neglected Diseases||2|||f||||t||||||||||2017-10-11 02:30:50.392077|2017-10-11 02:30:50.392077
NCT01685814|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2017-02-07|||May 2012||2012-05-01|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|September 2016|Actual|2016-09-01||Interventional|||Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance|Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance - A Randomized Multicenter Phase III Trial by Deutsche Studiengruppe Multiples Myelom (DSMM XIV|Active, not recruiting||Phase 3|406|Anticipated|Wuerzburg University Hospital||4|||f||||f||||||||||2017-10-11 02:30:50.560307|2017-10-11 02:30:50.560307
NCT01685801|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2015-04-30|2015-04-30||September 2012||2012-09-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Full Analysis Set (FAS) included all randomized participants who received at least 1 dose of study drug (ivacaftor or placebo).|Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function|A Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis, Residual CFTR Function, and FEV1 ≥40% Predicted|Completed||Phase 2|24|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||f||||||||||2017-10-11 02:30:50.827593|2017-10-11 02:30:50.827593
NCT01685788|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2016-10-25|||October 2012||2012-10-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Study of Sensory Deficits in the Upper Limb After Stroke|Prospective Longitudinal Study: Sensory Deficits in the Upper Limb After Stroke.|Completed||N/A|40|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 02:30:51.907962|2017-10-11 02:30:51.907962
NCT01685775|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-10-12|||February 2010||2010-02-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|NATCH||Needlescopic Versus Transvaginal/Transumbilical Cholecystectomy|Needlescopic Versus Transvaginal/Transumbilical Cholecystectomy: a Randomized Clinical Trial|Completed||N/A|40|Actual|University of Witten/Herdecke||2|||f||||f||||||||||2017-10-11 02:30:52.028004|2017-10-11 02:30:52.028004
NCT01685762|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-05-04|||September 2012||2012-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 1, 2015|Actual|2015-12-01||Interventional|||Metformin for the Treatment of Endometrial Hyperplasia|Metformin for the Treatment of Endometrial Hyperplasia|Active, not recruiting||Early Phase 1|18|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:30:52.164798|2017-10-11 02:30:52.164798
NCT01685749|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-10-25|||July 2012||2012-07-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||The Natural History of Human Stingray Injuries|The Natural History of Human Stingray Injuries|Completed||N/A|300|Actual|University of California, Irvine|||1||f||||f||||||||No|NO IPD will be shared with other researchers|2017-10-11 02:30:52.283982|2017-10-11 02:30:52.283982
NCT01685736|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-11|||February 2012||2012-02-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|OSA||Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea|Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea|Unknown status|Recruiting|N/A|50|Anticipated|University of Athens|||1||f||||f||||||||||2017-10-11 02:30:52.360422|2017-10-11 02:30:52.360422
NCT01685723|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-26|2013-11-26|||September 2012||2012-09-01|November 2013|2013-11-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01||Interventional|||Smoking Cessation in Cancer Patients|Helping Cancer Patients Quit Smoking by Improving Their Risk Communication: a Cluster Randomized Controlled Trial|Unknown status|Recruiting|N/A|560|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:30:52.451293|2017-10-11 02:30:52.451293
NCT01685710|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-06-01|||April 2013||2013-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas|The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas|Completed||Phase 4|200|Actual|University Hospital Birmingham||2|||f||||t||||||||||2017-10-11 02:30:52.540654|2017-10-11 02:30:52.540654
NCT01685684|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-01-03|2016-05-25|2015-05-22|August 2012||2012-08-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)|A Phase 3, Multi-Center, Randomized, Double-blind, Placebo-Controlled, Safety, Tolerability, and Efficacy Study of Oxycodone DETERx™ Versus Placebo in Opioid-Experienced and Opioid-Naive Subjects With Moderate-to-Severe Chronic Low Back Pain|Completed||Phase 3|740|Actual|Collegium Pharmaceutical, Inc.||2|||f||||f||||||||||2017-10-11 02:30:52.932128|2017-10-11 02:30:52.932128
NCT01685671|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-05-22|||October 26, 2012|Actual|2012-10-26|May 2017|2017-05-01|January 15, 2013|Actual|2013-01-15|December 25, 2012|Actual|2012-12-25||Interventional|||Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers|A Randomized, Double-blind, Active Control, Single Dosing, Crossover Clinical Trial to Investigate the Pharmacokinetics of CKD-11101 and NESP After SC Administration in Health Male Volunteers|Completed||Phase 1|34|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:30:53.67752|2017-10-11 02:30:53.67752
NCT01685658|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-04-06|||September 2016||2016-09-01|April 2016|2016-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PIVKIV||Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations|Comparing the Efficacy of Intravenous Paracetamol and Ketoprofen When Treating Renal Colic in Emergency Situations: a Randomized, Bi-centric, Double-blind Controlled Trial|Not yet recruiting||Phase 4|338|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 02:30:53.808417|2017-10-11 02:30:53.808417
NCT01685645|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-03-25|||July 2013||2013-07-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|ALGISCAN||Does the Measurement of Pupillary Reactivity by an Automated Pupillometer Determine the Effectiveness of Local Anesthesia Under General Anesthesia?|Does the Measurement of Pupillary Reactivity to Painful Stimulation by an Automated Pupillometer Determine the Effectiveness of Local Anesthesia When Undergoing General Anesthesia?|Completed||N/A|100|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-11 02:30:53.992041|2017-10-11 02:30:53.992041
NCT01685632|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-10-16|||September 2012||2012-09-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|CHIP||Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences|Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences|Terminated||N/A|60|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 02:30:54.077439|2017-10-11 02:30:54.077439
NCT01685437|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-09-07|2015-02-04||September 2012||2012-09-01|September 2017|2017-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease|A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease|Completed||Phase 3|189|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:30:58.062165|2017-10-11 02:30:58.062165
NCT01685619|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-01-30|||September 2012||2012-09-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Observational|||AML-MDS Novel Prognostic Tests Clinical Study|A Multi-Centre Observational Prospective Cohort Study Involving the Collection of Clinical Information and Biological Specimens for the Evaluation of Novel Prognostic Tests for Myelodysplasia and Acute Myeloid Leukemia|Active, not recruiting||N/A|400|Anticipated|Nova Scotia Health Authority|||2||f||||t||||||Samples With DNA|"     Some of the laboratory tests that will be evaluated as part of this study will utilize RNA     and/or DNA. There may be biospecimens left over after the work related to this study is     complete. At the time of consent for the study, participants will be asked to provide consent     (or decline their consent) regarding the use of leftover specimens (including RNA and DNA)     for other research. The details regarding this other research are provided in the protocol     and consent template.   "|||2017-10-11 02:30:54.167859|2017-10-11 02:30:54.167859
NCT01685606|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2015-07-17|2015-06-04||March 2013||2013-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|273||Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma|BrUOG 273:Cellular Immunotherapy For Refractory Hematological Malignancies:A Brown University Oncology Research Group Study|Terminated||Phase 2|6|Actual|Brown University||1||Lack of accrual and low efficacy|f||||t||||||||||2017-10-11 02:30:54.257775|2017-10-11 02:30:54.257775
NCT01685593|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-13|||January 2001||2001-01-01|September 2012|2012-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Abdominal Binder Study to Decrease Postoperative Pain|A Controlled Randomized Trial Examining the Ability of the Mott Compression Bonder to Decrease Postoperative Pain in Gynecologic Abdominal Laparotomy Patients.|Completed||N/A|76|Actual|Brooke Army Medical Center||2|||f||||t||||||||||2017-10-11 02:30:54.536752|2017-10-11 02:30:54.536752
NCT01685580|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2017-01-13|||October 2012||2012-10-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|préOVNI||Non-Invasive Ventilation Preoperative Lung Resection Surgery|Evaluation of Non-Invasive Ventilation Preoperative Lung Resection Surgery|Recruiting||N/A|300|Anticipated|University Hospital, Brest||2|||f||||t||||||||||2017-10-11 02:30:54.624476|2017-10-11 02:30:54.624476
NCT01685567|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-06-12|2016-12-20||November 2012||2012-11-01|June 2017|2017-06-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|ROADSTER||Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure|INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.|Completed||Phase 3|219|Actual|Silk Road Medical||1|||f||||t||||||||||2017-10-11 02:30:56.46801|2017-10-11 02:30:56.46801
NCT01685554|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-10-17|||March 2010||2010-03-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Normothermiс Cardiopulmonary Bypass Increases Cerebral Oxygenation During Valve Surgery|Normothermiс Cardiopulmonary Bypass Increases Cerebral Oxygenation During Combined Valve Surgery: Single Center, Randomized Trial|Completed||N/A|40|Actual|Northern State Medical University||2|||f||||f||||||||||2017-10-11 02:30:56.953919|2017-10-11 02:30:56.953919
NCT01685541|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2012-09-13|||December 2010||2010-12-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Evaluation of Computer Generated After Visit Summaries|Evaluation of Computer Generated After Visit Summaries to Support Patient-Centered Care|Completed||Phase 3|272|Actual|Baylor College of Medicine||4|||f||||f||||||||||2017-10-11 02:30:57.033527|2017-10-11 02:30:57.033527
NCT01685528|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-04-05|||December 2012||2012-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|May 2014|Actual|2014-05-01||Interventional|VA-HELPS||VA Home-Based Emotional Learning With Practical Skills|VA Home-Based Emotional Learning With Practical Skills (VA-HELPS): Treatment for Depressed and/or Anxious Rural Veterans in Home-Based Primary Care|Completed||N/A|18|Actual|Baylor College of Medicine||1|||f||||f||||||||||2017-10-11 02:30:57.222056|2017-10-11 02:30:57.222056
NCT01685515|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2016-09-01|||August 2012||2012-08-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease|Phase 1 Study of Oral Decitabine and Tetrahydrouridine (THU) in Patients With High Risk Sickle Cell Disease|Active, not recruiting||Phase 1|25|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-10-11 02:30:57.318071|2017-10-11 02:30:57.318071
NCT01685502|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-10-17|||November 2010||2010-11-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|September 2013|Actual|2013-09-01||Observational|||Special Drug Use Investigation of Glucobay OD|Special Drug Use Investigation of Glucobay OD|Completed||N/A|2289|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:30:57.436525|2017-10-11 02:30:57.436525
NCT01685489|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2015-10-23|||May 2013||2013-05-01|October 2015|2015-10-01||||||||Interventional|||A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer|A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer|Withdrawn||Phase 1|0|Actual|Bastyr University||2||funding sequestered|f||||t||||||||||2017-10-11 02:30:57.527201|2017-10-11 02:30:57.527201
NCT01685476|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-07-04|||January 2011||2011-01-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|MINIPIC REA||NIMI-NICU: Non Invasive Monitoring of the Intracranial Pressure - NeuroIntensive Care Unit|Validation of a New Non Invasive Method for Intracranial Pressure Monitoring|Completed||Phase 4|20|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 02:30:57.668552|2017-10-11 02:30:57.668552
NCT01685463|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-13|||September 2008||2008-09-01|September 2008|2008-09-01||||September 2013|Anticipated|2013-09-01||Interventional|||Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving|Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving|Unknown status|Recruiting|Early Phase 1|20|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 02:30:57.795421|2017-10-11 02:30:57.795421
NCT01685450|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-09-11|||June 2010||2010-06-01|September 2012|2012-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|MINIPIC||NIMIP: Non Invasive Measurement of the Intracranial Pressure|Validation of a New Non Invasive Method of Indirect Measurement of the Intracranial Pressure Variations|Unknown status|Recruiting|Phase 4|25|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 02:30:57.935466|2017-10-11 02:30:57.935466
NCT01683760|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2014-11-17|||September 2012||2012-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetic Study of Fluconazole in Premature Infants||Completed||Phase 2|80|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 02:31:28.33028|2017-10-11 02:31:28.33028
NCT01685424|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-06-08|||June 30, 2006|Actual|2006-06-30|June 2017|2017-06-01|March 1, 2015|Actual|2015-03-01|March 1, 2015|Actual|2015-03-01||Observational|||Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)|Etoricoxib Prescribing Patterns and Adverse Events of Interest During Etoricoxib Treatment in UK Primary Care; an Updated Analysis|Completed||N/A|79189|Actual|Merck Sharp & Dohme Corp.|||3||f||||f||||||||||2017-10-11 02:30:58.457304|2017-10-11 02:30:58.457304
NCT01685411|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-10-04|||January 2013||2013-01-01|September 2017|2017-09-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Interventional|||Busulfan and Cyclophosphamide Followed By ALLO BMT|Busulfan and Cyclophosphamide Followed By Allogeneic Hematopoietic Cell Transplantation In Patients With Hematological Malignancies|Recruiting||N/A|30|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 02:30:58.594422|2017-10-11 02:30:58.594422
NCT01685398|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-11-26|||September 2012||2012-09-01|June 2012|2012-06-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Topical Timolol for Superficial Infantile Hemangioma|Treatment of Cutaneous Hemangioma of Infancy With Topical 0.5% Timolol Maleate Eye Drop Compared With Placebo in Pediatric Patients, Siriraj Hospital|Unknown status|Recruiting|Phase 3|46|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 02:30:58.759342|2017-10-11 02:30:58.759342
NCT01685385|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-08|2012-10-10|||October 2012||2012-10-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|B-RAPID||B-type NAtriuretic Peptide In Critically Ill : A Multicentric Diagnostic Study (B-rAPID)|B-type NAtriuretic Peptide In Critically Ill : A Multicentric Diagnostic Study (B-rAPID)|Unknown status|Recruiting|N/A|800|Anticipated|Mahatma Gandhi Institute of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:30:58.859682|2017-10-11 02:30:58.859682
NCT01685359|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-09-11|||February 2013||2013-02-01|September 2012|2012-09-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects|Phase 1 Assessment of Pharmacokinetics and Pharmacodynamics of Two Epoetin Alfa, Human Recombinant Epoetin (Blau Farmacêutica) and Eprex (Janssen-Cilag), After Multiple Dose, Intravenous Administration in Healthy Subjects: a Randomized Parallel Study.|Unknown status|Not yet recruiting|Phase 1|80|Anticipated|Azidus Brasil||2|||f||||t||||||||||2017-10-11 02:30:59.129007|2017-10-11 02:30:59.129007
NCT01685346|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-07-09|||October 2012||2012-10-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study|Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study|Terminated||N/A|8|Actual|Case Comprehensive Cancer Center||1||Research Cancelled|f||||t||||||||||2017-10-11 02:30:59.266069|2017-10-11 02:30:59.266069
NCT01685333|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-09-11|||February 2013||2013-02-01|September 2012|2012-09-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.|Phase 1 Assessment of Pharmacokinetics and Pharmacodynamics of Two Epoetin Alfa, Human Recombinant Epoetin (Blau Farmacêutica) and Eprex (Janssen-Cilag), After Single Dose, Intravenous Administration in Healthy Subjects: a Randomized Crossover Study.|Unknown status|Not yet recruiting|Phase 1|28|Anticipated|Azidus Brasil||2|||f||||t||||||||||2017-10-11 02:30:59.549271|2017-10-11 02:30:59.549271
NCT01685320|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2013-03-13|2013-02-08||January 2011||2011-01-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Force and Pressure Distribution Using Macintosh and GlideScope Laryngoscopes in Normal Airway: an in Vivo Study|Force and Pressure Distribution Using Macintosh and GlideScope Laryngoscopes in Normal Airway: an in Vivo Study|Completed||N/A|30|Actual|Campus Bio-Medico University|"Patients studied were classified with “normal airways”, while difficult intubations were not considered.
We excluded patients with CL grade 2 or greater.
We employed only the Macintosh size 3 blade to avoid additional variables."|2|||f||||t||||||||||2017-10-11 02:30:59.682514|2017-10-11 02:30:59.682514
NCT01685307|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-09-11|||February 2012||2012-02-01|September 2012|2012-09-01||||September 2012|Actual|2012-09-01||Interventional|||Impact of Cooking Process on Meat Protein Digestion and Metabolism||Unknown status|Recruiting|N/A|48|Anticipated|Institut National de la Recherche Agronomique||2|||f||||t||||||||||2017-10-11 02:31:00.061795|2017-10-11 02:31:00.061795
NCT01685294|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-01-12|||December 2011||2011-12-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression|Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression|Completed||Phase 3|181|Actual|Brown University||2|||f||||t||||||||||2017-10-11 02:31:00.161|2017-10-11 02:31:00.161
NCT01685281|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2014-01-13|||August 2013||2013-08-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder|Randomized, Double-blind, Single-center, Dose-finding Study Designed to Compare Two Doses of MG01CI (Metadoxine Extended Release) and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder|Completed||Phase 2|36|Actual|Alcobra Ltd.||3|||f||||f||||||||||2017-10-11 02:31:00.325351|2017-10-11 02:31:00.325351
NCT01685268|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-09-06||2016-01-08|September 2012||2012-09-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate|A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate in the Treatment of Castration-Resistant Prostate Cancer (CRPC) no Longer Responding to Abiraterone|Completed||Phase 1/Phase 2|49|Actual|Astex Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:31:00.497426|2017-10-11 02:31:00.497426
NCT00005172|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||December 1984||1984-12-01|August 2004|2004-08-01|April 1997|Actual|1997-04-01|||||Observational|||Socioeconomic Status, John Henryism and Hypertension Risk in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.472101|2017-10-11 04:26:35.472101
NCT01685255|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-06-06||2015-11-04|August 2012||2012-08-01|June 2017|2017-06-01|October 23, 2014|Actual|2014-10-23|October 23, 2014|Actual|2014-10-23||Interventional|||A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy|A Randomized, Open-Label, Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-Recurrent-Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, or Fallopian Tube Cancer Following Complete Remission With First-Line Chemotherapy|Terminated||Phase 2|83|Actual|Incyte Corporation||2||Study was terminated by the sponsor for lack of evidence of superiority and slow study accrual.|f||||t||||||||Undecided||2017-10-11 02:31:00.724048|2017-10-11 02:31:00.724048
NCT01685216|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-10-01|2015-10-01||September 2012||2012-09-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||The Intent-to-Treat population, defined as all participants who received at least 1 study drug infusion (full or partial).|Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease|A Multi-center, Open-label, Efficacy and Safety Study of Velaglucerase Alfa Enzyme Replacement Therapy in Children and Adolescents With Type 3 Gaucher Disease|Completed||Phase 1/Phase 2|7|Actual|Shire||1|||f||||f||||||||||2017-10-11 02:31:02.377368|2017-10-11 02:31:02.377368
NCT01685203|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-12|2016-02-17|2015-06-09||August 2012||2012-08-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional|PEARL-I|All participants who received at least 1 dose of study drug.|A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection|A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Coadministration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection (PEARL-I)|Completed||Phase 2|316|Actual|AbbVie||8|||f||||f||||||||||2017-10-11 02:31:02.97727|2017-10-11 02:31:02.97727
NCT01685190|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-04-03|||June 2011||2011-06-01|April 2013|2013-04-01|March 2018|Anticipated|2018-03-01|December 2013|Anticipated|2013-12-01||Interventional|PIVOTAL||A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer|A Randomised Phase II Trial of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer|Active, not recruiting||Phase 2|110|Anticipated|Institute of Cancer Research, United Kingdom||2|||f||||t||||||||||2017-10-11 02:31:04.576429|2017-10-11 02:31:04.576429
NCT01685177|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-11|||September 2009||2009-09-01|September 2012|2012-09-01||||||||Observational|SADI vs CD||Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient|Prospective Randomized Trial Comparing Single-Anastomosis Duodeno-Ileal Bypass With Standard Roux-en-Y Duodenal Switch as a Second Step After a Sleeve Gastrectomy in the Super-Morbid Obese Patient|Unknown status|Recruiting|N/A|30|Anticipated|Hospital San Carlos, Madrid|||1||f||||f||||||Samples With DNA|"     Fat, liver tissue   "|||2017-10-11 02:31:04.716767|2017-10-11 02:31:04.716767
NCT01685164|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-04-08|||January 2011||2011-01-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||The Effect of Uterine Size and Posture on Intrauterine Contraception in Nulliparous Women|The Effect of Uterine Size and Posture on Intrauterine Contraception in Nulliparous Women|Completed||N/A|161|Actual|Helsinki University Central Hospital|||2||f||||||||||||||2017-10-11 02:31:04.803402|2017-10-11 02:31:04.803402
NCT01685151|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2013-01-22|||September 2012||2012-09-01|January 2013|2013-01-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar 1 Disorder in Adult Subjects|Withdrawn||Phase 3|0|Actual|Takeda||3||Business Decision (please see below)|f||||f||||||||||2017-10-11 02:31:04.903049|2017-10-11 02:31:04.903049
NCT01685138|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-07-19|||December 20, 2012|Actual|2012-12-20|July 2017|2017-07-01|December 29, 2017|Anticipated|2017-12-29|December 29, 2017|Anticipated|2017-12-29||Interventional|||LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer|A Phase II, Multicenter, Single-arm Study of Oral LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|126|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:31:05.03801|2017-10-11 02:31:05.03801
NCT01685125|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-07-05|||September 2012||2012-09-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|March 2016|Actual|2016-03-01||Interventional|||Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer|A Randomized Phase II Trial of Dasatinib Plus Abiraterone Compared to Abiraterone Alone for Metastatic, Castration-Resistant Prostate Cancer Prior to Chemotherapy|Active, not recruiting||Phase 2|96|Anticipated|University of Southern California||2|||f||||t||||||||||2017-10-11 02:31:05.264257|2017-10-11 02:31:05.264257
NCT01685112|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-10-10|||September 2012||2012-09-01|September 2012|2012-09-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Comparison of ECMO Use and Conventional Treatment in Adults With Septic Shock|Comparison of ECMO Use and Conventional Treatment in Adults With Septic Shock|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 02:31:05.388726|2017-10-11 02:31:05.388726
NCT01685099|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-11|||August 2012||2012-08-01|August 2012|2012-08-01||||||||Observational|||Evaluating the Diagnostic Validity of Inflammation-associated Markers for Tuberculous Pleurisy|Evaluating the Diagnostic Validity of Inflammation-associated Markers for Tuberculous Pleurisy|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples Without DNA|"     pleural effusion   "|||2017-10-11 02:31:05.496034|2017-10-11 02:31:05.496034
NCT01685086|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-12|||March 2012||2012-03-01|November 2011|2011-11-01||||||||Observational|||Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term Dialysis|Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term Dialysis|Unknown status|Recruiting|N/A|500|Anticipated|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-11 02:31:05.631368|2017-10-11 02:31:05.631368
NCT01685073|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-09-12|||September 2012||2012-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|||The Role of Sleep in the Treatment of Cannabis Use Disorders|The Role of Sleep in the Treatment of Cannabis Use Disorders|Active, not recruiting||Phase 2/Phase 3|100|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:31:05.768271|2017-10-11 02:31:05.768271
NCT01685060|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-05-25|2017-03-27||November 26, 2012|Actual|2012-11-26|May 2017|2017-05-01|March 29, 2016|Actual|2016-03-29|March 29, 2016|Actual|2016-03-29||Interventional||Full Analysis Set (FAS) consisted of all patients who received at least one dose of ceritinib.|LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib|A Phase II, Multicenter, Single-arm Study of Oral LDK378 in Adult Patients With ALK-activated Non-small Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib|Completed||Phase 2|140|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:31:05.972957|2017-10-11 02:31:05.972957
NCT01685034|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-08-17||||||August 2016|2016-08-01||||||||Interventional|AIMEE||Allergy Immunotherapy in the Management of Eosinophilic Esophagitis|Evaluation of the Clinical, Endoscopic and Histologic Effects of Environmental Allergy Immunotherapy in the Treatment of Eosinophilic Esophagitis|Withdrawn||N/A|0|Actual|United States Naval Medical Center, San Diego||1||Researcher deployed before approval|f||||t||||||||||2017-10-11 02:31:06.910599|2017-10-11 02:31:06.910599
NCT01685021|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2015-04-27|||April 2013||2013-04-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL)|A Phase IIa, Single-arm, Open-label Study of MOR00208, a Humanized Fc-Engineered Anti-CD19 Antibody, in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)|Terminated||Phase 2|22|Actual|MorphoSys AG||1|||f||||f||||||||||2017-10-11 02:31:06.989132|2017-10-11 02:31:06.989132
NCT01685008|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2017-08-09|||May 2013||2013-05-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin´s Lymphoma (NHL)|A Phase IIa, Open-label, Multicenter Study of Single-Agent MOR00208, an Fc-optimized Anti-CD19 Antibody in Patients With Relapsed or Refractory Non-Hodgkin´s Lymphoma (NHL)|Active, not recruiting||Phase 2|120|Anticipated|MorphoSys AG||1|||f||||f||||||||||2017-10-11 02:31:07.081876|2017-10-11 02:31:07.081876
NCT01684995|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-09-12|||December 1996||1996-12-01|August 2012|2012-08-01|November 1999|Actual|1999-11-01|November 1999|Actual|1999-11-01||Interventional|||Motivation and Nicotine Patch Treatment for Under-served Smokers|Motivation and Nicotine Patch Treatment for Under-served Smokers|Completed||N/A|||The Miriam Hospital||2|||f||||f||||||||||2017-10-11 02:31:07.204739|2017-10-11 02:31:07.204739
NCT01684982|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-04-01|||April 2007||2007-04-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|RaCES-MI||Everolimus Stent in Myocardial Infarction|Randomized Comparison of Everolimus Eluting Stents and Sirolimus Eluting Stent in Patients With ST Elevation Myocardial Infarction (STEMI) (RaCES-MI Trial)|Completed||Phase 4|500|Actual|San Giuseppe Moscati Hospital||2|||f||||f||||||||||2017-10-11 02:31:07.271295|2017-10-11 02:31:07.271295
NCT01684969|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-03-16|||March 2012||2012-03-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Evidence of Haloperidol Absorption After Topical Administration|Topical Haloperidol: Evidence of Absorption After Topical Administration|Withdrawn||Early Phase 1|0|Actual|Mayo Clinic||2||lack of accrual and funding is about to expire.|f||||f||||||||||2017-10-11 02:31:07.358741|2017-10-11 02:31:07.358741
NCT01684956|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-09-06|||August 2012||2012-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2014|Actual|2014-07-01||Interventional|||Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes|Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Volunteers With Type 1 Diabetes|Active, not recruiting||Phase 2|20|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:31:07.426799|2017-10-11 02:31:07.426799
NCT01684943|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-02-06|||July 2010||2010-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|||Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling|Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling|Active, not recruiting||Phase 2|33|Actual|Massachusetts General Hospital||2|||f||||t||||||||Yes||2017-10-11 02:31:07.515258|2017-10-11 02:31:07.515258
NCT01684930|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-08-26|2015-11-25||June 2012||2012-06-01|August 2017|2017-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|NO-PAD||Nitrites, Exercise, and Peripheral Arterial Disease|Increased Plasma Nitrite, Tissue Oxygenation and Functional Changes in PAD|Completed||Phase 2|32|Actual|Duke University|The largest limitation to the study was the evolving knowledge on conversion rates of oral inorganic nitrate to nitrite. We found a good deal of unexpected inter and intra-subject variation in conversion rates.|2|||f||||f||||||||||2017-10-11 02:31:07.59269|2017-10-11 02:31:07.59269
NCT01684917|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-10-26|||April 2012||2012-04-01|September 2012|2012-09-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Interventional|NutriTech||Application of New Technologies and Tools to Nutrition Research|Application of New Technologies and Tools to Nutrition Research|Completed||Phase 3|74|Actual|Imperial College London||3|||f||||t||||||||||2017-10-11 02:31:07.865763|2017-10-11 02:31:07.865763
NCT01684904|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-12-14|||July 2012||2012-07-01|August 2016|2016-08-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Proton Therapy for Esophageal Cancer|A Phase II Trial of Proton Chemotherapy (PCT) for Resectable Esophageal or Esophagogastric Junction Cancer|Recruiting||N/A|38|Anticipated|Loma Linda University||1|||f||||t||||||||No||2017-10-11 02:31:07.946645|2017-10-11 02:31:07.946645
NCT01684891|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-11-01|||September 2012||2012-09-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers|Single-center, Open Label, Multiple Dose Study to Investigate the Pharmacokinetics of RG1662 Given BID Over 28 Days, and in Addition, the Excretion and Metabolism of [13C]-Labelled IV Microdoses and an Oral [14C]-Labelled Dose of RG1662 in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:31:08.24841|2017-10-11 02:31:08.24841
NCT01684878|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-04-13|2016-10-03||October 22, 2012|Actual|2012-10-22|April 2017|2017-04-01|April 28, 2016|Actual|2016-04-28|January 30, 2015|Actual|2015-01-30||Interventional||Part 1: all participants enrolled and treated in Part 1 of the study (‘as treated’ analysis) and Part 2: intent-to-treat (ITT) population was defined as all randomized participants in the group to which they were randomly assigned (‘as randomized’ analysis).|Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)|A Two-Part, Randomized Phase III, Double-Blind, Multicenter Trial Assessing The Efficacy And Safety of Pertuzumab In Combination With Standard Chemotherapy Vs. Placebo Plus Standard Chemotherapy In Women With Recurrent Platinum-Resistant Epithelial Ovarian Cancer And Low HER3 mRNA Expression|Completed||Phase 3|208|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 02:31:08.407223|2017-10-11 02:31:08.407223
NCT01684865|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-08-22|||October 22, 2012|Actual|2012-10-22|August 2017|2017-08-01|July 13, 2018|Anticipated|2018-07-13|July 13, 2018|Anticipated|2018-07-13||Observational|||An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's Lymphoma|Prospective, Non Interventional Study to Evaluate the Safety Profile of First- Line Rituximab Maintenance Therapy in Patients With Follicular Non-Hodgkin's Lymphoma|Active, not recruiting||N/A|22|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:31:10.248447|2017-10-11 02:31:10.248447
NCT01684852|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-01-29|||May 2012||2012-05-01|January 2013|2013-01-01||||December 2012|Actual|2012-12-01||Observational|||Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution|Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution (BAT04) Compared to HA Eye Drops in the Treatment of Dry Eye Disease|Completed||N/A|64|Actual|Bitop AG|||1||f||||f||||||||||2017-10-11 02:31:10.352245|2017-10-11 02:31:10.352245
NCT01684839|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-08-19|2013-06-03||May 2007||2007-05-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2010|Actual|2010-03-01||Interventional|||Treatment of Painful Digital Neuroma Using A Pedicled Nerve Flap||Completed||N/A|9|Actual|The Second Hospital of Tangshan||1|||f||||||||||||||2017-10-11 02:31:10.449811|2017-10-11 02:31:10.449811
NCT01684826|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-11-07|2013-08-26||September 2012||2012-09-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||X-ray Dose Reduction Study for Cardiac Angiography and Intervention|Clinical Validation and Evaluation of ClarityIQ Cardiac Image Processing for Cardiac Angiography and Intervention|Completed||N/A|50|Actual|Philips Healthcare||2|||f||||f||||||||||2017-10-11 02:31:10.654866|2017-10-11 02:31:10.654866
NCT01684813|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2014-09-19|||October 2012||2012-10-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|VERDI||VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel|A Randomized Study With Loading Dose of Prasugrel Opposed to the Standard Dose of Clopidogrel in Type 2 Diabetic Patients in Acute Coronary Syndrome, Revascularized Through Drug-eluting Stent.|Completed||Phase 4|65|Anticipated|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f||||||||||2017-10-11 02:31:10.881574|2017-10-11 02:31:10.881574
NCT01684800|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-08-22|||September 2012||2012-09-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|NOC||Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women|A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial Investigating the Efficacy and Safety of Two Different Dose Levels of Desmopressin for the Treatment of Nocturia in Adult Women|Completed||Phase 2|178|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:31:10.983245|2017-10-11 02:31:10.983245
NCT01684787|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-11|2012-09-12|||September 2006||2006-09-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|CONTRA||Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients|Open Multicentre, Phase IV Study to Evaluate Efficacy and Safety of Pegylated Interferon Alpha-2a (40 KD) Plus Ribavirin for Chronic Hepatitis C With Normal Transaminases in Human Immunodeficiency Virus-infected Patients|Completed||Phase 4|80|Actual|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 02:31:11.142586|2017-10-11 02:31:11.142586
NCT01684774|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-12|||December 2012||2012-12-01|September 2012|2012-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Comparison Between Ultrasound-guided and Landmark-guided Ankle Blocks||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||2||f||||f||||||||||2017-10-11 02:31:11.26502|2017-10-11 02:31:11.26502
NCT01684761|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-01-09|||August 2012||2012-08-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|Abili-T||Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis|A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis|Completed||Phase 2|183|Actual|Opexa Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 02:31:11.343206|2017-10-11 02:31:11.343206
NCT01684748|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2015-01-08|2014-05-29||February 2009||2009-02-01|January 2015|2015-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|ARB||Angiotensin II Blockade and Inflammation in Obesity|Angiotensin II Blockade and Adipose Tissue Inflammation in Obesity|Completed||Phase 4|20|Actual|Virginia Polytechnic Institute and State University||2|||f||||t||||||||||2017-10-11 02:31:11.72615|2017-10-11 02:31:11.72615
NCT01684735|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-09-12|||March 2012||2012-03-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Observational|||Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation|Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation|Unknown status|Recruiting|N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 02:31:12.177272|2017-10-11 02:31:12.177272
NCT01684722|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-01-18|||July 2010||2010-07-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|VITAL-DKD||Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease|Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease|Active, not recruiting||N/A|1320|Anticipated|University of Washington||4|||f||||t||||||||||2017-10-11 02:31:12.2422|2017-10-11 02:31:12.2422
NCT01684683|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2015-03-10|||November 2012||2012-11-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|||The Effect of Theophylline in the Treatment of Bronchiectasis|Clinical Efficacy and Safety of Theophylline in the Treatment of Non-Cystic Fibrosis(NCF) Bronchiectasis|Completed||Phase 4|100|Actual|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 02:31:12.582232|2017-10-11 02:31:12.582232
NCT01684670|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-11-22|||February 2014||2014-02-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Intensive Dysarthria Sessions in Adults and Children With Down Syndrome|Intensive Dysarthria Sessions in Adults and Children With Down Syndrome|Completed||N/A|5|Actual|Duke University||1|||f||||t||||||||||2017-10-11 02:31:12.837605|2017-10-11 02:31:12.837605
NCT01684657|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-05-19|||September 2012||2012-09-01|May 2014|2014-05-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering|A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering|Suspended||Phase 3|32|Anticipated|University of California, Irvine||2||Study transferring to another facility|f||||t||||||||||2017-10-11 02:31:12.908341|2017-10-11 02:31:12.908341
NCT01684644|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-06-29|||September 2012||2012-09-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|D'SNAPP||A Controlled Study of Parent Training in the Treatment of ADHD in Young Children|Parent Training for Preschool ADHD: A Randomised Controlled, Multicentre Effectiveness Trial of the New Forest Parenting Programme in a Clinical Sample of Danish Children|Completed||N/A|164|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:31:12.991421|2017-10-11 02:31:12.991421
NCT01684631|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-09-23|||January 2009||2009-01-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|||Evaluation of Implant Survival in Patients With a Pinnacle Ultamet Device in Conventional Total Hip Joint Replacement|Prospective, Multicentric, Observational Cohort Study for the Evaluation of Implant Survival in Patients With a Metal-on-Metal Pinnacle(R) Ultamet(TM) Device in Conventional Total Hip Joint Replacement.|Completed||N/A|107|Actual|DePuy International|||1||f||||f||||||||||2017-10-11 02:31:13.084155|2017-10-11 02:31:13.084155
NCT01684618|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-11-06|||September 2012||2012-09-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Neonatal Cerebral Oxygenation and Changes in CPAP Flow Pressure - Evaluation With INVOS Oximeter|Oxygenation of the Neonatal Brain - a Study Using the INVOS Oximeter|Completed||N/A|13|Actual|Copenhagen University Hospital, Hvidovre||1|||f||||f||||||||||2017-10-11 02:31:13.164229|2017-10-11 02:31:13.164229
NCT01684605|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-05-22|||October 12, 2012|Actual|2012-10-12|May 2017|2017-05-01|January 3, 2013|Actual|2013-01-03|November 13, 2012|Actual|2012-11-13||Interventional|||Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers|A Randomized, Double-blind, Active Control, Single Dosing, Crossover Clinical Trial to Investigate the Pharmacokinetics of CKD-11101 and NESP After IV Administration in Health Male Volunteers|Completed||Phase 1|31|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:31:13.248509|2017-10-11 02:31:13.248509
NCT01684579|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2013-03-18|||June 2011||2011-06-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|August 2012|Actual|2012-08-01||Interventional|||Exercising Our ABC's (African- American Breast Cancer Survivors)|Exercising Our ABC's (African- American Breast Cancer Survivors)|Completed||Early Phase 1|19|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:31:13.472187|2017-10-11 02:31:13.472187
NCT01684566|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2016-02-17|2015-11-12||February 2013||2013-02-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|episil(R)|Intention to treat (ITT)|A Comparative Investigation of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Mucositis|A Multicenter, Open-label, Parallel Group Investigation to Compare the Performance of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Mucositis in Patients Receiving Conditioning Treatment for Hematopoietic Stem Cell Transplantation|Completed||N/A|116|Actual|Camurus AB||2|||f||||f||||||||No||2017-10-11 02:31:13.588391|2017-10-11 02:31:13.588391
NCT01684553|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-12|||February 2011||2011-02-01|September 2012|2012-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|EatSpeed||The Effect of Changing the Eating Speed on Energy Intake|The Effect of Changing the Eating Speed on Energy Intake: a Randomized Cross-over Study|Completed||N/A|70|Actual|Texas Christian University||2|||f||||t||||||||||2017-10-11 02:31:14.179858|2017-10-11 02:31:14.179858
NCT01684540|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-21|||February 2012||2012-02-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|SNS01||Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis|Non-interventional Study: Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis|Completed||N/A|66|Actual|Bitop AG|||1||f||||f||||||||||2017-10-11 02:31:14.291255|2017-10-11 02:31:14.291255
NCT01684527|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-10|||October 2012||2012-10-01|September 2012|2012-09-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Immature Myeloid Cells in Respiratory Syncytial Virus Bronchioliltis||Unknown status|Not yet recruiting|N/A|55|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-10-11 02:31:14.37717|2017-10-11 02:31:14.37717
NCT01684514|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2016-08-16|||October 2012||2012-10-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of Treatment|Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of Treatment|Completed||N/A|29|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 02:31:14.467063|2017-10-11 02:31:14.467063
NCT01684501|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-04-10|||May 2010|Actual|2010-05-01|April 2017|2017-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Comparing Active and Passive Ankle-foot Prostheses|Comparing Active and Passive Ankle-foot Prostheses|Completed||N/A|6|Actual|Spaulding Rehabilitation Hospital|||1||f||||f|f|f||||||No||2017-10-11 02:31:14.573753|2017-10-11 02:31:14.573753
NCT01684488|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-01-17|||April 2012||2012-04-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|YRI||Trial of the Youth Readiness Intervention|A Feasibility Trial of the Youth Readiness Intervention: A Group Psychosocial Intervention for War-affected Youth in Sierra Leone|Completed||N/A|443|Actual|Harvard School of Public Health||4|||f||||f||||||||||2017-10-11 02:31:14.653435|2017-10-11 02:31:14.653435
NCT01684475|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2012-09-12|||September 2012||2012-09-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|September 2013||2013-09-01||Interventional|||A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE|A STUDY TO EVALUATE THE EFFICACY OF CJH1 [CLR4001] IN THE TREATMENT OF PARKINSON'S DISEASE|Unknown status|Recruiting|Phase 1/Phase 2|21|Anticipated|Alexandra Marine and General Hospital||1|||f||||f||||||||||2017-10-11 02:31:14.772394|2017-10-11 02:31:14.772394
NCT01684462|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-11-28|||September 2012||2012-09-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|ALbumin||The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke|A Phase IIB Placebo Comparative, Double Blinded, Randomized, Multi-center Study to Evaluate the Efficacy and Safety of ALbumin Therapy in Acute Ischemic Stroke Patients in Korea.|Terminated||Phase 2|2|Actual|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-11 02:31:14.847309|2017-10-11 02:31:14.847309
NCT01684449|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-10-26|||January 2010||2010-01-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma|Phase 1/2, Randomized, Multicenter, Prospective Study of Gemcitabine and Rapamycin (Sirolimus) Combination Versus Gemcitabine Only to Treat Advanced Soft Tissue Sarcoma|Completed||Phase 1/Phase 2|28|Actual|Grupo Espanol de Investigacion en Sarcomas||1|||f||||t||||||||||2017-10-11 02:31:14.948639|2017-10-11 02:31:14.948639
NCT01684436|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2014-08-14|2014-07-10||October 2012||2012-10-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||The number of participants for analysis includes all patients who completed the study|Safety and Efficacy of Punctal Plug Insertion in Patients With Dry Eye||Completed||Phase 4|30|Actual|Allergan||1|||f||||f||||||||||2017-10-11 02:31:15.074457|2017-10-11 02:31:15.074457
NCT01684423|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-11|2017-08-25|2017-08-25||February 19, 2013|Actual|2013-02-19|August 2017|2017-08-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Interventional|EINSTEINJunior||Oral Rivaroxaban in Children With Venous Thrombosis|30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Children With Various Manifestations of Venous Thrombosis|Completed||Phase 2|64|Actual|Bayer||5|||f||||t|t|f||||||||2017-10-11 02:31:15.397166|2017-10-11 02:31:15.397166
NCT01684410|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2016-01-11|2015-08-10||August 2012||2012-08-01|January 2016|2016-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Intent-To-Treat (ITT) Population: included all subjects who were randomized (included those withdrawn from treatment for any reason).|Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis|A Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.|Completed||Phase 2|30|Actual|Grifols Therapeutics Inc.||3|||f||||t||||||||||2017-10-11 02:31:16.955653|2017-10-11 02:31:16.955653
NCT01684397|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-03-07|||October 5, 2012|Actual|2012-10-05|March 2017|2017-03-01|February 5, 2019|Anticipated|2019-02-05|February 5, 2018|Anticipated|2018-02-05||Interventional|||Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer|A Phase I/II Trial of Pazopanib Alternating With Bevacizumab in Treatment-Naive Metastatic Clear Cell Renal Cell Carcinoma Patients|Recruiting||Phase 1/Phase 2|66|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 02:31:17.648852|2017-10-11 02:31:17.648852
NCT01684384|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-11-26|||September 2012||2012-09-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Research to Evaluate a Possible Relation Between Values Obtained After Processing CT Images, Lung Function Tests and the Experience of the Patient During an Exacerbation in COPD Patients.|Correlation of Functional Respiratory Imaging Parameters With Lung Function Parameters and Patient Reported Outcome Measures During Exacerbation of COPD.|Completed||N/A|53|Actual|FLUIDDA nv||1|||f||||f||||||||||2017-10-11 02:31:17.795892|2017-10-11 02:31:17.795892
NCT01684371|ClinicalTrials.gov processed this data on October 10, 2017|2009-04-22|2012-09-10|||November 2008||2008-11-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Observational|||The Effects of Elmore Oil on Patients With Osteoarthritis|The Effects of a Herbal Remedy, Elmore Oil, on Pain and Well-being in Patients With Osteoarthritis: A Double-blind, Placebo-controlled, Randomised Trial.|Completed||N/A|60|Actual|Elmore Oil Company Pty Ltd|||2||f||||f||||||||||2017-10-11 02:31:17.917483|2017-10-11 02:31:17.917483
NCT01684358|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-11-04|||September 2012||2012-09-01|April 2013|2013-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|SIS||A Trial on the Effect of Sino-implant (II) Use on Condom Use Among Women in Kingston, Jamaica|A Randomized Controlled Trial on the Effect of Sino-implant (II) Use on Condom Use Among Women in Kingston, Jamaica|Completed||N/A|414|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 02:31:18.045556|2017-10-11 02:31:18.045556
NCT01684345|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-04-07|||August 2012||2012-08-01|April 2016|2016-04-01||||February 2016|Actual|2016-02-01||Interventional|EYEGUARD™-A||Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis|A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis|Terminated||Phase 3|200|Actual|XOMA (US) LLC||3|||f||||f||||||||||2017-10-11 02:31:18.179202|2017-10-11 02:31:18.179202
NCT01684332|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-18|||September 2010||2010-09-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Postprandial Response to Different Jams|Study of the Effects of Three Strawberry Jams, Differing in Carbohydrate and Antioxidant Content, on Postprandial Response in Healthy Subjects|Completed||N/A|16|Actual|Clinica Universidad de Navarra, Universidad de Navarra||3|||f||||f||||||||||2017-10-11 02:31:18.563225|2017-10-11 02:31:18.563225
NCT01684319|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-01-03|||August 2012||2012-08-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Milk-induced Gastrointestinal Symptoms in Infants|Prospective, Randomized, Double Blind and Placebo Controlled Study With the Aim to Establish the Role of Milk Proteins in Gastrointestinal Diseases (GERD, Constipation and Colics) of Young Infants and to Determine the Diagnostic Value of Immunological Tests in These Pathologies.|Completed||N/A|120|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 02:31:18.658453|2017-10-11 02:31:18.658453
NCT01684306|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-12|||February 2011||2011-02-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional|MODREST||Pharmacological Cognitive Enhancement|Acute Effects of Modafinil on Brain Resting State Networks in Young Healthy Subjects|Completed||Early Phase 1|26|Actual|Università degli Studi 'G. d'Annunzio' Chieti e Pescara||2|||f||||f||||||||||2017-10-11 02:31:18.745637|2017-10-11 02:31:18.745637
NCT01684293|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-05-12|||July 2013||2013-07-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study|Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study|Recruiting||N/A|20|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:31:18.82752|2017-10-11 02:31:18.82752
NCT01684280|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-11|||June 2010||2010-06-01|September 2012|2012-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Obesity-related Genes in Taiwanese Undergoing Weight Loss|Searching for the Most Influential Obesity-related Diabetic Genes and Exploring the Expression Profiles of Those Genes in Taiwanese Undergoing Weight Loss|Completed||N/A|20|Actual|Taipei Medical University Hospital|||1||f||||t||||||None Retained|"     Paired samples of abdominal subcutaneous and intrabdominal omental adipose tissue were     obtained from men and women who underwent laparoscopic bariatric surgery.   "|||2017-10-11 02:31:18.928963|2017-10-11 02:31:18.928963
NCT01684267|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-04-21|||January 2012||2012-01-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Pelvic Obliquity Rehabilitation in Stroke Patients Using Robotically Generated Force Fields|Pelvic Obliquity Rehabilitation in Stroke Patients Using Robotically Generated Force Fields|Active, not recruiting||N/A|30|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||f||||||||||2017-10-11 02:31:19.026823|2017-10-11 02:31:19.026823
NCT01684254|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-03-09|||May 2010||2010-05-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||An In-Shoe Device to Monitor Toe-Walking in Children With Cerebral Palsy|An In-Shoe Device to Monitor Toe-Walking in Children With Cerebral Palsy|Terminated||N/A|7|Actual|Spaulding Rehabilitation Hospital|||1|Lack of funding|f||||||||||||||2017-10-11 02:31:19.097382|2017-10-11 02:31:19.097382
NCT01684241|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-07-21|||June 2012||2012-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|MERIT||RBL001/RBL002 Phase I Clinical Trial|Clinical First-in-human Dose Escalation Study Evaluating the Safety and Tolerability of Intranodal Administration of an RNA-based Cancer Vaccine Targeting Two Tumor-associated Antigens in Patients With Advanced Melanoma|Completed||Phase 1|29|Actual|Biontech RNA Pharmaceuticals GmbH||1|||f||||t||||||||||2017-10-11 02:31:19.165084|2017-10-11 02:31:19.165084
NCT01684228|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-05-06|||August 2010||2010-08-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Impact of Hemodialysis on Exhaled Volatile Organic Compounds in End Stage Renal Disease|Impact of Hemodialysis on Exhaled Volatile Organic Compounds in End Stage Renal Disease|Completed||N/A|37|Actual|Rambam Health Care Campus|||1||f||||f||||||Samples Without DNA|"     exhaled breath   "|||2017-10-11 02:31:19.258052|2017-10-11 02:31:19.258052
NCT01684215|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-08-22|2016-11-09||October 2012|Actual|2012-10-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2016|Actual|2016-03-01||Interventional||Safety analysis set included all enrolled participants who received at least 1 dose of study drug (PD-0332991).|A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer|A Phase 1/2 Study Of The Efficacy, Safety, And Pharmacokinetics Of Oral Pd-0332991, A Cyclin-dependent Kinase 4 And 6 (cdk4/6) Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-line Treatment Of Postmenopausal Japanese Patients With Er (+) Her2 (-) Advanced Breast Cancer|Active, not recruiting||Phase 2|61|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:31:19.538033|2017-10-11 02:31:19.538033
NCT01684202|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-07-07|||July 2012||2012-07-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)|A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)|Completed||Phase 2|43|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:31:21.443216|2017-10-11 02:31:21.443216
NCT01684189|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-11|||November 2011||2011-11-01|November 2011|2011-11-01|August 2013|Anticipated|2013-08-01|||||Observational|||Registry of Febrile Neutropenia and Invasive Fungal Infections|A Non-interventional Prospective Registry to Monitor the Events of Febrile Neutropenia and Invasive Fungal Infections and the Diagnostic and Therapeutic Management in Patients With Malignant Hematologic Diseases After Chemotherapy|Unknown status|Recruiting|N/A|100|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-11 02:31:21.523051|2017-10-11 02:31:21.523051
NCT01684176|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-01-19|||August 2012||2012-08-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|February 2013|Actual|2013-02-01||Interventional|||Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication|Pharmacist Intervention Programme to Improve Medication Adherence in Stroke Patients|Completed||N/A|211|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 02:31:23.180372|2017-10-11 02:31:23.180372
NCT01684163|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2016-02-18||2016-02-18|November 2012||2012-11-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants|Phase 2, Double-Blind, Placebo Controlled, Randomized Withdrawal, Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder|Completed||Phase 2|369|Actual|Naurex, Inc||3|||f||||f||||||||||2017-10-11 02:31:23.323177|2017-10-11 02:31:23.323177
NCT01684150|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2016-08-02|||September 2012||2012-09-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving|A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving Translocation of the MLL Gene at 11q23 or Advanced Hematologic Malignancies|Completed||Phase 1|51|Actual|Epizyme, Inc.||1|||f||||f||||||||||2017-10-11 02:31:23.491566|2017-10-11 02:31:23.491566
NCT01684137|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-09-10|||August 2012||2012-08-01|September 2012|2012-09-01||||August 2013|Anticipated|2013-08-01||Interventional|||Monitoring of Allergic and Asthmatic Symptoms in Patients Taking Dietary Supplements Joalis Bambi Bronchi and Joalis Bambi Analerg||Unknown status|Recruiting|N/A|100|Anticipated|DSC Services, s.r.o.||2|||f||||f||||||||||2017-10-11 02:31:23.619426|2017-10-11 02:31:23.619426
NCT01684124|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2013-07-09|||March 2012||2012-03-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||An Assessment of the Feasibility and Safety of Conservative Oxygen Therapy in Critically Ill Patients|A Before-and-after Assessment of Conservative Oxygen Therapy vs. Standard Care in Critically Ill Mechanically Ventilated Patients|Completed||Phase 1/Phase 2|105|Actual|Austin Health||2|||f||||f||||||||||2017-10-11 02:31:23.703198|2017-10-11 02:31:23.703198
NCT01684111|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-01-15|||June 2013||2013-06-01|January 2016|2016-01-01||||January 2016|Actual|2016-01-01||Interventional|VENUS-1||An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1)|An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV|Completed||Phase 1|7|Actual|Aktion Bronchialkarzinom e.V.||1|||f||||f||||||||||2017-10-11 02:31:23.81229|2017-10-11 02:31:23.81229
NCT01684098|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-09|||August 2003||2003-08-01|September 2012|2012-09-01|August 2005||2005-08-01|||||Interventional|||Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor|A Phase II Clinical Study to Evaluate the Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor|Completed||Phase 2|40||Endocyte||1|||f||||||||||||||2017-10-11 02:31:23.924949|2017-10-11 02:31:23.924949
NCT01684085|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-10-07|||October 2012||2012-10-01|October 2012|2012-10-01||||September 2014|Anticipated|2014-09-01||Interventional|||Explanation About Sleep in Post Trauma Patients|Explanation About Sleep Given After Traumatic Event, and Its Effect on the Trajectory of Post Traumatic Stress Disorder (PTSD)|Unknown status|Not yet recruiting|N/A|70|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:31:24.012976|2017-10-11 02:31:24.012976
NCT01684072|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-09|||January 2011||2011-01-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin|Evaluation of Safety and Immunogenicity Receiving Live Attenuated Vaccine Against Varicella Without Gelatin|Completed||Phase 4|1200|Actual|Beijing Center for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 02:31:24.18057|2017-10-11 02:31:24.18057
NCT01684059|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2012-09-11|||July 2011||2011-07-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide Pathway|Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide Pathway|Completed||N/A|60|Actual|Babylon University|||1||f||||f||||||||||2017-10-11 02:31:24.356582|2017-10-11 02:31:24.356582
NCT01684046|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-03-27|2014-03-27||November 2012||2012-11-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||This analysis population includes all participants who were exposed to a study regimen (test or control).|Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2|Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2|Completed||N/A|196|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:31:24.453372|2017-10-11 02:31:24.453372
NCT01684033|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2014-03-12|2014-03-12||November 2012||2012-11-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||This analysis population includes all participants who were exposed to a study regimen (test or control).|Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1|Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1|Completed||N/A|207|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:31:24.674055|2017-10-11 02:31:24.674055
NCT01684020|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-09-12|||November 2012||2012-11-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|November 2014|Anticipated|2014-11-01||Interventional|||A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty|A Prospective, Double-Blinded, Randomized Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty|Unknown status|Recruiting|Phase 2|10|Anticipated|DeNova Research||2|||f||||f||||||||||2017-10-11 02:31:24.956024|2017-10-11 02:31:24.956024
NCT01684007|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-05-26|2015-05-08||November 2012||2012-11-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||This analysis population includes all implanted subjects.|A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract Patients|Clinical Outcomes After Implantation of the AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (MIOL) in the Dominant Eye and Randomization of the AcrySof® IQ ReSTOR® +2.5 D or +3.0 D MIOL in the Fellow Eye|Completed||N/A|112|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:31:25.128958|2017-10-11 02:31:25.128958
NCT01683994|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-08|2017-08-05|||September 6, 2012||2012-09-06|August 4, 2017|2017-08-04|June 1, 2018|Anticipated|2018-06-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer|A Phase I and Randomized Phase II Multicenter Study of Cabozantinib (XL184) Plus Docetaxel and Prednisone in Metastatic Castrate Resistant Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 02:31:25.522952|2017-10-11 02:31:25.522952
NCT01683981|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2013-08-08|||August 2012||2012-08-01|September 2012|2012-09-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate|Exercise Capacity and Quality of Life in Patients With Idiopathic Pulmonary Hypertension and Eisenmenger Syndrome Receiving Short Term Oral L-Citrulline Malate|Unknown status|Recruiting|Early Phase 1|25|Anticipated|Masih Daneshvari Hospital||1|||f||||t||||||||||2017-10-11 02:31:25.645537|2017-10-11 02:31:25.645537
NCT01683968|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-08|2012-09-12|||September 2012||2012-09-01|September 2012|2012-09-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Diastolic Dysfunction in Sickle Cell Disease During Vaso-occlusive Crisis|Diastolic Dysfunction in Sickle Cell Disease During Vaso-occlusive Crisis|Unknown status|Recruiting|N/A|216|Anticipated|King Abdullah International Medical Research Center|||1||f||||t||||||||||2017-10-11 02:31:25.750075|2017-10-11 02:31:25.750075
NCT01683955|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-08|2014-02-24|||January 2013||2013-01-01|February 2014|2014-02-01|May 2014|Anticipated|2014-05-01|March 2014|Anticipated|2014-03-01||Interventional|||Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty|Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty|Unknown status|Recruiting|Phase 1|228|Anticipated|Henry Ford Health System||2|||f||||f||||||||||2017-10-11 02:31:25.823953|2017-10-11 02:31:25.823953
NCT01683942|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2012-09-10|||August 2012||2012-08-01|September 2012|2012-09-01||||||||Observational|||A New Reproducible Method of Measuring C/D Ratio of Digital Stereo Images of Optic Disc|A New Reproducible Method of Measuring C/D Ratio of Digital Stereo Images of Optic Disc|Completed||N/A|250|Actual|Meir Medical Center|||1||f||||f||||||||||2017-10-11 02:31:25.927109|2017-10-11 02:31:25.927109
NCT01683929|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2015-04-13|||May 2013||2013-05-01|May 2014|2014-05-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||The Effects of Oral Glucose Compared to Sweetener Drinking on Hormonal/Metabolic Responses|The Effects of Oral Glucose Compared to Sweetener Drinking on Hormonal/Metabolic Responses and 24 Hour Macronutrient Consumption - A Double Blind, Cross-over Study|Completed||N/A|12|Actual|Meir Medical Center||2|||f||||f||||||||||2017-10-11 02:31:25.97386|2017-10-11 02:31:25.97386
NCT01683916|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-08|2017-07-19|||January 2011|Actual|2011-01-01|December 2010|2010-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Anesthetic Requirement and Stress Hormone Response During Surgery in Spinal Cord-injured Patients|Chonnam National University Hospital IRB|Completed||N/A|45|Actual|Chonnam National University Hospital|||1||f||||f||||||||||2017-10-11 02:31:26.046596|2017-10-11 02:31:26.046596
NCT01683903|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-09-10|||August 2012||2012-08-01|September 2012|2012-09-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|INCARD||"Comparison of Cardiac Rehabilitation Benefits Between Coronary and Non-coronary Patients Through a 24 Months Follow-up After Myocardial Infarction: the INCARD Study"|"Comparison of Cardiac Rehabilitation Benefits Between Coronary and Non-coronary Patients Through a 24 Months Follow-up : the INCARD Study"|Unknown status|Recruiting|N/A|150|Anticipated|Centre Hospitalier Sud Francilien|||2||f||||f||||||||||2017-10-11 02:31:26.115008|2017-10-11 02:31:26.115008
NCT01683890|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-05-27|||September 2012||2012-09-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Study on Bladder and Sexual Function Change After Simple Hysterectomy|Incidence and Pattern of Overactive Bladder Symptoms Occurring After Hysterectomy|Active, not recruiting||N/A|300|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-11 02:31:26.207171|2017-10-11 02:31:26.207171
NCT01683877|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2017-05-27|||September 2012||2012-09-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy Study of FloSeal in Hemostasis After Laparoscopic Ovarian Cystectomy|PROSPECTIVE RANDOMIZED CONPARISON OF ELECTRONIC DIATHERMY VERSUS FLOSEAL IN HEMOSTASIS AFTER LAPAROSCOPIC OVARIAN CYSTECTOMY|Active, not recruiting||N/A|130|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:31:26.28461|2017-10-11 02:31:26.28461
NCT01683851|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2013-12-12|||August 2012||2012-08-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Isolite and Dental Treatment Under Conscious Sedation|Isolite and Dental Treatment Under Conscious Sedation: a Pilot Study to Assess the Upper Airway in a Pediatric Population|Completed||N/A|20|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-10-11 02:31:26.639865|2017-10-11 02:31:26.639865
NCT01683838|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-07-27|2013-07-23||June 2002||2002-06-01|January 2014|2014-01-01|February 2004|Actual|2004-02-01|November 2003|Actual|2003-11-01||Interventional||"104 patients randomized to Fampridine-SR 50mg/day 100 patients randomized to Placebo. Total patients randomized = 204.
Overall, 203 (99.5%) patients were included in the ITT population, 182 (89.2%) in the Efficacy population and 203 (99.5%) in the Safety population."|Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury|Double-Blind, Placebo-Controlled, 12-Week Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Moderate to Severe Spasticity Resulting From Chronic, Incomplete Spinal Cord Injury|Completed||Phase 3|204|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-10-11 02:31:26.771113|2017-10-11 02:31:26.771113
NCT01683825|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-07-11|||September 2012||2012-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography|Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography|Recruiting||Phase 4|45|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 02:31:27.691975|2017-10-11 02:31:27.691975
NCT01683812|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-02-09|2016-12-15||May 2012||2012-05-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Cranial Cup Use for Correction of Head Shape Deformities|Cranial Cup Use for the Correction of Positional Head Shape Deformities in Hospitalized Premature Infants|Completed||N/A|23|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 02:31:27.794397|2017-10-11 02:31:27.794397
NCT01683799|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-09-28|||February 2013||2013-02-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2015|Actual|2015-07-01||Interventional|||Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis|Slow Wave Sleep and Inflammatory Processes in Pain|Completed||N/A|48|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 02:31:27.975923|2017-10-11 02:31:27.975923
NCT01683773|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2014-09-16|||September 2012||2012-09-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A|A Phase I, Open Label Trial to Evaluate the Safety and Immunogenicity of AERAS-402 Followed by MVA85A in BCG Vaccinated Adults (TB032)|Completed||Phase 1|40|Actual|University of Oxford||3|||f||||f||||||||||2017-10-11 02:31:28.228828|2017-10-11 02:31:28.228828
NCT01683747|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-09|2015-11-16|||June 2012||2012-06-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Single Dose Enteral Tranexamic Acid in Critically Ill Patients|Single Dose Enteral Tranexamic Acid for the Reduction of Morbidity in Hospitalized Critically Ill Patients|Terminated||Phase 2|4|Actual|San Diego Veterans Healthcare System||2||Lower than anticipated enrollment|f||||t||||||||||2017-10-11 02:31:28.418651|2017-10-11 02:31:28.418651
NCT01683734|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-02-03|||May 2012||2012-05-01|February 2015|2015-02-01||||December 2019|Anticipated|2019-12-01||Observational|||Assessing Renal Function in Patients With an Antibiotic Laden Spacer|Nephrotoxicity Following 2-Stage Exchange With Associated Antibiotic Laden Spacer in Patients With Infected Total Hip/Knee Arthroplasty|Recruiting||N/A|60|Anticipated|Central DuPage Hospital|||1||f||||f||||||||||2017-10-11 02:31:28.519583|2017-10-11 02:31:28.519583
NCT01683721|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2013-09-03|||September 2012||2012-09-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Observational|UNMASK||Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)|The UNMASK Study: A Post-Market Longitudinal Observational Study of the WinxTM Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA)|Unknown status|Recruiting|N/A|1000|Anticipated|ApniCure, Inc.|||1||f||||f||||||||||2017-10-11 02:31:28.600068|2017-10-11 02:31:28.600068
NCT01683708|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-10|||November 2008||2008-11-01|September 2012|2012-09-01||||||||Observational|||Effectiveness Of Symbiotic Therapy In Jaundiced Patients|Effectiveness of Perioperative Symbiotic Therapy to Reduce Infectious Morbidity in Jaundiced Patients: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|20|Anticipated|Azienda Ospedaliera Ordine Mauriziano di Torino|||2||f||||f||||||||||2017-10-11 02:31:28.701948|2017-10-11 02:31:28.701948
NCT01683695|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-01-20|||June 2012||2012-06-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Safety Study of AMG 557 in Subjects With Lupus Arthritis|A Randomized, Double-blind, Parallel, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Systemic Lupus Erythematosus (SLE) Subjects With Active Lupus Arthritis|Completed||Phase 1|20|Actual|Amgen||2|||f||||f||||||||||2017-10-11 02:31:28.810235|2017-10-11 02:31:28.810235
NCT01683682|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-01-22|||April 2013||2013-04-01|January 2015|2015-01-01||||January 2015|Actual|2015-01-01||Interventional|VENUS-2||An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2)|An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV|Completed||Phase 1|8|Actual|Aktion Bronchialkarzinom e.V.||1|||f||||f||||||||||2017-10-11 02:31:28.982795|2017-10-11 02:31:28.982795
NCT01683669|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-05-01|||August 2012||2012-08-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Effect of Variable PSV in Acute Lung Injury: Part I and Part II|Physiological Research on Variable Pressure Support Ventilation in Patients With Acute Acute Lung Injury: Part I and Part II|Completed||N/A|20|Actual|University of Genova||2|||f||||t||||||||||2017-10-11 02:31:29.170088|2017-10-11 02:31:29.170088
NCT01683656|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2013-03-14|||August 2012||2012-08-01|March 2013|2013-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|NILACH||ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART|ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART|Terminated||Phase 4|4|Actual|University Hospital, Geneva||2||Withdrawal of IMP from the market. Data on risk-benefit ratio pending.|f||||t||||||||||2017-10-11 02:31:29.401069|2017-10-11 02:31:29.401069
NCT01683643|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-05-09|||April 2012||2012-04-01|May 2017|2017-05-01|March 31, 2017|Actual|2017-03-31|March 31, 2017|Actual|2017-03-31||Interventional|SBIRT||Screening, Brief Intervention, and Referral to Treatment for Offenders|Screening, Brief Intervention, and Referral to Treatment for Offenders|Completed||N/A|800|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:31:29.629063|2017-10-11 02:31:29.629063
NCT01683630|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-08-29|2015-06-30||April 2012||2012-04-01|August 2016|2016-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada|Comparison of the Epidemiology and Clinical Outcomes of Laboratory-Confirmed Influenza A and Influenza B Cases in Manitoba, Canada|Completed||N/A|1849|Actual|International Centre for Infectious Diseases, Canada|||1||f||||f||||||||No||2017-10-11 02:31:29.750013|2017-10-11 02:31:29.750013
NCT01683617|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-01-31|||May 2012||2012-05-01|January 2014|2014-01-01|July 2015|Anticipated|2015-07-01|January 2014|Anticipated|2014-01-01||Interventional|INTERSTRESS||Management and Treatment of Stress-related Disorders (INTERSTRESS)|INTERSTRESS - Interreality in the Management and Treatment of Stress-related Disorders|Unknown status|Active, not recruiting|Phase 1/Phase 2|100|Actual|Istituto Auxologico Italiano||2|||f||||f||||||||||2017-10-11 02:31:30.165674|2017-10-11 02:31:30.165674
NCT01683604|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-06-10|2016-04-20||July 2012||2012-07-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational||Full Analysis Set (FAS): All enrolled participants who received at least 1 dose of tocilizumab.|Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia|A Multi-National, Multi-Center Non-Interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab (ACT-UP)|Completed||N/A|37|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:31:30.33953|2017-10-11 02:31:30.33953
NCT01683591|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-09-07|||April 2009||2009-04-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|||||Observational|DASH||Dysphagia Assessment in Acute Ischemic Stroke Using High-resolution Manometry|Dysphagia Screening in Acute Stroke Using High-resolution Impedance Manometry (DASH); Its Implication to Diet Decision and Clinical Outcome|Completed||N/A|293|Actual|The Catholic University of Korea|||3||f||||f||||||||||2017-10-11 02:31:33.57767|2017-10-11 02:31:33.57767
NCT01683578|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2016-03-30|||September 2012||2012-09-01|March 2016|2016-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|PROVAR||Protective Variable Ventilation for Open Abdominal Surgery|Effects of Variable Tidal Volumes During Open Abdominal Surgery on Lung Function and Systemic Inflammation|Completed||N/A|50|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-10-11 02:31:33.670802|2017-10-11 02:31:33.670802
NCT01683565|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-06-29|||September 2012|Actual|2012-09-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|March 2015|Actual|2015-03-01||Interventional|||Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood|Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood|Completed||Phase 4|31|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-11 02:31:33.749031|2017-10-11 02:31:33.749031
NCT01683552|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-11|||September 2010||2010-09-01|September 2012|2012-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|AprepIt||Aprepitant in the Management of Biological Therapies-related Severe Pruritus|Aprepitant in the Management of Biological Therapies-related Severe Pruritus: a Pilot Study in 45 Cancer Patients|Completed||Phase 2|45|Actual|Campus Bio-Medico University||2|||f||||f||||||||||2017-10-11 02:31:33.820735|2017-10-11 02:31:33.820735
NCT01683539|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-08-09|||September 2012|Actual|2012-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|Cog-2||Understanding How Cognitive Remediation Works|A Dismantling Study of Cognitive Remediation for Supported Employment|Active, not recruiting||N/A|244|Anticipated|Boston University Charles River Campus||2|||f||||t||||||||||2017-10-11 02:31:33.93347|2017-10-11 02:31:33.93347
NCT01683526|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-10-09|2014-05-23||August 2012||2012-08-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Safety and Efficacy of Endotracheal Intubation Using Glidescope Video-Laryngoscope|Safety and Efficacy of Endotracheal Intubation by Pulmonary Critical Care Physicians in Critically-Ill Patients Using Glidescope Video-Laryngoscope|Completed||N/A|117|Actual|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-11 02:31:34.0588|2017-10-11 02:31:34.0588
NCT01683513|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-03-20|||November 2011||2011-11-01|March 2017|2017-03-01||||January 2018|Anticipated|2018-01-01||Interventional|||Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients|Prospective Randomized Trial on GnRH Agonist Triggering Versus hCG Triggering in IVF Stimulation in PCOS Patients|Recruiting||Phase 4|120|Anticipated|AZ Jan Palfijn Gent||2|||f||||t||||||||||2017-10-11 02:31:34.357122|2017-10-11 02:31:34.357122
NCT01683500|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-06-02|||August 2012||2012-08-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)|Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)|Completed||Phase 3|4|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 02:31:34.536202|2017-10-11 02:31:34.536202
NCT01683487|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-05-26|||October 2012||2012-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Observational|||Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.|Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. Analysis of Risk Factors and Impact on the Outcome.|Completed||Phase 4|122|Actual|University of Zurich|||1||f||||t||||||||||2017-10-11 02:31:34.624588|2017-10-11 02:31:34.624588
NCT01683474|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-01-03|||September 2012||2012-09-01|January 2015|2015-01-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|Venus-A||Safety and Performance of TAVI of Venus MedTech Aortic Valve Prosthesis|Clinical Evaluation of the Safety and Performance of Percutaneous Implantation of the Venus MedTech Aortic Valve Prosthesis for Patients Who Cannot Undergo Surgical Valve Replacement|Unknown status|Recruiting|N/A|80|Anticipated|Venus MedTech (HangZhou) Inc.||1|||f||||t||||||||||2017-10-11 02:31:34.709959|2017-10-11 02:31:34.709959
NCT01683461|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-10|||May 2008||2008-05-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SAHAPS||Efficacy of HIV Post-Test Support for ANC in South Africa|Efficacy of HIV Posttest Support for ANC in South Africa|Completed||N/A|1500|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:31:34.802363|2017-10-11 02:31:34.802363
NCT01683448|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-07-06|||February 2010|Actual|2010-02-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery|The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery|Completed||N/A|1|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 02:31:34.893128|2017-10-11 02:31:34.893128
NCT01683435|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-08-31|||November 2011||2011-11-01|August 2015|2015-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||The Value of HBA in the Evaluation of Idiopathic Infertility|The Value of Hyaluronic Binding Assays (HBA) in the Evaluation of Idiopathic Infertility|Completed||N/A|35|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||f||||||||||2017-10-11 02:31:34.971016|2017-10-11 02:31:34.971016
NCT01683422|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-12-14|||December 2011||2011-12-01|August 2016|2016-08-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer|A Phase II Trial of Gemcitabine and Erlotinib (GE) Plus Proton-chemotherapy (PCT) and Capox for Locally Advanced Pancreatic Cancer (LAPC)|Recruiting||Phase 2|43|Anticipated|Loma Linda University||1|||f||||t||||||||No||2017-10-11 02:31:35.146716|2017-10-11 02:31:35.146716
NCT01683409|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-06-02|2017-03-10|2015-01-16|August 2012||2012-08-01|June 2017|2017-06-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional||All participants that received at least one dose of study drug.|A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2 Study to Evaluate the Safety and Renal Efficacy of Baricitinib in Patients With Diabetic Kidney Disease|Completed||Phase 2|130|Actual|Eli Lilly and Company||5|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 02:31:35.363955|2017-10-11 02:31:35.363955
NCT01683396|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-03-03|||July 2012||2012-07-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand|A Phase 2 Proof-of-Concept Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand|Completed||Phase 2|87|Actual|XOMA (US) LLC||2|||f||||f||||||||||2017-10-11 02:31:40.08092|2017-10-11 02:31:40.08092
NCT01683383|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-12-01|2014-11-21||September 2012||2012-09-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|CTCT|Eligible newborns|California Transport Cooling Trial|A Randomized Clinical Trial of Therapeutic Hypothermia During Transport for Hypoxic Ischemic Encephalopathy (HIE): Device-regulated Cooling Versus Standard Practice.|Completed||N/A|101|Actual|Stanford University|1, The criteria used to initiate hypothermia varied. 2, Operational errors occurred in 9 newborns during device regulated cooling. 3, 9.6% of temperatures in the control arm were missing.|2|||f||||t||||||||||2017-10-11 02:31:40.232776|2017-10-11 02:31:40.232776
NCT01683370|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-04-26|||August 2012||2012-08-01|April 2016|2016-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Pediatric FN Definition 2012 Bern|Pediatric FN Definition 2012 Bern The Impact of Lowering Fever Limits on the Rate of Fever in Chemotherapy-induced Neutropenia (FN). A Prospective Single-center Observational Study in Children and Adolescents With Cancer.|Completed||N/A|39|Actual|Swiss Pediatric Oncology Group|||1||f||||f||||||Samples Without DNA|"     1 mL serum, kept refrigerated until the end of study, then analyed as batch for cortisol,     then discarded.   "|||2017-10-11 02:31:41.374552|2017-10-11 02:31:41.374552
NCT01683357|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-09-06|||September 2001||2001-09-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Observational|||Prognosis of One-stage Hepatectomy for Bilobar Colorectal Metastases|LONG-TERM RESULTS AFTER ONE-STAGE ULTRASOUND-GUIDED HEPATECTOMY IN PATIENTS WITH MULTIPLE BILOBAR COLORECTAL LIVER METASTASES: TOWARDS NEW CONCEPTS OF RADICAL RESECTION BY MEANS OF AN INTENTION TO TREAT ANALYSES|Completed||N/A|58|Actual|University of Milan|||1||f||||f||||||||||2017-10-11 02:31:41.467854|2017-10-11 02:31:41.467854
NCT01683331|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-02-20|||August 2012|Actual|2012-08-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|ITP-NODAT||A Clinical Trial to Prevent New Onset Diabetes After Transplantation|A Clinical Trial to Prevent New Onset Diabetes After Transplantation|Active, not recruiting||Phase 4|300|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-11 02:31:41.56952|2017-10-11 02:31:41.56952
NCT01683318|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-11-11|||September 2012||2012-09-01|September 2012|2012-09-01||||October 2013|Actual|2013-10-01||Interventional|||Treatment of Meibomian Gland Dysfunction|Thermal Pulsation System for the Treatment of Meibomian Gland Dysfunction|Completed||N/A|25|Actual|Singapore National Eye Centre||1|||f||||f||||||||||2017-10-11 02:31:41.655884|2017-10-11 02:31:41.655884
NCT01683305|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-10|||March 2013||2013-03-01|September 2012|2012-09-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Observational|||Biomarker Breast Pap Test||Unknown status|Not yet recruiting|N/A|500|Anticipated|Silbiotech|||3||f||||f||||||||||2017-10-11 02:31:41.736409|2017-10-11 02:31:41.736409
NCT01683292|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-07|||January 2006||2006-01-01|September 2012|2012-09-01|May 2007|Actual|2007-05-01|June 2006|Actual|2006-06-01||Interventional|||Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease|An Ascending-Dose, Single-Centre Study Investigating the Safety, Tolerability, Efficacy, and Pharmacokinetics of VR040(Inhaled Apomorphine)in Parkinson's Disease|Completed||Phase 2|29|Actual|South Glasgow University Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 02:31:41.817367|2017-10-11 02:31:41.817367
NCT01683279|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-05-01|||December 2012||2012-12-01|May 2017|2017-05-01|January 2031|Anticipated|2031-01-01|January 2031|Anticipated|2031-01-01||Interventional|||A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia|Pediatric Leukemia Adoptive Therapy (PLAT)-01: A Phase 1 Feasibility and Safety Study of Cellular Immunotherapy for Relapsed Pediatric CD19+ Acute Lymphoblastic Leukemia Using Autologous T-cells Lentivirally Transduced To Express a CD19-Specific Chimeric Antigen Receptor|Active, not recruiting||Phase 1|18|Anticipated|Seattle Children's Hospital||1|||f||||t||||||||||2017-10-11 02:31:41.977917|2017-10-11 02:31:41.977917
NCT01683266|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-05-28|2015-03-24|2014-11-14|September 2012||2012-09-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|EDITION IV|Randomized population: all screened participants (who originally met inclusion criteria and signed informed consent) allocated to a treatment group and recorded in Interactive Voice/Web Response System (IVRS/IWRS) database, regardless of whether treatment was used or not. Participants were analyzed in treatment group to which they were randomized.|Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus|A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Injected in the Morning or Evening in Patients With Type 1 Diabetes Mellitus With a 6-month Safety Extension Period|Completed||Phase 3|549|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:31:42.223335|2017-10-11 02:31:42.223335
NCT01683253|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-10-10|||November 2012||2012-11-01|October 2012|2012-10-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|REIN-PD||Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa|The REmission of the Impulse Control Disorder and the Changes of the Neuropsychiatric Characteristics After Switching Into Levodopa/Carbidopa in Patients With Parkinson's Disease Who Have Developed Impulse Control Disorders Due to the Dopamine Replacement Therapy|Unknown status|Not yet recruiting|Phase 4|78|Anticipated|Sandoz||1|||f||||f||||||||||2017-10-11 02:31:44.09618|2017-10-11 02:31:44.09618
NCT01683240|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-05-10|||February 2011||2011-02-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|SAC||Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones|Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones|Completed||N/A|59|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||Undecided||2017-10-11 02:31:44.172843|2017-10-11 02:31:44.172843
NCT01683227|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-04-18|||April 2010||2010-04-01|April 2016|2016-04-01|August 2012|Actual|2012-08-01|June 2011|Actual|2011-06-01||Interventional|SBIRT||Screening, Brief Intervention, and Referral to Treatment for Drug Use|Screening and Brief Intervention for Latino and Non-Latino White Drug Users|Completed||N/A|700|Actual|San Diego State University||2|||f||||f||||||||||2017-10-11 02:31:44.356131|2017-10-11 02:31:44.356131
NCT01683214|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-04-10|||August 2012||2012-08-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|BNA-Mood||Brain Network Activation Analysis to Diagnose/Assess Treatment of Unipolar Major Depression and Bipolar I Depression|Potential Use of Brain Network Activation (BNA) Analysis Using Evoked Response Potentials to Diagnose Unipolar Major Depression and Bipolar I Depression and Assess Response to Treatment|Enrolling by invitation||N/A|250|Anticipated|Rush University Medical Center|||1||f||||f||||||||||2017-10-11 02:31:44.457369|2017-10-11 02:31:44.457369
NCT01683201|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-03-18|||September 2012||2012-09-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|January 2014|Actual|2014-01-01||Interventional|FEATHER||Functional Exercise After Total Hip Replacement|Functional Exercise After Total Hip Replacement: A Randomised Controlled Late Phase Trial|Completed||N/A|72|Actual|Health Service Executive, Ireland||2|||f||||f||||||||||2017-10-11 02:31:44.522245|2017-10-11 02:31:44.522245
NCT01683006|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2017-08-28|||April 2012|Actual|2012-04-01|August 2017|2017-08-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Influence of Skeletal Muscle Paralysis on Metabolism in Hypothermic Patients After Cardiac Arrest|Influence of Skeletal Muscle Paralysis on Metabolism in Hypothermic Patients After Cardiac Arrest|Completed||N/A|43|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:31:47.778832|2017-10-11 02:31:47.778832
NCT01683188|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-02-03|||August 2012||2012-08-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|PROCLIVITY 01||HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma|A Multi-Center Study of High Dose Aldesleukin (Interleukin-2) + Vemurafenib Therapy in Patients With BRAFV600 Mutation Positive Metastatic Melanoma|Terminated||Phase 4|53|Actual|Prometheus Laboratories||2||A shift in the melanoma treatment landscape adversely affected accrual & to early closure.|f||||t||||||||||2017-10-11 02:31:44.614232|2017-10-11 02:31:44.614232
NCT01683175|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-10-19|||August 2012||2012-08-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation|A Prospective, Open-labelled, Randomized, Multicenter Phase II Study to Evaluate Efficacy and Safety of Erlotinib vs NP Chemotherapy as Adjuvant Therapy in Post Radical Operation NSCLC Patients With EGFR19 or 21 Exon Mutation|Active, not recruiting||Phase 2|94|Actual|Tianjin Medical University Cancer Institute and Hospital||2|||f||||f||||||||||2017-10-11 02:31:44.748702|2017-10-11 02:31:44.748702
NCT01683162|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-09-15|||July 2012||2012-07-01|September 2012|2012-09-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|||Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants|Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants|Unknown status|Recruiting|Phase 4|150|Anticipated|Shanghai Jiao Tong University School of Medicine||3|||f||||t||||||||||2017-10-11 02:31:44.876207|2017-10-11 02:31:44.876207
NCT01683149|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-03-03|||January 2013||2013-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies|Phase I, Traditional 3+3, Trial of PO Sorafenib and Topotecan in Refractory or Recurrent Pediatric Solid Malignancies|Completed||Phase 1|13|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 02:31:44.988546|2017-10-11 02:31:44.988546
NCT01683136|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-09-06|||September 2012||2012-09-01|September 2012|2012-09-01||||March 2014|Anticipated|2014-03-01||Interventional|||Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder||Unknown status|Not yet recruiting|N/A|20|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 02:31:45.147359|2017-10-11 02:31:45.147359
NCT01683123|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-10|||July 2007||2007-07-01|September 2012|2012-09-01|October 2012|Anticipated|2012-10-01|June 2011|Actual|2011-06-01||Observational|BUFLU||Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT|Phase 2 Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning For HLA Identical Sibling Allogeneic HSCT In Myeloid Malignancies. Retrospective Analysis.|Unknown status|Active, not recruiting|N/A|143|Actual|Grupo Espanol de trasplantes hematopoyeticos y terapia celular|||1||f||||t||||||||||2017-10-11 02:31:45.277461|2017-10-11 02:31:45.277461
NCT01683110|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2013-01-15||||||January 2013|2013-01-01||||||||Expanded Access|||Expanded Access of Cabozantinib in Medullary Thyroid Cancer|An Open-Label, Expanded Access Study of Cabozantinib (XL184) in Subjects With Unresectable, Locally Advanced, or Metastatic Medullary Thyroid Cancer|Approved for marketing||N/A|||Exelixis|||||||||||||||||||2017-10-11 02:31:45.380193|2017-10-11 02:31:45.380193
NCT01683097|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-09-07|||March 2009||2009-03-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Patient Understanding of End of Life Care|Assessing Patient Understanding and Factors That Govern Advanced Directives and End of Life Discussion|Completed||N/A|300|Actual|Partners in Internal Medicine||2|||f||||f||||||||||2017-10-11 02:31:45.466922|2017-10-11 02:31:45.466922
NCT01683084|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-09-15|||September 19, 2012|Actual|2012-09-19|September 2017|2017-09-01|March 30, 2016|Actual|2016-03-30|March 30, 2016|Actual|2016-03-30||Interventional|TEDY||Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms|Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms|Completed||Phase 4|22|Actual|Palo Alto Veterans Institute for Research||2|||f||||f||||||||||2017-10-11 02:31:45.593871|2017-10-11 02:31:45.593871
NCT01683071|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-03-24||2014-03-24|September 2012||2012-09-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia Following Total Knee Arthroplasty|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Single Injection Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia in Subjects Undergoing Total Knee Arthroplasty|Completed||Phase 2/Phase 3|278|Actual|Pacira Pharmaceuticals, Inc||4|||f||||t||||||||||2017-10-11 02:31:45.747817|2017-10-11 02:31:45.747817
NCT01683058|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-03-25|2014-12-23||January 2013||2013-01-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia|A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia|Completed||Phase 3|74|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 02:31:46.075428|2017-10-11 02:31:46.075428
NCT01683045|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-04-22|||September 2012||2012-09-01|April 2014|2014-04-01|May 2014|Anticipated|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats|Ablation for the Treatment of Concomitant Atrial Fibrillation in Non-Paroxysmal Patients (ATTAC-AF)|Terminated||N/A|6|Actual|Endoscopic Technologies, Inc||1|||f||||f||||||||||2017-10-11 02:31:46.988587|2017-10-11 02:31:46.988587
NCT01683032|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-26|2014-11-18|||October 2012||2012-10-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|May 2013|Actual|2013-05-01||Interventional|||A Study on the Effect of Methylphenidate on Creativity of Healthy Adults||Completed||N/A|38|Actual|Shalvata Mental Health Center||1|||f||||t||||||||||2017-10-11 02:31:47.09603|2017-10-11 02:31:47.09603
NCT01626729|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-20|||May 2011||2011-05-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Facts-Up-Front Versus Traffic-Light Food Labels|Facts-Up-Front Versus Traffic-Light Food Labels: A Randomized Controlled Trial|Completed||N/A|703|Actual|Yale University||5|||f||||f||||||||||2017-10-11 02:49:00.107389|2017-10-11 02:49:00.107389
NCT01682993|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2017-04-25|||January 2010||2010-01-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Corneal Cross Linking and Topography Guided Excimer Laser Treatment|Topography Guided Excimer Laser Surface Ablation in Combination With Corneal Cross-linking (CCL) in Patients With Progressive Ectatic Corneal Disorders.|Terminated||Phase 3|30|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:31:47.87427|2017-10-11 02:31:47.87427
NCT01682980|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-10-22|||March 2013||2013-03-01|October 2014|2014-10-01|December 2025|Anticipated|2025-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy of Exercise on Physical Function and Cartilage Health in Patients With Knee Osteoarthritis|Efficacy of Strength and Aerobic Exercise on Patient-reported Outcomes and Structural Changes in Patients With Knee Osteoarthritis - A Randomised Controlled Trial.|Recruiting||N/A|207|Anticipated|Oslo University Hospital||3|||f||||t||||||||||2017-10-11 02:31:47.977256|2017-10-11 02:31:47.977256
NCT01682967|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-09-26|||January 2012||2012-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|AHEAD||Alteration in Hearing Following Accidental Dural Puncture. A Study in Parturients|Alteration in Hearing Following Accidental Dural Puncture. A Study in Parturients|Completed||N/A|21|Actual|Örebro University, Sweden|||3||f||||t||||||||||2017-10-11 02:31:48.092932|2017-10-11 02:31:48.092932
NCT01682954|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-10-22|2014-10-16||November 2012||2012-11-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of a Lifestyle Intervention for Employees With Prediabetes|Evaluation of a Lifestyle Intervention for Employees With Prediabetes|Completed||N/A|78|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 02:31:48.169919|2017-10-11 02:31:48.169919
NCT01682941|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2016-09-29|||October 2009||2009-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2015|Actual|2015-06-01||Interventional|||Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific Antigen|Bioavailability of Isoflavones Delivered by Soy Almond Bread in Men With Recurring Prostate Cancer and Rising Prostate Specific Antigen|Active, not recruiting||Phase 2|40|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:31:48.424241|2017-10-11 02:31:48.424241
NCT01682928|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2016-11-22|||August 2012||2012-08-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|STRONG||Hydrotherapy for the Reversal of Oligohydramnios|Submersion Therapy for the Reversal of Oligohydramnios; A Non-invasive Gentle Approach|Terminated||N/A|4|Actual|Mednax Center for Research, Education and Quality||2||Poor enrollment|f||||f||||||||No||2017-10-11 02:31:48.668214|2017-10-11 02:31:48.668214
NCT01682915|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-07|||August 2012||2012-08-01|September 2012|2012-09-01|July 2015|Anticipated|2015-07-01|||||Observational|||Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of ADHD|Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of Attention-deficit Hyperactivity Disorder|Unknown status|Recruiting|N/A|240|Anticipated|National Taiwan University Hospital|||5||f||||t||||||||||2017-10-11 02:31:48.771788|2017-10-11 02:31:48.771788
NCT01682902|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-01-06|||September 2012||2012-09-01|January 2017|2017-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes|A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes|Completed||Phase 1|43|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 02:31:48.881016|2017-10-11 02:31:48.881016
NCT01682889|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2012-09-06|||January 2007||2007-01-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation|The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation: a Randomized, Controlled Clinical Trial in Patients Receiving Peripheral Vascular Surgery|Completed||Phase 4|40|Actual|Medical Scientific Fund of the Mayor of Vienna||2|||f||||||||||||||2017-10-11 02:31:49.057784|2017-10-11 02:31:49.057784
NCT01682876|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2015-02-20|2014-06-06||October 2012||2012-10-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|||Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.|A Phase 3b, Randomized, Observer-Blind, Placebo-Controlled Multi-Center Study Comparing Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine, Administered to Healthy Children 2 to 10 Years of Age.|Completed||Phase 3|715|Actual|Novartis||4|||f||||f||||||||||2017-10-11 02:31:49.263271|2017-10-11 02:31:49.263271
NCT01682863|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-02-29|2015-06-22||October 2012||2012-10-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||The Full Analysis set (FAS) included all randomized patients who received at least one dose of study medication. Patients were analyzed according to the treatment they were assigned to at randomization.|A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation|A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation|Completed||Phase 3|614|Actual|Novartis||3|||f||||t||||||||||2017-10-11 02:31:50.9562|2017-10-11 02:31:50.9562
NCT01682850|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-03-17|||August 2013||2013-08-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||Pulmonary Rehabilitation Before Lung Cancer Resection|Pulmonary Rehabilitation Before Lung Cancer Resection|Enrolling by invitation||N/A|154|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 02:31:52.918438|2017-10-11 02:31:52.918438
NCT01682837|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-03-17|2016-09-22||October 2012||2012-10-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Thirty (30) subjects participated in the trial. Each subject completed all four phases of the trial.|Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension|Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension|Completed||Phase 2|35|Actual|University of Texas Southwestern Medical Center||24|||f||||f||||||||No||2017-10-11 02:31:53.045307|2017-10-11 02:31:53.045307
NCT01682824|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-06-16|||May 2013|Actual|2013-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||MyChoice: An Application of the Three-Factor Eating Questionnaire (TFEQ-R18v2) Among Adolescent and Young Adult Survivors of Central Nervous System (CNS) Tumors|MyChoice: An Application of the Three-Factor Eating Questionnaire (TFEQ-R18v2) Among Adolescent and Young Adult Survivors of Central Nervous System (CNS) Tumors|Recruiting||N/A|250|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 02:31:53.869188|2017-10-11 02:31:53.869188
NCT01682811|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-10-13|||November 2011||2011-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|October 2016|Actual|2016-10-01||Interventional|||Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)|Photodynamic Therapy for Benign Dermal Neurofibromas Using Levulan Kerastick For Topical Solution, Plus Illumination With Red Light|Active, not recruiting||Phase 1|30|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 02:31:55.608047|2017-10-11 02:31:55.608047
NCT01682798|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2012-10-24|||May 2009||2009-05-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||"Study of Yili Changqing Pro-ABB Yoghurt in the Improvement of Human Gastrointestinal Tract System"|"The Clinical Research on the Efficiency of Yili Changqing Pro-ABB Probiotic Yogurt in the Improvement of Human Gastrointestinal Tract System"|Completed||N/A|400|Actual|Inner Mongolia Yili Industrial Group Co., Ltd||3|||f||||||||||||||2017-10-11 02:31:55.779373|2017-10-11 02:31:55.779373
NCT01682785|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2012-09-10|||September 2012||2012-09-01|September 2012|2012-09-01||||||||Observational|||Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder|Incidence and Prevalence of and Factors Associated With Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder|Unknown status|Not yet recruiting|N/A|140|Anticipated|ChaingMai University|||1||f||||||||||||||2017-10-11 02:31:55.895895|2017-10-11 02:31:55.895895
NCT01682772|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-10-02|||July 2012||2012-07-01|October 2014|2014-10-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|TOPARP||TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer|A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer (TOPARP)|Unknown status|Recruiting|Phase 2|89|Anticipated|Institute of Cancer Research, United Kingdom||1|||f||||t||||||||||2017-10-11 02:31:55.961376|2017-10-11 02:31:55.961376
NCT01682759|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2016-01-06|2016-01-06||September 2012||2012-09-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)|A Phase III, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK-3102 Compared With the Addition of Glimepiride in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin|Completed||Phase 3|751|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 02:31:56.119501|2017-10-11 02:31:56.119501
NCT01682746|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-01-16|||March 2013||2013-03-01|January 2017|2017-01-01|April 2024|Anticipated|2024-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors|Photodynamic Therapy (PDT) for Poor Prognosis Recurrent/Refractory Malignant Brain Tumors - A Phase I Study|Recruiting||Phase 1|24|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 02:31:56.91078|2017-10-11 02:31:56.91078
NCT01682733|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2015-04-06|||August 2012||2012-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Endoscopic Gastric Reduction for Weight Management|Endoscopic Gastric Reduction for Weight Management: A Pilot Feasibility Study|Completed||Phase 1|10|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:31:57.086453|2017-10-11 02:31:57.086453
NCT01682720|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-10-08|2014-10-02||September 2012||2012-09-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional||Safety Analysis Set: participants who were randomized and received at least 1 dose of study drug.|Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GS-7977+Ribavirin for 12 Weeks in Treatment Naive and Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection.|Completed||Phase 3|421|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 02:31:57.205547|2017-10-11 02:31:57.205547
NCT01682707|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-01|2012-09-10|||February 2010||2010-02-01|April 2012|2012-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Assessment of Hemodynamic Response During Intubation Between Rigid Laryngoscopy and Track Light in Coronary Patients|Randomized Clinical Trials to Compare the Hemodynamic Response During Intubation Between Rigid Laryngoscopy and Track Light in Coronary Patients Undergoing CABG|Completed||Phase 4|40|Actual|Federal University of Juiz de Fora||2|||f||||t||||||||||2017-10-11 02:31:58.670427|2017-10-11 02:31:58.670427
NCT01682694|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2014-05-23|||September 2012||2012-09-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|GLANCE||Glucosamine and Chondroitin Effects|Glucosamine and Chondroitin Effects|Completed||N/A|20|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 02:31:58.771089|2017-10-11 02:31:58.771089
NCT01682681|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2013-08-21|2013-06-12||July 2007||2007-07-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational||Full analysis set (FAS) population included all participants who met all the eligibility criteria.|An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With Epilepsy|A Prospective, Observational, Multi-center Study to Assess Long-term Retention Rate of Topiramate in Patients With Epilepsy|Completed||Phase 4|1234|Actual|Janssen Korea, Ltd., Korea|The study design is single arm and open label, so bias could not be excluded in the subjective evaluation by Participants and Investigators.||1||f||||t||||||||||2017-10-11 02:31:58.91942|2017-10-11 02:31:58.91942
NCT01682668|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-02-23|||February 2013||2013-02-01|February 2016|2016-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|GB-MOV||Subthalamic Nucleus, Akinesia and Parkinson's Disease|Role of the Subthalamic Nucleus in the Control of Movement: Physiopathology of Akinesia in Parkinson's Disease.|Recruiting||N/A|60|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 02:31:59.351359|2017-10-11 02:31:59.351359
NCT01682655|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2015-03-10|||July 2012||2012-07-01|November 2013|2013-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Genetic Variant in Apolipoprotein C3 Gene and Fatty Liver in Obese Children|The Influence of Apolipoprotein C3 Variants on Liver Steatosis and Serum Liver Enzyme Values in Obese Children|Completed||N/A|500|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||Samples With DNA|"     serum, WBC DNA   "|||2017-10-11 02:31:59.468037|2017-10-11 02:31:59.468037
NCT01682642|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-03-09|2015-02-05||March 2012||2012-03-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||women between 18 and 38 years|The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis.|IVF Outcome in Patients With Peritoneal Endometriosis. The Impact of a Hormonal Treatment of the Endometriosis Prior to the IVF on the Pregnancy Rates.|Completed||Phase 4|120|Actual|AZ Jan Palfijn Gent||2|||f||||t||||||||||2017-10-11 02:31:59.552662|2017-10-11 02:31:59.552662
NCT01682629|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-10|||April 2009||2009-04-01|September 2012|2012-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|EXPRESS||Examining the Effect of a Scripted Debriefing on Resuscitation Performance in Pediatrics|Examining Pediatric Resuscitation Education Using Simulation and Scripted Debriefing: A Multicenter, Randomized Controlled Trial|Completed||N/A|443|Actual|Express Collaborative||4|||f||||f||||||||||2017-10-11 02:31:59.970572|2017-10-11 02:31:59.970572
NCT01682616|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-07-17|||August 6, 2012||2012-08-06|July 2017|2017-07-01|June 28, 2019|Anticipated|2019-06-28|May 15, 2019|Anticipated|2019-05-15||Interventional|||A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Active, not recruiting||Phase 1|50|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-11 02:32:00.081178|2017-10-11 02:32:00.081178
NCT01682603|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2017-02-13|2014-05-16||September 2012||2012-09-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Botulinum Toxin A on Detrusor Overactivity and Renal Function in Chronic Spinal Cord Injured Patients|Effect of Botulinum Toxin A on Detrusor Overactivity and Renal Function in Chronic Spinal Cord Injured Patients - Clinical Effects and Investigating Mechanism of Action|Completed||Phase 2|34|Actual|Buddhist Tzu Chi General Hospital||1|||f||||f||||||||||2017-10-11 02:32:00.196583|2017-10-11 02:32:00.196583
NCT01682590|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-10|2017-02-01|||July 2012||2012-07-01|January 2016|2016-01-01||||October 2016|Actual|2016-10-01||Interventional|IDEAL-ICU||I.D.E.A.L.-I.C.U. (Initiation of Dialysis EArly Versus deLayed in Intensive Care Unit)|Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial|Terminated||Phase 3|500|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||t||||||||||2017-10-11 02:32:00.670352|2017-10-11 02:32:00.670352
NCT01682577|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2012-09-06|||September 2008||2008-09-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition|Bioequivalence Study of 4 mg Perindopril Tablets Produced by PT Dexa Medica in Comparison With the Reference Tablets (Prexum® 4 mg, Servier)Under Fasting Condition|Completed||N/A|18|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 02:32:00.824074|2017-10-11 02:32:00.824074
NCT01682564|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2015-09-22|||January 2012||2012-01-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CANTABILE||To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure|Open Label, Randomized, Active Drug Comparative, Parallel Group, Multi-center, Phase IV Study to Compare and Evaluate the Efficacy and Safety of Candemore Tab and Atacand Tab.|Completed||Phase 4|169|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:32:00.950806|2017-10-11 02:32:00.950806
NCT01682551|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-13|||September 2012||2012-09-01|September 2012|2012-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness|Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness|Unknown status|Not yet recruiting|Phase 2|240|Anticipated|China Medical University Hospital||2|||f||||||||||||||2017-10-11 02:32:01.150721|2017-10-11 02:32:01.150721
NCT01682538|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-07|2014-02-20|2013-10-08||August 2012||2012-08-01|February 2014|2014-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Bioequivalence of Orfadin Suspension Compared to Orfadin Capsules, and the Effect of Food on the Bioavailability of the Suspension|A Study to Evaluate the Bioequivalence of Orfadin Suspension 4 mg/mL Compared to Orfadin Capsules 10 mg, and the Effect of Food on the Bioavailability of the Suspension. An Open-label, Randomized, Cross-over, Single-dose Study in Healthy Volunteers|Completed||Phase 1|12|Actual|Swedish Orphan Biovitrum||3|||f||||f||||||||||2017-10-11 02:32:01.282183|2017-10-11 02:32:01.282183
NCT01682525|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-02-03|||May 2012||2012-05-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Ovarian Tissue Cryopreservation for Fertility Preservation|Ovarian Tissue Cryopreservation for Fertility Preservation|Withdrawn||N/A|0|Actual|Boston IVF||1|||f||||f||||||||No||2017-10-11 02:32:01.826872|2017-10-11 02:32:01.826872
NCT01682512|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-03-02|||September 2012||2012-09-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis|Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.|Completed||Phase 3|237|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 02:32:02.1293|2017-10-11 02:32:02.1293
NCT01682499|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-09-24|||August 2012||2012-08-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy|Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy in Earlier Stage Breast Cancer|Completed||Phase 1|50|Actual|Beth Israel Medical Center||1|||f||||t||||||||||2017-10-11 02:32:02.509174|2017-10-11 02:32:02.509174
NCT01682486|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-06-17|||April 2012||2012-04-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|BIPETT||BIP ETT Clinical Tolerability, Safety and Performance Study|Evaluation of Tolerability, Safety and Performance of BIP Endotracheal Tubes With Bactiguard Coating|Completed||N/A|30|Actual|Bactiguard AB||2|||f||||t||||||||No||2017-10-11 02:32:02.658828|2017-10-11 02:32:02.658828
NCT01682473|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-07-03|||September 20, 2012|Actual|2012-09-20|July 2017|2017-07-01|April 20, 2015|Actual|2015-04-20|April 2, 2015|Actual|2015-04-02||Interventional|||A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies|A Phase 1, Multi-Center, Open Label, Uncontrolled, Serial Cohort, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of ZSTK474 in Japanese Patients With Advanced Solid Malignancies|Completed||Phase 1|20|Actual|Zenyaku Kogyo Co., Ltd.||2|||f||||t||||||||||2017-10-11 02:32:02.781997|2017-10-11 02:32:02.781997
NCT01682460|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-05-01|2014-05-14||August 2012||2012-08-01|May 2017|2017-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|IVES||Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients|Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients|Completed||Phase 4|15|Actual|University of Waterloo||1|||f||||f||||||||||2017-10-11 02:32:02.912971|2017-10-11 02:32:02.912971
NCT01682447|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-06-27|||January 2011||2011-01-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPD|Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Active, not recruiting|N/A|128|Anticipated|University of Tilburg||2|||f||||f||||||||||2017-10-11 02:32:03.316022|2017-10-11 02:32:03.316022
NCT01682434|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2014-04-30|||May 2011||2011-05-01|April 2014|2014-04-01||||January 2014|Actual|2014-01-01||Interventional|||Wavefront-guided LASIK for Correction of Myopia|Wavefront-guided LASIK for Correction of Myopia|Withdrawn||N/A|0|Actual|Aarhus University Hospital||2||"Institution changed surgical method to small-incision lenticule extraction. Study never   started."|f||||f||||||||||2017-10-11 02:32:03.447263|2017-10-11 02:32:03.447263
NCT01682421|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2014-04-30|||September 2012||2012-09-01|April 2014|2014-04-01||||September 2012|Actual|2012-09-01||Interventional|||Topical Steroid Treatment After Posterior Lamellar Corneal Transplantation|Investigation of Treatment With Topical Corticosteroid After Posterior Lamellar Corneal Transplantation|Withdrawn||N/A|0|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 02:32:03.564973|2017-10-11 02:32:03.564973
NCT01682408|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2012-12-27|||September 2012||2012-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PK Combination||Assess Pharmacokinetics of Fostamatinib in Fed and Fasted State in Combination With Ranitidine to Assess Bioavailability|An Open-label, Single-center, 2-Part, Randomized Study to Assess the Pharmacokinetics of R406 in Healthy Subjects When Fostamatinib 150 mg is Administered Alone in Fed and Fasted State and in Combination With Ranitidine in Fasted State, and to Assess the Relative Bioavailability of Process Variants of Tablets|Completed||Phase 1|28|Actual|AstraZeneca||5|||f||||||||||||||2017-10-11 02:32:03.701551|2017-10-11 02:32:03.701551
NCT01682395|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2015-05-19|||February 2013||2013-02-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Best Management of Sigmoid Volvulus: A Prospective Randomized Trial|Best Management of Sigmoid Volvulus: A Prospective Randomized Trial|Completed||N/A|29|Actual|University of North Carolina, Chapel Hill||4|||f||||t||||||||||2017-10-11 02:32:03.839572|2017-10-11 02:32:03.839572
NCT01682382|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-01-16|||August 2012||2012-08-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Observational|||Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)|Collection of Whole Blood Specimens and Buccal Swabs From Subjects Diagnosed With CNV AMD, Dry AMD, and Age-Matched Controls to Assess the Association of Genetic Variants in Complement Factor H With Risk of Progression to CNV.|Completed||N/A|45|Actual|Sequenom, Inc.|||3||f||||f||||||Samples With DNA|"     DNA extracted from whole blood and buccal cells will be analyzed. Remnant samples will be     stored for future research in AMD.   "|||2017-10-11 02:32:03.986587|2017-10-11 02:32:03.986587
NCT01682369|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-09-29|||September 2012||2012-09-01|September 2017|2017-09-01|January 2015|Actual|2015-01-01|February 2013|Actual|2013-02-01||Interventional|||ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses|A Multi-centre, Phase II, Open Labelled Randomised Control Trial to Describe Immune & Transcriptomic Responses to Trivalent Inactivated Vaccine (TIV) & MF59 Adjuvanted Influenza Vaccine (ATIV) in 14 -26 Month Healthy Children|Completed||Phase 2|90|Actual|University of Oxford||6|||f||||t||||||||||2017-10-11 02:32:04.096434|2017-10-11 02:32:04.096434
NCT01682356|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-01-30|||January 2012||2012-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Dietary Nitrates for Heart Failure (HF)|Dietary Nitrates for Heart Failure|Recruiting||Phase 1/Phase 2|126|Anticipated|Washington University School of Medicine||2|||f||||t||||||||Undecided||2017-10-11 02:32:04.226177|2017-10-11 02:32:04.226177
NCT01682343|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2012-09-10|||May 2012||2012-05-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effect of High-calcium Intake on Appetite, Insulinemia and Incretins|Effect of High-calcium Intake on Appetite, Insulinemia and Incretins|Completed||N/A|10|Actual|Northumbria University||2|||f||||f||||||||||2017-10-11 02:32:04.404886|2017-10-11 02:32:04.404886
NCT01682330|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-07|||November 2011||2011-11-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||The Long-term Effects of Training on Muscle Strength and Functionality||Completed||N/A|65|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||||||||||||2017-10-11 02:32:04.504866|2017-10-11 02:32:04.504866
NCT01682317|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-07-14|||August 2012|Actual|2012-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|HEP||Healthy Eating Patterns During a Lifestyle Intervention|Healthy Eating Patterns During a Lifestyle Intervention|Active, not recruiting||N/A|30|Anticipated|University of Tennessee||2|||f||||t||||||||||2017-10-11 02:32:04.560502|2017-10-11 02:32:04.560502
NCT01682304|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2015-04-22|||May 2012||2012-05-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension|Observational Study of Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension|Completed||N/A|12|Actual|Ohio State University|||1||f||||f||||||Samples With DNA|"     Sputum and peripheral blood will be collected for DNA extraction and epigenetic analyses.   "|||2017-10-11 02:32:04.655598|2017-10-11 02:32:04.655598
NCT01682291|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|PYRAMIDS||Prehypertension and Dietary Supplements - The PYRAMIDS Study|Pre-hYpertension tReament With A coMbinatIon of Dietary Supplements and Life-style Modifications|Not yet recruiting||Phase 4|500|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 02:32:04.739336|2017-10-11 02:32:04.739336
NCT01682278|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-05-13|||September 2012||2012-09-01|May 2016|2016-05-01|June 2021|Anticipated|2021-06-01|December 2017|Anticipated|2017-12-01||Observational|||Prospective Cohort Study of Health Complaints|Amalgam Removal in Patients With Health Complaints Attributed to Amalgam Restorations: A Prospective Cohort Study|Active, not recruiting||N/A|118|Actual|Uni Research|||3||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-11 02:32:04.854141|2017-10-11 02:32:04.854141
NCT01682265|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-10-04|||March 2012||2012-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|SIRUP||Stretta In Reflux Uncontrolled by IPP|Stretta In Reflux Uncontrolled by Intake of Inhibitors of Protons Pump (IPP).- The SIRUP Trial- Multicentric, Randomized, Double Blind, Prospective Study|Recruiting||N/A|60|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 02:32:04.954577|2017-10-11 02:32:04.954577
NCT01682252|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-02-08|||May 2012||2012-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Observational|||Analysis of Blood During Surgery for Musculoskeletal Tumors|Cellular Analysis of Blood Suctioned During Surgery for Musculoskeletal Tumors|Terminated||N/A|34|Actual|Rutgers, The State University of New Jersey|||1|investigators felt sufficient data has been collected|f||||f||||||||No||2017-10-11 02:32:05.083639|2017-10-11 02:32:05.083639
NCT01682239|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2012-09-07|||September 2012||2012-09-01|September 2012|2012-09-01|August 2015|Anticipated|2015-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Effects of Right Ventricular Pacemaker Lead Position Assessed by MRI|Effects of Different Right Ventricular Lead Positioning on Cardiac Contraction Measured by Cardiac MRI: a Pilot Trial|Unknown status|Enrolling by invitation|N/A|24|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:32:05.164853|2017-10-11 02:32:05.164853
NCT01682226|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-06-20|||September 2012|Actual|2012-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies|Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies|Recruiting||Phase 2|100|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:32:05.242143|2017-10-11 02:32:05.242143
NCT01682213|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-06-12|||September 2012||2012-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation|A Phase 2 Trial of Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation|Active, not recruiting||Phase 2|23|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:32:05.341431|2017-10-11 02:32:05.341431
NCT01682200|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2012-09-07|||October 2009||2009-10-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|March 2010|Actual|2010-03-01||Interventional|||Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne|An Open Label Pilot Clinical Trial on the Efficacy and Safety of ProOxy Facial Spray (Topical 15% Oxygen Solution) in the Treatment of Moderate Facial Acne Vulgaris Among Filipino Patients|Completed||Phase 1|50|Actual|Medivet Pty Ltd||1|||f||||f||||||||||2017-10-11 02:32:05.535328|2017-10-11 02:32:05.535328
NCT01682187|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-01-06|||December 2005||2005-12-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|May 2012|Actual|2012-05-01||Interventional|||A Dose-Escalation Study in Participants With Recurrent Malignant Glioma|Phase 1 Dose-Escalation Study of LY2157299 Monotherapy and in Combination With Lomustine in Patients With Recurrent Malignant Glioma|Active, not recruiting||Phase 1|66|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:32:05.716247|2017-10-11 02:32:05.716247
NCT01682174|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2013-05-07|||September 2012||2012-09-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Glycaemic Response to a Liquid Meal Tolerance Test|Effects of Dehydrated Vegetable Powder on Glycaemic Responses to a Liquid Meal Tolerance Test (LMTT)|Completed||N/A|13|Actual|Mondelēz International, Inc.||2|||f||||f||||||||||2017-10-11 02:32:05.828016|2017-10-11 02:32:05.828016
NCT01682161|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-07-31|||January 2012||2012-01-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate|An Open-Label, Comparative Study of Immediate or Delayed Switch to Paliperidone Palmitate in Patients Unsatisfied With Current Oral Atypical Antipsychotics to Evaluate the Evolution of Medication Satisfaction and Adherence|Completed||Phase 4|154|Actual|Janssen Korea, Ltd., Korea||2|||f||||f||||||||||2017-10-11 02:32:05.924393|2017-10-11 02:32:05.924393
NCT01682135|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2016-07-15|2016-03-14||November 2012||2012-11-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||All randomized participants who received at least one dose of study drug.|A Study in Participants With Advanced Solid Tumors|Phase I Study of Ramucirumab in Patients With Advanced Solid Tumors|Completed||Phase 1|28|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:32:06.26738|2017-10-11 02:32:06.26738
NCT01682122|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-07|||August 2012||2012-08-01|September 2012|2012-09-01||||August 2013|Anticipated|2013-08-01||Observational|||Frequency and Persistence of Wide Pulse Pressure in the Neonatal Population|Evaluation of the Frequency and Persistence of Wide Pulse Pressure in the Neonatal Population|Unknown status|Not yet recruiting|N/A|196|Anticipated|Staten Island University Hospital|||1||f||||t||||||||||2017-10-11 02:32:07.499109|2017-10-11 02:32:07.499109
NCT01682109|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-05-24|||September 2012||2012-09-01|January 2016|2016-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|VALID-0||Palatability Testing of a New Paediatric Formulation of Valacyclovir|Palatability Testing of a New Paediatric Formulation of Valacyclovir for the Prophylaxis and Treatment of VZV and HSV Infections in Children|Completed||Phase 4|41|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 02:32:07.597021|2017-10-11 02:32:07.597021
NCT01682096|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2013-10-15|||January 2010||2010-01-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Pilot Safety Study of Coronary CTA for the Diagnosis of Acute Coronary Syndrome in the Emergency Room|Usefulness of Coronary CTA for the Diagnosis of Acute Coronary Syndrome in the Emergency Room.|Completed||N/A|150|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 02:32:07.708348|2017-10-11 02:32:07.708348
NCT01682083|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-08-29|||January 8, 2013|Actual|2013-01-08|August 2017|2017-08-01|March 15, 2023|Anticipated|2023-03-15|June 30, 2017|Actual|2017-06-30||Interventional|COMBI-AD||A Study of the BRAF Inhibitor Dabrafenib in Combination With the MEK Inhibitor Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma After Surgical Resection.|COMBI-AD: A Phase III Randomized Double Blind Study of Dabrafenib (GSK2118436) in COMBInation With Trametinib (GSK1120212) Versus Two Placebos in the ADjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma After Surgical Resection|Active, not recruiting||Phase 3|852|Anticipated|Novartis||2|||f||||t|t|f||||||||2017-10-11 02:32:07.881222|2017-10-11 02:32:07.881222
NCT01682070|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2013-05-28|||September 2012||2012-09-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||SUBLIVAC FIX Phleum Pratense DT/DRF|A Randomized, Double-blind, Placebo-controlled Study to Determine Safety, Tolerability and the Optimal Effective Dose of SUBLIVAC FIX Phleum Pratense in Patients With Allergic Rhinitis/Rhinoconjunctivitis Caused by Grass Pollen|Completed||Phase 2|266|Actual|HAL Allergy||5|||f||||t||||||||||2017-10-11 02:32:08.406156|2017-10-11 02:32:08.406156
NCT01682057|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2015-01-27|||October 2011||2011-10-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Multicenter Study to Evaluate the ROX Anastomotic Coupler System (ACS) In Patients With Severe Hypertension|A Prospective, Non-Randomized, Open Label, Multi-Center Study to Evaluate the ROX Anastomotic Coupler System (ACS) in Patients With Severe Hypertension|Completed||Phase 2|8|Actual|ROX Medical, Inc.||1|||f||||f||||||||||2017-10-11 02:32:08.546797|2017-10-11 02:32:08.546797
NCT01682031|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-08-08|2014-06-26||June 2009||2009-06-01|August 2014|2014-08-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy|Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trial of Selenomethionine as a Modulator of Efficacy and Toxicity of Chemoradiation in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 2|18|Actual|Roswell Park Cancer Institute|Due to the study’s early termination and inadequate number of patients, no patients were analyzed.|2||Due to a lack of funding|f||||t||||||||||2017-10-11 02:32:09.418591|2017-10-11 02:32:09.418591
NCT01682018|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-07|||September 2012||2012-09-01|July 2012|2012-07-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||The Value of Bronchoscopic Lung Volume Reduction by Endobronchial Valves in Patients With Single Lung Transplantation and Overinflation of the Native Lung|Clinical Trial to Evaluate the Value of Bronchoscopic Lung Volume Reduction by Endobronchial Valves in Patients With Single Lung Transplantation and Overinflation of the Native Lung|Unknown status|Not yet recruiting|N/A|15|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 02:32:10.293686|2017-10-11 02:32:10.293686
NCT01682005|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-08-28|||August 2012||2012-08-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination|Clinical and Cost Impact of Complete and Incomplete Rotavirus Vaccination|Completed||N/A|1|Actual|GlaxoSmithKline|||7||f||||||||||||||2017-10-11 02:32:10.394725|2017-10-11 02:32:10.394725
NCT01681979|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-09-29|||July 2012||2012-07-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes|WEUSRTP4850: Phase II: Asthma Treatment in Pregnancy and the Frequency of Adverse Pregnancy Outcomes|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 02:32:10.846155|2017-10-11 02:32:10.846155
NCT01681966|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2015-11-22|||September 2012||2012-09-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||A Single-dose Open-Label Study to Assess the Safety and Preliminary Efficacy of PRF 110 in Open Herniorrhaphy Surgery|A Single-dose, Open-Label, Multi-center Study to Assess the Safety and Preliminary Efficacy of PRF 110 (Formerly LNP) in Open Herniorrhaphy Surgery|Recruiting||Phase 2|30|Anticipated|PainReform LTD||1|||f||||f||||||||||2017-10-11 02:32:10.94564|2017-10-11 02:32:10.94564
NCT01681953|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-03-28|||August 2012||2012-08-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial, Investigating the Efficacy and Safety of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis.|Completed||Phase 3|25|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||t||||||||||2017-10-11 02:32:11.055664|2017-10-11 02:32:11.055664
NCT01681940|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-03-28|||January 2012||2012-01-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|August 2012|Actual|2012-08-01||Interventional|||Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis|A Multi-Center, Open-Label Trial of the Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis|Completed||Phase 2|10|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-11 02:32:11.204187|2017-10-11 02:32:11.204187
NCT01681927|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-11-02|||September 2011||2011-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Study of Idiopathic Edema|Study of Idiopathic Edema|Completed||N/A|4|Actual|Winthrop University Hospital|||3||f||||f||||||||||2017-10-11 02:32:11.346444|2017-10-11 02:32:11.346444
NCT01681914|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2013-08-09|||April 2012||2012-04-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique|"Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique: A Country-specific Public Health Evaluation. (CDC)"|Completed||N/A|492|Actual|Vanderbilt University|||3||f||||f||||||||||2017-10-11 02:32:11.467375|2017-10-11 02:32:11.467375
NCT01681901|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-04-12|||June 7, 2006|Actual|2006-06-07|April 2017|2017-04-01|April 2007|Anticipated|2007-04-01|April 2007|Anticipated|2007-04-01||Observational|||Ultrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast Sonography|Lymph Node Evaluation in the Axilla of Symptomatic Older Women During Breast Sonography.|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center|||1|no patient accrual|f||||t||||||||||2017-10-11 02:32:11.572022|2017-10-11 02:32:11.572022
NCT01681888|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-08-17|||May 2012||2012-05-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Surface EMG Biofeedback for Children With Cerebral Palsy|Clinical Trial of Surface EMG Biofeedback for Children With Cerebral Palsy and Associated Movement Disorders|Recruiting||N/A|100|Anticipated|University of Southern California||1|||f||||f||||||||||2017-10-11 02:32:11.674932|2017-10-11 02:32:11.674932
NCT01681875|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2014-09-17|||June 2013||2013-06-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|P1S1||Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes|Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes|Completed||N/A|840|Anticipated|University of Pittsburgh||7|||f||||t||||||||||2017-10-11 02:32:11.784161|2017-10-11 02:32:11.784161
NCT01681862|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2015-10-05|||September 2012||2012-09-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Insights for Community Health|Insights for Community Health|Completed||N/A|55|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 02:32:11.902358|2017-10-11 02:32:11.902358
NCT01681849|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-06-26|2016-11-28||July 2009||2009-07-01|June 2017|2017-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder|Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder|Completed||Phase 4|91|Actual|Emory University||3|||f||||t||||||||||2017-10-11 02:32:12.018058|2017-10-11 02:32:12.018058
NCT01681823|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2017-05-25|||June 2013||2013-06-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA|Phase III, Single-Center, Open Label, Trial Evaluating the Safety and Efficacy of PectaSol-C Modified Citrus Pectin on PSA Kinetics in Prostate Cancer in the Setting of Serial Increases in PSA|Recruiting||Phase 3|60|Anticipated|EcoNugenics||1|||f||||t||||||||||2017-10-11 02:32:12.475037|2017-10-11 02:32:12.475037
NCT01681810|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-07-24|||October 2012||2012-10-01|July 2017|2017-07-01||||December 2017|Anticipated|2017-12-01||Interventional|ONTX||Oral Nitrite in Adults With Metabolic Syndrome and Hypertension|An Open-Label Study of Oral Nitrite in Adults With Metabolic Syndrome and Hypertension|Recruiting||Phase 2|20|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 02:32:12.592934|2017-10-11 02:32:12.592934
NCT01681797|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-05-02|||August 2012||2012-08-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|AFLU||Fluorescence Angiography: Planning and Monitoring of Perforator Flaps|Fluorescence Angiography With Fluobeam™ Camera (Fluoptics Company): Planning and Monitoring of Perforator Flaps|Recruiting||N/A|40|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 02:32:12.67816|2017-10-11 02:32:12.67816
NCT01681784|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-07|||January 2009||2009-01-01|March 2009|2009-03-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Studies of Biomarkers in Female Lower Urinary Tract Symptoms|Studies of Biomarkers in Different Urodynamic Diagnoses of Female Patients With Lower Urinary Tract Symptoms|Unknown status|Recruiting|N/A|1000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     Patients' voided urine   "|||2017-10-11 02:32:12.768117|2017-10-11 02:32:12.768117
NCT01681771|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-05-16|||February 2014||2014-02-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Internet Cognitive Behavioural Therapy to Patients With Heart Failure and Depression|Internet Cognitive Behavioural Therapy to Patients With Heart Failure and Depression A Randomised Controlled Study of Short and Long Term Effects on Depressive Symptoms|Completed||N/A|50|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-11 02:32:12.827293|2017-10-11 02:32:12.827293
NCT01681758|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2013-07-09|||January 2012||2012-01-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||An Assessment of Pulse Pressure Variation to Guide Fluid Therapy in Cardiac Surgery Patients|A Before-and-after Assessment of Pulse Pressure Variation Guided Fluid Therapy in Cardiac Surgery Patients Receiving Mandatory Mechanical Ventilation|Completed||Phase 2|104|Actual|Austin Health||2|||f||||f||||||||||2017-10-11 02:32:12.905008|2017-10-11 02:32:12.905008
NCT01681745|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-04-14|||August 2012||2012-08-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects|Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|MyoScience, Inc||1|||f||||f||||||||||2017-10-11 02:32:12.980483|2017-10-11 02:32:12.980483
NCT01681732|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-03-31|||September 2012||2012-09-01|March 2017|2017-03-01|August 29, 2014|Actual|2014-08-29|August 29, 2014|Actual|2014-08-29||Interventional|||A Pilot Study of Personalized Medicine for Pediatric Asthma|A Pilot Study of Personalized Medicine for Pediatric Asthma|Completed||N/A|22|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||No||2017-10-11 02:32:13.051848|2017-10-11 02:32:13.051848
NCT01681719|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-09-05|||January 2011||2011-01-01|September 2012|2012-09-01||||December 2011|Actual|2011-12-01||Interventional|EVAWIE||Ergospirometric Values and WBV in Elderly|Whole Body Vibration as Alternative for Improve the Ergospirometric Values in Elderly: a Randomized Clinical Trial|Completed||N/A|25|Actual|Universidade Federal de Pernambuco||3|||f||||t||||||||||2017-10-11 02:32:13.142218|2017-10-11 02:32:13.142218
NCT01681706|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-09-05|||February 2012||2012-02-01|September 2012|2012-09-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Observational|HIDES||HIV Indicator Diseases Across Europe Study|HIV Indicator Diseases Across Europe Study|Unknown status|Recruiting|N/A|14000|Anticipated|University of Copenhagen|||1||f||||f||||||||||2017-10-11 02:32:13.384257|2017-10-11 02:32:13.384257
NCT01681693|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-10-21|||February 2010||2010-02-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|#6113||Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans|Effect of Genetic Variants in MATE1 and OCT3 Transporters on the Pharmacodynamics of Metformin in African Americans With Type II Diabetes Mellitus.|Completed||Phase 1|33|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:32:13.486101|2017-10-11 02:32:13.486101
NCT00005173|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1985||1985-04-01|July 2000|2000-07-01|April 1989|Actual|1989-04-01|||||Observational|||Myocardial Infarction and Past Oral Contraceptive Use||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.526042|2017-10-11 04:26:35.526042
NCT01681680|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-06-30|||October 2010||2010-10-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|#6112||Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the PKPD of Metformin|Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the Pharmacokinetics and Pharmacodynamics of Metformin|Completed||Phase 1|41|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:32:13.595187|2017-10-11 02:32:13.595187
NCT01681667|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-06|2014-03-10|||September 2013||2013-09-01|March 2014|2014-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain|Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain|Unknown status|Recruiting|Phase 4|100|Anticipated|Albany Medical College||2|||f||||t||||||||||2017-10-11 02:32:13.678925|2017-10-11 02:32:13.678925
NCT01681654|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-10-24|||June 2012||2012-06-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|ENHANCE||Exercise and Nutrition for Head and Neck Cancer Patients|Exercise and Nutrition for Head and Neck Cancer Patients: A Patient Oriented, Clinic-Supported Randomized Controlled Trial|Completed||N/A|60|Actual|University of Calgary||4|||f||||f||||||||||2017-10-11 02:32:13.794696|2017-10-11 02:32:13.794696
NCT01681641|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-05-28|||February 2011||2011-02-01|September 2012|2012-09-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Managing Changes in Life After Deep Brain Stimulation for Parkinson's Disease|Managing Changes in Life After Deep Brain Stimulation for Parkinson's Disease - Designing and Developing a Targeted Nursing Program to Patients and Spouses.|Completed||N/A|32|Actual|University of Aarhus||2|||f||||f||||||||No||2017-10-11 02:32:13.935237|2017-10-11 02:32:13.935237
NCT01681628|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-02|2017-03-18|2016-05-01||June 2012||2012-06-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|July 2012|Actual|2012-07-01||Interventional||Local population from Kasese district in Uganda who admitted to symptoms suggestive of PTSD and volunteered to participate. Non-attenders at Time 2 were not included in the analysis.|Community Self-help Using Thought Field Therapy in a Traumatised Population in Uganda: a Randomised Trial|Effectiveness of Thought Field Therapy Provided by Newly Instructed Community Workers to a Traumatized Population in Uganda: A Randomised Trial|Completed||N/A|256|Actual|Thought Field Therapy Foundation (UK) Ltd|Only one assessment tool for PTSD was used. The 19 month data interpretation was limited by the high drop-out rate.|2|||f||||f||||||||Yes|Spreadsheet available on request. Individual paper copies also available.|2017-10-11 02:32:14.104054|2017-10-11 02:32:14.104054
NCT01681615|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-09-12|||September 2012||2012-09-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|March 2013|Anticipated|2013-03-01||Interventional|||Challenge Test for Acetylsalicylic Acid Hypersensitivity|Challenge Test for Acetylsalicylic Acid Hypersensitivity|Unknown status|Not yet recruiting|N/A|50|Anticipated|Helse Stavanger HF||2|||f||||f||||||||||2017-10-11 02:32:14.627094|2017-10-11 02:32:14.627094
NCT01681602|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2014-11-28|||January 2012||2012-01-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|ADEX||Effect of Physical Exercise in Alzheimer Patients|Preserving Quality of Life, Physical Health and Functional Ability in Alzheimer's Disease: The Effect of Physical Exercise|Completed||Phase 3|200|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 02:32:14.779837|2017-10-11 02:32:14.779837
NCT01681589|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-08-10|||August 2012||2012-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI)|Relationship Between Attention and Emotional Regulation Post-TBI: Probing Neural Circuitry With Transcranial Direct Current Stimulation|Recruiting||N/A|40|Anticipated|New York University School of Medicine||3|||f||||f|f|t|f|f|f|||||2017-10-11 02:32:14.897911|2017-10-11 02:32:14.897911
NCT01681576|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-10-12|2015-07-10||August 2012||2012-08-01|October 2015|2015-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension|A Randomized, Double-blind, Crossover Study to Assess the Effects of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension|Completed||Phase 2|72|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:32:15.045936|2017-10-11 02:32:15.045936
NCT01681563|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2016-12-27|||September 2011||2011-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|||Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia|A Single-arm Multi-center Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia|Completed||Phase 2|47|Actual|Niguarda Hospital||1|||f||||f||||||||||2017-10-11 02:32:15.585957|2017-10-11 02:32:15.585957
NCT01681550|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-02|2012-09-08|||October 2012||2012-10-01|September 2012|2012-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years|Effect of Incretin-based Therapy Combined With Insulin on HbA1c, Hypoglycemia and Chronic Diabetic Complications in Type 2 Diabetic Patients|Not yet recruiting||N/A|500|Anticipated|Nagaoka Red Cross Hospital||1|||f||||t||||||||||2017-10-11 02:32:15.715004|2017-10-11 02:32:15.715004
NCT01681537|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-02|2016-03-15|||September 2012||2012-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Lenalidomide Plus Chemotherapy for AML|A Phase I Study of Lenalidomide Plus Chemotherapy With Mitoxantrone, Etoposide, and Cytarabine for the Reinduction of Patients With Acute Myelogenous Leukemia|Completed||Phase 1|36|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:32:15.803953|2017-10-11 02:32:15.803953
NCT01681524|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-05-29|||November 2012||2012-11-01|April 2013|2013-04-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Interventional|||Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI|A Phase 3, Open Label, Multicenter Study for the Assessment of Myocardial Perfusion Using Positron Emission Tomography (PET) Imaging of Flurpiridaz F18 Injection in Patients With Suspected or Known Coronary Artery Disease (CAD)|Withdrawn||Phase 3|0|Actual|Lantheus Medical Imaging||1||delayed study start|f||||t||||||||||2017-10-11 02:32:15.898898|2017-10-11 02:32:15.898898
NCT01681511|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2014-04-09|2013-10-29||May 2012||2012-05-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Overall Number of Baseline Participants (95 participants) includes 4 individuals who were randomized, but not treated.|A Trial for the Safety and Effectiveness of a Novel Antimicrobial-Coated Foley Catheter for Reduction of CAUTI.|A Randomized Trial for the Safety and Effectiveness of a Novel Antimicrobial-Coated Foley Catheter Attached to an Antimicrobial Anti-Reflux Device for Reduction of Catheter-Associated Urinary Tract Infection|Terminated||N/A|100|Actual|Innovative Chemical and Environmental Technologies, Inc|Study could not be completed for business reasons.|2||Business Reasons|f||||t||||||||||2017-10-11 02:32:16.011266|2017-10-11 02:32:16.011266
NCT01681498|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2014-09-01|||May 2013||2013-05-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Fetal Electrocardiogram Extraction-Pilot Study|Fetal Electrocardiogram Extraction-Pilot Study|Terminated||Phase 2|20|Actual|Huntleigh Healthcare Ltd|||1|Indeterminate performance during the first half of the trial.|f||||f||||||||||2017-10-11 02:32:16.739853|2017-10-11 02:32:16.739853
NCT01681485|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-07-31|||June 2012||2012-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Survey on Chinese Medicine Syndrome for Patients With Non Small Cell Lung Cancer|The Changing Pattern of Chinese Medicine Syndrome for Patients With Non Small Cell Lung Cancer in Hong Kong: A Longitudinal Survey|Terminated||N/A|49|Actual|Hong Kong Baptist University|||1|Inability to recruit adequate number of patients|f||||t||||||||||2017-10-11 02:32:16.817005|2017-10-11 02:32:16.817005
NCT01681472|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-04-20|2015-05-21||September 2012||2012-09-01|April 2016|2016-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||PK/PD Investigation of Modufolin® in Plasma, Tumor and Adjacent Mucosa in Patients With Colon Cancer|A Single-Blind, Randomized Phase I/II Study of Pharmacokinetic and Pharmacodynamic Investigation of Modufolin® (60 or 200 mg/m2) Compared to Levoleucovorin (60 or 200 mg/m2) in Tumor, Adjacent Mucosa and Plasma for Patients With Colon Cancer|Completed||Phase 1/Phase 2|32|Actual|Isofol Medical AB||4|||f||||f||||||||||2017-10-11 02:32:16.953903|2017-10-11 02:32:16.953903
NCT01681459|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-02-18|||January 2012||2012-01-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||Effects of Lipids on Gastric Emptying, Satiety Hormones, and Appetite in Severe Overweight|Effects of Lipids on Gastric Emptying, Satiety Hormones, and Appetite in Severe Overweight|Completed||N/A|20|Actual|Hvidovre University Hospital|||1||f||||t||||||Samples Without DNA|"     Plasma   "|||2017-10-11 02:32:17.651024|2017-10-11 02:32:17.651024
NCT01681446|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-02-02|||August 2012||2012-08-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|August 2016|Anticipated|2016-08-01||Interventional|||The Effect of Postoperative Interferon- Alpha Treatment in Low miR-26 Expression Patients With HCC|The Effect of Postoperative Interferon- Alpha Treatment in Low miR-26 Expression Patients With Hepatocellular Carcinoma: a Muti-center Randomized Clinical Trail.|Recruiting||N/A|506|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 02:32:17.714353|2017-10-11 02:32:17.714353
NCT01681433|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-09-05|||December 2012|Actual|2012-12-01|September 2017|2017-09-01|June 21, 2017|Actual|2017-06-21|June 21, 2017|Actual|2017-06-21||Interventional|||OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone|The Pacific Clinical Trial: A Randomized Phase II Study Evaluating OGX-427 in Patients With Metastatic Castrate-Resistant Prostate Cancer (MCRPC)Who Have Prostate-Specific Antigen (PSA) Progression While Receiving Abiraterone: Hoosier Oncology Group GU12-159|Terminated||Phase 2|72|Actual|Hoosier Cancer Research Network||2||lack of accrual|f||||t||||||||||2017-10-11 02:32:17.858089|2017-10-11 02:32:17.858089
NCT01681420|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2013-04-11|||March 2012||2012-03-01|April 2013|2013-04-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Improving Blood Safety and HIV Testing in Brazil|Improving Blood Safety and HIV Testing in Brazil: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|12000|Anticipated|Blood Systems Research Institute||3|||f||||t||||||||||2017-10-11 02:32:17.975164|2017-10-11 02:32:17.975164
NCT01681407|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2015-06-18|||November 2011||2011-11-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Observational|MIRPROT||Peripheral Plasma Micro-RNA and Proteomics Mapping in Depressive Patients, Treated With SSRI Medications|Peripheral Plasma Micro-RNA and Proteomics Mapping in Depressive Patients, Treated With SSRI Medications.|Terminated||N/A|17|Actual|HaEmek Medical Center, Israel|||3|Insufficient microRNA for the analysis|f||||t||||||Samples With DNA|"     Subjects and patients will be asked to give blood samples at 4 points of time for the lab     processing: micro-RNA and proteome profiling/   "|||2017-10-11 02:32:18.076169|2017-10-11 02:32:18.076169
NCT01681394|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-07-02|||June 2012||2012-06-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Effect of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression|Effect of the Administration of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression in Humans|Completed||N/A|25|Actual|Technological Centre of Nutrition and Health, Spain||2|||f||||f||||||||||2017-10-11 02:32:19.816977|2017-10-11 02:32:19.816977
NCT01681381|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-02-20|||September 2012||2012-09-01|November 2012|2012-11-01|September 2018|Anticipated|2018-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization|A Prospective, Open Label, Randomized Study to Evaluate Safety And Effectiveness Of The Tivoli® Biodegradable Polymer Rapamycin-Eluting Stent and The FIREBIRD2® Rapamycin-Eluting Coronary CoCr Stent For Treatment Coronary Revascularization|Recruiting||N/A|2790|Anticipated|Essen Technology (Beijing) Co., Ltd.||2|||f||||t||||||||||2017-10-11 02:32:19.913043|2017-10-11 02:32:19.913043
NCT01681368|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-04-24|2015-01-21||August 15, 2012|Actual|2012-08-15|April 2017|2017-04-01|April 30, 2014|Actual|2014-04-30|December 9, 2013|Actual|2013-12-09||Interventional|||Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer|Phase II Open Label Non-Randomized Single Agent Study of the SMAC (Second Mitochondrial-Derived Activator of Caspases)-Mimetic Birinapant (TL32711; NSC 756502) in Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer, Primary Peritoneal|Terminated||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||1||Accrual was terminated for lack of a clinical benefit.|f||||f|t|f||||||No||2017-10-11 02:32:20.016335|2017-10-11 02:32:20.016335
NCT01681355|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-01-08|||September 2012||2012-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|BOOGIE||Gastrointestinal Tolerance Study of a New Infant Formula|Open-label Study to Evaluate the Gastrointestinal Tolerance of a New Infant Formula in Healthy, Term, Asian Infants|Completed||N/A|50|Actual|Danone Asia Pacific Holdings Pte, Ltd.||1|||f||||f||||||||||2017-10-11 02:32:20.553973|2017-10-11 02:32:20.553973
NCT01681342|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-07-24|||June 2011||2011-06-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Sparing of Organs at Risk in High Dose Rate Brachytherapy|Prospective Study on the Sparing of Organs at Risk in High Dose Rate Brachytherapy for Cervix Cancer|Completed||N/A|24|Actual|Centre Oscar Lambret|||1||f||||f||||||||||2017-10-11 02:32:20.643331|2017-10-11 02:32:20.643331
NCT01675687|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-03-06|||August 2012||2012-08-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Web Based Follow up Intervention in Obesity Treatment for Women|Effects on Self-efficacy, Sustainability and Drop Out Rate Using Web Based Follow up Intervention in Obesity Treatment for Women|Completed||N/A|84|Actual|FEM Süd||2|||f||||f||||||||||2017-10-11 02:33:53.909435|2017-10-11 02:33:53.909435
NCT01681329|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-01-31|||September 2012||2012-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CBT+IMT-GAD||Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder|Improving Outcomes for Adults With Generalized Anxiety Disorder: Combining Cognitive-Behavioral Treatment and Interpretation Modification Training|Recruiting||N/A|138|Anticipated|Concordia University||2|||f||||f||||||||||2017-10-11 02:32:20.712844|2017-10-11 02:32:20.712844
NCT01681316|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-10-11|||December 2012||2012-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Danhong Injection in the Treatment of Chronic Stable Angina|A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Danhong Injection in the Treatment of Chronic Stable Angina|Completed||Phase 4|920|Actual|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 02:32:20.961967|2017-10-11 02:32:20.961967
NCT01681303|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2013-08-03|||January 2009||2009-01-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.||Completed||Phase 4|51|Actual|Chang Gung Memorial Hospital||2|||f||||||||||||||2017-10-11 02:32:21.126979|2017-10-11 02:32:21.126979
NCT01681290|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2015-01-28|||October 2012||2012-10-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CBX129801 (Ersatta™), Long-Acting Synthetic C-Peptide, in Type 1 Diabetes Mellitus Subjects With Mild to Moderate Diabetic Peripheral Neuropathy|Completed||Phase 2|250|Actual|Cebix Incorporated||3|||f||||f||||||||||2017-10-11 02:32:21.204219|2017-10-11 02:32:21.204219
NCT01681277|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2016-11-23|2016-11-23||September 2012||2012-09-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Treated Set (TS): This set included all subjects who were dispensed study medication and were documented to have taken at least one dose of study drug. The TS included all 48 treated subjects.|Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 113608 in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 113608 Powder for Oral Solution in Healthy Male Volunteers q.d. or b.i.d. for 14 Days (a Randomised, Double-blind, Placebo-controlled Within Dose Groups Phase I Trial)|Completed||Phase 1|48|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 02:32:21.425479|2017-10-11 02:32:21.425479
NCT01681264|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-06-12|||November 2013||2013-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance|Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance|Recruiting||Phase 4|200|Anticipated|Massachusetts General Hospital||5|||f||||t||||||||||2017-10-11 02:32:22.226765|2017-10-11 02:32:22.226765
NCT01681251|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2013-11-07|||August 2010||2010-08-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Goal Directed Therapy for Patients Undergoing Major Vascular Surgery|Goal Directed Therapy for Patients Undergoing Major Vascular Surgery|Completed||Phase 1|40|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 02:32:22.357979|2017-10-11 02:32:22.357979
NCT01681238|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-05|||September 2012||2012-09-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Goal-directed Therapy in High-risk Surgery|A Randomized Study of Goal-directed Therapy in the Elderly High-risk Patients Undergoing Total Hip Replacement|Unknown status|Active, not recruiting|N/A|72|Anticipated|Guangzhou First People's Hospital||2|||f||||t||||||||||2017-10-11 02:32:22.442069|2017-10-11 02:32:22.442069
NCT01681225|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2017-10-02|||October 31, 2012|Actual|2012-10-31|October 2017|2017-10-01|September 14, 2018|Anticipated|2018-09-14|October 12, 2017|Anticipated|2017-10-12||Interventional|EPVent2||EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures|EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures (EPVent2)|Active, not recruiting||N/A|202|Actual|Beth Israel Deaconess Medical Center||2|||f||||t|f|f||||||||2017-10-11 02:32:22.528006|2017-10-11 02:32:22.528006
NCT01681212|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2015-06-09|2015-05-22||October 2012||2012-10-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||All participants who received at least 1 dose of treatment medication|Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma|Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Previously Untreated Unresectable or Metastatic Melanoma|Completed||Phase 2|21|Actual|Bristol-Myers Squibb|This study was discontinued due to severe liver toxicity.|1|||f||||f||||||||||2017-10-11 02:32:22.663343|2017-10-11 02:32:22.663343
NCT01681199|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-09-05|||July 2012||2012-07-01|September 2012|2012-09-01|August 2014|Anticipated|2014-08-01|April 2014|Anticipated|2014-04-01||Interventional|FAITH||Fluvastatin AmelIorates aTHerosclerosis Study|The Efficacy of Lescol XL(Fluvastatin Extended Release 80 mg) on Atherosclerosis Progression in Patients With Newly Diagnosed Coronary Heart Disease|Unknown status|Recruiting|Phase 4|140|Anticipated|Beijing Anzhen Hospital||1|||f||||f||||||||||2017-10-11 02:32:23.232016|2017-10-11 02:32:23.232016
NCT01681186|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2013-01-11|||September 2012||2012-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study of LY2940680 in Healthy Participants|A Single Ascending Dose and Relative Bioavailability Study of LY2940680 in Healthy Subjects|Completed||Phase 1|38|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 02:32:23.346801|2017-10-11 02:32:23.346801
NCT01681173|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2015-02-04|||May 2010||2010-05-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||OPTIFIT-Optimal Fiber Trial for Diabetes Prevention|Investigation of the Effect of Insoluble Dietary Fiber on Carbohydrate and Lipid Metabolism and the Prevention of Diabetes Mellitus Type 2 in Subjects With Impaired Glucose Tolerance|Completed||N/A|200|Anticipated|German Institute of Human Nutrition||2|||f||||f||||||||||2017-10-11 02:32:23.437966|2017-10-11 02:32:23.437966
NCT01681160|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-09-07|||January 2009||2009-01-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional|MDT||Study of Maggot Therapy in Diabetic Foot Ulcers|Maggot Therapy in Diabetic Foot Ulcers|Completed||N/A|128|Actual|Kerman Medical University||1|||f||||t||||||||||2017-10-11 02:32:23.562177|2017-10-11 02:32:23.562177
NCT01681147|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-03-06|||June 2012||2012-06-01|March 2017|2017-03-01|February 2, 2018|Anticipated|2018-02-02|November 20, 2017|Anticipated|2017-11-20||Interventional|||Barriers to Adherence to Recommended Follow-up in Women With a History of Gestational Diabetes|Barriers to Adherence to Recommended Follow-up in Women With a History of Gestational Diabetes|Active, not recruiting||N/A|30|Anticipated|Joslin Diabetes Center||3|||f||||f||||||||||2017-10-11 02:32:23.657255|2017-10-11 02:32:23.657255
NCT01681134|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2012-11-06|||July 2012||2012-07-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male Volunteers|A Comparison of Effects of Short-Term Steady State Low Dose Exposure of Extended Release (Advagraf®) and Immediate Release (Prograf®) Formulations of Tacrolimus on Renal Perfusion and Function in Healthy Male Volunteers|Completed||Phase 1|19|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:32:23.758293|2017-10-11 02:32:23.758293
NCT01681121|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-09-15|2014-09-04||September 2012||2012-09-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy|A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy|Completed||Phase 2|93|Actual|Jazz Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:32:23.883956|2017-10-11 02:32:23.883956
NCT01681108|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2012-09-06|||June 2006||2006-06-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Childhood Obesity-A Study of Intervention|Childhood Obesity-A Study of Intervention|Completed||N/A|6|Actual|Winthrop University Hospital||1|||f||||t||||||||||2017-10-11 02:32:24.278973|2017-10-11 02:32:24.278973
NCT01681095|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-01-10|2016-04-26||August 2012||2012-08-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|August 2014|Actual|2014-08-01||Interventional|||Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent|Custodiol-HTK Solution as a Cardioplegic Agent- A Prospective Non-Inferiority Randomized Clinical Trial|Completed||Phase 2|110|Actual|William Beaumont Hospitals|Adverse events (not serious adverse events) are listed only for events occurring with greater than 5% frequency in at least one of the groups.|2|||f||||t||||||||No||2017-10-11 02:32:24.388662|2017-10-11 02:32:24.388662
NCT01681082|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-12-01|||September 2012||2012-09-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Psychological Effects of Tai Chi Training|Psychological Effects of Tai Chi Training|Completed||N/A|161|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-11 02:32:25.215371|2017-10-11 02:32:25.215371
NCT01681069|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2015-10-05|2015-09-01||October 2012||2012-10-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||*Only 117 out of 118 subjects included in the intention-to-treat population as one subject was lost to follow-up after visit 3|Efficacy and Safety of IQP-VV-102 in Weight Management|Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate the Safety and Efficacy of IQP-VV-102 in Reducing Body Weight in Overweight and Obese Subjects|Completed||Phase 3|120|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-11 02:32:25.309419|2017-10-11 02:32:25.309419
NCT01681056|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-10-02|||August 2010||2010-08-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|May 2011|Actual|2011-05-01||Interventional|ESAQoGe||Efficacy Study of Autosuggestion for Quality of Life of Geriatric Patients|Quality of Life and Psycho-Neuro-Endocrine-Immunology Pathway of Geriatric Patients: A Trial of Autosuggestion|Completed||N/A|51|Actual|Indonesia University||2|||f||||t||||||||||2017-10-11 02:32:25.627883|2017-10-11 02:32:25.627883
NCT01681043|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-03-24|||September 2012||2012-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Sleep Investigation in Respirator Treated ICU Patients: the Importance of Intensive Environment||Completed||N/A|19|Actual|Vejle Hospital||2|||f||||f||||||||||2017-10-11 02:32:25.881428|2017-10-11 02:32:25.881428
NCT01681030|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-05|2014-09-09||2014-09-09|August 2012||2012-08-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||The Fibrin Pad Cardiovascular Study|A Randomized, Controlled, Comparative Phase II Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery|Completed||Phase 2|42|Actual|Ethicon, Inc.||3|||f||||t||||||||||2017-10-11 02:32:25.960136|2017-10-11 02:32:25.960136
NCT01681017|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2015-10-13|||September 2012||2012-09-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|||Global Network Implementation of Helping Babies Breathe (HBB)|Global Network for Women's and Children's Health Research Does Implementation of HELPING BABIES BREATHE (HBB) Save Lives?|Completed||N/A|70704|Actual|NICHD Global Network for Women's and Children's Health||4|||f||||t||||||||||2017-10-11 02:32:26.067575|2017-10-11 02:32:26.067575
NCT01681004|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2017-08-23|2017-06-22||September 2012||2012-09-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|February 2015|Actual|2015-02-01||Interventional|INSITE|Of the 442 patients who were screened for participation at 19 sites, 159 (37.8%) were enrolled. Eleven subjects withdrew before treatment (1 before randomization and 10 after randomization but before any treatment was performed), yielding a total of 148 subjects who were enrolled, randomized and treated (102 to iFuse Implant System & 46 to NSM).|Investigation of Sacroiliac Fusion Treatment (INSITE)|INSITE Investigation of Sacroiliac Fusion Treatment|Completed||N/A|159|Actual|SI-BONE, Inc.|Open-label (non-blinded) study. Most (>90%) NSM subjects with continued pain crossed over after the 6-month visit. Analysis across groups after 6 months is therefore biased, since surgery by definition is not a component of non-surgical treatment.|2|||f||||f||||||||||2017-10-11 02:32:26.264965|2017-10-11 02:32:26.264965
NCT01680991|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-03-23|2016-03-23||September 2012||2012-09-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Safety analysis population included all participants who received at least 1 dose of study drug.|A Study of Obinutuzumab in Chinese Participants With CD20+ Malignant Disease|A Multi-Center, Open Label, Single Arm, Multiple Dose Study to Assess the Pharmacokinetics of RO5072759 in Chinese Patients With CD20+ Malignant Disease|Completed||Phase 1|48|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 02:32:28.208386|2017-10-11 02:32:28.208386
NCT01680978|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-11-01|||October 2012||2012-10-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease|A SINGLE CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSSOVER, PHASE II STUDY TO ASSESS THE EFFECT OF ALEGLITAZAR ON CARDIAC ENERGETICS AND FUNCTION IN PATIENTS WITH UNCOMPLICATED TYPE 2 DIABETES MELLITUS AND NO HISTORY OF CORONARY ARTERY DISEASE WHO ARE DRUG-NAÏVE OR TREATED WITH STABLE METFORMIN MONOTHERAPY|Completed||Phase 2|18|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:32:29.432141|2017-10-11 02:32:29.432141
NCT01626716|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-03-10|||June 2012||2012-06-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Collaborative Care for Depressed Elderly in Korea||Completed||N/A|80|Actual|National Clinical Research Coordination Center, Seoul, Korea||2|||f||||||||||||||2017-10-11 02:49:00.277828|2017-10-11 02:49:00.277828
NCT01680965|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-08-29|||November 14, 2012|Actual|2012-11-14|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease|Ofatumumab in Combination With Glucocorticoids for Primary Therapy of Chronic Graft Versus Host Disease|Active, not recruiting||Phase 1/Phase 2|44|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t|t|f||||||||2017-10-11 02:32:29.531317|2017-10-11 02:32:29.531317
NCT01680952|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-03-07|||September 2012||2012-09-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), Versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate Mofetil in Kidney Transplant Patients||Completed||Phase 4|158|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:32:29.646944|2017-10-11 02:32:29.646944
NCT01680926|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-09-09|||July 2009||2009-07-01|September 2012|2012-09-01|October 2011|Actual|2011-10-01|February 2011|Actual|2011-02-01||Interventional|Almased100||Metabolic Activation With Almased for Type 2 Diabetes Patients|Protein-rich Meal Replacement Significantly Reduces Weight, HbA1c and Daily Insulin Requirement Long-term in Patients With Type 2 Diabetes Mellitus and >100 U Insulin Per Day|Completed||Early Phase 1|22|Actual|West German Center of Diabetes and Health||1|||f||||f||||||||||2017-10-11 02:32:29.845972|2017-10-11 02:32:29.845972
NCT01680913|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-11-10|||January 2013||2013-01-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Does Ultrasound Guidance Improve Time to Perform a Spinal or Number of Attempts in Obese Patients?|Does Ultrasound Guidance Improve Time to Perform a Spinal or Number of Attempts in Obese Patients? A Randomized Controlled Study.|Completed||N/A|67|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 02:32:29.943433|2017-10-11 02:32:29.943433
NCT01680900|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-01-13|2014-12-04||November 2012||2012-11-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Vilazodone for Menopausal Hot Flashes|Vilazodone for Menopausal Hot Flashes: A Proof in Principle Study|Completed||N/A|36|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 02:32:30.230063|2017-10-11 02:32:30.230063
NCT01680887|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-09-06|||August 2012||2012-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence|A Phase II, Randomized, Double-Blind Trial of Varenicline for the Treatment of Cocaine Dependence|Recruiting||Phase 2|200|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 02:32:30.65725|2017-10-11 02:32:30.65725
NCT01680874|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2015-12-01|||February 2013||2013-02-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|PICO||Probiotics for Clostridium Difficile Infection in Older Adults|A Pilot Study to Examine the Role of Probiotics for Improving Outcomes of C. Difficile|Completed||Phase 2|33|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 02:32:30.759187|2017-10-11 02:32:30.759187
NCT01680861|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-10-21|2016-06-20||November 2012||2012-11-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium|Randomized, Open-Label Trial of Tacrolimus/Everolimus vs. Tacrolimus/Enteric-Coated Mycophenolate Sodium to Prevent Biopsy-Proven Acute Rejection and Chronic Allograft Injury in Adult, Primary Kidney Transplantation|Completed||Phase 3|32|Actual|University of Miami||2|||f||||t||||||||No||2017-10-11 02:32:30.881989|2017-10-11 02:32:30.881989
NCT01680848|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-10-18|2016-01-20||May 2010||2010-05-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|October 2012|Actual|2012-10-01||Observational|||Assessment of Caries Diagnosis and Caries Treatment in Dental PBRN Japan|Assessment of Caries Diagnosis and Caries Treatment in Dental PBRN Japan|Completed||N/A|282|Actual|Dental PBRN Japan|||1||f||||f||||||||No|Currently, we have no plan.|2017-10-11 02:32:32.32347|2017-10-11 02:32:32.32347
NCT01680835|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-03-14|||September 2012||2012-09-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|DURABILITY PAS||EverFlex Post Approval Study|The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the EverfLex NitInol STent System Post Approval Study|Active, not recruiting||N/A|108|Actual|Medtronic Endovascular||1|||f||||f||||||||||2017-10-11 02:32:32.58854|2017-10-11 02:32:32.58854
NCT01680822|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-11-16|||September 2012||2012-09-01|November 2014|2014-11-01||||November 2014|Actual|2014-11-01||Observational|||Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease|Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease in the University of Illinois Hospital & Health Sciences System|Completed||N/A|150|Actual|University of Illinois at Chicago|||1||f||||f||||||||||2017-10-11 02:32:32.687258|2017-10-11 02:32:32.687258
NCT01680809|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-09-04|||September 2012||2012-09-01|September 2012|2012-09-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Compliance of Compression Therapy in Healed Venous Ulcerations|Compliance of Compression Therapy in Healed Venous Ulcerations|Unknown status|Not yet recruiting|N/A|60|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-11 02:32:32.799681|2017-10-11 02:32:32.799681
NCT01680796|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2013-02-18|||February 2013||2013-02-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma|Phase I, Open Label, Clinical Study to Determine the Maximum Tolerated Dose (MTD) of Oral Dovitinib (TKI258) When Given in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma Patients|Withdrawn||Phase 1|0|Actual|University of Florida||1||"The target drug, dovitinib, failed as a single agent in prior studies in patients with heavily   treated multiple myeloma."|f||||t||||||||||2017-10-11 02:32:32.919269|2017-10-11 02:32:32.919269
NCT01680770|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-09-11|||July 2010||2010-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Use of Ultrasonography to Determine Fluid-responsiveness for Shock in a Population of Intensive Care Unit Patients|Use of Ultrasonography to Determine Fluid-responsiveness for Shock in a Population of Intensive Care Unit Patients|Active, not recruiting||N/A|124|Anticipated|University of Chicago|||1||f||||t||||||||||2017-10-11 02:32:33.434216|2017-10-11 02:32:33.434216
NCT01680757|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-02-21|||September 2012||2012-09-01|February 2013|2013-02-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|PLACE III||Study of Left Atrial Appendage Closure in Patients With Atrial Fibrillation - III|Multicenter Registry of Permanent Ligation Approximation Closure Exclusion of the Left Atrial Appendage in Patients With Atrial Fibrillation III (PLACE III)|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||1||This study has been withdrawn prior to enrollment|f||||f||||||||||2017-10-11 02:32:33.52918|2017-10-11 02:32:33.52918
NCT01680744|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-12-02|||May 2012||2012-05-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup||Completed||N/A|370|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:32:33.649756|2017-10-11 02:32:33.649756
NCT01680731|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2014-02-19|||October 2011||2011-10-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|VADUS||3D Ultrasound in Women With Vacuum or Forceps Deliveries|3-Dimension Ultrasound Findings in Women Who Have Undergone Vacuum Versus Forceps-Assisted Vaginal Deliveries|Completed||N/A|45|Actual|University of Rochester|||4||f||||f||||||||||2017-10-11 02:32:33.734175|2017-10-11 02:32:33.734175
NCT01680718|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-05-27|||October 2012||2012-10-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Neuropeptides and Social Behavior|Neuropeptides and Social Behavior|Completed||Early Phase 1|160|Actual|University of California, Los Angeles||3|||f||||f||||||||||2017-10-11 02:32:33.837769|2017-10-11 02:32:33.837769
NCT01680705|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2014-12-01|||July 2012||2012-07-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery|Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery|Completed||N/A|75|Actual|University of Calgary||3|||f||||f||||||||||2017-10-11 02:32:33.962002|2017-10-11 02:32:33.962002
NCT01680692|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-07-22|||August 2012||2012-08-01|July 2016|2016-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Continuous Femoral and Tibial Nerve Blocks in TKA Patients|A Prospective, Randomized Study Comparing Continuous Femoral and Tibial Nerve Blocks vs. Continuous Femoral and Single Shot Sciatic Nerve Block in Total Knee Arthroplasties.|Terminated||Early Phase 1|2|Actual|Texas Tech University Health Sciences Center, El Paso||2||Principal Investigator left institution--no subjects completed the study|f||||f||||||||||2017-10-11 02:32:34.087709|2017-10-11 02:32:34.087709
NCT01680679|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-03-23|||May 2012||2012-05-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Influenza Immunization of Children in India|Influenza Immunization of Children in India|Completed||Phase 4|18163|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-10-11 02:32:34.220377|2017-10-11 02:32:34.220377
NCT01680666|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-01-26|2015-01-26||May 2009||2009-05-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Prospective Trial of Ultrasound Versus Landmark Guided Central Venous Access in the Pediatric Population|A Prospective Randomized Trial of Ultrasound Versus Landmark Guided Central Venous Access in Children|Completed||N/A|150|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 02:32:34.985956|2017-10-11 02:32:34.985956
NCT01680627|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-09-06||||||September 2012|2012-09-01||||||||Observational|CASI||The Effect of Computerized Alcohol Screening and Brief Intervention (CASI) on Alcohol Consumption in Adolescent Patients in the Emergency Department||Unknown status|Recruiting|N/A|||University of California, Irvine|||1||f||||||||||||||2017-10-11 02:32:35.627735|2017-10-11 02:32:35.627735
NCT01680614|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-09-06||||||September 2012|2012-09-01||||||||Observational|CASI||The Efficacy of Computerized Alcohol Screening and Intervention (CASI) in At-Risk Emergency Department and Trauma Patients||Unknown status|Recruiting|N/A|||University of California, Irvine|||1||f||||||||||||||2017-10-11 02:32:35.710899|2017-10-11 02:32:35.710899
NCT01680601|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-04-17|||January 2013||2013-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Remote Ischaemic Preconditioning in Children Undergoing Cardiac Surgery|Effect of Remote Ischaemic Preconditioning in Cardiac Dysfunction and End-organ Injury Following Cardiac Surgery With Cardiopulmonary Bypass in Children.|Completed||N/A|51|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 02:32:35.802157|2017-10-11 02:32:35.802157
NCT01680588|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-03-29|||August 2012||2012-08-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease|A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET in the Detection of Beta Amyloid in Subjects With Probable Alzheimer's Disease, Older Healthy Volunteers, and Young Healthy Volunteers|Active, not recruiting||Phase 2|70|Anticipated|Navidea Biopharmaceuticals||1|||f||||f||||||||||2017-10-11 02:32:35.935204|2017-10-11 02:32:35.935204
NCT01680575|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-05-27|||September 2012||2012-09-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer|Development of a Risk Model Predicting Chemotherapy-induced Grade 3-4 Neutropenia by Paclitaxel/Carboplatin in Epithelial Ovarian Cancer: Prospective Observational Study for Model Development and Retrospective Study for Validation of Developed Model|Recruiting||N/A|750|Anticipated|Asan Medical Center|||2||f||||f||||||||||2017-10-11 02:32:36.06128|2017-10-11 02:32:36.06128
NCT01680562|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-09-04|||January 2010||2010-01-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|July 2012|Actual|2012-07-01||Observational|||In-vivo Optical Coherence Tomography Imaging in Dermatooncology|Improving Diagnosis of Skin Cancer Patients Via Optical Coherence Tomography and Teledermatology- A Pilot Study|Unknown status|Active, not recruiting|N/A|37|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 02:32:36.187975|2017-10-11 02:32:36.187975
NCT01680549|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-01-26|2016-11-28||September 2012||2012-09-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|L12-078||Pain Control With Total Knee Replacement|Pain Control With Total Knee Replacement: Does Gabapentin Affect Narcotic Usage and Functional Outcome? A Randomized Controlled Trial.|Completed||Phase 4|50|Actual|Texas Tech University Health Sciences Center||2|||f||||f||||||||No||2017-10-11 02:32:36.335698|2017-10-11 02:32:36.335698
NCT01680536|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-02-26|||November 2012||2012-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|CINAMMON||A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study||Completed||Phase 4|19|Actual|St Stephens Aids Trust||1|||f||||||||||||||2017-10-11 02:32:37.883426|2017-10-11 02:32:37.883426
NCT01680523|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-05-27|||September 2012||2012-09-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Radical Hysterectomy Followed by Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)|A Randomized Controlled Trial Comparing Radical Hysterectomy Plus Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)|Recruiting||N/A|409|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:32:38.253606|2017-10-11 02:32:38.253606
NCT01680510|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-01-01|||September 2012||2012-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil|The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Patients With Retinitis Pigmentosa|Recruiting||Phase 2/Phase 3|100|Anticipated|Sheba Medical Center||2|||f||||t||||||||||2017-10-11 02:32:38.394417|2017-10-11 02:32:38.394417
NCT01680497|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2015-06-05|2015-06-05||June 2012||2012-06-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Post-Market Study of JUVÉDERM VOLIFT™ With Lidocaine for the Correction of Nasolabial Folds||Completed||N/A|70|Actual|Allergan||1|||f||||f||||||||||2017-10-11 02:32:38.567346|2017-10-11 02:32:38.567346
NCT01680484|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-09-06|||February 2011||2011-02-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Bitter Chocolate or Orange Juice for Non-reactive Non-stress Test (NST) Patterns|Bitter Chocolate Versus Orange Juice for Non-reactive Non-stress Test (NST) Patterns: A Randomized Prospective Controlled Study|Completed||N/A|180|Actual|Dr. Sami Ulus Children's Hospital||3|||f||||||||||||||2017-10-11 02:32:39.052026|2017-10-11 02:32:39.052026
NCT01680471|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-01-03|||July 2012||2012-07-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study on the Effects of Midazolam on Delirium After Sevoflurane Anesthesia in Pediatric Strabismus Surgery|Comparative Study on the Effects of Capacities of Midazolam on Delirium After Sevoflurane Anesthesia in Pediatric Strabismus Surgery : a Randomized Double- Blinded Trial|Completed||N/A|90|Actual|Korea University Anam Hospital||3|||f||||t||||||||||2017-10-11 02:32:39.169938|2017-10-11 02:32:39.169938
NCT01680458|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2015-11-04|2015-11-04||November 2012||2012-11-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|DREAM|In total, 30 participants were enrolled in the study. Of the 30 participants, a total of 3 participants were excluded from the baseline analysis because of protocol violation.|Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication|Special Investigation Of Fluconazole For Pediatric Subjects|Completed||N/A|30|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 02:32:39.305994|2017-10-11 02:32:39.305994
NCT01680445|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2012-09-04|||March 2011||2011-03-01|September 2012|2012-09-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Observational|||Telephone Interview Study for Men and Women With Osteoarthritis|Observational Telephone Interview Study for Men and Women With Osteoarthritis|Completed||N/A|23|Actual|Health Outcomes Solutions|||1||f||||t||||||||||2017-10-11 02:32:39.620517|2017-10-11 02:32:39.620517
NCT01680432|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-09-06|||January 2012||2012-01-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of the Consumption of a Cheese Enriched With Probiotic Organisms in Improving Symptoms of Constipation|Effect of the Consumption of a Cheese Enriched With Probiotic Organisms (Bifidobacterium Lactis Bi-07) in Improving Symptoms of Constipation: a Randomized Controlled Trial|Completed||N/A|30|Actual|Centro Universitário Univates||2|||f||||t||||||||||2017-10-11 02:32:39.713381|2017-10-11 02:32:39.713381
NCT01680419|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-07-31|||September 2012||2012-09-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families|Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families|Completed||Phase 2|320|Actual|Collinge and Associates, Inc.||4|||f||||f||||||||||2017-10-11 02:32:39.810419|2017-10-11 02:32:39.810419
NCT01680406|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-01-18|||October 2012||2012-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Ethiopia Antimalarial in Vivo Efficacy Study 2012|Ethiopia Antimalarial in Vivo Efficacy Study 2012: Evaluating the Efficacy of Artemether-lumefantrine Alone Compared to Artemether-lumefantrine Plus Primaquine and Chloroquine Alone Compared to Chloroquine Plus Primaquine for Plasmodium Vivax Infection|Completed||Phase 4|398|Actual|Centers for Disease Control and Prevention||4|||f||||t||||||||||2017-10-11 02:32:39.948147|2017-10-11 02:32:39.948147
NCT01680393|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-09-04|||May 2011||2011-05-01|September 2012|2012-09-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Sequential Compression Device (SCD) for Stabilizing Hemodynamics in the Beach Chair Position|Stabilizing Cerebral and Circulatory Hemodynamics During Shoulder Surgery in the Beach Chair Position Using Sequential Compression Device (SCD) or TED Stockings Compared to a Control Group|Unknown status|Recruiting|N/A|60|Anticipated|Bispebjerg Hospital||3|||f||||f||||||||||2017-10-11 02:32:40.115744|2017-10-11 02:32:40.115744
NCT01680380|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-07-05|||October 2012||2012-10-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Tracking Breathing During Sleep With Non-contact Sensors|Tracking Breathing During Sleep With Non-contact Sensors|Withdrawn||N/A|0|Actual|Oregon Health and Science University|||1|Superseded by larger funded study|f||||f||||||||||2017-10-11 02:32:40.237246|2017-10-11 02:32:40.237246
NCT01680367|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-03-16|||November 2008||2008-11-01|March 2016|2016-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Wound Dressings For Split-Thickness Skin Graft Donor Sites in Patients Undergoing Surgery|A Comparative Study of Dressings for Split-Thickness Skin Graft Donor Sites.|Completed||N/A|69|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:32:40.324856|2017-10-11 02:32:40.324856
NCT01680354|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2014-04-30|||September 2012||2012-09-01|April 2014|2014-04-01||||September 2012|Anticipated|2012-09-01||Interventional|||Surgical Correction of Astigmatism|Comparative Study of Surgical Laser Correction of Astigmatism|Withdrawn||N/A|0|Actual|Aarhus University Hospital||2||"Institution changed surgical method to small incision lenticule extraction. Study never   started."|f||||f||||||||||2017-10-11 02:32:40.439809|2017-10-11 02:32:40.439809
NCT01680341|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-02-09|2015-10-16|2013-11-07|August 2012||2012-08-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|BOOST®||Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine|A Trial Comparing the Efficacy and Safety of Two Different Titration Algorithms for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine (BOOST®: SIMPLE vs. STEPWISE)|Completed||Phase 3|272|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:32:40.53945|2017-10-11 02:32:40.53945
NCT01680328|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-01-18|2013-12-06||August 2012||2012-08-01|January 2017|2017-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations|Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations|Completed||Phase 1|82|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 02:32:41.084069|2017-10-11 02:32:41.084069
NCT01680315|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-09-03|||May 2012||2012-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Calorie Anticipation and Food Intake|Differences in Physiological Responses of Satiety and Reward After (in)Consistent Calorie Cues.|Completed||N/A|12|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 02:32:41.861573|2017-10-11 02:32:41.861573
NCT01680302|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2017-02-02|||September 2012||2012-09-01|February 2017|2017-02-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Effect of 3 Years of Exercise on Development of Atrial Fibrillation|"Effect of 3 Years of Exercise on Development of Atrial Fibrillation - A Generation 100 Substudy"|Active, not recruiting||N/A|4000|Anticipated|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 02:32:41.941364|2017-10-11 02:32:41.941364
NCT01680289|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-11-25|||August 2012||2012-08-01|September 2012|2012-09-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Influence of the Number of Layers of a One Bottle Adhesive on the Longevity of Composite Restorations in Primary Molars|Influence of the Number of Layers of a One Bottle Adhesive on the Longevity of Composite Resin Restorations in Primary Molars - Randomized Controlled Clinical Study.|Unknown status|Recruiting|N/A|60|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 02:32:42.038005|2017-10-11 02:32:42.038005
NCT01680276|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-05-20|||November 2012||2012-11-01|June 2015|2015-06-01|November 2016|Anticipated|2016-11-01|November 2015|Actual|2015-11-01||Interventional|PBS||Clinical and Cost Effectiveness of Positive Behaviour Support: a Trial|Clinical and Cost Effectiveness of Staff Training in Positive Behaviour Support (PBS) for Treating Challenging Behaviour in People With Intellectual Disability: A Cluster Randomised Controlled Trial|Unknown status|Active, not recruiting|Phase 3|246|Actual|University College, London||2|||f||||t||||||||||2017-10-11 02:32:42.154045|2017-10-11 02:32:42.154045
NCT01680263|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-09-03|||February 2012||2012-02-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis|Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis|Completed||N/A|46|Actual|Shiraz University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:32:42.27829|2017-10-11 02:32:42.27829
NCT01680250|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-09-03|||September 2011||2011-09-01|September 2012|2012-09-01|August 2015|Anticipated|2015-08-01|September 2014|Anticipated|2014-09-01||Interventional|SILVER||Sirolimus for Massive Polycystic Liver|An Open-label, Prospective Clinical Trial to Evaluate the Effectiveness and Safety of Sirolimus to Reduce Cyst Growth in ADPKD Patients With Massive Polycystic Liver|Unknown status|Recruiting|Phase 2/Phase 3|44|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 02:32:42.381012|2017-10-11 02:32:42.381012
NCT01680237|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-10-21|||October 2011||2011-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia|Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia|Recruiting||Phase 2|250|Anticipated|Ruhr University of Bochum||2|||f||||f||||||||Yes|Data will be available upon request.|2017-10-11 02:32:44.567432|2017-10-11 02:32:44.567432
NCT01680211|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-09-03|||April 2012||2012-04-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients|Efficacy and Safety Study of Herbal Supplements (SR-L-01, SR-B-01 and SI-S-01) in the Management of Prediabetes and Mild to Moderate Hyperlipidemia|Completed||N/A|40|Actual|Olive Lifesciences Pvt Ltd||4|||f||||t||||||||||2017-10-11 02:32:44.870363|2017-10-11 02:32:44.870363
NCT01680198|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-10-01|||June 2011||2011-06-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PENNY||Paricalcitol and Endothelial Function in Chronic Kidney Disease Patients (the PENNY Study)|Effect of Paricalcitol on Endothelial Function in Chronic Kidney Disease (CKD) Patients (the PENNY Study)|Completed||Phase 3|88|Actual|"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"||2|||f||||t||||||||||2017-10-11 02:32:44.975105|2017-10-11 02:32:44.975105
NCT01680185|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-01-27|||August 2012||2012-08-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|SAPT-NODAT||Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation|Treat-To-Target Trial of Continuous Subcutaneous, Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation (SAPT-NODAT)|Active, not recruiting||Phase 3|85|Actual|Medical University of Vienna||3|||f||||f||||||||||2017-10-11 02:32:45.095543|2017-10-11 02:32:45.095543
NCT01680172|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2016-01-29|2016-01-29||August 2012||2012-08-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer|Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer|Terminated||Phase 2|5|Actual|Mayo Clinic|The study was terminated due to slow accrual rate. Data analysis limited to 5 participants.|2||Slow enrollment|f||||f||||||||No||2017-10-11 02:32:45.226481|2017-10-11 02:32:45.226481
NCT01680159|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-01-23|2016-11-09||July 2012||2012-07-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis||Completed||Phase 3|51|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 02:32:45.705756|2017-10-11 02:32:45.705756
NCT01680146|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-11-27|||October 2012||2012-10-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|Pro-Fat||Impact of Fat Co-ingestion With Protein on the Post-prandial Anabolic Response in Elderly Men|Impact of Fat Co-ingestion With Protein on the Post-prandial Anabolic Response in Elderly Men (Pro-Fat Study)|Completed||N/A|24|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:32:47.78442|2017-10-11 02:32:47.78442
NCT01680133|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-10-11|||June 2007||2007-06-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes|Regulation of Lipolysis by Insulin in Skeletal Muscle and Adipose Tissue in Type 2 Diabetes|Completed||N/A|20|Actual|Maastricht University Medical Center|||2||f||||||||||Samples With DNA|"     adipose tissue and skeletal muscle biopsies   "|||2017-10-11 02:32:47.879547|2017-10-11 02:32:47.879547
NCT01680107|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2015-12-02|||October 2012||2012-10-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||D-cycloserine Augmented CBT for Panic Disorder|The Effect of a Single-dose of D-cycloserine on the Basic Effects of Cognitive-behaviour Therapy for Panic Disorder - a Randomized Placebo-controlled Trial|Recruiting||Phase 3|50|Anticipated|University of Oxford||2|||f||||t||||||||||2017-10-11 02:32:48.119157|2017-10-11 02:32:48.119157
NCT01680094|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2014-02-24|||September 2012||2012-09-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|CLEAR||Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART|The Safety and Efficacy of The Histone Deacetylase Inhibitor Panobinostat for Purging HIV-1 From The Latent Reservoir (CLEAR) Study|Completed||Phase 1/Phase 2|15|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 02:32:48.224065|2017-10-11 02:32:48.224065
NCT01680081|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2016-10-17|||October 2011||2011-10-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Adenosine-induced Stress Dynamic Myocardial Perfusion Imaging With Dual-source CT||Recruiting||Phase 4|152|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 02:32:48.333377|2017-10-11 02:32:48.333377
NCT01680068|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2013-12-04|||September 2012||2012-09-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Air Tamponade in Macular Hole Surgery|Air Tamponade in Macular Hole Surgery|Completed||N/A|20|Actual|Helse Stavanger HF||1|||f||||f||||||||||2017-10-11 02:32:48.571647|2017-10-11 02:32:48.571647
NCT01680055|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2016-04-18|||February 2009||2009-02-01|September 2012|2012-09-01|November 2012|Anticipated|2012-11-01|||||Observational|||Collection of Blood and Bone Marrow From Patients With Aplastic Anemia for Analysis of Adhesion Molecules, Chemokines and Their Receptors||Withdrawn||N/A|0|Actual|Shandong University|||1|No eligible patient was enrolled.|f||||||||||||||2017-10-11 02:32:48.659727|2017-10-11 02:32:48.659727
NCT01680042|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2012-10-01|||October 2012||2012-10-01|October 2012|2012-10-01||||March 2013|Anticipated|2013-03-01||Interventional|||Clinical Effect of Phenytoin Mucoadhesive Paste on Wound Healing After Oral Biopsy|Phase 1 Study of Phenytoin Mucoadhesive Paste for Wound Healing After Oral Biopsy|Unknown status|Recruiting|Phase 1|40|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:32:48.741998|2017-10-11 02:32:48.741998
NCT01680029|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2013-11-08|||January 2013||2013-01-01|November 2013|2013-11-01||||||||Interventional|||PBASE-system Acute Migraine Clinical Investigation|A Clinical Investigation to Evaluate the Safety and Performance of the PBASE-system When Used in the Treatment of Acute Migraine Episodes of Moderate to Severe Intensity|Terminated||N/A|50|Anticipated|Chordate Medical||1||Too slow recruitment rate|f||||f||||||||||2017-10-11 02:32:48.859974|2017-10-11 02:32:48.859974
NCT01680016|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2014-04-22|2014-01-07||September 2012||2012-09-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Enrolled set:All subjects who had signed an informed consent, undergone screening procedure(s) and were randomized|A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults|A Phase IIIb, Randomized, Open-label Study Comparing Two Different Rabies Vaccine Post-exposure Schedules (Zagreb 2-1-1 and Rabipur® Essen 1-1-1-1-1) in Chinese Children and Older Adults|Completed||Phase 3|644|Actual|Novartis||4|||f||||f||||||||||2017-10-11 02:32:48.975745|2017-10-11 02:32:48.975745
NCT01680003|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2013-04-10|||September 2012||2012-09-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|Hepar-P||Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease|A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy and Safety of HEPAR-P Capsule for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)|Unknown status|Recruiting|Phase 2|50|Anticipated|Nova Laboratories Sdn Bhd||2|||f||||f||||||||||2017-10-11 02:32:50.29168|2017-10-11 02:32:50.29168
NCT01679990|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-02|2017-01-22|||October 2012||2012-10-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)|A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel- Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects With Intermittent Claudication (IC)|Active, not recruiting||Phase 2|172|Actual|Pluristem Ltd.||4|||f||||||||||||||2017-10-11 02:32:50.415207|2017-10-11 02:32:50.415207
NCT01679977|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2016-03-04|||June 2008||2008-06-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|MOBIL||Vibrational-proprioceptive Resistance Exercise Training Versus Neuromuscular Electrical Stimulation Training in Elderly People With Muscle Weakness||Completed||N/A|150|Anticipated|Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation||3|||f||||f||||||||||2017-10-11 02:32:50.582929|2017-10-11 02:32:50.582929
NCT01679951|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2017-03-23||2014-12-29|October 2012||2012-10-01|March 2017|2017-03-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate|A Phase 2b Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel Group, Dose Range Finding Study of JNJ-38518168 in Subjects With Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy|Terminated||Phase 2|272|Actual|Janssen Research & Development, LLC||4||The decision was made to prematurely discontinue this trial due to lack of efficacy.|f||||t||||||||||2017-10-11 02:32:50.913742|2017-10-11 02:32:50.913742
NCT01679938|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-09-03|||May 2011||2011-05-01|September 2012|2012-09-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||A Child Care-based Obesity Prevention Intervention|Prevention of Obesity in Children: An Intervention Based on Child Care Centers Belonging to the Mexican Institute of Social Security|Unknown status|Active, not recruiting|N/A|640|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||t||||||||||2017-10-11 02:32:51.281418|2017-10-11 02:32:51.281418
NCT01679925|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2015-03-25|||October 2012||2012-10-01|July 2012|2012-07-01|February 2015|Actual|2015-02-01|July 2014|Actual|2014-07-01||Observational|PUPSY||Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years|Qualitative Assessment of the Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years|Completed||N/A|30|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 02:32:51.3577|2017-10-11 02:32:51.3577
NCT01679912|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-12-12|||March 2013||2013-03-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|SOS AOH||A Call Center During HAE Attacks (SOS HAE)|Hereditary Angioedema : Interest From the Use of a Call Center During the Attacks.|Completed||Phase 4|200|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:32:51.418891|2017-10-11 02:32:51.418891
NCT01679899|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-02|2016-11-02|||December 2012||2012-12-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|BoneGlyc||Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability|Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability.A Comparison Between Vildagliptin and Gliclazide MR|Completed||Phase 4|56|Actual|Centro de Diabetes Curitiba Ltda||2|||f||||f||||||||No||2017-10-11 02:32:51.50859|2017-10-11 02:32:51.50859
NCT01679886|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2017-02-20|||September 2012||2012-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|RUBIS||Comparison of Rubidium PET and SPECT With CZT Crystals for Detection of Myocardial Ischemia in Overweighed Patients and Women|Comparison of the Diagnostic Performances of 82Rubidium Positron Emission Tomography and Conventional Scintigraphy With CZT Cameras for Detection of Myocardial Ischemia in a Population of Overweighed Patients and Women|Completed||N/A|313|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||Undecided||2017-10-11 02:32:51.592546|2017-10-11 02:32:51.592546
NCT01679873|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2013-12-20|||October 2012||2012-10-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|ACOPI||Abstract' Content and GPs' Confidence in the Conclusion|Impact of Reporting Funding Sources and Conflicts of Interest in RCTs' Abstracts on General Practitioners' Confidence: a 3-arms Randomized Controlled Trial.|Completed||N/A|354|Actual|Hotel Dieu Hospital||3|||f||||f||||||||||2017-10-11 02:32:51.670834|2017-10-11 02:32:51.670834
NCT01679860|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-09-03|||November 2006||2006-11-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|December 2011|Actual|2011-12-01||Interventional|PTCL-06||Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma|Intensive Chemo-immunotherapy as First-line Treatment in Adult Patients With Peripheral T-cell Lymphoma (PTCL)|Completed||Phase 2|92|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||t||||||||||2017-10-11 02:32:51.756662|2017-10-11 02:32:51.756662
NCT01679847|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2012-09-07|||September 2012||2012-09-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Observational|||Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.||Unknown status|Not yet recruiting|Phase 1|8|Anticipated|Dalian Holley Kingkong Pharmaceutical Co., Ltd|||1||f||||t||||||Samples Without DNA|"     Plasma and Cerebrospinal fluid   "|||2017-10-11 02:32:51.876054|2017-10-11 02:32:51.876054
NCT01679834|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2016-11-01|||November 2014||2014-11-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C|A Roche Project in Cooperation With the Bng (Association of German Resident Gastroenterologists) for Quality Assurance in the Dual- or Triple-therapy of Chronic Hepatitis C With Peg-(40kd)-Interferon Alfa 2a (Pegasys) at Hepatology Centers|Recruiting||N/A|7500|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:32:51.947948|2017-10-11 02:32:51.947948
NCT01679639|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2016-11-01|||August 2012||2012-08-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy Volunteers|An Open-label, Fixed-sequence, Three-period, Single Group Study to Investigate the Effects of Rifampicin as an OATP1B1 Inhibitor and a CYP2C8 Inducer on the Pharmacokinetics of Aleglitazar in Healthy Subjects|Completed||Phase 1|24|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:32:53.411438|2017-10-11 02:32:53.411438
NCT01679626|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2012-09-06|||June 2011||2011-06-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Airway Manoeuvers - Implications for Airway Management?|The Effect of Cricoid Pressure and Backward Upward Rightward Pressure on Airway Dimensions - Implications for Airway Management?|Completed||N/A|200|Actual|Catharina Ziekenhuis Eindhoven|||1||f||||t||||||||||2017-10-11 02:32:53.527037|2017-10-11 02:32:53.527037
NCT01679821|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2012-09-05|||December 2010||2010-12-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Observational|||Prevalence of Signs and Symptoms of TMD in Patients Wearing Double Complete Dentures, RPD and in Dentistry Students.|Prevalence of Signs and Symptoms of Temporomandibular Disorders (TMD) in Patients Wearing Double Complete Dentures, Removable Partial Dentures and Dentistry Students at State University of West of Paraná - UNIOESTE|Completed||N/A|210|Actual|Universidade Estadual do Oeste do Paraná|||3||f||||t||||||None Retained|"     The sample consisted of 210 individuals, aged 19-90 years (average 44.5 years) of both     genders, divided into 3 groups:      Group 1 - seventy dental students of State University of West of Paraná - UNIOESTE; Group 2 -     seventy patients treated at the UNIOESTE Dental Clinic that wore removable partial denture     (partially edentulous); Group 3 - seventy patients with double complete dentures treated in     Center for Dental Specialties of Cascavel - PR.      Students in orthodontic treatment or with less than one year after the end of orthodontic     treatment were excluded from the research. Patients wearing a complete denture in one     maxillary and a removable partial denture in another maxillary, and patients wearing just one     complete denture were not included in the research.   "|||2017-10-11 02:32:52.029238|2017-10-11 02:32:52.029238
NCT01679808|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2012-09-03|||August 2004||2004-08-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|August 2006|Actual|2006-08-01||Observational|PDTO||Pressure Dependent Tracheal Obstruction in Copd Patients|Pressure Dependent Tracheal Obstruction in Copd Patients|Completed||N/A|104|Actual|LHL Helse|||1||f||||t||||||||||2017-10-11 02:32:52.112371|2017-10-11 02:32:52.112371
NCT01679795|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2015-04-02|||February 2012||2012-02-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Vascular Effect of Tibolone Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery||Completed||N/A|60|Actual|Federal University of Minas Gerais||2|||f||||||||||||||2017-10-11 02:32:52.185384|2017-10-11 02:32:52.185384
NCT01679782|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2015-03-09|||July 2012||2012-07-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|DesCoM-1||Involvement of Nervous System in Muscle Weakness in COPD Patients|Phase 1 Impact of Nocturnal Desaturations on Central Motor Drive in COPD Patients: A New Insight on the Systemic Effects of the Disease.|Completed||N/A|137|Actual|5 Santé|||3||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 02:32:52.281496|2017-10-11 02:32:52.281496
NCT01679769|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2015-11-04|||May 2012||2012-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01|2 Weeks|Observational [Patient Registry]|||Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B|Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic|Completed||N/A|818|Actual|Peking University First Hospital|||1||f||||t||||||Samples Without DNA|"     liver biopsy samples and blood samples   "|||2017-10-11 02:32:52.356869|2017-10-11 02:32:52.356869
NCT01679756|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2012-09-01|||March 2013||2013-03-01|September 2012|2012-09-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|INEXTREMO||INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer|INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer: a Randomized Clinical Trial. (IN EXTREMO Study)|Unknown status|Not yet recruiting|N/A|384|Anticipated|Ospedale Misericordia e Dolce||2|||f||||t||||||||||2017-10-11 02:32:52.434445|2017-10-11 02:32:52.434445
NCT01679743|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2017-06-30|||August 29, 2012||2012-08-29|August 11, 2014|2014-08-11|August 11, 2014|Anticipated|2014-08-11|August 11, 2014|Anticipated|2014-08-11||Interventional|||GRN1005 for Brain Metastases From Breast or Lung Cancer|A Pilot Study of GRN1005 for Resectable Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 02:32:52.57438|2017-10-11 02:32:52.57438
NCT01679730|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-03-09|||June 2012||2012-06-01|September 2012|2012-09-01||||April 2016|Anticipated|2016-04-01||Observational|||Changes of Microbiota in Irritable Bowel Syndrome Patients||Unknown status|Recruiting|N/A|40|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 02:32:52.676811|2017-10-11 02:32:52.676811
NCT01679717|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-05-04|||June 2012||2012-06-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Postoperative Therapy After Interposition Arthroplasty in CMC1|Postoperative Therapy After Interposition Arthroplasty in CMC1|Unknown status|Recruiting|N/A|70|Anticipated|Diakonhjemmet Hospital||2|||f||||t||||||||||2017-10-11 02:32:52.744418|2017-10-11 02:32:52.744418
NCT01679704|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2014-08-01|||February 2012||2012-02-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Determination of Glycemic Index (GI) of Ten Food Products|Determination of Glycemic Index (GI) of Ten Food Products|Completed||N/A|15|Actual|Danone Asia Pacific Holdings Pte, Ltd.||1|||f||||f||||||||||2017-10-11 02:32:52.863993|2017-10-11 02:32:52.863993
NCT01679691|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2016-01-11|||September 2011||2011-09-01|September 2012|2012-09-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||The Effect of Epidural Anesthesia on the Intra-operative and Post-operative Amount of Bleeding Following Lower Limb Salvage Surgery|The Effect of Epidural Anesthesia on the Intra-operative and Post-operative Amount of Bleeding Following Lower Limb Salvage Surgery|Suspended||N/A|45|Anticipated|Children's Cancer Hospital Egypt 57357||2||Till IRB renewal|f||||t||||||||||2017-10-11 02:32:52.954031|2017-10-11 02:32:52.954031
NCT01679678|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-03-29|||November 2012||2012-11-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of PolyHeal-2 Versus PolyHeal in Once Daily Regimen|A Double Blind, Randomized, Controlled Study, Performed in Subjects With Post Traumatic-post Surgical, Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of Polyheal-2 vs PolyHeal in Once Daily Regimen|Terminated||Phase 2|15|Actual|MediWound Ltd||2||Business considerations|f||||f||||||||||2017-10-11 02:32:53.053063|2017-10-11 02:32:53.053063
NCT01679665|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2013-05-07|||August 2012||2012-08-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Systems Biology of Vaccination for EV71 Vaccine in Humans|Systems Biology of Vaccination for EV71 Vaccine in Chinese Healthy Children Aged From 2 to 5 Years Old|Completed||Phase 2|72|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 02:32:53.157379|2017-10-11 02:32:53.157379
NCT01679652|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-01|2014-03-01|||August 2012||2012-08-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|NEBI||The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension|The Effects of Nebivolol on the NO-system in Patients With Essential|Completed||Phase 2|25|Actual|Regional Hospital Holstebro||2|||f||||t||||||||||2017-10-11 02:32:53.269182|2017-10-11 02:32:53.269182
NCT01679613|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2014-11-26|2014-11-14||September 2012||2012-09-01|November 2014|2014-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||The treated set (TS) includes all subjects who were dispensed study medication and were documented to have taken at least one dose of study medication (nintedanib or ketoconazole).|Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers|Relative Bioavailability of Nintedanib Given Alone and in Combination With Ketoconazole at Steady State in Healthy Male Volunteers (an Open-label, Randomised, Two-way Cross-over Clinical Phase I Study)|Completed||Phase 1|34|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 02:32:53.604296|2017-10-11 02:32:53.604296
NCT01679600|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-07-30|2015-07-03||August 2012||2012-08-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Cardiovascular Rehabilitation Early After Stroke Using Feedback-controlled Robotics-assisted Treadmill Exercise|Cardiovascular Rehabilitation Early After Stroke Using Feedback-controlled Robotics-assisted Treadmill Exercise: A Randomised Controlled Pilot Trial|Completed||N/A|20|Actual|Bern University of Applied Sciences||2|||f||||t||||||||||2017-10-11 02:32:54.020642|2017-10-11 02:32:54.020642
NCT01679587|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2016-04-29|||September 2012||2012-09-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)|Multicenter, Randomized, Single-blind, Placebo-controlled, Combined 2-fold Cross-over and Group-comparison, Dose-escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Oral Doses of BAY 85-3934 in Subjects With Chronic Kidney Disease (CKD)|Completed||Phase 1|49|Actual|Bayer||4|||f||||f||||||||||2017-10-11 02:32:54.342135|2017-10-11 02:32:54.342135
NCT01679574|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-09-06|||January 2009||2009-01-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|PCO||Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian Syndrome|Letrozole Versus Clomiphene Citrate Plus Metformin in the First Treatment of Infertility in Patients With Polycystic Ovarian Syndrome|Completed||N/A|200|Actual|Assiut University||2|||f||||f||||||||||2017-10-11 02:32:54.453414|2017-10-11 02:32:54.453414
NCT01679561|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2013-10-11|||February 2012||2012-02-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|August 2012|Actual|2012-08-01||Interventional|ILRIFRM||Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical Trial|Phase 4 Study of the Efficacy of Intralipid Treatment in Patients With Recurrent Implantation Failure and Miscarriages With High Peripheral and Uterine Natural Killer Cells|Unknown status|Recruiting|Phase 4|380|Anticipated|Woman's Health University Hospital, Egypt||1|||f||||t||||||||||2017-10-11 02:32:54.533929|2017-10-11 02:32:54.533929
NCT01679548|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2017-05-27|||September 2012||2012-09-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of Laparoendoscopic Single Site Hysterectomy in Benign and Preinvasive Uterine Disease|Prospective Randomized Comparison of Single-port and Three-port Laparoscopic Assisted Vaginal Hysterectomy|Recruiting||N/A|424|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:32:54.707059|2017-10-11 02:32:54.707059
NCT01679535|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-02-04|||November 2011||2011-11-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Nutrition/Hygiene Education Program for the Prevention of Child Malnutrition in Rural Kenya|A Nutrition/Hygiene Education Program for the Prevention of Child Malnutrition in Rural Kenya|Completed||N/A|246|Actual|University of New Mexico||1|||f||||f||||||||||2017-10-11 02:32:54.795956|2017-10-11 02:32:54.795956
NCT01679522|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2017-05-27|||September 2012||2012-09-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|LESS-E||Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer|Prospective Randomized Comparison of Single-port and Four-port Laparoscopic Staging Operation for Endometrial Cancer|Recruiting||N/A|108|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:32:54.879844|2017-10-11 02:32:54.879844
NCT01679509|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2017-05-27|||September 2012||2012-09-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of Laparoendoscopic Single Site Adnexal Surgery for Benign Ovarian and Tubal Disease|Prospective Randomized Comparison of Single-port and Three-port Laparoscopic Adnexal Surgery|Recruiting||N/A|330|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:32:55.019973|2017-10-11 02:32:55.019973
NCT01679496|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2015-02-03|||June 2012||2012-06-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|NoMa||Fat Quality on Blood Lipids and Immune Response||Completed||N/A|180|Actual|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-11 02:32:55.120722|2017-10-11 02:32:55.120722
NCT01679483|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2017-05-27|||September 2012||2012-09-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer|THE ROLE OF FLOSEAL IN THE PREVENTION OF LYMPHOCELE AND LYMPHATIC ASCITES AFTER LYMPH NODE DISSECTION FOR GYNECOLOGIC CANCER: A RANDOMIZED CONTROLLED TRIAL|Completed||N/A|40|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:32:55.212252|2017-10-11 02:32:55.212252
NCT01679470|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-11-02|||October 2012||2012-10-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors|A Pilot Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors|Terminated||N/A|1|Actual|Nanospectra Biosciences, Inc.||1|||f||||t||||||||||2017-10-11 02:32:55.301001|2017-10-11 02:32:55.301001
NCT01679457|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-03-26|||September 2012||2012-09-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Assessing Models of Exposure Therapy|Assessing Models of Exposure Therapy|Active, not recruiting||N/A|30|Anticipated|Mclean Hospital||2|||f||||t||||||||||2017-10-11 02:32:55.3874|2017-10-11 02:32:55.3874
NCT01679444|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2014-06-27|||August 2012||2012-08-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||MRS Probe Study of Alcohol|Magnetic Resonance Spectroscopy Probe Study of Alcohol Use|Completed||N/A|40|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:32:55.461398|2017-10-11 02:32:55.461398
NCT01679431|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-03-06|||April 2005||2005-04-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|PROGRESSA||Metabolic Determinants of the Progression of Aortic Stenosis|Metabolic Determinants of the Progression of Aortic Stenosis - PROGRESSA Study|Recruiting||N/A|250|Anticipated|Laval University|||1||f||||f||||||Samples With DNA|"     Fasting blood sample (serum, lithium-heparin, EDTA) and white cells - Tissue (explanted     aortic valves)   "|||2017-10-11 02:32:55.545048|2017-10-11 02:32:55.545048
NCT01679418|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-02-24|||November 2007||2007-11-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|PONTS||Impact of Drains on Postoperative Nausea and Vomiting After Thyroid Surgery|Randomized Controlled Trial on the Impact of Postoperative Drainage on Nausea and Vomiting After Thyroid- and Parathyroid Surgery|Completed||N/A|139|Actual|Kantonsspital Liestal||2|||f||||t||||||||||2017-10-11 02:32:55.67352|2017-10-11 02:32:55.67352
NCT01679392|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2015-03-19|||August 2012||2012-08-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||A Study Investigating Properties of the Transversus Abdominis Plane Block|Transversus Abdominis Plane Block: A Placebo-controlled Study in Healthy Volunteers|Completed||N/A|16|Actual|Hillerod Hospital, Denmark||1|||f||||t||||||||||2017-10-11 02:32:55.855436|2017-10-11 02:32:55.855436
NCT01679379|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-03|2013-05-23|||July 2012||2012-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Wound Infection in Obese Women After Cesarean Delivery|Surgical Site Infection in Obese Women After Cesarean Section; A Randomized Controlled Trial of Absorbable Versus Non Absorbable Sutures for Skin Closure.|Completed||N/A|200|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 02:32:55.938104|2017-10-11 02:32:55.938104
NCT01679366|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-10-21|||October 2012||2012-10-01|November 2011|2011-11-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||The Effectiveness of Probiotics for the Therapy of Acute Pharyngotonsillitis in Adult Patients|The Effectiveness of Probiotics for the Therapy of Acute Pharyngotonsillitis in Adult Patients|Completed||Phase 3|57|Actual|Ziv Hospital||3|||f||||t||||||||||2017-10-11 02:32:56.029134|2017-10-11 02:32:56.029134
NCT01679353|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2014-06-10|||September 2012||2012-09-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Analgesic Effect of Magnesium Added to Ropivacaine and Ropivacaine Alone in Caudal Analgesia on Postoperative Pain Control in Pediatric Patients Undergoing Inguinal Hernia Repair||Completed||N/A|80|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:32:56.106595|2017-10-11 02:32:56.106595
NCT01679340|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2015-05-17|||April 2011||2011-04-01|May 2015|2015-05-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|||A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery|Phase Ⅱ Study of S-1 Combined With Oxaliplatin (SOX)Verse S-1 Combined With Cisplatin(SP) in Adjuvant Chemotherapy After D2 Surgery|Recruiting||Phase 2|160|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 02:32:56.184447|2017-10-11 02:32:56.184447
NCT01679327|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2012-09-05|||March 2012||2012-03-01|September 2012|2012-09-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer|Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer|Unknown status|Recruiting|Phase 2|100|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:32:56.28029|2017-10-11 02:32:56.28029
NCT01679314|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-05-02|2015-01-16||July 2012||2012-07-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Study to Compare (COPD) Assessment Test in COPD Stage III and IV in a Prophylactic Treatment|A Prospective, Single Site, Randomized, Controlled, Parallel Group Study in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Stage III and IV Using AlphaCore or Sham (Control, Not Active) as a Prophylactic Treatment|Completed||N/A|54|Actual|ElectroCore LLC||2|||f||||t||||||||No|No description|2017-10-11 02:32:56.378921|2017-10-11 02:32:56.378921
NCT01679288|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-10-15|||January 2011||2011-01-01|October 2014|2014-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|ECO-AAA||Screening for Abdominal Aortic Aneurysm and Abdominal Aortic Atherosclerosis by Hand-Held Ultrasonography|Feasibility of Hand-Held-Ultrasonography in Primary Care in the Screening of Abdominal Aortic Aneurysm and Abdominal Aortic Atheromatosis.|Completed||N/A|106|Actual|Consorci d'Atenció Primària de Salut de l'Eixample||1|||f||||t||||||||||2017-10-11 02:32:56.925835|2017-10-11 02:32:56.925835
NCT01679275|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-12-07|||October 2012||2012-10-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|CHD-NIRS||Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease|Longitudinal Pre-operative Measurements of Cerebral Oxygenation Using Near Infrared Spectroscopy in Neonates With Congenital Heart Disease.|Recruiting||N/A|75|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 02:32:57.016336|2017-10-11 02:32:57.016336
NCT01679262|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-08-31|||May 2010||2010-05-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Determination of the Optimal Size of Oropharyngeal Airway; Correlation With External Body Measurements||Completed||N/A|149|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 02:32:57.119405|2017-10-11 02:32:57.119405
NCT01679249|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-09-06|||January 2012||2012-01-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Blood Volume Analysis and Related Outcomes in Hemodialysis|Blood Volume Analysis and Related Outcomes in Hemodialysis|Completed||N/A|10|Actual|VA New York Harbor Healthcare System|||1||f||||f||||||||||2017-10-11 02:32:57.191238|2017-10-11 02:32:57.191238
NCT01679236|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-05-19|2014-05-19||September 2006||2006-09-01|May 2014|2014-05-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Interventional||Total randomized|Pilot Study on Mindfulness for Tobacco and Alcohol in University Students|Pilot Study on Mindfulness for Tobacco and Alcohol in University Students|Completed||Early Phase 1|55|Actual|University of Wisconsin, Madison|"Participants were not blinded to their respective treatment conditions.
Attrition reduced power and generalizability."|2|||f||||t||||||||||2017-10-11 02:32:57.276961|2017-10-11 02:32:57.276961
NCT01675323|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-02-28|||August 2012||2012-08-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Glutamate, Hyperarousal and Restless Legs Syndrome|Glutamate, Hyperarousal and Restless Legs Syndrome|Completed||N/A|77|Actual|Johns Hopkins University|||2||f||||f||||||Samples With DNA|"     Whole blood and urine (female participants only)   "|||2017-10-11 02:34:26.288748|2017-10-11 02:34:26.288748
NCT01679223|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-01-08|||February 2014||2014-02-01|January 2015|2015-01-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12|Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12|Recruiting||N/A|60|Anticipated|University of Nevada, Las Vegas|||3||f||||f||||||||||2017-10-11 02:32:57.500448|2017-10-11 02:32:57.500448
NCT01679210|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-10-24|||January 2013||2013-01-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of a Postpartum Diabetes Prevention Program for Hispanic Women|Estudio PARTO: Proyecto pAra Reducir Diabetes Tipo dOs / Project Aiming to Reduce Type twO Diabetes|Recruiting||N/A|300|Anticipated|University of Massachusetts, Amherst||2|||f||||t||||||||No||2017-10-11 02:32:57.585984|2017-10-11 02:32:57.585984
NCT01679197|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-05-11|2017-03-28||October 8, 2012|Actual|2012-10-08|May 2017|2017-05-01|July 13, 2016|Actual|2016-07-13|July 13, 2016|Actual|2016-07-13||Interventional|||Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy|Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy|Completed||Phase 2|23|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 02:32:57.686889|2017-10-11 02:32:57.686889
NCT01679184|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-11-10|||June 2013||2013-06-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||XM-One Study for Living Donor Program|XM-One Study for Living Donor Program|Terminated||N/A|4|Actual|University of Miami|||1|Lack of staff to enroll patients in this study|f||||f||||||Samples Without DNA|"     A total of 6 teaspoons of blood will be drawn.   "|||2017-10-11 02:32:58.049404|2017-10-11 02:32:58.049404
NCT01679171|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-05-11|||September 19, 2012|Actual|2012-09-19|May 2017|2017-05-01|July 10, 2015|Actual|2015-07-10|July 10, 2015|Actual|2015-07-10||Observational|SENIOREA||One Year Outcome of Elderly Patients Admitted to an ICU and Mechanically Ventilated|One Year Outcome of Elderly Patients Admitted to an ICU and Mechanically Ventilated|Completed||N/A|489|Actual|University Hospital, Angers|||1||f||||t||||||||||2017-10-11 02:32:58.135119|2017-10-11 02:32:58.135119
NCT01679158|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-04-01|||February 2012||2012-02-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|MOTIVATE||MOTIVATE Weight Loss Study|Evaluating MOTIlity, Hormonal Impact, Satiety, and Weight Changes With VArying Procedural TEchniques Utilizing the Incisionless Operating Platform for the Treatment of Primary Obesity|Completed||N/A|18|Actual|USGI Medical||3|||f||||t||||||||||2017-10-11 02:32:58.338642|2017-10-11 02:32:58.338642
NCT01679145|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-07-27|||January 2012||2012-01-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01|1 Year|Observational [Patient Registry]|LeAD||Learning and Relapse Risk in Alcohol Dependence|Learning Mechanisms as Predictors of Treatment Outcome in Alcohol- Dependent Patients|Completed||N/A|225|Actual|Technische Universität Dresden|||2||f||||f||||||Samples With DNA|"     liver encymes   "|||2017-10-11 02:32:58.427359|2017-10-11 02:32:58.427359
NCT01679132|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-01-18|||January 2013||2013-01-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||BAROSTIM NEO HTN Pivotal Trial|CVRx BAROSTIM NEO Hypertension Pivotal Trial|Active, not recruiting||N/A|310|Anticipated|CVRx, Inc.||2|||f||||t||||||||||2017-10-11 02:32:58.516505|2017-10-11 02:32:58.516505
NCT01679119|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-05-03|||October 2013||2013-10-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|October 2017|Anticipated|2017-10-01||Interventional|INCA||Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy|A Randomised Phase II Trial of Inotuzumab Ozogamicin Plus Rituximab & CVP (IO-R-CVP) vs Gemcitabine Plus Rituximab & CVP (Gem-R-CVP) for the First Line Treatment of Patients With DLBCL Who Are Not Suitable for Anthracycline Containing Chemotherapy|Recruiting||Phase 2|132|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 02:32:58.633372|2017-10-11 02:32:58.633372
NCT01679106|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-05-20|||August 2012||2012-08-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effects of Continuous Transversus Abdominis Plane (TAP) Catheters on Postoperative Pain After Renal Transplantation||Terminated||N/A|3|Actual|The Cleveland Clinic||2||Study closed because of low enrolment|f||||f||||||||||2017-10-11 02:32:58.981748|2017-10-11 02:32:58.981748
NCT01679093|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-10-26|||June 2009||2009-06-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|ANPATHY||Antagonism Research Between Antiemetics Agents and Acetaminophen in Thyroidectomy's Post-operative Analgesia.|Antagonism Research Between Antiemetics Agents (Droperidol, Dexametasone, Ondansetron) and Acetaminophen in Thyroidectomy's Post-operative Analgesia.|Completed||Phase 3|66|Actual|University Hospital, Lille||3|||f||||t||||||||No||2017-10-11 02:32:59.100837|2017-10-11 02:32:59.100837
NCT01679080|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-01-06|||November 2012||2012-11-01|January 2016|2016-01-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta|The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta|Recruiting||Phase 2|80|Anticipated|University of Aarhus||3|||f||||f||||||||||2017-10-11 02:32:59.247354|2017-10-11 02:32:59.247354
NCT01679067|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-01-12|||June 2011||2011-06-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients|Phase IV Longitudinal Study of Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients Before and During Antiretroviral Therapy (ART)|Completed||N/A|30|Actual|University of Cologne|||1||f||||f||||||Samples With DNA|"     Endoscopic biopsies, PBMC   "|||2017-10-11 02:32:59.378489|2017-10-11 02:32:59.378489
NCT01679054|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-08-31|||October 2011||2011-10-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong|Cost-minimization Analysis of Xeloda® vs 5-fluorouracil-based Treatment for Gastric Cancer Patients in Hong Kong|Completed||N/A|58|Actual|Chinese University of Hong Kong|||2||f||||f||||||||||2017-10-11 02:32:59.462037|2017-10-11 02:32:59.462037
NCT01679041|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2013-11-21|||November 2012||2012-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment|A Phase II Study of High Dose Chemotherapy With Autologous Hematopoietic Progenitor Cell Transplant for Multiple Sclerosis That Failed at Least Two Lines of Therapy|Terminated||Phase 2|1|Actual|Texas Oncology Cancer Center||1||Insufficient accruals; PI leaving site|f||||t||||||||||2017-10-11 02:32:59.541743|2017-10-11 02:32:59.541743
NCT01679028|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2014-11-16|2014-05-06||August 2012||2012-08-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional||Placebo Group A: 2 T89 Group A: 4 Placebo Group B: 2 T89 Group B: 4 Placebo Group C: 2 T89 Group C: 6|Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese|Single- and Multiple- Dose-Escalation Study to Investigate the Safety and Tolerability of T89 in Japanese Healthy Volunteers|Completed||Phase 1|20|Actual|Tasly Pharmaceuticals, Inc.||6|||f||||f||||||||||2017-10-11 02:32:59.683702|2017-10-11 02:32:59.683702
NCT01679015|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-06-02|||August 2012||2012-08-01|January 2013|2013-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes|Concomitant Dry Eye in Patients With Ocular Allergy: an Under Recognized and Poorly Managed Syndrome|Completed||N/A|250|Actual|Schwartz Laser Eye Center|||1||f||||f||||||||||2017-10-11 02:33:00.237504|2017-10-11 02:33:00.237504
NCT01679002|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-12-31|2014-11-28||October 2003||2003-10-01|December 2014|2014-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers|Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers|Completed||Phase 1|12|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 02:33:00.346792|2017-10-11 02:33:00.346792
NCT01678989|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-09-04|||July 2011||2011-07-01|August 2012|2012-08-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||Evaluation of Brain MRI and Clinical Characteristics of Adolescents With Bipolar Disorder and Children of Parents With Bipolar Disorder||Unknown status|Recruiting|N/A|60|Anticipated|Turkish Psychiatry Association|||3||f||||f||||||||||2017-10-11 02:33:01.704787|2017-10-11 02:33:01.704787
NCT01678976|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-12-19|2014-11-28||March 2002||2002-03-01|December 2014|2014-12-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers|Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers|Completed||Phase 1|13|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 02:33:01.833491|2017-10-11 02:33:01.833491
NCT01678963|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2015-06-11|||November 2012||2012-11-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)|Phase II Study of the Efficacy and Safety of Squalamine Lactate Ophthalmic Formulation 0.2% BID in Subjects With Neovascular AMD.|Completed||Phase 2|142|Actual|Ohr Pharmaceutical Inc.||2|||f||||f||||||||||2017-10-11 02:33:02.231032|2017-10-11 02:33:02.231032
NCT01678950|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-06-24|||June 2011||2011-06-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|PRAM||MostCare Versus Echo-Doppler for Cardiac Output Measurement|Comparison Between MostCare and Echo-Doppler for Cardiac Output Measurement: an Observational Study|Completed||N/A|400|Actual|Azienda Ospedaliera Universitaria Senese|||1||f||||t||||||||||2017-10-11 02:33:02.347529|2017-10-11 02:33:02.347529
NCT01678937|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2015-04-14|||September 2007||2007-09-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Observational|||Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents|Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents|Completed||N/A|31|Actual|Northwestern University|||3||f||||f||||||Samples With DNA|"     Blood tests: Monotherapy patients        1. Regulatory/Suppressor Cells (CD4+CD25+FOXP3+CD127low; and CD8+ CD28-FOXP3+CD127low          cells).        2. Dendritic cell assays: myeloid vs. lymphoid (CD11c; CD123); maturation and ability to          process antigens (CD83; CD205); markers that have been shown to induce regulatory T          cells (ILT3; ILT4).        3. Soluble HLA G      Blood tests: Conversion patients        1. Regulatory/Suppressor Cells (CD4+CD25+FOXP3+CD127low; and CD8+ CD28-FOXP3+CD127low          cells).        2. Dendritic cell assays: myeloid vs. lymphoid (CD11c; CD123); maturation and ability to          process antigens (CD83; CD205); markers that have been shown to induce regulatory T          cells (ILT3; ILT4),        3. Soluble HLA G, and        4. Liver function and drug levels.      Blood tests: Healthy controls (same tests as Monotherapy Group)   "|||2017-10-11 02:33:02.434752|2017-10-11 02:33:02.434752
NCT01678911|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-06-26|2015-05-20||August 2012||2012-08-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy of Gralise® for Chronic Pelvic Pain|Efficacy of Gralise® for Chronic Pelvic Pain|Terminated||Phase 4|11|Actual|Shirley Ryan AbilityLab|This study was terminated early due to low recruitment. Therefore, the data presented represents a very small sample, with low 'n's in each group. The data tables represent all available data for the small sample.|2||Study ended due to difficulties in recruitment and low enrollment.|f||||t||||||||||2017-10-11 02:33:02.770013|2017-10-11 02:33:02.770013
NCT01678898|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-04-18|||October 2012||2012-10-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients|A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients|Completed||Phase 1/Phase 2|18|Actual|Protalix||3|||f||||f||||||||||2017-10-11 02:33:03.073398|2017-10-11 02:33:03.073398
NCT01678885|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-05-28|2012-12-20||May 2007||2007-05-01|February 2017|2017-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|EnergyBalanc||Assessment of Energy Balance|Assessment of Energy Balance|Completed||N/A|87|Actual|Pennington Biomedical Research Center|The study included a 2-week doubly labeled water phase; hence, the activity and energy intake assessments were limited this period.|2|||f||||f||||||||Undecided||2017-10-11 02:33:03.190579|2017-10-11 02:33:03.190579
NCT01678872|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-05-28|||August 2012||2012-08-01|May 2014|2014-05-01|November 2027|Anticipated|2027-11-01|November 2027|Anticipated|2027-11-01||Interventional|||A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration|A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration|Enrolling by invitation||Phase 1|21|Anticipated|Oxford BioMedica||1|||f||||t||||||||||2017-10-11 02:33:03.502852|2017-10-11 02:33:03.502852
NCT01678859|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2013-09-05|||August 2012||2012-08-01|September 2013|2013-09-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|C-MIS||Cervical Mucus - the Biochemical and Molecular Properties in Fertile and Subfertile Women (C-MIS Study)|Cervical Mucus - the Biochemical and Molecular Properties in Fertile and Subfertile Women|Unknown status|Recruiting|N/A|90|Anticipated|Merrion Fertility Clinic|||1||f||||f||||||Samples With DNA|"     cervical mucus serum   "|||2017-10-11 02:33:03.5713|2017-10-11 02:33:03.5713
NCT01678846|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2015-12-17|2015-10-08||June 2012||2012-06-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|GSS|"The baseline survey total participants is shown here (whereas the number in the participant flow is the number of participants at endline, in both the started and completed)"|Good Schools Study|The Good Schools Study: Cluster Randomised Controlled Trial of a Program to Prevent Violence Against Children in Schools|Completed||N/A|3820|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 02:33:03.652224|2017-10-11 02:33:03.652224
NCT01678833|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-06-30|||July 19, 2012||2012-07-19|March 7, 2016|2016-03-07|March 7, 2016||2016-03-07|||||Observational|||Understanding Drug Abuse Treatment Outcomes|Neural Mechanistic Explanations for Differential Drug Abuse Treatment Outcomes|Completed||N/A|18|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:33:03.963833|2017-10-11 02:33:03.963833
NCT01678820|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-04-06|2014-10-16||October 10, 2012|Actual|2012-10-10|April 2017|2017-04-01|November 1, 2013|Actual|2013-11-01|November 1, 2013|Actual|2013-11-01||Interventional||All participants randomized population. Study specific baseline characteristics include all randomized participants with data.|A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)|A Phase III, Randomized, Double-blind, Clinical Trial to Study the Efficacy and Safety of MK-0431D (a Fixed-dose Combination [FDC] of Sitagliptin and Simvastatin) for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy|Terminated||Phase 3|299|Actual|Merck Sharp & Dohme Corp.|Study was terminated for business reasons in November 2013.|3||Merck terminated the study for business reasons in November 2013.|f||||f||||||||||2017-10-11 02:33:04.07757|2017-10-11 02:33:04.07757
NCT01678807|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-09-14|2016-12-20||October 2012||2012-10-01|September 2017|2017-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)|Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)|Completed||Phase 1|195|Actual|ALK-Abelló A/S||3|||f||||f||||||||||2017-10-11 02:33:06.799689|2017-10-11 02:33:06.799689
NCT01678794|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2017-10-03|||February 2012||2012-02-01|October 2017|2017-10-01|March 30, 2018|Anticipated|2018-03-30|January 31, 2018|Anticipated|2018-01-31||Interventional|||CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function|Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function|Recruiting||Phase 1/Phase 2|76|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 02:33:07.266905|2017-10-11 02:33:07.266905
NCT01678781|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2013-09-06|||July 2012||2012-07-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide|Open International Study on Quality of Life in IBS Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide|Completed||N/A|607|Actual|Abbott|||1||f||||f||||||||||2017-10-11 02:33:07.382696|2017-10-11 02:33:07.382696
NCT01678755|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-03-04||2015-03-04|August 2012||2012-08-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Smokers|Completed||Phase 2|157|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 02:33:07.512748|2017-10-11 02:33:07.512748
NCT01678742|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-25|2015-03-31|||August 2012||2012-08-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effects of Jeju Red Horsehead Fish-based, High Protein Diet on Satiety and Incretin Hormones in Diabetes Patients|Effects of Jeju Red Horsehead Fish-based, High Protein Diet on Satiety and Incretin Hormones in Diabetes Patients|Completed||N/A|40|Actual|Jeju National University Hospital||2|||f||||f||||||||||2017-10-11 02:33:07.673419|2017-10-11 02:33:07.673419
NCT01678729|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-09-04|||January 2009||2009-01-01|August 2012|2012-08-01||||||||Observational|||Does Pupil Size Matters in Refractive Surgery?||Unknown status|Active, not recruiting|N/A|60|Anticipated|Ziv Hospital|||1||f||||||||||||||2017-10-11 02:33:07.79043|2017-10-11 02:33:07.79043
NCT01678716|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-02-29|||April 2010||2010-04-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Impact of Behavior Change Communications and Market-based Approach to Delivering Micronutrient Powders on Stunting, Infant Feeding Practices and Anemia in Bangladesh|1) Impact Evaluation of Behavior Change Communication and Micronutrient Supplementation Interventions on Infant and Young Child Feeding (IYCF) Practices and on Childhood Stunting and Anaemia 2) Evaluation of the Public Health Impact of a Market-based Approach to Improving Diet Quality of Infants and Young Children Through the Use of Sprinkles in Bangladesh|Completed||N/A|8800|Actual|International Food Policy Research Institute||4|||f||||f||||||||||2017-10-11 02:33:07.87327|2017-10-11 02:33:07.87327
NCT01678703|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-08-30|||November 2007||2007-11-01|July 2012|2012-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical Abortion|Randomized Controlled Study: Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical Abortion|Completed||N/A|84|Actual|Wolfson Medical Center||2|||f||||t||||||||||2017-10-11 02:33:07.983392|2017-10-11 02:33:07.983392
NCT01678690|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-08-31|||August 2012||2012-08-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors|An Open-Label, Exploratory, Limited Dose Escalation Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors|Completed||Early Phase 1|11|Actual|InnoPharmax Inc.||1|||f||||f||||||||||2017-10-11 02:33:08.078628|2017-10-11 02:33:08.078628
NCT01678677|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-05-12|||August 31, 2012|Actual|2012-08-31|May 2017|2017-05-01|January 30, 2014|Actual|2014-01-30|January 30, 2014|Actual|2014-01-30||Interventional|||A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers|An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers|Completed||Phase 1|272|Actual|GlaxoSmithKline||10|||f||||||||||||||2017-10-11 02:33:08.191562|2017-10-11 02:33:08.191562
NCT01678664|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-08-02|||October 2012||2012-10-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|EVACEL||Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors|Everolimus as Treatment After Embolization or Chemoembolization for Liver Metastases From Digestive Endocrine Tumors|Active, not recruiting||Phase 2|74|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||t||||||||||2017-10-11 02:33:08.331776|2017-10-11 02:33:08.331776
NCT01678651|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-02-23|||August 2012||2012-08-01|March 2015|2015-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Embryo Kinetics and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH|Embryo Kinetcis From Embryos Deriving From Egg Donation Cycle With Different Stimulation Protocol: Recombinant FSH vs Human FSH|Terminated||N/A|80|Actual|IVI Madrid||2|||f||||f||||||||||2017-10-11 02:33:08.475693|2017-10-11 02:33:08.475693
NCT01678638|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-05-12|||June 2013||2013-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|July 2018|Anticipated|2018-07-01||Interventional|||Timing of Inguinal Hernia Repair in Premature Infants|Timing of Inguinal Hernia Repair in Premature Infants: A Randomized Trial|Recruiting||N/A|600|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-10-11 02:33:08.571723|2017-10-11 02:33:08.571723
NCT01678625|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-03-28|||June 2012||2012-06-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Electromyographic Assessment of Onset and Recovery of Neuromuscular Blockade|Electromyographic Assessment of Onset and Recovery of Neuromuscular Blockade|Terminated||N/A|30|Actual|NorthShore University HealthSystem Research Institute|||2|"Company making the device no longer in existence. Did not finish supplying data to research   team"|f||||f||||||||||2017-10-11 02:33:08.76645|2017-10-11 02:33:08.76645
NCT01678612|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-25|2014-04-09|||November 2012||2012-11-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of Copper in Reducing Health-Acquired Infections in a Pediatric Intensive Care Unit|Efficacy of Copper in Reducing Health-Acquired Infections and Microbial Burden as Measured on High Touch Surfaces in a Pediatric Intensive Care Unit. A Controlled Clinical Trial.|Completed||N/A|1012|Actual|Codelco||2|||f||||f||||||||||2017-10-11 02:33:08.847273|2017-10-11 02:33:08.847273
NCT01678599|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-08-30|||April 2011||2011-04-01|August 2012|2012-08-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|PCR||Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease|Optimization of Sampling Procedure for PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease Treated With Benznidazole in Aiquile, Bolivia|Unknown status|Active, not recruiting|Phase 4|220|Anticipated|Drugs for Neglected Diseases||1|||f||||f||||||||||2017-10-11 02:33:09.059752|2017-10-11 02:33:09.059752
NCT01678586|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2016-08-02|||December 2012||2012-12-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Effect of Acupuncture and Pain Medication on Radicular Pain Using QST|Effect of Acupuncture and Pain Medication on Radicular Pain Using QST|Recruiting||N/A|100|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:33:09.157908|2017-10-11 02:33:09.157908
NCT01678573|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2013-09-05|||July 2012||2012-07-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male Participants|A Single-Dose, Randomized, Open-Label, Three-Way Crossover Study to Evaluate the Pharmacokinetics of Abiraterone in Chinese Healthy Male Subjects|Completed||Phase 1|15|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 02:33:09.264383|2017-10-11 02:33:09.264383
NCT01678560|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-12-19|||January 2014||2014-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Remote Monitoring in Obstructive Sleep Apnea|Remote Monitoring in Obstructive Sleep Apnea Management in Military Veterans|Terminated||N/A|52|Actual|VA Connecticut Healthcare System||2||Recruitment was halted due to the difficulties in recruiting.|f||||f||||||||||2017-10-11 02:33:09.396677|2017-10-11 02:33:09.396677
NCT01678547|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2014-02-12|||September 2012||2012-09-01|February 2014|2014-02-01|September 2015|Anticipated|2015-09-01|August 2014|Anticipated|2014-08-01||Interventional|||Robot Walking Rehabilitation in Stroke Patients|Effect of Robot Assisted Treatment on Gait Performace in Stroke Patients|Unknown status|Recruiting|N/A|90|Anticipated|IRCCS San Raffaele||3|||f||||f||||||||||2017-10-11 02:33:09.51922|2017-10-11 02:33:09.51922
NCT01678534|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-02-14|||September 2014||2014-09-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|AMASCIS-01||Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial|Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue. Safety Assessment. A Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial.(AMASCIS-01/2011)|Recruiting||Phase 2|20|Anticipated|Instituto de Investigación Hospital Universitario La Paz||2|||f||||t||||||||||2017-10-11 02:33:09.684355|2017-10-11 02:33:09.684355
NCT01678521|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2014-12-18|||September 2012||2012-09-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients|Effect of LDL-apheresis on Pentraxin3 Plasma Levels in Hypercholesterolemic Patients With Coronary Artery Disease|Completed||N/A|12|Actual|Universita di Verona|||1||f||||f||||||Samples Without DNA|"     serum and plasma   "|||2017-10-11 02:33:09.838558|2017-10-11 02:33:09.838558
NCT01678508|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-09-04|||January 2002||2002-01-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Observational|||Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia|Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia - Influence on Cure Rates and Risk of Second Cancer|Completed||N/A|1020|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples With DNA|"     whole blood stored for a subset of patients   "|||2017-10-11 02:33:09.96894|2017-10-11 02:33:09.96894
NCT01678495|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-08-07|||August 2012||2012-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Sonothrombolysis Potentiated by Microbubbles for Acute Ischemic Stroke|Sonothrombolysis Potentiated by Microbubbles as a Novel Treatment of Acute Ischemic Stroke: a Prospective Randomized Pilot Study|Completed||Phase 2|24|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-11 02:33:10.064295|2017-10-11 02:33:10.064295
NCT01678482|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2012-08-31|||November 2011||2011-11-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment|Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for the Treatment of Mild to Moderate Inflammatory Acne.|Completed||N/A|50|Actual|Home Skinovations Ltd.||1|||f||||f||||||||||2017-10-11 02:33:10.168522|2017-10-11 02:33:10.168522
NCT01678469|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-31|2015-07-01|||November 2011||2011-11-01|July 2015|2015-07-01|May 2016|Anticipated|2016-05-01|November 2015|Anticipated|2015-11-01||Interventional|2011-23||Lipophilic Micronutrients, Adipokines and Gestational Diabetes Mellitus|Lipophilic Micronutrients, Adipokines and Gestational Diabetes Mellitus|Unknown status|Recruiting|N/A|500|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-10-11 02:33:10.279488|2017-10-11 02:33:10.279488
NCT01678456|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-08-19|||February 2004||2004-02-01|August 2012|2012-08-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Observational|AFNET A7||Prospective Registration and Assessment of Serious Adverse Events Within the AFNET|Prospective Registration and Independent Assessment of Incidence, Clinical Relevance and Outcome of Serious Adverse Events (SAE) Registered in the German Competence Network on Atrial Fibrillation|Completed||N/A|13000|Actual|German Atrial Fibrillation Network|||1||f||||f||||||||||2017-10-11 02:33:10.394883|2017-10-11 02:33:10.394883
NCT01678430|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-10-12|||December 2011||2011-12-01|August 2012|2012-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIAltO||A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment|A Randomised Investigation of Alternative Ofatumumab-containing Regimens in Less Fit Patients With CLL|Recruiting||Phase 3|670|Anticipated|University of Liverpool||2|||f||||t||||||||||2017-10-11 02:33:10.70818|2017-10-11 02:33:10.70818
NCT01678417|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-09-04|||June 2012||2012-06-01|August 2012|2012-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell Lymphoma|A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Follicular or Mantle Cell Lymphoma|Unknown status|Recruiting|Phase 2|29|Anticipated|Korea Cancer Center Hospital||1|||f||||f||||||||||2017-10-11 02:33:10.969046|2017-10-11 02:33:10.969046
NCT01678404|ClinicalTrials.gov processed this data on October 10, 2017|2012-09-04|2012-09-04|||October 2011||2011-10-01|August 2012|2012-08-01|September 2016|Anticipated|2016-09-01|September 2014|Anticipated|2014-09-01||Interventional|||131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma|A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma|Unknown status|Recruiting|Phase 2|28|Anticipated|Korea Cancer Center Hospital||1|||f||||f||||||||||2017-10-11 02:33:11.145169|2017-10-11 02:33:11.145169
NCT01678391|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-07-25|||August 2012||2012-08-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|June 2015|Actual|2015-06-01||Interventional|||Feasibility of Endoscopic Ultrasound Based Biliary Stone Removal Without Fluoroscopy|Feasibility of Endoscopic Ultrasound Based Biliary Stone Removal Without Fluoroscopy|Completed||N/A|33|Actual|California Pacific Medical Center Research Institute||1|||f||||f||||||||||2017-10-11 02:33:11.284315|2017-10-11 02:33:11.284315
NCT01678378|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-04-24|||September 2012||2012-09-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|SHARP||School Health Center Healthy Adolescent Relationship Program|School Health Center Healthy Adolescent Relationship Program|Completed||N/A|1012|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:33:11.409764|2017-10-11 02:33:11.409764
NCT01678365|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-09-03|||July 2008||2008-07-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children|Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children|Completed||Phase 4|43|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-11 02:33:11.530771|2017-10-11 02:33:11.530771
NCT01678352|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-01-12|||October 2012||2012-10-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas|A Pilot Study to Evaluate the Effects of Imiquimod and Tumor Lysate Vaccine Immunotherapy for Adults With High Risk or Recurrent/Post-Chemotherapy WHO Grade II Gliomas|Recruiting||Early Phase 1|27|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 02:33:11.632591|2017-10-11 02:33:11.632591
NCT01678339|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2012-10-02|||September 2012||2012-09-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|||||Observational|HEALTH-DB ACS||Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients|Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients|Withdrawn||N/A|0|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:33:11.797474|2017-10-11 02:33:11.797474
NCT01678326|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-02-22|||August 2012||2012-08-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||EUS-Guided Rendezvous or Direct Interventions Versus Advanced ERCP Techniques for Biliary Access and Therapy|Endoscopic Ultrasound Guided Rendezvous or Direct Interventions Versus Advanced ERCP Techniques for Biliary Access and Therapy|Recruiting||N/A|230|Anticipated|California Pacific Medical Center Research Institute||2|||f||||f||||||||||2017-10-11 02:33:11.914911|2017-10-11 02:33:11.914911
NCT01678313|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-07-02|2014-04-08||August 2012||2012-08-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels|COX-2 Inhibitor Reduces Serum PSA Levels Might Predict a Lower Risk of Prostatic Cancer in Men With LUTS/BPH With an Elevated PSA Level|Completed||Phase 2|140|Actual|Buddhist Tzu Chi General Hospital||2|||f||||f||||||||||2017-10-11 02:33:12.085591|2017-10-11 02:33:12.085591
NCT01678300|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-11-13|||August 2012||2012-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)|Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)|Completed||N/A|70|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-11 02:33:12.830052|2017-10-11 02:33:12.830052
NCT01678287|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2012-08-30|||November 2007||2007-11-01|August 2012|2012-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy Adults|A Phase 1, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Dosing of ASP1941 and to Explore the Effect of ASP1941 on Glucose Levels in Healthy Adult Subjects (18 to 45 Years and ≥ 65 Years)|Completed||Phase 1|65|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 02:33:12.948514|2017-10-11 02:33:12.948514
NCT01678274|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-05-23|||December 2013||2013-12-01|June 2015|2015-06-01|October 2016|Anticipated|2016-10-01|March 2016|Actual|2016-03-01||Observational|TSCORII||Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.|Prospective Characterization of the Heart, Aorta and Blood Pressure in Women With Turner Syndrome. Association With Aortic Dissection.|Unknown status|Active, not recruiting|N/A|106|Actual|University of Aarhus|||2||f||||f||||||Samples With DNA|"     Blood Serum   "|||2017-10-11 02:33:13.097186|2017-10-11 02:33:13.097186
NCT01678261|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-05-23|||September 2012||2012-09-01|June 2015|2015-06-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Observational|||X-chromosome Inactivation, Epigenetics and the Transcriptome|X-chromosome Inactivation, Epigenetics and the Transcriptome|Completed||N/A|110|Actual|University of Aarhus|||13||f||||f||||||Samples With DNA|"     Whole blood      Serum      White cells      Tissue   "|||2017-10-11 02:33:13.248962|2017-10-11 02:33:13.248962
NCT01678248|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-08-29|||January 2006||2006-01-01|August 2012|2012-08-01||||||||Observational|||The Effectiveness of Intravitreal Avastin Injection for CRVO|The Effectiveness of Intravitreal Avastin Injection for CRVO|Unknown status|Recruiting|N/A|68|Anticipated|Ziv Hospital|||1||f||||t||||||||||2017-10-11 02:33:13.380365|2017-10-11 02:33:13.380365
NCT01678235|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-10-06|||September 2011||2011-09-01|August 2012|2012-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus|The Impact Of Insulin Glulisine In Comparison With Aspart On Postprandial Glycemia After The High-Glycemic Index Meal In Children With Type 1 Diabetes - Cross-Over Double-Blind, Randomized Clinical Trial.|Completed||Phase 4|64|Actual|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 02:33:13.477589|2017-10-11 02:33:13.477589
NCT01678222|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-06-30|||August 25, 2012||2012-08-25|February 24, 2017|2017-02-24||||||||Observational|||The COX-2 Gene and the Immune System|The Role of Functionally Relevant Cyclooxygenase-2 (COX-2) Gene Single Nucleotide Polymorphisms -765G>C and 8473T>C in Lymphocyte Differentiation|Completed||N/A|117|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:33:13.632691|2017-10-11 02:33:13.632691
NCT01678209|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-03-27|||October 2012||2012-10-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach|Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach|Recruiting||Phase 4|144|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||||2017-10-11 02:33:13.77105|2017-10-11 02:33:13.77105
NCT01678196|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-09-14|2016-01-27||May 2013||2013-05-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Interventional|||Helping Families Help Veterans With PTSD and Alcohol Abuse: An RCT of VA-CRAFT|Helping Families Help Veterans With PTSD and Alcohol Abuse: An RCT of VA-CRAFT|Completed||N/A|66|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 02:33:13.96659|2017-10-11 02:33:13.96659
NCT01678183|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-01-30|||September 2012||2012-09-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|April 2014|Actual|2014-04-01||Interventional|FIMA||Financial Incentives for Medication Adherence|Financial Incentives for Medication Adherence|Completed||N/A|74|Actual|Boston Medical Center||3|||f||||f||||||||||2017-10-11 02:33:14.548772|2017-10-11 02:33:14.548772
NCT01678170|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-12-21|||September 2012||2012-09-01|May 2012|2012-05-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Clinical Application of Breast Blood-oxygen Functional Imaging Technology|Clinical Application of Breast Blood-oxygen Functional Imaging Technology|Unknown status|Recruiting|N/A|200|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||1||f||||t||||||||||2017-10-11 02:33:14.688877|2017-10-11 02:33:14.688877
NCT01678157|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-12-03|||March 2012||2012-03-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|Strattice||Use of Strattice Mesh in Paraesophageal Hernia Surgery|Use of Strattice in the Laparoscopic Suture Closure of a Paraesophageal Hernia|Completed||N/A|35|Actual|University of Nebraska|||1||f||||t||||||||||2017-10-11 02:33:14.818524|2017-10-11 02:33:14.818524
NCT01678144|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-12-21|||June 2011||2011-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|||Study on Safety and Performance of Medtentia Mitral Valve Repair System in Surgical Repair of Mitral Regurgitation|Evaluation of the Safety and Performance of the Medtentia Mitral Valve Repair System When Used in Adults Undergoing Mitral Valve Repair Surgery|Completed||N/A|12|Actual|Medtentia International Ltd Oy||1|||f||||t||||||||||2017-10-11 02:33:14.921445|2017-10-11 02:33:14.921445
NCT01678131|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-03-03|2014-09-26||October 2012||2012-10-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)|A Randomized Clinical Trial Using Fine Needle Aspiration For Evaluation of Hepatic Pharmacokinetics of MK-7009 in Chronic Hepatitis C Patients|Completed||Phase 1|31|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 02:33:15.041889|2017-10-11 02:33:15.041889
NCT01678118|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-07-05|||April 2011|Actual|2011-04-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care|Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care|Active, not recruiting||N/A|100|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 02:33:15.462708|2017-10-11 02:33:15.462708
NCT01678105|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-09-16|||November 2012||2012-11-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|DOVE||A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|A Phase II Study of DOVitinib in REcurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands (DOVE)|Completed||Phase 2|21|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-10-11 02:33:15.569716|2017-10-11 02:33:15.569716
NCT01678092|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-11-24|||May 2004||2004-05-01|November 2015|2015-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|OXAD||Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis|Phase 1, Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis|Completed||Phase 1|8|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 02:33:15.686864|2017-10-11 02:33:15.686864
NCT01678079|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2014-11-17|||February 2013||2013-02-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ENCAP||Encapsulated Calcium Absorption in Pregnancy|Bioavailability and Acceptability of Enteric-Coated Microencapsulated Calcium During Pregnancy: A Randomized Crossover Trial in Bangladesh (Encapsulated Calcium Absorption in Pregnancy)|Completed||Phase 1|61|Actual|The Hospital for Sick Children||6|||f||||f||||||||||2017-10-11 02:33:15.773925|2017-10-11 02:33:15.773925
NCT01678066|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-31|||September 2012||2012-09-01|August 2012|2012-08-01|February 2013|Anticipated|2013-02-01|||||Observational|||A Prospective Study to Bilaterally Compare a Non-Invasive Cardiac Output Monitor|A Prospective Study to Bilaterally Compare a New FDA-Approved Non-Invasive Cardiac Output Monitor in Children Undergoing General Anesthesia|Unknown status|Not yet recruiting|N/A|50|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:33:15.890738|2017-10-11 02:33:15.890738
NCT01678053|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-03-24|||September 2012||2012-09-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas|A Randomized Controlled Trial Comparing Proton Pump Inhibitor Therapy With and Without Interarytenoid Botulinum Toxin Injection for Vocal Fold Granuloma|Withdrawn||Phase 2|0|Actual|Massachusetts Eye and Ear Infirmary||2||Was not able to recruit patients for randomization.|f||||t||||||||||2017-10-11 02:33:16.005839|2017-10-11 02:33:16.005839
NCT01678040|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-30|||May 2012||2012-05-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|August 2012|Actual|2012-08-01||Observational|||Ventricular Volume as Assessed by Cardiac Magnetic Resonance|MRI Assessment of the Effect of Preload on Ventricular Volumes and Function in Healthy Adult Volunteers|Unknown status|Active, not recruiting|N/A|15|Anticipated|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 02:33:16.143076|2017-10-11 02:33:16.143076
NCT01678027|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-04-28|||November 2004||2004-11-01|April 2016|2016-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication|Helicobacter Pylori Eradication to Prevent Gastric Cancer in Subjects With Family History of Gastric Cancer: A Randomized Controlled Study|Active, not recruiting||Phase 3|1810|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||Undecided||2017-10-11 02:33:16.231764|2017-10-11 02:33:16.231764
NCT01678014|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-09-01|||April 2012||2012-04-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Deep Brain Stimulation and Capsulotomy for the Treatment of Refractory Anorexia Nervosa|Phase 1 Study of Deep Brain Stimulation and Capsulotomy for the Treatment of Refractory Anorexia|Unknown status|Recruiting|Phase 1|48|Anticipated|Ruijin Hospital||1|||f||||t||||||||||2017-10-11 02:33:16.333782|2017-10-11 02:33:16.333782
NCT01678001|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-01-13|||August 2012||2012-08-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|Xeomin||Treatment of Plantar Fasciitis With Xeomin|Treatment of Plantar Fasciitis With Xeomin: A Randomized, Placebo-Controlled, Double-Blinded, Prospective Study|Completed||Phase 4|50|Actual|Rothman Institute Orthopaedics||2|||f||||f||||||||||2017-10-11 02:33:16.458374|2017-10-11 02:33:16.458374
NCT01677988|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-12-11|2015-10-28||July 2012||2012-07-01|July 2015|2015-07-01||||October 2015|Actual|2015-10-01||Interventional|||Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma|Phase II Study of Neoadjuvant Folfirinox Chemotherapy Followed by Capecitabine With Concurrent Limited Field Radiation Therapy in Patients With Localized Pancreatic Head Adenocarcinoma|Terminated||Phase 2|3|Actual|Medical University of South Carolina||1||Study was terminated due to low accrual.|f||||t||||||||||2017-10-11 02:33:16.564424|2017-10-11 02:33:16.564424
NCT01677975|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-31|||September 2012||2012-09-01|August 2012|2012-08-01||||||||Interventional|||The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With Melanoma||Unknown status|Enrolling by invitation|N/A|||Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 02:33:16.945594|2017-10-11 02:33:16.945594
NCT01677962|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-12-13|||August 2012||2012-08-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|September 2014|Actual|2014-09-01||Interventional|||A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma|A Feasibility and Safety Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma|Completed||Phase 1|12|Actual|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 02:33:17.02319|2017-10-11 02:33:17.02319
NCT01677949|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-04-21|||December 2013||2013-12-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia|A Phase II Trial Investigating Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||2||Slow accrual|f||||t||||||||||2017-10-11 02:33:17.255551|2017-10-11 02:33:17.255551
NCT01677936|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-03-22|2014-02-02||June 2012||2012-06-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional||51 total subjects were randomized. 5 were excluded (1 snack; 4 raisin) due to lack of post-randomization evaluable data. Thus, the full analysis data set included 27 raisin and 19 snack.|Study of Raisins Versus Alternative Snacks in Patients With Type 2 Diabetes Mellitus|A Randomized, Unblinded, Single Research Site, Comparator Study of Raisins Versus Alternative Snacks on Glycemic Control and Other Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|51|Actual|Louisville Metabolic and Atherosclerosis Research Center|This study was limited by being an un-blinded, single site study of modest size.|2|||f||||f||||||||||2017-10-11 02:33:17.381378|2017-10-11 02:33:17.381378
NCT01677923|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-03-02|||May 2013||2013-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|April 2014|Actual|2014-04-01||Interventional|OCA||Obesity in Children and Adolescents: Associated Risks and Early Intervention|Phase 3: Effect of Diet, Physical Activity and Insulin Sensitizer Metformin on Obesity and Associated Risks in Children and Adolescents.|Completed||Phase 3|182|Actual|Lithuanian University of Health Sciences||4|||f||||t||||||||Undecided|Study results are in progress with statistical analysis|2017-10-11 02:33:17.751665|2017-10-11 02:33:17.751665
NCT01677910|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-08-18|2017-03-29||October 2012||2012-10-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||Safety population|TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)|A Phase 3, Randomized, Placebo-controlled, Parallel Group, Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of Telotristat Etiprate (LX1606) in Patients With Carcinoid Syndrome Not Adequately Controlled by Somatostatin Analog (SSA) Therapy|Completed||Phase 3|135|Actual|Lexicon Pharmaceuticals||3|||f||||t||||||||||2017-10-11 02:33:17.877182|2017-10-11 02:33:17.877182
NCT01677897|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-09-09|||August 2013||2013-08-01|September 2014|2014-09-01|April 2015|Anticipated|2015-04-01|December 2014|Anticipated|2014-12-01||Interventional|MetAb-Pro||Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients|Impact of the Addition of Metformin to Abiraterone in Pre-docetaxel Metastatic Castration-resistant Prostate Cancer Patients Progressing on Abiraterone Treatment (MetAb-Pro): a Phase II Pilot Study|Unknown status|Recruiting|Phase 2|25|Anticipated|Kantonsspital Graubünden||1|||f||||t||||||||||2017-10-11 02:33:19.088767|2017-10-11 02:33:19.088767
NCT01677884|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-06-08|||November 2012||2012-11-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|BEVIAC||Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy|Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy in Hepatic Metastases of Metastatic Colorectal Cancer: a Phase II Multicentric Study With Patients in Progression After First Line Systemic Chemotherapy|Completed||Phase 2|10|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||t||||||||||2017-10-11 02:33:19.201687|2017-10-11 02:33:19.201687
NCT01677871|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2013-12-16|||September 2012||2012-09-01|December 2013|2013-12-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease|Study of Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease|Unknown status|Recruiting|N/A|120|Anticipated|Institute of Liver and Biliary Sciences, India||4|||f||||f||||||||||2017-10-11 02:33:19.290958|2017-10-11 02:33:19.290958
NCT01677858|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-08-23|2017-07-11||July 4, 2012||2012-07-04|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|July 22, 2016|Actual|2016-07-22||Interventional|CHAMPION 1||A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma|A Phase 1/2 Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|116|Actual|Amgen||1|||f||||t||||||||||2017-10-11 02:33:19.473267|2017-10-11 02:33:19.473267
NCT01677845|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-08-25|||May 2012||2012-05-01|August 2017|2017-08-01|August 25, 2017|Actual|2017-08-25|February 2017|Actual|2017-02-01||Interventional|||Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer|Phase I Study of Hypo-Fractionated Radiation Therapy (HRT) for Localized Prostate Cancer|Terminated||Phase 1|9|Actual|New York University School of Medicine||1||PI no longer with the institution|f||||t|f|f||||||||2017-10-11 02:33:23.316055|2017-10-11 02:33:23.316055
NCT01677832|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-30|||January 2012||2012-01-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|||||Observational|||Executive Functions and Self-Regulation Among Children With and Without ADHD in Germany and Taiwan|Neuronal Correlates of Executive Functions and Self-Regulation Among Children and Adolescents With and Without ADHD in Germany and Taiwan|Unknown status|Recruiting|N/A|180|Anticipated|National Taiwan University Hospital|||4||f||||t||||||||||2017-10-11 02:33:23.438572|2017-10-11 02:33:23.438572
NCT01677819|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-30|||November 2011||2011-11-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|||||Observational|||Inhibition Control of Children and Adolescents With ADHD|Inhibition Control of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder|Completed||N/A|60|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:33:23.537336|2017-10-11 02:33:23.537336
NCT01677806|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2014-09-09|||October 2012||2012-10-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Safety and Efficacy Study of Percutaneous Vertebroplasty for Painful Acute Osteoporotic Spine Fractures|Investigational Percutaneous Vertebroplasty Efficacy and Safety Trial|Unknown status|Enrolling by invitation|Phase 3|140|Anticipated|Jinan Military General Hospital||2|||f||||t||||||||||2017-10-11 02:33:23.629914|2017-10-11 02:33:23.629914
NCT01677793|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-31|||January 2012||2012-01-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|||||Observational|||Developmental Trajectory of Brain Structural Connectivity and Cognitive Function From Childhood to Adulthood|Developmental Trajectory of Brain Structural Connectivity and Cognitive Function From Childhood to Adulthood|Unknown status|Recruiting|N/A|140|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:33:23.75405|2017-10-11 02:33:23.75405
NCT01677780|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-07-05|||November 28, 2012|Actual|2012-11-28|July 2017|2017-07-01|June 26, 2017|Actual|2017-06-26|June 26, 2017|Actual|2017-06-26||Interventional|||An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies|A Multi-Center, Open-Label, Extension Study of RO5045337 (MDM2 Antagonist) Administered Orally in Patients Treated With RO5045337 on Previous Roche-Sponsored Phase 1 Cancer Studies|Completed||Phase 1|11|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:33:23.843474|2017-10-11 02:33:23.843474
NCT01677767|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-06-13|2016-01-06||April 30, 2011|Actual|2011-04-30|May 2017|2017-05-01|September 30, 2013|Actual|2013-09-30|September 30, 2013|Actual|2013-09-30||Observational||Intention-to-Treat (ITT) population included all the participants who received at least 1 dose of C.E.R.A and for whom data for at least one follow-up variable was available|An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia|Efficacy of C.E.R.A. for Correction of Anemia and Maintenance of the Hb Levels in CKD Patients on Dialysis , Treated According to Routine Clinical Practice|Completed||N/A|127|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:33:24.004981|2017-10-11 02:33:24.004981
NCT00004343|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|December 2003|2003-12-01||||||||Observational|||Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome||Unknown status|Active, not recruiting|N/A|40||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.754213|2017-10-11 04:25:04.754213
NCT01677754|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-05-25||2016-07-20|October 24, 2012|Actual|2012-10-24|May 2017|2017-05-01|June 12, 2015|Actual|2015-06-12|June 12, 2015|Actual|2015-06-12||Interventional|MAyflOwer RoAD||A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy|A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of RO4602522 Added to Background Alzheimer's Disease Therapy in Patients With Moderate Severity Alzheimer's Disease|Completed||Phase 2|542|Actual|Hoffmann-La Roche||3|||f|||||t|f||||||||2017-10-11 02:33:24.412441|2017-10-11 02:33:24.412441
NCT01677741|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-08-31|||February 27, 2013|Actual|2013-02-27|August 2017|2017-08-01|September 2, 2019|Anticipated|2019-09-02|March 2, 2019|Anticipated|2019-03-02||Interventional|||A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects|Phase I/IIa, 2-Part, Multi-Center, Single-Arm, Open-Label Study to Determine the Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib in Children and Adolescent Subjects With Advanced BRAF V600-Mutation Positive Solid Tumors|Recruiting||Phase 1|86|Anticipated|Novartis||5|||f||||f|t|f||||||||2017-10-11 02:33:24.87533|2017-10-11 02:33:24.87533
NCT01677728|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-30|||January 2007||2007-01-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases|A Randomized, Controlled Trial of Target Therapy Plus Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases|Unknown status|Recruiting|N/A|60|Anticipated|Fudan University|||2||f||||f||||||||||2017-10-11 02:33:25.04387|2017-10-11 02:33:25.04387
NCT01677715|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2012-10-12|||August 2011||2011-08-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Interventional|||Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive System|Study on Evaluating the Promote Effect of Yili Mei Yi Tian Active Lactobacillus Drink on Immunity and Physical Intestinal Canal|Completed||N/A|240|Actual|Inner Mongolia Yili Industrial Group Co., Ltd||2|||f||||||||||||||2017-10-11 02:33:25.464295|2017-10-11 02:33:25.464295
NCT01677702|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2012-10-24|||March 2011||2011-03-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization|The Clinical Research on the Efficiency of Yili Lactoferrin Shuhua Milk in the Improvement of Human Immunization|Completed||N/A|240|Actual|Inner Mongolia Yili Industrial Group Co., Ltd||3|||f||||||||||||||2017-10-11 02:33:25.569294|2017-10-11 02:33:25.569294
NCT01677689|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-08-02|||September 1, 2018|Anticipated|2018-09-01|August 2017|2017-08-01|October 31, 2019|Anticipated|2019-10-31|April 30, 2019|Anticipated|2019-04-30||Interventional|||Study to Investigate the Efficacy and Safety of Apomivir®|A Prospective, Randomized, Double-blind, Parallel, Placebo-controlled, Multi-center Study to Investigate the Efficacy and Safety of Apomivir® in Relieving Influenza Symptoms|Not yet recruiting||Phase 2|196|Anticipated|Far East Bio-Tec Co., Ltd||2|||f||||f|t|f||||||||2017-10-11 02:33:25.68771|2017-10-11 02:33:25.68771
NCT01677676|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2013-07-26|||January 2012||2012-01-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1)|A Randomised, Double-Blind, Double Observer, Study to Assess the Safety, Tolerability and Immunogenicity of Repeated Intramuscular Administration of Two Different Formulations of an Influenza A Vaccine (FP-01.1)|Completed||Phase 1|48|Actual|Immune Targeting Systems Ltd||4|||f||||t||||||||||2017-10-11 02:33:25.819505|2017-10-11 02:33:25.819505
NCT01677663|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-31|||August 2011||2011-08-01|August 2012|2012-08-01|July 2016|Anticipated|2016-07-01|||||Observational|||Neuropsychopathological Study of Autism|Neuropsychopathological Study of Autism: From Clinical, Neurocognitive, to Genetic Studies and Animal Models|Unknown status|Recruiting|N/A|350|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     The subjects will receive blood withdrawal. The blood sample will be used for establishing     lymphoblastoid cell lines, which will be used for molecular genetic experiments.   "|||2017-10-11 02:33:25.908211|2017-10-11 02:33:25.908211
NCT01677650|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2015-04-21|||March 2014||2014-03-01|April 2015|2015-04-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Pharmacogenomics of Methadone in Spine Fusion Surgery|The Influence of Pharmacogenetics on Methadone Dose, Safety, and Outcomes After Spine Fusion|Withdrawn||Phase 1|0|Actual|Northwestern University||5||Investigator moved to new institution|f||||f||||||||||2017-10-11 02:33:26.012229|2017-10-11 02:33:26.012229
NCT01677637|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2014-08-18|||February 2012||2012-02-01|May 2013|2013-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|OSTRIA||Osteoporosis Screening Trial|Epidemiological, Observational, Multicenter Clinical Trial|Completed||N/A|5500|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 02:33:26.143062|2017-10-11 02:33:26.143062
NCT01677624|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-01-25|2015-12-11||August 2012||2012-08-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional||The analysis was performed using the Safety Analysis Set defined as all participants who received the embolization therapy with E7040 and had at least 1 evaluable safety data after the procedure.|A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation|A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation|Completed||Phase 3|28|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 02:33:26.273188|2017-10-11 02:33:26.273188
NCT01677611|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-31|||December 2008||2008-12-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|September 2010|Actual|2010-09-01||Interventional|RED||Effects of Resveratrol in Patients With Type 2 Diabetes|Effects of Resveratrol in Patients With Type 2 Diabetes: The RED Trial|Completed||Phase 1|10|Actual|Khoo Teck Puat Hospital||2|||f||||t||||||||||2017-10-11 02:33:26.662511|2017-10-11 02:33:26.662511
NCT01677598|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2016-01-25|||December 2011||2011-12-01|January 2016|2016-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|MARCOPOLO||A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries|A Study to Evaluate Ustekinumab in Clinical Practice in Patients With Plaque Psoriasis in Asia-Pacific Countries|Completed||Phase 4|169|Actual|Johnson & Johnson Pte Ltd|||1||f||||f||||||||||2017-10-11 02:33:26.796504|2017-10-11 02:33:26.796504
NCT01677585|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2017-03-07|||August 2012||2012-08-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|December 2015|Actual|2015-12-01||Observational|PEChina||Post-Approval Study of PROMUS Element™ in China|PROMUS Element™ China Post-Approval Study|Active, not recruiting||N/A|2016|Actual|Boston Scientific Corporation|||1||f||||f||||||||No||2017-10-11 02:33:26.921856|2017-10-11 02:33:26.921856
NCT01677559|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-07-17|||May 7, 2013|Actual|2013-05-07|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2014|Actual|2014-09-30||Interventional|||Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies|Phase I Study Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies|Active, not recruiting||Phase 1|34|Actual|Washington University School of Medicine||5|||f||||t|t|f||||||||2017-10-11 02:33:27.241587|2017-10-11 02:33:27.241587
NCT01677546|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-08-29|||January 2011||2011-01-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Bolus Calculator and Wireless Communication With Blood Glucose Meter in Management of Type 1 Diabetes Mellitus (T1DM).|The Impact of Insulin Pump Bolus Calculator and Wireless Communication With Blood Glucose Meter on Metabolic Control in Children With Type 1 Diabetes Mellitus - Randomised Control Trial|Completed||N/A|156|Actual|Medical University of Warsaw||3|||f||||f||||||||||2017-10-11 02:33:27.393489|2017-10-11 02:33:27.393489
NCT01677533|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-12-19|||September 2009||2009-09-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|September 2012|Actual|2012-09-01||Interventional|PROVE||Program for Research on the Outcomes of VA Education|Program for Research on the Outcomes of VA Education: Controlled Study of Panel Management and Microsystem Education Interventions to Improve Outcomes in Hypertension and Smoking Cessation|Unknown status|Active, not recruiting|Phase 2|38000|Anticipated|VA New York Harbor Healthcare System||3|||f||||t||||||||||2017-10-11 02:33:27.518558|2017-10-11 02:33:27.518558
NCT01677520|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-01-08|||March 2011||2011-03-01|January 2015|2015-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Investigation of Stem Cells in Human Lipoaspirate|Investigation of Adipose-Derived Stem Cells in Human Lipoaspirate|Recruiting||N/A|240|Anticipated|University of Nevada, Las Vegas|||1||f||||f||||||Samples Without DNA|"     Cells from lipoaspirate maximum of 20 days   "|||2017-10-11 02:33:27.699055|2017-10-11 02:33:27.699055
NCT01677507|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-08-14|2017-08-14||August 2012||2012-08-01|August 2017|2017-08-01|August 30, 2016|Actual|2016-08-30|August 30, 2016|Actual|2016-08-30||Interventional||In addition to the 119 participants who were randomized to actual treatment, the baseline population includes the 9 who came for full baseline measurements before they were excluded or chose to withdraw.|Glaucoma Biomarkers|Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance|Completed||Phase 4|135|Actual|University of Michigan||2|||f|||||t|f|||f|||||2017-10-11 02:33:27.837935|2017-10-11 02:33:27.837935
NCT01677494|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-02|2014-09-01|||September 2010||2010-09-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|COLLAG4||Collagen Markers in Heart Failure and Preserved Ejection Fraction|To Assess the 12-month Prognostic Significance of Left Ventricular Collagen Markers in Patients With Heart Failure and Preserved Ejection Fraction.|Terminated||N/A|84|Actual|University Hospital, Rouen|||1|lack of recruitment|f||||f||||||Samples Without DNA|"     Proteomics   "|||2017-10-11 02:33:28.418907|2017-10-11 02:33:28.418907
NCT01677481|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-03-11|||February 2011||2011-02-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|REVERE||Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial|Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial.|Completed||N/A|1500|Actual|Total Cardiovascular Solutions|||3||f||||f||||||||No||2017-10-11 02:33:28.507762|2017-10-11 02:33:28.507762
NCT01677468|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-08-29|||August 2012||2012-08-01|August 2012|2012-08-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma|Phase Study About Feeding Artery Obliteration by Chemoembolization on Survival of Patients With Unresectable Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|250|Anticipated|Hallym University Medical Center||2|||f||||f||||||||||2017-10-11 02:33:28.602466|2017-10-11 02:33:28.602466
NCT01677455|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-11-04|||July 2012||2012-07-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|Enchant||An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer|An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer|Completed||Phase 2|51|Actual|Synta Pharmaceuticals Corp.||3|||f||||f||||||||||2017-10-11 02:33:28.823248|2017-10-11 02:33:28.823248
NCT01677442|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-08-31|||July 2011||2011-07-01|April 2012|2012-04-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Nonintubated Thoracic Epidural Anesthesia Versus Double-lumen Intubated Anesthesia in Video-assisted Thoracic Surgery|Nonintubated Thoracic Epidural Anesthesia Versus Double-lumen Intubated Anesthesia in Video-assisted Thoracic Surgery|Unknown status|Recruiting|Phase 1/Phase 2|500|Anticipated|Guangzhou Institute of Respiratory Disease||2|||f||||t||||||||||2017-10-11 02:33:29.073937|2017-10-11 02:33:29.073937
NCT01677429|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2015-06-23|||June 2015||2015-06-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Interventional|||The Assessment and Treatment of Balance Impairment Using Virtual Reality (VR) in Panic Disorder Patients||Unknown status|Not yet recruiting|N/A|80|Anticipated|Sheba Medical Center||3|||f||||f||||||||||2017-10-11 02:33:29.223788|2017-10-11 02:33:29.223788
NCT01677416|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2012-08-29|||March 2011||2011-03-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet|Joint Ultrasound Evaluation of Asymptomatic Feet in Patients With Rheumatoid Arthritis: A Controlled Study|Completed||N/A|100|Actual|Federal University of São Paulo|||2||f||||f||||||||||2017-10-11 02:33:29.330927|2017-10-11 02:33:29.330927
NCT01677403|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-26|2012-12-04|||August 2012||2012-08-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis|A Randomized,Controlled Study to Evaluate the Efficacy,Indications,Adverse Reactions and Resistance of Combined Administration of Nebulized Tobramycin Compared With Systemic Administration Alone in Patients With Bronchiectasis|Unknown status|Recruiting|Phase 4|120|Anticipated|Shandong University||2|||f||||f||||||||||2017-10-11 02:33:29.413469|2017-10-11 02:33:29.413469
NCT01677390|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2014-01-24|||August 2012||2012-08-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma|A Phase 1b, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Combination With Everolimus in Patients With CD70-positive Metastatic Renal Cell Carcinoma|Terminated||Phase 1|4|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-10-11 02:33:29.494333|2017-10-11 02:33:29.494333
NCT01677377|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2016-05-11||2015-08-07|August 2012||2012-08-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy|Phase 2A Study as an Open Label, Multiple Ascending Dose With Randomized Subjects to Receive a Single Dose of One of Three Dose Levels|Completed||Phase 2|45|Actual|Indivior Inc.||3|||f||||f||||||||||2017-10-11 02:33:29.58776|2017-10-11 02:33:29.58776
NCT01677364|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-26|2012-08-29|||July 2009||2009-07-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Elective Induction vs Spontaneous Labour in Patients With Heart Disease|ELECTIVE INDUCTION OF LABOUR VS SPONTANEOUS LABOUR IN WOMEN WITH HEART DISEASE - A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL|Completed||N/A|50|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||||||||||||2017-10-11 02:33:29.67636|2017-10-11 02:33:29.67636
NCT01677351|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-31|||July 2011||2011-07-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Assessment of the Effect of Clonidine for Cataract Surgery|Assessment of the Effect of Clonidine on Pain, Arterial and Intraocular Pressure and Arrhythmias for Cataract Surgery|Unknown status|Recruiting|Phase 2|40|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 02:33:29.747896|2017-10-11 02:33:29.747896
NCT01677338|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-05-12||2015-10-20|July 2013||2013-07-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects|A Multi-center, Open-label Comparison Study of a 13C-uracil Breath Test Versus 99mTechnetium Sulfur Colloid Gastric Emptying Scintigraphy to Evaluate Normal, and Delayed Gastric Emptying Time in Dyspeptic Subjects|Completed||Phase 2|20|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:33:29.842368|2017-10-11 02:33:29.842368
NCT01677325|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-09-04|||January 2007||2007-01-01|September 2012|2012-09-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine|The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine|Completed||Phase 1|40|Actual|Fudan University||1|||f||||t||||||||||2017-10-11 02:33:30.217573|2017-10-11 02:33:30.217573
NCT01677299|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-08-12|2014-02-12||May 2012||2012-05-01|August 2016|2016-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM|A Randomized, Crossover Study Assessing the Effects of pH 6.5 Enteric Coating of Metformin HCl Tablets on Pharmacokinetics and Changes in Circulating Glucose and Gastrointestinal Hormone Concentrations in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|24|Actual|Elcelyx Therapeutics, Inc.||4|||f||||f||||||||||2017-10-11 02:33:30.429169|2017-10-11 02:33:30.429169
NCT01677286|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-07-04|2017-03-19||July 2012|Actual|2012-07-01|July 2017|2017-07-01|December 15, 2015|Actual|2015-12-15|May 22, 2015|Actual|2015-05-22||Interventional|||Safety and Effect of Doxycycline in Patients With Amyloidosis|A Phase II Study of Doxycycline in Patients With Amyloidosis|Completed||Phase 2|25|Actual|Boston University||1|||f||||f|t|f|||t|||||2017-10-11 02:33:31.391233|2017-10-11 02:33:31.391233
NCT01677273|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2013-07-26|||September 2012||2012-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|HerKulES||The Effect of Hydrolyzed Casein on Energy Expenditure and Subjective Appetite|The Effect of Hydrolyzed Casein on Energy Expenditure and Subjective Appetite|Completed||N/A|33|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 02:33:32.311159|2017-10-11 02:33:32.311159
NCT01677260|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-08-30|||October 2009||2009-10-01|August 2012|2012-08-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet|A Combined Single Dose Study Under Fasting Condition And Multiple Doses Study Under Normal Diabetic Meal Comparing the Bioavailability of Two Formulations of 500 mg Metformin Hydrochloride Extended Release Tablets.|Completed||N/A|38|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 02:33:32.475458|2017-10-11 02:33:32.475458
NCT01677247|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-08-30|||February 2011||2011-02-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Bioequivalence Study of 4 mg Glimepiride Tablet|Bioequivalence Study of Two Formulations of Glimepiride Tablet in Healthy Subjects|Completed||N/A|24|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 02:33:32.656125|2017-10-11 02:33:32.656125
NCT01677208|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-10-09|||December 2012||2012-12-01|October 2016|2016-10-01||||December 2019|Anticipated|2019-12-01||Interventional|||Danhong Injection in the Treatment of Acute Ischemic Stroke|A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Danhong Injection in the Treatment of Acute Ischemic Stroke|Recruiting||Phase 4|1513|Anticipated|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 02:33:32.990151|2017-10-11 02:33:32.990151
NCT01674608|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-05-04|||July 2012||2012-07-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|TEAM||TEAM: Trial of Early Activity and Mobilization|TEAM: An Multi-centre Observational Study of Early Activity and Mobilization in Australia and New Zealand|Completed||N/A|192|Actual|Australian and New Zealand Intensive Care Research Centre|||1||f||||f||||||||||2017-10-11 02:34:41.637795|2017-10-11 02:34:41.637795
NCT01677195|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-03-20|2015-12-14||September 2012||2012-09-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|RDMEACCS100|Participants had detectable levels of aflatoxin in serum sample and were otherwise healthy.|"Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"|"Phase II, Reduction of Dietary Mycotoxin Exposure in Persons in Bexar County, Texas by Ingestion of ACCS100 Capsules Compared to Placebo."|Completed||Phase 2|234|Actual|Texas Enterosorbents Incorporated|Unlike our clinical trials in Africa, where maximum compliance was achieved through the daily in-home monitoring, the current study relied on participant reports during monthly visits in which total compliance was difficult to assess.|3|||f||||t||||||||Yes|Study submitted for publication in Tier 1 Toxicology Journal|2017-10-11 02:33:33.395682|2017-10-11 02:33:33.395682
NCT01677182|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-02-16|2016-02-16||August 2012||2012-08-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional||Baseline analysis population included all randomized participants.|Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated With Bipolar 1 Disorder in Adult Subjects|Terminated||Phase 3|535|Actual|Takeda||3||Business Decision; Terminated due to futility, with no safety concerns (see below)|f||||t||||||||||2017-10-11 02:33:33.879767|2017-10-11 02:33:33.879767
NCT01677169|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-08-30|||September 2000||2000-09-01|August 2012|2012-08-01|August 2006|Actual|2006-08-01|November 2005|Actual|2005-11-01||Interventional|||Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Heavy Smokers|Double Blind, Randomized, Placebo-controlled Clinical Trial of the Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Current Heavy Smokers|Completed||Phase 2|317|Actual|Tahitian Noni International, Inc.||3|||f||||t||||||||||2017-10-11 02:33:35.63309|2017-10-11 02:33:35.63309
NCT01677143|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-04-25|||February 2013||2013-02-01|April 2016|2016-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Pre-emptive Local Anaesthesia in Gynecological Laparoscopy|Pre-emptive Local Anaesthesia in Gynecological Laparoscopy|Completed||Phase 4|24|Actual|Helse Stavanger HF||2|||f||||f||||||||||2017-10-11 02:33:35.793528|2017-10-11 02:33:35.793528
NCT01677130|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-12-05|||January 2012||2012-01-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|||Standardized Application of High Frequency Oscillatory Ventilation in the Acute Respiratory Distress Syndrome (ARDS)||Completed||N/A|24|Actual|Southeast University, China|||1||f||||f||||||||||2017-10-11 02:33:35.877832|2017-10-11 02:33:35.877832
NCT01677117|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-08-29|||August 2012||2012-08-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|||||Observational|||Clinical Studies of the Effects of Extracorporeal Membrane Oxygenation for Severe ARDS Mortality||Unknown status|Not yet recruiting|N/A|25|Anticipated|Southeast University, China|||1||f||||t||||||||||2017-10-11 02:33:35.929363|2017-10-11 02:33:35.929363
NCT01677104|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-04-12|||August 2012||2012-08-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Microvascular Function of GLP-1 and Its Analogues|The Microvascular Function of GLP-1 and Its Analogues in Humans, in Vivo: the Role of DPP-IV Inhibition|Completed||N/A|63|Anticipated|Royal Devon and Exeter NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:33:35.973287|2017-10-11 02:33:35.973287
NCT01677091|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-05-10|||May 2013||2013-05-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|AVCPOSTIM||Balance Rehabilitation With Sensory Recalibration After Stroke|Effectiveness of a Balance Rehabilitation Program With Sensory Recalibration After Stroke: A Randomized Controlled Trial.|Recruiting||N/A|148|Anticipated|Rennes University Hospital||4|||f||||f||||||||||2017-10-11 02:33:36.048538|2017-10-11 02:33:36.048538
NCT01677078|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-04-11|||November 2012||2012-11-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|TMS||Coupling Repetitive Transcranial Magnetic Stimulation With a Neuronavigation System in Treatment Resistant Depression|Assessment of the Neuronavigation System Coupled With Repetitive Transcranial Magnetic Stimulation. A Randomized Double Blind Study|Recruiting||Phase 3|120|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 02:33:36.18018|2017-10-11 02:33:36.18018
NCT01677065|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-10-22|||September 2012||2012-09-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers|An Open-label, Single-dose, Randomized, Two-way Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers|Completed||Phase 1|14|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 02:33:36.30989|2017-10-11 02:33:36.30989
NCT01677052|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-09-24|||August 2012||2012-08-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Observational|||THERMOCOOL® SMARTTOUCH™ Registry|THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Atrial Fibrillation- Registry|Completed||N/A|426|Actual|Biosense Webster, Inc.|||1||f||||t||||||||||2017-10-11 02:33:36.399505|2017-10-11 02:33:36.399505
NCT01677039|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-12-10|||September 2012||2012-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation|An Open-label, Single-dose, Randomized, Three-way Crossover Study to Estimate the Effects of Ethanol 20% and 40% on the Bioavailability a Controlled Release Formulation of Oxycodone 20 Mg With Sequestered Naltrexone 2.4 Mg in Healthy Volunteers|Completed||Phase 1|19|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:33:36.506792|2017-10-11 02:33:36.506792
NCT01676662|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-06-22|||September 2012|Actual|2012-09-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|June 2014|Actual|2014-06-01||Interventional|SOLECT||Solace European Confirmatory Trial|An Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects With Stress Urinary Incontinence|Completed||N/A|80|Actual|Solace Therapeutics, Inc.||2|||f||||f||||||||No|Pending publication of results|2017-10-11 02:33:42.723222|2017-10-11 02:33:42.723222
NCT01677026|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-05-23|||September 2012||2012-09-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01|5 Years|Observational [Patient Registry]|||Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache|Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache|Active, not recruiting||N/A|150|Anticipated|Autonomic Technologies, Inc.|||1||f||||f||||||||||2017-10-11 02:33:38.293429|2017-10-11 02:33:38.293429
NCT01677013|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-09-30|||May 2011||2011-05-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|May 2015|Actual|2015-05-01||Interventional|||Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus|Efficacy of Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Selective Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|1026|Actual|Peking University Aerospace Centre Hospital||4|||f||||t||||||||||2017-10-11 02:33:38.378914|2017-10-11 02:33:38.378914
NCT01677000|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-09-29|||June 2012||2012-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|October 2018|Anticipated|2018-10-01||Observational|CPP Infection||CPP Bone Infection Registry|Clinical Priority Program: Bone Infection; Use of a Registry on Infection to Improve Patient Outcomes and Research Efforts|Active, not recruiting||N/A|300|Anticipated|AO Clinical Investigation and Documentation|||1||f||||t||||||Samples With DNA|"     blood samples nasal and wound specimen   "|||2017-10-11 02:33:38.470757|2017-10-11 02:33:38.470757
NCT01676974|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-07-29|||November 2012||2012-11-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|November 2013|Actual|2013-11-01||Observational|COMBAT||Carriage Of Multiresistant Bacteria After Travel|Impact of International Travel on the Emergence and Spread of Antimicrobial Resistance in The Netherlands|Completed||N/A|2215|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     Fecal Swab   "|||2017-10-11 02:33:38.668273|2017-10-11 02:33:38.668273
NCT01676961|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-08-03|2017-08-03||January 2013||2013-01-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Confirmed diagnosis of multiple myeloma.|Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy|Phase II Trial Evaluating the Efficacy and Safety of Romiplostim (Nplate) Treatment of Chemotherapy Induced Thrombocytopenia in Patients With Multiple Myeloma|Terminated||Phase 2|5|Actual|New York University School of Medicine||1||PI left the institution|f||||t|t|f||||||||2017-10-11 02:33:38.771207|2017-10-11 02:33:38.771207
NCT01676948|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2015-10-13|||January 2013||2013-01-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|β-SPECIFIC 4Pa||An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)|An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)|Withdrawn||Phase 3|0|Actual|Novartis||6|||f||||||||||||||2017-10-11 02:33:38.967815|2017-10-11 02:33:38.967815
NCT01676935|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-03-21|||August 2012||2012-08-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease|Long-Term Safety and Tolerability of ABT-126 in Subjects With Mild-to-Moderate Alzheimer's Disease: An Open-Label Extension Study for Subjects Completing Study M10-985|Terminated||Phase 2|349|Actual|AbbVie||1||Data obtained from the M11-427 study is not critical to the continued evaluation of ABT-126.|f||||f||||||||||2017-10-11 02:33:39.205706|2017-10-11 02:33:39.205706
NCT01676922|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||An Observational Study of Avastin and Conventional Chemotherapy in Patients >/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS)|Prospective Non-interventional Study to Collect Data on the Use of Avastin and Conventional Chemotherapy for the Treatment of Previously Untreated Metastatic Colorectal Cancer in Patients >/= 70 Years|Completed||N/A|256|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:33:39.374185|2017-10-11 02:33:39.374185
NCT01676909|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-08-04|||October 1, 2013|Actual|2013-10-01|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|December 31, 2016|Actual|2016-12-31||Interventional|||Wellness Self-Management|A Hybrid Effectiveness-Implementation Trial of a Wellness Self-Management Program|Active, not recruiting||N/A|250|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 02:33:39.527944|2017-10-11 02:33:39.527944
NCT01676896|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2015-04-02|2014-12-03||December 2008||2008-12-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|September 2013|Actual|2013-09-01||Interventional|||Asthma in Central Texas Project|Enhancing Children's and Parents' Asthma Management|Completed||N/A|292|Actual|University of Texas at Austin||3|||f||||t||||||||||2017-10-11 02:33:39.651513|2017-10-11 02:33:39.651513
NCT01676883|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-06-14|||October 2012||2012-10-01|June 2016|2016-06-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Plantar Callosities and the Validity of Body Composition Assessment by Bio-impedance in Severely Obese Persons|Plantar Callosities and the Validity of Body Composition Assessment by Bio-impedance in Severely Obese Persons|Completed||N/A|40|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||Undecided||2017-10-11 02:33:40.633053|2017-10-11 02:33:40.633053
NCT01676870|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-06-06|||January 2012|Actual|2012-01-01|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|EX-MET||Exercise in Prevention of Metabolic Syndrome|Exercise in Prevention of Metabolic Syndrome|Active, not recruiting||N/A|465|Anticipated|Norwegian University of Science and Technology||3|||f||||f|f|f||||||||2017-10-11 02:33:40.717991|2017-10-11 02:33:40.717991
NCT01676857|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-09-12|||May 2010||2010-05-01|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Chemokine Mechanisms in Chronic Pelvic Pain|Chemokine Mechanisms in Chronic Pelvic Pain|Recruiting||N/A|264|Anticipated|Northwestern University|||2||f||||f||||||Samples With DNA|"     Expressed prostatic secretions, urine with or without cells, blood for cells and plasma   "|||2017-10-11 02:33:40.823272|2017-10-11 02:33:40.823272
NCT01676844|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2012-08-30|||February 2013||2013-02-01|August 2012|2012-08-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Investigating a New Way of Giving Medicine to Newborn and Preterm Babies|Oral Potassium Acid Phosphate Supplementation for Preterm Neonates; a Comparison of Oral Thin Films and Standard Oral Therapy.|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|University of Strathclyde||2|||f||||f||||||||||2017-10-11 02:33:40.904538|2017-10-11 02:33:40.904538
NCT01676831|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2016-09-18|||February 2012||2012-02-01|July 2016|2016-07-01||||January 2015|Actual|2015-01-01||Interventional|||Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)|A Phase I/IIa, Dose-Ranging Safety and Efficacy Study of Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|13|Actual|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 02:33:41.143769|2017-10-11 02:33:41.143769
NCT01676818|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-04-18|||August 9, 2012|Actual|2012-08-09|April 2017|2017-04-01|August 9, 2019|Anticipated|2019-08-09|August 9, 2018|Anticipated|2018-08-09||Interventional|||Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer|Phase II Clinical Trial of Eribulin in Advanced or Recurrent Cervical Cancer|Recruiting||Phase 2|30|Anticipated|University of Southern California||1|||f||||t|t|f||||||||2017-10-11 02:33:41.246434|2017-10-11 02:33:41.246434
NCT01676805|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-06-30|||August 20, 2012||2012-08-20|February 8, 2017|2017-02-08||||||||Observational|||Tissue Collection for Studies of Lymph Cancer|Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:33:41.345145|2017-10-11 02:33:41.345145
NCT01676792|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-04-21|||April 2011||2011-04-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional|||SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma|A Pilot Study to Assess the Efficacy & Safety of Topical SR-T100 Gel in the Treatment of Human Vulva Pre-cancerous Lesions (Vulvar Intraepithelial Neoplasia; VIN) & Cutaneous Condyloma(External Genital Warts; EGWs)|Completed||Early Phase 1|29|Actual|National Cheng-Kung University Hospital||1|||f||||f||||||||||2017-10-11 02:33:41.453984|2017-10-11 02:33:41.453984
NCT01676779|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-05-23|||October 2012|Actual|2012-10-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|DC-MEL||mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma|Randomized Controlled Phase II Clinical Trial on mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma Patients Who Are Disease-free Following the Local Treatment of Macrometastases.|Completed||Phase 2|88|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 02:33:41.569938|2017-10-11 02:33:41.569938
NCT01676766|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-11-04|||September 2012||2012-09-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease|Novel Quantification Methods for Fundus Flavoprotein Fluorescence and Lipofuscin Fluorescence to Detect Progression in Stargardt Disease|Terminated||N/A|2|Actual|University of Michigan|||1|"Flavoprotein fluorescence machine for the trial is not working so the trial was terminated. No   study data was collected prior to termination."|f||||f||||||||||2017-10-11 02:33:41.673997|2017-10-11 02:33:41.673997
NCT01676753|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-03-15|||June 2016||2016-06-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase 1b Dose De-escalation Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer|A Phase 1b Dose De-escalation Trial of the Cyclin-dependent Kinase Inhibitor Dinaciclib in Combination With Pembrolizumab in Patients With Advanced Breast Cancer and Assessment of MYC Oncogene Overexpression|Recruiting||Phase 1/Phase 2|32|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:33:41.763759|2017-10-11 02:33:41.763759
NCT01676740|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-08-31|||November 2012||2012-11-01|August 2012|2012-08-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Iron and Vitamin Adminstration Prior to Joint Replacement to Prevent Transfusion|Randomized Ttrial to Establish the Efficacy of Hematinic Agents in Patietns With Mild Anemia Undergoing Total Hip or Knee Replacement in Avoiding Blood Transfusion|Unknown status|Not yet recruiting|N/A|120|Anticipated|Meir Medical Center||3|||f||||f||||||||||2017-10-11 02:33:41.869949|2017-10-11 02:33:41.869949
NCT01676714|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-05-16|2017-03-17||February 2013||2013-02-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer|Phase II Study of Dovitinib and Pilot Study of Fibroblast Growth Factor Receptor Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer Previously Treated With Anti-Vascular Endothelial Growth Factor Therapy|Completed||Phase 2|10|Actual|University of California, Davis||1|||f||||t|t|f||||||||2017-10-11 02:33:42.08257|2017-10-11 02:33:42.08257
NCT01676701|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2014-01-07||2014-01-07|September 2012||2012-09-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)|Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate|Completed||Phase 3|8|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:33:42.376221|2017-10-11 02:33:42.376221
NCT01676688|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2012-11-08|||January 2012||2012-01-01|August 2012|2012-08-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|||Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home|Safety Study of Alfalastin (Human Alpha-1 Antitrypsin, 33.33 mg/ml) Administered at Home to Patients Suffering From Severe Forms of Primary Deficiency in Alpha-1 Antitrypsin, Phenotype PIZZ or PISZ, With Pulmonary Emphysema.|Completed||N/A|17|Actual|Laboratoire français de Fractionnement et de Biotechnologies|||1||f||||f||||||||||2017-10-11 02:33:42.545763|2017-10-11 02:33:42.545763
NCT01676675|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2013-03-14|||August 2012||2012-08-01|March 2013|2013-03-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|||A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults|A Single Center, Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase I Clinical Trial for Safety and Preliminary Immunogenicity of a Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults, on Day 0 and 21 Intramuscularly|Withdrawn||Phase 1|0|Actual|Jiangsu Province Centers for Disease Control and Prevention||8|||f||||f||||||||||2017-10-11 02:33:42.618922|2017-10-11 02:33:42.618922
NCT01676649|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2017-02-28|||November 2012||2012-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma|A Phase II Study of Ipilimumab in Combination With Carboplatin and Paclitaxel in Patients With Unresectable Stage III or Stage IV Melanoma|Active, not recruiting||Phase 2|30|Actual|Jewish General Hospital||2|||f||||f||||||||||2017-10-11 02:33:42.840997|2017-10-11 02:33:42.840997
NCT01676636|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-04-12|||October 2012||2012-10-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Delivery Vehicles for Prenatal Calcium Supplementation|Preference, Acceptability, and Palatability of Alternative Delivery Vehicles for Prenatal Calcium Supplementation Among Pregnant Women in Bangladesh|Completed||N/A|149|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 02:33:42.945963|2017-10-11 02:33:42.945963
NCT01676623|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-02-29|||April 2010||2010-04-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Impact Evaluation of a Social Franchise Model for Improving Infant and Young Child Feeding and Child Nutrition in Vietnam|Impact Evaluation of a Social Franchise Model Implemented by Alive & Thrive for Improving Infant and Young Child Feeding and Child Nutrition in Rural Vietnam|Completed||N/A|4000|Actual|International Food Policy Research Institute||2|||f||||f||||||||||2017-10-11 02:33:43.044674|2017-10-11 02:33:43.044674
NCT01676610|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2014-05-21|||January 2012||2012-01-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|iPOP||Infant Pulse Oximetry in Pakistan Study|Infant Pulse Oximetry in Pakistan (iPOP) Study: Utility and Feasibility of Integrating Pulse Oximetry Into the Routine Assessment of Young Infants at First-level Clinics in Karachi, Pakistan|Completed||N/A|3149|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 02:33:43.142853|2017-10-11 02:33:43.142853
NCT01676597|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2013-12-16|||September 2012||2012-09-01|December 2012|2012-12-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome||Unknown status|Recruiting|N/A|80|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 02:33:43.218678|2017-10-11 02:33:43.218678
NCT01676584|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2016-11-01|||September 2012||2012-09-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study of Single Dose RO6811135 in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO6811135 in Healthy Subjects.|Completed||Phase 1|56|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:33:43.301966|2017-10-11 02:33:43.301966
NCT01676571|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-29|2013-01-15|||October 2012||2012-10-01|January 2013|2013-01-01||||November 2012|Actual|2012-11-01||Interventional|||Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women|A Single-centre, Open-label, Single-dose Interventional Study Investigating the Pharmacokinetic Properties of Lu AA21004 in Healthy Young Chinese Men and Women|Completed||Phase 1|16|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 02:33:43.374642|2017-10-11 02:33:43.374642
NCT01676558|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-11-13|||June 2012||2012-06-01|August 2012|2012-08-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)|A Phase II Study of 131I-rituximab for Elderly or Poor Performance Status Patients With Diffuse Large B Cell Lymphoma (DLBCL) or for Adult Patients With Relapsed or Refractory DLBCL|Unknown status|Recruiting|Phase 2|24|Anticipated|Korea Cancer Center Hospital||1|||f||||f||||||||||2017-10-11 02:33:43.461999|2017-10-11 02:33:43.461999
NCT01676545|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-30|2012-08-30|||July 2011||2011-07-01|August 2012|2012-08-01||||||||Observational|||Genetics of Periodontal Diseases in Chinese||Unknown status|Active, not recruiting|N/A|||Shanghai Stomatological Disease Center|||2||f||||||||||||||2017-10-11 02:33:43.69069|2017-10-11 02:33:43.69069
NCT01676532|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-04-15|2015-11-17||January 2012||2012-01-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Feasibility Study on the Model School Pediatric Health Initiative Pilot Project|Feasibility Study on the Model School Pediatric Health Initiative Pilot Project|Completed||N/A|127|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 02:33:43.78808|2017-10-11 02:33:43.78808
NCT01676519|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2012-08-30|||July 2002||2002-07-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|May 2007|Actual|2007-05-01||Observational|||Impact of Critical Limb Ischemia on Long Term Cardiac Mortality in Diabetic Patients Undergoing Percutaneous Coronary Revascularization||Completed||N/A|764|Actual|Ospedale San Donato|||1||f||||f||||||||||2017-10-11 02:33:44.126966|2017-10-11 02:33:44.126966
NCT01676506|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-08-30|||October 2011||2011-10-01|August 2012|2012-08-01|October 2015|Anticipated|2015-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)|The Impact of Genetic Polymorphisms on Ranibizumab Treatment Outcomes in Wet Age-Related Macular Degeneration (AMD)|Unknown status|Recruiting|N/A|300|Anticipated|Russian Academy of Medical Sciences|||||f||||f||||||||||2017-10-11 02:33:44.202942|2017-10-11 02:33:44.202942
NCT01676493|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2014-02-12|||August 2012||2012-08-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural Pain|A Multicenter, Open-Label, Safety and Pharmacokinetic Study of Oral Codeine Sulfate Administration in Pediatric Subjects 2 Years Old Through 17 Years Old With Post-procedural Pain|Terminated||Phase 3|31|Actual|Roxane Laboratories||1||Decision to stop study due to low recruitment.|f||||f||||||||||2017-10-11 02:33:44.297227|2017-10-11 02:33:44.297227
NCT01676480|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-09-03|||September 2009||2009-09-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy|The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving ADT|Completed||N/A|20|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 02:33:44.378902|2017-10-11 02:33:44.378902
NCT01676467|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-01-07|||September 2012||2012-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Sample Collection in Smoking Asthma|A Sample Collection Protocol for Disease Profiling of Smoking Asthma.|Completed||N/A|23|Actual|Respivert Ltd|||6||f||||f||||||Samples With DNA|"     serum sputum   "|||2017-10-11 02:33:44.462841|2017-10-11 02:33:44.462841
NCT00004344|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1997||1997-01-01|February 2000|2000-02-01||||||||Observational|||Purification of Testis-Stimulating Factor in Precocious Puberty||Completed||N/A|4||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:04.819399|2017-10-11 04:25:04.819399
NCT01676454|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-01-03|||November 2012||2012-11-01|January 2017|2017-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Serum Vasopressin Levels and Severe Hemorrhagic Shock|Determination of Serum Vasopressin Levels and Correlation With Life-threatening Complications in Adults With Severe Hemorrhagic Shock.|Withdrawn||N/A|0|Actual|Poudre Valley Health System|||1|Study closed without enrollment .|f||||f||||||||No||2017-10-11 02:33:44.53467|2017-10-11 02:33:44.53467
NCT01676441|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-10-06|||August 2008||2008-08-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|March 2020|Anticipated|2020-03-01||Interventional|||Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury|A Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Patients With Chronic Spinal Cord Injury.|Active, not recruiting||Phase 2/Phase 3|32|Anticipated|Pharmicell Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:33:44.627164|2017-10-11 02:33:44.627164
NCT01676428|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-10-30|||May 2012||2012-05-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|October 2014|Actual|2014-10-01||Interventional|FASTRACK||A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases|A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases|Completed||N/A|42|Actual|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-11 02:33:44.73995|2017-10-11 02:33:44.73995
NCT01676415|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-03-27|2017-01-27||August 2012||2012-08-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)|Role of Short Term Systemic Corticosteroid Therapy in the Management of Chronic Rhinosinusitis Without Nasal Polyps|Terminated||Phase 4|9|Actual|Northwestern University|Study had difficult accruing sufficient numbers of patients. Additional Institutional Review Board mandated testing for potential participants made study flow challenging. Study was closed for failure to accrue sufficient patients.|2||participants are no longer receiving intervention due to clinical logistics|f||||||||||||||2017-10-11 02:33:44.865908|2017-10-11 02:33:44.865908
NCT01676402|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2014-07-17|||August 2012||2012-08-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years|Open-Label, Randomized Phase 1b Study of the Safety & Immunogenicity of Investigational Seasonal Influenza DNA Vaccine Followed by TIV Administered Intradermally (ID) or Intramuscularly (IM) in Healthy Adults 18-70 Years|Completed||Phase 1|316|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||f||||||||||2017-10-11 02:33:45.229762|2017-10-11 02:33:45.229762
NCT01676389|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-01-19|||January 2013||2013-01-01|September 2014|2014-09-01|May 2015|Actual|2015-05-01|October 2014|Actual|2014-10-01||Interventional|OMMA||Osteopathic Manual Medicine Treatment in Autism|Osteopathic Manual Medicine Treatment in Autism, A Pilot Study|Completed||N/A|3|Actual|New York Institute of Technology||2|||f||||f||||||||||2017-10-11 02:33:45.369157|2017-10-11 02:33:45.369157
NCT01676363|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-06-16|||March 2013||2013-03-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pilot Study of Diflunisal in HIV-infected Adults|Pilot Study of Diflunisal in HIV-infected Adults|Suspended||Phase 4|20|Anticipated|University of British Columbia||1||Awaiting efficacy results of first subjects enrolled. No safety issues identified.|f||||f||||||||||2017-10-11 02:33:45.70542|2017-10-11 02:33:45.70542
NCT01676350|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-06-04|||August 2014||2014-08-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction|Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction|Unknown status|Recruiting|N/A|280|Anticipated|WellSpan Health||2|||f||||f||||||||||2017-10-11 02:33:45.797433|2017-10-11 02:33:45.797433
NCT01676337|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-05-26|||July 2012||2012-07-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|TAR||Text Message Appointment Reminders|A Text-message Appointment Reminder System to Improve Patient Adherence With Outpatient Follow-up Appointments|Completed||N/A|374|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 02:33:45.901561|2017-10-11 02:33:45.901561
NCT01676324|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-06-05|||September 2012||2012-09-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Observational|FOCUS||FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)|FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of IBD|Completed||N/A|289|Actual|University of British Columbia|||1||f||||t||||||||||2017-10-11 02:33:45.98558|2017-10-11 02:33:45.98558
NCT01676311|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-09-27|||December 2013||2013-12-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of Huperzine A in Treatment of Moderate to Severe TBI|Huperzine A for the Treatment of Cognitive, Mood, and Functional Deficits After Moderate and Severe TBI|Recruiting||Phase 2|30|Anticipated|Spaulding Rehabilitation Hospital||2|||f||||t||||||||||2017-10-11 02:33:46.058675|2017-10-11 02:33:46.058675
NCT01676298|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-12-03|2012-11-06||August 2012||2012-08-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Observational|||Spartan FRX Project Reproducibility Study|Study of the Analytical Reproducibility of the Spartan FRX CYP2C19 *2,*3 and *17 Genotyping System.|Completed||N/A|8|Actual|Spartan Bioscience Inc.|||1||f||||f||||||||||2017-10-11 02:33:46.167304|2017-10-11 02:33:46.167304
NCT01676285|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-09-09|||January 2012||2012-01-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|CARE Cirrhosis||Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis|Effect of Metoprolol Succinate in Cardiac Remodeling Related to Nonalcoholic Cirrhosis. Randomized Study.|Completed||Phase 3|125|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 02:33:46.67181|2017-10-11 02:33:46.67181
NCT01676103|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-04-15|||September 2012||2012-09-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease|The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease|Completed||Phase 1/Phase 2|40|Actual|New York Institute of Technology||2|||f||||f||||||||||2017-10-11 02:33:49.865818|2017-10-11 02:33:49.865818
NCT01676272|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-11-16|||July 2012||2012-07-01|November 2015|2015-11-01|November 2015|Anticipated|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Multi Center Site , Controlled Trial Comparing a Bioengineered Skin Substitute to a Human Skin Allograft|Proposal for a Multi- Center Site Randomized, Prospective Controlled Head-to-head Clinical Trial Comparing a Bioengineered Skin Substitute to a Human Skin Allograf|Enrolling by invitation||N/A|100|Anticipated|Soluble Systems, LLC|||1||f||||f||||||||||2017-10-11 02:33:46.785978|2017-10-11 02:33:46.785978
NCT01676259|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-11-09|||February 2017||2017-02-01|October 2016|2016-10-01|June 2020|Anticipated|2020-06-01|February 2019|Anticipated|2019-02-01||Interventional|||A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer|A Phase II, Randomized, Open Label Study of Single Dose siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer|Not yet recruiting||Phase 2|80|Anticipated|Silenseed Ltd||2|||f||||t||||||||||2017-10-11 02:33:46.865562|2017-10-11 02:33:46.865562
NCT01676246|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||May 2008||2008-05-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Pharmacokinetics, Metabolism and Analgesic Effects of Flupirtine|Pharmacokinetics, Metabolism and Analgesic Effects of Flupirtine After Intravenous, Single Dose and Chronic Oral Administration in Healthy Subjects Genotyped for NAT2, UGT1A1 and GSTP1|Completed||Phase 1|36|Actual|University Medicine Greifswald||3|||f||||f||||||||||2017-10-11 02:33:46.984901|2017-10-11 02:33:46.984901
NCT01676233|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-08-16|||September 2012||2012-09-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus|A Randomized, Open-label, 2-treatment Crossover Study of a New Formulation of Insulin Glargine Comparing to Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus on Treatment With Basal-bolus Insulin|Completed||Phase 1|20|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:33:47.075141|2017-10-11 02:33:47.075141
NCT01676220|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-05-28|2015-03-24|2014-11-14|August 2012||2012-08-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|EDITION III|Randomized population: all screened participants (who originally met inclusion criteria and signed informed consent) allocated to a treatment group and recorded in Interactive Voice/Web Response System (IVRS/IWRS) database, regardless of whether treatment was used or not. Participants were analyzed in treatment group to which they were randomized.|Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy|6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Non-Insulin Antihyperglycemic Drugs With a 6-month Safety Extension Period|Completed||Phase 3|878|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:33:47.193014|2017-10-11 02:33:47.193014
NCT01676207|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-01-15|||July 2012||2012-07-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Prevalence of Extracardiac Coronary Collateral Supply Via the Internal Mammary Arteries|Prevalence of Extracardiac Coronary Collateral Supply Via the Internal Mammary Arteries|Completed||N/A|120|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-11 02:33:48.868341|2017-10-11 02:33:48.868341
NCT01676194|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-10-27|||August 2012||2012-08-01|October 2015|2015-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|CATCH||Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma|Efficacy of Transarterial Chemoembolization With DC-BeadsR Prior to Liver Transplantation for Hepatocellular Carcinoma on Patient Survival : A Prosepctive Multicentre and Randomized Study|Unknown status|Active, not recruiting|Phase 3|140|Anticipated|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 02:33:48.958578|2017-10-11 02:33:48.958578
NCT01676181|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-02-25|||November 2011||2011-11-01|February 2016|2016-02-01|August 2022|Anticipated|2022-08-01|August 2014|Actual|2014-08-01||Interventional|RCT ATE/ATT||ATT Compared With ATE in OSAS Children|Randomised Surgical Intervention Study Between Adenotonsillectomy and Adenotonsillotomy in Children With Obstructive Sleep Apnea Syndrome|Active, not recruiting||N/A|70|Anticipated|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 02:33:49.063772|2017-10-11 02:33:49.063772
NCT01676168|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||July 2012||2012-07-01|August 2012|2012-08-01||||July 2013|Anticipated|2013-07-01||Observational|||To Study Gene Expression of Postburn Hypertrophic Scar|To Study Gene Expression of Postburn Hypertrophic Scar|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples With DNA|"     Hypertrophic scar from post-burn patient   "|||2017-10-11 02:33:49.144852|2017-10-11 02:33:49.144852
NCT01676155|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||September 2011||2011-09-01|June 2012|2012-06-01||||||||Observational|||The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis|The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis|Unknown status|Recruiting|N/A|400|Anticipated|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-11 02:33:49.214228|2017-10-11 02:33:49.214228
NCT01676142|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||January 2011||2011-01-01|June 2011|2011-06-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Establishing a Diagnostic Test for Non-tuberculous Mycobacteria Lung Infection Using Non-tuberculous Mycobacteria Antigen Stimulation Test: From Immune Base, Standardized Setup to Validation|Establishing a Diagnostic Test for Non-tuberculous Mycobacteria Lung Infection Using Non-tuberculous Mycobacteria Antigen Stimulation Test: From Immune Base, Standardized Setup to Validation|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||3||f||||f||||||||||2017-10-11 02:33:49.313062|2017-10-11 02:33:49.313062
NCT01676129|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||July 2012||2012-07-01|August 2012|2012-08-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Nocipoint Therapy Versus Standard Physical Therapy Using Electrical Stimulation in Treating Pain From TMJ Disorder|Comparing the Effect of Typical Electrical Stimulation Therapy With Nocipoint Stimulation Therapy on TMD-Related Myofascial Pain|Unknown status|Recruiting|N/A|90|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:33:49.423874|2017-10-11 02:33:49.423874
NCT01676116|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-12-15||2014-11-20|August 2012||2012-08-01|December 2016|2016-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|DUAL™ III||The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy|The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (DUAL™ III -GLP-1 Switch)|Completed||Phase 3|438|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:33:49.553808|2017-10-11 02:33:49.553808
NCT01676090|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2013-12-19|||July 2012||2012-07-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|EDISON||IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population|An Epidemiologic, Descriptive and Cross-sectional Study of the IGF-1, IGFBP-3 and ALS Normative Ranges in a Healthy Paediatric Spanish Population, Divided Into Chronological Age, Sex and Pubertal Stage|Terminated||N/A|304|Actual|Ipsen|||1|Participant enrolment was lower than expected|f||||f||||||||||2017-10-11 02:33:49.977606|2017-10-11 02:33:49.977606
NCT01676077|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-03-29|||September 2012||2012-09-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|Jain COS||Clinical Outcome Study for Dysferlinopathy|International Clinical Outcome Study for Dysferlinopathy|Active, not recruiting||N/A|150|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||t||||||Samples With DNA|"     Serum, Plasma, DNA, RNA, Skin fibroblasts   "|||2017-10-11 02:33:50.162997|2017-10-11 02:33:50.162997
NCT01676064|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2012-08-27|||August 2012||2012-08-01|August 2012|2012-08-01||||August 2013|Anticipated|2013-08-01||Interventional|||Influence of Perioperative Fluid Management on Intraocular Pressure During Hynecologic Laparoscopic Pelvic Surgery|Influence of Perioperative Fluid Management on Intraocular Pressure During Hynecologic Laparoscopic Pelvic Surgery|Unknown status|Not yet recruiting|N/A|50|Anticipated|Ziv Hospital||2|||f||||t||||||||||2017-10-11 02:33:50.288409|2017-10-11 02:33:50.288409
NCT01676051|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-06-02|||December 2012||2012-12-01|June 2015|2015-06-01||||December 2014|Actual|2014-12-01||Observational|||Surgical Prep in Hand Surgery|Efficacy of Surgical Preparation Solutions in Hand Surgery|Completed||N/A|240|Actual|University of Pittsburgh|||3||f||||t||||||||||2017-10-11 02:33:50.379416|2017-10-11 02:33:50.379416
NCT01676038|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-12-19|||July 2011||2011-07-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|June 2012|Actual|2012-06-01||Interventional|||Pinless-Navigated Versus Conventional Total Knee Arthroplasty|Radiographic Analysis Comparing Pinless-Navigated and Conventional Total Knee Arthroplasty: A Randomized Controlled Trial|Completed||N/A|100|Actual|Singapore General Hospital||2|||f||||t||||||||||2017-10-11 02:33:50.475458|2017-10-11 02:33:50.475458
NCT01676025|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-10-04|||September 2012||2012-09-01|October 2017|2017-10-01|February 28, 2016|Actual|2016-02-28|February 28, 2016|Actual|2016-02-28||Interventional|PRA||Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy|Randomized Controlled Trial Between PRA(Posterior Retroperitoneoscopic Adrenalectomy) and LA(Laparoscopic Adrenalectomy)|Completed||N/A|83|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:33:50.549851|2017-10-11 02:33:50.549851
NCT01676012|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-05-08|2015-03-17||September 2012||2012-09-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||A total of 32 patients were enrolled. Two patients had a insecure airway so bronchoscopy was performed in 30 patients and a complete set of videos was available for analysis in 29 patients.|Hd-bronchoscopy, Comparison to Standard White Light and Autofluorescence Bronchoscopy|High Definition Bronchoscopy; an Exploratory Study of Diagnostic Value in Comparison to Standard White Light Bronchoscopy and Autofluorescence Bronchoscopy|Completed||N/A|32|Actual|Radboud University|||1||f||||f||||||||||2017-10-11 02:33:50.629457|2017-10-11 02:33:50.629457
NCT01675999|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-01-14|||May 2012||2012-05-01|January 2012|2012-01-01|February 2021|Anticipated|2021-02-01|May 2012|Actual|2012-05-01||Interventional|ECKINOXE||Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer|PRODIGE 22-ECKINOXE : Randomized Phase II Trial of Neoadjuvant FOLFOX 4 Versus FOLFOX 4 With Cetuximab Versus Immediate Surgery in Locally Advanced Colon Cancer|Recruiting||Phase 2|186|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-10-11 02:33:50.956721|2017-10-11 02:33:50.956721
NCT01675986|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-10-10||||||October 2016|2016-10-01||||November 2014|Actual|2014-11-01||Interventional|||Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score||Completed||Phase 2|306|Actual|Poitiers University Hospital||3|||f||||||||||||||2017-10-11 02:33:51.114177|2017-10-11 02:33:51.114177
NCT01675973|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-12-04|||July 2012||2012-07-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine|A Phase 1, Parallel-group, Open-label, Multiple-dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Ranolazine ER in Subjects With Severe Renal Impairment as Compared to Healthy Subjects With Normal Renal Function|Terminated||Phase 1|4|Actual|Gilead Sciences||2||Study met stopping criteria specified within protocol.|f||||||||||||||2017-10-11 02:33:51.196589|2017-10-11 02:33:51.196589
NCT01675960|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-02-27|||April 2012||2012-04-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children|A Phase II, Randomized, Placebo-controlled, Double Blind, Cross-over, Study of the Effects of Gabapentin on Chronic Irritability in Neurologically Impaired Children|Active, not recruiting||Phase 2|40|Anticipated|Gillette Children's Specialty Healthcare||2|||f||||t||||||||||2017-10-11 02:33:51.286308|2017-10-11 02:33:51.286308
NCT01675947|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-12-08|||February 2012||2012-02-01|December 2015|2015-12-01|February 2016|Anticipated|2016-02-01|June 2015|Actual|2015-06-01||Interventional|Sirolimus||Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy|Multi-Center, Randomized, Single Masked Phase 2 Study of Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration|Terminated||Phase 2|52|Actual|National Eye Institute (NEI)||2||"On May 30, 2014, study injections were discontinued at the request of the DSMC. No further   recruitment will occur."|f||||t||||||||||2017-10-11 02:33:51.407905|2017-10-11 02:33:51.407905
NCT01675934|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-01-06|||February 2012||2012-02-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Right-sided Retroflexion With Standard Adult Versus Pediatric Colonoscopes|Right-sided Retroflexion With Standard Adult Versus Pediatric Colonoscopes|Withdrawn||N/A|0|Actual|Medical College of Wisconsin||2||PI has left institution|f||||f||||||||||2017-10-11 02:33:51.540792|2017-10-11 02:33:51.540792
NCT01675921|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2016-11-07|||September 2012||2012-09-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|C2MA||Implementation of ACT Through Facebook for Teenagers With Asthma|Implementation of ACT Through Facebook for Teenagers With Asthma|Completed||N/A|120|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:33:51.638325|2017-10-11 02:33:51.638325
NCT01675908|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-08-02|||July 2010||2010-07-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression|Multicenter Randomized Trial Comparing Covered Metal and Plastic Stents for Preoperative Biliary Decompression in Pancreatic Cancer|Recruiting||N/A|84|Anticipated|Florida Hospital||2|||f||||t||||||||||2017-10-11 02:33:51.724963|2017-10-11 02:33:51.724963
NCT01675895|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-12-17|||July 2009||2009-07-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration|Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration: Randomized Controlled Trial|Completed||Phase 4|40|Actual|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-11 02:33:51.839997|2017-10-11 02:33:51.839997
NCT01675882|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-09-28||2015-09-28|August 2012||2012-08-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|VIPES||Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy|A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.|Completed||Phase 2|221|Actual|DBV Technologies||4|||f||||t||||||||||2017-10-11 02:33:51.956432|2017-10-11 02:33:51.956432
NCT01675869|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-02-02|||July 2012||2012-07-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|ETAM||Executive Function/Metacognitive Training for At-Risk Preschoolers|Executive Function/Metacognitive Training for At-Risk Preschoolers|Completed||N/A|68|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 02:33:52.134859|2017-10-11 02:33:52.134859
NCT01675856|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2016-12-21|||July 2012||2012-07-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Urgent vs. Early Endoscopy in High Risk Patients With Upper Gastrointestinal Bleeding (UGIB)|Urgent vs. Early Endoscopy in High Risk Patients With UGIB|Recruiting||Phase 4|516|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-11 02:33:52.254915|2017-10-11 02:33:52.254915
NCT01675843|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||May 2010||2010-05-01|August 2012|2012-08-01||||March 2012|Actual|2012-03-01||Interventional|OSIPS||Ovarian Stimulation and Intrauterine Insemination in Women With Polycystic Ovarian Syndrome|Ovarian Stimulation and Intrauterine Insemination in Women With Polycystic Ovarian Syndrome|Completed||Phase 4|140|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 02:33:52.384636|2017-10-11 02:33:52.384636
NCT01675830|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-03-11|2015-02-11||November 2011||2011-11-01|March 2015|2015-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Heat Retention Head Wrap Use for Re-warming of Infants Requiring Cardio-Pulmonary Bypass|Heat Retention Head Wrap Use for Re-warming of Infants Requiring Cardio-Pulmonary Bypass|Completed||Phase 1|10|Actual|Cardiology Clinical Research & Regulatory Group|Investigators could not account for differences in the room temperature, heated and humidified gases, CPB regulation, regulation of forced air warming system, warming of IV fluids, and temperature of irrigation solutions in the OR.|1|||f||||t||||||||||2017-10-11 02:33:52.492285|2017-10-11 02:33:52.492285
NCT01675817|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-09-27|||April 2011||2011-04-01|September 2012|2012-09-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||Evaluation of Heparin Rebound in Cardiac Surgery|Evaluation of Heparin Rebound in Cardiac Surgery|Unknown status|Recruiting|N/A|40|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-11 02:33:52.700063|2017-10-11 02:33:52.700063
NCT01675804|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2015-04-03|||November 2011||2011-11-01|April 2015|2015-04-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD|A Randomized Clinical Trial Comparing Computer-assisted Cognitive Rehabilitation (CACR), Psycho-stimulants, and Placebo CACR in the Treatment of Attention Deficit/ Hyperactivity Disorder|Completed||Phase 3|34|Actual|Allameh Tabatabai University||3|||f||||f||||||||||2017-10-11 02:33:52.789357|2017-10-11 02:33:52.789357
NCT01675791|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2014-01-20|||August 2012||2012-08-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet|A Dose-response Evaluation of ALK Tree AIT|Completed||Phase 2|637|Actual|ALK-Abelló A/S||7|||f||||f||||||||||2017-10-11 02:33:52.903767|2017-10-11 02:33:52.903767
NCT01675778|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2012-08-28|||October 2011||2011-10-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Association Between Body Size and Response to Hydromorphone in ED|Influence of Body Size and Composition on Response to Hydromorphone in ED Patients With Acute Pain|Unknown status|Recruiting|N/A|200|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 02:33:53.030812|2017-10-11 02:33:53.030812
NCT01675765|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-08-28|||August 2012||2012-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma|A Phase 1B Study to Evaluate the Safety and Induction of Immune Response of CRS-207 in Combination With Pemetrexed and Cisplatin as Front-line Therapy in Adults With Malignant Pleural Mesothelioma|Active, not recruiting||Phase 1|60|Actual|Aduro Biotech, Inc.||2|||f||||f||||||||||2017-10-11 02:33:53.177413|2017-10-11 02:33:53.177413
NCT01675752|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||May 2011||2011-05-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Observational|SHARP||Small Hyperplastic and Adenomatous Reliability Protocol|Accuracy of Narrow Band Imaging in Predicting Colonoscopy Surveillance Intervals and Histology of Distal Diminutive Polyps (Small Hyperplastic and Adenomatous Reliability Protocol; SHARP Trial)|Completed||N/A|300|Actual|Istituto Clinico Humanitas|||1||f||||f||||||||||2017-10-11 02:33:53.3691|2017-10-11 02:33:53.3691
NCT01675739|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-29|||October 2011||2011-10-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effectiveness of Fixed PC Interval Using SMS for Afternoon Colonoscopy|Effectiveness of Fixed Preparation-to-Colonoscopy Interval Using Short Message Service (SMS) for Afternoon Colonoscopy: a Randomized Control Study|Completed||N/A|280|Actual|Inje University||2|||f||||f||||||||||2017-10-11 02:33:53.456937|2017-10-11 02:33:53.456937
NCT01675726|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-08-29|||January 2013||2013-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|January 2016|Actual|2016-01-01||Interventional|||QUALITY OF LIFE OF CHILDREN BORN VERY PRETERM AT SCHOOL-AGE|QUALITY OF LIFE OF CHILDREN BORN VERY PRETERM AT SCHOOL-AGE|Completed||N/A|350|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:33:53.547382|2017-10-11 02:33:53.547382
NCT01675713|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-04-14|||September 2009||2009-09-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|July 2013|Actual|2013-07-01||Interventional|||Lifestyleintervention for the Treatment of Severe Obesity|Intensive Lifestyleintervention for the Treatment of Severe Obesity|Completed||N/A|149|Actual|Norwegian School of Sport Sciences||2|||f||||t||||||||||2017-10-11 02:33:53.631265|2017-10-11 02:33:53.631265
NCT01675700|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||January 2009||2009-01-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Topical Nitrates for Myofascial Trigger Points||Completed||N/A|10|Actual|GF Strong Rehabilitation Centre||1|||f||||f||||||||||2017-10-11 02:33:53.756058|2017-10-11 02:33:53.756058
NCT01675674|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2013-05-23|||September 2011||2011-09-01|May 2013|2013-05-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics|Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population|Terminated||N/A|3000|Anticipated|National MPS Society|||1|Funding withdrawn due to insufficient enrollment rate|f||||t||||||||||2017-10-11 02:33:54.017108|2017-10-11 02:33:54.017108
NCT01675661|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2017-03-07|2017-01-18||January 2014||2014-01-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|ACCENT||Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment|Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment (ACCENT)|Completed||Phase 3|302|Actual|Medical University of South Carolina||2|||f||||t||||||||Yes|The lead investigator will submit coded individual level data on Clinical Trials Network (CTN) study participants to the Data Management Center contracted by NIDA Center for CTN. These data may include but are not limited to: demographic information, date of birth, medical history, substance use history, psychiatric history, objective measures of substance use and psychiatric status, HIV status and genetic information. Data will be submitted without information that could readily identify the study participant (i.e. We will not share medical record numbers, social security numbers or participant names or phone numbers with the Data Management Center). De-identified data will be made publicly available per the CTN's policies.|2017-10-11 02:33:54.160973|2017-10-11 02:33:54.160973
NCT01675648|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-08-26|||August 2012||2012-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Lofexidine for Inpatient Opiate Detox in Singapore|A Double-blind Randomised Controlled Clinical Trial of Lofexidine Versus Diazepam in the Management of the Opioid Withdrawal Syndrome During Inpatient Detoxification in Singapore|Completed||Phase 4|112|Actual|Institute of Mental Health, Singapore||2|||f||||t||||||||||2017-10-11 02:33:54.990339|2017-10-11 02:33:54.990339
NCT01675635|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-08-11|||July 2011||2011-07-01|August 2015|2015-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||OxyNorm Capsules in Post-Operative Pain Study|A Double-blind, Randomized, Parallel Group Study to Compare the Efficacy and Safety, of Oxycodone Immediate-release Capsules Versus Morphine Immediate-release Tablets in Hospitalized Patients With Moderate to Severe Pain Following Surgery.|Completed||Phase 3|240|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||2|||f||||t||||||||||2017-10-11 02:33:57.195023|2017-10-11 02:33:57.195023
NCT01675622|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-08-11|||December 2010||2010-12-01|August 2015|2015-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Immediate-Release Oxycodone Capsules Study in Cancer Pain|A Comparative Study of Immediate-Release Oxycodone Capsules Versus Immediate-Release Morphine Tablets for the Treatment of Chinese Patients With Cancer Pain.|Completed||Phase 3|240|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||2|||f||||t||||||||||2017-10-11 02:33:57.350165|2017-10-11 02:33:57.350165
NCT01675609|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2014-07-28||2014-07-28|August 2012||2012-08-01|July 2014|2014-07-01||||October 2012|Actual|2012-10-01||Interventional|||Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects|A Single-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects|Completed||Phase 2|57|Actual|Eye Therapies, LLC||2|||f||||f||||||||||2017-10-11 02:33:57.42992|2017-10-11 02:33:57.42992
NCT01675596|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-08-17|||April 2012|Actual|2012-04-01|August 2017|2017-08-01|April 2021|Anticipated|2021-04-01|February 2016|Actual|2016-02-01||Interventional|SOLACE-AU||The SOLACE-AU Clinical Trial|A Multicentre, Non-Randomised Controlled Study of the Safety, Performance, Quality of Life and Cost Effectiveness Outcomes of the Edwards SAPIEN XT™ Transcatheter Heart Valve in an Australian Population|Active, not recruiting||N/A|198|Actual|Edwards Lifesciences||1|||f||||t|f|t|f|f|t|||||2017-10-11 02:33:57.497963|2017-10-11 02:33:57.497963
NCT01675583|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-06-28|||August 2012||2012-08-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Laser Speckle Imaging for Wound Perfusion Monitoring (WoundImager)|Laser Speckle Imaging for Wound Perfusion Monitoring (WoundImager)|Completed||N/A|20|Anticipated|CW Optics, Inc.|||2||f||||||||||||||2017-10-11 02:33:57.608728|2017-10-11 02:33:57.608728
NCT01675570|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-02-07|||August 2012||2012-08-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of RX-10045 in the Treatment of Dry Eye Disease|A Phase II, Multi-Center, Randomized, Placebo-Controlled, Double-Masked Study of RX-10045 (0.09%) in the Treatment of Dry Eye Disease|Completed||Phase 2|150|Actual|C.T. Development America, Inc.||2|||f||||t||||||||||2017-10-11 02:33:57.705242|2017-10-11 02:33:57.705242
NCT01675557|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-02-24|||September 2012||2012-09-01|February 2015|2015-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis|Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney|Completed||Phase 4|30|Actual|Creighton University||3|||f||||f||||||||||2017-10-11 02:33:58.516226|2017-10-11 02:33:58.516226
NCT01675544|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2015-11-27|2014-09-25||August 2012||2012-08-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|PREEMT-HF||PRospective Evaluation of Electrocardiographic Voltage Changes and Six Minute Walk Test for Predicting Readmissions in Heart Failure (PREEMT-HF Study)||Completed||N/A|46|Actual|Creighton University|||1||f||||f||||||||||2017-10-11 02:33:58.6319|2017-10-11 02:33:58.6319
NCT01675531|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2016-10-25|2016-07-05||December 2012||2012-12-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional||Safety set: 72 subjects|A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)|A Multicenter, Phase IV, Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy Who Need Opioid Combination Treatment With Existing Pregabalin Treatment|Completed||Phase 4|73|Actual|Mundipharma Korea Ltd||1|||f||||f||||||||No||2017-10-11 02:33:58.882452|2017-10-11 02:33:58.882452
NCT01675518|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2012-08-28|||January 2012||2012-01-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers|A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Oral Administration of ASP7991 in Healthy Volunteers|Completed||Phase 1|56|Actual|Astellas Pharma Inc||9|||f||||f||||||||||2017-10-11 02:33:59.445235|2017-10-11 02:33:59.445235
NCT01675505|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-07-09|||May 2012||2012-05-01|July 2013|2013-07-01||||||||Observational|||Psychological Well-being Outcomes in Disease-free Survivors of Colorectal Cancer Following Curative Surgery|Psychological Well-being Outcomes in Disease-free Survivors of Colorectal Cancer Following Curative Surgery|Unknown status|Recruiting|N/A|80|Anticipated|Aristotle University Of Thessaloniki|||1||f||||t||||||||||2017-10-11 02:33:59.588117|2017-10-11 02:33:59.588117
NCT01675492|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-05-23|2017-02-03||December 6, 2012|Actual|2012-12-06|May 2017|2017-05-01|November 22, 2016|Actual|2016-11-22|November 22, 2016|Actual|2016-11-22||Interventional|||Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism|A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System|Completed||N/A|126|Actual|Abbott Medical Optics||1|||f||||f||||||||||2017-10-11 02:33:59.691732|2017-10-11 02:33:59.691732
NCT01675479|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2017-04-04|||December 2012||2012-12-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refractive Errors|A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided Lasik Correction of Hyperopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4 IR™ Excimer Laser System|Completed||N/A|135|Actual|Abbott Medical Optics||1|||f||||f|f|t|t|f||||No|No Plan|2017-10-11 02:34:00.011023|2017-10-11 02:34:00.011023
NCT01675466|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-03-24|||August 2012||2012-08-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|FLO||Study Comparing Early Laparoscopy With Active Observation in Acute Non-specific Abdominal Pain|First Laparoscopy or Active Observation in Acute Non-specific Abdominal Pain: The FLO Trial|Terminated||Phase 4|17|Actual|Mid Western Regional Hospital, Ireland||2||Difficulties with recruitment|f||||f||||||||||2017-10-11 02:34:00.160311|2017-10-11 02:34:00.160311
NCT01675453|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2016-04-29|2014-05-18||January 2012||2012-01-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|ESHHS||The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients.|The Efficacy and Safety of 7.2% NaCl Plus 6% Hydroxyethyl 200/0.5 in Patients Scheduled for First-time Coronary Artery Bypass Grafting With Cardiopulmonary Bypass.|Completed||Phase 2|40|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 02:34:00.314762|2017-10-11 02:34:00.314762
NCT01675440|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-04-27|||August 2012||2012-08-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|August 2017|Anticipated|2017-08-01||Observational|||Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement|Medtronic CoreValve® U.S. Expanded Use Study|Active, not recruiting||N/A|782|Actual|Medtronic Cardiovascular|||6||f||||t||||||||||2017-10-11 02:34:00.669387|2017-10-11 02:34:00.669387
NCT01675427|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2015-08-12|2015-05-21||August 2011||2011-08-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Core Analysis Population: All participants enrolled who had a blood sample drawn for genotyping with available data for the primary variables, and who met all eligibility criteria for analysis.|A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C|An International, Multi-Center Study Evaluating the Correlation of IL28B Genotypes With Patient Demographics and Disease Characteristics in Patients With Chronic Hepatitis C|Completed||Phase 4|4766|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:34:02.367679|2017-10-11 02:34:02.367679
NCT01675414|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-08-29|||September 2008||2008-09-01|August 2012|2012-08-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Observational|||Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD)|Understanding Gastrointestinal Conditions in Children With ASD|Completed||N/A|131|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:34:25.42766|2017-10-11 02:34:25.42766
NCT01675401|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-10-31|||September 2012||2012-09-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Body Weight and Vascular Function|Vascular Function Markers: Differences Between Lean and Abdominally Overweight / Obese Men and Effects of Weight Loss|Completed||N/A|75|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:34:25.722753|2017-10-11 02:34:25.722753
NCT01675388|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2014-11-17|||August 2012||2012-08-01|November 2014|2014-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Hypothermia During ECMO to Decrease Brain Injury|Hypothermia as Neuroprotection During ECMO: Is Brain MRI a Biomarker of Outcomes?|Withdrawn||N/A|0|Actual|Sood, Beena G., MD, MS||1||No funding|f||||f||||||||||2017-10-11 02:34:25.820676|2017-10-11 02:34:25.820676
NCT01675375|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-28|2013-02-01|||March 2012||2012-03-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating Pain|Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating Pain|Completed||N/A|125|Actual|FORSIGHT Vision3||1|||f||||t||||||||||2017-10-11 02:34:25.922332|2017-10-11 02:34:25.922332
NCT01675362|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2014-10-08|||August 2012||2012-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|SWL||Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?|A Randomized Controlled Trial for Evaluating Protective Effects of Antioxidants (Selenium and Vitamins A, C and E), Calcium Channel Blocker (Verapamil) and Angiotensin Receptor Blocker (Losartan) Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury|Completed||Phase 4|160|Actual|Mansoura University||4|||f||||t||||||||||2017-10-11 02:34:26.008478|2017-10-11 02:34:26.008478
NCT01675349|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2014-05-22|||November 2012||2012-11-01|August 2012|2012-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Biological Standardization of Chenopodium Album Allergen Extract|Biological Standardization of Chenopodium Album Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units|Completed||Phase 2|48|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 02:34:26.144425|2017-10-11 02:34:26.144425
NCT01675336|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2012-08-28|||August 2011||2011-08-01|August 2012|2012-08-01||||||||Observational|||Genetics of Periodontal Diseases in Chinese (Taiwan)|The Association Between Interleukin-1 Gene Variations and Adult Chronic Periodontal Disease in Chinese (Taiwan))|Unknown status|Active, not recruiting|N/A|400|Anticipated|Kaohsiung Medical University|||1||f||||f||||||||||2017-10-11 02:34:26.229333|2017-10-11 02:34:26.229333
NCT01675310|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2015-03-23|||January 2012||2012-01-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women|EFFECTIVITY OF MEDICAL NUTRITION THERAPY PLUS TRANSGESTATIONAL METFORMIN FOR PREVENTING THE INCIDENCE OF GESTATIONAL DIABETES MELLITUS IN HIGH RISK MEXICAN WOMEN.|Completed||Phase 4|90|Actual|Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes||2|||f||||t||||||||||2017-10-11 02:34:26.402192|2017-10-11 02:34:26.402192
NCT01675297|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2013-01-17|||July 2011||2011-07-01|January 2013|2013-01-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis|For 12months, the Multi Center, Randomized, Open-label, Active Controlled Comparative Clinical Study to Assess the Efficacy and the Safety of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis|Unknown status|Recruiting|Phase 4|1170|Anticipated|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:34:26.492652|2017-10-11 02:34:26.492652
NCT01675284|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2013-10-23|||August 2012||2012-08-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine|A Phase I, Prospective, Randomized, Open Label, Observer-Blind, Single Center Study to Evaluate the Safety, Reactogenicity and Immunogenicity of an Inactivated H5N1 Influenza Vaccine Produced in Madin-Darby Canine Kidney (MDCK) Cells|Completed||Phase 1|36|Actual|Medigen Biotechnology Corporation||3|||f||||f||||||||||2017-10-11 02:34:26.616019|2017-10-11 02:34:26.616019
NCT01675271|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2015-03-20|||February 2012||2012-02-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|September 2015|Anticipated|2015-09-01||Interventional|ANS-EXE||Autonomic Nervous System and Exercise In Gestational Diabetes|Effect Of Individual Exercise Prescription On Cardiovascular Risk Factors In Woman At Risk For Gestational Diabetes - Focus On Autonomic Nervous System And Inflammation|Unknown status|Active, not recruiting|N/A|60|Anticipated|Helsinki University Central Hospital||3|||f||||f||||||||||2017-10-11 02:34:26.708814|2017-10-11 02:34:26.708814
NCT01675258|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2012-08-27|||September 2012||2012-09-01|July 2012|2012-07-01||||September 2013|Anticipated|2013-09-01||Observational|||Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic Cancers||Unknown status|Not yet recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||2||f||||||||||Samples With DNA|"     whole saliva   "|||2017-10-11 02:34:26.80343|2017-10-11 02:34:26.80343
NCT01675245|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2014-06-10|||March 2006||2006-03-01|June 2014|2014-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade|Velcade (Bortezomib for Injection) Observational Study|Completed||Phase 4|532|Actual|Xian-Janssen Pharmaceutical Ltd.|||1||f||||f||||||||||2017-10-11 02:34:27.04184|2017-10-11 02:34:27.04184
NCT01675232|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-07-25|||July 2012||2012-07-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis|A Randomized, Investigator-Blinded Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis|Completed||N/A|45|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:34:27.190029|2017-10-11 02:34:27.190029
NCT01675219|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-25|2015-11-05|||December 2012||2012-12-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)|Treatment of Ta Bladder Cancer in High Risk of Recurrence - Fluorescence Cystoscopy With Optimized Adjuvant Mitomycin-C (FinnBladder 9)|Recruiting||Phase 3|400|Anticipated|Turku University Hospital||4|||f||||t||||||||||2017-10-11 02:34:27.288664|2017-10-11 02:34:27.288664
NCT01675206|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-08-25|||May 2011||2011-05-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|September 2011|Actual|2011-09-01||Interventional|||Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients|Randomized Prospective Open Interventional Multi-centre Study on Finding the Optimal Dose of Vitamin K2 Supplements for Hemodialysis Patients|Completed||Phase 3|165|Actual|Onze Lieve Vrouw Hospital||3|||f||||f||||||||||2017-10-11 02:34:27.460201|2017-10-11 02:34:27.460201
NCT01675193|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-08-18|||February 2012||2012-02-01|August 2017|2017-08-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Disinvestment Study of Population-Based Vision Screening in Children|Disinvestment Study of Population-Based Vision Screening in Preverbal Children in the Netherlands|Completed||N/A|10803|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-11 02:34:27.557743|2017-10-11 02:34:27.557743
NCT01675180|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2015-10-29|||February 2013||2013-02-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|August 2016|Anticipated|2016-08-01||Interventional|||Self Reported Oral Health, Awareness and Attitude Towards Dental Care Among Pregnant Women|Self Reported Oral Health, Awareness and Attitude Towards Dental Care and Risk of Dental Caries Among Pregnant Women in Norway|Unknown status|Recruiting|N/A|200|Anticipated|University of Tromso||2|||f||||f||||||||||2017-10-11 02:34:27.647145|2017-10-11 02:34:27.647145
NCT01675167|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-01-12|2015-11-04|2015-03-02|September 2012||2012-09-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Analysis based on Intent-to-Treat (ITT) population; all randomized subjects who received at least 1 dose of double-blind study medication. One (1) subject did not receive double-blind study medication and an additional 19 subjects from 1 site were excluded from the population.|Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects|Phase 3, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety, and Tolerability of Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects With Chronic Lower Back Pain Requiring Opioid Analgesia|Completed||Phase 3|815|Actual|BioDelivery Sciences International||2|||f||||f||||||||||2017-10-11 02:34:27.769367|2017-10-11 02:34:27.769367
NCT01675154|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-06-16|||November 2015||2015-11-01|June 2017|2017-06-01|July 31, 2019|Anticipated|2019-07-31|July 31, 2019|Anticipated|2019-07-31||Interventional|||Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia|Phase 2 Study of Orlistat and SLx-4090 for Teh Treatment of Type 1 Hyperlipoproteinemia|Recruiting||Phase 2|20|Anticipated|University of Texas Southwestern Medical Center||4|||f||||t||||||||||2017-10-11 02:34:28.847357|2017-10-11 02:34:28.847357
NCT01675141|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-25|2017-04-04|2017-04-04||August 20, 2012|Actual|2012-08-20|April 2017|2017-04-01|March 10, 2017|Actual|2017-03-10|May 5, 2016|Actual|2016-05-05||Interventional|||Lenalidomide Maintenance Therapy for Multiple Myeloma|Lenalidomide Maintenance Therapy in Multiple Myeloma: A Phase II Clinical and Biomarker Study|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f|t|f|||t|||No||2017-10-11 02:34:29.004523|2017-10-11 02:34:29.004523
NCT01675128|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-25|2016-03-22|2015-11-30||August 2012||2012-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer|A Phase I/II Study of ISIS 183750 in Combination With Irinotecan in Irinotecan-refractory Colorectal Cancer|Completed||Phase 1/Phase 2|24|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||t||||||||||2017-10-11 02:34:29.465087|2017-10-11 02:34:29.465087
NCT01675115|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-07-27|||August 2012||2012-08-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|BNG-1||Efficacy of BNG-1 to Treat Acute Ischemic Stroke|A Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Compare the Functional Outcome and Safety of Treatment With BNG-1 in Combination With Aspirin With That of Aspirin Alone in Ischemic Stroke Recovery|Completed||Phase 3|129|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:34:31.127143|2017-10-11 02:34:31.127143
NCT01675102|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2014-10-02|||August 2010||2010-08-01|October 2014|2014-10-01||||June 2015|Anticipated|2015-06-01||Observational|17p-CLL NIS||Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)|Allogeneic HSCT in 17p- CLL in First or Second Partial or Complete Remission at Transplant: a Non-interventional Prospective Study.|Unknown status|Recruiting|N/A|41|Anticipated|European Group for Blood and Marrow Transplantation|||1||f||||f||||||||||2017-10-11 02:34:31.236847|2017-10-11 02:34:31.236847
NCT01675089|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2014-05-16|||July 2012||2012-07-01|March 2013|2013-03-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|||Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation|A Prospective and Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year After Kidney Transplantation|Completed||Phase 4|34|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 02:34:31.33583|2017-10-11 02:34:31.33583
NCT01675076|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-06-23|||January 2013||2013-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BRUISECONTROL2||Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events|A Randomized Controlled Trial to Investigate Whether a Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at the Time of Device Surgery, in Patients With Moderate to High Risk of Arterial Thrombo-embolic Events, Leads to a Reduction in the Incidence of Clinically Significant Hematoma|Active, not recruiting||Phase 3|663|Actual|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 02:34:31.446026|2017-10-11 02:34:31.446026
NCT01675063|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-03-27|2016-10-11||August 2012||2012-08-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Minimally Invasive Cardiac Output Monitoring Device|Development of a Minimally Invasive Cardiac Output Monitoring Device for Critically Ill Patients|Completed||N/A|77|Actual|University of Michigan||1|||f||||f||||||||No||2017-10-11 02:34:31.626093|2017-10-11 02:34:31.626093
NCT01675050|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-08-01|2017-05-26||August 2012||2012-08-01|August 2017|2017-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain|A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain|Terminated||Phase 2|4|Actual|University of Michigan|Statistical analyses were not conducted due to small sample size. Results should be interpreted with extreme caution.|2||"Due to the wide availability of the drug in clinical practice, it was impossible to recruit   adequate numbers for scientific power."|f||||t||||||||||2017-10-11 02:34:32.503206|2017-10-11 02:34:32.503206
NCT01675037|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-03-12|||July 2012|Actual|2012-07-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Hypothalamic-pituitary Effects After Endoscopic Third Ventriculostomy|Hypothalamic-pituitary Effects After Endoscopic Third Ventriculostomy|Terminated||N/A|11|Actual|University Hospital, Toulouse|||1|Recruitment failure|f||||f||||||None Retained|"     Whole blood, and urine   "|No||2017-10-11 02:34:32.854504|2017-10-11 02:34:32.854504
NCT01675024|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2012-12-03|||August 2012||2012-08-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects|A Single-site, Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects.|Completed||Phase 1|24|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 02:34:32.955462|2017-10-11 02:34:32.955462
NCT01675011|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-25|2016-02-10|2015-01-28||August 2012||2012-08-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Embozene Microspheres for Uterine Fibroid Embolization (UFE)|Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization Compared to Embosphere for Symptomatic Relief From Uterine Fibroids|Terminated||N/A|4|Actual|Boston Scientific Corporation|The trial was terminated early due to insufficient enrollment, therefore formal statistical analyses were not possible.|2||Inadequate enrollment|f||||t||||||||||2017-10-11 02:34:33.100762|2017-10-11 02:34:33.100762
NCT01674998|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2012-08-27|||July 2012||2012-07-01|August 2012|2012-08-01||||||||Observational|||Understanding the Natural History of REM Sleep Behavior Disorder|Understanding Autonomic Function in REM Sleep Behavior Disorder, Parkinsonism and Controls|Unknown status|Recruiting|N/A|15|Anticipated|The Parkinson's Institute|||1||f||||||||||Samples With DNA|"     Blood and/or saliva DNA   "|||2017-10-11 02:34:33.512497|2017-10-11 02:34:33.512497
NCT01674985|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-25|2016-07-12|||September 2009||2009-09-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|October 2013|Actual|2013-10-01||Interventional|||Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes||Completed||Phase 1/Phase 2|43|Actual|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||1|||f||||f||||||||||2017-10-11 02:34:33.607598|2017-10-11 02:34:33.607598
NCT01674972|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-08-24|||January 2011||2011-01-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Observational|||Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls|Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls|Completed||N/A|102|Actual|University Hospital, Basel, Switzerland|||2||f||||f||||||Samples With DNA|"     Plasma samples   "|||2017-10-11 02:34:33.703986|2017-10-11 02:34:33.703986
NCT01674959|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-26|2015-02-03|||October 2011||2011-10-01|February 2015|2015-02-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients|Phase II Study of Postoperative Intensity-modulated Radiotherapy (IMRT) Combined With Capecitabine for Stage II/III Gastric Cancer Patients|Recruiting||Phase 2|40|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:34:33.79987|2017-10-11 02:34:33.79987
NCT01674946|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-08-24|||September 2011||2011-09-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Bile Acids on the Secretion of Satiation Peptides in Humans|Effect of Intraduodenal Perfusion of Bile Acids on the Secretion of Gastrointestinal Satiation Peptides in Healthy Male Volunteers|Completed||Phase 1|12|Actual|University Hospital, Basel, Switzerland||6|||f||||t||||||||||2017-10-11 02:34:33.89987|2017-10-11 02:34:33.89987
NCT01674933|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-05-03|||October 2012||2012-10-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|PT@3||Fluoride Varnish For Childsmile Nursery School Attenders|Comparison Of The Caries-Protective Effect Of Fluoride Varnish (Duraphat®) With Treatment As Usual In Nursery School Attendees Receiving Preventive Oral Health Support Through The Childsmile Oral Health Improvement Programme: An RCT|Active, not recruiting||Phase 4|1610|Anticipated|University of Glasgow||2|||f||||f||||||||||2017-10-11 02:34:34.005143|2017-10-11 02:34:34.005143
NCT01674920|ClinicalTrials.gov processed this data on October 10, 2017|2008-05-18|2012-08-27|||January 2006||2006-01-01|August 2012|2012-08-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|CHOICES||CHOICES: Family Physicians Treat Overweight Children|CHOICES: Family Physicians Treat Overweight Children|Completed||N/A|35|Actual|University of Arizona||1|||f||||t||||||||||2017-10-11 02:34:34.122825|2017-10-11 02:34:34.122825
NCT01674907|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-11-01|||March 2010||2010-03-01|November 2016|2016-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS)|Non-interventional Study of Avastin in 1st Line Metastatic Colorectal Cancer|Completed||N/A|27|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:34:34.248546|2017-10-11 02:34:34.248546
NCT01674894|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-08-25|||January 2013||2013-01-01|August 2017|2017-08-01|March 10, 2016|Actual|2016-03-10|December 10, 2015|Actual|2015-12-10||Observational|||Study of the Cleavage of the Egg in Relation to the Stimulation Treatment|Kinetics in Time-lapse Culture of Human Preembryos|Completed||N/A|356|Actual|Ferring Pharmaceuticals|||2||f||||f||||||||||2017-10-11 02:34:34.359971|2017-10-11 02:34:34.359971
NCT01674881|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2015-04-13|||September 2012||2012-09-01|August 2013|2013-08-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||The Effectiveness of Mindfulness on Chronic Pain in Breast Cancer Survivors|A Randomized Controlled Trial of Mindfulness-based Cognitive Therapy (MBCT) on Chronic Pain in Women Treated for Breast Cancer|Completed||N/A|130|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:34:34.45286|2017-10-11 02:34:34.45286
NCT01674868|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2015-06-14|||April 2013||2013-04-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|FLAN||Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic Stroke|Pilot RCT of Fluoxetine vs Placebo to Treat Motor, Language and Unilateral Neglect After Ischemic Stroke|Withdrawn||N/A|0|Actual|Spaulding Rehabilitation Hospital||2||unable to find patients meeting inclusion/exclusion criteria|f||||f||||||||||2017-10-11 02:34:34.539046|2017-10-11 02:34:34.539046
NCT01674855|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-09-29|||February 2012||2012-02-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|PEG-G-CSF||Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia|Randomized, Open, Multi-Center, Phase III Study to Evaluate Efficacy and Safety in Chemotherapy-induced Neutropenia of Once-per-cycle DA-3031(PEG-G-CSF) and Daily G-CSF in Patients With Malignancies Receiving Myelosuppressive Chemotherapy|Completed||Phase 3|74|Anticipated|Dong-A ST Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:34:34.623164|2017-10-11 02:34:34.623164
NCT01674842|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-07-25|||October 2012||2012-10-01|July 2017|2017-07-01|October 2023|Anticipated|2023-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Cisplatin + RT for Triple Negative Breast Cancer|A Phase I Dose-Escalation Study of Cisplatin and Radiation Therapy for Patients With Triple Negative Breast Cancer|Recruiting||Phase 1|39|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 02:34:34.706762|2017-10-11 02:34:34.706762
NCT01674829|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-10-22|||September 2012||2012-09-01|August 2012|2012-08-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|||A Phase I/IIa, Open-Label, Single-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial(MA09-hRPE) Cells in Patients With Advanced Dry Age-related Macular Degeneration(AMD)|A Phase I/IIa, Open-Label, Single-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial(MA09-hRPE) Cells in Patients With Advanced Dry Age-related Macular Degeneration(AMD)|Unknown status|Recruiting|Phase 1/Phase 2|12|Anticipated|CHABiotech CO., Ltd||1|||f||||t||||||||||2017-10-11 02:34:34.80881|2017-10-11 02:34:34.80881
NCT01674816|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-07-21|||August 2017|Anticipated|2017-08-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Minimally Invasive Three-dimensional Knee Kinematic Assessment and Surgical Guidance Using Ultrasonic Rigid Registration|(Étude de la cinématique Tridimensionnelle du Genou et Guidage Chirurgical Minimalement Effractifs Par Recalage Rigide échographique)|Not yet recruiting||N/A|30|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t|f|f||||||||2017-10-11 02:34:34.900565|2017-10-11 02:34:34.900565
NCT01674803|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-07-21|||December 21, 2012|Actual|2012-12-21|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 24, 2016|Actual|2016-08-24||Interventional|BIO-RESORT||Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)|Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion: Randomized Multicenter Trial in an All Comers Population Treated Within thE NeThErlands 3 (TWENTE 3)|Active, not recruiting||N/A|3514|Actual|Cardio Research Enschede BV||3|||f||||t||||||||||2017-10-11 02:34:35.039261|2017-10-11 02:34:35.039261
NCT01674790|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2014-10-29|||September 2012||2012-09-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Combined Effects of Aerobic Exercise and Cognitive Training on Cognition After Stroke|Exploring Potential Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition After Stroke.|Unknown status|Recruiting|N/A|20|Anticipated|Nova Scotia Health Authority||4|||f||||f||||||||||2017-10-11 02:34:35.129701|2017-10-11 02:34:35.129701
NCT01674777|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-27|||October 2010||2010-10-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941|A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of ASP1941|Completed||Phase 1|30|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 02:34:35.254021|2017-10-11 02:34:35.254021
NCT01674764|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-03-31|||November 2012||2012-11-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|December 2018|Anticipated|2018-12-01||Observational|SCI-POEM||Surgical Treatment for Spinal Cord Injury|Prognostic Factors and Therapeutic Effects of Surgical Treatment for Traumatic Spinal Column Injury With Spinal Cord Injury: A Prospective, Observational European Multi-center Study.|Recruiting||N/A|300|Anticipated|AOSpine Europe|||2||f||||t||||||||||2017-10-11 02:34:35.34536|2017-10-11 02:34:35.34536
NCT01674751|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2014-02-21|||June 2012||2012-06-01|August 2012|2012-08-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||What to Eat for Lunch? A Pilot Study to Improve Healthier Eating at Work|What to Eat for Lunch? A Pilot Study to Improve Healthier Eating at Work|Completed||N/A|31|Actual|Albert Einstein Healthcare Network||2|||f||||f||||||||||2017-10-11 02:34:35.723124|2017-10-11 02:34:35.723124
NCT01674738|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2013-10-10||||||October 2013|2013-10-01||||||||Interventional|SELECT-A||TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV|TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV|Withdrawn||Phase 2|0|Actual|Aktion Bronchialkarzinom e.V.||2||Decision of the Sponsor, as the funding of the study was no longer guaranteed.|f||||t||||||||||2017-10-11 02:34:35.830129|2017-10-11 02:34:35.830129
NCT01674725|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2015-10-13|2014-12-23||August 2012||2012-08-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|January 2014|Actual|2014-01-01||Interventional|PEARL-II|All participants who received at least 1 dose of study drug.|A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C|A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin in Treatment-Experienced Subjects With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection (PEARL-II)|Completed||Phase 3|187|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 02:34:35.988245|2017-10-11 02:34:35.988245
NCT01674712|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-11-24|2014-10-27||June 2012||2012-06-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Full analysis subject sample|A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease|A 12-week, Double-blind, Randomized Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate / Simvastatin 145/20mg and Fenofibrate / Simvastatin 145/40mg Tablets vs. Matching Monotherapies in Dyslipidemic Subjects at High Risk of Cardiovascular Disease.|Completed||Phase 3|575|Actual|Abbott||5|||f||||||||||||||2017-10-11 02:34:36.629279|2017-10-11 02:34:36.629279
NCT01674699|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2012-08-28|||August 2012||2012-08-01|August 2012|2012-08-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Observational|||Berlin Heart EXCOR Pediatric Post Approval Study|Berlin Heart EXCOR Pediatric Post Approval Study|Unknown status|Enrolling by invitation|N/A|49|Anticipated|Berlin Heart, Inc|||1||f||||f||||||||||2017-10-11 02:34:38.228387|2017-10-11 02:34:38.228387
NCT01674686|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2014-10-19|||August 2012||2012-08-01|October 2014|2014-10-01|February 2016|Anticipated|2016-02-01|August 2015|Anticipated|2015-08-01||Interventional|||The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm|A Prospective, Single-center, Randomized Study to Evaluate the Effect of Sarpogrelate, a Selective Serotonin Receptor Antagonist, and High Dose Statin on the Reduction of Coronary Spasm in the Patients With Variant Angina|Unknown status|Recruiting|Phase 4|200|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:34:38.372413|2017-10-11 02:34:38.372413
NCT01674673|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2013-12-26|||February 2012||2012-02-01|August 2012|2012-08-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|||A Long-term Observational Study on the Efficacy of SSRIs or Combined Treatment(SSRIs+ CBT) in Panic Disorder Patients|A Long-term Observational Study on the Efficacy of SSRIs Pharmacotherapy or Combined Treatment(SSRIs Pharmacotherapy + CBT) in Panic Disorder Patients|Unknown status|Recruiting|N/A|110|Anticipated|Samsung Medical Center|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 02:34:38.52606|2017-10-11 02:34:38.52606
NCT01674660|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-29|||September 2012||2012-09-01|August 2012|2012-08-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Observational|||Factors Associated With Interdialytic Blood Pressure Variability in Maintenance Hemodialysis Patients|Factors Associated With Interdialytic Blood Pressure Variability in Maintenance Hemodialysis Patients|Unknown status|Not yet recruiting|N/A|100|Anticipated|Beijing Chao Yang Hospital|||3||f||||||||||Samples With DNA|"     whole blood, serum, white cells, urine.   "|||2017-10-11 02:34:38.618829|2017-10-11 02:34:38.618829
NCT01674647|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2015-04-10|2015-01-08||October 2012||2012-10-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|X-VERT||Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion|A Prospective, Randomized, Open-label, Parallel-group, Active-controlled, Multicenter Study Exploring the Efficacy and Safety of Once-daily Oral Rivaroxaban (BAY59-7939) Compared With That of Dose-adjusted Oral Vitamin K Antagonists (VKA) for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion|Completed||Phase 3|1504|Actual|Bayer||2|||f||||t||||||||||2017-10-11 02:34:38.767084|2017-10-11 02:34:38.767084
NCT01674634|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2017-09-07|2015-02-04||September 2012||2012-09-01|September 2017|2017-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures|A Phase 3b Open-label, Historically-controlled Study to Assess the Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures With Palpable Cords|Completed||Phase 3|715|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:34:40.120543|2017-10-11 02:34:40.120543
NCT01674621|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-10-25|2016-10-25||August 2012||2012-08-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 (Abaloparatide) Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal (Abaloparatide Transdermal)) in Healthy Postmenopausal Women With Osteoporosis|Completed||Phase 2|250|Actual|Radius Health, Inc.||5|||f||||f||||||||||2017-10-11 02:34:40.826764|2017-10-11 02:34:40.826764
NCT01674595|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-27|2013-04-29|||September 2012||2012-09-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy|An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy|Completed||Phase 2/Phase 3|93|Actual|ALK-Abelló A/S||1|||f||||f||||||||||2017-10-11 02:34:41.754414|2017-10-11 02:34:41.754414
NCT01674582|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-09-13|||October 2012||2012-10-01|September 2016|2016-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters|Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters.|Recruiting||N/A|150|Anticipated|Lund University Hospital||1|||f||||f||||||||||2017-10-11 02:34:41.852388|2017-10-11 02:34:41.852388
NCT01674569|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-03-08|||October 2012||2012-10-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pilot Study of X-82 in Patients With Wet AMD|A Phase 1 Open-label, Dose Escalation Clinical Trial to Evaluate the Safety and Preliminary Biologic Activity/Efficacy of the VEGFR/PDGFR Inhibitor X-82 Administered Per Os in Subjects With Neovascular Age-related Macular Degeneration (AMD)|Completed||Phase 1/Phase 2|35|Actual|Tyrogenex||1|||f||||f||||||||No||2017-10-11 02:34:41.956669|2017-10-11 02:34:41.956669
NCT01674556|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-09-23|||February 2012||2012-02-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer|Treatment of Pancreatic Adenocarcinoma by Combining Contrast Agent and Gemitabine Under Sonification|Completed||Phase 1|25|Actual|Haukeland University Hospital||1|||f||||f||||||||||2017-10-11 02:34:42.070727|2017-10-11 02:34:42.070727
NCT01674543|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2014-08-11|||February 2010||2010-02-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|December 2010|Actual|2010-12-01||Interventional|||Clinical Symptoms of Schizophrenia and Physical Exercise|Schizophrenia and Physical Exercise: Effect of 20 Weeks of Training in Symptoms and Concentration in Serum IGF-1 and BDNF|Completed||N/A|47|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-10-11 02:34:42.166345|2017-10-11 02:34:42.166345
NCT01674530|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-04-02|||October 2012||2012-10-01|August 2012|2012-08-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation|A,Randomized , Double-blind,Double -Dummy Placebo-controlled,Parallel -Group, Multicenter Study to Evaluate the Clinical Equivalence of Lubiprostone 24 mcg Capsules ( Dr. Reddy's Laboratories Ltd.) With AMITIZA® (Lubiprostone ) 24 mcg Capsules ( Sucampo Pharmaceuticals, Inc. ) in the Treatment of Chronic Idiopathic Constipation|Completed||Phase 3|909|Actual|Dr. Reddy's Laboratories Limited||3|||f||||f||||||||||2017-10-11 02:34:42.296898|2017-10-11 02:34:42.296898
NCT01674517|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-24|||February 2010||2010-02-01|August 2012|2012-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fed Conditions.|Completed||Phase 1|35|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:34:42.633675|2017-10-11 02:34:42.633675
NCT01674504|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-24|||January 2010||2010-01-01|August 2012|2012-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fasting Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fasting Conditions.|Completed||Phase 1|63|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:34:42.715351|2017-10-11 02:34:42.715351
NCT01674491|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-27|||July 2011||2011-07-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|||Effects of Black Soy Peptide Supplementation on Blood Pressure|Effects of Black Soy Peptide Supplementation on Blood Pressure and Oxidative Stress:A Randomized Controlled Trial|Completed||Phase 3|100|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 02:34:42.810472|2017-10-11 02:34:42.810472
NCT01674478|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2017-03-17|||October 2012|Actual|2012-10-01|March 2017|2017-03-01|March 17, 2015|Actual|2015-03-17|March 17, 2015|Actual|2015-03-17||Interventional|EMLFO-2||Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies|Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies|Completed||N/A|18|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 02:34:42.908737|2017-10-11 02:34:42.908737
NCT01674465|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-10-17|||November 2012||2012-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Nox2||Role of Nox2 in CNI-induced Renal Fibrosis|The Role of Nox2 in CNI-Induced Renal Fibrosis|Recruiting||Early Phase 1|20|Anticipated|University of Wisconsin, Madison|||1||f||||t||||||||||2017-10-11 02:34:43.005134|2017-10-11 02:34:43.005134
NCT01674452|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-24|||January 2010||2010-01-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|February 2011|Actual|2011-02-01||Interventional|||Home-based Exercises for Patients With Stroke|Home-based Exercises for Patients With Stroke|Completed||N/A|90|Actual|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-11 02:34:43.100476|2017-10-11 02:34:43.100476
NCT01674439|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-08-27|||January 2010||2010-01-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells|Randomized Controlled Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells for Facial Soft Tissue Augmentation in Patients With Craniofacial Microsomia.|Completed||Phase 2|29|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:34:43.173468|2017-10-11 02:34:43.173468
NCT01674426|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-06-28|||November 1997||1997-11-01|June 2017|2017-06-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Pathogenesis of Functional Hypothalamic Amenorrhea|Pathogenesis of Functional Hypothalamic Amenorrhea|Completed||N/A|17|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 02:34:43.248224|2017-10-11 02:34:43.248224
NCT01674413|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-05-23|||October 2013||2013-10-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CADHUM||Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)|Calprotectin-Directed Humira® Maintenance Therapy, a Double-blind, Double-dummy, Randomized Controlled Trial in Crohn's Disease|Withdrawn||Phase 3|0|Actual|University of Michigan||3||Unable to recruit; all patients interested simply wanted to stop medication|f||||f||||||||No|no data collected|2017-10-11 02:34:43.342176|2017-10-11 02:34:43.342176
NCT01674400|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2013-07-31|||September 2011||2011-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:34:43.45799|2017-10-11 02:34:43.45799
NCT01674387|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-05-04|||August 2012||2012-08-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional|||Clinical Study on Electroacupuncture Therapy for Chronic Neck Pain|Lu's Acupuncture Protocol for Chronic Neck Pain|Completed||Phase 3|60|Actual|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 02:34:43.507538|2017-10-11 02:34:43.507538
NCT01674374|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-05-14|||May 2013||2013-05-01|May 2013|2013-05-01||||July 2015|Anticipated|2015-07-01||Interventional|||Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy|A Phase 2 Placebo Controlled Randomized Study of the Effect of SAMITAL on Severity and Duration of Mucositis Induced by Chemoradiation for Head and Neck Cancer (HNC)|Withdrawn||Phase 2|0|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-11 02:34:43.606086|2017-10-11 02:34:43.606086
NCT01674361|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-07-31||2013-09-10|December 31, 2012|Actual|2012-12-31|July 2017|2017-07-01|April 30, 2015|Actual|2015-04-30|April 30, 2015|Actual|2015-04-30||Interventional|||A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)|A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo−Controlled Study to Evaluate Efficacy and Safety of RO4917838 in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive Compulsive Disorder|Completed||Phase 2|99|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 02:34:43.724978|2017-10-11 02:34:43.724978
NCT01674348|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-08-02|||April 2011||2011-04-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes|A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Two-staged, Fixed Design Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Overweight/Obese Patients of Type 2 Diabetes Mellitus Inadequately Controlled on Metformin, Sulphonylurea, or Both.|Terminated||Phase 2|48|Actual|Piramal Enterprises Limited||2||"Due to non-recruitment, the study is being halted. There are no major safety or tolerability   concerns in the study conducted so far."|f||||t||||||||||2017-10-11 02:34:44.014563|2017-10-11 02:34:44.014563
NCT01674335|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-08-31|||September 2012||2012-09-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effectiveness of Operant Learning Versus Energy Conservation Activity Pacing Treatments in Fibromyalgia|Operant Learning Versus Energy Conservation Activity Pacing Interventions in a Sample of Fibromyalgia Patients: A Randomized Controlled Trial|Completed||N/A|69|Actual|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-11 02:34:44.106747|2017-10-11 02:34:44.106747
NCT01674322|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-11-04|||August 2012||2012-08-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study to Determine the Absorption, Metabolism, and Routes of Excretion of (14C) Radiolabeled Ibrutinib in Healthy Male Participants|An Open-Label Phase 1 Study to Determine the Pharmacokinetics, Metabolism, and Routes of Excretion of (14C) Radiolabeled PCI-32765 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 02:34:44.250152|2017-10-11 02:34:44.250152
NCT01674309|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-08-02|||April 2012||2012-04-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|January 2016|Actual|2016-01-01||Interventional|||First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis|Phase II: First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis|Active, not recruiting||Phase 2|65|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||t||||||||||2017-10-11 02:34:44.363536|2017-10-11 02:34:44.363536
NCT01674296|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-09-22|||June 2012|Actual|2012-06-01|September 2017|2017-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|LENAS||Seasonal Patterns of Stress, Diet and Physical Activity - Life in All Seasons (LENAS)|Seasonality of Stress, Diet, and Physical Activity in Mid-Life Women|Completed||N/A|52|Actual|USDA Grand Forks Human Nutrition Research Center|||2||f||||t||||||Samples With DNA|"     Serum, Plasma, Buffy Coat, Urine, Saliva   "|||2017-10-11 02:34:44.541429|2017-10-11 02:34:44.541429
NCT01674283|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-07-24|||October 2013||2013-10-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization|Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization|Withdrawn||Phase 4|0|Actual|OVO R & D||2||Uterine contractility not possible to visualize with our ultrasound machines|f||||f||||||||||2017-10-11 02:34:44.642951|2017-10-11 02:34:44.642951
NCT01674270|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-12-21|||August 2012||2012-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Interventional|||Degarelix Neo-Adjuvant Radical Prostatectomy Trial|Phase II Randomized Open Label Study of Neo-Adjuvant Degarelix vs. LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy|Completed||Phase 2|35|Actual|University Health Network, Toronto||3|||f||||t||||||||||2017-10-11 02:34:44.718084|2017-10-11 02:34:44.718084
NCT01674257|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2013-03-05|||January 2013||2013-01-01|March 2013|2013-03-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Observational|MICA||Metabolic Imaging in Carotid Atherosclerosis|An Investigation of the Role of 18F-Sodium Fluoride and 18F-Flurodeoxyglucose PET CT and USPIO Enhanced MRI in Imaging Carotid Artery Inflammation and Mineralization.|Unknown status|Recruiting|N/A|60|Anticipated|University of Edinburgh|||1||f||||f||||||Samples With DNA|"     Blood and excised carotid atheroma   "|||2017-10-11 02:34:44.811742|2017-10-11 02:34:44.811742
NCT01674244|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2015-04-14|||March 2013||2013-03-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Integrative Exercise for Post-Deployment Stress|Integrative Exercise for Post-Deployment Stress|Unknown status|Active, not recruiting|N/A|40|Anticipated|Northern California Institute of Research and Education||2|||f||||t||||||||||2017-10-11 02:34:44.934971|2017-10-11 02:34:44.934971
NCT01674231|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-05-25|||August 2012||2012-08-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||The Effects Grapes on Health Indices|Pilot Study: The Effects of Whole Grapes on Markers of Health|Completed||N/A|20|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 02:34:45.014738|2017-10-11 02:34:45.014738
NCT01674036|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2014-03-17|||August 2012||2012-08-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men|A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Single Oral Doses of Genz-682452 With a Pilot Investigation of Food Effect in Healthy Adult Male Subjects.|Completed||Phase 1|63|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:34:56.800796|2017-10-11 02:34:56.800796
NCT01674218|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2014-11-13|||September 2012||2012-09-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers|Phase I, Double-Blind, Randomized, Single-Center, Five-Period Crossover Study to Assess the Effects of Single Oral Doses of 400 mg and 1000 mg of PA-824 and 400 mg of PA-824 Plus 400 mg of Moxifloxacin on QTc Interval Compared to Placebo, Using AVELOX™ (Moxifloxacin) as a Positive Control, in Healthy Male and Female Volunteers Aged 18 to 45 Years|Completed||Phase 1|74|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||||||||||||||||2017-10-11 02:34:45.125358|2017-10-11 02:34:45.125358
NCT01674205|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-12-14|||September 2012||2012-09-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines|Exploratory Evaluation of Host Biomarkers That Predict the Vaccine Virus Replication and Immunogenicity of Seasonal and Pandemic Formulations of Live Attenuated Influenza A Virus Vaccines Based on the A/Ann Arbor/6/60 ca Master Donor Virus (MDV)|Completed||Phase 1|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||f||||||||||2017-10-11 02:34:45.234962|2017-10-11 02:34:45.234962
NCT01674192|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-08-27|||July 1997||1997-07-01|June 2012|2012-06-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Prucalopride Subjects With Renal Impairment|Single Dose Pharmacokinetic Trial of Oral Prucalopride (R093877) in Subjects With Mild, Moderate and Severe Renal Impairment|Completed||Phase 1|34|Actual|Movetis||1|||||||||||||||||2017-10-11 02:34:45.33201|2017-10-11 02:34:45.33201
NCT01674179|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-10|2016-10-12|||July 2010||2010-07-01|October 2016|2016-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|FMQEEG-10-26||Quantitative EEG During PSG in Patients With and Without Fibromyalgia|Quantitative EEG During PSG in Patients With and Without Fibromyalgia|Completed||N/A|560|Actual|SouthCoast Medical Group|||2||f||||f||||||||||2017-10-11 02:34:45.402055|2017-10-11 02:34:45.402055
NCT01674166|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-08-27|||November 1998||1998-11-01|June 2012|2012-06-01|May 1999|Actual|1999-05-01|May 1999|Actual|1999-05-01||Interventional|||Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal Retention|A Single-dose Pharmacokinetic Trial of 0.03 mg/kg R108512 Solution in Paediatric Subjects, Aged >= 4 to <= 12 Years With Functional Faecal Retention (FFR).|Completed||Phase 1|38|Actual|Movetis||1|||||||||||||||||2017-10-11 02:34:45.477353|2017-10-11 02:34:45.477353
NCT01674153|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2014-04-01|||August 2012||2012-08-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|April 2014|Anticipated|2014-04-01||Interventional|||Investigating the Effects of Exercise on Physiological Changes and Toxin Removal in Hemodialysis Patients|A Multi Protocol Investigation to Compare the Effects of Intra-dialytic Exercise on Physiological Changes and Toxin Removal in Maintenance Hemodialysis Patients|Unknown status|Recruiting|N/A|15|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-11 02:34:45.555121|2017-10-11 02:34:45.555121
NCT01674140|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-07-12|||April 2013||2013-04-01|July 2017|2017-07-01|January 2030|Anticipated|2030-01-01|December 2022|Anticipated|2022-12-01||Interventional|e3||S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer|Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer|Recruiting||Phase 3|1900|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 02:34:48.605703|2017-10-11 02:34:48.605703
NCT01674127|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-08-27|||August 2011||2011-08-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild Preeclampsia||Completed||Phase 2|50|Actual|Isfahan University of Medical Sciences||2|||f||||||||||||||2017-10-11 02:34:55.533569|2017-10-11 02:34:55.533569
NCT01674114|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-01-13|||September 2012||2012-09-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Postoperative Morphine Consumption After Caesarean Section- TAP Block vs Intracutaneous Infiltration|Postoperative Morphine Consumption After Caesarean Section- TAP Block vs Intracutaneous Infiltration|Completed||N/A|57|Actual|St. Olavs Hospital||2|||f||||f||||||||||2017-10-11 02:34:55.612596|2017-10-11 02:34:55.612596
NCT01674101|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-12-03|||September 2012||2012-09-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy|A Pilot Study on the Effects of Preoperative Physical Therapy in Adolescents and Young Adults Diagnosed With a Lower Extremity Malignancy|Completed||N/A|20|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 02:34:55.718999|2017-10-11 02:34:55.718999
NCT01674088|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2014-02-06|||October 2012||2012-10-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|||Sucrose Breath Test to Determine Intestinal Permeability in IBS|The Use of a Novel 13C Sucrose Breath Test (13C SBT) to Determine Intestinal Permeability in Irritable Bowel Syndrome (IBS) Patients|Completed||N/A|40|Anticipated|Metabolic Solutions Inc.|||2||f||||t||||||||||2017-10-11 02:34:55.810938|2017-10-11 02:34:55.810938
NCT01674075|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2013-07-10|||September 2012||2012-09-01|July 2013|2013-07-01||||February 2013|Actual|2013-02-01||Observational|||Lidocaine Serum Levels in Healthy Adult Volunteers: a Pilot Evaluation of the J-Tip Delivery System||Completed||N/A|10|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:34:55.885219|2017-10-11 02:34:55.885219
NCT01674062|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-07-20|2015-08-11||May 2006||2006-05-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|February 2008|Actual|2008-02-01||Interventional||All Treated Population: All randomized participants who received any amount of study medication.|A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer|An Exploratory Phase II, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Pertuzumab and Herceptin (Trastuzumab) in Patients With HER2-Positive Metastatic Breast Cancer|Completed||Phase 2|95|Actual|Hoffmann-La Roche|Although the study was designed as single-arm study, as reflected in the study title, an additional cohort was opened to evaluate the efficacy and safety of single-agent pertuzumab.|2|||f||||||||||||||2017-10-11 02:34:55.96276|2017-10-11 02:34:55.96276
NCT01674049|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-08-28|||October 2010||2010-10-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Nutrient Timing Following Resistance Exercise|Nutrient Timing Following Resistance Exercise in Young Overweight and Obese Young Men With a Family History of Diabetes|Completed||N/A|11|Actual|George Washington University||2|||f||||t||||||||||2017-10-11 02:34:56.693257|2017-10-11 02:34:56.693257
NCT01674023|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-03-31|||August 2012||2012-08-01|March 2015|2015-03-01||||December 2014|Actual|2014-12-01||Observational|||MicroRNA Expression Profile in Human Vitreous of Patients With Various Vitreoretinal Diseases Requiring Vitrectomy||Completed||N/A|8|Actual|Kyorin University|||1||f||||f||||||Samples Without DNA|"     3ml of blood serum and 1ml of vitreous   "|||2017-10-11 02:34:56.890144|2017-10-11 02:34:56.890144
NCT01674010|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-05-17|2015-09-14||August 2012||2012-08-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Safety and Efficacy Study of Oral ELND005 as an Adjunctive Maintenance Treatment in Patients With Bipolar I Disorder|Terminated||Phase 2|309|Actual|Transition Therapeutics Ireland Limited||2||Business Decision|f||||t||||||||||2017-10-11 02:34:56.994212|2017-10-11 02:34:56.994212
NCT01673997|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2012-09-24|||December 2010||2010-12-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Oral Bioequivalence Study of Metoprolol Succinate Extended-Release Tablets 200mg of Dr. Reddy's Laboratories Limited, India Comparing With That of TOPROL-XL® (Containing Metoprolol Succinate) Extended-Release Tablets 200mg of AstraZeneca LP Wilmington, DE in Healthy, Adult, Human Subjects Under Fasting Conditions|Completed||Phase 1|48|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 02:34:57.963668|2017-10-11 02:34:57.963668
NCT01673984|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-08-28|2015-07-10||August 2012||2012-08-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|GREAT||GP Extended Action Triptorelin|A Phase IV, Randomised, Open-label, Multi-centre Study to Assess the Impact on Disease Control, Safety, Patient and Clinician Experience of Changing Patients With Advanced Prostate Cancer From a 3-monthly LHRH Agonist to 6-monthly Injections of Decapeptyl® SR 22.5 MG|Terminated||Phase 4|27|Actual|Ipsen||2||The study was discontinued prematurely by the sponsor due to non-medical reasons|f||||f||||||||||2017-10-11 02:34:58.088097|2017-10-11 02:34:58.088097
NCT01673971|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-07-31|||May 2012||2012-05-01|July 2017|2017-07-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Observational|||Optical Tomographic Imaging of Infantile Hemangiomas|Optical Tomographic Imaging of Infantile Hemangiomas|Active, not recruiting||N/A|15|Actual|Columbia University|||2||f||||t||||||||||2017-10-11 02:34:59.072569|2017-10-11 02:34:59.072569
NCT01673958|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-08-24|||February 2012||2012-02-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Stair Descending vs. Stair Ascending Exercise|The Effect of Stair Descending and Stair Ascending Exercise on Muscle Strength and Performance: the SmartEscalator Device|Completed||N/A|12|Actual|European University Cyprus||2|||f||||f||||||||||2017-10-11 02:34:59.169207|2017-10-11 02:34:59.169207
NCT01673945|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-08-24|||June 2012||2012-06-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|January 2013|Anticipated|2013-01-01||Interventional|||FV-EUS Endoscope Versus CLA-EUS for EUS-FNA of Solid Lesions|Forward Viewing US Endoscope Versus Standard Viewing US Endoscope in the Performance of EUS-guided Fine Needle Aspiration of Solid Lesions of the Gastrointestinal Tract and of Adjacent Organs: A Prospective Randomized Controlled Study|Unknown status|Recruiting|N/A|124|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 02:34:59.282323|2017-10-11 02:34:59.282323
NCT01673932|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-07-25|||October 2012||2012-10-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke|Phase 1 Clinical Trial to Establish the Safety and Feasibility of Transplants of Umbilical Cord Blood Mononuclear Cells in Chronic Ischemic Stroke|Recruiting||Phase 1|12|Anticipated|China Spinal Cord Injury Network||2|||f||||t||||||||||2017-10-11 02:34:59.404569|2017-10-11 02:34:59.404569
NCT01673919|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-09-14|2016-09-14||February 2012||2012-02-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||The intent-to-treat (ITT) population included all the participants who had at least one efficacy assessment.|A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study|Long-term, Interventional, Open Label Extension Study Evaluating the Safety of Tocilizumab Treatment in Patients With Polyarticular-course Juvenile Idiopathic Arthritis From France Who Completed the Global, Multinational Trial (WA19977)|Completed||Phase 3|7|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:34:59.580125|2017-10-11 02:34:59.580125
NCT01673906|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-07-01|||August 2012||2012-08-01|July 2014|2014-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours|Accuracy and Clinical Impact of 68-Ga-labeled Octreotide Analogues PET in Diagnosis and Staging of Duodenal-pancreatic Neuroendocrine Tumours; Proposal of a Multicenter, Prospective Clinical Trial|Unknown status|Recruiting|Phase 2|142|Anticipated|Arcispedale Santa Maria Nuova-IRCCS||1|||f||||t||||||||||2017-10-11 02:35:00.381168|2017-10-11 02:35:00.381168
NCT01673880|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2013-05-20|||August 2012||2012-08-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations|A Single-center, Open-label, Randomized, Multi-cohort, Crossover Study of Relative Bioavailability of Tablet Versus Capsule Formulation of E2006 in Healthy Adult Subjects|Completed||Phase 1|40|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-11 02:35:00.839262|2017-10-11 02:35:00.839262
NCT01673867|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2017-06-12|2016-01-29||November 2, 2012|Actual|2012-11-02|June 2017|2017-06-01|November 2, 2018|Anticipated|2018-11-02|February 5, 2015|Actual|2015-02-05||Interventional|CheckMate057|All randomized participants|Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC|An Open-Label Randomized Phase III Trial of BMS-936558 (Nivolumab) Versus Docetaxel in Previously Treated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 3|792|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 02:35:00.960282|2017-10-11 02:35:00.960282
NCT00004345|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|July 2002|2002-07-01||||||||Observational|||Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome||Terminated||N/A|100||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.898041|2017-10-11 04:25:04.898041
NCT01673854|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-24|2016-06-20|2015-07-03||September 2012||2012-09-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|July 2014|Actual|2014-07-01||Interventional|||Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma|A Single Arm Open-Label Phase II Study of Vemurafenib Followed by Ipilimumab in Subjects With Previously Untreated V600 BRAF Mutated Advanced Melanoma|Completed||Phase 2|70|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 02:35:03.230646|2017-10-11 02:35:03.230646
NCT01673841|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2012-08-28|||October 2009||2009-10-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Relation Between Mixed Venous Oxygen Saturation and Cerebral Oxygen Saturation Measured by Absolute and Relative Near-infrared Spectroscopy During Off-pump Coronary Artery Bypass Grafting.|Relation Between Mixed Venous Oxygen Saturation and Cerebral Oxygen Saturation Measured by Absolute and Relative Near-infrared Spectroscopy During Off-pump Coronary Artery Bypass Grafting.|Completed||N/A|42|Actual|University Hospital, Ghent|||1||f||||f||||||||||2017-10-11 02:35:03.990656|2017-10-11 02:35:03.990656
NCT01673828|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-05-25|2017-03-20||April 2013||2013-04-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|May 2015|Actual|2015-05-01||Interventional|||Allopregnanolone for the Treatment of Traumatic Brain Injury|A Double-blind, Placebo-controlled, Randomized Clinical Trial of Allopregnanolone for the Treatment of Traumatic Brain Injury|Completed||Phase 2|13|Actual|University of California, Davis|One subject receiving active treatment died during initial hospitalization; the death was not considered related to the study treatment. Early termination leading to small numbers of subjects analyzed.|2|||f||||t||||||||||2017-10-11 02:35:04.065552|2017-10-11 02:35:04.065552
NCT01673815|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2012-08-23|||August 2011||2011-08-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|CAFE||Video Diversion During Fundoscopic Exam in Children|Video Diversion During Fundoscopic Exam in Children: A Randomized Controlled Trial|Completed||N/A|60|Actual|University of British Columbia||4|||f||||t||||||||||2017-10-11 02:35:04.735204|2017-10-11 02:35:04.735204
NCT01673802|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-04-12|2014-05-20||August 2012||2012-08-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma|The Role of Gadoxetate Enhanced Spectral Dual-Energy CT in Evaluating Hilar Cholangiocarcinoma|Completed||Early Phase 1|18|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-11 02:35:04.838074|2017-10-11 02:35:04.838074
NCT01673789|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-23|||August 2012||2012-08-01|August 2012|2012-08-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Stem Cell Educator Therapy in Alopecia Areata|Phase 1/Phase 2 Study of Stem Cell Educator Therapy in Alopecia Areata|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Tianhe Stem Cell Biotechnologies Inc.||1|||f||||t||||||||||2017-10-11 02:35:04.995859|2017-10-11 02:35:04.995859
NCT01673776|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-01-18|||March 2012||2012-03-01|January 2017|2017-01-01|October 15, 2016|Actual|2016-10-15|October 2016|Actual|2016-10-01||Observational|FEMO||Multimodal Approach to Improve the Outcome of Patients With a Proximal Femoral Fracture|Can a Multimodal Approach Improve the Outcome of Patients With a Proximal Femoral Fracture?|Completed||N/A|132|Actual|Technische Universität München|||2||f||||t||||||||||2017-10-11 02:35:05.148052|2017-10-11 02:35:05.148052
NCT01673750|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-04-11|||October 2012||2012-10-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Body Image in Youth With HIV|Body Image in Youth With HIV|Completed||N/A|146|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 02:35:05.338394|2017-10-11 02:35:05.338394
NCT01673737|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-04-09|||August 2012||2012-08-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer|A Phase I/Ib Study for the Evaluation of SAR260301, Administered Orally in Monotherapy in Patients With Advanced Solid Tumors or Lymphomas, and in Combination With Vemurafenib in Patients With Unresectable / Metastatic BRAF-mutated Melanoma|Completed||Phase 1|75|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:35:05.426886|2017-10-11 02:35:05.426886
NCT01673724|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-09-14|||February 2012||2012-02-01|September 2017|2017-09-01|May 23, 2016|Actual|2016-05-23|May 23, 2016|Actual|2016-05-23||Interventional|||Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease|Effect of Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease: Multicenter, Open-label, Parallel, Randomized Study|Completed||Phase 4|121|Actual|Sandoz||2|||f||||f||||||||||2017-10-11 02:35:05.509774|2017-10-11 02:35:05.509774
NCT01673711|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-05-13|||July 2012||2012-07-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer|Correlation of [D10] Phenanthrene Metabolism With Bronchoepithelial Dysplasia and Metaplasia in Smokers at High Risk for Lung Cancer|Recruiting||N/A|350|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-11 02:35:05.696858|2017-10-11 02:35:05.696858
NCT01673698|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-11-02|2015-08-25|2014-10-02|August 2012||2012-08-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|||A Prospective, Randomized Multicenter Study to Evaluate the Safety and Efficacy of the ReShape Duo™ Intragastric Balloon System in Obese Subjects|A Prospective, Randomized Multicenter Study to Evaluate the Safety and Efficacy of the ReShape Duo™ Intragastric Balloon System in Obese Subjects|Completed||N/A|326|Actual|ReShape Medical, Inc.|There are no overall limitations and caveats.|2|||f||||t||||||||||2017-10-11 02:35:05.811375|2017-10-11 02:35:05.811375
NCT01673685|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-04-06|||October 2010||2010-10-01|April 2017|2017-04-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Trial of Portable Oxygen Cylinders Versus Battery Powered Portable Oxygen Concentrators|Randomised Crossover Trial of Portable Oxygen Cylinders Versus Battery Powered Portable Oxygen Concentrators|Completed||N/A|32|Actual|The Queen Elizabeth Hospital||2|||f||||t||||||||Yes|IPD will be available upon request.|2017-10-11 02:35:06.422714|2017-10-11 02:35:06.422714
NCT01670058|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-09-18|||January 31, 2012|Actual|2012-01-31|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Pattern Of Use Of Belatacept In US Transplant Recipients|Pattern Of Use Of Belatacept In US Transplant Recipients|Active, not recruiting||N/A|5000|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 02:36:04.949167|2017-10-11 02:36:04.949167
NCT01673672|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2014-05-13|||November 2012||2012-11-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma|A Randomized, Placebo-Controlled, Phase IIb Dose-Finding Study of CYT003-QbG10, a TLR9-Agonist, in Patients With Moderate to Severe Allergic Asthma Not Sufficiently Controlled on Current Standard Therapy (GINA Steps 3+4)|Terminated||Phase 2|365|Actual|Cytos Biotechnology AG||4||primary endpoint missed|f||||t||||||||||2017-10-11 02:35:06.506088|2017-10-11 02:35:06.506088
NCT01673659|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2013-09-23||2013-09-23|August 2012||2012-08-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 Mcg/Actuation Compared With Nasonex® Nasal Spray 50 Mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)||Completed||Phase 3|1220|Actual|Perrigo Company||3|||f||||f||||||||||2017-10-11 02:35:06.690794|2017-10-11 02:35:06.690794
NCT01673633|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2012-08-27|||January 2012||2012-01-01|August 2012|2012-08-01||||||||Observational|||Sacroiliitis in Systemic Sclerosis||Completed||N/A|175|Actual|Cukurova University|||3||f||||||||||||||2017-10-11 02:35:06.912828|2017-10-11 02:35:06.912828
NCT01673620|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-03-07|2014-11-06||July 2012||2012-07-01|March 2017|2017-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety of Combination Montelukast/Loratadine (MK-0476A) in Mexican Patients With Allergic Rhinitis|Completed||Phase 3|69|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:35:06.987437|2017-10-11 02:35:06.987437
NCT01673607|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-10-10||||||October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|METAHEP||Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal Cancer||Recruiting||Phase 2|||Poitiers University Hospital|||||f||||||||||||||2017-10-11 02:35:07.229692|2017-10-11 02:35:07.229692
NCT01673594|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-10-07|2016-06-28||September 2012||2012-09-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Baseline characteristics are reported for subjects who made it to week 3 of the trial and were included in analysis.|Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist|Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist|Completed||Phase 4|37|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:35:07.320065|2017-10-11 02:35:07.320065
NCT01673581|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-08-28|||August 2012||2012-08-01|August 2017|2017-08-01||||December 2015|Actual|2015-12-01||Observational|||Shared Decision Making in Low Risk Prostate Cancer|Shared Decision Making: A Study Assessing the Benefit of a Web Based Aid Presenting Treatment Options for Patients With Low Risk Prostate Cancer|Active, not recruiting||N/A|141|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:35:07.921276|2017-10-11 02:35:07.921276
NCT01673568|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2014-05-21|2014-02-18||October 2012||2012-10-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ABD- BINDER|patiens were median 51 years, gender M:F=22:6.|Abdominal Binder to Reduce Pain and Seroma Formation|Postoperative Abdominal Binder in Reducing Seroma Formation and Pain After Ventral (Umbi/Epi) Hernia Repair.|Completed||N/A|56|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 02:35:08.035342|2017-10-11 02:35:08.035342
NCT01673555|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-06-07|||May 15, 2012|Actual|2012-05-15|June 2017|2017-06-01|November 19, 2012|Actual|2012-11-19|November 19, 2012|Actual|2012-11-19||Interventional|||Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers|A Randomized, Placebo-controlled, Study to Evaluate the Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers|Completed||Phase 1|49|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:35:08.318304|2017-10-11 02:35:08.318304
NCT01673542|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-10-10|||August 2012||2012-08-01|October 2016|2016-10-01||||May 2013|Actual|2013-05-01||Interventional|||Evaluating the Effectiveness of Dermal Analgesia Provided by the Application of Lidocaine and Prilocaine Cream 5% on the Puncture Site of Axillary Blocks||Completed||Phase 2|32|Actual|Poitiers University Hospital||2|||f||||t||||||||||2017-10-11 02:35:08.43879|2017-10-11 02:35:08.43879
NCT01673529|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-06-07|||July 17, 2012|Actual|2012-07-17|June 2017|2017-06-01|October 4, 2012|Actual|2012-10-04|October 4, 2012|Actual|2012-10-04||Interventional|||Investigation of Topical SB705498 on Healthy Volunteers|A Two Part Randomized, Double-blind, Placebo Controlled Study to Investigate the Effects of Topical Doses of SB705498 Oncapsaicin, Histamine, and Cowhage Responses in Healthy Volunteers.|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:35:08.524558|2017-10-11 02:35:08.524558
NCT01673516|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-10-29|||August 2012||2012-08-01|October 2015|2015-10-01|August 2022|Anticipated|2022-08-01|December 2013|Actual|2013-12-01||Interventional|OsloRDN||Effect of Renal Sympathetic Denervation on Resistant Hypertension and Cardiovascular Hemodynamic in Comparison to Intensive Medical Therapy Utilizing Impedance Cardiography|Effect of Renal Sympathetic Denervation on Resistant Hypertension and Cardiovascular Hemodynamic in Comparison to Intensive Medical Therapy Utilizing Impedance Cardiography|Active, not recruiting||Phase 2|60|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 02:35:08.633178|2017-10-11 02:35:08.633178
NCT01673503|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2013-01-23|||May 2011||2011-05-01|January 2013|2013-01-01||||||||Interventional|||A Prospective Study of Femtosecond Laser Intracorneal Lensectomi|A Prospective Study of Femtosecond Laser Intracorneal Lensectomi in Treatment of Moderate to High Myopia|Completed||Phase 3|35||Odense University Hospital||2|||f||||t||||||||||2017-10-11 02:35:08.747146|2017-10-11 02:35:08.747146
NCT01673308|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-05-10|||August 2012||2012-08-01|May 2016|2016-05-01|November 2016|Anticipated|2016-11-01|November 2015|Actual|2015-11-01||Interventional|VIOLET||Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome|Salvage in Patients With Myelodysplastic Syndrome After Failure of Hypomethylating Agents: Lenalidomide as a Second-line Therapy|Active, not recruiting||Phase 2|35|Anticipated|Ulsan University Hospital||1|||f||||f||||||||||2017-10-11 02:35:11.491062|2017-10-11 02:35:11.491062
NCT01673490|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-11-16|2015-10-08||June 2012||2012-06-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|FDC114785||Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia|A Pivotal, Open-label Trial Assessing the Safety and Efficacy of the 0.5 mg Dutasteride and 0.4 mg Tamsulosin Combination Once Daily for Six Months in Patients With Benign Prostatic Hyperplasia|Terminated||Phase 4|59|Actual|GlaxoSmithKline||1||"The sole investigative site refused to accept the amended protocol and declined to continue the   study. There was no safety signal nor any other reason."|f||||f||||||||||2017-10-11 02:35:08.863121|2017-10-11 02:35:08.863121
NCT01673464|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-04-08|||August 2012||2012-08-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Observational|||A Prospective Study of Brain Network Activation (BNA) Changes in High School Athletes Following Concussion|A Prospective Study of Brain Network Activation (BNA) Changes in High School Athletes Following Concussion|Completed||N/A|126|Actual|ElMindA Ltd|||1||f||||f||||||||||2017-10-11 02:35:09.522777|2017-10-11 02:35:09.522777
NCT01673451|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-10-10|||August 2012||2012-08-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects|A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of E2006 in Healthy Adult and Elderly Subjects|Completed||Phase 1|24|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 02:35:09.583855|2017-10-11 02:35:09.583855
NCT01673438|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-04-18|||July 2012||2012-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors|An Open-Label Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL Administered as Infusions Every 3 Weeks in Subjects With Advanced Solid Tumors|Completed||Phase 1|15|Actual|CytRx||1|||f||||f||||||||||2017-10-11 02:35:09.663836|2017-10-11 02:35:09.663836
NCT01673425|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-09-02|2014-07-29||September 2012||2012-09-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluating Immune Response to Seasonal FluMist in Healthy Adults|Evaluating Immune Response to Seasonal FluMist in Healthy Adults|Terminated||N/A|5|Actual|National Center for Occupational Health and Infection Control||1||Low accrual(4 completed subjects over 2 months)& inconclusive nasal wash assays.|f||||f||||||||||2017-10-11 02:35:09.736098|2017-10-11 02:35:09.736098
NCT01673412|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-23|||January 2003||2003-01-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Research of Prognostic Factors Associated With Healing of Venous Leg Ulcers|Research of Prognostic Factors Associated With Healing of Venous Leg Ulcers|Completed||N/A|104|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 02:35:09.903573|2017-10-11 02:35:09.903573
NCT01673399|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-03-20|||February 2012||2012-02-01|March 2017|2017-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Oxytocin Antagonist in Patients With Repeated Failure of Implantation|Oxytocin Antagonist in Patients With Repeated Failure of Implantation. A Prospective Randomized Placebo-controlled Double-blind Study.|Recruiting||Phase 4|290|Anticipated|AZ Jan Palfijn Gent||2|||f||||t||||||||||2017-10-11 02:35:10.137688|2017-10-11 02:35:10.137688
NCT01673386|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2015-06-22|||July 2012||2012-07-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|TAURUS||A Subject Treatment Preference Study of Tivozanib Hydrochloride Versus Sunitinib in Subjects With Metastatic Renal Cell Carcinoma|A Phase 2 Randomized, Double-Blind, Crossover, Controlled, Multi-Center Subject Preference Study of Tivozanib Hydrochloride Versus Sunitinib in the Treatment of Subjects With Metastatic Renal Cell Carcinoma|Completed||Phase 2|58|Actual|AVEO Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:35:10.244898|2017-10-11 02:35:10.244898
NCT01673373|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-02-23|||October 2012|Actual|2012-10-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|ARTISAN||Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension|ARTISAN: iCAST™ RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients With Resistant Hypertension|Recruiting||N/A|138|Anticipated|Atrium Medical Corporation||1|||f||||t||||||||No||2017-10-11 02:35:10.452271|2017-10-11 02:35:10.452271
NCT01673360|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2016-06-16|||September 2012||2012-09-01|June 2016|2016-06-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|CAPTURE||Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices|Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices|Terminated||N/A|401|Actual|ASTORA Women's Health|||3|Sponsor is winding down business operations|f||||f||||||||No||2017-10-11 02:35:10.713132|2017-10-11 02:35:10.713132
NCT01673347|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-04-19|2017-04-19||September 2010|Actual|2010-09-01|April 2017|2017-04-01|March 10, 2017|Actual|2017-03-10|May 2014|Actual|2014-05-01||Interventional|MTP||Allograft Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe|Allograft Knee Meniscal Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe|Completed||Phase 3|24|Actual|William Beaumont Hospitals|Allograft failure (dissolution) and obliteration of the MTP joint space found in 29% of subjects within 2 years of follow-up; therefore study was discontinued. No data collected for later time points.|1|||f||||t|t|f||||||No||2017-10-11 02:35:10.901815|2017-10-11 02:35:10.901815
NCT01673334|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-08-24|||September 2011||2011-09-01|August 2012|2012-08-01||||July 2013|Anticipated|2013-07-01||Interventional|||Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms|Prospective Paired Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms|Unknown status|Active, not recruiting|Phase 4|40|Anticipated|University of Virginia||1|||f||||t||||||||||2017-10-11 02:35:11.237212|2017-10-11 02:35:11.237212
NCT01673321|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-08-24|||February 2012||2012-02-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Protein Concentrations in Yogurt and Satiety, Food Intake and Glycemia in Healthy Men|Effect of Varied Protein Concentrations in Greek Yogurt on Glycemic Response, Satiety and Next Meal Food Intake in Healthy Young Men|Completed||N/A|20|Actual|University of Toronto||5|||f||||f||||||||||2017-10-11 02:35:11.341914|2017-10-11 02:35:11.341914
NCT01671670|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-11-25|||September 2012||2012-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Acupuncture for Patients With Function Dyspepsia|Phase III Study of Acupuncture for Patients With Functional Dyspepsia|Completed||Phase 2/Phase 3|200|Actual|Chengdu University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 02:35:42.329001|2017-10-11 02:35:42.329001
NCT01673295|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2015-05-27|||November 2014||2014-11-01|May 2015|2015-05-01|November 2016|Anticipated|2016-11-01|November 2015|Anticipated|2015-11-01||Interventional|RING||RING - Rituximab for Lupus Nephritis With Remission as a Goal|RING - Rituximab for Lupus Nephritis With Remission as a Goal, an Investigator-initiated Randomized International Open Multicentric Study|Unknown status|Recruiting|Phase 3|194|Anticipated|Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 02:35:11.612317|2017-10-11 02:35:11.612317
NCT01673282|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-09-26|2016-06-29||July 2012||2012-07-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|VICTOS|The analysis group for Baseline Characteristics is the Safety Set (SS). The Safety Set consists of all patients who received at least 1 dose of Lacosamide.|Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy|A Non-interventional, Observational Study Evaluating Changes in Drug Load and Seizure Frequency Using Vimpat (Lacosamide) in Daily Clinical Practice in Combination Therapy With Sodium Channel Blocking Anti-epileptic Drugs (AEDs) or Non Sodium Channel Blocking AEDs|Completed||N/A|315|Actual|UCB Pharma|||2||f||||f||||||||||2017-10-11 02:35:11.75802|2017-10-11 02:35:11.75802
NCT01673269|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-05-15|||July 2012||2012-07-01|May 2017|2017-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD|Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD|Completed||N/A|60|Actual|Texas Tech University Health Sciences Center, El Paso||1|||f||||t||||||||No||2017-10-11 02:35:12.317574|2017-10-11 02:35:12.317574
NCT01673256|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2015-03-16|2015-01-05||September 2012||2012-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||DEtermining Accuracy and TrEnding CharacTerization of AF|DEtermining Accuracy and TrEnding CharacTerization of AF|Completed||N/A|90|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 02:35:12.425828|2017-10-11 02:35:12.425828
NCT01673243|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2015-03-04|||September 2012||2012-09-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting|Tobacco Trials at St. Jude: Parent Willingness to Participate Among Families of Children With Cancer, Sickle Cell Disease, or Survivors of Childhood Cancer|Completed||N/A|88|Actual|St. Jude Children's Research Hospital|||3||f||||f||||||||||2017-10-11 02:35:12.60909|2017-10-11 02:35:12.60909
NCT01673230|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2015-09-11|||September 2012||2012-09-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|ALTERVOL||Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%)|Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%): Sensibility and Specificity of Respiratory Variations of Pulse Pressure (∆PP), Photoplethysmography (∆POP), Perfusion Index (PVI), Before and After Fluid Expansion.|Unknown status|Recruiting|N/A|80|Anticipated|Rennes University Hospital||1|||f||||||||||||||2017-10-11 02:35:12.725405|2017-10-11 02:35:12.725405
NCT01673217|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2014-01-10|||April 2009||2009-04-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|October 2011|Actual|2011-10-01||Interventional|||Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer|A Phase I Clinical Trial of NY-ESO-1 Protein Immunization in Combination With 5-AZA-2'-Deoxycytidine (Decitabine) in Patients Receiving Liposomal Doxorubicin for Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 1|18|Actual|Roswell Park Cancer Institute||1|||f||||f||||||||||2017-10-11 02:35:12.866711|2017-10-11 02:35:12.866711
NCT01673204|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-02-12|||October 2012||2012-10-01|February 2014|2014-02-01||||April 2014|Anticipated|2014-04-01||Interventional|||Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy||Unknown status|Recruiting|Phase 4|276|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 02:35:13.001993|2017-10-11 02:35:13.001993
NCT01673191|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-02-20|2017-02-20||November 2012||2012-11-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus|A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus|Completed||Phase 2|40|Actual|Retinal Consultants of Arizona|Limitations of our study include a small sample size and short-term follow up. Additional studies are needed to determine whether combination therapy with other treatments would be beneficial to patients.|2|||f||||f||||||||No||2017-10-11 02:35:13.133153|2017-10-11 02:35:13.133153
NCT01673178|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2015-01-28|2015-01-06||October 2012||2012-10-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional||Analysis set included all participants who received at least 1 dose of study medication.|Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus|A Phase 1, Placebo-controlled, Randomized Trial To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Iv Doses Of Pf-05231023 In Obese Hyperlipidemic Adult Subjects With And Without Type 2 Diabetes Mellitus On A Background Of Atorvastatin|Completed||Phase 1|107|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 02:35:13.932035|2017-10-11 02:35:13.932035
NCT01673165|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2015-10-13|||June 2012||2012-06-01|October 2014|2014-10-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Fortified Skimmed Mother's Milk in the Management of Chylothorax|A Comparison of the Effectiveness of Fortified Skimmed Mother's Milk Versus Specialized Formula in the Management of Chylous Effusion in Infants Following Cardiothoracic Surgery|Completed||N/A|17|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 02:35:18.973356|2017-10-11 02:35:18.973356
NCT01673152|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-01-15|||February 2012||2012-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of the Oligofructose Supplementation on Body Weight in Overweight and Obese Children|The Effect of the Oligofructose Supplementation on Body Weight in Overweight and Obese Children: a Randomized, Double Blind, Placebo-controlled Trial|Completed||N/A|96|Anticipated|Medical University of Warsaw||2|||f||||t||||||||||2017-10-11 02:35:19.090664|2017-10-11 02:35:19.090664
NCT01671657|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-10-19|||January 2013||2013-01-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|US EPIC||US Eeva™ Pregnancy Investigational Clinical Study (US EPIC)|US Eeva™ Pregnancy Investigational Clinical Study (US EPIC)|Unknown status|Active, not recruiting|N/A|100|Anticipated|Progyny, Inc.|||2||f||||f||||||||||2017-10-11 02:35:42.41515|2017-10-11 02:35:42.41515
NCT01673139|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-09-17|||September 2012|Actual|2012-09-01|September 2017|2017-09-01|January 2028|Anticipated|2028-01-01|August 2018|Anticipated|2018-08-01||Interventional|||Effect of 3 Years of Exercise in Patients With Atrial Fibrillation|Effect of 3 Years of Exercise in Patients With Atrial Fibrillation - A Generation 100 Substudy|Active, not recruiting||N/A|150|Anticipated|Norwegian University of Science and Technology||3|||f||||f|f|f||||||||2017-10-11 02:35:19.191341|2017-10-11 02:35:19.191341
NCT01673126|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-05-12|2013-12-18||January 2010||2010-01-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|August 2010|Actual|2010-08-01||Interventional|tDCS in DOC|"36 patients received first the anodal stimulation and 26 received first the sham stimulation.
Each patient received both stimulation exept for 7 patients. They were excluded due to diagnosis change between the 2 stimulations."|Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness|Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness: a Sham-controlled Randomised Double Blind Study|Completed||Phase 2|55|Actual|University Hospital of Liege||2|||f||||f||||||||||2017-10-11 02:35:19.293602|2017-10-11 02:35:19.293602
NCT01673113|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-04-07|2014-11-05||December 2012||2012-12-01|April 2017|2017-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||BMI of <30 kg/m^2|Characterization of Transient Alterations of Cutaneous Sensory Nerve Function by Cryolipolysis|Characterization of Transient Alterations of Cutaneous Sensory Nerve Function by Cryolipolysis|Completed||N/A|11|Actual|Massachusetts General Hospital||2|||f||||f||||||||No||2017-10-11 02:35:20.805682|2017-10-11 02:35:20.805682
NCT01673100|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2014-12-01|||March 2011||2011-03-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Physical Activity Telehealth Intervention After Percutaneous Coronary Procedures|Physical Activity Telehealth Intervention After Percutaneous Coronary Procedures|Completed||N/A|50|Actual|University of Nebraska||2|||f||||t||||||||||2017-10-11 02:35:21.061559|2017-10-11 02:35:21.061559
NCT01673087|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-09-01|||October 2012||2012-10-01|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures|Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures|Recruiting||Phase 4|350|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-11 02:35:21.142184|2017-10-11 02:35:21.142184
NCT01673074|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-07-15|||November 2007||2007-11-01|July 2016|2016-07-01||||December 2013|Actual|2013-12-01||Interventional|||HPPH and PDT for Pleural Malignancy|A Phase 1 Trial of Photodynamic Therapy With HPPH in Patients With Pleural Malignancy|Active, not recruiting||Phase 1|37|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 02:35:21.233442|2017-10-11 02:35:21.233442
NCT01673061|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-06-20|||August 2012||2012-08-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage|Vapocoolant Spray as a Novel Local Anesthetic for Cutaneous Abscess Incision and Drainage|Terminated||Phase 4|21|Actual|Albert Einstein Healthcare Network||2||"Vapocoolant was not effective in controlling/preventing pain during an abscess incision and   drainage when compared with Lidocaine."|f||||t||||||||||2017-10-11 02:35:21.298292|2017-10-11 02:35:21.298292
NCT01673048|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2014-02-13|||January 2009||2009-01-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|ESIN||Modification of ESIN-osteosynthesis in a Femoral Fracture Model and Its Transmission to Clinical Practice|From Bench to Bedside: Modification of Elastic Stable Intramedullary Nailing With a 3rd Nail in a Femoral Spiral Fracture Model and Its Transmission to Clinical Practice|Completed||N/A|18|Actual|University of Luebeck||1|||f||||f||||||||||2017-10-11 02:35:21.398579|2017-10-11 02:35:21.398579
NCT01673035|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-03-02|||September 2012||2012-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|HA-X||Internet Treatment for Health Anxiety|Cognitive Behavior Therapy vs. Behavioral Stress Management for Severe Health Anxiety: a Randomized Controlled Trial of Two Internet-based Treatments|Completed||N/A|178|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:35:21.485449|2017-10-11 02:35:21.485449
NCT01673022|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-07-12|||May 2012||2012-05-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|FIRES||Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging|Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging for Detecting Metastatic Endometrial and Cervical Cancer|Completed||N/A|490|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 02:35:21.580543|2017-10-11 02:35:21.580543
NCT01673009|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-04-05|2016-02-24||May 2006||2006-05-01|April 2016|2016-04-01|August 2012|Actual|2012-08-01|December 2011|Actual|2011-12-01||Interventional|||Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas|Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas|Completed||Phase 2|36|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 02:35:21.765395|2017-10-11 02:35:21.765395
NCT01672996|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-05-13|2014-01-17||July 2012||2012-07-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers|A Phase 1/2, Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Contrast-Enhanced Abdominal Computed Tomography in Healthy Volunteers|Completed||Phase 1/Phase 2|66|Actual|GE Healthcare||3|||f||||f||||||||||2017-10-11 02:35:22.114761|2017-10-11 02:35:22.114761
NCT01672983|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2015-10-27|2015-10-27||July 2012||2012-07-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Baseline characteristics were summarized by treatment arm for all participants who received at least 1 dose of study drug.|A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection|A Phase 2 Study to Evaluate the Safety, Tolerability, Antiviral Activity, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection|Completed||Phase 2|110|Actual|AbbVie||6|||f||||f||||||||||2017-10-11 02:35:23.059234|2017-10-11 02:35:23.059234
NCT01672970|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-02-29|2016-01-28||July 2012||2012-07-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational||Full analysis set (FAS) population included all participants who received at least one dose of tocilizumab and provided evaluable data.|A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis|Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With Tocilizumab.|Completed||N/A|291|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:35:24.840156|2017-10-11 02:35:24.840156
NCT01672957|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-08-16|2016-08-16||September 2011||2011-09-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|ORANGE|ITT population included all enrolled renal transplant participants who received mycophenolate mofetil containing immunosuppressive combination therapy and had no major protocol violation.|An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil|Non-interventional Clinical Study With Target of Kidney Function Follow-up in Routine Clinical Practice on De Novo Kidney Transplant Recipients Who Are on CellCept Immunosuppressive Combination Therapy in Routine Clinical Practice|Completed||N/A|128|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:35:26.124122|2017-10-11 02:35:26.124122
NCT01672944|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-05-18|||September 27, 2010|Actual|2010-09-27|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|August 31, 2016|Actual|2016-08-31||Interventional|||Evaluating Biobanking Educational Tools|Evaluating Biobanking Educational Tools|Active, not recruiting||N/A|339|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-11 02:35:26.671179|2017-10-11 02:35:26.671179
NCT01672931|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2012-08-22|||September 2012||2012-09-01|August 2012|2012-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization||Unknown status|Not yet recruiting|N/A|60|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-10-11 02:35:26.771263|2017-10-11 02:35:26.771263
NCT01672918|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-06-30|||August 6, 2012||2012-08-06|February 27, 2015|2015-02-27|February 27, 2015||2015-02-27|||||Observational|||Fluorodeoxyglucose Imaging Studies to Detect Lymphoma|Use of Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography for the Evaluation of Autoimmune Lymphoproliferative Syndrome Lymphadenopathy Suggestive of Lymphoma|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:35:26.880868|2017-10-11 02:35:26.880868
NCT01672905|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-23|2017-05-16|||December 7, 2012|Actual|2012-12-07|May 2017|2017-05-01|January 7, 2013|Actual|2013-01-07|January 7, 2013|Actual|2013-01-07||Observational|||PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802|Evaluation of PSA Antibody on E9802: Confirmation and Concordance|Completed||N/A|20|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 02:35:26.966966|2017-10-11 02:35:26.966966
NCT01672879|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-02-23||2017-02-23|October 29, 2012|Actual|2012-10-29|January 2017|2017-01-01|January 3, 2017|Actual|2017-01-03|July 28, 2016|Actual|2016-07-28||Interventional|NASH||Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH|A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects With Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)|Terminated||Phase 2|259|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-11 02:35:27.584606|2017-10-11 02:35:27.584606
NCT01672866|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-02-23||2017-02-23|December 5, 2012|Actual|2012-12-05|January 2017|2017-01-01|December 29, 2016|Actual|2016-12-29|July 25, 2016|Actual|2016-07-25||Interventional|||Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)|A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like Molecule 2 (LOXL2), in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)|Terminated||Phase 2|222|Actual|Gilead Sciences||3|||f||||t|t|f||||||||2017-10-11 02:35:27.840863|2017-10-11 02:35:27.840863
NCT01672853|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-02-23||2017-02-23|February 2013||2013-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC)|A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase Like 2 (LOXL2) in Subjects With Primary Sclerosing Cholangitis (PSC)|Completed||Phase 2|235|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 02:35:28.150039|2017-10-11 02:35:28.150039
NCT01672840|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2014-12-31|||July 2012||2012-07-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|DARC||Effects of Cocoa on Ambulatory Blood Pressure and Vascular Function in Patients With Stage I Hypertension|Effects of Cocoa on Ambulatory Blood Pressure and Vascular Function in Patients With Stage I Hypertension|Completed||N/A|120|Actual|Griffin Hospital||2|||f||||f||||||||||2017-10-11 02:35:28.402686|2017-10-11 02:35:28.402686
NCT01672827|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2013-12-18|2013-08-14||July 2012||2012-07-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images|A Study to Evaluate the Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images.|Completed||Phase 3|276|Actual|GE Healthcare||1|||f||||f||||||||||2017-10-11 02:35:28.494368|2017-10-11 02:35:28.494368
NCT01672814|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-08-24|||August 2012||2012-08-01|August 2017|2017-08-01|June 1, 2017|Actual|2017-06-01|June 1, 2017|Actual|2017-06-01||Interventional|||Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus|A Randomized, Controlled Study of the Vedera™ KXS Microwave System With Corneal Collagen Cross-Linking Compared With Corneal Collagen Cross-Linking Alone for Eyes With Keratoconus|Completed||Phase 3|3|Actual|Cornea and Laser Eye Institute||2|||f||||f||||||||||2017-10-11 02:35:28.855651|2017-10-11 02:35:28.855651
NCT01672801|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-01-11|||September 2012||2012-09-01|July 2015|2015-07-01|October 2015|Actual|2015-10-01|April 2014|Actual|2014-04-01||Interventional|NIMO||Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT|Using Nimodipine, a Calcium Channel Blocker, to Prevent LH Surge in Women Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: a Double-blinded, Randomized Controlled Study|Completed||N/A|22|Actual|Boston IVF||2|||f||||t||||||||||2017-10-11 02:35:28.938028|2017-10-11 02:35:28.938028
NCT01671644|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-10-19|||February 2013||2013-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Observational|EPIC||Eeva™ Pregnancy Investigational Clinical Study: A Postmarket Follow-Up Study|Eeva™ Pregnancy Investigational Clinical Study: A Postmarket Follow-Up Study|Completed||N/A|104|Actual|Progyny, Inc.|||2||f||||f||||||||||2017-10-11 02:35:42.599188|2017-10-11 02:35:42.599188
NCT01672788|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2015-08-04|2015-06-26||August 2012||2012-08-01|August 2015|2015-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets|Bioequivalence of Empagliflozin/Metformin (850 mg) Fixed Dose Combination Tablets Compared to Single Tablets Administered Together in Healthy Male and Female Volunteers Under Fed Conditions (an Open-label, Randomised, Single-dose, Four-way Crossover Study)|Completed||Phase 1|36|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 02:35:29.031584|2017-10-11 02:35:29.031584
NCT01672775|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-04-13|||July 18, 2012|Actual|2012-07-18|April 2017|2017-04-01|February 21, 2017|Actual|2017-02-21|February 21, 2017|Actual|2017-02-21||Interventional|||A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology|A Phase 1, Open Label, Multi-center Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology|Completed||Phase 1|34|Actual|Astellas Pharma Inc||8|||f||||f||||||||Undecided||2017-10-11 02:35:29.706508|2017-10-11 02:35:29.706508
NCT01672762|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2016-01-19|||June 2012||2012-06-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients|Phase 3 Study of ASP1941 - A Long-term Administration Study in Subjects With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 3|174|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-10-11 02:35:29.835053|2017-10-11 02:35:29.835053
NCT01672749|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-22|2017-03-31|||June 2015||2015-06-01|March 2017|2017-03-01|April 2027|Anticipated|2027-04-01|April 2020|Anticipated|2020-04-01||Observational|||Evaluation of a Modern System to Allow for Growth in Children With Scoliosis Versus a Conventional Treatment|Evaluation of a Growth Guiding Construct vs. Standard Dual Growing Rods and VEPTR for the Treatment of Early Onset Scoliosis Patients: A Prospective Multi-center Cohort Study With a Matched Historical Control|Recruiting||N/A|51|Anticipated|AO Clinical Investigation and Documentation|||2||f||||t||||||||||2017-10-11 02:35:29.958239|2017-10-11 02:35:29.958239
NCT01672736|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-10-31|||September 2012||2012-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma|A Phase 1/2 Trial of ASP7487 OSI-906)in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|75|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 02:35:30.090958|2017-10-11 02:35:30.090958
NCT01672723|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-12-10|2015-05-29||October 2012||2012-10-01|December 2015|2015-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Neuropharmacological Basis of Social Connection: The Role of Opioids|Neuropharmacological Basis of Social Connection: The Role of Opioids|Completed||N/A|34|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:35:30.210698|2017-10-11 02:35:30.210698
NCT01672710|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-12-09|||April 2010||2010-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Gulf War Illness: Evaluation of an Innovative Detoxification Program|Pilot Study of Application of the Hubbard Detoxification Program to Veterans With Gulf War Illness|Completed||Phase 1|32|Actual|University at Albany||2|||f||||t||||||||||2017-10-11 02:35:30.470042|2017-10-11 02:35:30.470042
NCT01672697|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-03-14|||July 2012||2012-07-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|November 2016|Actual|2016-11-01||Interventional|||Physical Therapy for Women With Obstetric Trauma and Anal Incontinence|Effects of Physical Therapy on Pelvic Floor Symptoms and Quality of Life in Postpartum Women Following Severe Perineal Trauma: a Randomized Controlled Trial|Active, not recruiting||N/A|65|Anticipated|TriHealth Inc.||2|||f||||f||||||||Undecided||2017-10-11 02:35:30.559595|2017-10-11 02:35:30.559595
NCT01672684|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2014-10-15|||October 2012||2012-10-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Phase I: At-Home Support for Rural Women Using Group Video Calling|At-Home Support for Rural Women Using Group Video Calling|Completed||Phase 1|34|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 02:35:30.651309|2017-10-11 02:35:30.651309
NCT01672671|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-11-01|||August 2011||2011-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|||BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy|Identification of BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy|Completed||Phase 2|41|Actual|Russian Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:35:30.749194|2017-10-11 02:35:30.749194
NCT01672658|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-03-03|2015-05-22||January 2012||2012-01-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|December 2013|Actual|2013-12-01||Interventional|||Traditional Balance vs Vibrotactile Feedback Training for Vestibular Rehabilitation|Standard Vestibular Rehabilitation Training (VRT) vs. Sensory Kinetics Balance System (SKBS) + VRT on Balance and Functional Outcomes in the Mild Traumatic Brain Injury (mTBI) Population.|Completed||N/A|31|Actual|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 02:35:30.842965|2017-10-11 02:35:30.842965
NCT01672645|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-01-25|||June 2012||2012-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.|A Phase 1, Randomized, Double Blind, Placebo Controlled Study To Evaluate The Safety, Tolerability, Immunogenicity, And Exploratory Efficacy Of Multiple Ascending Dose Levels Of Pf-05402536 And Pf-06413367 In Healthy Adult Smokers|Completed||Phase 1|277|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:35:31.268207|2017-10-11 02:35:31.268207
NCT01672632|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-09-26|||May 2008||2008-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|February 2012|Actual|2012-02-01||Interventional|EAT||Fat Cell Size and Overfeeding and Etopic Study|Fat Cell Size and Overfeeding and Etopic Study|Active, not recruiting||N/A|40|Actual|Pennington Biomedical Research Center||1|||f||||t||||||||||2017-10-11 02:35:31.347342|2017-10-11 02:35:31.347342
NCT01672619|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2012-08-22|||June 2010||2010-06-01|June 2010|2010-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|Nautilus||Nautilus: Dynamic Craniotomy; New Surgical Technique and Preliminary Results|Nautilus: Dynamic Craniotomy; New Surgical Technique and Preliminary Results|Completed||N/A|10|Actual|Nucleo de Plastica Avancada|||1||f||||t||||||||||2017-10-11 02:35:31.411262|2017-10-11 02:35:31.411262
NCT01672606|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-02-26|||May 2012||2012-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea|Effect of Partial Neuromuscular Blockade by Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea-before and After Three Month CPAP Treatment. A Non-randomized, Non-blinded Study.|Completed||N/A|11|Actual|Karolinska University Hospital||1|||f||||t||||||||||2017-10-11 02:35:31.48821|2017-10-11 02:35:31.48821
NCT01672593|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2014-03-10|||May 2012||2012-05-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|Glue-sealing||Glue Sealing for Patients With Low-Output ECFs|A Randomized Controlled Trial to Evaluate Endoscopy Assisted Fibrin Glue Application in the Treatment of Low-Output ECFs|Unknown status|Recruiting|N/A|30|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 02:35:31.558276|2017-10-11 02:35:31.558276
NCT01672580|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-03-18|||August 2012||2012-08-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|||Social Network Interventions in Rural Honduras|Diffusion of Health Interventions Across Social Networks in Honduran Villages|Completed||N/A|5773|Actual|Harvard University||6|||f||||f||||||||||2017-10-11 02:35:31.64105|2017-10-11 02:35:31.64105
NCT01672567|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2012-08-22|||October 2010||2010-10-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effects of Egg Ingestion on Endothelial Function in Adults With Coronary Artery Disease|Effects of Egg Ingestion on Endothelial Function in Adults With Coronary Artery Disease: A Randomized, Controlled, Crossover Trial|Completed||N/A|34|Actual|Griffin Hospital||3|||f||||f||||||||||2017-10-11 02:35:31.758736|2017-10-11 02:35:31.758736
NCT01672554|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2012-08-22|||December 2008||2008-12-01|August 2012|2012-08-01|October 2013|Anticipated|2013-10-01|April 2012|Actual|2012-04-01||Interventional|||Clinical Benefits of Seroquel XR in Anxiety Disorder|Open Label, Non-randomised, Single Arm, Phase IIIB Switch Study: Evaluating the Clinical Benefits of Quetiapine XR in Patients With Schizophrenia and Anxiety Disorder.|Unknown status|Active, not recruiting|Phase 3|40|Anticipated|Corporation de Recherche en Neuropsycho Pharmacologie de Quebec||1|||f||||f||||||||||2017-10-11 02:35:31.892076|2017-10-11 02:35:31.892076
NCT01672541|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-10-03|||August 2012||2012-08-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|DM||Dating Matters: Strategies to Promote Healthy Teen Relationships|"Randomized Controlled Trial of the Dating Matters: Strategies to Promote Healthy Teen Relationships Comprehensive Approach"|Active, not recruiting||N/A|10000|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 02:35:32.770855|2017-10-11 02:35:32.770855
NCT01672528|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-07-18|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Patient Reported Outcome Measures for Ablation of Cardiac Arrhythmias|A Multicentre, Prospective Observational Study to Develop, Evaluate and Validate Patient Reported Outcome Measures (PROMs) for Patients Treated With Cardiac Ablation for Symptomatic Cardiac Arrhythmias|Active, not recruiting||N/A|630|Anticipated|Cardiff and Vale University Health Board|||1||f||||f||||||||||2017-10-11 02:35:32.924468|2017-10-11 02:35:32.924468
NCT01672515|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2012-08-22|||October 2012||2012-10-01|August 2012|2012-08-01||||October 2013|Anticipated|2013-10-01||Interventional|||Protective Effects of Remote Limb Ischemic Preconditioning on Acute Cerebral Infarction|Phase 2 Study of Remote Limb Ischemic Preconditioning on Acute Cerebral Infarction|Unknown status|Not yet recruiting|Phase 1/Phase 2|80|Anticipated|Capital Medical University||2|||f||||t||||||||||2017-10-11 02:35:33.055413|2017-10-11 02:35:33.055413
NCT01672502|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-03-15|||September 2012||2012-09-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Fire Fighter Fatigue Management Program: Operation Fight Fatigue|Fire Fighter Fatigue Management Program: Operation Fight Fatigue|Completed||N/A|620|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 02:35:33.274876|2017-10-11 02:35:33.274876
NCT01672489|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-08-06|||July 2011||2011-07-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Objective Assessment of the Effects of Shift Work on Drowsiness and Driving Impairment in Hospital Staff|Objective Assessment of the Effects of Shift Work on Drowsiness and Driving Impairment in Hospital Staff|Unknown status|Active, not recruiting|N/A|19|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-10-11 02:35:33.404535|2017-10-11 02:35:33.404535
NCT01672476|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-06-30|||April 2012||2012-04-01|June 2016|2016-06-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|fimasartan||A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension|A Randomized, Double-Blind, Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 3|293|Actual|Boryung Pharmaceutical Co., Ltd||3|||f||||t||||||||||2017-10-11 02:35:33.50898|2017-10-11 02:35:33.50898
NCT01672463|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-09-22|||December 2012||2012-12-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|OKN-007||Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients|Phase 1b Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients|Recruiting||Phase 1|31|Anticipated|Oblato, Inc.||1|||f||||t||||||||||2017-10-11 02:35:33.663532|2017-10-11 02:35:33.663532
NCT01672450|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-07-07|||September 2012||2012-09-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma|A Phase I Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma|Completed||Phase 1|12|Actual|University of Utah||1|||f||||t||||||||||2017-10-11 02:35:33.765699|2017-10-11 02:35:33.765699
NCT01672437|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-09-15|||November 2012||2012-11-01|September 2017|2017-09-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|NewPreBP||NewPreBP: Project Newborn -Preparation for Birth and Parenthood|NewPreBP: Project Newborn -Preparation for Birth and Parenthood. A Large Interdisciplinary Randomised Trial on the Effect of Birth and Parent Preparation|Completed||N/A|1766|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 02:35:33.857865|2017-10-11 02:35:33.857865
NCT01672424|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-02-01|||May 2012||2012-05-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Ultrasound Assessment of Gastric Emptying|Ultrasound Assessment of Gastric Emptying Following the Addition of a High Protein Drink vs Ice Chips During Labor|Completed||N/A|18|Actual|University of Pittsburgh|||2||f||||t||||||||||2017-10-11 02:35:33.998126|2017-10-11 02:35:33.998126
NCT01672411|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-02-23|||April 2012||2012-04-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer|Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates, %p2psa and Prostate Health Index in the Detection of Prostate Cancer and in Predicting Aggressive Disease: a Prospective Study|Completed||N/A|250|Actual|University Of Perugia|||1||f||||f||||||||||2017-10-11 02:35:34.098554|2017-10-11 02:35:34.098554
NCT01672398|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-11-04|||August 2012||2012-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Trial of the CarePartner Program for Improving the Quality of Transition Support|Trial of the CarePartner Program for Improving the Quality of Transition Support|Completed||N/A|271|Actual|University of Michigan||2|||f||||t||||||||No||2017-10-11 02:35:34.164906|2017-10-11 02:35:34.164906
NCT01672385|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-11-04|||August 2012||2012-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Improving Transition Outcomes Through Accessible Health IT and Caregiver Support|Improving Transition Outcomes Through Accessible Health IT and Caregiver Support|Completed||N/A|246|Actual|University of Michigan||2|||f||||t||||||||No||2017-10-11 02:35:34.245234|2017-10-11 02:35:34.245234
NCT01672372|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-08-04|||January 2011||2011-01-01|August 2014|2014-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Effect of Methylated Vitamin B Complex on Depression|The Effect of Methylated Vitamin B Complex on Depression|Completed||N/A|60|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 02:35:34.335034|2017-10-11 02:35:34.335034
NCT01672359|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2014-08-04|||May 2011||2011-05-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Evaluating Whole Foods Supplementation on Cognition|The Effect of Whole-Food Dietary Supplementation on Cognitive and Immune Functioning and Quality of Life in Healthy Older Adults|Completed||N/A|97|Actual|University of Miami||3|||f||||f||||||||||2017-10-11 02:35:34.429419|2017-10-11 02:35:34.429419
NCT01672346|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-05-19|||May 2013||2013-05-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|ZODIAC||PV Reconnection After PVAI at Different Power Settings and Adenosine Provocation|Pulmonary Vein (PV) Reconnection After Pulmonary Vein Antrm Isolation (PVAI) at Different Power Settings and Adenosine Provocation|Unknown status|Recruiting|Phase 3|188|Anticipated|Texas Cardiac Arrhythmia Research Foundation||2|||f||||f||||||||||2017-10-11 02:35:34.548745|2017-10-11 02:35:34.548745
NCT01672333|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-03-18|||June 2008||2008-06-01|March 2014|2014-03-01||||March 2011|Actual|2011-03-01||Interventional|TOX||Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma|Phase 2 Study of Response Rate and Side Effects of Preoperative Chemotherapy With Docetaxel, Oxaliplatin and Capcitabine (TOX) in Patients With Locally Advanced Operable Gastric Adenocarcinoma|Completed||Phase 2|50|Actual|Milad Hospital||1|||f||||t||||||||||2017-10-11 02:35:34.661871|2017-10-11 02:35:34.661871
NCT01672320|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2013-11-04|||January 2013||2013-01-01|November 2013|2013-11-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Observational|||Outcomes of Robotic Total Hip Arthroplasty|Outcomes of Robotic Total Hip Arthroplasty: A Prospective Study|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||2|"No patients will be recruited at Massachsetts General hospital. IRB approval changed to core   center."|f||||f||||||||||2017-10-11 02:35:34.754503|2017-10-11 02:35:34.754503
NCT01672307|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2013-06-18|||September 2012||2012-09-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||Minoxidil 2% for Eyebrow Enhancement|Efficacy and Tolerability of Minoxidil 2% for Eyebrow Enhancement : A Randomized , Double-blind , Placebo-controlled , Split-face Comparative Study|Completed||Phase 4|40|Actual|Mae Fah Luang University Hospital||2|||f||||f||||||||||2017-10-11 02:35:34.877567|2017-10-11 02:35:34.877567
NCT01672294|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-03-03|2017-01-06||June 2013||2013-06-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Caregiver Outlook: An Intervention to Improve Caregiving in Serious Illness|Caregiver Outlook: An Intervention to Improve Caregiving in Serious Illness|Completed||N/A|286|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 02:35:35.059836|2017-10-11 02:35:35.059836
NCT01672281|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-05-13|||November 2011||2011-11-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||vibroX-training in Endurance Trained Men|Influence of vibroX-training on the Power-duration-relationship and Maximal Force in Relation to Conventional Resistance Training in Endurance Trained Men|Completed||N/A|30|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 02:35:36.856108|2017-10-11 02:35:36.856108
NCT01672268|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2014-11-24|||February 2012||2012-02-01|April 2012|2012-04-01|November 2014|Actual|2014-11-01|November 2012|Actual|2012-11-01||Interventional|CT-TAVI||Interest of Cardiac Computed Tomography to Optimize and Improve the Procedure of TAVI|Interest of Cardiac Computed Tomography (CT) to Optimize and Improve the Procedure of Transcatheter Aortic Valve Implantation (TAVI)|Completed||Phase 3|70|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 02:35:36.949371|2017-10-11 02:35:36.949371
NCT01672255|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-03-28|||October 2012||2012-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)|Hypoglycemia Associated Autonomic Failure in Type 1 DM, SSRI and Exercise|Recruiting||Early Phase 1|64|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-11 02:35:37.03096|2017-10-11 02:35:37.03096
NCT01672242|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-04-25|||July 2012||2012-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)|Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)|Completed||Phase 4|6|Actual|University of Maryland||1|||f||||t||||||||||2017-10-11 02:35:37.122474|2017-10-11 02:35:37.122474
NCT01672229|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-01-19|||July 2012||2012-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bortezomib in Patients With Chronic Graft Versus Host Disease|A Pilot Study Of Weekly Subcutaneous Bortezomib In Patients With Steroid-Refractory Or -Dependent Chronic Graft Versus Host Disease|Active, not recruiting||Phase 1|16|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-11 02:35:37.195425|2017-10-11 02:35:37.195425
NCT01671631|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2012-08-22||||||August 2012|2012-08-01||||||||Observational|FORECAST||The Diastolic Pressure Gradient for Patients With Acute Coronary Syndrome: Evaluation of Non Culprit Lesions||Unknown status|Recruiting|N/A|||University Magna Graecia|||1||f||||f||||||||||2017-10-11 02:35:42.700354|2017-10-11 02:35:42.700354
NCT01672216|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-09-20|||August 2012||2012-08-01|September 2013|2013-09-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Interventional|3T-CO||Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation|Triple Target Treatment (3T) Combining Amplitude Modulated Middle Frequency (AM-MF) Stimulation With Electromyography (EMG)EMG-Biofeedback Versus EMG-Biofeedback in Chronic Obstipation|Unknown status|Recruiting|Phase 3|140|Anticipated|University of Giessen||2|||f||||t||||||||||2017-10-11 02:35:37.289439|2017-10-11 02:35:37.289439
NCT01672203|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-08-23|||January 2009||2009-01-01|August 2012|2012-08-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Observational|||Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Incidence in Patients With Central Versus Peripheral Embolism|Incidence of CTEPH in Dependence of Thrombus Location in Patients With Acute Pulmonary Embolism and Index Fibrinolysis|Unknown status|Recruiting|N/A|500|Anticipated|University of Cologne|||4||f||||t||||||||||2017-10-11 02:35:37.419796|2017-10-11 02:35:37.419796
NCT01672190|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-01-16|||August 2012||2012-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|LILY||Lessening Incontinence by Learning Yoga||Completed||N/A|20|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:35:37.487274|2017-10-11 02:35:37.487274
NCT01672177|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-04-15|||August 2011||2011-08-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|SCOPE||Self Care for Older Persons in Singapore: An Intervention Study|Self Care for Older Persons in Singapore: An Intervention Study|Completed||N/A|400|Anticipated|National University, Singapore||2|||f||||f||||||||||2017-10-11 02:35:37.557462|2017-10-11 02:35:37.557462
NCT01672164|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-09-01|||August 2012||2012-08-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PROGENI-LI||Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients|Discovery and Validation of Proteogenomic Biomarker Panels in a Prospective Serial Blood and Urine Monitoring Study of Liver Transplant Recipients - Transplant Proteogenomics|Completed||N/A|202|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     whole blood, plasma, serum, urine supernatant, urine pellet and tissue   "|Yes|The plan is to share data in ImmPort, a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools that are available to researchers who register online and subsequently receive DAIT approval.|2017-10-11 02:35:37.756808|2017-10-11 02:35:37.756808
NCT01672151|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2012-08-23|||November 2011||2011-11-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|ITP||Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia|Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia|Completed||N/A|35|Actual|First Affiliated Hospital of Suzhou Medical College|||1||f||||t||||||||||2017-10-11 02:35:37.854426|2017-10-11 02:35:37.854426
NCT01672138|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-04-25|||February 2013||2013-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|TANTRA||Pulmonary Vein Antrum Isolation (PVAI) Plus Isolation of Complex Fractionated Atrial Electrograms (CAFE) and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation|PVAI Plus Isolation of CAFEs and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation|Active, not recruiting||Phase 3|186|Anticipated|Texas Cardiac Arrhythmia Research Foundation||3|||f||||f||||||||||2017-10-11 02:35:37.932067|2017-10-11 02:35:37.932067
NCT01672125|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-23|||November 2012||2012-11-01|August 2012|2012-08-01||||||||Observational|||Effect of Upper Limb Posture on Limb Volume as Expressed in Circumference Measurement in Healthy Women and in Women With Breast Cancer Related Lymphedema|Effect of Upper Limb Posture on Limb Volume as Expressed in Circumference Measurement in Healthy Women and in Women With Breast Cancer Related Lymphedema|Unknown status|Not yet recruiting|N/A|45|Anticipated|Tel-Aviv Sourasky Medical Center|||3||f||||f||||||||||2017-10-11 02:35:38.025338|2017-10-11 02:35:38.025338
NCT01672112|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-05-13|||July 2012||2012-07-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of the Efficacy of Oral Oxycodone and Oral Codeine in the Treatment of Postcraniotomy Pain|Comparison of the Efficacy of Oral Oxycodone and Oral Codeine in the Treatment of Postcraniotomy Pain|Completed||Phase 4|40|Actual|Tan Tock Seng Hospital||2|||f||||t||||||||||2017-10-11 02:35:38.097134|2017-10-11 02:35:38.097134
NCT01672099|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-08-21|||September 2010||2010-09-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Dairy on Vitamin K-status|The Effects of a Vitamin K-enriched Dairy Product on Vitamin K-status|Completed||N/A|62|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:35:38.25895|2017-10-11 02:35:38.25895
NCT01672086|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-10-12|||August 2012||2012-08-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System|Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System|Terminated||N/A|347|Actual|StelKast, Inc.|||1|Product is no longer being manufactured and marketed.|f||||f||||||||||2017-10-11 02:35:38.354452|2017-10-11 02:35:38.354452
NCT01672073|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-08-08|||January 2013||2013-01-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Analysis of the Arterial Pressure Wave Form Through the Proxima Device|An Open, Non-randomised, Study to Provide Data on the Arterial Pressure Wave Form Obtained Through the Proxima 3 in Patients Who Require the Insertion of an Arterial Line|Completed||N/A|10|Actual|Sphere Medical Ltd.|||1||f||||f||||||||||2017-10-11 02:35:38.432828|2017-10-11 02:35:38.432828
NCT01672060|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-12-21|||October 2013||2013-10-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|BCHCP||BC Healthy Connections Project|A Scientific Evaluation of the Nurse-Family Partnership (NFP) Program in British Columbia|Active, not recruiting||N/A|739|Actual|Simon Fraser University||2|||f||||t||||||||||2017-10-11 02:35:38.504989|2017-10-11 02:35:38.504989
NCT01672047|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-29|||April 2012||2012-04-01|August 2012|2012-08-01|December 2015|Anticipated|2015-12-01|April 2014|Anticipated|2014-04-01||Interventional|EVIDENCE||Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients|Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients|Unknown status|Recruiting|N/A|350|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-10-11 02:35:38.599577|2017-10-11 02:35:38.599577
NCT00004401|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||January 1998||1998-01-01|March 2000|2000-03-01|June 1998||1998-06-01|||||Interventional|||Study of Human Botulism Immunoglobulin in Infants With Botulism||Completed||N/A|120|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.259547|2017-10-11 04:25:19.259547
NCT01672034|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-11-04|||November 2012||2012-11-01|November 2014|2014-11-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Impact of Laparoscopic Gastric Bypass Surgery and Weight Reduction on Lower Esophageal Sphincter (LES)|Impact of Laparoscopic Gastric Bypass Surgery and Weight Reduction an Lower Esophageal Sphincter. A Study of Morbidly Obese Patients Before and After Surgery.|Withdrawn||N/A|0|Actual|Örebro University, Sweden|||1|no patient enrolled|f||||f||||||||||2017-10-11 02:35:38.696547|2017-10-11 02:35:38.696547
NCT01672021|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-09-28|||July 2012|Actual|2012-07-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer Patients|Initial Assessment of 18FDG-PET/MRI in Determining the Extent of Systemic Disease in Breast Cancer Patients.|Active, not recruiting||N/A|81|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 02:35:38.769785|2017-10-11 02:35:38.769785
NCT01671995|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2012-08-21|||January 1996||1996-01-01|August 2012|2012-08-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|OPTIMAL||Optimising Congestive Heart Failure Outpatient Clinic Project|Optimising Congestive Heart Failure Outpatient Clinic Project (OPTIMAL)|Completed||N/A|208|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:35:38.94873|2017-10-11 02:35:38.94873
NCT01671982|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-05-28|||August 2012||2012-08-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|January 2014|Actual|2014-01-01||Interventional|ALTER||ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment|Tenofovir Pharmacokinetics in HIV-infected Thai Adults With Moderate Renal Function Impairment Receiving Either a Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based or Lopinavir/Ritonavir-based Antiretroviral Therapy|Completed||Phase 1|40|Actual|Institut de Recherche pour le Developpement||1|||f||||f||||||||||2017-10-11 02:35:39.054937|2017-10-11 02:35:39.054937
NCT01671969|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-08-27|||March 2012||2012-03-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Very Low Calorie Diet for Diabetic Kidney Disease||Completed||N/A|10|Actual|Indiana University||1|||f||||f||||||||||2017-10-11 02:35:39.162138|2017-10-11 02:35:39.162138
NCT01671956|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2016-10-20|||July 2015||2015-07-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study Designed to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Profile of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis|Recruiting||Phase 2|42|Anticipated|Immune Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:35:39.257996|2017-10-11 02:35:39.257996
NCT01671943|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2015-02-05|||August 2012||2012-08-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ICE-BREACCER||Cryotherapy for Breast Cancer Trial|Evaluation of Safety and Feasibility of ICE-SENSE3TM , a Cryotherapy Device for Office-based Ultrasound- Guided Treatment of Breast Cancer|Completed||N/A|4|Actual|IceCure Medical Ltd.||1|||f||||f||||||||||2017-10-11 02:35:39.396248|2017-10-11 02:35:39.396248
NCT01671930|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-05-26|||April 2007||2007-04-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Maastricht Biomarker CT Study|Maastricht Biomarker CT Study. Relation Between Cardiovascular Biomarkers and Coronary Atherosclerosis in Patients Undergoing Multi Detector Cardiac Computed Tomography.|Completed||N/A|5000|Actual|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-11 02:35:39.490601|2017-10-11 02:35:39.490601
NCT01671917|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-06-27|||October 2012||2012-10-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|EDEX||Evaluation of an Educational Program Associated With Exercises (EDEX) Before Total Knee Arthroplasty|Evaluation of an Educational Program Associated With Exercises (EDEX) Before Total Knee Arthroplasty|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:35:39.576383|2017-10-11 02:35:39.576383
NCT01671904|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-09-06|||January 13, 2014|Actual|2014-01-13|September 2017|2017-09-01|July 30, 2020|Anticipated|2020-07-30|July 30, 2020|Anticipated|2020-07-30||Interventional|||A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)|A Phase IB, Open-Label Study Evaluating the Safety and Pharmacokinetics of Venetoclax (GDC-0199, ABT-199) in Combination With Bendamustine+Rituximab (BR) or Bendamustine+Obinutuzumab (BG) in Patients With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|84|Actual|Genentech, Inc.||9|||f||||||||||||||2017-10-11 02:35:39.705076|2017-10-11 02:35:39.705076
NCT01671891|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-08-21|||February 2012||2012-02-01|August 2012|2012-08-01|February 2013|Anticipated|2013-02-01|||||Observational|||Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer|Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer|Unknown status|Recruiting|N/A|100|Anticipated|Fudan University|||1||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 02:35:39.916188|2017-10-11 02:35:39.916188
NCT01671878|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-05-06|||September 2012||2012-09-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Glucose and Insulin Responses to Test Foods|Characterization of the Postprandial Glucose and Insulin Responses to Test Foods in Lean and Overweight Subjects|Completed||N/A|12|Actual|Mondelēz International, Inc.||3|||f||||f||||||||||2017-10-11 02:35:40.022061|2017-10-11 02:35:40.022061
NCT01671865|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-03-01|||March 2012|Actual|2012-03-01|March 2017|2017-03-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy|Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy|Recruiting||N/A|75|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|||1||f||||f|f|f||||||No||2017-10-11 02:35:40.108317|2017-10-11 02:35:40.108317
NCT01671683|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-21|||July 2010||2010-07-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|||||Observational|||Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer|A Phase II Study of Additional Four-week Chemotherapy With Capecitabine During the Resting Periods After Six-week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer|Completed||N/A|44|Actual|Chungnam National University|||1||f||||f||||||||||2017-10-11 02:35:42.271081|2017-10-11 02:35:42.271081
NCT01671852|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-07-28|||May 2012||2012-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Nasonex OSA||Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy|A Randomized Controlled Trial of Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy|Withdrawn||Phase 3|0|Actual|Children's & Women's Health Centre of British Columbia||2||Could not obtain funding.|f||||f||||||||||2017-10-11 02:35:40.195221|2017-10-11 02:35:40.195221
NCT01671839|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-03-23|2014-07-25||August 2012||2012-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|September 2013|Actual|2013-09-01||Interventional|||Study of the Cabochon System for Improvement in the Appearance of Cellulite|Pivotal Study of the Cabochon System for Improvement in the Appearance of Cellulite|Completed||N/A|55|Actual|Cabochon Aesthetics, Inc.||1|||f||||t||||||||||2017-10-11 02:35:40.310374|2017-10-11 02:35:40.310374
NCT01671826|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2016-06-23|||October 2012||2012-10-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|LATMM||Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years|Prospective, Observational, Multicenter Trial Evaluating Autologous Stem Cell Transplantation for Myeloma Patients Over the Age of 65|Active, not recruiting||N/A|55|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 02:35:40.545106|2017-10-11 02:35:40.545106
NCT01671813|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-07-24|||March 2013||2013-03-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly|Pilot Study of Brentuximab Vedotin in CD30 Positive EBV Positive Diffuse Large B-Cell Lymphomas of the Elderly|Withdrawn||N/A|0|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||Terminated by pharmaceutical sponsor - no accrual|f||||f||||||||||2017-10-11 02:35:40.628398|2017-10-11 02:35:40.628398
NCT01671800|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2013-01-08|||September 2008||2008-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating|Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis Associated Symptomatic Sweating, or Residual Limb Hyperhidrosis in Amputees|Completed||Phase 1|20|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-10-11 02:35:40.71|2017-10-11 02:35:40.71
NCT01671787|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2014-05-08|||March 2012||2012-03-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B|A Phase 1b Randomized, Open Label, Active-Controlled Study to Assess the Safety, Viral Kinetics, and Anti-HBV Activity of GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B (CHB) Infection|Completed||Phase 1|51|Actual|Gilead Sciences||5|||f||||f||||||||||2017-10-11 02:35:40.80689|2017-10-11 02:35:40.80689
NCT01671774|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-06-30|||August 2012||2012-08-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PILOT||Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer|Multicenter, Open-label, Exploratory Phase I Pilot Study to Investigate Safety, Pharmacodynamics and Pharmacokinetics of Immunological Effects and Activity of Combining Multiple Doses of IMAB362 With Immunomodulation (Zoledronic Acid, Interleukin-2) in Patients With Advanced Adenocarcinoma of the Stomach, the Lower Esophagus or the Gastro-esophageal Junction.|Completed||Phase 1|32|Actual|Astellas Pharma Inc||4|||f||||t||||||||||2017-10-11 02:35:40.957439|2017-10-11 02:35:40.957439
NCT01671761|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-04-08|||August 2012||2012-08-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Observational|||Normative Data of Brain Network Activation in Adolescents and Young Adults|Establishment of Normative Data of Brain Network Activation (BNA) Using Evoked Response Potentials in Adolescents and Young Adults|Completed||N/A|43|Actual|ElMindA Ltd|||2||f||||f||||||||||2017-10-11 02:35:41.087096|2017-10-11 02:35:41.087096
NCT01671748|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2015-07-29|2015-06-04||August 2012||2012-08-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||MIST Ultrasound Therapy Compared to United Kingdom Standard Care for the Treatment of Non-healing Venous Leg Ulcers|Pragmatic Randomised Controlled Trial of MIST Ultrasound Therapy Compared to UK Standard Care for the Treatment of Non-healing Venous Leg Ulcers.|Completed||N/A|47|Actual|Cardiff and Vale University Health Board|"Difference in treatment frequency between the groups which could potentially bias results.
Standard deviation proved to be larger than estimated from the available literature which resulted in the study having reduced statistical power."|2|||f||||f||||||||||2017-10-11 02:35:41.390669|2017-10-11 02:35:41.390669
NCT01671735|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2012-10-12|||September 2012||2012-09-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|||VA Diabetes Prevention: Epidemiology of Pre-Diabetes and Implementation Pilot|VA Diabetes Prevention: Epidemiology of Pre-Diabetes and Implementation Pilot|Withdrawn||N/A|0|Actual|VA Office of Research and Development||2||"Not considered a clinical trial because both treatment protocols have been approved as usual   care"|f||||f||||||||||2017-10-11 02:35:41.914354|2017-10-11 02:35:41.914354
NCT01671722|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-22|||February 2010||2010-02-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fed Conditions.|Completed||Phase 1|43|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:35:42.004122|2017-10-11 02:35:42.004122
NCT01671709|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2012-08-22|||February 2010||2010-02-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study in Healthy, Adult, Human Subjects Under Fasting Conditions.|Completed||Phase 1|41|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:35:42.087122|2017-10-11 02:35:42.087122
NCT01671696|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-21|2017-02-13|||September 2011||2011-09-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|May 2018|Anticipated|2018-05-01||Observational|||Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy|Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy: A Cardiac Magnetic Resonance and Biomarker Imaging and Serological Biomarker Study|Recruiting||N/A|80|Anticipated|Connecticut Children's Medical Center|||1||f||||f||||||||Undecided|pending PI review.|2017-10-11 02:35:42.186536|2017-10-11 02:35:42.186536
NCT01671618|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-06-29|||July 2012||2012-07-01|June 2016|2016-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Point-of-Care Focused Cardiac Ultrasound in Assessing the Thoracic Aorta|A Prospective Study on Point-of-Care Focused Cardiac Ultrasound in Assessing for Thoracic Aortic Dimensions, Dilation, and Aneurysm in Correlation With CT Angiogram in Suspected Cases of Pathology|Completed||N/A|97|Actual|Yale University|||1||f||||f||||||||||2017-10-11 02:35:42.794444|2017-10-11 02:35:42.794444
NCT01671605|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-03-10|2016-11-22||February 2013||2013-02-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational||With or without Chronic Kidney Disease|Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation|Mechanisms of CKD-Induced Foam Cell Formation|Completed||N/A|103|Actual|Vanderbilt University Medical Center|||2||f||||t||||||||No||2017-10-11 02:35:42.877976|2017-10-11 02:35:42.877976
NCT01671592|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-09-25|||January 2013||2013-01-01|September 2017|2017-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)|Safety and Feasibility Evaluation of the MRI-based Tracking of Alpha-type-1 Dendritic Cell Vaccines in Patients With Colorectal Cancer|Completed||Phase 1|6|Actual|University of Pittsburgh||4|||f||||t||||||||||2017-10-11 02:35:43.286811|2017-10-11 02:35:43.286811
NCT01671579|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-07-18|||March 2012||2012-03-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease|Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Sm. Bowel Crohn Disease.|Terminated||N/A|33|Actual|Children's Hospital Medical Center, Cincinnati||1||PI changed institutions|f||||t||||||||||2017-10-11 02:35:43.407977|2017-10-11 02:35:43.407977
NCT01671566|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-03-03|||September 2012||2012-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Interval Training in Adults With Congenital Heart Disease a Randomized Trial|Effect of Home Based Interval Training on Exercise Capacity and Quality of Life in Adults With Congenital Heart Disease - a Randomized Controlled Multicenter Trial|Completed||N/A|26|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 02:35:43.525207|2017-10-11 02:35:43.525207
NCT01671553|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2012-08-20|||October 2011||2011-10-01|August 2012|2012-08-01|October 2012|Anticipated|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Helping Smokers to Quit Via the Smoke-free Teen Contest 2011: A Randomized Controlled Trial|Helping Smokers to Quit Via the Smoke-free Teen Contest 2011: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|269|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:35:43.648343|2017-10-11 02:35:43.648343
NCT01671540|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-05-27|||September 2011||2011-09-01|May 2015|2015-05-01||||December 2015|Anticipated|2015-12-01||Interventional|IPV||Effects of IPV Assessed With Functional Imaging|Evaluation of the Effects of Intrapulmonary Percussive Ventilation Using Functional Respiratory Imaging|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Antwerp||2|||f||||t||||||||||2017-10-11 02:35:43.732006|2017-10-11 02:35:43.732006
NCT01671527|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-06-09|||August 2012||2012-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Observational|||Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia|Pathophysiological Insights Into STN DBS for Primary Cervical Dystonia|Completed||N/A|29|Actual|University of Florida|||3||f||||t||||||||||2017-10-11 02:35:43.842726|2017-10-11 02:35:43.842726
NCT01671514|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-06-01|||July 2012||2012-07-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Dark Chocolate on Exercise Capacity, and Mitochondrial Structure and Function|Effects of Epicatechin-enriched Dark Chocolate on Mitochondrial Function and Exercise Capacity in Patients With Both Diabetes and Heart Failure and in Sedentary Individuals|Completed||N/A|21|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-11 02:35:43.935635|2017-10-11 02:35:43.935635
NCT01671501|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-07-07|||March 2013||2013-03-01|July 2017|2017-07-01|August 2017|Anticipated|2017-08-01|August 2016|Actual|2016-08-01||Interventional|||Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients|Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients|Active, not recruiting||N/A|600|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 02:35:44.045498|2017-10-11 02:35:44.045498
NCT01671488|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-07-26|2016-12-13||February 2013|Actual|2013-02-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|276||A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer|BrUOG 276: A Phase I/II Evaluation of ADXS11-001, Mitomycin,5-fluorouracil (5-FU) and IMRT for Anal Cancer|Active, not recruiting||Phase 1/Phase 2|11|Actual|Brown University||1|||f||||t||||||||||2017-10-11 02:35:44.289408|2017-10-11 02:35:44.289408
NCT01671462|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2014-02-19|||August 2012||2012-08-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System|European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System|Completed||N/A|1365|Actual|Becton, Dickinson and Company|||1||f||||f||||||||||2017-10-11 02:35:44.759862|2017-10-11 02:35:44.759862
NCT01671449|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-11-26|||December 2012||2012-12-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|SOPP||S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer|Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer|Completed||Phase 3|338|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:35:44.858403|2017-10-11 02:35:44.858403
NCT01671436|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-05-11|||September 2012||2012-09-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|CMIT||Meditation for Depression|Central Meditation and Imagery Therapy for Depression|Completed||N/A|13|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:35:45.167448|2017-10-11 02:35:45.167448
NCT01671423|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-05-04|||August 2012||2012-08-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis|Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis|Completed||N/A|42|Actual|Albert Einstein Healthcare Network||2|||f||||t||||||||No||2017-10-11 02:35:45.243695|2017-10-11 02:35:45.243695
NCT01671410|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-10-13|||August 2012||2012-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MOPPlus||Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines|A Randomized, Open Label Clinical Trial of Buprenorphine in the Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines or Are Breastfeeding|Completed||Phase 1|11|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 02:35:45.336033|2017-10-11 02:35:45.336033
NCT01671397|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2014-04-30|||September 2012||2012-09-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Women's Health Project for Women Wanting to Lose Weight|Intervention Study in Women Wanting to Lose Weight (Women's Health Project)|Completed||N/A|40|Actual|Texas Tech University Health Sciences Center||2|||f||||f||||||||||2017-10-11 02:35:45.426732|2017-10-11 02:35:45.426732
NCT01671384|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2015-12-31|||August 2013||2013-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Valproate and Levocarnitine in Children With Spinal Muscular Atrophy|Randomized Placebo Controlled Trial of Valproate and Levocarnitine in Children With Spinal Muscular Atrophy Aged 2-15 Years|Recruiting||Phase 3|60|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 02:35:45.505438|2017-10-11 02:35:45.505438
NCT01671371|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-06-29|||July 2012||2012-07-01|June 2016|2016-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Point-of-Care Ultrasound in the Emergency Department Evaluation of Syncope|A Randomized, Prospective Study on Point-of-Care Focused Cardiac Ultrasound in Patients Presenting to the Emergency Department With Syncope|Terminated||N/A|45|Actual|Yale University||2||unable to meet enrollment projections|f||||f||||||||||2017-10-11 02:35:45.597979|2017-10-11 02:35:45.597979
NCT01671358|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-06-01|||August 2012||2012-08-01|June 2015|2015-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms|Comparison of Contamination Rates of Medication Storage Cabinets Between Isolation and Non-isolation Rooms With Methicillin-resistant Staphylococcus Aureus (MRSA)|Completed||N/A|400|Actual|West Virginia University|||2||f||||f||||||||||2017-10-11 02:35:45.697038|2017-10-11 02:35:45.697038
NCT01671345|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-04-06|||November 27, 2013|Actual|2013-11-27|April 2017|2017-04-01|January 9, 2017|Actual|2017-01-09|November 30, 2016|Actual|2016-11-30||Interventional|ACTIVet||An Educational Intervention for Type 2 Diabetes Patients|A Randomized Trial of an Educational Intervention in Type 2 Diabetes Patients|Completed||N/A|169|Actual|VA Office of Research and Development||2|||f||||f||||||||Undecided||2017-10-11 02:35:45.767642|2017-10-11 02:35:45.767642
NCT01671306|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2012-08-22|||January 2011||2011-01-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||The Association Between Monocyte Subsets and Coronary Collateral Development in Diabetes Mellitus|The Association Between Monocyte Subsets and Coronary Collateral Development in Diabetes Mellitus|Completed||N/A|83|Actual|Samsun Education and Research Hospital|||2||f||||f||||||||||2017-10-11 02:35:46.066453|2017-10-11 02:35:46.066453
NCT01671293|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-06-25|2015-01-07||September 2011||2011-09-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|MTELECAREP||Multicomponent Telecare Model for Supporting Prediabetes Patients|Remote Care Model for Supporting Prediabetes Patients|Completed||N/A|70|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 02:35:46.132069|2017-10-11 02:35:46.132069
NCT01671280|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-03-15|2017-03-15||September 20, 2012|Actual|2012-09-20|March 2017|2017-03-01|April 22, 2016|Actual|2016-04-22|April 22, 2016|Actual|2016-04-22||Observational|RESCUE|A total of 401 participants completed this study. Of the 401 participants, 1 participant was excluded from the baseline analysis due to protocol violation.|Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)|Drug Use Investigation Of Azithromycin Iv|Completed||N/A|403|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 02:35:46.376162|2017-10-11 02:35:46.376162
NCT01671267|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2014-01-26|||August 2012||2012-08-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|IRMA||Implementation of Physical Exercise at the Workplace (IRMA06) - Slaughterhouse Workers|Implementation of Physical Exercise at the Workplace (IRMA06) - Slaughterhouse Workers|Completed||N/A|66|Actual|National Research Centre for the Working Environment, Denmark||2|||f||||f||||||||||2017-10-11 02:35:46.686383|2017-10-11 02:35:46.686383
NCT01671254|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2012-08-20|||August 2012||2012-08-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation|A Double-blind, Placebo-controlled Trial of a Dietary Supplement Containing Citrus Bioflavonoids and Vitamin E at 2 Doses in Conjunction With Fish Oil Supplementation in Hyperlipidemic Subjects|Unknown status|Recruiting|N/A|72|Anticipated|MetaProteomics LLC||3|||f||||f||||||||||2017-10-11 02:35:46.766432|2017-10-11 02:35:46.766432
NCT01671241|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-08-22|||January 2011||2011-01-01|August 2012|2012-08-01||||||||Interventional|||Heat Loss Prevention in Very Preterm Infants in Delivery Rooms: A Multicenter, Randomized, Controlled Trial of Polyethylene Occlusive Total Body Skin Wrapping||Unknown status|Recruiting|Phase 3|80|Anticipated|University of Padova||2|||f||||t||||||||||2017-10-11 02:35:46.881794|2017-10-11 02:35:46.881794
NCT01671228|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-04-30|||January 2011||2011-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|YoDDA||Developing and Evaluating the Yorkshire Dialysis Decision Aid|Development of a Patient Decision Aid (PtDA) to Facilitate Renal Patients Informed Decisions About Dialysis Treatments|Completed||Phase 1|488|Actual|University of Leeds||4|||f||||t||||||||||2017-10-11 02:35:48.912732|2017-10-11 02:35:48.912732
NCT01671189|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2012-08-22|||October 2012||2012-10-01|August 2012|2012-08-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Automated SMS-Based Appointment Validation Tool|An Automated SMS-Based Reminder and Rescheduling Tool to Improve Appointment Adherence Rates and Glycemic Control Among Diabetes Patients in San Mateo County|Unknown status|Not yet recruiting|Early Phase 1|300|Anticipated|Medic Mobile||2|||f||||f||||||||||2017-10-11 02:35:49.114167|2017-10-11 02:35:49.114167
NCT01671176|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-04-09|||May 2012||2012-05-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Wide Diameter Bone Anchored Implant Study|A Clinical Study of the Oticon Medical Ponto 4.5mm Wide Implant|Completed||N/A|30|Actual|Oticon Medical||1|||f||||f||||||||||2017-10-11 02:35:49.210335|2017-10-11 02:35:49.210335
NCT01671163|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-09-14|||July 2012||2012-07-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiotherapy|EUS-Guided Fiducial Placement for Stereotactic Body Radiotherapy|Recruiting||N/A|200|Anticipated|University of Florida|||1||f||||f|f|f||||||||2017-10-11 02:35:49.366264|2017-10-11 02:35:49.366264
NCT01671150|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-06-16|||March 2011||2011-03-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Inflammation-Induced Depressed Mood: The Role of Social Neurocognitive Mechanisms|Inflammation-Induced Depressed Mood: The Role of Social Neurocognitive Mechanisms|Completed||Early Phase 1|100|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:35:49.457914|2017-10-11 02:35:49.457914
NCT01671137|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-20|||September 2012||2012-09-01|August 2012|2012-08-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|||Probiotic for the Prevention of Functional Disorders in Childhood|A Randomized Controlled Trial of Lactobacillus Rhamnosus Strain GG for The Prevention of Functional Abdominal Pain Children After Acute Gastroenteritis|Unknown status|Not yet recruiting|N/A|400|Anticipated|University of Bari||2|||f||||t||||||||||2017-10-11 02:35:49.549417|2017-10-11 02:35:49.549417
NCT01671124|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-09-09|||September 2012||2012-09-01|August 2012|2012-08-01|November 2013|Anticipated|2013-11-01|July 2013|Anticipated|2013-07-01||Observational|||The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression|Phase IIa Study of Antidepression Use Natural Plants Extracted of Soline Capsule.|Unknown status|Recruiting|N/A|1|Anticipated|Taipei Medical University Hospital|||1||f||||t||||||||||2017-10-11 02:35:49.667255|2017-10-11 02:35:49.667255
NCT01671111|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-07-10|2015-07-10||August 2012||2012-08-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Safety set included all participants who had taken at least 1 dose of investigational product.|Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184)|A Phase 2, Open-label, Multicentre, Extension Safety and Tolerability Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using SSP-004184 (SPD602)|Terminated||Phase 2|30|Actual|Shire|This study was terminated early due to non-clinical safety results. Not all participants completed the study. The available efficacy data were analyzed as specified in the statistical analysis plan; however, no efficacy conclusions were drawn.|1||"This study was terminated due to treatment stop resulting in an inability to draw conclusions   from the data. Evaluation of nonclinical rat findings is ongoing."|f||||||||||||||2017-10-11 02:35:49.799959|2017-10-11 02:35:49.799959
NCT01671098|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-08-18|||August 2013||2013-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Sinonasal Gas Exchange Dynamics|Sinonasal Gas Exchange Dynamics The Aerodynamic Theory of the Sinonasal Interface|Completed||N/A|12|Actual|Louisiana State University Health Sciences Center Shreveport|||3||f||||f||||||||||2017-10-11 02:35:50.32402|2017-10-11 02:35:50.32402
NCT01671085|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2013-04-30|||August 2012||2012-08-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of LY3015014 in Healthy Participants With High Cholesterol|A Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3015014 in Subjects With Elevated LDL-C on a Stable Statin Therapy|Completed||Phase 1|12|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:35:50.41621|2017-10-11 02:35:50.41621
NCT01671072|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2015-01-21|||July 2011||2011-07-01|January 2015|2015-01-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis|A Placebo Controlled, Single-blind, Randomized, Multi-center Phase 2B Study to Determine the Efficacy and Safety of TissueGene-C, an Allogeneic Human Chondrocytes Expressing TGF-b1, in Patients With Degenerative Arthritis|Completed||Phase 2|54|Actual|Kolon Life Science||2|||f||||t||||||||||2017-10-11 02:35:50.522774|2017-10-11 02:35:50.522774
NCT01671059|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-01-06|2016-10-07||July 2012||2012-07-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational||Enrolled participants.|A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)|A Multi-Center, Non-Interventional Study to Evaluate Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab (ACROSS)|Completed||Phase 4|80|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:35:50.653766|2017-10-11 02:35:50.653766
NCT01671046|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection|Prospective Multicenter Observational Trial to Evaluate Correlation Between Liver Biopsy and Transient Elastography in Liver Fibrosis Assessment and Correlation Between Viral Kinetics and Transient Elastography Evolution During Hepatitis C Treatment in a Population of Chronic HCV Infected Patients|Completed||N/A|123|Actual|Hoffmann-La Roche|||1||f||||||||||Samples With DNA|"     Biopsy of the liver   "|||2017-10-11 02:35:51.237597|2017-10-11 02:35:51.237597
NCT01671033|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2012-08-22|||February 2010||2010-02-01|April 2010|2010-04-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring|Muscle Relaxation With Biofeedback Via Internet for Panic disorder-a Randomized Pilot Study|Terminated||N/A|9|Actual|Chimei Medical Center||3||The drop-out rate was too high.|f||||t||||||||||2017-10-11 02:35:51.326955|2017-10-11 02:35:51.326955
NCT01671020|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-06-29|||June 2012||2012-06-01|June 2016|2016-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects|Open-label, Randomized, Crossover Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects|Completed||Phase 1|16|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-10-11 02:35:51.419178|2017-10-11 02:35:51.419178
NCT01671007|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-10-03|||August 22, 2012|Actual|2012-08-22|October 2017|2017-10-01|January 14, 2020|Anticipated|2020-01-14|January 14, 2020|Anticipated|2020-01-14||Observational|||GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)|GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase II/III - EU/EEA Member States)|Recruiting||N/A|18000|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 02:35:51.567031|2017-10-11 02:35:51.567031
NCT01670994|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2016-10-26|||August 2012||2012-08-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|August 2013|Actual|2013-08-01||Interventional|||QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma|A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma|Terminated||Phase 1/Phase 2|6|Actual|Altor BioScience||1||Patient population did not benefit from single agent treatment.|f||||t||||||||No||2017-10-11 02:35:52.822588|2017-10-11 02:35:52.822588
NCT01670981|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-20|2017-03-06||2016-11-03|October 2012||2012-10-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|February 2016|Actual|2016-02-01||Interventional|ixCELL DCM||An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Tolerability of Transendocardial Injection of Ixmyelocel-T in Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM).|Active, not recruiting||Phase 2|114|Actual|Vericel Corporation||2|||f||||t||||||||||2017-10-11 02:35:53.030782|2017-10-11 02:35:53.030782
NCT01670968|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2013-01-25|||September 2009||2009-09-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|HIV RCTS||HIV Reverse Cholesterol Transport Study|The Effect of Antiretroviral Therapy and HIV on Reverse Cholesterol Transport in Blood( HIV Reverse Cholesterol Transport Study- HIV RCTS)|Unknown status|Recruiting|N/A|100|Anticipated|University College Dublin|||1||f||||f||||||||||2017-10-11 02:35:53.210478|2017-10-11 02:35:53.210478
NCT01670955|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2016-05-17|||December 2012||2012-12-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological Patients|A Prospective Phase II/III Randomized, Blinded Study to Demonstrate the Safety and Effectiveness of Jobelyn ( a Herbal Preparation ) in Pre-operative Management of Anaemia in Gynaecological Patients|Completed||Phase 2|73|Actual|Lagos State University||2|||f||||t||||||||No||2017-10-11 02:35:53.29789|2017-10-11 02:35:53.29789
NCT01670942|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-18|2014-04-25|||October 2012||2012-10-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Hypobaria and Traumatic Pneumothorax|The Effects of Hypobaric Conditions on Small, Traumatic Pneumothoraces|Completed||N/A|20|Actual|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-10-11 02:35:53.415833|2017-10-11 02:35:53.415833
NCT01670929|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-04-03|||September 2012||2012-09-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|||Pr-conceptional Progesterone for Unexplained Recurrent Miscarriage||Completed||Phase 4|700|Actual|Woman's Health University Hospital, Egypt||2|||f||||t||||||||||2017-10-11 02:35:53.495992|2017-10-11 02:35:53.495992
NCT01670916|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2013-09-30|||March 2010||2010-03-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Observational|||Probiotics to Prevent NEC - a Historical Control Study|Probiotics to Prevent NEC Stage II+ in Very Preterm Infants - a Historical Control Study|Completed||Phase 4|714|Actual|Rigshospitalet, Denmark|||2||f||||||||||||||2017-10-11 02:35:53.59447|2017-10-11 02:35:53.59447
NCT01670903|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2012-08-19|||May 2011||2011-05-01|August 2012|2012-08-01||||||||Observational|||The Effect of Angiotensin II Type 1 Receptor Antagonists on the Size and Expansion Rate of Abdominal Aortas in Hypertensive Patients|the Effect of Angiotensin II Type 1 Receptor Antagonists on the Size and Expansion Rate of Abdominal Aortas in Hypertensive Patients|Unknown status|Recruiting|N/A|150|Anticipated|Sheba Medical Center|||3||f||||f||||||||||2017-10-11 02:35:53.701459|2017-10-11 02:35:53.701459
NCT01670890|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2012-08-21|||August 2012||2012-08-01|August 2012|2012-08-01||||August 2014|Anticipated|2014-08-01||Interventional|||Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas|Efficacy and Safety of Salvage Treatment With Dose-dense TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas: a Multicentre,Prospective Clinical Study|Unknown status|Recruiting|Phase 2|120|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 02:35:53.811925|2017-10-11 02:35:53.811925
NCT01670877|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-06-14|||December 11, 2012|Actual|2012-12-11|June 2017|2017-06-01|November 30, 2020|Anticipated|2020-11-30|December 31, 2018|Anticipated|2018-12-31||Interventional|||Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer|A Phase II Study of Neratinib Alone and in Combination With Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer|Recruiting||Phase 2|70|Anticipated|Washington University School of Medicine||4|||f||||t|t|f||||||No||2017-10-11 02:35:53.95242|2017-10-11 02:35:53.95242
NCT01670864|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2013-07-22|||July 2012||2012-07-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Promoting Smoking Cessation in the Community Via Quit to Win Contest 2012|Promoting Smoking Cessation in the Community Via Quit to Win Contest 2012: Aa Cluster Randomized Controlled Trial of 18 Districts in Hong Kong|Completed||N/A|1193|Actual|The University of Hong Kong||3|||f||||t||||||||||2017-10-11 02:35:54.140726|2017-10-11 02:35:54.140726
NCT01670851|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2015-12-07|||March 2013||2013-03-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|PRESSUR||Perineal Reconstruction Following eLAPE and Simultaneous Stoma Sublay Reinforcement|Perineal Reconstruction Following Extralevator Abdominoperineal Excision of Rectum and Simultaneous Stoma Sublay Reinforcement|Completed||N/A|20|Actual|University Hospitals, Leicester|||1||f||||f||||||||||2017-10-11 02:35:54.218297|2017-10-11 02:35:54.218297
NCT01670838|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2017-03-01|||February 2012||2012-02-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|SAHHEART||Cardiopulmonary Complication in Aneurysmal Subarachnoid Haemorrhage Patients|Cardiopulmonary Complication in Aneurysmal Subarachnoid Haemorrhage Patients|Recruiting||N/A|200|Anticipated|Kuopio University Hospital|||1||f||||t||||||Samples With DNA|"     MICRORNA   "|No||2017-10-11 02:35:54.293593|2017-10-11 02:35:54.293593
NCT01670825|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2017-01-10|2016-08-10||August 2012||2012-08-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pulsed Radiofrequency vs. Steroid Injections for Occipital Neuralgia|Randomized, Double-blind, Comparative-effectiveness Study Comparing Corticosteroid Injections to Pulsed Radiofrequency for Occipital Neuralgia|Completed||N/A|81|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:35:54.415762|2017-10-11 02:35:54.415762
NCT01670812|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-19|2012-08-19|||January 2012||2012-01-01|August 2012|2012-08-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia|Clinical Study of Chemoimmunotherapy With Fresh Frozen Plasma, High Dose Methylprednisolone and Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia|Unknown status|Recruiting|Phase 3|100|Anticipated|The First Affiliated Hospital with Nanjing Medical University||1|||f||||t||||||||||2017-10-11 02:35:55.438552|2017-10-11 02:35:55.438552
NCT01670799|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-09-15|||March 2012||2012-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer|A Pilot Trial to Study the Availability and Effect of Post-OP IV Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer, Cells Retrieved From the Peritoneal Cavity|Active, not recruiting||Early Phase 1|60|Anticipated|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-11 02:35:55.604578|2017-10-11 02:35:55.604578
NCT01670786|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2014-05-12|||January 2010||2010-01-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion|Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion|Completed||Phase 4|60|Actual|Grupo de Pesquisa em Pleura e Oncologia Toracica||2|||f||||f||||||||||2017-10-11 02:35:55.763431|2017-10-11 02:35:55.763431
NCT01670773|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-10-29|||August 2012||2012-08-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study of CAT-1004 Biomarkers in Healthy Subjects|A Phase 1, Single Center, Biomarker Study in Healthy Subjects Receiving Single Doses of CAT-1004|Completed||Phase 1|9|Actual|Catabasis Pharmaceuticals||3|||f||||f||||||||||2017-10-11 02:35:55.856649|2017-10-11 02:35:55.856649
NCT01670760|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-17|||August 2012||2012-08-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Zero Heat Flux Thermometry System Comparison Trial|3M(TM)SpotOn(TM) Temperature Monitoring System Thermometry Trial|Unknown status|Not yet recruiting|N/A|20|Anticipated|Arizant Healthcare||1|||f||||f||||||||||2017-10-11 02:35:55.942743|2017-10-11 02:35:55.942743
NCT01670747|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-03-18|||September 2012||2012-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Evaluation of the Lung Recruitment and End-expiratory Lung Collapse in Acute Respiratory Distress Syndrome (ARDS)|Evaluation of the Lung Recruitment and End-expiratory Lung Collapse in Patients With Acute Respiratory Distress Syndrome|Completed||N/A|30|Anticipated|Policlinico Hospital|||1||f||||f||||||||||2017-10-11 02:35:56.058043|2017-10-11 02:35:56.058043
NCT01670734|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-06-27|||September 2012||2012-09-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects|An Open-Label, Pharmacokinetic and Tolerability Study of SAR236553/REGN727 Given as a Single SC Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function|Completed||Phase 1|25|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:35:56.134506|2017-10-11 02:35:56.134506
NCT01670721|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-10-04|2016-06-08||August 2012||2012-08-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|AFEQT||Colorectal Cancer Metastatic|A Multicenter, Single Arm, Open Label Clinical Trial Evaluating Safety and Health Related Quality of Life of Aflibercept in Combination With Irinotecan/5-FU Chemotherapy (FOLFIRI) in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen|Completed||Phase 3|175|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:35:56.250015|2017-10-11 02:35:56.250015
NCT01670708|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-07-05|||August 2012||2012-08-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2014|Actual|2014-09-01||Interventional|||HOPE Demonstration Field Experiment Multisite Evaluation|Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment|Active, not recruiting||N/A|1600|Anticipated|RTI International||2|||f||||f||||||||||2017-10-11 02:35:56.921297|2017-10-11 02:35:56.921297
NCT01670695|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-04-07|||January 2012|Actual|2012-01-01|April 2017|2017-04-01|January 2032|Anticipated|2032-01-01|January 2032|Anticipated|2032-01-01||Observational|||A Prospective Cohort Study of IgG4RD in China|Cohort Study of Patients With IgG4-Related Disease|Recruiting||N/A|1000|Anticipated|Peking Union Medical College Hospital|||1||f||||t||||||Samples With DNA|"     blood samples (serum and plasma, with DNA)   "|||2017-10-11 02:35:57.032303|2017-10-11 02:35:57.032303
NCT01670682|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-08-18|||August 2012||2012-08-01|August 2012|2012-08-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Ischia Spinous Fascia Fixation Procedure Versus Modified Total Pelvic Floor Reconstructive Surgery for Pelvic Organ Prolapse Stage III|A Prospective，Multicenter Pilot Study to Compare Ischia Spinous Fascia Fixation Procedure With Modified Total Pelvic Floor Reconstruction Surgery For Pelvic Organ Prolapse Stage III|Unknown status|Recruiting|N/A|80|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 02:35:57.143221|2017-10-11 02:35:57.143221
NCT01670669|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-20|||November 1998||1998-11-01|August 2012|2012-08-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Interventional|||Prucalopride in Paediatric Subjects, With Functional Faecal Retention|An Open-label Follow-up Study of 0.01 mg/kg/Day to 0.03 mg/kg/Day Prucalopride (R108512) Oral Solution in Paediatric Subjects, Aged >= 4 to <= 12 Years With Functional Faecal Retention (FFR), Who Participated in the PRU-USA-12.|Completed||Phase 1|37|Actual|Movetis||1|||||||||||||||||2017-10-11 02:35:57.247919|2017-10-11 02:35:57.247919
NCT01670656|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-09-06|2017-07-25||January 21, 2013|Actual|2013-01-21|September 2017|2017-09-01|September 12, 2013|Actual|2013-09-12|September 11, 2013|Actual|2013-09-11||Interventional|||A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)|A Multicenter, Randomized, Partially Blinded, Placebo-controlled Clinical Trial to Evaluate the Effect on Primary Dysmenorrhea of Vaginal Rings With an Average Daily Release of 700 μg Nomegestrol Acetate (NOMAC) and 300 μg Estradiol (E2), or 900 μg Nomegestrol Acetate (NOMAC) and 300 μg Estradiol (E2), or 100 μg Etonogestrel (ENG) and 300 μg E2, or 125 μg Etonogestrel (ENG) and 300 μg E2. Protocol MK-8175A/MK-8342B 057 (Abbreviated as P057), Also Known as SCH900121/SCH900432 08257 (Abbreviated as P08257)|Completed||Phase 2|439|Actual|Merck Sharp & Dohme Corp.||5|||f||||f|f|f||||||||2017-10-11 02:35:57.338213|2017-10-11 02:35:57.338213
NCT01670643|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-06|2017-03-23|||January 2010||2010-01-01|March 2017|2017-03-01|February 2011|Actual|2011-02-01|April 2010|Actual|2010-04-01||Observational|||Reading Performance With a Video Magnifier|The Effect of Video Camera Magnifier Use on Reading|Completed||N/A|120|Actual|Massachusetts Eye and Ear Infirmary|||1||f||||f||||||||No||2017-10-11 02:35:57.954756|2017-10-11 02:35:57.954756
NCT01670630|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-02-28|||July 2012||2012-07-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Comparison of a Sheathed to a Standard Speculum for Visualization of the Cervix|A Comparison of a Novel Sheathed Speculum to a Standard Speculum for Visualization of the Cervix|Completed||N/A|136|Anticipated|Florida Hospital||2|||f||||f||||||||||2017-10-11 02:35:58.046779|2017-10-11 02:35:58.046779
NCT01670617|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-01-25|||March 2012||2012-03-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|||DeNovo NT Natural Tissue Graft Stratified Knee Study|A Stratified, Post-Market Study of DeNovo NT for the Treatment of Femoral and Patellar Articular Cartilage Lesions of the Knee|Active, not recruiting||N/A|90|Actual|Zimmer Orthobiologics, Inc.||1|||f||||f||||||||||2017-10-11 02:35:58.144263|2017-10-11 02:35:58.144263
NCT01670604|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2012-08-20|||January 2012||2012-01-01|August 2012|2012-08-01||||March 2013|Anticipated|2013-03-01||Interventional|||Use of Two Modern Hydroxyethyl Starch Solutions in Major Urological Procedures|The Use of Two Modern Hydroxyethyl Starch Solutions in Major Urological Procedures: Effect on Acid-Base Status and Renal Functions|Unknown status|Recruiting|Phase 4|40|Anticipated|Kasr El Aini Hospital||2|||f||||t||||||||||2017-10-11 02:35:58.270231|2017-10-11 02:35:58.270231
NCT01670591|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-08-20|||January 2009||2009-01-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Prevention in School (PS): a Swedish School-wide Positive Behavior Support Program at the Primary Prevention Level||Completed||N/A|3207|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:35:58.368832|2017-10-11 02:35:58.368832
NCT01670578|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-05-23|||February 2009||2009-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional|PRP||Platelet-rich Plasma vs Viscosupplementation in the Treatment of Knee Articular Degenerative Pathology|Platelet-rich Plasma (PRP) vs Viscosupplementation in the Treatment of Knee Articular Degenerative Pathology: a Randomized Double-blind Controlled Trial|Completed||Phase 4|192|Actual|Istituto Ortopedico Rizzoli||2|||f||||t||||||||||2017-10-11 02:35:58.451675|2017-10-11 02:35:58.451675
NCT01670565|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-03-15|||August 2012||2012-08-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis|Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis: A Phase 2a, Single-centered, Randomized, Placebo-controlled, Double-blind, Proof-of-concept Pilot Study.|Completed||Phase 2|20|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 02:35:58.752228|2017-10-11 02:35:58.752228
NCT01670552|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-06-09|||February 2016||2016-02-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients|Parallel Study, Double-blind, Randomized, to Compare the Safety of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients.|Recruiting||Phase 3|452|Anticipated|EMS||2|||f||||t||||||||||2017-10-11 02:35:58.854153|2017-10-11 02:35:58.854153
NCT01670539|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-08-21|||June 2010||2010-06-01|August 2012|2012-08-01|May 2013|Anticipated|2013-05-01|December 2012|Anticipated|2012-12-01||Interventional|HTPLC||Home Telemonitoring for Patients With Lung Cancer|PILOT: Home Telemonitoring for Self-Management Education of Patients With Lung Ca|Unknown status|Recruiting|N/A|70|Anticipated|West Virginia University||2|||f||||t||||||||||2017-10-11 02:35:58.948957|2017-10-11 02:35:58.948957
NCT01670526|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-08-01|2017-05-23||December 2012||2012-12-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|June 2016|Actual|2016-06-01||Interventional|RIVET||Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI|Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI|Active, not recruiting||Phase 3|94|Actual|VA Office of Research and Development||2|||f||||t|t|f||||||||2017-10-11 02:35:59.054301|2017-10-11 02:35:59.054301
NCT01670513|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-04-23|||June 2012||2012-06-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|May 2013|Anticipated|2013-05-01||Interventional|IDP-118||A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118|A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|Dow Pharmaceutical Sciences||2|||f||||f||||||||||2017-10-11 02:35:59.565504|2017-10-11 02:35:59.565504
NCT01670500|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-10-03|||October 2012||2012-10-01|October 2017|2017-10-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa|A Randomized Phase II Trial of Neoadjuvant Cisplatin vs. Doxorubicin/Cyclophosphamide (AC) in Women With Newly Diagnosed Breast Cancer and Germline BrCa Mutations|Recruiting||Phase 2|170|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 02:35:59.67571|2017-10-11 02:35:59.67571
NCT01670487|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-07-29|2016-02-01||October 2012||2012-10-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional||adults undergoing IV annulation in ED|Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients|Prospective,Randomized,Blinded, Comparative,Efficacy and Safety Trial of Vapocoolant (Pain Ease Medium Stream) for Intravenous Cannulation in Emergency Department Patients.|Completed||Phase 4|300|Actual|The Cleveland Clinic||2|||f||||t||||||||No||2017-10-11 02:35:59.886978|2017-10-11 02:35:59.886978
NCT01670474|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-08-20|||January 2011||2011-01-01|August 2012|2012-08-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|PROCOPrt-PA||Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA|Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA - PROCOPrt-PA Trial|Unknown status|Recruiting|Phase 4|240|Anticipated|Centre Hospitalier du Centre du Valais||3|||f||||t||||||||||2017-10-11 02:36:00.155134|2017-10-11 02:36:00.155134
NCT01670461|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-05-19|||January 2009||2009-01-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|FACE||FAmily CEntered (FACE) Advance Care Planning for Teens With Cancer|FAmily CEntered (FACE) Advance Care Planning for Teens With Cancer|Completed||N/A|60|Actual|Children's Research Institute||2|||f||||f||||||||||2017-10-11 02:36:00.272661|2017-10-11 02:36:00.272661
NCT01670448|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-08-31|||January 2014||2014-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PECBLOC||PECBLOCK for the Treatment of Pain After Breast Surgery|The Pectoral Nerve Block (PECBLOCK) for the Treatment of Pain After Breast Cancer Surgery.|Completed||N/A|128|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 02:36:00.384482|2017-10-11 02:36:00.384482
NCT01669681|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-04-06|||December 20, 2011|Actual|2011-12-20|March 2017|2017-03-01|December 16, 2016|Actual|2016-12-16|December 16, 2014|Actual|2014-12-16||Observational|Cobra||Cobra (Severe Asthma)Medical-economic|Medical Economic Evaluation of the Care of the Severe Asthma : Cohort COBRA|Completed||N/A|81|Actual|University Hospital, Montpellier|||1||f||||t||||||||||2017-10-11 02:36:13.118243|2017-10-11 02:36:13.118243
NCT01670435|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-27|||May 2007||2007-05-01|August 2012|2012-08-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Observational|||Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance|Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance|Completed||N/A|3274|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:36:00.466688|2017-10-11 02:36:00.466688
NCT01670422|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-21|||January 1980||1980-01-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Observational|||Risk Factors Associated With Recurrence and Life-threatening Complications for CSOJ|Risk Factors Associated With Recurrence and Life-threatening Complications for Patients Hospitalized With Chronic Suppurative Osteomyelitis of the Jaw|Completed||N/A|322|Actual|West China College of Stomatology|||1||f||||f||||||||||2017-10-11 02:36:00.558969|2017-10-11 02:36:00.558969
NCT01670409|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2015-08-27|||August 2012||2012-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer|A Phase II Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma|Completed||Phase 2|85|Actual|Shantou University Medical College||1|||f||||f||||||||||2017-10-11 02:36:00.628544|2017-10-11 02:36:00.628544
NCT01670396|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-08-19|||March 2012||2012-03-01|August 2012|2012-08-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Observational|ISR||Genetics Study of In-stent Restenosis|G Protein β3 Subunit (GNB3) Polymorphism and Restenosis of Coronary Drug-eluting Stents|Unknown status|Recruiting|N/A|300|Anticipated|Shanghai Zhongshan Hospital|||2||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 02:36:00.745737|2017-10-11 02:36:00.745737
NCT01670383|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-10-14|||July 2006||2006-07-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|December 2020|Anticipated|2020-12-01||Observational|||Repository for Sepsis and Postresuscitation Samples|Repository for Samples Collected From Sepsis and Postresuscitation Patients in Emergency Intensive Care Unit|Recruiting||N/A|500|Anticipated|Seoul National University Hospital|||2||f||||t||||||Samples Without DNA|"     Patients sera at ICU admission, day-1, day-3 and day-7 are stored in deep freezer.   "|||2017-10-11 02:36:00.838075|2017-10-11 02:36:00.838075
NCT01670370|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-19|||January 2012||2012-01-01|August 2012|2012-08-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Trial of GemOx±R Regimen in First-line Treatment of Elderly Aggressive B Cell Lymphoma|Randomized Controlled Trial of GemOx±R Regimen in First-line Treatment of Elderly Aggressive B Cell Lymphoma|Unknown status|Recruiting|Phase 3|100|Anticipated|The First Affiliated Hospital with Nanjing Medical University||2|||f||||t||||||||||2017-10-11 02:36:00.95324|2017-10-11 02:36:00.95324
NCT01670357|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-09-29|||April 2012||2012-04-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|DES||Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome|Placebo Controlled, Dose-Response, Randomized, Double Blind, Phase II Study to Evaluate the Efficacy and Safety of DA-6034 Eye Drops in Patients With Dry Eye Syndrome|Completed||Phase 2|150|Anticipated|Dong-A ST Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:36:01.147142|2017-10-11 02:36:01.147142
NCT01670344|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2013-06-20|||July 2012||2012-07-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|VIPS||Evaluation of an Innovative Medical Device Supporting Orthopedic Surgical Interventions|Virtual Implant Planning System - A Method to Support Image-guided Surgical Interventions|Completed||N/A|80|Actual|Siemens Healthcare QT||2|||f||||f||||||||||2017-10-11 02:36:01.312199|2017-10-11 02:36:01.312199
NCT01670331|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-08-23|||March 2013||2013-03-01|August 2013|2013-08-01|June 2014|Anticipated|2014-06-01|October 2013|Anticipated|2013-10-01||Interventional|||Psychological Preparation Prior to Bariatric Surgery|Psychological Preparation Prior to Bariatric Surgery: A Feasibility Study|Unknown status|Recruiting|N/A|60|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:36:01.421078|2017-10-11 02:36:01.421078
NCT01670318|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-21|||August 2012||2012-08-01|August 2012|2012-08-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|SPECIALIST||Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets|Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets|Unknown status|Recruiting|N/A|800|Anticipated|The PCI Guideline Research Society||1|||f||||t||||||||||2017-10-11 02:36:01.57511|2017-10-11 02:36:01.57511
NCT01670305|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-09-10|||February 2011||2011-02-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|May 2011|Actual|2011-05-01||Interventional|||Photodynamic Therapy and Periodontal Therapy. A Clinical, Microbiological and Immunoenzymatic Analysis|Photodynamic Therapy and Periodontal Therapy. A Clinical, Microbiological and Immunoenzymatic Analysis.|Completed||N/A|75|Actual|Paulista University||5|||f||||t||||||||||2017-10-11 02:36:01.888574|2017-10-11 02:36:01.888574
NCT01670279|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-01-05|2015-08-04||July 2012||2012-07-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder|A Phase 1, Multicenter, Randomized, Double-blind, Sequential Cohort, Placebo-controlled Trial to Assess the Safety and Tolerability of Ascending Multiple Oral Doses of Brexpiprazole as Adjunctive Therapy in the Treatment of Elderly Subjects With Major Depressive Disorder|Completed||Phase 1|18|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|Cohort 3 was not initiated based on the safety/tolerability results from Cohorts 1 and 2.|4|||f||||f||||||||||2017-10-11 02:36:02.111394|2017-10-11 02:36:02.111394
NCT01670266|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2013-05-31|||August 2012||2012-08-01|May 2013|2013-05-01||||May 2013|Actual|2013-05-01||Interventional|||Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma|A Double-masked, Placebo-controlled, Dose-escalation Study and Double-masked, Two-sequence, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-9054 in Patients With Ocular Hypertension or Mild Open-Angle Glaucoma|Completed||Phase 1|60|Actual|Ono Pharmaceutical Co. Ltd||5|||f||||f||||||||||2017-10-11 02:36:02.847743|2017-10-11 02:36:02.847743
NCT01670253|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-21|||August 2012||2012-08-01|August 2012|2012-08-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|RETIME||Reduction of Starvation Time Prior to Gastroscopy|Randomized, Double-blind, Controlled, Parallel-group Study Reduction of Starvation Time Prior to Gastroscopy|Unknown status|Not yet recruiting|N/A|600|Anticipated|Odense University Hospital||2|||f||||f||||||||||2017-10-11 02:36:02.936051|2017-10-11 02:36:02.936051
NCT01670240|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-01-27|||August 2012||2012-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|ADAP||Adalimumab in the Treatment of Chronic Pouchitis|Adalimumab (Humira) in the Treatment of Chronic Pouchitis|Completed||Phase 3|13|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-11 02:36:02.999249|2017-10-11 02:36:02.999249
NCT01670227|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-03-01|||September 2005||2005-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ParentCorps||ParentCorps: Promoting Healthy Development in Children From Low Income Communities|Preventing Conduct Problems in Poor Urban Preschoolers|Completed||N/A|1050|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 02:36:03.083526|2017-10-11 02:36:03.083526
NCT01670214|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-02-15|||January 2012||2012-01-01|August 2012|2012-08-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Pulsed Electromagnetic Field Therapy in the Refractory Migraine|A Randomized, Placebo-control of Pulsed Electromagnetic Field Therapy as Preventive Treatment of Refractory Migraine|Completed||N/A|30|Actual|Niyayesh Clinic||2|||f||||t||||||||||2017-10-11 02:36:03.166846|2017-10-11 02:36:03.166846
NCT01670201|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-09-03|2014-04-03||September 2012||2012-09-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||An Investigation to Evaluate a New Donor Site Dressing in Surgical Burn Patients|A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Adequacy of a New Donor Site Dressing in Surgical Burn Patients.|Completed||N/A|8|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 02:36:03.484465|2017-10-11 02:36:03.484465
NCT01670188|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-04-22|||August 2012||2012-08-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||SCD Use to Prevent DVT in Patients With PICC Lines|Sequential Pneumatic Compression to Prevent PICC-related Upper Extremity Venous Thrombosis in Critically Ill Neurological Patients|Enrolling by invitation||N/A|102|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:36:03.66032|2017-10-11 02:36:03.66032
NCT01670175|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-06-20|||August 2012||2012-08-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors|A Phase I Study of Sirolimus in Combination With Oral Cyclophosphamide and Oral Topotecan in Children and Young Adults With Relapsed and Refractory Solid Tumors|Completed||Phase 1|21|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:36:03.73495|2017-10-11 02:36:03.73495
NCT01670162|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2014-10-27|||August 2012||2012-08-01|October 2014|2014-10-01|January 2016|Anticipated|2016-01-01|November 2015|Anticipated|2015-11-01||Interventional|ROLL||On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)|On-label tReatment With Intravitreal Aflibercept Injection for Patients With Persistent Pigment Epithelial Detachments in Neovascular AMD.|Unknown status|Active, not recruiting|Phase 4|30|Actual|Tennessee Retina||1|||f||||f||||||||||2017-10-11 02:36:03.813866|2017-10-11 02:36:03.813866
NCT01670149|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-05-05|||December 2012||2012-12-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|RAPID||Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea|"A Randomised Placebo Controlled Trial of Follow on Rifaximin for the Prevention of Relapse of Clostridium Associated Diarrhoea"|Completed||Phase 4|151|Actual|University of Nottingham||2|||f||||t||||||||No||2017-10-11 02:36:03.928023|2017-10-11 02:36:03.928023
NCT01670136|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-11-01|||February 2013||2013-02-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Pharmacokinetics of Sildenafil in Premature Infants|Pharmacokinetics of Sildenafil in Premature Infants|Completed||Phase 1|34|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-11 02:36:04.022444|2017-10-11 02:36:04.022444
NCT01670123|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2014-07-24|||July 2010||2010-07-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PRISM||Development of a Personalized Real-time Intervention for Bipolar Disorder|Development of a Personalized Real-time Intervention for Bipolar Disorder|Completed||N/A|90|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 02:36:04.256662|2017-10-11 02:36:04.256662
NCT01670110|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-09-06|||August 2012||2012-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|SOM230||Pasireotide LAR in Severe Polycystic Liver Disease|A Randomized, Placebo Controlled Clinical Trial of SOM230 (Pasireotide LAR) In Severe Polycystic Liver Disease|Active, not recruiting||Phase 2|48|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 02:36:04.356492|2017-10-11 02:36:04.356492
NCT01670097|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-06-19|||January 2013|Actual|2013-01-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Dexamethasone Dyspnea Study|A Preliminary Study of Dexamethasone for Dyspnea in Cancer Patients|Active, not recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 02:36:04.476999|2017-10-11 02:36:04.476999
NCT01670084|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-10-29|||December 2012||2012-12-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia|A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage|Withdrawn||Phase 2|0|Actual|Mayo Clinic||1||No Accrual|f||||t||||||||||2017-10-11 02:36:04.627246|2017-10-11 02:36:04.627246
NCT01670071|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-04-12|||January 2013||2013-01-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia|A Randomized, Open-Label, Study To Evaluate The Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Selected Cognitive Domains in Clinically Stable Subjects With Schizophrenia|Terminated||Phase 4|17|Actual|Johnson & Johnson Taiwan Ltd||2||The study was terminated due to insufficient sample size and protocol compliance issue.|f||||f||||||||||2017-10-11 02:36:04.819411|2017-10-11 02:36:04.819411
NCT01670045|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-09-14|2016-04-06||March 2012||2012-03-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational||Intent-to-treat (ITT) population included all enrolled participants who received at least one dose of tocilizumab.|A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis|A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab|Completed||N/A|43|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:36:05.056571|2017-10-11 02:36:05.056571
NCT01670032|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2014-08-08||2014-08-07|August 2012||2012-08-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo|A Multicenter, Double Blind, Randomized, Vehicle Controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of CD 07223 1.5% Topical Gel in Impetigo|Completed||Phase 2/Phase 3|328|Actual|NovaBay Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 02:36:05.575449|2017-10-11 02:36:05.575449
NCT01670019|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-08-31|2015-06-29||October 2012||2012-10-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression|A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy|Completed||Phase 4|46|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:36:05.709948|2017-10-11 02:36:05.709948
NCT01670006|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-09-23|||October 2012||2012-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:36:06.034924|2017-10-11 02:36:06.034924
NCT01669993|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-01-04|||May 2012||2012-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Factors Predictive of Adverse Postoperative Outcomes in Children Undergoing Tonsillectomy|Factors Predictive of Adverse Postoperative Outcomes in Children Undergoing|Recruiting||N/A|2000|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||||||2017-10-11 02:36:06.081867|2017-10-11 02:36:06.081867
NCT01669980|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-10-05||2015-10-05|October 2012||2012-10-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)|A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline Versus Ceftriaxone Plus Vancomycin in Pediatric Subjects With Complicated Community-acquired Bacterial Pneumonia (CABP)|Completed||Phase 4|40|Actual|Forest Laboratories||2|||f||||t||||||||||2017-10-11 02:36:06.193102|2017-10-11 02:36:06.193102
NCT01669967|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-03-19|||September 2011||2011-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin|The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin|Completed||N/A|34|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:36:06.328658|2017-10-11 02:36:06.328658
NCT01669954|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-17|||February 2009||2009-02-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|Probono1||Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study|Prospective Study to Determine the Optimum Age for Routine DEXA Screening for Osteopenia/Osteoporosis in People With HIV Infection|Completed||N/A|440|Actual|King's College London|||4||f||||f||||||Samples Without DNA|"     Plasma and urine   "|||2017-10-11 02:36:06.414909|2017-10-11 02:36:06.414909
NCT01669941|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-03-03|||August 2012||2012-08-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|October 2014|Actual|2014-10-01||Interventional|STOP MiP KENYA||Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya|Intermittent Screening and Treatment (IST) or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya: a Randomized Controlled Trial|Completed||Phase 4|1546|Actual|Kenya Medical Research Institute||3|||f||||t||||||||||2017-10-11 02:36:06.481424|2017-10-11 02:36:06.481424
NCT01669928|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2015-09-08|||April 2012||2012-04-01|February 2015|2015-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|HARMONY||Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control|Hellenic Anglo Research Into Morning Or Evening Antihypertensive Drug deliverY Trial|Completed||Phase 4|103|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 02:36:06.584853|2017-10-11 02:36:06.584853
NCT01669915|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2017-01-30|||August 2010||2010-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VITAL-Cog||A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline|A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline|Active, not recruiting||N/A|3992|Actual|Brigham and Women's Hospital||4|||f||||f||||||||||2017-10-11 02:36:06.694414|2017-10-11 02:36:06.694414
NCT01669902|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2015-10-21|2015-10-21||April 2012||2012-04-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational||Safety Analysis Set included all data from all participants who received at least one injection with tocilizumab.|An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis|HAQIMONO a Non-interventional National Multicenter Study, Observing RA Patients Treated With Tocilizumab in Mono-therapy, i.e. Without Combination With DMARD|Completed||N/A|107|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:36:06.813257|2017-10-11 02:36:06.813257
NCT01669889|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-11-01|||January 2013||2013-01-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome|A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.|Completed||N/A|38|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:36:07.622397|2017-10-11 02:36:07.622397
NCT01669707|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-17|||April 2011||2011-04-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|April 2013|Anticipated|2013-04-01||Interventional|||Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)|Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|60|Anticipated|Beijing Chest Hospital||2|||f||||t||||||||||2017-10-11 02:36:12.923593|2017-10-11 02:36:12.923593
NCT01669876|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-04-28|||August 2012||2012-08-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|ASAP||Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease|3-Month, Single Site or Multi-Site, Double Blind, Randomized, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety Tolerability and Potential Effects of the Dietary Supplement Anatabloc(R) in Subjects With Alzheimer's Disease|Terminated||Phase 2|85|Actual|Rock Creek Pharmaceuticals, Inc.||2||Administrative status of active ingredient anatabine|f||||f||||||||||2017-10-11 02:36:07.689231|2017-10-11 02:36:07.689231
NCT01669863|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-04-22|2015-03-17||August 2012||2012-08-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS)|Awake Extracorporeal Membrane Oxygenation (ECMO) for Acute Respiratory Failure A Non-controlled, Single-center, Investigator-initiated Prove-of-concept Study|Completed||Phase 1/Phase 2|6|Actual|Hannover Medical School||1|||f||||f||||||||||2017-10-11 02:36:07.794479|2017-10-11 02:36:07.794479
NCT01669850|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-09-04|||August 2012||2012-08-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Clipped Versus Handsewn Arteriovenous Fistula Anastomosis|The Safety and Effectiveness of Clipped Technique vs. Hand-Sewn Technique for Anastomosis in Arteriovenous Fistulas|Terminated||N/A|38|Actual|Gundersen Lutheran Medical Foundation||2||minimal accrual|f||||f||||||||||2017-10-11 02:36:07.961492|2017-10-11 02:36:07.961492
NCT01669837|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2016-06-07|||August 2012||2012-08-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||An Efficiency/Safety Study of Surgical Tissue Glue to Treat Inguinal Hernias|Cyanoacrylate Fixation for Laparoscopic Repair of Inguinal Hernias: a Prospective, Multicenter Registry|Recruiting||N/A|500|Anticipated|be Medical|||1||f||||f||||||||||2017-10-11 02:36:08.046748|2017-10-11 02:36:08.046748
NCT01669824|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2012-08-17|||August 2007||2007-08-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|||||Observational|||Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg|Tolerability, Compliance and Indications of Aspirin Protect 100 mg in Longterm Use (12 Months) Under Everyday's Conditions - Data Collection With Questionnaires Handed Out in Pharmacies to Aspirin Protect 100 mg Consumers|Completed||N/A|4235|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:36:08.123725|2017-10-11 02:36:08.123725
NCT01669811|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2015-08-19|2015-05-18||August 2012||2012-08-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||It was found that 2 patients in D961H 20 mg QD + Placebo group had no refractory RE after randomisation. Therefore, these two patients were excluded from the full analysis set, which was the primary analysis set of this study and was used for summaries of baseline characteristics and outcome measures.|Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)|A Multicentre, Randomised, Double-blind, Parallel-group, Comparative Study to Compare the Efficacy and Safety of D961H 20 mg Twice Daily Oral Administration and D961H 20 mg Once Daily Oral Administration in Patients With Refractory Reflux Esophagitis|Completed||Phase 3|1398|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:36:08.207533|2017-10-11 02:36:08.207533
NCT01669798|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-03-11|||February 2013||2013-02-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer|Phase II Evaluation of BIBF 1120 in the Treatment of Bevacizumab-Resistant, Persistent, or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Recruiting||Phase 2|56|Anticipated|Duke University||1|||f||||f||||||||||2017-10-11 02:36:11.198097|2017-10-11 02:36:11.198097
NCT01669785|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2014-08-20|2014-02-20||March 2012||2012-03-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study|NUPRO Sensodyne Prophylaxis Paste With NovaMin for the Treatment of Dentin Hypersensitivity.|Completed||N/A|139|Actual|Dentsply International||3|||f||||f||||||||||2017-10-11 02:36:11.343826|2017-10-11 02:36:11.343826
NCT01669772|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2014-07-02|||March 2012||2012-03-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|||Study on the Effects of DA-9701 on Gastrointestinal Motility on Healthy Adult Volunteers|Study on the Effects of DA-9701 on Gastrointestinal Motility on Healthy Adult Males and Female Subjects|Completed||Phase 1/Phase 2|31|Actual|The Catholic University of Korea||2|||f||||t||||||||||2017-10-11 02:36:12.064868|2017-10-11 02:36:12.064868
NCT01669759|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-20|||July 2012||2012-07-01|August 2012|2012-08-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||The Study in the Correlation Between the Severity of Post-stroke Fatigue and the Severity of qi Deficiency and Blood Stasis|The Study in the Correlation Between the Severity of Post-stroke Fatigue and the Severity of qi Deficiency and Blood Stasis in Chinese Medicine.|Unknown status|Recruiting|N/A|90|Anticipated|China Medical University Hospital|||1||f||||f||||||||||2017-10-11 02:36:12.172239|2017-10-11 02:36:12.172239
NCT01669746|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-17|2013-07-09|||June 2012||2012-06-01|July 2013|2013-07-01||||April 2013|Actual|2013-04-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)|A Multi-center, Phase 2 Study of Ji Gami(TM) CN That Evaluates the Efficacy and Safety of ex Vivo-cultured, Expanded, Occipital Autologous Dermal and Epidermal Cells, Injected Into the Hair Loss Area of the Scalp of Male and Female Subjects With Alopecia|Completed||Phase 2|34|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 02:36:12.26413|2017-10-11 02:36:12.26413
NCT01669733|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-08-21|||August 2012||2012-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|July 2014|Actual|2014-07-01||Interventional|||The Effects of Perioperative Music Therapy on Women Undergoing Breast Biopsy Surgery|The Effects of Perioperative Music Therapy on Women Undergoing Breast Biopsy Surgery|Completed||N/A|201|Actual|Case Comprehensive Cancer Center||3|||f||||f||||||||||2017-10-11 02:36:12.385555|2017-10-11 02:36:12.385555
NCT01669720|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-02-11|2016-01-08||December 2012||2012-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|C261||Adjuvant Aflibercept for Metastatic Colorectal Cancer|BrUOG C261:Single Agent Adjuvant Aflibercept for Patients With Resected or Ablated Metastatic Colorectal Cancer: A Randomized Phase II Study|Terminated||Phase 2|10|Actual|Brown University||2||Lack of efficacy and enrollment|f||||t||||||||||2017-10-11 02:36:12.506703|2017-10-11 02:36:12.506703
NCT01669694|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-10-13|||October 2011||2011-10-01|October 2015|2015-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Pelvic Floor Physical Therapy-Biomarkers Project|Women's Urology Center-Physical Therapy-Biomarkers Project|Completed||N/A|59|Actual|William Beaumont Hospitals|||1||f||||f||||||Samples With DNA|"     serum and urine   "|||2017-10-11 02:36:13.040053|2017-10-11 02:36:13.040053
NCT01669668|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-07-15|||December 2014||2014-12-01|July 2014|2014-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)|Radiofrequency Ablation Under Ideal Conditions in Hepatocellular Carcinoma|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||1||Lack of referrals.|f||||f||||||||||2017-10-11 02:36:13.188432|2017-10-11 02:36:13.188432
NCT01669655|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-01-19|||June 2012||2012-06-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||Plasma Profile of Exclusively Breastfed Infants|Plasma Profile of Exclusively Breastfed Infants|Completed||N/A|56|Actual|Abbott Nutrition|||1||f||||f||||||Samples With DNA|"     Blood sample; Human Milk sample   "|||2017-10-11 02:36:13.30426|2017-10-11 02:36:13.30426
NCT01669642|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-11-19|||April 2012||2012-04-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study to Find the Dose of Rapidly Administered Ketamine for Brief Painful Procedures in Children|Mean Effective Dose of Rapidly Administered Ketamine for Brief Pediatric Procedural Sedation|Completed||N/A|112|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 02:36:13.379227|2017-10-11 02:36:13.379227
NCT01669629|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-03-25|2013-12-09||August 2012||2012-08-01|March 2016|2016-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||All enrolled subjects.|Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear|Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear|Completed||N/A|183|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 02:36:13.48306|2017-10-11 02:36:13.48306
NCT01669616|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-01-13|||August 2012||2012-08-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|POSSE||Point of Service Diabetes Screening Evaluation|Point of Service Diabetes Screening Evaluation|Completed||N/A|667|Actual|VeraLight, Inc.|||1||f||||f||||||||||2017-10-11 02:36:13.959439|2017-10-11 02:36:13.959439
NCT01669603|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-04-20|2017-03-08||August 2012||2012-08-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|EPIARR|Volunteers challenged with rhinovirus who met protocol definitions for analysis.|Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)|Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)|Completed||N/A|789|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 02:36:14.051237|2017-10-11 02:36:14.051237
NCT01669590|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-11-15|||December 2011||2011-12-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Nutrient Regulation of Amino Acid Transporters in Aging Human Skeletal Muscle|Nutrient Regulation of Amino Acid Transporters in Aging Human Skeletal Muscle|Completed||N/A|28|Actual|University of Utah|||2||f||||t||||||||||2017-10-11 02:36:14.440823|2017-10-11 02:36:14.440823
NCT01669577|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-01-08|2014-12-24||October 2010||2010-10-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|June 2013|Actual|2013-06-01||Observational||severe polytrauma patients|Independent Predictors of Mortality in Polytrauma Patients|Independent Predictors of Mortality in Polytrauma Patients: a Prospective, Observational, Longitudinal Study|Completed||Phase 3|200|Actual|University of Sao Paulo|single center trial, majority of TBI and male patients||1||f||||t||||||||||2017-10-11 02:36:14.516268|2017-10-11 02:36:14.516268
NCT01669564|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-12-01|||February 2013||2013-02-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|FAST-PRI||Functional Assessment Screening Patient Reported Information|Functional Assessment Screening Patient Reported Information|Completed||N/A|666|Actual|University of Pittsburgh||4|||f||||t||||||||||2017-10-11 02:36:14.734051|2017-10-11 02:36:14.734051
NCT01669551|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-12-08|||July 2012||2012-07-01|August 2012|2012-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||A Phase 1 Feasbility Study Of Volume Intracardiac Echo In Assessment Of Patients With Structural And Valvular Heart Disease Undergoing Percutaneous Transcatheter Therapy|A Phase 1 Feasbility Study Of Volume Intracardiac Echo In Assessment Of Patients With Structural And Valvular Heart Disease Undergoing Percutaneous Transcatheter Therapy|Completed||N/A|30|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 02:36:14.830325|2017-10-11 02:36:14.830325
NCT01669538|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-09-22|||August 2012||2012-08-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|February 2018|Anticipated|2018-02-01||Interventional|GAL-K||Effect of Galantamine on Short-term Abstinence|Repurposing Cholinesterase Inhibitors for Smoking Cessation.|Recruiting||Phase 2|80|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 02:36:14.890948|2017-10-11 02:36:14.890948
NCT01669525|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-07-17|||November 2009||2009-11-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Placental Growth and Adverse Pregnancy Outcomes|Placental Growth and Maternal Serum Biomarkers in the Prediction of Adverse Pregnancy Outcome|Completed||N/A|1043|Actual|University of Pennsylvania|||1||f||||f||||||Samples Without DNA|"     Maternal serum will be collected. Placental biopsies may be collected.   "|||2017-10-11 02:36:15.037403|2017-10-11 02:36:15.037403
NCT01669512|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-01-06|||August 2012||2012-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Adjuvanting Viral Vectored Malaria Vaccines With Matrix M|Safety and Immunogenicity of ChAd63 ME-TRAP / MVA ME-TRAP Heterologous Prime Boost Malaria Vaccination Adjuvanted With Matrix M™|Completed||Phase 1|23|Actual|University of Oxford||3|||f||||f||||||||||2017-10-11 02:36:15.134539|2017-10-11 02:36:15.134539
NCT01669499|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-11-15|||January 2012||2012-01-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009|Dexamethasone for the Prevention of a Pain Flare After Palliative Radiotherapy for Painful Bone Metastases: a Multi-center Double-blind Placebo-controlled Randomized Study|Completed||Phase 3|411|Anticipated|UMC Utrecht||3|||f||||t||||||||||2017-10-11 02:36:15.227631|2017-10-11 02:36:15.227631
NCT01669486|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2013-04-22|||June 2012||2012-06-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|ICPain||The Pain in Intensive Care Unit: Different Rating System Comparing|The Pain in Intensive Care Unit: An Experimental Research to Compare Behavioural Pain Scale (BPS) and Critical Care Pain Observation Tool (CPOT)|Completed||N/A|100|Actual|Università degli Studi dell'Insubria|||1||f||||t||||||||||2017-10-11 02:36:15.327264|2017-10-11 02:36:15.327264
NCT01669473|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-09-20|||June 2013||2013-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use|A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use|Completed||N/A|541|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 02:36:15.461917|2017-10-11 02:36:15.461917
NCT01669460|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-12-18|||July 2012||2012-07-01|December 2013|2013-12-01||||July 2013|Actual|2013-07-01||Interventional|||Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy|A Phase II, Open Label Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy|Completed||Phase 2|20|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 02:36:15.577074|2017-10-11 02:36:15.577074
NCT01669447|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-20|||September 2012||2012-09-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis|Assessment in Early Changes in the Parameters of Optical Coherence Tomography (OCT Spectral Domain) in Patients With Subfoveal Neovascular Membranes Related to Age After Treatment With a Single Intravitreal Injection of Lucentis.|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|University of Campinas, Brazil||1|||f||||f||||||||||2017-10-11 02:36:15.666409|2017-10-11 02:36:15.666409
NCT01669408|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-06-21|||September 2012||2012-09-01|June 2013|2013-06-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|PreCOOL||Prehospital COOLing 1 (PreCOOL 1)|A Randomized Controlled Trial Evaluating Cold Infusions for Prehospital Induction of Cooling in Awake Stroke Patients (PreCOOL 1)|Unknown status|Recruiting|Phase 2|40|Anticipated|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-11 02:36:16.013521|2017-10-11 02:36:16.013521
NCT01669395|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-16|||September 2012||2012-09-01|August 2012|2012-08-01|July 2016|Anticipated|2016-07-01|September 2015|Anticipated|2015-09-01||Interventional|||Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial|Early Homebased Rehabilitation for Patients With Severe Heart Failure - An Intersectoral Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|80|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-10-11 02:36:16.108392|2017-10-11 02:36:16.108392
NCT01669382|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-02-02|||January 2012||2012-01-01|February 2015|2015-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites|ACCESS: A Randomized, Multicenter, Single-Blinded Trial to Compare the Extrafemoral Closure Device Exo-Seal® and the Collagen-based Intravascular Device Angio-SealTM for Arterial Puncture Site Closure.|Completed||Phase 3|304|Actual|University Hospital Erlangen||2|||f||||t||||||||||2017-10-11 02:36:16.215321|2017-10-11 02:36:16.215321
NCT01669369|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-10-31|||January 2013||2013-01-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|Li2CO3||Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma|A Prospected Randomized Multicenter Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma|Recruiting||Phase 4|400|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Undecided|Because our research has not yet finished, we would decide whether or not make individual participant data (IPD) available to other researchers according to the result of this study.|2017-10-11 02:36:16.30281|2017-10-11 02:36:16.30281
NCT01669356|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-11|2014-03-30|||July 2012||2012-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Parenteral Nutrition Supplement on Esophagectomy Patients|The Effect of Parenteral Nutrition Supplement Versus Enteral Nutrition Alone on Nutrition Status After Esophagectomy: A Prospective Randomized Controlled Trial|Completed||N/A|95|Actual|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-11 02:36:16.395601|2017-10-11 02:36:16.395601
NCT01669343|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-04-29|||September 2012||2012-09-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Interventional|||Aromatase Inhibitor Host Factors Study|Patient-related Predictors of Estrogen Suppression in Postmenopausal Women Using Adjuvant Letrozole|Active, not recruiting||N/A|113|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 02:36:16.464949|2017-10-11 02:36:16.464949
NCT01669330|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-04-09|||January 2001||2001-01-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Laparoscopic Nissen Versus Anterior Partial Fundoplication|Comparison of Laparoscopic Nissen Versus Anterior Partial Fundoplication ad Modum Watson, A Prospective Randomized Trial|Completed||N/A|72|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 02:36:16.659778|2017-10-11 02:36:16.659778
NCT01669317|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-12-17|||June 2014||2014-06-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|CHERRY JUICE||Mechanisms Underlying the Sleep Promoting Effect of Cherry Juice Standardized to Its Proanthocyanidin Content|Mechanisms Underlying the Sleep Promoting Effect of Cherry Juice Standardized to Its Proanthocyanidin Content|Completed||N/A|10|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 02:36:16.746077|2017-10-11 02:36:16.746077
NCT01669304|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-08-20|||August 2012||2012-08-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness|Pharmacologic Dissection of Vestibular Migraine and Chronic Subjective Dizziness: A Double-Blind Parallel Group Trial Comparing Response to Verapamil Versus Sertraline|Completed||Phase 1|32|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:36:16.838268|2017-10-11 02:36:16.838268
NCT01669291|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-06-03|||July 2012||2012-07-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation|Effect of GnRH Antagonist Protocol vs Agonist Long Protocol During Controlled Hyperstimulation (COH)for Assisted Reproduction on IVF Outcome, Peak Estradiol Level, and Duration of Stimulation.|Completed||N/A|43|Actual|Main Line Fertility Center||2|||f||||f||||||||||2017-10-11 02:36:16.943045|2017-10-11 02:36:16.943045
NCT01669265|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-11-17|||June 2012||2012-06-01|November 2014|2014-11-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Observational|SOLO-1||Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer|Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer|Completed||N/A|701|Actual|SOLTI Breast Cancer Research Group|||1||f||||f||||||||||2017-10-11 02:36:17.124182|2017-10-11 02:36:17.124182
NCT01669252|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-08-05|||August 2012||2012-08-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|NeoEribulin||Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer|A Phase II, Open-label, Single-arm, Exploratory Pharmacogenomic Study of Single Agent Eribulin (HALAVEN®) as Neoadjuvant Treatment for Operable Stage I-II HER2 Non-overexpressing Breast Cancer.|Completed||Phase 2|163|Actual|SOLTI Breast Cancer Research Group||1|||f||||t||||||||||2017-10-11 02:36:17.248978|2017-10-11 02:36:17.248978
NCT01669239|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2016-04-21|||June 2013||2013-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|OptiHER-Heart||Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer|OptiHER-Heart: A Prospective, Multicenter, Single-arm, Phase II Study to Evaluate the Safety of Neoadjuvant Liposomal Doxorubicin (Myocet®) Plus Paclitaxel, Trastuzumab, and Pertuzumab in Patients With HER2-positive Breast Cancer|Completed||Phase 2|83|Actual|SOLTI Breast Cancer Research Group||1|||f||||t||||||||||2017-10-11 02:36:17.4311|2017-10-11 02:36:17.4311
NCT01669226|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-12-15|||April 2009||2009-04-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|September 2015|Actual|2015-09-01||Interventional|AICE||First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer|A Phase II,Randomized Study of an Addition Intraperitoneal Cisplatin and Etoposide to Standard First-line Therapy in Stage IIIC and Stage IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (EOC, FTC, PPC)|Completed||Phase 2|215|Actual|Shanghai Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 02:36:17.577825|2017-10-11 02:36:17.577825
NCT01669213|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-17|||August 2012||2012-08-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|December 2012|Anticipated|2012-12-01||Interventional|||Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension|Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension After Spinal Anesthesia|Unknown status|Active, not recruiting|N/A|100|Anticipated|Seoul National University Hospital||4|||f||||||||||||||2017-10-11 02:36:17.697376|2017-10-11 02:36:17.697376
NCT01669200|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-06-06|||August 2012||2012-08-01|June 2014|2014-06-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment|Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment|Unknown status|Recruiting|N/A|20|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 02:36:17.785403|2017-10-11 02:36:17.785403
NCT01669187|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2014-04-09|||December 2011||2011-12-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effects of Pre-operative Physical Therapy Education|Phase 1 of the The Effects of Pre-operative Physical Therapy Education and Exercise on Patient Outcomes Post Breast Cancer Surgery: a Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Oakland University||2||Study withdrawn.|f||||f||||||||||2017-10-11 02:36:17.877644|2017-10-11 02:36:17.877644
NCT01669174|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-04-27|2015-12-01||September 2012||2012-09-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia|A Randomized, Double Blind, Placebo Controlled, Multi-centre Study to Asses the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of BYM338 in Chronic Obstructive Pulmonary Disease Patients With Cachexia|Completed||Phase 2|67|Actual|Novartis||2|||f||||t||||||||||2017-10-11 02:36:17.977606|2017-10-11 02:36:17.977606
NCT01669161|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-10-13|||February 2013||2013-02-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Paired Vagus Nerve Stimulation (VNS) With Rehabilitation for Upper Limb Function Improvement After Stroke|A Proof-of-Concept Pilot Study Assessing Vagus Nerve Stimulation (VNS) Paired With Rehabilitation for Improved Upper Limb Function After Stroke (MicroTransponder's Vivistim System)|Completed||N/A|21|Actual|MicroTransponder Inc.||2|||f||||t||||||||No||2017-10-11 02:36:18.614051|2017-10-11 02:36:18.614051
NCT01669148|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-30|2017-05-19|2017-04-12||November 2007||2007-11-01|January 2017|2017-01-01|October 2012|Actual|2012-10-01|June 2011|Actual|2011-06-01||Interventional||"496 participants enrolled overall, but no information available to distinguish study arms:
Conventional+Tomosynthesis First Then Tomo alone 1 mo. Later (number of participants enrolled in arm is unknown).
Tomosynthesis alone First Then Conventional+Tomo 1 mo. Later (number of participants enrolled in arm is unknown)."|Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography|Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography|Completed||N/A|496|Actual|Massachusetts General Hospital|PI left institution in 2012; Data remaining did not include outcome measure and adverse event data. Institution contacted PI on numerous occasions. PI also does not have data.|2|||f||||f||||||||||2017-10-11 02:36:18.705007|2017-10-11 02:36:18.705007
NCT01669135|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2012-08-17|||December 2010||2010-12-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Spinal Anesthesia for Cesarean Delivery is Associated With Decreases in Regional Cerebral Oxygen Saturation as Assessed by Near- Infrared Spectroscopy||Completed||N/A|34|Actual|University of Athens||1|||f||||f||||||||||2017-10-11 02:36:18.868162|2017-10-11 02:36:18.868162
NCT01669122|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-01-12|2013-07-18||June 2012||2012-06-01|October 2014|2014-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pharmacokinetic Study of 4 mg Nicotine Lozenge.|A Randomized, Cross-Over, Single Dose Pharmacokinetic Study of 4mg Nicotine Lozenges.|Completed||Phase 2|40|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:36:18.97639|2017-10-11 02:36:18.97639
NCT01669109|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-01-09|||September 2012||2012-09-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|YoCo||Hatha Yoga for Patients With Colorectal Cancer|Hatha Yoga for Patients With Colorectal Cancer - a Randomized Controlled Trial|Completed||N/A|54|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-11 02:36:19.528325|2017-10-11 02:36:19.528325
NCT01669083|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-06-06|||August 16, 2012|Actual|2012-08-16|June 2017|2017-06-01|March 9, 2013|Actual|2013-03-09|March 9, 2013|Actual|2013-03-09||Interventional|||Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing|A Phase I Non-Randomized Multi Cohort, Open Label, Bridging Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing|Completed||Phase 1|36|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:36:19.764971|2017-10-11 02:36:19.764971
NCT01669070|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-06-09|||August 15, 2012|Actual|2012-08-15|June 2017|2017-06-01|November 16, 2012|Actual|2012-11-16|November 16, 2012|Actual|2012-11-16||Interventional|||A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)|An Open Label, Part-randomised, Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate (FF) When Administered as FF Inhalation Powder From the Novel Dry Powder Inhaler in Healthy Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:36:19.90457|2017-10-11 02:36:19.90457
NCT01669057|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2015-03-09|||October 2011||2011-10-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|||||Observational|SCPRFGBCHD||Study on Clinical Prognosis, Risk Factors and Genetic Basis of Congenital Heart Disease|Case-control Study on Environmental and Genetic Factors of Congenital Heart Disease|Completed||N/A|6000|Anticipated|Children's Hospital of Fudan University|||2||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 02:36:20.070396|2017-10-11 02:36:20.070396
NCT01669044|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-20|||May 2012||2012-05-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|||||Observational|||Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients|Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients|Unknown status|Recruiting|N/A|80|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||2||f||||t||||||||||2017-10-11 02:36:20.259846|2017-10-11 02:36:20.259846
NCT01669031|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-16|||August 2012||2012-08-01|August 2012|2012-08-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Randomized Controlled Trial on Visual Field Training|Effect of Exposure to Computer Simulated Visual Field Testing on Variability and Reliability of Test Results: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|200|Anticipated|Oftalmologia Hospital Sotero del Rio||2|||f||||t||||||||||2017-10-11 02:36:20.357115|2017-10-11 02:36:20.357115
NCT01669018|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-01-30|||August 2012||2012-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SSPS||Ultrasound Guided Blockade of the Lumbar Plexus - the Supra Sacral Parallel Shift|The Supra Sacral Parallel Shift (SSPS) - Ultrasound Guided Blockade of the Lumbar Plexus|Completed||N/A|20|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:36:20.464594|2017-10-11 02:36:20.464594
NCT01669005|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-17|||November 2007||2007-11-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|MedIso||The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies|Obtaining Early Diagnosis and Prognosis in Urgent Sepsis (OEDIPUS) Study|Completed||N/A|84|Actual|Centre Hospitalier Universitaire Vaudois|||1||f||||f||||||Samples With DNA|"     3 ml of EDTA-blood   "|||2017-10-11 02:36:20.552548|2017-10-11 02:36:20.552548
NCT01668992|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-11-07|||September 2011||2011-09-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Impact Evaluation of a Family-based Intervention With Burmese Migrant and Displaced Children and Families in Tak Province, Thailand|Impact Evaluation of a Family-based Intervention With Burmese Migrant and Displaced Children and Families in Tak Province, Thailand|Completed||N/A|992|Actual|International Rescue Committee||2|||f||||f||||||||||2017-10-11 02:36:20.619847|2017-10-11 02:36:20.619847
NCT01668979|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-16|||September 2012||2012-09-01|August 2012|2012-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||Assessment of a New System to Detect, Quantify and Treat Near Falls in Older Adults|Assessment of a New System to Detect, Quantify and Treat Near Falls in Older Adults|Unknown status|Not yet recruiting|N/A|20|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 02:36:20.710473|2017-10-11 02:36:20.710473
NCT01668953|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-03-15|||August 2012||2012-08-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|IMPROVE||Comparison of Platelet Rich Plasma and Alternative Therapies for the Treatment of Tennis Elbow (Lateral Epicondylitis)|Impact of Platelet Rich Plasma Over Alternative Therapies in Patients With Lateral Epicondylitis|Recruiting||N/A|100|Anticipated|McMaster University||4|||f||||t||||||||||2017-10-11 02:36:20.906046|2017-10-11 02:36:20.906046
NCT01668940|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-07-20|||August 2012||2012-08-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Freezie Remedy to Alleviate Morning Sickness|Effectiveness of a Natural Non-medicinal Freezie Remedy to Alleviate Morning Sickness|Terminated||Phase 2|53|Actual|The Hospital for Sick Children||4||Study Lapsed in July 2014|f||||t||||||||No||2017-10-11 02:36:21.01638|2017-10-11 02:36:21.01638
NCT01668927|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-06-01|||July 2012||2012-07-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Empirical Rescue Therapies of Helicobacter Pylori Infection|Helicobacter Pylori Treatment|Completed||Phase 4|424|Actual|Shanghai Jiao Tong University School of Medicine||4|||f||||f||||||||||2017-10-11 02:36:21.106185|2017-10-11 02:36:21.106185
NCT01668914|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2013-08-24|||August 2012||2012-08-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|IMSLNB-CANP||Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive|Phase II Trail of Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive|Unknown status|Recruiting|Phase 2|4|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||f||||||||||2017-10-11 02:36:21.21077|2017-10-11 02:36:21.21077
NCT01668901|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-10-24|||September 2012||2012-09-01|August 2012|2012-08-01|June 2016|Anticipated|2016-06-01|September 2015|Anticipated|2015-09-01||Interventional|||Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease|A Randomized Controlled Prospective Trial of Warfarin Versus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation and Chronic Kidney Disease|Withdrawn||Phase 4|0|Actual|Seoul National University Hospital||2||Financial problem|f||||f||||||||No||2017-10-11 02:36:21.321567|2017-10-11 02:36:21.321567
NCT01668888|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-16|||May 2012||2012-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Progranulin and CTRP3 in Metabolic Syndrome||Completed||N/A|127|Actual|Korea University|||1||f||||t||||||||||2017-10-11 02:36:21.417923|2017-10-11 02:36:21.417923
NCT01668875|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-11-17|||September 2012||2012-09-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Hemodynamic and Ventilatory Responses to Head-down Postural Drainage Position|Acute Hemodynamic and Ventilatory Responses to Head-down 30° Postural Drainage Position in Critically Traumatic Patients|Completed||N/A|11|Actual|Khon Kaen University||2|||f||||t||||||||||2017-10-11 02:36:21.484792|2017-10-11 02:36:21.484792
NCT01668862|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-08-16|||March 2012||2012-03-01|July 2012|2012-07-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Interventional|||A Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate in Lateral Epicondylitis (Tennis Elbow)|A Prospective, Multicentric, Open Label, Randomised, Bio-Interventional Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For The Treatment Of Lateral Epicondylitis (Tennis Elbow)|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Kasiak Research Pvt. Ltd.||2|||f||||t||||||||||2017-10-11 02:36:21.5851|2017-10-11 02:36:21.5851
NCT01668849|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-11-21|||August 2012||2012-08-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer|Preliminary Clinical Trial Investigating the Ability of Plant Exosomes to Abrogate Oral Mucositis Induced by Combined Chemotherapy and Radiation in Head and Neck Cancer Patients|Recruiting||Phase 1|60|Anticipated|James Graham Brown Cancer Center||2|||f||||t||||||||||2017-10-11 02:36:21.672492|2017-10-11 02:36:21.672492
NCT01668836|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-03-17|2015-08-24||August 2012||2012-08-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years|Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years.|Completed||N/A|48|Actual|InCor Heart Institute||4|||f||||f||||||||||2017-10-11 02:36:21.817761|2017-10-11 02:36:21.817761
NCT01668823|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-07-30|||February 2004||2004-02-01|July 2014|2014-07-01|June 2014||2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Photodynamic Therapy in Treating Patients With Lung Cancer|A Phase I Study of Light Dose for Photodynamic Therapy(PDT) Using 2-[ 1-hexyloxyethel]-2-devinyl Pyropheophorbide-a (HPPH) for Treatment of Non-small Cell Carcinoma in Situ or Non-small Cell Microinvasive Carcinoma. A Dose Ranging Study|Completed||Phase 1|17|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 02:36:23.145426|2017-10-11 02:36:23.145426
NCT01668810|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-17|||July 2012||2012-07-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|September 2012|Anticipated|2012-09-01||Observational|||The Third Survey of Prescription Pattern of Psychotropic Drugs in China|The Third Survey on China Psychotropic Prescription for Schizophrenia, Depression and Bipolar Disorder|Unknown status|Recruiting|N/A|7000|Anticipated|Peking University|||10||f||||t||||||||||2017-10-11 02:36:23.231357|2017-10-11 02:36:23.231357
NCT01668797|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-11-17|2016-01-05||October 2012||2012-10-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|EQUATOR|The enrolled sample was defined as all participants who signed the informed consent for the trial and entered Phase A or Phase B.|Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia|Completed||Phase 3|524|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|As the interim analysis results were positive, the trial was completed as it achieved the primary endpoint of a significant delay in time to impending relapse for participants randomized to brexpiprazole when compared to participants in placebo.|2|||f||||t||||||||||2017-10-11 02:36:23.471381|2017-10-11 02:36:23.471381
NCT01668784|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-09-01|2016-03-28||September 27, 2012|Actual|2012-09-27|September 2017|2017-09-01|September 28, 2018|Anticipated|2018-09-28|May 6, 2015|Actual|2015-05-06||Interventional||All randomized participants; any participants that was randomized to any treatment group in the study.|Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)|A Randomized, Open-Label, Phase 3 Study of Nivolumab (BMS-936558) vs. Everolimus in Subjects With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy|Active, not recruiting||Phase 3|1068|Actual|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-11 02:36:25.843923|2017-10-11 02:36:25.843923
NCT01668771|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-06-30|||August 11, 2012||2012-08-11|May 13, 2013|2013-05-13|May 13, 2013||2013-05-13|||||Observational|||Self-Affirmation and Response to Health Risk Information|Self-Affirmation, Affect, and Implementation Intentions for Alcohol Cessation|Completed||N/A|1116|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:36:28.488226|2017-10-11 02:36:28.488226
NCT01668758|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-06-30|||July 25, 2012||2012-07-25|July 1, 2013|2013-07-01|July 1, 2013||2013-07-01|||||Observational|||fMRI and NIRS Imaging for Traumatic Brain Injury|Detection of Hemodynamic Changes in Traumatic Brain Injuries Population With Functional Near Infrared Spectroscopy|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:36:28.556098|2017-10-11 02:36:28.556098
NCT01668745|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-08-06|||May 2013||2013-05-01|August 2014|2014-08-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.|A Two-site Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality in Rural Areas of Burkina Faso and Guinea-Bissau|Unknown status|Recruiting|Phase 4|4050|Anticipated|Bandim Health Project||2|||f||||||||||||||2017-10-11 02:36:28.621711|2017-10-11 02:36:28.621711
NCT01668407|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-08-17|||February 2012||2012-02-01|August 2012|2012-08-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|Robopark||Robot Walking Rehabilitation in Parkinson's Disease|Use of a Robot for the Rehabilitation of Walking in Patients With Parkinson's Disease.|Unknown status|Recruiting|N/A|80|Anticipated|IRCCS San Raffaele||2|||f||||f||||||||||2017-10-11 02:36:37.328929|2017-10-11 02:36:37.328929
NCT01668732|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2012-08-17|||August 2012||2012-08-01|August 2012|2012-08-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Decision Making Deficit and DNA Methylation in Opioid Receptor Genes Among Community Heroin Addicts|Decision Making Deficit and DNA Methylation in Opioid Receptor Genes Among Community Heroin Addicts|Unknown status|Not yet recruiting|N/A|1|Anticipated|National Health Research Institutes, Taiwan|||1||f||||f||||||||||2017-10-11 02:36:28.741715|2017-10-11 02:36:28.741715
NCT01668719|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2017-07-12|||November 2012||2012-11-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|||S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma|A Randomized Phase I/II Study of Optimal Induction Therapy of Bortezomib, Dexamethasone and Lenalidomide With or Without Elotuzumab (NSC-764479) for Newly Diagnosed High Risk Multiple Myeloma (HRMM)|Recruiting||Phase 1/Phase 2|122|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 02:36:28.947855|2017-10-11 02:36:28.947855
NCT01668706|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-11-08|||March 2009||2009-03-01|August 2012|2012-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts|Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts|Completed||N/A|340|Actual|National Health Research Institutes, Taiwan|||4||f||||f||||||Samples With DNA|"     plasma, DNA and urine   "|||2017-10-11 02:36:30.219993|2017-10-11 02:36:30.219993
NCT01668693|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2015-10-16|||January 2010||2010-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|ERA||ERA Test in Patients With Recurrent Implantation Failure|The Endometrial Receptivity Array (ERA) as Diagnosis and Personalized Embryo Transfer (pET) as Treatment in Patients With Receptive Implantation Failure (RIF).|Unknown status|Recruiting|N/A|150|Anticipated|Igenomix||2|||f||||f||||||||||2017-10-11 02:36:30.318731|2017-10-11 02:36:30.318731
NCT01668680|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2015-07-06|||September 2012||2012-09-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma|Metronomic Chemotherapy With Anti-angiogenic Effect as Maintenance Treatment for Metastatic Colorectal Carcinoma Following Response to FOLFIRI+Bevacizumab: Clinical and Laboratory Studies|Terminated||Phase 2|80|Anticipated|HaEmek Medical Center, Israel||2||No satisfactory acrual|f||||f||||||||||2017-10-11 02:36:30.432182|2017-10-11 02:36:30.432182
NCT01668667|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2014-11-17|2014-07-14||June 2012||2012-06-01|November 2014|2014-11-01||||November 2013|Actual|2013-11-01||Interventional|CONCORD|mITT (modified intent to treat) Population: The mITT population will include all randomly assigned subjects who received at least 1 dose (or any portion of a dose) of study medication as defined above for the Safety population, have a baseline IRLS Rating Scale total score, and have at least 1 on-treatment IRLS Rating Scale total score.|Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome Post Marketing Commitment Study|A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group Study to Compare the Efficacy, Tolerability, and Safety of 3 Doses of Gabapentin Enacarbil (GSK1838262) With Placebo in the Treatment of Subjects With Moderate-to-Severe Primary Restless Legs Syndrome (RLS)|Completed||Phase 4|501|Actual|XenoPort, Inc.||4|||f||||f||||||||||2017-10-11 02:36:30.55173|2017-10-11 02:36:30.55173
NCT01668654|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-11-18|2014-07-10||September 2012||2012-09-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS|RTG113388, a Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects With Partial Onset Seizures (>= 12 Years Old) and Subjects With Lennox-Gastaut Syndrome (>=12 Years Old)|Terminated||Phase 3|4|Actual|GlaxoSmithKline|This study was terminated early and only 4 of the planned 500 participants were enrolled. Due to the early study termination and small sample size, many planned analyses were not completed therefore lmiited results data were available.|1||"FDA placed a clinical hold on the Pediatric Program requiring retigabine discontinuation in   subjects; early termination allows for timely reporting of results."|f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:36:33.246738|2017-10-11 02:36:33.246738
NCT01668641|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-06-26|||May 2012||2012-05-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients|Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Study to Compare Four Dose Regimens of GLPG0634 Versus Placebo, in Combination With Methotrexate, Administered for 4 Weeks in the Treatment of Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Alone|Completed||Phase 2|91|Actual|Galapagos NV||5|||f||||f||||||||||2017-10-11 02:36:34.057108|2017-10-11 02:36:34.057108
NCT01668628|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-08-21|2015-06-26||August 2010||2010-08-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|QOLD||Quality of Life and Depression in Dialysis Patients|Quality of Life and Depression in Peritoneal Dialysis Patients and Hemodialysis Patients|Completed||N/A|1068|Actual|Fresenius Medical Care Korea|||3||f||||f||||||||||2017-10-11 02:36:34.221887|2017-10-11 02:36:34.221887
NCT01668615|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-10-21|||January 2011||2011-01-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|ITP||Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia|Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia|Completed||N/A|35|Actual|First Affiliated Hospital of Suzhou Medical College|||1||f||||t||||||||||2017-10-11 02:36:34.789288|2017-10-11 02:36:34.789288
NCT01668602|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-07-27|||August 2013||2013-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Stroke Gait Rehabilitation Using Functional Electrical Stimulation|Cortical and Spinal Correlates of Post-stroke Gait Rehabilitation|Recruiting||N/A|80|Anticipated|Emory University||2|||f||||f||||||||||2017-10-11 02:36:34.870146|2017-10-11 02:36:34.870146
NCT01668589|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-10-07|2016-08-01||November 2011||2011-11-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational||Full analysis set (FAS), defined as all enrolled patients with enrollment date into the electronic trial operations system, provided informed consent, and received 1 pre-enrollment denosumab injection.|Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis|Prospective Observational Study to Evaluate Medication-taking Behavior With Denosumab (Prolia) and Patient Characteristics in Postmenopausal Women With Osteoporosis in Routine Clinical Practice in Germany, Austria, Greece and Belgium|Completed||N/A|1501|Actual|Amgen|||1||f||||f||||||||||2017-10-11 02:36:34.996786|2017-10-11 02:36:34.996786
NCT01668576|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-01-13|||August 2012||2012-08-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Properties of Mesenchymal Stem Cells in Lung Transplant|Properties of Mesenchymal Stem Cells in Lung Transplant Candidates|Terminated||N/A|4|Actual|Emory University|||1|Loss of funding|f||||f||||||Samples With DNA|"     mesenchymal stem cells derived from subject bone marrow aspiration   "|||2017-10-11 02:36:35.989454|2017-10-11 02:36:35.989454
NCT01668563|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-08-01|||November 12, 2012|Actual|2012-11-12|August 2017|2017-08-01|June 2024|Anticipated|2024-06-01|December 2023|Anticipated|2023-12-01||Interventional|ISAT II||International Subarachnoid Aneurysm Trial II|International Subarachnoid Aneurysm Trial II Comparing Clinical Outcomes of Surgical Clipping and Endovascular Coiling for Ruptured Intracranial Aneurysms Not Included in the Original ISAT Study.|Recruiting||N/A|1724|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 02:36:36.064999|2017-10-11 02:36:36.064999
NCT01668550|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-07-25|||October 2012||2012-10-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|AZD0424||A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours|A Cancer Research UK Phase I Study to Determine the Maximum Tolerated Dose of the Oral Src/Abl Inhibitor AZD0424, and to Identify Tolerable and Effective AZD0424 Combination Regimens for the Treatment of Advanced Solid Tumours|Terminated||Phase 1|43|Actual|Cancer Research UK||1||"Single agent phase completed, insufficient supportive preclinical data to proceed with   combination phase"|f||||f||||||||||2017-10-11 02:36:36.201408|2017-10-11 02:36:36.201408
NCT01668537|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-09-22|||March 2013||2013-03-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects|A Randomized, Double-blind, Multicenter Phase II Trial to Compare the Immunogenicity and Safety of a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects|Completed||Phase 2|651|Actual|Bavarian Nordic||2|||f||||t||||||||||2017-10-11 02:36:36.283684|2017-10-11 02:36:36.283684
NCT01668524|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-09-05|||August 2012||2012-08-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects|A Phase 2a Open-Label, Dose-ranging Study of the Safety and Tolerability of ATS907 in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension|Completed||Phase 2|12|Actual|Altheos, Inc.||1|||f||||f||||||||||2017-10-11 02:36:36.379261|2017-10-11 02:36:36.379261
NCT01668511|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2013-11-04|||September 2012||2012-09-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee|A Randomized, Double-Blind, Placebo Controlled Study in Patients With Osteoarthritis of the Knee to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of ABT-981|Completed||Phase 1|36|Actual|AbbVie||4|||f||||f||||||||||2017-10-11 02:36:36.458583|2017-10-11 02:36:36.458583
NCT01668498|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2016-04-18|||May 2011||2011-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|January 2015|Actual|2015-01-01||Interventional|||Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer|Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of Quality of Life in Patients With Ras-wildtype Colorectal Cancer|Completed||Phase 2|88|Actual|AIO-Studien-gGmbH||2|||f||||f||||||||||2017-10-11 02:36:36.554464|2017-10-11 02:36:36.554464
NCT01668485|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-17|||November 2001||2001-11-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|||Mechanisms of Glucose Counterregulation in Pancreatic Islet Transplantation|Metabolic Studies in Type 1 Diabetic Patients After Allogenic Intraportal Islet Transplantation.|Completed||Phase 4|36|Actual|University of Giessen||3|||f||||f||||||||||2017-10-11 02:36:36.662666|2017-10-11 02:36:36.662666
NCT01668472|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2013-12-20|||August 2012||2012-08-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Observational|||A Comparison of Rapid Immunoassay Tests for the Detection of Ruptured Membranes|A Comparison of Rapid Immunoassay Tests for the Detection of Ruptured Membranes|Withdrawn||N/A|0|Actual|University of Colombo|||1||f||||t||||||Samples Without DNA|"     Sample of diluted vaginal secretion into buffer   "|||2017-10-11 02:36:36.796919|2017-10-11 02:36:36.796919
NCT01668459|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2013-01-23|||January 2013||2013-01-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|CabB1||Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel|Cabazitaxel in Platinum Pre-treated Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma Who Developed Disease Progression Within 12 Months of Platinum Based Chemotherapy.|Unknown status|Recruiting|Phase 2/Phase 3|96|Anticipated|University Hospital Birmingham NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:36:36.886007|2017-10-11 02:36:36.886007
NCT01668446|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2012-09-11|||September 2009||2009-09-01|September 2012|2012-09-01|February 2011|Actual|2011-02-01|September 2009|Actual|2009-09-01||Interventional|sildenafil||Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles|Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles|Completed||Phase 4|2|Actual|Shahid Sadoughi University of Medical Sciences and Health Services||2|||f||||t||||||||||2017-10-11 02:36:37.036586|2017-10-11 02:36:37.036586
NCT01668433|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-11-02|||July 2013||2013-07-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency|Open Label Randomized Controlled Trial Pharmacokinetic and Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency|Completed||Phase 1|20|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 02:36:37.135829|2017-10-11 02:36:37.135829
NCT01668420|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2012-11-07|||December 2009||2009-12-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effect of Thermal Stimulation for Lower Extremity Movement and Function in Patients With Stroke|Effect of Thermal Stimulation for Lower Extremity Movement and Function in Patients With Stroke|Completed||N/A|34|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||f||||||||||2017-10-11 02:36:37.22763|2017-10-11 02:36:37.22763
NCT01668394|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-09-13|||November 2010||2010-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|May 2016|Actual|2016-05-01||Interventional|LC-REHAB||Effect of Learning and Coping Strategies in Cardiac Rehabilitation - Group Study|Effect of Learning and Coping Strategies in Cardiac Rehabilitation - A Randomised Controlled Parallel Group Study|Active, not recruiting||N/A|825|Actual|Herning Hospital||2|||f||||f||||||||||2017-10-11 02:36:37.436746|2017-10-11 02:36:37.436746
NCT01668381|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2013-02-20|||August 2012||2012-08-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy|Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy|Unknown status|Active, not recruiting|N/A|20|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||f||||||||||2017-10-11 02:36:37.535751|2017-10-11 02:36:37.535751
NCT01668368|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-08-14|||September 2012||2012-09-01|August 2012|2012-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance|Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance Approach Guided by Esophageal Pressure in Acute Respiratory Failure.|Unknown status|Not yet recruiting|N/A|50|Anticipated|Wolfson Medical Center||1|||f||||f||||||||||2017-10-11 02:36:37.627869|2017-10-11 02:36:37.627869
NCT01668355|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-09-07|||September 1, 2015|Actual|2015-09-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|September 30, 2018|Anticipated|2018-09-30||Interventional|SMI-PACT||PACT for Individuals With Serious Mental Illness|PACT to Improve Health Care in People With Serious Mental Illness (SMI-PACT)|Recruiting||N/A|314|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 02:36:37.720361|2017-10-11 02:36:37.720361
NCT01668342|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2015-05-26|||June 2012||2012-06-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Mobile Phone Text Message Program to Understand Symptoms and Improve Outcomes in Minor Head Injury Patients|Mobile Phone Text Message Program to Understand Symptoms and Improve Outcomes in Minor Head Injury Patients|Completed||Phase 1|45|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:36:37.842098|2017-10-11 02:36:37.842098
NCT01668329|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-08|2015-01-16|||September 2009||2009-09-01|August 2012|2012-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|BIOSEPSIS||Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)|Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)|Completed||N/A|64|Actual|University Hospital, Grenoble|||1||f||||t||||||Samples Without DNA|"     hormons, inflammatory markers, vitamines recovered from the patients serum.   "|||2017-10-11 02:36:37.935995|2017-10-11 02:36:37.935995
NCT01668316|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-14|||July 2012||2012-07-01|August 2012|2012-08-01||||October 2013|Anticipated|2013-10-01||Interventional|GEM||Get Active and Eat Right: Moms at Work|Get Active and Eat Right: Moms at Work|Unknown status|Recruiting|N/A|78|Anticipated|University of North Carolina, Greensboro||2|||f||||||||||||||2017-10-11 02:36:38.018384|2017-10-11 02:36:38.018384
NCT01668303|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-14|||June 2004||2004-06-01|August 2012|2012-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|JDC||Family-Based Juvenile Drug Court Services|Family-Based Juvenile Drug Court Services|Completed||N/A|112|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 02:36:38.176814|2017-10-11 02:36:38.176814
NCT01668290|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-03-15|||July 2012||2012-07-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|IMAGE-CAD||Assessment of Patients With Suspected Coronary Artery Disease (CAD): What is the Best Initial Imaging Strategy?|Assessment of Patients With Suspected CAD: What is the Best Initial Imaging Strategy? Cardiac Computed Tomographic Angiography,(CCTA) vs Stress Echocardiography (SE) vs SPECT|Completed||N/A|173|Actual|University of Alberta|||3||f||||f||||||||No||2017-10-11 02:36:38.371155|2017-10-11 02:36:38.371155
NCT01668277|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-12-19|||August 2012||2012-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Saline on Circulation in Children|Effects of Hypertonic Saline on the Pulmonary Circulation in Children|Completed||Phase 2|15|Actual|The Hospital for Sick Children||3|||f||||f||||||||||2017-10-11 02:36:38.474822|2017-10-11 02:36:38.474822
NCT01668264|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-06-22||||||June 2016|2016-06-01||||||||Interventional|||Imaging Assessment of Diastolic Function|Combined Echocardiographic and MRI Assessment of Diastolic Function in Patients With Congenital Heart Disease|Not yet recruiting||Phase 2|200|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 02:36:38.575596|2017-10-11 02:36:38.575596
NCT01668251|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-08-14|||January 2006||2006-01-01|August 2012|2012-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Turner Syndrome Prenatal Diagnosis Study|National Collaborative Study of Girls Prenatally Diagnosed With Turner Syndrome Karyotypes|Unknown status|Recruiting|N/A|60|Anticipated|Seattle Children's Hospital|||2||f||||f||||||||||2017-10-11 02:36:38.693997|2017-10-11 02:36:38.693997
NCT01668238|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-14|||August 2011||2011-08-01|August 2012|2012-08-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|||Detection of Benign and Malignant Thyroid and Breast Tumors by Fourier Transform Infrared Spectrometry|Detection of Benign and Malignant Thyroid and Breast Tumors by Fourier Transform Infrared Spectrometry|Unknown status|Recruiting|N/A|600|Anticipated|Peking University|||3||f||||f||||||||||2017-10-11 02:36:38.814944|2017-10-11 02:36:38.814944
NCT01668225|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-07-24|||March 2012||2012-03-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|G-CSF FIVnat||Impact of Follicular and Blood G-CSF on Pregnancy and Implantation Rate During Modified Natural in Vitro Fertility Cycle|Impact of Follicular and Blood G-CSF on Pregnangcy and Implantation Rate During Modified Natural in Vitro Fertility Cycle|Recruiting||N/A|224|Anticipated|OVO R & D|||1||f||||f||||||Samples Without DNA|"     Serum sample Follicular fluid   "|||2017-10-11 02:36:38.949403|2017-10-11 02:36:38.949403
NCT01668212|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-06-21|||March 2012||2012-03-01|June 2013|2013-06-01||||May 2013|Actual|2013-05-01||Observational|||Perifollicular Doppler in Natural Cycle In Vitro Fertilization|Perifollicular Doppler in Natural Cycle In Vitro Fertilization|Completed||N/A|160|Actual|OVO R & D|||1||f||||f||||||||||2017-10-11 02:36:39.053653|2017-10-11 02:36:39.053653
NCT01668199|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2012-08-16|||February 2012||2012-02-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101|An Open-Label, Single-Dose, Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101|Completed||Phase 1|6|Actual|Norgine||1|||f||||f||||||||||2017-10-11 02:36:39.15874|2017-10-11 02:36:39.15874
NCT01668186|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-03-21|||January 2012||2012-01-01|September 2016|2016-09-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)|Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)|Recruiting||N/A|100|Anticipated|McGill University Health Center|||1||f||||f||||||Samples With DNA|"     Blood, Dried blood spots, Urine, Cultured fibroblasts   "|||2017-10-11 02:36:39.256085|2017-10-11 02:36:39.256085
NCT01668173|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-04-11|2016-01-04||August 2012||2012-08-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET|A Phase II Study of the HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET|Terminated||Phase 2|7|Actual|Memorial Sloan Kettering Cancer Center|Early termination leading to small numbers of subjects analyzed.|1||patient safety|f||||||||||||||2017-10-11 02:36:39.390547|2017-10-11 02:36:39.390547
NCT01668160|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2013-11-04|||February 2012||2012-02-01|November 2013|2013-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis|Analysis of the Stability of Total Hip Arthroplasty Implants Used in Revision Surgery Using Radiostereometric Analysis (RSA)|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:36:39.688819|2017-10-11 02:36:39.688819
NCT01668147|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-10-31|||August 2012||2012-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|dLOP||Efavirenz and Ritonavir on Human Brian P-Glycoprotein|Influence of Efavirenz and Ritonavir on Human Brain P-Glycoprotein Activity Using PET Imaging|Completed||N/A|13|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 02:36:39.801391|2017-10-11 02:36:39.801391
NCT01668134|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-02-16|||December 16, 2009|Actual|2009-12-16|February 2017|2017-02-01|December 22, 2015|Actual|2015-12-22|August 30, 2014|Actual|2014-08-30||Interventional|||Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma|Feasibility Study of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma|Completed||Phase 1|28|Actual|Washington University School of Medicine||1|||f||||t|f|t|f|f|f|||No||2017-10-11 02:36:39.909819|2017-10-11 02:36:39.909819
NCT01668121|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-11-22|||August 2012||2012-08-01|August 2012|2012-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|REFLI||Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers|Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers, Two Batches of Symbicort Turbuhaler and Budesonide/Formoterol Easyhaler: Randomised, Double-blind, Double-dummy, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|48|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-11 02:36:39.988271|2017-10-11 02:36:39.988271
NCT01668108|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-02-22|||August 2012||2012-08-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer|Open, Multicenter Observational Study of Paclitaxel Utilized in Mono- or Combination Therapy for the Treatment of Breast Cancer, Non-small Cell Lung Cancer and Ovarial Cancer.|Recruiting||N/A|250|Anticipated|Onkovis GmbH|||1||f||||f||||||||||2017-10-11 02:36:40.084393|2017-10-11 02:36:40.084393
NCT01668095|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-05-17|||August 2012||2012-08-01|May 2016|2016-05-01||||October 2012|Actual|2012-10-01||Observational|||Biomarkers in Patients With Advanced Rhabdomyosarcoma|Developmental Pathway Drug-Targets in Advanced Rhabdomyosarcomas|Completed||N/A|10|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     tumor tissue   "|||2017-10-11 02:36:40.178529|2017-10-11 02:36:40.178529
NCT01668082|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-06-07|||August 2009||2009-08-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection|An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection|Recruiting||N/A|40|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-11 02:36:40.260295|2017-10-11 02:36:40.260295
NCT01668069|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-04-04|||October 2012||2012-10-01|April 2016|2016-04-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|||Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy|Is Zofran Superior to Pyridoxine at Reducing Nausea and Vomiting in Pregnancy|Completed||N/A|36|Actual|United States Naval Medical Center, San Diego||2|||f||||t||||||||No||2017-10-11 02:36:40.364153|2017-10-11 02:36:40.364153
NCT01668056|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2013-09-09|||January 2012||2012-01-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence|The Role of Controlling Follicular Wave Emergence to Synchronize Ovarian Stimulation for in Vitro Fertilization|Unknown status|Recruiting|N/A|30|Anticipated|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-11 02:36:40.463553|2017-10-11 02:36:40.463553
NCT01668043|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-08-18|||September 2012||2012-09-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults|A Phase IIa, Open-label, Multiple-Dose Trial to Investigate the Safety and Efficacy of the UB-421 in Asymptomatic HIV-1 Infected Adults|Completed||Phase 2|29|Actual|United Biomedical||2|||f||||t||||||||||2017-10-11 02:36:40.601329|2017-10-11 02:36:40.601329
NCT01668030|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-07-27|2017-04-05||February 2012|Actual|2012-02-01|July 2017|2017-07-01|August 2014|Actual|2014-08-01|November 2013|Actual|2013-11-01||Interventional|||Comparison of Wound Bed Establishment in Facial Burns|Comparison of Wound Bed Establishment in Facial Burns Using Two Standard Ointments|Completed||Phase 4|10|Actual|University of Louisville|Small sample size. The study did not differentiate between deep partial thickness and superficial partial thickness burns. another way to trial this study methodology would be to use animal subjects.|2|||f||||f||||||||||2017-10-11 02:36:40.710893|2017-10-11 02:36:40.710893
NCT01667835|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-11-16|||November 2012||2012-11-01|November 2012|2012-11-01|August 2015|Anticipated|2015-08-01|December 2014|Anticipated|2014-12-01||Interventional|SAWYES||South Asian Women & Yoga Education Study|Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study|Unknown status|Recruiting|Phase 1|50|Anticipated|Kwantlen Polytechnic University||2|||f||||f||||||||||2017-10-11 02:36:46.839032|2017-10-11 02:36:46.839032
NCT01668017|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-07-19|2017-02-12||September 30, 2012|Actual|2012-09-30|July 2017|2017-07-01|May 31, 2015|Actual|2015-05-31|May 31, 2015|Actual|2015-05-31||Interventional||Safety analysis set included all subjects who received at least one administration of pimasertib.|A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy|A Multicentre, Open Label, Phase I Trial in Japan of the MEK Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy|Terminated||Phase 1|26|Actual|Merck KGaA|Due to the Sponsor’s decision not to pursue the study drug as monotherapy, the Expansion Phase (Part 2) of the study was not conducted.|5||The sponsor decided not to conduct the expansion part of trial (part 2)|f||||t||||||||||2017-10-11 02:36:41.071243|2017-10-11 02:36:41.071243
NCT01668004|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-03-13|2016-04-15||September 2012||2012-09-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|GO-EASY||The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)|Open-Label, Phase 4 Study, Investigating the Incidence of Extra-Articular Manifestations in Subjects With Ankylosing Spondylitis Treated With Golimumab; Protocol No. MK-8259-012|Completed||Phase 4|101|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:36:43.169057|2017-10-11 02:36:43.169057
NCT01667991|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2012-08-17|||April 2010||2010-04-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|||||Observational|||Evaluation of the American Thoracic Society Criteria for Predicting Multidrug-resistant Bacteria in Critically Ill Patients||Completed||N/A|610|Actual|Southeast University, China|||1||f||||t||||||||||2017-10-11 02:36:43.487421|2017-10-11 02:36:43.487421
NCT01667978|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-08-19|2015-05-27||June 2012||2012-06-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|NET||The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception|The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception|Completed||N/A|35|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 02:36:43.558677|2017-10-11 02:36:43.558677
NCT01667965|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-07-13|||August 2012||2012-08-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Use of a Video Decision Tool to Improve Informed Decision-Making in Hospitalized Patients Considering Palliative Radiation Therapy|Use of a Video Decision Tool to Improve Informed Decision-Making in Hospitalized Patients Considering Palliative Radiation Therapy|Completed||N/A|43|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 02:36:43.916253|2017-10-11 02:36:43.916253
NCT01667952|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-09-05|||August 2012||2012-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness|Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness|Recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     Saliva or blood samples will be collected in the clinic at the time of a routine visit.   "|||2017-10-11 02:36:44.062403|2017-10-11 02:36:44.062403
NCT01667939|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-08-16|||June 2009||2009-06-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||A Supervised Nutritional Program in Pregnancies and NF-κB Expression in Placenta|A Supervised Nutritional Program in Pregnancies Diminish the NF-κB Expression in Placenta|Completed||Phase 1|26|Actual|Materno-Perinatal Hospital of the State of Mexico||2|||f||||f||||||||||2017-10-11 02:36:44.168975|2017-10-11 02:36:44.168975
NCT01667926|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-04-18|2017-03-02||January 2013||2013-01-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder|Randomized, Double-blind Ketamine Augmentation in Chronically Suicidal, Treatment-resistant Major Depression|Completed||N/A|37|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:36:44.272495|2017-10-11 02:36:44.272495
NCT01667913|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2013-11-13|||September 2012||2012-09-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Reliability of 6-Minutes Walking Test in Hip Fracture Patients|The Relative and Absolute Reliability of 6-Minutes Walking Test in Hip Fracture Patients|Terminated||N/A|20|Actual|Lolland Community, Denmark||1||Due to low inclusion rate we terminated this study with n=20 participants instead of n=50.|f||||f||||||||||2017-10-11 02:36:44.649211|2017-10-11 02:36:44.649211
NCT01667900|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-02-08|2015-06-09||August 2012||2012-08-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||All enrolled participants.|A Study of Dulaglutide in Chinese Participants|Pharmacokinetics of a Single Dulaglutide Dose in Healthy Chinese Subjects and of Multiple Dulaglutide Doses in Chinese Patients With T2DM|Completed||Phase 1|58|Actual|Eli Lilly and Company||8|||f||||f||||||||||2017-10-11 02:36:44.769656|2017-10-11 02:36:44.769656
NCT01667887|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2013-01-28|||April 2011||2011-04-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|May 2012|Actual|2012-05-01||Observational|||Plating of Distal Femur Fractures by Far Cortical Locking Using MotionLoc Screws|MotionLoc Study: Healing of Distal Femur Fractures Stabilized With a Flexible Plating Construct Using MotionLoc Screws|Completed||N/A|33|Anticipated|Legacy Biomechanics Laboratory|||1||f||||t||||||||||2017-10-11 02:36:46.313576|2017-10-11 02:36:46.313576
NCT01667874|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-02-14|||January 2013||2013-01-01|February 2017|2017-02-01|September 1, 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Use of Collatamp G Antibiotic Impregnated Sponges in the Treatment of Peri-prosthetic Total Joint Infections|Use of Collatamp G Antibiotic Impregnated Sponges in the Treatment of Peri-prosthetic Total Joint Infections|Terminated||Phase 3|17|Actual|Lawson Health Research Institute||2||Difficulty in recruiting patients for the study|f||||f||||||||No||2017-10-11 02:36:46.392029|2017-10-11 02:36:46.392029
NCT01667861|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-05-22|||October 2011||2011-10-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Observational|||Risk Factors for Glaucoma in Musicians|Risk Factors for Glaucoma in Musicians|Completed||N/A|40|Actual|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-11 02:36:46.485311|2017-10-11 02:36:46.485311
NCT01667848|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-05-04|2013-09-30||July 2011||2011-07-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Warmed, Humidified Carbon Dioxide Insufflation vs Standard Carbon Dioxide in Laparoscopic Cholecystectomy|Warmed, Humidified Carbon Dioxide Insufflation vs Standard Carbon Dioxide in Laparoscopic Cholecystectomy: a Double-blinded Randomized Controlled Trial|Completed||N/A|148|Actual|Ludwig Boltzmann Institute for Operative Laparoscopy||2|||f||||f||||||||||2017-10-11 02:36:46.569218|2017-10-11 02:36:46.569218
NCT01667809|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-03-02|||August 2012||2012-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||CBT vs RTW Intervention for Patients With Common Subclinical Mental Illness in Primary Care|Cognitive Behavior Therapy Versus a Return to Work Intervention for Sick-listed Patients With Subclinical Common Mental Illness in Primary Care: a Randomized Controlled Trial|Completed||Phase 3|5|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:36:47.243993|2017-10-11 02:36:47.243993
NCT01667796|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-03-06|2015-08-25||November 2010||2010-11-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health|Pharmacodynamic and Immunologic Effects of Vitamin D Supplementation in Patients With Multiple Sclerosis and Healthy Controls|Completed||Phase 1|57|Actual|Johns Hopkins University|The generalizability of the findings of this study (beyond female Caucasians) has to be further tested. It is possible that there were unmeasured confounders influencing results.|1|||f||||t||||||||||2017-10-11 02:36:47.34228|2017-10-11 02:36:47.34228
NCT01667783|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-03-30|||August 2012||2012-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|IDeaLS||Improving Diabetes Through Lifestyle and Surgery|Improving Diabetes Through Lifestyle and Surgery Study|Completed||Phase 2/Phase 3|15|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 02:36:47.712493|2017-10-11 02:36:47.712493
NCT01667770|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-12-12|||January 2012||2012-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|DECOMPRESS||Dural Graft Equivalent Comparison Trial|Dural Graft Equivalent Comparison Trial|Recruiting||N/A|200|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||f||||||||||2017-10-11 02:36:47.803046|2017-10-11 02:36:47.803046
NCT01667757|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2015-03-23|||March 2010||2010-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Optimal Physiologic Intravascular Ultrasound Imaging Criteria After Drug Eluting Stent Implantation|Angiographic and IVUS Criteria Defining Physiologic Optimization By the Fractional Flow Reserve After DES Implantation|Completed||N/A|200|Actual|Inje University|||2||f||||t||||||||||2017-10-11 02:36:47.900319|2017-10-11 02:36:47.900319
NCT01667744|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2016-02-17|||January 2018||2018-01-01|February 2016|2016-02-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||Citalopram for Sx/Util in Acute Coronary Syndrome Patients|Citalopram for Sx/Util in Acute Coronary Syndrome Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Henry Ford Health System||1||unfunded|f||||t||||||||Undecided|Study not funded.|2017-10-11 02:36:47.980126|2017-10-11 02:36:47.980126
NCT01667731|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-11-14|2014-11-14||July 2012||2012-07-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional||Safety Analysis Set: participants who were enrolled and received at least 1 dose of study drug|Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults|A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects|Completed||Phase 3|224|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 02:36:48.078974|2017-10-11 02:36:48.078974
NCT01667718|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-12-12|||May 2012||2012-05-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment|Levofloxacin-containing Therapy for Helicobacter Pylori Treatment|Completed||Phase 4|161|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||||2017-10-11 02:36:49.786661|2017-10-11 02:36:49.786661
NCT01667705|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-11-29|||March 2012||2012-03-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|Skyceiling||To Examine the Effect of a View of Nature on Patient's Stress and Anxiety|Patient Experience in the CT Scan Suite|Completed||N/A|120|Actual|Erasmus Medical Center|||2||f||||f||||||||||2017-10-11 02:36:49.895032|2017-10-11 02:36:49.895032
NCT01667692|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2012-08-15|||March 2011||2011-03-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Interventional|H-pylori||Aizthromycin or Clarithromycin in H-pylori Eradication Regimen|Comparison of Azithromycin or Clarithromycin in 3drugs Protocol of H-pylori Eradication Regimen|Completed||Phase 4|78|Actual|Shahid Sadoughi University of Medical Sciences and Health Services||2|||f||||f||||||||||2017-10-11 02:36:49.975128|2017-10-11 02:36:49.975128
NCT01667679|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-03-14|2016-10-13||August 2012||2012-08-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|COMPASS|Baseline data are reported for participants in the Safety Analysis Set, defined as all randomized participants who received at least one dose of sumatriptan (20 mg nasal powder or 100 mg tablet).|Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura|A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Cross-Over Study Evaluating the Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura|Completed||Phase 3|275|Actual|Avanir Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:36:50.150907|2017-10-11 02:36:50.150907
NCT01667666|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-12-21|||May 2012||2012-05-01|December 2016|2016-12-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury|A Clinical Study to Determine if Nebulized Hypertonic Saline Attenuates Acute Lung Injury Following Trauma and Hemorrhagic Shock|Recruiting||Phase 1|20|Anticipated|Denver Health and Hospital Authority||1|||f||||t||||||||||2017-10-11 02:36:52.278004|2017-10-11 02:36:52.278004
NCT01667653|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-08-14|||March 2012||2012-03-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Probiotic Product in Healthy Adults Undergoing Antibiotic Treatment|A Randomized Parallel Group Study to Evaluate the Effect of a Probiotic Product in Healthy Adults Undergoing Antibiotic Treatment|Completed||Phase 2|80|Actual|Danisco||2|||f||||f||||||||||2017-10-11 02:36:52.364349|2017-10-11 02:36:52.364349
NCT01667640|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-04-28|||April 2012||2012-04-01|April 2015|2015-04-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Sector Irradiation Versus Whole Brain Irradiation for Brain Metastasis|Sector Irradiation Versus Whole Brain Irradiation After Resection of Singular or Solitary Brain Metastasis - a Prospective Randomized Monocentric Trial|Unknown status|Recruiting|N/A|50|Anticipated|Medical University Innsbruck||2|||f||||f||||||||||2017-10-11 02:36:52.463421|2017-10-11 02:36:52.463421
NCT01667627|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2014-03-26|||November 2013||2013-11-01|August 2012|2012-08-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|IBS-D||Probiotic in Irritable Bowel Syndrome (IBS) Patients With Diarrhea|A Double-blind, Placebo-controlled Study to Assess the Effect of Probiotic on Symptom Relief and Indices of Micro-inflammation and Cholinergic Status in IBS Patients With Diarrhea.|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 02:36:52.583509|2017-10-11 02:36:52.583509
NCT01667614|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-08-27|||May 2010||2010-05-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure|Comparison of Efficacy of Losartan/Spironolactone and Losartan/Enalapril on Urinary Albumin Excretion, Estimated Glomerular Filtration Rate, and Blood Pressure in Patients With Type 2 Diabetes Nephropathy|Completed||Phase 2|136|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:36:52.683078|2017-10-11 02:36:52.683078
NCT01667601|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-07-02|||August 2010||2010-08-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|June 2016|Actual|2016-06-01||Interventional|MBPP||Mindfulness-based Illness Management Program for Schizophrenia|The Effectiveness of a Mindfulness-based Illness Management Program for Chinese Patients With Schizophrenia: An Randomised Controlled Trial|Completed||Phase 2/Phase 3|342|Actual|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-11 02:36:52.766936|2017-10-11 02:36:52.766936
NCT01667588|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-05-20|||August 2012||2012-08-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Sleep Disorders in Pediatric Dialysis|Sleep Disorders in Pediatric Dialysis|Completed||N/A|19|Actual|The Hospital for Sick Children|||2||f||||f||||||||||2017-10-11 02:36:52.879781|2017-10-11 02:36:52.879781
NCT01667575|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2013-06-01|||August 2012||2012-08-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori||Completed||Phase 4|180|Actual|Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||||2017-10-11 02:36:52.947505|2017-10-11 02:36:52.947505
NCT01667562|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-08-28|||January 20, 2012|Actual|2012-01-20|August 2017|2017-08-01|February 26, 2025|Anticipated|2025-02-26|February 26, 2025|Anticipated|2025-02-26||Interventional|ESSENCE||A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Phase IIIb, Open-Label Study of Erlotinib (Tarceva®) Treatment in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Present Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor|Active, not recruiting||Phase 3|30|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:36:53.098992|2017-10-11 02:36:53.098992
NCT01667549|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-09-02|||August 2012||2012-08-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Sensitive Periods in Human Flavor Learning|Sensitive Periods in Human Flavor Learning|Completed||N/A|254|Actual|Monell Chemical Senses Center||4|||f||||f||||||||||2017-10-11 02:36:53.19609|2017-10-11 02:36:53.19609
NCT01667536|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-12-14|2015-12-15||August 2012||2012-08-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology|A Phase 2 Assessment of the Diagnostic Accuracy of 99mTc-MIP-1404 Imaging in Men With High-Risk Prostate Cancer Scheduled for Radical Prostatectomy (RP) and Extended Pelvic Lymph Node Dissection (EPLND) Compared to Histopathology|Completed||Phase 2|105|Actual|Molecular Insight Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:36:53.320435|2017-10-11 02:36:53.320435
NCT01667523|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-12|2012-08-16|||February 2011||2011-02-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||The Effect of Capsaicin and Cinnamaldehyde on Intestinal Permeability|The Effect of Capsaicin and Cinnamaldehyde on Intestinal Permeability, Gallbladder Motility and Satiety|Completed||N/A|13|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 02:36:53.665195|2017-10-11 02:36:53.665195
NCT01667510|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2012-08-15|||August 2012||2012-08-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Interventional|||Effect of Cardio Mato (a Tomato Extracted Lycopene) on Blood Pressure and Serum Lycopene, Phytofluene, and Phytoene Levels in Pre-hypertensive Otherwise Healthy Subjects|Effect of Cardio Mato (Grade A Lyc-O-Mato, a Tomato Extracted Lycopene) on Blood Pressure and Serum Lycopene, Phytofluene, and Phytoene Levels in Pre-hypertensive Otherwise Healthy Subjects|Unknown status|Recruiting|Phase 2|80|Anticipated|LycoRed Ltd.||2|||f||||f||||||||||2017-10-11 02:36:53.748315|2017-10-11 02:36:53.748315
NCT01667497|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2015-09-01|||September 2012||2012-09-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?|Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients? A Cross Over Study|Completed||Phase 2/Phase 3|60|Actual|London Health Sciences Centre||2|||f||||f||||||||||2017-10-11 02:36:53.832399|2017-10-11 02:36:53.832399
NCT01667484|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2015-05-07|||September 2012||2012-09-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2013|Actual|2013-02-01||Interventional|||Adderall XR and Processing Speed in Multiple Sclerosis (MS)|Does Adderall XR Improve Processing Speed in Cognitively Impaired MS Patients?|Completed||Phase 2/Phase 3|70|Actual|London Health Sciences Centre||3|||f||||f||||||||||2017-10-11 02:36:53.903203|2017-10-11 02:36:53.903203
NCT01667471|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-11-01|2015-07-09||January 2012||2012-01-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||All participants who received at least one dose of study drug were included in the Safety Analysis Set.|A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study|Long-term, Interventional, Open Label Extension Study Evaluating the Safety of Tocilizumab Treatment in Patients With Polyarticular-course Juvenile Idiopathic Arthritis Who Completed the Global, Multinational Trial (WA19977)|Completed||Phase 3|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:36:54.013046|2017-10-11 02:36:54.013046
NCT01667458|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-11-01|||September 2011||2011-09-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)|F-ACT Trial: Observational Study on Fatigue and Its Evolution During Treatment With Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis in Daily Clinical Practice|Completed||N/A|59|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:36:54.820004|2017-10-11 02:36:54.820004
NCT00005294|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1989||1989-07-01|April 2000|2000-04-01|June 1995|Actual|1995-06-01|||||Observational|||Developmental Sequelae of Severe Chronic Lung Disorders||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.27641|2017-10-11 04:27:57.27641
NCT01667445|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-04-27|||September 2012||2012-09-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of the Use of Spinal Epimorph in Total Knee Arthroplasty|Determination of Effectiveness of Periarticular Local Infiltration When Compared to Spinal Epimorph for Analgesia in Total Knee Arthroplasty|Completed||Phase 4|113|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:36:54.920176|2017-10-11 02:36:54.920176
NCT01667432|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-03-10|2015-10-01||July 8, 2011|Actual|2011-07-08|March 2017|2017-03-01|August 12, 2014|Actual|2014-08-12|August 12, 2014|Actual|2014-08-12||Observational||Intent-to-treat population: All participants who received at least 1 dose of peginterferon alfa-2a.|An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B|A Multicenter, Prospective, Observational, Non-interventional Study Evaluating On-treatment Predictors of Response in Subjects With HBeAg Positive or HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS® (Peginterferon Alfa-2a 40KD)|Completed||N/A|141|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:36:55.037979|2017-10-11 02:36:55.037979
NCT01667419|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-09-26|||September 24, 2012|Actual|2012-09-24|September 2017|2017-09-01|October 14, 2020|Anticipated|2020-10-14|June 23, 2017|Actual|2017-06-23||Interventional|BRIM8||A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Vemurafenib (RO5185426) Adjuvant Therapy in Patients With Surgically Resected, Cutaneous BRAF-Mutant Melanoma at High Risk for Recurrence|Active, not recruiting||Phase 3|475|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:36:55.246393|2017-10-11 02:36:55.246393
NCT01667406|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-08-30|||June 2012||2012-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|August 2016|Anticipated|2016-08-01||Interventional|||The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment|The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment|Recruiting||Phase 2|102|Anticipated|Imperial College London||1|||f||||t||||||||No|Data will be presented in anonymised groups|2017-10-11 02:36:57.531855|2017-10-11 02:36:57.531855
NCT01667393|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-06-17|||January 2013||2013-01-01|June 2015|2015-06-01||||||||Interventional|PARADIGM||Popliteal Artery of Treatment With Balloon Angioplasty vs. SUPERA VERITAS Peripheral Stent System|Popliteal Artery Trial of Patients Undergoing Treatment With Balloon Angioplasty vs. the Adaptive SUPERA VERITAS Peripheral Stent System|Withdrawn||Phase 3|0|Actual|Abbott Vascular||2|||f||||t||||||||||2017-10-11 02:36:57.619209|2017-10-11 02:36:57.619209
NCT01667380|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-11-01|||April 2012||2012-04-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)|Non-interventional Study on the Use of Mircera in the Treatment of Chronic Renal Anemia in Patients With Chronic Kidney Disease Stages III-IV Not on Dialysis and in Patients on Stage V on Hemodialysis|Completed||N/A|78|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:36:57.82047|2017-10-11 02:36:57.82047
NCT01667367|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-09-01|||August 2012||2012-08-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Molecular and Functional Brain Imaging Study in Individuals With Down Syndrome and Healthy Controls Following Single Dose RG1662|A Single-center, Single Blind Molecular and Functional Imaging Study to Assess GABAAalpha5 Receptor Expression, Occupancy and Functional Connectivity in the Brains of Individuals With Down Syndrome and Healthy Controls Following a Single Oral Administration of RG1662 or Placebo|Completed||Phase 1|13|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:36:57.91775|2017-10-11 02:36:57.91775
NCT01667341|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-01-12||2015-12-01|July 2012||2012-07-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine|A Phase I/IIa, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study of the Safety and Immunogenicity of a HSV-2 Vaccine Containing Matrix M-2 Adjuvant in Individuals With Documented Genital HSV-2 Genital Infection|Completed||Phase 1/Phase 2|143|Actual|Genocea Biosciences, Inc.||7|||f||||t||||||||||2017-10-11 02:36:58.133532|2017-10-11 02:36:58.133532
NCT01667328|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-05-08|||June 2012||2012-06-01|May 2016|2016-05-01|December 31, 2017|Anticipated|2017-12-31|December 2017|Anticipated|2017-12-01||Interventional|||Preoperative Massage in Breast Surgery Patients|Utility of Preoperative Massage in Breast Surgery Patients|Recruiting||N/A|300|Anticipated|Vassar Brothers Medical Center||2|||f||||f||||||||||2017-10-11 02:36:58.255391|2017-10-11 02:36:58.255391
NCT01667315|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-16|||August 2012||2012-08-01|August 2012|2012-08-01|September 2013|Anticipated|2013-09-01|January 2013|Anticipated|2013-01-01||Interventional|||Minimum Effective Volume of 0.375% Bupivacaine in Interscalene Brachial Plexus Block|Minimum Effective Volume of 0.375% Bupivacaine in Ultrasound- and Nerve Stimulator-guided Interscalene Brachial Plexus Block for Shoulder Surgery|Unknown status|Recruiting|Phase 2|33|Anticipated|Federal University of São Paulo||1|||f||||f||||||||||2017-10-11 02:36:58.347039|2017-10-11 02:36:58.347039
NCT01667302|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2013-03-02|||June 2012||2012-06-01|March 2013|2013-03-01|December 2016|Anticipated|2016-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma|A Phase II Study of Radiotherapy Followed by Chemotherapy With DICEP Regimen in Patients With NK/T-cell Lymphoma|Unknown status|Recruiting|Phase 2|30|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 02:36:58.429316|2017-10-11 02:36:58.429316
NCT01667289|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2013-03-02|||June 2012||2012-06-01|March 2013|2013-03-01|June 2017|Anticipated|2017-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma|A Randomized Phase II Study of Comparing Radiotherapy Alone With Concurrent Chemoradiation in Patients With Low Risk NK/T-cell Lymphoma|Terminated||Phase 2|4|Actual|Fudan University||2||unexpected high grade of mucositis observed|f||||f||||||||||2017-10-11 02:36:58.533326|2017-10-11 02:36:58.533326
NCT01667276|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-07-16|||July 2012||2012-07-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|||Acceptability of Depo-subQ in Uniject|Acceptability of Depo-subQ in Uniject|Completed||N/A|476|Actual|FHI 360|||1||f||||f||||||||||2017-10-11 02:36:58.624746|2017-10-11 02:36:58.624746
NCT00004402|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||November 1999||1999-11-01|January 2001|2001-01-01|June 2000||2000-06-01|||||Interventional|||Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis||Completed||Phase 3|30||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.35907|2017-10-11 04:25:19.35907
NCT01667263|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-09-03|||June 1, 2012|Actual|2012-06-01|April 2017|2017-04-01|February 1, 2017|Actual|2017-02-01|July 1, 2016|Actual|2016-07-01||Interventional|||The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia|The Combination of Oral All-trans Retinoic Acid and Danazol vs Danazol as Second-line Treatment in Adult Immune Thrombocytopenia: a Multicenter, Randomized, Open-label Trial|Completed||Phase 2|130|Actual|Peking University People's Hospital||2|||f||||t||||||||||2017-10-11 02:36:58.71015|2017-10-11 02:36:58.71015
NCT01667250|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-02-17||2016-02-17|October 2012||2012-10-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Non-Invasive Neurostimulation for the Prevention of Chronic Migraine|Non-Invasive Neurostimulation of the Vagus Nerve With the GammaCore Device for the Prevention of Chronic Migraine|Completed||N/A|59|Actual|ElectroCore LLC||2|||f||||||||||||||2017-10-11 02:36:58.84306|2017-10-11 02:36:58.84306
NCT01667237|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-01|2013-01-09|||March 2010||2010-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Feasibility of a Short Home-based Rehabilitation Program for Cancer Patients Waiting for Lung Resection Surgery|Feasibility of a Short Home-based Rehabilitation Program for Cancer Patients Waiting for Lung Resection Surgery|Completed||Early Phase 1|13|Actual|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec||1|||f||||t||||||||||2017-10-11 02:36:58.946459|2017-10-11 02:36:58.946459
NCT01667224|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-01-05|2014-03-16||October 2009||2009-10-01|January 2017|2017-01-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||Efficacy and Safety of Actiponin on Antiobesity in Obese Korean Subjects.|Actiponin Supplementation Reduces Abdominal Fat Area, Weight, Body Fat Mass and BMI in Obese Korean Subjects.|Completed||Phase 2|80|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:36:59.031837|2017-10-11 02:36:59.031837
NCT01667211|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-08-21|||November 2011||2011-11-01|August 2012|2012-08-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|CSAPPPCC||Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer|A Single Center, Non-randomized, Open Phase II Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Patients With Advanced, Recurrent Metastatic Cervical Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:36:59.503565|2017-10-11 02:36:59.503565
NCT01667198|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-04-15|||July 2012||2012-07-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Randomized Study of Train the Colonoscopy Leaders Course Versus Audit and Feedback on Colonoscopy Quality Indicators|Quality Improvement in Screening Colonoscopy - a Randomized Trial of Tailored Training Intervention Versus Simple Feedback on the Quality Indicators.|Completed||N/A|40|Actual|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||f||||||||||2017-10-11 02:36:59.702359|2017-10-11 02:36:59.702359
NCT01667185|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2013-02-07|||July 2012||2012-07-01|February 2013|2013-02-01||||December 2012|Actual|2012-12-01||Observational|||Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes Mellitus|Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes Mellitus.|Completed||N/A|176|Actual|DexCom, Inc.|||1||f||||f||||||||||2017-10-11 02:36:59.800159|2017-10-11 02:36:59.800159
NCT01667172|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-15|||April 2012||2012-04-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Technical Accuracy and Userfriendliness of Two Point-of-care C Reactive Protein Devices in Comparison With Laboratory CRP Testing.|Study of Technical Accuracy and Userfriendliness of Two Point-of-care C Reactive Protein Devices|Completed||N/A|300|Actual|Katholieke Universiteit Leuven||1|||f||||f||||||||||2017-10-11 02:36:59.888275|2017-10-11 02:36:59.888275
NCT01667159|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-07-31|||July 2012||2012-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||Community-Based Integrated Treatment for Adolescents|Adolescents With Major Depression and AUD: Community-Based Integrated Treatment|Active, not recruiting||Phase 1|114|Anticipated|Brown University||2|||f||||t||||||||||2017-10-11 02:36:59.975159|2017-10-11 02:36:59.975159
NCT01667146|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2017-09-07|||October 2012||2012-10-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Interventional|PHARLAP||A Multi-centre Trial of an Open Lung Strategy Including Permissive Hypercapnia, Alveolar Recruitment and Low Airway Pressure in Patients With Acute Respiratory Distress Syndrome|A Multi-centre Randomised Controlled Trial of an Open Lung Strategy Including Permissive Hypercapnia, Alveolar Recruitment and Low Airway Pressure in Patients With Acute Respiratory Distress Syndrome.|Recruiting||N/A|340|Anticipated|Australian and New Zealand Intensive Care Research Centre||2|||f||||f||||||||||2017-10-11 02:37:00.107634|2017-10-11 02:37:00.107634
NCT01667133|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-09-05|||August 2012||2012-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase 1/2 Study of Ponatinib in Japanese Patients With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)|A Phase 1/2 Multi-center, Open-label Study of Ponatinib in Japanese Patients With Chronic Myeloid Leukemia (CML) Who Have Failed Dasatinib or Nilotinib or Ph+ Acute Lymphoblastic Leukemia (ALL) Who Have Failed Prior Tyrosine Kinase Inhibitors (TKIs)|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Ariad Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:37:00.310139|2017-10-11 02:37:00.310139
NCT01667120|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2012-08-16|||July 2012||2012-07-01|August 2012|2012-08-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||The Use of Ketorolac in Surgical Neonates||Unknown status|Not yet recruiting|Phase 2|106|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-11 02:37:00.465228|2017-10-11 02:37:00.465228
NCT01667107|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-03-03|2014-12-22||January 2013||2013-01-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PAPAL||A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)|A Pharmacokinetic Analysis of Posaconazole in the Plasma and Alveolar Compartment of Lung Transplant Recipients|Terminated||Phase 4|26|Actual|Merck Sharp & Dohme Corp.||2||Study terminated due to an unfavorable risk-benefit analysis|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:37:00.575344|2017-10-11 02:37:00.575344
NCT01667094|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-04-18|||September 2012||2012-09-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|CISTIC||A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis|Continuous-infusion Anti-pseudomonal β-lactams for the Treatment of Acute, Infective Pulmonary Exacerbations in Cystic Fibrosis|Active, not recruiting||Phase 4|50|Actual|The Alfred||2|||f||||f||||||||||2017-10-11 02:37:00.992385|2017-10-11 02:37:00.992385
NCT01667081|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-09-25|||October 17, 2012|Actual|2012-10-17|September 2017|2017-09-01|July 7, 2023|Anticipated|2023-07-07|July 7, 2023|Anticipated|2023-07-07||Observational|||Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)|A Long-Term Follow-Up Study to Evaluate the Durability of Virologic Response and/or Viral Resistance Patterns of Subjects With Chronic Hepatitis C Who Have Been Previously Treated With MK-5172 in a Prior Clinical Trial|Enrolling by invitation||N/A|3250|Anticipated|Merck Sharp & Dohme Corp.|||1||f||||f||||||Samples With DNA|"     Blood samples will be collected and retained for purposes of DNA testing and plasma will be     retained for future biomedical research.   "|||2017-10-11 02:37:01.132873|2017-10-11 02:37:01.132873
NCT01667068|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-16|2014-10-27|||April 2012||2012-04-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Observational|||Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up|HIV-HEART STUDY: A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk in HIV-infected Patients|Completed||N/A|1481|Actual|University Hospital, Essen|||1||f||||t||||||Samples With DNA|"     Stored blood samples   "|||2017-10-11 02:37:01.203382|2017-10-11 02:37:01.203382
NCT01667055|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-07-25|||November 2012||2012-11-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||The Diagnosis of Penicillin/Aminopenicillin Allergy in Thailand|The Optimized Diagnostic Methods for the Confirmation of Penicillin/Aminopenicillin Allergy in Thailand|Completed||N/A|160|Actual|Chulalongkorn University|||1||f||||t||||||Samples Without DNA|"     Peripheral blood mononuclear cells in patients with a history of non-immediate reaction   "|No||2017-10-11 02:37:01.310906|2017-10-11 02:37:01.310906
NCT01667042|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-01-07|||August 2012||2012-08-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Observational|||Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough|Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough|Completed||N/A|7|Actual|Mayo Clinic|||2||f||||f||||||||||2017-10-11 02:37:01.385556|2017-10-11 02:37:01.385556
NCT01667029|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-07-12|||May 2013||2013-05-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Sulfasalazine in Treating Painful Neuropathy|A Single-center, Randomized, Double-blind Clinical Study to Evaluate the Effect of Sulfasalazine on Painful Neuropathy|Recruiting||Phase 2|55|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:37:01.453317|2017-10-11 02:37:01.453317
NCT01667016|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-09-26|||August 2012|Actual|2012-08-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||BIOFLOW-III Austria Satellite Registry|BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Austria|Completed||N/A|305|Actual|Biotronik Vertriebs-GmbH|||1||f||||f||||||||||2017-10-11 02:37:01.540581|2017-10-11 02:37:01.540581
NCT01667003|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2017-09-26|||August 2012|Actual|2012-08-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|||BIOFLOW-III Sweden Satellite Registry|BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Sweden|Completed||N/A|406|Actual|Biotronik ApS|||1||f||||f||||||||||2017-10-11 02:37:01.638432|2017-10-11 02:37:01.638432
NCT01666990|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2015-08-14|||June 2012||2012-06-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection|Phase 1/2 Study of Tripterygium Wilfordii Hook F (TwHF) Treatment for Evaluation the Efficacy and Safety in Immune Non-responders With HIV-1 Infection|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||||2017-10-11 02:37:01.730641|2017-10-11 02:37:01.730641
NCT01666977|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2016-05-18||2016-03-10|August 2012||2012-08-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer|A Phase 1b/2 Trial of AMG 386 in Combination With Pemetrexed and Carboplatin as First Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|36|Actual|Amgen||3|||f||||t||||||||||2017-10-11 02:37:01.846517|2017-10-11 02:37:01.846517
NCT01666964|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-14|||October 2012||2012-10-01|August 2012|2012-08-01|May 2015|Anticipated|2015-05-01|December 2014|Anticipated|2014-12-01||Observational|||Hormone Deficiency After Brain Injury During Combat|Prevalence of Hypopituitarism Following Combat-related Traumatic Brain Injury in a Military Population|Unknown status|Not yet recruiting|N/A|200|Anticipated|Walter Reed National Military Medical Center|||2||f||||f||||||Samples Without DNA|"     No specimens will be stored.      Blood Testing:      Testosterone 2ml Estradiol 2ml LH/FSH 3ml Prolactin 2ml IGF-1 1ml TSH 2ml Free T4 1ml Sodium     2ml Total blood for cosyntropin stim test 9ml Total blood for glucagon stim test 15ml Water     deprivation testing 12ml-32ml      Urine Testing:      HCG 2ml Water deprivation testing 8ml-18ml   "|||2017-10-11 02:37:02.139769|2017-10-11 02:37:02.139769
NCT01666951|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-06-30|2015-05-19||November 2012||2012-11-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional||The two patients that were randomized but not does (one in eacj treatment arm) are not included in the demographics|Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant|Ph 2 Double-blind, Double-dummy, Multicenter, Prospective, Rand Study of PK of LCP-Tacro™ Tablets Once Daily, Compared to Prograf® Caps, Twice Daily, for Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients|Completed||Phase 2|36|Actual|Veloxis Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:37:02.275205|2017-10-11 02:37:02.275205
NCT01666938|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-03-23|||April 2012||2012-04-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Telephone Counselling to Promote Physical Activity in Diabetes Mellitus People|The Use of a Telephone Counselling as a Strategy to Promote Physical Activity in Diabetes Mellitus People|Completed||N/A|26|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-11 02:37:03.60947|2017-10-11 02:37:03.60947
NCT01666925|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-12-11|||March 2012||2012-03-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy of Malaria Vaccines in Kenyan Adults|Efficacy Study of ChAd63MVA ME-TRAP Prime-boost Vaccination Against Plasmodium Falciparum Infection.|Completed||Phase 2|120|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 02:37:03.712658|2017-10-11 02:37:03.712658
NCT00004403|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||May 2000||2000-05-01|January 2001|2001-01-01|March 2002||2002-03-01|||||Interventional|||Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis||Completed||N/A|120||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.431343|2017-10-11 04:25:19.431343
NCT01666912|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-03-20|2017-01-13||August 2012||2012-08-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PPImplant||Postpartum Etonogestrel Implant for Adolescents|Etonogestrel-releasing Subdermal Implant for Adolescents in the Postpartum Period: a Randomized Controlled Trial|Completed||Phase 4|96|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 02:37:03.81988|2017-10-11 02:37:03.81988
NCT01666899|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-05-24|||October 2012||2012-10-01|May 2017|2017-05-01|June 15, 2015|Actual|2015-06-15|June 15, 2015|Actual|2015-06-15||Interventional|||Effect of Radiation on Tissue for Delayed Breast Reconstruction|Effect of Radiation on Tissue for Delayed Breast Reconstruction|Completed||N/A|10|Actual|University of Michigan Cancer Center||1|||f||||t|f|f||||||||2017-10-11 02:37:04.229447|2017-10-11 02:37:04.229447
NCT01666886|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-06-19|||August 2012||2012-08-01|June 2013|2013-06-01||||||||Interventional|||Efficacy of Additional Titration During Oral Appliance Treatment for Sleep-disordered Breathing.|Efficacy of Additional Titration During Oral Appliance Treatment for Sleep-disordered Breathing.|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Antwerp||1|||f||||||||||||||2017-10-11 02:37:04.317216|2017-10-11 02:37:04.317216
NCT01666873|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-12-04|||September 2012||2012-09-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|January 2016|Anticipated|2016-01-01||Observational|||Correlation Between Alignment of Lower Limb and Clinical Outcome After Total Knee Prosthesis.|Correlation Between Alignment of Lower Limb and Clinical Outcome After Total Knee Prosthesis.|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Ghent|||1||f||||f||||||||||2017-10-11 02:37:04.411524|2017-10-11 02:37:04.411524
NCT01666860|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-16|||November 2010||2010-11-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Observational|||Long-term Follow-up of the Anterior Lumbar Interbody Fusion Procedure.|Long-term Follow-up of the Anterior Lumbar Interbody Fusion Procedure.|Completed||N/A|56|Actual|University Hospital, Ghent|||1||f||||f||||||||||2017-10-11 02:37:04.497425|2017-10-11 02:37:04.497425
NCT01666847|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-11-22|||October 2012||2012-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Milking the Umbilical Cord for Extreme Preterm Infants|Milking the Umbilical Cord for Extreme Preterm Infants|Active, not recruiting||N/A|80|Anticipated|St. Louis University||2|||f||||t||||||||||2017-10-11 02:37:04.565093|2017-10-11 02:37:04.565093
NCT01666834|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-01-02|||July 2012||2012-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Cross-section Survey of Mechanical Ventilation and Acute Respiratory Distress Syndrome in China|Southeast Univerity|Completed||N/A|555|Actual|Southeast University, China|||1||f||||f||||||||||2017-10-11 02:37:04.651115|2017-10-11 02:37:04.651115
NCT01666821|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-14|||May 2004||2004-05-01|August 2012|2012-08-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Observational|||A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population|A Population-based Study of Macular Choroidal Neovascularization Using Optical Coherence Tomography in a Chinese Population|Completed||N/A|59|Actual|Shanghai University of Traditional Chinese Medicine|||1||f||||t||||||||||2017-10-11 02:37:04.7104|2017-10-11 02:37:04.7104
NCT01666808|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-07-10|||September 2012|Actual|2012-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||FACBC Outcomes for Post Prostatectomy|Advanced Molecular Imaging With Anti-3-[18F]FACBC PET-CT to Improve the Selection and Outcomes of Prostate Cancer Patients Receiving Post-prostatectomy Radiotherapy|Recruiting||Phase 2/Phase 3|162|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 02:37:04.778684|2017-10-11 02:37:04.778684
NCT01666795|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-04-18|||February 2005||2005-02-01|August 2012|2012-08-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Observational|||Autoantibody Specificity and Response to IVIG in ITP|Autoantibody Specificity and Response to Intravenous Immunoglobulin G (IVIG) in Immune Thrombocytopenia (ITP): a Retrospective Cohort Study|Completed||N/A|672|Actual|Shandong University|||1||f||||t||||||||No||2017-10-11 02:37:04.854814|2017-10-11 02:37:04.854814
NCT01666782|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-05-23|2016-01-29||August 2012||2012-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|IMMUNE||Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy|A Randomized Pilot Study Comparing High-Dose Influenza Vaccine to Standard-Dose Influenza Vaccine in Adult Oncology Patients Less Than 65 Years Receiving Chemotherapy|Completed||Phase 2|105|Actual|Rochester General Hospital||2|||f||||f||||||||||2017-10-11 02:37:04.935302|2017-10-11 02:37:04.935302
NCT01666769|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-05-31|||January 2013||2013-01-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation|Safety and Pharmacokinetics of Micafungin in Children Supported With Extracorporeal Membrane Oxygenation|Recruiting||Phase 1|50|Anticipated|Duke University||3|||f||||f||||||||||2017-10-11 02:37:05.582888|2017-10-11 02:37:05.582888
NCT01666756|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-03-08|||May 6, 2013|Actual|2013-05-06|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer|A Phase I Open Label Study Investigating the Combination of KD018 and Sorafenib (Nexavar) in Patients With Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 1|18|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 02:37:05.710028|2017-10-11 02:37:05.710028
NCT01666743|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-02-07|||November 2012||2012-11-01|February 2013|2013-02-01|March 2014|Anticipated|2014-03-01|September 2013|Anticipated|2013-09-01||Interventional|||Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia|A Multicenter Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Elderly Subjects With Community-Acquired Bacterial Pneumonia|Withdrawn||Phase 4|0|Actual|Forest Laboratories||1||Change in strategy.|f||||f||||||||||2017-10-11 02:37:05.847498|2017-10-11 02:37:05.847498
NCT01666730|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-07-17|||February 15, 2013|Actual|2013-02-15|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer|A Phase II Study of Metformin Plus Modified FOLFOX 6 in Patients With Metastatic Pancreatic Cancer|Recruiting||Phase 2|43|Anticipated|Case Comprehensive Cancer Center||1|||f||||t|t|f|||f|||||2017-10-11 02:37:05.939003|2017-10-11 02:37:05.939003
NCT01666717|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-16|||August 2008||2008-08-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|||||Observational|||Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling|Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling|Completed||N/A|204|Actual|Katholieke Universiteit Leuven|||2||f||||f||||||Samples With DNA|"     Fecal samples   "|||2017-10-11 02:37:06.042212|2017-10-11 02:37:06.042212
NCT01666704|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-06-19|||April 2014||2014-04-01|June 2013|2013-06-01|May 2016|Anticipated|2016-05-01|October 2015|Anticipated|2015-10-01||Interventional|||Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis|A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Effects of BMS-823778 on Atherosclerotic Plaque Inflammation as Measured by Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET) in Patients With Atherosclerotic Cardiovascular Disease|Withdrawn||Phase 2|0|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 02:37:06.10655|2017-10-11 02:37:06.10655
NCT01666691|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-07-13|||August 2012||2012-08-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects|Randomized, Double-Blind, Placebo Controlled, Dose Ranging Phase 2 Trial of Beloranib (ZGN-440 for Injectable Suspension), A Novel Methionine Aminopeptidase 2 Inhibitor, in Obese Subjects to Evaluate Weight Reduction, Safety, and Pharmacokinetics Over 12 Weeks|Completed||Phase 2|160|Actual|Zafgen, Inc.||6|||f||||t||||||||||2017-10-11 02:37:06.19436|2017-10-11 02:37:06.19436
NCT01666678|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-08-20|||January 2012||2012-01-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|Morpheus PK||Compare Pharmacokinetic (PK) Profiles of Naproxen Sodium, Diphenhydramine Hydrochloride, and Naproxen Sodium and Diphenhydramine Hydrochloride Combination|A Bioavailability Study of Naproxen Sodium and Diphenhydramine Hydrochloride Under Fasting Conditions and Naproxen Sodium and Diphenhydramine Hydrochloride Combination Under Fasting and Fed Conditions|Completed||Phase 1|32|Actual|Bayer||4|||f||||f||||||||||2017-10-11 02:37:06.302804|2017-10-11 02:37:06.302804
NCT01666665|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-06-28|||November 2012||2012-11-01|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin|Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin|Recruiting||Phase 2/Phase 3|100|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||No||2017-10-11 02:37:06.405589|2017-10-11 02:37:06.405589
NCT01666639|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-01-26|||March 2011||2011-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|VBT||Behavioral Exercise Therapy and Multidisciplinary Rehabilitation for Chronic Non-specific Low Back Pain|Behavioral Exercise Therapy to Optimize Inpatient Behavioral Orthopedic Rehabilitation for Chronic Non-specific Low Back Pain|Completed||N/A|351|Actual|University of Erlangen-Nürnberg||2|||f||||f||||||||||2017-10-11 02:37:06.641874|2017-10-11 02:37:06.641874
NCT01666626|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-07-29|||September 2012||2012-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Ultrasound Stiffness Imaging in Crohn's Disease|Investigating Ultrasound Stiffness Imaging for Predicting Outcomes in Crohn's Disease|Completed||N/A|30|Actual|University of Michigan|||2||f||||t||||||||||2017-10-11 02:37:06.764908|2017-10-11 02:37:06.764908
NCT01666613|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-12-18|||November 2012||2012-11-01|December 2012|2012-12-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD8683 When Administered in Different Ways|A Phase I, Single-centre, Open-label, Partly Randomised, Cross-over Single Dose Study in Healthy Volunteers to Evaluate the Absolute Pulmonary Bioavailability of AZD8683 When Administered Inhaled Via a New Dry Powder Inhaler and Via Turbuhaler™|Withdrawn||Phase 1|0|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 02:37:06.85717|2017-10-11 02:37:06.85717
NCT01666600|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-05-16|||August 2012||2012-08-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|March 2017|Actual|2017-03-01||Interventional|||NOA-12: BIBF1120 and R-RT in Glioblastoma|A Phase I/II, Randomized, Open-label, Multi-centre Study of BIBF1120 + Reirradiation (R-RT) Versus Reirradiation in the Treatment of Patients With First or Second Progression of Glioblastoma|Terminated||Phase 1/Phase 2|63|Actual|University Hospital Heidelberg||2||Interim Analysis for Feasibility|f||||t||||||||||2017-10-11 02:37:06.958567|2017-10-11 02:37:06.958567
NCT01666587|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-05-10|||August 2012||2012-08-01|May 2017|2017-05-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Ischemia Reperfusion: Prostaglandins and Antioxidants|The Role of Prostaglandin and Anti-oxidant Availability on Recovery From Forearm Ischemia-reperfusion Injury in Humans|Completed||N/A|12|Actual|University of Essex||4|||f||||t||||||||||2017-10-11 02:37:07.052865|2017-10-11 02:37:07.052865
NCT01666574|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-12-17|||August 2012||2012-08-01|December 2015|2015-12-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Oat Based Breakfast Cereals on Satiety and Food Intake|The Effect of Oat Based Breakfast Cereals on Satiety and Food Intake.|Completed||N/A|47|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 02:37:07.14643|2017-10-11 02:37:07.14643
NCT01666561|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2015-12-17|||August 2012||2012-08-01|December 2015|2015-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Quaker A||The Effect of Oat Based Breakfast Cereals on Satiety and Food Intake.|The Effect of Oat Based Breakfast Cereals on Satiety and Food Intake.|Completed||N/A|48|Actual|Pennington Biomedical Research Center||3|||f||||f||||||||||2017-10-11 02:37:07.254928|2017-10-11 02:37:07.254928
NCT01666548|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-09-03|||February 2012||2012-02-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects|Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects|Completed||N/A|89|Actual|University Children's Hospital, Zurich|||1||f||||f||||||Samples Without DNA|"     urine, native-blood, blood plasma, EDTA stabilized blood, heparin blood   "|||2017-10-11 02:37:07.375796|2017-10-11 02:37:07.375796
NCT01666535|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-05-05|||September 2012||2012-09-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01||Interventional|||Infliximab IBD Influenza Vaccine Study|Effect of Influenza Vaccination Timing on Immune Response in Patients With Inflammatory Bowel Disease on Infliximab Therapy: A Randomized Equivalence Trial|Completed||N/A|137|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 02:37:07.475771|2017-10-11 02:37:07.475771
NCT01666522|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-10|||April 2011||2011-04-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Vitamin D and Physical Activity for Prevention of Sarcopenia in Osteoporosis|Effect of Vitamin D Supplementation and Physical Activity in Preventing Sarcopenia in Older Adults With Osteoporosis|Completed||N/A|145|Actual|Faculty of Medicine, University of Alexandria||4|||f||||t||||||||||2017-10-11 02:37:07.581161|2017-10-11 02:37:07.581161
NCT01666509|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-01-04|||July 2012||2012-07-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)|A Post Marketing Clinical Follow-up, Randomised, Double-blind Study Comparing the Efficacy and Tolerability of Topical Rossoseq™ With Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)|Completed||N/A|61|Actual|PBB Entrepreneur Ltd.||2|||f||||f||||||||||2017-10-11 02:37:07.711197|2017-10-11 02:37:07.711197
NCT01666496|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-06-26|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|June 18, 2016|Actual|2016-06-18|June 18, 2016|Actual|2016-06-18||Interventional|||An Interactive Game for HIV Prevention in Early Adolescents|An Interactive Video Game for HIV Prevention in Early Adolescents|Completed||N/A|333|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:37:07.807304|2017-10-11 02:37:07.807304
NCT01666483|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-08-14|||May 2011||2011-05-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|MLPS/LESS||Micro-laparoscopy and Single-port Hysterectomy|Micro-laparoscopic Versus Single-port Total Hysterectomy: a Randomized Trial.|Completed||N/A|71|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 02:37:07.934836|2017-10-11 02:37:07.934836
NCT01666470|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2017-02-22|||August 2012||2012-08-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|August 2017|Anticipated|2017-08-01||Observational|||Quality of Life of Patients With a History of Drug Allergy in Thailand|Quality of Life of Patients With a History of Drug Allergy in Thailand|Recruiting||N/A|400|Anticipated|Chulalongkorn University|||1||f||||f||||||||||2017-10-11 02:37:08.037115|2017-10-11 02:37:08.037115
NCT01666457|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-16|||September 2009||2009-09-01|August 2012|2012-08-01||||September 2011|Actual|2011-09-01||Observational|||Impact of Implementing an Infant Driven Feeding Program on Oral Feeding and Growth Outcomes of Medically Fragile Infants in the Neonatal ICU (NICU)|The Impact of Implementing an Infant Driven Feeding Program on Oral Feeding and Growth Outcomes of Medically Fragile Infants in the NICU|Completed||N/A|156|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||||2017-10-11 02:37:08.162922|2017-10-11 02:37:08.162922
NCT01666431|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-12-02|||June 2012||2012-06-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment||Terminated||Phase 2|10|Actual|University of Zurich||1|||f||||||||||||||2017-10-11 02:37:08.76384|2017-10-11 02:37:08.76384
NCT01666418|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-12-02|||August 2012||2012-08-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|October 2014|Actual|2014-10-01||Interventional|||Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel||Unknown status|Active, not recruiting|Phase 2|18|Anticipated|University of Zurich||1|||f||||||||||||||2017-10-11 02:37:08.91535|2017-10-11 02:37:08.91535
NCT01666405|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-10-28|||August 2012||2012-08-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence|A Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence|Terminated||Phase 1|30|Actual|Uroplasty, Inc||1||business reasons|f||||f||||||||||2017-10-11 02:37:09.026307|2017-10-11 02:37:09.026307
NCT01666392|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-10-08|||August 2012||2012-08-01|August 2012|2012-08-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||﻿﻿Omega-3 Fatty Acid Supplementation in Older Adults|The Impact of ﻿﻿Omega-3 Fatty Acid Supplementation on Markers of Inflammation and Lean Body Mass in Older Adults|Withdrawn||N/A|0|Actual|University of Memphis||2|||f||||f||||||||||2017-10-11 02:37:09.12277|2017-10-11 02:37:09.12277
NCT01666379|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-08-10|||January 2009||2009-01-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Pain Management After Forefoot Surgery||Completed||Phase 4|60|Actual|Turku University Hospital||2|||f||||f||||||||||2017-10-11 02:37:09.228357|2017-10-11 02:37:09.228357
NCT01666366|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-10|||February 2003||2003-02-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|August 2006|Actual|2006-08-01||Interventional|||Comparison Between 2 Bilateral Internal Thoracic Artery Coronary Artery Bypass Grafting Configurations|Comparison of Bilateral Internal Thoracic Artery Revascularization Using in Situ or Y Graft Configurations: a Prospective Randomized Clinical, Functional and Angiographic Evaluation|Completed||Phase 4|304|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 02:37:09.312064|2017-10-11 02:37:09.312064
NCT01666353|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2015-03-17|||April 2012||2012-04-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy|PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy|Unknown status|Active, not recruiting|Early Phase 1|20|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:37:09.418515|2017-10-11 02:37:09.418515
NCT01666340|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-09-18|||August 2012|Actual|2012-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|GEN100||Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study|Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study|Active, not recruiting||N/A|4000|Anticipated|Norwegian University of Science and Technology||2|||f||||t|f|f||||||||2017-10-11 02:37:09.518587|2017-10-11 02:37:09.518587
NCT01666327|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-09-04|||June 2012||2012-06-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease|An Open-Label Study to Evaluate the Safety, Tolerability, Pharmacodynamics of a Single Oral Dose of MT-1303 in Subjects With Inflammatory Bowel Disease.|Completed||Phase 1|18|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||||||||||||2017-10-11 02:37:09.666271|2017-10-11 02:37:09.666271
NCT01666314|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-09-19||2016-03-28|September 2012||2012-09-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancer|A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancer|Completed||Phase 1/Phase 2|137|Actual|Takeda||8|||f||||f||||||||||2017-10-11 02:37:09.762909|2017-10-11 02:37:09.762909
NCT01666301|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-16|||February 2010||2010-02-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||ESAs, Reticulocyte Dynamic and Hemoglobin Variability|Reticulocyte Dynamic and Related Hemoglobin Variability in Hemodialysis Patients Treated With Darbepoetin Alfa and C.E.R.A.: a Randomized Controlled Trial|Completed||N/A|31|Actual|Ospedale Regionale di Locarno||2|||f||||||||||||||2017-10-11 02:37:09.911687|2017-10-11 02:37:09.911687
NCT01666288|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-10-11|||April 2012||2012-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Metabolomics of Anaphylaxis to Immunotherapy|The Metabolomics of Anaphylaxis to Immunotherapy|Active, not recruiting||N/A|12|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     Plasma will be collected and retained from whole blood samples that are spun.   "|||2017-10-11 02:37:10.112565|2017-10-11 02:37:10.112565
NCT01666275|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-10-11|||March 2012||2012-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Metabolomics of Anaphylaxis|The Metabolomics of Anaphylaxis|Active, not recruiting||N/A|12|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     We retain and freeze the plasma from blood after spinning down whole-blood samples.   "|||2017-10-11 02:37:10.215852|2017-10-11 02:37:10.215852
NCT01666262|ClinicalTrials.gov processed this data on October 10, 2017|2010-01-11|2012-08-10|||September 2009||2009-09-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|||||Interventional|||Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais|Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais|Completed||Phase 1/Phase 2|363|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 02:37:10.30316|2017-10-11 02:37:10.30316
NCT01666249|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-04-07|||February 2013||2013-02-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk.|Evaluation of the Clinic Efficacy of Immunoglobulin Anti-RhD KamRho-D® (Panamerican) in Postpartum Immunization of Rh-negative and Coombs Negative Women at Sensitization Risk.|Recruiting||Phase 3|232|Anticipated|Azidus Brasil||1|||f||||t||||||||Undecided||2017-10-11 02:37:10.445829|2017-10-11 02:37:10.445829
NCT01666236|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-08-11|||September 2012||2012-09-01|August 2015|2015-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy|Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy.|Withdrawn||Phase 4|0|Actual|Federal University of São Paulo||1||Lack of resources|f||||f||||||||||2017-10-11 02:37:10.58697|2017-10-11 02:37:10.58697
NCT01666223|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-12-21|||November 2012||2012-11-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Bile Acids on GLP-1 Secretion|Effect of Bile Acids in the Gut on GLP-1 Secretion in Healthy Subjects and Patients With Type 2 Diabetes|Completed||N/A|20|Actual|University Hospital, Gentofte, Copenhagen||4|||f||||t||||||||||2017-10-11 02:37:10.701002|2017-10-11 02:37:10.701002
NCT01666210|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2017-03-15|2016-02-09||October 2012|Actual|2012-10-01|March 2017|2017-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery|A Prospective, Multicenter, Randomized, Parallel-Arm, Double-Masked, Vehicle Controlled Phase II Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery|Completed||Phase 2|60|Actual|Ocular Therapeutix, Inc.||2|||f||||f||||||||||2017-10-11 02:37:10.85041|2017-10-11 02:37:10.85041
NCT01666197|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2014-03-31|2014-02-12||August 2012||2012-08-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain|A Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain|Completed||Phase 4|100|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:37:11.171011|2017-10-11 02:37:11.171011
NCT01666184|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-14|||September 2012||2012-09-01|August 2012|2012-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Biomarkers Study in Pancreatic Cancer|Biomarkers Study in Pancreatic Cancer|Enrolling by invitation||N/A|270|Anticipated|National Health Research Institutes, Taiwan|||1||f||||f||||||Samples With DNA|"     The specimen and clinical information will be collected and delivered to the laboratory of     Dr. Hui-Ju Ch'ang over NICR, NHRI, Tainan .   "|||2017-10-11 02:37:11.507001|2017-10-11 02:37:11.507001
NCT01666171|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-07-09|||August 2012||2012-08-01|January 2013|2013-01-01||||April 2013|Anticipated|2013-04-01||Observational|||Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32|Change in Mammographic Density With Metformin Use: A Companion Study to NCIC Study MA.32|Unknown status|Not yet recruiting|N/A|458|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 02:37:11.576465|2017-10-11 02:37:11.576465
NCT01666158|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-09-27|||January 2013||2013-01-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Prehabilitation for Esophageal Resection Surgery|Prehabilitation to Enhance Postoperative Functional Capacity Following Esophageal Resection|Recruiting||N/A|68|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-11 02:37:11.674009|2017-10-11 02:37:11.674009
NCT01666132|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-08-19|||January 2011||2011-01-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||METHOD - Bone Marrow Derived Mononuclear Cells in Chronic Ischemic Disease|METHOD - Phase I/II Study of Intramyocardial Injection of Bone Marrow Derived Mononuclear Cells in Chronic Ischemic Disease|Terminated||Phase 1/Phase 2|10|Actual|Cardiocentro Ticino||3||"Due to the slow recruitment process and the progress of newer cell types we decided to stop the   trial after the phase 1 (after 10 patients included)"|f||||f||||||||||2017-10-11 02:37:11.886018|2017-10-11 02:37:11.886018
NCT01666119|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-02-13|2015-02-02||August 2012||2012-08-01|February 2017|2017-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects|An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)|Completed||Phase 2|249|Actual|BioDelivery Sciences International||1|||f||||f||||||||No||2017-10-11 02:37:11.979712|2017-10-11 02:37:11.979712
NCT01666106|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-06-19|||October 1, 2012|Actual|2012-10-01|June 2017|2017-06-01|April 9, 2021|Anticipated|2021-04-09|April 9, 2021|Anticipated|2021-04-09||Observational|||Osteonecrosis of the Jaw (ONJ) Case Registry|Osteonecrosis of the Jaw (ONJ) Case Registry|Active, not recruiting||N/A|327|Actual|Amgen|||1||f||||f||||||||||2017-10-11 02:37:12.227648|2017-10-11 02:37:12.227648
NCT01666093|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-08-15|||August 2012||2012-08-01|August 2012|2012-08-01|August 2015|Anticipated|2015-08-01|August 2014|Anticipated|2014-08-01||Interventional|NEWLI||Non-Healing Ulcers Without Critical Limb Ischemia|NON-HEALING ULCERS WITHOUT CRITICAL LIMB ISCHEMIA (NEWLI-Trial): A Single Center Pilot Trial on the Efficacy of an Endovascular Approach for Treatment of Non-healing Lower Limb Ulcers in Patients Presenting With a Mild to Moderate Peripheral Artery Disease|Unknown status|Recruiting|Phase 2|30|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-10-11 02:37:12.424677|2017-10-11 02:37:12.424677
NCT01666080|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-08-15|||August 2012||2012-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)|Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)|Recruiting||N/A|30|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-10-11 02:37:12.519009|2017-10-11 02:37:12.519009
NCT01666067|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2014-11-01|||November 2011||2011-11-01|August 2012|2012-08-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Vascular and Metabolic Effects of Vytorin vs Simvastatin||Completed||Phase 4|204|Actual|Gachon University Gil Medical Center||3|||f||||t||||||||||2017-10-11 02:37:12.648958|2017-10-11 02:37:12.648958
NCT01666054|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-04-23|||March 2009||2009-03-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Weaning on Pressure Support vs. Proportional Assist Ventilation: A Pilot Study|Is Respiratory Rate an Adequate Indicator of Respiratory Distress During Weaning? A Comparison of Weaning on Pressure Support vs. Proportional Assist Ventilation.|Completed||N/A|54|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:37:12.722663|2017-10-11 02:37:12.722663
NCT01666041|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-15|2014-11-01|||January 2012||2012-01-01|August 2012|2012-08-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate||Completed||Phase 4|120|Anticipated|Gachon University Gil Medical Center||3|||f||||t||||||||||2017-10-11 02:37:12.809063|2017-10-11 02:37:12.809063
NCT01666028|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-12-01|||November 2012||2012-11-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|AP@home02||Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes|An Open-label, Three-centre, Randomised, Two-period Crossover Study to Assess the Safety, Efficacy and Utility of Automated Closed-loop Glucose Control in Comparison With Continuous Subcutaneous Insulin Infusion Combined With Continuous Glucose Monitoring in Adults With Type 1 Diabetes - A Combined Clinical Research Facility and Home Study|Completed||Phase 2|18|Actual|University of Cambridge||2|||f||||f||||||||||2017-10-11 02:37:12.881826|2017-10-11 02:37:12.881826
NCT01666015|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-10-24|||June 2012||2012-06-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Interventional|SCORE||Exercise in Pediatric Autologous Stem Cell Transplant Patients|Exercise in Pediatric Autologous Stem Cell Transplant Patients: A Randomized Controlled Trial Protocol|Terminated||N/A|24|Anticipated|University of Calgary||2||Due to inability to recruit participants.|f||||t||||||||||2017-10-11 02:37:13.051949|2017-10-11 02:37:13.051949
NCT01666002|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-04-21|2014-12-16||September 2011||2011-09-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional||Sample size calculations (STATA 10, Stat Corp, College Station, TX) indicated that we needed to enroll 24 patients at a 2:1 ratio for 80% power to detect a minimal proximal nail plate difference of 2.5 mm in the 2 groups with a 2-sided alpha of 0.05.|Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser|Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser|Completed||N/A|27|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 02:37:13.143395|2017-10-11 02:37:13.143395
NCT01665989|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-09-23|||August 2012||2012-08-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|IDOLc||Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)Study|Improving Diabetes Outcomes Through Lifestyle Change (IDOLc) Translation Study|Completed||N/A|57|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:37:13.526457|2017-10-11 02:37:13.526457
NCT01665976|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2016-11-01|||August 2012||2012-08-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of the Relative Bioavailability of Single Dose RO4917838 and the Effect of Food in Healthy Volunteers|A Single Center, Randomized, Single Dose, Open-label, Four Period Cross-over Study to Investigate the Relative Bioavailability of RO4917838 and the Effect of Food Following Oral Administration in Healthy Subjects|Completed||Phase 1|16|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 02:37:13.658938|2017-10-11 02:37:13.658938
NCT01665963|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2012-08-14|||September 2012||2012-09-01|August 2012|2012-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Efficacy of TopClosure(C)System in Healing Complicated Pacemaker Wounds||Unknown status|Not yet recruiting|N/A|40|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 02:37:13.782671|2017-10-11 02:37:13.782671
NCT01665950|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2017-04-03|2016-11-30||August 2012||2012-08-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Simvastatin Augmentation of Lithium Treatment in Bipolar Depression|Simvastatin Augmentation of Lithium Treatment in Bipolar Depression|Terminated||Phase 2|4|Actual|Massachusetts General Hospital|The study was terminated early because delays in study initiation and insufficient recruitment. Our statisticians have advised us that this analysis is uninformative as it represents the change for one individual in 2 of the three arms of the study.|3||Lack of enrollment|f||||t||||||||||2017-10-11 02:37:13.914052|2017-10-11 02:37:13.914052
NCT01665937|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-27|2014-03-19|||August 2010||2010-08-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||STA-9090 in Patients With Advanced Hepatocellular Cancer|A Phase I Study of STA-9090 in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 1|16|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:37:14.349455|2017-10-11 02:37:14.349455
NCT01665924|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-14|2013-03-26|||July 2012||2012-07-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects|Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects|Completed||Phase 1|36|Actual|Galapagos NV||3|||f||||f||||||||||2017-10-11 02:37:14.46783|2017-10-11 02:37:14.46783
NCT01665911|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-02-03|2014-08-05||August 2012||2012-08-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||An in Situ Study on the Impact of Fluoride Dose and Concentration in Milk on Its Anti-caries Efficacy|An in Situ Study on the Impact of Fluoride Dose and Concentration in Milk on Its Anti-caries Efficacy|Completed||N/A|28|Actual|Indiana University||5|||f||||f||||||||||2017-10-11 02:37:14.591194|2017-10-11 02:37:14.591194
NCT01665898|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-03-24|||August 2012||2012-08-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||Comparing Cold Biopsy Forceps Versus Cold Snare Biopsy for Colon Polyps|Randomized Controlled Trial Comparing Cold Biopsy Forceps Versus Cold Snare Biopsy for Colon Polyps|Completed||N/A|138|Actual|Incheon St.Mary's Hospital||2|||f||||t||||||||||2017-10-11 02:37:15.20038|2017-10-11 02:37:15.20038
NCT01665885|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2015-02-16|||August 2012||2012-08-01|June 2013|2013-06-01|November 2015|Anticipated|2015-11-01|August 2015|Anticipated|2015-08-01||Interventional|HAIS-SE||Hypothermia in Acute Ischemic Stroke - Surface Versus Endovascular Cooling (HAIS-SE)|HAIS-SE (Hypothermia in Acute Ischemic Stroke - Surface Versus Endovascular Cooling): A Randomized Trial Comparing Surface Versus Endovascular Cooling in Awake Stroke Patients Treated With Thrombolysis|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|University Hospital Heidelberg||3|||f||||f||||||||||2017-10-11 02:37:15.317301|2017-10-11 02:37:15.317301
NCT01665872|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-08-01|||September 2011|Actual|2011-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|August 2016|Actual|2016-08-01||Interventional|||New Haven MOMS Partnership|New Haven Mental Health Outreach for MotherS (MOMS) Partnership|Completed||N/A|176|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:37:15.468999|2017-10-11 02:37:15.468999
NCT01665859|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-13|||January 2007||2007-01-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|January 2011|Actual|2011-01-01||Observational|||Risk Factors for Poor Outcome After Epigastric and Umbilical Hernia Repair|Nationwide Prospective Study of Surgical Risk Factors for Poor Outcome After Epigastric and Umbilical Hernia Repair|Completed||N/A|6783|Actual|University Hospital Koge|||1||f||||f||||||||||2017-10-11 02:37:15.566964|2017-10-11 02:37:15.566964
NCT01665846|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-15|||July 2011||2011-07-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders|Neuroimaging Correlates of Monocyte/Macrophage Infiltration in HIV-infected Individuals: A Cross-sectional Pilot Study Using IV Ferumoxytol|Completed||Phase 1|4|Actual|University of Hawaii||1|||f||||f||||||||||2017-10-11 02:37:15.670117|2017-10-11 02:37:15.670117
NCT01665833|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-13|||January 2003||2003-01-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Impact of Coronary Anatomy on Angina Relief in Patients Undergoing Coronary Revascularization|A Retrospective Analysis Determining the Impact of Coronary Anatomy on Angina Relief in Patients Undergoing Coronary|Completed||N/A|4000000|Actual|North Texas Veterans Healthcare System|||1||f||||||||||||||2017-10-11 02:37:15.750766|2017-10-11 02:37:15.750766
NCT01665820|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2013-06-06|||October 2012||2012-10-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Auscultate Obese Patients Using Electronic and Traditional Stethoscopes|Study EM-05-012530 Benefit of Auscultation With 3M™ Littmann® 3200 Electronic Stethoscope to Diagnose Murmurs and Heart Pathologies in Overweight and Obese Patients With Increased Layers of Adipose Tissue|Completed||Phase 4|30|Actual|3M|||2||f||||f||||||||||2017-10-11 02:37:15.819236|2017-10-11 02:37:15.819236
NCT01665807|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-03-22|2013-07-31||September 2012||2012-09-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine|A Time-Motion Study to Compare Self-vaccination With Intanza® Intradermal Influenza Vaccine to Nurse-administered Vaxigrip® Intramuscular Influenza Vaccine in Small Group Settings of Health Care Workers|Completed||Phase 4|868|Actual|Mount Sinai Hospital, Canada||3|||f||||f||||||||||2017-10-11 02:37:15.903338|2017-10-11 02:37:15.903338
NCT01665794|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-08-07|||August 13, 2012|Actual|2012-08-13|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|Multicenter, Open-label, Single-arm, Phase 1b/2 Study of the Safety and Efficacy of Combination Treatment With Pomalidomide, Dexamethasone, and Carfilzomib (PdC) in Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|20|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 02:37:16.234501|2017-10-11 02:37:16.234501
NCT01665781|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2013-03-16|||August 2012||2012-08-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EPO-AMS||Erythropoietin in the Prevention of Acute Mountain Sickness|Randomized, Controlled Trial of Erythropoietin in the Prevention of Acute Mountain Sickness|Completed||Phase 4|39|Actual|University of Ulsan||2|||f||||t||||||||||2017-10-11 02:37:16.370471|2017-10-11 02:37:16.370471
NCT01665768|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-07-12|||August 2012||2012-08-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma|A Trial of Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in CD20+, B-cell Lymphomas, Gray Zone Lymphoma, and Hodgkin's Lymphoma|Active, not recruiting||Phase 2|49|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:37:16.457078|2017-10-11 02:37:16.457078
NCT01665755|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-02-09|||December 2016||2016-12-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||To Determine Optimal Time for Delivering Electrical Shocks to Cardiac Arrest Patients|A Multicenter Randomised Controlled Trial Comparing Shock Success With Synchronized Defibrillation (Compression Upstroke Versus Precompression) During Ongoing Mechanical Cardiopulmonary Resuscitation In The Emergency Department|Not yet recruiting||Phase 4|288|Anticipated|Singapore General Hospital||2|||f||||t||||||||||2017-10-11 02:37:16.613547|2017-10-11 02:37:16.613547
NCT01665742|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2014-12-05|||January 2012||2012-01-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Anti-inflammatory Dietary Intervention in Overweight and Obese Adolescents|Novel Anti-inflammatory Dietary Intervention to Improve the Metabolic Phenotype of Overweight and Obese 13-18 Year Old Adolescents - Insights Into Potential Genetic Susceptibility|Completed||N/A|58|Actual|University College Dublin||2|||f||||f||||||||||2017-10-11 02:37:16.707604|2017-10-11 02:37:16.707604
NCT01665729|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2012-08-14|||June 2011||2011-06-01|August 2012|2012-08-01|December 2015|Anticipated|2015-12-01|August 2012|Actual|2012-08-01||Observational|||Diagnosis and Treatment of Minor Ischaemic Stroke According to the Etiology and Pathogenesis|Diagnosis and Treatment of Minor Ischaemic Stroke According to the Etiology and Pathogenesis|Unknown status|Recruiting|N/A|1000|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University|||3||f||||t||||||||||2017-10-11 02:37:16.935148|2017-10-11 02:37:16.935148
NCT01665716|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2014-04-10|||July 2011||2011-07-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|OVADIA||Ovarian Ageing in Type 1 Diabetes Mellitus|Ovarian Ageing in Type 1 Diabetes Mellitus: the Role of Vascular Factors|Completed||N/A|290|Actual|UMC Utrecht|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 02:37:17.042462|2017-10-11 02:37:17.042462
NCT01665703|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-05-02|||August 2012||2012-08-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|November 2014|Actual|2014-11-01||Interventional|||Imaging Correlates of Renal Cell Carcinoma Biological Features|LCCC 1213: Defining Molecular and Functional Imaging Correlates of Renal Cell Carcinoma Biological Features|Active, not recruiting||N/A|17|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:37:17.133778|2017-10-11 02:37:17.133778
NCT01665690|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-15|||July 2007||2007-07-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|December 2010|Actual|2010-12-01||Interventional|||Washington State Community Expedited Partner Treatment (EPT) Trial|A Community-level RCT of Expedited Partner Treatment for Gonorrhea and Chlamydia|Completed||Phase 4|33222|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 02:37:17.26371|2017-10-11 02:37:17.26371
NCT01665677|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-06-12|||September 2012||2012-09-01|June 2017|2017-06-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation|Phase II Study of Atorvastatin, Micro-dose Methotrexate and Tacrolimus Administered Only to Transplant Recipients for the Prophylaxis of Acute Graft-versus-host Disease Following Allogeneic Hematopoietic Cell Transplantation|Active, not recruiting||Phase 2|60|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-11 02:37:17.394412|2017-10-11 02:37:17.394412
NCT01665664|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-14|||September 2012||2012-09-01|August 2012|2012-08-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||Hypocaloric vs. Full Energy Enteral Feeding in Critically Ill Patients|Hypocaloric vs. Full Energy Enteral Feeding in Critically Ill Patients Guided by Indirect Calorimetry, a Prospective, Blinded, Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Wolfson Medical Center||2|||f||||f||||||||||2017-10-11 02:37:17.530489|2017-10-11 02:37:17.530489
NCT01665651|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-05-04|||August 2012||2012-08-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy|Effect of Kidney Yin/Yang Replenishment on Bone Metabolism in Patients With Renal Osteodystrophy|Withdrawn||Phase 2|0|Actual|Shanghai University of Traditional Chinese Medicine||4||Hard to enroll participants|f||||t||||||||||2017-10-11 02:37:17.612157|2017-10-11 02:37:17.612157
NCT01665638|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2013-06-06|||September 2012||2012-09-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effects of Canagliflozin on C-peptide Clearance in Healthy Volunteers|A Double-Blind, Randomized, Placebo-Controlled, 2-Way Cross-Over Study to Evaluate the Effect of Single Dose Canagliflozin on Kinetics of C-Peptide in Healthy Subjects|Completed||Phase 1|10|Actual|Janssen-Cilag International NV||2|||f||||f||||||||||2017-10-11 02:37:17.704995|2017-10-11 02:37:17.704995
NCT01665625|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2012-08-10|||August 2012||2012-08-01|August 2012|2012-08-01|February 2016|Anticipated|2016-02-01|August 2015|Anticipated|2015-08-01||Interventional|||Regional Versus Systemic Chemotherapy in the Treatment of Unresectable Pancreatic Cancer|A Prospective Randomized Trial of Regional Versus Systemic Continuous Gemcitabine Chemotherapy in the Treatment of Unresectable Pancreatic Cancer|Unknown status|Not yet recruiting|N/A|90|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 02:37:17.814287|2017-10-11 02:37:17.814287
NCT01665612|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-03-05|||August 2012||2012-08-01|March 2015|2015-03-01||||January 2015|Actual|2015-01-01||Interventional|||The Clinical and Subjective Performance of Three Different MPDS With Silicon Hydrogel Lenses|The Evaluation of the Clinical and Subjective Performance of Three Different Contact Lens Care Solutions With Silicon Hydrogel Lenses|Completed||N/A|40|Actual|Finnsusp Ltd.||3|||f||||t||||||||||2017-10-11 02:37:17.927119|2017-10-11 02:37:17.927119
NCT01665599|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-09-19|2017-07-03|2014-04-08|July 2012||2012-07-01|September 2017|2017-09-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional||Demographics analysis was done on the intent-to-treat (ITT) population consisting of all participants who received at least one dose of investigational medicinal product (IMP).|A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel|A Phase 3, Open-label, Non-randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males|Completed||Phase 3|180|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:37:18.038875|2017-10-11 02:37:18.038875
NCT01665586|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2014-07-24|||March 2012||2012-03-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study||Completed||N/A|82|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:37:20.613804|2017-10-11 02:37:20.613804
NCT01665573|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-02-22|||May 2012||2012-05-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Cannabinoid Augmentation of Fear Response in Humans|Cannabinoid Augmentation of Fear Response in Humans|Suspended||Phase 2|150|Anticipated|Yale University||2||IND placed on clinical hold|f||||t||||||||||2017-10-11 02:37:20.684143|2017-10-11 02:37:20.684143
NCT01665560|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-09|||June 2005||2005-06-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Neural, Behavioral and Physiological Correlates of Feeding in Humans|Neural, Behavioral and Physiological Correlates of Feeding in Humans|Completed||N/A|27|Actual|Yale University|||2||f||||t||||||Samples With DNA|"     saliva samples were obtained and are stored using a coded ID in a secure part of our facility   "|||2017-10-11 02:37:20.753288|2017-10-11 02:37:20.753288
NCT01665547|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2013-09-09|||July 2012||2012-07-01|September 2013|2013-09-01|September 2013|Anticipated|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Adding L-carnitine in Clomiphene Resistant Polycystic Ovary Improves the Quality of Ovulation and the Pregnancy Outcome|Adding L-carnitine in Clomiphene Resistant Pco Improves the Quality of Ovulation and the Pregnancy Outcome,a Randomized Clinical Trial|Unknown status|Enrolling by invitation|Phase 4|157|Anticipated|Woman's Health University Hospital, Egypt||1|||f||||t||||||||||2017-10-11 02:37:20.823833|2017-10-11 02:37:20.823833
NCT01665534|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-12|||March 2010||2010-03-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Inflammatory Response to Salt in Essential Hypertension|Procalcitonin and the Inflammatory Response to Salt in Essential Hypertension: a Randomised Cross-over Clinical Trial.|Completed||Phase 3|32|Actual|"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"||1|||f||||f||||||||||2017-10-11 02:37:20.894115|2017-10-11 02:37:20.894115
NCT01665521|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-10-02|||September 2012||2012-09-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|February 20, 2016|Actual|2016-02-20||Interventional|HEART Pathway||Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain|Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain|Active, not recruiting||N/A|282|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 02:37:20.973581|2017-10-11 02:37:20.973581
NCT01665508|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-03-08|2016-09-12||April 2013||2013-04-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|NIRVANA||Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease|Nebivolol for the Relief of Microvascular Angina in Women|Completed||Phase 4|12|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:37:21.235084|2017-10-11 02:37:21.235084
NCT01665495|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2012-08-14|||December 2011||2011-12-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|DROP||Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention|Drainage or Pericardiocentesis Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention.|Unknown status|Recruiting|N/A|122|Anticipated|Maria Vittoria Hospital||2|||f||||t||||||||||2017-10-11 02:37:21.610961|2017-10-11 02:37:21.610961
NCT01665482|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2012-08-14|||March 2012||2012-03-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Dietary Fats on Cardiovascular Health and Insulin Sensitivity in Subjects With Abdominal Obesity|Effects of Dietary Fats on Cardiovascular Health and Insulin Sensitivity in Subjects With Abdominal Obesity|Completed||N/A|47|Actual|Malaysia Palm Oil Board||3|||f||||t||||||||||2017-10-11 02:37:21.738148|2017-10-11 02:37:21.738148
NCT01665469|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-12-19|||November 2012||2012-11-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Interventional|||Effect of Tomato Extracted Lycopene on Postprandial Oxidation and inﬂammation in Healthy Weight Men and Women||Unknown status|Recruiting|Phase 2|30|Anticipated|LycoRed Ltd.||2|||f||||f||||||||||2017-10-11 02:37:21.833864|2017-10-11 02:37:21.833864
NCT01665417|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-12|2017-02-07|||August 2012||2012-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma|Randomized, Open Label, Positive Controlled, Multicenter Trial to Evaluate Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma|Recruiting||Phase 4|100|Anticipated|Betta Pharmaceuticals Co.,Ltd.||3|||f||||t||||||||||2017-10-11 02:37:22.118539|2017-10-11 02:37:22.118539
NCT01665404|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy Volunteers|A Single-Center, Open-Label, One-Sequence, Crossover Study to Investigate the Effects of Multiple Doses of Fluvoxamine on the Pharmacokinetics of a Single Dose RO4917523 in Healthy Subjects|Completed||Phase 1|16|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:37:22.224862|2017-10-11 02:37:22.224862
NCT01665391|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2015-08-12||2015-08-12|August 2012||2012-08-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|FSGS||A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)|A Phase 2, Multicenter, Double-Blind, Parallel Dosing, Randomized Study of Fresolimumab or Placebo in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis|Completed||Phase 2|36|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 02:37:22.302771|2017-10-11 02:37:22.302771
NCT01665378|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2016-11-07|||October 2011||2011-10-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2014|Actual|2014-09-01||Interventional|||Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child Outcomes|Impact of Pre-Pregnancy Micronutrient Supplementation on Maternal and Child Outcomes|Active, not recruiting||Phase 3|5011|Actual|Emory University||6|||f||||f||||||||||2017-10-11 02:37:22.47843|2017-10-11 02:37:22.47843
NCT01665365|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2015-04-13|||February 2007||2007-02-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|September 2013|Actual|2013-09-01||Interventional|||Long-term Clinical Outcome in Patients Undergoing Remote Ischemic Conditioning Before Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: a Follow-up Study|Long-term Clinical Outcome in Patients Undergoing Remote Ischemic Conditioning Before Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: a Follow-up Study|Unknown status|Active, not recruiting|N/A|251|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 02:37:22.593569|2017-10-11 02:37:22.593569
NCT01665352|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-02-09||2015-04-14|August 2012||2012-08-01|February 2017|2017-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes|Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Evaluate the Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin|Completed||Phase 2|186|Actual|vTv Therapeutics||4|||f||||f||||||||||2017-10-11 02:37:22.673274|2017-10-11 02:37:22.673274
NCT01665339|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-14|||September 2011||2011-09-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Preload, Weight Management, Risk of Cardiovascular Disease|Effect of Preload on Body Weight and Cardiovascular Risks|Completed||Phase 3|60|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:37:22.893449|2017-10-11 02:37:22.893449
NCT01665326|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-07-13|||September 2009||2009-09-01|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease|Determination of Cross-Reactive Immunological Material (CRIM) Status and Longitudinal Follow-up of Individuals With Pompe Disease|Recruiting||N/A|300|Anticipated|Duke University|||1||f||||t||||||||||2017-10-11 02:37:22.972347|2017-10-11 02:37:22.972347
NCT01665313|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2013-07-25|||July 2012||2012-07-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Comparison of Attention of Physician After Outpatient Clinic|Comparison of Performance, Attention, and Emotion of Physician Before and After Outpatient Clinic Session|Completed||N/A|46|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 02:37:23.076392|2017-10-11 02:37:23.076392
NCT01665300|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-04-26|||July 2011||2011-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Observational|||Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity|Usefulness of Myocardial Deformation Imaging in Breast Cancer Patients Treated With Trastuzumab for Early Detection of Myocardial Dysfunction|Completed||N/A|120|Actual|Seoul National University Hospital|||1||f||||f||||||Samples With DNA|"     genetic susceptibility for HER2(+)cardiotoxicity   "|||2017-10-11 02:37:23.155992|2017-10-11 02:37:23.155992
NCT01665287|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2013-01-14|||August 2012||2012-08-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|||||Observational|||Cerebral Oximetry in Newborns - Comparing INVOS 5100 and FORE-SIGHT Cerebral Oximeters|Cerebral Oximetry in Newborns - Comparing INVOS 5100 and FORE-SIGHT Cerebral Oximeters Absolute Values, Sensitivity for Low Oxygen Levels and Reproducibility..|Completed||N/A|12|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 02:37:23.244496|2017-10-11 02:37:23.244496
NCT01665274|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2017-08-14|||September 2013||2013-09-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|August 2018|Anticipated|2018-08-01||Interventional|repeat||Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer|A Randomized Single Center Controlled Study of Perioperative Chemotherapy of Oxaliplatin Combined With Capecitabine (XELOX) Versus XELOX as Post-operative Chemotherapy in Advanced Gastric Adenocarcinoma With D2 Dissection|Recruiting||Phase 2|300|Anticipated|Harbin Medical University||2|||f||||t||||||||||2017-10-11 02:37:23.320333|2017-10-11 02:37:23.320333
NCT01665261|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-03-10|||July 2012||2012-07-01|March 2015|2015-03-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Observational|NSCHD||Newborn Screening for Congenital Heart Disease|Accuracy Assessment of 7 Clinical Indicators in Newborn Screening for Congenital Heart Disease|Completed||N/A|6730|Actual|Children's Hospital of Fudan University|||1||f||||t||||||||||2017-10-11 02:37:23.441765|2017-10-11 02:37:23.441765
NCT01665248|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2014-07-25|||August 2012||2012-08-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina|Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina|Terminated||N/A|20|Actual|CardioVascular Research Foundation, Korea||1|||f||||f||||||||||2017-10-11 02:37:23.557488|2017-10-11 02:37:23.557488
NCT01665235|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-14|||August 2012||2012-08-01|August 2012|2012-08-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis|The Correlation Study Between Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis|Unknown status|Recruiting|N/A|200|Anticipated|RenJi Hospital||2|||f||||t||||||||||2017-10-11 02:37:23.648227|2017-10-11 02:37:23.648227
NCT01665222|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-13|||October 2006||2006-10-01|August 2012|2012-08-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions|Single Dose Two-Way Crossover Fasted Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets in Healthy Volunteers.|Completed||Phase 1|26|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 02:37:23.753734|2017-10-11 02:37:23.753734
NCT01665209|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2012-08-13|||October 2006||2006-10-01|August 2012|2012-08-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions|Single Dose Two-Way Crossover Fed Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets in Healthy Volunteers.|Completed||Phase 1|24|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 02:37:23.837118|2017-10-11 02:37:23.837118
NCT01665196|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-13|2017-04-05|||September 2012||2012-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||18F-FDG PET/CT for IgG4-Related Disease|Evaluation of 18F-FDG PET/CT in Diagnosis and Response Assessment of Patients With IgG4-Related Disease|Recruiting||Early Phase 1|100|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-11 02:37:23.91304|2017-10-11 02:37:23.91304
NCT01665183|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-02-24|||September 2012||2012-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma|Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma or Other Advanced Solid Malignancies|Completed||Phase 1|8|Actual|Polaris Group||1|||f||||f||||||||||2017-10-11 02:37:24.013039|2017-10-11 02:37:24.013039
NCT01665170|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-11-04|2013-06-12||May 2012||2012-05-01|November 2015|2015-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pilot Study on the Efficacy of Pascoflair in an Acute Stressful Situation (TSST)|A Randomized, Double Blind, Placebo-controlled Pilot Study on the Efficacy of Passiflora Incarnata L. in an Acute Stressful Situation|Completed||Phase 3|60|Actual|Pascoe Pharmazeutische Praeparate GmbH||2|||f||||f||||||||||2017-10-11 02:37:24.133138|2017-10-11 02:37:24.133138
NCT01665157|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-02-18|2013-02-21||November 2011||2011-11-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy|A Randomized, Single-blinded, Comparative Study to Evaluate the Efficacy and the Acceptability of Low-residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy|Completed||N/A|180|Actual|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-11 02:37:24.883662|2017-10-11 02:37:24.883662
NCT01665144|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-09-15|||December 20, 2012|Actual|2012-12-20|September 2017|2017-09-01|June 30, 2023|Anticipated|2023-06-30|June 30, 2023|Anticipated|2023-06-30||Interventional|||Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)|A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Variable Treatment Duration Study Evaluating the Efficacy and Safety of Siponimod (BAF312) in Patients With Secondary Progressive Multiple Sclerosis Followed by Extended Treatment With Open-label BAF312.|Active, not recruiting||Phase 3|1652|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:37:25.514656|2017-10-11 02:37:25.514656
NCT01665131|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-13|||November 2012||2012-11-01|August 2012|2012-08-01|November 2015|Anticipated|2015-11-01|November 2014|Anticipated|2014-11-01||Interventional|SUBTRACT||The Use of Subcutaneous Implantable Cardiac Defibrillators (ICDs) Following Extraction of Conventional ICDs|The Use of Subcutaneous Implantable Cardiac Defibrillators (ICDs) Following Extraction of Conventional ICDs|Unknown status|Not yet recruiting|N/A|50|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 02:37:26.375882|2017-10-11 02:37:26.375882
NCT01665118|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-09-09|||August 2012||2012-08-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||The Trusculpt (Radio Frequency) Device For Thigh Circumference Reduction|The Cutera Trusculpt Device For Thigh Circumference Reduction|Completed||N/A|45|Actual|Cutera Inc.||2|||f||||f||||||||||2017-10-11 02:37:26.464562|2017-10-11 02:37:26.464562
NCT01665105|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-07-11|||July 2012||2012-07-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||Study on the Effect of Electroacupuncture at Both Zusanli and at Both Yanglingquan Acupoints on Cardiovascular Activity|Study on the Effect of Electroacupuncture at Both Zusanli and at Both Yanglingquan Acupoints on Autonomic Nerve Modulating Cardiovascular Activity , and Skin Blood Flow and Skin Temperature|Completed||N/A|24|Actual|China Medical University Hospital||3|||f||||f||||||||||2017-10-11 02:37:26.567396|2017-10-11 02:37:26.567396
NCT01665092|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-11|2017-08-23|||January 2013||2013-01-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|RACE||Rapid Administration of Carnitine in sEpsis|Phase 2 Study of Levo-Carnitine for Vasopressor Dependent Septic Shock|Recruiting||Phase 2|250|Anticipated|University of Mississippi Medical Center||4|||f||||t||||||||||2017-10-11 02:37:26.667025|2017-10-11 02:37:26.667025
NCT01665079|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-08-14|||April 2011||2011-04-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Propofol Effect-Site Target Controlled Infusion in the Obese: Characterization of the Time Profile of Bispectral Index Response|Propofol Effect-Site Target Controlled Infusion in the Obese: Characterization of the Time Profile of Bispectral Index Response.|Completed||Phase 4|14|Actual|Universidad del Desarrollo||1|||f||||t||||||||||2017-10-11 02:37:26.836526|2017-10-11 02:37:26.836526
NCT01665066|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-12-12|||May 2012||2012-05-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|KINECIG||Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes|Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes: a Randomised Cross-over Trial KINECIG|Completed||N/A|15|Actual|Universita degli Studi di Catania||5|||f||||f||||||||||2017-10-11 02:37:26.924786|2017-10-11 02:37:26.924786
NCT01665053|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-03-10|2015-12-01||November 2012||2012-11-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|September 2014|Actual|2014-09-01||Interventional|||The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)|EVOLVE II: A Prospective Multicenter Trial to Assess the Safety and Effectiveness of the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System) for the Treatment of Atherosclerotic Lesion(s)|Active, not recruiting||Phase 3|1684|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-11 02:37:27.112646|2017-10-11 02:37:27.112646
NCT01665040|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2013-11-06|||August 2012||2012-08-01|November 2013|2013-11-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain|Precision Spectra™ Neurostimulator System for the Treatment of Chronic Intractable Pain of the Trunk and/or Limbs|Unknown status|Recruiting|N/A|40|Anticipated|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 02:37:28.946589|2017-10-11 02:37:28.946589
NCT01665027|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-14|||December 2010||2010-12-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Vacuum on Fetal and Maternal Complications During Difficult Caesarean Section||Completed||Phase 3|108|Actual|Shahid Sadoughi University of Medical Sciences and Health Services||2|||f||||||||||||||2017-10-11 02:37:29.044482|2017-10-11 02:37:29.044482
NCT01665014|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-11|2012-08-16|||August 2012||2012-08-01|August 2012|2012-08-01|August 2016|Anticipated|2016-08-01|December 2015|Anticipated|2015-12-01||Interventional|||Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma|Efficacy and Safety of Double Autologous Hematopoietic Stem Cell Transplantation With Sequential Use of Total Marrow Irradiation and High-dose Melphalan in Multiple Myeloma|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice||1|||f||||t||||||||||2017-10-11 02:37:29.137814|2017-10-11 02:37:29.137814
NCT01665001|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-11|2012-08-16|||August 2012||2012-08-01|August 2012|2012-08-01|August 2018|Anticipated|2018-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Personalized Therapy of Precursor Lymphoid Neoplasms|Optimization of the Treatment of Adults With Precursor Lymphoid Neoplasms With Adjustment of the Type and Intensity of the Therapy for Age, Status of Minimal Residual Disease, Genetic and Phenotypic Features|Not yet recruiting||Phase 2|200|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice||1|||f||||t||||||||||2017-10-11 02:37:29.263742|2017-10-11 02:37:29.263742
NCT01664975|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-08-10|2016-08-10||August 2011||2011-08-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Treatment of Peripheral T-cell Lymphoma|A Randomized Controlled Multi-center Clinical Trial on Treatment of Peripheral T-cell Lymphoma With DGPT Regiment (Gemcitabine,Cisplatin,Prednisone ,Thalidomide )|Completed||Phase 4|100|Actual|Zhengzhou University||2|||f||||f||||||||||2017-10-11 02:37:29.465267|2017-10-11 02:37:29.465267
NCT01664962|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-08-13|||November 2008||2008-11-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Observational|||Search for Genetic Basis of Vulvodynia||Completed||N/A|168|Actual|Western Galilee Hospital-Nahariya|||2||f||||||||||||||2017-10-11 02:37:29.798452|2017-10-11 02:37:29.798452
NCT01664949|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-09-08|2015-05-22||January 2013||2013-01-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease||Completed||Phase 3|460|Actual|Allergan||2|||f||||f||||||||||2017-10-11 02:37:29.879169|2017-10-11 02:37:29.879169
NCT01664936|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-03-24|||August 2012||2012-08-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes|Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes|Active, not recruiting||N/A|27|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 02:37:30.338544|2017-10-11 02:37:30.338544
NCT01664923|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-09-28|2016-02-22||August 7, 2012|Actual|2012-08-07|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|February 1, 2015|Actual|2015-02-01||Interventional|STRIVE||Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer|Strive: A Multicenter Phase 2, Randomized, Double-blind, Efficacy And Safety Study Of Enzalutamide Vs. Bicalutamide In Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy|Active, not recruiting||Phase 2|389|Actual|Pfizer||2|||f||||||||||||||2017-10-11 02:37:30.472704|2017-10-11 02:37:30.472704
NCT01664910|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-03-03|||October 2012|Actual|2012-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies|Anti-CD22 Immunoconjugate Inotuzumab Ozogamicin (CMC-544) Added to Fludarabine, Bendamustine and Rituximab and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies|Recruiting||Phase 1/Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:37:32.341141|2017-10-11 02:37:32.341141
NCT01664897|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-06-16|||May 2013||2013-05-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Pilot Phase II - Erlotinib for Acute Myeloid Leukemia (AML)|A Pilot Phase II Study of Erlotinib for the Treatment of Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 2|29|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:37:32.467457|2017-10-11 02:37:32.467457
NCT01664884|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-15|||June 2012||2012-06-01|August 2012|2012-08-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|ESTINT||Internalized Stigma in Patients With Bipolar Disorder or Schizophrenia|Internalized Stigma in a Sample of Young Adults With Bipolar Disorder or Schizophrenia.|Unknown status|Recruiting|N/A|120|Anticipated|University of Sao Paulo|||2||f||||f||||||||||2017-10-11 02:37:32.598718|2017-10-11 02:37:32.598718
NCT01664845|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-13|||August 2012||2012-08-01|August 2012|2012-08-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance|Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|Kaohsiung Veterans General Hospital.||2|||f||||f||||||||||2017-10-11 02:37:33.589809|2017-10-11 02:37:33.589809
NCT01664832|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-06-26|||July 2012||2012-07-01|June 2013|2013-06-01||||September 2013|Anticipated|2013-09-01||Interventional|N_SIMV||Is Synchronization More Effective During Noninvasive Ventilation in Immediately Extubated Preterm Infants?|Is Synchronization More Effective During Noninvasive Ventilation in Immediately Extubated Preterm Infants?|Unknown status|Recruiting|N/A|18|Anticipated|University of Ulm||2|||f||||f||||||||||2017-10-11 02:37:33.710404|2017-10-11 02:37:33.710404
NCT01664819|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-06-09|||July 2012||2012-07-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|February 2018|Anticipated|2018-02-01||Interventional|||Antioxidants for Prevention of Cataracts Follow-up Study|Antioxidants for Prevention of Cataracts Follow-up Study|Enrolling by invitation||N/A|798|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:37:33.854762|2017-10-11 02:37:33.854762
NCT01664806|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2013-03-18|2013-01-25||November 2010||2010-11-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|August 2011|Actual|2011-08-01||Interventional|||Laparoscopic Cholecystectomy And Capacitive Coupling - Coag Versus Blend Mode Causing Thermal Injury at Port Site Skin|Laparoscopic Cholecystectomy And Capacitive Coupling - Coag Versus Blend Mode and Thermal Injury to Tissue Adjacent to Port Sites|Completed||Phase 3|40|Actual|University of Colorado, Denver|This is a pilot study with no funding so data is limited.|2|||f||||f||||||||||2017-10-11 02:37:33.95805|2017-10-11 02:37:33.95805
NCT01664793|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-11-21|2014-05-27||October 2010||2010-10-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|February 2013|Actual|2013-02-01||Interventional||Children enrolled at family medicine practices and pediatric practices in the year preceding the intervention year for both intervention and control groups who were seen for a visit between 3/1/2010 and 2/28/2011.|From Innovation to Solutions: Childhood Influenza Vaccination Planning|From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vaccination Assessment as a Vital Sign to Increase Childhood Influenza Vaccination in Diverse Settings|Completed||N/A|87665|Actual|University of Pittsburgh|2 offices of 1 practice were randomized to each arm potentially causing carryover of the intervention.|2|||f||||f||||||||||2017-10-11 02:37:35.876761|2017-10-11 02:37:35.876761
NCT01664780|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-13|||May 2012||2012-05-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Acoustic Radiation Force Impulse Imaging (ARFI) in Patients After Liver Transplantation|Acoustic Radiation Force Impulse Imaging (ARFI) in Patients After Liver Transplantation|Unknown status|Recruiting|N/A|100|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-10-11 02:37:36.185242|2017-10-11 02:37:36.185242
NCT01664767|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2013-12-27|||November 2011||2011-11-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Sulfur Thermal Water Inhalation on Airway Oxidative Stress in COPD Patients|Placebo Controlled Study Evaluating the Modulatory Effects of Sulfur Thermal Water Inhalation on Superoxide Anion Levels in Exhaled Breath Condensate in COPD Patients|Completed||N/A|40|Actual|Università degli Studi di Ferrara||2|||f||||f||||||||||2017-10-11 02:37:36.276571|2017-10-11 02:37:36.276571
NCT01664754|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-09-12|||September 7, 2012|Actual|2012-09-07|September 2016|2016-09-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer|Phase I Dose Escalation Study of Carboplatin, Pemetrexed and Exemestane in Post-menopausal Women With Metastatic Non-squamous NSCLC|Active, not recruiting||Phase 1|6|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:37:36.379275|2017-10-11 02:37:36.379275
NCT01664741|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-03-08|||April 2012||2012-04-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|April 2018|Anticipated|2018-04-01||Interventional|||Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging|Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging|Recruiting||Phase 4|90|Anticipated|Johns Hopkins University||3|||f||||t||||||||Undecided||2017-10-11 02:37:36.502487|2017-10-11 02:37:36.502487
NCT01664728|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2013-04-18|||April 2007||2007-04-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|February 2009|Actual|2009-02-01||Interventional|||An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001|An Expanded Access Open Label Study of CB7630 (Abiraterone Acetate) in Patients With Advanced Prostate Cancer Who Have Completed CB7630 Clinical Study COU-AA-001|Completed||Phase 1|54|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 02:37:36.618793|2017-10-11 02:37:36.618793
NCT01664715|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-08-01|||August 2012|Actual|2012-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|POWeR||A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain|A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain|Active, not recruiting||N/A|287|Actual|University of Kansas||3|||f||||t||||||||||2017-10-11 02:37:37.285147|2017-10-11 02:37:37.285147
NCT01664702|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-13|||January 2005||2005-01-01|August 2012|2012-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Substrate Oxidation in Children in Response to High and Low Dairy Intake|Substrate Oxidation in Children in Response to Exercise With High and Low Dairy Intake|Completed||N/A|24|Actual|University of Kansas||2|||f||||t||||||||||2017-10-11 02:37:37.407073|2017-10-11 02:37:37.407073
NCT01664689|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-13|||October 2011||2011-10-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During Phacoemulsification||Completed||N/A|120|Actual|Iladevi Cataract and IOL Research Center||3|||f||||||||||||||2017-10-11 02:37:37.499376|2017-10-11 02:37:37.499376
NCT01664676|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2014-02-27|||December 2012||2012-12-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients|A Randomised, Double-blinded, Cross-over Study Investigating the Short-term Impact of Liraglutide on Kidney Function in Diabetic Patients|Completed||Phase 4|11|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 02:37:37.600462|2017-10-11 02:37:37.600462
NCT01664663|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2014-12-08|||September 2011||2011-09-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|November 2013|Actual|2013-11-01||Interventional|PLANET||Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy|Phase II Randomized Study on Locally Advanced Non Small Cell Lung Cancer Escalated Dose on Individual Basis Treatment With Radiochemotherapy|Terminated||Phase 2|37|Actual|Swedish Lung Cancer Study Group||2||Safety analysis showed increased grade 5 toxicity in experimental arm.|f||||t||||||||||2017-10-11 02:37:37.691919|2017-10-11 02:37:37.691919
NCT01664650|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-09|||September 2008||2008-09-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Interventional|||Effects of Genistein in Postmenopausal Women With Metabolic Syndrome|Role of Genistein on Metabolic Syndrome in Post-menopausal Women|Completed||Phase 2/Phase 3|120|Actual|University of Messina||2|||f||||f||||||||||2017-10-11 02:37:37.791585|2017-10-11 02:37:37.791585
NCT01664637|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-12-18|||August 2012||2012-08-01|December 2012|2012-12-01|February 2013|Anticipated|2013-02-01|January 2013|Anticipated|2013-01-01||Interventional|DIGEST||Diabetic Gastroparesis Efficacy/Safety Study of TZP-102|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of TZP-102 Given Orally Three Times a Day for the Treatment of Symptoms Associated With Diabetic Gastroparesis|Terminated||Phase 2|120|Anticipated|Tranzyme, Inc.||2||Insufficient efficacy in planned interim futility analysis|f||||t||||||||||2017-10-11 02:37:37.891648|2017-10-11 02:37:37.891648
NCT01664624|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-12-02|2013-11-25||July 2012||2012-07-01|September 2016|2016-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes|A Phase 1b, Randomized, Double-Blind, Active Comparator (Open-Label Exenatide) Controlled Study to Evaluate the Effect of Roflumilast Plus Alogliptin on Postprandial Active GLP-1 Level and 24-hour Glucose Level in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on a Stable Dose of Metformin|Completed||Phase 1|40|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 02:37:38.075215|2017-10-11 02:37:38.075215
NCT01664611|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-03-17|||September 26, 2012|Actual|2012-09-26|August 2012|2012-08-01|October 30, 2016|Actual|2016-10-30|October 30, 2016|Actual|2016-10-30||Interventional|DREAM||Daily REmote Ischaemic Conditioning Following Acute Myocardial Infarction|The DREAM Study (Daily Remote Ischaemic Conditioning Following Acute Myocardial Infarction)|Completed||Phase 2|90|Anticipated|University of Leicester||2|||f||||f|f|f||||||No||2017-10-11 02:37:39.10657|2017-10-11 02:37:39.10657
NCT01660529|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-07-18|||June 2012||2012-06-01|July 2016|2016-07-01||||December 2015|Actual|2015-12-01||Interventional|||Multi-peptide Vaccine With Basilixumab for Breast Cancer|A Study of hTERT/Survivin Multi-Peptide Vaccination With Basiliximab And Prevnar For Patients With Metastatic Breast Cancer|Recruiting||N/A|12|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 02:39:00.14854|2017-10-11 02:39:00.14854
NCT01664585|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-05-02|||September 17, 2012|Actual|2012-09-17|May 2017|2017-05-01|July 3, 2015|Actual|2015-07-03|July 3, 2015|Actual|2015-07-03||Interventional|HEADEX||Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life|EXERCISE TRAINING WITH PHYSICALLY ACTIVE LIFESTYLE TO REDUCE HEADACHE AND INCREASE QUALITY OF LIFE. A Randomised Controlled Trial of the Effectiveness and Cost-effectiveness of Exercise Training and Physical Activity on Chronic Headache|Completed||N/A|116|Actual|UKK Institute||2|||f||||f||||||||No||2017-10-11 02:37:39.29069|2017-10-11 02:37:39.29069
NCT01664572|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-06-13|||June 2012||2012-06-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Observational|METHODO-LSCI||Methodological Issues and Laser Speckle Contrast Imaging|Methodological Issues of Laser Speckle Contrast Imaging for Studying Microcirculation.|Completed||N/A|75|Actual|University Hospital, Angers|||1||f||||f||||||||||2017-10-11 02:37:39.403972|2017-10-11 02:37:39.403972
NCT01664559|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-11-18|2015-07-22||July 2012||2012-07-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pain Control for Intrauterine Device Placement: A Trial of Ketorolac Prior to Intrauterine Device Placement|Pain Control for Intrauterine Device Placement: A Randomized, Double Blind Control Trial of Ketorolac Prior to Intrauterine Device Placement.|Completed||N/A|67|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 02:37:39.471553|2017-10-11 02:37:39.471553
NCT01664546|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-14|||September 2012||2012-09-01|August 2012|2012-08-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Observational|||Study of the Best Blastocyst Post Transfer by aCGH|Study of the Best Blastocyst Post Transfer by aCGH|Unknown status|Not yet recruiting|N/A|150|Anticipated|University of Buenos Aires|||1||f||||f||||||Samples With DNA|"     Removed cells from human trophectoderm   "|||2017-10-11 02:37:40.405362|2017-10-11 02:37:40.405362
NCT01664533|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-11-23|2015-10-09||September 2011||2011-09-01|November 2015|2015-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|TIME|Baseline analysis population is represented as the per protocol population.|An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy|Prospective, Open-label, Multicenter, National, Non-interventional Phase IV Trial of the Effectiveness, Safety and Tolerability of Tarceva as Second-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC), After Failure of First-line Treatment With a Pemetrexed-containing Chemotherapy Regimen|Completed||N/A|57|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:37:40.53273|2017-10-11 02:37:40.53273
NCT01664520|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-04|2017-02-03|||June 2013||2013-06-01|February 2017|2017-02-01|December 30, 2016|Actual|2016-12-30|November 30, 2016|Actual|2016-11-30||Interventional|||Dexmedetomidine and Subarachnoid Haemorrhage|The Effects of Dexmedetomidine on Cerebral Autoregulation and Cerebral Oxygenation in Subarachnoid Haemorrhage Patients|Completed||Phase 1/Phase 2|10|Actual|Turku University Hospital||1|||f||||f||||||||||2017-10-11 02:37:40.923474|2017-10-11 02:37:40.923474
NCT01664507|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-09|||September 2012||2012-09-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||The Effect and Safety of Low Dose Nebulized Epinephrine in Croup|The Effect and Safety of Low Dose Nebulized Epinephrine in the Treatment of Croup|Unknown status|Not yet recruiting|Phase 4|132|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:37:41.022141|2017-10-11 02:37:41.022141
NCT01664494|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-03-29|2015-11-19||April 2010||2010-04-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer|A Non-Interventional Trial of Xeloda in Metastatic Colorectal Cancer, Adjuvant Colon Cancer, Advanced Gastric Cancer and Breast Cancer|Completed||N/A|563|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:37:41.133174|2017-10-11 02:37:41.133174
NCT01664273|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-06-19|||July 2012||2012-07-01|June 2014|2014-06-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer|Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer|Terminated||Phase 1|7|Actual|Copenhagen University Hospital at Herlev||1||Production of the IMP (plasmid AMEP) has been terminated by the supplier (BioAlliance Pharma)|f||||t||||||||||2017-10-11 02:37:41.52947|2017-10-11 02:37:41.52947
NCT01664260|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-09-17|||November 2012||2012-11-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress Disorder|Elucidation of Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress Disorder: An 8-week Multimodal Neuroimaging and Neurocognitive Study|Unknown status|Recruiting|Phase 2|96|Anticipated|Ewha Womans University||2|||f||||t||||||||||2017-10-11 02:37:41.631481|2017-10-11 02:37:41.631481
NCT01664247|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-08-25|2015-10-23|2014-01-24|October 1, 2012|Actual|2012-10-01|August 2017|2017-08-01|December 31, 2013|Actual|2013-12-31|December 31, 2013|Actual|2013-12-31||Interventional|||The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification|The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification|Completed||Phase 3|346|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:37:41.816096|2017-10-11 02:37:41.816096
NCT01664234|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2012-08-10|||August 2012||2012-08-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Oxygen Insuflation and ArterialDesaturation During Tracheal Intubation in Children||Unknown status|Recruiting|N/A|48|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:37:42.768844|2017-10-11 02:37:42.768844
NCT01663857|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-06-01|||July 2012||2012-07-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of LY2228820 for Recurrent Ovarian Cancer|A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Study of LY2228820, a p38 MAPK Inhibitor, Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin for Women With Platinum-Sensitive Ovarian Cancer|Active, not recruiting||Phase 1/Phase 2|116|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 02:37:52.302461|2017-10-11 02:37:52.302461
NCT01664221|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-08-10|||February 2013||2013-02-01|August 2012|2012-08-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.|Phase 1 Assessment of Pharmacokinetics and Pharmacodynamics of Two Epoetin Alfa, Eritromax (Blau Farmacêutica) and Eprex (Janssen-Cilag), After Multiple Dose, Intravenous Administration in Healthy Subjects: a Randomized Parallel Study.|Unknown status|Not yet recruiting|Phase 1|80|Anticipated|Azidus Brasil||2|||f||||t||||||||||2017-10-11 02:37:42.868718|2017-10-11 02:37:42.868718
NCT01664195|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-08-10|||February 2013||2013-02-01|August 2012|2012-08-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects|Phase 1 Assessment of Pharmacokinetics and Pharmacodynamics of Two Epoetin Alfa, Eritromax (Blau Farmacêutica) and Eprex (Janssen-Cilag), After Single Dose, Intravenous Administration in Healthy Subjects: a Randomized Study.|Unknown status|Not yet recruiting|Phase 1|28|Anticipated|Azidus Brasil||2|||f||||t||||||||||2017-10-11 02:37:42.95552|2017-10-11 02:37:42.95552
NCT01664182|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-09-12|||August 1, 2012|Actual|2012-08-01|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer|A Randomized Phase 2 Study of AMG 386 With or Without Continued Anti-vascular Endothelial Growth Factor (VEGF) Therapy in Patients With Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib|Active, not recruiting||Phase 2|78|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 02:37:43.055463|2017-10-11 02:37:43.055463
NCT01664169|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-08-07|||August 2012||2012-08-01|August 2017|2017-08-01||||January 2100|Anticipated|2100-01-01||Observational|||Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303|Validation of Circulating Biomarkers Using the Immunological Multiparameter Chip Technology (IMPACT) on Plasma Specimens Collected on CALGB 80303|Active, not recruiting||N/A|307|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     The following markers are analyzed in EDTA plasma samples using the IMPACT a Roche     proprietary multiplex ELISA platform: VEGF-A, VEGF-C, VEGF-R1, VEGF-R2, E-selectin, VEGF-R3,     IL-8, bFGF, PDGF-C, ICAM-1, and PlGF.   "|||2017-10-11 02:37:43.189491|2017-10-11 02:37:43.189491
NCT01664156|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-03-12|||October 2012||2012-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Korean Red Ginseng on Women With Cold Hypersensitivity of Hands and Feet|Effect of Korean Red Ginseng on Women With Cold Hypersensitivity of Hands and Feet : a Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 4|80|Actual|The Korean Society of Ginseng||2|||f||||t||||||||||2017-10-11 02:37:43.269632|2017-10-11 02:37:43.269632
NCT01664143|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Single-Center Study of RO5508887 in Healthy Volunteers|A Single-Center, Randomized, Investigator/Subject-Blind, Multiple Ascending-Dose, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5508887 Following Oral Administration in Healthy Subjects|Completed||Phase 1|36|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:37:43.396454|2017-10-11 02:37:43.396454
NCT01664130|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2016-02-04|||July 2012||2012-07-01|February 2016|2016-02-01||||December 2014|Actual|2014-12-01||Interventional|||High-Dose Stereotactic Radiation for Prostate Cancer|High-Dose Stereotactic Body Radiation Therapy in Treating Patients With Low-, Intermediate-, or High-Risk Localized Prostate Cancer|Active, not recruiting||N/A|35|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:37:43.477674|2017-10-11 02:37:43.477674
NCT01664117|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-03-15|2016-02-01||June 2012||2012-06-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy|Study of the Profile and Clinical Management of Patients With Rheumatoid Arthritis Treated With Biologic Therapy Alone|Completed||N/A|210|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:37:43.611324|2017-10-11 02:37:43.611324
NCT01664104|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-04-14|2017-01-26||June 2012||2012-06-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational||All enrolled participants evaluable for primary objective: All enrolled participants except participants who withdrew from study for reasons not related to TCZ and had not interrupted TCZ treatment at withdrawal; lost to follow-up participants in treatment with TCZ at withdrawal; or premature termination occurring until 5 months from start of TCZ.|A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting|CRP and BMI Study: Evaluation in Real Life of Clinical Remission Rate and Correlation Between CRP and BMI in Patients Treated With Tocilizumab|Completed||N/A|151|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:37:46.352425|2017-10-11 02:37:46.352425
NCT01664091|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-06-06|||October 2009||2009-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT|An Evaluation of Cosmetic Results and Toxicity in the Use of Post-Mastectomy Immediate Reconstruction With a Tissue Expander and Acellular Dermal Matrix Followed by Radiation Therapy|Active, not recruiting||N/A|32|Actual|Dana-Farber Cancer Institute|||1||f||||t||||||||||2017-10-11 02:37:48.336337|2017-10-11 02:37:48.336337
NCT01664078|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-08-18||2017-06-08|July 2012||2012-07-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2014|Actual|2014-10-01||Interventional|INSPIRATION||A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)|A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)|Active, not recruiting||N/A|190|Actual|Cordis Corporation||1|||t||||t||||||||||2017-10-11 02:37:48.431242|2017-10-11 02:37:48.431242
NCT01664065|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2017-09-01|||February 2013||2013-02-01|September 2017|2017-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects|An Open-label, Nonrandomised, Phase I Study to Assess the Pharmacokinetics of Ceftaroline After Intravenous Administration of aSingle Dose of Ceftaroline Fosamil (200 mg) to Patients With End-stage Renal Disease Undergoing Haemodialysis When Compared to a Single Dose of Ceftaroline Fosamil (600 mg)|Completed||Phase 1|15|Actual|Pfizer||2|||f||||||||||||||2017-10-11 02:37:48.559917|2017-10-11 02:37:48.559917
NCT01664039|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-10|2015-07-13|2015-06-19||September 2012||2012-09-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||This analysis population includes all randomized subjects.|An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®|Assessing the Efficacy and Tolerability of TRAVATAN® Solution Without BAK, Containing Polyquad® Preservative (Travoprost 0.004%) Versus LUMIGAN® 0.01% Solution With BAK (Bimatoprost 0.01%) in Treatment Naïve Patients With Ocular Hypertension or Open Angle Glaucoma|Completed||Phase 4|104|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:37:49.223126|2017-10-11 02:37:49.223126
NCT01664026|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-08-10|||August 2012||2012-08-01|August 2012|2012-08-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors|A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support|Unknown status|Active, not recruiting|N/A|350|Anticipated|Clínica Bazterrica||3|||f||||f||||||||||2017-10-11 02:37:49.701441|2017-10-11 02:37:49.701441
NCT01664013|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-08-18|||October 2012||2012-10-01|August 2013|2013-08-01||||October 2013|Anticipated|2013-10-01||Interventional|||The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients|The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients|Unknown status|Recruiting|Phase 4|20|Anticipated|Chulalongkorn University||1|||f||||||||||||||2017-10-11 02:37:49.769401|2017-10-11 02:37:49.769401
NCT01664000|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-02-23|||October 2012||2012-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors|A Phase 1, Open-Label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin (Thioureidobutyronitrile) Administered Intravenously, in Patients With Advanced Solid Tumors|Completed||Phase 1|48|Actual|Cellceutix Corporation||1|||f||||t||||||||Yes||2017-10-11 02:37:49.858887|2017-10-11 02:37:49.858887
NCT01663987|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-06-17|2015-05-01||August 2012||2012-08-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Treated Set (TS): The treated set included all patients randomized and who took at least one dose of the study drug.|Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1|A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Study to Assess the Safety and Efficacy of Tiotropium Bromide (18 µg) Delivered Via the HandiHaler® in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering From Hospitalization for an Acute Exacerbation (Hospital Discharge Study 1)|Completed||Phase 4|79|Actual|Boehringer Ingelheim|The original protocol planned to randomize 604 subjects, however this was not reached due to low patient enrollment. All results are descriptive only.|2|||f||||||||||||||2017-10-11 02:37:49.963096|2017-10-11 02:37:49.963096
NCT01663974|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-03-06|||April 2013||2013-04-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|POLARIS||Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder|Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder|Terminated||N/A|125|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:37:50.907907|2017-10-11 02:37:50.907907
NCT01663961|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-08-31|||September 2008||2008-09-01|August 2015|2015-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178|An Open-label, One-sequence Crossover Study to Evaluate the Effect of Multiple Doses of YM178 on the Pharmacokinetics of Digoxin in Healthy Subjects|Completed||Phase 1|25|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:37:51.19108|2017-10-11 02:37:51.19108
NCT01663948|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-02-21|||July 2012||2012-07-01|February 2017|2017-02-01|July 2022|Anticipated|2022-07-01|July 2022|Anticipated|2022-07-01||Observational|||International Plastic Bronchitis Registry|International Plastic Bronchitis Registry|Recruiting||N/A|100|Anticipated|Virginia Commonwealth University|||1||f||||f|f|f||||Samples With DNA|"     Airway Casts   "|||2017-10-11 02:37:51.319674|2017-10-11 02:37:51.319674
NCT01663935|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-05-03|||August 2012||2012-08-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Vision Response to Dopamine Replacement|Interventional Study of Levodopa Replacement on Retinal Function in Oculocutaneous Albinism|Recruiting||Phase 2|50|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 02:37:51.415066|2017-10-11 02:37:51.415066
NCT01663922|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-09-23|2014-07-14||August 2012||2012-08-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||All enrolled participants.|Boceprevir and Ucalm (St John&Apos;s Wort)|Phase I Evaluation of the Pharmacokinetics and Safety of Boceprevir and Ucalm (St John&Apos;s Wort) When Co-administered to Male and Female Healthy Volunteers.|Completed||Phase 1|17|Actual|St Stephens Aids Trust||2|||f||||f||||||||||2017-10-11 02:37:51.591262|2017-10-11 02:37:51.591262
NCT01663909|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-08-09|||May 2010||2010-05-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Pain Management Using Guided Imagery for Adolescents Post-spinal Fusion|The Efficacy of Guided Imagery on Pain, Anxiety, and Coping for Adolescents Post-spinal Fusion|Completed||N/A|40|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 02:37:51.855065|2017-10-11 02:37:51.855065
NCT01663883|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-08-09|||February 2012||2012-02-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Optic Nerve Head Autoregulation During Changes in Arterial Blood Pressure||Completed||N/A|40|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 02:37:52.109453|2017-10-11 02:37:52.109453
NCT01663870|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-01-17|||February 2013||2013-02-01|January 2017|2017-01-01||||February 2019|Anticipated|2019-02-01||Observational|||Technology and Navigation to Improve Survivorship Care|Integrating Technology and Navigation to Improve Survivorship Care in Underserved Populations|Active, not recruiting||N/A|80|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-10-11 02:37:52.192704|2017-10-11 02:37:52.192704
NCT01663844|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2015-09-01|||January 2013||2013-01-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||New Clinical Applications for Internet-based Cognitive Behavior Therapy for Insomnia and Depression|New Clinical Applications for Internet-based Cognitive Behavior Therapy: An Adaptive Treatment Strategy to Decrease the Number of Failed Treatments, and a Combination Treatment for Insomnia and Depression.|Unknown status|Recruiting|N/A|440|Anticipated|Karolinska Institutet||4|||f||||f||||||||||2017-10-11 02:37:52.511428|2017-10-11 02:37:52.511428
NCT01663831|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2014-01-31|||May 2012||2012-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|MalaResT||Repellents as Added Control Measure to Long Lasting Insecticidal Nets|Repellents as Added Control Measure to Long Lasting Insecticidal Nets to Target the Residual Transmission in Southeast Asia: a Step Forwards to Malaria Elimination|Completed||N/A|40000|Actual|Institute of Tropical Medicine, Belgium||2|||f||||t||||||||||2017-10-11 02:37:52.623845|2017-10-11 02:37:52.623845
NCT01663818|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-09-19|||August 2012||2012-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|TOBA||Tack Optimized Balloon Angioplasty (TOBA) Study|Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular Stapler|Active, not recruiting||N/A|138|Anticipated|Intact Vascular||1|||f||||t||||||||||2017-10-11 02:37:52.79713|2017-10-11 02:37:52.79713
NCT01663805|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-08-09|||January 2012||2012-01-01|April 2012|2012-04-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||"Effects of the Use of de Novo Everolimus in Renal Tranplant Population"|"Effects of the Use of de Novo Everolimus for the Expression of Cytokines in Kidneys From Extended Criteria Donors and With Delayed Graft Function"|Unknown status|Recruiting|Phase 4|80|Anticipated|Instituto de Urologia e Nefrologia||2|||f||||f||||||||||2017-10-11 02:37:52.991044|2017-10-11 02:37:52.991044
NCT01663792|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2016-01-14|||October 2006||2006-10-01|January 2016|2016-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dietary Seaweed and Early Breast Cancer: A Randomized Trial|Dietary Seaweed and Early Breast Cancer: A Randomized Trial|Completed||N/A|15|Actual|University of South Carolina||3|||f||||f||||||||||2017-10-11 02:37:53.142018|2017-10-11 02:37:53.142018
NCT01663779|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-08-05|2015-03-30||August 2012||2012-08-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Comparison of Ultrasound-guided Versus Blind Insertion of Radial Artery Catheters|Comparison of Ultrasound-guided Versus Blind Insertion of Radial Artery Catheters.|Terminated||N/A|50|Actual|Yale University||2||Inability to recruit further.|f||||f||||||||||2017-10-11 02:37:53.267048|2017-10-11 02:37:53.267048
NCT01663766|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-03-02|||December 2013||2013-12-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Phase I Study of Milatuzumab for Graft Versus Host Disease|A Phase I Study of Milatuzumab (hLL1) for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With Hematologic Malignancies|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|Immunomedics, Inc.||1|||f||||f||||||||||2017-10-11 02:37:53.528837|2017-10-11 02:37:53.528837
NCT01663753|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-05-29|||January 2012||2012-01-01|May 2017|2017-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|ERRICC||Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy|Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy|Recruiting||N/A|148|Anticipated|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 02:37:53.617932|2017-10-11 02:37:53.617932
NCT01663727|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-08-08|2016-01-12||August 27, 2012|Actual|2012-08-27|July 2017|2017-07-01|January 31, 2019|Anticipated|2019-01-31|November 30, 2014|Actual|2014-11-30||Interventional||Intent-to-treat (ITT) population: All participants randomized to study treatment irrespective of whether the assigned treatment was actually received.|Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer|Active, not recruiting||Phase 3|481|Actual|Hoffmann-La Roche|The results represent the data up to primary completion date (30 Nov 2014).|2|||f||||||||||||||2017-10-11 02:37:54.077736|2017-10-11 02:37:54.077736
NCT01663714|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2016-11-21|2012-09-20||February 2000||2000-02-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.|Phase II Multicenter Study of Cyclophosphamide, Vincristine, and Prednisone (CVP) Followed by Iodine-131 Anti-B1 Antibody for Patients With Untreated Low-grade Non-Hodgkin's Lymphoma (NHL).|Completed||Phase 2|30|Actual|GlaxoSmithKline||1|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:37:55.764376|2017-10-11 02:37:55.764376
NCT01661374|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-12-09|||July 2012||2012-07-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||The Effect of Humidification on Mucus Rheology|The Effect of Humidification on Mucus Rheology|Completed||N/A|18|Actual|Virginia Commonwealth University|||2||f||||f||||||Samples With DNA|"     Sputum   "|||2017-10-11 02:38:24.508933|2017-10-11 02:38:24.508933
NCT01663688|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-01-16|||July 2012||2012-07-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Observational|||Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye|Normative Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for the Measurements of Retinal and RNFL Thickness and Optic Disc Analysis|Completed||N/A|279|Actual|Nidek Co. LTD.|||1||f||||f||||||||||2017-10-11 02:37:58.186679|2017-10-11 02:37:58.186679
NCT01663675|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-11-22|||November 2014||2014-11-01|November 2016|2016-11-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Observational|||Trisomy 21 in Adulthood|Trisomy 21 in Adulthood. Evaluation of Health and Social State in Alsace (North-eastern France)|Recruiting||N/A|80|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 02:37:58.256598|2017-10-11 02:37:58.256598
NCT01663662|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-12-10|||August 2012||2012-08-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study|The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Acute Decompensated Heart Failure-Pilot Study|Withdrawn||Phase 4|0|Actual|University of Michigan||2||Lack of eligible patients|f||||f||||||||||2017-10-11 02:37:58.354849|2017-10-11 02:37:58.354849
NCT01663649|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-03-24|||June 2012||2012-06-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Effectiveness of Web-based Treatment for Depression in Patients With Neurologic Disorders|Evaluation of the Effectiveness of a Web-based Treatment Program for Depression (Deprexis) for the Reduction of Depressive Symptoms in Patients With Multiple Sclerosis and Epilepsy. A Randomized Controlled Trial|Completed||N/A|180|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 02:37:58.435457|2017-10-11 02:37:58.435457
NCT01663623|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-09-21|||March 20, 2013|Actual|2013-03-20|September 2017|2017-09-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|BREVAS||Belimumab in Remission of VASculitis|A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination With Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis|Completed||Phase 3|106|Actual|GlaxoSmithKline||2|||f||||t|t|f||||||||2017-10-11 02:37:58.639915|2017-10-11 02:37:58.639915
NCT01663610|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-05-15|||October 2012||2012-10-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|VardagsSMART||Online Course Teachning Adults With ADHD How to Use a Smartphone|Online Course for Adults With ADHD or Subclinical ADHD Teaching How to Use a Smartphone as a Support in Their Everyday Life|Completed||N/A|58|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 02:37:58.953377|2017-10-11 02:37:58.953377
NCT01663597|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2013-08-28|||August 2012||2012-08-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Optical Biometry and Spherical Aberration in Ametropic and Emmetropic Eyes|Optical Biometry and Spherical Aberration in Ametropic and Emmetropic Eyes|Completed||N/A|160|Actual|Medical University of Vienna|||4||f||||||||||||||2017-10-11 02:37:59.062141|2017-10-11 02:37:59.062141
NCT01663584|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2013-07-12|||August 2012||2012-08-01|July 2013|2013-07-01||||June 2013|Actual|2013-06-01||Observational|||Multi-disease Carrier Screening Test Validation|Collection of Blood Samples for Development of Multi-disease Carrier Testing|Withdrawn||N/A|0|Actual|Natera, Inc.|||1|Samples were not needed for test development, therefore subjects were not recruited or enrolled|f||||f||||||Samples With DNA|"     De-identified samples may be retained for future research.   "|||2017-10-11 02:37:59.163536|2017-10-11 02:37:59.163536
NCT01663571|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2016-10-03|||May 2012||2012-05-01|October 2016|2016-10-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|||STAT3 in T Cells: At The Crossroads of Inflammation and Cancer|STAT3 in T Cells: At The Crossroads of Inflammation and Cancer|Recruiting||N/A|100|Anticipated|New York University School of Medicine|||1||f||||||||||Samples With DNA|"     Skin biopsy specimens from cutaneous T cell lymphoma (CTCL) patients and benign skin     conditions namely eczema, dermatitis and psoriasis will be obtained through a standard punch     biopsy procedure from the skin lesion. The investigators will assay the mRNA levels of the     transcription factors of the different T effector cells by qPCR.   "|||2017-10-11 02:37:59.243373|2017-10-11 02:37:59.243373
NCT01663558|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2016-08-18|||May 2015||2015-05-01|August 2016|2016-08-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV|Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV|Withdrawn||Phase 4|0|Actual|United States Naval Medical Center, San Diego||3||funding not available|f||||f||||||||No||2017-10-11 02:37:59.310644|2017-10-11 02:37:59.310644
NCT01663545|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-10-05|||July 31, 2012||2012-07-31|October 4, 2017|2017-10-04|October 4, 2017||2017-10-04|||||Observational|||Brain P-gp and Inflammation in People With Epilepsy|Positron Emission Tomography Measurement of Neuroinflammation in Focal Epilepsy|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:37:59.396479|2017-10-11 02:37:59.396479
NCT01663532|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-02-12|2014-12-19|2014-10-10|October 2012||2012-10-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia|A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia|Completed||Phase 3|340|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-10-11 02:37:59.496427|2017-10-11 02:37:59.496427
NCT01663519|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-10-06|||January 2008||2008-01-01|October 2014|2014-10-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|||Effectiveness of Insoles Provided to Patients With Diabetes. A Longitudinal Randomized Controlled Study in Gothenburg|Effectiveness of Insoles Provided to Diabetic Patients at Risk to Develop Ulcers|Completed||N/A|114|Actual|Sahlgrenska University Hospital, Sweden||3|||f||||f||||||||||2017-10-11 02:38:01.001393|2017-10-11 02:38:01.001393
NCT01662388|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-04-19|||November 2007||2007-11-01|April 2017|2017-04-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|Automatrix||A Clinical Trial of Proximal Composite Restorations|A Clinical Trial of Proximal Composite Restorations|Completed||N/A|188|Actual|Aga Khan University||2|||f||||t||||||||||2017-10-11 02:38:27.527526|2017-10-11 02:38:27.527526
NCT01663506|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-11-03|2015-11-03||April 2012||2012-04-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational||Full analysis set (FAS) included all participants who were enrolled in this study.|A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)|A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab|Completed||N/A|23|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:38:01.168647|2017-10-11 02:38:01.168647
NCT01663493|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2017-02-11|||October 2015|Actual|2015-10-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Comparing Methods to Biopsy Pancreas Mass|Randomized Trial Comparing 2 Needles During EUS-FNA of Solid Pancreatic Masses|Completed||N/A|59|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 02:38:02.521993|2017-10-11 02:38:02.521993
NCT01663480|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-07-28|||March 2011||2011-03-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||To Identify the Proportionality of Respiratory Work Under Different NAVA Level|Assessment of Patient-ventilator Breath Contribution (PVBC) During Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Acute Respiratory Failure|Completed||N/A|12|Actual|Southeast University, China|||1||f||||t||||||||||2017-10-11 02:38:02.587021|2017-10-11 02:38:02.587021
NCT01663467|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-10-23|||September 2014||2014-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy|Efficacy of Internet and Smartphone Application-delivered TRT|Withdrawn||N/A|0|Actual|Seoul National University Hospital||2||there was no participants who were enrolled in this study|f||||f||||||||No||2017-10-11 02:38:02.652002|2017-10-11 02:38:02.652002
NCT01663454|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-10-07|||September 2012||2012-09-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Working Memory Training in Children With Cerebral Palsy, a Pilot Study|Computer Based Working Memory Training in Children With Cerebral Palsy, a Pilot Study|Completed||N/A|6|Actual|Helse Stavanger HF||1|||f||||f||||||||||2017-10-11 02:38:02.73404|2017-10-11 02:38:02.73404
NCT01663441|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-03-23|||March 2015||2015-03-01|March 2015|2015-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Phase Ⅲ Study of Genetically Modified Recombinant Human Interleukin-11|Multicenter, Randomized Phase Ⅲ Study of Genetically Modified Recombinant Human Interleukin-11 to Prevent Chemotherapy-induced Thrombocytopenia in Cancer Patients Receiving Chemotherapy.|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|Beijing Northland Biotech. Co., Ltd.||4|||f||||t||||||||||2017-10-11 02:38:02.806477|2017-10-11 02:38:02.806477
NCT01663428|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2013-08-28|||July 2012||2012-07-01|August 2013|2013-08-01|August 2019|Anticipated|2019-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Sup-ER Splint for Children With Birth Related Brachial Plexus Injury|Sup-ER Splinting: Does Early Passive Positioning in Supination and External Rotation in Children With Birth Related Brachial Plexus Injury Have Benefit?|Withdrawn||N/A|0|Actual|University of British Columbia||2||It was decided to change the study from a cohort to a randomized controlled trial.|f||||f||||||||||2017-10-11 02:38:02.90988|2017-10-11 02:38:02.90988
NCT01663415|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-09-14|||August 2012||2012-08-01|September 2012|2012-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer|A Phase 2, Multicenter, Single-arm Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer|Withdrawn||Phase 2|0|Actual|Astellas Pharma Inc||1||A business decision was made to not initiate this study.|f||||f||||||||||2017-10-11 02:38:02.994572|2017-10-11 02:38:02.994572
NCT01663402|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-03-02|||October 2012||2012-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome|Active, not recruiting||Phase 3|18600|Anticipated|Sanofi||2|||f||||t||||||||||2017-10-11 02:38:03.471491|2017-10-11 02:38:03.471491
NCT01663389|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-06-09|||August 10, 2012|Actual|2012-08-10|June 2017|2017-06-01|October 5, 2012|Actual|2012-10-05|October 5, 2012|Actual|2012-10-05||Interventional|||A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose|An Open Label, Non-Randomized, Single Dose, Two Period, Cross-Over, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects|Completed||Phase 1|5|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:38:06.904176|2017-10-11 02:38:06.904176
NCT01663376|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-03-24|||January 2009||2009-01-01|March 2014|2014-03-01|April 2011|Actual|2011-04-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia|Effects of Adipose Tissue Derived Stem Cells Implantation in Patients With Critical Limb Ischemia|Completed||Phase 1/Phase 2|20|Actual|Biostar||1|||f||||f||||||||||2017-10-11 02:38:06.987148|2017-10-11 02:38:06.987148
NCT01663363|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-09-30|2015-05-28||August 2012||2012-08-01|June 2015|2015-06-01|July 2015|Actual|2015-07-01|March 2014|Actual|2014-03-01||Interventional||The number of participants is 170, but 334 eyes were evaluated among these 170 participants.|Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors|A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Myopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4IR™ Excimer Laser|Completed||Phase 3|170|Actual|Abbott Medical Optics||1|||f||||f||||||||||2017-10-11 02:38:07.05734|2017-10-11 02:38:07.05734
NCT01663350|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-07-12|||July 2012||2012-07-01|July 2013|2013-07-01||||July 2013|Actual|2013-07-01||Observational|CARE||Comparison of Aneuploidy Risk Evaluations|Performance of the Verinata Health Prenatal Aneuploidy Test Compared to Current Fetal Aneuploidy Screening Results and Pregnancy Outcomes in an 'All‐Risk' Population|Completed||N/A|3000|Anticipated|Verinata Health, Inc.|||1||f||||f||||||Samples With DNA|"     Plasma   "|||2017-10-11 02:38:07.228606|2017-10-11 02:38:07.228606
NCT00005295|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||July 1989||1989-07-01|January 2016|2016-01-01|June 1995||1995-06-01|||||Observational|||Idiopathic Pulmonary Fibrosis: a Case-control Study||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-10-11 04:27:57.341785|2017-10-11 04:27:57.341785
NCT01663337|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-12-27|||March 2013||2013-03-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Sequence of Symptom Change During AUD or PTSD Treatment for Comorbid PTSD/AUD|Sequence of Symptom Change During AUD (Alcohol Use or Dependence) or PTSD (Posttraumatic Stress Disorder) Treatment for Comorbid PTSD/AUD|Recruiting||N/A|235|Anticipated|University of Washington||3|||f||||t||||||||||2017-10-11 02:38:07.336537|2017-10-11 02:38:07.336537
NCT01663324|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-05-17|||July 2012||2012-07-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|Multisite rTMS||rTMS for the Treatment of Chronic Tinnitus: Optimization by Simulation of the Cortical Tinnitus Network|Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Tinnitus: Optimization by Stimulation of the Cortical Tinnitus Network|Completed||N/A|50|Actual|University of Regensburg||2|||f||||f||||||||||2017-10-11 02:38:07.5909|2017-10-11 02:38:07.5909
NCT01663311|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-04-25|||July 2012||2012-07-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|Ti-CDC||Repetitive Transcranial Magnetic Stimulation With Double Cone Coil in Chronic Tinnitus|Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) With Double-Cone-Coil in Patients With Chronic Tinnitus (Ti-CDC)|Completed||N/A|40|Actual|University of Regensburg||2|||f||||f||||||||||2017-10-11 02:38:07.70203|2017-10-11 02:38:07.70203
NCT01663298|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-04-14|||August 2010||2010-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics|FGF2 Promoter Hypermethylation and Implant Wound Healing Among Smokers and Diabetics|Recruiting||N/A|44|Anticipated|University of North Carolina, Chapel Hill|||3||f||||f||||||Samples With DNA|"     Gingival tissues, gingival crevicular fluid, saliva   "|||2017-10-11 02:38:07.7835|2017-10-11 02:38:07.7835
NCT01663285|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-11-04|2014-09-11||September 2012||2012-09-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)|Phase II Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)|Terminated||Phase 2|1|Actual|University of Michigan Cancer Center|The study was terminated prematurely due to poor patient accrual. Study objectives were not analyzed.|1||Low study participant enrollment.|f||||t||||||||||2017-10-11 02:38:07.915276|2017-10-11 02:38:07.915276
NCT01663259|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-03-03|||June 2010||2010-06-01|March 2017|2017-03-01|January 2021|Anticipated|2021-01-01|June 2020|Anticipated|2020-06-01||Interventional|||Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients|Reduced-intensity Therapy for Advanced Oropharyngeal Cancer in Non-smoking Human Papilloma Virus (HPV)-16 Positive Patients|Active, not recruiting||N/A|43|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 02:38:08.222659|2017-10-11 02:38:08.222659
NCT01663246|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-08-14|||April 2006||2006-04-01|August 2014|2014-08-01|December 2008|Actual|2008-12-01|October 2007|Actual|2007-10-01||Interventional|||Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer|Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer|Completed||N/A|50|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 02:38:08.292903|2017-10-11 02:38:08.292903
NCT01663233|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-10-01|2015-07-21||August 2012||2012-08-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine|A Randomized, 8-week, Double-blind, Parallel-group, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Patients With Essential Hypertension Not Adequately Responsive to Amlodipine 5 mg Monotherapy Treatment|Completed||Phase 3|266|Actual|Novartis||2|||f||||t||||||||||2017-10-11 02:38:08.376216|2017-10-11 02:38:08.376216
NCT01663220|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2013-08-13|||May 2012||2012-05-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus|Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus|Completed||N/A|20|Anticipated|Foundation for the National Institutes of Health|||1||f||||f||||||||||2017-10-11 02:38:09.004179|2017-10-11 02:38:09.004179
NCT01663207|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2014-07-14|||May 2012||2012-05-01|August 2012|2012-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes|Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes|Completed||N/A|20|Anticipated|Foundation for the National Institutes of Health|||1||f||||f||||||||||2017-10-11 02:38:09.117525|2017-10-11 02:38:09.117525
NCT01663194|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2012-08-13|||January 2000||2000-01-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Neutrophil/Lymphocyte (N/L) Ratio and Long Term Follow-up in ST-elevation Myocardial Infarction|Observational Study of N/L Ratio in Patients With STEMI|Completed||N/A|1034|Actual|TC Erciyes University|||3||f||||f||||||Samples Without DNA|"     serum and plasma of blood   "|||2017-10-11 02:38:09.215908|2017-10-11 02:38:09.215908
NCT01663181|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2016-08-10|||May 2009||2009-05-01|August 2016|2016-08-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Observational|||Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study|Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study|Completed||N/A|109|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 02:38:09.304244|2017-10-11 02:38:09.304244
NCT01663168|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-08-08|||December 2011||2011-12-01|August 2012|2012-08-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||EARNEST Rifabutin Pharmacokinetics (PK) Substudy|Toxicity and Pharmacokinetics of Different Rifabutin Doses in HIV-infected Adults and Adolescents Taking Lopinavir / Ritonavir as Second-line Anti-retroviral Therapy (ART) (EARNEST Rifabutin PK Substudy)|Unknown status|Recruiting|Phase 2|140|Anticipated|Medical Research Council||2|||f||||f||||||||||2017-10-11 02:38:09.387882|2017-10-11 02:38:09.387882
NCT01663155|ClinicalTrials.gov processed this data on October 10, 2017|2008-11-10|2017-05-17|||September 2008||2008-09-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Chest Imaging, Breath, and Biomarkers in a Screening Trial|A Clinical Trial to Develop Chest Imaging, Breath, and Biomarkers in a Screening Trial|Completed||N/A|1424|Actual|The Cleveland Clinic|||1||f||||t||||||Samples With DNA|"     Blood draw includes 2 10 mL red top tubes for serum retrieval, and 2 7 mL EDTA tubes for     plasma and buffy coat retrieval   "|||2017-10-11 02:38:09.568694|2017-10-11 02:38:09.568694
NCT01663142|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-10-30|||October 2010||2010-10-01|May 2010|2010-05-01|December 2017|Anticipated|2017-12-01|October 2013|Actual|2013-10-01||Observational|||Early Postoperative Recurrence in Crohn's Disease: Predictors of Research Targeting the Constitutional Mutation of IRGM|Early Postoperative Recurrence in Crohn's Disease: Predictors of Research Targeting the Constitutional Mutation of IRGM|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||Samples With DNA|"     Lesional tissue samples and healthy in cryotubes, taken from surgical specimens or biopsies.   "|||2017-10-11 02:38:09.659666|2017-10-11 02:38:09.659666
NCT01663129|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-09-26|||January 2005||2005-01-01|September 2017|2017-09-01|March 6, 2014|Actual|2014-03-06|March 6, 2014|Actual|2014-03-06||Observational|STOPP-CIS||Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study|Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study (STOPP-CIS)|Completed||N/A|406|Actual|Children's Hospital of Eastern Ontario|||3||f||||f||||||||||2017-10-11 02:38:09.760708|2017-10-11 02:38:09.760708
NCT01663116|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-03-05|||March 2011||2011-03-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients|"Phase Ib/IIa, Escalating Dose, Single Blind, Clinical Trial to Assess the Safety of the i.v Administration of Allogeneic Adipose-derived Mesenchymal Cells (eASCs) to Refractory Rheumatoid Arthritis (RA) Patients."|Completed||Phase 1/Phase 2|53|Actual|Cellerix||2|||f||||t||||||||||2017-10-11 02:38:09.900271|2017-10-11 02:38:09.900271
NCT01663103|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-08-02|2016-04-06||August 2012||2012-08-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)|Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)|Completed||Phase 4|42|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 02:38:10.071976|2017-10-11 02:38:10.071976
NCT01663090|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-28|2016-11-21|||September 2012||2012-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas|Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations|Withdrawn||N/A|0|Actual|Dana-Farber Cancer Institute||1||Inability to accrue.|f||||t||||||||||2017-10-11 02:38:10.469088|2017-10-11 02:38:10.469088
NCT01663064|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-06-30|||June 2012||2012-06-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|October 2015|Actual|2015-10-01||Interventional|PBCT||Zenith® p-Branch™: Single-Center Study|Zenith® p-Branch™: Single-Center Study|Active, not recruiting||N/A|23|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 02:38:10.647979|2017-10-11 02:38:10.647979
NCT01663051|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-10-31|||November 2012||2012-11-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|VIVO EU||Evaluation of the Zilver® Vena™ Venous Stent|Evaluation of the Zilver® Vena™ Venous Stent|Completed||N/A|35|Actual|Cook Group Incorporated|||1||f||||||||||||||2017-10-11 02:38:10.720872|2017-10-11 02:38:10.720872
NCT01663038|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-20|2012-08-10|||December 2010||2010-12-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|January 2011|Actual|2011-01-01||Interventional|||Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination|Comparative Pharmacokinetics of Clopidogrel 75mg and Aspirin 100mg After Single Oral Administration as a Fixed Dose Combination Versus Separate Combination in Healthy Male Volunteers|Completed||Phase 1|60|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:38:10.810739|2017-10-11 02:38:10.810739
NCT01663025|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-05-16|||January 2013||2013-01-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||The Effects of Intra Operative Hand Reflexology for Patients Receiving Out Patient Vein Surgery|Evaluating The Effects Of Intra Operative Hand Reflexology on Pain and Anxiety During Out Patient Vein Surgery|Completed||N/A|100|Actual|The Whiteley Clinic||2|||f||||t||||||||||2017-10-11 02:38:10.904432|2017-10-11 02:38:10.904432
NCT01663012|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-01-25|2015-05-28||July 2012||2012-07-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma|A Phase II, Single Arm, Open Label Study Of NKTR-102 In Bevacizumab-Resistant High Grade Glioma|Completed||Phase 2|20|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 02:38:11.123286|2017-10-11 02:38:11.123286
NCT01662999|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-04-21|2013-11-01||August 2012||2012-08-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants|A Single-dose, Open-label, Randomized, 3 Period, 3 Treatment Crossover Study to Evaluate the Pharmacokinetics of Saxagliptin 5 mg and Dapagliflozin 10 mg When Coadministered to Fasted Healthy Subjects|Completed||Phase 1|42|Actual|AstraZeneca||6|||f||||f||||||||||2017-10-11 02:38:11.519384|2017-10-11 02:38:11.519384
NCT01662986|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-09|2015-07-17|2015-04-24||August 2012||2012-08-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Treated set (TS): The treated set included all patients randomized and who took at least one dose of the study drug.|Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2|A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multi Center Study to Assess the Safety and Efficacy of Tiotropium Bromide (18 µg) Delivered Via the HandiHaler® in Chronic Obstructive Pulmonary Disease (COPD) Subjects Recovering From Hospitalization for an Acute Exacerbation (Hospital Discharge Study 2)|Completed||Phase 4|79|Actual|Boehringer Ingelheim|The original protocol planned to randomize 604 subjects. However this was not reached due to low patient enrollment.|2|||f||||||||||||||2017-10-11 02:38:12.803135|2017-10-11 02:38:12.803135
NCT01662973|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2013-05-30|||October 2011||2011-10-01|May 2013|2013-05-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis|Phase 1/2 Study of UC-MSC Treatment for Evaluation the Efficacy and Safety in Patients With Primary Biliary Cirrhosis|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||||2017-10-11 02:38:15.075103|2017-10-11 02:38:15.075103
NCT01662960|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-04-03|||September 7, 2012|Actual|2012-09-07|April 2017|2017-04-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke|Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke|Completed||N/A|72|Actual|Albert Einstein Healthcare Network||2|||f||||f||||||||||2017-10-11 02:38:15.17915|2017-10-11 02:38:15.17915
NCT01662947|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-08|||May 2012||2012-05-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|WristBPM01||Clinical Study of Wrist Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 Standard|Verify Wrist BPM TMB-1117 to Comply With ANSI/AAMI SP10|Completed||N/A|85|Actual|BTS International||2|||f||||f||||||||||2017-10-11 02:38:15.258593|2017-10-11 02:38:15.258593
NCT01662921|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-05-18|||April 2013||2013-04-01|May 2015|2015-05-01|October 2017|Anticipated|2017-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes|Non-inferiority Trial Comparing Insulin Glulisine to Insulin Lispro as Part of a Basal-bolus Insulin Regimen for the Treatment of Gestational Diabetes.|Unknown status|Active, not recruiting|Phase 2|74|Anticipated|William Sansum Diabetes Center||2|||f||||f||||||||||2017-10-11 02:38:15.429332|2017-10-11 02:38:15.429332
NCT01662908|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-05-11|2016-09-28||August 2012|Actual|2012-08-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|eTRIS||A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis|A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis - Edoxaban Thrombus Reduction Imaging Study|Completed||Phase 2|85|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 02:38:15.667914|2017-10-11 02:38:15.667914
NCT01662895|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-09-10|||March 2013|Actual|2013-03-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|HI-DEF||High-Dose Deferoxamine in Intracerebral Hemorrhage|Futility Study of Deferoxamine in Intracerebral Hemorrhage|Suspended||Phase 2|324|Anticipated|Beth Israel Deaconess Medical Center||2||By DSMB due to increased incidence of ARDS. See modified protocol [NCT02175225|f||||t||||||||||2017-10-11 02:38:16.481292|2017-10-11 02:38:16.481292
NCT01662882|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-07-16|2013-07-16||October 2012||2012-10-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)|An Open Label, Parallel Group, Multicenter Study, Evaluating the Safety and Imaging Characteristics of Florbetapir (18F) in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)|Completed||Phase 2/Phase 3|48|Actual|Avid Radiopharmaceuticals||3|||f||||||||||||||2017-10-11 02:38:16.684685|2017-10-11 02:38:16.684685
NCT01662869|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-11-01|||November 2012||2012-11-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer|A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Onartuzumab (MetMAb) in Combination With 5-Fluorouracil, Folinic Acid, and Oxaliplatin (mFOLFOX6) in Patients With Metastatic HER2-Negative, MET-Positive Gastroesophageal Cancer|Completed||Phase 3|564|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:38:17.075499|2017-10-11 02:38:17.075499
NCT01662856|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-02-21|2016-12-16||August 2012||2012-08-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery|A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Peripheral Vascular Surgery|Completed||Phase 3|225|Actual|Grifols Biologicals Inc.||2|||f||||||||||||||2017-10-11 02:38:17.575897|2017-10-11 02:38:17.575897
NCT01662843|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-08-13|||October 2011||2011-10-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|BRIPPED||BRIPPED Scan for Evaluation of Emergency Department (ED) Patients With Shortness of Breath|BRIPPED Scan for Evaluation of Emergency Department Patients With Shortness of Breath|Completed||N/A|104|Actual|Eastern Virginia Medical School|||2||f||||t||||||||||2017-10-11 02:38:18.311816|2017-10-11 02:38:18.311816
NCT01662830|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-08|||April 2010||2010-04-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||A Retrospective Chart Review of Three Medifast Weight Control Centers|Use of the Medifast Meal Replacement Program for Weight Loss in Obese Patients: A Restrospective Chart Review of Three Medifast Weight Control Centers (MWCC)|Completed||N/A|446|Actual|Medifast, Inc.|||1||f||||f||||||||||2017-10-11 02:38:18.390325|2017-10-11 02:38:18.390325
NCT01662817|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-08-08|||September 2009||2009-09-01|August 2012|2012-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Major Depressive Disorder (MDD)|Effectiveness of Physicians' Education, Implementation and Follow up of Current Recommendations Regarding Screening for Major Depressive Disorder in High Risk Patients on Improving the Under-Recognition Rates of Depression in Primary Care|Completed||N/A|525|Actual|Eli Lilly and Company|||2||f||||f||||||||||2017-10-11 02:38:18.470998|2017-10-11 02:38:18.470998
NCT01662375|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-10-20|||August 2012||2012-08-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|October 2013|Actual|2013-10-01||Observational|MIII||A Prospective Study Evaluating the Feasibility and Ethical Perspective of Maastricht III Organ Procurement in French Intensive Care Unit Patients||Completed||N/A|29|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 02:38:27.610137|2017-10-11 02:38:27.610137
NCT01662804|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-06-07|||August 2012||2012-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors|Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors|Active, not recruiting||Phase 1|14|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:38:18.563332|2017-10-11 02:38:18.563332
NCT01662791|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-06-23|2015-12-16||September 2012||2012-09-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth|Weight Loss in Parkinson's Disease and the Potential Role of Small Bowel Bacterial Overgrowth|Completed||Phase 3|49|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:38:18.675212|2017-10-11 02:38:18.675212
NCT01662765|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-12-23|2016-01-18||November 2003||2003-11-01|December 2016|2016-12-01|May 2012|Actual|2012-05-01|May 2010|Actual|2010-05-01||Interventional|||Conservative Versus Surgical Treatment of Umbilical Pilonidal Disease|Conservative Versus Surgical Treatment of Umbilical Pilonidal Sinus Disease: A Prospective, Randomised, and Multicenter Clinical Trial|Completed||N/A|84|Actual|Medical Park Gaziantep Hospital||2|||f||||t||||||||No||2017-10-11 02:38:19.526331|2017-10-11 02:38:19.526331
NCT01662752|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-02-17|||May 2013||2013-05-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Lymphatic Mapping for Sentinel Node Identification and Analysis|A Study to Assess Near Infrared Laparoscopy With Indocyanine Green (ICG) for Intraoperative Lymphatic Imaging and Sentinel Lymph Node Identification During Standard Surgical Resection for Colonic Cancer|Completed||Phase 2|30|Actual|Imperial College London||1|||f||||t||||||||No||2017-10-11 02:38:19.967679|2017-10-11 02:38:19.967679
NCT01662739|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-03-03|||January 2010||2010-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Cremona Population-Based Gastric Tumors Registry|Epidemiological, Clinical and Pathological Characteristics of Gastric Tumors. The Population Based Specialized Registry in Northern Italy|Recruiting||N/A|1000|Anticipated|Medicina e Arte Onlus|||1||f||||t||||||Samples With DNA|"     Blood and Cancer Tissue Sample   "|||2017-10-11 02:38:20.079351|2017-10-11 02:38:20.079351
NCT01662726|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-03-11|||August 2012||2012-08-01|August 2013|2013-08-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|IPET||A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth|A Phase II, Open Label, Preoperative Study to Assess the Efficacy of the Novel Steroid Sulfatase Inhibitor Irosustat in Postmenopausal Women With Early Oestrogen Receptor Positive Breast Cancer|Terminated||Phase 2|13|Actual|Imperial College London||1||"Recruitment challenging: lack of suitable pts; recruiting so soon after diagnosis; competing   studies. Funding ended despite extensions to grant."|f||||f||||||||No||2017-10-11 02:38:20.182363|2017-10-11 02:38:20.182363
NCT01662713|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-08-07|||March 1, 2017|Actual|2017-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|OFDI||Optical Frequency Domain Imaging for Non-melanoma Skin Cancers|Optical Frequency Domain Imaging for Non-melanoma Skin Cancers|Recruiting||N/A|90|Anticipated|Massachusetts General Hospital||1|||f||||f|f|f||||||||2017-10-11 02:38:20.279097|2017-10-11 02:38:20.279097
NCT01662700|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2013-01-24|||October 2012||2012-10-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in Thailand|An Open Label Randomized Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in Thailand|Unknown status|Recruiting|Phase 4|120|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 02:38:20.373422|2017-10-11 02:38:20.373422
NCT01662687|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2012-08-15|||February 2012||2012-02-01|August 2012|2012-08-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Interventional|||Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)|Randomized Study of the Efficacy and Safety of Transdermal Granisetron Compared With Intravenous and Oral Agent in the Control of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy|Unknown status|Recruiting|Phase 4|276|Anticipated|LG Life Sciences||2|||f||||f||||||||||2017-10-11 02:38:20.550264|2017-10-11 02:38:20.550264
NCT01662674|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-04-02|||October 2012||2012-10-01|April 2015|2015-04-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone|A Randomized, Open-label, Oral Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered in Healthy Male Volunteers|Completed||Phase 1|27|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 02:38:20.663982|2017-10-11 02:38:20.663982
NCT01662661|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2013-07-22|||July 2012||2012-07-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy Participants|A Phase I, Open-Label, Randomized, 2-way Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of a Single Oral Dose of JNJ-47910382 Formulated as a Tablet and as a Suspension|Completed||Phase 1|14|Actual|Janssen R&D Ireland||2|||f||||f||||||||||2017-10-11 02:38:20.737666|2017-10-11 02:38:20.737666
NCT01662648|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-04-17|2013-12-17||June 2007||2007-06-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia|An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia|Completed||Phase 3|1117|Actual|Janssen Pharmaceutica||2|||f||||f||||||||||2017-10-11 02:38:20.844732|2017-10-11 02:38:20.844732
NCT01662362|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-01-08|2014-01-08||July 2012||2012-07-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ESA|Donor specimens PRISM Chagas Repeatly Reactive|Abbott ESA Chagas Assay Post-Market Study|Abbott ESA Chagas Assay Post-Market Study|Completed||N/A|63|Actual|Abbott Diagnostics Division||1|||f||||f||||||||||2017-10-11 02:38:27.689172|2017-10-11 02:38:27.689172
NCT01662635|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2016-08-29|2014-09-23||February 2011||2011-02-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|ALK|The population evaluated included mexican patients, females and males, with ages between 18 and 80 years old, who had advanced lung cancer, who were referred to the Instituto Nacional de Cancerología in Mexico, between February 01, 2011 and September 01, 2014|Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)|CLINICOPATHOLOGICAL FEATURES OF NON-SMALL CELL LUNG CANCER PATIENTS ASSOCIATED WITH THE CHOROMOSOME 2p (EML4-ALK) INVERSION IN MEXICAN POPULATION.|Completed||N/A|230|Actual|Instituto Nacional de Cancerologia de Mexico|There were no limitations in obtaining the planned number of samples. Two-hundred and thirty patients with advanced NSCLC were analyzed by FISH. Among the FISH tests performed, 30 were not evaluable due to scarce samples.||1||f||||f||||||Samples With DNA|"     FISH studies were performed in 3-mm to 4-mm thick paraffin sections from 230 NSCLCs and 1     ALCL specimen with t(2;5) that was used as a positive control for the break-apart detection.      48 patients were analyzed for the presence of EML4-ALK gene fusion variants using the RNA     from frozen tissue sections   "|Undecided||2017-10-11 02:38:21.723474|2017-10-11 02:38:21.723474
NCT01662622|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2012-08-12|||March 2012||2012-03-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Minimal Alveolar Concentration of Sevoflurane Inducing Isoelectric Electroencephalogram|Minimal Alveolar Concentration of Sevoflurane Inducing Isoelectric Electroencephalogram|Completed||Phase 4|31|Actual|Huazhong University of Science and Technology||1|||f||||t||||||||||2017-10-11 02:38:22.101513|2017-10-11 02:38:22.101513
NCT01662609|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-06-30|||June 1, 2007|Actual|2007-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer|Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer at Moffitt Cancer Center and Lehigh Valley Hospital|Recruiting||N/A|75|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||1||f||||f||||||||||2017-10-11 02:38:22.189582|2017-10-11 02:38:22.189582
NCT01662596|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-08|||August 2012||2012-08-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|September 2012|Anticipated|2012-09-01||Observational|||Detection of Risk Factors for Fetal Anomalies in a Rural Hospital Population|Detection of Risk Factors for Fetal Anomalies in a Rural Hospital Population|Unknown status|Not yet recruiting|N/A|320|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 02:38:22.296407|2017-10-11 02:38:22.296407
NCT01662583|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-07-19|2015-05-17||September 2012||2012-09-01|July 2015|2015-07-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children|Pragmatic Clinical Trial of Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children|Completed||N/A|660|Actual|Columbia University||3|||f||||f||||||||||2017-10-11 02:38:22.385729|2017-10-11 02:38:22.385729
NCT01662570|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-14|||March 2008||2008-03-01|November 2011|2011-11-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Beverage Choice and Lifestyle Modification in Overweight Youth|Beverage Choice and Lifestyle Modification in Overweight Youth|Completed||N/A|65|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 02:38:22.74526|2017-10-11 02:38:22.74526
NCT01662557|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-14|||February 2008||2008-02-01|January 2011|2011-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Treatment of Early Childhood Overweight in Primary Care: Pilot Study|Treatment of Early Childhood Overweight in Primary Care: Pilot Study|Completed||N/A|51|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 02:38:22.852296|2017-10-11 02:38:22.852296
NCT01662544|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-07-18|||August 2012||2012-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|May 2015|Actual|2015-05-01||Interventional|HHFNC||Heated High Flow Oxygen Use in Infants With Bronchiolitis and Hypoxia|Comparison of Heated Humidified High-flow Nasal Cannula (HHFNC) Versus Standard Nasal Cannula Oxygen Delivery on Respiratory Distress and Length of Stay in Infants With Bronchiolitis and Hypoxia|Active, not recruiting||N/A|56|Actual|Children's Hospitals and Clinics of Minnesota||2|||f||||t||||||||||2017-10-11 02:38:22.99276|2017-10-11 02:38:22.99276
NCT01662531|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-04-03|2016-04-03|2015-11-05|January 2013||2013-01-01|April 2016|2016-04-01||||October 2014|Actual|2014-10-01||Interventional||All 27 subjects were included in the Safety, Pharmacokinetic and Efficacy populations.|A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B|A Phase III Open-label, Multicenter, Pharmacokinetic, Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Previously Treated Children With Hemophilia B|Completed||Phase 3|27|Actual|CSL Behring||1|||f||||||||||||||2017-10-11 02:38:23.108975|2017-10-11 02:38:23.108975
NCT01662518|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-01-30|||July 2011||2011-07-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|DDS-25||DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)|A Safety and Efficacy Study to Assess DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)|Completed||Phase 1/Phase 2|10|Actual|Centro de Pesquisa Rubens Siqueira||1|||f||||f||||||||Yes|"Retin Cases Brief Rep. 2016 Sep 14. [Epub ahead of print] SAFETY AND FEASIBILITY OF A NOVEL 25-GAUGE BIODEGRADABLE IMPLANT OF DEXAMETHASONE FOR TREATMENT OF MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION: A PHASE I CLINICAL TRIAL.
Cunha RB1, Siqueira RC, Messias A, Scott IU, Fialho SL, Cunha-Junior AD, Jorge R."|2017-10-11 02:38:23.732267|2017-10-11 02:38:23.732267
NCT01662505|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2015-07-30|||August 2012||2012-08-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)|An Open Label, Phase I Trial of Intravenous Once Every 2 Weeks Administration of BI 6727 (Volasertib) in Japanese Patients With Acute Myeloid Leukemia|Completed||Phase 1|19|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:38:23.824713|2017-10-11 02:38:23.824713
NCT01662492|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-08-03|2017-08-03||October 2012||2012-10-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine|191622-103 BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Adolescents (Children 12 to < 18 Years of Age) With Chronic Migraine|Completed||Phase 3|125|Actual|Allergan||3|||f||||t||||||||||2017-10-11 02:38:23.94109|2017-10-11 02:38:23.94109
NCT01660945|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-11-01|||July 2011||2011-07-01|August 2012|2012-08-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|||Vascular and Metabolic Effects of Vytorin||Completed||Phase 4|204|Actual|Gachon University Gil Medical Center||3|||f||||t||||||||||2017-10-11 02:38:50.896554|2017-10-11 02:38:50.896554
NCT01661361|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2012-08-08|||September 2012||2012-09-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Optimalisation of Therapeutic Drug Monitoring (TDM) of Vancomycin in Patients With Central Venous Port Devices|Optimalisation of Therapeutic Drug Monitoring (TDM) of Vancomycin in Patients With Central Venous Port Devices|Unknown status|Not yet recruiting|N/A|15|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"     blood samples   "|||2017-10-11 02:38:24.599421|2017-10-11 02:38:24.599421
NCT01661348|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2013-10-15|||July 2012||2012-07-01|October 2013|2013-10-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||The Use of the Prevena Incision Management System to Reduce Post-operative Cesarean Delivery Wound Complications|Reduction of Post Operative Wound Complications in Patients Undergoing Cesarean Delivery With the Use of the Prevena Incision Management System|Withdrawn||N/A|0|Actual|University of Oklahoma|||2|Did not receive funding.|f||||f||||||||||2017-10-11 02:38:24.691029|2017-10-11 02:38:24.691029
NCT01661335|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-03-29|||June 1, 2012|Actual|2012-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Aprepitant (Emend®) in Children|Efficacy of Aprepitant (Emend®) in Children Receiving Highly Emetogenic Chemotherapy|Recruiting||Phase 3|50|Anticipated|University of Oklahoma||2|||f||||t|t|f||||||No||2017-10-11 02:38:24.763703|2017-10-11 02:38:24.763703
NCT01661322|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-07-26|||April 2009||2009-04-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|TARDIS||Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke|Safety and Efficacy of Intensive Versus Guideline Antiplatelet Therapy in High Risk Patients With Recent Ischaemic Stroke or Transient Ischaemic Attack: a Randomised Controlled Trial|Terminated||Phase 3|3096|Actual|University of Nottingham||2||Trial reached a definitive answer ahead of full recruitment.|f||||t||||||||Undecided||2017-10-11 02:38:24.890991|2017-10-11 02:38:24.890991
NCT01661309|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-05-18|||March 2012||2012-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians - Clinical Trial|To Critically Investigate and Evaluate Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians, Who May Have a Resultant Susceptibility to Hyperhomocysteinemia Related Diseases.|Completed||N/A|50|Actual|University of West London||2|||f||||t||||||||||2017-10-11 02:38:25.01956|2017-10-11 02:38:25.01956
NCT01661296|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-31|||August 2009||2009-08-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India|An Open Label Study of RFH Therapy as Treatment for CL Caused by Leishmania Tropica in India|Completed||Phase 4|100|Actual|Sarder Patel Medical College||2|||f||||t||||||||||2017-10-11 02:38:25.142893|2017-10-11 02:38:25.142893
NCT01662479|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2017-05-02|||September 2012||2012-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:38:25.229912|2017-10-11 02:38:25.229912
NCT01662466|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-01-13|||July 2012||2012-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Testosterone Treatment on Embryo Quality|A Randomized Double Blind Control Trial of Transdermal Testosterone Supplementation vs Placebo on Follicular Development and Atresia, Oocyte and Embryo Quality Among Women With Diminished Ovarian Reserve Undergoing in Vitro Fertilization|Recruiting||Phase 1/Phase 2|180|Anticipated|Center for Human Reproduction||2|||f||||t||||||||Undecided||2017-10-11 02:38:25.278862|2017-10-11 02:38:25.278862
NCT01662453|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-07-07|||June 2011||2011-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SUDEP||Risk Factors for Sudden Unexplained Death in Epilepsy|Risk Factors for Sudden Unexplained Death in Epilepsy (SUDEP)|Recruiting||N/A|400|Anticipated|New York University School of Medicine|||2||f||||f||||||Samples With DNA|"     If the family is willing to donate tissue, the family's permission is recorded in writing and     it is filed in the subject's study record. The family can contact Autism Tissue Program (ATP)     themselves or we will transfer the call to the ATP for them. The ATP has a 24/7 on call duty     in place to receive new donors. The ATP coordinator will facilitate the donation process by     coordinating with the family, medical examiner's office or hospital. The coordinator will     also communicate to the research assistant when the donation is complete. In the case the     participant does not want to donate tissue, but would like to donate other DNA samples, they     will be able to do so through the NYU Biorepository. The participant will be consented, by     research personnel, with the specific DNA collection consent form. Mucosal swaps or blood     samples will be collected if available, if neither is available, we will collect hair or     nails.   "|||2017-10-11 02:38:25.419758|2017-10-11 02:38:25.419758
NCT01662427|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-08-18|||November 2012||2012-11-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Nocturnal Parkinson's Disease Symptoms Study Group|Nocturnal Parkinson's Disease Symptoms Study Group|Completed||N/A|300|Actual|Chulalongkorn University|||1||f||||||||||||||2017-10-11 02:38:27.271103|2017-10-11 02:38:27.271103
NCT01662414|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-09-27|||April 2011||2011-04-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease|Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function|Completed||Phase 4|38|Actual|Chulalongkorn University||2|||f||||||||||||||2017-10-11 02:38:27.336945|2017-10-11 02:38:27.336945
NCT01662401|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-06-28|||May 2008||2008-05-01|August 2012|2012-08-01||||January 2010|Actual|2010-01-01||Interventional|||Postoperative Pain Control in Children Undergoing Laparoscopic Appendectomy: Peripheral Nerve Block Versus Local Anesthetic|Postoperative Pain Control in Children Undergoing Laparoscopic Appendectomy: Comparison of Peripheral Nerve Blocks to Local Anesthetic|Completed||Phase 2|66|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 02:38:27.430659|2017-10-11 02:38:27.430659
NCT01662349|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-09-12|||August 2012||2012-08-01|September 2017|2017-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety Study of Plasma Treatment System to Treat Back Acne|A Single Center, Pilot Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of the Plasma Treatment System in Treating Back Acne|Terminated||N/A|8|Actual|Moe Medical Devices||1||The study was stopped due to other research priorities.|f||||||||||||||2017-10-11 02:38:27.893876|2017-10-11 02:38:27.893876
NCT01662323|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-11-13|||June 2009||2009-06-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|TOPHU||Study to Improve the Treatment of Patients With Heart Failure by General Practitioners|Therapy OPtimization Heart Failure Utrecht|Completed||Phase 4|683|Actual|Julius Center||2|||f||||f||||||||||2017-10-11 02:38:28.063356|2017-10-11 02:38:28.063356
NCT01662310|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-09-15|2014-04-30||June 2011||2011-06-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia|Paliperidone Extended Release Tablets for the Prevention of Relapse in Subjects With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study|Completed||Phase 3|201|Actual|Janssen Research & Development, LLC|Independent Data Monitoring Committee (IDMC) conducted an interim analysis after 61st relapse in double-blind (DB) phase and DB phase completed on 09-Nov-2012 based on positive results of interim analysis.|3|||f||||t||||||||||2017-10-11 02:38:28.279478|2017-10-11 02:38:28.279478
NCT01662284|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-01-30|||July 2012||2012-07-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Study of 124I-NM404 in Advanced Solid Malignancies|A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies|Terminated||N/A|12|Actual|University of Wisconsin, Madison|||9|Sponsor determined this trial does not support their anticipated clinical development program.|f||||t||||||||||2017-10-11 02:38:29.295838|2017-10-11 02:38:29.295838
NCT01662271|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-09-14|||July 2012|Actual|2012-07-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|YES||Course of Obesity and Extreme Obesity in Adolescents|Course of Obesity and Extreme Obesity in Adolescents, in the Context of Different Treatment Options - a Longitudinal Prospective Observation Study|Active, not recruiting||N/A|429|Actual|University of Ulm|||2||f||||t||||||Samples With DNA|"     Samples of fasting plasma, serum, DNA, and urine will be retained.   "|||2017-10-11 02:38:29.400722|2017-10-11 02:38:29.400722
NCT01662258|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-04-18|||October 2012||2012-10-01|April 2016|2016-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|NIHCAP||Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP|Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For Community-Acquired Pneumonia|Withdrawn||N/A|0|Actual|University of Pittsburgh||2||Decision by NIH|f||||t||||||||||2017-10-11 02:38:29.515675|2017-10-11 02:38:29.515675
NCT01662232|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-02-02|||August 2012||2012-08-01|February 2016|2016-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Improvement of Endothelial Function by EGCG|The Role of EGCG in Different Application Forms on Flow-mediated Dilation in Healthy Volunteers|Completed||N/A|50|Actual|Charite University, Berlin, Germany||4|||f||||f||||||||||2017-10-11 02:38:29.623218|2017-10-11 02:38:29.623218
NCT01662219|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-08-18|||August 2012||2012-08-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|QoR||Effect of Superficial Cervical Plexus Block on the Postoperative Quality of Recovery|Effect of Superficial Cervical Plexus Block on the Postoperative Quality of Recovery After Anterior Cervical Discectomy and Fusion|Completed||N/A|46|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 02:38:29.721004|2017-10-11 02:38:29.721004
NCT01662206|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2013-04-15|||July 2012||2012-07-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Probiotics (L. Gasseri, B. Bifidum, B. Longum) on Immune and Intestinal Health in Healthy Older Adults|Probiotics (Lactobacillus Gasseri, Bifidobacterium Bifidum, Bifidobacterium Longum) on Immune and Intestinal Health in Healthy Older Adults|Completed||N/A|46|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 02:38:29.849745|2017-10-11 02:38:29.849745
NCT01662193|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2012-08-10|||February 2012||2012-02-01|August 2012|2012-08-01||||February 2013|Anticipated|2013-02-01||Interventional|||Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic Patients|Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic Patients|Unknown status|Recruiting|N/A|120|Anticipated|Isfahan University of Medical Sciences||4|||f||||t||||||||||2017-10-11 02:38:29.968165|2017-10-11 02:38:29.968165
NCT01662180|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-12-12|||December 2012||2012-12-01|December 2012|2012-12-01|March 2015|Anticipated|2015-03-01|September 2014|Anticipated|2014-09-01||Observational|||Predicting Ovarian Response in Artificial Insemination With Low Stimulation|Predicting Ovarian Response in Artificial Insemination With Low Stimulation|Unknown status|Recruiting|N/A|510|Anticipated|Isala|||1||f||||f||||||Samples With DNA|"     blood sample tested for FSH, E2 and AMH   "|||2017-10-11 02:38:30.146159|2017-10-11 02:38:30.146159
NCT01662167|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2012-08-09|||January 2008||2008-01-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy|Comparison of Single and Multiple-dose Methotrexate Therapy for Ectopic Pregnancy: a Clinical Trail|Completed||Phase 4|87|Actual|Hormozgan University of Medical Sciences||2|||f||||||||||||||2017-10-11 02:38:30.350892|2017-10-11 02:38:30.350892
NCT01662154|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-05-21|||July 2012||2012-07-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|July 2013|Actual|2013-07-01||Interventional|||Neurometer vs Nerve Stimulator: Block Patients|Percutaneous Nerve Stimulation as a Means to Assess Nerve Block Effectiveness|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 02:38:30.465935|2017-10-11 02:38:30.465935
NCT01662141|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-07|||February 2010||2010-02-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Measure Cardiac Output Using Ultrasound Dilution in Mechanically Ventilated Children|Investigation of the Reliability to Measure Cardiac Output by a New Ultrasound Dilution Method in Mechanically Ventilated Children After Pediatric Cardiac Surgery|Completed||N/A|33|Actual|Transonic Systems Inc.|||1||f||||f||||||||||2017-10-11 02:38:30.546721|2017-10-11 02:38:30.546721
NCT01662128|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-07|||June 2012||2012-06-01|August 2012|2012-08-01|June 2022|Anticipated|2022-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer|Randomized Controlled Trials of Efficacy and Safety With Xeloda as Sequential Adjuvant Therapy After Chemotherapy of Anthracycline and/or Taxane in Breast Cancer of Triple Negative or HER-2 Positive or Axillary Lymph Node Metastasis ≥4|Recruiting||Phase 2/Phase 3|600|Anticipated|Tianjin Medical University||1|||f||||t||||||||||2017-10-11 02:38:30.619161|2017-10-11 02:38:30.619161
NCT01662115|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-08-21|2017-04-13||August 2012||2012-08-01|August 2017|2017-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Nicotine Gum Recovery After Colorectal Surgery|Does Nicotine Gum Enhance Bowel Recovery After Colorectal Surgery?|Terminated||Phase 4|4|Actual|The Cleveland Clinic|Principal Investigator decided for an early termination of the enrollment period due to small numbers of subjects consented, with limited data to make conclusions.|3||"Study has been terminated due linability to recruit the targeted participants. Aimed for 300   participants and only 4 were enrolled after 1 year."|f||||f||||||||||2017-10-11 02:38:30.739666|2017-10-11 02:38:30.739666
NCT01662102|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2015-12-04|2015-10-16||September 2012||2012-09-01|December 2015|2015-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Patients who received at least one dose of Zevalin.|Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)|An Open-Label, Multicenter, Randomized Study in Previously Untreated Follicular Lymphoma Patients to Evaluate the Efficacy of Consolidation With Zevalin® Versus Maintenance Treatment With Rituximab After Initial Therapeutic Response to Rituximab Plus Chemotherapy|Terminated||Phase 3|1|Actual|Spectrum Pharmaceuticals, Inc||2||Sponsor decision|f||||f||||||||||2017-10-11 02:38:31.188537|2017-10-11 02:38:31.188537
NCT01662089|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2012-08-07|||January 2012||2012-01-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement|A Pilot Study of the Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Oral Chelated Zinc Supplement|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Siriraj Hospital||2|||f||||t||||||||||2017-10-11 02:38:31.57131|2017-10-11 02:38:31.57131
NCT01662076|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-05-19|||August 2012||2012-08-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Homeopathic Treatment of Fatigue in Children Receiving Chemotherapy|A Feasibility Pilot Trial of Individualized Homeopathic Treatment of Fatigue in Children Receiving Chemotherapy|Completed||Phase 3|9|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 02:38:31.677903|2017-10-11 02:38:31.677903
NCT01662063|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-08-17|2016-05-23||August 2012||2012-08-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional||Safety Population: All participants who received at least one dose of study medication and had at least one post-dose safety assessment.|A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)|A Multicenter Open-Label, Long-Term Extension Study of WA22762 and NA25220 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|218|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 02:38:31.837171|2017-10-11 02:38:31.837171
NCT01662037|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2012-08-07|||January 2010||2010-01-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|September 2011|Actual|2011-09-01||Interventional|||Bosentan Therapy in Children With Functional Single Ventricle|Bosentan Therapy for High Risk Staged Fontan Procedure in Children With Functional Single Ventricle|Completed||Phase 2|34|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 02:38:35.287633|2017-10-11 02:38:35.287633
NCT01662024|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-02-12|2016-12-07||February 2013||2013-02-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Interventional|PROMISE|Adults who are suffering from obesity with a Body Mass Index (BMI) of 30 - 35 kg/m^2 seeking a minimally invasive alternative to bariatric surgery.|Endoscopic Suturing for Primary Obesity Treatment|Primary Obesity Multicenter Incisionless Suturing Evaluation: The PROMISE Trial|Completed||N/A|20|Actual|Brigham and Women's Hospital|"Early termination and withdrawal of 5 subjects leads to small numbers of subjects analyzed.
No sham comparator.
Durability measures at 12 month endoscopy was difficult to quantify."|1|||f||||f|f|t|f|f|f|||Yes|Data is available immediately. We will share the outcomes data if a request is made via email to the PI and the data transfer is completed between institutions. Identifying information will not be provided.|2017-10-11 02:38:35.394275|2017-10-11 02:38:35.394275
NCT01662011|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-08-07|||January 2010||2010-01-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Application of Neurally Adjusted Ventilatory Assist to Children After Congenital Cardiac Surgery|Application of Neurally Adjusted Ventilatory Assist to Children After Congenital Cardiac Surgery: the Effect of Patient-ventilator Interaction, Gas Exchange and Hemodynamics|Unknown status|Recruiting|Phase 3|72|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 02:38:35.834188|2017-10-11 02:38:35.834188
NCT01661998|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-04-18|||June 2008||2008-06-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|POM||Prospective Study of Motion Preservation Evaluation Below Fusions of the Spine in Adolescent Idiopathic Scoliosis|Motion Preservation Evaluation Below Fusions of the Spine in Adolescent Idiopathic Scoliosis|Enrolling by invitation||N/A|273|Actual|Setting Scoliosis Straight Foundation|||1||f||||f||||||||||2017-10-11 02:38:35.929934|2017-10-11 02:38:35.929934
NCT01661985|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-12-12|||February 2010||2010-02-01|December 2014|2014-12-01|September 2016|Anticipated|2016-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced|Study of Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Antibiotic Treatment|Unknown status|Recruiting|Phase 4|160|Anticipated|Ostergotland County Council, Sweden||3|||f||||f||||||||||2017-10-11 02:38:36.039947|2017-10-11 02:38:36.039947
NCT01661972|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-07-27|2017-06-09||August 2012||2012-08-01|July 2017|2017-07-01|June 12, 2016|Actual|2016-06-12|June 12, 2016|Actual|2016-06-12||Interventional|X-TRAP||Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer|X-TRAP: Phase I/II Study of Capecitabine Plus Aflibercept in Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|63|Actual|Duke University||2|||f||||t|t|f||||||||2017-10-11 02:38:36.16369|2017-10-11 02:38:36.16369
NCT01661959|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-04-18|||January 2005||2005-01-01|April 2016|2016-04-01||||December 2020|Anticipated|2020-12-01||Observational|AIS||Adolescent Idiopathic Scoliosis Outcomes Database Registry|Scoliosis Outcomes Database Registry|Enrolling by invitation||N/A|4121|Actual|Setting Scoliosis Straight Foundation|||2||f||||f||||||||||2017-10-11 02:38:36.787942|2017-10-11 02:38:36.787942
NCT01661946|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-08-21|||August 2012||2012-08-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye|Systemic Absorption of Bevacizumab and Ranibizumab in Humans Treated for Diabetic Macular Edema|Completed||Phase 3|10|Actual|Queen's University||2|||f||||f||||||||||2017-10-11 02:38:36.88542|2017-10-11 02:38:36.88542
NCT01661933|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-10-10|2014-09-21||August 2012||2012-08-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|NaCeD|Mean age 53 years, range 39-67; females 9.|Desensitising Celiac Disease Patients With the Human Hookworm|Combining Necator Americanus With Trace Gluten to Restore Tolerance in Coeliac Disease: a Pilot Clinical and a Detailed in Vitro Immunological Study.|Completed||Phase 1/Phase 2|12|Actual|The Prince Charles Hospital|Open study. Small number. Historical controls.|1|||f||||t||||||||||2017-10-11 02:38:36.966939|2017-10-11 02:38:36.966939
NCT01661920|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-08-19|||January 2012||2012-01-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|CAPTIME||Suitability of Antibiotic Treatment for CAP|Suitability of Antibiotic Treatment for Community-acquired Pneumonia|Completed||N/A|602|Actual|Hospital Galdakao-Usansolo||2|||f||||f||||||||||2017-10-11 02:38:37.210803|2017-10-11 02:38:37.210803
NCT01661907|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-10-28|||November 2011||2011-11-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Anesthesia-analgesia Methods and Postoperative Delirium|Effects of Two Different Anesthesia-analgesia Methods on the Incidence of Postoperative Delirium: a Multicenter, Randomized Controlled Trial|Completed||N/A|1800|Actual|Peking University First Hospital||2|||f||||t||||||||||2017-10-11 02:38:37.337827|2017-10-11 02:38:37.337827
NCT01661894|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-07-24|||April 2012||2012-04-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|3ECog||Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly|Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly|Completed||Phase 1|82|Actual|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-11 02:38:37.447705|2017-10-11 02:38:37.447705
NCT01661881|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2016-11-15|2016-09-15||August 2012||2012-08-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|February 2015|Actual|2015-02-01||Interventional|||Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma|A Phase II Study of Rituximab/Bendamustine Followed by Rituximab/Cytarabine for Untreated Mantle Cell Lymphoma|Active, not recruiting||Phase 2|23|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 02:38:39.131079|2017-10-11 02:38:39.131079
NCT01661868|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-08-18|||August 2012||2012-08-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer|Phase II Study of Single Agent Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer With No Prior PARP Exposure or Prior PARP Inhibitor Exposure|Withdrawn||Phase 2|0|Actual|Dana-Farber Cancer Institute||2||Drug not available.|f||||t||||||||||2017-10-11 02:38:39.463377|2017-10-11 02:38:39.463377
NCT01661855|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-03-17|||September 2013||2013-09-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|RILISE||A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD|A Pilot Study of Riluzole vs. Placebo in the Treatment of Children and Adolescents With Autism Spectrum Disorders|Completed||Phase 2|58|Actual|Anagnostou, Evdokia, M.D.||2|||f||||t||||||||No||2017-10-11 02:38:39.544113|2017-10-11 02:38:39.544113
NCT01661842|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2013-05-30|||October 2011||2011-10-01|May 2013|2013-05-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis|Phase 1/2 Study of UC-MSC Treatment for Evaluation the Efficacy and Safety in Patients With Autoimmune Liver Disease|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Beijing 302 Hospital||2|||f||||t||||||||||2017-10-11 02:38:39.646191|2017-10-11 02:38:39.646191
NCT01661829|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2015-02-02|||March 2012||2012-03-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||An RCT for the Effect of Biofeedback Therapy the Prevention of AR Syndrome in Rectal Cancer Patients|A Randomised Controlled Trial for the Effect of Biofeedback Therapy for the Preveintion of Anterior Resection Syndrome in Rectal Cancer Patients Who Have Undergone Low Anterior Resection With Total Mesorectal Excision Following Neoadjuvant Chemoradiation Therapy|Completed||N/A|56|Actual|The Catholic University of Korea|||2||f||||t||||||||||2017-10-11 02:38:39.761961|2017-10-11 02:38:39.761961
NCT01661816|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-07|||April 2007||2007-04-01|August 2012|2012-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|KALICOU||Breast Cancer and Quality of Life|Impact of Breast Cancer on Quality of Life of the Young Women, Her Life Partner and Her Couple|Completed||N/A|171|Actual|Centre Oscar Lambret|||5||f||||f||||||||||2017-10-11 02:38:39.83113|2017-10-11 02:38:39.83113
NCT01661803|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-04|2012-08-09|||November 2009||2009-11-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Intrathecal Bupivacaine Versus Bupivacaine and Clonidine in Paediatrics Age Group:A Comparative Evaluation|Intrathecal Bupivacaine Versus Bupivacaine and Clonidine in Paediatrics Age Group:A Comparative Evaluation|Completed||N/A|60|Actual|ACPM Medical College|||2||f||||t||||||||||2017-10-11 02:38:39.910951|2017-10-11 02:38:39.910951
NCT01660932|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-11-01|||March 2011||2011-03-01|August 2012|2012-08-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Vascular and Metabolic Effects of Omega-3 Fatty Acids||Completed||Phase 4|176|Actual|Gachon University Gil Medical Center||4|||f||||t||||||||||2017-10-11 02:38:51.010394|2017-10-11 02:38:51.010394
NCT01661790|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2015-03-13|2015-02-16||August 2009||2009-08-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer|Open-labeled, Randomized, Multicenter Phase III Study of Adjuvant Chemotherapy Comparing Bevacizumab Plus Cisplatin With Cisplatin Regimen in Malignant Pleural Effusion of Advanced Stage Non-Small-Cell Lung Cancer Patients|Completed||Phase 3|72|Actual|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 02:38:39.974111|2017-10-11 02:38:39.974111
NCT01661777|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2014-05-28|||August 2012||2012-08-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops|Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops?|Withdrawn||N/A|0|Actual|Vanderbilt University||3|||f||||f||||||||||2017-10-11 02:38:40.513129|2017-10-11 02:38:40.513129
NCT01661764|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-02-21|||February 4, 2013|Actual|2013-02-04|February 2017|2017-02-01|December 31, 2017|Anticipated|2017-12-31|December 26, 2016|Actual|2016-12-26||Interventional|||Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention|Fatty Acid Desaturase Activity, Fish Oil and Colorectal Cancer Prevention|Active, not recruiting||Phase 2|142|Actual|Vanderbilt University Medical Center||6|||f||||t||||||||||2017-10-11 02:38:40.666834|2017-10-11 02:38:40.666834
NCT01661751|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-06|||May 2006||2006-05-01|August 2012|2012-08-01|August 2006|Actual|2006-08-01|May 2006|Actual|2006-05-01||Interventional|||Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003|Phase III Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine|Completed||Phase 3|900|Actual|Hualan Biological Engineering, Inc.||2|||f||||t||||||||||2017-10-11 02:38:40.828885|2017-10-11 02:38:40.828885
NCT01661738|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-06|||May 2006||2006-05-01|August 2012|2012-08-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002|Phase II Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine|Completed||Phase 2|360|Actual|Hualan Biological Engineering, Inc.||1|||f||||t||||||||||2017-10-11 02:38:40.930021|2017-10-11 02:38:40.930021
NCT01661725|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-06|||April 2006||2006-04-01|August 2012|2012-08-01|May 2006|Actual|2006-05-01|April 2006|Actual|2006-04-01||Interventional|||Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001|Phase I Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine|Completed||Phase 1|60|Actual|Hualan Biological Engineering, Inc.||1|||f||||t||||||||||2017-10-11 02:38:41.008438|2017-10-11 02:38:41.008438
NCT01661699|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-08-26|||August 2011||2011-08-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Oxidative Stress in Obstructive Sleep Apnea: Correlation of Biomarkers and Nasal CPAP Compliance|Oxidative Stress in Obstructive Sleep Apnea: Correlation of Biomarkers and Nasal CPAP Compliance|Completed||N/A|24|Actual|Georgetown University|||1||f||||f||||||||||2017-10-11 02:38:41.183796|2017-10-11 02:38:41.183796
NCT01661686|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-08-16|||July 2012||2012-07-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|April 2016|Actual|2016-04-01||Interventional|COPAC||Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures|A Randomized Comparison of a Fully Covered Self Expandable Metal Stent Versus a Partially Covered Self Expandable Metal Stent in Malignant Esophageal Strictures|Active, not recruiting||N/A|98|Actual|Foundation for Liver Research||2|||f||||f||||||||||2017-10-11 02:38:41.258175|2017-10-11 02:38:41.258175
NCT01661673|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-01-10|||November 2012||2012-11-01|January 2014|2014-01-01||||October 2013|Actual|2013-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease|Safety, Tolerability, Pharmacokinetics, and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease|Completed||Phase 2|52|Actual|FORUM Pharmaceuticals Inc||5|||f||||f||||||||||2017-10-11 02:38:41.356712|2017-10-11 02:38:41.356712
NCT01661660|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-03-21|||September 2012||2012-09-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2012|Actual|2012-09-01||Interventional|Dem@Care||Ecological Assessment of Autonomy and Apathy|Ecological Assessment of Autonomy and Apathy in Alzheimer Patients at Mild and Moderate Stages, as Welle as in Healthy Control Particpants|Recruiting||N/A|150|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 02:38:41.439118|2017-10-11 02:38:41.439118
NCT01661647|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-07-21|||October 2017|Anticipated|2017-10-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||3D Kinematic Assessment of the Human Knee During Physical and Daily Life Activities|(Étude de la cinématique Tridimensionnelle du Genou Humain Lors de Gestes Sportifs et de la Vie Courante)|Not yet recruiting||N/A|10|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t|f|f||||||||2017-10-11 02:38:41.524131|2017-10-11 02:38:41.524131
NCT01661634|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-09-07|||July 2012||2012-07-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|TRUE-AHF||Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure|Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering From Acute Decompensated Heart Failure [TRUE-AHF]|Completed||Phase 3|2157|Actual|Cardiorentis||2|||f||||t||||||||||2017-10-11 02:38:41.623743|2017-10-11 02:38:41.623743
NCT01661621|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-06-23|2014-04-21||August 2012||2012-08-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1|Antimuscarinics as the First-line Treatment for Male With International Prostate Symptom Score (IPSS) Voiding-to-storage Subscore Rati (IPSS-V/S)≤1-- A Prospective Randomized Study Comparing With α-blockers|Completed||Phase 4|395|Actual|Buddhist Tzu Chi General Hospital||2|||f||||f||||||||||2017-10-11 02:38:42.166197|2017-10-11 02:38:42.166197
NCT01661608|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-07|||December 2008||2008-12-01|August 2012|2012-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Gastric Restriction Using the EndoSurgical Operating System|Gastric Restriction Using the EndoSurgical Operating System|Terminated||N/A|32|Actual|USGI Medical||1||FDA indicated study should have had prior IDE submission & approval|f||||t||||||||||2017-10-11 02:38:42.635966|2017-10-11 02:38:42.635966
NCT01661595|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-12-03|||November 2012||2012-11-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Effect of Sildenafil and Tadalafil on Skeletal Muscle and Perceptual Fatigue|The Effect of Sildenafil and Tadalafil on Skeletal Muscle and Perceptual Fatigue.|Completed||N/A|30|Actual|The University of Texas Medical Branch, Galveston||3|||f||||t||||||||||2017-10-11 02:38:42.737819|2017-10-11 02:38:42.737819
NCT01661582|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2014-12-02|||October 2012||2012-10-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01||Interventional|MIDAS||Myocardial Ischaemia After Exposure to Diesel Exhaust|Myocardial Ischaemia After Exposure to Diesel Exhaust|Unknown status|Recruiting|N/A|24|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-10-11 02:38:42.840065|2017-10-11 02:38:42.840065
NCT01661569|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-07|||August 2012||2012-08-01|August 2012|2012-08-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||A Randomised Controlled Trial to Investigate the Effects of a Mindfulness Smartphone App on Well-being in the Workplace|A Randomised Controlled Trial to Investigate the Effects of the Headspace Mindfulness Smartphone App on Psychological Well-being and Biological Indicators of Stress in the Workplace|Unknown status|Not yet recruiting|N/A|120|Anticipated|University College, London||2|||f||||f||||||||||2017-10-11 02:38:42.973855|2017-10-11 02:38:42.973855
NCT01661556|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2014-12-01|||October 2011||2011-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|February 2015|Anticipated|2015-02-01||Interventional|||Clinical Trial of Hydroquinone Versus Miconazol in Melasma|Double Blind Randomized Study of 2% Miconazol Versus 4% Hydroquinone in the Treatment for Melasma.|Unknown status|Recruiting|Phase 4|60|Anticipated|Universidad Autonoma de San Luis Potosí||3|||f||||f||||||||||2017-10-11 02:38:43.088671|2017-10-11 02:38:43.088671
NCT01661543|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-12-22|||January 2013||2013-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||U of A/ U of M Beans and Peas Health Claim Project|Substantiating a Health Claim for Pulses (Beans and Peas) and Cholesterol Lowering Abilities|Completed||Phase 1/Phase 2|180|Actual|University of Alberta||3|||f||||f||||||||||2017-10-11 02:38:43.22857|2017-10-11 02:38:43.22857
NCT01661530|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2014-01-13|||December 2012||2012-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional|||Piloting a Dietary Vitamin E Intervention During Pregnancy|A Double Blind Randomised Placebo Controlled Pilot Study of a Dietary Soup Intervention During Pregnancy to Optimise Dietary Vitamin E Intake in Relation to Childhood Asthma.|Completed||N/A|59|Actual|University of Aberdeen||2|||f||||t||||||||||2017-10-11 02:38:43.330811|2017-10-11 02:38:43.330811
NCT01661517|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-10-15|||September 2011||2011-09-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|September 2013|Actual|2013-09-01||Interventional|||Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting|Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting (Screening and Brief Treatment for Substance Use Disorders in the Emergency Room Department)|Terminated||Early Phase 1|5271|Actual|University of Alabama at Birmingham||1||incomplete data|f||||f||||||||||2017-10-11 02:38:43.41153|2017-10-11 02:38:43.41153
NCT01661504|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-07-19|||March 2013||2013-03-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluating Violence Against Women Screening in Mexico|Evaluating Violence Against Women Screening in Mexico|Completed||N/A|959|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:38:43.503726|2017-10-11 02:38:43.503726
NCT01661491|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-12-01|||August 2012||2012-08-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis|Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis|Recruiting||N/A|60|Anticipated|Yale University|||2||f||||f||||||Samples Without DNA|"     Fecal samples   "|No||2017-10-11 02:38:43.608958|2017-10-11 02:38:43.608958
NCT01661478|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-01-13|||September 2011||2011-09-01|January 2017|2017-01-01||||||||Observational|||Healthcare Provider Attitudes Towards Patients With Substance Use Before and After Implementation of the SBIRT Model in the Emergency Room|Healthcare Provider Attitudes Towards Patients With Substance Use Before and After Implementation of the SBIRT Model in the Emergency Room|Completed||N/A|200|Actual|University of Alabama at Birmingham|||2||f||||||||||||||2017-10-11 02:38:43.711924|2017-10-11 02:38:43.711924
NCT01661465|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-03-13|||May 2011||2011-05-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Routine Clinical Screening for Substance Use Disorders in the Emergency Room Setting|Routine Clinical Screening for Substance Use Disorders in the Emergency Room Setting|Terminated||N/A|9212|Actual|University of Alabama at Birmingham|||1|The Principal Investigator left the site.|f||||f||||||||||2017-10-11 02:38:43.80423|2017-10-11 02:38:43.80423
NCT01661452|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-12-02|||June 2011||2011-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Observational|||Development of Post Traumatic Stress Disorder After Natural Disaster|Development of Post Traumatic Stress Disorder After Natural Disaster|Completed||N/A|629|Actual|University of Alabama at Birmingham|||1||f||||||||||||||2017-10-11 02:38:43.864079|2017-10-11 02:38:43.864079
NCT01661439|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2014-06-20|||March 2012||2012-03-01|March 2012|2012-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome|A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)|Unknown status|Recruiting|N/A|316|Anticipated|Woman's Health University Hospital, Egypt|||1||f||||t||||||||||2017-10-11 02:38:43.927662|2017-10-11 02:38:43.927662
NCT01661426|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-06-07|||April 2012||2012-04-01|June 2017|2017-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Weight Loss Diet Study: Low Carb vs Low Fat|Weight Loss Diet Study: Low Carbohydrate vs. Low Fat and Insulin Resistance Status|Completed||N/A|61|Actual|Stanford University||2|||f||||f|f|f||||||No||2017-10-11 02:38:44.016232|2017-10-11 02:38:44.016232
NCT01661413|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-07-26|||July 2012||2012-07-01|July 2013|2013-07-01||||December 2013|Anticipated|2013-12-01||Observational|||Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy|Chemotherapy-induced Nausea and Vomiting in Children Receiving Intrathecal Methotrexate With/Without Vincristine|Unknown status|Recruiting|N/A|100|Anticipated|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 02:38:44.110098|2017-10-11 02:38:44.110098
NCT01660919|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-08|2014-11-01|||October 2011||2011-10-01|August 2012|2012-08-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|||Vascular and Metabolic Effects of Rosuvastatin||Completed||Phase 4|160|Anticipated|Gachon University Gil Medical Center||4|||f||||t||||||||||2017-10-11 02:38:51.185388|2017-10-11 02:38:51.185388
NCT01661400|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-11-01|||October 2012||2012-10-01|November 2016|2016-11-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01||Interventional|ASCR||Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors|Anti-Angiogenic Therapy After Autologous Stem Cell Rescue (ASCR) for Pediatric Solid Tumors|Recruiting||Early Phase 1|12|Anticipated|Washington University School of Medicine||3|||f||||f||||||||||2017-10-11 02:38:44.202564|2017-10-11 02:38:44.202564
NCT01661387|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-01-26|||August 2012||2012-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)|A European, Multi-Centre, Multi-Country, Post-Authorisation, Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)|Recruiting||N/A|3000|Anticipated|Shire|||2||f||||f||||||||||2017-10-11 02:38:44.467854|2017-10-11 02:38:44.467854
NCT01661283|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-10-12|||September 2012||2012-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors|Phase 2 Study of the mTOR Inhibitor Everolimus in Combination With Bevacizumab in Patients With Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors|Active, not recruiting||Phase 2|25|Anticipated|Sarcoma Alliance for Research through Collaboration||1|||f||||||||||||||2017-10-11 02:38:44.669526|2017-10-11 02:38:44.669526
NCT01661270|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-08-24|2015-10-22||July 2012||2012-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|AFLAME||A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy|A Multinational, Randomized, Double-Blind Study of Aflibercept Versus Placebo With Irinotecan/ 5-FU Combination (FOLFIRI) in Patients With Metastatic Colorectal Cancer (MCRC) After Failure of an Oxaliplatin Based Regimen|Completed||Phase 3|332|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 02:38:44.820748|2017-10-11 02:38:44.820748
NCT01661257|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-07|||October 2009||2009-10-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy|Expression of T-cell Immunoglobulin- and Mucin-domain-containing Molecule 3 (TIM-3)and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy|Completed||Phase 3|20|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 02:38:46.059042|2017-10-11 02:38:46.059042
NCT01661244|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-03-01|||September 2012||2012-09-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers|A Randomised, Double-blind, Placebo-controlled, Two Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treatment With Single and Repeat Doses of Inhaled RV568 in Healthy Volunteers|Completed||Phase 1|50|Actual|Respivert Ltd||2|||f||||f||||||||||2017-10-11 02:38:46.156662|2017-10-11 02:38:46.156662
NCT01661231|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-02-02|||October 2012||2012-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|September 2015|Actual|2015-09-01||Interventional|BIOFLEX-I EU||Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe|BIOTRONIK - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe)|Active, not recruiting||N/A|456|Anticipated|Biotronik AG||1|||f||||||||||||||2017-10-11 02:38:46.242031|2017-10-11 02:38:46.242031
NCT01661218|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-06|||August 2012||2012-08-01|August 2012|2012-08-01|September 2014|Anticipated|2014-09-01|August 2014|Anticipated|2014-08-01||Observational|CVCCP||Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients|Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients(CVCCP)|Unknown status|Enrolling by invitation|N/A|3500|Anticipated|Beijing Huanxing Cancer Hospital|||1||f||||t||||||||||2017-10-11 02:38:46.354704|2017-10-11 02:38:46.354704
NCT01661205|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-04-07|2017-02-07||August 2012||2012-08-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Staged DEEP|Number of Treated Subjects|Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)|Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation|Completed||N/A|30|Actual|AtriCure, Inc.||1|||f||||t||||||||||2017-10-11 02:38:46.443233|2017-10-11 02:38:46.443233
NCT01661192|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-01-10|||January 2013||2013-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|AAT Extension||Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes|Open Label Study (Extension 001)to Evaluate Long Term Treatment Effect of the Safety, Tolerability and Efficacy of Intervenous ALPHA-1 ANTITRYSIN (AAT)Glasia™ in Type 1 Diabetes Mellitus (Extension to KAMADA AAt 008, PHASE I/II Study)|Completed||Phase 2|12|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 02:38:46.877873|2017-10-11 02:38:46.877873
NCT01661179|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-10-11|2014-12-08||November 2012||2012-11-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|||Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma|A Phase I/II, Open-label Study to Evaluate the Safety and Tolerability of Vandetanib 300 mg/Day in Japanese Patients With Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma|Completed||Phase 1/Phase 2|14|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:38:46.981|2017-10-11 02:38:46.981
NCT01661166|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-07-31|||January 2012||2012-01-01|July 2017|2017-07-01||||April 2013|Actual|2013-04-01||Interventional|||A Study of the Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Laparoscopic Prostatectomy|A Phase IV, Randomized, Double-Blind, Placebo-Controlled, Single-Center Study of the Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Laparoscopic Prostatectomy )|Active, not recruiting||Phase 4|146|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-10-11 02:38:47.319881|2017-10-11 02:38:47.319881
NCT01661153|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-08-24|||March 2, 2011|Actual|2011-03-02|August 2017|2017-08-01|September 14, 2016|Actual|2016-09-14|September 14, 2016|Actual|2016-09-14||Observational|||An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer|A Non-interventional Study of Avastin in Combination With Paclitaxel for First Line Treatment in HER2 Negative Metastatic Breast Cancer|Completed||N/A|16|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:38:47.503396|2017-10-11 02:38:47.503396
NCT01661140|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-08-19|2016-04-26||September 2012||2012-09-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage|Randomized, Phase IV, Placebo-controlled, Comparative Study to Evaluate the Efficacy and Safety of Tapering Methotrexate (MTX) Dosage Versus Maintaining the Dosage in Patients With Severe Active Rheumatoid Arthritis (RA) Who Have Demonstrated an Inadequate Response (IR) to Prior Disease-modifying Anti-rheumatic Drugs (DMARDs) Treatment and Have Initiated RoActemra (RoActemra, TCZ) in Combination With MTX|Terminated||Phase 4|427|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:38:47.613303|2017-10-11 02:38:47.613303
NCT01661127|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2014-11-03|||June 2012||2012-06-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Observational|||Clinical Study of PET/CT and Association With Metabolic Syndrome/Depressive Symptoms in Psoriasis|Phase 0 Clinical Study of PET/CT and Association With Metabolic Syndrome/Depressive Symptoms in Psoriasis|Unknown status|Recruiting|N/A|10|Anticipated|Pusan National University Hospital|||1||f||||f||||||Samples Without DNA|"     Peripheral blood and 18-F-FDG PET/CT images   "|||2017-10-11 02:38:48.838173|2017-10-11 02:38:48.838173
NCT01661114|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-09-01|2016-01-05||July 2011||2011-07-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|December 2014|Actual|2014-12-01||Interventional|||A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers|A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers|Completed||Phase 2|39|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 02:38:48.935175|2017-10-11 02:38:48.935175
NCT01661101|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-07-26|||January 2013|Actual|2013-01-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|MANAGE||Management of Myocardial Injury After Noncardiac Surgery Trial|A Large, International, Randomized, Placebo-controlled Trial to Assess the Impact of Dabigatran (a Direct Thrombin Inhibitor) and Omeprazole (a Proton-pump Inhibitor) in Patients Suffering Myocardial Injury After Noncardiac Surgery|Active, not recruiting||Phase 3|1754|Actual|Population Health Research Institute||4|||f||||t||||||||||2017-10-11 02:38:49.350882|2017-10-11 02:38:49.350882
NCT01661088|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-12-16|||June 2011||2011-06-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients|A Phase II Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients With Borderline Resectable Pancreatic Cancer|Recruiting||Phase 2|31|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 02:38:49.639008|2017-10-11 02:38:49.639008
NCT01661062|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-07-26|2014-10-21||January 2009||2009-01-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2011|Actual|2011-03-01||Interventional||Although 23 patients were enrolled, only 18 completed treatment.|A Study Using Cone Beam CT for Head and Neck Cancer|A Pilot Study of Tumor and Critical Normal Tissue Motion in Head and Neck Cancer Using Cone Beam CT|Completed||N/A|23|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 02:38:49.860876|2017-10-11 02:38:49.860876
NCT01661049|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2012-08-08|||March 2012||2012-03-01|August 2012|2012-08-01||||||||Observational|||Duodenal Cancer - Retrospective Analysis|1997-2011 Duodenal Cancer Analysis in Southern Denmark|Completed||N/A|55|Actual|Odense University Hospital|||1||f||||f||||||||||2017-10-11 02:38:50.192864|2017-10-11 02:38:50.192864
NCT01661036|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-06-30|||July 23, 2012||2012-07-23|August 7, 2015|2015-08-07|August 7, 2015||2015-08-07|||||Observational|||Testing the FLASHE Survey|Cognitive Testing of the Family Life, Activity, Sun, Health, and Eating (FLASHE) Survey|Completed||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:38:50.248883|2017-10-11 02:38:50.248883
NCT01661023|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-10-05|||July 19, 2012||2012-07-19|July 3, 2017|2017-07-03||||||||Observational|||The Ghana Breast Health Study|A Multidisciplinary Study of Breast Cancer in Ghana|Completed||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:38:50.321459|2017-10-11 02:38:50.321459
NCT01661010|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-10-03|||July 30, 2012||2012-07-30|September 28, 2017|2017-09-28||||||||Observational|||The Clinical Study of Sex Chromosome Variants|The Clinical Study of Patients With Sex Chromosome Variants|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:38:50.414089|2017-10-11 02:38:50.414089
NCT01660997|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-10-05|||July 30, 2012||2012-07-30|March 11, 2014|2014-03-11|March 11, 2014|Actual|2014-03-11|March 11, 2014|Actual|2014-03-11||Interventional|||MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma|MLN9708 and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:38:50.501888|2017-10-11 02:38:50.501888
NCT01660984|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-06-30|||July 24, 2012||2012-07-24|January 23, 2017|2017-01-23||||||||Observational|||Natural History Study of Children and Young Adults With Medullary Thyroid Cancer|Longitudinal Assessment and Natural History Study of Children and Young Adults With MEN2A or MEN2B With or Without Medullary Thyroid Carcinoma|Recruiting||N/A|180|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:38:50.574151|2017-10-11 02:38:50.574151
NCT01660971|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2017-09-12|||July 30, 2012|Actual|2012-07-30|September 2017|2017-09-01||||October 31, 2018|Anticipated|2018-10-31||Interventional|||Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery|A Phase 1 Study of Gemcitabine, Dasatinib and Erlotinib in Patients With Advanced Pancreatic Carcinoma|Active, not recruiting||Phase 1|24|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:38:50.67039|2017-10-11 02:38:50.67039
NCT01660906|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-11-17|2016-09-28||December 2012||2012-12-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||All treated participants.|Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib|A Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib|Completed||Phase 4|39|Actual|Bristol-Myers Squibb||1|||f||||t||||||||||2017-10-11 02:38:51.307783|2017-10-11 02:38:51.307783
NCT01660893|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-08-01|2016-10-06|2015-05-15|August 2012||2012-08-01|August 2017|2017-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth|A Phase III, Multi-Center, Randomized, Double-Blind, Parallel-Groups Clinical Trial Comparing the Efficacy and Safety of Intranasally Administered Kovacaine Mist to Tetracaine Alone and to Placebo for Anesthetizing Maxillary Teeth in Adults|Terminated||Phase 3|26|Actual|St. Renatus, LLC||3|||f||||f||||||||||2017-10-11 02:38:52.004459|2017-10-11 02:38:52.004459
NCT01660880|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-05-18|||December 2012||2012-12-01|May 2013|2013-05-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Observational|||Validation of Receptor Occupancy Simulation||Unknown status|Recruiting|N/A|20|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 02:38:53.136698|2017-10-11 02:38:53.136698
NCT01660867|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-08|||August 2012||2012-08-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department|Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department|Unknown status|Active, not recruiting|Phase 4|336|Anticipated|Seoul National University Hospital||3|||f||||||||||||||2017-10-11 02:38:53.226403|2017-10-11 02:38:53.226403
NCT01660854|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-02-12|||July 2012||2012-07-01|July 2012|2012-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|TIP4||Re-exposure of Human Volunteers to a Heterologous Strain of P. Falciparum Sporozoites|Re-exposure of Previously Immunized and Challenged Human Volunteers to a Heterologous Strain of P. Falciparum Sporozoites|Completed||N/A|21|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 02:38:53.314544|2017-10-11 02:38:53.314544
NCT01660841|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2014-09-30|||September 2012||2012-09-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging|A Multicenter, Open-label, Phase III Study to Determine the Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects Referred for Contrast-enhanced MRI of the Central Nervous System (CNS)|Completed||Phase 3|223|Actual|Bayer||1|||f||||f||||||||||2017-10-11 02:38:53.41225|2017-10-11 02:38:53.41225
NCT01660828|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-08-08|||September 2011||2011-09-01|August 2011|2011-08-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Exercise Test and Cardiac Injury|The Effect of Remote Ischemic Preconditioning on Plasma Troponin I Appearance After a Standardized Cycling Test in Healthy Volunteers|Completed||N/A|20|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 02:38:53.526587|2017-10-11 02:38:53.526587
NCT01660815|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2013-07-16|2013-07-16||August 2012||2012-08-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of Florbetapir (18F) in Japanese Healthy Volunteers|PET Whole Body Biodistribution Using Florbetapir (18F)|Completed||Phase 1|7|Actual|Avid Radiopharmaceuticals||1|||f||||||||||||||2017-10-11 02:38:53.617859|2017-10-11 02:38:53.617859
NCT01660802|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-05-22|2015-04-02||September 2012||2012-09-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)||Completed||Phase 3|262|Actual|Allergan||2|||f||||f||||||||||2017-10-11 02:38:53.919646|2017-10-11 02:38:53.919646
NCT01660789|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-08-30|||January 2012||2012-01-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|FFK||"Fit For Kids-Copenhagen"|"Fit For Kids Copenhagen - an Interventions Study on Obesity and Physical Inactivity in Children."|Completed||N/A|37|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 02:38:54.370705|2017-10-11 02:38:54.370705
NCT01660776|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-01-16|||June 2012||2012-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|BMS_PD-L1||BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology|BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology|Recruiting||N/A|325|Anticipated|Rennes University Hospital|||6||f||||f||||||Samples Without DNA|"     Biomedical research on total blood at diagnosis.   "|||2017-10-11 02:38:54.438175|2017-10-11 02:38:54.438175
NCT01660763|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2015-09-30|2013-10-24||August 2012||2012-08-01|September 2015|2015-09-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery|P3 - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Knee or Hip Replacement Surgery|Completed||Phase 3|419|Actual|AcelRx Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:38:54.566187|2017-10-11 02:38:54.566187
NCT01660750|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-07|2016-07-12|||January 2013||2013-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|11-MM-01||A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma|A Multi-Center Phase Ib, Open-Label, Dose-Finding Pilot Study to Evaluate the Combination of Carfilzomib and Cyclophosphamide With Dexamethasone Prior to ASCT in Patients With Transplant Eligible Newly Diagnosed Myeloma|Completed||Phase 1|29|Actual|Academic Myeloma Consortium||1|||f||||f||||||||Undecided||2017-10-11 02:38:55.0796|2017-10-11 02:38:55.0796
NCT01660737|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-04-04|2016-04-21||February 2012||2012-02-01|April 2017|2017-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Observational Study With PASCALLERG ® in Patients With Hay Fever|Observational Study With PASCALLERG ® in Patients With Hay Fever|Completed||N/A|123|Actual|Pascoe Pharmazeutische Praeparate GmbH|||1||f||||f||||||||||2017-10-11 02:38:55.197805|2017-10-11 02:38:55.197805
NCT01660724|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-08-02|||July 2012||2012-07-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Ultrasound Guided Arterial Puncture|Ultrasound Guided Arterial Puncture: a Prospective, Blinded, Randomised Controlled Trial.|Completed||N/A|238|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 02:38:58.079566|2017-10-11 02:38:58.079566
NCT01660711|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-01-30|||July 2012||2012-07-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|March 2017|Anticipated|2017-03-01||Interventional|||A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma|A Pilot Study of Neoadjuvant and Adjuvant mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|21|Anticipated|NorthShore University HealthSystem||1|||f||||t||||||||||2017-10-11 02:38:58.161028|2017-10-11 02:38:58.161028
NCT01660698|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-07-11|2013-04-02||May 2011||2011-05-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|August 2011|Actual|2011-08-01||Interventional|||Immune-modulatory Effect of Probiotic Strain on Grass Pollen Allergic Individuals|Immune-modulatory Effect of Candidate Probiotic Strain on Whole Blood Cells of Grass Pollen Allergic Individuals|Completed||N/A|20|Actual|Nestlé||2|||f||||t||||||||||2017-10-11 02:38:58.261477|2017-10-11 02:38:58.261477
NCT01660685|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2013-01-31|||August 2012||2012-08-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Journaling on Weight Loss|Effects of Journaling on Weight Loss|Completed||N/A|100|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 02:38:58.59995|2017-10-11 02:38:58.59995
NCT01660672|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-08-03|2014-08-11||January 2013||2013-01-01|August 2016|2016-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|LVT1||Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria|A Dose-Escalation, Safety And Feasibility Study Of Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria|Completed||Phase 1/Phase 2|7|Actual|University of Rochester||1|||f||||t||||||||||2017-10-11 02:38:58.833379|2017-10-11 02:38:58.833379
NCT01660659|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2015-10-23|||January 2012||2012-01-01|April 2015|2015-04-01|August 2015|Actual|2015-08-01|June 2012|Actual|2012-06-01||Interventional|||Indoor Air Pollution (IAP) Carriage Study|Use of Biomass Briquettes: Its Effect on Indoor Air Pollution and on Pneumococcal Nasopharyngeal Carriage. A Randomized Clinical Trial|Completed||N/A|500|Actual|Medical Research Council Unit, The Gambia||2|||f||||f||||||||||2017-10-11 02:38:59.122853|2017-10-11 02:38:59.122853
NCT01660646|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-11-12|||June 2012||2012-06-01|April 2015|2015-04-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|ECF||Determining the Impact of Enhanced Case Finding on Tuberculosis Notification in The Gambia|A Cluster Randomised Trial to Assess the Impact of an Enhanced Case Finding Strategy on Tuberculosis Notification in The Gambia|Completed||N/A|650000|Actual|Medical Research Council Unit, The Gambia||2|||f||||f||||||||||2017-10-11 02:38:59.233114|2017-10-11 02:38:59.233114
NCT01660633|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-05-11||2015-02-13|December 2012||2012-12-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation|A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation|Completed||Phase 2|61|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||t||||||||||2017-10-11 02:38:59.315258|2017-10-11 02:38:59.315258
NCT01660620|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2013-01-02|||April 2011||2011-04-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Topical Betaxolol for the Prevention of Retinopathy of Prematurity|Topical Betaxolol for the Prevention of Retinopathy of Prematurity|Completed||Phase 1|23|Actual|Smith-Kettlewell Eye Research Institute||2|||f||||t||||||||||2017-10-11 02:38:59.421826|2017-10-11 02:38:59.421826
NCT01660607|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-08-09|||December 2011||2011-12-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I/II MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell|Phase I/II Trial for Patients With Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT With a T Cell Depleted Graft With Simultaneous Infusion of Conventional T Cells and Regulatory T Cells|Recruiting||Phase 1/Phase 2|54|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 02:38:59.500829|2017-10-11 02:38:59.500829
NCT01660594|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-08|||June 2011||2011-06-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||CT Calcium Scoring in Suspected Stable Angina|Comparison of CT Coronary Artery Calcium Scoring With Traditional Assessment in Patients Presenting to the Rapid Access Chest Pain Clinic With Non-acute Chest Pain and Its Prognostic Value|Completed||N/A|705|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 02:38:59.605072|2017-10-11 02:38:59.605072
NCT01660581|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-09-27|||June 2012||2012-06-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|RegentVsel||Intracardiac CD133+ Cells in Patients With No-option Resistant Angina|A Randomized,Prospective,Double-blind Study to Evaluate Intracardiac Injections of Bone Marrow,Autologous CD133+Cells(Electromechanical Mapping Based)in Patients With Resistant Angina and no Effective Revascularization Option. RegentVsel|Completed||Phase 2|31|Actual|Medical University of Silesia||2|||f||||f||||||||||2017-10-11 02:38:59.724574|2017-10-11 02:38:59.724574
NCT01660568|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2013-02-11|||August 2012||2012-08-01|August 2012|2012-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Gemcitabine in NK/T Cell Lymphoma|Gemcitabine in Pretreated/Refractory NK/T Cell Lymphoma|Completed||N/A|20|Actual|Samsung Medical Center|||1||f||||||||||||||2017-10-11 02:38:59.856421|2017-10-11 02:38:59.856421
NCT01660555|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-09-01|||August 2012||2012-08-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||The Real Distribution of Microbiota Along the Colon Using a Novel Device Along the Colon Using a Novel Device|The Real Distribution of Microbiota Along the Colonic Mucosa Using a Novel Device Capable of Taking 'Protected' Biopsies|Completed||N/A|10|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples With DNA|"     mucosal biopsies will be screened for diversity by Denaturing Gradient Gel Electrophoresis of     16S rRNA genes and subsequently analysed with the HITChip.      (-> DNA from microbiota instead of human DNA will be analysed)   "|||2017-10-11 02:38:59.946851|2017-10-11 02:38:59.946851
NCT01660542|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2016-10-30|||April 2011||2011-04-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer||Completed||Phase 4|96|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 02:39:00.057332|2017-10-11 02:39:00.057332
NCT01626703|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-03-09|||June 2012||2012-06-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Depressin Screening and Care Program at Community Health Center||Completed||N/A|86|Actual|National Clinical Research Coordination Center, Seoul, Korea||2|||f||||||||||||||2017-10-11 02:49:00.368304|2017-10-11 02:49:00.368304
NCT01660516|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2013-02-01|||August 2011||2011-08-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Effect of Tea on Endothelial Function and Ischaemia-reperfusion Injury|Effect of Black Tea Consumption on Endothelial Function and Ischaemia-reperfusion Injury in Humans|Completed||N/A|23|Actual|Radboud University|||1||f||||f||||||||||2017-10-11 02:39:00.22907|2017-10-11 02:39:00.22907
NCT01660503|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-03-10|||June 2012||2012-06-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Dose Effects of SCF on Calcium Metabolism and GI Microflora in Adolescents|Dose Response Effects of Soluble Corn Fiber (SCF) on Calcium Metabolism and Gastrointestinal Microflora in Adolescents|Unknown status|Active, not recruiting|N/A|30|Anticipated|Purdue University||3|||f||||f||||||||||2017-10-11 02:39:00.32224|2017-10-11 02:39:00.32224
NCT01660490|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-03-18|||September 2012||2012-09-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Observational|||Development and Validation of Intraoperative Image-quality Criteria|Development and Validation of Intraoperative Image-quality Criteria A Retrospective Multicenter Case Series to Validate a Set of Intraoperative Image-quality Criteria|Completed||N/A|200|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 02:39:00.455235|2017-10-11 02:39:00.455235
NCT01660477|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-02-20|||June 2012||2012-06-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole|A Phase 1, Open-Label, Parallel Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Multiple Doses of Lopinavir/Ritonavir and the Effects of Lopinavir/Ritonavir on the Pharmacokinetics of Multiple Doses of Isavuconazole in Healthy Adult Subjects|Completed||Phase 1|68|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 02:39:00.578544|2017-10-11 02:39:00.578544
NCT01660464|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-04-14|||January 2012||2012-01-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)|Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): A Feasibility and Effectiveness Study|Completed||N/A|50|Anticipated|University of Cologne||1|||f||||f||||||||||2017-10-11 02:39:00.701008|2017-10-11 02:39:00.701008
NCT01660438|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-05-19|||August 2010||2010-08-01|May 2016|2016-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Urethral Length Measurement in Women Undergoing Suburethral Sling Operative Procedure|Prospective, Non-randomized, Observational Study of the Surgical Management of Suburethral Slings in Women With Stress Urinary Incontinence|Completed||N/A|188|Actual|Cantonal Hospital, Frauenfeld|||1||f||||t||||||||Undecided||2017-10-11 02:39:01.799163|2017-10-11 02:39:01.799163
NCT01660425|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-03-12|||May 2012||2012-05-01|March 2014|2014-03-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Enhancement of Methylphenidate Treatment by Psychosocial Intervention and Support|Enhancement of Psychosocial Functioning, Quality of Life, Satisfaction With Medication and Medication Compliance of Methylphenidate Treatment by Psychosocial Intervention and Support|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-11 02:39:01.903053|2017-10-11 02:39:01.903053
NCT01660412|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-12-16|||August 2012||2012-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|buffering SLN||Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?|Does Alkalinization of Technetium-99m Sulfur Colloid Reduce Perceived Pain Levels During Non-breast Sentinel Lymphoscintigraphy?|Completed||N/A|60|Actual|University of Arkansas||2|||f||||t||||||||||2017-10-11 02:39:02.080068|2017-10-11 02:39:02.080068
NCT01660399|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2015-12-21|||August 2012||2012-08-01|August 2012|2012-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy|Boanmycin Hydrochloride for Injection in Combination With Docetaxel for Patients With Advanced Lung Squamous Cell Carcinoma as Salvage Chemotherapy: a Prospective, Randomized, Parallel and Controlled Clinical Trial|Unknown status|Recruiting|Phase 2|300|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 02:39:02.212154|2017-10-11 02:39:02.212154
NCT01660373|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2012-12-16|||August 2012||2012-08-01|December 2012|2012-12-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|TE-CLOT||Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome|Ticagrelor vs. Tirofiban, Comparison of Anti-platelet Effects in Patients With Non-ST Elevation Acute Coronary Syndrome(TE-CLOT Trial : Ticagrelor's Effect for CLOT Prevention) ; A Single Center, Open-label Randomized Controlled Study|Unknown status|Recruiting|Phase 3|100|Anticipated|Pusan National University Yangsan Hospital||2|||f||||t||||||||||2017-10-11 02:39:02.453771|2017-10-11 02:39:02.453771
NCT01660360|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-01-27|||November 2011||2011-11-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer|A Phase I Study of the Safety and Pharmacokinetics of a Fully Human Monoclonal Antibody to the Vascular Endothelial Growth Factor Receptor2 (Tanibirumab) in Patients With Advanced Cancers or Metastatic Cancer|Completed||Phase 1|26|Actual|PharmAbcine||1|||f||||f||||||||||2017-10-11 02:39:02.57961|2017-10-11 02:39:02.57961
NCT01621607|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-10-05|||June 8, 2012||2012-06-08|October 3, 2017|2017-10-03|October 3, 2017||2017-10-03|||||Observational|||Individual Differences in Reward and Impulse Control|Gene x Environment Interactions as Risk Factors for Addiction|Completed||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:50:19.041514|2017-10-11 02:50:19.041514
NCT01660347|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2016-10-19|||August 2012||2012-08-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant|Compassionate Use of the CliniMACS® CD34 Reagent System for Patients Requiring a Post Hematopoietic Stem Cell Transplant Boost of Donor Hematopoietic Stem Cells|Withdrawn||N/A|0|Actual|Thomas Jefferson University||1||Slow accrual|f||||t||||||||||2017-10-11 02:39:02.685826|2017-10-11 02:39:02.685826
NCT01660334|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2013-10-30|2013-05-14||July 2006||2006-07-01|October 2013|2013-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)|Special Investigation of Vfend on Scedosporisis|Completed||N/A|13|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 02:39:02.785443|2017-10-11 02:39:02.785443
NCT01660321|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-11-16|2012-08-20||September 2011||2011-09-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation|A Single Treatment, Pharmacokinetic (PK) and Tolerance Study of Natroba (Spinosad) Topical Suspension, 0.9% in Pediatric Subjects 6 Months to 4 Years of Age With an Active Head Lice Infestation|Completed||Phase 4|26|Actual|ParaPRO LLC|It is suspected for Subject 02-202, at 0.5 hours, the sample to determine the spinosyn A and spinosyn D concentrations were possibly contaminated with Natroba.|1|||f||||f||||||||||2017-10-11 02:39:02.987|2017-10-11 02:39:02.987
NCT01660308|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2016-07-04|||June 2011||2011-06-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia|Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia|Recruiting||N/A|40|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 02:39:03.263453|2017-10-11 02:39:03.263453
NCT01660295|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-08-05|||December 2011||2011-12-01|August 2012|2012-08-01||||June 2012|Actual|2012-06-01||Interventional|||Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects|An Open-label, Single Center, Parallel-group Study to Compare the Single- and Repeated-dose Pharmacokinetics of Stepwise Increasing Doses of Subcutaneous Certoparin (3000 IU o.d., 3000 IU b.i.d., 8000 IU o.d., and 8000 IU b.i.d.) in Subjects With Severe Renal Insufficiency and Healthy Subjects|Completed||Phase 1/Phase 2|32|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:39:03.336176|2017-10-11 02:39:03.336176
NCT01660256|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2013-06-09|||August 2012||2012-08-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Confirmatory Study of OPC-12759 Ophthalmic Solution|Confirmatory Study of OPC-12759 Ophthalmic Solution in Patients With Dry Eye|Completed||Phase 3|209|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:39:03.415188|2017-10-11 02:39:03.415188
NCT01660243|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-02-18||2015-10-20|September 2012||2012-09-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis|A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis|Terminated||Phase 2|45|Actual|Toray Industries, Inc||4||This study has been terminated because of insufficient patient recruitment.|f||||f||||||||||2017-10-11 02:39:03.646431|2017-10-11 02:39:03.646431
NCT01660230|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2014-02-27|2014-02-27||August 2012||2012-08-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult Volunteers|A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC, a Recombinant Variant of Human Activated Protein C (APC), in Healthy Adult Volunteers|Completed||Phase 1|64|Actual|ZZ Biotech, LLC|Samples were analyzed from 4 treated subjects in the 6 μg/kg dose group, but all values were below the lower limit of quantitation for the assay (75 ng/mL) and therefore no PK analysis could be performed.|11|||f||||t||||||||||2017-10-11 02:39:03.814698|2017-10-11 02:39:03.814698
NCT01660217|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-03|||June 2011||2011-06-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management|Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management: A Randomized Controlled Trial|Completed||N/A|37|Actual|Dermatology & Aesthetics of Wicker Park||2|||f||||f||||||||||2017-10-11 02:39:06.190326|2017-10-11 02:39:06.190326
NCT01660204|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2014-04-22|||February 2011||2011-02-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|CAP-START||Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract Infections|Antibiotic Treatment of Community-acquired Pneumonia: a Prospective Comparison of Dutch Guideline Advices.|Completed||N/A|2283|Actual|UMC Utrecht||3|||f||||f||||||||||2017-10-11 02:39:06.289649|2017-10-11 02:39:06.289649
NCT01660191|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-11-22|2016-02-15||December 2011||2011-12-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|SPARQ||A Study Comparing CoQ10 Levels While Taking 3 Different Statins|A Study Comparing the Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on Plasma Levels of CoQ10 (SPARQ)|Completed||Phase 4|134|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-10-11 02:39:06.440823|2017-10-11 02:39:06.440823
NCT01660178|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-07|||January 2011||2011-01-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|||||Observational|||Profile of Newborn Undergoing Early Stimulation in a Neonatal Intensive Care Unit|Profile of Newborn Undergoing Early Stimulation in a Neonatal Intensive Care Unit.|Completed||N/A|||Universidade Federal do Rio de Janeiro|||1||f||||f||||||||||2017-10-11 02:39:06.951822|2017-10-11 02:39:06.951822
NCT01660165|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-01-16|||November 2009||2009-11-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|November 2011|Actual|2011-11-01||Observational|||Nutritional Status and Mental Health During Pregnancy and Postpartum: a Cohort Study in Rio de Janeiro, Brazil|Mental Health and Nutritional Status During Pregnancy and Postpartum: A Prospective Study With a Nested Clinical Trial|Completed||N/A|299|Actual|Universidade Federal do Rio de Janeiro|||1||f||||f||||||Samples With DNA|"     Fatty acids C-reactive protein Interleukin-6   "|||2017-10-11 02:39:07.026963|2017-10-11 02:39:07.026963
NCT01660087|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-04-16|||April 2012||2012-04-01|April 2017|2017-04-01|September 30, 2015|Actual|2015-09-30|September 30, 2015|Actual|2015-09-30||Interventional|||Diagnosis of Lung Cancer From Exhaled Breath With Silicon Biophotonic Device|Diagnosis of Lung Cancer From Exhaled Breath With Silicon Biophotonic Device.|Withdrawn||N/A|0|Actual|National University Hospital, Singapore||1|||f||||f||||||||||2017-10-11 02:39:14.76259|2017-10-11 02:39:14.76259
NCT01660152|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-04-12|||September 2011||2011-09-01|April 2017|2017-04-01|July 17, 2013|Actual|2013-07-17|July 17, 2013|Actual|2013-07-17||Interventional|||Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery|Analysis of Technique Comparison With a Vacuum Erection Device as Part of an Erectile Rehabilitation Program Following Robotic Radical Prostatectomy: A Randomized Comparison of Methodology|Completed||N/A|2|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:39:07.095155|2017-10-11 02:39:07.095155
NCT01660139|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-05-13|||July 2012||2012-07-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics|Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics|Unknown status|Recruiting|N/A|400|Anticipated|Northwestern University|||2||f||||f||||||||||2017-10-11 02:39:07.372706|2017-10-11 02:39:07.372706
NCT01660126|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-03-09|||May 2014||2014-05-01|March 2017|2017-03-01|November 18, 2016|Actual|2016-11-18|November 18, 2016|Actual|2016-11-18||Interventional|TRUST||Thyroid Hormone Replacement for Subclinical Hypothyroidism|Multi-modal Effects of Thyroid Hormone Replacement for Untreated Older Adults With Subclinical Hypothyroidism; a Randomised Placebo-controlled Trial|Completed||Phase 4|737|Actual|NHS Greater Glasgow and Clyde||2|||f||||t||||||||||2017-10-11 02:39:07.49516|2017-10-11 02:39:07.49516
NCT01659021|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-08-23|2017-02-14|2015-11-05|December 4, 2012|Actual|2012-12-04|August 2017|2017-08-01|March 2023|Anticipated|2023-03-01|January 15, 2015|Actual|2015-01-15||Interventional||Intent-to-Treat (ITT) Analysis Set: participants who are randomized in the study with treatment group designated according to initial randomization.|Efficacy and Safety of Idelalisib (GS-1101; CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia|A Phase 3, Randomized, Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 3|261|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 02:39:07.697847|2017-10-11 02:39:07.697847
NCT01659008|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2015-02-13|||June 2012||2012-06-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding|Estradiol Versus Tranexamic Acid on the Amount and Duration of Acute Cyclic Heavy Menstrual Bleeding|Unknown status|Recruiting|N/A|100|Anticipated|Eastern Virginia Medical School||2|||f||||t||||||||||2017-10-11 02:39:09.77174|2017-10-11 02:39:09.77174
NCT01658995|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-10-23|||August 2012||2012-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Management of Etonogestrel Subdermal Implant-related Bleeding|Management of Etonogestrel Subdermal Implant-related Bleeding in US Women: a Prospective, Randomized, Placebo-controlled Trial.|Recruiting||Phase 3|350|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:39:09.922225|2017-10-11 02:39:09.922225
NCT01658982|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2013-11-27|||August 2012||2012-08-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot Study|Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot Study|Completed||N/A|6|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 02:39:10.128939|2017-10-11 02:39:10.128939
NCT01658956|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2015-01-05|||July 2012||2012-07-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|PAPALDO||Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia|A Phase II Randomized Study to Verify the Papaldo's Hypothesis : the Effectiveness of a Reduced Dosing of G-CSF in Chemotherapy-treated Patients With a Low to Moderate Risk of Febrile Neutropenia|Unknown status|Recruiting|Phase 2|142|Anticipated|Jules Bordet Institute||2|||f||||f||||||||||2017-10-11 02:39:10.237024|2017-10-11 02:39:10.237024
NCT01658943|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-02-10|2016-02-10||August 2012||2012-08-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|S1115|Eligible and analyzable patients.|Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy|Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs mFOLFOX in Patients With Metastatic Pancreatic Cancer After Prior Chemotherapy|Completed||Phase 2|137|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 02:39:10.586213|2017-10-11 02:39:10.586213
NCT01658904|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-05-02|2015-10-14||July 2012||2012-07-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma|Phase I / II Study Of Carfilzomib (CFZ) Intensification Early After Autologous Transplantation (AHCT) For Plasma Cell Myeloma|Terminated||Phase 1/Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)|The study was closed prematurely because the investigator left the National Institutes of Health.|3||study closed prematurely because investigator left National Institutes of Health|f||||f||||||||No||2017-10-11 02:39:14.028582|2017-10-11 02:39:14.028582
NCT01660113|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-02-05|||March 2012||2012-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:39:14.546607|2017-10-11 02:39:14.546607
NCT01660100|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-10-17|||July 2012||2012-07-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation|Freedom From Atrial Arrhythmia in Atrial Fibrillation Patients After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation|Active, not recruiting||N/A|400|Anticipated|Texas Cardiac Arrhythmia Research Foundation||2|||f||||f||||||||||2017-10-11 02:39:14.591879|2017-10-11 02:39:14.591879
NCT01660074|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2012-08-07|||July 2008||2008-07-01|August 2012|2012-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|GI||Glycemic Index and Glycemic Response of Food and Products|Glycemic Index and Glycemic Response of Food and Products That Produced in Taiwan|Completed||N/A|10|Actual|National Pingtung University Science and Technology||1|||f||||t||||||||||2017-10-11 02:39:14.868943|2017-10-11 02:39:14.868943
NCT01660061|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-04-14|||July 2011||2011-07-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome|Monitoring Anticoagulant Therapy With Vitamin-K Antagonists in Patients With Antiphospholipid Syndrome|Completed||N/A|150|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma samples.   "|||2017-10-11 02:39:14.9905|2017-10-11 02:39:14.9905
NCT01660048|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-03-18|||December 2011||2011-12-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|SILSTEP||A Prospective Study Comparing Single and Multiport Laparoscopic Inguinal Hernia Repair|Prospective Randomized Single Blind Controlled Study Comparing Single and Multiport Laparoscopic Total Extraperitoneal Inguinal Hernia Repair|Completed||N/A|100|Actual|The Sydney Hernia Specialists Clinic||2|||f||||t||||||||||2017-10-11 02:39:15.122148|2017-10-11 02:39:15.122148
NCT01660035|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-10-04|||April 2012|Actual|2012-04-01|October 2017|2017-10-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Observational|PSR-REVERSE||The Product Surveillance Registry REVERSE Post Approval Study|The REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) Post Approval Study|Recruiting||N/A|500|Anticipated|Medtronic|||1||f||||f||||||||||2017-10-11 02:39:15.263946|2017-10-11 02:39:15.263946
NCT01660022|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-01-07|2014-12-15||September 2012||2012-09-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Safety Population|Safety Tolerability & Pharmacokinetics of Co-administered Single Doses of OZ439 & Piperaquine to Healthy Subjects|A Phase I Study to Investigate the Safety, Tolerability & Pharmacokinetics of Co-administered Single Doses of OZ439 and Piperaquine to Healthy Subjects|Completed||Phase 1|59|Actual|Medicines for Malaria Venture||9|||f||||f||||||||||2017-10-11 02:39:15.678432|2017-10-11 02:39:15.678432
NCT01660009|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-08-10|||June 2012||2012-06-01|April 2015|2015-04-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans|Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans|Terminated||N/A|5|Actual|Medical College of Wisconsin||2||Insufficient Funding|f||||f||||||||||2017-10-11 02:39:16.584415|2017-10-11 02:39:16.584415
NCT01659996|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-11-10|2015-09-29||July 2012||2012-07-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional||The demographic and baseline characteristics are in the safety analysis set (SafAS)|Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age|An Immunogenicity and Safety Evaluation of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered to Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age.|Completed||Phase 4|1394|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:39:16.700567|2017-10-11 02:39:16.700567
NCT01659983|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-04-05|||November 2012||2012-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy Study of Delayed Primary Closure to Reduce Rate of Wound Infection in Complicated Appendicitis|Comparison of Surgical Site Infection Between Delayed Primary Closure Versus Primary Closure in Complicated Appendicitis: A Multicenter Randomized Controlled Trial|Completed||Phase 3|600|Actual|Ramathibodi Hospital||2|||f||||t||||||||||2017-10-11 02:39:18.171314|2017-10-11 02:39:18.171314
NCT01659970|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-11-01|||June 2012||2012-06-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer|A Prospective Cohort Study Assessing the Efficacy and Safety of Tarceva in 2nd Line in Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)|Completed||N/A|152|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:39:18.29212|2017-10-11 02:39:18.29212
NCT01659957|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-03-19|||November 2010||2010-11-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|CALM||Couples Therapy for Alcoholic Patients|Behavioral Couples Group Therapy for Alcholic Patients: Clinical and Cost Outcomes|Completed||Phase 2|285|Actual|Harvard University||2|||f||||t||||||||||2017-10-11 02:39:18.608702|2017-10-11 02:39:18.608702
NCT01659944|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-03-19|||May 2012||2012-05-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy Adults|A Single-site, Open-label, Fixed-sequence Phase 1 Study Evaluating the Effect of Eliglustat (Genz-112638) on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy Adult Subjects.|Completed||Phase 1|14|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:39:18.703487|2017-10-11 02:39:18.703487
NCT01659931|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-06|||February 2008||2008-02-01|August 2012|2012-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 10 mg Tablets Under Fasted Conditions|Completed||Early Phase 1|34|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:39:18.810687|2017-10-11 02:39:18.810687
NCT01659918|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-07|||February 2008||2008-02-01|August 2012|2012-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 10 mg Tablets Under Fed Conditions|Completed||Early Phase 1|35|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:39:18.893605|2017-10-11 02:39:18.893605
NCT01659905|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-07|||August 2008||2008-08-01|August 2012|2012-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 5 mg Chewable Tablets Under Fasted Conditions|Completed||Early Phase 1|35|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:39:18.974427|2017-10-11 02:39:18.974427
NCT01659541|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-01-28|||April 2015||2015-04-01|January 2016|2016-01-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Stimulation With Wire Leads to Restore Cough|Spinal Cord Stimulation With Wire Leads to Restore Cough|Recruiting||N/A|16|Anticipated|Case Western Reserve University||1|||f||||t||||||||||2017-10-11 02:39:23.781521|2017-10-11 02:39:23.781521
NCT01659892|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-07|||August 2008||2008-08-01|August 2012|2012-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 5 mg Chewable Tablets Under Fed Conditions|Completed||Early Phase 1|36|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 02:39:19.083752|2017-10-11 02:39:19.083752
NCT01659879|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-02-12|||January 2011||2011-01-01|February 2017|2017-02-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Interventional|||Multimedia Based Information to Parents in a Pediatric Acute Ward: A Randomized Controlled Trial|Multimedia Based Information to Parents in a Pediatric Acute Ward: A Randomized Controlled Trial|Completed||N/A|101|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 02:39:19.223502|2017-10-11 02:39:19.223502
NCT01659853|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-07-08|2014-01-15||September 2012||2012-09-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea|A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea|Completed||Phase 3|70|Actual|Galderma Laboratories, L.P.|A significant period effect was observed for CEA indicating there was carryover from period 1 to period 2. Therefore, as stated a priori in the protocol, only data from period 1 were used to analyze efficacy. All safety data are reported.|1|||f||||f||||||||||2017-10-11 02:39:19.478909|2017-10-11 02:39:19.478909
NCT01659840|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-07|||September 2010||2010-09-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|TMD||Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders|Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders - A Double-blind, Randomized, Parallel Clinical Trial|Completed||N/A|116|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 02:39:19.844002|2017-10-11 02:39:19.844002
NCT01659827|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-12-10|||September 2012||2012-09-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis|A Prospective, Randomized, Blinded, Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis|Completed||N/A|45|Actual|MiMedx Group, Inc.||3|||f||||||||||||||2017-10-11 02:39:19.953719|2017-10-11 02:39:19.953719
NCT01659814|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-04-22|||March 2011||2011-03-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Dopamine Neurotransmission in Major Depression|Dopamine Neurotransmission in Major Depression|Completed||N/A|71|Actual|Mclean Hospital|||2||f||||f||||||||||2017-10-11 02:39:20.145214|2017-10-11 02:39:20.145214
NCT01659801|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-05||||||August 2012|2012-08-01||||||||Interventional|||Evaluation of the BunnyLens TR Intraocular Lens|Clinical Evaluation of the Toric BuunyLens TR Intra-ocular Lens|Unknown status|Not yet recruiting|Phase 3|35|Anticipated|Hanita Lenses||1|||f||||t||||||||||2017-10-11 02:39:20.2469|2017-10-11 02:39:20.2469
NCT01659788|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2012-08-07|||September 2012||2012-09-01|August 2012|2012-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Co Enzyme Q10 Improves IVF Outcome in With Advanced Reproductive Age|Co Enzyme Q10 Improves IVF Outcome in With Advanced Reproductive Age|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 02:39:20.337433|2017-10-11 02:39:20.337433
NCT01659775|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2013-07-23|||August 2011||2011-08-01|January 2012|2012-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)|A Multicenter, Randomized, Open-label, Paralleled-group, Active-controlled, Phase IV Study to Evaluate the Efficacy and Safety of Sancuso Patch (Granisetron) in Chemotherapy-induced Nausea and Vomiting (CINV) Associated With the Administration of Highly Emetogenic (HE) Chemotherapy|Completed||Phase 4|389|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 02:39:20.46475|2017-10-11 02:39:20.46475
NCT01659762|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-10-13|||July 2012||2012-07-01|October 2016|2016-10-01||||July 2015|Actual|2015-07-01||Interventional|EPIC/MSC/IBD||A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.|A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stromal (MSC) Cells in Adults With Moderate to Severe Crohn's Disease.|Completed||Phase 1|16|Actual|Emory University||1|||f||||t||||||||||2017-10-11 02:39:20.574557|2017-10-11 02:39:20.574557
NCT01659749|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2015-12-09|||June 1995||1995-06-01|December 2015|2015-12-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria|Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria (PKU) or Maple Syrup Urine Disease (MSUD).|Completed||N/A|35|Actual|Emory University||1|||f||||t||||||||||2017-10-11 02:39:20.68366|2017-10-11 02:39:20.68366
NCT01659736|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2016-03-25|2015-04-08||May 2012||2012-05-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder|Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder|Completed||N/A|26|Actual|Hartford Hospital||2|||f||||f||||||||No||2017-10-11 02:39:20.750001|2017-10-11 02:39:20.750001
NCT01659723|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-02-01|||August 2012||2012-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RICH-ART||Radiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial|Radiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|80|Anticipated|Göteborg University||2|||f||||t||||||||||2017-10-11 02:39:21.282032|2017-10-11 02:39:21.282032
NCT01658852|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-06|||May 2011||2011-05-01|August 2012|2012-08-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Effects and Safety of Metronidazole in Patients With Gastrectomy||Unknown status|Active, not recruiting|Phase 3|170|Anticipated|The Catholic University of Korea||2|||f||||||||||||||2017-10-11 02:39:31.556007|2017-10-11 02:39:31.556007
NCT01659710|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2015-08-10|||January 2012||2012-01-01|August 2015|2015-08-01||||March 2018|Anticipated|2018-03-01||Observational|CIMA||Effects of Medical Complexity Using GMA on Lurie Children's In- and Outpatients|Effects of Medical Complexity on the Development of Fidgety Movements and Feasibility of Screening Utilizing the General Movement Assessment for Lurie Children's ICU Patients and Graduates|Recruiting||N/A|220|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||||2017-10-11 02:39:21.41093|2017-10-11 02:39:21.41093
NCT01659697|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2012-08-05|||August 2012||2012-08-01|August 2012|2012-08-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Observational|DPEP||Diabetes Prevention in Prediabetic Patients|Diabetes Prevention in Patients Aged 25-55 From Ethiopian Origin With Prediabetes: Evaluation of Feasibility and Efficacy of Intensive or Less Intensive Lifestyle Intervention|Unknown status|Not yet recruiting|N/A|200|Anticipated|Meir Medical Center|||2||f||||f||||||||||2017-10-11 02:39:21.497947|2017-10-11 02:39:21.497947
NCT01659684|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-03|||October 2010||2010-10-01|August 2012|2012-08-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection|Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection|Unknown status|Recruiting|N/A|300|Anticipated|Fondazione Onlus Camillo De Lellis||1|||f||||f||||||||||2017-10-11 02:39:21.584433|2017-10-11 02:39:21.584433
NCT01659671|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2014-12-12|||June 2007||2007-06-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|December 2011|Actual|2011-12-01||Interventional|SKUP3||RCT of the Effect of Uvulopalatopharyngoplasty Compared to Expectancy in Patients With Obstructive Sleep Apnea||Completed||N/A|65|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 02:39:21.685917|2017-10-11 02:39:21.685917
NCT01659658|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-06-08|||December 26, 2012|Actual|2012-12-26|June 2017|2017-06-01|September 1, 2018|Anticipated|2018-09-01|September 1, 2018|Anticipated|2018-09-01||Interventional|||Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis|A Phase 3, Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physicians Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis|Recruiting||Phase 3|248|Anticipated|Takeda||2|||f||||t|t|f||||||||2017-10-11 02:39:21.786678|2017-10-11 02:39:21.786678
NCT01659645|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-10-26|||August 2012||2012-08-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast|Amino Acid Transport Imaging of Breast Carcinoma Via Anti-3-[18F]FACBC PET-CT: A Pilot Study|Completed||Early Phase 1|12|Actual|Emory University||1|||f||||t||||||||||2017-10-11 02:39:22.211053|2017-10-11 02:39:22.211053
NCT01659632|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2012-08-06|||April 2010||2010-04-01|August 2012|2012-08-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Observational|||Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer|Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer|Unknown status|Recruiting|N/A|1000|Anticipated|The Catholic University of Korea|||1||f||||f||||||||||2017-10-11 02:39:22.295481|2017-10-11 02:39:22.295481
NCT01659619|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2013-02-20|||April 2012||2012-04-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis|Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis : Randomized and Prospective Study|Completed||Phase 2|114|Actual|The Catholic University of Korea||2|||f||||f||||||||||2017-10-11 02:39:22.361061|2017-10-11 02:39:22.361061
NCT01659606|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2017-07-21|||July 2012||2012-07-01|July 2017|2017-07-01|December 2034|Anticipated|2034-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita|Radiation- and Alkylator-free Hematopoietic Cell Transplantation for Bone Marrow Failure Due to Dyskeratosis Congenita / Telomere Disease|Recruiting||Phase 2|20|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 02:39:22.465487|2017-10-11 02:39:22.465487
NCT01659593|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-06|2016-03-07|||September 2012||2012-09-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|September 2016|Anticipated|2016-09-01||Interventional|PROCOG-SEP||Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients|Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients. A Double Blind Randomized Multicenter Trial.|Recruiting||N/A|140|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-10-11 02:39:22.632555|2017-10-11 02:39:22.632555
NCT01659580|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-03-07|||August 2012||2012-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CAESA||Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina|Phase III Confirmatory Trial to Confirm the Anti-anginal Effect of Dantonic® (T89) in Patients With Chronic Stable Angina|Completed||Phase 3|1004|Actual|Tasly Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-11 02:39:22.759668|2017-10-11 02:39:22.759668
NCT01659567|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-05-05|2017-05-05||April 6, 2011|Actual|2011-04-06|May 2017|2017-05-01|October 20, 2015|Actual|2015-10-20|October 20, 2015|Actual|2015-10-20||Observational||Analysis population included all treated participants.|A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C|Prospective, Observational Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Patients With Hepatitis C in Georgia|Completed||N/A|516|Actual|Hoffmann-La Roche|||1||f|||||t|f||||||||2017-10-11 02:39:23.089471|2017-10-11 02:39:23.089471
NCT01659554|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-01-30|2014-11-03||March 2012||2012-03-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|HIPEC||A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers|A Phase II Combined Modality Protocol of Debulking Surgery With Heated Intraoperative Chemotherapy (HIPEC) Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancers|Terminated||Phase 2|4|Actual|Columbia University|"Zero participants analyzed due to early termination of study. Adverse Events could not be collected over the pre-specified Time Frame (5 years) due to study termination"|1||Principal Investigator left institution|f||||t|t|f|||f|||No||2017-10-11 02:39:23.569388|2017-10-11 02:39:23.569388
NCT00004404|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||April 1997||1997-04-01|May 1998|1998-05-01|September 2002||2002-09-01|||||Interventional|||Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes||Completed||N/A|20|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.52253|2017-10-11 04:25:19.52253
NCT01659528|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-05|2013-01-31|||July 2012||2012-07-01|January 2013|2013-01-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Establishing Nomograms of Penile Length and Width Throughout the Weeks of Pregnancy|Establishing Nomograms of Penile Length and Width Throughout the Weeks of Pregnancy - A Prospective Descriptive Study.|Withdrawn||N/A|0|Actual|Carmel Medical Center|||1|A similar article was already published by another investigator.|f||||f||||||||||2017-10-11 02:39:23.91622|2017-10-11 02:39:23.91622
NCT01659515|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-08-24||||||August 2016|2016-08-01||||||||Expanded Access|||Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria|Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria|Available||N/A|||U.S. Army Medical Research and Materiel Command|||||||||||||||||||2017-10-11 02:39:24.127308|2017-10-11 02:39:24.127308
NCT01659502|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-12-04|||December 2013||2013-12-01|December 2013|2013-12-01||||October 2014|Anticipated|2014-10-01||Interventional|||Investigator's Initiated Phase II Study for Pancreatic Cancer Patients||Unknown status|Not yet recruiting|Phase 2|10|Anticipated|Tiltan Pharma Ltd.||1|||f||||||||||||||2017-10-11 02:39:24.21006|2017-10-11 02:39:24.21006
NCT01659489|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-04-19|||August 2012||2012-08-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Observational|ATOMS||ADnexal TOrsion Markers Study|Blood and Serum Markers in Patients Operated for Suspected Ovarian Torsion|Recruiting||N/A|200|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples Without DNA|"     Serum will be frozen for evaluation   "|||2017-10-11 02:39:24.307897|2017-10-11 02:39:24.307897
NCT01659476|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-03-31|||October 2012||2012-10-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Bronchodilating and Bronchoprotective Effects of Deep Inspirations|Bronchodilating and Bronchoprotective Effects of Deep Inspirations in Asthma, Cough Variant Asthma and Chronic Cough With Normal Airway Sensitivity and Sensory-Mechanical Responses to High-Dose Methacholine in Healthy Normal Subjects|Active, not recruiting||N/A|36|Anticipated|Queen's University||4|||f||||f||||||||||2017-10-11 02:39:24.386396|2017-10-11 02:39:24.386396
NCT01659463|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-21|||April 2011||2011-04-01|August 2012|2012-08-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Resin Infiltratration on the Sealing of Proximal Early Caries|Resin Infiltration on Teh Sealing of Proximal Early Caries Lesins: a Randomized Trial|Unknown status|Recruiting|N/A|39|Anticipated|Universidade Federal de Santa Maria||2|||f||||f||||||||||2017-10-11 02:39:24.485551|2017-10-11 02:39:24.485551
NCT01659450|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-07|||January 2011||2011-01-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Low Energy Dense, Weight Maintenance, Risk of Cardiovascular Disease|Low Energy Density Diet and Weight Loss Maintenance|Completed||Phase 3|35|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:39:24.586628|2017-10-11 02:39:24.586628
NCT01659437|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-01-21|||December 2012||2012-12-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8|Randomized Controlled Trial Comparing Efficacy of 8 Weeks Treatment With Clarithromycin and Rifampicin Versus Streptomycin and Rifampicin for Buruli Ulcer (M. Ulcerans Infection)|Active, not recruiting||Phase 2/Phase 3|415|Anticipated|University Medical Center Groningen||2|||f||||t||||||||Yes|after completion, IPD will be made available at the time of publication; enrollment is according to schedule, with 275 participants enrolled by 20/4/2016|2017-10-11 02:39:24.679633|2017-10-11 02:39:24.679633
NCT01659424|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-12-17|||June 2011||2011-06-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|HDRBT||Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy and FOLFOX Chemotherapy for Rectal Cancer|Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy (BT) FOLFOX Chemotherapy for Stage II/III Rectal Cancer|Withdrawn||Phase 2|0|Actual|Beth Israel Medical Center||1||No participants were enrolled|f||||f||||||||||2017-10-11 02:39:24.8095|2017-10-11 02:39:24.8095
NCT01659411|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-04-21|||December 1, 2011||2011-12-01|April 2017|2017-04-01|August 1, 2018|Anticipated|2018-08-01|June 1, 2018|Anticipated|2018-06-01|3 Years|Observational [Patient Registry]|||Adult Congenital Heart Disease Registry (QuERI)|Adult Congenital Heart Disease Quality Enhancement Research Initiative|Active, not recruiting||N/A|800|Anticipated|Actelion|||1||f||||f||||||||||2017-10-11 02:39:24.931007|2017-10-11 02:39:24.931007
NCT01659398|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-01-12|||June 2012||2012-06-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients|Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients|Completed||Early Phase 1|8|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 02:39:25.179552|2017-10-11 02:39:25.179552
NCT01659385|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-05-09|||August 2012||2012-08-01|May 2017|2017-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|LL-PTC||Leptin Levels in Papillary Thyroid Cancer|Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls|Completed||N/A|18|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 02:39:25.285453|2017-10-11 02:39:25.285453
NCT01659372|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-04|2012-08-06|||June 2012||2012-06-01|August 2012|2012-08-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain|Phase 1 Study of Low Level Laser Therapy Versus Naproxen|Unknown status|Recruiting|Phase 1|40|Anticipated|Shahid Beheshti University||2|||f||||f||||||||||2017-10-11 02:39:25.355869|2017-10-11 02:39:25.355869
NCT01659359|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-04|2012-08-07|||January 2011||2011-01-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||The Effect of Virtual Reality Glasses on Pain and Anxiety|Vice-presidency for Research|Completed||Phase 2/Phase 3|30|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:39:25.469456|2017-10-11 02:39:25.469456
NCT01659346|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-04|2017-09-23|||February 2016||2016-02-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.|A Prospective Randomized Controlled Trial Comparing Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis|Recruiting||N/A|84|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 02:39:25.541333|2017-10-11 02:39:25.541333
NCT01659333|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-04|2012-08-04|||January 2011||2011-01-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Observational|||The Association Between Arterial Stiffness and Assessment of Hydration State in Peritoneal Dialysis Patients|Volume Status in Peritoneal Dialysis Patients With Using Different Determining Methods.|Completed||N/A|60|Actual|TC Erciyes University|||2||f||||f||||||||||2017-10-11 02:39:25.642351|2017-10-11 02:39:25.642351
NCT01659320|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-04-04|2017-02-17||March 2012||2012-03-01|April 2017|2017-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Open Treatment of Minocycline in Geriatric Depression|Open Treatment of Minocycline in Geriatric Depression|Completed||N/A|16|Actual|Weill Medical College of Cornell University||1|||f||||t||||||||Undecided||2017-10-11 02:39:25.719462|2017-10-11 02:39:25.719462
NCT01659307|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-04|2017-02-04|||September 2012||2012-09-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|ARENA||The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury|The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury|Recruiting||Phase 2|33|Anticipated|Belfast Health and Social Care Trust||3|||f||||t||||||||||2017-10-11 02:39:27.767632|2017-10-11 02:39:27.767632
NCT01659294|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-01-26|||August 2012||2012-08-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|DONCM||Diabetes Outcomes and Nurse Case Manager Study|Impact of Nurse Case Management on Diabetes-related Health Outcomes in a Specialty Care Setting: A Randomized Controlled Trial|Completed||N/A|140|Actual|BCDiabetes.Ca||2|||f||||f||||||||||2017-10-11 02:39:27.859469|2017-10-11 02:39:27.859469
NCT01659281|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-26|2012-08-06|||September 2007||2007-09-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, Thailand|Efficacy of Artesunate-Mefloquine Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Trat Province, Thailand|Completed||N/A|13|Actual|Armed Forces Research Institute of Medical Sciences, Thailand||2|||f||||f||||||||||2017-10-11 02:39:27.941491|2017-10-11 02:39:27.941491
NCT01659268|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-05-07|2013-08-11||September 2012||2012-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|LMANURSING||Performance of Baccalaureate Nursing Students in Insertion of Laryngeal Mask: a Trial in Mannequins|Performance of Nursing Students in the Insertion of Supraglottic Device (Laryngeal Mask): Randomized Controlled Trial on Mannequins.|Completed||N/A|17|Actual|University of Sao Paulo|The limitations of this study are due to the small number of participants in the sample, even after running wide dissemination workshop for print and electronic media with students nursing institution involved in research.|2|||f||||t||||||||||2017-10-11 02:39:28.039964|2017-10-11 02:39:28.039964
NCT01659255|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-03-25|||August 2012||2012-08-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Phase I Study of ONO-4059 (ONO/GS-4059) Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL|An Open-label, Multi-Center, Non-Randomised Phase I Dose-Escalation Study to Investigate the Safety and Tolerability of ONO-4059 (ONO/GS-4059) Given as Monotherapy in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL) and Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL)|Completed||Phase 1|90|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 02:39:28.363753|2017-10-11 02:39:28.363753
NCT01659242|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-11-26|||July 2012||2012-07-01|November 2014|2014-11-01||||December 2012|Actual|2012-12-01||Interventional|||Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study|Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis Patients With Active Disease Despite Methotrexate: an Ultrasound and Magnetic Resonance Imaging Study|Terminated||Phase 4|1|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-10-11 02:39:28.444099|2017-10-11 02:39:28.444099
NCT01659229|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-16|||October 2011||2011-10-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|July 2012|Actual|2012-07-01||Observational|||Fluoroscopic Analysis of PFC CR 150 Versus Standard PFC CR Total Knee Arthroplasty Implants in Deep Flexion|Fluoroscopic Analysis Comparing the Dynamic Flexion of 2 Different Knee Arthroplasty Implants|Unknown status|Active, not recruiting|N/A|12|Actual|Singapore General Hospital|||2||f||||f||||||||||2017-10-11 02:39:28.528397|2017-10-11 02:39:28.528397
NCT01659216|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-08-06|||January 2002||2002-01-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Observational|||The Long-term Efficacy of Electrical Pudendal Nerve Stimulation for the Urgency-Frequency Syndrome in Women|The Long-term Efficacy of Electrical Pudendal Nerve Stimulation for the Urgency-Frequency Syndrome in Women|Completed||N/A|90|Actual|Shanghai Institute of Acupuncture, Moxibustion and Meridian|||1||f||||t||||||||||2017-10-11 02:39:28.592714|2017-10-11 02:39:28.592714
NCT01659203|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-09-15|||December 2012||2012-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Proton or Photon RT for Retroperitoneal Sarcomas|Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) or Photon (IMRT) With Simultaneously Integrated Boost to the High Risk Margin for Retroperitoneal Sarcomas|Recruiting||Phase 1/Phase 2|80|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:39:28.778145|2017-10-11 02:39:28.778145
NCT01659190|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2014-01-10|||August 2012||2012-08-01|June 2012|2012-06-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|LINIPOCHE||The Painful Real-life Experience of the Child of Less Than Three Years During the Removal of the Collecting Bags in the Pediatric Urgency: What Strategy of Coverage?|The Painful Real-life Experience of the Child of Less Than Three Years During the Removal of the Collecting Bags in the Pediatric Urgency: What Strategy of Coverage?|Completed||N/A|136|Actual|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 02:39:28.913823|2017-10-11 02:39:28.913823
NCT01659177|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-09-28|||August 2012||2012-08-01|September 2012|2012-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||A Study of LY2140023 in Healthy Participants|The Effect of Food on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects After Administration of the Commercial Tablet Formulation of LY2140023|Withdrawn||Phase 1|0|Actual|Eli Lilly and Company||2||"The decision to stop the trial was based on efficacy results in the overall schizophrenia   patient population."|f||||f||||||||||2017-10-11 02:39:28.991144|2017-10-11 02:39:28.991144
NCT01659164|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2015-04-01|||August 2012||2012-08-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Psychological Treatment for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|Psychological Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) - Pilot Evaluation of a New Treatment Manual Based on CBT and DBT|Completed||N/A|18|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 02:39:29.06868|2017-10-11 02:39:29.06868
NCT01659151|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-05-22|||July 26, 2012|Actual|2012-07-26|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma|A Phase II Clinical Trial of Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Patients With Metastatic Melanoma|Active, not recruiting||Phase 2|17|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f|t|f||||||||2017-10-11 02:39:29.164266|2017-10-11 02:39:29.164266
NCT01659138|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-07-12||2015-11-03|August 2012||2012-08-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|June 2014|Actual|2014-06-01||Interventional|FUSCIA||Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)|Terminated||Phase 2|28|Actual|Sanofi||2||Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.|f||||t||||||||||2017-10-11 02:39:29.280229|2017-10-11 02:39:29.280229
NCT01659125|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2015-12-02|2015-04-08||August 2012||2012-08-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)|Effectiveness and Neuropsychological Predictors of Guided Self-Help for OCD|Completed||N/A|26|Actual|Hartford Hospital||1|||f||||f||||||||||2017-10-11 02:39:29.457886|2017-10-11 02:39:29.457886
NCT01659112|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-10-15|||March 2008||2008-03-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Core Stabilization Approach on Patients With Upper Extremity Injuries|Does Core Stabilization Enhance Neuromuscular Control and Functional Status of the Upper Extremity?|Completed||N/A|27|Actual|Hacettepe University||2|||f||||t||||||||||2017-10-11 02:39:29.664454|2017-10-11 02:39:29.664454
NCT01659099|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2017-03-08|||September 2012||2012-09-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|GAINED||GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma|Randomized Phase III Study Using a Pet-driven Strategy and Comparing GA101 OR Rituximab Associated to a Chemotherapy Delivered Every 14 Days (ACVBP or CHOP) in DLBCL CD20+ Lymphoma Untreated Patients From 18 to 60 Presenting With 1 or More Adverse Prognostic Factors of the Age-adjusted IPI|Active, not recruiting||Phase 3|670|Anticipated|The Lymphoma Academic Research Organisation||2|||f||||t||||||||||2017-10-11 02:39:29.755063|2017-10-11 02:39:29.755063
NCT01659086|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-05-09|||August 22, 2012|Actual|2012-08-22|May 2017|2017-05-01|March 19, 2014|Actual|2014-03-19|October 26, 2012|Actual|2012-10-26||Interventional|||Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age|An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age|Completed||Phase 1|422|Actual|GlaxoSmithKline||11|||f||||||||||||||2017-10-11 02:39:30.20937|2017-10-11 02:39:30.20937
NCT01659073|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-08-09|||September 2012||2012-09-01|August 2012|2012-08-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|||Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation|Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation|Unknown status|Not yet recruiting|N/A|6|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 02:39:30.347882|2017-10-11 02:39:30.347882
NCT01659060|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-02|||July 2008||2008-07-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Chocolate Consumption in Healthy Pregnant Women Trial|Assessment of Blood Pressure and Endothelial Function Pregnancy After Acute and Daily Consumption Flavanol-rich Chocolate Among Healthy Pregnant Women: a Pilot Randomized Controlled Trial|Completed||Phase 2|44|Actual|Laval University||2|||f||||t||||||||||2017-10-11 02:39:30.479994|2017-10-11 02:39:30.479994
NCT01659047|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2012-09-06|||August 2012||2012-08-01|September 2012|2012-09-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia|A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia|Withdrawn||Phase 2|0|Actual|Gilead Sciences||1|||f||||t||||||||||2017-10-11 02:39:30.626221|2017-10-11 02:39:30.626221
NCT01659034|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-12-09|||September 2012||2012-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|STOPDAPT||Short and Optimal Duration of Dual Antiplatelet Therapy Study|Short and Optimal Duration of Dual Antiplatelet Therapy Study|Completed||Phase 4|1525|Actual|Kyoto University, Graduate School of Medicine||1|||f||||t||||||||||2017-10-11 02:39:30.756919|2017-10-11 02:39:30.756919
NCT01658891|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2013-02-18|||February 2014||2014-02-01|February 2013|2013-02-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children|A SINGLE CENTRE, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, 2-WAY CROSS OVER STUDY TO COMPARE SAFETY ASSESSED BY KNEMOMETRY AND URINARY CORTISOL MEASUREMENTS OF CHF1535 50/6 NEXThaler® (FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE AND FORMOTEROL FUMARATE) AND THE FREE COMBINATION OF LICENSED BECLOMETHASONE DIPROPIONATE AND FORMOTEROL FUMARATE IN ASTHMATIC CHILDREN ALREADY TREATED WITH INHALED CORTICOSTEROIDS|Withdrawn||Phase 3|0|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 02:39:30.917519|2017-10-11 02:39:30.917519
NCT01658878|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-09-27|||September 26, 2012|Actual|2012-09-26|September 2017|2017-09-01|July 9, 2019|Anticipated|2019-07-09|July 22, 2018|Anticipated|2018-07-22||Interventional|CheckMate040||An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer|A Phase 1/2, Dose-escalation, Open-label, Non-comparative Study of Nivolumab or Nivolumab in Combination With Ipilimumab in Advanced Hepatocellular Carcinoma Subjects With or Without Chronic Viral Hepatitis; and a Randomized, Open-label Study of Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Subjects Who Are Naive to Systemic Therapy|Recruiting||Phase 1/Phase 2|620|Anticipated|Bristol-Myers Squibb||9|||f||||t|t|f||||||||2017-10-11 02:39:31.035103|2017-10-11 02:39:31.035103
NCT01658839|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-03-04|2014-06-24||January 2013||2013-01-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||This analysis population includes all enrolled participants.|Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients|An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients|Completed||Phase 1|25|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 02:39:31.637822|2017-10-11 02:39:31.637822
NCT01658826|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2016-09-21||2014-07-08|October 2012||2012-10-01|September 2016|2016-09-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes|"A Double-blind, Double Dummy, Randomized Crossover Trial to Compare the Effect of AIC316 (Pritelivir) 100 mg Once Daily Versus Valacyclovir 500 mg Once Daily on Genital HSV Shedding in HSV-2 Seropositive Adults."|Terminated||Phase 2|91|Actual|AiCuris Anti-infective Cures GmbH||2|||f||||f||||||||||2017-10-11 02:39:31.890413|2017-10-11 02:39:31.890413
NCT01658813|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-11-10|2015-12-29||July 2012||2012-07-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer|Phase II Trial of Chemoimmunotherapy With 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer|Completed||Phase 2|18|Actual|Western Regional Medical Center||1|||f||||f||||||||||2017-10-11 02:39:31.976399|2017-10-11 02:39:31.976399
NCT01658800|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-03-05|||September 2012||2012-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49|Phase I Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49|Completed||Phase 1|275|Actual|VaxInnate Corporation||1|||f||||t||||||||||2017-10-11 02:39:32.215781|2017-10-11 02:39:32.215781
NCT01658787|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-03|2017-09-07|||December 2010||2010-12-01|September 2017|2017-09-01|September 2026|Anticipated|2026-09-01|September 2026|Anticipated|2026-09-01|10 Years|Observational [Patient Registry]|GREAT||Global Registry for Endovascular Aortic Treatment (GREAT)|'GREAT' Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation|Active, not recruiting||N/A|4625|Actual|W.L.Gore & Associates|||1||f||||t||||||||||2017-10-11 02:39:32.302692|2017-10-11 02:39:32.302692
NCT01658774|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-04-09|||January 2013||2013-01-01|February 2014|2014-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children|Impact of Repeated Anthelminthic Treatment on Malaria in School Children: an Individual Randomized, Double-blind, Placebo-controlled Trial in Western Kenya|Completed||N/A|2377|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 02:39:32.389981|2017-10-11 02:39:32.389981
NCT01658761|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-28|2012-08-01|||September 1998||1998-09-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|February 2011|Actual|2011-02-01||Interventional|||Surgical Outcome of Vitrectomy for Myopic Traction Maculopathy in Highly Myopic Eyes|Surgical Outcome of Vitrectomy for Myopic Traction Maculopathy in Highly Myopic Eyes|Completed||N/A|64|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 02:39:32.658858|2017-10-11 02:39:32.658858
NCT01658748|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-28|2013-05-28|||January 2013||2013-01-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|ADIP||A Pilot Study of Deep Brain Stimulation of the Amygdala for Treatment-Refractory Combat Post-Traumatic Stress Disorder|A Pilot Study to Examine Deep Brain Stimulation (DBS) in the Basolateral Nucleus (BLn) of the Amygdala for the Management of Symptoms in Veterans With Chronic and Treatment-Refractory Combat-related Post-Traumatic Stress Disorder (PTSD)|Withdrawn||N/A|0|Actual|VA Office of Research and Development||2||Funding not finalized|f||||t||||||||||2017-10-11 02:39:32.785881|2017-10-11 02:39:32.785881
NCT01658735|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-02-24|2015-02-09||July 2012||2012-07-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Comparison of Electrotherapies for Chronic Low Back Pain|Electrical Stimulation for Chronic Non-specific Low Back Pain in a Working-Age Population: A 12-Week Double Blinded Randomized Controlled Trial|Completed||N/A|113|Actual|University of Utah|Participant enrollment was based on chronic pain VAS score of >= 5.0 (0-10 scale). High baseline VAS scores did not translate to a priori hypothesized high ODI scores, resulting in study being underpowered to detect differences in primary outcomes.|3|||f||||t||||||||||2017-10-11 02:39:33.13784|2017-10-11 02:39:33.13784
NCT01658722|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-08-31|||December 2011||2011-12-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|RAPID||Retrieval of Patient Information After Discontinuation|A Phase 3b Study of Subjects With Alzheimer's Disease Who Discontinued Treatment in Bapineuzumab Phase 3 Clinical Studies (ELN115727-301/302/351) or Who Completed Studies ELN15727-301 and 302 But Did Not Enroll in Study ELN115727-351|Terminated||N/A|169|Actual|JANSSEN Alzheimer Immunotherapy Research & Development, LLC|||1||f||||||||||||||2017-10-11 02:39:34.687172|2017-10-11 02:39:34.687172
NCT01658709|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-12-09|||September 2012||2012-09-01|December 2013|2013-12-01||||September 2030|Anticipated|2030-09-01||Observational|||Predicting Ankle Injury Through Clinical Functional Measures in Adolescent Athletes|Using Dynamic Postural Control and Functional Testing to Predict Ankle Injury in Adolescent Athletes|Active, not recruiting||N/A|700|Anticipated|University of Toledo Health Science Campus|||2||f||||f||||||||||2017-10-11 02:39:34.76826|2017-10-11 02:39:34.76826
NCT01658696|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-12-11|||August 2012||2012-08-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy of Candidate Malaria Vaccines in Senegalese Adults|Efficacy Study of ChAd63-MVA ME-TRAP Prime-boost Vaccination Against Plasmodium Falciparum Infection|Completed||Phase 2|120|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 02:39:34.871595|2017-10-11 02:39:34.871595
NCT01658683|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-04-11|||October 2012||2012-10-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|ECOPCR||The Efficacy and Economics of Exercise Maintenance Post-Cardiac Rehabilitation|Ecologically Optimizing Exercise Maintenance in Men and Women Post-Cardiac Rehabilitation: A Randomized Controlled Trial of Efficacy With Economics|Active, not recruiting||N/A|451|Actual|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-11 02:39:34.980775|2017-10-11 02:39:34.980775
NCT01658670|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-06-14|||April 2012||2012-04-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2016|Actual|2016-12-01||Interventional|HEART Camp||HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure|HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure|Active, not recruiting||N/A|246|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-10-11 02:39:35.139408|2017-10-11 02:39:35.139408
NCT01658657|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2015-08-17|2015-06-03||October 2012||2012-10-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension|A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension|Completed||N/A|17|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:39:35.304335|2017-10-11 02:39:35.304335
NCT01658644|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-04-04|||August 2012||2012-08-01|August 2012|2012-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Face2Name||Put a Face to a Name (Part A): The Effects of Photographic Aids on Patient Satisfaction, Clinician Communication, and Quality of Care|Put a Face to a Name (Part A): The Effects of Photographic Aids on Patient Satisfaction,Clinician Communication, and Quality of Care|Completed||N/A|256|Actual|University Health Network, Toronto||3|||f||||||||||||||2017-10-11 02:39:35.571076|2017-10-11 02:39:35.571076
NCT01658631|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-11-02|||August 2012||2012-08-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Evaluation of Nexfin During Anesthesia and in Intensive Care (NexfinEval)|Evaluation of Nexfin During Induction of General Anesthesia and in Intensive Care During a Passive Legs Raising Test|Completed||N/A|97|Actual|Hopital Foch|||2||f||||f||||||||||2017-10-11 02:39:35.671953|2017-10-11 02:39:35.671953
NCT01658605|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-06-20|||February 2013||2013-02-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|February 2013|Actual|2013-02-01||Interventional|||A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis|A Phase II, 20-week, Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group Proof of Concept Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||2||"Study CCX115383 has been terminated prior to enrolment of any patients. A decision was made by   GSK to delay pursuit of this indication as the biology evolves."|f||||||||||||||2017-10-11 02:39:35.97934|2017-10-11 02:39:35.97934
NCT01658592|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-08-02|||July 2012||2012-07-01|August 2012|2012-08-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Deep Brain Stimulation of the Nucleus Accumbens and the Ventral Anterior Internal Capsule for Severe Alcohol Addiction|Deep Brain Stimulation of the Nucleus Accumbens and the Ventral Anterior Internal Capsule as a Novel Treatment in Severe Alcohol Addiction|Unknown status|Recruiting|N/A|20|Anticipated|Tang-Du Hospital||4|||f||||t||||||||||2017-10-11 02:39:36.097297|2017-10-11 02:39:36.097297
NCT01658579|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-05-07|2015-03-24|2014-04-08|August 2012||2012-08-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Randomized population: all screened participants (who originally met inclusion criteria and signed informed consent) allocated to a treatment arm and recorded in Interactive Voice/Web Response System (IVRS/IWRS) database, regardless of whether treatment was used or not. Participants were analyzed in treatment arm to which they were randomized.|Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin|A 16-week, Randomized, Open-label, Controlled Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine Versus Lantus in Patients With Type 1 Diabetes Mellitus|Completed||Phase 2|59|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 02:39:36.248874|2017-10-11 02:39:36.248874
NCT01658553|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-02-12|||September 2012||2012-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212|A Phase I, Single-Sequence, Placebo-Controlled, Single-Blind Study to Evaluate the Effect of Repeat Oral Dosing of GSK1120212 on Cardiac Repolarization in Subjects With Solid Tumors|Completed||Phase 1|35|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 02:39:37.264668|2017-10-11 02:39:37.264668
NCT01658540|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-09-30|||October 2012||2012-10-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Observational|DEB-SFA-LONG||Drug Eluting Balloon (DEB) and Long Lesions of Superficial Femoral Artery (SFA) Ischemic Vascular Disease|Safety and Efficacy of the Drug Eluting Balloon (DEB) for the Treatment of the Superficial Femoral Artery (SFA) Ischemic Vascular Disease in Symptomatic Patients Presenting With Long Lesions: a Pilot Study|Completed||N/A|105|Actual|Ettore Sansavini Health Science Foundation|||1||f||||f||||||||No||2017-10-11 02:39:37.409625|2017-10-11 02:39:37.409625
NCT01658527|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2016-06-09|||January 2014||2014-01-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||TAK-700 in Castration Resistant Prostate Cancer|Phase II Randomized Comparative Trial of TAK-700 (Orteronel) Versus Bicalutamide in Metastatic Prostate Cancer Patients Failing 1st Line Treatment With LHRH Agonists or Surgical Castration.|Withdrawn||Phase 2|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2||Pharmaceutical company has terminated orteronel (TAK-700) development for Prostate Cancer|f||||t||||||||||2017-10-11 02:39:37.510821|2017-10-11 02:39:37.510821
NCT01658514|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-11-25|2015-10-12||January 2014||2014-01-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Randomized Population - All subjects were to receive all interventions and are distributed in this module according to their renal function cohort to inform PK analyses comparing these populations|Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction|A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction|Completed||Phase 2|39|Actual|Elcelyx Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 02:39:37.656055|2017-10-11 02:39:37.656055
NCT01658501|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-11-05||2014-10-28|July 2012||2012-07-01|November 2015|2015-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM|Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the Pharmacodynamic Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Once-Weekly Subcutaneous Dosing in Adult Subjects With Inadequately Treated Type 2 Diabetes Mellitus|Completed||Phase 2|593|Actual|PhaseBio Pharmaceuticals Inc.||7|||f||||t||||||||||2017-10-11 02:39:38.505828|2017-10-11 02:39:38.505828
NCT01658488|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-12-17|||July 2012||2012-07-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Pilot Study of the Effect of Iron Fortified Rice in Iron Deficient Anemic Women|Pilot Study of the Effect of Iron Fortified Rice on Iron Stores and Reticulocytes in Iron Deficient Anemic Women|Completed||N/A|20|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 02:39:38.808289|2017-10-11 02:39:38.808289
NCT01658462|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-07-28|||May 2013||2013-05-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|VAROCE-1206||Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer|A Phase II Randomized Study of Docetaxel With or Without NINTEDANIB (BIBF-1120) in Patient Receiving a First or Second-line of Chemotherapy for HER Negative Metastatic or Locally Recurrent Breast Cancer|Active, not recruiting||Phase 2|51|Actual|Centre Oscar Lambret||2|||f||||t||||||||No||2017-10-11 02:39:39.002576|2017-10-11 02:39:39.002576
NCT01658449|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-08-09|||December 2009||2009-12-01|February 2009|2009-02-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Comparison of the Tolerability of Two Formulations of Hypertonic Saline in Cystic Fibrosis Patients||Completed||N/A|40|Actual|Ospedale Civile Ca' Foncello||2|||f||||||||||||||2017-10-11 02:39:39.150192|2017-10-11 02:39:39.150192
NCT01658436|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-04-19|2016-03-11||November 2012||2012-11-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||The Full Analysis Set (FAS) comprised of all patients who received at least one dose of study treatment (Stage 1). This set was known as ‘Analysis Set Stage 1’ (AS1).|BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.|A Multicenter, Two Stage, Phase II Study, Evaluating the Efficacy of Oral BEZ235 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in the Treatment of Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.|Completed||Phase 2|31|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:39:39.258969|2017-10-11 02:39:39.258969
NCT01658423|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-06|||March 2011||2011-03-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Observational|MMF||Maturity and Motor Fitness|EFFECT OF MATURITY ON SPRINT AND JUMP PERFORMANCES IN ADOLESCENT BOYS.|Completed||N/A|107|Actual|National Institute of Fitness and Sports in Kanoya|||1||f||||t||||||||||2017-10-11 02:39:39.976991|2017-10-11 02:39:39.976991
NCT01658410|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-08-02|||July 2012||2012-07-01|August 2012|2012-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG|Short-term Endothelin A Receptor Blockade in Patients With On-pump Coronary Artery Bypass Grafting|Unknown status|Enrolling by invitation|Phase 2|120|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:39:40.15452|2017-10-11 02:39:40.15452
NCT01658397|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-02-08|||September 2012||2012-09-01|February 2017|2017-02-01|July 21, 2014|Actual|2014-07-21|July 21, 2014|Actual|2014-07-21||Interventional|||The Effect of Calorie Deprivation on Adipose Tissue Distribution|The Effect of Calorie Deprivation on Adipose Tissue Distribution|Completed||N/A|12|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 02:39:40.26979|2017-10-11 02:39:40.26979
NCT01658384|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2015-03-30|||September 2011||2011-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|CogMS||Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients|Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients|Completed||Phase 4|63|Actual|Clinique Neuro-Outaouais|||1||f||||f||||||||||2017-10-11 02:39:40.355459|2017-10-11 02:39:40.355459
NCT01658371|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-08-02|||May 2008||2008-05-01|August 2012|2012-08-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Observational|||Preference of Genetic Polymorphism and Pharmacokinetics|Preference of CYP450 2B6 516 G>T Polymorphism and Pharmacokinetics of Plasma Efavirenz in A Group of HIV Infected Southern Chinese|Completed||N/A|100|Actual|Chinese University of Hong Kong|||1||f||||f||||||||||2017-10-11 02:39:40.453807|2017-10-11 02:39:40.453807
NCT01658358|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2013-02-26|||July 2012||2012-07-01|February 2013|2013-02-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||ErbB2 Positive Metastatic Breast Cancer|A Phase I/II Study of Lapatinib (Tykerb) Plus Liposomal Doxorubicin Hydrochloride ( Lipo-Dox) for Patients With ErbB2 Positive Metastatic Breast Cancer|Terminated||Phase 1/Phase 2|15|Anticipated|China Medical University Hospital||2|||f||||f||||||||||2017-10-11 02:39:40.525647|2017-10-11 02:39:40.525647
NCT01658345|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2015-02-20|||April 2012||2012-04-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|November 2013|Actual|2013-11-01||Observational|PRIMID-AS||Microvascular Dysfunction in Aortic Stenosis|Prognostic Importance of Microvascular Dysfunction in Asymptomatic Patients With Aortic Stenosis (PRIMID-AS)|Completed||N/A|175|Actual|University Hospitals, Leicester|||1||f||||t||||||Samples Without DNA|"     With consent, a blood sample (up to 50ml) will be drawn and banked for prospective research     studies. All research projects will be related to cardiovascular disease and approved by the     Trial Steering Committee (TSC) or a committee delegated this responsibility by the TSC.      All tissue will be collected, stored and disposed of in accordance with the Codes of Practice     as laid out by the Human Tissue Authority.   "|||2017-10-11 02:39:40.615226|2017-10-11 02:39:40.615226
NCT01658332|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2015-07-29|||June 2012||2012-06-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CIRCUBRONCH||Circulating Tumor Cells in Lung Cancer|Circulating Tumor Cells Identification in Advanced Stage Non-small Cell Lung Cancer|Terminated||N/A|59|Actual|Central Hospital, Nancy, France||1||unavailability of the investigator due to an overloaded planning|f||||f||||||||||2017-10-11 02:39:40.6844|2017-10-11 02:39:40.6844
NCT01658319|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-08-12|||May 2011||2011-05-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies|Phase I Trial of Fludarabine and Methoxyamine (TRC102) for Relapsed or Refractory Hematologic Malignancies|Completed||Phase 1|20|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:39:40.756586|2017-10-11 02:39:40.756586
NCT01657916|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-06-08|||June 2012||2012-06-01|June 2017|2017-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||5-Year Objective and Subjective Results of a Mid-Urethral Sling|5-Year Objective and Subjective Results of a Mid-Urethral Sling|Completed||N/A|90|Actual|Atlantic Health System|||1||f||||t||||||||||2017-10-11 02:39:45.337904|2017-10-11 02:39:45.337904
NCT01658306|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2014-11-25|||July 2012||2012-07-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|RIPC-SVD||Clinical Trial on Remote Ischemic Preconditioning and Cerebral Small Vessel Disease|A Random Controlled, Double-Blind Clinical Trial: Remote Ischemic Preconditioning and Cerebral Small Vessel Disease|Completed||Phase 3|30|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 02:39:40.877666|2017-10-11 02:39:40.877666
NCT01658293|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-06|||July 2011||2011-07-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|TSSP||Thermal Stimulation for Stroke Patients|Facilitation of Sensory and Motor Recovery by Means of Heat and Cold-water Stimulation on the Paretic Upper Limb of After Stroke: One Year Follow up|Unknown status|Recruiting|N/A|60|Anticipated|Buddhist Tzu Chi General Hospital||2|||f||||t||||||||||2017-10-11 02:39:40.955604|2017-10-11 02:39:40.955604
NCT01658280|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-02-02|||August 2012||2012-08-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies|Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration, Using Rapid On-site Cytological Evaluation, for the Diagnosis of Hilar/Mediastinal Enlarged Lymph Nodes: a Randomized Controlled Trial.|Completed||Phase 4|253|Actual|Azienda Ospedaliero, Universitaria Ospedali Riuniti||2|||f||||f||||||||||2017-10-11 02:39:41.187896|2017-10-11 02:39:41.187896
NCT01658267|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-01-19|||October 2011||2011-10-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Compliance With Dietary Recommendations in Children at Risk for Undernutrition|Compliance With Dietary Recommendations in Meeting Nutritional Requirements in Children at Risk of Undernutrition|Completed||Phase 3|200|Actual|Abbott Nutrition||1|||f||||t||||||||||2017-10-11 02:39:41.290329|2017-10-11 02:39:41.290329
NCT01658241|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-09-18|||July 2012||2012-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2016|Actual|2016-07-01||Interventional|VEG VCA1||Panobinostat Biological Correlates Study|A Phase II Study to Investigate Biological Correlates of Clinical Response to Panobinostat in Haematological Malignancy|Active, not recruiting||Phase 2|30|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-11 02:39:41.465724|2017-10-11 02:39:41.465724
NCT01658215|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-12-10|||August 2012||2012-08-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Nicotine Patch - Multidose Bioequivalence Study||Completed||Phase 1|43|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 02:39:41.703209|2017-10-11 02:39:41.703209
NCT01658202|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-12-10|||August 2012||2012-08-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Nicotine Patch Bioequivalence Study||Completed||Phase 1|28|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 02:39:41.805452|2017-10-11 02:39:41.805452
NCT01658189|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-06|||June 2012||2012-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:39:41.919173|2017-10-11 02:39:41.919173
NCT01658176|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-10-26|||January 2013||2013-01-01|October 2012|2012-10-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer|An Open-Label Randomized Phase 2 Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Estrogen Receptor Positive, Her-2 Negative Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:39:41.993858|2017-10-11 02:39:41.993858
NCT01658163|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2013-01-03|||June 2009||2009-06-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|||||Observational|||Use of 2-octyl-cyanoacrylate Together With a Self-adhering Mesh|Use of 2 Octyl-cyanoacrylate Together With a Self-adhering Mesh for Skin Closure Following Abdominoplasty: An Open, Prospective, Controlled, Randomized Clinical Study|Completed||N/A|2|Actual|Medical University of Graz|||1||f||||t||||||||||2017-10-11 02:39:42.127599|2017-10-11 02:39:42.127599
NCT01658150|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-08-19|||September 2012||2012-09-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder|A Molecular Approach to Treat Cognition in Schizophrenia: Ca2+ Channel Blockade|Recruiting||N/A|36|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-11 02:39:42.213495|2017-10-11 02:39:42.213495
NCT01658137|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-28|2016-06-05|||July 2012||2012-07-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|DIGEST||Diet Intervention and GEnetic STudy (DIGEST-Pilot)|Dietary Intervention Trial to Understand the Mechanism Underlying the 9p21 Variant Interaction With High Fruits and Vegetable Consumption|Active, not recruiting||N/A|84|Actual|McMaster University||2|||f||||f||||||||No|Because sensitive genetic material was collected as part of this pilot study, data from this study will not be shared.|2017-10-11 02:39:42.36854|2017-10-11 02:39:42.36854
NCT01658124|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-12-19|||January 2013||2013-01-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|HALT-IT||Haemorrhage Alleviation With Tranexamic Acid- Intestinal System|Tranexamic Acid for the Treatment of Gastrointestinal Haemorrhage: an International Randomised, Double Blind Placebo Controlled Trial|Recruiting||Phase 3|8000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 02:39:42.539054|2017-10-11 02:39:42.539054
NCT01658111|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-08-31|||July 2012||2012-07-01|August 2012|2012-08-01|August 2014|Anticipated|2014-08-01|July 2013|Anticipated|2013-07-01||Interventional|MITEEG||Robot-aided Therapy in Stroke Patients for Upper Limb Rehabilitation|Robot-aided Therapy in Acute Stroke Patients for the Upper Limb Rehabilitation With Long-term Follow-up.|Unknown status|Recruiting|N/A|50|Anticipated|IRCCS San Raffaele||2|||f||||f||||||||||2017-10-11 02:39:42.683026|2017-10-11 02:39:42.683026
NCT01658098|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-08-01|||September 2012||2012-09-01|July 2012|2012-07-01|February 2013|Anticipated|2013-02-01|November 2012|Anticipated|2012-11-01||Observational|||Prevalence of Postpartum Depression in Hospital Jose E. Gonzalez|Prevalence of Postpartum Depression in the Jose E. Gonzalez Hospital, Using the Edinburgh Postpartum Depression Scale|Unknown status|Not yet recruiting|N/A|348|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez|||1||f||||t||||||||||2017-10-11 02:39:42.844598|2017-10-11 02:39:42.844598
NCT01658085|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-08-01|||February 2009||2009-02-01|August 2012|2012-08-01|August 2012|Anticipated|2012-08-01|March 2010|Actual|2010-03-01||Observational|TIME||Budget Impact of Harmonic FOCUS in Thyroidectomy|Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid Disease. A Randomized, Prospective Study|Unknown status|Active, not recruiting|N/A|56|Actual|Hospital Universitari de Bellvitge|||2||f||||t||||||||||2017-10-11 02:39:42.970692|2017-10-11 02:39:42.970692
NCT01658072|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-04-04|2016-04-04||February 2012||2012-02-01|April 2016|2016-04-01||||May 2013|Actual|2013-05-01||Interventional|PAI Hip||Analgesia After Total Hip Arthroplasty: Peri-Articular Injection Versus Epidural Patient Controlled Analgesia (PCA)|Analgesia After Total Hip Arthroplasty: Peri-Articular Injection Versus Epidural Patient Controlled Analgesia|Completed||N/A|90|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 02:39:43.131934|2017-10-11 02:39:43.131934
NCT01658046|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-03|||July 2009||2009-07-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effects of Neuromuscular Electrical Stimulation as an Adjunct to Exercise Training in Stable Chronic Obstructive Pulmonary Disease (COPD)|Effects of Neuromuscular Electrical Stimulation as an Adjunct to Exercise Training in Stable COPD|Completed||N/A|27|Actual|Hacettepe University||2|||f||||t||||||||||2017-10-11 02:39:43.564094|2017-10-11 02:39:43.564094
NCT01658033|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2015-09-08|||May 2012||2012-05-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|||Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients|Phase II Study of Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Patients With Metastatic Breast Cancer|Completed||Phase 2|72|Actual|Fudan University||1|||f||||f||||||||||2017-10-11 02:39:43.681|2017-10-11 02:39:43.681
NCT01658020|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2014-10-02|2014-09-01||August 2012||2012-08-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Interventional|DW224-III-3||A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg|Clinical Trials to Evaluate Efficacy and Safety of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg After Multi-dose Oral Administration in Patients With Acute Bacterial Exacerbation of Chronic Obstructive Pulmonary Disease.|Completed||Phase 3|345|Actual|Dong Wha Pharmaceutical Co. Ltd.||2|||f||||f||||||||||2017-10-11 02:39:43.830834|2017-10-11 02:39:43.830834
NCT01658007|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-09-28|||August 2012||2012-08-01|September 2017|2017-09-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|SIR-MO-1101||Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma|Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma|Terminated||N/A|3|Actual|Children's Hospital Medical Center, Cincinnati||1||Slow Accrual|f||||t||||||||||2017-10-11 02:39:44.458022|2017-10-11 02:39:44.458022
NCT01657994|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-08-31|||May 2012||2012-05-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Combined Functional Electrical Stimulation & Robotic Gait Training for Children With Cerebral Palsy|Combined Functional Electrical Stimulation & Robotic Gait Training for Children With Cerebral Palsy|Completed||N/A|6|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 02:39:44.555254|2017-10-11 02:39:44.555254
NCT01657981|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-06-24|||February 2007||2007-02-01|August 2012|2012-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects|An Open Label Study to Evaluate the Pharmacokinetics of YM150 After a Single Oral Dose of C14-labeled YM150 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:39:44.652419|2017-10-11 02:39:44.652419
NCT01657968|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-01-17|||August 2012||2012-08-01|January 2013|2013-01-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||Procalcitonin-guided Detection of Streptococcal Acute Tonsillitis|Procalcitonin-guided Detection of Streptococcal Acute Tonsillitis|Unknown status|Recruiting|N/A|200|Anticipated|Aarhus University Hospital|||2||f||||t||||||Samples With DNA|"     Patients with acute tonsillitis:        -  Oral temperature, streptococcal rapid antigen detection test, Tonsil surface swab for          microbiological culture and a blood sample (measuring the infection markers:          Procalcitonin, C-reactive protein, White blood cell count and Absolute neutrophile          count).      Healthy control patients:        -  Tonsil surface swab for microbiological culture.   "|||2017-10-11 02:39:44.754373|2017-10-11 02:39:44.754373
NCT01657955|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-03|||January 2011||2011-01-01|August 2012|2012-08-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|CLL||Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia|Study of Bendamustine Hydrochloride Injection in Previously Untreated Chronic Lymphocytic Leukemia Patients|Unknown status|Recruiting|Phase 3|96|Anticipated|Shandong Lanjin Pharmaceuticals Co.,Ltd||2|||f||||t||||||||||2017-10-11 02:39:44.87468|2017-10-11 02:39:44.87468
NCT01657942|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-08-30|||October 2013|Actual|2013-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions|Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions|Recruiting||N/A|100|Anticipated|InSightec||1|||f||||t||||||||||2017-10-11 02:39:45.060264|2017-10-11 02:39:45.060264
NCT01657929|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-02-24|||September 2012||2012-09-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers|A Phase 1, Randomized Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the H5-VLP + GLA-AF Pandemic Influenza Vaccine in Healthy Adult Subjects|Completed||Phase 1|105|Actual|IDRI||5|||f||||t||||||||||2017-10-11 02:39:45.221763|2017-10-11 02:39:45.221763
NCT01657903|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-01-22|2014-01-16||November 2011||2011-11-01|July 2014|2014-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental Erosion|A Placebo Controlled Study to Evaluate the Effectiveness of Experimental Foaming Gel Toothpastes Using an In-situ Erosion Remineralization Model|Completed||N/A|56|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:39:45.43796|2017-10-11 02:39:45.43796
NCT01657890|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-08-31|||June 2012||2012-06-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects|A Phase 1, Open Label, Parallel Group, Single Dose Study to Evaluate the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects|Completed||Phase 1|28|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 02:39:45.786639|2017-10-11 02:39:45.786639
NCT01657877|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-09-18|2014-06-19||May 2012||2012-05-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice|In Situ Study to Confirm the Anti-caries Potential of a 1.1365% w/w Sodium Monofluorophosphate (1500ppm F) Dentifrice|Completed||Phase 2|100|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 02:39:45.887278|2017-10-11 02:39:45.887278
NCT01657864|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-02|||May 2012||2012-05-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||WEUSKOP6166: Lamotrigine and Aseptic Meningitis|WEUSKOP6166: Prevalence of Aseptic Meningitis Among Lamotrigine Users|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 02:39:48.011805|2017-10-11 02:39:48.011805
NCT01657851|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-06-19|||August 23, 2012|Actual|2012-08-23|June 2017|2017-06-01|December 5, 2012|Actual|2012-12-05|December 5, 2012|Actual|2012-12-05||Interventional|||Bioequivalence - Duodart Against Avodart & Omnic|An Open-Label, Randomized, Single Dose Crossover Study to Determine the Bioequivalence of Duodart® 0.5mg/0.4mg (Capsule Formulation of Dutasteride 0.5mg and Tamsulosin Hydrochloride 0.4mg) Compared to Concomitant Dosing of Avodart® 0.5mg and Omnic® 0.4mg Commercial Capsules in Healthy Male Subjects.|Completed||Phase 1|35|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 02:39:48.097712|2017-10-11 02:39:48.097712
NCT01657838|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-08-31|||May 2012||2012-05-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects|A Phase 1, Randomized, Open-Label, Two-Arm, Parallel Group Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:39:48.229159|2017-10-11 02:39:48.229159
NCT01657825|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-27|||June 2012||2012-06-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects|A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Warfarin in Healthy Male Subjects|Completed||Phase 1|20|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:39:48.338167|2017-10-11 02:39:48.338167
NCT01657812|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-03|||July 2012||2012-07-01|August 2012|2012-08-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||A Comparison of Dexmedetomidine and Epidural Anesthesia Under General Anesthesia in Patients Undergoing Gastrectomy|A Comparison of Dexmedetomidine and Epidural Anesthesia Under General Anesthesia in Patients Undergoing Gastrectomy|Unknown status|Recruiting|Phase 4|90|Anticipated|Anhui Medical University||3|||f||||t||||||||||2017-10-11 02:39:48.439011|2017-10-11 02:39:48.439011
NCT01657799|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-01-22||2016-01-22|October 2012||2012-10-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Clinical Study Conducted in Multiple Centers Comparing Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Subjects With Brain Metastases From Non Small Cell Lung Cancer (NSCLC)|A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects With Brain Metastases From Non-Small Cell Lung Cancer|Completed||Phase 2|307|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 02:39:48.541458|2017-10-11 02:39:48.541458
NCT01657786|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-28|2012-08-03|||May 2008||2008-05-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Association of 5-HT3 Receptor Gene Polymorphism With the Efficiency of Ondansetron for Postoperative Nausea and Vomiting||Completed||N/A|198|Actual|Yonsei University||1|||f||||t||||||||||2017-10-11 02:39:48.928174|2017-10-11 02:39:48.928174
NCT01657773|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2012-08-03|||April 2012||2012-04-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|NWC||Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm|Study of the Prevalence of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease.|Completed||N/A|2315|Actual|Wenzhou Medical University|||2||f||||t||||||||||2017-10-11 02:39:49.042003|2017-10-11 02:39:49.042003
NCT01657760|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-09-26|||April 7, 2014|Actual|2014-04-07|September 2017|2017-09-01|September 1, 2017|Actual|2017-09-01|August 31, 2017|Actual|2017-08-31||Interventional|CECDRAAD||Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics|Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics|Completed||Phase 1|35|Actual|VA Office of Research and Development||2|||f||||t|t|f|||f|||||2017-10-11 02:39:49.159586|2017-10-11 02:39:49.159586
NCT01657747|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-07-01|||November 2011||2011-11-01|September 2011|2011-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|S53580||Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer|Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer|Completed||N/A|350|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 02:39:49.260403|2017-10-11 02:39:49.260403
NCT01657734|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-08-01|||September 2011||2011-09-01|May 2011|2011-05-01||||||||Observational|||Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell Therapy||Unknown status|Recruiting|N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||||||||||||2017-10-11 02:39:49.388932|2017-10-11 02:39:49.388932
NCT01657721|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-08-03|||May 2012||2012-05-01|August 2012|2012-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Working Memory Training in ADHD (The Engage Study)|Working Memory Training in Attention-Deficit/Hyperactivity Disorder: Neural Mechanisms of Change|Unknown status|Recruiting|Phase 1|160|Anticipated|University of Toronto||3|||f||||f||||||||||2017-10-11 02:39:49.496194|2017-10-11 02:39:49.496194
NCT01657695|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2012-09-29|||June 2008||2008-06-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Observational|UniRer||Hepatocellular Carcinoma Growth and Molecular Aggressiveness|"Integrated Molecular/Imaging Technology for Characterization of Biological Aggressiveness of HCC in Patients Candidate to Liver Transplant"|Completed||N/A|78|Actual|University of Modena and Reggio Emilia|||1||f||||f||||||Samples With DNA|"     We have designed custom arrays selecting those genes that, on the basis of literature and our     own data, will be most informative regarding molecular pathways of relevance for HCC onset     and progression and which have been already associated with decreased survival. These genes     belong to cell cycle, apoptosis, cell proliferation, cell signaling, hypoxia and     metastasis-prone pathways.   "|||2017-10-11 02:39:49.728021|2017-10-11 02:39:49.728021
NCT01657682|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-01-26|||October 2012||2012-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations|A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations|Recruiting||Phase 2|70|Anticipated|Arog Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 02:39:49.819805|2017-10-11 02:39:49.819805
NCT01657669|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-07-24|||October 2012||2012-10-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|November 2014|Actual|2014-11-01||Interventional|||Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results|Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results|Unknown status|Active, not recruiting|Phase 4|22|Actual|Retina Research Institute, LLC||1|||f||||f||||||||||2017-10-11 02:39:49.9618|2017-10-11 02:39:49.9618
NCT01657656|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2014-07-29|||October 2012||2012-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia|Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia|Completed||N/A|350|Anticipated|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 02:39:50.095629|2017-10-11 02:39:50.095629
NCT01657643|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-28|2015-05-26|||January 2011||2011-01-01|May 2015|2015-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections|Effect of Lactobacillus Rhamnosus LGG® and Bifidobacterium Animalis Ssp Lactis BB-12® on Health-related Quality of Life in College Students With Upper Respiratory Infections|Completed||N/A|231|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 02:39:50.213034|2017-10-11 02:39:50.213034
NCT01657630|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-03-11|||September 2012||2012-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Accu-Chek Combo in Young Patients|Evaluation of the Use of the Accu-Chek Combo System in Young Patients With Type 1 Diabetes|Completed||N/A|13|Actual|Rabin Medical Center|||1||f||||f||||||||||2017-10-11 02:39:50.326708|2017-10-11 02:39:50.326708
NCT01657617|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-03-14|||October 2007||2007-10-01|March 2017|2017-03-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung Cancer|Stereotactic Body Radiation Therapy for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|37|Actual|University of Kentucky||1|||f||||t||||||||||2017-10-11 02:39:50.484891|2017-10-11 02:39:50.484891
NCT01657604|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-08-21|||August 24, 2012|Actual|2012-08-24|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|TIGER||Tasigna and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study|Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy|Active, not recruiting||Phase 3|717|Actual|University of Jena||2|||f||||t||||||||||2017-10-11 02:39:50.612566|2017-10-11 02:39:50.612566
NCT01657591|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-08-16|||July 27, 2012|Actual|2012-07-27|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|September 20, 2016|Actual|2016-09-20||Interventional|||Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma|Phase I Study of Escalating Doses of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma|Active, not recruiting||Phase 1|21|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 02:39:51.204937|2017-10-11 02:39:51.204937
NCT01657578|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-10-10|||June 2007||2007-06-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|December 2010|Actual|2010-12-01||Interventional|OMEPRAZOLE-1||Optimal Dosing of Omeprazole in Neonates|Optimal Dose and Population Pharmacokinetics of Omeprazole in Neonates With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 2|55|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-10-11 02:39:51.329056|2017-10-11 02:39:51.329056
NCT01657565|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-03|||January 2006||2006-01-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Appendectomy in Children Performed by Residents in the Era of Laparoscopic Surgery|Appendectomy in Children Performed by Residents in the Era of Laparoscopic Surgery|Completed||N/A|390|Actual|Odense University Hospital|||2||f||||f||||||||||2017-10-11 02:39:51.44727|2017-10-11 02:39:51.44727
NCT01657552|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-05-16|||August 2012||2012-08-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects|A Phase I, Open-label, Three-Period, Single Sequence, Crossover Study Evaluating the Drug-Drug Interaction Between Eltrombopag and Boceprevir and Between Eltrombopag and Telaprevir in Healthy Adult Subjects|Completed||Phase 1|56|Actual|GlaxoSmithKline||5|||f||||t||||||||||2017-10-11 02:39:51.541095|2017-10-11 02:39:51.541095
NCT01657539|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-09-17|||August 2011||2011-08-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|August 2012|Actual|2012-08-01||Interventional|||Effect of Probiotics Containing Yogurts on the Composition of Biofilms in Patients Under Orthodontic Treatment|Effects of Yogurt Containing Bifidobacterium Animalis Ssp. Lactis dn- 1173010 Probiotics in the Composition of Biofilms and Saliva of Orthodontic Patients: a Crossover, Double-blind, Randomized and Placebo Controlled Clinical Trial.|Completed||Phase 2/Phase 3|30|Actual|Federal University of Pelotas||2|||f||||||||||||||2017-10-11 02:39:51.675914|2017-10-11 02:39:51.675914
NCT01656798|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-09-14|||August 2012||2012-08-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Food Effect Study For New Formulation|An Open-Label, Randomized, Single-Dose, 2-Way Crossover Study In Healthy Subjects Assessing The Pharmacokinetics And Safety Of Powder For Oral Suspension Of Sildenafil Citrate Administered Under Fasted And Fed Conditions|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:40:06.253445|2017-10-11 02:40:06.253445
NCT01657526|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-05-12|||August 8, 2012|Actual|2012-08-08|May 2017|2017-05-01|November 25, 2013|Actual|2013-11-25|November 25, 2013|Actual|2013-11-25||Interventional|||Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine|An Observer-blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Healthy Adults|Completed||Phase 1|48|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-10-11 02:39:51.800025|2017-10-11 02:39:51.800025
NCT01657513|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-08-03|||June 2012||2012-06-01|August 2012|2012-08-01||||July 2013|Anticipated|2013-07-01||Interventional|||TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis|Production of Antibodies Against Tnf-alfa Blockers in Patients With Psoriasis|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Gentofte, Copenhagen||1|||f||||f||||||||||2017-10-11 02:39:51.940838|2017-10-11 02:39:51.940838
NCT01657500|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-08-03|||June 2011||2011-06-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Life 4°C Versus Optisol in Corneal Storage Media|A Randomized, Prospective, Double Masked Clinical Trial of Life 4°C Versus Optisol GS Corneal Storage Media|Unknown status|Active, not recruiting|Phase 3|76|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 02:39:52.110787|2017-10-11 02:39:52.110787
NCT01657487|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-03|||April 2010||2010-04-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients||Unknown status|Recruiting|Phase 4|120|Anticipated|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:39:52.253492|2017-10-11 02:39:52.253492
NCT01657474|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2013-12-10|||September 2012||2012-09-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers|A Prospective, Randomized, Comparative Study of Amniotic Membrane Wound Graft With Weekly Versus BiWeekly Application In the Management of Diabetic Foot Ulcers|Completed||N/A|40|Actual|MiMedx Group, Inc.||2|||f||||||||||||||2017-10-11 02:39:52.367956|2017-10-11 02:39:52.367956
NCT01657461|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-04-07|2016-11-15||December 2012||2012-12-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SWIFT PRIME|Two subjects in the IV t-PA arm withdrew and requested all data removed and was not included in analysis.|Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial|Solitaire™ FR With the Intention For Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) Clinical Trial|Completed||N/A|196|Actual|Medtronic Neurovascular Clinical Affairs||2|||f||||t||||||||||2017-10-11 02:39:52.525824|2017-10-11 02:39:52.525824
NCT01657448|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2015-08-24|||January 2016||2016-01-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria|Phase III, Prospective, Multicenter, Single-blind, Randomized, Superiority to Evaluate the Efficacy and Safety of Methenamine Association 250mg + Methylthioninium Chloride 20 mg Compared to Phenazopyridine 100 mg in Symptomatic Control of Dysuria|Unknown status|Not yet recruiting|Phase 3|316|Anticipated|EMS||2|||f||||t||||||||||2017-10-11 02:39:54.516463|2017-10-11 02:39:54.516463
NCT01657435|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-08-14|||May 1, 2012|Actual|2012-05-01|August 2017|2017-08-01|January 1, 2024|Anticipated|2024-01-01|January 1, 2024|Anticipated|2024-01-01||Interventional|COC28||28mm Ceramic-on-Ceramic Total Hip Replacement Study|Ceramax™ Ceramic-on-Ceramic Acetabular Cup Prothesis System|Recruiting||N/A|250|Anticipated|DePuy Orthopaedics||1|||f||||f||||||||||2017-10-11 02:39:54.689175|2017-10-11 02:39:54.689175
NCT01657422|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-08-03|||August 2000||2000-08-01|August 2012|2012-08-01|April 2006|Actual|2006-04-01|November 2004|Actual|2004-11-01||Interventional|PACEAdol||PACE+: Counseling Adolescents for Exercise and Nutrition|PACE+: Counseling Adolescents for Exercise and Nutrition|Completed||N/A|819|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 02:39:54.853972|2017-10-11 02:39:54.853972
NCT01657409|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-02-14|||August 2012|Actual|2012-08-01|February 2017|2017-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome|Comparison of the Therapeutic Effects of Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome|Completed||Phase 2|90|Actual|Buddhist Tzu Chi General Hospital||3|||f||||f||||||||||2017-10-11 02:39:54.980934|2017-10-11 02:39:54.980934
NCT01657396|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-02-19|||July 2012||2012-07-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Implementation and Evaluation of Revised Protocols for Oral Hygiene for Mechanically Ventilated Patients|Implementation and Evaluation of Revised Protocols for Oral Hygiene for Mechanically Ventilated Patients in Alberta Health Services Calgary Region - a Pilot Project.|Completed||N/A|150|Actual|University of Calgary||3|||f||||f||||||||||2017-10-11 02:39:55.197702|2017-10-11 02:39:55.197702
NCT01657383|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-07-31|||April 2012|Actual|2012-04-01|July 2017|2017-07-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Observational|||Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery|Surgical Outcomes Database for Faculty of Hepatopancreatico Biliary Surgery|Completed||N/A|74|Actual|Carolinas Healthcare System|||1||f||||t||||||||||2017-10-11 02:39:55.33296|2017-10-11 02:39:55.33296
NCT01657370|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2016-10-18|2016-08-08||August 2012||2012-08-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional||All Subjects as Treated Population included all randomized participants who received at least 1 dose of study treatment.|A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007)|A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine|Completed||Phase 2|195|Actual|Allergan||6|||f||||f||||||||||2017-10-11 02:39:55.47483|2017-10-11 02:39:55.47483
NCT01657357|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-01-30|||January 2012||2012-01-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Observational|||Routine Follow up After Total Hip Arthroplasty Prior Periacetabular Osteotomy|Routine Follow up After THA in PAO Patient|Completed||N/A|40|Actual|University of Aarhus|||1||f||||t||||||||||2017-10-11 02:39:56.686451|2017-10-11 02:39:56.686451
NCT01657344|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-08-24|||January 2011||2011-01-01|August 2017|2017-08-01|July 20, 2017|Actual|2017-07-20|July 20, 2017|Actual|2017-07-20||Observational|||PECARN Emergency Care Registry|Improving the Quality of Pediatric Emergency Care Using an Electronic Medical Record Registry and Clinician Feedback|Completed||N/A|1943606|Actual|Children's Hospital of Philadelphia|||2||f||||f||||||||||2017-10-11 02:39:56.785664|2017-10-11 02:39:56.785664
NCT01657331|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2017-05-18|||July 2012|Actual|2012-07-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|SGN+Benda||Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)|A Phase I/II Clinical Trial of the Combination of Brentuximab Vedotin and Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|71|Actual|Columbia University||1|||f||||t|t|f||||||Undecided||2017-10-11 02:39:56.861377|2017-10-11 02:39:56.861377
NCT01657318|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-02|2012-08-03|||September 2012||2012-09-01|August 2012|2012-08-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Observational|||Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers|A Prospective Observational Study on the Use of a Olivamine-containing Products in the Management of Patients With Compromised Nonhealing Lower Extremity Ulcers|Unknown status|Not yet recruiting|N/A|50|Anticipated|De La Salle University Medical Center|||1||f||||f||||||||||2017-10-11 02:39:56.958744|2017-10-11 02:39:56.958744
NCT01657292|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2015-08-28|2015-07-31||August 2012||2012-08-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|||Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds|Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Healing of Grade 2a Partial-Thickness Burn Wounds|Completed||Phase 3|61|Actual|Amryt Pharma||2|||f||||f||||||||||2017-10-11 02:39:57.194489|2017-10-11 02:39:57.194489
NCT01657279|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-10-27|||July 2012||2012-07-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|JURASSIC||Clinician JUdgment Versus Risk Score to Predict Stroke outComes: The JURASSIC Clinical Trial|Clinician JUdgment Versus Risk Score to Predict Stroke outComes:|Completed||N/A|111|Actual|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-11 02:39:57.659191|2017-10-11 02:39:57.659191
NCT01657240|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2013-06-03|||November 2014||2014-11-01|June 2013|2013-06-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis|Phase 3 Clinical Trial to Evaluate the Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis|Suspended||Phase 3|300|Anticipated|Laboratorios Sophia S.A de C.V.||2||Formula Reformulation|f||||t||||||||||2017-10-11 02:39:57.924855|2017-10-11 02:39:57.924855
NCT01657227|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-06-06|||January 2013||2013-01-01|June 2017|2017-06-01|October 20, 2016|Actual|2016-10-20|October 20, 2016|Actual|2016-10-20||Interventional|INDICA||Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands Study|Effectiveness and Cost-effectiveness of Two Multi-component Interventions to Improve the Health Outcomes in People With Type 2 Diabetes Mellitus|Completed||N/A|2334|Actual|Servicio Canario de Salud||4|||f||||f||||||||Undecided||2017-10-11 02:39:57.995182|2017-10-11 02:39:57.995182
NCT01657214|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-02-16|||September 2012||2012-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|SARMETA||Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients|Phase I, Dose Escalation Study of Safety, Pharmacokinetic and Pharmacodynamic of SAR125844 Administered Weekly as Intravenous Infusion in Asian Adult Patients With Advanced Malignant Solid Tumors|Completed||Phase 1|70|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:39:58.094014|2017-10-11 02:39:58.094014
NCT01657201|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2012-12-20|||September 2012||2012-09-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)|A Randomized, Open-label, Two-Treatment, Two-Period, Two-Sequence, Cross-over Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend) in Healthy Male Volunteers|Completed||Phase 1|59|Actual|Samyang Biopharmaceuticals Corporation||2|||f||||f||||||||||2017-10-11 02:39:58.176364|2017-10-11 02:39:58.176364
NCT01657188|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-03-02|||May 2009||2009-05-01|March 2017|2017-03-01|March 2022|Anticipated|2022-03-01|December 2021|Anticipated|2021-12-01||Observational|||Effects of Adaptive Servoventilation in Patients With Systolic Heart Failure and Sleep-Disordered Breathing|Effects of Adaptive Servoventilation in Patients With Systolic Heart Failure and Sleep-Disordered Breathing|Active, not recruiting||N/A|1500|Anticipated|Ruhr University of Bochum|||1||f||||f||||||||||2017-10-11 02:39:58.273703|2017-10-11 02:39:58.273703
NCT01657175|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-04-11|||January 2009||2009-01-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional|||Quality of Life After Oesophageal or Gastric Cancer Surgery|Quality of Life and Supportive Care Needs After Oesophageal or Gastric Cancer Surgery.|Completed||N/A|82|Actual|Region Skane||2|||f||||f||||||||No||2017-10-11 02:39:58.368157|2017-10-11 02:39:58.368157
NCT01657162|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-04-12|||October 2012||2012-10-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|ACTIVExtend||Twenty Four Month Extension Study of BA058-05-003|An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003|Completed||Phase 3|1200|Anticipated|Radius Health, Inc.||1|||f||||f||||||||||2017-10-11 02:39:58.490025|2017-10-11 02:39:58.490025
NCT01657149|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2016-04-05|||December 2015||2015-12-01|August 2015|2015-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Influence of Manual Lymph Drainage During Hospitalization on Swelling, Function and Pain in Patients After Total Knee Replacement|Influence of Manual Lymph Drainage During Hospitalization on Swelling, Function and Pain in Patients After Total Knee Replacement - Randomized Control Trial.|Terminated||N/A|20|Actual|Rabin Medical Center||2||a cardinal member of The research team withdrawn from study, the study has beem terminated.|f||||t||||||||||2017-10-11 02:39:58.685939|2017-10-11 02:39:58.685939
NCT01657136|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-09-29|||September 2013||2013-09-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|CIBIST||Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia|Comparison of Ivabradine and Beta-blockers Administration in the Treatment of Inappropriate Sinus Tachycardia|Completed||Phase 3|20|Actual|Policlinico Casilino ASL RMB||2|||f||||f||||||||||2017-10-11 02:39:58.774515|2017-10-11 02:39:58.774515
NCT01657123|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-02|||January 2013||2013-01-01|August 2012|2012-08-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Exercise Capacity and Recovery in Addison's Disease|Effect of Hydrocortisone Stress Dose on Exercise Capacity and Post-exercise Recovery in Patients With Addison's Disease|Unknown status|Not yet recruiting|N/A|20|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-11 02:39:58.885216|2017-10-11 02:39:58.885216
NCT01657110|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-01-27|||December 2012||2012-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne|Uncontrolled, Open-label, Phase II Pilot Study to Evaluate the Efficacy, Tolerability and Acceptability of 200mg/g Tea Tree Oil Gel Applied Topically Twice Daily for the Treatment of Mild to Moderate Facial Acne|Completed||Phase 2|18|Actual|The University of Western Australia||1|||f||||f||||||||||2017-10-11 02:39:59.009337|2017-10-11 02:39:59.009337
NCT01657097|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-03|||February 1997||1997-02-01|August 2012|2012-08-01|April 1997|Actual|1997-04-01|April 1997|Actual|1997-04-01||Interventional|||Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge|Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge. Impact on Bronchial Hyperresponsiveness and the Effect of Intranasal Corticosteroid Treatment|Completed||Phase 4|24|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:39:59.136925|2017-10-11 02:39:59.136925
NCT01657084|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-05-19|||September 2012||2012-09-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|EpiCapno||Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask|Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask|Completed||N/A|10|Actual|University of Aarhus||3|||f||||t||||||||||2017-10-11 02:39:59.242883|2017-10-11 02:39:59.242883
NCT01657071|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-08-02|||March 2012||2012-03-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects|A Randomized, Open-label, Single Dose, 2-treatment, 2-period, 2-way Crossover Study to Assess the Pharmacokinetic Characteristics of YH14659, a Fixed Dose Combination Compared With Coadministration of Separate Constituents Under Fasted Conditions in Healthy Male Subjects|Completed||Phase 1|60|Actual|Yuhan Corporation||2|||f||||f||||||||||2017-10-11 02:39:59.331426|2017-10-11 02:39:59.331426
NCT01657058|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-03-06|||July 2012||2012-07-01|March 2014|2014-03-01|October 2014|Anticipated|2014-10-01|December 2012|Actual|2012-12-01||Interventional|FI-FORM||Effects of Mode of Administration of Soluble Fibre Blend on Glycemia, Appetite & Sensory Parameters|The Effects of Different Modes of Administration of Soluble Fibre on Postprandial and Second Meal Blood Glucose Response, Appetite and Sensory Parameters in Healthy Individuals|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|St. Michael's Hospital, Toronto||5|||f||||f||||||||||2017-10-11 02:39:59.437401|2017-10-11 02:39:59.437401
NCT01657045|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2013-07-22|||July 2012||2012-07-01|July 2013|2013-07-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy|A Phase I Randomized, Double-Blind, Placebo Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Needle-free Dermal Injection to Cohorts of Adults Receiving Surgical Sternotomy Incisions|Unknown status|Recruiting|Phase 1|25|Anticipated|SironRX Therapeutics, Inc.||3|||f||||t||||||||||2017-10-11 02:39:59.546401|2017-10-11 02:39:59.546401
NCT01657032|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-02-14|2013-11-20||August 2010||2010-08-01|January 2010|2010-01-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis|Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis: A Double Blind Randomized, Placebo- Controlled Trial|Completed||Phase 4|88|Actual|Medical University of Warsaw|A potential limitation of our study is the lack of perfect blinding. Patients received smectite or placebo in identical packages from the hospital pharmacy. After being dissolved in water, they were of different colors.|2|||f||||t||||||||||2017-10-11 02:39:59.993427|2017-10-11 02:39:59.993427
NCT01657019|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-11-10|2015-10-05||August 2012||2012-08-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Safety Analysis Set, defined as all participants who took at least 1 dose of investigational product and who had at least 1 post-Visit 0 safety assessment in the study.|Open Label Extension in Adults With Binge Eating Disorder (BED)|A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder|Completed||Phase 3|604|Actual|Shire||1|||f||||||||||||||2017-10-11 02:40:00.62245|2017-10-11 02:40:00.62245
NCT01657006|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-03-18|||August 2012||2012-08-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||HeartTrends Heart Rate Variability (HRV) Algorithm for the Diagnosis of Myocardial Ischemia|HeartTrends HRV Algorithm for the Diagnosis of Myocardial Ischemia|Completed||N/A|450|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 02:40:01.464051|2017-10-11 02:40:01.464051
NCT01656993|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-05-04|||November 2012|Actual|2012-11-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts|Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts|Completed||N/A|25|Actual|University of Utah|||1||f||||t||||||||||2017-10-11 02:40:01.56451|2017-10-11 02:40:01.56451
NCT01656785|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-04-05|||February 2012||2012-02-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GRGDS||68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke|68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Angiogenesis Following Stroke|Recruiting||Early Phase 1|50|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||||2017-10-11 02:40:06.333449|2017-10-11 02:40:06.333449
NCT01656980|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-02|||August 2012||2012-08-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|||Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma|Phase 3 Study of Carmustine Sustained Release Implant (CASANT) to Treat Newly Diagnosed Malignant Glioma|Unknown status|Not yet recruiting|Phase 3|236|Anticipated|Shandong Lanjin Pharmaceuticals Co.,Ltd||2|||f||||t||||||||||2017-10-11 02:40:01.688514|2017-10-11 02:40:01.688514
NCT01656967|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-11-29|2016-03-22||July 2010||2010-07-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||All enrolled patients, except for one in the Ambu group who was withdrawn due to a faulty monitor|AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA|Flexible Optical Intubation Via the AMBU Aura-I Versus Blind Intubation Via the Fastrach Single Use Intubating LMA - A Prospective Randomized Clinical Trial|Completed||N/A|66|Actual|The University of Texas Health Science Center, Houston|Experience of the residents, some only had 6 months experience When using AScope, there were secretions and no suctioning capability Sample size ILMA is a straightforward attempt; whereas, AScope needs to maneuver and go all the way to carina|2|||f||||f||||||||Undecided||2017-10-11 02:40:01.833632|2017-10-11 02:40:01.833632
NCT01656954|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-08-15|||August 2011||2011-08-01|July 2012|2012-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|PVRS||Predicting Volume Response Study|Change in Stroke Volume During Passive Leg Raise Predicts Volume Challenge Response as Measured by Arterial Pressure Cardiac Output Monitor.|Completed||N/A|7|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 02:40:02.403691|2017-10-11 02:40:02.403691
NCT01656941|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-06-26|||March 2011||2011-03-01|June 2017|2017-06-01|December 2026|Anticipated|2026-12-01|December 2024|Anticipated|2024-12-01||Observational|GECHO||Genetic Determinants of Congenital Heart Disease Outcomes|The GECHO Trial: Genetic Determinants of Congenital Heart Disease Outcomes|Recruiting||N/A|800|Anticipated|University of Michigan|||2||f||||f||||||Samples With DNA|"     Whole blood samples will be frozen and stored until DNA can be isolated. Eventually, isolated     DNA samples will be frozen and stored in a biorepository.   "|||2017-10-11 02:40:02.516769|2017-10-11 02:40:02.516769
NCT01656928|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-08-02|||September 2008||2008-09-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|September 2010|Actual|2010-09-01||Interventional|||Effects of a Pre-school-based Nutritional Intervention on Children's Eating Behavior and Anthropometric Parameters|Effects of a Pre-school-based Nutritional Intervention on Children's Eating Behavior and Anthropometric Parameters: a Cluster-randomized Trial|Completed||N/A|375|Actual|Heidelberg University||2|||f||||f||||||||||2017-10-11 02:40:02.638789|2017-10-11 02:40:02.638789
NCT01656915|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2013-06-18|||June 2012||2012-06-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Observational|||Ex Vivo LPS Stimulation in Healthy and Compromised Subjects|Ex Vivo LPS Stimulation in Healthy and Compromised Subjects|Completed||N/A|36|Actual|TNO|||2||f||||t||||||Samples Without DNA|"     Blood samples will be obtained for standard clinical chemistry, heamatology, cytokines and ex     vivo LPS stimulation.   "|||2017-10-11 02:40:02.724477|2017-10-11 02:40:02.724477
NCT01656902|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-10-19|||January 2013||2013-01-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|March 2019|Anticipated|2019-03-01||Interventional|N3D||Phase III Study to Evaluate Safety and Effectiveness of NOVOCART 3D Plus vs. Microfracture to Treat Cartilage Defects of the Knee|A Prospective Randomized Controlled Multicenter Phase-III Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART® 3D Plus Compared to the Standard Procedure Microfracture in the Treatment of Articular Cartilage Defects of the Knee|Recruiting||Phase 3|261|Anticipated|Tetec AG||2|||f||||t||||||||||2017-10-11 02:40:02.813897|2017-10-11 02:40:02.813897
NCT01656889|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-02-16|2016-01-19|2015-01-05|August 2012||2012-08-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||ITT population|Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers|A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers|Completed||Phase 3|447|Actual|Healthpoint||2|||f||||t||||||||||2017-10-11 02:40:03.078771|2017-10-11 02:40:03.078771
NCT01656876|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2015-11-03|||September 2010||2010-09-01|November 2012|2012-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effects of Mirror Therapy on Upper Extremity in Stroke Patients|The Effects of Mirror Therapy on Upper Extremity in Stroke Patients|Completed||N/A|60|Actual|Taipei Medical University Hospital||3|||f||||f||||||||||2017-10-11 02:40:04.554306|2017-10-11 02:40:04.554306
NCT01656863|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-02|||August 2012||2012-08-01|August 2012|2012-08-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Oral Rehydration Therapy in Children With Mild to Moderate Dehydration||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 02:40:04.641151|2017-10-11 02:40:04.641151
NCT01656850|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-11-14|2015-10-19||November 2011||2011-11-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Whole Almonds on Biomarkers of Cardiovascular Disease in Chinese Patients With Type 2 Diabetes|The Effect of Whole Almonds on Glucoregulation, Endothelial Function, Inflammation, Lipid Profile, and Oxidative Stress in Chinese Patients With Type 2 Diabetes|Completed||N/A|40|Actual|Taipei Medical University||2|||f||||t||||||||No||2017-10-11 02:40:04.824709|2017-10-11 02:40:04.824709
NCT01656837|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-09-29|||April 2011||2011-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Family-Based Treatment for Parental Substance Abuse and Child Maltreatment|Family-Based Treatment for Parental Substance Abuse and Child Maltreatment|Completed||N/A|191|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 02:40:06.010329|2017-10-11 02:40:06.010329
NCT01656824|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2013-11-20|||August 2012||2012-08-01|November 2013|2013-11-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Observational|||Tissue Study of Bv8/PK-2 Inhibition in Human Cancer|Study of Human Primary Cancer Tissue Implanted in Mice Lacking Bv8/PH-2 in Their Bone Marrow-derived Cells|Unknown status|Recruiting|N/A|20|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples With DNA|"     cancer tissues   "|||2017-10-11 02:40:06.103117|2017-10-11 02:40:06.103117
NCT01656811|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-07-31|||October 2001||2001-10-01|July 2012|2012-07-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma|An Efficacy, Safety, and Tolerability Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma|Completed||Phase 2|146|Actual|Sunovion||4|||f||||f||||||||||2017-10-11 02:40:06.174763|2017-10-11 02:40:06.174763
NCT01656772|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-06-04|2015-05-20||August 2012||2012-08-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|VERSATILE||Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study|Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study|Completed||Phase 3|120|Actual|Stereotaxis||2|||f||||t||||||||||2017-10-11 02:40:06.418527|2017-10-11 02:40:06.418527
NCT01656759|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2016-01-11|2015-10-27||May 2012||2012-05-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Use of a Novel Fibrin Sealant in Total Knee Arthroplasty|Use of a Novel Fibrin Sealant in Total Knee Arthroplasty: A Prospective Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|73|Actual|Rush University Medical Center||2|||f||||t||||||||||2017-10-11 02:40:06.771867|2017-10-11 02:40:06.771867
NCT01656746|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2013-11-04|||May 2010||2010-05-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease|Single Incision Laparoscopic Surgery (SILS) for Colorectal Disease - A Novel Approach|Completed||N/A|10|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:40:07.2775|2017-10-11 02:40:07.2775
NCT01656733|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-08-10|||December 2010||2010-12-01|August 2017|2017-08-01|January 11, 2017|Actual|2017-01-11|June 2, 2016|Actual|2016-06-02||Interventional|||Nicotine Replacement for Smoking Cessation During Pregnancy|Nicotine Replacement for Smoking Cessation During Pregnancy|Completed||Phase 4|360|Anticipated|UConn Health||2|||f||||t||||||||||2017-10-11 02:40:07.37985|2017-10-11 02:40:07.37985
NCT01656720|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-06-08|||February 2012||2012-02-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional|||A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period|A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period|Completed||Phase 2|417|Actual|Norgine||4|||f||||||||||||||2017-10-11 02:40:07.487373|2017-10-11 02:40:07.487373
NCT01656707|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-04-10|||September 2011||2011-09-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Adaptive Treatment for Adolescent Cannabis Use Disorders|Adaptive Treatment for Adolescent Cannabis Use Disorders|Completed||N/A|172|Actual|UConn Health||2|||f||||t||||||||||2017-10-11 02:40:07.687116|2017-10-11 02:40:07.687116
NCT01656694|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-10-30|||August 2012||2012-08-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||A Single-Center, Epidemiological Study of the Survivorship of the DePuy Sigma HP Unicompartmental Knee Prosthesis|Two and Five-Year Survivorship of Unicompartmental Knee Arthroplasty Using DePuy Sigma HP Replacement|Unknown status|Active, not recruiting|N/A|300|Anticipated|Mississippi Sports Medicine and Orthopaedic Center|||1||f||||f||||||||||2017-10-11 02:40:07.770511|2017-10-11 02:40:07.770511
NCT01656681|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-06|||May 2011||2011-05-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects|A 64-week Pilot Trial to Evaluate the Effects of a Novel Nutraceutical on Weight Loss and Weight Loss Maintenance in Obese Subjects|Unknown status|Active, not recruiting|N/A|124|Anticipated|MetaProteomics LLC||2|||f||||f||||||||||2017-10-11 02:40:07.847521|2017-10-11 02:40:07.847521
NCT01656668|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2013-08-01|||July 2012||2012-07-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study of the Safety and Effectiveness of BC1036 Capsules to Treat Frequent Long-Term Cough|A Multicentre, Double-Blind, Placebo-Controlled, Adaptive Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough|Completed||Phase 3|288|Anticipated|Respicopea Limited||2|||f||||f||||||||||2017-10-11 02:40:07.950224|2017-10-11 02:40:07.950224
NCT01656655|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2012-08-02|||May 2012||2012-05-01|August 2012|2012-08-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Observational|||Effect of Post Traumatic Stress Disorder on Parenting|Parenting With and Without PTSD: The Effect of Attachment, Symptoms and Posttraumatic Growth|Unknown status|Recruiting|N/A|120|Anticipated|Hadassah Medical Organization|||2||f||||t||||||||||2017-10-11 02:40:08.085079|2017-10-11 02:40:08.085079
NCT01656642|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-08-14|||August 13, 2012|Actual|2012-08-13|August 2017|2017-08-01|November 28, 2018|Anticipated|2018-11-28|November 28, 2018|Anticipated|2018-11-28||Interventional|||A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma|A Phase Ib, Open-Label Study of The Safety and Pharmacology of Atezolizumab (Anti PD-L1 Antibody) Administered in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Patients With BRAFV600-Mutation Positive Metastatic Melanoma|Active, not recruiting||Phase 1|67|Actual|Genentech, Inc.||7|||f||||||||||||||2017-10-11 02:40:08.183935|2017-10-11 02:40:08.183935
NCT01656629|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2016-08-18|||August 2012||2012-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Stem Cell Recruitment in Osteoporosis Therapy||Active, not recruiting||N/A|46|Actual|Johns Hopkins University||3|||f||||||||||||||2017-10-11 02:40:08.314511|2017-10-11 02:40:08.314511
NCT01656616|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-05-16|||August 1, 2012|Actual|2012-08-01|May 2017|2017-05-01|August 1, 2012|Actual|2012-08-01|August 1, 2012|Actual|2012-08-01||Observational|||Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis|Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis|Withdrawn||N/A|0|Actual|Maine Medical Center|||1||f||||f||||||||||2017-10-11 02:40:08.390663|2017-10-11 02:40:08.390663
NCT01656603|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-04-20|||February 2012||2012-02-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation|A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients|Recruiting||Phase 2|9999|Anticipated|New York Blood Center||1|||f||||t||||||||Undecided||2017-10-11 02:40:08.479134|2017-10-11 02:40:08.479134
NCT01656590|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-04-09|||October 2012||2012-10-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease|High Protein Nutrition and Exercise Therapy (HPET) Plus Nocturnal Enteral Feeding (NEF) in Juvenile-onset Pompe Disease.|Withdrawn||Phase 2|0|Actual|Columbia University||1||PI left the institution|f||||f||||||||||2017-10-11 02:40:10.872791|2017-10-11 02:40:10.872791
NCT01656577|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-08-17|||June 2012||2012-06-01|June 2012|2012-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pexacerfont for Stress-induced Food Craving|Pexacerfont for Reduction of Stress-Induced Food Craving and Eating in Humans|Terminated||Early Phase 1|31|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:40:10.963574|2017-10-11 02:40:10.963574
NCT01656564|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-10-05|||July 10, 2012||2012-07-10|July 12, 2017|2017-07-12||||||||Observational|||Clinical Outcomes in Persons With HIV Acquired Early in Life|Clinical Outcomes in Persons With HIV Acquired Early in Life (COPE)|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:40:11.046711|2017-10-11 02:40:11.046711
NCT01656551|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-10-05|||August 2012|Actual|2012-08-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|November 2016|Actual|2016-11-01||Interventional|MILES-4||MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer|A Factorial Study Comparing Pemetrexed With Gemcitabine and Testing the Efficacy of the Addition of Cisplatin in Elderly Patients With Non Squamous Advanced, Metastatic or Recurrent NSCLC.|Active, not recruiting||Phase 3|232|Actual|National Cancer Institute, Naples||4|||f||||f||||||||||2017-10-11 02:40:11.144705|2017-10-11 02:40:11.144705
NCT01656538|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-03-10|||July 30, 2012|Actual|2012-07-30|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|November 18, 2016|Actual|2016-11-18||Interventional|||A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer|A Randomized Phase II Study of Reolysin For Patients Receiving Standard Weekly Paclitaxel Therapy as Therapy For Advanced/Metastatic Breast Cancer|Active, not recruiting||Phase 2|81|Actual|Canadian Cancer Trials Group||2|||f||||f||||||||||2017-10-11 02:40:11.33004|2017-10-11 02:40:11.33004
NCT01656525|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-09-17|||June 2012||2012-06-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients|A Multi-center, Multiple-ascending Dose, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability and Pharmacokinetics of Gantenerumab Following Subcutaneous Injection in Japanese AD Patients|Completed||Phase 1|28|Actual|Chugai Pharmaceutical||4|||f||||f||||||||||2017-10-11 02:40:11.552736|2017-10-11 02:40:11.552736
NCT01656512|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-02-12|||October 2011||2011-10-01|August 2012|2012-08-01|August 2015|Actual|2015-08-01|January 2014|Actual|2014-01-01||Interventional|||Zometa Study in Pediatric Acute Lymphoblastic Leukemia|"Analysis of Outcome of Bisphosphonate Use in Children With ALL- Case Controlled Study"|Completed||N/A|95|Actual|Children's Cancer Hospital Egypt 57357||2|||f||||t||||||||||2017-10-11 02:40:11.665435|2017-10-11 02:40:11.665435
NCT01656499|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-01-13|||March 2011||2011-03-01|January 2015|2015-01-01|September 2012|Actual|2012-09-01|July 2011|Actual|2011-07-01||Interventional|||Effect of AXOS on the Colon Metabolism in Healthy Volunteers|Effect of AXOS on the Colon Metabolism in Healthy Volunteers|Completed||Phase 2|20|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 02:40:11.765035|2017-10-11 02:40:11.765035
NCT01656486|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2014-02-14|2014-02-14||July 2012||2012-07-01|February 2014|2014-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Stereotactic Radiation to Decrease Pancreatic Secretions|Utilization of Stereotactic Radiation in Patients With Pancreatic Fistula to Decrease Pancreatic Secretions|Completed||N/A|1|Actual|Carolinas Healthcare System||1|||f||||t||||||||||2017-10-11 02:40:11.846492|2017-10-11 02:40:11.846492
NCT01656473|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2015-07-22|||July 2012||2012-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Evaluating the Effectiveness of Motivational Interviewing and a Dialectical Therapy Skills- Based Intervention for Youth|CIHR Team in Innovations in Child and Youth Concurrent Disorders: Service Delivery and Treatment Subproject|Completed||N/A|48|Actual|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-10-11 02:40:12.047062|2017-10-11 02:40:12.047062
NCT01656460|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-07-25|2015-06-29||April 2012||2012-04-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2015|Actual|2015-03-01||Interventional|||Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer|Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer|Active, not recruiting||Phase 2|12|Actual|Brown University||4|||f||||t||||||||||2017-10-11 02:40:12.152911|2017-10-11 02:40:12.152911
NCT01656447|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2017-03-13|||August 2006||2006-08-01|March 2017|2017-03-01||||January 2030|Anticipated|2030-01-01||Observational|||Scleroderma Registry & Repository at the Hospital for Special Surgery|The Scleroderma Registry & Repository|Recruiting||N/A|300|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||Samples With DNA|"     Research bloods will be collected if the patient gives permission. These bloods can be     donated at the time of a patient's private visit with a physician at Hospital for Special     Surgery, or at an independent research visit.   "|||2017-10-11 02:40:12.588029|2017-10-11 02:40:12.588029
NCT01656434|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-06-01|2015-02-09||November 2, 2012|Actual|2012-11-02|June 2017|2017-06-01|February 12, 2014|Actual|2014-02-12|February 12, 2014|Actual|2014-02-12||Interventional||All Subjects as Treated Population, which consisted of all randomized participants who took at least one dose of trial medication.|Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)|A Phase III, Randomized, Open-label, Active-controlled, Multicenter Trial to Study the Contraceptive Efficacy and Safety of the Commercial Batch of Oral Tablets of MK-8175A (Nomegestrol Acetate - 17ß-estradiol) in Healthy, Sexually-active Women Aged 18-50 Years|Terminated||Phase 3|3173|Actual|Merck Sharp & Dohme Corp.||2||Business reasons|f||||f||||||||||2017-10-11 02:40:12.697563|2017-10-11 02:40:12.697563
NCT01656421|ClinicalTrials.gov processed this data on October 10, 2017|2012-08-01|2015-07-27|||May 2011||2011-05-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Observational|ARCADE||Assessment of Risk in Chronic Airways Disease Evaluation|Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE)|Active, not recruiting||N/A|750|Anticipated|Cardiff University|||2||f||||f||||||||||2017-10-11 02:40:13.200542|2017-10-11 02:40:13.200542
NCT01656408|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-03-30|2016-03-29||August 1, 2012|Actual|2012-08-01|March 2017|2017-03-01|May 23, 2013|Actual|2013-05-23|May 3, 2013|Actual|2013-05-03||Interventional|||A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)|A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150|Completed||Phase 1|103|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-10-11 02:40:13.790769|2017-10-11 02:40:13.790769
NCT01655810|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-08-01|||July 2012||2012-07-01|July 2012|2012-07-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Vitamin D, Cardiovascular Disease, and African Americans|Vitamin D and Early Markers of Cardiovascular Disease in African Americans|Unknown status|Recruiting|N/A|86|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:40:26.012865|2017-10-11 02:40:26.012865
NCT01656395|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2015-07-29|||August 2012||2012-08-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Adaptive-Design, Dose-Ranging Study of MK-1029 in Adult Subjects With Persistent Asthma|Terminated||Phase 2|557|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-10-11 02:40:18.558404|2017-10-11 02:40:18.558404
NCT01656382|ClinicalTrials.gov processed this data on October 10, 2017|2007-04-24|2012-08-02|||January 2007||2007-01-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex|Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex at 10 mg/kg/d for 7 Days or 5.0 mg/kg/d for 14 Days as Induction Therapy for Disseminated Cryptococcosis in Patients With HIV|Completed||Phase 4|18|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-11 02:40:18.663234|2017-10-11 02:40:18.663234
NCT01656369|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-11-20|||January 2007||2007-01-01|January 2007|2007-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Comparative Study Between Delorme Operation With or Without Postanal Repair in Treatment of Complete Rectal Prolapse|Comparative Study Between Delorme Operation With or Without Postanal Repair and Levatorplasty in Treatment of Complete Rectal Prolapse.|Completed||N/A|82|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 02:40:18.741296|2017-10-11 02:40:18.741296
NCT01656356|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-08-07|||May 2012||2012-05-01|August 2012|2012-08-01||||August 2012|Actual|2012-08-01||Interventional|||Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers|Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers|Completed||Phase 1|||Mahidol University||2|||f||||t||||||||||2017-10-11 02:40:18.837423|2017-10-11 02:40:18.837423
NCT01656343|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-09-18|||October 31, 2011|Actual|2011-10-31|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients|Belatacept and Risk of PTLD in US Renal Transplant Recipients|Active, not recruiting||N/A|5000|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 02:40:18.909444|2017-10-11 02:40:18.909444
NCT01656330|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-01-23|||July 2012||2012-07-01|January 2017|2017-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers|Randomized, Parallel-Group, Open-Label Study to Assess the Effects of 3-Factor and 4-Factor Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban|Completed||Phase 1|35|Actual|Janssen Research & Development, LLC||3|||f||||||||||||||2017-10-11 02:40:19.031901|2017-10-11 02:40:19.031901
NCT01656317|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-03-14|||January 1, 2012|Actual|2012-01-01|March 2017|2017-03-01|December 20, 2015|Actual|2015-12-20|February 27, 2014|Actual|2014-02-27||Interventional|SAH||Rehabilitation of Patients After Subarachnoid Hemorrhage|Effect of Early Rehabilitation in Patients With Acute Subarachnoid Hemorrhage|Completed||N/A|171|Actual|Oslo University Hospital||2|||f||||t|f|f||||||Undecided||2017-10-11 02:40:19.294224|2017-10-11 02:40:19.294224
NCT01656304|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-03-25|2014-06-06||May 2007||2007-05-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy|Phase II Trial of Bevacizumab in PSA Relapse Androgen Independent Prostate Cancer (AVF3952sn)|Completed||Phase 2|16|Actual|Barbara Ann Karmanos Cancer Institute|There was a small sample size.|1|||f||||t||||||||||2017-10-11 02:40:19.421416|2017-10-11 02:40:19.421416
NCT01656278|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-06-22|||March 2012|Actual|2012-03-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|IMAGINE-RA||An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis|Does an MRI-guided Treatment Strategy Reduce Disease Activity and Progression in Patients With Rheumatoid Arthritis (RA): a Randomised Controlled Trial|Completed||N/A|200|Actual|King Christian X´Hospital for Rheumatic Diseases||2|||f||||t||||||||||2017-10-11 02:40:19.752545|2017-10-11 02:40:19.752545
NCT01656265|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-02-28|||July 2012||2012-07-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of ARQ 197 in Hepatocellular Carcinoma (HCC)|Phase I Study of ARQ 197 in Advanced Hepatocellular Carcinoma|Completed||Phase 1|24|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-11 02:40:19.879513|2017-10-11 02:40:19.879513
NCT01656252|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-06-26|2016-12-08||July 2012||2012-07-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PrE0901|Eligible, treated patients|Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission|Phase I Dose Finding/Phase II Placebo-Controlled Trial of Eltrombopag During Consolidation Therapy in Adults With Acute Myeloid Leukemia (AML) in Complete Remission|Terminated||Phase 1/Phase 2|15|Actual|PrECOG, LLC.||3||Study stopped per Novartis request due to futility from another study.|f||||t||||||||No|Data is proprietary.|2017-10-11 02:40:19.997234|2017-10-11 02:40:19.997234
NCT01656239|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2014-06-18||2014-06-18|August 2012||2012-08-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Dose Range Finding Study of Fedovapagon in Men With Nocturia|A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Dose Range Finding Study To Determine The Efficacy And Safety Of Fedovapagon In Men With Nocturia|Completed||Phase 2|358|Actual|Vantia Ltd||4|||f||||f||||||||||2017-10-11 02:40:20.447314|2017-10-11 02:40:20.447314
NCT01656226|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2013-10-10|||July 2012||2012-07-01|August 2012|2012-08-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis|A Randomised Double-blind Parallel-group Study to Evaluate the Long-term Effects of Eryfotona AK-NMSC® Cream in the Treatment of Cancerization Field in Patients With Actinic Keratosis.|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|ISDIN||2|||f||||f||||||||||2017-10-11 02:40:20.930061|2017-10-11 02:40:20.930061
NCT01656213|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-02-15|||July 2012||2012-07-01|July 2012|2012-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Randomised Control Trial for Improving Functional Outcome From Stroke in End Stage Renal Disease Patients|Randomised Control Trial for Improving Functional Outcome From Stroke in End Stage Renal Disease Patients|Completed||N/A|110|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 02:40:21.050642|2017-10-11 02:40:21.050642
NCT01655797|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-30|||May 2008||2008-05-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|TIRED||Cognitive Behavior Therapy for Insomnia in Primary Care|Treating Insomnia in Primary Care: A Study of Effectiveness and Dissemination|Completed||N/A|66|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 02:40:26.145602|2017-10-11 02:40:26.145602
NCT01656187|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-08-29|||January 2012||2012-01-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Attenuation of Corticosteroid Induced Hippocampal Changes|Attenuation of Corticosteroid Induced Hippocampal Changes|Completed||Phase 4|46|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 02:40:21.213913|2017-10-11 02:40:21.213913
NCT01656174|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2015-03-19|||August 2012||2012-08-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|||Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross|Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross|Completed||N/A|35035|Actual|Gen-Probe, Incorporated|||1||f||||f||||||||||2017-10-11 02:40:21.346558|2017-10-11 02:40:21.346558
NCT01656161|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2015-08-13|2015-08-13||July 2012||2012-07-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Safety Analysis Set, defined as all enrolled subjects who received at least one dose of study treatment.|Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer|A Multicentre, Open, Non-comparative, Phase III Study on the Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 22.5 mg 6-month Formulation in Patients With Advanced Prostate Cancer|Completed||Phase 3|120|Actual|Debiopharm International SA||1|||f||||f||||||||||2017-10-11 02:40:21.448074|2017-10-11 02:40:21.448074
NCT01656148|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2014-05-09|||June 2012||2012-06-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|FAME||FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra|Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra|Completed||Phase 4|125|Anticipated|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 02:40:22.018885|2017-10-11 02:40:22.018885
NCT01656135|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-03-08|||December 2012||2012-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Reference Group Trial for The ONE Study|Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation|Completed||Phase 4|70|Actual|University of Regensburg||1|||f||||f||||||||||2017-10-11 02:40:22.153207|2017-10-11 02:40:22.153207
NCT01656122|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-02-18|||July 2012||2012-07-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Abacavir and Lamivudine PK in Children|Pharmacokinetics of Abacavir Once Daily vs. Twice Daily and Lamivudine Once Daily vs. Twice Daily in HIV-infected Thai Children|Completed||Phase 2/Phase 3|30|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||f||||||||||2017-10-11 02:40:22.287815|2017-10-11 02:40:22.287815
NCT01656109|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2014-08-25|||July 2011||2011-07-01|August 2014|2014-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Atazavanir/Ritonavir-based HAART in Children|The Study of Atazavanir/Ritonavir-based HAART in Thai HIV-infected Children|Completed||Phase 2|20|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||f||||||||||2017-10-11 02:40:22.422194|2017-10-11 02:40:22.422194
NCT01656096|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-10-27|||July 2012||2012-07-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Renal Sympathetic Denervation in Mild Refractory Hypertension|Renal Sympathetic Denervation in Patients With Mild Refractory Hypertension|Completed||Phase 4|71|Actual|University of Leipzig||2|||f||||f||||||||||2017-10-11 02:40:22.543751|2017-10-11 02:40:22.543751
NCT01656083|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-01|||May 2010||2010-05-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|July 2011|Actual|2011-07-01||Observational|CV-SM||The Compliance of Varenicline With Short-massage|The Compliance of Varenicline Usage and the Smoking Abstinence Rate Via Mobile Phone Text Messaging Combine With Varenicline: a Single-blind, Randomised Control Trial|Unknown status|Recruiting|N/A|220|Anticipated|China-Japan Friendship Hospital|||2||f||||t||||||||||2017-10-11 02:40:22.649726|2017-10-11 02:40:22.649726
NCT01656070|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-01|||April 2011||2011-04-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Vitamin D Supplementation in HIV-infected Youth|Vitamin D Status and T Cell Phenotype in HIV-infected Youth Supplemented With Cholecalciferol: a Randomized Clinical Trial.|Completed||Phase 2|50|Actual|University of Milan||2|||f||||f||||||||||2017-10-11 02:40:22.767755|2017-10-11 02:40:22.767755
NCT01656057|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2015-07-10|||July 2012||2012-07-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|||The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion|The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion|Completed||N/A|10|Actual|University Hospital, Gentofte, Copenhagen||6|||f||||f||||||||||2017-10-11 02:40:22.92988|2017-10-11 02:40:22.92988
NCT01656044|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-08-14|||June 2012||2012-06-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer|The Effect of Negative Pressure Therapy on Incisional Surgical Site Infections|Completed||N/A|375|Actual|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-11 02:40:23.052828|2017-10-11 02:40:23.052828
NCT01656031|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-05-25|2013-01-10||February 2005||2005-02-01|February 2017|2017-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia|A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia|Completed||Phase 2|39|Actual|Wake Forest University Health Sciences||1|||f||||t|t|f||||||||2017-10-11 02:40:23.174904|2017-10-11 02:40:23.174904
NCT01656018|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-04-06|||November 2012||2012-11-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants|Phase 1 Open Label Safety, Acceptability, Pharmacokinetic and ex Vivo Pharmacodynamic Study of TMC278 Long Acting (LA) Administered Intramuscularly to HIV-1 Seronegative Individuals|Completed||Phase 1|4|Actual|Janssen Research & Development, LLC||10|||f||||f||||||||||2017-10-11 02:40:23.824589|2017-10-11 02:40:23.824589
NCT01656005|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-08-17|||August 2012||2012-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|ANDA2||Beta Blocker Therapy in Moderate to Severe COPD|Evaluation of Effects of Chronic Dose Exposure to Cardioselective and Non-cardioselective Beta Blockers on Measures of Cardiopulmonary Function in Moderate to Severe COPD.|Completed||Phase 4|18|Actual|University of Dundee||2|||f||||f||||||||||2017-10-11 02:40:23.970061|2017-10-11 02:40:23.970061
NCT01655992|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-01-03|||January 2012||2012-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)|A Randomized Open Label Multicenter Phase 3 Trial Comparing S1 Generic With Capecitabine in Patients With Metastatic Breast Cancer.|Active, not recruiting||Phase 3|386|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 02:40:24.133342|2017-10-11 02:40:24.133342
NCT01655979|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-07-31|||August 2011||2011-08-01|July 2012|2012-07-01||||April 2012|Actual|2012-04-01||Interventional|MEP||Medium-term Bedrest Whey Protein (MEP)||Completed||N/A|10|Actual|DLR German Aerospace Center||2|||f||||||||||||||2017-10-11 02:40:24.244595|2017-10-11 02:40:24.244595
NCT01655966|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2014-01-28|||May 2012||2012-05-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|February 2014|Anticipated|2014-02-01||Interventional|||Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis c|Vitamin D in Addition to Pegylated Interferon and Ribavirin Compared to Pegylated Interferon and Ribavirin Alone in the Treatment of Chronic Hepatitis C Genotype 4.|Unknown status|Active, not recruiting|Phase 3|80|Anticipated|Cairo University||2|||f||||t||||||||||2017-10-11 02:40:24.352422|2017-10-11 02:40:24.352422
NCT01655953|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-08-01|||July 2007||2007-07-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|||||Interventional|SL8||Changes in Acid Base Status During High Salt Intake||Completed||N/A|8|Actual|DLR German Aerospace Center||2|||f||||||||||||||2017-10-11 02:40:24.445932|2017-10-11 02:40:24.445932
NCT01655940|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-08-01|||May 2011||2011-05-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Observational|||Cerebral Oximeter Comparison Study|Comparison of the FORE-SITE and INVOS Cerebral Oximeters During Cardiac Surgery|Completed||N/A|50|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 02:40:24.546186|2017-10-11 02:40:24.546186
NCT01655927|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-07-31|||July 2012||2012-07-01|July 2012|2012-07-01||||July 2013|Anticipated|2013-07-01||Interventional|COLFIRE||Efficacy of Tranexamic Acid in Brain Tumor Resections|PHASE 3 STUDY OF EFFICACY OF TRANEXAMIC ACID IN BRAIN TUMORS RESECTIONS|Unknown status|Recruiting|Phase 3|100|Anticipated|Colombian Foundation for Epilepsy and Neurological Disease||2|||f||||t||||||||||2017-10-11 02:40:24.619393|2017-10-11 02:40:24.619393
NCT01655914|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-01-29|||July 2010||2010-07-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults|Open Label, Randomized, Three-way Crossover Study to Assess the Safety and the Pharmacokinetics of Sublingual Flumazenil (CRLS035) in Healthy Adults|Completed||Phase 1|10|Actual|Coeruleus Ltd.||2|||f||||||||||||||2017-10-11 02:40:24.911193|2017-10-11 02:40:24.911193
NCT01655901|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-02-02|||September 2012||2012-09-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Active Video Games and Appetite Control in Adolescents|Effects of Active Video Games on Energy Balance: a Randomized Crossover Study in Adolescents|Completed||N/A|30|Actual|Children's Hospital of Eastern Ontario||3|||f||||f||||||||||2017-10-11 02:40:24.994044|2017-10-11 02:40:24.994044
NCT01655888|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-07-31|||July 2012||2012-07-01|July 2012|2012-07-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma|A SECOND-LINE, SINGLE ARM, PHASE II CLINICAL STUDY WITH TREMELIMUMAB, A FULLY HUMAN ANTI-CTLA-4 MONOCLONAL ANTIBODY, AS MONOTHERAPY IN PATIENTS WITH UNRESECTABLE MALIGNANT MESOTHELIOMA. The MESOT-TREM-2012|Unknown status|Recruiting|Phase 2|29|Anticipated|Azienda Ospedaliera Universitaria Senese||1|||f||||t||||||||||2017-10-11 02:40:25.103398|2017-10-11 02:40:25.103398
NCT01655875|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-04-04|||June 2012||2012-06-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|BMTAMD3100||AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia|A Pilot Study of AMD3100 as a Sensitizing Agent in Myeloablative Allogeneic Blood and Marrow Transplantation for Chemotherapy Resistant Pediatric Acute Leukemia|Terminated||Phase 1|1|Actual|Emory University||1||lack of patient enrollment|f||||t||||||||||2017-10-11 02:40:25.222674|2017-10-11 02:40:25.222674
NCT01655862|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2017-03-28|||July 2012||2012-07-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA|Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Cervical Dystonia and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (POSTURe)|Completed||N/A|62|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:40:25.322598|2017-10-11 02:40:25.322598
NCT01655849|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2013-12-11|||August 2012||2012-08-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy and Safety of Z160 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy|Completed||Phase 2|141|Actual|Zalicus||2|||f||||f||||||||||2017-10-11 02:40:25.445333|2017-10-11 02:40:25.445333
NCT01655836|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2016-10-19|||October 2012||2012-10-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer|Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients|Recruiting||Phase 1|42|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 02:40:25.595281|2017-10-11 02:40:25.595281
NCT01655823|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-06-01|||July 2012||2012-07-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|January 2015|Actual|2015-01-01||Interventional|TTX-CINP-201||The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment|A Randomized, Double-Blind, Dose-Finding, Placebo Controlled, Phase II Multicenter Study of Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain|Terminated||Phase 2|125|Actual|Wex Pharmaceuticals Inc.||5||Interim analysis completed and decided to terminate and proceed to Phase 3 trial.|f||||t||||||||||2017-10-11 02:40:25.85759|2017-10-11 02:40:25.85759
NCT01655784|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-02-27|||August 2012||2012-08-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|August 2018|Anticipated|2018-08-01||Interventional|FEAT||Framing Eighteen Coils in Cerebral Aneurysms Trial|Framing Eighteen Coils in Cerebral Aneurysms Trial: FEAT|Recruiting||Phase 3|660|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 02:40:26.294632|2017-10-11 02:40:26.294632
NCT01655771|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2014-12-01|||August 2012||2012-08-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects|A Phase 1, Open-Label, Single-Dose, Parallel-Group Study to Assess the Safety, Tolerability, and Pharmacokinetics of TD-1211 Administered Orally to Elderly and Young Healthy Subjects|Completed||Phase 1|47|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||||2017-10-11 02:40:26.563319|2017-10-11 02:40:26.563319
NCT01655758|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2012-08-01|||January 2002||2002-01-01|July 2012|2012-07-01|February 2004|Actual|2004-02-01|December 2003|Actual|2003-12-01||Interventional|||24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension|The 24 Control of IOP in Ocular Hypertension: a Cross-over Study on Inflow Versus Outflow Drugs.|Completed||Phase 4|61|Actual|University of Parma||5|||f||||f||||||||||2017-10-11 02:40:26.655833|2017-10-11 02:40:26.655833
NCT01655745|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-10-03|||July 24, 2012|Actual|2012-07-24|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer|LCCC 1209: Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging (FDG-PET-MRI) for Staging of Muscle-Invasive Bladder Cancer|Active, not recruiting||N/A|22|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:40:26.787917|2017-10-11 02:40:26.787917
NCT01655732|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-13|||May 2012||2012-05-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|ART||Effect of Atraumatic Restorative Treatment on Streptococcus Mutans Count in Saliva of Pregnant Women|Effect of Atraumatic Restorative Treatment on Streptococcus Mutans Count in Saliva of Pregnant Women, A Randomized Control Trial|Completed||Phase 2|94|Actual|Sheikh Zayed Federal Postgraduate Medical Institute||1|||f||||f||||||||||2017-10-11 02:40:26.891545|2017-10-11 02:40:26.891545
NCT01655706|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2016-10-12|||March 2013||2013-03-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|CAN-BIND-1||Canadian Biomarker Integration Network for Depression Study|Integrated Biological Markers for the Prediction of Treatment Response in Depression|Active, not recruiting||Phase 3|211|Actual|University Health Network, Toronto||2|||f||||t||||||||Yes|"This study is funded by the Ontario Brain Institute (OBI). Data collected from this study is entered into a research database called Brain-CODE, deployed at a High Performance Computer Virtual Lab (HPCVL). The HPCVL supports the regulatory-compliant (e.g. 21 CRF Part 11, HIPPA, PIPEDA) processes for securing privacy of healthcare data."|2017-10-11 02:40:27.106117|2017-10-11 02:40:27.106117
NCT01655693|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-10-03|||June 2012||2012-06-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|September 2017|Actual|2017-09-01||Interventional|ReLive||Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma|Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Slow Repeated IV Infusions of 2 Doses of Doxorubicin Transdrug™ (DT) (20mg/m2 and 30mg/m2) to Those of Best Standard of Care (BSC) in Patients With Advanced Hepatocellular Carcinoma (HCC) After Failure or Intolerance to Sorafenib. ReLive Study.|Active, not recruiting||Phase 3|390|Anticipated|Onxeo||3|||f||||t||||||||||2017-10-11 02:40:27.258517|2017-10-11 02:40:27.258517
NCT01655680|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-04-28||2015-04-28|May 2012||2012-05-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS) in Nonsmokers|Completed||Phase 2|432|Actual|AbbVie||4|||f||||t||||||||||2017-10-11 02:40:27.539024|2017-10-11 02:40:27.539024
NCT01655667|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-08-01|||December 2010||2010-12-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|February 2011|Actual|2011-02-01||Observational|||Comorbidities and Healthcare Utilisation: Indicators for Improving COPD Diagnosis|Improving Diagnosis of COPD Through Characterisation of Comorbidities Present at, and Healthcare Utilisation Prior to, Diagnosis of COPD in UK. A Retrospective Primary Care Database.|Completed||N/A|38859|Actual|Research in Real-Life Ltd|||1||f||||t||||||||||2017-10-11 02:40:27.842764|2017-10-11 02:40:27.842764
NCT01655654|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-05-21|||August 2012||2012-08-01|May 2013|2013-05-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Prevalence, Awareness and Management of Hypertension in Acute Care Personnel|Prevalence, Awareness and Management of Hypertension in Acute Care Personnel|Unknown status|Active, not recruiting|N/A|160|Anticipated|Providence Health & Services||2|||f||||f||||||||||2017-10-11 02:40:27.91708|2017-10-11 02:40:27.91708
NCT01655641|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-10-14|||July 2012||2012-07-01|October 2012|2012-10-01|July 2014|Anticipated|2014-07-01|June 2013|Anticipated|2013-06-01||Interventional|TMGS||Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery|Role of Tranexamic Acid for Reducing Blood Loss in Patients Undergoing Major Gastro-intestinal Surgery|Unknown status|Active, not recruiting|Phase 2/Phase 3|118|Anticipated|Tribhuvan University Teaching Hospital, Institute Of Medicine.||2|||f||||t||||||||||2017-10-11 02:40:28.018433|2017-10-11 02:40:28.018433
NCT01655628|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-08-01|||July 2012||2012-07-01|July 2012|2012-07-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma|Autologous Cytokine-Induced Killer Cell Transfusion in Combination With Gemcitabine Plus Cisplatin Regimen Chemotherapy for Metastatic Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2|40|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 02:40:28.147586|2017-10-11 02:40:28.147586
NCT01655615|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-10-27|||September 2011||2011-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Does Delaying Adolescent Substance Use Lead to Improved Cognitive Function and Reduce Risk for Addiction?|Co-venture: A Cluster Randomized Trial Investigating the Effects of Selective Intervention on Adolescent Cognitive Development and Addiction|Active, not recruiting||N/A|31|Actual|St. Justine's Hospital||1|||f||||t||||||||||2017-10-11 02:40:28.286418|2017-10-11 02:40:28.286418
NCT01655602|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-08-01|||July 2012||2012-07-01|July 2012|2012-07-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|||Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation|Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation|Unknown status|Recruiting|Phase 1|10|Anticipated|Siriraj Hospital||3|||f||||t||||||||||2017-10-11 02:40:28.395529|2017-10-11 02:40:28.395529
NCT01655589|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2012-07-31|||January 2008||2008-01-01|July 2012|2012-07-01||||||||Observational|||VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents|VEGF Gene Polymorphism and Response to Intravitreal Anti-VEGF Agents in Neovascular Age-related Macular Degeneration|Unknown status|Recruiting|N/A|74|Anticipated|Institute of Vision, Brasil|||1||f||||||||||||||2017-10-11 02:40:28.50786|2017-10-11 02:40:28.50786
NCT01655576|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-06-04|||August 2012||2012-08-01|July 2012|2012-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PLADRAINAGE||Effectiveness of Placental Drainage in the Third Stage of Labor: a Randomized Clinical Trial|Effectiveness of Placental Drainage in the Third Stage of Labor: a Randomized Clinical Trial|Completed||N/A|226|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||t||||||||||2017-10-11 02:40:28.576543|2017-10-11 02:40:28.576543
NCT01655563|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2016-08-18|||September 2011||2011-09-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation|A Pharmacogenetic Trial of Tacrolimus Dosing After Pediatric Transplantation|Completed||Phase 2|75|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 02:40:28.661487|2017-10-11 02:40:28.661487
NCT01655537|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-31|2013-09-16|||July 2012||2012-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Cognitive Dysfunction in Fibromyalgia Patients|Cognitive Dysfunction in Fibromyalgia Patients: Specific Neuro-psychological Dysfunctions, Psychiatric Comorbidity and Integrative Assessments|Completed||N/A|25|Actual|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 02:40:29.10122|2017-10-11 02:40:29.10122
NCT01655524|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2014-03-14|||July 2012||2012-07-01|July 2012|2012-07-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|ASSUAGE-MPI||The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion|The Impact of Routine Administration of Aminophylline Following Regadenoson According to the ASSUAGE Protocol on the Accuracy of Regadenoson Stress Myocardial Perfusion Imaging: A Single-Blinded Cross-Over Clinical Trial|Suspended||Phase 4|60|Anticipated|Rush University Medical Center||1||Due to nationwide shortage of Aminophylline.|f||||t||||||||||2017-10-11 02:40:29.169478|2017-10-11 02:40:29.169478
NCT01655511|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-09-26|||July 2012||2012-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Crossover, Ascending Dose-Tolerance Study To Assess The Safety And Pharmacokinetics Of Tafamidis Doses Greater Than 120 Mg As Oral Solution In Healthy Volunteers|Completed||Phase 1|9|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:40:29.262632|2017-10-11 02:40:29.262632
NCT01655498|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-05-22|2015-04-01||August 2012||2012-08-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|LIFE|All subjects who were successfully fit with the VBC device (now called Eclipse)|A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE)|A Clinical Evaluation of the LivSure Vaginal Bowel Control (VBC) System for the Treatment of Fecal Incontinence in Women.|Completed||N/A|61|Actual|Pelvalon, Inc.||1|||f||||f||||||||||2017-10-11 02:40:29.360955|2017-10-11 02:40:29.360955
NCT01655485|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-08-06|||October 2011||2011-10-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of a Social Script iPAD Application for Children With Autism Spectrum Disorder|Effect of a Social Script iPAD Application for Children With Autism Spectrum Disorder(ASD) Undergoing Medical Imaging Procedures|Completed||N/A|32|Actual|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 02:40:29.732024|2017-10-11 02:40:29.732024
NCT01655472|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2012-07-31|||July 2012||2012-07-01|July 2012|2012-07-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Schizophrenia Imaging|Prospective Ultrasonographic and Magnetic Resonance Imaging (MRI) Assessment of General and Brain Fetal Development in Offspring of Schizophrenic Patients|Unknown status|Not yet recruiting|N/A|80|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 02:40:29.833808|2017-10-11 02:40:29.833808
NCT01655459|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-07-29|||January 2012||2012-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Evaluation of the LMA Position Using Ultrasound in Pediatric Patients||Completed||N/A|100|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 02:40:29.975297|2017-10-11 02:40:29.975297
NCT01655446|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-29|||August 2011||2011-08-01|July 2012|2012-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Effects of RR and MT on Patient With Stroke|Randomized Trials of Robotic Rehabilitation, Mirror Therapy, and Dose-Matched Control Intervention for Upper-Limb Rehabilitation in Patients With Chronic Stroke: Comparative Efficacy and Clinimetric Study|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||5|||f||||f||||||||||2017-10-11 02:40:30.149457|2017-10-11 02:40:30.149457
NCT01655433|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2014-07-24|||November 2012||2012-11-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|VELOCITY||Evaluation of Ultrafast Hypothermia Before Reperfusion in STEMI Patients|VELOCITY: Pilot Study to Evaluate Ultrafast Hypothermia Before Reperfusion in Patients With Acute ST-Elevation Myocardial Infarction|Terminated||Phase 2|54|Actual|Velomedix, Inc.||2||Sponsor business decision, not safety related|f||||t||||||||||2017-10-11 02:40:30.348736|2017-10-11 02:40:30.348736
NCT01655420|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2014-02-13|||July 2012||2012-07-01|February 2014|2014-02-01||||||||Observational|PROWL-2||Patient Reported Outcomes With LASIK: PROWL-2|Patient-Reported Outcomes With LASIK: PROWL-2|Completed||N/A|300|Anticipated|Food and Drug Administration (FDA)|||1||f||||f||||||||||2017-10-11 02:40:30.511366|2017-10-11 02:40:30.511366
NCT01655407|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-08-29|||September 2016||2016-09-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds|Evaluation of Autologous Engineered Skin Substitute (ESS-W) Compared to Meshed, Split-Thickness Autograft (AG) for Treatment of Deep Partial- and Full-Thickness Thermal Burn Wounds in Adult Patients|Not yet recruiting||Phase 2|10|Anticipated|Amarantus BioScience Holdings, Inc.||2|||f||||t||||||||Undecided||2017-10-11 02:40:30.627144|2017-10-11 02:40:30.627144
NCT01655394|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2014-12-11|||October 2012||2012-10-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|December 2014|Actual|2014-12-01||Observational|||Change of Nerve Conduction Properties in IVIg Dependent Neuropathies|Change of Nerve Conduction Properties in IVIg Dependent Neuropathies|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of Cologne|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 02:40:30.781777|2017-10-11 02:40:30.781777
NCT01655381|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-12-07|2016-10-07||April 2012||2012-04-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Analysis was performed in Included population, defined as all participants who entered the study.|A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis|A Multicenter, Open-label, Single Arm, Long-term Extension Study of WA19926 to Describe Safety During Treatment With Tocilizumab in Patients With Early, Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|15|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:40:30.913068|2017-10-11 02:40:30.913068
NCT01655368|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2016-06-14|||May 2012||2012-05-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|STEM||Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM)|Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM)|Completed||N/A|486|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 02:40:31.986323|2017-10-11 02:40:31.986323
NCT01655355|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-07-31||||||July 2012|2012-07-01||||||||Observational|||Revision of the Hip Joint - Prospective Study||Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 02:40:32.122738|2017-10-11 02:40:32.122738
NCT01655342|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-09-01|||August 2012||2012-08-01|August 2016|2016-08-01||||August 2015|Actual|2015-08-01||Observational|||Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth|Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth.|Active, not recruiting||N/A|60|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-10-11 02:40:32.18761|2017-10-11 02:40:32.18761
NCT01655329|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2014-06-09|2014-02-02||August 2012||2012-08-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Observational||Board Certified Radiologists|Reader Study to Demonstrate That Use of ClearRead Confirm is Superior to the Use Standard AP/PA X-ray Image|Reader Study to Demonstrate That Use of ClearRead Confirm is Superior to the Use Standard AP/PA X-ray Image. AP Stands for Antero-Posterior. PA Stands for Postero-anterior.|Completed||N/A|10|Actual|Georgetown University|||2||f||||f||||||||||2017-10-11 02:40:32.272637|2017-10-11 02:40:32.272637
NCT01655316|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-11-12|||October 2010||2010-10-01|November 2012|2012-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control||Completed||Phase 4|90|Actual|Tehran University of Medical Sciences||1|||f||||f||||||||||2017-10-11 02:40:32.533075|2017-10-11 02:40:32.533075
NCT01655303|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-07-30|||February 2011||2011-02-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Rate Control in Atrial Fibrillation|Oral Propranolol, Diltiazem, Metoprolol and Verapamil in Atrial Fibrillation Rate Control in Patients With Stable Hemodynamic Status|Completed||Phase 4|90|Actual|Tehran University of Medical Sciences||4|||f||||||||||||||2017-10-11 02:40:32.621586|2017-10-11 02:40:32.621586
NCT01655290|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-03-16|||August 2012||2012-08-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional|Gadovit||Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI|Intraindividual Comparison of the Diagnostic Accuracy Using Gadobutrol (Gadovist®) Versus Gadobenat Dimeglumin (Multihance®) for Delayed Enhancement MRI of Myocardial Infarction.|Completed||Phase 2|20|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-10-11 02:40:32.923063|2017-10-11 02:40:32.923063
NCT01655277|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-07-30|||February 2012||2012-02-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Ultrasound Guided Adductor Canal Block Versus Femoral Nerve Block for Quadriceps Strength and Fall-risk|The Effects of Ultrasound Guided Adductor Canal Block Versus Femoral Nerve Block on Quadriceps Strength and Fall-risk: a Blinded Randomized Trial of Volunteers|Completed||Phase 4|16|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||||||||||||2017-10-11 02:40:33.010272|2017-10-11 02:40:33.010272
NCT01655264|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-10-10|||July 2012||2012-07-01|October 2012|2012-10-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|GertnerTMR||Evaluation of the Gertner Tele-Motion-Rehabilitation System for Stroke Rehabilitation|Randomized Controlled Trial of Gertner Tele-Motion-Rehabilitation|Unknown status|Recruiting|N/A|24|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:40:33.127026|2017-10-11 02:40:33.127026
NCT01655251|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-07-30|||February 2011||2011-02-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Video Discharge Instructions for Fever and ED Recidivism|Video Discharge Instructions for Fever and ED Recidivism|Completed||N/A|273|Actual|Connecticut Children's Medical Center||2|||f||||f||||||||||2017-10-11 02:40:33.298909|2017-10-11 02:40:33.298909
NCT01655238|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-01-07|||July 2012||2012-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Obesity Guidelines for Outpatient Surgery|Have NCH Obesity Guidelines Made an Impact? Differences in Anesthetizing the Obese Child in Outpatient Sites Versus Main OR at NCH.|Completed||N/A|1327|Actual|Nationwide Children's Hospital|||3||f||||f||||||||||2017-10-11 02:40:33.395199|2017-10-11 02:40:33.395199
NCT01655225|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-09-21|||July 31, 2012|Actual|2012-07-31|September 2017|2017-09-01|October 2020|Anticipated|2020-10-01|May 2018|Anticipated|2018-05-01||Interventional|||A Study of LY3023414 in Participants With Advanced Cancer|A Phase 1 First-in-Human Dose Study of LY3023414 in Patients With Advanced Cancer|Recruiting||Phase 1|130|Anticipated|Eli Lilly and Company||9|||f||||f||||||||||2017-10-11 02:40:33.50611|2017-10-11 02:40:33.50611
NCT01653145|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-01-15|||July 2010||2010-07-01|January 2016|2016-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Positive Energy I Through Overfeeding|Behavioral Response to Short-term (Two-day) Positive Energy Balance Through Overfeeding (ENERGY I)|Completed||N/A|20|Actual|Pennington Biomedical Research Center||3|||f||||f||||||||||2017-10-11 02:41:11.775043|2017-10-11 02:41:11.775043
NCT01655212|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-06-17|||June 2012||2012-06-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|CONCERT||Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial|Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial|Terminated||Phase 3|2|Actual|Leiden University Medical Center||2||"1 Indication for further investigations (brain ultrasound). 2 Change of study design to   efficacy study with historical control group."|f||||t||||||||||2017-10-11 02:40:34.260912|2017-10-11 02:40:34.260912
NCT01655199|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-09-17|||September 2012||2012-09-01|September 2013|2013-09-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|CODEx||Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease|Measurement of Exertional Dyspnea in the Primary Care Setting in Patients With COPD, Phase III: Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With COPD|Unknown status|Recruiting|N/A|40|Anticipated|Laval University||1|||f||||t||||||||||2017-10-11 02:40:34.39059|2017-10-11 02:40:34.39059
NCT01655186|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-10-19|||September 2012||2012-09-01|October 2012|2012-10-01|October 2013|Anticipated|2013-10-01|October 2012|Actual|2012-10-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus||Withdrawn||Phase 2|0|Actual|Reata Pharmaceuticals, Inc.||2||IDMC recommendation for safety concerns|f||||||||||||||2017-10-11 02:40:34.522265|2017-10-11 02:40:34.522265
NCT01655160|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-06-04|||August 2012||2012-08-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects and Mechanisms of Treatment Intensity of Mirror Therapy in Patients With Subacute Stroke|Effects and Mechanisms of Treatment Intensity of Mirror Therapy in Patients With Subacute Stroke: Outcomes in Brain and Movement Reorganization, Sensorimotor and Daily Functions, and Measures of Physiological Markers.|Completed||N/A|2|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-11 02:40:34.71584|2017-10-11 02:40:34.71584
NCT01655147|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2013-01-08|||January 2012||2012-01-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants|An Open-Label Drug-Drug Interaction Study to Assess the Effect of Rifampicin on the Pharmacokinetics of Abiraterone (JNJ-589485) Following Administration of Abiraterone Acetate (JNJ-212082) Tablets in Healthy Male Subjects|Completed||Phase 1|19|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 02:40:34.817914|2017-10-11 02:40:34.817914
NCT01655134|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2014-03-20|||November 2012||2012-11-01|July 2013|2013-07-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|BIOMIC||Biomarkers and Therapeutic Modelisation in Heart Failure|Home-based Assessment of Plasma Volume, Serum Potassium and Renal Function Variations in Patients With Heart Failure and Low Left Ventricular Ejection Fraction: Pilot Study BIOMIC. Biomarkers and Therapeutic Modelisation in Heart Failure|Unknown status|Recruiting|N/A|20|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-10-11 02:40:34.905739|2017-10-11 02:40:34.905739
NCT01655121|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-08-18|||January 2012||2012-01-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of High-protein High-fiber Diet in Patients With Autoimmune Hepatitis|Effect of a High-protein High-fiber Diet and Nutritional Status, Serum Ammonia Concentration and Plasma Cytokines in Patients With Autoimmune Hepatitis|Completed||N/A|40|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||||2017-10-11 02:40:34.996345|2017-10-11 02:40:34.996345
NCT01655108|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2013-09-23|||March 2012||2012-03-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients|BLIND RANDOMIZED COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MESOTHERAPY MINOXIDIL HAIR WITH 0.5% / 2ML VERSUS PLACEBO IN THE TREATMENT OF FEMALE ANDROGENETIC ALOPECIA|Unknown status|Active, not recruiting|Phase 3|60|Anticipated|Brasilia University Hospital||2|||f||||f||||||||||2017-10-11 02:40:35.099245|2017-10-11 02:40:35.099245
NCT01655095|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-11-30|||July 2012||2012-07-01|September 2015|2015-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Improving Bowel Preparation for the Colon Capsule|Improving Bowel Preparation for the Colon Capsule: Picosalax and Prucalopride vs. PEG and Prucalopride|Completed||Phase 3|20|Actual|Queen's University||2|||f||||t||||||||||2017-10-11 02:40:35.20484|2017-10-11 02:40:35.20484
NCT01655082|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-12-10|||August 2012||2012-08-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Nicotine Patch Safety Study||Completed||Phase 2|160|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 02:40:35.328399|2017-10-11 02:40:35.328399
NCT01655056|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2013-06-24|||June 2006||2006-06-01|July 2012|2012-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body|A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YM150 in Healthy Caucasian and Japanese Male and Female Subjects|Completed||Phase 1|82|Actual|Astellas Pharma Inc||5|||f||||f||||||||||2017-10-11 02:40:37.666523|2017-10-11 02:40:37.666523
NCT01617889|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2013-02-14|||March 2011||2011-03-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Healthy Term Infants Fed Milk-Based Formulas|Healthy Term Infants Fed Milk-Based Formulas With Different Fat Blends|Completed||Phase 3|17|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-10-11 02:51:16.627573|2017-10-11 02:51:16.627573
NCT01655043|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-03-30|2015-02-10||September 2012||2012-09-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||20 participants with suspected coronary artery disease|Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI|Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI|Completed||Phase 2|20|Actual|Northwestern University|The small number of subjects results in reduced statistical power; The cohort was selected from patients at a single medical center, potentially reducing generalizability|1|||f||||t||||||||||2017-10-11 02:40:37.80791|2017-10-11 02:40:37.80791
NCT01655030|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2015-12-01|||July 2012||2012-07-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Creatine Monohydrate as Adjuvant Therapy for Bipolar Depression|A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Creatine Monohydrate as Adjunctive Therapy for Bipolar Depression|Recruiting||Phase 4|44|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:40:38.152092|2017-10-11 02:40:38.152092
NCT01655017|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-02-20|||April 2012||2012-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|fibrota||Fibrosis a New Pathological Actor in Adipose Tissue|Fibrosis a New Pathological Actor in Adipose Tissue|Recruiting||N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:40:38.288744|2017-10-11 02:40:38.288744
NCT01655004|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2016-06-21|||August 2012||2012-08-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD|Prospective Study of UDP-gluconoryltransferase (UGT) 2B17 Genotype as a Predictive Marker of Exemestane Pharmacokinetics and Pharmacodynamics in Asian Women With Hormone Receptor-positive Advanced Breast Cancer|Recruiting||N/A|110|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-11 02:40:38.426383|2017-10-11 02:40:38.426383
NCT01654991|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2013-10-30|||June 2010||2010-06-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Randomized Trial of Home Versus Clinic-Based STD Testing|A Randomized Trial of Home Versus Clinic-Based STD Testing Among Men|Completed||N/A|200|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-10-11 02:40:38.552978|2017-10-11 02:40:38.552978
NCT01654965|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-09-12|||July 24, 2012|Actual|2012-07-24|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I Study of ARQ 197 in Combination With IV Topotecan in Advanced Solid Tumors With an Expansion Cohort in Small Cell Lung Cancer|Active, not recruiting||Phase 1|34|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 02:40:38.777363|2017-10-11 02:40:38.777363
NCT01654939|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-09-25|||October 2012||2012-10-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease|Impact of Rifaximin on Liver Fibrosis in HIV-Infected Patients With Liver Disease|Withdrawn||Phase 4|0|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-11 02:40:38.909055|2017-10-11 02:40:38.909055
NCT01654926|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-29|2015-03-08|||December 2012||2012-12-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Feasibility Assessment of the Aquadex FlexFlowTM Ultrafiltration System in Treating Non Hospitalized Heart Failure Patients in Dedicated Heart Failure Centers|Feasibility Assessment of the Aquadex FlexFlowTM Ultrafiltration System in Treating Non Hospitalized Heart Failure Patients in Dedicated Heart Failure Centers|Completed||N/A|38|Actual|Clalit Health Services|||1||f||||f||||||||||2017-10-11 02:40:39.01645|2017-10-11 02:40:39.01645
NCT01654913|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-10-28|||July 2012||2012-07-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Hb-O2||Influence of Oxygen on Non-invasive Measurement of Hemoglobin|Influence of the Inspired Oxygen Fraction on the Noninvasive Measurement of Hemoglobin Using Two Different Devices (Namely Pronto 7 and NBM-200)|Completed||N/A|47|Actual|Hopital Foch||1|||f||||f||||||||||2017-10-11 02:40:39.13103|2017-10-11 02:40:39.13103
NCT01654900|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-31|||October 2012||2012-10-01|July 2012|2012-07-01||||||||Observational|||Mid-term Survival and Quality of Life of Elderly Patients Undergoing Open Heart Surgery|Mid -Term Survival and Quality of Life of Elderly Patients Undergoing Open Heart Surgery|Unknown status|Not yet recruiting|N/A|207|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 02:40:39.220417|2017-10-11 02:40:39.220417
NCT01654887|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-01-20|2016-06-20||August 2012||2012-08-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Randomized Controlled Trial of Lung Ultrasound Compared to Chest X-ray for Diagnosing Pneumonia in the Emergency Department|Comparative Effectiveness of Lung Ultrasound vs. Chest X-ray for the Diagnosis of Pneumonia in the Emergency Department|Completed||N/A|191|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 02:40:39.335551|2017-10-11 02:40:39.335551
NCT01654874|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-11-23|||July 2012||2012-07-01|November 2015|2015-11-01||||February 2013|Actual|2013-02-01||Interventional|||99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404|99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404|Completed||Phase 1|6|Actual|Molecular Insight Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 02:40:39.928035|2017-10-11 02:40:39.928035
NCT01654861|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-04-29|2014-11-26||June 2012||2012-06-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy Study of Gemcitabine Combined With High Dose Intravenous Vitamin C (HDIVC) for Patients With Metastatic Adenocarcinoma of the Pancreas|Evaluation of the Safety and Efficacy of Standard Dose Gemcitabine Combined With High Dose Intravenous Vitamin C (HDIVC) Treatment for Patients With Metastatic Adenocarcinoma of the Pancreas.|Terminated||Phase 1|3|Actual|Eastern Regional Medical Center||1||recruiting or enrolling participants has halted prematurely and will not resume|f||||f||||||||||2017-10-11 02:40:40.037925|2017-10-11 02:40:40.037925
NCT01654848|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-07-31|||January 2010||2010-01-01|July 2012|2012-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|HITOLT||Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients|Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients: a Prospective Multivariate Analysis of Prognostic Factors and Haemostaseological Findings|Completed||N/A|39|Actual|CHIR-Net|||1||f||||f||||||||||2017-10-11 02:40:40.250561|2017-10-11 02:40:40.250561
NCT01654835|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-08-10|||July 2012||2012-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Effectiveness Trial of Early Hemodynamic Support in Patients Demonstrating a Low Systolic Blood Pressure|A Effectiveness Trial of Early Hemodynamic Support in Patients Demonstrating a Low Systolic Blood Pressure|Active, not recruiting||N/A|711|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-11 02:40:40.330994|2017-10-11 02:40:40.330994
NCT01654822|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-11-08|||August 2012||2012-08-01|November 2012|2012-11-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|||AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections|Single Center, Placebo Controlled, Double-Blind Study to the Treatment of HPV Infected Cervix With AV2 Antiviral Spray and Assessment of Viral Load|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Cesa Projects International||2|||f||||f||||||||||2017-10-11 02:40:40.411777|2017-10-11 02:40:40.411777
NCT01654809|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-28|2012-09-30|||August 2010||2010-08-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups|Evaluation of Safety and Immunogenicity Among Different Age-groups Receiving Different Split Influenza Vaccines|Completed||Phase 4|900|Actual|Beijing Center for Disease Control and Prevention||3|||f||||f||||||||||2017-10-11 02:40:40.527296|2017-10-11 02:40:40.527296
NCT01654796|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-08-02|2017-04-17||April 2013|Actual|2013-04-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|RAPID|Please note that while 85 subjects were randomized, only 84 subjects were included in the outcome analysis due to missing data.|Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression|Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression|Completed||N/A|84|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 02:40:40.647062|2017-10-11 02:40:40.647062
NCT01654783|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2015-02-17|||September 2012||2012-09-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA|Observational Study on Clinical Practice in the Management of Ulcerative Colitis With Oral 5-Aminosalicylic Acid in Japan|Completed||N/A|5704|Actual|Kyorin Pharmaceutical Co.,Ltd|||1||f||||f||||||||||2017-10-11 02:40:41.639605|2017-10-11 02:40:41.639605
NCT01654770|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2012-07-31|||October 2010||2010-10-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||A Prospective Study Comparing Urgent Video Capsule Endoscopy With Urgent Double-balloon Enteroscopy|A Prospective Study Comparing Urgent Video Capsule Endoscopy With Urgent Double-balloon Enteroscopy in Patients With Massive Overt Obscure Gastrointestinal Bleeding|Completed||Phase 4|27|Actual|King Chulalongkorn Memorial Hospital||2|||f||||f||||||||||2017-10-11 02:40:41.719105|2017-10-11 02:40:41.719105
NCT01654731|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-02-20|||October 2012||2012-10-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|BEZURSO||Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis|Multicenter, Randomized, Double-blind Placebo Controlled Trial of Bezafibrate for the Treatment of Primary Biliary Cirrhosis in Patients With Incomplete Response to Ursodesoxycholic Acid Therapy.|Completed||Phase 3|100|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:40:41.806203|2017-10-11 02:40:41.806203
NCT01654718|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-07-28|||October 2008||2008-10-01|June 2012|2012-06-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|||Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover Bioequivalence Study Comparing Pantoprazole Sodium 40 mg Delayed Release Tablets (Containing 45.1 mg of Pantoprazole Sodium Sesquihydrate is Equivalent to 40 mg of Pantoprazole) of OHM Laboratories Inc. USA (a Subsidiary of Ranbaxy Pharmaceuticals Inc. USA) With PROTONIX® 40 mg Delayed Release Tablets (Containing 45.1 mg of Pantoprazole Sodium Sesquihydrate is Equivalent to 40 mg of Pantoprazole) of Wyeth Laboratories in Healthy, Adult, Human, Male Subjects Under Fed Conditions.|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 02:40:41.913701|2017-10-11 02:40:41.913701
NCT01654705|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-07-28|||September 2009||2009-09-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover Bioequivalence Study Comparing Pantoprazole Sodium 40 mg Delayed Release Tablets (Containing 45.1 mg of Pantoprazole Sodium Sesquihydrate Equivalent to 40 mg of Pantoprazole) of Ohm Laboratories Inc. (a Subsidiary of Ranbaxy Pharmaceuticals Inc, USA) With PROTONIX® 40 mg Delayed Release Tablets (Containing 45.1 mg of Pantoprazole Sodium Sesquihydrate Equivalent to 40 mg of Pantoprazole) of Wyeth Pharmaceuticals Inc. in Healthy, Adult, Male, Human Subjects Under Fasting Conditions.|Completed||N/A|80|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 02:40:41.996654|2017-10-11 02:40:41.996654
NCT01654692|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-05-12|||June 2010||2010-06-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|May 2012|Actual|2012-05-01||Interventional|NIBIT-M1||A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma|A Phase II Study of the Combination of Ipilimumab and Fotemustine in Patients With Unresectable Locally Advanced or Metastatic Malignant Melanoma|Completed||Phase 2|86|Actual|Italian Network for Tumor Biotherapy||1|||f||||t||||||||||2017-10-11 02:40:42.1054|2017-10-11 02:40:42.1054
NCT01654679|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-22|2012-09-05|||August 2008||2008-08-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|June 2010|Actual|2010-06-01||Interventional|Hydrosun||Impact of Preoperative Local Water-Filtered Infrared-A (wIRA) Irradiation on Postoperative Wound Healing|Impact of Preoperative Local Water-Filtered Infrared-A (wIRA) Irradiation on Postoperative Wound Healing - A Randomized Patient- and Observer Blinded Controlled Clinical Trial|Completed||N/A|400|Actual|German Research Foundation||2|||f||||f||||||||||2017-10-11 02:40:42.242345|2017-10-11 02:40:42.242345
NCT01654666|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-10-13|2015-07-23||July 2012||2012-07-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Interventional||Baseline Analysis Population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.|Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting|Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting|Completed||Phase 2|189|Actual|Capital Medical University||3|||f||||t||||||||||2017-10-11 02:40:42.397051|2017-10-11 02:40:42.397051
NCT01654653|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-07-27|||July 2008||2008-07-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients|A Phase , Prospective, Randomized, Open-label Study to Compare the Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG (Coronary Artery Bypass Grafting) Patients|Completed||Phase 4|100|Actual|Innogene Kalbiotech Pte. Ltd||2|||f||||f||||||||||2017-10-11 02:40:43.111989|2017-10-11 02:40:43.111989
NCT01654640|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2015-12-07|||July 2012||2012-07-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|April 2016|Anticipated|2016-04-01||Interventional|||The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine|Phase 4 Study of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine|Recruiting||Phase 4|30|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:40:43.234598|2017-10-11 02:40:43.234598
NCT01654627|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2013-08-26|||April 2013||2013-04-01|August 2013|2013-08-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Guided Bone Regeneration Using Synthetic Membrane|Horizontal Guided Bone Regeneration for Dental Implants Using Synthetic Membrane (Regenecures' AMCA GBR Dental Membrane) a Prospective, Randomized,Controlled Study.|Unknown status|Recruiting|Phase 1/Phase 2|32|Anticipated|RegeneCure, Ltd.||2|||f||||t||||||||||2017-10-11 02:40:43.371828|2017-10-11 02:40:43.371828
NCT01654614|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-22|2017-01-14|||November 2011||2011-11-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|||Diagnostic Capacity of Keratoconus Match Index and Keratoconus Match Probability in Forme Fruste Keratoconus|Diagnostic Capacity of Keratoconus Match Index and Keratoconus Match Probability in Forme Fruste Keratoconus|Completed||N/A|120|Actual|Democritus University of Thrace|||2||f||||t||||||||||2017-10-11 02:40:43.481276|2017-10-11 02:40:43.481276
NCT01654601|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-02-22|2013-12-17||June 2012||2012-06-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|DWCZP-I-1||A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg|Clinical Trials to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg After a Multi-dose Oral Administration in Schizophrenia Patients|Completed||Phase 1|28|Actual|Dong Wha Pharmaceutical Co. Ltd.||2|||f||||f||||||||No||2017-10-11 02:40:43.57149|2017-10-11 02:40:43.57149
NCT01654588|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-12-10|||September 2011||2011-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Different End Points for Bronchial Hyperactivity (BHR) Tests.|Different End Points for Bronchial Hyperactivity (BHR) Tests, What Comes First?|Completed||N/A|501|Actual|Wolfson Medical Center|||1||f||||f||||||||||2017-10-11 02:40:44.092231|2017-10-11 02:40:44.092231
NCT01654575|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-07-28|||July 2011||2011-07-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Methotrexate in Symptomatic Knee Osteoarthritis|Randomized Controlled Trial Using Methotrexate for Knee Osteoarthritis|Completed||N/A|88|Actual|Faculty of Medicine, University of Alexandria||2|||f||||t||||||||||2017-10-11 02:40:44.183573|2017-10-11 02:40:44.183573
NCT01654562|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-10-14|||December 2012||2012-12-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia|A Repeated Measures Study of Simvastatin on Choroideremia: Simvastatin Intervention and Reversal in Choroideremia Patients and Age-matched Controls.|Terminated||Phase 1/Phase 2|2|Actual|University of Alberta||2||The study has been terminated due to limited participant enrollment.|f||||f||||||||||2017-10-11 02:40:44.468985|2017-10-11 02:40:44.468985
NCT01654549|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-11-21|2012-10-20||April 2012||2012-04-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis|The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-diabetic Subjects With Non-alcoholic Fatty Liver Disease|Completed||Phase 2|40|Actual|Tehran University of Medical Sciences|No limitations and Caveats|2|||f||||f||||||||||2017-10-11 02:40:44.589869|2017-10-11 02:40:44.589869
NCT01654536|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-07-23|2014-06-25||September 2012||2012-09-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)|A 6 Month Randomized, Open Label, Parallel Group, Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis|Completed||Phase 4|737|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 02:40:45.025638|2017-10-11 02:40:45.025638
NCT01654523|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2016-06-21|2016-01-28||January 2005||2005-01-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania|Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania|Completed||Phase 2|33|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-11 02:40:46.874037|2017-10-11 02:40:46.874037
NCT01654510|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-07-30|||April 2008||2008-04-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Systems Level Intervention for Unemployed Persons With Social Anxiety Disorder|A Systems Level Intervention for Unemployed Persons With Social Anxiety|Completed||Phase 2/Phase 3|165|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 02:40:47.123681|2017-10-11 02:40:47.123681
NCT01654497|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-07-05|||June 2012||2012-06-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|September 2015|Actual|2015-09-01||Interventional|||Dexanabinol in Patients With Brain Cancer|A Phase I, Sequential Cohort, Open-Label, Dose-escalation Study of the Safety and CNS Pharmacokinetics of Dexanabinol in Patients With Brain Cancer|Completed||Phase 1|26|Actual|University of California, San Diego||1|||f||||t||||||||||2017-10-11 02:40:47.194474|2017-10-11 02:40:47.194474
NCT01654484|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-12-14|||July 2012||2012-07-01|October 2012|2012-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT|A Phase I/II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension|Completed||Phase 1/Phase 2|60|Actual|Santen Inc.||8|||f||||f||||||||||2017-10-11 02:40:47.285512|2017-10-11 02:40:47.285512
NCT01654471|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-11-19|||August 2012||2012-08-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease|Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease|Completed||N/A|47|Actual|Seoul National University Hospital|||2||f||||t||||||||||2017-10-11 02:40:47.392204|2017-10-11 02:40:47.392204
NCT01654458|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-03-23|||July 2012||2012-07-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer|A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer|Active, not recruiting||N/A|420|Anticipated|Women's College Hospital||2|||f||||f||||||||||2017-10-11 02:40:47.480343|2017-10-11 02:40:47.480343
NCT01654432|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2013-11-15|||July 2011||2011-07-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||A Randomized Controlled Comparative Study of Ultrasound-guided Paravertebral Blocks as Part of a Multimodal Regimen for Ambulatory Breast Cancer Surgery|A Randomized Controlled Comparative Study of Ultrasound-guided Paravertebral Blocks as Part of a Multimodal Regimen for Ambulatory Breast Cancer Surgery|Unknown status|Active, not recruiting|N/A|60|Anticipated|Women's College Hospital||2|||f||||f||||||||||2017-10-11 02:40:47.694409|2017-10-11 02:40:47.694409
NCT01654419|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-30|||March 2010||2010-03-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Interventional|||Comparison of the Quantity of Distal Movement of the Upper Canine and Molar|Comparison of the Quantity of Distal Movement of the Upper Canine and Molar Using Class II Elastics With and Without Sliding Jig in a Period of 3 Months|Completed||N/A|30|Actual|Universidad de Antioquia||2|||f||||t||||||||||2017-10-11 02:40:47.786188|2017-10-11 02:40:47.786188
NCT01654406|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-07-12|||July 2012||2012-07-01|July 2012|2012-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Fractional CO2 Laser in the Treatment for Cesarian Scar||Terminated||N/A|8|Actual|Taipei Medical University WanFang Hospital||2||"because 1 patient's scar becomes more severe than before, and most patient have satificated   outcome"|f||||||||||||||2017-10-11 02:40:47.879745|2017-10-11 02:40:47.879745
NCT01654380|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2013-10-18|||July 2012||2012-07-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study of LY2605541 Versus Insulin Glargine on Blood Sugar|Comparison of the Effects of LY2605541 and Insulin Glargine on Endogenous Glucose Output and Peripheral Glucose Disposal in Healthy Subjects and Patients With Type 1 Diabetes Mellitus|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 02:40:48.183003|2017-10-11 02:40:48.183003
NCT01654367|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-26|||January 2012||2012-01-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|esozao||Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer|The Effectiveness and Safety of Treating Operable Breast Cancer by the Adjuvant Therapy of Zoledronic Acid and Aromatase Inhibitors and/or Ovarian Function Inhibition|Unknown status|Recruiting|Phase 2/Phase 3|300|Anticipated|Tianjin Medical University||1|||f||||t||||||||||2017-10-11 02:40:48.291798|2017-10-11 02:40:48.291798
NCT01654354|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2014-01-13|||July 2012||2012-07-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2012|Actual|2012-11-01|8 Days|Observational [Patient Registry]|||Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT|Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT|Completed||Phase 4|104|Actual|Seoul National University Hospital|||1||f||||||||||||||2017-10-11 02:40:48.399889|2017-10-11 02:40:48.399889
NCT01654341|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2016-03-22|||December 2013||2013-12-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|MID-Frail||Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes|A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI-MODAL INTERVENTION IN FRAIL AND PREFRAIL OLDER PEOPLE WITH TYPE 2 DIABETES ON FRAILTY AND QUALITY OF LIFE: THE MID-Frail STUDY|Active, not recruiting||N/A|986|Actual|Hospital Universitario Getafe||2|||f||||f||||||||||2017-10-11 02:40:48.461529|2017-10-11 02:40:48.461529
NCT01654328|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2015-03-31|||August 2012||2012-08-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|INOVATIO||Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy|Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy|Terminated||N/A|256|Actual|Radboud University||2||slow inclusion|f||||t||||||||||2017-10-11 02:40:48.571064|2017-10-11 02:40:48.571064
NCT01654302|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-04-22|2014-09-29||September 2013||2013-09-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional||Baseline analysis performed for participants that completed study.|Efficacy and Safety of Synera in Osteoarthritis Pain|Efficacy and Safety of Synera in OA Pain|Completed||Phase 1/Phase 2|40|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 02:40:48.760888|2017-10-11 02:40:48.760888
NCT01654289|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-04-03|||June 2012||2012-06-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|MEPARI-2||University of Wisconsin Meditation & Exercise Cold Study|Meditation or Exercise for Preventing Acute Respiratory Infection (MEPARI-2)|Completed||Phase 2|413|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 02:40:49.070315|2017-10-11 02:40:49.070315
NCT01654276|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-11-18|2015-04-02||May 2012||2012-05-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome|Effects of Pharmacological Reversal of Hyperuricemia on Features of the Metabolic Syndrome|Completed||Phase 4|24|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||No||2017-10-11 02:40:49.180332|2017-10-11 02:40:49.180332
NCT01654263|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-02-23|2016-08-11||October 10, 2012|Actual|2012-10-10|April 15, 2016|2016-04-15|August 21, 2015|Actual|2015-08-21|August 21, 2015|Actual|2015-08-21||Interventional||All participants are included in the baseline analysis population.|A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine|A Phase IIb, Open-Label, Dose-Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine|Completed||Phase 2|884|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f|||||t|f|||f|||||2017-10-11 02:40:49.566374|2017-10-11 02:40:49.566374
NCT01654250|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-01-04|2016-01-04|2013-11-05|July 2012||2012-07-01|January 2016|2016-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Intent to treat (ITT) population included all randomized participants who received at least 1 dose of double-blind study medication (either NWP09 or matching placebo) and had at least 1 post-baseline assessment of the primary efficacy variable.|NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)|A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom|Completed||Phase 3|90|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:40:51.271134|2017-10-11 02:40:51.271134
NCT01654237|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-07-31|||October 2010||2010-10-01|July 2012|2012-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|FIPMCAWMI||Musculoskeletal Complaints in an Industry|Factors That Influence the Prevalence of Musculoskeletal Complaints Among Workers in Different Sectors of an Industry|Completed||N/A|185|Actual|University of Sao Paulo General Hospital||1|||f||||t||||||||||2017-10-11 02:40:52.47149|2017-10-11 02:40:52.47149
NCT01654224|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-06-13|2016-02-12||November 2011||2011-11-01|June 2017|2017-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting|Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting|Completed||Phase 4|205|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:40:52.571312|2017-10-11 02:40:52.571312
NCT01654211|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers|A Three-Part Study Evaluating the Pharmacokinetics of Intravenous (IV) Danoprevir (DNV)/Oral Low-Dose Ritonavir (RTV), the Absolute Bioavailability of DNV With and Without Oral Low-Dose RTV, and the Effect of Oral Cyclosporine on IV DNV/Oral Low-Dose RTV in Healthy Adult Volunteers|Completed||Phase 1|33|Actual|Hoffmann-La Roche||7|||f||||||||||||||2017-10-11 02:40:53.150443|2017-10-11 02:40:53.150443
NCT01654198|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2016-09-21|||July 2012||2012-07-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||PET/CT in Psoriatic Arthritis|FDG-PET/CT in the Diagnosis and Monitoring of Psoriatic Arthritis|Recruiting||N/A|24|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Plasma, Serum, and Plasma Cells   "|||2017-10-11 02:40:53.245773|2017-10-11 02:40:53.245773
NCT01654185|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-03-13|||July 2012||2012-07-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2014|Actual|2014-07-01||Interventional|||Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer|Phase II Study of Dimethyldiguanide Combined With AI Compared to AI in Postmenopausal HR(+) Metastatic Breast Cancer.|Completed||Phase 2|60|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 02:40:53.326992|2017-10-11 02:40:53.326992
NCT01654172|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-07-30|||September 2006||2006-09-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Flavanol-rich Cocoa on Peripheral and Cerebral Blood Flow in Type 2 Diabetes|Effect of Flavanol-rich Cocoa on Peripheral and Cerebral Blood Flow in Type 2 Diabetes|Completed||N/A|18|Actual|University of Nottingham||2|||f||||t||||||||||2017-10-11 02:40:53.43057|2017-10-11 02:40:53.43057
NCT01654159|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-01-30|||September 2013||2013-09-01|July 2016|2016-07-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|||Assessment of Visual Function and Optics in Intraocular Lenses|Evaluating Subjective and Objective Performance of Instrumentation Used and Devices Implanted in Cataract Surgery|Enrolling by invitation||N/A|500|Anticipated|Aston University||3|||f||||f||||||||Yes|Data collaboration will be considered on request|2017-10-11 02:40:53.526778|2017-10-11 02:40:53.526778
NCT01654146|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-07-26|||June 2011||2011-06-01|July 2012|2012-07-01||||June 2017|Anticipated|2017-06-01||Interventional|ICON8||ICON8: Weekly Chemotherapy in Ovarian Cancer|An International Phase III Randomised Trial of Dose Fractionated Chemotherapy Compared to Standard Three Weekly Chemotherapy, Following Immediate Primary Surgery or as Part of Delayed Primary Surgery, for Women With Newly Diagnosed Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Unknown status|Recruiting|Phase 3|1485|Anticipated|Medical Research Council||3|||f||||t||||||||||2017-10-11 02:40:53.632801|2017-10-11 02:40:53.632801
NCT01654133|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-04-17|||July 2012||2012-07-01|April 2017|2017-04-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Visceral (Kidney and Abdominal Organ) Function After Fenestrated and Branched Endovascular Aneurysm Repair (FEVAR/BEVAR) of Thoracoabdominal Aortic Aneurysms|Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts|Enrolling by invitation||N/A|210|Anticipated|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 02:40:53.731942|2017-10-11 02:40:53.731942
NCT01654120|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-04-16|||December 2011||2011-12-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics|Liraglutide and Insulin-001 A Randomized Prospective Trial of Liraglutide Added to High-Dose Insulin Therapy vs. High-Dose Insulin Therapy Alone in Insulin-Resistant Patients With Type 2 Diabetes|Completed||Phase 4|36|Anticipated|Mountain Diabetes and Endocrine Center||2|||f||||f||||||||||2017-10-11 02:40:53.830845|2017-10-11 02:40:53.830845
NCT01654107|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-07-13|2015-08-17||July 2012||2012-07-01|July 2017|2017-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|PTSC||Persistence-Targeted Smoking Cessation|Persistence-Targeted Smoking Cessation|Completed||Phase 1|58|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-11 02:40:53.929535|2017-10-11 02:40:53.929535
NCT01653899|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-07-05|||June 2012||2012-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Caspase Inhibition in Islet Transplantation|Improving Engraftment, Islet Survival and Metabolic Reserve in Clinical Islet Transplantation Using Caspase Inhibitor - IDN-6556|Completed||Phase 1/Phase 2|12|Actual|University of Alberta||1|||f||||t||||||||||2017-10-11 02:40:56.252389|2017-10-11 02:40:56.252389
NCT01654094|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-09-29|||October 2012||2012-10-01|September 2017|2017-09-01|September 29, 2017|Actual|2017-09-29|September 2014|Actual|2014-09-01||Interventional|||Study of Low Adherent Dressing Versus the Standard of Care for the Management of Skin Grafts Over Thermal Burns|A Multicenter, Prospective, Randomized Study to Compare Milliken Dressing P6 to Mafenide Acetate 5% Solution as a Split Thickness Skin Graft Cover Dressing in Burn Wound Patients.|Completed||N/A|80|Anticipated|Milliken Healthcare Products, LLC||2|||f||||f||||||||||2017-10-11 02:40:54.283495|2017-10-11 02:40:54.283495
NCT01654081|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-05-28|||October 2013||2013-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Protocol of Irinotecan for Carcinoma of the Lung|A Non-randomized Phase II Protocol of Irinotecan for Patients With Previously Treated, Advanced ISG15-positive Non-small Cell Carcinoma of the Lung|Withdrawn||Phase 2|0|Actual|University of Kentucky||1||Slow accrual|f||||t||||||||||2017-10-11 02:40:54.386373|2017-10-11 02:40:54.386373
NCT01654068|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-08-03|||December 2009||2009-12-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine|Conformal High Dose Intensity Modulated Radiation Therapy for Asymptomatic Metastatic Disease to the Thoracic and Lumbar Spine|Active, not recruiting||Phase 2|16|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-11 02:40:54.498894|2017-10-11 02:40:54.498894
NCT01654055|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-02-21|||October 2011||2011-10-01|February 2017|2017-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|EI-Morphinique||International Prospective Study on Morphine-induced Adverse Drug Reactions in Emergency Departments.|International Multicentre Prospective Study on Morphine-induced Adverse Drug Reactions in Emergency Departments: Description and Predictive Factors.|Completed||N/A|1128|Actual|University Hospital, Toulouse|||1||f||||f||||||||No||2017-10-11 02:40:54.589132|2017-10-11 02:40:54.589132
NCT01654042|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2014-03-18|||April 2014||2014-04-01|March 2014|2014-03-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|PRINT-II||Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II|Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II (the PRINT II Study): a Randomized Controlled, Non-inferiority Trial Comparing 4-weekly With 12-weekly Testing and Dose-assessment|Withdrawn||Phase 3|0|Actual|McMaster University||2||No funding obtained|f||||f||||||||||2017-10-11 02:40:54.683366|2017-10-11 02:40:54.683366
NCT01654029|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2014-04-23|||September 2010||2010-09-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|PCCI||Patient Centred Communication Intervention|Patient Centred Communication Intervention|Completed||N/A|120|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 02:40:54.805827|2017-10-11 02:40:54.805827
NCT01654016|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-05-15|||August 2012||2012-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Antiinflammatory Effects of Detralex (Daflon)|Study of Antiinflammatory Effects of Detralex (Daflon) in Patients With Chronic Venous Disease|Enrolling by invitation||Phase 4|84|Anticipated|University Hospital Dubrava||2|||f||||f||||||||||2017-10-11 02:40:54.940943|2017-10-11 02:40:54.940943
NCT01654003|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-05-11|||April 2010||2010-04-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Impact of Early Goal-directed Fluid Therapy in Septic Patients Undergoing Emergency Surgery|Impact of Early Goal-directed Fluid Therapy in Septic Patients Undergoing Emergency Surgery. A Prospective, Randomised, Open Trial|Terminated||N/A|20|Actual|University Hospital, Geneva||2||recrutment difficulties|f||||t||||||||||2017-10-11 02:40:55.073861|2017-10-11 02:40:55.073861
NCT01653990|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-07-30|||July 2012||2012-07-01|July 2012|2012-07-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Interventional|||Moxifloxacin_QT Study in Chinese Healthy Volunteer|A Single-center, Randomized, Double-blinded, 2-way Crossover, Placebo-controlled Study to Assess the QT/QTc Interval After Administration of Single Oral Dose of 400mg Moxifloxacin in Healthy Chinese Subjects|Unknown status|Recruiting|N/A|36|Anticipated|Peking University Third Hospital||2|||f||||f||||||||||2017-10-11 02:40:55.199162|2017-10-11 02:40:55.199162
NCT01653977|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-05-11|||February 2010||2010-02-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency Surgery|Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency Surgery A Prospective, Randomised, Open Trial|Terminated||N/A|20|Actual|University Hospital, Geneva||2||recrutment difficulties|f||||t||||||||||2017-10-11 02:40:55.306957|2017-10-11 02:40:55.306957
NCT01653964|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-09-14|2017-04-28||July 2012||2012-07-01|September 2017|2017-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|Split-Dose||Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing|Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing|Completed||N/A|83|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:40:55.441813|2017-10-11 02:40:55.441813
NCT01653951|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-07-16|||August 2011||2011-08-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Comparative Effectiveness of Two Approaches to Diabetes Management in the Uninsured|Comparative Effectiveness of Two Community Based Diabetes Management Approaches|Completed||N/A|64|Actual|Summa Health System||2|||f||||t||||||||||2017-10-11 02:40:55.851184|2017-10-11 02:40:55.851184
NCT01653938|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-07-30|||April 2011||2011-04-01|July 2012|2012-07-01||||September 2012|Anticipated|2012-09-01||Interventional|||A Trial of a CPR Video in Heart Failure Patients|A Randomized Controlled Trial of a CPR Video in Heart Failure Patients|Unknown status|Recruiting|N/A|50|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:40:55.927375|2017-10-11 02:40:55.927375
NCT01653925|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-02-01|||November 2010|Actual|2010-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression|Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression|Active, not recruiting||N/A|120|Actual|CHU de Quebec-Universite Laval||2|||f||||t||||||||Undecided||2017-10-11 02:40:56.015946|2017-10-11 02:40:56.015946
NCT01653886|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-02-03|||October 2010||2010-10-01|February 2016|2016-02-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||Palatability (Energy I Pilot)|Palatability of Meals That Vary in Fat and Energy Density. A Pilot Study to the Behavioral Response to Short-Term (Two Day) Positive Energy Balance Through Overfeeding (ENERGY I)|Completed||N/A|16|Actual|Pennington Biomedical Research Center||4|||f||||f||||||||||2017-10-11 02:40:56.330875|2017-10-11 02:40:56.330875
NCT01653873|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-01-23|||July 2012||2012-07-01|January 2014|2014-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Imaging Parameters to Predict Future Vertebral Fracture in Osteoporosis|to Compare the Efficacy of Parameters From Different Imaging Modality in Predicting the Risk of Future Vertebral Compression Fracture in Osteoporotic Patients.|Recruiting||N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 02:40:56.432176|2017-10-11 02:40:56.432176
NCT01653860|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-03-27|||July 2012||2012-07-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Partner Violence and Anger Management|Partner Violence and Anger Management: a Randomised Controlled Study of the Effectiveness of Cognitive Behavioral Therapy|Active, not recruiting||N/A|134|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 02:40:56.518725|2017-10-11 02:40:56.518725
NCT01653847|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-09-12|||February 2013||2013-02-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|May 2020|Anticipated|2020-05-01||Interventional|||Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens|Impact of Two Prednisone-free Maintenance Immunosuppressive Regimens With Reduced Dose FK506+Everolimus vs. Standard Dose Tacrolimus (FK506)+ Mycophenolate Mofetil (MMF) on Subpopulation of T and B Cells, Renal Allograft Function and Gene Expression Profiles in Renal Allograft Biopsies at 12 Months Post-transplant. Prospective Single Center Study in Recipients of Renal Transplant Allograft.|Active, not recruiting||N/A|88|Actual|Northwestern University||3|||f||||f||||||||||2017-10-11 02:40:56.613058|2017-10-11 02:40:56.613058
NCT01653834|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-08-11|||July 2012||2012-07-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Lymphocyte Reinfusion|Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas|Completed||N/A|10|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:40:56.748939|2017-10-11 02:40:56.748939
NCT01653821|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-10-14|||August 2012||2012-08-01|October 2016|2016-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|FIM||Surgical Removal of Carotid Body in Patients With Systolic Heart Failure|Surgical Removal of Carotid Body in Patients With Systolic Heart Failure.|Completed||N/A|10|Actual|Noblewell||1|||f||||f||||||||||2017-10-11 02:40:56.995347|2017-10-11 02:40:56.995347
NCT01653808|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-09-13|||April 2009||2009-04-01|November 2008|2008-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||In Vivo Evaluation of the Nipro Elisio™ Dialyzer|In Vivo Evaluation of the Nipro Elisio™ Dialyzer|Completed||N/A|20|Actual|Nipro Europe N.V.||2|||f||||t||||||||||2017-10-11 02:40:57.089149|2017-10-11 02:40:57.089149
NCT01653782|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-02-15|2013-09-25||September 2009||2009-09-01|February 2016|2016-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|MYTH||Cost Effectiveness of Medical Yoga Therapy on Low Back Pain|Cost Effectiveness of Early Interventions for Non-specific Low Back Pain: A Randomized Controlled Study Investigating Medical Yoga, Exercise Therapy and Evidence Based Advice|Completed||N/A|159|Actual|Karolinska Institutet|Problems in recruiting eligible subject and drop outs especially in the control group resulted in a small number of subjects analysed.|3|||f||||f||||||||No||2017-10-11 02:40:57.338378|2017-10-11 02:40:57.338378
NCT01653769|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-06-29|||June 2012||2012-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Observational|||CoSeal for Hemostasis of Aortic Anastamoses|CoSeal for Hemostasis of Aortic Anastomoses: A Propensity-Matched Cohort Study|Completed||N/A|150|Actual|The Methodist Hospital System|||1||f||||t||||||None Retained|"     Time perspective is both retrospective and prospective.   "|No|No plan to share available data.|2017-10-11 02:40:57.792202|2017-10-11 02:40:57.792202
NCT01653756|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-07-31|||July 2012||2012-07-01|July 2017|2017-07-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multi-Dose, Cross-Over, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects Undergoing Allergen Challenge|Completed||Phase 2|50|Actual|Verastem, Inc.||2|||f||||f||||||||||2017-10-11 02:40:57.900441|2017-10-11 02:40:57.900441
NCT01653743|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-12-01|2015-12-01||September 2012||2012-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional||Safety population included all the subjects who received investigational medicinal product ([IMP]; MSJ-0011 or u-hCG)|Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women|Open-Label, Parallel-Group, Randomized, Multicenter Phase III Trial to Compare the Efficacy and Safety of a 250 mcg SC Dose of MSJ-0011 to a 5,000 IU IM Dose of Urinary Human Chorionic Gonadotropin in Inducing Ovulation in Japanese Women Diagnosed With Anovulation or Oligo-Ovulation Secondary to Hypothalamic-Pituitary Dysfunction or Polycystic Ovarian Syndrome, and Who Are Undergoing Ovulation Induction With Follitropin Alfa|Completed||Phase 3|81|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-11 02:40:58.040493|2017-10-11 02:40:58.040493
NCT01653730|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-27|||February 2010||2010-02-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung Disease|A Comparative Pilot Study of the Efficacy of Three Portable Oxygen Concentrators During a 6-Minute Walk Test in Patients With Chronic Lung Disease|Completed||N/A|24|Actual|Ottawa Hospital Research Institute||4|||f||||f||||||||||2017-10-11 02:40:58.55012|2017-10-11 02:40:58.55012
NCT01653717|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-08-14|||June 11, 2013|Actual|2013-06-11|August 2017|2017-08-01|August 7, 2017|Actual|2017-08-07|August 7, 2017|Actual|2017-08-07||Interventional|||CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)|Autologous CD19 Specific T-cell Infusion in Patients With B-cell Chronic Lymphocytic Leukemia (B-CLL)|Completed||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:40:58.684673|2017-10-11 02:40:58.684673
NCT01653691|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2012-07-30|||May 2012||2012-05-01|July 2012|2012-07-01|January 2015|Anticipated|2015-01-01|March 2014|Anticipated|2014-03-01||Interventional|LaserTherapy||Laser Therapy for Treating Hypertrophic Burn Scars in Children|Tunable-Dye Laser Therapy to Ameliorate Hypertrophic Scarring in Burned Children|Unknown status|Not yet recruiting|N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:40:58.899538|2017-10-11 02:40:58.899538
NCT01653678|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2017-09-04|||November 2011||2011-11-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)|Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension|Active, not recruiting||N/A|25875|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:40:59.008707|2017-10-11 02:40:59.008707
NCT01653665|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2015-10-05|||August 2012||2012-08-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|GMCSF||Does GM-CSF Restore Neutrophil Phagocytosis in Critical Illness?|Does GM-CSF Restore Effective Neutrophil Function in Critically Ill Patients?|Completed||Phase 1/Phase 2|70|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 02:40:59.132747|2017-10-11 02:40:59.132747
NCT01653652|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2013-11-19|||April 2012||2012-04-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Effect of a Probiotic on Seasonal Allergic Rhinitis Symptoms|Mitigation of Seasonal Allergic Rhinitis Symptoms in Adults by Probiotic Intervention|Completed||N/A|131|Actual|Nestlé||2|||f||||t||||||||||2017-10-11 02:40:59.269384|2017-10-11 02:40:59.269384
NCT01653639|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2014-01-08|||July 2012||2012-07-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222|Single Dose, Open-label, Randomized, Crossover Study in Subjects With Severe Hemophilia A to Compare the Bioavailability of 2 Different Strengths of Kogenate FS (BAY14-2222)|Completed||Phase 1|18|Actual|Bayer||2|||f||||f||||||||||2017-10-11 02:40:59.357331|2017-10-11 02:40:59.357331
NCT01653613|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-27|2013-07-09|||August 2010||2010-08-01|July 2012|2012-07-01||||February 2013|Anticipated|2013-02-01||Observational|||Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia|Genomic Analysis of Adolescent and Young Adult Acute Lymphoblastic Leukemia|Unknown status|Not yet recruiting|N/A|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 02:40:59.531558|2017-10-11 02:40:59.531558
NCT01653600|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2012-07-27|||September 2012||2012-09-01|July 2012|2012-07-01|August 2015|Anticipated|2015-08-01|August 2014|Anticipated|2014-08-01||Interventional|SENS-FP-2||Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease|Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROLTM Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease : Prospective, Multicenter, Randomized, Controlled Trial (SENS-FP-2 Trial)|Unknown status|Not yet recruiting|Phase 4|346|Anticipated|Korea University Guro Hospital||2|||f||||t||||||||||2017-10-11 02:40:59.631766|2017-10-11 02:40:59.631766
NCT01653587|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-08-30|||July 2012||2012-07-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|ARISE||AngioSeal Versus Radial Approach in Acute Coronary Syndrome|Randomized Trial Between the Transfemoral Approach With AngioSeal and the Transradial Approach to Prevent Vascular Access Complications in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Submitted To Early Invasive Strategy|Completed||Phase 4|240|Actual|Irmandade Santa Casa Misericórdia Marília||2|||f||||f||||||||No||2017-10-11 02:40:59.742031|2017-10-11 02:40:59.742031
NCT01653574|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-12-01|||May 2012||2012-05-01|March 2013|2013-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer|A Single-Institutional, Phase II, Open-label, Single Arm Trial of Famitinib Malate in in HER2-negative Metastatic Breast Cancer|Completed||Phase 2|28|Actual|Fudan University||1|||f||||t||||||||||2017-10-11 02:41:00.016655|2017-10-11 02:41:00.016655
NCT01653561|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-12-02|||November 2011||2011-11-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer|A Multi-institutional, Open-label, Single Arm Study of Apatinib in Non-triple-negative Metastatic Breast Cancer|Completed||Phase 2|20|Actual|Fudan University||1|||f||||t||||||||||2017-10-11 02:41:00.129294|2017-10-11 02:41:00.129294
NCT01653548|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-06-21|||August 2012||2012-08-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|EMOGEN||Evaluating a Novel Method of Generalizing Emotion Regulation|Evaluating a Novel Method of Generalizing Emotion Regulation|Completed||N/A|372|Actual|Duke University||3|||f||||f||||||||||2017-10-11 02:41:00.21875|2017-10-11 02:41:00.21875
NCT01653522|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-12-27|||July 2012||2012-07-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine|The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine|Withdrawn||N/A|0|Actual|The Cleveland Clinic||4||No participants enrolled|f||||f||||||||No||2017-10-11 02:41:00.483659|2017-10-11 02:41:00.483659
NCT00004406|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||October 1999||1999-10-01|January 2000|2000-01-01|July 2004||2004-07-01|||||Interventional|||Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis||Completed||N/A|36|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.611575|2017-10-11 04:25:19.611575
NCT01653509|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2014-07-10|2013-09-05||July 2012||2012-07-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode|An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode|Completed||Phase 1|60|Actual|GlaxoSmithKline|The study was not formally powered to detect statistically significant differences, but to provide information for methods development and develop sample size calculation for future studies.|2|||f||||f||||||||||2017-10-11 02:41:00.599933|2017-10-11 02:41:00.599933
NCT01653496|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-02-01|||July 2012||2012-07-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ERAS||Compliance to ERAS After Gastric Surgery|Phase II Study Evaluating the Compliance to the Enhanced Recovery After Surgery (ERAS) Program in Patients Undergoing Gastrectomy for Gastric Carcinoma|Completed||Phase 2|168|Actual|Chonnam National University Hospital||1|||f||||f||||||||No||2017-10-11 02:41:01.081908|2017-10-11 02:41:01.081908
NCT01653483|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-11-08|||September 2012||2012-09-01|November 2012|2012-11-01|March 2013|Anticipated|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||Aura Adolescent PK Study GSK2829332|A Randomized, Double-blind, Placebo-controlled, Repeat Dose, 2-period Incomplete Block Crossover Safety and Pharmacokinetic Study of Umeclidinium in Adolescent Asthma Subjects|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||2||FDA advised that study is no longer required|f||||f||||||||||2017-10-11 02:41:01.165849|2017-10-11 02:41:01.165849
NCT01653470|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-05-15|||October 12, 2012|Actual|2012-10-12|May 2017|2017-05-01|June 15, 2017|Anticipated|2017-06-15|June 14, 2017|Anticipated|2017-06-14||Interventional|||Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors|A Phase Ib Ascending Multi-arm, Dose Escalation Study of BMS-906024 Combined With Several Chemotherapy Regimens in Subjects With Advanced or Metastatic Tumors|Active, not recruiting||Phase 1|95|Anticipated|Bristol-Myers Squibb||5|||f||||f|t|f||||||||2017-10-11 02:41:01.311514|2017-10-11 02:41:01.311514
NCT01653457|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-30|||September 2012||2012-09-01|July 2012|2012-07-01|May 2013|Anticipated|2013-05-01|October 2012|Anticipated|2012-10-01||Interventional|||Randomised Controlled Trial of Memantine in Fibromyalgia|Efficacy of Memantine in the Treatment of Fibromyalgia: a Double-blind Randomized Trial|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Aragon Institute of Health Sciences||2|||f||||f||||||||||2017-10-11 02:41:01.45374|2017-10-11 02:41:01.45374
NCT01653444|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-06-23|||November 2012||2012-11-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|May 2014|Actual|2014-05-01||Interventional|||Evaluate the Safety and Exploratory Efficacy of GC1119|Multicenter and Dose Escalation Phase 1 Study to Evaluate the Safety and Exploratory Efficacy of GC1119(Recombinant Human α-galactosidase A) for Enzyme Replacement Therapy in Fabry Disease Patients|Completed||Phase 1|8|Actual|Green Cross Corporation||2|||f||||f||||||||No||2017-10-11 02:41:01.56488|2017-10-11 02:41:01.56488
NCT01653431|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-30|2017-08-07|||January 2013||2013-01-01|July 2015|2015-07-01||||July 2018|Anticipated|2018-07-01||Interventional|||Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment||Recruiting||Phase 1/Phase 2|58|Anticipated|The University of New South Wales||2|||f||||||||||||||2017-10-11 02:41:01.657474|2017-10-11 02:41:01.657474
NCT01653418|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-10-08|2014-09-26||September 2012||2012-09-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|V-BEAM||Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation|A Phase II Study of V-BEAM (Bortezomib, Carmustine, Etoposide, Cytarabine, and Melphalan) as Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation for Multiple Myeloma|Terminated||Phase 2|10|Actual|Washington University School of Medicine|2 early deaths caused a concern for safety and resulted in suspension of enrollment in May 2013. After a review of the data, the investigators determined that this regimen had unexpected toxicity & the trial was closed to enrollment in June 2013.|1||Due to the high rate of morbidity and mortality|f||||f||||||||||2017-10-11 02:41:01.738841|2017-10-11 02:41:01.738841
NCT01653392|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-08-28|||July 2012||2012-07-01|August 2017|2017-08-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Observational|||BioThrax® (Anthrax) Vaccine in Pregnancy Registry|BioThrax® (Anthrax) Vaccine in Pregnancy Registry|Recruiting||N/A|580|Anticipated|Emergent BioSolutions|||1||f||||f||||||||||2017-10-11 02:41:03.957675|2017-10-11 02:41:03.957675
NCT01653379|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-08-14||2017-08-14|August 2012||2012-08-01|August 2017|2017-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism|A Phase 2A, Open-label, Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis|Completed||Phase 2|42|Actual|Deltanoid Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:41:04.042806|2017-10-11 02:41:04.042806
NCT01653366|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-08-15|||December 2012||2012-12-01|June 2012|2012-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway|Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway|Terminated||N/A|4|Actual|Dartmouth-Hitchcock Medical Center||2||primary goal not achievable|f||||t||||||||||2017-10-11 02:41:04.142669|2017-10-11 02:41:04.142669
NCT01653353|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-10-01|||July 2012||2012-07-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Swiss Study on Vitamin D and Calcium in Nursing Homes|Swiss Study on Vitamin D and Calcium in Nursing Homes|Completed||N/A|71|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 02:41:04.240802|2017-10-11 02:41:04.240802
NCT01653327|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-05-23|||June 2010||2010-06-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head and Neck Cancer|Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head and Neck Cancer|Recruiting||Phase 2|10|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 02:41:04.44883|2017-10-11 02:41:04.44883
NCT01653314|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-07-26|||January 2012||2012-01-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers|A Randomized, Open-label, Single Dose, 2-Treatment, 2-Period, 2-Way Crossover Study to Assess Safety and Pharmacokinetics of Megavec 400 mg (Imatinib Mesylate) Under Fasted Conditions in Healthy Male Subjects|Completed||Phase 1|40|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-11 02:41:04.633863|2017-10-11 02:41:04.633863
NCT01653301|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-07-26|||October 2005||2005-10-01|July 2012|2012-07-01||||December 2012|Anticipated|2012-12-01||Interventional|INTERACT||Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study|INTEnsification Radiotherapy With Accelerated Fractionation or ChemoTherapy And Local Excision After 3D External Radio-chemotherapy|Unknown status|Recruiting|Phase 3|616|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 02:41:04.817461|2017-10-11 02:41:04.817461
NCT01653288|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-08-01|||March 2013||2013-03-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|March 2016|Actual|2016-03-01||Interventional|||"A Trial of Coping Coach, a Web-based Preventive Intervention for Children"|"A Randomized Controlled Trial of Coping Coach, a Web-based Preventive Intervention for Children"|Active, not recruiting||Phase 1/Phase 2|97|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 02:41:04.933942|2017-10-11 02:41:04.933942
NCT01653275|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-05-08|||April 2012|Actual|2012-04-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MedSD||Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover|Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover|Completed||N/A|22|Actual|UConn Health||1|||f||||t|f|f||||||Undecided|only deidentified data will be available to share|2017-10-11 02:41:05.040041|2017-10-11 02:41:05.040041
NCT01653262|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-07-05|2016-03-14|2013-12-20|July 2012||2012-07-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Baseline Characteristics refer to the Enrolled Set.|Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)|An Open-label, Multicenter, Single-arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects With Epilepsy Switching From Levetiracetam to Brivaracetam Due to Nonpsychotic Behavioral Side Effects Phase 3b|Completed||Phase 3|29|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 02:41:05.167328|2017-10-11 02:41:05.167328
NCT01653249|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-10-11|||August 2012||2012-08-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Phase I Clinical Trial of an HPV Therapeutic Vaccine|A Phase I Clinical Trial of an HPV Therapeutic Vaccine|Completed||Phase 1|52|Actual|University of Arkansas||1|||f||||t||||||||||2017-10-11 02:41:05.550973|2017-10-11 02:41:05.550973
NCT01653223|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-04-24|||January 2013||2013-01-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery|A Study of Simvastatin on Myocardial Protection and Cardiac Function Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Recruiting||N/A|369|Anticipated|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 02:41:05.724773|2017-10-11 02:41:05.724773
NCT01653197|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-09-27|||August 2014||2014-08-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evive Health Randomized Controlled Trials|Evive Health Randomized Controlled Trials|Completed||N/A|29|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-11 02:41:05.889878|2017-10-11 02:41:05.889878
NCT01653184|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-12-09|||July 2012||2012-07-01|December 2016|2016-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration|The Effect of Oral Supplementation With Omega-3 Fatty Acids on Serum Omega-3 Levels in Patients With Age-related Macular Degeneration: A Randomized Controlled Trial.|Completed||N/A|30|Actual|Wills Eye||2|||f||||f||||||||No||2017-10-11 02:41:05.981202|2017-10-11 02:41:05.981202
NCT01653171|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2013-12-08|||July 2012||2012-07-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|PRUE||Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy|Effectiveness of Premedication With Simethicone or Simethicone Plus N-acetylcysteine vs. Placebo in Improving Visibility During Upper Endoscopy.|Completed||Phase 4|230|Actual|Pontificia Universidad Catolica de Chile||5|||f||||t||||||||||2017-10-11 02:41:06.069503|2017-10-11 02:41:06.069503
NCT01653158|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2013-10-04|2013-01-18||March 2005||2005-03-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies|A Phase 1b Dose Escalation, Open-label Study Of CP-751,871 In Combination With Docetaxel In Advanced Non-hematologic Malignancies|Completed||Phase 1|46|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 02:41:06.278673|2017-10-11 02:41:06.278673
NCT01653132|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-02-03|2016-03-10||March 2012||2012-03-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Ten subjects were recruited; nine completed both periods of the study. One subject dropped out after the first injection because he wanted to start anticholinergics for symptomatic treatment of tremor, and this was an exclusion criterion. His data was excluded.|Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism|Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism|Completed||Phase 2|10|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-10-11 02:41:11.91187|2017-10-11 02:41:11.91187
NCT01653119|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-07-26|||April 2012||2012-04-01|March 2012|2012-03-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|PROMISS||Peking and Rotterdam on Mission to Reduce Coronary Artery Disease|Peking and Rotterdam on Mission to Reduce Coronary Artery Disease|Unknown status|Recruiting|N/A|1000|Anticipated|Peking University Third Hospital||2|||f||||t||||||||||2017-10-11 02:41:12.263426|2017-10-11 02:41:12.263426
NCT01653106|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-06-23|||April 2012|Actual|2012-04-01|June 2017|2017-06-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients|A Randomized Study to Compare the Effect of Short- and Long-Term Schedules of Cryotherapy on the Incidence and Severity of Mucositis in High-Dose Melphalan|Completed||N/A|148|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:41:12.370083|2017-10-11 02:41:12.370083
NCT01653093|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-09-21|||September 2007||2007-09-01|September 2017|2017-09-01|July 3, 2018|Anticipated|2018-07-03|July 3, 2018|Anticipated|2018-07-03||Interventional|||3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer|Imaging of the Prostate Gland Using High Field Strength 3T MRI|Recruiting||N/A|170|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:41:12.502316|2017-10-11 02:41:12.502316
NCT01653080|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-09-21|||June 2004||2004-06-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||MRI in Diagnosing Solid Tumors of the Eye and Orbit|Dynamic Contrast Enhanced Magnetic Resonance Imaging for Non-Invasive Diagnostic Work-Up in Solid Tumors of the Eye and Orbit.|Recruiting||Phase 1|40|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:41:12.620816|2017-10-11 02:41:12.620816
NCT01653067|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-10-26|||September 2012||2012-09-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|STORM||STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma|A Phase II Trial to Evaluate the Safety, Feasibility and Efficacy of a Salvage Therapy Consisting of Temsirolimus Added to the Standard Therapy R-DHAP for the Treatment of Patients With Relapsed or Refractory DLBCL - the STORM Trial|Active, not recruiting||Phase 2|88|Anticipated|University Hospital Heidelberg||1|||f||||t||||||||||2017-10-11 02:41:12.755931|2017-10-11 02:41:12.755931
NCT01653054|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-07-27|||October 2011||2011-10-01|June 2012|2012-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|HPVIBD||Anal Dysplasia in Patients With Inflammatory Bowel Disease|The Incidence of Abnormal Anal Pap Smears in Patients With Inflammatory Bowel Disease|Unknown status|Recruiting|N/A|40|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-10-11 02:41:12.898667|2017-10-11 02:41:12.898667
NCT01653041|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-08-15|||August 2012||2012-08-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|||Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors|Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors|Completed||Phase 4|47|Actual|Hospital do Rim e Hipertensão||1|||f||||f||||||||||2017-10-11 02:41:13.017993|2017-10-11 02:41:13.017993
NCT01653028|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-11-01|2016-08-22||August 2012||2012-08-01|November 2016|2016-11-01||||August 2015|Actual|2015-08-01||Interventional|||Alisertib in Treating Patients With Advanced or Metastatic Sarcoma|Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma|Active, not recruiting||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:41:13.183392|2017-10-11 02:41:13.183392
NCT01653015|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-08-03|||November 2012|Actual|2012-11-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Live Versus Inactivated Influenza Vaccine Study in Hutterite Children|A Randomized Controlled Trial of Live Attenuated Vaccine Versus Trivalent Inactivated Vaccine in Hutterite Children|Completed||Phase 4|4611|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 02:41:15.85177|2017-10-11 02:41:15.85177
NCT01653002|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-10-24|||February 2012||2012-02-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|February 2012|Actual|2012-02-01||Observational|||Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging||Completed||N/A|200|Actual|University Hospital, Essen|||1||f||||f||||||||||2017-10-11 02:41:15.938281|2017-10-11 02:41:15.938281
NCT01652989|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-11-30|||September 2010||2010-09-01|July 2012|2012-07-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|P@W||PILI at Work a 5-Year Controlled Intervention Trial: Testing DVD Versus Group Delivery of a Weight-Loss Maintenance Intervention in Native Hawaiian- Serving Worksites|5-Year Controlled Intervention Trial: Testing DVD Versus Group Delivery of a Weight-Loss Maintenance Intervention in Native Hawaiian- Serving Worksites|Completed||N/A|200|Anticipated|University of Hawaii||2|||f||||t||||||||||2017-10-11 02:41:16.156707|2017-10-11 02:41:16.156707
NCT01652976|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-06-21|||July 2012|Actual|2012-07-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|FOLFOX-D||Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma|Phase II Study of 5-Fluorouracil, Oxaliplatin Plus Dasatinib (FOLFOX-D) in First-line Metastatic Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|44|Actual|University of Florida||1|||f||||t||||||||||2017-10-11 02:41:16.34314|2017-10-11 02:41:16.34314
NCT01652963|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-11-20|||July 2012||2012-07-01|November 2012|2012-11-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Picture-based Computerised Assessment and Training of Cognitive Behaviour Therapy Skills|Evaluating a Picture-based Computerised Assessment and Training Paradigm for Cognitive Behaviour Therapy Skills in Adults With Intellectual Disabilities|Unknown status|Recruiting|N/A|132|Anticipated|University of East Anglia||2|||f||||t||||||||||2017-10-11 02:41:16.460768|2017-10-11 02:41:16.460768
NCT01652586|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-07-27|||April 2011||2011-04-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Sedation Regimen in Patients Undergoing Cardiac Electrophysiology Study and Ablation : a Comparison Between Dexmedetomidine-remifentanil and Midazolam-remifentanil Combinations||Completed||N/A|90|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:41:26.623643|2017-10-11 02:41:26.623643
NCT01652950|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-25|||July 2010||2010-07-01|July 2012|2012-07-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|PAIS||Study Comparing the Effectiveness of Incentives on Physical Activity Behavior in a Health Insured Population|A Prospective, Randomized, Study Comparing the Effectiveness of Different Types of Incentives in Increasing Physical Activity Behaviour on the Vitality Health Promotion Programme|Completed||N/A|10907|Actual|University of Cape Town||6|||f||||f||||||||||2017-10-11 02:41:16.56478|2017-10-11 02:41:16.56478
NCT01652937|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2013-09-12|||August 2012||2012-08-01|October 2012|2012-10-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|EMBRACE||BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs|A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of BIIB057 in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs|Withdrawn||Phase 2|0|Actual|Biogen||4|||f||||t||||||||||2017-10-11 02:41:16.663214|2017-10-11 02:41:16.663214
NCT01652924|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-07-27|||May 2012||2012-05-01|July 2012|2012-07-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Efficacy of Mechanical Ventilation With Facial Mask to Reduce Gastric Insufflation|Efficacy and Safety of Pressure-controlled Ventilation Compared With Manual Ventilation to Reduce Gastric Insufflation During Induction of Anesthesia in Children: Controlled Trial Randomized, Double-blind|Unknown status|Recruiting|N/A|180|Anticipated|Universidad de Antioquia||2|||f||||t||||||||||2017-10-11 02:41:16.747149|2017-10-11 02:41:16.747149
NCT01652911|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-07-06|||June 2012||2012-06-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation|A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation|Terminated||Phase 1/Phase 2|3|Actual|University of Alberta||1|||f||||t||||||||||2017-10-11 02:41:16.844489|2017-10-11 02:41:16.844489
NCT01652898|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-09-04|||July 2012||2012-07-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||A Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers|A Single Centre Prospective, Randomized, Double Blind, Crossover, Three-treatment Periods PK, PD, Safety and Tolerability Study to Compare Bolus Administration of AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers After a Pilot Phase of AOP LDLA202 Safety and Local Tolerability Assessment.|Completed||Phase 1|12|Actual|AOP Orphan Pharmaceuticals AG||3|||f||||f||||||||||2017-10-11 02:41:16.92826|2017-10-11 02:41:16.92826
NCT01652885|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-03-12|2017-01-11|2014-01-17|July 2012||2012-07-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional||Safety population included all participants who were enrolled and had received any amount of study drug.|Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis|An Open-Label Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of AN2728 Ointment in Adolescents With Atopic Dermatitis|Completed||Phase 1/Phase 2|23|Actual|Pfizer||1|||f||||||||||||||2017-10-11 02:41:17.04627|2017-10-11 02:41:17.04627
NCT01652872|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-06-13|||July 30, 2012|Actual|2012-07-30|June 2017|2017-06-01|October 25, 2017|Anticipated|2017-10-25|October 25, 2017|Anticipated|2017-10-25||Interventional|START-CKD||Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease|Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease|Active, not recruiting||Phase 3|756|Actual|Amgen||2|||f||||t||||||||||2017-10-11 02:41:17.901715|2017-10-11 02:41:17.901715
NCT01652859|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-11-25|||February 2012||2012-02-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects|An Open-label, Randomized, Balanced, Crossover Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects|Completed||Phase 1|36|Actual|Taiwan Liposome Company||2|||f||||f||||||||||2017-10-11 02:41:18.679814|2017-10-11 02:41:18.679814
NCT01651754|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-07-26|||September 2010||2010-09-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|August 2011|Actual|2011-08-01||Interventional|||Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome|Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome.|Completed||N/A|72|Actual|Radboud University||1|||f||||f||||||||||2017-10-11 02:41:18.759815|2017-10-11 02:41:18.759815
NCT01651741|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-09-20|||May 2012||2012-05-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Seaweeds Combined With Probiotics on Intestinal Function of Healthy Subjects|Effects of Seaweeds Combined With Probiotics on Intestinal Function of Healthy Subjects: a Randomized, Double-blind, Placebo-controlled, Waiting-list Clinical Trial|Completed||N/A|40|Actual|Korea Institute of Planning & Evalution for Technology of Food, Agriculture, Forestry & Fisherie||2|||f||||t||||||||||2017-10-11 02:41:18.867421|2017-10-11 02:41:18.867421
NCT01651728|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-08-02|||July 2012||2012-07-01|August 2012|2012-08-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients|Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients: A Study of Immunological, Inflammatory, and Coagulation Responses in Relation to Reduce Mortality During Hospitalization|Unknown status|Recruiting|Phase 3|200|Anticipated|Indonesia University||2|||f||||t||||||||||2017-10-11 02:41:18.969972|2017-10-11 02:41:18.969972
NCT01651715|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-08-05|||September 2012||2012-09-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|ESTUAR||Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections|Multicentre, Randomised, Double-blind, Parallel, Placebo-controlled Study Evaluating the Efficacy and Safety of Early Self-Treatment of Viral Upper Respiratory Tract Infections With Homeopathic Oral Antibodies to the TLR3 FYW Peptide (TAO1)|Completed||Phase 1/Phase 2|232|Actual|Theranor s.p.r.l||2|||f||||f||||||||||2017-10-11 02:41:19.11505|2017-10-11 02:41:19.11505
NCT01651702|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-04-12|||July 2015||2015-07-01|April 2017|2017-04-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|||Comparison of Carto Versus Ensite 3D Electroanatomical Mapping Systems for Arrhythmias Ablations|Comparative Study of Two 3D Electroanatomical Mapping Systems for Ablations of Different Complex Arrhythmias|Withdrawn||N/A|0|Actual|Rabin Medical Center||2||Poor recruit rate|f||||f||||||||||2017-10-11 02:41:19.297788|2017-10-11 02:41:19.297788
NCT00005296|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||January 1990||1990-01-01|August 2000|2000-08-01|December 1994||1994-12-01|||||Observational|||Sleep Apnea: Age Effects On Prevalence and Natural History||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.398652|2017-10-11 04:27:57.398652
NCT01651689|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-07-25|||October 2010||2010-10-01|July 2012|2012-07-01|May 2013|Anticipated|2013-05-01|April 2013|Anticipated|2013-04-01||Observational|ThaiScalpBx||Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia|Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Siriraj Hospital|||1||f||||t||||||Samples Without DNA|"     scalp biopsy specimen   "|||2017-10-11 02:41:19.380567|2017-10-11 02:41:19.380567
NCT01651676|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-11-30|||July 2012||2012-07-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|EPIC||Estimation of the VQ11 Auto-questionnaire, to Follow Patients With Chronic Obstructive Pulmonary Disease|Evaluation of the VQ11 Auto-questionnaire of Quality of Life in Pneumology Investigation, During the Implementation of a Long-acting Bronchodilator Treatment of Patients With COPD.|Recruiting||N/A|250|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||t||||||||||2017-10-11 02:41:19.471058|2017-10-11 02:41:19.471058
NCT01651663|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2013-07-26|||September 2011||2011-09-01|July 2013|2013-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|ARBITR||A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold|Double-blind, Randomized, Placebo-controlled Clinical Study Investigating Efficacy and Safety of Arbidol (Umifenovir) in Treatment and Prophylaxis of Influenza and Common Cold.|Unknown status|Recruiting|Phase 4|840|Anticipated|Pharmstandard||4|||f||||f||||||||||2017-10-11 02:41:19.61825|2017-10-11 02:41:19.61825
NCT01651650|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-03-28|||June 2012||2012-06-01|March 2017|2017-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|NEXThalerPIF||An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device||Completed||Phase 2|41|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-11 02:41:19.705973|2017-10-11 02:41:19.705973
NCT01651637|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-03-28|||October 2012||2012-10-01|March 2017|2017-03-01||||January 2015|Actual|2015-01-01||Interventional|||First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome|A First in Human Clinical Study on the Safety and Tolerability of Two Escalating Single Doses of CHF 5633 (Synthetic Surfactant) in Preterm Neonates With Respiratory Distress Syndrome|Completed||Phase 1|40|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||t||||||||||2017-10-11 02:41:19.78157|2017-10-11 02:41:19.78157
NCT01651624|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-07-31|||December 2012||2012-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SAVE||Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District|Comparison Between Faecal Occult Blood Test (FOBT), Computed Tomographic Colonography (CTC) With Computer Aided Diagnosis (CAD) and Colonoscopy as a Primary Screening Test for Colorectal Cancer. Validation of a Teleradiology Model. Biological Banking in Subjects Recruited for Colonoscopy or CTC.|Active, not recruiting||N/A|14000|Anticipated|Cancer Prevention and Research Institute, Italy||4|||f||||t||||||||||2017-10-11 02:41:19.878628|2017-10-11 02:41:19.878628
NCT01651611|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-08-26|||September 2011||2011-09-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents|Health Advocates as a Vehicle to Improve Treatment for Smokers in Public Housing|Completed||N/A|330|Actual|Boston University||2|||f||||t||||||||No||2017-10-11 02:41:19.961817|2017-10-11 02:41:19.961817
NCT01651598|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-10-31|||July 2012||2012-07-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients|Safety, Tolerability, Pharmacokinetics, and Exploratory Pharmacodynamics of Multiple Rising Doses of BI 144807 Powder for Oral Drinking Solution Over a Period of 14 Days in Otherwise Healthy Controlled Asthmatic Subjects in a Randomised, Double-blind, Placebo-controlled Trial|Completed||Phase 1|57|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:41:20.321266|2017-10-11 02:41:20.321266
NCT01652846|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-07-31|||July 2012||2012-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:41:20.431392|2017-10-11 02:41:20.431392
NCT01652833|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-02-29|||March 2012||2012-03-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||European Physician Survey of EGFR Inhibitor Prescribing Patterns|Survey of Oncologists in Europe to Evaluate Their Knowledge of KRAS Testing|Completed||N/A|453|Actual|Amgen|||3||f||||f||||||||||2017-10-11 02:41:20.474215|2017-10-11 02:41:20.474215
NCT01652820|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-27|||October 2001||2001-10-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|July 2006|Actual|2006-07-01||Interventional|GECP0008||Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer|Randomized Phase II Trial Using Concomitant Chemoradiation Plus Induction or Consolidation Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer Patients|Completed||Phase 2|140|Actual|Spanish Lung Cancer Group||2|||f||||t||||||||||2017-10-11 02:41:20.563539|2017-10-11 02:41:20.563539
NCT01652807|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-01-12|||February 2012||2012-02-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Yoga for Stress and Mental Health|An 8-Week Hatha Yoga Intervention for Stress and Mental Health|Completed||N/A|52|Actual|Southern Methodist University||2|||f||||f||||||||||2017-10-11 02:41:20.651264|2017-10-11 02:41:20.651264
NCT01652794|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-08-03|||May 2012||2012-05-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer|A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer|Completed||Phase 1|12|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:41:20.736305|2017-10-11 02:41:20.736305
NCT01652781|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-11-18|||March 2012||2012-03-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome|A Randomized, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of 5-day Azacitidine for Patients With Lower-risk Myelodysplastic Syndrome|Recruiting||Phase 2|92|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-11 02:41:20.854012|2017-10-11 02:41:20.854012
NCT01650064|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-01-23|||January 2013||2013-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Observational|LAMOS||Latin America Hip Fracture Mortality Study|Latin America Hip Fracture Mortality Study|Completed||N/A|168|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 02:42:03.542333|2017-10-11 02:42:03.542333
NCT01652768|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2013-08-28|||December 2011||2011-12-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors|PRESENCE Project: An Early Palliative Care Intervention for Patients With Malignant Brain Tumors and Their Primary Caregivers|Terminated||N/A|1|Actual|Case Comprehensive Cancer Center||2||Research Cancelled|f||||f||||||||||2017-10-11 02:41:21.022444|2017-10-11 02:41:21.022444
NCT01652755|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-08-03|||April 2011||2011-04-01|August 2012|2012-08-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Plasma Cystatin C and Acute Kidney Injury|Use of Cystatin C in Predicting AKI in Patients Undergone Cardiopulmonary Bypass Surgery|Unknown status|Recruiting|N/A|100|Anticipated|Jinhua Central Hospital|||2||f||||f||||||||||2017-10-11 02:41:21.140151|2017-10-11 02:41:21.140151
NCT01652742|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2013-03-06|||July 2012||2012-07-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study to Explore Pharmacokinetics and Pharmacodynamics of a Single Rising Dose of BI 135585 XX|Pharmacokinetics and Pharmacodynamics of BI 135585 XX Administered as Oral Dose in Healthy Male Volunteers (Open-label, Single-dose Trial)|Completed||Phase 1|9|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:41:21.34019|2017-10-11 02:41:21.34019
NCT01652729|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-07-31|2015-04-03||February 2013||2013-02-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|DURATION-NEO-2|Modified Intent-to-Treat: Subjects who were randomized and received at least one dose of study drug.|Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus|A Randomized, Long-Term, Open-Label, 3-Arm, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|365|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 02:41:21.440207|2017-10-11 02:41:21.440207
NCT01652716|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-12-22|2015-08-04||January 2013||2013-01-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|DURATION-NEO-1|Modified Intent-to-Treat: Subjects who were randomized and received at least one dose of study drug|Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes|A Randomized, Open-Label, Long-Term, Parallel-Group, Comparator-Controlled, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Exenatide Twice Daily in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|377|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 02:41:22.46607|2017-10-11 02:41:22.46607
NCT01652703|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2017-02-07|2015-09-03|2014-05-12|July 2012||2012-07-01|February 2017|2017-02-01||||May 2013|Actual|2013-05-01||Interventional|AMG145|Full analysis set (all randomized participants who received at least 1 dose of investigational product).|A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Stable Statin Therapy in Japanese Subjects With Hypercholesterolemia and High Cardiovascular Risk|Completed||Phase 2|310|Actual|Amgen||6|||f||||t||||||||||2017-10-11 02:41:23.35666|2017-10-11 02:41:23.35666
NCT01652690|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-04-20|2016-04-20||June 2012||2012-06-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice|Prospective Observational Study to Describe Characteristics and Management of Patients With Postmenopausal Osteoporosis Treated With Prolia® in Routine Clinical Practice|Completed||N/A|600|Actual|Amgen|||1||f||||f||||||||||2017-10-11 02:41:24.96412|2017-10-11 02:41:24.96412
NCT01652677|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-04-30|||January 2012||2012-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|NTMSR||Navigation Repetitive Transcranial Magnetic Stimulation in Stroke Rehabilitation|"Randomized Controlled Single-blind Research Navigation Repetitive Transcranial Magnetic Stimulation in Stroke Rehabilitation"|Completed||Phase 4|100|Anticipated|Russian Academy of Medical Sciences||4|||f||||t||||||||||2017-10-11 02:41:25.735358|2017-10-11 02:41:25.735358
NCT01652664|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-06-30|2015-03-31||September 2012||2012-09-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||This analysis population includes all participants who received study drug and completed at least 1 scheduled on-therapy visit.|Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients|A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients|Completed||Phase 3|184|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:41:25.898294|2017-10-11 02:41:25.898294
NCT01652651|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-07-25|||May 2009||2009-05-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|April 2012|Actual|2012-04-01||Interventional|||Risk and Resilience Factors in Learning Disabilities Population|The Contribution of Risk and Resilience Factors in Learning Disabilities Population to Academic and Emotional Development|Unknown status|Recruiting|N/A|70|Anticipated|Rabin Medical Center||1|||f||||||||||||||2017-10-11 02:41:26.20917|2017-10-11 02:41:26.20917
NCT01652638|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2012-08-10|||February 2013||2013-02-01|August 2012|2012-08-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS||Unknown status|Not yet recruiting|Phase 1|44|Anticipated|Azidus Brasil||2|||f||||||||||||||2017-10-11 02:41:26.287692|2017-10-11 02:41:26.287692
NCT01652625|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-07-25|||March 2010||2010-03-01|July 2012|2012-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Efficacy and Safety Study of Yunnan Baiyao on Minor Recurrent Aphthous Stomatitis|Efficacy and Safety Study of Yunnan Baiyao on Minor Recurrent Aphthous Stomatitis|Completed||Phase 2|227|Actual|Peking University||2|||f||||t||||||||||2017-10-11 02:41:26.378138|2017-10-11 02:41:26.378138
NCT01652612|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-07-03|||August 2011||2011-08-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Positive End-expiratory Pressure and Alveolar Recruitment for One Lung Ventilation|Effects of Positive End-expiratory Pressure and Alveolar Recruitment on the Oxygenation and Respiratory Mechanics During One-lung Ventilation in the Supine Position|Completed||N/A|99|Actual|Yonsei University||3|||f||||t||||||||||2017-10-11 02:41:26.443065|2017-10-11 02:41:26.443065
NCT01652599|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2014-01-03|||June 2012||2012-06-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|||Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT|Eltrombopag and High-dose Dexamethasone as First Line Treatment for Immune Thrombocytopenia|Completed||Phase 2|30|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||f||||||||||2017-10-11 02:41:26.538532|2017-10-11 02:41:26.538532
NCT01652573|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-04-25|2017-03-06||March 2011||2011-03-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Calcitonin for Treating X-linked Hypophosphatemia|Calcitonin for Treating X-linked Hypophosphatemia|Completed||N/A|21|Actual|Yale University|It is possible that there is a threshold serum concentration of drug required to suppress FGF23 levels and our sample size was small.|2|||f||||t||||||||||2017-10-11 02:41:26.724974|2017-10-11 02:41:26.724974
NCT01652560|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2012-07-25|||June 2012||2012-06-01|July 2012|2012-07-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Observational|BIBC||Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy|Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy|Unknown status|Recruiting|N/A|50|Anticipated|Xijing Hospital|||1||f||||f||||||||||2017-10-11 02:41:27.293607|2017-10-11 02:41:27.293607
NCT01652547|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-03-20|||November 2012||2012-11-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma|A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma|Completed||Phase 1|10|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:41:27.385435|2017-10-11 02:41:27.385435
NCT01652534|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-03-28|||June 2011||2011-06-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease|Efficacy of Amantadine for Gait Dysfunction and Gait Freezing in Patients With Parkinson's Disease|Terminated||Phase 3|1|Actual|Northwestern University||2||Low enrollment|f||||f||||||||No||2017-10-11 02:41:27.487771|2017-10-11 02:41:27.487771
NCT01652521|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-07-25|||July 2012||2012-07-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||Effects of Pleural Effusion Drainage on Respiratory System Mechanics|Effects of Pleural Effusion Drainage on Respiratory System Mechanics in Mechanically Ventilated Patients, as Measured by Esophageal Balloon.|Unknown status|Not yet recruiting|N/A|20|Anticipated|Wolfson Medical Center|||1||f||||f||||||||||2017-10-11 02:41:27.575395|2017-10-11 02:41:27.575395
NCT01652508|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2015-06-09|||July 2012||2012-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|ACT||Acceptance and Commitment Therapy for Smoking Cessation in the Primary Care Setting|Individual, Telephone-delivered Acceptance and Commitment Therapy for Smoking Cessation in the Primary Healthcare Setting: Feasibility and Potential Efficacy|Completed||N/A|156|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 02:41:27.651676|2017-10-11 02:41:27.651676
NCT01652495|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2014-08-23|2014-03-22||March 2012||2012-03-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|TPESP2011-12||Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection|Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to a Single Intrabursal Injection of Corticosteroids in Patients With Shoulder Calcific Tendinopathy|Completed||Phase 4|44|Actual|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-11 02:41:27.739334|2017-10-11 02:41:27.739334
NCT01652482|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-11-01||2016-08-04|October 2012||2012-10-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)|A Phase II, Multicenter, Open-Label, Randomized Study Evaluating the Efficacy and Safety of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI in Second Line in Patients With KRAS Wildtype Metastatic Colorectal Cancer|Completed||Phase 2|135|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 02:41:28.043628|2017-10-11 02:41:28.043628
NCT01652469|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2016-01-22|||August 2012||2012-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EMPHASIS||Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.|A Randomized Phase III Trial of Erlotinib Versus Docetaxel in Patients With Advanced Squamous Cell Non-small Cell Lung Cancer Who Failed First Line Platinum Based Doublet Chemotherapy Stratified by VeriStrat Good vs VeriStrat Poor|Completed||Phase 3|81|Actual|European Thoracic Oncology Platform||2|||f||||t||||||||No||2017-10-11 02:41:28.247722|2017-10-11 02:41:28.247722
NCT01652456|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-26|2014-08-21|||October 2012||2012-10-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Alcohol and Tobacco Consumption in Patients With Head and Neck Cancer : Interest of an Addiction Support|Alcohol and TObacco Consumption in Patients With Head and Neck Cancer : Interest of an Addiction Support|Withdrawn||N/A|0|Actual|Centre Oscar Lambret||2|||f||||f||||||||||2017-10-11 02:41:28.419877|2017-10-11 02:41:28.419877
NCT01652443|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-05-12|||April 2011|Actual|2011-04-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|December 2015|Actual|2015-12-01||Observational|||Relationships and Health in the OEF/OIF Veteran Population|Relationships and Health in the OEF/OIF Veteran Population|Completed||N/A|69|Actual|VA Eastern Colorado Health Care System|||1||f||||f||||||||No||2017-10-11 02:41:28.710893|2017-10-11 02:41:28.710893
NCT01652430|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2015-01-06|||October 2010||2010-10-01|July 2012|2012-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder|Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder|Completed||N/A|78|Actual|VA Eastern Colorado Health Care System|||2||f||||f||||||||||2017-10-11 02:41:28.782718|2017-10-11 02:41:28.782718
NCT01652417|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-02-24|||October 2012||2012-10-01|October 2015|2015-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|CORTICOIDOSE||Treatment of Renal Sarcoidosis by Methylprednisolone Bolus|Randomized, Multicentric Study Evaluating the Efficacy and the Safety of Methylprednisolone Bolus in the Treatment of Renal Sarcoidosis|Terminated||N/A|40|Actual|Assistance Publique - Hôpitaux de Paris||2||insufficient recruitment|f||||f||||||||||2017-10-11 02:41:28.852145|2017-10-11 02:41:28.852145
NCT01652404|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-07-27|||March 2011||2011-03-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|ProShort-Ped||PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) Trial|PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) Trial|Unknown status|Recruiting|Phase 3|600|Anticipated|Hunan Children's Hospital||2|||f||||f||||||||||2017-10-11 02:41:28.934004|2017-10-11 02:41:28.934004
NCT01652391|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-12-29|||July 2011||2011-07-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Modulation of Cognitive Control by Transcranial Direct Current Stimulation|Modulation of Cognitive Control in Healthy and Depressed Subjects by Transcranial Direct Current Stimulation|Completed||N/A|44|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-11 02:41:29.033223|2017-10-11 02:41:29.033223
NCT01652378|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-05-29|||August 2012||2012-08-01|June 2012|2012-06-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|phMRI||Pharmacologic MRI in Cocaine Addiction|Pharmacologic MRI in Cocaine-addiction|Unknown status|Recruiting|Phase 4|30|Anticipated|University of Texas Southwestern Medical Center|||2||f||||f||||||||||2017-10-11 02:41:29.106875|2017-10-11 02:41:29.106875
NCT01652365|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-07-27|||March 2011||2011-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Feasibility and Impact of Malaria Rapid Diagnostic Tests in the African Retail Sector|Evaluation of the Feasibility and Impact of Introducing Malaria Rapid Diagnostic Tests in the Retail Sector: A Randomized Controlled Trial in Eastern Uganda|Completed||N/A|2800|Actual|Harvard School of Public Health||4|||f||||f||||||||||2017-10-11 02:41:29.192555|2017-10-11 02:41:29.192555
NCT01652352|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-13|2012-07-27|||August 2010||2010-08-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|HRI||Experimental Evaluation of Wheelchair-Mounted Robotic Arms|HRI: Maximizing Manipulation of Persons With Disabilities Using a Smart Wheelchair-Mounted Robotic System|Completed||N/A|20|Actual|University of South Florida|||2||f||||t||||||||||2017-10-11 02:41:29.276466|2017-10-11 02:41:29.276466
NCT01652339|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2013-03-25|||July 2012||2012-07-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects||Completed||Phase 1|40|Actual|Hanlim Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:41:29.352387|2017-10-11 02:41:29.352387
NCT01652326|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-01-12|||July 2012||2012-07-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome|Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome|Completed||N/A|792|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-10-11 02:41:29.433768|2017-10-11 02:41:29.433768
NCT01652313|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-07-25|||May 2012||2012-05-01|July 2012|2012-07-01||||June 2012|Actual|2012-06-01||Interventional|||Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women|A Single Centre, Open-label, Multiple-dose Interventional Study Investigating the Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women|Completed||Phase 1|12|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-10-11 02:41:29.61306|2017-10-11 02:41:29.61306
NCT01652300|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-27|||June 2008||2008-06-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of Oral Health Education in Pregnancy|Oral Health Education in Pregnancy Promotes Knowledge,Attitude and Performance of Pregnant Women About Oral Health.|Completed||Phase 2/Phase 3|142|Actual|Gonabad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:41:29.692036|2017-10-11 02:41:29.692036
NCT01652287|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-04-21|2017-01-19||February 2013||2013-02-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children|Yogurt Beverages as a Vehicle to Deliver High Dose Probiotics|Completed||Phase 1|62|Actual|Georgetown University||2|||f||||t||||||||||2017-10-11 02:41:29.794045|2017-10-11 02:41:29.794045
NCT01652274|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2012-08-16|||June 2012||2012-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Level of Knowledge and Habitual Concepts of Turkish Parents on Child Passenger Safety|"Too Small for a Car Seat. An Unnoticed Obstacle to the Proper Use of Car Seats!"|Completed||N/A|98|Actual|Fatih University|||2||f||||t||||||||||2017-10-11 02:41:30.427709|2017-10-11 02:41:30.427709
NCT01652261|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-06-13|||May 2013||2013-05-01|June 2014|2014-06-01|March 2022|Anticipated|2022-03-01|March 2020|Anticipated|2020-03-01||Interventional|H11||Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)|Very Early FDG-PET/CT-response Adapted Therapy for Advanced Stage Hodgkin Lymphoma, a Randomized Phase III Non-inferiority Study of the EORTC Lymphoma Group|Withdrawn||Phase 3|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2||Study closed due to lack of recruitment|f||||t||||||||||2017-10-11 02:41:30.5214|2017-10-11 02:41:30.5214
NCT01652248|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-12-01|||April 2008||2008-04-01|December 2015|2015-12-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|PRE-Empt||Pacemaker Upgrade to Cardiac Resynchronisation Therapy in Patients With Left Ventricular Dysfunction Dependant Upon Right Ventricular Pacing|Pacemaker Upgrade to Cardiac Resynchronisation Therapy in Patients With Left Ventricular Dysfunction Dependant Upon Right Ventricular Pacing.|Completed||N/A|50|Actual|University of Leeds||2|||f||||f||||||||||2017-10-11 02:41:30.633696|2017-10-11 02:41:30.633696
NCT01652235|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-02-28|||July 2008||2008-07-01|February 2017|2017-02-01|April 2024|Anticipated|2024-04-01|April 2024|Anticipated|2024-04-01||Interventional|FENP||Zenith® p-Branch® and Zenith® Fenestrated AAA Endovascular Graft Clinical Study|Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment With the Zenith® Fenestrated AAA Endovascular Graft and the Zenith® p-Branch® and the Effects on Organ and Extremity Perfusion|Recruiting||N/A|40|Anticipated|Cook Group Incorporated||1|||f||||t||||||||||2017-10-11 02:41:30.74042|2017-10-11 02:41:30.74042
NCT01652222|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2014-07-08|||January 2012||2012-01-01|July 2014|2014-07-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||"Experimental Study to Validate the Therapeutic Game CONEM-BETA"|"Experimental Study to Validate the Therapeutic Game CONEM-BETA"|Completed||N/A|101|Actual|Barcelonabeta Brain Research Center, Pasqual Maragall Foundation||3|||f||||f||||||||||2017-10-11 02:41:30.862312|2017-10-11 02:41:30.862312
NCT01652209|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-09-18|||September 1, 2013|Actual|2013-09-01|July 2016|2016-07-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Interventional|||RELIEF(A Randomized,Open labEled, muLticenter Trial for Safety and Efficacy of Intracoronary Adult Human Mesenchymal stEm Cells Acute Myocardial inFarction)|A Multi-center, Open-label, Comparison and a Parallel Group Study (3 Groups) Phase 3 Clinical Trial for a Comparative Evaluation With the Existing Treatments, in Order to Verify the Long-term Efficacy and Safety of the First Cell Treatment Using Hearticellgram-AMI(Autologous Human Bone Marrow Derived Mesenchymal Stem Cells) in AMI Patients, and to Observe the Efficacy of the Second Cell Treatment.|Recruiting||Phase 3|135|Anticipated|Pharmicell Co., Ltd.||3|||f||||t||||||||||2017-10-11 02:41:31.022705|2017-10-11 02:41:31.022705
NCT01652196|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-09-15|||November 14, 2012||2012-11-14|September 2017|2017-09-01|September 1, 2018|Anticipated|2018-09-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer|A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|56|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-11 02:41:31.140517|2017-10-11 02:41:31.140517
NCT01652183|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-07-26|||October 2008||2008-10-01|July 2012|2012-07-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Paracetamol for Catheter Related Bladder Discomfort|THE EFFECT OF INTRAOPERATIVE PARACETAMOL ON CATHETER-RELATED BLADDER DISCOMFORT: A PROSPECTIVE, RANDOMISED, DOUBLE-BLIND STUDY|Completed||Phase 4|64|Actual|Baskent University||2|||f||||t||||||||||2017-10-11 02:41:31.307282|2017-10-11 02:41:31.307282
NCT01652170|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2014-03-20|||January 2013||2013-01-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|APPY1||The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis|The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis in Children, Adolescents, and Young Adults Presenting to the Emergency Department|Completed||N/A|2201|Actual|Venaxis, Inc.|||1||f||||t||||||Samples Without DNA|"     Surplus plasma samples will be retrieved by the Sponsor for future development of protein     biomarkers.   "|||2017-10-11 02:41:31.400985|2017-10-11 02:41:31.400985
NCT01652157|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-08-30|||July 31, 2012||2012-07-31|August 2017|2017-08-01|July 29, 2022|Anticipated|2022-07-29|July 29, 2022|Anticipated|2022-07-29||Observational|||Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)|A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients With Cystic Fibrosis Treated With Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors|Recruiting||N/A|50|Anticipated|AbbVie|||1||f||||||||||||||2017-10-11 02:41:31.542489|2017-10-11 02:41:31.542489
NCT01652144|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-10-25|||August 2012||2012-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell Lymphoma|A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell Lymphoma|Completed||Phase 2|12|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-10-11 02:41:32.015051|2017-10-11 02:41:32.015051
NCT01652131|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-11-18|||May 2012||2012-05-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Behaviour of Intravenous Solutions in Obese Patients Under General Anesthesia|Colloid Volume Kinetics in Morbidly Obese Patients Under General Anaesthesia|Unknown status|Recruiting|N/A|12|Anticipated|National Institute of Medical Sciences and Nutrition, Salvador Zubiran||1|||f||||t||||||||||2017-10-11 02:41:32.104343|2017-10-11 02:41:32.104343
NCT01652118|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-22|2012-07-26|||October 2011||2011-10-01|July 2012|2012-07-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|Claprum||Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis|Prophylaxis of Bronchopulmonary Dysplasia With Clarithromycin|Unknown status|Recruiting|Phase 3|250|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-11 02:41:32.196681|2017-10-11 02:41:32.196681
NCT01652105|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-08-06|||September 2012||2012-09-01|August 2012|2012-08-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Interventional|||Randomized Trial of Preoperative Diets Before Bariatric Surgery|Comparison of Preoperative Diets Before Bariatric Surgery: a Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|Lievensberg Ziekenhuis||2|||f||||f||||||||||2017-10-11 02:41:32.308704|2017-10-11 02:41:32.308704
NCT01652092|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-10-04|||September 4, 2012||2012-09-04|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies|Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies|Recruiting||N/A|30|Anticipated|Masonic Cancer Center, University of Minnesota||4|||f||||t||||||||||2017-10-11 02:41:32.400593|2017-10-11 02:41:32.400593
NCT01652079|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-09-28|||April 2012||2012-04-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer|A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer|Active, not recruiting||Phase 2|63|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:41:32.578043|2017-10-11 02:41:32.578043
NCT01652066|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-07-25|||May 2011||2011-05-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|PROBIMMUNE||Effect of a Mixture of Probiotics on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adults|Effect of a Mixture of Probiotics ( Lactobacillus Gasseri PA16/8,Bifidobacterium Longum SP07/3, Bifidobacterium Bifidum MF 20/5) on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adult|Completed||N/A|430|Actual|Merck Medication Familiale||2|||f||||f||||||||||2017-10-11 02:41:32.690727|2017-10-11 02:41:32.690727
NCT01652053|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-11-01|||January 2012||2012-01-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||A Pilot Study of the InterCushion Disc Nucleus Prosthesis (DNP) in Patients Receiving Discectomy|A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy|Recruiting||N/A|100|Anticipated|Vertebral Technologies, Inc.|||1||f||||f||||||||No||2017-10-11 02:41:32.798118|2017-10-11 02:41:32.798118
NCT01652040|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2017-07-07|||July 2, 2012|Actual|2012-07-02|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|December 18, 2016|Actual|2016-12-18||Interventional|||Resistance Training and Testosterone After Spinal Cord Injury|Effects of Evoked Resistance Training and Testosterone After Spinal Cord Injury|Active, not recruiting||Phase 2/Phase 3|24|Anticipated|VA Office of Research and Development||2|||f||||f|t|t|f|f||||||2017-10-11 02:41:32.905325|2017-10-11 02:41:32.905325
NCT01652027|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-05-27|||July 2011||2011-07-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|HIPS||Hemophilia Inhibitor Previously Untreated Patient Study|Study of Immunologic Determinants of Inhibitor Development in Previously Untreated Patients With Hemophilia|Recruiting||N/A|50|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||t||||||Samples With DNA|"     Plasma samples, lymphocyte cell lines, Genomic DNA, RNA   "|||2017-10-11 02:41:33.001853|2017-10-11 02:41:33.001853
NCT01652014|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-07-13|||January 2014||2014-01-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies|Hematopoietic Stem Cell Transplantation Using Alternate Donor Umbilical Cord Blood Options|Withdrawn||Phase 2|0|Actual|Rutgers, The State University of New Jersey||2||Funding unavailable|f||||f||||||||||2017-10-11 02:41:33.167366|2017-10-11 02:41:33.167366
NCT01652001|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-04-04|2014-12-03||January 2011||2011-01-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity|Effectiveness of Malic Acid 1% in Patients With Xerostomia Induced by Drugs. Determination of Salivary Mucins and Buffering Capacity|Completed||Phase 2/Phase 3|185|Actual|Universidad de Granada|Some of the participants forgot the appointment because the time between phases were of two weeks|2|||f||||t||||||||No||2017-10-11 02:41:33.330692|2017-10-11 02:41:33.330692
NCT01651988|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2012-07-26|||March 2011||2011-03-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Efficacy of Ketamine-Propofol for Short Surgical Procedures|EFFICACY OF KETAMINE-PROPOFOL COMBINATION FOR SHORT SURGICAL PROCEDURES|Completed||Phase 4|77|Actual|Universidad de Cartagena||2|||f||||t||||||||||2017-10-11 02:41:33.622879|2017-10-11 02:41:33.622879
NCT01651975|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-05-25|||November 2009||2009-11-01|May 2017|2017-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Evaluation of Two Different Thickening Products in Patients With Dysphagia|Evaluation of Two Different Thickening Products in Patients With Dysphagia|Completed||Phase 4|100|Actual|University of California, Davis||1|||f||||f||||||||||2017-10-11 02:41:33.704293|2017-10-11 02:41:33.704293
NCT01651962|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-01-15|||August 2012||2012-08-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement|Intravenous Terbutaline to Facilitate Epidural Catheter Placement for Parturients With Labor Pain|Unknown status|Recruiting|Phase 4|250|Anticipated|University of Arizona||3|||f||||f||||||||||2017-10-11 02:41:34.646797|2017-10-11 02:41:34.646797
NCT01651949|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-03-23|2015-02-24||October 29, 2012|Actual|2012-10-29|March 2017|2017-03-01|August 4, 2014|Actual|2014-08-04|August 4, 2014|Actual|2014-08-04||Interventional|||Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)|A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of 9vHPV (V503), a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women|Completed||Phase 3|2520|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:41:36.865897|2017-10-11 02:41:36.865897
NCT01651936|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-01-03|2017-01-03||August 2012||2012-08-01|December 2016|2016-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||All randomized participants|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Worldwide, Proof-of-Concept Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Subjects With Active Rheumatoid Arthritis and an Inadequate Response or Intolerance to Anti-TNF-α Therapy|Terminated||Phase 2|56|Actual|Merck Sharp & Dohme Corp.|This study was terminated early (12 September 2013) based on preliminary analysis of data. The results of this study need to be interpreted with caution given the small sample size (56 participants) resulting from early termination of the study.|3|||f||||f||||||||||2017-10-11 02:41:37.62551|2017-10-11 02:41:37.62551
NCT01651923|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-08-10|||February 2013||2013-02-01|August 2012|2012-08-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS||Unknown status|Not yet recruiting|Phase 1|60|Anticipated|Azidus Brasil||2|||f||||||||||||||2017-10-11 02:41:38.354403|2017-10-11 02:41:38.354403
NCT01651910|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2014-04-09|||July 2012||2012-07-01|November 2012|2012-11-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Observational|||The Pain and Unmet Needs Study|A Prospective Longitudinal Survey Exploring the Unmet Needs of Cancer Patients in Pain.|Terminated||N/A|162|Actual|University of Surrey|||3|Recruitment issues, interim analysis indicated a reduced sample size of 162 was acceptable.|f||||f||||||||||2017-10-11 02:41:38.484542|2017-10-11 02:41:38.484542
NCT01651897|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-02-25|||March 1, 2012|Actual|2012-03-01|February 2017|2017-02-01|April 30, 2015|Actual|2015-04-30|November 30, 2014|Actual|2014-11-30||Observational|DELINEATE||Delirium in the Emergency Department and Its Extension Into Hospitalization||Completed||N/A|228|Actual|Vanderbilt University Medical Center|||2||f||||f||||||Samples Without DNA|"     15-30 cc of blood   "|||2017-10-11 02:41:38.564541|2017-10-11 02:41:38.564541
NCT01651884|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-08-25|||March 2012||2012-03-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|tDCS- Aphasia||Effects of tDCS Versus HD-tDCS for Stroke Rehabilitation|High Definition-transcranial Direct Current Stimulation (HD-tDCS) for Stroke Rehabilitation|Completed||Phase 1|||Soterix Medical||2|||f||||f||||||||||2017-10-11 02:41:38.665474|2017-10-11 02:41:38.665474
NCT01651871|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2013-05-30|||July 2012||2012-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis|A Phase 2, Multicenter, Parallel-Group, Randomized, Double-Blind, Placebo- And Active Comparator-Controlled, Combination Study Of S-555739 And Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis|Completed||Phase 2|779|Actual|Shionogi Inc.||5|||f||||||||||||||2017-10-11 02:41:38.781644|2017-10-11 02:41:38.781644
NCT01651858|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2012-07-25|||February 2012||2012-02-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|||||Interventional|||Nurigra Chewable Tablet in Healthy Adult Male Volunteers|Nurigra Chewable Tablet in Healthy Adult Male Volunteers|Completed||Phase 1|52|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||t||||||||||2017-10-11 02:41:38.928367|2017-10-11 02:41:38.928367
NCT01651845|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2015-05-18|||July 2012||2012-07-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|JDRTC/UHN||Evaluation of a 'Hand-held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring (JDRTC/UHN)|Evaluation of a 'Hand-held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring (JDRTC/UHN)|Unknown status|Enrolling by invitation|N/A|80|Anticipated|University Health Network, Toronto|||2||f||||f||||||||||2017-10-11 02:41:39.004132|2017-10-11 02:41:39.004132
NCT01651832|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-10-24|||July 2012||2012-07-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SCAN||Supportive Cancer Care Networkers (SCAN)|Supportive Cancer Care Networkers - a Prospective Randomized Controlled Multi-center Trial|Completed||N/A|261|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-10-11 02:41:39.111863|2017-10-11 02:41:39.111863
NCT01651819|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-02-17|||March 2012||2012-03-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|December 2014|Actual|2014-12-01||Interventional|UROHTLV||Urological Physical Therapy in HTLV-1 With Urinary Symptoms|TREATMENT OF NEUROGENIC BLADDER IN PATIENTS INFECTED WITH HUMAN T-LYMPHOTROPIC VIRUS 1|Enrolling by invitation||N/A|20|Actual|Hospital Universitário Professor Edgard Santos||1|||f||||f||||||||||2017-10-11 02:41:39.287521|2017-10-11 02:41:39.287521
NCT01651780|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-03-09|2017-01-09||October 2012||2012-10-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|BRAVO 2/3|Participants in the ITT population.|Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH|Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)|Completed||Phase 3|803|Actual|The Medicines Company||2|||f||||t|||||t|||||2017-10-11 02:41:39.670958|2017-10-11 02:41:39.670958
NCT01651767|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2014-05-09|||August 2012||2012-08-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382|A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Trial in Caucasian Genotype 1 Chronic HCV-Infected Subjects to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Repeated Doses of JNJ-47910382 Given in Different Doses and Dose Regimens|Terminated||Phase 1|11|Actual|Janssen R&D Ireland||4||"Because of many competing trials using the same mechanism of action, but being further advanced   in development"|f||||f||||||||||2017-10-11 02:41:41.085067|2017-10-11 02:41:41.085067
NCT01651585|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2015-07-20|||July 2011||2011-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|CYMEVAL2||In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir|In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir : Prospective Multicenter Nonrandomized Trial|Completed||Phase 4|41|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 02:41:41.211713|2017-10-11 02:41:41.211713
NCT01651572|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-03-09|||July 2012||2012-07-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia|Assessment of Post-operative Residual Curarization (PORC) Incidence in Patients Undergoing Surgery With General Anaesthesia; Comparison Between Cisatracurium and Rocuronium. A Randomised, Single-blind Phase 4 Study.|Completed||Phase 4|120|Actual|Azienda Ospedaliera di Padova||2|||f||||f||||||||||2017-10-11 02:41:41.310784|2017-10-11 02:41:41.310784
NCT01651559|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-11-14|||November 2012||2012-11-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||The Efficacy Of A Dead Sea Mineral Enriched Body Cream vs Its Carrier as an Adjuvant Treatment For Psoriatic Patients|A Double Blind Controlled Clinical Trial Comparing The Efficacy Of A Dead Sea Mineral Enriched Body Cream vs Its Carrier as an Adjuvant Treatment For Psoriatic Patients Undergoing Phototherapy|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Ahava Dead Sea Laboratories|||1||f||||f||||||||||2017-10-11 02:41:41.404877|2017-10-11 02:41:41.404877
NCT01651546|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2015-06-12|||March 2013||2013-03-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|I-CAT||Intermittent Catheterization Acceptance Test|"Development and Psychometric Validation of a Scale Assessing the Acceptance of Clean Intermittent Self Catheterization in a Neurological and no Neurological Population With Indication to Self Catheterization."|Completed||N/A|200|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 02:41:41.480535|2017-10-11 02:41:41.480535
NCT01651533|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-01-04|||September 2010||2010-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Mental Practice in Chronic, Stroke Induced Hemiparesis|Mental Practice in Chronic, Stroke-Induced Hemiparesis|Completed||Phase 2/Phase 3|100|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 02:41:41.561737|2017-10-11 02:41:41.561737
NCT01651520|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-08-14|||June 2013|Actual|2013-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|Flumatep_2||Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis|Prognosis Value of the Neuronal Damage Detected by Positrons Emission Tomography (PET) With 11C-Flumazenil in Early Multiple Sclerosis.|Active, not recruiting||N/A|60|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||||2017-10-11 02:41:41.649121|2017-10-11 02:41:41.649121
NCT01651507|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2016-04-15|||June 1989||1989-06-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|February 2005|Actual|2005-02-01||Observational|HLP||Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function|Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function. A Multicenter Retrospective Study|Completed||N/A|49|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 02:41:41.747809|2017-10-11 02:41:41.747809
NCT01651494|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-04-06|||August 12, 2011|Actual|2011-08-12|April 5, 2017|2017-04-05|September 18, 2012|Actual|2012-09-18|September 18, 2012|Actual|2012-09-18||Interventional|||Influenza Antiviral DAS-181-F04 in Healthy Adults|A Phase 1 Clinical Study With Influenza Antiviral DAS181-F04: Double-Blind, Randomized, Placebo-Controlled, Multi Dose Study in Healthy Adults|Completed||Phase 1|9|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-11 02:41:41.826402|2017-10-11 02:41:41.826402
NCT01651481|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-08-12|||July 2012||2012-07-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination|Open-label, Randomized, Single Dose Crossover Study to Evaluate the Pharmacokinetics and Safety of Singulair (10 mg) and Xyzal (5 mg) in Free Combination and Fixed-dose Combination as HCP1102 in Healthy Male Volunteers|Completed||Phase 1|28|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 02:41:41.910593|2017-10-11 02:41:41.910593
NCT01651468|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-02-22|||September 2016||2016-09-01|February 2017|2017-02-01|December 2023|Anticipated|2023-12-01|January 2020|Anticipated|2020-01-01||Interventional|||"The Effect of the Nutraceutical Hemofix on the Coagulation System"|"Phase 1 Study of the Nutraceutical Hemofix Safety and Effect on the Coagulation System"|Withdrawn||N/A|0|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 02:41:42.016264|2017-10-11 02:41:42.016264
NCT01651455|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-07-30|||September 2012||2012-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Observational|MAESTRALE||Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000|Maintaining Lung Function in Cystic Fibrosis Patients: Evaluation and Comparison Between Two Decades in a Retrospective Monocentric Observational Study|Completed||N/A|92|Actual|Chiesi Farmaceutici S.p.A.|||2||f||||t||||||||||2017-10-11 02:41:42.11819|2017-10-11 02:41:42.11819
NCT01651442|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-04-27|||June 2011|Actual|2011-06-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|February 28, 2017|Actual|2017-02-28||Interventional|||Sequenced Therapies for Comorbid and Primary Insomnias|Sequenced Therapies for Comorbid and Primary Insomnias|Active, not recruiting||Phase 4|224|Anticipated|National Jewish Health||4|||f||||t||||||||||2017-10-11 02:41:42.220218|2017-10-11 02:41:42.220218
NCT01651429|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-06-13|||April 2013||2013-04-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Predicting Cognitive Resilience Against Sleep Loss|Multimodal Neuroimaging to Predict Cognitive Resilience Against Sleep Loss|Completed||N/A|48|Actual|Mclean Hospital||1|||f||||f||||||||||2017-10-11 02:41:42.3077|2017-10-11 02:41:42.3077
NCT01651416|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2015-09-17|||July 2012||2012-07-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghana|An Individually Randomised Trial of Seasonal Malaria Chemoprevention Versus a Long-acting Artemisinin Combination Therapy for the Prevention of Malaria and Anaemia in Children Living in an Area of Extended Seasonal Transmission in Ghana.|Completed||Phase 4|2400|Actual|Centre for Global Health Research, Ghana||3|||f||||t||||||||||2017-10-11 02:41:42.41231|2017-10-11 02:41:42.41231
NCT01651403|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2017-08-14|||December 6, 2012|Actual|2012-12-06|August 2017|2017-08-01|March 2025|Anticipated|2025-03-01|August 7, 2017|Actual|2017-08-07||Interventional|||Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection|A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients With Chronic Hepatitis B Infection|Active, not recruiting||Phase 3|100|Anticipated|Gilead Sciences||4|||f||||t||||||||||2017-10-11 02:41:42.515901|2017-10-11 02:41:42.515901
NCT01651390|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-09-23|||June 2012||2012-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|January 2015|Actual|2015-01-01||Interventional|BIOLUX-RCT||Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.|BIOLUX RCT - Clinical Performance of the Pantera LUX Paclitaxel Releasing Balloon Versus the Drug Eluting Orsiro Hybrid Stent System in Patients With In-stent Restenosis - a Randomized Controlled Trial|Completed||N/A|231|Actual|Biotronik AG||2|||f||||t||||||||||2017-10-11 02:41:42.798609|2017-10-11 02:41:42.798609
NCT01651377|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2014-07-18|||October 2011||2011-10-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pramipexole as a Treatment for Cocaine Dependence|Pramipexole as a Treatment for Cocaine Dependence|Completed||Phase 1|10|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 02:41:42.985844|2017-10-11 02:41:42.985844
NCT01651364|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-07-25|||July 2011||2011-07-01|July 2012|2012-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence|A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence|Completed||Phase 1|11|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 02:41:43.084794|2017-10-11 02:41:43.084794
NCT01651351|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-06-26|2014-04-29|2014-01-31|July 2012||2012-07-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Safety Analysis Set|GLASSIA Infusion Rate Study|A Phase 4 Double-Blind Study to Assess the Safety and Tolerability of Intravenous Administration of GLASSIA in Healthy Adult Volunteers|Completed||Phase 4|30|Actual|Baxalta US Inc.|Simultaneous infusion of GLASSIA and placebo did not allow adverse events (AEs) to be unquestionably ascribed to either one. Any observed AE which was assessed by the investigator as related to treatment was conservatively attributed to GLASSIA.|2|||f||||f||||||||||2017-10-11 02:41:43.188767|2017-10-11 02:41:43.188767
NCT01651338|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-25|||January 2009||2009-01-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Quality of Life and Acupuncture on Chronic Pain: A Randomized Study Before and After Performing|Islamic Azad University and Dr Sadre Nabavi Clinic|Terminated||Phase 2/Phase 3|150|Actual|Islamic Azad University, Tehran||1||This study was completed.|f||||t||||||||||2017-10-11 02:41:43.58614|2017-10-11 02:41:43.58614
NCT01651325|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-02-20|||May 2012||2012-05-01|February 2015|2015-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects|A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Dextromethorphan in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:41:43.68624|2017-10-11 02:41:43.68624
NCT01651312|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-09-04|||January 2003||2003-01-01|September 2013|2013-09-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||A Study to Assess the Systemic Pharmacokinetics, Metabolism and Excretion Routes of YM178 in Man, After Administration of Radio-labeled YM178|An Open-label Study to Evaluate the Pharmacokinetics of YM178 After Single Oral Administration of 14C-labeled YM178 in Healthy Male Volunteers|Completed||Phase 1|4|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:41:43.796458|2017-10-11 02:41:43.796458
NCT01651299|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-25|2013-05-10|||July 2012||2012-07-01|September 2012|2012-09-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Observational|||Copperhead Envenomation Observational Study|Observational Study of Recovery From Copperhead Snake Envenomation|Completed||N/A|20|Actual|BTG International Inc.|||1||f||||f||||||||||2017-10-11 02:41:43.919908|2017-10-11 02:41:43.919908
NCT01651286|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-01-15|||June 2012||2012-06-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Nasal Mask Ventilation During the Induction of General Anesthesia|Determination of the Efficacy of Nasal Mask Ventilation During the Induction of General Anesthesia|Completed||N/A|52|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:41:44.033659|2017-10-11 02:41:44.033659
NCT01651273|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2013-08-02|||November 2012||2012-11-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia|A Site and Subject Blinded Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS 852927 in Patients With Primary Hypercholesterolemia on a Stable Dose of Statin Therapy|Terminated||Phase 1|97|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 02:41:44.147505|2017-10-11 02:41:44.147505
NCT01651260|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-02-23|2014-03-18||July 2012||2012-07-01|February 2016|2016-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Complete demographic profiles were obtained for 63 participants|Assessment of an Endotracheal Tube Securement Device|Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device|Completed||N/A|65|Actual|Hollister Incorporated|Adult subjects in respiratory insufficiency in ICU setting were intubated with only four ET tube sizes: 7.0, 7.5, 8.0 and 8.5 mm. No other sizes were represented in the sample population.|1|||f||||f||||||||No||2017-10-11 02:41:44.288795|2017-10-11 02:41:44.288795
NCT01651247|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-24|||May 2010||2010-05-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines|Blinded Retrospective Laboratory Evaluations to Assess the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants Aged 2 and 6 Months and Toddlers Aged 4-6 Years Following Administration of GlaxoSmithKline (GSK) Biologicals' IPV-containing Vaccines|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||||||||Samples With DNA|"     Serum   "|||2017-10-11 02:41:44.556924|2017-10-11 02:41:44.556924
NCT01651234|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-08-27|||March 2012||2012-03-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers|A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC-4401C in Healthy Subjects|Completed||Phase 1|48|Actual|Green Cross Corporation||2|||f||||f||||||||||2017-10-11 02:41:44.64775|2017-10-11 02:41:44.64775
NCT01651221|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-01-26|||July 2012||2012-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Repeated Food Exposure Via the Olfactory and Gustatory Systems|Repeated Food Exposure Via the Olfactory and Gustatory Systems|Completed||N/A|45|Anticipated|University of Tennessee||3|||f||||t||||||||||2017-10-11 02:41:44.742852|2017-10-11 02:41:44.742852
NCT01651208|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-05-09|2014-05-14||January 2010||2010-01-01|May 2017|2017-05-01|June 2012|Actual|2012-06-01|November 2011|Actual|2011-11-01||Interventional|||Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations|Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations|Completed||N/A|452|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 02:41:44.849771|2017-10-11 02:41:44.849771
NCT01651195|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-01-07|||July 2012||2012-07-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Probiotics and Infections in Conscripts in Military Service|Probiotic and Respiratory and Gastrointestinal Tract Infections in Finnish Military Conscripts - a Randomized and Placebo-controlled Double-blinded Study|Active, not recruiting||Phase 3|900|Anticipated|Helsinki University Central Hospital||2|||f||||||||||||||2017-10-11 02:41:45.364004|2017-10-11 02:41:45.364004
NCT01651182|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-09-17|||March 2014||2014-03-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection|Open Label, Non-Randomized, Study to Evaluate the Pharmacokinetics of Tranexamic Acid in Patients Undergoing Major Liver Resection|Completed||Phase 3|24|Actual|Sunnybrook Health Sciences Centre||3|||f||||f||||||||||2017-10-11 02:41:45.464207|2017-10-11 02:41:45.464207
NCT01651169|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-11-15|||September 2012||2012-09-01|November 2014|2014-11-01|March 2016|Anticipated|2016-03-01|November 2015|Anticipated|2015-11-01||Interventional|ADHD||Methylphenidate on Intracortical Inhibition in Methamphetamine Abusers Attention Deficit Hyperactivity Disorder (ADHD)|Evaluating the Effect of Methylphenidate on Intracortical Inhibition in Methamphetamine Abusers Comorbid With Attention Deficit Disorder With Hyperactivity(ADHD) in TMS Unit, Neurcognitive Lab, Iranian National Center for Addiction Studies (INCAS), in 2012. A Randomized, Controlled Trial|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:41:45.576796|2017-10-11 02:41:45.576796
NCT01651156|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2013-12-25|||July 2012||2012-07-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema|Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel Phase 3 Study to Evaluate the Efficacy and Safety of Tolvaptan in the Treatment of Patients With Cardiac Edema Based on the Conventional Therapy|Completed||Phase 3|244|Actual|Otsuka Beijing Research Institute||2|||f||||f||||||||||2017-10-11 02:41:45.678084|2017-10-11 02:41:45.678084
NCT01651143|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-02-26||2016-02-26|January 2013||2013-01-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|||Proof of Biological Activity of SAR100842 in Systemic Sclerosis|Double-blind, Randomized, 8-week Placebo-controlled, and 16-week Open-label Extension Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of SAR100842 Given Orally to Patients With Diffuse Cutaneous Systemic Sclerosis|Completed||Phase 2|32|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:41:45.766594|2017-10-11 02:41:45.766594
NCT01651130|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2013-05-28|||June 2012||2012-06-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Carbetocin at Elective Cesarean Delivery Part 3|Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study Part 3|Completed||N/A|40|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||6|||f||||f||||||||||2017-10-11 02:41:45.907695|2017-10-11 02:41:45.907695
NCT01651117|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-05-25|||September 1, 2012|Actual|2012-09-01|May 2017|2017-05-01|October 8, 2018|Anticipated|2018-10-08|April 8, 2018|Anticipated|2018-04-08||Interventional|||Using Peer Mentors to Support PACT Team Efforts to Improve Diabetes Control|Using Peer Mentors to Support PACT Team Efforts to Improve Diabetes Control|Active, not recruiting||N/A|698|Anticipated|VA Office of Research and Development||3|||f||||f|f|f|||f|||Yes|Data will be made available upon request of the PI|2017-10-11 02:41:46.035906|2017-10-11 02:41:46.035906
NCT01651104|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-04-03|2013-07-11||July 2012||2012-07-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Baseline analysis was performed on all enrolled subjects.|Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects|A Phase 2, Open Label, Uncontrolled, Multicenter Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine (Fluad®), Formulation 2012/2013, When Administered to Elderly Subjects|Completed||Phase 2|63|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:41:46.144982|2017-10-11 02:41:46.144982
NCT01651091|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-08-06|||March 2013||2013-03-01|August 2012|2012-08-01||||November 2013|Anticipated|2013-11-01||Interventional|||Effects of Meditation Awareness Training on Psychosocial Functioning in Prison Participants|Effects of Meditation Awareness Training on Psychosocial Functioning in Prison Participants: A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|102|Anticipated|Nottingham Trent University||2|||f||||t||||||||||2017-10-11 02:41:46.614236|2017-10-11 02:41:46.614236
NCT01651078|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-08-17|||July 2012||2012-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|LAASR||Laser Ablation After Stereotactic Radiosurgery|Laser Ablation After Stereotactic Radiosurgery|Completed||N/A|44|Actual|Monteris Medical|||1||f||||t||||||||||2017-10-11 02:41:46.713305|2017-10-11 02:41:46.713305
NCT01651065|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-03-15|||June 2011||2011-06-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Micro-Clinic Obesity and Metabolic Risk Prevention Program|Micro-Clinic Obesity and Metabolic Risk Prevention Program: A Randomized-Control Trial of a Social-Network Based Intervention|Completed||N/A|919|Actual|Microclinic International||2|||f||||f||||||||||2017-10-11 02:41:46.844643|2017-10-11 02:41:46.844643
NCT01651052|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-07-13|||July 2011||2011-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000|Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000|Active, not recruiting||N/A|200|Anticipated|Edwards Lifesciences||1|||f||||t||||||||||2017-10-11 02:41:46.966496|2017-10-11 02:41:46.966496
NCT01651039|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-01-26|||July 2012||2012-07-01|January 2017|2017-01-01|December 21, 2016|Actual|2016-12-21|December 21, 2016|Actual|2016-12-21||Interventional|||Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)|A Phase II, Single-Center, Open-Label Study Of Oral Panobinostat (LBH589) When Administered In Combination With Lenalidomide And Weekly Dexamethasone In Patients With Multiple Myeloma|Completed||Phase 2|29|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 02:41:47.08512|2017-10-11 02:41:47.08512
NCT01651026|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-07-14|||January 2011||2011-01-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Observational|CROSS-1||Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer|Multicentered Observational Prospective Cohort Study on Multidisciplinary Treatment of Rectal Cancer|Recruiting||N/A|600|Anticipated|National Cancer Institute, Naples|||1||f||||f||||||||||2017-10-11 02:41:47.20219|2017-10-11 02:41:47.20219
NCT01651013|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-11-25|||October 2010||2010-10-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|CALLAS||Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras|Multicentered Observational Prospective Cohort Study on the Treatment of Metastatic Colorectal Cancer and the Role of Evaluating K-Ras|Recruiting||Phase 2|500|Anticipated|National Cancer Institute, Naples|||1||f||||f||||||||||2017-10-11 02:41:47.306967|2017-10-11 02:41:47.306967
NCT01651000|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-08-22|2016-07-08|2015-10-22|September 2012||2012-09-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Intent to Treat|Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency|Completed||Phase 3|213|Actual|OPKO Health, Inc.||2|||f||||t||||||||||2017-10-11 02:41:47.420683|2017-10-11 02:41:47.420683
NCT01650987|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-08-05|||May 2009||2009-05-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Observational|SEXUTOX||Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function|Prospective Observational Study of Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function|Completed||N/A|72|Actual|Centre Oscar Lambret|||6||f||||f||||||||No||2017-10-11 02:41:48.131587|2017-10-11 02:41:48.131587
NCT01650974|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-03-02|||July 2012||2012-07-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|HFNOT||High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy|High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy: A Prospective, Randomized, Controlled Study|Recruiting||N/A|152|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 02:41:48.228543|2017-10-11 02:41:48.228543
NCT01650961|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2013-08-06|||July 2012||2012-07-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of Palonosetron on the QTc Interval During Perioperative Period|The Effect of Palonosetron on the QTc Interval During Perioperative Period|Completed||N/A|100|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 02:41:48.334755|2017-10-11 02:41:48.334755
NCT01650948|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-01-16|||July 2012||2012-07-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|RPED Genetics||Genetic Load and Phenotype in Aggressive AMD|Evaluation of Genetic Variants in Patients Under Treatment for Choroidal Neovascular (CNV) Age-related Macular Degeneration (AMD), Receiving Intravitreal antiVEGF Injections to Evaluate the Association Between Genetic Load and Phenotypes Associated With More Aggressive Forms of Disease.|Completed||N/A|100|Actual|Sequenom, Inc.|||2||f||||f||||||Samples With DNA|"     DNA samples and remnants will be destroyed after analysis.   "|||2017-10-11 02:41:48.422184|2017-10-11 02:41:48.422184
NCT01650922|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2012-07-25|||September 2005||2005-09-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples|Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples|Completed||N/A|4|Actual|Stanford University|||1||f||||||||||Samples With DNA|"     the investigators will sample a single blood sample or buccal swab and if obtained at the     time of diagnosis, brain tumor biopsy.   "|||2017-10-11 02:41:48.608392|2017-10-11 02:41:48.608392
NCT01650909|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-04-21|||July 2012||2012-07-01|April 2014|2014-04-01||||||||Observational|||The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKU|The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical Phenylketonuria|Withdrawn||Phase 3|0|Actual|Stanford University|||1|Withdrawn due to no funding|f||||||||||Samples With DNA|"     Blood and urine will be collected to anaylze redox biomarkers   "|||2017-10-11 02:41:48.682683|2017-10-11 02:41:48.682683
NCT01650896|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-24|||July 2012||2012-07-01|July 2012|2012-07-01|July 2016|Anticipated|2016-07-01|July 2014|Anticipated|2014-07-01||Interventional|CADIS||Prospective Randomised Controlled Trial of Delirium Management by Geriatric Medicine Versus General Medicine|Prospective Randomised Controlled Trial of Delirium Management The Central Coast Australia Delirium Intervention Study (CADIS|Unknown status|Recruiting|N/A|250|Anticipated|Central Coast Local Health District||2|||f||||t||||||||||2017-10-11 02:41:48.767944|2017-10-11 02:41:48.767944
NCT01650870|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-08-07|||July 2012||2012-07-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults|A Single Center, Randomized, Single-blind Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Split-Dose Regimen of Crystalline Lactulose for Cleansing of the Colon as a Preparation for Colonoscopy in Adults|Completed||Phase 2|40|Actual|Benaroya Research Institute||2|||f||||f||||||||||2017-10-11 02:41:48.974358|2017-10-11 02:41:48.974358
NCT01650857|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2015-08-19|||April 2010||2010-04-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Observational|||Pulmonary Hypertension: Efficacy of a 3 Week Inpatient Rehabilitation on Physical Condition, Body Composition and Health Related Quality of Life|Pulmonary Hypertension: Efficacy of a 3 Week Inpatient Pulmonary Rehabilitation on Physical Condition, Body Composition and Health Related Quality of Life - an Observational Study|Recruiting||N/A|100|Anticipated|Hannover Medical School|||1||f||||f||||||||||2017-10-11 02:41:49.080102|2017-10-11 02:41:49.080102
NCT01650844|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-10-05|||August 2012||2012-08-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Interventional|SB-TEAM||School-Based Telemedicine Enhanced Asthma Management|School-Based Telemedicine Enhanced Asthma Management: A Randomized Control Trial Using Novel Technology to Improve Preventive Asthma Care|Active, not recruiting||N/A|400|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 02:41:49.204506|2017-10-11 02:41:49.204506
NCT01650831|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-03-17|2013-05-28||October 2012||2012-10-01|March 2016|2016-03-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection|Clinical Study to Evaluate the Equivalence of the Modified BreathID Compared to Currently Approved BreathID System in Detection of H.Pylori Infection|Completed||N/A|113|Actual|Exalenz Bioscience LTD.||1|||f||||t||||||||||2017-10-11 02:41:49.304307|2017-10-11 02:41:49.304307
NCT01650818|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2013-09-08|||January 2012||2012-01-01|September 2013|2013-09-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|ENDURANCE||Aerobic Exercise Training in Amyotrophic Lateral Sclerosis|Exercise traiNing in Amyotrophic Lateral Sclerosis: a ranDomized Trial Comparing Home-based Aerobic endUrance tRAiNing vs. Usual physiCal Therapy intErvention|Unknown status|Recruiting|N/A|40|Anticipated|Fondazione Salvatore Maugeri||2|||f||||t||||||||||2017-10-11 02:41:49.573191|2017-10-11 02:41:49.573191
NCT01650805|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-11-05|2014-10-15||June 2012||2012-06-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||ITT Population|Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)|A Phase 3 Randomized,Open-Label Study of Ponatinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase|Terminated||Phase 3|307|Actual|Ariad Pharmaceuticals|Trial was discontinued early.|2||Study terminated based on evaluation of safety data.|t||||t||||||||||2017-10-11 02:41:49.755401|2017-10-11 02:41:49.755401
NCT01650792|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-03-01|||July 2012|Actual|2012-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CLINICS||Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)|CHADSS: Chagas Disease Scan Study|Recruiting||Phase 4|500|Anticipated|Federal University of Bahia||2|||f||||f||||||||||2017-10-11 02:41:51.41811|2017-10-11 02:41:51.41811
NCT01650779|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-06-09|2014-06-09||April 2012||2012-04-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||All enrolled participants were included in the analysis.|A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta|Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The INFORM Study)|Completed||Phase 4|15|Actual|Sanofi|This is considered to be an exploratory study for the following reasons: it was based on a small number of participants and has been designed as an open-label, single-arm study as opposed to a two-arm crossover design.|1|||f||||f||||||||||2017-10-11 02:41:51.560115|2017-10-11 02:41:51.560115
NCT01650766|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-07-24|||February 2012||2012-02-01|July 2012|2012-07-01|October 2012|Anticipated|2012-10-01|||||Observational|||Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers|Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers|Unknown status|Recruiting|N/A|80|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences|||1||f||||f||||||Samples With DNA|"     The paraffin-embedded pathelogical tissues of tumors and the blood samples before and after     medication are retained.   "|||2017-10-11 02:41:52.052717|2017-10-11 02:41:52.052717
NCT01650753|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-11-05|||August 2012||2012-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|June 2013|Actual|2013-06-01||Interventional|||Colonization and Persistence of Bifidobacterium Longum|Quantitative Evaluation of the Colonization and Persistence of Bifidobacterium Longum Ssp Longum AH1206 in the Gastrointestinal Tract and Its Tolerance by Human Subjects|Completed||N/A|24|Actual|University of Nebraska Lincoln||2|||f||||f||||||||||2017-10-11 02:41:52.158863|2017-10-11 02:41:52.158863
NCT01650740|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-12-19|||August 2012||2012-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder|A Randomized Trial of Sequenced Treatment Using Placebo Without Deception Followed by Open-Label Antidepressant Versus Immediate Open-Label Antidepressant Treatment for Major Depressive Disorder|Terminated||N/A|1|Actual|Sunnybrook Health Sciences Centre||3||Poor recruitment results.|f||||t||||||||||2017-10-11 02:41:52.260344|2017-10-11 02:41:52.260344
NCT01650727|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-02-09|||October 2012||2012-10-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)|A Phase 1b Trial of Dinaciclib in Combination With Rituximab in Subjects With Relapsed and Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Completed||Phase 1|5|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 02:41:52.379685|2017-10-11 02:41:52.379685
NCT01650714|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-05-13|||September 2012||2012-09-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Endoscopic Full Thickness Biopsy, Gastric Wall.|Endoscopic Full Thickness Biopsy of the Gastric Wall in Patients With Refractory Idiopathic Gastroparesis: Pilot Study to Detect Neuromuscular and Immune Pathologic Changes|Completed||N/A|3|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:41:52.474012|2017-10-11 02:41:52.474012
NCT01650701|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-07-11|||February 2012||2012-02-01|July 2017|2017-07-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Interventional|RELEVANCE||A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma|"A PHASE 3 OPEN-LABEL RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF RITUXIMAB PLUS LENALIDOMIDE (CC-5013) VERSUS RITUXIMAB PLUS CHEMOTHERAPY FOLLOWED BY RITUXIMAB IN SUBJECTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA The RELEVANCE Trial (Rituximab Lenalidomide Versus ANy ChEmotherapy)is Being Conducted as Two Companion Studies: RV-FOL-GELARC-0683 (N=750) and RV-FOL-GELARC-0683C (N=250); the Combined Total of 1000 Patients Enrolled in Both Studies Will be Analyzed."|Active, not recruiting||Phase 3|1031|Actual|The Lymphoma Academic Research Organisation||2|||f||||t||||||||||2017-10-11 02:41:52.56092|2017-10-11 02:41:52.56092
NCT01650688|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2012-07-23|||July 2012||2012-07-01|July 2012|2012-07-01|September 2012|Anticipated|2012-09-01|July 2012|Actual|2012-07-01||Observational|||Difference in Grades of Epiblepharon According to Positional Changes and General Anesthesia||Unknown status|Active, not recruiting|N/A|63|Anticipated|Yonsei University|||1||f||||f||||||||||2017-10-11 02:41:52.739991|2017-10-11 02:41:52.739991
NCT01650675|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-12-07|||June 2012||2012-06-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Indirect Assessment and Intervention for Perinatal Drug Use|Indirect Assessment and Intervention for Perinatal Drug Use|Completed||Phase 2|500|Actual|Wayne State University||2|||f||||f||||||||||2017-10-11 02:41:52.799934|2017-10-11 02:41:52.799934
NCT01650662|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-04-15|||January 2012||2012-01-01|October 2013|2013-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CYCLE||CYCLosporinE A in Reperfused Acute Myocardial Infarction|CYCLosporinE A in Reperfused Acute Myocardial Infarction Prospective, Controlled, Randomized, Multicentre Trial to Examine Whether a Single i.v. Bolus of Cyclosporine A Before PCI Can Reduce Myocardial Reperfusion Injury in Patients With STEMI.|Completed||Phase 3|410|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||t||||||||||2017-10-11 02:41:52.884337|2017-10-11 02:41:52.884337
NCT01650649|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-05-01|||July 2012||2012-07-01|May 2017|2017-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Electrocardiographic Effects of Lofexidine When Administered Orally to Methadone Maintained Adult Subjects|Completed||Phase 1|27|Actual|US WorldMeds LLC||2|||f||||f||||||||||2017-10-11 02:41:53.030287|2017-10-11 02:41:53.030287
NCT01650636|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-07-19|||October 2010||2010-10-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process|Patient-Partner Stress Management Effects on CFS Symptoms and Neuroimmune Process|Completed||N/A|150|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 02:41:53.189499|2017-10-11 02:41:53.189499
NCT01650623|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-11-06|||July 2012||2012-07-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|May 2013|Anticipated|2013-05-01||Interventional|||Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled Trial|Gait Training Associated With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled Trial|Unknown status|Recruiting|N/A|30|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:41:53.27707|2017-10-11 02:41:53.27707
NCT01650610|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-11-06|||July 2012||2012-07-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|February 2013|Anticipated|2013-02-01||Interventional|||Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Study Protocol|Gait Training Associated With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Study Protocol|Unknown status|Recruiting|N/A|30|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 02:41:53.36119|2017-10-11 02:41:53.36119
NCT01650597|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-07-04|||August 2011||2011-08-01|May 2014|2014-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Participants|A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Subjects|Completed||Phase 1|29|Actual|Janssen-Cilag International NV||3|||f||||f||||||||||2017-10-11 02:41:53.447755|2017-10-11 02:41:53.447755
NCT01650584|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-05-08|||June 2012||2012-06-01|May 2017|2017-05-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of Ocular Comfort With ISTA Tears vs Systane|Evaluation of Ocular Comfort With ISTA Tears vs Systane|Completed||N/A|35|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 02:41:53.54679|2017-10-11 02:41:53.54679
NCT01650571|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-08-25|||October 2012|Actual|2012-10-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|SMH/UHN||Evaluation of a 'Hand-Held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring (SMH/UHN)|Evaluation of a 'Hand-Held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring (SMH/UHN)|Completed||N/A|7|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 02:41:53.617158|2017-10-11 02:41:53.617158
NCT01650558|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-09-18|||November 2012||2012-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|TSCQ||Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi|Randomized, Open-label Controlled Trial of Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on Anti-retroviral Therapy in Malawi|Active, not recruiting||N/A|1500|Anticipated|University of Maryland||3|||f||||t||||||||||2017-10-11 02:41:53.672516|2017-10-11 02:41:53.672516
NCT01650545|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2015-04-21|||June 2012||2012-06-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients|A Pilot Study to Demonstrate Efficacy and Safety of Aerosol Liposomal Cyclosporine (L-CsA) in the Treatment of Bronchiolitis Obliterans Syndrome After Lung Transplantation|Completed||Phase 1/Phase 2|21|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 02:41:53.764735|2017-10-11 02:41:53.764735
NCT01650532|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-02-21|||May 2012||2012-05-01|February 2017|2017-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|SAYExercise||Stretching and Yoga Exercise Study|The Effects of an 8-Week Yoga Intervention on Cognition and Functional Fitness in Older Adults|Completed||N/A|118|Actual|University of Illinois at Urbana-Champaign||2|||f||||f||||||||No||2017-10-11 02:41:53.842746|2017-10-11 02:41:53.842746
NCT01650519|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-05-17|2014-04-15||September 2012||2012-09-01|May 2016|2016-05-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional||The Intent-to-treat population consists of all patients who received at least a partial dose of study medication.|A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery|A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery|Completed||Phase 4|51|Actual|Cumberland Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:41:53.918316|2017-10-11 02:41:53.918316
NCT01650506|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-08-28|||July 2012|Actual|2012-07-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of Erlotinib and Metformin in Triple Negative Breast Cancer|Phase I Study of Erlotinib and Metformin in Triple Negative Breast Cancer|Completed||Phase 1|8|Actual|Columbia University||1|||f||||t|t|f|||f|||||2017-10-11 02:41:56.103227|2017-10-11 02:41:56.103227
NCT01650493|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2014-07-09|||June 2012||2012-06-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Observational|||In-situ Evaluation of Anti-caries Technology|In-situ Evaluation of Anti-caries Technology|Completed||N/A|29|Actual|3M|||3||f||||f||||||||||2017-10-11 02:41:56.201441|2017-10-11 02:41:56.201441
NCT01650480|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-02-11|||January 2012||2012-01-01|July 2012|2012-07-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|HELP-COPD||HELPing Older People With Very Severe Chronic Obstructive Pulmonary Disease Towards the End of Their Lives: Developing, Piloting and Refining a Practical Intervention (HELP-COPD)|HELPing Older People With Very Severe Chronic Obstructive Pulmonary Disease (COPD) Towards the End of Their Lives: Developing, Piloting and Refining a Practical Intervention (HELP-COPD)|Completed||Early Phase 1|44|Actual|University of Edinburgh||2|||f||||t||||||||||2017-10-11 02:41:56.310386|2017-10-11 02:41:56.310386
NCT01650467|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-01-31|||December 2014||2014-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|abl LMC||Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms|Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes|||3|Funding is late, unforseeable.|f||||f||||||Samples With DNA|"     Two 7 ml EDTA tubes for genotyping abl and bcr-abl polymorphisms   "|||2017-10-11 02:41:56.413543|2017-10-11 02:41:56.413543
NCT01650454|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-11-10|||January 2013||2013-01-01|November 2014|2014-11-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|SCOAL||Sleep, Cognition and Memory Disorder||Unknown status|Active, not recruiting|N/A|185|Anticipated|University Hospital, Bordeaux||4|||f||||f||||||||||2017-10-11 02:41:56.509478|2017-10-11 02:41:56.509478
NCT01650441|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2015-05-27|||April 2012||2012-04-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients|OPEN-LABEL, PROSPECTIVE EXPLORATORY STUDY TO ASSESS THE EFFECTS OF FORMOTEROL AND BECLOMETASONE DIPROPIONATE COMBINATION THERAPY USING A DPI DEVICE ON CENTRAL AND PERIPHERAL AIRWAY DIMENSIONS IN ASTHMATIC PATIENTS.|Completed||Phase 2|31|Actual|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-11 02:41:56.626814|2017-10-11 02:41:56.626814
NCT01650428|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-09-19|||April 2013||2013-04-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|October 2017|Anticipated|2017-10-01||Interventional|BACCHUS||Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery|A Phase II, Multicentre, Open-Label, Randomised Study of Neoadjuvant Chemotherapy and Bevacizumab in Patients With MRI Defined High-Risk Cancer of the Rectum|Active, not recruiting||Phase 2|60|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 02:41:56.728143|2017-10-11 02:41:56.728143
NCT01650402|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-12-14|||December 2011||2011-12-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People|Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People|Active, not recruiting||Phase 4|199|Actual|UConn Health||2|||f||||t||||||||||2017-10-11 02:41:57.170913|2017-10-11 02:41:57.170913
NCT01638130|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-11|||February 2011||2011-02-01|July 2012|2012-07-01||||||||Observational|||Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers|Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers|Unknown status|Recruiting|N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 02:45:53.514695|2017-10-11 02:45:53.514695
NCT01650389|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-09-29|||October 2012||2012-10-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MVA(TB)029||Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination|Phase II Randomised Controlled Trial to Evaluate Safety and Immunogenicity of MVA85A and Selective, Delayed Bacille Calmette-Guerin (BCG) Vaccination in Infants of HIV Infected Mothers|Completed||Phase 2|248|Actual|University of Cape Town||2|||f||||t||||||||||2017-10-11 02:41:57.284295|2017-10-11 02:41:57.284295
NCT01650376|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-04-25|||August 2012||2012-08-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer|Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients|Active, not recruiting||Phase 1/Phase 2|52|Anticipated|Swedish Medical Center||1|||f||||f||||||||||2017-10-11 02:41:57.399581|2017-10-11 02:41:57.399581
NCT01650363|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-23|||October 2012||2012-10-01|July 2012|2012-07-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||CAM in Post Surgical Management in Cardiothoracic Surgery|Effect of Complementary and Alternative Medical Methods on the Post Operative Recovery Following Cardio-thoracic Surgery- a Pragmatic, Randomized,Single Blinded, Placebo Controlled Study|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-10-11 02:41:57.55223|2017-10-11 02:41:57.55223
NCT01650350|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-07-27|2014-08-14||November 2012||2012-11-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer|Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer: A Phase II Brown University Oncology Group Research Project|Terminated||Phase 2|7|Actual|Brown University||1||Study stopped 10/24/13 secondary to lack of patients/slow enrollment|f||||t||||||||||2017-10-11 02:41:57.722697|2017-10-11 02:41:57.722697
NCT01650337|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-06-02|||August 2012||2012-08-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|mFIT||mFit: The Mobile Fitness Project|Randomized Trial of a Smartphone Application for Weight Loss in Primary Care|Completed||N/A|212|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:41:58.004337|2017-10-11 02:41:58.004337
NCT01650324|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2014-08-15|2014-05-20||July 2012||2012-07-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||All enrolled participants.|A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects|A Double-blind, Randomized, Placebo-controlled, Dose-ranging, Single-dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of DBPR108 in Healthy Male Subjects|Completed||Phase 1|32|Actual|National Health Research Institutes, Taiwan||2|||f||||f||||||||||2017-10-11 02:41:58.119133|2017-10-11 02:41:58.119133
NCT01650311|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2017-03-22|||July 2012||2012-07-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|IBD||Investigating Serotonin Signalling in IBD Patients|Investigating Serotonin Signalling in IBD Patients|Active, not recruiting||N/A|60|Anticipated|McMaster University|||3||f||||f||||||Samples With DNA|"     Samples will be collected from inflamed and non-inflamed regions, spanning the distal colon     to distal ileum.   "|No||2017-10-11 02:41:58.697706|2017-10-11 02:41:58.697706
NCT01650298|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-11-01|||January 2013||2013-01-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|TACTIC AF||Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation|Pilot Study: Tailored Anticoagulation for Noncontinuous AF|Enrolling by invitation||N/A|200|Anticipated|St. Jude Medical||2|||f||||t||||||||||2017-10-11 02:41:58.827533|2017-10-11 02:41:58.827533
NCT01650285|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2015-06-09|2014-07-14||January 2013||2013-01-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL)|Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL) Following Radical Prostatectomy|Terminated||Phase 2|5|Actual|Brown University||1|||f||||t||||||||||2017-10-11 02:41:58.912995|2017-10-11 02:41:58.912995
NCT01650272|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-07-25|||June 2012||2012-06-01|July 2012|2012-07-01|April 2013|Anticipated|2013-04-01|February 2013|Anticipated|2013-02-01||Interventional|||Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia|An Efficacy and Safety Pilot Study Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Treatment of AGA|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Siriraj Hospital||2|||f||||t||||||||||2017-10-11 02:41:59.13224|2017-10-11 02:41:59.13224
NCT01650259|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-08-25|||July 2012||2012-07-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus|Post Marketing Surveillance on Long Term Drug Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus|Active, not recruiting||N/A|4554|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-10-11 02:41:59.407372|2017-10-11 02:41:59.407372
NCT01650246|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2016-04-20|2016-01-14|2015-03-23|August 2012||2012-08-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Open-Label Lesinurad Monotherapy Extension Study in Gout|A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout|Completed||Phase 3|143|Actual|Ardea Biosciences, Inc.||1|||f||||t||||||||||2017-10-11 02:42:01.193322|2017-10-11 02:42:01.193322
NCT01650233|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-10-05|||August 2009||2009-08-01|October 2017|2017-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Improving Wellness for Young Men|Improving Wellness for Young Men|Completed||N/A|41|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:42:01.727304|2017-10-11 02:42:01.727304
NCT01650051|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2014-06-25||2014-06-25|February 2012||2012-02-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|||Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)|A Double-Blind, Randomized, Multi-Center, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)|Completed||Phase 3|424|Actual|Amneal Pharmaceuticals, LLC||2|||f||||t||||||||||2017-10-11 02:42:03.666601|2017-10-11 02:42:03.666601
NCT01650220|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2013-04-25|||April 2012||2012-04-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|CVMarkers||Cardiovascular Risk Markers in Veterans With Post Traumatic Stress Disorder|Cardiovascular Risk Markers in Veterans With PTSD|Terminated||N/A|13|Actual|INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium|||2|"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the   end of the grant"|f||||t||||||Samples With DNA|"     For the assessment of CVD risk, high-sensitivity CRP (hs-CRP) measurements will be used.     Standard assays detect 1,000 fold increases in CRP in response to infection or inflammation;     these high levels cannot be used to stratify with respect to CVD risk. Hs-CRP, however,     measurement can detect CRP levels as low as 0.5 mg/L. Though mainly used for research     purposes, high-sensitivity IL-6 assays are also able to discriminate IL-6 levels within the     normal range for CVD risk stratification. Both CRP and IL-6 levels will be analyzed as     continuous quantitative traits.      Though no DNA analysis is planned for this study, subjects are asked if they are willing to     have their samples banked for future research.   "|||2017-10-11 02:42:01.849801|2017-10-11 02:42:01.849801
NCT01650207|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-25|||July 2011||2011-07-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Acupuncture for Hemiplegic Shoulder Pain||Completed||N/A|60|Actual|Changhua Christian Hospital||3|||f||||||||||||||2017-10-11 02:42:02.072664|2017-10-11 02:42:02.072664
NCT01650194|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-09-20|||July 9, 2012|Actual|2012-07-09|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients|A Phase 2 Study Determining Safety and Tolerability of Enzalutamide (Formerly MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients|Active, not recruiting||Phase 2|60|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:42:02.181369|2017-10-11 02:42:02.181369
NCT01650181|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-08-18|||November 2011||2011-11-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis|Biochemical and Echosonographic Impacts Using Siliphos-Selenium-Methionine-Alpha Lipoic Acid + Metformin Versus Metformin in Patients With Fatty Liver and Steatohepatitis|Completed||Phase 4|50|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-10-11 02:42:02.30655|2017-10-11 02:42:02.30655
NCT01650168|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2017-05-17|||July 2012||2012-07-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|February 2020|Anticipated|2020-02-01||Observational|PRO-E2||Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)|Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)|Recruiting||N/A|101000|Anticipated|Center for Epidemiology and Health Research, Germany|||2||f||||t||||||||||2017-10-11 02:42:02.421399|2017-10-11 02:42:02.421399
NCT01650155|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-10-14|||July 2012||2012-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.|Safety, Tolerability, Pharmacokinetics and Early Pharmacodynamics of Single Rising Intravenous and Subcutaneous Doses of BI 1005273 in Healthy Male Volunteers (Randomised, Single-blind, Placebo-controlled Within Dose Groups, Clinical Phase I Study)|Completed||Phase 1|88|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 02:42:02.530865|2017-10-11 02:42:02.530865
NCT01650142|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-06-13|||May 2012||2012-05-01|June 2014|2014-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|NFGENMODIF||Modifying Genes in Neurofibromatosis 1|Study of the Neurofibromatosis 1 Expression: Identification of the Modifying Genes|Unknown status|Active, not recruiting|N/A|450|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Whole blood for DNA samples   "|||2017-10-11 02:42:02.623585|2017-10-11 02:42:02.623585
NCT01650129|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2017-02-22|||December 13, 2000|Actual|2000-12-13|February 2017|2017-02-01|October 18, 2001|Actual|2001-10-18|October 18, 2001|Actual|2001-10-18||Interventional|||Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes|An Open-labelled, Randomised, Parallel Group, Multicentre, Safety and Efficacy Study of NN-X14Mix50 (BIAsp50) in a Twice Daily Regimen in Type 2 Diabetic Subjects|Completed||Phase 3|83|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:42:02.741088|2017-10-11 02:42:02.741088
NCT01650116|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-11-19|||July 2012||2012-07-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Evaluation of Hemodynamics and Amount of Blood Flowing Through the Kidneys During Liver Transplant by Measuring Some Physiological Substances in Blood and Urines|Evaluation of Sodium Urinary Excretion, Chlorine Urinary Excretion, Urinary Partial CO2 Pressure as Renal Perfusion Indicators During Liver Transplant. Comparison With Other Polemic State Indicators (Such as PiCCO, ScvO2, O2 Delivery).|Unknown status|Recruiting|N/A|50|Anticipated|Azienda Ospedaliera di Padova|||1||f||||f||||||||||2017-10-11 02:42:02.893636|2017-10-11 02:42:02.893636
NCT01650103|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-11-19|||July 2012||2012-07-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Evaluation of Hemodynamics and Amount of Blood Flowing Through the Kidneys by Measuring Some Physiological Substances in Blood and Urines|Hemodynamic Indexes and Renal Perfusion: Indirect Evaluation of Blood Volume Using the Association Between ScvO2 and Urinary Electrolytes in Patients Undergoing Major Surgery.|Unknown status|Recruiting|N/A|50|Anticipated|Azienda Ospedaliera di Padova|||1||f||||f||||||||||2017-10-11 02:42:03.026285|2017-10-11 02:42:03.026285
NCT01650090|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-01-19|||August 2012||2012-08-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma|Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma|Active, not recruiting||Phase 2|50|Anticipated|Eleison Pharmaceuticals LLC.||1|||f||||f||||||||||2017-10-11 02:42:03.123886|2017-10-11 02:42:03.123886
NCT01650077|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2014-08-22|||September 2012||2012-09-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2013|Actual|2013-12-01||Observational|ProAcTyon||Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria|Early Assessment of Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria: Retrospective Study of Feasibility|Unknown status|Active, not recruiting|N/A|134|Actual|Centre Oscar Lambret|||1||f||||f||||||||||2017-10-11 02:42:03.387531|2017-10-11 02:42:03.387531
NCT01650038|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-12-28|||May 2011||2011-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|TURN||Transplantation of Faeces in Ulcerative Colitis; Restoring Nature's Homeostasis|Transplantation of Faeces in Ulcerative Colitis; Restoring Nature's Homeostasis.|Completed||Phase 2|50|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 02:42:03.770746|2017-10-11 02:42:03.770746
NCT01650025|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-01-30|||August 2012||2012-08-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|VAIIO||Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90°|Effects of the Probiotic Preparation VSL#3 on the Metabolic, Endocrine, Lipidomic and Inflammatory Parameters as Well as Variation of the Microbiota in Pediatric Patients With Body Mass Index >90°|Completed||N/A|48|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||t||||||||||2017-10-11 02:42:03.9148|2017-10-11 02:42:03.9148
NCT01650012|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-09-24|||March 2013||2013-03-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PHASE||Eplerenone in Hemodialysis Trial|Pilot Trial of Hemodialysis Patient Aldosterone antagoniSm With Eplerenone Trial|Completed||N/A|158|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 02:42:04.018229|2017-10-11 02:42:04.018229
NCT01649999|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-08-21||2017-08-21|March 1, 2012|Actual|2012-03-01|August 2017|2017-08-01|July 1, 2013|Actual|2013-07-01|July 1, 2013|Actual|2013-07-01||Interventional|||A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects|A Phase 2b Study of ASP015K -Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study in Moderate to Severe Rheumatoid Arthritis Subjects -|Completed||Phase 2|281|Actual|Astellas Pharma Inc||5|||f||||f|t|f|||t|||||2017-10-11 02:42:04.134554|2017-10-11 02:42:04.134554
NCT01649986|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|PIN||Nutraceuticals to Improve Lipid Profile in European Countries|Additive Effects of Nutraceuticals to Non-pharmacologic Intervention to Improve Lipid Profile in the Real World Clinical Practice in European Countries - The PIN (Portugul Italy Nutraceutical) Study|Not yet recruiting||Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 02:42:04.25349|2017-10-11 02:42:04.25349
NCT01649973|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-01-02|||March 2010||2010-03-01|January 2014|2014-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy|Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy|Completed||N/A|8|Actual|National Medical Center, Seoul|||1||f||||t||||||||||2017-10-11 02:42:04.3489|2017-10-11 02:42:04.3489
NCT01649960|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-12-06|||August 2012||2012-08-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CARE||Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial|Role of Exercise and Low-Dose Rapamycin on Age-Associated Impairments in Older Adults With Coronary Artery Disease: Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial|Completed||Phase 1|13|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:42:04.410551|2017-10-11 02:42:04.410551
NCT01649934|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-22|2017-03-23|||June 2013||2013-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Use of Implementation Intentions to Increase the Appointment Attendance of OEF/OIF Veterans|The Use of Implementation Intentions to Increase the Appointment Attendance of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans|Recruiting||N/A|60|Anticipated|VA Connecticut Healthcare System||3|||f||||f||||||||No||2017-10-11 02:42:04.646572|2017-10-11 02:42:04.646572
NCT01649921|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-09-28|||November 2012|Actual|2012-11-01|April 2014|2014-04-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis|The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis, a Randomised Double-blind Placebo-controlled Pilot (Phase IIIb) Study|Completed||Phase 3|4|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 02:42:04.804402|2017-10-11 02:42:04.804402
NCT01649908|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2012-08-06|||July 2012||2012-07-01|August 2012|2012-08-01||||||||Observational|OBI||Open Bifurcation Surgery Study|Evaluation of Cardiac Function in Different Techniques in Infrarenal Aortic Surgery|Unknown status|Active, not recruiting|N/A|60|Actual|Heidelberg University|||3||f||||f||||||||||2017-10-11 02:42:04.939198|2017-10-11 02:42:04.939198
NCT01649895|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-12-09|||August 2012||2012-08-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||D-Cycloserine as an Adjunct to Internet-CBT for OCD|Internet-based Cognitive Behavior Therapy in Combination With D-Cycloserine for Obsessive Compulsive Disorder: A Double Blinded Randomized Controlled Trial|Completed||Phase 4|128|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:42:05.024838|2017-10-11 02:42:05.024838
NCT01649882|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-05-29|||July 2012||2012-07-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Ultrasound Evaluation of Endotracheal Tube Depth|Ultrasound Evaluation of Endotracheal Tube Depth for Proper Tube Placement in Different Patient Groups|Unknown status|Recruiting|N/A|100|Anticipated|University of Arizona||1|||f||||f||||||||||2017-10-11 02:42:05.146269|2017-10-11 02:42:05.146269
NCT01649869|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-05-23|||March 2015||2015-03-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy|A Phase II Randomized and Controlled Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children With Congenital Cytomegalovirus Infection and Hearing Loss|Recruiting||Phase 2|54|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 02:42:05.263595|2017-10-11 02:42:05.263595
NCT01649687|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-09-11|||May 2012||2012-05-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells|Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells|Completed||Phase 1/Phase 2|7|Actual|National Yang Ming University||1|||f||||t||||||||||2017-10-11 02:42:11.082286|2017-10-11 02:42:11.082286
NCT01649843|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-22|||August 2010||2010-08-01|July 2012|2012-07-01|December 2014|Anticipated|2014-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia|Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia|Unknown status|Recruiting|N/A|450|Anticipated|Shanghai Zhongshan Hospital||1|||f||||t||||||||||2017-10-11 02:42:08.385491|2017-10-11 02:42:08.385491
NCT01649817|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)|Multicenter REtrospective Study to Evaluate coMpliance to Therapy and Drug survIval of Tocilizumab (TCZ) in patientS With Moderate to Severe actIve rheumatOid Arthritis in routiNe Daily Clinical Practice (REMISSION II Study)|Completed||N/A|183|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:42:08.649138|2017-10-11 02:42:08.649138
NCT01649804|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-09-30|2016-06-06||July 2012||2012-07-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Analysis population included all the enrolled participants in the study.|A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis|A MULTICENTER, OPEN-LABEL, SINGLE ARM, LONG-TERM EXTENSION STUDY OF WA19926 TO DESCRIBE SAFETY DURING TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH EARLY, MODERATE TO SEVERE RHEUMATOID ARTHRITIS|Completed||Phase 3|12|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:42:08.783912|2017-10-11 02:42:08.783912
NCT01649791|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-05-26|2013-12-26||January 2010||2010-01-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|May 2012|Actual|2012-05-01||Interventional||All treated and eligible patients.|Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia|A Pilot Study of Lenalidomide as a Chemopreventive Agent for Patients With High-Risk, Early Stage B-Chronic Lymphocytic Leukemia (CLL)|Terminated||N/A|8|Actual|Roswell Park Cancer Institute|This trial did not reach full accrual.|1|||f||||f||||||||||2017-10-11 02:42:09.204671|2017-10-11 02:42:09.204671
NCT01649778|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-07-12|||July 19, 2012|Actual|2012-07-19|July 2017|2017-07-01|July 3, 2017|Actual|2017-07-03|July 3, 2017|Actual|2017-07-03||Observational|PRINCIPAL||Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma|PRINCIPAL: A Prospective Observational Study of Real World Treatment Patterns and Treatment Outcomes in Patients With Advanced or Metastatic Renal Cell Carcinoma Receiving Pazopanib|Completed||N/A|662|Actual|Novartis|||1||f||||f||||||None Retained|"     Not applicable. This is a Non-interventional study collecting prospective observational data.   "|||2017-10-11 02:42:09.784285|2017-10-11 02:42:09.784285
NCT01649765|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-07-25|||September 7, 2012|Actual|2012-09-07|July 2017|2017-07-01|January 31, 2028|Anticipated|2028-01-31|January 15, 2018|Anticipated|2018-01-15||Interventional|PLUTO||Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy|A Multi-center, Randomized, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Patients With Systemic Lupus Erythematosus|Active, not recruiting||Phase 2|70|Anticipated|GlaxoSmithKline||2|||t||||t||||||||||2017-10-11 02:42:10.285673|2017-10-11 02:42:10.285673
NCT01649752|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-06-27|||April 2015||2015-04-01|July 2012|2012-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Role of Stem Cells in Improving Implantation Rates in ICSI Patients|Phase I Study of Role of Stem Cells in Improving Implantation Rates in ICSI Patients|Unknown status|Recruiting|Phase 1|60|Anticipated|Kasr El Aini Hospital||3|||f||||t||||||||||2017-10-11 02:42:10.527827|2017-10-11 02:42:10.527827
NCT01649739|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-22|2012-07-24|||September 2012||2012-09-01|July 2012|2012-07-01|January 2014|Anticipated|2014-01-01|May 2013|Anticipated|2013-05-01||Interventional|||Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost||Unknown status|Not yet recruiting|Phase 4|20|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-11 02:42:10.627729|2017-10-11 02:42:10.627729
NCT01649726|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-10-10|||July 2013||2013-07-01|October 2016|2016-10-01||||December 2014|Actual|2014-12-01||Interventional|||Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain Death in Potential Organ Donors (CPAPNEE STUDY)||Completed||N/A|208|Actual|Poitiers University Hospital||2|||f||||||||||||||2017-10-11 02:42:10.75788|2017-10-11 02:42:10.75788
NCT01649713|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-10-11|||August 2012||2012-08-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season|Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection (Trivalent, Seasonal Influenza Vaccine, Active Ingredient Content: 15 ugHA/Strain/0.5mL) in Adult and Elderly Subjects|Completed||Phase 4|120|Actual|Fluart Innovative Vaccine Ltd, Hungary||1|||f||||f||||||||||2017-10-11 02:42:10.888892|2017-10-11 02:42:10.888892
NCT01649700|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2014-09-11|||October 2011||2011-10-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells|Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells|Completed||Phase 1/Phase 2|1|Actual|National Yang Ming University||1|||f||||f||||||||||2017-10-11 02:42:10.992939|2017-10-11 02:42:10.992939
NCT00005297|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||April 1990||1990-04-01|March 2005|2005-03-01|June 1997|Actual|1997-06-01|||||Observational|||Age-related Prevalence of Sleep Respiratory Disturbances||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.449942|2017-10-11 04:27:57.449942
NCT01649674|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-03-28|||November 2011||2011-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|PRECOL2011-1||Comparison of Bowel Cleansing Regimens Prior to Colonoscopy|PRECOL2011-1: Sodium Picophosphate and Magnesium Citrate Versus Polyethylene Glycol as Evacuating Treatment Prior to Colonoscopy: Phase IV Randomized Trial.|Active, not recruiting||Phase 4|525|Anticipated|National Cancer Institute, Naples||2|||f||||f||||||||||2017-10-11 02:42:11.181602|2017-10-11 02:42:11.181602
NCT01649661|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-08-03|||July 2012||2012-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk|Epidemiology of MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk|Active, not recruiting||N/A|420|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples Without DNA|"     Blood sample collected at time of MRI for serum hormone analysis Postmenopausal women only   "|||2017-10-11 02:42:11.289312|2017-10-11 02:42:11.289312
NCT01649648|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-01-25|||September 2011|Actual|2011-09-01|April 2012|2012-04-01|November 2015|Actual|2015-11-01|November 2013|Actual|2013-11-01||Interventional|||Autologous Cord Blood Cells for Brain Injury in Term Newborns|Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy: Phase I Study of Feasibility and Safety|Completed||Phase 1|2|Actual|National University Hospital, Singapore||1|||f||||f||||||||No||2017-10-11 02:42:11.415062|2017-10-11 02:42:11.415062
NCT01649635|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-07-04|||July 2012||2012-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|January 2014|Actual|2014-01-01||Interventional|PROSPECTA||Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer|A Phase IV, Multicenter, National, Non-comparative, Open-label Study of Cabazitaxel, Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Second-line Treatment of Patients With Metastatic Castration-resistant Prostate Cancer and After Failure of Docetaxel-based Chemotherapy. Descriptive Assessment of the Circulating Tumor Cells in This Context.|Completed||Phase 4|45|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:42:11.537415|2017-10-11 02:42:11.537415
NCT01649622|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2012-11-07|||December 2012||2012-12-01|November 2012|2012-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)|Phase II Trial of Bendamustine in Adult Patients With Acute Lymphoblastic Leukemia/Lymphoma|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:42:11.671821|2017-10-11 02:42:11.671821
NCT01649609|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-07-18|||March 2012||2012-03-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Using mTOR Inhibitors in the Prevention of BK Nephropathy|Using mTOR Inhibitors in the Prevention of BK Nephropathy|Completed||N/A|41|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 02:42:11.823351|2017-10-11 02:42:11.823351
NCT01649583|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-03-30|||August 2012||2012-08-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Feasibility Study of Dynasplint to Prevent Trismus in Head and Neck Cancer|A Feasibility Study to Evaluate Use of the Jaw Dynasplint System to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy|Completed||N/A|40|Actual|Vanderbilt University Medical Center||2|||f||||f|f|f||||||||2017-10-11 02:42:12.072017|2017-10-11 02:42:12.072017
NCT01649570|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2012-07-24|||March 2002||2002-03-01|July 2012|2012-07-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Efficacy of Insulin Aspart in Type 2 Diabetes|An Open-labelled, Single-arm, Multi-centre, 6-month Study to Investigate the Safety and Efficacy of NovoRapid as Meal Time Insulin in Type 2 Diabetes Patients Treated on a Basal-bolus Regimen With NPH Human Insulin|Completed||Phase 4|123|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 02:42:12.192092|2017-10-11 02:42:12.192092
NCT01649557|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-09-29|2015-08-04|2012-09-04|August 2009||2009-08-01|September 2015|2015-09-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|STEP 210||Multicenter, Open-label, Safety and Tolerability Study|A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia|Completed||Phase 2|244|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t||||||||||2017-10-11 02:42:12.662105|2017-10-11 02:42:12.662105
NCT01649544|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-11-30|||March 2012||2012-03-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|EPICAF||Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology or Drug Therapy for Patients With AF Requiring Mitral Valve Surgery|Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology (EPICOR) or Drug Therapy (Cordarone) for Patients With AF Requiring Mitral Valve Surgery|Terminated||N/A|6|Actual|Centre Hospitalier Universitaire de Saint Etienne||2||End of commercialization of the medical device|f||||f||||||||||2017-10-11 02:42:14.123945|2017-10-11 02:42:14.123945
NCT01649531|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-02-22|||July 2012||2012-07-01|February 2017|2017-02-01||||December 2018|Anticipated|2018-12-01||Interventional|||Two Implants Versus One Implant With a Cantilever - a Randomized Controlled Clinical Trial||Active, not recruiting||N/A|34|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 02:42:14.247938|2017-10-11 02:42:14.247938
NCT01649518|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-06-01|||November 2012||2012-11-01|June 2012|2012-06-01||||July 2015|Actual|2015-07-01||Observational|||A Measurement of Knee Osteoarthritis Usual Care||Completed||N/A|284|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||||||||||||2017-10-11 02:42:14.346293|2017-10-11 02:42:14.346293
NCT01649505|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-03-13|2013-02-11||January 2011||2011-01-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction|Intraoperative Use of Fibrin Glue Sealant Combined With Sharp Dissection Technique as a Preventative Measure for Seromas|Terminated||N/A|2|Actual|OHSU Knight Cancer Institute|Early termination due to low accrual; no participants were analyzed.|2||Low patient enrollment and no clinical findings.|f||||t||||||||||2017-10-11 02:42:14.421235|2017-10-11 02:42:14.421235
NCT01649492|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2012-07-20|||September 2012||2012-09-01|July 2012|2012-07-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||In Vivo Inhibition Profile of CYP2C9 by Pineapple Juice|In Vivo Inhibition Profile of CYP2C9 by Pineapple Juice|Unknown status|Not yet recruiting|Phase 4|10|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 02:42:14.733658|2017-10-11 02:42:14.733658
NCT01649479|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-03-24|||April 2013||2013-04-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|MENT-APL-O||Comparative Prevalence of Psychiatric Manifestations in Purely Obstetrical Antiphospholipid Syndrome|Comparative Prevalence of Psychiatric Manifestations in Purely Obstetrical Antiphospholipid Syndrome|Terminated||N/A|20|Actual|Centre Hospitalier Universitaire de Nīmes||3||"Impossible to include patients at a correct rate; patients don't want to come back so they   refuse participation."|f||||f||||||||||2017-10-11 02:42:14.836944|2017-10-11 02:42:14.836944
NCT01649466|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-11-16|||August 2012||2012-08-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|BENEFIT||Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.|A Randomized Open-label Study to Compare Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Patients With Type 2 Diabetes Mellitus That do Not Reach Adequate Glycemic Control on Their Current Sulfonylurea Monotherapy.|Completed||Phase 4|162|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:42:14.986179|2017-10-11 02:42:14.986179
NCT01649453|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2013-03-04|||May 2012||2012-05-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Observational|||A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test|A Prospective Study of Clinical Outcomes for the Pathwork® Tissue of Origin Test|Terminated||N/A|19|Actual|Cedar Associates LLC|||1|Terminated by sponsor.|f||||f||||||Samples With DNA|"     Tissue biopsy specimen.   "|||2017-10-11 02:42:15.266365|2017-10-11 02:42:15.266365
NCT01649440|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2014-01-13|||July 2010||2010-07-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Sepsis Metabolomics|Systemic Metabolic Changes of Sepsis Patients Revealed by an LC-MS/MS Based Metabolomic Approach|Completed||N/A|65|Actual|Chinese PLA General Hospital|||5||f||||t||||||||||2017-10-11 02:42:15.351128|2017-10-11 02:42:15.351128
NCT01649401|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-01-31|||December 2012||2012-12-01|January 2017|2017-01-01|November 4, 2016|Actual|2016-11-04|November 4, 2016|Actual|2016-11-04||Interventional|LC SPRINT Sp||Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age|Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age|Completed||N/A|110|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 02:42:15.600461|2017-10-11 02:42:15.600461
NCT01649388|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-08-25|||May 2012||2012-05-01|August 2017|2017-08-01|December 2030|Anticipated|2030-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Delayed Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion|Delayed Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|University of Louisville||1|||f||||t|t|f||||||||2017-10-11 02:42:15.718352|2017-10-11 02:42:15.718352
NCT01649375|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-04-20|||October 18, 2012|Actual|2012-10-18|April 2017|2017-04-01|October 2, 2018|Anticipated|2018-10-02|October 2, 2018|Anticipated|2018-10-02||Interventional|MEASURE2||16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis|A Randomized, Double-blind, Placebo-controlled Phase III Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate Efficacy at 16 Weeks and to Assess Long-term Efficacy, Safety and Tolerability up to 5 Years in Patients With Active Ankylosing Spondylitis|Active, not recruiting||Phase 3|219|Actual|Novartis||3|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 02:42:15.796348|2017-10-11 02:42:15.796348
NCT01649362|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-02-09|2013-10-29||June 2011||2011-06-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Prefeeding Oral Stimulation on Feeding Performance in Preterm Infants|Effects of Prefeeding Oral Stimulation on Feeding Performance in Preterm Infants Born Between 26 and 33+6 Weeks' Gestational Age: a Case-control Study|Completed||N/A|101|Actual|Centre Hospitalier du Luxembourg||2|||f||||f||||||||||2017-10-11 02:42:15.981063|2017-10-11 02:42:15.981063
NCT01649349|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-07-22|||May 2012||2012-05-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Feasibility Study of Dual-Section Nasogastric Tube|The Feasibility Study of Dual-Section Nasogastric Tube in Dysphagia Patients|Completed||Early Phase 1|10|Actual|Changhua Christian Hospital||1|||f||||||||||||||2017-10-11 02:42:16.531946|2017-10-11 02:42:16.531946
NCT01649336|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-22|2016-04-21|||July 2012||2012-07-01|April 2016|2016-04-01||||March 2016|Actual|2016-03-01||Interventional|||A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer||Completed||Phase 1|36|Anticipated|Array BioPharma||1|||f||||f||||||||||2017-10-11 02:42:16.596789|2017-10-11 02:42:16.596789
NCT01649310|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-12-01|||February 2012||2012-02-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients|Effects of Whole Body Vibration Training in Chronic Obstructive Pulmonary Disease (COPD) Patients: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|21|Anticipated|Universidade Federal de Pernambuco||1|||f||||t||||||||||2017-10-11 02:42:16.696684|2017-10-11 02:42:16.696684
NCT01649128|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-24|||August 2009||2009-08-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations|Screening Models for Early Detection of Late-onset Preeclampsia With Various Markers in Low-risk Pregnancy Populations|Completed||N/A|262|Actual|CHA University|||1||f||||t||||||||||2017-10-11 02:42:20.409529|2017-10-11 02:42:20.409529
NCT01648517|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-01|2014-03-04|||July 2012||2012-07-01|March 2014|2014-03-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy||Unknown status|Recruiting|Phase 2|162|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:42:33.115057|2017-10-11 02:42:33.115057
NCT01649297|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2015-06-26|2015-06-26|2014-03-27|October 2012||2012-10-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Full Analysis Set: FAS being defined as all patients randomised, treated with at least one dose of study drug, had a baseline Glycosylated Haemoglobin (HbA1c) and at least one on-treatment HbA1c assessment.|A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy|A Randomised, Double Blind, Placebo Controlled, Parallel Group Efficacy and Safety Study of Oral Administration of Empagliflozin Twice Daily Versus Once Daily in Two Different Daily Doses Over 16 Weeks as add-on Therapy to a Twice Daily Dosing Regimen of Metformin in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control|Completed||Phase 2|983|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 02:42:16.826687|2017-10-11 02:42:16.826687
NCT01649284|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2016-11-29|||July 2012||2012-07-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Expanded Access|||Afatinib Expanded Access Program|LUX-Lung EAP US; An Open Label Expanded Access Program of Afatinib (BIBW 2992) for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)|Approved for marketing||N/A|||Boehringer Ingelheim|||||||||||||||||||2017-10-11 02:42:18.119067|2017-10-11 02:42:18.119067
NCT01649258|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-09-12|||September 4, 2012|Actual|2012-09-04|September 2017|2017-09-01|September 4, 2018|Anticipated|2018-09-04|May 22, 2017|Actual|2017-05-22||Interventional|||Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy|A Pilot Study to Evaluate the Efficacy of Fosaprepitant and Granisetron Transdermal System for the Prevention of Acute and Delayed Nausea and Vomiting in Breast Cancer Patients and to Identify Predictors of Response|Terminated||N/A|29|Actual|University of Southern California||1||Lack of Efficacy|f||||t||||||||||2017-10-11 02:42:18.519134|2017-10-11 02:42:18.519134
NCT01649245|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-01-12|||August 2012||2012-08-01|January 2013|2013-01-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|HAPIC||Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C|Efficacy and Safety of a Hansenula-derived Pegylated Interferon α2a (Reiferon Retard®) in Treatment of Patients With Chronic Hepatitis C Virus Infection: A National Multi-center Phase IV Open Label Non-Randomized Trial|Unknown status|Recruiting|Phase 4|5000|Anticipated|MinaPharm Pharmaceuticals||1|||f||||t||||||||||2017-10-11 02:42:18.661711|2017-10-11 02:42:18.661711
NCT01649232|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-04-19|2012-12-15||June 2012||2012-06-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|tdcs&adhd||ADHD Electrophysiological Subtypes and Implications in Transcranial Direct-current Stimulation|Implications of Electrophysiological ADHD Endophenotypes to Predict Response to Transcranial Direct-Current Stimulation|Completed||Phase 3|60|Actual|Spanish Foundation for Neurometrics Development||2|||f||||t||||||||||2017-10-11 02:42:18.81317|2017-10-11 02:42:18.81317
NCT01649219|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2012-07-24|||January 2010||2010-01-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2010|Actual|2010-06-01||Interventional|PreDiabEx||Intensity of Exercise and Glucose Metabolism||Unknown status|Active, not recruiting|Phase 4|80|Actual|University of Oulu||2|||f||||f||||||||||2017-10-11 02:42:19.386371|2017-10-11 02:42:19.386371
NCT01649206|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-25|||January 2010||2010-01-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Percutaneous Radiofrequency Thermal Ablation in Compressive Thyroid Nodules|Thyroid Nodules Treated With Percutaneous Radiofrequency Thermal Ablation: a Comparative Study|Completed||Phase 3|40|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 02:42:19.483282|2017-10-11 02:42:19.483282
NCT01649193|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-11-04|||March 2012||2012-03-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Observational|||What is an Important Change in the Short Physical Performance Battery (SPPB)?|Determining the Minimal Important Difference of the Short Physical Performance Battery and 4m Gait Speed in Chronic Respiratory Disease Patients.|Completed||N/A|400|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Blood taken and stored as whole blood, serum, and plasma.   "|||2017-10-11 02:42:19.595814|2017-10-11 02:42:19.595814
NCT01649180|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2017-04-20|2016-12-06||July 2012||2012-07-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|PrE0801||NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma|NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition (TKI) at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma (RCC)|Terminated||Phase 2|3|Actual|PrECOG, LLC.||1||Closed due to prolonged enrollment timelines|f||||t||||||||No|Data is proprietary.|2017-10-11 02:42:19.723401|2017-10-11 02:42:19.723401
NCT01649167|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-24|||February 2009||2009-02-01|July 2012|2012-07-01|November 2010|Actual|2010-11-01|||||Observational|||Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia|Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia|Completed||N/A|55|Actual|Materno-Perinatal Hospital of the State of Mexico|||3||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 02:42:20.074572|2017-10-11 02:42:20.074572
NCT01649154|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2012-07-20|||April 2011||2011-04-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Clinical Trial on Harmonic Focus Shears Versus Ligasure Small Jaw and Clamp-and-tie Technique for Total Thyroidectomy||Completed||N/A|120|Actual|Ospedale Regina Apostolorum||3|||f||||f||||||||||2017-10-11 02:42:20.175207|2017-10-11 02:42:20.175207
NCT01649141|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-20|||August 2006||2006-08-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Trauma-Focused Cognitive Behavior Therapy for Youth: Effectiveness in a Community Setting|National Child Traumatic Stress Initiative: Community Treatment and Service Centers|Unknown status|Active, not recruiting|N/A|110|Actual|Delaware Division of Prevention and Behavioral Health Services||1|||f||||f||||||||||2017-10-11 02:42:20.271126|2017-10-11 02:42:20.271126
NCT01648907|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-05-23|||October 15, 2007|Actual|2007-10-15|May 2017|2017-05-01|April 20, 2020|Anticipated|2020-04-20|June 20, 2016|Actual|2016-06-20||Observational|DESIR||French Cohort of Undifferentiated Spondyloarthritis|French Cohort on Outcome of Recent Undifferentiated Spondyloarthritis|Active, not recruiting||N/A|708|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-11 02:42:23.585758|2017-10-11 02:42:23.585758
NCT01649115|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-08-08|||August 2012||2012-08-01|August 2012|2012-08-01|August 2017|Anticipated|2017-08-01|August 2013|Anticipated|2013-08-01||Interventional|HLPP||The Healthy Lifestyles Passport Program: a Nutrition Education Program to Prevent Childhood Obesity|The Healthy Lifestyles Passport Program: a Randomized Control Trial of a Prenatal Maternal Education Program to Prevent Infant and Childhood Obesity (HLPP)|Unknown status|Not yet recruiting|N/A|150|Anticipated|Bronx-Lebanon Hospital Center Health Care System||2|||f||||f||||||||||2017-10-11 02:42:20.505853|2017-10-11 02:42:20.505853
NCT01649102|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-01-13|||March 2010||2010-03-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Impact of Catheter Design on Catheter Survival in Chronic Hemodialysis Patients|Impact of Catheter Design on Catheter Survival in Chronic Hemodialysis Patients|Completed||Phase 4|302|Actual|AZ Sint-Jan AV||2|||f||||t||||||||||2017-10-11 02:42:20.600306|2017-10-11 02:42:20.600306
NCT01649089|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2017-08-22|||October 1, 2012|Actual|2012-10-01|August 2017|2017-08-01||||February 1, 2021|Anticipated|2021-02-01||Interventional|||Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer|Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (? 2CM) Cervical Cancer|Recruiting||N/A|600|Anticipated|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 02:42:20.691786|2017-10-11 02:42:20.691786
NCT01649063|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2012-07-24|||April 2010||2010-04-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Observational|||Comparing the Shape and Frequency of Uterine Contractions|Principle Investigator|Completed||N/A|95|Actual|Mashhad University of Medical Sciences|||2||f||||t||||||||||2017-10-11 02:42:21.655008|2017-10-11 02:42:21.655008
NCT01649050|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-04-19|||October 2016||2016-10-01|August 2014|2014-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis|A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Assess the Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis|Withdrawn||Phase 2|0|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:42:21.729239|2017-10-11 02:42:21.729239
NCT01649037|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-21|2016-08-30|||August 2012||2012-08-01|December 2013|2013-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome|A Randomised, Open Label Study to Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome|Withdrawn||N/A|0|Actual|Institute of Liver and Biliary Sciences, India||2||lack of funds|f||||f||||||||||2017-10-11 02:42:21.871237|2017-10-11 02:42:21.871237
NCT01649024|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-20|||May 2009||2009-05-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2012|Actual|2012-06-01||Interventional|||A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma|A Second-line, Single Arm, Phase II Clinical Study With Tremelimumab, a Fully Human Anti-CTLA-4 Monoclonal Antibody as Monotherapy in Patients With Unresectable Malignant Mesothelioma|Unknown status|Active, not recruiting|Phase 2|29|Actual|Azienda Ospedaliera Universitaria Senese||1|||f||||t||||||||||2017-10-11 02:42:22.02235|2017-10-11 02:42:22.02235
NCT01649011|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-25|||July 2012||2012-07-01|July 2012|2012-07-01||||March 2013|Anticipated|2013-03-01||Observational|||Validation of a Translation Into Spanish of the Oswestry Disability Index|Validation of a Translation Into Spanish of the Oswestry Disability Index|Unknown status|Recruiting|N/A|150|Anticipated|American British Cowdray Medical Center|||1||f||||f||||||||||2017-10-11 02:42:22.164059|2017-10-11 02:42:22.164059
NCT01648998|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-02-23|||May 2012||2012-05-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Fludrocortisone and Information Processing in Healthy Volunteers|The Effects of Fludrocortisone on Information Processing in Healthy Female Volunteers|Completed||Phase 1|40|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-11 02:42:22.325418|2017-10-11 02:42:22.325418
NCT01648985|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-08-22|||May 2010||2010-05-01|August 2012|2012-08-01|June 2018|Anticipated|2018-06-01|June 2013|Anticipated|2013-06-01||Observational|||Diabetes in Minor Stroke and TIA, Glucose Tolerance and Haemostasis, a Long-term-follow-up Study and Intervention With Yoga|Diabetes in Minor Stroke and TIA, Glucose Tolerance and Haemostasis, a Long-term-follow-up Study and Intervention With Yoga|Recruiting||N/A|300|Anticipated|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 02:42:22.467322|2017-10-11 02:42:22.467322
NCT01648972|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-24|2014-07-02|||September 2012||2012-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|GAP||Gastrografin in Postoperative Ileus|Randomised Double-blind Placebo-controlled Trial of Gastrografin in the Therapeutic Management of Prolonged Postoperative Ileus Following Elective Surgery.|Completed||Phase 2/Phase 3|||University of Auckland, New Zealand||2|||f||||f||||||||||2017-10-11 02:42:22.58888|2017-10-11 02:42:22.58888
NCT01648959|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-02-09|||July 2012||2012-07-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Intra Cranial EEG Activity During Dexmedetomidine Sedation|Intra Cranial EEG Activity During Dexmedetomidine Sedation.Comparing the Effects of Dexmedetomidine on the Cortical and the Sub Cortical(Hippocampus) Structures.|Terminated||N/A|20|Actual|University Health Network, Toronto|||1|Lack of funding|f||||f||||||||||2017-10-11 02:42:22.681786|2017-10-11 02:42:22.681786
NCT01648946|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-11-05|||June 2012||2012-06-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|TRICCOP||Transfusion Requirements in Critically Ill Oncologic Patient|Transfusion Requirements in Critical Clinical Oncologic Patients: a Phase 3 Randomized Controlled Clinical Trial (TRICCOP STUDY)|Unknown status|Recruiting|Phase 3|300|Anticipated|Instituto do Cancer do Estado de São Paulo||2|||f||||t||||||||||2017-10-11 02:42:22.789779|2017-10-11 02:42:22.789779
NCT01648933|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-06-13|||July 2012||2012-07-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2015|Actual|2015-09-01||Interventional|PARCS||Perfusion Analysis Using Rubidium in Cardiac Sarcoidosis|Perfusion Analysis Using Rubidium in Cardiac Sarcoidosis|Active, not recruiting||N/A|53|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||Undecided||2017-10-11 02:42:22.974936|2017-10-11 02:42:22.974936
NCT01648920|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-04-08|2013-11-27||June 2012||2012-06-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational||50 subjects appeared to be a representative sample to generate summary statistics to characterize the data collected.|A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma||Completed||N/A|50|Actual|Aerocrine AB|||1||f||||f||||||||||2017-10-11 02:42:23.084011|2017-10-11 02:42:23.084011
NCT01648894|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-11-25|||October 2012||2012-10-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2015|Actual|2015-04-01||Interventional|GRECCAR6||Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer|Randomized Control Trial Comparing the Impact of a Lengthening of the Interval Between the Radiochemotherapy and Surgery (7 Weeks vs. 11 Weeks) on Complete Pathological Response in Rectal Cancer|Active, not recruiting||Phase 3|265|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:42:23.678109|2017-10-11 02:42:23.678109
NCT01648881|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-06-13|||May 2011||2011-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Observational|DADI||Imaging of Dissection of the Descending Aorta|Dissection of Aorta: Descending Part, Imaging|Active, not recruiting||N/A|89|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||Undecided||2017-10-11 02:42:23.764432|2017-10-11 02:42:23.764432
NCT01648868|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-06-23|||April 2011||2011-04-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|TMSAUTISME||Transcranial Magnetic Stimulation (rTMS) and Autism.|Transcranial Magnetic Stimulation (rTMS) and Autism.Implication of the Superior Temporal Sulcus in Normal and Abnormal Social Perception|Recruiting||N/A|150|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||No||2017-10-11 02:42:23.827565|2017-10-11 02:42:23.827565
NCT01648855|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-06-23|||June 2012||2012-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Observational|ANGIODYS||Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn|Consequences of Circulating Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn|Completed||N/A|33|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||No||2017-10-11 02:42:23.92012|2017-10-11 02:42:23.92012
NCT01648842|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-06-23|||April 2012||2012-04-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|December 2015|Actual|2015-12-01||Observational|FEPED||Vitamin D and Preeclampsia|Vitamin D Status in Pregnant Women With Preeclampsia|Active, not recruiting||N/A|3174|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 02:42:24.17198|2017-10-11 02:42:24.17198
NCT01648829|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|PORTO||PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity|Pharmacodynamic Comparison of Pitavastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease Treated With Dual Antiplatelet Therapy - The PORTO Trial|Not yet recruiting||Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 02:42:24.257577|2017-10-11 02:42:24.257577
NCT01648816|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2017-06-13|||November 2, 2011|Actual|2011-11-02|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 4, 2016|Actual|2016-09-04||Observational|IGEDEPP||Interaction Between Genetic Factors and Maternal Stressors During Pregnancy in the Risk of Postpartum Depression|Interaction Between Genetic Factors and Maternal Stressors During Pregnancy in the Risk of Postpartum Depression|Active, not recruiting||N/A|3000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||Samples With DNA|"     Blood sample   "|Undecided||2017-10-11 02:42:24.372365|2017-10-11 02:42:24.372365
NCT01648803|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-11-09|||January 2012||2012-01-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|APDMclinic||Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease|Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease|Completed||N/A|12|Actual|University of Rochester|||1||f||||f||||||||||2017-10-11 02:42:24.460496|2017-10-11 02:42:24.460496
NCT01648790|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-08-30|2013-08-30||July 2012||2012-07-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study of Prasugrel in Healthy Participants|Relative Bioavailability of Prasugrel Orally Disintegrating Tablet Formulations and the Effect of Food on the Bioavailability of the Orally Disintegrating Tablet in Healthy Subjects|Completed||Phase 1|20|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 02:42:24.540469|2017-10-11 02:42:24.540469
NCT01648777|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-04-23|||March 2012||2012-03-01|November 2013|2013-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|STERNOCAT||Catheter Outcomes With Sternotomy Cardiac Operated|Cicatricial Analgesia Catheters Outcome on Bronchopulmonary Infection Number With Sternotomy Cardiac Operated|Completed||Phase 3|1502|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:42:24.983351|2017-10-11 02:42:24.983351
NCT01648764|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2012-11-28|||September 2008||2008-09-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread|Phase 1 Dose Escalation Study of LY2334737 Using 2 Dosing Regimens in Patients With Advanced and/or Metastatic Solid Tumors|Completed||Phase 1|90|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:42:25.102755|2017-10-11 02:42:25.102755
NCT01648751|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-10-05|||May 2012||2012-05-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse|Impact of Vaginal Estrogen in the Treatment of Symptomatic Mild Pelvic Organ Prolapse With Pelvic Floor Physical Therapy|Recruiting||N/A|53|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:42:25.199159|2017-10-11 02:42:25.199159
NCT01648738|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-06-27|||July 2012||2012-07-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|ITILO||Effectiveness of a Short, Intensive and Standardised Spa Therapy for Low Back Pain on Sick Leave Duration|Effectiveness of a Short, Intensive and Standardised Spa Therapy for Subacute and Chronic Low Back Pain on Return to Work for Patients in Sick Leave From 4 to 24 Weeks Duration : a Randomized Controlled Trial Using a Modified Zelen Method|Completed||N/A|88|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:42:25.301406|2017-10-11 02:42:25.301406
NCT01648725|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-10-28|||July 2012||2012-07-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|LoopHypnosis||Hypnosis and Closed-Loop Anesthesia System|Influence of Hypnosis on the Propofol Requirement to Induce General Anesthesia|Completed||Phase 4|97|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 02:42:25.431692|2017-10-11 02:42:25.431692
NCT01648712|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2012-08-02|||September 2012||2012-09-01|August 2012|2012-08-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery|Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery|Unknown status|Not yet recruiting|Phase 4|74|Anticipated|Hôpital Necker-Enfants Malades||2|||f||||t||||||||||2017-10-11 02:42:25.522336|2017-10-11 02:42:25.522336
NCT01648699|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2013-10-01|2013-03-15||April 2010||2010-04-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain|Study on the Effectiveness and Safety of OROS Hydromorphone in Pain Management Among Patients With Cancer Pain|Terminated||Phase 4|20|Actual|Janssen Pharmaceutica|The study was prematurely terminated due to administrative reason.|1||the study was stopped due to non-availability of 4mg|f||||f||||||||||2017-10-11 02:42:25.62521|2017-10-11 02:42:25.62521
NCT01648686|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-07-05|||September 2012||2012-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|BOCOMEDEN||Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly|Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os (70 mg Weekly)|Active, not recruiting||N/A|66|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:42:27.918714|2017-10-11 02:42:27.918714
NCT01648673|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-07-15|||August 2012||2012-08-01|July 2015|2015-07-01|April 2017|Anticipated|2017-04-01|February 2015|Actual|2015-02-01||Observational|||Pilot Evaluation of the JHI Platform|Pilot Evaluation of the Janssen Healthcare Innovation Integrated Cardiovascular Rehabilitation Management Platform (JHI PLATFORM).|Unknown status|Active, not recruiting|N/A|500|Actual|Henry Ford Health System|||1||f||||f||||||||||2017-10-11 02:42:28.057171|2017-10-11 02:42:28.057171
NCT01648660|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2013-01-09|||May 2009||2009-05-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2)|Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients for Two More Years (LUTEGA 2)|Completed||N/A|80|Actual|University of Jena||3|||f||||f||||||||||2017-10-11 02:42:28.120147|2017-10-11 02:42:28.120147
NCT01648647|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2012-07-20|||May 2012||2012-05-01|July 2012|2012-07-01||||||||Observational|CARE||Copeptin in Aortic Valve Replacement|GE DHM-AN-OR-2012/01|Completed||N/A|50|Actual|Deutsches Herzzentrum Muenchen|||1||f||||f||||||||||2017-10-11 02:42:28.179412|2017-10-11 02:42:28.179412
NCT01648634|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-12-14|||March 2012||2012-03-01|December 2016|2016-12-01|February 2022|Anticipated|2022-02-01|August 2021|Anticipated|2021-08-01||Interventional|NEBIDYS||Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy|A Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Examine the Effect of Nebivolol, a Beta-Blockade Drug, for the Prevention of Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy|Active, not recruiting||Phase 3|51|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:42:28.24028|2017-10-11 02:42:28.24028
NCT01648621|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-11-10|||August 2012||2012-08-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PICCOPD+||Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple Comorbidities|Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple Comorbidities: A Randomized Controlled Trial|Completed||N/A|470|Actual|Toronto East General Hospital||2|||f||||t||||||||||2017-10-11 02:42:28.357401|2017-10-11 02:42:28.357401
NCT01648608|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-08-02|||January 2012||2012-01-01|August 2012|2012-08-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer|Study to Assessment the Efficacy and Safety of Joint TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Operable Breast Cancer|Unknown status|Recruiting|Phase 2/Phase 3|600|Anticipated|Tianjin Medical University||1|||f||||t||||||||||2017-10-11 02:42:28.470383|2017-10-11 02:42:28.470383
NCT01648595|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-23|||January 2006||2006-01-01|January 2006|2006-01-01|September 2006||2006-09-01|August 2006||2006-08-01||Interventional|||Effect of Fentanyl on Pain Severity and Duration of Labor|Principal Investigator|Terminated||Phase 2/Phase 3|70||Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:42:28.557367|2017-10-11 02:42:28.557367
NCT01648582|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-05-30|2015-05-08|2014-09-29|July 2012||2012-07-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional||Baseline characteristics are reported for the modified intent-to-treat (mITT) population, who are all randomized participants with a baseline glycosylated hemoglobin (HbA1c) measurement, at least 1 post-baseline HbA1c measurement, and received at least 1 dose of study drug.|A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus|The Efficacy and Safety of Once-Weekly, Subcutaneous Dulaglutide Compared to Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea|Completed||Phase 3|774|Actual|Eli Lilly and Company||3|||f||||t||||||||Yes|Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement.|2017-10-11 02:42:28.749452|2017-10-11 02:42:28.749452
NCT01648569|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-23|||January 2012||2012-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Observational|||Long-term Outcomes of Total Thyroidectomy Versus Less Than Total Thyroidectomy for Papillary Thyroid Microcarcinoma|Proper Extent of Surgery for Papillary Microcarcinoma|Completed||N/A|2014|Actual|Korean Association of Endocrine Surgeons|||1||f||||t||||||||||2017-10-11 02:42:32.602553|2017-10-11 02:42:32.602553
NCT01648556|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-08-01|||September 2012||2012-09-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|PREDI-PTI||Research of Predictive Factors to Immune Thrombopenic Purpura|Research of Predictive Factors to Immune Thrombopenic Purpura in Front of a Thrombopenia in Appearance Isolated in the Elderly|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire, Amiens||1|||f||||t||||||||||2017-10-11 02:42:32.673472|2017-10-11 02:42:32.673472
NCT01648543|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-23|||June 2012||2012-06-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Comparison of Methods of Lumbar Sympathetic Ganglion Block: Distance vs Angle||Unknown status|Recruiting|N/A|194|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:42:32.766496|2017-10-11 02:42:32.766496
NCT01648530|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2015-01-21|2015-01-21||July 2012||2012-07-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Chronic Migraine Epidemiology and Outcomes Study||Completed||N/A|16789|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:42:32.853361|2017-10-11 02:42:32.853361
NCT01648504|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2014-03-26|||June 2012||2012-06-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Johns Hopkins Interactive eGuide to Colonoscopy and Ipad Office Education to Improve Colonoscopy|Integration of an Electronic Education System Into Colonoscopy: Improving Education, Consent and Compliance of Patients at Colonoscopy With an Ipad-based Secure Video Intervention|Completed||N/A|40|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 02:42:33.20944|2017-10-11 02:42:33.20944
NCT01648491|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-11-13|2016-05-12||October 2011||2011-10-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|July 2012|Actual|2012-07-01||Interventional|||Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use|Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use|Completed||N/A|1|Actual|William Beaumont Hospitals|This is a single patient compassionate use treatment.|1|||f||||f||||||||No|Data will not be shared|2017-10-11 02:42:33.300184|2017-10-11 02:42:33.300184
NCT01648478|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-09-10|||June 2012||2012-06-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|IRAP||IRAPs (Secreted Insulin Regulated AminoPeptidase): a New Insulin Sensitivity Biomarker|Evaluation of Plasma IRAP Secreted Protein as a New Insulin Sensitivity Biomarker, Using Hyperinsulinemic Euglycemic Clamp|Completed||N/A|21|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 02:42:33.528751|2017-10-11 02:42:33.528751
NCT01648465|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2017-05-09|||July 2012||2012-07-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|January 2017|Actual|2017-01-01||Interventional|||Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors|Phase II Multicenter Single-arm Study Evaluating the Safety and Efficacy of Everolimus as a First-line Treatment in Newly-diagnosed Patients With Advanced GI Neuroendocrine Tumors.|Active, not recruiting||Phase 2|25|Actual|Hellenic Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 02:42:33.618478|2017-10-11 02:42:33.618478
NCT01648452|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-20|2016-09-30|2014-01-09||July 2012||2012-07-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|March 2013|Actual|2013-03-01||Interventional|CNTF-CNGB3-1||CNTF Implants for CNGB3 Achromatopsia|A Phase I/II Study of the NT-501 Intraocular Implant Releasing Ciliary Neurotrophic Factor (CNTF) in Participants With CNGB3 Achromatopsia|Completed||Phase 1/Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||No||2017-10-11 02:42:33.763282|2017-10-11 02:42:33.763282
NCT01648335|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-03-21||||||March 2013|2013-03-01|July 2013||2013-07-01|||||Interventional|||A Prospective Study of the Effect of Treatment of First Time Traumatic Shoulder Anterior Dislocation by Immobilization in External Rotation on the Incidence of Recurrent Dislocation||Unknown status|Not yet recruiting|Phase 2|||Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 02:42:37.029167|2017-10-11 02:42:37.029167
NCT01648309|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-08-15|||September 2012||2012-09-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|TAVIPSYCH||Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation|Neuropsychological Testing in Patients Undergoing TAVI|Withdrawn||N/A|0|Actual|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 02:42:37.235834|2017-10-11 02:42:37.235834
NCT01648296|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-05-25|||August 2012||2012-08-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Fatty Acid Radiotracer Comparison Study in Heart Failure Patients|Measurements of Myocardial Fatty Acid Metabolism With PET and [F-18]FluorbetaOx in Humans With Heart Failure With and Without Diabetes: Comparison With [C-11]Palmitate|Active, not recruiting||Early Phase 1|28|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:42:37.345152|2017-10-11 02:42:37.345152
NCT01648283|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-06-16|||May 2012||2012-05-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||CYP2B6 Polymorphisms in Methadone|Role of CYP2B6 Polymorphisms in Methadone Metabolism and Clearance|Active, not recruiting||N/A|80|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 02:42:37.469492|2017-10-11 02:42:37.469492
NCT01648270|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-05-08|||April 2012||2012-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|BUPCsa||Disposition Effects of Cyclosporin on Buprenorphine|Influence of Cyclosporine on Buprenorphine Disposition and Effect|Completed||N/A|29|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 02:42:37.580997|2017-10-11 02:42:37.580997
NCT01648257|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-08-11|||August 2012||2012-08-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Relative Bioavailability Study of GSK1265744 Formulations|A Single-center, Randomized, Open-label, Crossover Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 in Healthy Adult Subjects|Completed||Phase 1|18|Actual|ViiV Healthcare||3|||f||||f||||||||||2017-10-11 02:42:37.706943|2017-10-11 02:42:37.706943
NCT01648244|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-11-24|||March 2012||2012-03-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CADS||The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes|The Use of a Computer Assisted Diabetes Decision Support (CADS) System to Improve Outcomes in Patients With Type 2 Diabetes Who Are Treated by Primary Care Providers|Completed||N/A|28|Actual|Walter Reed National Military Medical Center||1|||f||||t||||||||||2017-10-11 02:42:37.80613|2017-10-11 02:42:37.80613
NCT01648075|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-01-20|||July 2012||2012-07-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Probiotics||Effect of the Consumption of Probiotics in the Reduction of Incidence of Carious Lesions in Preschool Children|Effect of the Consumption of Probiotics Lactobacilli Enriched Milk in the Reduction of Incidence of Carious Lesions in Preschool Children|Completed||N/A|261|Actual|University of Chile||2|||f||||f||||||||||2017-10-11 02:42:46.967012|2017-10-11 02:42:46.967012
NCT01648231|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-07-24|||August 6, 2012|Actual|2012-08-06|July 2017|2017-07-01|September 25, 2012|Actual|2012-09-25|September 25, 2012|Actual|2012-09-25||Interventional|||Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers|An Open-label, Randomized, Single Dose, Three-way Crossover Study to Determine the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine (5mg) and Losartan (100mg) in Healthy Adult Male and Female Subjects Under Fasting Conditions|Completed||Phase 1|23|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 02:42:37.90165|2017-10-11 02:42:37.90165
NCT01648218|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-12-08|||August 2012||2012-08-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|PTHG||Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia|Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia|Terminated||Phase 4|5|Actual|Vancouver General Hospital||3||Poor enrollment|f||||f||||||||||2017-10-11 02:42:38.028565|2017-10-11 02:42:38.028565
NCT01648205|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-09-28|||September 2012||2012-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Efficacy Study of Sodium Channel Blocker in LQT3 Patients|Ranolazine in LQT3 Patients|Recruiting||Phase 2|60|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 02:42:38.161077|2017-10-11 02:42:38.161077
NCT01648192|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-07-24|||July 24, 2012|Actual|2012-07-24|July 2017|2017-07-01|October 26, 2012|Actual|2012-10-26|October 26, 2012|Actual|2012-10-26||Interventional|||Phase I Study of GW856553 (Losmapimod)|A Phase I, Randomized, Single-Blind, Three-Period Cross-Over, Placebo-Controlled, Single Oral Dose, Dose-Escalation (Part 1), Fixed Sequence, and Repeat Dose (Part 2) Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Losmapimod in Healthy Japanese Subjects.|Completed||Phase 1|20|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 02:42:38.282767|2017-10-11 02:42:38.282767
NCT01648179|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-03-21|||March 2012||2012-03-01|March 2017|2017-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects|A Single Dose, Open Label, Randomized, Balanced, Crossover Study to Assess the Relative Bioavailability of ThreeFormulations and Food Effect on GSK1322322 in Healthy Subjects|Completed||Phase 1|24|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:42:38.404216|2017-10-11 02:42:38.404216
NCT01648166|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-07-11|||January 2012||2012-01-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Observational|||A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens|A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens|Active, not recruiting||N/A|1800|Anticipated|University of Kentucky|||2||f||||t||||||Samples With DNA|"     Blood, live lymphocytes, serum, plasma, radon test kit, urine, water, soil, toenails, and     hair.   "|||2017-10-11 02:42:38.503498|2017-10-11 02:42:38.503498
NCT01648140|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-04-25|2017-04-25|2015-02-16|August 1, 2012||2012-08-01|November 2016|2016-11-01|July 16, 2014|Actual|2014-07-16|July 1, 2014|Actual|2014-07-01||Interventional|HAI115879||Dose Ranging of GSK2336805 in Combination Therapy|A Phase II Multicenter, Parallel-Group, Randomized, Dose-Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following 12 Weeks of Oral Administration of GSK2336805 With Pegylated Interferon and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 or 4 Hepatitis C Infection|Completed||Phase 2|286|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:42:39.12578|2017-10-11 02:42:39.12578
NCT01648127|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-03-12|||July 2012||2012-07-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Pharmacokinetics of Ceftaroline in Normal and Obese Subjects|Pharmacokinetics of Ceftaroline in Normal and Obese Subjects|Completed||Phase 1|32|Actual|University of Illinois at Chicago||1|||f||||f||||||||||2017-10-11 02:42:45.54593|2017-10-11 02:42:45.54593
NCT01648114|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-03-12|||August 2012||2012-08-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|May 2013|Actual|2013-05-01||Interventional|ABFS||A Randomized Controlled Trial of an Antenatal Intervention to Increase Exclusive Breastfeeding|A Randomized Controlled Trial of an Antenatal Intervention to Increase Exclusive Breastfeeding|Completed||N/A|472|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:42:45.624254|2017-10-11 02:42:45.624254
NCT01648101|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-01-31|2014-08-14||August 2012||2012-08-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures|A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study to Determine the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures.|Terminated||Phase 3|76|Actual|GlaxoSmithKline|RTG114855 was designed for registration of retigabine as add-on treatment of drug-resistant POS in South Korea/Taiwan/ Vietnam. GSK decided not to pursue registration in these countries and terminated the study early based on new safety information.|3||Registration of the medicine is no longer being pursued in South Korea, Taiwan or Vietnam|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:42:45.876657|2017-10-11 02:42:45.876657
NCT01648088|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-03-18|||September 2012||2012-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|Staph||Detection of Staph Colonization in Pre-op Arthroplasty Patients|Enhanced Detection of Staphylococcus Aureus Colonization in Patients Undergoing Prosthetic Joint Implantation.|Completed||N/A|234|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 02:42:46.886333|2017-10-11 02:42:46.886333
NCT01648062|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-19|||October 2008||2008-10-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Sleep Self-Regulation Using Mental Imagery|Using Mental Imagery to Deliver Self-Regulation Techniques That Target Sleep Initiation Behaviors and Pre-Sleep Arousal|Completed||N/A|104|Actual|University of Auckland, New Zealand||4|||f||||f||||||||||2017-10-11 02:42:47.068721|2017-10-11 02:42:47.068721
NCT01648049|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-11-30|||June 2012||2012-06-01|November 2015|2015-11-01||||March 2015|Actual|2015-03-01||Interventional|TIDE||Treatment of Insomnia and Depression in Elders (TIDE)|Treatment of Insomnia and Depression in Elders (TIDE)|Active, not recruiting||N/A|46|Anticipated|University of Alabama, Tuscaloosa||2|||f||||t||||||||||2017-10-11 02:42:47.197296|2017-10-11 02:42:47.197296
NCT01648036|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-14|2014-07-09|||July 2012||2012-07-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot|Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot|Completed||Phase 2|76|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-11 02:42:47.310002|2017-10-11 02:42:47.310002
NCT01648023|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-04-18|||July 2012||2012-07-01|August 2016|2016-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|DELTIC||Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin|Comparative, Prospective, Open-labeled, Randomized Phase II Study of Cisplatin or Carboplatin With Gemcitabine in Combination With Irinotecan-loaded Beads (LC or ONCOZENE) Versus Cisplatin or Carboplatin With Gemcitabine Alone in the Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma|Recruiting||Phase 2|48|Anticipated|University of Louisville||2|||f||||t||||||||||2017-10-11 02:42:47.444136|2017-10-11 02:42:47.444136
NCT01648010|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2013-05-06|||November 2011||2011-11-01|December 2012|2012-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer|An Open Label Study Evaluating Short Term Safety and Tolerability of Patients With MUSCLE INVASIVE BLADDER CANCER- for Intravesical Instillation Mitomycin c Mixed With Disposable Device Which Prevents Drug Drainage Out of the Patient's Bladder|Completed||N/A|7|Actual|UroGen Pharma Ltd.||2|||f||||f||||||||||2017-10-11 02:42:47.555039|2017-10-11 02:42:47.555039
NCT01647997|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-19|||April 2002||2002-04-01|July 2012|2012-07-01|December 2004|Actual|2004-12-01|March 2004|Actual|2004-03-01||Interventional|||Lactate Metabolism After an Endotoxin Challenge in Healthy Humans|Effects of an Acute Administration of Bacterial Endotoxin on Whole Body and Regional Lactate Metabolism in Healthy Male Volunteers|Completed||N/A|14|Actual|University of Lausanne||4|||f||||f||||||||||2017-10-11 02:42:47.656119|2017-10-11 02:42:47.656119
NCT01647984|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-02-02|||December 2012||2012-12-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias|Study on the Role of a Combination of Nutraceuticals (Ritmonutra) With an Effect on Benign Supraventricular and Ventricular Arrhythmias in Subjects Free of a Specific Organic Heart Disease.|Completed||Phase 4|1500|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 02:42:47.761318|2017-10-11 02:42:47.761318
NCT01647971|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-05-12|||August 2012||2012-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma|An Open Label Phase I/II Study of the Efficacy and Safety of Ublituximab in Patients With B-cell Non-Hodgkin Lymphoma Who Have Relapsed or Are Refractory After CD20 Directed Antibody Therapy|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|TG Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 02:42:48.067434|2017-10-11 02:42:48.067434
NCT01647958|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-02-07|||June 2012||2012-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|October 2015|Actual|2015-10-01||Interventional|TEMPO||The EndoGastric Solutions TEMPO Trial|Transoral Incisionless Fundoplication (TIF) Versus Medical Proton Pump Inhibitor (PPI) Management of Refractory Gastroesophageal Reflux Disease (GERD) Symptoms|Active, not recruiting||N/A|65|Actual|EndoGastric Solutions||2|||f||||f||||||||Undecided||2017-10-11 02:42:48.177234|2017-10-11 02:42:48.177234
NCT01647945|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-08-11|2016-06-24||July 2012||2012-07-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|TransformPAH||FK506 (Tacrolimus) in Pulmonary Arterial Hypertension|Single-Center Randomized Controlled Phase II Study of Safety and Efficacy of FK-506 (Tacrolimus) in Pulmonary Arterial Hypertension|Completed||Phase 2|23|Actual|Stanford University|"Due to slow patient recruitment in single academic center we recruited fewer patients than originally expected.
Follow-up multicenter phase IIb efficacy trial is planned"|4|||f||||t||||||||||2017-10-11 02:42:48.290796|2017-10-11 02:42:48.290796
NCT01647932|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-04-27|||October 2014||2014-10-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|November 2018|Anticipated|2018-11-01||Interventional|CLOROTIC||Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart Failure|Safety and Efficacy of the Combination of Loop Diuretics With Thiazide-type Diuretics in Patients With Decompensated Heart Failure: a Double-blind, Randomized, Placebo-controlled Trial (CLOROTIC Trial).|Recruiting||Phase 4|304|Anticipated|Spanish Society of Internal Medicine||2|||f||||f||||||||||2017-10-11 02:42:48.766829|2017-10-11 02:42:48.766829
NCT01647919|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2013-08-06|||May 2012||2012-05-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MemIprov||Effects of cogniVida™ on Learning and Memory and in Comparison to Placebo After Long-term Supplementation|Effects of cogniVida™ on Learning and Memory and in Comparison to Placebo After Long-term Supplementation|Completed||Phase 2|88|Actual|DSM Nutritional Products, Inc.||2|||f||||f||||||||||2017-10-11 02:42:48.866571|2017-10-11 02:42:48.866571
NCT01647906|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2015-01-23|||May 2012||2012-05-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SoFI||Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)|A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)|Enrolling by invitation||N/A|244|Anticipated|Valeant Pharmaceuticals International, Inc.|||1||f||||f||||||||||2017-10-11 02:42:48.981152|2017-10-11 02:42:48.981152
NCT01645150|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-03-21|||May 2012||2012-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|RECAP||Reduction of Cancer Related Fatigue in Patients During TKI Therapy|Pilot Study on the Effects of Strength Training on Cancer Related Fatigue in Cancer Patients During Tyrosine Kinase Inhibitor Therapy|Completed||N/A|20|Actual|German Cancer Research Center||2|||f||||f||||||||||2017-10-11 02:43:33.181591|2017-10-11 02:43:33.181591
NCT01647893|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-19|||July 2012||2012-07-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Phase 1 Single Dose Escalation Study of CTB-001|A Phase 1 Clinical Study, Randomized, Double-blind, Placebo-controlled, Single-dose, Dose Escalation Study of the Safety and Pharmacokinetic/Pharmacodynamic Profiles of CTB-001 Intravenously Administered in Healthy Male Subjects|Unknown status|Recruiting|Phase 1|33|Anticipated|Chem Tech Research Incorporation||4|||f||||f||||||||||2017-10-11 02:42:49.186088|2017-10-11 02:42:49.186088
NCT01647880|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-23|2017-08-01|||July 2013||2013-07-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MOVING||MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study)|Phase II/III Study to Investigate the Effects of Fingolimod Versus Interferon Beta-1b on Visual Recovery After Optic Neuritis|Terminated||Phase 2/Phase 3|8|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:42:49.282008|2017-10-11 02:42:49.282008
NCT01647867|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-01-05|||July 2012||2012-07-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2015|Actual|2015-07-01||Interventional|MetLung||Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers|Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers|Active, not recruiting||N/A|57|Anticipated|Centre Oscar Lambret||1|||f||||f||||||||||2017-10-11 02:42:49.381013|2017-10-11 02:42:49.381013
NCT01647854|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2015-09-22|||August 2012||2012-08-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Operation of a Mobile Telemedicine System in the EMS|Introduction and Operation of a Mobile Telemedicine System to Support Paramedics in the Emergency Medical Service|Completed||N/A|425|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 02:42:49.461229|2017-10-11 02:42:49.461229
NCT01647841|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2013-09-26|||April 2012||2012-04-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth||Completed||N/A|218|Actual|Cornell University|||1||f||||f||||||||||2017-10-11 02:42:49.547665|2017-10-11 02:42:49.547665
NCT01647828|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-09-16|||October 2012||2012-10-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|ALPINE||A Phase 1b/2 Study of OMP-59R5 in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer|A Phase 1b/2 Study of OMP-59R5 in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer|Completed||Phase 1/Phase 2|217|Actual|OncoMed Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 02:42:49.621746|2017-10-11 02:42:49.621746
NCT01647815|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-03-25|||August 2012||2012-08-01|March 2015|2015-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|AnatoAbord||Ultrasound Comparison of the Surface of the Subclavian and the Axillary Vein Versus the Surface of the Subclavian Vein|Ultrasound Comparison of the Surface of the Subclavian Vein (Arm in Abduction (90°) and External Rotation (90 °)) and the Surface of the Axillary Vein (Arms Along the Body) Versus the Surface of the Subclavian Vein (Arm Along the Body)|Completed||N/A|50|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-11 02:42:49.767659|2017-10-11 02:42:49.767659
NCT01647802|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-03-25|||September 2012||2012-09-01|March 2015|2015-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|VTT||Cross-over Study of Three Modular Devices for Aid in Patient Standing and Transfer|Cross-over Study of Three Modular Devices for Aid in Patient Standing and Transfer|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Nīmes||6|||f||||f||||||||||2017-10-11 02:42:49.865763|2017-10-11 02:42:49.865763
NCT01647789|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-01-16|||December 2012||2012-12-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer|A Phase I/II, Multicenter, Open-label Dose Finding Study of Oral CFG920 in Patients With Metastatic Castration-resistant Prostate Cancer|Terminated||Phase 1/Phase 2|31|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:42:49.973037|2017-10-11 02:42:49.973037
NCT01647776|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-03-16|||April 1, 2012||2012-04-01|March 2017|2017-03-01|December 15, 2017|Anticipated|2017-12-15|December 15, 2017|Anticipated|2017-12-15||Observational|||Screening and Risk Factors of Colon Neoplasia|Screening and Risk Factors of Colon Neoplasia|Recruiting||N/A|1600|Anticipated|Case Comprehensive Cancer Center|||2||f||||f|f|f||||Samples With DNA|"     Whole Blood, Urine, Stool samples, Colon polyps   "|||2017-10-11 02:42:50.101451|2017-10-11 02:42:50.101451
NCT01647763|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-07-20|||July 2011||2011-07-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Hemorrhoidal Artery Ligation and Rectoanal Repair Versus Stapled Hemorrhoidopexy|Hemorrhoidal Artery Ligation and Rectoanal Repair Versus Stapled Hemorrhoidopexy|Recruiting||N/A|84|Anticipated|Cantonal Hospital of St. Gallen||2|||f||||f||||||||||2017-10-11 02:42:50.234114|2017-10-11 02:42:50.234114
NCT01647750|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2015-10-07|||August 2012||2012-08-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|SORTED||Study of Optimal Replacement of Thyroxine in the Elderly|Study of Optimal Replacement of Thyroxine in the Elderly (SORTED) SORTED 1 - a Randomised Controlled Trial (Pilot Study), SORTED 2 - Qualitative Interviews, SORTED 3 - Retrospective Cohort|Completed||Phase 4|48|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 02:42:50.379101|2017-10-11 02:42:50.379101
NCT01647737|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-03-17|2015-01-23||March 2011||2011-03-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Consented subjects diagnosed with Xerostomia and meeting all inclusion exclusion criteria|Green Tea Lozenges for the Management of Dry Mouth|A Natural Formulation for Patients Diagnosed With Xerostomia|Completed||Phase 1/Phase 2|60|Actual|Augusta University||2|||f||||f||||||||||2017-10-11 02:42:50.472843|2017-10-11 02:42:50.472843
NCT01647724|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-23|||September 2012||2012-09-01|May 2012|2012-05-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Observational|NMDSS2||New Methods of Distribution of a Self Sampler Kit for Cervical Cancer Screening|Experimentation of New Organizational Models of Cervical Cancer Screening Programs, Upon the Use of HPV Test as First Level: Evaluation of the Methodologies Proposed of the Use of Self-sampling Devices to Recover Non-responders.|Unknown status|Not yet recruiting|N/A|15000|Anticipated|Azienda Sanitaria Locale 4, Teramo|||3||f||||f||||||Samples Without DNA|"     vaginal washings   "|||2017-10-11 02:42:50.809461|2017-10-11 02:42:50.809461
NCT01646333|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-01-06|||July 2012||2012-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease|A Randomized Controlled Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease|Completed||N/A|32|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 02:43:10.725913|2017-10-11 02:43:10.725913
NCT01647711|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-12-08|2016-09-22||July 2012||2012-07-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Treated set which included all patients who took at least one dose of afatinib.|A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations|A Phase 1b Study of Intermittent Administration of High Doses of the Irreversible EGFR Inhibitor Afatinib as a Means of Achieving Plasma Levels Active Against Non-small Cell Lung Cancer With Known T790M Mutations|Completed||Phase 1|35|Actual|Boehringer Ingelheim|One patient was screened in part B of the study, the patient did not meet eligibility requirements and was not treated. The trial completed enrollment in Part A before any additional patients were screened for Part B.|1|||f||||||||||||||2017-10-11 02:42:50.95251|2017-10-11 02:42:50.95251
NCT01647698|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-06-30|||October 2013||2013-10-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|PDWM||Pilot Study to Determine if Working Memory Training Aids Cognitive Functioning in Patients With Parkinson's Disease|Beyond the Physical: Enhancing Psychosocial Functioning in Parkinson's Disease|Recruiting||N/A|30|Anticipated|Nova Scotia Health Authority||3|||f||||f||||||||||2017-10-11 02:42:52.560467|2017-10-11 02:42:52.560467
NCT01647685|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-07-19|||May 2012||2012-05-01|May 2012|2012-05-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|DELIVER||A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort|A Proof of Concept Study to Determine the Local Delivery and Efficacy of Intravenously Injected PEG-liposomal Prednisolone Sodium Phosphate (Nanocort) in Atherosclerotic Tissue in Subjects With Peripheral Artery Disease.|Unknown status|Recruiting|Phase 1/Phase 2|21|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||t||||||||||2017-10-11 02:42:52.912194|2017-10-11 02:42:52.912194
NCT01647672|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-24|||January 2012||2012-01-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer|A Study to Assess the Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in the Treatment of Operable Breast Cancer|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Tianjin Medical University||1|||f||||t||||||||||2017-10-11 02:42:53.057452|2017-10-11 02:42:53.057452
NCT01647659|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-12-06|||July 2012||2012-07-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation|An Open-Label, Two-Period, Randomized, Crossover Study to Assess the Relative Bioavailability of GSK1120212 Tablet Formulation and the GSK1120212 Pediatric Oral Solution Formulation Following Single-Dose Administration to Adult Subjects With Solid Tumors|Completed||Phase 1|15|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:42:53.158107|2017-10-11 02:42:53.158107
NCT01647646|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-23|||March 2009||2009-03-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|February 2011|Actual|2011-02-01||Interventional|||Real Life Effectiveness in Patients With Not Optimally Controlled Asthma|Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA|Completed||Phase 4|200|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:42:53.263173|2017-10-11 02:42:53.263173
NCT01647633|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-05-21|||May 2012||2012-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|||Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash|Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash on Patient-Perceived Breathing Comfort|Completed||Phase 1/Phase 2|17|Actual|Drexel University||1|||f||||f||||||||||2017-10-11 02:42:53.347361|2017-10-11 02:42:53.347361
NCT01647620|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-02-23|||February 2012||2012-02-01|July 2012|2012-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.|A Randomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics (PK), Pharmacodynamics (PD), PK/PD Characteristics and Safety of Multiple Once-daily Oral Dosing of DPOC-4088 in Healthy Young Male Subjects|Terminated||Phase 1|30|Anticipated|Diakron Pharmaceuticals||2||Diakron Pharmaceuticals couldn't fulfill the financial responsibility of the study|f||||f||||||||||2017-10-11 02:42:53.448589|2017-10-11 02:42:53.448589
NCT01647607|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-05-11|||June 2012||2012-06-01|May 2017|2017-05-01|August 2020|Anticipated|2020-08-01|August 2015|Actual|2015-08-01||Interventional|Y&S||Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer|Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer|Active, not recruiting||N/A|610|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 02:42:53.613455|2017-10-11 02:42:53.613455
NCT01647594|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-01-04|||March 2011||2011-03-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|YWI Pilot||Pilot Study for Young Women's Intervention|Qualitative Assessment and Pilot Study for Young Women's Intervention|Completed||N/A|93|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 02:42:53.719137|2017-10-11 02:42:53.719137
NCT01647581|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-07-21|||September 1, 2011|Actual|2011-09-01|July 2017|2017-07-01|December 3, 2018|Anticipated|2018-12-03|December 3, 2018|Anticipated|2018-12-03||Interventional|||Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping|Risk of Post-Polypectomy Bleeding With Prophylactic Hemoclipping|Recruiting||N/A|1750|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 02:42:53.824693|2017-10-11 02:42:53.824693
NCT01647568|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-19|||December 2009||2009-12-01|July 2012|2012-07-01||||March 2012|Actual|2012-03-01||Observational|||Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study||Completed||N/A|715|Actual|Dallas VA Medical Center|||2||f||||f||||||||||2017-10-11 02:42:54.137317|2017-10-11 02:42:54.137317
NCT01647555|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2014-08-22|||November 2006||2006-11-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|May 2012|Actual|2012-05-01||Observational|||Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer|Prospective Study About the Association of Radiotherapy and Cetuximab in the Treatment of Epidermoid Cancers, Locally Advanced, of the Head and Neck.|Unknown status|Active, not recruiting|N/A|57|Actual|Centre Oscar Lambret|||1||f||||f||||||||||2017-10-11 02:42:54.228947|2017-10-11 02:42:54.228947
NCT01646151|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-05-15|2014-02-18||May 2012||2012-05-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension||Completed||N/A|2580|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:43:17.080969|2017-10-11 02:43:17.080969
NCT01647542|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-10-15|2015-07-22||October 2012||2012-10-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|GRAND-307|The randomized set included all participants who were randomized.|Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-week Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg Compared With Placebo in Asia Pacific Subjects With Type 2 Diabetes|Terminated||Phase 3|393|Actual|Takeda||3||Due to potential concerns about liver safety (See Detailed Description)|f||||t||||||||||2017-10-11 02:42:54.392856|2017-10-11 02:42:54.392856
NCT01647529|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-11-16|||July 2012||2012-07-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|Virgan||Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis|Intra-cameral Penetration of Ganciclovir Following Topical Administration of 0.15% Ganciclovir Gel (VIRGAN©) for CMV Anterior Uveitis / Endotheliitis|Completed||N/A|29|Actual|Singapore National Eye Centre||1|||f||||t||||||||||2017-10-11 02:42:55.714723|2017-10-11 02:42:55.714723
NCT01647516|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-06-16||2016-05-26|December 12, 2012|Actual|2012-12-12|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|October 8, 2014|Actual|2014-10-08||Interventional|||Efficacy and Safety Study of RPC1063 in Ulcerative Colitis|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis|Active, not recruiting||Phase 2|197|Actual|Celgene||3|||f||||t||||||||||2017-10-11 02:42:55.824463|2017-10-11 02:42:55.824463
NCT01647503|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-04-15|||July 2012||2012-07-01|April 2014|2014-04-01||||September 2015|Anticipated|2015-09-01||Observational|||Differentially Expressed Proteins in Sporadic Parathyroid Tumors|Identification of Differentially Expressed Proteins in Parathyroid Tumors and Their Clinical Correlation With the Disease|Unknown status|Recruiting|N/A|50|Anticipated|Postgraduate Institute of Medical Education and Research|||2||f||||t||||||||||2017-10-11 02:42:56.020785|2017-10-11 02:42:56.020785
NCT01647490|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-19|||April 2012||2012-04-01|July 2012|2012-07-01|July 2015|Anticipated|2015-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Right Ventricular Lead Placement in a Pacemaker Population: Evaluation of Apical and Alternative Position|Right Ventricular Lead Placement in a Pacemaker Population: Evaluation of Apical and Alternative Position - Right Pace Study|Unknown status|Recruiting|N/A|408|Anticipated|Ospedale Santa Maria di Loreto Mare||2|||f||||f||||||||||2017-10-11 02:42:56.136507|2017-10-11 02:42:56.136507
NCT01647477|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-07-28|||December 2012||2012-12-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|October 2014|Actual|2014-10-01||Interventional|DEREDIA||Interventional Study Collecting Quantitative and Qualitative Data About Patient With Non Treated Cancer|Determinants of the Consultation Delay in Cancers of the Upper Aero Digestive Tract|Terminated||N/A|90|Actual|Centre Oscar Lambret||2||lack of enrollment|f||||f||||||||No||2017-10-11 02:42:56.239683|2017-10-11 02:42:56.239683
NCT01647464|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-03-28|2015-10-23||July 2012||2012-07-01|March 2016|2016-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational||Subjects undergoing contrast echo|Renal Retention of Microbubbles|Study of Whether There is Renal Retention of Lipid Microbubble Ultrasound Contrast Agents|Completed||N/A|10|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 02:42:56.330757|2017-10-11 02:42:56.330757
NCT01647451|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-02-06||2013-11-07|September 2012||2012-09-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis|A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|62|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:42:56.509882|2017-10-11 02:42:56.509882
NCT01647438|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-10-01|2015-07-17||August 2012||2012-08-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|December 2013|Actual|2013-12-01||Interventional|||Translating a Heart Disease Lifestyle Intervention Into the Community|Translating a Heart Disease Lifestyle Intervention Into the Community|Completed||N/A|63|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 02:42:56.913409|2017-10-11 02:42:56.913409
NCT01647425|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-09-29|||April 2012||2012-04-01|August 2014|2014-08-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Observational|ALTAK||Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer|Prevalence and Risk Factors for Persistent Tobacco or Alcohol Use Over the First Year of a First Lung or Head and Neck Cancer|Terminated||N/A|385|Actual|Centre Oscar Lambret|||1|Low recruitment|f||||f||||||||||2017-10-11 02:42:57.197103|2017-10-11 02:42:57.197103
NCT01647412|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-04-09|||March 2012||2012-03-01|April 2015|2015-04-01||||||||Interventional|||Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease|Growth Hormone and Nutrition Therapy in Juvenile Crohn's Disease, a Randomized Clinical Trial|Withdrawn||Phase 2|0|Actual|Columbia University||2||PI left the institution|f||||t||||||||||2017-10-11 02:42:57.287852|2017-10-11 02:42:57.287852
NCT01647399|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-08-14|||July 2012||2012-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|August 2017|Actual|2017-08-01||Observational|AsthMaP2||Vitamin D, Steroids, and Asthma in African American Youth|AsthMaP 2: Vitamin D, Steroids, and Asthma in African American Youth|Active, not recruiting||N/A|500|Anticipated|Children's Research Institute|||1||f||||t||||||Samples With DNA|"     Blood, urine, tissue   "|||2017-10-11 02:42:57.399356|2017-10-11 02:42:57.399356
NCT01647386|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-02-01|||September 2013||2013-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Pilot Study Using Radiostereometric Analysis (RSA) to Evaluate the Fixation of the Tibial Components in the DePuy M.B.T. Revision Knee System|Pilot Study Using Radiostereometric Analysis (RSA) to Evaluate the Fixation of the Tibial Components in the DePuy M.B.T. Revision Knee System|Active, not recruiting||N/A|10|Anticipated|Nova Scotia Health Authority|||1||f||||f||||||||||2017-10-11 02:42:57.510062|2017-10-11 02:42:57.510062
NCT01647373|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2013-06-11|||July 2013||2013-07-01|July 2012|2012-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Axial Length Change in Eyes Treated by Silicone Sponge Scleral Buckling|Axial Length Change in Eyes Treated by Silicone Sponge Scleral Buckling.|Unknown status|Not yet recruiting|N/A|50|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 02:42:57.582525|2017-10-11 02:42:57.582525
NCT01645956|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-02-18|||July 2012||2012-07-01|July 2012|2012-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Consistency in Individual Differences in Energy Intake Following Acute Exercise|Consistency in Individual Differences in Energy Intake Following Acute Exercise|Completed||N/A|28|Actual|The Miriam Hospital|||1||f||||f||||||||||2017-10-11 02:43:25.293896|2017-10-11 02:43:25.293896
NCT01647360|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2013-05-27|||June 2012||2012-06-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment|A Post- Marketing, Prospective,Multicenter, Observational Program: Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment|Completed||N/A|210|Actual|Abbott|||1||f||||f||||||||||2017-10-11 02:42:57.658276|2017-10-11 02:42:57.658276
NCT01647347|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-12-20|||August 2012||2012-08-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|PJB 1||PVP Iodine Effect on Post Debridement Bacteraemia|Effects of Ultrasonic Debridement With PVP-iodine Irrigation on Post-treatment Bacteraemia Compared to Ultrasonic Debridement With Water|Completed||Phase 4|20|Actual|University of Zurich||2|||f||||t||||||||||2017-10-11 02:42:57.782823|2017-10-11 02:42:57.782823
NCT01647334|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2015-02-17|||January 2013||2013-01-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer|Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer|Terminated||N/A|29|Anticipated|Lawson Health Research Institute||1||Poor accrual|f||||t||||||||||2017-10-11 02:42:57.890314|2017-10-11 02:42:57.890314
NCT01647321|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-08-29|||July 2012|Actual|2012-07-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis|Evaluating the Effects of Functional Electrical Stimulation on Ambulation in Individuals With Secondary Progressive Multiple Sclerosis|Recruiting||Phase 1|20|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:42:57.972003|2017-10-11 02:42:57.972003
NCT01647308|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2014-07-11|||July 2012||2012-07-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes|A Randomized, Double Blind, Placebo-Controlled, Phase 2 Study to Investigate the Effects of ISIS 304801 Lowering of ISIS-APOCIIIRX on Triglyceride Levels and Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 2|15|Actual|Ionis Pharmaceuticals, Inc.||2||"The study was terminated for business planning purposes. Assessments of APOCIIIRx in this   population will be explored in a larger efficacy study"|f||||f||||||||||2017-10-11 02:42:58.070765|2017-10-11 02:42:58.070765
NCT01647295|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2016-02-24|||February 2013||2013-02-01|February 2016|2016-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|ISEOP||Social Interactions: Ocular Explorations and Pupillometry in Autism|Social Interactions: Ocular Explorations and Pupillometry in Autism|Recruiting||N/A|150|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-10-11 02:42:58.137348|2017-10-11 02:42:58.137348
NCT01647269|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2015-03-18|||July 2011||2011-07-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Tourette Syndrome|A Randomised, Controlled, Crossover Trial of Bilateral Deep Brain Stimulation to the Globus Pallidus Internum in Severe Tourette Syndrome|Completed||Phase 2|15|Actual|University College, London||2|||f||||t||||||||||2017-10-11 02:42:58.296498|2017-10-11 02:42:58.296498
NCT01647256|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-09-16|||July 2012||2012-07-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Nikkomycin Z Bioavailability Under Fed and Fasting Conditions|Comparison of Nikkomycin Z Bioavailability After Single Dose Administration Under Fed (High Fat Meal) Compared to Fasting Conditions|Terminated||Phase 1|5|Actual|University of Arizona||2||Insufficient # subjects available for 2nd group; evaluating alternate study site|f||||f||||||||||2017-10-11 02:42:58.382655|2017-10-11 02:42:58.382655
NCT01647243|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-07-20|||January 2012||2012-01-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Preoperative Strength Training in Patients With Total Knee Arthroplasty|Effect of Preoperative Strength Training on Postoperative Quadriceps Strength and Ability of Function in Patients With Total Knee Arthroplasty in Fast Track Regi|Unknown status|Recruiting|N/A|70|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 02:42:58.464218|2017-10-11 02:42:58.464218
NCT01647230|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-07-24|||February 2012||2012-02-01|July 2012|2012-07-01|February 2013|Anticipated|2013-02-01|||||Observational|||Cerebral Oxygenation and Spinal Anaesthesia in Elderly Patients With Hip Fracture|Observational Study of Cerebral Oxygenation and Spinal Anaesthesia in Elderly Patients With Hip Fracture|Unknown status|Recruiting|N/A|70|Anticipated|Hospital de Sabadell|||1||f||||t||||||||||2017-10-11 02:42:58.582475|2017-10-11 02:42:58.582475
NCT01647217|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-05-31|2015-11-05||February 2014||2014-02-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|DBTS||Demodex Blepharitis Treatment Study|Safety and Efficacy of Single-use Terpinen-4-ol Pads for Treating Ocular Mites A Randomized Clinical Trial|Completed||Phase 1|17|Actual|Tissue Tech Inc.||2|||f||||t||||||||||2017-10-11 02:43:00.920771|2017-10-11 02:43:00.920771
NCT01647204|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-11-03|||November 2009||2009-11-01|November 2014|2014-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|SMAS||Southampton Mealtime Assistance Study|Introduction of Mealtime Assistance Onto an Acute Medical Ward for Older People|Completed||N/A|342|Actual|University Hospital Southampton NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:43:01.198187|2017-10-11 02:43:01.198187
NCT01647191|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-07-18|||July 2011||2011-07-01|July 2012|2012-07-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China|Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China|Unknown status|Active, not recruiting|N/A|340|Anticipated|Shanghai Mental Health Center||2|||f||||f||||||||||2017-10-11 02:43:01.293822|2017-10-11 02:43:01.293822
NCT01647178|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-08-31|||March 2012||2012-03-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|TORQClin||TORQ Clinical Study|The Influence of the TORQ Sternal Closure Assistance Device on Post-Operative Pain, Pulmonary Function and Quality of Life Compared to Traditional Manual Wire Closure: A Randomized Controlled Trial.|Completed||N/A|92|Actual|Kardium Inc.||2|||f||||f||||||||||2017-10-11 02:43:01.403472|2017-10-11 02:43:01.403472
NCT01647165|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-07-06|||July 11, 2012||2012-07-11|March 11, 2014|2014-03-11|June 26, 2015|Anticipated|2015-06-26|June 26, 2015|Anticipated|2015-06-26||Interventional|||Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance|Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:43:01.497473|2017-10-11 02:43:01.497473
NCT01647152|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2017-06-30|||July 3, 2012||2012-07-03|September 5, 2014|2014-09-05|June 30, 2015|Anticipated|2015-06-30|June 30, 2015|Anticipated|2015-06-30||Interventional|||Ustekinumab for Active Sight-Threatening Uveitis|A Pilot Study to Investigate Ustekinumab (StelaraTM) for the Treatment of Active Sight-Threatening Uveitis|Withdrawn||Phase 1/Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:43:01.635964|2017-10-11 02:43:01.635964
NCT01646866|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-03-02|||December 2010||2010-12-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Early Detection of Autism Spectrum Disorder in Children|Early Detection of Autism Spectrum Disorder in Children|Completed||N/A|37|Actual|St. Louis University|||1||f||||f||||||Samples With DNA|"     Saliva will be collected   "|||2017-10-11 02:43:01.742767|2017-10-11 02:43:01.742767
NCT01646853|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-07-18|||August 2012||2012-08-01|July 2012|2012-07-01||||December 2013|Anticipated|2013-12-01||Interventional|||Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer||Unknown status|Not yet recruiting|N/A|500|Anticipated|Simcere Pharmaceutical Co., Ltd||1|||f||||||||||||||2017-10-11 02:43:01.864088|2017-10-11 02:43:01.864088
NCT01646840|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-12-10|||July 2012||2012-07-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study Of The PF-04958242 Blood Concentrations Of A Capsule Formulation Of PF-04958242 Compared To A Solution Formulation|a Phase 1, Open-Label, Single Dose, Relative Bioavailability Study In Healthy Volunteers Comparing PF-04958242 Capsule Formulation To PF-04958242 Oral Solution In The Fasted State|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:43:01.964906|2017-10-11 02:43:01.964906
NCT01646827|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-07-01|2014-04-30||May 2012||2012-05-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia|An Open-label, Randomized, Parallel Arm, Bioavailability Trial of Aripiprazole IM Depot Administered in the Deltoid or Gluteal Muscle in Adult Subjects With Schizophrenia|Completed||Phase 1|37|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-10-11 02:43:02.310143|2017-10-11 02:43:02.310143
NCT01646814|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-09-03|2015-06-18||September 2012||2012-09-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects|A Randomized, Blinded, Endoscopic Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects|Completed||Phase 2|247|Actual|PLx Pharma||2|||f||||t||||||||||2017-10-11 02:43:03.393443|2017-10-11 02:43:03.393443
NCT01646801|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-22|||January 2013||2013-01-01|July 2012|2012-07-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Study of NMB Drug Ejecting Balloon for Peripheral Arteries|The Use of NMB Drug Ejecting Balloon for Treatment of Patients With Peripheral Arterial Disease|Unknown status|Not yet recruiting|N/A|20|Anticipated|N.M.B. Medical Applications Ltd||1|||f||||||||||||||2017-10-11 02:43:03.642998|2017-10-11 02:43:03.642998
NCT01646788|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-22|||January 2013||2013-01-01|July 2012|2012-07-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Study of NMB Drug Ejecting Balloon for Arteriovenous Fistulae||Unknown status|Not yet recruiting|N/A|10|Anticipated|N.M.B. Medical Applications Ltd||1|||f||||||||||||||2017-10-11 02:43:03.719425|2017-10-11 02:43:03.719425
NCT01646775|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-06-20|||July 2012||2012-07-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||The Effect of Epidural Fentanyl on Immune Function|The Effect of Perioperative Epidural Opioids on Inflammatory Cytokines and Immune Function|Unknown status|Recruiting|N/A|30|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 02:43:03.820334|2017-10-11 02:43:03.820334
NCT01646749|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-07-10|||September 2012||2012-09-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effects of Beef Protein Consumption on Energy Intake|Effects of Beef Protein Consumption on Energy Intake - The Protein Leverage Hypothesis|Completed||N/A|30|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 02:43:04.481167|2017-10-11 02:43:04.481167
NCT01646736|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-19|||July 2012||2012-07-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis|Evaluation of Efficacy and Safety of Glucocorticosteroid Combined With Oral T2 (Chloroform/Methanol Extract of Tripterygium Wilfordii Hook F) in the Treatment of Patients With Lupus Nephritis.|Unknown status|Recruiting|Phase 2/Phase 3|130|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 02:43:04.60548|2017-10-11 02:43:04.60548
NCT01646723|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-04-13|||June 2012||2012-06-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|VALID||Volunteers Adding Life in Dementia|Volunteers Adding Life in Dementia (VALID)|Completed||N/A|75|Actual|Queen's University||1|||f||||f||||||||||2017-10-11 02:43:04.752405|2017-10-11 02:43:04.752405
NCT01646710|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-14|2014-11-18|||October 2011||2011-10-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|July 2012|Actual|2012-07-01||Interventional|Optifood||Optifood, An Approach to Improve Nutrition|Optifood, An Approach to Improve Nutrition|Completed||N/A|36|Anticipated|Society for Applied Studies||1|||f||||f||||||||||2017-10-11 02:43:04.865132|2017-10-11 02:43:04.865132
NCT01646697|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-06-08|||November 7, 2011|Actual|2011-11-07|June 2017|2017-06-01|February 6, 2016|Actual|2016-02-06|February 6, 2016|Actual|2016-02-06||Interventional|||Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery|Cytopathologic Margin Evaluation in Patients Undergoing Pancreatic Cancer Resection|Completed||N/A|90|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:43:04.967327|2017-10-11 02:43:04.967327
NCT01646684|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-10-03|||March 8, 2013|Actual|2013-03-08|October 2017|2017-10-01|September 30, 2018|Anticipated|2018-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer|Phase 1 Study to Evaluate Safety, and Preliminary Efficacy of Pasireotide LAR in Castration Resistant Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|9|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-11 02:43:05.104755|2017-10-11 02:43:05.104755
NCT01646671|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-10-02|2015-07-08||July 2012||2012-07-01|October 2015|2015-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Treatment Assignment Set (TRTAG): This set included all patients who entered the treatment epoch.|Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients|A Multi-center, Open Label Study for Evaluation of the Safety, Tolerability and Efficacy of 8-week Treatment With LCZ696 in Japanese Patients With Severe Hypertension|Completed||Phase 3|35|Actual|Novartis||3|||f||||t||||||||||2017-10-11 02:43:05.208713|2017-10-11 02:43:05.208713
NCT01646645|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-02-27|||July 2012|Actual|2012-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation|A Phase II Trial of Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation|Recruiting||Phase 2|80|Anticipated|Atara Biotherapeutics||1|||t|||||t|f||||||||2017-10-11 02:43:05.876272|2017-10-11 02:43:05.876272
NCT01646632|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-18|||October 2009||2009-10-01|July 2012|2012-07-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|BENENFIT||Exercise Intervention in Institutionalized Elderly People|Effects of Exercise on ADL Performance, Physical Fitness, and Care Dependency in Institutionalized Elderly People|Unknown status|Active, not recruiting|Phase 2|164|Actual|Hanze University||2|||f||||t||||||||||2017-10-11 02:43:05.994576|2017-10-11 02:43:05.994576
NCT01646619|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2013-04-03|||May 2012||2012-05-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|MagCool||Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy|A Multicenter Randomized Controlled Trial of Therapeutic Hypothermia Plus Magnesium Sulphate (MgSO4) Versus Therapeutic Hypothermia Plus Placebo in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy|Unknown status|Recruiting|Phase 3|300|Anticipated|Hamad Medical Corporation||2|||f||||t||||||||||2017-10-11 02:43:06.111902|2017-10-11 02:43:06.111902
NCT01646606|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2016-07-23|||March 2012||2012-03-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Monitoring OXYgen in Infants Hospitalized With Bronchiolitis: A Best Practices Trial (The MOXY Trial)|Monitoring OXYgen in Infants Hospitalized With Bronchiolitis: A Best Practices Trial (The MOXY Trial)|Completed||Phase 1/Phase 2|33|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 02:43:06.382281|2017-10-11 02:43:06.382281
NCT01646593|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-12-12||||||December 2014|2014-12-01||||||||Expanded Access|||Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy|An Open-label Expanded Access Program of Regorafenib in Patients With Gastrointestinal Stromal Tumors (GIST) After Disease Progression on or Intolerance to Imatinib and Sunitinib|No longer available||N/A|||Bayer|||||||||||||||||||2017-10-11 02:43:06.475111|2017-10-11 02:43:06.475111
NCT01646567|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-07-10|||September 2012||2012-09-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||SHP-141C in Plaque Type Psoriasis|A Double-Blind, Within-Subject Randomised, Placebo-Controlled, Proof of Concept, Comparison Study of SHP-141C Topical Cream in Psoriasis, Using the Microplaque Assay.|Completed||Phase 1|14|Actual|TetraLogic Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:43:06.654879|2017-10-11 02:43:06.654879
NCT01646554|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-05-08|||December 2012||2012-12-01|May 2017|2017-05-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|BOS3||Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases|BOS3: Randomized Phase II/III Trial Evaluating the Efficacy of FOLFOX Alone Versus FOLFOX Plus Aflibercept in K-ras Mutant as Perioperative Treatment in Patients With Resectable Liver Metastases From Colorectal Cancer.|Withdrawn||Phase 2/Phase 3|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 02:43:06.784395|2017-10-11 02:43:06.784395
NCT01646541|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-05-02|||July 2012||2012-07-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery|Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery: Pilot, Screening Study|Completed||N/A|100|Actual|Duke University|||2||f||||f||||||||||2017-10-11 02:43:06.931277|2017-10-11 02:43:06.931277
NCT01646528|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-07-19|||June 2012||2012-06-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||The Value of Black Spots in Diagnosing Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy|The Value of Mesenchymal Black Spots in Diagnosing Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy|Unknown status|Recruiting|N/A|30|Anticipated|Shandong University|||1||f||||t||||||Samples With DNA|"     Taken biopsies during endoscopy   "|||2017-10-11 02:43:07.039478|2017-10-11 02:43:07.039478
NCT01645358|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-10-05|||July 2012||2012-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Helmet Ventilation in Acute Hypercapnic Respiratory Failure|"Hypercapnic Acute Respiratory Failure: Is the Helmet an Effective Interface?"|Completed||Phase 4|80|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||f||||||||||2017-10-11 02:43:29.918847|2017-10-11 02:43:29.918847
NCT01646502|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-10-03|||July 2014||2014-07-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Chronic Wound Biofilms|Treatment of Chronic Wound Staphylococcus Aureus Biofilms With Staphylococcus Epidermidis Esp Protein to Promote Healing|Withdrawn||N/A|0|Actual|University of British Columbia||2||"Project was discontinued. Ran into difficulties with purification at the protein production   stage"|f||||f||||||||||2017-10-11 02:43:07.254257|2017-10-11 02:43:07.254257
NCT01646489|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-11-09|||June 2012||2012-06-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects|A Phase 1, Open-Label, Drug Interaction Study to Assess Safety, Tolerability, and Pharmacokinetics of Co-Administered Miravirsen and Telaprevir in Healthy Subjects|Completed||Phase 1|5|Actual|Santaris Pharma A/S||2|||f||||f||||||||||2017-10-11 02:43:07.367256|2017-10-11 02:43:07.367256
NCT01646476|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-02-27|||July 2012||2012-07-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Covered Versus Uncovered Self-expandable Metallic Stents for Malignant Gastric Outlet Obstruction|Comparison of Efficacy of Covered Versus Uncovered Self-expandable Metallic Stents for Treatment of Malignant Gastric Outlet Obstruction: a Prospective, Randomized Study|Completed||Phase 3|102|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 02:43:07.474139|2017-10-11 02:43:07.474139
NCT01646463|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-12-17|||January 2011||2011-01-01|December 2014|2014-12-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Pilot Trial of CenteringPregnancy With Mindfulness Skills|Integrative Stress Reduction for Maternal-Child Health|Unknown status|Active, not recruiting|Phase 1/Phase 2|49|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:43:07.58159|2017-10-11 02:43:07.58159
NCT01646450|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-09-05|||July 2012||2012-07-01|September 2015|2015-09-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients|An Open Lable, Single Arm, Phase IV Study of Icotinib as First-line Treatment in Elder NSCLC Patients With EGFR Mutation|Unknown status|Active, not recruiting|Phase 4|35|Anticipated|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 02:43:07.836597|2017-10-11 02:43:07.836597
NCT01646437|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-10-28|||June 2012||2012-06-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|June 2019|Anticipated|2019-06-01||Interventional|TIPS-3||The International Polycap Study 3 (TIPS-3)|The International Polycap Study 3 (TIPS-3) is a Randomized Double-blind Placebo-controlled Trial for the Evaluation of a Polycap, Low Dose Aspirin and Vitamin D Supplementation in Primary Prevention|Recruiting||Phase 3|5000|Anticipated|Population Health Research Institute||3|||f||||t||||||||Undecided||2017-10-11 02:43:07.961926|2017-10-11 02:43:07.961926
NCT01646424|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-19|2012-10-15|||August 2012||2012-08-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)|Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination DPI in COPD|Completed||N/A|446|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:43:08.116295|2017-10-11 02:43:08.116295
NCT01646411|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-19|||August 2012||2012-08-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|December 2012|Anticipated|2012-12-01||Observational|Antibody 300||300 Antibody Diagnostic Test Kit|Phase I Study for Positive IgM Antibody Detection in New Diagnostic Test Kit for for Acute Phase Infection|Unknown status|Enrolling by invitation|N/A|300|Anticipated|The Plasma Source|||1||f||||t||||||Samples Without DNA|"     Serum collected in two 10ml sst and two 8ml edta venipuncture tubes.   "|||2017-10-11 02:43:08.280203|2017-10-11 02:43:08.280203
NCT01646398|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2013-07-17|2013-07-17||June 2012||2012-06-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older|A Phase 3, Randomized, Modified Double-Blind, Active-Controlled Trial Evaluating The Safety, Tolerability, And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine In Japanese Elderly Adults Aged 65 Years Old And Older Who Are Naive To Pneumococcal Vaccine|Completed||Phase 3|764|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:43:08.403735|2017-10-11 02:43:08.403735
NCT01646385|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2014-07-07|2014-04-03||February 2012||2012-02-01|July 2014|2014-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational||Safety analysis population included all participants treated with ETN or nbDMARDs who had a physician diagnosis of rheumatoid arthritis and a minimum of one consultant follow-up after baseline registration.|Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry|Long-term Safety and Efficacy of Etanercept in a UK Observational Cohort Study - a Retrospective Database Analysis of British Society of Rheumatology Biologics Registry (BSRBR) Data|Completed||N/A|6393|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 02:43:09.496006|2017-10-11 02:43:09.496006
NCT01646372|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-04-26|||July 2012||2012-07-01|April 2017|2017-04-01|January 31, 2017|Actual|2017-01-31|October 31, 2016|Actual|2016-10-31||Interventional|||Does Instruction on Cognitive Aid Use Improve Performance and Retention of Skills?|Does Instruction on Cognitive Aid Use Improve Performance and Retention of Skills? A Simulation Based Randomized Controlled Trial|Completed||N/A|55|Actual|Ottawa Hospital Research Institute||3|||f||||f|f|f||||||||2017-10-11 02:43:10.466266|2017-10-11 02:43:10.466266
NCT01646359|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2012-07-19|||March 2011||2011-03-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Value of Pulse Pressure Variations and Corrected Flow Time in Esophageal Doppler as a Predictor of Fluid Responsiveness in Prone Position During Spinal Surgery||Completed||N/A|45|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 02:43:10.552327|2017-10-11 02:43:10.552327
NCT01646346|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2017-08-02|||January 10, 2012|Actual|2012-01-10|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|July 17, 2017|Actual|2017-07-17||Interventional|||4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast Cancer|A Pilot Study of Four-Dimensional Conformal Image Guided Accelerated Partial Breast Irradiation In The Treatment Of Stage 0 and l Breast Cancer|Active, not recruiting||N/A|30|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 02:43:10.632664|2017-10-11 02:43:10.632664
NCT01645163|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-14|2014-11-18|||November 2011||2011-11-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|August 2012|Actual|2012-08-01||Interventional|mHealth||mHealth - A Novel Approach to Improve Child Nutrition in India|mHealth - A Novel Approach to Improve Child Nutrition in India|Completed||N/A|72|Anticipated|Society for Applied Studies||1|||f||||f||||||||||2017-10-11 02:43:33.074787|2017-10-11 02:43:33.074787
NCT01646320|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-05-18|2016-03-09||September 2012||2012-09-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|August 2014|Actual|2014-08-01||Interventional||All randomized subjects who received at least one dose of study medication|Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Therapy With Dapagliflozin Added to Saxagliptin in Combination With Metformin Compared to Therapy With Placebo Added to Saxagliptin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin and Saxagliptin|Completed||Phase 3|320|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 02:43:10.848563|2017-10-11 02:43:10.848563
NCT01646307|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-18|||January 2012||2012-01-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|January 2013|Anticipated|2013-01-01||Interventional|ARISE||Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing PCI|Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 4|1000|Anticipated|Beijing Anzhen Hospital||3|||f||||t||||||||||2017-10-11 02:43:11.84933|2017-10-11 02:43:11.84933
NCT01646294|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2013-07-01|||January 2005||2005-01-01|July 2013|2013-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions|An Exploratory Open Label, Three-way Crossover Study to Compare the Pharmacokinetic Profiles of Three Different YM178 Modified Release (OCAS) Formulations Under Fasted and Fed Conditions With YM178 Immediate Release (IR) Formulation Under Fasted Conditions in Healthy Subjects|Completed||Phase 1|34|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 02:43:11.960461|2017-10-11 02:43:11.960461
NCT01646281|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-07-18|||August 2012||2012-08-01|July 2012|2012-07-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Vernakalant Versus Flecainide: Atrial Contractility|Effects of Vernakalant and Flecainide on Atrial Contractility in Patients With Atrial Fibrillation|Unknown status|Not yet recruiting|Phase 4|70|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 02:43:12.117454|2017-10-11 02:43:12.117454
NCT01646268|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-07-14|2015-05-20||July 2012||2012-07-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Baseline Demographics data is taken from the Randomized Set (RS). The RS includes all subjects that were randomized.|Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients|A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Of The Efficacy And Safety Of The Rotigotine Transdermal Patch In Chinese Subjects With Early-stage Idiopathic Parkinson's Disease|Completed||Phase 3|249|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 02:43:12.302098|2017-10-11 02:43:12.302098
NCT01646255|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-01-29|2015-10-08||July 2012||2012-07-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Baseline Characteristics refers to to the Safety Set (SS), consisting of all randomized subjects who received at least 1 dose of study medication.|Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients|A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of The Efficacy And Safety of Rotigotine Transdermal Patch In Chinese Subjects With Advanced-stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled On Levodopa|Completed||Phase 3|346|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 02:43:12.910018|2017-10-11 02:43:12.910018
NCT01646242|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-10-13|||July 2012||2012-07-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Cold Snare Versus Double Biopsy Polypectomy Technique for Removal of Diminutive Colorectal Polyps|Cold Snare Versus Double Biopsy Polypectomy Technique for Removal of Diminutive Colorectal Polyps: a Prospective Randomized Trial|Completed||Phase 4|54|Actual|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-11 02:43:13.685087|2017-10-11 02:43:13.685087
NCT01646229|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-05-11|||January 2012||2012-01-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Impact of Early Peri-operative Use of Polymyxin-B Hemoperfusion in Septic Patients Undergoing Emergent Abdominal Surgery|Impact of Early Per-operative Use of Polymyxin-B Hemoperfusion in Septic Patients Undergoing Emergent Abdominal Surgery|Completed||N/A|30|Actual|University Hospital, Geneva||2|||f||||t||||||||||2017-10-11 02:43:13.792109|2017-10-11 02:43:13.792109
NCT01646216|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-05-02|||June 2012||2012-06-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Long Term Split Belt Treadmill Training for Stroke Recovery|Long Term Split Belt Treadmill Training for Stroke Recovery|Active, not recruiting||Phase 1|19|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||f||||||||||2017-10-11 02:43:13.926022|2017-10-11 02:43:13.926022
NCT01646190|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-20|||December 2009||2009-12-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|FT-SS||Fast-Track Colorectal Surgery in Senior Patients|Fast-Track Perioperative Care After Elective Colorectal Surgery in Senior Patients. Randomized Controlled Trial|Unknown status|Recruiting|N/A|150|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 02:43:14.147084|2017-10-11 02:43:14.147084
NCT01646164|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-19|||May 2009||2009-05-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Observational|||Effect of Dill Seed on Uterus Contractions Pattern||Completed||N/A|100|Actual|Mashhad University of Medical Sciences|||2||f||||||||||||||2017-10-11 02:43:16.985545|2017-10-11 02:43:16.985545
NCT01646138|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-04-05|2015-07-02||February 2012||2012-02-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Influenza A 2009 H1N1 Challenge Study in Healthy Adults|Influenza A 2009 H1N1 Human Challenge Study in Healthy Adult Volunteers|Completed||Phase 1/Phase 2|49|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||Yes|Data will be shared through the NIH data repository BTRIS - Biomedical Translational Research Information System|2017-10-11 02:43:17.501767|2017-10-11 02:43:17.501767
NCT01646125|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-01-23|2016-11-03||November 2012||2012-11-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Full analysis set (FAS) comprised of all patients who were randomized to a study treatment.|An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations|A Multicenter, Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations Who Have Progressed on Prior EGFR TKI Treatment|Terminated||Phase 2|52|Actual|Novartis|The data monitoring committee (DMC's) recommendation based on the Interim Analysis (IA) results to terminate the study early due to futility, data was not collected for this assessment on many of the secondary endpoints.|2||"An interim analysis was conducted in May-2014. Upon review of the data, the committee   recommended study termination due to futility."|f||||t||||||||||2017-10-11 02:43:18.305463|2017-10-11 02:43:18.305463
NCT01646112|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-06-30|||April 25, 2012||2012-04-25|February 5, 2016|2016-02-05|February 5, 2016||2016-02-05|||||Observational|||Uncertain Genetic Test Results for Lynch Syndrome|Living in Lynch Syndrome Limbo: Exploring the Meaning of Uncertain Genetic Test Results|Completed||N/A|34|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:43:19.233109|2017-10-11 02:43:19.233109
NCT01646099|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-04-21|||November 2013||2013-11-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Sun Protection of Kidney Transplant Recipients|Internet-Based Sun Protection Program for Kidney Transplantation Recipients|Completed||N/A|335|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 02:43:19.316777|2017-10-11 02:43:19.316777
NCT01646086|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-11-30|||July 2012||2012-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|Tracking||Weight Tracking and Weight Loss Outcomes: Establishing the Standard of Care|Weight Tracking and Weight Loss Outcomes: Establishing the Standard of Care|Completed||N/A|339|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-11 02:43:19.407211|2017-10-11 02:43:19.407211
NCT01646073|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-01-14|2014-12-19||August 2012||2012-08-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Adalimumab (Humira®) in Chinese Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 3|425|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 02:43:19.544851|2017-10-11 02:43:19.544851
NCT01646060|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-07-17|||November 2011||2011-11-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw|Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw|Completed||Phase 1|10|Actual|Zynex Monitoring Solutions||1|||f||||f||||||||||2017-10-11 02:43:22.575782|2017-10-11 02:43:22.575782
NCT01646047|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2015-01-20|||May 2012||2012-05-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|DiVFuSS||Diabetes Visual Function Supplement Study|Effects of a Novel Dietary Supplement on Visual Function in Patients With Diabetes With and Without Early Diabetic Retinopathy|Completed||N/A|70|Actual|ZeaVision, LLC||4|||f||||t||||||||||2017-10-11 02:43:22.669955|2017-10-11 02:43:22.669955
NCT01646034|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-09-13|||September 2014||2014-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|Oligo||High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer|High-dose Alkylating Chemotherapy in Oligo-metastatic Breast Cancer Harboring Homologous Recombination Deficiency|Recruiting||Phase 3|86|Anticipated|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-11 02:43:22.766102|2017-10-11 02:43:22.766102
NCT01646021|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-01-11|2016-06-02||December 2012||2012-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|June 2015|Actual|2015-06-01||Interventional||Intent-to-treat (ITT) population included all participants randomized into the study.|Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy|A Randomized, Controlled, Open-Label, Multicenter Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, Versus Temsirolimus in Subjects With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy|Completed||Phase 3|280|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 02:43:22.931705|2017-10-11 02:43:22.931705
NCT01646008|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-12-02|||April 2012||2012-04-01|December 2015|2015-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood|Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood in Chronic Obstructive Pulmonary Disease (COPD) in Intensive Care Unit With Nasal Cannula|Completed||N/A|32|Actual|Hospital Universitario Getafe|||1||f||||f||||||||||2017-10-11 02:43:24.96596|2017-10-11 02:43:24.96596
NCT01645995|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-12-03|||March 2012||2012-03-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|REFORM||The Impact of Reformulated Foods on Cardiovascular Risk Factors|The Impact of Reformulated Product Consumption on Energy and Nutrient Intake, Body Composition, Vascular Function and Plasma Lipid and Glucose Concentrations|Completed||N/A|50|Actual|University of Reading||2|||f||||t||||||||||2017-10-11 02:43:25.05734|2017-10-11 02:43:25.05734
NCT01645982|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-02-09|||July 2012||2012-07-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Observational|||Comparative Analysis of Cerebral Oximetry and Mean Arterial Pressures at the Cerebral Level in the Beach Chair Position||Completed||N/A|60|Actual|Holy Cross Hospital, Florida|||1||f||||f||||||||||2017-10-11 02:43:25.144034|2017-10-11 02:43:25.144034
NCT01645969|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-11-01|||April 2011||2011-04-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265|A Follow-up Study to Evaluate the One-year Post Treatment Effects of Peginterferon Alfa-2a (PEGASYS) in Patients With HBeAg Positive Chronic Hepatitis B From the Original Study ML 22265|Completed||N/A|65|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:43:25.203066|2017-10-11 02:43:25.203066
NCT01645943|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-10-24|||January 2012||2012-01-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|MOSCA||Invasive vs Conservative Strategies in Non-ST-elevation Acute Coronary Syndrome and Comorbidities|Randomized Comparison Between Invasive and Conservative Strategies in Patients With Non-ST-segment Elevation Acute Coronary Syndrome and Comorbidities|Completed||Phase 4|109|Actual|University of Valencia||2|||f||||t||||||||||2017-10-11 02:43:25.469795|2017-10-11 02:43:25.469795
NCT01645930|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-07-17|||December 17, 2012|Actual|2012-12-17|July 2017|2017-07-01|April 10, 2017|Actual|2017-04-10|April 4, 2017|Actual|2017-04-04||Interventional|||Phase 1 Pharmacokinetic Study of Oral IXAZOMIB Plus Lenalidomide and Dexamethasone in Adult Asian Patients With Relapsed and/or Refractory Multiple Myeloma|A Phase 1 Pharmacokinetic Study of Oral IXAZOMIB (MLN9708) Plus Lenalidomide and Dexamethasone in Asian Patients With Multiple Myeloma|Completed||Phase 1|19|Actual|Takeda||1|||f||||f||||||||||2017-10-11 02:43:25.671229|2017-10-11 02:43:25.671229
NCT01645917|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-02-03|||August 2012||2012-08-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|SUPIR||Durability of Pulmonary Vein Isolation Following Cryoablation for Treatment of Paroxysmal Atrial Fibrillation|SUstained PV Isolation With aRctic Front Advance|Completed||Phase 4|21|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||f||||||||||2017-10-11 02:43:25.798473|2017-10-11 02:43:25.798473
NCT01645904|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2016-11-07|||February 2013||2013-02-01|November 2016|2016-11-01||||February 2018|Anticipated|2018-02-01||Observational|||A Social Media Approach to Improve Genetic Risk Communication Phase I|A Social Media Approach to Improve Genetic Risk Communication Phase I|Active, not recruiting||Phase 1|49|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-10-11 02:43:25.922472|2017-10-11 02:43:25.922472
NCT01645891|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2017-02-08|||April 2012||2012-04-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers|TCO2-2012-01 A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers|Completed||N/A|146|Actual|Electrochemical Oxygen Concepts, Inc.||2|||f||||f||||||||||2017-10-11 02:43:26.05121|2017-10-11 02:43:26.05121
NCT01645878|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-19|||January 2010||2010-01-01|January 2010|2010-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Education on Breast Feeding on Primiparous Women||Terminated||Phase 2/Phase 3|136|Actual|Mashhad University of Medical Sciences||3|||f||||t||||||||||2017-10-11 02:43:26.288759|2017-10-11 02:43:26.288759
NCT01645865|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-11-12|||May 2011||2011-05-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost|Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost|Completed||N/A|600|Actual|Elizabeth Glaser Pediatric AIDS Foundation|||2||f||||f||||||||||2017-10-11 02:43:26.365419|2017-10-11 02:43:26.365419
NCT01645852|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-02-06|||June 2012||2012-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection|A Randomized Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection|Completed||N/A|65|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 02:43:26.470777|2017-10-11 02:43:26.470777
NCT01645839|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-07-28|||August 2011||2011-08-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|DEPOSEIN||Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer|Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer. Randomized Phase III Study.|Recruiting||Phase 3|80|Anticipated|Centre Oscar Lambret||2|||f||||t||||||||No||2017-10-11 02:43:26.558361|2017-10-11 02:43:26.558361
NCT01645826|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2013-09-06|||July 2012||2012-07-01|September 2013|2013-09-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Efficacy Study of Cardizem in Pulmonary Arterial Hypertension|Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.|Unknown status|Recruiting|N/A|40|Anticipated|University of South Florida||2|||f||||t||||||||||2017-10-11 02:43:26.810384|2017-10-11 02:43:26.810384
NCT01645800|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2015-10-20|||August 2012||2012-08-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study|Effects of Lysozyme On Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study|Completed||Phase 4|408|Actual|Eisai Inc.||2|||f||||t||||||||||2017-10-11 02:43:26.931154|2017-10-11 02:43:26.931154
NCT01645774|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2012-07-19|||January 2011||2011-01-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Comparing Pain and Bruising of Subcutaneous Heparin Injection||Terminated||Phase 2/Phase 3|90|Actual|Mashhad University of Medical Sciences||4|||f||||t||||||||||2017-10-11 02:43:27.176748|2017-10-11 02:43:27.176748
NCT01645761|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-01-20|||June 2012||2012-06-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori|Additive Effect of Endonase on Eradication Rate of the 7-day Standard Proton Pump Inhibitor-based Triple Therapy for Helicobacter Pylori|Completed||N/A|112|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||||2017-10-11 02:43:27.265719|2017-10-11 02:43:27.265719
NCT01645748|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-18|||October 2008||2008-10-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|TPSHNSCC||Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer|Multicenter Phase II Study of Weekly Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|35|Actual|Chonnam National University Hospital||1|||f||||t||||||||||2017-10-11 02:43:27.362435|2017-10-11 02:43:27.362435
NCT01645735|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-12-24|2014-09-29||October 2012||2012-10-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||"Safety: all randomized who received any amount of study drug
MITT: all randomized who received any amount of IV study drug & had a confirmed CABP w/risk factors for MRSA (excluding those w/sole atypical pathogen)
mMITT: MITT subset, including subjects w/at least 1 typical bacterial pathogen identified from adequate micro specimen at baseline"|Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus|A Multicenter, Multinational, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil Versus Ceftriaxone Plus Vancomycin in Adult Subjects With Community-acquired Bacterial Pneumonia at Risk for Infection Due to Methicillin-resistant Staphylococcus Aureus|Completed||Phase 4|49|Actual|Forest Laboratories|Small number of subjects enrolled|2|||f||||f||||||||||2017-10-11 02:43:27.518842|2017-10-11 02:43:27.518842
NCT01645722|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-10-19|||July 2012||2012-07-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|AMP-5||Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites|Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites|Active, not recruiting||N/A|5|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 02:43:28.266384|2017-10-11 02:43:28.266384
NCT01645709|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2014-08-26|2014-08-26||April 2012||2012-04-01|August 2014|2014-08-01||||February 2013|Actual|2013-02-01||Interventional||Study was terminated and no data is available|Safety, Tolerability, and Efficacy of IA Verapamil in the Treatment of Joint Pain in Subjects With Osteoarthritis of the Knee|CS-201: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Intra-Articular Verapamil in the Treatment of JoinT Pain in Subjects With Osteoarthritis of the Knee|Terminated||Phase 1/Phase 2|81|Actual|Calosyn Pharma, Inc.||2||Sponsor decision to terminate study|f||||f||||||||||2017-10-11 02:43:28.545966|2017-10-11 02:43:28.545966
NCT01645696|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2013-04-19|||June 2012||2012-06-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics|Three-day, In-clinic, Clamp Evaluation of the BD 2nd Generation Continuous Glucose Sensor in Subjects With Type 1 Diabetes|Completed||Phase 1/Phase 2|30|Actual|Becton, Dickinson and Company||3|||f||||f||||||||||2017-10-11 02:43:28.8564|2017-10-11 02:43:28.8564
NCT01645566|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2012-07-19|||December 2007||2007-12-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Task Focusing Strategy During a Simulated Cardiopulmonary Resuscitation|Impact of a Task Focusing Strategy on Perceived Stress Levels and Performance During a Simulated Cardiopulmonary Resuscitation: A Randomized Controlled Trial|Completed||N/A|124|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 02:43:28.962274|2017-10-11 02:43:28.962274
NCT01645475|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2014-12-04|||April 2011||2011-04-01|December 2014|2014-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|SLEEP||Desmopressin Melt: Impact on Sleep and Daytime Functioning|Desmopressin Melt: Impact on Sleep and Daytime Functioning? A Prospective Study.|Completed||Phase 4|30|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 02:43:29.062384|2017-10-11 02:43:29.062384
NCT01645449|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-19|||June 2010||2010-06-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-way Crossover Oral BE Study of Atorvastatin Ca 80 mg Tablets of Dr. Reddy's and Lipitor 80 mg Tablets of Pfizer in Healthy Adult, Human Subjects Under Fasting Conditions|Completed||Phase 1|77|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 02:43:29.189267|2017-10-11 02:43:29.189267
NCT01645436|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2016-05-31|||September 2012||2012-09-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PAPEC||Physical Activity in Pediatric Cancer (PAPEC)|Physical Activity in Pediatric Cancer Patients With Solid Tumor Trial|Completed||N/A|49|Actual|Universidad Europea de Madrid||2|||f||||t||||||||||2017-10-11 02:43:29.286554|2017-10-11 02:43:29.286554
NCT01645423|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-19|||August 2009||2009-08-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-way Crossover Oral BE Study of Atorvastatin Ca 80 mg Tablets of Dr. Reddy's and Lipitor 80 mg Tablets of Pfizer in Healthy Adult, Human Subjects Under Fed Conditions|Completed||Phase 1|77|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 02:43:29.39273|2017-10-11 02:43:29.39273
NCT01645410|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-19|||March 2009||2009-03-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed Conditions|Open-label, Balanced, Randomized, Two-treatment, Two-sequence, Two-period, Single Oral Dose, Crossover BE Study of Atorvastatin Ca 40mg Tablets of Dr.Reddy's With Lipitor® 40 mg Tablets of Pfizer in Healthy Subjects Under Fed Conditions|Completed||Phase 1|71|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 02:43:29.502295|2017-10-11 02:43:29.502295
NCT01645397|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-01-15|||June 2011||2011-06-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Observational|||Exhaled Nitric Oxide and Airway Caliber in Children With Asthma|Exhaled Nitric Oxide and Airway Caliber in Children With Asthma|Completed||N/A|20|Actual|Atlantic Health System|||1||f||||f||||||||||2017-10-11 02:43:29.603378|2017-10-11 02:43:29.603378
NCT01645384|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-07-19|||May 2009||2009-05-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions|An Open-label, Randomized, Single Oral Dose, Two Way Crossover Bioequivalence Study of Atorvastatin Ca 40 mg Tablets of Dr.Reddy's With Lipitor® 40 mg Tablets of Pfizer in 74 Healthy, Adult, Human Subjects Under Fasting Conditions|Completed||Phase 1|69|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 02:43:29.689777|2017-10-11 02:43:29.689777
NCT01645371|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-10-17|||August 2012||2012-08-01|October 2014|2014-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Assessing a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation|Assessing the Content Validity of a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation|Completed||N/A|79|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:43:29.811556|2017-10-11 02:43:29.811556
NCT00005298|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1990||1990-07-01|June 2000|2000-06-01|June 1993|Actual|1993-06-01|||||Observational|||Inflammation, Autonomic Dysfunction and Airway Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.521729|2017-10-11 04:27:57.521729
NCT01645345|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-07-18|||July 2012||2012-07-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles|RF Pixel With Micro-Plasma Technology: Fractional Ablative Radiofrequency for the Treatment of Acne Scars and RF Pixel With Micro-Plasma Technology: Fractional Ablative Radiofrequency for the Treatment of Acne Scars and|Unknown status|Active, not recruiting|N/A|200|Anticipated|Alma Lasers Inc.||1|||f||||f||||||||||2017-10-11 02:43:30.027553|2017-10-11 02:43:30.027553
NCT01645332|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-10-07|||July 2012||2012-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus|Role of DLBS3233 in the Treatment of Subjects With New Onset of Type 2 Diabetes Mellitus|Completed||Phase 3|104|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 02:43:30.123992|2017-10-11 02:43:30.123992
NCT01645319|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-01-07|||February 2011||2011-02-01|July 2012|2012-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01|12 Months|Observational [Patient Registry]|RiGOR||Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma|A Prospective Observational Study Comparing the Effectiveness of Treatment Strategies for Open-Angle Glaucoma|Completed||N/A|2597|Actual|Agency for Healthcare Research and Quality (AHRQ)|||12||f||||f||||||||||2017-10-11 02:43:30.237936|2017-10-11 02:43:30.237936
NCT01645306|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-06-29|||March 2013||2013-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|Revacept/CS/02||Revacept in Symptomatic Carotid Stenosis (Revacept/CS/02)|Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups|Recruiting||Phase 2|150|Anticipated|AdvanceCor GmbH||3|||f||||t||||||||||2017-10-11 02:43:30.337194|2017-10-11 02:43:30.337194
NCT01645293|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-17||||||July 2012|2012-07-01||||||||Interventional|TECLA||Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides|Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides|Unknown status|Not yet recruiting|Phase 1|15|Anticipated|University of Cologne||1|||f||||t||||||||||2017-10-11 02:43:30.568297|2017-10-11 02:43:30.568297
NCT01645280|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-05-10|2014-12-12||August 2012||2012-08-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional||Analysis population included all randomized participants.|A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy|Completed||Phase 2|274|Actual|Janssen Research & Development, LLC||5|||f||||t||||||||||2017-10-11 02:43:30.691005|2017-10-11 02:43:30.691005
NCT01645267|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-19|||October 2010||2010-10-01|July 2012|2012-07-01|October 2013|Anticipated|2013-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Calcaneal Neck Lengthening Osteotomy With Artificial Bone Graft|Calcaneal Neck Lengthening Osteotomy - Allogen Bone Graft Material Versus a Hydroxyappatite / β- Tricalcium Phosphate Bone Substitute|Unknown status|Active, not recruiting|N/A|10|Anticipated|Aarhus University Hospital||1|||f||||t||||||||||2017-10-11 02:43:32.03593|2017-10-11 02:43:32.03593
NCT01645254|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-10-01|||September 2012||2012-09-01|October 2012|2012-10-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Interventional|||Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali|Phase 1b Clinical Trial Using Argemone Mexicana in Healthy Adults Infected or Not Infected With Plasmodium Falciparum in Mali: Pharmacokinetics and Observational Study|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|University of Bamako||1|||f||||f||||||||||2017-10-11 02:43:32.105956|2017-10-11 02:43:32.105956
NCT01645241|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2014-10-24|||July 2012||2012-07-01|March 2013|2013-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation|Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation|Completed||N/A|15|Actual|Institut Universitari Dexeus||1|||f||||f||||||||||2017-10-11 02:43:32.205501|2017-10-11 02:43:32.205501
NCT01645228|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-18|2012-08-14|||August 2012||2012-08-01|August 2012|2012-08-01|July 2013|Anticipated|2013-07-01|||||Observational|||Could Non-invasive Biochemical, Image or Physiological Index Predict Significant Coronary Arterial Stenosis in Symptomatic Adults?|Could Non-invasive Biochemical, Image or Physiological Index Predict Significant Coronary Arterial Stenosis in Symptomatic Adults?|Unknown status|Recruiting|N/A|120|Anticipated|Cathay General Hospital|||1||f||||t||||||||||2017-10-11 02:43:32.301442|2017-10-11 02:43:32.301442
NCT01645215|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2013-09-29|||January 2011||2011-01-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors|Phase I Study of Safety and Pharmacokinetics of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors|Completed||Phase 1|40|Actual|Hutchison Medipharma Limited||1|||f||||t||||||||||2017-10-11 02:43:32.438602|2017-10-11 02:43:32.438602
NCT01645202|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-06-18|||March 2012||2012-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2013|Actual|2013-12-01||Interventional|CHOICE||A Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: The CHOICE Trial|A Randomized Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: Medtronic CoreValve Versus Edwards SAPIEN XT (The CHOICE Trial)|Active, not recruiting||Phase 3|240|Anticipated|Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH||2|||f||||t||||||||||2017-10-11 02:43:32.674285|2017-10-11 02:43:32.674285
NCT01645189|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-07-07|||July 2012||2012-07-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|GC1111||Safety and Efficacy of Hunterase|To Evaluate the Safety and Efficacy of Hunterase(Idursulfase-beta) in Hunter Syndrome Patients < 6 Years of Age Receiving Idursulfase Enzyme Replacement Therapy|Completed||Phase 3|6|Actual|Green Cross Corporation||1|||f||||f||||||||||2017-10-11 02:43:32.768857|2017-10-11 02:43:32.768857
NCT01645176|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-03-26|2016-12-20||May 2012||2012-05-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional||Osteoarthritis of knee|Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee|Hydroxychloroquine/Atorvastatin in the Treatment of OA of the Knee|Completed||Phase 2|21|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 02:43:32.875971|2017-10-11 02:43:32.875971
NCT01645137|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2014-04-24|||July 2012||2012-07-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Effectiveness Of Osteopathic Manipulative Treatment In NICU: A Multicenter Clinical Trial|Effectiveness Of Osteopathic Manipulative Treatment In Neonatal Intensive Care Units: A Multicenter Randomized Clinical Trial|Completed||N/A|690|Anticipated|European Institute for Evidence Based Osteopathic Medicine||2|||f||||||||||||||2017-10-11 02:43:33.3157|2017-10-11 02:43:33.3157
NCT01645124|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-19|||May 2008||2008-05-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|June 2012|Actual|2012-06-01||Interventional|CYTO-PV||Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)|A Large-scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events In Patients With Polycythemia Vera (PV)|Terminated||Phase 3|365|Actual|Consorzio Mario Negri Sud||2||Low accrual rate not allowing planned sample size leads to a futility condition|f||||f||||||||||2017-10-11 02:43:33.436909|2017-10-11 02:43:33.436909
NCT01645111|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-02-03|2015-02-03||June 2012||2012-06-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||An Open-label Trial of Clevidipine for Controlled Hypotension During Spinal Fusion|An Open-label Trial of Clevidipine for Controlled Hypotension During Spinal Fusion|Completed||Phase 2/Phase 3|50|Actual|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-11 02:43:33.644245|2017-10-11 02:43:33.644245
NCT01645098|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-02-25|2015-02-04||August 2011||2011-08-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy|Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy|Completed||N/A|53|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 02:43:33.952033|2017-10-11 02:43:33.952033
NCT01645085|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2013-03-18|||July 2012||2012-07-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|Fosta BE||A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib|An Open-label, Single-center, Randomized, 4-way Crossover Study to Assess the Bioequivalence of R406 in Healthy Volunteers When 100 and 150mg of Fostamatinib Are Administered as the 13% Drug-loaded Tablet Versus the 38% Drug-loaded Tablet|Completed||Phase 1|88|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 02:43:34.382221|2017-10-11 02:43:34.382221
NCT01645059|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2013-11-20|2013-07-09||July 2011||2011-07-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|PRIMHER||Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy|Observational, Cross-sectional, Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy (PRIMHER)|Completed||N/A|129|Actual|Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica|||1||f||||f||||||||||2017-10-11 02:43:35.682644|2017-10-11 02:43:35.682644
NCT01645033|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2014-09-11|||April 2012||2012-04-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients|Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients|Completed||N/A|63|Actual|Yale University||2|||f||||t||||||||||2017-10-11 02:43:36.263254|2017-10-11 02:43:36.263254
NCT01645020|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-18|||August 2008||2008-08-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|January 2013|Anticipated|2013-01-01||Observational|||Comparison Between Two Types of Meshes Used in Pelvic Organs Prolapse Procedures|Comparison Between Two Types of Meshes Used in Pelvic Organs Prolapse Procedures|Unknown status|Recruiting|N/A|240|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||t||||||||||2017-10-11 02:43:36.363173|2017-10-11 02:43:36.363173
NCT01645007|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2014-06-17||||||June 2014|2014-06-01||||||||Observational|||Prevalence of Hepatitis B Infection in the Galilee Region, Israel||Withdrawn||N/A|0|Actual|Western Galilee Hospital-Nahariya|||1|The study was not carried out due to lack of funding and budget problems|f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 02:43:36.442498|2017-10-11 02:43:36.442498
NCT01644994|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-08-22|||November 2012||2012-11-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma|Phase I Dose-Escalation /Phase II Monocentric Open Trial for Evaluation of Safety and Efficacy of Intracavitary Cisplatin-Fibrin Localized Chemotherapy After Pleurectomy/Decortication or Extrapleural Pneumonectomy for the Treatment of Patients With Malignant Pleural Mesothelioma|Recruiting||Phase 1/Phase 2|54|Anticipated|University of Zurich||1|||f||||f|f|f||||||||2017-10-11 02:43:36.511504|2017-10-11 02:43:36.511504
NCT01644981|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-05-09|||May 2012||2012-05-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational|||Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia|Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia|Completed||N/A|110|Actual|University of Zurich|||1||f||||f||||||Samples Without DNA|"     EDTA plasma   "|Undecided||2017-10-11 02:43:36.646708|2017-10-11 02:43:36.646708
NCT01644968|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-06-13|||November 2003|Actual|2003-11-01|June 2017|2017-06-01|April 2017|Actual|2017-04-01|May 2009|Actual|2009-05-01||Interventional|||Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer|Phase 1 Trial of a Monoclonal Antibody to OX40 in Patients With Advanced Cancer.|Completed||Phase 1|30|Actual|Providence Health & Services||2|||f||||f||||||||No||2017-10-11 02:43:36.751827|2017-10-11 02:43:36.751827
NCT01644604|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-06-30|||July 2012||2012-07-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|April 2015|Actual|2015-04-01||Interventional|HTN-J||Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension|The Clinical Study of Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension|Completed||N/A|41|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-10-11 02:43:48.549789|2017-10-11 02:43:48.549789
NCT01644955|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-09-25|||June 2012|Actual|2012-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Carboplatin in Treating Patients With Recurrent High-Grade Gliomas|Intracerebral Convection Enhanced Delivery of Carboplatin for Treatment of Recurrent High-grade Gliomas|Recruiting||Phase 1|42|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:43:36.884947|2017-10-11 02:43:36.884947
NCT01644942|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2013-06-17|||May 2008||2008-05-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Identification in Obese Patients of the Mechanism Involved in Intramuscular Lipid Accumulation|Identification in Obese Patients of the Mechanisms Involved in Intramuscular Lipid Accumulation.|Completed||N/A|33|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 02:43:37.042729|2017-10-11 02:43:37.042729
NCT01644929|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-09-18|||March 2013||2013-03-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|RECOMBINE||Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke|Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke to Increase Upper Limb Motor Recovery, a Randomised, Controlled, Double-blind Study|Recruiting||N/A|36|Anticipated|Ospedale Civico, Lugano||3|||f||||t||||||||||2017-10-11 02:43:37.159589|2017-10-11 02:43:37.159589
NCT01644916|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-04-04|||August 2012||2012-08-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|COPD_HSRG||"Consultation Liaison and Integrated Care for COPD Patients With Psychiatric Co-Morbidity"|"Consultation Liaison and Integrated Care for COPD Patients With Psychiatric Co-Morbidity"|Active, not recruiting||N/A|900|Anticipated|National University, Singapore||2|||f||||t||||||||||2017-10-11 02:43:37.30217|2017-10-11 02:43:37.30217
NCT01644903|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-09-19|||April 2010||2010-04-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|"Mini-Liver"||Proteogenomic Monitoring and Assessment of Liver Transplant Recipients|Proteogenomic Monitoring and Assessment of Liver Transplant Recipients|Recruiting||N/A|1000|Anticipated|Northwestern University|||1||f||||f||||||Samples With DNA|"     Urine Sample - One half cup of urine (100 mL) will be taken for research tests at each study     visit.      Blood Sample - About 1.5 tablespoons (20.5 mL) will be taken for research tests at each study     visit.      Liver Biopsy - A liver biopsy is a procedure to remove and examine a small piece of liver     tissue. For this study, an extra tissue sample will possibly be taken during your biopsy. One     additional needle pass may be made to collect the sample for this study.   "|||2017-10-11 02:43:37.433686|2017-10-11 02:43:37.433686
NCT01644890|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-02-01|||July 2012||2012-07-01|February 2016|2016-02-01|January 2017|Actual|2017-01-01|July 2016|Actual|2016-07-01||Interventional|||A Phase III Study of NK105 in Patients With Breast Cancer|A Multi-national Phase III Clinical Study Comparing NK105 Versus Paclitaxel in Patients With Metastatic or Recurrent Breast Cancer|Completed||Phase 3|436|Actual|Nippon Kayaku Co.,Ltd.||2|||f||||t||||||||||2017-10-11 02:43:37.522403|2017-10-11 02:43:37.522403
NCT01644877|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-09-21|||March 2014||2014-03-01|September 2017|2017-09-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|DAS181-2-05||A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen|A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen|Completed||Phase 2|111|Actual|Ansun Biopharma, Inc.||2|||f||||t||||||||||2017-10-11 02:43:37.620667|2017-10-11 02:43:37.620667
NCT01644864|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-05-03|||July 2012||2012-07-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|TAP||Can Post-operative TAP Block Improve Quality of Recovery After C-sections in Patients on Methadone Maintenance?|Can Post-operative TAP Block Improve Quality of Recovery After C-sections in Patients on Methadone Maintenance Therapy for Opioid Abstinence?|Withdrawn||Phase 4|0|Actual|Thomas Jefferson University||2||No participants were enrolled. The PI left the institution.|f||||t||||||||||2017-10-11 02:43:37.798494|2017-10-11 02:43:37.798494
NCT01644838|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-19|||August 2010||2010-08-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Effect of Hyoscine and Promethazine on Labor Pain|Principal Investigator|Completed||Phase 2/Phase 3|93|Actual|Mashhad University of Medical Sciences||2|||f||||||||||||||2017-10-11 02:43:37.969075|2017-10-11 02:43:37.969075
NCT01644825|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-07-14|||December 2010||2010-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|May 2014|Actual|2014-05-01||Interventional|MITO-11||Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer|MITO-11: A Randomized Multicentre Phase II Trial With Pazopanib and Weekly Paclitaxel vs Weekly Paclitaxel in Platinum Resistant or Refractory Ovarian Cancer|Active, not recruiting||Phase 2|72|Anticipated|National Cancer Institute, Naples||2|||f||||f||||||||||2017-10-11 02:43:38.042068|2017-10-11 02:43:38.042068
NCT01644812|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2013-08-16|||March 2012||2012-03-01|August 2013|2013-08-01||||July 2013|Actual|2013-07-01||Interventional|||Lifestyle Interventions for Generalized Anxiety Disorder|Lifestyle Interventions for Generalized Anxiety Disorder|Terminated||N/A|10|Actual|Southern Methodist University||2|||f||||f||||||||||2017-10-11 02:43:38.200958|2017-10-11 02:43:38.200958
NCT01644799|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-04-25|||July 2013||2013-07-01|April 2017|2017-04-01||||August 2014|Actual|2014-08-01||Interventional|||Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma|A Phase I Trial of Lenalidomide and Idelalisib in Recurrent Follicular Lymphoma|Active, not recruiting||Phase 1|8|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 02:43:38.543573|2017-10-11 02:43:38.543573
NCT01644786|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-01-27|||August 2012||2012-08-01|September 2016|2016-09-01|August 2025|Anticipated|2025-08-01|August 2022|Anticipated|2022-08-01||Observational|||The Head and Neck Tumor Biobank|"Storage of Head and Neck Tumor Samples in a Biobank for Future Genomic-based Research Aiming at Improved Outcome Prediction:  The Head and Neck Tumor Biobank."|Recruiting||N/A|800|Anticipated|Maastricht Radiation Oncology|||1||f||||f||||||Samples With DNA|"     mucosal HNSCC oropharynx, hypopharynx, larynx, nasopharynx, oral cavity   "|No||2017-10-11 02:43:38.690178|2017-10-11 02:43:38.690178
NCT01644773|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-07-31|||November 27, 2012|Actual|2012-11-27|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)|Phase I Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)|Recruiting||Phase 1|50|Anticipated|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-11 02:43:38.860543|2017-10-11 02:43:38.860543
NCT01644760|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-03-25|||September 2012||2012-09-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Respiratory Variations in the Diameter of the Inferior Vena Cava With Spontaneous Ventilation|Respiratory Variations in the Diameter of the Inferior Vena Cava With Spontaneous Ventilation: A Physiological Study on Healthy Volunteers|Completed||N/A|52|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-11 02:43:39.022249|2017-10-11 02:43:39.022249
NCT01644747|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-08-22|||July 2012||2012-07-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|STICODEP||tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients|tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients: a Randomized, Double-blind, Placebo Controlled Study|Recruiting||Phase 2|120|Anticipated|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||No||2017-10-11 02:43:39.173863|2017-10-11 02:43:39.173863
NCT01644734|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2014-04-30|2014-03-28||November 2011||2011-11-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Patients from the Treated Set (TS) which are dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test|MATHS: Assessment of Health-status of Patients With COPD on MAintenance THerapy With Spiriva® HH Measured by CAT Test|Completed||Phase 4|1328|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:43:39.425696|2017-10-11 02:43:39.425696
NCT01644721|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2014-08-06|||July 2012||2012-07-01|August 2014|2014-08-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial of Additional Measles Vaccine to Reduce Child Mortality|A Two-site Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality in Rural Areas of Burkina Faso and Guinea-Bissau|Unknown status|Recruiting|Phase 4|3750|Anticipated|Bandim Health Project||2|||f||||t||||||||||2017-10-11 02:43:40.312684|2017-10-11 02:43:40.312684
NCT01644708|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2013-06-06|||January 2012||2012-01-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|ADPB-EMPW||Empowerment and Overweight - a Prospective Observational Study|Th Efficacy of Individual Empowerment on Overweight and Obese Patients - a Prospective Observational Study.|Completed||N/A|80|Actual|Azienda Per I Servizi Sanitari N. 2 Isontina|||1||f||||f||||||||||2017-10-11 02:43:40.41846|2017-10-11 02:43:40.41846
NCT01644695|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-09-11|2012-09-11||October 2011||2011-10-01|September 2012|2012-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|BARS||Review of Complex Recurrent Hernia Repair|Repair of Complex Recurrent Incisional Hernias With The Bony Anchoring Reinforcement System (BARS)|Enrolling by invitation||N/A|85|Actual|Institute For Advanced Reconstruction|||1||f||||t||||||||||2017-10-11 02:43:40.54736|2017-10-11 02:43:40.54736
NCT01644682|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-08-28|||May 2012||2012-05-01|July 2012|2012-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Replacement of Insecticides to Control Visceral Leishmaniasis (VL)|Replacement of Insecticides to Control Visceral Leishmaniasis|Completed||Phase 3|3600|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||t||||||||||2017-10-11 02:43:40.801903|2017-10-11 02:43:40.801903
NCT01644669|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-09-19|||May 2012|Actual|2012-05-01|September 2017|2017-09-01|December 2024|Anticipated|2024-12-01|February 2023|Anticipated|2023-02-01||Interventional|||Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System|A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer|Recruiting||N/A|1200|Anticipated|Xoft, Inc.||1|||f||||t||||||||||2017-10-11 02:43:40.930528|2017-10-11 02:43:40.930528
NCT01644656|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-03-27|||July 2012||2012-07-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)|Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease|Recruiting||N/A|75|Anticipated|VA Connecticut Healthcare System||1|||f||||f||||||||||2017-10-11 02:43:41.151022|2017-10-11 02:43:41.151022
NCT01644643|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-08-31|2015-09-28||January 2013||2013-01-01|August 2017|2017-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Microbiological modified intent to treat: all patients who have a diagnosis of cIAI or cUTI with a ceftazidime-resistant Gram-negative pathogen on the study-qualifying culture and who received at least 1 dose of study therapy.|Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens|An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens|Completed||Phase 3|345|Actual|Pfizer||2|||f||||||||||||||2017-10-11 02:43:41.373994|2017-10-11 02:43:41.373994
NCT01644630|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-02-22|||June 2012||2012-06-01|February 2017|2017-02-01||||December 2018|Anticipated|2018-12-01||Interventional|||To Compare Cemented Versus Screw-retained Implant-supported Single Crowns With Customized Zirconia Abutments|A Randomized Controlled Clinical Trial Comparing Cemented Versus Screw-retained Implant-supported Single Crowns With Customized Zirconia Abutments|Active, not recruiting||N/A|34|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 02:43:47.444433|2017-10-11 02:43:47.444433
NCT01644617|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-09-14|2016-12-20||October 2012||2012-10-01|September 2017|2017-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)|A Phase IIb, Randomized, Placebo-Controlled, Dose-Finding Clinical Trial to Study the Safety and Efficacy of MK-8237 Using an Environmental Exposure Chamber in Subjects With House Dust Induced Allergic Rhinitis/Rhinoconjunctivitis|Completed||Phase 2|124|Actual|ALK-Abelló A/S||3|||f||||f||||||||||2017-10-11 02:43:47.541735|2017-10-11 02:43:47.541735
NCT01644591|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-11-10|||August 2012||2012-08-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||Trial to Determine Local Control and Neurocognitive Preservation After Initial Treatment With Stereotactic Radiosurgery (SRS) for Patients With >3 Melanoma Brain Metastases|A Phase II Trial to Determine Local Control and Neurocognitive Preservation After Initial Treatment With Stereotactic Radiosurgery (SRS) for Patients With >3 Melanoma Brain Metastases|Recruiting||Phase 2|49|Anticipated|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 02:43:48.661262|2017-10-11 02:43:48.661262
NCT01644578|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-04-04|||October 2012||2012-10-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Prospective Use of Real-time MRI|Prospective Use of Real-time MRI|Recruiting||N/A|200|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:43:48.757273|2017-10-11 02:43:48.757273
NCT01644552|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-07-18|||August 2010||2010-08-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Positive Angle Kappa|Positive Angle Kappa: a Sign in Aniridia|Completed||N/A|16|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||||2017-10-11 02:43:48.954417|2017-10-11 02:43:48.954417
NCT01644539|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-05-01|||July 2011||2011-07-01|May 2017|2017-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Brain Activity and Hormonal Changes During Food Administration|Functional MRI of Satiety, the Interaction Between Gastric and Oral Stimulation and Related Hormones in Healthy Men|Completed||N/A|16|Actual|UMC Utrecht||3|||f||||f||||||||||2017-10-11 02:43:49.027658|2017-10-11 02:43:49.027658
NCT01644526|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-09-09|||January 2016|Actual|2016-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement|A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement|Terminated||N/A|6|Actual|Diaxamed LLC||1||An enhanced device has been developed|f||||t||||||||||2017-10-11 02:43:49.132792|2017-10-11 02:43:49.132792
NCT01644513|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2013-02-11|||July 2012||2012-07-01|July 2012|2012-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|EVERGREEN||Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients|Evaluation of Genetic Variants in Patients Under Treatment for Choroidal Neovascular (CNV) Age-related Macular Degeneration (AMD), Receiving Intravitreal Anti-VEGF Injections (Bevacizumab or Ranibizumab) to Evaluate the Association Between Genetic Load and Response to Therapy/Treatment Burden|Completed||N/A|196|Actual|Sequenom, Inc.|||2||f||||f||||||None Retained|"     Remnant samples of DNA will be destroyed after analysis is complete.   "|||2017-10-11 02:43:49.217003|2017-10-11 02:43:49.217003
NCT01644500|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-11-16|2015-08-03||July 2012||2012-07-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Baseline characteristics is reported for the modified intent-to-treat population, who are all randomized participants with a baseline glycosylated hemoglobin (HbA1c) measurement, with at least 1 post-baseline HbA1c measurement, and who received at least one dose of study drug.|A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus|The Efficacy and Safety of Once-Weekly, Subcutaneous Dulaglutide Monotherapy Compared to Glimepiride in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|807|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-10-11 02:43:49.36827|2017-10-11 02:43:49.36827
NCT01644487|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-08-15|||July 2012||2012-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|September 6, 2016|Actual|2016-09-06||Interventional|SENS-BTK||Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries(SENS-BTK)|Efficacy of Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries Following Successful Balloon Angioplasty Trial (Korean Vascular Intervention Multicenter Study)|Active, not recruiting||N/A|232|Anticipated|Korea University Guro Hospital||2|||f||||||||||||||2017-10-11 02:43:52.18266|2017-10-11 02:43:52.18266
NCT01644474|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2015-10-07|2015-08-20|2014-07-07|July 2012||2012-07-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|ODYSSEY MONO||Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia|A Randomized, Double-Blind, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy And Safety of SAR236553/REGN727 Over 24 Weeks in Patients With Hypercholesterolemia|Completed||Phase 3|103|Actual|Sanofi|Due to administrative error in the automated process (which was detected after database lock), planned dose up­titration criteria for LDL­C levels was changed from ≥100 mg/dL to ≥70 mg/dL.|2|||f||||t||||||||||2017-10-11 02:43:52.299922|2017-10-11 02:43:52.299922
NCT01644461|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-24|||April 2012||2012-04-01|July 2012|2012-07-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Interventional|||A Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Facial Wrinkles(Nasolabial Folds)|A Prospective, Multicentric, Open Label, Bio-Interventional, Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment of Facial Wrinkles (Nasolabial Folds)|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|Kasiak Research Pvt. Ltd.||1|||f||||t||||||||||2017-10-11 02:43:53.024501|2017-10-11 02:43:53.024501
NCT01644448|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-24|||March 2012||2012-03-01|July 2012|2012-07-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Interventional|||A Study to Determine the Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Dark Circles|A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate Safety & Efficacy Of Autologous Human Platelet Lysate (HPL) for Treatment of Periorbital Hyperpigmentation (Dark Circles)|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|Kasiak Research Pvt. Ltd.||2|||f||||t||||||||||2017-10-11 02:43:53.098287|2017-10-11 02:43:53.098287
NCT01644071|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-09-28|||February 2012||2012-02-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|Serogen||Serotonergic System and Violent Video Games|Genetic-pharmacological Neuroimaging of the Serotonergic System in Violent Video Games|Completed||N/A|47|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 02:44:03.215723|2017-10-11 02:44:03.215723
NCT01644435|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-10-12|||May 2012||2012-05-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring|A Prospective, Multicentric, Open Label, Bio Interventional, Phase I, Phase II Pilot Study to Evaluate the Safety and Efficacy of Autologous Human Platelet Lysate (HPL) for Treatment of Acne Scarring|Completed||Phase 1/Phase 2|19|Actual|Kasiak Research Pvt. Ltd.||2|||f||||t||||||||||2017-10-11 02:43:53.175303|2017-10-11 02:43:53.175303
NCT01644422|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-24|||January 2012||2012-01-01|July 2012|2012-07-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Interventional|||Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant|A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate Safety & Efficacy Of Autologous Human Platelet Lysate For Treatment Of Androgenetic Alopecia In Patients Undergoing Hair Transplant|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|Kasiak Research Pvt. Ltd.||3|||f||||t||||||||||2017-10-11 02:43:53.263086|2017-10-11 02:43:53.263086
NCT01644409|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-18|||January 2012||2012-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Observational|||Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up|Urgent-SQ Implant in Treatment of Overactive Bladder Syndrome: Nine-year Follow-up Study|Completed||N/A|8|Actual|Radboud University|||1||f||||t||||||||||2017-10-11 02:43:53.339175|2017-10-11 02:43:53.339175
NCT01644396|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2014-09-22|2014-09-09||May 2012||2012-05-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Intent-to-treat population, defined as all enrolled participants who received at least 1 dose of adalimumab.|An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation|An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab (Humira®) in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation|Completed||Phase 4|50|Actual|AbbVie||1|||f||||||||||||||2017-10-11 02:43:53.548129|2017-10-11 02:43:53.548129
NCT01644383|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-08-17|||February 2011||2011-02-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Meaning of Life in HIV-infected Youths|Meaning in Life of Youth Infected With HIV|Completed||N/A|48|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||f||||||||||2017-10-11 02:43:54.425966|2017-10-11 02:43:54.425966
NCT01644370|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2016-02-19|||September 2011||2011-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|July 2014|Actual|2014-07-01||Interventional|||Children With HIV and Asthma (CHIVAS)|Allergen Specific T Effector and T Regulatory Cell Response to Common Aeroallergens Following Immune Restoration in HIV-infected Children|Completed||N/A|20|Actual|The HIV Netherlands Australia Thailand Research Collaboration||3|||f||||f||||||||||2017-10-11 02:43:54.542038|2017-10-11 02:43:54.542038
NCT01644357|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2013-03-04|||August 2008||2008-08-01|March 2013|2013-03-01||||August 2011|Actual|2011-08-01||Interventional|||Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma|PROJECT IMPLEMENTATION OF PHARMACEUTICAL CARE IN SEVERE ASTHMA IN OUTPATIENT PHARMACY DEPARTMENT.|Unknown status|Recruiting|N/A|40|Anticipated|Federal University of Bahia||2|||f||||t||||||||||2017-10-11 02:43:54.657889|2017-10-11 02:43:54.657889
NCT01644344|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-10-03|||January 2012||2012-01-01|March 2012|2012-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|SPOR||A Prospective Trial Comparing the Cost of Post Operative X-rays for Fractures Treated With Stable Internal Fixation|Pilot Study for a Randomized Control Trial Comparing the Cost of a Simplified Post-Operative Radiographic (SPOR) Protocol for Fractures With Stable Internal Fixation Treated at Health Sciences Centre|Completed||Phase 3|39|Actual|University of Manitoba||2|||f||||||||||||||2017-10-11 02:43:54.768003|2017-10-11 02:43:54.768003
NCT01644331|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2017-03-17|2017-01-06||October 2012||2012-10-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|TACTICS-HF||Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure|The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study|Completed||Phase 3|257|Actual|Duke University||2|||f||||t||||||||Undecided|Not yet decided.|2017-10-11 02:43:54.868606|2017-10-11 02:43:54.868606
NCT01644318|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-18||||||July 2012|2012-07-01||||||||Observational|||CXCL9 and CXCL11 Levels in Patients With Autoimmune Thyroiditis and Habitual Abortions||Unknown status|Active, not recruiting|N/A|||Ankara Education and Research Hospital|||3||f||||||||||||||2017-10-11 02:43:55.950918|2017-10-11 02:43:55.950918
NCT01644305|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-17|2012-07-18||||||July 2012|2012-07-01||||||||Observational|||Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.||Unknown status|Active, not recruiting|N/A|||Ankara Education and Research Hospital|||3||f||||||||||||||2017-10-11 02:43:56.029102|2017-10-11 02:43:56.029102
NCT01644292|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-02-12|2013-08-12||August 2012||2012-08-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EPIC WheelS||Enhancing Participation In the Community by Improving Wheelchair Skills: Phase 2|Enhancing Participation In the Community by Improving Wheelchair Skills (EPIC WheelS): Phase 2|Completed||Phase 1|2|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 02:43:56.10846|2017-10-11 02:43:56.10846
NCT01644279|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-11-02|||March 2006||2006-03-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Skeletal Muscle Apoptosis and Physical Performance; Oxidative RNA/DNA Damage and Repair in Aged Human Muscle|Claude D. Pepper Older Americans Independence Center (OAIC); Skeletal Muscle Apoptosis and Physical Performance; Oxidative RNA/DNA Damage and Repair in Aged Human Muscle|Completed||N/A|63|Actual|University of Florida|||3||f||||t||||||Samples With DNA|"     Skeletal muscle biopsy; plasma, serum, urine.   "|||2017-10-11 02:43:56.361757|2017-10-11 02:43:56.361757
NCT01644253|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-06-22|||September 2012||2012-09-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab, Obinutuzumab, Idelalisib, or Ibrutinib in Chronic Lymphocytic Leukemia|A Phase 1b, Open Label Study to Evaluate the Safety and Efficacy of TRU 016 in Combination With Rituximab, in Combination With Obinutuzumab, in Combination With Rituximab and Idelalisib, or in Combination With Ibrutinib in Patients With Chronic Lymphocytic Leukemia|Recruiting||Phase 1|123|Anticipated|Aptevo Therapeutics||7|||f||||f||||||||||2017-10-11 02:43:56.584376|2017-10-11 02:43:56.584376
NCT01643863|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-11-01|||August 2012||2012-08-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)|A Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab (TCZ)|Terminated||N/A|1|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:44:15.501319|2017-10-11 02:44:15.501319
NCT01644240|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2017-04-18|2016-12-21||September 2012|Actual|2012-09-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Intravenous Dose Study to Examine the Safety, Tolerability, and Pharmacokinetics of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects|Terminated||Phase 1|16|Actual|Theravance Biopharma R & D, Inc.|Early termination leading to small numbers of subjects analyzed.|3||For business reasons|f||||f||||||||Undecided||2017-10-11 02:43:56.785261|2017-10-11 02:43:56.785261
NCT01644227|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2016-05-11|||June 2012||2012-06-01|October 2015|2015-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Dual Mobility Cup in Total Hip Arthroplasty Preventing Dislocation in Patients at Risk|Dual Mobility Cup in Total Hip Arthroplasty Preventing Dislocation in Patients at Risk|Completed||N/A|34|Actual|Sundsvall Hospital|||1||f||||f||||||||||2017-10-11 02:43:58.066199|2017-10-11 02:43:58.066199
NCT01644214|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2016-11-07|||November 2016||2016-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|EPIC||Extended Pessary Interval for Care (EPIC Study)|Extended Pessary Interval for Care (EPIC Study): Patient Preference for 3 Verus 6 Month Follow-up|Recruiting||N/A|70|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 02:43:58.170871|2017-10-11 02:43:58.170871
NCT01644201|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-02-14|||October 2012||2012-10-01|October 2012|2012-10-01||||January 2014|Anticipated|2014-01-01||Interventional|||A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics|A Randomized, Double Blind, Placebo Controlled Trial Evaluating the Effects of a Highly Viscous Non-starch Polysaccharide (PolyGlycopleX® - PGX®), on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics Enrolled in a Medically Supervised Weight Management Program.|Unknown status|Recruiting|Phase 3|200|Anticipated|InovoBiologic Inc.||2|||f||||f||||||||||2017-10-11 02:43:58.315805|2017-10-11 02:43:58.315805
NCT01644188|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-06-23|2015-08-20|2015-02-09|August 2012||2012-08-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)|A Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 Versus Ezetimibe in High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Statin Therapy|Completed||Phase 3|720|Actual|Sanofi|"Manual reclassification was done by the Sponsor for the other reasons of non-completion of study as specified in the electronic case report form (eCRF)."|2|||f||||t||||||||||2017-10-11 02:43:58.494886|2017-10-11 02:43:58.494886
NCT01644175|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2015-10-07|2015-08-20|2015-02-09|July 2012||2012-07-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 in High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy|Completed||Phase 3|316|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 02:44:00.940302|2017-10-11 02:44:00.940302
NCT01644162|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-10-15|||July 2012||2012-07-01|March 2012|2012-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Ventilator Monitoring in Early Exacerbation Detection|Use of Ventilator Monitoring for Early Detection of Exacerbations of Chronic Lung Disease|Completed||N/A|30|Actual|ResMed||1|||f||||f||||||||||2017-10-11 02:44:02.50926|2017-10-11 02:44:02.50926
NCT01644149|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-03-14||2013-03-04|January 2012||2012-01-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe|A Randomized Controlled Clinical Trial Assessing the Immunologic Response to an FDA-approved Influenza Vaccine Delivered Using an FDA-Cleared Jet Injection Vaccine Delivery Device or a Needle and Syringe|Completed||Phase 4|83|Actual|PharmaJet, Inc.||2|||f||||f||||||||||2017-10-11 02:44:02.595704|2017-10-11 02:44:02.595704
NCT01644136|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-16|||July 2011||2011-07-01|July 2012|2012-07-01||||July 2012|Anticipated|2012-07-01||Interventional|||Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer|A Pilot Clinical Trial for the Prevention of Postoperative Lymphoceles Using Absorbable Micorporous Polysaccharide Hemosphere Particles During Robotic Assisted Prostatectomy With Lymph Node Dissection|Unknown status|Recruiting|N/A|100|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:44:02.696316|2017-10-11 02:44:02.696316
NCT01644123|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-01-25|||April 2013||2013-04-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Reliability of an Algorithm to Diagnose Spasticity|Inter-Rater Reliability of a Spasticity Diagnosis Algorithm|Completed||N/A|72|Actual|Vanderbilt University|||1||f||||f||||||||||2017-10-11 02:44:02.786725|2017-10-11 02:44:02.786725
NCT01644110|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-12-10|||August 2013||2013-08-01|December 2014|2014-12-01|January 2021|Anticipated|2021-01-01|January 2018|Anticipated|2018-01-01||Interventional|POMINC||Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF|A Phase-Ib/II Study of Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary Myelofibrosis|Recruiting||Phase 1/Phase 2|72|Anticipated|University of Ulm||1|||f||||t||||||||||2017-10-11 02:44:02.882489|2017-10-11 02:44:02.882489
NCT01644097|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-02-12|||November 2012||2012-11-01|February 2014|2014-02-01||||September 2014|Anticipated|2014-09-01||Interventional|||Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy|A Phase II Feasibility and Correlative Study of Probiotic Supplementation in Cancer Patients Receiving Chemotherapy or Tyrosine Kinase Inhibitors (TKIs)|Withdrawn||Phase 2|0|Actual|Stanford University||2||issues with obtaining study product|f||||t||||||||||2017-10-11 02:44:02.988406|2017-10-11 02:44:02.988406
NCT01644084|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-18|||June 2009||2009-06-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||A Comparison Between 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 in Priming Solution for Cardiopulmonary Bypass and Post-bypass Maintenance Fluid in High-risk Patients||Completed||N/A|54|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 02:44:03.101876|2017-10-11 02:44:03.101876
NCT01644058|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-05-01|2013-08-26||June 2011||2011-06-01|May 2017|2017-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Immediate Loading Of Dental Implants: A Pilot Clinical Study|Immediate Loading Of Dental Implants In Mandible Full-Arch: A Pilot Clinical Study On Patients Satisfaction, Quality Of Life And Implant Success|Completed||N/A|18|Actual|Université de Montréal|Phase-I clinical trial with small sample size and a pre-post design with no control group.|1|||f||||t||||||||||2017-10-11 02:44:03.329845|2017-10-11 02:44:03.329845
NCT01644045|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-09-21|||August 2012||2012-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2013|Actual|2013-07-01||Interventional|||Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation|Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation|Completed||N/A|17|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 02:44:03.53467|2017-10-11 02:44:03.53467
NCT01644032|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-09-21|||August 2012||2012-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2013|Actual|2013-07-01||Interventional|||Telemedically Supported Analgesia in the Emergency Medical Service|Telemedically Supported Analgesia in the Emergency Medical Service|Completed||N/A|106|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 02:44:03.624128|2017-10-11 02:44:03.624128
NCT01644019|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-09-21|||August 2012||2012-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2013|Actual|2013-07-01||Interventional|||Prehospital Telemedical Support in Acute Stroke|Prehospital Telemedical Support in Acute Stroke|Completed||N/A|28|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 02:44:03.702881|2017-10-11 02:44:03.702881
NCT01644006|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-09-21|||August 2012||2012-08-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|July 2013|Actual|2013-07-01||Interventional|||Telemedical Support in Prehospital Emergency Care of Acute Coronary Syndrome|Telemedical Support in Prehospital Emergency Care of Acute Coronary Syndromes|Completed||N/A|39|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 02:44:03.787489|2017-10-11 02:44:03.787489
NCT01643993|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-01-21|||May 2012||2012-05-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|January 2014|Actual|2014-01-01||Interventional|||Intrauterine Human Chorionic Gonadotropin at the Time of Embryo Transfer|Intrauterine Human Chorionic Gonadotropin at the Time of Embryo Transfer: A Randomized Controlled Trial|Completed||N/A|300|Actual|Reproductive Medicine Associates of New Jersey||2|||f||||f||||||||||2017-10-11 02:44:03.863996|2017-10-11 02:44:03.863996
NCT01643980|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-10-14|||August 2012||2012-08-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|PESAPRO||Prevention of Preterm Birth in Pregnant Women at Risk Identified by Ultrasound: Evaluation of Two Treatment Strategies|Prevention of Preterm Birth in Pregnant Women at Risk Identified by Ultrasound: Evaluation of Two Treatment Strategies|Completed||Phase 4|254|Actual|Puerta de Hierro University Hospital||2|||f||||f||||||||||2017-10-11 02:44:04.134858|2017-10-11 02:44:04.134858
NCT01643967|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-07-16|||June 2012||2012-06-01|July 2012|2012-07-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|PHIOZO0110||Clinical Trial to Evaluate the Efficacy and Safety of the Use of Ozone Versus Sunflower Oil in Treating Diabetic Foot|Clinical Trial, Open, Phase III, Multicenter, Randomized to Evaluate the Efficacy and Safety of the Use of Ozone Released by Philozon Medplus Device Versus Conventional Therapy in Treating Patients With Diabetic Foot.|Unknown status|Recruiting|Phase 3|100|Anticipated|Philozon Geradores de Ozonio LTDA||2|||f||||t||||||||||2017-10-11 02:44:04.268029|2017-10-11 02:44:04.268029
NCT01643954|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2013-12-19|||September 2008||2008-09-01|December 2013|2013-12-01|December 2035|Anticipated|2035-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James|Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at Ohio State University/The James.|Active, not recruiting||N/A|4000|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:44:04.379743|2017-10-11 02:44:04.379743
NCT01643941|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-07-25||2014-07-25|August 2012||2012-08-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|May 2013|Actual|2013-05-01||Interventional|||Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years|A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial to Evaluate the Safety, Tolerability and Immunogenicity of 3 Ascending Dose Levels of a 4-antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to < 86 Years|Completed||Phase 1/Phase 2|284|Actual|Pfizer||5|||f||||t||||||||||2017-10-11 02:44:04.468636|2017-10-11 02:44:04.468636
NCT01643928|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-05-09|2017-02-23||August 16, 2012||2012-08-16|April 2017|2017-04-01|March 14, 2016|Actual|2016-03-14|March 14, 2016|Actual|2016-03-14||Interventional|||Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)|Extension Study Evaluating Treatment With Pf-05280586 Versus Rituximab In Subjects With Active Rheumatoid Arthritis Who Have Participated In Other Pf-05280586 Clinical Trials|Completed||N/A|185|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 02:44:04.932188|2017-10-11 02:44:04.932188
NCT01643915|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-05-26|||September 2012||2012-09-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Behavior Management Using Audiovisual Tools|Behavior Management Using Audiovisual Tools in Pediatric Dental Patients|Unknown status|Recruiting|N/A|224|Anticipated|Universitat Internacional de Catalunya||3|||f||||f||||||||||2017-10-11 02:44:14.640488|2017-10-11 02:44:14.640488
NCT01643902|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-03-05|2016-01-19||January 2013||2013-01-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SAIL-ON||Safety of Intravenous Thrombolytics in Stroke on Awakening|Safety of Intravenous Thrombolytics in Stroke on Awakening|Completed||Phase 2|20|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 02:44:14.746692|2017-10-11 02:44:14.746692
NCT01643889|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-06-21|||July 2012||2012-07-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers|A Randomized, Double-Blind, Placebo- and Positive-Controlled, Single- and Multiple-Dose, 4-Way Crossover Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Subjects|Completed||Phase 1|44|Actual|Janssen Research & Development, LLC||4|||f||||||||||||||2017-10-11 02:44:15.100297|2017-10-11 02:44:15.100297
NCT01643876|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-12-23|2013-07-23||July 2012||2012-07-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Palatal Brushing on Denture Stomatitis|Phase-I Clinical Trial on the Effect of Palatal Brushing on Denture Stomatitis|Completed||Phase 1|48|Actual|Université de Montréal|One group pre-test post-test study. External validity limitations|1|||f||||t||||||||||2017-10-11 02:44:15.222435|2017-10-11 02:44:15.222435
NCT01643850|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-05-03|||April 23, 2012|Actual|2012-04-23|May 2017|2017-05-01|September 26, 2019|Anticipated|2019-09-26|September 26, 2019|Anticipated|2019-09-26||Interventional|||MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCTTS)|A Phase II Randomized, Double-blind (Part A, B and C), Placebo Controlled (Part A and B Only), Study to Assess Safety, Tolerability and Efficacy of MCS110 on Tumor Size in Patients With Pigmented Villonodular Synovitis (PVNS)|Recruiting||Phase 2|39|Anticipated|Novartis||2|||f||||f|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 02:44:15.590183|2017-10-11 02:44:15.590183
NCT01643837|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-01-19|||February 2016||2016-02-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Mastalgia Treatment: Is There a Role for Osteopathic Manipulative Treatment|Mastalgia Treatment: Is There a Role for Osteopathic Manipulative Treatment?|Not yet recruiting||N/A|87|Anticipated|New York Institute of Technology||3|||f||||f||||||||||2017-10-11 02:44:15.739242|2017-10-11 02:44:15.739242
NCT01643824|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-10-05|||June 2012||2012-06-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma|A Phase II Study Using Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|135|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-10-11 02:44:15.877452|2017-10-11 02:44:15.877452
NCT01643811|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-03-23|||April 2012||2012-04-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients|Effect of Gastrectomy and Anastomosis on Chronic Metabolic Disease Such as Diabetes and Hypertension in Early Gastric Cancer Patients|Completed||N/A|159|Actual|National Cancer Center, Korea|||2||f||||t||||||||||2017-10-11 02:44:15.979699|2017-10-11 02:44:15.979699
NCT01643798|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2014-03-10|2013-11-18||January 2011||2011-01-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia|Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia|Completed||N/A|15|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 02:44:16.06928|2017-10-11 02:44:16.06928
NCT01643785|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-01-20|||June 2012||2012-06-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection|Additive Effect of Endonase on the Efficacy of Bismuth-containing Quadruple Therapy as Second-line Treatment for Helicobacter Pylori Infection|Terminated||N/A|30|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||||2017-10-11 02:44:16.371658|2017-10-11 02:44:16.371658
NCT01643772|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-08-26|||May 2011||2011-05-01|August 2015|2015-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study|OxyNorm® Capsules (Immediate-Release) PK Study|Completed||Phase 1|61|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||1|||f||||f||||||||||2017-10-11 02:44:16.471514|2017-10-11 02:44:16.471514
NCT01643759|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-07-07|||July 2009||2009-07-01|July 2015|2015-07-01||||March 2010|Actual|2010-03-01||Interventional|||Norspan Transdermal Patches Study in Osteoarthritis Patients|A Single Dose PK Study of BTDS 5, 10, and 20 in Chinese Osteoarthritis Patients|Completed||Phase 1|30|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||1|||f||||f||||||||||2017-10-11 02:44:16.717287|2017-10-11 02:44:16.717287
NCT01643746|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-08-02|||December 2017|Anticipated|2017-12-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusive Disease|C-arm CT Evaluation of Luminal Expansion in Stenting Severe Femoro-popliteal Atherosclerotic Disease: Supera Versus LifeStent|Not yet recruiting||N/A|100|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f|f|t|f|f|t|||||2017-10-11 02:44:16.814769|2017-10-11 02:44:16.814769
NCT01643733|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-03-22|||October 2012||2012-10-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Study on Fistuloplasty Using Flow Measurement Guidance|Confirmation of Clinical Effectiveness and Safety of Use of Transonics in Determining Success of Intervention in Dialysis Fistulae|Terminated||N/A|26|Actual|McGill University Health Center||2||Not enough recruitment|f||||t||||||||||2017-10-11 02:44:16.915569|2017-10-11 02:44:16.915569
NCT01643720|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2015-04-07|||November 2010||2010-11-01|September 2013|2013-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Emotion Regulation in Preschoolers With Autism and Their Parents|Emotion Regulation in Preschoolers With Autism and Their Parents|Completed||N/A|80|Actual|Meir Medical Center|||2||f||||f||||||Samples Without DNA|"     Saliva used for cortisol and oxytocin extraction   "|||2017-10-11 02:44:17.006059|2017-10-11 02:44:17.006059
NCT01643707|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-10-04|||July 2012|Actual|2012-07-01|October 2017|2017-10-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|IMPROVE Brady||Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)|Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)|Recruiting||N/A|14850|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||2||f||||f||||||||||2017-10-11 02:44:17.079132|2017-10-11 02:44:17.079132
NCT01643694|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2013-09-27|||July 2012||2012-07-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Individualized Electronic Intervention to Promote Work Engagement|Randomized Controlled Trial Evaluating the Effect of An Individualized Electronic Intervention to Promote Resilience, Meaning, and Engagement for Physicians|Completed||N/A|288|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:44:17.264294|2017-10-11 02:44:17.264294
NCT01643681|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-03-24|||July 2012||2012-07-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|||Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration|Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration|Unknown status|Recruiting|Phase 1/Phase 2|8|Anticipated|Biostar||1|||f||||f||||||||||2017-10-11 02:44:17.424262|2017-10-11 02:44:17.424262
NCT01643668|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-06-14|2017-05-15||July 2012||2012-07-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation|Phase II Study of Reduced Intensity Conditioning With Busulfan/Clofarabine Followed by Allogeneic Stem Cell Transplantation|Completed||Phase 2|34|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:44:17.534905|2017-10-11 02:44:17.534905
NCT01643655|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-08-30|||May 2012||2012-05-01|August 2017|2017-08-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head|Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head|Completed||N/A|15|Actual|Biostar||1|||f||||f||||||||||2017-10-11 02:44:18.10501|2017-10-11 02:44:18.10501
NCT01643642|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2013-06-10|||March 2010||2010-03-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|K&K||Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders|A Efficacy and Cost-effectiveness Study of a Brief Interventions for Mood and Anxiety Disorders: Brief Intake, Treatment and Routine Outcome Monitoring (ROM)|Completed||N/A|182|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-11 02:44:18.19449|2017-10-11 02:44:18.19449
NCT01643629|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-24|||January 2012||2012-01-01|July 2012|2012-07-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Interventional|||A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia|A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment Of Androgenetic Alopecia (AGA)|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|Kasiak Research Pvt. Ltd.||2|||f||||t||||||||||2017-10-11 02:44:18.281871|2017-10-11 02:44:18.281871
NCT01643616|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-08-27|2013-03-21||November 2010||2010-11-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Ultrasound Guided Distal Sciatic Nerve Block - a Comparison With Nerve Stimulator Technique|Ultrasound Guided Distal Sciatic Nerve Block - a Randomised Comparison With Nerve Stimulator Technique|Completed||N/A|250|Actual|Helios Research Center||2|||f||||f||||||||||2017-10-11 02:44:18.374759|2017-10-11 02:44:18.374759
NCT01643603|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-04-09|||May 2012||2012-05-01|April 2017|2017-04-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|||Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies|Phase I/II Study of Dasatinib in Recipients of Allogeneic Stem Cell Transplantation for Hematologic Malignancies.|Recruiting||Phase 1/Phase 2|30|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 02:44:18.771673|2017-10-11 02:44:18.771673
NCT01643590|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-02-06|||July 2012||2012-07-01|February 2014|2014-02-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|STOP-HF||Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.|A Phase II Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of a Single Dose of JVS-100 Administered by Endomyocardial Injection to Cohorts of Adults With Ischemic Heart Failure|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|Juventas Therapeutics, Inc.||3|||f||||t||||||||||2017-10-11 02:44:18.947808|2017-10-11 02:44:18.947808
NCT01643577|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-08-31|||November 2011||2011-11-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Acupuncture Treatment for Gastroparesis: a Pilot Study|Acupuncture Treatment for Gastroparesis: a Pilot Study|Completed||Phase 1/Phase 2|20|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:44:19.072107|2017-10-11 02:44:19.072107
NCT01643564|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-01-06|||November 2011||2011-11-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Cytokine Profiling Post-Heart Transplant|Cytokine Profiling of Cardiac Transplant Recipients|Terminated||N/A|34|Actual|University of Minnesota - Clinical and Translational Science Institute|||4|Subject Recruitment|f||||f||||||||||2017-10-11 02:44:19.163874|2017-10-11 02:44:19.163874
NCT01643551|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-12-16|||June 2012||2012-06-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Observational|NSE-LVAD||Neuron Specific Enolase in Ventricular Assist Device Recipients|Neuron Specific Enolase in Ventricular Assist Device Recipients|Completed||N/A|15|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-11 02:44:19.223138|2017-10-11 02:44:19.223138
NCT01643538|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-03-04|||August 2012||2012-08-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Social Goals and Individual Incentives to Promote Walking in Older Adults|Social Goals and Individual Incentives to Promote Walking in Older Adults (Way to Walk II)|Completed||N/A|94|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 02:44:19.307505|2017-10-11 02:44:19.307505
NCT01643525|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2015-06-02|2015-06-02||June 2012||2012-06-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke|A NonRandomized, Multicenter, NonSig Risk Study With a NonInv, Passive PressureWave Method of Diagnosing Cerebral Anomalies to Develop a Diag. Algorithm for Cerebral Isch and to Test Sens./Spec. of This Algorithm in Determining Isch Stroke|Terminated||Phase 2|29|Actual|Jan Medical, Inc.||1||Insufficient Subject Recruitment|f||||f||||||||||2017-10-11 02:44:19.395399|2017-10-11 02:44:19.395399
NCT01643512|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-17|||August 2011||2011-08-01|July 2012|2012-07-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members|Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members|Unknown status|Recruiting|N/A|500|Anticipated|University of California, San Diego|||1||f||||f||||||Samples With DNA|"     serum, plasma, urine, stool, DNA   "|||2017-10-11 02:44:19.548696|2017-10-11 02:44:19.548696
NCT01617499|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-05-19|||January 2012||2012-01-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|PACE||Physical Activity for Campus Employees|Physical Activity for Campus Employees|Completed||N/A|141|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 02:51:23.802112|2017-10-11 02:51:23.802112
NCT01643486|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-07-17|||June 2012||2012-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|||Development of a 'Phosphate Counting Program'|Development of a 'Phosphate Counting Program' on an iTouch to Simplify Self-management of Dietary Phosphate by Patients With End Stage Renal Disease(ESRD) Treated With Peritoneal Dialysis|Active, not recruiting||N/A|80|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 02:44:19.918601|2017-10-11 02:44:19.918601
NCT01643473|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-10-04|||April 2013||2013-04-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Tailored Approaches to Improve Medication Adherence|Tailored Approaches to Improve Medication Adherence|Recruiting||N/A|40|Anticipated|New York University School of Medicine||2|||f||||t|f|f||||||||2017-10-11 02:44:20.010172|2017-10-11 02:44:20.010172
NCT01643460|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-08-08|||September 2009||2009-09-01|August 2017|2017-08-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts|Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts|Recruiting||N/A|22|Anticipated|Indiana University||1|||f||||f||||||||||2017-10-11 02:44:20.134467|2017-10-11 02:44:20.134467
NCT01643447|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-03-30|||May 2012||2012-05-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)|A Prospective Randomized Trial Comparing Ulinastatin's Drug Protection in Hepatocellular Carcinoma(HCC)Patients'Postoperative Hepatic Failure|Completed||N/A|200|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 02:44:20.242501|2017-10-11 02:44:20.242501
NCT01643434|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-06-06|||August 2012||2012-08-01|June 2013|2013-06-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Interventional|ReHOT||Resistant Hypertension Optimal Treatment|Multicenter Study of Patients With Hypertension Resistant to Patient Identification and Standardization of Therapeutic|Unknown status|Recruiting|Phase 4|2000|Anticipated|Instituto do Coracao||2|||f||||t||||||||||2017-10-11 02:44:20.33776|2017-10-11 02:44:20.33776
NCT01643421|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-08-07|||January 2011||2011-01-01|August 2014|2014-08-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Effect of a Program of Deep Inspiration Combined to Expiratory Positive Airway Pressure in Asthmatic|Effects of a Program of Deep Inspiration Combined to Expiratory Positive Airway in Quality of Life and Heart Rate Variability|Completed||N/A|14|Actual|Federal University of Health Science of Porto Alegre||2|||f||||t||||||||||2017-10-11 02:44:20.449337|2017-10-11 02:44:20.449337
NCT01643408|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-05-08|||November 2012||2012-11-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy|Phase II, An Open Label, Single Arm, Multi-Center Pharmacokinetic Study of Intravenous Erwinaze (Asparaginase Erwinia Chrysanthemi)Following Allergy to Native E. Coli Asparaginase (Elspar or Kidrolase), Pegaspargase (Oncaspar) or Calaspargase Pegol (EZN-2285) in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma.|Completed||Phase 2|30|Actual|Jazz Pharmaceuticals||1|||f||||t||||||||||2017-10-11 02:44:20.525057|2017-10-11 02:44:20.525057
NCT01643395|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2014-02-14|||September 2010||2010-09-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|VOLCANO||VertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures|VertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures|Completed||Phase 3|99|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:44:20.739389|2017-10-11 02:44:20.739389
NCT01643382|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-03-03|||August 2012|Actual|2012-08-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|HiRT||Hyperglycemia in Renal Transplantation|Randomized Study of the Impact of Peri-operative Glucose Control on Short Term Renal Allograft Function After Transplantation|Completed||N/A|60|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:44:20.84693|2017-10-11 02:44:20.84693
NCT01643369|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2014-12-05|||November 2012||2012-11-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Sounds of Compassion: Testing How Specific Elements of Meditation Change Daily Life|The Sounds of Compassion: Testing How Specific Elements of Meditation Change Daily Life|Completed||N/A|32|Actual|University of Arizona||3|||f||||t||||||||||2017-10-11 02:44:20.948741|2017-10-11 02:44:20.948741
NCT01643356|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-05-09|||July 2012||2012-07-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Interventions to Reduce Excess Weight Gain in Pregnancy|Interventions to Reduce Excess Weight Gain in Pregnancy in Overweight and Obese Mothers|Completed||N/A|50|Actual|Tufts University||3|||f||||f||||||||||2017-10-11 02:44:21.032709|2017-10-11 02:44:21.032709
NCT01643343|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-16|||October 2011||2011-10-01|July 2012|2012-07-01|October 2014|Anticipated|2014-10-01|October 2013|Anticipated|2013-10-01||Observational|||Measurement of Joint Attention Fluency|Measurement of Joint Attention Fluency|Unknown status|Recruiting|N/A|100|Anticipated|The Vista School|||2||f||||f||||||||||2017-10-11 02:44:21.125466|2017-10-11 02:44:21.125466
NCT01643330|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-02-25||2015-07-24|July 2012||2012-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|CUPID-2b||A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure|A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure|Completed||Phase 2|250|Actual|Celladon Corporation||2|||f||||t||||||||||2017-10-11 02:44:21.229199|2017-10-11 02:44:21.229199
NCT01643317|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-05-23|||July 2012||2012-07-01|May 2013|2013-05-01||||July 2013|Anticipated|2013-07-01||Observational|SCAN||Screening Cardiovascular Patients for Aortic Aneurysms|Screening Cardiovascular Patients for Aortic Aneurysms|Unknown status|Recruiting|N/A|1|Anticipated|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||||2017-10-11 02:44:21.451178|2017-10-11 02:44:21.451178
NCT01643304|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-11-20|||May 2012||2012-05-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|||||Observational|||A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings|A Swedish Cross-sectional Study With Questionnaire to Investigate Perception of Menstrual Bleeding|Completed||N/A|1547|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:44:21.539577|2017-10-11 02:44:21.539577
NCT01643122|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2014-10-10|||August 2012||2012-08-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Observational|VALEPRO||Validation Study for Endometriosis PRO|Validation Study to Assess Psychometric Properties of a Newly Developed Patient Reported Outcome Tool for Endometriosis|Completed||N/A|275|Actual|Bayer|||2||f||||f||||||||||2017-10-11 02:44:22.944127|2017-10-11 02:44:22.944127
NCT01643291|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-02-04|||July 2012||2012-07-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Ultrasound Use for Difficult Lumbar Punctures in Pediatric Oncology Patients|Ultrasound Imaging Facilitates Lumbar Punctures in Pediatric Oncology Patients With Difficult Surface Landmarks and/or a History of Difficult Lumbar Puncture|Terminated||N/A|3|Actual|Nationwide Children's Hospital||1||We were unable to recruit subjects for this study.|f||||f||||||||||2017-10-11 02:44:21.641136|2017-10-11 02:44:21.641136
NCT01643278|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-01-09|||July 2012||2012-07-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic|Phase I Study of Dasatinib in Combination With Ipilimumab for Patients With Advanced Gastrointestinal Stromal Tumor and Other Sarcomas|Completed||Phase 1|29|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 02:44:21.723834|2017-10-11 02:44:21.723834
NCT01643265|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-02-13|||July 2012||2012-07-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids|Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids|Completed||N/A|8|Actual|Metabolic Technologies Inc.||2|||f||||f||||||||||2017-10-11 02:44:21.832374|2017-10-11 02:44:21.832374
NCT01643252|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-06-20|||July 2012||2012-07-01|June 2017|2017-06-01||||||||Interventional|||Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery|A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery|Withdrawn||Phase 3|0|Actual|Avedro, Inc.||2||This study was withdrawn for business reasons.|f||||f||||||||||2017-10-11 02:44:21.91259|2017-10-11 02:44:21.91259
NCT01643239|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2013-02-27|||August 1996||1996-08-01|February 2013|2013-02-01||||September 2012|Actual|2012-09-01||Interventional|||Effects of Forms of Modified CIT on Upper Extremity Performance in Cerebral Palsy|Effects of Forms of Modified Constraint-induced Therapy on Functional Performance of Upper Extremity in Children With Cerebral Palsy With Asymmetric Motor Impairments: A Follow up Study of Kinematic and Clinical Analyses|Completed||N/A|60|Actual|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-10-11 02:44:22.003914|2017-10-11 02:44:22.003914
NCT01643226|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2017-06-20||2016-06-27|July 2012||2012-07-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus|A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus|Completed||Phase 3|230|Actual|Avedro, Inc.||2|||f||||f||||||||No||2017-10-11 02:44:22.111941|2017-10-11 02:44:22.111941
NCT01643213|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-05-05|2016-05-05||July 2012||2012-07-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|RESCUE||Randomized Study of Failed SCS Trials Comparing Outcomes Using the Observational Mechanical Gateway (OMG) Connector|Randomized Study of Failed SCS Trials Comparing Outcomes Using the Observational Mechanical Gateway (OMG) Connector|Completed||N/A|27|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 02:44:22.227686|2017-10-11 02:44:22.227686
NCT01643200|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2016-07-29|||October 2009||2009-10-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ZEN||Safety and Feasibility of the Zotarolimus Stent in Treating Males With Erectile Dysfunction (ED)|The Medtronic Zotarolimus-Eluting Peripheral Stent System for the Treatment of Erectile Dysfunction in Males With Sub-optimal Response to PDE5 Inhibitors|Terminated||Phase 2|30|Actual|Medtronic Endovascular||1||Sponsor chose not to pursue indication for erectile dysfunction|f||||t||||||||Undecided|The ZEN study was only a feasibility study with 30 subjects enrolled to see if therapy for this indication was viable. Although the preliminary data showed slight applicability/effectiveness, and no safety concerns, from a business standpoint, Medtronic chose not to pursue a pivotal trial and submit a PMA.|2017-10-11 02:44:22.456238|2017-10-11 02:44:22.456238
NCT01643187|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-07-16|||July 2012||2012-07-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Comparison of the Effect of Two Treatments on the Nutritional and Micronutrient Status of Malnourished Children|Comparison of the Effect of Two Treatments on the Nutritional and Micronutrient Status of Malnourished Children From the Takalik Abaj|Unknown status|Not yet recruiting|Phase 2|1000|Anticipated|Association for the Study and Prevention of HIV/AIDS||2|||f||||f||||||||||2017-10-11 02:44:22.557319|2017-10-11 02:44:22.557319
NCT01643174|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2013-06-19|||February 2012||2012-02-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Observational|PT||Predictors of Mortality and Morbidity in the Surgical Management of Primary Tumors of the Spine|Predictors of Mortality and Morbidity in the Surgical Management of Primary Tumors of the Spine: A Multi-center Retrospective Cohort Study With a Cross-Sectional Survival Check|Completed||N/A|1600|Actual|AOSpine International|||1||f||||f||||||||||2017-10-11 02:44:22.659955|2017-10-11 02:44:22.659955
NCT01643161|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-09-30|||April 2012||2012-04-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|||Guided Self-Help for Functional Neurological Symptoms|Guided Self-Help for Functional Neurological Symptoms: A Randomized Controlled Efficacy Trial|Terminated||N/A|33|Actual|Mayo Clinic||2||Slow accrual.|f||||f||||||||||2017-10-11 02:44:22.727386|2017-10-11 02:44:22.727386
NCT01643148|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2012-07-17|||January 2011||2011-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|October 2011|Actual|2011-10-01||Observational|leptin||The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer|Phase 1. Collect Samples of Breast Biopsy Patients Treated at the Hospital Radiology Service Maternal Perinatal Monica Pretelini|Completed||N/A|88|Actual|Materno-Perinatal Hospital of the State of Mexico|||2||f||||f||||||None Retained|"     serum   "|||2017-10-11 02:44:22.793756|2017-10-11 02:44:22.793756
NCT01643135|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-16|2013-12-17|||June 2012||2012-06-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Reduction Bleeding in Laminectomy With Double Doses of Tranexamic Acid|Reduction Perioperative Bleeding in Laminectomy With Instrumentation or More Than or Equal to 3 Levels Laminectomy: The Comparison Between Placebo, and Double Doses of Tranexamic Acid (15 mg/kg and 15 mg/kg)|Completed||Phase 4|78|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 02:44:22.851179|2017-10-11 02:44:22.851179
NCT00004407|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||February 1998||1998-02-01|January 2001|2001-01-01|March 2000||2000-03-01|||||Interventional|||Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy||Terminated||N/A|75||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.680208|2017-10-11 04:25:19.680208
NCT01643109|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-01-11|||March 2012||2012-03-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|OBI_CIMT||Constraint Induced Movement Therapy (CIMT)- Neuroimaging Predictors of Positive Response to Constraint|Childhood Hemiplegic CP Integrated Neuroscience Discovery Network (CP-NET) Theme IIIa: Constraint Induced Movement Therapy (CIMT)- Neuroimaging Predictors of Positive Response to Constraint|Completed||N/A|26|Actual|Holland Bloorview Kids Rehabilitation Hospital||2|||f||||t||||||||||2017-10-11 02:44:23.069474|2017-10-11 02:44:23.069474
NCT01643096|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2012-07-16|||August 2012||2012-08-01|July 2012|2012-07-01|August 2014|Anticipated|2014-08-01|August 2013|Anticipated|2013-08-01||Interventional|||The Effect of Thyme and Sumac on the Thermic Effect of Food and Comparison Between Warm and Cold Temperament People||Unknown status|Not yet recruiting|N/A|40|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:44:23.19136|2017-10-11 02:44:23.19136
NCT01643083|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2015-11-30|||January 2013||2013-01-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Rifaximin for Functional Dyspepsia|Use of Rifaximin in Patients With Functional Dyspepsia: A Randomized Controlled Trial|Completed||Phase 2/Phase 3|95|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:44:23.279925|2017-10-11 02:44:23.279925
NCT01643070|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-01-11|||January 2010||2010-01-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|September 2014|Actual|2014-09-01||Interventional|||Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases|Randomized Phase II Trial of Preoperative Chemoradiation With or Without Induction Chemotherapy In Patients With Locally Advanced Or Borderlinely Resectable Rectal Cancer With Resectable Synchronous Liver Metastases|Active, not recruiting||Phase 2|38|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:44:23.371404|2017-10-11 02:44:23.371404
NCT01643057|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-09-09|||July 2012||2012-07-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Stochastic Resonance Mattress (Physiological Interventions) and Biomarkers for Enhancing Neonatal Health|Stochastic Resonance Mattress (Physiological Interventions) and Biomarkers for Enhancing Neonatal Health|Completed||N/A|36|Actual|Wyss Institute at Harvard University|||1||f||||f||||||||||2017-10-11 02:44:23.45895|2017-10-11 02:44:23.45895
NCT01643044|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2014-07-07|2014-07-07||April 2011||2011-04-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Computer-delivered Screening and Brief Intervention for Alcohol Use in Pregnancy|Computer-delivered SBIRT for Alcohol Use in Pregnancy: Planning a Stage II Trial|Completed||Phase 1|48|Actual|Wayne State University||2|||f||||f||||||||||2017-10-11 02:44:23.54279|2017-10-11 02:44:23.54279
NCT01643031|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2013-06-14|||August 2012||2012-08-01|June 2013|2013-06-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|MATTIS-D||Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel|Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel|Unknown status|Not yet recruiting|Phase 4|500|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 02:44:24.033227|2017-10-11 02:44:24.033227
NCT01643018|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-07-16|||November 2006||2006-11-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|November 2010|Actual|2010-11-01||Interventional|||Laparoscopic Versus Open Surgery for the Management of Cystic Echinococcosis of the Liver|Laparoscopic Versus Open Conservative Surgery for the Management of Cystic Echinococcosis of the Liver: Prospective, Randomized, and Controlled Clinical Trial of Efficacy and Safety|Completed||N/A|350|Actual|Medical Park Gaziantep Hospital||2|||f||||t||||||||||2017-10-11 02:44:24.147528|2017-10-11 02:44:24.147528
NCT01643005|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-16|||August 2012||2012-08-01|July 2012|2012-07-01|July 2014|Anticipated|2014-07-01|January 2014|Anticipated|2014-01-01||Interventional|||A Couple-Based Relationship Strengthening HIV Intervention for Young Parents|Pilot Phase of Couples-Based Intervention to Reduce HIV/STD Risk (Concurrency, Number of Partners, Unprotected Sex), Strengthen Relationships, and Improve Parenting Among Young Parenting Heterosexual Couples|Unknown status|Not yet recruiting|N/A|100|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 02:44:24.256507|2017-10-11 02:44:24.256507
NCT01642992|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2013-01-09|||January 2011||2011-01-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Korean Coronary Bifurcation Stenting (COBIS) Registry II|Korean Coronary Bifurcation Stenting (COBIS) Registry II|Completed||N/A|2873|Actual|Samsung Medical Center|||1||f||||||||||||||2017-10-11 02:44:24.354313|2017-10-11 02:44:24.354313
NCT01642979|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-14|2013-01-01|||July 2012||2012-07-01|January 2013|2013-01-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|PNH-2012||Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria|Phase II Study of the Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|Institute of Hematology & Blood Diseases Hospital||3|||f||||t||||||||||2017-10-11 02:44:24.41796|2017-10-11 02:44:24.41796
NCT01642966|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-01-21|||September 2012||2012-09-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention|Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.|Completed||Phase 4|56|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 02:44:24.527202|2017-10-11 02:44:24.527202
NCT01642953|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-14|2012-07-18|||July 2012||2012-07-01|July 2012|2012-07-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|||Early Recovery After Gastric Cancer Surgery|Prospective Clinical Study for Early Recovery After Gastric Cancer Surgery|Unknown status|Recruiting|Phase 2|109|Anticipated|Ajou University School of Medicine||1|||f||||f||||||||||2017-10-11 02:44:24.610948|2017-10-11 02:44:24.610948
NCT01642940|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-01-21|||June 2012||2012-06-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study|Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study|Completed||Phase 4|30|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 02:44:24.787077|2017-10-11 02:44:24.787077
NCT01642927|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-01-19|||February 2012|Actual|2012-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|PWA-HF||Pulse Wave Analysis in Advanced Heart Failure|Pulse Wave Analysis in Advanced Heart Failure Patients Before and After Ventricular Assist Device|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute|||7|PI left University|f||||f||||||||||2017-10-11 02:44:24.863879|2017-10-11 02:44:24.863879
NCT01642914|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-03-24|2014-05-29||August 2012||2012-08-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional||A total of 487 patients were randomized to treatment (Randomized Population). The Safety population consists of the 486 randomized who received at least one dose of study drug. The Demographic and Baseline Characteristics data reported here is for the Safety Population.|Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating|Phase 3b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Chronic Constipation and Prominent Abdominal Bloating at Baseline|Completed||Phase 3|487|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 02:44:24.985194|2017-10-11 02:44:24.985194
NCT01642901|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-01-12|||May 2012||2012-05-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Zoledronic Acid in Acute Spinal Cord Injury|Zoledronic Acid to Prevent Bone Loss After Acute Spinal Cord Injury|Recruiting||Phase 3|48|Anticipated|Thomas Jefferson University||2|||f||||t||||||||Yes||2017-10-11 02:44:26.57766|2017-10-11 02:44:26.57766
NCT01642888|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-04-13|||September 2012||2012-09-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI|A Phase III Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®-TB Gold In-Tube, in Combination With a Double Blind Randomized Split Body Safety Assessment of C-Tb Versus 2 T.U. Tuberculin PPD RT23 SSI (PPD)|Completed||Phase 3|1190|Actual|Statens Serum Institut||2|||f||||t||||||||||2017-10-11 02:44:26.69808|2017-10-11 02:44:26.69808
NCT01642875|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-11-22|||November 2016||2016-11-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy|Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy for Periampullary Tumors: a Prospective, Randomized, Controlled Clinical Trial|Recruiting||Phase 4|96|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 02:44:26.813738|2017-10-11 02:44:26.813738
NCT01642862|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2015-06-02|||July 2012||2012-07-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Interventional|||Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration|A Phase I, Randomized, Open Label, Mono-centered, Prospective Study to Evaluate the Pharmacokinetics of Different Formulations and Doses of Simvastatin in Healthy Subjects and in Subjects With Celiac Disease in Remission|Terminated||Phase 1|12|Actual|University of Zurich||2||Low recruitment rate|f||||t||||||||||2017-10-11 02:44:26.930417|2017-10-11 02:44:26.930417
NCT01642849|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-13|||January 2009||2009-01-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|January 2013|Anticipated|2013-01-01||Interventional|||Effect of Diet Composition on Weight Change and Metabolic Parameters|Effect of Diet Composition on Weight Change and Metabolic Parameters|Unknown status|Recruiting|N/A|24|Anticipated|University of Tennessee||2|||f||||f||||||||||2017-10-11 02:44:27.011648|2017-10-11 02:44:27.011648
NCT01642836|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-01-23|||July 2012||2012-07-01|January 2014|2014-01-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|Stanford GOALS||Clinic, Family & Community Collaboration to Treat Overweight and Obese Children (Stanford GOALS)|Clinic, Family & Community Collaboration to Treat Overweight and Obese Children|Unknown status|Active, not recruiting|Phase 2|240|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 02:44:27.126716|2017-10-11 02:44:27.126716
NCT01642823|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-03-02|||July 2012||2012-07-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Cancer Biology of Retinoblastoma|Cancer Biology of Retinoblastoma|Terminated||N/A|8|Actual|Stanford University|||1|Logistics|f||||t||||||Samples With DNA|"     retinoblastoma tumor tissue sample   "|||2017-10-11 02:44:27.220578|2017-10-11 02:44:27.220578
NCT01642810|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2015-11-30|||September 2012||2012-09-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|||Online Acceptance-based Behavioural Treatment for Fibromyalgia|Online Acceptance-Based Behavioural Treatment for Fibromyalgia|Completed||Phase 3|67|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-11 02:44:27.306356|2017-10-11 02:44:27.306356
NCT01642797|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-17|||August 2012||2012-08-01|July 2012|2012-07-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|||Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma|Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma: A Multicenter, Randomized, Controlled Trial|Unknown status|Not yet recruiting|N/A|242|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-11 02:44:27.396238|2017-10-11 02:44:27.396238
NCT01642784|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-07-02|||November 2011||2011-11-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|CORAMIreg||Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction|Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction Registry(CORAMIreg)|Completed||N/A|100|Actual|Fundacja Ośrodek Badań Medycznych|||2||f||||f||||||||||2017-10-11 02:44:27.507755|2017-10-11 02:44:27.507755
NCT01642771|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2017-04-18|||June 2012||2012-06-01|April 2017|2017-04-01|May 2020|Anticipated|2020-05-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer|A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer|Active, not recruiting||Phase 3|636|Anticipated|China Breast Cancer Clinical Study Group||2|||f||||t||||||||||2017-10-11 02:44:27.602521|2017-10-11 02:44:27.602521
NCT01642758|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-03-13|||May 2012||2012-05-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|LB-04-THAL||Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon|An Open-Label Phase 2 Study of HQK-1001 in Subjects With Beta Thalassemia Intermedia|Completed||Phase 2|10|Actual|Boston University||1|||f||||t||||||||||2017-10-11 02:44:27.769471|2017-10-11 02:44:27.769471
NCT01642745|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-10-26|||November 2011||2011-11-01|October 2016|2016-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Mannitol (Aridol) and Methacholine (Provocholine) Responsiveness|Mannitol and Methacholine Responsiveness: Effects of Deep Inhalations|Completed||Phase 4|20|Actual|University of Saskatchewan||3|||f||||f||||||||No||2017-10-11 02:44:27.869723|2017-10-11 02:44:27.869723
NCT01642732|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2017-05-24|2014-11-13||October 2012||2012-10-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer|A Multi-institutional Phase I and Biomarker Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer|Terminated||Phase 1|1|Actual|University of Michigan Cancer Center|Only one patient was enrolled to the trial and consent was withdrawn prior to treatment therefore the primary objective could not be analyzed.|1||Lack of accrual and funding expires in June, 2014.|f||||t||||||||||2017-10-11 02:44:27.944506|2017-10-11 02:44:27.944506
NCT01642719|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2017-08-15|||July 1, 2012|Actual|2012-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|August 1, 2017|Actual|2017-08-01||Interventional|MSSS||Chronic Moderate Sleep Restriction in Older Adults|Chronic Moderate Sleep Restriction in Older Long Sleepers and Older Average Sleepers|Active, not recruiting||Phase 1|200|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:44:28.257951|2017-10-11 02:44:28.257951
NCT01642706|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-11-19|||July 2012||2012-07-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments|Regulatory B Cells in Inflammatory Rheumatisms, Systemic Auto-immune Diseases in Adults and Biomarkers of Response to Biologic Treatments|Recruiting||N/A|200|Anticipated|University Hospital, Montpellier|||2||f||||f||||||Samples Without DNA|"     Comparison of Bregs levels      Lymphocytes will be analyzed from :        -  circulating blood        -  serum        -  articular serum        -  synovial membrane   "|||2017-10-11 02:44:28.391275|2017-10-11 02:44:28.391275
NCT01642693|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-07-16|||June 2006||2006-06-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Histological Change of The Dentinal-Pulp Complex and Root Resorption|Histological Changes of The Dentinal-Pulp Complex and Root Resorption in Maxillary Premolars With Intrusive Orthodontic Movements Under a Low Power Laser Effect|Completed||Phase 1/Phase 2|34|Actual|Universidad de Antioquia||2|||f||||t||||||||||2017-10-11 02:44:28.469748|2017-10-11 02:44:28.469748
NCT01642680|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2017-04-20|||January 2013||2013-01-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|ACT||Optimal Timing of Physical Activity in Cancer Treatment|Optimal Timing of a Tailored Physical Activity Program During Chemotherapeutic Cancer Treatment to Reduce Long-term Cardiovascular Morbidity|Recruiting||N/A|206|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 02:44:28.539748|2017-10-11 02:44:28.539748
NCT01642667|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2012-07-26|||November 2008||2008-11-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|||Pharmacoinvasive Therapy With Prourokinase|The Efficacy and Safety of Pharmacoinvasive Therapy With Prourokinase for Acute ST Segment Elevation Myocardial Infarction Patients With Expected Percutaneous Coronary Intervention Related Delay|Completed||Phase 2/Phase 3|197|Actual|Suzhou Landing Pharmaceuticals||2|||f||||t||||||||||2017-10-11 02:44:28.626111|2017-10-11 02:44:28.626111
NCT01642654|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-16|||May 2010||2010-05-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Water Exercise and Vascular Function in Elderly|Nitrite Levels and Vascular Function in Elderly Women Submitted to Water Exercise: a Randomised Controlled Trial|Completed||N/A|40|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||t||||||||||2017-10-11 02:44:28.690264|2017-10-11 02:44:28.690264
NCT01642641|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-09-18|||January 2013||2013-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Different Surgical Modalities in the Treatment of Periodontitis|The Efficacy of Different Surgical Modalities in the Treatment of Periodontitis. A Randomised Controlled Trial|Recruiting||N/A|53|Anticipated|Queen Mary University of London||3|||f||||f||||||||||2017-10-11 02:44:28.76074|2017-10-11 02:44:28.76074
NCT01642628|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-03-28|||August 2012||2012-08-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Mirror Education for Women Undergoing Mastectomy|The Effect of Pre-Operative Education and Self-Reflection on Anxiety, Body Image, Depression and Emotional Well-Being of Women Undergoing Mastectomy|Completed||N/A|19|Actual|Texas Woman's University||2|||f||||f||||||||||2017-10-11 02:44:28.983534|2017-10-11 02:44:28.983534
NCT01642615|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-05-08|2015-05-08||July 2012||2012-07-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||Baseline measures are based on the Safety Analysis Set and included all enrolled participants who received at least one dose of study drug.|Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents|A Phase 2 Multicenter, 36-Week Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn, in Adolescent Subjects Aged 12 to 17 Years|Completed||Phase 2|63|Actual|Takeda||3|||f||||f||||||||||2017-10-11 02:44:29.1225|2017-10-11 02:44:29.1225
NCT01642602|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-07-14|2014-07-13||July 2012||2012-07-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Full analysis set: All participants who received at least 1 dose of study drug and had post-baseline data (and baseline data if applicable) for the appropriate efficacy variable.|Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents|A Phase 2 Open-Label, Multicenter, 4-Week Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Relief of Heartburn, in Adolescent Subjects Aged 12 to 17 Years With Symptomatic Non-Erosive Gastroesophageal Reflux Disease|Completed||Phase 2|104|Actual|Takeda||1|||f||||f||||||||||2017-10-11 02:44:29.964223|2017-10-11 02:44:29.964223
NCT01642589|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2013-11-08|2013-08-29||July 2012||2012-07-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea|Safety and Immunogenicity Study for Use of Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) Versus Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®) in Subjects 11 to 55 Years of Age in South Korea|Completed||Phase 3|300|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:44:30.497923|2017-10-11 02:44:30.497923
NCT01642199|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-01-31|||January 2013||2013-01-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Lay Health Coaches for Weight Loss: Peers Versus Mentors|A Randomized Trial Testing Lay Health Coaches for Obesity Treatment|Unknown status|Recruiting|Phase 3|272|Anticipated|The Miriam Hospital||3|||f||||t||||||||||2017-10-11 02:44:42.385093|2017-10-11 02:44:42.385093
NCT01642576|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-07-27|||July 2010||2010-07-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Comparing Effects of Diet, With or Without Exercise, on Sexual, Urinary and Endothelial Function, Inflammatory Profile and Quality of Life in Obese Men|Comparing Effects of Diet, With or Without Exercise, on Sexual, Urinary and Endothelial Function, Inflammatory Profile and Quality of Life in Obese Men|Completed||Phase 4|90|Actual|Changi General Hospital||2|||f||||f||||||||||2017-10-11 02:44:31.047233|2017-10-11 02:44:31.047233
NCT01642563|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-07-27|||October 2010||2010-10-01|September 2014|2014-09-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|IPTAS||Italian Platelet Technology Assessment Study|A Multi-center, Single-blind, Randomized, Parallel, Non Inferiority Study to Separately Investigate the Effect of Standard Platelets Versus Platelets Prepared With Two Commercial Procedures of Pathogen Reduction Technologies (PRT) on Bleeding Incidence and Severity in Thrombocytopenic Recipients|Terminated||Phase 3|456|Actual|Centro Nazionale Sangue||2||Patient enrolment below planned schedule|f||||t||||||||||2017-10-11 02:44:31.13446|2017-10-11 02:44:31.13446
NCT01642550|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-09-21||2015-12-02|November 2012||2012-11-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa|A Phase 2, Investigator-Initiated, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa|Completed||Phase 2|20|Actual|Motus Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 02:44:31.319922|2017-10-11 02:44:31.319922
NCT01642537|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-05-24|||November 2012||2012-11-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|December 2013|Actual|2013-12-01||Interventional|||Electroanatomical Mapping of Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System and Catheter|Electroanatomical Mapping of Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System and Catheter|Completed||N/A|7|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 02:44:31.431219|2017-10-11 02:44:31.431219
NCT01642524|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-13|||April 2004||2004-04-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|January 2006|Actual|2006-01-01||Interventional|TOPHR HIT||The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial (TOPHR HIT)|The Toronto Prehospital Hypertonic Resuscitation-Head Injury and Multi Organ Dysfunction Trial|Completed||Phase 3|114|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 02:44:31.518663|2017-10-11 02:44:31.518663
NCT01642511|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-08-24|||January 2012||2012-01-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|IMSLNB-EBCP||Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative|Phase II Trail of Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative|Unknown status|Recruiting|Phase 2|4|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||f||||||||||2017-10-11 02:44:31.630358|2017-10-11 02:44:31.630358
NCT01642498|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-09-15|||September 2012||2012-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension|ROX CONTROL HTN Study: A Prospective, Randomized, Open-Label, Multicenter Study to Evaluate the ROX Coupler in Patients With Resistant Hypertension|Active, not recruiting||Phase 3|100|Anticipated|ROX Medical, Inc.||2|||f||||t||||||||||2017-10-11 02:44:31.836371|2017-10-11 02:44:31.836371
NCT01642485|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-08-19|2014-06-06||July 2011||2011-07-01|August 2014|2014-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|C11035|The study population consisted of healthy non-smoking, subjects. Electrocardiograms in the placebo arm were recorded twice in fasted and fed condition.|Food and Insulin Effect on QT/QTC Interval of ECG|Evaluation of the Effect of Different Foods, Carbohydrate Meal, and a Euglycaemic Insulin Clamp on the QT/QTc Interval Using a Single Dose of Moxifloxacin as a Positive Control in Healthy Male and Female, Caucasian and Japanese Volunteers|Completed||Phase 1|32|Actual|Richmond Pharmacology Limited|Our findings based on the confirmatory and concentration-effect analysis suggest that any difference between ethnicities was most likely attributable to differences in plasma concentrations and not differences in sensitivity to moxifloxacin.|2|||f||||f||||||||||2017-10-11 02:44:32.183863|2017-10-11 02:44:32.183863
NCT01642472|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-01-07|||July 2012||2012-07-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|PEARLext2||PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata|A Phase III, Multicentre, Extension Study Investigating the Efficacy and Safety of Repeated Intermittent 3-month Courses of Open-label Administration of Ulipristal Acetate, in Subjects With Symptomatic Uterine Myomas and Heavy Uterine Bleeding|Completed||Phase 3|64|Actual|PregLem SA||1|||f||||t||||||||||2017-10-11 02:44:32.82529|2017-10-11 02:44:32.82529
NCT01642459|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-05-19|||September 2012||2012-09-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.|The Outcomes of Arteriovenous Fistula (AVF) Cannulated From Different Direction in Maintenance Hemodialysis Patients.|Terminated||N/A|10|Actual|Capital Medical University||2||The patients enrolled are limited.|f||||t||||||||||2017-10-11 02:44:32.947007|2017-10-11 02:44:32.947007
NCT01642446|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-10-14|||January 2013||2013-01-01|October 2016|2016-10-01|June 2022|Anticipated|2022-06-01|June 2022|Anticipated|2022-06-01||Interventional|||Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension|A Randomized Control Clinical Trial Between Precise Hepatectomy and Combined Interventional Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension|Recruiting||Phase 3|360|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 02:44:33.031443|2017-10-11 02:44:33.031443
NCT01642433|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-07-15|||July 2012||2012-07-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Prazosin for Smoking Cessation|Prazosin as a Novel Treatment for Smoking Cessation|Terminated||Phase 2|1|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 02:44:33.138556|2017-10-11 02:44:33.138556
NCT01642420|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-09-12|||April 2012||2012-04-01|September 2012|2012-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|DEMPROG||Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression|Quantitative Electroencephalography, Cerebrospinal Fluid Biomarkers, Linear CT Analyses and Timed Up and GO Dual Task as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression.|Unknown status|Recruiting|N/A|115|Anticipated|Zealand University Hospital|||3||f||||f||||||Samples Without DNA|"     Cerebrospinalfluid (CSF) CSF is analysed to find Alzheimer Disease biomarkers   "|||2017-10-11 02:44:33.230505|2017-10-11 02:44:33.230505
NCT01642407|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-04-03|2016-11-03||August 24, 2012|Actual|2012-08-24|April 2017|2017-04-01|December 30, 2017|Anticipated|2017-12-30|May 20, 2016|Actual|2016-05-20||Interventional||Efficacy analysis set included all participants who received at least 1 dose of study drug.|Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension|A Phase 3, Multi-center, Open-label Study To Investigate Safety, Efficacy, And Tolerability Of Sildenafil Citrate In Pediatric Patients With Pulmonary Arterial Hypertension|Active, not recruiting||Phase 3|6|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 02:44:33.339947|2017-10-11 02:44:33.339947
NCT01642394|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-05-25|||October 1, 2011|Actual|2011-10-01|May 2017|2017-05-01|December 1, 2016|Actual|2016-12-01|December 30, 2014|Actual|2014-12-30||Interventional|||Impact of Self-care Education Program in Patients With Type 2 Diabetes in Primary Care in the Basque Country|"Impact of Self-care Education Program Active Patient in Metabolic Control, Cardiovascular Risk and Quality of Life in Patients With Type 2 Diabetes in Primary Care in the Basque Country: Randomized Clinical Trial of 2 Years of Follow up"|Completed||N/A|594|Actual|Osakidetza||2|||f||||f||||||||No||2017-10-11 02:44:36.404376|2017-10-11 02:44:36.404376
NCT01642381|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-09-09|||May 2012||2012-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|April 2016|Actual|2016-04-01||Interventional|||Component Analysis for Motivational Interviewing|Component Analysis for Motivational Interviewing|Completed||N/A|139|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 02:44:36.542699|2017-10-11 02:44:36.542699
NCT01642368|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-14|2017-04-06|||June 2012||2012-06-01|April 2017|2017-04-01|September 2020|Anticipated|2020-09-01|November 2013|Actual|2013-11-01||Interventional|||The Optimum Omega-3 (003) Diet Study|The Optimum Omega -3 (003) Diet Study|Active, not recruiting||N/A|72|Anticipated|Pennington Biomedical Research Center||3|||f||||f||||||||||2017-10-11 02:44:36.636353|2017-10-11 02:44:36.636353
NCT01642355|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-12-30|||June 2012||2012-06-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|IMPACT||Prevention Trial to Achieve Cardiovascular Targets|Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets|Completed||N/A|400|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-10-11 02:44:36.739253|2017-10-11 02:44:36.739253
NCT01642342|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-14|2017-04-18|||September 6, 2012|Actual|2012-09-06|April 2017|2017-04-01|September 6, 2019|Anticipated|2019-09-06|September 6, 2018|Anticipated|2018-09-06||Interventional|||Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors|A First-In-Human Phase I Study of sEphB4-HSA in Patients With Advanced Solid Tumors With Expansion at the Maximum Tolerated Dose (MTD) or Recommended Phase II Dose (RP2D).|Recruiting||Phase 1|138|Anticipated|University of Southern California||3|||f||||t|t|f||||||||2017-10-11 02:44:36.84445|2017-10-11 02:44:36.84445
NCT01642329|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-10-07|||January 2002||2002-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ProACS||Portuguese Registry on Acute Coronary Syndromes|Portuguese Registry on Acute Coronary Syndromes|Recruiting||N/A|50000|Anticipated|Portuguese Society of Cardiology|||1||f||||f||||||None Retained|"     no samples retained   "|||2017-10-11 02:44:37.155262|2017-10-11 02:44:37.155262
NCT01642316|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-23|||October 2008||2008-10-01|October 2008|2008-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||The Effect of Washback on Reading Comprehension||Terminated||Phase 2/Phase 3|130|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:44:37.275406|2017-10-11 02:44:37.275406
NCT01642303|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-17|||January 2010||2010-01-01|January 2010|2010-01-01|January 2012|Actual|2012-01-01|June 2010|Actual|2010-06-01||Interventional|||The Effect of Vodcasting on Listening Comprehension||Terminated||Phase 2/Phase 3|106|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:44:37.34755|2017-10-11 02:44:37.34755
NCT01642277|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2015-10-30|2015-06-10||July 2012||2012-07-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional||Baseline analyses includes the baseline information of individuals lacking primary outcome measurements (i.e., patients that withdrew for any reason n = 24).|Bacterial Genomic Sequencing in Overactive Bladder|The Effect of Short Term Solifenacin for Overactive Bladder on the Female Urinary Microbiome|Completed||Phase 2|134|Actual|Loyola University||2|||f||||f||||||||||2017-10-11 02:44:37.439865|2017-10-11 02:44:37.439865
NCT01642264|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-16|||March 2008||2008-03-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|WeBREATHe II||Web-Based Respiratory Education About Tobacco and Health Phase II|Web-Based Respiratory Education About Tobacco and Health (WeBREATHe) Phase II|Completed||Early Phase 1|217|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-10-11 02:44:38.337374|2017-10-11 02:44:38.337374
NCT01642238|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-06-01|2014-08-14||July 2012||2012-07-01|June 2016|2016-06-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Antithrombotic Effects of Ticagrelor Versus Clopidogrel|Randomized, Crossover Study of the Antithrombotic Effects of Ticagrelor Plus Aspirin Versus Clopidogrel Plus Aspirin When Administered With Bivalirudin|Completed||Phase 4|15|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 02:44:39.796|2017-10-11 02:44:39.796
NCT01642225|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-10-17|||June 2012||2012-06-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Desensitization Protocol for Deceased Donor List|Desensitization Protocol for Deceased Donor List|Completed||N/A|180|Actual|University of Miami|||1||f||||f||||||||||2017-10-11 02:44:40.176324|2017-10-11 02:44:40.176324
NCT01642212|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-11-03|2015-09-30||July 2012||2012-07-01|March 2014|2014-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||The Safety Analysis Set, defined as all randomized participants who received at least 1 dose of double-blind study drug (placebo or OBS); subjects were analyzed based on the actual treatment received.|OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension|Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension|Completed||Phase 2|93|Actual|Shire||2|||f||||f||||||||||2017-10-11 02:44:40.398553|2017-10-11 02:44:40.398553
NCT01642186|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-08-15|||July 2012||2012-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)|A Randomized Three Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)|Active, not recruiting||Phase 2|84|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-11 02:44:42.667883|2017-10-11 02:44:42.667883
NCT01642173|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-09-30|||October 2010||2010-10-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Assessment of Coronary Plaque Composition Using Optical Coherence Tomography|Assessment of Coronary Plaque Composition Using Optical Coherence Tomography During Chronic Inhibition of Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity|Completed||Phase 1|41|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 02:44:42.776217|2017-10-11 02:44:42.776217
NCT01642160|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2013-03-05|||July 2012||2012-07-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|ICAN||Continous Positive Airway Pressure (CPAP) Compliance Study|ICAN (Improvement in CPAP Adherence Via the Net) Study|Completed||N/A|50|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:44:42.856542|2017-10-11 02:44:42.856542
NCT01642147|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2013-05-15|2013-03-09||November 2012||2012-11-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy|Cerebral Hyperemia During Emergence From General Anesthesia for Craniotomy of Patients With Brain Tumor|Completed||N/A|60|Actual|Huashan Hospital|The study population was not homogenous according to tumor size and location.|2|||f||||t||||||||||2017-10-11 02:44:42.95398|2017-10-11 02:44:42.95398
NCT01642134|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-06-02|||April 2013||2013-04-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|AUREA||Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI|PHASE IV Study of Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After Percutaneous Aortic Valve Implantation. Multicenter Randomized Clinical Trial|Recruiting||Phase 4|124|Anticipated|Hospital de Meixoeiro||2|||f||||t||||||||||2017-10-11 02:44:43.480981|2017-10-11 02:44:43.480981
NCT01642121|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-05-17|||August 2012||2012-08-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia|Observational - Rapid Identification of Leukemia Stem Cells Associated With AML1-ETO and Inv(16) Through Characterization of Oncogene-Induced Changes in Cell-Surface Antigen Profiles on Hematopoietic Stem Cells|Completed||N/A|20|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     bone marrow   "|||2017-10-11 02:44:43.720127|2017-10-11 02:44:43.720127
NCT01642108|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-08-19|||July 2012||2012-07-01|August 2012|2012-08-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Interventional|||Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus|The Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Glycemic Control and Inappropriate Glucagon Secretion in Non-obese Japanese Patients With Type 2 Diabetes.|Unknown status|Recruiting|N/A|40|Anticipated|Niigata Medical Center||1|||f||||f||||||||||2017-10-11 02:44:43.814527|2017-10-11 02:44:43.814527
NCT01642095|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2014-02-14|||August 2012||2012-08-01|February 2014|2014-02-01||||September 2012|Actual|2012-09-01||Observational|||Studying Biomarkers in Samples From Younger Patients With Kidney Cancer|Focal Adhesion Kinase Expression in Pediatric Renal Tumors|Withdrawn||N/A|0|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 02:44:43.914825|2017-10-11 02:44:43.914825
NCT01642082|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2017-05-03|2016-01-07||September 2012||2012-09-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Dalantercept, a Novel Soluble Recombinant Activin Receptor-Like Kinase 1 (ALK-1) Inhibitor Receptor-Fusion Protein, in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|28|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 02:44:44.02027|2017-10-11 02:44:44.02027
NCT01642069|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-15|2016-05-17|||July 2012||2012-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia|Observational - NUP98/JARID1A as a Recurrent Aberration in Pediatric Acute Megakaryoblastic Leukemia|Completed||N/A|100|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 02:44:44.550782|2017-10-11 02:44:44.550782
NCT01642056|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-14|2017-10-05|||June 22, 2012||2012-06-22|October 2, 2017|2017-10-02|April 1, 2018|Anticipated|2018-04-01|April 1, 2018|Anticipated|2018-04-01||Interventional|||EPI-743 for Metabolism or Mitochondrial Disorders|Therapeutic Trial of EPI -743 In Patients With Disorders of Energy Utilization or Oxidation-Reduction|Active, not recruiting||Phase 2|19|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:44:44.635468|2017-10-11 02:44:44.635468
NCT01642043|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-04-13|||June 2012||2012-06-01|April 2015|2015-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome|Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome (GTPS)|Unknown status|Active, not recruiting|N/A|120|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:44:44.719042|2017-10-11 02:44:44.719042
NCT01642030|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-09-07|||August 2013|Actual|2013-08-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance|Analgesic Effects and Abuse Liability of Intravenous Hydromorphone and Buprenorphine in Pain-free Opioid Dependent Participants|Completed||Phase 1|132|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 02:44:44.793279|2017-10-11 02:44:44.793279
NCT01642017|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2015-03-26|||March 2015||2015-03-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|October 2015|Anticipated|2015-10-01||Interventional|VOTRAGE||Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria|Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria|Unknown status|Recruiting|Phase 1|30|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||||2017-10-11 02:44:44.901189|2017-10-11 02:44:44.901189
NCT01641354|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-07|2012-07-12|||May 2009||2009-05-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|July 2012|Anticipated|2012-07-01||Interventional|||Comparison of Two Surgical Techniques to Treat Knock Knees in Children|Reversible Hemiepiphysiodesis in Children - Stapling Versus Eight Plate|Unknown status|Active, not recruiting|N/A|14|Anticipated|Aarhus University Hospital||1|||f||||t||||||||||2017-10-11 02:45:07.709964|2017-10-11 02:45:07.709964
NCT01642004|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-06-12|2016-02-19|2015-11-17|October 16, 2012|Actual|2012-10-16|June 2017|2017-06-01|January 23, 2018|Anticipated|2018-01-23|November 17, 2014|Actual|2014-11-17||Interventional||All randomized participants|Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)|An Open-Label Randomized Phase III Trial of BMS-936558 (Nivolumab) Versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 3|352|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-11 02:44:45.073374|2017-10-11 02:44:45.073374
NCT01641991|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-04-24|2014-04-17||July 2012||2012-07-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional||All participants are included in the baseline analysis population.|Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule|A Randomized Trial for the Assessment of Immunogenicity and Safety of Four Different Dosing Regimens of BioThrax® for Post-Exposure Prophylaxis for Anthrax in Adults|Completed||Phase 4|328|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 02:44:46.74404|2017-10-11 02:44:46.74404
NCT01641978|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-06-29|2013-07-01||January 2012||2012-01-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Observational|||Study of Glasgow Coma Scale in Neurological Patients|Study of Interobserver Correlation of Glasgow Coma Scale in Critical Neurological Patients|Completed||N/A|125|Actual|Hospital Universitario Getafe|||1||f||||f||||||||No||2017-10-11 02:44:49.350085|2017-10-11 02:44:49.350085
NCT01641965|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-02-19|||April 2012||2012-04-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Patients|Impact of Early Non-invasive Ventilation in Amyotrophic Lateral Sclerosis Patients: a Randomized Controlled Trial|Completed||N/A|42|Actual|Hospital Universitari de Bellvitge||2|||f||||t||||||||No||2017-10-11 02:44:49.545077|2017-10-11 02:44:49.545077
NCT01641952|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-07-07|2016-07-07||October 2011||2011-10-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational||Full analysis population included all participants who has fulfilled the eligibility criteria, and signed the informed consent form, participated at the screening examination.|An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent|Non-interventional, Prospective, Multicenter Study to Assess Efficacy and Safety of MabtheRA (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response or Intolerance to One Anti-TNF Agent - FAST 2 SWITCH Program|Completed||N/A|505|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:44:49.63122|2017-10-11 02:44:49.63122
NCT01641939|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2017-05-05|2016-06-30||September 3, 2012|Actual|2012-09-03|May 2017|2017-05-01|April 30, 2016|Actual|2016-04-30|June 30, 2015|Actual|2015-06-30||Interventional||Intent to treat (ITT) analysis population included all randomized participants; participants grouped according to the therapy they were randomized to receive.|A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer|A Randomized, Multicenter, Adaptive Phase II/III Study To Evaluate The Efficacy And Safety Of Trastuzumab Emtansine (T-DM1) Versus Taxane (Docetaxel Or Paclitaxel) In Patients With Previously Treated Locally Advanced Or Metastatic HER2-Positive Gastric Cancer, Including Adenocarcinoma Of The Gastroesophageal Junction|Terminated||Phase 2/Phase 3|415|Actual|Hoffmann-La Roche|The study was terminated by the Sponsor as the primary analysis results did not meet the primary endpoint.|3|||f||||||||||||||2017-10-11 02:44:50.321923|2017-10-11 02:44:50.321923
NCT01641926|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-03-10|2016-11-16||November 2012||2012-11-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||All Participants as Treated (APaT: all randomized participants who received ≥1 dose of study medication|A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)|A Multicenter Open-label Study to Evaluate the Safety and Efficacy of PEG-Intron™ Versus PEGASYS™ in Subjects With HBeAg Positive Chronic Hepatitis B and HBeAg Negative Chronic Hepatitis B Protocol No. MK-4031-376-00 (Also Known as SCH 054031, P08450)|Terminated||Phase 3|402|Actual|Merck Sharp & Dohme Corp.||4||This study was terminated early due to poor recruitment|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:44:52.491498|2017-10-11 02:44:52.491498
NCT01641913|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-06-20|||August 2012||2012-08-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients|Determination of Intestinal Permeability and Response to Treatment in Patients With Eosinophilic Esophagitis|Completed||Phase 1|20|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:44:53.449338|2017-10-11 02:44:53.449338
NCT01641900|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-05-16|2017-02-24||July 2012||2012-07-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||All participants completed both the Drug and Placebo arms|Effects of Eszopiclone on Sleep and Memory in Schizophrenia|Sleep-dependent Memory Processing in Schizophrenia|Completed||N/A|59|Actual|Massachusetts General Hospital||2|||f||||f||||||||No|There is no plan to share IPD data.|2017-10-11 02:44:53.536206|2017-10-11 02:44:53.536206
NCT01641887|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-04-01|||January 2014||2014-01-01|April 2013|2013-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Decision Aid for Gastroesophageal Reflux Disease Management|Personalized Decision Aid for the Management of Gastroesophageal Reflux Disease|Unknown status|Not yet recruiting|N/A|100|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:44:53.947649|2017-10-11 02:44:53.947649
NCT01641874|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2015-09-10|||November 2009||2009-11-01|September 2015|2015-09-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||The McKenzie System With Arthritic Knees: Do Some Knees Respond to Specific Exercise More Than General or no Exercise|The McKenzie System's Derangement Classification in Osteoarthritic Knees: Efficacy of McKenzie Treatment Versus Evidence Based Care: A Randomised Controlled Trial|Completed||Phase 1/Phase 2|180|Actual|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-11 02:44:54.042833|2017-10-11 02:44:54.042833
NCT01641341|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2014-06-23|||November 2010||2010-11-01|June 2014|2014-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Irritable Bowel Syndrome Evaluation and Treatment in Primary Care|Irritable Bowel Syndrome Evaluation and Treatment in Primary Care|Completed||Phase 4|61|Actual|American Academy of Family Physicians||2|||f||||f||||||||||2017-10-11 02:45:07.775237|2017-10-11 02:45:07.775237
NCT01641861|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-02-03|2015-12-06||August 2012||2012-08-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Comparative Study of Papacarie® and the Conventional Method for Dental Caries Treatment|Study of Papacarie® for Caries Removal.|Completed||N/A|488|Actual|Khon Kaen University|The limitations: First, the long duration of the trial caused participants to lost to follow up. Second, the operator and patients could not be blinded from the treatment status because of the apparent difference in the intervention techniques.|2|||f||||f||||||||No||2017-10-11 02:44:54.127808|2017-10-11 02:44:54.127808
NCT01641848|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2014-05-06||2014-04-15|December 2010||2010-12-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||INBONE™ Total Ankle Prosthesis With Long Talar Stem|Limited Enrollment of the INBONE™ Total Ankle Prosthesis With Long Talar Stem|Terminated||N/A|1|Actual|Wright Medical Technology||1||Lack of patient enrollment|f||||t||||||||||2017-10-11 02:44:54.451608|2017-10-11 02:44:54.451608
NCT01641835|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-10-26|2014-08-01||July 2012||2012-07-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Optical Coherence Tomography (OCT) Data Collection Study|"Optical Coherence Tomography (OCT) Data Collection Study S-2012-1 Norm-cc"|Completed||N/A|303|Actual|Heidelberg Engineering GmbH|||1||f||||t||||||||||2017-10-11 02:44:54.526177|2017-10-11 02:44:54.526177
NCT01641822|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-13|2016-04-06|2016-01-15||December 2012||2012-12-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|AZLI CAT|Intent-to-Treat (ITT) Analysis Set: all randomized participants|Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas Aeruginosa Infection in Subjects With Cystic Fibrosis|Completed||Phase 3|107|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 02:44:54.866441|2017-10-11 02:44:54.866441
NCT01641809|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-09-18||2014-03-13|August 1, 2012||2012-08-01|September 2017|2017-09-01|December 1, 2020|Anticipated|2020-12-01|October 10, 2013|Actual|2013-10-10||Interventional|||Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine|A Phase IIb, Dose Ranging Study of Oral GSK1265744 in Combination With Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus -1 (HIV-1) Virologic Suppression Followed by an Evaluation of Maintenance of Virologic Suppression When Oral GSK1265744 is Combined With Oral Rilpivirine in HIV-1 Infected, Antiretroviral Therapy Naive Adult Subjects|Active, not recruiting||Phase 2|244|Actual|ViiV Healthcare||4|||f||||f||||||||||2017-10-11 02:44:56.153564|2017-10-11 02:44:56.153564
NCT01641783|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-13|||July 2012||2012-07-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients|To Evaluate the Efficacy and Safety of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients:a Phase II Single Center Prospective Clinical Trial|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|The Third Affiliated Hospital of Harbin Medical University||1|||f||||t||||||||||2017-10-11 02:44:56.524343|2017-10-11 02:44:56.524343
NCT01641770|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-16|||October 2010||2010-10-01|July 2012|2012-07-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Oral Nutritional Supplementation in Hospital Patients|Oral Nutritional Supplementation in Hospital Patients|Completed||Phase 3|212|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-10-11 02:44:56.627705|2017-10-11 02:44:56.627705
NCT01641757|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-17|||May 2012||2012-05-01|July 2012|2012-07-01|October 2012|Anticipated|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Non-Surgical Periodontal Therapy on Serum Albumin Levels of Patients on Maintenance Hemodialysis Therapy,|Effect of Non-Surgical Periodontal Therapy on Serum Albumin Levels of Patients on Maintenance Hemodialysis Therapy, A Randomized Control Trial|Unknown status|Enrolling by invitation|Phase 2|160|Actual|University of the Punjab||1|||f||||t||||||||||2017-10-11 02:44:56.764349|2017-10-11 02:44:56.764349
NCT01641744|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-07-14|||August 2012||2012-08-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Efficacy of Group Attachment Based Intervention for Vulnerable Families|Birth to Three: A Pragmatic Clinical Trial for Child Maltreatment Prevention|Recruiting||N/A|100|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 02:44:56.865253|2017-10-11 02:44:56.865253
NCT01641731|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2012-07-12|||March 2009||2009-03-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Interventional|||Specific Oral Tolerance Induction in Children Allergic to Cow's Milk Proteins|Efficacy and Safety of Specific Oral Tolerance Induction in Children Allergic to Cow's Milk Proteins According to Their Serum Specific IgE Level|Completed||N/A|55|Actual|Instituto de Investigación Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-11 02:44:56.981193|2017-10-11 02:44:56.981193
NCT01641718|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-04-14|||January 2013||2013-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|TISTA||Use of Human Fibrin Glue Versus Staples for Mesh Fixation in Laparoscopic Transabdominal Preperitoneal Hernioplasty|Use of Human Fibrin Glue (Tisseel) Versus Staples for Mesh Fixation in Laparoscopic Transabdominal Preperitoneal Hernioplasty (TISTA)|Completed||N/A|82|Actual|Cantonal Hospital of St. Gallen||4|||f||||f||||||||||2017-10-11 02:44:57.071883|2017-10-11 02:44:57.071883
NCT01641705|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-07-16|||July 2010||2010-07-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|December 2012|Anticipated|2012-12-01||Observational|||Analysis of Respiratory Mechanics in Patients With Rheumatoid Arthritis|Analysis of Respiratory Mechanics in Patients With Rheumatoid Arthritis: Effect of Duration of Disease|Unknown status|Recruiting|N/A|90|Anticipated|Hospital Universitario Pedro Ernesto|||5||f||||f||||||||||2017-10-11 02:44:57.198961|2017-10-11 02:44:57.198961
NCT01640964|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-03-11|2015-12-14||April 2013||2013-04-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension|An Exploratory Study to Investigate the Haemodynamic Effects of Serelaxin (RLX030) in Patients With Compensated Cirrhosis and Portal Hypertension|Completed||Phase 2|47|Actual|Novartis||3|||f||||f||||||||||2017-10-11 02:45:13.817011|2017-10-11 02:45:13.817011
NCT01641692|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-01-27|2014-05-08|2013-07-25|May 2012||2012-05-01|January 2017|2017-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma|A Multi-national, Randomized, Double-blind, Placebo-controlled, 3-period Crossover Study With GSK 573719 as Monotherapy in Adult Subjects With Asthma|Completed||Phase 2|350|Actual|GlaxoSmithKline||8|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:44:57.363566|2017-10-11 02:44:57.363566
NCT01641679|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-06-16|||August 2012||2012-08-01|June 2014|2014-06-01|January 2016|Anticipated|2016-01-01|August 2015|Anticipated|2015-08-01||Observational|THYROPET||PET Evaluation of Recurrent Differentiated Thyroid Cancer|Recurrent Differentiated Thyroid Cancer: Towards Personalized Treatment Based on Evaluation of Tumor Characteristics With PET (THYROPET|Unknown status|Not yet recruiting|N/A|100|Anticipated|The Netherlands Cancer Institute|||1||f||||f||||||||||2017-10-11 02:45:00.609775|2017-10-11 02:45:00.609775
NCT01641666|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-09-07|||May 2014||2014-05-01|September 2015|2015-09-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)|An Open-Label Study to Assess the Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Any Interferon Plus Ribavirin in Vietnam|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 02:45:00.761801|2017-10-11 02:45:00.761801
NCT01641653|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-09-27|2014-10-02||June 2011||2011-06-01|November 2014|2014-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||non diabetics undergoing hernia repair|Does Preop Midazolam Maintain Blood Glucose Norms in the Non Diabetic Perioperative Period|Does the Administration of Preop Midazolam Assist in Maintaining Blood Glucose Norms in Non-diabetic Patient During the Perioperative Period|Completed||Phase 4|60|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 02:45:00.869826|2017-10-11 02:45:00.869826
NCT01641640|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-04-08|2014-02-25||June 2012||2012-06-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|NEUTRINO|Safety Analysis Set|Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection|A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of GS-7977 With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection|Completed||Phase 3|328|Actual|Gilead Sciences||1|||f||||t||||||||||2017-10-11 02:45:01.269813|2017-10-11 02:45:01.269813
NCT01641627|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-04-08|||March 2012||2012-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|PrevAtrophy||Preventive Effect of Proprioceptive Stimulation on Muscle Atrophy|Phase 2 Randomized Clinical Trial, Efficy of a Proprioceptive Stimulation Device in Term of Prevention of Muscle Atrophy of the Calf After Total Knee Replacement|Completed||Phase 1/Phase 2|34|Actual|University Hospital, Lille||1|||f||||t||||||||||2017-10-11 02:45:03.726059|2017-10-11 02:45:03.726059
NCT01641614|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-17|||April 2010||2010-04-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|March 2011|Actual|2011-03-01||Interventional|BAHMVR||Beating Versus Arrested Heart for Mitral Valve Replacement|Clinical and Ultramicroscopic Myocardial Randomized Study of On-Pump Beating Heart Mitral Valve Replacement|Completed||Phase 4|34|Actual|Federal University of Bahia||2|||f||||t||||||||||2017-10-11 02:45:03.833522|2017-10-11 02:45:03.833522
NCT01641601|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2014-12-02|||July 2012||2012-07-01|December 2014|2014-12-01||||July 2015|Anticipated|2015-07-01||Interventional|"PRIME"||Prehospital Cervical Ripening Before Induction and the Maternal Experience|Randomized Controlled Trial of Prehospital Cervical Ripening With an Outpatient Transcervical Foley Balloon and the Duration of Induction and Maternal Satisfaction|Unknown status|Recruiting|Phase 1/Phase 2|80|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:45:03.932739|2017-10-11 02:45:03.932739
NCT01641588|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-12|||March 2012||2012-03-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|sitstandcef||Are You Sitting Down: Cognitive Exectutive Function Task Comparison Between Seated and Standing Positions|Are You Sitting Down: Cognitive Exectutive Function Task Comparison Between Seated and Standing Positions Using Assessments From CNS Vital Signs Test Battery|Completed||Phase 1/Phase 2|19|Actual|University of Southampton||1|||f||||t||||||||||2017-10-11 02:45:04.010723|2017-10-11 02:45:04.010723
NCT01641575|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-03-08|||July 2012||2012-07-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin|A Phase I Open-Label, Ascending Dose Cohort Study of Gemcitabine Elaidate and Cisplatin in Patients With Advanced Solid Tumors Followed by an Expanded Cohort of Patients With Stage IIIb/IV NSCLC.|Terminated||Phase 1|8|Actual|Clovis Oncology, Inc.||1||"Registrational study did not meet endpoint so entire program (including CO-101-011) was   terminated."|f||||f||||||||||2017-10-11 02:45:04.078333|2017-10-11 02:45:04.078333
NCT01641562|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2016-01-27|||January 2012||2012-01-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Observational|CARDIOTAX||Diagnosis and Prediction of Taxanes Induced Cardiac Dysfunction|Diagnosis and Prediction of Subclinical Cardiac Dysfunction Induced by Therapy With Taxanes in Patients With Breast Cancer|Recruiting||N/A|60|Anticipated|Carol Davila University of Medicine and Pharmacy|||1||f||||t||||||Samples With DNA|"     Biomarkers: brain natriuretic peptides, troponin T, markers of myocardial fibrosis (β cross     laps and procollagen type-1 amino terminal), and markers of inflammation (PCR-hs, IL1, IL6,     IL 10, TNFalpha).      Markers of the oxidative stress: concentration of carbonyl in plasmatic proteins, and the     antioxidant capacity of plasma.      Genetic tests of susceptibility to cardiotoxicity: genomic DNA extraction kit/DNA     quantification tests/PCR tests.   "|||2017-10-11 02:45:04.173227|2017-10-11 02:45:04.173227
NCT01641549|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-03-08|||April 2017|Anticipated|2017-04-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|SAFE-PVT||Surgery Versus Fibrinolytic Therapy for Left-sided Prosthetic Heart Valve Thrombosis|Surgery Compared to Fibrinolytic Therapy for Symptomatic Patients With Left-sided Prosthetic Heart Valve Thrombosis|Not yet recruiting||Phase 3|115|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t|t|f|||f|||Undecided||2017-10-11 02:45:05.51913|2017-10-11 02:45:05.51913
NCT01641536|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2013-06-19|||November 2011||2011-11-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients|An Open-label, Dose-escalating Clinical Study to Evaluate the Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation (EP) in an Add-on Therapy With Entecavir in Chronic Hepatitis B Patients|Completed||Phase 1|9|Actual|Genexine, Inc.||3|||f||||f||||||||||2017-10-11 02:45:05.616574|2017-10-11 02:45:05.616574
NCT01641523|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-08-18|||January 2007||2007-01-01|August 2015|2015-08-01|September 2011|Actual|2011-09-01|January 2007|Actual|2007-01-01||Observational|||Controlled Study in Cranioplasty Reconstruction|Multicenter Prospective Controlled Study in Cranioplasty Reconstruction|Completed||N/A|91|Actual|Azienda Ospedaliero-Universitaria di Parma|||3||f||||t||||||||||2017-10-11 02:45:05.722528|2017-10-11 02:45:05.722528
NCT01641510|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-07-28|||October 2013||2013-10-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|PRAISE-GENE||PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants|Phase 3 Study Comparing the Efficacy and Safety of Prasugrel and Clopidogrel in Acute Coronary Syndrome Patients With CYP2C19 Polymorphism Who Undergo Percutaneous Coronary Intervention.|Recruiting||Phase 3|70|Anticipated|Dong-A University||2|||f||||t||||||||||2017-10-11 02:45:05.80893|2017-10-11 02:45:05.80893
NCT01641497|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-07-19|||May 2012|Actual|2012-05-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|TOMOGYN||Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer|Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer of 70 Years Old Women : Contribution of Oncogeriatric Evaluation to the Study of Acute Toxicity|Terminated||N/A|26|Actual|Centre Oscar Lambret||2||Recruitment difficulties|f||||t|f|f||||||||2017-10-11 02:45:05.924639|2017-10-11 02:45:05.924639
NCT01641484|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-07-19|||January 2012||2012-01-01|July 2017|2017-07-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|ANOXICOL||Study of a Predictor for Cervix Cancer|Study Evaluating Predictive Value of Local Control at 19.8 (MRI and TEP Scan) for Patient With Stade I to IIIB Cervix Carcinoma Treated by Radiotherapy|Terminated||N/A|9|Actual|Centre Oscar Lambret||1||unreached recruitment objectives|f||||f||||||||||2017-10-11 02:45:06.042195|2017-10-11 02:45:06.042195
NCT01641471|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-08-18|2016-02-11||December 2012||2012-12-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation of Electrical Nerve Stimulation (TENS) Therapy for Pain Relief Following Total Knee Arthroplasty (TKA)|Prospective Evaluation of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Relief Following Total Knee Arthroplasty (TKA)|Completed||N/A|116|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 02:45:06.134884|2017-10-11 02:45:06.134884
NCT01641458|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-01-31|||October 2012||2012-10-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|FLOXTOX2||Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients|Pharmacogenetics and Therapeutic Drug Monitoring for the Optimization of Fluoropyrimidine Treatment in Patients With Advanced Colorectal Cancer|Completed||Phase 4|37|Actual|Cantonal Hospital of St. Gallen||1|||f||||t||||||||||2017-10-11 02:45:06.441979|2017-10-11 02:45:06.441979
NCT01641445|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-01-11|||July 2012||2012-07-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|IMPACT||Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms|Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms|Recruiting||Phase 1/Phase 2|160|Anticipated|Brown University||2|||f||||t||||||||||2017-10-11 02:45:06.660957|2017-10-11 02:45:06.660957
NCT01641432|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-07-21|||July 2011||2011-07-01|July 2014|2014-07-01||||July 2013|Actual|2013-07-01||Interventional|||Computerized Attention Training for Individuals With Acquired Brain Injury|Computerized Cognitive Treatment of Vigilance Deficits in Individuals With Acquired Brain Injury|Completed||Phase 1|27|Actual|Posit Science Corporation||2|||f||||||||||||||2017-10-11 02:45:06.778299|2017-10-11 02:45:06.778299
NCT01641419|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-03-13|||July 2012||2012-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Trial Comparing Duration of Analgesia After Popliteal Fossa Sciatiac Nerve Block With Ropivacaine 0.5% When Combined With Placebo, Dexamethasone 4mg or Dexamethasone 8 mg|Randomized, Controlled Trial Comparing Duration of Analgesia After Popliteal Fossa Sciatiac Nerve Block With Ropivacaine 0.5% When Combined With Placebo, Dexamethasone 4mg or Dexamethasone 8 mg|Withdrawn||N/A|0|Actual|Baylor College of Medicine||3||"Inability to recruit subjects at our hospital due to change in surgical patient population. Not   worth to continue."|f||||f||||||||||2017-10-11 02:45:06.918204|2017-10-11 02:45:06.918204
NCT01641406|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-12|||March 2011||2011-03-01|July 2012|2012-07-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|NACprotocol||"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"|"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"|Unknown status|Recruiting|Phase 2|60|Anticipated|Auxilio Mutuo Cancer Center||3|||f||||t||||||||||2017-10-11 02:45:07.054479|2017-10-11 02:45:07.054479
NCT01641393|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-03-13|||June 2012||2012-06-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.|A Randomised, Double-Blind, Active-Controlled, Two-Treatment, Crossover, Multinational, Multicentre Study to Compare Two Pancreatic Enzyme Products in the Treatment of Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis|Completed||Phase 3|96|Actual|Forest Laboratories||2|||f||||t||||||||||2017-10-11 02:45:07.201645|2017-10-11 02:45:07.201645
NCT01641367|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-02-16|||October 2012||2012-10-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|November 23, 2016|Actual|2016-11-23||Interventional|MULTI-OCTAVE||A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure|Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)|Active, not recruiting||Phase 4|545|Actual|AIDS Clinical Trials Group||6|||f||||t||||||||||2017-10-11 02:45:07.55573|2017-10-11 02:45:07.55573
NCT01641328|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-13|||October 2012||2012-10-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Interventional|FarbMCI2012||Cognitive Activation Therapy for MCI: A Randomized Control Study|Phase 1 Study of Cognitive Activation Behavioral Therapy for MCI: A Randomized Waitlist-Control and Delayed Active-Control Study|Unknown status|Not yet recruiting|Phase 1|30|Anticipated|Rotman Research Institute at Baycrest||2|||f||||f||||||||||2017-10-11 02:45:07.890257|2017-10-11 02:45:07.890257
NCT01641315|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-11-23|||September 2015||2015-09-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins|Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins for Post-exposure Rabies Treatment|Recruiting||N/A|75|Anticipated|Queen Saovabha Memorial Institute||3|||f||||f||||||||||2017-10-11 02:45:07.976349|2017-10-11 02:45:07.976349
NCT01641302|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2013-08-05|||June 2012||2012-06-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||The Effect of Pneumoperitoneum and Trendelenburg Position on Intracranial Pressure: Ultrasonographic Measurement of Optic Nerve Sheath Diameter||Completed||N/A|20|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 02:45:08.065649|2017-10-11 02:45:08.065649
NCT01641289|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-03-16|||July 2012||2012-07-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria|Paracetamol Effect on Oxidative Stress and Renal Function in Severe Falciparum Malaria With Intravascular Haemolysis: A Randomised Controlled Clinical Trial|Active, not recruiting||N/A|62|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 02:45:08.117282|2017-10-11 02:45:08.117282
NCT01641276|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-09-10|||April 2012||2012-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|THBC-HSL2||Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma|Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma|Completed||N/A|60|Actual|Hospital Sirio-Libanes||2|||f||||t||||||||||2017-10-11 02:45:08.200826|2017-10-11 02:45:08.200826
NCT01641263|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-08-14|||July 2012||2012-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|PRO-SHARE||Promoting Sleep and Healthy Aging Research Study (PRO-SHARE)|Aging: Sleep and Inflammatory Mechanism in Depression Prevention|Active, not recruiting||Phase 1|300|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:45:08.28113|2017-10-11 02:45:08.28113
NCT01641250|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-11-01|||August 2012||2012-08-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia|Open Label, Multicenter, Dose Escalation Phase 1a/b Study of RO5429083, Administered as Intravenous Infusion Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia (AML).|Completed||Phase 1|44|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:45:08.359293|2017-10-11 02:45:08.359293
NCT01641237|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-07-17|2013-05-30||March 2012||2012-03-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions|The Effect of Fluoride in an Experimental Dentifrice on Remineralization of Erosive Lesions In-Situ|Completed||Phase 3|72|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:45:08.600747|2017-10-11 02:45:08.600747
NCT01641224|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-05-09|||May 2012||2012-05-01|May 2014|2014-05-01|May 2014|Anticipated|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome|A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome|Unknown status|Active, not recruiting|N/A|800|Anticipated|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-11 02:45:09.17066|2017-10-11 02:45:09.17066
NCT01641211|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2013-04-08|||July 2012||2012-07-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||ENLaCE Pilot Study|Using MEDUCATION to Improve Asthma Medication Device Technique|Completed||N/A|92|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:45:09.289893|2017-10-11 02:45:09.289893
NCT01641185|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-05-01|||May 2012||2012-05-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IPI||Ion Prostate Irradiation|Hypofractionated Ion Irradiation (Carbon Ions Versus Protons) of the Prostate|Completed||Phase 2|92|Actual|Heidelberg University||2|||f||||t||||||||||2017-10-11 02:45:09.489034|2017-10-11 02:45:09.489034
NCT01641172|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2016-04-14|||June 2012||2012-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|TASTY||Taste, Smell and Chemotherapy (TASTY)|Taste and Smell Changes in Testicular Cancer Patients Treated With Cisplatin Based Chemotherapy|Completed||Phase 4|140|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 02:45:09.601646|2017-10-11 02:45:09.601646
NCT01641159|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-12-18|2014-12-09||August 2012||2012-08-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|BRAC|Baseline characteristics of all randomized participants|Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence|A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence (BRAC)|Completed||Phase 2|62|Actual|University of Cincinnati||2|||f||||t||||||||||2017-10-11 02:45:09.725276|2017-10-11 02:45:09.725276
NCT01641146|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-11-25|||December 2008||2008-12-01|November 2016|2016-11-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|ES-HIM||An HIV Intervention for Black Men at Risk - The Enhanced Sexual Health Intervention for Men (ES-HIM)|An HIV Intervention for Black Men at Risk|Completed||Phase 2|118|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:45:10.302439|2017-10-11 02:45:10.302439
NCT00004408|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2012-03-05|||November 1997||1997-11-01|March 2012|2012-03-01|November 1999|Actual|1999-11-01|||||Interventional|||Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease||Completed||Phase 3|300||Mast Therapeutics, Inc.|||||f||||||||||||||2017-10-11 04:25:19.761947|2017-10-11 04:25:19.761947
NCT01641133|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-01-09|2017-01-09|2013-08-22|September 2012||2012-09-01|September 2016|2016-09-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|||Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™|Two-dose Primary Vaccination With Either GSK Biologicals' 10-valent Pneumococcal Vaccine (Synflorix™) or Pfizer's Prevenar 13™ or Both Vaccines Followed by a Booster Dose of Synflorix™|Completed||Phase 3|457|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 02:45:10.434886|2017-10-11 02:45:10.434886
NCT01641120|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2015-12-18|2015-07-13||May 2012||2012-05-01|December 2015|2015-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Assessing Tolerability of Avonex Intramuscular Injections|Assessing Tolerability of Avonex Intramuscular Injections With a 25 Gauge Needle Versus 30 Gauge Needle|Completed||N/A|20|Actual|Saint Francis Care||2|||f||||f||||||||||2017-10-11 02:45:11.679328|2017-10-11 02:45:11.679328
NCT01641107|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-08-31|||October 2014|Actual|2014-10-01|August 2017|2017-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|LAL1811||Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.|Front-line Treatment of Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia With Ponatinib, a New Potent Tyrosine Kinase Inhibitor.|Active, not recruiting||Phase 2|44|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-11 02:45:11.979766|2017-10-11 02:45:11.979766
NCT01641094|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-03-10|||May 2012||2012-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|ETIM||Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms|Effect of Telaprevir in Triple Therapy on Intrahepatic Immunological Mechanisms.|Completed||N/A|20|Actual|Foundation for Liver Research|||1||f||||t||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 02:45:12.148805|2017-10-11 02:45:12.148805
NCT01641081|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-01-16|2016-10-27|2013-02-13|June 2012||2012-06-01|January 2017|2017-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma|Phase II, Randomized, Placebo-controlled, Double-blind, Double-dummy, 5-period Complete Crossover Study of the Bronchodilator Effects of Formoterol Fumarate Inhalation Powder in Patients With Mild to Moderate Asthma.|Completed||Phase 2|174|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 02:45:12.25499|2017-10-11 02:45:12.25499
NCT01641068|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-05-22|||September 2012|Actual|2012-09-01|May 2017|2017-05-01||||April 2018|Anticipated|2018-04-01||Interventional|||Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms|Behavioral and Neural Indices of Cognitive Rehabilitation in Women's Cancer: A Pilot Study|Recruiting||N/A|30|Anticipated|University of Washington||2|||f||||f||||||||||2017-10-11 02:45:12.850967|2017-10-11 02:45:12.850967
NCT01641055|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-12-19|||July 2012||2012-07-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of the Effects of Fish Protein Intake on Glucose Homeostasis and Inflammation in Overweight and Obese Adults.|A 8 wk Study to Compare the Effects of Proteins and Peptides From Various Fish Species (Salmon, Herring, Cod) on Glucose Homeostasis and Inflammatory Markers in Overweight and Obese Adults.|Completed||N/A|94|Actual|University of Bergen||4|||f||||f||||||||||2017-10-11 02:45:12.965177|2017-10-11 02:45:12.965177
NCT01641029|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-04-23|||July 2013||2013-07-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis|Surveillance and Risk Factor Analysis of Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis in the United States|Completed||N/A|720|Actual|Olive View-UCLA Education & Research Institute|||1||f||||f||||||||||2017-10-11 02:45:13.24843|2017-10-11 02:45:13.24843
NCT01641016|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-02-27|||April 2011||2011-04-01|July 2013|2013-07-01|June 2016|Anticipated|2016-06-01|June 2014|Actual|2014-06-01||Interventional|BREATHER||BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection|BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection|Unknown status|Active, not recruiting|Phase 2/Phase 3|160|Anticipated|PENTA Foundation||2|||f||||t||||||||||2017-10-11 02:45:13.327419|2017-10-11 02:45:13.327419
NCT01641003|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-07-11|||July 2012||2012-07-01|July 2012|2012-07-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Observational|||Isolation and Characterization of Cancer Stem Cells Using iFP Technique|Isolation and Characterization of Cancer Stem Cells Using iFP Technique|Unknown status|Not yet recruiting|N/A|15|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples Without DNA|"     Samples of fresh tumors taken after surgery without compromising final histology diagnosis.     These specimens will be used to isolate and grow cancer stem cells.   "|||2017-10-11 02:45:13.493402|2017-10-11 02:45:13.493402
NCT01640990|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-06-09|||November 22, 2011|Actual|2011-11-22|June 2017|2017-06-01|December 9, 2011|Actual|2011-12-09|December 9, 2011|Actual|2011-12-09||Interventional|||A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers|A Single-centre, Escalating Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Slow Intravenous Infusion of GW328267X in Healthy Volunteers|Completed||Phase 1|3|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:45:13.58893|2017-10-11 02:45:13.58893
NCT01640977|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-04-29|||June 2012||2012-06-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Observational|||A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF|A Prospective Non-current Concurrent Controlled Evaluation of Open and MAS® PLIF for the Treatment of Symptomatic Lumbar Degenerative Conditions|Completed||N/A|67|Actual|NuVasive|||2||f||||f||||||||||2017-10-11 02:45:13.685491|2017-10-11 02:45:13.685491
NCT01640418|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-07-20|||September 2012||2012-09-01|July 2015|2015-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|SACRESS||Prevention of Sacral Pressure Ulcers With Preventive Dressings||Completed||N/A|253|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:45:19.299396|2017-10-11 02:45:19.299396
NCT01640951|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-04-20|||September 16, 2012|Actual|2012-09-16|April 2017|2017-04-01|May 12, 2017|Anticipated|2017-05-12|May 12, 2017|Anticipated|2017-05-12||Interventional|||Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Secukinumab Phase III Studies|Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Secukinumab Phase III Studies|Active, not recruiting||Phase 3|675|Actual|Novartis||5|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 02:45:14.259453|2017-10-11 02:45:14.259453
NCT01640925|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-09-21|2015-04-15||July 2012||2012-07-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|May 2013|Actual|2013-05-01||Interventional|||Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit|Randomized Controlled Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit|Completed||N/A|350|Actual|The Methodist Hospital System||2|||f||||f||||||||Undecided|Plan to share data to be determined.|2017-10-11 02:45:14.660247|2017-10-11 02:45:14.660247
NCT01640912|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2014-09-16|||June 2012||2012-06-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109|A Phase 1 Single Center, Randomized, Double-Blind, Ascending Dose, Within-Subject Controlled Study of RXI-109 for the Treatment of Incision Scars Made in the Pannus of Healthy Women Who Will Later Undergo Elective Abdominoplasty|Completed||Phase 1|15|Actual|RXi Pharmaceuticals, Corp.||2|||f||||t||||||||||2017-10-11 02:45:14.926741|2017-10-11 02:45:14.926741
NCT01640886|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-01-14|||June 2012||2012-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA|Prospective Study Into the Performance of the KeyPathtm MRSA/MSSA Blood Culture Test - BTA|Terminated||N/A|764|Actual|MicroPhage, Inc.|||2|Results did not meet study requirements.|f||||f||||||Samples Without DNA|"     Retention of de-identified blood culture specimens only.   "|||2017-10-11 02:45:15.087193|2017-10-11 02:45:15.087193
NCT01640873|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-01-19|||September 2012||2012-09-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002 AM1)|A Randomized Double-Blind Placebo-Controlled Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Subjects With Type 2 Diabetes|Completed||Phase 1|33|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:45:15.163821|2017-10-11 02:45:15.163821
NCT01640860|ClinicalTrials.gov processed this data on October 10, 2017|2008-01-07|2012-07-16|||December 2007||2007-12-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2009|Actual|2009-12-01||Observational|||Concurrent Chemoradiotherapy With Docetaxel and Cisplatin in Esophageal Cancer|A Phase II Study of Concurrent Chemoradiotherapy With Weekly Docetaxel and Cisplatin in Inoperable Esophageal Cancer|Completed||N/A|36|Actual|Chonnam National University Hospital|||1||f||||t||||||||||2017-10-11 02:45:15.245264|2017-10-11 02:45:15.245264
NCT01640847|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2017-02-03|||July 2012||2012-07-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases|Phase II Trial of Phillips MRI-Guided High Intensity Focused Ultrasound (Sonalleve) and Lyso-thermosensitive Liposomal Doxorubicin (ThermoDox) for Palliation of Painful Bone Metastases|Withdrawn||Phase 2|0|Actual|Celsion||2|||f||||||||||||||2017-10-11 02:45:15.320126|2017-10-11 02:45:15.320126
NCT01640834|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-09-20|||July 2012||2012-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study of LY2409021 in Participants With Type 1 Diabetes|Pilot Study of the Effects of LY2409021 in Patients With Type 1 Diabetes Mellitus|Completed||Phase 1|30|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 02:45:15.406347|2017-10-11 02:45:15.406347
NCT01640821|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-09-11|||September 2010||2010-09-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|CHOIX-CSSS||"Dissemination of the Choisir de Maigrir? Program"|"Dissemination of the Choisir de Maigrir? Program in Health and Social Service Centers in Québec: Evaluation of Its Implementation and Impact on Lifestyle Habits and Well-being"|Completed||N/A|328|Actual|Laval University||2|||f||||f||||||||||2017-10-11 02:45:15.489744|2017-10-11 02:45:15.489744
NCT01640808|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2015-03-23|||April 2012||2012-04-01|February 2015|2015-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC|NIK-333 (Peretinoin) Phase ⅢStudy Investigation of the Efficacy and Safety to Suppress Recurrence of Hepatitis C Virus (HCV)-Positive Hepatocellular Carcinoma(HCC）, Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel-group Study|Unknown status|Active, not recruiting|Phase 3|600|Anticipated|Kowa Company, Ltd.||2|||f||||||||||||||2017-10-11 02:45:15.583399|2017-10-11 02:45:15.583399
NCT01640795|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-12|||June 2010||2010-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:45:15.810003|2017-10-11 02:45:15.810003
NCT01640782|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-07-17|||February 2005||2005-02-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|ITACA-S||Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach|Open Label, Randomised, Multicenter Phase III Study of Adjuvant Chemotherapy in Radically Resected Adenocarcinoma of the Stomach or Gastroesophageal Junction: Comparison of a Sequential Treatment (CPT-11+5-FU/LV --> TXT+CDDP) Versus a 5-FU/LV Regimen|Completed||Phase 3|1100|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||t||||||||||2017-10-11 02:45:15.868701|2017-10-11 02:45:15.868701
NCT01640769|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-07-11|||August 2012||2012-08-01|July 2012|2012-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Imaging Study of Allocation of Pacing Targets in Cardiac Resynchronization Therapy|MRI Allocation of Pacing Targets in Cardiac Resynchronization Therapy|Not yet recruiting||Phase 3|328|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 02:45:16.335297|2017-10-11 02:45:16.335297
NCT01640756|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-01-11||2016-01-11|July 2012||2012-07-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|||AqueSys Microfistula Implant in Refractory Glaucoma|A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys Microfistula Implant in Subjects With Refractory Glaucoma|Completed||Phase 3|60|Actual|AqueSys, Inc.||1|||f||||f||||||||||2017-10-11 02:45:16.415538|2017-10-11 02:45:16.415538
NCT01640743|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2015-03-24|||March 2010||2010-03-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Interventional|EVERTWIST||Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation|Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation: a Randomized Study|Completed||N/A|58|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-11 02:45:16.516684|2017-10-11 02:45:16.516684
NCT01640730|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2014-01-15|||May 2012||2012-05-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer|An Open Label Safety and Exploratory Efficacy Study of Kanglaite Injection in Patients Having Progressive Stage IV NSCLC Who Are Not Candidates for Other Anti-cancer Treatment|Terminated||Phase 2|1|Actual|KangLaiTe USA||1||poor enrollment|f||||t||||||||||2017-10-11 02:45:16.60749|2017-10-11 02:45:16.60749
NCT01640717|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2016-02-17|||November 2012||2012-11-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)|A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)|Completed||N/A|15|Actual|Alexion Pharmaceuticals|||1||f||||f||||||||||2017-10-11 02:45:16.680097|2017-10-11 02:45:16.680097
NCT01640704|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-13|||July 2003||2003-07-01|July 2012|2012-07-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Impact of Computerized Reminders on Blood Pressure Documentation and Control||Completed||Phase 1|||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 02:45:16.751033|2017-10-11 02:45:16.751033
NCT01640691|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2012-07-12|||July 2012||2012-07-01|July 2012|2012-07-01||||April 2013|Anticipated|2013-04-01||Interventional|||Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults|A Clinical Study to Evaluate the Immunogenicity and Safety of Pandemic Influenza Vaccine, AdimFlu-W (H5N1), in Healthy Adults|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Adimmune Corporation||1|||f||||t||||||||||2017-10-11 02:45:16.811118|2017-10-11 02:45:16.811118
NCT01640678|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-12|2013-08-02|||June 2012||2012-06-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients|Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients: a Randomized Controlled Pilot Study|Unknown status|Active, not recruiting|Phase 4|10|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||3|||f||||f||||||||||2017-10-11 02:45:16.883751|2017-10-11 02:45:16.883751
NCT01640665|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-09-15|||July 2012||2012-07-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors|Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors|Completed||Phase 1|24|Actual|Yale University||1|||f||||t||||||||||2017-10-11 02:45:16.952819|2017-10-11 02:45:16.952819
NCT01640652|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-03-28|||August 2012||2012-08-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|July 2013|Actual|2013-07-01||Interventional|||MenPF-1 - A New Vaccine Against Meningococcal Disease|A Phase I, Single Centre, Open-label Dose-escalation Study to Assess the Safety and Immunogenicity of Three Doses of 25µg or 50 µg of Meningococcal Serogroup B Outer Membrane Vesicle Vaccine MenPF-1|Active, not recruiting||Phase 1|52|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 02:45:17.134656|2017-10-11 02:45:17.134656
NCT01640639|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-03-06|||July 2012||2012-07-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|THUNDER||THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure|Effects of Thalidomide on Left Ventricular Morphology and Function in Patients With Congestive Heart Failure - The THUNDER Trial|Unknown status|Recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 02:45:17.229924|2017-10-11 02:45:17.229924
NCT01640626|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-06-22|||July 2012||2012-07-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Impact of Health Education on School Children|The Impact of Health Education in Controlling Soil-transmitted Helminthiasis Among Orang Asli Schoolchildren|Completed||Phase 1|317|Actual|University of Malaya||2|||f||||t||||||||||2017-10-11 02:45:17.317829|2017-10-11 02:45:17.317829
NCT01640613|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2014-03-05|||April 2012||2012-04-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Anterior Ultrasound-guided Cervical Plexus Block for Carotid Endarterectomy|Anterior Approach Ultrasound-guided Intermediate Cervical Plexus Block for Carotid Endarterectomy|Completed||N/A|116|Actual|Hôpital Edouard Herriot|||1||f||||f||||||||||2017-10-11 02:45:17.394275|2017-10-11 02:45:17.394275
NCT01640600|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-06-02|||October 2011||2011-10-01|December 2016|2016-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|PABKids||Yale Pink and Blue Kids: Effects of Exposure During Pregnancy to Nicotine or Antidepressants in 4-8 Year Old Children|Yale Pink and Blue Kids: Effects of in Utero Exposure to Nicotine and Selective Serotonin Reuptake Inhibitors in 4-8 Year Old Children|Completed||N/A|61|Actual|Yale University|||3||f||||t||||||Samples With DNA|"     We will be collecting saliva from mothers and their children in order to look at certain     genes that may be related to developmental outcomes.   "|||2017-10-11 02:45:17.465836|2017-10-11 02:45:17.465836
NCT01640041|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-01-23|||May 2008||2008-05-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Feasibility Study for Enhancing Gait Following Stroke With Implanted Microstimulators|Feasibility Study for Enhancing Gait Following Stroke With Implanted Microstimulators|Completed||N/A|1|Actual|The Alfred E. Mann Foundation for Scientific Research||1|||f||||f||||||||||2017-10-11 02:45:26.489824|2017-10-11 02:45:26.489824
NCT01640587|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-06-07|||November 2013|Actual|2013-11-01|June 2017|2017-06-01|March 30, 2017|Actual|2017-03-30|March 2017|Actual|2017-03-01||Interventional|RDM||Compare the Effectiveness Between Existing Treatment and New Treatment|Randomized Open-label Trial of Comparison Between DHA-Piperaquine and Mefloquine Artesunate Combinations 3 Day-regimens for the Treatment of Uncomplicated Plasmodium Falciparum Malaria on the Thai-Myanmar Border (RDM)|Completed||N/A|76|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 02:45:17.533693|2017-10-11 02:45:17.533693
NCT01640574|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-04-27|||February 2012||2012-02-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD)|Randomised Parallel Open Label Comparison Between 7 and 14 Day Primaquine Combined With 3-day Dihydroartemisinin-piperaquine or 3-day Chloroquine Regimens for Radical Cure of Plasmodium Vivax|Completed||Phase 3|680|Actual|University of Oxford||4|||f||||f||||||||||2017-10-11 02:45:17.620728|2017-10-11 02:45:17.620728
NCT01640561|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-11|||January 2012||2012-01-01|July 2012|2012-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|MISC||Enhancing Ugandan HIV-Affected Child Development With Caregiver Training|Enhancing Ugandan HIV-Affected Child Development With Caregiver Training|Unknown status|Recruiting|N/A|300|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 02:45:17.715936|2017-10-11 02:45:17.715936
NCT01640548|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-11-01|2015-08-12||September 2012||2012-09-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational||Included all the participants who entered the retrospective chart review.|A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis|A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis|Completed||N/A|320|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:45:17.838517|2017-10-11 02:45:17.838517
NCT01640535|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-04-04|||June 2012||2012-06-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients|Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients : A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Clinical Trial|Completed||Phase 3|283|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 02:45:18.34431|2017-10-11 02:45:18.34431
NCT01640522|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-16|2015-12-23|||January 2008||2008-01-01|July 2012|2012-07-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|CaSSY||Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms|Phase III Randomized Controlled Trial of a Collaborative Care Intervention to Manage Cancer Related Symptoms in Patients Diagnosed With Hepatobiliary Carcinoma|Completed||Phase 3|261|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 02:45:18.454515|2017-10-11 02:45:18.454515
NCT01640509|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2013-11-08|||June 2012||2012-06-01|November 2013|2013-11-01|June 2019|Anticipated|2019-06-01|June 2014|Anticipated|2014-06-01||Interventional|ESRF||Synchrotron Radiation to the Treatment of Intracranial Tumors|A Phase I-II Synchrotron Radiation Application to the Treatment of Intracranial Tumors|Recruiting||Phase 1/Phase 2|50|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 02:45:18.545362|2017-10-11 02:45:18.545362
NCT01640496|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-12-01|||July 2012||2012-07-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|Vitamin D||Vitamin D Treatment in Ulcerative Colitis|Vitamin D Treatment in Ulcerative Colitis|Withdrawn||N/A|0|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 02:45:18.645929|2017-10-11 02:45:18.645929
NCT01640483|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-06-03|||December 2012||2012-12-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PsychodynDep||Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients|Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients: an Experimental Single Case Design.|Unknown status|Recruiting|N/A|9|Anticipated|University Ghent||3|||f||||f||||||||||2017-10-11 02:45:18.775176|2017-10-11 02:45:18.775176
NCT01640470|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2016-04-08|||December 2011||2011-12-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|May 2016|Anticipated|2016-05-01||Interventional|CATS||A Multi-Site Trial of the Impact of Assistive Technology With Assistance Users and Their Caregivers|A Multi-Site Trial of the Impact of Assistive Technology With Individuals With Mobility Limitations and Their Caregivers.|Active, not recruiting||Phase 2|240|Anticipated|Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal||2|||f||||t||||||||||2017-10-11 02:45:18.885547|2017-10-11 02:45:18.885547
NCT01640457|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-04-12|||August 2012||2012-08-01|April 2016|2016-04-01|August 2021|Anticipated|2021-08-01|August 2018|Anticipated|2018-08-01||Interventional|NDisc||Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine|A Prospective Randomized Multicentre Phase I/II Clinical Trial to Evaluate Safety and Efficacy of NOVOCART® Disc Plus Autologous Disc Chondrocyte Transplantation (ADCT) in the Treatment of Nucleotomized and Degenerative Lumbar Discs to Avoid Secondary Disease|Active, not recruiting||Phase 1/Phase 2|120|Actual|Tetec AG||3|||f||||t||||||||||2017-10-11 02:45:18.986047|2017-10-11 02:45:18.986047
NCT01640444|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-07-31|||July 2012|Actual|2012-07-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|VISNU-2||Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)|Randomized Phase II Study to Explore the Influence of BRAF and PIK3K Status on the Efficacy of FOLFIRI Plus Bevacizumab or Cetuximab, as First Line Therapy of Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells|Active, not recruiting||Phase 2|240|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||2|||f||||f||||||||||2017-10-11 02:45:19.119458|2017-10-11 02:45:19.119458
NCT01640431|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-12|||March 2011||2011-03-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|August 2011|Actual|2011-08-01||Interventional|||Lumbar Segmental Stabilization and TENS in Lumbar Disc Herniation|Lumbar Segmental Stabilization and TENS in Lumbar Disc Herniation: a Randomized Clinical Trial|Unknown status|Recruiting|N/A|60|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 02:45:19.203258|2017-10-11 02:45:19.203258
NCT01640405|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-07-31|||July 2012||2012-07-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|VISNU-1||Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells|Phase III, Randomized Clinical Trial to Evaluate FOLFOX + Bevacizumab Versus FOLFOXIRI + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells.|Active, not recruiting||Phase 3|350|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||2|||f||||f||||||||||2017-10-11 02:45:19.409246|2017-10-11 02:45:19.409246
NCT01640392|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-12|||April 2012||2012-04-01|July 2012|2012-07-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|MLMS||MyLife MyStyle Evaluation Project|Evaluating Locally Developed Homegrown HIV Prevention Interventions|Unknown status|Recruiting|N/A|528|Anticipated|Los Angeles County Department of Public Health||2|||f||||f||||||||||2017-10-11 02:45:19.52451|2017-10-11 02:45:19.52451
NCT01640379|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-01-01|||July 2012||2012-07-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|June 2017|Anticipated|2017-06-01||Interventional|TECH-N||Technology Enhanced Community Health Nursing (TECH-N) Study|Technology Enhanced Community Health Nursing (TECH-N) to Prevent Recurrent Sexually Transmitted Infections After Pelvic Inflammatory Disease|Recruiting||N/A|350|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:45:19.604537|2017-10-11 02:45:19.604537
NCT01640353|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-02-03|2016-07-11||July 2012||2012-07-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|January 2015|Actual|2015-01-01||Observational|SIFI||Sacroiliac Joint Fusion With iFuse Implant System (SIFI)|Sacroiliac Joint Fusion With iFuse Implant System (SIFI)|Completed||N/A|194|Actual|SI-BONE, Inc.|Lack of concurrent control group undergoing non-surgical treatment and a 24-month follow up rate that was not as high as desired.||1||f||||f||||||||Yes|Data is shared with YODA project.|2017-10-11 02:45:19.937733|2017-10-11 02:45:19.937733
NCT01640340|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-10-13|2013-07-19||January 2011||2011-01-01|October 2013|2013-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)|Pilot Study on the Efficacy of an Ondansetron Versus Palonosetron-containing Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC).|Completed||N/A|40|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:45:20.57058|2017-10-11 02:45:20.57058
NCT01640327|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2015-10-28|2013-07-11||July 2012||2012-07-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Analysis was done on all enrolled subjects.|Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above|A Phase 3, Open Label, Uncontrolled, Multicenter Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Influenza Vaccine (Fluvirin®), Formulation 2012/2013, When Administered to Adult and Elderly Subjects|Completed||Phase 3|126|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:45:21.057854|2017-10-11 02:45:21.057854
NCT01640314|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-01-19|2013-07-11||July 2012||2012-07-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above|A Phase 3 Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture (Optaflu®), Formulation 2012/2013, When Administered to Adult and Elderly Subjects|Completed||Phase 3|126|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:45:21.476869|2017-10-11 02:45:21.476869
NCT01640301|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-07-26|||December 6, 2012|Actual|2012-12-06|July 2017|2017-07-01||||October 1, 2017|Anticipated|2017-10-01||Interventional|||Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant|Phase I/II Study of Adoptive Immunotherapy After Allogeneic HCT With Virus Specific CD8+ T Cells That Have Been Transduced to Express a WT1-specific T Cell Receptor for Patients With Relapsed AML|Suspended||Phase 1/Phase 2|55|Anticipated|Fred Hutchinson Cancer Research Center||2||Study may re-open|f||||t||||||||||2017-10-11 02:45:21.912323|2017-10-11 02:45:21.912323
NCT01640288|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-04-19|||January 2013||2013-01-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|DIAL1001004||Imaging Regional Lung Defect Severity|Human Lung Regional Ventilation Defect Severity Measured by Fluorine-19 Gas MRI|Recruiting||Phase 1/Phase 2|250|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 02:45:22.037587|2017-10-11 02:45:22.037587
NCT01640275|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-08-03|||March 2012||2012-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|MAD-PIA||Markers of Alzheimers Disease After Propofol or Isoflurane Anesthesia|The Effect of Isoflurane Versus Propofol Anesthesia on Alzheimers Disease CSF Markers|Completed||Phase 1|105|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:45:22.127887|2017-10-11 02:45:22.127887
NCT01640262|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-02-02|||August 2011||2011-08-01|May 2014|2014-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup|Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup|Completed||N/A|170|Actual|Copenhagen University Hospital at Herlev|||1||f||||f||||||||||2017-10-11 02:45:22.218638|2017-10-11 02:45:22.218638
NCT01640249|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-12-17|||July 2012||2012-07-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of LY3006072 in Healthy Participants|A Single Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY3006072 in Healthy Subjects|Completed||Phase 1|26|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:45:22.295528|2017-10-11 02:45:22.295528
NCT01640236|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-07-14|||July 2012||2012-07-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Flare Measurements in Human Radiation Therapy Patients||Completed||N/A|10|Actual|ChromoLogic, LLC|||1||f||||f||||||||||2017-10-11 02:45:22.385408|2017-10-11 02:45:22.385408
NCT01640223|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-10-24|||March 2012||2012-03-01|October 2014|2014-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|DiabeloopWP3||Creation of a Patient Database for Silicon Patient Simulation, Glucose Sensor Variability and Pharmacokinetic Study of Debiotech Jewelpump|"SEMI-CLOSED LOOP FOR THE CONTROL OF BLOOD GLUCOSE IN DIABETIC SUBJECTS DIABELOOP First CLINICAL PROJECT: Under Project 3 (UP3), CREATING A DATABASE"|Completed||N/A|40|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||2|||f||||f||||||||||2017-10-11 02:45:22.4453|2017-10-11 02:45:22.4453
NCT01640210|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-07-12|||November 2011||2011-11-01|December 2011|2011-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|DIABELOOP||Technical Evaluation Of JewelPUMP In Type 1 Diabetic Patients Treated With Extern Insulin Pump|TECHNICAL EVALUATION OF JEWELPUMP IN TYPE 1 DIABETIC PATIENTS TREATED WITH EXTERN INSULIN PUMP|Completed||N/A|28|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||1|||f||||f||||||||||2017-10-11 02:45:22.530332|2017-10-11 02:45:22.530332
NCT01640197|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-10-17|2012-09-11||February 2011||2011-02-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Chronic Resveratrol Supplementation in Healthy Humans|The Effects of Chronic Trans- Resveratrol Supplementation on Aspects of Cognitive Performance, Mood, Sleep, Health and Cerebral Blood Flow in Healthy, Young Humans.|Completed||Phase 1|60|Actual|Northumbria University||2|||f||||||||||||||2017-10-11 02:45:22.610033|2017-10-11 02:45:22.610033
NCT01640184|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-08-23|2015-10-21||August 2012||2012-08-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients|Study of the Efficacy and Safety on the Ultrasonic Ablation Treatment for Secondary Hyperthyroidism in Chronic Kidney Disease Patients.|Completed||N/A|79|Actual|Capital Medical University||3|||f||||t||||||||||2017-10-11 02:45:23.223277|2017-10-11 02:45:23.223277
NCT01640171|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-04-18|2013-11-30||July 2012||2012-07-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional||57 patients were treated differently in each eye.|Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival|Topical Lidocaine Gel With and Without Subconjunctival Lidocaine Injection for Intravitreal Injection: a Within-patient Study|Completed||N/A|57|Actual|Retina Vitreous Associates of Florida|Most patients were treated with subconjunctival anesthetic prior to the study.|1|||f||||f||||||||||2017-10-11 02:45:23.760109|2017-10-11 02:45:23.760109
NCT01640158|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-03-27|||September 2013||2013-09-01|March 2017|2017-03-01|March 2, 2017|Actual|2017-03-02|March 2, 2017|Actual|2017-03-02||Interventional|BRAVE||Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury|BRAVE Trial: Broad-spectrum Cognitive Remediation Available to Veterans: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury (mTBI)|Completed||N/A|86|Actual|Posit Science Corporation||2|||f||||t||||||||||2017-10-11 02:45:23.995427|2017-10-11 02:45:23.995427
NCT01640145|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-01-05|||July 2012||2012-07-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Low Intensity Exercise and Protein Intake on Skeletal Muscle Protein Synthesis in Elderly|Impact of Acute Low Intensity Exercise and Protein Intake on Skeletal Muscle Protein Synthesis in Elderly: a Randomized Controlled Trial|Completed||N/A|30|Actual|Bispebjerg Hospital||3|||f||||||||||||||2017-10-11 02:45:24.095813|2017-10-11 02:45:24.095813
NCT01640119|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-09-17|||July 2014||2014-07-01|September 2014|2014-09-01|December 2017|Anticipated|2017-12-01|December 2014|Anticipated|2014-12-01||Interventional|UBI||Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)|A Prospective, Controlled, Randomized, Multicentric Study: Correction of Metabolic Acidosis With Use of Bicarbonate in Chronic Renal Insufficiency (CKD3b-4)|Recruiting||Phase 3|728|Anticipated|Azienda Sanitaria ASL Avellino 2||2|||f||||t||||||||||2017-10-11 02:45:24.17453|2017-10-11 02:45:24.17453
NCT01640106|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-07-12|||June 2012||2012-06-01|July 2012|2012-07-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Interventional|||Feasibility of Omega-3 Supplementation for Children With Language Impairments|Feasibility of Omega-3 Fatty Acid Supplementation for Children With Early Developmental Impairment in Language|Unknown status|Recruiting|Phase 3|30|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 02:45:24.279915|2017-10-11 02:45:24.279915
NCT01640093|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-03-01|||May 2012||2012-05-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Comparative Study of Bioavailability of 3 New Abiraterone Acetate Tablets With Current Commercial Tablet|A Single-Dose, Open-Label, Randomized, 4-Way Crossover Study to Assess the Relative Bioavailability of 3 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Subjects|Completed||Phase 1|32|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-11 02:45:24.36504|2017-10-11 02:45:24.36504
NCT01640080|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2016-03-22||2014-04-29|June 2012||2012-06-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression|A Double-Blind, Double-Randomization, Placebo-Controlled Study of the Efficacy of Intravenous Esketamine in Adult Subjects With Treatment-Resistant Depression|Completed||Phase 2|30|Actual|Janssen Research & Development, LLC||3|||f||||||||||||||2017-10-11 02:45:24.465306|2017-10-11 02:45:24.465306
NCT01640067|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-12-29|||December 2011||2011-12-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|hNSCALS||Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)|Intra-spinal Cord Delivery of Human Neural Stem Cells in ALS Patients: Proposal for a Phase I Study/ Trapianto Intramidollare di Cellule Staminali Neurali Umane Come Terapia Putativa Per la SLA: Proposta di un Trial Clinico di Fase I|Completed||Phase 1|18|Actual|Azienda Ospedaliera Santa Maria, Terni, Italy||1|||f||||t||||||||||2017-10-11 02:45:24.570867|2017-10-11 02:45:24.570867
NCT01640054|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-02-27|2013-11-21||July 2012||2012-07-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|OSKIRA-Asia-1X||A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis|(OSKIRA-Asia-1X): A Long-term Study to Assess the Safety of Fostamatinib in the Treatment of Rheumatoid Arthritis in Asia|Terminated||Phase 2|115|Actual|AstraZeneca|Insufficient efficacy data was available for analysis due to sparse data collection and the early termination of the study.|1||"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to   Rigel Pharmaceuticals."|f||||t||||||||||2017-10-11 02:45:24.659594|2017-10-11 02:45:24.659594
NCT01640028|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-03-08|||July 2012||2012-07-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|||Exploratory Study of Intra and Inter-subject Variability in Sebum Excretion Rate|Exploratory Study of Intra and Inter-subject Variability in Sebum Excretion Rate|Completed||N/A|41|Actual|Innovaderm Research Inc.|||1||f||||f||||||||||2017-10-11 02:45:26.575794|2017-10-11 02:45:26.575794
NCT01640015|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-12|||August 2012||2012-08-01|July 2012|2012-07-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|||The Effect of Eating Frequency on Blood Pressure|The Effect of Number of Eating Episodes Per Day on Blood Pressure. A Randomised Controlled Trial|Unknown status|Not yet recruiting|N/A|30|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 02:45:26.634167|2017-10-11 02:45:26.634167
NCT01640002|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-12|||May 2012||2012-05-01|July 2012|2012-07-01|April 2013|Anticipated|2013-04-01|October 2012|Anticipated|2012-10-01||Interventional|||A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder|A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder|Unknown status|Recruiting|Phase 1|42|Anticipated|Hospital Universitário Professor Edgard Santos||2|||f||||t||||||||||2017-10-11 02:45:26.707832|2017-10-11 02:45:26.707832
NCT01639989|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-12|||September 2012||2012-09-01|July 2012|2012-07-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Observational|||Doppler Assesment of Blood Flow in the Spiral Arteries|Pilot Study Which is Aiming at the Feasibility of Performing Doppler Studies of the Spiral Arteries|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 02:45:26.808799|2017-10-11 02:45:26.808799
NCT01639976|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-12|||September 2012||2012-09-01|July 2012|2012-07-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||Doppler Flow Measurements in Patients With Misoprostol Treatment for Arrested Pregnancy|Testing the Connection Between the Existence of Endometrial Flows With Doppler Examination if the Treatment Cytotec Success in Women With Miss Abortion|Unknown status|Not yet recruiting|N/A|20|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 02:45:26.873813|2017-10-11 02:45:26.873813
NCT01639950|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-06-30|||June 20, 2012||2012-06-20|May 26, 2017|2017-05-26||||||||Observational|||Validating Pain Scales in Children and Young Adults|Validation of the English Version of the Pain Interference Index and the Pain Rating Scale in Children, Adolescents, and Young Adults With Chronic Illness and Their Parents|Recruiting||N/A|267|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:45:26.949186|2017-10-11 02:45:26.949186
NCT01639937|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-08-05|||June 20, 2012||2012-06-20|August 4, 2017|2017-08-04||||||||Observational|||Myocardial Perfusion and Scarring in Congenital Heart Disease|Quantitative Myocardial Perfusion, Myocardial Scarring and Their Contribution to Late Clinical Decompensation in Adults With Congenital Heart Disease|Completed||N/A|9|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:45:27.040893|2017-10-11 02:45:27.040893
NCT01639924|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-08-22|||June 15, 2012||2012-06-15|August 11, 2017|2017-08-11||||||||Observational|||Evaluation of People With Gastrointestinal Disease|Evaluation of Patients With Gastrointestinal Disease|Recruiting||N/A|999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:45:27.147057|2017-10-11 02:45:27.147057
NCT01639911|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-04-18|||August 14, 2013|Actual|2013-08-14|April 2017|2017-04-01|July 28, 2016|Actual|2016-07-28|July 28, 2016|Actual|2016-07-28||Interventional|||Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors|STM-01: Phase I EffTox Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) Given in Combination With Selective VEGFR Inhibitor Pazopanib (Votrient) for Therapy of Solid Tumors|Completed||Phase 1|28|Actual|University of Illinois at Chicago||1|||f||||t|t|||||||||2017-10-11 02:45:27.267553|2017-10-11 02:45:27.267553
NCT01639898|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-03-08|||July 2012||2012-07-01|March 2015|2015-03-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|POEMS||POEMS Syndrome Treatment With Lenalidomide|Phase II Trial With Lenalidomide-Dexamethasone Combination in the Treatment of POEMS Syndrome.|Unknown status|Recruiting|Phase 2|66|Anticipated|University Hospital, Limoges||2|||f||||t||||||||||2017-10-11 02:45:27.590646|2017-10-11 02:45:27.590646
NCT01639885|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2014-01-06|||August 2011||2011-08-01|January 2014|2014-01-01||||January 2014|Actual|2014-01-01||Interventional|CHIP||Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer|Chemo-Immunotherapy, Gemcitabine With Pegylated Interferon Alpha-2b (Peg-Intron) With and Without p53 Synthetic Long Peptide (p53 SLP) Vaccine, for Patients With Platinum Resistant Ovarian Cancer CHIP Trial|Completed||Phase 1/Phase 2|15|Actual|Leiden University Medical Center||3|||f||||t||||||||||2017-10-11 02:45:27.864206|2017-10-11 02:45:27.864206
NCT01639872|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-02-10|||April 2013||2013-04-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|CLOCS||Clozapine for Cannabis Use in Schizophrenia|Clozapine for Cannabis Use Disorder in Schizophrenia|Active, not recruiting||Phase 4|132|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 02:45:28.007186|2017-10-11 02:45:28.007186
NCT01639859|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2013-08-07|||October 2011||2011-10-01|September 2011|2011-09-01|August 2013|Actual|2013-08-01|October 2012|Actual|2012-10-01||Interventional|PROSTATE SSI||Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci|Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci|Completed||N/A|30|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 02:45:28.203688|2017-10-11 02:45:28.203688
NCT01639846|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-02-07|||July 2012||2012-07-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis|A Single-Center, Double-Masked, Randomized, Vehicle Controlled Evaluation of the Onset and Duration of Action of RX-10045 Ophthalmic Solution, 0.09% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis|Completed||Phase 2|60|Actual|C.T. Development America, Inc.||2|||f||||||||||||||2017-10-11 02:45:28.324935|2017-10-11 02:45:28.324935
NCT01639833|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2014-06-03|2014-06-03||August 2012||2012-08-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery|A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery|Completed||N/A|90|Actual|Medtronic - MITG||2|||f||||t||||||||||2017-10-11 02:45:28.486361|2017-10-11 02:45:28.486361
NCT01639820|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-07|2013-08-21|||January 2009||2009-01-01|December 2011|2011-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SENTICOL2||Comparison of Pelvic Lymphadenectomy Versus Isolated Sentinel Lymph Node Biopsy Procedure for Early Stages of Cervical Cancers : a Multicenter Study With Evaluation of Medico-economic Impacts|Comparison of Pelvic Lymphadenectomy Versus Isolated Sentinel Lymph Node Biopsy Procedure for Early Stages of Cervical Cancers : a Randomized Multicenter Study With Evaluation of Medico-economic Impacts|Completed||N/A|267|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:45:29.241216|2017-10-11 02:45:29.241216
NCT01639807|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2012-07-11|||October 2011||2011-10-01|July 2012|2012-07-01|December 2014|Anticipated|2014-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP|A Prospective, Randomized, Controlled Clinical Trial Comparing Topical Medical Therapy With Selective Laser Trabeculoplasty in South Indian Population|Unknown status|Recruiting|N/A|600|Anticipated|Aurolab||2|||f||||f||||||||||2017-10-11 02:45:29.320113|2017-10-11 02:45:29.320113
NCT01639794|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-01-16|||February 2012||2012-02-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|VIM||Vesitirim™ in Men Postmarketing Observational Study|An Irish Observational Study to Evaluate LUTS Storage Symptom Improvement in Men Being Treated With Vesitirim™ (Solifenacin)|Completed||N/A|12|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 02:45:29.405172|2017-10-11 02:45:29.405172
NCT01639781|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-12-14|||November 2011||2011-11-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Age-dependent Effects of Flavanols on Vascular Status|Age-dependent Effects of Flavanol Metabolism and Absorption on Vascular Status After Acute and Chronic Application.|Completed||Phase 1|44|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 02:45:29.50833|2017-10-11 02:45:29.50833
NCT01639768|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-05-28|||July 2012||2012-07-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding|A Randomized, Double-blind, Placebo-controlled Study to Determine Safety, Tolerability and the Optimal Effective Dose of SUBLIVAC FIX Birch in Patients With Allergic Rhinitis/Rhinoconjunctivitis Caused by Birch Pollen|Completed||Phase 2|270|Actual|HAL Allergy||5|||f||||t||||||||||2017-10-11 02:45:29.5868|2017-10-11 02:45:29.5868
NCT01639755|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-05-17|2015-07-02||June 18, 2012|Actual|2012-06-18|May 2017|2017-05-01|October 1, 2017|Anticipated|2017-10-01|January 30, 2013|Actual|2013-01-30||Interventional|||European New Texture Implant Clinical Experience With Shaped Breast Implants||Active, not recruiting||Phase 4|19|Actual|Allergan||1|||f||||f|f|f||||||||2017-10-11 02:45:29.872235|2017-10-11 02:45:29.872235
NCT01639742|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-05-17|2015-07-02||June 18, 2012|Actual|2012-06-18|May 2017|2017-05-01|October 18, 2017|Anticipated|2017-10-18|January 30, 2013|Actual|2013-01-30||Interventional|||European New Texture Implant Clinical Experience With Round Breast Implants||Active, not recruiting||N/A|18|Actual|Allergan||1|||f||||f|f|f||||||||2017-10-11 02:45:30.129649|2017-10-11 02:45:30.129649
NCT01639729|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2015-09-16|2013-11-25||July 2012||2012-07-01|September 2015|2015-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Randomly assigned to one of 6 sequences|Effect of Delivery Route on PK of Sufentanil NanoTab|Effect of Delivery Route on the Pharmacokinetics of Sufentanil NanoTab® in Healthy Subjects|Completed||Phase 1|25|Actual|AcelRx Pharmaceuticals, Inc.||6|||f||||f||||||||||2017-10-11 02:45:30.41109|2017-10-11 02:45:30.41109
NCT01639716|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-12|||May 2011||2011-05-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|||Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers|Aggressive Non-Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers|Completed||N/A|58|Actual|Guler, Nil, M.D.|||7||f||||t||||||Samples Without DNA|"     periperal blood sample   "|||2017-10-11 02:45:30.859877|2017-10-11 02:45:30.859877
NCT01639703|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-07-11|2016-12-16||April 2012||2012-04-01|July 2017|2017-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Hepatic Xenetix-CT Perfusion|Diagnostic Contribution of XENETIX® CT PERFUSION in Pre-therapeutical Assessment of Hepatocellular Carcinoma|Completed||Phase 4|96|Actual|Guerbet||1|||f||||f||||||||||2017-10-11 02:45:30.962863|2017-10-11 02:45:30.962863
NCT01639690|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2017-08-03|||July 2012||2012-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene|A Phase I Clinical Trial for the Treatment of ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene|Active, not recruiting||Phase 1|10|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:45:31.589786|2017-10-11 02:45:31.589786
NCT01639677|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2012-07-10|||April 2000||2000-04-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|April 2001|Actual|2001-04-01||Interventional|LOK||Clinical Trial Between Laparoscopic Gastric Bypass and Laparoscopic Vertical Banded Gastroplasty for Morbid Obesity|Randomized Clinical Trial Between Laparoscopic Gastric Bypass and Laparoscopic Vertical Banded Gastroplasty for Morbid Obesity|Completed||Phase 4|100|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 02:45:31.682181|2017-10-11 02:45:31.682181
NCT01639664|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-03-06|||September 2013||2013-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|COMPACT-2||COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2|COMPACT (COMbining Plasma-filtration and Adsorption Clinical Trial): Efficacy and Safety of High Doses CPFA (Coupled Plasma Filtration Adsorption) for Septic Shock in the ICU|Recruiting||Phase 4|350|Anticipated|Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva||2|||f||||t||||||||||2017-10-11 02:45:31.761891|2017-10-11 02:45:31.761891
NCT01639651|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-09-01|||June 2012||2012-06-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Acute Effect of a Mobilization With Movement Technique to Improve Internal Rotation of the Shoulder|Principal Investigator|Completed||Early Phase 1|40|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 02:45:31.941721|2017-10-11 02:45:31.941721
NCT01639638|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-03-11|||June 2010||2010-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Interventional|||Recurrent and Nonrecurrent Condyloma Treatment|Randomised, Blind and Placebo-controlled Trial for the CIGB-300 Perilesional Application in Two Dose Levels in the Recurrent and Non Recurrent Genital Condyloma|Terminated||Phase 2/Phase 3|132|Actual|Laboratorio Elea S.A.C.I.F. y A.||3|||f||||f||||||||||2017-10-11 02:45:32.017046|2017-10-11 02:45:32.017046
NCT01639625|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2016-08-01|||May 2011||2011-05-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application|Open Clinical Trial, Uncontrolled in Patients Bearing Squamous Cell Carcinoma or Adenocarcinoma of the Cervix Stage IIA and IIB FIGO Classification Treated With Radiotherapy External Endocavitary Brachytherapy + Concurrent Hemotherapy Weekly Systemic and Local Application of CIGB-300 Dose Escalation|Completed||Phase 2|18|Actual|Laboratorio Elea S.A.C.I.F. y A.||1|||f||||f||||||||||2017-10-11 02:45:32.08508|2017-10-11 02:45:32.08508
NCT01639612|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-04-19|||June 2012||2012-06-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma|A Pilot Safety Study of the Administration of Bone Marrow Derived Stem Cells (ALD-451) in WHO Grade IV Malignant Glioma|Completed||Phase 1|11|Actual|Duke University||1|||f||||t||||||||||2017-10-11 02:45:32.143439|2017-10-11 02:45:32.143439
NCT01639599|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2014-06-12|||March 2012||2012-03-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk Patients|Phase 4 Study of Optimal Dose of Haloperidol|Completed||N/A|150|Actual|The Catholic University of Korea||3|||f||||t||||||||||2017-10-11 02:45:32.207593|2017-10-11 02:45:32.207593
NCT01639586|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-07-10|||August 2011||2011-08-01|July 2012|2012-07-01|April 2013|Anticipated|2013-04-01|October 2012|Anticipated|2012-10-01||Interventional|COMPARSE||Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care|Comparaison du Service Rendu à la Personne Atteinte d'Une Maladie d'Alzheimer et de l'Aidant Par Trois Types de Prises en Charge (Plateforme, Accueil de Jour et Groupe contrôle|Unknown status|Recruiting|N/A|360|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 02:45:32.289195|2017-10-11 02:45:32.289195
NCT01639573|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2016-08-05|||April 2011||2011-04-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|CAMPATH-1H||Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis|Campath-1h as Immunoablative Therapy for Children and Adolescents With Treatment Refractory Systemic Sclerosis|Recruiting||N/A|3|Anticipated|Children's Hospital Los Angeles|||1||f||||t||||||||||2017-10-11 02:45:32.553007|2017-10-11 02:45:32.553007
NCT01639560|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-10-12|2016-08-18||January 2013||2013-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|ChanLight||Varenicline for Light Smokers|Varenicline for Light Smokers|Completed||Phase 4|93|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 02:45:32.652871|2017-10-11 02:45:32.652871
NCT01639547|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-07-27|||July 2012||2012-07-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis C|A Randomized, Open-lable, Multicenter, Parallel Group Study to Compare SVR Rate of Pegasys Plus Ribavirin for 48 Weeks vs. 36 Weeks in Patients With Chronic Hepatitis C|Terminated||N/A|410|Anticipated|Chang Gung Memorial Hospital||2||early termination due to difficult collection of patients|f||||f||||||||||2017-10-11 02:45:33.204659|2017-10-11 02:45:33.204659
NCT01639534|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-06-13|||March 2011||2011-03-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures|Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures|Active, not recruiting||N/A|10|Anticipated|Virginia Commonwealth University|||1||f||||f||||||Samples Without DNA|"     An aliquot of each sample will be stored for potentialconfirmatory reanalysis in the future     at this or a contracted insitution.   "|||2017-10-11 02:45:33.295057|2017-10-11 02:45:33.295057
NCT01639521|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-01-27|||May 2013||2013-05-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer|Randomized Phase II Trial Of Adjuvant Chemotherapy For Urothelial Carcinoma Comparing GC To Dose-Dense MVAC|Withdrawn||Phase 2|0|Actual|University of Southern California||2||Lack of funding|f||||t||||||||||2017-10-11 02:45:33.357076|2017-10-11 02:45:33.357076
NCT01639508|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-02-13|||July 2012|Actual|2012-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity|A Phase II Study of Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity|Recruiting||Phase 2|68|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:45:33.479906|2017-10-11 02:45:33.479906
NCT01639482|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-09-15|||April 2010||2010-04-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Neuroimaging Studies of the Treatment of Bipolar Depression With Citalopram||Completed||N/A|60|Actual|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-11 02:45:33.747455|2017-10-11 02:45:33.747455
NCT01639469|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-06-22|2017-04-04||January 2013|Actual|2013-01-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|||Telemedicine Intervention to Improve Physical Function|A Telemedicine Intervention to Improve Physical Function in Patients With PD|Completed||N/A|169|Actual|VA Office of Research and Development||2|||f||||f|f|f||||||No||2017-10-11 02:45:33.810221|2017-10-11 02:45:33.810221
NCT01639456|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-03-04|||October 2013||2013-10-01|March 2014|2014-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission|A Randomized Trial Comparing CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy in Older Adults With Acute Myelogenous Leukemia in First Complete Remission|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||2||study was abandoned and a new study was written to replace this one|f||||t||||||||||2017-10-11 02:45:34.02358|2017-10-11 02:45:34.02358
NCT01639443|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-03-03|2016-06-30||July 8, 2013|Actual|2013-07-08|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|July 6, 2015|Actual|2015-07-06||Interventional|No-show|All Participants in all study phases.|Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy|Reducing VA No-Shows: Evaluation of Predictive Overbooking Applied to Colonoscopy|Active, not recruiting||N/A|180|Actual|VA Office of Research and Development|This study was impeded by our ability to schedule Veterans into Fast-Tracked appointments. Although the method is very promising, integration of predictive scheduling is vital for this program to benefit Veterans on a large scale.|2|||f||||f||||||||No||2017-10-11 02:45:34.139339|2017-10-11 02:45:34.139339
NCT01639430|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-11|||May 2012||2012-05-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Diagnostic Accuracy of Body Temperature Measurement in Geriatric Patients|Diagnostic Accuracy of Body Temperature Measurement in Geriatric Patients Presenting to the Emergency Department|Completed||N/A|427|Actual|Klinikum Nürnberg|||1||f||||||||||||||2017-10-11 02:45:34.661571|2017-10-11 02:45:34.661571
NCT01639417|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-04-14|||May 2012||2012-05-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Observational|||Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients|Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients|Completed||N/A|39|Actual|University of Michigan Cancer Center|||1||f||||t||||||||||2017-10-11 02:45:34.721484|2017-10-11 02:45:34.721484
NCT01639404|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-08-08|||July 2012||2012-07-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Umbilical Cord Blood Therapy for Children With Cerebral Palsy|Allogeneic Umbilical Cord Blood Therapy for Children With Cerebral Palsy|Completed||N/A|17|Actual|Bundang CHA Hospital||1|||f||||f||||||||||2017-10-11 02:45:34.787384|2017-10-11 02:45:34.787384
NCT01639391|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-12-05|||November 2012||2012-11-01|December 2012|2012-12-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|ALSCELL||Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study|Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study|Unknown status|Recruiting|N/A|30|Anticipated|Institut Pasteur||1|||f||||f||||||||||2017-10-11 02:45:34.882378|2017-10-11 02:45:34.882378
NCT01639378|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-11-10|||August 2012||2012-08-01|August 2016|2016-08-01||||April 2017|Anticipated|2017-04-01||Interventional|REACH||Renal Artery Denervation in Chronic Heart Failure Study|Impact of Renal Artery Denervation in Patients With Chronic Heart Failure Compared With Sham Procedure|Active, not recruiting||Phase 3|76|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 02:45:34.96564|2017-10-11 02:45:34.96564
NCT01639365|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2015-09-04|||July 2012||2012-07-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|January 2015|Actual|2015-01-01||Observational|||SmartTouch Catheter in Ablation of Ventricular Tachycardia|Usefulness of the SmartTouch Catheter to Assess the Areas of Myocardial Scar in Patients With Ventricular Tachycardia|Unknown status|Active, not recruiting|N/A|20|Anticipated|Hospital Universitario Virgen de la Arrixaca|||1||f||||f||||||||||2017-10-11 02:45:35.074262|2017-10-11 02:45:35.074262
NCT01639352|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-06-13|2017-05-02||July 2012||2012-07-01|June 2017|2017-06-01|February 2017|Actual|2017-02-01|August 2016|Actual|2016-08-01||Interventional|||Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma|Phase II Trial of SOM230 (Pasireotide LAR) in Patients With Unresectable Hepatocellular Carcinoma (HCC)|Completed||Phase 2|20|Actual|University of Miami||1|||f||||t||||||||No||2017-10-11 02:45:35.201016|2017-10-11 02:45:35.201016
NCT01639339|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-07-06|||July 12, 2012||2012-07-12|July 2017|2017-07-01|February 7, 2020|Anticipated|2020-02-07|July 26, 2019|Anticipated|2019-07-26||Interventional|BLISS-LN||Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis|Recruiting||Phase 3|464|Anticipated|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 02:45:36.099413|2017-10-11 02:45:36.099413
NCT01639326|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2015-05-06|||July 2012||2012-07-01|June 2012|2012-06-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|FOLFIRI-AD||Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1|Phase II Randomized Pharmacogenetic Study to Evaluate the Efficacy and Safety of FOLFIRI Schedule With High Doses of Irinotecan (FOLFIRI-AD) in Patients With Metastatic Colorectal Cancer According to UGT1A Genotype 1.|Recruiting||Phase 2|96|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-11 02:45:37.042168|2017-10-11 02:45:37.042168
NCT01639313|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-07-09|||June 2011||2011-06-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Comparison of Nexfin Pulse Contour Analysis and Cardiac Magnetic Resonance Imaging for the Measurement of Cardiac Output|Is Arterial Pulse Contour Analysis Using Nexfin a New Option in the Non-invasive Measurement of Cardiac Output? - A Pilot Study|Completed||N/A|39|Actual|Universitätsmedizin Mannheim|||1||f||||||||||||||2017-10-11 02:45:37.155135|2017-10-11 02:45:37.155135
NCT01639300|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-04-17|||July 2012||2012-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety Study of GNbAC1 in Multiple Sclerosis Patients|Randomised Placebo-Controlled Single Blind Study to Investigate Single Ascending Doses of GNbAC1 in Multiple Sclerosis Patients Followed by Open-label Extension With Repeated Doses of GNbAC1|Completed||Phase 2|10|Actual|GeNeuro Innovation SAS||2|||f||||f||||||||||2017-10-11 02:45:37.219521|2017-10-11 02:45:37.219521
NCT01639287|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-11|||July 2012||2012-07-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|December 2012|Anticipated|2012-12-01||Observational|||Painless Synovitis in Patients With Longstanding Rheumatoid Arthritis|"Correlation of Painless Synovitis With Clinical, Laboratory and Radiological (X-ray, Sonography) Finds in Patients With Longstanding Rheumatoid Arthritis (RA)."|Unknown status|Recruiting|N/A|60|Anticipated|Federal University of São Paulo|||2||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-11 02:45:37.320901|2017-10-11 02:45:37.320901
NCT01639274|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-11-07|||January 2012||2012-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|HIV and COPD||Human Immunodeficiency Virus (HIV)and Chronic Obstructive Pulmonary Disease (COPD)|Prevalence of Chronic Obstructive Pulmonary Disease in HIV-patient Population|Completed||N/A|639|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 02:45:37.407851|2017-10-11 02:45:37.407851
NCT01638728|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2014-01-23|||July 2012||2012-07-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Change of Depth in a RAE Tube: Tube Fixation at the Midline or Angle and in a Neutral or Neck Extended Position||Completed||N/A|100|Actual|Kyung Hee University Hospital at Gangdong|||1||f||||||||||||||2017-10-11 02:45:47.722384|2017-10-11 02:45:47.722384
NCT01639261|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-07-11|||July 2012||2012-07-01|July 2012|2012-07-01|September 2014|Anticipated|2014-09-01|December 2013|Anticipated|2013-12-01||Interventional|IFN_BOSZT_01||A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT|Eine Phase II Studie über Interferon Gamma 1b Zur Behandlung Der steroidrefraktären Bronchiolitis Obliterans Nach Allogener SZT|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|University Hospital Regensburg||1|||f||||f||||||||||2017-10-11 02:45:37.489478|2017-10-11 02:45:37.489478
NCT01639248|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-06-23|||July 2012||2012-07-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC|A Phase II Study of the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced and Metastatic Triple-Negative Breast Cancer|Completed||Phase 2|41|Actual|CASI Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 02:45:37.577751|2017-10-11 02:45:37.577751
NCT01639235|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-08-10|||January 2005||2005-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|FAMRI||Effects of Secondhand Smoke on Flight Attendant Health|Cardiopulmonary Effects of Secondhand Smoke Exposure on Flight Attendants|Recruiting||N/A|2000|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     There is an optional blood draw blood portion to the research study. A sample is collected     from the interested flight attendant. The majority of the sample is processed and stored in     the FAMRI biorepository for future research purposes to identify biomarkers of cardiovascular     risk and secondhand smoke. The remainder of the sample is analyzed for the flight attendant.     A lipid profile is sent to the flight attendant participant.   "|||2017-10-11 02:45:37.694401|2017-10-11 02:45:37.694401
NCT01639222|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2013-08-13|2013-03-25||July 2012||2012-07-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|Osteopro||Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy Participants|A Two Period, One-sequence Open-label Study of a Newly Developed Calcium Carbonate-vitamin D3 Chewable Tablet Formulation (Calcium 500 mg and Vitamin D3 800) Dosed for Three Days to Investigate the Effect on Urine Calcium and Serum Parathyroid Hormone (PTH) as Measurements of Intestinal Calcium Absorption in Healthy Postmenopausal Women and Healthy Men Compared to Baseline.|Completed||Phase 1|55|Actual|Takeda||1|||f||||f||||||||||2017-10-11 02:45:37.812575|2017-10-11 02:45:37.812575
NCT01639209|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-08-15|||August 2012|Actual|2012-08-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment|A Randomised Controlled Trial Comparing Pneumatic Retinopexy Versus Vitrectomy for the Management of Primary Retinal Detachment; Anatomical Success, Functional Success and Impact on Patient Quality of Life|Completed||N/A|176|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 02:45:38.06675|2017-10-11 02:45:38.06675
NCT01639196|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-01-11|||July 2012||2012-07-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Brief Online Intervention for Chronic Pain|The Expressive Writing Paradigm: A Study of Therapeutic Effectiveness for Chronic Pain|Completed||N/A|93|Actual|University of Maryland||2|||f||||f||||||||||2017-10-11 02:45:38.160281|2017-10-11 02:45:38.160281
NCT01639183|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2013-07-23|||September 2012||2012-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Power Toothbrush Use in Nursing Homes to Eliminate Mouth and Body Inflammation|The Effects of Daily Power Toothbrushing on Caregiver Compliance and on Oral and Systemic Inflammation in a Nursing Home Population: A Randomized Controlled Trial|Completed||N/A|58|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 02:45:38.248295|2017-10-11 02:45:38.248295
NCT01639170|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-16|||June 2011||2011-06-01|June 2012|2012-06-01||||June 2012|Actual|2012-06-01||Interventional|||Abdominal Free Air After Surgery|Intra-abdominal Free Air on a Plain Radiograph After Surgery. Could it be a Finding That May Predict Gastrointestinal Perforation?|Unknown status|Recruiting|N/A|600|Anticipated|Federico II University||1|||f||||||||||||||2017-10-11 02:45:38.342642|2017-10-11 02:45:38.342642
NCT01639157|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-01-22|2015-12-04||September 2012||2012-09-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine|Human Laboratory Study of the Impact of Buspirone Maintenance on the Reinforcing, Subjective and Performance Effects of Cocaine|Completed||N/A|9|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-11 02:45:38.462684|2017-10-11 02:45:38.462684
NCT01639144|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2015-05-21|2015-04-06||July 2012||2012-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|PRP|Patients having foot and/or ankle surgery.|Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing|Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing After Elective Foot and Ankle Surgery in Healthy Adults|Completed||N/A|515|Actual|UHZ Sports Medicine Institute|Originally intended to enroll more patients but due to apparent lack of effect of PRP treatment, enrollment was truncated to n = 250 per study group.|2|||f||||t||||||||||2017-10-11 02:45:39.451838|2017-10-11 02:45:39.451838
NCT01639131|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-12-14|||August 2012||2012-08-01|December 2016|2016-12-01||||August 2018|Anticipated|2018-08-01||Interventional|||Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma|A Multi-institutional Open Label, Trial Evaluating the Efficacy of Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma With Methylated CHFR and/or Microsatellite Instability Phenotype|Recruiting||Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:45:39.995168|2017-10-11 02:45:39.995168
NCT01639118|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-11-18|||March 2012||2012-03-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|SITUP||Prospective Study Of A Size Tailored Approach To Repair Umbilical And Epigastric Primary Ventral Hernias|Prospective Observational Cohort Study Of A Size Tailored Approach To Repair Umbilical And Epigastric Primary Ventral Hernias|Terminated||N/A|11|Actual|Algemeen Ziekenhuis Maria Middelares|||1|"Perception of an increased incidence of C-Qur V-patch mesh infection, with need for removal,   compared to other meshes used for umbilical hernia repair."|f||||f||||||||||2017-10-11 02:45:40.114489|2017-10-11 02:45:40.114489
NCT01639105|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-12-04|||February 2013||2013-02-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||10 600 nm Ablative Fractional Laser Treatment of Scars: a Prospective Single Blinded Within Patient Controlled Randomized Trial|10 600 nm Ablative Fractional Laser Treatment of Scars: a Prospective Single Blinded Within Patient Controlled Randomized Trial|Unknown status|Recruiting|N/A|16|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 02:45:40.183153|2017-10-11 02:45:40.183153
NCT01639092|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-07-24|||September 2012||2012-09-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2014|Actual|2014-06-01||Interventional|IN-US-0202||Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B|A Multicenter Randomized Controlled Open-label Trial of Tenofovir vs. Tenofovir Plus Entecavir in Chronic Hepatitis B Patients With Genotypic Resistance to Entecavir and Partial Virologic Response to Ongoing Treatment|Active, not recruiting||Phase 4|88|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:45:40.272087|2017-10-11 02:45:40.272087
NCT01639079|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-04-18|||June 2012||2012-06-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|TC5Redes||Comparison of Internet Stop Smoking Intervention to Usual Care on Smoking Cessation at 6 Months|Smoking Cessation Through the Web: Latino Smokers Follow-Up Study|Completed||Phase 4|146|Actual|University of California, San Francisco||2|||f||||f||||||||No||2017-10-11 02:45:40.394279|2017-10-11 02:45:40.394279
NCT01639066|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2016-07-24|||September 2012||2012-09-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|June 2014|Actual|2014-06-01||Interventional|IN-US-0205||Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B|A Multicenter Randomized Controlled Open-label Trial of Tenofovir Plus Entecavir Combination vs. Tenofovir Monotherapy in Chronic Hepatitis B Patients With Genotypic Resistance to Adefovir and Partial Virologic Response to Ongoing Treatment|Active, not recruiting||Phase 4|102|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:45:40.718807|2017-10-11 02:45:40.718807
NCT01639053|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2017-05-05|||April 2012||2012-04-01|May 2017|2017-05-01|March 2025|Anticipated|2025-03-01|March 2025|Anticipated|2025-03-01||Observational|||Sientra Post-Approval Study|U.S. Postapproval Study of Sientra Silicone Gel Breast Implants|Active, not recruiting||N/A|5000|Anticipated|Sientra, Inc.|||2||f||||f||||||||No||2017-10-11 02:45:40.872119|2017-10-11 02:45:40.872119
NCT01639027|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2013-01-17|||May 2012||2012-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Drotaverine to Shorten the Length of Labor|Use of Antispasmodic Drotaverine to Shorten the Length of Labor in Nulliparous Women|Completed||Phase 2/Phase 3|352|Actual|Ain Shams Maternity Hospital||2|||f||||t||||||||||2017-10-11 02:45:41.145571|2017-10-11 02:45:41.145571
NCT01639014|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2015-03-31|||July 2012||2012-07-01|March 2014|2014-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|LIFE||Effect of F2695 on Functional Recovery After Ischemic Stroke|Effect of 3-month Treatment With F2695 (75mg OD) on Improving Functional Recovery of Patients With Ischemic Stroke. A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-Controlled Study|Completed||Phase 3|532|Actual|Pierre Fabre Medicament||2|||f||||f||||||||||2017-10-11 02:45:41.281966|2017-10-11 02:45:41.281966
NCT01638988|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-07-24|||September 2013||2013-09-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|November 2013|Actual|2013-11-01||Interventional|||Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin|Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome (PCOS) and a Resistance to Insulin. Randomised Controlled Study|Withdrawn||Phase 3|0|Actual|OVO R & D||2||Previous studies have been done regarding same condition|f||||f||||||||||2017-10-11 02:45:43.561333|2017-10-11 02:45:43.561333
NCT01638975|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2014-01-17|||October 2010||2010-10-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Response Inhibition Training for Individuals With Trichotillomania|Testing the Feasibility of Response Inhibition Enhancement Training for Individuals With Trichotillomania|Completed||N/A|20|Actual|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-10-11 02:45:43.660391|2017-10-11 02:45:43.660391
NCT01638962|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-08-01|||August 2012||2012-08-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|August 2015|Actual|2015-08-01||Interventional|EXERPHARMA||The Effect on Knee Joint Loads of Analgesic Use Compared With Exercise in Patients With Knee Osteoarthritis - An RCT|The Effect on Knee Joint Loads of Instruction in Analgesic Use Compared With NEUROMUSCULAR Exercise in Patients With Knee Osteoarthritis - A Single Blind RCT|Completed||N/A|93|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 02:45:43.78153|2017-10-11 02:45:43.78153
NCT01638949|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-04-08|||May 2012||2012-05-01|April 2014|2014-04-01||||December 2021|Anticipated|2021-12-01||Interventional|IMAP+||Multi-modal Neuroimaging in Alzheimer's Disease|Study of the Predictive Markers and the Pathophysiological Mechanisms of Alzheimer's Disease: Transverse and Longitudinal Approach in Anatomical and Functional Multimodal Imaging|Recruiting||N/A|295|Anticipated|University Hospital, Caen||8|||f||||t||||||||||2017-10-11 02:45:43.936535|2017-10-11 02:45:43.936535
NCT01638936|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-08-31|||July 2012||2012-07-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|July 2018|Anticipated|2018-07-01||Interventional|||BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma|A Phase I/IIa Multi-dose Escalation Study of BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Subjects With Relapsed or Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|64|Actual|Biotest Pharmaceuticals Corporation||1|||f||||t||||||||||2017-10-11 02:45:44.183513|2017-10-11 02:45:44.183513
NCT01638338|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-07-04|||December 1, 2012|Actual|2012-12-01|July 2017|2017-07-01|December 30, 2015|Actual|2015-12-30|December 30, 2015|Actual|2015-12-30||Interventional|EFAR-FVG||Risky Drinkers and the Web: a RCT Study in Region Friuli-Venezia Giulia.|Optimizing and Integrating the Delivery of Primary Care Services for Risky Drinkers in Region Friuli-Venezia Giulia|Completed||N/A|674|Actual|Azienda Per I Servizi Sanitari N. 2 Isontina||2|||f||||f||||||||||2017-10-11 02:45:51.792812|2017-10-11 02:45:51.792812
NCT01638923|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-07-08|||June 2012||2012-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding|A Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled, 7 Cycle Duration (196 Days), Phase 3 Study to Investigate the Efficacy and Safety of Oral Estradiol Valerate / Dienogest Tablets for the Treatment of Heavy Menstrual Bleeding|Completed||Phase 3|339|Actual|Bayer||2|||f||||f||||||||||2017-10-11 02:45:44.31978|2017-10-11 02:45:44.31978
NCT01638910|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-12-16|||June 2012||2012-06-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects|A Multi-center, Open, Uncontrolled Phase 3 Study to Investigate the Efficacy and Safety of a 4-phasic Oral Contraceptive SH T00658ID Containing Estradiol Valerate and Dienogest in a 28-day Regimen for 13 Cycles in Healthy Female Subjects|Completed||Phase 3|955|Actual|Bayer||1|||f||||f||||||||||2017-10-11 02:45:44.55507|2017-10-11 02:45:44.55507
NCT01638897|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-07-06|||January 2012||2012-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||DF4 Connector System Post-Approval Study|DF4 Connector System Post-Approval Study|Active, not recruiting||N/A|1778|Anticipated|Medtronic|||1||f||||f||||||||||2017-10-11 02:45:44.747807|2017-10-11 02:45:44.747807
NCT01638884|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2014-04-08|||September 2010||2010-09-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|IMPRO||Prospective Memory Imaging|Cerebral Substrates of Prospective Memory in Healthy Young Adults and Disruptions in Normal Aging and Alzheimer Disease: a Study in Anatomical, Functional and Diffusion Tensor MRI.|Unknown status|Recruiting|N/A|118|Anticipated|University Hospital, Caen||5|||f||||t||||||||||2017-10-11 02:45:46.588821|2017-10-11 02:45:46.588821
NCT01638871|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2014-02-19|||October 2012||2012-10-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PainCOACH||Internet-Based Osteoarthritis Pain Coping Skills Intervention|Internet-Based Osteoarthritis Pain Coping Skills Intervention|Completed||Phase 3|113|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:45:46.687558|2017-10-11 02:45:46.687558
NCT01638858|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-07-04|||October 2011||2011-10-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Interventional|||Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)|A Prospective, Non-randomized, Mono-center, Cohort Study of Evaluate the Effects of 0.5mg Intraocular Ranibizumab (Lucentis)Injections on Retinal Function in Patients With Diabetic Macular Edema (DME) During Twelve Months|Completed||N/A|25|Actual|University of Luebeck||1|||f||||||||||||||2017-10-11 02:45:46.770032|2017-10-11 02:45:46.770032
NCT01638845|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-08-16|||July 2012||2012-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Hip Fracture and Perineural Catheter||Completed||N/A|166|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 02:45:46.843403|2017-10-11 02:45:46.843403
NCT01638832|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-07-11|||June 2012||2012-06-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease|Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease|Unknown status|Recruiting|N/A|572|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||||2017-10-11 02:45:47.017706|2017-10-11 02:45:47.017706
NCT01638819|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-05-10|||August 2012||2012-08-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Autologous Cord Blood Stem Cells for Autism|A Randomized, Blinded, Placebo-controlled, Crossover Study to Assess the Efficacy of Stem Cells From Autologous Umbilical Cord Blood to Improve Language and Behavior in Children With Autism|Completed||Phase 2|29|Actual|Sutter Health||2|||f||||t||||||||||2017-10-11 02:45:47.095101|2017-10-11 02:45:47.095101
NCT01638806|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-10-03|||June 2012||2012-06-01|October 2017|2017-10-01|June 2022|Anticipated|2022-06-01|April 2017|Actual|2017-04-01||Interventional|NONSTEMI||Acute Versus Subacute Angioplasty in Patients With NON-ST-Elevation Myocardial Infarction|Acute Versus Subacute Angioplasty in Patients With NON-ST-Elevation Myocardial Infarction (NON-ST-Elevation Myocardial Infarction=NONSTEMI Trial)|Terminated||N/A|500|Actual|Aarhus University Hospital Skejby||2||slow recuritment|f||||t||||||||||2017-10-11 02:45:47.180985|2017-10-11 02:45:47.180985
NCT01638793|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-11|2013-10-24|||June 2012||2012-06-01|June 2012|2012-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Capnographic Monitoring of Propofol-sedation During Colonoscopy|Capnographic Monitoring of Propofol-sedation During Colonoscopy|Completed||N/A|528|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 02:45:47.281482|2017-10-11 02:45:47.281482
NCT01638780|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2014-09-03|||May 2012||2012-05-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Resveratrol and Type 2 Diabetes|Effect of Resveratrol on Insulin Sensitivity and Metabolic Profile in Type 2 Diabetics|Unknown status|Active, not recruiting|N/A|24|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:45:47.36165|2017-10-11 02:45:47.36165
NCT01638767|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2015-07-24|||July 2012||2012-07-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles|Effect of Using the Nuvaring on the Level of Satisfaction, Stress on Users and on Coordinating In Vitro Fertilization (IVF) Cycles: Randomized Public Study|Terminated||Phase 4|7|Actual|OVO R & D||2||Difficulty to recruit patient due to lack of eligible patient|f||||f||||||||||2017-10-11 02:45:47.45533|2017-10-11 02:45:47.45533
NCT01638754|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-07-11|||May 2011||2011-05-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Interventional|MAPIT-TOO||Image Guided Mapping for Cardiac Pacing Intervention|Multi-Modality Imaging Assessment for Pacing Interventions in Heart Failure: Targeting Optimal Sites and Outcomes|Unknown status|Active, not recruiting|N/A|50|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 02:45:47.567686|2017-10-11 02:45:47.567686
NCT01638741|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2013-04-23|||September 2011||2011-09-01|April 2013|2013-04-01|October 2014|Anticipated|2014-10-01|June 2013|Anticipated|2013-06-01||Observational|||The Need for Rehabilitation and the Connection With Attachment Styles Among Patients With Gynaecological Cancer|Rehabilitation and the Association With Attachment Styles Among Patients With Gynaecological Cancer|Unknown status|Recruiting|N/A|150|Anticipated|Odense University Hospital|||1||f||||f||||||||||2017-10-11 02:45:47.642307|2017-10-11 02:45:47.642307
NCT00004409|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||August 1995||1995-08-01|May 2001|2001-05-01|April 2004||2004-04-01|||||Interventional|||Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease||Completed||Phase 2|36|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.82786|2017-10-11 04:25:19.82786
NCT01638715|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-09-14|||May 2012||2012-05-01|September 2017|2017-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action|A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action|Recruiting||Phase 4|200|Anticipated|Medical University of Vienna||4|||f||||f||||||||||2017-10-11 02:45:47.783691|2017-10-11 02:45:47.783691
NCT01638702|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2016-03-14|||October 2012||2012-10-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study of Complication Rates Associated With PICC for Left vs Right|Assessment of Impact of Choice of Arm for Access on Rate of Complications in Peripherally Inserted Central Venous Catheters|Completed||N/A|203|Actual|McGill University Health Center||2|||f||||t||||||||Undecided||2017-10-11 02:45:47.941281|2017-10-11 02:45:47.941281
NCT01638689|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-11|||September 2010||2010-09-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|February 2011|Actual|2011-02-01||Interventional|||A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram|A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram|Completed||Phase 1|10|Actual|Karolinska Institutet||1|||f||||||||||||||2017-10-11 02:45:48.010423|2017-10-11 02:45:48.010423
NCT01638676|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-11-21|||July 2012||2012-07-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients|A Phase I/II Trial of Vemurafenib and Metformin to Unresectable Stage IIIC and Stage IV BRAF.V600E+ Melanoma Patients|Recruiting||Phase 1/Phase 2|55|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-10-11 02:45:48.070897|2017-10-11 02:45:48.070897
NCT01638663|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2014-10-08|||May 2012||2012-05-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)|Effect of Vasopressin Antagonism on Renal Sodium and Water Handling and Circulation During Inhibition of the Nitric Oxide System in Healthy Subjects|Completed||Phase 2|20|Actual|Regional Hospital Holstebro||2|||f||||t||||||||||2017-10-11 02:45:48.160383|2017-10-11 02:45:48.160383
NCT01638650|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-11-01|||January 2012||2012-01-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients|To Determine the Effect of the Modified SQV/r (Saquinavir-boosted by Ritonavir) Regimen (500/100 mg for the 1st Week Followed by 1000/100 mg for the 2nd Week) on the QTc Interval, Pharmacokinetics, and Antiviral Activity in Treatment-naive HIV-1 Infected Patients|Completed||Phase 1|23|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:45:48.255484|2017-10-11 02:45:48.255484
NCT01638637|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2013-10-16|||February 2012||2012-02-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Prospective Collection of Female and Male Specimens for PANTHER® System Testing|Prospective Collection of Female First-catch Urine, Vaginal Swab, Cervical, and Endocervical Swab Specimens and Male Urethral Swab and First-catch Urine Specimens for Testing With the PANTHER® System|Completed||N/A|1492|Actual|Gen-Probe, Incorporated|||1||f||||f||||||Samples With DNA|"     urine   "|||2017-10-11 02:45:48.334452|2017-10-11 02:45:48.334452
NCT01638624|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-06-10|||June 2012||2012-06-01|July 2012|2012-07-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||The Effect of Propofol Infusion on Total Antioxidant Status During Tourniquet-Induced Ischemia-Reperfusion Injury|The Effect of Propofol Infusion on Total Antioxidant Status During Tourniquet-Induced Ischemia-Reperfusion Injury in Total Knee Arthroplasty|Completed||Phase 4|36|Actual|Diskapi Teaching and Research Hospital||2|||f||||||||||||||2017-10-11 02:45:48.626486|2017-10-11 02:45:48.626486
NCT01638611|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-11-14|||July 2012||2012-07-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|HIP2B||A Study of Subcutaneous Doses of HIP2B in Healthy Male Subjects|A Randomized, Double-blind, Third Party (Sponsor) Open, Placebo-controlled Study of the Tolerability and Pharmacokinetics of Single Ascending Subcutaneous Doses of HIP2B in Healthy Male Subjects|Completed||Phase 1|40|Actual|CureDM||2|||f||||f||||||||No||2017-10-11 02:45:48.748479|2017-10-11 02:45:48.748479
NCT01638598|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2013-10-31|||July 2012||2012-07-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers (Placebo-controlled, Randomised and Double-blind Within Dose Groups)|Completed||Phase 1|80|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 02:45:48.835415|2017-10-11 02:45:48.835415
NCT01638585|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2014-04-04|||June 2011||2011-06-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|August2||Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia|Patients With Diabetic Foot Syndrome and Critical Limb Ischemia - a Randomized Clinical Trial With Urokinase|Terminated||Phase 3|34|Actual|GWT-TUD GmbH||2||recruition number was not reached|f||||t||||||||||2017-10-11 02:45:48.933828|2017-10-11 02:45:48.933828
NCT01638572|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2012-07-08|||January 2010||2010-01-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma|Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma|Completed||N/A|90|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 02:45:49.056886|2017-10-11 02:45:49.056886
NCT01638559|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-05-19|2017-05-17||August 2012||2012-08-01|May 2017|2017-05-01|May 28, 2018|Anticipated|2018-05-28|March 2016|Actual|2016-03-01||Interventional|iWITH|Intent to Treat|Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients|Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients|Active, not recruiting||Phase 2|88|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t|t|f||||||Yes|The plan, upon completion of the study, is to share data in ImmPort [https://immport.niaid.nih.gov/ ], a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 02:45:49.120165|2017-10-11 02:45:49.120165
NCT01638546|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-02-09|||June 2012||2012-06-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer|A Multi-Center, Randomized, Double-Blind Phase II Study Comparing ABT-888, a PARP Inhibitor, Versus Placebo With Temozolomide in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer|Completed||Phase 2|110|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 02:45:49.455216|2017-10-11 02:45:49.455216
NCT01638533|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-09-12|||June 12, 2012|Actual|2012-06-12|September 2017|2017-09-01|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction|A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia and Select Solid Tumors and Varying Degrees of Liver Dysfunction|Recruiting||Phase 1|132|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 02:45:49.611965|2017-10-11 02:45:49.611965
NCT01638520|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-03-30|||June 2012||2012-06-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|February 2017|Actual|2017-02-01||Interventional|||Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis|Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Combination Therapy for Pulmonary Tuberculosis (TB): a Randomized, Double-blind, Placebo-controlled, Proof-of-concept Clinical Trial|Active, not recruiting||Phase 2|32|Actual|National University Hospital, Singapore||2|||f||||t||||||||||2017-10-11 02:45:49.767476|2017-10-11 02:45:49.767476
NCT01638507|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-04-18|2015-10-23||July 2012||2012-07-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|RI-US||An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System|Resolute Integrity US A Postapproval Study of the Medtronic Resolute™ Integrity Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2 mm|Completed||N/A|230|Actual|Medtronic Vascular||1|||f||||f||||||||||2017-10-11 02:45:49.874746|2017-10-11 02:45:49.874746
NCT01638494|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-07-09|||December 2008||2008-12-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Calcium and Vitamin D Intakes in Children||Completed||N/A|184|Actual|Federico II University||1|||f||||f||||||||||2017-10-11 02:45:50.271632|2017-10-11 02:45:50.271632
NCT01638481|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-07-13|||July 2012||2012-07-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Chronology of Occult and Gross Coagulopathy in Burn Patients|Determining the Chronology of Occult and Gross Coagulopathy in Thermally Injured Patients: A Systems Biology Approach|Recruiting||N/A|85|Anticipated|Medstar Health Research Institute|||5||f||||f||||||||||2017-10-11 02:45:50.334215|2017-10-11 02:45:50.334215
NCT01638468|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-09-12|2016-09-12||January 2013||2013-01-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PERFUSE||Multicenter, Nonrandomized, Prospective Study of Pulmonary Embolism Removal With the AngioJet 6F Ultra System|Pulmonary Embolism Removal With the AngioJet 6F Ultra SystEm (PERFUSE)|Terminated||Phase 4|7|Actual|Boston Scientific Corporation||1||Slow Enrollment|f||||t||||||||No||2017-10-11 02:45:50.420248|2017-10-11 02:45:50.420248
NCT01638455|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-05-11|||June 2012|Actual|2012-06-01|May 2017|2017-05-01|September 7, 2016|Actual|2016-09-07|September 7, 2016|Actual|2016-09-07||Interventional|||Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples|Noninvasive Parameter Testing With Pulse CO-Oximetry and Measurement of Blood Constituents With In-Vitro Analyzers|Completed||N/A|2776|Actual|Masimo Corporation||1|||f||||f||t|t|||||||2017-10-11 02:45:50.837925|2017-10-11 02:45:50.837925
NCT01638442|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-07-18|||June 2012||2012-06-01|July 2012|2012-07-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Interventional|8265134||Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects|An Open-label, Randomized, Two-way Crossover Trial of the Effect of a High-Fat Meal on the Pharmacokinetics of Oral Tosedostat (CHR 2797) in Healthy Male Subjects|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|CTI BioPharma||2|||f||||f||||||||||2017-10-11 02:45:50.897145|2017-10-11 02:45:50.897145
NCT01638416|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-08-17|||October 2012||2012-10-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|April 2017|Actual|2017-04-01||Interventional|TRANSFUSE||Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial|A Multi-centre Randomised Double Blinded Phase III Trial of the Effect of Standard Issue Red Blood Cell Blood Units on Mortality Compared to Freshest Available Red Blood Cell Units|Completed||Phase 3|4994|Actual|Australian and New Zealand Intensive Care Research Centre||2|||f||||t||||||||||2017-10-11 02:45:51.056069|2017-10-11 02:45:51.056069
NCT01638403|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-01-30|||November 2010||2010-11-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Interventional|||Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.|Randomized, Double-blind, Placebo and Comparator-controlled, Parallel-group, Multi-center Trial Assessing the Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy|Completed||Phase 3|180|Actual|Bioprojet||3|||f||||t||||||||||2017-10-11 02:45:51.255459|2017-10-11 02:45:51.255459
NCT01638390|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-01-30|||July 2012||2012-07-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Use of the Visumax™ Femtosecond Laser|Use of the Visumax™ Femtosecond Laser Lenticule Removal Procedure for the Correction of Myopia|Completed||Phase 1|357|Actual|Carl Zeiss Meditec, Inc.||1|||f||||t||||||||||2017-10-11 02:45:51.361816|2017-10-11 02:45:51.361816
NCT01638377|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-04-01|||August 2012||2012-08-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers|A Multi-site Study to Disseminate and Evaluate Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers|Terminated||Phase 4|2|Actual|Centre for Addiction and Mental Health||2||Recruitment proved to be extremely difficult.|f||||f||||||||||2017-10-11 02:45:51.463742|2017-10-11 02:45:51.463742
NCT01638364|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-07-27|||January 2013||2013-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Dopamine Release in the Human Brain Following Alcohol Administration|Imaging Alcohol Induced Dopamine Release in the Human Brain: a PET/[11C](+)PHNO Study|Completed||Phase 1|8|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 02:45:51.588871|2017-10-11 02:45:51.588871
NCT01638351|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2012-11-15|||December 2011||2011-12-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Resistance Training in Diabetic Elder Patients|Effects of Resistance Training on Muscle Dysfunction in Elderly Patients With Type 2 Diabetes Mellitus|Completed||N/A|49|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 02:45:51.694334|2017-10-11 02:45:51.694334
NCT01638325|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-06-13|||July 2012||2012-07-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants|A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of Single Subcutaneous Injections of Insulin Lispro With BioChaperone Excipient in Healthy Volunteers|Completed||Phase 1|37|Actual|Adocia||2|||f||||f||||||||||2017-10-11 02:45:51.92709|2017-10-11 02:45:51.92709
NCT01638312|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-09-03|2015-02-10||June 2011||2011-06-01|September 2012|2012-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Development of Method of Fructose Identification in Urine to Detect the Viral Infection|The Development of Fast and Simple Method of Fructose Identification in Urine to Detect the Viral Infection in Early Stage|Completed||N/A|50|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||t||||||None Retained|"     urine   "|||2017-10-11 02:45:52.029856|2017-10-11 02:45:52.029856
NCT01638299|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-09-19|||July 2012||2012-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC Setting|Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia and Hyperglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting|Completed||Phase 1|20|Actual|Animas Corporation||1|||f||||f||||||||||2017-10-11 02:45:52.259944|2017-10-11 02:45:52.259944
NCT01638286|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-03-08|||August 2012||2012-08-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Observational|||Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects||Completed||N/A|24|Actual|Hanmi Pharmaceutical Company Limited|||3||f||||f||||||||||2017-10-11 02:45:52.344127|2017-10-11 02:45:52.344127
NCT01638273|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-11-11|||February 2014||2014-02-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|GLA5PR-102||PK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects|A Randomized, Open-label, Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg and Immediate Release Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects|Completed||Phase 1|24|Actual|GL Pharm Tech Corporation||2|||f||||f||||||||||2017-10-11 02:45:52.406742|2017-10-11 02:45:52.406742
NCT01638260|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2013-12-16|||October 2012||2012-10-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||GLP-1 and Non-exercise Activity Thermogenesis in RHZ|Liraglutide With or Without NEAT in Type 2 Diabetes Mellitus; Effects on HbA1c, Weight, Blood Pressure, Quality of Life and Health Care Costs.|Terminated||Phase 4|22|Actual|Maastricht University Medical Center||2||Terminated because of insufficient number of subjects included.|f||||t||||||||||2017-10-11 02:45:52.523844|2017-10-11 02:45:52.523844
NCT01638247|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2017-08-25|||August 2012||2012-08-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MALE||Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients|A Prospective, Randomised, Multi-centre Phase II Study Evaluating the Adjuvant, Neoadjuvant or Palliative Treatmant With Tamoxifen +/- GnRH Analogue Versus Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients|Active, not recruiting||Phase 3|56|Actual|German Breast Group||3|||f||||t||||||||||2017-10-11 02:45:52.618895|2017-10-11 02:45:52.618895
NCT01638234|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2015-04-16|||January 2012||2012-01-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic Dermatitis|Effectiveness of Melatonin Supplement in the Management of Sleep Disturbances in Children With Atopic Dermatitis|Completed||Phase 2/Phase 3|48|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:45:52.72875|2017-10-11 02:45:52.72875
NCT01638221|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-07-31|||July 2012||2012-07-01|July 2012|2012-07-01||||July 2013|Anticipated|2013-07-01||Observational|||Comparison of Patient Perceived Pain and Satisfaction Between Lightweight and Heavyweight Mesh for Laparoscopic Inguinal Hernia Repair|Comparison of Patient Perceived Pain and Satisfaction Between Lightweight and Heavyweight Mesh for Laparoscopic Inguinal Hernia Repair|Unknown status|Recruiting|N/A|200|Anticipated|Genesys Regional Medical Center|||2||f||||t||||||||||2017-10-11 02:45:52.832729|2017-10-11 02:45:52.832729
NCT01638208|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-09|||August 2012||2012-08-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-D|Spectrum of Gastrointestinal Microbiota in Patients With IBS-D Before and After Treatment With VSL#3.|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Asian Institute of Gastroenterology, India||2|||f||||f||||||||||2017-10-11 02:45:52.904719|2017-10-11 02:45:52.904719
NCT01638195|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2015-04-10|||June 2012||2012-06-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Safety Evaluation of Renal Denervation Using Focused Therapeutic Ultrasound on Patients With Refractory Hypertension|A Feasibility Study: A Safety Evaluation of Renal Denervation Using Focused Therapeutic Ultrasound on Patients With Refractory Hypertension|Completed||Phase 1|18|Actual|Kona Medical Inc.||1|||f||||f||||||||||2017-10-11 02:45:53.012333|2017-10-11 02:45:53.012333
NCT01638182|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-07-10|||March 2011||2011-03-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Biocomparison Study|Comparison of Effects of Nutritional Doses Vitamin K1 and K2 on Carboxylation|Completed||N/A|81|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 02:45:53.090511|2017-10-11 02:45:53.090511
NCT01638169|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-04-07|||May 2013||2013-05-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Contribution of Heels for Walking Quality Among Children With Muscular Dystrophy||Completed||N/A|11|Actual|Alyn Pediatric & Adolecent Rehabilitation Center|||1||f||||t||||||||||2017-10-11 02:45:53.179941|2017-10-11 02:45:53.179941
NCT01638156|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2013-08-19|||June 2013||2013-06-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Observational|||Cardiac MRI for Severe Aortic Stenosis|Arterial Stiffness and Wave Reflections as Determinants of Regression of Left Ventricular Hypertrophy and Fibrosis Assessed With Cardiac MRI After Aortic Valve Replacement for Severe Aortic Stenosis|Unknown status|Recruiting|N/A|80|Anticipated|American College of Radiology Imaging Network|||1||f||||t||||||Samples Without DNA|"     Collecting three tubes of blood: 10-mL of blood for plasma sampling, 10-mL of serum, and a     microtube or other adequate sample for hematocrit measurements. Hematocrit measurements     within 24 hours prior to the cardiac MRI scan. Serum and plasma samples will be stored at     -80°C in 0.5 mL vials.   "|||2017-10-11 02:45:53.265458|2017-10-11 02:45:53.265458
NCT01638117|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-01-19|||April 2012||2012-04-01|January 2014|2014-01-01||||August 2012|Actual|2012-08-01||Interventional|||Cumulative Irritation Test of PAC-14028 in Healthy Volunteers|Phase I Clinical Trial to Investigate the Cumulative Skin Irritation of PAC-14028 in Healthy Volunteers|Completed||Phase 1|35|Actual|Amorepacific Corporation||6|||f||||f||||||||||2017-10-11 02:45:53.570821|2017-10-11 02:45:53.570821
NCT01638091|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-10|||March 2011||2011-03-01|July 2012|2012-07-01||||March 2012|Actual|2012-03-01||Interventional|||Practice-Based Learning to Predict Polyp Histology at Colonoscopy|Practice-Based Learning to Predict Polyp Histology at Colonoscopy: A Demonstration Project in Community Practice|Completed||N/A|14|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 02:45:53.745316|2017-10-11 02:45:53.745316
NCT01638078|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|June 2015|Anticipated|2015-06-01||Interventional|TOP RACER||Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation|Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation - The TOP RACER Trial|Not yet recruiting||Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 02:45:53.824782|2017-10-11 02:45:53.824782
NCT01638065|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2014-01-30|||May 2012||2012-05-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Observational|||A Comprehensive Look at Vascular Access|A Comprehensive Look at Vascular Access: Utilizing a Near Infrared Vein Visualization Device For Vascular Access Planning, Attempts, and Post Access|Completed||N/A|196|Actual|Christie Medical Holdings, Inc.|||2||f||||f||||||||||2017-10-11 02:45:53.931911|2017-10-11 02:45:53.931911
NCT01638052|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2013-03-19|||February 2006||2006-02-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Great Auricular Nerve Block for Tympanomastoid Surgery: Will the Addition of Clonidine Enhance the Duration of Analgesia?|Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery: Does the Addition of Clonidine Increase the Duration of Postoperative Analgesia?|Completed||Phase 2|56|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 02:45:54.115721|2017-10-11 02:45:54.115721
NCT01638039|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2012-07-08|||July 2012||2012-07-01|July 2012|2012-07-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections||Unknown status|Not yet recruiting|N/A|330|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 02:45:54.198171|2017-10-11 02:45:54.198171
NCT01638026|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2017-08-27|||September 2012||2012-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG|Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG|Completed||Phase 4|93|Actual|HaEmek Medical Center, Israel||1|||f||||t||||||||||2017-10-11 02:45:54.314854|2017-10-11 02:45:54.314854
NCT01638000|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2016-09-07|2016-07-19||June 2012||2012-06-01|September 2016|2016-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|BEYOND|Safety Analysis Set (SAF) - consisted of all randomized patients who received ≥ 1 dose of double-blind study drug.|A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.|A Double-Blind, Randomized, Parallel Group, Multi-Centre Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Subjects With Overactive Bladder (OAB) Treated With Antimuscarinics and Dissatisfied Due to Lack of Efficacy|Completed||Phase 3|1887|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:45:55.150988|2017-10-11 02:45:55.150988
NCT01637987|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-10-24|||July 2012||2012-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Nurse PIV Insertion Success With and Without Assistive Devices in Patients 0-12 Months of Age|Nurse Peripheral Intravenous Catheter Insertion Success With and Without Assistive Devices in Patients 0-12 Months of Age|Terminated||N/A|104|Actual|University of Nebraska||3||"Combination of insufficient research staff support, insufficient subjects meeting enrollment   criteria, and investigators changing role responsibilities."|f||||f||||||||||2017-10-11 02:46:00.712257|2017-10-11 02:46:00.712257
NCT01637974|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-07-30|||December 2012||2012-12-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery|Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery - a Prospective Double Blind Randomized Study|Unknown status|Recruiting|N/A|130|Anticipated|Carmel Medical Center||2|||f||||f||||||||||2017-10-11 02:46:00.807889|2017-10-11 02:46:00.807889
NCT01637961|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2017-04-11|2015-04-29||August 2012||2012-08-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Eligible and treated patients.|Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus|A Phase II Evaluation of MLN8237 (NSC# 747888) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 02:46:00.923288|2017-10-11 02:46:00.923288
NCT01637948|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-07-10|||October 2010||2010-10-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|May 2011|Actual|2011-05-01||Interventional|||Controlled Clinical Trial of Traditional Chinese Medicine Mouthrinse|Controlled Clinical Trial of Traditional Chinese Medicine Mouthrinse In Improving Oral Health in Orthodontic Patients|Completed||Phase 1|90|Actual|The University of Hong Kong||3|||f||||f||||||||||2017-10-11 02:46:01.429964|2017-10-11 02:46:01.429964
NCT01637935|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-07|2015-12-09|2012-08-31||July 2004||2004-07-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes|Cohort Study of Pioglitazone and Bladder Cancer in Patients With Diabetes|Completed||N/A|193099|Actual|Takeda|||2||f||||f||||||||||2017-10-11 02:46:01.522744|2017-10-11 02:46:01.522744
NCT01637922|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2015-07-03|2015-07-03||August 2012||2012-08-01|July 2015|2015-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||This set included all subjects who were dispensed study medication and were documented to have taken at least one dose of study drug.|Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone|Effect of Multiple Dosing With BI 201335 on the Safety, Pharmacokinetics and Pharmacodynamics of Steady-state Methadone and Buprenorphine/Naloxone in Subjects on Stable Addiction Management Therapy|Completed||Phase 1|34|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:46:02.271471|2017-10-11 02:46:02.271471
NCT01637909|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2015-11-10|||September 2011||2011-09-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Korean Life-Style Modification Effects on Blood Pressure||Completed||N/A|85|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 02:46:02.973817|2017-10-11 02:46:02.973817
NCT01637896|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-07|2012-07-11|||June 2010||2010-06-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|December 2011|Actual|2011-12-01||Interventional|ELICOPTER||A Comparison Between Paclitaxel-eluting Balloon in Combination With BMS Implantation vs Conventional Balloon and DES Implantation|A Comparison Between Paclitaxel-eluting Balloon in Combination With BMS Implantation vs Conventional Balloon and DES Implantation: the ELICOPTER Trial|Terminated||Phase 4|125|Actual|Ospedale San Donato||2||"the study was halted after an interim analysis perfomed for a perceived excess of target vessel   revascularization in the DEB+BMS arm"|f||||f||||||||||2017-10-11 02:46:03.044927|2017-10-11 02:46:03.044927
NCT01637883|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-07|2012-07-25|||January 2011||2011-01-01|July 2012|2012-07-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|POST||Benzydamine HCl for Postoperative Sore Throat|Efficacy of Benzydamine Hydrochloride Dripping at Endotracheal Tube Cuff for Prevention of Postoperative Sore Throat|Unknown status|Recruiting|Phase 3|86|Anticipated|Prince of Songkla University||2|||f||||t||||||||||2017-10-11 02:46:03.113044|2017-10-11 02:46:03.113044
NCT01637857|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2013-01-10|||January 2006||2006-01-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Oligo-antigenic Diet in the Treatment of Chronic Anal Fissures.|Oligo-antigenic Diet in the Treatment of Chronic Anal Fissures. Evidence for a Relationship Between Food Hypersensitivity and Anal Fissures|Completed||N/A|161|Actual|University of Palermo||2|||f||||t||||||||||2017-10-11 02:46:03.265838|2017-10-11 02:46:03.265838
NCT01637844|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2014-11-30|||April 2012||2012-04-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV|Telbivudine in the Third Trimester of Pregnancy to Prevent Mother-to-infant Transmission of HBV|Completed||Phase 4|335|Actual|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||||2017-10-11 02:46:03.597649|2017-10-11 02:46:03.597649
NCT01637831|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-10|||March 2010||2010-03-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep Apnea|CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea. Does It Offer a Better Quality of Life and Sleep?|Completed||N/A|12|Actual|University of Crete||1|||f||||f||||||||||2017-10-11 02:46:03.678161|2017-10-11 02:46:03.678161
NCT01637818|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-11|||September 1999||1999-09-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Long-term Follow-up of Lichtenstein's Operation Versus Mesh Plug Repair|Long-term Follow-up of a Randomized Clinical Trial of Lichtenstein's Operation Versus Mesh Plug for Inguinal Hernia Repair|Completed||N/A|594|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 02:46:03.753298|2017-10-11 02:46:03.753298
NCT01637805|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-03-07|||May 2012||2012-05-01|July 2012|2012-07-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|AAV-DC-CTL||Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer|Phase 1 Study of Antigen-specific Cytotoxic T Lymphocytes Induced by Dendritic Cells Infected by Recombinant Adeno-associated Virus With CEA Gene in Stage IV Gastric Cancer|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||||||||||||2017-10-11 02:46:03.847221|2017-10-11 02:46:03.847221
NCT01637792|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-01|2016-07-20|||June 2004||2004-06-01|July 2016|2016-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD|Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD|Completed||Phase 4|139|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||No||2017-10-11 02:46:03.908448|2017-10-11 02:46:03.908448
NCT01637779|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2013-10-26|||July 2012||2012-07-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Randomized Controlled Trial About Teaching Parents How to Manage Childhood Immunization Pain|A Randomized Clinical Trial to Evaluate the Impact of a Fact Sheet About Childhood Immunization Pain Management on Parental Knowledge|Completed||Phase 3|120|Actual|University of Toronto||4|||f||||f||||||||||2017-10-11 02:46:03.995505|2017-10-11 02:46:03.995505
NCT01637766|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2017-01-12|||April 2012||2012-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|SIAC||Intra-arterial Chemotherapy for Spinal Metastases|Selective Intra-arterial Chemotherapy in the Treatment Strategy of Metastatic Spinal Disease|Recruiting||Phase 1|20|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-11 02:46:04.095732|2017-10-11 02:46:04.095732
NCT01637753|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-08|||June 2012||2012-06-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma|Phase 3 Study of Carmustine Sustained Release Implant (CASANT) to Treat Recurrent Malignant Glioma|Unknown status|Recruiting|N/A|212|Anticipated|Shandong Lanjin Pharmaceuticals Co.,Ltd||2|||f||||t||||||||||2017-10-11 02:46:04.186445|2017-10-11 02:46:04.186445
NCT01637740|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-07|2012-07-10|||August 2009||2009-08-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Pseudoexfoliation Syndrome in Myopes|Pseudoexfoliation Syndrome in Myopes Defined With Optical Low Coherence Reflectometry|Completed||N/A|5753|Actual|General Hospital Sveti Duh|||2||f||||||||||||||2017-10-11 02:46:04.273432|2017-10-11 02:46:04.273432
NCT01637727|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2012-07-12|||September 2012||2012-09-01|July 2012|2012-07-01||||September 2015|Anticipated|2015-09-01||Observational|GDM||Long Term Effects of Gestational Diabetes Mellitus in a Population of Parous Women|Long Term Effects of Gestational Diabetes Mellitus in a Population of Parous Women|Unknown status|Not yet recruiting|N/A|324|Anticipated|Shaare Zedek Medical Center|||2||f||||f|||||||"     the women will undergo a physical examination which will include measurements of blood     pressure, height, weight and waist circumference.Blood samples will be obtained for     evaluation of fasting glucose level, HbA1c, lipid profile and kidney functions.   "|||2017-10-11 02:46:04.326288|2017-10-11 02:46:04.326288
NCT01637714|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-06-17|||July 2012||2012-07-01|June 2013|2013-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome|The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome: Double-blind, Randomized, Placebo-controlled Trial|Unknown status|Recruiting|N/A|70|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 02:46:04.40185|2017-10-11 02:46:04.40185
NCT01637701|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-07|||June 2004||2004-06-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2006|Actual|2006-12-01||Interventional|||Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate|Comparison of Pasmakinetic Enucleation of the Prostate With Bipolar Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hypertrophy Patients With Large Prostate|Completed||N/A|80|Actual|Fuzhou General Hospital||2|||f||||t||||||||||2017-10-11 02:46:04.556015|2017-10-11 02:46:04.556015
NCT01637688|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-09-21|||April 2013||2013-04-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Growth and Plasma Amino Acids in Infants With CMPA and Treated With a Newly Innovated Amino Acid Formula|Growth and Plasma Amino Acid Levels in Infants With Cow's Milk Protein Allergy and Treated With a Newly Innovated Amino Acid Formula Compared to a Commercial Amino Acid Formula|Recruiting||Phase 1/Phase 2|74|Anticipated|Mahidol University|||1||f||||t||||||||||2017-10-11 02:46:04.656222|2017-10-11 02:46:04.656222
NCT01637675|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-01|2014-03-28|||May 2013||2013-05-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|STS||Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension|Clinical Study of Effects of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension|Unknown status|Recruiting|Phase 2/Phase 3|90|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 02:46:04.753296|2017-10-11 02:46:04.753296
NCT01637662|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-07|2015-07-27|||July 2012||2012-07-01|July 2015|2015-07-01||||January 2014|Actual|2014-01-01||Interventional|||Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow|Mechanisms and Biological Markers During Headache Induced by Natriuretic Peptides|Completed||N/A|6|Actual|Danish Headache Center||1|||f||||f||||||||||2017-10-11 02:46:04.86127|2017-10-11 02:46:04.86127
NCT01637649|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-07|2013-06-17|||June 2012||2012-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Diaphragmatic Function in Stroke Patients.|Diaphragm Function Evaluation in Stroke Patients During Voluntary Cough Using Sonography|Completed||N/A|75|Actual|The Catholic University of Korea|||3||f||||t||||||||||2017-10-11 02:46:04.935648|2017-10-11 02:46:04.935648
NCT01637636|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-02-14|||June 2012||2012-06-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.|An Open-label, Single-sequence Study in Two Cohorts of Healthy Subjects to Evaluate the Single-dose Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.|Completed||Phase 1|48|Actual|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:46:05.039561|2017-10-11 02:46:05.039561
NCT01637623|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-06-01|||June 2012||2012-06-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CVD/OSA||Study of Cardiovascular Disease and Obstructive Sleep Apnea|Pharmacologic Interventions for Cardiovascular Disease in Obstructive Sleep Apnea|Completed||Phase 2|90|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 02:46:05.159458|2017-10-11 02:46:05.159458
NCT01637610|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-05-26|||September 2011||2011-09-01|July 2012|2012-07-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Observational|||Detection of PPROM With AmniSure PAMG-1 Rapid Immunoassay|Detection of Preterm Prelabour Rupture of Membranes With AmniSure Placental Alpha Macroglobulin-1 Rapid Immunoassay|Terminated||N/A|85|Actual|University of Saskatchewan|||1|Lack of support with enrollment.|f||||f||||||||||2017-10-11 02:46:05.273582|2017-10-11 02:46:05.273582
NCT01637597|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-07-20|||June 2012||2012-06-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase Translocation|An Exploratory Study Of Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase Translocation Determined By Different Molecular Diagnostic Methods|Active, not recruiting||N/A|12|Actual|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     Blood and tumor tissue are being collected during the course of this study, to assess the     safety and tolerability and spectrum of side effects of the study drug. However, it is     possible that after completion of all study-related analyses, some volume of samples may     remain. These left-over samples could be a valuable resource for future research.      Before any left-over samples can be used for any research other than that specified in the     protocol, patient must sign an additional future use consent from indicating they give their     permission for these samples to be used in future research. By signing the main consent form,     patients are only giving their permission to use their samples for the study related     procedures.   "|||2017-10-11 02:46:05.390809|2017-10-11 02:46:05.390809
NCT01637584|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-04-20|2016-01-07||April 2010||2010-04-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|NOSSTIP|Comparison on demographic variables|Neurobiology of Sleep and Sleep Treatment Response in Returning Veterans|Neurobiology of Sleep and Sleep Treatment Response in Returning Veterans|Completed||N/A|40|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:46:05.457936|2017-10-11 02:46:05.457936
NCT01637571|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-07-10||||||July 2012|2012-07-01||||||||Interventional|Dexilant||Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain|The Effect of Dexilant Treatment on Esophageal Hypersensitivity in GERD Related Non Cardiac Chest Pain Patients|Withdrawn||Phase 4|0|Actual|University of Iowa||2||Sponsor could not fund|f||||||||||||||2017-10-11 02:46:05.709229|2017-10-11 02:46:05.709229
NCT01637558|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-10-26|||November 2012||2012-11-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|DATiC||Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)|Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)|Recruiting||Phase 4|240|Anticipated|University of Cape Town||4|||f||||t||||||||Undecided||2017-10-11 02:46:05.800474|2017-10-11 02:46:05.800474
NCT01637545|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-08|2015-05-07|||December 2011||2011-12-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Safety and Efficacy of Nasea(R)/Ramosetron Inj. in Patients Undergoing Facial Bone Fracture Operations|Phase 4 Study of Nasea(R)/Ramosetron Inj.as Anti-emetics in the Patients Undergoing Facial Bone Fracture Operations|Terminated||Phase 4|49|Actual|Seoul National University Hospital||3||Principal Investigator is away on business|f||||f||||||||||2017-10-11 02:46:05.892807|2017-10-11 02:46:05.892807
NCT01637532|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2016-01-25|||February 2011||2011-02-01|January 2016|2016-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|PITCH||Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer|Chemo-Immunotherapy: Observational Trial of Carboplatin-pegylated Liposomal Doxorubicin (PLD) or Doxorubicin Combination Chemotherapy With Tocilizumab, a Humanized Monoclonal Antibody Against the Human Interleukin-6 (IL-6) Receptor, and Pegylated Interferon Alpha (Peg-Intron) for Patients With Recurrent Ovarian Cancer.|Completed||Phase 1/Phase 2|21|Actual|Leiden University Medical Center||3|||f||||t||||||||||2017-10-11 02:46:05.989275|2017-10-11 02:46:05.989275
NCT01637519|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-03-01|||August 2012||2012-08-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Observational|||Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis|Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis|Completed||N/A|9|Actual|University of British Columbia|||1||f||||t||||||Samples With DNA|"     Urine   "|No||2017-10-11 02:46:06.069746|2017-10-11 02:46:06.069746
NCT01637506|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-07-04|||July 2012||2012-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Urine and Stool Analysis in Kidney Stone Disease|Correlation Between Excretion Metabolites in Urine and Bacterial Microflora in Patients With Urinary Stone Disease|Recruiting||N/A|20|Anticipated|University of British Columbia|||2||f||||t||||||Samples With DNA|"     De-identified and study coded urine and stool are collected, processed and analysed in the     research laboratory.   "|||2017-10-11 02:46:06.140398|2017-10-11 02:46:06.140398
NCT01637480|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2015-01-09|||July 2012||2012-07-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity|Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity in People With and Without Patellofemoral Pain Syndrome|Completed||N/A|42|Actual|Texas Woman's University||2|||f||||t||||||||||2017-10-11 02:46:06.326508|2017-10-11 02:46:06.326508
NCT01637467|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-02-05|||July 2012||2012-07-01|May 2015|2015-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effect of Electrical Muscle Stimulation in Critically Ill Patients|The Effects of Electrical Muscle Stimulation (EMS) on Muscle Atrophy and Functional Outcomes in Critically Ill Patients; a Pilot Randomized Controlled Trial|Completed||Phase 1/Phase 2|30|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 02:46:06.394548|2017-10-11 02:46:06.394548
NCT01637454|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-07-10|||January 2009||2009-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|Type2 HRS||TYPE 2 HEPATORENAL SYNDROME|NORADRENALINE VERSUS TERLIPRESSIN IN THE TREATMENT OF TYPE 2 HEPATORENAL SYNDROME:A RANDOMIZED STUDY|Completed||Phase 3|46|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 02:46:06.469013|2017-10-11 02:46:06.469013
NCT01637441|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2015-11-03|||September 2012||2012-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|PROSPERE||Prosthetic Pelvic Organ Prolapse Repair|Randomized Study Comparing Laparoscopic Sacropexy and Vaginal Mesh Surgery in Cystocele Repair|Completed||N/A|262|Actual|University Hospital, Lille||2|||f||||t||||||||||2017-10-11 02:46:06.547915|2017-10-11 02:46:06.547915
NCT01637428|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-07-15|||July 2012||2012-07-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome|The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic Syndrome|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-10-11 02:46:06.843999|2017-10-11 02:46:06.843999
NCT01637415|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-01-28|||May 2012||2012-05-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|PAWSS||"The Prediction of Alcohol Withdrawal Severity Scale (PAWSS)"|"The Prediction of Alcohol Withdrawal Severity Scale (PAWSS): Development and Psychometric Characteristics of a New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome."|Completed||N/A|409|Actual|Stanford University|||1||f||||f||||||||||2017-10-11 02:46:06.939118|2017-10-11 02:46:06.939118
NCT01637402|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-06-06|||March 2013||2013-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|||A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer|A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer (CRPC)|Active, not recruiting||Phase 2|33|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:46:07.005888|2017-10-11 02:46:07.005888
NCT01637389|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-10|||July 2009||2009-07-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of Safe-Water Programs in Baja California Sur, Mexico|A Stepped Wedge, Cluster-randomized Impact Evaluation of a Household UV-treatment and Safe Storage Drinking Water Intervention in Rural Baja California Sur, Mexico|Completed||N/A|1731|Actual|University of California, Berkeley||3|||f||||f||||||||||2017-10-11 02:46:07.083491|2017-10-11 02:46:07.083491
NCT01637376|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2014-01-14|||July 2012||2012-07-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer|Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer|Withdrawn||Phase 1|0|Actual|University of Arkansas||1||No participants were enrolled|f||||f||||||||||2017-10-11 02:46:07.155382|2017-10-11 02:46:07.155382
NCT01637363|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-05-11|||September 2012||2012-09-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Psychoeducation to Sick-listed Individuals With Mental Health Problems|Psychoeducation to Sick-listed Individuals With Mental Health Problems|Completed||N/A|400|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:46:07.222586|2017-10-11 02:46:07.222586
NCT01637350|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-02-14|||August 2012||2012-08-01|August 2012|2012-08-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|||Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes|The Effect of Blood Glucose to Different Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||4||f||||f||||||||||2017-10-11 02:46:07.298008|2017-10-11 02:46:07.298008
NCT01637337|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-04-19|||May 2012||2012-05-01|April 2016|2016-04-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Laparoscopic Pyelolithotomy Versus Percutaneous Nephrolothotomy for Management of >3cm Renal Pelvis Stone||Completed||Phase 2/Phase 3|60|Actual|Shiraz University of Medical Sciences||2|||f||||||||||||||2017-10-11 02:46:07.36669|2017-10-11 02:46:07.36669
NCT01637324|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-05-08|||May 2011||2011-05-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2015|Actual|2015-05-01||Observational|||Multidisciplinary Services to Enhance HIV Testing and Linkage to Care Among MSM|The Thai Red Cross AIDS Research Centre|Completed||N/A|350|Actual|Thai Red Cross AIDS Research Centre|||1||f||||f||||||||||2017-10-11 02:46:07.423696|2017-10-11 02:46:07.423696
NCT01637311|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-06|||January 2010||2010-01-01|May 2012|2012-05-01|December 2014|Anticipated|2014-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Peroral Endoscopic Remyotomy for Failed Heller Myotomy|Peroral Endoscopic Remyotomy for Failed Heller Myotomy|Unknown status|Recruiting|N/A|20|Anticipated|Shanghai Zhongshan Hospital||1|||f||||t||||||||||2017-10-11 02:46:07.478738|2017-10-11 02:46:07.478738
NCT01637298|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-05-08|||December 2009||2009-12-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|August 2015|Actual|2015-08-01||Observational|||Biomarkers to Detect Anal Intraepithelial Neoplasia in Thai Men Who Have Sex With Men|The Thai Red Cross AIDS Research Centre|Completed||N/A|450|Actual|Thai Red Cross AIDS Research Centre|||1||f||||f||||||||||2017-10-11 02:46:07.558023|2017-10-11 02:46:07.558023
NCT01637285|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-07-30|||August 2012||2012-08-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers|A Phase 1, Randomized, Open-label, Parallel-group Study To Evaluate The Pharmacokinetics Of Pf-04856883 (Cvx-096) Following Subcutaneous Administration In Healthy Volunteers|Completed||Phase 1|49|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:46:07.697349|2017-10-11 02:46:07.697349
NCT01637272|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-03-31|2016-07-29||January 8, 2013|Actual|2013-01-08|March 2017|2017-03-01|August 7, 2015|Actual|2015-08-07|August 7, 2015|Actual|2015-08-07||Interventional||The overall study full analysis set (FAS) consisted of all patients who were enrolled in the study (whether treated or not).|Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome|A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome|Completed||Phase 2|43|Actual|Novartis|All safety parameters were analyzed by study phase (sc/LAR)|1|||f||||f||||||||||2017-10-11 02:46:07.808679|2017-10-11 02:46:07.808679
NCT01637259|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2016-01-18|||June 2012||2012-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MARCHrenal||MARCH Renal Substudy|Maraviroc Switch Collaborative Study Renal Substudy|Completed||Phase 4|76|Actual|Kirby Institute||3|||f||||t||||||||||2017-10-11 02:46:09.123209|2017-10-11 02:46:09.123209
NCT01637246|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2012-08-21|2012-08-21||April 2009||2009-04-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy||Completed||N/A|4385|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:46:09.315919|2017-10-11 02:46:09.315919
NCT01637233|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2016-01-18|||June 2012||2012-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||MARCH Central Nervous System Substudy|Maraviroc Switch Central Nervous System (CNS) Substudy: a Substudy of MARCH, a Randomised, Open-label Study to Evaluate the Efficacy and Safety of Maraviroc (MVC) as a Switch for Either Nucleoside or Nucleotide Analogue Reverse Transcriptase Inhibitors (N(t)RTI) or Boosted Protease Inhibitors (PI/r) in HIV-1 Infected Individuals With Stable, Well-controlled Plasma HIV-RNA While Taking Their First N(t)RTI + PI/r Regimen of Combination Antiretroviral Therapy (cART).|Completed||N/A|28|Actual|Kirby Institute|||3||f||||t||||||Samples Without DNA|"     plasma and CSF   "|||2017-10-11 02:46:09.510185|2017-10-11 02:46:09.510185
NCT01637220|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-01-16|||August 2012||2012-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Observational|NASA||Role of Neutrophil Activation in Anaphylaxis to Curare|Role of Neutrophil Activation in Anaphylaxis to Curare|Completed||N/A|200|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 02:46:09.630778|2017-10-11 02:46:09.630778
NCT01637207|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-07-10|||August 2012||2012-08-01|July 2012|2012-07-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|||How Easy is it to Identify the Cricothyroid Membrane in Children? Can Ultrasound Imagine be Used to Aid Identification?|How Easy is it to Identify the Cricothyroid Membrane in Children? Can Ultrasound Imaging me Used to Aid Identification?|Unknown status|Not yet recruiting|N/A|20|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:46:09.709689|2017-10-11 02:46:09.709689
NCT01637194|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-07-06|||November 2008||2008-11-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer|A Phase I Evaluation of Cetuximab and RAD001 in Patients With Solid Tumors|Completed||Phase 1|12|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 02:46:09.779411|2017-10-11 02:46:09.779411
NCT00005377|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2009-05-01|||July 1994||1994-07-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Molecular Epidemiology of Essential Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.513006|2017-10-11 04:28:04.513006
NCT01637181|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-02-10|||May 2012||2012-05-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|COLA||Clinical Trial of Endovenous 940 and 1470 Laser Ablation for Treating Great Saphenous Veins|Comparative Randomized Clinical Trial of Endovenous 940 nm Laser Ablation Versus Endovenous 1470 nm Laser Ablation for Treatment of Great Saphenous Veins|Completed||N/A|142|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-10-11 02:46:09.893041|2017-10-11 02:46:09.893041
NCT01637168|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-09-24|||November 2013||2013-11-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders|Clinical Phase III, Randomized, Double-blind, Prospective Study, for Efficacy and Safety Evaluation of Panax Ginseng + Associations Compared to Ginkgo Biloba in Symptomatic Cognitive Function Disorder Treatment.|Unknown status|Not yet recruiting|Phase 3|138|Anticipated|EMS||2|||f||||t||||||||||2017-10-11 02:46:09.968268|2017-10-11 02:46:09.968268
NCT01637155|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-10|2012-07-10||||||July 2012|2012-07-01||||||||Interventional|PK-VIT-D||Study to Evaluate the Pharmacokinetics of Vitamin D (Cholecalciferol) in Patients Undergoing Obesity Surgery in a Deficit Situation and After Standardization|Study to Evaluate the Pharmacokinetics of Vitamin D (Cholecalciferol) in Patients Undergoing Obesity Surgery in a Deficit Situation and After Standardization|Unknown status|Not yet recruiting|Phase 2|44|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-11 02:46:10.083544|2017-10-11 02:46:10.083544
NCT01637142|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-08-09|||July 2012||2012-07-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study of LY2140023 in Healthy Participants|An Absolute Bioavailability Study of LY2140023 and LY404039 in Healthy Subjects Using the Intravenous Tracer Method|Completed||Phase 1|18|Anticipated|Eli Lilly and Company||2|||f||||||||||||||2017-10-11 02:46:10.185667|2017-10-11 02:46:10.185667
NCT01637129|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-03-31|||May 2012||2012-05-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|TMSCS||Transcranial Magnetic Stimulation in Children With Stroke|Transcranial Magnetic Stimulation in Children With Stroke|Completed||Phase 1|4|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-11 02:46:10.260957|2017-10-11 02:46:10.260957
NCT01637116|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-07-27|||July 2011||2011-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|PURIST||Profiling Urticaria for the Identification of Subtypes|Profiling Urticaria for the Identification of Subtypes|Completed||N/A|195|Actual|Charite University, Berlin, Germany|||3||f||||f||||||||||2017-10-11 02:46:10.335458|2017-10-11 02:46:10.335458
NCT01637103|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-05-09|||September 2011||2011-09-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Treatment of Depressive Symptoms in Breast Cancer Patients: Comparison of Cognitive Therapy and Bright Light Therapy|Treatment of Depressive Symptoms in Breast Cancer Patients: Comparison of Cognitive Therapy and Bright Light Therapy|Completed||N/A|62|Actual|CHU de Quebec-Universite Laval||3|||f||||f||||||||||2017-10-11 02:46:10.396241|2017-10-11 02:46:10.396241
NCT01637090|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-11-25|2016-09-12||June 2012||2012-06-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CTCL||Everolimus in Treating Cutaneous T-cell Lymphoma|PHASE II TRIAL OF THE mTOR INHIBITOR EVEROLIMUS IN RELAPSED OR REFRACTORY CUTANEOUS T-CELL LYMPHOMA (CTCL)|Terminated||Phase 2|3|Actual|Boston Medical Center||1||Poor enrollment|f||||t||||||||No||2017-10-11 02:46:10.472709|2017-10-11 02:46:10.472709
NCT01637077|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-06-13|||January 2012||2012-01-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|November 2013|Actual|2013-11-01||Interventional|||Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel|RC11C3, Pilot Placebo-controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome|Completed||N/A|46|Actual|Academic and Community Cancer Research United||2|||f||||t||||||||Undecided||2017-10-11 02:46:10.894447|2017-10-11 02:46:10.894447
NCT01637064|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2015-11-05|||April 2013||2013-04-01|November 2015|2015-11-01||||December 2015|Anticipated|2015-12-01||Observational|ADAPT||Dermatomyositis and Polymyositis Registry|Acthar Dermatomyositis and Polymyositis Treatment|Enrolling by invitation||N/A|100|Anticipated|Phoenix Neurological Associates, LTD|||1||f||||t||||||None Retained|"     This is a retrospective and prospective study   "|||2017-10-11 02:46:10.988342|2017-10-11 02:46:10.988342
NCT01637051|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2015-10-27|||July 2012||2012-07-01|October 2015|2015-10-01|August 2025|Anticipated|2025-08-01|May 2015|Actual|2015-05-01||Interventional|||The Importance of Different Modularity of the Polyethylene Insert for Tibial Component Migration and Adaptive Bone Remodeling After Uncemented Total Knee Arthroplasty Using Trabecular Metal Technology (TMT) Zimmer NexGen®, (Monoblock vs. Modular Design)|The Importance of Different Modularity of the Polyethylene Insert for Tibial Component Migration and Adaptive Bone Remodeling After Uncemented Total Knee Arthroplasty Using Trabecular Metal Technology (TMT) Zimmer NexGen®, (Monoblock vs. Modular Design)|Active, not recruiting||N/A|60|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 02:46:11.074164|2017-10-11 02:46:11.074164
NCT01637038|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-12-24|||June 2012||2012-06-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||The Effect of Remote Ischemic Postconditioning on Liver Graft and Renal Function in Patients Undergoing Living-related Liver Transplantation|The Effect of Remote Ischemic Postconditioning on Liver Graft and Renal Function in Patients Undergoing Living-related Liver Transplantation|Completed||N/A|80|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 02:46:11.170142|2017-10-11 02:46:11.170142
NCT01637025|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-01-23|||May 2012||2012-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|OCEAN||Oxidized Cellulose hEmostAsis evaluatioN|A Prospective, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of Traumastem as an Adjunct to Hemostasis for Tissue Bleeding in Open Cardiac, Intra-abdominal (Including Retroperitoneal) and Pelvic Surgery|Completed||N/A|111|Actual|Baxter Healthcare Corporation||2|||f||||||||||||||2017-10-11 02:46:11.247185|2017-10-11 02:46:11.247185
NCT01637012|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2014-03-12|||February 2012||2012-02-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ALEX OCT||Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease|Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease. Study With Angiography and OCT Follow-up.|Completed||Phase 4|60|Actual|Balton Sp.zo.o.||1|||f||||f||||||||||2017-10-11 02:46:11.378816|2017-10-11 02:46:11.378816
NCT01636999|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-09|||September 2012||2012-09-01|July 2012|2012-07-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Comparing Sedara to Butorphanol in Early Labor|Comparing Pain Relief in Early Labor: Nitrous Oxide Versus Butorphonol Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|West Penn Allegheny Health System||1|||f||||t||||||||||2017-10-11 02:46:11.569089|2017-10-11 02:46:11.569089
NCT01636986|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-11-25|2013-11-25||July 2012||2012-07-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||This reporting group includes all enrolled and randomized participants who completed the study.|A Prospective Study of Two Daily Disposable Contact Lenses|Impact of a Novel Silicone Hydrogel in Reducing Contact Lens-Related Dryness Symptoms in Existing Contact Lens Wearers|Completed||N/A|62|Actual|Alcon Research|The study was not powered to detect differences in individual items.|2|||f||||f||||||||||2017-10-11 02:46:11.701443|2017-10-11 02:46:11.701443
NCT01636973|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-07-09|||March 2011||2011-03-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Humidified Ventilation on Arterial Oxygenation and Respiratory Mechanics During One Lung Ventilation||Completed||N/A|60|Actual|Yonsei University||1|||f||||t||||||||||2017-10-11 02:46:12.02777|2017-10-11 02:46:12.02777
NCT01636960|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-05-19|2015-01-26||December 25, 2012|Actual|2012-12-25|May 2017|2017-05-01|November 4, 2015|Actual|2015-11-04|March 26, 2014|Actual|2014-03-26||Interventional|||A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370)|An Open-Label, Single-arm, Multicenter Phase I Study of SCH 54031 (Pegylated Interferon Alfa-2b) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (Protocol No. MK-4031 370 Also Known as SCH 54031, P08556)|Terminated||Phase 1|9|Actual|Merck Sharp & Dohme Corp.|The study was terminated after 118 weeks from the study start, during the maintenance phase, due to regulatory approval in Japan.|1||"The study was terminated after 118 weeks from the study start, during the maintenance phase,   due to regulatory approval in Japan."|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:46:12.183273|2017-10-11 02:46:12.183273
NCT01636947|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-04-24|2015-07-02||December 12, 2012|Actual|2012-12-12|April 2017|2017-04-01|August 4, 2014|Actual|2014-08-04|August 4, 2014|Actual|2014-08-04||Interventional|KMEC|The Baseline Analysis Population consists of All Treated Participants. Two participants in each treatment group did not receive study drug.|A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)|A Korean Multicenter, Randomized, Double-Blind, Clinical Trial to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapies (MEC, Non-AC Regimes) With Broad Range of Tumor Types (KMEC Study)|Completed||Phase 4|494|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:46:12.676247|2017-10-11 02:46:12.676247
NCT01636934|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-08-25|||July 2012|Actual|2012-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy|A Randomized, Placebo Controlled-Double Blind Study of Minocycline for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer|Active, not recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 02:46:13.678961|2017-10-11 02:46:13.678961
NCT01636921|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-07-09|||January 2008||2008-01-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Sorafenib and Thoracic Radiation for Non-Small Cell Lung Cancer|Phase II Trial of Sorafenib With Concurrent Thoracic Radiotherapy for Poor Prognosis Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Terminated with slow accrual in early phase of study.|f||||f||||||||||2017-10-11 02:46:13.784361|2017-10-11 02:46:13.784361
NCT01636908|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-04-06|||August 2011||2011-08-01|April 2017|2017-04-01||||December 2017|Anticipated|2017-12-01||Interventional|ICK||Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.|Pilot Study on the Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.|Active, not recruiting||N/A|43|Actual|VU University Medical Center||1|||f||||f||||||||||2017-10-11 02:46:13.883315|2017-10-11 02:46:13.883315
NCT01636895|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-08-21|||January 2011||2011-01-01|August 2012|2012-08-01|February 2013|Anticipated|2013-02-01|November 2012|Anticipated|2012-11-01||Interventional|OR1||Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria|An Evaluation of Sulfadoxine-pyrimethamine Resistance and Effectiveness of IPTp in Nigeria|Unknown status|Recruiting|Phase 4|600|Anticipated|Malaria Consortium, UK||1|||f||||t||||||||||2017-10-11 02:46:13.983718|2017-10-11 02:46:13.983718
NCT01636882|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-08-18|||June 2012||2012-06-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy and Safety of Intratumoral CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks|A Phase 2 Study of the Efficacy and Safety of Intratumoral CAVATAK™ (Coxsackievirus A21, CVA21) in Patients With Stage IIIc and Stage IV Malignant Melanoma to Extend Dosing for up to 48 Weeks Total|Completed||Phase 2|16|Actual|Viralytics||1|||f||||||||||||||2017-10-11 02:46:14.100438|2017-10-11 02:46:14.100438
NCT01636869|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-07-25|||July 2012||2012-07-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Plasma Concentrations of Bupivacaine After Peri-articular Injection in Total Knee Arthroplasty|Plasma Concentrations of Bupivacaine After Spinal Anesthesia With Single Shot Femoral Nerve Block and Peri-articular Injection in Total Knee Arthroplasty|Completed||Phase 4|43|Actual|Mahidol University||1|||f||||t||||||||||2017-10-11 02:46:14.175382|2017-10-11 02:46:14.175382
NCT01636856|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-05-27|||December 2011||2011-12-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|EOE||Effects of Oropharyngeal Exercises on Patients With Primary Snore, Mild and Moderate Obstructive|Effects of Oropharyngeal Exercises on Snoring Intensity, Symptoms, Upper Airway Anatomy and Collapsability of Upper Airway Awake and Asleep in Patients With Primary Snoring and Mild to Moderate Obstructive Sleep Apnea|Unknown status|Recruiting|N/A|40|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:46:14.246308|2017-10-11 02:46:14.246308
NCT01636843|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2014-11-19|||October 2012||2012-10-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate|A Randomised, Double Blind, Placebo-controlled, Multiple Dose, Phase 2b, 24 Week Trial Followed by an Open Label Extension of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate|Terminated||Phase 2|298|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 02:46:14.341597|2017-10-11 02:46:14.341597
NCT01636817|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2014-11-19|||August 2012||2012-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics|A Randomised, Double Blind, Placebo-controlled, Multiple Dose, Phase 2b, 24 Week Trial Followed by an Open Label Extension of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics|Terminated||Phase 2|239|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 02:46:14.844712|2017-10-11 02:46:14.844712
NCT01636804|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2013-08-06|||July 2012||2012-07-01|August 2013|2013-08-01||||||||Observational|||Incidence & Predictors of Mechanical Abnormalities of QuickSite® and QuickFlex® Left Ventricular Pacing Leads|Incidence & Predictors of Mechanical Abnormalities of QuickSite® and QuickFlex® Left Ventricular Pacing Leads: Impact on Electrophysiological Profile|Completed||N/A|190|Anticipated|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-11 02:46:15.140297|2017-10-11 02:46:15.140297
NCT01636791|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-03-02|||September 2012||2012-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CBT vs RTW I||CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care|Cognitive Behavior Therapy Versus a Return to Work Intervention for Sick-listed Patients With Common Mental Illness in Primary Care: a Randomized Clinical Trial|Completed||Phase 3|211|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 02:46:15.223106|2017-10-11 02:46:15.223106
NCT01636778|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-02-01|2015-01-22||July 2012||2012-07-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients|Non-randomised, Open Label, Multi-centre Phase II Study to Assess the Efficacy and Safety of SB-497115-GR in Thrombocytopenic Subjects With Chronic Hepatitis C and Compensated Liver Cirrhosis.|Completed||Phase 2|45|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 02:46:15.613321|2017-10-11 02:46:15.613321
NCT01636765|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-09|2013-09-12|2013-09-12||May 2012||2012-05-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale||Completed||N/A|104|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:46:23.631928|2017-10-11 02:46:23.631928
NCT01636752|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-05-26|||July 2012||2012-07-01|May 2015|2015-05-01|February 2017|Anticipated|2017-02-01|February 2015|Actual|2015-02-01||Interventional|EVIDENT||Effectiveness of Internet-based Depression Treatment||Unknown status|Active, not recruiting|N/A|1000|Anticipated|University of Luebeck||2|||f||||t||||||||||2017-10-11 02:46:23.79026|2017-10-11 02:46:23.79026
NCT01636739|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-10-29|||July 2012||2012-07-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Special Drug Use Investigation for ROTARIX®|Special Drug Use Investigation for ROTARIX|Completed||N/A|10982|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 02:46:23.868123|2017-10-11 02:46:23.868123
NCT01636726|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-03-26|||March 2012||2012-03-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction|WEUKBRE5554: IMI PROTECT (Work Package 2): Use of Long Acting beta2 Adrenoceptor Agonists and Acute Myocardial Infarction (AMI)|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 02:46:23.942248|2017-10-11 02:46:23.942248
NCT01636713|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-11-18|2014-05-01||July 2012||2012-07-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD|A 24-week Randomised, Double-blind and Placebo-controlled Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo Inhalation Powder Delivered Once-daily Via a Novel Dry Powder Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|581|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:46:24.030879|2017-10-11 02:46:24.030879
NCT01636700|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-07-27|||October 2011||2011-10-01|February 2014|2014-02-01|October 2014|Anticipated|2014-10-01|July 2014|Anticipated|2014-07-01||Interventional|||Tramadol Infiltration for Tonsillectomy|Comparative Study of Analgesic Effect and Serum IL-6 With Tramadol Infiltration or Intravenous After Tonsillectomy|Withdrawn||N/A|0|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 02:46:24.797157|2017-10-11 02:46:24.797157
NCT01636687|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-01-30|||October 2012||2012-10-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|JUNCTURE||Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)|A Randomized, Double-blind, Placebo Controlled, Multicenter Study of Subcutaneous Secukinumab in Autoinjectors to Demonstrate Efficacy After Twelve Weeks of Treatment, and to Assess the Safety, Tolerability, Usability and Long-term Efficacy in Subjects With Chronic Plaque-type Psoriasis|Completed||Phase 3|182|Actual|Novartis||3|||f||||t||||||||||2017-10-11 02:46:24.895742|2017-10-11 02:46:24.895742
NCT01636674|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-09|||July 2009||2009-07-01|July 2012|2012-07-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|COLOPET1||18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer|Value of 18F-Fluordeoxyglucose Positron Emission Tomography/ Computed Tomography and Molecular Tumor Characterisation in Preoperative Staging og Postoperative Control of Colon Cancer|Unknown status|Active, not recruiting|N/A|66|Actual|Naestved Hospital||1|||f||||f||||||||||2017-10-11 02:46:25.100155|2017-10-11 02:46:25.100155
NCT01636661|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2015-10-07|2015-06-22||July 2012||2012-07-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|tDCS|Pilot study estimating a sample of children with hemiparesis. No formal sample size nor power analysis was performed.|Safety of Transcranial Direct Current Stimulation in Pediatric Hemiparesis|Safety of Transcranial Direct Current Stimulation in Pediatric Hemiparesis|Completed||Early Phase 1|13|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 02:46:25.175552|2017-10-11 02:46:25.175552
NCT01636648|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-04-28|||August 2012||2012-08-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Enable I Long-term Follow-up Study|Enable I Long-term Follow-up Study|Terminated||N/A|42|Actual|Medtronic Cardiovascular|||1||f||||f||||||||No||2017-10-11 02:46:25.439093|2017-10-11 02:46:25.439093
NCT01636635|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-11-12|||March 2011||2011-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|HEP||Effect of Age and Weight Loss on Inflammation and Iron Homeostasis|Effect of Age and Weight Loss on Obesity-related Inflammation and Iron Homeostasis in Women|Completed||N/A|44|Actual|Tufts University||2|||f||||f||||||||||2017-10-11 02:46:25.698791|2017-10-11 02:46:25.698791
NCT01636622|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-05-19|||July 2012|Actual|2012-07-01|May 2017|2017-05-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Study of Vemurafenib, Carboplatin, and Paclitaxel|Phase I Study of the Combination of Vemurafenib With Carboplatin and Paclitaxel in Patients With Advanced Malignancy|Active, not recruiting||Phase 1|96|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:46:25.778332|2017-10-11 02:46:25.778332
NCT01636609|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-04-06|||November 2012|Actual|2012-11-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Combination Study of Cytarabine and Tosedostat in Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS)|Phase I/II Study of Cytarabine or 5-Azacitidine Combined With Tosedostat to Evaluate the Safety and Tolerability in Older Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS)|Active, not recruiting||Phase 1/Phase 2|96|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 02:46:25.87534|2017-10-11 02:46:25.87534
NCT01636596|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2014-03-12|||September 2013||2013-09-01|March 2014|2014-03-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease|Evaluating the Efficacy of Controlled Pulsatile Intravenous Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease- A Pilot Study|Withdrawn||N/A|0|Actual|Louisiana State University Health Sciences Center Shreveport||1|||f||||t||||||||||2017-10-11 02:46:26.00274|2017-10-11 02:46:26.00274
NCT01636583|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-11-07|||June 2012||2012-06-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Zinc Absorption From Fortified Water|Zinc Absorption From Enriched Drinking Water Compared With the Zinc Absorption From a Fortified Maize Pudding in Healthy Young Adults.|Completed||N/A|18|Actual|Swiss Federal Institute of Technology||3|||f||||f||||||||||2017-10-11 02:46:26.083232|2017-10-11 02:46:26.083232
NCT01636570|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-04-24|||August 2012||2012-08-01|April 2017|2017-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Vitamin D3 Supplementation for Heart Failure Patients|Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients|Completed||Phase 2|40|Actual|Saint Patrick Hospital||2|||f||||t||||||||No||2017-10-11 02:46:26.178693|2017-10-11 02:46:26.178693
NCT01636557|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2017-03-06|||October 11, 2012|Actual|2012-10-11|March 2017|2017-03-01|October 19, 2013|Actual|2013-10-19|October 19, 2013|Actual|2013-10-19||Interventional|||A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis|A Phase I, Open-label, Drug Interaction Study to Evaluate the Effect of a Single-dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Subjects With Rheumatoid Arthritis|Completed||Phase 1|12|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 02:46:26.280589|2017-10-11 02:46:26.280589
NCT01636544|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-04-04|||June 2012||2012-06-01|April 2013|2013-04-01|July 2015|Anticipated|2015-07-01|February 2015|Anticipated|2015-02-01||Interventional|INECOC||Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity|Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity|Unknown status|Recruiting|N/A|100|Anticipated|Institut Pasteur||1|||f||||f||||||||||2017-10-11 02:46:26.388907|2017-10-11 02:46:26.388907
NCT01636531|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study of A High Concentration Liquid Formulation Versus A Lyophilized Formulation of Gantenerumab in Healthy Volunteers|A Multi-center, Randomized Open-label, Single-dose, Parallel Group Investigation of the Relative Bioavailability, Tolerability and Dose-exposure Relationship of a High Concentration Liquid Formulation (HCLF) Versus a Lyophilized Formulation (LyoF) of RO4909832 (Gantenerumab) When Administered by su|Completed||Phase 1|120|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:46:26.487209|2017-10-11 02:46:26.487209
NCT01636518|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-04-20|||July 2012||2012-07-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Hybrid AF -- A Prospective Registry|Hybrid Procedure for the Treatment of Long Standing Persistent Atrial Fibrillation - A Prospective Registry|Withdrawn||N/A|0|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-11 02:46:26.571788|2017-10-11 02:46:26.571788
NCT01636505|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-07-09|||September 2012||2012-09-01|July 2012|2012-07-01|September 2013|Anticipated|2013-09-01|February 2013|Anticipated|2013-02-01||Interventional|||The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol||Unknown status|Not yet recruiting|Phase 3|200|Anticipated|European Hospital||2|||f||||f||||||||||2017-10-11 02:46:26.735041|2017-10-11 02:46:26.735041
NCT01636492|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-11-01|||November 2005||2005-11-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study of Bitopertin (RO4917838) in Healthy Male Volunteers|Single Oral Ascending Dose Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO4917838 in Healthy Male Volunteers.|Completed||Phase 1|71|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:46:26.835062|2017-10-11 02:46:26.835062
NCT01636479|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-08-10|||July 13, 2012|Actual|2012-07-13|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Phase 1 Safety Testing of SAR405838|A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Biological Activity of SAR405838 in Patients With Advanced Cancer|Active, not recruiting||Phase 1|82|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-11 02:46:26.91324|2017-10-11 02:46:26.91324
NCT01636466|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-05-26|2015-05-26||June 2013||2013-06-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|E-TEST||The Everolimus-Transplant Exit Strategy Trial (E-TEST)|Zortress (Everolimus) to Prevent Alloantibody Formation in Patients With Late Stage Renal Allograft Failure: The Everolimus-Transplant Exit Strategy Trial (E-TEST)|Terminated||Phase 3|1|Actual|Emory University||2||Feasibility|f||||t||||||||||2017-10-11 02:46:27.017315|2017-10-11 02:46:27.017315
NCT01636453|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-09-26|||September 2012||2012-09-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms|The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms|Active, not recruiting||Phase 3|120|Actual|Penumbra Inc.||1|||f||||t||||||||||2017-10-11 02:46:27.238134|2017-10-11 02:46:27.238134
NCT01636440|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2013-01-18|||June 2012||2012-06-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Reliability of Measuring Conditioned Pain Modulation With the Nociceptive Withdrawal Reflex|Reliability of Measuring Conditioned Pain Modulation With the Nociceptive Withdrawal Reflex|Completed||N/A|39|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-10-11 02:46:27.332216|2017-10-11 02:46:27.332216
NCT01636427|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2012-07-17|||January 2007||2007-01-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||STEMI Versus NSTEMI: Clinical and Angiographic Differences|STEMI Versus NSTEMI: a Mono Versus a Multivessel Disease?|Completed||N/A|200|Actual|Federico II University|||1||f||||f||||||||||2017-10-11 02:46:27.408463|2017-10-11 02:46:27.408463
NCT01636414|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2016-07-21|2016-03-23||May 2012||2012-05-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|June 2014|Actual|2014-06-01||Interventional||All patients who completed the study are included in the reported results. Patients that were withdrawn from the study did not receive treatment.|Reinfusion Drains vs Tranexamic Acid in Total Joint Arthroplasty||Completed||Phase 4|204|Actual|OrthoCarolina Research Institute, Inc.||3|||f||||t||||||||||2017-10-11 02:46:27.485708|2017-10-11 02:46:27.485708
NCT01636401|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2013-08-20|||August 2012||2012-08-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|||Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-11 02:46:27.783456|2017-10-11 02:46:27.783456
NCT01636388|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-10-04|||January 2013||2013-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma|A Multicenter Pilot Study of Reduced Intensity Allogeneic Stem Cell Transplantation Followed by Adoptive Cellular Immunotherapy With Donor Derived Latent Membrane Protein (LMP) Specific-CTLs in Patients With Epstein-Barr Virus (EBV)Positive Refractory or Recurrent Hodgkin Lymphoma|Recruiting||Phase 2|45|Anticipated|New York Medical College||1|||f||||t||||||||||2017-10-11 02:46:27.876427|2017-10-11 02:46:27.876427
NCT01636375|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-12-14|||May 2012||2012-05-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Comparison of Muscle Atrophy After Direct Anterior & Posterior Total Hip Arthroplasty|The Influence of Operative Approach on Muscle Atrophy After Total Hip Arthroplasty: A Comparison of Anterior and Posterior Approaches|Active, not recruiting||N/A|19|Actual|Northwell Health|||2||f||||f||||||||||2017-10-11 02:46:27.977999|2017-10-11 02:46:27.977999
NCT01636362|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-09-29|2014-08-26||August 2012||2012-08-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns|An Open, Non Controlled, Multi-centre, Clinical Investigation to Evaluate Efficacy in Partial Thickness (Superficial, Deep and Mixed) Second Degree Burns When Using a Soft Silicone, Silver Containing, Wound Contact Layer, Mepitel Ag.|Completed||N/A|45|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 02:46:28.055792|2017-10-11 02:46:28.055792
NCT01636349|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-12-06|||November 2011||2011-11-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Health Effects of Recreational Soccer in Type 2 Diabetic Men|Cardiovascular, Muscular Adaptations and Glycaemic Control to 6 Months of Recreational Soccer in Type 2 Diabetic Men|Completed||N/A|22|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 02:46:28.247294|2017-10-11 02:46:28.247294
NCT01636336|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-01-14|||September 2008||2008-09-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects||Suspended||N/A|45|Anticipated|Mclean Hospital||2||Clinical studies are stopped, pending funding|f||||f||||||||||2017-10-11 02:46:28.321434|2017-10-11 02:46:28.321434
NCT01636323|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-01-14|||December 2008||2008-12-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Smoked Nicotine Induced Changes in Hormone Function, Mood States and Behaviors||Suspended||N/A|300|Anticipated|Mclean Hospital||2||Clinical studies stopped, pending funding|f||||f||||||||||2017-10-11 02:46:28.410124|2017-10-11 02:46:28.410124
NCT01636310|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-01-14|||December 2005||2005-12-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Multiple Cigarette Induced Changes in Hormone Function, Mood States and Behavior||Suspended||N/A|72|Anticipated|Mclean Hospital||2||Clinical studies stopped, pending funding|f||||f||||||||||2017-10-11 02:46:28.495985|2017-10-11 02:46:28.495985
NCT01636297|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-06|2016-12-13|||June 2013||2013-06-01|December 2016|2016-12-01||||December 2016|Actual|2016-12-01||Interventional|CYCLE||The Cyclical Lower-extremity Exercise for Parkinson's Trial|The Cyclical Lower-extremity Exercise for Parkinson's Trial|Active, not recruiting||Phase 2/Phase 3|100|Anticipated|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 02:46:28.569438|2017-10-11 02:46:28.569438
NCT01636284|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-23|2016-01-19|||June 2012||2012-06-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|FLASH||A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer|A Single-Arm, Open-Label Phase 2 Study of JX 594 (Thymidine Kinase-Deactivated Vaccinia Virus Plus GM-CSF) Administered by Weekly Intravenous (IV) Infusions in Sorafenib-naïve Patients With Advanced Hepatocellular Carcinoma (HCC)|Completed||Phase 2|16|Actual|SillaJen, Inc.||1|||f||||t||||||||||2017-10-11 02:46:28.643421|2017-10-11 02:46:28.643421
NCT01636271|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-10-30|||October 2011||2011-10-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)|SB-480848 in Major Adverse Cardiovascular Events - Integrated Phase III Summary of Efficacy and Safety|Completed||N/A|28855|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 02:46:28.72325|2017-10-11 02:46:28.72325
NCT01636258|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-05-21|2013-10-31||May 2012||2012-05-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|FRESH||FRESH Study (Fitness, Relaxation and Eating to Stay Healthy)|Diet, Exercise, Cooking, and Stress Management for Patients With Prediabetes: A Pilot Randomized Controlled Study|Completed||N/A|27|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 02:46:28.79725|2017-10-11 02:46:28.79725
NCT01636245|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2013-03-13|||July 2012||2012-07-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine|Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine: A Double-blind, Randomized and Controlled Trial|Completed||Phase 3|1400|Actual|Sinovac Biotech Co., Ltd||4|||f||||t||||||||||2017-10-11 02:46:29.344511|2017-10-11 02:46:29.344511
NCT01636232|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-06-03|||October 2011||2011-10-01|June 2016|2016-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Vitamin D and Critically Ill Patients|Vitamin D Levels and Risk of Infection, Assessment for Disease Severity, and Predictor of Mortality in the Chinese Intensive Care Units: a Prospective Cohort Study|Completed||N/A|234|Actual|Chinese PLA General Hospital|||3||f||||f||||||||||2017-10-11 02:46:29.458074|2017-10-11 02:46:29.458074
NCT01636219|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-02-06|||September 2012||2012-09-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Observational|||Cough Efficiency in Cystic Fibrosis|Cough Efficiency in Cystic Fibrosis|Completed||N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 02:46:29.5278|2017-10-11 02:46:29.5278
NCT01636206|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-01-05|2016-08-09|2014-04-07|July 2012||2012-07-01|January 2017|2017-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|SONATA|Randomized population.|Safety Study of Lifitegrast to Treat Dry Eye|A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)|Completed||Phase 3|332|Actual|Shire||2|||f||||f||||||||||2017-10-11 02:46:29.612238|2017-10-11 02:46:29.612238
NCT01636193|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2015-08-13|||June 2012||2012-06-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Drug Use Investigation for ROTARIX®|Drug Use Investigation for ROTARIX|Completed||N/A|1607|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 02:46:30.042277|2017-10-11 02:46:30.042277
NCT01636180|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-03-05|||March 2012||2012-03-01|March 2015|2015-03-01||||May 2015|Anticipated|2015-05-01||Interventional|REL-0609||Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment.|Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment.|Withdrawn||Phase 4|0|Actual|Fundacja Ośrodek Badań Medycznych||2|||f||||f||||||||||2017-10-11 02:46:30.151296|2017-10-11 02:46:30.151296
NCT01636167|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-07-09|||July 2011||2011-07-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Construction of Computerized Intraoperative Keratometer and Experimental Study|Construction of Computerized Intraoperative Keratometer and Experimental Study|Completed||N/A|60|Actual|Wenzhou Medical University||1|||f||||t||||||||||2017-10-11 02:46:30.246867|2017-10-11 02:46:30.246867
NCT01636154|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-08-04|||January 2012||2012-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations|Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations:A Prospective Randomized Controlled Multi-site Clinical Trial About Fractions-based Herbal Combinations of Clearing Heat and Promoting Blood Circulation|Completed||N/A|120|Actual|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||4|||f||||t||||||||||2017-10-11 02:46:30.324696|2017-10-11 02:46:30.324696
NCT01636141|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-09-05|||June 2012||2012-06-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects|A Phase 1, Randomized, Dose Escalation, Single Center, Safety Study of Single and Multi-Dose, Topically Applied OLT1177 Gel in Healthy Subjects|Completed||Phase 1|36|Actual|Olatec Industries LLC||2|||f||||f||||||||||2017-10-11 02:46:30.434868|2017-10-11 02:46:30.434868
NCT01636128|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-07-28|||March 2014||2014-03-01|July 2014|2014-07-01|April 2016|Anticipated|2016-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Urinary Biomarker Study With Sulindac and Difluoromethylornithine|A Phase 2 Urinary Biomarker Study of Polyamine Inhibition With Sulindac and Difluoromethylornithine (DFMO)|Withdrawn||Phase 2|0|Actual|Cancer Prevention Pharmaceuticals, Inc.||2||Funding and staffing|f||||t||||||||||2017-10-11 02:46:30.560722|2017-10-11 02:46:30.560722
NCT01636115|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-12-05|||May 2012||2012-05-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Validation of Muscle Strength Testing for Pectoralis Major|Validation of Muscle Strength Testing for Pectoralis Major|Completed||N/A|24|Actual|National Science Council, Taiwan|||1||f||||||||||||||2017-10-11 02:46:30.652199|2017-10-11 02:46:30.652199
NCT01636102|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-11-02|2013-07-11||July 2012||2012-07-01|November 2015|2015-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above|A Phase II Open Label, Uncontrolled, Multicenter Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Influenza Vaccine (Agrippal®), Formulation 2012/2013, When Administered to Adult and Elderly Subjects|Completed||Phase 2|126|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:46:30.741338|2017-10-11 02:46:30.741338
NCT01636089|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-02-02|||February 2012||2012-02-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|HYDRAREA||Bicarbonates Versus Saline for Contrast Induced Acute Kidney Injury Prevention in Intensive Care Unit||Completed||Phase 3|300|Actual|University Hospital, Caen||2|||f||||||||||||||2017-10-11 02:46:31.192404|2017-10-11 02:46:31.192404
NCT00005378|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1994||1994-07-01|November 2001|2001-11-01|May 1998|Actual|1998-05-01|||||Observational|||Impact of Sleep Disordered Breathing in Older Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.611602|2017-10-11 04:28:04.611602
NCT01636076|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-11-13|2014-09-10||November 2012||2012-11-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, 12-week Treatment, Parallel-group Study to Evaluate the Efficacy and Safety of QMF149 (150 µg/160 µg o.d.) Compared With Salmeterol Xinafoate/Fluticasone Propionate (50 µg/500 µg b.i.d.) in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|629|Actual|Novartis||2|||f||||t||||||||||2017-10-11 02:46:31.3507|2017-10-11 02:46:31.3507
NCT01636063|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-04-10|2017-02-23||June 2012|Actual|2012-06-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|MIMI11-15||Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks|Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks|Terminated||N/A|42|Actual|Boston University||2||Poor subject enrollment|f||||t||||||||No||2017-10-11 02:46:33.341196|2017-10-11 02:46:33.341196
NCT01636050|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2012-07-09|||January 2012||2012-01-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|CET||Effect of Squat Training on Body Composition, Muscular Strength and Motor Fitness for Youth- Randamized Trial|Phase 1 Study of Child Exercise Training|Completed||Phase 1|2|Actual|National Institute of Fitness and Sports in Kanoya||2|||f||||t||||||||||2017-10-11 02:46:33.646021|2017-10-11 02:46:33.646021
NCT01636037|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-03-11|||September 2012||2012-09-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Antipsychotic Augmentation With L-Dopa|Augmentation of Antipsychotics With L-Dopa (Sinemet)|Completed||Phase 2|13|Actual|Centre for Addiction and Mental Health||1|||f||||t||||||||No||2017-10-11 02:46:33.706346|2017-10-11 02:46:33.706346
NCT01636024|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2013-06-19|||September 2012||2012-09-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594|A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Ascending Inhaled Doses of AZD7594 in Healthy Male Volunteers|Completed||Phase 1|73|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:46:33.810795|2017-10-11 02:46:33.810795
NCT01635998|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2017-06-28|||September 2012||2012-09-01|June 2017|2017-06-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|H-FIB||Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation|Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation|Recruiting||N/A|300|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-11 02:46:34.067585|2017-10-11 02:46:34.067585
NCT01635985|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-01-13|||August 2012||2012-08-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways|A Phase I, Single Centre, Open, Partly Randomised, Crossover Study in Healthy Subjects to Evaluate AZD5423 Absolute Pulmonary Bioavailability When Administered Inhaled Via a New Dry Powder Inhaler, Turbuhaler, Spira Nebulizer and I-neb AAD System|Completed||Phase 1|18|Actual|AstraZeneca||6|||f||||||||||||||2017-10-11 02:46:34.23779|2017-10-11 02:46:34.23779
NCT01635972|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-08-31|||June 2012||2012-06-01|August 2015|2015-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion|A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Bupropion|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:46:34.360598|2017-10-11 02:46:34.360598
NCT01635959|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2014-10-02|||July 2012||2012-07-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|GERD Q NIS||Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt|Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt|Completed||N/A|3170|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:46:34.458088|2017-10-11 02:46:34.458088
NCT01635946|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2015-02-20|||August 2012||2012-08-01|February 2015|2015-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin|A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Atorvastatin|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:46:34.622432|2017-10-11 02:46:34.622432
NCT01635933|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-04-25|2014-02-18||June 2012||2012-06-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||The analysis population includes all participants exposed to the study product (363).|A Comparison of AIR OPTIX® COLORS Versus FRESHLOOK® COLORBLENDS|A Comparison of a Colored Silicone Hydrogel Lens Versus a Colored HEMA Lens|Completed||N/A|370|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:46:34.72701|2017-10-11 02:46:34.72701
NCT01635920|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-02-18|2014-02-18||June 2012||2012-06-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||The analysis population includes all enrolled and randomized participants who received study lenses (251).|A Comparison of Silicone Hydrogel Contact Lenses: AIR OPTIX® COLORS Versus AIR OPTIX® AQUA|A Comparison of Silicone Hydrogel Lenses: Colored Versus Non-Colored|Completed||N/A|258|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:46:35.153602|2017-10-11 02:46:35.153602
NCT01635907|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2016-09-23|||June 2012||2012-06-01|September 2016|2016-09-01||||March 2016|Actual|2016-03-01||Interventional|||Dovitinib in Neuroendocrine Tumors|A Phase 2 Study of Dovitinib in Adults With Advanced Malignant Pheochromocytoma or Paraganglioma|Active, not recruiting||Phase 2|25|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||t||||t||||||||||2017-10-11 02:46:35.554833|2017-10-11 02:46:35.554833
NCT01635530|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-06|||August 2012||2012-08-01|July 2012|2012-07-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Study of Lyme Neuroborreliosis|Study of Lyme Neuroborreliosis: Epidemiology, Manifestations, Diagnostics and Treatment|Unknown status|Not yet recruiting|Phase 4|150|Anticipated|Turku University Hospital||2|||f||||||||||||||2017-10-11 02:46:43.603793|2017-10-11 02:46:43.603793
NCT01635894|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2015-11-04|||April 2002||2002-04-01|November 2015|2015-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Community Intervention Study of Female Pelvic Floor Condition and Knowledge of Pelvic Floor Exercises|A Community Intervention Study of Female Pelvic Floor Condition and Knowledge of Pelvic Floor Exercises|Completed||N/A|240|Actual|Plymouth Hospitals NHS Trust||3|||f||||f||||||||||2017-10-11 02:46:36.36059|2017-10-11 02:46:36.36059
NCT01635881|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-10-14|2013-08-09|2013-02-11|July 2012||2012-07-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter|EMERGE: Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilatation Catheter|Completed||Phase 3|60|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 02:46:36.492435|2017-10-11 02:46:36.492435
NCT01635868|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2014-02-19|||December 2012||2012-12-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|ABSNOME||The Effect of Sutures Versus Mesh in Umbilical Hernia Repair|Long Term Recurrence and Chronic Pain After Repair for Small Umbilical or Epigastric Hernias. A Regional Cohort Study.|Completed||N/A|1313|Actual|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 02:46:37.012066|2017-10-11 02:46:37.012066
NCT01635855|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-05|2014-07-03|2014-04-02||June 2012||2012-06-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||The number of participants included in the analysis was per protocol. There were no imputation techniques used in the safety study.|Belotero Post Approval Study|Belotero® Post Approval Study for the Treatment of Nasolabial Folds|Completed||Phase 4|117|Actual|Merz Pharmaceuticals, LLC||1|||f||||f||||||||||2017-10-11 02:46:37.105893|2017-10-11 02:46:37.105893
NCT01635842|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-03-02|||June 2012||2012-06-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||Informed Consent and Clinical Trials|Informed Consent and Clinical Trials: a Survey on the Patient's Level of Understanding|Completed||N/A|50|Actual|Azienda Usl di Bologna|||1||f||||f||||||||||2017-10-11 02:46:37.393789|2017-10-11 02:46:37.393789
NCT01635829|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2013-10-23|||May 2012||2012-05-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and Telaprevir|A Phase I, Open-label, Randomized, 2-panel, Sequential Treatment Study in Healthy Subjects to Investigate the Potential Pharmacokinetic Interactions Between Multiple Doses of Phenytoin or Carbamazepine and Telaprevir at Steady-state|Completed||Phase 1|24|Actual|Janssen Infectious Diseases BVBA||2|||f||||f||||||||||2017-10-11 02:46:37.488341|2017-10-11 02:46:37.488341
NCT01635816|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2016-11-28|||May 2012||2012-05-01|July 2012|2012-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Immunogenicity of SA 14-14-2 JE Vaccine|A Clinical Trial in Healthy Infants to Assess Lot-to-lot Consistency of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine Manufactured in a New Good Manufacturing Practices Facility and Non-inferiority With Respect to an Earlier Product.|Completed||Phase 4|1000|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||t||||||||||2017-10-11 02:46:37.589266|2017-10-11 02:46:37.589266
NCT01635803|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-06-30|||June 2012||2012-06-01|June 2015|2015-06-01||||June 2016|Anticipated|2016-06-01||Interventional|BRVO||Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)|Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (The BRVO Study)|Unknown status|Recruiting|Phase 2/Phase 3|296|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 02:46:37.856047|2017-10-11 02:46:37.856047
NCT01635790|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-06-30|||June 2012||2012-06-01|June 2015|2015-06-01||||June 2016|Anticipated|2016-06-01||Interventional|BRDME||Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)|Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (The BRDME Study)|Unknown status|Recruiting|Phase 2/Phase 3|246|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 02:46:37.968796|2017-10-11 02:46:37.968796
NCT01635777|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-09|||July 2007||2007-07-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)||Completed||Phase 2|37|Actual|AB Foundation||2|||f||||f||||||||||2017-10-11 02:46:38.066281|2017-10-11 02:46:38.066281
NCT01635764|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-09-05|2017-08-03||April 2012|Actual|2012-04-01|September 2017|2017-09-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|PIONEER (OLE)|Baseline characteristics provided by reporting groups defined by treatment received in the prior phase 3 studies, plus adalimumab every week (EW) received in M12-555. Baseline defined as the last measurement prior to the first dose of study drug in the prior phase 3 study (M11-810 or M11-310 for baseline characteristics.|Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa|A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)|Completed||Phase 3|508|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 02:46:38.248352|2017-10-11 02:46:38.248352
NCT01635751|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2013-01-25|||October 2012||2012-10-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|GLA5PR-101||A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects|A Randomized, Open-label, 3-way Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects|Completed||Phase 1|30|Actual|GL Pharm Tech Corporation||3|||f||||f||||||||||2017-10-11 02:46:41.848099|2017-10-11 02:46:41.848099
NCT01635738|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2015-08-31|||December 2011||2011-12-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|probiotics||Probiotics and Allergic Diseases|Probiotics and Allergic Diseases|Completed||N/A|240|Actual|GenMont Biotech Incorporation||4|||f||||t||||||||||2017-10-11 02:46:41.953155|2017-10-11 02:46:41.953155
NCT01635725|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2017-03-23|||July 2012||2012-07-01|March 2017|2017-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||New Bowel Preparation Scale for Measuring Colon Cleanliness|New Bowel Preparation Scale for Measuring the Cleansing of the Colon for Colonoscopy|Completed||N/A|150|Actual|Gastroenterology Services, Ltd.|||1||f||||f||||||||||2017-10-11 02:46:42.046923|2017-10-11 02:46:42.046923
NCT01635712|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2017-04-25|||February 2014|Actual|2014-02-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|January 2016|Actual|2016-01-01||Interventional|||Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies|A Phase 1, Open-label, Dose-escalation Study of the Safety of SNX-5422 Mesylate in Subjects With Refractory Hematological Malignancies|Completed||Phase 1|10|Actual|Esanex Inc.||1|||f||||f||||||||||2017-10-11 02:46:42.113711|2017-10-11 02:46:42.113711
NCT01635699|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-06|||June 2008||2008-06-01|July 2012|2012-07-01|March 2011|Actual|2011-03-01|June 2008|Actual|2008-06-01||Observational|||Effect of Modified Fujita Technique Uvulopalatoplasty on Oxidative DNA Damage Levels in Patients With Obstructive Sleep Apnea SyndromE (OSAS)|Effect of Modified Fujita Technique Uvulopalatoplasty on Oxidative DNA Damage Levels in Patients With Obstructive Sleep Apnea SyndromE|Completed||N/A|49|Actual|Erzurum Regional Training & Research Hospital|||1||f||||f||||||Samples Without DNA|"     serum, whole blood   "|||2017-10-11 02:46:42.193986|2017-10-11 02:46:42.193986
NCT01635686|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-25|||September 2012||2012-09-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers|A Randomized, Double-blind, Single-dosing, Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers|Unknown status|Not yet recruiting|Phase 1|38|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-11 02:46:42.253941|2017-10-11 02:46:42.253941
NCT01635673|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-06|||May 2010||2010-05-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|VIBES||Effects of Whole Body Vibration Exercise on Metabolic Systems in Latino Boys|Effects of Whole Body Vibration Exercise on Metabolic Systems in Latino Boys|Completed||N/A|20|Actual|University of Southern California||2|||f||||f||||||||||2017-10-11 02:46:42.341325|2017-10-11 02:46:42.341325
NCT01635660|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2015-08-01|||October 2011||2011-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|July 2014|Actual|2014-07-01||Interventional|||Out-of-Hospital Randomized Comparison of Video-assisted Endotracheal Intubation|Prospective, Randomized, Multicentre Evaluation of Different Video-assisted, for Emergency Use Designed Intubation Aids for Out-of-hospital Endotracheal Intubation. Comparison of C-MAC System PM (Karl Storz), AP Advance (Venner Medical), and King Vision (King Systems) at Four German HEMS.|Completed||N/A|182|Actual|University of Schleswig-Holstein||3|||f||||f||||||||||2017-10-11 02:46:42.55346|2017-10-11 02:46:42.55346
NCT01635647|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-02-12|||November 2012||2012-11-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso|A Phase 1/2b Double Blind Randomised Controlled Trial of the Efficacy, Safety and Immunogenicity of Heterologous Prime-boost Immunisation With the Candidate Malaria Vaccines ChAd63 ME-TRAP and MVA ME-TRAP in 5-17 Month Old Burkinabe Infants and Children|Completed||Phase 1/Phase 2|730|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 02:46:42.687994|2017-10-11 02:46:42.687994
NCT01635634|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2015-04-21|||June 2012||2012-06-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Interventional|CuFib||Cupping in Fibromyalgia|Randomized Controlled Pilot Trial: The Effectiveness of Cupping in Patients With Fibromyalgia|Completed||N/A|141|Actual|Universität Duisburg-Essen||3|||f||||f||||||||||2017-10-11 02:46:42.798576|2017-10-11 02:46:42.798576
NCT01635621|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-10-29|||June 2012||2012-06-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease|A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Olokizumab Administered Subcutaneously to Subjects With Moderate to Severe Crohn's Disease|Withdrawn||Phase 2|0|Actual|UCB Pharma||4||"Study was withdrawn due to delay in timelines. There were no safety concerns regarding the   study or the compound in the decision to withdraw the trial."|f||||f||||||||||2017-10-11 02:46:42.915268|2017-10-11 02:46:42.915268
NCT01635608|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-04|||April 2011||2011-04-01|July 2012|2012-07-01||||July 2011|Actual|2011-07-01||Interventional|||Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water|Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water|Completed||Phase 1|12|Actual|University Medicine Greifswald||2|||f||||f||||||||||2017-10-11 02:46:43.044763|2017-10-11 02:46:43.044763
NCT01635595|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-24|||January 2006||2006-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|||||Observational|||Nodal Status in Adenocarcinoma of the Esophagus an Cardia|AdCa of the Esophagus and Cardia (ADEC): Relationship Between Nodal Metastasization and the Presence Absence of Intestinal Metaplasia in the Esophagus and Stomach|Completed||N/A|194|Actual|University of Bologna|||2||f||||f||||||||||2017-10-11 02:46:43.155997|2017-10-11 02:46:43.155997
NCT01635582|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2014-10-11|||June 2012||2012-06-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Home Based Computer Gaming Hand Exercise Regimen for People With Arthritis Affecting the Hands|Effects of Home Based Computer Gaming Hand Exercise Regimen in People With Rheumatoid Arthritis (RA) or Osteoarthritis (OA) -A Randomized Controlled Pilot Trial|Completed||Phase 2|16|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 02:46:43.242807|2017-10-11 02:46:43.242807
NCT01635569|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2017-07-04|||October 2012||2012-10-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder|Clinical Outcomes Following Group-based Family Cognitive-Behaviour Therapy in Pediatric Obsessive-Compulsive Disorder (OCD)|Recruiting||N/A|180|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:46:43.342445|2017-10-11 02:46:43.342445
NCT01635556|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-05-03|||September 2012|Actual|2012-09-01|November 2014|2014-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Evaluation of a Modified Dialectical Behavior Therapy Program|Evaluation of a Modified Dialectical Behavior Therapy Program for Borderline Personality Disorder|Completed||N/A|16|Actual|University of Manitoba|||1||f||||t||||||||No||2017-10-11 02:46:43.443308|2017-10-11 02:46:43.443308
NCT01635543|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2013-10-16|||October 2011||2011-10-01|October 2013|2013-10-01|October 2013|Anticipated|2013-10-01|June 2013|Anticipated|2013-06-01||Observational|||Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas|Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas|Withdrawn||N/A|0|Actual|University of British Columbia|||1|This study was terminated due to some challenges in recruitment process|f||||t||||||||||2017-10-11 02:46:43.52638|2017-10-11 02:46:43.52638
NCT01635517|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-06-01|||July 1, 2012|Actual|2012-07-01|June 2017|2017-06-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|MT FUJI||Efficacy and Safety of Tolvaptan in Japanese Patients With Acute Heart Failure|Multicenter Tolvaptan Study For Uncontrolled Volume Overload in Japanese Acute Decompensated Heart faIlure Patients: A Prospective Observational Multicenter Cohort Study|Completed||N/A|274|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||f||||||||||2017-10-11 02:46:43.69846|2017-10-11 02:46:43.69846
NCT01635504|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-08-20|2015-05-27||October 2012||2012-10-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||HIV Posterior Cheek Enlargement|Posterior Cheek Enlargement in HIV: Anatomic Characterization and Treatment With Botulinum Toxin A|Completed||N/A|5|Actual|University of British Columbia|This was a pilot study with only 5 participants. This study can only serve as a guide for larger studies.|1|||f||||f||||||||||2017-10-11 02:46:43.772817|2017-10-11 02:46:43.772817
NCT01635491|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-12-06|||April 2012||2012-04-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Gastrointestinal Transit Times and Motility in Healthy Volunteers Obtained by Motilis-3D-transit|Gastrointestinal Transit Times and Motility in Healthy Volunteers Obtained by Motilis-3D-transit|Completed||N/A|20|Actual|University of Aarhus|||1||f||||t||||||||||2017-10-11 02:46:43.989534|2017-10-11 02:46:43.989534
NCT01635478|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2012-07-04|||April 2011||2011-04-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||A Observational Study of Assessment and Treatment Adequacy of Emergency Cancer Pain in Tertiary Cancer Hospital|A Prospective Observational Study of Assessment of Emergency Cancer Pain and Its Treatment Adequacy in Emergency Department of Tertiary Care Cancer Hospital.|Completed||N/A|100|Actual|Tata Memorial Hospital|||1||f||||t||||||||||2017-10-11 02:46:44.09071|2017-10-11 02:46:44.09071
NCT01635465|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2015-12-21|||November 2016||2016-11-01|July 2012|2012-07-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer|A Randomised Controlled Phase II Trial of Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer.|Unknown status|Not yet recruiting|N/A|120|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||2||f||||t||||||||||2017-10-11 02:46:44.158231|2017-10-11 02:46:44.158231
NCT01635452|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-01-26|||May 2012||2012-05-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|April 2014|Actual|2014-04-01||Observational|PREMYA||A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids||Unknown status|Active, not recruiting|N/A|1500|Anticipated|PregLem SA|||1||f||||f||||||||||2017-10-11 02:46:44.259494|2017-10-11 02:46:44.259494
NCT01635439|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2014-01-07|2012-07-06||December 2010||2010-12-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Prostin and Propess in Induction of Labor|Induction of Labour: A Comparison Between Propess Vaginal Delivery System and Prostin E2 Vaginal Suppositories, A Randomized Controlled Trial.|Completed||Phase 3|200|Actual|Ain Shams University||2|||f||||t||||||||||2017-10-11 02:46:44.636326|2017-10-11 02:46:44.636326
NCT01635426|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2017-03-09|||March 2012||2012-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages|Aspirin Versus Clopidogrel Effect on Uterine Perfusion in Women With Unexplained Recurrent Pregnancy Loss With Decreased Uterine Artery Pulsatility Index: A Randomized Controlled Trial|Recruiting||Phase 2/Phase 3|32|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 02:46:45.124543|2017-10-11 02:46:45.124543
NCT01635413|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-12-13|||September 2012||2012-09-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|GET FIT||Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)|Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)|Completed||N/A|444|Actual|OHSU Knight Cancer Institute||3|||f||||t||||||||||2017-10-11 02:46:45.250521|2017-10-11 02:46:45.250521
NCT01635400|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-07-06|||June 2012||2012-06-01|June 2012|2012-06-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer|Phase Ⅱ Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|50|Anticipated|Zhejiang Cancer Hospital||3|||f||||t||||||||||2017-10-11 02:46:45.404717|2017-10-11 02:46:45.404717
NCT01635387|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-07-04|||February 2010||2010-02-01|July 2012|2012-07-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||RAAS Inhibitor Drugs in Dialysis Patients|Upstream Use of Aliskiren in Hypertensive Haemodialysis Patients: Effects on Cardiovascular Outcomes|Unknown status|Active, not recruiting|Phase 4|350|Anticipated|"University of Campania Luigi Vanvitelli"||2|||f||||f||||||||||2017-10-11 02:46:45.522736|2017-10-11 02:46:45.522736
NCT01635374|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2015-01-05|||July 2010||2010-07-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|May 2012|Actual|2012-05-01||Interventional|POEM||Per-Oral Endoscopic Esophagomyotomy (POEM)|Per-Oral Endoscopic Esophagomyotomy (POEM)|Completed||N/A|400|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-11 02:46:45.603856|2017-10-11 02:46:45.603856
NCT01635361|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-05-27|||August 2012||2012-08-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|NMS||Understanding and Appraising the New Medicine Service in England|Understanding and Appraising the New Medicine Service in England|Completed||N/A|504|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-11 02:46:45.696266|2017-10-11 02:46:45.696266
NCT01635348|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2015-07-28|||January 2011||2011-01-01|June 2012|2012-06-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|2-STEP||Thinking, Walking Outcomes by Type of Exercise|Benefits of Two Types of Therapeutic Exercise on Gait and Cognition|Completed||Phase 2|22|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:46:45.817905|2017-10-11 02:46:45.817905
NCT01635335|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2016-09-20|||August 2010||2010-08-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|LatinoSTYLE||Randomized Control Trial of Family-Based HIV Prevention for Latinos|A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth|Completed||Phase 2|542|Actual|University of South Florida||2|||f||||t||||||||||2017-10-11 02:46:45.952288|2017-10-11 02:46:45.952288
NCT00005402|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-16|||May 1996||1996-05-01|April 2002|2002-04-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Observational|||Transfusion Associated HCV in a Pediatric Population||Completed||N/A|||Children's Research Institute|||||f||||||||||||||2017-10-11 04:28:06.192554|2017-10-11 04:28:06.192554
NCT01635322|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-03-27|||July 2012|Actual|2012-07-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Sagittal Plane Correction With Pass-LP Device in Adult Deformity Patients|The Relationship Between Sagittal Plane Correction and Quality of Life in Adult Deformity Patients Treated With Posterior Instrumentation|Completed||N/A|54|Actual|Medicrea International|||1||f||||f||||||||||2017-10-11 02:46:46.074409|2017-10-11 02:46:46.074409
NCT01635309|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-04|2015-04-27|||May 2007||2007-05-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|CTA-VISION||Coronary CT Angiography to Predict Vascular Events In Noncardiac Surgery patIents cOhort evaluatioN (CTA -VISION) Study|Coronary CT Angiography to Predict Vascular Events In Noncardiac Surgery patIents cOhort evaluatioN (CTA -VISION) Study|Completed||N/A|987|Actual|McMaster University|||1||f||||t||||||||||2017-10-11 02:46:46.199283|2017-10-11 02:46:46.199283
NCT01635296|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia|A Multicenter, Open Label, Phase 1B Study of Escalating Doses of RO5045337 Administered Orally, With Cytarabine Administered A) Subcutaneously, or B) Intravenously, in Patients With Acute Myelogenous Leukemia (AML)|Completed||Phase 1|43|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:46:46.317399|2017-10-11 02:46:46.317399
NCT01635283|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-01-29|||January 2012||2012-01-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma|A Phase II Clinical Trial Evaluating Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen for the Treatment of Low-grade Glioma|Active, not recruiting||Phase 2|18|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 02:46:46.480887|2017-10-11 02:46:46.480887
NCT01635270|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-08-04|||September 12, 2012|Actual|2012-09-12|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2019|Anticipated|2019-03-01||Interventional|midP||Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma|Randomized Phase 2 Study Evaluating the Interest of Mid-position Strategy Versus ITV (Internal Target Volume) Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-resected Non-small Cell Lung Carcinoma (NSCLC).|Recruiting||Phase 2|54|Anticipated|Centre Leon Berard||2|||f||||t||||||||||2017-10-11 02:46:46.570163|2017-10-11 02:46:46.570163
NCT01635257|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-01|2013-03-14|||June 2012||2012-06-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|SPES||Accuracy of Multi-organ Ultrasound for the Diagnosis of Pulmonary Embolism|Accuracy of Multi-organ Ultrasound (Venous, Cardiac and Thoracic) for the Diagnosis of Pulmonary Embolism: Suspected Pulmonary Embolism Sonographic Assessment (SPES) Multicenter Prospective Study|Completed||N/A|357|Actual|Azienda Ospedaliero-Universitaria Careggi|||1||f||||f||||||||||2017-10-11 02:46:46.680864|2017-10-11 02:46:46.680864
NCT01635244|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-01|2016-12-10|2016-12-10||July 2012||2012-07-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Hemodynamic Comparison of Tissue Aortic Valves|Trifecta Comparative Stress Hemodynamic Study (Randomized Comparison of Exercise Hemodynamics and Left Ventricular Remodeling With Aortic Bioprostheses After Aortic Valve Replacement for Aortic Stenosis)|Completed||N/A|60|Actual|University of Michigan||3|||f||||f||||||||||2017-10-11 02:46:46.761083|2017-10-11 02:46:46.761083
NCT01635231|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-03-01|||July 2012||2012-07-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|THAM||The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy Subjects|Effect of Thiazide, Amiloride and Hypertonic Saline on Sodium- and Water Channel Activity in the Nephron in Healthy Subjects Estimated by Urinary Biomarkers|Completed||N/A|24|Actual|Regional Hospital Holstebro||3|||f||||t||||||||||2017-10-11 02:46:47.210978|2017-10-11 02:46:47.210978
NCT01635218|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2014-09-30|2014-09-08||March 2012||2012-03-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|HOMDEP-MENOP|All patientes under randomization were included in the primary efficacy population (intention-to-treat population).|Homeopathic Treatment for Depression in Peri- and Postmenopausal Women|Efficacy of Individualized Homeopathic Treatment for Moderate to Severe Depression in Peri- and Postmenopausal Women: a Randomized Placebo-controlled, Double-blind, Double-dummy, Study Protocol|Completed||Phase 2|133|Actual|Hospital Juarez de Mexico||3|||f||||t||||||||||2017-10-11 02:46:47.324856|2017-10-11 02:46:47.324856
NCT01635205|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-17|2014-04-23|||October 2011||2011-10-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Paraspinous Anesthetic Block for Non-Responsive Pelvic Pain|Efficacy of Paraspinous Anesthetic Block in Patients With Chronic Pelvic Pain Non-Responsive to Pharmacological Treatment|Completed||Phase 4|60|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 02:46:48.247504|2017-10-11 02:46:48.247504
NCT01635192|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-05-21|||December 2011||2011-12-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Probiotic VSL#3 on Expression of Small Intestinal Renin-angiotensin System|Effects of Probiotic VSL#3 on Expression of Small Intestinal Mucosal Renin-angiotensin System and Glucose Absorption in Man - a Doubleblind, Randomized Parallel Arm Placebo Controlled Exploratory Study in Healthy Volunteers|Completed||Early Phase 1|24|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 02:46:48.348411|2017-10-11 02:46:48.348411
NCT01635179|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-04-24|||April 2012||2012-04-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Laryngeal View With Videolaryngoscopy|Laryngeal View With Intubation by Videolaryngoscopy With and Without Sellicks Maneuver.|Completed||N/A|50|Actual|Glostrup University Hospital, Copenhagen||1|||f||||t||||||||||2017-10-11 02:46:48.434332|2017-10-11 02:46:48.434332
NCT01635153|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2015-02-09|||May 2012||2012-05-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|DarDar||Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis|Randomized Controlled Trial of a Protein-calorie Supplement for HIV-infected Women With Tuberculosis|Completed||Phase 2|151|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 02:46:48.620728|2017-10-11 02:46:48.620728
NCT01635127|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-09-26|||June 2012||2012-06-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|URTICANA||Efficacy Study of Canakinumab to Treat Urticaria|A Phase II Randomized Double-Blind Placebo Controlled Single Center Study of Canakinumab Treatment of Adult Patients With Moderate to Severe Chronic Idiopathic Urticaria|Recruiting||Phase 2|20|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 02:46:48.806039|2017-10-11 02:46:48.806039
NCT01635114|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-10-24|||June 2012||2012-06-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|December 2013|Actual|2013-12-01||Interventional|resVida NAFL||Effect of resVida on Liver Fat Content|Evaluate the Effects of resVidaTM on Liver Fat Content, Body Fat Distribution and Insulin Sensitivity|Completed||N/A|112|Actual|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-11 02:46:48.917818|2017-10-11 02:46:48.917818
NCT01635101|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-08-09||2016-08-09|June 2012||2012-06-01|August 2016|2016-08-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|||A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients|A Randomized, Placebo Controlled, Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients|Completed||Phase 3|215|Actual|Mallinckrodt||2|||f||||f||||||||||2017-10-11 02:46:49.012966|2017-10-11 02:46:49.012966
NCT01635088|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2013-08-30|||June 2011||2011-06-01|August 2013|2013-08-01||||December 2011|Actual|2011-12-01||Interventional|||Onset and Duration of Mometasone by Oscillometry and Spirometry|Onset and Duration of Action of Mometasone Inhalation Powder as Measured by Oscillometry Versus Spirometry|Completed||Phase 4|21|Actual|California Allergy and Asthma Medical Group, Inc.||2|||f||||f||||||||||2017-10-11 02:46:49.172016|2017-10-11 02:46:49.172016
NCT01635075|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-09-25|||June 2012||2012-06-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Acute Effects of Exercise in Smokers With Schizophrenia|Acute Effects of Exercise in Smokers With Schizophrenia|Completed||Phase 2|30|Actual|Brown University||2|||f||||f||||||||||2017-10-11 02:46:49.269345|2017-10-11 02:46:49.269345
NCT01635062|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-02-28|2017-01-06||September 2012||2012-09-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|VALIDATE-D||The VALIDATE-D Study|Evaluating Hormonal Mechanisms for Vitamin D Receptor Agonist Therapy in Diabetes: The VALIDATE-D Study|Completed||N/A|41|Actual|Brigham and Women's Hospital|This was a small physiological study, not a treatment study or a typical Phase 1-4 study. The objective was to investigate the mechanistic link between vitamin D receptor agonist therapy and the renin-angiotensin system.|2|||f||||t||||||||||2017-10-11 02:46:49.370531|2017-10-11 02:46:49.370531
NCT01635049|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2015-01-12|||June 2012||2012-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|CCS||Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results|Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results,Implantation and Live Birth|Completed||N/A|110|Actual|Progyny, Inc.|||1||f||||f||||||||||2017-10-11 02:46:49.792837|2017-10-11 02:46:49.792837
NCT01635036|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-01-09|||June 2012||2012-06-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|NDS||Eeva 12-well Dish Study|Eeva 12-well Dish Study|Completed||N/A|17|Actual|Progyny, Inc.|||1||f||||f||||||||||2017-10-11 02:46:49.894788|2017-10-11 02:46:49.894788
NCT01635023|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-10-24|||July 2012||2012-07-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|AZD6244Formula||A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244|A Phase I, Single-center, Randomized, Open-label, Crossover Study to Compare the White (Current Phase II) and Blue (Planned Phase III) Capsule Formulations of AZD6244 Hyd-Sulfate in Healthy Male Subjects|Completed||Phase 1|27|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 02:46:49.980608|2017-10-11 02:46:49.980608
NCT01635010|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-07-05|||December 2008||2008-12-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Obstructive Sleep Apnea in the Absence of Metabolic Syndrome|Obstructive Sleep Apnea in the Absence of Metabolic Syndrome: Pulse Wave Velocity, Inflammatory and Oxidative Stress Markers|Completed||Phase 4|34|Actual|Associação Fundo de Incentivo à Pesquisa||2|||f||||f||||||||||2017-10-11 02:46:50.113251|2017-10-11 02:46:50.113251
NCT01634997|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-03|||June 2012||2012-06-01|July 2012|2012-07-01||||||||Observational|||Evaluation of SCOUT DS Device in the Diagnosis of Diabetes|An Evaluation of the SCOUT DS Device. Random Capillary Glucose and Leicester Diabetes Risk Score for Screening Subjects at Risk for Type 2 Diabetes|Unknown status|Recruiting|N/A|330|Anticipated|VeraLight, Inc.|||1||f||||f||||||||||2017-10-11 02:46:50.19301|2017-10-11 02:46:50.19301
NCT01634984|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2015-12-21|||January 2012||2012-01-01|January 2012|2012-01-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer|The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer|Unknown status|Recruiting|N/A|500|Anticipated|Tianjin Medical University Cancer Institute and Hospital|||1||f||||t||||||||||2017-10-11 02:46:50.278912|2017-10-11 02:46:50.278912
NCT01634971|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-02-14|||May 2012||2012-05-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|EDIDPD||External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent After Pancreaticoduodenectomy (EDIDPD)|Phase II Study of External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent|Unknown status|Recruiting|Phase 2|120|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 02:46:50.360546|2017-10-11 02:46:50.360546
NCT01634958|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-11-18|||October 2012||2012-10-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma|A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma|Completed||Phase 2|308|Actual|Leti Pharma GmbH||4|||f||||t||||||||||2017-10-11 02:46:50.491609|2017-10-11 02:46:50.491609
NCT01634945|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-09-23|||April 2012||2012-04-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy of Iron Fortified Complementary Food and IPT of Malaria in Young Children in Côte d'Ivoire|Aetiology, Prevention and Control of Anaemia in Sub-Saharan Africa - Work Package 2: Efficacy Study: Efficacy of 2 Iron Fortified Porridges and IPT for the Prevention of Anemia in Young Children in Côte d'Ivoire.|Completed||N/A|629|Actual|Swiss Federal Institute of Technology||5|||f||||t||||||||||2017-10-11 02:46:50.60336|2017-10-11 02:46:50.60336
NCT01634932|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-11-07|||July 2012||2012-07-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Iron Absorption From Regular, Biofortified and Post-harvest Fortified Pearl Millet|Comparison of Iron Absorption From Regular-iron, Iron Biofortified, and Post-harvest Iron-fortified Pearl Millet Using Multiple Meals in Young Women|Completed||N/A|22|Actual|Swiss Federal Institute of Technology||3|||f||||||||||||||2017-10-11 02:46:50.714205|2017-10-11 02:46:50.714205
NCT01634906|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-03-21|||July 2012||2012-07-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EBABAST||Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy|Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy|Completed||N/A|55|Actual|Sint Franciscus Gasthuis||1|||f||||f||||||||||2017-10-11 02:46:50.902755|2017-10-11 02:46:50.902755
NCT01634893|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-03-24|||June 2012||2012-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors|A Phase I Dose-Escalation Trial of Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors|Completed||Phase 1|18|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 02:46:51.021694|2017-10-11 02:46:51.021694
NCT01634880|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-05-19|||July 2012||2012-07-01|May 2016|2016-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies|Phase II Trial of Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies|Withdrawn||Phase 2|0|Actual|The University of Texas Health Science Center at San Antonio||1||Lack of accrual.|f||||t||||||||||2017-10-11 02:46:51.109693|2017-10-11 02:46:51.109693
NCT01634867|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-12-19|||September 2012||2012-09-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access in Pediatric Patients|A Pilot Study of Intubating Conditions Comparing Intraosseous Vascular Access With Peripheral Intravenous Access for Drug Delivery in Rapid Sequence Intubation Using Rocuronium as the Paralytic Agent|Withdrawn||N/A|0|Actual|Vidacare Corporation|||2|No subject enrollment.|f||||f||||||||||2017-10-11 02:46:51.189429|2017-10-11 02:46:51.189429
NCT01634854|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-05-26|2017-04-14||July 2012||2012-07-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study Comparing Vaginal Misoprostol and Intravenous Oxytocin for Induction of Labor|Randomized Comparison of Vaginal Misoprostol and Intravenous Oxytocin for Labor Induction in Multiparous Women|Completed||N/A|130|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||No||2017-10-11 02:46:51.271696|2017-10-11 02:46:51.271696
NCT01634841|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-06-16|||April 2012||2012-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|WAHA||Walnuts and Healthy Aging|Effect of Daily Ingestion of Walnuts for 2 Years on Age-related Cognitive Decline and Macular Degeneration in Healthy Elderly Subjects: A Randomized, Single Blind, Dual Center, Controlled Trial|Completed||N/A|708|Actual|Loma Linda University||2|||f||||t||||||||||2017-10-11 02:46:51.956382|2017-10-11 02:46:51.956382
NCT01634828|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-05-10|||July 2012||2012-07-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|EBL||Method for Improved Intraoperative Blood Loss Estimates|Method for Improved Intraoperative Blood Loss Estimates|Completed||N/A|47|Actual|University of Utah|||2||f||||f||||||||||2017-10-11 02:46:52.055208|2017-10-11 02:46:52.055208
NCT01634815|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2015-06-22|||February 2013||2013-02-01|June 2015|2015-06-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|ELIT||Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization|Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization.|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 02:46:52.121896|2017-10-11 02:46:52.121896
NCT01634802|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-05|||August 2012||2012-08-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|CDSS||Evaluation of Use of Clinical Decision Support System in HIV Care in Resource Constrained Settings|Evaluation of Use of Clinical Decision Support System for Early Detection of Immunological Treatment Failure Among HIV Patients in Resource Constrained Settings|Unknown status|Not yet recruiting|N/A|1460|Anticipated|Kenya Medical Research Institute||2|||f||||f||||||||||2017-10-11 02:46:52.236908|2017-10-11 02:46:52.236908
NCT01634789|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-01-17|||August 2012||2012-08-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women|A Phase 1, Open-label, Single-dose, Randomized, 4-treatment, 4- Period, Crossover, Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene (Bza) Compared With A Reference Tablet Formulation of Bza/Conjugated Estrogens (ce) in Healthy Postmenopausal Women|Terminated||Phase 1|2|Actual|Pfizer||4||"This study was terminated on 10 December 2012 due to low enrollment. The decision to terminate   the study was not based on safety or efficacy issues."|f||||f||||||||||2017-10-11 02:46:52.356939|2017-10-11 02:46:52.356939
NCT01634594|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-02-13|||June 2012||2012-06-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||The Effect of Deliberate Hypotension on QTc, Tp-e Intervals and Heart Rate Variability||Completed||Phase 4|66|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 02:46:54.849694|2017-10-11 02:46:54.849694
NCT01634776|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2013-03-04|||February 2009||2009-02-01|March 2013|2013-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Behavioral, Genetic, and Epigenetic Implications of Dietary Supplementation With Alpha-linolenic Acid in Humans|Behavioral, Genetic, and Epigenetic Implications of Dietary Supplementation With Alpha-linolenic Acid in Humans.|Completed||N/A|66|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:46:52.463432|2017-10-11 02:46:52.463432
NCT01634763|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-07-25|||June 2012||2012-06-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)|A Phase I, Multicenter, Open-label Dose Escalation Study of LDK378, Administered Orally in Japanese Patients With Tumors Characterized by Genetic Alterations in ALK|Completed||Phase 1|22|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:46:52.54551|2017-10-11 02:46:52.54551
NCT01634750|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-06-30|||September 7, 2012||2012-09-07|February 24, 2017|2017-02-24|May 29, 2013|Actual|2013-05-29|||||Interventional|||Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)|A Phase 1 Randomized, Placebo-Controlled, Double-Blind, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)|Completed||Phase 1|26|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 02:46:52.66576|2017-10-11 02:46:52.66576
NCT01634737|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2014-03-06|||September 2010||2010-09-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|November 2011|Actual|2011-11-01||Observational|||Crustacean Allergy and Dust Mites Sensitization|Crustacean Allergy and Sensitization to Dust Mites in Patients With Respiratory Allergy: Clinical Study and Analysis of Common and Peculiar Allergens|Completed||N/A|100|Actual|Niguarda Hospital|||2||f||||f||||||Samples Without DNA|"     Blood for in vitro investigations   "|||2017-10-11 02:46:52.793776|2017-10-11 02:46:52.793776
NCT01634724|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-07|||July 2012||2012-07-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|July 2012|Actual|2012-07-01||Interventional|||GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation|Study of Effect of GnRHa Withdrawal at Late Stage of Long Protocol on the Risk of Ovarian Hyper-stimulation in Patients With Polycystic Ovary (PCO) Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles|Unknown status|Recruiting|N/A|96|Anticipated|Nanjing University||2|||f||||t||||||||||2017-10-11 02:46:52.898036|2017-10-11 02:46:52.898036
NCT01634711|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-04-24|||June 2013||2013-06-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Evaluation of a Resorbable PLLA Implant for Regeneration of the Anterior Cruciate Ligament (ACL)|A Prospective and Consecutive Clinical Evaluation of Soft Tissue Regeneration's L-C Ligament® in Primary ACL Reconstruction|Active, not recruiting||Phase 2|15|Actual|Soft Tissue Regeneration, Inc.||1|||f||||f||||||||No||2017-10-11 02:46:53.04051|2017-10-11 02:46:53.04051
NCT01634698|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-07-02|||October 2007||2007-10-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Relative-dose-response Test (RDR) Adaptation for Chronic Liver Disease|Responsiveness of RDR Test to Assess Hepatic Vitamin A Stores in Chronic Liver Disease|Completed||N/A|178|Actual|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-11 02:46:53.173247|2017-10-11 02:46:53.173247
NCT01634685|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-02-29|||August 2012||2012-08-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma|A Phase I Study of the Phosphatidylserine-Targeting Antibody Bavituximab in Combination With Capecitabine and Radiation Therapy for the Treatment of Stage II and III Rectal Adenocarcinoma|Active, not recruiting||Phase 1|18|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||No||2017-10-11 02:46:53.301986|2017-10-11 02:46:53.301986
NCT01634659|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-11-27|2013-09-27||July 2012||2012-07-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||This reporting group includes all randomized and dispensed participants.|Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses|Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses|Completed||N/A|330|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:46:53.565007|2017-10-11 02:46:53.565007
NCT01634646|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-07-12|||May 2012||2012-05-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Lyzme5||Observational Study of Lyzme5 Impact on Cholesterol and Body Weight in Man|A Placebo-Controlled Pilot Study to Observe the Impact Lyzme5 Has on Cholesterol and Body Weight in Man|Terminated||N/A|19|Actual|All American Pharmaceutical||1||Unable to recruit sufficient local qualifying volunteers for study.|f||||t||||||||||2017-10-11 02:46:53.93964|2017-10-11 02:46:53.93964
NCT01634633|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-05|||January 2011||2011-01-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Observational|||Endometrial Nerve Fibers Detection in Patients With Different Gynecological Pathologies|Endometrial Nerve Fibers Detection in Patients With Different Gynecological Pathologies|Unknown status|Recruiting|N/A|300|Anticipated|Ain Shams Maternity Hospital|||1||f||||f||||||||||2017-10-11 02:46:54.034759|2017-10-11 02:46:54.034759
NCT01634620|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2014-01-15|2013-08-30||June 2012||2012-06-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational||Per-protocol Population|Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease|Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease|Completed||N/A|200|Actual|Aerocrine AB|||1||f||||f||||||||||2017-10-11 02:46:54.141074|2017-10-11 02:46:54.141074
NCT01634607|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-10-19|||October 2010||2010-10-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2018|Anticipated|2018-10-01||Observational|BHVD||Bone Health and Vitamin D Status|Bone Health and Vitamin D Status in Thai HIV-1 Infected and Uninfected Adults (A Substudy of TNT-HIV 003: Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study)|Enrolling by invitation||N/A|235|Anticipated|Thai Red Cross AIDS Research Centre|||3||f||||f||||||||||2017-10-11 02:46:54.724534|2017-10-11 02:46:54.724534
NCT01634568|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-07-09|||August 2011||2011-08-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men|A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of V81444 in Healthy Male Volunteers|Completed||Phase 1|49|Actual|Vernalis (R&D) Ltd||2|||f||||f||||||||||2017-10-11 02:46:54.9889|2017-10-11 02:46:54.9889
NCT01634555|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-05-25|2014-06-12||October 2012||2012-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2013|Actual|2013-08-01||Interventional||All enrolled participants who received at least 1 dose of study drug.|A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI|A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Irinotecan and Its Metabolite SN-38 When Coadministered With Folinic Acid and 5 Fluorouracil in Patients With Advanced Malignant Solid Tumors|Active, not recruiting||Phase 2|29|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:46:55.22288|2017-10-11 02:46:55.22288
NCT01634542|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-11-01|||February 2011||2011-02-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia|A Non-Interventional Prospective Cohort Study of Patients With Persistent Symptoms of Schizophrenia to Describe The Course and Burden of Illness|Completed||N/A|1433|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:46:55.684872|2017-10-11 02:46:55.684872
NCT01634529|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-07-10|||March 2011||2011-03-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers|A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of V158866 in Healthy Volunteers|Completed||Phase 1|50|Actual|Vernalis (R&D) Ltd||2|||f||||f||||||||||2017-10-11 02:46:56.005025|2017-10-11 02:46:56.005025
NCT01634516|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-08-11|||May 2012||2012-05-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|||Effectiveness of Mediterranean Diet Intervention in Pregnant Women|An Investigation of the Effectiveness of the Mediterranean Diet in Pregnant Women at Risk of Developing Allergy in Their Infants: Pilot Randomised Controlled Trial|Completed||N/A|30|Actual|Heriot-Watt University||2|||f||||t||||||||||2017-10-11 02:46:56.081002|2017-10-11 02:46:56.081002
NCT01634503|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2014-02-14|||November 2012||2012-11-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|CIN3||Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3|A Single Center, Open-label, Dose-escalating, Phase Ι Study to Evaluate the Safety of GX-188E Administered by Electroporation (EP) in DNA-based Therapeutic Vaccine for Patients With Cervical Intraepithelial Neoplasia Grade 3 (CIN 3)|Completed||Phase 1|9|Actual|Genexine, Inc.||3|||f||||f||||||||||2017-10-11 02:46:56.163683|2017-10-11 02:46:56.163683
NCT01634490|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-05|||October 2008||2008-10-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy||Completed||N/A|300|Actual|Federico II University|||5||f||||f||||||||||2017-10-11 02:46:56.25494|2017-10-11 02:46:56.25494
NCT01634477|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-01-17|||January 2010||2010-01-01|October 2016|2016-10-01|October 2022|Anticipated|2022-10-01|October 2020|Anticipated|2020-10-01||Observational|TNT-HIV||Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study|Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study|Active, not recruiting||N/A|816|Anticipated|Thai Red Cross AIDS Research Centre|||2||f||||f||||||||||2017-10-11 02:46:56.460109|2017-10-11 02:46:56.460109
NCT01634464|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-07-05|||March 2007||2007-03-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|October 2010|Actual|2010-10-01||Observational|PREOBE||Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue|The Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue. Search for Markers of the Obesity Risk in Early Stages of Life|Unknown status|Recruiting|N/A|300|Anticipated|Universidad de Granada|||4||f||||f||||||Samples With DNA|"     Maternal blood and blood from the umbilical cord, serum, plasma, placental tissue, placental     tissue treated with RNAlater, saliva, oral mucosa, urine, faeces, human milk   "|||2017-10-11 02:46:56.556969|2017-10-11 02:46:56.556969
NCT01634451|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-06-10|||June 2012||2012-06-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|DESIST||Development and Evaluation of Strategies to Improve Sedation Quality in InTensive Care|Development and Evaluation of Strategies to Improve Sedation Quality in InTensive Care|Completed||N/A|1637|Actual|University of Edinburgh||4|||f||||f||||||||||2017-10-11 02:46:56.671142|2017-10-11 02:46:56.671142
NCT01634438|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-07-02|||July 2008||2008-07-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Heparin Dose for Radial Angiography|Low Versus High Dose Unfractionated Heparin in Patients Undergoing Angiography Via the Radial Artery|Completed||Phase 4|49|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 02:46:56.815128|2017-10-11 02:46:56.815128
NCT01634425|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2015-10-19|||November 2011||2011-11-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|PROACT||Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT)|Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT) Novel Proximal Pathways for Non ST Elevation Myocardial Infarction|Completed||Phase 4|601|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 02:46:56.92131|2017-10-11 02:46:56.92131
NCT01634412|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-09-24|||June 2012||2012-06-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|||Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults|A Single-Dose, Open-Label, Randomized Study of the Comparative Pharmacokinetics of Sublingual TNX-102 2.4 mg at pH 3.5 and 7.1, Oral Cyclobenzaprine 5 mg Tablets, and Intravenous Cyclobenzaprine 2.4 mg in Healthy Adults|Completed||Phase 1|24|Actual|Tonix Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 02:46:57.046347|2017-10-11 02:46:57.046347
NCT01634399|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-07-02||||||July 2012|2012-07-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fed Conditions|An Open-Label, Randomised, 2-Period, 2-Treatment, 2-sequence, Crossover Single-dose Bioequivalence Study of Quetiapine 25 mg Tablet [Test Formulation; Torrent Pharmaceuticals Ltd., India] Versus Seroquel® 25 mg Tablet [Reference Formulation; AstraZeneca, USA] in Healthy Human Volunteers Under Fed Condition.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 02:46:57.160083|2017-10-11 02:46:57.160083
NCT01634386|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-07-02||||||July 2012|2012-07-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fasting Conditions|An Open-Label, Randomised, 2-Period, 2-Treatment, 2-sequence, Crossover, Single-dose Bioequivalence Study of Quetiapine 25 mg Tablet [Test Formulation; Torrent Pharmaceuticals Ltd., India] Versus Seroquel® 25 mg Tablet [Reference Formulation; AstraZeneca, USA] in Healthy Human Volunteers Under Fasting Condition.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 02:46:57.231764|2017-10-11 02:46:57.231764
NCT01634373|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-07-02||||||July 2012|2012-07-01||||||||Interventional|||Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets|An Open-Label, Randomised, 2-Period, 2-Treatment, 2-sequence, Crossover, Steady State Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets [Test Formulation; Torrent Pharmaceuticals Ltd., India] Versus Seroquel® 300 mg Tablet [Reference Formulation; AstraZeneca, USA] in Schizophrenic Patients.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 02:46:57.294962|2017-10-11 02:46:57.294962
NCT01634360|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2014-06-25|2012-10-23|2012-08-14|November 2004||2004-11-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations|"A 48-month Open Label Multi-centered Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of E2007 in Patients With Parkinson's Disease With Wearing Off Motor Fluctuations and on Period Dyskinesias"|Terminated||Phase 2|185|Actual|Eisai Inc.|Due to early termination, no subjects completed this open-label extension study.|1||Due to termination of clinical program for Parkinson's Disease|f||||f||||||||||2017-10-11 02:46:57.394225|2017-10-11 02:46:57.394225
NCT01634347|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2017-05-11|||January 2012||2012-01-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Memory Reconsolidation Blockade for Treating Drug Addiction|Memory Reconsolidation Blockade for Treating Drug Addiction: a Feasibility Study|Completed||Phase 2|17|Actual|Douglas Mental Health University Institute||2|||f||||f||||||||||2017-10-11 02:46:58.305135|2017-10-11 02:46:58.305135
NCT01634334|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-04-13|||May 2012||2012-05-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ProjFreshAir||Improving Household Air Quality in Homes With Children|Innovation for Smoke-Free Homes: Real-Time Feedback|Completed||N/A|298|Actual|San Diego State University||2|||f||||t||||||||||2017-10-11 02:46:58.403735|2017-10-11 02:46:58.403735
NCT01634321|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2014-08-01|||July 2011||2011-07-01|August 2014|2014-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty|The Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty; A Single, Open, Multi-center, Prospective Study|Completed||Phase 4|63|Actual|Daewoong Pharmaceutical Co. LTD.||1|||f||||||||||||||2017-10-11 02:46:58.487996|2017-10-11 02:46:58.487996
NCT01634308|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-12|||June 2010||2010-06-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation||Completed||Phase 3|||Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-11 02:46:58.559632|2017-10-11 02:46:58.559632
NCT01634295|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-06-20|||July 2012||2012-07-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety of CKD-828 to Stage 2 Hypertension|A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of S-Amlodipine and Telmisartan(CKD-828) Versus S-Amlodipine Monotherapy in Patients With Stage 2 Hypertension|Completed||Phase 3|103|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 02:46:58.641023|2017-10-11 02:46:58.641023
NCT01634282|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-01-06|||August 2009||2009-08-01|January 2014|2014-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Along-term Study of OPC-262 in Patients With Type 2 Diabetes|A Long-term Clinical Study of OPC-262 in Patients With Type 2 Diabetes on Study (Extension From Study 262-09-001)|Completed||Phase 3|222|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-11 02:46:58.759216|2017-10-11 02:46:58.759216
NCT01634256|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-09-04|2012-07-11||February 2011||2011-02-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||A Human Trial to Evaluate the Efficacy and Safety of Fermented Turmeric in Subjects Showing Mild Hepatic Injury||Completed||Phase 2/Phase 3|60|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 02:46:58.92871|2017-10-11 02:46:58.92871
NCT01634243|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-02-03|2014-02-03||January 2005||2005-01-01|February 2014|2014-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients|A Open-label Dose-ranging Study for SPM 962 in Parkinson's Disease Patients|Completed||Phase 2|64|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:46:59.242474|2017-10-11 02:46:59.242474
NCT01634230|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-06-02||2014-06-02|June 2012||2012-06-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Emergency Use of OCR-002 in Acute Liver Failure|Emergency Use of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure|Completed||Phase 2|10|Anticipated|Ocera Therapeutics||1|||f||||f||||||||||2017-10-11 02:46:59.821981|2017-10-11 02:46:59.821981
NCT01634217|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-12-07|||November 2013||2013-11-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|September 2016|Actual|2016-09-01||Interventional|||Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation|Dose Escalation Study With Extension of Inducible Regulatory T Cells (iTregs) in Adult Patients Undergoing Non-Myeloablative HLA Identical Sibling Donor Peripheral Blood Stem Cell Transplantation|Active, not recruiting||Phase 1|16|Actual|Masonic Cancer Center, University of Minnesota||5|||f||||t||||||||||2017-10-11 02:46:59.898443|2017-10-11 02:46:59.898443
NCT01634204|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-05|||September 2011||2011-09-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|October 2012|Anticipated|2012-10-01||Interventional|||Efficacy of a Web-based Weight Loss Program|Is the Support of a Web-based Weight Loss Program Effective in Supporting Self-initiated Weight Loss and Lifestyle Changes?|Unknown status|Active, not recruiting|Phase 2|84|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:46:59.98471|2017-10-11 02:46:59.98471
NCT01634191|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-03-24|||February 2012||2012-02-01|March 2016|2016-03-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Pharmacokinetics of Apremilast (CC-10004) in Healthy Elderly Subjects|An Open-Label, Single-Dose Study to Evaluate the Effects of Age and Sex on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects|Completed||Phase 1|36|Actual|Celgene Corporation||2|||f||||f||||||||||2017-10-11 02:47:00.099485|2017-10-11 02:47:00.099485
NCT01634178|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2012-07-05|||February 2012||2012-02-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects|A Phase 1, Open-Label, Randomized, Two-Period, Two-Sequence Crossover Study to Assess the Effect of Food on the Pharmacokinetics of a Single 30 mg Tablet of Apremilast (CC-10004) in Healthy Subjects|Completed||Phase 1|46|Actual|Celgene||2|||f||||f||||||||||2017-10-11 02:47:00.217377|2017-10-11 02:47:00.217377
NCT01634165|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-10-03|2014-10-03||July 2012||2012-07-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||Participants who received at least one dose of study drug.|A Study of LY2963016 in Healthy Participants|Pharmacokinetics and Pharmacodynamics of LY2963016 Compared to Lantus® in Healthy Subjects Following Two Single Subcutaneous Doses|Completed||Phase 1|24|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 02:47:00.342019|2017-10-11 02:47:00.342019
NCT01634152|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2015-12-22|2015-11-17||July 2012||2012-07-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Treated set which included all randomised patients who were dispensed study medication and were documented to have taken at least 1 dose of investigational treatment.|Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma|A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma|Completed||Phase 3|401|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:47:02.585359|2017-10-11 02:47:02.585359
NCT01634139|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2016-06-02|2016-06-02||July 2012||2012-07-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional||Treated Set (TS): This patient set included all randomised patients who were dispensed study medication and were documented to have taken at least 1 dose of investigational treatment.|Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma|A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma|Completed||Phase 3|403|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:47:04.329316|2017-10-11 02:47:04.329316
NCT01634126|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-09-14|||August 2012||2012-08-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|MY-FIT||Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening|Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening|Completed||Early Phase 1|2761|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-11 02:47:06.753482|2017-10-11 02:47:06.753482
NCT01634113|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-06-03|2015-06-03||July 2012||2012-07-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Treated set which included all randomised patients who received at least one dose of trial medication|Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma|A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma|Completed||Phase 2|102|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:47:06.855599|2017-10-11 02:47:06.855599
NCT01634100|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2014-06-27|2014-05-16||June 2012||2012-06-01|June 2014|2014-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Treated Set. Total number of patients randomised and treated in the study.|Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid|A Randomised, Open-label, Three-way Crossover Trial to Investigate the Effect of Rifampicin and Probenecid on Empagliflozin Pharmacokinetics in Healthy Male and Female Subjects|Completed||Phase 1|18|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:47:07.871999|2017-10-11 02:47:07.871999
NCT01634087|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2013-11-26||2013-06-16|June 2012||2012-06-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||A Study of Escalating Doses of INCB039110 Administered Orally in Patients With Plaque Psoriasis|A Double-Blind, Placebo-Controlled Study Exploring the Safety, Tolerability, and Efficacy of a 28-Day Course of Escalating Doses of Oral INCB039110 in Subjects With Stable, Chronic Plaque Psoriasis|Completed||Phase 2|50|Actual|Incyte Corporation||8|||f||||f||||||||||2017-10-11 02:47:08.306922|2017-10-11 02:47:08.306922
NCT01634074|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2013-11-21|||July 2012||2012-07-01|November 2013|2013-11-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Reiterative Development and Evaluation Study of OSA Therapy System|A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)|Unknown status|Recruiting|N/A|150|Anticipated|ApniCure, Inc.|||1||f||||f||||||||||2017-10-11 02:47:08.450909|2017-10-11 02:47:08.450909
NCT01634061|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-09-10|||September 2012||2012-09-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients|Phase Ib Dose Finding Study of Abiraterone Acetate Plus BEZ235 or BKM120 in Patients With Castration-resistant Prostate Cancer.|Completed||Phase 1|43|Actual|Novartis||4|||f||||f||||||||||2017-10-11 02:47:08.565823|2017-10-11 02:47:08.565823
NCT01634048|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2016-11-18|||July 2012||2012-07-01|September 2012|2012-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ProteinRich||The Effect of Protein-enriched Diet on Body Composition and Appetite|The Effect of Protein-enriched Diet on Body Composition and Appetite|Completed||N/A|35|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 02:47:08.70751|2017-10-11 02:47:08.70751
NCT01634035|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-03|2012-07-02|||March 2009||2009-03-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients|Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients.|Completed||N/A|159|Actual|Northwell Health|||1||f||||f||||||None Retained|"     review of previous blood tests   "|||2017-10-11 02:47:08.795162|2017-10-11 02:47:08.795162
NCT01634022|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-07-02|||May 2005||2005-05-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Effectiveness of Acupuncture for Depressed Patients Not Taking Antidepressant Medications|Effectiveness of Acupuncture on Treating Major Depressive Disorder|Completed||N/A|64|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 02:47:08.913669|2017-10-11 02:47:08.913669
NCT01634009|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-09-21|||July 2012||2012-07-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Soy-Ready to Use Therapeutic Food (RUTF) in Severely Malnourished Children|Efficacy of Ready to Use Therapeutic Food Using Soy Protein Isolate in Under-5 Children With Severe Acute Malnutrition in Bangladesh|Completed||Phase 2/Phase 3|260|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-10-11 02:47:09.005055|2017-10-11 02:47:09.005055
NCT01633996|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-07-02|||August 2007||2007-08-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Effectiveness of Acupuncture for Depressed Patients Taking Antidepressant Medications|Effectiveness of Acupuncture Augmentation on Treatment Resistant Depressed Patients|Completed||N/A|45|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 02:47:09.106405|2017-10-11 02:47:09.106405
NCT01633983|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2012-07-18|||August 2012||2012-08-01|July 2012|2012-07-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|MTX4CSC||Methotrexate for Central Serous Chorioretinopathy Treatment Trial|Phase 2 Study of Escalating Oral Methotrexate for Central Serous Chorioretinopathy|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 02:47:09.212994|2017-10-11 02:47:09.212994
NCT01633970|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-07-03|||July 11, 2012|Actual|2012-07-11|July 2017|2017-07-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors||Active, not recruiting||Phase 1|240|Actual|Genentech, Inc.||6|||f||||||||||||||2017-10-11 02:47:09.334559|2017-10-11 02:47:09.334559
NCT01633957|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-07-22|||June 2012||2012-06-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|SYSU-WARFA||A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve|Academic Leader，Head of Cardiac Surgery,Principal Investigator, Clinical Professor|Recruiting||N/A|200|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 02:47:09.512331|2017-10-11 02:47:09.512331
NCT01633944|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-01-12|2015-11-03|2014-03-14|August 2012||2012-08-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Analysis based on intent-to-treat (ITT) population; all randomized subjects who received at least 1 dose of double-blind study medication. One (1) subject did not receive double-blind study medication and an additional 41 subjects from 1 site were excluded from the population.|Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects|Phase 3, Double-Blind, Placebo-Controlled, Study to Evaluate the Analgesic Efficacy, Safety, and Tolerability of Buprenorphine HCl Buccal Film in Opioid-Naive Subjects With Chronic Lower Back Pain Requiring Opioid Analgesia|Completed||Phase 3|752|Actual|BioDelivery Sciences International||2|||f||||f||||||||||2017-10-11 02:47:09.649727|2017-10-11 02:47:09.649727
NCT01633931|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-08-31|||March 2012|Actual|2012-03-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|April 2012|Actual|2012-04-01||Observational|||Treatment of Adolescent Idiopathic Scoliosis Patients Using the Ellipse MAGEC System|Treatment of Adolescent Idiopathic Scoliosis Patients Using the Ellipse MAGEC System|Active, not recruiting||N/A|20|Anticipated|Ellipse Technologies, Inc.|||1||f||||f||||||||||2017-10-11 02:47:10.591107|2017-10-11 02:47:10.591107
NCT01633918|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2015-12-07|||August 2012||2012-08-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|FeetEnergy||FeetEnergy Approach to Increase Physical Activity and Reduce Screen Time in Adolescents|Integrating Internet-supported FeetEnergy Approach in Health Education Lessons to Increase Physical Activity and Reduce Screen Time in Adolescents|Completed||N/A|1291|Actual|UKK Institute||2|||f||||f||||||||||2017-10-11 02:47:10.75204|2017-10-11 02:47:10.75204
NCT01633905|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-06-16|||December 2010||2010-12-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|ALCOLAT||Electrophysiological Correlates of Emotional and Crossmodal Stimuli Processing Among Alcohol-dependent Participants|Electrophysiological Correlates of Emotional and Crossmodal Stimuli Processing Among Alcohol-dependent Participants : Exploration of the Peripheral Presentation Effect|Completed||N/A|80|Actual|University Hospital, Lille|||2||f||||f||||||||||2017-10-11 02:47:10.852885|2017-10-11 02:47:10.852885
NCT01633892|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-04-24|2016-05-12||June 2012||2012-06-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|ARM5||Use of Concentrated Endogenous Autologous Adipose Stromal Cells in Fat Grafts for Craniofacial Trauma|Use of Concentrated Endogenous Autologous Adipose Stromal Cells in Fat Grafts for Craniofacial Trauma|Terminated||N/A|5|Actual|University of Pittsburgh||1||funding ended|f||||t||||||||Undecided||2017-10-11 02:47:10.945978|2017-10-11 02:47:10.945978
NCT01633879|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-07-03|||July 2009||2009-07-01|July 2012|2012-07-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Interventional|||Addressing Proven Factors in HIV Prevention for Latino Youth|Health and Success: Addressing Proven Factors in HIV Prevention for Latino Youth|Unknown status|Enrolling by invitation|Phase 2/Phase 3|3400|Anticipated|Education Development Center, Inc.||3|||f||||f||||||||||2017-10-11 02:47:11.186838|2017-10-11 02:47:11.186838
NCT01633866|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-08-31|||July 2012||2012-07-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Pediatric Radio Frequency Coils Generic|Pediatric Radio Frequency Coil Development on Clinical and Research MR Scanners|Recruiting||Phase 1/Phase 2|75|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||||||2017-10-11 02:47:11.258526|2017-10-11 02:47:11.258526
NCT01633853|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-01-16|2015-10-21||July 2012||2012-07-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder|Study of Vitamin D2 Virus 1,25(OH)2-Vitamin D3 in the Treatment of Chronic Kidney Disease Mineral and Bone Disease|Completed||Phase 4|204|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 02:47:11.335099|2017-10-11 02:47:11.335099
NCT01633840|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-06-29|||September 2008||2008-09-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges|New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges|Completed||N/A|275|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 02:47:11.825075|2017-10-11 02:47:11.825075
NCT01633827|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-01-11|2016-01-13||August 2012||2012-08-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||During the placebo arm, one participant did not have OSA and another exhibited predominantly central sleep apnoea; both were excluded from the analysis.|Combination Therapy to Treat Sleep Apnea|Combination Therapy for the Treatment of Obstructive Sleep Apnea|Completed||N/A|22|Actual|Brigham and Women's Hospital|The overall limitation is that we have only assessed the impact of combination therapy on one night. Thus, longitudinal studies will be needed to determine if the treatments remain effective.|2|||f||||f||||||||Undecided||2017-10-11 02:47:11.927669|2017-10-11 02:47:11.927669
NCT01633814|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-07-11|2017-05-01||September 2011|Actual|2011-09-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Total enrollment was 4 women. Study was terminated prematurely early due to poor enrollment and the fact that the PI was moving to another institution. No data was analyzed.|Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women|Influence of Hormone Replacement on Neural Cardiovascular Control in Postmenopausal Women|Terminated||N/A|4|Actual|University of Missouri-Columbia|Total enrollment was 4 women. Study was terminated prematurely early due to poor enrollment and the fact that the PI was moving to another institution. No data was analyzed.|2||PI left institution prior to completion of study. Data unavailable..|f||||t||||||||||2017-10-11 02:47:12.325925|2017-10-11 02:47:12.325925
NCT01633788|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2017-08-10|2017-08-10||August 22, 2012|Actual|2012-08-22|August 2017|2017-08-01|February 5, 2015|Actual|2015-02-05|February 5, 2015|Actual|2015-02-05||Interventional|||A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction||Completed||Phase 2|232|Actual|Allergan||4|||f||||t|t|f||||||||2017-10-11 02:47:12.621675|2017-10-11 02:47:12.621675
NCT01633775|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-07-03|||December 2007||2007-12-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Glaucoma|Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Primary Open Angle Glaucoma: a Three-year Comparative Study|Completed||N/A|100|Actual|Vanak Eye Surgery Center|||2||f||||t||||||||||2017-10-11 02:47:13.440439|2017-10-11 02:47:13.440439
NCT01633762|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-11-30|||April 2012||2012-04-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ERA||Eradication of Gut Microbiota|Eradication of Gut Microbiota - Effects on Postprandial Gut Hormone Secretion, Glucose Metabolism, Bone Metabolism and Gut Microbiome|Completed||Early Phase 1|12|Actual|University Hospital, Gentofte, Copenhagen||1|||f||||f||||||||||2017-10-11 02:47:13.584322|2017-10-11 02:47:13.584322
NCT01633749|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2012-08-03|||July 2012||2012-07-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season|Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Northern Hemisphere Season 2012/2013. An Open-label, Baseline-controlled Study in Two Age Groups: Adult Subjects ≥ 18 and ≤ 60 Years and Elderly Subjects ≥ 61 Years of Age|Completed||Phase 3|120|Actual|Abbott||1|||f||||f||||||||||2017-10-11 02:47:13.718092|2017-10-11 02:47:13.718092
NCT01633736|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-07-03|||December 2011||2011-12-01|July 2012|2012-07-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Targeted Hip Strength Training in Children With Cerebral Palsy (CP)|Targeted Hip Progressive Resistance Training to Improve Single Leg Balance and Walking in Children With Cerebral Palsy|Unknown status|Recruiting|Phase 3|20|Anticipated|University of Nottingham||1|||f||||f||||||||||2017-10-11 02:47:13.831049|2017-10-11 02:47:13.831049
NCT01633723|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2013-08-12|||August 2012||2012-08-01|August 2013|2013-08-01||||December 2013|Anticipated|2013-12-01||Interventional|||Phase I Clinical Trial of DA-6886 in Healthy Male Subjects|A Phase I, Dose Block-randomized, Double-blind, Placebo-controlled, Single/Multiple Dosing, Dose Escalation Clinical Trial With Open-labelled Food Effect Study of Single Dose to Investigate the Safety, Tolerability and Pharmacokinetics of DA-6886 After Oral Administration in Healthy Male Subjects|Unknown status|Recruiting|Phase 1|88|Anticipated|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-11 02:47:13.994827|2017-10-11 02:47:13.994827
NCT01633710|ClinicalTrials.gov processed this data on October 10, 2017|2009-07-16|2012-07-03|||May 2009||2009-05-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Multicentre Study to Investigate the Performance of the Padd Device in the Assessment of Peripheral Arterial Disease|Protocol for a Multicentre Study to Investigate the Performance of the Padd Device in the Assessment of Peripheral Arterial Disease|Terminated||N/A|86|Actual|University Hospitals, Leicester|||1|Redesigned sensor to be subjected to a new protocol|f||||f||||||||||2017-10-11 02:47:14.096703|2017-10-11 02:47:14.096703
NCT01633697|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2014-12-18|||September 2012||2012-09-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|May 2015|Anticipated|2015-05-01||Interventional|||Study of the Effects of Education on Patients With Chronic Obstructive Pulmonary Disease|Study of the Effects of Education on Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|42|Anticipated|University of Vermont||2|||f||||t||||||||||2017-10-11 02:47:14.19346|2017-10-11 02:47:14.19346
NCT01633684|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-10-30|||August 2012||2012-08-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Type 1 Diabetes Mellitus Effect on Bone Mineral Density|Type 1 DM Effect on BMD: a Longitudinal Study in Adults|Completed||N/A|123|Actual|Creighton University|||2||f||||f||||||Samples Without DNA|"     We will be storing serum samples. No genetic tests will be performed on these.   "|||2017-10-11 02:47:14.323714|2017-10-11 02:47:14.323714
NCT01633671|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-07-04|||November 2008||2008-11-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||NT-proBNP as a Tool for the Detection of Acute Pulmonary Artery Embolism (APE)|NT-proBNP: a Useful Tool for the Detection of Acute Pulmonary Artery Embolism in Post-surgical Patients|Completed||N/A|44|Actual|University of Ulm|||1||f||||f||||||||||2017-10-11 02:47:14.416467|2017-10-11 02:47:14.416467
NCT01633463|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-07-03|||April 2011||2011-04-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||An Observational Study of Pain Assessment and Treatment Adequacy of Emergency Cancer Pain|A Prospective Observational Study of Assessment of Pain and Its Treatment Adequacy in Emergency Department at Tertiary Care Cancer Hospital.|Completed||N/A|100|Actual|Tata Memorial Hospital|||1||f||||f||||||||||2017-10-11 02:47:17.023356|2017-10-11 02:47:17.023356
NCT01633658|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2013-05-27|||November 2012||2012-11-01|May 2013|2013-05-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3|The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3 Compared to Native Vitamin D3: A Short Term Pharmacokinetic Study|Withdrawn||N/A|0|Actual|Creighton University||2||Protocol has changed|f||||f||||||||||2017-10-11 02:47:14.517897|2017-10-11 02:47:14.517897
NCT01633645|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-09-25|||June 2009||2009-06-01|September 2015|2015-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II, Open-Label Trial of Bortezomib (VELCADE®) in Combination With Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|53|Actual|University Hospital of Crete||1|||f||||f||||||||||2017-10-11 02:47:14.824822|2017-10-11 02:47:14.824822
NCT01633632|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2015-12-10|||August 2012||2012-08-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Hatha Yoga for Smoking Cessation|Hatha Yoga as an Adjunct to Cognitive Behavioral Therapy for Smoking Cessation|Completed||N/A|67|Actual|Creighton University||3|||f||||f||||||||||2017-10-11 02:47:14.961036|2017-10-11 02:47:14.961036
NCT01633619|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2012-07-03|||January 2013||2013-01-01|July 2012|2012-07-01||||January 2015|Anticipated|2015-01-01||Observational|EICS||European Implant Cohort Study|European Implant Cohort Study|Unknown status|Not yet recruiting|N/A|4000|Anticipated|Centre Hospitalier Universitaire Vaudois|||1||f||||t||||||||||2017-10-11 02:47:15.082792|2017-10-11 02:47:15.082792
NCT01633606|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-02|2014-01-28|||February 2013||2013-02-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Drawing the Line Between Medium Care and Intensive Care. A Prospective Observational Study Based on the Nursing Activities Score|Drawing the Line Between Medium Care and Intensive Care. A Prospective Observational Study Based on the Nursing Activities Score|Completed||N/A|1000|Anticipated|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-11 02:47:15.18506|2017-10-11 02:47:15.18506
NCT01633593|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2015-12-20|||August 2012||2012-08-01|December 2015|2015-12-01|August 2018|Anticipated|2018-08-01|December 2015|Actual|2015-12-01||Interventional|||Treatment of Delirium in the Elderly With Donepezil: a Double-blind, Randomized, Placebo-controlled Clinical Trial|Treatment of Delirium in the Elderly With Donepezil: a Double-blind, Randomized, Placebo-controlled Clinical Trial|Terminated||Phase 4|19|Actual|University of Sao Paulo||2||Difficulty in recruiting subjects for the trial.|f||||f||||||||||2017-10-11 02:47:15.268945|2017-10-11 02:47:15.268945
NCT01633580|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2014-12-02|||December 2011||2011-12-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists|Follicular Phase Endocrine Characteristics During Ovarian Stimulation and GnRH Antagonist Co-treatment for IVF; Randomized Trial Comparing Corifollitropin Alfa (Elonva) Initiated on Cycle Day 2 or 4.|Completed||Phase 4|67|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 02:47:15.379601|2017-10-11 02:47:15.379601
NCT01633567|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-05-03|||May 2012|Actual|2012-05-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Culturally Targeted & Individually Tailored Smoking Cessation Study: LGBT Smokers|A Culturally Targeted and Individually Tailored Smoking Cessation Intervention for LGBT Smokers|Completed||N/A|400|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||No||2017-10-11 02:47:15.639528|2017-10-11 02:47:15.639528
NCT01633554|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-01|2012-07-03|||January 2011||2011-01-01|July 2012|2012-07-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Observational|||ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B|The Ability of Prediction of Fibrosis for ST-2 as a Non-invasive Marker in Chronic Hepatitis B|Unknown status|Recruiting|N/A|95|Anticipated|Turkiye Yuksek Ihtisas Education and Research Hospital|||3||f||||t||||||||||2017-10-11 02:47:15.791775|2017-10-11 02:47:15.791775
NCT01633541|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-09-14|||March 2012||2012-03-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer|UMCC 2010.101 Concomitant Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Bio-selection For Organ Preservation In Patients With Advanced Laryngeal Cancer|Recruiting||Phase 2|52|Anticipated|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 02:47:15.916828|2017-10-11 02:47:15.916828
NCT01633528|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-01-15|||May 2012||2012-05-01|March 2012|2012-03-01|February 2015|Actual|2015-02-01|September 2012|Actual|2012-09-01||Interventional|||The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy|To Evaluate the Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy in Frozen Embryo Transfer Cycles|Completed||Phase 3|60|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 02:47:16.077131|2017-10-11 02:47:16.077131
NCT01633515|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-09|2013-12-02|||July 2012||2012-07-01|December 2013|2013-12-01|July 2014|Anticipated|2014-07-01|April 2014|Anticipated|2014-04-01||Interventional|||Intralesional Cryosurgery for Basal Cell Carcinoma - a Feasibility Study|Intralesional Cryosurgery for the Treatment of Basal Cell Carcinoma of the Lower Extremities in the Elderly - a Feasibility Study|Unknown status|Recruiting|N/A|10|Anticipated|Carmel Medical Center||1|||f||||f||||||||||2017-10-11 02:47:16.23058|2017-10-11 02:47:16.23058
NCT01633502|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-12-13|||December 2012||2012-12-01|December 2012|2012-12-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|DanShock||Danish Cardiogenic Shock Trial|Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial|Recruiting||Phase 3|360|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 02:47:16.389429|2017-10-11 02:47:16.389429
NCT01633489|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-02-17|||December 2012||2012-12-01|February 2017|2017-02-01|June 2029|Anticipated|2029-06-01|June 2029|Anticipated|2029-06-01|15 Years|Observational [Patient Registry]|ALX-LALD-501||Lysosomal Acid Lipase (LAL) Deficiency Registry|An Observational Disease and Clinical Outcomes Registry of Patients With Lysosomal Acid Lipase (LAL) Deficiency|Recruiting||N/A|1000|Anticipated|Alexion Pharmaceuticals|||1||f||||f||||||||No||2017-10-11 02:47:16.612647|2017-10-11 02:47:16.612647
NCT01633476|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-11-29|||July 2013||2013-07-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|February 2016|Actual|2016-02-01||Interventional|CANVAS||CMV Modulation of the Immune System in ANCA-associated Vasculitis|Does CMV Reactivation Cause Functional Impairment of CMV Specific CD4+ T-cells? The Potential for Valaciclovir to Prevent CMV-mediated Adverse Modulation of the Immune System in Patients With ANCA-associated Vasculitis|Active, not recruiting||Phase 2|38|Actual|University of Birmingham||2|||f||||f||||||||||2017-10-11 02:47:16.848334|2017-10-11 02:47:16.848334
NCT01633450|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2013-06-06|||June 2012||2012-06-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Zinc Absorption From Biofortified Rice|Bioavailability of Zinc From Rice Biofortified With 70Zn and Rice Extrinsically Labeled With 70Zn in Young Adults: a Randomized, Single-blind Study|Completed||N/A|16|Actual|Swiss Federal Institute of Technology||2|||f||||||||||||||2017-10-11 02:47:17.117552|2017-10-11 02:47:17.117552
NCT01633437|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-06-29|||September 2010||2010-09-01|June 2012|2012-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|CX157-112||Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers|A Phase I, Multiple-Dose, Randomized, Double-Blind, Oral Tyramine Pressor Response Study Comparing CX157 Tablets to Placebo in Healthy Male Volunteers|Completed||Phase 1|12|Actual|CeNeRx BioPharma Inc.||2|||f||||f||||||||||2017-10-11 02:47:17.247241|2017-10-11 02:47:17.247241
NCT01633424|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2013-08-27|||October 2011||2011-10-01|August 2013|2013-08-01||||October 2016|Anticipated|2016-10-01||Observational|||"The Stanford Integrated Psychosocial Assessment for Transplant (SIPAT)"|"The Stanford Integrated Psychosocial Assessment for Transplant (SIPAT): Psychometric Characteristics of a New Scale for the Prediction of Post-transplant Psychosocial and Medical Outcomes."|Unknown status|Active, not recruiting|N/A|600|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 02:47:17.392177|2017-10-11 02:47:17.392177
NCT01633411|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-04-24|||December 2011||2011-12-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|||Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium|Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium|Completed||Phase 1|39|Actual|C2 Therapeutics, Inc.|||3||f||||t||||||||||2017-10-11 02:47:17.501666|2017-10-11 02:47:17.501666
NCT01633398|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2016-10-04|||September 2012||2012-09-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|ASIANHF||ASIAN HF Registry, A Prospective Observational Study|Asian Sudden Cardiac Death in Heart Failure(ASIAN-HF) Prospective Observational Study|Recruiting||N/A|8000|Anticipated|National University Health System, Singapore|||1||f||||f||||||||||2017-10-11 02:47:17.676404|2017-10-11 02:47:17.676404
NCT01633385|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2013-04-03|||April 2012||2012-04-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|FRABO-02||Bronchial Inflammation in Patients With Bronchiolithis Obliterans|Lung Function and Bronchial Inflammation in Patients With Bronchiolithis Obliterans|Completed||N/A|37|Actual|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples With DNA|"     blood, sputum cells, sputum supernatans   "|||2017-10-11 02:47:17.872427|2017-10-11 02:47:17.872427
NCT01633372|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-08-10||2014-03-26|April 2012||2012-04-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2013|Actual|2013-12-01||Interventional|||An Open Label Study of INCB039110 Administered Orally in Patients With Myelofibrosis|An Open-Label, Multiple Simon 2-Stage Study of INCB039110 Administered Orally to Subjects With Primary Myelofibrosis (PMF), Post Polycythemia Vera Myelofibrosis (PPV-MF) or Post Essential Thrombocythemia Myelofibrosis (PET-MF)|Active, not recruiting||Phase 2|125|Anticipated|Incyte Corporation||5|||f||||f||||||||||2017-10-11 02:47:17.992588|2017-10-11 02:47:17.992588
NCT01633359|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-07-04|||July 2012||2012-07-01|July 2012|2012-07-01|May 2013|Anticipated|2013-05-01|December 2012|Anticipated|2012-12-01||Interventional|VSEL-CAD||The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients|The Randomly Controlled Clinical Trial of the Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients|Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Beijing Anzhen Hospital||2|||f||||t||||||||||2017-10-11 02:47:18.212587|2017-10-11 02:47:18.212587
NCT01633346|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-11-10|||June 2010||2010-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|July 2016|Actual|2016-07-01||Observational|||Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients|Regulation of the Immune System in Response to the Treatment With Tocilizumab in RA Patients|Completed||N/A|50|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||||||2017-10-11 02:47:18.351644|2017-10-11 02:47:18.351644
NCT01633333|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2014-02-11|||June 2012||2012-06-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Water Exchange Versus Carbon Dioxide for Colonoscopy|Water Exchange Versus Carbon Dioxide Insufflation to Improve Colonoscopy Screening - a Randomized Controlled Trial|Completed||N/A|473|Actual|Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-11 02:47:18.462742|2017-10-11 02:47:18.462742
NCT01633320|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-11-13|2012-08-06||July 2012||2012-07-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Non-invasive Assessment of Immediate Postoperative Analgesia Using Analgesia/Nociception Index (ANI)|Non-invasive Assessment of Immediate Postoperative Analgesia Using Analgesia/Nociception Index (ANI): A Prospective and Observational Study|Completed||N/A|200|Actual|Hôpital Edouard Herriot|||1||f||||t||||||||||2017-10-11 02:47:18.629665|2017-10-11 02:47:18.629665
NCT01633307|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-07-03|||January 2007||2007-01-01|June 2012|2012-06-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|PERMI||Decrease the Frequency of Inappropriate Intravenous Lines in Internal Medicine|Effect of a Nationwide Teaching Program on the Frequency of Inappropriate Intravenous Lines in Internal Medicine: A Randomized Controlled Trial|Completed||Phase 4|59|Actual|Hopital Lariboisière||2|||f||||t||||||||||2017-10-11 02:47:18.992247|2017-10-11 02:47:18.992247
NCT01633294|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-23|2016-11-24|||October 2008||2008-10-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term|Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term - a Randomized Controlled Trial|Completed||Phase 2/Phase 3|161|Actual|Hospital de Santa Maria, Portugal||2|||f||||f||||||||||2017-10-11 02:47:19.065829|2017-10-11 02:47:19.065829
NCT01633281|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2015-11-18|||June 2012||2012-06-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Acupuncture for Peripheral Neuropathy|A Study of Acupuncture for Bortezomib or Thalidomide -Induced Peripheral Neuropathy in Patients With Multiple Myeloma or Lymphoma|Terminated||Phase 2|8|Actual|Singapore General Hospital||1||poor recruitment and expiry of funding|f||||f||||||||||2017-10-11 02:47:19.162918|2017-10-11 02:47:19.162918
NCT01633268|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2017-07-11|||June 1, 2012||2012-06-01|July 6, 2017|2017-07-06||||||||Observational|||Estimating Brain Biomechanics Using MRI|Estimation of Brain Biomechanics Using MRI|Recruiting||N/A|90|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:47:19.250038|2017-10-11 02:47:19.250038
NCT01633255|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2017-06-30|||April 18, 2012||2012-04-18|April 23, 2014|2014-04-23|April 23, 2014|Actual|2014-04-23|April 23, 2014|Actual|2014-04-23||Interventional|||[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment|A Pilot, Open-label, Proof-of-Concept Study of the Use of [18F] Fluciclatide PET/CT Imaging in the Evaluation of Anti-AngiogenicTherapy in Renal Cancers|Withdrawn||Phase 1/Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:47:19.33272|2017-10-11 02:47:19.33272
NCT01633242|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2017-06-30|||February 24, 2012||2012-02-24|October 11, 2016|2016-10-11|October 11, 2016||2016-10-11|||||Observational|||Heart Imaging in Children With Muscular Dystrophy|A Pilot Study of Cardiac Magnetic Resonance in Patients With Muscular Dystrophy|Terminated||N/A|2|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:47:19.548215|2017-10-11 02:47:19.548215
NCT01633229|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2017-06-30|||November 8, 2011||2011-11-08|May 10, 2017|2017-05-10|July 11, 2013|Actual|2013-07-11|July 1, 2013|Actual|2013-07-01||Interventional|||Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications|A Phase I Study of Bone Marrow Stromal Cell Infusions to Treat Acute Graft Versus Host Disease, Marrow Failure and Tissue Injury After Allogeneic Stem Cell Transplantation|Completed||Phase 1|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:47:19.620928|2017-10-11 02:47:19.620928
NCT01633216|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2013-01-06|||May 2012||2012-05-01|June 2012|2012-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Poliovirus Vaccine Trial in Bangladesh|Assessment of the Immunogenicity of Three Doses of Bivalent, Trivalent or Type One Monovalent Oral Poliovirus Vaccines Provided at 2 or 4 Week Intervals|Completed||Phase 4|1000|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||5|||f||||t||||||||||2017-10-11 02:47:19.725087|2017-10-11 02:47:19.725087
NCT01633203|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-30|2017-03-06|||August 2010||2010-08-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Observational|PRECISO||Observational Study of Perioperative Chemotherapy in Gastric Cancer|Prospective Observational Study of Patients With Locally Advanced Gastric Cancer Treated With Perioperative Chemotherapy and Surgery|Active, not recruiting||N/A|61|Actual|Grupo Oncologico Cooperativo Chileno de Investigation|||1||f||||f|f|f||||||Yes|IPD are planned to be shared once the final results have been published, foreseen for 2018, data include all datapoints incorporated in the anonymized data base. The investigators who wish to use the data should submit the protocol (approved by an IRB) and the request to access the database to GOCCHI (admin@gocchi.org)|2017-10-11 02:47:19.86287|2017-10-11 02:47:19.86287
NCT01633190|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-03-15|||March 2012||2012-03-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)|Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT): Assessment of Hospitalizations and Emergency Department Visits - the Impact of Publicly Funded Vaccine Programs in Canada|Recruiting||N/A|2500|Anticipated|Canadian Paediatric Society|||1||f||||f||||||||No||2017-10-11 02:47:19.981553|2017-10-11 02:47:19.981553
NCT01633177|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-06-02|||September 2010||2010-09-01|June 2014|2014-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes|Diabetes Prevention in the Vitamin D and Omega-3 Trial|Unknown status|Active, not recruiting|N/A|25875|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:47:20.18346|2017-10-11 02:47:20.18346
NCT01633164|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-01-30|||April 2012||2012-04-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Re-Inventing Yourself After Spinal Cord Injury|Re-Inventing Yourself After SCI: A Site-Specific Randomized Clinical Trial|Active, not recruiting||N/A|81|Actual|Craig Hospital||2|||f||||f||||||||||2017-10-11 02:47:20.336402|2017-10-11 02:47:20.336402
NCT01633151|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2013-09-29|||June 2012||2012-06-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Validation Study for an Unobtrusive Online Sleep Measurement System|Validation Study for an Unobtrusive Online Sleep Measurement System|Completed||N/A|20|Actual|Beddit.com Ltd|||1||f||||f||||||||||2017-10-11 02:47:20.444362|2017-10-11 02:47:20.444362
NCT01633138|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2015-07-16|||September 2012||2012-09-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Performance-based Reinforcement to Enhance Cognitive Remediation Therapy|Pilot Study of Performance-based Reinforcement to Enhance Cognitive Remediation Therapy for Substance Users|Completed||Phase 1|40|Actual|Yale University||2|||f||||t||||||||||2017-10-11 02:47:20.530332|2017-10-11 02:47:20.530332
NCT01633125|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-07-03|||April 2012||2012-04-01|June 2012|2012-06-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Group Music Therapy for Chinese Prisoners|Group Music Therapy for Chinese Prisoners: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|192|Anticipated|Aalborg University||2|||f||||||||||||||2017-10-11 02:47:20.607126|2017-10-11 02:47:20.607126
NCT01633112|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-04-03|||August 9, 2012|Actual|2012-08-09|April 2017|2017-04-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone|A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis|Active, not recruiting||Phase 4|1064|Actual|Novartis||3|||f||||f||||||||||2017-10-11 02:47:20.693558|2017-10-11 02:47:20.693558
NCT01633086|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-03-11|||July 2012||2012-07-01|March 2015|2015-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Painful Diabetic Neuropathy|A Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Painful Diabetic Neuropathy|Completed||Phase 2|24|Actual|China Medical University Hospital||2|||f||||f||||||||||2017-10-11 02:47:22.749226|2017-10-11 02:47:22.749226
NCT01632709|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2015-07-20|2015-06-01||May 2012||2012-05-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|PPAP||Pathophysiology of Post Amputation Pain|Pathophysiology of Post Amputation Pain|Completed||Phase 4|16|Actual|Shirley Ryan AbilityLab||4|||f||||f||||||||||2017-10-11 02:47:28.555743|2017-10-11 02:47:28.555743
NCT01633073|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-10-01|||June 2012||2012-06-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Comparison of the Laryngeal Mask Airway (LMA) Supreme and I-gel in Children|A Randomized Trial Comparing the Laryngeal Mask Airway-SupremeTM With the i-gelTM in Children|Completed||N/A|170|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 02:47:22.84145|2017-10-11 02:47:22.84145
NCT01633060|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-09-12|||October 3, 2012|Actual|2012-10-03|September 2017|2017-09-01|October 18, 2017|Anticipated|2017-10-18|October 18, 2017|Anticipated|2017-10-18||Interventional|BELLE-3||A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi|A Phase III Randomized, Double Blind, Placebo Controlled Study of BKM120 With Fulvestrant, in Postmenopausal Women With Hormone Receptor-positive HER2-negative AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTOR Inhibitor Based Treatment|Active, not recruiting||Phase 3|432|Actual|Novartis||2|||f||||t||||||||||2017-10-11 02:47:22.97221|2017-10-11 02:47:22.97221
NCT01633047|ClinicalTrials.gov processed this data on October 10, 2017|2012-07-03|2015-07-16|||June 2015||2015-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Electrostimulation in Anterior Cruciate Ligament Reconstruction|Effects of Low Frequency Neuromuscular Electrical Stimulation Applied to the Quadriceps in the Production of Knee Extension Strength and Control of Edema After Anterior Cruciate Ligament Reconstruction|Completed||N/A|24|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 02:47:23.617074|2017-10-11 02:47:23.617074
NCT01633034|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-12-23|||January 2011||2011-01-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Observational|||Tissue Collection for Understanding Intervertebral Disc Degeneration and Back Pain|Tissue Collection for Understanding Intervertebral Disc Degeneration and Back Pain|Recruiting||N/A|200|Anticipated|Northwell Health|||1||f||||f||||||Samples Without DNA|"     Intervertebral disc tissue Spinal Ligament Tissue Blood serum   "|No||2017-10-11 02:47:23.692833|2017-10-11 02:47:23.692833
NCT01633021|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-10-05|||June 13, 2012||2012-06-13|August 3, 2017|2017-08-03||||||||Observational|||Developing the Family Map: Looking at Communal Coping|Development of the Family Map: Examination of Communal Coping Across Disease Context|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:47:23.769981|2017-10-11 02:47:23.769981
NCT01633008|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-10-05|||June 15, 2012||2012-06-15|January 10, 2017|2017-01-10|January 10, 2017|Actual|2017-01-10|May 1, 2014|Actual|2014-05-01||Interventional|||Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain|Acceptance and Commitment Therapy for Adolescents and Adults With Neurofibromatosis Type 1 and Chronic Pain: A Pilot Study|Completed||Early Phase 1|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:47:23.84769|2017-10-11 02:47:23.84769
NCT01632995|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-01-30|2016-11-16||October 2012||2012-10-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics|Implementation of HIV Pre-exposure Prophylaxis (PrEP): A Demonstration Project|Completed||N/A|557|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 02:47:23.946025|2017-10-11 02:47:23.946025
NCT01632982|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-09-13|||July 2013||2013-07-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|November 2016|Actual|2016-11-01||Interventional|MobileMMT||Mobile Psychosocial Interventions for MMT Clients|Providing Psychosocial Interventions to Substance Abusers Via Mobile Technology|Active, not recruiting||N/A|219|Anticipated|National Development and Research Institutes, Inc.||3|||f||||f||||||||||2017-10-11 02:47:24.492501|2017-10-11 02:47:24.492501
NCT01632969|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2015-03-04|||June 2012||2012-06-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Improving End of Life Care in Head and Neck Cancer|Improving End of Life Care in Head and Neck Cancer|Terminated||N/A|2|Actual|Memorial Sloan Kettering Cancer Center|||1|Lack of accrual|f||||||||||||||2017-10-11 02:47:24.621851|2017-10-11 02:47:24.621851
NCT01632956|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2014-02-05|||June 2012||2012-06-01|February 2014|2014-02-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer|Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer: A Pilot Study|Withdrawn||N/A|0|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 02:47:24.766085|2017-10-11 02:47:24.766085
NCT01632943|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-02-03|||October 2013||2013-10-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|HTN-India||Single-arm Study of Symplicity™ Renal Denervation System in Patients With Uncontrolled HyperTensioN in India|A Prospective, Multi-center, Non-randomized, Controlled Trial in India to Evaluate Efficacy and Safety of Renal Denervation in the Treatment of Uncontrolled Hypertension|Terminated||N/A|14|Actual|Medtronic Vascular||1||Study Enrollment was stopped pending review of another study in the same therapeutic area.|f||||f||||||||||2017-10-11 02:47:24.891506|2017-10-11 02:47:24.891506
NCT01632930|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-08-17|||July 2, 2012|Actual|2012-07-02|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|June 2020|Anticipated|2020-06-01||Interventional|||Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis|Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis|Active, not recruiting||N/A|962|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:47:24.981726|2017-10-11 02:47:24.981726
NCT01632917|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-09-24|||June 2012||2012-06-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Open-Label Pharmacokinetic Study of Final Formulations of ATX-101|Phase 1, Open-Label, Randomized, Safety and Pharmacokinetic Study of Two Final Formulations of ATX-101 (Sodium Deoxycholate Injection) Following Subcutaneous Injections in the Submental Fat|Completed||Phase 1|24|Actual|Kythera Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 02:47:25.114363|2017-10-11 02:47:25.114363
NCT01632904|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-08-01|2015-03-26|2014-04-03|June 2012||2012-06-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|March 2014|Actual|2014-03-01||Interventional|||Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study|Polycythemia Vera Symptom Study Evaluating Ruxolitinib Versus Hydroxyurea in a Randomized, Multicenter, Double-Blind, Double-Dummy, Phase 3 Efficacy and Safety Study of Patient Reported Outcomes|Completed||Phase 3|110|Actual|Incyte Corporation||2|||f||||f||||||||||2017-10-11 02:47:25.21118|2017-10-11 02:47:25.21118
NCT01632137|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-04-17||2014-04-17|June 2012||2012-06-01|April 2014|2014-04-01||||June 2013|Actual|2013-06-01||Interventional|||Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome|A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome|Completed||Phase 3|564|Actual|Acucela Inc.||2|||f||||f||||||||||2017-10-11 02:47:37.692186|2017-10-11 02:47:37.692186
NCT01632878|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-04-04|2015-12-22||July 2012||2012-07-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study|Omacor Plus Standard Therapies In Post MI Subjects Evaluation: The OPTIMISE Study|Completed||N/A|1531|Actual|Mylan Inc.|Adverse Events (non-serious) were not monitored in this observational study. This explains why 0/0 was reported||1||f||||f||||||||||2017-10-11 02:47:26.038296|2017-10-11 02:47:26.038296
NCT01632865|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-01-23|||April 2013|Actual|2013-04-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Recanalization and Stenting for Non-acute Veterbrobasilar Artery Occlusion|Recanalization and Stenting for Subacute and Chronic Veterbrobasilar Artery Occlusion|Completed||N/A|60|Actual|Zhengzhou University||1|||f||||t||||||||||2017-10-11 02:47:26.319551|2017-10-11 02:47:26.319551
NCT01632852|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2015-10-08|||July 2012||2012-07-01|October 2015|2015-10-01||||August 2015|Actual|2015-08-01||Interventional|||A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission|A Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients With CD123+ Acute Myeloid Leukemia in Complete Remission or Complete Remission With Incomplete Platelet Recovery at High Risk for Early Relapse|Completed||Phase 1|30|Actual|CSL Limited||1|||f||||t||||||||||2017-10-11 02:47:26.40419|2017-10-11 02:47:26.40419
NCT01632839|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-04-05|||January 2013||2013-01-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Psychometric Validation of a French Version of the PISQ-R and a New Questionnaire About Sexuality|Psychometric Validation of a French Version of the PISQ-R and a New Questionnaire About Sexuality: Tools for Evaluating Sexuality in Patients With From Urinary Incontinence or Pelvic Organ Prolapse|Active, not recruiting||N/A|298|Actual|Centre Hospitalier Universitaire de Nīmes|||8||f||||f||||||||||2017-10-11 02:47:26.651248|2017-10-11 02:47:26.651248
NCT01632826|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-04-24||||||April 2017|2017-04-01||||||||Expanded Access|PEXIUS||Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma|A Multicenter, Single-Arm, Open-Label Treatment Use Protocol for Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma|Approved for marketing||N/A|||Celgene|||||||||||||||||||2017-10-11 02:47:26.795493|2017-10-11 02:47:26.795493
NCT01632813|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2016-01-07|||July 2012||2012-07-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|Leuven-GID||Leuven Growing Into Deficit Follow-up Study|Neurocognitive Development in Children With Congenital Heart Disease: Growing Into Deficit|Completed||N/A|172|Actual|Katholieke Universiteit Leuven|||2||f||||f||||||||||2017-10-11 02:47:26.983382|2017-10-11 02:47:26.983382
NCT01632800|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-17|2016-05-07|2016-05-07||August 2011||2011-08-01|May 2016|2016-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Sensory Effects of Rapidly-Changing Magnetic Fields|Sensory Effects of Rapidly-Changing Magnetic Fields|Completed||N/A|26|Actual|Weinberg Medical Physics LLC||1|||f||||t||||||||No||2017-10-11 02:47:27.085155|2017-10-11 02:47:27.085155
NCT01632787|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2015-12-08|||April 2012||2012-04-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Observational|VH||Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria|Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria|Recruiting||N/A|100|Anticipated|Vision Specialists of Birmingham|||1||f||||f||||||||||2017-10-11 02:47:27.366218|2017-10-11 02:47:27.366218
NCT01632774|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-07-02|||January 1990||1990-01-01|June 2012|2012-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Observational|||Analysis of Risk Factors for Death After Blunt Traumatic Rupture of the Thoracic Aorta|Analysis of Risk Factors for Death After Blunt Traumatic Rupture of the Thoracic Aorta|Completed||N/A|85|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 02:47:27.4682|2017-10-11 02:47:27.4682
NCT01632761|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2017-02-01|||November 2012||2012-11-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia|Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia in the Elderly|Enrolling by invitation||N/A|2000|Anticipated|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 02:47:27.545071|2017-10-11 02:47:27.545071
NCT01632748|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2012-09-20|||June 2012||2012-06-01|June 2012|2012-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Validation Study in Healthy Female Volunteers: A Comparison of Two Neurotech Vital Devices Set up to Provide Different Types of Electrical Stimulation|Validation Study in Healthy Female Volunteers: A Comparison of Two Neurotech Vital Devices Set up to Provide Different Types of Electrical Stimulation|Completed||Phase 1|20|Actual|Bio-Medical Research, Ltd.||2|||f||||f||||||||||2017-10-11 02:47:27.690582|2017-10-11 02:47:27.690582
NCT01632735|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-29|2015-07-28|2015-06-22||February 2012||2012-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional||This study included 80 substance abusing youth who completed treatment and participated in a pilot aftercare project called Project ESQYIR (Educating & Supporting inquisitive Youth in Recovery). Youth were randomized to the mobile aftercare intervention (n=40) or aftercare as usual control (n=40).|Mobile Continuing Care Approach for Youth|Mobile Continuing Care Approach for Youth|Completed||N/A|80|Actual|Azusa Pacific University|Pilot study limiting number of participants recruited.|2|||f||||t||||||||||2017-10-11 02:47:27.77973|2017-10-11 02:47:27.77973
NCT01632722|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-01-10|||June 2012||2012-06-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets|A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases (APPROACH)|Active, not recruiting||Phase 2|218|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:47:28.42878|2017-10-11 02:47:28.42878
NCT00005403|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||February 1991||1991-02-01|June 2000|2000-06-01|January 1993|Actual|1993-01-01|||||Observational|||Heart Disease and the Black Health Disadvantage||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:06.24471|2017-10-11 04:28:06.24471
NCT01632696|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-07-07|||June 2012||2012-06-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors|Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors|Terminated||Early Phase 1|11|Actual|Peregrine Pharmaceuticals||1||Sponsor decision|f||||f||||||||||2017-10-11 02:47:29.377229|2017-10-11 02:47:29.377229
NCT01632683|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-10-13|2014-09-30||May 2013||2013-05-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|STAGE||STorz Against Glidescope Effectiveness|Comparative Effectiveness of the C-MAC D-blade to Glidescope Videolaryngoscope in the Predicted Difficult Airway|Completed||N/A|1100|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 02:47:29.465739|2017-10-11 02:47:29.465739
NCT01632670|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2013-10-27|||June 2012||2012-06-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|FEAT||Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy|FEAT: Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy|Completed||Phase 4|70|Anticipated|North Texas Veterans Healthcare System||2|||f||||f||||||||||2017-10-11 02:47:29.692819|2017-10-11 02:47:29.692819
NCT01632657|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-05-10|||June 2012||2012-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy|Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy|Recruiting||N/A|92|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 02:47:29.78125|2017-10-11 02:47:29.78125
NCT01632644|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-09-03|||July 2012||2012-07-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Identifying Skin Biopsy Sites|Pilot Study of Skin Biopsy Sites: A Consensus Approach Based on Patient and Physician Interviews|Completed||N/A|59|Actual|Northwestern University|||2||f||||t||||||||||2017-10-11 02:47:29.862915|2017-10-11 02:47:29.862915
NCT01632631|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-08-11|||February 2013||2013-02-01|August 2015|2015-08-01|October 2015|Anticipated|2015-10-01|June 2014|Actual|2014-06-01||Observational|||Patient-specific Virtual Reality Rehearsal Prior to EVAR: Influence on Technical and Non-technical Operative Performance|Patient-specific Virtual Reality Rehearsal Prior to EVAR: Influence on Technical and Non-technical Operative Performance. A Randomized Controlled Trial.|Unknown status|Active, not recruiting|N/A|100|Anticipated|University Hospital, Ghent|||2||f||||f||||||||||2017-10-11 02:47:29.935587|2017-10-11 02:47:29.935587
NCT01632618|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-09-20|||May 2007||2007-05-01|September 2016|2016-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Trunk Muscle Training and Neuromuscular Electrical Stimulation to Improve Function in Older Adults With Chronic Low Back Pain|Trunk Muscle Training and Neuromuscular Electrical Stimulation to Improve Function in Older Adults With Chronic Low Back Pain|Completed||Phase 1|64|Actual|University of Delaware||2|||f||||f||||||||||2017-10-11 02:47:30.015229|2017-10-11 02:47:30.015229
NCT01632605|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2012-06-28|||November 2009||2009-11-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|RAP||The Vienna RAP Pilot Study|Rapamycin in Advanced Polycystic Kidney Disease Pilot Study|Completed||N/A|8|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 02:47:30.082199|2017-10-11 02:47:30.082199
NCT01632592|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-01-23|||January 2014||2014-01-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue|Abdominal Obesity, Cardiovascular Inflammation, and Effects of a Growth Hormone Releasing Hormone Analogue to Reduce Inflammation|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||2||No funding available|f||||t||||||||||2017-10-11 02:47:30.175888|2017-10-11 02:47:30.175888
NCT01632566|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-04-30|||June 2012||2012-06-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Multiple-dose Study of LY3031207 in Healthy Participants|A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3031207 in Healthy Subjects|Terminated||Phase 1|90|Anticipated|Eli Lilly and Company||4||"Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some   participants."|f||||f||||||||||2017-10-11 02:47:30.506177|2017-10-11 02:47:30.506177
NCT01632553|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-12-04|||August 2012||2012-08-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|CEASE||Cortisol Evaluation in Abuse Survivors|Longitudinal Measurement of Cortisol in Association With Mental Health and Experience of Domestic Violence and Abuse|Completed||N/A|214|Actual|University of Bristol|||2||f||||f||||||Samples Without DNA|"     Saliva   "|||2017-10-11 02:47:30.614397|2017-10-11 02:47:30.614397
NCT01632540|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-04-14|||July 2012||2012-07-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01|6 Months|Observational [Patient Registry]|BALANCE||Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis|Investigation of the Real World Effectiveness of Beclomethasone Dipropionate (BDP) Nasal Aerosol in Perennial Allergic Rhinitis (PAR) Patients|Completed||N/A|824|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-10-11 02:47:30.74902|2017-10-11 02:47:30.74902
NCT01632527|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-09-10|||June 2012||2012-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)|Phase I/II Study of the Safety and Preliminary Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration|Completed||Phase 1/Phase 2|15|Actual|StemCells, Inc.||1|||f||||t||||||||||2017-10-11 02:47:30.942812|2017-10-11 02:47:30.942812
NCT01632514|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-05-10|||June 2012||2012-06-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Vitamin D Deficiency and Postoperative Hypocalcemia|Correction of Vitamin D Deficiency to Prevent Postoperative Hypocalcemia After Thyroidectomy|Active, not recruiting||Phase 4|90|Anticipated|University of Sao Paulo General Hospital||3|||f||||f||||||||||2017-10-11 02:47:31.06449|2017-10-11 02:47:31.06449
NCT00006497|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2008-08-20|||September 2000||2000-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Long-Term Effects of Subclinical CAD on Cardiac Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:25.085358|2017-10-11 04:28:25.085358
NCT01632501|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-07-02|||January 2011||2011-01-01|January 2011|2011-01-01||||March 2012|Actual|2012-03-01||Interventional|Tsunami||Safety and Efficacy of the Percutaneous Intervention Performed With Devices of a Single-brand|Safety and Efficacy of the Percutaneous Intervention Performed With Devices of a Single-brand|Completed||N/A|84|Actual|Hospital Sao Lucas da PUCRS||1|||f||||t||||||||||2017-10-11 02:47:31.150543|2017-10-11 02:47:31.150543
NCT01632488|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-06-28|||June 2012||2012-06-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome|Assessment of Small Intestinal Bowel Epithelial Gaps in Patients With Irritable Bowel Syndrome by Confocal Laser Endomicroscopy|Unknown status|Recruiting|N/A|45|Anticipated|Shandong University|||3||f||||t||||||Samples With DNA|"     Taken biopsies during endoscopy   "|||2017-10-11 02:47:31.219635|2017-10-11 02:47:31.219635
NCT01632475|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2016-10-12|||September 2011||2011-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia|Long Term Follow-Up Study of the Safety and Exploratory Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia|Active, not recruiting||Phase 1|9|Actual|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 02:47:31.296553|2017-10-11 02:47:31.296553
NCT01632462|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-08-10|||September 2012||2012-09-01|August 2014|2014-08-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease|A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease|Unknown status|Recruiting|Phase 4|30|Anticipated|Federico II University||2|||f||||t||||||||||2017-10-11 02:47:31.41731|2017-10-11 02:47:31.41731
NCT01632449|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-05-30|||July 2012||2012-07-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers.|A Randomized, Single-Blind, Two-Period Crossover Study in Healthy Volunteers to Establish the Bioequivalence of BG00012 Supplied by Two Different Manufacturers.|Completed||Phase 1|80|Actual|Biogen||2|||f||||f||||||||||2017-10-11 02:47:31.529039|2017-10-11 02:47:31.529039
NCT01632436|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-06-28|||May 2012||2012-05-01|June 2012|2012-06-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Interventional|Hepatic||Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment|A Non-randomized Cohort Study With Matched Controls Investigating Pharmacokinetic Parameters and Safety of a Single Dose of Pixantrone With Metastatic Cancer and Moderate, Severe, or No Hepatic Impairment.|Active, not recruiting||Phase 1|32|Anticipated|CTI BioPharma||2|||f||||f||||||||||2017-10-11 02:47:31.612039|2017-10-11 02:47:31.612039
NCT01632423|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-08-21|2012-08-21||February 2010||2010-02-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)||Completed||N/A|10337|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:47:31.71379|2017-10-11 02:47:31.71379
NCT01632410|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-07-02|||July 2012||2012-07-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|November 2012|Anticipated|2012-11-01||Observational|||The Autonomic Nervous System State and Response to Different Stimuli Among Patients Post Stroke: A Follow-up Study|The Cardiac Autonomic Nervous System State and Response to Reflective, Motor and Cognitive Stimuli Among Patients Post Stroke: A Follow-up Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||5||f||||f||||||||||2017-10-11 02:47:31.951055|2017-10-11 02:47:31.951055
NCT01632397|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-02-08|||August 2011||2011-08-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PrEPare||Pre-exposure Prophylaxis Adherence Intervention for MSM|Optimizing Antiretroviral-Based Prevention by Enhancing PrEP Adherence in MSM|Completed||Phase 4|103|Actual|Fenway Community Health||2|||f||||t||||||||||2017-10-11 02:47:32.071591|2017-10-11 02:47:32.071591
NCT01632384|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-01-30|||February 2012||2012-02-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|SmokeAtt04||The Effects of Smoking Withdrawal On Resting State Functional Connectivity|The Effects of Smoking Withdrawal on Resting State Functional Connectivity|Withdrawn||N/A|0|Actual|Duke University||1||study close-out|f||||f||||||||||2017-10-11 02:47:32.195917|2017-10-11 02:47:32.195917
NCT01632371|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-11-18|||June 2012||2012-06-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|August 2015|Actual|2015-08-01||Interventional|ISAR-DESIRE 4||Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4|"ISAR-DESIRE 4: Randomized Trial Of Scoring Balloon in Patients With Restenosis in Limus-Eluting Coronary Stents Undergoing Angioplasty With Paclitaxel-Coated Balloon"|Completed||Phase 4|252|Actual|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||||2017-10-11 02:47:32.297909|2017-10-11 02:47:32.297909
NCT01632358|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2013-11-27|||June 2012||2012-06-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients|A Randomized, Double-blind, Placebo Controlled, Crossover Study to Assess Safety and Tolerability, Pharmacokinetics, and Explore Pharmacodynamics of TAP311 in Patients With Mixed Dyslipidaemia|Completed||Phase 1|279|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:47:32.412089|2017-10-11 02:47:32.412089
NCT01632345|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-04-05|||October 2012||2012-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2014|Actual|2014-12-01||Interventional|||A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)|Multicenter, Double-Blind, Randomized, 2-Part, Dose Ranging Study to Compare the Safety, and Antiretroviral Activity of MK-1439 Plus TRUVADA Versus Efavirenz Plus TRUVADA in Antiretroviral Treatment-Naive, HIV-1 Infected Patients|Completed||Phase 2|342|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-11 02:47:32.509903|2017-10-11 02:47:32.509903
NCT01632332|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-04-08|||July 2012||2012-07-01|April 2014|2014-04-01||||June 2015|Anticipated|2015-06-01||Interventional|||Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer|A Phase I Trial of the Safety and Immunogenicity of a Multi-epitope HER-2/Neu Peptide Vaccine in Subjects Previously Treated for HER-2 Positive Breast Cancer|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:47:32.616595|2017-10-11 02:47:32.616595
NCT01632319|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-06-29|||May 2012||2012-05-01|June 2012|2012-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|TREADS||Therapy for Undergraduate College Students Who Binge Drink and Are Depressed|Treatment for Excessive Alcohol Use and Depression in Students (TREADS)|Unknown status|Recruiting|N/A|100|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:47:32.73874|2017-10-11 02:47:32.73874
NCT01632306|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-03-28||2016-03-28|March 2013||2013-03-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer|Phase I/II Study of LY2090314 and Chemotherapy in Metastatic Pancreatic Cancer Patients With Metastases Amenable to Biopsy|Terminated||Phase 1/Phase 2|13|Actual|Eli Lilly and Company||3||Study has been terminated due to slow enrollment.|f||||f||||||||||2017-10-11 02:47:32.870027|2017-10-11 02:47:32.870027
NCT01632293|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-02-22|||April 2012||2012-04-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Evaluating Intervention Responsiveness in People With Multiple Sclerosis|Evaluating Intervention Responsiveness in People With Multiple Sclerosis|Completed||N/A|60|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||f||||||||||2017-10-11 02:47:32.993908|2017-10-11 02:47:32.993908
NCT01632280|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-08-24|||June 2012||2012-06-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|December 31, 2015|Actual|2015-12-31||Interventional|"Neuroband"||Enhancement of Brain Circuit of Inhibitory Control in Obese Patients Undergoing Gastric Banding|"Neuroband: The Effect of Perioperative Enhancement of the Brain Circuit of Inhibitory Control in Obese Patients Undergoing Laparoscopic Adjustable Gastric Banding (LAGB)"|Active, not recruiting||N/A|14|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 02:47:33.12142|2017-10-11 02:47:33.12142
NCT01632267|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2015-12-04|2013-02-14||January 2011||2011-01-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Observational|UHS||Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm|A Retrospective Analysis of Outcomes in Outpatients With Major Depressive Disorder (MDD) in a Staff Model HMO: Pharmacogenetic Algorithm for Psychotropic Pharmacotherapeutic Applications|Completed||N/A|104|Actual|Assurex Health Inc.|||1||f||||f||||||Samples With DNA|"     Buccal samples   "|||2017-10-11 02:47:33.306745|2017-10-11 02:47:33.306745
NCT01632254|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-07-19|||July 2009||2009-07-01|May 2012|2012-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Study to Investigate the Sensitivity and Specificity of 3.0 Tesla MRI for Carotid Artery Plaque|Study to Investigate the Sensitivity and Specificity of 3.0 Tesla MRI, MRS and Ultrasound Imaging for Carotid Artery Plaque Dimension and Composition Assessment|Unknown status|Recruiting|N/A|30|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||||||2017-10-11 02:47:33.517728|2017-10-11 02:47:33.517728
NCT01632228|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-01-26||2017-01-19|June 2012||2012-06-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study Evaluating the Efficacy and Safety of Onartuzumab in Combination With Bevacizumab or Onartuzumab Monotherapy in Patients With Recurrent Glioblastoma|Completed||Phase 2|135|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:47:34.114174|2017-10-11 02:47:34.114174
NCT01632215|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-05-19|2014-02-24||March 2010||2010-03-01|May 2014|2014-05-01|March 2012|Actual|2012-03-01|August 2011|Actual|2011-08-01||Interventional|||Preoperative Gabapentine for Carpal Tunnel|Effect of Preoperative Gabapentine for Carpal Tunnel Syndrome|Completed||Phase 3|40|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 02:47:34.869758|2017-10-11 02:47:34.869758
NCT01632202|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2013-07-29|||May 2012||2012-05-01|July 2013|2013-07-01||||January 2014|Anticipated|2014-01-01||Interventional|Seprafilm||Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy|The Role of Seprafilm Bioresorbable Slurry in the Prevention of Intrauterine Synechiae in Patients Undergoing Hysteroscopic Myomectomy|Unknown status|Recruiting|Phase 4|328|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-11 02:47:35.224385|2017-10-11 02:47:35.224385
NCT01632189|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-01-26|||September 2012||2012-09-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Varenicline on D2/D3 Receptor Binding in Smokers|Investigating the Effects of Varenicline on D2/3 Receptor Binding in Brain of Tobacco-smokers: a PET/[11C](+)PHNO Study|Completed||N/A|8|Actual|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-10-11 02:47:35.416577|2017-10-11 02:47:35.416577
NCT01632176|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-03-17|||July 2012|Actual|2012-07-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|January 2013|Actual|2013-01-01||Interventional|||A Brief Intervention|A Brief Intervention to Prevent Adolescent Dating Aggression Perpetration|Completed||N/A|36|Actual|Boston University||2|||f||||t|f|f||||||No||2017-10-11 02:47:35.551725|2017-10-11 02:47:35.551725
NCT01632163|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-06-12|||October 2012||2012-10-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin|A Randomized, Double-blind, Placebo-controlled, 2-arm Parallel-group, Multicenter Study With a 24-week Treatment Period Assessing the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin With or Without Metformin|Completed||Phase 3|447|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 02:47:35.680725|2017-10-11 02:47:35.680725
NCT01632150|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-03-17|2015-12-22|2015-09-23|May 2012||2012-05-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|October 2013|Actual|2013-10-01||Interventional||All participants who received thalidomide +elotuzumab + dexamethose (40) and had cyclophosphamide added to the regimen (11).|Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma|Phase 2a Single-Arm Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Subjects With Relapsed and/or Refractory Multiple Myeloma|Completed||Phase 2|51|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 02:47:35.997032|2017-10-11 02:47:35.997032
NCT01632124|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-06-28|||January 2012||2012-01-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Rituximab-induced Pulmonary Function Changes|Rituximab-induced Pulmonary Function Changes - an Observational Study in Patients With Rheumatoid Arthritis and Inflammatory Myositis|Unknown status|Recruiting|N/A|80|Anticipated|University of Zurich|||1||f||||f||||||||||2017-10-11 02:47:37.856214|2017-10-11 02:47:37.856214
NCT01632111|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2014-05-26|||July 2012||2012-07-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Pulmonary Involvement in Patients With Fabry Disease|Impact of the Treatment With Agalsidase Alpha on Lung Function and on Pulmonary Involvement in Patients With Fabry Disease. A Multicenter, Retrospective Observational Study|Completed||N/A|110|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 02:47:37.92858|2017-10-11 02:47:37.92858
NCT01632098|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-09-14|||July 2012||2012-07-01|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|YES||Economic Aspects of Extreme Obesity in Adolescent|Medical and Psychosocial Implications of Adolescent Extreme Obesity - Acceptance and Effects of Structured Care Study, Subproject 4|Active, not recruiting||N/A|429|Actual|University of Ulm|||2||f||||t||||||||||2017-10-11 02:47:38.009768|2017-10-11 02:47:38.009768
NCT01632085|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-28|||June 2012||2012-06-01|June 2012|2012-06-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|MUUR||Comparison of Two Laryngoscopes: Single-use Device Laryngobloc ® (SU) Versus Reusable Handle With Disposable Metal Blade (R)|Comparison of Two Laryngoscopes: Single-use Device Laryngobloc ® (SU) Versus Reusable Handle With Disposable Metal Blade (R) : Quality of Laryngoscopy and Bacterial Contamination of the Handle|Unknown status|Recruiting|N/A|480|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-10-11 02:47:38.11348|2017-10-11 02:47:38.11348
NCT01632072|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-09-18|||June 2012||2012-06-01|September 2017|2017-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Undernourished Patient: Prevention and Treatment|The Undernourished Patient: Prevention and Treatment|Completed||Phase 2|100|Actual|University of Oslo||2|||f||||f||||||||||2017-10-11 02:47:38.218276|2017-10-11 02:47:38.218276
NCT01632059|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-08-02|||February 2012|Actual|2012-02-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|March 2013|Actual|2013-03-01||Observational|ADSeS||Examination of ADMA Serum Level and DDAH II|Examination of ADMA (Asymmetric-dimethylarginine)-Serum Level and DDAH II (Dimethylarginine Dimethylaminohydrolase)- Polymorphism in Patients With Severe Sepsis and Septic Shock as Prognostic Value|Completed||N/A|120|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:47:38.331549|2017-10-11 02:47:38.331549
NCT01632046|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2012-06-28|||March 2004||2004-03-01|June 2012|2012-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|BIOKID||Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children|Randomized, Long-Term Administration of pH-Neutral PD Solutions Containing Lactate (BALANCE) or Bicarbonate (BICAVERA) in Children|Completed||Phase 4|42|Actual|Heidelberg University||2|||f||||t||||||||||2017-10-11 02:47:38.437199|2017-10-11 02:47:38.437199
NCT01632033|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-07-16|||July 2012||2012-07-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|WELCH-bis||Functional Evaluation With Questionnaire in Patients Investigated for Suspected Peripheral Artery Disease|Estimation de la capacité Fonctionnelle a la Marche Par Questionnaire Clinique Chez Des Patients adressés Pour Bilan artériel Des Membres inférieurs: Etude WELCH-bis|Completed||N/A|150|Actual|University Hospital, Angers|||1||f||||t||||||||||2017-10-11 02:47:38.576364|2017-10-11 02:47:38.576364
NCT01632020|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2016-05-31|2016-02-19||August 2012||2012-08-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth|Pilot Study: Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth|Terminated||Phase 2|7|Actual|University of Arkansas|Early termination leading to small numbers of subjects. Outcome measures not computed because data would not be statistically relevant.|2||Inadequate accrual|f||||f||||||||No||2017-10-11 02:47:38.678775|2017-10-11 02:47:38.678775
NCT01632007|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-01-13|||May 2012||2012-05-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Double-blind Comparative Study of SYR-472||Completed||Phase 3|245|Anticipated|Takeda||3|||f||||f||||||||||2017-10-11 02:47:39.066871|2017-10-11 02:47:39.066871
NCT01631994|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2016-01-11|||September 2011||2011-09-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study to Evaluate the Efficacy of Oral Dissolving Metoclopramide Before Video Capsule Endoscopy|Title: A Prospective, Single Center, Randomized, Single Blinded Study to Evaluate the Efficacy of Oral Dissolving Metoclopramide Before Video Capsule Endoscopy.|Completed||N/A|4|Actual|Winthrop University Hospital||2|||f||||t||||||||||2017-10-11 02:47:39.181937|2017-10-11 02:47:39.181937
NCT01631981|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-06-02|||June 2012||2012-06-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional|AMBER||PGL2001 Proof of Concept Study in Symptomatic Endometriosis|A Phase II, Multicentre, Randomised, Two-Arm, Parallel Group, Double-Blind, Placebo Controlled Study of the Steroid Sulfatase Inhibitor PGL2001 With Concomitant Administration of NETA (Norethisterone Acetate) for the Treatment of Symptoms Related to Endometriosis|Completed||Phase 2|162|Actual|PregLem SA||2|||f||||f||||||||||2017-10-11 02:47:39.253818|2017-10-11 02:47:39.253818
NCT01631968|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2016-02-23|||September 2007||2007-09-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|March 2011|Actual|2011-03-01||Interventional|||Incidence of Infection After Total Knee Arthroplasty Using an Erythromycin and Colistin Loaded Cement or a Standard Cement|Incidence of Infection After Total Knee Arthroplasty Using an Erythromycin and Colistin Loaded Cement or a Standard Cement|Completed||N/A|2948|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 02:47:39.371149|2017-10-11 02:47:39.371149
NCT01631955|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-06-28|||October 2009||2009-10-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|February 2011|Actual|2011-02-01||Observational|||Assessment of UTI Symptoms and Quality of Life According to Antibiotics Treatment in Acute Uncomplicated Cystitis|A Study of Quality of Life and Changes to Symptom Relief for Acute Uncomplicated Cystitis Treated With Antibiotics (Ciprobay); Prospective, Open-label, Multicenter, Observational Study|Completed||N/A|386|Actual|Soonchunhyang University Hospital|||1||f||||||||||||||2017-10-11 02:47:39.443979|2017-10-11 02:47:39.443979
NCT01631552|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-06-13|||February 2013||2013-02-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers|A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers|Recruiting||Phase 1/Phase 2|250|Anticipated|Immunomedics, Inc.||1|||f||||f||||||||||2017-10-11 02:47:47.840818|2017-10-11 02:47:47.840818
NCT01631942|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-02-09|||June 2012||2012-06-01|February 2017|2017-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|explorer™2||A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects|A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects|Terminated||Phase 1|4|Actual|Novo Nordisk A/S||3||See detailed description|f||||f||||||||||2017-10-11 02:47:39.520244|2017-10-11 02:47:39.520244
NCT01631929|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-12-19|2015-08-19||August 2012||2012-08-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Two Bag System for Hydration in Diabetes|Two Bag System vs. One Bag System for Hydration Patients With Diabetic Ketoacidosis|Terminated||N/A|12|Actual|Hospital General de Niños Pedro de Elizalde||2||Monitoring Committee found significant & meaningful difference on main outcome|f||||f||||||||||2017-10-11 02:47:39.619439|2017-10-11 02:47:39.619439
NCT01631916|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-02-26|||November 2015||2015-11-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Corticosteroids in Community-acquired Pneumonia|Use of Corticosteroids in Children Hospitalized With Community-acquired Pneumonia|Withdrawn||N/A|0|Actual|Hospital General de Niños Pedro de Elizalde||2||Unable to find patients matching inclusion criteria|f||||t||||||||||2017-10-11 02:47:40.073991|2017-10-11 02:47:40.073991
NCT01631903|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-04-15|||September 2012||2012-09-01|November 2012|2012-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Extension of Study ZPV-200|A Phase 2, Multi-Center, Five-Arm, Parallel Design, Randomized, Single-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound|Completed||Phase 2|48|Anticipated|Repros Therapeutics Inc.||5|||f||||f||||||||||2017-10-11 02:47:40.199664|2017-10-11 02:47:40.199664
NCT01631890|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-11-07|||June 2012||2012-06-01|June 2012|2012-06-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||To Compare the Efficacy of Endoscopic Ultrasound Assisted Endoscopic Glue Injection and Conventional Endoscopic Injection Therapy for Prevention of Gastric Variceal Rebleed|Phase III Study of the Efficacy of Endoscopic Ultrasound (EUS) Assisted Endoscopic Glue Injection and Conventional Endoscopic Injection Therapy for Prevention of Gastric Variceal Rebleed|Withdrawn||Phase 3|0|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 02:47:40.310014|2017-10-11 02:47:40.310014
NCT01631877|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2016-12-04|||June 2012||2012-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver||Recruiting||N/A|44|Anticipated|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 02:47:40.404783|2017-10-11 02:47:40.404783
NCT01631864|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2015-07-11|2015-07-11||October 2012||2012-10-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects|A Randomized, Double-blind, Parallel Group Study to Evaluate Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects|Completed||Phase 2|98|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:47:40.534539|2017-10-11 02:47:40.534539
NCT01631851|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-07-07|||May 2011||2011-05-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder||Unknown status|Recruiting|N/A|10|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 02:47:41.024432|2017-10-11 02:47:41.024432
NCT01631838|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2013-12-19|||May 2012||2012-05-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|August 2012|Actual|2012-08-01||Interventional|||Effects of Tocotrienols Supplementation on Platelet Aggregation in Subjects With Metabolic Syndrome|Effects of Tocotrienols Supplementation on Platelet Aggregation in Subjects With Metabolic Syndrome|Completed||N/A|32|Actual|Malaysia Palm Oil Board||2|||f||||f||||||||||2017-10-11 02:47:41.128103|2017-10-11 02:47:41.128103
NCT01631825|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-02-03|2014-02-03||October 2009||2009-10-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients|An Open-label Long-term Extension Trial From Phase III of SPM962 (243-08-002) in Advanced Parkinson's Disease Patients With Concomitant Treatment of L-dopa|Completed||Phase 3|321|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:47:41.2783|2017-10-11 02:47:41.2783
NCT01631812|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-02-03|2014-02-03||December 2006||2006-12-01|February 2014|2014-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients|An Open-label Long-term Extension Trial From Late Phase II of SPM962 (243-05-001) in Advanced Parkinson's Disease Patients With Concomitant Treatment of L-dopa|Completed||Phase 2|130|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:47:42.282167|2017-10-11 02:47:42.282167
NCT01631799|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-06-27|||October 2008||2008-10-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Outcome of Patients After Total Knee Replacement: A Comparison of Femoral Nerve Block and Epidural Anesthesia|Outcome of Patients After Total Knee Replacement: A Comparison of Femoral Nerve Block and Epidural Anesthesia. A Randomized, Controlled Trial|Completed||N/A|80|Actual|University of Rostock||2|||f||||f||||||||||2017-10-11 02:47:42.687726|2017-10-11 02:47:42.687726
NCT01631786|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-09-19|||August 2011||2011-08-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Observational|||Synchrotron Imaging of Human Ovaries Ex Situ|Synchrotron Imaging of Human Ovaries Ex Situ|Completed||N/A|10|Actual|University of Saskatchewan|||2||f||||f||||||Samples With DNA|"     surgically removed human ovarian tissues and Formalin-fixed human ovarian tissues   "|||2017-10-11 02:47:42.772286|2017-10-11 02:47:42.772286
NCT01631565|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-11-23|||May 2012||2012-05-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional|PACO||Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care|Management of Symptoms in Patients With Advanced Lung Cancer: Early Incorporation of Patient and Family to Attention and Care Program in Oncology|Completed||Phase 3|201|Actual|Instituto Nacional de Cancerologia de Mexico||2|||f||||t||||||||Yes||2017-10-11 02:47:47.744125|2017-10-11 02:47:47.744125
NCT00006498|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2016-03-15|||September 2000||2000-09-01|January 2006|2006-01-01|August 2005|Actual|2005-08-01|||||Observational|||Chronic Life Stress and Incident Asthma in Adult Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:25.145289|2017-10-11 04:28:25.145289
NCT01631773|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-10-06|||August 2011||2011-08-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only|A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only|Completed||N/A|26|Actual|University of South Florida|||2||f||||t||||||Samples With DNA|"     Nasal epithelial tissue will be collected from the inferior nasal turbinates of ten subjects     with nasal polyps and AERD disease and from the inferior turbinates of ten subjects with     nasal polyps but without AERD. A rhinoprobe™ will be used to collect this epithelial tissue.     These samples will be analyzed by miRNA assay to determine if there is a difference in     mircroRNA expression between the two subject groups.   "|||2017-10-11 02:47:42.878419|2017-10-11 02:47:42.878419
NCT01631760|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-10-06|||October 2011||2011-10-01|October 2014|2014-10-01||||February 2014|Actual|2014-02-01||Observational|||Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation|Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation|Withdrawn||N/A|0|Actual|University of South Florida|||3||f||||f||||||||||2017-10-11 02:47:42.958748|2017-10-11 02:47:42.958748
NCT01631747|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-08-11|||November 2012||2012-11-01|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|MOMFIT||Maternal-Offspring Metabolics:Family Intervention Trial|Maternal-Offspring Metabolics:Family Intervention Trial (MOMFIT)|Completed||N/A|281|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 02:47:43.072834|2017-10-11 02:47:43.072834
NCT01631721|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-03-21|||November 2010||2010-11-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|CFC||Couple & Family Contexts|Affective Influences on Adolescent Sexual Risk Behavior: Couple & Family Contexts|Completed||N/A|2960|Actual|New York University|||3||f||||t||||||||||2017-10-11 02:47:43.158711|2017-10-11 02:47:43.158711
NCT01631708|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2016-09-25|||June 2012||2012-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Mi-iron||Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?|Mi-Iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?|Completed||N/A|100|Actual|Murdoch Childrens Research Institute||2|||f||||t||||||||||2017-10-11 02:47:43.22907|2017-10-11 02:47:43.22907
NCT01631695|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-10-27|||November 2009||2009-11-01|October 2013|2013-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Clinical Evaluation of Medasense Pain Monitor Performances|Evaluation of the Performances of Medasense Pain Monitor During General Anesthesia and Postoperative Recovery Compared to Pain Related Physiological Indicators and to Subjective Assessment of Pain by Anesthesiologist|Completed||N/A|96|Actual|Medasense Biometrics Ltd|||1||f||||f||||||||||2017-10-11 02:47:43.332286|2017-10-11 02:47:43.332286
NCT01631682|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-01-03|2016-09-13||November 2010||2010-11-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders|Psychophysiology of Delayed Extinction and Reconsolidation in Humans|Completed||Phase 4|186|Actual|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-11 02:47:43.406412|2017-10-11 02:47:43.406412
NCT01631669|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-06-29|||May 2012||2012-05-01|June 2012|2012-06-01|June 2018|Anticipated|2018-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification|Prophylaxis of Heterotopic Ossification (HO) in Wartime Extremity Injuries, a Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|Walter Reed National Military Medical Center||2|||f||||f||||||||||2017-10-11 02:47:43.799953|2017-10-11 02:47:43.799953
NCT01631643|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-12-06|||December 2012||2012-12-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||One Touch® Verio®IQ European Clinical Outcomes Study|One Touch® Verio®IQ European Clinical Outcomes Study|Withdrawn||Phase 4|0|Actual|LifeScan||1||Business decision to withdraw trial|f||||f||||||||||2017-10-11 02:47:43.968781|2017-10-11 02:47:43.968781
NCT01631630|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2017-01-27|2016-10-21||May 2012||2012-05-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Role of Proinflammatory Signaling in Alcohol Craving|Role of Proinflammatory Signaling in Alcohol Craving|Terminated||Phase 2|16|Actual|National Institutes of Health Clinical Center (CC)|This study was terminated early, so the number of subjects analyzed is small.|2||The study was closed to recruitment due to feasibility problems.|f||||t||||||||No||2017-10-11 02:47:45.699057|2017-10-11 02:47:45.699057
NCT01631617|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-07-21|||June 20, 2012||2012-06-20|December 8, 2016|2016-12-08|June 1, 2019|Anticipated|2019-06-01|June 30, 2018|Anticipated|2018-06-30||Interventional|||Effects of Treatments on Atopic Dermatitis|Effects of Treatments on the Microbiome in Healthy Volunteers and Patients With Atopic Dermatitis|Recruiting||Phase 2|113|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 02:47:47.372213|2017-10-11 02:47:47.372213
NCT01631604|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2017-04-26|||June 2012||2012-06-01|June 2012|2012-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Gait Characteristics Following a Fall|Quantification of Gait Parameters and Muscle Activation Patterns Following a Fall|Unknown status|Active, not recruiting|N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 02:47:47.502458|2017-10-11 02:47:47.502458
NCT01631591|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-10-06|||May 2011||2011-05-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|EE||Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis|Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis|Completed||N/A|31|Actual|University of South Florida|||2||f||||t||||||||||2017-10-11 02:47:47.591527|2017-10-11 02:47:47.591527
NCT01631578|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-08-19|||January 2012||2012-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Improving the Reproductive Outcome of Poor Quality Ova by Injection of Autologous Somatic Mitochondria|Phase 1 Study of the Impact of Injecting an Autologous Somatic Mitochondrial Concentrate Into Poor Quality Ova.|Withdrawn||Phase 1/Phase 2|0|Actual|Hadassah Medical Organization||2||PI moved from medical center|f||||f||||||||||2017-10-11 02:47:47.660009|2017-10-11 02:47:47.660009
NCT00006499|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2016-03-15|||June 2000||2000-06-01|July 2004|2004-07-01|April 2004|Actual|2004-04-01|||||Observational|||Genetics of Hypertension and Its Intermediate Phenotypes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:25.198586|2017-10-11 04:28:25.198586
NCT01631539|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-12-03|||September 2012||2012-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC|Chemoembolisation With Irinotecan Loaded DC Bead (DEBIRI) in Combination With Cetuximab and 5FU/LV in the First Line Treatment of Patients With KRAS Wildtype Metastatic Colorectal Cancer (mCRC)|Withdrawn||N/A|0|Actual|Universitaire Ziekenhuizen Leuven||1||No patients enrolled|f||||f||||||||||2017-10-11 02:47:48.004733|2017-10-11 02:47:48.004733
NCT01631526|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2017-08-15|||June 2012||2012-06-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Vitamin D Loading Dose in Advanced Lung Cancer|Open Clinical Trial to Validate a Short-term Vitamin D Loading and Maintenance Dose Protocol in People With Advanced Lung Cancer|Completed||N/A|80|Actual|Jewish General Hospital||1|||f||||f|f|f||||||||2017-10-11 02:47:48.09632|2017-10-11 02:47:48.09632
NCT01631513|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2013-03-04|||August 2012||2012-08-01|March 2013|2013-03-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)|An Open-label, Multi-center, Single-arm, Phase IV Clinical Trial Assessing Conversion From Hydrocodone, Oxycodone CR or Morphine SR to Tapentadol ER in Subjects With Moderate to Severe Chronic Low Back or OA Pain of the Hip or Knee|Terminated||Phase 4|150|Anticipated|Janssen Scientific Affairs, LLC||1|||f||||f||||||||||2017-10-11 02:47:48.187717|2017-10-11 02:47:48.187717
NCT01631500|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2012-08-29|||January 2010||2010-01-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effects of an Integrative Treatment Model to Reduce Anxiety and Depression in Minor Mental Health Problems and Medically Unexplained Symptoms||Completed||N/A|120|Actual|Göteborg University||3|||f||||t||||||||||2017-10-11 02:47:48.295719|2017-10-11 02:47:48.295719
NCT01631487|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2013-06-24|||July 2012||2012-07-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants|A Double-Blind, Randomized, Placebo-Controlled, Sequential Group, Single Ascending and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Subjects|Completed||Phase 1|86|Actual|Janssen Research & Development, LLC||9|||f||||||||||||||2017-10-11 02:47:48.381577|2017-10-11 02:47:48.381577
NCT01631474|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2015-03-27||2015-03-27|June 2012||2012-06-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris|A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety and Efficacy of Cortexolone 17a-Propionate (CB-03-01) Cream Applied Once or Twice-Daily for 12 Weeks in Subjects With Facial Acne Vulgaris|Completed||Phase 2|363|Actual|Intrepid Therapeutics, Inc.||5|||f||||f||||||||||2017-10-11 02:47:48.493584|2017-10-11 02:47:48.493584
NCT01631461|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-11-14|||December 2006||2006-12-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Painful Breastfeeding and Bacterial or Yeast Infection|The Prevalence of Yeast and Bacteria in Women With Painful Breastfeeding and the Diagnostic Value of Signs and Symptoms|Completed||N/A|136|Actual|Göteborg University|||3||f||||f||||||||||2017-10-11 02:47:48.712001|2017-10-11 02:47:48.712001
NCT01631435|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-03-11|2014-12-04||June 2012||2012-06-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||PillCam® Platform With the PillCam Crohn's Disease Capsule|Evaluation of the PillCam® Platform With the PillCam Crohn's Disease Capsule in Visualization of Lesions in the Small Bowel and Colon That May Indicate Crohn's Disease|Completed||Phase 1/Phase 2|75|Actual|Given Imaging Ltd.||1|||f||||f||||||||||2017-10-11 02:47:48.885474|2017-10-11 02:47:48.885474
NCT01631422|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-11-01|||June 2012||2012-06-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers|Single-Center, Open-label Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-Radio-labeled RO4602522 in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:47:49.075442|2017-10-11 02:47:49.075442
NCT01631409|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-04-07|||September 2013||2013-09-01|April 2014|2014-04-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|CSWTSPB40||Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy|Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy in the General System of Noninvasive, Invasive, and Surgical Treatment of Ischemic Heart Disease in the Conditions of a Large General City Hospital|Withdrawn||N/A|0|Actual|City Hospital No 40, Saint Petersburg, Russia|||7|The study has been withdrawn due to organizational problems|f||||t||||||||||2017-10-11 02:47:49.145559|2017-10-11 02:47:49.145559
NCT01631396|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2014-06-24|||July 2012||2012-07-01|March 2012|2012-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Comparison of Two Neuromuscular Anesthetics Reversal in Obese Patient Undergoing Bariatric Surgery|Comparison of Two Neuromuscular Anesthetics Reversal in Obese Patient Undergoing Bariatric Surgery|Completed||N/A|40|Actual|Assuta Hospital Systems|||2||f||||f||||||||||2017-10-11 02:47:49.258303|2017-10-11 02:47:49.258303
NCT01631383|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-07-06|||October 2012|Actual|2012-10-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use|Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use|Completed||Phase 1|20|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 02:47:49.340536|2017-10-11 02:47:49.340536
NCT01631370|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-12-23|||June 2012||2012-06-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||The Effects of Renal Denervation on Insulin Sensitivity|The Effects of Renal Sympathetic Denervation on Insulin Sensitivity in Patients With Resistant Essential Hypertension|Unknown status|Enrolling by invitation|N/A|8|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-10-11 02:47:49.43438|2017-10-11 02:47:49.43438
NCT01631357|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2015-12-21|||November 2016||2016-11-01|February 2013|2013-02-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|CIK||Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer|Phase II/III Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy in Stage IIIb-IV Squamous Non-Small-Cell Lung Cancer|Unknown status|Not yet recruiting|Phase 2/Phase 3|200|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 02:47:49.52989|2017-10-11 02:47:49.52989
NCT01631344|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-10-03|||February 2011||2011-02-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Interventional|||Effectiveness of Lifestyle Counseling Versus Physical Therapy on Chronic Low Back Pain|"Intervention Study to Examine the Effectiveness of Lifestyle Counseling Using the Stage of Change Model Versus Conventional Physical Therapy on Chronic Low Back Pain"|Active, not recruiting||N/A|220|Actual|Assuta Hospital Systems||2|||f||||f||||||||||2017-10-11 02:47:49.622371|2017-10-11 02:47:49.622371
NCT01631331|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-08-15|2017-02-02||June 2012||2012-06-01|August 2017|2017-08-01|May 31, 2016|Actual|2016-05-31|September 17, 2015|Actual|2015-09-17||Interventional||We enrolled patients with at least 1 biopsy-conﬁrmed BCC of any histologic subtype, more than 5 mm in diameter, eligible for surgical removal. Only patients who were treated with vismodegib for an average of 4 months were included in our analysis.|Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)|A Pilot Study to Investigate the Off Label Use of Vismodegib as an Adjuvant to Surgery for Basal Cell Carcinoma Tumors (BCCs)|Completed||Early Phase 1|15|Actual|Stanford University||1|||f||||t|t|f|||f|||||2017-10-11 02:47:49.710571|2017-10-11 02:47:49.710571
NCT01631318|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-01-10|||November 2012||2012-11-01|January 2017|2017-01-01||||April 2019|Anticipated|2019-04-01||Interventional|||Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases|Pilot Technical Feasibility Study on 3D Contrast-enhanced Ultrasound Imaging and to Assess Whether Change in Ultrasound 3D Perfusion Pattern Can Predict Treatment Response|Recruiting||N/A|10|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 02:47:50.079756|2017-10-11 02:47:50.079756
NCT01631305|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-03-04|||January 2012||2012-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Levothyroxine for Children With Euthyroid Sick Syndrome|Efficacy and Safety of Levothyroxine in Critical Children With Euthyroid Sick Syndrome in a Pediatric Intensive Care Unit.|Completed||Phase 4|80|Anticipated|Sinaloa Pediatric Hospital||2|||f||||f||||||||||2017-10-11 02:47:50.180175|2017-10-11 02:47:50.180175
NCT01631292|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-08-14|||January 2010||2010-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|May 2015|Actual|2015-05-01||Interventional|||Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)|A Pilot Dose Response Study to Vitamin D in Obesity and Weight Loss: Effect on Bone|Active, not recruiting||N/A|81|Actual|Rutgers University||3|||f||||f||||||||||2017-10-11 02:47:50.272212|2017-10-11 02:47:50.272212
NCT01631279|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2014-06-13|||August 2012||2012-08-01|June 2014|2014-06-01|August 2015|Anticipated|2015-08-01|March 2015|Anticipated|2015-03-01||Interventional|||A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors|A Phase I/II, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR610 Given Weekly in Subjects With Solid Tumors|Terminated||Phase 1/Phase 2|33|Actual|Proacta, Incorporated||1||Study was prematurely discontinued due to unacceptable toxicity.|f||||f||||||||||2017-10-11 02:47:50.351429|2017-10-11 02:47:50.351429
NCT01631266|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-28|2015-04-16|||July 2012||2012-07-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI|A Phase III Contact Tracing Trial Comparing the Diagnostic Performance of C-Tb to QuantiFERON®-TB Gold In-Tube, in Combination With a Double Blind Randomized Split Body Safety Assessment of C-Tb Versus 2 T.U. Tuberculin PPD RT23 SSI|Completed||Phase 3|979|Actual|Statens Serum Institut||2|||f||||t||||||||||2017-10-11 02:47:50.472542|2017-10-11 02:47:50.472542
NCT01631253|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-30|||October 2011||2011-10-01|June 2012|2012-06-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation|The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation|Unknown status|Recruiting|Phase 4|90|Anticipated|CHA University||3|||f||||f||||||||||2017-10-11 02:47:50.602524|2017-10-11 02:47:50.602524
NCT01631240|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-07-25|||June 2011||2011-06-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||NHANES Urinary Sodium Calibration Study|National Health and Nutrition Examination Survey (NHANES), Urinary Sodium Calibration Study|Completed||N/A|441|Actual|Centers for Disease Control and Prevention|||1||f||||f||||||Samples Without DNA|"     urine specimens   "|Yes|Data are available through the NCHS Research Data Center|2017-10-11 02:47:50.686321|2017-10-11 02:47:50.686321
NCT01631227|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2014-07-18|2014-04-28||June 2012||2012-06-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Full analysis set consists of 330 and 331 patients respectively.|Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension|A Prospective, Randomized Double-blind Parallel Group Study to Compare the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Subjects With Mild to Moderate Essential Hypertension|Completed||Phase 3|665|Actual|Abbott||2|||f||||f||||||||||2017-10-11 02:47:50.76707|2017-10-11 02:47:50.76707
NCT01631214|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-07-25|||May 4, 2012|Actual|2012-05-04|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|February 27, 2017|Actual|2017-02-27||Interventional|||Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis|A Multicenter, International, Randomized, Double-blind, Alendronate-controlled Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 3|4093|Actual|Amgen||2|||f||||t||||||||||2017-10-11 02:47:51.276592|2017-10-11 02:47:51.276592
NCT01631201|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-04-25|||July 2012||2012-07-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women|A Phase 2b, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Safety and Efficacy of Rifalazil (25 Milligram) Compared With Azithromycin (1 Gram) for the Treatment of Uncomplicated Genital Chlamydia Trachomatis Infection in Women|Completed||Phase 2|82|Actual|ActivBiotics Pharma, LLC||2|||f||||f||||||||||2017-10-11 02:47:52.188866|2017-10-11 02:47:52.188866
NCT00006500|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2016-06-22|||April 2000||2000-04-01|June 2016|2016-06-01|March 2002||2002-03-01|||||Observational|||Trends in Trans-Fatty Acid Intake Between 1980 and 1997||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:28:25.241225|2017-10-11 04:28:25.241225
NCT01631188|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2013-11-13|||December 2011||2011-12-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Use of Transvenous Pacing Wire During Minimally Invasive Port Access Aortic Valve Surgery|Use of Transvenous Pacing Wire During Minimally Invasive Port Access Aortic Valve Surgery|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-10-11 02:47:52.327067|2017-10-11 02:47:52.327067
NCT01631175|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-05-13|||January 2011||2011-01-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Indication-based Identification and Psychosocial Treatment of Orthopedic Cancer Patients|Establishment of an Indication-based Identification and Psychosocial Treatment of Orthopedic Cancer Patients Suffering From Psychosocial Stress|Completed||Phase 3|100|Actual|Technische Universität München||1|||f||||t||||||||||2017-10-11 02:47:52.428567|2017-10-11 02:47:52.428567
NCT01631162|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-06-28|||May 2012||2012-05-01|June 2012|2012-06-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|PHNOSE||The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples|Application of Nanotechnology and Chemical Sensors for Lung Diseases by Respiratory Samples|Unknown status|Recruiting|N/A|500|Anticipated|Carmel Medical Center||1|||f||||f||||||||||2017-10-11 02:47:52.505033|2017-10-11 02:47:52.505033
NCT01631149|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-08-23|2013-04-12||June 2012||2012-06-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|BLISS||Effect of Deep BLock on Intraoperative Surgical Conditions|Effect of Deep BLock on Intraoperative Surgical Conditions, Perioperative Hemodynamic Status and Respiratory Parameters Following Reversal With Sugammadex in Patients Undergoing Laparoscopic Renal and Prostate Surgery.|Completed||Phase 4|24|Actual|Leiden University Medical Center||2|||f||||f||||||||Undecided||2017-10-11 02:47:52.60598|2017-10-11 02:47:52.60598
NCT01631136|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-09-01|||July 2012||2012-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer|Phase III Study Evaluating Two Strategies of Maintenance, One With Pemetrexed in Continuous Strategy and One According to the Response of Induction Chemotherapy, in Non Squamous Non Small Cell Lung Cancer of Advanced Stage|Active, not recruiting||Phase 3|932|Actual|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||t||||||||Undecided||2017-10-11 02:47:52.971986|2017-10-11 02:47:52.971986
NCT01631123|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2013-01-23|||September 2009||2009-09-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|January 2010|Actual|2010-01-01||Interventional|NUGAT||NUtriGenomic Analysis in Twins|Genetic Determinants of Metabolic Responses to Isocaloric Carbohydrate and Fat Diet Strategies|Completed||N/A|120|Actual|German Institute of Human Nutrition||1|||f||||f||||||||||2017-10-11 02:47:53.336659|2017-10-11 02:47:53.336659
NCT01631110|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-12-19|2013-10-25||July 2012||2012-07-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains|Open, Non-randomized Trial to Assess the Immunogenicity and Safety of the 2012/2013-Season Influenza Vaccine in Elderly and Young Subjects According to EMA Regulations|Completed||Phase 3|110|Actual|Crucell Holland BV||2|||f||||f||||||||||2017-10-11 02:47:53.452656|2017-10-11 02:47:53.452656
NCT01631097|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2014-01-23|||May 2012||2012-05-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function|A Phase 1, Open-label, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function|Completed||Phase 1|44|Anticipated|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:47:53.931537|2017-10-11 02:47:53.931537
NCT01631084|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2016-12-29|||April 2012||2012-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AP-JD||Comparing the Effect of Structured Care Versus Usual Care in Type 2 Diabetes Patients Across the Asia Pacific Region|A Multicentre Randomized Program to Compare the Effect of the Joint Asia Diabetes Evaluation (JADE, Structured Care) Versus the DIAbetes MONitoring Database (DIAMOND, Usual Care) Programs in Type 2 Diabetes in the Asia Pacific Region|Active, not recruiting||N/A|50000|Anticipated|Asia Diabetes Foundation||2|||f||||t||||||||||2017-10-11 02:47:54.016829|2017-10-11 02:47:54.016829
NCT01631071|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-12-19|2013-10-25||July 2012||2012-07-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains|Open, Non-randomized Trial to Assess the Immunogenicity and Safety of the 2012/2013-Season Virosomal Subunit Influenza Vaccine in Elderly and Young Subjects According to EMA Regulations|Completed||N/A|110|Actual|Crucell Holland BV||2|||f||||f||||||||||2017-10-11 02:47:54.107145|2017-10-11 02:47:54.107145
NCT01631058|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-12-03|||July 2012||2012-07-01|January 2013|2013-01-01|June 2019|Anticipated|2019-06-01|July 2014|Actual|2014-07-01||Interventional|||Renal Transplantation in the Elderly - nEverOld Study|Immunosuppression in Renal Transplantation in The Elderly: Time to Rethink. - nEverOld Study|Recruiting||Phase 4|90|Anticipated|University of Sao Paulo General Hospital||1|||f||||t||||||||||2017-10-11 02:47:54.438591|2017-10-11 02:47:54.438591
NCT01631045|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2013-07-02|||April 2010||2010-04-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|Satiety||The Effect of a Meal on Brain Activation in Reward Pathways|The Effect of a Meal on Brain Activation in Reward Pathways|Completed||N/A|24|Actual|University of Washington|||7||f||||t||||||||||2017-10-11 02:47:54.551952|2017-10-11 02:47:54.551952
NCT01631032|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2015-08-05|||July 2012||2012-07-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis|Phase 3 Study of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis|Completed||Phase 3|112|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:47:54.620265|2017-10-11 02:47:54.620265
NCT01631019|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-07-04|||January 2007||2007-01-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|December 2007|Actual|2007-12-01||Interventional|||Mobile-phone-based Home Exercise in Chronic Obstructive Pulmonary Disease|Influence of Long-term Cell-phone Based Home Exercise on Biomarkers, Skeletal Muscle and Mortality in Patients With COPD|Completed||Phase 2|26|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:47:54.733276|2017-10-11 02:47:54.733276
NCT01630824|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2013-05-21|||June 2012||2012-06-01|May 2013|2013-05-01||||June 2014|Anticipated|2014-06-01||Interventional|||Development and Effects of a Structural Education Program in Adult Kidney Transplant Recipients|Development an Effects of a Structural Education Programm in Adult Kidney Transplant Recipients|Unknown status|Recruiting|N/A|180|Anticipated|University of Jena||2|||f||||f||||||||||2017-10-11 02:47:56.366467|2017-10-11 02:47:56.366467
NCT01631006|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-12-18|||January 2012||2012-01-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|CPAPandHCM||Effects of Continous Positive Airway Pressure (CPAP) in Hypertrophic Cardiomyopathy|Acute Hemodynamic Effects of Continous Positive Airway Pressure (CPAP) in Patients With Hypertrophic Cardiomyopathy|Completed||N/A|26|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:47:55.033455|2017-10-11 02:47:55.033455
NCT01630993|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-10-01|||May 2008||2008-05-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|April 2009|Actual|2009-04-01||Interventional|||Milking the Umbilical Cord at Term Cesarean Birth|Milking the Umbilical Cord at Term Cesarean Birth: Effect on Hemoglobin Levels in the First 48 Hours of Life|Completed||Early Phase 1|24|Actual|University of Rhode Island||2|||f||||t||||||||||2017-10-11 02:47:55.108151|2017-10-11 02:47:55.108151
NCT01630980|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2015-05-26|||May 2012||2012-05-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome|Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome: A Systematic Review and Meta-analysis of Controlled Dietary Trials to Provide Evidence-based Guidance for Nutrition Guidelines Development|Completed||N/A|1|Actual|University of Toronto|||1||f||||f||||||||||2017-10-11 02:47:55.194197|2017-10-11 02:47:55.194197
NCT01630967|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-06-27|||August 2012||2012-08-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)|A Phase II Single Arm Study of Degarelix in Men With Castrate Resistant Prostate Cancer With a Rising Prostate-Specific Antigen (PSA) Despite LHRH Agonist Therapy.|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 02:47:55.283145|2017-10-11 02:47:55.283145
NCT01630954|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2016-03-22|||June 2012||2012-06-01|March 2016|2016-03-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole|A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform|Recruiting||Phase 4|120|Anticipated|Nilratan Sircar Medical College||2|||f||||t||||||||||2017-10-11 02:47:55.393895|2017-10-11 02:47:55.393895
NCT01630941|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-04-04|||August 7, 2012|Actual|2012-08-07|April 2017|2017-04-01|March 30, 2017|Actual|2017-03-30|January 16, 2017|Actual|2017-01-16||Interventional|||Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty|Uncemented Total Hip Implant and Subcutaneous Injections of Denosumab for Patients With Osteoarthritis of the Hip. A Randomized Double Blind Placebo Controlled Study on the Effects on Bone Evaluated With DXA, PET/CT and Biochemical Markers|Completed||Phase 2|64|Actual|Uppsala University Hospital||2|||f||||f||||||||||2017-10-11 02:47:55.488217|2017-10-11 02:47:55.488217
NCT01630928|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-05-13|||March 2013||2013-03-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Re-Shape||Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors|Renal Sympathetic Denervation for Treatment Resistant Hypertension and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors (The Re-Shape CV-Risk Study)|Completed||N/A|50|Actual|University Hospital of North Norway||1|||f||||t||||||||||2017-10-11 02:47:55.575523|2017-10-11 02:47:55.575523
NCT01630915|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27||||||June 2012|2012-06-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Clopidogrel Tablets Under Fed Condition|An Open Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Crossover, Single-Dose Bioequivalence Study of Clopidogrel Tablets USP 75mg [Test Formulation, Torrent Pharmaceutical Limited., India] Versus Plavix® (Clopidogrel Bisulfate Tablets) 75mg [Reference Formulation, Bristol-Myers Squibb/Sanofi Pharmaceuticals, USA], in Healthy Human Volunteers Under Fed Condition|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 02:47:55.670516|2017-10-11 02:47:55.670516
NCT01630902|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27||||||June 2012|2012-06-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Felodipine Extended-Release Tablets Under Fed Condition|An Open Label, Randomised, 2-period, 2-treatment, 2-sequence, Cross-over, Single-dose Bioequivalence Study of Felodipine Extended-Release Tablets USP 10 mg (Test, Torrent Pharmaceuticals Ltd., India) Versus Felodipine Extended-Release Tablets USP 10 mg (Reference, Mylan Pharmaceuticals Inc., USA) in Healthy Human Volunteers Under Fed Condition|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 02:47:55.731457|2017-10-11 02:47:55.731457
NCT01630889|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-04-14|||May 2012||2012-05-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|||Open Label Extension Study for the Long-term Efficacy and Safety of FG-4592 in Dialysis and Non-dialysis Chronic Kidney Disease Patients|Open-Label Extension Study to Evaluate the Efficacy and Safety of FG-4592 for the Long-Term Maintenance Treatment of Anemia in Dialysis and Non-Dialysis Patients With Chronic Kidney Disease|Enrolling by invitation||Phase 2/Phase 3|50|Anticipated|FibroGen||1|||f||||t||||||||Yes||2017-10-11 02:47:55.797875|2017-10-11 02:47:55.797875
NCT01630876|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-10-01|||January 2012||2012-01-01|October 2012|2012-10-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Outcomes of Vitrectomy Combined With Subtenon Triamcinolone Injection for the Idiopathic Epiretinal Membrane|Anatomic and Functional Outcomes of 23-gauge Vitrectomy Combined With Posterior Subtenon Triamcinolone Injection for the Treatment of Idiopathic Epiretinal Membrane|Unknown status|Recruiting|N/A|50|Anticipated|Yeungnam University College of Medicine||2|||f||||f||||||||||2017-10-11 02:47:55.970189|2017-10-11 02:47:55.970189
NCT01630863|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-02-13|||June 2012||2012-06-01|February 2015|2015-02-01|March 2015|Anticipated|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy|The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy|Unknown status|Recruiting|N/A|45|Anticipated|Yeungnam University College of Medicine||3|||f||||||||||||||2017-10-11 02:47:56.068922|2017-10-11 02:47:56.068922
NCT01630850|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-06-08|||May 2012||2012-05-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|May 2018|Anticipated|2018-05-01||Interventional|||"Islet Transplantation in Patients With Brittle Type I Diabetes"|"Islet Transplantation in Patients With Brittle Type I Diabetes"|Recruiting||N/A|20|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 02:47:56.173118|2017-10-11 02:47:56.173118
NCT01630837|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27|||May 2011||2011-05-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Frequency of Oral Hygiene|Frequency of Oral Hygiene in the Maintenance of Gingival Health|Completed||N/A|52|Actual|Universidade Federal de Santa Maria||4|||f||||t||||||||||2017-10-11 02:47:56.281294|2017-10-11 02:47:56.281294
NCT01630798|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-10-07|||July 2012||2012-07-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|NTR 1B||A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract|A Phase 1B In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract|Completed||Phase 1|60|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 02:47:56.56746|2017-10-11 02:47:56.56746
NCT01630785|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-05-30|||January 2012||2012-01-01|May 2016|2016-05-01|December 2023|Anticipated|2023-12-01|December 2022|Anticipated|2022-12-01||Observational|||Observation of Neurosurgical Interventions With Intraoperative Neurophysiological Monitoring IONM|Observation of Neurosurgical Interventions With Intraoperative Neurophysiological Monitoring IONM|Enrolling by invitation||N/A|5000|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 02:47:56.634891|2017-10-11 02:47:56.634891
NCT01630772|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-06-27|||June 2012||2012-06-01|June 2012|2012-06-01|February 2013|Anticipated|2013-02-01|January 2013|Anticipated|2013-01-01||Interventional|FPE||Physical Therapy in Pregnant Women With Preeclampsia|Influence of a Physical Therapy Protocol in Maternal and Fetal Hemodynamics in Pregnant Women With Preeclampsia|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 02:47:56.701643|2017-10-11 02:47:56.701643
NCT01630759|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2014-01-24|||January 2012||2012-01-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|Tele-Mum||Remote Monitoring of Diabetes in Pregnancy: a Feasibility Study|Remote Monitoring of Diabetes in Pregnancy: a Feasibility Study for a Randomised Controlled Trial|Completed||N/A|50|Actual|University of Ulster||2|||f||||t||||||||||2017-10-11 02:47:56.779363|2017-10-11 02:47:56.779363
NCT01630746|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-02-07|||July 2012||2012-07-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis||Completed||Phase 3|19|Actual|Takeda||2|||f||||||||||||||2017-10-11 02:47:56.892248|2017-10-11 02:47:56.892248
NCT01630733|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-06-29|||September 2012||2012-09-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer|A Multinational, Randomized, Open-Label Phase III Study of Custirsen (TV-1011/OGX-011) In Combination With Docetaxel Versus Docetaxel As A Second-Line Treatment In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer|Recruiting||Phase 3|700|Anticipated|Achieve Life Sciences||2|||f||||t||||||||||2017-10-11 02:47:57.01432|2017-10-11 02:47:57.01432
NCT01630720|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2015-08-31|||June 2011||2011-06-01|August 2015|2015-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Vitamin Therapy in JGH Patients|Vitamin Therapy in JGH Patients|Completed||Phase 2|88|Actual|Jewish General Hospital||2|||f||||f||||||||||2017-10-11 02:47:57.295302|2017-10-11 02:47:57.295302
NCT01630707|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2013-03-19|||August 2012||2012-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:47:57.381824|2017-10-11 02:47:57.381824
NCT01630694|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2015-12-14|2015-11-02||July 2010||2010-07-01|December 2015|2015-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Males and Females 18 years and older|Three-dimensional Craniofacial Phenotyping of Patients With Difficult Airway|Three -Dimensional (3-D) Craniofacial Phenotyping of Patients With Difficult Airway|Terminated||N/A|28|Actual|University of Rochester||2||study stopped due to not meeting enrollment goal.|f||||f||||||||||2017-10-11 02:47:57.430085|2017-10-11 02:47:57.430085
NCT01630681|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-02-15|||April 2013||2013-04-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|AdultCan||Internet Based Screening and Stepped Care for Cancer Patients With Anxiety and Depression Symptoms|Uppsala University Psychosocial Care Programme: Internet Based Screening and Stepped Care for Adult Cancer Patients With Anxiety and Depression Symptoms - A Randomized Controlled Trial|Completed||N/A|229|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 02:47:57.719822|2017-10-11 02:47:57.719822
NCT01630668|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-06-25|||August 2012||2012-08-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule||Completed||Phase 2|150|Actual|Micropharma Limited||2|||f||||f||||||||||2017-10-11 02:47:57.811192|2017-10-11 02:47:57.811192
NCT01630655|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27||||||June 2012|2012-06-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Felodipine Extended-Release Tablets Under Fasting Condition|An Open Label, Randomised, 2-period, 2-treatment, 2-sequence, Cross-over, Single-dose Bioequivalence Study of Felodipine Extended-Release Tablets USP 10 mg (Test, Torrent Pharmaceuticals Ltd., India) Versus Felodipine Extended-Release Tablets USP 10 mg (Reference, Mylan Pharmaceuticals Inc., USA) in Healthy Human Volunteers Under Fasting Condition|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 02:47:57.877161|2017-10-11 02:47:57.877161
NCT01630642|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-26||||||June 2012|2012-06-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Clopidogrel Tablets Under Fasting Conditions|An Open Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Crossover, Single-Dose Bioequivalence Study of Clopidogrel Tablets USP 75mg [Test Formulation, Torrent Pharmaceutical Limited., India] Versus Plavix® (Clopidogrel Bisulfate Tablets) 75mg [Reference Formulation, Bristol-Myers Squibb/Sanofi Pharmaceuticals, USA], in Healthy Human Volunteers Under Fasting Condition.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||f||||||||||2017-10-11 02:47:57.936994|2017-10-11 02:47:57.936994
NCT01630629|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-06-15|||August 2012||2012-08-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Longitudinal Lactation Bone Density Study|"Bone Density and Calcitropic Hormones During Lactation in African-American and Caucasian Women"|Completed||N/A|77|Actual|University of Pittsburgh|||2||f||||f||||||Samples Without DNA|"     Blood and breast milk   "|No||2017-10-11 02:47:58.006059|2017-10-11 02:47:58.006059
NCT01617486|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-06-08|||January 2007||2007-01-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|BALANCE||Achieving Energy Balance in Post Partum Teens|Achieving Energy Balance in Overweight Post Partum Teens|Completed||N/A|1325|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 02:51:23.893151|2017-10-11 02:51:23.893151
NCT01630603|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-02-11|||July 2012||2012-07-01|June 2012|2012-06-01||||July 2014|Anticipated|2014-07-01||Observational|Vitamin D||Maternal Vitamin D Status and Neonatal Bone Strength|Maternal Vitamin D Status and Neonatal Bone Strength|Unknown status|Recruiting|N/A|100|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 02:47:58.190935|2017-10-11 02:47:58.190935
NCT01630590|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-04-17|||January 8, 2014|Actual|2014-01-08|April 2017|2017-04-01|January 8, 2019|Anticipated|2019-01-08|January 8, 2019|Anticipated|2019-01-08||Interventional|||Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer|An Observational Study of XL-184 Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer|Active, not recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:47:58.448928|2017-10-11 02:47:58.448928
NCT01630577|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-05-04|||January 2012||2012-01-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|CVPCHI||Central Venous Pressure Change With Volume Challenge in Patients With Hemodynamic Instability|Early Change of Central Venous Pressure With Volume Challenge as Predictor of Fluid Responsiveness in Patients With Hemodynamic Instability|Completed||Phase 3|70|Actual|University of Monastir||1|||f||||t||||||||Undecided||2017-10-11 02:47:58.547065|2017-10-11 02:47:58.547065
NCT01630564|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-04-03|||March 2013|Actual|2013-03-01|April 2017|2017-04-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Phase I Study of Cord Blood Lymphocyte Infusion|Phase I Study of Ex Vivo Expanded Donor Cord Blood T-Lymphocyte Infusion in Post-Transplant Relapsed Patients|Active, not recruiting||Phase 1|18|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:47:58.628649|2017-10-11 02:47:58.628649
NCT01630551|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-02-24|||April 2012||2012-04-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Omega 3 Supplementation and Ocular Surface Disease in Glaucoma|Omega-3 Fatty Acid Nutritional Supplementation in the Treatment of Ocular Surface Disease Associated With Intraocular Pressure-Lowering Medications|Withdrawn||N/A|0|Actual|University of Illinois at Chicago||2||No participants enrolled|f||||f||||||||||2017-10-11 02:47:58.710771|2017-10-11 02:47:58.710771
NCT01630538|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-04-10|||June 2013||2013-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants|Phase II Pilot Study of Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection in Kidney Transplantation|Active, not recruiting||Phase 2|4|Actual|University of Manitoba||1|||f||||t||||||||Undecided||2017-10-11 02:47:58.790842|2017-10-11 02:47:58.790842
NCT01630525|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-01-22|||December 2012||2012-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|LYLO||" The Eyes Have it  : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease"||Completed||N/A|83|Actual|University Hospital, Bordeaux|||3||f||||f||||||||||2017-10-11 02:47:58.889648|2017-10-11 02:47:58.889648
NCT01630512|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2014-09-10|||May 2011||2011-05-01|September 2014|2014-09-01||||May 2014|Actual|2014-05-01||Interventional|||Mindfulness-Based Cognitive Therapy (MBCT) and Cognitive Behavioral Therapy (CBT) for Depression in Diabetes Patients|Mindfulness-Based Cognitive Therapy (MBCT) and Cognitive Behavioral Therapy (CBT) for Depression in Patients With Diabetes: a Randomized Controlled Trial|Completed||N/A|94|Actual|University Medical Center Groningen||3|||f||||f||||||||||2017-10-11 02:47:58.995975|2017-10-11 02:47:58.995975
NCT01630499|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-09-28|||October 2012||2012-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|MyLIFE||My Lifestyle Intervention of Food and Exercise|Preventing Breast Cancer Recurrence Through a Tailored Lifestyle Intervention.|Completed||N/A|87|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 02:47:59.089928|2017-10-11 02:47:59.089928
NCT01630486|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-04-21|||March 2011||2011-03-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|KNOW-CKD||KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease : A 10-year Longitudinal Cohort Study of the Chronic Kidney Disease|KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease|Active, not recruiting||N/A|2450|Actual|Seoul National University Hospital|||4||f||||f||||||Samples With DNA|"     A biobank is also established for the DNA, serum and urine taken at regular interval.   "|||2017-10-11 02:47:59.224509|2017-10-11 02:47:59.224509
NCT01630473|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-08-13|||August 2011||2011-08-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Corticotomy on the Orthodontic Tooth Movement|Clinical Comparison Between the Corticotomy-assisted Orthodontics and Conventional Orthodontics|Completed||N/A|10|Actual|Universidad de Antioquia||2|||f||||t||||||||||2017-10-11 02:47:59.398525|2017-10-11 02:47:59.398525
NCT01630460|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-09-08|||April 2009||2009-04-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|CMD||Genetic and Functional Analysis of Craniometaphyseal Dysplasia (CMD)|Identification of Mutations That Lead to Craniometaphyseal Dysplasia in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms|Recruiting||N/A|600|Anticipated|UConn Health|||1||f||||f||||||Samples With DNA|"     Saliva, blood, bone tissue   "|||2017-10-11 02:47:59.501426|2017-10-11 02:47:59.501426
NCT01630447|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-09-08|||April 2009||2009-04-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|CBM||Genetic and Functional Analysis of Cherubism|Identification of Mutations That Lead to Cherubism in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms|Recruiting||N/A|600|Anticipated|UConn Health|||1||f||||f||||||Samples With DNA|"     Saliva, blood, bone tissue   "|||2017-10-11 02:47:59.616171|2017-10-11 02:47:59.616171
NCT01630434|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-05-19||2015-11-02|November 2011||2011-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|September 2014|Actual|2014-09-01||Interventional|INSPIRE||International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation|Prospective, International, Multi-Center, Randomized Clinical Investigation of TransMedics Organ Care System (OCS LUNG) for Lung Preservation and Transplantation|Completed||Phase 3|316|Actual|TransMedics||2|||f||||t||||||||||2017-10-11 02:47:59.761321|2017-10-11 02:47:59.761321
NCT01630421|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-09-08|||April 2009||2009-04-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|ACC||Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)|Identification of Mutations That Lead to Aplasia Cutis Congenita in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms|Recruiting||N/A|600|Anticipated|UConn Health|||1||f||||f||||||Samples With DNA|"     Saliva, blood, bone tissue, skin   "|||2017-10-11 02:47:59.949797|2017-10-11 02:47:59.949797
NCT01630408|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2013-08-15|||March 2014||2014-03-01|August 2013|2013-08-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Interventional|AVID-LAVI||The Effects of Active VItamin D on Left Atrial Volume Index|A Pilot Study of the Effects of Active VItamin D on Left Atrial Volume Index in Patients With Heart Failure and Preserved Ejection Fraction|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||1||Investigator decided not to pursue.|f||||f||||||||||2017-10-11 02:48:00.06913|2017-10-11 02:48:00.06913
NCT01630395|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-04-20|||June 2012||2012-06-01|June 2012|2012-06-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of Recruitment Maneuver With Protective Ventilation During Thoracic Surgery|The Effect of Recruitment Maneuver With Protective Ventilation on the Pulmonary and Systemic Inflammatory Response to One-lung Ventilation|Completed||N/A|60|Actual|Seoul National University Hospital||3|||f||||||||||||||2017-10-11 02:48:00.161306|2017-10-11 02:48:00.161306
NCT01630382|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27|||June 2012||2012-06-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Observational|||Cerebrospinal Fluid Congestion in Spinal Stenosis Patients||Unknown status|Not yet recruiting|N/A|30|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 02:48:00.240123|2017-10-11 02:48:00.240123
NCT01630369|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-05-16|||February 2012||2012-02-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SPIRIT||Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes|Multicenter, Open, Non-randomized 6 Months Study to Evaluate Efficacy and Safety Insuman® Basal, Insuman® Comb 25, Insuman® Rapid in Insulin-naÏve Patients With T2DM Who Received Baseline Education Course in the Diabetes School.|Completed||Phase 4|552|Actual|Sanofi||1|||f||||t||||||||||2017-10-11 02:48:00.320708|2017-10-11 02:48:00.320708
NCT01630356|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27|||April 2010||2010-04-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Controlled Trial to Reduce Secondhand Smoke Exposure at Homes in Armenia|Monitoring Secondhand Smoke Exposure in Buildings in Armenia: Controlled Trial|Completed||N/A|250|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 02:48:00.415139|2017-10-11 02:48:00.415139
NCT01630343|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-06-29|||January 2010||2010-01-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Pain Management in Geriatric Hip Fracture|The Efficacy of Pain Management Protocol for Elderly Hip Fracture Patients After Surgery: A Prospective Cohort Study|Completed||Phase 2|400|Actual|Queen Elizabeth Hospital, Hong Kong||2|||f||||f||||||||||2017-10-11 02:48:00.537496|2017-10-11 02:48:00.537496
NCT01630330|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-26|||May 2012||2012-05-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Contact Force Sensing Use in Atrial Fibrillation Ablation|The Role of Contact Force Sensing in Electrical Pulmonary Vein Isolation When Conducting Atrial Fibrillation Ablation|Unknown status|Recruiting|N/A|40|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:48:00.66509|2017-10-11 02:48:00.66509
NCT01630317|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-04-25|||November 2011||2011-11-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|October 2013|Actual|2013-10-01||Interventional|||Slow Continuous Ultrafiltration Using Central vs Peripheral Line: Feasibility of Implementation, Safety and Efficacy in Acute Heart Failure Syndromes.|Slow Continuous Ultrafiltration Using Central vs Peripheral Line: Feasibility of Implementation, Safety and Efficacy in Acute Heart Failure Syndromes.|Active, not recruiting||N/A|33|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 02:48:00.777681|2017-10-11 02:48:00.777681
NCT01630304|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2015-12-17|||January 2013||2013-01-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||WelTel Retain: Promoting Engagement in Pre-ART HIV Care Through SMS|WelTel Retain: Promoting Engagement in Pre-ART HIV Care Through SMS|Active, not recruiting||N/A|700|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 02:48:00.863488|2017-10-11 02:48:00.863488
NCT01630291|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2014-12-08|||July 2012||2012-07-01|December 2014|2014-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Effect of Electrical Stimulation on Tear Production|A Non-Randomized, Open-Label Study to Determine the Effect of Electrical Stimulation on Tear Production|Completed||N/A|4|Actual|Oculeve, Inc.||1|||f||||f||||||||||2017-10-11 02:48:00.951521|2017-10-11 02:48:00.951521
NCT01630265|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-23|2012-06-27|||April 2010||2010-04-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Caregivers' Knowledge of Emergency Department Discharge Instructions Improves With the Use of Video||Completed||N/A|436|Actual|Augusta University||2|||f||||f||||||||||2017-10-11 02:48:01.134836|2017-10-11 02:48:01.134836
NCT01630252|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-06-02|||June 2012||2012-06-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|JADE||PGL5001 Proof of Concept Study in Inflammatory Endometriosis|A Phase IIa Efficacy and Safety Study of PGL5001 Versus Placebo Administered for up to 5 Months With Concomitant Administration of Depot Medroxyprogesterone Acetate for the Treatment of Peritoneal and/or Ovarian Endometriosis With an Inflammatory Component.|Completed||Phase 2|24|Actual|PregLem SA||5|||f||||t||||||||||2017-10-11 02:48:01.21544|2017-10-11 02:48:01.21544
NCT01630239|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2015-05-01|||June 2012||2012-06-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||MR-Guided Laser Ablation of Hepatic Tumors|Technical Success, Safety, and Short-term Efficacy for MR-Guided Laser Ablation of Hepatic Tumors|Completed||Early Phase 1|1|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:48:01.302111|2017-10-11 02:48:01.302111
NCT01630044|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-12-20|||May 2012||2012-05-01|December 2016|2016-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Neurostimulation Device for Treatment of Migraine Headache|Clinical Pilot Study to Evaluate a Non-Invasive, Neurostimulation Device for Treatment of Migraine Headache|Completed||N/A|7|Actual|Scion NeuroStim||1|||f||||f||||||||No||2017-10-11 02:48:04.763558|2017-10-11 02:48:04.763558
NCT01630226|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-07-10|||June 2007||2007-06-01|July 2012|2012-07-01||||December 2013|Anticipated|2013-12-01||Interventional|||Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland|Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland|Unknown status|Recruiting|Phase 2|100|Anticipated|Pomeranian Medical University Szczecin||1|||f||||f||||||||||2017-10-11 02:48:01.365343|2017-10-11 02:48:01.365343
NCT01630213|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-02-17|||July 2010||2010-07-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|October 2020|Anticipated|2020-10-01||Interventional|VITAL-Echo||Impact of Vitamin D Supplementation on Cardiac Structure and Function|Vitamin D and Omega-3 Trial: Ancillary Study (VITAL-Echo) on the Impact of Vitamin D Supplementation on Cardiac Structure and Function|Active, not recruiting||N/A|1000|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-11 02:48:01.455943|2017-10-11 02:48:01.455943
NCT01630200|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-09-21|||May 2012||2012-05-01|September 2015|2015-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|ELASTIC||Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)|Effects of ROFLUMILAST on Markers of Subclinical Atherosclerosis In Stable COPD; the ELASTIC-trial|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology||2|||f||||t||||||||||2017-10-11 02:48:01.552063|2017-10-11 02:48:01.552063
NCT01630187|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2013-05-27|||April 2012||2012-04-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section|Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony During Elective Cesarean Section: a Randomized Controlled Trial|Completed||Phase 4|72|Actual|Laval University||2|||f||||f||||||||||2017-10-11 02:48:01.659662|2017-10-11 02:48:01.659662
NCT01630174|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-27|2012-06-27|||October 2009||2009-10-01|June 2012|2012-06-01||||||||Observational|||IMRT/Pemetrexed/Cisplatin in Esophageal Cancer|Phase I Study of Concurrent Selective Lymph Node Late Course Accelerated Hyper-fractionated Radiotherapy and Pemetrexed, Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma|Unknown status|Recruiting|N/A|30|Anticipated|Shandong Cancer Hospital and Institute|||1||f||||t||||||||||2017-10-11 02:48:01.742081|2017-10-11 02:48:01.742081
NCT01630161|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-06-30|||January 4, 2012|Actual|2012-01-04|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|June 8, 2016|Actual|2016-06-08||Interventional|||Smoking Relapse-Prevention Intervention for Cancer Patients|Smoking Relapse-Prevention Intervention for Cancer Patients|Active, not recruiting||N/A|441|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-11 02:48:01.813365|2017-10-11 02:48:01.813365
NCT01630148|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-10-03|||July 2012||2012-07-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries|Bemiparin as a Thromboprophylaxis After Benign Gynaecological Surgeries:A Randomized Clinical Trial|Completed||N/A|774|Actual|Hawler Medical University||2|||f||||t||||||||||2017-10-11 02:48:01.912033|2017-10-11 02:48:01.912033
NCT01630135|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-11-20|2013-03-14||June 2012||2012-06-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis|Study FFR116364, a Double-blind, Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis|Completed||Phase 3|261|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:48:02.069227|2017-10-11 02:48:02.069227
NCT01630122|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-08-14|||June 2012|Actual|2012-06-01|August 2017|2017-08-01|August 18, 2015|Actual|2015-08-18|August 18, 2015|Actual|2015-08-18||Observational|||Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates|Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates|Completed||N/A|103|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-11 02:48:03.491331|2017-10-11 02:48:03.491331
NCT01630109|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-01-09|2013-08-23||December 2012||2012-12-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study of Metoclopramide in Small Bowel Capsule Endoscopy|Metoclopramide As An Adjunct To Small Bowel Capsule Endoscopy: Rate of Complete Evaluation And Affect on Transit Times|Completed||Phase 4|5|Actual|Genesys Regional Medical Center|The main limitation of this study was that there was a lower number of capsule studies performed at the study center than anticipated so it was difficult to find patients to enroll.|3|||f||||||||||||||2017-10-11 02:48:03.57605|2017-10-11 02:48:03.57605
NCT01630096|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-08-16|||June 2012||2012-06-01|August 2012|2012-08-01||||June 2014|Anticipated|2014-06-01||Interventional|COLITIS||Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe|COLITIS: Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe|Unknown status|Recruiting|Phase 4|200|Anticipated|Genesys Regional Medical Center||2|||f||||t||||||||||2017-10-11 02:48:03.957002|2017-10-11 02:48:03.957002
NCT01630083|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-06-30|||June 2012||2012-06-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|FAST||Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer|A Randomized Phase II Multicenter, Open-Label Study Evaluating the Efficacy and Safety of IMAB362 in Combination With the EOX Regimen as First-Line Treatment of Patients With CLDN18.2-positive Adenocarcinomas of the Stomach, the Esophagus or the Gastroesophageal Junction.|Active, not recruiting||Phase 2|252|Actual|Astellas Pharma Inc||3|||f||||t||||||||||2017-10-11 02:48:04.052398|2017-10-11 02:48:04.052398
NCT01630070|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-03-06|||January 2012||2012-01-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|PES-BTK-70||Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK Arteries|A Prospective, Multi-center, Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent in the Treatment of Atherosclerotic Tibial-peroneal Arteries|Completed||Phase 2/Phase 3|70|Actual|Flanders Medical Research Program||1|||f||||t||||||||||2017-10-11 02:48:04.43419|2017-10-11 02:48:04.43419
NCT01630057|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-16|2014-07-11|||September 2009||2009-09-01|July 2014|2014-07-01|July 2012|Actual|2012-07-01|June 2011|Actual|2011-06-01||Interventional|||Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug|An Open-label, Randomized, Multi-centre, Superiority Study to Compare, in Patients With Partial Onset Seizures, the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug|Completed||Phase 4|200|Actual|Eisai Inc.||2|||f||||t||||||||||2017-10-11 02:48:04.614856|2017-10-11 02:48:04.614856
NCT01630031|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-23|2012-06-26|||November 2010||2010-11-01|June 2012|2012-06-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Observational|||Contact Force Sensing and Pulmonary Vein Isolation|Pulmonary Vein Isolation: Interest of Real-Time Contact Force Sensing During Radiofrequency Catheter Ablation for Paroxysmal Atrial Fibrillation|Unknown status|Active, not recruiting|N/A|60|Actual|Clinique Pasteur|||2||f||||f||||||||||2017-10-11 02:48:04.872533|2017-10-11 02:48:04.872533
NCT01630018|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-09-20|||January 2011||2011-01-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial|A Phase Ⅱb, Randomized, Open, Parallel-Group, Multi-Center Trial to Assess the Efficacy and Safety of Belotecan(CamtoBell Inj.) or Topotecan in Patients With Recurrent or Refractory Ovarian Cancer|Completed||Phase 2|141|Actual|Chong Kun Dang Pharmaceutical||2|||f||||t||||||||||2017-10-11 02:48:04.976331|2017-10-11 02:48:04.976331
NCT01630005|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-10-30|||February 2011||2011-02-01|December 2010|2010-12-01|March 2013|Actual|2013-03-01|May 2012|Actual|2012-05-01||Interventional|PS-POST AVC||Talk Therapy After Stroke|Talk Therapy After Stroke. PS-POST AVC|Terminated||N/A|2|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 02:48:05.108309|2017-10-11 02:48:05.108309
NCT01629992|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27|||January 2009||2009-01-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Preoperative Counseling in Cholecystectomy|Preoperative Counseling in Cholecystectomy. A Randomized Trial|Completed||Phase 2/Phase 3|119|Actual|Federal University of Mato Grosso do Sul||2|||f||||t||||||||||2017-10-11 02:48:05.218893|2017-10-11 02:48:05.218893
NCT01629979|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-05-29|||May 2011||2011-05-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|VITICELL||Epidermal Cell Transplantation in Vitiligo Skin|Efficacy and Tolerance of Transplantation of Harvested Epidermal Cells and Narrow-Band UVB in Vitiligo|Completed||Phase 2/Phase 3|23|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 02:48:05.932333|2017-10-11 02:48:05.932333
NCT01629966|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-02-27||2015-02-27|June 2012||2012-06-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|VLZ-MD-05||Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder|A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.|Completed||Phase 3|680|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 02:48:06.063558|2017-10-11 02:48:06.063558
NCT01629940|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-12-17|||June 2012||2012-06-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Observational|ECP-013||Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status|Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status|Completed||N/A|36|Actual|Edimer Pharmaceuticals|||2||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:48:06.381656|2017-10-11 02:48:06.381656
NCT01629927|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27|||March 2012||2012-03-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Observational|ECP-012||Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)|Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)|Completed||N/A|30|Actual|Edimer Pharmaceuticals|||2||f||||f||||||||||2017-10-11 02:48:06.504592|2017-10-11 02:48:06.504592
NCT01629914|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-01-30|||June 2012||2012-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|EFMImaging||Executive Functioning and Mindfulness in Adults With Attention Deficit/Hyperactivity Disorder Imaging|Executive Functioning and Mindfulness in Adults With ADHD Imaging|Withdrawn||N/A|0|Actual|Duke University||1||study close-out|f||||f||||||||||2017-10-11 02:48:06.612986|2017-10-11 02:48:06.612986
NCT01629901|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2017-03-20|||June 2012||2012-06-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Caloric Stimulation on Cerebral Blood Flow|The Effect of Vestibular Stimulation on Cerebral Blood Flow|Completed||N/A|10|Actual|Duke University||1|||f||||f|f|f||||||||2017-10-11 02:48:06.690945|2017-10-11 02:48:06.690945
NCT01629888|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-10-07|||February 2010||2010-02-01|October 2016|2016-10-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||A Clinical Study for Evaluating the Safety of Excessive Consumption of a Plant Sterol-enriched Yoghurt Drink|A Clinical Study for Evaluating the Safety of Excessive Consumption of a Plant Sterol-enriched Yoghurt Drink|Completed||N/A|48|Actual|Danone Research||2|||f||||||||||||||2017-10-11 02:48:06.763039|2017-10-11 02:48:06.763039
NCT01629875|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-11-05|||March 2012||2012-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line|Efficacy and Safety of DWP450 Compared With Botox in Patients With Moderate to Severe Glabellar Line: Active Controlled, Double-blind, Randomized, Multi-center, Phase I/III Clinical Trial|Completed||Phase 3|268|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-11 02:48:06.838528|2017-10-11 02:48:06.838528
NCT01629862|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-05-26|||April 2012||2012-04-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea|Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.|Completed||Phase 2|53|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:48:06.909589|2017-10-11 02:48:06.909589
NCT01629849|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-05-15|||July 2012||2012-07-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 Tablets in Otherwise Healthy Controlled Asthmatic Subjects (Phase I, Randomised, Placebo-controlled, Double-blind Within Dose Groups)|Completed||Phase 1|84|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 02:48:06.991351|2017-10-11 02:48:06.991351
NCT01629823|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-04-06|2017-01-30||July 2012|Actual|2012-07-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|CPAP||Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP)|Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma|Completed||N/A|209|Actual|American Lung Association Asthma Clinical Research Centers||3|||f||||t||||||||||2017-10-11 02:48:07.13685|2017-10-11 02:48:07.13685
NCT01629810|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27|||August 2011||2011-08-01|June 2012|2012-06-01||||August 2013|Anticipated|2013-08-01||Interventional|Exer-Rest||Use of Whole-Body Periodic Acceleration Therapy To Aches and Pains|An Unblinded Crossover Study of The Use of Whole-Body Periodic Acceleration Therapy To Treat Pain, Stiffness, Abnormal Gait and Balance|Unknown status|Recruiting|Phase 3|30|Anticipated|Center for Translational Medicine||1|||f||||f||||||||||2017-10-11 02:48:07.99672|2017-10-11 02:48:07.99672
NCT01629797|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2013-04-29|2013-04-29||May 2012||2012-05-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne|Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne|Completed||N/A|100|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 02:48:08.090555|2017-10-11 02:48:08.090555
NCT01629784|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2013-04-15|2013-04-15||May 2012||2012-05-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus|Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus|Completed||N/A|31|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 02:48:08.496336|2017-10-11 02:48:08.496336
NCT01629771|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-02-24|2013-06-03||May 2012||2012-05-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India|Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India|Completed||N/A|72|Actual|Northwestern University|||2||f||||t||||||||||2017-10-11 02:48:08.808379|2017-10-11 02:48:08.808379
NCT01629758|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-03-05|||June 2012||2012-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors|A Phase 1 Dose Escalation Study of BMS-982470 (Recombinant Interleukin-21, rIL-21) in Combination With BMS-936558 (Anti-PD-1) in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|33|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 02:48:09.121159|2017-10-11 02:48:09.121159
NCT01629745|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-05-17|||June 2012||2012-06-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|August 2012|Actual|2012-08-01||Observational|||Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial|Feasibility of Minimal Residual Disease (MRD) Determination in Pediatric B-Lineage ALL Using Deep Sequencing of the Immunoglobulin Heavy Chain Locus|Completed||N/A|99|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 02:48:09.226046|2017-10-11 02:48:09.226046
NCT01629732|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-05-08|||March 2013||2013-03-01|May 2014|2014-05-01|June 2014|Anticipated|2014-06-01|February 2014|Anticipated|2014-02-01||Interventional|||Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C|Phase 2b Evaluation of PegIFNα Free Combinations of BMS-986094 (INX-08189) and Daclatasvir, With or Without Ribavirin, in Treatment Naive and Treatment Experienced Patients With Chronic Hepatitis C|Withdrawn||Phase 2|0|Actual|Bristol-Myers Squibb||7|||f||||f||||||||||2017-10-11 02:48:09.296275|2017-10-11 02:48:09.296275
NCT01629719|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2012-06-27|||June 2012||2012-06-01|June 2012|2012-06-01||||||||Observational|||Study Phase III Comparison of Superiority, Open With Blind Appraiser, to Evaluate the Efficacy and Safety of Barium Sulphate 66.7% With V (OPTI-BAR) Compared to Proceedings in Inert Radiological Examinations for the Diagnosis of Diseases for Image the Tratogastrointstinal|STUDY PHASE III COMPARISON OF SUPERIORITY, OPEN WITH BLIND APPRAISER, TO EVALUATE THE EFFICACY AND SAFETY OF BARIUM SULPHATE 66.7% W / V (OPTI-BAR) COMPARED TO PROCEEDINGS IN INERT RADIOLOGICAL EXAMINATIONS FOR THE DIAGNOSIS OF DISEASES FOR IMAGE THE TRATOGASTROINTSTINAL.|Unknown status|Not yet recruiting|N/A|73|Anticipated|Alko Do Brasil Industria e Comercio Ltda|||1||f||||f||||||||||2017-10-11 02:48:09.402604|2017-10-11 02:48:09.402604
NCT01629706|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2015-02-12|2015-01-29||September 2012||2012-09-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ABBOTSFORD|This analysis population includes all enrolled participants.|Determination of Cell Population in Solution-Induced Corneal Staining (SICS) and Symptomatic Versus Asymptomatic Lens Wearers|Determination of Cell Population in SICS and Symptomatic Versus Asymptomatic Lens Wearers|Completed||N/A|92|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:48:09.453314|2017-10-11 02:48:09.453314
NCT01629693|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2014-11-03|2014-11-03||July 2013||2013-07-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||This analysis population includes all randomized participants who utilized the study lenses.|Clinical Evaluation of Two Monthly Replacement Silicone Hydrogel Contact Lenses|Clinical Evaluation of Two Monthly Replacement Silicone Hydrogel Contact Lenses|Completed||N/A|398|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:48:11.52586|2017-10-11 02:48:11.52586
NCT01629680|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-26|||October 2010||2010-10-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||A Randomized, Placebo-controlled Study Investigating the Effects of Moxaverine on Ocular Blood Flow After Oral Administration in Healthy Subjects|A Randomized, Placebo-controlled Study Investigating the Effects of Moxaverine on Ocular Blood Flow After Oral Administration in Healthy Subjects|Completed||Phase 2|16|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:48:11.771751|2017-10-11 02:48:11.771751
NCT01629667|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-04-28|2017-01-19||October 2012||2012-10-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Interventional||The intent-to-treat (ITT) population is all randomized participants who receive any study investigational product and participants were analysed according to the randomization.|A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis|A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis|Terminated||Phase 2|409|Actual|MedImmune LLC|Study was early terminated due to lack of efficacy.|3||Early termination of the study due to lack of efficacy.|f||||t||||||||||2017-10-11 02:48:11.908637|2017-10-11 02:48:11.908637
NCT01629654|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-06-25|||March 2011||2011-03-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Poststroke Fatigue - Developing and Testing a Program to Reduce and Cope With Fatigue|Poststroke Fatigue - Developing and Testing a Program to Reduce and Cope With Fatigue|Completed||N/A|41|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 02:48:14.217583|2017-10-11 02:48:14.217583
NCT01629641|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-06-26|||January 2012||2012-01-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Observational|||Reliability and Validity of Goniometric iPhone Applications|Reliability and Validity of Goniometric iPhone Applications for the Assessment of Active Shoulder External Rotation|Completed||N/A|94|Actual|Texas Woman's University|||1||f||||f||||||||||2017-10-11 02:48:14.308491|2017-10-11 02:48:14.308491
NCT01629628|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-25|||July 2012||2012-07-01|June 2012|2012-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|POPART||Adalimumab for the Management of Post-operative Crohn's Disease (CD)|An Investigator Initiated Prospective, Single Center, Randomized, Open Label Study to Assess the Efficacy of Adalimumab for the Maintenance of Remission in Post-operative CD Patients|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 02:48:14.384352|2017-10-11 02:48:14.384352
NCT01629615|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-04-21|||June 2012||2012-06-01|July 2015|2015-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer|A Phase II Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer|Completed||Phase 2|50|Actual|SOLTI Breast Cancer Research Group||1|||f||||t||||||||||2017-10-11 02:48:14.493064|2017-10-11 02:48:14.493064
NCT01629602|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-06-26|||July 2008||2008-07-01|May 2011|2011-05-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Treatment of Soft Tissue Loss With Nerve Defect in the Finger Using the Boomerang Nerve Flap||Completed||N/A|49|Actual|The Second Hospital of Tangshan||1|||f||||f||||||||||2017-10-11 02:48:14.763199|2017-10-11 02:48:14.763199
NCT01629589|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-02-02|2013-08-16||June 2012||2012-06-01|February 2016|2016-02-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents|Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents|Completed||Phase 4|423|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:48:14.859181|2017-10-11 02:48:14.859181
NCT01629576|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-25|||March 2010||2010-03-01|June 2012|2012-06-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|Obesity||Obesity and Financial Incentives|Finanzielle Anreize Zur Reduktion Von Übergewicht|Unknown status|Active, not recruiting|Early Phase 1|700|Actual|Rhine-Westphalia Institute for Economic Research||3|||f||||||||||||||2017-10-11 02:48:15.467126|2017-10-11 02:48:15.467126
NCT01629563|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-12-07|||June 2012||2012-06-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|PEARLIV||PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata|A Phase III, Multicentre, Randomized, Double-blind Clinical Study, Investigating the Efficacy and Safety of Repeated 12-week Courses of Daily 5mg or 10mg Doses of PGL4001 for the Long-term Management of Symptomatic Uterine Fibroids|Completed||Phase 3|451|Actual|PregLem SA||2|||f||||t||||||||||2017-10-11 02:48:15.560978|2017-10-11 02:48:15.560978
NCT01629550|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-10-10|||October 2012||2012-10-01|March 2014|2014-03-01||||||||Interventional|CLEAN||Prospective Randomized Controlled Multicenter Trial of 4 Antiseptic Strategies for Prevention of Catheter Infection in Intensive Care Unit for Adults Patients||Completed||Phase 4|2400||Poitiers University Hospital||4|||f||||||||||||||2017-10-11 02:48:15.821792|2017-10-11 02:48:15.821792
NCT01629537|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-03-28|||June 2011||2011-06-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder|A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder|Completed||Phase 2|41|Anticipated|United States Naval Medical Center, San Diego||2|||f||||t||||||||||2017-10-11 02:48:15.959875|2017-10-11 02:48:15.959875
NCT01629524|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-01-28|||June 2012||2012-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Influence of Tumor Associated Immunity on the Number of Lymph Node Retrieved After Colorectal Cancer Surgery (Preliminary Study)||Completed||N/A|25|Actual|Yonsei University|||1||f||||f||||||Samples Without DNA|"     Serum and postoperative specimen   "|||2017-10-11 02:48:16.05831|2017-10-11 02:48:16.05831
NCT01629511|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-05-26|||November 2012|Actual|2012-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Allogeneic Stem Cell Transplant for Chronic Lymphocytic Leukemia (CLL)|Clofarabine, Gemcitabine and Busulfan Followed by Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)|Recruiting||Phase 1/Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:48:16.136959|2017-10-11 02:48:16.136959
NCT01629498|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-08-09|||September 2012|Actual|2012-09-01|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Intensity-Modulated Scanning Beam Proton Therapy (IMPT) With Simultaneous Integrated Boost (SIB)|Phase I/II Trial of Image-Guided, Intensity-Modulated Photon (IMRT) or Scanning Beam Proton Therapy (IMPT) Both With Simultaneous Integrated Boost (SIB) Dose Escalation to the Gross Tumor Volume (GTV) With Concurrent Chemotherapy for Stage II/III Non-Small Cell Lung Cancer (NSCLC)|Recruiting||Phase 1/Phase 2|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 02:48:16.334532|2017-10-11 02:48:16.334532
NCT01629485|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-04-30|||September 2011||2011-09-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Part vs Whole Task Mastery Training for Laparoscopic Hernia Repair|Part vs Whole Task Mastery Simulation Training for Laparoscopic Hernia Repair: A Randomized Trial|Completed||N/A|40|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:48:16.466546|2017-10-11 02:48:16.466546
NCT01629472|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-07-19|||October 2010||2010-10-01|July 2016|2016-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Protection From Gender-based Violence in Cote d'Ivoire|Protection From Gender-based Violence in Cote d'Ivoire|Completed||N/A|981|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:48:16.562692|2017-10-11 02:48:16.562692
NCT01629459|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-01-06|||June 2012||2012-06-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Resistance Exercise in Barth Syndrome|Effects of Resistance Exercise Training on Cardiac, Metabolic and Muscle Function and Quality of Life in Barth Syndrome|Recruiting||Phase 2|12|Anticipated|Washington University School of Medicine||1|||f||||t||||||||No||2017-10-11 02:48:16.648282|2017-10-11 02:48:16.648282
NCT01629446|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-05-01|||May 2012||2012-05-01|May 2017|2017-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Lofexidine Mass Balance in Volunteers|A Single-Center, Open-Label, Single-Period, Single-Treatment Study to Determine the Mass Balance of a Single Oral Dose of 14C Labeled Lofexidine|Completed||Phase 1|6|Actual|US WorldMeds LLC||1|||f||||f||||||||||2017-10-11 02:48:16.765673|2017-10-11 02:48:16.765673
NCT01629433|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-06-25|||January 2009||2009-01-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|June 2011|Actual|2011-06-01||Observational|Onab/A-NGF||Onabotulinumtoxina Intradetrusorial Injections and NGF Expression|PHASE IV STUDY ON THE EFFECTS OF ONABOTULINUMTOXINA INTRADETRUSORIAL INJECTIONS ON BLADDER EXPRESSION OF NGF, TRKA, P75 AND TRPV1 IN PATIENTS WITH DETRUSOR OVERACTIVITY|Completed||Phase 4|25|Actual|University Of Perugia|||1||f||||t||||||Samples With DNA|"     Bladder biopsy specimens obtained from the postero-lateral wall of the bladder with cold cup     resection. Deep bladder wall biopsy including urothelium and smooth muscle were performed. No     biopsies were taken from the bladder neck or the trigone.   "|||2017-10-11 02:48:16.853553|2017-10-11 02:48:16.853553
NCT01629420|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-05-29||||||May 2014|2014-05-01||||||||Interventional|||A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis|A Multicenter, Randomized, Open Label Phase II Study of KLH-2109 in Patients With Endometriosis(3)|Completed||Phase 2|20||Kissei Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:48:16.940001|2017-10-11 02:48:16.940001
NCT01629407|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-06-19|||June 2009||2009-06-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years||Completed||N/A|315|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:48:17.026145|2017-10-11 02:48:17.026145
NCT01629394|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2012-06-25|||January 2012||2012-01-01|June 2012|2012-06-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Interventional|||Comparative Study of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Morbidly Obese Patients|Comparative Study of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Morbidly Obese Patients Undergoing Weight Loss Surgery.Use of Acceleromyography Monitoring in Adductor Pollicis and Corrugator Supercilii.|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|University of Patras||8|||f||||t||||||||||2017-10-11 02:48:17.114355|2017-10-11 02:48:17.114355
NCT01629368|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-11-01|||June 2012||2012-06-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of the Effect of Carbamazepine on the Pharmacokinetics of RO4917523 in Healthy Volunteers|A Single-Center, Open-Label, One-Sequence, Crossover Study to Investigate the Effects of Multiple Doses of Carbamazepine on the Pharmacokinetics of a Single Dose RO4917523 in Healthy Subjects|Completed||Phase 1|16|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:48:17.519677|2017-10-11 02:48:17.519677
NCT01629355|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-08-31|||July 2012||2012-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Observational|||Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder|Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder|Completed||N/A|66|Actual|University Hospital of North Norway|||4||f||||f||||||||||2017-10-11 02:48:17.610053|2017-10-11 02:48:17.610053
NCT01629342|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-06-27|||June 2012||2012-06-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Observational|||Standardized Physical Activities Measured by Accelerometers||Unknown status|Recruiting|N/A|25|Anticipated|Hillerod Hospital, Denmark|||1||f||||t||||||||||2017-10-11 02:48:17.806773|2017-10-11 02:48:17.806773
NCT01629329|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-06-24|||November 2010||2010-11-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|Migraine||Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine|A Randomized, Double-blind Comparison of Single Dose Prochlorperazine Versus Acetaminophen, Aspirin and Caffeine for the Treatment of Acute Migraine in the Emergency Department.|Terminated||Phase 4|93|Actual|Albert Einstein Healthcare Network||2||no difference found between two groups in a preliminary analysis|f||||f||||||||||2017-10-11 02:48:17.93613|2017-10-11 02:48:17.93613
NCT01629316|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-06-09|||March 2012||2012-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|imPACT||Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX|CID 1007 - Randomized Controlled Trial of an Augmented Test, Treat, Link & Retain Model for NC and TX Prisoners (imPACT Study)|Completed||N/A|381|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 02:48:18.045799|2017-10-11 02:48:18.045799
NCT01629303|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2015-07-22|||June 2012||2012-06-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|November 2013|Actual|2013-11-01||Interventional|CONSTIMOD||Efficacy of Sacral Nerve Modulation in Severe Refractory Constipation|Efficacy of Sacral Nerve Modulation in Severe Refractory Constipation|Completed||Phase 2|20|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 02:48:18.144492|2017-10-11 02:48:18.144492
NCT01629290|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2017-04-09|2017-02-01||June 2012||2012-06-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes|In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes|Completed||N/A|15|Actual|University of Michigan||4|||f||||f|f|t|f|f|f|||No||2017-10-11 02:48:18.252282|2017-10-11 02:48:18.252282
NCT01629277|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-04|2012-06-26|||July 2011||2011-07-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Closing the Loop in Adolescents During Non-compliance Behaviours|An Open-label, Single-centre, Randomised, 2-period Cross-over Study to Assess the Efficacy and Safety of 24-hour Closed-loop Glucose Control in Comparison With Conventional Subcutaneous Insulin Pump Treatment Simulating Non-compliant Behaviours in Adolescents With Type 1 Diabetes|Completed||Phase 2|12|Actual|University of Cambridge||2|||f||||f||||||||||2017-10-11 02:48:18.613859|2017-10-11 02:48:18.613859
NCT01629264|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2016-03-14|||June 2012||2012-06-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||The Influence of Hormonal Changes During Pregnancy on Corneal Biomechanics in Humans|Influence of Pregnancy-related Hormonal Fluctuations on Corneal Biomechanics in Humans|Completed||N/A|50|Actual|University Hospital, Geneva|||1||f||||t||||||||Undecided||2017-10-11 02:48:18.701017|2017-10-11 02:48:18.701017
NCT01629251|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-05|2012-06-25|||April 2011||2011-04-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing||Completed||Phase 2|8|Actual|University of Cambridge||2|||f||||f||||||||||2017-10-11 02:48:18.800467|2017-10-11 02:48:18.800467
NCT01629212|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-26|||December 2011||2011-12-01|June 2012|2012-06-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome|Comparative and Analytical Study for Effectiveness and Safety of Tiropramide HCl and Octylonium Bromide in the Treatment of Irritable Bowel Syndrome: Mullticenter, Randomized, Double Blind, Active Controlled Study|Unknown status|Recruiting|Phase 4|||Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-11 02:48:19.071129|2017-10-11 02:48:19.071129
NCT01629199|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-08-01|||October 2010||2010-10-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus|The Clinical Trial for Evaluation of Efficacy and Safety of rhEGF(Recombinant Human Epidermal Growth Factor) in Diabetic Foot Ulcer Patients With Uncontrolled Diabetes Mellitus.|Completed||Phase 3|176|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||||||||||||2017-10-11 02:48:19.164601|2017-10-11 02:48:19.164601
NCT01629186|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2012-06-24|||January 2007||2007-01-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|NPO-NC-AC||Nose-close and Abdomen-compression in Pediatric Flexible Bronchoscopy|Nasopharyngeal Oxygen With Nose-close and Abdomen-compression in Pediatric Flexible Bronchoscopy|Completed||N/A|156|Actual|Taipei Veterans General Hospital, Taiwan||1|||f||||t||||||||||2017-10-11 02:48:19.254605|2017-10-11 02:48:19.254605
NCT01629173|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2012-06-24|||April 2011||2011-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Analysis and Applications of Dynamic Impression Insole|The Effect of Dynamic Impression Insoles on Plantar Pressure and Pain in Persons With Metatarsal Pain|Completed||Early Phase 1|50|Actual|Taipei Veterans General Hospital, Taiwan||4|||f||||t||||||||||2017-10-11 02:48:19.349983|2017-10-11 02:48:19.349983
NCT01629160|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-01-13|||July 2012||2012-07-01|January 2014|2014-01-01||||January 2014|Actual|2014-01-01||Observational|||Ventricular Wall Motion Characterization|Characterization of Normal and Abnormal Ventricular Wall Motion|Completed||N/A|30|Actual|St. Jude Medical|||1||f||||t||||||||||2017-10-11 02:48:19.446521|2017-10-11 02:48:19.446521
NCT01629147|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-05-21|||July 2014||2014-07-01|May 2014|2014-05-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Treatment of Chronic Constipation in Children With Lactobacillus Reuteri|Treatment of Chronic Constipation in Children With Lactobacillus Reuteri (Biogaia): A Prospective Placebo-controlled Trial|Unknown status|Not yet recruiting|N/A|40|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:48:19.506632|2017-10-11 02:48:19.506632
NCT01629134|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-10-03|2013-03-21||June 2012||2012-06-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips||Completed||N/A|62|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:48:19.612992|2017-10-11 02:48:19.612992
NCT01629121|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-06-19|||September 2010||2010-09-01|June 2013|2013-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Prevention of Traumatic Brain Injury in Youth and Adolescents|Prevention of Traumatic Brain Injury in Youth and Adolescents|Completed||Phase 1|120|Actual|Augusta University||2|||f||||f||||||||||2017-10-11 02:48:19.955844|2017-10-11 02:48:19.955844
NCT01629108|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-06-30|||June 14, 2012||2012-06-14|April 4, 2017|2017-04-04||||||||Observational|||Normal Values in Hearing and Balance Testing|Normative Values in Audiovestibular Testing|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:48:20.053685|2017-10-11 02:48:20.053685
NCT01629095|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-10-05|||June 1, 2012||2012-06-01|January 9, 2017|2017-01-09||||||||Observational|||Genetic Studies of Non-Alcoholic Fatty Liver Disease|Genetic Studies of Non-Alcoholic Fatty Liver Disease|Completed||N/A|17|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:48:20.132147|2017-10-11 02:48:20.132147
NCT01629082|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-06-30|||June 5, 2012||2012-06-05|February 13, 2017|2017-02-13|October 27, 2015|Actual|2015-10-27|October 27, 2015|Actual|2015-10-27||Interventional|||Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia|Clofarabine Followed by Lenalidomide for Treatment of High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia|Completed||Phase 1|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:48:20.202408|2017-10-11 02:48:20.202408
NCT01629069|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2014-10-06|||September 2012||2012-09-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Transplant or Cancer Resilience Intervention|A Resilience Intervention Involving Mindfulness Training for Transplant and Cancer Patients and Their Caregivers|Completed||N/A|60|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 02:48:20.279531|2017-10-11 02:48:20.279531
NCT01629043|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-05-25|||July 2009||2009-07-01|May 2017|2017-05-01||||||||Observational|NPF-QII||National Parkinson Foundation Quality Improvement Initiative|National Parkinson Foundation Quality Improvement Initiative|Recruiting||N/A|10000|Anticipated|National Parkinson Foundation|||1||f||||f||||||||||2017-10-11 02:48:20.459601|2017-10-11 02:48:20.459601
NCT01629030|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-07-08|||June 2012||2012-06-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Risk Factors of Sternal Wound Infection After Coronary Artery Bypass Graft|Risk Factors of Sternal Wound Infection After Coronary Artery Bypass Graft|Unknown status|Recruiting|N/A|1850|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 02:48:20.606371|2017-10-11 02:48:20.606371
NCT01629017|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-10-31|||January 1995||1995-01-01|October 2016|2016-10-01|January 2099|Anticipated|2099-01-01|January 2099|Anticipated|2099-01-01||Observational|||Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation|Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation|Recruiting||N/A|800|Anticipated|Stanford University|||1||f||||||||||Samples With DNA|"     blood, saliva   "|||2017-10-11 02:48:20.762982|2017-10-11 02:48:20.762982
NCT01629004|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-12-19|||April 2011||2011-04-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Increasing Uptake of Colorectal Cancer Screening in Ontario|Increasing Uptake of Colorectal Cancer Screening in Ontario|Completed||N/A|5155|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 02:48:20.833657|2017-10-11 02:48:20.833657
NCT01628991|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-06-26|||April 2008||2008-04-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Behavioral Intervention Program and Vaginal Cones on SUI|Comparison of the Effect of Vaginal Cones and Behavioral Intervention Program on Urinary Stress Incontinence in Women|Completed||Phase 2/Phase 3|60|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:48:20.910336|2017-10-11 02:48:20.910336
NCT01628978|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-11-10|||June 2012||2012-06-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Verification of Appropriate Insertion Depth of Endotracheal Tube Placement|Verification of Appropriate Insertion Depth of Endotracheal Tube Placement in Infants and Young Children by Ultrasonography|Unknown status|Recruiting|N/A|60|Anticipated|Samsung Medical Center|||2||f||||f||||||||||2017-10-11 02:48:20.988171|2017-10-11 02:48:20.988171
NCT01628965|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2014-02-03|2014-02-03||January 2008||2008-01-01|February 2014|2014-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients|An Open-label Long-term Extension Trial From Phase II/III of SPM962 (243-07-001) in Early Parkinson's Disease Patients With Non-concomitant Treatment of L-dopa|Completed||Phase 2/Phase 3|143|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:48:21.166972|2017-10-11 02:48:21.166972
NCT01628952|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-03-19|||June 2012||2012-06-01|June 2012|2012-06-01||||January 2013|Actual|2013-01-01||Interventional|||Comparison of the Bilateral TAP Block Versus Curare in Muscle Relaxation of the Abdominal Wall During Laparoscopic Digestive Surgery: Prospective Randomized Study|Comparison of the Bilateral Transversus Abdominis Plane (TAP) Block Versus Curare in Muscle Relaxation of the Abdominal Wall During Laparoscopic Digestive Surgery: Prospective Randomized Study|Completed||Phase 4|60|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-11 02:48:21.520281|2017-10-11 02:48:21.520281
NCT01628939|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-06-24|||June 2009||2009-06-01|June 2012|2012-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Association Between Clinical Signs and MRI Findings of the Lumbar Facet Joints|Association Between Clinical Signs Assessed by Manual Segmental Examination and Findings of the Lumbar Facet Joints in Magnetic-resonance Scans in Subjects With and Without Current Low Back - a Prospective Single-blinded Study|Completed||N/A|150|Actual|Ruhr University of Bochum|||2||f||||f||||||||||2017-10-11 02:48:21.608514|2017-10-11 02:48:21.608514
NCT01628926|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-04-23|2014-02-03||June 2009||2009-06-01|April 2014|2014-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||6 subjects were excluded. Met the exclusion criteria: 2 of SPM962, 1 of ropinirole Lack of efficacy observation: 2 of SPM962, 1 of Placebo|A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients|A Double-Blind, 3-Arm, Parallel Group, Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients With Concomitant Treatment of L-dopa|Completed||Phase 3|420|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:48:21.716071|2017-10-11 02:48:21.716071
NCT01628913|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-03-09|2015-08-19||October 2012||2012-10-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors|Randomized Phase II Study of BEZ235 or Everolimus in Advanced Pancreatic Neuroendocrine Tumors|Terminated||Phase 2|62|Actual|Novartis|Trial terminated based on the results of a pre-planned interim analysis of the primary OM ( which demonstrated BEX235 not having improved PFS (progression free survival) vs everolimus)..The secondary OM analyses were not conducted|2||"This trial was terminated based on an interim analysis as BEZ235 did not demonstrate a   progression free survival advantage to everolimus treatment."|f||||f||||||||||2017-10-11 02:48:22.781278|2017-10-11 02:48:22.781278
NCT01628900|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2013-10-07|||May 2012||2012-05-01|June 2011|2011-06-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|PROPA||Prospective Study in the Emergency|New Prognostic Classification of Acute Pyelonephritis With Adaptation of the Therapeutic. Prospective Randomized Study in the Emergency|Terminated||Phase 2|23|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:48:23.622747|2017-10-11 02:48:23.622747
NCT01628887|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2013-07-12|||August 2012||2012-08-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors|Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors|Terminated||N/A|4|Actual|City of Hope Medical Center||1||Proposal will not be submitted and low accrual.|f||||t||||||||||2017-10-11 02:48:23.707597|2017-10-11 02:48:23.707597
NCT01628874|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2016-10-24|||September 2012||2012-09-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|JTIP||Jet Injection of 1% Buffered Lidocaine Versus Topical EMLA for Local Anesthesia Before Lumbar Puncture in Children|A Double-Blind, Randomized Controlled Trial of Jet Injection of 1% Buffered Lidocaine Versus Topical EMLA for Local Anesthesia Before Lumbar Puncture in Children|Completed||N/A|387|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:48:23.806653|2017-10-11 02:48:23.806653
NCT01628861|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-06-26|||March 2010||2010-03-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Point-of-Choice Prompts to Reduce Prolonged Sitting Time at Work|Point-of-Choice Prompts to Reduce Prolonged Sitting Time at Work: A Randomised Trial|Completed||Phase 1|30|Actual|Glasgow Caledonian University||2|||f||||f||||||||||2017-10-11 02:48:23.966995|2017-10-11 02:48:23.966995
NCT01628848|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-02-03|2014-02-03||August 2006||2006-08-01|February 2014|2014-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||Excluded 1 sebject of each arm by vaiolation of protocol|A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients|A Placebo-controlled Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients With Concomitant Treatment of L-dopa|Completed||Phase 2|174|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:48:24.086442|2017-10-11 02:48:24.086442
NCT01628835|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2016-08-23|||June 2012||2012-06-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Low Glycemic Index (GI) Diet Management for Pregnant Woman With Overweight|Low Glycemic Index Diet Intervention on Insulin Resistance of Overweight Pregnant Women.|Completed||N/A|400|Actual|Children's Hospital of Fudan University||2|||f||||t||||||||||2017-10-11 02:48:24.690201|2017-10-11 02:48:24.690201
NCT01628627|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-23|2012-06-26|||May 2006||2006-05-01|June 2012|2012-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy|Long Term, Double Blind, Randomized, Placebo Controlled Multi-center Study of FRE.M.S.- Frequency Modulated Neural Stimulation Lorenz Therapy™ in Symptomatic Diabetic Neuropathy|Completed||Phase 4|164|Actual|Lorenz Biotech S.p.A.||2|||f||||f||||||||||2017-10-11 02:48:27.695196|2017-10-11 02:48:27.695196
NCT01628822|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-04-27|||January 2012||2012-01-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Sophrodol-1||Efficacy Study of Relaxation to 12 Weeks Against Placebo in the Overall Care Chronic Pain in Patients With Fibromyalgia|Pilot Study, Prospective, Single Center,Randomized, Single Blind, Evaluating the Efficacy of Relaxation to 12 Weeks Against Placebo, in the Overall Care Chronic Pain in Patients With Fibromyalgia|Completed||Phase 3|80|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-11 02:48:24.783243|2017-10-11 02:48:24.783243
NCT01628809|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-07-27|||January 2011||2011-01-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Mindfulness-Based Meditation to Treat Stress in Unemployed Community Adults|Stress Reduction and Healthy Living in Pittsburgh|Completed||N/A|35|Actual|Carnegie Mellon University||2|||f||||f||||||||||2017-10-11 02:48:24.953204|2017-10-11 02:48:24.953204
NCT01628796|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-26|||July 2012||2012-07-01|June 2012|2012-06-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Ultrasound Examination and Guided Injection Into the Acromio-clavicular Joint|Ultrasound Measurement of the Acromio-clavicular Joint and Injection of Standard Contrast Material Into the Joint Under Ultrasonic Control|Unknown status|Not yet recruiting|N/A|30|Anticipated|The Baruch Padeh Medical Center, Poriya||1|||f||||t||||||||||2017-10-11 02:48:25.062229|2017-10-11 02:48:25.062229
NCT01628783|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2012-06-26|||June 2012||2012-06-01|June 2012|2012-06-01|October 2015|Anticipated|2015-10-01|December 2014|Anticipated|2014-12-01||Interventional|STRIDE||Sequence Towards Remission in Depression|Sequence Towards Remission in Depression|Unknown status|Recruiting|Phase 4|90|Anticipated|Helsinki University||2|||f||||f||||||||||2017-10-11 02:48:25.140111|2017-10-11 02:48:25.140111
NCT01628770|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-08-01|||May 2012||2012-05-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia|Iron Isomaltoside 1000 (Monofer)|Completed||N/A|271|Actual|Dow University of Health Sciences||2|||f||||t||||||||||2017-10-11 02:48:25.253335|2017-10-11 02:48:25.253335
NCT01628757|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-26|2016-05-13||||||May 2016|2016-05-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Observational|||Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer|Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer|Recruiting||N/A|1400|Anticipated|Huazhong University of Science and Technology|||1||f||||t||||||Samples With DNA|"     Samples with DNA from blood,TCT,pap smear,and hpv, as well as body fluid and tissues.   "|||2017-10-11 02:48:25.526551|2017-10-11 02:48:25.526551
NCT01628744|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2012-06-26|||January 2011||2011-01-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|||||Observational|||Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection||Unknown status|Recruiting|N/A|100|Anticipated|China Medical University Hospital|||1||f||||f||||||||||2017-10-11 02:48:25.636154|2017-10-11 02:48:25.636154
NCT01628731|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-24|2014-07-23|||October 2012||2012-10-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease|Phase III Study of Furosemide Continuous Infusion Versus Ethacrynic Acid Continuous Infusion in Children Undergoing Cardiac Surgery: Randomized Double Blind Controlled Clinical Trial|Completed||Phase 3|74|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||t||||||||||2017-10-11 02:48:25.725027|2017-10-11 02:48:25.725027
NCT01628718|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-05-19|||March 2013||2013-03-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Adaptive Disclosure|Adaptive Disclosure: A Combat-Specific PTSD Treatment|Active, not recruiting||N/A|266|Anticipated|Veterans Medical Research Foundation||2|||f||||t||||||||No||2017-10-11 02:48:25.839956|2017-10-11 02:48:25.839956
NCT01628705|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-07-19|||April 2007||2007-04-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|GTRoxLDL||Moderated-fat Diet Complemented With Green Tea Reduces oxLDL and Fat Mass in Obese Women|Moderated-fat Diet Complemented With Green Tea Reduces oxLDL and Fat Mass in Obese Women: A Randomized, Controlled Clinical Trial|Completed||Phase 4|64|Actual|University of Guadalajara||2|||f||||t||||||||||2017-10-11 02:48:25.945901|2017-10-11 02:48:25.945901
NCT01628692|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2017-01-10|2015-08-13||July 2012||2012-07-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional||The analysis was performed on the treated participants defined as all randomized participants who received at least 1 dose of active study therapy.|Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus|A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy With Genotype 1 Chronic Hepatitis C|Completed||Phase 2|230|Actual|Bristol-Myers Squibb||4|||f||||t||||||||||2017-10-11 02:48:26.052479|2017-10-11 02:48:26.052479
NCT01628679|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2017-05-30|||August 2012||2012-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Physiotherapy Intervention for Provoked Vulvar Vestibulodynia|Physiotherapy Intervention for Provoked Vulvar Vestibulodynia|Recruiting||N/A|50|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 02:48:27.169228|2017-10-11 02:48:27.169228
NCT01628666|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-09-26|||December 2012||2012-12-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Prevention of Arrhythmia Device Infection Trial (PADIT)|Prevention of Arrhythmia Device Infection Trial (PADIT) Cluster Crossover Study|Active, not recruiting||Phase 4|12814|Actual|Population Health Research Institute||2|||f||||t||||||||||2017-10-11 02:48:27.277288|2017-10-11 02:48:27.277288
NCT01628653|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-23|2012-06-23|||June 2011||2011-06-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|U-SMART||Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training|Feasibility and Efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (U-SMART) on Mild Cognitive Impairment|Completed||Phase 1|10|Actual|Seoul National University Bundang Hospital||1|||f||||t||||||||||2017-10-11 02:48:27.420479|2017-10-11 02:48:27.420479
NCT01628614|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-08-02|2012-08-02||November 2010||2010-11-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)||Completed||N/A|4812|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:48:27.8739|2017-10-11 02:48:27.8739
NCT01628601|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-08-21|2012-08-21||May 2010||2010-05-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy||Completed||N/A|392|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:48:28.121671|2017-10-11 02:48:28.121671
NCT01628588|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-25|2012-08-21|2012-08-21||March 2010||2010-03-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)||Completed||N/A|854|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:48:28.37811|2017-10-11 02:48:28.37811
NCT01628575|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-23|2012-06-26|||May 2012||2012-05-01|June 2012|2012-06-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Observational|||Periodontally Accelerated Orthodontics - A Novel Technique For a Shortened Orthodontic Treatment With a Stable Result. A Clinical and Computerized Tomography Analysis||Unknown status|Recruiting|N/A|20|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 02:48:28.650397|2017-10-11 02:48:28.650397
NCT01628562|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2015-02-14|||June 2012||2012-06-01|December 2012|2012-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol in Intracranial Surgery|A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol: a Double Blind Randomized Controlled Study|Completed||Phase 4|40|Actual|Diskapi Teaching and Research Hospital||2|||f||||f||||||||||2017-10-11 02:48:28.752226|2017-10-11 02:48:28.752226
NCT01628549|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2015-04-09||2013-12-11|June 2012||2012-06-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of P005672 in Treatment of Facial Acne Vulgaris|A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Different Doses of P005672 Compared to Placebo in the Treatment of Facial Acne Vulgaris|Completed||Phase 2|285|Actual|Warner Chilcott||4|||f||||f||||||||||2017-10-11 02:48:28.850022|2017-10-11 02:48:28.850022
NCT01628536|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-02-27|||June 2012||2012-06-01|February 2016|2016-02-01|June 2016|Actual|2016-06-01|January 14, 2016|Actual|2016-01-14||Interventional|||A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ|A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ|Completed||N/A|33|Actual|Yale University||1|||f||||t||||||||||2017-10-11 02:48:29.019408|2017-10-11 02:48:29.019408
NCT01628510|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-08-15|2013-12-17||January 2011||2011-01-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2011|Actual|2011-12-01||Interventional|||The Developmental Effects of NICU Positioning|Randomized Clinical Trial Investigating the Developmental Effects of Two Different Methods of Neonatal Positioning in the NICU|Completed||N/A|100|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 02:48:29.180949|2017-10-11 02:48:29.180949
NCT01628497|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-04-05|||May 2012||2012-05-01|April 2017|2017-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Exhaled NO Testing in Filariasis|Exhaled NO Testing in Filariasis|Completed||N/A|96|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||||2017-10-11 02:48:29.432906|2017-10-11 02:48:29.432906
NCT01628484|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-11-06|||July 2012||2012-07-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation|Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutaneous Allergen Exposure|Completed||Phase 1|20|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 02:48:29.488117|2017-10-11 02:48:29.488117
NCT01628471|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-09-21|||November 2012||2012-11-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer|A Phase I/IIa Dose-Escalation Study of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) Subjects|Completed||Phase 1/Phase 2|20|Actual|Uman Pharma||1|||f||||t||||||||||2017-10-11 02:48:29.568078|2017-10-11 02:48:29.568078
NCT01628458|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-01-29|||September 2012||2012-09-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|RFA of LAPC||Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer|Phase II Study: Radiofrequency Ablation of Locally Advanced Pancreatic Cancer|Completed||Phase 2|17|Actual|UMC Utrecht||1|||f||||t||||||||||2017-10-11 02:48:29.653239|2017-10-11 02:48:29.653239
NCT01628445|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-01-20|||August 2012||2012-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|SAIL||Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin|Phase 3 Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin|Terminated||Phase 3|52|Actual|University of Manitoba||2||Error made by local pharmacy caused mixed randomization of 20 participants|f||||f||||||||||2017-10-11 02:48:29.744521|2017-10-11 02:48:29.744521
NCT01628432|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-05-03|||July 2012||2012-07-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|August 2017|Anticipated|2017-08-01||Interventional|SALPINGOVA||Effect of Salpingectomy During Conservative Hysterectomy|Effect of Total Salpingectomy During Conservative Hysterectomy for Benign Disease on Ovarian Function: Non Inferiority Randomized Controlled Trial|Recruiting||N/A|350|Anticipated|University Hospital, Tours||2|||f||||f||||||||||2017-10-11 02:48:29.83613|2017-10-11 02:48:29.83613
NCT01628419|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-12-08|||July 2012||2012-07-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Health Promotion Intervention Program at the Workplace|Health Promotion Intervention Program at the Workplace|Completed||N/A|70|Actual|Wingate Institute||1|||f||||f||||||||||2017-10-11 02:48:30.063327|2017-10-11 02:48:30.063327
NCT00004762|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||December 1994||1994-12-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis||Completed||Phase 2|5||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.754023|2017-10-11 04:25:21.754023
NCT01628393|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-07-27||2016-05-04|September 18, 2012|Actual|2012-09-18|July 2017|2017-07-01|May 3, 2016|Actual|2016-05-03|April 15, 2014|Actual|2014-04-15||Interventional|||Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis Patients (Radiance Study)|A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients|Completed||Phase 2/Phase 3|258|Actual|Celgene||3|||f||||t||||||||||2017-10-11 02:48:30.270018|2017-10-11 02:48:30.270018
NCT01628380|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2014-08-27|||June 2012||2012-06-01|August 2014|2014-08-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|CHORINE||Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer|Stage IIIC Unresectable Epithelial Ovarian/Tubal Cancer With Partial or Complete Response After 1st Line Neoadjuvant Chemotherapy (3 Cycles CBDCA+Paclitaxel): a Phase 3 Prospective Randomized Study Comparing Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy (CDDP+Paclitaxel) + 3 Cycles CBDCA+Paclitaxel vs Cytoreductive Surgery Alone + 3 Cycles CBDCA+Paclitaxel.|Recruiting||Phase 3|94|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||t||||||||||2017-10-11 02:48:30.592268|2017-10-11 02:48:30.592268
NCT01628367|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-02-10|2016-12-20||July 2012||2012-07-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Guided Bone Regeneration Around Immediate Implants|The Effectiveness of the Cytoplast Technique in Preventing Bone Loss Around Immediate Implant Placement in the Esthetic Zone. A Randomized Clinical Trial.|Completed||Phase 4|32|Actual|University of Michigan||2|||f||||t||||||||No||2017-10-11 02:48:30.78114|2017-10-11 02:48:30.78114
NCT01628354|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-26|||February 2008||2008-02-01|June 2012|2012-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration|A Study to Investigate the Safety and Efficacy of Lucentis (Ranibizumab) in Patients With CNV Due to Causes Other Than AMD and in Patients Where Pigment Epithelial Detachments Are the Primary Manifestation of Their AMD.|Completed||Phase 4|49|Actual|University of Melbourne||1|||f||||t||||||||||2017-10-11 02:48:31.554268|2017-10-11 02:48:31.554268
NCT01628341|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-01-18|||May 2012||2012-05-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|DIALOG||French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients|French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients|Completed||N/A|4424|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 02:48:31.694036|2017-10-11 02:48:31.694036
NCT01628328|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-21|||July 2010||2010-07-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|||Colonic Stent and Tumor Cell Dissemination|Impact of Metallic Stent Insertion for Obstructing Colorectal Cancer on Circulating Tumor Cell Dissemination|Completed||N/A|40|Actual|The University of Hong Kong|||2||f||||f||||||||||2017-10-11 02:48:31.857081|2017-10-11 02:48:31.857081
NCT01628315|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-02-11|||March 2009||2009-03-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|March 2009|Actual|2009-03-01||Observational|ASA||Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study|Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study|Completed||N/A|159|Actual|University at Buffalo|||1||f||||f||||||||||2017-10-11 02:48:31.947525|2017-10-11 02:48:31.947525
NCT01628302|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-22|||March 2011||2011-03-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Salt Restriction on Renin Activation|Investigation of Salt Restriction Effect on Renin Activation|Completed||N/A|28|Actual|Turkish Society of Hypertension and Renal Diseases||2|||f||||f||||||||||2017-10-11 02:48:32.082567|2017-10-11 02:48:32.082567
NCT01628289|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-21|||February 2009||2009-02-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|||The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong|The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong|Completed||N/A|4644|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:48:32.174965|2017-10-11 02:48:32.174965
NCT01628276|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-09-11|||July 2012||2012-07-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Brain Functional Connectivity Changes Following Cognitive Rehabilitation in Multiple Sclerosis: an fMRI Study||Completed||N/A|45|Actual|Sina Hospital, Iran||3|||f||||t||||||||||2017-10-11 02:48:32.276127|2017-10-11 02:48:32.276127
NCT01628263|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-25|||December 2011||2011-12-01|June 2012|2012-06-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|PICUfu||Does a Follow-up Appointment Help Parents of Children on PICU?|Does Screening Parents Allow Targeting of a Paediatric Intensive Care Follow-up Clinic? A Feasibility Study|Unknown status|Recruiting|N/A|150|Anticipated|University Hospitals Bristol NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:48:32.364763|2017-10-11 02:48:32.364763
NCT01628250|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-05-21|2015-11-07||June 2012||2012-06-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|LCME||Laparoscopic Complete Mesocolic Excision on Colon Cancer|Clinical Research on the Efficacy and Feasibility of Laparoscopic Complete Mesocolic Excision on Colon Cancer: A Randomized Controlled Study|Completed||N/A|99|Actual|Ruijin Hospital||2|||f||||t||||||||||2017-10-11 02:48:32.485291|2017-10-11 02:48:32.485291
NCT01628237|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-02-13|||May 2012||2012-05-01|March 2014|2014-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|ESTIMET||Effectiveness and Cost Management of Multicolumn Spinal Cord Stimulation in Neuropathic Pain Patients With Failed Back Surgery Syndrome||Completed||N/A|115|Actual|Poitiers University Hospital||2|||f||||||||||||||2017-10-11 02:48:32.79269|2017-10-11 02:48:32.79269
NCT01628224|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-03-04|||October 2011||2011-10-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|February 2012|Actual|2012-02-01||Observational|||Enhanced Critical Care Air Transport Team Training for Mitigation of Task Saturation|Enhanced Critical Care Air Transport Team Training for Mitigation of Task Saturation|Completed||N/A|48|Actual|University of Cincinnati|||1||f||||f||||||||||2017-10-11 02:48:32.875446|2017-10-11 02:48:32.875446
NCT01628211|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-03-28|||April 2012||2012-04-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|September 2017|Anticipated|2017-09-01||Interventional|HIPEC||Second Look Laparoscopy in Colorectal Cancer|Randomized Phase 2 Study Comparing Second Look Laparoscopy to Standard Follow up in Patients With no Radiologic Evidence of Disease at 6 Months After Complete Resection of Colorectal Mucinous Carcinoma|Recruiting||Phase 2|140|Anticipated|National Cancer Institute, Naples||2|||f||||f||||||||||2017-10-11 02:48:32.957324|2017-10-11 02:48:32.957324
NCT01628185|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-12-16|||January 2012||2012-01-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Pain Assessment in the Intensive Care Unit|Pain Assessment in the Intensive Care Unit|Completed||N/A|30|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 02:48:33.192811|2017-10-11 02:48:33.192811
NCT01628172|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-06-28|||January 2011||2011-01-01|June 2016|2016-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|RELIEF||Renal Sympathetic Denervation for the Management of Chronic Hypertension|Renal Sympathetic Denervation for the Management of Chronic Hypertension|Completed||N/A|96|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-10-11 02:48:33.26808|2017-10-11 02:48:33.26808
NCT01628159|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-03-30|||June 2012||2012-06-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||LEVANT 2 Continued Access Registry|A Prospective, Multicenter, LEVANT 2 Continuation Registry of the Moxy™ Drug Coated Balloon for Treatment of Femoropopliteal Arteries|Active, not recruiting||N/A|675|Actual|C. R. Bard||1|||f||||t||||||||No|Not at this time.|2017-10-11 02:48:33.378813|2017-10-11 02:48:33.378813
NCT01628146|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-05-19|||September 2012||2012-09-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|||Prospective Investigation of SUPRACOR Visual Outcomes of Presbyopic Hyperopic Patients With and Without Astigmatism|PHASE IV STUDY # 1162. Prospective Investigation of SUPRACOR Visual Outcomes of Presbyopic Hyperopic Patients With and Without Astigmatism|Unknown status|Active, not recruiting|Phase 4|40|Anticipated|Technolas Perfect Vision GmbH||1|||f||||f||||||||||2017-10-11 02:48:33.572097|2017-10-11 02:48:33.572097
NCT01628133|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2014-06-18|||December 2011||2011-12-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Observational|||Packed Red Blood Cell Transfusion and Intestinal Blood Flow in Preterm Neonates|Packed Red Blood Cell Transfusion and Intestinal Blood Flow in Preterm Infants|Completed||N/A|25|Actual|St. Louis University|||1||f||||t||||||||||2017-10-11 02:48:33.659653|2017-10-11 02:48:33.659653
NCT01628120|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2015-12-22||2015-12-22|May 2012||2012-05-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|AiME - 04||A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin|A Phase 3, Open-Label, Multicenter, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment|Completed||Phase 3|173|Actual|Hospira, now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-10-11 02:48:33.825426|2017-10-11 02:48:33.825426
NCT01628107|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2015-12-22||2015-12-22|July 2012||2012-07-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|AiME - 03||A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin|A Phase 3, Open-Label, Multicenter, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment|Completed||Phase 3|414|Actual|Hospira, now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-10-11 02:48:33.984578|2017-10-11 02:48:33.984578
NCT01628094|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-11-01||2016-06-30|June 2012||2012-06-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment|Randomized, Open-Label, Multicenter Study of Safety, Efficacy, and Tolerability of the Combination of RO5466731, RO5190591, Ritonavir, and Copegus With or Without RO5024048 in HCV Genotype 1 Infected Patients Who Are Either Treatment Naïve or Null Responders to Previous Interferon-Based Treatment|Completed||Phase 2|110|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-11 02:48:34.147823|2017-10-11 02:48:34.147823
NCT01628081|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-25|||June 2012||2012-06-01|June 2012|2012-06-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||The Effect of Alga Dunaliella Bardawil on Psoriasis|A Randomized, Double-Blind, , Placebo Controlled, 18 Week Study To Evaluate the Efficacy of Adjuvant 9-cis-β-Carotene Rich Powder of the Alga Dunaliella Bardawil in Subjects With Plaque Type Psoriasis.|Unknown status|Recruiting|Phase 3|46|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:48:34.294422|2017-10-11 02:48:34.294422
NCT01628068|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-06-25|||February 2012||2012-02-01|June 2012|2012-06-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Interventional|ELIGIBLE||ELIGIBLE (Efficacy of Left atrIal Appendage Closure After GastroIntestinal BLEeding)|Efficacy of Left Atrial Appendage Closure After Gastrointestinal Bleeding|Unknown status|Recruiting|Phase 3|120|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 02:48:34.374656|2017-10-11 02:48:34.374656
NCT01628055|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2013-11-07|||March 2013||2013-03-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2013|Anticipated|2013-08-01||Interventional|IVIG/AIS||IVIG in Acute Ischemic Stroke: A Pilot Study|IVIG in Acute Ischemic Stroke: A Pilot Study|Withdrawn||Phase 1|0|Actual|Inova Health Care Services||2||difficult recruitment and new black box warning for IVIG|f||||f||||||||||2017-10-11 02:48:34.468233|2017-10-11 02:48:34.468233
NCT01628042|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-08-19|2016-06-27||July 2012||2012-07-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014)|An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency|Completed||Phase 1|32|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 02:48:36.227007|2017-10-11 02:48:36.227007
NCT01628029|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-06-20|||January 15, 2014|Actual|2014-01-15|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Multimodal Therapy for the Treatment of Sleep Disturbance in Patients With Advanced Cancer|Multimodal Therapy for the Treatment of Sleep Disturbance in Patients With Advanced Cancer|Active, not recruiting||Phase 2|68|Actual|M.D. Anderson Cancer Center||8|||f||||t|t|f||||||||2017-10-11 02:48:36.694797|2017-10-11 02:48:36.694797
NCT01628003|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-25|||August 2009||2009-08-01|June 2012|2012-06-01||||January 2014|Anticipated|2014-01-01||Interventional|||Study of Reserves After Traumatic Brain Injury|Study of Reserves After Traumatic Brain Injury:Influence of Brain, Cognitive, and Emotional Reserves on Long-Term Consequences of Traumatic Brain Injury|Unknown status|Active, not recruiting|N/A|240|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:48:37.380449|2017-10-11 02:48:37.380449
NCT01627990|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2015-07-23|||June 2011||2011-06-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Nivestim™ in Treatment of Malignant Diseases|The Compatibility of Nivestim™ Under Cytotoxic Chemotherapy in the Treatment of Malignant Diseases|Completed||N/A|386|Actual|Hospira, now a wholly owned subsidiary of Pfizer|||1||f||||f||||||Samples With DNA|"     -  CD34+ cell count in peripheral blood (low/high at Visit 1)        -  Concentrations of haemoglobin, thrombocytes, leukocytes, neutrophil and CRP are          represented across time (v1, 2 and 3)   "|||2017-10-11 02:48:37.476535|2017-10-11 02:48:37.476535
NCT01627977|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-03-15|||October 2012||2012-10-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy|A Descriptive Study to Evaluate the Effectiveness of the Dye Compound of the Combination of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy|Completed||Phase 3|18|Actual|Federal University of São Paulo||1|||f||||t||||||||Yes|data published: Graefes Arch Clin Exp Ophthalmol. 2014 Jul;252(7):1071-8.|2017-10-11 02:48:37.778731|2017-10-11 02:48:37.778731
NCT01627964|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-06-25|||August 2011||2011-08-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Motion Analysis and Assessment of Cardiac Function for Cardiac Images|Motion Analysis and Assessment of Cardiac Function for Cardiac Images|Completed||N/A|20|Actual|Far Eastern Memorial Hospital|||2||f||||f||||||||||2017-10-11 02:48:37.88558|2017-10-11 02:48:37.88558
NCT01627951|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-11-26|||August 2012||2012-08-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|TIP3||Comparison of Three Plasmodium Falciparum Isolates in a Controlled Human Malaria Infection|Comparison of NF54, NF135 and NF166 Strains of Plasmodium Falciparum in a Controlled Human Malaria Infection (TIP3)|Completed||N/A|15|Actual|Radboud University||3|||f||||t||||||||||2017-10-11 02:48:37.972673|2017-10-11 02:48:37.972673
NCT01627938|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2014-11-04|||April 2012||2012-04-01|November 2014|2014-11-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Interventional|MSCardioPro||Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination|A Phase II Proof of Concept Study Evaluating the Reduction of Mitoxantrone-induced Cardiotoxicity and Neurological Outcome in the Combined Use of Mitoxantrone and Dexrazoxane (Cardioxane®) in Multiple Sclerosis (MSCardioPro)|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Ruhr University of Bochum||2|||f||||t||||||||||2017-10-11 02:48:38.091021|2017-10-11 02:48:38.091021
NCT01627925|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-01-15|||June 2012||2012-06-01|January 2017|2017-01-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Interventional|||Safety Study of Positive Airway Pressure Via a Nasal Mask in Obese Patients|Safety Study of Positive Airway Pressure Via a Nasal Mask on Upper Airway Patency During Induction of Anesthesia in Obese Patients|Withdrawn||Phase 3|0|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:48:38.210238|2017-10-11 02:48:38.210238
NCT01627899|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2014-01-29|||October 2012||2012-10-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||One Touch VerioIQ US Clinical Outcomes Study|One Touch VerioIQ US Clinical Outcomes Study|Terminated||Phase 4|5|Actual|LifeScan||1||Business decision to terminate trial|f||||f||||||||||2017-10-11 02:48:38.457064|2017-10-11 02:48:38.457064
NCT01627886|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-06-27|||September 2008||2008-09-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition|Open-Label, Balanced, Randomized,Two-Treatment, Two-Sequence, Two-Period, Single-Dose, Crossover Oral Bioequivalence Study Of Ibandronate Sodium 150 mg Tablets Of Dr. Reddy's Laboratories Limited, India and 'BONIVA®' 150 mg (Ibandronate Sodium) Tablets Of Roche Laboratories Inc., USA In Healthy, Adult, Human Subjects Under Fasting Conditions.|Completed||Phase 1|100|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:48:38.525591|2017-10-11 02:48:38.525591
NCT01627873|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-22|||August 2009||2009-08-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Remifentanil on Postoperative Cognition Function in Patients Undergoing Major Abdominal Surgery|Effect of Remifentanil on Postoperative Cognitive Function in Patients Undergoing Major Abdominal Surgery|Completed||Phase 4|622|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 02:48:38.640273|2017-10-11 02:48:38.640273
NCT01627860|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-09-24|2012-09-06||February 2010||2010-02-01|September 2013|2013-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|TEAMS||First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients|Topiramate in the Treatment of Epilepsy: 1st Add-on vs. Mono-therapy Study in Neuro-Surgical Patients|Completed||Phase 4|55|Actual|Johnson & Johnson Taiwan Ltd|No limitations were reported in this study.|2|||f||||f||||||||||2017-10-11 02:48:38.75899|2017-10-11 02:48:38.75899
NCT01627847|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-09-27|||October 2009||2009-10-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition|Open Label, Balanced, Randomized, Two-treatment, Two-sequence, Two-period, Single-dose, Crossover Oral Bioequivalence Study of Ropinirole Hydrochloride Extended Release Tablets 2 mg of Dr. Reddy's Laboratories Limited, India With REQUIP@ XL (Ropinirole Hydrochloride Extended Release) 2 mg Tablets of Glaxosmithkline, USA, in Normal, Healthy, Adult, Human Subjects Under Fed Condition.|Completed||Phase 1|48|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:48:39.05161|2017-10-11 02:48:39.05161
NCT01627834|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-09-27|||October 2009||2009-10-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition|Open Label, Balanced, Randomized, Two-treatment, Two-sequence, Two-period, Single-dose, Crossover Oral Bioequivalence Study of Ropinirole Hydrochloride Extended Release Tablets 2 mg of Dr. Reddy's Laboratories Limited, India With REQUIP@ XL (Ropinirole) 2 mg ER Tablets of Glaxosmithkline, USA, in Normal, Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|48|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 02:48:39.137994|2017-10-11 02:48:39.137994
NCT01627808|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2012-06-25|||September 2011||2011-09-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Observational|||Fluid Optimization in Liver Surgery|Study on Fluid Optimization in Liver Surgery Trough Vigileo/FloTac System Associated to Traditional Monitoring.|Completed||N/A|17|Actual|Catholic University of the Sacred Heart|||1||f||||f||||||||||2017-10-11 02:48:39.294149|2017-10-11 02:48:39.294149
NCT01627795|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-03-28|||December 2016||2016-12-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment|A Single-center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment - A Phase IIa Study|Not yet recruiting||Phase 1/Phase 2|17|Anticipated|Oshadi Drug Administration||1|||f||||f||||||||||2017-10-11 02:48:39.365833|2017-10-11 02:48:39.365833
NCT01627782|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2016-06-24|2016-05-10|2014-06-25|August 2012||2012-08-01|June 2016|2016-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||The Intent-To-Treat (ITT) analysis set is defined as participants who were randomized and received at least 1 dose of the study drug.|A Study of Ketamine in Patients With Treatment-resistant Depression|A Double-blind, Randomized, Placebo-controlled, Parallel Group, Dose Frequency Study of Ketamine in Subjects With Treatment-resistant Depression|Completed||Phase 2|68|Actual|Janssen Research & Development, LLC||4|||f||||||||||||||2017-10-11 02:48:39.4835|2017-10-11 02:48:39.4835
NCT01627769|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2017-02-15|||July 2012||2012-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|||Evaluation and Comparison of Keloids and Second Degree Burns Blisters Fluid|Comparison of the Blister Fluid Components of Second Degree Burned Patients With the Blister Fluid Components Following Intralesional Cryosurgery of Keloid Scars - A Feasibility Study.|Recruiting||N/A|20|Anticipated|Carmel Medical Center|||2||f||||t||||||Samples With DNA|"     blister fluid of kryosurgery and second degree burns Following the results of the above study     a further extension of the study is progressing in which the identification of the cell     population in the blister fluid following intralesional cryosurgery of keloid scars is     examined   "|||2017-10-11 02:48:40.906077|2017-10-11 02:48:40.906077
NCT01627756|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-25|||April 2009||2009-04-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Continued Ventilation During Cardiopulmonary Bypass|Continued Mechanical Ventilation During CABG Operation Attenuates Systemic Immune Modulation|Completed||N/A|30|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:48:41.010403|2017-10-11 02:48:41.010403
NCT01627743|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-22|2013-02-20|||July 2012||2012-07-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|RELIEF||CorRELation Between PatIent PErception and Findings on Clinical Examination|CorRELation Between PatIent PErception of the Ability to Perform Morning Activities and Findings on Clinical Examination in COPD Patients|Completed||N/A|505|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:48:41.105977|2017-10-11 02:48:41.105977
NCT01627730|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-03-14|||June 2011||2011-06-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|October 2015|Actual|2015-10-01||Interventional|CAI||Computer-Assisted Instruction: Arterial Blood Gases|Development and Assessment of On-line Computer-Assisted Instruction: Arterial Blood Gases|Enrolling by invitation||N/A|1000|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 02:48:41.231884|2017-10-11 02:48:41.231884
NCT01627717|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-05-30|||June 2012||2012-06-01|May 2013|2013-05-01|February 2014|Anticipated|2014-02-01|November 2013|Anticipated|2013-11-01||Interventional|||The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers|The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers|Unknown status|Recruiting|Phase 1|11|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 02:48:41.305091|2017-10-11 02:48:41.305091
NCT01627704|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-10-13|||June 2012||2012-06-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|ESTROTEPREDIC||Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer|16α-[18F]-Fluoro-œstradiol PET: an in Vivo Biomarker Predicting Response to Hormone Treatment of Metastatic Breast Cancer?|Completed||N/A|72|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 02:48:41.432989|2017-10-11 02:48:41.432989
NCT01627691|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-04-11|||October 8, 2012|Actual|2012-10-08|April 2017|2017-04-01|June 13, 2019|Anticipated|2019-06-13|May 30, 2014|Actual|2014-05-30||Interventional|||REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System|REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Evaluation of Safety and Performance|Active, not recruiting||N/A|250|Actual|Boston Scientific Corporation||1|||f||||t|f|f||||||No||2017-10-11 02:48:41.540065|2017-10-11 02:48:41.540065
NCT01627678|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2014-01-13|||September 2012||2012-09-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART|Immunotherapy of HIV-infected Patients An Open, Dose-escalating Assessment of Vacc-C5 With Either GM-CSF or Alhydrogel as Adjuvant in HIV-1-infected Subjects on Antiretroviral Therapy (ART)|Completed||Phase 1/Phase 2|36|Actual|Bionor Immuno AS||2|||f||||f||||||||||2017-10-11 02:48:41.722636|2017-10-11 02:48:41.722636
NCT01574014|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-12-04|||July 2009||2009-07-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Glucocorticoid Treatment for Social Phobia|Glucocorticoid Treatment for Social Phobia|Terminated||Phase 2|66|Actual|University Hospital Inselspital, Berne||2||Recruiting problems|f||||f||||||||||2017-10-11 03:05:26.4722|2017-10-11 03:05:26.4722
NCT01627665|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2014-10-08|||October 2011||2011-10-01|March 2011|2011-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DRIVING||Pharmacogenomic Study on PKD/PKC of Dabigatran Etexilate and Rivaroxaban|New Oral Anticoagulant Drugs Dabigatran Etexilate and Rivaroxaban: Influence of Genetic Factors in Healthy Volunteers|Completed||Phase 2/Phase 3|64|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||||2017-10-11 02:48:41.838652|2017-10-11 02:48:41.838652
NCT01627652|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-06-21|||April 2012||2012-04-01|June 2012|2012-06-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Interventional|||Human Adaptation to High Altitude|Human Adaptation to High Altitude|Unknown status|Recruiting|N/A|8|Anticipated|Zurich Center for Integrative Human Physiology||1|||f||||f||||||||||2017-10-11 02:48:41.951724|2017-10-11 02:48:41.951724
NCT01627639|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-10-05|||October 2011||2011-10-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|DIABOLO||Effectiveness of Acetazolamide for Reversal of Metabolic Alkalosis in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients|A Randomized Trial to Evaluate Effectiveness of Acetazolamide in COPD Patients Developing Metabolic Alkalosis During Invasive Mechanical Ventilation|Completed||Phase 4|380|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:48:42.057749|2017-10-11 02:48:42.057749
NCT01627626|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-21|||August 2011||2011-08-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||Effect of 0.1% Pilocarpine Mouthwash on Xerostomia|Effect of 0.1% Pilocarpine Mouthwash on Xerostomia : Double-blind, Randomized Controlled Trial|Completed||N/A|60|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:48:42.1797|2017-10-11 02:48:42.1797
NCT01627613|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-08-28|||July 2012||2012-07-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury|Proof of Concept Study in Male and Female Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury|Completed||Phase 2|40|Actual|Apeptico Forschung und Entwicklung GmbH||2|||f||||t||||||||||2017-10-11 02:48:42.276186|2017-10-11 02:48:42.276186
NCT01627600|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-10-02|||June 2012||2012-06-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|TAP||Door-to-door Survey of Cardiovascular Health, Stroke and Ischemic Heart Disease in Atahualpa|The Atahualpa Project, a 3-phase Epidemiologic Survey|Completed||Phase 1|642|Actual|Hospital Clínica Kennedy|||1||f||||f||||||||||2017-10-11 02:48:42.507006|2017-10-11 02:48:42.507006
NCT01627587|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-06-13|||December 12, 2011|Actual|2011-12-12|June 2017|2017-06-01|February 9, 2012|Actual|2012-02-09|February 9, 2012|Actual|2012-02-09||Interventional|||A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole|A Two Cohort, Open-label Study to Evaluate the Pharmacokinetics of GSK2847065, the Metabolite of Retosiban (GSK221149) After Single and Repeat Oral Doses, the Pharmacokinetics of GSK221149 Coadministered With a High Fat Meal, and the Pharmacokinetics of GSK221149 Coadministered With an Inhibitor of CYP3A4 (Ketoconazole)|Completed||Phase 1|46|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:48:42.591302|2017-10-11 02:48:42.591302
NCT01627574|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-06-01|||August 2012|Actual|2012-08-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Contraceptive Awareness and Reproductive Education|Contraceptive Awareness and Reproductive Education|Recruiting||N/A|325|Anticipated|University of Rhode Island||2|||f||||t|f|f||||||No||2017-10-11 02:48:42.688092|2017-10-11 02:48:42.688092
NCT01627561|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-01-23|2015-04-23||October 2012||2012-10-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old|Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old|Completed||Phase 3|149|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-10-11 02:48:42.930605|2017-10-11 02:48:42.930605
NCT01627548|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-21|||January 2012||2012-01-01|June 2012|2012-06-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|CCCV||UCLA Couples Counseling for Combat Veterans|UCLA Welcome Back Veterans Family Resilience Center Couples Counseling for Combat Veterans|Unknown status|Recruiting|N/A|24|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:48:45.930367|2017-10-11 02:48:45.930367
NCT01627535|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-01-19|||May 2013||2013-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors|Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors|Completed||N/A|4|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 02:48:46.035575|2017-10-11 02:48:46.035575
NCT01627522|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-04-19|||January 2012||2012-01-01|April 2016|2016-04-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|TURP||Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate||Completed||Phase 2/Phase 3|60|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-10-11 02:48:46.119413|2017-10-11 02:48:46.119413
NCT01627509|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-21|||May 2012||2012-05-01|June 2012|2012-06-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Observational|||Comparison of Two Insulin Regimens in Optimally-controlled Patients With DM2.|Comparison of Modern Premixed Insulin and Basal-Bolus Regimens on Blood Glucose Control Using CGMS Device in Optimally-controlled Subjects With DM2.|Unknown status|Recruiting|N/A|40|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 02:48:46.196476|2017-10-11 02:48:46.196476
NCT01627496|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-07-03|||September 2010||2010-09-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Observational|NSQLOP||Nutritional Status and Quality of Life in Older Adults|Nutritional Status and Quality of Life in Older Hospitalised Adults|Completed||N/A|40|Actual|University of Surrey|||1||f||||f||||||||||2017-10-11 02:48:46.276378|2017-10-11 02:48:46.276378
NCT01627483|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-21|||April 2009||2009-04-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Interventional|||Randomized Controlled Trial of Effects of Physician's Medication Reviews on Prescribing in Older Hip Fracture Patients|Improving Treatment With Fracture-preventing and Fall-risk-increasing Drugs in Older Hip Fracture Patients: Effects of Medication Reviews Performed by a Physician - a Randomized Controlled Trial|Completed||N/A|200|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-11 02:48:46.345412|2017-10-11 02:48:46.345412
NCT01627470|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-06-22|||August 2011||2011-08-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||Comparison of Continuous Non-invasive Pressure Device Versus Invasive Pressure Measurement During Prehospital Emergency|Evaluation of a Continuous Non-invasive Arterial Pressure Device in Comparison With Invasive Pressure Measurement During Out-of-hospital Emergency|Unknown status|Recruiting|N/A|40|Anticipated|University of Schleswig-Holstein|||1||f||||f||||||||||2017-10-11 02:48:46.438635|2017-10-11 02:48:46.438635
NCT01627457|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-11-26|||September 2011||2011-09-01|November 2013|2013-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|PreGEx||Heart Cycle Prestudy|"Heart Cycle Prestudy Guided Exercise (GEx) for Coronary Artery Disease Patients (CAD) GEx Home Application Testing"|Completed||N/A|50|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 02:48:46.526566|2017-10-11 02:48:46.526566
NCT01627444|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-06-22|||August 2011||2011-08-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Acupuncture in Mothers of Very Low Birth Weight Infants|Ear Acupuncture for Anxiety in Mothers of Very Low Birth Weight Infants|Unknown status|Recruiting|Phase 2|20|Anticipated|University of Sao Paulo||2|||f||||||||||||||2017-10-11 02:48:46.605261|2017-10-11 02:48:46.605261
NCT01627431|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-11-27|||July 2012||2012-07-01|November 2012|2012-11-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|TRAIANO||Residual Platelet Activity In Advanced Peripheral Artery Disease|Tailored Strategy for Residual Platelet Activity In Advanced Peripheral Artery Disease: New Optimal Management.|Unknown status|Recruiting|Phase 4|410|Anticipated|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-11 02:48:46.70746|2017-10-11 02:48:46.70746
NCT01627418|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-06-15|||April 2009||2009-04-01|June 2015|2015-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|WHEZ||Warm Homes for Elder New Zealanders|Warm Homes for Elder New Zealanders: a Community Trial of People With COPD|Completed||N/A|522|Actual|University of Otago||2|||f||||f||||||||||2017-10-11 02:48:46.833848|2017-10-11 02:48:46.833848
NCT01627405|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-09-29|||May 2012||2012-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:48:46.931263|2017-10-11 02:48:46.931263
NCT01627392|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-12-01|||July 2012||2012-07-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|NMR||Mechanisms of the Nicotine Metabolism Effect on Tobacco Dependence|Mechanisms of the Nicotine Metabolism Effect on Tobacco Dependence|Completed||N/A|305|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 02:48:46.974359|2017-10-11 02:48:46.974359
NCT01627379|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-01-20|||May 2012||2012-05-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|May 2015|Actual|2015-05-01||Interventional|POWER||Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer|An Open-label, Randomized Phase III Trial of Cisplatin and 5-fluorouracil With or Without Panitumumab for Patients With Nonresectable, Advanced or Metastatic Esophageal Squamous Cell Cancer|Active, not recruiting||Phase 3|300|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-10-11 02:48:47.053102|2017-10-11 02:48:47.053102
NCT01627366|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-07-29|||August 2012||2012-08-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors|Survivorship Plans and Outcomes in Underserved Breast Cancer Survivors RCT|Completed||N/A|500|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:48:47.164105|2017-10-11 02:48:47.164105
NCT01627353|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-06-18|||January 2012||2012-01-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Post Hysterectomy Pain Prevention: Pre-op Wound Infiltration With Anesthetic Protocol Versus Standard of Care|Post Hysterectomy Pain Prevention: Randomized Clinical Trial of High Volume Preoperative Wound Infiltration and Pain Specific Anesthetic Protocol Versus Standard of Care (no Wound Infiltration and Routine Anesthetic Protocol)|Terminated||Phase 4|16|Actual|University of Calgary||2||Funding withdrawn|f||||f||||||||||2017-10-11 02:48:47.249969|2017-10-11 02:48:47.249969
NCT01627340|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-01-05|2014-12-15||July 2012||2012-07-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus|An Open-label Study to Assess the Immunogenicity and Safety of GSK Biologicals' Hepatitis B Vaccine Engerix™-B (103860) in Adults With or Without Type 2 Diabetes Mellitus|Completed||Phase 4|667|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:48:47.36475|2017-10-11 02:48:47.36475
NCT01627327|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-03-21|2013-08-29|2013-06-20|April 2012||2012-04-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease|A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once-Daily Via a Novel Dry Powder Inhaler Compared With Tiotropium Bromide Inhalation Powder 18mcg Delivered Once-Daily Via the HandiHaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Who Have or Are at Risk for Co-morbid Cardiovascular Disease|Completed||Phase 3|623|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:48:47.945798|2017-10-11 02:48:47.945798
NCT01627314|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-08-17|||July 2012||2012-07-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|||The PUMA Trial is a Trial of a Single ProHema Modulated-CB Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.|A Phase 2 Controlled Trial of a Single ProHema®-CB Unit (Ex Vivo Modulated Human Cord Blood) As Part of a Double Umbilical Cord Blood Transplant Following Myeloablative or Reduced Intensity Conditioning For Patients Age 15-65 Years With Hematologic Malignancies.|Terminated||Phase 2|54|Actual|Fate Therapeutics||2||Business decision|f||||t||||||||||2017-10-11 02:48:48.60854|2017-10-11 02:48:48.60854
NCT01627301|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-12-20|||July 2012||2012-07-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|SO-PTSD||Sympathetic Overactivity in Post-traumatic Stress Disorder|Mechanisms of Sympathetic Overactivity in Post-traumatic Stress Disorder|Recruiting||Phase 2|100|Anticipated|Emory University||2|||f||||f||||||||||2017-10-11 02:48:48.710904|2017-10-11 02:48:48.710904
NCT00004797|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1995||1995-08-01|December 2001|2001-12-01||||||||Interventional|||Pilot Study of Fructose for Sickle Cell Crisis||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.241539|2017-10-11 04:25:23.241539
NCT01627288|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-01-10|||June 2012||2012-06-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|August 2019|Anticipated|2019-08-01||Interventional|IDEAL||Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)|Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)|Active, not recruiting||N/A|12|Actual|Duke University||4|||f||||f||||||||||2017-10-11 02:48:48.816231|2017-10-11 02:48:48.816231
NCT01627275|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-01-26|||June 2012||2012-06-01|January 2017|2017-01-01|June 18, 2018|Anticipated|2018-06-18|December 5, 2017|Anticipated|2017-12-05||Interventional|||Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant|Naive T-Cell Depleted Donor Lymphocyte Infusion Following Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 1|28|Actual|Duke University||1|||f||||t||||||||||2017-10-11 02:48:48.907036|2017-10-11 02:48:48.907036
NCT01627262|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-01-20|||May 2002||2002-05-01|January 2016|2016-01-01|April 2006|Actual|2006-04-01|August 2004|Actual|2004-08-01||Interventional|||Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study|Double-blind, Randomised, Placebo-controlled, Parallel-group, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Mesalazine Pellets vs. Placebo in Diverticular Disease|Completed||Phase 2|123|Actual|Dr. Falk Pharma GmbH||2|||f||||f||||||||||2017-10-11 02:48:48.980777|2017-10-11 02:48:48.980777
NCT01627249|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-07-03|2015-09-29||August 2012||2012-08-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2014|Actual|2014-10-01||Interventional|Protocol T||Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema|A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema|Active, not recruiting||Phase 3|660|Actual|Jaeb Center for Health Research||3|||f||||t||||||||||2017-10-11 02:48:49.097549|2017-10-11 02:48:49.097549
NCT01627236|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2013-10-09|||December 2012||2012-12-01|August 2013|2013-08-01|November 2014|Anticipated|2014-11-01|August 2014|Anticipated|2014-08-01||Interventional|||Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis B||Unknown status|Recruiting|N/A|120|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-11 02:48:51.597008|2017-10-11 02:48:51.597008
NCT01627223|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2016-10-16|||July 2012||2012-07-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|NUC115132||Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation|Comparison Between Lamivudine and Entecavir Treatment in Patients With Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B.|Terminated||Phase 4|17|Actual|Taichung Veterans General Hospital||2||Slow progress in recruiting study patients|f||||f||||||||||2017-10-11 02:48:51.722062|2017-10-11 02:48:51.722062
NCT01627210|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-02-11|||May 2012||2012-05-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|GLYCOAIM||Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System|Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study|Completed||N/A|60|Actual|DexCom, Inc.|||1||f||||f||||||||||2017-10-11 02:48:51.851751|2017-10-11 02:48:51.851751
NCT01627184|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-02-10|||May 2012||2012-05-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Observational|LUCID||Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus|Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus|Completed||N/A|13|Actual|DexCom, Inc.|||1||f||||f||||||||||2017-10-11 02:48:52.016139|2017-10-11 02:48:52.016139
NCT01627171|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-01-28|||September 2012||2012-09-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|COIN||Colonoscopy Preparation Optimization for INpatients- COIN Study|A Randomized Control Trial Comparing 4L PEGlyte to Regular Dose Pico-Salax and Split Dose Pico-Salax for Colonoscopy Bowel Preparation in Hospitalized Patients|Unknown status|Recruiting|Phase 4|126|Anticipated|St. Joseph's Healthcare Hamilton||3|||f||||f||||||||||2017-10-11 02:48:52.091198|2017-10-11 02:48:52.091198
NCT01627158|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-10-12|||June 2012||2012-06-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|ADECO||Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte|Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte; a Randomised, Double-blind, Double-dummy, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|72|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-10-11 02:48:52.195518|2017-10-11 02:48:52.195518
NCT01627145|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-11-14|||August 2012||2012-08-01|November 2012|2012-11-01|July 2015|Anticipated|2015-07-01|January 2015|Anticipated|2015-01-01||Interventional|||Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug|Post-treatment Normallized Urodynamic Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Correlations With Voiding Diary, King＇s Health Questionnaire, and Overactive Bladder Sympto|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 02:48:52.273754|2017-10-11 02:48:52.273754
NCT01627132|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-06-22|||February 2012||2012-02-01|June 2012|2012-06-01|January 2019|Anticipated|2019-01-01|February 2017|Anticipated|2017-02-01||Interventional|||Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial|Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial|Recruiting||Phase 2|50|Anticipated|Shimousa Hematology Study Group||1|||f||||t||||||||||2017-10-11 02:48:52.364098|2017-10-11 02:48:52.364098
NCT01627119|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-22|||July 2009||2009-07-01|June 2012|2012-06-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Observational|CTGF||The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer|The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer|Unknown status|Recruiting|N/A|120|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     Cancer tissue and adjacent normal tissue Urine Blood serum and blood plasma   "|||2017-10-11 02:48:52.500292|2017-10-11 02:48:52.500292
NCT01627106|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-08-23|||September 2012||2012-09-01|August 2013|2013-08-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Interventional|||A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)|A Multicentered, Randomized, Open-Label, Pragmatic Use Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation|Withdrawn||Phase 4|0|Actual|Cardiome Pharma||2|||f||||t||||||||||2017-10-11 02:48:52.6145|2017-10-11 02:48:52.6145
NCT01627093|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-09-13|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Prospective Data Collection of Patients Treated With Proton Therapy for Head and Neck Malignancies|Prospective Data Collection of Patients Treated With Proton Therapy for Head and Neck Malignancies|Recruiting||N/A|450|Anticipated|M.D. Anderson Cancer Center|||1||f||||t|f|f||||||||2017-10-11 02:48:52.727294|2017-10-11 02:48:52.727294
NCT01627080|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2014-07-25|||April 2014||2014-04-01|July 2014|2014-07-01||||April 2024|Anticipated|2024-04-01||Observational|||Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation|Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     Blood draws include troponin I, NT-proBNP, and BNP.   "|||2017-10-11 02:48:52.826251|2017-10-11 02:48:52.826251
NCT01627067|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-07-06|||September 2012|Actual|2012-09-01|July 2017|2017-07-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Exemestane-RAD001-Metformin|Circulating FGF21 Levels and Efficacy of Exemestane, Everolimus and Metformin in Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer and BMI >/= 25|Active, not recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:48:52.927913|2017-10-11 02:48:52.927913
NCT01627054|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-10-25|||August 2012||2012-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|March 2014|Actual|2014-03-01||Interventional|||A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia|A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 2|7|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-10-11 02:48:53.014599|2017-10-11 02:48:53.014599
NCT01627041|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-09-04|||September 16, 2011|Actual|2011-09-16|May 2017|2017-05-01||||October 1, 2022|Anticipated|2022-10-01||Interventional|||Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia|Randomized Phase II Study of Epigenetic Priming Using Decitabine With Induction Chemotherapy in Patients With Acute Myelogenous Leukemia (AML)|Active, not recruiting||Phase 2|180|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 02:48:53.096479|2017-10-11 02:48:53.096479
NCT01627028|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-21|||March 2011||2011-03-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Observational|||Thai Traditional Massage Increases Biochemical Marker of Bone Formation in Postmenopausal Women|Thai Traditional Massage Increases Biochemical Marker of Bone Formation in Postmenopausal Women: a Randomized Crossover Trial|Completed||Phase 3|48|Actual|Mahidol University|||1||f||||f||||||||||2017-10-11 02:48:53.225721|2017-10-11 02:48:53.225721
NCT01627015|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-03-06|||June 2012||2012-06-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety, Acceptance and Metabolic Effects in Infants Receiving a Novel Low Glycaemic Index follow-on Formula|Safety, Acceptance and Metabolic Effects in Infants Receiving a Novel Low Glycaemic Index follow-on Formula|Completed||N/A|50|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 02:48:53.279275|2017-10-11 02:48:53.279275
NCT01627002|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2013-07-18|2013-07-18||May 2012||2012-05-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401|A Phase 1, FIH, Double-blind, Randomised Placebo-controlled Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of PA401, and the Effects of PA401 Following LPS Challenge, in Healthy Subjects|Terminated||Phase 1|49|Actual|ProtAffin Biotechnologie AG|Part B of the study was terminated early which led to a small number of subjects analyzed. Pharmacokinetic parameters were not calculated for Part A 0.3mg and 10 mg PA401|2|||f||||f||||||||||2017-10-11 02:48:53.378595|2017-10-11 02:48:53.378595
NCT01626989|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-06-20|||June 2010||2010-06-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders|Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With|Completed||N/A|20|Actual|Philips Respironics||2|||f||||f||||||||||2017-10-11 02:48:56.273769|2017-10-11 02:48:56.273769
NCT01626976|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-03-12|||June 2012||2012-06-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects|A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Controlled, Single Dose Escalating Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects|Completed||Phase 1|42|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 02:48:56.376514|2017-10-11 02:48:56.376514
NCT01626963|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2016-03-22|||January 2014||2014-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Single-port Versus Conventional Laparoscopic Colorectal Surgery|Randomised-controlled Trial on the Immune Response to Single-port Access Versus Conventional Laparoscopic Colorectal Surgery|Recruiting||Phase 1/Phase 2|50|Anticipated|North Tees and Hartlepool NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:48:56.490175|2017-10-11 02:48:56.490175
NCT01626950|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-03-25|||May 2012||2012-05-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Living Conditions and Breast Cancer|Living Conditions and Breast Cancer|Completed||N/A|684|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 02:48:56.611971|2017-10-11 02:48:56.611971
NCT01626937|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-22|||June 2012||2012-06-01|January 2012|2012-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|VeNIS BPCO||Multicenter National Randomized Controlled Open Label Study Assessing Interest of Non Invasive Ventilation in out-of Hospital Setting During Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients. VeNIS BPCO|Multicenter National Randomized Controlled Open Label Study Assessing Interest of Non Invasive Ventilation in out-of Hospital Setting During Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients. VeNIS BPCO|Unknown status|Not yet recruiting|N/A|398|Anticipated|Centre Hospitalier d'Agen||2|||f||||||||||||||2017-10-11 02:48:56.83427|2017-10-11 02:48:56.83427
NCT01626924|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-05-23|||June 2012||2012-06-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|October 2014|Actual|2014-10-01||Interventional|||A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia|A Multi-centre, Randomised, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) in Neonates With ≥36 Weeks GA With Moderate to Severe Perinatal Asphyxia|Terminated||Phase 2|6|Actual|Neurophyxia B.V.||1||Recruitment too slow and site decided to use hypothermia (exclusion criteria)|f||||t||||||||||2017-10-11 02:48:56.946227|2017-10-11 02:48:56.946227
NCT01626911|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2013-12-06|||September 2011||2011-09-01|December 2013|2013-12-01||||December 2013|Anticipated|2013-12-01||Interventional|CRAI-H||Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis||Unknown status|Recruiting|N/A|60|Anticipated|Nanjing University School of Medicine||2|||f||||f||||||||||2017-10-11 02:48:57.60884|2017-10-11 02:48:57.60884
NCT01626898|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-02-02|||August 2012||2012-08-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention|HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention|Completed||N/A|304|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 02:48:57.734164|2017-10-11 02:48:57.734164
NCT01626885|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-01-22|||May 2012||2012-05-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia|A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia|Completed||Phase 2/Phase 3|42|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||||||||||||2017-10-11 02:48:57.82379|2017-10-11 02:48:57.82379
NCT01626872|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-04-05|||June 2012||2012-06-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Long-Term Study of MP-214 in Patients With Schizophrenia|Long-Term Extension Study of MP-214 in Patients With Schizophrenia|Completed||Phase 2/Phase 3|254|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||||||||||||2017-10-11 02:48:57.899284|2017-10-11 02:48:57.899284
NCT01626859|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-06-03|||May 2012||2012-05-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia|A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia (12 Weeks Treatment Study)|Completed||Phase 2/Phase 3|38|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||||||||||||2017-10-11 02:48:58.011579|2017-10-11 02:48:58.011579
NCT01626846|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2012-06-22|||June 2012||2012-06-01|June 2012|2012-06-01|September 2012|Anticipated|2012-09-01|||||Observational|||How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem|Cognitive Impairments, Self-Esteem & Academic Performance in Teenagers With Neurofibromatosis Type 1|Unknown status|Recruiting|N/A|50|Anticipated|John Jay High School|||1||f||||f||||||||||2017-10-11 02:48:58.10707|2017-10-11 02:48:58.10707
NCT01626833|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-01-13|||March 2013||2013-03-01|August 2016|2016-08-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Interventional|OREX||Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone|Severe Decrease of Growth Velocity in Children With Anorexia Nervosa. Therapeutic Trial of Growth Hormone|Recruiting||Phase 2/Phase 3|20|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:48:58.197924|2017-10-11 02:48:58.197924
NCT01626820|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2016-09-22|2013-08-08||July 2012||2012-07-01|September 2016|2016-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults|Immunogenicity and Safety Study of GSK Biologicals' Trivalent Split Virion Influenza Vaccine (GSK1536489A) Fluviral® (2012/2013 Season) in Adults Aged 18 Years and Older|Completed||Phase 3|113|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:48:58.335052|2017-10-11 02:48:58.335052
NCT01626807|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2017-04-24|||December 2012||2012-12-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional|||Evaluation of a Walking School Bus Program|Evaluation of a Walking School Bus Program: A Cluster Randomized Controlled Trial|Completed||N/A|838|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 02:48:58.965518|2017-10-11 02:48:58.965518
NCT01626794|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-01-26|||July 2014||2014-07-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)|A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX Made With the Varicella Enhanced Process (VEP)|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:48:59.074919|2017-10-11 02:48:59.074919
NCT01626781|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2013-10-21||||||October 2013|2013-10-01||||||||Expanded Access|PROCAPP||A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer|A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer|No longer available||N/A|||AIO-Studien-gGmbH|||||f||||||||||||||2017-10-11 02:48:59.193187|2017-10-11 02:48:59.193187
NCT01626768|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-07-16|||June 2012||2012-06-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Medtronic Market-Released DF4 Lead Imaging||Completed||N/A|37|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-10-11 02:48:59.308708|2017-10-11 02:48:59.308708
NCT01626755|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-10-19|||August 2013||2013-08-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|PLATA||Prevention of Phantom Limb Pain After Transtibial Amputation|Prevention of Phantom Limb Pain After Transtibial Amputation (PLATA) - Randomized, Double-blind, Controlled, Multi-center Trial Comparing Optimized Intravenous Pain Control vs Optimized Intravenous Pain Control Plus Nerve Block.|Unknown status|Recruiting|N/A|400|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 02:48:59.37712|2017-10-11 02:48:59.37712
NCT01626742|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-21|2015-04-24|||May 2012||2012-05-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study|A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients|Completed||Phase 3|652|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-10-11 02:48:59.500367|2017-10-11 02:48:59.500367
NCT01626690|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-07-20|2016-01-21||May 2012||2012-05-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Prospective Trial of the Effect of Preoperative Forced-air Warming on Perioperative Body Temperature Following Neuraxial Anesthesia in Total Hip Arthroplasty Patients|Prospective Randomized Control Trial of the Effect of Preoperative Forced-air Warming on Perioperative Body Temperature Following Neuraxial Anesthesia in Total Hip Arthroplasty Patients|Terminated||Phase 4|100|Actual|University of Wisconsin, Madison||2||Surgeons change in preference for perioperative warming.|f||||||||||||||2017-10-11 02:49:00.452693|2017-10-11 02:49:00.452693
NCT01626677|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-04-19|||June 2012||2012-06-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect|Long Term Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee|Completed||Phase 3|103|Actual|Medipost Co Ltd.||2|||f||||t|f|f||||||Undecided||2017-10-11 02:49:00.91134|2017-10-11 02:49:00.91134
NCT01626664|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-06-27||2016-06-14|June 2012||2012-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|August 2015|Actual|2015-08-01||Interventional|||KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)|Multi-Center, Open-Label, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)|Active, not recruiting||Phase 2|71|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||2|||f||||f||||||||||2017-10-11 02:49:01.051036|2017-10-11 02:49:01.051036
NCT01626651|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-06-18|||June 2012||2012-06-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Ibrutinib in Healthy Participants|An Open-Label, Sequential Design Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Ibrutinib in Healthy Subjects|Completed||Phase 1|21|Actual|Janssen Research & Development, LLC||1|||f||||||||||||||2017-10-11 02:49:01.200889|2017-10-11 02:49:01.200889
NCT01626638|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-01-25|||February 2013||2013-02-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MEC ORL||Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL)|Clinical Evaluation of Confocal Microscopy in Head and Neck Cancer|Recruiting||N/A|40|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 02:49:01.307662|2017-10-11 02:49:01.307662
NCT01626625|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-06-22|||April 2010||2010-04-01|June 2012|2012-06-01|January 2016|Anticipated|2016-01-01|April 2015|Anticipated|2015-04-01||Interventional|||Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture||Unknown status|Recruiting|Phase 1|10|Anticipated|Indonesia University||2|||f||||t||||||||||2017-10-11 02:49:01.404225|2017-10-11 02:49:01.404225
NCT01626612|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-04-20|||February 2012||2012-02-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis|De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis: A Randomized Clinical Trial (DEA Study)|Completed||Phase 3|120|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 02:49:01.52444|2017-10-11 02:49:01.52444
NCT01626599|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-09-17||2015-08-19|June 2012||2012-06-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data|Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data|Completed||N/A|147|Actual|Cyberonics, Inc.||1|||f||||f||||||||||2017-10-11 02:49:01.632226|2017-10-11 02:49:01.632226
NCT01626586|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-02-10|||May 2012|Actual|2012-05-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|||Diabetes Adolescent and Family Group Therapy|Adjustment and Self-Management Intervention Groups for Youth With Type 1 Diabetes Mellitus|Recruiting||N/A|80|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 02:49:01.791327|2017-10-11 02:49:01.791327
NCT01626573|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-03-26||2014-03-26|March 2012||2012-03-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of INCB039110 in Subjects With Active Rheumatoid Arthritis|A Double- Blind, Placebo Controlled Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of INCB039110 in Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|106|Actual|Incyte Corporation||12|||f||||f||||||||||2017-10-11 02:49:01.898501|2017-10-11 02:49:01.898501
NCT01626560|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-03-19|||July 2012||2012-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin|Effects of Daptomycin in the Levels of IL-1, IL-6 and TNF in Patients With Complicated Cellulitis/Erisipela in Comparison With Vancomycin or Oxacillin|Completed||Phase 4|20|Actual|Hospital Universitario Evangelico de Curitiba||2|||f||||f||||||||||2017-10-11 02:49:02.024759|2017-10-11 02:49:02.024759
NCT01626547|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-03-16|||December 2010||2010-12-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Observational|||Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology|Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology; Non-interventional, Observational, Prospective Study|Completed||N/A|291|Actual|Hospira, now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-10-11 02:49:02.122106|2017-10-11 02:49:02.122106
NCT01626534|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-08-27|||March 2012||2012-03-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome|Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome.|Completed||Phase 3|125|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 02:49:02.465446|2017-10-11 02:49:02.465446
NCT01626521|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-06-21|||July 2012||2012-07-01|June 2012|2012-06-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Value of Prothrombin Fragment F1+2 in the Diagnosis of Pulmonary Embolism in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbation||Unknown status|Not yet recruiting|N/A|20|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 02:49:02.569585|2017-10-11 02:49:02.569585
NCT01626508|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-01-04|||April 2012||2012-04-01|January 2013|2013-01-01||||||||Observational|ADiLL||Prospective Evaluation in Older Premature, Untreated Breast Milk and Milk Processed by the Breast-milk Bank|Directed Donation of Untreated Milk or Milk Processed by the Breast-milk : Prospective Evaluation in Older Premature|Unknown status|Recruiting|N/A|90|Anticipated|Centre Hospitalier Universitaire Dijon|||2||f||||t||||||Samples Without DNA|"     blood sample milk   "|||2017-10-11 02:49:02.664602|2017-10-11 02:49:02.664602
NCT01626495|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-06-26|||August 2011||2011-08-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|September 2016|Actual|2016-09-01||Interventional|Pedi CART19||Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma|CHP 959 - A Phase I/IIA Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRzeta and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant Or Refractory CD19+ Leukemia and Lymphoma|Active, not recruiting||Phase 1|76|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 02:49:02.755675|2017-10-11 02:49:02.755675
NCT01626482|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2013-07-30|||September 2011||2011-09-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Kinesio Tape in Muscle Fatigue Measured by Biering-Sorensen Test||Completed||Phase 2|100|Actual|CEU San Pablo University||2|||f||||||||||||||2017-10-11 02:49:02.837462|2017-10-11 02:49:02.837462
NCT01626469|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-07-11|||May 2012|Actual|2012-05-01|July 2017|2017-07-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic Patients|Eye Blood Flow and the Kidney|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 02:49:02.924179|2017-10-11 02:49:02.924179
NCT01626456|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2016-09-08|2016-04-29||June 2012||2012-06-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Safety population includes all subjects who receive at least 1 dose of ALKS 9072 in the current study.|A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)|A Phase 3, Multicenter, Extension of Study ALK9072-003 to Assess the Long-term Safety and Durability of Effect of ALKS 9072 in Subjects With Stable Schizophrenia|Completed||Phase 3|478|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-10-11 02:49:03.039922|2017-10-11 02:49:03.039922
NCT01626443|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-02-13|||January 2014|Actual|2014-01-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Role of Myo-inositol and D-chiro Inositol on the Ovaric and Metabolic Functions||Completed||Phase 4|46|Actual|Lo.Li.Pharma s.r.l||2|||f||||||||||||||2017-10-11 02:49:03.920697|2017-10-11 02:49:03.920697
NCT01626430|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2015-10-05|||January 2012||2012-01-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Acute Effects of Tocotrienols on Insulin Sensitivity and Metabolic Risk Markers in Individuals at Risk for Metabolic Syndrome|Acute Effects of Tocotrienols on Insulinaemic and Inflammatory Responses in Metabolic Syndrome Subjects|Completed||N/A|30|Actual|Malaysia Palm Oil Board||3|||f||||t||||||||||2017-10-11 02:49:04.028525|2017-10-11 02:49:04.028525
NCT01626417|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-11-13|||May 2012||2012-05-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of Transfer Kinematics and Kinetics in Patients Chronic Post-stroke Using the Tibion Bionic Leg|A Prospective, Experimental Study to Evaluate Transfer Kinematics and Kinetics of Chronic Post-stroke Patients With Tibion Bionic Leg|Completed||N/A|20|Actual|Tibion Bionics, Inc.||1|||f||||f||||||||||2017-10-11 02:49:04.123448|2017-10-11 02:49:04.123448
NCT01626404|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-04-15|||October 2012||2012-10-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|SEE-HF||Screening for Advanced Heart Failure Treatment (SEE-HF)|Screening for Advanced Heart Failure Treatment (SEE-HF)|Completed||N/A|99|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 02:49:04.22048|2017-10-11 02:49:04.22048
NCT01626391|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-06-10|2014-04-28||September 2012||2012-09-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Safety Population|Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease|A Double-Blind, Placebo-Controlled, Randomised, 4-Week Safety and Tolerability Study of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease on Pre-Existing Stable Acetylcholinesterase Inhibitor and/or Memantine Therapy|Terminated||Phase 2|9|Actual|TauRx Therapeutics Ltd|Early termination leading to small numbers of subjects analyzed|2||This study has been terminated for administrative reasons only.|f||||t||||||||||2017-10-11 02:49:04.323702|2017-10-11 02:49:04.323702
NCT01626378|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-04-07|||May 2013||2013-05-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)|A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)|Completed||Phase 3|220|Actual|TauRx Therapeutics Ltd||2|||f||||t||||||||||2017-10-11 02:49:04.765878|2017-10-11 02:49:04.765878
NCT01626365|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-12-16|||May 2012||2012-05-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Thermosoftening of Double-lumen Tube to Reduce Sore Throat|The Effect of Double-lumen Tube Thermosoftening Before Intubation to Reduce Hoarseness and Sore Throat|Completed||N/A|154|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 02:49:04.972524|2017-10-11 02:49:04.972524
NCT01626339|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-06-21|||April 2012||2012-04-01|June 2012|2012-06-01||||June 2012|Anticipated|2012-06-01||Interventional|||Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter|Effect of Intravitreal Anti-Vascular Endothelial Growth Factors on Retinal Vessels Diameter|Unknown status|Recruiting|N/A|30|Anticipated|University of Malaya|||||f||||t||||||||||2017-10-11 02:49:05.272265|2017-10-11 02:49:05.272265
NCT01626326|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-05-21|||June 2012||2012-06-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|TCapp-1||San Francisco Stop Smoking App - Pilot Study|Evaluation of a Stop Smoking iPhone App|Unknown status|Recruiting|Phase 1|12000|Anticipated|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 02:49:05.364892|2017-10-11 02:49:05.364892
NCT01626313|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-06-20|||December 2011||2011-12-01|June 2012|2012-06-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|FOCUS||UCLA FOCUS Family Resiliency Training Research Study|UCLA FOCUS (Families OverComing Under Stress) Family Resiliency Training Research Study|Unknown status|Recruiting|N/A|24|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 02:49:05.467436|2017-10-11 02:49:05.467436
NCT01626300|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-06-19|||December 2007||2007-12-01|May 2017|2017-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens|The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens: A Randomized Placebo-controlled Clinical Trial|Completed||N/A|45|Actual|University of California, Davis|||1||f||||f||||||||||2017-10-11 02:49:05.558377|2017-10-11 02:49:05.558377
NCT01626287|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-05-22|||November 2012||2012-11-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Reduction of Perineal Pain After Vaginal Birth With Black Tea: Pilot Randomized Study||Completed||N/A|43|Actual|Fraser Health||2|||f||||t||||||||||2017-10-11 02:49:05.615391|2017-10-11 02:49:05.615391
NCT01626274|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2013-11-26|||January 2012||2012-01-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|LAVIMO||Long Term Vital Parameter Monitoring (LAVIMO)|Long Term Vital Parameter Monitoring Pilot Study to Evaluate Measurement Data Via In-ear Sensor in Comparison to Standard Polysomnography in Sleep Laboratory|Completed||N/A|8|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 02:49:05.693944|2017-10-11 02:49:05.693944
NCT01626261|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-04-30|||September 2009||2009-09-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|FEMU||Examination of Implant´s Safety in an Electronic and Magnetic Field Environment|Study of Provocation Concerning Implants´Safety in Electronic and Magnetic Fields in Their Environment|Recruiting||N/A|200|Anticipated|RWTH Aachen University|||1||f||||f||||||Samples Without DNA|"     blood (serum and plasma) urine   "|||2017-10-11 02:49:05.78588|2017-10-11 02:49:05.78588
NCT01626248|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2013-06-12|||July 2012||2012-07-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|||Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control|Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in a Natalizumab Treated Population With Active Control Assessment|Completed||N/A|164|Actual|Rocky Mountain MS Research Group, LLC|||5||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 02:49:05.886475|2017-10-11 02:49:05.886475
NCT01626222|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-02-21|||June 2012||2012-06-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|MACS2096||4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer|A Phase IIIB, Multi-Center, Open Label Study For Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) in Combination With Exemestane: 4EVER - Efficacy, Safety, Health Economics, Translational Research|Completed||Phase 3|301|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:49:06.09398|2017-10-11 02:49:06.09398
NCT01626209|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-02-05|||July 2012||2012-07-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors|A Phase I Study of BKM120, Administered Orally in Adult Chinese Patients With Advanced Solid Tumors|Completed||Phase 1|32|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:49:06.37905|2017-10-11 02:49:06.37905
NCT01626196|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-07-10|||February 2012||2012-02-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Evaluation of the Main Determinants of Patient Acceptability of the Bowel Cleansing Procedure, and of Success of Bowel Cleansing and Caecal Intubation|Multicentre, Observational, Prospective Study, Conducted on Italian Out-patients Undergoing Colonoscopy, for the Evaluation of the Main Determinants of the Patient's Acceptability of Bowel Cleansing Procedure, and of the Success of Bowel Cleansing and Caecal Intubation|Completed||N/A|600|Actual|Norgine|||1||f||||f||||||||||2017-10-11 02:49:06.477765|2017-10-11 02:49:06.477765
NCT01626183|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-05-13|||May 2012||2012-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia|Molecular Taxonomy in Pediatric Cancer- IncRNA Expression in Primary T-ALL|Completed||N/A|20|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     RNA   "|||2017-10-11 02:49:06.546328|2017-10-11 02:49:06.546328
NCT01626170|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-07-13|||June 2012||2012-06-01|July 2016|2016-07-01||||October 2013|Actual|2013-10-01||Observational|||Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma|Observational - Identifying and Validating Novel Mechanisms of Radiation Resistance in Rhabdomyosarcoma|Completed||N/A|20|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 02:49:06.613382|2017-10-11 02:49:06.613382
NCT01626157|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-04-03|||May 2011||2011-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF)|A Novel Assay to Quantify Treatment Response in CF|Active, not recruiting||N/A|120|Actual|National Jewish Health|||1||f||||f|f|f||||||No||2017-10-11 02:49:06.69357|2017-10-11 02:49:06.69357
NCT01626144|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-06-21|||September 2011||2011-09-01|June 2012|2012-06-01|January 2017|Anticipated|2017-01-01|||||Observational|||Metabolizing Enzyme Genotype Versus Exemestane Metabolism Profiles|Metabolizing Enzyme Genotype Versus Exemestane Metabolism Profiles|Unknown status|Recruiting|N/A|200|Anticipated|Milton S. Hershey Medical Center|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, urine   "|||2017-10-11 02:49:06.763896|2017-10-11 02:49:06.763896
NCT01626131|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2013-04-24|||October 2011||2011-10-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Exercise: A Novel Treatment for Combat Post Traumatic Stress Disorder|Exercise: A Novel Treatment for Combat PTSD|Terminated||Phase 2|11|Actual|INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium||2||"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the   end of the grant."|f||||t||||||||||2017-10-11 02:49:06.856856|2017-10-11 02:49:06.856856
NCT01626118|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-02-17|2013-12-11||May 2012||2012-05-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Study of Indomethacin Capsules to Treat Pain Following Bunionectomy|A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Indomethacin Nanoformulation Capsules for the Treatment of Acute Postoperative Pain After Bunionectomy|Completed||Phase 3|373|Actual|Iroko Pharmaceuticals, LLC||4|||f||||f||||||||||2017-10-11 02:49:06.97795|2017-10-11 02:49:06.97795
NCT01626105|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-07-25|||June 2012||2012-06-01|July 2012|2012-07-01|June 2014|Anticipated|2014-06-01|April 2013|Anticipated|2013-04-01||Observational|PPTIH||Personalized Prediction of Tolerance and Immunogenicity in Hemophilia|Study of Severe Hemophilia A Patients Who Have Only Received a Single Recombinant FVIII Therapeutic for the Purpose of Identifying the Pharmacogenetic Determinants of Tolerance and Immunogenicity|Unknown status|Not yet recruiting|N/A|55|Anticipated|Los Angeles Orthopaedic Hospital|||1||f||||f||||||Samples With DNA|"     A core laboratory exists for this study and will house a Biorepository containing the     following:        1. White blood cells        2. Blood plasma   "|||2017-10-11 02:49:08.082337|2017-10-11 02:49:08.082337
NCT01626092|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-02-17|2016-08-17||July 11, 2012|Actual|2012-07-11|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders|Treatment of High Risk, Inherited Lysosomal and Peroxisomal Disorders by Reduced-Intensity Hematopoietic Cell Transplantation and Low-Dose Total Body Irradiation With Marrow Boosting by Volumetric-Modulated Arc Therapy (VMAT)|Completed||N/A|3|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 02:49:08.178856|2017-10-11 02:49:08.178856
NCT01626079|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2017-07-14|||August 2012||2012-08-01|July 2017|2017-07-01|July 2024|Anticipated|2024-07-01|July 2018|Anticipated|2018-07-01||Interventional|COAPT||Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial)|A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects|Recruiting||N/A|610|Anticipated|Evalve||2|||f||||t||||||||||2017-10-11 02:49:08.458744|2017-10-11 02:49:08.458744
NCT01626066|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-12-08|||June 2012||2012-06-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|LUM015||Cathepsin Activatable Fluorescent Probe|A Phase I Study of the Safety and Activation of a Cathepsin-Activatable Fluorescent Cancer Specific Probe LUM015|Completed||Phase 1|15|Actual|Duke University||1|||f||||t||||||||||2017-10-11 02:49:09.244718|2017-10-11 02:49:09.244718
NCT01626053|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-06-21|||March 2009||2009-03-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|ASMART||The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 Diabetes|The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 Diabetes|Completed||N/A|182|Actual|KRJG Services Inc.||2|||f||||f||||||||||2017-10-11 02:49:09.351637|2017-10-11 02:49:09.351637
NCT01626040|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-01-16|||June 2012||2012-06-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Evaluation of One-day Polyethylene Glycol Powder Solution for Colonoscopy in Children|Evaluation of One-day Polyethylene Glycol Powder Solution for Colonoscopy in Children|Completed||N/A|178|Actual|Children's Hospital of Philadelphia|||1||f||||f|||||||"     No biospecimens are to be retained   "|||2017-10-11 02:49:09.449934|2017-10-11 02:49:09.449934
NCT01626027|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-08-01|||June 2012||2012-06-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Observational|CDCare||Depression Care for Hospitalized Coronary Heart Disease Patients: Prospective Cohort Study|Depression Care for Hospitalized Coronary Heart Disease Patients: Bridging the Gap Between Guidelines and Reality|Completed||N/A|1265|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||Undecided||2017-10-11 02:49:09.544238|2017-10-11 02:49:09.544238
NCT01626014|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-11-30|||August 2012||2012-08-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Interactive Educational Website for Women With Ovarian Cancer & Caregivers|Making End of Life Decision in Ovarian Cancer: When to Enter Hospice? A Prototype Interactive Computer Program for Patients and Providers|Completed||Early Phase 1|53|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 02:49:09.624851|2017-10-11 02:49:09.624851
NCT01626001|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-11-16|||July 2012||2012-07-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Imaging Study Compare 4DCT Image|An Imaging Study to Compare Methods to Reduce 4DCT Image Acquisition Artifacts|Completed||Phase 1|52|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 02:49:09.72403|2017-10-11 02:49:09.72403
NCT01625988|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-04-14||2014-04-14|June 2012||2012-06-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of LY2951742 in Participants With Migraine|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Migraine|Completed||Phase 2|190|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:49:09.82527|2017-10-11 02:49:09.82527
NCT01625975|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2014-04-07|||July 2012||2012-07-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Observational|||Retrospective Eight Plate Study|A Retrospective Study to Assess the Outcome After Treatment With the Eight Plate System in Pediatric Patients|Completed||N/A|138|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-10-11 02:49:10.013358|2017-10-11 02:49:10.013358
NCT01625962|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2015-08-06|||October 2011||2011-10-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|December 2014|Actual|2014-12-01||Observational|||Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)|Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury|Unknown status|Active, not recruiting|N/A|200|Anticipated|INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium|||2||f||||t||||||||||2017-10-11 02:49:10.129691|2017-10-11 02:49:10.129691
NCT01625949|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2012-06-22|||March 2011||2011-03-01|June 2012|2012-06-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|COAT||Stem Cell Therapy in Patients With Myocardial Infarction and Persistent Total Occlusion of Infarct Related Artery|Study of Stem Cell Therapy in Patients With Myocardial Infarction and Persistent Total Occlusion of Infarct Related Artery|Unknown status|Recruiting|N/A|40|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 02:49:10.212064|2017-10-11 02:49:10.212064
NCT00004799|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||April 1991||1991-04-01|January 1997|1997-01-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines||Completed||Phase 3|10000||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.310919|2017-10-11 04:25:23.310919
NCT01625936|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-20|2016-07-18|||June 2012||2012-06-01|October 2015|2015-10-01||||June 2014|Actual|2014-06-01||Interventional|||CRLX101 Plus Bevacizumab in Advanced RCC|Phase 1b Study Of CRLX 101 (Cerulean) In Combination With Bevacizumab In The Treatment Of Patients With Advanced Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 1|22|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 02:49:10.368391|2017-10-11 02:49:10.368391
NCT01625923|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-06-29|||January 2013||2013-01-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis|A Pilot Study on the Efficacy and Safety of Olanzapine in Improving Symptoms and Gastric Motility in Gastroparesis|Recruiting||N/A|20|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-11 02:49:10.465436|2017-10-11 02:49:10.465436
NCT01625910|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-01-26|2013-04-09||September 2011||2011-09-01|January 2017|2017-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Random allocation resulted in 35 participants in the intervention group and 37 in the control group. However, one participant in the control group was not included in the final analyses due to an interim injury (unrelated to the study) and prolonged cast treatment.|For the Health of Our Children--Clinic Based Treatment of Childhood Obesity|For the Health of Our Children--Clinic Based Treatment of Childhood Obesity: The Feasibility of Recruitment and the Effectiveness of a Low-intensity Stage|Completed||N/A|72|Actual|University of Minnesota - Clinical and Translational Science Institute|There were no adverse events during this 3-month trial comparing a parent-based behavioral intervention with usual care.|2|||f||||t||||||||||2017-10-11 02:49:10.590752|2017-10-11 02:49:10.590752
NCT01625897|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-04-17|||May 2012||2012-05-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia|A Long-term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia|Completed||Phase 2/Phase 3|125|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||||||||||||2017-10-11 02:49:10.88851|2017-10-11 02:49:10.88851
NCT01625884|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-01-08|||October 2012||2012-10-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|STAY||Observational Study to Understand Patients' and Physicians' Attitudes to Statins in TurkeY|Observational Study to Understand Patients' and Physicians' Attitudes to Statins in TurkeY|Completed||N/A|500|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 02:49:10.972834|2017-10-11 02:49:10.972834
NCT01625858|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-09-01|||May 2012||2012-05-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Evaluation of Supraglottic Airway Devices in Children and Comparison to Historic Control|Prospective Evaluation of Pediatric Supraglottic Airways in Anesthetized Children|Completed||N/A|250|Actual|University Hospital Inselspital, Berne|||1||f||||t||||||||||2017-10-11 02:49:11.168566|2017-10-11 02:49:11.168566
NCT01625845|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-10-30|2015-05-28||June 2012||2012-06-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|INFLAMED||Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)|Targeting Systemic Inflammation to Concurrently Treat Late-Life Depression and Reduce Coronary Artery Disease Risk|Completed||Phase 2|36|Actual|Indiana University|"Missing data precluded analysis of two secondary outcome variables: IL-1α and IL-1β.
Due to the very small sample of randomized patients, conclusions should not be drawn from the results of this pilot trial."|2|||f||||t||||||||||2017-10-11 02:49:11.25318|2017-10-11 02:49:11.25318
NCT01625832|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-20|||September 2011||2011-09-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effects of Coronary Sinus Occlusion on Myocardial Ischemia (Pilot Study)|Effects of Coronary Sinus Occlusion on Myocardial Ischemia (Pilot Study)|Completed||N/A|35|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 02:49:11.792385|2017-10-11 02:49:11.792385
NCT01625819|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-01-07|||August 2010||2010-08-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|April 2014|Actual|2014-04-01||Interventional|||Exploring Behavioral Interventions to Improve Heart Failure|Exploring Tai Chi as a Behavioral Intervention for Heart Failure Patients|Completed||N/A|135|Actual|University of California, San Diego||4|||f||||t||||||||||2017-10-11 02:49:11.881422|2017-10-11 02:49:11.881422
NCT01625806|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study of The Effects of Multiple Doses of Ketoconazole on Single Dose Pharmacokinetics of RO4602522 in Healthy Male Volunteers|A Single-Center, Open-Label, Parallel Study to Investigate the Effects of Multiple Doses of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of RO4602522 in Healthy Male Subjects|Completed||Phase 1|34|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:49:11.98751|2017-10-11 02:49:11.98751
NCT01625793|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2013-07-18|||June 2012||2012-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes|Inflammation, Stress and Social Behavior: Using Ecological Assessments and Model Systems to Enhance Relevance to Health Outcomes|Withdrawn||N/A|0|Actual|University of Arizona||2||New medication coming on the market, made study obsolete.|f||||t||||||||||2017-10-11 02:49:12.084778|2017-10-11 02:49:12.084778
NCT01625780|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2016-10-24|||April 2012||2012-04-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|August 2014|Actual|2014-08-01||Interventional|||Comparing Ilioinguinal Single-shot and Three-layer Blocks|A New Approach to Ilio-inguinal Nerve Blocks: 3-layer Injection vs Conventional Ultrasound-guided Single-shot Approach|Terminated||N/A|32|Actual|University of Alberta||2||Not a significant difference in outcomes between groups|f||||f||||||||||2017-10-11 02:49:12.188747|2017-10-11 02:49:12.188747
NCT01625767|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-08-19|||September 2011||2011-09-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|AAT-1||Tobacco Approach Avoidance Training for Adolescent Smokers-1|Tobacco Approach Avoidance Training for Smoking Cessation in Adolescent Smokers-Study 1|Completed||Phase 2|40|Actual|Yale University||1|||f||||t||||||||||2017-10-11 02:49:12.290743|2017-10-11 02:49:12.290743
NCT01625572|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-07-28|||July 2012||2012-07-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|TAPPro||Ultrasound-assisted Bilateral Transversus Abdominis Plane Block for Open Prostatectomy|Ultrasound-assisted Bilateral Transversus Abdominis Plane Block for Open Prostatectomy|Completed||N/A|66|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 02:49:16.135519|2017-10-11 02:49:16.135519
NCT01625754|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-04-26|||November 2011||2011-11-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||The Heart-Mind Connection: Evaluating the Association Between Ceramides and Cognitive Decline in Coronary Artery Disease|The Heart-Mind Connection: Evaluating the Association Between Ceramides and Cognitive Decline in Coronary Artery Disease|Active, not recruiting||N/A|129|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||Samples With DNA|"     Whole blood for ApoE4 genotyping   "|No||2017-10-11 02:49:12.392339|2017-10-11 02:49:12.392339
NCT01625741|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-09-28|||July 2012||2012-07-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|HYDRIC||Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy|Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy|Terminated||Phase 2|6|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1||Stopped by Principal Investigator decision|f||||f||||||||||2017-10-11 02:49:12.493035|2017-10-11 02:49:12.493035
NCT01625728|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-02-21|||June 2012||2012-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Vocal Demands Among Classroom Teachers|A Comparison of Vocal Demands With Vocal Performance Among Classroom Teachers|Recruiting||N/A|100|Anticipated|Southern Illinois University Carbondale|||2||f||||f||||||||No||2017-10-11 02:49:12.61009|2017-10-11 02:49:12.61009
NCT01625715|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-20|||January 2011||2011-01-01|June 2012|2012-06-01|September 2012|Anticipated|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization|A Prospective, Randomized, Case Controlled, Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization in Children With Peanut Allergies.|Unknown status|Active, not recruiting|Phase 2|6|Anticipated|Gordon Sussman Clinical Research||2|||f||||f||||||||||2017-10-11 02:49:14.638765|2017-10-11 02:49:14.638765
NCT01625702|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-05-07|||June 2012||2012-06-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|July 2014|Actual|2014-07-01||Interventional|||Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer||Completed||N/A|138|Actual|Peking University||2|||f||||||||||||||2017-10-11 02:49:14.817146|2017-10-11 02:49:14.817146
NCT01625689|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-05-15|2015-04-28||June 2012||2012-06-01|June 2012|2012-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||All participants enrolled who received a single dose of LAIV or placebo.|Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine|Assessment of the Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine Among Children Aged 24 Through 59 Months in Bangladesh|Completed||Phase 2|309|Actual|PATH||2|||f||||t||||||||||2017-10-11 02:49:14.918939|2017-10-11 02:49:14.918939
NCT01625676|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-19|||August 2004||2004-08-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|October 2010|Actual|2010-10-01||Interventional|MCIAT||Study of Modified Constraint-Induced Aphasia Therapy Schedule to Treat Patients Following Sub-acute Stroke|Constraint-Induced Aphasia Therapy Following Sub-acute Stroke: A Modified Therapy Schedule|Completed||N/A|100|Actual|NRZ Magdeburg Median Kliniken GmbH & Co||2|||f||||f||||||||||2017-10-11 02:49:15.32787|2017-10-11 02:49:15.32787
NCT01625663|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-01-10|||June 2012||2012-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Heart and Muscle Metabolism in Barth Syndrome|Heart and Skeletal Muscle Metabolism, Energetics and Function in Barth Syndrome|Recruiting||N/A|60|Anticipated|Washington University School of Medicine|||2||f||||t||||||Samples With DNA|"     Serum, skin biopsy, breath, urine   "|||2017-10-11 02:49:15.405425|2017-10-11 02:49:15.405425
NCT01625650|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-02-18|||October 2010||2010-10-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01|1 Year|Observational [Patient Registry]|CERTAIN||Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study|The Corrona Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions Sub-study: The Corrona CERTAIN Sub-study|Completed||N/A|2795|Actual|Corrona, LLC.|||1||f||||f||||||Samples With DNA|"     Blood tests: at each study blood is obtained to examine, lipid levels with direct ( non     fasting) LDL, a high sensitivity CRP as well as toxicity monitoring labs including a complete     blood count and a comprehensive panel. During the baseline visit DNA is collected upon     consent - to allow future genetic and pharmacogenetic studies- and also serology markers and     immunoglobulin levels. During the first three visits RNA serum and plasma for storage and     future experiments are collected.   "|||2017-10-11 02:49:15.494783|2017-10-11 02:49:15.494783
NCT01625637|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-01-17|||May 2012||2012-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|AAT-2||Tobacco Approach Avoidance Training for Adolescent Smokers-2|Tobacco Approach Avoidance Training for A Smoking Cessation in Adolescent Smokers- Study 2|Completed||Phase 2|66|Actual|Yale University||2|||f||||t||||||||||2017-10-11 02:49:15.566142|2017-10-11 02:49:15.566142
NCT01625624|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2013-05-07|||June 2012||2012-06-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Evaluating the Effects of Food Products on Energy and Performance|Effect of Food Products on Perceived Energy and Task Performance|Completed||N/A|48|Actual|Mondelēz International, Inc.||2|||f||||f||||||||||2017-10-11 02:49:15.637871|2017-10-11 02:49:15.637871
NCT01625611|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-09-22|||February 2011||2011-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors|Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors|Recruiting||Phase 1|97|Anticipated|Yale University||1|||f||||t||||||||||2017-10-11 02:49:15.826424|2017-10-11 02:49:15.826424
NCT01625598|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-04-21|||April 2012||2012-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|CDDR||Computer Detection of Diabetic Retinopathy Compared to Clinical Examination|A Multicenter Masked Study to Compare Analysis of the Detection Program IDx-DR Against Standard of Care Clinical Examination by Ophthalmologists to Differentiate Levels of Diabetic Retinopathy and Diabetic Macular Edema|Completed||N/A|600|Actual|IDx LLC|||1||f||||||||||||||2017-10-11 02:49:15.941867|2017-10-11 02:49:15.941867
NCT01625585|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-10-14|||May 2011||2011-05-01|October 2013|2013-10-01||||March 2012|Actual|2012-03-01||Observational|||Single Balloon Enterosocpy Obscure Gastrointestinal Bleeding Bleed|LONG-TERM OUTCOMES AFTER SINGLE-BALLOON ENTEROSCOPY IN PATIENTS WITH OBSCURE GASTROINTESTINAL BLEEDING|Completed||N/A|147|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 02:49:16.060034|2017-10-11 02:49:16.060034
NCT01625559|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-02-16|||September 2012||2012-09-01|August 2012|2012-08-01|June 2015|Anticipated|2015-06-01|March 2015|Anticipated|2015-03-01||Interventional|||Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)|A Phase I, Open-Label, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial(MA09-hRPE) Cells in Patients With Stargardt's Macular Dystrophy(SMD)|Unknown status|Active, not recruiting|Phase 1|3|Anticipated|CHABiotech CO., Ltd||1|||f||||t||||||||||2017-10-11 02:49:16.255138|2017-10-11 02:49:16.255138
NCT01625546|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-08-06|||July 2012||2012-07-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Whole Body Hyperthermia and Major Depression (MDD)|Whole Body Hyperthermia and Major Depression (MDD)|Completed||N/A|34|Actual|University of Arizona||2|||f||||t||||||||||2017-10-11 02:49:16.344867|2017-10-11 02:49:16.344867
NCT01625533|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2015-06-03|||June 2012||2012-06-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Safety and Efficacy Study of Dual-axis Rotational Versus Standard Coronary Angiography|Randomized Study on the Safety and Efficacy of Dual-axis Rotational Versus Standard Coronary Angiography|Completed||N/A|576|Actual|General Hospital of Chinese Armed Police Forces|||2||f||||t||||||||||2017-10-11 02:49:16.45358|2017-10-11 02:49:16.45358
NCT01625520|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2016-04-22|||February 2012||2012-02-01|April 2016|2016-04-01||||March 2016|Actual|2016-03-01||Interventional|||SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer|Mono Centre, Open Label Proof of Concept Study SOM230 in Progressive Medullary Thyroid Cancer Patients and the Combination With RAD001 Upon Progression|Completed||Phase 2|19|Actual|Federico II University||1|||f||||t||||||||||2017-10-11 02:49:16.563886|2017-10-11 02:49:16.563886
NCT01625507|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-12-09|2014-11-18||October 2012||2012-10-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||The Alberta Diet: Effectiveness Study|The Alberta Diet: a Proposal for Its Implementation|Completed||Phase 2|73|Actual|University of Alberta||1|||f||||f||||||||||2017-10-11 02:49:16.666856|2017-10-11 02:49:16.666856
NCT01625494|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-01-17|||May 2012||2012-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy|A Prospective Open-label Multicentre Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg or Amlodipine 5 mg Monotherapy|Completed||Phase 3|158|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 02:49:17.036126|2017-10-11 02:49:17.036126
NCT01625481|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2014-05-26|||July 2012||2012-07-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Seal-V Safety and Performance Study|Prospective, Single Arm, Open Label, Non-randomized Study to Evaluate The Safety and Performance of The Seal-V System|Completed||Phase 1|23|Actual|Sealantis Ltd.||1|||f||||f||||||||||2017-10-11 02:49:17.139212|2017-10-11 02:49:17.139212
NCT01625468|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-03-07|||June 2012||2012-06-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households|Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households|Completed||N/A|500|Actual|Emory University||2|||f||||f||||||||||2017-10-11 02:49:17.219375|2017-10-11 02:49:17.219375
NCT01625455|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-03-30|2016-11-30||February 2012||2012-02-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome|Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome|Terminated||Phase 4|7|Actual|Vanderbilt University Medical Center||2||Difficulty recruiting.|f||||f||||||||||2017-10-11 02:49:17.307348|2017-10-11 02:49:17.307348
NCT01625442|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-20|||January 2010||2010-01-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Interventional|||Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome|Effect of Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) on Metabolic Syndrome|Completed||Phase 4|732|Actual|Birjand University of Medical Sciences||3|||f||||t||||||||||2017-10-11 02:49:17.592707|2017-10-11 02:49:17.592707
NCT01625429|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-11-08|||June 2012||2012-06-01|November 2012|2012-11-01|June 2017|Anticipated|2017-06-01|September 2013|Anticipated|2013-09-01||Interventional|||Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer|A Single-center, Prospective, Phase II Study of Albumin-bound Paclitaxel (Nab-paclitaxel) and Carboplatin With or Without Trastuzumab (Herceptin) as Neoadjuvant Therapy in Locally Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Shanghai Cancer Hospital, China||1|||f||||f||||||||||2017-10-11 02:49:17.69949|2017-10-11 02:49:17.69949
NCT01625403|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-08-05|||July 2012||2012-07-01|August 2012|2012-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Recombinant BNP on Heart and Renal Function in Acute Heart Failure|Effect of Recombinant BNP on Heart and Renal Function in Acute Decompensated Heart Failure Patients With Acute Renal Injury|Unknown status|Recruiting|Phase 2|100|Anticipated|Shanghai Chest Hospital||2|||f||||f||||||||||2017-10-11 02:49:18.122568|2017-10-11 02:49:18.122568
NCT01625390|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-06-04||2015-06-04|June 2012||2012-06-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150|A Phase 2/3, Multicenter, Open-label Clinical Study to Assess the Safety and Efficacy of BAY86-6150 in Subjects With Hemophilia A or B With Inhibitors, Composed of 2 Parts (A & B). Part A: Sequential Cohorts of Four Dose Levels of the Modified rFVIIa BAY86-6150 Assessed in a Non-controlled Dose Response Design in Acutely Bleeding Subjects and for PK/ PD in an Intra-individual Crossover Design Compared With One Fixed Dose of Eptacog Alfa in Non-bleeding Subjects. Part B: Confirmatory Study to Further Investigate the Efficacy and Safety of BAY86-6150|Completed||Phase 2/Phase 3|10|Actual|Bayer||3|||f||||t||||||||||2017-10-11 02:49:18.270071|2017-10-11 02:49:18.270071
NCT01625208|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-04-21|||March 2012||2012-03-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|July 2013|Actual|2013-07-01||Interventional|||Supraclavicular Versus Combined Block for Ulnar and Median Distribution Hand Surgery|Standard Supraclavicular Block Versus Low-Volume Supraclavicular Block Plus Ulnar or Median Nerve Block for Hand Surgery in the Ulnar or Median Nerve Distribution|Unknown status|Active, not recruiting|N/A|160|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 02:49:22.760871|2017-10-11 02:49:22.760871
NCT01625377|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-03-25|2016-03-25||December 2012||2012-12-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SIMCER|Randomized population|A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients|A National, Multi-center, Randomized, Open Label Study to Evaluate the Efficacy and Safety of Everolimus Combined With Enteric-coated Mycophenolate Sodium Compared to the Standard Treatment Combining Tacrolimus and Enteric-coated Mycophenolate Sodium in de Novo Liver Transplant Recipients|Completed||Phase 3|188|Actual|Novartis||2|||f||||t||||||||||2017-10-11 02:49:18.547164|2017-10-11 02:49:18.547164
NCT01625364|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-11-06|||September 2009||2009-09-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|July 2013|Actual|2013-07-01||Interventional|CAPS||Comparison of Asthma Programs for Schools|Comparison of Asthma Programs for Schools|Completed||N/A|432|Actual|University of Texas at Austin||2|||f||||t||||||||||2017-10-11 02:49:19.609149|2017-10-11 02:49:19.609149
NCT01625351|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-08-17|||August 20, 2012|Actual|2012-08-20|August 2017|2017-08-01|August 19, 2019|Anticipated|2019-08-19|April 14, 2016|Actual|2016-04-14||Interventional|||A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas|A Phase I Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas|Active, not recruiting||Phase 1|23|Actual|St. Jude Children's Research Hospital||1|||f||||f|t|t|t|f||||||2017-10-11 02:49:19.691189|2017-10-11 02:49:19.691189
NCT01625338|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2015-10-09|2015-10-09||June 2012||2012-06-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional||Safety Analysis Set: participants who were enrolled and received at least 1 dose of study drug.|Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies|An Open-Label Study of GS-7977 + Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies|Completed||Phase 3|534|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|3|||f||||t||||||||||2017-10-11 02:49:19.867312|2017-10-11 02:49:19.867312
NCT01625325|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-09-14|||July 2012|Actual|2012-07-01|September 2017|2017-09-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|YES||Identification and Characterization of Youth With Extreme Obesity|Medical and Psychosocial Implications of Adolescent Extreme Obesity - Acceptance and Effects of Structured Care Study, Subproject 1|Completed||N/A|429|Actual|University of Ulm|||2||f||||t||||||Samples With DNA|"     Samples of fasting plasma, serum, DNA, and urine will be retained.   "|||2017-10-11 02:49:21.587163|2017-10-11 02:49:21.587163
NCT01625312|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2015-05-03|||December 2012||2012-12-01|September 2014|2014-09-01|December 2014|Actual|2014-12-01|October 2013|Actual|2013-10-01||Observational|||China PEACE-Prospective 3-vessel Disease Study|The China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Prospective Study of Revascularization in Patients With Three-vessel Coronary Heart Disease|Completed||N/A|2339|Actual|China National Center for Cardiovascular Diseases|||3||f||||t||||||Samples With DNA|"     A venous blood sample of 20mL will be collected at 1-month visit and 12-month visit for     biomarker analysis and storage for future genetic studies;      A urine samples of 40mL will be collected at 1-month visit and 12-month visit for biomarker     analysis and storage.   "|||2017-10-11 02:49:21.687117|2017-10-11 02:49:21.687117
NCT01625299|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-19|||October 2008||2008-10-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Pilot Study of Diet and Behavior in Children With Autism|PILOT STUDY: The Physiological Basis for Dietary Protein Intolerance in Children With Autism|Completed||N/A|12|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 02:49:21.765783|2017-10-11 02:49:21.765783
NCT01625286|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-05-17|||October 3, 2012|Actual|2012-10-03|May 2017|2017-05-01|September 15, 2017|Anticipated|2017-09-15|January 28, 2017|Actual|2017-01-28||Interventional|BEECH||Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients|A Phase I/II Study of AZD5363 Combined With Paclitaxel in Patients With Advanced or Metastatic Breast Cancer. Comprising a Safety Run-In and a Placebo-controlled Randomised Expansion in ER+ve Patients Stratified by PIK3CA Mutation Status|Active, not recruiting||Phase 1/Phase 2|151|Actual|AstraZeneca||4|||f||||t||||||||||2017-10-11 02:49:21.862317|2017-10-11 02:49:21.862317
NCT01625273|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-01-25|||January 2010||2010-01-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Supplementation of Infant Formula With Synbiotics|Supplementation of Infant Formula With the Synbiotics (Lactobacillus Paracasei Ssp. Paracasei Strain F19 and Fructo- and Galactooligosaccharides).|Completed||N/A|182|Actual|Arla Foods||2|||f||||f||||||||No||2017-10-11 02:49:22.079131|2017-10-11 02:49:22.079131
NCT01625260|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-01-23|||April 2012||2012-04-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|April 2015|Actual|2015-04-01||Interventional|||A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer|A Phase Ib/II Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-muscle Invasive Bladder Cancer|Active, not recruiting||Phase 1/Phase 2|52|Anticipated|Altor BioScience||1|||f||||t||||||||No||2017-10-11 02:49:22.178451|2017-10-11 02:49:22.178451
NCT01625247|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-06-20|||June 2009||2009-06-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Drainage is Not Necessary Procedure After Laparoscopic Cholecystectomy Due to Severe Acute Cholecystitis||Unknown status|Recruiting|Phase 3|162|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:49:22.282895|2017-10-11 02:49:22.282895
NCT01625234|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-08-15|||June 2012||2012-06-01|August 2017|2017-08-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer|Phase 1/2, First-in-Human, Dose-Escalation Study of X-396 (Ensartinib) in Patients With Advanced Solid Tumors and Expansion Phase in Patients With ALK-positive Non-Small Cell Lung Cancer|Recruiting||Phase 1/Phase 2|150|Anticipated|Xcovery Holding Company, LLC||1|||f||||f||||||||||2017-10-11 02:49:22.366556|2017-10-11 02:49:22.366556
NCT01625221|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-04-19|2013-11-26||December 2008||2008-12-01|November 2015|2015-11-01|March 2016|Actual|2016-03-01|March 2012|Actual|2012-03-01||Interventional|||Feasibility Study of the Magnetic Anal Sphincter (FENIX System)|An Observational Clinical Feasibility Study of The Magnetic Anal Sphincter|Completed||N/A|35|Actual|Torax Medical Incorporated||1|||f||||f||||||||||2017-10-11 02:49:22.570728|2017-10-11 02:49:22.570728
NCT01625195|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-20|||May 2012||2012-05-01|June 2012|2012-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|MOP201109||Causal Relationships Between LC-omega-3-enriched Diet and Cognition|Causal Relationships Between LC-omega-3-enriched Diet and Cognition|Unknown status|Recruiting|N/A|300|Anticipated|Université de Sherbrooke||2|||f||||t||||||||||2017-10-11 02:49:22.851736|2017-10-11 02:49:22.851736
NCT01625182|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-08-22|2017-08-17||December 22, 2012|Actual|2012-12-22|August 2017|2017-08-01|September 3, 2016|Actual|2016-09-03|September 3, 2016|Actual|2016-09-03||Interventional|||Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.|A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Fingolimod 0.5 mg Administered Orally Once Daily Versus Placebo in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)|Completed||Phase 3|106|Actual|Novartis||2|||f||||t|t|f||||||||2017-10-11 02:49:22.985495|2017-10-11 02:49:22.985495
NCT01625169|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-08-11|2014-06-09||April 2010||2010-04-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma|Antiretroviral Drug Concentrations and HIV Viral Load in Breast Milk and Plasma in HIV+ Women Receiving HAART (Highly Active Antiretroviral Therapy) Therapy: Etravirine (ETR) Pharmacokinetics (PK) in Breast Milk and Plasma|Completed||N/A|9|Actual|University of Southern California||1|||f||||f||||||||||2017-10-11 02:49:24.758546|2017-10-11 02:49:24.758546
NCT01625156|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-10-19|||May 2012||2012-05-01|May 2015|2015-05-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery|A Phase 1 Study of ARQ 197 in Combination With Temsirolimus in Advanced Solid Tumors|Completed||Phase 1|11|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:49:25.174456|2017-10-11 02:49:25.174456
NCT01625143|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2016-05-17|||June 2012||2012-06-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia|Molecular Taxonomy of Pediatric Cancer|Completed||N/A|40|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Archived bone marrow samples   "|||2017-10-11 02:49:25.333985|2017-10-11 02:49:25.333985
NCT01625130|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-06-10|||October 2013||2013-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|BroccOz||Effect of Sulforaphane-rich Broccoli Sprout Homogenate on Ozone Induced Inflammation Through Modulation of NRF2|Down Regulation of Oxidant Induced Airway Inflammation Through Modulation of NRF2|Completed||N/A|16|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:49:25.468239|2017-10-11 02:49:25.468239
NCT01625117|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-06-25|||May 2011||2011-05-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||Mental Health and Aggression in Congolese Ex-combatants||Completed||Phase 2|38|Actual|University of Konstanz||2|||f||||f||||||||||2017-10-11 02:49:25.589763|2017-10-11 02:49:25.589763
NCT01625091|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-07-06|2017-07-06||December 2012|Actual|2012-12-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|WHATIF||Clinical Trial to Reduce Drinking in Women With HIV|Pharmacotherapy for Alcohol Consumption in HIV Infected Women: Randomized Trial|Completed||Phase 3|194|Actual|University of Florida||2|||f||||t|t|f||||||||2017-10-11 02:49:25.846826|2017-10-11 02:49:25.846826
NCT01625078|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2014-05-28|||March 2012||2012-03-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Observational Study of Baska Mask, a New Supraglottic Airway Device in Children|Observational Study of Baska Mask, a New Supraglottic Airway Device in Children|Completed||Phase 2|20|Actual|University College Hospital Galway||1|||f||||f||||||||||2017-10-11 02:49:26.402566|2017-10-11 02:49:26.402566
NCT01625065|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-20|||May 2010||2010-05-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Observational|||Study of Medication Compliance - a Comparison of Patients in Pain Management and Pre-surgical Patients|Toxicological Analyses of Blood and Urine Samples in Pain Patients and Pre-surgical Control Patients to Investigate Incidences of Concealed and Feigned Substances|Completed||N/A|343|Actual|Ruhr University of Bochum|||2||f||||f|||||||"     serum, urine   "|||2017-10-11 02:49:26.470464|2017-10-11 02:49:26.470464
NCT01625052|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-12-22|||January 2012||2012-01-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Determination of the Optimal Approach to Select the Best Size of BASKA Mask to Use in Male Patients|Determination of the Optimal Approach to Select the Best Size of BASKA Mask to Use in Male Patients|Completed||Phase 2|50|Anticipated|University College Hospital Galway||1|||f||||f||||||||||2017-10-11 02:49:26.539577|2017-10-11 02:49:26.539577
NCT01625026|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-10-15|||September 2013||2013-09-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|OCABSGS||Obeticholic Acid in Bariatric and Gallstone Disease|Effects of Obeticholic Acid on Hepatic Fatty Acid/Triglyceride Metabolism and Hepatobiliary Detoxification/Elimination in Morbidly Obese and Gallstone Patients|Completed||Phase 2|40|Actual|Sahlgrenska University Hospital, Sweden||4|||f||||f||||||||||2017-10-11 02:49:26.708101|2017-10-11 02:49:26.708101
NCT01625013|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-08-04|||July 2012||2012-07-01|August 2014|2014-08-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|SYNVISC-ONE||Synvisc-One for Younger, Active Patients With Osteoarthritis|"Long-Term Management of Younger, Active Patients With Pain From Early Knee Osteoarthritis With Synvisc-One (Hylan G-F 20)"|Unknown status|Recruiting|N/A|150|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 02:49:26.807605|2017-10-11 02:49:26.807605
NCT00004800|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||September 1992||1992-09-01|February 1998|1998-02-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines||Completed||Phase 3|13250||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.381198|2017-10-11 04:25:23.381198
NCT01625000|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-09-26|||May 2012||2012-05-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy of MP-214 in Patients With Schizophrenia|A Double-Blind, Placebo-Controlled Study of MP-214 in Patients With Schizophrenia|Completed||Phase 2/Phase 3|512|Actual|Mitsubishi Tanabe Pharma Corporation||5|||f||||||||||||||2017-10-11 02:49:26.915789|2017-10-11 02:49:26.915789
NCT01624987|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-07-29|||June 2012||2012-06-01|July 2013|2013-07-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Intervention to Support the Reintegration of Former Combatants and Soldiers||Unknown status|Enrolling by invitation|Phase 2/Phase 3|100|Anticipated|University of Konstanz||1|||f||||f||||||||||2017-10-11 02:49:27.029748|2017-10-11 02:49:27.029748
NCT01624974|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-05-07|||August 2012||2012-08-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Crossover Study of MK-1029 in Adult Subjects With Persistent Asthma Who Remain Uncontrolled While Being Maintained on Montelukast|Completed||Phase 2|107|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:49:27.195198|2017-10-11 02:49:27.195198
NCT01624961|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2016-03-31|||June 2012||2012-06-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|||Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults|Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults|Completed||Phase 1|30|Actual|Sanaria Inc.||5|||f||||t||||||||||2017-10-11 02:49:27.288643|2017-10-11 02:49:27.288643
NCT01624948|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2016-07-01|2016-04-12||September 2012||2012-09-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients|Safety and Efficacy of Mycophenolic Acid Withdrawal With Conversion to Zortress (Everolimus) in Renal Transplant Recipients With BK Virus Infection|Completed||Phase 4|40|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 02:49:27.401724|2017-10-11 02:49:27.401724
NCT01624935|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-09-30|||July 2011||2011-07-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Clinical Trial of Interpersonal Therapy for Survivors of the Sichuan Earthquake|Randomized Controlled Clinical Trial of Interpersonal Therapy for Survivors of the Sichuan Earthquake|Completed||N/A|60|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:49:28.231223|2017-10-11 02:49:28.231223
NCT01624922|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2015-08-27|||December 2012||2012-12-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|August 2013|Actual|2013-08-01||Observational|||China PEACE-Prospective PCI Study|The China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Prospective Study of Percutaneous Coronary Intervention|Completed||N/A|5185|Actual|China National Center for Cardiovascular Diseases|||1||f||||t||||||Samples With DNA|"     A venous blood sample of 20mL will be collected at 1-month visit and 12-month visit for     biomarker analysis and storage for future genetic studies;      A urine samples of 40mL will be collected at 1-month visit and 12-month visit for biomarker     analysis and storage.   "|||2017-10-11 02:49:28.317378|2017-10-11 02:49:28.317378
NCT01624909|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2015-08-27|||December 2012||2012-12-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|May 2014|Actual|2014-05-01||Observational|||China PEACE-Prospective AMI Study|The China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Prospective Study of Acute Myocardial Infarction|Completed||N/A|4286|Actual|China National Center for Cardiovascular Diseases|||1||f||||t||||||Samples With DNA|"     A venous blood sample of 20mL will be collected at 1-month visit and 12-month visit for     biomarker analysis and storage for future genetic studies;      A urine samples of 40mL will be collected at 1-month visit and 12-month visit for biomarker     analysis and storage.   "|||2017-10-11 02:49:28.421379|2017-10-11 02:49:28.421379
NCT01624896|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2014-06-29|||April 2012||2012-04-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||China PEACE-Retrospective CathPCI Study|The China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Prospective Study of Coronary Catheterization and Percutaneous Coronary Intervention|Completed||N/A|12000|Actual|China National Center for Cardiovascular Diseases|||1||f||||t||||||||||2017-10-11 02:49:28.500954|2017-10-11 02:49:28.500954
NCT01624883|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2014-06-29|||April 2012||2012-04-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||China PEACE-Retrospective AMI Study|The China PEACE (Patient-centered Evaluative Assessment of Cardiac Events Retrospective Study of Acute Myocardial Infarction|Completed||N/A|18000|Actual|China National Center for Cardiovascular Diseases|||1||f||||t||||||||||2017-10-11 02:49:28.56376|2017-10-11 02:49:28.56376
NCT01624857|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2013-08-13|||June 2012||2012-06-01|May 2012|2012-05-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|Stress CABG||Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft|Perioperative Statin for Depression in Patients Undergoing Coronary Artery Bypass Surgery|Unknown status|Recruiting|Phase 3|400|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||t||||||||||2017-10-11 02:49:28.708083|2017-10-11 02:49:28.708083
NCT01624844|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-06-05|||September 2012||2012-09-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Predictive Value of Ultrasound Measurement of the Dural Sac Volume on the Sensory Level in Spinal Anesthesia|Predictive Value of an Ultrasound Model of Measurement of the Dural Sac Volume on the Sensory Level Obtained by Spinal Anesthesia|Completed||N/A|45|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 02:49:28.790683|2017-10-11 02:49:28.790683
NCT01624831|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-04-24|||November 2011||2011-11-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Social Cognition in Longstanding Psychosis|Social Cognition in Longstanding Psychosis|Terminated||N/A|9|Actual|University of Arizona|||1|Lack of funding|f||||f||||||||||2017-10-11 02:49:28.867556|2017-10-11 02:49:28.867556
NCT00004801|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||March 1992||1992-03-01|January 1998|1998-01-01||||||||Interventional|||Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency||Completed||Phase 1/Phase 2|3||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.460291|2017-10-11 04:25:23.460291
NCT01624818|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2012-06-20|||March 2013||2013-03-01|June 2012|2012-06-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Active With Heart Disease|Coping With Physical Activity and Psychosocial Challenges in Children With Heart Disease at Geilomo Childrens Hospital|Unknown status|Not yet recruiting|Early Phase 1|48|Anticipated|Oslo University Hospital||2|||f||||||||||||||2017-10-11 02:49:28.956754|2017-10-11 02:49:28.956754
NCT01624805|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-01-05|||June 2012||2012-06-01|January 2017|2017-01-01||||June 2018|Anticipated|2018-06-01||Interventional|||Horse ATG in Patients With Aplastic Anemia (AA) or Low/Int-1 Risk Myelodysplastic Syndrome (MDS)|Phase II Study of Horse Anti-Thymocyte Globulin (hATG), Cyclosporine, Methylprednisone, and GCSF (Filgrastim or Pegfilgrastim) in Patients With Aplastic Anemia (AA), or Low/Int-1 Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:49:29.039038|2017-10-11 02:49:29.039038
NCT01624792|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-02-28|||October 2011||2011-10-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|June 2016|Actual|2016-06-01||Interventional|||Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2|Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2|Active, not recruiting||N/A|64|Actual|Texas A&M University||2|||f||||f||||||||||2017-10-11 02:49:29.151515|2017-10-11 02:49:29.151515
NCT01624779|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-02-11|||April 2012||2012-04-01|June 2012|2012-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury|The Effect of Intrathecal Transplantation of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Patients With Spinal Cord Injury, Phase I Clinical Study|Completed||Phase 1|15|Anticipated|Bukwang Pharmaceutical||1|||f||||f||||||||||2017-10-11 02:49:29.243333|2017-10-11 02:49:29.243333
NCT01624766|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2017-09-13|||June 2012|Actual|2012-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Anakinra or Denosumab and Everolimus in Advanced Cancer|A Phase I Trial of Anakinra (IL-1 Receptor Antagonist) or Denosumab (Anti-RANKL Monoclonal Antibody) in Combination With Everolimus (mTOR Inhibitor) in Patients With Advanced Malignancies|Recruiting||Phase 1|147|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 02:49:29.634908|2017-10-11 02:49:29.634908
NCT01624753|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-10-27|||May 2012||2012-05-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Fibered Confocal Fluorescence Microscopy Imaging in Patients With Diffuse Parenchymal Lung Diseases|Clinical Utility of Fibered Confocal Fluorescence Microscopy Imaging in Patients With Diffuse Parenchymal Lung Diseases|Recruiting||N/A|150|Anticipated|Singapore General Hospital||1|||f||||f||||||||||2017-10-11 02:49:29.750117|2017-10-11 02:49:29.750117
NCT01624740|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-03-09|2014-12-18||June 2012||2012-06-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional||Baseline measurements were taken for all enrolled subjects (n = 20), but 2 subjects randomized to first receive low rate stimulation withdrew prior to stimulation. Thus, 11 subjects in that group had baseline measurements, but only 9 of them received stimulation.|High Rate Spinal Cord Stimulation (SCS) for Chronic Pain|Precision Plus™ High-Rate Subperception SCS for the Treatment of Chronic Intractable Pain|Completed||N/A|20|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 02:49:29.8721|2017-10-11 02:49:29.8721
NCT01624727|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-09-26|||June 2009||2009-06-01|September 2017|2017-09-01|January 15, 2015|Actual|2015-01-15|January 15, 2015|Actual|2015-01-15||Interventional|HEARTS||Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids|Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (HEARTS)|Completed||N/A|338|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-11 02:49:30.209209|2017-10-11 02:49:30.209209
NCT01624714|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-03-08|||September 2012||2012-09-01|March 2014|2014-03-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|||Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects|Phase I Trial Monitoring Efficacy and Safety in Treatment of Alemtuzumab Naive Subjects and Data Collecting and Monitoring of Alemtuzumab Experienced Subjects With Refractory Multiple Sclerosis|Unknown status|Active, not recruiting|Phase 1|60|Anticipated|Advanced Neurosciences Institute||2|||f||||f||||||||||2017-10-11 02:49:30.320246|2017-10-11 02:49:30.320246
NCT01624701|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-11-26|||March 2012||2012-03-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells|Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells: A Pilot Trial in Collaboration With the Massachusetts Institute of Technology|Terminated||Phase 1/Phase 2|3|Actual|Singapore General Hospital||1||Funding expired|f||||t||||||||||2017-10-11 02:49:30.45012|2017-10-11 02:49:30.45012
NCT01624688|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2013-06-27|||July 2011||2011-07-01|June 2013|2013-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Optimizing Tattoo Removal: a Side-by-side Comparison in the Search for One Treatment Tattoo Removal|Optimizing Tattoo Removal: a Side-by-side Comparison in the Search for One Treatment Tattoo Removal|Unknown status|Active, not recruiting|N/A|32|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:49:30.548658|2017-10-11 02:49:30.548658
NCT01624675|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-10-13|||September 2012||2012-09-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder|A Double-blind, Placebo-controlled Study, Followed by an Open-label Extension Study Evaluating the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder|Completed||Phase 3|39|Actual|Janssen Pharmaceutical K.K.||2|||f||||f||||||||||2017-10-11 02:49:30.62675|2017-10-11 02:49:30.62675
NCT01624662|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-09-26||2016-07-21|October 2013||2013-10-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate|A 16-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate|Completed||Phase 3|323|Actual|Optinose US Inc.||4|||f||||f||||||||Yes|randomization codes sent to PIs|2017-10-11 02:49:30.852972|2017-10-11 02:49:30.852972
NCT01623700|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-06-15|||January 2006||2006-01-01|May 2011|2011-05-01||||||||Observational|||Outcome of Longterm Antithrombotic Therapy in Acute Coronary Syndrome Patients|A Retrospective Epidemiological Study to Investigate Outcome and Mortality With Longterm Antithrombotic Therapy in Acute Coronary Syndrome Patients|Unknown status|Active, not recruiting|N/A|78000|Actual|Uppsala University|||3||f||||f||||||||||2017-10-11 02:49:46.709102|2017-10-11 02:49:46.709102
NCT01624649|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-19|2015-06-08|||February 2012||2012-02-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors|Prospective Follow-Up Observational Study to Examine the Progression of ADHD Drug Treatment and to Analyze Associated Factors|Completed||Phase 4|289|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 02:49:30.974536|2017-10-11 02:49:30.974536
NCT01624636|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2016-03-22||2016-03-22|December 2012||2012-12-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).|A Multiple Dose, Two-cohort Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous LFG316 in Patients With Neovascular Age-related Macular Degeneration|Terminated||Phase 2|1|Actual|Novartis||3|||f||||||||||||||2017-10-11 02:49:31.103857|2017-10-11 02:49:31.103857
NCT01624623|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-09-09|||March 2010||2010-03-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Observational|||Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate Cancer|Post-prostatectomy Daily Target Guided Radiotherapy Using Real-Time, State-of-the-Art Motion Tracking With the Calypso 4D Localization System: A Feasibility Study|Unknown status|Active, not recruiting|N/A|20|Anticipated|U.S. Army Medical Research Acquisition Activity|||1||f||||t||||||||||2017-10-11 02:49:31.219868|2017-10-11 02:49:31.219868
NCT01624610|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2016-03-30|||July 2012||2012-07-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome|Comparing the Effectiveness of Two Diets to Control the Symptoms of Irritable Bowel Syndrome With Diarrhea (IBS-D): a Randomized, Controlled Trial and Gastrointestinal Microbiome Analysis|Completed||N/A|100|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 02:49:31.304389|2017-10-11 02:49:31.304389
NCT01624597|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-02-17|||June 2011|Actual|2011-06-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|May 2015|Actual|2015-05-01||Interventional|||A Randomized Controlled Trial to Improve Teen Driving|A Randomized Controlled Trial to Improve Teen Driving|Active, not recruiting||N/A|153|Actual|University of Iowa||3|||f||||t||||||||||2017-10-11 02:49:31.471647|2017-10-11 02:49:31.471647
NCT01624584|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2015-04-08|||June 2012||2012-06-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study Comparing Two Treatments for Child With Anxiety|A Randomized-controlled Study Comparing Two Treatments for Children With Anxiety Disorders|Completed||Phase 3|15|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:49:31.61656|2017-10-11 02:49:31.61656
NCT01624571|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2013-02-26|||March 2012||2012-03-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO|A Double-blind, Multi-center, Randomized, Placebo-controlled, Parallel, Phase II Clinical Trial to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO in Patients Undergoing Colon Resection|Completed||Phase 2|147|Actual|LG Life Sciences||4|||f||||t||||||||||2017-10-11 02:49:31.776236|2017-10-11 02:49:31.776236
NCT01624558|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-09-09|||July 2012||2012-07-01|September 2014|2014-09-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Effectiveness of Carbon Filters to Reduce the Anesthetic Gas Concentration in an Anesthetized Patient|Effectiveness of Carbon Filters to Reduce the Anesthetic Gas Concentration in an Anesthetized Patient|Withdrawn||N/A|0|Actual|Johns Hopkins University||2||Measurement device not performing to standard in study environment|f||||f||||||||||2017-10-11 02:49:31.868054|2017-10-11 02:49:31.868054
NCT01624545|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-02-10|||June 1, 2012|Actual|2012-06-01|February 2017|2017-02-01|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|TOSCAN||To Scan or Not to Scan: The Role of Follow-up CT Scanning for Management of Chronic Subdural Hematoma After Neurosurgical Evacuation|To Scan or Not to Scan: The Role of Follow-up CT Scanning for Management of Chronic Subdural Hematoma After Neurosurgical Evacuation - a Prospective, Randomized, Controlled Trial|Completed||N/A|368|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 02:49:31.982598|2017-10-11 02:49:31.982598
NCT01624532|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-02-24|||November 2011||2011-11-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|October 2012|Actual|2012-10-01||Interventional|GC1109||A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109|A Phase 2 Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 Administered in Multi Intramuscular Doses to Healthy Subjects|Suspended||Phase 2|299|Anticipated|Green Cross Corporation||4|||f||||t||||||||||2017-10-11 02:49:32.102349|2017-10-11 02:49:32.102349
NCT01624519|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-06-18|||August 2012||2012-08-01|June 2012|2012-06-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit|Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of California, Los Angeles||1|||f||||t||||||||||2017-10-11 02:49:32.269842|2017-10-11 02:49:32.269842
NCT01624506|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-03-03|||January 2010||2010-01-01|September 2014|2014-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Observational Study of Anti-Reflux Surgery|Observational Study of Anti-Reflux Surgery: Clinical Experience With the LINX Reflux Management System and Fundoplication|Completed||N/A|734|Actual|Torax Medical Incorporated|||3||f||||f||||||||||2017-10-11 02:49:32.426981|2017-10-11 02:49:32.426981
NCT01624493|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-12-21|||October 2012||2012-10-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients|Phase I/II BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients in First or Second Relapse|Withdrawn||Phase 1/Phase 2|0|Actual|Hoosier Cancer Research Network||2||Phase I was conducted Australia. Phase II not conducted and no US pts enrolled.|f||||t||||||||||2017-10-11 02:49:32.572577|2017-10-11 02:49:32.572577
NCT01624480|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2015-12-08|||July 2012||2012-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy|A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy|Completed||Phase 1|40|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 02:49:32.784754|2017-10-11 02:49:32.784754
NCT01624467|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-06-13|2015-12-21|2014-09-29|August 2012||2012-08-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|May 2014|Actual|2014-05-01||Interventional||All QTc evaluable participants who received at least 1 dose of study drug.|A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors|A Study to Determine Whether Necitumumab (IMC-11F8) Monotherapy Affects the Corrected QT (QTc) Interval in Patients With Advanced Solid Tumors|Completed||Phase 2|75|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:49:33.020455|2017-10-11 02:49:33.020455
NCT01624454|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-05-07|||April 2012||2012-04-01|June 2012|2012-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Optimal Bowel Cleansing Trial|Osmotic or Large Volume Lavage for Optimal Bowel Preparation - a Single-blind Randomized Trial|Completed||N/A|380|Actual|Helse Stavanger HF||2|||f||||f||||||||||2017-10-11 02:49:34.008711|2017-10-11 02:49:34.008711
NCT01624441|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-09-04|||August 21, 2012|Actual|2012-08-21|July 2017|2017-07-01||||September 16, 2013|Actual|2013-09-16||Interventional|||Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer|A Phase 1 Study With Dose Expansion of Dinaciclib (SCH 727965) in Combination With Epirubicin in Patients With Metastatic Triple Negative Breast Cancer|Active, not recruiting||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:49:34.09502|2017-10-11 02:49:34.09502
NCT01624428|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-01-30|||June 2012||2012-06-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|GRAND||Varenicline on Reward Responses and Cognition in Adolescent Smokers|Examining the Effects of Varenicline on Reward Responses,Cognition, and Tobacco Cues in Adolescent Smokers|Completed||Phase 1|16|Actual|Yale University||2|||f||||t||||||||||2017-10-11 02:49:34.183729|2017-10-11 02:49:34.183729
NCT01624415|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-06-28|||June 2012||2012-06-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|Stereopsis||Subjective Image Quality in Stereoscopic Image Modifications||Completed||N/A|30|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-11 02:49:34.276901|2017-10-11 02:49:34.276901
NCT01624402|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-01-10|||March 2012||2012-03-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Ecosystem Focused Therapy in Post Stroke Depression|Ecosystem Focused Therapy in Post Stroke Depression|Recruiting||N/A|160|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-11 02:49:34.326485|2017-10-11 02:49:34.326485
NCT01624389|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-06-17|||January 2012||2012-01-01|January 2012|2012-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|Alzheimer's||Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study|Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study|Unknown status|Recruiting|N/A|200|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 02:49:34.423982|2017-10-11 02:49:34.423982
NCT01624376|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2014-02-03|||June 2012||2012-06-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|||Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease|A Randomized, Double-blind, Placebo-controlled Phase I/IIa Study in Patients With Abdominal or Perianal Fistulizing Crohn's Disease to Explore the Safety, Tolerability and Preliminary Efficacy of Locally Administered DLX105.|Completed||Phase 2|18|Actual|Delenex Therapeutics AG||2|||f||||f||||||||||2017-10-11 02:49:34.505937|2017-10-11 02:49:34.505937
NCT01624363|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-04-18|2016-05-03||September 2009||2009-09-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Observational|||Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound|Prevalence of Pancreatic Cysts During Routine EUS|Completed||N/A|341|Actual|Indiana University|||1||f||||t||||||||Yes|Results publication|2017-10-11 02:49:34.591131|2017-10-11 02:49:34.591131
NCT01624350|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2016-11-29|2016-07-21||September 2012||2012-09-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|||A Prospective, Multi-center, Observational Study of the Use of Permacol™ Collagen Paste to Treat Anorectal Fistulas|MASERATI 100 - A Prospective, Multi-center, Post-mArket, Single-arm obsERvATIonal Study to Collect Clinical Outcome Data on the Use of Permacol™ Collagen Paste in the Treatment of Anorectal Fistulas|Completed||N/A|100|Actual|Medtronic - MITG|||1||f||||t||||||||||2017-10-11 02:49:34.85546|2017-10-11 02:49:34.85546
NCT01624337|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2016-07-11|||May 2012||2012-05-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|MPC||Malaria Prevention Cambodia|A Randomized, Double Blind, Placebo-controlled Clinical Trial of Monthly DHA-piperaquine for Malaria Prevention in Cambodia.|Terminated||N/A|231|Anticipated|Armed Forces Research Institute of Medical Sciences, Thailand||2||Medication safety concern|f||||t||||||||||2017-10-11 02:49:35.519256|2017-10-11 02:49:35.519256
NCT01624324|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-07-08|||November 2010||2010-11-01|July 2012|2012-07-01||||||||Observational|||Aminoglycoside Plasma Level Measurement in Neonates With Infection|Aminoglycoside Plasma Level Measurement in Neonates With Infection|Unknown status|Recruiting|N/A|25|Anticipated|Indonesia University|||1||f||||f|||||||"     Plasma, Urine   "|||2017-10-11 02:49:35.66597|2017-10-11 02:49:35.66597
NCT01624311|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2015-05-28|||August 2007||2007-08-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants|Hypothermia Treatment in Hyperammonemia and Encephalopathy|Completed||Phase 2|5|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 02:49:35.771833|2017-10-11 02:49:35.771833
NCT01624285|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-08-24|||July 16, 2012|Actual|2012-07-16|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer|A Phase II Randomized Multicenter Placebo-Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant (OLT) Recipients With Hepatocellular Carcinoma (HCC)|Recruiting||Phase 2|356|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:49:36.012868|2017-10-11 02:49:36.012868
NCT01623687|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-04-03|||August 2011||2011-08-01|April 2014|2014-04-01|March 2015|Anticipated|2015-03-01|September 2014|Anticipated|2014-09-01||Interventional|||Bone Forming at Prosthetic Surfaces. Fingerprint2|Bone Forming at Prosthetic Surfaces. A Randomized Clinical F-PET/CT Study|Unknown status|Recruiting|Phase 4|26|Anticipated|Uppsala University||4|||f||||f||||||||||2017-10-11 02:49:46.800545|2017-10-11 02:49:46.800545
NCT01624272|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-03-23|||November 2008||2008-11-01|March 2014|2014-03-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|||Respiratory Muscle Training in Institutionalized Elderly Population|The Effectiveness of Pranayama Breathing Exercises vs. Threshold Inspiratory Muscle Trainer to Improve Respiratory Muscle Function in an Institutionalized Frail Elderly Population|Completed||N/A|71|Actual|University of Valencia||3|||f||||f||||||||||2017-10-11 02:49:36.226361|2017-10-11 02:49:36.226361
NCT01624259|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-10-03|2014-10-03|2014-01-07|June 2012||2012-06-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|AWARD-6|Participants who were randomized and received at least 1 dose of LY2189265 or Liraglutide|A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes|A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide With Once-Daily Liraglutide in Patients With Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation of LY2189265 in Diabetes-6)|Completed||Phase 3|599|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:49:36.393301|2017-10-11 02:49:36.393301
NCT01624246|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-04-06|||May 2012||2012-05-01|April 2017|2017-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance|A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance|Completed||Phase 1|12|Actual|Forest Laboratories||1|||f||||f||||||||||2017-10-11 02:49:38.164678|2017-10-11 02:49:38.164678
NCT01624233|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-07-05|2016-04-20|2014-04-25|June 2012||2012-06-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2013|Actual|2013-09-01||Interventional|UNCOVER-J|All enrolled participants.|A Study in Japanese Participants With Moderate-to-Severe Psoriasis|A Multicenter, Open-Label, Long-Term Study to Evaluate the Efficacy and Safety of LY2439821 in Japanese Patients With Moderate-to-Severe Psoriasis|Active, not recruiting||Phase 3|91|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:49:38.458975|2017-10-11 02:49:38.458975
NCT01624220|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-09-19|||June 2012|Actual|2012-06-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy|A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy|Active, not recruiting||N/A|41|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 02:49:39.299272|2017-10-11 02:49:39.299272
NCT01624207|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-12-15|||March 2010||2010-03-01|December 2013|2013-12-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg|A Multi-center, Randomized, Open-labeled Clinical Trial to Evaluate Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg in Korean Patients With Hypercholesterolemia|Completed||Phase 4|376|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:49:39.413123|2017-10-11 02:49:39.413123
NCT01624181|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2013-01-09|||June 2012||2012-06-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Fast Identification of Pathogen in the Setting of Hospital-acquired Pneumonia Using Ion Mobility Spectrometry|Identification of Microbes Through Detection of Pathogen Specific Volatile Compound Patterns, Using Multi-capillary Column Coupled Ion Mobility Spectrometry (MCC-IMS) in the Setting of Hospital-acquired Pneumonia|Completed||N/A|24|Actual|University of Göttingen|||1||f||||f||||||Samples Without DNA|"     aspiration samples from the respiratory system (tracheal secretion sample, BAL)   "|||2017-10-11 02:49:39.628802|2017-10-11 02:49:39.628802
NCT01624168|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2016-01-06|2015-08-31||January 2013||2013-01-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults|Effects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults|Completed||N/A|75|Actual|Appalachian State University|None of the reported Serious Adverse Events or Adverse Events were determined to be a result of participation in the intervention.|3|||f||||t||||||||||2017-10-11 02:49:39.74403|2017-10-11 02:49:39.74403
NCT01624155|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2013-02-20|||May 2012||2012-05-01|February 2013|2013-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|TLC||Increasing Contraception Utilization Among Women Prescribed Teratogenic Medications|Utilizing the Electronic Medical Record to Collaborate With a Community- Based Organization to Increase More Effective Contraception Utilization Among Women Prescribed Teratogenic Medications|Unknown status|Recruiting|N/A|100|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-10-11 02:49:40.327835|2017-10-11 02:49:40.327835
NCT01624142|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-06-12|||June 1, 2012|Actual|2012-06-01|June 2017|2017-06-01|March 12, 2020|Anticipated|2020-03-12|March 12, 2020|Anticipated|2020-03-12||Interventional|TAUSSIG||Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders|A Multicenter, Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of Evolocumab (AMG145) on LDL-C in Subjects With Severe Familial Hypercholesterolemia|Active, not recruiting||Phase 2/Phase 3|300|Actual|Amgen||2|||f||||f|t|f||||||||2017-10-11 02:49:40.432856|2017-10-11 02:49:40.432856
NCT01624129|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-08|2012-06-16|||January 2011||2011-01-01|February 2011|2011-02-01||||||||Observational|||New Serological Markers for Eosinophilic Esophagitis||Unknown status|Recruiting|N/A|20|Anticipated|Technische Universität München|||1||f||||f||||||||||2017-10-11 02:49:40.634282|2017-10-11 02:49:40.634282
NCT01624116|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-06-19|||August 2011||2011-08-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes|A Comparison of Four Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetic Patients and the Effect of Add-On Acarbose on Glycaemic Excursions During Ramadan Fasting|Completed||N/A|161|Actual|Services Hospital, Lahore||4|||f||||f||||||||||2017-10-11 02:49:40.732856|2017-10-11 02:49:40.732856
NCT01624103|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2015-03-02|||November 2012||2012-11-01|March 2015|2015-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|US-SCB||Comfort Score During Ultrasound Guided Supraclavicular Brachial Plexus Block Placement in Elderly Patients|Influence of Anesthetic Volume on Comfort Score During US-SCB Placement in Elderly Patients|Unknown status|Recruiting|N/A|50|Anticipated|Šarić, Jadranka Pavičić, M.D.||2|||f||||f||||||||||2017-10-11 02:49:40.827905|2017-10-11 02:49:40.827905
NCT01624077|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-02-21|||December 2014||2014-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|Treg||Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance|Phase 1 Clinical Trial Using Regulatory T Cells as Individualized Medicine to Promote Donor-specific Clinical Liver Transplantation Tolerance in Nanjing|Unknown status|Active, not recruiting|Phase 1|1|Anticipated|Nanjing Medical University||1|||f||||t||||||||||2017-10-11 02:49:41.046816|2017-10-11 02:49:41.046816
NCT01624064|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2012-06-19|||August 2012||2012-08-01|June 2012|2012-06-01|October 2013|Anticipated|2013-10-01|October 2012|Anticipated|2012-10-01||Interventional|CKDu||Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology|A Double Blind Clinical Trial to Examine the Renal Effects of an Angiotensin Converting Enzyme Inhibitor (Enalapril) in Adults With Chronic Kidney Disease of Uncertain Aetiology (CKDu)|Unknown status|Not yet recruiting|Phase 1/Phase 2|200|Anticipated|Ministry of Health, Sri Lanka||4|||f||||t||||||||||2017-10-11 02:49:41.130379|2017-10-11 02:49:41.130379
NCT01624051|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2014-09-26|||July 2014||2014-07-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer|A Phase II Double Blind Randomized Trial Comparing Standard Dosing Based on Body Surface Area Versus Dosing Based on Personalized Lean Body Mass in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Receiving First Line Cisplatin Based Chemotherapy|Unknown status|Recruiting|Phase 2|144|Anticipated|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-10-11 02:49:41.238456|2017-10-11 02:49:41.238456
NCT01624038|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-06-18|||June 2012||2012-06-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.|Phase 2 Study of Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.|Unknown status|Not yet recruiting|Phase 2/Phase 3|40|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 02:49:41.332929|2017-10-11 02:49:41.332929
NCT01624025|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-08-16|||June 2012||2012-06-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin||Completed||Phase 2|22|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:49:41.432851|2017-10-11 02:49:41.432851
NCT01624012|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-05-10|||August 2011||2011-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Interventional|NIV NAVA||Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist Versus Nasal Continuous Airway Pressure in Premature Infants|Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist (NIV NAVA) Versus Nasal Continuous Airway Pressure (NCPAP) in Premature Infants|Completed||N/A|40|Actual|University of Oulu||2|||f||||f||||||||||2017-10-11 02:49:41.784892|2017-10-11 02:49:41.784892
NCT01623986|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-08-14|||March 2013||2013-03-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|||Correlation of Measurements From Mespere Venus 1000 System & Echocardiography to Estimate Right Atrial Pressure|Technical Correlation of a Noninvasive Estimation of Central Venous Pressure From the Mespere Venus 1000 System and the Inferior Vena Cava From Echocardiography, to Estimate Right Atrial Pressure|Completed||N/A|45|Actual|Mespere Lifesciences Inc.|||1||f||||f||||||||||2017-10-11 02:49:41.932969|2017-10-11 02:49:41.932969
NCT01623973|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-06-19|||March 2011||2011-03-01|June 2012|2012-06-01||||May 2012|Actual|2012-05-01||Interventional|||Impact of Restriction of the Non Paretic Upper Limb Rehabilitation of Patients a With Stroke:Randomized Clinical Trial|Impact of the Restriction of the Non Paretic Upper Limb in Rehabilitation of Patients Post-stroke:Randomized Clinical Trial|Completed||N/A|19|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 02:49:42.024588|2017-10-11 02:49:42.024588
NCT01623960|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-06-17|||October 2012||2012-10-01|June 2012|2012-06-01|February 2014|Anticipated|2014-02-01|October 2013|Anticipated|2013-10-01||Observational|TurkHaemQoL||Quality of Life in Adult Patients With Severe Haemophilia in Turkey|A Nationwide Multicenter Study on the Quality of Life in Adult Patients With Severe Haemophilia in Turkey|Unknown status|Not yet recruiting|N/A|500|Anticipated|Turkish Society of Hematology|||1||f||||t||||||||||2017-10-11 02:49:42.114025|2017-10-11 02:49:42.114025
NCT01623947|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-04-18|||June 2012||2012-06-01|April 2013|2013-04-01|May 2013|Anticipated|2013-05-01|October 2012|Actual|2012-10-01||Interventional|||Effects of Sustamine(TM) on Cycling Time Trial Performance|Effects of Sustamine(TM) on Cycling Time Trial Performance Following Prolonged Cycling|Unknown status|Active, not recruiting|N/A|14|Anticipated|University of Texas at Austin||3|||f||||t||||||||||2017-10-11 02:49:42.172254|2017-10-11 02:49:42.172254
NCT01623934|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-05-01|||January 2010||2010-01-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|GEN3G||Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development|Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development|Active, not recruiting||N/A|1086|Actual|Université de Sherbrooke|||2||f||||t||||||Samples With DNA|"     plasma, whole cord blood, serum cord blood, white cells, sample of placenta   "|||2017-10-11 02:49:42.26029|2017-10-11 02:49:42.26029
NCT01623921|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-06-19|||August 2012||2012-08-01|June 2012|2012-06-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma||Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||4|||f||||||||||||||2017-10-11 02:49:42.336549|2017-10-11 02:49:42.336549
NCT01623908|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2012-10-17|||July 2011||2011-07-01|October 2012|2012-10-01|June 2017|Anticipated|2017-06-01|June 2014|Anticipated|2014-06-01||Interventional|BLAZE||Bone Loss Treatment From Adjuvant Zoledronate Efficacy|An Open,Multicentre,Prospective Study of Adjuvant Zoledronate Treatment in Osteoporosis Women With Breast Cancer|Unknown status|Recruiting|N/A|200|Anticipated|First Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||||2017-10-11 02:49:42.430578|2017-10-11 02:49:42.430578
NCT00004834|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2013-02-20|||May 1998||1998-05-01|February 2013|2013-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder||Completed||N/A|326||Northwell Health|||||f||||||||||||||2017-10-11 04:25:24.924328|2017-10-11 04:25:24.924328
NCT01623895|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-07-11|||December 2007||2007-12-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Pharmacogenetic Study in Patients Received Iron Chelating Agent|Pharmacogenetic Study in Patients Received Iron Chelating Agent|Completed||N/A|100|Anticipated|Seoul National University Hospital|||1||f||||f||||||Samples With DNA|"     Candidate genes exhibit polymorphisms and encodes proteins that are involved in the     pharmacokinetics and pharmacodynamics of deferasirox.      Candidate genes : MRP2, BCRP, UGT1A subfamily   "|||2017-10-11 02:49:42.567946|2017-10-11 02:49:42.567946
NCT01623882|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-04-23|||June 2012||2012-06-01|April 2013|2013-04-01|December 2015|Anticipated|2015-12-01|June 2014|Anticipated|2014-06-01||Observational|OG/SNaP||Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System|Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Negative Pressure Wound Therapy System for Treatment of Non-responding Venous Stasis and Diabetic Lower Extremity Ulcers|Unknown status|Recruiting|N/A|60|Anticipated|Spiracur, Inc.|||1||f||||t||||||||||2017-10-11 02:49:42.62449|2017-10-11 02:49:42.62449
NCT01623869|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2015-09-28|2015-06-05||July 2012||2012-07-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|September 2014|Actual|2014-09-01||Interventional|||Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery|Phase II Study of the Angiopoietin-1 and -2 Peptibody AMG 386 for the Treatment of Angiosarcoma|Completed||Phase 2|16|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:49:42.730039|2017-10-11 02:49:42.730039
NCT01623856|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-05-06|||June 2012||2012-06-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients|Observational - Candidate Gene Variants and Childhood/Adolescent Non-Hodgkin Lymphoma: A Preliminary Investigation|Completed||N/A|483|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 02:49:43.16446|2017-10-11 02:49:43.16446
NCT01623843|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2017-06-06|||September 2012||2012-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|August 2018|Anticipated|2018-08-01||Interventional|FIRST||Femoroacetabular Impingement RandomiSed Controlled Trial|Femoroacetabular Impingement RandomiSed Controlled Trial (FIRST); Sub-study: Femoroacetabular Impingement RandomiSed Controlled Trial With an Embedded Prospective Cohort (FIRST-EPIC)|Recruiting||N/A|220|Anticipated|McMaster University||2|||f||||t||||||||Undecided||2017-10-11 02:49:43.253447|2017-10-11 02:49:43.253447
NCT01623830|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-12-09|2016-10-14||July 2012||2012-07-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Targeting Reconsolidation to Prevent Return of Fear|Targeting Memory Reconsolidation to Prevent the Return of Fear in a Pilot Randomized Clinical Trial|Completed||N/A|89|Actual|Emory University||2|||f||||f||||||||||2017-10-11 02:49:45.342805|2017-10-11 02:49:45.342805
NCT01623817|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-06-19|||June 2012||2012-06-01|June 2012|2012-06-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Effectiveness of Vancomycin Loading Therapy|Effectiveness of Vancomycin Loading Therapy|Unknown status|Not yet recruiting|N/A|20|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:49:45.658358|2017-10-11 02:49:45.658358
NCT01623804|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-04-07|||July 2012||2012-07-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|RELIEF||Randomized Trial in knEe Osteoarthritis Using Low Intensity Ultrasound - Evaluating Feasibility (RELIEF)|Can Very Low Intensity Ultrasound Therapy Improve Pain in People With Knee Osteoarthritis? A Pilot Randomized Controlled Trial|Terminated||N/A|1|Actual|McMaster University||2||funding to support alternate feasible recruitment strategy was not acquired|f||||t||||||||||2017-10-11 02:49:45.759439|2017-10-11 02:49:45.759439
NCT01623778|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-16|2012-06-19|||January 2009||2009-01-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Optimization of Antiviral Therapy of Chronic HBV Infection|Observation Study of Different Optimized Therapy Method of Patients With Chronic Hepatitis B|Completed||N/A|67|Actual|Changhai Hospital|||2||f||||f||||||Samples With DNA|"     Blood samples were retented at 12w,24w and 48w after optimized therapy   "|||2017-10-11 02:49:45.946093|2017-10-11 02:49:45.946093
NCT01623765|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-02-08|||January 2010||2010-01-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Lung Cancer Diagnosis and Staging Using Ultrasound Guidance|Diagnosis and Staging of Lung Cancer Using Minimally Invasive Technique With Ultrasound Guidance|Completed||N/A|680|Actual|Singapore General Hospital|||1||f||||f||||||||||2017-10-11 02:49:46.038128|2017-10-11 02:49:46.038128
NCT01623752|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-10-03|||March 2012|Actual|2012-03-01|October 2017|2017-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|PRERA||Prospective Evaluation of the Radiographic Efficacy of Enbrel|A Prospective Evaluation Of The Radiographic Efficacy Of Etanercept In Patients With Rheumatoid Arthritis Or Psoriatic Arthritis.|Enrolling by invitation||N/A|2000|Anticipated|Pfizer|||2||f||||f||||||||||2017-10-11 02:49:46.104055|2017-10-11 02:49:46.104055
NCT01623726|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2013-12-13|||August 2012||2012-08-01|December 2013|2013-12-01|August 2014|Anticipated|2014-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia|Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia: a Double-blind Randomized Clinical Trial|Withdrawn||Phase 2|0|Actual|University of Sao Paulo||2||To be submitted for grant application|f||||f||||||||||2017-10-11 02:49:46.501147|2017-10-11 02:49:46.501147
NCT01623713|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2013-11-17|||June 2012||2012-06-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia|A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia|Completed||Phase 2|260|Actual|Jiangsu Hansoh Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 02:49:46.624184|2017-10-11 02:49:46.624184
NCT01623674|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-05-19|||December 2011||2011-12-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Laparoscopic Skills and Cognitive Function Are Not Affected by Night Shifts in Surgeons|Laparoscopic Skills and Cognitive Function Are Not Affected by Night Shifts in Surgeons|Completed||N/A|30|Actual|Herlev Hospital|||1||f||||f||||||Samples Without DNA|"     Urin (melatonine) Saliva (cortisol)   "|||2017-10-11 02:49:46.954682|2017-10-11 02:49:46.954682
NCT01623661|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-03-03|||December 2011||2011-12-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|CASE||Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease|Effect of Intravenous Sodium Chloride on Urinary Biomarkers for Measurement of Sodium- and Water Channel Activity in the Nephron in Healthy Subject an Patients With Chronic Kidney Disease. A Case Control Study|Completed||N/A|47|Actual|Regional Hospital Holstebro||1|||f||||t||||||||||2017-10-11 02:49:47.032731|2017-10-11 02:49:47.032731
NCT01623648|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2016-07-03|||February 2013||2013-02-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Interventional|HPB||High Protein Breakfast on Appetite, Postprandial Glycemia and Weight Loss in T2D|Effect of Whey Protein vs Other Proteins in the Breakfast on Appetite, Overall Postprandial Glycemia and Weight Loss, in Obese Diabetic Individuals|Active, not recruiting||N/A|58|Anticipated|Hospital de Clinicas Caracas||3|||f||||t||||||||||2017-10-11 02:49:47.130545|2017-10-11 02:49:47.130545
NCT01623635|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-06-19|||February 2012||2012-02-01|February 2012|2012-02-01||||September 2012|Anticipated|2012-09-01||Interventional|||Intraperitoneal Atomization of Ropivacaine During Gynecologic Laparoscopic Surgery|Intraperitoneal Atomization of Ropivacaine During Gynecologic Laparoscopic Surgery: Impact on Pain, Opioid Use and Length of Recovery Room Stay|Unknown status|Recruiting|Phase 3|200|Anticipated|University of Padova||4|||f||||f||||||||||2017-10-11 02:49:47.261519|2017-10-11 02:49:47.261519
NCT01623622|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-02-13|||July 2012||2012-07-01|February 2015|2015-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke|A Phase 2 Study of HC-58 in Patients With Severe Upper Limb Hemiplegia After Stroke|Completed||Phase 2|270|Anticipated|Asahi Kasei Pharma Corporation||3|||f||||f||||||||||2017-10-11 02:49:47.376839|2017-10-11 02:49:47.376839
NCT01623609|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2014-10-13|||July 2012||2012-07-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol|A Phase I, Randomised, Open-label, 3 Way Cross-over Study in Healthy Volunteers to Demonstrate the Bioequivalence of the Naloxegol 25 mg Commercial and Phase III Formulations and to Assess the Effect of Food Administration on the Pharmacokinetics of the Commercial Formulation.|Completed||Phase 1|42|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 02:49:47.507146|2017-10-11 02:49:47.507146
NCT01623583|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-08-15|||April 2014||2014-04-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias|A Randomized Controlled Study of the Effect of a Needle Phobia or Apprehension Intervention With or Without Synera® on Conversion From Central Venous Catheters to Arteriovenous Fistula or Graft|Terminated||Phase 4|10|Actual|Davita Clinical Research||2||limited qualifying patient population|f||||f||||||||||2017-10-11 02:49:48.284166|2017-10-11 02:49:48.284166
NCT01623570|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-17|2012-06-17|||March 2011||2011-03-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP|Prospective Randomized Open Label Study to Compare the Efficacy and Safety of Ovarian Stimulation With Pergoveris® and Menopur® in Women With Severe Luteinizing Hormone (LH) and Follicular Stimulating Hormone (FSH) Deficiency.|Completed||N/A|40|Actual|Centro Riproduzione e Andrologia||2|||f||||f||||||||||2017-10-11 02:49:48.401936|2017-10-11 02:49:48.401936
NCT01623557|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2015-02-12|||April 2012||2012-04-01|February 2015|2015-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|VAC045||A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates|A Phase I/IIa Sporozoite Challenge Study to Assess the Protective Efficacy of Two Prime-Boost Malaria Vaccine Candidates: ChAd63 and MVA Encoding ME-TRAP and the Same Viral Vectors Encoding CS|Completed||Phase 1/Phase 2|30|Actual|University of Oxford||3|||f||||f||||||||||2017-10-11 02:49:48.534747|2017-10-11 02:49:48.534747
NCT01623544|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2013-02-22|||June 2012||2012-06-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Observational|Asthma CER||Asthma Comparative Effectiveness Study|A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol Combination (BFC) and Fluticasone Propionate/Salmeterol Combination (FSC) Among Asthma Patients|Completed||Phase 4|6086|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 02:49:48.650552|2017-10-11 02:49:48.650552
NCT01623531|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-01-31|||February 2014||2014-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery|The Use of Fibrinogen Concentrate in High-Risk Cardiac Surgery. A Prospective, Double-blinded, Randomized, Controlled Study|Recruiting||Phase 3|222|Anticipated|Nova Scotia Health Authority||2|||f||||t||||||||||2017-10-11 02:49:48.733226|2017-10-11 02:49:48.733226
NCT01623518|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-12-01|||June 2012||2012-06-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1|A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1|Completed||Phase 1|15|Actual|University of Oxford||1|||f||||t||||||||||2017-10-11 02:49:48.853229|2017-10-11 02:49:48.853229
NCT01623505|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-04-12|||June 2010||2010-06-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|RW||Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling|"Interventions for Cardiovascular Disease: Real-World Effectiveness of Combined Pharmacotherapy and Behavioural Counseling for Smoking Cessation"|Completed||Phase 4|738|Actual|Ottawa Heart Institute Research Corporation||3|||f||||t||||||||||2017-10-11 02:49:48.955836|2017-10-11 02:49:48.955836
NCT01623492|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-04-21|||July 1, 2012||2012-07-01|April 2017|2017-04-01|June 1, 2018|Anticipated|2018-06-01|April 1, 2018|Anticipated|2018-04-01|3 Years|Observational [Patient Registry]|ES-QuERI||Eisenmenger Quality Enhancement Research Initiative|Eisenmenger Quality Enhancement Research Initiative|Active, not recruiting||N/A|200|Anticipated|Actelion|||1||f||||f||||||Samples Without DNA|"     Blood samples will be collected at Baseline and at each of the annual visits. In addition,     urine sampling will be performed at Baseline. An analysis of biomarkers will be performed at     a hospital core laboratory.   "|||2017-10-11 02:49:49.096149|2017-10-11 02:49:49.096149
NCT01623479|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2012-08-16|2012-08-16||November 2010||2010-11-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes||Completed||N/A|585|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:49:49.346606|2017-10-11 02:49:49.346606
NCT01623466|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-07-26|2017-07-26||July 2012|Actual|2012-07-01|July 2017|2017-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|ATI-CL21|Safety population|Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches|A Randomized, Open-Label, Parallel Group Study To Evaluate Pharmacokinetic Profile, Wearability And Safety of Two Progestin-Only Patches Containing Different Doses Of Levonorgestrel (LNG)|Completed||Phase 1/Phase 2|36|Actual|Agile Therapeutics||2|||f||||f||||||||||2017-10-11 02:49:49.611212|2017-10-11 02:49:49.611212
NCT01623453|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-11-21|||September 2010||2010-09-01|June 2012|2012-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|ANTG||Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211)|A Follow-up Study to Evaluate the Sustained Healing Effect the Patients Who Showed Complete Closure of Fistula the Previous ANTG-ASC-210 Study|Terminated||N/A|6|Actual|Anterogen Co., Ltd.|||2|Difficulty recruiting subjects|f||||t||||||||Undecided||2017-10-11 02:49:49.984818|2017-10-11 02:49:49.984818
NCT01623427|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2015-11-30|||August 2012||2012-08-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2014|Actual|2014-08-01||Interventional|AVATAR||The AVATAR Trial: Applying VAcuum To Accomplish Reduced Wound Infections|The AVATAR Trial: Applying VAcuum To Accomplish Reduced Wound Infections in Laparoscopic Pediatric Surgery|Terminated||N/A|150|Actual|University of Manitoba||2||Difficulty recruiting enough patients|f||||t||||||||||2017-10-11 02:49:50.190167|2017-10-11 02:49:50.190167
NCT01623414|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2015-02-04|||September 2012||2012-09-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Observational|||Sunlight Exposure and Vitamin D Status of Children of South Asian Ethnicity Living in the UK|Sunlight Exposure and Vitamin D Status of Children of South Asian Ethnicity Living in the UK|Completed||N/A|131|Actual|University of Manchester|||1||f||||f||||||||||2017-10-11 02:49:50.276007|2017-10-11 02:49:50.276007
NCT01623401|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-10-04|||May 17, 2012|Actual|2012-05-17|October 2017|2017-10-01|August 24, 2012|Actual|2012-08-24|August 24, 2012|Actual|2012-08-24||Interventional|||A Phase 1, Open-Label, 10 Day Safety Study|Phase 1, Open-Label, Ophthalmology and Neurology Safety Study of Oral 200 mg TR-701 FA Once Daily for 10 Days in Healthy Adults|Completed||Phase 1|72|Actual|Trius Therapeutics LLC||1|||f||||f||||||||||2017-10-11 02:49:50.3418|2017-10-11 02:49:50.3418
NCT01623388|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2014-01-07|||January 2013||2013-01-01|January 2014|2014-01-01||||January 2014|Actual|2014-01-01||Observational|||Epigenetic Modifications of Diabetes Mellitus Type I|Epigenetic Modifications Induced by Glycemic Variability|Withdrawn||N/A|0|Actual|Scripps Translational Science Institute|||1||f||||||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:49:50.451892|2017-10-11 02:49:50.451892
NCT01623375|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-02-18|||June 2012||2012-06-01|February 2015|2015-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects|A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects|Completed||Phase 1|18|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:49:50.527507|2017-10-11 02:49:50.527507
NCT01623362|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-06-15|||September 2010||2010-09-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Interventional|||Evaluation of a Low Fluoride Dentifrice for Caries Control|Low-fluoride Acidic Liquid Dentifrice in Non-fluoridated Communities: a Randomized Clinical Trial|Completed||Phase 3|212|Actual|Federal University of Paraíba||3|||f||||f||||||||||2017-10-11 02:49:50.630059|2017-10-11 02:49:50.630059
NCT01623349|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-03-22|||September 2012||2012-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer|Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer|Active, not recruiting||Phase 1|118|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 02:49:50.737641|2017-10-11 02:49:50.737641
NCT01623336|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-15|||January 2012||2012-01-01|November 2011|2011-11-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|BIP48II/III||BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C|Safety and Efficacy of BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C: Randomized, Multicentric Study With Blinded Analysis|Unknown status|Recruiting|Phase 2/Phase 3|740|Anticipated|The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)||2|||f||||t||||||||||2017-10-11 02:49:51.041681|2017-10-11 02:49:51.041681
NCT01623323|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2016-08-25|2016-02-02||September 2013||2013-09-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps|A 3-Month Open-Label Multicenter Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps|Completed||Phase 3|705|Actual|Optinose US Inc.||1|||f||||f||||||||||2017-10-11 02:49:51.171162|2017-10-11 02:49:51.171162
NCT01623310|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-09-18||2016-07-25|September 2013||2013-09-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device|12-Month OL Evaluating the Safety of Intranasal Administration Fluticasone BID Using OptiNose Device in Subjects With CS With or Without Nasal Polyps|Completed||Phase 3|223|Actual|Optinose US Inc.||1|||f||||f||||||||||2017-10-11 02:49:51.422044|2017-10-11 02:49:51.422044
NCT01623297|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-06-15|||January 2012||2012-01-01|June 2012|2012-06-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Confusion in the Elderly After Colon Surgery|Cognitive Changes After Surgery in the Elderly: Does Minimally Invasive Surgery Influence the Incidence of Postoperative Cognitive Changes Compared to Open Colon Surgery?|Unknown status|Recruiting|N/A|52|Anticipated|New York Hospital Queens|||2||f||||f||||||Samples Without DNA|"     Plasma samples stored up to 7 months then expired and discarded   "|||2017-10-11 02:49:51.53597|2017-10-11 02:49:51.53597
NCT01623284|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2015-12-21|||March 2010||2010-03-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||PiB PET Scanning in Speech and Language Based Dementias|PiB PET Scanning in Speech and Language Based Dementias|Completed||Phase 1|168|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:49:51.656169|2017-10-11 02:49:51.656169
NCT01623271|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-02-15|2016-12-22||May 2013||2013-05-01|February 2017|2017-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)|Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)|Terminated||N/A|5|Actual|Massachusetts General Hospital|Problems with recruitment and early termination of the study consequently resulted in uninterpretable data.|1||Due to limited population of research participants.|f||||f||||||||No||2017-10-11 02:49:51.784449|2017-10-11 02:49:51.784449
NCT01623258|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-18|||December 2002||2002-12-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||A Prospective Randomized Study Comparing Sentinel Lymph Node (SLN) Evaluation With Standard Pathological Evaluation for the Staging of Colon Carcinoma||Completed||N/A|34|Actual|Walter Reed Army Medical Center|||2||f||||f||||||||||2017-10-11 02:49:52.02673|2017-10-11 02:49:52.02673
NCT01623245|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-07-08|||June 2012||2012-06-01|July 2014|2014-07-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Observational|Amylo||Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy|Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy|Unknown status|Active, not recruiting|N/A|260|Anticipated|French Cardiology Society|||1||f||||t||||||Samples With DNA|"     10 mL of whole blood in EDTA tube   "|||2017-10-11 02:49:52.124469|2017-10-11 02:49:52.124469
NCT01623232|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-09-25|||October 2012||2012-10-01|September 2012|2012-09-01|June 2014|Anticipated|2014-06-01|November 2013|Anticipated|2013-11-01||Interventional|CCTA #0005||MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly|MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly|Withdrawn||Phase 1/Phase 2|0|Actual|VA Office of Research and Development||4||FDA hold on the project|f||||t||||||||||2017-10-11 02:49:52.247497|2017-10-11 02:49:52.247497
NCT01623219|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-08-18|||March 2012||2012-03-01|August 2015|2015-08-01||||January 2013|Actual|2013-01-01||Interventional|||Community-Based Telemedicine to Reduce Risk to Georgia Veterans With Post Traumatic Stress Disorder|Community-Based Telemedicine to Reduce Risk to Georgia Veterans With PTSD|Withdrawn||N/A|0|Actual|Emory University||1||Unable to recruit|f||||f||||||||||2017-10-11 02:49:52.40228|2017-10-11 02:49:52.40228
NCT01623206|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2017-08-23|||April 2013||2013-04-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding|Prospective, Open-labelled, Phase II Study, of the Administration of Desmopressin in Patients With Colorectal Cancer, With or Without Metastasis, With Rectal Bleeding, Before Treatment With Surgery and/or Chemotherapy and/or Radiotherapy.|Completed||Phase 2|30|Actual|Laboratorio Elea S.A.C.I.F. y A.||1|||f||||f||||||||||2017-10-11 02:49:52.493308|2017-10-11 02:49:52.493308
NCT01623193|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-05-13|||August 2012||2012-08-01|May 2014|2014-05-01||||||||Interventional|ABC||The ABC Trial Does All-Blood Cardioplegia Prevent Blood Transfusion in Cardiac Surgery? A Single Centre Pilot Study|The ABC Trial - Does All-Blood Cardioplegia Prevent Blood Transfusion in Cardiac Surgery|Unknown status|Recruiting|Phase 4|48|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 02:49:52.58053|2017-10-11 02:49:52.58053
NCT01623180|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-08-17|||December 2012||2012-12-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|May 2015|Actual|2015-05-01||Interventional|Leaders Free||A Randomized Clinical Evaluation of the BioFreedom™ Stent|A Prospective Randomized Comparison of the BioFreedom Biolimus A9 Drug Coated Stent Versus the Gazelle Bare Metal Stent in Patients With High Risk of Bleeding.|Unknown status|Active, not recruiting|N/A|2456|Anticipated|Biosensors Europe SA||2|||f||||t||||||||||2017-10-11 02:49:52.714091|2017-10-11 02:49:52.714091
NCT01623167|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-08-04|||June 7, 2012||2012-06-07|July 28, 2017|2017-07-28|January 30, 2024|Anticipated|2024-01-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia|Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia|Recruiting||Phase 1/Phase 2|150|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:49:52.814062|2017-10-11 02:49:52.814062
NCT01623154|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-02-02|2014-04-29||July 2012||2012-07-01|January 2015|2015-01-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional||95 evaluable subjects for initial diagnosis- each patient received the BreathTek UBT test. Collected breath samples were analyzed on both the UBiT-IR300 and the POC-one.|POCone-UBiT-IR300 Pediatric Comparison Study|A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the UBiT®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms|Completed||Phase 4|99|Actual|Otsuka America Pharmaceutical||1|||f||||f||||||||||2017-10-11 02:49:52.943197|2017-10-11 02:49:52.943197
NCT01623141|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-18|||October 2010||2010-10-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Correlation Between 3 Phase Bone Scintigraphy and Pressure Pain Thresholds in Patients With Complex Regional Pain Syndrome (CRPS)|Correlation Between 3 Phase Bone Scintigraphy and Pressure Pain Thresholds in Patients With CRPS|Completed||N/A|53|Actual|Ruhr University of Bochum|||3||f||||f||||||||||2017-10-11 02:49:53.22305|2017-10-11 02:49:53.22305
NCT01623128|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2013-12-18|||March 2010||2010-03-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|PEVS||Prenatal Education Video Study|Prenatal Education Video Study|Completed||N/A|522|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 02:49:53.313883|2017-10-11 02:49:53.313883
NCT01623115|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2016-01-11|2015-08-20|2015-02-09|July 2012||2012-07-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|ODYSSEY FH I||Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy|Completed||Phase 3|486|Actual|Sanofi|"Manual reclassification was done by the Sponsor for the other reasons of non-completion of study as specified in the electronic case report form (eCRF)."|2|||f||||t||||||||||2017-10-11 02:49:53.454025|2017-10-11 02:49:53.454025
NCT01623102|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2013-02-11|||February 2013||2013-02-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|||Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer|An Open-label Randomized Phase II Trial of Gemcitabine and Cisplatin With or Without Bevacizumab in EGFR Wild-type Non-squamous Non-small-cell Lung Cancer Patients|Unknown status|Recruiting|Phase 2|40|Anticipated|Sichuan Cancer Hospital and Research Institute||2|||f||||f||||||||||2017-10-11 02:49:55.229559|2017-10-11 02:49:55.229559
NCT01623089|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-02-09|||January 2011||2011-01-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Identification of Asthma Phenotypes in Severe Asthmatics|Identification of Asthma Phenotypes in Severe Asthmatics|Recruiting||N/A|500|Anticipated|Singapore General Hospital|||1||f||||f||||||||||2017-10-11 02:49:55.357761|2017-10-11 02:49:55.357761
NCT01623076|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-06-25|||June 2012||2012-06-01|June 2017|2017-06-01|June 2022|Anticipated|2022-06-01|June 2020|Anticipated|2020-06-01||Observational|||The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders|Collaboration on Neuroimmunology: Question, Understand, Educate, Restore - The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders|Recruiting||N/A|150|Anticipated|University of Texas Southwestern Medical Center|||4||f||||f||||||Samples With DNA|"     Patients will donate serum, plasma, DNA, RNA and white blood cells.   "|Yes|Deidentified data can be shared with IRB approved researchers upon request and approval from PI|2017-10-11 02:49:55.439198|2017-10-11 02:49:55.439198
NCT01623063|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-18|||January 2012||2012-01-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|||Histomorphometry Analysis in Fertile and Infertile Patients|Histomorphometry Analysis in Fertile and Infertile Patients|Unknown status|Recruiting|N/A|40|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:49:55.567924|2017-10-11 02:49:55.567924
NCT01623050|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-10-30|2014-09-26||April 2012||2012-04-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|June 2013|Actual|2013-06-01||Interventional||36 patients were enrolled; 2 patients withdrew consent prior to treatment.|Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium|SinuSys Patency of Maxillary Sinus Ostia Study|Completed||Phase 1|36|Actual|SinuSys Corporation||1|||f||||f||||||||||2017-10-11 02:49:55.697403|2017-10-11 02:49:55.697403
NCT01623037|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-06-20|||June 2012||2012-06-01|June 2012|2012-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pilot Study on The Flanks of Asian Patients|PILOT STUDY OF NON-INVASIVE FAT LAYER REDUCTION IN THE FLANKS OF ASIAN PATIENTS WITH THE COOLCURVE+ APPLICATOR|Completed||N/A|15|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 02:49:56.001823|2017-10-11 02:49:56.001823
NCT01623024|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-20|||September 2012||2012-09-01|June 2012|2012-06-01||||September 2014|Anticipated|2014-09-01||Interventional|||Effect on Liver Histology of Vitamin D in Patients With Non-alcoholic Steatohepatitis|A Randomised Controlled Trial of Vitamin D Plus Plus Lifestyle Versus Lifestyle in Patients With Non-alcoholic Steatohepatitis:Effect on Liver Histology and Metabolic Parameters|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|University of Palermo||2|||f||||f||||||||||2017-10-11 02:49:56.081826|2017-10-11 02:49:56.081826
NCT01623011|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-06-18|||July 2012||2012-07-01|June 2015|2015-06-01|April 2017|Anticipated|2017-04-01|January 2016|Anticipated|2016-01-01||Interventional|CSAW||Can Shoulder Arthroscopy Work|What is the Clinical and Cost Effectiveness of Arthroscopic Sub-acromial Decompression Surgery?|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Oxford||3|||f||||t||||||||||2017-10-11 02:49:56.190441|2017-10-11 02:49:56.190441
NCT01622998|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-04-16|||January 2011||2011-01-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|STEP||Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation|Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation in Smokers Motivated to Quit|Completed||Phase 4|303|Actual|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 02:49:56.310906|2017-10-11 02:49:56.310906
NCT01622972|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2014-04-11|||September 2011||2011-09-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Mode of Action of Moviprep|Mode of Action of Moviprep:Impact on Distribution of Intestinal Fluid and Colonic Microbiota|Completed||Phase 4|72|Actual|University of Nottingham||3|||f||||f||||||||||2017-10-11 02:49:56.397651|2017-10-11 02:49:56.397651
NCT01622959|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2013-09-11|||June 2013||2013-06-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Use of ACUPUNCTURE in Emergency Departement|Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in Emergency Department (ED)|Unknown status|Recruiting|N/A|200|Anticipated|University of Monastir||2|||f||||t||||||||||2017-10-11 02:49:56.512255|2017-10-11 02:49:56.512255
NCT01622946|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-18|||April 2012||2012-04-01|April 2012|2012-04-01||||December 2012|Anticipated|2012-12-01||Interventional|||The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach|The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach. A Prospective, Double Blind, Placebo-controlled Clinical Trial.|Unknown status|Recruiting|Phase 4|80|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||||||||||||2017-10-11 02:49:56.643436|2017-10-11 02:49:56.643436
NCT01622933|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-08-30|||June 2012||2012-06-01|May 2016|2016-05-01|August 2017|Actual|2017-08-01|May 2016|Actual|2016-05-01||Interventional|||Multiple Antigen-Engineered DC Vaccine for Melanoma|A Phase I Trial Testing Multiple Antigen-Engineered DC Followed by IFNa2b Boost for Immunization of HLA-Unrestricted Melanoma Patients|Completed||Phase 1|35|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:49:56.738808|2017-10-11 02:49:56.738808
NCT00004838|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||September 1997||1997-09-01|September 1998|1998-09-01|July 1998||1998-07-01|||||Interventional|||Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children||Completed||N/A|175||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:24.998035|2017-10-11 04:25:24.998035
NCT01622920|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2013-03-15|||November 2012||2012-11-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|UMET||Preliminary Clinical Study of Ultrasound to Measure Enamel Thickness|Preliminary Clinical Study of Ultrasound to Measure Enamel Thickness|Completed||Phase 1|30|Actual|University of Leeds||1|||f||||f||||||||||2017-10-11 02:49:56.843989|2017-10-11 02:49:56.843989
NCT01622894|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-06-13|||November 2009||2009-11-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|GMAJ||Genetics of Mendelian Forms of Young Onset Alzheimer Disease|Genetics of Mendelian Forms of Young Onset Alzheimer Disease. Identification of Novel Genetic Causes of AD Are of Importance in Completing the Mechanisms of the Amyloid Hypothesis. This Project is Useful to Promote the Guidelines on the Genetic Diagnosis of AD in France.|Active, not recruiting||N/A|150|Anticipated|University Hospital, Rouen|||1||f||||t||||||Samples With DNA|"     samples with DNA   "|||2017-10-11 02:49:57.093186|2017-10-11 02:49:57.093186
NCT01622881|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-08-18|||June 2012||2012-06-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation|Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation : Randomized Controlled Study|Completed||N/A|98|Actual|Severance Hospital||2|||f||||f||||||||||2017-10-11 02:49:57.155325|2017-10-11 02:49:57.155325
NCT01622855|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-04-21|||March 1997||1997-03-01|April 2015|2015-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Acute Intervention to Reduce Distress Following Sexual Assault|Prevention of Post-Rape Psychopathology and Drug Abuse|Completed||Phase 1/Phase 2|442|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 02:49:58.649796|2017-10-11 02:49:58.649796
NCT01622842|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2012-06-21|||September 2011||2011-09-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|SenseC1||Bioimpedance and Arterial Distension|Bioimpedance of Human Tissue of the Upper Arm and Arterial Distension|Completed||N/A|16|Actual|Sense A/S|||1||f||||f||||||||||2017-10-11 02:49:58.736642|2017-10-11 02:49:58.736642
NCT01622829|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-19|||February 2012||2012-02-01|June 2012|2012-06-01|September 2013|Anticipated|2013-09-01|December 2012|Anticipated|2012-12-01||Interventional|||Activity on Prescription to Promote Physical Activity in Hospitalized Patients|Pilot Study on Physical Activity|Unknown status|Recruiting|N/A|120|Anticipated|Heidelberg University||3|||f||||||||||||||2017-10-11 02:49:58.813042|2017-10-11 02:49:58.813042
NCT01622816|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-11-09|||March 2012||2012-03-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|||Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart|Prospective Determination of Agreement Between Standard ETDRS (Early Treatment Diabetic Retinopathy Study) Chart and Handheld Illuminated ETDRS Equivalent Chart in Eyes With Retinal Pathology|Completed||N/A|70|Actual|Wills Eye|||1||f||||f||||||||No||2017-10-11 02:49:58.895892|2017-10-11 02:49:58.895892
NCT01622803|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-04-24|||August 2011||2011-08-01|April 2016|2016-04-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction|Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction|Withdrawn||Phase 3|0|Actual|Samsung Medical Center||2||Patients enrollment problem|f||||t||||||||||2017-10-11 02:49:58.966739|2017-10-11 02:49:58.966739
NCT01622790|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-10-11|||June 2012||2012-06-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Evaluation of the Bioequivalence of a Combined Formulated Tablet|An Evaluation of the Bioequivalence of a Combined Formulated Tablet (50mg/600mg/300mg Dolutegravir/Abacavir/Lamivudine) Compared to One Dolutegravir 50mg Tablet and One EPZICOM† (600mg/300mg Abacavir/Lamivudine) Tablet Administered Concurrently and the Effect of Food on Bioavailability of the Combined Formulation in Healthy Adult Subjects|Completed||Phase 1|66|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 02:49:59.048561|2017-10-11 02:49:59.048561
NCT01622777|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-18|||February 2010||2010-02-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study|Phase IIa Randomized Double-blind Placebo-controlled Study to Evaluate the Effect of Rosuvastatin in Diabetic Polyneuropathy|Completed||Phase 2|34|Actual|University of Guadalajara||2|||f||||t||||||||||2017-10-11 02:49:59.163765|2017-10-11 02:49:59.163765
NCT01622764|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2014-03-27|||September 2014||2014-09-01|March 2014|2014-03-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|||89Zr-RO5323441 PET Imaging in Glioblastoma|89Zr-RO5323441 PET Imaging in Patients With Recurrent Glioblastoma Treated With Bevacizumab|Withdrawn||Phase 2|0|Actual|University Medical Center Groningen||1||No funding from the sponsor|f||||f||||||||||2017-10-11 02:49:59.274108|2017-10-11 02:49:59.274108
NCT01622751|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-06-14|||January 2007||2007-01-01|June 2012|2012-06-01|June 2007|Actual|2007-06-01|||||Observational|||Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome|Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome|Completed||N/A|46|Actual|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 02:49:59.365922|2017-10-11 02:49:59.365922
NCT01622725|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2014-12-04|||February 2013||2013-02-01|December 2014|2014-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|TIGR||Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh.|Recurrence Rate After Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh.|Unknown status|Recruiting|N/A|268|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 02:49:59.440665|2017-10-11 02:49:59.440665
NCT01622712|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2014-12-04|||February 2013||2013-02-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|REBOUND||Evaluation of Mesh Integration and Mesh Contraction After Open Preperitoneal Inguinal Hernia Repair Using a Memory Ring Containing Device|Evaluation of Mesh Integration and Mesh Contraction After Open Preperitoneal Inguinal Hernia Repair Using a Memory Ring Containing Device.|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 02:49:59.617711|2017-10-11 02:49:59.617711
NCT01622699|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-07-18|||October 2013||2013-10-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Implementation of a Transcutaneous Bilirubinometer|Implementation of a Transcutaneous Bilirubinometer in Jaundiced Newborns: a Randomised Controlled Trial|Completed||N/A|430|Actual|Princess Amalia Children's Clinic||2|||f||||f||||||||||2017-10-11 02:49:59.71702|2017-10-11 02:49:59.71702
NCT01622686|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-18|||November 2011||2011-11-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||PlainLanguageRx: Improving Medication Labels to Reduce Health Disparities|PlainLanguageRx: Improving Medication Labels to Reduce Health Disparities|Completed||N/A|470|Actual|PictureRx, LLC||2|||f||||f||||||||||2017-10-11 02:49:59.850788|2017-10-11 02:49:59.850788
NCT01622673|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-02-14|2013-07-11||June 2012||2012-06-01|February 2017|2017-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247)|A Study to Evaluate the Effect of Metal Cation-Containing Antacids on Raltegravir Pharmacokinetics in HIV-Infected Subjects on a Stable Raltegravir-Containing Regimen|Completed||Phase 1|27|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:49:59.990588|2017-10-11 02:49:59.990588
NCT01622660|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-07-24|2017-01-23||June 2012||2012-06-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy|Phase II Study of Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy|Terminated||Phase 2|2|Actual|Memorial Sloan Kettering Cancer Center||1||Safety reasons|f||||||||||||||2017-10-11 02:50:00.796414|2017-10-11 02:50:00.796414
NCT01622647|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2013-09-05|||July 2012||2012-07-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of Nasal Continuous Positive Airway Pressure (N-CPAP) on Arterial pCO2 During Spinal Anesthesia|The Effect of Nasal Continuous Positive Airway Pressure (N-CPAP) on Arterial pCO2 During Spinal Anesthesia With Intravenous Sedation for Total Knee Arthroplasty|Completed||N/A|40|Anticipated|Mednax Center for Research, Education and Quality||2|||f||||f||||||||||2017-10-11 02:50:01.067578|2017-10-11 02:50:01.067578
NCT01622634|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-09-24|||February 2012||2012-02-01|September 2015|2015-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EPHIT||Effect of a High-Protein Diet and/or High-Intensity Training on Metabolic Syndrome|The E-PHIT Study: Eggs, Protein, and High-Intensity Training: A Diabetes Prevention Program for Women|Completed||N/A|49|Actual|University of Georgia||4|||f||||f||||||||||2017-10-11 02:50:01.132939|2017-10-11 02:50:01.132939
NCT01622621|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-07-03|||May 2012||2012-05-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer|Randomized Phase II Trial of Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients With Early Stage Non-Small Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|96|Anticipated|Mayo Clinic||4|||f||||f||||||||||2017-10-11 02:50:01.221692|2017-10-11 02:50:01.221692
NCT01622608|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2013-12-20|||August 2012||2012-08-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Adolescent Vaccination Kiosk Project|Adolescent Vaccination Kiosk Project|Completed||N/A|42|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 02:50:01.305715|2017-10-11 02:50:01.305715
NCT01622595|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-10-26|||November 2009||2009-11-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients|A Non-interventional Observational Study of Infectious Complications in Cancer Patients|Withdrawn||N/A|0|Actual|University of Arkansas|||1|Principal Investigator has left the institution.|f||||f||||||||||2017-10-11 02:50:01.396634|2017-10-11 02:50:01.396634
NCT01622582|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2015-03-02|||January 2006||2006-01-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma|Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma|Completed||N/A|796|Actual|University of Arkansas|||1||f||||f||||||||||2017-10-11 02:50:01.468096|2017-10-11 02:50:01.468096
NCT01622569|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-09-26||2016-07-25|October 2013||2013-10-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety|A 16-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety|Completed||Phase 3|323|Actual|Optinose US Inc.||4|||f||||f||||||||||2017-10-11 02:50:01.533129|2017-10-11 02:50:01.533129
NCT01622543|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-09-11|||June 11, 2012|Actual|2012-06-11|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer|A Randomized Phase II Study of Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Patients With Metastatic Colorectal Cancer.|Active, not recruiting||Phase 2|109|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 02:50:02.090387|2017-10-11 02:50:02.090387
NCT01622530|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-03-28|||July 2010||2010-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Development of a Simulation Tool for Upper Extremity Prostheses|Development of a Simulation Tool for Upper Extremity Prostheses|Recruiting||N/A|30|Anticipated|University of South Florida|||2||f||||t||||||||||2017-10-11 02:50:02.342934|2017-10-11 02:50:02.342934
NCT01622517|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2016-10-13|||September 2011||2011-09-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|CRISP||Computed Tomography Perfusion (CTP) to Predict Response to Recanalization in Ischemic Stroke Project (CRISP)|Computed Tomography Perfusion (CTP) to Predict Response to Recanalization in Ischemic Stroke Project|Completed||N/A|201|Actual|Stanford University|||1||f||||t||||||||||2017-10-11 02:50:02.461327|2017-10-11 02:50:02.461327
NCT01622504|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-19|||June 2012||2012-06-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||Naloxone Nasal Spray Pharmacokinetic Study|A Phase I Single Dose, Open Label, Randomized, Three Period Crossover Pilot Study to Compare the Pharmacokinetics, Safety and Tolerability of MVP005 Intranasal Spray With Intranasal Administration of Naloxone Solution for Injection in Healthy Adult Subjects|Unknown status|Not yet recruiting|Phase 1|6|Anticipated|Mitovie Pharma Ltd||3|||f||||f||||||||||2017-10-11 02:50:02.54924|2017-10-11 02:50:02.54924
NCT01622478|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-08-14|||December 2006||2006-12-01|August 2012|2012-08-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Observational|VSNBNAC||Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph Nodes|Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Radiologically Positive Axillary Lymph Nodes|Completed||N/A|120|Actual|Gangnam Severance Hospital|||1||f||||t||||||||||2017-10-11 02:50:02.854116|2017-10-11 02:50:02.854116
NCT01622465|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-12-03|||August 2011||2011-08-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Cycle Ergometer in the Rehabilitation of Elderly Patients With Total Hip Arthroplasty|Effect of Cycle Ergometer in the Rehabilitation of Elderly Patients With Total Hip Arthroplasty: Randomized Controlled Trial|Completed||Phase 2|14|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 02:50:02.985195|2017-10-11 02:50:02.985195
NCT01622452|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2013-08-14|||October 2013||2013-10-01|August 2013|2013-08-01|October 2016|Anticipated|2016-10-01|July 2016|Anticipated|2016-07-01||Observational|CardChNeuroMRI||Post Cardiac Surgery Neurocognitive Decline: Correlations Between Neuropsychological Tests and Functional MRI Techniques|Neurocognitive Deficits Related to Cardiac Surgery Intervention With Extracorporeal Circulation. Correlations Between Neuropsychological Tests and Functional MRI Techniques (Spectroscopy, Diffusion and Morphometry)|Unknown status|Not yet recruiting|N/A|50|Anticipated|Fondazione Toscana Gabriele Monasterio|||1||f||||f||||||||||2017-10-11 02:50:03.10688|2017-10-11 02:50:03.10688
NCT01622439|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-03-06|||June 2012||2012-06-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|VALFRID||Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma|Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Lund University Hospital||1|||f||||f||||||||||2017-10-11 02:50:03.174245|2017-10-11 02:50:03.174245
NCT01622426|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2012-06-18|||October 2008||2008-10-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|June 2010|Actual|2010-06-01||Interventional|||Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy|Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy|Completed||N/A|60|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 02:50:03.276553|2017-10-11 02:50:03.276553
NCT01622413|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-09-22|||September 2013||2013-09-01|September 2017|2017-09-01|September 22, 2017|Actual|2017-09-22|January 2017|Anticipated|2017-01-01||Interventional|TESCORT||Trial to Show Non-inferiority / Superiority of an Endoscopic Transforaminal Discectomy to Standard Microdiscectomy|Transforaminal Endoscopic Surgery Cost Outcome Research Trial|Withdrawn||N/A|0|Actual|Joimax GmbH||2||"Patients did not consent to randomization in any study center, since they preferred endoscopic   surgery. The recruitment of patients was impossible."|f||||f||||||||||2017-10-11 02:50:03.412577|2017-10-11 02:50:03.412577
NCT01622400|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-04-07|||September 2011||2011-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy of a Dedicated Therapeutic Education Program in Patients at High Cardiovascular Risk|Randomized Prospective Trial Evaluating the Efficacy of a Dedicated Therapeutic Education Program on the Blood Pressure and Other Cardiovascular Risk Factors Control in General Practice Patients at High Cardiovascular Risk|Completed||N/A|240|Actual|University Hospital, Lille||2|||f||||f||||||||||2017-10-11 02:50:03.559989|2017-10-11 02:50:03.559989
NCT01622387|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-09-08||||||August 2015|2015-08-01||||||||Interventional|||Radial Artery Versus Saphenous Vein Patency (RSVP) Trial - 10 Year Follow-up|Randomised, Controlled Trial Comparing Angiographic Patency of the Radial Artery Versus the Saphenous Vein Used as Free Aorto-coronary Grafts in Coronary Revascularisation (Radial Artery Versus Saphenous Vein Patency (RSVP) Trial) - 10-year Follow-up|Withdrawn||N/A|0|Actual|Imperial College London||2||No funding|f||||f||||||||||2017-10-11 02:50:03.667992|2017-10-11 02:50:03.667992
NCT01622374|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-18|||January 2011||2011-01-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||"Effects of Music for the Mind on Pre-operative Anxiety in Dentistry"|"a Randomized Controlled Clinical Trial on the Effects of Music for the Mind on Pre-operative Anxiety in Dentistry"|Completed||Phase 2/Phase 3|120|Actual|Azad University of Medical Sciences||4|||f||||t||||||||||2017-10-11 02:50:03.780384|2017-10-11 02:50:03.780384
NCT01622361|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-09-26|||June 2012||2012-06-01|September 2013|2013-09-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|NEST||Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer|A Phase III, Open-Label, Prospective, Randomized, Multicenter, Neo-adjuvant Study of Chemotherapy Versus Endocrine Therapy in Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer|Unknown status|Recruiting|Phase 3|290|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:50:03.896285|2017-10-11 02:50:03.896285
NCT01622335|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-02-03|||May 2012||2012-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect OF Nitrous Oxide On Acute Pain and Opioid Consumption, and Chronic Pain After Hysterectomy|Effect OF Nitrous Oxide On Acute Pain and Opioid Consumption, and Chronic|Active, not recruiting||N/A|200|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 02:50:04.126572|2017-10-11 02:50:04.126572
NCT01622322|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-15|2017-10-04|||May 2012||2012-05-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect Nitrous Oxide On Acute Postoperative Pain and Opioid Consumption and Chronic Pain After Inguinal Hernia Repair Surgery||Recruiting||N/A|200|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 02:50:04.222603|2017-10-11 02:50:04.222603
NCT01622309|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-12-02|||March 2012||2012-03-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Balanced Hypocaloric Diet Associated With Supplementation of Eggplant Meal in the Remission of Cardiovascular Risk Factors|Effect of Balanced Hypocaloric Diet Associated With Supplementation of Eggplant Meal in the Remission of Cardiovascular Risk Factors|Completed||N/A|363|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 02:50:04.322633|2017-10-11 02:50:04.322633
NCT01622296|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-02-10|2013-12-17||April 2012||2012-04-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|BufferDent|per protocol|Comparison of Pain of Conventional to Buffered Local Anesthesia During Injection in Pediatric Dental Patients|Comparison of Pain of Conventional to Buffered Local Anesthesia During Injection in Pediatric Dental Patients. A Prospective, Double-blind, Randomized, Crossover Study|Completed||Phase 4|20|Actual|University of California, San Francisco|The variation of VAS scores was found to be larger than that used in the sample size calculation; thus, the study was underpowered to reach statistical significance.|2|||f||||t||||||||||2017-10-11 02:50:04.41135|2017-10-11 02:50:04.41135
NCT01622283|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-06-09|||May 2, 2012|Actual|2012-05-02|June 2017|2017-06-01|June 10, 2012|Actual|2012-06-10|June 10, 2012|Actual|2012-06-10||Interventional|||Pharmacokinetic Study of Levocetirizine Oral Solution|Pharmacokinetic Study of Levocetirizine Oral Solution-An Open-label, Randomized, Cross-over Study to Evaluate the Pharmacokinetics, the Safety and Tolerability of Levocetirizine Oral Solution (5 mg) and Cetirizine Dry Syrup (10 mg), Following a Single Dose in Japanese Healthy Male Subjects-|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:50:04.671651|2017-10-11 02:50:04.671651
NCT01622270|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-14|||June 2012||2012-06-01|January 2012|2012-01-01||||June 2013|Anticipated|2013-06-01||Observational|||Energy Expenditure in Patients With Crohn's Disease||Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||||||||||||2017-10-11 02:50:04.776825|2017-10-11 02:50:04.776825
NCT01622257|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-18|2017-03-09|2012-10-14||June 2011||2011-06-01|March 2017|2017-03-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Cavitation Ultrasound in Treatment of Patients With PCOS|Comparison of Cavitation Ultrasound, Metformin or the Combination of Both in Obese Women With Polycystic Ovary Syndrome|Completed||Phase 2|198|Actual|Ain Shams University||3|||f||||t||||||||||2017-10-11 02:50:04.873098|2017-10-11 02:50:04.873098
NCT01622244|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-10-29|||November 2012||2012-11-01|June 2012|2012-06-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|CATCH-ED||Coordinated Access to Care From Hospital Emergency Departments|Coordinated Access to Care From Hospital Emergency Departments - Assessing Effectiveness and Cost-Effectiveness|Completed||N/A|166|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 02:50:06.114508|2017-10-11 02:50:06.114508
NCT01622231|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-11-18|2013-05-30||June 2012||2012-06-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis|Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis|Completed||Phase 3|61|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:50:06.374303|2017-10-11 02:50:06.374303
NCT01622218|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2014-11-30|||August 2012||2012-08-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||The Impact of Medical Clowning on Pain and Stress Level in Pediatric Patients Undergoing Hernia Repair Surgery LAUGH Study.|The Impact of Medical Clowning on Pain and Stress Level in Pediatric Patients Undergoing Hernia Repair Surgery LAUGH Study|Unknown status|Recruiting|N/A|100|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-10-11 02:50:09.454739|2017-10-11 02:50:09.454739
NCT01622205|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-02-01|||May 2011||2011-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GOTVED||GOThenburg Very Early Supported Discharged|Phase 2 Study of Very Early Supported Discharge From a Stroke Unit in|Enrolling by invitation||Phase 2|110|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-11 02:50:09.557051|2017-10-11 02:50:09.557051
NCT01622192|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-06-18|||April 2012||2012-04-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|||A Comparison Between the Repeatability of Probing Pocket Depths Achieved With Manual and Automated Periodontal Probes|A Comparison Between the Repeatability of Probing Pocket Depths Achieved With Manual and Automated Periodontal Probes|Unknown status|Recruiting|Phase 2|30|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 02:50:09.646443|2017-10-11 02:50:09.646443
NCT00004840|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||May 1998||1998-05-01|October 1998|1998-10-01|June 1998||1998-06-01|||||Interventional|||Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants||Completed||N/A|996||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:25.07112|2017-10-11 04:25:25.07112
NCT01622166|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-10-22|||August 2011||2011-08-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|KUSS||Art Therapy in Acute Schizophrenia|Art Therapy for Symptom Reduction in Acute Schizophrenia - a Randomised Controlled Trial (Kunsttherapie Zur Symptomreduktion Bei Akuter Schizophrenie - Eine Randomisierte Kontrollierte Pilotstudie)|Completed||N/A|60|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:50:09.957672|2017-10-11 02:50:09.957672
NCT01622153|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-05-09|||June 2011||2011-06-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Electrical and Formocresol Pulpotomy in Primary Molars|A Prospective Study and Clinical Evaluation of Pre & Post Operative Treatment Comparison of Electrical and Formocresol Pulpotomy Procedures in Primary Molars of Children Undergoing General Anesthesia|Terminated||N/A|120|Anticipated|University Hospitals Cleveland Medical Center||2||Use of Formocresol for pulpotomies ws discontinued.|f||||f||||||||||2017-10-11 02:50:10.056326|2017-10-11 02:50:10.056326
NCT01622140|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-02-01|||October 2012||2012-10-01|January 2016|2016-01-01|September 2021|Anticipated|2021-09-01|June 2017|Anticipated|2017-06-01||Observational|||Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis|Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis|Recruiting||N/A|42647|Anticipated|Centers for Disease Control and Prevention|||1||f||||f||||||||||2017-10-11 02:50:10.156522|2017-10-11 02:50:10.156522
NCT01622127|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2014-12-04|||February 2012||2012-02-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Observational|||Progrip Ventral Study for Sublay Repair|Efficacy of Self-fixating Mesh in Ventral and Incisional Hernia Repair|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Ghent|||1||f||||f||||||||||2017-10-11 02:50:10.345369|2017-10-11 02:50:10.345369
NCT01622114|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2016-01-13|||September 2011||2011-09-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MENSTRALEAN||Evaluation of the Association Between the Menstrual Cycle and Weight Loss in Healthy, Overweight Premenopausal Women|Evaluation of the Association Between the Menstrual Cycle and Weight Loss in Healthy, Overweight Premenopausal Women - A 6-Month Intervention|Completed||N/A|60|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:50:10.436354|2017-10-11 02:50:10.436354
NCT01622101|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-20|||May 2007||2007-05-01|June 2012|2012-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|ZANTREX||Thermogenic Properties of Zantrex-3|Acute Effects of Zantrex-3 on Energy Expenditure and Appetite Sensations|Completed||N/A|23|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:50:10.57232|2017-10-11 02:50:10.57232
NCT01622088|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-11-24||2014-11-24|June 2012||2012-06-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|ENVISION||Phase 3 Extension Study of Dexpramipexole in ALS|An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis|Terminated||Phase 3|616|Actual|Knopp Biosciences||1||The Initial Phase 3 Study (NCTO1281189) did not meet its primary efficacy endpoint.|f||||t||||||||||2017-10-11 02:50:10.690682|2017-10-11 02:50:10.690682
NCT01622075|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-07-22|||March 2011||2011-03-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|PEPCAD||A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent|A Multicenter, Randomized, Active Controlled Clinical Study to Evaluate the Safety and Efficacy of the Treatment of In-stent Restenosis Lesion by Paclitaxel-eluting PTCA- Balloon Catheter Versus Paclitaxel-eluting Stent|Completed||Phase 3|220|Actual|B. Braun Medical International Trading Company Ltd.||2|||f||||f||||||||||2017-10-11 02:50:11.046222|2017-10-11 02:50:11.046222
NCT01622062|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-06-28|||June 30, 2012|Actual|2012-06-30|June 2017|2017-06-01|October 30, 2018|Anticipated|2018-10-30|October 30, 2018|Anticipated|2018-10-30||Interventional|||"Immunogenicity and Safety of Verorab® in a One-week Intradermal Post-exposure Prophylaxis Regimen"|Verorab® Immunogenicity and Safety After a One-week, 4-site, Intradermal (ID) Post-exposure Prophylaxis Regimen (4-4-4-0-0) Followed by a One-visit, 4-site, ID Booster at Five Years|Active, not recruiting||Phase 3|600|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:50:11.160033|2017-10-11 02:50:11.160033
NCT01622049|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-05|2013-03-13|||October 2006||2006-10-01|November 2012|2012-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|TTTS||Selective Laser Photocoagulation of Communicating Vessels in Twin-Twin Transfusion Syndrome|Selective Laser Photocoagulation of Communicating Vessels in Twin-Twin Transfusion Syndrome|Completed||N/A|77|Actual|University of South Florida|||1||f||||f||||||||||2017-10-11 02:50:11.265729|2017-10-11 02:50:11.265729
NCT01622036|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2015-12-01|||June 2012||2012-06-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Observational|PreMiO||Prevalence of Malnutrition in Oncology (PreMiO)|The PreMiO Study: The Prevalence of Malnutrition in Oncology.|Completed||N/A|1978|Actual|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 02:50:11.351965|2017-10-11 02:50:11.351965
NCT01622023|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2013-07-18|||October 2010||2010-10-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Timing of Intrauterine Insemination (IUI) 24 or 48 Hours After Spontaneous Luteinizing Hormone (LH) Peak|Timing of IUI 24 or 48 Hours After Spontaneous LH Peak: a Randomised Controlled Trial|Completed||Phase 4|435|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 02:50:11.440547|2017-10-11 02:50:11.440547
NCT01621997|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-09-21|||January 2012||2012-01-01|September 2017|2017-09-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Different Retraining Methods vs Usual Care on the Prevention of Peritonitis in Peritoneal Dialysis|Retraining Via Operation Inspection or Verbal Education vs Usual Care on the Prevention of Peritonitis in Peritoneal Dialysis|Active, not recruiting||N/A|150|Anticipated|Peking University First Hospital||3|||f||||f||||||||||2017-10-11 02:50:11.655498|2017-10-11 02:50:11.655498
NCT01621984|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-10-24|||June 2011||2011-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|TR NMD||Therapeutic Riding and Neuromuscular Disease|The Evaluation of Therapeutic Riding in Children and Adolescent With Kinetic Deficits Because of Neuromuscular Disease.|Completed||Phase 1|60|Actual|University of Ioannina||2|||f||||||||||||||2017-10-11 02:50:11.88826|2017-10-11 02:50:11.88826
NCT01621971|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-18|||January 2003||2003-01-01|June 2012|2012-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients|Comparative Effects of Brief Inhaled Milrinone Versus Intravenous Milrinone on Pulmonary Arterial Pressure in Patients Undergoing Mitral Valve Surgery|Completed||Phase 3|20|Actual|Konkuk University Medical Center||2|||f||||t||||||||||2017-10-11 02:50:11.987041|2017-10-11 02:50:11.987041
NCT01621958|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-04-24|||September 2008||2008-09-01|April 2014|2014-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Motor Training for Fall Prevention|Motor Training for Fall Prevention: Adaptation and Retention in Older Adults|Completed||N/A|212|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 02:50:12.098293|2017-10-11 02:50:12.098293
NCT01621945|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2014-09-05|||April 2012||2012-04-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Observational|Exten Effivac||Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)|Phase 3, Vaccinal Activity Assessment of MenBVac Against Neisseria Meningitidis B:14,P1.7,16 Strain in Child|Completed||Phase 3|120|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-11 02:50:12.188511|2017-10-11 02:50:12.188511
NCT01621932|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-09-11|||March 1, 2012|Actual|2012-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Anterior Capsulectomy vs. Repair in Direct Anterior THA|Anterior Capsulectomy vs. Repair in Direct Anterior THA|Active, not recruiting||N/A|82|Actual|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-11 02:50:12.262607|2017-10-11 02:50:12.262607
NCT01621919|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-14|||December 2010||2010-12-01|June 2012|2012-06-01|May 2013|Anticipated|2013-05-01|December 2012|Anticipated|2012-12-01||Observational|||Concentration of S-1 Metabolites in Tear and Plasma of Patients Receiving TS-1|Concentration of S-1 Metabolites in Tear and Plasma and Correlation With Its Side Effects in Patients Receiving S-1 Adjuvant Chemotherapy|Unknown status|Recruiting|N/A|200|Anticipated|Seoul National University Bundang Hospital|||1||f||||f||||||Samples Without DNA|"     plasma tears   "|||2017-10-11 02:50:12.34278|2017-10-11 02:50:12.34278
NCT01621906|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-03-02|||June 2012||2012-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain|Pilot Study of 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain|Recruiting||N/A|20|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:50:12.418036|2017-10-11 02:50:12.418036
NCT01621893|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-08-31|||March 26, 2012|Actual|2012-03-26|January 2017|2017-01-01|April 30, 2022|Anticipated|2022-04-30|March 31, 2018|Anticipated|2018-03-31||Observational|SCP||Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions|Prospective Efficacy Evaluation of Subchondroplasty™ for the Treatment of Defects Associated With Tibial Bone Marrow Lesions|Active, not recruiting||N/A|70|Actual|Zimmer Biomet|||1||f||||f|f|f|||t|||||2017-10-11 02:50:12.544365|2017-10-11 02:50:12.544365
NCT01621880|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2013-12-09|||June 2012||2012-06-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|BRAIN||Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma|Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma|Completed||Phase 2|43|Actual|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 02:50:12.660046|2017-10-11 02:50:12.660046
NCT01621867|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-10-21|||May 2012||2012-05-01|November 2012|2012-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Repeated Application of Gene Therapy in CF Patients|A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic Fibrosis|Completed||Phase 2|130|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 02:50:12.769368|2017-10-11 02:50:12.769368
NCT01621854|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-08-26|||October 2012||2012-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ProGem1||NUC-1031 in Patients With Advanced Solid Tumours|A Two-part, Phase I Open Label Dose-escalation Study to Assess the Safety, Pharmacokinetics and Clinical Activity of NUC-1031, a Nucleotide Analogue, in Patients With Advanced Solid Tumours.|Completed||Phase 1|68|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 02:50:12.88849|2017-10-11 02:50:12.88849
NCT01621841|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2013-12-18|||June 2012||2012-06-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Observational|ENVOL||Analysis of Visual Pathways in Glaucoma Patients Using a 3tesla-MRI||Completed||N/A|114|Actual|University Hospital, Bordeaux|||2||f||||t||||||||||2017-10-11 02:50:13.001631|2017-10-11 02:50:13.001631
NCT01621828|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-15|||July 2012||2012-07-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|MIPA||Multimedia Information and Pre-operative Anxiety|A Prospective Randomised Controlled Trial of the Impact of Multimedia Information to Reduce Pre-operative Anxiety in Patients Undergoing Major Elective Surgery|Unknown status|Not yet recruiting|N/A|50|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 02:50:13.077063|2017-10-11 02:50:13.077063
NCT01621815|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-05-19|||July 2012||2012-07-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Variance of Video Games Playing Patterns Among Adolescents With Psychiatric Disorders|Variance of Video Games Playing Patterns Among Adolescents With Psychiatric Disorders: Diagnostical and Dynamic Meanings|Completed||N/A|46|Actual|Shalvata Mental Health Center||5|||f||||f||||||||||2017-10-11 02:50:13.173869|2017-10-11 02:50:13.173869
NCT01621789|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2016-03-15|||June 2012||2012-06-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy of Lutein, Zeaxanthine and Trypan Blue to Stain the Anterior Lens Capsule|A Descriptive Study to Evaluate the Efficacy of the Dye Compound of the Combination of Lutein, Zeaxanthin and Trypan Blue to Stain the Anterior Lens Capsule During Cataract Phacoemulsification.|Completed||Phase 3|25|Actual|Federal University of São Paulo||1|||f||||t||||||||Yes||2017-10-11 02:50:16.186349|2017-10-11 02:50:16.186349
NCT01621776|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2013-09-12|2013-06-21||June 2011||2011-06-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||In the first year (Camp 2011) there were 2 arms, the Humalog and Apidra. In the second year (Camp 2012) there were 3 arms, the Humalog, Apidra, and Novolog. Therefore, there will be more participants in the Humalog and Apidra arms.|Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia|Comparison of Effectiveness of Glulisine and Lispro in Decreasing Post-Prandial Hyperglycemia in a Real-World Setting|Completed||N/A|107|Actual|University of Florida|In the first year (Camp 2011) there were 2 arms, the Humalog and Apidra. In the second year (Camp 2012) there were 3 arms, the Humalog, Apidra, and Novolog. Therefore, there will be more participants in the Humalog and Apidra arms.|3|||f||||f||||||||||2017-10-11 02:50:16.308994|2017-10-11 02:50:16.308994
NCT01621763|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-22|||September 2008||2008-09-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions|An Open Label, Balanced, Randomized, Two Treatment, Two Sequence, Two Period, Single-dose, Crossover Oral Bioequivalence Study of Clopidogrel 300 mg Tablets of Dr. Reddy's India and Plavix® 300 mg Tablets Under Fed Conditions|Completed||Phase 1|68|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 02:50:16.869405|2017-10-11 02:50:16.869405
NCT01621750|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-14|||August 2008||2008-08-01|August 2008|2008-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions|An Open Label, Balanced, Randomized, Two Treatment, Two Sequence, Two Period, Single-dose, Crossover Oral Bioequivalence Study of Clopidogrel Bisulfate 300 mg Tablets of Dr. Reddy's Laboratories Ltd., India and Plavix® (Clopidogrel Bisulfate) 300 mg Tablets Under Fasting Conditions|Completed||Phase 1|68|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 02:50:16.965924|2017-10-11 02:50:16.965924
NCT01621737|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2017-01-11|||June 2011||2011-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Antipsychotic Effects of Oxytocin|Antipsychotic Effects of Oxytocin|Suspended||N/A|102|Actual|University of California, San Diego||3||Break in funding|f||||f||||||||||2017-10-11 02:50:17.065491|2017-10-11 02:50:17.065491
NCT01621724|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-07-19|||April 2012||2012-04-01|December 2016|2016-12-01|October 2019|Anticipated|2019-10-01|May 2019|Anticipated|2019-05-01||Interventional|||WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study|WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study|Suspended||Phase 1/Phase 2|18|Anticipated|Cell Therapy Catapult||1||Change on Sponsorship|f||||t||||||||||2017-10-11 02:50:17.191837|2017-10-11 02:50:17.191837
NCT01621711|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-05-05|||March 2011||2011-03-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Linkage||Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care|Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care|Active, not recruiting||N/A|504|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:50:17.294659|2017-10-11 02:50:17.294659
NCT01621698|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-09-04|||July 2012||2012-07-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ErLaPara||Study of Use of Paravertebral Blocks for Pain Relief in Video Assisted Lung Surgery|Early Versus Late Paravertebral Block for Analgesia in Video Assisted Thoracoscopic Lung Resection.|Completed||N/A|100|Anticipated|University Hospitals Bristol NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:50:17.470319|2017-10-11 02:50:17.470319
NCT01621685|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-05|2012-06-15|||September 2004||2004-09-01|June 2012|2012-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|Capsaicin||Human Safety of Capsaicin Inhalation Challenge Testing for Young and Older Men|The Role of Age on the Human Cough Reflex|Completed||Phase 1|40|Actual|University of South Florida||1|||f||||f||||||||||2017-10-11 02:50:17.596792|2017-10-11 02:50:17.596792
NCT01621672|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-09-29|2015-08-12||April 2010||2010-04-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma|Myeloma Cure Project: Prospective, Randomized Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma Who Have Completed 3 Years of VTD/TD or VTD or VRD Maintenance on Total Therapy 3 (TT3) Trials 2003-33 and 2006-66|Completed||Phase 3|42|Actual|University of Arkansas||2|||f||||t||||||||||2017-10-11 02:50:17.702427|2017-10-11 02:50:17.702427
NCT01621659|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-05-26|||May 2014||2014-05-01|May 2015|2015-05-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|TITAN||Multidisciplinary Team IntervenTion in CArdio-ONcology (TITAN Study)|Multidisciplinary Team IntervenTion in CArdio-ONcology|Recruiting||Phase 2|282|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 02:50:18.216437|2017-10-11 02:50:18.216437
NCT01621646|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-08-31|||July 2012||2012-07-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Daily Consumption of Eggs on Cognitive Function in the Elderly|The Effect of Consumption of 2 Eggs or 4 oz of Egg Substitute Daily for 6 Months on Cognitive Function in Older Adults.|Completed||N/A|44|Actual|Tufts University||2|||f||||f||||||||||2017-10-11 02:50:18.419314|2017-10-11 02:50:18.419314
NCT01621633|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-07-11|2015-07-11||September 2012||2012-09-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers|A Single-dose, Open-label Parallel-group Study to Assess the Pharmacokinetics of LCZ696 in Subjects With Hepatic Impairment Compared to Matched Healthy Subjects|Completed||Phase 2|32|Actual|Novartis||3|||f||||f||||||||||2017-10-11 02:50:18.518039|2017-10-11 02:50:18.518039
NCT01621620|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2012-06-15|||August 2012||2012-08-01|June 2012|2012-06-01|August 2014|Anticipated|2014-08-01|August 2013|Anticipated|2013-08-01||Interventional|||The Role of Sympatho-vagal Balance on Different Limbs of Pain Perception in Healthy Subjects|The Role of Sympatho-vagal Balance on Different Limbs of Pain Perception in Healthy Subjects|Unknown status|Not yet recruiting|N/A|20|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 02:50:18.964722|2017-10-11 02:50:18.964722
NCT01621594|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-09-12|||May 18, 2012||2012-05-18|August 24, 2017|2017-08-24||||||||Observational|||Evaluating New Radiation Techniques for Cardiovascular Imaging|Prospective Evaluation of New Techniques in Radiation Reduction for Cardiovascular Computed Tomographic Angiography|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:50:19.121717|2017-10-11 02:50:19.121717
NCT01621581|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-08-25|||May 29, 2012||2012-05-29|August 24, 2017|2017-08-24|December 31, 2027|Anticipated|2027-12-31|January 1, 2025|Anticipated|2025-01-01||Interventional|||AAV2-GDNF for Advanced Parkinson s Disease|A Phase 1 Open-Label Dose Escalation Safety Study of Convection Enhanced Delivery (CED) of Adeno-Associated Virus Encoding Glial Cell Line-Derived Neurotrophic Factor (AAV2-GDNF) in Subjects With Advanced Parkinson's Disease|Recruiting||Phase 1|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:50:19.196673|2017-10-11 02:50:19.196673
NCT01621568|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-09-12|||April 18, 2012||2012-04-18|September 1, 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2018|Anticipated|2018-04-30||Interventional|||Sunitinib for Advanced Thymus Cancer Following Earlier Treatment|A Phase II Study of Sunitinib in Patients With Advanced Relapsed or Refractory Thymoma or Thymic Carcinoma With at Least One Prior Line of Platinum-Based Systemic Chemotherapy|Active, not recruiting||Phase 2|45|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:50:19.277167|2017-10-11 02:50:19.277167
NCT01621555|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-14|||August 2012||2012-08-01|June 2012|2012-06-01|November 2014|Anticipated|2014-11-01|||||Observational|PSOASS||Pain Sensitivity and Outcome in Arthroscopic Shoulder Surgery|Pain Sensitivity and Outcome in Arthroscopic Shoulder Surgery|Unknown status|Not yet recruiting|N/A|200|Anticipated|NHS Fife|||1||f||||f||||||||||2017-10-11 02:50:19.377999|2017-10-11 02:50:19.377999
NCT01621542|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-06-02|||July 2012||2012-07-01|June 2017|2017-06-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|||Clinical Study of WT2725 in Patients With Advanced Malignancies|Initial Phase 1 Study of WT2725 in Patients With Advanced Malignancies|Completed||Phase 1|64|Actual|Sunovion||1|||f||||f||||||||||2017-10-11 02:50:19.467184|2017-10-11 02:50:19.467184
NCT01621529|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-06-15|||February 2010||2010-02-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|VOSETEP||Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer|Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer|Completed||N/A|30|Actual|Centre Henri Becquerel|||1||f||||t||||||||||2017-10-11 02:50:19.566455|2017-10-11 02:50:19.566455
NCT01621516|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-11-09|||June 2012||2012-06-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|April 2014|Actual|2014-04-01||Observational|||Measurement of the Pancreas Function in Patients With More Than One Pancreas After Liver and Small Bowel Transplantation|Measurement of ß-cell Function and Insulin Sensitivity in Non-diabetic Patients With En-bloc Liver, Pancreas and Small Bowel Transplant Using a Hyperglycemic Clamp|Completed||N/A|6|Actual|Katholieke Universiteit Leuven|||3||f||||f||||||||||2017-10-11 02:50:19.629753|2017-10-11 02:50:19.629753
NCT01621503|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2013-06-26|||April 2011||2011-04-01|July 2012|2012-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Prospective Comparative Clinical Study to Investigate the Use of the NON CONTACT TONO/PACHYMETER NT-530P|Prospective Comparative Clinical Study to Investigate the Use of the NON CONTACT TONO/PACHYMETER NT-530P|Completed||N/A|250|Actual|Nidek Co. LTD.||1|||f||||f||||||||||2017-10-11 02:50:19.6958|2017-10-11 02:50:19.6958
NCT01621490|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-09-01|||September 27, 2012|Actual|2012-09-27|September 2017|2017-09-01|December 2, 2018|Anticipated|2018-12-02|September 7, 2017|Anticipated|2017-09-07||Interventional|PD-1||PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma|An Exploratory Study of the Biologic Effects of Nivolumab and Ipilimumab Monotherapy and Nivolumab in Combination With Ipilimumab Treatment in Subjects With Advanced Melanoma (Unresectable or Metastatic)|Active, not recruiting||Phase 1|175|Anticipated|Bristol-Myers Squibb||6|||f||||f|t|f||||||||2017-10-11 02:50:19.768031|2017-10-11 02:50:19.768031
NCT01621477|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-12-28|2016-10-17||August 2012||2012-08-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant|T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant|Terminated||Phase 2|34|Actual|St. Jude Children's Research Hospital||1||Study was terminated in August 2016 due to replacement by a new study.|f||||f||||||||||2017-10-11 02:50:19.923846|2017-10-11 02:50:19.923846
NCT01621464|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-04-11|||May 2006||2006-05-01|April 2014|2014-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|SPAIN||Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)|Closed Loop Stimulation for Neuromediated Syncope|Unknown status|Active, not recruiting|Phase 4|55|Anticipated|Spanish Society of Cardiology||2|||f||||f||||||||||2017-10-11 02:50:20.618707|2017-10-11 02:50:20.618707
NCT01621451|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-11-20|||June 2012||2012-06-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Interventional|||Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?|Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?|Unknown status|Enrolling by invitation|Phase 4|400|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 02:50:20.699782|2017-10-11 02:50:20.699782
NCT01621438|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-08-24|||May 2012||2012-05-01|August 2017|2017-08-01|September 2018|Anticipated|2018-09-01|March 2015|Actual|2015-03-01||Observational|||Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)|Influence of Total Atherosclerotic Burden Assessed by 3-vessel Fractional Flow Reserve (FFR) on the Clinical Outcomes of the Patients With Multi-vessel Disease|Active, not recruiting||N/A|1136|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 02:50:20.783814|2017-10-11 02:50:20.783814
NCT01621425|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-08-12|||June 2012||2012-06-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|LEANDOC||Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity|Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity|Completed||N/A|25|Actual|Radboud University|||2||f||||f||||||Samples Without DNA|"     Blood samples for docetaxel concentration measurement (n=4)   "|||2017-10-11 02:50:20.921315|2017-10-11 02:50:20.921315
NCT00005174|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1985||1985-07-01|July 2000|2000-07-01|June 1990|Actual|1990-06-01|||||Observational|||Western Collaborative Group Study (WCGS): 25-Year Follow-up of Cardiovascular Disease Morbidity and Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.578703|2017-10-11 04:26:35.578703
NCT01621412|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-12-21|||April 2012||2012-04-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|RSAD-VIH-11||HIV Disclosure and Medication Adherence, a Pilot Study|HIV Disclosure and Medication Adherence, a Pilot Study|Completed||N/A|120|Anticipated|Policlinique Médicale Universitaire|||1||f||||f||||||||||2017-10-11 02:50:21.029864|2017-10-11 02:50:21.029864
NCT01621399|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2013-08-20|||May 2012||2012-05-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Safety and Efficacy Study to Treat Bacterial Vaginosis|A Phase 3, Multicenter, Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Product 55394 in the Treatment of Bacterial Vaginosis|Completed||Phase 3|651|Actual|Medicis Global Service Corporation||2|||f||||f||||||||||2017-10-11 02:50:21.180854|2017-10-11 02:50:21.180854
NCT01621386|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-04-19|||January 2013||2013-01-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|September 2015|Actual|2015-09-01||Interventional|||Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)|A Study Comparing Measures of Ventilatory Heterogeneity (VH) in Asthma Patients|Completed||Phase 1|34|Actual|Duke University||1|||f||||f||||||||||2017-10-11 02:50:21.366245|2017-10-11 02:50:21.366245
NCT01621373|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-05-28|||August 2012||2012-08-01|August 2012|2012-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|NEOPROP||Exploratory Propofol Dose Finding Study In Neonates|Prospective Exploratory Dose-finding Study in Neonates Receiving a Single Intravenous Propofol Bolus for Endotracheal Intubation During (Semi-)Elective INSURE Procedure or Non-INSURE Procedures in Neonates|Completed||Phase 2|50|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 02:50:21.479863|2017-10-11 02:50:21.479863
NCT01621360|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-02-06|||May 2011||2011-05-01|February 2013|2013-02-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement|A Randomized Controlled Trial Comparing Arthroscopic Surgery to Conservative Management of Femoroacetabular Impingement|Unknown status|Recruiting|N/A|140|Anticipated|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 02:50:21.566331|2017-10-11 02:50:21.566331
NCT01621347|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-12-21|||March 2012||2012-03-01|December 2015|2015-12-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Observational|||Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women|Retrospective Study: Evaluation of Antiretroviral Adherence During Pregnancy and Postpartum Using Electronic Monitoring Data|Completed||N/A|26|Anticipated|Policlinique Médicale Universitaire|||1||f||||f||||||||||2017-10-11 02:50:21.667062|2017-10-11 02:50:21.667062
NCT01621334|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-06-13|||September 2009||2009-09-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|MDACU||The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use|Stage 1B Study Motivating Substance Abusing Batterers to Seek Treatment.|Completed||Phase 1|140|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 02:50:21.7405|2017-10-11 02:50:21.7405
NCT01621321|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-01-02|||June 2013||2013-06-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis|A Randomized Controlled Trial of Voriconazole in Allergic Bronchopulmonary Aspergillosis|Completed||Phase 2/Phase 3|50|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 02:50:21.84078|2017-10-11 02:50:21.84078
NCT01621308|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2014-03-18|||December 2012||2012-12-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|IPvsSC||Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus|Intraperitoneal Insulin Administration as Alternative for Intensive Subcutaneous Insulin Therapy in Patients With Type 1 Diabetes Mellitus.|Completed||N/A|190|Actual|Medical Research Foundation, The Netherlands|||2||f||||f||||||||||2017-10-11 02:50:21.939773|2017-10-11 02:50:21.939773
NCT01621295|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2016-01-18|||May 2012||2012-05-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Assessing the Patient Experience in Cancer Care|Assessing the Patient Experience in Cancer Care: An Observational Communication Study|Completed||N/A|408|Actual|Mayo Clinic|||1||f||||t||||||||||2017-10-11 02:50:22.066013|2017-10-11 02:50:22.066013
NCT01621282|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2012-07-11|||November 2011||2011-11-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Running Successful Journal Club|Effect of Education on Running Successful Journal Club|Terminated||Phase 2/Phase 3|40|Actual|Mashhad University of Medical Sciences||2|||f||||f||||||||||2017-10-11 02:50:22.14531|2017-10-11 02:50:22.14531
NCT01621269|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-04-19|||June 2013||2013-06-01|September 2014|2014-09-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|ENGYNE||ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon|A 12-month, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Fingolimod in the Treatment of Relapsing-remitting Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta|Withdrawn||Phase 4|0|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:50:22.217728|2017-10-11 02:50:22.217728
NCT01621256|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-09-28|||May 2013||2013-05-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|||Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss|Double-blind, Randomized, Placebo-controlled Study on Efficacy, Safety and Tolerability of Ancrod in Patients With Sudden Sensorineural Hearing Loss (SSHL)|Recruiting||Phase 1/Phase 2|115|Anticipated|Nordmark Arzneimittel GmbH & Co. KG||2|||f||||f||||||||||2017-10-11 02:50:22.29804|2017-10-11 02:50:22.29804
NCT01621243|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-01-04|||May 2012||2012-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer|A Phase I/II, Two-Part, Multicenter Study to Evaluate the Safety and Efficacy of M402 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer|Terminated||Phase 1/Phase 2|128|Actual|Momenta Pharmaceuticals, Inc.||2||"The study was terminated after a pre-planned futility analyses showed an insufficient level of   efficacy in the study population to warrant continuation."|f||||f||||||||||2017-10-11 02:50:22.419894|2017-10-11 02:50:22.419894
NCT01621217|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-03-06|||June 2012||2012-06-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|NOAC8||Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0|Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0|Active, not recruiting||Phase 1|21|Anticipated|Lund University Hospital||1|||f||||f||||||||||2017-10-11 02:50:22.714327|2017-10-11 02:50:22.714327
NCT01621204|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-04-06|||October 2012||2012-10-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients|Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study|Recruiting||Phase 3|74|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-11 02:50:22.817415|2017-10-11 02:50:22.817415
NCT01621191|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2015-01-27|2015-01-27||June 2012||2012-06-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Enrolled participants who received at least 1 dose of study drug and had at least 1 post-baseline observation.|An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)|An Open Label Extension Study of Phase 3 Trial of Duloxetine in Patients With Fibromyalgia|Completed||Phase 3|149|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:50:23.011758|2017-10-11 02:50:23.011758
NCT01621178|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-14|2017-06-21|2017-06-21||July 2012||2012-07-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|AWARD-7|All participants who received at least one dose of study drug and had evaluable post-baseline measurements.|A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)|A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease|Completed||Phase 3|577|Actual|Eli Lilly and Company||3|||f||||f||||||||Yes|Lilly provides access to the individual participant data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement.|2017-10-11 02:50:23.791418|2017-10-11 02:50:23.791418
NCT01621165|ClinicalTrials.gov processed this data on October 10, 2017|2009-03-17|2012-06-15|||March 2009||2009-03-01|June 2012|2012-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Prazosin as an Antimanic Agent in Severe Mania or Mixed States|Prazosin as an Antimanic Agent in Severe Mania or Mixed Episodes: a Double-blind, Placebo-controlled Study|Withdrawn||N/A|0|Actual|Mclean Hospital||2||unable to recruit subjects given short length of stay in hospital|f||||||||||||||2017-10-11 02:50:25.739737|2017-10-11 02:50:25.739737
NCT01621152|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-03-21|||June 2012||2012-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PRAISE||PRevention of Acute Kidney Injury Initiated With Electronic Surveillance Enhancement|Electronic Surveillance Sniffer for Early Detection and Intervention for Acute Kidney Injury: PRAISE Trial|Active, not recruiting||N/A|984|Anticipated|Mayo Clinic||2|||f||||f||||||||Undecided|We plan to share IPD after initiation of patient recruitment.|2017-10-11 02:50:25.822976|2017-10-11 02:50:25.822976
NCT01621139|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-11-12|||January 2011||2011-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||A Pilot Clinical Trial to Evaluate the Effects of Acupuncture in Patients on Prolonged Mechanical Ventilation|A Pilot Prospective Randomized Study to Evaluate the Effects of Acupuncture in Patients on Prolonged Mechanical Ventilation|Completed||Phase 1/Phase 2|20|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:50:25.906209|2017-10-11 02:50:25.906209
NCT01621126|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-04-19|2015-04-07||June 2011||2011-06-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|June 2013|Actual|2013-06-01||Interventional||40 subjects were enrolled; however, there were some subjects that were excluded for reasons that are explained in the published paper that resulted from this study. The total number of subjects excluded was 6, leaving 34 participants to be analyzed.|Neuromonitoring During the Latarjet Procedure|Neuromonitoring During the Latarjet Procedure|Completed||N/A|40|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 02:50:25.98054|2017-10-11 02:50:25.98054
NCT01621113|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-06-12|||June 2012||2012-06-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|October 2017|Anticipated|2017-10-01||Interventional|||Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury|Restoring Lost Functions After Spinal Cord Injury: Combination Therapy With Dalfampridine and Locomotor Training for Persons With Chronic, Motor Incomplete Spinal Cord Injury|Recruiting||Phase 2|46|Anticipated|Kessler Foundation||2|||f||||t||||||||Undecided||2017-10-11 02:50:26.145207|2017-10-11 02:50:26.145207
NCT01621100|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2013-09-05|||December 2011||2011-12-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients|A Prospective, Open-Label, Multicenter, Single-Arm, Interventional Study to Evaluate the Efficacy and Tolerability of Once-Daily Oros Hydromorphone for Cancer Pain Treatment in Korean Cancer Patients.|Completed||Phase 4|106|Actual|Janssen Korea, Ltd., Korea||1|||f||||f||||||||||2017-10-11 02:50:26.278513|2017-10-11 02:50:26.278513
NCT01621087|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-06-15|||February 1966||1966-02-01|June 2012|2012-06-01||||June 1973|Actual|1973-06-01||Interventional|||Dietary Linoleic Acid for Secondary Prevention of Coronary Heart Disease and Death in the Sydney Heart Study: an RCT|Dietary Linoleic Acid for Secondary Prevention of Coronary Heart Disease and Death in the Sydney Heart Study: a Randomized Controlled Dietary Trial|Completed||N/A|458|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 02:50:26.384428|2017-10-11 02:50:26.384428
NCT01621074|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2013-04-11|||October 2011||2011-10-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Interventional|||Influence of Sodium Bicarbonate on Time-to-exhaustion at Critical Power in Endurance Athletes||Completed||N/A|12|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 02:50:26.468894|2017-10-11 02:50:26.468894
NCT01621061|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-05-14|||June 2012||2012-06-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders|Sleep Apnea and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders|Completed||N/A|125|Actual|University of Zurich|||3||f||||f||||||||||2017-10-11 02:50:26.562087|2017-10-11 02:50:26.562087
NCT01621048|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-03-11|||June 2012||2012-06-01|March 2013|2013-03-01||||December 2016|Anticipated|2016-12-01||Observational|||Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer|Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer and Correlation With Dose to Organs at Risk|Unknown status|Recruiting|N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 02:50:26.658399|2017-10-11 02:50:26.658399
NCT01621035|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-26|||November 2011||2011-11-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Objective Assessment of Physical Activity in Older Adults||Completed||N/A|90|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||||||||||||2017-10-11 02:50:26.735927|2017-10-11 02:50:26.735927
NCT01621022|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-12-05|||January 2001||2001-01-01|December 2016|2016-12-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Bupropion Alone or Combined With Nicotine Gum|Efficacy of Bupropion Alone and in Combination With Nicotine Gum|Completed||Phase 4|608|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 02:50:26.791903|2017-10-11 02:50:26.791903
NCT01621009|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2015-12-16|2015-05-27||January 2001||2001-01-01|December 2015|2015-12-01|October 2003|Actual|2003-10-01|October 2002|Actual|2002-10-01||Interventional|||Bupropion SR Plus Counseling for Smoking Cessation|A Randomized Controlled Clinical Trial of Bupropion SR and Individual Smoking Cessation Counseling|Completed||Phase 4|463|Actual|University of Wisconsin, Madison|Lack of a no-treatment control condition; limited ability to generalize to broader population|4|||f||||f||||||||||2017-10-11 02:50:26.874083|2017-10-11 02:50:26.874083
NCT01620996|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-14|||March 2006||2006-03-01|June 2008|2008-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|ANCHOR||A Novel Approach to Cardiovascular Health by Optimizing Risk Management (ANCHOR)|A Novel Approach to Cardiovascular Health by Optimizing Risk Management (ANCHOR): A Primary Prevention Initiative Examining The Impact Of Global Risk Factor Assessment & Management On Health Care In Nova Scotia|Completed||Phase 3|1708|Actual|Nova Scotia Health Authority||3|||f||||t||||||||||2017-10-11 02:50:27.253164|2017-10-11 02:50:27.253164
NCT01620983|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-09-11|||December 2012||2012-12-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 27, 2017|Actual|2017-06-27||Interventional|KASTPain||Knee Arthroplasty Pain Coping Skills Training (KASTPain): A Randomized Trial|Knee Arthroplasty Pain Coping Skills Training (KASTPain): A Randomized Trial|Active, not recruiting||N/A|402|Actual|Virginia Commonwealth University||3|||f||||t||||||||||2017-10-11 02:50:27.344783|2017-10-11 02:50:27.344783
NCT01620970|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-13|||July 2012||2012-07-01|June 2012|2012-06-01|October 2013|Anticipated|2013-10-01|January 2013|Anticipated|2013-01-01||Interventional|||PF-03446962 in Relapsed or Refractory Urothelial Cancer|Phase II Study of the Fully Human Monoclonal Antibody Against Transforming Growth Factor-beta (TGFβ) Receptor ALK1 (PF-03446962) in Relapsed or Refractory Urothelial Cancer (UC) Failing First-line Treatment.|Unknown status|Not yet recruiting|Phase 2|45|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||1|||f||||t||||||||||2017-10-11 02:50:27.617741|2017-10-11 02:50:27.617741
NCT01620957|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2015-04-24|||July 2012||2012-07-01|April 2015|2015-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|ACI-Coma||Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering From Coma|Analyse de l'activité cérébrale intrinsèque Pendant le Coma et Lors du Retour à la Conscience|Unknown status|Recruiting|N/A|153|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-10-11 02:50:27.716332|2017-10-11 02:50:27.716332
NCT01620944|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-11-26|||July 2012||2012-07-01|November 2013|2013-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC|A 48-Week, Randomized, Open-Label Phase 3B Study Comparing the Antiviral Efficacy and Safety of ATV/RTV 3TC With ATV/RTV Plus TDF/FTC In HIV-1-Infected, Treatment-Naïve Subjects, Followed By a 48-Week Period on ATV/RTV Plus 3TC|Terminated||Phase 3|3|Actual|Bristol-Myers Squibb||2||Business objectives have changed|f||||f||||||||||2017-10-11 02:50:27.81542|2017-10-11 02:50:27.81542
NCT01620931|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2013-02-04|||November 2011||2011-11-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers|A Single-Center, Randomized, Observer-Blinded, Placebo-Controlled, Single-Ascending-Dose (SAD) Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5469754, a Humanized Monoclonal Antibody, Following Intravenous or Subcutaneous Administration in Healthy Adults|Completed||Phase 1|36|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:50:27.909038|2017-10-11 02:50:27.909038
NCT01620918|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-12-04|||August 2012||2012-08-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|January 2015|Anticipated|2015-01-01||Interventional|STRANDI||Soft Tissue Responses Around Nanostructured Calcium-phosphate-coated Implant Abutments on Dental Implants: Histological, Genetic and Clinical Evaluation in Smokers and Non-smokers.|Soft Tissue Responses Around Nanostructured Calcium-phosphate-coated Implant Abutments on Dental Implants: Histological, Genetic and Clinical Evaluation in Smokers and Non-smokers.|Unknown status|Recruiting|N/A|100|Anticipated|University Ghent||1|||f||||f||||||||||2017-10-11 02:50:27.979873|2017-10-11 02:50:27.979873
NCT01620905|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-05-10|||November 2008||2008-11-01|May 2016|2016-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Development of a Clinical Prediction Rulefor Neck Manipulation|Development of a Clinical Prediction Rule to Identify Patients With Neck Pain Likely to Benefit From Cervical Spine Manipulation and Exercise|Completed||N/A|82|Actual|University of Nevada, Las Vegas||1|||f||||t||||||||||2017-10-11 02:50:28.065474|2017-10-11 02:50:28.065474
NCT01620892|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-05-12|||June 2012||2012-06-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Study of Patient Outcomes 5 Years After Partial Knee Replacement|Outcomes of Patients With Unicompartmental Arthritis of the Knee Five Years After Treatment With Partial Knee Replacement|Completed||N/A|159|Actual|Athens Orthopedic Clinic, P.A.|||1||f||||f||||||||||2017-10-11 02:50:28.140695|2017-10-11 02:50:28.140695
NCT01620866|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-18|||November 2010||2010-11-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|BET||A Eye Movement Desensitization Reprocessing (EMDR) Study in Bipolar Traumatized Patients|A Controlled, Single-blind Pilot Study of EMDR in Bipolar, Subsyndromal Patients With Trauma|Completed||N/A|20|Actual|FIDMAG Germanes Hospitalàries||2|||f||||f||||||||||2017-10-11 02:50:28.220485|2017-10-11 02:50:28.220485
NCT00005175|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1985||1985-07-01|May 2000|2000-05-01|June 1990|Actual|1990-06-01|||||Observational|||Coronary Heart Disease Risk Factors in Upwardly Mobile Blacks and Whites||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.632438|2017-10-11 04:26:35.632438
NCT01620853|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2015-02-05|||May 2012||2012-05-01|February 2015|2015-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)|Concordance Study for Detection of Chromosomal Aberrations Using FISH (ALK Test)in Non-small Cell Lung Cancer (NSCLC)|Completed||N/A|1|Actual|Applied Spectral Imaging Ltd.|||1||f||||f||||||||||2017-10-11 02:50:28.313486|2017-10-11 02:50:28.313486
NCT01620840|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2015-05-27|||June 2011||2011-06-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|LCM||Lacosamid-i.v.-Register|Lacosamid-i.v.-Register|Completed||N/A|130|Actual|University of Schleswig-Holstein|||1||f||||t||||||||||2017-10-11 02:50:28.39116|2017-10-11 02:50:28.39116
NCT01620827|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-08-17|||February 2012||2012-02-01|August 2016|2016-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|FURS||Hospital vs. Cell Phone Number Follow-Up Randomization Study|Study Subject Responsiveness to Follow-Up Phone Calls From a Hospital Landline as Compared With From a Private Cellular Phone Number|Completed||N/A|400|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 02:50:28.562978|2017-10-11 02:50:28.562978
NCT01620814|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-08-06|||July 2012||2012-07-01|August 2012|2012-08-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|||Intravaginal Misoprostol Versus Dinoprostone Before Diagnostik Hysteroscopy|Comparison of Intravaginal Misoprostol and Dinoprostol for the Purpose of Cervical Ripening Before Diagnostic Hysteroscopy in the Women at the Reproductive Age:RANDOMİSED,CONTROLLED PROSPECTİVE TRİAL|Unknown status|Recruiting|Phase 4|30|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||3|||f||||f||||||||||2017-10-11 02:50:28.655798|2017-10-11 02:50:28.655798
NCT01620801|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-09-28|||October 2012||2012-10-01|September 2017|2017-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Hemophilia B Gene Therapy With AAV8 Vector|A Phase 1 Safety Study in Subjects With Severe Hemophilia B (Factor IX Deficiency) Using a Single-Stranded, Adeno-Associated Pseudotype 8 Viral Vector to Deliver the Gene for Human Factor IX|Terminated||Phase 1|4|Actual|Spark Therapeutics||3|||f||||t||||||||||2017-10-11 02:50:28.787339|2017-10-11 02:50:28.787339
NCT01620788|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-01-26|||May 2017|Anticipated|2017-05-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment|Randomized, Phase 3, Multicenter, Open Label, Evaluating the Effect of the Treatment of Indapamide 1.5mg/Losartan 50mg and Indapamide 1.5mg/Losartan 100mg, Compared With Hyzaar® in the Treatment of Hypertension|Not yet recruiting||Phase 3|636|Anticipated|EMS||4|||f||||t|f|f||||||||2017-10-11 02:50:28.909375|2017-10-11 02:50:28.909375
NCT01620775|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-04-21|||September 2012||2012-09-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain|MR (Magnetic Resonance) Imaging of the Excitatory and Inhibitory Neurotransmitters in Chronic Pain|Recruiting||N/A|170|Anticipated|University of Michigan||4|||f||||t|f|||||||No||2017-10-11 02:50:29.009267|2017-10-11 02:50:29.009267
NCT01620762|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-07-26||2017-07-26|October 2012||2012-10-01|July 2017|2017-07-01||||June 2016|Actual|2016-06-01||Interventional|||Phase III Cat-PAD Study|A Double-Blind, Randomised, Placebo-Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects|Completed||Phase 3|1408|Actual|Circassia Limited||3|||f||||t||||||||||2017-10-11 02:50:29.118118|2017-10-11 02:50:29.118118
NCT01620749|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2012-06-14|||June 2010||2010-06-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|March 2012|Actual|2012-03-01||Interventional|MEL050||Of 18F MEL050 Using PET/CT in Metastatic Melanoma|A Phase 0 Exploratory Microdosing Study of 6-18fluoro-N-[2-(Diethylamino)Ethyl]Pyridine-3-carboxamide (18F MEL050) Using PET/CT in Patients With Metastatic Melanoma|Unknown status|Active, not recruiting|Early Phase 1|12|Actual|Cooperative Research Centre for Biomedical Imaging Development||1|||f||||t||||||||||2017-10-11 02:50:29.423696|2017-10-11 02:50:29.423696
NCT01620736|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-06-14|||January 2012||2012-01-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load|Phase II Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 02:50:29.503063|2017-10-11 02:50:29.503063
NCT01620723|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-02-10|||May 2013||2013-05-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|December 2014|Actual|2014-12-01||Interventional|||Evaluation of Breastfeeding Support After Short Time Hospitalization|Effect Evaluation of a Theory and Evidence Based Programme for Establishing Effective Breastfeeding After Short Time Hospitalization Post Partum|Completed||N/A|3541|Actual|Danish Committee for Health Education||2|||f||||f||||||||||2017-10-11 02:50:29.584993|2017-10-11 02:50:29.584993
NCT01620710|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-05-01|||February 2012||2012-02-01|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|September 2015|Actual|2015-09-01||Interventional|PRIAMOS||Safety Study of a Shorter (Hypofractionated) Radiotherapy for the Prostate Bed With or Without the Pelvic Lymph Nodes|Hypofractionated Helical Intensity-Modulated Radiotherapy of the Prostate Bed After Prostatectomy With or Without the Pelvic Lymph Nodes - the PRIAMOS Trial|Active, not recruiting||Phase 2|80|Actual|Heidelberg University||2|||f||||f||||||||||2017-10-11 02:50:29.711581|2017-10-11 02:50:29.711581
NCT01620697|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-15|||January 2009||2009-01-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Visceral Obesity and Colorectal Surgery|Value of Perirenal Fat Surface as a Risk Factor for Morbidity After Elective Colorectal Surgery|Completed||N/A|224|Actual|University Hospital, Geneva|||1||f||||||||||||||2017-10-11 02:50:29.818971|2017-10-11 02:50:29.818971
NCT01620684|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-09-08|||February 2013||2013-02-01|September 2014|2014-09-01||||December 2014|Anticipated|2014-12-01||Interventional|||Cortisol and Nutritional Sympathetic Responsiveness|The Effects of Cortisol Blockade on Nutritional Sympathetic Nervous System Responsiveness in Overweight and Obese Subjects With Metabolic Syndrome|Unknown status|Recruiting|Phase 4|24|Anticipated|Baker Heart Research Institute||2|||f||||f||||||||||2017-10-11 02:50:30.287284|2017-10-11 02:50:30.287284
NCT01620645|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-13|||February 2011||2011-02-01|June 2012|2012-06-01||||||||Observational|COPDMAP||The MRC/ABPI COPD Cohort v1.7|The Mechanisms of Inflammation and Immunity in COPD and Their Relationship to Exacerbations and Disease Progression.|Unknown status|Recruiting|N/A|400|Anticipated|University College, London|||1||f||||t||||||Samples With DNA|"     Blood, sputum and urine samples will be collected. Commercially available ELISA assays will     be be used to qualify inflammatory markers.      Quantitative bacterial culture will be performed on sputum samples. Bacterial and viral load     will be determined by polymerase chain reaction (PCR). Proteomics such as Cholesterol, BNP,     CRP by routine hospital assay techniques. Specific DNA sections will be selected from the     genome to identify/confirm genes believed to be associated with different COPD phenotypes by     molecular techniques.   "|||2017-10-11 02:50:30.681101|2017-10-11 02:50:30.681101
NCT01620632|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-12-22|||December 2011||2011-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome|Prospective Evaluation of the Clinical Utility of Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatomy|Recruiting||N/A|100|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-11 02:50:30.798819|2017-10-11 02:50:30.798819
NCT01620619|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-04-24|||February 2010||2010-02-01|April 2014|2014-04-01||||May 2016|Anticipated|2016-05-01||Interventional|||The Role of Rotator Interval Closure in Bankart Lesion Repair|The Role of Rotator Interval Closure in Bankart Lesion Repair|Unknown status|Recruiting|N/A|142|Anticipated|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 02:50:30.918473|2017-10-11 02:50:30.918473
NCT01620606|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2015-10-05|||September 2011||2011-09-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|MCAP||Managing Childhood Abdominal Pain|Parent Training to Address Pediatric Functional Abdominal Pain|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Washington||3|||f||||t||||||||||2017-10-11 02:50:31.045535|2017-10-11 02:50:31.045535
NCT01620593|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-09-20|||April 2011||2011-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer|Phase II, Randomized, Placebo Controlled, Double Blind, Prospective Study of Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer.|Completed||Phase 2|38|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 02:50:31.177987|2017-10-11 02:50:31.177987
NCT01620580|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-06-14|||September 2011||2011-09-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Symptom Management Program for Hemodialysis Patients|Symptom Management Program for Hemodialysis Patients|Completed||N/A|60|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 02:50:31.295816|2017-10-11 02:50:31.295816
NCT01620567|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-08-16|||August 2012||2012-08-01|August 2013|2013-08-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Interventional|||Consumption of Potatoes, Avocados and Chickpeas and Cognitive Function in Older Adults|The Effect of Consumption of Potatoes, Avocados and Chickpeas Daily for 6 Months on Cognitive Function in Older Adults|Unknown status|Recruiting|Early Phase 1|44|Anticipated|Tufts University||2|||f||||f||||||||||2017-10-11 02:50:31.404005|2017-10-11 02:50:31.404005
NCT01620554|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2012-06-13|||October 2010||2010-10-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)|Minimum Effective Dose-Finding Study of BF2.649, in Patients With Moderate to Severe OSA, Experiencing EDS Despite Regular Use of nCPAP, and Patients Having Refused This Therapy - Randomized, Double Blind Study With BF2.649 or Placebo|Completed||Phase 2|110|Actual|Bioprojet||5|||f||||t||||||||||2017-10-11 02:50:31.572025|2017-10-11 02:50:31.572025
NCT01620541|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-10-12|||May 2012||2012-05-01|October 2016|2016-10-01|May 2027|Anticipated|2027-05-01|July 2022|Anticipated|2022-07-01||Observational|||Comparing Ankle Fusion to Ankle Replacement|Comparing Ankle Arthrodesis to Ankle Arthroplasty|Active, not recruiting||N/A|516|Actual|Seattle Institute for Biomedical and Clinical Research|||2||f||||t||||||||||2017-10-11 02:50:31.681834|2017-10-11 02:50:31.681834
NCT01620528|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-03-18||2015-11-13|May 2012||2012-05-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|November 2014|Actual|2014-11-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain|Completed||Phase 3|872|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 02:50:31.836942|2017-10-11 02:50:31.836942
NCT01620515|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-03-09||2017-03-09|February 21, 2012|Actual|2012-02-21|March 2017|2017-03-01|October 21, 2015|Actual|2015-10-21|October 21, 2015|Actual|2015-10-21||Interventional|||Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer|Phase 2 Multicenter Prospective Open Label 2-Dose Level Clinical Safety and Efficacy Evaluation of Injection of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer|Completed||Phase 2|141|Actual|Nymox Corporation||3|||f||||t||||||||||2017-10-11 02:50:32.348037|2017-10-11 02:50:32.348037
NCT01620502|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-10-26|||July 2009||2009-07-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression|N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression|Completed||N/A|230|Actual|National Science Council, Taiwan||3|||f||||t||||||||||2017-10-11 02:50:32.478768|2017-10-11 02:50:32.478768
NCT01620489|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-01-25|2014-08-20||June 2012||2012-06-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment|Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment. A 26-week Double-blind Placebo-controlled, Randomised, Multicentre, Multi-national, Parallel-group Trial|Completed||Phase 3|279|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:50:32.61289|2017-10-11 02:50:32.61289
NCT01620476|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-01-24|||September 2003||2003-09-01|January 2017|2017-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers|A Randomised, Double-blind, Single-centre, Placebo-controlled, 21-day Multiple s.c. Doses, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide (NNC 90-1170) in Healthy Japanese Male Subjects|Completed||Phase 1|24|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 02:50:33.882014|2017-10-11 02:50:33.882014
NCT01620463|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-01-23|||December 2002||2002-12-01|January 2017|2017-01-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers|A Randomised, Double-blind, Single-centre, Placebo-controlled, Ascending Single s.c. Dose, Sequential Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC 90-1170 in Healthy Japanese Male Subjects|Completed||Phase 1|32|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:50:33.986223|2017-10-11 02:50:33.986223
NCT01620450|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-02-28|||November 20, 2004|Actual|2004-11-20|February 2017|2017-02-01|February 26, 2005|Actual|2005-02-26|February 26, 2005|Actual|2005-02-26||Interventional|||Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese|A Single-centre, Randomised, Double Blind, Cross-over Trial Demonstrating the Bioequivalence Between NN2000-Mix30 and NN-X14Mix30 (NovoRapid® 30 Mix) in Healthy Japanese Subjects|Completed||Phase 1|34|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:50:34.08863|2017-10-11 02:50:34.08863
NCT01620437|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-02-22|||November 29, 2003|Actual|2003-11-29|February 2017|2017-02-01|December 30, 2003|Actual|2003-12-30|December 30, 2003|Actual|2003-12-30||Interventional|||Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects|A Randomised, Double-blind, Single-centre, Two-Period Crossover Trial Testing the Bioequivalence of Two Formulations of NN-X14Mix50 in Healthy Japanese Subjects|Completed||Phase 1|30|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:50:34.172415|2017-10-11 02:50:34.172415
NCT01620424|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-01-04|||February 2001||2001-02-01|January 2017|2017-01-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes|A Randomised, Double-blind, Single-centre, Two-Period Crossover Trial Investigating the Pharmacokinetics and Pharmacodynamics of NN-X14Mix30 and NN-X14Mix50 in Type 2 Diabetic Patients|Completed||Phase 1|10|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:50:34.268331|2017-10-11 02:50:34.268331
NCT01620411|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-06-17|||June 2012||2012-06-01|June 2013|2013-06-01||||June 2016||2016-06-01||Interventional|||War Wounded, a Comparison of Two Pain Management Approaches|Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty. Comparison of Spinal Cord Stimulation and Comprehensive Medical Management.|Withdrawn||Phase 4|0|Actual|University of California, San Diego||2||Site was never activated by sponsor|f||||t||||||||||2017-10-11 02:50:34.391209|2017-10-11 02:50:34.391209
NCT01620398|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-05-26|||February 2012||2012-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BALANCE||Brazilian Cardioprotective Nutritional Program Trial|The Brazilian Cardioprotective Nutritional Program to Reduce Events and Risk Factors in Secondary Prevention for Cardiovascular Disease|Active, not recruiting||N/A|2468|Actual|Hospital do Coracao||2|||f||||f||||||||No||2017-10-11 02:50:34.488457|2017-10-11 02:50:34.488457
NCT01620385|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2012-06-12|||June 2011||2011-06-01|June 2012|2012-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|ciPDA||Cochlear Implant PDA Based Research Platform|Multi Center Clinical Study to Assess the Safety of the UTD Cochlear Implant PDA (ciPDA) REsearch Platform|Unknown status|Recruiting|Phase 1|60|Anticipated|The University of Texas at Dallas||1|||f||||f||||||||||2017-10-11 02:50:34.771745|2017-10-11 02:50:34.771745
NCT01620372|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-10-08|||November 2011||2011-11-01|October 2012|2012-10-01|November 2031|Anticipated|2031-11-01|||||Observational|FCCSS||French Childhood Cancer Survivor Study|Constitution d'Une Cohorte Nationale rétrospective de Survivants d'un Cancer Solide de l'Enfant diagnostiqué Avant 2000|Recruiting||N/A|18000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||3||f||||t||||||Samples With DNA|"     saliva and blood samples (under another protocol)   "|||2017-10-11 02:50:34.873563|2017-10-11 02:50:34.873563
NCT01620359|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-08-29|||June 2011||2011-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Study of ExAblate Focused Ultrasound Ablation of Breast Cancer|Study of ExAblate Focused Ultrasound Ablation of Breast Cancer Under MR Guidance (MRgFUS) and MRI Evaluation of Ablation|Completed||Phase 2|14|Actual|InSightec||1|||f||||f||||||||||2017-10-11 02:50:35.077963|2017-10-11 02:50:35.077963
NCT01620346|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-01-07|||November 2011||2011-11-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|IMSIAMA||Intracytoplasmic Morphologically Selected Sperm Injection and Advanced Maternal Age|Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) Benefits in the Presence of Advanced Maternal Age: a Prospective Randomized Study|Completed||N/A|66|Actual|Sapientiae Institute||2|||f||||f||||||||||2017-10-11 02:50:35.176579|2017-10-11 02:50:35.176579
NCT01620333|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-01-04|||February 2000||2000-02-01|January 2017|2017-01-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers|A Randomised, Open-labelled, Single-centre, Two-period Crossover Trial Characterizing the Pharmacokinetics and Pharmacodynamics of NN-X14Mix50 and NN-X14Mix70 in Healthy Male Subjects|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:50:35.278094|2017-10-11 02:50:35.278094
NCT01620320|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-16|2013-06-24|||July 2010||2010-07-01|June 2013|2013-06-01|July 2013|Anticipated|2013-07-01|July 2012|Anticipated|2012-07-01||Observational|ESTRIE-TC||Stress Echocardiography Versus Coronary Angiography for Left Main Stenosis Detection|Évaluation de l'Echographie de Stress Par Comparaison à la Coronarographie Comme Outil Non Invasif de détection de la resténose Intra endoprothèse du Tronc Commun|Withdrawn||N/A|0|Actual|Université de Sherbrooke|||1|No Funding|f||||f||||||||||2017-10-11 02:50:35.403328|2017-10-11 02:50:35.403328
NCT01620307|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2012-06-14|||June 2009||2009-06-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|||Rapamune Improves Outcomes of Severe H1N1 Pneumonia|Adjuvant Treatment With a mTOR Inhibitor, Rapamune Improves Outcomes of Severe H1N1 Pneumonia With Acute Respiratory Failure|Completed||Phase 2|38|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:50:35.506988|2017-10-11 02:50:35.506988
NCT01620294|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-10|2012-06-14|||November 2009||2009-11-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|April 2010|Actual|2010-04-01||Interventional|TCS09||Abdominal Wall Closure With Triclosan-coated Suture|Abdomen Closure Using Triclosan Coated Absorbable Suture vs Uncoated Sutures of the Same Base Material|Completed||Phase 3|1|Actual|University of Pecs||2|||f||||t||||||||||2017-10-11 02:50:35.587125|2017-10-11 02:50:35.587125
NCT01620281|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2013-08-04|||June 2012||2012-06-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|LBP-1||The Efficacy of the no!no!Back for Chronic Low Back Pain|The no!no!Back Continuous Passive Motion Device for the Treatment of Chronic Low Back Pain: A Randomized Controlled Pilot Study|Completed||N/A|36|Actual|Radiancy||2|||f||||f||||||||||2017-10-11 02:50:35.702319|2017-10-11 02:50:35.702319
NCT01620268|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2016-07-25|||July 2012||2012-07-01|July 2016|2016-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria|An Open-Label, Phase 2 Study to Treat Patients With Renal Allograft and Polyoma BK Viruria to Prevent Polyoma BK Viremia, Polyoma BK Nephropathy and Renal Allograft Rejection|Recruiting||Phase 2|60|Anticipated|Changzheng-Cinkate||2|||f||||t||||||||||2017-10-11 02:50:35.799929|2017-10-11 02:50:35.799929
NCT01620255|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-05-15|2016-11-15|2015-11-05|November 2012||2012-11-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|September 2014|Actual|2014-09-01||Interventional|TURANDOT||A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis|A Double-blind, Randomized, Placebo-controlled, Parallel, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Moderate To Severe Ulcerative Colitis (Turandot)|Completed||Phase 2|357|Actual|Shire||5|||f||||t||||||||||2017-10-11 02:50:36.133722|2017-10-11 02:50:36.133722
NCT01620242|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-06-16|||April 2012||2012-04-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|ORL03||A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes|A PHASE II, OPEN-LABEL, MULTICENTER TRIAL OF CABAZITAXEL IN PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK CANCER AFTER FAILURE OF CISPLATIN, CETUXIMAB AND TAXANES.|Completed||Phase 2|31|Actual|UNICANCER||1|||f||||t||||||||No|IPD will not be shared at an individual level, those data will be part of the study database including all enrolled patients.|2017-10-11 02:50:39.870907|2017-10-11 02:50:39.870907
NCT01620229|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2014-04-17|||June 2013||2013-06-01|April 2014|2014-04-01||||April 2014|Actual|2014-04-01||Interventional|||Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies|Maintenance Therapy With Brentuximab Vedotin (SGN-35) After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma and CD30+ Hematologic Malignancies|Withdrawn||Phase 1/Phase 2|0|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 02:50:40.00912|2017-10-11 02:50:40.00912
NCT01620216|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-09-20|||May 11, 2012|Actual|2012-05-11|September 2017|2017-09-01|March 30, 2019|Anticipated|2019-03-30|March 30, 2019|Anticipated|2019-03-30||Interventional|||Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia|A Phase II Proof-of-Concept Trial to Study Kinase Inhibition in Relapsed/Refractory Acute Leukemias: Using a Comprehensive In Vitro Kinase Inhibitor Panel to Select Individualized, Targeted Therapies|Recruiting||Phase 2|24|Anticipated|OHSU Knight Cancer Institute||5|||f||||t||||||||||2017-10-11 02:50:40.14311|2017-10-11 02:50:40.14311
NCT01620190|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-13|2017-10-02|||November 6, 2012|Actual|2012-11-06|October 2017|2017-10-01|May 23, 2021|Anticipated|2021-05-23|May 23, 2018|Anticipated|2018-05-23||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer|A Phase II Study of Weekly Abraxane for Patients With Advanced NSCLC With EGFR Mutations or With Durable Response to an EGFR Tyrosine Kinase Inhibitor Following Front Line Therapy With EGFR Tyrosine Kinase Inhibitors|Active, not recruiting||Phase 2|27|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 02:50:40.391504|2017-10-11 02:50:40.391504
NCT01620177|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-05-31|2017-04-17||July 2012||2012-07-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||There was no baseline group, but rather all subjects who completed experienced the baseline dosing condition of placebo cannabis and placebo alcohol.|Effects of Inhaled Cannabis on Driving Performance|Effects of Inhaled Cannabis on Driving Performance|Completed||N/A|98|Actual|University of Iowa|This study examined only occasional users and the generalization to new or frequent cannabis users is unclear.|6|||f||||t||||||||||2017-10-11 02:50:40.518347|2017-10-11 02:50:40.518347
NCT01620164|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-05-10|||November 2011||2011-11-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Interventional|3Dparks||Assessment of Three-dimensional Vision Alteration in Parkinson Disease|Assessment of Three-dimensional Vision Alteration in Parkinson Disease.|Completed||N/A|36|Actual|University Hospital, Toulouse||3|||f||||f||||||||||2017-10-11 02:50:41.127207|2017-10-11 02:50:41.127207
NCT01620151|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-12-18|||February 2012||2012-02-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Open Thyroid Surgery With Pillow Versus no Pillow for Better Post-operative Outcomes|A Randomized Controlled Trial Comparing Post-operative Pain & Outcomes of Open Thyroidectomy; Extended Neck vs No Extended Neck|Completed||N/A|180|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 02:50:41.222292|2017-10-11 02:50:41.222292
NCT01620138|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2016-07-21|2015-06-01||March 2010||2010-03-01|July 2016|2016-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas|Somatostatin and Dopamine Receptors Expression in Non-functioning Pituitary Adenomas and Resistant Prolactinomas: Correlation With in Vitro and in Vivo Responsiveness to Somatostatin Analogs and Dopamine Agonist|Completed||Phase 2/Phase 3|21|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||Undecided||2017-10-11 02:50:41.326799|2017-10-11 02:50:41.326799
NCT01619748|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2013-08-06|||June 2012||2012-06-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Observational|||Peripheral Vascular Function in Obstructive Sleep Apnoea|Effects of Obstructive Sleep Apnoea and Its Treatment on Macrovascular and Microvascular Function|Completed||N/A|45|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||4||f||||f||||||||||2017-10-11 02:50:48.654635|2017-10-11 02:50:48.654635
NCT01620125|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-06-14|||May 2012||2012-05-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients|Metabolic Control of Type 2 Diabetes Patients Before and After Dietary Supplementation With the Probiotic Lactobacillus Reuteri DSM 17938 - a Pilot Study|Unknown status|Recruiting|Early Phase 1|12|Anticipated|Vastra Gotaland Region||1|||f||||f||||||||||2017-10-11 02:50:41.584463|2017-10-11 02:50:41.584463
NCT01620112|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-09|2012-06-14|||February 2009||2009-02-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Effects of Different Clonidine Concentrations on Axillary Brachial Plexus Block With 1,5% Lidocaine|The Effects of Different Clonidine Concentrations on Axillary Brachial Plexus Block With 1,5% Lidocaine for Upper Limb Surgery: a Prospective Randomized Study|Completed||Phase 2|60|Actual|Universidade Federal do Rio de Janeiro||4|||f||||t||||||||||2017-10-11 02:50:41.706635|2017-10-11 02:50:41.706635
NCT01620099|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-05-05|||November 2011||2011-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study|Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study|Completed||Phase 4|60|Anticipated|Università degli Studi di Ferrara||2|||f||||f||||||||||2017-10-11 02:50:41.828711|2017-10-11 02:50:41.828711
NCT01620086|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-10-28|2016-07-25||June 2012||2012-06-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia|Effect of Repetitive Transcranial Magnetic Stimulation (RTMS) on Resting State Brain Activity in Schizophrenia|Completed||N/A|26|Actual|University of Arkansas||2|||f||||f||||||||||2017-10-11 02:50:41.965566|2017-10-11 02:50:41.965566
NCT01620073|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2013-08-27|||July 2012||2012-07-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Home-Based Versus Partner-Friendly Clinic Testing to Enhance Male Partner HIV-1 Testing During Pregnancy|Home-Based Versus Partner-Friendly Clinic Testing to Enhance Male Partner HIV-1 Testing During Pregnancy: A Randomized Clinical Trial|Completed||N/A|488|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 02:50:42.328822|2017-10-11 02:50:42.328822
NCT01620060|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-03-10|2014-04-10||June 2012||2012-06-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Lurasidone Pediatric Pharmacokinetics Study|A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders|Completed||Phase 1|105|Actual|Sunovion||1|||f||||f||||||||||2017-10-11 02:50:42.407184|2017-10-11 02:50:42.407184
NCT01620047|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2013-09-12|2013-05-23||March 2011||2011-03-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Postoperative Knee Strength Following Total Knee Replacement: A Double-Blinded Randomized Comparison Study|Postoperative Knee Strength Following Total Knee Replacement: A Double-Blinded Randomized Comparison Study|Completed||N/A|60|Actual|University of South Florida||3|||f||||f||||||||||2017-10-11 02:50:42.69856|2017-10-11 02:50:42.69856
NCT01620034|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2015-06-22|||May 2010||2010-05-01|June 2015|2015-06-01||||August 2012|Actual|2012-08-01||Interventional|||Lung Stereotactic Body Radiotherapy (SBRT) Delivered Over 4 Days Versus 11 Days|A Randomized Study of Stereotactic Body Radiotherapy (SBRT) for Lung Tumours Delivered Over 4 Days Versus 11 Days|Unknown status|Active, not recruiting|Phase 2|50|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 02:50:44.86043|2017-10-11 02:50:44.86043
NCT01620021|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-05-06|||April 2011||2011-04-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Feasibility of Wearable Sensors to Determine Gait Parameters|Feasibility of Wearable Sensors to Determine Gait Parameters|Completed||N/A|10|Actual|University of South Florida|||1||f||||t||||||||||2017-10-11 02:50:44.992383|2017-10-11 02:50:44.992383
NCT01620008|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-11-27|||October 2012||2012-10-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|IBS||Delayed Cord Clamping and Infant Brain Study|Effects of Placental Transfusion on Early Brain Development|Active, not recruiting||N/A|128|Anticipated|University of Rhode Island||2|||f||||f||||||||||2017-10-11 02:50:45.069422|2017-10-11 02:50:45.069422
NCT01619995|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-07-21|||August 2011||2011-08-01|July 2017|2017-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|NIRS/fBFB||Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder|Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder|Completed||N/A|43|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 02:50:45.180285|2017-10-11 02:50:45.180285
NCT01619969|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2013-11-28|||July 2012||2012-07-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|CELADEN||Celgosivir as a Treatment Against Dengue|Celgosivir Proof of Concept Trial for Treatment of Acute Dengue Fever|Completed||Phase 1/Phase 2|50|Actual|Singapore General Hospital||2|||f||||t||||||||||2017-10-11 02:50:45.359986|2017-10-11 02:50:45.359986
NCT01619956|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-09|2012-06-14|||January 2010||2010-01-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Osteotome Sinus Floor Elevation With or Without Grafting|Osteotome Sinus Floor Elevation With or Without Grafting: a Randomized Controlled Study|Completed||N/A|92|Actual|Shanghai 9th People's Hospital||2|||f||||t||||||||||2017-10-11 02:50:45.45274|2017-10-11 02:50:45.45274
NCT01619943|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-06-13|||January 2011||2011-01-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||The Value of the Canadian CT Head Rule and the New Orleans Criteria in Minor Head Trauma|Prediction Value of the Canadian CT Head Rule and the New Orleans Criteria for Positive Head CT Scan and Acute Neurosurgical Procedures in Minor Head Trauma: a Multicenter External Validation Study|Completed||N/A|1600|Actual|University of Monastir|||1||f||||f||||||||||2017-10-11 02:50:45.559102|2017-10-11 02:50:45.559102
NCT01619345|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-02-20|||June 2012||2012-06-01|February 2015|2015-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects|Pharmacoscintigraphic Investigation NN9924 in Healthy Male Subjects|Completed||Phase 1|27|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:50:52.374799|2017-10-11 02:50:52.374799
NCT01619930|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-10-31|||August 2012||2012-08-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|January 2017|Anticipated|2017-01-01||Interventional|||The Effects of Behavioral Activation and Physical Exercise on Depression|The Effects on Depression of Internet-administered Behavioural Activation and Physical Exercise With Treatment Rationale and Relapse Prevention: Study Protocol for a Randomised Controlled Trial|Active, not recruiting||N/A|319|Anticipated|Umeå University||9|||f||||f||||||||||2017-10-11 02:50:45.659527|2017-10-11 02:50:45.659527
NCT01619917|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-11-11|||November 2012||2012-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars|The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars|Recruiting||Phase 1|12|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 02:50:45.812126|2017-10-11 02:50:45.812126
NCT01619904|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-12-01|||November 2011||2011-11-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||GDT Vs ST for Pancreas Transplant Surgery|Effects of Goal-Directed Therapy on Inflammatory Mediators and Postoperative Outcome in Pancreas Transplant: a Prospective Randomised Clinical Trial|Completed||N/A|60|Actual|University of Manchester||2|||f||||f||||||||||2017-10-11 02:50:46.060311|2017-10-11 02:50:46.060311
NCT01619878|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-06-01|2015-05-11||October 2012||2012-10-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg|An Open-label, Single-arm Study to Evaluate the Efficacy, Safety and PK of Artemether-lumefantrine Dispersible Tablet in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Infants <5 kg Body Weight|Completed||Phase 2/Phase 3|20|Actual|Novartis||1|||f||||||||||||||2017-10-11 02:50:46.251082|2017-10-11 02:50:46.251082
NCT01619865|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-04-30|||February 2012|Actual|2012-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|GA-68||Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors|Safety & Efficacy of 68Ga-DOTA-tyr3-Octreotide PET/CT in Diagnosis, Staging & Measurement of Response to Treatment in Patients With Somatostatin Receptor Positive Tumors: Comparison to Octreoscan Plus High-Resolution, Contrast Enhanced CT.|Active, not recruiting||N/A|200|Anticipated|University of Iowa||1|||f||||t||||||||Undecided|IPD are entered into the subject's electronic medical record and are shared with referring physicians when obtained.|2017-10-11 02:50:46.617568|2017-10-11 02:50:46.617568
NCT01619839|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-08-14||2014-08-12|June 2012||2012-06-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||A Phase 2 Study To Assess The Efficacy, Tolerability, And Safety OF NKTR-181 In Subjects With Chronic OA Knee Pain|A Phase 2, Enriched-Enrollment, Randomized-Withdrawal, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Tolerability, and Safety of NKTR-181 in Opioid-Naïve Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee|Completed||Phase 2|213|Actual|Nektar Therapeutics||5|||f||||f||||||||||2017-10-11 02:50:46.84245|2017-10-11 02:50:46.84245
NCT01619826|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-07-11|||April 2012||2012-04-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|FITKids2||Enhancing Children's Cognitive and Brain Health Through Physical Activity Training (FITKids2)|Enhancing Children's Cognitive and Brain Health Through Physical Activity Training|Completed||N/A|300|Actual|University of Illinois at Urbana-Champaign||2|||f||||t||||||||||2017-10-11 02:50:47.030032|2017-10-11 02:50:47.030032
NCT01619813|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-05-24|||July 2012||2012-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer|A Randomized Phase II Study of Reolysin in Combination With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Patients With Metastatic Castration Resistant Prostate Cancer|Completed||Phase 2|85|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 02:50:47.146792|2017-10-11 02:50:47.146792
NCT01619800|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-04-15|2015-02-17||March 2012||2012-03-01|April 2017|2017-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|ABSOLVE CI||The Effect of Blended Sensor Efficiency on Relieving the Heart's Inability to Increase Its Rate During Exercise|The impAct of Blended Sensor Optimization on resoLVing Chronotropic Incompetence: ABSOLVE CI|Terminated||N/A|2|Actual|Icahn School of Medicine at Mount Sinai|2 subjects enrolled, unable to meet goal of 38 enrollments. Data not analyzed.|2||The study was terminated due to poor enrollment.|f||||t||||||||No||2017-10-11 02:50:47.259405|2017-10-11 02:50:47.259405
NCT01619787|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-11-11|2016-04-14||January 2011||2011-01-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|Grocery|Age and Body Mass Index (BMI) were measured at the end of the study; therefore 5 participants were lost to follow up and the baseline measures are reported on 212 participants.|Price Changes and Hypothetical Food Purchases in Adult Grocery Shoppers|Experimental Analysis of Price Changes and Food Purchases in Obese and Lean Mothers|Completed||N/A|217|Actual|State University of New York at Buffalo|||1||f||||f||||||||No||2017-10-11 02:50:47.518071|2017-10-11 02:50:47.518071
NCT01619774|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-10-19|2016-07-18||September 2012||2012-09-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor|An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor|Completed||Phase 2|28|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:50:48.000822|2017-10-11 02:50:48.000822
NCT01619761|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-08-16|||May 3, 2013|Actual|2013-05-03|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Natural Killer (NK) Cells in Cord Blood Transplantation|Natural Killer Cells In Allogeneic Cord Blood Transplantation|Recruiting||Phase 1|13|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:50:48.510736|2017-10-11 02:50:48.510736
NCT01619735|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-10-06|||April 2013||2013-04-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||"Dusting Versus Basketing - Treatment Of Intrarenal Stones"|"Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of Dusting Versus Basketing With Holmium Laser Lithotripsy"|Active, not recruiting||N/A|178|Actual|Mayo Clinic|||2||f||||f||||||||||2017-10-11 02:50:48.750841|2017-10-11 02:50:48.750841
NCT01619722|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-11-15|||February 2012||2012-02-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|ECOPHEN||Study of a National Cohort of Adult Patients With Phenylketonuria|Study of a National Cohort of Adult Patients With Phenylketonuria|Active, not recruiting||N/A|220|Anticipated|University Hospital, Tours|||1||f||||t||||||Samples Without DNA|"     Plasma an serum at the beginning of study and at 5 years   "|||2017-10-11 02:50:48.865411|2017-10-11 02:50:48.865411
NCT01619709|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-02-21|||January 2012||2012-01-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|COGHIC-AV45||Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage|Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage|Recruiting||N/A|70|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-11 02:50:48.979974|2017-10-11 02:50:48.979974
NCT01619696|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2013-01-22|||March 2011||2011-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas|Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas.|Terminated||Phase 2|3|Actual|University Hospital, Toulouse||1||Insufficient recruitment|f||||f||||||||||2017-10-11 02:50:49.097692|2017-10-11 02:50:49.097692
NCT01619683|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-09-29|||September 2012||2012-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism|A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism|Completed||Phase 3|300|Actual|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 02:50:49.209238|2017-10-11 02:50:49.209238
NCT01619670|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-03-09|||June 2012||2012-06-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa|A Prospective Single Center Within Subject Controlled Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa|Terminated||Phase 4|3|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 02:50:49.408415|2017-10-11 02:50:49.408415
NCT01619657|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-05-03|||June 2012||2012-06-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|November 2016|Actual|2016-11-01||Interventional|PRESIS||Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis|Randomized, Double-blind, Controlled Pilot Study on Safety of Hypertonic Saline as Preventive Inhalation Therapy in Newborns and Infants With Cystic Fibrosis|Active, not recruiting||Phase 2|40|Anticipated|Heidelberg University||2|||f||||t||||||||||2017-10-11 02:50:49.525039|2017-10-11 02:50:49.525039
NCT01619644|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-03-17|||April 2012||2012-04-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|RUBIVAL||Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial|Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial|Completed||Phase 2|41|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 02:50:49.653042|2017-10-11 02:50:49.653042
NCT01619631|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-11-30|||February 2012||2012-02-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|June 2014|Actual|2014-06-01||Interventional|||Tai Chi Intervention for Chinese Americans With Depression|Tai Chi Intervention for Chinese Americans With Depression|Completed||N/A|94|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 02:50:49.762983|2017-10-11 02:50:49.762983
NCT01619618|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-05-16|||June 1, 2012|Actual|2012-06-01|May 2017|2017-05-01|July 1, 2012|Actual|2012-07-01|July 1, 2012|Actual|2012-07-01||Observational|||Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial|Evaluation of Polymorphisms and Mutations in Genes Postulated to Alter the Efficacy of Gefitinib in Samples From E1302|Completed||N/A|183|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 02:50:49.887917|2017-10-11 02:50:49.887917
NCT01619605|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-06-14|||June 2006||2006-06-01|June 2012|2012-06-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||The Utility of Serum Tryptase in the Diagnosis of Shrimp- Induced Anaphylaxis|The Utility of Serum Tryptase in the Diagnosis of Shrimp- Induced Anaphylaxis|Completed||N/A|39|Actual|Mahidol University||1|||f||||t||||||||||2017-10-11 02:50:49.973873|2017-10-11 02:50:49.973873
NCT01619592|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-06-24|||June 2012||2012-06-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|Telediabetes||Web-based Education for Diabetes Patients on Adaptable Insulin Schedules|The Belgian Quality of Life and Costs Study on Web-based Education for Diabetes Patients on Adaptable Insulin Schedules|Completed||N/A|153|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 02:50:50.067589|2017-10-11 02:50:50.067589
NCT01619579|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-12-05|2015-07-30|2015-07-13|June 2011||2011-06-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|AVACEN: TES||Investigation of AVACEN Thermal Exchange System for Fibromyalgia Pain|Effects of a 4 Week AVACEN Treatment on Pain Perception in Fibromyalgia - An Open Label Study|Completed||Phase 2|22|Actual|Avacen, Inc.||1|||f||||t||||||||||2017-10-11 02:50:50.19721|2017-10-11 02:50:50.19721
NCT01619566|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-10-24|||June 2012||2012-06-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed|Duloxetine (Cymbalta): for Fibromyalgia: An Open Label Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therpeutic Responsiveness to Duloxetine.|Withdrawn||Phase 4|0|Actual|University of California, San Diego||2||Sponsor related|f||||t||||||||No||2017-10-11 02:50:50.534715|2017-10-11 02:50:50.534715
NCT01619553|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-09-08|||April 2009||2009-04-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||Genetic Analysis of Keloids|Identification of Genetic Variants That Contribute to Keloid Formation in Families and Isolated Cases.|Recruiting||N/A|4000|Anticipated|UConn Health|||2||f||||f||||||Samples With DNA|"     Saliva, blood, scar tissue   "|||2017-10-11 02:50:50.621556|2017-10-11 02:50:50.621556
NCT01619540|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2013-09-23|||May 2011||2011-05-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Valsalva Manœuvre in the Diagnosis of Left Ventricular Failure in Chronic Obstructive Pulmonary Disease Exacerbation|Study of the Valsalva Manœuvre in the Diagnosis of Left Ventricular Failure During Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Completed||N/A|150|Actual|University of Monastir||2|||f||||t||||||||||2017-10-11 02:50:50.689048|2017-10-11 02:50:50.689048
NCT01619527|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2013-03-01|||April 2012||2012-04-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions|A Single-Dose, Open-Label, 3-Panel, Randomized, Pivotal Crossover Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat as Either a Fixed Dose Combination Tablet (G006) or as Single Agents Under Fed and Fasted Conditions in Healthy Subjects|Completed||Phase 1|133|Actual|Janssen R&D Ireland||6|||f||||f||||||||||2017-10-11 02:50:50.783402|2017-10-11 02:50:50.783402
NCT01619514|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-10|||March 2012||2012-03-01|December 2013|2013-12-01||||March 2014|Anticipated|2014-03-01||Observational|||Uncovering Potential Breast Cancer Biomarkers Amp; Possible Drug Targets Using Advanced Quantitative Mass Spectrometry||Unknown status|Recruiting|N/A|||National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 02:50:50.887102|2017-10-11 02:50:50.887102
NCT01619501|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2013-12-10|||April 2012||2012-04-01|December 2013|2013-12-01||||March 2014|Anticipated|2014-03-01||Observational|||Dysregulation of the C/EBPa Pathway in Human Lung Cancer and Search for New Biomarkers and/or Therapeutic Targets||Unknown status|Recruiting|N/A|||National University Hospital, Singapore|||1||f||||||||||||||2017-10-11 02:50:50.956255|2017-10-11 02:50:50.956255
NCT01619488|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2014-07-17|||August 2007||2007-08-01|July 2014|2014-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Laparoscopic Adjustable Gastric Banding in Adolescents|Laparoscopic Adjustable Gastric Banding for Treatment of Morbid Obesity in Adolescents|Active, not recruiting||Phase 3|75|Anticipated|Nemours Children's Clinic||1|||f||||t||||||||||2017-10-11 02:50:51.023177|2017-10-11 02:50:51.023177
NCT01619475|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-08-27|||February 2011|Actual|2011-02-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|A2ALL-2||Adult-to-Adult Living Donor Transplant Cohort Study|A2ALL: Adult-to-Adult Living Transplant Cohort Study|Completed||N/A|1871|Actual|Arbor Research Collaborative for Health|||3||f||||t||||||Samples With DNA|"     To collect biosamples prior to, during, and after LDLT among all donors and recipients. These     biosamples include, liver biopsy,whole blood for genetic studies and DNA extraction, plasma,     serum and peripheral cells to be retained in the bio-repository.   "|||2017-10-11 02:50:51.216136|2017-10-11 02:50:51.216136
NCT01619462|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2014-03-20|||November 2011||2011-11-01|September 2012|2012-09-01|November 2016|Anticipated|2016-11-01|April 2014|Anticipated|2014-04-01||Interventional|PCV1103||Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children|A Study of Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines to Inform Policy Regarding Pneumococcal Vaccination of Papua New Guinean Children|Unknown status|Recruiting|Phase 3|200|Anticipated|Papua New Guinea Institute of Medical Research||2|||f||||t||||||||||2017-10-11 02:50:51.36209|2017-10-11 02:50:51.36209
NCT01619449|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2015-05-26|||April 2012||2012-04-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant|Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant: A Randomized Trial|Withdrawn||N/A|0|Actual|University of Chicago||2||Research never begun and no subjects enrolled. Protocol term with IRB in Dec 2014|f||||t||||||||||2017-10-11 02:50:51.468001|2017-10-11 02:50:51.468001
NCT01619436|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-06-13|||January 2011||2011-01-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|||The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass|The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.|Completed||Phase 4|46|Actual|Federal University of Juiz de Fora||2|||f||||t||||||||||2017-10-11 02:50:51.565963|2017-10-11 02:50:51.565963
NCT01619423|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-01-11|||September 2012||2012-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|PLIANT||A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer|A Double Blinded Randomised Three Armed Phase II Trial of PledOx in Two Different Doses in Combination With FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Advanced Metastatic Colorectal (Stage IV) Cancer|Completed||Phase 1/Phase 2|186|Actual|PledPharma AB||3|||f||||t||||||||||2017-10-11 02:50:51.671165|2017-10-11 02:50:51.671165
NCT01619410|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-06-08|||January 2012||2012-01-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections|Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute S. Aureus Skin and Skin Structure Infections in Patients With Comorbid Conditions: A Randomized Trial|Active, not recruiting||N/A|26|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 02:50:51.908575|2017-10-11 02:50:51.908575
NCT01619397|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-09-07|||September 2012||2012-09-01|September 2017|2017-09-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Evaluation of Tolerance and Acceptability of a Coated Condom|A Clinical Investigation to Evaluate In-use Genital Tolerance and User Acceptability of a Xanthan Gum Coating on a Standard Natural Rubber Latex Condom in Healthy Volunteer Mutually Monogamous Adult Couples|Completed||N/A|50|Actual|Reckitt Benckiser LLC||1|||f||||f||||||||||2017-10-11 02:50:52.011149|2017-10-11 02:50:52.011149
NCT01619384|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-11-17|||July 2010||2010-07-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Mindfulness-Based Stress Reduction and the Microbiome|Pyrosequencing to Identify Alterations in Intestinal Microbiota Following a Stress Reduction Course|Completed||N/A|55|Actual|Seattle Institute for Biomedical and Clinical Research||2|||f||||f||||||||||2017-10-11 02:50:52.101389|2017-10-11 02:50:52.101389
NCT01619358|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-10|||March 2012||2012-03-01|December 2013|2013-12-01||||February 2017|Anticipated|2017-02-01||Observational|||Genomic-Based Diagnosis, Classification and Targeted Treatment of Multiple Myeloma||Unknown status|Recruiting|N/A|150|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 02:50:52.288217|2017-10-11 02:50:52.288217
NCT01619332|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-03-30||2016-03-30|March 2012||2012-03-01|March 2016|2016-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763|A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes|Completed||Phase 1/Phase 2|220|Actual|Novartis||3|||f||||f||||||||||2017-10-11 02:50:52.468709|2017-10-11 02:50:52.468709
NCT01619319|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-09-03|||July 2010||2010-07-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis|Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis|Completed||N/A|32|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 02:50:52.612175|2017-10-11 02:50:52.612175
NCT01619306|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-10|||January 2011||2011-01-01|December 2013|2013-12-01||||December 2014|Anticipated|2014-12-01||Observational|||Knowledge and Attitudes of Patients and Healthcare Professionals on a Spectrum of Genetic Tests Relevant to Breast Cancer Patients||Unknown status|Recruiting|N/A|850|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 02:50:52.700682|2017-10-11 02:50:52.700682
NCT01619293|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-11-20|||May 2012||2012-05-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||The Neuromarker S-100B in Patients With Different Types of Intracranial Injury|The Neuromarker S-100B in Patients With Subarachnoidal, Epidural, Subdural, and Intracerebral Hematoma, Edema Cerebri, and Concussion|Completed||N/A|1800|Anticipated|Medical University of Vienna|||6||f||||f||||||Samples Without DNA|"     7ml of blood drawed from peripheral vein   "|||2017-10-11 02:50:52.775742|2017-10-11 02:50:52.775742
NCT01619280|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-06-12|||May 2012||2012-05-01|June 2012|2012-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury|A Phase 1 Study: The Determination of the Maximum Tolerable Dosage of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury|Unknown status|Recruiting|Phase 1|30|Anticipated|Mount Sinai Hospital, Canada||1|||f||||f||||||||||2017-10-11 02:50:52.857527|2017-10-11 02:50:52.857527
NCT01619267|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-04-07|||January 2012||2012-01-01|April 2017|2017-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Observational|DIRT||Role of New Diagnostic Tool in Device (ICD / PM) Associated Infections|Device Associated Infections - Role of New Diagnostic Tools|Completed||N/A|103|Actual|Deutsches Herzzentrum Muenchen|||2||f||||f||||||Samples Without DNA|"     new inflammatory biomarkers such as procalcitonine   "|||2017-10-11 02:50:52.968587|2017-10-11 02:50:52.968587
NCT01619254|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-09|2015-01-31|||July 2012||2012-07-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Impact of Hand Hygiene Activities on the Prevention of Intestinal Parasitic Infections and Anaemia Among School Children|Hand Hygiene Promotion Activities: Effect on Intestinal Parasitic Infections and Anaemia Among School-aged Children in Eastern Tigray, Ethiopia: a Factorial Randomised Controlled Trial|Completed||N/A|365|Actual|Mekelle University||4|||f||||t||||||||||2017-10-11 02:50:53.047598|2017-10-11 02:50:53.047598
NCT01619241|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2012-06-12|||June 2012||2012-06-01|June 2012|2012-06-01|August 2015|Anticipated|2015-08-01|August 2013|Anticipated|2013-08-01||Observational|||Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer|The Role of F-18 FLT PET/CT for Selecting the Patients Who Need Maintenance Treatment After First-line Chemotherapy in Advanced Non-small Cell Lung Cancers|Unknown status|Not yet recruiting|N/A|15|Anticipated|The Catholic University of Korea|||1||f||||f||||||||||2017-10-11 02:50:53.140693|2017-10-11 02:50:53.140693
NCT01619228|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-08-03|||April 2012||2012-04-01|June 2015|2015-06-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||Skin Maturation in Premature Infants|Ontogeny of Skin Barrier Maturation in Premature Infants|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 02:50:53.252777|2017-10-11 02:50:53.252777
NCT01619215|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2017-02-28|||June 2012||2012-06-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver Disease|The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver Disease|Recruiting||N/A|35|Anticipated|King Saud University|||1||f||||t||||||Samples With DNA|"     Blood (serum, plasma, and RNA isolate) Liver core biopsy Subcutaneous fat Visceral fat     Abdominal wall muscle   "|||2017-10-11 02:50:53.385155|2017-10-11 02:50:53.385155
NCT01619202|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-01-23|||June 2012||2012-06-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Comparing Driving Performance Among Trained and Untrained Drivers Using a Driving Simulator|Comparison of Driving Performance Among Trained and Untrained Novice Drivers: Validation of a Multidimensional Simulated Driving Assessment|Completed||N/A|50|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 02:50:53.543165|2017-10-11 02:50:53.543165
NCT01619189|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2015-02-03|||June 2007||2007-06-01|February 2015|2015-02-01||||December 2014|Actual|2014-12-01||Interventional|TC181||Cell Therapy in Failure Syndromes in Limbal Stem Cells|Thérapie Cellulaire au Cours Des Syndromes d'Insuffisance en Cellules Souches Limbiques|Unknown status|Active, not recruiting|Phase 2|15|Anticipated|Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts||1|||f||||f||||||||||2017-10-11 02:50:53.649288|2017-10-11 02:50:53.649288
NCT01619176|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2013-12-12|||October 2012||2012-10-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Interventional|||Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood|Non Inferiority Trial for the Study of Acupuncture on Rheumatoid Arthritis|Completed||N/A|15|Anticipated|Chinese Academy of Sciences||2|||f||||f||||||||||2017-10-11 02:50:53.734456|2017-10-11 02:50:53.734456
NCT01619163|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2012-06-13|||November 2011||2011-11-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Prednisolone for Pain Reduction in Knee OA|Phase 4 Study of Low Dose Prednisolone for Knee Osteoarthritis|Completed||Phase 4|125|Actual|Faculty of Medicine, University of Alexandria||2|||f||||t||||||||||2017-10-11 02:50:53.852229|2017-10-11 02:50:53.852229
NCT01619137|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-10-05|||August 2011||2011-08-01|October 2012|2012-10-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Soap Versus Normal Salin Plus Povidone-iodine in Ununion Wound|Comparison of the Effect of Water and Soap Irrigation With With Povidone-iodine And Normal Salin Treatment of Patients With Ununion Laparatomy or Episiotomy Wound ( a Pilot Study)|Unknown status|Recruiting|N/A|40|Anticipated|Hormozgan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:50:54.082597|2017-10-11 02:50:54.082597
NCT01619124|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-03-04|||March 2012||2012-03-01|March 2014|2014-03-01|March 2020|Anticipated|2020-03-01|March 2016|Anticipated|2016-03-01||Observational|OPAL||Osteonecroses in Pediatric Patients With ALL|Part I: Incidence, Clinical Course and Significance of MRI for Early Diagnosis of Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Part II: Susceptibility for Aseptic Osteonecroses in Children and Adolescents With Chemotherapy for ALL or LBL|Recruiting||N/A|400|Anticipated|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 02:50:54.170456|2017-10-11 02:50:54.170456
NCT01619111|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-06-06|||February 2012||2012-02-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|DETECT III||DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs|DETECT III - A Multicenter, Randomized, Phase III Study to Compare Standard Therapy Alone Versus Standard Therapy Plus Lapatinib in Patients With Initially HER2-negative Metastatic Breast Cancer and HER2-positive Circulating Tumor Cells|Recruiting||Phase 3|120|Anticipated|University of Ulm||2|||f||||t||||||||||2017-10-11 02:50:54.341291|2017-10-11 02:50:54.341291
NCT01619098|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-01-21|||October 2011||2011-10-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|||Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population|Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population|Completed||N/A|1510|Actual|Harvard Pilgrim Health Care||2|||f||||f||||||||||2017-10-11 02:50:54.437485|2017-10-11 02:50:54.437485
NCT01619085|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-08-25|||June 2012||2012-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis|An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Active, not recruiting||Phase 3|759|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:50:54.53935|2017-10-11 02:50:54.53935
NCT01619072|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2013-11-21|||November 2012||2012-11-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Misoprostol for Treatment of Postpartum Hemorrhage at Community-level Births in Egypt|A Randomized Controlled Community Study of the Effectiveness of Misoprostol for PPH Treatment at the Community Level (Home Births Attended by Primary Care Unit Staff) in Etay El Barood and Kafr El Dawar Districts (El Beheira Governorate), Egypt|Completed||N/A|82|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 02:50:55.103813|2017-10-11 02:50:55.103813
NCT01619059|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-03-24|2016-02-18||June 2012||2012-06-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Triple Therapy With Saxagliptin Added to Dapagliflozin in Combination With Metformin Compared to Therapy With Placebo Added to Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin and Dapagliflozin|Completed||Phase 3|315|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 02:50:55.226324|2017-10-11 02:50:55.226324
NCT01619046|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-07-02|||March 2013||2013-03-01|July 2014|2014-07-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A|Determination of Safety, Efficacy and Pharmacokinetics of GreenGene™ F in Previously Treated Patients 12 Years of Age or Older Diagnosed With Severe Hemophilia A|Unknown status|Recruiting|Phase 3|124|Anticipated|Green Cross Corporation||4|||f||||f||||||||||2017-10-11 02:50:55.969633|2017-10-11 02:50:55.969633
NCT01619033|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2013-04-11|||July 2011||2011-07-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pharmacokinetics of BF2.649 in Renal Impairment|Pharmacokinetics of 20 mg BF2.649 in Single Dose, in Subjects With Normal Renal Function Compared to Subject With Impaired Renal Function|Completed||Phase 1|25|Actual|Bioprojet||2|||f||||f||||||||||2017-10-11 02:50:56.317402|2017-10-11 02:50:56.317402
NCT01619020|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-09-11|||October 2012||2012-10-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|FlaxFx||FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health|Gut Microbiota and Colonic Gene Expression: A Lignan Trial in Humans|Completed||N/A|66|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 02:50:56.42258|2017-10-11 02:50:56.42258
NCT01619007|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-01-20|||June 2012||2012-06-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Observational|XALIA||Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy|Xarelto® for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE)|Completed||N/A|5145|Actual|Bayer|||2||f||||f||||||||||2017-10-11 02:50:56.548451|2017-10-11 02:50:56.548451
NCT01618994|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-06-08|||April 2011||2011-04-01|June 2017|2017-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Validation Study for Robotic Surgery Simulator|Validation Study for Robotic Surgery Simulator|Completed||N/A|14|Actual|Atlantic Health System|||3||f||||t||||||||||2017-10-11 02:50:56.744893|2017-10-11 02:50:56.744893
NCT01618981|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2014-01-06|||September 2012||2012-09-01|January 2014|2014-01-01||||||||Interventional|LEAD||LEft Atrial Pacing in Diastolic Heart Failure|LEft Atrial Pacing in Diastolic Heart Failure|Unknown status|Recruiting|N/A|||Centre Hospitalier Universitaire Dijon||2|||f||||t||||||||||2017-10-11 02:50:56.916874|2017-10-11 02:50:56.916874
NCT01618968|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-05-08|2014-02-27||May 2012||2012-05-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||In total, 50 subjects were randomized, of which 49 were included in the safety population. Of 49, 47 completed the study and 2 discontinued from the study after first dose.|Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device|Exposure, Safety and Local Tolerance Study Comparing the Relative Bioavailability of Oral Methotrexate and the VIBEX™ MTX Device in Adult Subjects With Rheumatoid Arthritis|Completed||Phase 2|49|Actual|Antares Pharma Inc.||4|||f||||f||||||||||2017-10-11 02:50:57.036329|2017-10-11 02:50:57.036329
NCT01618955|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-03-31|2014-02-14||May 2012||2012-05-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||A total of 101 patients were included in the Safety Population, which consisted of all patients who received study drug and administered a successful or unsuccessful self-injection.|Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device|Phase 2, Multi-Center, Open-Label, Single-Dose, Single Arm, In-Clinic Study to Evaluate the Actual Human Use of Methotrexate Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device in Adult Patients With Rheumatoid Arthritis.|Completed||Phase 2|101|Actual|Antares Pharma Inc.||1|||f||||f||||||||||2017-10-11 02:50:57.762457|2017-10-11 02:50:57.762457
NCT01618942|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-04-07|2013-05-23||June 2012||2012-06-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research|To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research|Completed||N/A|100|Actual|Huazhong University of Science and Technology|There was no significant limitation in the study.|2|||f||||t||||||||||2017-10-11 02:50:58.580324|2017-10-11 02:50:58.580324
NCT01618929|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-08-11|||March 2013||2013-03-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Montelukast in Asthmatic Children With and Without Food Allergy|Phase 4 Study of Effects of Montelukast Treatment on Allergic Inflammation in Children With and Without Food Allergy, Single Centered, Randomised, Double Blind, Placebo Controlled Parallel Group Cross-over Study|Completed||Phase 4|113|Actual|Hacettepe University||2|||f||||t||||||||||2017-10-11 02:50:58.981598|2017-10-11 02:50:58.981598
NCT01618916|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2013-02-26|||June 2012||2012-06-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol|A Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3015014 in Japanese and Non-Japanese Subjects With Elevated LDL-C|Completed||Phase 1|48|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 02:50:59.11919|2017-10-11 02:50:59.11919
NCT01618903|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-08-02|||May 2012||2012-05-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese|A Monocenter, Open-label, Two-way Randomized Cross-over Study to Evaluate the Bioequivalence of Levetiracetam Administered as a 45 Minutes Intravenous Infusion and Same Dosage Levetiracetam Oral Tablet (Part A); and a Randomized, Double-blind, Placebo-controlled, Parallel Study on the Safety, Tolerability and Pharmacokinetics of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of b.i.d. Dosing (Part B), in Chinese Healthy Volunteers|Completed||Phase 1|24|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 02:50:59.236101|2017-10-11 02:50:59.236101
NCT01618890|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-06-21|||September 2012||2012-09-01|June 2017|2017-06-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|Porthos||Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding|A Multi-center Randomized Controlled Study of Primary Prevention of Esophageal Variceal Bleeding in Cirrhotic Patients Treated With HVPG-guided Beta- Blocker Therapy or Standard Heart Rate-guided Beta-blocker Therapy|Recruiting||Phase 3|78|Anticipated|Leiden University Medical Center||2|||f||||t||||||||||2017-10-11 02:50:59.353302|2017-10-11 02:50:59.353302
NCT01618877|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-08-02|||May 2012||2012-05-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers|A Monocenter, Open-label, Two-way Randomized Cross-over Study to Evaluate the Bioequivalence of Levetiracetam Administered as a 45 Minutes Intravenous Infusion and Same Dosage Levetiracetam Oral Tablet (Part A); and a Randomized, Double-blind, Placebo-controlled, Parallel Study on the Safety, Tolerability and Pharmacokinetics of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of b.i.d. Dosing (Part B), in Chinese Healthy Volunteers|Completed||Phase 1|24|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 02:50:59.774059|2017-10-11 02:50:59.774059
NCT01618864|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-07-20|2014-06-10||March 2012||2012-03-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea|Safety and Efficacy Evaluation of the Luxe™ Device for the Treatment of Facial Wrinkles and Rosacea|Completed||N/A|23|Actual|Syneron Medical|Small number of subjects analyzed for post-marketing study.|1|||f||||f||||||||||2017-10-11 02:50:59.941857|2017-10-11 02:50:59.941857
NCT01618851|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-05-16|||November 2009||2009-11-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer|Phase II Study to Evaluate the Efficacy of Intensity Modulated Radiation Therapy With Hypofractionated Radiosurgical Boosts in the Treatment of Clinically Localized Prostate Cancer|Active, not recruiting||N/A|70|Anticipated|Georgetown University||1|||f||||t||||||||||2017-10-11 02:51:00.276906|2017-10-11 02:51:00.276906
NCT01618838|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2017-03-27|2014-03-21||February 2011||2011-02-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Age: median 75.5 y/o Race: 2 Blacks, 1 Caucasian and 1 Asian|Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer|Prospective Endoscopic Safety Evaluation of Late Rectal Mucosal Injury Following CyberKnife Radiosurgery for Clinically Localized Prostate Cancer|Terminated||Phase 2|4|Actual|Georgetown University||1||"The study only accrued 4 patients in 2 years, far below target (40). It was closed with no   subject reached the primary endpoint, thus no results to publish."|f||||t||||||||||2017-10-11 02:51:00.415813|2017-10-11 02:51:00.415813
NCT01618825|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-11|||March 2012||2012-03-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition|An Open Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Crossover, Balanced, Single Dose Oral Bioequivalence Study of Lamotrigine Tablets 25 mg (2 × 25 mg Tablets) and 'LAMICTAL®' (Lamotrigine) Tablets 25 mg (2 × 25 mg Tablets) in Healthy Adult Human Subjects Under Fed Conditions.|Completed||Phase 1|28|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:51:00.712367|2017-10-11 02:51:00.712367
NCT01617694|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-11|||June 2011||2011-06-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Comparison Between Remifentanil Target-controlled Infusion and Dexmedetomidine Bolus Administration for Smooth Emergence From General Sevoflurane Anesthesia||Completed||N/A|65|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:51:18.291881|2017-10-11 02:51:18.291881
NCT01618812|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-12|||September 2010||2010-09-01|June 2012|2012-06-01|April 2013|Anticipated|2013-04-01|October 2012|Anticipated|2012-10-01||Observational|||Calcaneal Neck Lengthening Osteotomy in Children With Artificial Bone Graft|Calcaneal Neck Lengthening Osteotomy - Allogen Bone Graft Material Versus a Hydroxyapatite / β- Tricalcium Phosphate Bone Substitute|Unknown status|Active, not recruiting|N/A|10|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-11 02:51:00.826076|2017-10-11 02:51:00.826076
NCT01618799|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-11|||March 2012||2012-03-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition|An Open Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Crossover, Balanced, Single Dose Oral Bioequivalence Study of Lamotrigine Tablets 25 mg (2 × 25 mg Tablets) and 'LAMICTAL®' (Lamotrigine) Tablets 25 mg (2 × 25 mg Tablets) in Healthy Adult Human Subjects Under Fasting Conditions.|Completed||Phase 1|28|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:51:00.975715|2017-10-11 02:51:00.975715
NCT01618786|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-06-06|||September 2013||2013-09-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FLIP||Flooring for Injury Prevention Trial|Randomized Controlled Trial of Compliant Flooring to Reduce Injuries Due to Falls in Older Adults in a Long-Term Care Facility|Active, not recruiting||N/A|151|Anticipated|Simon Fraser University||2|||f||||t||||||||Undecided||2017-10-11 02:51:01.108811|2017-10-11 02:51:01.108811
NCT01618773|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2016-02-15|||June 2012||2012-06-01|February 2016|2016-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|ELANG||Long-term Study of Epiduo in Patients With Moderate to Severe Acne|Epiduo in the Long-term Treatment of Moderate to Severe Acne With or Without Concomitant Medication|Completed||N/A|6036|Actual|Galderma Laboratorium GmbH|||1||f||||t||||||||No||2017-10-11 02:51:01.275421|2017-10-11 02:51:01.275421
NCT01618760|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-11|||May 2012||2012-05-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Risperidone Tablet 1 mg With Risperdal® 1 mg in Normal, Healthy, Adult, Human Subjects Under Fed Condition|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:51:01.437905|2017-10-11 02:51:01.437905
NCT01618747|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2013-03-18|||May 2013||2013-05-01|March 2013|2013-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse|A Single-arm, Open-label, Multicenter, Non-interventional Study to Assess Bevacizumab (Avastin) in Relapsed Glioblastoma|Unknown status|Not yet recruiting|N/A|20|Anticipated|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:51:01.60768|2017-10-11 02:51:01.60768
NCT01618734|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-12|||January 2012||2012-01-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.|Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP).|Completed||N/A|50|Actual|Henri Mondor University Hospital|||1||f||||f||||||||||2017-10-11 02:51:01.727647|2017-10-11 02:51:01.727647
NCT01618721|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-12|2014-06-23|||December 2011||2011-12-01|August 2011|2011-08-01||||October 2013|Actual|2013-10-01||Observational|||Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)|Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)|Terminated||N/A|200|Anticipated|Echosense Ltd.|||1|Low recruiting rate and fulfill requirements|f||||||||||||||2017-10-11 02:51:01.859365|2017-10-11 02:51:01.859365
NCT01618708|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-05-31|2016-05-31||September 2012||2012-09-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Intent-to-treat (ITT) population included all randomized participants who received study medication or part of the treatment administration.|A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip|A Pivotal, Multicenter, Double Blind Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Mild to Moderate Primary Osteoarthritis of the Hip|Completed||N/A|357|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:51:01.997042|2017-10-11 02:51:01.997042
NCT01618695|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-08-21|||May 17, 2012|Actual|2012-05-17|August 2017|2017-08-01|September 2019|Anticipated|2019-09-01|September 15, 2014|Actual|2014-09-15||Interventional|||A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures|A Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures|Active, not recruiting||Phase 3|465|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 02:51:02.695704|2017-10-11 02:51:02.695704
NCT01618682|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-04-14|||March 2012||2012-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Cortical Organization in Allogeneic Transplants or Heterotopic Hand Replants|Cortical Organization in Allogeneic Transplants or Heterotopic Hand Replants|Recruiting||N/A|60|Anticipated|Christine M. Kleinert Institute for Hand and Microsurgery|||2||f||||f||||||||||2017-10-11 02:51:02.964873|2017-10-11 02:51:02.964873
NCT01618669|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-01-07|2015-12-14||June 2012||2012-06-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|EXERRT|All randomized participants who took at least 1 dose of study drug (Safety Analysis Set).|A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)|A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)|Completed||Phase 3|1147|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 02:51:03.114498|2017-10-11 02:51:03.114498
NCT01618656|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-06-21|||June 2012||2012-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal|FAAH-Inhibitor for Cannabis Dependence|Active, not recruiting||Phase 2|120|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 02:51:04.871895|2017-10-11 02:51:04.871895
NCT01617902|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2012-06-14|||June 2012||2012-06-01|June 2012|2012-06-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Observational|||Hyperbilirubinemia After Cardiac Surgery|Hyperbilirubinemia After Major Cardiac or Thoracic Aorta Surgery: Predictors and Clinical Significance|Unknown status|Recruiting|N/A|1000|Anticipated|Asan Medical Center|||1||f||||t||||||||||2017-10-11 02:51:16.514722|2017-10-11 02:51:16.514722
NCT01618643|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-13|||November 2010||2010-11-01|June 2012|2012-06-01|November 2013|Anticipated|2013-11-01|September 2011|Actual|2011-09-01||Observational|||Aceto-whitening in the Assessment of Gastrointestinal Neoplasia|Acetowhitening Time as a Novel Objective Tool for the Diagnosis of High Risk Neoplasia in Barrett's Oesophagus|Unknown status|Recruiting|N/A|150|Anticipated|Portsmouth Hospitals NHS Trust|||1||f||||t||||||None Retained|"     Only pathology retained is for NHS purposes only. No separate tissue retained for the study   "|||2017-10-11 02:51:06.742|2017-10-11 02:51:06.742
NCT01618630|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-06-28|||May 2012||2012-05-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|ExAA||Amino Acid Supplementation in Recovery From Severe Burn|Amino Acid Supplementation in Recovery From Severe Burn|Active, not recruiting||N/A|40|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 02:51:06.85688|2017-10-11 02:51:06.85688
NCT01618617|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-11-29|||June 2012||2012-06-01|June 2012|2012-06-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Multistrain Probiotic for Functional Constipation|Dose-response Effectiveness of 6-week Multistrain Probiotic Supplementation on Whole Gut Transit Time, Quality of Life, and Gastrointestinal Symptoms in Adults With Functional Constipation|Unknown status|Recruiting|Phase 2/Phase 3|81|Anticipated|Renew Life Formulas Inc||3|||f||||f||||||||||2017-10-11 02:51:06.941194|2017-10-11 02:51:06.941194
NCT01618604|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-12-30|||May 2012||2012-05-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|CPM||QST in Context With Conditioned Pain Modulation|Quantitative Sensory Testing in Context With Conditioned Pain Modulation (CPM)|Completed||N/A|26|Actual|Ruhr University of Bochum|||1||f||||f||||||||||2017-10-11 02:51:07.040719|2017-10-11 02:51:07.040719
NCT01618591|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-11-24|||September 2012||2012-09-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|TrEAT TD||Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea|A Randomized, Double-Blind, Clinical Trial Evaluating Three Single Dose Regimens With Loperamide for Treatment of Ambulatory Watery Travelers' Diarrhea, and Azithromycin With and Without Loperamide for Treatment of Ambulatory Dysentery/Febrile Diarrhea|Terminated||N/A|384|Actual|Uniformed Services University of the Health Sciences||2||"AWD arm was completed. ADF diarrhea arm was unable to fill completely and there are no funds   remaining to continue recruiting/enrolling."|f||||t||||||||||2017-10-11 02:51:07.152842|2017-10-11 02:51:07.152842
NCT01618578|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-24|||May 2010||2010-05-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||The Rubber Hand Illusion (RHI) in Patients With CRPS|Comparable Induction of the Rubber Hand Illusion (RHI) in Complex Regional Pain Syndrome Type 1 (CRPS 1) and Healthy Subjects|Completed||N/A|69|Actual|Ruhr University of Bochum|||3||f||||f||||||||||2017-10-11 02:51:07.279127|2017-10-11 02:51:07.279127
NCT01618565|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2013-03-08|||April 2012||2012-04-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Objective Structured Assessment of Technical Skills (OSATS) Evaluation of Shoulder Dystocia Management|Objective Structured Assessment of Technical Skills (OSATS) Evaluation of Theoretical Versus Hands-On Training of Shoulder Dystocia Management: a Randomized Trial|Completed||Phase 3|203|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-11 02:51:07.392825|2017-10-11 02:51:07.392825
NCT01618552|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-11-30|||April 2013||2013-04-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Training Doctors to Support Patient Self-Care of Depression|Physician Training to Support Patient Self-Efficacy for Depression Care Behaviors|Completed||N/A|182|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 02:51:07.498965|2017-10-11 02:51:07.498965
NCT01618539|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-03-10|||June 2012|Actual|2012-06-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Correlation of Bispectral Index Score and Total Intravenous Anesthesia (TIVA)|A Prospective Study to Establish a Correlation Between Infusion Rate of Propofol and Bispectral Index (BIS) in Patients Receiving Total Intravenous Anesthesia (TIVA)|Terminated||N/A|31|Actual|Rutgers, The State University of New Jersey|||1|PI retired prior to final N number reached|f||||f||||||||No||2017-10-11 02:51:07.636381|2017-10-11 02:51:07.636381
NCT01618526|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-05-28|||April 2012||2012-04-01|August 2013|2013-08-01|May 2015|Actual|2015-05-01|December 2013|Actual|2013-12-01||Interventional|||ButCoIns GUTS: - Gut Immunological Effects of Resistant Starch and Arabinoxylans in Subjects With Metabolic Syndrome|ButCoIns GUTS: - Gut Immunological Effects of Resistant Starch and Arabinoxylans in Subjects With Metabolic Syndrome|Completed||N/A|22|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 02:51:07.725137|2017-10-11 02:51:07.725137
NCT01618513|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-01-25|||June 2012|Actual|2012-06-01|December 2014|2014-12-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target|Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target|Completed||Phase 4|84|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 02:51:07.952509|2017-10-11 02:51:07.952509
NCT01618500|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-11|||January 2012||2012-01-01|June 2012|2012-06-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||Computerised Testing of Cognitive Response to Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure Hydrocephalus|Computerised Testing of Cognitive Response to Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure Hydrocephalus|Unknown status|Recruiting|N/A|80|Anticipated|Umeå University|||1||f||||f||||||||||2017-10-11 02:51:08.046448|2017-10-11 02:51:08.046448
NCT01618487|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-04-14|||February 2012||2012-02-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Comparison of Surgical Interventions for Lateral Epicondylitis: A Prospective Study|Comparison of Surgical Interventions for Lateral Epicondylitis: A Randomized, Prospective Study|Recruiting||Phase 2|150|Anticipated|Christine M. Kleinert Institute for Hand and Microsurgery||3|||f||||f||||||||||2017-10-11 02:51:08.145115|2017-10-11 02:51:08.145115
NCT01618474|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2015-12-21|||May 2012||2012-05-01|May 2012|2012-05-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients|A Phase II Randomized Controlled Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients (IIIb-IIIc)|Unknown status|Enrolling by invitation|Phase 2|100|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 02:51:08.245171|2017-10-11 02:51:08.245171
NCT01618461|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-11|||June 2011||2011-06-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||PictureRx: An Intervention to Reduce Latino Health Disparities (Supplement: Medical Icons)|PictureRx: An Intervention to Reduce Latino Health Disparities (Supplement: Medical Icons)|Completed||N/A|200|Actual|PictureRx, LLC||4|||f||||f||||||||||2017-10-11 02:51:08.34197|2017-10-11 02:51:08.34197
NCT01618448|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-06-01|||July 2012||2012-07-01|January 2013|2013-01-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure|A Multicenter, Double-blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure|Completed||Phase 3|85|Actual|Taiwan Otsuka Pharm. Co., Ltd||2|||f||||f||||||||||2017-10-11 02:51:08.433894|2017-10-11 02:51:08.433894
NCT01618435|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-09-05|||March 2012||2012-03-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|June 2013|Actual|2013-06-01||Interventional|IVANOS||The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Spondylodesis Operation in the Elderly With Spinal Stenosis Due to Degenerative Spondylolisthesis|The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Spondylodesis Operation|Active, not recruiting||Phase 3|108|Anticipated|Sygehus Lillebaelt||2|||f||||f||||||||||2017-10-11 02:51:08.531844|2017-10-11 02:51:08.531844
NCT01618422|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2015-11-03|2015-09-01||March 2009||2009-03-01|November 2015|2015-11-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|||Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou|A Randomized, Parallel, Controlled Study to Evaluate the Role of Directly Observed Therapy Short Course-Plus (DOTS-Plus) Versus DOTS for Retreatment of Relapsed Pulmonary TB in Guangzhou.|Completed||N/A|225|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:51:08.64195|2017-10-11 02:51:08.64195
NCT01618409|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-11|||March 2011||2011-03-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||PictureRx: An Intervention to Reduce Latino Health Disparities|PictureRx: An Intervention to Reduce Latino Health Disparities|Completed||N/A|200|Actual|PictureRx, LLC||2|||f||||f||||||||||2017-10-11 02:51:08.994042|2017-10-11 02:51:08.994042
NCT01618396|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-12|||March 2011||2011-03-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effects of Sedatives on Sublingual Microcirculation of Patients With Septic Shock|Effects of Sedatives on Sublingual Microcirculation of Patients With Septic Shock|Completed||N/A|16|Actual|Casa de Saúde São José||1|||f||||f||||||||||2017-10-11 02:51:09.075021|2017-10-11 02:51:09.075021
NCT01618383|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-11-30|||March 2012||2012-03-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|EnteroLarc||Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation|Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation|Terminated||N/A|19|Actual|Nantes University Hospital||1||Lack of patients|f||||t||||||||||2017-10-11 02:51:09.157904|2017-10-11 02:51:09.157904
NCT01618370|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-03-30|||July 22, 2012|Actual|2012-07-22|March 2017|2017-03-01|February 28, 2016|Actual|2016-02-28|August 13, 2014|Actual|2014-08-13||Interventional|||Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases|Radium-223 Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases|Completed||Phase 3|705|Actual|Bayer||1|||f||||f||||||||||2017-10-11 02:51:09.288793|2017-10-11 02:51:09.288793
NCT01618357|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-09-21|||September 2012||2012-09-01|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Pre-Operative Radiation and Veliparib for Breast Cancer|Pre-Operative PARPi and Irradiation (POPI) in Women With an Incomplete Response to Neo-Adjuvant Chemotherapy for Breast Cancer|Recruiting||Phase 1|44|Anticipated|Indiana University||1|||f||||t|t|f||||||||2017-10-11 02:51:10.207799|2017-10-11 02:51:10.207799
NCT01618331|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2014-06-04|||March 2012||2012-03-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|FSHD||Protein Supplementation and Exercise in Patients With FSH Muscular Dystrophy- a Randomized Placebo Controlled Study|The Effect of Protein Supplementation Doing Regular Exercise in Patients With Facioscapulohumeral Muscular Dystrophy - a Blinded RCT Study|Completed||N/A|42|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-11 02:51:10.468891|2017-10-11 02:51:10.468891
NCT01618318|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2013-12-04|||June 2012||2012-06-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|GLAAS||Glasgow Asthma and Allergy Study|Cross Sectional Study to Evaluate and Associate Clinical and Laboratory Features of People With Allergic and Non-allergic Asthma|Completed||N/A|105|Actual|National Services for Health Improvement Ltd|||1||f||||f||||||||||2017-10-11 02:51:10.559923|2017-10-11 02:51:10.559923
NCT01618305|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-08-11|||July 2013||2013-07-01|August 2017|2017-08-01|July 2019|Anticipated|2019-07-01|August 2018|Anticipated|2018-08-01||Interventional|||Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission|A Phase IV Randomized Trial to Evaluate the Virologic Response and Pharmacokinetics of Two Different Potent Regimens in HIV Infected Women Initiating Triple Antiretroviral Regimens Between 20 and 36 Weeks of Pregnancy for the Prevention of Mother-to-Child Transmission: NICHD P1081|Recruiting||Phase 4|394|Anticipated|Westat||2|||f||||t||||||||||2017-10-11 02:51:10.652355|2017-10-11 02:51:10.652355
NCT01618292|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2014-01-27|||January 2007||2007-01-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy|Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy|Completed||N/A|393|Actual|Atlantic Health System|||1||f||||t||||||||||2017-10-11 02:51:10.868114|2017-10-11 02:51:10.868114
NCT01618279|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-04-07|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Tryptase and Coronary Heart Disease|Evaluation of Tryptase as a Biomarker of Coronary Heart Disease|Active, not recruiting||N/A|350|Actual|Niguarda Hospital|||1||f||||f||||||Samples Without DNA|"     Venous blood   "|||2017-10-11 02:51:10.96614|2017-10-11 02:51:10.96614
NCT01618266|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2016-02-16|2016-01-13||November 2011||2011-11-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|April 2013|Actual|2013-04-01||Observational|||Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion||Completed||N/A|375|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:51:11.076827|2017-10-11 02:51:11.076827
NCT01618253|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-09-04|||June 2012||2012-06-01|September 2013|2013-09-01|June 2016|Anticipated|2016-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma|Phase I Study of Radiation Therapy With Concurrent Sorafenib for Hepatocellular Carcinoma Not Responding to Transarterial Chemoembolization|Withdrawn||Phase 1|0|Actual|Medical College of Wisconsin||1||Closed due to poor accrual.|f||||t||||||||||2017-10-11 02:51:11.502039|2017-10-11 02:51:11.502039
NCT01618240|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-10-02|2013-05-21||January 2011||2011-01-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational||30 long-term ventilated subjects were included (ventilated > 10 days). Subjects had a Richmond Agitation Sedation score of >0, had no delirium, had no abnormalities of the larynx or pharynx, and no history of chemotherapy or radiotherapy to the head/ neck, or of degenerative neurological disease.|Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients|Determining Predictors of Adequate Upper Airway Function in Long-term Ventilated Patients|Completed||N/A|30|Actual|Massachusetts General Hospital|||1||f||||t||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 02:51:11.634929|2017-10-11 02:51:11.634929
NCT01618227|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-02-02|2016-12-06||September 2008||2008-09-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Rehabilitation With or Without Static Progressive Splinting for Wrist Stiffness|A Prospective Randomized Trial of Rehabilitation With or Without Static Progressive Splinting for Wrist Stiffness|Terminated||N/A|4|Actual|Massachusetts General Hospital||2||"Due to a lack of resources and the principal investigator leaving the institution, we stopped   the study prior to reaching enrollment target."|f||||f||||||||||2017-10-11 02:51:11.846488|2017-10-11 02:51:11.846488
NCT01618214|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-01-10|2014-01-30||June 2012||2012-06-01|January 2017|2017-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes|A 20-week, Randomised, Open-label, 2-armed, Parallel Group Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes Inadequately Controlled With Premixed Human Insulin|Completed||Phase 4|344|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:51:12.235335|2017-10-11 02:51:12.235335
NCT01618201|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2012-06-12|||June 2012||2012-06-01|September 2009|2009-09-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Inflammatory Markers Identification in Migraine Patients|Inflammatory Markers Identification in Migraine Patients|Unknown status|Not yet recruiting|N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center|||4||f||||f||||||||||2017-10-11 02:51:12.929009|2017-10-11 02:51:12.929009
NCT01618188|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-01-16|||June 2012||2012-06-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes|Completed||Phase 1|52|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 02:51:12.99815|2017-10-11 02:51:12.99815
NCT01618175|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2012-06-12|||October 2012||2012-10-01|May 2012|2012-05-01|August 2014|Anticipated|2014-08-01|June 2013|Anticipated|2013-06-01||Interventional|||Home Oxygen Treatment of Childhood Acute Bronchiolitis||Unknown status|Not yet recruiting|N/A|85|Anticipated|Soroka University Medical Center||1|||f||||||||||||||2017-10-11 02:51:13.088255|2017-10-11 02:51:13.088255
NCT01618162|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-03-24|2016-12-20|2013-11-07|August 2012||2012-08-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|DUAL™IV|Full analysis set (FAS) included all randomized subjects.|The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy|The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy|Completed||Phase 3|435|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:51:13.214954|2017-10-11 02:51:13.214954
NCT01618149|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2012-06-12|||July 2012||2012-07-01|June 2012|2012-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||Use Quantitative Microradiography to Predict the Periprosthetic Bone Loss in Distal Femur After Total Knee Arthroplasty|Use Dual-energy X-ray Absorptiometry and Quantitative Microradiography to Predict the Periprosthetic Bone Loss in Distal Femur After Total Knee Arthroplasty|Unknown status|Not yet recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     A 2X1X0.5cm bone fragment harvested during the chamfer cut of total knee arthroplasty   "|||2017-10-11 02:51:13.984069|2017-10-11 02:51:13.984069
NCT01618136|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-11-15|||January 2012||2012-01-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors|An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors|Completed||Phase 1/Phase 2|41|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-11 02:51:14.090094|2017-10-11 02:51:14.090094
NCT01618123|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2016-10-19|||October 2012||2012-10-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Association of Endothelial Function and Clinical Outcomes in Subjects Admitted to Chest Pain Unit|The Impact of Short- and Long-term Endothelial Function Assessment by Peripheral Arterial Tonometry (PAT) on Clinical Outcome in Subjects Admitted to Chest Pain Unit (CPU)|Active, not recruiting||N/A|300|Anticipated|Sheba Medical Center|||1||f||||f||||||||No||2017-10-11 02:51:14.193712|2017-10-11 02:51:14.193712
NCT01618110|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2012-06-18|||July 2012||2012-07-01|June 2012|2012-06-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders|Transcranial Magnetic Stimulation of the Pre-Frontal Cortex in the Treatment of Attention Deficit/Hyperactivity Disorders: A Randomized, Controlled, Double Blind Study.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Shalvata Mental Health Center||2|||f||||f||||||||||2017-10-11 02:51:14.289647|2017-10-11 02:51:14.289647
NCT01618097|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-03-04|||January 2012||2012-01-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Evaluation of DVD and Internet Decision Aids for Hip and Knee Osteoarthritis: Focus on Health Literacy|Evaluation of DVD and Internet Decision Aids for Hip and Knee Osteoarthritis: Focus on Health Literacy|Completed||N/A|155|Actual|Duke University||2|||f||||f||||||||||2017-10-11 02:51:14.399682|2017-10-11 02:51:14.399682
NCT01618084|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-06-11|||November 2011||2011-11-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|RSA||RSA Study Using Two Types of Uncemented Acetabular Components and the Uncemented HA Coated Symax Stem|A Prospective Randomised Rontgen Stereophotogrammatic Analysis (RSA) Study Using the Uncemented Trident Tritanium Acetabular Component and the Uncemented HA Coated Symax Hip Stem in a Single Centre: Assessment of Implant Migration, Bone Remodeling and Clinical Function|Unknown status|Recruiting|Phase 4|50|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 02:51:14.498481|2017-10-11 02:51:14.498481
NCT01618071|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2012-10-10|||June 2012||2012-06-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Vascular Effects of Triglyceride-rich Lipoproteins|Unravelling the Mechanisms of Vascular Protection by n3-PUFAs to Optimise and Support Their Use as Bioactives by the Food Industry|Completed||N/A|16|Anticipated|King's College London||4|||f||||f||||||||||2017-10-11 02:51:14.601728|2017-10-11 02:51:14.601728
NCT01618058|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-08-25|||June 2012||2012-06-01|August 2012|2012-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials|A Long-Term Observational Cohort Study of HIV Infection in Participants Who Seroconvert After Enrolment in Dapivirine Vaginal Ring Trials|Completed||N/A|68|Actual|International Partnership for Microbicides, Inc.|||2||f||||t||||||||||2017-10-11 02:51:14.718593|2017-10-11 02:51:14.718593
NCT01618045|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-11|2017-01-20|||May 2012||2012-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|FPPT2DM-II||Nutritional Regulation of Wound Inflammation: Part II|Nutritional Regulation Of Wound Inflammation: Part II|Active, not recruiting||N/A|25|Anticipated|Ohio State University|||1||f||||f||||||Samples Without DNA|"     Blood will be drawn for the study.   "|||2017-10-11 02:51:14.801537|2017-10-11 02:51:14.801537
NCT01618032|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2012-11-30|||November 2010||2010-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Two Techniques of Mobilization in the Dorsiflexion on Patients With Chronic Ankle Instability|The Effects of Two Techniques of Mobilization in the Improvement of Dorsiflexion on Chronic Instability Ankles. A Double Blind Randomized Controlled Trial|Completed||N/A|52|Actual|CEU San Pablo University||3|||f||||t||||||||||2017-10-11 02:51:14.885194|2017-10-11 02:51:14.885194
NCT01618019|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2012-08-30|2012-06-17||November 2010||2010-11-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||N-3 PUFA and Rheumatoid Arthritis in Korea|Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Patients With Rheumatoid Arthritis|Completed||N/A|109|Actual|Hanyang University||2|||f||||f||||||||||2017-10-11 02:51:14.963951|2017-10-11 02:51:14.963951
NCT01618006|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2015-03-18|||January 2012||2012-01-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|ASACABG||Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery|Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery|Completed||Phase 2|120|Actual|Hamilton Health Sciences Corporation||3|||f||||f||||||||||2017-10-11 02:51:15.419109|2017-10-11 02:51:15.419109
NCT01617993|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2014-01-09|||June 2012||2012-06-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|CAS||Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting|Eeva Continued Access Study.|Completed||N/A|31|Actual|Progyny, Inc.|||1||f||||f||||||||||2017-10-11 02:51:15.685788|2017-10-11 02:51:15.685788
NCT01617980|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-03-14|||April 2012||2012-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|HIL||Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer||Terminated||N/A|4|Actual|German Cancer Research Center||1||Slow accrual|f||||f||||||||||2017-10-11 02:51:15.801112|2017-10-11 02:51:15.801112
NCT01617967|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-07-13||2017-06-02|May 2012||2012-05-01|July 2017|2017-07-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis|A Phase 2, Open-Label, Multi-Dose, Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Infusions of ALN-TTR02 in Patients With TTR Amyloidosis|Completed||Phase 2|29|Actual|Alnylam Pharmaceuticals||1|||||||f|t|||||||||2017-10-11 02:51:15.888107|2017-10-11 02:51:15.888107
NCT01617954|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-01-28|||May 2012||2012-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PROMIS||PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score|PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score|Completed||N/A|820|Actual|Agendia|||1||f||||f||||||Samples With DNA|"     Patients have the option to agree to the storage of excess samples at Agendia.   "|||2017-10-11 02:51:16.011139|2017-10-11 02:51:16.011139
NCT01617941|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2017-04-19|||May 2016||2016-05-01|September 2014|2014-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention|A Multi-center, Randomized, Double-blind, Parallel Group, Placebo Controlled, Study in Patients With Non-chronic Migraine to Assess the Efficacy, Safety and Tolerability of BID Oral Doses of BGG492 in Migraine Prevention.|Withdrawn||Phase 2|0|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:51:16.246975|2017-10-11 02:51:16.246975
NCT01617928|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2013-07-09|||May 2012||2012-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors|A Phase 1 Study of Veliparib (ABT-888) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Solid Tumors|Completed||Phase 1|12|Actual|AbbVie||1|||f||||t||||||||||2017-10-11 02:51:16.333736|2017-10-11 02:51:16.333736
NCT01617915|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-10|2017-05-08|||October 2012||2012-10-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Tumor Specific Plasma DNA|Tumor Specific Plasma DNA|Active, not recruiting||N/A|6|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||||2017-10-11 02:51:16.431632|2017-10-11 02:51:16.431632
NCT01617876|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-09|2012-06-09|||March 2010||2010-03-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Observational|||Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer|A Prospective Study on the Accuracy of Enhanced Magnifying Endoscopy for Differential Diagnosis of Small Focal Gastric Lesions Identified With White-light Endoscopy|Completed||N/A|282|Actual|Peking Union Medical College Hospital|||1||f||||f||||||Samples Without DNA|"     Biopsy of gastric lesions   "|||2017-10-11 02:51:16.738219|2017-10-11 02:51:16.738219
NCT01617863|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2012-07-02|||June 2012||2012-06-01|June 2012|2012-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Hemodynamics During the Soccer Championship 2012|Central Hemodynamics, Arterial Stiffness, Heartrate and Endothelial Dysfunktion During the European Soccer Championship 2012|Completed||N/A|180|Anticipated|University of Schleswig-Holstein|||1||f||||f||||||Samples Without DNA|"     EDTA-Blood, Serum   "|||2017-10-11 02:51:16.853832|2017-10-11 02:51:16.853832
NCT01617850|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-05-21|||April 2011||2011-04-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy of Physical Exercise in Cardiac Rehabilitation||Completed||N/A|70|Anticipated|Aarhus University Hospital Skejby||2|||f||||f||||||||||2017-10-11 02:51:16.936277|2017-10-11 02:51:16.936277
NCT01617837|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-09|2013-09-17|||November 2011||2011-11-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy|The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy. - a Randomized, Double-blinded, Placebo Controlled Study.|Completed||Phase 2/Phase 3|80|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 02:51:17.061191|2017-10-11 02:51:17.061191
NCT01617824|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2014-12-18|||September 2012||2012-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes|Rapid Effects of the DPP-4 Inhibitor Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetic Patients With and Without Chronic Renal Failure. A Randomized Cross-over Trial Versus Placebo|Completed||Phase 4|45|Actual|University of Padova||2|||f||||f||||||||||2017-10-11 02:51:17.209256|2017-10-11 02:51:17.209256
NCT01617811|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-09|||August 2007||2007-08-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Epidural Anesthesia and Analgesia on Patients' Outcomes After Liver Resection|Effects of Epidural Anesthesia and Analgesia on Postoperative Metabolic, Immune Function and Hemodynamic Changes of Open Liver Resection|Completed||N/A|26|Actual|Sir Run Run Shaw Hospital||1|||f||||t||||||||||2017-10-11 02:51:17.304939|2017-10-11 02:51:17.304939
NCT01617798|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-06-26|||June 2012||2012-06-01|June 2012|2012-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|SHUM||Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis|Stop Hypernatremia, Use Metolazone for Aggressive, Controlled, Effective Diuresis|Unknown status|Recruiting|N/A|54|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 02:51:17.390325|2017-10-11 02:51:17.390325
NCT01617785|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2013-08-13|||December 2011||2011-12-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|PEACE3VD||PEACE Prospective Study of Patients With Three-vessel Disease|Patient-centered Evaluative Assessment of Cardiac Events (PEACE): Prospective Study of Patients With Three-vessel Coronary Heart Disease|Unknown status|Recruiting|N/A|4500|Anticipated|China National Center for Cardiovascular Diseases|||3||f||||t||||||||||2017-10-11 02:51:17.509307|2017-10-11 02:51:17.509307
NCT01617772|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-04-30|||January 1, 2016|Actual|2016-01-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|NALCAT||Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis|Comparison the Effectiveness of L-Carnitine With Atorvastatin in Non-Alcoholic Steatohepatitis (NASH)|Recruiting||Phase 2|440|Anticipated|Tehran University of Medical Sciences||4|||f||||t||||||||||2017-10-11 02:51:17.611412|2017-10-11 02:51:17.611412
NCT01617759|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-05-05|||September 2007||2007-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Aspergillus-specific PCR Assay in Cerebrospinal Fluid Samples for Detection of Central Nervous System Aspergillosis|Diagnostic Study on the Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis|Enrolling by invitation||N/A|200|Anticipated|Heidelberg University|||1||f||||f||||||Samples With DNA|"     fungal DNA from CSF samples   "|||2017-10-11 02:51:17.72942|2017-10-11 02:51:17.72942
NCT01617746|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-06-10|||November 2012||2012-11-01|June 2012|2012-06-01|December 2015|Anticipated|2015-12-01|May 2014|Anticipated|2014-05-01||Interventional|||Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma|Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma|Unknown status|Not yet recruiting|Phase 2|18|Anticipated|University of Glasgow||3|||f||||f||||||||||2017-10-11 02:51:17.815039|2017-10-11 02:51:17.815039
NCT01617733|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-11-01|||March 2011||2011-03-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Pasireotide Therapy in Patients With Nelson's Syndrome|An Open Label, Longitudinal Study of the Effects of Subcutaneous Acute and Chronic Pasireotide (som230) Therapy on Adrenocorticotrophic Hormone and Tumour Volume in Patients With Nelson's Syndrome|Terminated||Phase 2|8|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1||Inadequate patient recruitment|f||||t||||||||||2017-10-11 02:51:17.985192|2017-10-11 02:51:17.985192
NCT01617720|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-06-29|||May 2012||2012-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|MITRAFIT||MITRAFIT- Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)|MITRAFIT Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)|Completed||N/A|45|Actual|Valtech Cardio Ltd|||1||f||||t||||||||||2017-10-11 02:51:18.107202|2017-10-11 02:51:18.107202
NCT01617707|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2014-03-04|||June 2012||2012-06-01|March 2014|2014-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Safe and Effective Sedation in Chronic Alcoholic Patients Underwent Diagnostic Endoscopic Procedures: Study Comparing Midazolam and Propofol With Midazolam|Safe and Effective Sedation in Chronic Alcoholic Patients Underwent Diagnostic Endoscopic Procedures: a Prospective, Randomized Study Comparing Midazolam and Propofol With Midazolam|Unknown status|Recruiting|N/A|56|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 02:51:18.188677|2017-10-11 02:51:18.188677
NCT00005200|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1987||1987-07-01|April 2000|2000-04-01|June 1991|Actual|1991-06-01|||||Observational|||Adolescent Blood Pressure Variation and Ventricular Mass||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.426268|2017-10-11 04:26:37.426268
NCT01617681|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-08-28|2017-07-24||November 8, 2012|Actual|2012-11-08|August 2017|2017-08-01|January 24, 2017|Actual|2017-01-24|January 24, 2017|Actual|2017-01-24||Interventional|||Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD|A 6 Week, Randomized, Multicenter, Double-blind, Double-dummy Study to Evaluate the Dose Response of Valsartan on Blood Pressure Reduction in Children 1-5 Years Old With Hypertension, With or Without Chronic Kidney Disease, Followed by a 20 Week Open-label Titration Phase|Completed||Phase 3|127|Actual|Novartis||3|||f||||f|f|f||||||||2017-10-11 02:51:18.411065|2017-10-11 02:51:18.411065
NCT01617668|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-08-30|2015-09-18||August 2012||2012-08-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||The Full Analysis Set (FAS) was composed of all patients who received at least one full or partial dose of LCL161 + paclitaxel or one full or partial dose of paclitaxel alone.|A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer|A Phase II Multi-center, Open-label, Neoadjuvant, Randomized Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer|Completed||Phase 2|209|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:51:19.169368|2017-10-11 02:51:19.169368
NCT01617655|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-09-27|2015-08-20|2015-02-09|June 2012||2012-06-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of SAR236553/REGN727 in Patients With Heterozygous Familial Hypercholesterolemia and LDL-C Higher or Equal to 160mg/dL With Their Lipid-Modifying Therapy|Completed||Phase 3|107|Actual|Sanofi|"Manual reclassification was done by the Sponsor for the other reasons of non-completion of study as specified in the electronic case report form (eCRF)."|2|||f||||t||||||||||2017-10-11 02:51:20.67893|2017-10-11 02:51:20.67893
NCT01617642|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-08|||July 2012||2012-07-01|June 2012|2012-06-01|December 2021|Anticipated|2021-12-01|August 2017|Anticipated|2017-08-01||Observational|||Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)|Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)|Not yet recruiting||N/A|150|Anticipated|Nordlandssykehuset HF|||2||f||||f||||||Samples With DNA|"     Serum and plasma. Urine samples. Pax tubes for RNA/DNA samples.   "|||2017-10-11 02:51:22.166555|2017-10-11 02:51:22.166555
NCT01617629|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-04-04|||December 2011||2011-12-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CAN-003X||Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study|An Open-Label Safety Trial of Cvac (Autologous Dendritic Cells Pulsed With Recombinant Human Fusion Protein Coupled to Oxidized Polymannose) for Epithelial Ovarian Cancer Patients Who Have Progressed During the CAN-003 Study|Completed||Phase 2|9|Actual|Prima BioMed Ltd||1|||f||||t||||||||||2017-10-11 02:51:22.272107|2017-10-11 02:51:22.272107
NCT01617616|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-04-18|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|February 12, 2014|Actual|2014-02-12|February 12, 2014|Actual|2014-02-12||Observational|POTS||Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects|Tilt Table and Autonomic Testing in Suspected POTS Subjects|Completed||N/A|48|Actual|Wake Forest University Health Sciences|||4||f||||t|f|f||||||||2017-10-11 02:51:22.385117|2017-10-11 02:51:22.385117
NCT01617603|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2013-07-05|2013-04-02||April 2009||2009-04-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||A Comparison Chocolate With and Without High Cocoa Solids in Patients With Type 2 Diabetes in a Randomised Clinical Trial||Completed||N/A|62|Actual|Nestlé||3|||f||||t||||||||||2017-10-11 02:51:22.489701|2017-10-11 02:51:22.489701
NCT01617590|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2012-06-12|||May 2012||2012-05-01|June 2012|2012-06-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|DCCT||Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research|A 48-week, Multi-center, Randomized, Open-lable, Controlled Study to Assess the Response (ACR20) Using Different Disease-Modifying Antirheumatic Drugs Cycle Combination Regimen in Adult Patients With Active Rheumatoid Arthritis|Unknown status|Recruiting|N/A|500|Anticipated|Shanxi Medical University||2|||f||||t||||||||||2017-10-11 02:51:22.838297|2017-10-11 02:51:22.838297
NCT01617577|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2012-11-26|2012-06-29||June 2009||2009-06-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|FFAD||Efficacy and Safety of Filgrastim in Alzheimer's Disease|Efficacy and Safety of Filgrastim as a Pro‐Cognitive Agent in Alzheimer's Disease|Completed||Phase 1/Phase 2|8|Actual|University of South Florida||2|||f||||t||||||||||2017-10-11 02:51:22.951644|2017-10-11 02:51:22.951644
NCT01617564|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-05-15|||May 2012||2012-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Paracervical Block During II-trimester Abortion|Paracervical Block (PCB) During II-trimester Abortion- A Randomized Controlled Trial|Completed||N/A|112|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:51:23.319868|2017-10-11 02:51:23.319868
NCT01617551|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-03-01|||March 2012||2012-03-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|RENO||Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones|Effect of Renal Denervation on NO-mediated Regulation of Salt- and Water Excretion, Vasoactive Hormones and Tubular Transport Proteins in Patients With Resistant Hypertension|Unknown status|Recruiting|N/A|30|Anticipated|Regional Hospital Holstebro||2|||f||||f||||||||||2017-10-11 02:51:23.407229|2017-10-11 02:51:23.407229
NCT01617538|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-06-11|||January 2012||2012-01-01|June 2012|2012-06-01|September 2013|Anticipated|2013-09-01|March 2013|Anticipated|2013-03-01||Interventional|||Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis|Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis After 24-week Atorvastatin Treatment|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Capital Medical University||2|||f||||f||||||||||2017-10-11 02:51:23.512968|2017-10-11 02:51:23.512968
NCT01617525|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2016-05-10|||January 2012||2012-01-01|May 2016|2016-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Comparison of the Effects on Cardiovascular Risk Factors of Korean and American Dietary Profiles|A Comparison of the Effects on Cardiovascular Risk Factors of Korean and American Dietary Profiles|Completed||N/A|29|Actual|USDA Beltsville Human Nutrition Research Center||3|||f||||f||||||||||2017-10-11 02:51:23.638548|2017-10-11 02:51:23.638548
NCT01617512|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-04-10|||February 2012||2012-02-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Study Accelerometer Signals to Measure Daily Activities (SASMDA)|Study Accelerometer Signals to Measure Daily Activities: a Pilot Study|Completed||N/A|30|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 02:51:23.728537|2017-10-11 02:51:23.728537
NCT01617473|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-09-27|||October 2015||2015-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Randomized Trial of Mobilized Blood/Marrow Versus Blood Transplant|Randomized Trial of Unmanipulated Mobilized Blood/Marrow Versus Blood Haploidentical Transplant With Standard-risk Leukemia|Withdrawn||N/A|0|Actual|Peking University People's Hospital||2||patients' reluctance|f||||||||||||||2017-10-11 02:51:23.966479|2017-10-11 02:51:23.966479
NCT01617447|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-02-28|2017-01-04||July 2012||2012-07-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder|A Short-term Administration Study of Aripiprazole in Children and Adolescents (Age: 6 to 17 Years) With Autistic Disorder|Completed||Phase 3|92|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:51:24.139306|2017-10-11 02:51:24.139306
NCT01617434|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-01-25|2014-10-22||September 2012||2012-09-01|January 2017|2017-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes|The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes|Completed||Phase 3|451|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:51:26.180507|2017-10-11 02:51:26.180507
NCT01617421|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-06-30|||May 29, 2012||2012-05-29|April 25, 2017|2017-04-25|January 3, 2017|Actual|2017-01-03|January 3, 2017|Actual|2017-01-03||Interventional|||Yoga as Self-Care for Arthritis in Minority Communities|Pilot Study of Yoga as Self-Care for Arthritis in Minority Communities|Completed||Phase 1|37|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:51:27.052432|2017-10-11 02:51:27.052432
NCT01617408|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-10-05|||May 17, 2012||2012-05-17|September 27, 2017|2017-09-27||||||||Observational|||Brain Stimulation and Vision Testing|TMS Investigations of the Human Visual System|Recruiting||N/A|345|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:51:27.169508|2017-10-11 02:51:27.169508
NCT01617395|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-09-26|||April 27, 2012||2012-04-27|September 18, 2017|2017-09-18||||||||Observational|||Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility|Integrating Genetic and Environmental Risk Scores Into an Algorithm to Predict Multiple Sclerosis Susceptibility|Recruiting||N/A|2080|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:51:27.294689|2017-10-11 02:51:27.294689
NCT01617382|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-07-28|||May 2012||2012-05-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|HIPEC||Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed|Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed|Recruiting||N/A|125|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||No||2017-10-11 02:51:27.392871|2017-10-11 02:51:27.392871
NCT01617369|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-04-28|2017-02-15||June 2012||2012-06-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Healthy subjects of any ethnicity between 18-55 years of age, without respiratory or cardiac comorbidities, FEV1 greater than or equal to 80% predicted, FEV1/FVC ratio greater than 70%, non-pregnant female subjects, and subjects who are capable of providing their written informed consent.|Study to Characterize the Durability of Hypertonic Saline to Enhance Mucociliary Clearance in Healthy Subjects|A Study to Characterize the Durability of Hypertonic Saline for the Enhancement of Mucociliary Clearance in Healthy Subjects|Completed||N/A|12|Actual|University of North Carolina, Chapel Hill||2|||f||||f|f|t||||||No||2017-10-11 02:51:27.51205|2017-10-11 02:51:27.51205
NCT01617356|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-03-08|||June 2012||2012-06-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection|Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection: A Randomised Clinical Trial of Efficacy|Unknown status|Enrolling by invitation|Phase 2/Phase 3|42|Anticipated|Frusso, Ricardo, M.D.||2|||f||||t||||||||||2017-10-11 02:51:27.748567|2017-10-11 02:51:27.748567
NCT01617343|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-04-07|||August 2012||2012-08-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients|The HEP-OKS Pilot Study - a Randomized Controlled Trial of Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients|Completed||Phase 3|23|Actual|University of Luebeck||2|||f||||f||||||||||2017-10-11 02:51:27.851074|2017-10-11 02:51:27.851074
NCT01617330|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-11|||March 2001||2001-03-01|June 2012|2012-06-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|DALLER||Controlled Exposure to Diesel Exhaust in Subjects With Allergic Rhinitis|Controlled Exposure to Diesel Exhaust in Subjects With Allergic Rhinitis|Completed||N/A|14|Actual|University Hospital, Umeå||2|||f||||f||||||||||2017-10-11 02:51:27.94501|2017-10-11 02:51:27.94501
NCT01617317|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-02|2012-06-07|||January 2010||2010-01-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Interventional|||H-IVIG Treatment for Severe H1N1 2009|Hyperimmune Intravenous Immunoglobulin Treatment for Severe H1N1 2009 Infection|Completed||N/A|34|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 02:51:28.061264|2017-10-11 02:51:28.061264
NCT01617304|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-01-08|||December 2011||2011-12-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|Age-2||Effects of Food Cooking on Diabetes-2 Risk Factors||Completed||N/A|100|Anticipated|University of Copenhagen||4|||f||||t||||||||||2017-10-11 02:51:28.21771|2017-10-11 02:51:28.21771
NCT01617291|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2014-02-12|||March 2013||2013-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Therapeutic Hypothermia After the Return of Spontaneous Circulation|Induction of Therapeutic Hypothermia in the Pre-hospital Setting After the Return on Spontaneous Circulation: A Randomized Controlled Study|Terminated||N/A|46|Actual|University of California, San Francisco||2||A similar study was recently published with definitive results.|f||||t||||||||||2017-10-11 02:51:28.337597|2017-10-11 02:51:28.337597
NCT01617278|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-07-03|||January 2012||2012-01-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||I-Scan Versus High-definition White Light|A Randomized Controlled Trial Comparing High-definition White Light Colonoscopy to I-Scan Enhanced Colonoscopy for Adenoma Detection in a Population at Increased Risk of Colorectal Cancer. (A Pilot Study)|Completed||N/A|150|Actual|University of Calgary||3|||f||||f||||||||||2017-10-11 02:51:28.434128|2017-10-11 02:51:28.434128
NCT01617265|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-08-25|||June 2012||2012-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|AWARE||Study of a Strategy to Prevent Oversedation in Intensive Care Patients Under Mechanical Ventilation|Prevention of Oversedation in Intensive Care Patients Under Mechanical Ventilation : the AWARE Multicentric Randomized Trial|Completed||N/A|1180|Actual|French Society for Intensive Care||2|||f||||t||||||||||2017-10-11 02:51:28.547662|2017-10-11 02:51:28.547662
NCT01617252|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-09-11|||June 2011||2011-06-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Optiflow||High Flow Nasal Oxygen Therapy for Hypoxemy After Cardiac Surgery|High Flow Nasal Oxygen Therapy for Hypoxemy After Cardiac Surgery|Completed||N/A|90|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 02:51:28.863754|2017-10-11 02:51:28.863754
NCT01617239|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-08-19|||June 2012||2012-06-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine|A Phase I, Open Label, Randomized Study in Healthy Adults to Compare Safety and Immunogenicity of Different Administration Schedules of Virosomal Influenza Vaccine|Completed||Phase 1|84|Actual|Crucell Holland BV||3|||f||||f||||||||||2017-10-11 02:51:28.942508|2017-10-11 02:51:28.942508
NCT01617226|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-05-31|||September 2012||2012-09-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2015|Actual|2015-09-01||Interventional|RAvVA||Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS|Phase II Randomised Trial of 5-azacitidine Versus 5-azacitidine in Combination With Vorinostat in Patients With Acute Myeloid Leukaemia or High Risk Myelodysplastic Syndromes Ineligible for Intensive Chemotherapy|Active, not recruiting||Phase 2|260|Anticipated|University of Birmingham||2|||f||||t||||||||||2017-10-11 02:51:29.05622|2017-10-11 02:51:29.05622
NCT01617200|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-05-26|||December 2012||2012-12-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)|A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine Using Olanzapine as an Active Control in Subjects Diagnosed With Schizophrenia Who Completed Protocol P05688|Completed||Phase 3|105|Actual|Forest Laboratories||4|||f||||f||||||||||2017-10-11 02:51:29.319216|2017-10-11 02:51:29.319216
NCT01617187|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-08-31|2015-07-31||December 4, 2012|Actual|2012-12-04|August 2017|2017-08-01|September 9, 2014|Actual|2014-09-09|August 11, 2014|Actual|2014-08-11||Interventional||All randomized participants who received ≥1 dose of study drug.|A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)|A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-Week Trial of the Efficacy and Safety of Asenapine Compared With Placebo Using Olanzapine as an Active Control in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 3|360|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 02:51:29.683173|2017-10-11 02:51:29.683173
NCT01617174|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2013-11-06|||June 2012||2012-06-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer|Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer|Withdrawn||N/A|0|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 02:51:33.427436|2017-10-11 02:51:33.427436
NCT01617161|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-07-19|||July 2012||2012-07-01|July 2017|2017-07-01|December 2026|Anticipated|2026-12-01|December 2018|Anticipated|2018-12-01||Interventional|PARTIQoL||Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer|Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs IMRT for Low or Intermediate Risk Prostate Cancer|Recruiting||Phase 3|400|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:51:33.497445|2017-10-11 02:51:33.497445
NCT01617135|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-07-25|||May 2012||2012-05-01|July 2017|2017-07-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||"Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and Off Episodes"|"A Randomized, Placebo-Controlled, Phase 2 Study of the Safety, Pharmacokinetics and Pharmacodynamics of CVT-310 (Levodopa Inhalation Powder) in Patients With Parkinson's Disease and Motor Response Fluctuations (Off Episodes)"|Completed||Phase 2|25|Actual|Acorda Therapeutics||4|||f||||f||||||||||2017-10-11 02:51:33.714664|2017-10-11 02:51:33.714664
NCT01617122|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-05|2012-07-16|||October 1995||1995-10-01|July 2012|2012-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|Bacteriophage||Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD)|To Evaluate Bacteriophage OX174 Antigen as a Useful Immunogen in Patients With Immune Deficiency|Unknown status|Recruiting|N/A|200|Anticipated|University of South Florida||1|||f||||f||||||||||2017-10-11 02:51:33.860948|2017-10-11 02:51:33.860948
NCT01617109|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-08-09|||June 2012||2012-06-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|January 2014|Actual|2014-01-01||Interventional|||Optimizing Vitamin D Status During Initial Military Training|Optimizing Vitamin D Status During Initial Military Training: A Randomized, Double-blind, Placebo-controlled Trial|Active, not recruiting||N/A|1400|Anticipated|United States Army Research Institute of Environmental Medicine||2|||f||||f||||||||Undecided||2017-10-11 02:51:33.971353|2017-10-11 02:51:33.971353
NCT01617096|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-09-05||2017-02-02|June 2012|Actual|2012-06-01|September 2017|2017-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ASPIRE||Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring Containing Dapivirine for the Prevention of HIV-1 Infection in Women|Completed||Phase 3|3540|Actual|International Partnership for Microbicides, Inc.||2|||f||||t|t|f||||||||2017-10-11 02:51:34.271238|2017-10-11 02:51:34.271238
NCT01617070|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-11-08|2016-11-08||May 2012||2012-05-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Kuvan on Melatonin Secretion|Pilot Study to Evaluate Melatonin Secretion as a Marker of Decreased Serotonin in Individuals With PKU: Evaluation of the CNS Effects of Tetrahydrobiopterin|Completed||Phase 4|10|Actual|University of Southern California||1|||f||||f||||||||||2017-10-11 02:51:34.640511|2017-10-11 02:51:34.640511
NCT01617057|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-11-24|||May 2012||2012-05-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|March 2016|Actual|2016-03-01||Interventional|OTOPHOS||Therapeutic Efficacy of Tiludronic Acid on Inner Ear Involvement in Advanced Otosclerosis|Therapeutic Efficacy of Tiludronic Acid on Inner Ear Involvement in Advanced Otosclerosis|Terminated||Phase 3|31|Actual|Assistance Publique - Hôpitaux de Paris||2||lack of inclusion|f||||f||||||||No||2017-10-11 02:51:34.991181|2017-10-11 02:51:34.991181
NCT01617044|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-01-19|||May 2012||2012-05-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome|Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome-A Double-blind, Randomized Controlled Study|Completed||Phase 2|61|Actual|Children's Hospitals and Clinics of Minnesota||2|||f||||f||||||||||2017-10-11 02:51:35.120176|2017-10-11 02:51:35.120176
NCT01617018|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-11-11|||July 2012||2012-07-01|November 2015|2015-11-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|PSOBIOTEQ||Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis|French Multicentric Prospective Observational Cohort of Patients Receiving Systemic Treatment for Cutaneous Psoriasis|Recruiting||N/A|2636|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-11 02:51:35.364014|2017-10-11 02:51:35.364014
NCT01617005|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-10-07|2016-10-07||May 2012||2012-05-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational||All participants who were enrolled in the study.|A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)|Non-interventional Local Study to Describe the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-biologic DMARD|Completed||N/A|50|Actual|Hoffmann-La Roche|||1||f||||f||||||||||2017-10-11 02:51:35.47622|2017-10-11 02:51:35.47622
NCT01616992|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-02-02|||September 2009||2009-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|ICEPAC||Interstitial Cystitis: Elucidation of the Psychophysiologic and Autonomic Characteristics (ICEPAC) Study|Interstitial Cystitis: Elucidation of the Psychophysiologic and Autonomic|Completed||N/A|200|Actual|Case Western Reserve University|||4||f||||t||||||||||2017-10-11 02:51:35.745964|2017-10-11 02:51:35.745964
NCT01616979|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-08-16|||March 2008||2008-03-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Observational|||Saline Bag and TEE During Cardiac Displacement|Placing a Saline Bag Underneath the Heart Enhances Transgastric Transoesophageal Echocardiographic Imaging During Cardiac Displacement for Off-pump Coronary Artery Bypass Surgery|Completed||Early Phase 1|13|Actual|Konkuk University Medical Center|||1||f||||t||||||||||2017-10-11 02:51:35.846043|2017-10-11 02:51:35.846043
NCT01616966|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-06-29|||August 2010||2010-08-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Laryngeal Injuries After Removal of the Tracheal Tube: A Comparison Between Sevoflurane and Propofol|Laryngeal Injuries After Removal of the Tracheal Tube: A Comparison Between Anesthesia With Sevoflurane and Intravenous Anesthesia With Propofol A Randomized, Prospective, Controlled Trial|Completed||N/A|65|Actual|University of Rostock||2|||f||||f||||||||||2017-10-11 02:51:35.947567|2017-10-11 02:51:35.947567
NCT01616953|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2017-03-23|2017-03-23||August 2012||2012-08-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Cell Therapy for Craniofacial Bone Defects|Cell Therapy for Craniofacial Bone Defects|Completed||Phase 1/Phase 2|18|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 02:51:36.049845|2017-10-11 02:51:36.049845
NCT01616940|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-03-21|||September 2011||2011-09-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Minority AIDS Initiative Retention and Re-Engagement Project|Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project|Completed||N/A|348|Actual|Boston University||2|||f||||f||||||||||2017-10-11 02:51:36.600954|2017-10-11 02:51:36.600954
NCT01616927|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-05-19|||June 2012||2012-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|DIPAK1||Study of Lanreotide to Treat Polycystic Kidney Disease|The DIPAK 1 Study: A Randomised, Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in ADPKD|Active, not recruiting||Phase 3|300|Anticipated|University Medical Center Groningen||2|||f||||t||||||||||2017-10-11 02:51:36.69456|2017-10-11 02:51:36.69456
NCT01616914|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2013-04-01|||January 2010||2010-01-01|June 2012|2012-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|ZZH-2||Subclinical Delirium and Clinical Outcome|Delirium and Clinical Outcome|Completed||N/A|250|Actual|Jinhua Central Hospital|||2||f||||t||||||||||2017-10-11 02:51:36.817927|2017-10-11 02:51:36.817927
NCT00005201|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1987||1987-07-01|May 2000|2000-05-01|June 1992|Actual|1992-06-01|||||Observational|||Idiopathic Dilated Cardiomyopathy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.475581|2017-10-11 04:26:37.475581
NCT01616901|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-05-30|||April 2012||2012-04-01|June 2012|2012-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Wean Obese Study : Determination of the Optimal Spontaneous Breathing Trial for Obese Patient|Wean Obese Study : Determination of the Optimal Spontaneous Breathing Trial for Obese Patient|Completed||N/A|31|Actual|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 02:51:36.89894|2017-10-11 02:51:36.89894
NCT01616888|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2014-12-05|||June 2012||2012-06-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Paclitaxel Eluting Balloon for SFA In-stent Restenosis|Rug Eluting Balloon With Paclitaxel for Treatment of In-stent Restenosis in Femoropopliteal Arteries|Unknown status|Active, not recruiting|N/A|30|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 02:51:37.159351|2017-10-11 02:51:37.159351
NCT01616875|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-04-19|||May 2012||2012-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|September 2017|Anticipated|2017-09-01||Interventional|||Bristol Bladder Trial|A Phase II Trial of Combination Cabazitaxel and Cisplatin Chemotherapy in the Neo-adjuvant Treatment of Transitional Cell Carcinoma of the Urinary Bladder|Recruiting||Phase 2|30|Anticipated|University Hospitals Bristol NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 02:51:37.262886|2017-10-11 02:51:37.262886
NCT01616862|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-05-29|||February 2012||2012-02-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Observational|||The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis|The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis|Completed||N/A|53|Actual|State University of New York - Upstate Medical University|||2||f||||f||||||||||2017-10-11 02:51:37.879161|2017-10-11 02:51:37.879161
NCT01616849|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2015-09-19|||May 2012||2012-05-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma|Open-Label, Uncontrolled, Multicenter Phase II Study of Cisplatin and 5-Fu Combined With Nimotuzumab As First-Line Treatment in Patients With Untreated Metastatic Nasopharyngeal Carcinoma|Completed||Phase 2|39|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 02:51:38.000405|2017-10-11 02:51:38.000405
NCT01616836|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-04-12|||September 2012||2012-09-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|OPRA||Optimizing Pain and Rehabilitation After Knee Arthroplasty|Optimizing Pain and Rehabilitation After Knee Arthroplasty - Randomized, Blinded Clinical Trial Comparing Continuous Femoral Nerve Block Versus Single Injection Femoral Nerve Block Versus Local Infiltration Analgesia|Completed||Phase 3|100|Actual|Sunnybrook Health Sciences Centre||3|||f||||t||||||||||2017-10-11 02:51:38.117955|2017-10-11 02:51:38.117955
NCT01616823|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-06-08|||January 2009||2009-01-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|||Fetal HIV Transmission Risk and Duration of Membrane Rupture|Duration of Rupture of Membranes and Risk of Fetal Transmission of HIV in Optimally Managed HIV Positive Mothers|Completed||N/A|210|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-11 02:51:38.241804|2017-10-11 02:51:38.241804
NCT01616810|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2012-06-08|||January 2007||2007-01-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|October 2007|Actual|2007-10-01||Observational|LUTS-2||Lower Urinary Tract Symptoms Screening Questionnaire|Lower Urinary Tract Symptoms Screening Questionnaire Validation STudy|Completed||N/A|300|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-10-11 02:51:38.332109|2017-10-11 02:51:38.332109
NCT01616797|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-01-19|||February 2014||2014-02-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan|A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression|Recruiting||Phase 1|30|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 02:51:38.392483|2017-10-11 02:51:38.392483
NCT01616784|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-11-20|||November 2011||2011-11-01|November 2014|2014-11-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|REPOSE||The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial|The Relative Effectiveness of Pumps Over Multiple Dose Injections and Structured Education Trial|Completed||Phase 3|267|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 02:51:38.49356|2017-10-11 02:51:38.49356
NCT01616771|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2014-11-03|2013-11-21||February 2011||2011-02-01|November 2014|2014-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||GlideScope®Video Laryngoscope for Difficult Intubation: Implication of the Size of Blade|GlideScope®Video Laryngoscope for Difficult Intubation: Implication of the Size of Blade|Completed||N/A|23|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 02:51:38.759525|2017-10-11 02:51:38.759525
NCT01616758|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-03-14|||April 2013|Actual|2013-04-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|June 2014|Actual|2014-06-01||Interventional|||Phase II Study of GTx024 in Women With Metastatic Breast Cancer|Phase II, Open Label Study to Examine Androgen Receptor Status and the Activity of GTx-024 Hormonal Therapy in Women With Estrogen Receptor Positive Metastatic Breast Cancer Who Have Previously Responded to Hormone Therapy|Completed||Phase 2|22|Actual|GTx||1|||f||||f||||||||||2017-10-11 02:51:39.043943|2017-10-11 02:51:39.043943
NCT01616745|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2012-06-11|||July 2011||2011-07-01|June 2012|2012-06-01|February 2021|Anticipated|2021-02-01|||||Observational|Korean NTM||Phenotypic Clinical, and Genetic Characteristics of Patients With Nontuberculosis Mycobacteria|Characteristics of Patients With Nontuberculosis Mycobacteria in Korean Population|Recruiting||N/A|500|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 02:51:39.180885|2017-10-11 02:51:39.180885
NCT01616732|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2016-06-03|||April 2013||2013-04-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Testosterone and Weight Loss|Effect of Testosterone and Diet on Weight|Completed||Phase 2|100|Actual|Austin Health||2|||f||||f||||||||||2017-10-11 02:51:39.276574|2017-10-11 02:51:39.276574
NCT01616719|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-10-17|||May 2012||2012-05-01|October 2016|2016-10-01|February 2015|Anticipated|2015-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease|Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease|Withdrawn||N/A|0|Actual|Providence Medical Technology, Inc.||1|||f||||||||||||||2017-10-11 02:51:39.382276|2017-10-11 02:51:39.382276
NCT01616693|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2013-08-28|||July 2012||2012-07-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines|Supplementation With Zinc and/or Probiotics to Enhance the Immune Response of Oral Rotavirus and Polio Vaccines in Indian Infants|Completed||Phase 4|620|Actual|PATH||4|||f||||t||||||||||2017-10-11 02:51:39.489475|2017-10-11 02:51:39.489475
NCT01616680|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2013-06-25|||September 2012||2012-09-01|June 2013|2013-06-01||||June 2016|Anticipated|2016-06-01||Interventional|||Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease|Phase II Study to Evaluate the Efficacy of Brentuximab Vedotin in Patients With Steroid-Resistant Acute GVHD|Withdrawn||Phase 2|0|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 02:51:39.593173|2017-10-11 02:51:39.593173
NCT01616667|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-06-03|||May 2012||2012-05-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|COMPALA||Comparing the Clinical Effects of Posterior Approach Versus Lateral Approach in Osteoarthritis Patients With a THA|Posterior Approach Versus Lateral Approach in Osteoarthritis Patients, With Primary Total Hip Arthroplasty. The Effect on Early Physical Function, Pain, Patient Reported Outcome Measures, Gait and Muscle Weakness A Randomized Clinical Trial|Completed||Phase 2|80|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 02:51:39.708202|2017-10-11 02:51:39.708202
NCT01616654|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2014-01-14||2014-01-14|June 2012||2012-06-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Dose Range Study of CD5789 in Acne Vulgaris|A Randomized, Multi-center, Investigator-blind, Vehicle- and Active-controlled, Phase 2 Study to Assess the Efficacy and Safety of Different Concentrations of CD5789 Cream Applied Once Daily in Subjects With Moderate to Severe Acne Vulgaris|Completed||Phase 2|304|Actual|Galderma||5|||f||||f||||||||||2017-10-11 02:51:39.83024|2017-10-11 02:51:39.83024
NCT01616641|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2012-06-11|||June 2011||2011-06-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|||||Observational|||Orofacial Evaluation in Women With Rheumatoid Arthritis|Orofacial Evaluation in Women With Rheumatoid Arthritis|Completed||N/A|150|Actual|Federal University of São Paulo|||2||f||||t||||||||||2017-10-11 02:51:39.988512|2017-10-11 02:51:39.988512
NCT01616628|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-01-23|||November 2010||2010-11-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Use of Incentives to Promote Healthier Eating in Low-income Communities|The Use of Incentives to Promote Healthier Eating in Low-income Communities|Completed||N/A|58|Actual|Albert Einstein Healthcare Network||2|||f||||f||||||||||2017-10-11 02:51:40.095445|2017-10-11 02:51:40.095445
NCT01616615|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2015-08-17|||September 2012||2012-09-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|ASAP||Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation|Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation|Completed||Phase 2|190|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 02:51:40.208337|2017-10-11 02:51:40.208337
NCT01616602|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-08|2012-06-11||||||December 2011|2011-12-01||||||||Interventional|||Prone Versus Left-sided Colonoscopy in Obese Patients||Completed||N/A|100||Dallas VA Medical Center||2|||f||||||||||||||2017-10-11 02:51:40.333422|2017-10-11 02:51:40.333422
NCT01616589|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-06-07|||July 2012||2012-07-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay|Acquisition of Saliva Samples for Validation as a Specimen Type in the Esoterix Genetic Laboratories Fragile X Assay|Unknown status|Not yet recruiting|N/A|100|Anticipated|Esoterix Genetic Laboratories, LLC|||3||f||||f||||||Samples With DNA|"     In some cases, the de-identified, residual saliva specimen may be used in quality assurance;     it may be used in clinical testing as a control; it may be used for future research studies.   "|||2017-10-11 02:51:40.424779|2017-10-11 02:51:40.424779
NCT01616576|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2014-08-28|2014-02-26|2013-01-27|May 2012||2012-05-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear||Completed||N/A|36|Actual|Advanced Bionics||2|||f||||f||||||||||2017-10-11 02:51:40.537905|2017-10-11 02:51:40.537905
NCT01616563|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-07-04|||June 2012||2012-06-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|CHANGE||Canadian Health Advanced By Nutrition and Graded Exercise|Canadian Health Advanced By Nutrition and Graded Exercise: CHANGE Health Paradigm|Completed||N/A|305|Actual|Clinical Evaluation Research Unit at Kingston General Hospital||1|||f||||f||||||||||2017-10-11 02:51:40.948379|2017-10-11 02:51:40.948379
NCT01616550|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2013-09-12|||September 2012||2012-09-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Quality of Postoperative Pain Management Following Thoracic Surgery|Quality of Postoperative Pain Management Following Thoracic Surgery: a Prospective Observational Study.|Completed||N/A|250|Actual|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-10-11 02:51:41.1659|2017-10-11 02:51:41.1659
NCT01616537|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2015-11-13|||November 2011||2011-11-01|February 2013|2013-02-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|QASICC-EVA||Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter|Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter: Confirmatory Validation of QASICC Questionnaire|Terminated||N/A|990|Actual|Centre Antoine Lacassagne||1|||f||||t||||||||||2017-10-11 02:51:41.263432|2017-10-11 02:51:41.263432
NCT01616524|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2015-09-23||2015-09-23|July 2012||2012-07-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|PRINCIPAL||Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3|A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, With and Without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combination With Ribavirin, in the Treatment of Naïve Genotype 2 and 3 Chronic Hepatitis C Subjects|Completed||Phase 3|880|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 02:51:41.419073|2017-10-11 02:51:41.419073
NCT01616511|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-01-05|||June 2012||2012-06-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Pathway CH-1 Long-Term Follow-Up|Long-Term Follow-Up for the Pathway CH-1 Trial: Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache|Completed||N/A|33|Actual|Autonomic Technologies, Inc.|||1||f||||f||||||||||2017-10-11 02:51:42.042588|2017-10-11 02:51:42.042588
NCT01616316|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-06-07|||March 2010||2010-03-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients|Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients: Prospective Randomized Study|Completed||Phase 2/Phase 3|86|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:51:47.182508|2017-10-11 02:51:47.182508
NCT01616498|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-03-10|||June 2012||2012-06-01|March 2017|2017-03-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Observational|LEAN||Lean Muscle Function|Obesity and Muscle Function Pilot Study|Completed||N/A|24|Actual|Wake Forest University Health Sciences|||1||f||||t||||||Samples Without DNA|"     serum and plasma to be retained   "|Yes|All data will be made available upon email request to the study PI and upon completion of a data-sharing agreement. This agreement will require that data be used only for research purposes, that no attempts be made to identify individual patients, that the data will be kept secure, that the user will not distribute the data to other researchers, that the user will return the files or destroy them once the project is completed, and that the user will acknowledge the data source. All data files will be de-identified. In addition, variables that could permit linkages to individual research participants and variables that could lead to deductive disclosure of the identity of individual subjects will be removed or recoded. We will create a link on our website that describes our study and the data available for data sharing with descriptions.|2017-10-11 02:51:42.117976|2017-10-11 02:51:42.117976
NCT01616485|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-06-12|||March 2004||2004-03-01|June 2012|2012-06-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo|A Double-blind, Randomized, Crossover Evaluation of the Hemodynamic Response to Sublingual Glyceryl Trinitrate in Patients Receiving TA-1790, Sildenafil, and Placebo|Completed||Phase 1|106|Actual|VIVUS, Inc.||3|||f||||t||||||||||2017-10-11 02:51:42.185224|2017-10-11 02:51:42.185224
NCT01616472|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-04-21|||April 2012||2012-04-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)|WEUKBRE5716: Quantifying the Burden of Steroid-related Damage in Systemic Lupus Erythematosus in the Hopkins Lupus Cohort|Completed||N/A|1|Actual|GlaxoSmithKline|||10||f||||f||||||||||2017-10-11 02:51:42.262917|2017-10-11 02:51:42.262917
NCT01616459|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-06-06|2014-04-10|2013-08-22|July 1, 2012||2012-07-01|May 2017|2017-05-01|January 22, 2014|Actual|2014-01-22|April 25, 2013|Actual|2013-04-25||Interventional|||Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants|Immunogenicity and Safety Study of Two Formulations of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants|Completed||Phase 2|953|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:51:42.421917|2017-10-11 02:51:42.421917
NCT01616446|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-06-08|||February 2007||2007-02-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Observational|||Pharmacokinetics of Cyclosporin in Nephrotic Syndrome|PHARMACOKINETICS OF CYCLOSPORIN - A MICROEMULSION IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME|Completed||N/A|10|Actual|University of Sao Paulo|||2||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 02:51:46.161862|2017-10-11 02:51:46.161862
NCT01616433|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2014-12-17|||March 2012||2012-03-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|AFEP+10 Keys||"Arthritis Foundation Exercise Program & 10 Keys to Healthy Aging--Prevention Research Center"|"Arthritis Foundation Exercise Program & 10 Keys to Healthy Aging"|Completed||Phase 2|462|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:51:46.247265|2017-10-11 02:51:46.247265
NCT01616420|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-04-06|||June 2012||2012-06-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|APS||Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya|Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya|Completed||N/A|2424|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 02:51:46.332447|2017-10-11 02:51:46.332447
NCT01616407|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-01-20|||August 2012||2012-08-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Effects of MDMA and Methylphenidate on Social Cognition|Effects of MDMA (Ecstasy) and Methylphenidate (Ritalin) on Social Cognition|Completed||Early Phase 1|30|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 02:51:46.460477|2017-10-11 02:51:46.460477
NCT01616394|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-11-18|||February 2012||2012-02-01|September 2013|2013-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Postoperative Troponin in Children With Congenital Heart Disease||Completed||N/A|180|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-10-11 02:51:46.563237|2017-10-11 02:51:46.563237
NCT01616381|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-08-14|||March 2013|Actual|2013-03-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Interventional|SilHF||Sildenafil Versus Placebo in Chronic Heart Failure|Sildenafil in Heart Failure (SilHF); An Investigator Initiated Multinational Randomized Controlled Clinical Trial.|Recruiting||Phase 3|120|Anticipated|Helse Stavanger HF||2|||f||||t|f|f|||f|||||2017-10-11 02:51:46.651173|2017-10-11 02:51:46.651173
NCT01616368|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-11-18|||January 2012||2012-01-01|November 2014|2014-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Effects of Mindfulness Training on Eating Behaviors and Food Intake|The Effects of Mindfulness Training on Eating Behaviors and Food Intake|Completed||Early Phase 1|19|Actual|Seattle Institute for Biomedical and Clinical Research||1|||f||||f||||||||||2017-10-11 02:51:46.817943|2017-10-11 02:51:46.817943
NCT01616355|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-06-08|||August 2011||2011-08-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Evaluation of Sodium Hypochlorite as a Denture Cleanser|Denture Condition: Influence on Masticatory Performance, Volatile Sulfur Compounds and Presence of Biofilm|Completed||N/A|15|Actual|University of Campinas, Brazil||1|||f||||f||||||||||2017-10-11 02:51:46.899601|2017-10-11 02:51:46.899601
NCT01616342|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2012-06-07|||December 2011||2011-12-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|War Wounded||Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty|Investigator Initiated Trial- Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty. Comparison of Spinal Cord Stimulation and Comprehensive Medical Management|Unknown status|Recruiting|Phase 4|180|Anticipated|Sceptor Pain Foundation||2|||f||||t||||||||||2017-10-11 02:51:46.975235|2017-10-11 02:51:46.975235
NCT01616329|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-04-11|||January 2009||2009-01-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|R-FACT||R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions|R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions|Recruiting||N/A|1500|Anticipated|Sanquin Research & Blood Bank Divisions|||1||f||||f||||||Samples With DNA|"     Blood samples from consenting participants collected and retained: plasma,serum and buffy     coat   "|||2017-10-11 02:51:47.089682|2017-10-11 02:51:47.089682
NCT01616303|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-09-18|||June 2012||2012-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer|Phase 2: A Randomized Controlled Study on Effectiveness of Chemotherapy (Carboplatin-Paclitaxel) Versus Chemo-immunotherapy (Carboplatin-Paclitaxel-Oregovomab) in Patients With Advanced Epithelial Ovarian, Adnexal or Peritoneal Carcinoma|Active, not recruiting||Phase 2|97|Actual|Quest PharmaTech Inc.||2|||f||||f||||||||||2017-10-11 02:51:47.276205|2017-10-11 02:51:47.276205
NCT01616290|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-08-07|||October 2012||2012-10-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2014|Actual|2014-06-01||Interventional|||Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)|Open-Label, Dose-Escalation, Pilot Study of PRT-201 Administered Following Angioplasty in Patients With Peripheral Artery Disease in the Lower Extremity|Completed||Phase 1|14|Actual|Proteon Therapeutics||1|||f||||t||||||||||2017-10-11 02:51:47.422405|2017-10-11 02:51:47.422405
NCT01616277|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-09-23|||June 2012||2012-06-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-06252616 In Healthy Subjects|Completed||Phase 1|86|Anticipated|Pfizer||7|||f||||f||||||||||2017-10-11 02:51:49.520103|2017-10-11 02:51:49.520103
NCT01616264|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-06-08|||January 2006||2006-01-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Observational|||Reproducibility of Computed Tomography|Evaluation of the Reproducibility of Computed Tomography for the Measurement of Tuberculosis Pleural Effusion|Completed||N/A|20|Actual|Universidade Federal do Rio de Janeiro|||1||f||||t||||||||||2017-10-11 02:51:49.650521|2017-10-11 02:51:49.650521
NCT01616251|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-06-29|||August 2012||2012-08-01|June 2016|2016-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PAVA-II||Acute Effect of Animal and Vegetable Protein Rich Meals With Comparable Dietary Fibers Content on Appetite Sensation and Energy Intake|Acute Effect of Animal and Vegetable Protein Rich Meals With Comparable Dietary Fibers Content on Appetite Sensation and Energy Intake|Completed||N/A|33|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-11 02:51:49.726955|2017-10-11 02:51:49.726955
NCT01616238|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-05-05|||December 2012||2012-12-01|May 2017|2017-05-01||||December 2018|Anticipated|2018-12-01||Interventional|UKALL60+||A Study for Older Adults With Acute Lymphoblastic Leukaemia|A Phase 2 Study for Older Adults With Acute Lymphoblastic Leukaemia|Recruiting||Phase 3|148|Anticipated|University College, London||5|||f||||t||||||||||2017-10-11 02:51:49.828662|2017-10-11 02:51:49.828662
NCT01616225|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-07-22|||June 2012||2012-06-01|July 2014|2014-07-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Interventional|||Growth Hormone in Poor Responders to IVF Trial|Adjuvant Growth Hormone in Infertile Women With Prior Poor IVF Response: a Randomized, Controlled, Open-label Study|Terminated||Phase 2/Phase 3|60|Anticipated|Pacific Centre for Reproductive Medicine||3||Insufficient/slow patient recruitment|f||||f||||||||||2017-10-11 02:51:50.085525|2017-10-11 02:51:50.085525
NCT01616212|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-10-08|||July 2011||2011-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MAST1||Early Intervention for Minors in Possession of Alcohol/Drugs: A Feasibility Study|Early Intervention for Minors in Possession of Alcohol/Drugs: A Feasibility Study|Completed||Phase 1|239|Actual|Oregon Research Institute||4|||f||||f||||||||||2017-10-11 02:51:50.205297|2017-10-11 02:51:50.205297
NCT01616199|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-07-23||2015-04-30|August 2012||2012-08-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma|Phase 1/2 Study of PI-3K Inhibition With PX-866 Combined With Vemurafenib (BRAF Inhibitor) in Patients With BRAF-mutant Cancer Including Advanced Melanoma|Terminated||Phase 1/Phase 2|24|Actual|Cascadian Therapeutics Inc.||3||slow accrual|f||||t||||||||||2017-10-11 02:51:50.317027|2017-10-11 02:51:50.317027
NCT01616186|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-04-04|||July 2012||2012-07-01|April 2013|2013-04-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)|A Randomized Non-Comparative Multicenter Phase II Study of Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)|Withdrawn||Phase 2|0|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:51:50.56697|2017-10-11 02:51:50.56697
NCT01616173|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-11-12|2014-09-18||June 2012||2012-06-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block|The Effects of Perineural Versus Intravenous Dexamethasone on Sciatic Nerve Blockade Outcomes|Completed||Phase 4|80|Actual|Northwestern University|We enrolled a very specific surgical patient population and all surgical procedures required a saphenous nerve block and the pain in the saphenous nerve distribution could have affected some of our results.|3|||f||||f||||||||||2017-10-11 02:51:50.690633|2017-10-11 02:51:50.690633
NCT01616160|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2014-01-17|||July 2013||2013-07-01|January 2014|2014-01-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|MERK2||An Open-label Study to Identify Molecular Markers of Steroid Resistance|An Open-label Study to Identify Molecular Markers of Steroid Resistance in Nasal Polyposis Before and Following Treatment With Mometasone Furoate (MFNS) 2 Sprays/Nostril (100 Mcg/Nostril) Twice Daily for 4 Weeks.|Unknown status|Recruiting|Phase 4|24|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:51:51.093573|2017-10-11 02:51:51.093573
NCT01616147|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-12-06|||October 2012||2012-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|LIFT||LIFT: Lifestyle Interventions For Two|LIFT: Lifestyle Interventions For Two (Member of the LIFE Moms Consortium)|Active, not recruiting||N/A|210|Actual|Columbia University||2|||f||||t||||||||Undecided||2017-10-11 02:51:51.222|2017-10-11 02:51:51.222
NCT01616134|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-03-01|||August 2010||2010-08-01|March 2017|2017-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|KRGIS||Effect of Korean Red Ginseng on Insulin Sensitivity in Non Diabetic Overweight Korean Adults||Completed||N/A|80|Actual|The Korean Society of Ginseng||2|||f||||||||||||||2017-10-11 02:51:51.330214|2017-10-11 02:51:51.330214
NCT01616121|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-06-01|||June 2012||2012-06-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Preemptive Lung Impedance-Guided Therapy in Evolving Acute Heart Failure in Acute Myocardial Infarction Patients||Recruiting||Phase 3|300|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 02:51:51.428579|2017-10-11 02:51:51.428579
NCT01616108|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-10-13|||April 2012||2012-04-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Bupivacaine Injection of Eye Muscles to Treat Strabismus|Bupivacaine Injection of Eye Muscles to Treat Strabismus|Recruiting||Phase 2/Phase 3|120|Anticipated|Smith-Kettlewell Eye Research Institute||1|||f||||f||||||||No||2017-10-11 02:51:51.52621|2017-10-11 02:51:51.52621
NCT01616095|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2013-07-18|||June 2011||2011-06-01|July 2013|2013-07-01|August 2013|Anticipated|2013-08-01|May 2013|Actual|2013-05-01||Observational|GHAT||Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype|The Effect of a Long-Term Growth Hormone Supplementation on the Whole-Body Metabolic Characteristics and Adipose Tissue Phenotype in Growth Hormone Deficient Adults: the 5-yr Follow-up|Unknown status|Active, not recruiting|N/A|44|Actual|Slovak Academy of Sciences|||2||f||||t||||||Samples With DNA|"     plasma 2.5 ml, serum 5 ml, adipose tissue 300 mg taken by the percutaneous biopsy of     abdominal subcutaneous adipose tissue, in local anaesthesia.   "|||2017-10-11 02:51:51.647645|2017-10-11 02:51:51.647645
NCT01616069|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-05-29|||February 2012||2012-02-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|February 2012|Actual|2012-02-01||Interventional|||Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography|Assessment and Hemodynamic Response in CABG After Cardiopulmonary Bypass Using Intraoperative Transesophegeal Echocardiography|Completed||Phase 4|81|Actual|Federal University of Juiz de Fora||2|||f||||t||||||||||2017-10-11 02:51:51.86789|2017-10-11 02:51:51.86789
NCT01616056|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-07-14|2017-01-13||June 2012||2012-06-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease|A Single Center Phase II Study of Bandage Lenses for Ocular Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation|Completed||Phase 2|20|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 02:51:51.974375|2017-10-11 02:51:51.974375
NCT01616043|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-08-23|||February 2011||2011-02-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Glyaderm Clinical Evaluation Multicenter Study|Clinical Application of GLYADERM. A Multicentre, Prospective, Randomized Controlled, Comparative Trial of Glyaderm and Split Thickness Skin Graft Versus Split Thickness Skin Graft Alone in Full Thickness Skin Defects|Terminated||Phase 3|40|Actual|Euro Tissue Bank||2||delay in recruitment, lack of additional funding|f||||f||||||||||2017-10-11 02:51:52.386506|2017-10-11 02:51:52.386506
NCT01616030|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-05-14|||June 2012||2012-06-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Early Strength Training After Hip Fracture Surgery|Feasibility of Progressive Strength Training in the Early Post Surgical Rehabilitation Period After Hip Fracture Surgery|Completed||N/A|36|Actual|Copenhagen University Hospital, Hvidovre||1|||f||||t||||||||||2017-10-11 02:51:52.597922|2017-10-11 02:51:52.597922
NCT01616017|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-05-25|||May 2012||2012-05-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Comparison of Cardiac Output Measured by Ultrasound Dilution Method and Pulmonary Artery Thermodilution Technique|Comparison of Cardiac Output Measured by Ultrasound Dilution Method and Pulmonary Artery Thermodilution Technique|Completed||N/A|39|Actual|Transonic Systems Inc.|||1||f||||||||||||||2017-10-11 02:51:52.729081|2017-10-11 02:51:52.729081
NCT01616004|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2014-09-21|||October 2014||2014-10-01|June 2012|2012-06-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Interventional|N2O||Effect of Acute Treatment With N2O on Inhibitory Pain Mechanisms in Healthy Subject|Effect of Acute Treatment With N2O on Inhibitory Pain Mechanisms in Healthy Subject|Unknown status|Not yet recruiting|N/A|10|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-11 02:51:52.817372|2017-10-11 02:51:52.817372
NCT01615991|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-04-05|||May 2012||2012-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|RSO||Multicentre Canadian Study to Measure the Safety and Efficacy of Radiosynoviorthesis|Multicentre Canadian Study to Measure the Safety and Efficacy of Synoviorthesis Performed With Yttrium-90 or Rhenium-186 Sulfide|Recruiting||Phase 3|1500|Anticipated|Centre de recherche du Centre hospitalier universitaire de Sherbrooke||1|||f||||t||||||||||2017-10-11 02:51:52.905534|2017-10-11 02:51:52.905534
NCT01615978|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-01-24|||December 2003||2003-12-01|January 2017|2017-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes|A Randomised, Double-blind Within Dose Group, Single-centre, Placebo-controlled, Parallel 2-different Dose Group, 14-day Multiple s.c. Doses Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Liraglutide (NNC 90-1170) in Subjects With Type 2 Diabetes|Completed||Phase 1|15|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:51:53.04841|2017-10-11 02:51:53.04841
NCT01615965|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-27|2015-07-27|||February 2010||2010-02-01|July 2015|2015-07-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer|Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer|Active, not recruiting||N/A|160|Anticipated|Technische Universität München||1|||f||||f||||||||||2017-10-11 02:51:53.157496|2017-10-11 02:51:53.157496
NCT01615952|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2015-03-27|||January 2012||2012-01-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Patient Positioning on Supraclavicular Nerve Block||Terminated||N/A|6|Actual|Northwestern University|||3|Lack of recruitment|f||||f||||||||||2017-10-11 02:51:53.236143|2017-10-11 02:51:53.236143
NCT01615939|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-06-29|2016-05-23||June 2012||2012-06-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block|A Randomized Controlled Trial Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block|Terminated||Phase 4|17|Actual|Northwestern University|Early termination leading to small numbers of subjects analyzed|2||The study has been terminiated due to minimal subject recruitment|f||||f||||||||No||2017-10-11 02:51:53.318909|2017-10-11 02:51:53.318909
NCT00005202|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1987||1987-07-01|May 2000|2000-05-01|June 1992|Actual|1992-06-01|||||Observational|||Identifying High Risk Patients With Syncope||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.636746|2017-10-11 04:26:37.636746
NCT01615926|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2013-04-30|||June 2012||2012-06-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Assessment of The Clinical Course of Dyspnea in Acute Heart Failure Patients|Assessment of The Clinical Course of Dyspnea and Its Association With Respiratory Rate in Patients With Acute Heart Failure Syndromes|Terminated||N/A|16|Actual|Northwestern University|||1|Student related research project. Completion of allotted time.|f||||f||||||||||2017-10-11 02:51:53.718796|2017-10-11 02:51:53.718796
NCT01615913|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-06-06|||April 2012||2012-04-01|June 2012|2012-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole|Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine and Ketoconazole Formulation|Unknown status|Recruiting|Phase 1|18|Anticipated|Taiwan Biotech Co., Ltd.||3|||f||||t||||||||||2017-10-11 02:51:53.816134|2017-10-11 02:51:53.816134
NCT01615900|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2016-05-03|||February 2012||2012-02-01|May 2016|2016-05-01|September 2020|Anticipated|2020-09-01|June 2020|Anticipated|2020-06-01||Interventional|TELEGRAFT||Randomized Open Label Study Evaluating the Coverage by Teleconsultation Versus Standard Follow-up of Renal Transplant Patients According to a Risk Score of Early Graft Failure (KTFS)|Randomized Open Label Study Evaluating the Coverage by Teleconsultation Versus Standard Follow-up of Renal Transplant Patients According to a Risk Score of Early Graft Failure (KTFS)|Recruiting||N/A|250|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 02:51:53.919565|2017-10-11 02:51:53.919565
NCT01615887|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-23|2012-06-06|||November 2009||2009-11-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis|Effects of Lisdexamfetamine on Bradyphrenia in Multiple Sclerosis|Completed||Phase 2|63|Actual|State University of New York at Buffalo||2|||f||||||||||||||2017-10-11 02:51:54.04056|2017-10-11 02:51:54.04056
NCT01615874|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2015-09-25|||January 2013||2013-01-01|September 2015|2015-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)|A Six-week Evaluator-Blind, Randomized, Active-Controlled Evaluation of the Effects of Three Doses of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI), Montelukast, and Beclomethasone Dipropionate (BDP HFA) on the HPA Axis in Asthmatic Children 5 to 11 Years of Age (Protocol No. P05574/PN158)|Withdrawn||Phase 2|0|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-11 02:51:54.129588|2017-10-11 02:51:54.129588
NCT01615861|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-03-27|||November 2012||2012-11-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular Lens|Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular Lens|Unknown status|Active, not recruiting|Phase 4|103|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 02:51:54.234539|2017-10-11 02:51:54.234539
NCT01615848|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2013-02-19|||April 2013||2013-04-01|February 2013|2013-02-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Comparison Between Mediterranean Diet and High Protein Diet in Women With Polycystic Ovary Syndrome (PCOS)|Comparison Between Mediterranean Diet and High Protein Diet in Women With Pcos: Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|100|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-11 02:51:54.311303|2017-10-11 02:51:54.311303
NCT01615835|ClinicalTrials.gov processed this data on October 10, 2017|2007-12-21|2012-06-06|||April 2007||2007-04-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|Bi-VNavX||EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant|Mapping in the Coronary Sinus During Implant of a Bi-Ventricular Implantable Cardioverter Defibrillator Utilizing the NavX Mapping System|Completed||N/A|16|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 02:51:54.422799|2017-10-11 02:51:54.422799
NCT01615822|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2015-03-27|2015-03-17||August 2012||2012-08-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||In Cohort 2, one subject withdrew consent prior to dosing and is therefore not part of the safety population.|Safety, Tolerability & Pharmacokinetics (PK) of Co-administered Single Doses of OZ439 and Mefloquine (MQ) in Healthy Volunteers|A Phase I Healthy Volunteer Study Investigating the Safety, Tolerability & Pharmacokinetics of Co-administered Single Doses of OZ439 and Mefloquine|Terminated||Phase 1|25|Actual|Medicines for Malaria Venture||5||"Decision taken to halt progression of mefloquine as a potential partner for OZ439 as a single   dose cure due to low probability of success"|f||||t||||||||||2017-10-11 02:51:54.517188|2017-10-11 02:51:54.517188
NCT01615809|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-11-04|2015-08-28||October 2011||2011-10-01|November 2015|2015-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||pediatric patients|Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia|A Phase II Trial to Evaluate the Safety and Tolerability of Nebulised Amphotericin B Lipid Complex (ABELCET®) in the Prophylaxis of Invasive Pulmonary Aspergillosis During Prolonged Neutropenia in Paediatric Patients With Acute Leukaemia|Completed||Phase 2|32|Actual|Fundació Sant Joan de Déu||1|||f||||f||||||||||2017-10-11 02:51:55.005688|2017-10-11 02:51:55.005688
NCT01615796|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2017-05-05|||June 4, 2012|Actual|2012-06-04|May 2017|2017-05-01|February 21, 2014|Actual|2014-02-21|February 21, 2014|Actual|2014-02-21||Interventional|||Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses|A Two-Part Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses of GSK2140944 in Healthy Adult Subjects.|Completed||Phase 1|86|Actual|GlaxoSmithKline||12|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:51:55.282472|2017-10-11 02:51:55.282472
NCT01615783|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2012-06-21|||November 2010||2010-11-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population|Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population|Completed||N/A|40884|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 02:51:55.407423|2017-10-11 02:51:55.407423
NCT01615770|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-07|2016-03-01|||February 2004||2004-02-01|March 2016|2016-03-01|June 2009|Actual|2009-06-01|March 2006|Actual|2006-03-01||Interventional|||Behavioral Maintenance Treatment for Smoking Cessation|Behavioral Maintenance Treatment for Smoking Cessation|Completed||N/A|304|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 02:51:55.494575|2017-10-11 02:51:55.494575
NCT01615757|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-09-13|||August 2012||2012-08-01|September 2012|2012-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|Ara-c||Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation|Comparison of Ara-c 12 gm/m2 vs 18 gm/m2 Per Cycle for 3 Cycles Each as Consolidation in AML ; An Open Label Randomized Non-inferiority Study|Unknown status|Recruiting|Phase 3|180|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 02:51:55.696477|2017-10-11 02:51:55.696477
NCT01615744|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-07|||December 1993||1993-12-01|June 2012|2012-06-01|December 1998|Actual|1998-12-01|January 1994|Actual|1994-01-01||Observational|||Surgical vs Conservative Treatment of Displaced Intra-articular Calcaneal Fractures: A Prospective RCT|Surgical vs. Conservative Treatment of Displaced Intra-articular Calcaneal Fractures: A Prospective, Randomized, Controlled Multicenter Trial|Completed||N/A|82|Actual|Agren, Per-Henrik, M.D.|||2||f||||f||||||||||2017-10-11 02:51:55.809465|2017-10-11 02:51:55.809465
NCT01615731|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-01-26|2014-12-19||May 2012||2012-05-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks|Value of Mifepristone in Eliminating the Need for a Second Set of Osmotic Dilators Prior to Dilation and Evacuation Between 19-24 Weeks: A Randomized Trial|Completed||N/A|50|Actual|Stanford University|Failure of randomization with respect to assigning similar numbers of nulliparous women to both groups; inaccurate method for measurement of pre-operative cervical dilation; small size of cohort.|2|||f||||f||||||||||2017-10-11 02:51:55.942492|2017-10-11 02:51:55.942492
NCT01615718|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-03-17|||September 2013||2013-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Non-invasive Neurostimulation in Parkinson's Disease|Effects of Non-invasive Neurostimulation Methods on Motor Function in Parkinson's Disease Patients.|Recruiting||N/A|48|Anticipated|Spaulding Rehabilitation Hospital||4|||f||||f||f||||||||2017-10-11 02:51:56.346438|2017-10-11 02:51:56.346438
NCT01615705|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-06-06|||June 2004||2004-06-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|September 2010|Actual|2010-09-01||Observational|Bio-SOX||Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial|The Etiologic Role of Inflammation, Thrombophilia and Fibrinolysis in the Post-thrombotic Syndrome: The Bio-SOX Sub Study|Completed||Phase 3|803|Actual|Sir Mortimer B. Davis - Jewish General Hospital|||1||f||||t||||||Samples With DNA|"     Blood samples collected and processed by centrifuge to obtain serum, peripheral blood     leukocytes and platelet-poor plasma. Samples then aliquoted into 2.0ml microcentrifuge tubes     for storage at -80°C until further analysis.   "|||2017-10-11 02:51:56.471472|2017-10-11 02:51:56.471472
NCT01615692|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2014-04-14|||June 2004||2004-06-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||The 36-month Extension to Follow up Sub Study|The Extension to Follow up Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX Trial)|Unknown status|Active, not recruiting|N/A|300|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital|||1||f||||t||||||||||2017-10-11 02:51:56.609245|2017-10-11 02:51:56.609245
NCT01615679|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-04-14|||August 2012||2012-08-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Observational|IDEA||Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder|Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder (ADHD)|Completed||N/A|468|Actual|Medice Arzneimittel Pütter GmbH & Co KG|||1||f||||f||||||||||2017-10-11 02:51:56.761232|2017-10-11 02:51:56.761232
NCT01615666|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-01-13|||March 2009||2009-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||A Composite MR Neuroimaging Marker for Alzheimer's Disease|A Composite MR Neuroimaging Marker for Alzheimer's Disease|Withdrawn||N/A|0|Actual|Medical College of Wisconsin|||5|This was never a clinical trial and should never have been approved.|f||||f||||||Samples With DNA|"     Buccal (cheek) swab   "|||2017-10-11 02:51:56.877052|2017-10-11 02:51:56.877052
NCT01615653|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-07-21|||September 2009|Actual|2009-09-01|July 2017|2017-07-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|||EUS Guided Celiac Neurolysis|Prospective Randomized Trial of EUS Guided Celiac Ganglia Neurolysis (CGN) Versus EUS Guided Celiac Plexus Neurolysis (CPN) for Pancreatic Cancer Pain|Completed||N/A|110|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:51:56.978047|2017-10-11 02:51:56.978047
NCT01615640|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-06-07|||September 2010||2010-09-01|June 2012|2012-06-01||||||||Observational|||Diffusion Study on Patients With Osteosarcoma|Monitoring the Response of Osteosarcoma Under Neoadjuvant Chemotherapy: The Value of Dynamic Contrast Enhancement and Diffusion-weighted MRI|Unknown status|Recruiting|N/A|30|Anticipated|Klinikum Stuttgart|||1||f||||f||||||||||2017-10-11 02:51:57.086827|2017-10-11 02:51:57.086827
NCT01615627|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-06-11||||||June 2012|2012-06-01||||||||Interventional|||Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain|Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain|Unknown status|Not yet recruiting|Phase 4|12|Anticipated|Jewish General Hospital||2|||f||||f||||||||||2017-10-11 02:51:57.208234|2017-10-11 02:51:57.208234
NCT01615614|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-03-27|||April 2012||2012-04-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants|A Phase I, Open-Label Study in Healthy Subjects, to Explore the Pharmacokinetics of Different Dosing Regimens of Rilpivirine in Combination With Rifabutin, at Steady-State|Completed||Phase 1|20|Actual|Janssen R&D Ireland||3|||f||||f||||||||||2017-10-11 02:51:57.334387|2017-10-11 02:51:57.334387
NCT01615601|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-05-20|||October 2011||2011-10-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|POISE||An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients|PREZISTA or INTELENCE Switch Evaluation in Virologically Suppressed Patients Naïve to Darunavir or Etravirine and Who Are Intolerant of Their Current or Prior Combination Antiretroviral Therapy Regimen: A Phase IV, Open-label, Multicentre Observational Trial|Completed||Phase 4|77|Actual|Janssen Inc.|||2||f||||f||||||||||2017-10-11 02:51:57.449579|2017-10-11 02:51:57.449579
NCT01615588|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-06-07|||April 2012||2012-04-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Glycaemic Index of Manuka Honey|The Glycaemic Index of Manuka Honey|Completed||N/A|10|Actual|Waiariki Institute of Technology||1|||f||||t||||||||||2017-10-11 02:51:57.572939|2017-10-11 02:51:57.572939
NCT01553175|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-10|2016-07-13|||March 2012||2012-03-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Studying Gene Expression in Samples From Patients With Rhabdoid Tumors|Determination of the Frequency of BRG1 and BRM Loss in Rhabdoid Tumors|Completed||N/A|25|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:11:33.955824|2017-10-11 03:11:33.955824
NCT01615562|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-12-10|||December 2011||2011-12-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|April 2014|Actual|2014-04-01||Observational|||Blood Vessel Function in Adolescents and Women With Polycystic Ovary Syndrome|Endothelial Dysfunction in Adolescents and Women With Polycystic Ovary Syndrome (PCOS)|Terminated||N/A|18|Actual|Virginia Commonwealth University|||2|Difficulty in enrolling suitable subjects|f||||t||||||Samples Without DNA|"     serum and plasma for analysis of hormones   "|||2017-10-11 02:51:57.747534|2017-10-11 02:51:57.747534
NCT01615549|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2013-08-22|||April 2004||2004-04-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of Proficiency-based Versus Free Laparoscopic Training in Cholecystectomy on a Virtual Reality Simulator|Proficiency-based Versus Free Laparoscopic Training in Cholecystectomy Using the Simbionix LAP Mentor™. A Randomized Controlled Trial|Unknown status|Recruiting|N/A|64|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 02:51:57.827799|2017-10-11 02:51:57.827799
NCT01615536|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-01-08|||December 2010||2010-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|CFT||The Role of Canine Fossa Trephination in the Severely Diseased Maxillary Sinus|The Role of Canine Fossa Trephination in the Severely Diseased Maxillary Sinus|Withdrawn||N/A|0|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2||Inability to recruit subjects|f||||f||||||||||2017-10-11 02:51:57.966731|2017-10-11 02:51:57.966731
NCT01615523|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-06-07|||September 2012||2012-09-01|June 2012|2012-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Executive Function in Preterm Born Children: An Integrative Approach From Genetics to Brain Function||Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Zurich|||2||f||||f||||||||||2017-10-11 02:51:58.079844|2017-10-11 02:51:58.079844
NCT01615510|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-03-25|||October 2012||2012-10-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models|Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models of: 1) Cold and Mechanical Hyperalgesia Evoked by Topical High-concentration Menthol , 2) Heat and Mechanical Hyperalgesia by Capsaicin.|Terminated||Phase 1|24|Actual|University of Schleswig-Holstein||2|||f||||t||||||||||2017-10-11 02:51:58.175721|2017-10-11 02:51:58.175721
NCT01615497|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-07-15|||November 2012||2012-11-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CBT4CBT Etoh||Web-based CBT4CBT for Alcohol|Computer Based Training in Cognitive Behavioral Therapy Web-based Delivery of CBT4CBT for Alcohol|Completed||Phase 1|68|Actual|Yale University||3|||f||||t||||||||||2017-10-11 02:51:58.287356|2017-10-11 02:51:58.287356
NCT01615484|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-07-08|||September 2013||2013-09-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability|Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability|Suspended||Phase 2|10|Anticipated|University of North Carolina, Chapel Hill||2||Funding suspended, currently seeking other funding source(s).|f||||t||||||||Yes|De-identified individual clinical outcome data will be made available upon request|2017-10-11 02:51:58.41175|2017-10-11 02:51:58.41175
NCT01615471|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-02-23|||June 2012||2012-06-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|Lose Now NC||Lose Now North Carolina Community Weight Loss Program|Lose-Now-NC: Feasibility of a Large Group Format Community Weight Loss Program Coupled With Internet Support|Completed||N/A|195|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:51:58.625844|2017-10-11 02:51:58.625844
NCT01615458|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-06-08|||July 2010||2010-07-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Disseminating Evidence-based Mood Disorder Chronic Care Models||Completed||N/A|60|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 02:51:58.749586|2017-10-11 02:51:58.749586
NCT01615445|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-06-20|||February 2009||2009-02-01|June 2014|2014-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Resveratrol Supplementation on Exercise in Healthy Sedentary Adults|A Pilot Randomized Controlled Clinical Trial of Resveratrol Supplementation on Exercise in Healthy Sedentary Adults|Completed||Phase 2|13|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 02:51:58.869997|2017-10-11 02:51:58.869997
NCT01615432|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2013-05-15|||June 2012||2012-06-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|||Comparison of Synchrony Between 4 NIV Ventilators|Comparison of Four Different Ventilators for Noninvasive Ventilation in Terms of Patient-ventilator Synchrony and Comfort|Completed||N/A|22|Actual|University of Lausanne Hospitals||1|||f||||f||||||||||2017-10-11 02:51:58.959351|2017-10-11 02:51:58.959351
NCT01615419|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients|A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab|Completed||N/A|60|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:51:59.033783|2017-10-11 02:51:59.033783
NCT01615406|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-11-23|||April 2012||2012-04-01|November 2015|2015-11-01||||November 2012|Actual|2012-11-01||Interventional|||A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer|A Phase 1 Pilot Comparison Study of 99mTc-MIP-1404 Single Photon Emission Computed Tomography (SPECT)/CT Imaging to Histology in Men With Prostate Cancer|Completed||Phase 1|9|Actual|Molecular Insight Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:51:59.140581|2017-10-11 02:51:59.140581
NCT01615393|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-10-29|||June 2011||2011-06-01|October 2016|2016-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study to Compare the Bioavailability of Copegus and Vilona® in Healthy Volunteers|Prospective, Randomized, Single-blind, Cross-over, Comparative Study for Establishing Comparative Bioavailability of Copegus vs Vilona® in Healthy Volunteers|Completed||Phase 1|40|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:51:59.241018|2017-10-11 02:51:59.241018
NCT00005203|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||July 1987||1987-07-01|August 2004|2004-08-01|June 1992||1992-06-01|||||Observational|||Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:26:37.708629|2017-10-11 04:26:37.708629
NCT01615380|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-06-06|||September 2006||2006-09-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|September 2010|Actual|2010-09-01||Interventional|||Exercise to Enhance Smoking Cessation for Women at the YMCA|Using a YMCA Exercise Program to Enhance Nicotine Dependence Treatment for Women|Completed||Phase 2/Phase 3|408|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 02:51:59.339606|2017-10-11 02:51:59.339606
NCT01615367|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-08-08|||May 2012||2012-05-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|February 28, 2017|Actual|2017-02-28||Interventional|NEW Tx||Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder|Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder|Active, not recruiting||Phase 1/Phase 2|39|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 02:51:59.442221|2017-10-11 02:51:59.442221
NCT01615354|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers|Single-Center, Randomized, Double-Blind, Placebo Controlled, Crossover Study to Assess the Effect of Aleglitazar on the Pharmacokinetics and Pharmacodynamics of Ethinyl Estradiol and Levonorgestrel as Components of the Oral Contraceptive Microgynon®|Completed||Phase 1|18|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 02:51:59.750442|2017-10-11 02:51:59.750442
NCT01615341|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-06-07|||October 2011||2011-10-01|June 2012|2012-06-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Study of Subclinical Viral Infection|Subclinical Viral Infection and Renal Allograft Injury|Unknown status|Recruiting|N/A|100|Anticipated|Seattle Children's Hospital|||1||f||||f||||||Samples With DNA|"     If participant agrees, blood, tissue, and study data will be banked at Seattle Children's     Research Institute.   "|||2017-10-11 02:51:59.859278|2017-10-11 02:51:59.859278
NCT01615328|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-07-13|2013-09-15||November 2011||2011-11-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™|Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™|Completed||Phase 4|85|Actual|Seoul National University Hospital|Our study was included relatively small samples and short follow-up periods with 77 patients and one year duration. the measurement bias could be presented by individually different extent of neck flexion and extension in dynamic radiographs.|2|||f||||t||||||||||2017-10-11 02:51:59.960294|2017-10-11 02:51:59.960294
NCT01615315|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-08-27|||August 2012||2012-08-01|August 2012|2012-08-01||||August 2012|Actual|2012-08-01||Observational|||Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population||Completed||N/A|60048|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 02:52:00.315211|2017-10-11 02:52:00.315211
NCT01615302|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-08-21|||March 2012||2012-03-01|August 2012|2012-08-01|April 2016|Anticipated|2016-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Is the Use of Blood Platelets Effective in the Treatment of Difficult Fistulas Related to the Anal Sphincter?|Use of Platelet Rich Plasma (PRP) as an Adjunct in the Treatment of High Peri-anal Fistulas.|Unknown status|Recruiting|N/A|120|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 02:52:00.413096|2017-10-11 02:52:00.413096
NCT01615289|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-07|||July 2010||2010-07-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||Neural Effects of Green Tea Extract on Dorsolateral Prefrontal Cortex||Completed||N/A|12|Actual|University Hospital, Basel, Switzerland||4|||f||||f||||||||||2017-10-11 02:52:00.573593|2017-10-11 02:52:00.573593
NCT01615276|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-05-30|||October 2012||2012-10-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|ES-PRO||Neuromuscular Electrical Stimulation (NMES) and Muscle Protein Accretion (ES-PRO)|The Effect of Neuromuscular Electrical Stimulation on Post-prandial Muscle Protein Accretion in Healthy Elderly Men|Completed||N/A|10|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:52:00.699499|2017-10-11 02:52:00.699499
NCT01615263|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-02-27|2013-05-23||April 2012||2012-04-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional||Comparability test was calculated with a difference of 15% to allow a mean collapse time of 18 min with an alpha of 0.05 and power of 0.90. Sample size was estimated at 18 patients. 20 patients per group were randomized. 2 patients were excluded: 1 for tracheal origin of right upper lobe (RUL) bronchus, 1 for severe desaturation.|Lung Collapse With Bronchial Blocker|Isolated Lung Collapse in Two Stages With Bronchial Blocker: Comparison With Double Lumen Tube|Completed||N/A|40|Actual|Laval University||2|||f||||f||||||||||2017-10-11 02:52:00.827466|2017-10-11 02:52:00.827466
NCT01615250|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-06-08|||January 2012||2012-01-01|June 2012|2012-06-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|ISCIC||Implantation of Peripheral Stem Cells in Patient With Ischemic Cardiomyopathy|Phase I Study to Evaluate the Efficacy and Safety of Intramyocardial Implantation of Peripheral Mononuclear Cells With CD34+ Stem Cells in Patient With Ischemic Cardiomyopathy After Preparatory Course of Shock - Wave Therapy|Unknown status|Recruiting|Phase 1|50|Anticipated|Odessa National Medical University||2|||f||||||||||||||2017-10-11 02:52:01.370308|2017-10-11 02:52:01.370308
NCT01615237|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-09-20|||February 1, 2013|Actual|2013-02-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|DUET||Dentistry United to Extinguish Tobacco|Implementing Tobacco Use Treatment Guidelines in Dental Public Health Clinics|Completed||N/A|3207|Actual|New York University School of Medicine||3|||f||||f|f|f||||||||2017-10-11 02:52:01.482377|2017-10-11 02:52:01.482377
NCT01615224|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-03-02|||May 2012||2012-05-01|March 2017|2017-03-01|October 2020|Anticipated|2020-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Repeated Doses of Misoprostol for Medical Treatment of Missed Miscarriage|Repeated Doses of Misoprostol for Treatment of Missed Abortion|Suspended||Phase 2/Phase 3|140|Anticipated|Karolinska Institutet||2||No funding|f||||t||||||||||2017-10-11 02:52:01.650999|2017-10-11 02:52:01.650999
NCT01615211|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-05-15|||May 2012||2012-05-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Randomized Study of Letrozole and Trilostane for Medical Abortion|A Randomized Pilot Study of Two New Drug Combinations Fot the Termination fo Early Pregnancy|Terminated||Phase 2|36|Anticipated|Karolinska Institutet||3||No access to study drug Trilostan. Company closed down|f||||t||||||||||2017-10-11 02:52:01.772728|2017-10-11 02:52:01.772728
NCT01614821|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-09-05|||May 2012||2012-05-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia|Phase 2 Study of Bruton's Tyrosine Kinase (Btk) Inhibitor, Ibrutinib (PCI-32765), in Waldenstrom's Macroglobulinemia|Active, not recruiting||Phase 2|60|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 02:52:11.00426|2017-10-11 02:52:11.00426
NCT01615198|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-10-01|2015-07-20||August 2012||2012-08-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension|A 14 Week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension|Completed||Phase 3|588|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:52:01.946821|2017-10-11 02:52:01.946821
NCT01615185|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2016-02-27|||January 2008||2008-01-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia||Terminated||Phase 4|96|Actual|Kaohsiung Kai-Suan Psychiatric Hospital||2|||f||||t||||||||||2017-10-11 02:52:03.279523|2017-10-11 02:52:03.279523
NCT01615172|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-08-05|||January 2011||2011-01-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Cannulation of the Artery Axiliaris for Extracorporeal Circulation|Cannulation of the Artery Axiliaris for Extracorporeal Circulation|Unknown status|Recruiting|N/A|120|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 02:52:03.407492|2017-10-11 02:52:03.407492
NCT01615159|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-05-10|||June 2012||2012-06-01|May 2013|2013-05-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|SPICE||Maintenance of Recommended Sodium Intake|Maintenance of Recommended Sodium Intake|Unknown status|Active, not recruiting|N/A|40|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 02:52:03.507995|2017-10-11 02:52:03.507995
NCT01615146|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-09-01|||June 2012||2012-06-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|OPTIMAL||Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot|Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot|Terminated||N/A|9|Actual|Ottawa Hospital Research Institute||2||Poor recruitment|f||||t||||||||||2017-10-11 02:52:03.611446|2017-10-11 02:52:03.611446
NCT01615120|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-02-05|||July 2012||2012-07-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer|Phase II, Open Label Study of the Effect of GTx-758 as Secondary Hormonal Therapy on Serum PSA and Serum Free Testosterone Levels in Men With Metastatic Castration Resistant Prostate Cancer Maintained on Androgen Deprivation Therapy|Active, not recruiting||Phase 2|76|Anticipated|GTx||2|||f||||t||||||||||2017-10-11 02:52:03.722328|2017-10-11 02:52:03.722328
NCT01615107|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-06-06|||July 2012||2012-07-01|April 2012|2012-04-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Premature Rupture of Mambrane and Unfavourable Cervix|Comparison Between the Use of Standard Oxytocin Induction Protocol and the Double-balloon Catheter Device With Concurrent Oxytocin|Unknown status|Not yet recruiting|N/A|300|Anticipated|Hillel Yaffe Medical Center||2|||f||||f||||||||||2017-10-11 02:52:03.847048|2017-10-11 02:52:03.847048
NCT01615094|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-03-17|||January 2011||2011-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Observational|||Cardiac Health, Mood, & Neuroimmune Activation|BNP and Neuroimmune Characteristics of CHF and Depression (Competing Renewal)|Completed||N/A|456|Actual|University of California, San Diego|||1||f||||f||||||Samples With DNA|"     blood   "|||2017-10-11 02:52:03.989899|2017-10-11 02:52:03.989899
NCT01615081|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-10-04|||May 2012||2012-05-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|Harboe||The Acute Effect of Malt Extract Versus Sucrose on the Response of Glucose and Insulin, Subjective Appetite Sensations and ad Libitum Energy Intake||Completed||N/A|20|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 02:52:04.050034|2017-10-11 02:52:04.050034
NCT01615068|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-09-25|||June 5, 2012|Actual|2012-06-05|September 2017|2017-09-01|August 28, 2020|Anticipated|2020-08-28|August 28, 2020|Anticipated|2020-08-28||Observational|||An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)|An Observational Cohort Study Of Treatment Patterns And Outcomes In Patients With HER2 Positive (Her2+) Metastatic Breast Cancer (SystHERs Registry (Systematic Therapies for HER2+ Metastatic Breast Cancer Study)).|Active, not recruiting||N/A|1007|Actual|Genentech, Inc.|||1||f||||||||||Samples With DNA|"     Tissue and whole blood samples   "|||2017-10-11 02:52:04.282436|2017-10-11 02:52:04.282436
NCT01615055|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-02-04|||June 2018||2018-06-01|February 2016|2016-02-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Fluoxetine Prevention Trial|Prevention of Cognitive Decline After Chemotherapy, With Fluoxetine Treatment|Not yet recruiting||N/A|376|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:52:04.672924|2017-10-11 02:52:04.672924
NCT01615042|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-01-19|||August 2012||2012-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase I Study of Lenalidomide in Patients With Acute Leukemia|Phase I Trial of High Dose Lenalidomide in Patients With Refractory/Relapsed Acute Leukemia as a Bridge to Bone Marrow Transplant|Active, not recruiting||Phase 1|6|Actual|University of California, Davis||1|||f||||t||||||||||2017-10-11 02:52:04.794133|2017-10-11 02:52:04.794133
NCT01615029|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-07-21|2017-02-02|2016-09-07|January 8, 2012|Actual|2012-01-08|July 2017|2017-07-01|December 8, 2020|Anticipated|2020-12-08|October 2, 2015|Actual|2015-10-02||Interventional|||Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma|An Open Label, International, Multicenter, Dose Escalating Phase I/II Trial Investigating the Safety of Daratumumab in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Relapsed and Refractory Multiple Myeloma|Active, not recruiting||Phase 2|45|Actual|Janssen Research & Development, LLC||1|||f||||t|t|||||||||2017-10-11 02:52:04.968494|2017-10-11 02:52:04.968494
NCT01615016|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-08-19|||July 2012||2012-07-01|August 2017|2017-08-01|August 19, 2017|Actual|2017-08-19|August 19, 2017|Actual|2017-08-19||Interventional|MIsurf||MISurf Versus InSurE. A Comparison of Minimally Invasive Surfactant Application Techniques in Preterm Infants|Feasibility Study of A Comparison of Minimally Invasive Surfactant Application Techniques in Preterm Infants|Terminated||Phase 2|4|Actual|Hamilton Health Sciences Corporation||2||Delay due to infrastructural reasons. Funding withdrawn|f||||t||||||||||2017-10-11 02:52:07.348206|2017-10-11 02:52:07.348206
NCT01614808|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-05-06|||June 2012||2012-06-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor|Observational - Characterization of Urinary Metabolite Profiles in Wilms Tumor|Completed||N/A|90|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Urine   "|||2017-10-11 02:52:11.087686|2017-10-11 02:52:11.087686
NCT01615003|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2014-01-12|||May 2012||2012-05-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease|The Analysis of Blood Stasis Syndromeand of Coronary Heart Disease Related MicroRNA Genomics and Target Gene Regulatory Networks|Unknown status|Recruiting|Phase 2|70|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 02:52:07.460451|2017-10-11 02:52:07.460451
NCT01614990|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-05-02|||May 2012||2012-05-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia|Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia|Recruiting||Phase 2|8|Anticipated|Garcia, Jose M., MD, PhD||2|||f||||t||||||||||2017-10-11 02:52:07.577116|2017-10-11 02:52:07.577116
NCT01614977|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-11-26|||October 2011||2011-10-01|August 2011|2011-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled Study|Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled Study|Withdrawn||Phase 3|0|Actual|Rabin Medical Center||2||Technical problems.|f||||f||||||||||2017-10-11 02:52:07.702739|2017-10-11 02:52:07.702739
NCT01614964|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-08-11|||August 2013|Actual|2013-08-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|January 2016|Actual|2016-01-01||Interventional|||Studies of a Candidate Aminoquinoline Antimalarial (AQ-13)|Phase 2 Proof of Concept Study of a Candidate Aminoquinoline Antimalarial (AQ-13)|Completed||Phase 2|66|Actual|Tulane University||2|||f||||t||||||||||2017-10-11 02:52:07.839269|2017-10-11 02:52:07.839269
NCT01614951|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-04-24|||July 2012||2012-07-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Pulmonary Protection Trial|Pulmonary Dysfunction After Open Heart Surgery: Randomized Clinical Trial With Focus on Lung-protective Interventions|Completed||Phase 4|90|Actual|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-10-11 02:52:07.973771|2017-10-11 02:52:07.973771
NCT01614938|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-06|||August 2010||2010-08-01|June 2012|2012-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer|Phase II Trial of Docetaxel-Cisplatin Neoadjuvant Chemotherapy Followed by Concurrent Radiotherapy With Cetuximab or Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma|Unknown status|Active, not recruiting|Phase 2|46|Actual|Fudan University||2|||f||||t||||||||||2017-10-11 02:52:08.052597|2017-10-11 02:52:08.052597
NCT01614925|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-08-15|||November 2012||2012-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:52:08.154427|2017-10-11 02:52:08.154427
NCT01614886|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-06-30|2015-04-16||July 2012||2012-07-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Randomized set (RAN) The RAN consisted of all randomized patients. Patients were analyzed according to the treatment group they were assigned to at randomization. A patient was diagnosed of dementia with Lewy Bodies, different from AD, after randomization and was excluded from all analysis (SAF and FAS).|Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)|A 24-week, Multicenter, Parallel-group, Randomized,Double-blind Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Methods of Rivastigmine Patch (ENA713D/ONO-2540) in Patients With Mild to Moderate Alzheimer's Disease (MMSE 10-20)|Completed||Phase 3|216|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:52:08.406932|2017-10-11 02:52:08.406932
NCT01614873|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2013-04-11|||May 2012||2012-05-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Comparison of Breathing Pattern During Neurally Adjusted Ventilatory Assist Ventilation and Pressure Support Ventilation|Comparison of Breathing Pattern During PSV and NAVA|Completed||N/A|10|Actual|Centre d'Investigation Clinique et Technologique 805||2|||f||||t||||||||||2017-10-11 02:52:10.689591|2017-10-11 02:52:10.689591
NCT01614860|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-09-07|||May 2012||2012-05-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels|Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels|Completed||N/A|90|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"     Plasma storage for potential future studies with existing or novel biomarkers.   "|||2017-10-11 02:52:10.776292|2017-10-11 02:52:10.776292
NCT01614834|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-01-05|||July 2012||2012-07-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|UCT-V||Validation of an Urticaria Control Test|Development (and Validation) of an Instrument to Assess Disease Control in Patients With Urticaria (Urticaria Control Test)|Completed||N/A|120|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 02:52:10.936596|2017-10-11 02:52:10.936596
NCT01614431|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2012-06-19|||March 2011||2011-03-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|||N Acetyl Cysteine for Cystinosis Patients|N Acetyl Cysteine Can Decrease the Progression of Renal Disease in Cystinosis Patients|Completed||Phase 4|23|Actual|University of Sao Paulo||1|||f||||||||||||||2017-10-11 02:52:18.961641|2017-10-11 02:52:18.961641
NCT01614795|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-11-01|2015-03-19||June 2012||2012-06-01|November 2016|2016-11-01||||December 2013|Actual|2013-12-01||Interventional|||Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma|A Phase II Study of Cixutumumab (IMC-A12) in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors|Active, not recruiting||Phase 2|46|Actual|National Cancer Institute (NCI)||4|||f||||t||||||||||2017-10-11 02:52:11.189915|2017-10-11 02:52:11.189915
NCT01614782|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-02-03|||June 2012||2012-06-01|February 2016|2016-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)|A Multiple Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Healthy Overweight/Obese Subjects and Patients With Type 2 Diabetes Mellitus|Terminated||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 02:52:12.44417|2017-10-11 02:52:12.44417
NCT01614769|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-03-28|2014-01-02||July 18, 2012|Actual|2012-07-18|March 2017|2017-03-01|January 23, 2013|Actual|2013-01-23|January 9, 2013|Actual|2013-01-09||Interventional|||Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)|A Study to Assess the Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus|Completed||Phase 1|10|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 02:52:12.534999|2017-10-11 02:52:12.534999
NCT01614756|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2015-08-18|||July 2012||2012-07-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis|A Two-Part, Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Study of Subcutaneous and Intravenous Administration of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody; BMS-981164) in Healthy Subjects and Adult Subjects With Atopic Dermatitis|Completed||Phase 1|93|Actual|Bristol-Myers Squibb||14|||f||||f||||||||||2017-10-11 02:52:12.939489|2017-10-11 02:52:12.939489
NCT01614743|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-09-12|||June 2012||2012-06-01|September 2014|2014-09-01|November 2014|Anticipated|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea|A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|DeNova Research||2|||f||||f||||||||||2017-10-11 02:52:13.062141|2017-10-11 02:52:13.062141
NCT01614730|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2012-07-05|||June 2012||2012-06-01|June 2012|2012-06-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|BMR-12-1002||User Evaluation in Healthy Volunteers to Verify no Pelvic Floor Contraction is Stimulated When the Modified Neurotech Vital Device is Used Compared to the Neurotech Vital Device|User Evaluation Trial in Healthy Volunteers : Modified Neurotech Vital Device|Completed||Early Phase 1|10|Actual|Bio-Medical Research, Ltd.||2|||f||||f||||||||||2017-10-11 02:52:13.150864|2017-10-11 02:52:13.150864
NCT01614717|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-04-27|||July 2014||2014-07-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|TRICHAMPION||Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients - TRICHAMPION STUDY|Triple Chamber Pacing in HOCM Patients - TRICHAMPION STUDY|Recruiting||N/A|80|Anticipated|St. Jude Medical||2|||f||||f|f|f||||||No||2017-10-11 02:52:13.342794|2017-10-11 02:52:13.342794
NCT01614704|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-02-21|||October 2011||2011-10-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility|Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility|Terminated||N/A|135|Actual|Centre Oscar Lambret|||2|End of study|f||||f|f|f||||||No||2017-10-11 02:52:13.426089|2017-10-11 02:52:13.426089
NCT01614691|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2016-03-10|||June 2012||2012-06-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Efficacy of SPARC1203 in Allergic Rhinitis||Completed||Phase 2|159|Actual|Sun Pharma Advanced Research Company Limited||4|||f||||f||||||||||2017-10-11 02:52:13.498034|2017-10-11 02:52:13.498034
NCT01614678|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-05-03|||June 2012||2012-06-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Comparison of Manufacturing Processes for AIR OPTIX® COLORS Contact Lens|AIR OPTIX® COLORS: Automated vs Semi-automated Manufacturing Processes|Completed||N/A|49|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 02:52:13.570033|2017-10-11 02:52:13.570033
NCT01614665|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2017-09-26|||April 3, 2012|Actual|2012-04-03|September 2017|2017-09-01|May 2026|Anticipated|2026-05-01|May 2026|Anticipated|2026-05-01||Interventional|||A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time|A Phase II, Parallel Group, Randomized, Multicentre, Open Label Study to Compare the Pharmacokinetics of Tacrolimus in De Novo Pediatric Allograft Recipients Treated With an Advagraf® or Prograf® Based Immunosuppressive Regimen, Including a Long-Term Follow-Up|Active, not recruiting||Phase 2|44|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 02:52:13.658769|2017-10-11 02:52:13.658769
NCT01614652|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-06-21|||December 2012||2012-12-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|PARACHUTE IV||A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System|Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease|Terminated||Phase 3|331|Actual|CardioKinetix, Inc||2||Company is closed|f||||t||||||||||2017-10-11 02:52:13.80538|2017-10-11 02:52:13.80538
NCT01614639|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-09-12|||January 2012||2012-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|May 2017|Actual|2017-05-01||Interventional|||Brain Imaging Study of Acupuncture in Chronic Low Back Pain|A Physiological fMRI Study of Acupuncture and Perceptions of Pain in Chronic Low Back Pain Patients.|Active, not recruiting||N/A|138|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 02:52:14.04107|2017-10-11 02:52:14.04107
NCT01614626|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-07-19|||November 2012|Actual|2012-11-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort|Alcohol & Zinc Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort|Active, not recruiting||N/A|375|Anticipated|Boston Medical Center|||1||f||||t|f|f||||Samples With DNA|"     We are storing serum and plasma for future use, as well as dried blood spots for PEth     testing.   "|||2017-10-11 02:52:14.14776|2017-10-11 02:52:14.14776
NCT01614613|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2016-01-29|2013-06-30||May 2012||2012-05-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Comparison Evaluation of Blood Glucose Meter Systems in a Clinical Setting|Clinical Evaluation of Bayer G3 / Tatsu System and BGMs From Other Companies|Completed||N/A|146|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 02:52:14.23537|2017-10-11 02:52:14.23537
NCT01614600|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2013-09-27|2013-09-27||June 2012||2012-06-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||This reporting group includes all enrolled and dispensed participants.|Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens Wearers|Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens Wearers|Completed||N/A|88|Actual|Alcon Research||1|||f||||t||||||||||2017-10-11 02:52:14.582869|2017-10-11 02:52:14.582869
NCT01614587|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-06-08|||March 2012||2012-03-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?|Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?|Completed||N/A|50|Actual|Atlantic Health System|||2||f||||t||||||Samples With DNA|"     DNA obtained from a buccal swab   "|||2017-10-11 02:52:14.780958|2017-10-11 02:52:14.780958
NCT01614574|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-06|2014-07-08|2014-03-25||March 2012||2012-03-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease|A Multicenter, Open-Label Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease|Completed||Phase 3|6|Actual|Shire|All 6 enrolled patients received previous long-term treatment with the enzyme replacement therapy (ERT), imiglucerase. Key therapeutic parameters were expected to indicate stability after switching from imiglucerase.|1|||f||||f||||||||||2017-10-11 02:52:14.902163|2017-10-11 02:52:14.902163
NCT01614561|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-06-06|||August 2010||2010-08-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|CEPHEUS||An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and Lebanon|CEPHEUS Centralized Pan-Levant Survey on the Undertreatment of Hypercholesterolemia NIS-LT-CRE-2010/01 Version 1.0|Completed||N/A|1000|Actual|AstraZeneca|||1||f||||f||||||None Retained|"     Blood specimens, serum, non-retained   "|||2017-10-11 02:52:15.386431|2017-10-11 02:52:15.386431
NCT01614535|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2012-06-07|||August 2011||2011-08-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Comparison of the Effect Site Concentration of Remifentanil for Preventing Cough During Emergence Between Male and Female Patients With Thyroidectomy||Completed||N/A|46|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 02:52:15.669337|2017-10-11 02:52:15.669337
NCT01614522|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-01-13|||March 2012||2012-03-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2|Phase II Open Label Study to Evaluate the Biological Activity of ASLAN001 (ARRY 334543) in Patients With Recurrent/Metastatic Gastric, Gastro-oesophageal Junction, and Oesophageal Carcinoma Whose Tumours Are Epidermal Growth Factor Receptor-2 (HER 2) Amplified or Co-expressing Epidermal Growth Factor Receptor-1 (HER-1) and HER-2.|Completed||Phase 2|24|Actual|Aslan Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:52:15.770929|2017-10-11 02:52:15.770929
NCT01614509|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-12-03|2012-08-31||January 2012||2012-01-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion||Completed||N/A|45|Actual|Yeungnam University College of Medicine|The limitation of our study include short duration of follow up (6 months) and small populations of study enroll (45 patients)|2|||f||||f||||||||||2017-10-11 02:52:16.004414|2017-10-11 02:52:16.004414
NCT01614496|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-07|2013-09-23||||||June 2013|2013-06-01||||||||Interventional|||Rule-Based Closed Loop System for Type 1 Diabetes Control||Completed||N/A|||Corporacion Parc Tauli|||||f||||||||||||||2017-10-11 02:52:16.445079|2017-10-11 02:52:16.445079
NCT01614483|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2013-01-29|||May 2012||2012-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|CASSAVITA||Efficacy of Yellow Cassava to Improve Vitamin A Status of Kenyan School Children|Efficacy of Yellow Cassava to Improve Vitamin A Status of Mildly Deficient Primary School Children in Kenya: a Randomized Controlled Trial|Completed||N/A|341|Actual|Wageningen University||3|||f||||t||||||||||2017-10-11 02:52:16.521927|2017-10-11 02:52:16.521927
NCT01614470|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-10-23|2014-10-23||July 2012||2012-07-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|KONNECTION|Full Analysis Set (FAS) was defined as all randomized subjects who received at least 1 dose of study drug (ivacaftor or placebo).|Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have a Non-G551D CF Transmembrane Conductance Regulator (CFTR) Gating Mutation|A Phase 3, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Crossover Study With an Open-Label Period to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation|Completed||Phase 3|39|Actual|Vertex Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-10-11 02:52:16.695682|2017-10-11 02:52:16.695682
NCT01614457|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-01-31|2015-01-31|2014-10-31|July 2012||2012-07-01|January 2015|2015-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|KONDUCT|Full Analysis Set (FAS) included all randomized subjects who received at least 1 dose of study drug (ivacaftor or placebo).|Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation|Completed||Phase 3|70|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||t||||||||||2017-10-11 02:52:18.026283|2017-10-11 02:52:18.026283
NCT01614444|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-05-18|||June 13, 2012|Actual|2012-06-13|May 2017|2017-05-01|March 7, 2017|Actual|2017-03-07|August 11, 2014|Actual|2014-08-11||Interventional|||Acupressure and Stress Resilience|Using Complementary and Alternative Medicine (CAM) to Promote Stress Resilience in Those With Co-Occurring Mild TBI and PTSD|Completed||N/A|60|Actual|VA Eastern Colorado Health Care System||2|||f||||||||||||||2017-10-11 02:52:18.874573|2017-10-11 02:52:18.874573
NCT01614418|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-12-18|||September 2011||2011-09-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Radiofrequency Ablation for Gastric Metaplasia and Dysplasia|Endoscopic Radiofrequency Ablation for Gastric Metaplasia and Dysplasia|Completed||Phase 1/Phase 2|10|Anticipated|The University of Hong Kong||1|||f||||f||||||||||2017-10-11 02:52:19.049046|2017-10-11 02:52:19.049046
NCT01614405|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2015-11-30|||June 2012||2012-06-01|December 2014|2014-12-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|HAART||Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis|Randomized Controlled Pilot Study of Highly Active Anti-Retroviral Therapy for Patients With Primary Biliary Cirrhosis|Completed||N/A|13|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 02:52:19.114808|2017-10-11 02:52:19.114808
NCT01614379|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2013-04-11|||June 2012||2012-06-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||Non-enhanced Magnetic Resonance Angiography of Diabetic Ischemic Lower Limbs|Non-enhanced Magnetic Resonance Angiography of Diabetic Ischemic Lower Limbs|Withdrawn||N/A|0|Actual|Aarhus University Hospital|||2||f||||t||||||Samples Without DNA|"     Blood sample less then 250ml to determine Hba1c (blood glucose level).   "|||2017-10-11 02:52:19.393987|2017-10-11 02:52:19.393987
NCT01614366|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2015-11-11|||July 2012||2012-07-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension|A Phase II Study to Explore the Effect of Different Dose of DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension|Completed||Phase 2|111|Actual|TSH Biopharm Corporation Limited||4|||f||||f||||||||||2017-10-11 02:52:19.462298|2017-10-11 02:52:19.462298
NCT01614340|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-03-14|||October 2012||2012-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|July 2014|Actual|2014-07-01||Interventional|||Treating Pain to Reduce Disability Among Older Home Health Patients|Treating Pain to Reduce Disability Among Older Home Health Patients|Completed||N/A|658|Actual|Visiting Nurse Service of New York||2|||f||||t||||||||||2017-10-11 02:52:19.763657|2017-10-11 02:52:19.763657
NCT01614327|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-09-14|||August 2012||2012-08-01|September 2017|2017-09-01|February 24, 2015|Actual|2015-02-24|February 24, 2015|Actual|2015-02-24||Observational|||Computer-based Screening for Diabetic Retinopathy|Phase 0 Observational Study of a Computer-based Screening Algorithm for Detection of Diabetic Retinopathy|Completed||N/A|19199|Actual|VisionQuest Biomedical LLC|||1||f||||f||||||||||2017-10-11 02:52:19.844164|2017-10-11 02:52:19.844164
NCT01614314|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-07|||August 2011||2011-08-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Dressing of Tunneled Central Venous Catheter|Dressing of Tunneled Central Venous Catheter: Preceptorship's Presence or Use of Auto-instructional Guide|Completed||N/A|35|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 02:52:19.942056|2017-10-11 02:52:19.942056
NCT01614301|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-05|||May 2012||2012-05-01|June 2012|2012-06-01|May 2016|Anticipated|2016-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma|A Prospective Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial of Temsirolimus in Combination With Pioglitazone, Etoricoxib and Metronomic Low-dose Trofosfamide Versus Dacarbazine (DTIC) in Patients With Advanced Melanoma|Unknown status|Recruiting|Phase 1/Phase 2|136|Anticipated|University of Regensburg||2|||f||||t||||||||||2017-10-11 02:52:20.028915|2017-10-11 02:52:20.028915
NCT01614288|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-02-06||||||February 2013|2013-02-01||||||||Interventional|||High Tibial Osteotomy (HTO) With or Without Arthroscopy of the Knee Joint|A Randomized Clinical Trial to Compare the Effectiveness of High Tibial Osteotomy (HTO) With or Without Arthroscopy of the Knee Joint on Quality of Life, Function, Pain and Swelling for Patients With Medical Compartment Osteoarthritis of the Knee|Withdrawn||N/A|0|Actual|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 02:52:20.155783|2017-10-11 02:52:20.155783
NCT01614262|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-04-17|||June 2012||2012-06-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Examining The Role of CGM in T2DM|Examining the Role of Continuous Glucose Monitoring (CGM) in Non-Insulin Treated Type 2 Diabetes|Completed||N/A|35|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:52:20.44375|2017-10-11 02:52:20.44375
NCT01614249|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-02-09|2015-11-25||June 2012||2012-06-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Omega-3 Supplementation and Depression Clinical Trial|Role of Omega-3 Fish Oil Fatty Acids on Depression Among HIV-seropositive Pregnant Pregnant Women in Nairobi: A Randomized Double-blind Controlled Trial|Completed||Phase 2/Phase 3|216|Actual|University of Nairobi|Omega-3 intake value based on international database due to absence in local food composition database. Cellular level EPA/DHA not reported due to technical problems with collected samples.|2|||f||||t||||||||||2017-10-11 02:52:20.57888|2017-10-11 02:52:20.57888
NCT01614236|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2012-06-06|||July 2012||2012-07-01|June 2012|2012-06-01||||August 2013|Anticipated|2013-08-01||Interventional|||Pre- Versus Post-Incisional Pregabalin for Postoperative Pain Control||Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 02:52:21.560202|2017-10-11 02:52:21.560202
NCT01614028|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-04-08||||||April 2013|2013-04-01||||||||Interventional|||Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem||Unknown status|Recruiting|N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-11 02:52:23.371976|2017-10-11 02:52:23.371976
NCT01614223|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-04-24|||September 2010||2010-09-01|April 2014|2014-04-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Autologous Conditioned Plasma (ACP) for Patients With Plantar Fasciitis|A Randomized Double-Blind Clinical Trial to Investigate the Use of Autologous Conditioned Plasma (ACP) for Patients With Plantar Fasciitis|Unknown status|Recruiting|N/A|140|Anticipated|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 02:52:21.647567|2017-10-11 02:52:21.647567
NCT01614197|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-05-31|||March 2015||2015-03-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma|A Phase I Trial of Temsirolimus (CCI-779, Pfizer, Inc.) in Combination With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma|Recruiting||Phase 1|30|Anticipated|Therapeutic Advances in Childhood Leukemia Consortium||1|||f||||t||||||||No||2017-10-11 02:52:21.825825|2017-10-11 02:52:21.825825
NCT01614184|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-07-08|||May 2008||2008-05-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer|Fluorescein for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Operable Breast Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|University of Utah||1|||f||||t||||||||||2017-10-11 02:52:22.099829|2017-10-11 02:52:22.099829
NCT01614171|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-04-20|||December 2013||2013-12-01|April 2017|2017-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|GHOPPG||Growth Hormone for Osteoporosis Pseudoglioma Syndrome|Trial of Growth Hormone for Osteoporosis Pseudoglioma Syndrome|Withdrawn||N/A|0|Actual|University of Maryland||1||it was never started because it was never funded|f||||t||||||||||2017-10-11 02:52:22.207785|2017-10-11 02:52:22.207785
NCT01614158|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-05-27|||April 2009||2009-04-01|May 2014|2014-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|Pilot-SINN||Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy|Pilot SINN; Assessment of Visual Field (vf)-Related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy (N-AION)|Completed||N/A|16|Actual|University Hospital Tuebingen|||1||f||||f||||||||||2017-10-11 02:52:22.317109|2017-10-11 02:52:22.317109
NCT01614145|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-05-05|||September 2007||2007-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Diagnostic Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples|Diagnostic Study Evaluating the Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis|Enrolling by invitation||N/A|200|Anticipated|Heidelberg University|||2||f||||f||||||Samples With DNA|"     Aspergillus DNA samples   "|||2017-10-11 02:52:22.424665|2017-10-11 02:52:22.424665
NCT01614132|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-09-14|||January 2009||2009-01-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|September 2020|Anticipated|2020-09-01||Interventional|NOA-07||Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults|Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults (NOA-07)|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|University of Regensburg||1|||f||||f||||||||||2017-10-11 02:52:22.508062|2017-10-11 02:52:22.508062
NCT01614119|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-06-04|||June 2010||2010-06-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|CERVOX||Cerebral Responses During Exercise in Hypoxia|Evaluation of the Cerebral Responses to Exercise in Hypoxia|Completed||N/A|30|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-11 02:52:22.630488|2017-10-11 02:52:22.630488
NCT01614106|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-04-20|||January 2013||2013-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users|Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users|Active, not recruiting||N/A|360|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 02:52:22.717077|2017-10-11 02:52:22.717077
NCT01614093|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-08-24|2017-04-14||June 2012||2012-06-01|August 2017|2017-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia|Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia|Completed||Phase 4|24|Actual|University of Maryland||2|||f||||t|t|f||||||||2017-10-11 02:52:22.819127|2017-10-11 02:52:22.819127
NCT01614080|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-12-18|||November 2011||2011-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|OPHELIE||Outcome of Patients Treated by iv Rt-PA for Cerebral Ischaemia According to the Ratio Sc-tPA/Tc-tPA|Outcome of Patients Treated by iv Rt-PA for Cerebral Ischaemia According to the Ratio Sc-tPA/Tc-tPA in the Administered Rt-PA|Completed||N/A|700|Actual|University Hospital, Lille|||2||f||||t||||||||||2017-10-11 02:52:23.037635|2017-10-11 02:52:23.037635
NCT01614067|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-07-17|||May 2012||2012-05-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|DOS/DOR||Delayed Start to Ovarian Stimulation|Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial|Terminated||N/A|26|Actual|University of California, San Francisco||2||Slow enrollment resulted in withdraw of funding|f||||f||||||||||2017-10-11 02:52:23.109571|2017-10-11 02:52:23.109571
NCT01614054|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2014-03-14|||June 2012||2012-06-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|N-PATCH||Nicotine Replacement Provided at a Tertiary Care Hospital|A Patient-centered Approach to Behavioral Modification in a Tertiary-care University-affiliated Hospital and the Incidence of Smoking Cessation|Completed||N/A|100|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:52:23.200511|2017-10-11 02:52:23.200511
NCT01614041|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2016-10-13|||November 2011||2011-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|TACGAD||Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder|Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder: a Multi-center, Randomized, Usual Dose-controlled Trial|Recruiting||Phase 4|300|Anticipated|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.||2|||f||||t||||||||||2017-10-11 02:52:23.268556|2017-10-11 02:52:23.268556
NCT01614015|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-10-17|||September 2010||2010-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|BOOST||Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial|Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial|Completed||Phase 2|328|Actual|Oregon Research Institute||2|||f||||t||||||||||2017-10-11 02:52:23.545088|2017-10-11 02:52:23.545088
NCT01614002|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2015-06-03|||May 2012||2012-05-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer|Open, Multicenter Observational Study of Docetaxel Utilized in Mono- or Combination Therapy for Treatment of Breast Cancer, NSCLC, Prostate Carcinoma, Adenocarcinoma of Stomach and Advanced Squamous Cell Carcinoma of Head/Neck Region.|Completed||N/A|371|Actual|Onkovis GmbH|||1||f||||t||||||||||2017-10-11 02:52:23.632499|2017-10-11 02:52:23.632499
NCT01613989|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-08-20|||June 2012||2012-06-01|August 2014|2014-08-01|November 2014|Anticipated|2014-11-01|November 2013|Actual|2013-11-01||Interventional|NAVEOS||Total Hip Prosthesis Assisted by Computer|Total Hip Prosthesis Assisted by Computer Based on Pre-operative EOS Imaging|Unknown status|Active, not recruiting|N/A|78|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 02:52:23.865093|2017-10-11 02:52:23.865093
NCT01613976|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-01-13|||August 2012||2012-08-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients|A Phase Ib, Open-label, Multi-center, Dose-escalation Study of Oral Panobinostat (LBH589) Administered With 5-Azacitidine (Vidaza®) in Adult Japanese Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML)|Completed||Phase 1|10|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:52:23.961927|2017-10-11 02:52:23.961927
NCT01613963|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-06-05|||May 2012||2012-05-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Causes of Visual Loss in Retinal Disease|Observational Study of Visual Outcomes in Retinal Disease|Unknown status|Enrolling by invitation|N/A|2000|Anticipated|Royal Surrey County Hospital|||1||f||||f||||||||||2017-10-11 02:52:24.072768|2017-10-11 02:52:24.072768
NCT01613950|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-02-13|||December 2012||2012-12-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer|A Phase IB, Multicenter, Open-label Dose Escalation Study of the PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer Carrying a Molecular Alteration of PIK3CA or an Amplification of HER2|Completed||Phase 1|18|Actual|Novartis||1|||f||||||||||||||2017-10-11 02:52:24.178773|2017-10-11 02:52:24.178773
NCT01613937|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-11-17|||December 2009||2009-12-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2011|Actual|2011-09-01||Interventional|||Community Approach to Reduce the Risks of Diabetes After Gestational Diabetes Mellitus|Dulce Mothers: A Community Approach to Reduce the Risks of Developing Diabetes After Gestational Diabetes|Completed||N/A|67|Actual|Scripps Whittier Diabetes Institute||1|||f||||t||||||||||2017-10-11 02:52:24.292271|2017-10-11 02:52:24.292271
NCT01613924|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-12-02|||July 2013||2013-07-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of Handheld Acne Heat Device|Efficacy of a Handheld Heat Based Device for the Spot Treatment of Mild to Moderate Acne Vulgaris: A Controlled Study to Determine Time to Resolution of Individual Inflammatory Lesions Using an Over-the-counter Acne Heat Device.|Withdrawn||Phase 4|0|Actual|University of British Columbia||2||Lack of funding and resources|f||||f||||||||||2017-10-11 02:52:24.371576|2017-10-11 02:52:24.371576
NCT01613911|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-12-04|||March 2012||2012-03-01|September 2014|2014-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Study of Human Sensory Perception|A Combined fMRI and Electrophysiological Study of Human Sensory Perception|Completed||N/A|6|Actual|Swedish Medical Center|||1||f||||f||||||||||2017-10-11 02:52:24.452921|2017-10-11 02:52:24.452921
NCT01613898|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-06-06|||August 2010||2010-08-01|June 2012|2012-06-01|June 2015|Anticipated|2015-06-01|May 2013|Anticipated|2013-05-01||Observational|CTX||Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis|Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis|Unknown status|Recruiting|N/A|17|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples Without DNA|"     Lipid and lipoprotein profiles   "|||2017-10-11 02:52:24.529089|2017-10-11 02:52:24.529089
NCT01613885|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-11-24|||August 2010||2010-08-01|November 2015|2015-11-01||||December 2016|Anticipated|2016-12-01||Observational|||Understanding and Diagnosing Allergic Disease in Twins|Understanding and Diagnosing Allergic Disease in Twins|Recruiting||N/A|200|Anticipated|Stanford University|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 02:52:24.631757|2017-10-11 02:52:24.631757
NCT01613872|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-09-30|||May 2012||2012-05-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||The Effects of Mindfulness Based Stress Reduction on Patients With Traumatic Brain Injury|The Effects of Mindfulness Based Stress Reduction on Patients With Traumatic Brain Injury|Completed||N/A|8|Actual|Spaulding Rehabilitation Hospital||2|||f||||f||||||||||2017-10-11 02:52:24.720928|2017-10-11 02:52:24.720928
NCT01613859|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-05-25|||January 2012||2012-01-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Measurement of Cardiac Output and Intravascular Volume Status in Children Using COstatus (SH)|Measurement of Cardiac Output and Intravascular Volume Status in Critically Ill Children Using an Ultrasound Dilution Method (COstatus)|Completed||N/A|9|Actual|Transonic Systems Inc.|||1||f||||||||||||||2017-10-11 02:52:24.841652|2017-10-11 02:52:24.841652
NCT01613846|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-04-19|||May 2012||2012-05-01|April 2017|2017-04-01||||October 30, 2016|Actual|2016-10-30||Interventional|||Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)|Phase III Randomized Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma|Completed||Phase 3|544|Anticipated|Technische Universität München||2|||f||||||||||||||2017-10-11 02:52:24.934279|2017-10-11 02:52:24.934279
NCT01604356|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-03-03|||April 2012||2012-04-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa|Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa|Completed||Phase 1|19|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 02:56:29.20056|2017-10-11 02:56:29.20056
NCT01613820|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-03-02|||September 2015||2015-09-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder|Combination of Anticholinergic and Glutamatergic Effects in Treatment-resistant Major Depressive Disorder. A Pilot Study|Terminated||N/A|3|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 02:52:25.292966|2017-10-11 02:52:25.292966
NCT01613794|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-01-13|||December 2012||2012-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|START||Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis|Prospective Randomized Controlled, Open Label, Clinical Trial to Study if Rosuvastatin Use Improves the Coagulation Profile in Patients With Venous Thrombosis|Completed||N/A|255|Actual|Leiden University Medical Center||2|||f||||t||||||||Undecided||2017-10-11 02:52:25.474317|2017-10-11 02:52:25.474317
NCT01613781|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2013-12-24|||June 2012||2012-06-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery|Determination of Target of Adequate Partial Neuromuscular Blockade With Sevoflurane Anesthesia for Electrophysiologic Monitoring During Microvascular Decompression Surgery|Completed||N/A|61|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 02:52:25.58291|2017-10-11 02:52:25.58291
NCT01613768|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-02-17|||May 8, 2012|Actual|2012-05-08|February 2017|2017-02-01|September 1, 2017|Anticipated|2017-09-01|September 1, 2017|Anticipated|2017-09-01||Interventional|||Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer|Phase II Trial of Eribulin for Locally Advanced Refractory or Metastatic Salivary Gland Cancers|Active, not recruiting||Phase 2|29|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 02:52:25.694308|2017-10-11 02:52:25.694308
NCT01613755|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-04-26|||April 2012||2012-04-01|March 2012|2012-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|MetDipy||Metformin-Dipyridamole Interaction Trial|The Effect of Dipyridamole on the Pharmacokinetics of Metformin|Completed||Phase 4|18|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 02:52:25.816373|2017-10-11 02:52:25.816373
NCT01613742|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2013-11-21|||July 2012||2012-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:52:25.90289|2017-10-11 02:52:25.90289
NCT01613729|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-09-22|||July 2012||2012-07-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|Cor16||Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin|An Open-label, Randomized, Multi-centre, Phase IVb, Parallel Study Group to Compare the Efficacy and Safety of 5 mg and 10 mg Rosuvastatin|Unknown status|Enrolling by invitation|Phase 4|2000|Anticipated|D16 Pharma & Biotec Ltd.||2|||f||||t||||||||||2017-10-11 02:52:25.956869|2017-10-11 02:52:25.956869
NCT01613716|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-04-18|||July 2012|Actual|2012-07-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|OPERA||Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)|Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)|Completed||Phase 4|30|Actual|The Cleveland Clinic||1|||f||||t||||||||No||2017-10-11 02:52:26.071311|2017-10-11 02:52:26.071311
NCT01613703|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2013-05-31|||August 2012||2012-08-01|May 2013|2013-05-01||||March 2013|Actual|2013-03-01||Interventional|||ONO-2952 Single-dose PET Study in Healthy Adult Subjects|Open-Label, Single-Center, Single Dose Positron Emission Topography (PET) Using [11C]PBR28 to Evaluate Brain Translocator Protein 18KDa (TSPO) Occupancy of ONO-2952 in Healthy Adult Subjects|Completed||Phase 1|16|Actual|Ono Pharmaceutical Co. Ltd||1|||f||||||||||||||2017-10-11 02:52:26.166259|2017-10-11 02:52:26.166259
NCT01613690|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-05|||June 2010||2010-06-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment|An Open Label, Non-randomized, Parallel-group Study to Characterize and Compare the Pharmacokinetics, Safety, and Tolerability of a Single Dose of NVA237 in Subjects With Mild, Moderate, Severe and End-stage Renal Impairment With That in Matched Healthy Control Subjects|Completed||Phase 1|48|Actual|Novartis||5|||f||||||||||||||2017-10-11 02:52:26.250553|2017-10-11 02:52:26.250553
NCT01613677|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-04-19|||November 2015||2015-11-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer|Phase II, Open Label, Non-randomized, Trial of BKM120 as Palliative Treatment for Metastatic or Locally Advanced Cervical Cancer After Failure to Platinum Based Regimen|Withdrawn||Phase 2|0|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:52:26.365017|2017-10-11 02:52:26.365017
NCT01613664|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-01-30|||February 2014||2014-02-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|TISSEEL||Efficiency of TISSEEL for Sleeve Gastrectomy Complications|Randomized Prospective Clinical Study Evaluating the Usefulness of Fibrin Glue (TISSEEL® KIT) to Prevent Gastric Fistula, Intra Abdominal Haemorrhage and Intra Abdominal Loco Regional Collections After Laparoscopic Sleeve Gastrectomy|Recruiting||Phase 3|600|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||t||||||||||2017-10-11 02:52:26.458309|2017-10-11 02:52:26.458309
NCT00005204|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||August 1987||1987-08-01|November 2001|2001-11-01|July 1989|Actual|1989-07-01|||||Observational|||Blood Pressure and Diurnal Variation in Sodium, Potassium, and Water Excretion||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.772895|2017-10-11 04:26:37.772895
NCT01613651|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-09-13|||August 24, 2012|Actual|2012-08-24|September 2017|2017-09-01|September 11, 2017|Actual|2017-09-11|September 11, 2017|Actual|2017-09-11||Interventional|||Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer|A Prospective Randomized Trial of Pelvic Drain Placement Versus no Pelvic Drain Placement After Robotic Assisted Laparoscopic Prostatectomy (RALP) in Patients With Prostate Cancer|Completed||Phase 3|191|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 02:52:26.572234|2017-10-11 02:52:26.572234
NCT01613638|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-01-16|||October 2012||2012-10-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PENEW||Pregnancy Environment and Newborn Malformations|"Congenital Malformations and Intrauterine Pollutants Exposure (Alcohol, Solvents and Pesticides) in Brittany. Population Based Case-control Study Short Title : Malformations and Environment Acronym : PENEW for Pregnancy Environment and Newborn Malformations"|Recruiting||N/A|5000|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 02:52:26.677639|2017-10-11 02:52:26.677639
NCT01613625|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-26|2014-08-28|||January 2011||2011-01-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Interest Of Renal Elastography In Children As A Diagnostic Tool Of Renal Fibrosis: Confrontation To Histological Features Of Renal Biopsies|Interest Of Renal Elastography In Children As A Diagnostic Tool Of Renal Fibrosis: Confrontation To Histological Features Of Renal Biopsies|Unknown status|Active, not recruiting|N/A|100|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:52:26.855778|2017-10-11 02:52:26.855778
NCT01613612|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-08-12|||March 2009||2009-03-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Interventional|||Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH)|Control Study of Implantation of Enriched Bone Marrow Cells for the Treatment of Avascular Necrosis of Femoral Head|Unknown status|Enrolling by invitation|Phase 2/Phase 3|60|Anticipated|Guangdong General Hospital||2|||f||||f||||||||||2017-10-11 02:52:26.927974|2017-10-11 02:52:26.927974
NCT01613599|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-08-10|2016-07-06||June 20, 2012|Actual|2012-06-20|August 2017|2017-08-01|April 28, 2017|Actual|2017-04-28|July 13, 2015|Actual|2015-07-13||Observational||Safety population included all participants who received any dose of rituximab and whose safety data was verifiable.|An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis|Prospective, Observational Safety Study of Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Treated With Rituximab|Completed||N/A|100|Actual|Genentech, Inc.|||1||f||||t||||||||||2017-10-11 02:52:27.027107|2017-10-11 02:52:27.027107
NCT01613586|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-03-26|||May 2012||2012-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|AMARANTH||A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Adaptive, Combined Proof of Concept and Dose-Finding Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP3652 in the Treatment of Female Subjects With Bladder Pain Syndrome / Interstitial Cystitis|Completed||Phase 2|287|Actual|Astellas Pharma Inc||4|||f||||t||||||||||2017-10-11 02:52:27.498895|2017-10-11 02:52:27.498895
NCT01613573|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-06-13|||March 2010||2010-03-01|October 2010|2010-10-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|Phase 1||Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children|A Phase 1, Open-Label, Single and Multiple Dose Study to Assess the Safety and Pharmacokinetics of Pegylated Somatropin(PEG Somatropin) in GHD Children|Completed||Phase 1|12|Actual|GeneScience Pharmaceuticals Co., Ltd.||1|||f||||t||||||||||2017-10-11 02:52:27.87204|2017-10-11 02:52:27.87204
NCT01613560|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2017-02-24|||June 2012||2012-06-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy|Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy|Recruiting||Phase 2|404|Anticipated|Peking University||3|||f||||t||||||||||2017-10-11 02:52:27.964846|2017-10-11 02:52:27.964846
NCT01613547|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2014-05-20|||October 2012||2012-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of Routine Antibiotic Use in the Outpatient Treatment of Severely Malnourished Children Without Complications|The Effect of Routine Antibiotic Use in the Outpatient Treatment of Severely Malnourished Children Without Complications: Maradi, Niger|Completed||N/A|2412|Anticipated|Epicentre||2|||f||||f||||||||||2017-10-11 02:52:28.153869|2017-10-11 02:52:28.153869
NCT01613534|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-05|||June 2003||2003-06-01|June 2012|2012-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Combined Therapy in Radiation Proctopathy|Argon Plasma Coagulation Plus Placebo or Oral Sucralfate for Chronic Radiation Proctopathy: a Randomized Placebo Controlled Trial|Completed||Phase 4|122|Actual|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||f||||||||||2017-10-11 02:52:28.285183|2017-10-11 02:52:28.285183
NCT01613521|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2014-03-12|||June 2012||2012-06-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer|Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer|Terminated||N/A|3|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-11 02:52:28.453498|2017-10-11 02:52:28.453498
NCT01613508|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-01-22|||January 2013||2013-01-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Randomized Study of Approaches in Total Hip Arthroplasty|A Randomized Clinical Trial of Direct Anterior Approach and Mini-Posterior Approach Total Hip Arthroplasty|Active, not recruiting||N/A|116|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:52:28.593099|2017-10-11 02:52:28.593099
NCT01613495|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2012-06-04|||August 2005||2005-08-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|March 2009|Actual|2009-03-01||Interventional|||Ghrelin Suppression by Octreotide in Prader-Willi|Ghrelin Suppression by Sandostatin LAR® Depot (Octreotide Acetate for Injectable Suspension) in Patients With Prader-Willi Syndrome|Completed||N/A|2|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 02:52:28.693537|2017-10-11 02:52:28.693537
NCT00005229|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1988||1988-07-01|December 2001|2001-12-01|June 1993|Actual|1993-06-01|||||Observational|||HIV-Associated Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.410752|2017-10-11 04:26:39.410752
NCT01613482|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-06-06|||October 2007||2007-10-01|June 2012|2012-06-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|TSARINE||TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention|Interest of the Prophylactic Cerebral Radiotherapy in the Metastatic Breast Cancer Expressing HER2/NEU Treated by Trastuzumab|Terminated||Phase 3|13|Actual|Centre Oscar Lambret||2||Lack of enrollment|f||||f||||||||||2017-10-11 02:52:28.830671|2017-10-11 02:52:28.830671
NCT01613469|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-04-01|||August 2011||2011-08-01|April 2015|2015-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer|Maintenance of Chemotherapy Following Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer|Unknown status|Recruiting|Phase 2|35|Anticipated|Marks, John, M.D.||1|||f||||f||||||||||2017-10-11 02:52:29.015347|2017-10-11 02:52:29.015347
NCT01613456|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-05-13|||December 2011||2011-12-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome|Effect of S.Cerevisiae vs Placebo on the Improvement of Gastrointestinal Disorders,Especially During Irritable Bowel Syndrome. Randomized, Double-blind Study|Completed||N/A|364|Actual|Lesaffre International||2|||f||||||||||||||2017-10-11 02:52:29.147558|2017-10-11 02:52:29.147558
NCT01613443|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2017-04-04|||June 2012||2012-06-01|April 2017|2017-04-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Observational|||Ex-vivo Effect of New Oral Anticoagulants on Point-of-care Devices|Time-dependent ex Vivo Influence of Rivaroxaban on Point-of-care Devices|Completed||N/A|100|Actual|Cardioangiologisches Centrum Bethanien|||4||f||||f||||||||||2017-10-11 02:52:29.282309|2017-10-11 02:52:29.282309
NCT01613430|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-08-25|||June 2012||2012-06-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|COACH||Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors|Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors (COACH)|Unknown status|Active, not recruiting|N/A|1106|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 02:52:29.36049|2017-10-11 02:52:29.36049
NCT01613417|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-06-04|2015-04-28||August 2012||2012-08-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|TRUTH|Per Protocol|Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain|Phase IV, Double-blind, Multi-center, Randomized, Crossover Study to Compare 0.1 mmol/kg of Prohance® With 0.1 mmol/kg of Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain (TRUTH)|Completed||Phase 4|229|Actual|Bracco Diagnostics, Inc|Histologic confirmation of disease available for only 139/198 patients in the PP analysis. Of these, 128 patients had confirmed brain tumors and were available for the analyses of diagnostic performance (tumor detection and tumor characterization).|2|||f||||f||||||||||2017-10-11 02:52:29.506421|2017-10-11 02:52:29.506421
NCT01613404|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-01-20|||February 2012||2012-02-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|PROSTARRT||An Observational Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis|A Prospective, Observational, Randomized Comparative Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis|Completed||Phase 4|248|Actual|Janssen Inc.|||2||f||||t||||||||||2017-10-11 02:52:30.580809|2017-10-11 02:52:30.580809
NCT01613391|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-08|||July 2011||2011-07-01|June 2012|2012-06-01||||February 2012|Actual|2012-02-01||Observational|||Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides|Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides|Completed||N/A|30|Actual|Istanbul University|||2||f||||||||||||||2017-10-11 02:52:30.687208|2017-10-11 02:52:30.687208
NCT01613378|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-08-10|2016-01-14||February 2012||2012-02-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra)|A Multi-National, Multi-Center Non-Interventional Study in Rheumatoid Arthritis (RA) Patients Who Are Treated With Tocilizumab|Completed||N/A|200|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:52:30.768239|2017-10-11 02:52:30.768239
NCT01613365|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2015-08-06|||May 2012||2012-05-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CHLORHEX||Oropharyngeal and Nasopharyngeal Decontamination With Chlorhexidine Gluconate in the Reduction of the Postoperative Morbidity and Mortality After Major Pulmonary Resections|Oropharyngeal and Nasopharyngeal Decontamination With Chlorhexidine Gluconate in the Reduction of the Postoperative Morbidity and Mortality After Major Pulmonary Resections: a Multicentric, Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 3|474|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 02:52:31.388855|2017-10-11 02:52:31.388855
NCT01613352|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2012-06-05|||March 2008||2008-03-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Feasibility of Ambulatory Surgery for Early Breast Cancer|Same Day Discharge After Surgery for Early Breast Cancer - a Feasible Option|Completed||N/A|100|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 02:52:31.485235|2017-10-11 02:52:31.485235
NCT01613339|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-12-04|2013-06-07||October 2011||2011-10-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Body Awareness Therapy for People With Stroke|Body Awareness Therapy for People With Stroke|Completed||N/A|46|Actual|Örebro County Council||2|||f||||f||||||||||2017-10-11 02:52:31.581053|2017-10-11 02:52:31.581053
NCT01613326|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-04-22|2014-01-10||June 2012||2012-06-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|GLOW5||Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A 12-week Treatment, Randomized, Blinded, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of NVA237 (50 µg o.d.) Compared to Tiotropium (18 µg o.d.) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|657|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:52:31.934905|2017-10-11 02:52:31.934905
NCT01613313|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-08-25|2016-02-10||May 2012||2012-05-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma|A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma|Completed||Phase 2|14|Actual|Gerut, Zachary, M.D.||4|||f||||f||||||||No||2017-10-11 02:52:36.099534|2017-10-11 02:52:36.099534
NCT00005230|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1988||1988-07-01|December 2004|2004-12-01|June 2003|Actual|2003-06-01|||||Observational|||Epidemiology of Carotid Disease in Elderly Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.460307|2017-10-11 04:26:39.460307
NCT01613300|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-05|2016-08-31|||May 2012||2012-05-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients|Ofatumumab as Part of the Reduced Intensity Conditioning Regimen (RIC) for Patients With High Risk B Non Hodgkin's Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation|Active, not recruiting||Phase 2|33|Actual|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||f||||||||No||2017-10-11 02:52:37.066609|2017-10-11 02:52:37.066609
NCT01613287|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2013-12-06|||June 2012||2012-06-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension|A Clinical Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension|Completed||N/A|12|Actual|Miltenyi Biotec GmbH||1|||f||||t||||||||||2017-10-11 02:52:37.200143|2017-10-11 02:52:37.200143
NCT01613274|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2014-04-21|||June 2012||2012-06-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||The Effect of Gum Chewing on Bowel Motility in Post-operative Colon Resection Patients|The Effect of Gum Chewing on Bowel Motility in Post-operative Colon Resection Patients|Completed||Phase 3|80|Actual|Allina Health System||2|||f||||f||||||||||2017-10-11 02:52:37.324387|2017-10-11 02:52:37.324387
NCT01613261|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2013-10-31|||August 2013||2013-08-01|October 2013|2013-10-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|||Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies|A Multicenter, Open-label, Phase 1b Study of TAK-733 (an Oral MEK Inhibitor) in Combination With Alisertib (an Oral Aurora A Kinase Inhibitor) in Adult Patients With Advanced Nonhematologic Malignancies|Withdrawn||Phase 1|0|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:52:37.414224|2017-10-11 02:52:37.414224
NCT01613248|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-08-08|2016-08-08||July 2012||2012-07-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||All Subjects as Treated Population included all randomized participants who received at least 1 dose of study treatment.|A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)|A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine|Completed||Phase 2|834|Actual|Allergan||6|||f||||f||||||||||2017-10-11 02:52:37.556953|2017-10-11 02:52:37.556953
NCT01613235|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2015-02-02|||August 2010||2010-08-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|January 2015|Actual|2015-01-01||Interventional|HIMALAIA||Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage|Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage|Terminated||Phase 3|26|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2||As advised by the DSMB the study was stopped due to slow recruitment.|f||||t||||||||||2017-10-11 02:52:39.746603|2017-10-11 02:52:39.746603
NCT01613209|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-05-02|||December 2011||2011-12-01|May 2016|2016-05-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|Sevicontrol1||Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine|Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan 40 mg / Amlodipine 10 mg in Patients With Insufficiently Controlled Hypertension Under Monotherapy With Candesartan 32 mg - an Open Phase IIIb Trial|Completed||Phase 3|83|Actual|Institut für Pharmakologie und Präventive Medizin||1|||f||||t||||||||No||2017-10-11 02:52:40.106894|2017-10-11 02:52:40.106894
NCT01613196|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-06-13|||May 2012|Actual|2012-05-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|TUBOGTEP||Positron Emission Tomography in Extrapulmonary Tuberculosis|Evaluation of Positron Emission Tomography in Extrapulmonary Tuberculosis|Completed||N/A|55|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||Undecided||2017-10-11 02:52:40.246847|2017-10-11 02:52:40.246847
NCT01613183|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-06-04|||May 2012||2012-05-01|June 2012|2012-06-01||||||||Interventional|||Exploratory Study of Effective Core Formula of Chinese Medicine to Treat Primary Insomnia||Unknown status|Recruiting|N/A|2||China Academy of Chinese Medical Sciences||2|||f||||f||||||||||2017-10-11 02:52:40.331302|2017-10-11 02:52:40.331302
NCT01613170|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-04-18|||April 2012||2012-04-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Premarin Versus Toviaz for Treatment of Overactive Bladder|A Combined Treatment Program for the Symptoms of Urinary Urgency and Frequency With Toviaz and Premarin Vaginal Cream|Recruiting||Phase 4|90|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No||2017-10-11 02:52:40.417958|2017-10-11 02:52:40.417958
NCT01613157|ClinicalTrials.gov processed this data on October 10, 2017|2009-11-05|2012-06-04|||January 2006||2006-01-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression||Completed||N/A|88|Actual|Canadian Immunodeficiency Research Collaborative|||1||f||||||||||||||2017-10-11 02:52:40.54095|2017-10-11 02:52:40.54095
NCT01613144|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-01-15|||May 2012||2012-05-01|January 2016|2016-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|EVOLVE||OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate|Expandable Pedicle Screws Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate (PMMA): Complications and Clinical Outcomes in Patients With Osteoporosis or Poor Bone Quality|Active, not recruiting||N/A|90|Actual|Alphatec Spine, Inc.|||2||f||||f||||||||||2017-10-11 02:52:40.640565|2017-10-11 02:52:40.640565
NCT01613131|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-10-29|2015-08-11||April 2012||2012-04-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression|Effectiveness of Perimenopausal Hormone Therapy in Suppression of Ovulation, Stabilization of Reproductive Hormones and Symptom Control|Completed||N/A|39|Actual|University of Colorado, Denver|The main limitation was the sample size, which is consistent with a pilot study, and which can only inform the design of future research.|2|||f||||t||||||||||2017-10-11 02:52:40.779858|2017-10-11 02:52:40.779858
NCT01612923|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-08-25|||April 2011||2011-04-01|June 2012|2012-06-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Safety and Efficacy of Medical Abortion Provided by Midlevel Providers or Physicians|Safety and Efficacy of Medical Abortion Provided by Midlevel Providers or Physicians|Completed||Phase 3|1180|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 02:52:43.976674|2017-10-11 02:52:43.976674
NCT01613118|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-10-18|||December 2013||2013-12-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|June 2016|Actual|2016-06-01||Interventional|DUET||Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis|Efficacy and Safety of RE-021, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, in Patients With Focal Segmental Glomerulosclerosis (FSGS): a Randomized, Double-Blind, Active-Control, Dose-Escalation Study|Active, not recruiting||Phase 2|100|Anticipated|Retrophin, Inc.||4|||f||||t||||||||||2017-10-11 02:52:41.280983|2017-10-11 02:52:41.280983
NCT01613105|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-06-24|||April 2008||2008-04-01|June 2013|2013-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Diabetes Treatment With Glucobay in Combination With Sulfonylurea|Prospecitve, Non Interventional, Non Controlled, Post Marketing Survelliance Study to Evaluate Efficacy, Safety, Tolerability of Glucobay on Top of Sulfonylurea Under Daily Life Treatment Conditions|Completed||N/A|4564|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:52:41.529533|2017-10-11 02:52:41.529533
NCT01613092|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-10-09|||May 2011||2011-05-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Prevention of Arrhythmia Device Infection Trial (PADIT)|Prevention of Arrhythmia Device Infection Trial (PADIT) Cluster Crossover Pilot Study|Completed||Phase 4|241|Actual|Population Health Research Institute||2|||f||||t||||||||||2017-10-11 02:52:41.640749|2017-10-11 02:52:41.640749
NCT01613079|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-08-02|||May 2012||2012-05-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|TRIFRA||Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis|Evaluation of Oral T2 (Chloroform/Methanol Extract of Tripterygium Wilfordii Hook F) in the Treatment of RA Patients With Clinical Efficacy and Safety.|Completed||Phase 2/Phase 3|201|Actual|Peking Union Medical College Hospital||3|||f||||t||||||||||2017-10-11 02:52:41.756236|2017-10-11 02:52:41.756236
NCT01613066|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-06-05|||November 2008||2008-11-01|June 2012|2012-06-01|May 2013|Anticipated|2013-05-01|November 2012|Anticipated|2012-11-01||Interventional|||Intra-bone Cord Blood Transplantation in Patients With Haematological Malignancies|Intra-bone Cord Blood Transplantation in Patients With Haematological Malignancies|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Ospedale Santa Croce-Carle Cuneo||1|||f||||f||||||||||2017-10-11 02:52:41.850687|2017-10-11 02:52:41.850687
NCT01613053|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-04-23||||||April 2015|2015-04-01||||||||Expanded Access|MACS2226||Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination|Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination|No longer available||N/A|||Novartis|||||f||||f||||||||||2017-10-11 02:52:41.944531|2017-10-11 02:52:41.944531
NCT01613040|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-11-01|||January 2009||2009-01-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers|A Multiple-center, Multiple-dose, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Parallel Group Study to Investigate the Effect of RO4917838 on the QTc Interval in Healthy Subjects.|Completed||Phase 1|169|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 02:52:42.014484|2017-10-11 02:52:42.014484
NCT01613027|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2016-08-31|2016-08-31||February 2012||2012-02-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational||Intention-to Treat population, defined as all enrolled participants who received at least one dose of rituximab.|An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis|A Multicenter Observational Study of the Response to Rituximab (MabThera®) in Seropositive Patients With Rheumatoid Arthritis With Inadequate Response or Intolerance to Treatment With One or More Tumor Necrosis Factor Inhibitors (TNFi)|Completed||N/A|135|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:52:42.121378|2017-10-11 02:52:42.121378
NCT01613014|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-02-15|2016-09-29||February 2013||2013-02-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional||144 represents the modified intention to treat population (mITT) - took at least one dose of medication.|ABT-436 for Alcohol Dependence|A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence|Completed||Phase 2|150|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||2|||f||||t||||||||||2017-10-11 02:52:42.876177|2017-10-11 02:52:42.876177
NCT01613001|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-10-15|||March 2012||2012-03-01|July 2013|2013-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Obesity as a Risk Factor for Musculoskeletal Diseases in the U.S. Air Force: Associations and Implications for Force Readiness||Completed||N/A|67904|Actual|Mike O'Callaghan Federal Hospital|||1||f||||f||||||||||2017-10-11 02:52:43.328159|2017-10-11 02:52:43.328159
NCT01612988|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-03-15|||July 2012||2012-07-01|December 2015|2015-12-01|September 2019|Anticipated|2019-09-01|December 2015|Actual|2015-12-01||Interventional|BOMP||Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL|Phase II Salvage Treatment With Bendamustine, Ofatumumab and MethylPrednisolone (BOMP) in Relapsed B-cell Chronic Lymphocytic Leukemia (B-CLL)|Terminated||Phase 2|74|Actual|French Innovative Leukemia Organisation||1||Other drugs others studies|f||||t||||||||||2017-10-11 02:52:43.387208|2017-10-11 02:52:43.387208
NCT01612975|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-09-14|||April 2014||2014-04-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection|The Effect of Perioperative Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection|Active, not recruiting||Phase 2|300|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 02:52:43.490881|2017-10-11 02:52:43.490881
NCT01612962|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-02-05|||May 2011||2011-05-01|February 2014|2014-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Diagnostic Tests to Help Determine Osteomyelitis|Diagnostic Tests to Help Determine Osteomyelitis: an Analysis and Comparison of Clinical Signs, Microbiology, Pathology and Radiology.|Terminated||N/A|196|Actual|Georgetown University|||1||f||||f||||||||||2017-10-11 02:52:43.608078|2017-10-11 02:52:43.608078
NCT01612949|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-07-14|||May 2012||2012-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Facial Analysis to Classify Difficult Intubation|Comparison of a Computerized Image Analysis to Conventional Airway Examination Techniques to Predict Difficult Endotracheal Intubation|Recruiting||N/A|1000|Anticipated|Wake Forest University Health Sciences|||4||f||||f|f|||||||||2017-10-11 02:52:43.694896|2017-10-11 02:52:43.694896
NCT01612936|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-09-14|||September 2012||2012-09-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MGH-001||T Cell Effector and Regulatory Mechanisms in Asthma|T Cell Effector and Regulatory Mechanisms in Asthma|Completed||Phase 1|168|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:52:43.8352|2017-10-11 02:52:43.8352
NCT01612910|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-02-10|||June 2012||2012-06-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery|A Pilot Study of BR-DIM in Women With Stage II-III, Triple Negative, and Androgen Receptor Positive, Invasive Breast Cancer, Who Have Residual Disease Following Surgical Resection After Neoadjuvant Chemotherapy|Withdrawn||Phase 2|0|Actual|Barbara Ann Karmanos Cancer Institute||1||Research cancelled.|f||||t||||||||||2017-10-11 02:52:44.087419|2017-10-11 02:52:44.087419
NCT01612897|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-03-23|||September 2009||2009-09-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|CAAC||Study of the Effectiveness of a Computer Decision Support System to Improve Physicians' Screening for Autism|Computer Assisted Autism Care (CAAC)|Completed||N/A|368|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 02:52:44.223747|2017-10-11 02:52:44.223747
NCT01612884|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-04-06|||August 2011||2011-08-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)|Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)|Terminated||Phase 4|67|Actual|Indiana University||2||Slow enrollment|f||||||||||||||2017-10-11 02:52:44.338578|2017-10-11 02:52:44.338578
NCT01612871|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-09-08|||June 2012||2012-06-01|September 2014|2014-09-01|September 2016|Anticipated|2016-09-01|September 2015|Anticipated|2015-09-01||Interventional|MIRHO||Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer|Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer? Pilot Study.|Unknown status|Active, not recruiting|Phase 4|39|Actual|Institut Claudius Regaud||1|||f||||f||||||||||2017-10-11 02:52:44.453954|2017-10-11 02:52:44.453954
NCT01612858|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-05-12|2016-05-12||June 2011||2011-06-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Metabolic Abnormalities in HIV-infected Persons|Metabolic Abnormalities in HIV-infected Persons|Completed||Phase 4|20|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-10-11 02:52:44.587547|2017-10-11 02:52:44.587547
NCT01612845|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-06-05|||May 2007||2007-05-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|May 2009|Actual|2009-05-01||Interventional|PRP-Fibrin||Effect of Platelet-rich Fibrin on Rotator Cuff Repair|Platelet-Rich Fibrin for Arthroscopically Repaired Massive Rotator Cuff Tears: A Prospective Randomized Pilot Clinical Trial|Completed||Phase 2|28|Actual|Hospital Universitario La Paz||2|||f||||f||||||||||2017-10-11 02:52:44.952749|2017-10-11 02:52:44.952749
NCT01612832|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-06-05|||June 2012||2012-06-01|June 2012|2012-06-01||||June 2013|Anticipated|2013-06-01||Interventional|||Pregabalin for Post-craniotomy Pain Control|Peri-incisional Pregabalin for Postoperative Pain Attenuation and Analgesics Spare in Elective Neurosurgical Patients: A Randomized, Comparative, Placebo-controlled, Double Blind Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 02:52:45.085217|2017-10-11 02:52:45.085217
NCT01612819|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-03-30|||April 2012|Actual|2012-04-01|March 2017|2017-03-01|March 30, 2017|Actual|2017-03-30|March 30, 2017|Actual|2017-03-30||Observational|||DXR Stent(Previous Cilotax) Implantation Registry|Evaluation of Effectiveness and Safety of DXR(Previous Cilotax) Stent in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study (IRIS-CILOTAX)|Terminated||N/A|451|Actual|CardioVascular Research Foundation, Korea|||1|No more enrollment|f||||f||||||||No|This is not a publicly funded trial.|2017-10-11 02:52:45.165955|2017-10-11 02:52:45.165955
NCT01612806|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-08-07|||June 2011||2011-06-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers|A Multi-center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold, PriMatrix Ag Antimicrobial Dermal Repair Scaffold, and Standard of Care for the Treatment of Venous Leg Ulcers|Terminated||N/A|31|Actual|Integra LifeSciences Corporation||3||Site selection|f||||f||||||||||2017-10-11 02:52:45.312704|2017-10-11 02:52:45.312704
NCT01612793|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-03-11|||October 2012||2012-10-01|January 2013|2013-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations|Non-Invasive Vagus Nerve Stimulation With the AlphaCore Device for Management of Bronchoconstriction in Patients Hospitalized With COPD|Terminated||Phase 2|4|Actual|ElectroCore LLC|||1||f||||t||||||Samples Without DNA|"     Complete CBC and blood gases will be drawn at different time points to establish the medical     condition of the subjects.   "|||2017-10-11 02:52:45.409371|2017-10-11 02:52:45.409371
NCT01612780|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2014-05-20|||April 2012||2012-04-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Trans-Nasal Maxillary Multi-Sinus Balloon Dilation Study|Trans-Nasal Maxillary Multi-Sinus Balloon Dilation Study|Completed||N/A|81|Actual|Entellus Medical, Inc.||1|||f||||f||||||||||2017-10-11 02:52:45.520523|2017-10-11 02:52:45.520523
NCT01612754|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-06-05|||September 2010||2010-09-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|November 2011|Actual|2011-11-01||Interventional|||Prospective Trial on Noise Reduction in Surgical Operating Theaters|Noise Reduction Programme by Work Rules and Technical Devices (i.e.SoundEar-TM)for Surgical Theathres|Completed||N/A|16|Actual|Hannover Medical School||3|||f||||t||||||||||2017-10-11 02:52:47.147294|2017-10-11 02:52:47.147294
NCT01612741|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-07-07|||April 2008||2008-04-01|July 2014|2014-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Diabetes Treatment With Glucobay in Combination With Metformin|Prospecitve, Non Interventional, Non Controlled, Post Marketing Survelliance Study to Evaluate Efficacy, Safety, Tolerability of Glucobay on Top of Metformin Under Daily Life Treatment Conditions|Completed||N/A|19509|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:52:47.284573|2017-10-11 02:52:47.284573
NCT01612728|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2013-02-11|||October 2013||2013-10-01|February 2013|2013-02-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|AIA||Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer|Aromatase Inhibitor-Induced Arthralgia: A Proposed Management Algorithm|Withdrawn||Phase 2|0|Actual|Baylor Breast Care Center||2||The grant application for this project was rejected.|f||||f||||||||||2017-10-11 02:52:47.392185|2017-10-11 02:52:47.392185
NCT01612715|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-03-19|||January 2014||2014-01-01|March 2015|2015-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Analysis of Fel d 1-specific T Cells After Airway Allergen Challenge in Asthma|Analysis of Fel d 1-specific T Cells After Airway Allergen Challenge in Asthma:Frequency and Phenotype and Trafficking of Cat Allergen-specific T-cells in Blood, Bone Marrow and Bronchoalveolar Lavage Fluid (BALF) Following Segmental Allergen Challenge in Allergic Asthma.|Unknown status|Recruiting|N/A|48|Anticipated|Hamilton Health Sciences Corporation|||1||f||||f||||||||||2017-10-11 02:52:47.470524|2017-10-11 02:52:47.470524
NCT01612702|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2013-05-21|2012-06-06||April 2011||2011-04-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy and Safety of Single, Low-dose Dexamethasone in Patients After Total Knee Arthroplasty|The Use of a Single, Low-dose Dexamethasone in Total Knee Arthroplasty|Completed||Phase 4|291|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:52:47.562756|2017-10-11 02:52:47.562756
NCT01612689|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-08-06|||May 2012||2012-05-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|October 2012|Actual|2012-10-01||Interventional|||3-Dimensional Accelerometer Sub-Study|3-Dimensional Accelerometer Sub-Study for Patients Participating in the E-30 Study: Heart Rate Changes in Subjects With Epilepsy During an Epilepsy Monitoring Unit Admission|Completed||N/A|16|Actual|Cyberonics, Inc.||1|||f||||f||||||||||2017-10-11 02:52:47.855779|2017-10-11 02:52:47.855779
NCT01612676|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-02-20|2016-06-27|2014-11-03|June 2012||2012-06-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Full analysis set (FAS) was the primary dataset of interest. FAS comprised of all patients who were dosed.|Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock|An Open Label Feasibility Trial Investigating FE 202158 as Potential Primary Vasopressor Treatment in Patients With Vasodilatory Hypotension in Early Septic Shock.|Completed||Phase 2|31|Actual|Ferring Pharmaceuticals|There were no limitations or caveats in this trial|1|||f||||t||||||||||2017-10-11 02:52:47.978211|2017-10-11 02:52:47.978211
NCT01612663|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2012-06-05|||June 2012||2012-06-01|May 2012|2012-05-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Effect of Distal Needling on Knee Pain Using Acupuncture Techniques|Comparison of Different Acupuncture Methods on Knee Pain|Unknown status|Not yet recruiting|N/A|80|Anticipated|Hadassah Medical Organization||4|||f||||t||||||||||2017-10-11 02:52:49.847764|2017-10-11 02:52:49.847764
NCT01612650|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-06-20|||February 2012||2012-02-01|June 2014|2014-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|TOMOSEIN||Assessment of Substitution of Focused Cliches and Ultrasound for Tomosynthesis|Assessment of Substitution of Focused Cliches and Ultrasound for Tomosynthesis|Unknown status|Recruiting|Phase 2|1172|Anticipated|Centre Oscar Lambret||3|||f||||f||||||||||2017-10-11 02:52:49.948943|2017-10-11 02:52:49.948943
NCT01612637|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-02-02|||August 2012||2012-08-01|July 2014|2014-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Can Pelvic Floor Muscle Training Reduce my Prolapse|Can Pelvic Floor Muscle Training Reduce my Prolapse? A Randomised Controlled Trial Comparing the Effect of Pelvic Floor Muscle Training and Lifestyle Advice on Pelvic Organ Prolapse|Completed||N/A|108|Actual|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 02:52:50.091435|2017-10-11 02:52:50.091435
NCT01612624|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2012-06-05|||May 2012||2012-05-01|May 2012|2012-05-01||||||||Observational|||Prospective Study on Changes in Acromegaly|FACIAL AND HAND ANALYSIS, SLEEP APNEA AND SPEECH IN PATIENTS WITH ACROMEGALY: A PROSPECTIVE STUDY TO INVESTIGATE CHANGES IN CRANIOFACIAL AND HAND CHARACTERISTICS, SLEEP APNEA AND SPEECH DURING TREATMENT AND AFTER REMISSION|Unknown status|Recruiting|N/A|60|Anticipated|Radboud University|||1||f||||f||||||||||2017-10-11 02:52:50.202847|2017-10-11 02:52:50.202847
NCT01612598|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2014-01-29|||July 2012||2012-07-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional|||Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials|Feasibility of a Palliative Care Intervention for Patients on Phase 1 Clinical Trials|Completed||N/A|16|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 02:52:50.438263|2017-10-11 02:52:50.438263
NCT01612585|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-03|2012-06-07|||April 2012||2012-04-01|June 2012|2012-06-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|||Safety Study of Dengzhanxixin (a Chinese Medicine Injection) Used in Hospitals in China|A Registry Study on Safety Surveillance of Dengzhanxixin (a Chinese Medicine Injection) Used in China|Unknown status|Active, not recruiting|N/A|30000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t||||||||||2017-10-11 02:52:50.549768|2017-10-11 02:52:50.549768
NCT01612546|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-06-03|||November 2012||2012-11-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery|Pilot Trial of CRLX101 in the Treatment of Patients With Advanced Gastric, Gastroesophageal, or Esophageal Squamous or Adenocarcinoma|Completed||N/A|10|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 02:52:50.796401|2017-10-11 02:52:50.796401
NCT01611233|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-09-26|||September 2012||2012-09-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Observational|||Massachusetts General Hospital Evaluation of DePuy ASR Hip System|Clinical Follow-up of ASR Patients Post-Recall|Active, not recruiting||N/A|1950|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:53:09.858563|2017-10-11 02:53:09.858563
NCT01612520|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2015-02-02|||April 2012||2012-04-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Telecoaching of People With Type 2 Diabetes in Primary Care||Completed||N/A|574|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 02:52:50.947269|2017-10-11 02:52:50.947269
NCT01612507|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2017-08-31|||July 2012||2012-07-01|August 2017|2017-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects|A Phase I, Single Centre, Randomised, Double-blind, Placebo-controlled Parallel Group Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ceftaroline After Different Intravenous Dose Regimens of Ceftaroline Fosamil to Healthy Subjects|Completed||Phase 1|41|Actual|Pfizer||4|||f||||||||||||||2017-10-11 02:52:51.009379|2017-10-11 02:52:51.009379
NCT01612494|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-02-20|2013-06-17||March 2010||2010-03-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Hypertonic Saline as Therapy for Pediatric Concussion|Hypertonic Saline as Therapy for Pediatric Concussion: A Randomized Controlled Trial in the Emergency Department|Completed||Phase 1/Phase 2|44|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-11 02:52:51.142799|2017-10-11 02:52:51.142799
NCT01612481|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-07-28|||April 2012||2012-04-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma|Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma: Chest Radiograph Versus Chest CT|Terminated||Phase 2|11|Actual|Centre Oscar Lambret||2||lack of enrollment|f||||f||||||||No||2017-10-11 02:52:51.401693|2017-10-11 02:52:51.401693
NCT01612468|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2016-01-26|||June 2012||2012-06-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Liraglutide in Type 1 Diabetes|Liraglutide in Type 1 Diabetes. A Randomised, Double-blind, Placebo Controlled Study of the Effect of Liraglutide as an Additional Treatment to Insulin on HbA1c, Body Weight and Hypoglycaemia in Poorly Regulated Type 1 Diabetes Patients|Completed||Phase 4|100|Actual|Steno Diabetes Center||2|||f||||t||||||||||2017-10-11 02:52:51.50437|2017-10-11 02:52:51.50437
NCT01612455|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-07-19|||July 2012||2012-07-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|LINC||Linking Infectious and Narcology Care in Russia|Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & Outcomes|Completed||N/A|349|Actual|Boston Medical Center||2|||f||||f|f|f||||||||2017-10-11 02:52:51.615117|2017-10-11 02:52:51.615117
NCT01612442|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2012-06-03|||June 2010||2010-06-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Integrated Education Intervention to Improve Infant and Young Child Nutrition and Growth in Ghana||Completed||N/A|367|Actual|McGill University||3|||f||||f||||||||||2017-10-11 02:52:51.724311|2017-10-11 02:52:51.724311
NCT01612429|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-11-09|||January 2013||2013-01-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|CarRAAT||Carbamylation in Renal Disease-modulation With Amino Acid Therapy|Amino Acid Therapy to Modify Protein Carbamylation in End Stage Renal Disease|Completed||Early Phase 1|23|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-11 02:52:51.811479|2017-10-11 02:52:51.811479
NCT01612416|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-06-03|||November 2010||2010-11-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Spectral Domain Optical Coherence Tomography Analysis for Glaucoma|Comparison of Ganglion Cell and Retinal Nerve Fiber Layer Thickness in Primary Open Angle Glaucoma and Normal Tension Glaucoma With Spectral Domain OCT|Completed||N/A|169|Actual|Inonu University||3|||f||||f||||||||||2017-10-11 02:52:51.911009|2017-10-11 02:52:51.911009
NCT01612403|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-06-05|||July 2011||2011-07-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|supplement||Study the Effect of Oral Zinc Supplementation on High Molecular Weight Zinc Binding Protein in Semen|Study the Effect of Oral Zinc Supplementation on High Molecular Weight Zinc Binding Protein in Semen|Completed||N/A|37|Actual|Babylon University|||1||f||||t||||||||||2017-10-11 02:52:52.011758|2017-10-11 02:52:52.011758
NCT01612390|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-02|2012-06-04|||August 2012||2012-08-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Observational|||Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor|Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor|Unknown status|Not yet recruiting|Early Phase 1|180|Anticipated|Ain Shams University|||3||f||||t||||||||||2017-10-11 02:52:52.104199|2017-10-11 02:52:52.104199
NCT01612377|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-09-10|||March 2012||2012-03-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|July 2013|Anticipated|2013-07-01||Interventional|||Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis|A Phase II, Double-blind, Controlled, Multi-center, Randomized, Long Term Safety Trial of z102 and Prednisone (5 mg or 7.5 mg) in Patients With Moderate to Severe Rheumatoid Arthritis|Terminated||Phase 2|18|Actual|Zalicus||3||missed endpoint of meaningful clinical benefit, compared to prednisolone 2.7mg|f||||f||||||||||2017-10-11 02:52:52.184308|2017-10-11 02:52:52.184308
NCT01612364|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-06-01|||January 2010||2010-01-01|June 2012|2012-06-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||RCT :Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb|Double-Blind Randomized Controlled Trial: Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb|Unknown status|Recruiting|Phase 3|60|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:52:52.283217|2017-10-11 02:52:52.283217
NCT01612338|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2015-07-31|||July 2012||2012-07-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives|Interventions to Increase Screening Utilization by Breast Cancer Survivors and Their High Risk Female Relatives: Using Cancer Surveillance and the Michigan Genomics Academic-Practice Partnership|Completed||N/A|1290|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 02:52:52.542895|2017-10-11 02:52:52.542895
NCT01612325|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2015-08-26|||May 2012||2012-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|HEPAR-2||Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases|Radioactive Holmium Microspheres for the Treatment of Patients With Unresectable Liver Metastases; a Single Center, Interventional, Non-randomized, Phase II (HEPAR II) Trial|Completed||Phase 2|56|Actual|UMC Utrecht||1|||f||||t||||||||||2017-10-11 02:52:52.629053|2017-10-11 02:52:52.629053
NCT01612312|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-05-01|||March 2011||2011-03-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|June 2013|Actual|2013-06-01||Interventional|||Thrombus Aspiration in ThrOmbus Containing culpRiT Lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI)|Thrombus Aspiration in ThrOmbus Containing culpRiT Lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI)|Completed||Phase 4|400|Anticipated|University of Leipzig||2|||f||||t||||||||||2017-10-11 02:52:52.719524|2017-10-11 02:52:52.719524
NCT01612299|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-08-04|||May 2012||2012-05-01|August 2017|2017-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients|Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients|Withdrawn||N/A|0|Actual|University of Kentucky||2||Funding was withdrawn for this study by the sponsor.|f||||t||||||||||2017-10-11 02:52:52.870173|2017-10-11 02:52:52.870173
NCT01612286|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2014-02-16|||May 2012||2012-05-01|April 2013|2013-04-01|May 2014|Anticipated|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma|A Phase II Clinical Study of Endostar Combination With Chemotherapy in the Metastatic Nasopharyngeal Carcinoma|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-11 02:52:52.974257|2017-10-11 02:52:52.974257
NCT01612273|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-03-04|||April 2011||2011-04-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||The Effect of Triflusal on Peripheral Microcirculation Dysfunction|The Effect of Triflusal on Peripheral Microcirculation Dysfunction: A Double-Blind, Randomized, Controlled, Crossover Study.|Completed||Phase 4|92|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 02:52:53.078506|2017-10-11 02:52:53.078506
NCT01612260|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-01-07|||September 2012||2012-09-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat|Shensong Yangxin Capsule in the Treatment of Mild to Moderate Systolic Heart Failure Complicated With Ventricular Premature Beat: A Randomize, Double Blind, Placebo-controlled Multicenter Clinical Trial|Unknown status|Recruiting|Phase 4|460|Anticipated|Wuhan University||2|||f||||t||||||||||2017-10-11 02:52:53.180917|2017-10-11 02:52:53.180917
NCT01612247|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-06-04|||February 2011||2011-02-01|May 2012|2012-05-01|February 2014|Anticipated|2014-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy|Low Dose Metronomic Cyclophosphamide and Methotrexate Chemotherapy in Combination With Aspirin in Patients With Stage II-III Breast Cancer Who Fail to Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy|Unknown status|Recruiting|N/A|13|Anticipated|University of Vermont||1|||f||||t||||||||||2017-10-11 02:52:53.361932|2017-10-11 02:52:53.361932
NCT01612234|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-11-30|||April 2010||2010-04-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Saturated Fat Versus Monounsaturated Fat and Insulin Action|Palmitate Metabolism and Insulin Resistance|Completed||N/A|70|Actual|University of Vermont||2|||f||||f||||||||||2017-10-11 02:52:53.472864|2017-10-11 02:52:53.472864
NCT01612221|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-06-29|2017-03-07||September 2012||2012-09-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo|A Phase II Placebo-controlled Intervention Trial of Oral N-acetylcysteine (NAC) for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo|Completed||Phase 2|100|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 02:52:53.580677|2017-10-11 02:52:53.580677
NCT01612208|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-05-21|||April 2011||2011-04-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|May 2012|Actual|2012-05-01||Observational|||MotionLoc Study, Femur Fractures|Healing of Distal Femur Fractures Stabilized With a Flexible Plating Construct Using MotionLoc Screws|Completed||N/A|2|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 02:52:54.02237|2017-10-11 02:52:54.02237
NCT01612195|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-02|2013-05-16|||January 2007||2007-01-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|March 2009|Actual|2009-03-01||Interventional|||Success Rate, Continence, and Quality of Life With a Bioprosthetic Plug for Treating Complex Anal Fistula|Success Rate, Continence, and Quality of Life With a Bioprosthetic Plug for Treating Complex Anal Fistula|Completed||Phase 2|46|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-10-11 02:52:54.259792|2017-10-11 02:52:54.259792
NCT01612182|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-06-04|||March 2012||2012-03-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|||||Observational|||The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy||Completed||N/A|1289|Actual|Inje University|||2||f||||||||||||||2017-10-11 02:52:54.363106|2017-10-11 02:52:54.363106
NCT01612169|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-04|2016-03-10|||July 2012||2012-07-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CTN0049||Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users|NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users|Completed||N/A|801|Actual|Columbia University||3|||f||||t||||||||Yes|Information about the study and the de-identified study data will be available at https://datashare.nida.nih.gov/ within 18 months of the date the data are locked, as per the procedures of the National Drug Abuse Treatment Clinical Trials Network.|2017-10-11 02:52:54.479226|2017-10-11 02:52:54.479226
NCT01550211|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-07|||March 2012||2012-03-01|March 2012|2012-03-01||||March 2014|Anticipated|2014-03-01||Observational|||Changes in Brain Synchronization During Perceptual and Linguistic Tasks in Schizophrenic Patients||Unknown status|Not yet recruiting|N/A|150|Anticipated|Shalvata Mental Health Center|||4||f||||t||||||||||2017-10-11 03:12:20.451899|2017-10-11 03:12:20.451899
NCT01612156|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-01-16|2015-01-07||December 2011||2011-12-01|January 2015|2015-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Lubricant Versus Lidocaine Gel for Pain Control During Urodynamics|Use of 2% Lidocaine Gel Versus Water Based Lubrication: Is There a Difference in Pain During and After Multi-channel Urodynamics?|Completed||N/A|90|Actual|University of Southern California|Our patient population represented a predominantly Latina/Hispanic population, and our results might not be generalizable to other populations.|2|||f||||f||||||||||2017-10-11 02:52:54.628457|2017-10-11 02:52:54.628457
NCT01612143|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-11-01|||June 2012||2012-06-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy Volunteers|A Randomized, Open-label, Single Dose, Cross-over Study to Investigate the Relative Bioavailability of Setrobuvir (STV) Tablet Formulation Versus the Reference Setrobuvir Capsule Formulation Following Oral Administration With or Without a High Fat Meal in Healthy Subjects|Completed||Phase 1|40|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 02:52:54.981419|2017-10-11 02:52:54.981419
NCT01612130|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-06-05|||March 2003||2003-03-01|June 2012|2012-06-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Valerian for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery|Valeriana Officinalis L. for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery: A Randomized, Double-Blind, Placebo-Controlled Crossover Study|Completed||N/A|20|Actual|Federal University of the Valleys of Jequitinhonha and Mucuri||2|||f||||f||||||||||2017-10-11 02:52:55.079024|2017-10-11 02:52:55.079024
NCT01612117|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2014-05-27|||November 2011||2011-11-01|May 2014|2014-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in Invasive Cardiology|"Is Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) the Renal Troponin in Invasive Cardiology?"|Completed||N/A|244|Actual|University of Freiburg|||1||f||||f||||||Samples Without DNA|"     urinary samples   "|||2017-10-11 02:52:55.161061|2017-10-11 02:52:55.161061
NCT01612104|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-12-04|||March 2012||2012-03-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|July 2013|Actual|2013-07-01||Interventional|||Psychological First Aid With Children in a High Risk Group - a Repeated Single Case Design|Psychological First Aid With Children in a High Risk Group - a Repeated Single Case Design|Completed||Phase 1|11|Actual|Uni Research||1|||f||||f||||||||||2017-10-11 02:52:55.36046|2017-10-11 02:52:55.36046
NCT01612091|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-11-15|||November 2013||2013-11-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit|The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit|Withdrawn||N/A|0|Actual|University of British Columbia||2||Replaced with updated protocol as H16-02361|f||||f||||||||||2017-10-11 02:52:55.47651|2017-10-11 02:52:55.47651
NCT01612078|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2013-03-11|||June 2012||2012-06-01|March 2013|2013-03-01||||February 2013|Actual|2013-02-01||Interventional|OH||Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients|A Double-blind, Randomized and Placebo-controlled Study to Evaluate the Efficacy and Safety of L-threo-3,4-dihydroxyphenylserine (Droxidopa) on Orthostatic Hypotension Treatment in Hemodialysis Patients|Terminated||Phase 3|25|Actual|TSH Biopharm Corporation Limited||2|||f||||t||||||||||2017-10-11 02:52:55.595167|2017-10-11 02:52:55.595167
NCT01612065|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2013-04-10|||June 2012||2012-06-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Optimum Misoprostol Dose Prior to Office Hysteroscopy|The Optimum Dose of Vaginal Misoprostol Prior to Office Hysteroscopy: Double Blind Randomized Controlled Trial|Completed||Phase 3|132|Actual|Cairo University||2|||f||||||||||||||2017-10-11 02:52:55.693951|2017-10-11 02:52:55.693951
NCT01612052|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-02-18|||May 2011||2011-05-01|February 2013|2013-02-01|October 2013|Anticipated|2013-10-01|March 2013|Anticipated|2013-03-01||Interventional|||Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)|Double Blinded Prospective Randomized Controlled Trial Comparing Cefazolin Plus Vancomycin Versus Cefazolin Plus Daptomycin for Vascular Surgery Prophylaxis|Unknown status|Recruiting|Phase 4|200|Anticipated|CAMC Health System||2|||f||||f||||||||||2017-10-11 02:52:55.807776|2017-10-11 02:52:55.807776
NCT01612039|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-09-26||2016-04-20|July 2012||2012-07-01|September 2016|2016-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis|A Phase 2, Randomized, Double-Blind, Parallel, Placebo-Controlled, Proof-of-Concept Study to Assess the Efficacy, Safety, and Tolerability of ASP3291 in Patients With Active Ulcerative Colitis|Completed||Phase 2|112|Actual|Telsar Pharma Inc.||2|||f||||t||||||||No||2017-10-11 02:52:55.916529|2017-10-11 02:52:55.916529
NCT01612026|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-06-04|||May 2012||2012-05-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Observational|||Ultrasound Versus Fluoroscopically-guided Arterial Access in Non-cardiac Vascular Patients|Ultrasound Versus Fluoroscopically-guided Arterial Access in Non-cardiac Vascular Patients|Unknown status|Active, not recruiting|Phase 4|1052|Anticipated|CAMC Health System|||2||f||||f||||||||||2017-10-11 02:52:56.030117|2017-10-11 02:52:56.030117
NCT01612000|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-10-26|2014-12-19||May 2012||2012-05-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|PSC25|Healthy adults 18-49 years of age with no prior vaccination with H5 pandemic influenza|Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults|Phase 2 Observer-Blind, Randomized Trial to Evaluate the Immunogenicity and Safety of PanBlok at Three Dose Levels Adjuvanted With a Stable Oil-in-Water Emulsion Compared With PanBlok Without Adjuvant in Healthy Adults Aged 18 to 49 Years|Completed||Phase 1/Phase 2|341|Actual|Protein Sciences Corporation||4|||f||||f||||||||||2017-10-11 02:52:56.263809|2017-10-11 02:52:56.263809
NCT01611987|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-04-25|||September 2012||2012-09-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MStep||The Role of Exercise in Modifying Outcomes for People With Multiple Sclerosis|The Role of Exercise in Modifying Outcomes for People With Multiple Sclerosis|Active, not recruiting||N/A|240|Anticipated|McGill University||2|||f||||f||||||||||2017-10-11 02:52:57.291669|2017-10-11 02:52:57.291669
NCT01611974|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2015-11-13|2015-11-13||July 2012||2012-07-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||The Intent-to-Treat Safety population, defined as all randomized participants who received at least 1 dose of study drug.|Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients|A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients|Completed||Phase 2|120|Actual|Shire||3|||f||||t||||||||||2017-10-11 02:52:57.447441|2017-10-11 02:52:57.447441
NCT01611961|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-09-27|||August 2012||2012-08-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients|A Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Docetaxel Lipid Microsphere for Injection in Cancer Patients Receiving Chemotherapy|Unknown status|Recruiting|Phase 1|35|Anticipated|Shenyang Pharmaceutical University||2|||f||||t||||||||||2017-10-11 02:52:59.100482|2017-10-11 02:52:59.100482
NCT01611948|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2017-03-29|2017-02-06||May 2011||2011-05-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Treatment for Cannabis Withdrawal and Dependence|Pharmacological Treatment of Cannabis Withdrawal and Dependence|Completed||Phase 2|70|Actual|The Scripps Research Institute||2|||f||||f||||||||No||2017-10-11 02:52:59.194973|2017-10-11 02:52:59.194973
NCT01611935|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-06-14|||May 1, 2013|Actual|2013-05-01|June 2017|2017-06-01|September 6, 2016|Actual|2016-09-06|September 6, 2016|Actual|2016-09-06||Interventional|AVERTShock||AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock|AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock|Completed||Phase 2|100|Actual|University of Pennsylvania||2|||f||||t||||||||No||2017-10-11 02:52:59.432578|2017-10-11 02:52:59.432578
NCT01611922|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-06-04|||April 2012||2012-04-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|BURNABY||Optimization of Assessment and Grading for Lid Wiper Epitheliopathy|Optimization of Assessment and Grading for Lid Wiper Epitheliopathy|Completed||N/A|57|Actual|Alcon Research|||3||f||||f||||||||||2017-10-11 02:52:59.518159|2017-10-11 02:52:59.518159
NCT01611909|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-06-18|||July 2012||2012-07-01|June 2012|2012-06-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|||Citriodiol® and Impetigo|A Randomised, Double-blinded, Pilot Study Investigating the Safety and Efficacy of Topical P-menthane-3,8-diol Oil Extract in the Treatment of Childhood Impetigo.|Unknown status|Not yet recruiting|Phase 2/Phase 3|30|Anticipated|Royal North Shore Hospital||3|||f||||f||||||||||2017-10-11 02:52:59.592599|2017-10-11 02:52:59.592599
NCT01611896|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-10-27|||October 2012||2012-10-01|October 2015|2015-10-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|GRASS||Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism|GRAves Selenium Supplementation Trial (GRASS) - an Investigator-initiated Randomised, Blinded, Multicentre Clinical Trial of Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism|Recruiting||N/A|492|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 02:52:59.673937|2017-10-11 02:52:59.673937
NCT01611883|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-03-31|2014-12-09||July 2, 2012|Actual|2012-07-02|March 2017|2017-03-01|January 16, 2014|Actual|2014-01-16|January 16, 2014|Actual|2014-01-16||Interventional|||A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)|Examination of the Effect of Ezetimibe on Glucose Metabolism - Randomized, Double-blind, Placebo-controlled Study in Type 2 Diabetes Mellitus Patients With Hypercholesterolemia - Phase 4, Protocol No. 367 (Also Known as SCH 58235, P06541)|Completed||Phase 4|152|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:52:59.800154|2017-10-11 02:52:59.800154
NCT01611870|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-06-04|||May 2012||2012-05-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|AVAPS-AE COPD||AVAPS-AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD)Patients|Engineering Validation of the AVAPS-AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD)Patients|Unknown status|Recruiting|N/A|20|Anticipated|Philips Respironics||1|||f||||f||||||||||2017-10-11 02:53:00.22148|2017-10-11 02:53:00.22148
NCT01611857|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-10-03|2016-08-09||July 2012||2012-07-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional||In the Tivantinib + FOLFOX Dose Expansion 34 patients were enrolled; only 32 were treated. Two dropped out prior to treatment. The Intent-to-Treat (ITT) population includes all 34 patients. Safety assessment was based on the population that received at least one dose of drug (N = 32); the efficacy assessments used the ITT population (N = 34).|Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach|A Phase I/II Trial of the c-Met Inhibitor, Tivantinib, in Combination With FOLFOX for the Treatment of Patients With Advanced Solid Tumors (Phase I) and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal (GE) Junction, or Stomach (Phase II)|Completed||Phase 1/Phase 2|49|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 02:53:02.330666|2017-10-11 02:53:02.330666
NCT01611844|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2013-07-30|||September 2011||2011-09-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|June 2012|Actual|2012-06-01||Interventional|TB Dermatest||Optimization of Tuberculosis Intradermal Skin Test|Optimization of Tuberculosis Intradermal Skin Test: TB Dermatest WP 3.1|Completed||N/A|59|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:53:03.130766|2017-10-11 02:53:03.130766
NCT01611831|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-06-04|||January 2012||2012-01-01|May 2012|2012-05-01|January 2013|Anticipated|2013-01-01|July 2012|Anticipated|2012-07-01||Interventional|ACTGROUP||Efficacy of Acceptance and Commitment Therapy (ACT) in Group in Fibromyalgia|Efficacy of Acceptance and Commitment Therapy (ACT) in Group in Fibromyalgia: a Randomized, Controlled Study.|Unknown status|Active, not recruiting|N/A|80|Anticipated|Hospital Miguel Servet||2|||f||||f||||||||||2017-10-11 02:53:03.222973|2017-10-11 02:53:03.222973
NCT01611818|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-08-08|||September 2012||2012-09-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Low Intensity Versus Self-guided Internet-delivered Psychotherapy for Major Depression|Low Intensity Versus Self-guided Internet-delivered Psychotherapy for Major Depression: a Multicenter, Controlled, Randomised Study|Completed||N/A|300|Actual|Hospital Miguel Servet||3|||f||||f||||||||||2017-10-11 02:53:03.385606|2017-10-11 02:53:03.385606
NCT01611805|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-06-13|||July 22, 2010|Actual|2010-07-22|June 2017|2017-06-01|October 6, 2010|Actual|2010-10-06|October 6, 2010|Actual|2010-10-06||Interventional|||Japanese Phase I of GSK1605786|A Placebo-Controlled, Four-Period Crossover, Single Ascending Oral Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of the CCR9 Receptor Antagonist GSK1605786 in Japanese Healthy Male Subject|Completed||Phase 1|30|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 02:53:03.660871|2017-10-11 02:53:03.660871
NCT01611792|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-07-19|2017-02-20||March 2003||2003-03-01|February 2017|2017-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional||Based on subjects who completed the 10 week treatment protocol|Effects and Mechanisms of Specific Trunk Exercises in Low Back Pain|Effects and Mechanisms of Specific Trunk Exercises in Low Back Pain|Completed||N/A|58|Actual|University of Vermont||2|||f||||f||||||||||2017-10-11 02:53:03.779523|2017-10-11 02:53:03.779523
NCT01611779|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-01-10|2016-11-09||May 2012||2012-05-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|FAST|Patients with obstructive sleep apnea were enrolled in the trial. Subjects meeting the inclusion and exclusion criteria were invited to participate in the trial. Subjects were treated with the the Encore System, and followed at 1 week, and then at 1, 3, and 12 months.|FAST as a Treatment for Obstructive Sleep Apnea|Functional Advancement and Suspension of the Tongue (FAST) as a Treatment for Obstructive Sleep Apnea|Terminated||Phase 4|5|Actual|Siesta Medical, Inc.||1||Slow enrollment|f||||f||||||||No||2017-10-11 02:53:04.287654|2017-10-11 02:53:04.287654
NCT01611766|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-05-17|||January 2011||2011-01-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|January 2021|Anticipated|2021-01-01||Interventional|||Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?|Evaluation of Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Phase III, Multicenter, Randomized Trial|Recruiting||Phase 3|420|Anticipated|Shanghai Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 02:53:04.645871|2017-10-11 02:53:04.645871
NCT01611753|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2012-05-31|||April 2004||2004-04-01|May 2012|2012-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Red Blood Cell Transfusion Improves Perfusion Parameters in Septic Shock Patients With Hypoperfusion|Red Blood Cell Transfusion Improves Perfusion Parameters in Septic Shock Patients With Hypoperfusion: a Prospective Randomized Study|Completed||N/A|46|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 02:53:04.786453|2017-10-11 02:53:04.786453
NCT01611740|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-08-28|||May 2012||2012-05-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Observational|CARESS_PREMI||Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM Infants|Contribution of Computerized Real Time Analyses of Cardio-respiratory Signals to the Diagnosis of Infection in Preterm Infants|Recruiting||N/A|500|Anticipated|Rennes University Hospital|||1||f||||f||||||||||2017-10-11 02:53:04.882777|2017-10-11 02:53:04.882777
NCT01611727|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-07-10|||July 2007||2007-07-01|July 2012|2012-07-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|Cisplatin||Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients|Phase II Open-Label, Non-Randomized Trial of Cisplatin Chemotherapy in Patients With BRCA1-Positive Metastatic Breast Cancer|Completed||Phase 2|20|Actual|Pomeranian Medical University Szczecin||1|||f||||f||||||||||2017-10-11 02:53:05.01196|2017-10-11 02:53:05.01196
NCT01611714|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-01-28|||July 2010||2010-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|EDIT||Equity in Diagnostic Imaging Trial|Equity in Diagnostic Imaging Trial (EDIT)|Completed||N/A|181|Actual|Icahn School of Medicine at Mount Sinai||4|||f||||f||||||||||2017-10-11 02:53:05.116601|2017-10-11 02:53:05.116601
NCT01611701|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-06-01|||October 2009||2009-10-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Interventional|||Cryoballoon Ablation of Pulmonary Veins After Failed RF Ablation in Patients With Paroxysmal AF|Cryoballoon Ablation of Pulmonary Veins After Failed Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation|Completed||Phase 3|80|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 02:53:05.196652|2017-10-11 02:53:05.196652
NCT01611688|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-02-23|||June 4, 2012|Actual|2012-06-04|February 2017|2017-02-01|June 17, 2013|Actual|2013-06-17|June 17, 2013|Actual|2013-06-17||Interventional|||First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis|First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis|Completed||Phase 1|36|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:53:05.272891|2017-10-11 02:53:05.272891
NCT01611675|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2017-04-04|||July 2012||2012-07-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma|Leflunomide in Combination With Vemurafenib in Patients With V600 Mutant Metastatic Melanoma|Terminated||Phase 1|3|Actual|Massachusetts General Hospital||1||Adverse Events|f||||t||||||||||2017-10-11 02:53:05.36136|2017-10-11 02:53:05.36136
NCT01611662|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-02-21|2016-12-27||May 2012||2012-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2013|Actual|2013-12-01||Interventional||The tumor in patients was graded by TNM staging where T refers to the stage of primary tumor, n refers to the regional lymph nodes, M refers to distant metastasis. T0 - no evidence of primary tumor; N0- no regional lymph nodes; M0-no distant metastasis|Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer|Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer|Terminated||Phase 2|32|Actual|Fox Chase Cancer Center||1||Extreme Toxicity|f||||t||||||||||2017-10-11 02:53:05.47251|2017-10-11 02:53:05.47251
NCT01611649|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-04-20|||March 2012||2012-03-01|April 2015|2015-04-01||||September 2013|Actual|2013-09-01||Interventional|REBECA||Effect of a Mix of Dairy Lipids and Plant Oils in Infant Formula on Omega-3 Fatty Acid in Red Blood Cells|Profilo Degli Acidi Grassi Omega-3 Dei Globuli Rossi in Neonati Sani Alimentati Con Una Formula Per l'Infanzia Contenente Una Miscela di Grassi Del Latte e Oli Vegetali|Completed||Phase 2|117|Actual|Lactalis||4|||f||||t||||||||||2017-10-11 02:53:05.963799|2017-10-11 02:53:05.963799
NCT01611636|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2015-08-17|||January 2012||2012-01-01|August 2015|2015-08-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Clinical Characteristics of Allergy, Autoimmune and Rheumatic Diseases: A Ten Year Retrospective Study|Clinical Characteristics of Allergy, Autoimmune and Rheumatic Diseases: A Ten Year Retrospective Study|Recruiting||N/A|200000|Anticipated|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 02:53:06.051563|2017-10-11 02:53:06.051563
NCT00005231|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1988||1988-07-01|June 2000|2000-06-01|June 1991|Actual|1991-06-01|||||Observational|||Development, Testing, and Validation of A Protocol To Assess Cardiovascular Reactivity in Human Populations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.537104|2017-10-11 04:26:39.537104
NCT01611623|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-03-29|||May 2012||2012-05-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies|A Phase 1, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies or Non-Hodgkin's Lymphoma|Completed||Phase 1|9|Actual|Esanex Inc.||1|||f||||f||||||||||2017-10-11 02:53:06.125847|2017-10-11 02:53:06.125847
NCT01611610|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2014-03-04|||May 2011||2011-05-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)|Clinical Assessment of Spinal Muscular Atrophy Type II and III|Completed||N/A|4|Actual|Institut de Myologie, France||2|||f||||f||||||||||2017-10-11 02:53:06.199024|2017-10-11 02:53:06.199024
NCT01611597|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-04-18|||January 2012||2012-01-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Pre-Acti||Continuous Measurement of the Activity for Clinical Evaluation at Home, for Non-ambulant Neuromuscular Patients|Continuous Measurement of the Activity for Clinical Evaluation at Home, for Non-ambulant Neuromuscular Patients|Completed||N/A|8|Actual|Institut de Myologie, France||1|||f||||f||||||||||2017-10-11 02:53:06.29803|2017-10-11 02:53:06.29803
NCT01611584|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-11-11|||June 2010||2010-06-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer|A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer|Withdrawn||Phase 1|0|Actual|Dartmouth-Hitchcock Medical Center||1||PI left institution|f||||t||||||||||2017-10-11 02:53:06.380584|2017-10-11 02:53:06.380584
NCT01611571|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-01-15|2013-08-20||December 2003||2003-12-01|January 2014|2014-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|RPM||Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis|Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis|Completed||Phase 3|31|Actual|Columbia University||3|||f||||f||||||||||2017-10-11 02:53:06.461101|2017-10-11 02:53:06.461101
NCT01611558|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-07-27|2016-03-07||August 2012||2012-08-01|July 2017|2017-07-01|July 2019|Anticipated|2019-07-01|November 2014|Actual|2014-11-01||Interventional||All participants who received at least 1 dose of study drug|Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer|A Phase II Safety and Efficacy Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Subjects|Active, not recruiting||Phase 2|49|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 02:53:06.919291|2017-10-11 02:53:06.919291
NCT01611545|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-06-09|||June 2012||2012-06-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Pharmacogenomics and Effective Treatment With Clopidogrel|Can Pharmacogenomic Testing Improve Response and Avoid Adverse Effects With Clopidogrel Therapy? A Biospecimen Bank for Genetic and Genomic Investigation of Clopidogrel.|Completed||N/A|130|Actual|Avera McKennan Hospital & University Health Center|||1||f||||t||||||Samples With DNA|"     blood or buccal samples   "|||2017-10-11 02:53:07.451462|2017-10-11 02:53:07.451462
NCT01611532|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2012-06-01|||November 2010||2010-11-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Observational|||An Observational Study of the Role of Intra-abdominal Pressure Monitoring in Patients With Acute Pancreatitis|An Observational Study of the Role of Intra-abdominal Pressure Monitoring in Patients With Acute Pancreatitis|Completed||N/A|218|Actual|NHS Greater Glasgow and Clyde|||1||f||||f||||||||||2017-10-11 02:53:07.557398|2017-10-11 02:53:07.557398
NCT01611519|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2016-09-12|||December 2011||2011-12-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Early or Late Foley Removal After Thoracotomy|Optimal Timing of Foley Catheter Removal in Patients Undergoing Thoracic Surgery With Epidural Analgesia: A Randomized, Controlled Trial|Completed||N/A|375|Actual|Mayo Clinic|||2||f||||f||||||||No||2017-10-11 02:53:07.62797|2017-10-11 02:53:07.62797
NCT01611506|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2013-01-08|||February 2012||2012-02-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer|Integration of Cetuximab, in Combination With Local Radiotherapy, in Perioperative Chemotherapy of Resectable and Locally Advanced Gastric Cancer. A Pilot Phase Ib-trial|Terminated||Phase 1/Phase 2|1|Actual|Centre Hospitalier Universitaire Vaudois||1||"Outcome of EXPAND study (no benefit from adding cetuximab to the first-line chemotherapy in   advanced gastric cancer in the overall patient population)"|f||||t||||||||||2017-10-11 02:53:07.696915|2017-10-11 02:53:07.696915
NCT01611493|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-06-01|||March 2011||2011-03-01|June 2012|2012-06-01|September 2013|Anticipated|2013-09-01|November 2012|Anticipated|2012-11-01||Interventional|OCPTI||Osseotite Certain Prevail for the Preservation of Crestal Bone|A Prospective, Randomized-Controlled Evaluation of the Osseotite CP4 Certain Prevail Tapered Implant for the Preservation of Crestal Bone|Unknown status|Recruiting|Phase 3|40|Anticipated|CES University||2|||f||||f||||||||||2017-10-11 02:53:07.809889|2017-10-11 02:53:07.809889
NCT01611480|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2013-06-25||||||June 2013|2013-06-01||||January 2013|Actual|2013-01-01||Interventional|||Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head||Completed||Phase 2|||Moberg Pharma AB|||||f||||||||||||||2017-10-11 02:53:07.915775|2017-10-11 02:53:07.915775
NCT01611467|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2016-03-25|||June 2012||2012-06-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|AME/FE||A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 and the Effect of Food on the Pharmacokinetics of CC-223 in Healthy Male Adult Subjects|A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 and the Effect of Food on the Pharmacokinetics of CC-223 in Healthy Male Adult Subjects|Completed||Phase 1|18|Actual|Celgene Corporation||3|||f||||f||||||||||2017-10-11 02:53:07.978478|2017-10-11 02:53:07.978478
NCT01611220|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-12-07|||June 2012||2012-06-01|December 2015|2015-12-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|RePAN||Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa|Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa: A Randomized Control Trial|Recruiting||Phase 2|80|Anticipated|Villa Garda Hospital||2|||f||||t||||||||||2017-10-11 02:53:09.991771|2017-10-11 02:53:09.991771
NCT01611441|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-06-26|||December 2011||2011-12-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Investigation of Specific Protein/Markers in Patients With Osteoarthritis of the Knee Having a Total Knee Replacement|Investigation of Biomarkers in an Exploratory Study in Patients With Osteoarthritis of the Knee Undergoing Total Knee Replacement Surgery|Completed||N/A|125|Actual|AstraZeneca|||1||f||||f||||||Samples With DNA|"     Whole blood, plasma, serum, urine, synovial fluid, synovial membrane, cartilage   "|||2017-10-11 02:53:08.140312|2017-10-11 02:53:08.140312
NCT01611428|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-05-31|||June 2011||2011-06-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Absolute Bioavailability Study With Ipragliflozin|A Single Dose, Open-label, Randomized Two-period Crossover Study in Healthy Young Subjects to Assess the Absolute Bioavailability of Ipragliflozin|Completed||Phase 1|14|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:53:08.224552|2017-10-11 02:53:08.224552
NCT01611415|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-05-31|||July 2011||2011-07-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Drug to Drug Interaction Study With Ipragliflozin and Furosemide|A Clinical Pharmacological Study to Assess Pharmacodynamic and Pharmacokinetic Interactions Between Furosemide and Ipragliflozin in Healthy Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 02:53:08.333349|2017-10-11 02:53:08.333349
NCT01611402|ClinicalTrials.gov processed this data on October 10, 2017|2012-06-01|2017-06-30|||May 29, 2012||2012-05-29|April 6, 2016|2016-04-06|April 6, 2016||2016-04-06|||||Observational|||Gene Expression in HIV and Tuberculosis Co-infection|Transcriptional Signature of HIV And TB Co-Infection|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:53:08.514831|2017-10-11 02:53:08.514831
NCT01611389|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-06-04|||September 2010||2010-09-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Minimizing Ventricular Pacing|Minimizing Right Ventricular Pacing in Dual-chamber Pacemaker Patients With Sinus Node Disease and First Degree Atrioventricular Block.|Unknown status|Recruiting|N/A|60|Anticipated|Military Institute of Medicine, Poland||2|||f||||f||||||||||2017-10-11 02:53:08.606723|2017-10-11 02:53:08.606723
NCT01611376|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-08-16|||September 2012||2012-09-01|May 2012|2012-05-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Impedance Cardiography During Major Abdominal Surgery|Comparison of Cardiac Output Derived From Flotrac/Vigileo and Impedance Cardiography During Major Abdominal Surgery|Completed||Phase 4|11|Actual|Inje University||1|||f||||f||||||||||2017-10-11 02:53:08.688473|2017-10-11 02:53:08.688473
NCT01611363|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-08-21|||October 27, 2011|Actual|2011-10-27|August 2017|2017-08-01|February 3, 2012|Actual|2012-02-03|February 3, 2012|Actual|2012-02-03||Interventional|||A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin|An Exploratory Study to Investigate the Effects of Ipragliflozin (ASP1941) on Glucose Homeostasis and Urinary Glucose Excretion in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 1|44|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 02:53:08.767601|2017-10-11 02:53:08.767601
NCT01611350|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-06-02|||February 2012||2012-02-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Testing New Marketing Models for Improved Cookstoves - Uganda|Behavior Change Interventions to Improve the Acquisition and Correct Use of Improved Cookstoves|Unknown status|Recruiting|N/A|3500|Anticipated|University of California, Berkeley||5|||f||||t||||||||||2017-10-11 02:53:08.865077|2017-10-11 02:53:08.865077
NCT01611337|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-09-18|||June 2012||2012-06-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry|Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry|Completed||N/A|205|Actual|Centre Hospitalier Esquirol||1|||f||||f||||||||||2017-10-11 02:53:09.000777|2017-10-11 02:53:09.000777
NCT01611324|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-12-09|||May 2012||2012-05-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|EASE||Painless Local Infiltration Anesthesia|Efficacy of Alkalinised 2% Mepivacaine for Local Infiltration Anesthesia, in Ambulatory Phlebectomy|Completed||Phase 4|100|Actual|Campus Bio-Medico University||2|||f||||t||||||||||2017-10-11 02:53:09.091521|2017-10-11 02:53:09.091521
NCT01611311|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2013-10-31|||May 2012||2012-05-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306 Film-coated Tablets Given Orally q.d. for 14 Days in Young and Elderly Healthy Male/Female Volunteers (Randomized, Double-blind, Placebo Controlled Within Dose Groups Phase I Study)|Completed||Phase 1|40|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:53:09.197928|2017-10-11 02:53:09.197928
NCT01611298|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2014-04-01|||March 2008||2008-03-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|November 2012|Actual|2012-11-01||Interventional|TAR||Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR|Transfer of Donor-Derived Humoral Immunity Following Allogeneic Hematopoietic Stem Cell Transplantation|Completed||N/A|14|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 02:53:09.305214|2017-10-11 02:53:09.305214
NCT01611285|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-06-08|||November 2010||2010-11-01|June 2017|2017-06-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Observational|||Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach|Uphold Versus Robotic Surgery for Pelvic Prolapse Repair: A Decision Analytic Approach|Completed||N/A|20|Actual|Atlantic Health System|||2||f||||f||||||||||2017-10-11 02:53:09.39759|2017-10-11 02:53:09.39759
NCT01611272|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-07-11|||April 30, 2013|Actual|2013-04-30|July 2017|2017-07-01|July 20, 2016|Actual|2016-07-20|July 20, 2016|Actual|2016-07-20||Observational|||A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta|A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta|Completed||N/A|3402|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:53:09.486026|2017-10-11 02:53:09.486026
NCT01611246|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-07-21|||May 1, 2012|Actual|2012-05-01|July 2017|2017-07-01|August 1, 2012|Actual|2012-08-01|August 1, 2012|Actual|2012-08-01||Observational|||Earset Healthy Volunteer Study|Performance of the Acclarent Iontophoresis System With Earset (IPSES) in Healthy Volunteers|Completed||N/A|22|Actual|Acclarent|||1||f||||f||||||||||2017-10-11 02:53:09.716268|2017-10-11 02:53:09.716268
NCT01611207|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2013-05-17|||June 2012||2012-06-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|ISAW||Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine|Randomised Controlled Study to Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine.|Terminated||N/A|12|Actual|University of Witten/Herdecke||2||"The patient recruitment was behind target, no successful completion of the planned patient   numbers within trial period could be expected"|f||||t||||||||||2017-10-11 02:53:10.123489|2017-10-11 02:53:10.123489
NCT01611181|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-03-28|||May 2006||2006-05-01|March 2014|2014-03-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||Iron Substitution After Total Knee Arthroplasty|Iron Substitution After Total Knee Arthroplasty - a Randomized Study|Completed||Phase 1|72|Actual|Northern Orthopaedic Division, Denmark||3|||f||||f||||||||||2017-10-11 02:53:10.40805|2017-10-11 02:53:10.40805
NCT01611168|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-05-17|||April 2012|Actual|2012-04-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Remedies4D||REMEDIES4D: REdesigning MEDication Intensification Effectiveness Study for Diabetes|Redesigning Medication Intensification Effectiveness Study for Diabetes|Completed||N/A|240|Actual|University of Pittsburgh||2|||f||||f||||||||No||2017-10-11 02:53:10.52192|2017-10-11 02:53:10.52192
NCT01611155|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-12-20|||February 2012||2012-02-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Interventional|||Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy|A Pilot Randomized, Placebo-controlled, Double Blind Study of Venlafaxine to Prevent Oxaliplatin-Induced Neuropathy|Active, not recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 02:53:10.61148|2017-10-11 02:53:10.61148
NCT01611142|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-06-13|||April 2012||2012-04-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)|Open-Label, Multi-Center, Phase 2 Study of Anti-CCR4 Monoclonal Antibody KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)|Completed||Phase 2|38|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||f||||||||||2017-10-11 02:53:10.728756|2017-10-11 02:53:10.728756
NCT01611129|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2013-04-16|||November 2012||2012-11-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Internet-based Pre-fitting Counseling of Persons With Hearing Impairment|Use of the 'Patient Journey' Model in the Internet-based Pre-fitting Counseling of a Person With Hearing Impairment: A Randomized Controlled Trial|Completed||N/A|80|Actual|Linkoeping University||2|||f||||t||||||||||2017-10-11 02:53:10.866142|2017-10-11 02:53:10.866142
NCT01611116|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-08-16|||May 2012||2012-05-01|August 2017|2017-08-01|April 26, 2017|Actual|2017-04-26|April 26, 2017|Actual|2017-04-26||Interventional|TOR-AML||Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia|A Double-blind, Placebo-controlled, Randomized, Multicenter Phase II Trial to Assess the Efficacy of Temsirolimus Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML|Completed||Phase 2|33|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||t||||||||||2017-10-11 02:53:11.005528|2017-10-11 02:53:11.005528
NCT01611103|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-08-31|||June 2012||2012-06-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Cognitive Effects of Transcranial Direct Current Stimulation in Older Adults|Cognitive Effects of Transcranial Direct Current Stimulation in Older Adults|Completed||N/A|43|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:53:11.148107|2017-10-11 02:53:11.148107
NCT01611090|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-08-24|||September 19, 2012|Actual|2012-09-19|August 2017|2017-08-01|April 11, 2019|Anticipated|2019-04-11|January 19, 2019|Anticipated|2019-01-19||Interventional|||A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Randomized, Double-blind, Placebo-controlled Phase 3 Study of Ibrutinib, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Combination With Bendamustine and Rituximab (BR) in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Active, not recruiting||Phase 3|580|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 02:53:11.246293|2017-10-11 02:53:11.246293
NCT01611077|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-02-20|||January 2012||2012-01-01|February 2017|2017-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|Sevicontrol-2||Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg|Efficacy and Safety of a Sequential Therapy Change From Candesartan 32 mg to the Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg in Patients With Poorly Controlled Moderate Hypertension - an Open Phase IV Trial|Completed||Phase 4|88|Actual|Institut für Pharmakologie und Präventive Medizin||1|||f||||t||||||||Undecided||2017-10-11 02:53:11.75134|2017-10-11 02:53:11.75134
NCT01611064|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-05-27|||February 2012||2012-02-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|ReTAP||A Study Investigating Ways to Make Local Anaesthetic Hand Surgery Less Painful - Reducing Tourniquet Associated Pain|A Randomised Controlled Trial to Investigate Whether Oxygen Supplementation Can Extend the Time Tolerated or Reduce the Pain Associated With an Upper Limb Tourniquet for Hand Surgery Under Local Anaesthetic|Completed||N/A|50|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 02:53:11.881389|2017-10-11 02:53:11.881389
NCT01611051|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-01-05|||March 2012||2012-03-01|January 2013|2013-01-01||||January 2013|Actual|2013-01-01||Interventional|||A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy||Completed||Phase 3|330|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 02:53:11.981658|2017-10-11 02:53:11.981658
NCT01589809|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-06-30|||June 2012||2012-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Interventional|||Effect of Nicotinamide in Friedreich's Ataxia|Pharmacodynamic Studies of a Histone Deacetylase Inhibitor in Friedreich's Ataxia|Active, not recruiting||Phase 2|40|Anticipated|Imperial College London||1|||f||||f||||||||||2017-10-11 03:00:58.267661|2017-10-11 03:00:58.267661
NCT01611038|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-09-11|||October 2011||2011-10-01|September 2017|2017-09-01|June 2015|Actual|2015-06-01|July 2013|Actual|2013-07-01||Interventional|||Methylselenocysteine Effects on Circadian Rhythm|Chemoprevention of Breast and Prostate Cancers in Shift Workers by Dietary Methylselenocysteine: Effects on Circadian Rhythm and Estrogen Receptor-B Cycling|Completed||N/A|100|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 02:53:12.069122|2017-10-11 02:53:12.069122
NCT01611025|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-01|2012-06-01|||June 2011||2011-06-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|||||Observational|||Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Time|The Impact on the Hospital's Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic, Using Antibiotic Utilization and Hospital Susceptibility Data Over Time|Unknown status|Active, not recruiting|N/A|30000|Anticipated|Taipei Veterans General Hospital, Taiwan|||1||f||||f||||||||||2017-10-11 02:53:12.159756|2017-10-11 02:53:12.159756
NCT01611012|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-07-02|||May 2012||2012-05-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|AIR||The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma|The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma|Completed||N/A|115|Actual|UMC Utrecht|||1||f||||f||||||Samples Without DNA|"     Leukocytes in peripheral blood, serum samples for protein profiling and sputum samples.   "|||2017-10-11 02:53:12.248571|2017-10-11 02:53:12.248571
NCT01610999|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-05-05|||July 2013||2013-07-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|June 2014|Actual|2014-06-01||Interventional|||Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation|Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation|Terminated||Phase 1|7|Actual|Tufts Medical Center||3||Unavailability of study article|f||||t|t|f||||||No||2017-10-11 02:53:12.332748|2017-10-11 02:53:12.332748
NCT01610986|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-06-03|||May 2012||2012-05-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|LactEx||Effects of Glucose-fructose Drinks During Training on Lactate Transport|Effects of Glucose-fructose Drinks During Training on Lactate Transport and Oxidation and on Endurance Performance|Completed||N/A|17|Actual|University of Lausanne||2|||f||||f||||||||||2017-10-11 02:53:12.433396|2017-10-11 02:53:12.433396
NCT01610973|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-10-07|||June 2012||2012-06-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Comparison of Two Techniques in Achieving Corneal Graft|Comparison of Manual and Automated Techniques in Achieving Posterior Lamellar Transplantation of the Cornea|Completed||N/A|40|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 02:53:12.545922|2017-10-11 02:53:12.545922
NCT01610960|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-05-30|||April 2012||2012-04-01|May 2012|2012-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Three Noninvasive Ventilation Modes: a Physiological Study in Healthy Volunteers|Comparison of Helmet NEXT, Helmet Standard and Facemask for Noninvasive Ventilation: a Physiological Study in Healthy Volunteers|Completed||N/A|13|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 02:53:12.652376|2017-10-11 02:53:12.652376
NCT01610947|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-11-23|||May 2012||2012-05-01|November 2015|2015-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|SPACING||Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity|Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity: a Randomized Controlled Trial|Recruiting||N/A|398|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 02:53:12.772755|2017-10-11 02:53:12.772755
NCT01610934|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-09-04|||August 2012||2012-08-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)|Phase 2 Study: A Double-blind, Randomised, Clinical Cross-over Trial to Investigate the Treatment Potential of Liraglutide Compared to Glimepiride in MODY Patients|Completed||Phase 2/Phase 3|15|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-11 02:53:12.876011|2017-10-11 02:53:12.876011
NCT01610921|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-07-10|||February 2012||2012-02-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional|impact||Determining the Optimal Adenosine Provocation Test|Determining the Optimal Dry Powder Adenosine Provocation Test to Assess Small Airways Disease|Completed||N/A|11|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-11 02:53:13.010705|2017-10-11 02:53:13.010705
NCT01610908|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-05-26|||April 2011||2011-04-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|August 2016|Anticipated|2016-08-01||Interventional|MultiSETS||Multicenter Schroth Exercise Trial for Scoliosis|A Multicenter Randomized Controlled Trial to Compare the Effect of Schroth Exercises to Standard Care on Curve Characteristics, Posture, and Quality Of Life in Adolescents With Idiopathic Scoliosis|Unknown status|Recruiting|Phase 2|258|Anticipated|University of Alberta||3|||f||||f||||||||||2017-10-11 02:53:13.110036|2017-10-11 02:53:13.110036
NCT01610895|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-06-01|||December 2011||2011-12-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|August 2012|Anticipated|2012-08-01||Interventional|BP||Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet|A Randomized Prospective Trial Comparing Split Dose Polyethylene Glycol-Based Lavage With Clear Fluids Versus Split Dose Polyethylene Glycol-Based Lavage With a Low-Residue Diet in Preparation of Patients for Colonoscopy.|Unknown status|Recruiting|N/A|345|Anticipated|University of Calgary||2|||f||||f||||||||||2017-10-11 02:53:13.283179|2017-10-11 02:53:13.283179
NCT01610882|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-01-16|||May 2012||2012-05-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Panda||Panda: Evaluation of a Smartphone-based Perioperative Pain Assessment Tool|Panda: Evaluation of a Smartphone-based Perioperative Pain Assessment Tool|Completed||N/A|144|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 02:53:13.412182|2017-10-11 02:53:13.412182
NCT01610869|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2017-05-03|||August 2014||2014-08-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|METRO-BIBF||Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer|Phase II, Randomised, Placebo Controlled, Multicentre, Feasibility Study of Low Dose (Metronomic) Cyclophosphamide With and Without Nintedanib (BIBF 1120) in Advanced Ovarian Cancer|Active, not recruiting||Phase 2|124|Anticipated|University College, London||2|||f||||t||||||||No||2017-10-11 02:53:13.517709|2017-10-11 02:53:13.517709
NCT01610141|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-10-07|||June 2012||2012-06-01|October 2013|2013-10-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients|Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients|Unknown status|Recruiting|Phase 4|500|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 02:53:34.133656|2017-10-11 02:53:34.133656
NCT01610856|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-06-01|||March 2010||2010-03-01|May 2012|2012-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for Colonoscopy|A Randomized Prospective Trial Comparing Single Dose Polyethylene Glycol-based Lavage Versus Split Dose Polyethylene Glycol-based Lavage in the Preparation of Patients Undergoing Colonoscopy|Completed||N/A|250|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 02:53:13.649075|2017-10-11 02:53:13.649075
NCT01610843|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-03-28|||December 2011||2011-12-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|WISE||Worldwide Sarcoidosis Research Study|Worldwide Sarcoidosis Research Study|Recruiting||N/A|10000|Anticipated|University of Iowa|||1||f||||f|f|f||||Samples With DNA|"     Saliva samples will be collected and processed at the University of Iowa.   "|No||2017-10-11 02:53:13.761695|2017-10-11 02:53:13.761695
NCT01610830|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-04-22|||April 2010||2010-04-01|July 2012|2012-07-01|July 2014|Anticipated|2014-07-01|January 2013|Actual|2013-01-01||Observational|||Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura|Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura|Unknown status|Recruiting|N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||Samples With DNA|"     Blood and urine analysis - Skin and kidney biopsies   "|||2017-10-11 02:53:13.891321|2017-10-11 02:53:13.891321
NCT01610817|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-01-22|||May 2012||2012-05-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|InPAct||Impact of a Procedure for the Information and Active Participation of the Patient in the Primary Care Prescription of Antihypertensives|Impact of a Procedure for the Information and Active Participation of the Patient in the Primary Care Prescription of Antihypertensives : InPAct Study (Information for Participating Actively in Cardiovascular Treatment)|Completed||N/A|1100|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-11 02:53:13.99204|2017-10-11 02:53:13.99204
NCT01610804|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-06-01|||April 2011||2011-04-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Observational|||Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment|Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology|Completed||N/A|18|Actual|University Hospital Regensburg|||2||f||||f||||||||||2017-10-11 02:53:14.099141|2017-10-11 02:53:14.099141
NCT01610791|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-07-08|2014-05-07||March 2010||2010-03-01|July 2014|2014-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||Intention-to-treat (ITT) population, defined as participants who received at least one dose of tocilizumab (baseline) and for whom data for at least one follow-up variable were available.|A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)|A Single Arm, Open Label Study to Assess the Safety, Tolerability and Efficacy of Tocilizumab in Active Rheumatoid Arthritis Patients With Inadequate Response to the DMARDs (REMISSION Study)|Completed||Phase 3|121|Actual|Hoffmann-La Roche|Nonserious adverse events presented in this record include all adverse events reported during the study, not just nonserious events.|1|||f||||||||||||||2017-10-11 02:53:14.230881|2017-10-11 02:53:14.230881
NCT01610778|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-12-17|||May 2012||2012-05-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effects of 5-Aminolevulinic Acid on Glucose Metabolism|A Randomized, Double-blind, Cross-over Study to Assess Efficacy of 5-Aminolevulinic Acid in Type 2 Diabetic Patients on Medication.|Completed||N/A|35|Anticipated|Hiroshima University||2|||f||||f||||||||||2017-10-11 02:53:15.54476|2017-10-11 02:53:15.54476
NCT01610765|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-06-06|||January 2016||2016-01-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)|A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)|Withdrawn||Phase 1/Phase 2|0|Actual|University of Alabama at Birmingham||2||Study terminated because unable to obtain access to study drug for study population.|f||||t||||||||||2017-10-11 02:53:15.633878|2017-10-11 02:53:15.633878
NCT01610752|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-08-16|||December 2012||2012-12-01|August 2017|2017-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Personalized Management of Body Weight During Pregnancy|Expecting Success: Personalized Management of Body Weight During Pregnancy|Completed||N/A|54|Actual|Pennington Biomedical Research Center||3|||f||||t||||||||||2017-10-11 02:53:16.027594|2017-10-11 02:53:16.027594
NCT01610739|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-07-17|||July 2012||2012-07-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Carpal Tunnel Release Effects on Median Nerve Perfusion|Effect of Carpal Tunnel Release on Median Nerve Perfusion Using SPY Scope Imaging|Unknown status|Not yet recruiting|N/A|50|Anticipated|Henry Ford Health System||1|||f||||f||||||||||2017-10-11 02:53:16.182144|2017-10-11 02:53:16.182144
NCT01610726|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-09-01|||February 2012||2012-02-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Economic and Clinical Evaluation of Enhanced Recovery in Colorectal Surgery|Economic and Clinical Evaluation of Enhanced Recovery in Colorectal Surgery|Recruiting||N/A|320|Anticipated|Haukeland University Hospital||2|||f||||t||||||||Yes||2017-10-11 02:53:16.34321|2017-10-11 02:53:16.34321
NCT01610713|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-06-13|2012-07-18||May 2001||2001-05-01|June 2013|2013-06-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis|Double Blind, Randomised, Parallel Group, Placebo Controlled Trial of a Combination of THC and CBD in Patients With Multiple Sclerosis, Followed by an Open Label Assessment and Study Extension|Completed||Phase 3|154|Actual|GW Pharmaceuticals Ltd.||1|||f||||f||||||||||2017-10-11 02:53:16.602075|2017-10-11 02:53:16.602075
NCT01610700|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-06-13|2012-07-18||May 2001||2001-05-01|June 2013|2013-06-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients|Double Blind, Randomised, Parallel Group, Placebo Controlled Trial of a Combination of THC and CBD in Patients With Multiple Sclerosis, Followed by an Open Label Assessment and Study Extension|Completed||Phase 3|160|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-10-11 02:53:17.92478|2017-10-11 02:53:17.92478
NCT01610128|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-01-05|||October 2011||2011-10-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Observational|UCT-D||Development of an Urticaria Control Test|UCT - Development of an Instrument to Assess Disease Control in Patients With Chronic Urticaria (Urticaria Control Test)|Completed||N/A|508|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 02:53:34.241994|2017-10-11 02:53:34.241994
NCT01610687|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-06-18|2012-07-11||July 2001||2001-07-01|June 2013|2013-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis|A Double Blind, Randomised, Parallel Group, Placebo Controlled Trial of a Combination of THC and CBD in Patients With Multiple Sclerosis, Followed by an Open Label Assessment and Study Extension|Completed||Phase 3|137|Actual|GW Pharmaceuticals Ltd.||1|||f||||f||||||||||2017-10-11 02:53:19.061785|2017-10-11 02:53:19.061785
NCT01610674|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-06-01|||January 2009||2009-01-01|May 2012|2012-05-01|May 2013|Anticipated|2013-05-01|July 2012|Anticipated|2012-07-01||Interventional|||Developing and Testing an Implementation Strategy to Improve Perioperative Diabetes Care|Perioperative Diabetes Care: Developing and Testing an Implementation Strategy in Terms of Effectiveness, Experiences and Costs|Unknown status|Enrolling by invitation|N/A|800|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 02:53:19.57504|2017-10-11 02:53:19.57504
NCT01610661|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-04-24|||January 2012||2012-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|April 2015|Actual|2015-04-01||Interventional|||Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators|Dietary Carbohydrate Type and CVD Risk Indicators|Active, not recruiting||N/A|10|Anticipated|Tufts University||3|||f||||f||||||||||2017-10-11 02:53:19.779211|2017-10-11 02:53:19.779211
NCT01610648|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-04-20|||June 2012||2012-06-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|May 2013|Actual|2013-05-01||Observational|||Improving the STOP-Bang Screening Questionnaire for Patients With Sleep Apnea|Improving the Sensitivity and Specificity of the STOP-Bang Screening Questionnaire for Patients With Obstructive Sleep Apnea|Completed||N/A|258|Actual|Tufts Medical Center|||1||f||||f||||||||||2017-10-11 02:53:19.924655|2017-10-11 02:53:19.924655
NCT01610635|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2015-06-09|||June 2012||2012-06-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|INTERVAL||INTERVAL Study: To Determine Whether the Interval Between Blood Donations in England Can be Safely and Acceptably Decreased|A Randomised Trial to Determine Whether the Interval Between Blood Donations in England Can be Safely and Acceptably Decreased|Unknown status|Active, not recruiting|N/A|50000|Anticipated|University of Cambridge||6|||f||||t||||||||||2017-10-11 02:53:20.04175|2017-10-11 02:53:20.04175
NCT01610622|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-05-25|||March 2012||2012-03-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|CH||Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique|Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique|Completed||N/A|7|Actual|Transonic Systems Inc.|||1||f||||||||||||||2017-10-11 02:53:20.183526|2017-10-11 02:53:20.183526
NCT01610609|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-09-26|||June 2012||2012-06-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||Reducing Disparities in Primary Prevention of Cardiovascular Disease|Center for Advancing Equity in Clinical Preventive Services Project 2: Reducing Disparities in Primary Prevention of Cardiovascular Disease|Completed||N/A|646|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 02:53:20.267951|2017-10-11 02:53:20.267951
NCT01610596|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-04-11|2016-03-10|2013-06-04|November 2011||2011-11-01|April 2016|2016-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Baseline analyses are based on the Safety population. All participants enrolled in the study who were dispensed and applied test article at least once.|A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis|A Double-blind, Randomized, Multicenter, Vehicle-Controlled Parallel Group Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment|Completed||Phase 2|72|Actual|Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 02:53:20.370372|2017-10-11 02:53:20.370372
NCT01610583|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-06-30|||May 24, 2012||2012-05-24|February 23, 2015|2015-02-23|February 23, 2015||2015-02-23|||||Observational|||Testing Spanish-language Genetic Literacy|Development of a Tool to Assess Spanish-Language Genetic Literacy|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:53:23.289274|2017-10-11 02:53:23.289274
NCT01610570|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-09-07|2015-11-25||May 10, 2012|Actual|2012-05-10|September 2017|2017-09-01|May 21, 2014|Actual|2014-05-21|May 21, 2014|Actual|2014-05-21||Interventional|||Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma|Phase I/II Trial of Mithramycin in Children and Adults With Refractory Extracranial Solid Tumors (Phase I) or Ewing Sarcoma and EWSFLI1 Fusion Transcript (Phase II)|Terminated||Phase 1/Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||4||Study was closed to enrollment before dose level one was completed.|f||||f|t|f||||||||2017-10-11 02:53:23.385186|2017-10-11 02:53:23.385186
NCT01610557|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2016-08-18|2016-02-11||May 2012||2012-05-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||"Participants with both eyes enrolled are counted twice (by eye), once for each of the treatment sequences to which an eye was assigned randomly.
Although 56 participants enrolled, 6 participants had two eyes enrolled for a total of 62 eyes."|Ranibizumab and Bevacizumab for Diabetic Macular Edema|A Phase II Randomized Study to Compare Anti-VEGF Agents in the Treatment of Diabetic Macular Edema (CADME)|Completed||Phase 2|56|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||t||||||||No||2017-10-11 02:53:24.712966|2017-10-11 02:53:24.712966
NCT01610544|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-06-30|||May 10, 2012||2012-05-10|December 10, 2012|2012-12-10|December 10, 2012|Actual|2012-12-10|December 10, 2012|Actual|2012-12-10||Interventional|||18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma|A Pilot Study of 18F FLT PET/CT in Evaluating Early Response to Anti-Proliferative Therapies in Non Small Cell Lung Cancer and Thymic Tumors|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 02:53:26.583232|2017-10-11 02:53:26.583232
NCT01610531|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2013-09-18|||April 2011||2011-04-01|September 2013|2013-09-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||COPARIME: Pilot Study of a Target Detection of Malignant Melanoma|COPARIME: Pilot Study of a Target Detection of Malignant Melanoma|Recruiting||N/A|7700|Anticipated|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 02:53:26.692322|2017-10-11 02:53:26.692322
NCT01610518|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2012-06-01|||February 2011||2011-02-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||The Glycemic Response Elicited by Beta-glucans of Different Physical Properties and Form|The Glycemic Response Elicited by Beta-glucans of Different Physical Properties and Form|Completed||N/A|15|Actual|Guelph Food Research Centre||6|||f||||f||||||||||2017-10-11 02:53:26.816802|2017-10-11 02:53:26.816802
NCT01589250|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-04-30|||August 2009||2009-08-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|August 2011|Actual|2011-08-01||Observational|||Risk Scoring Systems in Upper GI-haemorrhage|Risk Scoring Systems in Upper GI-haemorrhage|Completed||N/A|831|Actual|Odense University Hospital|||1||f||||f||||||||||2017-10-11 03:01:06.743474|2017-10-11 03:01:06.743474
NCT01610505|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-06-13|||May 2012||2012-05-01|March 2017|2017-03-01|July 2020|Anticipated|2020-07-01|May 2017|Actual|2017-05-01||Interventional|GOAL||A Study of the KineSpring System Versus High Tibial Osteotomy Surgery for Medial Compartment Knee Osteoarthritis Treatment|Global, Prospective, Multi-Center, Non-randomized, Controlled Non-inferiority Trial to Evaluate Symptom Relief in Patients With Medial Knee Osteoarthritis Treated With the KineSpring® Knee Implant for Load Reduction Compared to HTO|Active, not recruiting||N/A|227|Actual|Moximed||2|||f||||f||||||||||2017-10-11 02:53:26.937706|2017-10-11 02:53:26.937706
NCT01610479|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-08-02|||June 2012||2012-06-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors|A Phase 1 Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors|Completed||Phase 1|120|Anticipated|Taiho Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:53:27.772857|2017-10-11 02:53:27.772857
NCT01610466|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-11-16|||July 2012||2012-07-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Design and Validation of a Simulation-based Training Curriculum for Laparoscopic Bariatric Surgery|Design and Validation of a Simulation-based Training Curriculum for Laparoscopic Bariatric Surgery|Completed||N/A|24|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 02:53:27.882765|2017-10-11 02:53:27.882765
NCT01610453|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-04-26|2016-04-25||January 2012||2012-01-01|April 2016|2016-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Prediction of Delivery With Transperineal Ultrasound in Women With Prolonged Labour. Multicentre Study|Prediction of Mode of Delivery With Transperineal Ultrasound in Women With Prolonged First Stage of Labour. A Multicentre Study|Completed||N/A|150|Actual|Helse Stavanger HF|||1||f||||t||||||||||2017-10-11 02:53:28.010019|2017-10-11 02:53:28.010019
NCT01610440|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-11-28|||October 2011||2011-10-01|November 2012|2012-11-01|October 2013|Anticipated|2013-10-01|March 2013|Anticipated|2013-03-01||Interventional|||Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy|Phase I/II Study of Stem Cell Therapy in Patients With Duchenne Muscular Dystrophy|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Shenzhen Beike Bio-Technology Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:53:28.277709|2017-10-11 02:53:28.277709
NCT01610414|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-05-25|||July 13, 2012|Actual|2012-07-13|May 2017|2017-05-01|February 1, 2017|Actual|2017-02-01|November 4, 2016|Actual|2016-11-04||Interventional|||Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A|Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A|Completed||Phase 3|1877|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:53:28.515456|2017-10-11 02:53:28.515456
NCT01610401|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-05-17|||May 2012||2012-05-01|February 2012|2012-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|MetFMD||The Metformin-FMD Trial|Can Metformin Prevent Endothelial Ischemia and Reperfusion Injury? The Metformin-FMD Trial|Completed||Phase 4|26|Actual|Radboud University||4|||f||||f||||||||||2017-10-11 02:53:29.189103|2017-10-11 02:53:29.189103
NCT01610388|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2017-06-09|||September 13, 2011|Actual|2011-09-13|June 2017|2017-06-01|January 26, 2012|Actual|2012-01-26|January 26, 2012|Actual|2012-01-26||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled Repeat Dose Escalation, First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects|Completed||Phase 1|61|Actual|GlaxoSmithKline||7|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:53:29.310963|2017-10-11 02:53:29.310963
NCT01610375|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-03-28|||June 2012||2012-06-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|March 2014|Actual|2014-03-01||Interventional|TEACUP||Telephone Follow-up After Treatment for Endometrial Cancer|Telephone Follow-up After Treatment for Endometrial Cancer.|Active, not recruiting||N/A|280|Anticipated|Queensland Centre for Gynaecological Cancer||1|||f||||f||||||||No||2017-10-11 02:53:29.556549|2017-10-11 02:53:29.556549
NCT01610362|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-11-23|||June 2012||2012-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response|Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response|Recruiting||N/A|50|Anticipated|Queen Saovabha Memorial Institute||2|||f||||f||||||||||2017-10-11 02:53:29.690922|2017-10-11 02:53:29.690922
NCT01610349|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-03-11|||July 2012||2012-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:53:29.844102|2017-10-11 02:53:29.844102
NCT01610336|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-07-29|||April 5, 2012|Actual|2012-04-05|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|January 30, 2018|Anticipated|2018-01-30||Interventional|||A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment|A Phase IB/II, Open Label, Multicenter Study of INC280 Administered Orally in Combination With Gefitinib in Adult Patients With EGFR Mutated, c-MET-amplified Non-small Cell Lung Cancer Who Have Progressed After EGFR Inhibitor Treatment|Active, not recruiting||Phase 2|161|Actual|Novartis||1|||f||||f|t|f|||t|||||2017-10-11 02:53:29.907468|2017-10-11 02:53:29.907468
NCT01610323|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-07-25|||October 2011||2011-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|InterGOFIT||Fitness Improvement in Obese, Pregnant Women: an Intervention Trial|Fitness Improvement in Obese, Pregnant Women: an Intervention Trial (InterGOFIT)|Completed||N/A|50|Actual|CHU de Quebec-Universite Laval||2|||f||||t||||||||||2017-10-11 02:53:30.194248|2017-10-11 02:53:30.194248
NCT01610310|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-06-12|||June 2012||2012-06-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers|A Randomized, Open-Label, Crossover Phase 1 Study to Evaluate the Pharmacokinetic Profile, Safety, and Tolerability of Peginterferon Beta-1a (BIIB017) Delivered by Pre-filled Syringe (PFS) or Autoinjector in Healthy Volunteers|Completed||Phase 1|55|Actual|Biogen||2|||f||||f||||||||||2017-10-11 02:53:30.318935|2017-10-11 02:53:30.318935
NCT01610297|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-09-12|2016-04-21||September 2013||2013-09-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Post Hematopoietic Stem Cell Transplantation|A Phase II, Multi-center, Single-arm, Prospective Study to Evaluate the Safety and Efficacy of Deferasirox in Beta-thalassemia Major Patients After Hematopoietic Stem Cell Transplantation.|Completed||Phase 4|27|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:53:30.461316|2017-10-11 02:53:30.461316
NCT01610284|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-05-27|||August 7, 2012|Actual|2012-08-07|May 2017|2017-05-01|September 20, 2017|Anticipated|2017-09-20|September 20, 2017|Anticipated|2017-09-20||Interventional|BELLE-2||Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor|A Phase III Randomized, Double Blind Placebo Controlled Study of BKM120 With Fulvestrant, in Postmenopausal Women With Hormone Receptor-positive HER2-negative Locally Advanced or Metastatic Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment|Active, not recruiting||Phase 3|1149|Actual|Novartis||2|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 02:53:30.906086|2017-10-11 02:53:30.906086
NCT01610258|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-31|2014-12-03|||March 2013||2013-03-01|April 2013|2013-04-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|ICAR||Maternal Plasmatic Regulatory T Cells and Th17 as Possible Diagnosis Markers of Acute Chorioamnionitis|Contribution of the Study of Maternal Plasmatic Regulator T Cells and Th17 for the Diagnosis of Acute Chorioanmionitis Among Women Hospitalized for Premature Rupture of Fetal Membranes (PPROM) Between 24 and 34 Gestation Weeks|Unknown status|Recruiting|N/A|120|Anticipated|Centre Hospitalier Universitaire Dijon||1|||f||||f||||||||||2017-10-11 02:53:31.948628|2017-10-11 02:53:31.948628
NCT01610245|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-02-27|||March 2013||2013-03-01|February 2017|2017-02-01|April 16, 2015|Actual|2015-04-16|March 2015|Actual|2015-03-01||Interventional|||Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide and Nitazoxanide Plus Oseltamivir in the Treatment of Acute Uncomplicated Influenza|Completed||Phase 3|1941|Actual|Romark Laboratories L.C.||4|||f||||f||||||||||2017-10-11 02:53:32.119198|2017-10-11 02:53:32.119198
NCT01610232|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-05-31|||December 2009||2009-12-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Infrared-LED During Physical Training for Rehabilitation, Physical Performance and Body Aesthetics|Effects of Infrared-LED Illumination Applied During Treadmill Training in Postmenopausal Women|Completed||Phase 1|45|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 02:53:32.76818|2017-10-11 02:53:32.76818
NCT01610219|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-05-31|||August 2008||2008-08-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth|Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth|Completed||N/A|52|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 02:53:32.921358|2017-10-11 02:53:32.921358
NCT01610206|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-05-01|||September 2012|Actual|2012-09-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|March 20, 2017|Actual|2017-03-20||Interventional|||A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer|A Randomized Open Label Phase II Study of Weekly Gemcitabine Plus Pazopanib Versus Weekly Gemcitabine Alone in the Treatment of Patients With Persistent or Relapsed Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Active, not recruiting||Phase 2|148|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 02:53:33.027628|2017-10-11 02:53:33.027628
NCT01610193|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-08-22|||June 2012||2012-06-01|August 2013|2013-08-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Observational|||The Value of Pancreatic Stone Protein in Predicting Acute Appendicitis|The Value of Pancreatic Stone Protein in Predicting Acute Appendicitis in Patients Presenting at the Emergency Department With Abdominal Pain|Unknown status|Recruiting|N/A|245|Anticipated|University of Zurich|||1||f||||t||||||Samples Without DNA|"     Whole blood and serum or plasma of 245 patients.   "|||2017-10-11 02:53:33.146595|2017-10-11 02:53:33.146595
NCT01610180|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-09-25|||June 2012||2012-06-01|September 2012|2012-09-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)|Open Label Multicenter Study of Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)|Unknown status|Recruiting|Phase 2|26|Anticipated|Fondazione Progetto Ematologia||1|||f||||t||||||||||2017-10-11 02:53:33.270575|2017-10-11 02:53:33.270575
NCT01610167|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-08-08|2013-02-20||September 2011||2011-09-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Intent to treat (ITT).|NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r)Sensitivity Relief Study|NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r) for the Treatment of Dentin Hypersensitivity.|Completed||N/A|151|Actual|Dentsply International||3|||f||||f||||||||||2017-10-11 02:53:33.396863|2017-10-11 02:53:33.396863
NCT01610154|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-04-05|2016-11-27||October 2012||2012-10-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|||Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics― the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics||Completed||Phase 4|85|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||1|||f||||t||||||||||2017-10-11 02:53:33.85012|2017-10-11 02:53:33.85012
NCT01610115|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-05-30|||January 2012||2012-01-01|May 2012|2012-05-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||HBV DNA Levels During Pregnancy in Chronic Hepatitis B|Serial HBV DNA Levels During Pregnancy in Patients With Chronic Hepatitis B: a Prospective Observational Follow-up Study|Unknown status|Recruiting|N/A|100|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-11 02:53:34.301385|2017-10-11 02:53:34.301385
NCT01610102|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-02-04|||July 2011||2011-07-01|February 2015|2015-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||PROGRESS-AMS 1.0 Clinical Long Term Follow-Up|Clinical Performance and Angiographic Results of Coronary Stenting With Absorbable Metal Stents, Clinical Long Term Follow-Up|Completed||N/A|55|Actual|Biotronik AG|||1||f||||f||||||||||2017-10-11 02:53:34.365527|2017-10-11 02:53:34.365527
NCT01610089|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-03-18|||December 2012||2012-12-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|NOASSD||Nitric Oxide Flux and Ureagenesis in Argininosuccinate Synthetase Deficiency (ASSD)(Citrullinemia I)|RDCRN 5110, Nitric Oxide Flux and Ureagenesis in Argininosuccinate Synthetase Deficiency (ASSD)(Citrullinemia I)(Version 24Feb12, NIH Approved 4/5/2012)|Completed||N/A|6|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 02:53:34.430742|2017-10-11 02:53:34.430742
NCT01610076|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-04-07|2015-08-22||November 2010||2010-11-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Code Status Video in the Intensive Care Unit: Video Assisted Patient Education|Pilot Study to Determine Effectiveness and Acceptance of a Code Status Video in the ICU|Completed||Phase 1/Phase 2|208|Actual|Mayo Clinic|In this study the patient outcomes were not addressed as the primary outcome was patient and family knowledge of CPR.|2|||f||||f||||||||||2017-10-11 02:53:34.547629|2017-10-11 02:53:34.547629
NCT01610063|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-02-10|2016-08-18||January 2009|Actual|2009-01-01|February 2017|2017-02-01|May 2013|Actual|2013-05-01|November 2011|Actual|2011-11-01||Interventional|||Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting|A Pilot Study for the Evaluation of the Clinic-wide Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting|Completed||N/A|227|Actual|Mayo Clinic||2|||f||||f|f|f||||||No||2017-10-11 02:53:35.019549|2017-10-11 02:53:35.019549
NCT01610050|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2014-11-09|||June 2012||2012-06-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase I Study of LFA102 in Japanese Patients|A Phase I, Multicenter, Open-label Study of LFA102 Administered Intravenously in Japanese Patients With Castration-resistant Prostate Cancer or Advanced Breast Cancer|Completed||Phase 1|14|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:53:35.496561|2017-10-11 02:53:35.496561
NCT01610037|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-05-09|2016-02-01||October 2012||2012-10-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||The RAN included all randomized patients regardless of whether or not they actually received study medication.|Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation|A Placebo and Active Controlled Study to Assess the Long-term Safety of Once Daily QVA149 for 52 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients With Moderate to Severe Airflow Limitation|Completed||Phase 3|1215|Actual|Novartis||3|||f||||t||||||||||2017-10-11 02:53:35.647944|2017-10-11 02:53:35.647944
NCT01610024|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-06-25|||August 2012||2012-08-01|June 2013|2013-06-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||Northern Board Beet Breathlessness Trial||Unknown status|Recruiting|Phase 1|8|Anticipated|Northern Health and Social Care Trust||1|||f||||f||||||||||2017-10-11 02:53:37.809136|2017-10-11 02:53:37.809136
NCT01610011|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2015-09-25|2015-05-11||July 2010||2010-07-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Subjects eligible to undergo magnetic resonance spectroscopy scans and consume a glycine-enriched beverage, who completed both procedures.|Acute Glycine Pharmacodynamic Study|Acute Glycine Pharmacodynamic Study|Completed||N/A|21|Actual|Mclean Hospital|This trial was limited by small sample sizes, especially in the GLDC mutation group, since this is a rare genetic mutation.|1|||f||||f||||||||||2017-10-11 02:53:37.919258|2017-10-11 02:53:37.919258
NCT01609998|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-10-15|||June 2012||2012-06-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents|Open-Label, Dose-Escalation, Phase I Study of the Prime-Boost Investigational 2012/13 Seasonal Influenza DNA Vaccine, VRC-FLUDNA063-00-VP, Followed by the 2012/2013 Seasonal TIV Compared to TIV Prime-Boost in Children/Adolescents Ages 6-17|Completed||Phase 1|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-11 02:53:38.778326|2017-10-11 02:53:38.778326
NCT01609985|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2013-06-28|||March 2012||2012-03-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Cutaneous Heart Sounds Data Collection During Cardiac Resynchronization Therapy (CRT) Optimization Study|Cutaneous Heart Sounds Data Collection During CRT Optimization Study|Completed||N/A|52|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-10-11 02:53:38.916154|2017-10-11 02:53:38.916154
NCT01609972|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-06-30|||June 2012||2012-06-01|June 2015|2015-06-01|June 2015|Anticipated|2015-06-01|May 2015|Actual|2015-05-01||Interventional|SENZA-RCT||Comparison of Senza to Commercial Spinal Cord Stimulation for the Treatment of Chronic Pain|Multi-Center, Prospective, Randomized, Controlled Clinical Trial to Demonstrate Non-Inferiority of the Senza™ Spinal Cord Stimulation (SCS) System in the Treatment of Chronic Pain as Compared to Commercially Available SCS Devices|Unknown status|Active, not recruiting|N/A|356|Anticipated|Nevro Corp||2|||f||||t||||||||||2017-10-11 02:53:39.008804|2017-10-11 02:53:39.008804
NCT01609959|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2013-10-28|||June 2012||2012-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|NARA||New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering|Effects of the New Angiotensin II Receptor Blocker Azilsartan Versus Valsartan on Blood Pressure in Japanese Patients With Hypertension|Completed||Phase 4|70|Actual|Nara Medical University||2|||f||||t||||||||||2017-10-11 02:53:39.111231|2017-10-11 02:53:39.111231
NCT01609946|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-07-13|||June 2012||2012-06-01|May 2012|2012-05-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Realtime-Elastography (RTE) and Thyroid Nodules|Evaluation of Realtime-Elastography for Differentiation of Thyroid Nodules: a Multicenter Study|Unknown status|Recruiting|N/A|593|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||||2017-10-11 02:53:39.222907|2017-10-11 02:53:39.222907
NCT01609933|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-05-12|||December 18, 2012|Actual|2012-12-18|May 2017|2017-05-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Interventional|||A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study|An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination With Peginterferon α-2a and Ribavirin (pegIFN/RBV) in Chronic Hepatitis C Virus (HCV) Infected Subjects Who Have Experienced Virologic Failure in a Previous AbbVie or Abbott DAA Combination Study|Completed||Phase 2|32|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 02:53:39.3414|2017-10-11 02:53:39.3414
NCT01609920|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-11-09|||May 2012||2012-05-01|May 2013|2013-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Nodal Staging in Breast Cancer With MRL|Non-invasive Nodal Staging in Breast Cancer With Magnetic Resonance Imaging Lymphography Using Gadofosveset|Terminated||N/A|97|Actual|Maastricht University Medical Center||1||Manufacturer recently halted production of gadofosveset.|f||||f||||||||||2017-10-11 02:53:39.539821|2017-10-11 02:53:39.539821
NCT01609907|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-05-31|||November 2011||2011-11-01|January 2012|2012-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan|A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan in Healthy Male Volunteer|Completed||Phase 1|30|Actual|Yuhan Corporation||6|||f||||f||||||||||2017-10-11 02:53:39.867965|2017-10-11 02:53:39.867965
NCT01609894|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-08-10|||August 2013||2013-08-01|August 2016|2016-08-01||||June 2018|Anticipated|2018-06-01||Interventional|IFO||Individualized Fortification of Breast Milk|Individualized Fortification of Breast Milk With Fat, Carbohydrate and Protein for Preterm Infants|Recruiting||N/A|112|Anticipated|McMaster Children's Hospital||2|||f||||t||||||||||2017-10-11 02:53:39.994784|2017-10-11 02:53:39.994784
NCT01609881|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-02-20|||March 2012|Actual|2012-03-01|February 2017|2017-02-01|October 19, 2016|Actual|2016-10-19|October 19, 2016|Actual|2016-10-19||Interventional|Prostaglandin||The Role of Prostaglandins in the Progression of Diabetic Retinopathy|The Role of Prostaglandins in the Progression of Diabetic Retinopathy and the Therapeutic Efficacy of Topical Ketorolac (Acuvail)|Withdrawn||Phase 1|0|Actual|Vanderbilt University Medical Center||2||Due to lack of funding|f||||f||||||||||2017-10-11 02:53:40.131786|2017-10-11 02:53:40.131786
NCT01609868|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-05-31|||June 2012||2012-06-01|May 2012|2012-05-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU|The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU|Unknown status|Not yet recruiting|N/A|60|Anticipated|University of Nebraska||2|||f||||f||||||||||2017-10-11 02:53:40.238755|2017-10-11 02:53:40.238755
NCT01609855|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-31|||January 2012||2012-01-01|May 2012|2012-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate?|Does Hyoscine N-butylbromide Administered During Colonoscopy Increase the Polyp Detection Rate? a Randomized, Single Center, Double Blind, Placebo-controlled Study|Unknown status|Recruiting|Phase 4|400|Anticipated|Valduce Hospital||2|||f||||f||||||||||2017-10-11 02:53:40.38091|2017-10-11 02:53:40.38091
NCT01609842|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-07-07|||January 20, 2014|Actual|2014-01-20|July 2017|2017-07-01|March 30, 2018|Anticipated|2018-03-30|October 31, 2017|Anticipated|2017-10-31||Interventional|||Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence|Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence|Active, not recruiting||N/A|2500|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 02:53:40.555919|2017-10-11 02:53:40.555919
NCT01609829|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-05-31|||January 2012||2012-01-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||iCOMtrain, Development and Evaluation of a Combined Training of Technical and Non-Technical Skills During the Management of Simulated Incidents in Intensive Care||Unknown status|Recruiting|N/A|200|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 02:53:40.669709|2017-10-11 02:53:40.669709
NCT01609816|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-07-12|||May 2012||2012-05-01|July 2017|2017-07-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma|Phase I/II Study of Dasatinib in Recipients of Autologous Stem Cell Transplantation for Hematologic Malignancies.|Recruiting||Phase 1/Phase 2|30|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 02:53:40.748526|2017-10-11 02:53:40.748526
NCT01609803|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2016-05-16|||June 2012||2012-06-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma|Tissue Microarray Studies of the 12q13-q14 Amplicon in Alveolar Rhabdomyosarcoma|Completed||N/A|99|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     tissue samples   "|||2017-10-11 02:53:41.029255|2017-10-11 02:53:41.029255
NCT01609790|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-07-25|2016-10-25||June 4, 2012|Actual|2012-06-04|July 2017|2017-07-01||||October 2, 2015|Actual|2015-10-02||Interventional||All eligible patients.|Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors|Phase II Double-Blinded Placebo-Controlled Study of Bevacizumab With or Without AMG 386 in Patients With Recurrent Glioblastoma or Gliosarcoma|Active, not recruiting||Phase 2|137|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 02:53:41.20757|2017-10-11 02:53:41.20757
NCT01609777|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-05-29|||June 2012||2012-06-01|May 2012|2012-05-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|HandSAFE||HandSAFE - Development and Evaluation of a Handover Tool for Doctors and Nurses|HandSAFE - Development and Evaluation of a Handover Tool for Doctors and Nurses|Unknown status|Not yet recruiting|N/A|80|Anticipated|University of Zurich||1|||f||||f||||||||||2017-10-11 02:53:43.42976|2017-10-11 02:53:43.42976
NCT01609764|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-03-15|||January 2013||2013-01-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|||Physical Activity, Sleep and Age|Physical Activity and Movement Efficiency and Quality Sleep With Increasing Age|Completed||N/A|45|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 02:53:43.52191|2017-10-11 02:53:43.52191
NCT01609751|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-03-01|||April 2013||2013-04-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|LACTOPRoD||Prevention of Diverticulitis by Taking a Daily Probiotic|Does a Daily Dose of the Probiotic Lactobacillus Casei Shirota Prevent Acute Episodes of Diverticulitis (LACTOPRoD) - a Pilot Study|Completed||N/A|26|Actual|University of Surrey||1|||f||||t||||||||||2017-10-11 02:53:43.622308|2017-10-11 02:53:43.622308
NCT01609738|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-04-07|||November 2012||2012-11-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum|Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum - Feasibility, Long-term Lead Stability and Safety|Completed||Phase 1/Phase 2|12|Actual|Maastricht University Medical Center|||2||f||||t||||||||||2017-10-11 02:54:46.374357|2017-10-11 02:54:46.374357
NCT01609725|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-06-08|||January 2012||2012-01-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|PerioCardio||Periodontal Therapy in Coronary Artery Patients|Impact of Periodontal Therapy in Flow-mediated Dilation and Serum Levels of Cardiovascular Risk Biomarkers in Coronary Artery Disease Patients: 12 Months Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|100|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 02:54:46.490819|2017-10-11 02:54:46.490819
NCT01609712|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-06-03|||May 2012||2012-05-01|June 2012|2012-06-01||||||||Observational|||Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation|Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Bonn|||1||f||||f||||||||||2017-10-11 02:54:46.60184|2017-10-11 02:54:46.60184
NCT01609699|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-05-31|||August 2012||2012-08-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Effectiveness Study of the UltraShape® Contour I-Y for Non-Invasive Reduction in Abdominal Circumference|A Baseline Controlled Study to Evaluate the Effectiveness of the UltraShape® Contour I - Y System for Non-Invasive Reduction in Abdominal Circumference|Unknown status|Not yet recruiting|N/A|30|Anticipated|UltraShape||2|||f||||f||||||||||2017-10-11 02:54:46.680727|2017-10-11 02:54:46.680727
NCT01609686|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-02-01|||January 2012||2012-01-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|||Pharmacokinetics of Tranexamic Acid in Patients With Varying Renal Function Undergoing Cardiac Surgery With the Use of Cardiopulmonary Bypass|Pharmacokinetics of Tranexamic Acid in Patients With Varying Renal Function Undergoing Cardiac Surgery With the Use of Cardiopulmonary Bypass|Completed||N/A|49|Actual|University Health Network, Toronto|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 02:54:46.769556|2017-10-11 02:54:46.769556
NCT01609673|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-06-11|||March 2013||2013-03-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study of Everolimus in de Novo Renal Transplant Recipients|Evaluation of the Early Conversion From a Calcineurin Inhibitor-based Immunosuppressive Regimen to Everolimus in de Novo Renal Transplant Recipients, a Multicenter Experience|Terminated||N/A|1|Actual|Fundação Instituto Mineiro de Estudo Pesquisa Em Nefrologi||2||"The inclusion of proposed sample turned to be infeasible due to Ethical Non-approval of 2   research sites and another site no transplant activity since 2012."|f||||t||||||||||2017-10-11 02:54:46.830935|2017-10-11 02:54:46.830935
NCT01609660|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2016-09-09|||March 2010||2010-03-01|September 2016|2016-09-01|March 2013|Actual|2013-03-01|July 2012|Actual|2012-07-01||Interventional|||Impact of Probiotics on the Intestinal Microbiota|Impact of Probiotics on the Intestinal Microbiota and Its Association With Postoperative Outcome After Colorectal Surgery|Completed||Phase 4|33|Actual|Federal University of Minas Gerais||2|||f||||f||||||||Yes|Scientific publications|2017-10-11 02:54:46.924359|2017-10-11 02:54:46.924359
NCT01609647|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-12-21|||September 2012||2012-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PRAISE-HPR||Reloading Prasugrel or Clopidogrel on High Platelet Reactivity Before Percutaneous Coronary Intervention|Comparison of Prasugrel and Clopidogrel Reloading on High Platelet Reactivity in Clopidogrel-loaded Patients Undergoing Percutaneous Coronary Intervention|Completed||Phase 3|76|Actual|Dong-A University||2|||f||||t||||||||||2017-10-11 02:54:46.999803|2017-10-11 02:54:46.999803
NCT01609634|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-08-03|||July 2012|Actual|2012-07-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|August 2016|Actual|2016-08-01||Interventional|Venus||New Infant Formula Trial in Healthy Term Subjects on Growth, Body Composition, Tolerance and Safety|A Randomised, Controlled, Double-blind Trial to Investigate the Effects of a New Infant Formula in Healthy Term Subjects on Growth, Body Composition, Tolerance and Safety.|Active, not recruiting||N/A|541|Actual|Danone Asia Pacific Holdings Pte, Ltd.||3|||f||||t||||||||||2017-10-11 02:54:47.09559|2017-10-11 02:54:47.09559
NCT01609621|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-12-19|||May 2012||2012-05-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Observational|||Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions|Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions|Completed||N/A|199|Actual|Cook Group Incorporated|||1||f||||||||||||||2017-10-11 02:54:47.489913|2017-10-11 02:54:47.489913
NCT01609608|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2012-05-30|||October 2009||2009-10-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Whole-Body Vibration for Functional Constipation|Whole-Body Vibration for Functional Constipation: A Single-Center, Single-Blinded, Randomized, Controlled Trial|Completed||N/A|26|Actual|Changhua Christian Hospital||2|||f||||t||||||||||2017-10-11 02:54:47.602793|2017-10-11 02:54:47.602793
NCT01609595|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2013-03-12|||March 2012||2012-03-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|ST20-P2T||Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand|An Open Label Academic Phase 2 Study of SDMB in Subjects in Thailand With Beta Thalassemia Intermedia|Completed||Phase 2|10|Actual|Boston University||1|||f||||t||||||||||2017-10-11 02:54:47.680117|2017-10-11 02:54:47.680117
NCT01609582|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-10-15|2015-07-24||June 2012||2012-06-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||The randomized set included all randomized participants.|Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects With Type 2 Diabetes and With Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events|Terminated||Phase 3|3207|Actual|Takeda||2||Due to potential concerns about liver safety (See Detailed Description)|f||||t||||||||||2017-10-11 02:54:47.865418|2017-10-11 02:54:47.865418
NCT01609569|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2013-02-20|||May 2012||2012-05-01|February 2013|2013-02-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Observational|||Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.|Utility of Pro-calcitonin as an Indicator of Ischemia in Patients Undergoing Percutaneous Coronary Intervention With Subsequent Coronary Complications.|Unknown status|Active, not recruiting|N/A|100|Anticipated|Saint Michael's Medical Center|||1||f||||f||||||||||2017-10-11 02:54:53.171179|2017-10-11 02:54:53.171179
NCT01609556|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2017-04-07|||May 2012||2012-05-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|IMGN-0401||First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors|A Phase 1, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors|Active, not recruiting||Phase 1|205|Anticipated|ImmunoGen, Inc.||1|||f||||f||||||||||2017-10-11 02:54:53.267898|2017-10-11 02:54:53.267898
NCT01609543|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2015-12-29|2015-12-29||May 2012||2012-05-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Intent-to-treat (ITT) population included all enrolled participants.|A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations|Open Label Study of Erlotinib (Tarceva®) as Single Agent First Line Treatment of Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With Activating Epidermal Growth Factor Receptor (EGFR) Mutations|Completed||Phase 4|62|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:54:53.375932|2017-10-11 02:54:53.375932
NCT01609530|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-05-13|||January 2012||2012-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy|Randomized Double Blind Study Comparing Liquid Nitrogen Cryotherapy With Nd:YAG in the Treatment of Verruca Vulgaris|Completed||Phase 4|31|Actual|Saint Joseph Mercy Health System||2|||f||||t||||||||||2017-10-11 02:54:53.721337|2017-10-11 02:54:53.721337
NCT01609517|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-10-29|||May 2012||2012-05-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||The Influence of Body-mass Index on the Outcome of Spinal Anesthesia for Total Knee Replacement Arthroplasty|The Influence of Body-mass Index on the Outcome of Spinal Anesthesia for Total Knee Replacement Arthroplasty|Completed||N/A|209|Actual|Samsung Medical Center|||2||f||||f||||||||||2017-10-11 02:54:53.822334|2017-10-11 02:54:53.822334
NCT01609504|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2012-05-29|||April 1997||1997-04-01|May 2012|2012-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|ELRRvsLTME||ELRR by TEM Versus Laparoscopic TME in iT2N0M0 SMALL LOW RECTAL CANCER|Randomized Controlled Clinical Trial: Endoluminal Loco-regional Resection (ELRR) by Transanal Endoscopic Microsurgery (TEM) Versus Laparoscopic Total Mesorectal Excision (LTME) in it2n0m0 Small Low Rectal Cancer|Completed||Phase 3|283|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 02:54:55.086173|2017-10-11 02:54:55.086173
NCT01609491|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2015-12-09|||January 2012||2012-01-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Phenylephrine Versus Norepinephrine in Ophthalmic Surgery|Comparison of the Effects of Phenylephrine and Norepinephrine on Hemodynamics and Tissue Oxygenation in Patients Undergoing Ophthalmic Surgery|Completed||N/A|60|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 02:54:55.172085|2017-10-11 02:54:55.172085
NCT01609478|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-01-15|2014-06-27||August 2012||2012-08-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma|A Multicenter, Randomized, Double-blind, Placebo-controlled, 12-week Treatment, Parallel-group Study to Assess the Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate (75 and 150 µg o.d.) in Patients With Persistent Asthma|Completed||Phase 2|335|Actual|Novartis||3|||f||||f||||||||||2017-10-11 02:54:55.298217|2017-10-11 02:54:55.298217
NCT01609465|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-05-29|||January 2010||2010-01-01|May 2012|2012-05-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Observational|||Prognostic Models for People With Stable Coronary Artery Disease|Prognostic Models for People With Stable Coronary Artery Disease|Unknown status|Active, not recruiting|N/A|300000|Anticipated|University College, London|||1||f||||t||||||||||2017-10-11 02:54:57.788496|2017-10-11 02:54:57.788496
NCT01609452|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2015-07-28|||December 2015||2015-12-01|July 2015|2015-07-01||||June 2016|Anticipated|2016-06-01||Interventional|||MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP|MONICA-SC: A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With Immune Thrombocytopenic Purpura (ITP)|Withdrawn||Phase 2/Phase 3|0|Actual|Anthera Pharmaceuticals||2|||f||||||||||||||2017-10-11 02:54:57.896794|2017-10-11 02:54:57.896794
NCT01609439|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-09-14||||||May 2012|2012-05-01||||||||Interventional|||Preoperative Vitamin D for Post-thyroidectomy Hypocalcemia|Pre-operative Vitamin D Supplementation to Reduce Post-operative Hypocalcemia in Patients Undergoing Total Thyroidectomy: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 02:54:57.990522|2017-10-11 02:54:57.990522
NCT01609426|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-03-24|||September 2012|Actual|2012-09-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|NEPHROVIR-2||Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome|Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome|Completed||N/A|351|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     DNA Peripheral Blood Mononuclear Cells Plasma   "|||2017-10-11 02:54:58.120563|2017-10-11 02:54:58.120563
NCT01609413|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-31|||October 2009||2009-10-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|COMCAL||The COMparison of CALcium Bioavailability Between AlgaeCal® and a Proprietary Supplement|A Human Crossover Study to Compare the Bioavailability of Calcium From AlgaeCal® Versus a Proprietary Calcium Dietary Supplement|Completed||Phase 1|20|Actual|SPRIM Advanced Life Sciences, SprimItalia||2|||f||||t||||||||||2017-10-11 02:54:58.417218|2017-10-11 02:54:58.417218
NCT01609400|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-02-26|||December 2011||2011-12-01|February 2015|2015-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast||Completed||N/A|11|Actual|Q-Med AB|||1||f||||f||||||||||2017-10-11 02:54:58.568873|2017-10-11 02:54:58.568873
NCT01609387|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-05-02|||July 2011||2011-07-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Postoperative Vitamin Supplementation in Morbidly Obese Patient (VITAAL Study)|Postoperative Vitamin Supplementation in Morbidly Obese Patient|Completed||Phase 4|300|Actual|Rijnstate Hospital||6|||f||||f||||||||||2017-10-11 02:54:58.661287|2017-10-11 02:54:58.661287
NCT01589055|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-03-18|||April 2005||2005-04-01|March 2013|2013-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||IV Nicotine Induced Changes in Hormone Function, Mood States and Behavior|IV Nicotine Induced Changes in Hormone Function, Mood States and Behavior|Suspended||N/A|180|Anticipated|Mclean Hospital||3|||f||||f||||||||||2017-10-11 03:01:10.660803|2017-10-11 03:01:10.660803
NCT01609374|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-09-25|||May 2014|Actual|2014-05-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Restore CLINICAL TRIAL|Prospective, Non-Randomized, Concurrently Controlled, Multi-Center Study to Evaluate the Safety and Effectiveness of the Spinal Kinetics™ M6-C Artificial Cervical Disc Compared to Anterior Cervical Discectomy and Fusion (ACDF) for the Treatment of Symptomatic Cervical Radiculopathy|Active, not recruiting||Phase 3|258|Actual|Spinal Kinetics||2|||f||||t||||||||||2017-10-11 02:54:58.855717|2017-10-11 02:54:58.855717
NCT01609361|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-08-18|||November 2012||2012-11-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|February 2016|Actual|2016-02-01||Interventional|REHAB||Benefit of Rehabilitation Program in Colorectal Surgery|Benefit of Rehabilitation Program in Colorectal Laparoscopic Surgery|Completed||N/A|270|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 02:54:59.004711|2017-10-11 02:54:59.004711
NCT01609335|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-08-07|||July 2012||2012-07-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults|Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults (30-49yo)|Completed||Phase 1|41|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:54:59.295719|2017-10-11 02:54:59.295719
NCT01609322|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2013-12-19|||August 2010||2010-08-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Exposure Therapy for Fear of Falling in Older Adults|Exposure Therapy for Fear of Falling in Older Adults|Completed||Phase 2|40|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-11 02:54:59.382853|2017-10-11 02:54:59.382853
NCT01609309|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-01-26|||September 2012||2012-09-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01)|Multicenter Study on Comparison of Long-term Outcome Between Laparoscopic and Open Distal Subtotal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer|Active, not recruiting||Phase 3|1056|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 02:54:59.499312|2017-10-11 02:54:59.499312
NCT01609283|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-05-15|||May 2012||2012-05-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis|A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis|Active, not recruiting||Phase 1|27|Actual|Mayo Clinic||1|||f||||t|t|f||||||No||2017-10-11 02:54:59.932714|2017-10-11 02:54:59.932714
NCT01609270|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-04-21|||October 2012||2012-10-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|April 2016|Anticipated|2016-04-01||Interventional|CardioRoot||CardioRoot Post-Marketing Surveillance Registry|CardioRoot Post-Marketing Surveillance Registry|Unknown status|Recruiting|N/A|50|Anticipated|Maquet Cardiovascular||1|||f||||f||||||||||2017-10-11 02:55:00.048428|2017-10-11 02:55:00.048428
NCT01609257|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-07-20|2015-12-08||July 16, 2012|Actual|2012-07-16|July 2017|2017-07-01|March 18, 2014|Actual|2014-03-18|March 1, 2014|Actual|2014-03-01||Interventional|||Norovirus Bivalent-Vaccine Efficacy Study|Phase 1-2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Safety, Immunogenicity, and Efficacy Study in Healthy Adults of Intramuscular Norovirus Bivalent Virus-like Particle Vaccine in Experimental Human Norovirus GII.4 Disease|Completed||Phase 1/Phase 2|132|Actual|Takeda||2|||f||||t||||||||||2017-10-11 02:55:00.328592|2017-10-11 02:55:00.328592
NCT01609244|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2016-01-06|||January 2010||2010-01-01|January 2016|2016-01-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|CSA-FKKG||Bilevel Versus Servoventilation in Complex Sleep Apnea|Bilevel Versus Servoventilation in Complex Sleep Apnea|Completed||N/A|30|Actual|Krankenhaus Kloster Grafschaft||2|||f||||f||||||||||2017-10-11 02:55:01.812582|2017-10-11 02:55:01.812582
NCT01609231|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-01-06|||July 2012||2012-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)|A Phase IIA Open Label, Adaptive, Randomized Clinical Trial of Dalotuzumab (MK-0646) Treatment in Combination With Irinotecan Versus Cetuximab and Irinotecan for Patients With Metastatic Rectal Cancers (mRC) Expressing High IGF-1/Low IGF-2 Levels|Completed||Phase 2|11|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:55:01.95321|2017-10-11 02:55:01.95321
NCT01609218|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-10-04|||May 2012||2012-05-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of LY2140023 in Healthy Participants|A Study to Evaluate the Impact of Activated Charcoal on the Absorption of LY2140023 in Healthy Subjects|Completed||Phase 1|18|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:55:02.075896|2017-10-11 02:55:02.075896
NCT01609205|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-07-21|||October 2012||2012-10-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|Muscara||Doppler Evaluation in RA Patients After Adalimumab.|Doppler Quantitative Evaluation and Follow-up Over 12 Months in RA Patients With Moderate and High Disease Activity Who Are Candidates for Biologic add-on Therapy With Adalimumab|Recruiting||Phase 4|120|Anticipated|Karolinska Institutet||1|||f||||t||||||||||2017-10-11 02:55:02.199555|2017-10-11 02:55:02.199555
NCT01609192|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2013-08-06|||April 2010||2010-04-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|HYDREP||Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated|Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated.|Completed||Phase 4|50|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 02:55:02.355234|2017-10-11 02:55:02.355234
NCT01589042|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-06-01|||May 2012||2012-05-01|June 2016|2016-06-01||||December 2015|Actual|2015-12-01||Observational|Chocolate BAR||Chocolate Balloon Angioplasty Registry|Chocolate Balloon Angioplasty Registry|Completed||N/A|490|Actual|TriReme Medical, LLC|||2||f||||f||||||||||2017-10-11 03:01:10.762677|2017-10-11 03:01:10.762677
NCT01609179|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-11-13|||March 2012||2012-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||IPI-926 Extension Protocol for Continuation of Treatment With IPI-926|IPI-926 Extension Protocol for Continuation of IPI-926 Treatment in Patients Experiencing Clinical Benefit While Enrolled in an IPI-926 Protocol|Completed||N/A|9|Actual|Infinity Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:55:02.46675|2017-10-11 02:55:02.46675
NCT01609166|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-05-22|||July 2011||2011-07-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome|Placebo-controlled Trial to Determine the Effectiveness of a 3% Allopurinol-base Topical Agent for Prevention of Capecitabine-induced Hand-foot Syndrome|Completed||Phase 2|60|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 02:55:02.566121|2017-10-11 02:55:02.566121
NCT01609153|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-07-21|||June 2012||2012-06-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|April 2019|Anticipated|2019-04-01||Interventional|COMBINE||Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy|A Randomized Double-blind Controlled Trial to Assess the Benefits of Olanzapine and Amisulpride Combination Treatment in Acutely Ill Schizophrenia Patients. - COMBINE|Recruiting||Phase 4|399|Anticipated|Heinrich-Heine University, Duesseldorf||3|||f||||t||||||||||2017-10-11 02:55:02.668089|2017-10-11 02:55:02.668089
NCT01609140|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease|A Phase II, Randomized, Placebo-Controlled, Double-Blind Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease|Completed||Phase 2|248|Actual|Genentech, Inc.||6|||f||||||||||||||2017-10-11 02:55:02.934399|2017-10-11 02:55:02.934399
NCT01609127|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-05-31|||May 2012||2012-05-01|May 2012|2012-05-01|July 2014|Anticipated|2014-07-01|September 2013|Anticipated|2013-09-01||Interventional|||Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer|A Randomized, Phase II Study of Tesetaxel Once Every 3 Weeks Versus Tesetaxel Once Weekly for 3 Weeks Versus Capecitabine Twice Daily for 14 Days as First-line Therapy for Subjects With Locally Advanced or Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|213|Anticipated|Genta Incorporated||3|||f||||f||||||||||2017-10-11 02:55:03.222003|2017-10-11 02:55:03.222003
NCT01609114|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-05-08|||April 2012||2012-04-01|May 2013|2013-05-01||||July 2016|Anticipated|2016-07-01||Observational|||Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer|Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer|Unknown status|Active, not recruiting|N/A|30|Actual|Far Eastern Memorial Hospital|||2||f||||t||||||||||2017-10-11 02:55:03.326046|2017-10-11 02:55:03.326046
NCT01609101|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-04-03|||May 2012||2012-05-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Oropharyngeal Space in Videolaryngoscopy|Oropharyngeal Space in Videolaryngoscopy: a Randomised Crossover Trial Measuring Remaining Space Adjacent to the Videolaryngoscope Blade|Completed||N/A|489|Actual|Catharina Ziekenhuis Eindhoven||7|||f||||t||||||||||2017-10-11 02:55:03.562651|2017-10-11 02:55:03.562651
NCT01609088|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-07-23|||May 2012||2012-05-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus|Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus|Completed||N/A|24|Actual|Boston University||1|||f||||f||||||||||2017-10-11 02:55:03.706395|2017-10-11 02:55:03.706395
NCT01609075|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-11-01|||June 2012||2012-06-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE)|Use of Bevacizumab in the Treatment of Metastatic Colorectal Cancer (mCRC) in Italy: an Observational Cohort Study|Completed||N/A|437|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:55:03.825879|2017-10-11 02:55:03.825879
NCT01609062|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-12-24|2015-11-12||April 2012||2012-04-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome|A Randomized, Double-Blind, Pilot Study of the Safety and Physiological Effects of Two Doses of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)|Terminated||Phase 2|25|Actual|BioMarin Pharmaceutical||2|||f||||t||||||||||2017-10-11 02:55:04.241063|2017-10-11 02:55:04.241063
NCT01609049|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-04-11|||December 7, 2011|Actual|2011-12-07|April 2017|2017-04-01|June 22, 2015|Actual|2015-06-22|June 22, 2015|Actual|2015-06-22||Observational|STANDART||An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis|Open-label, Multicenter, Non-Comparative, Prospective Observational Study to Evaluate Efficacy and Safety of Combined Ribavirin and Peginterferon Alfa-2a (40 kDa) Therapy in Patients With Chronic Hepatitis C (CHC) or Compensated Liver Cirrhosis in Real Clinical Practice|Completed||N/A|1496|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:55:06.167917|2017-10-11 02:55:06.167917
NCT01609036|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-11-01|||October 2012||2012-10-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma|An Observational Phase IV Non Interventional Study in Patients With Advanced Follicular Lymphoma (III-IV) Evaluating the Safety of Maintenance Therapy With Rituximab After 8 Cycles of Rituximab in Combination With Chemotherapy as Induction Therapy in Previously Untreated Patients in Greece.|Terminated||N/A|3|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:55:06.463077|2017-10-11 02:55:06.463077
NCT01609023|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-03-28|2017-03-28||April 2012||2012-04-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|CaLLypso|Intent-to-treat (ITT) population included all eligible participants.|A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia|A Non-Interventional, Observational Phase IV Study to Evaluate Safety of Rituximab (Mabthera®) in Combination With Chemotherapy in Patients Treated With CD20+ Β Chronic Lymphocytic Leukemia|Completed||N/A|67|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 02:55:06.589904|2017-10-11 02:55:06.589904
NCT01588080|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-05-25|||July 2012||2012-07-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Comparison Between Infant Flow SiPAP and Noninvasive NAVA in the Neonatal Intensive Care Unit|A Pilot Study Comparing Infant Flow SiPAP to Noninvasive NAVA|Completed||N/A|21|Actual|Fraser Health||2|||f||||f||||||||||2017-10-11 03:01:25.442771|2017-10-11 03:01:25.442771
NCT01609010|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-08-29|2014-05-23||October 2002||2002-10-01|August 2014|2014-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Intent to treat (ITT) population included all randomized participants.|A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma|Rituximab (Mabthera®) as Single Agent and in Combination With Interferon Alfa-2a (Roferon-A®), a Phase-III Randomized Trial in Patients With Follicular or Other CD20+ Low-grade (Indolent) Lymphoma|Completed||Phase 3|313|Actual|Hoffmann-La Roche|Nonserious AEs presented in this record include all AEs reported during the study, not just nonserious events, and information is presented by SOC as AE data by preferred term were not available within specified parameters (with 5% threshold).|2|||f||||||||||||||2017-10-11 02:55:06.996217|2017-10-11 02:55:06.996217
NCT01608997|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-05-29|||June 2012||2012-06-01|May 2012|2012-05-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Postoperative Multiparameter Outcomes During the Six Months After Rotator Cuff Repair||Unknown status|Not yet recruiting|N/A|50|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 02:55:08.094901|2017-10-11 02:55:08.094901
NCT01608984|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2013-07-15|||May 2012||2012-05-01|July 2013|2013-07-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|RIPCON||Effects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary Artery Bypass Grafting(RIPCON)|Effects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary|Unknown status|Recruiting|Phase 1|100|Anticipated|Heinrich-Heine University, Duesseldorf||4|||f||||t||||||||||2017-10-11 02:55:08.182044|2017-10-11 02:55:08.182044
NCT01608971|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-02-22|2015-03-17||January 2011||2011-01-01|February 2017|2017-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|PROTT||Protamine in Cardiac Surgery and Haemostasis|The Effects of Heparin Level Based Versus Weight Based Protamine Dosing on Protamine Demand, Markers of Haemostasis, Blood Product Utilization and Perioperative Blood Loss in Patients Undergoing Extended Cardiac Surgery Cardiac Surgery|Completed||N/A|30|Actual|Heart and Diabetes Center North-Rhine Westfalia|small study cohort||2||f||||f||||||||No||2017-10-11 02:55:08.425514|2017-10-11 02:55:08.425514
NCT01608958|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-03-25|||May 2012||2012-05-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage|Intravenous and Intramuscular Administration of Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage|Completed||N/A|653|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 02:55:08.999384|2017-10-11 02:55:08.999384
NCT01608945|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-05-30|||April 2008||2008-04-01|May 2012|2012-05-01||||||||Observational|||Prospective Randomized Study of Glucocorticoids in the Impact of the Liver Function and the Prognosis After Hepatectomy of HCC||Suspended||N/A|60|Actual|Eastern Hepatobiliary Surgery Hospital|||1||f||||||||||||||2017-10-11 02:55:09.174111|2017-10-11 02:55:09.174111
NCT01608932|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-10-27|||April 2012||2012-04-01|May 2012|2012-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Life-long Monitoring of Frail Patients With Chronic Diseases|RENEWING HEALTH - Telemonitoring of Elderly and Frail Patients With Multiple Chronic Diseases in Veneto Region|Completed||N/A|152|Actual|Regione Veneto||2|||f||||t||||||||||2017-10-11 02:55:09.288847|2017-10-11 02:55:09.288847
NCT01608919|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2015-08-07|||November 2012||2012-11-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection|Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection.|Terminated||N/A|4|Actual|University of Colorado, Denver||1||Sara Cheng, MD has left the University of Colorado and we have closed this study.|f||||f||||||||||2017-10-11 02:55:09.429646|2017-10-11 02:55:09.429646
NCT01608906|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-05-19|||May 2007||2007-05-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery|Efficacy of Low Dose Intravenous Heparin in Preventing Thromboembolism in the SICU.|Completed||N/A|113|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 02:55:09.532744|2017-10-11 02:55:09.532744
NCT01608893|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2016-08-24|||May 2012||2012-05-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Carvedilol for Prevention of Paroxysmal Atrial Fibrillation|Carvedilol for Prevention of Paroxysmal Atrial Fibrillation|Recruiting||N/A|300|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-11 02:55:09.670557|2017-10-11 02:55:09.670557
NCT01608880|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2014-09-08|||August 2012||2012-08-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Effect of Nitroglycerin Ointment on Mastectomy Flap Necrosis|Effect of Nitroglycerin Ointment on Mastectomy Flap Necrosis|Completed||N/A|154|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 02:55:09.816804|2017-10-11 02:55:09.816804
NCT01608867|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-07-25|||June 2012||2012-06-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|August 2016|Actual|2016-08-01||Interventional|||A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors|A Phase 1 Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors|Completed||Phase 1|26|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:55:09.934119|2017-10-11 02:55:09.934119
NCT01608854|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2016-06-08|||November 2008||2008-11-01|June 2016|2016-06-01|April 2012|Actual|2012-04-01|April 2011|Actual|2011-04-01||Observational|||Comparison of Antibiotic Protocols in Spine Patients With Postoperative Drains|Prospective, Randomized Study of the Utilization of Antibiotics and Drains in Spinal Surgery|Completed||N/A|539|Actual|New York University School of Medicine|||2||f||||f||||||||||2017-10-11 02:55:10.035849|2017-10-11 02:55:10.035849
NCT01608841|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2015-02-14|||July 2005||2005-07-01|February 2015|2015-02-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib|The Role of Epidermal Growth Factor Receptor (EGFR) Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib|Unknown status|Recruiting|Phase 2|88|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-11 02:55:10.171848|2017-10-11 02:55:10.171848
NCT01608828|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2017-05-02|||May 2012|Actual|2012-05-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Assessing the Functional and Psychosocial Impact of Strabismus in Asian Children Using the AS-20 and IXTQ Questionnaires|Assessing the Functional and Psychosocial Impact of Strabismus in Asian Children Using the AS-20 and IXTQ Questionnaires|Completed||N/A|120|Actual|Singapore National Eye Centre|||1||f||||f||||||||||2017-10-11 02:55:10.282626|2017-10-11 02:55:10.282626
NCT01608815|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2014-04-15|2014-03-07||May 2012||2012-05-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects|Immunogenicity and Safety of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine Given in Japanese Subjects|Completed||Phase 3|200|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:55:10.360239|2017-10-11 02:55:10.360239
NCT01608802|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2014-06-09|||May 2011||2011-05-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|TOPCare||Outcomes for Antiretroviral Therapy Patients Receiving Palliative Care|Phase 3 Trial of Palliative Care for HIV Patients on Antiretroviral Therapy|Completed||Phase 2/Phase 3|240|Actual|King's College London||2|||f||||t||||||||||2017-10-11 02:55:10.896884|2017-10-11 02:55:10.896884
NCT01608789|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2015-04-22|||August 2012||2012-08-01|April 2015|2015-04-01|February 2018|Anticipated|2018-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Virtue® European Study|Virtue® Male Sling European Study|Active, not recruiting||Phase 4|123|Actual|Coloplast A/S||1|||f||||f||||||||||2017-10-11 02:55:11.020732|2017-10-11 02:55:11.020732
NCT01608776|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2014-10-06|||May 2012||2012-05-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs|Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs|Terminated||Phase 4|13|Actual|Celleration, Inc.||2||Enrollment delays, business re-allocation of resources|f||||t||||||||||2017-10-11 02:55:11.13277|2017-10-11 02:55:11.13277
NCT01608763|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2014-12-05|||May 2012||2012-05-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||What is the Active Ingredient in Personalized Feedback Interventions for Problem Drinkers? A Randomized Controlled Trial|What is the Active Ingredient in Personalized Feedback Interventions for Problem Drinkers? A Randomized Controlled Trial|Completed||N/A|804|Actual|Centre for Addiction and Mental Health||4|||f||||f||||||||||2017-10-11 02:55:11.206843|2017-10-11 02:55:11.206843
NCT01608750|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2012-05-30|||June 2012||2012-06-01|May 2012|2012-05-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia|The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia: Randomised, Double-blind, Placebo-controlled Trial.|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Bezmialem Vakif University||2|||f||||t||||||||||2017-10-11 02:55:11.273934|2017-10-11 02:55:11.273934
NCT01608737|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2013-02-23|||September 2012||2012-09-01|February 2013|2013-02-01||||October 2015|Anticipated|2015-10-01||Interventional|||A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection|A Phase III, Randomised, Double-blind and Placebo-controlled Study of Once Daily BI 201335 for 12 or 24 Weeks in Combination With Pegylated interferon-a and Ribavirin in Treatment-naive and Prior Relapser Patients With Genotype 1 Chronic Hepatitis C Infection|Withdrawn||Phase 3|0|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 02:55:11.361963|2017-10-11 02:55:11.361963
NCT01608724|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2015-12-31|2015-05-14||November 2012||2012-11-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|SUNSHINE|Per-protocoal analysis set (PPS), including patients who took at least 1 dose of study drug, had baseline and post-baseline efficacy records, and had no major protocol deviations.|The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus|A Multicenter, Single Arm, Cohort Study to Evaluate the Efficacy and Safety of Saxagliptin 5mg, Once Daily for 24 Weeks, in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|2165|Actual|AstraZeneca|This was a single-arm study and thus potential placebo effect was unable to be adjusted in any efficacy analyses.|1|||f||||f||||||||||2017-10-11 02:55:11.465759|2017-10-11 02:55:11.465759
NCT01608711|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2017-05-15|||August 7, 2012|Actual|2012-08-07|May 2017|2017-05-01|November 16, 2015|Actual|2015-11-16|November 16, 2015|Actual|2015-11-16||Interventional|||A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002|An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002|Completed||Phase 2|2|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:55:11.978074|2017-10-11 02:55:11.978074
NCT01608698|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-04-07|||June 2012||2012-06-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Comparison of Body Weight Change During Contraception With Belara and Yasmin|A Comparison of Body Weight Changing and Side Effects Between Treatment With 30 mcg Ethinylestradiol/2 mg Chlormadinone Acetate (Belara®) and 30 mcg Ethinylestradiol/3 mg Drospirenone (Yasmin®): A Randomized Control Trial|Unknown status|Enrolling by invitation|Phase 4|100|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 02:55:12.160469|2017-10-11 02:55:12.160469
NCT01608685|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-05-30|||January 2010||2010-01-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients|Interferon Gamma Release Assays Versus Tuberculin Skin Testing for the Detection of Latent Tuberculosis Infection in Renal Transplant Recipients|Completed||N/A|205|Actual|Ligue Pulmonaire Genevoise|||1||f||||f||||||||||2017-10-11 02:55:12.271031|2017-10-11 02:55:12.271031
NCT01608672|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2013-11-04|2013-11-04||April 2012||2012-04-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®||Completed||N/A|207|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:55:12.375956|2017-10-11 02:55:12.375956
NCT01608659|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-29|2012-06-25|2012-06-25||April 2011||2011-04-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A||Completed||N/A|110|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:55:12.630594|2017-10-11 02:55:12.630594
NCT01608646|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2012-05-28|||March 2012||2012-03-01|May 2012|2012-05-01|August 2018|Anticipated|2018-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer|Study of Dihydropyrimidine Dehydrogenase for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer|Recruiting||Phase 2|200|Anticipated|Xijing Hospital||1|||f||||f||||||||||2017-10-11 02:55:12.866961|2017-10-11 02:55:12.866961
NCT01608633|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-27|2013-09-03|||March 2012||2012-03-01|September 2013|2013-09-01||||April 2013|Actual|2013-04-01||Interventional|||Effects of Spray and Stretch on Postneedling Soreness and Sensitivity After Dry Needling of a Latent Myofascial Trigger Point.||Completed||Phase 2|70|Actual|CEU San Pablo University||2|||f||||||||||||||2017-10-11 02:55:12.975859|2017-10-11 02:55:12.975859
NCT01608620|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2016-05-15|||May 2012||2012-05-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2014|Actual|2014-09-01||Observational|||Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease|The Relation of Total and Individual Fructose-containing Sugars With Incident Cardiometabolic Diseases: A Series of Systematic Reviews and Meta-analyses of Prospective Observational Studies|Active, not recruiting||N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-11 02:55:13.074833|2017-10-11 02:55:13.074833
NCT01608607|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-05-26|||May 2012||2012-05-01|May 2015|2015-05-01|October 2015|Anticipated|2015-10-01|September 2014|Actual|2014-09-01||Observational|||Meta-analysis of Fructose-Containing Sugar Sweetened Beverages (SSBs) and Weight Change|Effect of Fructose-containing Sugar Sweetened Beverages (SSBs) on Body Weight: A Systematic Review and Meta-analysis of Controlled Feeding Trials to Provide Evidence-based Guidance for Nutrition Guidelines Development|Unknown status|Active, not recruiting|N/A|1|Actual|University of Toronto|||1||f||||f||||||||||2017-10-11 02:55:13.209596|2017-10-11 02:55:13.209596
NCT01608594|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2017-09-25|||June 2013||2013-06-01|September 2017|2017-09-01|October 2027|Anticipated|2027-10-01|February 2018|Anticipated|2018-02-01||Interventional|||Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma|Neoadjuvant Combination Biotherapy With Ipilimumab (3 mg/kg or 10 mg/kg) and High Dose IFN-Α2B in Patients With Locally/Regionally Advanced/Recurrent Melanoma: a Randomized Safety, Efficacy and Biomarker Study|Active, not recruiting||Phase 1|30|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 02:55:13.312092|2017-10-11 02:55:13.312092
NCT01608568|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-05-31|||November 2010||2010-11-01|May 2012|2012-05-01|August 2013|Anticipated|2013-08-01|August 2012|Anticipated|2012-08-01||Interventional|Quill RALSC||Affixing Polypropylene Mesh Using Barbed Suture (Quill™ SRS) During Robotic Assisted Laparoscopic Sacrocolpopexy|AFFIXING POLYPROPYLENE MESH USING BARBED SUTURE (QUILL™ SRS) DURING ROBOTIC ASSISTED LAPAROSCOPIC SACROCOLPOPEXY RANDOMIZED CONTROLLED TRIAL|Unknown status|Recruiting|N/A|32|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 02:55:13.545841|2017-10-11 02:55:13.545841
NCT01608555|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-28|2012-07-23|||January 2012||2012-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic Fibrosis|Tobramycin 300 mg o.d. Aerosol in in Adult Patients With Cystic Fibrosis: Pilot Study on Antimicrobial Activity|Completed||Phase 4|10|Anticipated|University of Milan||1|||f||||t||||||||||2017-10-11 02:55:13.652536|2017-10-11 02:55:13.652536
NCT01608542|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-30|2012-12-18|||June 2012||2012-06-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese Subjects|A Phase I, Open-label Study to Assess the Pharmacokinetics of Oral Fostamatinib in Healthy Japanese Subjects After Single and Multiple Doses|Completed||Phase 1|24|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:55:13.758505|2017-10-11 02:55:13.758505
NCT01608529|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2013-05-16|||January 2011||2011-01-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|FB||Feel Breathe, Restriction Device Ventilatory Nasal|Phase 1: Effects of a Restriction Device Ventilatory Nasal Flow on Pulmonary Ventilation and Gas Exchange During Exercise|Completed||Phase 1|27|Actual|University of Cadiz||1|||f||||f||||||||||2017-10-11 02:55:13.854079|2017-10-11 02:55:13.854079
NCT01608516|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-11-13|||April 2012||2012-04-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque|Multimodal Assessment of the Inflammatory Atheromatous Plaque : Comparison Between 68Ga-NODAGA-RGD PET/CT, 18F-FDG PET/CT, MRI AND US|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Lausanne Hospitals||1|||f||||f||||||||No||2017-10-11 02:55:13.959729|2017-10-11 02:55:13.959729
NCT01608503|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2013-04-20|||May 2011||2011-05-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|SCVLD||Lung Deflation in Pediatric Subclavian Vein Catheterization|The Effect of Lung Deflation on the Position of the Pleura in Mechanically Ventilated Infants During Subclavian Vein Cannulation: an Ultrasound Study|Completed||N/A|41|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 02:55:14.067407|2017-10-11 02:55:14.067407
NCT01608490|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2017-06-07|2017-04-25||October 2012||2012-10-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|December 2015|Actual|2015-12-01||Interventional|RENEW||Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study|Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study|Active, not recruiting||N/A|315|Actual|PneumRx, Inc.||2|||f||||t||||||||Undecided||2017-10-11 02:55:14.190609|2017-10-11 02:55:14.190609
NCT01608477|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-06-12|||March 2012|Actual|2012-03-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|October 2015|Actual|2015-10-01||Observational|BRIGHT||Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation|Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation|Active, not recruiting||N/A|1365|Actual|University of Basel|||1||f||||f|f|f||||||No||2017-10-11 02:55:16.103448|2017-10-11 02:55:16.103448
NCT01608464|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2016-12-12|||May 2012||2012-05-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer|A Trial Comparing Pre-operative Chemo-radiotherapy With Cisplatin and Fluorouracil Versus Chemotherapy With Docetaxel and Irinotecan in PET Non Responders Resectable Cancer Esophagus: a Multicenter Study|Terminated||Phase 2|170|Actual|King Faisal Specialist Hospital & Research Center||2||poor accrual|f||||t||||||||Undecided||2017-10-11 02:55:16.242855|2017-10-11 02:55:16.242855
NCT01608451|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-10-18|||September 2007||2007-09-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer|Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer.|Active, not recruiting||Phase 3|800|Anticipated|Tata Memorial Hospital||4|||f||||t||||||||||2017-10-11 02:55:16.349108|2017-10-11 02:55:16.349108
NCT01608438|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-08-24|||February 2013||2013-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BMI||Motor Learning in a Customized Body-Machine Interface|Motor Learning in a Customized Body-Machine Interface for Persons With Paralysis|Recruiting||N/A|46|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 02:55:16.485898|2017-10-11 02:55:16.485898
NCT01608425|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-06-04|||April 2011||2011-04-01|June 2013|2013-06-01|November 2013|Anticipated|2013-11-01|June 2013|Anticipated|2013-06-01||Interventional|Telesaar||Ulcer Monitoring in Diabetes Mellitus|Impact Assessment by Introducing Telemedicine Consultations for Treatment of Diabetic Patients With Foot Ulcers in Region of Southern Denmark - Randomized Prospective Study|Unknown status|Recruiting|Phase 2|400|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 02:55:16.621027|2017-10-11 02:55:16.621027
NCT01608412|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-30|||February 2012||2012-02-01|August 2011|2011-08-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus|An Open-label Randomized Controlled Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus 3 Months After Kidney Transplantation.|Unknown status|Recruiting|Phase 4|120|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 02:55:16.770865|2017-10-11 02:55:16.770865
NCT01608399|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-05-25|||March 2012|Actual|2012-03-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Clinical Trial of the Effectiveness of Metacognitive Therapy in the Treatment of Patients With Major Depressive Disorder|A Randomized Controlled Trial of the Effectiveness of Metacognitive Therapy (MCT) in the Treatment of Patients With Major Depressive Disorder (MDD)|Completed||N/A|40|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 02:55:16.904552|2017-10-11 02:55:16.904552
NCT01608386|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-08-05|||May 2012||2012-05-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|AA+IVC||A Study of Anterior Approach Combined With Infrahepatic Inferior Vena Cava Clamping|Anterior Approach Combined With Infrahepatic Inferior Vena Cava Clamping Right Hepatic Resection for Large Hepatocellular Carcinoma: A Prospective Randomized Controlled Study|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-10-11 02:55:17.053807|2017-10-11 02:55:17.053807
NCT01608373|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2013-08-01|||July 2011||2011-07-01|July 2011|2011-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||The Effect of Intravenous Lidocaine and Intraperitoneal Lidocaine Irrigation on Pain After Laparoscopic Cholecystectomy|Comparison of Intravenous Lidocaine and Intraperitoneal Lidocaine Irrigation for Effective Pain Relief After Laparoscopic Cholecystectomy: A Prospective, Randomized, Double-blind, Placebo-controlled Study|Unknown status|Recruiting|Phase 4|83|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||3|||f||||t||||||||||2017-10-11 02:55:17.347714|2017-10-11 02:55:17.347714
NCT01608360|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2014-03-17|||July 2011||2011-07-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Effect of Intravenous Lidocaine on Pain After Thyroidectomy|Intravenous Lidocaine for Effective Pain Relief After Thyroidectomy: a Prospective, Randomized, Double-blind, Placebo-controlled Study|Unknown status|Recruiting|Phase 4|56|Anticipated|Chung-Ang University Hosptial, Chung-Ang University College of Medicine||2|||f||||f||||||||||2017-10-11 02:55:17.480316|2017-10-11 02:55:17.480316
NCT01608347|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-26|2017-01-23|||January 2010|Actual|2010-01-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|LMWH-APAN||Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies|Low Molecular Weight Heparin for Treatment of Recurrent Miscarriage With Negative Antiphospholipid Antibodies: a Randomized Controlled Trial|Completed||Phase 4|228|Actual|Assiut University||2|||f||||t||||||||||2017-10-11 02:55:17.626586|2017-10-11 02:55:17.626586
NCT01608334|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-05-29|||August 2011||2011-08-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Comparison of Intrathecal Fentanyl or Sufentanil in 1 mg Bupivacaine Spinal Anesthesia for TURP in Elderly Patients||Completed||N/A|56|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:55:17.715556|2017-10-11 02:55:17.715556
NCT01608321|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-04-10|2016-12-12||September 2012||2012-09-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|rTMS||rTMS for the Treatment of Chronic Pain in GW1 Veterans|rTMS for the Treatment of Chronic Pain in GW1 Veterans|Terminated||Phase 3|17|Actual|VA Office of Research and Development||2||Did not meet recruitment goals|f||||t||||||||No|Trial discontinued before an adequate number of subjects was tested.|2017-10-11 02:55:17.787436|2017-10-11 02:55:17.787436
NCT01608308|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-09-25|2015-06-12||July 2012||2012-07-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|IVAPAP|In total 62 subjects were enrolled. Two subjects were dropped due to pretrreatment medical and billing issues;therefore, in total 60 subjects were dosed.|Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery|A Double Blind, Randomized, Placebo-controlled Study to Investigate the Effectiveness of IV Acetominophen Administered During Functional Endoscopic Sinus Surgery in Reducing the Use of Opiates to Treat Postoperative Pain|Completed||N/A|62|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 02:55:18.33335|2017-10-11 02:55:18.33335
NCT01608295|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-05-08|2017-02-01||July 2012||2012-07-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Vilazodone for Treatment of Geriatric Depression|A Pilot Study of Double-blind Comparison of Vilazodone to Paroxetine in Geriatric Depression|Completed||Phase 4|65|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:55:18.789793|2017-10-11 02:55:18.789793
NCT01608282|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-06-27|||October 2012|Actual|2012-10-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|OPEN||Internet Intervention to Improve Physical Activity in Early Knee Osteoarthritis|Capitalizing on the Teachable Moment: the OPEN (Osteoarthritis Physical Activity & Exercise Net) for Improving Physical Activity in Early Knee Osteoarthritis|Terminated||N/A|75|Actual|University of British Columbia||2||Unable to reach recruitment target|f||||f||||||||No||2017-10-11 02:55:19.264939|2017-10-11 02:55:19.264939
NCT01608269|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-04-27|||November 2010||2010-11-01|May 2012|2012-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|EPZSwitch||Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy|Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy|Completed||Phase 4|30|Anticipated|Therapeutic Concepts||1|||f||||f||||||||||2017-10-11 02:55:19.376707|2017-10-11 02:55:19.376707
NCT01608256|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-05-29|||June 2012||2012-06-01|May 2012|2012-05-01|June 2014|Anticipated|2014-06-01|July 2013|Anticipated|2013-07-01||Observational|MCI||Driving Ability Among People With Mild Cognitive Impairment|Assessing the Effect of MCI on Driving Ability by Using on Road Driving Test. The Relationship Between Their Driving Outcome and Their Cognitive Decline Will be Examined|Unknown status|Not yet recruiting|N/A|60|Anticipated|Tel Aviv University|||2||f||||f||||||||||2017-10-11 02:55:19.463912|2017-10-11 02:55:19.463912
NCT01608243|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-06-30|||May 2012||2012-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts|Investigation of the Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adults With House Dust Mite-associated Allergic Asthma|Completed||Phase 1|94|Actual|Stallergenes Greer||2|||f||||f||||||||||2017-10-11 02:55:19.543064|2017-10-11 02:55:19.543064
NCT01608230|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-11-17|||April 2010||2010-04-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|HuTS||Human Tumor Sequencing Project|Human Tumor Sequencing Project|Completed||N/A|35|Actual|Scripps Translational Science Institute|||1||f||||f||||||||||2017-10-11 02:55:19.624585|2017-10-11 02:55:19.624585
NCT01608217|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-06-26|||June 2012||2012-06-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Delta-THC in Dementia|Efficacy and Safety of Delta-9-tetrahydrocannabinol (∆9-THC) in Behavioural Disturbances and Pain in Dementia|Completed||Phase 2|50|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 02:55:19.690192|2017-10-11 02:55:19.690192
NCT01608204|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-06-10|||January 2010||2010-01-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation||Completed||N/A|63|Actual|Rambam Health Care Campus|||1||f||||f||||||Samples With DNA|"     Peripheral Blood was used for DNA extraction   "|||2017-10-11 02:55:19.818961|2017-10-11 02:55:19.818961
NCT01608191|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2016-02-01|||March 2012||2012-03-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|LCD-KBT||Obesity Treatment With LCD in Primary Health Care|Obesity Treatment With LCD(Low Calorie Diet) in Primary Health Care - Long Term Effects With or Without Internet Based CBT (Cognitive Behavioral Therapy) , for Weight Stability|Active, not recruiting||Phase 3|200|Anticipated|Örebro County Council||2|||f||||f||||||||No||2017-10-11 02:55:19.87994|2017-10-11 02:55:19.87994
NCT01608178|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-06-30|||April 27, 2012||2012-04-27|December 16, 2013|2013-12-16|December 16, 2013||2013-12-16|||||Observational|||Taurine Therapy for SSADH Deficiency|Succinic Semialdehyde Dehydrogenase Deficiency: Physiological Markers of Taurine Therapy|Completed||N/A|7|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:55:19.966361|2017-10-11 02:55:19.966361
NCT01608165|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-12-04|||June 2012||2012-06-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|CONSERVE||A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm)|CONSERVE: a Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery (Partial Nephrectomy) With Needle Ablation Techniques (Radiofrequency Ablation/Cryotherapy) for the Treatment of People With Small Renal Masses (4cm)|Completed||N/A|17|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||3|||f||||t||||||||||2017-10-11 02:55:20.042842|2017-10-11 02:55:20.042842
NCT01608152|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-04-21|||February 2013|Actual|2013-02-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors|Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors|Active, not recruiting||N/A|40|Anticipated|M.D. Anderson Cancer Center|||2||f||||f|f|f||||||||2017-10-11 02:55:20.163636|2017-10-11 02:55:20.163636
NCT01608139|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-10-17|||November 2012||2012-11-01|October 2012|2012-10-01||||November 2022|Anticipated|2022-11-01||Interventional|||Study of Curcumin, Vorinostat, and Sorafenib|Pilot Study of Curcumin, Vorinostat, and Sorafenib in Patients With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 02:55:20.255164|2017-10-11 02:55:20.255164
NCT01608126|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-05-29|||January 2011||2011-01-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Medial Cervical Block for Carotid Endarterectomy Comparison With Standard Method|A Comparison of Medial Cervical Plexus Block Versus Combined (Superficial and Deep) Cervical Plexus Block for Carotid Endarterectomy: A Prospective, Randomized Single Blind Study|Completed||N/A|100|Actual|Masaryk Hospital Krajská zdravotní a.s.||2|||f||||f||||||||||2017-10-11 02:55:20.366962|2017-10-11 02:55:20.366962
NCT01608113|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-05-25|||September 2011||2011-09-01|May 2012|2012-05-01||||||||Observational|||Long-term Follow-up of Subfoveal Neovascular AMD||Unknown status|Recruiting|N/A|70|Anticipated|Medical University of Vienna|||1||f||||||||||||||2017-10-11 02:55:20.469218|2017-10-11 02:55:20.469218
NCT01608100|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-03-04|2014-12-03||June 2012||2012-06-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Evaluation of a New Cardiac Biomarker Assay|Design Validation Protocol for the Evaluation of ARCHITECT STAT High Sensitive Troponin I Assay|Completed||Phase 3|1101|Actual|Abbott Diagnostics Division|Some tube types and some time points may not have been obtained for each subject. Every attempt was made to collect all tube types within the time point windows described.|1|||f||||f||||||||||2017-10-11 02:55:20.573961|2017-10-11 02:55:20.573961
NCT01608087|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2013-05-15|||May 2012||2012-05-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects|Pharmacokinetics and Safety of BI 695502 in Healthy Subjects: a Randomized, Single-blind, Single-dose, Parallel-arm, Active-comparator Clinical Phase I Study|Completed||Phase 1|91|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 02:55:21.431168|2017-10-11 02:55:21.431168
NCT01608074|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-07-19|||December 2011|Actual|2011-12-01|July 2017|2017-07-01|October 2025|Anticipated|2025-10-01|October 2019|Anticipated|2019-10-01||Interventional|Fimbriectomy||Radical Fimbriectomy for Young BRCA Mutation Carriers|Radical Fimbriectomy for Young BRCA Mutation Carriers at Risk of Pelvic Serous Carcinoma|Active, not recruiting||N/A|123|Actual|Centre Oscar Lambret||1|||f||||t|f|f||||||||2017-10-11 02:55:21.510431|2017-10-11 02:55:21.510431
NCT01607489|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-07-12|||June 2011||2011-06-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography|Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography - Pilot Study|Completed||N/A|25|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-11 02:55:30.215597|2017-10-11 02:55:30.215597
NCT01608061|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-02-14|||May 2012||2012-05-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|June 2015|Actual|2015-06-01||Interventional|ADvance||ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease|A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease|Active, not recruiting||N/A|50|Anticipated|Functional Neuromodulation Ltd||2|||f||||t||||||||||2017-10-11 02:55:21.650278|2017-10-11 02:55:21.650278
NCT01608048|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-03-29|||May 2014||2014-05-01|November 2012|2012-11-01|February 2017|Anticipated|2017-02-01|April 2016|Anticipated|2016-04-01||Interventional|||Transcutaneous Electrical Acupoint Stimulation to Improve Pregnancy Rates for Women Undergoing in Vitro Fertilization|Transcutaneous Electrical Acupoint Stimulation to Improve Pregnancy Rates for Women Undergoing in Vitro Fertilization|Unknown status|Not yet recruiting|N/A|384|Anticipated|Huazhong University of Science and Technology||3|||f||||t||||||||||2017-10-11 02:55:21.758633|2017-10-11 02:55:21.758633
NCT01608035|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2016-05-18|||September 2012||2012-09-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Sciatic Perineural Versus Stump Catheter for Below Knee Amputation|Ultrasound Guided Sciatic Perineural Catheter vs Surgically Placed Sciatic Stump Catheter for Below Knee Amputations: Is There A Difference in Patient Outcomes|Completed||Early Phase 1|29|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 02:55:21.838106|2017-10-11 02:55:21.838106
NCT01608022|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-09-05|||July 2012||2012-07-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus||Completed||Phase 2|48|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 02:55:21.936311|2017-10-11 02:55:21.936311
NCT01608009|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-03-09|||July 2012||2012-07-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Interventional|PAZPET-1||[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer|Phase 1b Exploratory Study of [18F]Fluciclatide-PET as a Marker of Angiogenic Response to Combination Therapy With the Pan-VEGF Inhibitor, Pazopanib, and Weekly Paclitaxel in Platinum Resistant Ovarian Cancer|Completed||Phase 1|16|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 02:55:22.024709|2017-10-11 02:55:22.024709
NCT01607996|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-05-25|||July 2005||2005-07-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|August 2010|Actual|2010-08-01||Interventional|||Effect of Epidural Anesthesia on Pancreatic Perfusion and Clinical Outcome in Patients With Severe Acute Pancreatitis|Phase 1 Study of Epidural Anesthesia on Pancreatic Perfusion and Clinical Outcome in Patients With Severe Acute Pancreatitis|Completed||Phase 1|35|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 02:55:22.102516|2017-10-11 02:55:22.102516
NCT01607983|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-05-09|||June 2012||2012-06-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients|The Effect of Selective Pulmonary Vasodilation on Ventricular Afterload and Ventricular-arterial Coupling in Patients With Fontan Physiology and Validation of Echocardiographic Measures of Systolic and Diastolic Function.|Recruiting||Phase 3|30|Anticipated|University of California, San Francisco||1|||f||||f|t|f|||f|||Undecided||2017-10-11 02:55:22.182311|2017-10-11 02:55:22.182311
NCT01607970|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-25|||August 2011||2011-08-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making|Double-blind, Placebo-controlled, Randomized Study: Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making|Completed||Phase 1|80|Actual|University Hospital, Bonn||2|||f||||f||||||||||2017-10-11 02:55:22.277839|2017-10-11 02:55:22.277839
NCT01607957|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-10-05|||June 17, 2012|Actual|2012-06-17|October 2017|2017-10-01|May 23, 2016|Actual|2016-05-23|January 24, 2014|Actual|2014-01-24||Interventional|RECOURSE||Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies|Randomized, Double-blind, Phase 3 Study of TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies|Completed||Phase 3|800|Actual|Taiho Oncology, Inc.||2|||f||||t||||||||||2017-10-11 02:55:22.377371|2017-10-11 02:55:22.377371
NCT01607944|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-12-02|||April 2012||2012-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Observational|||Incretins and Metabolism|The Extrapancreatic Metabolic Effects of Incretin Hormones|Completed||N/A|20|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-11 02:55:24.350832|2017-10-11 02:55:24.350832
NCT01607931|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-08-11|||January 2013||2013-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|April 2016|Actual|2016-04-01||Interventional|||Exercise, Glucose Kinetics, and the Incretin Effect|The Effects of Acute Exercise on Glucose Kinetics, Beta-cell Function and the Incretin Effect in Subjects Representative of the Whole Glucose Tolerance Continuum|Completed||N/A|12|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:55:24.419971|2017-10-11 02:55:24.419971
NCT01607918|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-10-27|||February 2012||2012-02-01|October 2013|2013-10-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|THC||Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy|Comparison of the Efficacy of Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy for 10 Days in the First Line Therapy for Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial|Unknown status|Recruiting|Phase 4|1300|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:55:24.51373|2017-10-11 02:55:24.51373
NCT01607905|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-05-25|||June 2012||2012-06-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Safety Study of KPT-330 in Patients With Advanced or Metastatic Solid Tumor Cancer|A Phase I Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Doses of the Selective Inhibitor of Nuclear Export/SINE Compound KPT-330 in Patients With Advanced or Metastatic Solid Tumor Malignancies|Completed||Phase 1|189|Actual|Karyopharm Therapeutics Inc||1|||f||||f||||||||Yes||2017-10-11 02:55:24.612111|2017-10-11 02:55:24.612111
NCT01607892|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-05-25|||June 2012||2012-06-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer|A Phase I Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Doses of the Selective Inhibitor of Nuclear Export/SINE™ Compound KPT-330 in Patients With Advanced Hematological Malignancies|Completed||Phase 1|285|Actual|Karyopharm Therapeutics Inc||1|||f||||f||||||||Yes||2017-10-11 02:55:24.824763|2017-10-11 02:55:24.824763
NCT01607879|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-11-15|||March 2014||2014-03-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|October 2017|Anticipated|2017-10-01||Interventional|||Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation|Use of β-hydroxy-β-methylbutyrate to Counteract Loss of Muscle Mass and Strength in Older Men With Prostate Cancer Started on Androgen Deprivation Therapy|Recruiting||Phase 2|80|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-11 02:55:24.971034|2017-10-11 02:55:24.971034
NCT01607866|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-11-07|||June 2014||2014-06-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Quadrant Versus Superficial Parotidectomy|Quadrant Parotidectomy Versus Superficial Parotidectomy for Treatment of Pleomorphic Adenoma|Withdrawn||Phase 2/Phase 3|0|Actual|Mansoura University||2||Lack of enrollment of eligible patients for randomization.|f||||f||||||||||2017-10-11 02:55:25.144|2017-10-11 02:55:25.144
NCT01607853|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2015-03-25|2013-11-04||June 2012||2012-06-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris|A Phase IIa Exploratory Study Evaluating the Anti-psoriatic Effect of Daivobet® Gel Applied Then Removed After 10 Minutes, Daivobet® Gel Applied Then Removed After 20 Minutes, Daivobet® Gel Applied for 24 Hours and Daivobet® Gel Vehicle Applied for 24 Hours|Completed||Phase 2|24|Actual|LEO Pharma|"In this small exploratory trial the subjects received all 4 investigational products on small dermal test sites.
Regarding Adverse Events, only local dermal reactions could be potentially attributed to a specific investigational product."|1|||f||||f||||||||||2017-10-11 02:55:25.259756|2017-10-11 02:55:25.259756
NCT01607840|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-08-31|||June 2012||2012-06-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia|Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia|Completed||N/A|11|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 02:55:26.207366|2017-10-11 02:55:26.207366
NCT01607827|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2012-06-18|||April 2004||2004-04-01|June 2012|2012-06-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Colorectal Polypectomy Upon Insertion And Withdrawal Or Upon Withdrawal Only?|Colorectal Polypectomy Upon Insertion And Withdrawal Or Upon Withdrawal Only?|Completed||N/A|400|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 02:55:26.29443|2017-10-11 02:55:26.29443
NCT01607814|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-30|||November 2011||2011-11-01|May 2012|2012-05-01|November 2014|Anticipated|2014-11-01|November 2013|Anticipated|2013-11-01||Observational|||Oxidative Stress and Haemostasis Abnormalities in Cirrhosis|Oxidative Stress and Haemostasis Abnormalities in Cirrhosis|Unknown status|Recruiting|N/A|200|Anticipated|University of Roma La Sapienza|||2||f||||t||||||Samples Without DNA|"     Plasma, serum and urine samples   "|||2017-10-11 02:55:26.375755|2017-10-11 02:55:26.375755
NCT01607801|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-01-30|||January 2007||2007-01-01|January 2017|2017-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|UMBI-REC||Effect of Reoperation for Recurrence After Open Umbilical Hernia Repair|Effect of Reoperation for Recurrence After Open Surgery for Small Umbilical Hernia With Sutured Mesh or Plastic Surgery. A National Hernia Database Study.|Completed||N/A|4847|Actual|Zealand University Hospital|||4||f||||t||||||||||2017-10-11 02:55:26.455817|2017-10-11 02:55:26.455817
NCT01607788|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2012-05-29|||November 2009||2009-11-01|May 2012|2012-05-01|December 2017|Anticipated|2017-12-01|||||Observational|ProLit||Prospective Liver Tumor (ProLiT) Database|Prospective Database of Liver Transplantation for Hepatocellular Carcinoma|Recruiting||N/A|500|Anticipated|University of Geneva, Switzerland|||1||f||||f||||||||||2017-10-11 02:55:26.520217|2017-10-11 02:55:26.520217
NCT01607762|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2013-04-08|||February 2012||2012-02-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics|Comparison of Single-Dose Plasma and Blood Concentrations of Aripiprazole, Olanzapine, Quetiapine, Paliperidone and Risperidone After Capillary and Venous Blood Sample Collection|Completed||Phase 1|31|Actual|Janssen Research & Development, LLC||5|||f||||f||||||||||2017-10-11 02:55:26.817849|2017-10-11 02:55:26.817849
NCT01607736|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-05-29|||May 2011||2011-05-01|May 2012|2012-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Pilot Study of Virtual Gait Training in Older Adults|Pilot Study of Effects of Virtual Gait Training on Walking Stability in Older Adults|Completed||N/A|12|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 02:55:27.028789|2017-10-11 02:55:27.028789
NCT01607723|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2014-12-02|||May 2012||2012-05-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|May 2012|Actual|2012-05-01||Interventional|||"NAVA-PAV Study: a Cross-over Comparative Study of 2 Advanced Modes"|"Comparison of Two New Ventilatory Modes: NAVA vs PAV+: a Randomized Controlled Cross-over Study: the NAVA-PAV Study"|Completed||Phase 3|13|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 02:55:27.125973|2017-10-11 02:55:27.125973
NCT01607710|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2014-09-04|||July 2012||2012-07-01|March 2013|2013-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|fMRI||Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)|Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)|Completed||N/A|55|Actual|Hartford Hospital|||2||f||||f||||||||||2017-10-11 02:55:27.224041|2017-10-11 02:55:27.224041
NCT01607697|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-06-13|||March 2012||2012-03-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Mindfulness Based Intervention (MBI) on the Quality of Life and Non-Motor Symptoms (NMS) of Persons With PD|Mindfulness Based Intervention (MBI) on the Quality of Life and Non-Motor Symptoms (NMS) of Persons With Parkinson's Disease (PD)|Completed||Phase 2|42|Actual|University Hospital, Antwerp||2|||f||||f||||||||||2017-10-11 02:55:27.294587|2017-10-11 02:55:27.294587
NCT01607684|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2012-09-03|||January 2012||2012-01-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis|Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis|Completed||Phase 2|50|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-10-11 02:55:27.381721|2017-10-11 02:55:27.381721
NCT01607671|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2015-05-22|||June 2012||2012-06-01|May 2012|2012-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%|Can Urgent Reduction of Intraocular Pressure With Ophthalmic Timolol Improve Recovery From Non-arteritic Anterior Ischemic Optic Neuropathy (NAION): a Randomized Study.|Withdrawn||Phase 1|0|Actual|Fraser Health||2||Unable to recruit participants from recruiting sites.|f||||f||||||||||2017-10-11 02:55:27.473977|2017-10-11 02:55:27.473977
NCT01607645|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2017-02-14|2016-10-13||July 2012||2012-07-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS|Phase II Trial Examining Epigenetic Priming With Decitabine Followed by Idarubicin and Cytarabine for Patients With Relapsed or Refractory AML.|Terminated||Phase 2|7|Actual|Fred Hutchinson Cancer Research Center|Early termination due to similar competing protocol, which made statistical evaluation of primary endpoint and any meaningful evaluation of secondary time points not feasible.|2||The study was terminated early because there were other competing protocols.|f||||f||||||||Yes||2017-10-11 02:55:27.800421|2017-10-11 02:55:27.800421
NCT01607632|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-24|||January 2010||2010-01-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Loving-kindness Meditation for Posttraumatic Stress Disorder (PTSD)|An Open Pilot Study of Loving-Kindness Meditation for PTSD|Completed||N/A|42|Actual|Seattle Institute for Biomedical and Clinical Research||1|||f||||f||||||||||2017-10-11 02:55:28.601937|2017-10-11 02:55:28.601937
NCT01607619|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2013-01-24|||May 2011||2011-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Anatabine on Elevated Blood Levels of C-reactive Protein|A 12-week Multi-site Trial of the Dietary Supplement Anatabine (RCP006) to Determine the Effects on Peripheral Markers of Inflammation in Patients With Elevated Levels of C-reactive Protein (CRP)|Completed||N/A|117|Actual|Roskamp Institute Inc.||1|||f||||t||||||||||2017-10-11 02:55:28.699388|2017-10-11 02:55:28.699388
NCT01607606|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-29|||May 2012||2012-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:55:28.783605|2017-10-11 02:55:28.783605
NCT01607593|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2013-12-11|2013-09-26||August 2012||2012-08-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients|A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients|Completed||N/A|123|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 02:55:28.84721|2017-10-11 02:55:28.84721
NCT01607580|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-01-03|||June 2012||2012-06-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD)|Risk Stratification-directed Low-dose Glucocorticoid Prophylaxis for Acute GVHD After Unmanipulated Haploidentical Blood and Marrow Transplantation——a Randomized, Controlled, Clinical Trial|Unknown status|Active, not recruiting|N/A|145|Actual|Peking University People's Hospital||2|||f||||t||||||||||2017-10-11 02:55:29.322833|2017-10-11 02:55:29.322833
NCT01607554|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-06-07|||April 2012||2012-04-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer|A Pilot, Non-Randomized Phase II Protocol of Irinotecan for Patients With Previously Treated, Advanced, Non-Small Cell Lung Cancer With High ISG 15 Expression|Terminated||Phase 1/Phase 2|2|Actual|New Mexico Cancer Care Alliance||1||Inadequate enrollment (2 subjects in 4 years)|f||||t||||||||No||2017-10-11 02:55:29.584108|2017-10-11 02:55:29.584108
NCT01607541|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-06-08|||April 2012||2012-04-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|February 2015|Actual|2015-02-01||Interventional|BCAP||Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV|Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV|Completed||Phase 2/Phase 3|3400|Actual|New York University||2|||f||||t||||||||||2017-10-11 02:55:29.730657|2017-10-11 02:55:29.730657
NCT01607528|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-05-04|||July 2012||2012-07-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|PIC||Influence of Probiotics on Infections in Cirrhosis|Probiotic Modulation of Gut Microflora in Cirrhosis: Influence on Immune Function and Infections|Completed||N/A|92|Actual|Medical University of Graz||2|||f||||t||||||||Undecided||2017-10-11 02:55:29.852215|2017-10-11 02:55:29.852215
NCT01607515|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-09-07|||March 2012||2012-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Non Invasive Measurement of Cardiac Index by Impedance Cardiography|Non Invasive Measurement of Cardiac Index by Impedance Cardiography|Completed||N/A|89|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-11 02:55:29.98466|2017-10-11 02:55:29.98466
NCT01607502|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-08-08|||July 2010||2010-07-01|August 2017|2017-08-01|July 2024|Anticipated|2024-07-01|July 2024|Anticipated|2024-07-01||Observational|||Database for Clinical and Anamnestic Data in Pulmonary Hypertension|Database for Clinical and Anamnestic Data in Pulmonary Hypertension|Recruiting||N/A|900|Anticipated|Medical University of Graz|||1||f||||f||||||Samples With DNA|"     Blood samples are collected and stored anonymously in our biobank if patients give their     informed consent containing the option of DNA analysis.   "|||2017-10-11 02:55:30.101412|2017-10-11 02:55:30.101412
NCT01587482|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-05-19|||December 2011||2011-12-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|December 2012|Actual|2012-12-01||Observational|PLAISIR||PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis|PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis|Completed||N/A|53|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 03:01:36.180141|2017-10-11 03:01:36.180141
NCT01607476|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-03-21|2016-08-02||July 2012||2012-07-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|December 2014|Actual|2014-12-01||Interventional|||Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)|Bridging Study of C11 PiB and F18 Flutemetamol Brain PET|Completed||Phase 2|89|Actual|Mayo Clinic||3|||f||||t||||||||Undecided|This study was funded by an industrial partner (GE) and discussions with the company about sharing the data will be entertained after first publications.|2017-10-11 02:55:30.351891|2017-10-11 02:55:30.351891
NCT01607463|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-05-24|||May 2012||2012-05-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Venous Cannulation|The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Venous Cannulation|Completed||N/A|100|Actual|Kyungpook National University||2|||f||||f||||||||||2017-10-11 02:55:30.874336|2017-10-11 02:55:30.874336
NCT01607450|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-01-19|2015-11-16||May 2010||2010-05-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Modulation of Human Myocardial Metabolism by GLP-1 Dose Response|Modulation of Human Myocardial Metabolism by GLP-1 Dose Response|Completed||Phase 2/Phase 3|33|Actual|Indiana University|This was a dose-finding study of myocardial responses to systemically infused GLP-1. After ascertaining no detectable response in controls with low dose, we completed mid dose studies. Finding an important difference there we did not do the high dose|4|||f||||t||||||||||2017-10-11 02:55:31.005432|2017-10-11 02:55:31.005432
NCT01607437|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-25|2012-05-29|||February 2011||2011-02-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|Howell||Clinical Follow-up After ACL Reconstruction|10-year Follow-up After ACL Reconstruction With Howells Guide, Transtibial Drilling and Hamstrings Graft|Completed||N/A|96|Actual|Bergen Knee Group|||1||f||||f||||||||||2017-10-11 02:55:31.77677|2017-10-11 02:55:31.77677
NCT01607424|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2015-09-02|||December 2008||2008-12-01|September 2015|2015-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|RECOS||Specific Cognitive Remediation for Schizophrenia|Specific Versus General Cognitive Remediation for Schizophrenia|Completed||N/A|151|Actual|Hôpital le Vinatier||2|||f||||f||||||||||2017-10-11 02:55:31.867439|2017-10-11 02:55:31.867439
NCT01607411|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-08-07|2013-05-30||February 2012||2012-02-01|July 2014|2014-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model|A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model|Completed||Phase 3|55|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 02:55:31.995357|2017-10-11 02:55:31.995357
NCT01607398|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-04-24|2014-03-06||May 2012||2012-05-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease|A 12-week Randomised, Double-blind, Parallel-group Study to Evaluate the Anti-inflammatory Effects of ADOAIR® 50/250mcg Twice Daily Compared With Placebo Twice Daily in Japanese Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|56|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:55:32.614252|2017-10-11 02:55:32.614252
NCT01607385|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-07-24|||May 18, 2012|Actual|2012-05-18|July 2017|2017-07-01|December 3, 2012|Actual|2012-12-03|December 3, 2012|Actual|2012-12-03||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.|A Single Blind, Randomized, Placebo-controlled, Dose Escalating Study to Evaluate the Safety, Tolerability,Pharmacokinetic and Pharmacodynamic Parameters of Repeat Doses of GSK2330672 in Healthy Volunteers, Given Alone and With a Single Day of Dosing With GSK1614235|Completed||Phase 1|56|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:55:33.432199|2017-10-11 02:55:33.432199
NCT01607359|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-04-20|||May 2012||2012-05-01|December 2016|2016-12-01|April 20, 2017|Actual|2017-04-20|October 2012|Actual|2012-10-01||Observational|||Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation|Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation|Withdrawn||N/A|0|Actual|William Beaumont Hospitals|||2|Withdrawn: It was decided not to proceed with the study at this time.|f||||f||||||||||2017-10-11 02:55:33.70745|2017-10-11 02:55:33.70745
NCT01607346|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-08-28|2017-07-11||March 27, 2013|Actual|2013-03-27|August 2017|2017-08-01|November 16, 2016|Actual|2016-11-16|November 16, 2016|Actual|2016-11-16||Interventional|||An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures|An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures|Terminated||Phase 4|10|Actual|GlaxoSmithKline|The study was terminated after 10 of 100 subjects had been enrolled. Statistical analyses were not performed as the sample size enrolled was too small to allow for these analyses to be meaningful. The data are presented as summary statistics only.|1|||f||||f||||||||||2017-10-11 02:55:33.999935|2017-10-11 02:55:33.999935
NCT01607333|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-03-26|||December 2011||2011-12-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide|WEUKBRE5557: IMI PROTECT (Work Package 2): Use of Antiepileptics and Risk of Suicidality|Completed||N/A|1|Actual|GlaxoSmithKline|||3||f||||f||||||||||2017-10-11 02:55:34.664045|2017-10-11 02:55:34.664045
NCT01607320|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-05-12|2015-04-14||June 2012||2012-06-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|PCOS||Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome|Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome.|Terminated||N/A|3|Actual|Greenville Health System||2||Over budget, slow recruitment, and personnel change|f||||t||||||||||2017-10-11 02:55:34.78446|2017-10-11 02:55:34.78446
NCT00006552|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-28|2016-03-15|||September 1999||1999-09-01|May 2005|2005-05-01|August 2002|Actual|2002-08-01|||||Observational|||Adherence to Antihypertensive Therapy--Data Analyses||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:26.743528|2017-10-11 04:28:26.743528
NCT01607307|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2013-12-17|||August 2012||2012-08-01|August 2012|2012-08-01|August 2016|Anticipated|2016-08-01|December 2013|Actual|2013-12-01||Interventional|JAPAN-PD||Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy|Effect of Daikenchuto (TJ-100) on Intestinal Dysmotility and For the Prevention of Postoperative Paralytic Ileus in Patients Undergoing Pancreaticoduodenectomy: A Multicenter, Randomized, Placebo-Controlled Phase II Trial|Unknown status|Active, not recruiting|Phase 2|220|Anticipated|Wakayama Medical University||2|||f||||t||||||||||2017-10-11 02:55:35.088426|2017-10-11 02:55:35.088426
NCT01607294|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-08-27||2015-08-13|April 2012||2012-04-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes|A Placebo-Controlled, Randomized, Double-Blind, Parallel Group, Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes|Completed||Phase 2|60|Actual|Esperion Therapeutics||2|||f||||f||||||||||2017-10-11 02:55:35.242024|2017-10-11 02:55:35.242024
NCT01607281|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-06-10|||June 2012||2012-06-01|May 2012|2012-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||The Ability of Anesthesiologists Identifying Internal Jugular Vein Bilaterally by Anatomic Landmarks|The Ability of Anesthesiologists Identifying Internal Jugular Vein by Anatomic Landmark Technique|Completed||N/A|50|Actual|Diskapi Teaching and Research Hospital|||1||f||||f||||||||||2017-10-11 02:55:35.35478|2017-10-11 02:55:35.35478
NCT01607268|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-01-16|||July 2012||2012-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Magnetic Resonance Spectroscopy in Autonomic Failure|Proton Magnetic Resonance Spectroscopy in Primary Autonomic Failure|Terminated||N/A|6|Actual|Vanderbilt University Medical Center|||2|Could not enroll enough participants, and lost funding.|f||||f||||||||||2017-10-11 02:55:35.47348|2017-10-11 02:55:35.47348
NCT01607255|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-10-03|||May 16, 2013|Actual|2013-05-16|October 2017|2017-10-01|September 30, 2017|Actual|2017-09-30|June 30, 2017|Actual|2017-06-30||Interventional|||Comparative Efficacy of Water & Indigo Carmine vs. Water or Air Method on Adenoma Detection Rate (ADR) - a Randomized Controlled Trial (RCT)|Comparative Efficacy of Water & Indigo Carmine vs Water or Air Method|Completed||Phase 4|480|Actual|VA Office of Research and Development||3|||f||||t|t|f|||f|||||2017-10-11 02:55:35.58647|2017-10-11 02:55:35.58647
NCT01607242|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-05-24|||March 2012||2012-03-01|May 2012|2012-05-01||||||||Observational|||Impact of Total Thyroidectomy on Voice and Swallowing|Study of Total Thyroidectomy Effect on Voice and Swallowing Function|Unknown status|Recruiting|N/A|100|Anticipated|University of Thessaly|||1||f||||t||||||||||2017-10-11 02:55:35.707358|2017-10-11 02:55:35.707358
NCT01607229|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-24|||January 2010||2010-01-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Multi-frequency Bioelectrical Impedance for Estimating Total Body Water by Deuterium Dilution|Utility of Multi-frequency Bioelectrical Impedance Compared to Deuterium Dilution for Assessment of Total Body Water|Completed||N/A|25|Actual|University of Southern California|||1||f||||t||||||||||2017-10-11 02:55:35.853815|2017-10-11 02:55:35.853815
NCT01607216|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-05-02|||August 2011||2011-08-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies|Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies|Completed||N/A|277|Actual|University of Rochester|||2||f||||t||||||Samples With DNA|"     Several types of biospecimens are to be collected:      Cord Blood Tracheal Aspirates Urine Stool Saliva Blood      DNA collection is optional.   "|||2017-10-11 02:55:35.973056|2017-10-11 02:55:35.973056
NCT01607203|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-02-03|2013-12-30||November 2011||2011-11-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist|Randomised Controlled Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist|Completed||Phase 4|120|Actual|AZ Jan Palfijn Gent||2|||f||||t||||||||||2017-10-11 02:55:36.11009|2017-10-11 02:55:36.11009
NCT01607190|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-09-13|||November 2012||2012-11-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Observational|C-Tracer||Biomarkers of Diabetic Retinopathy Progression|Biomarkers of Diabetic Retinopathy Progression.|Active, not recruiting||N/A|200|Anticipated|Association for Innovation and Biomedical Research on Light and Image|||1||f||||f||||||||||2017-10-11 02:55:36.536433|2017-10-11 02:55:36.536433
NCT01607177|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-11-12|||August 2012||2012-08-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Do Text Message Reminders Increase Preoperative Exercise in Obesity Surgery Candidates?|Text Messaging to Improve Adherence to Prehabilitation in Patients Undergoing Bariatric Surgery: a Randomised Controlled Trial|Completed||Phase 3|102|Actual|University of Auckland, New Zealand||2|||f||||||||||||||2017-10-11 02:55:36.631279|2017-10-11 02:55:36.631279
NCT01607164|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-05-21|||April 2012||2012-04-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|DPC-R||Healthy Mood Internet Recruitment Study|Depression Prevention and Management Project|Completed||N/A|1226|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 02:55:36.735957|2017-10-11 02:55:36.735957
NCT01607151|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-08-04|||January 2013||2013-01-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2015|Actual|2015-06-01||Interventional|TTM-ICH||Safety and Feasibility Study of Targeted Temperature Management After ICH|Safety and Feasibility of a Protocol of Targeted Temperature Management After Intracerebral Hemorrhage|Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 02:55:36.855754|2017-10-11 02:55:36.855754
NCT01607138|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2012-05-25|||June 2012||2012-06-01|May 2012|2012-05-01|December 2014|Anticipated|2014-12-01|June 2013|Anticipated|2013-06-01||Observational|||Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life|Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life|Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 02:55:36.973462|2017-10-11 02:55:36.973462
NCT01607125|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-09-24|||July 2012||2012-07-01|September 2013|2013-09-01||||September 2013|Actual|2013-09-01||Interventional|||Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls|Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Exploratory Study Investigating the Effects of [Vortioxetine] Lu AA21004 on Cognition and BOLD fMRI Signals in Subjects Remitted From Depression and Controls|Completed||Phase 1|96|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 02:55:37.056515|2017-10-11 02:55:37.056515
NCT01607112|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-11-14|2013-07-25||July 2012||2012-07-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above|A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above|Completed||Phase 3|119|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:55:37.208188|2017-10-11 02:55:37.208188
NCT01607099|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-11-13|||September 2012||2012-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|||Sodium Picosulfate Plus Magnesium Citrate Versus Macrogol 4000 in the Bowel Cleansing Procedure: a Comparison of Efficiency and Compatibility|Sodium Picosulfate Plus Magnesium Citrate Versus Macrogol 4000 in the Bowel Cleansing Procedure: a Comparison of Efficiency and Compatibility|Completed||N/A|220|Actual|Technische Universität München||2|||f||||f||||||||||2017-10-11 02:55:38.324656|2017-10-11 02:55:38.324656
NCT01607086|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-08-01|||July 11, 2008|Actual|2008-07-11|August 2017|2017-08-01|July 18, 2008|Actual|2008-07-18|July 18, 2008|Actual|2008-07-18||Interventional|||Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo|A Randomised, Double-blind Study in Healthy Volunteers to Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:55:38.43105|2017-10-11 02:55:38.43105
NCT01607060|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-01-05|||September 2008||2008-09-01|October 2012|2012-10-01||||April 2012|Actual|2012-04-01||Interventional|||Impact of Laxative Therapy With Lactulose in the Evolution of Organ Dysfunction in Critically Ill Patients.|Impact of Laxative Therapy With Lactulose in the Evolution of Organ Dysfunction in Critically Ill Patients.|Completed||Phase 3|88|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 02:55:39.187749|2017-10-11 02:55:39.187749
NCT01607047|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-02-29|||December 2010||2010-12-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2012|Actual|2012-09-01||Observational|LEPTO||French West Indies Leptospirosis Study|Utility of Quantitative Polymerase Chain Reaction to Predict Clinical Outcome of Leptospirosis in French West Indies|Recruiting||N/A|150|Anticipated|University Hospital Center of Martinique|||1||f||||f||||||Samples With DNA|"     whole blood, serum, white cells, plasma, DNA   "|||2017-10-11 02:55:39.314636|2017-10-11 02:55:39.314636
NCT01607034|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-11-24|||June 2012||2012-06-01|November 2014|2014-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects|An Open-Label, Randomized, Crossover Study to Assess the Bioavailability of Dexpramipexole Administered in Soft Food and Water, and in Intact Tablet Form in the Fasted and Fed States in Healthy Volunteers|Completed||Phase 1|24|Actual|Knopp Biosciences||4|||f||||f||||||||||2017-10-11 02:55:39.445264|2017-10-11 02:55:39.445264
NCT01607021|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-08-14|||April 2012||2012-04-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection|Pharmacogenomics Study on IL28B Genetic Variants for Prediction of Drug Response in Chinese Children With HCV Infection.|Unknown status|Recruiting|N/A|200|Anticipated|Beijing 302 Hospital|||1||f||||t||||||||||2017-10-11 02:55:39.790515|2017-10-11 02:55:39.790515
NCT01607008|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-11-18|||September 2012||2012-09-01|November 2015|2015-11-01|May 2016|Anticipated|2016-05-01|April 2016|Anticipated|2016-04-01||Interventional|NA_00067284||MRI for Assessing Prostate Cancer Response|Multiparametric MRI for Assessing Radiotherapy Treatment Response of Prostate Cancer|Recruiting||N/A|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 02:55:39.936931|2017-10-11 02:55:39.936931
NCT01606995|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-01-19|||June 2012||2012-06-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|XANTUS||Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation|Xarelto® on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation|Completed||N/A|6784|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:55:40.128856|2017-10-11 02:55:40.128856
NCT01606982|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-02-15||||||February 2017|2017-02-01||||||||Expanded Access|||Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy|A Multicenter, Single-arm, Open Label Treatment Protocol to Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy|Approved for marketing||N/A|||Astellas Pharma Inc|||||||||||||||||||2017-10-11 02:55:40.360703|2017-10-11 02:55:40.360703
NCT01606969|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2014-03-04|||June 2012||2012-06-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Epinephrine-lidocaine Solution and Dexmedetomidine -Lidocaine Solution|Randomized Controlled Trial to Comparison of Epinephrine-lidocaine Solution and Dexmedetomidine -Lidocaine Solution for the Effect on Hemodynamic Response Due to Scalp Infiltration in Patients Undergoing Craniotomy|Completed||N/A|48|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:55:40.498221|2017-10-11 02:55:40.498221
NCT01606956|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-03-04|||May 2012||2012-05-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Comparison of Two Different Methods of Partial Inflation of Cuff for Facile Insertion of Laryngeal Mask Airway in Adult Patients|The Comparison of Two Different Methods of Partial Inflation of Cuff for Facile Insertion of Laryngeal Mask Airway in Adult Patients|Completed||N/A|80|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:55:40.622008|2017-10-11 02:55:40.622008
NCT01606943|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-05-25|||January 2009||2009-01-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|CPOAADCP||Clinical Profiles and Outcomes of Acute Aortic Dissection in the Chinese Patients|The Study of The Chinese Registry of Acute Aortic Dissection and Clinical Study of Acute Aortic Dissection in Chinese Patients|Completed||N/A|2000|Actual|Xijing Hospital|||1||f||||t||||||||||2017-10-11 02:55:40.735829|2017-10-11 02:55:40.735829
NCT01606917|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2012-05-25|||October 2004||2004-10-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|LÄTTA||Interventions for Lifestyle Changes to Promote Weight Reduction, a Randomized Controlled Trial in Primary Health Care|Interventions for Lifestyle Changes to Promote Weight Reduction, a Randomized Controlled Trial in Primary Health Care|Completed||N/A|133|Actual|Örebro County Council||2|||f||||f||||||||||2017-10-11 02:55:41.021731|2017-10-11 02:55:41.021731
NCT01606904|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-23|||May 2012||2012-05-01|May 2012|2012-05-01||||September 2015|Anticipated|2015-09-01||Interventional|CognObe||The Effect of CBT- Based Weight Loss Program on Eating Behavior, Weight Loss Result and Risk for Coronary Heart Diseases and Type 2 Diabetes||Unknown status|Recruiting|N/A|80|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-11 02:55:41.148024|2017-10-11 02:55:41.148024
NCT01606891|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-03-29|||June 2012||2012-06-01|March 2017|2017-03-01|March 21, 2017|Actual|2017-03-21|March 21, 2017|Actual|2017-03-21||Interventional|NET-Works||NET-Works:Community Preschooler Obesity Prevention|Linking Primary Care, Communities and Families to Prevent Obesity Among Preschoolers|Completed||N/A|534|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 02:55:41.300202|2017-10-11 02:55:41.300202
NCT01606878|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-05-10|||March 2013||2013-03-01|May 2017|2017-05-01||||October 2018|Anticipated|2018-10-01||Interventional|||Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma|A Phase 1 Study of Crizotinib (IND#105573) in Combination With Conventional Chemotherapy for Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma|Recruiting||Phase 1|65|Anticipated|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 02:55:41.462762|2017-10-11 02:55:41.462762
NCT01606865|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-10-22|||September 2010||2010-09-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|BIANCA||Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery|Does Platelet Inhibition Predict Surgery Related Bleeding in Patients Undergoing Non-Cardiac Surgery During Dual Antiplatelet Therapy|Completed||N/A|207|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-11 02:55:41.849034|2017-10-11 02:55:41.849034
NCT01606852|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2015-11-17|||March 2013||2013-03-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Interventional|PCS||Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients|Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients|Completed||Phase 1/Phase 2|38|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 02:55:41.960071|2017-10-11 02:55:41.960071
NCT01606839|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-02-18|||February 2012||2012-02-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Noninvasive Measurement of Cardiac Output in Pulmonary Hypertension Using Inert Gas Rebreathing|Noninvasive Measurement of Cardiac Output in Pulmonary Hypertension Using Inert Gas Rebreathing|Completed||N/A|34|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-11 02:55:42.091642|2017-10-11 02:55:42.091642
NCT01606826|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-09-25|||October 2012||2012-10-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|February 2019|Anticipated|2019-02-01||Observational|SARP||Severe Asthma Research Program|Severe Asthma Research Program|Active, not recruiting||N/A|715|Actual|Milton S. Hershey Medical Center|||1||f||||t||||||Samples With DNA|"     Blood: CBC/Diff, Total IgE, Serum, Plasma, DNA, RNA; Urine; EBC; Sputum: Supernatant, Cell     Pellet; Bronch: BAL, Bronchial Brushings, Bronchial Biopsy   "|||2017-10-11 02:55:42.180324|2017-10-11 02:55:42.180324
NCT01606813|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-12-06|||October 2012||2012-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||The Impact of Integrating an Internet Weight Control Program Into Primary Care|The Impact of Integrating an Internet Weight Control Program Into Primary Care|Completed||N/A|611|Actual|Milton S. Hershey Medical Center||3|||f||||t||||||||||2017-10-11 02:55:42.322321|2017-10-11 02:55:42.322321
NCT01606800|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-03-10|2016-01-26||January 2013||2013-01-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|START 4|All Treated Population, which included all participants who received at least one dose of study medication after RVR.|Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)|Randomized Open Label Study to Assess the Efficacy and Safety of Short Course Therapy (24 Weeks) With Peginterferon Alpha-2b and Ribavirin for Chronic Hepatitis C (Genotype 4) Patients Who Achieve a Rapid Virological Response (HCV -RNA Undetectable at Week 4 of Treatment)|Terminated||Phase 4|45|Actual|Merck Sharp & Dohme Corp.|This Trial was prematurely terminated due to the availability of more promising treatment for HCV participants and the change in treatment guidelines, which will offer the patient a better treatment opportunity.|2||The trial was terminated due to change in new standard of therapy during the study period.|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:55:42.493215|2017-10-11 02:55:42.493215
NCT01606787|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-04-03|||May 2012||2012-05-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes|Phase 3 Trial of Intravenous Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes|Active, not recruiting||Phase 3|210|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:55:42.752811|2017-10-11 02:55:42.752811
NCT01606774|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-02-03|||July 2012||2012-07-01|February 2017|2017-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Modernized Approach to Prenatal Care in Low Risk Women|A Modernized Approach to Prenatal Care in Low Risk Women|Completed||N/A|4|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-11 02:55:42.847684|2017-10-11 02:55:42.847684
NCT01606761|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2016-02-16||2016-01-18|August 2012||2012-08-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Interventional|||A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy|Completed||Phase 3|878|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 02:55:42.967983|2017-10-11 02:55:42.967983
NCT01606748|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2017-04-21|2015-12-21|2014-04-25|August 2012||2012-08-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2013|Actual|2013-06-01||Interventional||All participants who received at least one dose of study drug.|A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin|An Open-Label, Non-controlled, Non-randomized Sequential Design, Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin in Patients With Advanced Solid Cancers|Completed||Phase 2|35|Actual|Eli Lilly and Company||1|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 02:55:43.707641|2017-10-11 02:55:43.707641
NCT01606735|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2014-09-17|2014-09-02||April 2012||2012-04-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy and Safety of IBI-10090 in Ocular Surgery Patients|A Multicenter, Randomized, Double-masked, Dose-ranging, Phase 2 Study to Evaluate the Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Ocular Surgery|Completed||Phase 2|172|Actual|ICON Bioscience Inc||3|||f||||f||||||||||2017-10-11 02:55:46.856652|2017-10-11 02:55:46.856652
NCT01606722|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2013-07-10|||January 2010||2010-01-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|MonDar||Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy|Relation Between Darunavir Levels and Virological Efficacy, Integrated Proviral ADN and Resistance Mutations in HIV-infected Patients on Treatment With Darunavir/Ritonavir Monotherapy|Completed||N/A|150|Actual|Hospitales Universitarios Virgen del Rocío|||1||f||||t||||||Samples Without DNA|"     Blood samples (plasma and PBMC)   "|||2017-10-11 02:55:47.466298|2017-10-11 02:55:47.466298
NCT01606696|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-07-15|||August 2011||2011-08-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|November 2012|Actual|2012-11-01||Interventional|HIIT||Higher Intensity Interval Training in Cardiac Rehabilitation|Practical Use of Higher Intensity Interval Exercise in Cardiac Rehabilitation to Improve Aerobic Fitness|Completed||N/A|49|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-10-11 02:55:47.65841|2017-10-11 02:55:47.65841
NCT01606683|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-24|2015-02-02|||April 2012||2012-04-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|August 2013|Actual|2013-08-01||Interventional|||Impact of Infant Feeding on Newborn Metabolomic Profile|Impact of Infant Feeding on Newborn Metabolomic Profile|Completed||N/A|30|Actual|Heinz Italia SpA||3|||f||||f||||||||||2017-10-11 02:55:47.748087|2017-10-11 02:55:47.748087
NCT01606670|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-04-28|2015-04-01||May 2012||2012-05-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|NEUPAD|Baseline Characteristics refer to the Safety Set, including all enrolled patients who had applied the rotigotine transdermal patch at least once.|Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease|A Multicenter, Non-interventional Study With Neupro® to Evaluate the Perception of Pain Associated With Idiopathic Parkinson's Disease|Completed||N/A|93|Actual|UCB Pharma|||1||f||||f||||||||||2017-10-11 02:55:47.869725|2017-10-11 02:55:47.869725
NCT01606657|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-05-01|||August 2010||2010-08-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|September 2014|Actual|2014-09-01||Interventional|||Irrigation Versus no Irrigation for Cutaneous Abscess|Is Routine Irrigation of Cutaneous Abscesses Necessary?|Completed||N/A|201|Actual|University of California, San Francisco||2|||f||||f||||||||No||2017-10-11 02:55:48.184906|2017-10-11 02:55:48.184906
NCT01606644|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-06|2012-05-25|||May 2010||2010-05-01|May 2012|2012-05-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Hyperbaric Oxygen - a New Treatment Modality in Patients With Radiation Damaged Salivary Gland Tissue|Hyperbaric Oxygen - a New Treatment Modality in Patients With Radiation Damaged Salivary Gland Tissue.|Unknown status|Recruiting|Phase 3|60|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:55:48.270039|2017-10-11 02:55:48.270039
NCT01606631|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-05-23|||September 2009||2009-09-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Role of Beta-blockers in the Prevention on the Arisen of a Severe Sepsis (TESS)|Evaluation of the Protective Role of Beta-blockers Prescribed in a Chronic Way on the Arisen of a Severe Septic Syndrome or a Toxic Shock at Patients Having a Community Infection|Completed||N/A|2444|Actual|Rennes University Hospital|||2||f||||f||||||Samples Without DNA|"     Non applicable.   "|||2017-10-11 02:55:48.348721|2017-10-11 02:55:48.348721
NCT01606618|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-06-14|||January 2012||2012-01-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|ESTIME||Self-esteem and Neuro-urological Follow-up in Patients With Spina Bifida or Spinal Cord Injury|Analysis of Psychosocial Determinants of Observance of Monitoring Neuro-urological in Spina-bifida Adult Patients and in Spinal Cord Injury Patients: a Prospective, Comparative, Multicenter With Parallel Groups Study|Recruiting||N/A|330|Anticipated|Rennes University Hospital|||2||f||||f||||||||||2017-10-11 02:55:48.440057|2017-10-11 02:55:48.440057
NCT01606605|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2013-01-12|||January 2011||2011-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma|Retrospective Analysis of Diffuse Large B-cell Lymphoma: Identification of Factors Associated With Treatment Resistance Via Gene Expression Profile|Completed||N/A|350|Actual|Samsung Medical Center|||1||f||||f||||||Samples With DNA|"     Parrafin-embedded tissue blocks   "|||2017-10-11 02:55:48.588345|2017-10-11 02:55:48.588345
NCT01606592|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-08-18|||January 2010|Actual|2010-01-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Psychotherapy Outcome and Self-selection Effects in Panic Disorder|Phase 2/3 Study of Panic Control Treatment vs Panic-Focussed Psychodynamic Psychotherapy Under Randomized and Self-Selection Conditions|Active, not recruiting||N/A|216|Actual|Region Skane||5|||f||||t||||||||||2017-10-11 02:55:48.665274|2017-10-11 02:55:48.665274
NCT01606579|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-08-16|||July 2012||2012-07-01|May 2017|2017-05-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Interventional|||Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies|An Open-Label, Dose-Escalation Phase I/II Study of PRI-724 for Patients With Advanced Myeloid Malignancies|Completed||Phase 1/Phase 2|49|Actual|Prism Pharma Co., Ltd.||5|||f||||f||||||||||2017-10-11 02:55:48.772853|2017-10-11 02:55:48.772853
NCT01606566|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-09-27|||April 2012||2012-04-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||A Study to Evaluate the Safety and Efficacy of PC-A11 in Patients With Recurrent Head and Neck Squamous Cell Carcinoma|An Open-label, Single Arm, Multi-centre, Phase II Study to Evaluate the Safety and Efficacy of PC-A11 With Superficial and Interstitial Laser Light Application in Patients With Recurrent Head and Neck Squamous Cell Carcinoma Unsuitable for Surgery and Radiotherapy|Terminated||Phase 2|26|Actual|PCI Biotech AS||1||Business reasons|f||||t||||||||||2017-10-11 02:55:48.875794|2017-10-11 02:55:48.875794
NCT01606553|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-02-15|||October 2010||2010-10-01|February 2016|2016-02-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|INCA||Inspiratory Muscle Training in Patients With Chronic Heart Failure|The INCA Study: Inspiratory Muscle Training in Patients With Chronic Heart Failure|Completed||N/A|22|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 02:55:49.104203|2017-10-11 02:55:49.104203
NCT01606540|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-09-14|||June 2012||2012-06-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Non-steroid Antiinflammatory Drugs to Heal Colles Fracture|The Influence of Non-steroid Antiinflammatory Drugs (NSAID) to Heal Colles Fracture.|Active, not recruiting||N/A|192|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 02:55:49.219987|2017-10-11 02:55:49.219987
NCT01606527|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-05-23|||July 2012||2012-07-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||NSAID RCT for Prevention of Altitude Sickness|Prospective, Double-blind, Randomized, Placebo-controlled Trial of Ibuprofen Versus Placebo for Prevention of Neurologic Forms of Altitude Sickness|Unknown status|Not yet recruiting|Phase 2|300|Anticipated|Naval Health Research Center||2|||f||||f||||||||||2017-10-11 02:55:49.332835|2017-10-11 02:55:49.332835
NCT01606514|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-10-03|||December 2010||2010-12-01|August 2012|2012-08-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Web-based Intervention for Disaster-Affected Youth and Families|Web-based Intervention for Disaster-Affected Youth and Families|Completed||N/A|2000|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-10-11 02:55:49.46061|2017-10-11 02:55:49.46061
NCT01606501|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-06-12|||May 2012||2012-05-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|OUTLET||Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol|Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol (OUTLET Study)|Active, not recruiting||N/A|664|Actual|Major Extremity Trauma Research Consortium|||2||f||||t||||||||||2017-10-11 02:55:49.570121|2017-10-11 02:55:49.570121
NCT01606488|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-07-25|||May 2012||2012-05-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effects of Brain Beta-Amyloid on Postoperative Cognition|Effects of Brain Beta Amyloid on Postoperative Cognition and 18F-AV-45-A14: Clinical Evaluation of Florbetapir F 18 (18F-AV-45)|Recruiting||Phase 4|100|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 02:55:49.749522|2017-10-11 02:55:49.749522
NCT01606475|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-02-27||||||February 2017|2017-02-01||||||||Expanded Access|EXAX||Islet Transplant for Type 1 or Surgical Diabetes|Human Alloislet Transplant for Type 1 or Surgical Diabetes Mellitus With Complications|No longer available||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||||||||||||||||2017-10-11 02:55:49.913284|2017-10-11 02:55:49.913284
NCT01606462|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-12-02|||June 2011||2011-06-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Oxytocin and Social Cognition|Double-blind, Placebo-controlled, Randomized Study: Oxytocin and OXTR-genotypes Influence Behavioral and Neural Social Reactions|Completed||Phase 1|153|Actual|University Hospital, Bonn||2|||f||||f||||||||||2017-10-11 02:55:49.990751|2017-10-11 02:55:49.990751
NCT01606449|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-24|||January 1980||1980-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|||Follow-up of Patients Operated Upon for Type II-IV Hiatal Hernia|Thirty-year Follow-up of a Case Series of Patients Operated Upon for Type II-IV Hiatal Hernia|Completed||N/A|100|Actual|University of Bologna|||3||f||||f||||||||||2017-10-11 02:55:50.1429|2017-10-11 02:55:50.1429
NCT01606436|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-09-28|||June 2012||2012-06-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||A Study Measuring Effect of Pomaglumetad Methionil (LY2140023) on Electrocardiographs in Participants With Schizophrenia|A Placebo- and Positive-Controlled Study of the Electrophysiological Effects on the QT Interval After a Supratherapeutic Dose of LY2140023 in Subjects With Schizophrenia|Completed||Phase 1|60|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 02:55:50.239045|2017-10-11 02:55:50.239045
NCT01606423|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-23|||November 2007||2007-11-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants|The Effect of LY2409021 on Blood Glucose Concentrations During Hyperglucagonaemia in Healthy Male Subjects|Completed||Phase 1|21|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 02:55:50.339321|2017-10-11 02:55:50.339321
NCT01606410|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2013-11-19|||April 2011||2011-04-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||The Impact of Age and Fitness on Reperfusion Injury and Ischemic Preconditioning to Prevent This Injury|The Impact of Age and Fitness on Endothelial Reperfusion Injury and the Ability of Ischemic Preconditioning to Prevent This Injury|Completed||N/A|30|Actual|Radboud University|||4||f||||f||||||||||2017-10-11 02:55:50.443073|2017-10-11 02:55:50.443073
NCT01606397|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-23|||March 2008||2008-03-01|May 2012|2012-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes|The Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Multiple Escalating Doses of LY2409021 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|50|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 02:55:50.53953|2017-10-11 02:55:50.53953
NCT00005689|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||July 1991||1991-07-01|March 2001|2001-03-01|June 1995||1995-06-01|||||Observational|||Trial of Smoking Cessation Programs in Black Churches||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.567348|2017-10-11 04:28:53.567348
NCT01606384|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-24|||December 2006||2006-12-01|May 2012|2012-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|NAPA||Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder|A Double-blind, Placebo-controlled Study Evaluating the Pharmacodynamic Effects of Two Fixed Doses of SSR149415 (250 mg Bid and 100 mg Bid) on Hypothalamic-pituitary-adrenal Axis Function in Outpatients With Major Depressive Disorder|Completed||Phase 2|100|Actual|Sanofi||3|||f||||||||||||||2017-10-11 02:55:50.6478|2017-10-11 02:55:50.6478
NCT01606371|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-23|||May 2007||2007-05-01|May 2012|2012-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2409021 After Escalating Single Oral Dose Administration in Healthy Subjects and Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|32|Actual|Eli Lilly and Company||11|||f||||f||||||||||2017-10-11 02:55:50.747301|2017-10-11 02:55:50.747301
NCT01606358|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-08-08||||||August 2014|2014-08-01||||May 2016|Anticipated|2016-05-01||Observational|IClyCO||Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer|IClyCO Influence of Chemotherapy (Carboplatin and Taxol) on the ex Vivo Expansion and Functional Capacity of Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer|Withdrawn||N/A|0|Actual|Rennes University Hospital|||1||f||||f||||||Samples Without DNA|"     The VGAMMA9VDELTA2 T cells will be isolated from peripheral blood mononuclear cells of     patients with ovarian cancer.   "|||2017-10-11 02:55:50.878829|2017-10-11 02:55:50.878829
NCT01606345|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-04-21|||July 2012||2012-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma|Phase I Dose Escalation and Landmark Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma (UTUC) Following Endoscopic Resection|Completed||Phase 1|4|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 02:55:50.983151|2017-10-11 02:55:50.983151
NCT01606332|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2013-06-10|||June 2012||2012-06-01|June 2013|2013-06-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Indwelling Interscalene Nerve Catheters in Surgical Management of Idiopathic Adhesive Capsulitis|Indwelling Interscalene Nerve Catheters in Surgical Management of Idiopathic Adhesive Capsulitis|Unknown status|Recruiting|N/A|40|Anticipated|OAD Orthopaedics||2|||f||||f||||||||||2017-10-11 02:55:51.092443|2017-10-11 02:55:51.092443
NCT01606319|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-11-17|2016-09-13||February 2013||2013-02-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|AVICA||Acetaminophen Versus Ibuprofen in Children With Asthma|Acetaminophen vs. Ibuprofen in Children With Asthma|Completed||Phase 3|300|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 02:55:51.189224|2017-10-11 02:55:51.189224
NCT01606306|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-01-27|2016-09-15||February 2013||2013-02-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|INFANT|All randomized participants|Individualized Therapy For Asthma in Toddlers|Individualized Therapy For Asthma in Toddlers|Completed||Phase 3|300|Actual|Milton S. Hershey Medical Center||6|||f||||t||||||||||2017-10-11 02:55:51.764743|2017-10-11 02:55:51.764743
NCT01606293|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-12-19|||May 2012||2012-05-01|December 2016|2016-12-01||||May 2018|Anticipated|2018-05-01||Observational|||Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix|Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix|Recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 02:55:53.448252|2017-10-11 02:55:53.448252
NCT01606280|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-01-20|||June 2011||2011-06-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation|Reporting of Amyloidosis Stem Cell Transplantation Outcomes|Completed||N/A|400|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 02:55:53.615069|2017-10-11 02:55:53.615069
NCT01606267|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-05-24|||December 2010||2010-12-01|May 2012|2012-05-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Evaluation of Integrated Community Case Management in Ethiopia|Independent Prospective Evaluation of Integrated Community Case Management and Development and Implementation of a Method for Real-time Mortality Monitoring in the Oromia Region, Ethiopia|Unknown status|Enrolling by invitation|N/A|607770|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 02:55:53.719739|2017-10-11 02:55:53.719739
NCT01606254|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2013-05-28|2013-03-04||January 2007||2007-01-01|May 2013|2013-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia|A Repeated Dose Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia|Completed||Phase 2|56|Actual|Janssen Pharmaceutical K.K.||4|||f||||f||||||||||2017-10-11 02:55:53.913316|2017-10-11 02:55:53.913316
NCT01606241|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-08-28|||July 2012||2012-07-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Phase I Trial of the Safety and Immunogenicity of a Multi-epitope Folate Receptor Alpha Peptide Vaccine Used in Combination With Cyclophosphamide in Subjects Previously Treated for Breast or Ovarian Cancer|Active, not recruiting||Phase 1|24|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 02:55:56.00525|2017-10-11 02:55:56.00525
NCT01606228|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-09-19|2012-08-03||December 2007||2007-12-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia|An Open-Label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly-Dosed Paliperidone ER Among Treatment-Naïve and Newly Diagnosed Patients With Schizophrenia|Completed||Phase 3|188|Actual|Janssen Pharmaceutica||1|||f||||f||||||||||2017-10-11 02:55:56.182444|2017-10-11 02:55:56.182444
NCT01606215|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-08-26|||January 2013||2013-01-01|July 2015|2015-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|STREAMS||Stem Cells in Rapidly Evolving Active Multiple Sclerosis|Stem Cells in Rapidly Evolving Active Multiple Sclerosis|Completed||Phase 1/Phase 2|19|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 02:55:56.596121|2017-10-11 02:55:56.596121
NCT01606033|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-07-27|||March 2011||2011-03-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|IPSY||Study of Stress and Life Quality of Patients Participating in Clinical Trials Versus Patients Non Participating|Psychological and Emotional Impacts of Participation in Oncologic Clinical Trials|Completed||N/A|125|Actual|Centre Oscar Lambret||4|||f||||f||||||||No||2017-10-11 02:56:01.332648|2017-10-11 02:56:01.332648
NCT01606202|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-08-28|2012-07-19||July 2002||2002-07-01|August 2012|2012-08-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury|A Randomised, Double Blind, Placebo Controlled, Parallel Group Comparative Study of the Efficacy, Safety and Tolerability of Sublingual Cannabis Based Medicine Extracts and Placebo in Patients With Intractable Neuropathic Pain Associated With Spinal Cord Injury|Completed||Phase 3|116|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-10-11 02:55:56.716116|2017-10-11 02:55:56.716116
NCT01606189|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-02-18|2012-07-12||December 2001||2001-12-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain|A Double Blind, Randomised, Three Way Crossover Study Comparing Two Different Sublingual Cannabis Based Medicine Extracts With Placebo, in Patients With Chronic Pain Due to Brachial Plexus Injury.|Completed||Phase 3|48|Actual|GW Pharmaceuticals Ltd.||3|||f||||f||||||||||2017-10-11 02:55:57.668677|2017-10-11 02:55:57.668677
NCT01606176|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-08-28|2012-07-19||March 2002||2002-03-01|August 2012|2012-08-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin|A Multi Centre Randomised, Double Blind, Placebo Controlled, Parallel Group Comparison of the Effects of Cannabis Based Medicine Standardised Extracts Over 4 Weeks, in Patients With Chronic Refractory Pain Due to Multiple Sclerosis or Other Defects of Neurological Function.|Completed||Phase 3|70|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-10-11 02:55:58.387087|2017-10-11 02:55:58.387087
NCT01606163|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-01-01|||August 2012||2012-08-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection|A Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple-dose, Dose Escalation Study to Assess the Safety and Pharmacokinetics of GC1102 (Hepabig-Gene) in Healthy Male Adults|Completed||Phase 1|36|Actual|Green Cross Corporation||4|||f||||f||||||||||2017-10-11 02:55:59.090008|2017-10-11 02:55:59.090008
NCT01606150|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-10-20|2016-10-20||November 2012||2012-11-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Lumbar Punctures in Neonates: Improving Success Rates and Minimizing Pain|Lumbar Punctures in Neonates: Improving Success Rates and Minimizing Pain|Terminated||N/A|5|Actual|Georgetown University|This study proved to be very difficult to execute in a busy NICU due to clinical practice biases and technical difficulties in establishing masked treatment. The Investigator left the Fellowship program before any results could be analyzed.|2||Investigator left the insititution|f||||t||||||||No|THERE IS NO DATA TO SHARE|2017-10-11 02:55:59.189575|2017-10-11 02:55:59.189575
NCT01606137|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2013-06-13|2012-07-19||February 2002||2002-02-01|June 2013|2013-06-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Study of the Long-term Safety of Sativex Use|A Long-term, Open Label, Safety and Tolerability Study of Cannabis Based Medicine Extract in Patients Who Have Participated in a GW Clinical Study Using Cannabis Based Medicine.|Completed||Phase 3|507|Actual|GW Pharmaceuticals Ltd.||1|||f||||f||||||||||2017-10-11 02:55:59.404848|2017-10-11 02:55:59.404848
NCT01606124|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-08-28|2017-08-28||June 2012||2012-06-01|May 2017|2017-05-01|May 21, 2015|Actual|2015-05-21|May 21, 2015|Actual|2015-05-21||Interventional|||Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer|Randomized Phase II Trial of Polyphenon E vs.Placebo in Patients at High Risk of Recurrent Colonic Neoplasia|Terminated||Phase 2|39|Actual|Mayo Clinic||2||pending expiration of the supply of study agent.|f||||t||||||||||2017-10-11 02:56:00.214481|2017-10-11 02:56:00.214481
NCT01606111|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-02-09|||September 2013||2013-09-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|CAPTAIN||The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery|A Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin in Patients With Traumatic Brain Injury|Unknown status|Active, not recruiting|Phase 4|800|Anticipated|Ever Neuro Pharma GmbH||2|||f||||t||||||||||2017-10-11 02:56:00.502137|2017-10-11 02:56:00.502137
NCT01606098|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-01-31|||July 2012||2012-07-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|CAIRO4||The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer|The Role of Surgery of the Primary Tumour With Few or Absent Symptoms in Patients With Synchronous Unresectable Metastases of Colorectal Cancer, a Randomized Phase III Study. A Study of the Dutch Colorectal Cancer Group (DCCG)|Recruiting||Phase 3|360|Anticipated|Dutch Colorectal Cancer Group||2|||f||||t||||||||Undecided||2017-10-11 02:56:00.597396|2017-10-11 02:56:00.597396
NCT01606085|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2014-04-22|||September 2009||2009-09-01|September 2013|2013-09-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|QUALITYHF-DM||Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes|Cost Effectiveness and Quality of Life in Heart Failure Patients With Diabetes|Completed||N/A|141|Actual|Emory University||2|||f||||f||||||||||2017-10-11 02:56:00.945594|2017-10-11 02:56:00.945594
NCT01606072|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2015-08-27|||November 2011||2011-11-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||Perioperative Use of Desmopressin (DDAVP) in Breast Cancer|Perioperative Administration of Desmopressin to Subjects With Breast Cancer: A Phase IIa, Dose-Escalation Study|Completed||Phase 2|21|Actual|Laboratorio Elea S.A.C.I.F. y A.||1|||f||||f||||||||||2017-10-11 02:56:01.046387|2017-10-11 02:56:01.046387
NCT01606059|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2016-10-11|||May 2012||2012-05-01|October 2016|2016-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|DW0919-1003||Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition|A Randomized, Open Label, 2-treatment, 2-sequence, Cross-over Study to Compare the Safety and Pharmacokinetics of DW-0919 and DW-0920 After Single Oral Administration in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Daewon Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 02:56:01.148136|2017-10-11 02:56:01.148136
NCT01606046|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-06-19|||July 2011||2011-07-01|May 2012|2012-05-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Comparison of the Effects of Vapocoolant Spray and EMLA Cream on Pain During Needle Electromyography|Comparison of the Effects of Vapocoolant Spray and Topical Anesthetic Cream on Pain During Needle Electromyography: a Randomized Controlled Clinical Trial|Completed||Phase 4|99|Actual|The Catholic University of Korea||3|||f||||f||||||||||2017-10-11 02:56:01.232491|2017-10-11 02:56:01.232491
NCT01587092|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2013-11-14|||August 2012||2012-08-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Workstation Pilot Study|WorkStation Pilot Study|Completed||N/A|41|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 03:01:42.228838|2017-10-11 03:01:42.228838
NCT01606020|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-08-21|||September 2011||2011-09-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|PrivSom||Sleep Deprivation : Effects on Driving Performance and Central Fatigue|Effects of Sleep Deprivation on Driving Performance and Central Fatigue|Completed||N/A|12|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-11 02:56:01.465301|2017-10-11 02:56:01.465301
NCT01606007|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-03-29|2014-12-19||July 2012||2012-07-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Add-On Therapy With Saxagliptin and Dapagliflozin Added to Metformin Compared to Add-On Therapy With Saxagliptin in Combination With Metformin or Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone.|Completed||Phase 3|1282|Actual|AstraZeneca||3|||f||||t||||||||||2017-10-11 02:56:01.598189|2017-10-11 02:56:01.598189
NCT01605994|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2014-06-26|||July 2012||2012-07-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects|Placebo-Controlled, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043|Completed||Phase 1|115|Actual|Bristol-Myers Squibb||11|||f||||f||||||||||2017-10-11 02:56:02.758667|2017-10-11 02:56:02.758667
NCT01605981|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-04-19|||February 2014||2014-02-01|June 2014|2014-06-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|MACS1881||Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase.|A Phase II, Non Randomized, Open Label, Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase.|Withdrawn||Phase 4|0|Actual|Novartis||1|||f||||t||||||||||2017-10-11 02:56:02.929197|2017-10-11 02:56:02.929197
NCT01605968|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-07-12|||June 2012||2012-06-01|July 2017|2017-07-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||A Comparative Efficacy and Safety Study Between Two Silver Containing Dressings In Post-Op Wound Healing|A Comparative Efficacy and Safety Study Between BCT Silver Bandage and Aquacel® Ag. Dressing In Obstetrical and Gynecological Post-Op Wound Healing|Terminated||N/A|38|Actual|Bio-medical Carbon Technology Co., Ltd.||2||The rate of subject recruitment is too slow.|f||||f||||||||||2017-10-11 02:56:03.096108|2017-10-11 02:56:03.096108
NCT01605955|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2012-05-23|||November 2011||2011-11-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|||||Observational|||Fingertip Pulse Oximeter Clinical Test||Completed||N/A|10|Actual|Andon Health Co., Ltd|||2||f||||||||||||||2017-10-11 02:56:03.226332|2017-10-11 02:56:03.226332
NCT01605942|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2015-06-11|2015-06-11||June 2012||2012-06-01|June 2015|2015-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery||Terminated||Phase 1|8|Actual|Allergan||2||Study terminated due to corporate decision.|f||||f||||||||||2017-10-11 02:56:03.304305|2017-10-11 02:56:03.304305
NCT01605929|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2015-12-04|||July 2012||2012-07-01|December 2015|2015-12-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block|Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block|Withdrawn||N/A|0|Actual|Brigham and Women's Hospital||1||withdrawn before IRB approval|f||||f||||||||||2017-10-11 02:56:03.760556|2017-10-11 02:56:03.760556
NCT01605916|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-09-08|2016-04-06||June 2012||2012-06-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional||All subjects who received selumetinib were included into the baseline analysis population.|Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer|A Phase I, Open-Label Study to Investigate the Safety and Tolerability of AZD6244 (Selumetinib) When Given as a Monotherapy in Japanese Patients With Advanced Solid Malignancies, and When Given in Combination With Docetaxel as 2nd Line Therapy in Japanese Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB-IV)|Completed||Phase 1|33|Actual|AstraZeneca||5|||f||||||||||||||2017-10-11 02:56:03.909943|2017-10-11 02:56:03.909943
NCT01605903|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-23|2017-07-11|||May 5, 2012|Actual|2012-05-05|July 2017|2017-07-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|||Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy|Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy|Completed||Phase 2|741|Actual|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||||2017-10-11 02:56:05.635092|2017-10-11 02:56:05.635092
NCT01605877|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-06-08|2015-05-08||May 2012||2012-05-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||This analysis population includes all implanted subjects.|AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0] in Japan|Clinical Investigation of AcrySof® IQ ReSTOR® Multifocal Intraocular Lens Model SN6AD2|Completed||N/A|70|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 02:56:05.920602|2017-10-11 02:56:05.920602
NCT01605864|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2014-03-20|||May 2012||2012-05-01|May 2012|2012-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CAP||Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia|Ceftaroline Fosamil Versus Standard of Care for Community Acquired Bacterial Pneumonia (CABP): Clinical Outcomes Among Hospitalized Adults at a Single United States Hospital|Completed||Phase 3|12|Actual|Albany Medical College||1|||f||||f||||||||||2017-10-11 02:56:07.747476|2017-10-11 02:56:07.747476
NCT01605851|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2014-04-22|||May 2012||2012-05-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||GORE® Septal Occluder European Union Clinical Evaluation|GORE® Septal Occluder EU Clinical Evaluation: A Study to Evaluate Clinical Success and Performance in the Treatment of Transcatheter Closure of Patent Foramen Ovale (PFO)|Completed||N/A|150|Actual|W.L.Gore & Associates||1|||f||||f||||||||||2017-10-11 02:56:07.838785|2017-10-11 02:56:07.838785
NCT01605838|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-01-12|||August 2012||2012-08-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|June 2013|Anticipated|2013-06-01||Observational|REG01||Noninvasive Monitoring of Cerebral Blood Flow Autoregulation in Patients With Traumatic Brain Injury (TBI)|Pilot (Feasibility) Study of New Portable Monitor for Continuous Assessment of Cerebral Blood Flow (CBF) Autoregulation in Patients With Moderate to Severe Traumatic Brain Injury (TBI)|Withdrawn||N/A|0|Actual|Advanced Brain Monitoring, Inc.|||1|A series of administrative delays on all sides involved, combined with funding problems.|f||||f||||||||||2017-10-11 02:56:07.943765|2017-10-11 02:56:07.943765
NCT01605825|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-12-18|2014-01-28||May 2012||2012-05-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional||Safety Population: The Safety Population consists of all randomized subjects who took at least one dose of investigational product.|A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke|A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke|Completed||Phase 2|83|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-10-11 02:56:08.040245|2017-10-11 02:56:08.040245
NCT01605812|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2015-01-07|||April 2011||2011-04-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|||Evaluate Capsular Apposition to Intraocular Lens|Phase 1 Evaluate Capsular Apposition to Intraocular Lens in Subjects With High Myopia by Ultra-long Scan Depth Optical Coherence Tomography; Phase 2 Evaluate Capsular Apposition to Different Types of Intraocular Lens in Subjects|Unknown status|Recruiting|N/A|150|Anticipated|Wenzhou Medical University|||2||f||||t||||||||||2017-10-11 02:56:08.572081|2017-10-11 02:56:08.572081
NCT01605799|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-01-22|2015-11-13||October 2012||2012-10-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||IOK Treatment Study|A Novel PTSD Treatment for Veterans Who Killed in War|Completed||Phase 2|33|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 02:56:08.669695|2017-10-11 02:56:08.669695
NCT01605786|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-05-22|||May 2012||2012-05-01|May 2012|2012-05-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|PEBS-POC1||Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage)|Phase I and IIa Trial for Assessment of Safety, Immunogenicity (Phase Ia) and Efficacy (Phase IIa) Against Sporozoite Challenge of P. Falciparum Pre-Erythrocytic and Blood Stage (PfPEBS-LSP) Malaria Vaccine Candidate|Unknown status|Recruiting|Phase 1/Phase 2|36|Anticipated|Vac4All||3|||f||||t||||||||||2017-10-11 02:56:09.287351|2017-10-11 02:56:09.287351
NCT01605773|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-02-17|||November 8, 2001||2001-11-08|February 2017|2017-02-01|March 13, 2003|Actual|2003-03-13|March 13, 2003|Actual|2003-03-13||Interventional|||Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes|Repaglinide Versus Glyburide: Comparitive Effect on Postprandial Lipemia: An Open-labeled, Randomized, Parallel Group Study in Patients With Type 2 Diabetes|Completed||Phase 4|51|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:56:09.445345|2017-10-11 02:56:09.445345
NCT01605760|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-21|||January 2008||2008-01-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||House Dust Mite SLIT in Elderly Patients|House Dust Mite Sublingual Immunotherapy: a Double-blind, Placebo Control Study in Elderly Patients.|Completed||Phase 4|111|Actual|Medical University of Silesia||2|||f||||t||||||||||2017-10-11 02:56:09.534685|2017-10-11 02:56:09.534685
NCT01605747|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2013-11-12|||January 2011||2011-01-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|January 2013|Actual|2013-01-01||Interventional|||Study of Culturelle in the Prophylaxis of Infection and Diarrhea|A Blinded Placebo Controlled Clinical Outcomes Study of Culturelle® in the Prophylaxis of Infection and Diarrhea|Terminated||Phase 2|20|Actual|Shriners Hospitals for Children||2||Study was stopped due to inavailability of subjects meeting eligibility criteria.|f||||||||||||||2017-10-11 02:56:09.630724|2017-10-11 02:56:09.630724
NCT01605734|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-05-21|||July 2012||2012-07-01|May 2012|2012-05-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|||TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma|Phase II Trail of TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma|Unknown status|Not yet recruiting|Phase 2|120|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||t||||||||||2017-10-11 02:56:09.721031|2017-10-11 02:56:09.721031
NCT01605721|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-05-21|||May 2011||2011-05-01|May 2012|2012-05-01|April 2015|Anticipated|2015-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)||Unknown status|Recruiting|Phase 4|2000|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 02:56:09.865797|2017-10-11 02:56:09.865797
NCT01605708|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-09-27||2013-09-27|June 2012||2012-06-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis|Randomized, Double-Blind, Placebo-Controlled, Sequential Ascending Dose Study of the Clinical Activity, Safety, Tolerability and Pharmacokinetics of a Single IV Dose of REGN846 in Refractory Moderate-to-Severe Pruritus in Adult Patients With Moderate-to-Severe Atopic Dermatitis|Terminated||Phase 1/Phase 2|19|Actual|Regeneron Pharmaceuticals||1|||f||||f||||||||||2017-10-11 02:56:09.97156|2017-10-11 02:56:09.97156
NCT01605695|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2013-11-23|||May 2012||2012-05-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Observational|||Normal Human Plasma Level of iNOS Study|Determination of the Normal Human Plasma Level of Inducible Nitric Oxide Synthase (iNOS) Using the PliNOSa Test|Completed||N/A|100|Actual|Research & Diagnostic Antibodies|||1||f||||f||||||Samples Without DNA|"     heparinized plasma samples   "|||2017-10-11 02:56:10.155442|2017-10-11 02:56:10.155442
NCT01605682|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-21|||July 2011||2011-07-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Multi Dose Effects of a Berry Extract Upon Moodand Cognition in Healthy Young Adults|Multi Dose Effects of a Berry Extract Upon Mood, Attention and Memory in Healthy Young Adults.|Completed||N/A|36|Actual|Northumbria University||4|||f||||f||||||||||2017-10-11 02:56:10.229336|2017-10-11 02:56:10.229336
NCT01605669|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-08-17|2013-05-17||May 2012||2012-05-01|August 2016|2016-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|Cassette||Correlation of Auscultatory Severity of Aortic Stenosis With Trans Thoracic Echocardiography|Correlation of Auscultatory Severity of Aortic Stenosis With Trans Thoracic Echocardiography|Completed||N/A|50|Actual|United States Naval Medical Center, San Diego|Patients with significant concomitant valvular disease were not evaluated. The software does not provide immediate feedback on the severity of the stenosis. Multiple early recordings had artifact noise rquiring modificaiton of recording techniques.||1||f||||f||||||||No||2017-10-11 02:56:10.32518|2017-10-11 02:56:10.32518
NCT01605656|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-03-28|||July 2012||2012-07-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women|A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women|Completed||N/A|188|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 02:56:10.543234|2017-10-11 02:56:10.543234
NCT01605643|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-10-23|||March 2012||2012-03-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|MAW||Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women|Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women: Phase 1|Active, not recruiting||N/A|150|Actual|Mayo Clinic|||1||f||||t||||||Samples With DNA|"     urine and serum specimen samples collected from mother and infant pairs   "|||2017-10-11 02:56:10.674938|2017-10-11 02:56:10.674938
NCT01605630|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-07-05|||March 2012||2012-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Family Cancer Literacy to Promote Mammography Screening Among Navajo Women|Family Cancer Literacy to Promote Mammography Screening Among Navajo Women|Completed||Phase 1|40|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 02:56:10.755272|2017-10-11 02:56:10.755272
NCT01605617|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-12-16|2013-09-24||June 2012||2012-06-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate|Prospective Randomized Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate|Terminated||Phase 4|4|Actual|Mayo Clinic|The study was terminated due to a low recruitment rate prior to subjects completing treatment.|2||Low recruitment rate, and study patients were removed prior to completion|f||||f||||||||||2017-10-11 02:56:10.851803|2017-10-11 02:56:10.851803
NCT01605604|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-07-26|||October 2011||2011-10-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||Effectiveness of Buddhist Intergrated Group Intervention on Minefulness in Adolescents|Department of Orthopedic Surgery, Faculty of Medicine Siriraj Hospital|Completed||N/A|40|Actual|Mahidol University||1|||f||||f||||||||||2017-10-11 02:56:12.945711|2017-10-11 02:56:12.945711
NCT01605591|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2014-09-04|||August 2011||2011-08-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Different Bending Mode for Double-lumen Endotracheal Tube Intubation|Comparison of Different Bending Mode for Double-lumen Endotracheal Tube Intubation|Completed||N/A|66|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-11 02:56:13.084542|2017-10-11 02:56:13.084542
NCT01605578|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-05-21|||May 2012||2012-05-01|May 2012|2012-05-01|May 2014|Anticipated|2014-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Description of Abdominal and Gluteo-femoral Subcutaneous Adipose Tissue Cell Population in Women - GLUTAB|Description Des Populations Cellulaires Des Tissus Adipeux Sous-cutanés Abdominaux et glutéo-fémoraux Chez la Femme.|Unknown status|Recruiting|N/A|20|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||||||||||||2017-10-11 02:56:13.193765|2017-10-11 02:56:13.193765
NCT01605565|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-05-21|||November 2011||2011-11-01|May 2012|2012-05-01|November 2014|Anticipated|2014-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Functional Analysis by Dynamic Imaging of the Respiratory Epithelium in Infants With Cystic Fibrosis|Analyse Fonctionnelle Par Imagerie Dynamique de l'épithélium Respiratoire Chez Des Nourrissons Atteints de Mucoviscidose|Unknown status|Recruiting|N/A|30|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 02:56:13.300505|2017-10-11 02:56:13.300505
NCT01605552|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-03-23|2016-01-27||July 2011||2011-07-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|BtB-Heart||Beating the Blues for Your Heart|Computer-Based Depression Treatment to Reduce Coronary Artery Disease Risk|Completed||Phase 2|29|Actual|Indiana University|"Missing data precluded analysis of one secondary outcome variables: Tumor Necrosis Factor-Alpha (TNF-a).
Due to the very small sample of randomized patients, conclusions should not be drawn from the results of this pilot trial."|2|||f||||t||||||||||2017-10-11 02:56:13.418246|2017-10-11 02:56:13.418246
NCT01605539|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-10-05|2015-09-28||May 2012||2012-05-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans|Cannabidiol as Treatment Intervention for Opioid Relapse|Completed||Phase 2|10|Actual|Hurd,Yasmin, Ph.D.||3|||f||||t||||||||||2017-10-11 02:56:13.841165|2017-10-11 02:56:13.841165
NCT01605526|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma|A Multi-center, Open-label Phase IB Study of Escalating Doses of RO5045337, an Oral Small Molecule MDM2 Antagonist, in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma|Completed||Phase 1|23|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 02:56:14.872464|2017-10-11 02:56:14.872464
NCT01605513|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2016-01-23|||June 2011||2011-06-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PEG-IFN-SA||Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease|Phase I Clinical Trial of PEG-IFN-SA in HCV Disease: Evidence for Drug Safety, Tolerance, and Antiviral Activity|Completed||Phase 1/Phase 2|80|Actual|First Hospital of Jilin University||1|||f||||t||||||||||2017-10-11 02:56:15.047257|2017-10-11 02:56:15.047257
NCT01605500|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-02-18|||June 2012||2012-06-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators|Investigation of the Utility of the Audible Alert in Current Generation Medtronic ICDs|Completed||N/A|100|Actual|Englewood Hospital and Medical Center|||1||f||||f||||||||||2017-10-11 02:56:15.176336|2017-10-11 02:56:15.176336
NCT01605487|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2014-10-14|||June 2012||2012-06-01|April 2014|2014-04-01|October 2014|Actual|2014-10-01|September 2013|Actual|2013-09-01||Interventional|PAFCUTIII||Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria|Double-blind, Three-way Cross-over, Placebo-controlled Study to Assess the Efficacy, Safety and Mechanisms of Treatment With Rupatadine 20 mg and 40 mg in Cold Contact Urticaria (CCU)|Completed||Phase 2|24|Actual|Charite University, Berlin, Germany||6|||f||||f||||||||||2017-10-11 02:56:15.267147|2017-10-11 02:56:15.267147
NCT01604577|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-07-26|||May 2012||2012-05-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Targeting Social Determinants to Improve Chronic Kidney Disease Care|Targeting Social Determinants to Improve Chronic Kidney Disease Care|Completed||N/A|273|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 02:56:27.43144|2017-10-11 02:56:27.43144
NCT01605474|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-05-23|||April 2012||2012-04-01|May 2012|2012-05-01||||July 2014|Anticipated|2014-07-01||Interventional|||Patient Satisfaction of Cervical Ripening in an Outpatient Setting|Safety, Efficacy, and Patient Satisfaction of Cervical Ripening With Transcervical Use of the Foley Catheter in an Outpatient Setting|Unknown status|Recruiting|N/A|800|Anticipated|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-11 02:56:15.420658|2017-10-11 02:56:15.420658
NCT01605461|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-02-22|2016-01-21||May 2012||2012-05-01|February 2016|2016-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Treated set which included all subjects who were dispensed study medication and were documented to have taken the dose of investigational treatment|Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers|Metabolite Profile, Excretion Balance and Pharmacokinetics of BI 207127 NA Combined With [14C]-BI 207127 NA in Healthy Adult Male Volunteers After an 800 mg Single Oral Solution Dose; a Phase I, Single-arm, Open-label Trial|Completed||Phase 1|12|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 02:56:15.574393|2017-10-11 02:56:15.574393
NCT01605448|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2012-05-21|||January 2010||2010-01-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|May 2011|Actual|2011-05-01||Interventional|||Mindfulness Based Stress Reduction for Adults With Mild Cognitive Impairment|Mindfulness Based Stress Reduction for Adults With Mild Cognitive Impairment|Completed||N/A|14|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 02:56:15.915636|2017-10-11 02:56:15.915636
NCT01605422|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2015-05-26|||October 2011||2011-10-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|September 2013|Actual|2013-09-01||Observational|||Meta-analyses of the Effect of Dietary Pulses on Acute Postprandial Metabolic Control|Effect of Dietary Pulses on Acute Postprandial Glycemia and Food Intake Regulation: A Systematic Review and Meta-analyses|Unknown status|Active, not recruiting|N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-11 02:56:16.133044|2017-10-11 02:56:16.133044
NCT01605409|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-09-13|||November 2014||2014-11-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|November 2017|Anticipated|2017-11-01||Interventional|ECPB4OHCA||Emergency Cardiopulmonary Bypass for Cardiac Arrest|Emergency Cardiopulmonary Bypass After Cardiac Arrest With Ongoing Cardiopulmonary Resuscitation - a Pilot Randomized Trial|Recruiting||N/A|40|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 02:56:16.267794|2017-10-11 02:56:16.267794
NCT01605396|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-08-18|||July 4, 2012|Actual|2012-07-04|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|February 19, 2014|Actual|2014-02-19||Interventional|||A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)|A Phase II Randomized Trial of the Combination of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in High Proliferation, Estrogen Receptor Positive Breast Cancer Patients|Active, not recruiting||Phase 2|80|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:56:16.407309|2017-10-11 02:56:16.407309
NCT01605383|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-07-07|||July 2012||2012-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head|"A Pilot Clinical Trial of ex Vivo Expanded Autologous Bone Marrow Mesenchymal Stem Cells Fixed in Allogenic Human Bone Tissue (XCEL-MT-OSTEO- ALPHA) in Osteonecrosis of the Femoral Head"|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Banc de Sang i Teixits||2|||f||||f||||||||||2017-10-11 02:56:16.543774|2017-10-11 02:56:16.543774
NCT01605370|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-05-08|2014-04-04||June 2012||2012-06-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|Inapprop|The study was terminated early due to the difficulty in identifying subjects satisfying the inclusion criteria. Only 1 subject was enrolled.|Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?|Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?|Terminated||Phase 4|1|Actual|Mayo Clinic|The study was terminated early due to the difficulty in identifying subjects satisfying the inclusion criteria. Only 1 subject was enrolled.|2||Difficulty in identifying subjects satisfying the inclusion criteria.|f||||f||||||||||2017-10-11 02:56:16.693368|2017-10-11 02:56:16.693368
NCT01605357|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-12-09|||July 2012||2012-07-01|December 2016|2016-12-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|||Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury|A Randomized, Open Label Clinical Trial of Sustained Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury|Withdrawn||Phase 1/Phase 2|0|Actual|Massachusetts General Hospital||2||Never started.|f||||t||||||||||2017-10-11 02:56:17.154126|2017-10-11 02:56:17.154126
NCT01605344|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-02-26|||April 2012||2012-04-01|February 2014|2014-02-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI|A Prospective, Randomized, Crossover Evaluation of the Effect of Atorvastatin on the Pharmacokinetics of Irinotecan in Colorectal Cancer Patients Receiving FOLFIRI|Withdrawn||Phase 1|0|Actual|UNC Lineberger Comprehensive Cancer Center||2||Study was withdrawn due to lack of patient enrollment.|f||||t||||||||||2017-10-11 02:56:17.26826|2017-10-11 02:56:17.26826
NCT01605331|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-10-03|||December 2009||2009-12-01|October 2012|2012-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)||Completed||Phase 4|132|Actual|LG Life Sciences||1|||f||||||||||||||2017-10-11 02:56:17.41441|2017-10-11 02:56:17.41441
NCT01605318|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-03-18|||September 2012||2012-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer|A Phase I/II Study of Once or Twice Weekly IMMU-130 (hMN-14-SN38, Antibody-Drug Conjugate) in Patients With Colorectal Cancer.|Recruiting||Phase 1/Phase 2|104|Anticipated|Immunomedics, Inc.||1|||f||||f||||||||||2017-10-11 02:56:17.489283|2017-10-11 02:56:17.489283
NCT01605305|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-05-23|||September 2008||2008-09-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer|Phase II Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer|Completed||Phase 2|60|Actual|Fudan University||1|||f||||t||||||||||2017-10-11 02:56:17.661858|2017-10-11 02:56:17.661858
NCT01605292|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-02-25|2014-12-29||December 2011||2011-12-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|RAUST||Radial Artery Access With Ultrasound Trial|Radial Artery Access With Ultrasound Trial|Completed||N/A|698|Actual|University of California, Irvine|Blinding was not possible in this study. We cannot exclude a bias in the performance, measurement, or recording of the procedure or clinical data. Time to prepare the US probe was not included in the time to access.|2|||f||||f||||||||||2017-10-11 02:56:17.764816|2017-10-11 02:56:17.764816
NCT01605279|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-03-06|||September 2010||2010-09-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns|Randomised Double Blind Clinical Trial of Dobutamine Versus Placebo for Low Superior Vena Cava Flow Treatment in Low Birth Weight Infants: Systematic Assessment of Cerebral and Systemic Hemodynamics Effects|Completed||Phase 2|127|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz||2|||f||||t||||||||||2017-10-11 02:56:18.491419|2017-10-11 02:56:18.491419
NCT01605266|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-02-01|||January 2011||2011-01-01|February 2017|2017-02-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|INSIGHT||INSIGHT (Insight Into Nephrotic Syndrome)|INSIGHT (Insight Into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics)|Recruiting||N/A|1000|Anticipated|The Hospital for Sick Children|||1||f||||f||||||Samples With DNA|"     Blood is drawn for DNA, serum, plasma, buffy coat and whole blood. Urine and toenail     clippings are also collected.   "|No||2017-10-11 02:56:18.600041|2017-10-11 02:56:18.600041
NCT01605240|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2013-07-24|||July 2012||2012-07-01|July 2013|2013-07-01|August 2014|Anticipated|2014-08-01|December 2013|Anticipated|2013-12-01||Interventional|||Ibuprofen Versus Codeine. Is One Better for Post-operative Pain Relief Following Reduction of Paediatric Forearm Fractures?|Ibuprofen vs. Codeine. Is One Better for Post-operative Pain Relief Following Reduction of Paediatric Forearm Fractures?|Unknown status|Recruiting|N/A|50|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-11 02:56:18.839459|2017-10-11 02:56:18.839459
NCT01605214|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-04-30|||October 2015||2015-10-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Observational|||Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung Transplant|Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung Transplant|Recruiting||N/A|60|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 02:56:19.730106|2017-10-11 02:56:19.730106
NCT01605201|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-09-01|||May 2012||2012-05-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2017|Anticipated|2017-11-01||Interventional|Nose2Knee||Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage|Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage in the Knee After Traumatic Injury - a Phase I Clinical Trial-|Active, not recruiting||Phase 1|18|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 02:56:19.844441|2017-10-11 02:56:19.844441
NCT01605188|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-01-27|||May 2012||2012-05-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF|Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF.|Completed||N/A|132|Actual|Evangelismos Hospital|||1||f||||t||||||Samples With DNA|"     Whole blood Serum Bowel mucosal tissue   "|||2017-10-11 02:56:19.940542|2017-10-11 02:56:19.940542
NCT01605175|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-11-15|||May 2012||2012-05-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF|Predictors of Tissue Healing in Inflammatory Bowel Disease Patients Treated With Anti-TNF|Completed||N/A|21|Actual|Evangelismos Hospital|||1||f||||t||||||Samples With DNA|"     Whole blood Serum Bowel mucosal tissue   "|||2017-10-11 02:56:20.003286|2017-10-11 02:56:20.003286
NCT01605162|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-07-25||2016-06-22|May 2012||2012-05-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma|Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma|Terminated||Phase 2|8|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 02:56:20.08443|2017-10-11 02:56:20.08443
NCT01605149|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-03-25|||July 2012||2012-07-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence|Type 1 DM Bone Mineral Density in Childhood and Adolescence|Completed||N/A|60|Actual|Creighton University|||1||f||||f||||||||||2017-10-11 02:56:20.173975|2017-10-11 02:56:20.173975
NCT01605136|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2013-03-21|||May 2012||2012-05-01|March 2013|2013-03-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Phase III Confirmatory Study in Erythropoietic Protoporphyria|A Phase III, Multicentre, Double-Blind, Randomized, Placebo-Controlled Study to Confirm the Safety and Efficacy of Subcutaneous Bioresorbable Afamelanotide Implants in Patients With Erythropoietic Protoporphyria (EPP)|Unknown status|Active, not recruiting|Phase 3|93|Actual|Clinuvel Pharmaceuticals Limited||2|||f||||t||||||||||2017-10-11 02:56:20.263314|2017-10-11 02:56:20.263314
NCT01605123|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-02-24|||April 2007|Actual|2007-04-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Longitudinal Assessment of Cardiovascular and Metabolic Parameters in Obese and Lean Children|Leipzig Artherobesity Childhood Cohort|Recruiting||N/A|200|Anticipated|University of Leipzig|||4||f||||f||||||Samples With DNA|"     Serum samples, samples from oral glucose tolerance tests (oGTT), EDTA/DNA samples, primary     cells (endothelial progenitor cells), peripheral blood mononuclear cells), urine   "|No||2017-10-11 02:56:20.400296|2017-10-11 02:56:20.400296
NCT01605110|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2012-12-03|||August 2011||2011-08-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|BLEPH||Effects of Hyperbaric Oxygen Therapy on Surgical Wound Healing|Effects of HBOT for Edema/Ecchymosis After Upper Eyelid Blepharoplasty (Single Site Study)|Unknown status|Enrolling by invitation|N/A|164|Anticipated|Restorix Research Institute, LLLP||2|||f||||t||||||||||2017-10-11 02:56:20.555956|2017-10-11 02:56:20.555956
NCT01605097|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-02-19|||May 2012||2012-05-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|Dosepainting||High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule|High Dose Rate Prostate (HDR) Brachytherapy Dose Escalation to Dominant Intra-prostatic Nodule for Patients With Intermediate and High Risk Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|15|Anticipated|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 02:56:20.646939|2017-10-11 02:56:20.646939
NCT01605084|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-12-03|||June 2012||2012-06-01|December 2012|2012-12-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|SUPPRESS||Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone|An Open-Label Phase 3B Study in HIV-Infected Individuals With Viremia on or After Their First-Line Non-Nucleoside Reverse Transcriptase Inhibitor or Integrase Inhibitor-Based Regimen and Starting a Second-Line Regimen Consisting of ATV/RTV or DRV/RTV With an Optimized NRTI Backbone|Withdrawn||Phase 3|0|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 02:56:20.748073|2017-10-11 02:56:20.748073
NCT01605071|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-03-31|||September 2011||2011-09-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|November 2015|Actual|2015-11-01||Interventional|TEMPUS||Timing Estrogen After MenoPaUSe|Time Past Menopause, Duration of Estrogen Deficiency, and Insulin Action|Completed||N/A|55|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 02:56:20.931684|2017-10-11 02:56:20.931684
NCT01605058|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2012-05-25|||June 2012||2012-06-01|May 2012|2012-05-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Observational|||Visual Performance With a Trifocal Intraocular Lens|Visual Performance Adn Quality of Vision Evaluation After Implantation of a Trifocal Intraocular Lens|Unknown status|Not yet recruiting|N/A|30|Anticipated|BMI Southend Hospital|||1||f||||t||||||||||2017-10-11 02:56:21.077643|2017-10-11 02:56:21.077643
NCT01605045|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-10-11|||April 2012||2012-04-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Screening for Coronary Artery Disease Using Fluoroscopy During Coronary Angiography|Efficacy of Fluoroscopy-save Function During Cardiac Catheterization|Completed||Phase 4|50|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 02:56:21.14785|2017-10-11 02:56:21.14785
NCT01605032|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-01-11|||February 2012||2012-02-01|January 2016|2016-01-01||||January 2017|Anticipated|2017-01-01||Interventional|||Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma|Phase II Study Assessing the Efficacy and Toxicity of PK--directed Intravenous Busulfan in Combination With High--Dose Melphalan and Bortezomib as Conditioning Regimen for First--Line Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma|Active, not recruiting||Phase 2|42|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 02:56:21.256833|2017-10-11 02:56:21.256833
NCT01605006|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-04-12|||July 2012||2012-07-01|April 2016|2016-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis|HDE Post-Approval Study (PAS) of NeuRx DPS for ALS|Active, not recruiting||N/A|97|Actual|Synapse Biomedical||1|||f||||f||||||||||2017-10-11 02:56:21.515483|2017-10-11 02:56:21.515483
NCT01604993|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-03-07|||October 2011||2011-10-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Interventional|DNAB||Acute Effect of Nitrate From Natural Dietary Sources on Arterial Stiffness and Blood Pressures in Healthy Individuals|Acute Effect of Nitrate Supplementation From Natural Dietary Sources on Arterial Stiffness and Aortic and Brachial Blood Pressures: a Double-blind, Placebo-controlled, Randomized, Crossover Clinical Trial in Healthy Adults|Completed||Phase 2|31|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 02:56:21.646043|2017-10-11 02:56:21.646043
NCT01604980|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2013-08-16|||March 2012||2012-03-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Determination of Protein Requirements in Elderly Female Subjects >75 Yrs Old|Use of Indicator Amino Acid Oxidation Technique to Determine Protein Requirement of Elderly Female Subjects >75 Years Old|Completed||Early Phase 1|14|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 02:56:21.746033|2017-10-11 02:56:21.746033
NCT01604967|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-05-11|||May 2012||2012-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:56:21.848507|2017-10-11 02:56:21.848507
NCT01604954|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2015-08-31|||August 2011||2011-08-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|May 2013|Actual|2013-05-01||Interventional|MENU||Does Food Labeling Influence Long-term Food Intake and Eating-related Variables in Women?|Does Food Labeling Influence Long-term Food Intake and Eating-related Variables in Women?|Completed||N/A|160|Actual|Laval University||2|||f||||f||||||||||2017-10-11 02:56:21.914698|2017-10-11 02:56:21.914698
NCT01604941|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2015-07-22|2015-06-04||September 2012||2012-09-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Safety Set, defined as all participants who had taken at least 1 BID dose of investigational product.|Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy|A Phase 2, 24 Week, Open Label, Multi-Center Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SSP-004184 (SPD602) in the Treatment of Chronic Iron Overload Requiring Chelation Therapy|Terminated||Phase 2|32|Actual|Shire|This study was terminated due to treatment stop resulting in an inability to draw conclusions from the data. Evaluation of nonclinical rat findings is ongoing.|1||"This study was terminated due to treatment stop resulting in an inability to draw conclusions   from the data. Evaluation of nonclinical rat findings is ongoing."|f||||t||||||||||2017-10-11 02:56:22.051158|2017-10-11 02:56:22.051158
NCT01604928|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2017-02-14|||April 2004||2004-04-01|February 2017|2017-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|Blossom||Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder|A Randomized, Double-blind, Parallel Group, Proof of Concept Study of YM178 in Comparison With Placebo and Tolterodine in Patients With Symptomatic Overactive Bladder|Completed||Phase 2|260|Actual|Astellas Pharma Inc||4|||f||||f||||||||Yes|Details of the IPD sharing plan for this study can be found at www.clinicalstudydatarequest.com.|2017-10-11 02:56:23.222492|2017-10-11 02:56:23.222492
NCT01604915|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2013-07-05|||May 2012||2012-05-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||Comparison of Dexamethasone Added to Ropivacaine and Ropivacaine Alone in Caudal Analgesia in Children Undergoing Orchiopexy|Comparison of Analgesic Effect of Dexamethasone Added to Ropivacaine and Ropivacaine Alone in Caudal Analgesia on Postoperative Pain Control in Pediatric Patients Undergoing Orchiopexy|Completed||N/A|80|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 02:56:23.423987|2017-10-11 02:56:23.423987
NCT01604902|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-08-22|||March 2011||2011-03-01|January 2013|2013-01-01|January 2016|Anticipated|2016-01-01|March 2015|Anticipated|2015-03-01||Observational|||miRNAs and mRNAs in Psoriasis|miRNAs and mRNAs in Psoriasis During Treatment With Biological Drugs.|Unknown status|Recruiting|N/A|10|Anticipated|University of Aarhus|||1||f||||t||||||Samples With DNA|"     tissue: 4mm skin pinch biopsies for mRNA and miRNA extration.   "|||2017-10-11 02:56:23.515693|2017-10-11 02:56:23.515693
NCT01604889|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-05-03||2017-05-02|March 2012|Actual|2012-03-01|May 2017|2017-05-01|December 27, 2016|Actual|2016-12-27|December 27, 2016|Actual|2016-12-27||Interventional|||A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With INCB024360 or Placebo in Subjects With Unresectable or Metastatic Melanoma|A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With INCB024360 or Placebo in Subjects With Unresectable or Metastatic Melanoma|Terminated||Phase 1/Phase 2|136|Actual|Incyte Corporation||5||"Further development of this compound with ipilimumab in the treatment of melanoma is no longer   being pursued."|f||||f||||||||||2017-10-11 02:56:23.616823|2017-10-11 02:56:23.616823
NCT01604876|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-10-05|||May 2012||2012-05-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|LightPD||Effect of Bright Light on Mood and Sleep in Parkinson's Disease|Effect of Bright Light on Mood and Sleep in Parkinson's Disease|Active, not recruiting||N/A|83|Actual|VU University Medical Center||2|||f||||f||||||||Undecided|Data may be shared on reasonable request|2017-10-11 02:56:23.746316|2017-10-11 02:56:23.746316
NCT01604863|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-10-29|||June 2012||2012-06-01|October 2012|2012-10-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies|Multi-Center, Open-Label Phase 1B Study to Evaluate the Safety and Tolerability of HGS1036 in Combination With Paclitaxel and Carboplatin, Cisplatin and Etoposide, or Docetaxel in Subjects With Advanced Solid Malignancies|Suspended||Phase 1|54|Anticipated|GlaxoSmithKline||3||Study suspended prior to enrollment|f||||f||||||||||2017-10-11 02:56:23.85992|2017-10-11 02:56:23.85992
NCT01604850|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-05-09|2014-03-31||June 2012||2012-06-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|FUSION|Participants in the Safety Analysis Set (randomized and received at least 1 dose of study drug) were analyzed for baseline characteristics.|Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)|A Phase 3, Multicenter, Randomized, Double-Blind, Study to Investigate the Efficacy and Safety of GS-7977 + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection|Completed||Phase 3|202|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 02:56:23.996632|2017-10-11 02:56:23.996632
NCT01604837|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2013-12-24|||April 2012||2012-04-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||The Optimal Oblique and Axial Angle of Fluoroscope for Superior Hypogastric Plexus Block|The Optimal Oblique and Axial Angle of Fluoroscope for Superior Hypogastric Plexus Block|Completed||N/A|268|Actual|Samsung Medical Center|||2||f||||t||||||||||2017-10-11 02:56:25.060926|2017-10-11 02:56:25.060926
NCT01604811|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2014-01-14|||June 2012||2012-06-01|July 2013|2013-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|PERMIN||Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia)|Exploratory Study of L.S.E.S.r. (PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in the Treatment of Urinary Symptoms Related to BPH; a Multinational, Multicentric, Randomised, Double Blind Parallel-group Prospective Study|Completed||Phase 4|206|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-10-11 02:56:25.277883|2017-10-11 02:56:25.277883
NCT01604798|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-22|||January 2007||2007-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Serum Proteomic Profiling for the Early Diagnosis of Colorectal Cancer|Serum Proteomic Profiling for the Early Diagnosis of Colorectal Cancer|Completed||N/A|547|Actual|Fudan University|||2||f||||t||||||Samples Without DNA|"     All fasting blood samples were prepared without anticoagulant and left to clot at room     temperature for 1.5 h. The serum was then isolated by centrifugation at 3000 g for 10 min at     room temperature and stored at -80℃. All samples were subjected to one freeze-thaw cycle.   "|||2017-10-11 02:56:25.429035|2017-10-11 02:56:25.429035
NCT01604785|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-08-16|||November 2012||2012-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Low-dose Propofol for Pediatric Migraine|Low-dose Propofol for Abortive Therapy of Pediatric Migraine in the Emergency Department|Completed||Phase 2/Phase 3|74|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 02:56:25.512415|2017-10-11 02:56:25.512415
NCT01604772|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-22|2016-11-14|2015-06-04||July 2012||2012-07-01|November 2016|2016-11-01||||October 2013|Actual|2013-10-01||Interventional|||Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma|A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma|Active, not recruiting||Phase 2|16|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 02:56:25.61778|2017-10-11 02:56:25.61778
NCT01604759|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-03|2017-01-30|||December 2011||2011-12-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|PolProbe||Polarized Reflectance Spectroscopy for Oral Lesions|Evaluation of Polarized Reflectance Spectroscopy for Detection of High-risk Oral Lesions|Completed||Phase 1|40|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-10-11 02:56:26.002728|2017-10-11 02:56:26.002728
NCT01604746|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2015-10-07|||July 2012||2012-07-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801|Open-label Phase 3b Study to Investigate the Safety of Ross River Virus (RRV) Vaccine From 6 to 12 Months After the Third Vaccination in Healthy Adults (Follow up to Precursor Study 880801)|Completed||Phase 3|1146|Actual|Nanotherapeutics, Inc.||1|||f||||t||||||||||2017-10-11 02:56:26.08119|2017-10-11 02:56:26.08119
NCT01604733|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-23|||October 2010||2010-10-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|CEPHEUS||Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia|Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia|Completed||N/A|1000|Actual|AstraZeneca|||1||f||||f||||||None Retained|"     blood sample   "|||2017-10-11 02:56:26.325061|2017-10-11 02:56:26.325061
NCT01604720|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-01-13|||July 2012||2012-07-01|January 2015|2015-01-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Observational|||Sample Size Definition in Cochrane Hepato-Biliary Trials|Review: Analysis of the Sample Size Definitions in the Randomized Clinical Trials Included in Systematic Reviews of the Hepato-biliary Group of the Cochrane Collaboration|Unknown status|Recruiting|N/A|250|Anticipated|Azienda Ospedaliera di Lecco|||1||f||||f||||||||||2017-10-11 02:56:26.39707|2017-10-11 02:56:26.39707
NCT01604707|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-10-03|||March 2011||2011-03-01|October 2016|2016-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Medical Yoga for Patients With Stress-related Symptoms and Diagnoses|Medical Yoga for Patients With Stress-related Symptoms and Diagnoses in Primary Health Care - a Randomized Controlled Trial|Completed||N/A|44|Actual|Region Örebro County||2|||f||||f||||||||No||2017-10-11 02:56:26.506734|2017-10-11 02:56:26.506734
NCT01604694|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2014-05-09|||June 2012||2012-06-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|TAPlastie||Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty|Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty: Randomized- Controlled- Trial Double Blind Monocentric Study, Against Placebo|Completed||Phase 4|52|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 02:56:26.590173|2017-10-11 02:56:26.590173
NCT01604681|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-05-23|||January 2011||2011-01-01|December 2010|2010-12-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Supplementation With Flaxseed Oil in the State of Rio de Janeiro|The Effect of Flaxseed Oil Supplementation on Biomarkers, Quality of Life and Cognitive Function in Hypertensive and Dyslipidemic Subjects With or Without the C677T and A1298C Polymorphisms in MTHFR Gene in Different Municipalities of Rio de Janeiro|Unknown status|Recruiting|N/A|200|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-11 02:56:26.684869|2017-10-11 02:56:26.684869
NCT01604668|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2013-08-19|||May 2012||2012-05-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Comparative Accuracy of Three Versions of Non-Invasive Hemoglobin Monitoring|Comparative Accuracy of Three Versions of Non-Invasive Hemoglobin Monitoring.|Completed||N/A|10|Actual|University of California, San Francisco|||1||f||||t||||||||||2017-10-11 02:56:26.787205|2017-10-11 02:56:26.787205
NCT01604655|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-03-07|||September 2011||2011-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|PERFECT||ProspEctive First Evaluation in Chest Pain Trial|ProspEctive Randomized First Evaluation in Chest Pain Trial|Completed||N/A|411|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||f||||||||||2017-10-11 02:56:26.856813|2017-10-11 02:56:26.856813
NCT01604642|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-11-18|||May 2012||2012-05-01|November 2014|2014-11-01||||March 2014|Actual|2014-03-01||Interventional|||Role of Activin A (ActA) in the Human Cancer Cachexia|Role of Activin A (ActA) in the Human Cancer Cachexia|Unknown status|Active, not recruiting|N/A|80|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-11 02:56:26.942274|2017-10-11 02:56:26.942274
NCT01604629|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2015-11-16|||July 2012||2012-07-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|REDES-TNF||Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF|Evaluation of Clinical Value of Standardized Protocol for Dose-reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF Therapy: Open-label, Controlled, Randomized, Multicenter Trial.|Completed||Phase 4|120|Actual|Spanish Clinical Pharmacology Society||2|||f||||t||||||||||2017-10-11 02:56:27.026892|2017-10-11 02:56:27.026892
NCT01604616|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-22|||January 1998||1998-01-01|May 2012|2012-05-01|June 2012|Anticipated|2012-06-01|||||Observational|||Short Term Postoperative Tamponade Using Perfluorocarbon Liquid for Giant Retinal Tears|Short Term Postoperative Tamponade Using Perfluorocarbon Liquid for Giant Retinal Tears|Unknown status|Recruiting|N/A|40|Anticipated|Ziv Hospital|||2||f||||t||||||||||2017-10-11 02:56:27.202368|2017-10-11 02:56:27.202368
NCT01604590|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-04-10|||July 2012||2012-07-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Observational|||Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme|Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme Response to Treatment With Bevacizumab for Progressive Disease|Completed||N/A|13|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-10-11 02:56:27.339855|2017-10-11 02:56:27.339855
NCT00005232|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||August 1988||1988-08-01|June 2000|2000-06-01|July 1993|Actual|1993-07-01|||||Observational|||Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.604642|2017-10-11 04:26:39.604642
NCT01604564|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-07-28|||May 2012||2012-05-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|KOPOF||Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients|KOPOF Registry (Patients Characteristics, Operative Data, Postoperative Outcome, Functional Postoperative Recovery ) of Patients in Which a Pouch Has Been Created Due to Colitis Ulcerosa (CU) or Familial Adenomatous Polyposis(FAP)|Recruiting||N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||No||2017-10-11 02:56:27.535314|2017-10-11 02:56:27.535314
NCT01604551|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-31|||May 2003||2003-05-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|||||Observational|||Membrane Shedding During Septic Shock|Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical Relevance|Completed||N/A|100|Actual|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 02:56:27.623057|2017-10-11 02:56:27.623057
NCT01604538|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-21|||March 2006||2006-03-01|May 2012|2012-05-01||||||||Observational|IPER||Italian Pulmonary Embolism Registry - IPER|Italian Pulmonary Embolism Registry|Completed||N/A|1700|Actual|University Of Perugia|||1||f||||f||||||||||2017-10-11 02:56:27.703516|2017-10-11 02:56:27.703516
NCT01604525|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-21|||May 2011||2011-05-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|RealU||Tailored Web and Peer Email Cessation Counseling for College Smokers|RealU: Tailored Web and Peer Email Cessation Counseling for College Smokers|Completed||N/A|1699|Actual|University of Michigan||3|||f||||t||||||||||2017-10-11 02:56:27.75651|2017-10-11 02:56:27.75651
NCT01604512|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-08-24|||May 2012||2012-05-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression|Enhancing Brain Lesions After Radiation Therapy: A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression|Recruiting||N/A|140|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 02:56:27.854548|2017-10-11 02:56:27.854548
NCT01604499|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-10-02|||September 2012||2012-09-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Building on a Point-of-purchase Intervention to Encourage Healthy Food Choices|Building on a Point-of-purchase Intervention to Encourage Healthy Food Choices|Completed||N/A|2672|Actual|Massachusetts General Hospital||3|||f||||f||||||||||2017-10-11 02:56:27.977956|2017-10-11 02:56:27.977956
NCT01604486|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-10-01|||September 2009||2009-09-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Natural Ischaemic Preconditioning Before First Myocardial Infarction|Natural Ischaemic Preconditioning Before First Myocardial Infarction: an Analysis of Prospectively Collected UK Electronic Primary Care Records Linked to the National Registry of Acute Coronary Syndromes|Completed||N/A|16000|Actual|London School of Hygiene and Tropical Medicine|||4||f||||t||||||||||2017-10-11 02:56:28.065718|2017-10-11 02:56:28.065718
NCT01604473|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-12-01|||October 2010||2010-10-01|December 2015|2015-12-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Observational|EFAVF||Endothelial Function and Arterio-Venous Fistula Maturation|Endothelial Function and Arterio-Venous Fistula Maturation|Recruiting||N/A|100|Anticipated|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 02:56:28.170458|2017-10-11 02:56:28.170458
NCT01604460|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2013-02-08|||June 2012||2012-06-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part V|Randomized Evaluation of the Use of Plastic Bags to Prevent Neonatal Hypothermia in Developing Countries-Part V|Completed||Phase 4|275|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 02:56:28.297775|2017-10-11 02:56:28.297775
NCT01604447|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-02-23|||June 2012||2012-06-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|August 2014|Actual|2014-08-01||Interventional|||Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part IV|Randomized Evaluation of the Use of Plastic Bags to Prevent Neonatal Hypothermia in Developing Countries-Part IV|Completed||Phase 4|118|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 02:56:28.395996|2017-10-11 02:56:28.395996
NCT01604434|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-04-04|||June 2012||2012-06-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part III|Randomized Evaluation of the Use of Plastic Bags to Prevent Neonatal Hypothermia in Developing Countries-Part III|Recruiting||Phase 4|118|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 02:56:28.504744|2017-10-11 02:56:28.504744
NCT01604421|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-04-04|||February 2013||2013-02-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part II|Randomized Evaluation of the Use of Plastic Bags to Prevent Neonatal Hypothermia in Developing Countries-Part II|Recruiting||Phase 4|182|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 02:56:28.614602|2017-10-11 02:56:28.614602
NCT01604408|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-04-14||2014-04-14|May 2012||2012-05-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||A Study in Older Participants Who Have Fallen and Have Muscle Weakness|A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness|Completed||Phase 2|172|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 02:56:28.736728|2017-10-11 02:56:28.736728
NCT01604395|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-03-21|||January 2012||2012-01-01|March 2016|2016-03-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Observational|LGS||Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children|An Open, Multi-center, Prospective and Retrospective Observational Study to Evaluate the Long-term Safety and Effectiveness of Growth Hormone (Eutropin Inj. / Eutropin Plus Inj.) Treatment With GHD, TS, CRF, SGA and ISS in Children|Recruiting||N/A|2000|Anticipated|LG Life Sciences|||1||f||||t||||||||||2017-10-11 02:56:28.870246|2017-10-11 02:56:28.870246
NCT01604382|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2012-05-22|||September 2008||2008-09-01|May 2012|2012-05-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|||Early Mobilization After Total Knee Arthroplasty|A Randomized Study of Whether General or Regional Anesthesia for Patients Undergoing Elective Total Knee Arthroplasty Could Effect Length of Hospital Stay|Completed||N/A|60|Actual|Region Skane||2|||f||||t||||||||||2017-10-11 02:56:29.017057|2017-10-11 02:56:29.017057
NCT01604369|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-10-05|||June 2012||2012-06-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|CASTAF||Cryoablation as Standard Treatment of Atrial Flutter|Cryoablation as Standard Treatment of Atrial Flutter - Long Term Efficacy and Patient Content|Completed||N/A|193|Actual|Karolinska University Hospital||1|||f||||t||||||||||2017-10-11 02:56:29.111554|2017-10-11 02:56:29.111554
NCT01604343|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-12-23||2016-06-08|August 2012||2012-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|September 2015|Actual|2015-09-01||Interventional|||A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis Despite DMARD Therapy|Completed||Phase 3|1670|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 02:56:29.30553|2017-10-11 02:56:29.30553
NCT01604330|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-10-02|||May 29, 2012|Actual|2012-05-29|September 2017|2017-09-01|October 2015|Actual|2015-10-01|September 2014|Actual|2014-09-01||Interventional|BACLOVILLE||Baclofen for the Treatment of Alcohol Drinkers|Alcohol Treatment: Pragmatic Therapeutic Trial Randomized, Double-blind for a Year in Ambulatory Care of Baclofen Versus Placebo.|Completed||Phase 2/Phase 3|323|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 02:56:29.770892|2017-10-11 02:56:29.770892
NCT01604317|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-04-04|||June 2012||2012-06-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part I|Randomized Evaluation of the Use of Plastic Bags to Prevent Neonatal Hypothermia in Developing Countries-Part I|Recruiting||Phase 4|182|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 02:56:29.86805|2017-10-11 02:56:29.86805
NCT01604304|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-08-26|||May 2012||2012-05-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|CALIX-1||Flexible urétéroscopy Versus Extracorporeal Shockwave Lithotripsy in Renal Calculi|Flexible urétéroscopy Versus Extracorporeal Shockwave Lithotripsy in 5 to 20 mm Renal Calculi, Efficacity Prospective Randomized Trial|Completed||N/A|30|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 02:56:29.974218|2017-10-11 02:56:29.974218
NCT01604278|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-11-12|2014-07-28||May 2012||2012-05-01|November 2014|2014-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|GLOW6|The baseline characteristics table was based on the safety set.|Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A 12-week Multi-center, Randomized, Double-blind, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of the Co-administration of NVA237 + Indacaterol Once Daily vs. Indacaterol Once Daily in Patients With Moderate to Severe COPD|Completed||Phase 3|449|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:56:30.442051|2017-10-11 02:56:30.442051
NCT01604265|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2013-06-13|2012-07-18||March 2002||2002-03-01|June 2013|2013-06-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis|A Double Blind, Randomised, Parallel Group, Placebo Controlled Study of Sativex in the Treatment of Central Neuropathic Pain in Multiple Sclerosis.|Completed||Phase 3|66|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-10-11 02:56:31.656839|2017-10-11 02:56:31.656839
NCT01604252|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-07-25|||June 20, 2012|Actual|2012-06-20|June 2017|2017-06-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Observational|||An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)|A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients|Terminated||N/A|503|Actual|Genentech, Inc.|||1|"The study was terminated early by the Sponsor due to the high rate of discontinuation of   subjects unrelated to patient safety."|f||||||||||Samples With DNA|"     optional blood sample   "|||2017-10-11 02:56:32.459079|2017-10-11 02:56:32.459079
NCT01604239|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2013-11-11|||May 2012||2012-05-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis|A 24 Weeks, Multi-centers, Single Arm Phase IV Study to Evaluate the Safety of 'Shinbaro Capsule' Compared With Historical Data of 'Celebrex Capsule' in Patients With Osteoarthritis|Completed||Phase 4|761|Actual|Green Cross Corporation||1|||f||||f||||||||||2017-10-11 02:56:32.670588|2017-10-11 02:56:32.670588
NCT01604226|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-07-08|||April 2012||2012-04-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Predicting Bispectral Index Values by Estimated Effect-site Concentration of Propofol and Remifentanil Displayed on the Target-centered Infusion Pump|Predicting Bispectral Index Values by Estimated Effect-site Concentration of Propofol and Remifentanil Displayed on the Target-centered Infusion Pump|Unknown status|Recruiting|N/A|100|Anticipated|Samsung Medical Center|||2||f||||t||||||||||2017-10-11 02:56:32.770863|2017-10-11 02:56:32.770863
NCT01604213|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-04-17|||September 2012||2012-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|VAAST||Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease|Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetic Patients With Coronary Artery Disease|Completed||Phase 4|60|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:56:32.889931|2017-10-11 02:56:32.889931
NCT01604200|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2013-08-26||||||August 2013|2013-08-01||||||||Observational|Dental-PROBE||Dental PROBE (Dental Practice suRvey of Office Blood Pressure mEasurement)|A Mixed Methods Study to Assess How to Engage Dentists in Blood Pressure Screening|Withdrawn||N/A|0|Actual|Sunnybrook Health Sciences Centre|||1|Funding unsuccessful|f||||f||||||||||2017-10-11 02:56:32.991806|2017-10-11 02:56:32.991806
NCT01604174|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-23|||November 2008||2008-11-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|REHABITIC||Interactive Virtual Telerehabilitation After Total Knee Arthroplasty|Effectiveness of an Interactive Virtual Telerehabilitation System in Patients After Total Knee Arthroplasty. A Randomized Controlled Trial|Completed||N/A|140|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 02:56:33.171809|2017-10-11 02:56:33.171809
NCT01604161|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-07-02|||May 2005||2005-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|NordiPAD||Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome|A Multicentre, Open Label, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin® Formulation in Child Patients With GHD or Turner Short Stature Without Closure of Epiphyseal Discs.|Completed||N/A|2016|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 02:56:33.258292|2017-10-11 02:56:33.258292
NCT01604148|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-22|||July 2011||2011-07-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon|Retrospective Review of a Comprehensive Case Database of HoLEP (Holmium Laser Enucleation of Prostate) Procedure Performed by a Single Surgeon|Completed||N/A|300|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 02:56:33.349817|2017-10-11 02:56:33.349817
NCT01604135|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-04-22|||May 2012||2012-05-01|April 2016|2016-04-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|CXL-RCT||Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial|Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial|Recruiting||Phase 3|200|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-11 02:56:33.41657|2017-10-11 02:56:33.41657
NCT01604122|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-03-01|2016-07-14||April 18, 2012|Actual|2012-04-18|March 2017|2017-03-01|July 18, 2016|Actual|2016-07-18|July 27, 2015|Actual|2015-07-27||Observational||All participants who were enrolled in the study and completed the survey.|Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers|Cross-sectional, Non-interventional Burden Of Disease (Bod) Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (Ttr-fap) Or Transthyretin Cardiomyopathy (ttr-cm) And Caregivers|Completed||N/A|1|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 02:56:33.550104|2017-10-11 02:56:33.550104
NCT01604109|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2013-06-10|2013-06-10||July 2010||2010-07-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of CPP-ACP Paste on Dental Caries in Primary Teeth|Effect of CPP-ACP Paste on Dental Caries in Primary Teeth: A Randomized Trial|Completed||Phase 2|296|Actual|Thammasat University|This one year study was performed on high caries risk pre-school children who enrolled in government nursery schools in central part of Thailand.|2|||f||||f||||||||||2017-10-11 02:56:36.387265|2017-10-11 02:56:36.387265
NCT01604096|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-22|||November 2011||2011-11-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|LOCAAL||Controlled Trial to Evaluate a Local Information Campaign on Antibiotic Prescribing in Italy|Doctors and Local Media: a Synergy for Public Health Information? A Controlled Trial to Evaluate the Effects of a Multifaceted Campaign on Antibiotic Prescribing|Completed||Phase 2|||Regional Health and Social Care Agency, Italy||2|||f||||f||||||||||2017-10-11 02:56:36.668408|2017-10-11 02:56:36.668408
NCT01604083|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2016-04-08|||April 2013||2013-04-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Observational|ETPOS||European Transfusion Practice and Outcome Study|European Transfusion Practice and Outcome Study A Multi-central Evaluation of Standard of Transfusion Care and Clinical Outcome for Elective Surgical Patients. Observational Study.|Completed||N/A|6066|Actual|European Society of Anaesthesiology|||1||f||||f||||||||||2017-10-11 02:56:36.780572|2017-10-11 02:56:36.780572
NCT01604070|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-07-02|||May 2012||2012-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Observational|||Study to Evaluate Safety, of NextraTM in Surgery to Fuse the Proximal-interphalangeal- Joints|Randomized Multi-Center Post Market Clinical Study to Evaluate the Safety and Performance of NextraTM for Use in Foot Surgery to Fuse the Proximal-interphalangeal- Joints|Completed||N/A|98|Actual|eMedtrain Inc.|||2||f||||t||||||||||2017-10-11 02:56:37.037874|2017-10-11 02:56:37.037874
NCT01604057|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-05-21|||November 2011||2011-11-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass|A Parallel Group Study to Evaluate the Effect of Six Weeks of Treatment With Nasal Spray (NS) ZT-034, Compared to Subcutaneous (SC) Forteo and Placebo, on Bone Formation, as Assessed by Stimulation of Serum P1NP Levels in Postmenopausal Women With Low Bone Mass|Unknown status|Active, not recruiting|Phase 2|130|Actual|Azelon Pharmaceuticals||5|||f||||f||||||||||2017-10-11 02:56:37.14619|2017-10-11 02:56:37.14619
NCT01604044|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2014-09-04|||May 2012||2012-05-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.||Completed||Phase 1|579|Actual|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-11 02:56:37.28879|2017-10-11 02:56:37.28879
NCT01604031|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-02-05|||February 2013||2013-02-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|TAIL||Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide|Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide|Terminated||Phase 1|2|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 02:56:37.400431|2017-10-11 02:56:37.400431
NCT01604018|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-05-23|||February 2012||2012-02-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||An Optional Two Year Follow Up Study to Study CP005A|An Optional Two Year Follow Up Study to Evaluate the Continued Efficacy of Cat-PAD ToleroMune Peptide Immunotherapy in Cat Allergic Subjects Following Challenge to Cat Allergen in an Environmental Exposure Chamber|Completed||N/A|51|Actual|Circassia Limited|||3||f||||f||||||||||2017-10-11 02:56:37.530702|2017-10-11 02:56:37.530702
NCT01604005|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-09-10|||July 2012||2012-07-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|PIT||PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma|PIT: A Phase III Randomised Trial of Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma Following Invasive Chest Wall Intervention|Unknown status|Recruiting|Phase 3|374|Anticipated|The Christie NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:56:37.655498|2017-10-11 02:56:37.655498
NCT01603992|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2017-06-30|||November 8, 2005||2005-11-08|May 3, 2012|2012-05-03|May 3, 2012||2012-05-03|||||Observational|||Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms|Quitting Marijuana Use: Self-Report Study of Quitting Strategies and Withdrawal Symptoms|Completed||N/A|1230|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:56:38.003288|2017-10-11 02:56:38.003288
NCT01603979|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2015-04-06|||May 2012||2012-05-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors|A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors|Completed||Phase 1|24|Actual|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 02:56:38.097443|2017-10-11 02:56:38.097443
NCT01603966|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2012-07-14|||April 2012||2012-04-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Low Dose Aspirin Studied With the AggreGuide|Low Dose Aspirin Study With the AggreGuide|Completed||N/A|13|Actual|Aggredyne, Inc.|||1||f||||f||||||None Retained|"     whole blood   "|||2017-10-11 02:56:38.202661|2017-10-11 02:56:38.202661
NCT01603953|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2014-11-17|||January 2009||2009-01-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Observational|BIVA||Bioelectrical Impedance Vector Analysis in Cirrhotic Patients|Malnutrition Assessed Through Bioelectrical Impedance Vector Analysis is Related to Poor Prognosis in Cirrhosis|Completed||N/A|250|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||1||f||||f||||||||||2017-10-11 02:56:38.275894|2017-10-11 02:56:38.275894
NCT01603940|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2015-12-29|2015-08-18||May 2012||2012-05-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|CONTROL||Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine|Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients With Blood Pressure Not Controlled by Amlodipine: Effects on Echocardiographic Parameters, Vascular Stiffness and Endothelial Function.|Completed||Phase 4|30|Actual|Hospital Universitario Pedro Ernesto||2|||f||||f||||||||||2017-10-11 02:56:38.36075|2017-10-11 02:56:38.36075
NCT01603927|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-22|||June 2012||2012-06-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Observational|DISCARD2||Detect InSpect ChAracterise Resect and Discard 2|Detect InSpect ChAracterise Resect and Discard 2|Unknown status|Not yet recruiting|N/A|2500|Anticipated|South Tyneside NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 02:56:38.773207|2017-10-11 02:56:38.773207
NCT01603914|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2012-08-28|||May 2012||2012-05-01|May 2012|2012-05-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|CARB||Central Venous Catheter Replacement Strategies in Adult Patients With Major Burn Injury|Comparison of Three Strategies for Changing of Central Venous Catheters in Patients With Serious Burns for the Prevention of Catheter-associated Bacteremia: Randomized Clinical Trial|Unknown status|Recruiting|N/A|1120|Anticipated|Hospital Universitario Getafe||3|||f||||t||||||||||2017-10-11 02:56:39.56991|2017-10-11 02:56:39.56991
NCT01603901|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2012-05-22|||June 2012||2012-06-01|May 2012|2012-05-01|May 2013|Anticipated|2013-05-01|August 2012|Anticipated|2012-08-01||Interventional|||Regulated Negative Pressure-Assisted Wound Therapy Device||Unknown status|Not yet recruiting|N/A|10|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 02:56:39.771091|2017-10-11 02:56:39.771091
NCT01603888|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2013-09-15|||January 2013||2013-01-01|September 2013|2013-09-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Molecular Forms of Plasma and Urinary B-type Natriuretic Peptide and Its N-terminal Prohormone in Health and Disease in Pediatric Cardiology||Unknown status|Recruiting|N/A|40|Anticipated|Hadassah Medical Organization|||3||f||||||||||||||2017-10-11 02:56:39.878632|2017-10-11 02:56:39.878632
NCT01603875|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2014-01-03|2014-01-03||July 2012||2012-07-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Immune Response in Adults to PrEP and Simulated Booster PEP With a New CPRV|Immune Response in Adults to Pre-exposure Rabies Vaccination and Simulated Post-exposure Rabies Booster Vaccination With a New Chromatographically Purified Vero-cell Rabies Vaccine(SPEEDA®) : a Randomized Controlled Trial With Purified Vero-cell Rabies Vaccine (PVRV)|Completed||N/A|105|Actual|Queen Saovabha Memorial Institute||3|||f||||t||||||||||2017-10-11 02:56:40.019559|2017-10-11 02:56:40.019559
NCT01603862|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-04-25|||January 2010||2010-01-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|ThinkingFit||ThinkingFit: Combined Physical, Cognitive and Social Treatment in Mild Cognitive Impairment (MCI)|Piloting a Complex Intervention Involving Physical Exercise, Cognitive Training and Socialising to Delay the Onset of Dementia in Mild Cognitive Impairment|Completed||N/A|128|Anticipated|North Essex Partnership NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 02:56:40.646809|2017-10-11 02:56:40.646809
NCT01603849|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-03-01|||May 2012||2012-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|PCI||Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis|Randomized Phase II Trial of Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma Clinical Stage IIIB and IV With High Risk of Brain Metastasis|Active, not recruiting||N/A|128|Anticipated|Instituto Nacional de Cancerologia de Mexico||2|||f||||t||||||||No||2017-10-11 02:56:40.73842|2017-10-11 02:56:40.73842
NCT01603823|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2012-05-21|||August 2008||2008-08-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|February 2010|Actual|2010-02-01||Observational|||Angiographie and OCT in Macula and Retinal Diseases||Completed||N/A|30|Actual|Medical University of Vienna|||2||f||||t||||||||||2017-10-11 02:56:40.96929|2017-10-11 02:56:40.96929
NCT01603810|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2012-05-21||||||May 2012|2012-05-01||||||||Observational|||Evaluating In Vivo OCT Imaging for Periocular Basal Cell Carcinoma|An Investigation of the Correlation Between OCT and Histology in Defining the Margins of Periocular Basal Cell Carcinoma|Unknown status|Not yet recruiting|N/A|||Maidstone & Tunbridge Wells NHS Trust|||1||f||||||||||||||2017-10-11 02:56:41.078046|2017-10-11 02:56:41.078046
NCT01603797|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2012-10-02|||February 2010||2010-02-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Guided Internet-delivered Acceptance and Commitment Therapy for Chronic Pain Patients|Guided Internet-delivered Acceptance and Commitment Therapy for Chronic Pain Patients: a Randomized Controlled Trial|Completed||N/A|76|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-11 02:56:41.194549|2017-10-11 02:56:41.194549
NCT01603784|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2014-08-29|||March 2010||2010-03-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|August 2012|Actual|2012-08-01||Interventional|EXACT||Combining Exercise and Cognitive Training to Improve Everyday Function|Combining Exercise and Cognitive Training to Improve Everyday Function|Completed||Phase 3|96|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-10-11 02:56:41.299872|2017-10-11 02:56:41.299872
NCT01603771|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2014-08-29|||June 2011||2011-06-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|NAC||Neural Activation and Connectivity in Response to Exercise and Cognitive Training|Neural Activation and Connectivity in Response to Exercise and Cognitive Training|Completed||N/A|24|Actual|Washington University School of Medicine|||2||f||||f||||||||||2017-10-11 02:56:41.429963|2017-10-11 02:56:41.429963
NCT01603758|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-05-05|||January 2014||2014-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Physiological Study of Human Cholesterol Metabolism and Excretion|Reverse Cholesterol Transport in Humans|Completed||Phase 1|132|Actual|Washington University School of Medicine||2|||f||||f||||||||Undecided|Data will be shared subject to IRB and HIPAA restrictions.|2017-10-11 02:56:41.533085|2017-10-11 02:56:41.533085
NCT01603745|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-19|2012-05-21|||April 2012||2012-04-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome||Unknown status|Recruiting|Phase 1|10|Anticipated|Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-11 02:56:41.657013|2017-10-11 02:56:41.657013
NCT01603732|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-04-03|||January 2010||2010-01-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||"Association Between a Mother's Exposure to Strep Throat and Her Baby's Developing Heart Disease"|Evaluation of Maternal B-hemolytic Streptococcal Pharyngeal Exposure in Pregnancies Affected by Congenital Heart Disease(CHD)|Completed||N/A|397|Actual|Washington University School of Medicine|||4||f||||f||||||Samples With DNA|"     Confirmation of maternal ß-hemolytic streptococcal & enterovirus infection(s) will be     determined from nose and rectal swabs & blood samples assayed for standard marker antibodies     to ß-hemolytic streptococcal & enterovirus exposure.   "|||2017-10-11 02:56:41.801437|2017-10-11 02:56:41.801437
NCT01603719|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2015-12-17|||August 2011||2011-08-01|December 2015|2015-12-01|May 2016|Anticipated|2016-05-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety of an Infant Formula With Milkfat and Prebiotics|Safety and Efficacy of an Infant Starter Formula With Prebiotics (GOS) and a Higher Content of Beta-palmitate on Stool Characteristics, Food Tolerance, Calcium Uptake, and Incidence of Infectious Disease in the First Year of Life|Active, not recruiting||N/A|102|Anticipated|Waldkrankenhaus Protestant Hospital, Spandau||2|||f||||f||||||||||2017-10-11 02:56:41.890359|2017-10-11 02:56:41.890359
NCT01603706|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-07-28|||May 2012||2012-05-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|RAISE-CRT||Radial Strain ECHO-Guided Implantation of Cardiac Resynchronization Therapy|Radial Strain Imaging-Guided Lead Placement for Improving Response to Cardiac Resynchronization Therapy in Patients With Ischemic Cardiomyopathy: A Randomized Clinical Trial|Unknown status|Recruiting|N/A|212|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:56:42.001201|2017-10-11 02:56:42.001201
NCT01603693|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2013-09-08|||June 2012||2012-06-01|March 2012|2012-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Bone Quality and Quantity Following Guided Bone Regeneration Prior to Dental Implant Placement|Bone Quality and Quantity Following Guided Bone Regeneration With Bio-Oss Alone or Combined With BondBone, Prior to Dental Implant Placement|Unknown status|Recruiting|Phase 4|50|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 02:56:42.187575|2017-10-11 02:56:42.187575
NCT01603680|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-08-03|||January 2012||2012-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Distribution Circumferential Versus Non Circumferential of Mepivacaine in the Median and Ulnar Nerves|Circumferential Versus Not Circumferential Distribution of Mepivacaine Around the Median and Ulnar Nerves in the Carpal Tunnel Surgery. Randomized Clinical Trial, Double Blinded.|Completed||Phase 4|124|Actual|Complexo Hospitalario Universitario de A Coruña||2|||f||||t||||||||||2017-10-11 02:56:42.309858|2017-10-11 02:56:42.309858
NCT01603667|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-20|2016-11-03|||June 2012||2012-06-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Pass||PG2 Injection 500 mg in Acute Stroke Study (Pass)|PG2 Injection 500 mg in Acute Stroke Study (Pass): A Randomized, Double-Blind, Placebo-Controlled Study of PG2 Injection 500 mg in Patients With Treatment Started Within 3-6 Hrs of the Onset of Acute Ischemic Stroke|Completed||Phase 2|86|Actual|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 02:56:42.423155|2017-10-11 02:56:42.423155
NCT01603654|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-21|||January 2011||2011-01-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy|A Randomized Controlled Trial Comparing the Efficacy and Acceptability of Sodium Picosulphate/Magnesium Citrate With Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy.|Completed||Phase 4|300|Actual|ASST Fatebenefratelli Sacco||2|||f||||f||||||||||2017-10-11 02:56:42.53418|2017-10-11 02:56:42.53418
NCT01603628|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-09-01|||September 11, 2012|Actual|2012-09-11|September 2017|2017-09-01|June 28, 2017|Actual|2017-06-28|June 28, 2017|Actual|2017-06-28||Interventional|||BOTOX® Treatment in Pediatric Lower Limb Spasticity|BOTOX® Treatment in Pediatric Lower Limb Spasticity: Double-blind Study|Completed||Phase 3|384|Actual|Allergan||3|||f||||t||||||||||2017-10-11 02:56:43.049189|2017-10-11 02:56:43.049189
NCT01546740|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-06|||January 2012||2012-01-01|March 2012|2012-03-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Observational|||Prevalence of Glaucoma in the Israeli Arab Population|Glaucoma Prevalence in the Israeli Arab Population|Unknown status|Recruiting|N/A|15000|Anticipated|Ziv Hospital|||1||f||||t||||||||||2017-10-11 03:13:14.15256|2017-10-11 03:13:14.15256
NCT01603615|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-10-01|||October 30, 2012|Actual|2012-10-30|October 2017|2017-10-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2018|Anticipated|2018-08-01||Interventional|||BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity|BOTOX® Treatment in Pediatric Upper Limb Spasticity: Open-label Study|Active, not recruiting||Phase 3|213|Anticipated|Allergan||1|||f||||t||||||||||2017-10-11 02:56:43.280051|2017-10-11 02:56:43.280051
NCT01603602|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2017-09-01|||July 12, 2012||2012-07-12|September 2017|2017-09-01|July 6, 2017|Actual|2017-07-06|June 29, 2017|Actual|2017-06-29||Interventional|||BOTOX® Treatment in Pediatric Upper Limb Spasticity|BOTOX® Treatment in Pediatric Upper Limb Spasticity: Double-blind Study|Completed||Phase 3|235|Actual|Allergan||3|||f||||t||||||||||2017-10-11 02:56:43.515574|2017-10-11 02:56:43.515574
NCT01603589|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-21|2013-11-27|||January 2009||2009-01-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Comparison of Minimal Versus Conventional Extracorporeal Circulation in Coronary Surgery|Research on Remote End-organ Protection, Clinical Outcome and Quality of Life With Implementation of the Novel Minimal Extracorporeal Circulation Circuit in Open Heart Surgery|Unknown status|Recruiting|N/A|150|Anticipated|AHEPA University Hospital||2|||f||||f||||||||||2017-10-11 02:56:43.747813|2017-10-11 02:56:43.747813
NCT01603576|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-11-14|||May 2012||2012-05-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot Study of a Suprachoroidal Retinal Prosthesis|Safety and Feasibility Study of a Prototype Suprachoroidal Retinal Prosthesis for Vision Restoration|Completed||N/A|3|Actual|Center for Eye Research Australia||1|||f||||||||||||||2017-10-11 02:56:43.850111|2017-10-11 02:56:43.850111
NCT01603563|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-04-23|||July 2011||2011-07-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Stepped Care for Young Children After Trauma|Stepped Care for Young Children After Trauma|Completed||Phase 1/Phase 2|63|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 02:56:43.931032|2017-10-11 02:56:43.931032
NCT01603550|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-10-05|||June 2012||2012-06-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Brain Energy and Cognition|Brain Energy and Cognition|Completed||N/A|31|Actual|United States Army Research Institute of Environmental Medicine||2|||f||||f||||||||Undecided||2017-10-11 02:56:44.028746|2017-10-11 02:56:44.028746
NCT01603537|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-05-18|||January 2011||2011-01-01|May 2012|2012-05-01|September 2012|Anticipated|2012-09-01|May 2012|Anticipated|2012-05-01||Observational|||The Impact of Prehospital Trauma Life Support (PHTLS) on Outcome of Traffic Injury|Impact of Prehospital Trauma Life Support (PHTLS) Training of Ambulance Caregivers on Outcome of Traffic Injury Victims|Unknown status|Active, not recruiting|N/A|40000|Anticipated|Uppsala University Hospital|||2||f||||f||||||||||2017-10-11 02:56:44.10475|2017-10-11 02:56:44.10475
NCT01603524|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2015-06-01|||March 2012||2012-03-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|RCT-OMSC-PC||"Integrating the Ottawa Model for Smoking Cessation Into Primary Care Practice"|"Integrating the Ottawa Model for Smoking Cessation Into Routine Primary Care Practice: A Cluster Randomized Controlled Trial"|Completed||N/A|15|Actual|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-11 02:56:44.191606|2017-10-11 02:56:44.191606
NCT01603511|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2013-04-04|||June 2012||2012-06-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness of Heat Donation Through the Head or Torso on Mild Hypothermic Rewarming|Effectiveness of Heat Donation Through the Head or Torso on Mild Hypothermic Rewarming|Completed||N/A|7|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 02:56:44.278458|2017-10-11 02:56:44.278458
NCT01603498|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-21|||April 2011||2011-04-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Dexamethasone and Methylprednisolone on Pain, Swelling and Trismus After Third Molar Surgery|Preemptive Effect of Dexamethasone and Methylprednisolone on Pain, Swelling and Trismus After Third Molar Surgery: a Split-mouth Randomized Triple-blind Clinical Trial|Completed||N/A|18|Actual|Federal University of the Valleys of Jequitinhonha and Mucuri||2|||f||||t||||||||||2017-10-11 02:56:44.359259|2017-10-11 02:56:44.359259
NCT01603485|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-09-18|||June 2012||2012-06-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects|Open-Label, Randomized, Crossover Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-Release Lersivirine (UK-453,061) 500 mg in Healthy Subjects|Completed||Phase 1|16|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 02:56:44.468304|2017-10-11 02:56:44.468304
NCT01603472|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2013-07-26|||May 2012||2012-05-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|||Markers of Bone Disease in Children on Parenteral Nutrition|Markers of Parenteral Nutrition (PN) Associated Metabolic Bone Disease in Children on Long-Term PN for Intestinal Failure.|Completed||N/A|38|Actual|The Hospital for Sick Children|||2||f||||f||||||||||2017-10-11 02:56:44.561452|2017-10-11 02:56:44.561452
NCT01603459|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-03-27|2016-07-26|2015-09-10|May 2012||2012-05-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||The safety evaluation set (SES) is the subset of all subjects who were exposed to study medication at least once.|Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm|Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes|Completed||Phase 3|155|Actual|Merz Pharmaceuticals GmbH||1|||f||||t||||||||||2017-10-11 02:56:44.727234|2017-10-11 02:56:44.727234
NCT01603446|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2013-12-13|||May 2012||2012-05-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome|Pilot Study to Investigate the Efficacy of L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome.|Completed||Phase 2|7|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 02:56:47.534727|2017-10-11 02:56:47.534727
NCT01603433|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-04-29|||July 2011||2011-07-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2012|Actual|2012-07-01||Interventional|||The Sapheon Closure System Feasibility Study|The Sapheon Closure System Feasibility Study|Completed||N/A|38|Actual|Medtronic Endovascular||1|||f||||t||||||||No||2017-10-11 02:56:47.634482|2017-10-11 02:56:47.634482
NCT00005233|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1988||1988-09-01|July 2002|2002-07-01|August 1992|Actual|1992-08-01|||||Observational|||Patterns of Fatty Acids in Framingham Offspring||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.666824|2017-10-11 04:26:39.666824
NCT01603420|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-02-11|2015-07-31||July 2012||2012-07-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer|Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate|Terminated||Phase 2/Phase 3|2|Actual|Proton Collaborative Group||2||enrollment goals not met|f||||t||||||||||2017-10-11 02:56:47.747033|2017-10-11 02:56:47.747033
NCT01603407|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-01-04|||January 2013||2013-01-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|FOR-DMD||Finding the Optimum Regimen for Duchenne Muscular Dystrophy|Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen|Active, not recruiting||Phase 3|196|Actual|University of Rochester||3|||f||||t||||||||No||2017-10-11 02:56:48.407474|2017-10-11 02:56:48.407474
NCT01603394|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2014-06-06|2014-06-06||October 2012||2012-10-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia|A Phase 4 Multicenter, Open-Label, Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia|Terminated||Phase 4|9|Actual|Pfizer|Outcome measure PCS was removed in protocol amendment1. Study stopped due to low enrolment and not safety. Efficacy analyses were not performed; safety results are described. Overall risk-benefit of pregabalin has not changed due to trial termination|1||See termination reason in detailed description.|f||||f||||||||||2017-10-11 02:56:48.625877|2017-10-11 02:56:48.625877
NCT01603381|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-10-02|||June 2012||2012-06-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The Effect of Family History on Insomnia During Sobriety in Alcoholics|The Effect of Family History on Insomnia During Sobriety in Alcoholics|Completed||N/A|22|Actual|Corporal Michael J. Crescenz VA Medical Center||2|||f||||f||||||||||2017-10-11 02:56:49.08525|2017-10-11 02:56:49.08525
NCT01603355|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-07-07|||November 2013||2013-11-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis|An Open-label Trial to Assess the Efficacy and Safety of Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Vision-threatening Uveitis That is Refractory to Other Modes of Systemic Immunosuppression|Terminated||Phase 1/Phase 2|3|Actual|Oregon Health and Science University||1||insufficient enrollment|f||||||||||||||2017-10-11 02:56:49.291482|2017-10-11 02:56:49.291482
NCT01603342|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-11-23|||December 2007||2007-12-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers|A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers|Completed||Phase 1|18|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:56:49.39772|2017-10-11 02:56:49.39772
NCT01603329|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2015-10-22|||June 2012||2012-06-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Increasing Medication Adherence Through Physician Incentives and Messaging|Increasing Medication Adherence Through Physician Incentives and Messaging|Completed||N/A|734|Actual|National Bureau of Economic Research, Inc.||11|||f||||f||||||||||2017-10-11 02:56:49.510771|2017-10-11 02:56:49.510771
NCT01603316|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-07-11|||May 8, 2012|Actual|2012-05-08|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Food: A Three-Arm Study Examining Food Insecurity Interventions|Food: A Three-Arm Randomized Controlled Study Examining Food Insecurity Interventions|Recruiting||Phase 2|120|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-11 02:56:49.634068|2017-10-11 02:56:49.634068
NCT01603303|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-08-15|||December 5, 2012|Actual|2012-12-05|August 2017|2017-08-01|August 11, 2017|Actual|2017-08-11|August 11, 2017|Actual|2017-08-11||Interventional|||Preventing Sexual Dysfunction With Aromatase Inhibitors|Preventing Sexual Dysfunction in Women on Aromatase Inhibitors|Completed||Phase 2|187|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 02:56:49.771461|2017-10-11 02:56:49.771461
NCT01603290|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-05-18|||December 2011||2011-12-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Observational|||Change of Fatigue and Physical Fitness in Hospitalized Hematology Patients|Change of Fatigue and Physical Fitness and Their Related Factors in Hospitalized Hematology Patients|Unknown status|Enrolling by invitation|N/A|130|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:56:49.889772|2017-10-11 02:56:49.889772
NCT01603277|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2015-01-30|2015-01-12||July 2012||2012-07-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|KB003-04||Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids|A Phase 2, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids|Completed||Phase 2|160|Actual|KaloBios Pharmaceuticals||2|||f||||t||||||||||2017-10-11 02:56:49.980518|2017-10-11 02:56:49.980518
NCT01603264|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-12-15|||May 2012||2012-05-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01)|Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study Of PF-05280014 And Trastuzumab Sourced From US And EU Administered To Healthy Male Volunteers|Completed||Phase 1|105|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:56:50.752574|2017-10-11 02:56:50.752574
NCT01603251|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2013-04-17|||January 2013||2013-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ACTIVE||Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission|A Double Blind Randomized Controlled Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission|Completed||Phase 1/Phase 2|120|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-10-11 02:56:50.845897|2017-10-11 02:56:50.845897
NCT00005234|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1988||1988-09-01|April 2000|2000-04-01|August 1993|Actual|1993-08-01|||||Observational|||Cardiovascular Disease in Black Versus White Physicians||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.710234|2017-10-11 04:26:39.710234
NCT01603238|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-21|||May 2011||2011-05-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444|An Open Label, Single-Dose, Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444|Completed||Phase 1|6|Actual|LG Life Sciences||1|||f||||||||||||||2017-10-11 02:56:50.944336|2017-10-11 02:56:50.944336
NCT01603225|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-03-21|||October 2015||2015-10-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|October 2020|Anticipated|2020-10-01||Observational|||Transcranial Direct Current Stimulation and Autism|The Use of Transcranial Direct Current Stimulation (tDCS) to Improve Communicative Efforts, Speech, Language and Related Cognitive Functions in Individuals With Autism|Recruiting||N/A|40|Anticipated|Johns Hopkins University|||1||f||||t||||||||||2017-10-11 02:56:51.322437|2017-10-11 02:56:51.322437
NCT01603212|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-07-06|||July 18, 2013|Actual|2013-07-18|July 2017|2017-07-01|July 5, 2017|Actual|2017-07-05|July 5, 2017|Actual|2017-07-05||Interventional|||Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor|Systemic Therapy of Metastatic Melanoma With Multidrug Regimen Including Interferon, Interleukin-2 and BRAF Inhibitor|Completed||Phase 1/Phase 2|6|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 02:56:51.420562|2017-10-11 02:56:51.420562
NCT01603199|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-06-07|||September 2011||2011-09-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|July 2015|Actual|2015-07-01||Interventional|||High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis|Impact of a High-protein High-fiber Diet on the Nutritional Status of Patients With Primary Biliary Cirrhosis|Completed||N/A|36|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||||2017-10-11 02:56:51.529264|2017-10-11 02:56:51.529264
NCT01603186|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-07-05|||April 2011||2011-04-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition|A Randomized, Open Label, Two-Treatment, Two-Period, Two-Sequence, Crossover, Single Dose, Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg With Seroquel® 25 mg in Normal, Healthy, Adult, Human Subjects, Under Fed Condition|Completed||Phase 1|54|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:56:51.623971|2017-10-11 02:56:51.623971
NCT01603173|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-05-21|||April 2011||2011-04-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition|A Randomized, Open Label, Two-Treatment, Two-Period, Two-Sequence, Crossover, Single Dose, Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg With Seroquel® 25 mg in Normal, Healthy, Adult, Human Subjects, Under Fasting Condition|Completed||Phase 1|54|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:56:51.706817|2017-10-11 02:56:51.706817
NCT01603160|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-03-04|||September 2011||2011-09-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Improving Emergency Department Management of Adults With Sickle Cell Disease|Improving Emergency Department Management of Adults With Sickle Cell Disease|Completed||N/A|715|Actual|Duke University|||1||f||||t||||||||||2017-10-11 02:56:51.782113|2017-10-11 02:56:51.782113
NCT01603147|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2014-05-12|||April 2012||2012-04-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety Study of Ch-mAb7F9 for Methamphetamine Abuse|A Phase Ia, Double-blind, Randomized, Placebo-controlled, Ascending IV Single-dose Study to Evaluate the Safety and Pharmacokinetics of ch mAb7F9 in Healthy Subjects|Completed||Phase 1|42|Actual|InterveXion Therapeutics, LLC||2|||f||||t||||||||||2017-10-11 02:56:51.876397|2017-10-11 02:56:51.876397
NCT01603134|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-05-21|||November 2007||2007-11-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition|A Randomized, Open Label, Two-Period, Two-Treatment, Two-Sequence, Single Dose, Crossover Comparative Bioequivalence Study of Allopurinol 300 mg Tablets USP With Zyloprim® 300 mg in Normal, Healthy, Adult, Human Male Subjects Under Fasting Condition.|Completed||Phase 1|32|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 02:56:51.982877|2017-10-11 02:56:51.982877
NCT01603121|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2016-08-10|2015-03-22||February 2012||2012-02-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||All subjects enrolled into the study were included in the baseline analysis.|Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus|A Safety, Tolerability and Bioavailability Study of Lisofylline After Continuous Subcutaneous (12 mg/kg) and Intravenous (9 mg/kg) Administration in Subjects With Type 1 Diabetes Mellitus|Terminated||Phase 1/Phase 2|1|Actual|Eastern Virginia Medical School|Early termination due to difficulty recruiting subjects.|2||Unable to enroll sufficient number of subjects|f||||t||||||||||2017-10-11 02:56:52.075984|2017-10-11 02:56:52.075984
NCT01603108|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-04-21|||March 2012||2012-03-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|Rifaximin||Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant|Prospective Randomized Double Blind Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent Recurrent Fibrosis in Liver Transplant Recipients With Chronic Hepatitis C Virus Infection|Active, not recruiting||Phase 2|59|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 02:56:52.407401|2017-10-11 02:56:52.407401
NCT01603095|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-09-26|||April 2012||2012-04-01|September 2017|2017-09-01|February 2025|Anticipated|2025-02-01|October 2024|Anticipated|2024-10-01||Observational|||A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia|A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia|Enrolling by invitation||N/A|250|Anticipated|BioMarin Pharmaceutical|||1||f||||f||||||||||2017-10-11 02:56:52.52056|2017-10-11 02:56:52.52056
NCT01603082|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2015-11-09|2015-06-01||July 2012||2012-07-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Randomized Analysis Set, defined as all participants who signed informed consent, who provided demographic and/or baseline screening assessments, and who were randomized into the study regardless of the participant's randomization and treatment status in the study.|Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients|A Randomized, Open-label Study to Compare the Platelet Inhibition With VerifyNow Assay of Ticagrelor Versus Clopidogrel in Troponin Negative Acute Coronary Syndrome Subjects Undergoing Ad Hoc Percutaneous Coronary Intervention|Completed||Phase 4|343|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 02:56:52.665576|2017-10-11 02:56:52.665576
NCT01603069|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2013-07-18|||October 2012||2012-10-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease|A Phase IIa, 12 Week, Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease|Completed||Phase 2|51|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 02:56:53.287481|2017-10-11 02:56:53.287481
NCT01603056|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-03-29|2015-09-07||October 2009||2009-10-01|March 2016|2016-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Full Analysis Set|Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis|A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Clinical Trial Investigating the Efficacy and Safety of Pangramin SLIT HDM-mix in Chinese Population With House Dust Mite Induced Rhinitis With or Without Asthma.|Completed||Phase 3|617|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-10-11 02:56:53.475086|2017-10-11 02:56:53.475086
NCT01603043|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2013-12-03|2013-12-03||June 2012||2012-06-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)|A Multicenter, Randomized, Single-Masked, Sham-Controlled, Proof-of-Concept Study of Intravitreal AL-78898A in Patients With Bilateral Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)|Terminated||Phase 2|10|Actual|Alcon Research||2||Management Decision|f||||t||||||||||2017-10-11 02:56:54.342532|2017-10-11 02:56:54.342532
NCT01603030|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-22|2012-05-21|||June 2012||2012-06-01|May 2012|2012-05-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|||Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation|Efficacy of Moxifloxacin 0.5%/Prednisolone 1% Fixed Combination Compared With Individual Administration of Moxifloxacin 0.5% and Prednisolone 1% in the Prevention of Post Operative Inflammation in Patients Having Lasik Surgery|Unknown status|Not yet recruiting|Phase 3|66|Anticipated|Adapt Produtos Oftalmológicos Ltda.||2|||f||||t||||||||||2017-10-11 02:56:54.71389|2017-10-11 02:56:54.71389
NCT01603017|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-05-17|||September 2007||2007-09-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Nuclear Magnetic Resonance Therapy in Knee Osteoarthrosis|Nuclear Magnetic Resonance Therapy in Knee Osteoarthrosis: A Double Blind Ranomised Controlled Trial|Completed||N/A|100|Actual|NHS Grampian||2|||f||||t||||||||||2017-10-11 02:56:54.852799|2017-10-11 02:56:54.852799
NCT01603004|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-09-25|||May 2012|Actual|2012-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors|A Pilot Study to Identify Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors|Recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 02:56:54.959051|2017-10-11 02:56:54.959051
NCT01602991|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-09-22|||May 2012||2012-05-01|September 2015|2015-09-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|EGScan||Clinic-based Nasopharyngoesophagogastroscopy Following Bariatric Surgery|Sensitivity, Specificity, and Positive and Negative Predictive Values of Clinic-based Nasopharyngoesophagogastroscopy Following Bariatric Surgery|Withdrawn||N/A|0|Actual|McMaster University||1||difficulty obtaining funding|f||||f||||||||||2017-10-11 02:56:55.075385|2017-10-11 02:56:55.075385
NCT01602978|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-08-22|||February 2010||2010-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|Pleth||Comparison of Pulse Hemoglobin and Pleth Variability Index|Comparison of Pulse Hemoglobin and Pleth Variability Index to Standard Methods of Guiding Intraoperative Fluid and Transfusion Management During Major Surgical Procedures.|Active, not recruiting||N/A|240|Actual|Loma Linda University|||1||f||||f||||||||||2017-10-11 02:56:55.176036|2017-10-11 02:56:55.176036
NCT01602965|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-04-20|2017-02-03||September 2012||2012-09-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Effectiveness Between Nutritional Counseling Monthly Phone Call Versus Self Help Informative Booklet|Personalized Nutritional Program Plus a Nutritional Counseling Monthly Phone Call Versus a Personalized Nutritional Program With Self Help Informative Booklet|Completed||N/A|40|Actual|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-11 02:56:55.24564|2017-10-11 02:56:55.24564
NCT01602952|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-03-08|||July 2008||2008-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|October 2012|Actual|2012-10-01||Interventional|||Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI|A Phase I/II Multicenter Study of IY5511HCl in Philadelphia Chromosome Positive Chronic Myeloid Leukemia Patients Without Optimal Response or Tolerance to Bcr-Abl Tyrosine Kinase Inhibitors (Imatinib and/ or Dasatinib, Nilotinib)|Active, not recruiting||Phase 1/Phase 2|85|Actual|Il-Yang Pharm. Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:56:55.530966|2017-10-11 02:56:55.530966
NCT01602939|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-08-26|||May 2012||2012-05-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis|Subcutaneous Cladribine Plus Pegylated Interpheron Alfa-2a in Advanced Systemic Mastocytosis With D816V and Other Exon 17 KIT Mutations.|Recruiting||Phase 2/Phase 3|10|Anticipated|Hospital Virgen de la Salud||1|||f||||f||||||||Undecided||2017-10-11 02:56:55.878969|2017-10-11 02:56:55.878969
NCT01602926|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-08-24|||August 2012||2012-08-01|August 2012|2012-08-01|September 2018|Anticipated|2018-09-01|September 2015|Anticipated|2015-09-01||Interventional|Minibunion||Prospective Trial of Minimally Invasive Surgery Versus Standard Surgery for Correction of Hallux Valgus|Randomized Prospective Trial of Minimally Invasive Surgery Versus Standard Surgery for Correction of Hallux Valgus.|Recruiting||N/A|100|Anticipated|Henry DeGroot, M.D.||2|||f||||f||||||||||2017-10-11 02:56:55.97659|2017-10-11 02:56:55.97659
NCT01602913|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-06-30|||December 2011||2011-12-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine|Incident Type II Diabetes Mellitus Among Patients Exposed to the Combination of Pravastatin and Paroxetine|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 02:56:56.116379|2017-10-11 02:56:56.116379
NCT01602224|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2014-11-25||2014-09-29|July 2012||2012-07-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Study of Tabalumab in Participants With Previously Treated Multiple Myeloma (MM)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Tabalumab in Combination With Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma|Completed||Phase 2|181|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-10-11 02:57:12.29645|2017-10-11 02:57:12.29645
NCT01602900|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-06-19|||November 22, 2011|Actual|2011-11-22|June 2017|2017-06-01|April 12, 2012|Actual|2012-04-12|April 12, 2012|Actual|2012-04-12||Interventional|||Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease|An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain PDE4 Engagement, Pharmacokinetics and Safety of Single Oral Doses of GSK356278, Using 11C-(R)-Rolipram as a PET Ligand(s)|Completed||Phase 1|8|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:56:56.218352|2017-10-11 02:56:56.218352
NCT01602887|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-11-08|||May 2012||2012-05-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Relative Bioavailability Study|A Single Dose Open-Label Relative Bioavailability Study Comparing Two Capsule And A Solution Formulation Of PD-0332991 To The PD-0332991 Isethionate Capsule In Healthy Volunteers|Completed||Phase 1|24|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 02:56:56.314112|2017-10-11 02:56:56.314112
NCT01602874|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2013-02-21|||January 2011||2011-01-01|February 2013|2013-02-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia|Multicenter, Randomized, And Double-Blind Study To Evaluate The Safety Of Tigecycline Versus A Ceftriaxone Regimen In The Treatment Of Complicated Intra-Abdominal Infections And Community-Acquired Pneumonia In Subjects Of 8-17 Years|Withdrawn||Phase 3|0|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 02:56:56.425511|2017-10-11 02:56:56.425511
NCT01602861|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-01-23|||February 2013||2013-02-01|January 2014|2014-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|SPIREN||The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity|The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity|Unknown status|Enrolling by invitation|Phase 4|170|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 02:56:56.526826|2017-10-11 02:56:56.526826
NCT01602848|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-05-18|||August 2009||2009-08-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|September 2011|Actual|2011-09-01||Interventional|||A Patient Centered Intervention to Improve Health and Reduce Medicaid Costs|A Patient Centered Intervention to Improve Health and Reduce Medicaid Costs|Unknown status|Active, not recruiting|N/A|1000|Anticipated|New York City Health and Hospitals Corporation||2|||f||||f||||||||||2017-10-11 02:56:56.628759|2017-10-11 02:56:56.628759
NCT01602835|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-02-10|||September 2012||2012-09-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Human Urine Sample Collection for Alport Nephropathy Biomarker Studies|Human Urine Sample Collection for Alport Nephropathy Biomarker Studies|Terminated||N/A|80|Actual|Novartis|||1||f||||t||||||None Retained|"     urine   "|||2017-10-11 02:56:56.745937|2017-10-11 02:56:56.745937
NCT01602809|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-06-30|||April 27, 2012||2012-04-27|December 7, 2016|2016-12-07||||||||Observational|||Microvessels and Heart Problems in Sickle Cell Disease|Microvascular and Cardiac Dysfunction in Sickle Cell Disease|Completed||N/A|65|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:56:57.03653|2017-10-11 02:56:57.03653
NCT01602796|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2012-05-18|||September 2011||2011-09-01|May 2012|2012-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|ITACA||Effectiveness of Intervention on Reducing the Prevalence of Smoking Among Adolescents|Effectiveness of a Complex Intervention on Reducing the Prevalence of Smoking Among Adolescents: a Cluster Randomized Control Trial|Unknown status|Recruiting|N/A|2226|Anticipated|Fundació d'investigació Sanitària de les Illes Balears||2|||f||||f||||||||||2017-10-11 02:56:57.141141|2017-10-11 02:56:57.141141
NCT01602783|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-03-17|||December 2011||2011-12-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||11C Acetate Imaging Post Prostatectomy|Use of 11C Acetate Imaging for Improved Prediction of the Effectiveness of Salvage Pelvic Radiation Post Prostatectomy: A Pilot Study|Terminated||N/A|2|Actual|Massachusetts General Hospital||1||Slow accrual; no further funding|f||||t||||||||||2017-10-11 02:56:57.277132|2017-10-11 02:56:57.277132
NCT01602770|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-09-29|||July 27, 2015|Actual|2015-07-27|September 2017|2017-09-01|July 31, 2018|Anticipated|2018-07-31|January 15, 2018|Anticipated|2018-01-15||Observational|||Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy|Prospective, Non-interventional, 2-year Post-authorization Safety Study for QLAIRA®|Recruiting||N/A|300|Anticipated|Bayer|||1||f||||f||||||||||2017-10-11 02:56:57.410271|2017-10-11 02:56:57.410271
NCT01602757|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-10-15|||February 2010||2010-02-01|October 2012|2012-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Pharmacokinetic Study of Synera in Healthy Volunteers|An Open-Label Pharmacokinetic Study of the Synera Patch Applied for 2-, 4-, and 12-hours and a Lidocaine/Tetracaine Patch Without Heat Applied for 4 Hours in Healthy Adult Volunteers|Completed||Phase 1|12|Actual|ZARS Pharma Inc.||1|||f||||f||||||||||2017-10-11 02:56:57.537276|2017-10-11 02:56:57.537276
NCT01602744|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2014-03-23|2013-11-24||April 2012||2012-04-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|STOPP|All residents in the geriatric facility (382) were recruited for the trial. 23 were excluded for not fulfilling study entry criteria. The final study group was comprised of 359 residents. Residents were randomized to recieve either STOPP/START screening (intervention, n=183) or usual care (control, n=176).|The Use of STOPP/START Criteria for Medication Intervention Among Elderly Population Living in a Geriatric Hospital|The Use of STOPP/START Criteria for Medication Intervention and the Risk of Falls, Hospitalization, Functioning and Quality of Life Among Elderly Population Living in a Geriatric Hospital in Israel and Comparison to Beers|Completed||N/A|382|Actual|Wolfson Medical Center|The limitations of the study were that it was conducted in a single geriatric center. This precludes the possibility of generalizing its findings to other older segments of the community.|2|||f||||f||||||||||2017-10-11 02:56:57.657299|2017-10-11 02:56:57.657299
NCT01602731|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2015-10-07|2015-04-22||October 2012||2012-10-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|TARGET||Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With HF (TARGET)|Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With Heart Failure|Completed||N/A|45|Actual|VA Office of Research and Development|Low enrollment in the study reflects the fact that many patients with HF do not admit the need for assistance with their medications. Patients should first be tested for the presence of cognitive impairment and baseline medication adherence problems.|1|||f||||f||||||||||2017-10-11 02:56:58.101174|2017-10-11 02:56:58.101174
NCT01602718|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-11-16|||June 2012||2012-06-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Physical Activity and Functioning in Home Dialysis Patients|Physical Activity and Functioning in Home Dialysis Patients|Completed||N/A|120|Actual|University of Utah||3|||f||||f||||||||||2017-10-11 02:56:58.434341|2017-10-11 02:56:58.434341
NCT01602705|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-10-05|||June 2012||2012-06-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|EFIPPS||Effective Feedback to Improve Primary Care Prescribing Safety|Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS): a Randomised Controlled Trial Using ePrescribing Data|Completed||N/A|262|Actual|University of Dundee||3|||f||||f||||||||||2017-10-11 02:56:58.53556|2017-10-11 02:56:58.53556
NCT01602692|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-10-06|||August 2012||2012-08-01|October 2015|2015-10-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||A Comparison of Tumescence in Breast Reduction Surgery|A Comparison of Tumescence in Breast Reduction Surgery|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 02:56:58.640676|2017-10-11 02:56:58.640676
NCT01602679|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-02-23|||May 2012||2012-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Acute Effects of Progesterone on LH Pulses During the Follicular Phase (CRM006)|Acute Effects of Progesterone on LH Pulses During the Follicular Phase|Active, not recruiting||Phase 1|36|Anticipated|University of Virginia||2|||f||||t|t|f||||||Undecided|We do not have current plans to share IPD|2017-10-11 02:56:58.745359|2017-10-11 02:56:58.745359
NCT01602666|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-18|2017-02-08|||May 2012||2012-05-01|February 2017|2017-02-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Interventional|||Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors|Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)|Active, not recruiting||Phase 2|247|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 02:56:58.851746|2017-10-11 02:56:58.851746
NCT01602653|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-18|||November 2008||2008-11-01|May 2012|2012-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels|Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels|Completed||N/A|46|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 02:56:59.174098|2017-10-11 02:56:59.174098
NCT01602640|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-05-17|||January 2009||2009-01-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Comparison of Morphine and Fentanyl/Midazolam in Intensive Care Unit|Sedation and Analgesia in Intensive Care: Comparison of Morphine and Fentanyl/Midazolam|Completed||N/A|90|Actual|Clínica de Los Andes IPS||2|||f||||f||||||||||2017-10-11 02:56:59.262124|2017-10-11 02:56:59.262124
NCT01602627|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2013-02-06|||September 2011||2011-09-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies|A Phase I Dose Escalation, Single Center, Open-Label Study of AUY922 Administered IV on a Once-Weekly Schedule in Adult Patients 75 Years of Age or Older With Advanced Solid Malignancies|Terminated||Phase 1|2|Actual|Case Comprehensive Cancer Center||1||Slow accrual|f||||t||||||||||2017-10-11 02:56:59.345814|2017-10-11 02:56:59.345814
NCT01602614|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-05-23|||April 2013||2013-04-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|Gan Premie||Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection|Evaluation of the Pharmacokinetics and Pharmacodynamics of Ganciclovir in Premature Infants Receiving Treatment for Cytomegalovirus Infection|Recruiting||N/A|32|Anticipated|University of Alabama at Birmingham|||4||f||||t||||||Samples Without DNA|"     Remnant blood will be retained for future CMV studies if subjects/subject families consent to     future use. IRB approval for any future studies of remnant specimens will be required.   "|||2017-10-11 02:56:59.441934|2017-10-11 02:56:59.441934
NCT01602601|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-09-21|||April 9, 2012|Actual|2012-04-09|September 2017|2017-09-01|June 11, 2012|Actual|2012-06-11|June 11, 2012|Actual|2012-06-11||Observational|||A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723|A Study to Test the Possibility of Cross Reaction of the Antibodies Induced by the ELAPRASE (R) to GSK2788723 ELAPRASE is a Trade Mark Owned by a Third Party|Completed||N/A|10|Actual|GlaxoSmithKline|||1||f||||f||||||Samples With DNA|"     blood samples will be collected and serum will be analyzed and retained   "|||2017-10-11 02:56:59.601389|2017-10-11 02:56:59.601389
NCT01602588|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-11-07|||May 2013||2013-05-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|HCQ||A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)|A Randomised Phase 2 Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)|Active, not recruiting||Phase 2|54|Actual|University College, London||2|||f||||t||||||||||2017-10-11 02:56:59.70157|2017-10-11 02:56:59.70157
NCT01602575|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-03-14|||January 2013||2013-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Neuroimaging and Biomarkers in Chronic Visceral Pain|Neuroimaging Biomarkers of Mind-Body Treatment Response in Chronic Visceral Pain|Active, not recruiting||N/A|90|Anticipated|University of California, Los Angeles||1|||f||||t||||||||Yes|Neuroimaging data will be shared after initial analysis and publication at pain.ucla.edu to members of the Pain repository|2017-10-11 02:56:59.811982|2017-10-11 02:56:59.811982
NCT01539356|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-03-15|||March 2012||2012-03-01|November 2012|2012-11-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Observational|||Hepcidin Levels in Preterm Infants|Hepcidin Levels in Preterm Infants Receiving Blood Transfusion and During Sepsis.|Completed||N/A|62|Actual|Meir Medical Center|||1||f||||f||||||||||2017-10-11 03:15:28.720061|2017-10-11 03:15:28.720061
NCT01602562|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-11-18|2014-01-09||May 2012||2012-05-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients|A Multicenter, Open-label Study to Evaluate Preventive Efficacy for Herpes Simplex Virus Infection and Safety of 256U87 (Valaciclovir Hydrochloride) in Adult and Pediatric Hematopoietic Stem Cell Transplantation Patients|Completed||Phase 3|40|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 02:56:59.956975|2017-10-11 02:56:59.956975
NCT01602549|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-12-12|2016-12-12||July 2012||2012-07-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||"The GSK962040 data include 37 subjects who received the 50-mg dose and 1 subject who received the 125-mg dose in the baseline description."|A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying|A Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying|Completed||Phase 2|58|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 02:57:01.754441|2017-10-11 02:57:01.754441
NCT01602536|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2015-12-04|||January 2012||2012-01-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Twitter-enabled Mobile Messaging for Smoking Relapse Prevention|Twitter-enabled Mobile Messaging for Smoking Relapse Prevention|Completed||N/A|280|Actual|University of California, Irvine||2|||f||||f||||||||||2017-10-11 02:57:04.68313|2017-10-11 02:57:04.68313
NCT01602523|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-12-06|||March 2011||2011-03-01|December 2012|2012-12-01|August 2014|Anticipated|2014-08-01|April 2014|Anticipated|2014-04-01||Interventional|||Effect of Symbicort on Sleep Quality in Patients With Emphysema|Effect of Symbicort on Sleep Quality in Patients With Emphysema|Unknown status|Active, not recruiting|Phase 3|40|Anticipated|Temple University||2|||f||||f||||||||||2017-10-11 02:57:04.767006|2017-10-11 02:57:04.767006
NCT01602510|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-11-29|2016-09-19||August 2012||2012-08-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Lamotrigine Phase III Study in Bipolar I Disorder|A Fixed-Dose Study of Lamotrigine Versus Placebo in the Long Term Prevention of Relapse and/or Recurrence of a Manic, Hypomanic, Mixed or Depressive Episode in Adult Subjects With Bipolar I Disorder|Completed||Phase 3|265|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:57:04.883425|2017-10-11 02:57:04.883425
NCT01602497|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-05-18|||February 2012||2012-02-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|||Trial of Effect of High-frequency Transcranial Magnetic Stimulation in the Management of Borderline Personality Disorder|A Sham-controlled Trial of Effect of High-frequency Transcranial Magnetic Stimulation in the Management of Borderline Personality Disorder Patients|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:57:05.861142|2017-10-11 02:57:05.861142
NCT01602484|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-03-14|2013-02-15||October 2011||2011-10-01|March 2017|2017-03-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Application Time of Plaster-of-Paris Splint Packs Compared to Bulk Supplies Following Standard Orthopaedic Procedure|Application Time of Plaster-of-Paris Splint Packs Compared to Bulk Supplies Following Standard Orthopaedic Procedure|Completed||N/A|50|Actual|Brigham and Women's Hospital|Splinting for one patient was interrupted secondary to airway issues unrelated to the study, so this subject was excluded from the study.|2|||f||||t|f|t|f|f||||No||2017-10-11 02:57:05.970575|2017-10-11 02:57:05.970575
NCT01602471|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-07-26|2013-07-26||May 2012||2012-05-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Five participants enrolled, four complete and one withdrawal prior to receiving the investigational prodcut. Study was terminated early by the sponsor.|[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis|An Exploratory, Phase II, Open Label, Single-Center, Non-Randomized Study Of [F-18] RGD-K5 Positron Emission Tomography (PET) In Participants With Carotid Artery Stenosis|Terminated||Phase 2|5|Actual|Siemens Molecular Imaging||1||Sponsor decided to develop the product in collaboration|f||||f||||||||||2017-10-11 02:57:06.300342|2017-10-11 02:57:06.300342
NCT01602458|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-05-13|||May 2011||2011-05-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Randomized Control Trial for Preventative Scar Management|The Use of Pressure and Silicone in Children With Skin Grafts After Traumatic Skin Injury: A Randomized Control Trial for Preventative Scar Management|Completed||N/A|12|Actual|Seton Healthcare Family||2|||f||||t||||||||||2017-10-11 02:57:06.4696|2017-10-11 02:57:06.4696
NCT01602445|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-05-09|||July 2012||2012-07-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|REMARK||Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism|Analysis of Pro-coagulant and Thrombin-generation Markers for the Prediction of Therapeutic Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism: A Pilot Study|Completed||N/A|700|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||Samples With DNA|"     Serum specimens Optional DNA banking   "|Undecided||2017-10-11 02:57:06.564904|2017-10-11 02:57:06.564904
NCT01602432|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2014-09-08|||November 2012||2012-11-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients|Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients|Completed||N/A|143|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||||||2017-10-11 02:57:06.672067|2017-10-11 02:57:06.672067
NCT01602419|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-08-10|||October 2012|Actual|2012-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease|Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease|Active, not recruiting||N/A|50|Anticipated|Octapharma|||1||f||||f||||||Samples Without DNA|"     Serum Samples   "|||2017-10-11 02:57:06.760516|2017-10-11 02:57:06.760516
NCT01602406|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-09-07|||September 21, 2012|Actual|2012-09-21|September 2017|2017-09-01|August 2, 2017|Actual|2017-08-02|August 2, 2017|Actual|2017-08-02||Interventional|||Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer|A Multicenter, Open-label, Dose Escalation, Phase I Study of LJM716 Administered Intravenously in Combination With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast Cancer or Gastric Cancer|Completed||Phase 1|64|Actual|Novartis||1|||f||||f|t|f||||||||2017-10-11 02:57:06.86681|2017-10-11 02:57:06.86681
NCT01602380|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-06-30|2017-03-23||October 17, 2012|Actual|2012-10-17|June 2017|2017-06-01|February 12, 2018|Anticipated|2018-02-12|April 11, 2016|Actual|2016-04-11||Interventional|FALCON|The intention to treat (ITT) analysis set included all randomised patients.|A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.|A Randomised, Double-blind, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX) 500 mg With Anastrozole (ARIMIDEX) 1 mg as Hormonal Treatment for Postmenopausal Women With Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Been Treated With Any Hormonal Therapy.|Active, not recruiting||Phase 3|462|Actual|AstraZeneca|This study consists of a primary analysis and a survival follow-up phase. Only results for the primary analysis phase are currently reported. The OS results data will be presented at a later date once the survival follow-up phase is completed.|2|||f||||||||||||||2017-10-11 02:57:08.801517|2017-10-11 02:57:08.801517
NCT01602367|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2015-09-23||2015-09-23|July 2012||2012-07-01|September 2015|2015-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2B Trial to Evaluate the Safety and Efficacy of BMS-823778 in Overweight and Obese Subjects With Inadequately Controlled Hypertension|Terminated||Phase 2|7|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 02:57:10.10263|2017-10-11 02:57:10.10263
NCT01602354|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-06-27|||April 2012||2012-04-01|June 2012|2012-06-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Observational|||Endotoxin in Gram-negative Septic Shock|Endotoxin Activity Assay as a Prognostic Factor in Gram-negative Septic Shock|Unknown status|Recruiting|N/A|20|Anticipated|Azienda Ospedaliero, Universitaria Pisana|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 02:57:10.255751|2017-10-11 02:57:10.255751
NCT01602341|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2017-01-12|2017-01-11|2013-06-14|August 2012||2012-08-01|January 2017|2017-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Intent-to-treat (ITT) population included all participants who were randomized and received study drug.|Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis|A Multicenter, Randomized, Double-Blind, Four-Week, Bilateral Study of the Safety and Efficacy of Two Concentrations of AN2728 Ointment Administered Once or Twice a Day in Adolescents With Atopic Dermatitis|Completed||Phase 2|86|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:57:10.357569|2017-10-11 02:57:10.357569
NCT01602328|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-08-05|||June 2012||2012-06-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|ACT-AKI||A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects|A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of AC607 for the Treatment of Acute Kidney Injury in Cardiac Surgery Subjects|Terminated||Phase 2|156|Actual|AlloCure Inc.||2|||f||||t||||||||||2017-10-11 02:57:11.285294|2017-10-11 02:57:11.285294
NCT01602302|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-10-03|||June 2012||2012-06-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|RA-BioStop||Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis|Ultrasound as Biomarker for Withdrawal of Biological DMARDs in Rheumatoid Arthritis|Recruiting||Phase 4|110|Anticipated|Medical University of Graz||1|||f||||t||||||||||2017-10-11 02:57:11.649752|2017-10-11 02:57:11.649752
NCT01602289|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2015-06-04|||June 2012||2012-06-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of LY2875358 in Japanese Participants With Advanced Cancer|A Phase 1 Study of LY2875358 in Japanese Patients With Advanced Malignancies|Completed||Phase 1|17|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 02:57:11.780895|2017-10-11 02:57:11.780895
NCT01602276|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-09-06|||February 2012||2012-02-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||The Effect of tDCS on Subcortical Brain Functioning|The Effect of Transcranial Direct Current Stimulation on Subcortical Brain Functioning|Enrolling by invitation||N/A|150|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:57:11.878235|2017-10-11 02:57:11.878235
NCT01602263|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-09-06|||January 2009||2009-01-01|September 2016|2016-09-01|December 2030|Anticipated|2030-12-01|January 2025|Anticipated|2025-01-01||Observational|||Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing|Transcranial Direct Current Stimulation (tDCS)and Cognitive Processing|Active, not recruiting||N/A|300|Anticipated|Johns Hopkins University|||4||f||||t||||||||||2017-10-11 02:57:11.975783|2017-10-11 02:57:11.975783
NCT01602250|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-12-20|||January 2011||2011-01-01|November 2012|2012-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|TOXALIP||Local Anaesthetics Toxicity and Intralipid®|Prevention of Systemic Toxicity Induced by Levobupivacaine and Ropivacaine by Intralipid®|Completed||Phase 2|16|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||t||||||||||2017-10-11 02:57:12.080198|2017-10-11 02:57:12.080198
NCT01602237|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-08-11|||February 2012|Actual|2012-02-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2012|Actual|2012-12-01||Observational|Baker2012||Preventing Respiratory Health Problems in Bakery Employees|Preventing Respiratory Health Problems in Bakery Employees.|Completed||N/A|253|Actual|Haukeland University Hospital|||1||f||||f||||||Samples Without DNA|"     Serum, Nasal lavage fluid (without cells)   "|||2017-10-11 02:57:12.203691|2017-10-11 02:57:12.203691
NCT01602211|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-09-01|||May 14, 2013|Actual|2013-05-14|September 2017|2017-09-01|November 28, 2016|Actual|2016-11-28|November 28, 2016|Actual|2016-11-28||Interventional|INSPIRE||INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant|INSPIRE for Survivorship After Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-Media Program for Long-Term Hematopoietic Cell Transplantation Survivors|Completed||Phase 3|1600|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-11 02:57:12.502029|2017-10-11 02:57:12.502029
NCT01602198|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-01-09|2017-01-09||June 2011||2011-06-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients|24-week, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Exelon® [Rivastigmine] Transdermal Patch in 120 APOE e4 Positive Amnestic MCI Patients|Terminated||N/A|1|Actual|The Cleveland Clinic||2||Study revised to use a different study medication and patient population.|f||||f||||||||No|No data to share.|2017-10-11 02:57:12.61065|2017-10-11 02:57:12.61065
NCT01602159|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-10-05|||July 2009|Actual|2009-07-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ROBUST||Revascularization With Open Bypass Versus Angioplasty and STenting of the Lower Extremity Trial (ROBUST)|Revascularization With Open Bypass Versus Angioplasty and STenting of the Lower Extremity Trial (ROBUST)|Recruiting||N/A|70|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:57:13.439145|2017-10-11 02:57:13.439145
NCT01602146|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-11-09|||June 2012||2012-06-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|CHAMONIX2||Problems Associated With Ultramarathon|Acute and Chronic Problems Associated With the Practice of Mountain Ultramarathon|Completed||N/A|35|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 02:57:13.582867|2017-10-11 02:57:13.582867
NCT01602133|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2012-10-24|||June 2012||2012-06-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|ECLIPSE||Assessment of Ultrasound-guided Inserted Peripheral Intravenous Catheter|A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter|Unknown status|Recruiting|N/A|29|Anticipated|Prodimed SAS||1|||f||||t||||||||||2017-10-11 02:57:13.69963|2017-10-11 02:57:13.69963
NCT01602120|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-09-13|||May 29, 2012|Actual|2012-05-29|September 2017|2017-09-01|March 28, 2022|Anticipated|2022-03-28|June 29, 2019|Anticipated|2019-06-29||Interventional|||An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy|A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Lampalizumab (FCFD4514S) in Patients With Geographic Atrophy Who Have Completed Genentech-Sponsored Lampalizumab Studies|Active, not recruiting||Phase 2|159|Actual|Genentech, Inc.||3|||f||||||||||||||2017-10-11 02:57:13.834818|2017-10-11 02:57:13.834818
NCT01602107|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-09-26|||November 2011||2011-11-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|SUIPT||The Effect of Pre-operative Pelvic Floor Muscle Exercise on Surgical Outcomes in Women With Stress Urinary Incontinence|Optimizing Treatment Outcomes for Women With Stress Urinary Incontinence Through the Identification of Factors Contributing to Successful Interventions|Recruiting||Phase 1|400|Anticipated|Queen's University||2|||f||||t||||||||||2017-10-11 02:57:14.050264|2017-10-11 02:57:14.050264
NCT01602094|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-05-17|||July 2012||2012-07-01|May 2012|2012-05-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Observational|||Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors|Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors|Unknown status|Not yet recruiting|N/A|550|Anticipated|Queen Saovabha Memorial Institute|||2||f||||f||||||Samples Without DNA|"     Each participant will be taken blood sample approximately 8 ml. The blood sample will be     centrifuged and kept as serum. The serum will be kept under - 20 degree Celsius. Then, all     serum will be tested by ELISA.   "|||2017-10-11 02:57:14.216748|2017-10-11 02:57:14.216748
NCT01602081|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2015-02-10|||January 2013||2013-01-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|LIFT+Graft||Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula|Ligation of the Intersphincteric Fistula Tract With Tissue Graft Placement for Treatment of Persistent Trans-sphincteric Anal Fistula|Completed||N/A|28|Actual|Cook Group Incorporated|||1||f||||||||||||||2017-10-11 02:57:14.377888|2017-10-11 02:57:14.377888
NCT01602055|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-05-17|||October 2010||2010-10-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Bioequivalence Study of Two Azithromycin Tablet Formulations in Indonesian Healthy Subjects||Completed||Phase 1|24|Actual|PT Novell Pharmaceutical Laboratories||2|||f||||t||||||||||2017-10-11 02:57:14.616877|2017-10-11 02:57:14.616877
NCT01602042|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-12-03|||May 2012||2012-05-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Adaptive Portable Essential Tremor Monitor|Phase II Study: Adaptive Portable Essential Tremor Monitor|Completed||N/A|20|Actual|Great Lakes NeuroTechnologies Inc.|||1||f||||||||||||||2017-10-11 02:57:14.704426|2017-10-11 02:57:14.704426
NCT01602029|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2014-11-08|||August 2010||2010-08-01|May 2012|2012-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ROSES||Randomized Double Blind Placebo Control Study in Patients With Schizophrenia|Randomized Double Blind Placebo Controlled Study of Ondansetron and Simvastatis Added to Treatment as Usual in Patients With Schizophrenia|Completed||Phase 2|303|Actual|Pakistan Institute of Learning and Living||4|||f||||t||||||||||2017-10-11 02:57:14.791739|2017-10-11 02:57:14.791739
NCT01602016|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-01-05|2016-11-04||May 2012||2012-05-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||The study sponsor (UAMS) was unable to completely monitor the study or resolve outstanding queries. The study data cannot be fully validated by the sponsor. The study was placed on Full Clinical Hold by the FDA and terminated by the sponsor as a result of investigator non-compliance.|A Folinic Acid Intervention for Autism Spectrum Disorders|A Folinic Acid Intervention for ASD: Links to Folate Receptor-alpha Autoimmunity & Redox Metabolism|Terminated||Phase 2|99|Actual|University of Arkansas||3||Non-compliance|f||||f||||||||||2017-10-11 02:57:14.956312|2017-10-11 02:57:14.956312
NCT01602003|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-05-17|||December 2009||2009-12-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|June 2011|Actual|2011-06-01||Interventional|||Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes|A Multicenter, Multinational, Randomized, Active-controlled, Parallel Group, Double-blind, Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone|Completed||Phase 3|425|Actual|LG Life Sciences||3|||f||||||||||||||2017-10-11 02:57:15.215215|2017-10-11 02:57:15.215215
NCT01601990|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-05-17|||December 2009||2009-12-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|March 2011|Actual|2011-03-01||Interventional|||Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes|A Multicenter, Multinational, Randomized, Placebo-controlled, Parallel Group, Double-blind, Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes|Completed||Phase 3|189|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-11 02:57:15.323899|2017-10-11 02:57:15.323899
NCT01601977|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2016-07-11|2015-05-03||May 2012||2012-05-01|July 2016|2016-07-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|AVAPS-AE|Study participants had a pre-existing diagnosis of COPD-OSA and were established on NIV for at least 6 months prior to study enrollement. Patients needed to be clinically stable prior to trial initiation.|Validation of the AVAPS AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD) Patients|Validation of the AVAPS AE Algorithm in Chronic Obstructive Pulmonary Disease: A Non-randomised Pilot Study|Completed||Phase 2/Phase 3|10|Actual|Guy's and St Thomas' NHS Foundation Trust|Non-randomised controlled study|2|||f||||f||||||||Undecided||2017-10-11 02:57:15.425162|2017-10-11 02:57:15.425162
NCT01601964|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-17|2015-08-06|||May 2012||2012-05-01|August 2015|2015-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|VEGF||Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy|Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy|Completed||N/A|30|Actual|Bagcilar Training and Research Hospital|||2||f||||f||||||||||2017-10-11 02:57:15.714188|2017-10-11 02:57:15.714188
NCT01601951|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2014-03-14|||April 2012||2012-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Outcomes Data of Bone Marrow Stem Cells to Treat Hip and Knee Osteoarthritis|Autologous Bone Marrow Concentrate Database Outcomes Research Project|Completed||N/A|12|Actual|Regenerative Pain Center, Illinois|||2||f||||f||||||||||2017-10-11 02:57:15.785238|2017-10-11 02:57:15.785238
NCT01601938|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-03-03|||September 2012||2012-09-01|March 2016|2016-03-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Interventional|SEREAL||Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients|Effects of Selenium Replacement on Prognosis of Severe Sepsis and Septic Shock Patients and Their Initial Serum Selenium Level: a Randomized, Double-blind Placebo Controlled Phase 2 Study|Withdrawn||Phase 2|0|Actual|Seoul National University Hospital||2||We failed to obtain study drugs from the company|f||||t||||||||||2017-10-11 02:57:15.86829|2017-10-11 02:57:15.86829
NCT01601925|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-01-23|||January 2012||2012-01-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block|Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block|Unknown status|Recruiting|N/A|42|Anticipated|Yonsei University||1|||f||||f||||||||||2017-10-11 02:57:15.961762|2017-10-11 02:57:15.961762
NCT01601912|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2014-01-13|||February 2013||2013-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Unraveling the Nature of Impaired Pain Inhibition in Patients With Chronic Whiplash-associated Disorders|Unraveling the Nature of Impaired Pain Inhibition in Patients With Chronic Whiplash-associated Disorders: a Randomized Controlled Clinical Trial for the Treatment of Central Sensitization|Completed||Phase 4|59|Actual|Vrije Universiteit Brussel|||2||f||||f||||||||||2017-10-11 02:57:16.041459|2017-10-11 02:57:16.041459
NCT01601899|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-16|||October 2008||2008-10-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|CHRU01||Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients|Molecular, Biochemical and Clinical Differences Between Stavudine and Tenofovir, Each Combined With Lamivudine and Efavirenz in South African HIV-infected Patients|Terminated||Phase 4|60|Actual|University of Witwatersrand, South Africa||3||DSMB decision to begin closeout process in view of April 2010 SA HAART guideline|f||||t||||||||||2017-10-11 02:57:16.140652|2017-10-11 02:57:16.140652
NCT01601886|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-05-17|||April 2008||2008-04-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|November 2011|Actual|2011-11-01||Observational|||Delivery Room Practice Change Following the Initiation of the NICHD SUPPORT Trial|Delivery Room Practice Change Following the Initiation of the NICHD SUPPORT Trial|Completed||N/A|3843|Actual|University of Texas Southwestern Medical Center|||3||f||||f||||||||||2017-10-11 02:57:16.255247|2017-10-11 02:57:16.255247
NCT01601873|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2016-10-20|||November 2012||2012-11-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|PRICE||Propaten Randomized Investigation on Cost-benefit and Efficacy|A Randomized Controlled Comparative Study on Efficacy and Cost-effectiveness of Heparin-bonded Versus Non-heparin-bonded Polytetrafluroethylene Hemodialysis Access Grafts.|Recruiting||Phase 4|200|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||Yes|De-identified data will be available following institutional review board approval|2017-10-11 02:57:16.465583|2017-10-11 02:57:16.465583
NCT01601860|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2013-06-04|||January 2012||2012-01-01|June 2013|2013-06-01|July 2014|Anticipated|2014-07-01|June 2013|Anticipated|2013-06-01||Interventional|||The Maternal and Perinatal Outcomes Associated With the Use of Non-pharmacological in Labor|Evaluation of Maternal and Perinatal Outcomes Associated With the Use of Non-pharmacological in Parturients in Active Phase of Labor|Unknown status|Recruiting|Phase 4|60|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:57:16.603337|2017-10-11 02:57:16.603337
NCT01601847|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-07-10|||January 2013||2013-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|D-Wheeze||Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy|Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy|Active, not recruiting||Phase 4|300|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-10-11 02:57:16.702892|2017-10-11 02:57:16.702892
NCT01601834|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-07-03|||May 2012||2012-05-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340|A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Crossover Dose Escalation Study To Investigate The Safety, Toleration And Pharmacokinetics Of Pf-06273340 In Healthy Volunteers|Completed||Phase 1|20|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 02:57:16.804013|2017-10-11 02:57:16.804013
NCT01601821|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-04-29|2013-04-29||April 2006||2006-04-01|April 2013|2013-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids|An Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids With Further CSA Elimination In The Rapamune Arm With The Introduction Of MMF|Completed||Phase 4|245|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:57:16.934489|2017-10-11 02:57:16.934489
NCT01601808|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-05-16|||October 2011||2011-10-01|May 2012|2012-05-01|October 2013|Anticipated|2013-10-01|October 2012|Anticipated|2012-10-01||Interventional|ViP||Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma|A Prospective, Phase II, Double Blinded, Multicentre, Randomised Clinical Trial Comparing Combination Gemcitabine and Vandetanib Therapy With Gemcitabine Therapy Alone in Locally Advanced or Metastatic Pancreatic Carcinoma|Unknown status|Recruiting|Phase 2|120|Anticipated|University of Liverpool||2|||f||||t||||||||||2017-10-11 02:57:18.01455|2017-10-11 02:57:18.01455
NCT01601795|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2014-01-28|||July 2012||2012-07-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit)|Sevoflurane and Isoflurane - Cardioprotective Effects, Hemodynamic Stability and Pharmacokinetics During Cardiopulmonary Bypass With the MECC System|Completed||Phase 4|30|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 02:57:18.151029|2017-10-11 02:57:18.151029
NCT01601782|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2014-08-18|2013-12-10||August 2009||2009-08-01|August 2014|2014-08-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional||Patients were randomly evaluated without pre-selection of gender or race|Impact of Volume Imaging Using Diagnostic Ultrasound|Impact of Volume Imaging With Ultrasound|Terminated||N/A|16|Actual|University of Michigan|16 patients were studied as part of a pilot project to determine if 3D ultrasound offers any benefit over routine standard ultrasound imaging of the extremity. The study was terminated after evaluating 16 subjects.|1||It was determined that the volume imaging was not working.|f||||f||||||||||2017-10-11 02:57:18.250315|2017-10-11 02:57:18.250315
NCT01601769|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-16|||April 2011||2011-04-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|VITOM||Tissue Sparing Therapy of Female Precancerous Genital Lesions With VITOM|Development of a Tissue Sparing Procedure for the Diagnosis and Therapy of Female Precancerous Genital Lesions Combining Endoscopic and Ultrasound Technics.|Unknown status|Active, not recruiting|N/A|300|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 02:57:18.42608|2017-10-11 02:57:18.42608
NCT01601756|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-16|||September 2011||2011-09-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|NavRevKnie||Joint Line Reconstruction in Navigated Total Knee Arthroplasty Revision|Joint Line Reconstruction in Navigated Total Knee Arthroplasty Revision|Unknown status|Recruiting|N/A|40|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 02:57:18.509292|2017-10-11 02:57:18.509292
NCT01601743|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-01-26|||September 2011||2011-09-01|May 2012|2012-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Exercise as a Behavioral Treatment for Cocaine Dependence|Exercise as a Behavioral Treatment for Cocaine Dependence|Completed||N/A|24|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-10-11 02:57:18.601048|2017-10-11 02:57:18.601048
NCT01601730|ClinicalTrials.gov processed this data on October 10, 2017|2009-12-10|2012-05-16|||August 2010||2010-08-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Modafinil - Escitalopram Study for Cocaine Dependence|Combination Therapy With Modafinil and Escitalopram for the Treatment of Cocaine Dependence|Completed||Phase 1|68|Actual|Baylor College of Medicine||4|||f||||t||||||||||2017-10-11 02:57:18.704152|2017-10-11 02:57:18.704152
NCT01601717|ClinicalTrials.gov processed this data on October 10, 2017|2009-12-10|2012-05-16|||January 2010||2010-01-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||RTI-336 as a Treatment for Methamphetamine Dependence|RTI-336 for Methamphetamine Dependence|Withdrawn||Phase 1|0|Actual|Baylor College of Medicine||2|||t||||t||||||||||2017-10-11 02:57:18.815103|2017-10-11 02:57:18.815103
NCT01601704|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-02-24|2016-12-11||June 2012||2012-06-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Occurrence of Major Adverse Cardiovascular Events (MACE) in Overweight and Obese Subjects With Cardiovascular Risk Factors Receiving Naltrexone SR/Bupropion SR|Terminated||Phase 3|8910|Actual|Orexigen Therapeutics, Inc|The study was terminated early. Outcome measures data is based on the 50% interim analysis, designated as the primary analysis. Safety data is based on all available data at the time of database lock, which occurred after the 50% interim analysis.|2|||f||||t||||||||||2017-10-11 02:57:19.042419|2017-10-11 02:57:19.042419
NCT01601691|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2014-11-13|2014-11-04||April 2012||2012-04-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Protection of Rectum From High Radiation Doses|Protection of Rectum From High Radiation Doses|Completed||N/A|10|Actual|University of Oulu||1|||f||||f||||||||||2017-10-11 02:57:22.767592|2017-10-11 02:57:22.767592
NCT01601678|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-05-03|||December 2013||2013-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2015|Actual|2015-12-01||Interventional|POEM||Endoscopic Versus Laparoscopic Myotomy for Treatment of Idiopathic Achalasia: A Randomized, Controlled Trial|Endoscopic Versus Laparoscopic Myotomy for Treatment of Idiopathic Achalasia: A Randomized, Controlled Trial|Active, not recruiting||N/A|240|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-11 02:57:23.002313|2017-10-11 02:57:23.002313
NCT01601665|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2015-08-03|||February 2012||2012-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9|Post Approval Study of the AcrySof® IQ Toric High Cylinder Power IOL Models SN6AT6-SN6AT9|Completed||N/A|477|Actual|Alcon Research|||2||f||||f||||||||||2017-10-11 02:57:23.113994|2017-10-11 02:57:23.113994
NCT01601652|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-10-24|||November 2011||2011-11-01|October 2016|2016-10-01||||November 2021|Anticipated|2021-11-01||Interventional|||Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis|Open Label, Compassionate Use Protocol of an Intravenous Fish Oil Emulsion in Infants With Cholestasis|Enrolling by invitation||Phase 1/Phase 2|5|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-11 02:57:23.205291|2017-10-11 02:57:23.205291
NCT01601639|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-01-24|||September 2012||2012-09-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Endoscopic Band Ligation Versus Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial|Endoscopic Band Ligation vs Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial|Completed||Phase 3|30|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 02:57:23.297134|2017-10-11 02:57:23.297134
NCT01601626|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-02-14|||April 2013||2013-04-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|January 19, 2017|Actual|2017-01-19||Interventional|||Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV|A Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen With Rifampin-Based Tuberculosis Treatment Versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen With Rifabutin-Based Tuberculosis Treatment With or Without Raltegravir in HIV-1-Infected Persons Requiring Treatment for Active TB and HIV|Active, not recruiting||Phase 2|71|Actual|AIDS Clinical Trials Group||3|||f||||t||||||||||2017-10-11 02:57:23.401203|2017-10-11 02:57:23.401203
NCT01601613|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-01-10|||July 2001||2001-07-01|January 2017|2017-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever|A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Comparison of Recombinant Factor VIIa (NovoSeven®) and Standard Haemostatic Replacement Therapy in Patients With Dengue Haemorrhagic Fever|Completed||Phase 2|28|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:57:23.746785|2017-10-11 02:57:23.746785
NCT01601600|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-11-16|||January 2012||2012-01-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults|A Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults With Mobility Limitations|Completed||Phase 2|40|Actual|Novartis||2|||f||||t||||||||||2017-10-11 02:57:23.874289|2017-10-11 02:57:23.874289
NCT01601587|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-06-12|||May 2012|Actual|2012-05-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Introduction Seminar About Patient Participation and Treatment Options Decisional Preferences|Introduction Seminar About Patient Participation, Treatment Options and Decisional Preferences for Psychiatric Outpatients on Waiting List|Completed||N/A|52|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 02:57:23.978093|2017-10-11 02:57:23.978093
NCT01601574|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2014-10-14|||May 2012||2012-05-01|March 2012|2012-03-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|T2D||Weight Loss Study for People With Type 2 Diabetes|Effects on Glycemic Control and Weight of a Modified Commercial Weight Control Program for People With Type 2 Diabetes|Completed||Phase 3|563|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 02:57:24.0954|2017-10-11 02:57:24.0954
NCT01601561|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-05-17|||June 2010||2010-06-01|May 2012|2012-05-01||||December 2012|Anticipated|2012-12-01||Interventional|||The Effect of Insulin on Protein Metabolism After Cardiac Surgery|The Effect of Insulin on Protein Metabolism After Cardiac Surgery|Unknown status|Recruiting|N/A|30|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 02:57:24.25196|2017-10-11 02:57:24.25196
NCT01601548|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-01-22|||July 2012||2012-07-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy|Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy|Completed||N/A|45|Actual|Masonic Cancer Center, University of Minnesota||2|||f||||f||||||||||2017-10-11 02:57:24.375927|2017-10-11 02:57:24.375927
NCT01601535|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-09-01|||May 2012||2012-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of MLN8237 in Combination With Irinotecan and Temozolomide|Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma|Active, not recruiting||Phase 1/Phase 2|44|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-10-11 02:57:24.50178|2017-10-11 02:57:24.50178
NCT01601522|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-04-13|||February 2012||2012-02-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Peanut Allergy Oral Immunotherapy Desensitization|Peanut Allergy Oral Immunotherapy Desensitization|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 02:57:24.678826|2017-10-11 02:57:24.678826
NCT01601509|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2012-05-17|||April 2010||2010-04-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|NTD||Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and|Randomized Placebo-controlled Cross-over Trial of the Effect of Nasal Tramazoline With Dexamethasone in Obstructive Sleep Apnoea Patients|Completed||N/A|23|Actual|University of Athens||2|||f||||f||||||||||2017-10-11 02:57:24.770843|2017-10-11 02:57:24.770843
NCT01601483|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2014-04-24|||October 2012||2012-10-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration|Phase II/III Study of the Efficacy and Safety of Macuclear MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration|Terminated||Phase 2/Phase 3|22|Actual|MacuCLEAR, Inc.||2||Unmasked without Sponsor's prior knowledge or authorization by the PI.|f||||f||||||||||2017-10-11 02:57:24.981136|2017-10-11 02:57:24.981136
NCT01601470|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2015-10-06|2015-07-11||September 2012||2012-09-01|October 2015|2015-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension|An Open Label, Three-period, Single Sequence Study to Evaluate the Pharmacokinetic Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension|Completed||Phase 2|28|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:57:25.131526|2017-10-11 02:57:25.131526
NCT01601457|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-01-12|||September 2002||2002-09-01|January 2017|2017-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction|A Single-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial Evaluating the Efficacy and Safety of Activated Recombinant Coagulation Factor VII (rFVIIa, NovoSeven®) in Patients With Major Fractures of Pelvis or Pelvis and Acetabulum Undergoing Repair Surgery|Completed||Phase 2|48|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:57:25.551142|2017-10-11 02:57:25.551142
NCT01601444|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-16|||June 2012||2012-06-01|May 2012|2012-05-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|||Detection of Pleural Effusion by Internal Thoracic Impedance Method|Detection of Pleural Effusion by Internal Thoracic Impedance Method|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 02:57:25.662186|2017-10-11 02:57:25.662186
NCT01601418|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-05-16|||October 2001||2001-10-01|May 2012|2012-05-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Effect of Single Doses of YF476 on Stomach Acidity|Double-blind, Placebo-controlled, Single-dose, 5-way Crossover Study of the Effect of YF476 (1, 5, 25 & 100 mg) on Pentagastrin-induced Gastric Acid Output in Healthy Volunteers|Completed||Phase 1|12|Actual|Trio Medicines Ltd.|||||f||||f||||||||||2017-10-11 02:57:25.853436|2017-10-11 02:57:25.853436
NCT01601405|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-05-16|||October 2001||2001-10-01|May 2012|2012-05-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Effect of Repeated Doses of YF476 on Stomach Acidity|Open Study of the Effect of Repeated Doses of YF476 on Pentagastrin-induced Gastric Acid Output in Healthy Volunteers|Completed||Phase 1|10|Actual|Trio Medicines Ltd.|||||f||||f||||||||||2017-10-11 02:57:25.949599|2017-10-11 02:57:25.949599
NCT01601392|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-05-16|||January 2011||2011-01-01|May 2012|2012-05-01|June 2012|Anticipated|2012-06-01|May 2012|Anticipated|2012-05-01||Interventional|tDCS||Anodal and Cathodal Transcranial Direct Current Stimulation in Stroke Recovery|Effect of Anodal Versus Cathodal Transcranial Direct Current Stimulation on Stroke Recovery: a Pilot Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|40|Actual|Assiut University||3|||f||||||||||||||2017-10-11 02:57:26.380727|2017-10-11 02:57:26.380727
NCT01601379|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-05-25|||June 2010||2010-06-01|May 2016|2016-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|PROFILE||Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.|Symptoms of Gastroesophageal Reflux Disease (GERD): Classification of Adult Subjects Suffering From Typical GERD Symptoms and Description of the Most Frequent Symptom Profiles and Characteristics - European Observational Study|Completed||Phase 4|7964|Actual|Janssen-Cilag International NV|||1||f||||f||||||||||2017-10-11 02:57:26.489784|2017-10-11 02:57:26.489784
NCT01601366|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-05-16|||April 2012||2012-04-01|May 2012|2012-05-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|LNGIUSAD||LNG-IUS for Treatment of Dysmenorrhea|Levonorgestrel-releasing Intrauterine System Compared to Low Dose Combined Oral Contraceptive Pills for Treatment of Adenomyosis: a Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 2|62|Anticipated|Assiut University||2|||f||||t||||||||||2017-10-11 02:57:26.564563|2017-10-11 02:57:26.564563
NCT01601340|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-12|2015-03-17|||July 2012||2012-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Effects of HQK-1001 in Patients With Sickle Cell Disease|A Randomized, Placebo-controlled, Phase 2 Study of HQK-1001 in Sickle Cell Disease|Terminated||Phase 2|77|Actual|HemaQuest Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 02:57:26.721974|2017-10-11 02:57:26.721974
NCT01601327|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-05-17|||January 2008||2008-01-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effects of Medications in Patients With Hypogonadism|Effects of Three Different Medications on Metabolic Parameters and Testicular Volume in Patients With Hypogonadotropic Hypogonadism-Last Three Years Experience|Completed||Phase 4|119|Actual|Gulhane School of Medicine||2|||f||||t||||||||||2017-10-11 02:57:26.832577|2017-10-11 02:57:26.832577
NCT01601314|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-08-02|||October 2012||2012-10-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|MAGNA||Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients|Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients|Active, not recruiting||Phase 3|55|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 02:57:26.924181|2017-10-11 02:57:26.924181
NCT01532596|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-02-09|||January 2008||2008-01-01|February 2012|2012-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|MIND||Mindfulness Meditation in Older Adults|The Effects of Mindfulness Meditation in Older Adults|Completed||Early Phase 1|40|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 03:17:35.740124|2017-10-11 03:17:35.740124
NCT01601301|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-08-31|||July 2012||2012-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|PINS||Post-Market Study of the Ellipse PRECICE Intramedullary Limb Lengthening System|A Post-Market Prospective Evaluation of the Performance and Safety of the Ellipse PRECICE Intramedullary Limb Lengthening System|Active, not recruiting||N/A|32|Actual|Ellipse Technologies, Inc.||1|||f||||f||||||||||2017-10-11 02:57:27.002434|2017-10-11 02:57:27.002434
NCT01601288|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-10-27|||May 2012||2012-05-01|October 2016|2016-10-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Database of All Patients Who Have Undergone Pulmonary Function Testing at Singapore General Hospital|Prospective Database of All Patients Who Have Undergone Pulmonary Function Testing at Singapore General Hospital|Recruiting||N/A|25000|Anticipated|Singapore General Hospital|||1||f||||f||||||||||2017-10-11 02:57:27.090765|2017-10-11 02:57:27.090765
NCT01601275|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-10-27|||May 2012||2012-05-01|October 2016|2016-10-01|May 2022|Anticipated|2022-05-01|May 2022|Anticipated|2022-05-01||Observational|||Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection|Prospective Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection Treated at Singapore General Hospital|Recruiting||N/A|4000|Anticipated|Singapore General Hospital|||1||f||||f||||||||||2017-10-11 02:57:27.249202|2017-10-11 02:57:27.249202
NCT01601262|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-07-25|||July 2012||2012-07-01|July 2012|2012-07-01|January 2015|Anticipated|2015-01-01|July 2014|Anticipated|2014-07-01||Interventional|||Efficacy & Safety of a 2nd Series of Low Intensity Shock Waves for ED on Partial Responders to First Treatment|Efficacy and Safety of a Second Series of Low Intensity Extracorporeal Shock Wave Therapy (LI-ESWT) Treatment for Erectile Dysfunction Patients Who Were Partial Responders to the Initial Treatment.|Unknown status|Not yet recruiting|Phase 3|300|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-11 02:57:27.342318|2017-10-11 02:57:27.342318
NCT01601249|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-08-19|||September 2012||2012-09-01|May 2012|2012-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Improving IVF Embryo Quality Grading Using Polarized Light|A Prospective Comparison Between Conventional IVF Embryo Grading and Polscope Based Grading|Withdrawn||Phase 1|0|Actual|Hadassah Medical Organization||2||PI moved from Hadassah|f||||f||||||||||2017-10-11 02:57:27.449145|2017-10-11 02:57:27.449145
NCT01601236|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-07-21|2017-05-18||May 2012||2012-05-01|July 2017|2017-07-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional||All randomized subjects|Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive Design Pilot Safety and Efficacy Study of H.P. Acthar Gel (Acthar) in Patients With Diabetic Nephropathy and Proteinuria.|Completed||Phase 2|34|Actual|Mallinckrodt|Groups 5 & 6 were closed when 2 of the 1st 4 subjects met predefined tolerability criteria. Enrollment terminated early at 34/40 subjects due to slow recruitment.16 of 34 subjects discontinued prior to collecting primary endpoint data at week 36.|6|||f||||||||||||||2017-10-11 02:57:27.603583|2017-10-11 02:57:27.603583
NCT01601223|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-10-13|||January 2013||2013-01-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Observational|LAS VEGAS||Local Assessment of Ventilatory Management During General Anesthesia for Surgery|Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study|Completed||N/A|10690|Actual|European Society of Anaesthesiology|||1||f||||f||||||||||2017-10-11 02:57:29.552729|2017-10-11 02:57:29.552729
NCT01601210|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-10-24|||June 2012||2012-06-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder|Placebo-Controlled Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder: a Magnetic Resonance Spectroscopy Study|Completed||Early Phase 1|32|Actual|University of Utah||4|||f||||t||||||||Yes||2017-10-11 02:57:29.698976|2017-10-11 02:57:29.698976
NCT01601197|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2012-10-23|||May 2012||2012-05-01|October 2012|2012-10-01|May 2013|Anticipated|2013-05-01|December 2012|Anticipated|2012-12-01||Interventional|||A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization|A Study of Two Injection Techniques Added to Proven Strategies to Reduce Pain in One- to Twelve-month Old Infants Undergoing Immunization|Unknown status|Recruiting|Phase 3|120|Anticipated|University of Toronto||2|||f||||f||||||||||2017-10-11 02:57:29.795826|2017-10-11 02:57:29.795826
NCT01601184|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-10-31|||June 2012||2012-06-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|||Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway|An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway|Recruiting||Phase 1/Phase 2|38|Anticipated|Centre Leon Berard||3|||f||||t||||||||||2017-10-11 02:57:29.920849|2017-10-11 02:57:29.920849
NCT01601171|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-07-06|||March 2012||2012-03-01|July 2016|2016-07-01|March 2022|Anticipated|2022-03-01|March 2022|Anticipated|2022-03-01||Observational|||The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome)|The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome)|Recruiting||N/A|2000|Anticipated|Centre Hospitalier Universitaire Vaudois|||2||f||||f||||||Samples With DNA|"     whole blood, serum/plasma, white blood cells, DNA   "|||2017-10-11 02:57:30.183965|2017-10-11 02:57:30.183965
NCT01601158|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2014-01-08|||May 2012||2012-05-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Umbilical Cord Blood Therapy for Children With Global Developmental Delay|Safety and Efficacy of Allogeneic Umbilical Cord Blood Therapy for Children With Global Developmental Delay|Completed||N/A|10|Actual|Bundang CHA Hospital||1|||f||||f||||||||||2017-10-11 02:57:30.450153|2017-10-11 02:57:30.450153
NCT01601145|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2012-08-21|||January 2012||2012-01-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Probiotic on the Plaque pH. A Randomized Double Blind Interventional Study||Completed||Phase 4|192|Actual|Università degli Studi di Sassari||2|||f||||f||||||||||2017-10-11 02:57:30.561012|2017-10-11 02:57:30.561012
NCT01601132|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2013-04-18|2013-03-07||May 2012||2012-05-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Drug Interaction Study of Colchicine and Theophylline|An Open-Label, One Sequence, Pharmacokinetic Drug Interaction Study of Colchicine and Theophylline in Healthy Subjects|Completed||Phase 4|30|Actual|Takeda||2|||f||||f||||||||||2017-10-11 02:57:30.677003|2017-10-11 02:57:30.677003
NCT01601119|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2015-05-28|||January 2012||2012-01-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients|The Impact of Disease Modifying Therapies (DMTs) and Associated Support Services on Patient Reported Experience Measures (PREMs) and Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients|Completed||N/A|545|Actual|Merck KGaA|||2||f||||f||||||||||2017-10-11 02:57:31.169358|2017-10-11 02:57:31.169358
NCT01601106|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-05-18|||September 2011||2011-09-01|May 2012|2012-05-01||||May 2013|Anticipated|2013-05-01||Interventional|SILENCE||Silencing Inflammatory Activity by Injecting Nanocort in Patients at Risk for Atherosclerotic Disease|A Phase I/II, Single-Center, Randomized, Placebo-Controlled Study Evaluating the Therapeutic Efficacy of Intravenously Injected PEG-liposomal Prednisolone Sodium Phosphate (Nanocort®) in Subjects With Severe Inflamed Carotid or Aortic Atherosclerosis Plaques|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||||||||||||2017-10-11 02:57:31.268495|2017-10-11 02:57:31.268495
NCT01601093|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-06-03|||November 2011||2011-11-01|April 2012|2012-04-01|November 2013|Anticipated|2013-11-01|August 2013|Anticipated|2013-08-01||Interventional|CAZ-SBT||Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection|Phase Ⅱ Study on Ceftazidime Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection|Unknown status|Recruiting|Phase 2|288|Anticipated|Xiangbei Welman Pharmaceutical Co., Ltd||3|||f||||t||||||||||2017-10-11 02:57:31.382275|2017-10-11 02:57:31.382275
NCT01601080|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2014-02-03|||April 2012||2012-04-01|February 2014|2014-02-01||||October 2012|Actual|2012-10-01||Observational|READER||An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device|REbiSmart™ Retrospective ADherencE Review (READER) An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device|Completed||N/A|230|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 02:57:31.643691|2017-10-11 02:57:31.643691
NCT01601067|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-05-31|||January 21, 2013|Actual|2013-01-21|May 2017|2017-05-01|September 30, 2017|Anticipated|2017-09-30|April 30, 2017|Actual|2017-04-30||Interventional|||Integrated Alcohol Disorder and PTSD Treatment|Integrated Alcohol Disorder and PTSD Treatment|Active, not recruiting||Phase 2|118|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Yes|"Final data sets underlying all publications resulting from the proposed research will be shared outside VA.
A de-identified, anonymized dataset will be created and shared. Requests for access must be made in writing signed by a requestor from the United States and include an email address for delivery and an assurance that the recipient will not attempt to identify or re-identify any individual. The request should reference the publication underlying the request.
One or more data sets without personal identifiers will be generated during the data analysis phase of this study. The data sets will include all data underlying any publications generated by this study and therefore these will be sufficient to reproduce or verify any published findings.
Any HIPAA identifiers, or combinations of variables that could be used for re-identification, will be excluded, as will any proprietary information. The plan excludes access to individually identifiable or proprietary data."|2017-10-11 02:57:31.749276|2017-10-11 02:57:31.749276
NCT01601054|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-04-17|||May 2012||2012-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SALIF||Supplemental Anterior Lumbar Interbody Fusion (ALIF) in Spinal Deformity|Supplemental Anterior Lumbar Interbody Fusion in Posterior Instrumented Fusion in Surgical Treatment of Spinal Deformities. A Randomized Study|Completed||N/A|30|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 02:57:31.856429|2017-10-11 02:57:31.856429
NCT01601041|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-11-21|||December 2011||2011-12-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Role of Residual Urine and Asymptomatic Prostatitis in the Development of Urinary Tract Infections in Spinal Cord Injury|Role of Residual Urine and Asymptomatic Prostatitis in the Development of Lower Urinary Tract Infections in Spinal Cord Injury Patients - a Prospective Study|Completed||N/A|60|Actual|Swiss Paraplegic Centre Nottwil|||2||f||||f||||||||||2017-10-11 02:57:31.994239|2017-10-11 02:57:31.994239
NCT01601028|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2013-10-16|||July 2011||2011-07-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome|Phase 3 Study of Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome|Completed||Phase 3|39|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:57:32.100705|2017-10-11 02:57:32.100705
NCT01601015|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-05-16|||January 2010||2010-01-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Effectiveness of the Treatment of Tension-type Headache With Manual and Manipulative Therapy|Effectiveness of the Treatment of Tension-type Headache With Manual and Manipulative Therapy in the Perception of Pain and Cervical Motion: a Double-blind, Randomized, Placebo-controlled Clinical Trial.|Completed||N/A|84|Actual|University of Valencia||4|||f||||t||||||||||2017-10-11 02:57:32.221805|2017-10-11 02:57:32.221805
NCT01601002|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-04-20|||June 2012||2012-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression|Does LEPR Polymorphism Predict Variability in Weight Gain Induced by Mirtazapine in the Treatment of Late Life Depression?|Completed||Phase 4|19|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 02:57:32.35304|2017-10-11 02:57:32.35304
NCT01600989|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2014-04-24|||May 2012||2012-05-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|MitoSepsis||Mitochondrial Function of Immune Cells in Sepsis|Mitochondrial Function of Immune Cells in Severe Sepsis and Septic Shock - a Prospective Observational Cohort Study|Completed||N/A|60|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||Samples With DNA|"     Serum, isolated B-cells, T-cells, Monocytes   "|||2017-10-11 02:57:32.441683|2017-10-11 02:57:32.441683
NCT01600976|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2013-11-08|||June 2012||2012-06-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment|A Phase I Study to Assess the Safety and Pharmacokinetics of Telaprevir (VX-950) in Subjects With Moderate and Severe Hepatic Impairment|Completed||Phase 1|24|Actual|Janssen Infectious Diseases BVBA||3|||f||||f||||||||||2017-10-11 02:57:32.529583|2017-10-11 02:57:32.529583
NCT01600963|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-11-30|||March 2014||2014-03-01|November 2015|2015-11-01|November 2022|Anticipated|2022-11-01|July 2016|Anticipated|2016-07-01||Interventional|||A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis|A Phase III Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Efficacy and Safety of TMC207 in Subjects With Sputum Smear-positive Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB)|Withdrawn||Phase 3|0|Actual|Janssen Infectious Diseases BVBA||2||PhIII program revised; TMC207-C210 cancelled|f||||t||||||||||2017-10-11 02:57:32.646667|2017-10-11 02:57:32.646667
NCT01600950|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2014-10-03|2014-10-03||May 2012||2012-05-01|October 2014|2014-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||All randomized participants.|A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus|Pharmacodynamics of LY2963016 Compared to LANTUS® in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|20|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 02:57:32.884706|2017-10-11 02:57:32.884706
NCT01600937|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-03-22|||October 2012||2012-10-01|March 2017|2017-03-01|February 28, 2017|Actual|2017-02-28|February 28, 2017|Actual|2017-02-28||Interventional|IDES-2||Italian Diabetes and Exercise Study 2|Italian Diabetes and Exercise Study 2 - A Long-term Behavioural Intervention for Adoption and Maintenance of a Physically Active Lifestyle|Completed||N/A|300|Actual|Metabolic Fitness Association, Italy||2|||f||||f||||||||||2017-10-11 02:57:33.212896|2017-10-11 02:57:33.212896
NCT01600924|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-03-22|||September 2016|Actual|2016-09-01|March 2017|2017-03-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Observational|SAMBA||Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes|Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes|Recruiting||N/A|500|Anticipated|Metabolic Fitness Association, Italy|||1||f||||f||||||Samples Without DNA|"     Whole blood, plasma, serum and urine samples   "|No||2017-10-11 02:57:33.314854|2017-10-11 02:57:33.314854
NCT01600911|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-05-17|||December 2010||2010-12-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Establish a Vegetable Signature Database From Human Metabolomics Responses|Establish a Vegetable Signature Database From Human Metabolomics Responses|Unknown status|Active, not recruiting|N/A|50|Anticipated|National Health Research Institutes, Taiwan||1|||f||||f||||||||||2017-10-11 02:57:33.405841|2017-10-11 02:57:33.405841
NCT01600898|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-05-02|||March 2012||2012-03-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|DELPHI-2||Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers|Screening and Risk Factors of Pulmonary Arterial Hypertension in BMPR2 Mutation Asymptomatic Carriers|Completed||N/A|57|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-10-11 02:57:33.478687|2017-10-11 02:57:33.478687
NCT01600885|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-07-20|2014-08-29||August 2008||2008-08-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|GuaKet|Baseline population is the number of participants who started the study|The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects|The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects|Completed||N/A|16|Actual|Yale University||2|||f||||f||||||||||2017-10-11 02:57:33.564967|2017-10-11 02:57:33.564967
NCT01600872|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2013-11-04|||March 2012||2012-03-01|November 2013|2013-11-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||Oxidative Stress and Bisphenol A (BPA) Impact With Polycystic Ovary Syndrome (PCOS)|Oxidative Stress and BPA Impact With PCOS|Unknown status|Recruiting|N/A|300|Anticipated|Taipei Medical University WanFang Hospital|||2||f||||f||||||||||2017-10-11 02:57:34.147832|2017-10-11 02:57:34.147832
NCT01600859|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-12-29|||July 2012||2012-07-01|December 2016|2016-12-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease|Completed||Phase 1|65|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 02:57:34.23889|2017-10-11 02:57:34.23889
NCT01600846|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-07-27|||December 2012||2012-12-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Pharmacogenetic Testing in Primary Care|Delivery of Pharmacogenetic Testing in a Primary Care Setting|Completed||N/A|400|Anticipated|Duke University|||1||f||||t||||||||||2017-10-11 02:57:34.333956|2017-10-11 02:57:34.333956
NCT01600820|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-12-06|||February 2005||2005-02-01|December 2016|2016-12-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Spain)|A Randomised, Double-blind, Placebo-controlled, Parallel-group Clinical Study on the Effects of a Fermented Dairy Product Enriched With Phytosterols Over Blood Cholesterol Levels of Hypercholesterolemic Adult Subjects|Completed||N/A|126|Actual|Danone Research||3|||f||||f||||||||||2017-10-11 02:57:34.926713|2017-10-11 02:57:34.926713
NCT01600807|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-06-25||||||June 2013|2013-06-01||||||||Interventional|||OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas|Phase I/II Trial of OSI-906 in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Ductal Adenocarcinoma of the Pancreas|Withdrawn||Phase 1/Phase 2|0|Actual|Dana-Farber Cancer Institute||2||"Study was pending major changes and was on hold, pending activation; administratively   withdrawn; will be submitted as a new protocol if study is revised."|f||||t||||||||||2017-10-11 02:57:35.02918|2017-10-11 02:57:35.02918
NCT01600794|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-16|||October 2011||2011-10-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|||||Observational|||To Evaluate The Anrogens and Ovary Function in In Vitro Fertilization|To Evaluate The Androgens and Ovary Function Impact on The Pregnancy Outcome in In Vitro Fertilization|Suspended||N/A|1000|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 02:57:35.163142|2017-10-11 02:57:35.163142
NCT00004572|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-16|2005-06-23||||||April 2000|2000-04-01||||||||Observational|||Identification and Therapy Efficacy of Type 2 Diabetes in Hispanic Patients||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:50.416609|2017-10-11 04:26:50.416609
NCT01600781|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2015-02-08|||December 2011||2011-12-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Effect of Oral Supplementation With a Fibre Enriched Paediatric Sip Feed For Children With Acute Lymphocytic Leukemia|Effect of Oral Supplementation With a Fibre Enriched Paediatric Sip Feed on the Nutritional Status, Gut Microbiota and Quality of Life of Children With Acute Lymphocytic Leukemia: an Egyptian Pilot Study|Completed||N/A|120|Actual|Children's Cancer Hospital Egypt 57357||2|||f||||t||||||||||2017-10-11 02:57:35.24518|2017-10-11 02:57:35.24518
NCT01600768|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2012-05-16|||February 2012||2012-02-01|February 2012|2012-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients||Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||2|||f||||||||||||||2017-10-11 02:57:35.362976|2017-10-11 02:57:35.362976
NCT01600755|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2016-11-10|||May 2012||2012-05-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Autologous Cell Therapy for Treatment of Fecal Incontinence|A Prospective Nonrandomized Study of Autologous Muscle Derived Cell (AMDC) Transplantation for Treatment of Fecal Incontinence|Recruiting||Phase 1/Phase 2|50|Anticipated|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 02:57:35.495189|2017-10-11 02:57:35.495189
NCT01600742|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-01-07|||August 2012||2012-08-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Vorinostat and Concurrent Whole Brain Radiotherapy for Brain Metastasis|Vorinostat and Concomitant Whole Brain Radiation Therapy in Patients With Brain Metastases: A Randomized, Double-blind, Placebo-controlled, Phase II Study|Terminated||Phase 2|4|Actual|National Taiwan University Hospital||2||Sponsor stops to provide the study drug.|f||||t||||||||||2017-10-11 02:57:35.620905|2017-10-11 02:57:35.620905
NCT01600729|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2013-09-27|2013-07-12||June 2012||2012-06-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Reliability of the Facial Wrinkle Scale in Japanese Subjects||Completed||N/A|66|Actual|Allergan|||1||f||||f||||||||||2017-10-11 02:57:35.822143|2017-10-11 02:57:35.822143
NCT01600703|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-01-20|2014-03-24||July 2012||2012-07-01|January 2013|2013-01-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans|Sitagliptin (®Januvia) Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans|Completed||Phase 2/Phase 3|21|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 02:57:36.675578|2017-10-11 02:57:36.675578
NCT01600690|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2013-08-12|||May 2012||2012-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|SStatin-EPC||Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients|Evaluation of the Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients. A Controlled Randomized Study|Completed||Phase 4|34|Actual|University of Padova||2|||f||||f||||||||||2017-10-11 02:57:37.441358|2017-10-11 02:57:37.441358
NCT01600677|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-08-18|2016-01-14||May 2012||2012-05-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|EMMA-RCT||Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions|Determining the Impact of a Medication Delivery Unit on Medication Adherence Immediately Following Hospitalization of Adults With Common Cardiac Conditions|Terminated||N/A|11|Actual|University of Pittsburgh|We terminated the study early after exhausting all possible approaches to increasing participant enrollment.|2||Terminated on 2/28/13, low enrollment; last participant med visit 5/13/13.|f||||t||||||||||2017-10-11 02:57:37.580923|2017-10-11 02:57:37.580923
NCT01600664|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2014-05-04|||June 2012||2012-06-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||"The Effect of the Use of Computer Game- My Diabetic Friend in Children With Type 1 Diabetes"|"Randomized Controlled Trial to Evaluate the Effect of 3 Months Use With Interactive Computer Game- My Diabetic Friend-Comparing to Conventional Diabetes Education on Metabolic Control, Quality of Life and Diabetes Knowledge in Children With Type 1 Diabetes."|Completed||N/A|30|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 02:57:37.916309|2017-10-11 02:57:37.916309
NCT01600651|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2013-10-01|||April 2012||2012-04-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|DAMAGE||Diffuse Acute Respiratory Distress Syndrome (ARDS), Recruitment Maneuver, and sRAGE (DAMAGE Study)|Effects Of A Recruitment Maneuver On Plasma Levels of sRAGE, The Soluble Form of The Receptor For Advanced Glycation End Products, In Patients With Diffuse Acute Respiratory Distress Syndrome (ARDS)|Completed||Phase 4|24|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 02:57:38.055789|2017-10-11 02:57:38.055789
NCT01600638|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-06-20|||April 2012||2012-04-01|April 2012|2012-04-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature|Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature|Completed||N/A|25|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 02:57:38.190485|2017-10-11 02:57:38.190485
NCT01600625|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2014-03-04|||November 2011||2011-11-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Minocycline on Cytokine Levels in Severe Meibomian Gland Dysfunction||Completed||N/A|46|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 02:57:38.286232|2017-10-11 02:57:38.286232
NCT01600612|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2013-05-30|||September 2012||2012-09-01|May 2013|2013-05-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial|Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial|Unknown status|Recruiting|N/A|300|Anticipated|Sohag University||3|||f||||t||||||||||2017-10-11 02:57:38.375519|2017-10-11 02:57:38.375519
NCT01600391|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-12-02|||May 2012||2012-05-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|VCTpilot||Visual Cues for Gait Training Post-stroke|Visual Cue Training to Improve Walking and Turning After Stroke: a Pilot Study|Completed||N/A|60|Actual|University of Salford||3|||f||||t||||||||||2017-10-11 02:57:41.556853|2017-10-11 02:57:41.556853
NCT01600599|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-05-17|||January 2011||2011-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|LATA||Reducing Post Operative Bleeding Following Cabg|Efficacy in Controlling Bleeding Post-coronary Bypass Surgery Using Combination of Local Application of Tranexamic Acid and Intravenous Tranexamic Compared to Intravenous Tranexamic Acid Alone. A Randomized Controlled Trial|Completed||N/A|40|Actual|University of Malaya||2|||f||||f||||||||||2017-10-11 02:57:38.507606|2017-10-11 02:57:38.507606
NCT01600573|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-10-10|||May 2012||2012-05-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)|A Phase I/II Study of Pazopanib and Weekly Topotecan in Patients With Platinum-resistant or Intermediate-sensitive Recurrent Ovarian Cancer|Recruiting||Phase 1/Phase 2|68|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||No||2017-10-11 02:57:38.72655|2017-10-11 02:57:38.72655
NCT01600560|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-04-17|||May 2012|Actual|2012-05-01|April 2017|2017-04-01|July 5, 2016|Actual|2016-07-05|November 9, 2015|Actual|2015-11-09||Observational|||Facilitating Completion of HPV Vaccination|Facilitating the Completion of the 3-Dose Series of HPV Vaccination in Males and Females|Completed||N/A|223|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 02:57:38.84369|2017-10-11 02:57:38.84369
NCT01600547|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-12-05|||May 2012||2012-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|January 2013|Actual|2013-01-01||Observational|OFOS||Odense Fallers and Osteoporosis Study|Odense Fallers and Osteoporosis Study|Completed||N/A|322|Actual|University of Southern Denmark|||3||f||||t||||||||||2017-10-11 02:57:38.930645|2017-10-11 02:57:38.930645
NCT01600534|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2014-09-10|||May 2012||2012-05-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||GooDMoMS: A Multimodel Pregnancy and Postpartum Intervention for Gestational Diabetics|GooDMomS: A Multimodel Pregnancy and Postpartum Intervention for Gestational Diabetics|Completed||N/A|24|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:57:39.014508|2017-10-11 02:57:39.014508
NCT01600521|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-04-07|||November 2004||2004-11-01|April 2015|2015-04-01|March 2012|Actual|2012-03-01|April 2011|Actual|2011-04-01||Interventional|||A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications|A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications|Completed||N/A|1748|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-11 02:57:39.116763|2017-10-11 02:57:39.116763
NCT01600508|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-06-15|||September 2011||2011-09-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Videoconference in Stoma Out-patient Clinic|. A Randomized Controlled Trial Comparing Videoconference and Outpatient Stoma Care|Completed||N/A|110|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 02:57:39.714082|2017-10-11 02:57:39.714082
NCT01600495|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2015-09-18|2012-05-16||September 2011||2011-09-01|September 2015|2015-09-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Transcutaneous Electrical Nerve Stimulation for Pain Relief During the Active Phase of Labor|Effects of Transcutaneous Nerve Electrical Stimulation for Pain Relief in Nulliparous Women in Active Phase of Labor|Completed||Phase 4|46|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:57:39.818305|2017-10-11 02:57:39.818305
NCT01600482|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-16|2017-07-24|2017-05-16||May 2012||2012-05-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)|Clinical Investigation Plan (CIP) for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003|Completed||N/A|241|Actual|Vasorum Ltd||2|||f||||t||||||||||2017-10-11 02:57:40.443593|2017-10-11 02:57:40.443593
NCT01600469|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2013-06-03|||January 2012||2012-01-01|April 2011|2011-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease|NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease|Completed||Phase 2|86|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-11 02:57:40.861991|2017-10-11 02:57:40.861991
NCT01600456|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2016-03-03|||March 2011||2011-03-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|OPT||Optimizing Posttraumatic Stress Disorder Treatment: Prolonged Exposure (PE) Versus PE Plus Sertraline|Optimizing PTSD Treatment: PE Versus PE Plus Sertraline|Active, not recruiting||Phase 3|150|Actual|Case Western Reserve University||4|||f||||t||||||||||2017-10-11 02:57:40.970887|2017-10-11 02:57:40.970887
NCT01600443|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-01-31|||April 2012||2012-04-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Comparison of Microtrauma in Urethra After Usage of Different Catheters|A Randomized Cross-over Study on Urethral Microtrauma After Intermittent Catheterization.|Terminated||N/A|21|Actual|Wellspect HealthCare||6||Planned interim analysis showed study was underpowered|f||||||||||||||2017-10-11 02:57:41.073278|2017-10-11 02:57:41.073278
NCT01600430|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-02-08|||June 2012||2012-06-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Vitamin D Supplementation for Extremely Preterm Infants|Early Vitamin D Supplementation for Prevention of Respiratory Morbidity in Extremely Preterm Infants: A Randomized Clinical Trial|Completed||Phase 2/Phase 3|100|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-10-11 02:57:41.184308|2017-10-11 02:57:41.184308
NCT01600417|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-11-21|||May 2012||2012-05-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Investigation of Lumbo-sacral Instability Using Custom Made Table - a Pilot Study|Radiologic Presentation of Lumbo-sacral Instability Using a Custom Made Table - a Pilot Study|Terminated||N/A|4|Actual|Swiss Paraplegic Centre Nottwil|||1|principal investigator has left the institution|f||||f||||||||||2017-10-11 02:57:41.289729|2017-10-11 02:57:41.289729
NCT01600404|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-11-16|||December 2011||2011-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Effects of Antimuscarinics on Cognition in Spinal Cord Injury|Effects of Antimuscarinic Drugs on the Cognition of Patients With Acute Spinal Cord Injury|Completed||N/A|32|Actual|Swiss Paraplegic Centre Nottwil|||2||f||||f||||||||||2017-10-11 02:57:41.433485|2017-10-11 02:57:41.433485
NCT01600378|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-10-27|||May 2012||2012-05-01|October 2016|2016-10-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Observational|||Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases|Prospective Data Collection of Clinical, Pulmonary Function, Radiological, Bronchoscopic and Fibered Confocal Fluorescence Microscopy Imaging, and Pathological Characteristics in Patients With Diffuse Parenchymal Lung Diseases|Recruiting||N/A|500|Anticipated|Singapore General Hospital|||1||f||||f||||||||||2017-10-11 02:57:41.693434|2017-10-11 02:57:41.693434
NCT01600365|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-22|2012-05-15|||May 2012||2012-05-01|May 2012|2012-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus|"Prospective, Interventional, Randomized, Double-masked With the Use of Ganciclovir Gel 0.3% for Treatment of Conjunctivitis Caused by Adenovirus."|Unknown status|Not yet recruiting|Phase 3|22|Anticipated|Adapt Produtos Oftalmológicos Ltda.||2|||f||||t||||||||||2017-10-11 02:57:41.796324|2017-10-11 02:57:41.796324
NCT01600352|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2016-10-27|||May 2012||2012-05-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Specific Autoantibody Testing in Patients With Interstitial Lung Disease|To Evaluate the Clinical Utility of Specific Autoantibody Testing in Patients With Interstitial Lung Disease|Recruiting||N/A|20|Anticipated|Singapore General Hospital|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 02:57:41.906325|2017-10-11 02:57:41.906325
NCT01600339|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2015-05-10|||May 2012||2012-05-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)|A Single Arm, Multicenter, Open-label Phase II Trial of Cabazitaxel as Second Line Treatment of Patients With Locally Advanced or Metastatic Urothelial Carcinoma|Completed||Phase 2|19|Actual|Rambam Health Care Campus||1|||f||||t||||||||||2017-10-11 02:57:42.023411|2017-10-11 02:57:42.023411
NCT01600326|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-02-20|2017-02-20||July 2010|Actual|2010-07-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection|A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection Versus Tenotomy for Treatment of Gluteus Minimus and Medius Tendinosis|Completed||Phase 2|30|Actual|University of Michigan|Two limitations include the small sample size and the retrospective nature of the long term secondary patient outcome.|2|||f||||t|t|f|||f|||No||2017-10-11 02:57:42.13703|2017-10-11 02:57:42.13703
NCT01600313|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-05-16|||June 2008||2008-06-01|May 2012|2012-05-01|June 2012|Anticipated|2012-06-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Low Calorie Diet With Rice Bran Oil on Cardiovascular Risk Factors in Hyperlipidemic Patients|Effect of Low Calorie Diet With Rice Bran Oil on Cardiovascular Risk Factors in Hyperlipidemic Patients|Unknown status|Active, not recruiting|N/A|50|Anticipated|Qazvin University Of Medical Sciences||1|||f||||t||||||||||2017-10-11 02:57:42.515554|2017-10-11 02:57:42.515554
NCT01600300|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-15|||August 2002||2002-08-01|May 2012|2012-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy of Electrical Micro-current Retinal Stimulation for Treatment of Dry Age-related Macular Degeneration|A Double-Blind, Placebo-Controlled Feasibility Study to Evaluate the Efficacy of TESMAC™ (Transcutaneous Electrical Stimulation of the Macula)|Completed||Phase 1/Phase 2|40|Actual|Acuity Medical International, Inc.||2|||f||||||||||||||2017-10-11 02:57:42.623509|2017-10-11 02:57:42.623509
NCT01600287|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2013-07-10|2012-12-22||January 2012||2012-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Closed Loop Propofol Administration in Pediatric Cardiac Surgery|Evaluation of Closed Loop Anaesthesia Delivery System for Propofol Anaesthesia in Pediatric Cardiac Surgery|Completed||N/A|40|Actual|Postgraduate Institute of Medical Education and Research|anesthesiologist could get visual impression of his performance.|2|||f||||f||||||||||2017-10-11 02:57:42.764149|2017-10-11 02:57:42.764149
NCT01600261|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-06-27|||April 2012||2012-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|||iCam Clinical Validation Study|iCam Clinical Validation Study|Completed||N/A|131|Actual|Optovue|||1||f||||f||||||||||2017-10-11 02:57:43.502752|2017-10-11 02:57:43.502752
NCT01600248|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-08-19|||June 2012||2012-06-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Online Chronic Pain Therapy for Adults|Online Chronic Pain Therapy for Adults|Completed||N/A|25|Actual|University of Manitoba||1|||f||||t||||||||||2017-10-11 02:57:43.58306|2017-10-11 02:57:43.58306
NCT01600235|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2017-04-24|||June 2012||2012-06-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)|Safety and Efficacy of Therapeutic Induced Hypertension in Patients With Acute Non-cardioembolic Ischemic Stroke: A Multicenter, Randomized, Open Label, Prospective, Phase 3 Study|Recruiting||Phase 3|170|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 02:57:43.673239|2017-10-11 02:57:43.673239
NCT01600222|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-07-28|2015-11-13||May 2012||2012-05-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris|A Phase 2 Maximal Use Systemic Exposure (MUSE) Study Evaluating the Safety and Efficacy of LEO 90100 Used Once Daily in Subjects With Extensive Psoriasis Vulgaris|Completed||Phase 2|37|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-11 02:57:43.808824|2017-10-11 02:57:43.808824
NCT01600209|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2015-05-12|||October 2011||2011-10-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Observational|||Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing|Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing|Completed||N/A|674|Actual|Exact Sciences Corporation|||1||f||||f||||||Samples With DNA|"     Provide anonymous, clinically characterized specimens for bio-repository for future     colorectal cancer-related test development.   "|||2017-10-11 02:57:44.431274|2017-10-11 02:57:44.431274
NCT01600196|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2012-05-15|||January 2006||2006-01-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|July 2009|Actual|2009-07-01||Interventional|||Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus|Surgical Resection Versus Best Supportive Care for Resectable Hepatocellular Carcinoma Invading the First Branch of Portal Vein|Completed||Phase 4|126|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 02:57:44.542862|2017-10-11 02:57:44.542862
NCT01600183|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-15|||August 2012||2012-08-01|May 2012|2012-05-01||||August 2013|Anticipated|2013-08-01||Interventional|||Safety and Efficacy of the Universal Neonatal Foot Orthosis in the Treatment of Metatarsus Adductus (MTA)|Safety and Efficacy of the Universal Neonatal Foot Orthosis in the Treatment of Metatarsus Adductus (MTA)|Unknown status|Not yet recruiting|N/A|50|Anticipated|Unfo Ltd.||2|||f||||f||||||||||2017-10-11 02:57:44.626258|2017-10-11 02:57:44.626258
NCT01600170|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-01-13|||January 2013||2013-01-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)|Statin Modulation of Monocyte/Macrophage Activation for HAND Treatment|Active, not recruiting||Phase 4|30|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 02:57:44.706715|2017-10-11 02:57:44.706715
NCT01600157|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-12|2015-11-15|||April 2013||2013-04-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Ambulant Laparoscopic Nephrectomy; Are There Limiting Factors|Ambulant Laparoscopic Nephrectomy|Completed||N/A|62|Actual|University Hospital Roskilde||1|||f||||t||||||||||2017-10-11 02:57:44.807829|2017-10-11 02:57:44.807829
NCT01600144|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2014-08-06|||March 2012||2012-03-01|March 2012|2012-03-01||||August 2014||2014-08-01||Observational|||Data Collection for CAD Evaluation||Unknown status|Recruiting|N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 02:57:44.901033|2017-10-11 02:57:44.901033
NCT01600131|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-06-30|||June 22, 2015|Actual|2015-06-22|June 2017|2017-06-01|July 31, 2018|Anticipated|2018-07-31|May 31, 2018|Anticipated|2018-05-31||Interventional|RESCUE||RESCUE Stroke Caregiver Website to Enhance Discharge Planning|Utilizing the RESCUE Stroke Caregiver Website to Enhance Discharge Planning|Recruiting||N/A|240|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 02:57:44.990563|2017-10-11 02:57:44.990563
NCT01600118|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-10-09|||September 2011||2011-09-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Shock Waves on Dental Parameters|Effect of Low-energy Extracorporeal Shock Waves on Periodontal and Endodontic Parameters|Completed||Phase 2/Phase 3|72|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 02:57:45.156599|2017-10-11 02:57:45.156599
NCT01600105|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-07-13|||May 2010||2010-05-01|July 2016|2016-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)|Prospective Detection of Liver Fibrosis With MRI Compared to Fibroscan and Blood Tests|Recruiting||N/A|100|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-11 02:57:45.243411|2017-10-11 02:57:45.243411
NCT01600092|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-02-17|2015-03-09||April 2013||2013-04-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)|A Double-blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of a New Formulation of RotaTeq™|Completed||Phase 3|1020|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:57:45.36674|2017-10-11 02:57:45.36674
NCT01600079|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-08-17|||May 15, 2012|Actual|2012-05-15|August 2017|2017-08-01|October 30, 2023|Anticipated|2023-10-30|October 30, 2023|Anticipated|2023-10-30||Observational|||ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)|Post-Licensure Observational Study of the Long-term Effectiveness of ZOSTAVAX™|Active, not recruiting||N/A|30000|Anticipated|Merck Sharp & Dohme Corp.|||2||f||||t||||||||||2017-10-11 02:57:45.854924|2017-10-11 02:57:45.854924
NCT01600066|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-12-02|||May 2012||2012-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Erectile Dysfunction in Severe Obstructive Sleep Apnea: Effects of CPAP Therapy|Erectile Dysfunction in Severe Obstructive Sleep Apnea : Effects of CPAP Therapy|Completed||N/A|200|Actual|University of Giessen|||1||f||||t||||||Samples Without DNA|"     blood specimens for the determination of lipids and glucose   "|||2017-10-11 02:57:45.948507|2017-10-11 02:57:45.948507
NCT01600053|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-10-24|2015-12-16||November 2011||2011-11-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia|A Phase II Trial of Revlimid® as Consolidation Treatment of Residual Disease in Patients With Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 2|11|Actual|University of California, San Diego||1||interim analysis showed that the trial will not meet the interim endpoint.|f||||t||||||||||2017-10-11 02:57:46.01365|2017-10-11 02:57:46.01365
NCT01600040|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-04-19|||May 2013||2013-05-01|April 2017|2017-04-01|May 2021|Anticipated|2021-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix|Pilot Study of Adjuvant Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix With Metastases to Regional Lymph Nodes|Recruiting||N/A|30|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 02:57:48.055934|2017-10-11 02:57:48.055934
NCT01600027|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-03-15|||January 2012||2012-01-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Dexmedetomidine Addition to Fascia Iliaca Compartment Block|Effects of Dexmedetomidine Addition to Bupivacaine on the Quality of Fascia Iliaca Compartment Block (FICB) in Children Undergoing Femur Fracture Surgery|Completed||Phase 1|28|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 02:57:48.153568|2017-10-11 02:57:48.153568
NCT01600014|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-04-04|2015-12-17|2015-04-07|May 2012||2012-05-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp|Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp|Completed||Phase 3|463|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 02:57:48.248078|2017-10-11 02:57:48.248078
NCT01600001|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2013-10-29||||||October 2013|2013-10-01||||||||Interventional|||A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)|A Randomized, Double-blind, Placebo-controlled, Phase II Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)|Completed||Phase 2|75|Anticipated|Kissei Pharmaceutical Co., Ltd.||5|||f||||f||||||||||2017-10-11 02:57:48.736481|2017-10-11 02:57:48.736481
NCT01599988|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-01-15|||October 2011||2011-10-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Study to Compare Milk Protein Isolate (MPI) With Caseinate in Terms of Protein Utilization|A Randomised, Double-blinded Study to Compare Milk Protein Isolate (MPI)With Caseinate in Terms of Protein Utilization in Healthy Elderly Subjects|Completed||Phase 2/Phase 3|24|Actual|University College Cork||2|||f||||f||||||||||2017-10-11 02:57:48.826511|2017-10-11 02:57:48.826511
NCT01599975|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-14|||May 2012||2012-05-01|May 2012|2012-05-01|September 2014|Anticipated|2014-09-01|May 2014|Anticipated|2014-05-01||Interventional|||A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV|Phase III, Placebo-Controlled, Double-Blind Crossover Study of Slow-Release Methylphenidate (Concerta ™) for Treatment of HIV Associated Neurocognitive Disorder|Unknown status|Recruiting|Phase 3|40|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 02:57:49.018947|2017-10-11 02:57:49.018947
NCT01599962|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-10-02|||March 2012||2012-03-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|Mira-Basel||Influence of Cincalcet on Cognitive Functions in Healthy Human Subjects|Influence of Cincalcet on Cognitive Functions in Healthy Human Subjects|Completed||Phase 2|40|Actual|University of Basel||2|||f||||t||||||||||2017-10-11 02:57:49.147949|2017-10-11 02:57:49.147949
NCT01599949|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-05-27|||August 2012||2012-08-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy|A Phase 2, Multicenter, Single-Arm, Study to Evaluate the Efficacy and Safety of Single-Agent Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Subjects With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy|Completed||Phase 2|120|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 02:57:49.244167|2017-10-11 02:57:49.244167
NCT01599936|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-03-18|||April 2004||2004-04-01|March 2016|2016-03-01|June 2007|Actual|2007-06-01|October 2006|Actual|2006-10-01||Interventional|||Open Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation|Open Label, Confirmatory, Controlled Clinical Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation|Completed||Phase 3|50|Actual|Instituto Bioclon S.A. de C.V.||1|||f||||f||||||||||2017-10-11 02:57:49.483074|2017-10-11 02:57:49.483074
NCT01599923|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-14|||May 2005||2005-05-01|May 2012|2012-05-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|||Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation|Open Label, Confirmatory, Controlled Clinical Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation|Completed||Phase 3|29|Actual|Instituto Bioclon S.A. de C.V.||1|||f||||f||||||||||2017-10-11 02:57:49.594981|2017-10-11 02:57:49.594981
NCT01599910|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-01-04|||October 2011||2011-10-01|January 2017|2017-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Scribes in the Emergency Department|The Effect of Scribes in the Emergency Department|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center|||1|Funding not received|f||||f||||||||||2017-10-11 02:57:49.6953|2017-10-11 02:57:49.6953
NCT01599897|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-09-14|||August 2012||2012-08-01|September 2017|2017-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers|A Phase 1, Randomized, Dose-escalation Study to Evaluate the Safety and Immunogenicity of the ID93 + GLA-SE Vaccine at Two Dose Levels of the ID93 Antigen and the GLA-SE Adjuvant in Healthy Adults|Completed||Phase 1|60|Actual|IDRI||6|||f||||t||||||||||2017-10-11 02:57:49.773763|2017-10-11 02:57:49.773763
NCT01599871|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-08-28|||January 2011||2011-01-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|ASSET||Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease|Multicenter 52 Weeks Double Blind Placebo-controlled Trial for the Assessment of Theophylline on Top of Combination Therapy in Severe COPD|Completed||Phase 3|70|Actual|Hospital Son Espases||2|||f||||f||||||||||2017-10-11 02:57:49.984969|2017-10-11 02:57:49.984969
NCT01599858|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-05-14|||August 1996||1996-08-01|May 2012|2012-05-01|October 1996|Actual|1996-10-01|October 1996|Actual|1996-10-01||Interventional|||Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers|YF476: Effects of Repeated Dosing at 2 Dose Levels on 24-hour Ambulatory Gastric pH Compared With Placebo and Omeprazole in Healthy Volunteers|Completed||Phase 1|49|Actual|Trio Medicines Ltd.|||||f||||f||||||||||2017-10-11 02:57:50.115911|2017-10-11 02:57:50.115911
NCT01599845|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2012-05-14|||May 2012||2012-05-01|May 2012|2012-05-01|May 2013|Anticipated|2013-05-01|December 2012|Anticipated|2012-12-01||Observational|Nanoexposure||The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers|The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers (Nanoexposure)|Unknown status|Not yet recruiting|N/A|60|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 02:57:50.240271|2017-10-11 02:57:50.240271
NCT01599832|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-05-08|2016-10-25||June 2012||2012-06-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer|DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer|Terminated||N/A|20|Actual|University of Chicago||1||Poor accrual|f||||f||||||||||2017-10-11 02:57:50.345168|2017-10-11 02:57:50.345168
NCT01599819|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2015-06-26|||September 2011||2011-09-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||BAX 855 Dose-Escalation Safety Study|BAX 855 (PEGylated Recombinant Factor VIII): A Phase 1, Prospective, Open Label, Cross-Over, Dose-Escalation Study in Previously Treated Patients (PTPs) With Severe (FVIII < 1%) Hemophilia A|Completed||Phase 1|19|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-10-11 02:57:50.684095|2017-10-11 02:57:50.684095
NCT01599455|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-08-02|||May 2012||2012-05-01|August 2017|2017-08-01|May 2022|Anticipated|2022-05-01|May 2019|Anticipated|2019-05-01||Observational|||Baseline Cardiovascular Measurements in Pediatric Spinal Cord Injury|Cardiovascular Measurements at Baseline and During Cystometry in Pediatric Spinal Cord Injury|Recruiting||N/A|315|Anticipated|Shriners Hospitals for Children|||3||f||||f||||||||||2017-10-11 02:58:06.355149|2017-10-11 02:58:06.355149
NCT01599806|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-15|2017-08-31|2015-11-04||October 2012||2012-10-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Safety analysis set|Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)|A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults|Completed||Phase 3|641|Actual|Pfizer||2|||f||||||||||||||2017-10-11 02:57:51.105995|2017-10-11 02:57:51.105995
NCT01599793|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-07-05|||May 2012||2012-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib on Bone Metastases in Patients With Castrate Resistant Prostate Cancer|A Phase II Study of MRI Based Functional Imaging for the Evaluation of Bone Metastasis in Men With Castrate Resistant Prostate Cancer Receiving XL184|Active, not recruiting||Phase 2|25|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 02:57:55.786268|2017-10-11 02:57:55.786268
NCT01599780|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2016-10-21|||January 2010||2010-01-01|May 2016|2016-05-01||||February 2018|Anticipated|2018-02-01||Observational|||Language Development in Preterm Children|On- and Off-line Measures of Language Development in Preterm Children|Active, not recruiting||N/A|100|Anticipated|Stanford University|||2||f||||f||||||||||2017-10-11 02:57:55.880976|2017-10-11 02:57:55.880976
NCT01599767|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-03-17|||December 2011||2011-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Spaulding-Harvard Model System: Effects of Transcranial Direct Current Stimulation (tDCS) on Chronic Pain in Spinal Cord Injury|Spaulding-Harvard Spinal Cord Injury (SH-SCI) Study: Effects of tDCS on Chronic Pain in Spinal Cord Injury.|Completed||N/A|46|Actual|Spaulding Rehabilitation Hospital||2|||f||||f||||||||||2017-10-11 02:57:55.964|2017-10-11 02:57:55.964
NCT01599754|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-06-27|||April 2012||2012-04-01|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|ATLAS||Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients|Adjuvant Axitinib Treatment of Renal Cancer: A Randomized Double-blind Phase 3 Study of Adjuvant Axitinib vs. Placebo in Subjects at High Risk of Recurrent RCC|Active, not recruiting||Phase 3|700|Anticipated|SFJ Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 02:57:56.064292|2017-10-11 02:57:56.064292
NCT01599741|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-01-16|2013-09-27||June 2012||2012-06-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||X-ray Dose Reduction Study for Endovascular Interventional Radiology|Clinical Validation and Evaluation of X-ray Image Processing for Endovascular Digital Subtraction Angiography and Intervention|Completed||N/A|51|Actual|Philips Healthcare||2|||f||||f||||||||||2017-10-11 02:57:56.539881|2017-10-11 02:57:56.539881
NCT01599728|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2013-06-24|||May 2012||2012-05-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Urocortins in Patients With Heart Failure|Urocortins 2 & 3-Effects on Forearm Arterial Blood Flow in Patients With Heart Failure|Completed||N/A|22|Actual|University of Edinburgh||2|||f||||f||||||||||2017-10-11 02:57:56.807531|2017-10-11 02:57:56.807531
NCT01599715|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-05-10|||September 2010||2010-09-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TULIP||Translating Unique Learning for Incontinence Prevention|Translating Unique Learning for Incontinence Prevention for Women Over the Age of 55|Completed||Phase 2|647|Actual|University of Michigan||2|||f||||t||||||||Yes|Manuscript preparation for data dissemination is currently in progress.|2017-10-11 02:57:56.935158|2017-10-11 02:57:56.935158
NCT01599702|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-04-28|||May 2012||2012-05-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|IBD-02||Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease|A Prospective, Non-controlled, Safety Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease (PROMISE)|Completed||Phase 3|21|Actual|Pharmacosmos A/S||2|||f||||f||||||||||2017-10-11 02:57:57.051807|2017-10-11 02:57:57.051807
NCT01599676|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-07-31|||March 2011||2011-03-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CITREX||Citrulline, Exercise Training and Muscle Strength in the Elderly|"Effect of Citrulline Supplementation on Muscle Strength in Elderly Institutionalized Subjects Undergoing an Exercise Training Programme. "|Completed||N/A|91|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||Undecided||2017-10-11 02:57:57.267385|2017-10-11 02:57:57.267385
NCT01599650|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-09-21|2016-05-26||May 2012||2012-05-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|BRIGHTER||Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion|A 24-month, Phase IIIb, Open-label, Randomized, Active Controlled, 3-arm, Multicenter Study Assessing the Efficacy and Safety of an Individualized, Stabilization-criteria-driven PRN Dosing Regimen With 0.5-mg Ranibizumab Intravitreal Injections Applied as Monotherapy or With Adjunctive Laser Photocoagulation in Comparison to Laser Photocoagulation in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion|Completed||Phase 3|455|Actual|Novartis||3|||f||||f||||||||||2017-10-11 02:57:57.544201|2017-10-11 02:57:57.544201
NCT01599442|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2014-04-04|||June 2010||2010-06-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|August-1||Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia|Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia|Terminated||N/A|123|Actual|GWT-TUD GmbH|||1|recrution number was not reached|f||||f||||||||||2017-10-11 02:58:06.442742|2017-10-11 02:58:06.442742
NCT01599637|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2015-03-11|2014-09-10||April 2012||2012-04-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment|A Phase II, Multi-centre, Randomized, Double Blind, Placebo-controlled Study to Determine the Mode of Action of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)|Completed||Phase 2|40|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:58:00.335983|2017-10-11 02:58:00.335983
NCT01599624|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-08-17|||October 2012||2012-10-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SRTS||Stress Resilience Training System|Stress Resilience Training System|Completed||N/A|68|Actual|United States Naval Medical Center, San Diego||2|||f||||t||||||||No||2017-10-11 02:58:03.806038|2017-10-11 02:58:03.806038
NCT01599611|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-15|||March 2010||2010-03-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study|Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study|Completed||N/A|128|Actual|University of Aarhus|||2||f||||f||||||||||2017-10-11 02:58:03.903707|2017-10-11 02:58:03.903707
NCT01599598|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-08-17|||April 2012||2012-04-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Coherence Training for Military Personnel|Coherence Training for Military Personnel|Completed||N/A|192|Actual|United States Naval Medical Center, San Diego||2|||f||||f||||||||No||2017-10-11 02:58:03.981802|2017-10-11 02:58:03.981802
NCT01599585|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-03-28|2016-12-12||May 2012||2012-05-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|January 2015|Actual|2015-01-01||Interventional|||A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression|A Randomized Controlled Trial of In-Home Tele-behavioral Health Care Utilizing Behavioral Activation for Depression|Completed||N/A|121|Actual|National Center for Telehealth and Technology||2|||f||||t||||||||No||2017-10-11 02:58:04.089419|2017-10-11 02:58:04.089419
NCT01599572|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-05-19|||July 2009||2009-07-01|May 2015|2015-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effect of Zinc Supplementation on Serum Zinc Level in Nursing Home Elderly|Zinc Intervention in Nursing Home Elderly|Completed||Phase 1|31|Actual|Tufts University||1|||f||||f||||||||||2017-10-11 02:58:04.95241|2017-10-11 02:58:04.95241
NCT01599559|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-08-22|||November 2011||2011-11-01|July 2017|2017-07-01|May 2025|Anticipated|2025-05-01|May 2017|Actual|2017-05-01||Interventional|||Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma|IELSG37: A Randomized, Open-label, Multicentre, Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma (PMLBCL)|Recruiting||N/A|540|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||2|||f||||||||||||||2017-10-11 02:58:05.088254|2017-10-11 02:58:05.088254
NCT01599546|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-04-19|||January 2012||2012-01-01|May 2012|2012-05-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Observational|||Reading in Preterm and Full-term Children: Neural Basis and Prediction|Reading in Preterm and Full-term Children: Neural Basis and Prediction|Active, not recruiting||N/A|100|Anticipated|Stanford University|||2||f||||f||||||||||2017-10-11 02:58:05.61865|2017-10-11 02:58:05.61865
NCT01599533|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-10-17|||June 2012||2012-06-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|February 2017|Anticipated|2017-02-01||Interventional|||Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm|Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm : Prevalence, Description of the Different Thoracic Aortic Phenotypes by Aortic Volumetric Numerized Imaging and Their Relationship With Epidemiologic, Clinical, Biological and Genetic Factors|Recruiting||N/A|500|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 02:58:05.726469|2017-10-11 02:58:05.726469
NCT01599520|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-05-18|||January 9, 2012|Actual|2012-01-09|May 2017|2017-05-01|February 28, 2018|Anticipated|2018-02-28|September 1, 2016|Actual|2016-09-01||Interventional|||Stress Management Training for Latinas Receiving Chemotherapy|Stress Management Training for Latinas Receiving Chemotherapy|Active, not recruiting||N/A|140|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f|f|f||||||||2017-10-11 02:58:05.837337|2017-10-11 02:58:05.837337
NCT01599507|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2014-02-27|||December 2011||2011-12-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study of FG-4592 in Subjects With Chronic Kidney Disease in China|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Sequential Group, Dose Ranging Safety and Efficacy Study of FG 4592 in Non-dialysis Chronic Kidney Disease (CKD) Subjects With Anemia|Completed||Phase 2|91|Actual|FibroGen||2|||f||||f||||||||||2017-10-11 02:58:05.96142|2017-10-11 02:58:05.96142
NCT01599494|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-10-30|||March 2014||2014-03-01|October 2015|2015-10-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Interventional|||An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)|A Multi-center, Open-label, Randomized Trial in India to Investigate the Efficacy and Safety of a Single Injection of MK-8962 (Corifollitropin Alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation Using Daily Recombinant FSH as a Reference (Phase III, Protocol No. MK-8962-029-00 [Also Known as SCH900962, P07056])|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 02:58:06.078157|2017-10-11 02:58:06.078157
NCT01599481|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-08-19|||October 2011||2011-10-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CAREER||Career Management to Improve Education, Employment and Retention for People With Anxiety and Depression|Effectiveness and Cost Effectiveness of Individual Career Management for People With Anxiety and Depression: A Randomised Controlled Trial|Completed||Phase 2|261|Actual|South London and Maudsley NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 02:58:06.168412|2017-10-11 02:58:06.168412
NCT01599468|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-21|||July 2011||2011-07-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Can Tranexamic Acid Reduce Bleeding After Post Partum Hemorrhage in Cesarean Section Delivery|Effects of Tranexamic Acid on Post Partum Hemorrhage by Uterine Atony After Cesarean Section Delivery: a Randomized, Placebo Controlled Trial.|Completed||Phase 4|74|Actual|Hédi Chaker Hospital||2|||f||||f||||||||||2017-10-11 02:58:06.267422|2017-10-11 02:58:06.267422
NCT01599429|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2014-09-24|||October 2011||2011-10-01|September 2014|2014-09-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Observational|TEP-FLT-LMA||Study of the Predictive Marker FLT in Patients Suffering From AML|Use of FLT-TEP Scan as Predictive Marker and Early Prognostic in Patients Suffering From AML Treated by Chemotherapy|Unknown status|Recruiting|N/A|24|Anticipated|Centre de recherche du Centre hospitalier universitaire de Sherbrooke|||1||f||||t||||||||||2017-10-11 02:58:06.513846|2017-10-11 02:58:06.513846
NCT01599416|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-15|||June 2011||2011-06-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Influence of U-relax on Vaginal Health Promotion and HPV DNA Test Change From Positive to Negative|Randomized, Double-blind, Placebo-controlled Study ,Oral U-relax in the Influence of the Vaginal Environment Health Promotion, and the HPV DNA Test Index Change From Positive to Negative on the HPV Infection Women|Unknown status|Recruiting|Phase 2|80|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 02:58:06.617629|2017-10-11 02:58:06.617629
NCT01599403|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-02-09|||April 2012|Actual|2012-04-01|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Thoracic Blocks Versus Thoracic Epidural and Patient Controlled Anesthesia in Traumatic Rib Fracture Patients|Comparative Effectiveness of Continuous Thoracic Paravertebral Blocks Versus Thoracic Epidural and Continuous Intercostal Blocks Versus Patient-Controlled Anesthesia in Traumatic Rib Fracture Patients|Completed||N/A|50|Actual|Brigham and Women's Hospital||4|||f||||f||||||||||2017-10-11 02:58:06.708086|2017-10-11 02:58:06.708086
NCT01599390|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2013-02-21|||July 2012||2012-07-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Influenza Burden Assessment in the United States, July1997 - up to April 2009|Burden of Influenza in the United States, July 1997 up to April 2009|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 02:58:06.799166|2017-10-11 02:58:06.799166
NCT01599377|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-07-08|||May 2012||2012-05-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Tofacitinib Bioequivalence Study Comparing Tablets And Capsules|Phase 1, Open-Label, Randomized, Single-Dose, Cross-Over, Bioequivalence Study Comparing Tablets (5 And 10 Mg) And Capsules (5 And 10 Mg) Of Tofacitinib Under Fasted Conditions In Healthy Volunteers|Completed||Phase 1|50|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 02:58:06.888598|2017-10-11 02:58:06.888598
NCT01599364|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2016-08-14|||April 2014||2014-04-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|April 2016|Actual|2016-04-01||Interventional|ATLAS||Atazanavir/r + Lamivudine Dual Therapy|Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression|Active, not recruiting||Phase 4|266|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||No||2017-10-11 02:58:06.976233|2017-10-11 02:58:06.976233
NCT01599351|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-15|||July 2009||2009-07-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography Between Prone and Left Lateral Decubitus|Different Radiation Exposures to Patient and Endoscopists Between Performing ERCP in Patients Lying Prone and Left Lateral Decubitus|Completed||Phase 4|40|Actual|Chulalongkorn University||2|||f||||f||||||||||2017-10-11 02:58:07.118155|2017-10-11 02:58:07.118155
NCT01599338|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-31|||January 2011||2011-01-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|January 2011|Actual|2011-01-01||Interventional|||Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients|Influence du Victoza (Liraglutide,Analogue GLP-1) Sur Les Performances Gustatives, le Rassasiement Sensoriel spécifique, le Liking et le Wanting Chez Les Patients diabétiques de Type 2.|Completed||N/A|30|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||f||||||||||2017-10-11 02:58:07.194676|2017-10-11 02:58:07.194676
NCT01599325|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2017-01-30|2016-01-29||July 2012||2012-07-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|January 2015|Actual|2015-01-01||Interventional||ITT includes all participants who had been screened and enrolled into the study.|Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome|A Phase 2, Open-Label, Single-Arm Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Azacitidine in Adult Chinese Subjects With Higher-Risk Myelodysplastic Syndromes|Active, not recruiting||Phase 2|72|Actual|Celgene||1|||f||||f||||||||||2017-10-11 02:58:07.339643|2017-10-11 02:58:07.339643
NCT01599312|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2015-02-08|||May 2012||2012-05-01|February 2015|2015-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Forces on Teeth During Videolaryngoscopy|Forces Exerted on Upper and Lower Teeth During Intubation: a Randomized, Cross-over Trial Comparing Indirect Videolaryngoscopy to Direct Videolaryngoscopy.|Completed||N/A|100|Actual|Catharina Ziekenhuis Eindhoven||4|||f||||f||||||||||2017-10-11 02:58:08.591233|2017-10-11 02:58:08.591233
NCT01599299|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2014-03-05|||March 2012||2012-03-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|||Comparison of the Right and Left Internal Jugular Vein Using Ultrasound|Comparison of the Diameter, Cross-sectional Area and Position of the Left and Right Internal Jugular Vein in Adults Using Ultrasound|Completed||N/A|100|Actual|Catharina Ziekenhuis Eindhoven|||1||f||||t||||||||||2017-10-11 02:58:08.720109|2017-10-11 02:58:08.720109
NCT01599286|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-10-05|||September 2012|Actual|2012-09-01|October 2017|2017-10-01|December 2019|Anticipated|2019-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia|Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia|Recruiting||Phase 2|114|Anticipated|Children's Research Institute||2|||f||||t||||||||||2017-10-11 02:58:08.824919|2017-10-11 02:58:08.824919
NCT01599273|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-01-26|||May 2012||2012-05-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections||Completed||Phase 4|50|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 02:58:09.032928|2017-10-11 02:58:09.032928
NCT01599260|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-08-15|||May 2012|Actual|2012-05-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Resistance Exercise in Rheumatic Disease|Resistance Exercise in Rheumatic Disease|Recruiting||N/A|10|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 02:58:09.121892|2017-10-11 02:58:09.121892
NCT01594437|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2014-03-19|||May 2012||2012-05-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody|Phase 1 Study of TCN-202 (Human Anti-Cytomegalovirus Monoclonal Antibody) in Healthy Adult Volunteers|Completed||Phase 1|48|Actual|Theraclone Sciences, Inc.||2|||f||||t||||||||||2017-10-11 02:59:39.898087|2017-10-11 02:59:39.898087
NCT01599247|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2014-08-07|||July 2011||2011-07-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Natural History of Hopelessness, Suicidality, and Optimism in Psychiatric Inpatients Following Discharge|Natural History of Hopelessness, Suicidality, and Optimism in Psychiatric Inpatients Following Discharge|Completed||N/A|46|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:58:09.223253|2017-10-11 02:58:09.223253
NCT01599234|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2013-06-13|2012-07-11||March 2005||2005-03-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis|A Double Blind, Randomised, Placebo Controlled, Parallel Group Study of Sativex, in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis.|Completed||Phase 3|337|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-10-11 02:58:09.362109|2017-10-11 02:58:09.362109
NCT01599221|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-09-10|||March 2012||2012-03-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|July 2012|Actual|2012-07-01||Observational|||Observational Retrospective and Prospective Study on the Treatment of Femoral Fractures With EBA2|Observational Retrospective and Prospective Study on the Treatment of Lateral Proximal Femoral Fractures With Medical Device EBA2|Unknown status|Active, not recruiting|N/A|40|Anticipated|Citieffe S.r.l|||1||f||||f||||||||||2017-10-11 02:58:10.201931|2017-10-11 02:58:10.201931
NCT01599208|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2014-09-15|||August 2012||2012-08-01|September 2014|2014-09-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|||Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe|Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe|Suspended||Early Phase 1|80|Anticipated|Brainsway||6||no IRB|f||||t||||||||||2017-10-11 02:58:10.295077|2017-10-11 02:58:10.295077
NCT01599195|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-01-31|||April 2010|Actual|2010-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|September 2014|Actual|2014-09-01||Observational|||Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis|Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis|Terminated||N/A|18|Actual|Albert Einstein Healthcare Network|||1|Enrollment did not progress as anticipated|f||||f||t|f|f|f|||No||2017-10-11 02:58:10.379898|2017-10-11 02:58:10.379898
NCT01599182|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-06-22|||February 2012||2012-02-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer|Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer|Completed||N/A|9|Actual|University of Waterloo|||2||f||||f||||||Samples Without DNA|"     Measurements related to glucose, lipid and immune metabolism will be measured.   "|||2017-10-11 02:58:10.476636|2017-10-11 02:58:10.476636
NCT01599169|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2013-04-21|||May 2012||2012-05-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome|Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome. Double-blind, Randomized, Monocentric Trial With Two Parallel Groups (B-Back® Verum Versus B-Back® Placebo)|Completed||N/A|87|Actual|Université Victor Segalen Bordeaux 2||2|||f||||f||||||||||2017-10-11 02:58:10.5522|2017-10-11 02:58:10.5522
NCT01599156|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2013-01-14|||July 2012||2012-07-01|July 2012|2012-07-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Reflexology for Chronic Constipation|Reflexology for Patients Suffering From Chronic Constipation- a Phase II B, Single Armed, Open Label Study.|Unknown status|Recruiting|Phase 2|40|Anticipated|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-10-11 02:58:10.648222|2017-10-11 02:58:10.648222
NCT01599143|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-13|||January 2009||2009-01-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|mbsr||Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program|Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program|Completed||Phase 1|135|Actual|North York General Hospital||1|||f||||f||||||||||2017-10-11 02:58:10.73404|2017-10-11 02:58:10.73404
NCT01599130|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-14|||July 2012||2012-07-01|May 2012|2012-05-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss|The Efficacy of Peg-interferon α-2a in HBeAg (+) Chronic Hepatitis B Patients Who Have Been Treated by Entecavir for 48 Weeks But Without HBeAg Loss|Unknown status|Not yet recruiting|N/A|60|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 02:58:10.798307|2017-10-11 02:58:10.798307
NCT01599117|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2013-01-30|||October 2012||2012-10-01|January 2013|2013-01-01|May 2013|Anticipated|2013-05-01|April 2013|Anticipated|2013-04-01||Interventional|||A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF]|Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Heart Failure With Preserved Ejection Fraction: Phase III, Randomized, Double-blind, Placebo-controlled Trial [ULTIMATE-HFpEF Trial]|Unknown status|Recruiting|Phase 3|52|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:58:10.898924|2017-10-11 02:58:10.898924
NCT01599104|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2015-09-25|2015-07-11||June 2012||2012-06-01|September 2015|2015-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension|A Multi-center, Randomized, Double-blind, Active-controlled, 8-week Study to Evaluate the Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension|Completed||Phase 3|1161|Actual|Novartis||3|||f||||t||||||||||2017-10-11 02:58:11.227654|2017-10-11 02:58:11.227654
NCT01599091|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-09-08|||June 2012||2012-06-01|September 2013|2013-09-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Characterizing Gingival and Periodontal Ligament Fibroblasts Reaction to Infection With the Bacteria Porphyromonas Gingivalis|Characterizing Gingival and Periodontal Ligament Fibroblasts Reaction to Infection With the Perio- Pathogenic Bacteria Porphyromonas Gingivalis|Unknown status|Recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"     Anyway extracted teeth and gingiva. Patients undergoing tooth extraction will be asked     permission to use the anyway extracted teeth and gingiva in order to harvest fibroblasts for     further basic research.   "|||2017-10-11 02:58:11.944362|2017-10-11 02:58:11.944362
NCT01598896|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-04-26|||May 2012||2012-05-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|DCCS||Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia|Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia|Recruiting||Phase 2/Phase 3|18|Anticipated|Mclean Hospital||3|||f||||f||||||||||2017-10-11 02:58:16.144328|2017-10-11 02:58:16.144328
NCT01599078|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2012-05-13|||January 2012||2012-01-01|May 2012|2012-05-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Interventional|PacTAP||Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention|Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention (PacTAP Study): A Double Blind, Randomized Control Study|Unknown status|Recruiting|N/A|100|Anticipated|Midwest Cardiovascular Research Foundation||2|||f||||t||||||||||2017-10-11 02:58:12.092857|2017-10-11 02:58:12.092857
NCT01599065|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2013-10-18|||December 2011||2011-12-01|May 2012|2012-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|MAGNET||"Comparison of a MAGNET Protocol Versus off-on Protocol for Patients With Implantable Cardioverter Defibrillators"|"Comparison of a MAGNET Protocol Versus off-on Protocol for Patients With Implantable Cardioverter Defibrillators Undergoing Procedures Requiring Electrocautery"|Completed||N/A|80|Actual|Midwest Heart Foundation|||2||f||||f||||||||||2017-10-11 02:58:12.209453|2017-10-11 02:58:12.209453
NCT01599052|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-05-04|||March 2011||2011-03-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||Social Cognition in Children Treated for a Brain Tumour|Social Cognition in Children Treated for a Brain Tumour: A Prospective Longitudinal Multi-Centre Study|Active, not recruiting||N/A|113|Anticipated|University Medical Center Groningen|||3||f||||f||||||||||2017-10-11 02:58:12.301302|2017-10-11 02:58:12.301302
NCT01599039|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2016-09-26|||May 2012||2012-05-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2014|Actual|2014-01-01||Observational|||Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema|Prospective Controlled Study Comparing the Effectiveness and Specificity of Inverse Water Volumetry Versus Bio-impedance Spectroscopy in the Assessment of Early Recognition of Breast Cancer Related Lymphoedema.|Completed||N/A|80|Actual|Nij Smellinghe Hosptial|||3||f||||f||||||||||2017-10-11 02:58:12.385459|2017-10-11 02:58:12.385459
NCT01599026|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-14|2012-05-14|||April 2012||2012-04-01|May 2012|2012-05-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Observational|||Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function|Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function|Unknown status|Enrolling by invitation|N/A|120|Anticipated|Ain Shams Maternity Hospital|||1||f||||||||||||||2017-10-11 02:58:12.478711|2017-10-11 02:58:12.478711
NCT01599013|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-12-07|||February 2011||2011-02-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|JASINT1||JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin|Randomized Phase II Study Assessing the Combination of Vinflunine With Gemcitabine and Vinflunine With Carboplatin in Patients Ineligible to Cisplatin With Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|69|Actual|Pierre Fabre Medicament||2|||f||||t||||||||||2017-10-11 02:58:12.539141|2017-10-11 02:58:12.539141
NCT01599000|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2012-08-14|||March 2011||2011-03-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Artemether-Lumefantrine Clinical Effectiveness Study|Artemether-Lumefantrine Clinical Effectiveness Study|Completed||Phase 4|159|Actual|Papua New Guinea Institute of Medical Research||2|||f||||f||||||||||2017-10-11 02:58:12.629955|2017-10-11 02:58:12.629955
NCT01598987|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-04-13|2016-11-30||October 2012||2012-10-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional||Full analysis set (FAS): consisted of all patients enrolled into the study, including patients who did not receive any everolimus, but were followed beyond baseline.|Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.|A 24-month, Multi-center, Single Arm, Prospective Study to Evaluate Renal Function, Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.|Completed||Phase 3|56|Actual|Novartis|Based on DMC recommendation, enrolment was terminated and patients below 7 years were converted form study medication to local standard of care but patients were followed up until Month 24.|1|||f||||t||||||||||2017-10-11 02:58:12.753421|2017-10-11 02:58:12.753421
NCT01598974|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-09-12|||January 2012||2012-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|May 2017|Actual|2017-05-01||Interventional|LBP||Back Pain Response to Different Acupuncture Methods|Brain Plasticity Underlying Back Pain Response to Different Acupuncture Methods|Recruiting||N/A|129|Anticipated|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-11 02:58:15.471188|2017-10-11 02:58:15.471188
NCT01598961|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-12|2013-12-24|||May 2012||2012-05-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery|Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery|Completed||N/A|150|Actual|Samsung Medical Center||3|||f||||t||||||||||2017-10-11 02:58:15.646335|2017-10-11 02:58:15.646335
NCT01598948|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-12|2015-09-01|||August 2012||2012-08-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|MICA||Effect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular Apheresis|Effect of Mipomersen on LDL-Cholesterol Levels in Patients With Severe LDL-Hypercholesterolemia and Atherosclerosis Treated by Regular LDL-Apheresis|Completed||Phase 3|17|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 02:58:15.754164|2017-10-11 02:58:15.754164
NCT01598935|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-06-12|||October 2011||2011-10-01|June 2013|2013-06-01|April 2014|Anticipated|2014-04-01|January 2014|Anticipated|2014-01-01||Interventional|||Post-exercise Protein Intake for Active Children|Double Blind Controlled Trial of Protein in Active Children|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|McMaster University||4|||f||||f||||||||||2017-10-11 02:58:15.836466|2017-10-11 02:58:15.836466
NCT01598909|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-12|2015-08-21|||January 2013||2013-01-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ARINE||Efficacy of Arnica D1 Ointment After Upper Blepharoplasty|Efficacy of Arnica D1 Ointment After Upper Blepharoplasty: a Randomized, Double-blind Placebo-controlled Study|Completed||N/A|136|Actual|Isala||3|||f||||f||||||||||2017-10-11 02:58:16.043053|2017-10-11 02:58:16.043053
NCT01598883|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-12-13|||June 2012||2012-06-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||"Understanding Heparin Resistance in Cardiac Surgery"|"Understanding Heparin Resistance in Cardiac Surgery: Altered Heparin Responsiveness and Its Association With Acute Inflammatory Reactions"|Completed||Phase 1|504|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:58:16.270069|2017-10-11 02:58:16.270069
NCT01598870|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2015-01-13|||May 2012||2012-05-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Observational|ARSDIASP||Diagnosis of Spontaneous Bacterial Peritonitis|Redefinition of Diagnostic Criteria for Spontaneous Bacterial Peritonitis: Assessment of Accuracy of Available Tests and of Reference Standard|Unknown status|Recruiting|N/A|100|Anticipated|Azienda Ospedaliera di Lecco|||1||f||||f||||||Samples With DNA|"     Blood and ascitic fluid samples stored at -80°C   "|||2017-10-11 02:58:16.364298|2017-10-11 02:58:16.364298
NCT01598857|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2015-07-28|||December 2014||2014-12-01|July 2015|2015-07-01||||June 2015|Anticipated|2015-06-01||Interventional|BIANCA-SC||BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis|Withdrawn||Phase 2|0|Actual|Anthera Pharmaceuticals||2|||f||||||||||||||2017-10-11 02:58:16.450742|2017-10-11 02:58:16.450742
NCT01598844|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-07-06|||May 2012||2012-05-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|September 2015|Actual|2015-09-01||Observational|JUPITER||Longterm Safety and Performance of the JenaValve|"The JenaValve EvalUation of Long Term Performance and Safety In PaTients With SEvere AoRtic Stenosis"|Active, not recruiting||N/A|210|Actual|JenaValve Technology GmbH|||2||f||||f||||||||||2017-10-11 02:58:16.582054|2017-10-11 02:58:16.582054
NCT01598831|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-07-10|||August 2012||2012-08-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of ART-123 in Subjects With Severe Sepsis and Coagulopathy.|Recruiting||Phase 3|800|Anticipated|Asahi Kasei Pharma America Corporation||2|||f||||t||||||||||2017-10-11 02:58:16.781372|2017-10-11 02:58:16.781372
NCT01598818|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-07-03|||May 2012||2012-05-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||First-Sight Refractive Error Correction in the Developing World|First-Sight Refractive Error Correction in the Developing World|Completed||N/A|150|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 02:58:17.596346|2017-10-11 02:58:17.596346
NCT01598805|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-11-15|||June 2012||2012-06-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts|Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts|Completed||N/A|10000|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 02:58:17.670136|2017-10-11 02:58:17.670136
NCT01598792|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2016-05-17|||February 2012||2012-02-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|REALISTIC:||Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer|REALISTIC: A Phase I, Dose Escalation Trial Of Recombinant Listeria Monocytogenes (Lm)-Based Vaccine Encoding Human Papilloma Virus Genotype 16 Target Antigens (ADXS11-001) In Patients With HPV-16 +ve Oropharyngeal Carcinoma|Terminated||Phase 1|2|Actual|University of Liverpool||1||"Patient 2 suffered DLT post-vaccination. The vaccine manufacturers withdrew support for the   study on commercial grounds."|f||||t||||||||||2017-10-11 02:58:17.754402|2017-10-11 02:58:17.754402
NCT01598779|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2015-12-18|2014-12-09||June 2012||2012-06-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational||Women age 15–45 attending an outpatient consultation at clinics of the investigators or at University of Buenos Aires, with a lesion suspected of being HPV related.|Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population|Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population|Completed||N/A|150|Actual|University of Buenos Aires|||1||f||||t||||||Samples With DNA|"     Biopsy specimens will be held in a formol 10% solution and will be sent to the pathologist. A     portion of each sample will be processed for histological analysis, which will be performed     by one pathologist. The remainder of each specimen will be saved to extract DNA for PCR     analysis   "|||2017-10-11 02:58:17.844733|2017-10-11 02:58:17.844733
NCT01598766|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2013-02-04|||May 2012||2012-05-01|February 2013|2013-02-01|May 2020|Anticipated|2020-05-01|May 2013|Anticipated|2013-05-01||Interventional|||General Investigative MRI Protocol|General Investigational Protocol for EXCELART VANTAGE ZGV/XGV/AGV/ ATLAS/XGV/ZGV TITAN/XGV VANTAGE TITAN 3T|Recruiting||Phase 1|100|Anticipated|Toshiba America Medical Systems, Inc.||1|||f||||||||||||||2017-10-11 02:58:18.031609|2017-10-11 02:58:18.031609
NCT01598753|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-05-15|||May 2012||2012-05-01|May 2017|2017-05-01|July 31, 2018|Anticipated|2018-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|COMBAT-FM||Combined Behavioral and Analgesic Trial for Fibromyalgia|Phase 3 Double Blind Randomized Study Comparing Drug Treatment (Tramadol Versus Placebo) and Behavioral Health Treatments (Cognitive Behavior Therapy Versus Health Education)for Patients With Fibromyalgia|Recruiting||Phase 3|250|Anticipated|University of Washington||4|||f||||t||||||||||2017-10-11 02:58:18.129758|2017-10-11 02:58:18.129758
NCT01598740|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2013-07-12|2013-03-22||June 2012||2012-06-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease|A Phase 1, Open-label, Randomized, Crossover Study to Assess the Safety, Tolerability, and Efficacy of CLP With and Without Spironolactone in Adults With Heart Failure|Completed||Phase 1|18|Actual|Sorbent Therapeutics||2|||f||||f||||||||||2017-10-11 02:58:18.239475|2017-10-11 02:58:18.239475
NCT01598727|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-08-23|||July 2012||2012-07-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Near Infrared Fluorescent Imaging in Thyroid and Parathyroid Surgery With the Fluobeam(TM) System of Fluoptics|A Phase I Feasibility Study of Intra-operative Near Infra-red Fluorescent Imaging in Thyroid/Parathyroid Surgery With the Fluobeam(TM) System of Fluoptics|Completed||Phase 1|10|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 02:58:18.537939|2017-10-11 02:58:18.537939
NCT00005690|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1991||1991-08-01|January 2005|2005-01-01|November 2000|Actual|2000-11-01|||||Observational|||Improving Outcomes and Quality of Life After CABG||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.623213|2017-10-11 04:28:53.623213
NCT01598714|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-08-23|||July 2012||2012-07-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Comparison of Patient Satisfaction Between 3 Types Dressing Shoes|A Comparison of Patient Satisfaction Between Darco, Podalux and Standard Dressing Shoes Following Forefoot Surgery|Unknown status|Recruiting|N/A|90|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||3|||f||||f||||||||||2017-10-11 02:58:18.618304|2017-10-11 02:58:18.618304
NCT01598688|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-05-28|||February 2012||2012-02-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Cyclosporine (CSA) Level in Blood Samples Collected From Different Lines|Monitoring of Cyclosporine Serum Levels in Hematopoietic Stem Cell Transplantation|Completed||N/A|32|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:58:18.788351|2017-10-11 02:58:18.788351
NCT01598675|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-04-18|||January 2012||2012-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Error Based Learning for Restoring Gait Symmetry Post-Stroke|Error Based Learning for Restoring Gait Symmetry Post-Stroke|Completed||Phase 1|48|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 02:58:18.879744|2017-10-11 02:58:18.879744
NCT01598649|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2013-10-28|||June 2012||2012-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|December 2012|Actual|2012-12-01||Interventional|||Intervention With Lupin Protein-enriched Foods in Hypercholesterolemic Subjects|Influence of Intervention With Lupin Protein-enriched Foods on Cardiovascular Risk Factors in Hypercholesterolemic Subjects|Completed||N/A|72|Actual|University of Jena||3|||f||||t||||||||||2017-10-11 02:58:19.057906|2017-10-11 02:58:19.057906
NCT01598636|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-12-04|||February 2013||2013-02-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|LTT-HVDB||The Lateral Tibial Tunnel in ACL Surgery|The Lateral Tibial Tunnel in Anterior Cruciate Ligament Surgery. A Clinical and Ct-graphic Study.to Evaluate the Concept|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 02:58:19.260127|2017-10-11 02:58:19.260127
NCT01598623|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-11-22|||May 2012||2012-05-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|February 2014|Anticipated|2014-02-01||Interventional|OXY-S-01||Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients|A Randomized Trial Administering Oxytocin vs Placebo as add-on to Antipsychotics in Patients With Schizophrenia and Schizo-affective Disorder|Unknown status|Not yet recruiting|Phase 2|48|Anticipated|Sheba Medical Center||4|||f||||f||||||||||2017-10-11 02:58:19.378017|2017-10-11 02:58:19.378017
NCT01598610|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-13|2016-01-29|2013-05-30||May 2012||2012-05-01|January 2016|2016-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Performance Evaluation of an Investigational Blood Glucose Monitoring System|Performance of the CONTOUR® PLUS Blood Glucose Monitoring System With CONTOUR® PLUS Strip|Completed||N/A|220|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 02:58:19.511202|2017-10-11 02:58:19.511202
NCT01598597|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-05-07|||March 2012||2012-03-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)|An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Non-Squamous Non-Small Cell Lung Cancer, Recurrent Glioblastoma, or Metastatic Renal Cell Cancer Treated With Avastin|Completed||N/A|276|Actual|Genentech, Inc.|||1||f||||||||||Samples With DNA|"     saliva, optional blood   "|||2017-10-11 02:58:19.782215|2017-10-11 02:58:19.782215
NCT01598584|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2015-09-24|||June 2012||2012-06-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer|A Phase II/III Prospective Randomized Placebo-control Trail Compare Mirtazapine Plus Gemcitabine With Gemcitabine in Metastasis Pancreatic Cancer|Withdrawn||Phase 2/Phase 3|0|Actual|Tianjin Medical University Cancer Institute and Hospital||2||Gemcitabine is not the first choice for most pancreatic cancer patients nowdays|f||||t||||||||||2017-10-11 02:58:19.959186|2017-10-11 02:58:19.959186
NCT01598571|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-08-21|||May 2012||2012-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Study in Healthy Males to Assess Bioavailability of Single Fostamatinib With iv Micro Tracer Dose|A Study to Assess the Absolute Bioavailability of a Single Oral Dose of Fostamatinib With Respect to an Intravenous Micro Tracer Dose of [14C] R406 in Healthy Male Volunteers|Completed||Phase 1|37|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:58:20.082648|2017-10-11 02:58:20.082648
NCT01598558|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-10-03|||January 2012||2012-01-01|October 2016|2016-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT|Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT|Withdrawn||N/A|0|Actual|Stanford University||1||Accrual issues - Low Accrual|f||||t||||||||||2017-10-11 02:58:20.166927|2017-10-11 02:58:20.166927
NCT01598545|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-12-09|2014-12-09||February 2013||2013-02-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Hydromorphone and C-section|Determination of the ED50 of Intrathecal Hydromorphone for Post-cesarean Section Pain Relief|Completed||Phase 2|20|Actual|Emory University||1|||f||||t||||||||||2017-10-11 02:58:20.259856|2017-10-11 02:58:20.259856
NCT01593267|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-08-09|||November 2002||2002-11-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|April 15, 2017|Actual|2017-04-15||Interventional|BRAT||Barrow Ruptured Aneurysm Trial|Barrow Ruptured Aneurysm Study|Active, not recruiting||N/A|500|Actual|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||f||||||||||2017-10-11 02:59:45.994842|2017-10-11 02:59:45.994842
NCT01598532|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-08-23|2016-05-16||September 2009||2009-09-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|LED|Population was Males and Females, ages 18 to 65 years who sustained a mild traumatic brain injury at least 6 months prior to study participation|Effects of LEDs on Memory in TBI Patients|Treatment of Cognitive Dysfunction in Mild TBI With Transcranial Light Emitting Diodes- An Open Protocol, Pilot Study|Completed||N/A|22|Actual|Spaulding Rehabilitation Hospital|Small sample size & Open Protocol|1|||f||||f||||||||No||2017-10-11 02:58:20.49485|2017-10-11 02:58:20.49485
NCT01598519|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-05-10|||February 2011||2011-02-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||School-based Comprehensive Suicide Intervention in Shanghai, China||Unknown status|Recruiting|N/A|3000|Anticipated|Shanghai Mental Health Center||2|||f||||t||||||||||2017-10-11 02:58:20.803543|2017-10-11 02:58:20.803543
NCT01598506|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-11-04|2014-11-04||September 2013||2013-09-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Intrathecal Hydromorphone for Labor Analgesia|Determination of the ED50 of Intrathecal Hydromorphone in Laboring Women Using the Up-and-down Sequential Allocation Method|Completed||Phase 2|22|Actual|Emory University||1|||f||||t||||||||||2017-10-11 02:58:20.911501|2017-10-11 02:58:20.911501
NCT01598493|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-07-12|||May 2012||2012-05-01|July 2017|2017-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||To Study the Healing Effect of Silver Impregnated Activated Carbon Fiber Wound Dressing on Deep Dermal Burn|To Study the Healing Effect of Silver Impregnated Activated Carbon Fiber Wound Dressing on Deep Dermal Burn|Completed||N/A|30|Actual|Bio-medical Carbon Technology Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:58:21.152736|2017-10-11 02:58:21.152736
NCT01598480|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-07-12|||May 2012||2012-05-01|July 2017|2017-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||To Study the Healing Effect of Silver Impregnated Activated Carbon Fiber Wound Dressing on Superficial Dermal Burn|To Study the Healing Effect of Silver Impregnated Activated Carbon Fiber Wound Dressing on Superficial Dermal Burn|Completed||N/A|30|Actual|Bio-medical Carbon Technology Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:58:21.261366|2017-10-11 02:58:21.261366
NCT01598467|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-14|||August 2011||2011-08-01|May 2012|2012-05-01|August 2015|Anticipated|2015-08-01|August 2014|Anticipated|2014-08-01||Interventional|PARSEC||Prospective Assessment of Robotic Sacrocolpopexy: a European Multicentric Cohort (PARSEC)|Prospective Interventional Study on Robotic Sacrocolpopexy: a European Multicentric Cohort (PARSEC)|Unknown status|Recruiting|N/A|300|Anticipated|Cork University Hospital||1|||f||||f||||||||||2017-10-11 02:58:21.384099|2017-10-11 02:58:21.384099
NCT01598454|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-07-27|||February 2011||2011-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|March 2014|Actual|2014-03-01||Interventional|||Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides|Phase 1 Study on the Use of Racotumomab Anti-idiotype Antibody in Patients With Pediatric Malignancies That Express N-glycolylated Gangliosides and Are Resistant to Conventional Treatment.|Completed||Phase 1|15|Actual|Laboratorio Elea S.A.C.I.F. y A.||1|||f||||f||||||||||2017-10-11 02:58:21.50997|2017-10-11 02:58:21.50997
NCT01598441|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2016-11-20|||June 2012||2012-06-01|January 2016|2016-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)|Multi-centre, Randomized Study of Iloprost Inhaled in Preventing and Treating Reactive Pulmonary Hypertension (RPH) and Pulmonary Hypertensive Crisis (PHC) After Repair of Congenital Heart Diseases (CHD)|Completed||Phase 3|8|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 02:58:21.610402|2017-10-11 02:58:21.610402
NCT01598428|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-01-14|2014-06-17||January 2013||2013-01-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Anterior Capsule Polishing Effect on Effective Lens Position|Effect of Anterior Capsule Polishing on Effective Lens Position After Cataract Surgery|Completed||N/A|20|Actual|Shandong University||1|||f||||f||||||||||2017-10-11 02:58:21.719146|2017-10-11 02:58:21.719146
NCT01598415|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-10-16|||April 2012||2012-04-01|October 2014|2014-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II|A Two Part Protocol to Assess, Using Double Blind Placebo Control, the Safety, Tolerability, and Pharmacokinetics of Ascending Single Doses of a New Intra-articular Administration Formulation of SAR113945 (IKK Inhibitor) Followed by Assessment of Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose in Patients With Knee Osteoarthritis.|Completed||Phase 2|130|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:58:21.972336|2017-10-11 02:58:21.972336
NCT01598402|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2013-07-12|||December 2011||2011-12-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|PANTAP||Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia|Efficacy and Cost Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Locally Advanced Head and Neck Cancer to Prevent Aspiration Pneumonia. A Randomized Phase II-III Study|Unknown status|Recruiting|Phase 2/Phase 3|106|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 02:58:22.065473|2017-10-11 02:58:22.065473
NCT01598389|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-10|||October 2008||2008-10-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Eating Behaviors Among Weight-Discordant Siblings|Eating Behaviors Among Weight-Discordant Siblings|Completed||N/A|94|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-11 02:58:22.323109|2017-10-11 02:58:22.323109
NCT01598376|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-05-14|||June 2010||2010-06-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||A Prospective Double-blind Interventional Study of Tissue Reaction to Polyglycolic Acid Sutures in Human Skin|A Prospective Double-blind Interventional Study of Tissue Reaction to Polyglycolic Acid Sutures in Human Skin|Completed||N/A|42|Actual|The Royal Bournemouth Hospital||2|||f||||f||||||||||2017-10-11 02:58:22.427362|2017-10-11 02:58:22.427362
NCT01598363|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-11-01|||June 2012||2012-06-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers||Completed||Phase 1|32|Actual|Reata Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-11 02:58:22.539498|2017-10-11 02:58:22.539498
NCT01597453|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-02-19|||September 2010||2010-09-01|February 2016|2016-02-01|December 2035|Anticipated|2035-12-01|December 2015|Actual|2015-12-01||Interventional|NOR-SYS||NOR-SYS: The Norwegian Stroke in the Young Study|NOR-SYS: The Norwegian Stroke in the Young Study Young Ischemic Stroke and Family Risk Factors|Active, not recruiting||N/A|1062|Actual|Haukeland University Hospital||1|||f||||f||||||||||2017-10-11 02:58:47.358076|2017-10-11 02:58:47.358076
NCT01598350|ClinicalTrials.gov processed this data on October 10, 2017|2010-01-20|2013-11-12|2013-11-12||January 2010||2010-01-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Gait in Children With Down Syndrome While Wearing Orthoses|Using Anthropometric Measurements to Predict Orthotic Influence on Gait Parameters in Children With Down Syndrome|Completed||N/A|6|Actual|University of Puget Sound|small number of subject recruited.|1|||f||||f||||||||||2017-10-11 02:58:22.662891|2017-10-11 02:58:22.662891
NCT01598337|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-05-14|||April 2011||2011-04-01|May 2012|2012-05-01||||December 2013|Anticipated|2013-12-01||Interventional|||The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency|The Effect Of Antiplatelets Therapy, Tirafiban, Prasugrel, And Aspirin On Saphenous Vein Coronary Artery Bypass Graft Patency|Unknown status|Recruiting|Phase 3|200|Anticipated|Prince Sultan Cardiac Center, Adult Cardiology Department.||4|||f||||t||||||||||2017-10-11 02:58:22.858016|2017-10-11 02:58:22.858016
NCT01598324|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2013-08-10|||July 2012||2012-07-01|August 2013|2013-08-01||||April 2013|Actual|2013-04-01||Observational|||Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder|Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder|Terminated||N/A|1|Actual|Mclean Hospital|||3|Clinical trial from which subjects were recruited closed to enrollment|f||||f||||||||||2017-10-11 02:58:22.977544|2017-10-11 02:58:22.977544
NCT01598311|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-09-02|||May 2012||2012-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea|A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea|Completed||Phase 3|608|Actual|Cubist Pharmaceuticals LLC||2|||f||||f||||||||||2017-10-11 02:58:23.091033|2017-10-11 02:58:23.091033
NCT01598298|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-04-21|||May 2013||2013-05-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|December 2016|Actual|2016-12-01||Interventional|||S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy|A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer|Active, not recruiting||Phase 3|294|Anticipated|Southwest Oncology Group||2|||f||||t||||||||Yes|https://swog.org/Visitors/Download/Policies/Policy43.pdf|2017-10-11 02:58:23.332694|2017-10-11 02:58:23.332694
NCT01598285|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-06-07|||May 2012||2012-05-01|June 2013|2013-06-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Observational|||A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer|A Combined Genome-Wide Association Study (GWAS) and microRNA (miRNA) Profiling Approach for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer|Unknown status|Active, not recruiting|N/A|200|Anticipated|Spanish Breast Cancer Research Group|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 02:58:25.320501|2017-10-11 02:58:25.320501
NCT01598272|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-12-10|||July 2011||2011-07-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|Pharmanex||Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women|A Phase IV, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Single-Center Study on the Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women.|Completed||Phase 4|95|Actual|Pharmanex||2|||f||||t||||||||||2017-10-11 02:58:25.398576|2017-10-11 02:58:25.398576
NCT01598259|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-06-27|||May 2014||2014-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|Sleep6||Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation|Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation|Terminated||Phase 2|10|Actual|Shriners Hospitals for Children||2||lack or enrollment, funding depletion|f||||t||||||||No|given low level of enrollment and hence, randomization (n=3), no plans to provide data|2017-10-11 02:58:25.486987|2017-10-11 02:58:25.486987
NCT01598246|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2012-05-14|||May 2012||2012-05-01|May 2012|2012-05-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|RIPE||Study to Evaluate Causes of Failure to Extubate|Prospective Observational Study on Factors Influencing Re-Intubation Following a Planned Extubation (RIPE) in a Pediatric Intensive Care Unit: Identifying Targets for a Quality Improvement Initiative|Unknown status|Recruiting|N/A|500|Anticipated|Montefiore Medical Center|||2||f||||f||||||||||2017-10-11 02:58:25.567388|2017-10-11 02:58:25.567388
NCT01598233|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-12-16|||March 2011||2011-03-01|December 2014|2014-12-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Intragastric Balloon on Bone, Metabolic and Respiratory Parameters|Effects of Intragastric Balloon on Bone, Metabolic and Respiratory Parameters|Completed||Phase 3|50|Actual|Universidade Federal do Rio de Janeiro||1|||f||||f||||||||||2017-10-11 02:58:25.642796|2017-10-11 02:58:25.642796
NCT01598220|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-05-17|||September 2002||2002-09-01|May 2012|2012-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|CACREPS||Computer Assisted Cognitive Remediation Program in Schizophrenia|Efficacy Study of a Computer Cognitive Remediation Program in Patients With Schizophrenia|Completed||N/A|135|Actual|Consorci Sanitari de Terrassa||2|||f||||t||||||||||2017-10-11 02:58:25.71713|2017-10-11 02:58:25.71713
NCT01598207|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-04-26|2016-03-21||February 2011||2011-02-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain||Completed||Phase 4|13|Actual|University of Iowa||2|||f||||||||||||||2017-10-11 02:58:25.811309|2017-10-11 02:58:25.811309
NCT01598194|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2017-07-07|||January 30, 2012|Actual|2012-01-30|July 2017|2017-07-01|July 6, 2017|Actual|2017-07-06|July 6, 2017|Actual|2017-07-06||Interventional|||Comparison of a Novel 22-gauge Core Biopsy Needle|Prospective Comparison of a Novel 22-gauge Core Biopsy Needle With Reverse Bevel Design to a Standard Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) Needle for Diagnosis of Solid Pancreatic Mass Lesions|Completed||N/A|60|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 02:58:26.148738|2017-10-11 02:58:26.148738
NCT01598181|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-02-15|||December 2011||2011-12-01|June 2016|2016-06-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) as Treatment Method for Pain in Fibromyalgia|Transcranial Direct Current Stimulation (tDCS) as Treatment Method for Pain in Fibromyalgia|Completed||N/A|70|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 02:58:26.336998|2017-10-11 02:58:26.336998
NCT01598168|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-11|2016-03-24|||January 2013||2013-01-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia|Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia|Terminated||Phase 3|22|Actual|McMaster University||1||slow recruitment|f||||t||||||||||2017-10-11 02:58:26.417601|2017-10-11 02:58:26.417601
NCT01598155|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-12-07|||May 2012||2012-05-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Effect of Supragingival Control Versus Supra- and Subgingival Control in the Periodontal Health During the Maintenance|The Effect of Supragingival Biofilm Control, and the Combination of Supra and Subgingival Biofilm Control in Periodontal Health of Patients Participating in a Periodontal Preventive Maintenance Program - A Randomized Clinical Trial.|Unknown status|Active, not recruiting|N/A|70|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 02:58:26.500425|2017-10-11 02:58:26.500425
NCT01598142|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-05-14|||October 2007||2007-10-01|May 2012|2012-05-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Single-operator Wire-guided Endoscopic Retrograde Cholangiopancreatography Cannulation Technique|Single-operator Wire-guided ERCP Cannulation Technique: a Single-center Randomized Controlled Study|Completed||N/A|465|Actual|Zhejiang University||2|||f||||t||||||||||2017-10-11 02:58:26.595827|2017-10-11 02:58:26.595827
NCT01598129|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-10-21|2014-06-11||April 2012||2012-04-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers|Exploratory Open Label Study of GM-CSF Coding Oncolytic Adenovirus CGTG-102, With Low Dose Cyclophosphamide in Patients With Refractory Injectable Solid Tumours|Completed||Phase 1|12|Actual|Targovax ASA||1|||f||||t||||||||||2017-10-11 02:58:26.695149|2017-10-11 02:58:26.695149
NCT01598116|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-04-03|||December 2010||2010-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|||A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas|A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas.|Active, not recruiting||N/A|60|Anticipated|Ohio State University|||2||f||||f||||||Samples Without DNA|"     serum and urine   "|||2017-10-11 02:58:26.940839|2017-10-11 02:58:26.940839
NCT01598103|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-04-26|||January 2012||2012-01-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions|A Multi-center, Double-blind, Randomized, Placebo-controlled, Cross-over Study to Evaluate the Efficacy, Safety and Tolerability of SAF312 in Subjects With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions Who Are Inadequately Managed by Antimuscarinic Therapy|Terminated||Phase 2|9|Actual|Novartis||2|||f||||f||||||||||2017-10-11 02:58:27.020275|2017-10-11 02:58:27.020275
NCT01598090|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-03-03||2017-03-02|June 2012||2012-06-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|PEDESTAL||Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir|A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered With Telaprevir in Subjects With Genotype-1 Chronic Hepatitis C Who Are Treatment-naive or Relapsed on Prior Treatment With Peginterferon Alfa-2a and Ribavirin|Completed||Phase 3|646|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-10-11 02:58:27.12475|2017-10-11 02:58:27.12475
NCT01598077|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-04-21|||July 2012||2012-07-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer|A Phase I Study of LJM716 in Patients With Squamous Cell Carcinoma of Head and Neck, or HER2 Overexpressing Metastatic Breast Cancer or Gastric Cancer|Completed||Phase 1|54|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:58:27.624655|2017-10-11 02:58:27.624655
NCT01598064|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-09-09|2014-07-14||April 2012||2012-04-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Probiotics for Liver Cirrhosis With Portal Hypertension|Clinical Trial of Probiotics in Preventing Complication Related to Portal Hypertension in Cirrhotic Patients|Completed||N/A|49|Actual|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-11 02:58:27.802273|2017-10-11 02:58:27.802273
NCT01598051|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-03-09|||May 31, 2012|Actual|2012-05-31|March 2017|2017-03-01|January 17, 2020|Anticipated|2020-01-17|June 9, 2016|Actual|2016-06-09||Observational|||Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan|Treatment Satisfaction Under Rivaroxaban (ACTS/TSQM)|Active, not recruiting||N/A|741|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:58:28.756089|2017-10-11 02:58:28.756089
NCT01598038|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-07-27|||April 2012||2012-04-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma|Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma|Terminated||N/A|41|Actual|Centre Francois Baclesse||1|||f||||t||||||||||2017-10-11 02:58:28.868927|2017-10-11 02:58:28.868927
NCT01598025|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-06-01|||May 2012|Actual|2012-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor|Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor|Active, not recruiting||N/A|3|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:58:29.012803|2017-10-11 02:58:29.012803
NCT01598012|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2013-08-26|||December 2011||2011-12-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea|The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea|Completed||Phase 4|40|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 02:58:29.184034|2017-10-11 02:58:29.184034
NCT01597999|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2013-01-21|||February 2011||2011-02-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|July 2012|Actual|2012-07-01||Interventional|||Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer|Accuracy of Magnetic Resonance Imaging (MRI) in Predicting Aggressiveness of Early Breast Cancer According to Molecular Subtypes Identified by ER PR and HER-2 Status|Unknown status|Recruiting|Phase 4|60|Anticipated|Mahidol University||1|||f||||f||||||||||2017-10-11 02:58:29.296998|2017-10-11 02:58:29.296998
NCT01597258|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-09-12|||May 29, 2012|Actual|2012-05-29|September 2017|2017-09-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Observational|||Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)|Special Investigation Of Xalkori For Nsclc (Regulatory Post Marketing Commitment Plan)|Active, not recruiting||N/A|2044|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 02:58:49.273259|2017-10-11 02:58:49.273259
NCT01597986|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-07-12|||April 2012||2012-04-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone|A Phase 1, Open Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 02:58:29.393765|2017-10-11 02:58:29.393765
NCT01597973|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-05-26|||October 2012||2012-10-01|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|August 2020|Anticipated|2020-08-01||Interventional|||Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli|Randomized Controlled Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli|Recruiting||Phase 3|444|Anticipated|University of Michigan||2|||f||||t||||||||||2017-10-11 02:58:29.49378|2017-10-11 02:58:29.49378
NCT01597960|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-11-10|||June 2012||2012-06-01|June 2012|2012-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|YACHT||Yoga And Cardiovascular Health Trial|Yoga And Cardiovascular Health Trial|Completed||N/A|80|Actual|Imperial College London||2|||f||||t||||||||Undecided||2017-10-11 02:58:29.628773|2017-10-11 02:58:29.628773
NCT01597947|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2013-01-18|||May 2012||2012-05-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|||||Interventional|||A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers|A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous (IV) ACHN-975 in Normal Healthy Volunteers|Completed||Phase 1|50|Actual|Achaogen, Inc.||2|||f||||||||||||||2017-10-11 02:58:29.705566|2017-10-11 02:58:29.705566
NCT01597934|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-01-30|||August 2012||2012-08-01|January 2014|2014-01-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Antiviral Efficacy of Switching to ETV Plus TDF|A Randomized, Multicenter, Prospective Study to Compare Antiviral Efficacy and Safety of Switching to ETV Plus TDF Versus Maintaining LAM/LDT Plus ADF Combination in CHC With PVR to LAM/LDF Plus ADF Combination Rescue Therapy for YMDD Mutation|Unknown status|Active, not recruiting|Phase 4|104|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 02:58:29.806913|2017-10-11 02:58:29.806913
NCT01597921|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-08-08|||May 2012||2012-05-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer|Phase II, Double Blinded, Randomized Study of R1 and R2 (Waterjel) Verses Aloe Vera Jell for the Prevention and Treatment of Radiation Induced Dermatitis in Breast Cancer Patients|Terminated||N/A|50|Actual|Water-Jel|||1|The study was stopped due to unbalanced side effects|f||||f||||||||||2017-10-11 02:58:29.904993|2017-10-11 02:58:29.904993
NCT01597908|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-09-05|2014-12-01||June 4, 2012|Actual|2012-06-04|September 2017|2017-09-01|March 18, 2019|Anticipated|2019-03-18|April 1, 2014|Actual|2014-04-01||Interventional|COMBI-v||Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma|A Phase III, Randomised, Open-label Study Comparing the Combination of the BRAF Inhibitor, Dabrafenib and the MEK Inhibitor, Trametinib to the BRAF Inhibitor Vemurafenib in Subjects With Unresectable (Stage IIIc) or Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma|Active, not recruiting||Phase 3|704|Actual|Novartis||2|||f||||t||||||||||2017-10-11 02:58:30.253952|2017-10-11 02:58:30.253952
NCT01597895|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-09-18|||July 2012||2012-07-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects|Open-Label, Randomized, Fixed-Sequence, Crossover Study to Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects|Completed||Phase 1|14|Actual|ViiV Healthcare||3|||f||||f||||||||||2017-10-11 02:58:34.640288|2017-10-11 02:58:34.640288
NCT01597882|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-02-16|||October 2012||2012-10-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Improving Monitoring of Patients Receiving Case Management|Improved Targeting of Admission Avoidance Interventions in Older People With Long-term Conditions:An Observational,Longitudinal Study Exploring the Feasibility of Measures of Strength as a Monitoring Aid in Patients Receiving Case Management|Completed||N/A|114|Actual|University of Southampton|||1||f||||f||||||||||2017-10-11 02:58:34.751707|2017-10-11 02:58:34.751707
NCT01597869|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2013-01-01|||April 2012||2012-04-01|January 2013|2013-01-01||||January 2013|Anticipated|2013-01-01||Observational|||Safety of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration : A Prospective Study|Safety of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration : A Prospective Study|Unknown status|Recruiting|N/A|300|Anticipated|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 02:58:34.838932|2017-10-11 02:58:34.838932
NCT01597856|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-08-09|||March 18, 2013|Actual|2013-03-18|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|SBIRT-PTSD||Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims|Evaluation and Treatment of Substance Use in Veterans With PTSD Disability Claims|Active, not recruiting||Phase 1|640|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 02:58:34.914634|2017-10-11 02:58:34.914634
NCT01597843|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-04-06|2014-09-08||June 2012||2012-06-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional||We included the mean number of post members across the three data collection times as our best measure of participants|Veterans Service Organizations and My HealtheVet (MHV)|Working With Veterans Organizations to Encourage Use of My HealtheVet|Completed||N/A|282|Actual|VA Office of Research and Development|Response rates on surveys were lower than expected. One of the first round intervention posts almost certainly did not deliver anything resembling the planned educational intervention at any point.|3|||f||||f||||||||||2017-10-11 02:58:34.997978|2017-10-11 02:58:34.997978
NCT01597830|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2016-04-04|||July 2007||2007-07-01|April 2016|2016-04-01||||August 2013|Actual|2013-08-01||Interventional|||The Effects of Specialized Footwear in Osteoarthritis|The Effects of Specialized Footwear in Osteoarthritis|Completed||N/A|200|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 02:58:35.33353|2017-10-11 02:58:35.33353
NCT01597817|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-12-08|||November 2011||2011-11-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|2ndDermisII||Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic Dermatitis|A Randomized Controlled Trial of the Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic Dermatitis|Completed||Phase 2|78|Actual|Universidade do Porto||2|||f||||f||||||||||2017-10-11 02:58:35.556821|2017-10-11 02:58:35.556821
NCT01597804|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2016-04-26|||April 2011||2011-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2014|Actual|2014-02-01||Interventional|||Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing Surgery|"A Bathing Bundle Regimen to Reduce the Risk of Gynecological Surgical Site Infection"|Completed||N/A|435|Actual|Roswell Park Cancer Institute||1|||f||||f||||||||||2017-10-11 02:58:35.697857|2017-10-11 02:58:35.697857
NCT01597778|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-08-29|||June 2012|Actual|2012-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Double Cord Versus Haploidentical (BMT CTN 1101)|A Multi-Center, Phase III, Randomized Trial of Reduced Intensity Conditioning (RIC) and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) Versus HLA-Haploidentical Related Bone Marrow (Haplo) for Patients With Hematologic Malignancies (BMT CTN #1101)|Recruiting||Phase 3|410|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-10-11 02:58:36.292679|2017-10-11 02:58:36.292679
NCT01597752|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-11-29|||April 2012||2012-04-01|May 2012|2012-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Biological Standardization of Blomia Tropicalis Allergen Extract|Biological Standardization of Blomia Tropicalis Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units|Completed||Phase 2|20|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 02:58:36.842973|2017-10-11 02:58:36.842973
NCT01597739|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-04-07|||July 2012||2012-07-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy|A Phase 2a, Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of JNJ-40346527 in Subjects With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy|Completed||Phase 2|96|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 02:58:36.931103|2017-10-11 02:58:36.931103
NCT01597726|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2013-11-06|||May 2012||2012-05-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Cervical Priming Before Dilation & Evacuation|Cervical Priming Before Dilation & Evacuation: a Randomized Controlled Trial|Completed||N/A|159|Actual|Ibis Reproductive Health||2|||f||||f||||||||||2017-10-11 02:58:37.081751|2017-10-11 02:58:37.081751
NCT01597713|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-05-28|||May 2012||2012-05-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects|A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects|Completed||Phase 1|83|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:58:37.180594|2017-10-11 02:58:37.180594
NCT01597700|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-06-19|||January 13, 2012|Actual|2012-01-13|June 2017|2017-06-01|January 30, 2012|Actual|2012-01-30|January 30, 2012|Actual|2012-01-30||Interventional|||Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.|A RANDOMIZED, BALANCED, OPEN LABEL, CROSSOVER, TWO PERIOD, TWO TREATMENT, TWO SEQUENCE, SINGLE DOSE, BIOEQUIVALENCE STUDY OF ACOTRAL® EZETIMIBE 10 MG TABLETS CONTAINING EZETIMIBE MANUFACTURED BY LABORATORIOS PHOENIX S.A.I.C.F, ARGENTINA AND ZETIA® EZETIMIBE 10 MG TABLETS OF MERCK/SCHERING - PLOUGH PHARMACEUTICALS, USA IN HEALTHY ADULT HUMAN MALE SUBJECTS UNDER FASTING CONDITION|Completed||Phase 1|52|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:58:37.280471|2017-10-11 02:58:37.280471
NCT01597674|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-05-11|||April 1997||1997-04-01|May 2012|2012-05-01|June 1997|Actual|1997-06-01|June 1997|Actual|1997-06-01||Interventional|||Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy Volunteers|A Double-blind, Placebo-controlled, Parallel-group Study of the Effect of 5, 10 and 25 mg Daily of YF476 for 14 Days on 24-hour Ambulatory Gastric pH and Plasma Gastrin Concentrations in Healthy Volunteers|Completed||Phase 1|49|Actual|Trio Medicines Ltd.|||||f||||f||||||||||2017-10-11 02:58:37.474808|2017-10-11 02:58:37.474808
NCT01597661|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-07-03|||September 2011||2011-09-01|July 2014|2014-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Bupropion & Cardio Birth Defect (Slone)|Bupropion and Cardiac Birth Defects (Slone Epidemiology Center)|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 02:58:37.554825|2017-10-11 02:58:37.554825
NCT01597648|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-05-17|||November 2011||2011-11-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™|A Randomized, Open-Label, Crossover Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ Administered Concurrently in Healthy Adult Subjects|Completed||Phase 1|42|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 02:58:37.640041|2017-10-11 02:58:37.640041
NCT01597635|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-08-31|2017-07-23|2015-03-19|September 1, 2012||2012-09-01|August 2017|2017-08-01|October 6, 2014|Actual|2014-10-06|October 1, 2014|Actual|2014-10-01||Interventional|||The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury|A Two Part Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2586881 in Patients With Acute Lung Injury|Completed||Phase 2|44|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:58:38.308767|2017-10-11 02:58:38.308767
NCT01595607|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-02-23|||April 2012||2012-04-01|February 2016|2016-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Effect of Avocado Consumption on Vascular Health|The Influence of Daily Consumption of Avocado on Biomarkers of Vascular Health|Completed||N/A|60|Actual|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 02:59:17.91885|2017-10-11 02:59:17.91885
NCT01597622|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-09-14|||June 11, 2012|Actual|2012-06-11|September 2017|2017-09-01|June 29, 2018|Anticipated|2018-06-29|June 29, 2018|Anticipated|2018-06-29||Interventional|||BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115|BEL114333, a Multicenter, Continuation Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed the Phase III Study BEL113750 in Northeast Asia or Completed the Open-label Extension of HGS1006-C1115 in Japan|Active, not recruiting||Phase 3|420|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 02:58:44.623214|2017-10-11 02:58:44.623214
NCT01597609|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-06-16|||May 22, 2008|Actual|2008-05-22|June 2017|2017-06-01|March 4, 2010|Actual|2010-03-04|March 4, 2010|Actual|2010-03-04||Interventional|||A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects|A Single-blind, Randomised, Placebo-controlled, Parallel Group, Incomplete Block Design, Benchmark Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects|Completed||Phase 1|60|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 02:58:44.778535|2017-10-11 02:58:44.778535
NCT01597596|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-12-14|2015-09-25||August 2012||2012-08-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease|A Phase 3/4, Prospective, Multinational, Open-label, Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease|Terminated||Phase 4|4|Actual|Sanofi||2||Study was stopped due to approved label expansion of alglucosidase alfa.|f||||t||||||||||2017-10-11 02:58:44.889142|2017-10-11 02:58:44.889142
NCT01597583|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2013-12-09|||November 2011||2011-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||MobileMedMinder: A Networked Aide for Medication Compliances|MobileMedMinder: A Networked Aide for Medication Compliances|Completed||N/A|50|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-11 02:58:45.441928|2017-10-11 02:58:45.441928
NCT01597570|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-07-23|||May 2012||2012-05-01|July 2017|2017-07-01|December 10, 2012|Actual|2012-12-10|December 10, 2012|Actual|2012-12-10||Interventional|||Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable VCD and Perclose® ProGlide SMC System|Clinical Evaluation of Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable Vascular Access Closure System and Perclose® ProGlide Suture-Mediated Closure System; Randomized, Comparative Study|Terminated||Phase 3|52|Actual|Taewoong Medical Co., Ltd.||2|||f||||f||||||||||2017-10-11 02:58:45.518765|2017-10-11 02:58:45.518765
NCT01597557|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-07-18|||April 2012||2012-04-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|MICA||Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial|Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial|Completed||N/A|256|Actual|State University of New York at Buffalo||2|||f||||t||||||||||2017-10-11 02:58:45.604139|2017-10-11 02:58:45.604139
NCT01597544|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-07-20|||July 2012||2012-07-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Post-operative Voiding Dysfunction: the Preferred Method for Catheterization|Post-operative Voiding Dysfunction: the Preferred Method for Catheterization|Active, not recruiting||N/A|150|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-10-11 02:58:45.692256|2017-10-11 02:58:45.692256
NCT01597531|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-06-13|||June 2012||2012-06-01|June 2012|2012-06-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding|LIRAGLUTIDE AND ORLISTAT TREATMENT FOR PERSISTENT TYPE 2 DIABETES AFTER GASTRIC BANDING: A PILOT STUDY|Unknown status|Recruiting|Phase 4|9|Anticipated|East Carolina University||3|||f||||f||||||||||2017-10-11 02:58:45.817588|2017-10-11 02:58:45.817588
NCT01597518|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-06-05|||August 2013||2013-08-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|RISCIS||Riluzole in Spinal Cord Injury Study|A Multi-Center, Randomized, Placebo Controlled, Double-Blinded, Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury|Recruiting||Phase 2/Phase 3|351|Anticipated|AOSpine North America Research Network||2|||f||||t||||||||||2017-10-11 02:58:45.944316|2017-10-11 02:58:45.944316
NCT01597505|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-04-17|||May 16, 2012|Actual|2012-05-16|April 2017|2017-04-01|March 20, 2015|Actual|2015-03-20|March 20, 2015|Actual|2015-03-20||Interventional|||Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea|A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea|Completed||Phase 3|608|Actual|Cubist Pharmaceuticals LLC||2|||f||||f||||||||||2017-10-11 02:58:46.182656|2017-10-11 02:58:46.182656
NCT01597492|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-07-11|2016-04-28||May 2012||2012-05-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)|A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab; HGS1006) on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 4|79|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 02:58:46.285408|2017-10-11 02:58:46.285408
NCT01597479|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-02-19|2015-05-06||February 2012||2012-02-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Patients undergoing Ambulatory TRA|Ultrasound Guided Distal Peripheral Nerve Blocks and Postoperative Pain.|Effectiveness of Distal Peripheral Nerve Blocks on Postoperative Pain Management After Ambulatory Thumb Resection Arthroplasty.|Completed||Phase 4|52|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|We could included another group: distal blocks with 0,125% levobupivacaine+ 4mg dexamethasone; register patient satisfaction with anesthetic technique or patient risks factors for nausea and vomiting.|2|||f||||t||||||||Undecided||2017-10-11 02:58:46.979657|2017-10-11 02:58:46.979657
NCT01597466|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2016-11-02|||April 2013||2013-04-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Epidrum-Tho||Epidrum for Thoracic Epidural Analgesia|A Comparison Study of Two Different Techniques for Identifying the Epidural Space in Patients Requiring Thoracic Epidural Analgesia: a Prospective Multicentric Randomized Study|Completed||N/A|46|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 02:58:47.263383|2017-10-11 02:58:47.263383
NCT01594151|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-10-19|||March 2011||2011-03-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Modelling of the Upper Airway in Children With Controlled Asthma|Modelling of the Upper Airway in Children With Controlled Asthma|Completed||Phase 2|20|Actual|FLUIDDA nv||1|||f||||f||||||||||2017-10-11 02:59:50.328866|2017-10-11 02:59:50.328866
NCT01597440|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-03-15|2016-06-20||September 2012||2012-09-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||One participant, infant under 1 month old, with organic acidemia.|Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia|Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia|Terminated||Phase 2|1|Actual|Children's Research Institute||2||insufficient enrollment|f||||t||||||||No|A single participant was enrolled before the study closed. There are no analyses and if data are shared, this may compromise the confidentiality of this single participant from a very rare disease.|2017-10-11 02:58:47.453793|2017-10-11 02:58:47.453793
NCT01597427|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-10|||March 2009||2009-03-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|April 2011|Actual|2011-04-01||Interventional|||Reduction of Pulmonary Artery Pressure in Patients Subjected to Cardiac Surgery|Intravenous Clonidine Does Not Reduce Pulmonary Artery Pressure in Patients Subjected to Cardiac|Completed||Phase 2|29|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 02:58:47.890414|2017-10-11 02:58:47.890414
NCT01597414|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-10-25|||June 2013||2013-06-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|December 2016|Anticipated|2016-12-01||Interventional|||Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1|Pertuzumab + Trastuzumab (PH) Versus PH Plus Metronomic Chemotherapy (PHM) in the Elderly HER2+ Metastatic Breast Cancer Population Who May Continue on T-DM1 Alone Following Disease Progression While on PH / PHM: an Open-label Multicentre Randomized Phase II Selection Trial of the EORTC Elderly Task Force and Breast Cancer Group|Active, not recruiting||Phase 2|80|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 02:58:47.974314|2017-10-11 02:58:47.974314
NCT01597401|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-08-06|||May 2012||2012-05-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease|A Phase 1, Placebo-Controlled, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating, Single Oral Doses of Aes-103 in Subjects With Stable Sickle Cell Disease|Completed||Phase 1|19|Actual|Baxalta US Inc.||3|||f||||f||||||||||2017-10-11 02:58:48.109913|2017-10-11 02:58:48.109913
NCT01597375|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-01-04|||August 2012||2012-08-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|December 2016|Actual|2016-12-01||Interventional|Aspirin||Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)|Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)|Active, not recruiting||N/A|95|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 02:58:48.412366|2017-10-11 02:58:48.412366
NCT01597362|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-05-11|||February 2006||2006-02-01|May 2012|2012-05-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||Three Laparoscopic Access Techniques||Completed||N/A|608|Actual|Campus Bio-Medico University||3|||f||||f||||||||||2017-10-11 02:58:48.519599|2017-10-11 02:58:48.519599
NCT01597349|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-01-27||2014-01-27|May 2012||2012-05-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection|An Exploratory, Randomized, Placebo Controlled, Double Blind, Parallel Arm Dose Ranging Study to Determine the Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection|Completed||Phase 2|208|Actual|Cerecor Inc||3|||f||||f||||||||||2017-10-11 02:58:48.610632|2017-10-11 02:58:48.610632
NCT01597336|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-02-03|||June 2009||2009-06-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Treatment of Abdominal Abscesses With or Without Fibrinolysis|Treatment of Abdominal Abscesses With or Without Fibrinolysis|Completed||N/A|92|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-10-11 02:58:48.714974|2017-10-11 02:58:48.714974
NCT01597323|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-10-29|||October 2011||2011-10-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|September 2012|Actual|2012-09-01||Observational|||Safety & Efficacy Evaluation of a Radiofrequency & Laser/Light System for Improvement of Skin Texture|Safety and Efficacy Evaluation of the eTWO System for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction|Recruiting||N/A|150|Anticipated|Candela Corporation|||1||f||||f||||||Samples With DNA|"     Optional biopsy, for consenting subjects, of facial skin tissue from areas directly in front     of ear (Pre-Auricular)   "|||2017-10-11 02:58:48.807775|2017-10-11 02:58:48.807775
NCT01597310|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2014-11-24|||May 2012||2012-05-01|November 2014|2014-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study|An Open-Label Study to Assess the Effect of Dexpramipexole (BIIB050) on the Pharmacokinetics of Warfarin in Healthy Volunteers|Completed||Phase 1|15|Actual|Knopp Biosciences||2|||f||||f||||||||||2017-10-11 02:58:48.902842|2017-10-11 02:58:48.902842
NCT01597297|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-01-05|||August 2012||2012-08-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|MOBILE||Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Exploratory Study to Assess the Effect of Treatment With Prolonged-Release Fampridine (BIIB041) 10 mg Twice Daily on Walking Ability and Balance in Subjects With Multiple Sclerosis|Completed||Phase 2|132|Actual|Biogen||2|||f||||f||||||||||2017-10-11 02:58:49.002179|2017-10-11 02:58:49.002179
NCT01597284|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-02-09|||February 2012||2012-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Oral Therapies in Oncology: Cognitive Function and Compliance|Oral Therapies in Oncology: Cognitive Function and Compliance|Terminated||N/A|129|Actual|Centre Francois Baclesse|||1|Loss of recruitment|f||||f||||||||||2017-10-11 02:58:49.157555|2017-10-11 02:58:49.157555
NCT01597271|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2012-06-22|||May 2012||2012-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 02:58:49.223846|2017-10-11 02:58:49.223846
NCT01597245|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2016-08-27|2016-04-20|2015-01-16|May 2012||2012-05-01|August 2016|2016-08-01|July 2019|Anticipated|2019-07-01|March 2014|Actual|2014-03-01||Interventional|UNCOVER-2||A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis|Active, not recruiting||Phase 3|1224|Actual|Eli Lilly and Company||5|||f||||t||||||||||2017-10-11 02:58:49.507365|2017-10-11 02:58:49.507365
NCT01597232|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-01-11|||June 2012||2012-06-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|WCPTS||Clinic Trial for West China Perioperative Transfusion Score (WCPTS)|Effect of West China Perioperative Transfusion Score (WCPTS) on Red Blood Cells Transfusion in Patients Undergoing Major Surgery: a Prospective, Multicenter, Randomized Controlled Trial|Enrolling by invitation||Phase 3|3000|Anticipated|West China Hospital||3|||f||||t||||||||||2017-10-11 02:58:55.368367|2017-10-11 02:58:55.368367
NCT01597219|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-04-26|||March 2013||2013-03-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|UK-Haplo||Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers|A UK Multicentre Study of Haploidentical Stem Cell Transplantation in Patients With Haematological Malignancies|Recruiting||Phase 2|78|Anticipated|University College, London||2|||f||||t||||||||Undecided||2017-10-11 02:58:55.571962|2017-10-11 02:58:55.571962
NCT01597206|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-02-09|||January 2014||2014-01-01|January 2016|2016-01-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|SDA-RCT||Interventions for Patients With a Shortened Dental Arch|Outcomes of Interventions for Patients With a Reduced Posterior Dental Arch: A Randomized Controlled Trial|Completed||Phase 1/Phase 2|50|Actual|University of the Western Cape||2|||f||||t||||||||Yes|By publishing the results in a reputable (peer reviewed and accredited) journal|2017-10-11 02:58:55.703528|2017-10-11 02:58:55.703528
NCT01597193|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-08-01|||June 7, 2012|Actual|2012-06-07|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|December 15, 2015|Actual|2015-12-15||Interventional|||Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer|A Phase 1 Open-label, Dose Escalation Study Evaluating The Safety, Tolerability, And Pharmacokinetics Of Enzalutamide (Formerly Mdv3100) In Patients With Incurable Breast Cancer|Active, not recruiting||Phase 1|101|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 02:58:55.808833|2017-10-11 02:58:55.808833
NCT01597180|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-03-04|||July 2012||2012-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir|Pharmacokinetics, Pharmacodynamics and Genital Tract Viral Shedding in HIV+ Women Using Combined Oral Contraceptives and Raltegravir|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill|||1|Could not find subjects who met all the enrollment criteria so the study was stopped.|f||||f||||||||||2017-10-11 02:58:55.963211|2017-10-11 02:58:55.963211
NCT01597167|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-01-19|||October 2011||2011-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant Depression|A Double-blinded Randomized Study of IV Infusion of Magnesium Sulfate Versus 5% Dextrose in a Crossover Design in Male and Female Volunteers With Treatment Resistant Depression|Completed||N/A|21|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 02:58:56.024919|2017-10-11 02:58:56.024919
NCT01597154|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-07-28|||September 2012||2012-09-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|BDT||Lifestyle Therapy for Youth With Type 2 Diabetes|Beating Diabetes Together: A Randomized Controlled Trial for Intensive Lifestyle Therapy for Youth With Type 2 Diabetes|Completed||N/A|15|Actual|University of Manitoba||2|||f||||||||||||||2017-10-11 02:58:56.109138|2017-10-11 02:58:56.109138
NCT01597141|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-01-07|2015-10-22||May 2003||2003-05-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|EDIP||Psychosis: Early Detection, Intervention and Prevention|Psychosis: Early Detection, Intervention and Prevention|Completed||N/A|100|Actual|Maine Medical Center||2|||f||||t||||||||||2017-10-11 02:58:56.216726|2017-10-11 02:58:56.216726
NCT01597128|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-01-26|2016-06-24||March 2011||2011-03-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Flex HD||Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases|Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases|Completed||N/A|35|Actual|University of Kentucky|This is a Prospective Quasi-experimental study. Patients were randomized in the traditional sense.|2|||f||||t||||||||||2017-10-11 02:58:56.522383|2017-10-11 02:58:56.522383
NCT01597115|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2015-05-25|||May 2012||2012-05-01|May 2014|2014-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ENHANCE||ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment|ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment|Completed||N/A|150|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:58:57.03058|2017-10-11 02:58:57.03058
NCT01597102|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2013-01-09|||January 2012||2012-01-01|January 2013|2013-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|dARICULtx||Cerebrovascular Autoregulation During and After Liver Transplantation|Cerebrovascular Autoregulation During and After Liver Transplantation|Active, not recruiting||N/A|20|Anticipated|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-11 02:58:57.110412|2017-10-11 02:58:57.110412
NCT01597089|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-10|2017-10-05|||April 27, 2012||2012-04-27|April 28, 2017|2017-04-28||||||||Observational|||Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples|Detection of Respiratory Viruses in Upper and Lower Respiratory Tract Specimens Using a Rapid Multiplex PCR|Completed||N/A|35|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:58:57.206193|2017-10-11 02:58:57.206193
NCT01597076|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-12-02|||May 2012||2012-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effect of an Iridoid Enriched Beverage on Skin Autofluorescence||Completed||Phase 1|34|Actual|Tahitian Noni International, Inc.||1|||f||||t||||||||||2017-10-11 02:58:57.714808|2017-10-11 02:58:57.714808
NCT01595399|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2013-09-23|||April 2012||2012-04-01|May 2012|2012-05-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Atropine Versus no Atropine for Neonatal Rapid Sequence Intubation|Atropine Versus no Atropine for Neonatal Rapid Sequence Intubation|Unknown status|Recruiting|Phase 4|70|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 02:59:26.918844|2017-10-11 02:59:26.918844
NCT01597063|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-04-18|||July 2012||2012-07-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|February 2014|Actual|2014-02-01||Observational|||Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies|A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy|Completed||N/A|3333|Actual|Sequenom, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood specimens will be collected and processed to plasma. DNA will be extracted from     the plasma.   "|Yes|Upon analysis of collected samples and submission for publication, data will be shared as per journal requirements.|2017-10-11 02:58:57.803367|2017-10-11 02:58:57.803367
NCT01597050|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-06-15|2016-04-28||August 2012||2012-08-01|June 2016|2016-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|SKINDLE||Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions|Completed||Phase 2|54|Actual|Rigel Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:58:59.751556|2017-10-11 02:58:59.751556
NCT01597037|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-05-12|||June 2011||2011-06-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|||Aphasia Rehabilitation: Modulating Cues, Feedback & Practice|Aphasia Rehabilitation: Modulating Cues, Feedback & Practice|Recruiting||N/A|16|Anticipated|Shirley Ryan AbilityLab||4|||f||||f||||||||||2017-10-11 02:59:00.106286|2017-10-11 02:59:00.106286
NCT01597024|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-05-19|||May 2012||2012-05-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|F4H||Full4Health: Understanding Food-gut-brain Axis Across the Lifecourse|Full4Health: Neuro-gut Interactions in Humans Across the Lifecourse|Completed||N/A|718|Actual|University of Aberdeen||2|||f||||f||||||||||2017-10-11 02:59:00.20418|2017-10-11 02:59:00.20418
NCT01597011|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-03-17|||July 2012||2012-07-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Long-term Follow-up After Laparoscopic Inguinal Hernia Repair Using Tisseel for Mesh Fixation|Long-term Follow-up After Laparoscopic Inguinal Hernia Repair Using Tisseel for Mesh Fixation|Completed||N/A|2340|Actual|Herlev Hospital|||2||f||||f||||||||||2017-10-11 02:59:00.306889|2017-10-11 02:59:00.306889
NCT01596998|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-05-10|||December 2011||2011-12-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Plasma Concentrations of Levobupivacaine With and Without Epinephrine in Transversus Abdominis Plane Blocks|Comparison of Plasma Concentrations of Levobupivacaine With and Without Epinephrine for Transversus Abdominis Plane Block Under Ultrasound.|Completed||Phase 4|11|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 02:59:00.424062|2017-10-11 02:59:00.424062
NCT01596972|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-06-27|2014-05-15||June 2012||2012-06-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||The Role of a Semi-Quantitative Urine Pregnancy Test and Pregnancy Questionnaire After Uterine Evacuation for Undesired Pregnancy of Uncertain Location|The Role of a Semi-Quantitative Urine Pregnancy Test and Pregnancy Questionnaire After Uterine Evacuation for Undesired Pregnancy of Uncertain Location: A Pilot Randomized Controlled Trial|Completed||N/A|51|Actual|Planned Parenthood League of Massachusetts||2|||f||||f||||||||||2017-10-11 02:59:00.747789|2017-10-11 02:59:00.747789
NCT01596946|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-05-10|||November 2006||2006-11-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Home-sampling in Partner Notification of Chlamydia|Home-sampling as a Tool in a Chlamydia Trachomatis Partner Notification Context. A Multi-centre Cluster-randomized Controlled Trial.|Completed||N/A|633|Actual|Ostergotland County Council, Sweden||2|||f||||f||||||||||2017-10-11 02:59:01.299276|2017-10-11 02:59:01.299276
NCT01596933|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-03-09|||April 2012||2012-04-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|NUTRIOM||Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy|Multi-centric, Placebo-controlled Trial of Omega-3 Fatty Acid Supplementation in Weight Maintenance and Preservation of Lean Body Mass, in (Pre)Cachectic Head and Neck Cancer Patients, Undergoing Curative Radio(Chemo)Therapy|Completed||Phase 2/Phase 3|91|Actual|General Hospital Groeninge||2|||f||||t||||||||||2017-10-11 02:59:01.41023|2017-10-11 02:59:01.41023
NCT01596920|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-04-07|||April 2012||2012-04-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|August 2013|Actual|2013-08-01||Interventional|DFU||Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers|A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers|Completed||Phase 4|97|Actual|Osiris Therapeutics||2|||f||||f||||||||||2017-10-11 02:59:01.577182|2017-10-11 02:59:01.577182
NCT01596907|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-09-22|||May 2012||2012-05-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Treatment of Low Metabolic Rate Following Bariatric Surgery|Treatment of Low Metabolic Rate and Low Weight Loss Rate Following Bariatric Surgery|Completed||N/A|218|Actual|Oregon Weight Loss Surgery, LLC||2|||f||||f||||||||||2017-10-11 02:59:01.726399|2017-10-11 02:59:01.726399
NCT01596894|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-08-08|||October 2012||2012-10-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease|A Randomized, Single Blinded, Controlled, Multi Center Phase 4 Study for Induction of Remission in Active Pediatric Crohn's Disease, Using 2 Months Antibiotic Course of Azithromycin Combined With Metronidazole vs. Metronidazole Alone.|Completed||Phase 4|73|Actual|Wolfson Medical Center||2|||f||||f||||||||||2017-10-11 02:59:01.847711|2017-10-11 02:59:01.847711
NCT01596881|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-08-29|||April 2012||2012-04-01|August 2014|2014-08-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|OCT in MS||Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis|Using OCT to Capture Retinal Microvascular Changes Associated With MS|Unknown status|Active, not recruiting|N/A|80|Anticipated|Oregon Health and Science University|||2||f||||||||||||||2017-10-11 02:59:01.994983|2017-10-11 02:59:01.994983
NCT01596868|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2013-10-29|||May 2012||2012-05-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China|A Randomized, Phase II Trial Comparing Induction Chemotherapy Gemcitabine Plus Cisplatin With Docetaxel Plus Cisplatin Followed by Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma in Northwest China|Completed||Phase 2|60|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 02:59:02.08746|2017-10-11 02:59:02.08746
NCT01596855|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-01-31|||September 2011||2011-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China|A Phase 2, Randomized, Open-Label Active-Comparator (Epoetin Alfa) Dose-Ranging Safety and Exploratory Efficacy Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis (HD)|Completed||Phase 2|96|Actual|FibroGen||2|||f||||f||||||||||2017-10-11 02:59:02.205722|2017-10-11 02:59:02.205722
NCT01596842|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-03-08|2015-02-20||May 2012||2012-05-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Hemodialysis patients|Effect of Omega-3 Fatty Acid on Vitamin D Activation|Effect of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients|Completed||Phase 4|17|Actual|Dong-A University||2|||f||||t||||||||||2017-10-11 02:59:02.330435|2017-10-11 02:59:02.330435
NCT01596829|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-01-21|||December 2012||2012-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea|Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea|Terminated||Phase 2/Phase 3|258|Actual|Danisco||2||low incidence|f||||f||||||||No|Terminated prematurely.|2017-10-11 02:59:02.669664|2017-10-11 02:59:02.669664
NCT01596816|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2014-06-20|||August 2010||2010-08-01|June 2014|2014-06-01|September 2016|Anticipated|2016-09-01|September 2013|Actual|2013-09-01||Interventional|CKNO-PRO||Hypofractionated Stereotactic Boost in Prostate Cancer|Intermediate-risk Prostate Cancer : Assessment of Hypofractionated Stereotactic Boost - Prospective Phase II Study|Unknown status|Active, not recruiting|Phase 2|76|Actual|Centre Oscar Lambret||2|||f||||t||||||||||2017-10-11 02:59:02.766153|2017-10-11 02:59:02.766153
NCT01596803|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-05-09|||June 2010||2010-06-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|April 2013|Anticipated|2013-04-01||Interventional|FSHD||Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD)|Effects of Antioxidants Supplementation on Muscular Function of Patients Affected by Facioscapulohumeral Dystrophy (FSHD)|Unknown status|Recruiting|N/A|54|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 02:59:03.020759|2017-10-11 02:59:03.020759
NCT01596790|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-12-03|||April 2012||2012-04-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|February 2016|Anticipated|2016-02-01||Interventional|||COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer|Assessment by EPISPOT of Circulating Tumor Cells as an Early Predictive Marker of Response to Chemotherapy and Targeted Therapy in Patients With Metastatic Colorectal Cancer in First Line of Treatment|Unknown status|Recruiting|Phase 2|168|Anticipated|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 02:59:03.15779|2017-10-11 02:59:03.15779
NCT01596777|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-10-25|||January 2010||2010-01-01|October 2016|2016-10-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|LOP-MNTX-2009||Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects|Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects|Completed||Phase 1|15|Actual|University Medicine Greifswald||5|||f||||f||||||||||2017-10-11 02:59:03.273493|2017-10-11 02:59:03.273493
NCT01596764|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-09|||May 2011||2011-05-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|July 2011|Actual|2011-07-01||Interventional|||Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.|Effects of Extended Release Methylnaltrexone Bromide (150 mg b.i.d.) in Comparison to Extended Release Naloxone Hydrochloride (20 mg b.i.d.) on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time in Healthy Subjects.|Completed||Phase 1|16|Actual|University Medicine Greifswald||4|||f||||f||||||||||2017-10-11 02:59:03.426795|2017-10-11 02:59:03.426795
NCT01596751|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-08-04|||July 2012||2012-07-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|February 28, 2017|Actual|2017-02-28||Interventional|||Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer|Enhancing Efficacy of Chemotherapy in Triple Negative/Basal-Like Breast Cancer by Targeting Macrophages: A Multicenter Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer|Active, not recruiting||Phase 1/Phase 2|68|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:59:03.621418|2017-10-11 02:59:03.621418
NCT01596738|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2012-05-09|||October 2008||2008-10-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||Tranexamic Acid in On-pump CABG With Premature Clopidogrel Cessation|Tranexamic Acid in Patients Receiving Primary and Isolated On-pump CABG With Premature Clopidogrel Cessation to Reduce Postoperative Bleeding and Transfusion|Completed||N/A|120|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-10-11 02:59:03.788163|2017-10-11 02:59:03.788163
NCT01596725|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-02-05|||May 2012||2012-05-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2012|Actual|2012-08-01||Interventional|||A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2|A Phase 1 Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Indonesia/05/05 (H5N1) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Young Adults With and Without Adjuvant 2.|Completed||Phase 1|333|Actual|Novavax||6|||f||||t||||||||||2017-10-11 02:59:03.934347|2017-10-11 02:59:03.934347
NCT01596712|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-11-20|||March 2011||2011-03-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects|A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Following Subcutaneous Injections of QGE031 in Japanese Atopic Male Subjects|Completed||Phase 1|209|Actual|Novartis||4|||f||||||||||||||2017-10-11 02:59:04.121504|2017-10-11 02:59:04.121504
NCT01596699|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-05-02|||July 2012||2012-07-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation|A Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation|Suspended||N/A|31|Anticipated|University of California, San Francisco||2||Triggering of futility rule, requires study modification|f||||t||||||||||2017-10-11 02:59:04.263544|2017-10-11 02:59:04.263544
NCT01596686|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2013-12-23|||May 2012||2012-05-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Preparation Regimens for Colonoscopy||Completed||N/A|184|Actual|Clinical Hospital Colentina||2|||f||||t||||||||||2017-10-11 02:59:04.401152|2017-10-11 02:59:04.401152
NCT01596673|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-11-20|||March 2012||2012-03-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Assess the Abuse Potential of the Hydrocodone Bitartrate Extended-Release Tablet in Healthy, Nondependent, Recreational Opioid Users|Completed||Phase 1|100|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-10-11 02:59:04.530141|2017-10-11 02:59:04.530141
NCT01596660|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-09|||August 2011||2011-08-01|May 2012|2012-05-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|TAPBLOCK||Transversus Abdominis Bilateral Plane Block in Total Laparoscopic Hysterectomy : A Randomized Controlled Trial|Transversus Abdominis Bilateral Plane Block in Total Laparoscopic Hysterectomy : A Randomized Controlled Trial|Unknown status|Recruiting|N/A|200|Anticipated|CES University||2|||f||||t||||||||||2017-10-11 02:59:04.696405|2017-10-11 02:59:04.696405
NCT01596647|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-05-12|||May 2012||2012-05-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors|A Phase I, Multi-center, Open-label, Drug-drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered as a Four-drug Cocktail in Patients With Advanced Solid Tumors, Excluding Breast Cancer|Completed||Phase 1|39|Actual|Novartis||1|||f||||f||||||||||2017-10-11 02:59:04.823892|2017-10-11 02:59:04.823892
NCT01596634|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-05-25|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|October 10, 2015|Actual|2015-10-10|August 2015|Actual|2015-08-01||Interventional|||Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy|A Pilot Study of Bovine Lactoferrin in Patients With Colorectal Carcinoma Receiving Oxaliplatin-Based Chemotherapy and Self-Reported Taste Disturbances|Completed||N/A|12|Actual|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 02:59:04.934635|2017-10-11 02:59:04.934635
NCT01596621|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-08-25|||July 31, 2012|Actual|2012-07-31|August 2017|2017-08-01|April 28, 2017|Actual|2017-04-28|April 28, 2017|Actual|2017-04-28||Interventional|||Bendamustine in the Treatment of Chinese Patients With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment|An Open-Label Study to Evaluate Bendamustine Hydrochloride in the Treatment of Chinese Patients With Indolent Non-Hodgkin Lymphoma (NHL) Refractory to Rituximab Treatment|Completed||Phase 3|102|Actual|Teva Pharmaceutical Industries||1|||f||||t|f|f||||||||2017-10-11 02:59:05.055062|2017-10-11 02:59:05.055062
NCT01596608|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-01-26|||February 2012||2012-02-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder|Efficacy and Tolerability of Magnetic Seizure Therapy (MST) as an Alternative to Electroconvulsive Therapy (ECT) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder|Recruiting||N/A|250|Anticipated|Centre for Addiction and Mental Health||1|||f||||t||||||||||2017-10-11 02:59:05.200374|2017-10-11 02:59:05.200374
NCT01596595|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-02-27|||April 2013|Actual|2013-04-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|LSS of 4-SITE||Longitudinal Surveillance Study of the 4-SITE Lead/Header System|Longitudinal Surveillance Study of the 4-SITE Lead/Header System|Active, not recruiting||N/A|1820|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 02:59:05.347682|2017-10-11 02:59:05.347682
NCT01596582|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-03-20|2017-01-23||April 2012||2012-04-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening|Impact of Risk Stratification on Shared Decision-Making for Colorectal Cancer Screening|Completed||N/A|352|Actual|Boston Medical Center|Single institution setting; lack of provider education about the utility of risk stratification into their decision-making.|2|||f||||f|f|f||||||No||2017-10-11 02:59:05.815197|2017-10-11 02:59:05.815197
NCT01596569|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-05-26|||May 2012||2012-05-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|COST-TBI||Combined Transcranial Magnetic Stimulation and Cognitive Treatment in Blast Traumatic Brain Injury|Combining Cognitive Treatment With Noninvasive Brain Stimulation in Blast TBI|Recruiting||Phase 1/Phase 2|24|Anticipated|Boston Medical Center||2|||f||||f||||||||No||2017-10-11 02:59:06.589934|2017-10-11 02:59:06.589934
NCT01596556|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2014-05-08|||June 2012||2012-06-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Smoking on Thermoregulation|The Effect of Smoking on Thermoregulation|Completed||N/A|16|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 02:59:06.753352|2017-10-11 02:59:06.753352
NCT01596543|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2014-05-08|||November 2012||2012-11-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Partial and Complete Sleep Deprivation on Heat Tolerance|Thr Effect of Partial and Complete Sleep Deprivation on Heat Tolerance|Completed||N/A|12|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 02:59:06.86217|2017-10-11 02:59:06.86217
NCT00004573|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-18|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:50.468852|2017-10-11 04:26:50.468852
NCT01596530|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-12-13|||June 2012||2012-06-01|December 2012|2012-12-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|CHIVE||Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment|A Randomised Double-Blind Placebo-controlled Multicentre Phase I Study to Assess the Biological Activity of AZD8931 in Patients With Early Breast Cancer Who Are Ineligible for Treatment With Trastuzumab as Defined by IHC Status|Terminated||Phase 1|3|Actual|AstraZeneca||2||All AstraZeneca sponsored clinical trials of AZD8931 have been halted|f||||||||||||||2017-10-11 02:59:06.97519|2017-10-11 02:59:06.97519
NCT01596517|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-12|||June 2003||2003-06-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C|Efficacy and Effectiveness of Combination Therapy With Pegylated Interferon Alfa-2a and Ribavirin in Korean Patients With Chronic Hepatitis C|Completed||Phase 4|272|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 02:59:07.092107|2017-10-11 02:59:07.092107
NCT01596504|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-08-22|2016-08-22|2015-04-21|May 2012||2012-05-01|August 2016|2016-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin|An Open-label, Randomized, Three-parallel-group Study on Pharmacodynamic Effects of 8-week QD Treatment With Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin|Completed||Phase 2|142|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 02:59:07.230417|2017-10-11 02:59:07.230417
NCT01596491|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-12-19|||April 2011||2011-04-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain|Kind and Duration of Possible Changes of the Sensory Profiles After the Topical Application of Capsaicin (8%) in Patients With Peripheral Neuropathic Pain|Completed||N/A|20|Actual|Ruhr University of Bochum|||2||f||||f||||||||||2017-10-11 02:59:08.194688|2017-10-11 02:59:08.194688
NCT01596478|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-01-10|||December 2011||2011-12-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effectiveness of Therapy Treatment|Effectiveness of Cognitive-Motivational Behaviour Therapy in Community|Unknown status|Recruiting|N/A|150|Anticipated|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 02:59:08.276031|2017-10-11 02:59:08.276031
NCT01596465|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-10|||January 2011||2011-01-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of Two Teaching Techniques to Teach Cardiac Auscultation to Physicians|Self-Directed Study Using MP3 Players Versus Multimedia Lecture to Improve Auscultation Proficiency of Physicians: A Randomized, Controlled Trial.|Completed||N/A|83|Actual|The Reading Hospital and Medical Center||2|||f||||t||||||||||2017-10-11 02:59:08.362337|2017-10-11 02:59:08.362337
NCT01596452|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-08|||June 2012||2012-06-01|December 2013|2013-12-01||||May 2015|Anticipated|2015-05-01||Observational|||Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology||Unknown status|Recruiting|N/A|31|Anticipated|National University Hospital, Singapore|||1||f||||||||||||||2017-10-11 02:59:08.435012|2017-10-11 02:59:08.435012
NCT01596439|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-10|||June 2013||2013-06-01|December 2013|2013-12-01||||May 2014|Anticipated|2014-05-01||Observational|||A Prospective Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive Function of Breast Cancer Patients||Unknown status|Recruiting|N/A|100|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 02:59:08.50076|2017-10-11 02:59:08.50076
NCT01596426|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-08-15|||July 2018|Anticipated|2018-07-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years|An Open-label, Cross-over, Pharmacokinetic Study to Assess the Safety and Pharmacokinetics of Transdermal Granisetron (Sancuso® Patch) and IV Granisetron in a Pediatric Oncology Population (Aged 2 to 5 Years)|Not yet recruiting||Phase 1|16|Anticipated|Kyowa Kirin Pharmaceutical Development Ltd||2|||f|||||f|f||||||||2017-10-11 02:59:08.58715|2017-10-11 02:59:08.58715
NCT01596413|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-06-07||||||June 2017|2017-06-01||||||||Interventional|||Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years|An Open-label, Cross-over, Pharmacokinetic Study to Assess the Safety and Pharmacokinetics of Transdermal Granisetron (Sancuso® Patch) and IV Granisetron in a Pediatric Oncology Population (Aged 6 to 12 Years)|Not yet recruiting||Phase 1|16|Anticipated|Kyowa Kirin Pharmaceutical Development Ltd||2|||f||||||||||||||2017-10-11 02:59:08.659593|2017-10-11 02:59:08.659593
NCT01596400|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-07-11|||May 2012||2012-05-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years|An Open-label, Cross-over, Pharmacokinetic Study to Assess the Safety and Pharmacokinetics of Transdermal Granisetron (Sancuso® Patch) and IV Granisetron in a Pediatric Oncology Population (Aged 13 to 17 Years)|Completed||Phase 1|19|Actual|Kyowa Kirin Pharmaceutical Development Ltd||2|||f||||||||||||||2017-10-11 02:59:08.73117|2017-10-11 02:59:08.73117
NCT01596387|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-10|||March 2012||2012-03-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Validation of a Pharmacokinetic Pharmacodynamic Model to Administer Propofol in Obese Patients|Validation of a Pharmacokinetic Pharmacodynamic Model to Administer Propofol in Obese Patients|Completed||Phase 4|20|Actual|Pontificia Universidad Catolica de Chile||1|||f||||t||||||||||2017-10-11 02:59:08.831737|2017-10-11 02:59:08.831737
NCT01596374|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-10|||August 2011||2011-08-01|December 2013|2013-12-01||||July 2014|Anticipated|2014-07-01||Observational|||Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours||Unknown status|Recruiting|N/A|2000|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 02:59:08.913024|2017-10-11 02:59:08.913024
NCT01596361|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-10|||August 2011||2011-08-01|December 2013|2013-12-01||||August 2014|Anticipated|2014-08-01||Observational|||Verification of a Pharmacogenetic Approach to Customizing Chemotherapy to Asians||Unknown status|Recruiting|N/A|750|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 02:59:09.124005|2017-10-11 02:59:09.124005
NCT01596348|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2012-05-10|||June 2011||2011-06-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Exercise Perceptions and Preferences Among Rheumatoid Arthritis Patients|Perceived Exercise Benefits, Barriers and Preferences Among Swiss Rheumatoid Arthritis Patients|Completed||N/A|120|Actual|University of Lausanne|||1||f||||f||||||||||2017-10-11 02:59:09.211663|2017-10-11 02:59:09.211663
NCT01596335|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-04-09|||May 2012||2012-05-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease|To Evaluate the Efficacy and Safety of TA-650 in Comparison With a Control Drug Polyethylene Glycol-treated Human Immunoglobulin (VGIH) in Patients With Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin (IVIG).|Completed||Phase 3|31|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 02:59:09.338513|2017-10-11 02:59:09.338513
NCT01596322|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-22|2015-04-06|||September 2004||2004-09-01|April 2015|2015-04-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|UARTO||International HIV Antiretroviral Adherence, Resistance and Survival|Novel Approaches to Monitoring and Utilizing Adherence to HIV Therapy in Uganda|Unknown status|Recruiting|N/A|775|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     plasma, buffy coat, saliva   "|||2017-10-11 02:59:09.452761|2017-10-11 02:59:09.452761
NCT01596309|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2013-06-17|||January 2012||2012-01-01|September 2012|2012-09-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Cocoa Extract-enriched Meals and Cardiovascular Risk in Older Population|Study of the Effect of Ready-cooked Meals Containing Cocoa Extract, as a Potential Functional Ingredient, on Cardiovascular Risk Markers in Older Population|Completed||N/A|50|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||f||||||||||2017-10-11 02:59:09.543194|2017-10-11 02:59:09.543194
NCT01596296|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-10-12|||May 2012||2012-05-01|October 2016|2016-10-01||||February 2017|Anticipated|2017-02-01||Interventional|||Foley Catheter Versus Dinoprostone Vaginal Insert for Induction of Labor in Parous Women at Term: A Randomized Trial||Recruiting||N/A|154|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 02:59:09.685831|2017-10-11 02:59:09.685831
NCT01596270|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-10-24|||June 2012||2012-06-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma|A Phase 1 Dose-escalation Study of the Safety and Pharmacokinetics of a Tablet Formulation of SAR245409 Administered Daily to Patients With Solid Tumors or Lymphoma|Completed||Phase 1|49|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 02:59:09.899943|2017-10-11 02:59:09.899943
NCT01596257|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-03-13|||May 2012|Actual|2012-05-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation|Randomized Phase II Trial of Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation|Active, not recruiting||Phase 2|72|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 02:59:09.997929|2017-10-11 02:59:09.997929
NCT01596244|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-11-07|||April 2008||2008-04-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|April 2011|Actual|2011-04-01||Interventional|||Jordan Diabetes Microclinic Project|Pilot and Expansion Project for the Jordan Diabetes Microclinic Project|Completed||N/A|2400|Actual|Microclinic International||1|||f||||f||||||||||2017-10-11 02:59:10.190933|2017-10-11 02:59:10.190933
NCT01596231|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-10-15|2014-10-15||May 2010||2010-05-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|May 2013|Actual|2013-05-01||Interventional|KUDZU||Kudzu Treatment for Alcohol Abuse|Isoflavone (Kudzu) Extract Effects on Alcohol Drinking: Single Dose Pretreatment Study|Completed||Phase 2|20|Actual|Mclean Hospital||2|||f||||f||||||||||2017-10-11 02:59:10.298776|2017-10-11 02:59:10.298776
NCT01596218|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-03-21|||July 2012||2012-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|||Brentuximab Vedotin for Steroid Refractory GvHD|Phase I Trial of Brentuximab Vedotin for Steroid Refractory Acute Graft vs. Host Disease (GvHD)|Completed||Phase 1|34|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-11 02:59:10.740801|2017-10-11 02:59:10.740801
NCT01596205|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-05-09|||June 2011||2011-06-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||The Efficacy of Robot Assisted Group Cognitive Training in Elderly Adults Without Cognitive Impairment|The Efficacy of Robot Assisted Group Cognitive Training in Elderly Adults Without Cognitive Impairment|Completed||N/A|85|Actual|Samsung Medical Center||3|||f||||f||||||||||2017-10-11 02:59:10.886149|2017-10-11 02:59:10.886149
NCT01596192|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-09|||May 2012||2012-05-01|February 2012|2012-02-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Observational|PETGVHD-001||PETCT for Diagnosing and Monitoring Acute GVHD|The Sensitivity and Specificity of 18F-Fluorodeoxyglucose Positron Emission Tomography -Computed Tomography for the Diagnosis and Monitoring of Acute Graft vs. Host Disease|Unknown status|Not yet recruiting|N/A|30|Anticipated|Rabin Medical Center|||1||f||||f||||||Samples Without DNA|"     Levels of HGF, IL8, IL2R and TNFR1 will be measured at the onset of GVHD and prior to the     second PET-CT. Five cc blood will be drawn twice from each patient and will be collected in     an EDTA containing tube.   "|||2017-10-11 02:59:10.972322|2017-10-11 02:59:10.972322
NCT01596179|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-04-16|||February 2012||2012-02-01|January 2015|2015-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TENN||Technology Enhanced Nurse Navigator Trial (TENN Trial)|Technology Enhanced Nurse Navigator Trial (TENN Trial) Phase III Randomized Controlled Trial|Completed||Phase 3|101|Actual|Mercy Medical Center||2|||f||||f||||||||||2017-10-11 02:59:11.089978|2017-10-11 02:59:11.089978
NCT01596166|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-01-21|||February 2012||2012-02-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|EDMigraine-4||Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department|Efficacy of Combination Therapy With Intravenous Ketorolac and Metoclopramide for Pediatric Migraine Therapy in the Emergency Department|Completed||Phase 4|56|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 02:59:11.182364|2017-10-11 02:59:11.182364
NCT01596153|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-11-17||||||November 2014|2014-11-01||||||||Interventional|||Probiotics in Hospitalized Patients Study|Randomized Double-blind, Placebo-Controlled Trial Comparing the the Effect of Enhance Probiotic (EP, Go Live Rx,) Versus Placebo (Pl) on the Incidence of Clostridium Difficile Associated Diarrhea (CDAD) or Antibiotic-Associated Diarrhea (AAD)in Hospitalized Patients Initiated on Antibiotics|Withdrawn||N/A|0|Actual|South Shore Hospital||2||The study was not initiated|f||||f||||||||||2017-10-11 02:59:11.30089|2017-10-11 02:59:11.30089
NCT01596140|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-05-08|||December 2012|Actual|2012-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer|A Phase I Dose-Escalation Study of the BRAF Inhibitor Vemurafenib (Zelboraf®) in Combination With an mTOR Inhibitor, Everolimus (Afinitor®) or Temsirolimus (Torisel®), in Subjects With Advanced Cancer|Active, not recruiting||Phase 1|114|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 02:59:11.371441|2017-10-11 02:59:11.371441
NCT01596127|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-03-28|||January 24, 2013|Actual|2013-01-24|March 2017|2017-03-01|March 23, 2017|Actual|2017-03-23|March 23, 2017|Actual|2017-03-23||Interventional|||Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System|Safety and Efficacy of Intrathecal Rituximab in Patients With Lymphoid Malignancies Involving the Central Nervous System|Terminated||Phase 1/Phase 2|4|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f|t|f||||||||2017-10-11 02:59:11.481475|2017-10-11 02:59:11.481475
NCT01596114|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-08-23|||June 2012||2012-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|EURO-SKI||European Stop Tyrosine Kinase Inhibitor Study|Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukemia After Stopping TKI|Active, not recruiting||Phase 3|800|Actual|European LeukemiaNet||1|||f||||t||||||||||2017-10-11 02:59:11.598657|2017-10-11 02:59:11.598657
NCT01596101|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-08-10|||April 2009||2009-04-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|November 2013|Actual|2013-11-01||Observational|Sleep4||Circadian Rhythm of Melatonin in Burns|Role of Circadian Rhythm of Melatonin on Sleep-related Disturbances Postburn|Completed||N/A|86|Actual|Shriners Hospitals for Children|||2||f||||t||||||||||2017-10-11 02:59:11.806589|2017-10-11 02:59:11.806589
NCT01596088|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-03-18|2015-02-27|||||March 2015|2015-03-01||||January 2014|Actual|2014-01-01||Interventional|||A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents|A Multicenter, Open Label, Single-arm Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents|Completed||Phase 1/Phase 2|2|Actual|Kissei Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 02:59:11.907417|2017-10-11 02:59:11.907417
NCT01596075|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-09-09|||July 2012||2012-07-01|September 2012|2012-09-01||||July 2015|Anticipated|2015-07-01||Interventional|||Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation|Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 02:59:12.224549|2017-10-11 02:59:12.224549
NCT01596062|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-06-26|2014-03-17||March 2012||2012-03-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|IDEALE||Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)|Prospective, Multicenter, Randomized, Open-label, Phase 2, Lasting 12 Weeks, Evaluating the Pharmacodynamics, Efficacy and Safety of Basiliximab in de Novo Adult Renal Transplant Patients at Low Risk Receiving Either a Cumulative Dose of Basiliximab of 40 or 80 mg in Combination With Cyclosporine Microemulsion, or a Cumulative Dose of 80 mg of Basiliximab Without Calcineurin Inhibitor, With Additional Follow-up of 12 Weeks|Completed||Phase 2|16|Actual|Novartis||3|||f||||t||||||||||2017-10-11 02:59:12.363551|2017-10-11 02:59:12.363551
NCT01596049|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-08-17|||May 2012||2012-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||The Efficacy of a Self-fixating Mesh in Unilateral Open Inguinal Hernia Repair|The Efficacy of a Self-fixating Mesh in Unilateral Open Inguinal Hernia Repair, in Comparison to the Standard Treatment in the Literature|Terminated||N/A|7|Actual|Rambam Health Care Campus|||1|recruitment was not going well.|f||||f||||||||||2017-10-11 02:59:13.804149|2017-10-11 02:59:13.804149
NCT01596036|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-11-13|||February 2011||2011-02-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|ENROLL||Readiness for Behavior Change After a Heart Attack|Stages of Change Through the Cardiac Rehabilitation Experience After a Recent Hospitalization|Completed||N/A|150|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-10-11 02:59:13.897686|2017-10-11 02:59:13.897686
NCT01596023|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-01-14|||May 2012||2012-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients|Evaluation of Effect of Breathe Ventilation System on Work of Breathing in COPD Patients|Completed||N/A|14|Actual|Breathe Technologies, Inc.||1|||f||||f||||||||||2017-10-11 02:59:14.020572|2017-10-11 02:59:14.020572
NCT01596010|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-03-17|||October 2007||2007-10-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women|Single Dose, Double-blind, Two-way Cross-over Bioequivalence Trial With 2 Different Oral Formulations of Estradiol and Norethisterone|Completed||Phase 1|44|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 02:59:14.111348|2017-10-11 02:59:14.111348
NCT01595997|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2013-01-07|||February 2012||2012-02-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|2011-00500-15||Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris|A Multi-center, Double-blinded, Randomized, Placebo-controlled, Intra-individual Comparison, Phase Ib Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris|Completed||Phase 1/Phase 2|20|Anticipated|Delenex Therapeutics AG||2|||f||||t||||||||||2017-10-11 02:59:14.217273|2017-10-11 02:59:14.217273
NCT01595984|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2016-06-23|||May 2012||2012-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|CIME||Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)|Randomized, Multicenter, Open-label, Comparative Study of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI), Associating Myfortic ® and Neoral ® Compared to a CNI-free Treatment, Combining Myfortic ® and Certican ® , in Adult Patients With de Novo Renal Transplant|Active, not recruiting||Phase 3|90|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||t||||||||||2017-10-11 02:59:14.313966|2017-10-11 02:59:14.313966
NCT01594632|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-09-19|||January 2011||2011-01-01|September 2017|2017-09-01|July 4, 2017|Actual|2017-07-04|July 4, 2017|Actual|2017-07-04||Interventional|||Safety,Effectiveness and Acceptability of Sino-implant II in DR|A Study to Evaluate the Contraceptive Effectiveness, Safety and Acceptability of Sino-implant II|Completed||N/A|650|Actual|FHI 360||2|||f||||t||||||||||2017-10-11 02:59:37.168331|2017-10-11 02:59:37.168331
NCT01595971|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-05-12|||August 12, 2010|Actual|2010-08-12|September 2016|2016-09-01|December 16, 2011|Actual|2011-12-16|December 16, 2011|Actual|2011-12-16||Interventional|RESPIRANET||Distance Education Versus Usual Care Qualification in Asthma Care|Distance Education Versus Usual Care in the Qualification of Asthma Care: A Cluster Randomized Clinical Trial - RESPIRANET|Completed||N/A|467|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-10-11 02:59:14.407939|2017-10-11 02:59:14.407939
NCT01595958|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2014-04-30|||June 2010||2010-06-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CYRUS||Cyclosporine A in Cardiac Arrest|CYclosporine A in Non-shockable Out-of-hospital Cardiac Arrest ResUScitation|Completed||Phase 3|796|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 02:59:14.514879|2017-10-11 02:59:14.514879
NCT01595945|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-02-04|||April 2012||2012-04-01|February 2015|2015-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Effect of Caloric Restriction and Gastric Bypass on Resting Metabolic Rate|Effect of Caloric Restriction and Gastric Bypass on Resting Metabolic Rate in Obese Subjects|Terminated||N/A|75|Anticipated|KiloCoach e.U.||2|||f||||f||||||||||2017-10-11 02:59:14.612751|2017-10-11 02:59:14.612751
NCT01595932|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-05-09|||June 2009||2009-06-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy and Tolerability of α-galactosidase in Treating Gas-related Symptoms in Children|Efficacy and Tolerability of α-galactosidase in Treating Gas-related Symptoms in Children. A Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 4|52|Actual|Azienda Policlinico Umberto I||2|||f||||t||||||||||2017-10-11 02:59:14.701693|2017-10-11 02:59:14.701693
NCT01595919|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-06-14|||April 2011||2011-04-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Comparison of Beverages Consumed Within a Meal to Satiation on Meal-time Food Intake and Post-meal Appetite and Glycemic Response in Healthy Young Adults||Completed||N/A|26|Actual|University of Toronto||5|||f||||t||||||||||2017-10-11 02:59:14.783399|2017-10-11 02:59:14.783399
NCT01595906|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-05-14|||September 2012||2012-09-01|May 2012|2012-05-01|February 2013|Anticipated|2013-02-01|October 2012|Anticipated|2012-10-01||Interventional|||The Affect of a Ventilated Helmet on Physiological Load|The Affect of a Ventilated Helmet System on Human Physiological Load|Unknown status|Not yet recruiting|N/A|12|Anticipated|Medical Corps, Israel Defense Force||1|||f||||f||||||||||2017-10-11 02:59:14.863819|2017-10-11 02:59:14.863819
NCT01595893|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-06-10|||April 2012||2012-04-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|VitD-PLE_2012||Vitamin D Supplementation in Polymorphic Light Eruption|Vitamin D3 Supplementation in Polymorphic Light Eruption: Randomized Double-blinded Placebo-controlled Trial|Terminated||Phase 3|8|Actual|Medical University of Graz||2||Difficulties in recruiting the planned number of patients|f||||f||||||||||2017-10-11 02:59:14.963105|2017-10-11 02:59:14.963105
NCT01595880|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-02-02|||December 2014||2014-12-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone|A Randomized, Open-label, Oral Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone in Healthy Male Volunteers|Completed||Phase 1|29|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 02:59:15.079686|2017-10-11 02:59:15.079686
NCT01595867|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-06-07|||August 2010||2010-08-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo|A Randomized, Double-Blind, Placebo-Controlled, 3 Way Crossover Study Evaluating The Relative Abuse Potential Of Crushed Embeda Compared To Morphine Sulfate Controlled Release Tablets (Crushed) And Placebo In Non-Dependent, Recreational Opioid Users Following Intranasal Administration|Completed||Phase 1|33|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 02:59:15.170863|2017-10-11 02:59:15.170863
NCT01595854|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2013-06-18|2013-06-18||May 2012||2012-05-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran|Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor (Part 1 and 2, Open, Non-randomised, 2 Parallel Groups) and Assessment of Ticagrelor Interaction Potential With Dabigatran (Part 3, Open, Randomised, Two-period Cross-over) in Healthy Male Subjects|Completed||Phase 1|36|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 02:59:15.406369|2017-10-11 02:59:15.406369
NCT01595841|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-09-08|||December 2011||2011-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|SAVE||Sirolimus Use in Angioplasty for Vascular Access Extension|A Randomized Open Label Trial of Oral Sirolimus for Decrease of Stenosis in Arteriovenous Fistula in Hemo-dialysis Patients When Compared With Standard Therapy|Recruiting||Phase 2|36|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 02:59:15.971833|2017-10-11 02:59:15.971833
NCT01595828|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-07-19|||October 2010||2010-10-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|CAPITAIN||Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome|An Open Label Study of the Chronic and Acute Effects of Pitavastatin on Monocyte Phenotype, Endothelial Dysfunction and HDL Atheroprotective Function in Subjects With Metabolic Syndrome (CAPITAIN)|Completed||Phase 1|14|Actual|Kowa Research Europe||1|||f||||f||||||||||2017-10-11 02:59:16.077283|2017-10-11 02:59:16.077283
NCT01595815|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2014-01-06|||May 2007||2007-05-01|January 2014|2014-01-01|April 2016|Anticipated|2016-04-01|September 2011|Actual|2011-09-01||Interventional|||Successful Pregnancy and Delivery After AOA|Successful Pregnancy and Delivery After AOA in Couples With Repeated Complete Fertilization Failure or Low Fertilization Rates|Unknown status|Active, not recruiting|N/A|100|Anticipated|Maria Fertility Hospital||2|||f||||t||||||||||2017-10-11 02:59:16.156645|2017-10-11 02:59:16.156645
NCT01595802|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2016-02-23|||January 2012||2012-01-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|March 2013|Actual|2013-03-01||Interventional|||Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm|A Non-Randomized, Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM System to Transcranial Doppler as an Aid to Diagnosing Vasospasm|Completed||N/A|72|Actual|Jan Medical, Inc.||2|||f||||f||||||||No||2017-10-11 02:59:16.248157|2017-10-11 02:59:16.248157
NCT01595789|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-03-04|||May 2012||2012-05-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|AddHope2||The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes|Adding Liraglutide to the Backbone Therapy of Biguanide in Patients With Coronary Artery Disease and Newly Diagnosed Type-2 Diabetes|Completed||Phase 4|41|Actual|Haugaard, Steen Bendix, M.D., DMSc||2|||f||||t||||||||||2017-10-11 02:59:16.350457|2017-10-11 02:59:16.350457
NCT01595776|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-06-13|||January 2009||2009-01-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia|Autologous Immunomagnetic Selected cd133+ Cells in the Treatment of No-option Critical Limb Ischemia: Clinical and Ceus Assessed Results.|Completed||Phase 1/Phase 2|8|Actual|IRCCS Policlinico S. Matteo||1|||f||||t||||||||||2017-10-11 02:59:16.471384|2017-10-11 02:59:16.471384
NCT01595763|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-08|||November 2011||2011-11-01|April 2011|2011-04-01||||||||Observational|||Diagnostic Approach of Deep Vein Thrombosis in Primary Care|Orientación Diagnóstica de la Trombosis Venosa Profunda en la Atención Primaria. Estudio de Coste Efectividad|Unknown status|Recruiting|N/A|20|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||Samples Without DNA|"     blood to calculate the value of Dimer D   "|||2017-10-11 02:59:16.580345|2017-10-11 02:59:16.580345
NCT01595750|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2012-05-09|||May 2012||2012-05-01|May 2012|2012-05-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|REVASC||Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease|Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Not yet recruiting|Phase 4|150|Anticipated|Spanish Research Center for Respiratory Diseases||2|||f||||f||||||||||2017-10-11 02:59:16.67041|2017-10-11 02:59:16.67041
NCT01595737|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-03-11|||February 2011||2011-02-01|May 2012|2012-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Comparison of the Administration of Levosimendan and Placebo in the Preparation of Critical Patients for Heart Surgery|Comparison of the Administration of Levosimendan and Placebo in the Preparation of Critical Patients for Heart Surgery|Completed||Phase 4|30|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 02:59:16.802297|2017-10-11 02:59:16.802297
NCT01595724|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2015-07-09|||May 2012||2012-05-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|July 2014|Actual|2014-07-01||Observational|DIVA||Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life|Study to Characterize Patients Treated With Visanne for Their Endometriosis Under Real-life Practice Conditions and Evaluate Their Quality of Life at Baseline and After 6 Months of Treatment With Visanne.|Completed||N/A|3006|Actual|Bayer|||1||f||||f||||||||||2017-10-11 02:59:16.888096|2017-10-11 02:59:16.888096
NCT01595711|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-11-02|||April 2012||2012-04-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|D3C||Prediction of Chronic Pain by the Pain Monitor|Prediction of the Occurrence of Chronic Pain After Thoracotomy by Measuring Preoperative Skin Conductance (Pain Monitor Device)|Recruiting||N/A|230|Anticipated|Hopital Foch|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 02:59:17.027577|2017-10-11 02:59:17.027577
NCT01595698|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-06-08|||February 2010||2010-02-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Schizophrenia and Physical Exercise|Schizophrenia and Physical Exercise: Effect of 20 Weeks of Training in Symptoms and Concentration in Serum IGF-1 and BDNF|Completed||N/A|11|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 02:59:17.130757|2017-10-11 02:59:17.130757
NCT01595685|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-01-24|||May 2012||2012-05-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TERESA||Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B|A Randomized, Open-label Trial Comparing Telbivudine vs, Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B Who Have Achieved Serum HBV DNA Undetectability by Preceding Entecavir Treatment|Completed||Phase 3|98|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:59:17.233095|2017-10-11 02:59:17.233095
NCT01595672|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-05-08|||April 2012||2012-04-01|May 2012|2012-05-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Interventional|EHVCVVHSAP||Early High-volume Continuous Veno-venous Hemofiltration for Patients With Severe Acute Pancreatitis|Early High-volume Continuous Veno-venous Hemofiltration for Patients With Severe Acute Pancreatitis: Single-center, Randomized, Controlled Trial|Unknown status|Recruiting|N/A|56|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 02:59:17.343529|2017-10-11 02:59:17.343529
NCT01595659|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2012-05-08|||May 2012||2012-05-01|May 2012|2012-05-01||||April 2014|Anticipated|2014-04-01||Interventional|||Influence of Alcohol and Peer Passengers on Risky Driving Behavior in Young Adults|Influence of Alcohol and Peer Passengers on Risky Driving Behavior in Young Adults|Unknown status|Recruiting|N/A|200|Anticipated|Centre de recherche du Centre hospitalier universitaire de Sherbrooke||3|||f||||f||||||||||2017-10-11 02:59:17.468539|2017-10-11 02:59:17.468539
NCT01595633|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2012-05-09|||March 2012||2012-03-01|May 2012|2012-05-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy|Randomized Study Comparing Nucleoside Analogues Plus Tenofovir and Nucleoside Analogues Plus Adefovir in Chronic Hepatitis B Patients With Suboptimal Response to Adefovir-based Combination Therapy Due to Nucleoside Analogues Resistance|Unknown status|Recruiting|Phase 4|124|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 02:59:17.691596|2017-10-11 02:59:17.691596
NCT01595620|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-06-21|||December 2011||2011-12-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Cannabinoid Modulation of Pain|Cannabinoid Modulation of Pain|Active, not recruiting||N/A|120|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 02:59:17.819503|2017-10-11 02:59:17.819503
NCT01595594|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-07-15|||March 2010||2010-03-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Interventional|||Comparison Between aPDT and Systemic Doxycycline on Non-surgical Periodontal Therapy in Type 2 Diabetics|Effect of a PDT Protocol With Multiple Applications as an Adjuvant on the Non Surgical Treatment of Periodontal Disease in Patients With Type 2 Diabetes. A Clinical and Laboratorial Study in Humans|Completed||Phase 3|30|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-11 02:59:17.989728|2017-10-11 02:59:17.989728
NCT01595568|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-07-18|||February 2012||2012-02-01|July 2012|2012-07-01||||July 2012|Anticipated|2012-07-01||Interventional|||Prevention and Reduction of Alcohol and Drug Problems in a Clinical Psychiatric Youth Population||Unknown status|Recruiting|N/A|60|Anticipated|St. Justine's Hospital||4|||f||||f||||||||||2017-10-11 02:59:18.382245|2017-10-11 02:59:18.382245
NCT01595555|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-08-07|||September 2010||2010-09-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Effectiveness of Stress Free Now: an Internet-based Mindfulness Program for Stress Management|Effectiveness of an Internet-based Mindfulness Program for Stress Management|Completed||N/A|684|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 02:59:18.506315|2017-10-11 02:59:18.506315
NCT01595542|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-03-12|||September 2011||2011-09-01|March 2014|2014-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A School Health Center Intervention to Increase Adolescent Vaccination|A School Health Center Intervention to Increase Adolescent Vaccination|Completed||N/A|3417|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 02:59:18.636027|2017-10-11 02:59:18.636027
NCT01595529|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-12-27|||May 2012||2012-05-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|SCOUT||The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children|"Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children"|Recruiting||Phase 2|746|Anticipated|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 02:59:18.739544|2017-10-11 02:59:18.739544
NCT01595516|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-04-04|||February 2012||2012-02-01|April 2017|2017-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)|Nebivolol and Endothelial Regulation of Fibrinolysis|Active, not recruiting||Phase 4|54|Actual|University of Colorado, Boulder||3|||f||||t||||||||||2017-10-11 02:59:18.875306|2017-10-11 02:59:18.875306
NCT01595503|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2013-07-15|||May 2011||2011-05-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia|Functional Targeting of Transcranial Magnetic Stimulation for the Treatment of Refractory Auditory Hallucinations in Schizophrenia|Completed||N/A|5|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 02:59:18.979584|2017-10-11 02:59:18.979584
NCT01595490|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-01-27|||March 2012||2012-03-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Mind-Body Skills Groups for the Treatment of War-Related Trauma in Adolescents in Gaza|A Randomized Controlled Study of Mind-Body Skills Groups for the Treatment of War-Related Trauma in Adolescents in Gaza|Completed||N/A|121|Actual|The Center for Mind-Body Medicine||2|||f||||f||||||||||2017-10-11 02:59:19.064573|2017-10-11 02:59:19.064573
NCT01595477|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-01-27|||March 2012||2012-03-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Mind-Body Skills Groups for the Treatment of War-Related Trauma in Children in Gaza|A Randomized Controlled Study of Mind-Body Skills Groups for the Treatment of War-Related Trauma in Children in Gaza|Completed||N/A|114|Actual|The Center for Mind-Body Medicine||2|||f||||f||||||||||2017-10-11 02:59:19.160071|2017-10-11 02:59:19.160071
NCT01595464|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-01-27|||March 2012||2012-03-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Mind-Body Skills Groups for the Treatment of War-Related Trauma in Adults in Gaza|A Randomized Controlled Study of Mind-Body Skills Groups for the Treatment of War-Related Trauma in Adults in Gaza|Completed||N/A|148|Actual|The Center for Mind-Body Medicine||2|||f||||f||||||||||2017-10-11 02:59:19.262433|2017-10-11 02:59:19.262433
NCT01595451|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-09-12|||January 2012||2012-01-01|September 2017|2017-09-01|October 2017|Anticipated|2017-10-01|May 2017|Actual|2017-05-01||Interventional|||Brain Mechanisms of Acupuncture Treatment in Chronic Low Back Pain|Brain Mechanisms of Acupuncture Treatment in Chronic Low Back Pain|Active, not recruiting||N/A|88|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 02:59:19.371714|2017-10-11 02:59:19.371714
NCT01595438|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-08-31|2015-10-28||October 2012||2012-10-01|August 2017|2017-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Safety analysis set|Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)|A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults|Completed||Phase 3|598|Actual|Pfizer||2|||f||||||||||||||2017-10-11 02:59:19.771087|2017-10-11 02:59:19.771087
NCT01595425|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-12-11|||May 2012||2012-05-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects|A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Bioequivalence Study Comparing a Pellets Based Sachet Formulation of D961H 20 mg and a Commercial HPMC Capsule of D961H 20 mg After Repeated Oral Administration in Japanese Healthy Male Subjects|Completed||Phase 1|71|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 02:59:26.685576|2017-10-11 02:59:26.685576
NCT01595412|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-04-12|||April 2010||2010-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|LaProS||An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy|Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.|Recruiting||N/A|120|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No||2017-10-11 02:59:26.786384|2017-10-11 02:59:26.786384
NCT01595386|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-10-12|2015-01-28||April 2012||2012-04-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Postop Steroids on Cardiovascular/Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass|Effect of Postoperative Hydrocortisone on Cardiovascular and Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass|Completed||N/A|40|Actual|University of Alabama at Birmingham|small, single-center trial; included subjects from more than one surgeon; all patients received preoperative and rescue steroids; definition of low cardiac output syndrome although appropriate must ultimately be arbitrary.|2|||f||||t||||||||||2017-10-11 02:59:27.059466|2017-10-11 02:59:27.059466
NCT01595373|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2013-01-15|||June 2012||2012-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Local Metabolic Effects of Ghrelin in Skeletal Muscle and Adipose Tissue|Local Metabolic Effects of Ghrelin: A Clinical Microdialysis Study|Completed||Early Phase 1|10|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 02:59:27.931901|2017-10-11 02:59:27.931901
NCT01595360|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-09-13|||April 2012||2012-04-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction|A Phase 1, Randomized, Open, Controlled, Comparative Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction|Completed||Phase 1|24|Actual|Thrombotargets Europe S.L||2|||f||||t||||||||||2017-10-11 02:59:28.012254|2017-10-11 02:59:28.012254
NCT01595334|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-05-24|||April 2012||2012-04-01|May 2012|2012-05-01|November 2012|Anticipated|2012-11-01|September 2012|Anticipated|2012-09-01||Interventional|LH/M2-Oocyte||Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity|Is it Possible to Obtain Higher Yield of Mature M2 Oocytes by Establishing Appropriate Levels of LH During Controlled Ovarian Hyperstimulation (COH) in Antagonist Cycles for In-vitro Fertilization-embryo Transfer (IVF-ET)/ Intracytoplasmic Sperm Injection (ICSI)?|Unknown status|Recruiting|N/A|300|Anticipated|Southern Cross Fertility Centre||2|||f||||t||||||||||2017-10-11 02:59:28.280688|2017-10-11 02:59:28.280688
NCT01595321|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-10-05|||August 2012||2012-08-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|August 2018|Anticipated|2018-08-01||Interventional|||Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas|Pilot Study Evaluating An Allogeneic GM-CSF-Transduced Pancreatic Tumor Cell Vaccine (GVAX) and Low Dose Cyclophosphamide Integrated With Fractionated Stereotactic Body Radiation Therapy (SBRT) and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas|Active, not recruiting||N/A|19|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 02:59:28.413505|2017-10-11 02:59:28.413505
NCT01595308|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-05-10|||April 2011||2011-04-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers|A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers|Completed||Phase 1|12|Actual|POM Wonderful LLC||1|||f||||f||||||||||2017-10-11 02:59:28.508354|2017-10-11 02:59:28.508354
NCT01595295|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-04-04|||February 2009|Actual|2009-02-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Registry on Hypomethylating Agents in Myeloid Neoplasms|Registry on Hypomethylating Agents in Myeloid Neoplasms, Including Myelodysplastic Syndromes (MDS), Chronic Myelominocytic Leukemia (CMML) and Acute Myeloid Leukemia (AML)|Recruiting||N/A|1500|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie|||1||f||||f||||||Samples With DNA|"     From some patients with myeloid neoplasms blood or tissue samples will be stored for further     analyses. These samples will also be obtained from patients, who are not or not yet treated     with hypomethylating agents, to comprise a control.   "|||2017-10-11 02:59:28.653749|2017-10-11 02:59:28.653749
NCT01595282|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-06-30|2014-05-15||June 2011||2011-06-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Intramuscular Ketorolac Versus Oral Ibuprofen for Pain Relief in First Trimester Suction Curettage|Intramuscular Ketorolac Versus Oral Ibuprofen for Pain Relief in First Trimester Suction Curettage: a Randomized Clinical Trial.|Completed||N/A|94|Actual|Planned Parenthood League of Massachusetts||2|||f||||f||||||||||2017-10-11 02:59:28.786786|2017-10-11 02:59:28.786786
NCT01595269|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-03|2012-05-08|||April 2007||2007-04-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|eHealthDM||The Clinical and Economic Impacts of e-Heath on Diabetes|The Clinical and Economic Impacts of e-Heath on Diabetes|Completed||N/A|79|Actual|Pacaud, Danièle, M.D.||3|||f||||f||||||||||2017-10-11 02:59:29.14066|2017-10-11 02:59:29.14066
NCT01595256|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2014-10-13|||October 2011||2011-10-01|October 2014|2014-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Exploration the Effect of Walking Program in Patients With Colorectal Cancer|Exploration the Effect of Individualized Home-based Walking Program on Muscle Strength and Fatigue in Patients With Colorectal Cancer Both During and After Treatment|Completed||N/A|237|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:59:29.260014|2017-10-11 02:59:29.260014
NCT01595243|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-12-26|||October 2009||2009-10-01|November 2012|2012-11-01|February 2013|Anticipated|2013-02-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Telephone Consultations on Discharged Liver Cancer|Effects of Telephone Follow- up Consultations on Discharged Liver Cancer Following Non-surgical Treatment|Unknown status|Recruiting|N/A|254|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 02:59:29.344128|2017-10-11 02:59:29.344128
NCT01595230|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-09|2017-06-28|||May 2012||2012-05-01|June 2017|2017-06-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|||Internal Hernias After Gastric Bypass Can be Prevented Safely With Primary Closure of All Mesenteric Defects With Clips|Randomized Controlled Trial: Internal Hernias After Gastric Bypass Can be Prevented Safely With Primary Closure of All Mesenteric Defects With Clips|Active, not recruiting||N/A|405|Actual|Region Zealand||2|||f||||f||||||||||2017-10-11 02:59:29.448994|2017-10-11 02:59:29.448994
NCT01595191|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-08|||July 2010||2010-07-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||"Bach Music in Preterm Infants: No Mozart Effect on Resting Energy Expenditure"|"Bach Music in Preterm Infants: No Mozart Effect on Resting Energy Expenditure"|Completed||N/A|12|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 02:59:29.727974|2017-10-11 02:59:29.727974
NCT01595178|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-07|||June 2012||2012-06-01|May 2012|2012-05-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Combination SBIRT for Emergency Department Patients Who Drink and Smoke|Development of a Combined Screening and Intervention Program for Emergency Department Patients Who Both Drink and Smoke|Unknown status|Not yet recruiting|Early Phase 1|50|Anticipated|Yale University||1|||f||||f||||||||||2017-10-11 02:59:29.811257|2017-10-11 02:59:29.811257
NCT01595165|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-07-05|||July 2012||2012-07-01|July 2012|2012-07-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Transversus Abdominis Plane Block and Postoperative Pain After Laparoscopic Cholecystectomy|Effect of Subcostal Transversus Abdominis Plane Block on Early Postoperative Pain in Laparoscopic Cholecystectomy: Randomized, Controlled Trial|Unknown status|Recruiting|N/A|50|Anticipated|Soonchunhyang University Hospital||2|||f||||t||||||||||2017-10-11 02:59:29.902347|2017-10-11 02:59:29.902347
NCT01595152|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2012-05-14|||May 2012||2012-05-01|May 2012|2012-05-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms|Solifenacin Succinate vs. Fesoterodine A Comparison Trial for the Treatment of Bothersome Urgency Symptoms|Unknown status|Recruiting|N/A|60|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 02:59:30.032799|2017-10-11 02:59:30.032799
NCT01595139|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-02-03|||February 2012||2012-02-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||MicroRNAs in Patients With Neurofibromatosis Type 1|MicroRNAs as Disease Markers for Central Nervous System Tumors in Patients With Neurofibromatosis Type 1|Completed||N/A|9|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||Undecided||2017-10-11 02:59:30.184864|2017-10-11 02:59:30.184864
NCT01595126|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2016-02-03|||December 2011||2011-12-01|February 2016|2016-02-01||||December 2018|Anticipated|2018-12-01||Observational|||Longitudinal Study of Biomarkers|A Longitudinal Study of Biomarkers in Pediatric Patients With Central Nervous System Tumors|Recruiting||N/A|100|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||||||2017-10-11 02:59:30.269067|2017-10-11 02:59:30.269067
NCT01595113|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2013-11-13|||May 2012||2012-05-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Observational|||Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction|A Follow-up Observational Study of Safety of Clinical Trial Conducted With Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction|Completed||N/A|40|Anticipated|Pharmicell Co., Ltd.|||1||f||||t||||||||||2017-10-11 02:59:30.376532|2017-10-11 02:59:30.376532
NCT01595100|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-02-04|||January 2010||2010-01-01|February 2016|2016-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|Waist||Anthropometric Assessment of Abdominal Obesity and Health Risk in Children and Adolescents|Anthropometric Assessment of Abdominal Obesity and Health Risk in Children and Adolescents|Completed||N/A|423|Actual|Pennington Biomedical Research Center|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 02:59:30.430828|2017-10-11 02:59:30.430828
NCT01595087|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-11-12|||January 2012||2012-01-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)|A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)|Completed||Phase 1/Phase 2|28|Actual|DexTech Medical AB||1|||f||||t||||||||||2017-10-11 02:59:30.507951|2017-10-11 02:59:30.507951
NCT01595074|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2013-09-19|||May 2012||2012-05-01|August 2013|2013-08-01||||January 2100|Anticipated|2100-01-01||Observational|||Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy|The Identification, Validation and Implemention of Prognostic and/or Predictive Biomarkers for Adjuvant Chemotherapy in Early Stage Non-Small Cell Lung Cancer (NSCLC)|Not yet recruiting||N/A|950|Anticipated|National Cancer Institute (NCI)|||1||f||||||||||||||2017-10-11 02:59:30.58785|2017-10-11 02:59:30.58785
NCT01595061|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2017-08-22|||July 2, 2012|Actual|2012-07-02|August 2017|2017-08-01||||September 30, 2019|Anticipated|2019-09-30||Interventional|||Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva|A Phase II Trial Evaluating Cisplatin (NSC #119875) and Gemcitabine (NSC #613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Vulva (NCT #01595061)|Recruiting||Phase 2|52|Anticipated|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 02:59:30.705114|2017-10-11 02:59:30.705114
NCT01595035|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-04-05|||May 2012||2012-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|October 2015|Actual|2015-10-01||Interventional|||A Clinical Trial of a Psycho-educational Intervention to Improve Pain Management After Day Surgery|A Randomized Clinical Trial of a Psycho-educational Intervention to Improve Pain Management After Day Surgery|Active, not recruiting||N/A|200|Actual|Oslo and Akershus University College of Applied Sciences||2|||f||||f||||||||||2017-10-11 02:59:31.518472|2017-10-11 02:59:31.518472
NCT01595022|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-04-02|||January 2010||2010-01-01|April 2015|2015-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||FR01 and FR20 IUS (Intrauterine System) Wearing Study|A Multi-center, Single-blinded, Randomized, Controlled, Parallel-group Study to Evaluate the Wearing Comfort of Two Different Placebo Intrauterine Systems FR01 and FR20 Compared to a Placebo T-frame Intrauterine System for 3 Cycles in Healthy Women Aged 18-40 Years|Completed||Phase 1|90|Actual|Bayer||3|||f||||f||||||||||2017-10-11 02:59:31.611389|2017-10-11 02:59:31.611389
NCT01521351|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2015-05-26|||January 2012||2012-01-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Natural History of Carotid Atherosclerosis|A Prospective Natural History Study of Carotid Atherosclerosis|Recruiting||N/A|700|Anticipated|University of Athens|||4||f||||f||||||||||2017-10-11 03:20:45.618761|2017-10-11 03:20:45.618761
NCT01594996|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2015-05-26|||April 2012||2012-04-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|EUDUS||European Drug Utilization Study|A Multinational, Multicenter, Retrospective, Observational Drug Utilisation Study of Seroquel Extended Release (XR) Prescribed by Psychiatrists as Treatment for Major Depressive Disorder (MDD) in Selected Countries in the European Union (EU)|Completed||N/A|1008|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 02:59:31.853073|2017-10-11 02:59:31.853073
NCT01594983|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-10-05||2015-10-05|June 2012||2012-06-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia|A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia|Completed||Phase 2|58|Actual|Novartis||6|||f||||f||||||||||2017-10-11 02:59:31.945528|2017-10-11 02:59:31.945528
NCT01594970|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-01-27|2014-01-27||March 2012||2012-03-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)||Completed||Phase 4|800|Actual|Allergan||3|||f||||f||||||||||2017-10-11 02:59:32.145097|2017-10-11 02:59:32.145097
NCT01594957|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2013-05-23|||April 2012||2012-04-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment|An Open-label, Single Dose, Parallel-group Study to Evaluate the Pharmacokinetics of LCQ908 in Patients With Mild, Moderate and Severe Hepatic Impairment Compared to Age, Gender and Weight-matched Healthy Volunteers.|Completed||Phase 1|53|Actual|Novartis||3|||f||||||||||||||2017-10-11 02:59:32.616289|2017-10-11 02:59:32.616289
NCT01594944|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-08|||May 2012||2012-05-01|May 2012|2012-05-01||||||||Observational|||Fetal Orbital Measurements by 3D Ultrasound||Unknown status|Not yet recruiting|N/A|250|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 02:59:32.719709|2017-10-11 02:59:32.719709
NCT01594931|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-08|||July 2005||2005-07-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria|A Randomised, Multi-Centre, Phase II, Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Fixed Dose, Orally Administered Pyronaridine and Artesunate (3:1) in Adult Patients With Acute Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 2|477|Actual|Medicines for Malaria Venture||3|||f||||t||||||||||2017-10-11 02:59:32.776241|2017-10-11 02:59:32.776241
NCT01594918|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-07-20|||June 2012||2012-06-01|July 2017|2017-07-01|June 23, 2017|Actual|2017-06-23|August 2016|Actual|2016-08-01||Interventional|||Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer|A Phase I Study of Cabazitaxel, Mitoxantrone, and Prednisone (CAMP) for Patients With Metastatic Castration-Resistant Prostate Cancer and no Prior Chemotherapy|Completed||Phase 1|25|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 02:59:32.925042|2017-10-11 02:59:32.925042
NCT01594905|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2014-01-30|||August 2012||2012-08-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection|A Multicenter, Open-label, Prospective Study to Evaluate Antiviral Efficacy and Safety of Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 02:59:33.036828|2017-10-11 02:59:33.036828
NCT01594892|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-08-06|||April 2012||2012-04-01|August 2015|2015-08-01||||January 2015|Actual|2015-01-01||Interventional|DOSIS||Fractionated Radiosurgery for Painful Spinal Metastases|Dose-intensified Image-Guided Fractionated Radiosurgery for Spinal Metastases (DOSIS)|Unknown status|Active, not recruiting|Phase 2|60|Actual|Wuerzburg University Hospital||2|||f||||t||||||||||2017-10-11 02:59:33.148629|2017-10-11 02:59:33.148629
NCT01594879|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-08|||January 2012||2012-01-01|May 2012|2012-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer|Treatment With Medroxyprogesterone Acetate(MPA) Plus Levonorgestrel-releasing Intrauterine System(LNG-IUS) in Young Women With Early Stage Endometrial Cancer: Multicenter Study: Korean Gynecologic Oncology Group Study (KGOG2009)|Unknown status|Recruiting|Phase 2|39|Anticipated|Korean Gynecologic Oncology Group||1|||f||||f||||||||||2017-10-11 02:59:33.246543|2017-10-11 02:59:33.246543
NCT01594866|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-12-07|||May 2012||2012-05-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|LEADERS||Lexapro®'s Efficacy After Dose Escalation in Remission Study|A Double-blinded 6-week Prospective Study to Evaluate the Remission Rate According to Dose of Escitalopram (Lexapro®) in Patients With Major Depressive Disorder: a Preliminary Study|Recruiting||Phase 4|60|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 02:59:33.351876|2017-10-11 02:59:33.351876
NCT01594853|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-01-08|||May 2012||2012-05-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy|Exercise Study of Function and Pathology for Women With X-ALD|Completed||N/A|31|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||f||||||||||2017-10-11 02:59:33.465297|2017-10-11 02:59:33.465297
NCT01594840|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2014-03-24|||January 2012||2012-01-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Changing Chat: Diaper Tips to Improve Language Development|Changing Chat: Diaper Tips to Improve Language Development|Completed||N/A|70|Anticipated|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-11 02:59:33.561737|2017-10-11 02:59:33.561737
NCT01594827|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-08-21|||October 2012||2012-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PMEP||Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)|Persistent MRSA Eradication Protocol (PMEP)|Active, not recruiting||Phase 2|40|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 02:59:33.66915|2017-10-11 02:59:33.66915
NCT01594814|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-12-12|||January 2012||2012-01-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|PPRA||Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT|Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT - a Quality of Life, Utility and Willingness to Pay Study (PPRA Study)|Completed||N/A|82|Actual|Institute of Cardiology, Warsaw, Poland|||1||f||||t||||||||||2017-10-11 02:59:33.90081|2017-10-11 02:59:33.90081
NCT01594801|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2013-03-12|||May 2012||2012-05-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Testing the Effect of the InsuPad Device in Daily Life Conditions|Testing the Effect of the InsuPad Device in Daily Life Conditions - The InsuPad in Daily Life Study|Completed||N/A|145|Actual|Insuline Medical Ltd.||2|||f||||f||||||||||2017-10-11 02:59:34.040896|2017-10-11 02:59:34.040896
NCT01594788|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-08|||April 2011||2011-04-01|January 2012|2012-01-01|December 2012||2012-12-01|||||Observational|||Neutrophil Gelatinase-associated Lipocalin as a New Biomarker to Detect Acute Kidney Injury in Postoperative Cardiac Surgery|NGAL as a Marker of Acute Kidney Injury After Cardiac Surgery. Observational Study|Unknown status|Recruiting|N/A|340||Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||t||||||||||2017-10-11 02:59:34.155649|2017-10-11 02:59:34.155649
NCT01594775|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2014-02-24|||October 2011||2011-10-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Oxytocin, Couple Interaction and Wound Healing||Completed||Phase 1|160|Actual|University of Zurich||2|||f||||||||||||||2017-10-11 02:59:34.241364|2017-10-11 02:59:34.241364
NCT01594762|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-05-19|2017-04-14||June 2014||2014-06-01|April 2017|2017-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|OneStep-2||Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers|A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers|Completed||Phase 3|200|Actual|Dipexium Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 02:59:34.458581|2017-10-11 02:59:34.458581
NCT01594749|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-02-17|2015-08-26||September 2012||2012-09-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||The Baseline analysis population is consistent with the Intent-to-Treat (ITT) population, i.e., all randomized participants who received ≥1 dose of study drug within the assigned treatment regimen. Note: One participant with missing source documentation in the Fosaprepitant Regimen was excluded from the ITT population.|Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)|A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Efficacy and Safety of a Single 150 mg Dose of Intravenous Fosaprepitant Dimeglumine for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With Moderately Emetogenic Chemotherapy|Completed||Phase 3|1015|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 02:59:35.200328|2017-10-11 02:59:35.200328
NCT01594736|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-08-03|||April 2012||2012-04-01|August 2017|2017-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ORSIRO_OCT||ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography|Intracoronary Stenting and Angiographic Results: ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography|Completed||Phase 4|30|Actual|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||||2017-10-11 02:59:36.179792|2017-10-11 02:59:36.179792
NCT01594723|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-05-18||2015-09-03|May 2012||2012-05-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|March 2015|Actual|2015-03-01||Interventional|||A Study of LY2784544 in Participants With Myeloproliferative Neoplasms|A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms|Active, not recruiting||Phase 2|110|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 02:59:36.300537|2017-10-11 02:59:36.300537
NCT01594710|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-28|2015-10-12|||February 2012||2012-02-01|April 2014|2014-04-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Observational|||Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults||Completed||N/A|1800|Actual|Korea University|||1||f||||t||||||||||2017-10-11 02:59:36.490712|2017-10-11 02:59:36.490712
NCT01594697|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-10||||||May 2012|2012-05-01||||||||Interventional|||Metformin in Pregnancy in Women With Polycystic Ovary Syndrome||Completed||N/A|60|Actual|Catholic University of the Sacred Heart||1|||f||||||||||||||2017-10-11 02:59:36.557341|2017-10-11 02:59:36.557341
NCT01594684|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-06-16|||January 2012||2012-01-01|June 2012|2012-06-01|June 2016|Anticipated|2016-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Cotavance™ Paclitaxel-Coated Balloon Versus Uncoated Balloon Angioplasty for Treatment of In-stent Restenosis in SFA and Popliteal Arteries|Cotavance™ Paclitaxel-Coated Balloon Versus Uncoated Balloon Angioplasty for Treatment of In-stent Restenosis in SFA and Popliteal Arteries COPA CABANA Study|Unknown status|Recruiting|Phase 2/Phase 3|112|Anticipated|Klinikum Rosenheim||3|||f||||f||||||||||2017-10-11 02:59:36.658132|2017-10-11 02:59:36.658132
NCT01594671|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-12-18|||February 2012||2012-02-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|TRANEXTOP||Tranexamic Acid for Unilateral Total Knee Arthroplasty|Prevention of Postoperative Blood Loss: Randomised Multicentre Parallel Clinical Trial That Assess the Topical and Intravenous Tranexamic Acid in Surgical Patients With a Total Knee Arthroplasty.|Completed||Phase 3|150|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||3|||f||||f||||||||||2017-10-11 02:59:36.83573|2017-10-11 02:59:36.83573
NCT01594658|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-09-30|||July 2011||2011-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|February 2012|Actual|2012-02-01||Observational|VUTEF||Venous Ulcer Treatment With Foam Versus Conservative Treatment|Prospective Random Study for Handling Venous Ulcer With Conservative Treatment (Dressings Alone) and Foam Sclerotherapy Versus Conservative Treatment|Completed||N/A|46|Actual|Hospital Occidente de Kennedy|||2||f||||f||||||||||2017-10-11 02:59:36.950389|2017-10-11 02:59:36.950389
NCT01594645|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-08-19|||September 2012||2012-09-01|May 2012|2012-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Clinical Impact of Selecting Acrosome Reacted Spermatozoa for ICSI|The Impact of Selecting Acrosome Reacted Spermatozoa for ICSI- a Prospective RCT|Withdrawn||Phase 1|0|Actual|Hadassah Medical Organization||2||PI moved from Hadassah|f||||f||||||||||2017-10-11 02:59:37.062192|2017-10-11 02:59:37.062192
NCT00004574|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-17|2008-03-03|||February 2000||2000-02-01|December 1999|1999-12-01|May 2001||2001-05-01|||||Observational|||Vitamin Replacement in Abetalipoproteinemia|Vitamin Replacement in Abetalipoproteinemia|Completed||N/A|1||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:50.525853|2017-10-11 04:26:50.525853
NCT01594619|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-08|2014-10-13|||May 2012||2012-05-01|October 2014|2014-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Study in Healthy Volunteers to Investigate the Effects of Diltiazem on the Pharmacokinetics of Naloxegol|An Open-label, Sequential, 3-period Study to Assess the Effects of Diltiazem on the Pharmacokinetics of Naloxegol in Healthy Subjects|Completed||Phase 1|44|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 02:59:37.273829|2017-10-11 02:59:37.273829
NCT01594606|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-12-08|||May 2012||2012-05-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|||Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth|RCT of an Animal-Assisted Intervention With Adjudicated Youth|Completed||Phase 3|150|Actual|Wayne State University||2|||f||||f||||||||||2017-10-11 02:59:37.374394|2017-10-11 02:59:37.374394
NCT01594593|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-11-16|||March 2011||2011-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Acceptance-Based Treatment for Prostate Cancer Distress|Pilot Study of an Acceptance and Commitment Therapy Workshop for Distress and Decision Making in Early Stage Prostate Cancer in Veterans|Completed||N/A|24|Actual|Veterans Medical Research Foundation||2|||f||||f||||||||||2017-10-11 02:59:37.463087|2017-10-11 02:59:37.463087
NCT01594580|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-12-09|||April 2012||2012-04-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Contamination of Hospital Scrubs|A Novel Agent to Decrease Contamination of Hospital Scrubs|Completed||N/A|111|Actual|University of Maryland||2|||f||||f||||||||||2017-10-11 02:59:37.560654|2017-10-11 02:59:37.560654
NCT01594567|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-09-21|||March 2012||2012-03-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Meta-analyses of Dietary Pulses and Cardiometabolic Risk|Effect of Dietary Pulses on Cardiometabolic Risk in Humans: A Series of Systematic Reviews and Meta-analyses to Provide Evidence-based Guidance for Nutrition Guidelines Development|Unknown status|Active, not recruiting|N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-11 02:59:37.639754|2017-10-11 02:59:37.639754
NCT01594554|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-05-08|||April 2012||2012-04-01|May 2012|2012-05-01|September 2016|Anticipated|2016-09-01|April 2016|Anticipated|2016-04-01||Observational|||A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.|A 5-year Observational Follow-up Study to Describe Treatment Patterns and Outcomes in Real World Clinical Practice for Patients of Newly Confirmed HCV Infection in China (2012-2016)|Unknown status|Recruiting|N/A|600|Anticipated|Peking University People's Hospital|||1||f||||f||||||Samples With DNA|"     Samples with HCV RNA   "|||2017-10-11 02:59:37.754256|2017-10-11 02:59:37.754256
NCT01594541|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-03-21|||January 2013||2013-01-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|August 2013|Actual|2013-08-01||Observational|||A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients|Hyperhomocysteinemia in a Mild Cognitive Impairment and Dementia Population: the Effect of Treatment With Cerefolin NAC® in a Naturalistic Community-based Dementia Practice|Unknown status|Active, not recruiting|N/A|700|Anticipated|Pamlab, Inc.|||2||f||||f||||||||||2017-10-11 02:59:37.853171|2017-10-11 02:59:37.853171
NCT01594515|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2015-11-11|2015-11-11||May 2012||2012-05-01|November 2015|2015-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||The treated set (TS) included all subjects who were dispensed study medication and were documented to have taken at least 1 dose of the investigational treatment.|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers (a Partially Randomised, Partially Single-blind, Placebo-controlled Phase I Study)|Completed||Phase 1|70|Actual|Boehringer Ingelheim|BI 1015550 high dose 24mg was originally planned as 26 mg but reduced due to PK interim analysis results of previous dose group.|10|||f||||||||||||||2017-10-11 02:59:38.066531|2017-10-11 02:59:38.066531
NCT01594502|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-10-31|||September 2011||2011-09-01|October 2016|2016-10-01|July 2021|Anticipated|2021-07-01|July 2017|Anticipated|2017-07-01||Observational|||Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies|R01 CA155301: Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies|Active, not recruiting||N/A|300|Anticipated|University of Illinois at Chicago|||6||f||||f||||||Samples Without DNA|"     Biopsy tissue (Year 2 and Year 4) already collected in REDUCE trial   "|||2017-10-11 02:59:39.327241|2017-10-11 02:59:39.327241
NCT01594489|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2012-10-26|||January 2009||2009-01-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction|Effect of Aminophylline on Contrast Induced Acute Kidney Injury in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty|Completed||Phase 4|250|Actual|Ospedale Misericordia e Dolce||2|||f||||t||||||||||2017-10-11 02:59:39.423833|2017-10-11 02:59:39.423833
NCT01594476|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-10-14|||March 2012||2012-03-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Early Postpartum Intrauterine Device (IUD) Placement|Early Versus Standard Interval Postpartum Intrauterine Device (IUD) Placement at 3 Weeks or 6 Weeks Following Delivery: A Prospective Randomized Trial|Terminated||Phase 4|201|Actual|Oregon Health and Science University||2||Incomplete study enrollment prior to depletion of funding|f||||t||||||||||2017-10-11 02:59:39.512942|2017-10-11 02:59:39.512942
NCT01594463|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-05-10|||May 2012||2012-05-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|RECRET||Routine Ultrasound Screening in the Third Trimester|Third Trimester Routine Ultrasound in Low-risk Pregnancies : Comparison of Two Timing Periods Procedure for Screening Intrauterine Growth Restriction|Completed||N/A|3760|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 02:59:39.694391|2017-10-11 02:59:39.694391
NCT01594450|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2017-03-02|||May 2012|Actual|2012-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|SIMBIOSE||Biological Meshes in Infected Fields: a Randomized Controlled Trial|Use of Biological Mesh Versus Standard Wound Care in Infected Incisional Ventral Hernias: a Multicenter Randomized Controlled Trial, the SIMBIOSE Study|Active, not recruiting||Phase 3|110|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||Undecided||2017-10-11 02:59:39.787822|2017-10-11 02:59:39.787822
NCT01594424|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-07-25|2015-07-08||June 2012||2012-06-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation|A Phase I/II Trial of Tocilizumab + Intravenous Immunoglobulin (IVIG) as Agents to Reduce Donor-Specific Anti-HLA Antibodies (DSA) and Improve Transplant Rates in Highly-HLA Sensitized Patients Awaiting Kidney Transplantation|Completed||Phase 1/Phase 2|10|Actual|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-10-11 02:59:40.01214|2017-10-11 02:59:40.01214
NCT01594411|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2014-11-19|2013-09-03||April 2012||2012-04-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Observational|IMPACT-PCP|Sequentially enrolled subjects meeting the inclusion/exclusion criteria and have a resulted CORUS CAD test.|Primary Care Providers Use of a Gene Expression Test in Coronary Artery Disease Diagnosis|Investigation of a Molecular Personalized Coronary Gene Expression Test on Primary Care Practice Pattern|Completed||N/A|251|Actual|CardioDx|"Prospective design may have influenced the diagnostic strategy; but historical controls had a similar diagnostic strategy.
Possible Selection bias; we believe these pts are typical of each practice. Appropriateness of care not evaluated"||1||f||||f||||||Samples Without DNA|"     One 2.5 mL PAXgene (PreAnalytiXTM) (for RNA preservation) tube will be filled with     approximately 7.5 ml of blood and sent to CardioDx, Inc. for analysis.   "|||2017-10-11 02:59:40.86143|2017-10-11 02:59:40.86143
NCT01594398|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-06-29|||May 2012||2012-05-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|ENCORE110||Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer|A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer|Completed||Phase 1|14|Actual|Syndax Pharmaceuticals||2|||f||||f||||||||||2017-10-11 02:59:41.205421|2017-10-11 02:59:41.205421
NCT01594385|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-04-24|2014-05-10||April 2010||2010-04-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|OASIT||Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients|Seprafilm in Open Abdomens: a Prospective Evaluation of Wound and Adhesion Characteristics in Trauma Damage Control (OASIT)|Completed||N/A|30|Actual|St. Luke's Hospital and Health Network, Pennsylvania||2|||f||||t||||||||No|Currently, the only available data is de-identified dataset without any linkages to the original data. Data storage currently past record-keeping requirements. Study was permanently closed in June 2014.|2017-10-11 02:59:41.382476|2017-10-11 02:59:41.382476
NCT01594372|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-05-07|||January 2013||2013-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparison of Laparoscopic to Vaginal Surgical Repair for Uterine Prolapse|Randomized Trial Comparing Vaginal Hysterectomy to Laparoscopic Supracervical Hysterectomy With Vault Suspension for Symptomatic Uterine Prolapse|Terminated||N/A|14|Actual|Brigham and Women's Hospital||2||"Laproscopic procedure not offered at this time; will not be offered for the foreseeable, thus   we are unable to randomize participants between the two arms."|f||||f||||||||||2017-10-11 02:59:41.808375|2017-10-11 02:59:41.808375
NCT01594359|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-11-30|||August 2012||2012-08-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Nutrition Study of Effect of High Iron Beans on Iron Status|Efficacy of Iron Biofortified Beans in Improving the Iron Status of Rwandan Adolescent Girls: A Randomized Control Trial|Completed||N/A|300|Actual|Swiss Federal Institute of Technology||2|||f||||f||||||||||2017-10-11 02:59:41.936995|2017-10-11 02:59:41.936995
NCT01594346|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-05-08|||September 2000||2000-09-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Multicenter Vitamin E Trial in Aging Persons With Down Syndrome||Completed||Phase 3|349|Actual|New York State Institute for Basic Research||2|||f||||t||||||||||2017-10-11 02:59:42.085607|2017-10-11 02:59:42.085607
NCT01594333|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-08-22|||April 2013||2013-04-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|CIRT||Cardiovascular Inflammation Reduction Trial|A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome|Recruiting||Phase 3|7000|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 02:59:42.401509|2017-10-11 02:59:42.401509
NCT01594320|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2014-02-05|||April 2012||2012-04-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|July 2012|Actual|2012-07-01||Interventional|||A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1|A Phase 1 Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Indonesia/05/05 (H5N1) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Young Adults With and Without Adjuvant 1.|Completed||Phase 1|333|Actual|Novavax||6|||f||||t||||||||||2017-10-11 02:59:45.43618|2017-10-11 02:59:45.43618
NCT01593319|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-04-17|||January 2012||2012-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip||Terminated||Phase 4|37|Actual|Landstinget i Värmland||2|||f||||t||||||||||2017-10-11 02:59:45.615335|2017-10-11 02:59:45.615335
NCT01593306|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-05-07|||July 2011||2011-07-01|May 2012|2012-05-01|February 2013|Anticipated|2013-02-01|October 2012|Anticipated|2012-10-01||Interventional|||Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix||Unknown status|Recruiting|Phase 3|80|Anticipated|Indira Gandhi Medical College||2|||f||||t||||||||||2017-10-11 02:59:45.699181|2017-10-11 02:59:45.699181
NCT01593293|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-05-05|||March 2012||2012-03-01|May 2012|2012-05-01|November 2015|Anticipated|2015-11-01|November 2014|Anticipated|2014-11-01||Interventional|ACE||Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer|A Randomized, Open-label, Phase III Study Comparing Pemetrexed With and Without Carboplatin in Elderly Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 3|266|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 02:59:45.791469|2017-10-11 02:59:45.791469
NCT01593280|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-07|||May 2012||2012-05-01|May 2012|2012-05-01||||February 2013|Anticipated|2013-02-01||Interventional|||TAP Catheters Versus Intrathecal Morphine for Cesarean Section|Quality of Recovery Following Administration of Transverse Abdominus Plane (TAP) Catheter as Compared to Intrathecal Morphine After Cesarean Delivery Under Spinal Anesthesia: a Prospective, Randomized Trial|Unknown status|Recruiting|N/A|80|Anticipated|Stamford Anesthesiology Services, PC||2|||f||||t||||||||||2017-10-11 02:59:45.884636|2017-10-11 02:59:45.884636
NCT01593254|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-09-26|||October 29, 2012|Actual|2012-10-29|September 2017|2017-09-01|February 17, 2022|Anticipated|2022-02-17|January 30, 2022|Anticipated|2022-01-30||Interventional|DASCERN||Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib|An Open Label, Randomized (2:1) Phase IIb Study of Dasatinib Versus Imatinib in Patients With Chronic Phase Chronic Myeloid Leukemia Who Have Not Achieved an Optimal Response to 3 Months of Therapy With 400 mg Imatinib|Active, not recruiting||Phase 2|258|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-11 02:59:46.128889|2017-10-11 02:59:46.128889
NCT01593241|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-04-10|||May 2012||2012-05-01|April 2017|2017-04-01|June 2037|Anticipated|2037-06-01|October 2017|Anticipated|2017-10-01||Interventional|||Therapy De-escalation in Seminoma Stage IIA/B|Carboplatin Chemotherapy and Involved Node Radiotherapy in Stage IIA/B Seminoma|Recruiting||Phase 2|115|Anticipated|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||No||2017-10-11 02:59:46.56445|2017-10-11 02:59:46.56445
NCT01593228|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-09-12||2017-09-12|May 2012||2012-05-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial|International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study|Completed||Phase 3|37|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 02:59:46.821478|2017-10-11 02:59:46.821478
NCT01593215|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-01-07|2014-10-31||May 2012||2012-05-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|YOH1||Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant|Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant|Completed||Phase 2|50|Actual|Region Skane||2|||f||||t||||||||||2017-10-11 02:59:47.019098|2017-10-11 02:59:47.019098
NCT01593202|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-09-28|||January 2012||2012-01-01|September 2016|2016-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Long Term Efficacy of DBT-A in Adolescents With Repetitive Self-harming and Suicidal Behaviours|Long Term Efficacy of Dialectical Behaviour Therapy vs Enhanced Usual Care for Adolescents With Self-Harming and Suicidal Behaviours|Active, not recruiting||Phase 2|77|Actual|Oslo University Hospital||2|||f||||f||||||||No||2017-10-11 02:59:47.322196|2017-10-11 02:59:47.322196
NCT01593189|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-10-13|||April 2008||2008-04-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy Trial of the Kids in Transition to School (KITS) Program for Children With Developmental Disabilities and Behavioral Problems|A Randomized Efficacy Trial of the Kids in Transition to School (KITS) Program for Children With Developmental Disabilities and Behavioral Problems|Completed||N/A|209|Actual|Oregon Social Learning Center||2|||f||||f||||||||||2017-10-11 02:59:47.413484|2017-10-11 02:59:47.413484
NCT01593176|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-05-04|||May 2012||2012-05-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Observational|RSA||Radiostereometric Analysis of Fracture Healing in Distal Femur Fractures|Radiostereometric Analysis of Fracture Healing in Distal Femur Fractures|Unknown status|Recruiting|N/A|30|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 02:59:47.526336|2017-10-11 02:59:47.526336
NCT01593163|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-05-04|||May 2009||2009-05-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus|Randomised Controlled Clinical Trial of Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus: a Pilot Study|Completed||Phase 3|49|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz||2|||f||||t||||||||||2017-10-11 02:59:47.648045|2017-10-11 02:59:47.648045
NCT01593150|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-02-02|||November 2011||2011-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Early Versus Late DC-cardioversion of Persistent Atrial Fibrillation. Effect on Atrial Remodeling,Inflammatory and Neurohumoral Markers and Recurrence of Atrial Fibrillation|Early Versus Late DC-cardioversion of Persistent Atrial Fibrillation. Effect on Atrial Remodeling,Inflammatory and Neurohumoral Markers and Recurrence of Atrial Fibrillation.|Completed||N/A|141|Actual|Odense University Hospital||3|||f||||||||||||||2017-10-11 02:59:47.765676|2017-10-11 02:59:47.765676
NCT01593137|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-07-01|||May 2012||2012-05-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|ADELANTE||A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes|A Long-term, Randomized, Open-labeled, Parallel-group Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes|Withdrawn||Phase 4|0|Actual|Fundación Fernández-Cruz||2||Lack of patients with the criteria established in the protocol.|f||||f||||||||||2017-10-11 02:59:47.865185|2017-10-11 02:59:47.865185
NCT01593124|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-03-30|||May 2012||2012-05-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|Biomarkers||Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation|Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation|Completed||Phase 2|20|Actual|CONRAD||3|||f||||f||||||||||2017-10-11 02:59:47.958065|2017-10-11 02:59:47.958065
NCT01593111|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-02-02|||April 2011||2011-04-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ERA||Comparative Effectiveness of Environmental Intervention and Standard Care in Ability to Reduce Pharmacologic Therapy for Asthma|Comparative Effectiveness of Environmental Intervention and Standard Care in Ability to Reduce Pharmacologic Therapy for Asthma|Completed||N/A|243|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 02:59:48.055167|2017-10-11 02:59:48.055167
NCT01593098|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-04-20|||May 2010||2010-05-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|AN||A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)|A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)|Recruiting||N/A|600|Anticipated|Chinese University of Hong Kong|||2||f||||f||||||Samples With DNA|"     colonic biopsies, blood, stool   "|||2017-10-11 02:59:48.308379|2017-10-11 02:59:48.308379
NCT01593085|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-02-05|||April 2012||2012-04-01|April 2012|2012-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|DECAPAL||Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative|Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative|Completed||N/A|55|Actual|Centre Francois Baclesse|||1||f||||f||||||||||2017-10-11 02:59:48.419113|2017-10-11 02:59:48.419113
NCT01593072|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-01-23|||August 2012||2012-08-01|January 2013|2013-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Dose-Escalation A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers|Withdrawn||Phase 1|0|Actual|Sarepta Therapeutics||2||Terminated for convenience of the Government due to funding constraits|f||||t||||||||||2017-10-11 02:59:48.499214|2017-10-11 02:59:48.499214
NCT01594307|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2012-05-08|||February 2012||2012-02-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|||||Observational|||Blood Pressure Monitor Clinical Test (Cuff Range: 13.5 Cm-22cm)||Completed||N/A|85|Actual|Andon Health Co., Ltd|||2||f||||f||||||||||2017-10-11 02:59:48.605947|2017-10-11 02:59:48.605947
NCT01594294|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2014-06-27|2014-06-27||April 2012||2012-04-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ID11-56|This analysis population includes all participants who completed the study as per the protocol.|An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues|EVALUATION OF THE EFFECTS OF CLEAR CARE® / AOSEPT® PLUS HYDROGEN PEROXIDE SOLUTION ON THE EYELID TISSUES - Part III: COMPARATIVE EVALUATION WITH RENU® MPS OVER 3 MONTH OF WEAR - CONTROL EVALUATION WITH AIR OPTIX® AQUA and ACUVUE® 2®|Completed||N/A|100|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 02:59:48.691012|2017-10-11 02:59:48.691012
NCT01594281|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-07-31|||December 11, 2012|Actual|2012-12-11|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|PRIDE||Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)|Multicenter Randomized Open-label Three-arms Controlled 12 Months Clinical Proof of Concept Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy|Active, not recruiting||Phase 4|107|Actual|Novartis||3|||f|||||f|f||||||||2017-10-11 02:59:49.169926|2017-10-11 02:59:49.169926
NCT01594268|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-03-17|||March 2012||2012-03-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|CERKI||A Prospective, Open Label Study of CERtican in KIdney Transplantation|A Prospective, Open-label Study to Assess Safety of Certican in Kidney Transplant Patients|Completed||Phase 4|54|Actual|Novartis||1|||f||||||||||||||2017-10-11 02:59:49.326236|2017-10-11 02:59:49.326236
NCT01594255|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-05-07|||July 2009||2009-07-01|May 2012|2012-05-01||||September 2009|Actual|2009-09-01||Interventional|||CAEB071 Thorough QTc Study in Healthy Volunteers|A Randomized, Partially Blinded, 4-period, Crossover Study to Assess the Effects of Single-dose AEB071 Administration (300 and 900 mg) on Electrocardiographic QT Intervals Compared to Placebo in Healthy Volunteers|Completed||Phase 1|100|Actual|Novartis||4|||f||||||||||||||2017-10-11 02:59:49.433827|2017-10-11 02:59:49.433827
NCT01594242|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-09-23|||April 2012||2012-04-01|September 2016|2016-09-01||||June 2015|Actual|2015-06-01||Interventional|||Autophagy Induction After Bortezomib for Myeloma|A Phase 0 Study of Autophagy Induction After Bortezomib For Myeloma|Active, not recruiting||Early Phase 1|11|Actual|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 02:59:49.543006|2017-10-11 02:59:49.543006
NCT01594229|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-08-31|||June 11, 2012||2012-06-11|August 2017|2017-08-01|October 26, 2020|Anticipated|2020-10-26|October 26, 2020|Anticipated|2020-10-26||Interventional|||A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1|60|Anticipated|AbbVie||1|||f||||f||||||||||2017-10-11 02:59:49.647469|2017-10-11 02:59:49.647469
NCT01594216|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-09-23|||April 2012||2012-04-01|September 2016|2016-09-01||||April 2016|Actual|2016-04-01||Interventional|||Ruxolitinib in Estrogen Receptor Positive Breast Cancer|A Phase II Trial Of The JAK-Inhibitor Ruxolitinib (INCB018424) In Combination With Exemestane For Patients With Estrogen Receptor (ER) Positive Advanced Breast Cancer)|Active, not recruiting||Phase 2|29|Actual|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 02:59:49.767237|2017-10-11 02:59:49.767237
NCT01594203|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-07|||May 2012||2012-05-01|April 2012|2012-04-01|May 2013|Anticipated|2013-05-01|November 2012|Anticipated|2012-11-01||Observational|||Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma||Unknown status|Not yet recruiting|N/A|30|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-10-11 02:59:49.86802|2017-10-11 02:59:49.86802
NCT01594190|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-05-08|||September 2012||2012-09-01|May 2012|2012-05-01|September 2014|Anticipated|2014-09-01|July 2014|Anticipated|2014-07-01||Interventional|||Physical Activity Immediately After Acute Cerebral Ischemia|Physical Activity Immediately After Acute Cerebral Ischemia: Too Little or Too Much - a Randomized Controlled Study|Unknown status|Not yet recruiting|N/A|250|Anticipated|Hillerod Hospital, Denmark||2|||f||||f||||||||||2017-10-11 02:59:49.97778|2017-10-11 02:59:49.97778
NCT01594177|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-03-12|||May 2012||2012-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|DAFNE||Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy|Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy|Completed||Phase 2|65|Actual|German Breast Group||1|||f||||t||||||||||2017-10-11 02:59:50.114827|2017-10-11 02:59:50.114827
NCT01594164|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-10-19|||March 2011||2011-03-01|October 2012|2012-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Clinical Study to Assess Change in Upper Airway Geometry Between Upright and Supine Position|Clinical Study to Assess Change in Upper Airway Geometry Between Upright and Supine Position|Completed||Phase 1|20|Actual|FLUIDDA nv||1|||f||||f||||||||||2017-10-11 02:59:50.248603|2017-10-11 02:59:50.248603
NCT01594138|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-02-13|||September 2009||2009-09-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|November 2011|Actual|2011-11-01||Observational|||Linguistic Characteristics of Suicidal Patients in the Emergency Department|Linguistic Characteristics of Suicidal Patients in the ED (Emergency Department)|Completed||N/A|60|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||f|f|f||||||No|There is no plan to make individual participant data available.|2017-10-11 02:59:50.41649|2017-10-11 02:59:50.41649
NCT01594125|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-01-11|2015-11-17||May 2012||2012-05-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma|An Open Label, Dose Escalation Phase I Study to Evaluate the Safety and Tolerability of Continuous Twice-daily Oral Treatment of Nintedanib in Japanese Patients With Hepatocellular Carcinoma.|Completed||Phase 1|30|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 02:59:50.539517|2017-10-11 02:59:50.539517
NCT01594112|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-03-16|||March 15, 2012|Actual|2012-03-15|March 2017|2017-03-01|April 1, 2015|Actual|2015-04-01|September 27, 2013|Actual|2013-09-27||Observational|THORN||Ability of Home Monitoring® to Detect and Manage the Inappropriate Diagnoses in Implantable Cardioverter Defibrillators.|Inappropriate Therapies and Home Monitoring® in Implantable Cardioverter Defibrillators (ICD)|Completed||N/A|512|Actual|Biotronik SE & Co. KG|||1||f||||t|f|f||||||No||2017-10-11 02:59:52.107627|2017-10-11 02:59:52.107627
NCT01594099|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-05-06|||April 2012||2012-04-01|May 2012|2012-05-01|March 2014|Anticipated|2014-03-01|October 2013|Anticipated|2013-10-01||Interventional|||Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women|Weekly Cisplatin or Weekly Liposome Paclitaxel Concurrent Radiation Therapy in Treating Elderly People With Cervical Cancer|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|Health Science Center of Xi’an Jiaotong University||3|||f||||t||||||||||2017-10-11 02:59:52.309176|2017-10-11 02:59:52.309176
NCT01594086|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2013-07-14|||May 2012||2012-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Green Tea Consumption on Homocysteine Metabolism and Cognitive Dysfunction|Effects of Green Tea Consumption on Homocysteine Metabolism and Cognitive Dysfunction in Elderly: An Exploratory Clinical Study|Completed||N/A|15|Anticipated|University of Shizuoka||1|||f||||f||||||||||2017-10-11 02:59:52.414127|2017-10-11 02:59:52.414127
NCT01594073|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2017-08-13|||April 2012||2012-04-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Observational|BIOMARKERICD||Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in Implantable Cardioverter-defibrillator (ICD) Therapy|Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in ICD Therapy|Active, not recruiting||N/A|500|Anticipated|Hannover Medical School|||1||f||||f||||||Samples With DNA|"     Serum, plasma (EDTA, heparin), monocytes, DNA   "|||2017-10-11 02:59:52.518554|2017-10-11 02:59:52.518554
NCT01594060|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2016-09-07|||June 2012||2012-06-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards|A Randomized, Comparative Study of Basal-bolus Insulin Versus Conventional Sliding-scale Regular Insulin Therapy in Management of Non-critically Ill Patients Hospitalized in the Medical Ward.|Completed||Phase 4|36|Actual|HaEmek Medical Center, Israel||2|||f||||||||||||||2017-10-11 02:59:52.628225|2017-10-11 02:59:52.628225
NCT01594047|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2012-05-15|||December 2009||2009-12-01|May 2012|2012-05-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|||Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone|Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone|Unknown status|Recruiting|N/A|96|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||4|||f||||f||||||||||2017-10-11 02:59:52.760349|2017-10-11 02:59:52.760349
NCT01594034|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-05-11|||November 2009||2009-11-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability and Platelet Aggregation|Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability|Completed||N/A|9|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-10-11 02:59:52.964703|2017-10-11 02:59:52.964703
NCT01594021|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2016-10-28|||July 2012||2012-07-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|NICOM-MAP||Efficacy of Preemptive Volume Loading to Prevent Arterial Hypotension During Induction of General Anesthesia|Efficacy of Preemptive Volume Loading to Prevent Arterial Hypotension During Induction of General Anesthesia|Terminated||Phase 4|17|Actual|Hopital Foch||2||Difficulty of realization of the study|f||||f||||||||||2017-10-11 02:59:53.065359|2017-10-11 02:59:53.065359
NCT01594008|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-03-20|||January 2012||2012-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|FL89||The Effects of Antioxidants in Blueberry Powder on Inflammation Induced by a Single High Fat Meal.|Does Blueberry Intake Alleviate Postprandial Lipemia-induced Inflammation?|Completed||N/A|43|Actual|USDA, Western Human Nutrition Research Center||1|||f||||f||||||||||2017-10-11 02:59:53.189876|2017-10-11 02:59:53.189876
NCT01593995|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2014-11-02|||May 2012||2012-05-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|||EGF Ointment for Erlotinib Skin Lesion|Phase II Trial of Epidermal Growth Factor Ointment for Patients With Erlotinib Related Skin Effects|Completed||Phase 2|52|Actual|Dong-A University Hospital||1|||f||||t||||||||||2017-10-11 02:59:53.30253|2017-10-11 02:59:53.30253
NCT01593982|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-05-22|||March 2010||2010-03-01|May 2012|2012-05-01|March 2013|Anticipated|2013-03-01|August 2012|Anticipated|2012-08-01||Interventional|rTMSinADHD||Repetitive Transcranial Magnetic Stimulation in Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts|Effect of Repetitive Transcranial Magnetic Stimulation on Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts|Unknown status|Recruiting|Phase 2|40|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 02:59:53.402541|2017-10-11 02:59:53.402541
NCT01593969|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-08-15|||May 2012||2012-05-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|August 2013|Actual|2013-08-01||Interventional|Njugu Plus||A Trial of n-3 PUFA-Enriched Ready to Use Therapeutic Food for Childhood Severe Malnutrition|A Randomised Controlled Trial of n-3 Polyunsaturated Fatty Acid-Enriched Therapeutic Food for Childhood Severe Malnutrition|Completed||Phase 2|60|Actual|University of Oxford||3|||f||||f||||||||||2017-10-11 02:59:53.536947|2017-10-11 02:59:53.536947
NCT01583751|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-04-23|||March 2011||2011-03-01|April 2012|2012-04-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|videosinus||Videoendoscopic Pilonidal Sinus Surgery|Videoendoscopic Pilonidal Sinus Surgery. A New Technique|Unknown status|Recruiting|Phase 1|60|Anticipated|SB Istanbul Education and Research Hospital||1|||f||||f||||||||||2017-10-11 03:02:38.833992|2017-10-11 03:02:38.833992
NCT01593956|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-07|2013-05-22|||March 2012||2012-03-01|May 2013|2013-05-01||||July 2013|Anticipated|2013-07-01||Interventional|||Influence of Transcranial Direct Current Stimulation on Cortical Plasticity in Concussed Athletes|Influence of Anodal Transcranial Direct Current Stimulation on Cortical Plasticity in Concussed Athletes and Healthy Volunteers|Unknown status|Recruiting|N/A|30|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 02:59:53.657963|2017-10-11 02:59:53.657963
NCT01593943|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-12-03|||March 2012||2012-03-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|CHARM||Gender Equity-Focused, Male-Centered Family Planning for Rural India|Gender Equity-Focused, Male-Centered Family Planning for Rural India|Completed||Phase 3|2162|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-11 02:59:53.766697|2017-10-11 02:59:53.766697
NCT01593930|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2013-01-28|||May 2012||2012-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Evaluation of the Success Rate of Pulpal Anesthesia in Mandibular First Molar Following Infiltration of 4% Articaine Alone and as Supplemental Injection After Inferior Alveolar Nerve Block||Completed||N/A|60|Actual|Zahedan University of Medical Sciences||4|||f||||f||||||||||2017-10-11 02:59:53.890802|2017-10-11 02:59:53.890802
NCT01593917|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-04-26|||June 2012||2012-06-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Long Term Follow Up Study of the St. Jude Medical Trifecta Valve|Long Term Follow Up Study of the St. Jude Medical Trifecta™ Valve|Active, not recruiting||N/A|329|Actual|St. Jude Medical|||1||f||||t||||||||||2017-10-11 02:59:54.039021|2017-10-11 02:59:54.039021
NCT01593904|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2012-05-06|||January 2012||2012-01-01|May 2012|2012-05-01|January 2013|Anticipated|2013-01-01|||||Observational|VERIFYMS||Venous Irregularities, Flow and Perfusion in MS Study|Venous Irregularities, Flow and Perfusion in MS Study|Unknown status|Recruiting|N/A|400|Anticipated|Synergy Health Concepts, Inc.|||1||f||||t||||||||||2017-10-11 02:59:54.148726|2017-10-11 02:59:54.148726
NCT01593891|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2012-05-06|||August 2011||2011-08-01|May 2012|2012-05-01|September 2012|Anticipated|2012-09-01|||||Observational|Resrch_Reg_2||Radiographic and Intravascular (IVUS) Evaluation of Venous Morphology During CCSVI Treatment|Radiographic and Intravascular (IVUS) Evaluation of Venous Morphology During CCSVI Treatment|Unknown status|Active, not recruiting|N/A|45|Actual|Synergy Health Concepts, Inc.|||1||f||||t||||||||||2017-10-11 02:59:54.241135|2017-10-11 02:59:54.241135
NCT01593878|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-03-24|||June 2012||2012-06-01|March 2014|2014-03-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Media Background and Test Performance||Withdrawn||N/A|0|Actual|Seattle Children's Hospital||2|||f||||||||||||||2017-10-11 02:59:54.326758|2017-10-11 02:59:54.326758
NCT01593865|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2012-08-17|||April 2012||2012-04-01|August 2012|2012-08-01||||June 2014|Anticipated|2014-06-01||Observational|CATHEXIS||The Catholic University BIMA Grafting Study|Observational, Case-Control, Propensity-Matched Study of Bilateral Versus Monolateral Internal Mammary Artery Grafting for Severe Coronary Artery Disease. Assessment of Feasibility of Systematic Bilateral Mammary Artery Grafting and Early/Late Clinical Outcomes|Unknown status|Recruiting|N/A|1000|Anticipated|Catholic University, Italy|||2||f||||||||||||||2017-10-11 02:59:54.424112|2017-10-11 02:59:54.424112
NCT01593852|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-02-17|2013-12-09||April 2012||2012-04-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||X-ray Dose Reduction in Electrophysiology|X-ray Dose Reduction in Electrophysiology|Completed||N/A|136|Actual|Philips Healthcare||2|||f||||f||||||||||2017-10-11 02:59:54.560487|2017-10-11 02:59:54.560487
NCT01593839|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-05-07|||May 2012||2012-05-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Observational|||Functioning Disturbance in Chronic Back Pain: Altered Muscle Metabolism|Functioning Disturbance in Chronic Back Pain: Altered Muscle Metabolism|Unknown status|Recruiting|N/A|6|Anticipated|Oslo University Hospital|||1||f||||t||||||Samples Without DNA|"     Interstitial   "|||2017-10-11 02:59:55.013549|2017-10-11 02:59:55.013549
NCT01593826|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-11-21|||May 2012||2012-05-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler|Pharmacokinetic Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 320/9 Microg/Inhalation and Symbicort Turbuhaler Forte; a Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|72|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-10-11 02:59:55.113869|2017-10-11 02:59:55.113869
NCT01593813|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-05-07|||May 2012||2012-05-01|May 2012|2012-05-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|PQ||Repair or Not Repair Pronator Quadratus in the Volar Plating of Distal Radial Fracture Are Functional Outcomes Differ ?|Repair or Not Repair Pronator Quadratus in the Volar Plating of Distal Radial Fracture-Are Functional Outcomes Differ ?|Unknown status|Active, not recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 02:59:55.238543|2017-10-11 02:59:55.238543
NCT01593800|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2016-04-05|||May 2012||2012-05-01|February 2012|2012-02-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|PLI||The Effect of Probiotics on Lactose Intolerance|The Effect of Probiotics on Lactose Intolerance|Completed||N/A|60|Actual|Rabin Medical Center||1|||f||||t||||||||||2017-10-11 02:59:55.319885|2017-10-11 02:59:55.319885
NCT01593787|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-08-07|2015-07-08||May 2012||2012-05-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction|A Multi-center, Open Label Study for Evaluation of the Safety, Tolerability and Efficacy of 8-week Treatment With LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction|Completed||Phase 3|32|Actual|Novartis||3|||f||||t||||||||||2017-10-11 02:59:55.434292|2017-10-11 02:59:55.434292
NCT01593774|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2013-04-08|||May 2012||2012-05-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Melatonin for Prevention of Metabolic Side Effects of Olanzapine|Phase 2 Study of Melatonin Adjunct to Olanzapine for Prevention of Olanzapine-associated Metabolic Side Effects.|Completed||Phase 2|36|Actual|Guilan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 02:59:56.175266|2017-10-11 02:59:56.175266
NCT01593748|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-09-29|||May 2012||2012-05-01|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|March 2, 2018|Anticipated|2018-03-02||Interventional|||A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma|A Randomized, Open-label, Phase II, Multi-center Trial of Gemcitabine (G) With Pazopanib (P) or Gemcitabine (G) With Docetaxel (T) in Previously Treated Subjects With Advanced Soft Tissue Sarcoma|Active, not recruiting||Phase 2|90|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 02:59:56.395358|2017-10-11 02:59:56.395358
NCT01593735|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-01-21|||May 2012||2012-05-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)|A Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2748 in Hepatitis C-Infected Participants|Completed||Phase 1|30|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-10-11 02:59:56.552046|2017-10-11 02:59:56.552046
NCT01593722|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2016-09-20|2015-12-02||April 2012||2012-04-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional|||Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis|Comparison Between the Post-Treatment Reactions After Single-dose Ivermectin or DEC in Subjects With Loa Loa Infection|Completed||Phase 4|155|Actual|National Institutes of Health Clinical Center (CC)|Small number of subjects analyzed|2|||f||||t||||||||||2017-10-11 02:59:56.671585|2017-10-11 02:59:56.671585
NCT01593709|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2017-10-05|||April 19, 2012||2012-04-19|August 31, 2017|2017-08-31||||||||Observational|||Volunteer Screening for Vaccine and Antivirals Clinical Trials|Screening of Volunteers for Clinical Trials of Investigational and Licensed Vaccines, Antiviral Products, or Live Virus Challenge Studies|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 02:59:57.108924|2017-10-11 02:59:57.108924
NCT01593683|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2013-07-09|||March 2012||2012-03-01|July 2013|2013-07-01|September 2013|Anticipated|2013-09-01|January 2013|Actual|2013-01-01||Interventional|||Waitlist-controlled Trial of a Psychological Education Program for Nurses|Waitlist-controlled Trial of a Psychological Education Program for Nurses|Unknown status|Active, not recruiting|N/A|42|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 02:59:57.291998|2017-10-11 02:59:57.291998
NCT01593670|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-05-17|2017-03-29||March 2013||2013-03-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|October 2015|Actual|2015-10-01||Interventional|||Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes|Decitabine and Vorinostat With CD3/CD19 Depleted Haploidentical Donor Natural Killer (NK) Cells for the Treatment of High Risk Myelodysplastic Syndromes (MDS)|Terminated||Phase 2|9|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 02:59:57.381762|2017-10-11 02:59:57.381762
NCT01593657|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-07-28|||May 2012|Actual|2012-05-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Mindful Movement and Breathing to Improve Outcomes of Gynecologic Surgery|Mindful Movement and Breathing to Improve Outcomes of Gynecologic Surgery|Completed||N/A|10|Actual|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 02:59:57.707286|2017-10-11 02:59:57.707286
NCT01593644|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-06|2012-09-06|||June 2011||2011-06-01|September 2012|2012-09-01||||March 2013|Anticipated|2013-03-01||Interventional|||Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler|Phase 2, Monocentric, Single Blind Study, Comparing the Efficacy and Tolerance of a Dipyridamole/Adenosine Combination Given Intravenously, as a Slow Bolus and at Low Doses to Adenosine Alone for Coronary Flow Reserve Assessment (in Patients With Stable Ischemic Heart Disease) Using Transthoracic Echodoppler|Unknown status|Recruiting|Phase 2|75|Anticipated|Adenobio N.V||1|||f||||f||||||||||2017-10-11 02:59:57.800518|2017-10-11 02:59:57.800518
NCT01593631|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-05-07|||September 2009||2009-09-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Acid Lactase in Combination With Yoghurt Bacteria for Improvement of Lactose Digestion in Lactose Malabsorbers|A Combination of Yoghurt Bacteria and Acid Lactase From Aspergillus Oryzae Improves Lactose Digestion in Lactose Malabsorbers More Reliably Than Preparations Containing Acid Lactase or Yoghurt Bacteria Alone|Completed||N/A|24|Actual|Vitacare Gmbh & Co. KG||5|||f||||||||||||||2017-10-11 02:59:57.902914|2017-10-11 02:59:57.902914
NCT01593618|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-01-22|||August 2007||2007-08-01|January 2016|2016-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Empowering Cancer Survivors Through Information Technology|Empowering Cancer Survivors Through Information Technology|Completed||N/A|53|Actual|Masonic Cancer Center, University of Minnesota||2|||f||||f||||||||||2017-10-11 02:59:57.995664|2017-10-11 02:59:57.995664
NCT01593605|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-09-18|||February 2012||2012-02-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Resveratrol-Leucine Metabolite Synergy in Pre-diabetes|Resveratrol-Leucine Metabolite Synergy in Pre-diabetes|Completed||N/A|36|Actual|Vanderbilt University||3|||f||||t||||||||||2017-10-11 02:59:58.086982|2017-10-11 02:59:58.086982
NCT01593592|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2015-07-19|2015-03-07||June 2012||2012-06-01|July 2015|2015-07-01||||January 2013|Actual|2013-01-01||Interventional||All were dyspeptic patients|Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients|Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients: a Double Blind Placebo Controlled Randomized Clinical Trial|Completed||N/A|70|Actual|Zagazig University|no limitations|2|||f||||t||||||||||2017-10-11 02:59:58.197531|2017-10-11 02:59:58.197531
NCT01593579|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-12-18|||May 2012||2012-05-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|May 2015|Anticipated|2015-05-01||Observational|||Autonomic Phenotype Before and After Akt Inhibition|Autonomic Phenotype Before and After Akt Inhibition: Akt Therapy for Melanoma Sub-study|Withdrawn||N/A|0|Actual|Vanderbilt University|||1|Planned parent study never enrolled|f||||f||||||||||2017-10-11 02:59:58.514518|2017-10-11 02:59:58.514518
NCT01593566|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-04-08|||April 2011||2011-04-01|April 2015|2015-04-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|FNB for ACLR||Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction|Femoral Nerve Block Using 0.25% Versus 0.5% Bupivacaine for Analgesia After Arthroscopic Anterior Cruciate Ligament Reconstruction|Completed||Phase 4|100|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 02:59:58.603269|2017-10-11 02:59:58.603269
NCT01593553|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-08-30|||March 2012||2012-03-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden|Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden.|Active, not recruiting||N/A|7173|Actual|Karolinska University Hospital||2|||f||||||||||||||2017-10-11 02:59:58.694684|2017-10-11 02:59:58.694684
NCT01593540|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-28|2012-05-07|||September 2010||2010-09-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Clinical Examination of Metal Free Interdental Brushes|Clinical Efficacy and Patient Acceptance of Metal and Metal-Free Interdental Brushes: A Controlled Prospective Randomized Study|Completed||Phase 4|39|Actual|University of Freiburg||2|||f||||f||||||||||2017-10-11 02:59:58.772929|2017-10-11 02:59:58.772929
NCT01593527|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-04-19|||September 2012||2012-09-01|August 2013|2013-08-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease|A Randomized Double-blind Active-controlled Trial of Canakinumab Versus Triamcinolone Acetonide on Reducing the Proportion of Patients With Any New Gouty Arthritis Flare(s) in Patients With Chronic Kidney Disease|Withdrawn||Phase 3|0|Actual|Novartis||2|||f||||||||||||||2017-10-11 02:59:58.86614|2017-10-11 02:59:58.86614
NCT01593514|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-11-29|||December 2012||2012-12-01|November 2016|2016-11-01||||April 2013|Actual|2013-04-01||Interventional|||Understanding the Immune Response to Two Different Meningitis Vaccines|A Single Centre, Open-label, Randomised Clinical Study to Investigate Meningococcal Serogroup A and C Saccharide Specific B Cell Responses in Adult Volunteers to One of Three Regimens of Meningococcal ACWY Conjugate Vaccine or Meningococcal ACWY Polysaccharide Vaccine Priming Doses Followed by a Booster Dose of the Meningococcal ACWY Conjugate Vaccine|Completed||Phase 4|20|Actual|University of Oxford||4|||f||||f||||||||||2017-10-11 02:59:58.951946|2017-10-11 02:59:58.951946
NCT01593501|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-10-31|||May 2012||2012-05-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2013|Actual|2013-08-01||Interventional|||How Does Magnesium Status Influence Calcium Homeostasis?|How Does Magnesium Status Influence Calcium Homeostasis?|Completed||Phase 4|39|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 02:59:59.077433|2017-10-11 02:59:59.077433
NCT01593488|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-03-28|||March 2012||2012-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|CILI||Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children|Multicentered Phase II Study Evaluating the Activity and Toxicity of Liposomal Cytarabine in the Treatment of Children and Adolescents With Acute Lymphoblastic Leukemia With Resistent or Relapsed Central Nervous System Involvement|Recruiting||Phase 2|31|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-10-11 02:59:59.174167|2017-10-11 02:59:59.174167
NCT01593475|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-09-20|||March 2012||2012-03-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma|A Phase II Study of Induction Chemotherapy With Gemcitabine and Cisplatin Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Pancreatic Carcinoma|Active, not recruiting||Phase 2|34|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||No||2017-10-11 02:59:59.303385|2017-10-11 02:59:59.303385
NCT01593462|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-01-20|||May 2011||2011-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Comparative Effectiveness of MR Enterography|Comparative Effectiveness of MR Enterography, Enteric Ultrasound, and Ultrasound Elastography Imaging in the Evaluation of Pediatric Small Bowel Crohn Disease|Completed||N/A|30|Actual|University of Michigan||1|||f||||t||||||||No||2017-10-11 02:59:59.387061|2017-10-11 02:59:59.387061
NCT01593449|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-04-11|||January 2011||2011-01-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Community-based Social Networking Intervention to Increase Walking in Dog Owners|A Community-based Social Networking Intervention to Increase Walking in Dog Owners|Completed||Phase 1|107|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 02:59:59.458103|2017-10-11 02:59:59.458103
NCT01593436|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-11-27|||July 2011||2011-07-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|November 2011|Actual|2011-11-01||Interventional|||Polysomnography Evaluation of a Practice of Mindfulness in Menopausal Patients With Insomnia|Polysomnography and Sleep Quality Evaluation Before and After a Practice of Mindfulness in Menopausal Patients With Insomnia|Completed||N/A|54|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 02:59:59.531671|2017-10-11 02:59:59.531671
NCT01593423|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-11-15|||June 2012||2012-06-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Food Security and Nutrition in Rural Cambodia|Integration of Small-scale Aquaculture With Homestead Food Production for Improved Household Food Security and Nutrition in Rural Cambodia|Completed||N/A|900|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-11 02:59:59.620301|2017-10-11 02:59:59.620301
NCT01593410|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-09-18|||August 1, 2010|Actual|2010-08-01|September 2017|2017-09-01|January 3, 2013|Actual|2013-01-03|January 3, 2013|Actual|2013-01-03||Interventional|||Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma|A Multi-center, Open-Label Phase II Study to Determine the Efficacy and Safety of Lenalidomide Plus Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|194|Actual|Celgene||1|||f||||f||||||||||2017-10-11 02:59:59.694949|2017-10-11 02:59:59.694949
NCT01593397|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2016-10-12|||November 2011||2011-11-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity|Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity|Active, not recruiting||N/A|100|Actual|Stanford University||1|||f||||t||||||||Yes|pharmacokinetic models will be published after data analysis and study completion|2017-10-11 02:59:59.814828|2017-10-11 02:59:59.814828
NCT01593384|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-02-15|||April 2012||2012-04-01|February 2016|2016-02-01||||February 2013|Actual|2013-02-01||Observational|||Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography|To Determine the Clinical Impact of the Combination of Digital Breast Tomosynthesis and Digital Mammography on Screening for Breast Cancer|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center|||1|Funding unavailable|f||||f||||||||||2017-10-11 03:00:00.066217|2017-10-11 03:00:00.066217
NCT01593371|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2012-05-08|||July 2011||2011-07-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients|Comparing Effects of Metformin and Pioglitazone on Regulation of Serum Adipokines in Newly Diagnosed Type 2 Diabetes Patients|Completed||N/A|98|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:00:00.148704|2017-10-11 03:00:00.148704
NCT01593358|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-05|2012-05-05|||August 2011||2011-08-01|May 2012|2012-05-01|January 2014|Anticipated|2014-01-01|||||Observational|||Venous Obstruction in Neurodegenerative Disorders Research Registry|Venous Obstruction in Neurodegenerative Disorders Research Registry|Unknown status|Recruiting|N/A|2000|Anticipated|Synergy Health Concepts, Inc.|||1||f||||t||||||||||2017-10-11 03:00:00.257171|2017-10-11 03:00:00.257171
NCT01593345|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-12-18|||February 2013||2013-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Self-management of Chronic Mobility Limitations in MUHC Seniors|Promotion of Self-management of Chronic Mobility Limitations Among Vulnerable Seniors at the MUHC: Training the New Generation of Canadian Physiotherapists for This Role. Addendum: Planning Physiotherapy Services for Persons Treated at the MUHC for Cancer: A Needs Assessment|Completed||N/A|60|Anticipated|McGill University||2|||f||||f||||||||||2017-10-11 03:00:00.348257|2017-10-11 03:00:00.348257
NCT01593332|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-07|2012-05-05|||July 2010||2010-07-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis||Completed||Phase 4|44|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:00:00.488015|2017-10-11 03:00:00.488015
NCT01593059|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2014-04-25|||August 2012||2012-08-01|August 2012|2012-08-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|||BIOFLOW-III Romania Satellite Registry|BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Romania|Terminated||N/A|13|Actual|Biotronik Vertriebs-GmbH|||1|low enrollment|f||||f||||||||||2017-10-11 03:00:00.582953|2017-10-11 03:00:00.582953
NCT01593046|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-02-06|||May 2012||2012-05-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects|A Randomized, Open Label Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects|Completed||Phase 1|43|Actual|ViiV Healthcare||5|||f||||f||||||||||2017-10-11 03:00:00.685783|2017-10-11 03:00:00.685783
NCT01593033|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-01-11|||May 2012||2012-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effectiveness of Micronutrient Supplementation and Fish Oil + Micronutrient Supplementation in the Treatment of Environmental Enteropathy|Randomized, Double-blind, Placebo-controlled Trial Evaluating the Impact of Micronutrient Supplementation and Fish Oil + Micronutrient Supplementation in the Treatment of Sub-clinical Environmental Enteropathy in Rural Malawian Children|Completed||N/A|225|Actual|Washington University School of Medicine||3|||f||||||||||||||2017-10-11 03:00:00.834697|2017-10-11 03:00:00.834697
NCT01593020|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-06-16|||August 2012|Actual|2012-08-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2|A Randomized Phase II Neoadjuvant Study of Sequential Eribulin Followed by FAC/FEC-regimen Compared to Sequential Paclitaxel Followed by FAC/FEC-Regimen in Women With Early Stage Breast Cancer Not Overexpressing HER-2|Active, not recruiting||Phase 2|162|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 03:00:00.940726|2017-10-11 03:00:00.940726
NCT01593007|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-06-12|||June 2010||2010-06-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Inspiratory Muscular Training|REGIONAL LUNG VENTILATION DISTRIBUTION AMONG INDIVIDUALS WITH CHRONIC HEART FAILURE AFTER AN INSPIRATORY MUSCLE TRAINING PROGRAMM: A RANDOMIZED CONTROLLED CLINICAL TRIAL|Completed||N/A|19|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 03:00:01.10567|2017-10-11 03:00:01.10567
NCT01592994|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-12-03|||July 2010||2010-07-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|RHANI Wives||Enhancing HIV Risk Reduction Among Indian Women With Risky Husbands|Enhancing HIV Risk Reduction Among Indian Women With Risky Husbands|Completed||Phase 2|220|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 03:00:01.204664|2017-10-11 03:00:01.204664
NCT01592981|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2016-11-21|||January 2013||2013-01-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|March 2017|Anticipated|2017-03-01||Interventional|R2W||Randomised Trial in Waldenstrom's Macroglobulinaemia|Subcutaneous Bortezomib, Cyclophosphamide and Rituximab (BCR) Versus Fludarabine, Cyclophosphamide and Rituximab (FCR) for Initial Therapy of Waldenstrőm's Macroglobulinaemia (WM): a Randomized Phase II Trial|Active, not recruiting||Phase 2|60|Actual|University College, London||2|||f||||t||||||||||2017-10-11 03:00:01.291066|2017-10-11 03:00:01.291066
NCT01592968|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-07-12|||August 2, 2012|Actual|2012-08-02|July 2017|2017-07-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||A Prospective Phase III Trial to Compare Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy|A Prospective Phase III Randomized Trial to Compare Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy for >/= 4 Newly Diagnosed Non-Melanoma Brain Metastases|Recruiting||Phase 3|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|f|f||||||||2017-10-11 03:00:01.483798|2017-10-11 03:00:01.483798
NCT01592955|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2015-06-15|||May 2012||2012-05-01|March 2013|2013-03-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)|Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound With the EyeOP1 Medical Device.|Completed||Phase 4|84|Actual|EyeTechCare||1|||f||||t||||||||||2017-10-11 03:00:01.625347|2017-10-11 03:00:01.625347
NCT01592942|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-03-07|||August 2012||2012-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|October 2016|Actual|2016-10-01||Interventional|||Mesh Fixation in Lichtenstein Hernioplasty|A Randomized Multi-center Study of Tissue Glue Fixation of Optilene™ Mesh With Histoacryl™ or Self-gripping Parietex ProGrip™ Compared to Conventional Non-absorbable Suture Fixation of Ultrapro™ Mesh|Recruiting||N/A|650|Anticipated|Kuopio University Hospital||3|||f||||f||||||||||2017-10-11 03:00:01.751381|2017-10-11 03:00:01.751381
NCT01592929|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-10-02|||September 2012||2012-09-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Evaluation With Scans and Pharyngometry of the Possible Changes in Upper Airway Geometry Induced by Using Different Mouthpieces.|Assessment of the Effect of the Shape of an Inhaler's Mouthpiece on Upper Airway Geometry, Using Functional Respiratory Imaging and Pharyngometry.|Completed||N/A|12|Actual|FLUIDDA nv||1|||f||||f||||||||||2017-10-11 03:00:01.951797|2017-10-11 03:00:01.951797
NCT01592916|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2017-02-01|||May 2012||2012-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Acute Effects of Exercise in Women With Fibromyalgia (FM)|Acute Effects of Exercise in Women With FM|Recruiting||N/A|60|Anticipated|Göteborg University|||2||f||||f||||||Samples Without DNA|"     Blood serum   "|||2017-10-11 03:00:02.113239|2017-10-11 03:00:02.113239
NCT01592903|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2016-08-30|||April 2012||2012-04-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Somatic Stem Cells in Leiomyomas?|Identification and Characterization of Putative Leiomyoma Stem Cells.|Completed||N/A|16|Actual|Igenomix|||1||f||||f||||||Samples With DNA|"     PHASE 1:SAMPLE COLLECTION Duration: From the first month to 36th month approximately. PHASE     2: CELL PREPARATION PROTOCOL Duration: From the first month to 12th month PHASE 3: ISOLATION     OF PUTATIVE SOMATIC STEM CELLS Duration: From the third month (March 2010) to 12th month     PHASE 4: CELL CULTURE Duration: From the sixth month to 18th month PHASE 5: ENDOCRINE     CHARACTERIZATION Duration:From the 18th month to 36th month Biospecimen Retention Samples     With DNA - samples retained, with potential for extraction of DNA from at least one of the     types of samples retained (e.g., frozen tissue, whole blood) Biospecimen Description Samples     of human leiomyomas obtained from patients with symptomatic uterine fibroids.   "|||2017-10-11 03:00:02.265138|2017-10-11 03:00:02.265138
NCT01592890|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2016-11-01|||April 2012||2012-04-01|November 2016|2016-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers|Single-centre, Open-label Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Dose of 14C-labeled RO4917523 and an Intravenous Tracer Dose of 13C-labeled RO4917523 in Healthy Male Volunteers|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:00:02.363543|2017-10-11 03:00:02.363543
NCT01592877|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-07-30|||December 2011||2011-12-01|July 2012|2012-07-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Observational|||A Comparative Study of the Performance of a New Type Non-contact Patient Monitor|Clinical Test of Ultra-Wideband Non-contact Heart Rate and Breath Rate Monitor|Unknown status|Recruiting|N/A|50|Anticipated|Holux Technology, Inc.|||1||f||||t||||||||||2017-10-11 03:00:02.450937|2017-10-11 03:00:02.450937
NCT01592864|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-02-06|2013-05-16||March 2012||2012-03-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity|Completed||Phase 3|120|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:00:02.563087|2017-10-11 03:00:02.563087
NCT01592851|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-05-01|2013-04-05||April 2012||2012-04-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity|A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Short Term Relief From Dentinal Hypersensitivity|Completed||Phase 3|113|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:00:03.016581|2017-10-11 03:00:03.016581
NCT01592838|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-03-30|||December 2013||2013-12-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium|Feasibility Pilot Study Assessing the Impact on the Quality of Hospital Care After the Introduction of Rotavirus Vaccination in Belgium|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:00:03.480952|2017-10-11 03:00:03.480952
NCT01592825|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-06-23|||September 2009||2009-09-01|June 2017|2017-06-01|May 2021|Anticipated|2021-05-01|May 2011|Actual|2011-05-01||Observational|PiA||PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors|PiA Trial: a Cross-sectional, Multicenter, Consecutive Cohort Evaluating the Distribution of uPA/PAI-1 Versus St. Gallen Algorithm in >1000 Prospectively Included Patients|Active, not recruiting||N/A|1000|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||1||f||||f||||||Samples With DNA|"     Tumor specimen frozen Tumor specimen formalin fixed   "|||2017-10-11 03:00:03.602851|2017-10-11 03:00:03.602851
NCT01592812|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-03-15|||January 2012||2012-01-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Arterial Inflow and Muscle Ischemia During Calf Stimulation With the Veinoplus Device|Investigation of the Arterial Effects of the Veinoplus(r) Stimlator Device.|Completed||Phase 4|15|Actual|University Hospital, Angers||1|||f||||t||||||||||2017-10-11 03:00:03.699133|2017-10-11 03:00:03.699133
NCT01592786|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-07-15|2014-07-15||June 2012||2012-06-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional||A total of 906 patients were enrolled in the open-label study. Of these, 903 patients received at least 1 dose of open-label treatment to comprise the Safety Population. 868 patients in the Safety Population also had at least 1 post–Visit 1 assessment of the SRS total raw score to comprise the Intent to Treat (ITT) population|An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|Completed||Phase 2|906|Actual|Forest Laboratories||1|||f||||f||||||||||2017-10-11 03:00:04.012971|2017-10-11 03:00:04.012971
NCT01592604|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-08-23|||November 2011||2011-11-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||An Optimal Treatment for Avulsion Fractures of the Base of Fith Metatarsal Bone|An Optimal Treatment for Avulsion Fractures of the Base of Fith Metatarsal Bone. A Level I Prospective Randomised Control Trial|Completed||N/A|60|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:00:10.635733|2017-10-11 03:00:10.635733
NCT01592773|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-01-30|2015-01-30||October 2012||2012-10-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional||Demographic summaries were provided based on the 747 patients who received at least 1 dose of investigational product in the extension study (Safety Population).|Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|Terminated||Phase 2|747|Actual|Forest Laboratories||1||"Terminated because primary efficacy parameter failed to demonstrate statistically significant   difference between memantine and placebo in controlled trials"|f||||f||||||||||2017-10-11 03:00:05.028472|2017-10-11 03:00:05.028472
NCT01592760|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-02-08|2015-12-21||May 2012||2012-05-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial|Comparison of the Air-Q® Self-Pressurizing (SP) Intubating Laryngeal Airway With the Air-Q® Intubating Laryngeal Airway and I-gel for Airway Maintenance in Adults Under General Anesthesia|Completed||N/A|225|Actual|University of Wisconsin, Madison||3|||f||||f||||||||No|Not applicable. There is no plan to make individual participant data available to other researchers.|2017-10-11 03:00:07.087428|2017-10-11 03:00:07.087428
NCT01592734|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-04|2012-05-04|||May 2010||2010-05-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy and Tolerability of PEG-only Laxative for Fecal Impaction and Chronic Constipation in Children|Efficacy and Tolerability of PEG-only Laxative for Fecal Impaction and Chronic Constipation in Children. A Controlled Double Blind Randomized Study vs a Standard PEG-EL Laxative|Completed||Phase 4|96|Actual|Azienda Policlinico Umberto I||2|||f||||t||||||||||2017-10-11 03:00:08.921816|2017-10-11 03:00:08.921816
NCT01592721|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-01-05|||April 2013||2013-04-01|January 2017|2017-01-01|November 2024|Anticipated|2024-11-01|January 2024|Anticipated|2024-01-01||Interventional|||Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma|Safety and Efficacy of Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|42|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 03:00:09.008385|2017-10-11 03:00:09.008385
NCT01592708|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2014-08-15|2014-07-14||June 2012||2012-06-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery|A Prospective Evaluation of an Anesthesia Protocol to Reduce Post-operative and Post-discharge Nausea and Vomiting in a High Risk Orthognathic Surgery Population|Completed||N/A|233|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 03:00:09.111216|2017-10-11 03:00:09.111216
NCT01592695|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-06-20|2017-04-14||June 2012||2012-06-01|June 2017|2017-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Tailored Tobacco Quitline for Rural Veterans|Tailored Tobacco Cessation Program for Rural Veterans With Comorbid Depression, Alcoholism or Obesity|Completed||Phase 2|63|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 03:00:09.444406|2017-10-11 03:00:09.444406
NCT01592682|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-06-01|||April 2012||2012-04-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Creating Smokefree Living Together for Chinese Household Pairs|"Creating Smokefree Living Together: Smokefree Counseling Intervention for Chinese Smokers and Household Nonsmokers"|Completed||N/A|410|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 03:00:09.983516|2017-10-11 03:00:09.983516
NCT01592669|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-05-04|||September 2010||2010-09-01|May 2012|2012-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Passive Leg Raising Attenuates and Delays Tourniquet Deflation-induced Hypotension and Tachycardia|The Effect of Passive Leg Raising or Experimental Clinical Practices on the Prevention of Hypotension Following Tourniquet Release in Total Knee Arthroplasty Patients|Completed||N/A|35|Actual|Tri-Service General Hospital||2|||f||||t||||||||||2017-10-11 03:00:10.145167|2017-10-11 03:00:10.145167
NCT01592656|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-01-15|||February 2011||2011-02-01|October 2012|2012-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Long-term Effects of Non-invasive Ventilation in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Patients|Long-term Effects of Non-invasive Ventilation in Hypercapnic COPD Patients.|Terminated||Phase 2|40|Anticipated|FLUIDDA nv||2||Lack of budget|f||||f||||||||||2017-10-11 03:00:10.239769|2017-10-11 03:00:10.239769
NCT01592643|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-04-12|||March 2012||2012-03-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Nexis-CS0032||Post Photorefractive Keratectomy (PRK) Use of an Eye Shield for Maintaining Vision and Mitigating Pain|Post Photorefractive Keratectomy (PRK) Use of an Eye Shield for Maintaining Vision and Mitigating Pain|Active, not recruiting||Phase 4|30|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 03:00:10.333778|2017-10-11 03:00:10.333778
NCT01592630|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-12-05|||May 2012||2012-05-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections|Effectiveness of Adding Transverse Abdominus Plane (TAP) Catheter Blocks to Patient-controlled Analgesia (PCA) in Laparoscopic Colon Resections: a Prospective, Randomized Controlled Study|Withdrawn||Phase 3|0|Actual|Stamford Hospital||2||Investigator Left Institution|f||||t||||||||||2017-10-11 03:00:10.415446|2017-10-11 03:00:10.415446
NCT01592617|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-08-11|||May 2012||2012-05-01|August 2015|2015-08-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer|Phase II Study of Peptide Cancer Vaccine S-488410 to Treat Advanced Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|Shiga University||1|||f||||t||||||||||2017-10-11 03:00:10.516935|2017-10-11 03:00:10.516935
NCT01592578|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2013-04-25|||March 2012||2012-03-01|May 2012|2012-05-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||The Research of the Evaluation of Clinical Procedures in Gastroesophageal Varices in Patients With Liver Cirrhosis|A Randomized Controlled Trial of Ligation Versus Ligation Plus Sclerotherapy in Addition to Cyanoacrylate in Patients With Gastroesophageal Varices|Unknown status|Recruiting|N/A|96|Anticipated|Shanghai Zhongshan Hospital||2|||f||||f||||||||||2017-10-11 03:00:10.734048|2017-10-11 03:00:10.734048
NCT01592565|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-01-26|||August 2010||2010-08-01|January 2017|2017-01-01||||December 2014|Actual|2014-12-01||Interventional|EXACT||Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing|An In-state Multi-center Evaluation of Treadmill Exercise Stress Cardiac Magnetic Resonance|Completed||N/A|227|Actual|Ohio State University||1|||f||||t||||||||||2017-10-11 03:00:10.856663|2017-10-11 03:00:10.856663
NCT01592552|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-03-01|||November 2011||2011-11-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||A Biospecimen and Clinical Data Study on Patients With Alzheimer's, Multiple Sclerosis, Parkinson's, and Huntington's, for Drug & Biomarker Discovery|A Multi-Center Longitudinal Biorepository Study to Provide Biospecimens & Clinical Data From Neurological Disease Patients To Approved Pre-Clinical And Clinical Investigators for Drug & Biomarker Studies|Completed||N/A|20|Actual|Sanguine Biosciences|||2||f||||f||||||||||2017-10-11 03:00:10.966011|2017-10-11 03:00:10.966011
NCT01592539|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2015-02-25|||May 2012||2012-05-01|February 2015|2015-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls|Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls|Completed||N/A|78|Actual|Creighton University|||2||f||||f||||||||||2017-10-11 03:00:11.062113|2017-10-11 03:00:11.062113
NCT01592526|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-01-28|||June 2012||2012-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|January 2013|Actual|2013-01-01||Interventional|||Autonomic Nervous Activity During the Systemic Inflammatory Response in Trained and Untrained Healthy Volunteers|Autonomic Nervous Activity During the Systemic Inflammatory Response in Trained and Untrained Healthy Volunteers|Completed||Early Phase 1|23|Actual|Rigshospitalet, Denmark||4|||f||||t||||||||||2017-10-11 03:00:11.12394|2017-10-11 03:00:11.12394
NCT01592513|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-05-03|||April 2012||2012-04-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|August 2012|Anticipated|2012-08-01||Interventional|||Effect of BIS Monitoring on Propofol Usage During Elective Bronchoscopy|Effect of BIS Monitoring on Propofol Usage During Elective Bronchoscopy|Unknown status|Recruiting|N/A|80|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 03:00:11.341346|2017-10-11 03:00:11.341346
NCT01592500|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-11-10||2015-01-08|February 2012||2012-02-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children|Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily r-hGH Therapy in Pre-pubertal Growth Hormone Deficient Children|Completed||Phase 2|53|Actual|Opko Biologics||4|||f||||t||||||||||2017-10-11 03:00:11.493359|2017-10-11 03:00:11.493359
NCT01592487|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-02-11|||December 2013||2013-12-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Effects of a Breakfast and Snack on Cognitive Function in Preadolescents||Withdrawn||N/A|0|Actual|University of Arkansas|||2|Study never started, and there are no plans to initiate.|f||||t||||||||||2017-10-11 03:00:11.637168|2017-10-11 03:00:11.637168
NCT01592474|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-07-08|||October 2005||2005-10-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|August 2011|Actual|2011-08-01||Observational|||Evaluation of Brain Atrophy in CIS Patients on Avonex|Evolution of Gray Matter Atrophy Over 4 Years in Observational Study of Early IFNβ-1a I.M. Treatment in High Risk Subjects After Clinically Isolated Syndrome (SET Substudy)|Completed||N/A|180|Actual|University at Buffalo|||1||f||||f||||||||||2017-10-11 03:00:11.714424|2017-10-11 03:00:11.714424
NCT01592461|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2016-08-04|||September 2010||2010-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Starting Treatment With Agonist Replacement Therapies Follow-up Study|START Follow-up Study (NIDA CTN Protocol 0050)|Completed||N/A|877|Actual|University of California, Los Angeles|||1||f||||f||||||||Yes|Deidentified data will be shared via NIDA Clinical Trials Network Website|2017-10-11 03:00:11.785493|2017-10-11 03:00:11.785493
NCT01592448|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-11-17|||October 2012||2012-10-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Investigation of Efficacy of Improved Acetaminophen Labeling|Consumer Understanding and Use of Non-Prescription Analgesics, Investigation of Efficacy of Improved Acetaminophen Labeling|Completed||N/A|662|Actual|Northwestern University|||3||f||||t||||||||||2017-10-11 03:00:11.875796|2017-10-11 03:00:11.875796
NCT01592435|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-03-09|2016-09-14||April 2011||2011-04-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|LLI-MSE|76 subjects participated from both sites. 76 image sets were reconstructed with Cedara Accustitch software and the same 76 image sets were reconstructed with Carestream DR LLI software.|Carestream Digital Radiography Long Length Imaging Software Data Collection Protocol|Carestream Digital Radiography Long Length Imaging Manual Stitch Editor Software Data Collection|Completed||N/A|76|Actual|Carestream Health, Inc.|||1||f||||f||||||||No||2017-10-11 03:00:11.996216|2017-10-11 03:00:11.996216
NCT01592422|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-07-02|||July 2012||2012-07-01|July 2012|2012-07-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer|Maintenance Immunotherapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|60|Anticipated|People's Hospital of Guangxi||2|||f||||t||||||||||2017-10-11 03:00:12.189239|2017-10-11 03:00:12.189239
NCT01592409|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-07-18|||July 2012||2012-07-01|July 2017|2017-07-01|September 2016|Actual|2016-09-01|August 2016|Actual|2016-08-01||Interventional|||Cannabis Effects on Driving-related Skills of Young Drivers|Acute and Residual Effects of Cannabis on Young Drivers' Performance of Driving-related Skills|Completed||N/A|99|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 03:00:12.283282|2017-10-11 03:00:12.283282
NCT01592240|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2014-10-14||2014-10-14|July 2012||2012-07-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin|A Phase 2B Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Dose-Ranging Study To Assess The Efficacy, Safety And Tolerability Of PF-04950615 (RN316) Following Monthly And Twice Monthly Subcutaneous Dosing For Six Months In Hypercholesterolemic Subjects On A Statin|Completed||Phase 2|356|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:00:15.475679|2017-10-11 03:00:15.475679
NCT01592396|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-01-20|2016-10-03||June 2012||2012-06-01|January 2017|2017-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Pharmacokinetic (PK) population included all participants who received the investigational product and had at least 1 detectable post dosing tralokinumab (CAT-354) serum concentration.|A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With Asthma|A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of Tralokinumab in Adolescents With Asthma|Completed||Phase 1|30|Actual|MedImmune LLC|Dose-normalized AUC(0-infinity) and dose-normalized Cmax were not evaluated as they were not relevant for single-dose study.|1|||f||||f||||||||||2017-10-11 03:00:12.418426|2017-10-11 03:00:12.418426
NCT01592383|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-05-10|||June 2012||2012-06-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma|Phase II Study of Erlotinib for Patients With Malignant Peritoneal Mesothelioma (MPeM) Exhibiting EGFR Mutations|Completed||Phase 2|2|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 03:00:12.853999|2017-10-11 03:00:12.853999
NCT01592370|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2017-09-05|||June 27, 2012|Actual|2012-06-27|September 2017|2017-09-01|March 16, 2020|Anticipated|2020-03-16|March 15, 2020|Anticipated|2020-03-15||Interventional|||An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, With or Without Pomalidomide and Dexamethasone, in Patients With Multiple Myeloma|Multiple Phase 1 Safety Cohorts of Nivolumab Monotherapy or Nivolumab Combination Regimens Across Relapsed/Refractory Hematologic Malignancies|Active, not recruiting||Phase 1|375|Anticipated|Bristol-Myers Squibb||4|||f||||f|t|f||||||||2017-10-11 03:00:12.990672|2017-10-11 03:00:12.990672
NCT01592357|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2013-03-18|||November 2011||2011-11-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||The Effects of Tai Chi in Older Patients With Cardiovascular Disease|The Effects of Tai Chi in Older Patients With Cardiovascular Disease|Unknown status|Active, not recruiting|N/A|200|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 03:00:13.166906|2017-10-11 03:00:13.166906
NCT01592344|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2016-03-11|2016-01-16||April 2012||2012-04-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional||Adults having severe intractable chronic pain of peripheral nerve origin were enrolled and all were included in the 94 intent-to-treat analysis.|Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy|Prospective, Multi-Center, Randomized, Double-Blinded, Study to Assess Safety and Efficacy of the Bioness® StimRouter™ Neuromodulation System in Patients With Chronic Pain of Peripheral Nerve Origin|Completed||N/A|94|Actual|Bioness Inc|The device was designed for treatment of mononeuritis excluding the face. For this reason, mononeuropathies of the face were excluded.|2|||f||||f||||||||||2017-10-11 03:00:13.283045|2017-10-11 03:00:13.283045
NCT01592331|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Pharmacodynamic and Pharmacokinetic Study of RO5508887 in Healthy Volunteers|A Single-Center, Randomized, Investigator/Subject-Blind, Single Dose, Placebo-Controlled, Parallel Group Study to Investigate the Pharmacodynamic and Pharmacokinetic Behavior of RO5508887 in Plasma and Cerebral Spinal Fluid Following Oral Administration in Healthy Volunteers|Completed||Phase 1|42|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:00:13.850481|2017-10-11 03:00:13.850481
NCT01592318|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers|An Up to Two-Part Relative Bioavailability Study of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets as Compared to the Reference Phase 2 Ad Hoc Combination Tablets in Healthy Adult Volunteers|Completed||Phase 1|42|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:00:13.96315|2017-10-11 03:00:13.96315
NCT01592305|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir|A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir When Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir in Healthy Adult Volunteers|Completed||Phase 1|40|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:00:14.08053|2017-10-11 03:00:14.08053
NCT01592292|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-07-06|2016-05-03||November 2011||2011-11-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational||The intent to treat (ITT) set included participants who offered end-point results among the participants who received the study drugs after enrollment and met all inclusion/exclusion criteria.|An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy|A Non-interventional Study for Relative Efficacy Outcome of Rituximab Treatment in RA Patients Who Have Inadequate Response or Have Been Intolerant to a First Anti-TNF Agent|Completed||N/A|90|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-11 03:00:14.218467|2017-10-11 03:00:14.218467
NCT01592279|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-03|||June 2012||2012-06-01|April 2012|2012-04-01||||June 2014|Anticipated|2014-06-01||Interventional|||GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients||Unknown status|Not yet recruiting|Phase 4|124|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 03:00:15.227892|2017-10-11 03:00:15.227892
NCT01592266|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-05-03|||October 2012||2012-10-01|April 2012|2012-04-01||||October 2013|Anticipated|2013-10-01||Observational|AML F18-FLT||F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML)|F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With AML|Unknown status|Not yet recruiting|N/A|10|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-10-11 03:00:15.307072|2017-10-11 03:00:15.307072
NCT01592253|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2012-06-22|||May 2012||2012-05-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Study to Evaluate Safety and Immunologic Biomarker of Rapamune in Patients With Stable Renal Transplant Recipient|Investigation of the Safety and Immunologic Biomarker After Conversion From Calcineurin Inhibitor to Rapamune in Stable Renal Transplant Recipient|Unknown status|Recruiting|N/A|50|Anticipated|Seoul St. Mary's Hospital||1|||f||||f||||||||||2017-10-11 03:00:15.388718|2017-10-11 03:00:15.388718
NCT01592227|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-11-20|||December 2009||2009-12-01|June 2014|2014-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Compare Two Paracetamol Formulations.|A Pharmacokinetic Study Investigating the Rate and Extent of Absorption of Paracetamol and an Adjuvant From Two Different Paracetamol Formulations.|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:00:15.760008|2017-10-11 03:00:15.760008
NCT01592214|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2016-09-01|||August 2012||2012-08-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73|A Two-Part Phase I Study to Establish and Compare the Safety and Local Tolerability of Two Nasal Formulations of XF-73 for Decolonization of Staphylococcus Aureus: A Previously Investigated 0.5 mg/g Viscosified Gel Formulation Versus a Modified Formulation|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-10-11 03:00:15.846093|2017-10-11 03:00:15.846093
NCT01592201|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-06-24|||July 2012||2012-07-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug|An Open-label, Prospective, Randomized and Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug|Terminated||Phase 4|13|Actual|Janssen Korea, Ltd., Korea||2||This study was early terminated due to insufficient enrollment required for hypothesis testing.|f||||f||||||||||2017-10-11 03:00:15.959744|2017-10-11 03:00:15.959744
NCT01592188|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-11-13|||January 2012||2012-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Cognitively-Based Compassion Training and Mindfulness Attention Training Program|Cognitively-Based Compassion Training and Mindfulness Attention Training for Elementary School Students|Completed||Phase 3|53|Actual|Emory University||2|||f||||t||||||||||2017-10-11 03:00:16.071183|2017-10-11 03:00:16.071183
NCT01592175|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-05-03|||March 2012||2012-03-01|May 2012|2012-05-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||Magnetoencephalography (MEG), Attention and Conscience|Spatio-temporal Dynamic of the Relationship Between Spatial Attention and Visual Awareness|Unknown status|Recruiting|N/A|8|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||t||||||||||2017-10-11 03:00:16.149648|2017-10-11 03:00:16.149648
NCT01592162|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-11-02|||May 2013||2013-05-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|PropofolRemi||Comparison of Different Propofol Formulations With or Without Remifentanil|Dose-effect of Propofol for Anesthetic Induction: Double-blind Comparison of Different Propofol Formulations Administered Alone or With Remifentanil|Completed||Phase 4|409|Actual|Hopital Foch||9|||f||||f||||||||||2017-10-11 03:00:16.213647|2017-10-11 03:00:16.213647
NCT01592149|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-02-10|||May 2012||2012-05-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|March 2014|Actual|2014-03-01||Observational|SPLASH||Survey of Prevalence of Loss of Appetite in Subject With Health Disorders|Survey of Prevalence of Loss of Appetite in Subject With Health Disorders.|Completed||N/A|16629|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:00:16.336925|2017-10-11 03:00:16.336925
NCT01592136|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2013-03-12||||||January 2013|2013-01-01||||||||Expanded Access|||Expanded Access Program of Ponatinib|Expanded Access Program of Ponatinib (AP24534) for Patients With Refractory Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia|Approved for marketing||N/A|||Ariad Pharmaceuticals|||||||||||||||||||2017-10-11 03:00:16.424322|2017-10-11 03:00:16.424322
NCT01592123|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-03|||October 2010||2010-10-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|||||Observational|||Effects of Nasal Septal Surgery on Sleep Quality, Daytime and Dream Anxiety|Evaluation of Benefits of Nasal Septal Surgery on Subjective Sleep Quality, Daytime and Dream Anxiety|Completed||N/A|68|Actual|Ataturk Training and Research Hospital|||1||f||||f||||||||||2017-10-11 03:00:16.579989|2017-10-11 03:00:16.579989
NCT01592110|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2013-07-23|||July 2012||2012-07-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia|A Pilot, Open-Label, Non-Randomized, Single Ascending Dose, Safety and Pharmacokinetic Trial With Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|40|Actual|Zogenix, Inc.||4|||f||||t||||||||||2017-10-11 03:00:16.674867|2017-10-11 03:00:16.674867
NCT01592097|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-03-29|||June 2012||2012-06-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Observational|||Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS|A Non-randomized, Exploratory, Study to Assess Clinical Response to Gilenya® (Fingolimod) in a Cohort of Relapsing Remitting Hispanic MS Forms|Active, not recruiting||N/A|50|Anticipated|University of Southern California|||1||f||||f||||||Samples With DNA|"     DNA will be extracted from isolated cells; the remaining cells will be cryopreserved for any     duplicate analyses.   "|||2017-10-11 03:00:16.766402|2017-10-11 03:00:16.766402
NCT01592071|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2014-02-14|2012-08-23||October 2008||2008-10-01|February 2014|2014-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||IgG-mediated Food Test for Weight Loss|Eliminating IgG-mediated Reactive Foods From the Diet and Its Effect on Body Composition and Quality of Life in Overweight Persons|Completed||N/A|120|Actual|University of Miami||1|||f||||f||||||||||2017-10-11 03:00:16.914419|2017-10-11 03:00:16.914419
NCT01592058|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-07-30|||June 2010||2010-06-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|BMI||Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period|Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period|Completed||N/A|427|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 03:00:17.283923|2017-10-11 03:00:17.283923
NCT01592045|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-08-20|2015-06-03||August 2012||2012-08-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Twenty-eight subjects were enrolled in this study with all subjects receiving at least one dose of study therapy.|ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma|A Comparative Pharmacokinetic and Safety Study of Chimeric Monoclonal Antibody ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Interleukin-2 (IL-2) and Isotretinoin in High Risk Neuroblastoma Patients Following Myeloablative Therapy|Completed||Phase 1/Phase 2|28|Actual|United Therapeutics||2|||f||||t||||||||||2017-10-11 03:00:17.381484|2017-10-11 03:00:17.381484
NCT01592032|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-02-18|||May 2012||2012-05-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|January 2015|Actual|2015-01-01||Interventional|CONAN||Concentration of Antimicrobials in Catheter-lock Solutions|Concentration and Antibiotic Activity in Antibiotic Lock Solutions|Unknown status|Active, not recruiting|Phase 4|125|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||5|||f||||t||||||||||2017-10-11 03:00:18.352917|2017-10-11 03:00:18.352917
NCT01592019|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-12-12|||April 2012||2012-04-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Clinical Study to Evaluate the Role of Microdialysis for the Comparison of Topical Products|Use of Dermal Microdialysis to Evaluate the Effect of Skin Properties and Application Site on the Topical Bioequivalence of Diclofenac: The Main Study|Completed||Early Phase 1|6|Actual|University of Florida||4|||f||||||||||||||2017-10-11 03:00:18.515053|2017-10-11 03:00:18.515053
NCT01592006|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-05-11|2015-01-05||April 2012||2012-04-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients|A Pilot Study on the Efficicay and Safety of Pegylated Interferon, Ribavirin and Telaprevir in Recurrent Hepatitis C Virus (HCV) Infection in Orthotopic Liver Transplant (OLT) Recipients.|Terminated||Phase 4|3|Actual|University of Chicago||1||Low accrual|f||||f||||||||||2017-10-11 03:00:18.607069|2017-10-11 03:00:18.607069
NCT01591993|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-11-28|||October 2011||2011-10-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Determination of Sensitive Skin and Its Biophysical Response in a Latin-American Population|Determination of Sensitive Skin in a Mexican Population by Lactic Acid Testing and Its Analysis Through Biophysical Measures|Completed||Phase 4|260|Actual|Universidad Autonoma de San Luis Potosí||2|||f||||f||||||||||2017-10-11 03:00:18.817713|2017-10-11 03:00:18.817713
NCT01591980|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-02-18|||August 2013||2013-08-01|February 2014|2014-02-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Effects of Perioperative Pregabalin for Post-Craniotomy Pain|Effects of Perioperative Low-dose Pregabalin on Post-craniotomy Pain: A Two-centre Randomized Controlled Trial|Withdrawn||Phase 4|0|Actual|St. Michael's Hospital, Toronto||3||"Pfizer Canada and the SMH ORA could not come into an agreement on responsibility to be the   Importer of Record for the trial."|f||||t||||||||||2017-10-11 03:00:18.924728|2017-10-11 03:00:18.924728
NCT01591967|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-02|||January 2010||2010-01-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Measure the Effects of Specific Thoracic Chiropractic Adjustments on Blood Pressure and Pulse Rate|A Randomized Controlled Trial to Measure the Effects of Specific Thoracic Chiropractic Adjustments on Blood Pressure and Pulse Rate|Completed||Phase 1|290|Actual|Spinal Missions, Inc., LLC||3|||f||||t||||||||||2017-10-11 03:00:19.034357|2017-10-11 03:00:19.034357
NCT01591954|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-10-07|2016-08-02||January 2012||2012-01-01|October 2016|2016-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Feasibility Study of a Modular Video Augmentation System for Image-Guided Skull Base Surgery|A Feasibility/Pilot Study of a Modular Video Augmentation System for Image-Guided Endoscopic Skull Base Surgery|Terminated||N/A|1|Actual|Sidney Kimmel Comprehensive Cancer Center||1||3rd party proprietary software issue|f||||t||||||||||2017-10-11 03:00:19.112857|2017-10-11 03:00:19.112857
NCT01591941|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-05-03|||June 2006||2006-06-01|May 2012|2012-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effectiveness of a Novel Warm-up in Decreasing Risk Factors for ACL Injury in Female Youth Soccer Players|The Effectiveness of a Novel Warm-up in Decreasing Risk Factors for Anterior Cruciate Ligament Injury in Female Youth Soccer Players|Completed||Phase 2|20|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:00:19.276036|2017-10-11 03:00:19.276036
NCT01591928|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-05-08|||March 2012||2012-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Heterotaxy Syndrome and Intestinal Rotation Abnormalities - A Prospective Study|Heterotaxy Syndrome and Intestinal Rotation Abnormalities - A Prospective Study|Completed||N/A|40|Actual|University of Alberta|||1||f||||f||||||||No||2017-10-11 03:00:19.36421|2017-10-11 03:00:19.36421
NCT01591915|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-04-29|||January 2010||2010-01-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||A Randomized Controlled Mindfulness Based Stress Reduction Intervention in Women With Breast Cancer|A Randomized Controlled Mindfulness Based Stress Reduction Intervention in Women With Breast Cancer|Enrolling by invitation||N/A|150|Actual|Skaraborg Hospital||3|||f||||f||||||||||2017-10-11 03:00:19.458028|2017-10-11 03:00:19.458028
NCT01591902|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-08-12|||June 2012||2012-06-01|August 2016|2016-08-01|September 2024|Anticipated|2024-09-01|December 2023|Anticipated|2023-12-01||Interventional|||Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®|A Prospective, Randomized, Placebo-controlled, Double-blind Clinical Trial to Evaluate Whether EGRIFTA® (Tesamorelin for Injection), 2 mg Once Daily SC, Increases the Risk of Development or Progression of Diabetic Retinopathy When Administered to HIV-infected Subjects With Abdominal Lipohypertrophy and Concomitant Diabetes|Recruiting||Phase 4|648|Anticipated|Theratechnologies||2|||f||||t||||||||||2017-10-11 03:00:19.556794|2017-10-11 03:00:19.556794
NCT01591889|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2014-01-17|||September 2009||2009-09-01|January 2014|2014-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions|Completed||Phase 1|28|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 03:00:19.847587|2017-10-11 03:00:19.847587
NCT01591876|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-02-28|||November 2012||2012-11-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|July 2013|Anticipated|2013-07-01||Interventional|||Exercise and Vascular Function in Haemodialysis Patients|The Effect of an Intra-dialytic Aerobic Exercise Intervention on Vascular Function in People Undergoing Maintenance Haemodialysis Therapy for Chronic Kidney Disease Stage 5. An Exploratory Study|Unknown status|Recruiting|Phase 2|50|Anticipated|Queen Margaret University||2|||f||||f||||||||||2017-10-11 03:00:19.954966|2017-10-11 03:00:19.954966
NCT01591863|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-08-10|2015-03-05||June 15, 2012|Actual|2012-06-15|August 2017|2017-08-01|March 7, 2014|Actual|2014-03-07|March 7, 2014|Actual|2014-03-07||Interventional|||Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)|A Phase 2A, Multi-Center, Open-Label, Uncontrolled Study to Determine the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin Oral Suspension or Tablets in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)|Completed||Phase 2|38|Actual|Optimer Pharmaceuticals LLC||1|||f||||t||||||||||2017-10-11 03:00:20.125009|2017-10-11 03:00:20.125009
NCT01591850|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2016-11-01|||September 2011||2011-09-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers|A Randomized, Single-center, Open-label, One-sequence, Two-period Crossover Study in 3 Parts to Investigate the Effects of Multiple Doses of Ketoconazole (Part 1), Rifampicin (Part 2), and Ritonavir-boosted Atazanavir (Part 3) on the PK of a Single Dose of RO5093151 in Healthy Female & Male Subjects|Completed||Phase 1|51|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:00:20.421446|2017-10-11 03:00:20.421446
NCT01591837|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-03|2016-07-17|2013-06-06||May 2012||2012-05-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy Volunteers|A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2012/2013 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: 'Adults' (Aged 18 to 59 Years) and 'Older Adults' (Aged 60 Years or Older)|Completed||Phase 4|120|Actual|Seqirus||2|||f||||||||||||||2017-10-11 03:00:20.532519|2017-10-11 03:00:20.532519
NCT01591824|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-02-06|||May 2012||2012-05-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|Pold-LBP||Study of Effectiveness of Pold in Chronic Nonspecific Low Back Pain|Effectiveness of Resonant Oscillation, According to the Pold Concept in Chronic Nonspecific Low Back Pain|Completed||N/A|50|Actual|Omphis Foundation||2|||f||||f||||||||||2017-10-11 03:00:20.910941|2017-10-11 03:00:20.910941
NCT01591811|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-07-19|||April 2012||2012-04-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|March 2018|Anticipated|2018-03-01||Interventional|||Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost|Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost|Active, not recruiting||Phase 3|433|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 03:00:21.014481|2017-10-11 03:00:21.014481
NCT01591798|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-05-03|||March 2012||2012-03-01|May 2012|2012-05-01|December 2017|Anticipated|2017-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy Study of Robotic Surgery for Rectal Cancer|Clinical Assessment of Laparoscopic and Robotic Surgery for Rectal Cancer - Randomized Phase II Trial|Recruiting||Phase 2|146|Anticipated|National Cancer Center, Korea||2|||f||||||||||||||2017-10-11 03:00:21.16926|2017-10-11 03:00:21.16926
NCT01591772|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-05-05|||April 2012||2012-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer|Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer|Active, not recruiting||N/A|36|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 03:00:21.419052|2017-10-11 03:00:21.419052
NCT01591759|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-04-22|||April 2012||2012-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Pilot Trial of Citicoline in Individuals With Mild Traumatic Brain Injury (mTBI)|A Pilot Trial of Citicoline in Individuals With mTBI|Withdrawn||Phase 2|0|Actual|Mclean Hospital||2||Our citicoline supply expired and the exact product has discontinued.|f||||f||||||||||2017-10-11 03:00:21.527175|2017-10-11 03:00:21.527175
NCT01591746|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-09-29|||August 2012||2012-08-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction|Botulinum Toxin A in Tissue Expander Breast Reconstruction: A Double-Blinded Randomized Controlled Trial|Recruiting||Phase 3|128|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 03:00:21.610883|2017-10-11 03:00:21.610883
NCT01591733|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-09-28|||May 2012|Actual|2012-05-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|March 2017|Actual|2017-03-01||Interventional|||FOLFIRINOX + RT for Pancreatic Cancer|Phase II Study of Preoperative FOLFIRINOX Followed by Accelerated Short Course Radiation Therapy for Borderline-Resectable Pancreatic Cancer|Active, not recruiting||Phase 2|50|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:00:21.700865|2017-10-11 03:00:21.700865
NCT01591720|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-05-02|||September 2010||2010-09-01|May 2012|2012-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|TAYLOR2||Tailored Internet-delivered Cognitive Behaviour Therapy in Primary Care|Effectiveness Testing of a Tailored Internet-delivered Cognitive Behaviour Therapy Treatment for Symptoms of Depression, Anxiety and Comorbid Problems|Completed||N/A|64|Actual|Linkoeping University||1|||f||||f||||||||||2017-10-11 03:00:21.794834|2017-10-11 03:00:21.794834
NCT01591707|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-01-12|||July 2012||2012-07-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Evaluating a Social and Communication Intervention for Preschoolers|Evaluating a Social and Communication Intervention for Preschoolers|Recruiting||N/A|700|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||Yes|Individual participant data for teachers will be shared with the Delaware Autism Program to determine feasibility of model implementation. Child participant data will not be shared.|2017-10-11 03:00:21.882215|2017-10-11 03:00:21.882215
NCT01591694|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2016-05-18|||April 2012||2012-04-01|May 2016|2016-05-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Observational|||National Child Traumatic Stress Network (NCTSN) Quality Improvement Initiative Database|National Child Traumatic Stress Network (NCTSN) Quality Improvement Initiative Database|Recruiting||N/A|500|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|||4||f||||f||||||||||2017-10-11 03:00:21.982604|2017-10-11 03:00:21.982604
NCT01591681|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2016-08-26|2014-03-11||November 2012||2012-11-01|August 2016|2016-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||There were 45 participants who could use the Continuous Glucose Monitoring device and met a minimum amount of nocturnal hypoglycemia as well as successfully completed the run-in phase of system use at home for 5 nights to verify the ability to use it properly.|Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study|Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension: An Outpatient Pilot Feasibility and Efficacy Study|Completed||Phase 2|49|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-11 03:00:22.096336|2017-10-11 03:00:22.096336
NCT01591668|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-08-12|||March 2012||2012-03-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C|A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antiviral Activity of GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 1|51|Actual|Gilead Sciences||8|||f||||t||||||||||2017-10-11 03:00:23.901751|2017-10-11 03:00:23.901751
NCT01591655|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-11-22||2013-11-22|July 2012||2012-07-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery|The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.|Completed||Phase 3|363|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 03:00:24.005792|2017-10-11 03:00:24.005792
NCT01591642|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-05-02|||January 2011||2011-01-01|October 2010|2010-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Physical Activity, Functional Fitness and Quality of Life After Coronary Artery Bypass Grafting||Completed||N/A|315|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 03:00:24.106772|2017-10-11 03:00:24.106772
NCT01591629|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-06-21|||July 2011||2011-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The Effects of ∆-9-THC and Naloxone in Humans|Assessment of Cannabinoid-opiate Interactions in Humans With a Cannabis Use Disorder and Healthy Subjects|Active, not recruiting||Phase 1|56|Anticipated|Yale University||4|||f||||t||||||||||2017-10-11 03:00:24.163724|2017-10-11 03:00:24.163724
NCT01591616|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2014-02-20|2014-02-20||April 2010||2010-04-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel|A Phase 4 Pediatric Study to Assess the Pharmacokinetics and Safety of Oraqix Gel in Healthy Children and Adolescent Volunteers Following Tooth Extraction|Completed||Phase 4|16|Actual|Dentsply International||1|||f||||f||||||||||2017-10-11 03:00:24.351338|2017-10-11 03:00:24.351338
NCT01591603|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-07-17|||May 2012||2012-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of Perineural Catheter Depth for the Continuous Popliteal Nerve Block Using Ultrasound Guidance and Dermabond|Comparison of Perineural Catheter Depth for the Continuous Popliteal Nerve Block Using Ultrasound Guidance and Dermabond|Completed||N/A|83|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 03:00:25.395266|2017-10-11 03:00:25.395266
NCT01591590|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-09-06|||June 2012||2012-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|CORIOLAN||Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer|Correlating the Tumoral Metabolic Progression Index Measured by Serial FDG PET-CT and Apparent Diffusion Coefficient Measured by MRI to Patient's Outcome in Advanced Colorectal Cancer|Recruiting||Phase 2|53|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 03:00:25.478488|2017-10-11 03:00:25.478488
NCT01591577|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-08-17|||December 7, 2012|Actual|2012-12-07|August 2017|2017-08-01|December 7, 2019|Anticipated|2019-12-07|December 7, 2018|Anticipated|2018-12-07||Interventional|||Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme|Phase II Trial of Pulse Dosing of Lapatinib in Combination With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly-Diagnosed Glioblastoma Multiforme|Recruiting||Phase 2|70|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:00:25.579186|2017-10-11 03:00:25.579186
NCT01591564|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-03-30|||July 2012||2012-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Interpersonal Psychotherapy in Youth With Severe Mood Dysregulation-Pilot|Interpersonal Psychotherapy in Youth With Severe Mood Dysregulation-Pilot|Completed||N/A|3|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 03:00:25.646729|2017-10-11 03:00:25.646729
NCT01591551|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2014-01-28|||March 2012||2012-03-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness|NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Relapsing Forms of Multiple Sclerosis Experiencing Fatigue or Sleepiness|Completed||Phase 4|37|Actual|Cornerstone Health Care, PA||1|||f||||f||||||||||2017-10-11 03:00:25.707573|2017-10-11 03:00:25.707573
NCT01591538|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2014-05-28|||March 2012||2012-03-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|MARC||Multi-Antibiotic Resistance Carriage in Gut Flora|Prevalence Study Evaluating the Acquisition of Carriage of Resistant Bacteria in the Gut Flora in Volunteers From French Armed Forces Coming Back From External Operations|Completed||N/A|272|Actual|Da Volterra|||1||f||||f||||||Samples Without DNA|"     Stool   "|||2017-10-11 03:00:25.784396|2017-10-11 03:00:25.784396
NCT01591525|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-05-03|||June 2012||2012-06-01|May 2012|2012-05-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Diabetes Mellitus Community Based Screening in Minority Populations|Diabetes Mellitus Community Based Screening in Minority Populations|Unknown status|Not yet recruiting|N/A|100|Anticipated|Ethnicity and Disease Community Empowerment Center|||4||f||||||||||||||2017-10-11 03:00:25.851437|2017-10-11 03:00:25.851437
NCT01591512|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-03-04|||May 2011||2011-05-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer|A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell|Terminated||N/A|4|Actual|Fujirebio Diagnostics, Inc.|||1|Decision was made by Sponsor to stop the trial.|f||||||||||Samples Without DNA|"     Collection of whole blood and urine.   "|||2017-10-11 03:00:25.948952|2017-10-11 03:00:25.948952
NCT01591499|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-01-07|2013-12-30||September 2011||2011-09-01|January 2016|2016-01-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|INNOVATION|Population of patients having evaluated at least one lens (N=138)|Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal|Clinical Evaluation of the Biofinity Multifocal Lens Compared With the Air Optix Aqua Multifocal Lens and With PureVision Multifocal Lens (INNOVATION PRESBYOPIA Study)|Completed||Phase 4|142|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 03:00:26.152177|2017-10-11 03:00:26.152177
NCT01590953|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-05-02|||May 2012||2012-05-01|May 2012|2012-05-01||||||||Observational|||A Study of the Effects of an Employee Wellness Program||Unknown status|Recruiting|N/A|80|Anticipated|Ochsner Health System|||1||f||||f||||||||||2017-10-11 03:00:36.392113|2017-10-11 03:00:36.392113
NCT01591486|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-08-10|||January 1995||1995-01-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Observational|2NA3NANC||Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding|A Long-term Prospective Cohort Study of Testing for Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding With Low-dose Aspirin|Completed||N/A|904|Actual|Chinese University of Hong Kong|||3||f||||f||||||||||2017-10-11 03:00:26.976819|2017-10-11 03:00:26.976819
NCT01591473|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-02-22||2017-02-22|April 2012|Actual|2012-04-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Interventional|||Safety Study of FluMist With and Without Ampligen|A Phase I/II, Two-Staged, Single-Center, Randomized, Double-Blind, Antibody Titer Study to Assess Immunogenicity and Safety of FluMist® Intranasal Influenza Vaccine Administered With and Without a TLR-3 Agonist, Ampligen®.|Terminated||Phase 1/Phase 2|55|Actual|Hemispherx Biopharma||6||The CDC indicated nasal spray flu vaccine should not be used during 2016-2017|f||||t||||||||Undecided||2017-10-11 03:00:27.047728|2017-10-11 03:00:27.047728
NCT01591460|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-11-01|2015-07-10||August 2012||2012-08-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||All-Treated Population: All enrolled participants who received at least one dose of study medication.|A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C|An International, Multicenter, Open-Label Study Evaluating Sustained Virological Response and Safety With Boceprevir in Triple Combination Therapy With Peginterferon Alfa-2a (40KD) and Ribavirin in Treatment-Naïve Patients With Genotype 1 Chronic Hepatitis C|Completed||Phase 4|165|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:00:27.205949|2017-10-11 03:00:27.205949
NCT01591447|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-03-01||2014-02-06|May 2012||2012-05-01|March 2017|2017-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea|An Open-Label Study to Evaluate the Efficacy and Safety of a Single-Dose of Oral CEM-101 in the Treatment of Male and Female Patients With Uncomplicated Urogenital Gonorrhea|Completed||Phase 2|60|Actual|Cempra Inc||2|||f||||f||||||||||2017-10-11 03:00:29.107012|2017-10-11 03:00:29.107012
NCT01591434|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-07-29|||May 2012||2012-05-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers|An Open Randomised Comparative Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers|Completed||Phase 3|65|Actual|ConvaTec Inc.||2|||f||||f||||||||||2017-10-11 03:00:29.187432|2017-10-11 03:00:29.187432
NCT01591421|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-08-14|||May 1, 2012|Actual|2012-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|September 2015|Actual|2015-09-01||Interventional|||P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Patients With Metastatic or Advanced RAS-Wild Type Colorectal Cancer.|Phase I/II Study of the P13Kinase Inhibitor BKM120 Given in Combination With Panitumumab in Patients With Metastatic or Advanced RAS-Wild Type Colorectal Cancer.|Active, not recruiting||Phase 1/Phase 2|22|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-10-11 03:00:29.301211|2017-10-11 03:00:29.301211
NCT01591408|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-10-27|2016-08-23||May 2012||2012-05-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||EEG Biofeedback Therapy as an Adjunct Treatment for PTSD|Placebo-controlled Study of EEG Biofeedback Therapy as an Adjunct Treatment for PTSD, Evaluating Symptoms and EEG Dynamics|Completed||N/A|68|Actual|United States Naval Medical Center, San Diego||2|||f||||t||||||||No||2017-10-11 03:00:29.407989|2017-10-11 03:00:29.407989
NCT01591395|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-05-04|||August 2010||2010-08-01|May 2012|2012-05-01||||December 2012|Anticipated|2012-12-01||Interventional|||Prospective Randomized Trial Comparing Three-port and Single-port TEP Repair in Adults|Prospective Randomized Trial Comparing the Short-term and Long-term Outcomes of Three-port and Single-port TEP Repair in Adults|Unknown status|Recruiting|N/A|100|Anticipated|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation||2|||f||||t||||||||||2017-10-11 03:00:29.651982|2017-10-11 03:00:29.651982
NCT01591382|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-02-01|2017-02-01||September 2008||2008-09-01|February 2017|2017-02-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional||Baseline characteristics are based on the total number of participants who completed the study.|Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients|Hydromorphone PCA or Hydromorphone PCA With Ketamine for Acute Postoperative Pain Relief in Opioid-Dependent Chronic Pain Patients|Completed||Phase 4|64|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:00:29.755836|2017-10-11 03:00:29.755836
NCT01591369|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-08-13|||May 2012||2012-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:00:30.181609|2017-10-11 03:00:30.181609
NCT01591356|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-09-08|||July 2015|Actual|2015-07-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||EphA2 Gene Targeting Using Neutral Liposomal Small Interfering RNA Delivery|EphA2 Gene Targeting Using Neutral Liposomal Small Interfering RNA Delivery (IND# 72924): A Phase I Clinical Trial|Recruiting||Phase 1|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:00:30.22914|2017-10-11 03:00:30.22914
NCT01591343|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-11-08|||June 2012||2012-06-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma.|Prospective Study to Evaluate the Safety of a 4-month Treatment With Depigoid® Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml) in Patients With Allergic Rhinitis or Rhinoconjunctivitis With or Without Mild Persistent or Intermittent Asthma.|Terminated||Phase 2|8|Actual|Laboratorios Leti, S.L.||1||Study halted by Sponsor|f||||t||||||||||2017-10-11 03:00:30.31971|2017-10-11 03:00:30.31971
NCT01591330|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-07-02|||April 2012||2012-04-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of LY2140023 in Healthy Males and Females|A Particle Size Study of 3 Different Particle Size Test Tablet Formulations Compared to the Reference Tablet Formulation in Healthy Subjects|Completed||Phase 1|35|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 03:00:30.453733|2017-10-11 03:00:30.453733
NCT01591317|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-09-04|2012-09-04||March 2009||2009-03-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of Prasugrel in Korean Healthy Male Volunteers|Single and Multiple Dose Pharmacokinetics and Pharmacodynamics of Prasugrel (LY640315) in Korean Healthy Male Subjects|Completed||Phase 1|30|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:00:30.561739|2017-10-11 03:00:30.561739
NCT01591304|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2014-12-03|||August 2011||2011-08-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne|Feasibility Study: Evaluation of the Safety and Effectiveness of the Ulthera® System for the Treatment of Moderate to Severe Facial Acne|Completed||N/A|24|Actual|Ulthera, Inc||2|||f||||f||||||||||2017-10-11 03:00:31.1344|2017-10-11 03:00:31.1344
NCT01591291|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-05-02|||June 2012||2012-06-01|May 2012|2012-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacogenetic Treatments for Alcoholism|1/2 - Pharmacogenetic Treatments for Alcoholism|Not yet recruiting||Phase 2/Phase 3|256|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 03:00:31.228189|2017-10-11 03:00:31.228189
NCT01591278|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2014-11-11|||March 2012||2012-03-01|November 2014|2014-11-01|November 2014|Anticipated|2014-11-01|February 2014|Actual|2014-02-01||Interventional|||MTA and Biodentine in Pulpotomized Primary Molars|Clinical and Radiographic Outcomes of MTA and Biodentine in Pulpotomized Primary Molars. A Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Universitat Internacional de Catalunya||2|||f||||f||||||||||2017-10-11 03:00:31.338958|2017-10-11 03:00:31.338958
NCT01591265|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-06-29|||May 2014||2014-05-01|June 2015|2015-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|SIXES||SIXES; Should I eXtract Every Six?|SIXES; Should I eXtract Every Six?|Terminated||N/A|7|Actual|University of Dundee||2||Poor recruitment|f||||t||||||||||2017-10-11 03:00:31.425888|2017-10-11 03:00:31.425888
NCT01591252|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2016-05-31|||April 2012||2012-04-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Observational|||Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)|Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)|Completed||N/A|200|Anticipated|University of Alabama at Birmingham|||1||f||||t||||||||||2017-10-11 03:00:31.535365|2017-10-11 03:00:31.535365
NCT01591239|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2016-08-31|||September 2011||2011-09-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Home-Based Program to Help Parents of Drug Abusing Adolescents|Parents as Interventionists for Moderate Drug Abusing Adolescents|Completed||N/A|286|Actual|Treatment Research Institute||2|||f||||t||||||||||2017-10-11 03:00:31.593198|2017-10-11 03:00:31.593198
NCT01591226|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-11-21|||February 2012||2012-02-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Caffeine and Sodium Citrate Ingestion|Effects of Caffeine and Sodium Citrate Ingestion in 1500m Wheelchair Racing Athletes|Completed||N/A|9|Actual|Swiss Paraplegic Centre Nottwil||4|||f||||f||||||||||2017-10-11 03:00:31.686962|2017-10-11 03:00:31.686962
NCT01591213|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2015-01-12|||November 2012||2012-11-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)|St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)|Completed||N/A|426|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 03:00:31.795289|2017-10-11 03:00:31.795289
NCT01591200|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2016-09-14|||June 2012||2012-06-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis|A Parallel Group Randomized Open Blinded End Point Evaluation, Multicentric, Dose Escalation, Phase -II Study Assessing the Safety and Efficacy of Intraarterial (Hepatic) Ex-vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Alcoholic Liver Cirrhosis|Completed||Phase 2|40|Actual|Stempeutics Research Pvt Ltd||4|||f||||t||||||||||2017-10-11 03:00:31.86898|2017-10-11 03:00:31.86898
NCT01591187|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2015-03-04|||May 2012||2012-05-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Observational|||The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease|The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease|Completed||N/A|77|Actual|St. Jude Children's Research Hospital|||2||f||||f||||||||||2017-10-11 03:00:31.975605|2017-10-11 03:00:31.975605
NCT01591174|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-02-02|||May 2012||2012-05-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|GHR||Ghrelin and Gastric Emptying in Children With Functional Dyspepsia|Evaluation of Liquid Gastric Emptying and Plasma Ghrelin in Children With Functional Dyspepsia|Unknown status|Active, not recruiting|N/A|45|Anticipated|Children's Mercy Hospital Kansas City|||3||f||||f||||||Samples Without DNA|"     breath specimen blood plasma   "|||2017-10-11 03:00:32.052471|2017-10-11 03:00:32.052471
NCT01591161|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2013-11-22||2013-11-22|July 2012||2012-07-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery|The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery|Completed||Phase 3|369|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 03:00:32.252983|2017-10-11 03:00:32.252983
NCT01591148|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-10-12|||January 2011||2011-01-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects|A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects|Active, not recruiting||N/A|40|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 03:00:32.428717|2017-10-11 03:00:32.428717
NCT01591135|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-02-01|||April 2012||2012-04-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma|A Phase III Randomized Clinical Trial of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma|Active, not recruiting||Phase 3|436|Actual|Fudan University||2|||f||||t||||||||||2017-10-11 03:00:32.515917|2017-10-11 03:00:32.515917
NCT01591122|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2017-05-04|||March 27, 2012|Actual|2012-03-27|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer|A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (JNJ-212082) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 3|313|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 03:00:32.629969|2017-10-11 03:00:32.629969
NCT01591109|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-05-02|||January 2010||2010-01-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||A Reversal in the Vascularity of Metastatic Liver Tumors From Colorectal Cancer After the Cessation of Anti-VEGF Therapy|A Reversal in the Vascularity of Metastatic Liver Tumors in Patients With Colorectal Cancer After the Cessation of Anti-VEGF Therapy: A Study Using Contrast-enhanced Ultrasonography and Histological Techniques.|Completed||N/A|20|Actual|NHO - Matsumoto Medical Center|||2||f||||t||||||Samples Without DNA|"     formalin fixed oarafin embedded block of liver specimen   "|||2017-10-11 03:00:32.823986|2017-10-11 03:00:32.823986
NCT01591083|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-10-11|||August 2011||2011-08-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|DDE||The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers|The Studies of the Pathophysiologic Mechanisms of Poor Ulcer Healing & Clinical Improvement to the High Ulcer Rebleeding Rate for Patients With Comorbid Illnesses|Completed||Phase 4|474|Actual|National Cheng-Kung University Hospital||3|||f||||t||||||||||2017-10-11 03:00:33.047918|2017-10-11 03:00:33.047918
NCT01591070|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-08-07|||November 2010||2010-11-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis|Phase 4 Study of Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis|Completed||Phase 4|104|Actual|Pusan National University Hospital||3|||f||||f||||||||||2017-10-11 03:00:33.191396|2017-10-11 03:00:33.191396
NCT01591057|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-11-22|||June 2011||2011-06-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|BIOFAV||Effect of Fruit and Vegetable Intake on Markers of Fruit and Vegetable Consumption|Effect of Increased Fruit and Vegetable Intake on Biomarkers of Fruit and Vegetable Consumption|Completed||N/A|30|Anticipated|Queen's University, Belfast||3|||f||||t||||||||||2017-10-11 03:00:33.317111|2017-10-11 03:00:33.317111
NCT01591044|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2016-08-05|2016-05-17||July 2012||2012-07-01|August 2016|2016-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|SITAR|For the purpose of analysis, participants randomized to the two different dosage levels of the placebo were considered a single Arm/Group.|A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Doses of Inhaled R940343 in Patients With Mild to Moderate Allergic Asthma|Completed||Phase 2|301|Actual|Rigel Pharmaceuticals||3|||f||||f||||||||No||2017-10-11 03:00:33.482339|2017-10-11 03:00:33.482339
NCT01591031|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-02-13|||April 2012||2012-04-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Laryngeal Injuries After Anesthesia Induction With Sevoflurane and After Anesthesia Induction With Rocuronium|Laryngeal Injuries After Anesthesia Induction With Sevoflurane and After Anesthesia Induction With Rocuronium. A Randomized, Prospective, Controlled Trial|Completed||N/A|60|Actual|University of Rostock||2|||f||||f||||||||||2017-10-11 03:00:34.081738|2017-10-11 03:00:34.081738
NCT01591018|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-07-24|2016-07-24||September 2012||2012-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|SONORESCUE|In total, 120 of 214 screened patients fulfilled the inclusion criteria. Subjects were allocated to the sonolysis or control group randomly and equally.|SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry|Risk Reduction of Symptomatic and Silent Brain Infarctions During Cardiac Surgery Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring|Completed||Phase 3|120|Actual|University Hospital Ostrava||2|||f||||t||||||||Undecided||2017-10-11 03:00:34.248009|2017-10-11 03:00:34.248009
NCT01591005|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-07-24|2015-12-22||October 2010||2010-10-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|July 2014|Actual|2014-07-01||Interventional|SONOBUSTER|In total, 242 of the 495 screened patients fulfilled the inclusion criteria. Subjects were randomly and equally allocated to the sonolysis or control group. Clinical and procedural variables were well balanced between the groups|SONOlysis in Prevention of Brain Infarctions dUring Carotid Stenting and caroTid EndaRterectomy|Risk Reduction of Symptomatic and Silent Brain Infarctions During Carotid Endarterectomy and Carotid Stenting Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring|Completed||Phase 3|242|Actual|University Hospital Ostrava|Serial follow-up MRI was not done. A software package for mapping of brain infarction volume was not used. Single-centre investigation with mandatory use of brain protection device during carotid stenting and shunt during carotid endarterectomy.|4|||f||||t||||||||Undecided||2017-10-11 03:00:35.195285|2017-10-11 03:00:35.195285
NCT01590992|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-08-21|||May 2012||2012-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Globus Sensations With Psychotherapy|Psychotherapy and Psychobiology of Somatoform Disorders (Globus Sensations): A Randomized Controlled Trial|Active, not recruiting||Phase 2/Phase 3|175|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 03:00:35.85269|2017-10-11 03:00:35.85269
NCT01590979|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-02-01|2016-09-08||April 2012||2012-04-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation|Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation Rates in Post-Operative Cardiac Surgery Patients|Terminated||N/A|54|Actual|Northwell Health|Due to insufficient accrual rate the study was stopped before the recruitment total was met. Thus, a major limitation is small sample size.|2||The study was terminated due to slow rate of accrual resulting in a sample size.|f||||t||||||||No||2017-10-11 03:00:35.990032|2017-10-11 03:00:35.990032
NCT01590966|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2014-12-04|||September 2012||2012-09-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|SCINTRA||Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis|Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis|Unknown status|Recruiting|Phase 3|20|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:00:36.28265|2017-10-11 03:00:36.28265
NCT01590940|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2012-05-03|||April 2012||2012-04-01|May 2012|2012-05-01||||April 2013|Anticipated|2013-04-01||Observational|||Use of Parietex Plug and Patch Hernia System in Open Inguinal Hernia Repair|Use of Parietex Plug-and-patch Hernia Mesh in Elective Open Inguinal Hernia Repair: A Pilot Investigation|Unknown status|Recruiting|N/A|50|Anticipated|Owen Drive Surgical Clinic of Fayetteville|||1||f||||||||||||||2017-10-11 03:00:36.462277|2017-10-11 03:00:36.462277
NCT01590927|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-05-02|||August 2012||2012-08-01|May 2012|2012-05-01|May 2013|Anticipated|2013-05-01|February 2013|Anticipated|2013-02-01||Observational|||Reliability and Validation of 3-D Electromagnetic Tracking During Pelvic Floor Muscle (PFM) Activation - a Pilot Study|Reliability and Validation of 3-D Electromagnetic Tracking During Pelvic Floor Muscle (PFM) Activation - a Pilot Study|Unknown status|Not yet recruiting|N/A|20|Anticipated|Moser, Helene|||1||f||||f||||||||||2017-10-11 03:00:36.54825|2017-10-11 03:00:36.54825
NCT01590914|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2013-03-08|||January 2008||2008-01-01|March 2013|2013-03-01||||January 2014|Anticipated|2014-01-01||Interventional|||Brain Activation in Response to Appetitive Cues Pre- and Post- Bariatric Surgery|Brain Activation in Response to Appetite Cues Pre- and Post- Bariatric Surgery|Unknown status|Enrolling by invitation|N/A|120|Anticipated|New York Obesity and Nutrition Research Center||4|||f||||f||||||||||2017-10-11 03:00:36.626027|2017-10-11 03:00:36.626027
NCT01590901|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2013-06-04|||February 2012||2012-02-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|April 2012|Actual|2012-04-01||Interventional|||Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects|The Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects|Completed||Phase 1|12|Actual|Otsuka Beijing Research Institute||1|||f||||t||||||||||2017-10-11 03:00:36.705047|2017-10-11 03:00:36.705047
NCT01590888|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-06-07|2015-11-17||April 2012||2012-04-01|June 2016|2016-06-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Interventional|Reach2HD||Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability, and Efficacy of PBT2 in Patients With Early to Mid-stage Huntington Disease|Completed||Phase 2|109|Actual|Prana Biotechnology Limited||3|||f||||t||||||||||2017-10-11 03:00:36.816551|2017-10-11 03:00:36.816551
NCT01590875|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-03-22|2017-02-01||May 2012||2012-05-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation|Validation of the Durability of the Adenosine Effect in Verification of Pulmonary Vein Isolation|Completed||N/A|20|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 03:00:38.078558|2017-10-11 03:00:38.078558
NCT01590862|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-10-31|||June 2012||2012-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators|ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-11 03:00:38.467373|2017-10-11 03:00:38.467373
NCT01590849|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-02|||January 2011||2011-01-01|May 2012|2012-05-01||||May 2012|Anticipated|2012-05-01||Interventional|||Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone|Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone|Unknown status|Active, not recruiting|Phase 3|69|Actual|Instituto do Coracao||2|||f||||t||||||||||2017-10-11 03:00:38.562095|2017-10-11 03:00:38.562095
NCT01590836|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-02-09|||April 2012||2012-04-01|February 2017|2017-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes|Completed||Phase 1|22|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:00:38.64824|2017-10-11 03:00:38.64824
NCT01590823|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-10-31|||July 2012||2012-07-01|April 2012|2012-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients|Phase 1 Study of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients|Completed||Phase 1|10|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 03:00:38.737407|2017-10-11 03:00:38.737407
NCT01590810|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-03-30|2016-03-03||May 7, 2012|Actual|2012-05-07|March 2017|2017-03-01|February 5, 2013|Actual|2013-02-05|January 24, 2013|Actual|2013-01-24||Interventional|||A Single Rising Dose Study of MK-8150 (MK-8150-001)|A Single Rising Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150|Completed||Phase 1|34|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 03:00:38.910324|2017-10-11 03:00:38.910324
NCT01590797|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-03-23|2015-01-16||July 10, 2012|Actual|2012-07-10|March 2017|2017-03-01|June 25, 2014|Actual|2014-06-25|June 11, 2014|Actual|2014-06-11||Interventional|||A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial in China to Study the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Therapy, Alone or in Combination With Metformin|Completed||Phase 3|467|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:00:42.015752|2017-10-11 03:00:42.015752
NCT01590784|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-07-27|||January 2012||2012-01-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Observational|||Reliability and Validity of Thai Calgary Depression Scale of Schizophrenia (CDSS)|The Reliability and Validity of the Thai Version of Calgary Depression Scale for Schizophrenia (CDSS)|Completed||N/A|60|Actual|Chiang Mai University|||1||f||||f||||||||||2017-10-11 03:00:42.482552|2017-10-11 03:00:42.482552
NCT01590771|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-03-23|2015-04-16||July 9, 2012|Actual|2012-07-09|March 2017|2017-03-01|June 24, 2014|Actual|2014-06-24|June 10, 2014|Actual|2014-06-10||Interventional|||A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial in China to Study the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sulfonylurea Therapy, Alone or in Combination With Metformin|Completed||Phase 3|498|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:00:42.559916|2017-10-11 03:00:42.559916
NCT01590758|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-05-19|2017-04-14||June 2014||2014-06-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|OneStep-1||Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers|A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers|Completed||Phase 3|189|Actual|Dipexium Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 03:00:43.113941|2017-10-11 03:00:43.113941
NCT01590745|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-02-13|||June 2012||2012-06-01|February 2013|2013-02-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|CTS||Ultrasound Therapy for Carpal Tunnel Syndrome (CTS)|A Randomised Controlled Double Blind Trial Of Therapeutic Ultrasound in Carpal Tunnel Syndrome (CTS)|Unknown status|Recruiting|N/A|40|Anticipated|East Kent Hospitals University NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:00:45.565413|2017-10-11 03:00:45.565413
NCT01590732|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-09-28|||October 2012|Actual|2012-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Phase I Study of Romidepsin Plus ICE for Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma|Phase I Study of Romidepsin (ISTODAX®) Plus ICE for Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma|Active, not recruiting||Phase 1|22|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:00:45.702735|2017-10-11 03:00:45.702735
NCT01590719|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2016-08-04||2016-07-08|July 2012||2012-07-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer|A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating The Efficacy And Safety Of Onartuzumab (MetMAb) In Combination With 5-Fluorouracil, Folinic Acid, And Oxaliplatin (mFOLFOX6) In Patients With Metastatic HER2-Negative Gastroesophageal Cancer|Completed||Phase 2|123|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:00:45.855541|2017-10-11 03:00:45.855541
NCT01590706|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2014-04-01|||November 2011||2011-11-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Observational|||A Study of Characterizing Cognitive Decline and Functional Cardiac Senescence in Healthy Korean Volunteers|An Association Study of Characterizing Cognitive Decline and Functional Cardiac Senescence Profile Through the Association of Biomarkers and Clinical Outcomes in Healthy Middle Aged and Elderly Korean Volunteers|Completed||N/A|116|Anticipated|Korea Institute of Oriental Medicine|||1||f||||t||||||Samples With DNA|"     Samples for single nucleotide polymorphism, and for cardiac enzyme level detection   "|||2017-10-11 03:00:46.100101|2017-10-11 03:00:46.100101
NCT01590693|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-05-02|||November 2005||2005-11-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Interventional|||Botulinum Toxin A for Idiopathic Toe-walking|Botulinum Toxin A Does Not Improve Cast Treatment for Idiopathic Toe-walking- a Prospective Randomized Trial.|Completed||N/A|52|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:00:46.258284|2017-10-11 03:00:46.258284
NCT01590680|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-09-23||||||September 2016|2016-09-01||||||||Expanded Access|||Expanded Access Protocol Using I131-MIBG|An Open Label, Expanded Access Protocol Using 131I-metaiodobenzylguanidine (131I-MIBG)Therapy in Patients With Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma|Available||N/A|||Jubilant DraxImage Inc.|||||||||||||||||||2017-10-11 03:00:46.419538|2017-10-11 03:00:46.419538
NCT01590667|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-07-25|||May 2012||2012-05-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Litramine on Fat Excretion|Double-blind, Randomized, Placebo-controlled, Crossover Clinical Investigation to Evaluate the Effect of Litramine on Fecal Fat Excretion in Healthy Subjects|Completed||Phase 4|20|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-11 03:00:46.550299|2017-10-11 03:00:46.550299
NCT01590654|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-12-18|||April 2012||2012-04-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection|A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antiviral Activity of GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection|Completed||Phase 1|51|Actual|Gilead Sciences||8|||f||||t||||||||||2017-10-11 03:00:46.664863|2017-10-11 03:00:46.664863
NCT01590641|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-11-13|||April 2012||2012-04-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B|A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple- Dose Ranging, Adaptive Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antiviral Activity of GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B Virus Infection|Completed||Phase 1|49|Actual|Gilead Sciences||8|||f||||t||||||||||2017-10-11 03:00:46.863921|2017-10-11 03:00:46.863921
NCT01590628|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2017-08-06|||April 2012||2012-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study Evaluating Safety & Efficacy of a DCBT: NiCord® & UNM CBU to Patients With Hemaglobinopathies After Myeloablative Therapy|Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Combination With a Second, Unmanipulated Cord Blood Unit in Patients With Hemoglobinopathies|Recruiting||Phase 1/Phase 2|15|Anticipated|Gamida Cell ltd||1|||f||||t||||||||||2017-10-11 03:00:47.083389|2017-10-11 03:00:47.083389
NCT01590615|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-04-20|||April 26, 2012|Actual|2012-04-26|April 2017|2017-04-01|April 4, 2017|Actual|2017-04-04|April 4, 2017|Actual|2017-04-04|1 Year|Observational [Patient Registry]|||Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy|Observational, Post-marketing Renal Safety Surveillance Registry in Subjects With Chronic Hepatitis B (HBV) Infection With Decompensated Liver Disease Receiving Nucleotide/Side Therapy|Completed||N/A|54|Actual|Gilead Sciences|||1||f||||f||f||||||||2017-10-11 03:00:47.203627|2017-10-11 03:00:47.203627
NCT01590602|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-09-14|||November 2011||2011-11-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|JHD||REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)|REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)|Completed||N/A|78|Actual|European Huntington's Disease Network|||1||f||||f||||||||||2017-10-11 03:00:47.371099|2017-10-11 03:00:47.371099
NCT01590030|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-02|||September 2004||2004-09-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|December 2009|Actual|2009-12-01||Interventional|||Ovarian Mesial Incision: a New Safe and Fertility-sparing Technique|Mesial Incision for Laparoscopic Dermoid Cystectomy: a New Safe and Fertility-sparing Technique|Completed||N/A|67|Actual|University Magna Graecia||2|||f||||f||||||||||2017-10-11 03:00:53.693048|2017-10-11 03:00:53.693048
NCT01590589|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-09-14|||June 2004||2004-06-01|September 2017|2017-09-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|REGISTRY||REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)|REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)|Completed||N/A|10000|Actual|European Huntington's Disease Network|||1||f||||f||||||Samples With DNA|"     -  DNA from whole blood        -  DNA        -  Lymphoblastoid cell lines        -  Urine   "|||2017-10-11 03:00:47.52071|2017-10-11 03:00:47.52071
NCT01590576|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2016-09-05|||November 2014||2014-11-01|February 2016|2016-02-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|||Population-based Estimates of Medical Comorbidities in Women With Lower Urinary Tract Symptoms or Pelvic Organ Prolapse||Completed||N/A|2500|Actual|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-10-11 03:00:47.951088|2017-10-11 03:00:47.951088
NCT01590563|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-10-12|2013-11-05||April 2012||2012-04-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study to Evaluate the Safety and Initial Efficacy of a Novel Intrauterine Device|A Study to Evaluate the Safety and Initial Efficacy of a Spherical Copper Intrauterine Contraceptive Device the IUB(tm)|Completed||Phase 1|15|Actual|Ocon Medical Ltd.||1|||f||||f||||||||||2017-10-11 03:00:48.055489|2017-10-11 03:00:48.055489
NCT01590550|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2017-01-09|2016-02-02||May 2012||2012-05-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|January 2014|Actual|2014-01-01||Observational|||Observational Study of Citrate Based Dialysis in Pediatric Patients Receiving Hemodialysis|A Prospective Study of Citrate Based Dialysate in Pediatric Patients Receiving Intermittent Hemodialysis|Completed||N/A|18|Actual|Loma Linda University|No control group||1||f||||f||||||||No|Mean data will be presented|2017-10-11 03:00:48.300016|2017-10-11 03:00:48.300016
NCT01590537|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-02|2015-10-15|||September 2011||2011-09-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Observational|Mirabel||Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction|Prospective Multicentre Non-interventional Comparative Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction|Completed||N/A|2348|Actual|Bayer|||2||f||||f||||||||||2017-10-11 03:00:48.502603|2017-10-11 03:00:48.502603
NCT01590524|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-10-07|||April 2012||2012-04-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Feasibility Study on the Effect of Complementary Methods as Supportive Interventions for Parents of Children With Cancer|Randomized Control Trial for the Effect of Guided Imagery and Progressive Muscle Relaxation in Reducing Anxiety for Parents of Hospitalized Children With Cancer|Completed||N/A|52|Actual|Cyprus University of Technology||2|||f||||t||||||||||2017-10-11 03:00:48.591749|2017-10-11 03:00:48.591749
NCT01590511|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-12-03|||January 2013||2013-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|IVT NonVent||Echocardiographic Prediction of Fluid Responsiveness After a Mini-fluid Challenge in Non-ventilated Patients With Shock|Echocardiographic Prediction of Fluid Responsiveness After a Mini-fluid Challenge in Non-ventilated Patients With Shock|Completed||N/A|71|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 03:00:48.668576|2017-10-11 03:00:48.668576
NCT01590498|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-05-03|||May 2012||2012-05-01|May 2012|2012-05-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Radiotherapy vs Observation for CRPC|Salvage Radiotherapy vs Observation for Castration Resistant Prostate Cancer in Central China|Unknown status|Recruiting|N/A|2000|Anticipated|Zhengzhou University|||2||f||||f||||||Samples Without DNA|"     the biopsy specimens of prostate tissue   "|||2017-10-11 03:00:48.770254|2017-10-11 03:00:48.770254
NCT01590485|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-01-28|||May 2012||2012-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Evaluation of the Effect of Saffron (Crocus Sativus) on Pain Control After Root Canal Therapy in Teeth With Vital Pulps||Completed||N/A|36|Actual|Zahedan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:00:48.858316|2017-10-11 03:00:48.858316
NCT01590472|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-05-02|||June 2011||2011-06-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|||Do Your Genes Put You at a Higher Risk of Developing Mesothelioma|Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma|Completed||N/A|69|Actual|Wake Forest University Health Sciences|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:00:48.948847|2017-10-11 03:00:48.948847
NCT01590459|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-10-23||2015-10-23|April 2012||2012-04-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate|A 24-week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Phase 2 Study of Different Doses of VX-509 in Adult Subjects With Active Rheumatoid Arthritis on Stable Methotrexate Therapy With 104-Week Open Label Extension|Completed||Phase 2|359|Actual|Vertex Pharmaceuticals Incorporated||5|||f||||t||||||||||2017-10-11 03:00:49.07798|2017-10-11 03:00:49.07798
NCT01590446|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-06-07|||February 2012||2012-02-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers|A Phase 1, Two-Part, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BMN 111 Administered to Healthy Adult Volunteers|Completed||Phase 1|74|Anticipated|BioMarin Pharmaceutical||2|||f||||f||||||||||2017-10-11 03:00:49.335347|2017-10-11 03:00:49.335347
NCT01590433|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-03-14|||March 2012||2012-03-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Weight Loss With Exenatide Treatment|A Prospective Study of Patterns, Predictors, and Mechanisms of Weight Loss With Exenatide Treatment in Overweight and Obese Women Without Diabetes|Recruiting||N/A|300|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t|t|f||||||No||2017-10-11 03:00:49.406629|2017-10-11 03:00:49.406629
NCT01590420|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-05-02|||March 2011||2011-03-01|May 2012|2012-05-01|March 2014|Anticipated|2014-03-01|March 2011|Actual|2011-03-01||Interventional|||Cost-utility Study of Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnea Syndrome Patients|Cost-utility Study of CPAP Treatment in Obstructive Sleep Apnea Patients|Unknown status|Recruiting|Phase 4|1000|Anticipated|Associação Fundo de Incentivo à Pesquisa||1|||f||||t||||||||||2017-10-11 03:00:49.569852|2017-10-11 03:00:49.569852
NCT01590017|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-04-26|||April 2014||2014-04-01|April 2017|2017-04-01|April 20, 2017|Actual|2017-04-20|April 20, 2017|Actual|2017-04-20||Interventional|||Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer|Feasibility Study of Safety, Toxicity, and Compliance of Concomitant Chemoradiotherapy for HIV-Associated Locally-Advanced Cervical Cancer|Completed||Phase 2|41|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-10-11 03:00:53.800072|2017-10-11 03:00:53.800072
NCT01590407|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-01-22|||December 2011||2011-12-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1|A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-Part Study of Orally Administered ALS-002200 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosing and Food-effect in Healthy Volunteers, and Multiple Ascending Dosing in Subjects With Chronic Hepatitis C Genotype 1 Infection|Completed||Phase 1|71|Actual|Alios Biopharma Inc.||2|||f||||f||||||||||2017-10-11 03:00:49.714411|2017-10-11 03:00:49.714411
NCT01590381|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-05-01|||December 2011||2011-12-01|May 2012|2012-05-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Observational|||Assessment of HBV Vaccine Immunity After 18 Years|Assessment of the Immune Status of New Health Care Workers in the Israel Defense Forces (IDF) Vaccinated in Infancy Against Hepatitis B Virus (HBV), Before and After a Booster Dose.|Unknown status|Recruiting|N/A|545|Anticipated|Medical Corps, Israel Defense Force|||10||f||||f||||||Samples Without DNA|"     blood samples from study subjects vaccinated at infancy, before and after booster dose.   "|||2017-10-11 03:00:49.899015|2017-10-11 03:00:49.899015
NCT01590355|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-08-03|||June 2012||2012-06-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|ORATOR||A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR)|A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR)|Active, not recruiting||Phase 2|68|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 03:00:50.118262|2017-10-11 03:00:50.118262
NCT01590342|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-09-05|||May 2012||2012-05-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|January 2017|Actual|2017-01-01||Interventional|AINEP-1||Diclofenac for Submassive PE|Efficacy of Diclofenac for Patients With Acute Submassive Pulmonary Embolism: a Randomized Clinical Trial|Terminated||Phase 2/Phase 3|34|Actual|Ministry of Health, Spain||2||Low recruitment rate|f||||t||||||||||2017-10-11 03:00:50.249354|2017-10-11 03:00:50.249354
NCT01590329|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-05-01|||March 2012||2012-03-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds|A Proof of Concept Cases Series on the Use of the Epidermal Expansion System to Harvest and Place Suction Blister Epidermal Grafts on Hypopigmented Skin and Surgical Wounds|Unknown status|Recruiting|N/A|12|Anticipated|Momelan Technologies||1|||f||||f||||||||||2017-10-11 03:00:50.366969|2017-10-11 03:00:50.366969
NCT01590316|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-04-12|||June 2012||2012-06-01|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|December 2013|Actual|2013-12-01||Interventional|SafeBoosC||SafeBoosC - a Phase II Trial|SafeBoosC - Safeguarding the Brain of Our Smallest Children - an Investigator-initiated Randomised, Blinded, Multinational, Phase II Feasibility Clinical Trial on Near-infrared Spectroscopy Monitoring Combined With Defined Treatment Guidelines Versus Standard Monitoring and Treatment as Usual in Premature Infants|Active, not recruiting||N/A|165|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||Yes|Archieving anonymized data at Danish Data Archieve|2017-10-11 03:00:50.500857|2017-10-11 03:00:50.500857
NCT01590303|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-05-01|||May 2012||2012-05-01|May 2012|2012-05-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Interventional|||Outcome Following Vitamin C Administration in Sepsis|A Pilot Study Examining the Efficacy of Vitamin C Administration in Septic Patients.|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:00:50.617142|2017-10-11 03:00:50.617142
NCT01590290|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-01|||April 2012||2012-04-01|April 2012|2012-04-01||||April 2013|Anticipated|2013-04-01||Interventional|||Randomized Controlled Cluster Trial of Resident Pay for Performance and Cardiovascular Outcomes|Randomized Controlled Cluster Trial of Resident Pay for Performance and Cardiovascular Outcomes|Unknown status|Recruiting|Phase 3|38|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-11 03:00:50.74497|2017-10-11 03:00:50.74497
NCT01590277|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-05-22|||July 1, 2012|Actual|2012-07-01|May 2017|2017-05-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Interventional|||Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans|Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans|Recruiting||Phase 2|49|Anticipated|VA Office of Research and Development||4|||f||||f|t|f|||f|||Undecided||2017-10-11 03:00:50.858095|2017-10-11 03:00:50.858095
NCT01590264|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-02-25|2012-09-17||May 2012||2012-05-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||rTMS Bimodal Treatment For Tinnitus: A Pilot Study|rTMS Bimodal Treatment For Patients With Subjective Idiopathic Tinnitus: A Pilot Study|Completed||N/A|5|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 03:00:50.99957|2017-10-11 03:00:50.99957
NCT01590251|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-09-23|||April 2012||2012-04-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Yoga||Yoga for Pain and Opioid Dependence|Yoga for Pain and Opioid Dependence|Completed||Phase 1/Phase 2|8|Actual|Yale University||2|||f||||f||||||||||2017-10-11 03:00:51.263438|2017-10-11 03:00:51.263438
NCT01590238|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2016-12-29|2016-09-22||May 2012||2012-05-01|December 2016|2016-12-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)|Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)|Completed||Phase 3|15|Actual|The New York Eye & Ear Infirmary||1|||f||||f||||||||||2017-10-11 03:00:51.394638|2017-10-11 03:00:51.394638
NCT01583738|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2014-10-29|||April 2012||2012-04-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of V0251 in Acute Vertigo||Completed||Phase 2|132|Actual|Pierre Fabre Medicament||2|||f||||t||||||||||2017-10-11 03:02:38.93741|2017-10-11 03:02:38.93741
NCT01590225|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2015-02-20|||January 2013||2013-01-01|February 2015|2015-02-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)|A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 03:00:51.609775|2017-10-11 03:00:51.609775
NCT01590212|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2014-03-05|2013-07-31||May 2012||2012-05-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Two participants withdrew and two were unable to be contacted.|Mellow Bumps RCT - Antenatal Intervention for Vulnerable Women|Antenatal Parenting Support for Women Vulnerable in Pregnancy: an Exploratory Randomised Controlled Trial of Mellow Bumps|Completed||N/A|35|Actual|University of Glasgow|Participants lived in one health board area and one community health care partnership (CHCP) in the west of Scotland. Midwives may have approached only those potential participants who were thought to be likely to take part in the group programmes.|3|||f||||f||||||||||2017-10-11 03:00:51.7676|2017-10-11 03:00:51.7676
NCT01590199|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-10-03|||May 18, 2012|Actual|2012-05-18|October 2017|2017-10-01|May 1, 2020|Anticipated|2020-05-01|May 1, 2020|Anticipated|2020-05-01||Interventional|MACS2002||Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs|"Extension Study to the Open-label Phase I Study Evaluating the Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs - The COOPERATE-1 Study"|Active, not recruiting||Phase 1|17|Actual|Novartis||1|||f||||f|f|f||||||||2017-10-11 03:00:52.306841|2017-10-11 03:00:52.306841
NCT01590186|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-05|2014-03-28|||October 2002||2002-10-01|March 2014|2014-03-01|January 2004|Actual|2004-01-01|April 2003|Actual|2003-04-01||Observational|||Examination and Treatment of Pain in Front Foot|Examination and Treatment of Pain in Front Foot|Completed||N/A|40|Actual|Northern Orthopaedic Division, Denmark|||1||f||||f||||||||||2017-10-11 03:00:52.39409|2017-10-11 03:00:52.39409
NCT01590173|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2016-07-17|||January 2012||2012-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles|Addition of Prednisolone and Heparin in Patients With Repeated Implantation Failures: a Prospective Clinical Study|Completed||Phase 2/Phase 3|86|Actual|National and Kapodistrian University of Athens||2|||f||||||||||||||2017-10-11 03:00:52.466897|2017-10-11 03:00:52.466897
NCT01590160|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-05-02|||August 2013||2013-08-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|MESO-02||Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma|A Phase I/II Study of First Line Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma|Active, not recruiting||Phase 1/Phase 2|27|Actual|University College, London||2|||f||||t||||||||||2017-10-11 03:00:52.592067|2017-10-11 03:00:52.592067
NCT01590147|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-03-24|||June 2011||2011-06-01|March 2017|2017-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|SIPS||Supportive Intervention Programs Study|Supportive Intervention Programs to Lessen Treatment Related Symptoms|Completed||N/A|15|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 03:00:52.693133|2017-10-11 03:00:52.693133
NCT01590134|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-02-03|||March 2012||2012-03-01|April 2012|2012-04-01|December 2015|Anticipated|2015-12-01|December 2012|Actual|2012-12-01||Interventional|||The Efficacy and Safety of Iron Supplementation|Pilot Studies on the Efficacy and Safety of Dietary Iron Supplementation|Unknown status|Active, not recruiting|N/A|18|Actual|Imperial College London||3|||f||||f||||||||||2017-10-11 03:00:52.79354|2017-10-11 03:00:52.79354
NCT01590121|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-05-28|||January 2010||2010-01-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|Flying and HHT||Hereditary Haemorrhagic Telangiectasia Flight Safety Study|A Questionnaire Based Study to Evaluate the Safety of Flying in Hereditary Haemorrhagic Telangiectasia (HHT)|Completed||N/A|145|Actual|Imperial College London|||1||f||||f||||||||||2017-10-11 03:00:52.870012|2017-10-11 03:00:52.870012
NCT01590108|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2016-02-15|||March 2012||2012-03-01|April 2012|2012-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|EXAP||The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects|The Apelin-APJ System in Idiopathic Pulmonary Arterial Hypertension and Healthy Volunteers; Tissue Location and Cardiopulmonary Response.|Completed||Phase 1|12|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 03:00:52.945991|2017-10-11 03:00:52.945991
NCT01590095|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2016-10-27|||May 2012||2012-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||WASH Benefits Bangladesh|WASH Benefits Bangladesh: A Cluster Randomized Controlled Trial of the Benefits of Water, Sanitation, Hygiene Plus Nutrition Interventions on Child Growth|Active, not recruiting||N/A|5040|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||7|||f||||t||||||||||2017-10-11 03:00:53.037711|2017-10-11 03:00:53.037711
NCT01590069|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2016-12-05|||June 2012||2012-06-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Interventional|||Aerosol IL-2 for Pulmonary Metastases|Phase I/II Study of Aerosol Interleukin-2 for Pulmonary Metastases|Active, not recruiting||Phase 1/Phase 2|56|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:00:53.374146|2017-10-11 03:00:53.374146
NCT01590056|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-01|||March 2012||2012-03-01|May 2012|2012-05-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Emotional and Cognitive Subthalamic Nucleus in Deep Brain Stimulation Treated Parkinson Patients|Mapping and Manipulating the Motor, Emotional and Cognitive Territories of the Subthalamic Area in Deep Brain Stimulation Treated Parkinson Patients|Unknown status|Recruiting|N/A|20|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 03:00:53.470991|2017-10-11 03:00:53.470991
NCT01590043|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-09-06|||May 2012||2012-05-01|July 2012|2012-07-01||||May 2013|Anticipated|2013-05-01||Observational|||Identifying Saliva Markers in Inflammatory Bowel Disease||Unknown status|Recruiting|N/A|160|Anticipated|Hadassah Medical Organization|||3||f||||||||||Samples With DNA|"     Whole saliva   "|||2017-10-11 03:00:53.577891|2017-10-11 03:00:53.577891
NCT01590004|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-05-18|||August 2012||2012-08-01|May 2015|2015-05-01||||March 2016|Anticipated|2016-03-01||Observational|||Technical Description of Cooled Radiofrequency Ablation of Lumbar Medial Branches for the Treatment of Lumbar Facet Pain|Technical Description of Cooled Radiofrequency Ablation of Lumbar Medial Branches for the Treatment of Lumbar Facet Pain|Unknown status|Recruiting|N/A|10|Anticipated|MAPS Applied Research Center|||1||f||||t||||||||||2017-10-11 03:00:53.928294|2017-10-11 03:00:53.928294
NCT01589991|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-10-25|||January 2011||2011-01-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Anticaries Potential and Fluorosis Risk From Different Fluoride Toothpastes|Anticaries Potential and Fluorosis Risk From Different Fluoride Toothpastes|Completed||Phase 1|24|Actual|University of Campinas, Brazil||4|||f||||f||||||||||2017-10-11 03:00:54.028705|2017-10-11 03:00:54.028705
NCT01589978|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2017-02-01|2016-01-25||May 2012||2012-05-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|August 2014|Actual|2014-08-01||Interventional|||PROMUS Element Plus US Post-Approval Study|A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System|Active, not recruiting||Phase 4|2681|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 03:00:54.218263|2017-10-11 03:00:54.218263
NCT01589965|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-19|2012-05-01|||February 2010||2010-02-01|May 2012|2012-05-01|June 2012|Anticipated|2012-06-01|February 2010|Actual|2010-02-01||Interventional|||The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in Lesotho|The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence Among Youth: Evidence From a Randomized Controlled Field Trial in Lesotho|Unknown status|Active, not recruiting|Early Phase 1|5000|Anticipated|Bocconi University||3|||f||||t||||||||||2017-10-11 03:00:55.799812|2017-10-11 03:00:55.799812
NCT01589952|ClinicalTrials.gov processed this data on October 10, 2017|2012-05-01|2012-05-01|||March 2012||2012-03-01|May 2012|2012-05-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Interventional|Bangabandhu||Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)|Pilot Study of First Line Combination Treatment With Low Dose Pegylated Interferon and Entecavir in Treatment-naïve Patients With Chronic Hepatitis B.|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh||1|||f||||f||||||||||2017-10-11 03:00:55.890584|2017-10-11 03:00:55.890584
NCT01589939|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-05-13|||March 2009||2009-03-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Observational|PTV||Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization System|Reduced PTV Margins for the Treatment of Prostate Cancer With IMRT Using Real-Time, State-of-the-Art Motion Tracking With the Calypso 4D Localization System: A Feasibility Study|Active, not recruiting||N/A|40|Anticipated|U.S. Army Medical Research Acquisition Activity|||1||f||||t||||||||||2017-10-11 03:00:55.986956|2017-10-11 03:00:55.986956
NCT01589926|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-01|||July 2012||2012-07-01|May 2012|2012-05-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Bi-Level Positive Airway Ventilation for Acute Chest Syndrome|Early Bi-Level Positive Airway Pressure (BLPAP) Ventilation for Acute Chest Syndrome (ACS) - a Double-Blind Randomized Controlled Pilot Study|Unknown status|Not yet recruiting|N/A|60|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 03:00:56.059143|2017-10-11 03:00:56.059143
NCT01589913|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-05-08|||May 2012||2012-05-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2015|Actual|2015-11-01||Interventional|REACH-ICD||REmote Web Assisted Care for Heart Failure Patients With Implantable Cardioverter Defibrillators|Remote Care for Reducing Cardiac Fear, Fear of Dying, Depression, and Increasing Quality of Life in ICD‐Patients With Cardiac Insufficiency/at Risk for Fatal Cardiac Arrhythmia.|Active, not recruiting||N/A|118|Actual|Wuerzburg University Hospital||2|||f||||t||||||||No||2017-10-11 03:00:56.17569|2017-10-11 03:00:56.17569
NCT01589900|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-02|||January 2005||2005-01-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|December 2006|Actual|2006-12-01||Observational|||Identification the Expression of Sox2 in Colorectal Cancer Tissues|The Role of Sox2 in Tumor Genesis and Migration in Colorectal Cancer|Completed||N/A|136|Actual|Sun Yat-sen University|||1||f||||t||||||||||2017-10-11 03:00:56.31091|2017-10-11 03:00:56.31091
NCT01589874|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-04-30|||January 2008||2008-01-01|April 2012|2012-04-01|December 2014|Anticipated|2014-12-01|March 2012|Actual|2012-03-01||Observational|||Anemia of Inflammation: Investigation on Impaired Iron Regulation in Acutely Ill Patients and Their Clinical Outcome|Anemia of Inflammation: Investigation on Impaired Iron Regulation in Acutely Ill Patients and Their Clinical Outcome|Unknown status|Recruiting|N/A|100|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||1||f||||t||||||Samples With DNA|"     serum, buffy coat   "|||2017-10-11 03:00:56.374274|2017-10-11 03:00:56.374274
NCT01589861|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-03-27|||December 2011||2011-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PIKHER2||Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer|A Phase Ib/II Open-label Study Evaluating Safety and Efficacy of Oral BKM120 in Combination With Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Locally Advanced, Recurrent and Metastatic Breast Cancer. PIKHER2/IPC 2011-001|Suspended||Phase 1/Phase 2|106|Anticipated|Institut Paoli-Calmettes||1||Data analysis|f||||t||||||||||2017-10-11 03:00:56.471728|2017-10-11 03:00:56.471728
NCT01589848|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-07-02|||March 2013||2013-03-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|VWD||Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador|Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador|Completed||N/A|81|Actual|Universidad del Azuay|||1||f||||t||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 03:00:56.56439|2017-10-11 03:00:56.56439
NCT01589835|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2014-03-04|||July 2012||2012-07-01|March 2014|2014-03-01||||October 2013|Actual|2013-10-01||Interventional|FLIP||Preventing Diabetes in Those at Risk by Having a Facilitator and Family Doctor Encourage Healthy Activity and Eating Habits|Preventing Diabetes With Facilitated Lifestyle Intervention Prescriptions.Phase 2: Pilot Study|Completed||Phase 2|59|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:00:56.64843|2017-10-11 03:00:56.64843
NCT01589822|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-02-24|2014-07-16||June 2012||2012-06-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|January 2014|Actual|2014-01-01||Interventional||Subjects enrolled who consented and were randomized into the study or assigned to the non-randomized portion and had the investigational product applied were included in the analysis sets. The Safety Set consists of 125 subjects treated with EVICEL (41 Non- Randomized) and 89 subjects treated with Standard of Care.|The EVICEL® Gastrointestinal Study|A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques|Completed||Phase 2|214|Actual|Ethicon, Inc.||3|||f||||t||||||||||2017-10-11 03:00:56.780096|2017-10-11 03:00:56.780096
NCT01589796|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-04-30|||April 2012||2012-04-01|April 2012|2012-04-01||||February 2013|Anticipated|2013-02-01||Interventional|||Medial Versus Traditional Approach to US-guided TAP Blocks for Open Inguinal Hernia Repair|Effect of Medial vs Traditional Approach to US-guided Transverse Abdominis Plane (TAP) Blocks on Analgesia After Open Inguinal Hernia Repair|Unknown status|Recruiting|N/A|100|Anticipated|Stamford Anesthesiology Services, PC||2|||f||||t||||||||||2017-10-11 03:00:58.372665|2017-10-11 03:00:58.372665
NCT01589783|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2015-07-26|||May 2012||2012-05-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Observational|||Vitamin D During Pregnancy|Evaluation of the Influence of Education, Knowledge and Existing Guidelines on the Consumption of Vitamin D During Pregnancy.|Completed||N/A|764|Actual|Hadassah Medical Organization|||2||f||||f||||||||||2017-10-11 03:00:58.476456|2017-10-11 03:00:58.476456
NCT01589770|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-10-31|||August 2012||2012-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Inflammation and the Heart|Inflammation and the Heart|Active, not recruiting||N/A|345|Anticipated|Vanderbilt University|||2||f||||f||||||Samples With DNA|"     serum plasma DNA RNA   "|||2017-10-11 03:00:58.560033|2017-10-11 03:00:58.560033
NCT01589757|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-05-19|||October 2011||2011-10-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|GIinGDM||MAIN STUDY: Low Glycaemic Index (GI) Diet in the Management of GDM SUB-STUDY: The Breast Milk Sub-Study|The Effect of a Low GI Diet on Maternal and Neonatal Markers of Glycaemic Control and Postpartum Diabetes Risk SUBSTUDY The Effect of a Low GI Diet on Postpartum Markers of Oxidation in Breast Milk of Women With Gestational Hyperglycaemia|Completed||Phase 2/Phase 3|99|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 03:00:58.665663|2017-10-11 03:00:58.665663
NCT01589744|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-10-17|||July 2012||2012-07-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|HEMOGYN||Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta Assisted|Vacuum Device for Hemostasis in Obstetrics and Gynecology: Proof of Concept Study in the Post Partum Hemorrhage|Terminated||N/A|1|Actual|University Hospital, Grenoble||1||Non adequation between the medical device and the study population|f||||t||||||||||2017-10-11 03:00:58.845468|2017-10-11 03:00:58.845468
NCT01589731|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-04-30|||July 2010||2010-07-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Observational|ImmuneBLG||Polymerized Beta-lactoglobulin Comparative Immunoreactivity|Study of the Immunoreactivity of Native and Polymerized Beta-lactoglobulin in Children and Adults With Cow's Milk Allergy and/or Intolerance|Completed||N/A|114|Actual|University of Campinas, Brazil|||3||f||||f||||||||||2017-10-11 03:00:58.934933|2017-10-11 03:00:58.934933
NCT01589718|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2014-03-04|||April 2012||2012-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|No-Crunch01||A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy|A Phase III Randomized 1:1, Masked, Study of the Safety, Tolerability, and Efficacy of Intravitreal Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Adjuvant Management of TRD and Vit Hem Associated With PDR|Withdrawn||Phase 3|0|Actual|Greater Houston Retina Research||2||No patients were enrolled|f||||t||||||||||2017-10-11 03:00:59.049068|2017-10-11 03:00:59.049068
NCT01589705|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-07-29|||January 2012||2012-01-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||The Relation Between Uric Acid Level and Endothelial Dysfunction in Patients With Polycystic Kidney Disease|Endothelial Dysfunction in Patients With Polycystic Kidney Disease|Terminated||N/A|150|Actual|TC Erciyes University|||1|Patients recruitment and analysis were terminated|f||||f||||||||||2017-10-11 03:00:59.158761|2017-10-11 03:00:59.158761
NCT01589692|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-08-21|||April 2012||2012-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|WRIST||A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures|A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures. The Wrist and Radius Injury Surgical Trial (WRIST)|Active, not recruiting||N/A|623|Anticipated|University of Michigan||4|||f||||t|f|f||||||||2017-10-11 03:00:59.268261|2017-10-11 03:00:59.268261
NCT01589679|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-08-08|||April 2012||2012-04-01|August 2013|2013-08-01||||May 2016|Anticipated|2016-05-01||Interventional|Bunionectomy||Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial|Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial|Terminated||N/A|40|Actual|Dynasplint Systems, Inc.||2||Unrelated to Trial|f||||f||||||||||2017-10-11 03:00:59.432373|2017-10-11 03:00:59.432373
NCT01589666|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-02-06|||November 2013||2013-11-01|February 2017|2017-02-01|September 9, 2016|Actual|2016-09-09|September 9, 2016|Actual|2016-09-09||Interventional|||Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers|Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers|Completed||Phase 1|27|Actual|Entegrion, Inc.||1|||f||||t||||||||||2017-10-11 03:00:59.515521|2017-10-11 03:00:59.515521
NCT01589653|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-06-08|2016-06-29||May 26, 2012|Actual|2012-05-26|June 2017|2017-06-01|July 9, 2015|Actual|2015-07-09|July 9, 2015|Actual|2015-07-09||Interventional|||Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients|A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin|Completed||Phase 4|155|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:00:59.618771|2017-10-11 03:00:59.618771
NCT01589640|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-05-01|||May 2012||2012-05-01|April 2012|2012-04-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Observational|||Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance|Phase 4 Study Accessing Patient Satisfaction and Tear Osmolarity While Using Blink Tears, Blink Gel Tears and Systane Balance|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Ophthalmic Consultants of Connecticut|||3||f||||f||||||||||2017-10-11 03:01:00.189555|2017-10-11 03:01:00.189555
NCT01589627|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-04-30||||||April 2012|2012-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Wrist Extension Dynasplint (WED) Distal Radius Fracture|Contracture Reduction Following Distal Radius Fracture|Unknown status|Not yet recruiting|N/A|50|Anticipated|Dynasplint Systems, Inc.||2|||f||||||||||||||2017-10-11 03:01:00.291218|2017-10-11 03:01:00.291218
NCT01588067|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2015-07-06|||May 2011||2011-05-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|PAD||Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease|Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease.|Completed||N/A|271|Actual|Kaiser Permanente|||3||f||||f||||||||||2017-10-11 03:01:25.551233|2017-10-11 03:01:25.551233
NCT01589614|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2012-08-16|||June 2012||2012-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804|A Phase 1, Randomised, Open Label, Two Sequence, Two Treatment, Two Way Crossover Study to Estimate the Steady-state Effect of Erythromycin on the Single Dose Pharmacokinetics of Ph-797804 in Healthy Subjects|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:01:00.415903|2017-10-11 03:01:00.415903
NCT01589601|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-04-28|2017-02-27||August 2012||2012-08-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PAL-HF||Palliative Care in Heart Failure|Palliative Care in Heart Failure (PAL-HF)|Completed||N/A|150|Actual|Duke University||2|||f||||t||||||||||2017-10-11 03:01:00.587129|2017-10-11 03:01:00.587129
NCT01589588|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-10-09|||April 2012||2012-04-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Administration of Oxygen to Cluster Headache Patients||Completed||N/A|57|Actual|Danish Headache Center||4|||f||||||||||||||2017-10-11 03:01:01.246559|2017-10-11 03:01:01.246559
NCT01589575|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-03-30|||September 2012||2012-09-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|StressRéa||Anxiety and Depression in Relatives of Critically Ill Patients: Spouses Versus Other Close Relatives|Evaluation of the Impact of Symptoms of Anxiety and Depression in Relatives of Critically Ill Patients: Spouses Versus Other Close Relatives|Completed||N/A|208|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 03:01:01.358103|2017-10-11 03:01:01.358103
NCT01589562|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2013-01-21|||April 2012||2012-04-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition|A Randomized, Open Label, Single Dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of DW-ES(B) and Megace® Under Fed Conditions in Healthy Male Volunteers|Completed||Phase 1|28|Anticipated|Daewon Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:01:01.532333|2017-10-11 03:01:01.532333
NCT01589549|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-06-08|||April 2012||2012-04-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Mesenchymal Stromal Cells for Acute Graft Versus Host Disease|A Phase 2 Trial of Standard of Care Treatment Versus Mesenchymal Stromal Cell Therapy Together With Standard of Care for the Treatment of de Novo Acute Graft Versus Host Disease Following Allogeneic Bone Marrow Transplantation|Unknown status|Recruiting|Phase 2|66|Anticipated|Royal Perth Hospital||2|||f||||t||||||||||2017-10-11 03:01:01.680495|2017-10-11 03:01:01.680495
NCT01589536|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-05-01|||October 2011||2011-10-01|April 2012|2012-04-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|SINKO||Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval Rehabilitation.|Improvement of the Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity by the Use of Interval Rehabilitation.|Unknown status|Recruiting|N/A|480|Anticipated|Clinic Roderbirken||2|||f||||t||||||||||2017-10-11 03:01:01.798709|2017-10-11 03:01:01.798709
NCT01589523|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-12-06|||February 2006||2006-02-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis|Conjugated Cholic Acid for the Treatment of Inborn Errors in Bile Acid Synthesis Involving Side-Chain Conjugation|Enrolling by invitation||Phase 3|20|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 03:01:01.982535|2017-10-11 03:01:01.982535
NCT01589510|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2014-05-15|2014-01-21||April 2012||2012-04-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)||Completed||N/A|419|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:01:02.159917|2017-10-11 03:01:02.159917
NCT01589497|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2017-03-24|2017-01-24||June 2015||2015-06-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional||Intent to treat: All enrolled 69 participants were included in the baseline characteristics.|Essentiality of INH in TB Therapy|Essentiality of Isoniazid in Tuberculosis Therapy|Completed||Phase 2|69|Actual|AIDS Clinical Trials Group||4|||f||||t||||||||||2017-10-11 03:01:02.572326|2017-10-11 03:01:02.572326
NCT01589484|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2014-12-17|2014-12-05||April 2012||2012-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Impact of Renal Anatomy on Shock Wave Lithotripsy Outcomes for Lower Pole Kidney Stones|Impact of Renal Anatomy on Shock Wave Lithotripsy Outcomes for Lower Pole Kidney Stones: Results From a Prospective Multifactorial Analysis|Completed||N/A|104|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 03:01:03.832291|2017-10-11 03:01:03.832291
NCT01589471|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-05-07|||May 2012||2012-05-01|May 2015|2015-05-01|November 2015|Anticipated|2015-11-01|October 2015|Anticipated|2015-10-01||Interventional|||The Value of Botox-A for Management of Low Anterior Resection Syndrome|The Value of Botox-A Administered as a Single Intra-rectal Injection for the Management of Low Anterior Resection Syndrome: A Phase II Study|Unknown status|Active, not recruiting|Phase 2|23|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 03:01:04.108823|2017-10-11 03:01:04.108823
NCT01589458|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2012-05-01|||August 2011||2011-08-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Fluoride Availability in Saliva After Use of Sodium Fluoride or Monofluorophosphate Toothpastes|Fluoride Availability in Saliva After Use of NaF or MFP Toothpastes|Completed||Phase 1|12|Actual|University of Campinas, Brazil||3|||f||||f||||||||||2017-10-11 03:01:04.2585|2017-10-11 03:01:04.2585
NCT01589445|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2014-02-26|2012-05-05||November 2008||2008-11-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|T2DMCT||Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects|Modulation of Insulin Secretion and Insulin Sensitivity in Bangladeshi Type 2 Diabetic Subjects by an Insulin Sensitizer Pioglitazone and T2DM Association With PPARG Gene Polymorphism.|Completed||Phase 4|77|Actual|University of Dhaka|The sample size was relatively small for more detailed analysis, treatment period was also short and there was a possibility of confounding by the use of non-study medication.|2|||f||||t||||||||||2017-10-11 03:01:04.374928|2017-10-11 03:01:04.374928
NCT01587690|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-11-19|||November 2011||2011-11-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells|Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells|Completed||N/A|24|Actual|Rutgers, The State University of New Jersey|||3||f||||f||||||Samples With DNA|"     peripheral blood   "|||2017-10-11 03:01:33.055331|2017-10-11 03:01:33.055331
NCT01589432|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2013-01-02|||April 2012||2012-04-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy|A Randomized, Double-blind, Placebo and Active-controlled Study of the Electrophysiological Effects of ABT-639 on Spontaneous Activity in C-Nociceptors in Patients With Painful Diabetic Peripheral Neuropathy|Completed||Phase 2|39|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 03:01:05.020606|2017-10-11 03:01:05.020606
NCT01589419|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-30|2015-01-20|||June 2012||2012-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer|An Open-Label Phase 1b Study of the Safety and Tolerability of Veliparib in Combination With Capecitabine and Radiation in Subjects With Locally Advanced Rectal Cancer (LARC)|Completed||Phase 1|32|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 03:01:05.136389|2017-10-11 03:01:05.136389
NCT01589406|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2012-05-01|||June 2012||2012-06-01|April 2012|2012-04-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||Quality of Life and Sexuality in Women With Gynaecological Cancer|Quality of Life and Sexuality in Women With Gynaecological Cancer|Unknown status|Not yet recruiting|N/A|100|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 03:01:05.259253|2017-10-11 03:01:05.259253
NCT01589393|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-05-08|||September 2010||2010-09-01|April 2012|2012-04-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|OPTTTICH||OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Study)|OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Study)|Unknown status|Active, not recruiting|N/A|30|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 03:01:05.333487|2017-10-11 03:01:05.333487
NCT01589380|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2012-04-30|||April 2012||2012-04-01|April 2012|2012-04-01|December 2014|Anticipated|2014-12-01|May 2013|Anticipated|2013-05-01||Interventional|ALFA||A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)|Safety and Efficacy of Angiotensin Receptor Blocker, Fimasartan, on Patients With Aortic Stenosis|Unknown status|Recruiting|Phase 4|100|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:01:05.459602|2017-10-11 03:01:05.459602
NCT01589367|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-11-18|||May 2012||2012-05-01|June 2015|2015-06-01|April 2017|Anticipated|2017-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer|Phase II Randomized Study of Neoadjuvant Metformin Plus Letrozole vs Placebo Plus Letrozole for ER-positive Postmenopausal Breast Cancer|Unknown status|Recruiting|Phase 2|208|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:01:05.705445|2017-10-11 03:01:05.705445
NCT01589354|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2012-04-30|||May 2012||2012-05-01|April 2012|2012-04-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Effectiveness of Interscalene Brachial Plexus Block and Intra-articular Injection of Ropivacaine for Post-operative Analgesia in Arthroscopic Shoulder Stabilization Surgery|Effectiveness of Interscalene Brachial Plexus Block and Intra-articular Injection of Ropivacaine for Post-operative Analgesia in Arthroscopic Shoulder Stabilization Surgery|Unknown status|Not yet recruiting|N/A|60|Anticipated|NHS Grampian||2|||f||||f||||||||||2017-10-11 03:01:05.864731|2017-10-11 03:01:05.864731
NCT01589341|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-29|2016-05-17|||April 2012||2012-04-01|May 2016|2016-05-01||||August 2012|Actual|2012-08-01||Observational|||Studying Chromosomes in Samples From Younger Patients With Neuroblastoma|Prognostic Impact of Segmental Chromosome Aberrations in Non MYCN Amplified Neuroblastomas in Different Age Groups|Completed||N/A|300|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     tumor tissue   "|||2017-10-11 03:01:05.955573|2017-10-11 03:01:05.955573
NCT01589328|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-09-20|||April 2012||2012-04-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|EPADE-PB||Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB|Randomized Controlled Trials for the Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB|Recruiting||Phase 3|288|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||No||2017-10-11 03:01:06.040595|2017-10-11 03:01:06.040595
NCT01589315|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-04-29|||January 2007||2007-01-01|April 2012|2012-04-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|FEAST||Focal Electroconvulsive Therapy for Depression|Focal Electrical Administered Seizure Therapy (FEAST) for Major Depression|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Medical University of South Carolina||1|||f||||f||||||||||2017-10-11 03:01:06.127822|2017-10-11 03:01:06.127822
NCT01589302|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-03-20|||May 21, 2012|Actual|2012-05-21|March 2017|2017-03-01|December 31, 2019|Anticipated|2019-12-31|July 28, 2016|Actual|2016-07-28||Interventional|||PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia|A Phase 2 Study of the Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI-32765(Ibrutinib), in Relapsed and Refractory Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) and B-cell Prolymphocytic Leukemia (B-PLL)|Active, not recruiting||Phase 2|78|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:01:06.220363|2017-10-11 03:01:06.220363
NCT01589289|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-01-15|||September 2012||2012-09-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|Nidiag-Neuro||Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC|Rapid Diagnostic Tests in Association With Clinical and Laboratory Predictors for the Diagnosis of Neglected Tropical Diseases in Patients With Neurological Disorders in Rural Hospitals of Bandundu,Democratic Republic of Congo|Completed||Phase 3|352|Actual|Institute of Tropical Medicine, Belgium||1|||f||||f||||||||||2017-10-11 03:01:06.342997|2017-10-11 03:01:06.342997
NCT01589276|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-04-28|||January 2007||2007-01-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Observational|||Risk Factors and Results of Emergency Ventral Hernia Repair|Risk Factors and Results of Emergency Ventral Hernia Repair|Completed||N/A|10976|Actual|University Hospital Koge|||2||f||||f||||||||||2017-10-11 03:01:06.51453|2017-10-11 03:01:06.51453
NCT01589237|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-09-26|2016-06-17||February 2013||2013-02-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Full analysis set (FAS) – All subjects in the extension study who were in full analysis set in either study LCQ908A2212/NCT01146522 or LCQ908B2302/NCT01514461.|Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.|An Open Label, 52-week, Safety and Tolerability Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.|Terminated||Phase 3|38|Actual|Novartis|As the anticipated benefit from the continued participation of patients in 18 month extension (Part B) was not supported by results of the December 2014 interim analysis, Novartis decided to terminate the Part B to be effective as of May 31, 2015.|1||"Interim analysis suggested that size of benefit anticipated from continued participation of   patients in Part B no longer supported trial extension beyond Part A"|f||||f||||||||||2017-10-11 03:01:06.87821|2017-10-11 03:01:06.87821
NCT01589224|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-10-12|||May 2012||2012-05-01|April 2012|2012-04-01||||August 2012|Actual|2012-08-01||Observational|||Risk Factor Analysis for Coronary Atherosclerosis Measured by MDCT||Completed||N/A|150|Actual|Korea University|||1||f||||t||||||||||2017-10-11 03:01:09.228397|2017-10-11 03:01:09.228397
NCT01589211|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-04-30|||December 2011||2011-12-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|November 2012|Anticipated|2012-11-01||Interventional|BISQUITS||Brief Intervention Study for Quitting Smoking||Unknown status|Enrolling by invitation|N/A|800|Anticipated|Heidelberg University||3|||f||||f||||||||||2017-10-11 03:01:09.319084|2017-10-11 03:01:09.319084
NCT01589198|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-03-27|||January 2012||2012-01-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma|Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma|Completed||N/A|110|Actual|National Jewish Health|||1||f||||f||||||Samples Without DNA|"     Blood and lung samples will be retained for RNA purposes.   "|||2017-10-11 03:01:09.445689|2017-10-11 03:01:09.445689
NCT01589185|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2016-09-21|||April 2012||2012-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)|A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, Efficacy and Pharmacodynamics of KBSA301 in Severe Pneumonia (S. Aureus)|Completed||Phase 1/Phase 2|48|Actual|Aridis Pharmaceuticals, Inc.||5|||f||||t||||||||||2017-10-11 03:01:09.535028|2017-10-11 03:01:09.535028
NCT01589172|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-05-28|||May 2012||2012-05-01|May 2015|2015-05-01||||||||Observational|||Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury|Evaluating the Use of Thromboelastography to Diagnose and Monitor Coagulopathy Associated With Pediatric Traumatic Brain Injury|Unknown status|Recruiting|N/A|40|Anticipated|University of California, San Diego|||1||f||||f||||||||||2017-10-11 03:01:09.713136|2017-10-11 03:01:09.713136
NCT01589159|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-28|2017-02-24|||January 2013|Actual|2013-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|July 2016|Actual|2016-07-01||Interventional|||A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes|A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes|Completed||Phase 2|54|Actual|Peking University||1|||f||||t||||||||||2017-10-11 03:01:09.801428|2017-10-11 03:01:09.801428
NCT01589146|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-28|2012-04-28|||September 2010||2010-09-01|April 2012|2012-04-01||||December 2012|Anticipated|2012-12-01||Interventional|PRO-LAPS I||ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.|ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS IN PATIENTS WITH COLORECTAL CANCER UNDERGOING LAPAROSCOPIC SURGERY: INCIDENCE OF VENOUS THROMBOEMBOLISM AND BLEEDING COMPLICATIONS. THE PRO-LAPS STUDY.|Unknown status|Recruiting|Phase 3|400|Anticipated|University Of Perugia||2|||f||||f||||||||||2017-10-11 03:01:09.886703|2017-10-11 03:01:09.886703
NCT01589133|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-05-29|||May 2012||2012-05-01|April 2012|2012-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Surgiscreen Registration|A Multi-center Clinical Study for Assessment of the Consistency of the Results of Human Irregular Antibody Screening With Surgiscreen and Serascan Diana 3|Completed||N/A|3109|Actual|Johnson & Johnson Medical, China|||1||f||||f||||||Samples Without DNA|"     Plasma or Serum left after routine clinical testing.   "|||2017-10-11 03:01:09.977794|2017-10-11 03:01:09.977794
NCT01589120|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-28|2012-05-01|||April 2012||2012-04-01|May 2012|2012-05-01||||April 2014|Anticipated|2014-04-01||Interventional|VIDEO-HF||Using Videos to Facilitate Advance Care Planning for Patients With Heart Failure|Using Videos to Facilitate Advance Care Planning for Patients With Heart Failure|Unknown status|Recruiting|N/A|248|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:01:10.071949|2017-10-11 03:01:10.071949
NCT01589107|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-28|2012-05-01|||December 2011||2011-12-01|May 2012|2012-05-01||||December 2012|Anticipated|2012-12-01||Interventional|||A Randomized Controlled Trial of a Video Decision Making Aid to Obtain Informed Consent in the Surgical Intensive Care Unit|A Randomized Controlled Trial of a Video Decision Making Aid to Obtain Informed Consent in the Surgical Intensive Care Unit|Unknown status|Recruiting|N/A|52|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:01:10.21102|2017-10-11 03:01:10.21102
NCT01589094|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-05-05|||April 2012||2012-04-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer|Phase II Study of Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer|Active, not recruiting||Phase 2|46|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:01:10.333712|2017-10-11 03:01:10.333712
NCT01589081|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-01-14|||September 2008||2008-09-01|January 2013|2013-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect|Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect|Suspended||N/A|45|Anticipated|Mclean Hospital||2||Clinical studies are stopped, pending funding.|f||||f||||||||||2017-10-11 03:01:10.457808|2017-10-11 03:01:10.457808
NCT01589068|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-01-14|||January 2007||2007-01-01|January 2013|2013-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effects of Progesterone on IV Nicotine Induced Changes on BOLD fMRI Signal, Hormones and Subjective Ratings of Stimulant Drugs||Suspended||N/A|300|Anticipated|Mclean Hospital||3||Clinical studies stopped, pending funding.|f||||f||||||||||2017-10-11 03:01:10.558916|2017-10-11 03:01:10.558916
NCT01589029|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-11-23|||April 2012||2012-04-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|ILARIS||A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)|A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)|Terminated||Phase 1|6|Actual|Triemli Hospital||1||The results of the interim analysis showed that the primary endpoint was not met|f||||t||||||||||2017-10-11 03:01:10.868279|2017-10-11 03:01:10.868279
NCT01589016|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-09-18|||April 2012||2012-04-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Activin A and Inhibin A in Predicting Outcome of Pregnancies of Unknown Location After Assisted Reproductive Technology|Single Determination of Serum Activin A and Inhibin A in Predicting the Outcome of Pregnancies of Unknown Location (PUL) After IVF and Oocyte Donation.|Completed||N/A|96|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA|||3||f||||f||||||None Retained|"     Blood samples are to be taken at the time of the first ultrasound examination and stored at     -20ºC. Inhibin A and activin A to be determined by ELISA. β-hCG and P were also determined     using Microparticle Enzyme Inmunoassay (MEIA).   "|||2017-10-11 03:01:10.954166|2017-10-11 03:01:10.954166
NCT01589003|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-04-30|||April 2012||2012-04-01|April 2012|2012-04-01|February 2013|Anticipated|2013-02-01|October 2012|Anticipated|2012-10-01||Interventional|||The Impact of Milk-products Differing in Their Glycaemic Properties on the Behaviour of Infants|An Intervention Study to Consider the Impact of Milk-products Differing in Their Glycaemic Properties on the Behaviour of Infants.|Unknown status|Recruiting|N/A|70|Anticipated|International Medical University||2|||f||||t||||||||||2017-10-11 03:01:11.055424|2017-10-11 03:01:11.055424
NCT01588977|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-08-02|||April 2012||2012-04-01|August 2016|2016-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Observational|||Subchondral Microfracture of Tibia After Arthroscopic Anterior Cruciate Ligament Surgery Reconstruction|Subchondral Microfracture of Tibia After Arthroscopic Anterior Cruciate Ligament Surgery Reconstruction With Two Different Drilling Techniques. Correlation With Postoperative Pain|Completed||N/A|43|Actual|Hospital Ambroise Paré Paris|||3||f||||f||||||||||2017-10-11 03:01:11.358868|2017-10-11 03:01:11.358868
NCT01588964|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-28|||March 2005||2005-03-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|IPHC||IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer|Surgery and Intraperitoneal Hyperthermic Chemotherapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer .|Completed||Phase 2|30|Actual|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-11 03:01:11.433604|2017-10-11 03:01:11.433604
NCT01588951|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-05-01|2017-05-01||August 2013|Actual|2013-08-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior|Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior|Terminated||Phase 2/Phase 3|10|Actual|Sidney Kimmel Comprehensive Cancer Center||3|||f||||f||||||||No||2017-10-11 03:01:11.522858|2017-10-11 03:01:11.522858
NCT01588938|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-05-13|||December 2009||2009-12-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|September 2016|Anticipated|2016-09-01||Observational|||External Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the Prostate||Active, not recruiting||N/A|20|Anticipated|U.S. Army Medical Research Acquisition Activity|||1||f||||t||||||||||2017-10-11 03:01:11.986937|2017-10-11 03:01:11.986937
NCT01588925|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-10-02|||November 2011||2011-11-01|March 2013|2013-03-01|January 2014|Actual|2014-01-01|February 2013|Actual|2013-02-01||Interventional|||Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation|Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation|Completed||Phase 2|18|Actual|University of Sao Paulo General Hospital||3|||f||||f||||||||||2017-10-11 03:01:12.071426|2017-10-11 03:01:12.071426
NCT01588912|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-04-30|||April 2012||2012-04-01|April 2012|2012-04-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|TETRA||Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir|A Randomized, Prospective, Multicenter, Open-label Study to Evaluate the Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir in HBeAg-positive Chronic Hepatitis B Patients|Unknown status|Recruiting|Phase 4|104|Anticipated|Pusan National University Yangsan Hospital||2|||f||||f||||||||||2017-10-11 03:01:12.170096|2017-10-11 03:01:12.170096
NCT01588899|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-10-21|||May 2012||2012-05-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids|China Clinical Trial for Therapeutic MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids|Completed||N/A|107|Actual|Philips Healthcare||1|||f||||t||||||||||2017-10-11 03:01:12.331781|2017-10-11 03:01:12.331781
NCT01588886|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-02-15|||March 2012||2012-03-01|November 2013|2013-11-01|August 2015|Actual|2015-08-01|June 2012|Actual|2012-06-01||Observational|||Proton Pump Inhibitor Use is Associated With High Risk of Pneumonia in Chronic Kidney Disease Patients|Institute of Emergency and Critical Care Medicine , School of Yang-Ming University|Completed||N/A|9000|Actual|Far Eastern Memorial Hospital|||2||f||||t||||||||||2017-10-11 03:01:12.461271|2017-10-11 03:01:12.461271
NCT01588873|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-05-03|||April 2012||2012-04-01|May 2012|2012-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome|The Effects of Contraceptive Pill and Hormonal Vaginal Ring on Hormonal, Inflammatory and Metabolic Parameters in Women of Reproductive Age With Polycystic Ovary Syndrome (PCOS).|Recruiting||Phase 4|42|Anticipated|University of Oulu||2|||f||||f||||||||||2017-10-11 03:01:12.54052|2017-10-11 03:01:12.54052
NCT01588860|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-04-30|||January 2011||2011-01-01|December 2010|2010-12-01||||December 2011|Actual|2011-12-01||Observational|||Mutation Analysis and Copy Number Changes of KRAS and BRAF Gene in Taiwanese Cases of Biliary Tact Adenocarcinoma|Mutation Analysis and Copy Number Changes of KRAS and BRAF Gene in Taiwanese Cases of Biliary Tact Adenocarcinoma|Unknown status|Active, not recruiting|N/A|100|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||Samples Without DNA|"     Fixed tissue in the paraffin embedded blocks   "|||2017-10-11 03:01:12.679554|2017-10-11 03:01:12.679554
NCT01588847|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2014-12-10|||March 2012||2012-03-01|December 2014|2014-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Anesthesia and Cancer Recurrence im Malignant Melanoma|Long-term Outcome After Radical Lymph Node Dissection of Malignant Melanoma. Comparison Between Regional Versus General Anesthesia With Respect to Impact of Perioperative Immunoediting and Validation of New Potential Predictive Biomarkers|Recruiting||N/A|230|Anticipated|University Hospital Muenster||2|||f||||f||||||||||2017-10-11 03:01:12.735853|2017-10-11 03:01:12.735853
NCT01588834|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-05-19|||April 2012||2012-04-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Histology of Functional Density in Premenopausal Breast|Pilot Study to Examine Histological Characteristics of Mammographic Density With Molecular Breast Imaging: Part 2 - Premenopausal Women|Completed||Phase 3|23|Actual|Mayo Clinic|||1||f||||t||||||Samples Without DNA|"     core biopsy samples from mammographically dense breast tissue   "|||2017-10-11 03:01:12.828518|2017-10-11 03:01:12.828518
NCT01588821|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-09-26|||June 2012||2012-06-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|January 2017|Actual|2017-01-01||Interventional|||Cabozantinib in Advanced Solid Malignancies|Phase II Trial of Cabozantinib (XL184) in Patients With Advanced Solid (Non-breast, Non-prostate) Malignancies and Bony Metastases|Active, not recruiting||Phase 2|38|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:01:12.924529|2017-10-11 03:01:12.924529
NCT01588808|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-07-09|||May 2012||2012-05-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|IM-PRO||Immobilization and Protein Supplementation (IM-PRO)|The Impact of Dietary Protein Supplementation and Age on Muscle Mass Loss During Short Term One-legged Knee Immobilization|Completed||N/A|35|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 03:01:13.022424|2017-10-11 03:01:13.022424
NCT01588795|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-05-30|||April 2012||2012-04-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|DERENEDIAB||Renal Denervation in Diabetic Nephropathy|Renal Denervation in Patients With Diabetic Nephropathy and Persistent Proteinuria|Completed||Phase 4|25|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:01:13.125514|2017-10-11 03:01:13.125514
NCT01588782|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-11-23|||January 2012||2012-01-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men|An Open-Label Drug-Drug Interaction Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone (JNJ-589485) Following Administration of Abiraterone Acetate (JNJ-212082) Tablets in Healthy Male Subjects|Completed||Phase 1|20|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 03:01:13.220242|2017-10-11 03:01:13.220242
NCT01588769|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2016-06-03|||August 2011||2011-08-01|June 2016|2016-06-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|ALECSAT-GBM||A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients|A Phase I Study to Investigate Tolerability and Efficacy of Autologous Lymphoid Effector Cells Specific Against Tumour-cells (ALECSAT) Administered to Patients With Glioblastoma Multiforme (GBM)|Completed||Phase 1|23|Actual|CytoVac A/S||1|||f||||f||||||||Undecided||2017-10-11 03:01:13.317782|2017-10-11 03:01:13.317782
NCT01588756|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-02-27|||October 2010|Actual|2010-10-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|AcSDKP-NH2||Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)|Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)|Completed||Phase 1/Phase 2|100|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:01:13.407258|2017-10-11 03:01:13.407258
NCT01588743|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2012-04-30|||October 2008||2008-10-01|April 2012|2012-04-01||||December 2012|Anticipated|2012-12-01||Interventional|||Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Patients|Effects of Short-term Intensive Insulin Therapy on Insulin Resistance and Insulin Secretion in Newly Diagnosed Lean and Obese Type 2 Diabetes Patients|Unknown status|Active, not recruiting|N/A|130|Anticipated|China-Japan Friendship Hospital||1|||f||||||||||||||2017-10-11 03:01:14.969106|2017-10-11 03:01:14.969106
NCT01588730|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-08-08|||June 2011||2011-06-01|August 2013|2013-08-01||||June 2015|Anticipated|2015-06-01||Interventional|||Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy|Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy|Terminated||Phase 4|26|Actual|Dynasplint Systems, Inc.||2|||f||||t||||||||||2017-10-11 03:01:15.069341|2017-10-11 03:01:15.069341
NCT01588717|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-08-24|||April 2012||2012-04-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|AIDES-G||Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G)|A Pilot Study to Measure and Treat Antidepressant-Induced Excessive Sweating With Glycopyrrolate (AIDES-G)|Terminated||Phase 1|5|Actual|Thomas Jefferson University||1||PI left institution|f||||f||||||||||2017-10-11 03:01:15.15096|2017-10-11 03:01:15.15096
NCT01588704|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-01-21|||April 2012||2012-04-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma|A Phase II Study of Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma|Completed||Phase 2|42|Actual|Sun Yat-sen University||1|||f||||f||||||||||2017-10-11 03:01:15.227593|2017-10-11 03:01:15.227593
NCT01588691|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-03-20|||December 2011||2011-12-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|TBI||Traumatic Brain Injury Peripheral Nerve Study|A Feasibility Study to Examine the Efficacy of C2-C3 Dermatomal Peripheral Nerve Stimulation in Cognitive Improvements Following Persistent Impairment After Traumatic Brain Injury|Completed||Phase 1|3|Actual|St. Jude Medical||3|||f||||f||||||||||2017-10-11 03:01:15.312173|2017-10-11 03:01:15.312173
NCT01588678|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-04-02|||April 2012||2012-04-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas|A Phase 1, Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas|Completed||Phase 1|32|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-11 03:01:15.409784|2017-10-11 03:01:15.409784
NCT00005691|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1992||1992-09-01|July 2001|2001-07-01|August 1996|Actual|1996-08-01|||||Observational|||Psychosocial Risk Factors for Coronary Heart Disease in Swedish Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.679385|2017-10-11 04:28:53.679385
NCT01588665|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-02-14|||April 2012||2012-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Observational|||Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy|Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy|Active, not recruiting||N/A|23|Actual|Cornell University|||1||f||||f||||||Samples With DNA|"     -  A total of 45 mL maternal blood sample is collected at five study visits during          pregnancy        -  At delivery, an additional 10 mL maternal blood sample, a 30 mL cord blood, and the          placenta are collected   "|No||2017-10-11 03:01:15.501432|2017-10-11 03:01:15.501432
NCT01588639|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-01-11|||August 2012||2012-08-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Observational|SEAS||To Evaluate Clinical Outcome and Injection Compliance of Scilin|A Prospective Multi-centre, Non-randomized, Open-label, Non-interventional Study to Evaluate the Safety, Efficacy and Injection Compliance of Scilin N, Scilin R or Scilin M30 in Chinese Type 2 Diabetes Mellitus (T2DM)|Completed||N/A|2683|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:01:15.574352|2017-10-11 03:01:15.574352
NCT01588626|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-07-12|||May 2012||2012-05-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male Volunteers|A Phase I, Single Centre, Open Study to Assess the Pharmacokinetics of Oral AZD6140 After Single Dose in Healthy Japanese Male Volunteers|Completed||Phase 1|12|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 03:01:15.667944|2017-10-11 03:01:15.667944
NCT01588600|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-04-20|||April 2012||2012-04-01|April 2012|2012-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Fiber on Satiety|Effects of Fiber on Satiety and Food Intake in Men and Women|Completed||N/A|90|Actual|Ingredion Incorporated||3|||f||||f||||||||||2017-10-11 03:01:15.741659|2017-10-11 03:01:15.741659
NCT01588587|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-10-17|||October 2012||2012-10-01|April 2012|2012-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|||DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients|Effect of DPP-IV Inhibitors on Occurence of Cancers and the Mechanism Using AGE and RAGE in Patients With Type 2 Diabetes|Not yet recruiting||N/A|500|Anticipated|Nagaoka Red Cross Hospital|||1||f||||f||||||||||2017-10-11 03:01:15.827829|2017-10-11 03:01:15.827829
NCT01588574|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-09-05|||August 2012||2012-08-01|February 2013|2013-02-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia||Completed||Phase 2|60|Actual|Medy-Tox||2|||f||||t||||||||||2017-10-11 03:01:16.074796|2017-10-11 03:01:16.074796
NCT01588561|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2017-07-31|2016-11-29||October 2005||2005-10-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Nicotine Related Brain Activity: The Influence of Smoking History and Blood Nicotine Levels|Nicotine Related Brain Activity: The Influence of Smoking History and Blood Nicotine Levels, an Exploratory Study|Completed||N/A|15|Actual|Mclean Hospital|Small number of subjects completed due to a large shortage of Nicotine Bitartrate (the chemical used to create our IV Nicotine). We were unable to receive new nicotine shipments from 4/14 -2/15.Without this nicotine it was impossible to run subjects.|2|||f||||t||||||||||2017-10-11 03:01:16.180564|2017-10-11 03:01:16.180564
NCT01588548|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-10-06|2015-07-24||July 2012||2012-07-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma|A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD1208 in Patients With Advanced Solid Malignancies Including Malignant Lymphoma|Completed||Phase 1|43|Actual|AstraZeneca||1|||f||||t||||||||||2017-10-11 03:01:16.638896|2017-10-11 03:01:16.638896
NCT01588535|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-04-13||2013-12-03|May 2012||2012-05-01|March 2015|2015-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media|Phase 2, Multicenter, Placebo-controlled, Double-masked, Randomized Study to Demonstrate Reliability and Validity of FAECC Scale (Modified FLACC) to Evaluate Relief of Pain in Subjects With Acute Otitis Media Aged >/=2 Months to <5 Years|Completed||Phase 2|38|Actual|Arbor Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:01:18.432847|2017-10-11 03:01:18.432847
NCT01588522|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-04-21|||July 2012||2012-07-01|July 2016|2016-07-01|March 2017|Actual|2017-03-01|January 2017|Actual|2017-01-01||Interventional|||Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease|Phase I Dose-Escalation Study, to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 (Calcitriol, USP) in Adult Cancer Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Advanced or Recurrent Disease|Completed||Phase 1|30|Anticipated|Berg, LLC||1|||f||||t||||||||||2017-10-11 03:01:18.569546|2017-10-11 03:01:18.569546
NCT01588509|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-06-02|||March 30, 2012|Actual|2012-03-30|May 2017|2017-05-01|November 21, 2012|Actual|2012-11-21|November 21, 2012|Actual|2012-11-21||Interventional|||Transition From Alendronate to Romosozumab (AMG 785)|An Open-label, Randomized Study to Estimate the Percent Change From Baseline in Lumbar Spine Bone Mineral Density After 3 Months of AMG 785 Administration in Postmenopausal Women With Low Bone Mineral Density Previously Treated With Alendronate|Completed||Phase 1|60|Actual|Amgen||2|||f||||f||||||||||2017-10-11 03:01:18.675855|2017-10-11 03:01:18.675855
NCT01588496|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-02-07|2015-08-28|2014-05-02|April 2012||2012-04-01|February 2017|2017-02-01||||January 2014|Actual|2014-01-01||Interventional|TESLA||Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities|2-part, Phase 2/3 Study to Assess the Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia. Part A - Open-label, Single-arm, Multicenter Pilot Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia. Part B - Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia|Completed||Phase 2/Phase 3|58|Actual|Amgen||3|||f||||t||||||||||2017-10-11 03:01:18.899914|2017-10-11 03:01:18.899914
NCT01588483|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-05-17|||March 2012||2012-03-01|May 2016|2016-05-01||||March 2022|Anticipated|2022-03-01||Observational|ATACT||Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis|Prospective Study for the Follow-up of Aortic Diameter in Patients With Arteritis Temporalis / Giant Cell Arteritis.|Recruiting||N/A|150|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 03:01:20.131152|2017-10-11 03:01:20.131152
NCT01588457|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-03-21|||June 2011||2011-06-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|SMART||Sequential Multiple Assignment Treatment for Bipolar Disorder|Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder|Completed||Phase 4|110|Actual|The University of Texas Health Science Center at San Antonio||6|||f||||t||||||||||2017-10-11 03:01:20.336004|2017-10-11 03:01:20.336004
NCT01588444|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-10-01|2014-10-01||October 2010||2010-10-01|October 2015|2015-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||patietns requring tooth extraction adn ridge preservation|Ridge Preservation After Tooth Extraction Using Cortical Versus Cancellous Freeze Dried Bone Allograft|Histological Comparison of Healing Following Tooth Extraction With Ridge Preservation Using Cortical Versus Cancellous Freeze Dried Bone Allograft|Completed||N/A|40|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 03:01:20.50231|2017-10-11 03:01:20.50231
NCT01588431|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-01-05|||December 2011||2011-12-01|January 2017|2017-01-01|March 2022|Anticipated|2022-03-01|December 2021|Anticipated|2021-12-01||Interventional|||Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer|A Phase II Study of Induction Docetaxel, Cisplatin, Cetuximab and Bevacizumab (TPE-A) Followed by Concurrent Radiation, Cisplatin, Cetuximab and Bevacizumab (XPE-A) in Patients With Locally Advanced Head and Neck Cancer (CTRC# 11-36)|Active, not recruiting||Phase 2|33|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 03:01:20.84382|2017-10-11 03:01:20.84382
NCT01588418|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-04-17|2015-10-28||July 2010||2010-07-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||We studied male subjects with impaired fasting glucose or newly diagnosed type 2 diabetes.|Acute Effect of Exenatide on Brain Glucose Metabolism|Effect of Exenatide on Brain Glucose Uptake in Relations to Pancreatic, Adipose Tissue, and Hepatic Function|Completed||Phase 4|15|Actual|The University of Texas Health Science Center at San Antonio|Our study has several potential limitations. It included only men. During OGTT it is difficult to evaluate the separate contributions of glucose and insulin.|2|||f||||f||||||||No||2017-10-11 03:01:20.971656|2017-10-11 03:01:20.971656
NCT01588405|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-04-08|2015-08-20||April 2012||2012-04-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||Remodulin® to Oral Treprostinil Transition|A Multicenter, Open-Label Study of the Safety and Tolerability of Transitioning From Remodulin® to Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 2|33|Actual|United Therapeutics||1|||f||||f||||||||||2017-10-11 03:01:21.293211|2017-10-11 03:01:21.293211
NCT01588392|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2014-07-22|||November 2011||2011-11-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|STEP||Short bouTs of Exercise for Preschool-age Children|Effects of Short Bouts of Physical Activity in Low-income Preschool-age Children|Completed||N/A|323|Actual|University of Massachusetts, Amherst||2|||f||||f||||||||||2017-10-11 03:01:22.049238|2017-10-11 03:01:22.049238
NCT01588379|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-12-05|||January 2013||2013-01-01|December 2016|2016-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|MAGNET||Mothers and Girls Dancing Together Trial|Effects of an Afro-centric Dance Program for African-American Daughters and Mothers|Completed||N/A|152|Actual|University of Massachusetts, Amherst||3|||f||||f||||||||||2017-10-11 03:01:22.141006|2017-10-11 03:01:22.141006
NCT01588366|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2013-09-10|||April 2012||2012-04-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The Effects of LY2409021 on the Liver|Effects of LY2409021 on Hepatic Metabolism in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|36|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:01:22.228659|2017-10-11 03:01:22.228659
NCT01588353|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2017-02-14|2016-07-03||May 2012||2012-05-01|February 2017|2017-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CORD-J||Collagenase Option for Reduction of Dupuytren's Contracture in Japan|Phase III Study of AK160 in Patients With Dupuytren's Contracture|Completed||Phase 3|104|Actual|Asahi Kasei Pharma Corporation||1|||f||||||||||||||2017-10-11 03:01:22.331872|2017-10-11 03:01:22.331872
NCT01588340|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-05-29|||February 2012||2012-02-01|May 2015|2015-05-01|January 2018|Anticipated|2018-01-01|June 2017|Anticipated|2017-06-01||Interventional|||MRI Hydronephrosis Study|Comparison of Rapid Protocol Noncontrast MRI vs. Ultrasound in the Evaluation of Pediatric Hydronephrosis|Withdrawn||N/A|0|Actual|University of Michigan||2||PI leaving institution|f||||t||||||||||2017-10-11 03:01:22.864025|2017-10-11 03:01:22.864025
NCT01588327|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-04-27|||October 2011||2011-10-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||A Prospective Pharmacodynamic Study of Dabigatran|A Prospective Pharmacodynamic Study of Dabigatran Using Peak and Trough Coagulation Test Results in Patients on Therapeutic Doses of Dabigatran|Completed||N/A|65|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples Without DNA|"     Blood plasma   "|||2017-10-11 03:01:22.949573|2017-10-11 03:01:22.949573
NCT01588314|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-08-16|||April 2012||2012-04-01|August 2017|2017-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease|Placebo Controlled Trial Evaluating Gabapentin for the Treatment of Small Fiber Neuropathic Pain in Patients With Fabry Disease|Withdrawn||Phase 2|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||No patients were enrolled. No data & no study results to report.|f||||f||||||||||2017-10-11 03:01:23.005769|2017-10-11 03:01:23.005769
NCT01588301|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-09-11|||February 2012||2012-02-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|APACHE-2||Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention|Attitudes to Different Strategies Among Women Not Attending Cervical Cancer Screening: Further Invitation by Mail or Kit for Self-collected Vaginal Sample|Completed||Early Phase 1|5998|Actual|University Hospital, Tours||3|||f||||f||||||||||2017-10-11 03:01:23.102298|2017-10-11 03:01:23.102298
NCT01588288|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-10-07|||September 2012||2012-09-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|Galectins||Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter|Diagnosis Interest of Galectin 3 Dosage in Nodular and Multinodular Goiter Pretreatment|Completed||N/A|193|Actual|University Hospital, Rouen||1|||f||||t||||||||||2017-10-11 03:01:23.176251|2017-10-11 03:01:23.176251
NCT01588275|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-05-03|||May 24, 2012|Actual|2012-05-24|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|REST||MRA Therapy Versus CPAP Therapy in Moderate OSAS|Cost-effectiveness of obstRuctivE Sleep Apnea Therapy (REST Study): Comparison of MRA Therapy Versus CPAP Therapy in Moderate OSAS|Active, not recruiting||N/A|86|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 03:01:23.26151|2017-10-11 03:01:23.26151
NCT01588262|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-10-12|||May 2011||2011-05-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Early Rehabilitation of Cancer Patients|Early Rehabilitation of Cancer Patients|Completed||N/A|300|Actual|Haukeland University Hospital||2|||f||||t||||||||||2017-10-11 03:01:23.376914|2017-10-11 03:01:23.376914
NCT01588249|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-10-09|||April 2012||2012-04-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Novel Formulation of Pasteurized Maple Cough Syrup Compared With Placebo on Nocturnal Cough and Sleep Quality in Infants With Upper Respiratory Infection|A Novel Formulation of Pasteurized Maple Cough Syrup Compared With Placebo on Nocturnal Cough and Sleep Quality in Infants With Upper Respiratory Infection|Terminated||N/A|80|Anticipated|Zarbee's Inc.||2||Revisiting product options|f||||||||||||||2017-10-11 03:01:23.461738|2017-10-11 03:01:23.461738
NCT01588223|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2014-03-26|||January 2011||2011-01-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Non Invasive Diagnostic of Endometrial Receptivity|A Non Invasive Diagnostic of Endometrial Receptivity Based on Lipidomic Profile on Endometrial Fluid.|Completed||N/A|40|Actual|Igenomix||1|||f||||f||||||||||2017-10-11 03:01:23.685198|2017-10-11 03:01:23.685198
NCT01588210|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-05-17|||January 2008||2008-01-01|May 2012|2012-05-01|June 2010|Actual|2010-06-01|March 2008|Actual|2008-03-01||Interventional|||Fluoride Concentration in Inter-proximal Fluid From Dental Sealants|Fluoride Concentration in Inter-proximal Fluid From Dental Sealants.|Completed||N/A|2776|Actual|Università degli Studi di Sassari||3|||f||||f||||||||||2017-10-11 03:01:23.75353|2017-10-11 03:01:23.75353
NCT01588197|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-05-03|||November 2010||2010-11-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Real-Time fMRI Feedback Effects on Pain Perception|Real-Time fMRI Feedback Effects on Pain Perception|Active, not recruiting||N/A|30|Anticipated|Medical University of South Carolina||2|||f||||||||||||||2017-10-11 03:01:23.846045|2017-10-11 03:01:23.846045
NCT01588184|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-10-03|||July 2012||2012-07-01|October 2016|2016-10-01|May 2024|Anticipated|2024-05-01|May 2024|Anticipated|2024-05-01||Interventional|||An Extension Study to Provide Continued Avastin Therapy to Patients With Solid Tumours Who Were Previously Enrolled in a Roche/Genentech Sponsored Study|An Open Label Multicentre Extension Study of Bevacizumab Administered as Single Agent or in Combination With Other Anticancer Therapies in Patients on Study Treatment With Bevacizumab at the End of a F. Hoffmann-La Roche and/or Genentech Sponsored Study|Recruiting||Phase 4|200|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:01:23.932041|2017-10-11 03:01:23.932041
NCT01588171|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-03-17|||May 2012||2012-05-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum|Bemiparin Versus Enoxaparin as Thromboprophylaxis Following Vaginal and Abdominal Deliveries: A Prospective Clinical Trial|Completed||N/A|7020|Actual|Hawler Medical University||3|||f||||f||||||||||2017-10-11 03:01:24.160065|2017-10-11 03:01:24.160065
NCT01588158|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-02-02|2016-01-11||July 2012||2012-07-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Patient Satisfaction With Pain Relief After Ambulatory Hand Surgery|Satisfaction With Pain Relief After Carpal Tunnel Release Surgery|Terminated||Phase 4|7|Actual|Massachusetts General Hospital||2||"The PI of this study is leaving the institution and enrollment was progressing slowly so we   decided to close the study."|f||||f||||||||||2017-10-11 03:01:24.260646|2017-10-11 03:01:24.260646
NCT01588145|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-12-14|||March 2012||2012-03-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients|Phase I/II Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of HM61713 in NSCLC Patients With EGFR Mutation|Active, not recruiting||Phase 1/Phase 2|273|Actual|Hanmi Pharmaceutical Company Limited||1|||f||||f||||||||||2017-10-11 03:01:24.779387|2017-10-11 03:01:24.779387
NCT01588132|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-04-26|||September 2010||2010-09-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Anfibatide Phase 1 Clinical Trial in Healthy Volunteers|First Assessment of the Glycoprotein Ib-IV-V Complex Antagonist Anfibatide in Healthy Human Volunteers|Completed||Phase 1|94|Actual|Lee's Pharmaceutical Limited||11|||f||||f||||||||||2017-10-11 03:01:24.855249|2017-10-11 03:01:24.855249
NCT01588119|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-01-19|||November 2011||2011-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|NOAC||Register for New Oral Anticoagulants|Prospective Register Study to Record Safety and Efficacy of New Oral Anticoagulants|Recruiting||N/A|3500|Anticipated|GWT-TUD GmbH|||4||f||||f||||||||||2017-10-11 03:01:24.946063|2017-10-11 03:01:24.946063
NCT01588106|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-01-19|2017-01-19||June 2012||2012-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Observational|CONGO||Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic Patients|Evaluation of the Impact of the CONTOUR® USB Blood Glucose Monitoring System With Integrated Data Management on Glycaemic Control in Insulin-treated Diabetic Patients|Completed||N/A|154|Actual|GWT-TUD GmbH|||2||f||||f||||||||||2017-10-11 03:01:25.10456|2017-10-11 03:01:25.10456
NCT01588093|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2012-04-27|||April 2011||2011-04-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I Concentrations|Insulin-like Growth Factor (IGF-I) Induced Muscle Glucose Uptake and Interstitial IGF-1 Concentrations.|Completed||N/A|8|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 03:01:25.354297|2017-10-11 03:01:25.354297
NCT01508728|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-09-24|||March 2012||2012-03-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ORTHOSENS||Efficacy Study of a Sensory Feedback Knee Orthosis in Patients Suffering From Unoperated Severe Knee Sprain||Terminated||Phase 2|104|Anticipated|Thuasne||2|||f||||||||||||||2017-10-11 03:24:53.791333|2017-10-11 03:24:53.791333
NCT01588041|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-06-30|||September 2009||2009-09-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|MIOCT||Intraoperative OCT Guidance of Intraocular Surgery|Intraoperative OCT Guidance of Intraocular Surgery|Enrolling by invitation||N/A|802|Anticipated|Duke University|||8||f||||t||||||||||2017-10-11 03:01:25.747649|2017-10-11 03:01:25.747649
NCT01588028|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2014-10-16|||April 2012||2012-04-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||A Clinical Study Testing The Safety and Efficacy of CH5424802/RO5424802 in Patients With ALK Positive Non-Small Cell Lung Cancer|A Phase I/II Study of the ALK Inhibitor CH5424802/RO5424802 in Patients With ALK-Rearranged Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:01:25.871193|2017-10-11 03:01:25.871193
NCT01588015|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-05-17|||August 2012||2012-08-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant|A Phase I Trial to Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected With PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell Transplant|Active, not recruiting||Phase 1|36|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 03:01:25.990132|2017-10-11 03:01:25.990132
NCT01588002|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-11-01|||April 2012||2012-04-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir in Healthy Volunteers|A Study to Evaluate the Potential Drug-Drug Interaction Between Efavirenz and Danoprevir With Low Dose Ritonavir When Administered Together in Healthy Adult Volunteers|Completed||Phase 1|40|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:01:26.166136|2017-10-11 03:01:26.166136
NCT01587989|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-06-22|2015-06-22||February 2012||2012-02-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Intent to treat (ITT) population: all randomized participants who received at least 1 dose of study treatment.|A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate|A Multi-center Study of the Safety and Effect on Disease Activity of Tocilizumab (TCZ) in Combination With Methotrexate (MTX) Versus Tocilizumab Monotherapy in Patients With Mild to Moderate Rheumatoid Arthritis, With Inadequate Response to MTX (Defined as DAS 28 < 4,5 and >2,6)|Completed||Phase 3|77|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:01:26.27664|2017-10-11 03:01:26.27664
NCT01587976|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-03-27|||June 2011||2011-06-01|September 2013|2013-09-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|HQOL||Health Related Quality of Life After Surgery and Oncological Treatment of Colorectal Liver Metastases|Health Related Quality of Life After Surgery and Oncological Treatment of Colorectal Liver Metastases A Prospective Multicenter Study|Unknown status|Recruiting|N/A|100|Anticipated|Haukeland University Hospital|||1||f||||f||||||||||2017-10-11 03:01:26.931859|2017-10-11 03:01:26.931859
NCT01587963|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-03-31|2016-10-07||February 2013||2013-02-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|February 2014|Actual|2014-02-01||Interventional|VitC||High Dose Vitamin C in the Critically Ill Patient|The Efficacy of High Dose Vitamin C in the Critically Ill Patient Population|Terminated||Phase 2|11|Actual|Rutgers, The State University of New Jersey|Early termination leading to small number of subjects analyzed|2||PI's add. responsibilities and time commitment prevent him from completing trial|f||||t||||||||No||2017-10-11 03:01:27.054058|2017-10-11 03:01:27.054058
NCT01587950|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-04-09|2013-03-21||February 2009||2009-02-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||The Effects of Potassium Nitrate in Reducing Dentinal Hypersensitivity|An Exploratory Study Investigating the Effects of a Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity|Completed||Phase 1|12|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:01:27.480954|2017-10-11 03:01:27.480954
NCT01587937|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2014-11-17|||April 2010||2010-04-01|November 2014|2014-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Hospital Wide Roll-Out of Antimicrobial Stewardship|Hospital Wide Roll-Out of Antimicrobial Stewardship: A Stepped Wedge Randomized Controlled Trial|Completed||N/A|19220|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 03:01:28.083085|2017-10-11 03:01:28.083085
NCT01587924|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-08-14|2017-08-14|2015-04-27|May 23, 2012|Actual|2012-05-23|August 2017|2017-08-01|May 27, 2013|Actual|2013-05-27|May 27, 2013|Actual|2013-05-27||Interventional||The intent to treat (ITT) population included all randomized participants who received at least one dose of the study drug, had a baseline and at least one corresponding on treatment laboratory assessment.|4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease|A Four-week, Phase IIa, Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Switching Subjects From a Stable Dose of Recombinant Human Erythropoietin to GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease|Completed||Phase 2|80|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:01:28.24437|2017-10-11 03:01:28.24437
NCT01587911|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-08-10|||May 2008||2008-05-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|May 2009|Actual|2009-05-01||Interventional|CMP2||Casinomacropeptide and Satiety|Characterization of the Physiological and Subjective Satiety Response to Preloads Varying in Bioactive Dairy Proteins|Completed||N/A|20|Actual|University of California, Davis||6|||f||||f||||||||||2017-10-11 03:01:30.211642|2017-10-11 03:01:30.211642
NCT01587885|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2015-02-20|2013-04-04||January 2012||2012-01-01|February 2015|2015-02-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)|Protocol PT 11-29: Randomized, Open-label, Cross-over Pilot Study to Evaluate and Compare Two Omeprazole Containing Products for Relief of Frequent Heartburn|Completed||Phase 4|48|Actual|Bayer||2|||f||||f||||||||||2017-10-11 03:01:30.681869|2017-10-11 03:01:30.681869
NCT01587872|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2014-04-11|||October 2011||2011-10-01|April 2012|2012-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Double-balloon Colonoscopy to Increase Colonoscopy Completion Rate|Double-balloon Colonoscopy to Increase Cecal Intubation Rate in Technically Difficult Colonoscopies|Terminated||N/A|62|Anticipated|Sorlandet Hospital HF||1||"Slow patient recruitment, not enough patients willing to participate within the prespecified   time frame."|f||||f||||||||||2017-10-11 03:01:31.129759|2017-10-11 03:01:31.129759
NCT01587859|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-04-27|||January 1995||1995-01-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|SEHH||Short Esophagus in Type II-IV Hiatus Hernia|Frequency of True Short Esophagus in Type II-IV Hiatus Hernia|Completed||N/A|34|Actual|University of Bologna|||1||f||||f||||||||||2017-10-11 03:01:31.246671|2017-10-11 03:01:31.246671
NCT01587846|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-10-02|||October 2012||2012-10-01|October 2012|2012-10-01|October 2013|Anticipated|2013-10-01|June 2013|Anticipated|2013-06-01||Interventional|||Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children|Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children - Randomized, Double Blind, Placebo Controlled Study|Unknown status|Recruiting|Phase 3|300|Anticipated|Sisters of Mercy University Hospital||4|||f||||f||||||||||2017-10-11 03:01:31.332006|2017-10-11 03:01:31.332006
NCT01587833|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-07-03|||November 2011||2011-11-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||WEUKBRE5559: IMI PROTECT: Benzodiazepines & Fracture|WEUKBRE5559: IMI PROTECT (Work Package 2): Use of Benzodiazepines and Risk of Hip/Femur Fracture|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 03:01:31.442903|2017-10-11 03:01:31.442903
NCT01587820|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-12-04|||June 2012||2012-06-01|July 2014|2014-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer|A Pilot/ Feasibility Study Comparing Response Rates of Intra-arterial and Intravenous Cisplatin Chemotherapy, Combined With Radiation, in Patients With Locally Advanced Carcinoma of the Oral Cavity and Oropharynx|Terminated||Early Phase 1|1|Actual|Southern Illinois University||2||lack of enrollment|f||||t||||||||||2017-10-11 03:01:31.524195|2017-10-11 03:01:31.524195
NCT01587807|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-07-24|||March 28, 2012|Actual|2012-03-28|July 2017|2017-07-01|November 19, 2012|Actual|2012-11-19|November 19, 2012|Actual|2012-11-19||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057|A Two-part, Randomised, Placebo-controlled Study to Investigatethe Safety, Tolerability, Pharmacokinetics and Pharmacodynamicsof Single Doses of Inhaled GSK1995057 in Healthy Subjects|Completed||Phase 1|53|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-10-11 03:01:31.634145|2017-10-11 03:01:31.634145
NCT01587794|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2012-04-26|||April 2010||2010-04-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Topographic Changes of Retinal Layers After Resolution of Acute Retinal Detachment|Topographic Changes of Retinal Layers After Resolution of Acute Retinal|Completed||N/A|21|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:01:31.758459|2017-10-11 03:01:31.758459
NCT01587781|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-08-17|||November 2011||2011-11-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery|Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery|Active, not recruiting||N/A|12|Anticipated|Children's Research Institute|||1||f||||t||||||||||2017-10-11 03:01:31.827172|2017-10-11 03:01:31.827172
NCT01587768|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-12-08|||November 2011||2011-11-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics|WEUKBRE5555: IMI PROTECT (Work Package 2): The Risk of Acute Liver Injury Associated With the Use of Antibiotics|Completed||N/A|1|Actual|GlaxoSmithKline|||3||f||||||||||||||2017-10-11 03:01:31.905|2017-10-11 03:01:31.905
NCT01587755|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-03-06|||March 2012||2012-03-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PSO-TOP||Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP)|Optimising Outpatient Care in Mild to Moderate Psoriasis by a Newly Developed 'Topical Treatment Optimising Programme' - an International Study Using Daivobet®/Dovobet® Gel|Completed||Phase 4|1852|Actual|Reich, Kristian, M.D.||2|||f||||f||||||||||2017-10-11 03:01:32.053158|2017-10-11 03:01:32.053158
NCT01587742|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-12-18|||November 2011||2011-11-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Observational|||IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer|IMI PROTECT (Work Package 2): Calcium Channel Blocker Treatments and Cancer Risk|Completed||N/A|1|Actual|GlaxoSmithKline|||5||f||||f||||||||||2017-10-11 03:01:32.386888|2017-10-11 03:01:32.386888
NCT01587729|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-03-26|||November 2011||2011-11-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||IMI PROTECT(WP2): Antidepressants & Fractures|IMI PROTECT (Work Package 2): Use of Antidepressants and Risk of Hip and/or Hip/Femur Fracture|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 03:01:32.502767|2017-10-11 03:01:32.502767
NCT01587716|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-07-24|||April 23, 2012|Actual|2012-04-23|July 2017|2017-07-01|July 30, 2012|Actual|2012-07-30|July 30, 2012|Actual|2012-07-30||Interventional|||A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.|A Randomised, Double-blind, Placebo Controlled, Inhaled Single Escalating and Repeat Dose Study Using an Aqueous Droplet Inhaler to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.|Completed||Phase 1|36|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 03:01:32.631944|2017-10-11 03:01:32.631944
NCT01587703|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-06-22|||March 28, 2012||2012-03-28|June 2017|2017-06-01|September 9, 2019|Anticipated|2019-09-09|March 11, 2019|Anticipated|2019-03-11||Interventional|||A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers|A Phase I/II Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers|Recruiting||Phase 1|225|Anticipated|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 03:01:32.756202|2017-10-11 03:01:32.756202
NCT01587677|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-10-05|||February 2012||2012-02-01|October 2016|2016-10-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Observational|LAM FLISA||Evaluation of a LAM FLISA for the Diagnosis of Tuberculosis|Diagnostic Evaluation of a Urine and Plasma Based LAM FLISA for the Diagnosis of Infection With Mycobacterium Tuberculosis|Completed||N/A|92|Actual|Research Center Borstel|||4||f||||f||||||Samples Without DNA|"     Urine and EDTA plasma   "|||2017-10-11 03:01:33.122278|2017-10-11 03:01:33.122278
NCT01587664|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-04-07|||May 2012||2012-05-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||NewBreez Safety and Efficacy Evaluation|Safety and Efficacy Evaluation of the NewBreez Intra-laryngeal Prosthesis|Terminated||N/A|2|Actual|ProTiP Medical||1||Due to lack of recruitment and loss of the French principal investigator.|f||||f||||||||No||2017-10-11 03:01:33.20152|2017-10-11 03:01:33.20152
NCT01587651|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2014-03-26|2014-02-11||March 2012||2012-03-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|SWAP-2||Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease|A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents|Completed||Phase 4|110|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||||2017-10-11 03:01:33.305873|2017-10-11 03:01:33.305873
NCT01587638|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2012-04-26|||April 2009||2009-04-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Use of Beta-blockers and Risk of New Onset Diabetes|Use of Beta-blockers and Risk of New Onset Diabetes|Completed||N/A|12336|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:01:35.064137|2017-10-11 03:01:35.064137
NCT01587625|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-08-04|||August 2013||2013-08-01|August 2017|2017-08-01|October 8, 2016|Actual|2016-10-08|June 9, 2016|Actual|2016-06-09||Interventional|OxyHighLow||High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour|High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour|Completed||N/A|1376|Actual|Göteborg University||2|||f||||t||||||||||2017-10-11 03:01:35.162698|2017-10-11 03:01:35.162698
NCT01587612|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-05|2014-03-28|||August 2003||2003-08-01|March 2014|2014-03-01|March 2004|Actual|2004-03-01|December 2003|Actual|2003-12-01||Observational|||Study of Quantification of Hyperpronation|Study of Quantification of Hyperpronation|Completed||N/A|80|Actual|Northern Orthopaedic Division, Denmark|||1||f||||f||||||||||2017-10-11 03:01:35.267768|2017-10-11 03:01:35.267768
NCT01587586|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-04-27|||October 2011||2011-10-01|April 2012|2012-04-01||||December 2013|Anticipated|2013-12-01||Interventional|||Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With HCV Genotype 1 Infection|An Open-label, Randomized, Active Control Study to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of P1101 + Ribavirin in Treatment-Naïve Subjects With HCV Genotype 1 Infection|Unknown status|Recruiting|Phase 2|208|Anticipated|PharmaEssentia||4|||f||||f||||||||||2017-10-11 03:01:35.443727|2017-10-11 03:01:35.443727
NCT01587573|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-05-23|||April 2012||2012-04-01|May 2017|2017-05-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer|Pivotal Validation Study of Salivary Biomarkers for the Risk Stratification of Patients With Lesions Suspicious for Oral Squamous Cell Carcinoma|Recruiting||N/A|370|Anticipated|PeriRx|||1||f||||t||||||Samples With DNA|"     cell free saliva   "|Undecided||2017-10-11 03:01:35.564684|2017-10-11 03:01:35.564684
NCT01587560|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-08-29|||January 2012||2012-01-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||A Comparison Between a Pyrocarbon and a CoCr Shoulder Resurfacing Implant||Active, not recruiting||N/A|80|Anticipated|Danderyd Hospital||2|||f||||t||||||||||2017-10-11 03:01:35.673098|2017-10-11 03:01:35.673098
NCT01587547|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-05-07|||April 2012||2012-04-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Observational|EmbryoSure||Amino Acid Profiling of Spent Culture Medium|Amino Acid Profiling of Spent Culture Medium to Retrospectively Determine Individual Embryo Selection Criteria for Improved Clinical IVF Outcome|Terminated||N/A|10|Actual|Origio A/S|||1|ORIGIO a/s acquired by Cooper Surgical Inc. who decided to withdraw from the project|f||||t||||||Samples Without DNA|"     Spent culture medium from the individual embryos   "|||2017-10-11 03:01:35.758831|2017-10-11 03:01:35.758831
NCT01587534|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-04-13|||October 2011||2011-10-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)|Phase 2 Study of Randomized Controlled Trial of Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer|Completed||Phase 2|67|Actual|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 03:01:35.832335|2017-10-11 03:01:35.832335
NCT01587521|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-07-27|||January 2012||2012-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia|Prevalence of and Factors Associated With Metabolic Syndrome in Patients With Schizophrenia|Completed||N/A|80|Actual|Chiang Mai University|||1||f||||f||||||||||2017-10-11 03:01:35.914055|2017-10-11 03:01:35.914055
NCT01587508|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-04-29|||May 2013||2013-05-01|April 2012|2012-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago|A Phase III, Randomized, Single-Blind, Superiority Study Comparing The Efficacy And Tolerability Of A New Drug Containing The Combination Meloxicam And Cyclobenzaprine And The Same Components Alone In The Treatment Of Acute Lumbago|Withdrawn||Phase 3|0|Actual|Eurofarma Laboratorios S.A.||3||"The comparator product was withdrawn from the brazilian market not being possible to conduct   the design regarding initially planned."|f||||f||||||||||2017-10-11 03:01:35.980216|2017-10-11 03:01:35.980216
NCT01587495|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-05-19|||March 2012||2012-03-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Pharmacokinetics and Safety of Ertapenem in the Postpartum Period|Pharmacokinetics and Safety of Ertapenem in the Postpartum Period|Terminated||Phase 1|3|Actual|Duke University||1||study terminated due to low subject accrual|f||||f||||||||||2017-10-11 03:01:36.094711|2017-10-11 03:01:36.094711
NCT01587469|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-30|||April 2012||2012-04-01|April 2012|2012-04-01||||||||Observational|||Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects|Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects|Unknown status|Recruiting|N/A|1634|Anticipated|Cepheid|||1||f||||||||||Samples With DNA|"     Samples of sputum may be retained   "|||2017-10-11 03:01:36.281139|2017-10-11 03:01:36.281139
NCT01587456|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2016-06-15|||April 2012||2012-04-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|ARTEOS2||Arteos II Study: Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort|Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort.|Recruiting||N/A|300|Anticipated|Central Hospital, Nancy, France|||1||f||||t||||||Samples With DNA|"     Serum, Plasma and DNA   "|Undecided||2017-10-11 03:01:36.371908|2017-10-11 03:01:36.371908
NCT01587443|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-04-14|||January 2012||2012-01-01|April 2015|2015-04-01||||April 2015|Actual|2015-04-01||Observational|||Comparison of Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population|A Comparison of Patient-Reported, Economic and Clinical Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population|Unknown status|Active, not recruiting|N/A|200|Anticipated|National University, Singapore|||2||f||||f||||||||||2017-10-11 03:01:36.611066|2017-10-11 03:01:36.611066
NCT01587430|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2014-04-04|||January 2010||2010-01-01|April 2014|2014-04-01|January 2015|Anticipated|2015-01-01|April 2014|Anticipated|2014-04-01||Interventional|||3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia|Multicenter Randomised Clinical Trial in Acute Myeloid Leukemia Treatment Based on Three Anthracyclines, Comparing Two Types of Consolidation With Different ARA-C Doses Followed by One Year Maintenance|Unknown status|Active, not recruiting|Phase 4|245|Anticipated|National Research Center for Hematology, Russia||2|||f||||t||||||||||2017-10-11 03:01:36.683733|2017-10-11 03:01:36.683733
NCT01587417|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-10-31|||April 2012||2012-04-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL|A Randomised, Double-blind, Placebo-controlled Trial in Healthy Volunteers to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of 2.5 mg to 360 mg of BI 187004 CL|Completed||Phase 1|72|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:01:36.778528|2017-10-11 03:01:36.778528
NCT01587404|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-08-18|||April 2012||2012-04-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Catheter Contact Force and Electrograms|Relationship Between Catheter Contact Force and Electrogram Characteristics in Fibrillating Human Atrial Myocardium|Unknown status|Recruiting|Phase 4|55|Anticipated|Barts & The London NHS Trust||2|||f||||||||||||||2017-10-11 03:01:36.874144|2017-10-11 03:01:36.874144
NCT01587391|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-10-30|||April 2012||2012-04-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX|A Randomised, Double-blind, Placebo-controlled Trial in Healthy Volunteers to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of 2.5 mg to 160 mg of BI 163538 XX|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:01:36.973861|2017-10-11 03:01:36.973861
NCT01587378|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-10-05|||October 2012|Actual|2012-10-01|October 2017|2017-10-01|October 1, 2017|Actual|2017-10-01|August 2017|Actual|2017-08-01||Interventional|PregMet2||Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary Syndrome|A Prospective, Randomized, Double-blind, Multi-centre Study, Where the Possible Effect of Metformin to Prevent Late Miscarriage and Preterm Delivery is Studied in Women With Polycystic Ovary Syndrome (PCOS)|Completed||N/A|489|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 03:01:37.063994|2017-10-11 03:01:37.063994
NCT01587365|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-09-02|||May 2012||2012-05-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins|Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-962476 in Healthy Subjects and in Patients With Hypercholesterolemia on Statin Therapy|Completed||Phase 1|66|Actual|Bristol-Myers Squibb||8|||f||||f||||||||||2017-10-11 03:01:37.190655|2017-10-11 03:01:37.190655
NCT01587352|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-09-12|||April 20, 2012|Actual|2012-04-20|September 2017|2017-09-01||||November 20, 2017|Anticipated|2017-11-20||Interventional|||Vorinostat in Treating Patients With Metastatic Melanoma of the Eye|A Phase 2 Study of Vorinostat (NSC 701852) in Metastatic Uveal Melanoma|Suspended||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1||Non-compliance with Sponsor data reporting requirements|f||||t||||||||||2017-10-11 03:01:37.295483|2017-10-11 03:01:37.295483
NCT01587339|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2013-09-12|||September 2010||2010-09-01|September 2013|2013-09-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Observational|||Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy|Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy|Completed||N/A|6498|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:01:37.404939|2017-10-11 03:01:37.404939
NCT01587326|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2012-05-13|||April 2012||2012-04-01|May 2012|2012-05-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|BAFH||The Effects of Escitalopram on Cytokines|The Effects of Escitalopram on Cytokines in Depressive Patients|Unknown status|Recruiting|N/A|25|Anticipated|Beitou Armed Forces Hospital, Taipei, Taiwan||1|||f||||t||||||||||2017-10-11 03:01:37.49124|2017-10-11 03:01:37.49124
NCT01587313|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2015-08-04|||April 2012||2012-04-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers|A Four-arm, Single Dose, Two-Period, Pharmacokinetic Study of BiDil SR and IR Capsules and Commercial BiDil Tablets|Completed||Phase 1|36|Actual|Arbor Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 03:01:37.594997|2017-10-11 03:01:37.594997
NCT01587300|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2017-08-11|||July 2011||2011-07-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Neuroblastoma Biology Study|N2004-05: Neuroblastoma Biology Study|Recruiting||N/A|500|Anticipated|New Approaches to Neuroblastoma Therapy Consortium|||1||f||||t||||||Samples With DNA|"     The biospecimen includes blood and bone marrow and their derivatives (e.g., DNA, RNA, plasma,     lymphocytes) as well as tumors.   "|||2017-10-11 03:01:37.676837|2017-10-11 03:01:37.676837
NCT01587287|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-28|||April 2011||2011-04-01|January 2011|2011-01-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Observational|||A Comprehensive Assessment of Anterior Corneal Power by Different Devices|A Comprehensive Assessment of the Precision and Agreement of Anterior Corneal Power Measurements Obtained Using Different Devices|Completed||N/A|35|Actual|Wenzhou Medical University|||1||f||||t||||||||||2017-10-11 03:01:37.786793|2017-10-11 03:01:37.786793
NCT01587274|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2014-10-09|||April 2012||2012-04-01|October 2014|2014-10-01|January 2015|Anticipated|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||A Randomized Study of Three Medication Regimens for Acute Low Back Pain|A Randomized Three-armed Comparative Effectiveness Study of Various Medications for Musculoskeletal Low Back Pain: Defining the Added Benefit of Muscle Relaxants and Opioids.|Unknown status|Active, not recruiting|Phase 4|323|Anticipated|Montefiore Medical Center||3|||f||||t||||||||||2017-10-11 03:01:39.469606|2017-10-11 03:01:39.469606
NCT01587261|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-01-12|||June 2017||2017-06-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Vitamin C for Severe Thermal Injuries|Prospective Placebo-Controlled Double-Blinded Trial for High-Dose Vitamin C Administration During the Acute Resuscitative Phase of Severe Thermal Injuries|Not yet recruiting||Phase 2|54|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 03:01:39.568762|2017-10-11 03:01:39.568762
NCT01587248|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-26|||March 2010||2010-03-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|HMRM||Use of Harmonic in Breast Surgery|Harmonic Scalpel vs. Electrocautery Dissection in Modified Radical Mastectomy: A Randomized Controlled Trial|Completed||Phase 3|152|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-11 03:01:39.6731|2017-10-11 03:01:39.6731
NCT01587235|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-26|2014-12-29|||March 2013||2013-03-01|December 2014|2014-12-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|VYCTORY||A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)|A Multicenter, Open-label, 6 Week Study to Evaluate the Efficacy and Safety of Algorithm Based Intensive Treatment With Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Patients.|Withdrawn||Phase 4|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 03:01:39.770775|2017-10-11 03:01:39.770775
NCT01587222|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-27|2015-09-10|||July 2013||2013-07-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|July 2014|Actual|2014-07-01||Interventional|||Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure||Unknown status|Recruiting|Phase 2|15|Anticipated|Fundacion Clinic per a la Recerca Biomédica||1|||f||||f||||||||||2017-10-11 03:01:39.863151|2017-10-11 03:01:39.863151
NCT01587209|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-08-18|||August 2011||2011-08-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Microparticles in Scuba Divers With Decompression Sickness|Phase 1 Study Investigating Alterations of Circulating Microparticles in Scuba Divers With Decompression Sickness|Completed||N/A|1|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 03:01:39.942369|2017-10-11 03:01:39.942369
NCT01587196|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-09-29|||January 2012||2012-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|fMRI CURE||CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery|CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery - Prescription Opiates/Medication|Enrolling by invitation||Phase 2|72|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 03:01:40.032482|2017-10-11 03:01:40.032482
NCT01587183|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-08-20|||March 2012||2012-03-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|September 2012|Actual|2012-09-01||Interventional|RAPT||Running Against Prehypertension Trial (RAPT): A Pilot Trial|Running Against Prehypertension Trial (RAPT): A Pilot Randomized Controlled Trial|Completed||N/A|22|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-10-11 03:01:40.127249|2017-10-11 03:01:40.127249
NCT01587170|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-11-30|||January 2012||2012-01-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Observational|||Effects of Zolmitriptan on Sensory Transmission After Spinal Cord Injury|Phase 2: Effects of Zolmitriptan on Sensory Afferent Transmission After Spinal Cord Injury|Completed||N/A|13|Actual|University of Alberta|||2||f||||||||||||||2017-10-11 03:01:40.22053|2017-10-11 03:01:40.22053
NCT01587157|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-25|||August 2010||2010-08-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Capnography During Percutaneous Transhepatic Cholangiodrainage (PTCD) (HepaBreath)||Completed||Phase 3|20|Actual|Technische Universität München||1|||f||||f||||||||||2017-10-11 03:01:40.298742|2017-10-11 03:01:40.298742
NCT01587144|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-07-20|||March 2012||2012-03-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)|An International, Multi-Center, Randomized, Double Blind Placebo Controlled Phase II Study to Evaluate the Safety and Efficacy of Lucanthone Administered as an Adjunct to Radiation and Temozolomide for Primary Therapy of Glioblastoma Multiforme|Terminated||Phase 2|18|Actual|Spectrum Pharmaceuticals, Inc||2||Sponsor's decision|f||||t||||||||||2017-10-11 03:01:40.367333|2017-10-11 03:01:40.367333
NCT01587131|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-04-16|||June 2012||2012-06-01|January 2013|2013-01-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|||DNA-based Influenza Vaccine in the Elderly|Phase I, Open Label Study of a DNA Vaccine's Ability to Increase the Immune Response to the Trivalent Seasonal Influenza Vaccine in the Elderly|Completed||Phase 1|50|Actual|University of Manitoba||3|||f||||t||||||||||2017-10-11 03:01:40.6365|2017-10-11 03:01:40.6365
NCT01587118|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-10-12|2016-07-18||June 2012||2012-06-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder|An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder|Completed||Phase 4|18|Actual|Tuscaloosa Research & Education Advancement Corporation|"This study was limited by both the small number of subjects enrolled and its open-label design.
Average dose of asenapine was 13.6 ± 6.4 mg/d; at 12-weeks 15.9 ± 4.9 mg/d."|1|||f||||f||||||||No|No sharing of individual participant data|2017-10-11 03:01:41.419869|2017-10-11 03:01:41.419869
NCT01587105|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-05-12|2016-04-22||October 2010||2010-10-01|May 2017|2017-05-01|August 31, 2017|Anticipated|2017-08-31|September 2014|Actual|2014-09-01||Interventional|I3CN||Improving Care for Children With Complex Needs|Improving Care for Children With Complex Needs (I3CN) Study|Active, not recruiting||N/A|331|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 03:01:41.752566|2017-10-11 03:01:41.752566
NCT01587079|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-05-23|2016-05-23|2013-10-22|April 2012||2012-04-01|May 2016|2016-05-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional||ITT/Safety Population|Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Randomized, Double Blind, (Test Products), Chronic Dosing (7 Days), Four Period, Eight Treatment , Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Five Doses of PT003, One Dose of PT001 and One Dose of PT005 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide 18 µg, Open Label) as Active Control|Completed||Phase 2|159|Actual|Pearl Therapeutics, Inc.||8|||f||||f||||||||||2017-10-11 03:01:42.378585|2017-10-11 03:01:42.378585
NCT01587066|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-04-26|||August 2010||2010-08-01|April 2012|2012-04-01|September 2011|Anticipated|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression||Withdrawn||Phase 4|0|Actual|Naju National Hospital||2|||f||||f||||||||||2017-10-11 03:01:43.928745|2017-10-11 03:01:43.928745
NCT01587053|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-02-06|||April 2012|Actual|2012-04-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Observational|||Anti Vitamin K Therapeutic Education|Anti Vitamin K Therapeutic Education With INR Self Measure Device Within Children From 0 to 18 Years|Terminated||N/A|57|Actual|University Hospital, Montpellier|||1|Difficulty recruiting|f||||t||||||||||2017-10-11 03:01:44.038175|2017-10-11 03:01:44.038175
NCT01587040|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-03-16|||July 2012||2012-07-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen|International, Multicenter, Open-label, Treatment-extension Study for Subjects Who Completed a Phase 1 or Phase 2 Parental Study to Continue Receiving Treatment With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen|Active, not recruiting||Phase 1/Phase 2|150|Anticipated|Sanofi||2|||f||||f||||||||||2017-10-11 03:01:44.139698|2017-10-11 03:01:44.139698
NCT01587027|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-12-22|2013-08-07||December 2011||2011-12-01|December 2016|2016-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Participants must be healthy non-smoking adult male and female volunteers between the ages of 18 and 40 years, with a BMI of 18-30 kg/m2.|Safety Evaluation of Aminophylline and Methazolamide|The Safety Evaluation of Aminophylline and Methazolamide When Administered Orally Alone and in Combination to Healthy Volunteers|Completed||Phase 1|16|Actual|Poudre Valley Health System||2|||f||||t||||||||No||2017-10-11 03:01:44.27773|2017-10-11 03:01:44.27773
NCT01587014|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-01-03|2014-03-17||February 2012||2012-02-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|Prima-Temp|ICU patients|Safety and Feasibility of Prima-Temp Thermometer Patch|Safety and Feasibility of Prima-Temp Thermometer Patch in Determining Baseline Temperatures of Research Subjects in a Hospital Intensive Care Unit (ICU)|Completed||N/A|26|Actual|Poudre Valley Health System|||1||f||||f||||||||No||2017-10-11 03:01:44.654137|2017-10-11 03:01:44.654137
NCT01587001|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-03-27|2016-03-21||November 2011||2011-11-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis|The Effect of an Oral Antioxidant, N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis|Completed||N/A|17|Actual|National Jewish Health||2|||f||||t||||||||No||2017-10-11 03:01:44.862851|2017-10-11 03:01:44.862851
NCT01586988|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2016-11-23|||February 2011||2011-02-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|IMAGE||A Parenting and Self-Care Intervention for HIV Infected Mothers|A Parenting Intervention for HIV+ Moms: The IMAGE Program|Completed||N/A|124|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:01:45.243388|2017-10-11 03:01:45.243388
NCT01586975|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-12-02|2015-06-29||July 2007||2007-07-01|December 2015|2015-12-01|December 2011|Actual|2011-12-01|April 2010|Actual|2010-04-01||Interventional|||Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events|Multiphase Study to Determine if Platelet Function Analysis Results Correlate With Ischemic Events and Bleeding Complications|Completed||Phase 2/Phase 3|93|Actual|Northwestern University||3|||f||||f||||||||||2017-10-11 03:01:45.343388|2017-10-11 03:01:45.343388
NCT01586962|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2013-08-06|2013-04-25||May 2012||2012-05-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI|An Open Label, In-use Study to Assess the Warming Sensation, Acceptability and Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup Given as a 30 ml Single Dose in Subjects Suffering From Symptoms of an Upper Respiratory Tract Infection|Completed||Phase 3|56|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:01:45.790262|2017-10-11 03:01:45.790262
NCT01586949|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-09-22|||April 2012||2012-04-01|September 2015|2015-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effectiveness of a Well-being Web-based Intervention|A Randomized Controlled Trial of the Effectiveness of the Web-based Well-being Intervention Daily Challenge|Completed||N/A|1503|Actual|MeYou Health, LLC||2|||f||||f||||||||||2017-10-11 03:01:45.987455|2017-10-11 03:01:45.987455
NCT01586936|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-02-23|||March 10, 1999|Actual|1999-03-10|February 2017|2017-02-01|March 9, 2010|Actual|2010-03-09|March 9, 2010|Actual|2010-03-09||Observational|||Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors|Special Survey of Production of Antibody Against Coagulation|Completed||N/A|9|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 03:01:46.085103|2017-10-11 03:01:46.085103
NCT01586923|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-04-06|||February 2013||2013-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|May 2015|Actual|2015-05-01||Interventional|TOTAL||RBC Transfusion in Severe Anemia With Lactic Acidosis|A Prospective Study of RBC Transfusion in Children With Severe Anemia|Completed||Phase 3|290|Actual|Massachusetts General Hospital||2|||f||||t||||||||No|Data published|2017-10-11 03:01:46.169238|2017-10-11 03:01:46.169238
NCT01586910|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-08-22|||April 2012||2012-04-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|SURTAVI||Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).|Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)|Active, not recruiting||N/A|2500|Anticipated|Medtronic Cardiovascular||2|||f||||t||||||||||2017-10-11 03:01:46.29719|2017-10-11 03:01:46.29719
NCT01586897|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2015-12-08|2015-07-08||May 2012||2012-05-01|December 2015|2015-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care|The Medication Metronome Project|Completed||N/A|52|Actual|Massachusetts General Hospital|Study participants did not embrace this method of non-visit based care, with only 660 medication prescriptions using the Medication Metronome ordering option (21% of possible orders).|2|||f||||f||||||||||2017-10-11 03:01:46.758808|2017-10-11 03:01:46.758808
NCT01586884|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2014-09-08|||April 2012||2012-04-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study to Determine the Safety and Feasibility of Utilizing the CD Leycom Pressure/Conductance Catheter to Determine Optimal LV Pacing Site|Study to Determine the Safety and Feasibility of Utilizing the CD Leycom Pressure/Conductance Catheter to Determine Optimal LV Pacing Site|Withdrawn||Phase 1|0|Actual|Lancaster General Hospital||1|||f||||t||||||||||2017-10-11 03:01:47.080839|2017-10-11 03:01:47.080839
NCT01586871|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-09-01|||March 2012||2012-03-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|August 2016|Actual|2016-08-01||Observational|||Carotid Structure and Function in MPS Syndromes: A Multicenter Study of the Lysosomal Disease Network|Carotid Structure and Function in MPS Syndromes: A Multicenter Study of the Lysosomal Disease Network|Completed||N/A|27|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 03:01:47.179312|2017-10-11 03:01:47.179312
NCT01586858|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-04-25|||May 2012||2012-05-01|April 2012|2012-04-01||||||||Observational|RAVELOS||Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study|Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study|Unknown status|Enrolling by invitation|N/A|180|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 03:01:47.255762|2017-10-11 03:01:47.255762
NCT01586845|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2014-01-16|||March 2013||2013-03-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|INSPIRE||Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation|A Phase III, Randomized, Multicentre, Open-Label, Concentration-Controlled, Safety and Efficacy Study of Voclosporin and Tacrolimus in Renal Transplantation|Withdrawn||Phase 3|0|Actual|Aurinia Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 03:01:47.358285|2017-10-11 03:01:47.358285
NCT01586832|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-10-13|||January 2008||2008-01-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Stocking of a Busy Emergency Department|Stocking of a Busy Emergency Department|Completed||N/A|565|Actual|Lehigh Valley Hospital|||1||f||||f||||||||No|However, the overall study results were published in JONA, vol 44, issue 11, November, 2014.|2017-10-11 03:01:47.445636|2017-10-11 03:01:47.445636
NCT01586819|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-08-08|2017-04-12||September 2011|Actual|2011-09-01|August 2017|2017-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A|Treatment of Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A: A Split-face, Rater-blinded Randomized Control Trial|Completed||Phase 3|26|Actual|Loyola University|There are no limitations or caveats to disclose.|2|||f||||f||||||||||2017-10-11 03:01:47.524877|2017-10-11 03:01:47.524877
NCT01586806|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-10-07|2016-05-03||July 2012||2012-07-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction|Postoperative Analgesia Comparing Subsartorial Saphenous Nerve Block With and Without Dexamethasone in ACL Reconstruction|Completed||Phase 4|195|Actual|Hospital for Special Surgery, New York||3|||f||||t||||||||||2017-10-11 03:01:47.792803|2017-10-11 03:01:47.792803
NCT01586793|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-05-26|||May 2012||2012-05-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for Treating Resistant Bipolar Depression|A Randomized Trial Comparing the Effectiveness and Tolerability of High and Low Frequency Repetitive Transcranial Magnetic Stimulation for Treating Resistant Bipolar Depression: An Exploratory Study|Completed||Phase 2/Phase 3|8|Actual|Douglas Mental Health University Institute||2|||f||||f||||||||||2017-10-11 03:01:48.175424|2017-10-11 03:01:48.175424
NCT01586780|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-25|||August 2009||2009-08-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Metabolic Effects of a Pre-meal Protein Drink With or Without Added Amino Acids at a Subsequent Composite Meal|Effects of Pre-meal Drinks With Protein and Amino Acids on Glycemic and Metabolic Responses at a Subsequent Composite Meal|Completed||N/A|14|Actual|Lund University||7|||f||||f||||||||||2017-10-11 03:01:48.262306|2017-10-11 03:01:48.262306
NCT01586767|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-07-28|||July 2011||2011-07-01|July 2017|2017-07-01|July 2021|Anticipated|2021-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy|A Phase II Study of Intensity-Modulated or Proton Radiation Therapy for Locally Advanced Sinonasal Malignancy|Active, not recruiting||Phase 2|39|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:01:48.352885|2017-10-11 03:01:48.352885
NCT01586741|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-04-25|||December 2009||2009-12-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|November 2011|Actual|2011-11-01||Interventional|||A Study to Evaluate Two Different Surgical Methods for Treatment for Abdominal Wall Diastasis|A Prospective Randomized Study to Evaluate Two Different Surgical Methods for Treatment for Abdominal Wall Diastasis|Unknown status|Active, not recruiting|N/A|96|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 03:01:48.523449|2017-10-11 03:01:48.523449
NCT01586728|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-06-12|||October 2012||2012-10-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|MUCOXY||Oxygen Therapy in Cystic Fibrosis|Indication and Benefits of Nocturnal Oxygen Therapy in Cystic Fibrosis|Terminated||N/A|8|Actual|Assistance Publique - Hôpitaux de Paris||2||lack of inclusion in the study|f||||f||||||||||2017-10-11 03:01:48.615023|2017-10-11 03:01:48.615023
NCT01586715|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-25|||March 2012||2012-03-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Interventional|||Stem Cells Treatment for Extremely Complex Fistulae (HULPCIR)|A Phase IIa Clinical Trial to Study the Treatment of the Extremely Complex and Conventional Treatment Resistant Perianal Fistulae With Autologous Stem Cells From Lipoaspirate|Unknown status|Recruiting|Phase 2|10|Anticipated|Instituto de Investigación Hospital Universitario La Paz||1|||f||||f||||||||||2017-10-11 03:01:48.697339|2017-10-11 03:01:48.697339
NCT01586702|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-08-28|||September 2011||2011-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|INSPiRE-TMS||Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients|Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients (INSPiRE-TMS) A Randomized Trial Comparing a Patient Centered Support Program Versus Conventional Car|Recruiting||N/A|2082|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 03:01:48.805698|2017-10-11 03:01:48.805698
NCT01586689|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-01-11|||September 2006||2006-09-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Evaluating Alternative Aftercare Models for Ex-offenders|Evaluating Alternative Aftercare Models for Ex-offenders|Completed||Phase 2|270|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 03:01:48.908958|2017-10-11 03:01:48.908958
NCT01586676|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-01-10|||January 2009||2009-01-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Interventional|||Effectiveness of Motivational Interviewing Supervision in Community Programs|Effectiveness of Motivational Interviewing Supervision in Community Programs|Completed||Phase 2/Phase 3|450|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 03:01:49.031361|2017-10-11 03:01:49.031361
NCT01586663|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-04-27|||January 2010||2010-01-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Serial Night Time Position Splint on Systemic Sclerosis|Evaluation of Serial Night Time Position Splint on Range of Motion for Patients With Systemic Sclerosis|Unknown status|Recruiting|Phase 3|76|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 03:01:49.175292|2017-10-11 03:01:49.175292
NCT01586650|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2017-02-14|||July 2011||2011-07-01|February 2017|2017-02-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Aerobic Training in Patients With Ankylosing Spondylitis||Completed||Phase 3|70|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:01:49.29049|2017-10-11 03:01:49.29049
NCT01586637|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-04-25|||January 2011||2011-01-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Art Therapy to Treat Women With Fibromyalgia|Assessment of Art Therapy Program for Women With Fibromyalgia: Randomized, Controlled, Blinded Study|Completed||Phase 2|80|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:01:49.392485|2017-10-11 03:01:49.392485
NCT01586611|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-10-01|||June 2012||2012-06-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|Panc001||A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer|A Multicentre, Randomized, Open Label, Phase III Study of Gemcitabine Versus FOLFOX in the First Line Setting for Metastatic Pancreatic Cancer Patients Using Human Equilibrative Nucleoside Transporter 1 (hENT1) Biomarker Testing.|Unknown status|Recruiting|Phase 3|175|Anticipated|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-10-11 03:01:49.62874|2017-10-11 03:01:49.62874
NCT01586598|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-04-25|||April 2012||2012-04-01|April 2012|2012-04-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Sensory Retraining Facilitates Sensory Recovery After Mandibular Nerve Injury|Sensory Retraining Exercise Facilitates Sensory Recovery After Bilateral Sagittal Split Osteotomy - a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|80|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 03:01:49.743954|2017-10-11 03:01:49.743954
NCT01586585|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2013-10-23|||May 2012||2012-05-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|BTFL2012||Back to Functional Life Following Cardiac Surgery|Patient Rehabilitation Post Cardiac Surgery Based on Their Pre-op Status|Withdrawn||N/A|0|Actual|Carmel Medical Center|||1||f||||f||||||||||2017-10-11 03:01:49.839758|2017-10-11 03:01:49.839758
NCT01586572|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-06-26|||April 2012||2012-04-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SIAD||Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3|Comparison of Immunogenicity of Type 1 mOPV Administered at Short Intervals With Type 1 mOPV1 and Type 1 & 3 bOPV Oral Polio Vaccine Given at Standard Intervals in Pakistan:A Randomized Trial|Completed||N/A|1000|Actual|Aga Khan University||4|||f||||f||||||||||2017-10-11 03:01:49.908259|2017-10-11 03:01:49.908259
NCT01586559|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-04-26|||October 2010||2010-10-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|January 2011|Actual|2011-01-01||Observational|||Evaluation of the Long-term Stability of Sheath Plication Using Absorbable Sutures in Patients With Diastasis of the Recti Muscles: an Ultrasonography Study|Evaluation of the Long-term Stability of Sheath Plication Using Absorbable Sutures in Patients With Diastasis of the Recti Muscles: an Ultrasonography Study|Completed||N/A|65|Actual|Bulovka Hospital|||2||f||||||||||||||2017-10-11 03:01:50.006654|2017-10-11 03:01:50.006654
NCT01586546|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-26|||May 2012||2012-05-01|April 2012|2012-04-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||A Pilot Study To Assess Guidance in and Subsequent Use of Mind-Body Techniques on the Quality of Life of Cancer Patients|Quality of Life Outcomes Following Mind-body Skills Training for Cancer Patients That Are Facilitated Either Face-to-face or Online: A Pilot Study|Unknown status|Not yet recruiting|N/A|32|Anticipated|Absenger Cancer Education Foundation||4|||f||||f||||||||||2017-10-11 03:01:50.114983|2017-10-11 03:01:50.114983
NCT01507662|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-02-24|2017-02-24||February 2012||2012-02-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|PAADRN||Patient Activation After DXA Result Notification|Patient Activation After DXA Result Notification|Completed||N/A|7749|Actual|University of Iowa||2|||f||||t|f|f||||||Undecided||2017-10-11 03:25:13.522701|2017-10-11 03:25:13.522701
NCT01586533|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2014-01-07|||June 2012||2012-06-01|January 2014|2014-01-01||||April 2014|Anticipated|2014-04-01||Interventional|||Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis|A Phase II Double-blind, Randomized, Comparator-controlled Study of the Safety and Efficacy of Zoenasa™ Rectal Gel (Mesalamine Plus N-acetylcysteine) in Subjects With Left-sided Ulcerative Colitis|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|Altheus Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 03:01:50.220788|2017-10-11 03:01:50.220788
NCT01586520|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-09-14|||April 2011||2011-04-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|October 2014|Actual|2014-10-01||Observational|||Diagnosing Thyroid Cancer Using a Blood Test|Diagnosing Thyroid Cancer Using a Blood Test|Completed||N/A|400|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||2||f||||t||||||Samples With DNA|"     serum, DNA and RNA   "|||2017-10-11 03:01:50.539989|2017-10-11 03:01:50.539989
NCT01586507|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-08-28|||October 2007||2007-10-01|August 2012|2012-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of ULTRAM ER at Two Dose Levels in Adolescents With Pain|A Single Dose Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER at Two Dose Levels in Adolescents Twelve to Seventeen Years Old, Inclusive, With Pain|Completed||Phase 1|38|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 03:01:50.634893|2017-10-11 03:01:50.634893
NCT01586494|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-08-28|||October 2007||2007-10-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With Pain|A Single Dose Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER at Two Dose Levels in Children Seven to Eleven Years Old, Inclusive, With Pain|Completed||Phase 1|37|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 03:01:50.723067|2017-10-11 03:01:50.723067
NCT01586481|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2013-11-13|||June 2011||2011-06-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|SANIBA||Off- Loading Shoe to Improve Healing and Prevention of Recurrence of Neuropathic Diabetic Plantar Foot Ulcers|Effectiveness and Safety of an Off- Loading Shoe to Improve Healing and Prevention of Recurrence of Neuropathic Diabetic Plantar Foot Ulcers of the Fore Foot: a Prospective Randomised Pilot Study|Completed||Phase 3|33|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:01:50.812102|2017-10-11 03:01:50.812102
NCT01586468|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-04-25|||March 2010||2010-03-01|February 2010|2010-02-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS|A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS|Completed||Phase 2|60|Actual|Nuvo Research GmbH||2|||f||||f||||||||||2017-10-11 03:01:50.932845|2017-10-11 03:01:50.932845
NCT01586455|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-10-04|||April 2013||2013-04-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|HPDSC||Human Placental-Derived Stem Cell Transplantation|A Single-Arm Study to Assess the Safety of Transplantation With Human Placental-Derived Stem-Cells Combined With Unrelated and Related Cord Blood in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders|Recruiting||Phase 1|30|Anticipated|New York Medical College||4|||f||||t||||||||||2017-10-11 03:01:51.047283|2017-10-11 03:01:51.047283
NCT01586442|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-03-27|||March 2012||2012-03-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|March 2015|Actual|2015-03-01||Interventional|SNOW||Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes|A Comparison of the Effects of Selective and Non Selective Mineralocorticoid Antagonism on Glucose Homeostasis and Lipid Profile of Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes.|Active, not recruiting||Phase 3|62|Actual|Montreal Heart Institute||2|||f||||t||||||||||2017-10-11 03:01:51.199277|2017-10-11 03:01:51.199277
NCT01586429|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2012-04-25||||||February 2011|2011-02-01||||||||Observational|||Ultrasound Guided Femoral Nerve Block Catheter Analgesia Compared With Epidural Analgesia for Patients With Knee OA (Osteoarthritis) Who Underwent Unilateral Total Knee Replacement||Unknown status|Recruiting|Early Phase 1|||King Saud University|||2||f||||||||||||||2017-10-11 03:01:51.308096|2017-10-11 03:01:51.308096
NCT01586416|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-09-21|||December 2012||2012-12-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|September 2014|Actual|2014-09-01||Interventional|||Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients|Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:01:51.405314|2017-10-11 03:01:51.405314
NCT01586403|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-07-24|||July 2012||2012-07-01|July 2012|2012-07-01|September 2028|Anticipated|2028-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Transfer of Genetically Engineered Lymphocytes in Melanoma Patients|Transfer of Genetically Engineered Lymphocytes in Melanoma Patients: A Phase 1 Dose Escalation Study|Recruiting||Phase 1|15|Anticipated|Loyola University||4|||f||||t||||||||||2017-10-11 03:01:51.506734|2017-10-11 03:01:51.506734
NCT01586390|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-24|||June 2009||2009-06-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Functional Treatment for Acute Ankle Sprains: Softcast Wrap Versus MOKcast|Functional Treatment for Acute Ankle Sprains: Softcast Wrap Versus MOKcast. A Prospective Randomized Single-centre Trial|Completed||Phase 2|100|Actual|Spaarne Gasthuis||2|||f||||f||||||||||2017-10-11 03:01:51.643509|2017-10-11 03:01:51.643509
NCT01586377|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2013-07-02|||August 2011||2011-08-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Near-infrared Spectroscopic Measurement in Complex Regional Pain Syndrome|Near-infrared Spectroscopic Measurement of Tissue Oxygen Saturation and the Vascular Occlusion Test in Complex Regional Pain Syndrome|Completed||N/A|20|Actual|Lawson Health Research Institute|||2||f||||t||||||||||2017-10-11 03:01:51.725275|2017-10-11 03:01:51.725275
NCT01586364|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-05-21|2013-03-20||May 2006||2006-05-01|March 2013|2013-03-01||||||||Interventional|||Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus|Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus: A 52-Week Open-Label Follow-Up to Protocol 15-50310|Completed||Phase 3|301|Actual|Shionogi Inc.||1|||f||||||||||||||2017-10-11 03:01:51.928159|2017-10-11 03:01:51.928159
NCT01577043|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-04-12|||September 2011||2011-09-01|June 2011|2011-06-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy of Racecadotril in Acute Watery Diarrhea in Children|Efficacy of Racecadotril in the Management of Acute Watery Diarrhea in Children|Completed||Phase 4|52|Actual|Centro Pediatrico Albina de Patino||2|||f||||f||||||||||2017-10-11 03:04:34.399908|2017-10-11 03:04:34.399908
NCT01586351|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-04-21|||October 2012||2012-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2014|Actual|2014-02-01||Observational|||Rotator Cuff Reconstruction With Xenologous Dermis-patch Augmentation and ACP® - Injection|Arthroscopic Rotator Cuff Reconstruction With Xenologous Dermis-patch Augmentation and ACP® - Injection in Patients Over 60 Years (ACP = Autologous Conditioned Plasma)|Completed||N/A|20|Actual|Schulthess Klinik|||1||f||||f||||||||||2017-10-11 03:01:53.086067|2017-10-11 03:01:53.086067
NCT01586338|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-01-27|2016-01-27||March 2012||2012-03-01|January 2016|2016-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)|A Multicenter, Prospective, Open-label, Single Arm Study of the Efficacy and Safety of Synvisc® (Hylan G-F 20) in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)|Completed||Phase 4|237|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:01:53.204683|2017-10-11 03:01:53.204683
NCT01586325|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-07-10|||May 2012||2012-05-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients|A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Trial in Asian Genotype 1 Chronic HCV-Infected Subjects to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Repeated Doses of JNJ-47910382 Given in Different Doses and Dose Regimens|Unknown status|Recruiting|Phase 1|18|Anticipated|Janssen R&D Ireland||3|||f||||f||||||||||2017-10-11 03:01:53.745136|2017-10-11 03:01:53.745136
NCT01586312|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-09-26|2014-09-24||April 2012||2012-04-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|MSV_allo||Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells|Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Mesenchymal Stromal Cells From Valladolid|Completed||Phase 1/Phase 2|30|Actual|Red de Terapia Celular||2|||f||||t||||||||||2017-10-11 03:01:53.927743|2017-10-11 03:01:53.927743
NCT01586299|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-11-13|||March 2012||2012-03-01|January 2012|2012-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||NSAIDs Treatment in Children With Pleuropneumonia|The Role of Non Steroidal Anti Inflammatory Drugs in the Treatment of Pleuropneumonia in Children. a Randomized Controlled Trial|Unknown status|Recruiting|N/A|40|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 03:01:54.610364|2017-10-11 03:01:54.610364
NCT01586286|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2014-05-21|||July 2012||2012-07-01|May 2014|2014-05-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||A Study Examining the Use of Vaginal Nifedipine With Pelvic Floor Physical Therapy for Levator Myalgia and Pelvic Pain|Does Adjunctive Treatment With Vaginal Nifedipine Result in Symptomatic Improvement in Patients With Levator Myalgia and Pelvic Floor Pain Who Are Undergoing Pelvic Floor Physical Therapy?|Withdrawn||N/A|0|Actual|Vanderbilt University||2||No patients were recruited over a 12 month period|f||||f||||||||||2017-10-11 03:01:54.704718|2017-10-11 03:01:54.704718
NCT01586273|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-04-03|||September 2012||2012-09-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound for Pain Palliation of Bone Metastases|Magnetic Resonance-guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases - a Multicenter Study|Terminated||N/A|20|Actual|Philips Healthcare||1|||f||||t||||||||||2017-10-11 03:01:54.9215|2017-10-11 03:01:54.9215
NCT01586260|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-04-25|||June 2012|Actual|2012-06-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission|A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission|Active, not recruiting||Phase 2|89|Actual|Spectrum Health Hospitals||1|||f||||t||||||||||2017-10-11 03:01:55.066441|2017-10-11 03:01:55.066441
NCT01586247|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-26|||March 2008||2008-03-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||The Effect of a Prebiotic, Probiotic and Synbiotic on the Gut Microbiota and Immune Response of Older Volunteers (GOS)|A Double-blind, Placebo-controlled, Randomized Crossover Study of a Prebiotic (Galacto-oligosaccharides, GOS), Probiotic (B.Lactis, BI07) and Synbiotic (GOS + BI07) on the Gut Microbiota and Immune Response of Older Volunteers|Completed||N/A|40|Actual|University of Reading||4|||f||||f||||||||||2017-10-11 03:01:55.23728|2017-10-11 03:01:55.23728
NCT01586234|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-05-16|||January 2012||2012-01-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|DSAEK||OCT-guided DSAEK Graft Shaping and Smoothing|Randomized Clinical Trial of OCT-guided DSAEK Graft Shaping and Smoothing|Suspended||N/A|62|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 03:01:55.355067|2017-10-11 03:01:55.355067
NCT01586221|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2017-07-19|||January 1, 2012|Actual|2012-01-01|July 2017|2017-07-01|May 1, 2017|Actual|2017-05-01|May 2016|Actual|2016-05-01||Interventional|MT/PT||Music Therapy/Physical Therapy Intervention to Enhance Well-being and Functional Recovery Post-stroke|A Collaborative Music Therapy/Physical Therapy Intervention to Enhance Well-being and Functional Recovery Post-stroke|Completed||N/A|30|Actual|New York University School of Medicine||1|||f||||t|f|f||||||||2017-10-11 03:01:55.487552|2017-10-11 03:01:55.487552
NCT01586208|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2013-03-10|||January 2010||2010-01-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional|||Refractory Status Epilepticus Treatment Study|Refractory Status Epilepticus: Plasmatic Levels Monitorization Utility|Completed||Phase 3|5|Actual|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 03:01:55.610756|2017-10-11 03:01:55.610756
NCT01586195|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-04-24|2016-07-07||October 31, 2011|Actual|2011-10-31|April 2017|2017-04-01|April 30, 2015|Actual|2015-04-30|April 30, 2015|Actual|2015-04-30||Interventional||Intent to treat (ITT) population defined as all enrolled participants who received any amount of study drug.|Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E|An Open-Label, Multicenter, Phase II Study Of Continuous Oral Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E|Terminated||Phase 2|31|Actual|Genentech, Inc.||1||Recruitment challenges|f||||t||||||||||2017-10-11 03:01:55.78157|2017-10-11 03:01:55.78157
NCT01586182|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-09-02|||November 2011||2011-11-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|April 2012|Actual|2012-04-01||Interventional|||Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma|Stereotactic Boost for Poor-Prognosis Oropharyngeal Squamous Cell Carcinoma|Withdrawn||Phase 1/Phase 2|0|Actual|Dana-Farber Cancer Institute||1||Local IRB closed the study due to poor accural.|f||||t||||||||||2017-10-11 03:01:56.514802|2017-10-11 03:01:56.514802
NCT01586169|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-24|||February 2010||2010-02-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|AZIVAL||Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination|A Pharmacovigilance Study on the Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults Living in the Sikasso Region of Mali|Completed||N/A|3000|Actual|Centre d'Appui à la lutte contre la Maladie||1|||f||||t||||||||||2017-10-11 03:01:56.609144|2017-10-11 03:01:56.609144
NCT01586143|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-07-04|||May 2012||2012-05-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PARAJUG||Clinical Study Comparing the Efficacy of Transbuccal Paracetamol 125 mg Versus Paracetamol Injection 1g in Slow Infusion IV in Patients With Acute Pain|Clinical Study Comparing the Efficacy of Transbuccal Paracetamol 125 mg Versus Paracetamol Injection 1g in Slow Infusion IV in Patients With Acute Pain|Completed||Phase 3|43|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 03:01:56.83601|2017-10-11 03:01:56.83601
NCT01586130|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-01-11|||February 2012||2012-02-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|August 2014|Anticipated|2014-08-01||Interventional|ISOGO||Assessing the Impact of Isokinetic Muscular Strengthening in Eccentric Mode in the Medical Treatment of Knee Osteoarthritis|Assessing the Impact of Isokinetic Muscular Strengthening in Eccentric Mode in the Medical Treatment of Knee Osteoarthritis.|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 03:01:56.965272|2017-10-11 03:01:56.965272
NCT01586117|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2013-08-14|||February 2012||2012-02-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity|A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity|Unknown status|Recruiting|Phase 2|40|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:01:57.103344|2017-10-11 03:01:57.103344
NCT01586065|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-06-10|||February 2012||2012-02-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes|Use of CGM in Adolescents With Poorly-controlled Type 1 Diabetes|Completed||N/A|10|Actual|Nemours Children's Clinic||2|||f||||f||||||||No||2017-10-11 03:01:57.459428|2017-10-11 03:01:57.459428
NCT01586052|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-04-07|||June 2012||2012-06-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1|A Phase 1 Clinical Research of Erythropoietin Therapy for Children With Cerebral Palsy: Safety and Efficacy|Completed||Phase 1|11|Actual|Bundang CHA Hospital||1|||f||||f||||||||||2017-10-11 03:01:57.55622|2017-10-11 03:01:57.55622
NCT01586039|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-03-08|||August 2012||2012-08-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep|Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep.|Completed||N/A|36|Actual|Brigham and Women's Hospital||2|||f||||f||f||||||||2017-10-11 03:01:57.668638|2017-10-11 03:01:57.668638
NCT01586026|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-07-13|2014-07-10||April 2012||2012-04-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|DISTAL|Post-infusional chemotherapy subjects that had Bard implanted ports with distally valved catheters.|Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters|A Retrospective Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters|Terminated||N/A|171|Actual|C. R. Bard|||3|Insufficient number of adverse events|f||||f||||||||No|Study was terminated due to limited number of adverse events recorded.|2017-10-11 03:01:57.795132|2017-10-11 03:01:57.795132
NCT01586013|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-25|||October 2010||2010-10-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|ke0agedep||the Effect Site Equilibration Time of Propofol is Age Dependant|Importance of Age as Covariable in the Requirements to Determine the Drug Plasma -Site Effect Equilibration Time for TCI Propofol Pharmacokinetic Models|Completed||Phase 4|45|Actual|Universidad del Desarrollo||1|||f||||t||||||||||2017-10-11 03:01:58.161573|2017-10-11 03:01:58.161573
NCT01586000|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-02-19|||March 2012||2012-03-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women|A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women|Completed||Phase 2|197|Actual|Health Decisions||3|||f||||||||||||||2017-10-11 03:01:58.259193|2017-10-11 03:01:58.259193
NCT01585987|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-04-15|2015-07-15||July 2012||2012-07-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|July 2014|Actual|2014-07-01||Interventional||All participants randomized to a treatment arm are summarized.|An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy|A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer|Completed||Phase 2|143|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 03:01:58.401489|2017-10-11 03:01:58.401489
NCT01585974|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-10-18|||October 2012||2012-10-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Observational|TURCOS||Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma|Duration of Treatment With TKIs in the Treatment of Metastatic Renal Cell Carcinoma|Completed||N/A|151|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:01:59.617683|2017-10-11 03:01:59.617683
NCT01585961|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-01-20|2015-01-13||April 2012||2012-04-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|SFAF|Enrolled patients|NAVISTAR® THERMOCOOL® SF Catheter: Observational Study|NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population|Completed||Phase 4|511|Actual|Biosense Webster, Inc.|||1||f||||f||||||||||2017-10-11 03:01:59.749776|2017-10-11 03:01:59.749776
NCT01585948|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-05-03|||November 2009||2009-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2013|Actual|2013-05-01||Observational|||Study of the Effect of Diabetes on the Incidence and the Extent of Coronary Artery Disease|The Role of Newer and Traditional Risk Factors in the Development, Extent and Manifestation of Coronary Artery Disease|Active, not recruiting||N/A|1000|Anticipated|University of Ioannina|||3||f||||f||||||Samples With DNA|"     Includes retaining blood samples for DNA analyses and biochemical markers.   "|||2017-10-11 03:02:01.946557|2017-10-11 03:02:01.946557
NCT01585935|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-08-09|||June 2012||2012-06-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|June 2015|Actual|2015-06-01||Interventional|||Preventing Cholestasis Using SMOFLipid®|Preventing Cholestasis in Premature Infants Using SMOFLipid®|Active, not recruiting||Phase 4|200|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 03:02:02.042669|2017-10-11 03:02:02.042669
NCT01585922|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-09-10|||July 2012||2012-07-01|September 2012|2012-09-01||||July 2013|Anticipated|2013-07-01||Interventional|||Noninvasive Positive Pressure Ventilation in Moderate Acute Respiratory Distress Syndrome||Unknown status|Recruiting|N/A|200|Anticipated|Beijing Hospital||2|||f||||||||||||||2017-10-11 03:02:02.135199|2017-10-11 03:02:02.135199
NCT01585909|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-08-28|||July 2011||2011-07-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Intestinal Brush Border Enzyme Function in Critically Ill Patients|Evaluation of Intestinal Brush Border Enzyme Function in Patients With SIRS and Septic Shock Compared to Control Patients|Completed||N/A|39|Actual|Medical University of Vienna||3|||f||||f||||||||||2017-10-11 03:02:02.217435|2017-10-11 03:02:02.217435
NCT01585896|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-04-12|||April 2012||2012-04-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Self-Help Group for the Treatment of Hoarding Disorder|Self-Help Group for the Treatment of Hoarding Disorder|Recruiting||N/A|60|Anticipated|University of Miami||1|||f||||f||||||||||2017-10-11 03:02:02.299207|2017-10-11 03:02:02.299207
NCT01585883|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-03-04|||May 2012||2012-05-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Self-Management Intervention for Breathlessness in Lung Cancer|A Pilot Trial of a Self-Management Intervention for Breathlessness in Lung Cancer|Active, not recruiting||N/A|56|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:02:02.442781|2017-10-11 03:02:02.442781
NCT01585870|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-10-26|||July 2012||2012-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination|A Phase 1, Multi-center, Non-randomized, Open Label, Dose Escalation Design Study of Sorafenib (BAY43-9006) in Combination With Eribulin in Subjects With Advanced, Metastatic or Refractory Solid Tumors|Completed||Phase 1|40|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:02:02.596694|2017-10-11 03:02:02.596694
NCT01585857|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-12-03|||April 2012||2012-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||ADIPOA - Clinical Study|A Phase I, Prospective, Bi-centric,Single -Arm, Open-label, Dose-escalating Clinical Trial to Evaluate the Safety of a Single Injection of Autologous Adipose Derived Mesenchymal Stromal Cells in the Treatment of Severe Osteoarthritis of the Knee Joint|Completed||Phase 1|18|Actual|University Hospital, Montpellier||3|||f||||t||||||||||2017-10-11 03:02:02.696764|2017-10-11 03:02:02.696764
NCT01585844|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-25|||August 2008||2008-08-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|SAPSS||Sleep Apnea in Pregnancy Screening Study|Obstructive Sleep Apnea in Pregnancy:Epidemiology and Maternal/ Neonatal Morbidity|Completed||N/A|182|Actual|MetroHealth Medical Center|||2||f||||f||||||Samples With DNA|"     urine serum   "|||2017-10-11 03:02:02.787011|2017-10-11 03:02:02.787011
NCT01585831|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-06-28|||March 2012||2012-03-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|TestoXXY/KS||Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome|Psychological and Motor Effects of Testosterone Therapy in Adolescents With XXY/Klinefelter Syndrome|Recruiting||N/A|50|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 03:02:02.872601|2017-10-11 03:02:02.872601
NCT01585818|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2014-01-15|||August 2011||2011-08-01|January 2014|2014-01-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01||Interventional|DIDM||Dietary Intervention in Diabetes Mellitus (DIDM)- Intermediate and Acute Effects|Nutrition Studies and Dietary Intervention in Individuals With Type 2 Diabetes Mellitus of Chinese, Malay and Indian Ethnicity|Unknown status|Recruiting|Phase 2|160|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 03:02:02.984771|2017-10-11 03:02:02.984771
NCT01585805|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-07-25|||April 18, 2012|Actual|2012-04-18|July 2017|2017-07-01||||July 25, 2017|Anticipated|2017-07-25||Interventional|||Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Randomized Phase II Study of Gemcitabine, Cisplatin +/- Veliparib in Patients With Pancreas Adenocarcinoma and a Known BRCA/ PALB2 Mutation (Part I) and a Phase II Single Arm Study of Single-Agent Veliparib in Previously Treated Pancreas Adenocarcinoma (Part II)|Recruiting||Phase 2|107|Anticipated|National Cancer Institute (NCI)||3|||f||||f||||||||||2017-10-11 03:02:03.102099|2017-10-11 03:02:03.102099
NCT01585792|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2013-04-15|||May 2012||2012-05-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Double Blind Comparative Study of TAK-875||Completed||Phase 3|80|Actual|Takeda||4|||f||||||||||||||2017-10-11 03:02:03.325883|2017-10-11 03:02:03.325883
NCT01585779|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-05-04|2017-03-21||May 2012||2012-05-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|Contour3D||Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial|Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial|Completed||N/A|64|Actual|Medtronic Cardiovascular|||2||f||||f||||||||||2017-10-11 03:02:03.433322|2017-10-11 03:02:03.433322
NCT01585753|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2016-01-18|||June 2012||2012-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|MARCH VE||MARCH Vascular Endothelium Substudy|Maraviroc Switch Vascular Endothelium (VE) Substudy: a Substudy of MARCH|Completed||N/A|34|Actual|Kirby Institute|||3||f||||t||||||||||2017-10-11 03:02:04.564888|2017-10-11 03:02:04.564888
NCT01585740|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-06-13|||September 2011||2011-09-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Ringer's Lactate Versus Normal Saline in Caesarean Section|Effect of Ringer's Lactate on Maternal and Neonatal pH in Caesarean Section at Mulago Hospital, a Randomized Trial|Completed||N/A|500|Actual|Makerere University||2|||f||||t||||||||||2017-10-11 03:02:04.707831|2017-10-11 03:02:04.707831
NCT01585727|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-08-15|||June 2012||2012-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|NEUROS||Intraoperative Monitoring of the Pelvic Autonomic Nerves|Continuous Intraoperative Monitoring of the Pelvic Autonomic Nerves During Total Mesorectal Excision (TME) for the Prevention of Urogenital and Anorectal Dysfunction in Patients With Rectal Cancer.|Recruiting||N/A|188|Anticipated|Johannes Gutenberg University Mainz||2|||f||||t||||||||||2017-10-11 03:02:04.802709|2017-10-11 03:02:04.802709
NCT01585701|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-25|2017-02-22|||May 2012||2012-05-01|January 2017|2017-01-01||||May 2017|Anticipated|2017-05-01||Interventional|||Phase I Study of AT13148, a Novel AGC Kinase Inhibitor|A Cancer Research UK Phase I First in Man Study of the Novel AGC Kinase Inhibitor AT13148 Given Orally in Patients With Advanced Solid Tumours.|Recruiting||Phase 1|40|Anticipated|Cancer Research UK|||||f||||f||||||||||2017-10-11 03:02:04.912919|2017-10-11 03:02:04.912919
NCT01585688|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-09-03|||August 2012||2012-08-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|November 2016|Anticipated|2016-11-01||Interventional|||Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL|A Phase I/II Study of Immunotherapy With hLL1-DOX in Patients With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|Immunomedics, Inc.||1|||f||||f||||||||||2017-10-11 03:02:04.99946|2017-10-11 03:02:04.99946
NCT01585675|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-08-29|||November 2005||2005-11-01|August 2017|2017-08-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Observational|||Specimen Banking From Patients With Lung Cancer|Specimen Banking From Patients With Lung Cancer|Recruiting||N/A|1000|Anticipated|University of Colorado, Denver|||1||f||||t||||||Samples With DNA|"     Tissue, blood, urine, and sputum, breath   "|||2017-10-11 03:02:05.122214|2017-10-11 03:02:05.122214
NCT01585662|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-24|||January 2012||2012-01-01|April 2012|2012-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents|Random Comparing Study on Two Different EUS-guided Pseudocyst Drainage Methods--Modified Naso-pancreatic Tube Drainage and Stents Drainage|Unknown status|Recruiting|Phase 4|30|Anticipated|Fourth Military Medical University||2|||f||||f||||||||||2017-10-11 03:02:05.229947|2017-10-11 03:02:05.229947
NCT01585649|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-05-17|||July 2012||2012-07-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|June 2014|Actual|2014-06-01||Interventional|||PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma|Multicenter, Open-label Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, Safety, Tolerability, and Immunogenicity of a Single, Subcutaneous Dose of 100µg/kg XM22 in 21 Children With Ewing Family of Tumors or Rhabdomyosarcoma|Completed||Phase 1|21|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 03:02:05.353997|2017-10-11 03:02:05.353997
NCT01585636|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-08-16|||September 2006||2006-09-01|August 2013|2013-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers|A Phase Ia, Randomized, Placebo-Controlled, Single-Dose, Double-Blind, Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of SQ109 in Normal, Healthy Male and Female Volunteers|Completed||Phase 1|62|Actual|Sequella, Inc.||8|||f||||f||||||||||2017-10-11 03:02:05.475182|2017-10-11 03:02:05.475182
NCT01585623|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-03-21|||June 2012||2012-06-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Drug Interaction Study of SAR302503 in Patients With Solid Tumor|An Open-label, Two-treatment Crossover Pharmacokinetic Interaction Study of Repeated Doses of SAR302503 on Pharmacokinetics of a Single Dose Cocktail of Omeprazole, Metoprolol, and Midazolam Used as Probe Substrates for CYP2C19, CYP2D6 and CYP3A4 Activities, Respectively in Adult Patients With Refractory Solid Tumors|Completed||Phase 1|16|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:02:05.583377|2017-10-11 03:02:05.583377
NCT01585610|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-05-13|||September 2012||2012-09-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|August 2015|Anticipated|2015-08-01||Interventional|ABLE||Motivating Smokers With Mobility Impairments to Quit Smoking|Motivating Smokers With Mobility Impairments to Quit Smoking|Unknown status|Active, not recruiting|Phase 3|560|Anticipated|The Miriam Hospital||2|||f||||f||||||||||2017-10-11 03:02:05.674222|2017-10-11 03:02:05.674222
NCT01585597|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2014-07-07|2014-01-07||May 2012||2012-05-01|July 2014|2014-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|ReCCLAIM||Reperfusion With Cooling in Cerebral Acute Ischemia|Phase 1 Study of Mild Induced Hypothermia After Endovascular Revascularization in Acute Ischemic Stroke of the Anterior Circulation|Completed||Phase 1|20|Actual|Emory University||1|||f||||f||||||||||2017-10-11 03:02:05.78097|2017-10-11 03:02:05.78097
NCT01585584|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2015-08-22|2015-08-22||May 2012||2012-05-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|LeeG3||Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment|Triple-Therapy With PegInterferon α-2b + Ribavirin + Boceprevir in Patients With HCV Genotype 3 Who Previously Failed Treatment With PegInterferon α + Ribavirin|Completed||Phase 3|11|Actual|University of Calgary|Small sample size (n=11)|1|||f||||t||||||||||2017-10-11 03:02:05.985298|2017-10-11 03:02:05.985298
NCT01585571|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-02-08|||April 2012||2012-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Balance and Posture in Adults With Cerebral Palsy|Observational Study of Balance and Posture in Adults With Cerebral Palsy|Active, not recruiting||N/A|80|Actual|Temple University|||2||f||||f||||||||||2017-10-11 03:02:06.319897|2017-10-11 03:02:06.319897
NCT01585558|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-05-21|2013-03-20||May 2006||2006-05-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus|Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus: A 40 Week Randomized, Double Blind, Placebo Controlled, Follow-Up to Protocol 15-50310.|Completed||Phase 3|180|Actual|Shionogi Inc.||3|||f||||||||||||||2017-10-11 03:02:06.470283|2017-10-11 03:02:06.470283
NCT01585545|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2016-10-12|||October 2013||2013-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|||Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers|Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers|Recruiting||N/A|500|Anticipated|Samsung Medical Center|||1||f||||t||||||Samples With DNA|"     lung cance tissue   "|||2017-10-11 03:02:09.488837|2017-10-11 03:02:09.488837
NCT01585532|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-11-03|||January 2012||2012-01-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Observational|||Alere Mycobacterium Tuberculosis Urine Study|Evaluation of Various Methods for the Detection of Mycobacterium Tuberculosis Nucleic Acid|Completed||N/A|60|Actual|Research Center Borstel|||2||f||||f||||||Samples Without DNA|"     Urine Sputum Blood   "|||2017-10-11 03:02:09.58783|2017-10-11 03:02:09.58783
NCT01585519|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-10-15|||April 2012||2012-04-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|October 2013|Actual|2013-10-01||Interventional|APPS||A Study Examining Effects of Apples/ Apple Products on Heart Disease Risk|Effect of Increased Whole Apple Consumption, Apple Extract and Freeze-dried Apple Products on Biomarkers of Cardiovascular Disease Risk: a Randomised Intervention in Participants at Increased Risk of Cardiovascular Disease|Unknown status|Active, not recruiting|N/A|50|Anticipated|Queen's University, Belfast||5|||f||||t||||||||||2017-10-11 03:02:09.667421|2017-10-11 03:02:09.667421
NCT01585506|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-10-27|||September 2010||2010-09-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues|Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues|Completed||N/A|3618|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:02:09.807913|2017-10-11 03:02:09.807913
NCT01585493|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-10-26|||December 2012||2012-12-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||CHANGE -it is About Life|CHANGE.A Randomized Clinical Trial of Health Promoting Programme Versus Standard Treatment for Patients With Schizophrenia|Completed||Phase 3|428|Actual|Mental Health Services in the Capital Region, Denmark||3|||f||||f||||||||||2017-10-11 03:02:09.886455|2017-10-11 03:02:09.886455
NCT01585480|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-03-13|||November 2010||2010-11-01|March 2017|2017-03-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|Go!||"Preventing Obesity in the Worksite: A Multi-Message, Multi-Step Approach"|"Preventing Obesity in the Worksite: A Multi-Message, Multi-Step Approach"|Completed||N/A|499|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||No||2017-10-11 03:02:09.982125|2017-10-11 03:02:09.982125
NCT01585467|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-05-05|||February 2010||2010-02-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Anterior Shoulder Dislocation|Selective Radiography in Anterior Shoulder Dislocation: Prospective Validation Rule of Decision Rules Derived in Fresno and Quebec|Completed||N/A|300|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 03:02:10.094758|2017-10-11 03:02:10.094758
NCT01585454|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-06-30|||March 27, 2012||2012-03-27|January 20, 2016|2016-01-20|January 20, 2016||2016-01-20|||||Observational|||Healthy Lifestyle in Pregnancy|Healthy Lifestyle in Pregnancy|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:02:10.20543|2017-10-11 03:02:10.20543
NCT01585441|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-11-25|2014-10-29||April 2012||2012-04-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Finasteride for Chronic Central Serous Chorioretinopathy|Phase II, Randomized, Placebo-Controlled Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|This study was terminated early due to lack of enrollment.|2||This study was terminated early due to lack of enrollment.|f||||t||||||||||2017-10-11 03:02:10.295815|2017-10-11 03:02:10.295815
NCT01585428|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-02-01|2017-02-01||April 13, 2012|Actual|2012-04-13|January 2017|2017-01-01|August 1, 2016|Actual|2016-08-01|April 9, 2016|Actual|2016-04-09||Interventional|||Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers|A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Aldesleukin for Human Papillomavirus-Associated Cancers|Completed||Phase 2|29|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t|t|f||||||No||2017-10-11 03:02:10.993895|2017-10-11 03:02:10.993895
NCT01585415|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-10-05|||April 9, 2012||2012-04-09|July 21, 2016|2016-07-21|July 21, 2016|Actual|2016-07-21|July 21, 2016|Actual|2016-07-21||Interventional|||Vemurafenib and White Blood Cell Therapy for Advanced Melanoma|A Pilot Trial of the Combination of Vemurafenib With Adoptive Cell Therapy in Patients With Metastatic Melanoma|Terminated||Phase 1|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:02:11.664674|2017-10-11 03:02:11.664674
NCT01585402|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-06-30|||April 9, 2012||2012-04-09|December 16, 2016|2016-12-16|December 5, 2017|Anticipated|2017-12-05|December 5, 2017|Anticipated|2017-12-05||Interventional|||Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)|An Open-label, Non-Randomized, Single-Arm Pilot Study to Evaluate the Effectiveness of Etidronate Treatment for Arterial Calcifications Due to Deficiency in CD73 (ACDC)|Recruiting||Phase 1|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:02:11.826556|2017-10-11 03:02:11.826556
NCT01585389|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-05-17|||April 2012||2012-04-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Gene Expression and Location in Samples From Patients With Brain Tumors|Expression and Subcellular Localization of NEIL3 in Tumors|Completed||N/A|10|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:02:11.933607|2017-10-11 03:02:11.933607
NCT01585376|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-05-17|||April 2012||2012-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma|Study Recurrency Testing of Mutations Identified in WGS of Pediatric Rhabdomyosarcoma|Completed||N/A|58|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:02:12.011786|2017-10-11 03:02:12.011786
NCT01585350|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-08-11|||October 2012||2012-10-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|MEL58||A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients|A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients, With Evaluation of the Injection Site Microenvironment|Completed||Phase 1|53|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 03:02:12.095881|2017-10-11 03:02:12.095881
NCT01585337|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-07-07|||January 2012||2012-01-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|February 2016|Anticipated|2016-02-01||Observational|||Trunk Forward Ability in Patients With Lumbar Fusion|Joint Coordination Changes During Functional Activities After Lumbar Fusion|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 03:02:12.216728|2017-10-11 03:02:12.216728
NCT01585324|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-06-25|2015-06-25||January 2012||2012-01-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Intent-to-treat (ITT) analysis population included all enrolled participants who received at least 1 dose of study drug.|A Study of The Relationship Between Drop in Hemoglobin and Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a)|Open, Multicenter Phase IV Study, Evaluating Drop of Hemoglobin in Association to the Rate of Sustained Virological Response in Chronic Hepatitis C Patients Treated With Ribavirin (Copegus®) in Combination With Standard Treatment (ANECO)|Completed||Phase 4|30|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:02:12.342458|2017-10-11 03:02:12.342458
NCT01585311|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-24|||April 2012||2012-04-01|April 2012|2012-04-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Observational|||Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)|Impact of Prolonged Tachycardia on Cardiovascular Morbidity and Outcome After Subarachnoid Hemorrhage (SAH)|Unknown status|Enrolling by invitation|N/A|400|Anticipated|Columbia University|||1||f||||f||||||||||2017-10-11 03:02:12.717191|2017-10-11 03:02:12.717191
NCT01585298|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-02-28|||June 29, 2012|Actual|2012-06-29|February 2017|2017-02-01|December 12, 2016|Actual|2016-12-12|December 12, 2016|Actual|2016-12-12||Interventional|START||STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)|A 1-week, Open-label, Multi-center Study to Explore Conduction Abnormalities During First Dose Administration of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis|Completed||Phase 4|6996|Actual|Novartis||1|||f||||t||||||||||2017-10-11 03:02:12.845192|2017-10-11 03:02:12.845192
NCT01585285|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2017-08-02|||July 2012||2012-07-01|August 2017|2017-08-01|June 2028|Anticipated|2028-06-01|June 2019|Anticipated|2019-06-01||Interventional|AMI-PONT||Coronary Artery Bypass Grafting Strategies for the Anterolateral Territory: a Prospective Randomized Clinical Trial|Composite Arterial and Venous Grafting Strategy Versus Conventional Coronary Artery Bypass Grafting for the Anterolateral Territory: a Prospective Randomized Clinical Trial|Recruiting||N/A|200|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 03:02:13.767336|2017-10-11 03:02:13.767336
NCT01585272|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-09-22|2016-06-24||August 2012||2012-08-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia|A 52-week, Prospective, Multi-center, Open-label Study to Assess the Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Patients With Alzheimer's Dementia in a Controlled Titration Schedule|Completed||Phase 4|121|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:02:13.896393|2017-10-11 03:02:13.896393
NCT01585259|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-06-02|||July 2012||2012-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Anfibatide Phase Ib-IIa Clinical Trial|A Multi-center, Randomized, Double-blind, Multi-dose Group, Parallel Group and Placebo Controlled Phase Ib-IIa Clinical Study to Evaluate the Safety and Efficacy of Antiplatelet Thrombolysin for Injection for the Treatment of Patients With Non-ST Segment Elevation Myocardial Infarction (NSTEMI).|Completed||Phase 1/Phase 2|90|Anticipated|Lee's Pharmaceutical Limited||2|||f||||t||||||||||2017-10-11 03:02:14.275401|2017-10-11 03:02:14.275401
NCT01585246|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-07-13|2016-05-04||October 2011||2011-10-01|July 2017|2017-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Saw Palmetto: Symptom Management for Men During Radiation Therapy|Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients|Completed||Phase 1/Phase 2|48|Actual|Michigan State University||3|||f||||t||||||||||2017-10-11 03:02:14.363249|2017-10-11 03:02:14.363249
NCT01585233|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-01-19|||April 2012||2012-04-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Sequential, Multiple Dose Escalation Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 2|60|Actual|Astellas Pharma Inc||5|||f||||f||||||||||2017-10-11 03:02:15.103441|2017-10-11 03:02:15.103441
NCT01585220|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-24|||February 2012||2012-02-01|April 2012|2012-04-01|October 2012|Anticipated|2012-10-01|August 2012|Anticipated|2012-08-01||Interventional|||Efficacy and Safety Study of Neuramis in Correction of Nasolabial Fold|A Randomized, Multi-center, Double Masked, Matched Pairs, Active-controlled Clinical Trial to Evaluate the Efficacy and Safety of Injection With Neuramis as Compared to Restylane® in Correction of Nasolabial Fold|Unknown status|Recruiting|Phase 3|69|Anticipated|Medy-Tox||2|||f||||f||||||||||2017-10-11 03:02:15.237588|2017-10-11 03:02:15.237588
NCT01585194|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-10-05|||November 2012|Actual|2012-11-01|October 2017|2017-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Phase II Study of Nivolumab in Combination With Ipilimumab for Uveal Melanoma|Phase II Study of Nivolumab in Combination With Ipilimumab for Uveal Melanoma|Recruiting||Phase 2|52|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:02:15.443323|2017-10-11 03:02:15.443323
NCT01582984|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-04-21|||February 2008||2008-02-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Patient Understanding and Satisfaction in Informed Consent for Total Knee Arthroplasty|Patient Understanding and Satisfaction in Informed Consent for Total Knee Arthroplasty|Completed||N/A|176|Actual|Minneapolis Veterans Affairs Medical Center||3|||f||||f||||||||||2017-10-11 03:02:53.18168|2017-10-11 03:02:53.18168
NCT01585181|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-03-12|||April 2012||2012-04-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Interventional|||Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200|A Phase 1 Randomized, Double-Blind Placebo Controlled Study to Evaluate the Safety and Immunogenicity of the LIve Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae Serotype 01 Inaba CVD 103-HgR Vaccine Strain|Completed||Phase 1|66|Actual|PaxVax, Inc.||2|||f||||f||||||||||2017-10-11 03:02:15.558153|2017-10-11 03:02:15.558153
NCT01585168|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-06-20|||December 2011||2011-12-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CTNA||Functional Neuroimaging of Alcoholism Vulnerability (PIT)|Functional Neuroimaging of Alcoholism Vulnerability: Glutamate, Reward, Impulsivity and Pavlovian-to-Instrumental Transfer (PIT)|Completed||N/A|11|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:02:15.66643|2017-10-11 03:02:15.66643
NCT01585155|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-05-10|||February 2012||2012-02-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis|Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Pediatric Patients With Moderate to Severe Ulcerative Colitis.|Completed||Phase 3|21|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 03:02:15.765819|2017-10-11 03:02:15.765819
NCT01585142|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2015-01-15|||April 2012||2012-04-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Growth of Infants Fed With BabyNes System|Assessment of Growth of Infants Fed With BabyNes System (Single-serve Formulas, Adaptative System)|Completed||N/A|33|Actual|Nestlé||1|||f||||f||||||||||2017-10-11 03:02:16.030388|2017-10-11 03:02:16.030388
NCT01585129|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-06-02|||September 2010||2010-09-01|June 2017|2017-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TUPAC||Treatment Utility of Postpartum Antibiotics in Chorioamnionitis|Treatment Utility of Postpartum Antibiotics in Chorioamnionitis|Terminated||Phase 4|80|Actual|Washington University School of Medicine||2||"The trial was stopped for futility in patient enrollment following a planned interim analysis   after 80 patients were randomized."|f||||t||||||||||2017-10-11 03:02:16.128433|2017-10-11 03:02:16.128433
NCT01585090|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-24||||||April 2012|2012-04-01||||||||Interventional|||Effect of Ankle Position and Pelvic Floor Muscle Force With Relaxation of Pelvic Floor Muscles Syndrome||Withdrawn||Phase 2/Phase 3|0|Actual|Mashhad University of Medical Sciences||3|||f||||t||||||||||2017-10-11 03:02:16.340814|2017-10-11 03:02:16.340814
NCT01585077|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-01-13|||October 2012||2012-10-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|ChallengeIII||Exposure of Naive and Pre-immune Subjects to P. Vivax Challenge|Comparison of the Susceptibility of Naive and Pre-immune Volunteers to Infectious Challenge With Viable Plasmodium Vivax Sporozoites.|Completed||Phase 1/Phase 2|16|Actual|Malaria Vaccine and Drug Development Center||2|||f||||f||||||||||2017-10-11 03:02:16.411673|2017-10-11 03:02:16.411673
NCT01585064|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-24|||August 2006||2006-08-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Observational|||Optimization of Treatment With Adalimumab (Humira)|Optimization of Treatment With Adalimumab (HUMIRA): A Multi-center, Randomized, Single Blind, Controlled Clinical Trial|Completed||Phase 4|309|Actual|Lawson Health Research Institute|||3||f||||t||||||||||2017-10-11 03:02:16.497693|2017-10-11 03:02:16.497693
NCT01585051|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-24|||January 2009||2009-01-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D|Effect of Administration of 25(OH) Vitamin on Mean 24 Hour Blood Pressure and HBA1c Levels in Patients With Stable Type 2 Diabetes Mellitus|Completed||Phase 3|51|Actual|Kantonsspital Baselland Bruderholz||2|||f||||f||||||||||2017-10-11 03:02:16.619597|2017-10-11 03:02:16.619597
NCT01585038|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-07-27|2015-06-11||July 2012||2012-07-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress|A Randomized Controlled Trial Comparing Efavirenz With Rilpivirine on Changes in Endothelial Function, Inflammatory Markers, and Oxidative Stress in HIV-uninfected Healthy Volunteers|Completed||Phase 4|40|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 03:02:16.742015|2017-10-11 03:02:16.742015
NCT01585025|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-09-05|||April 2012||2012-04-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|OBADIAH1||Obeticholic Acid in Bile Acid Diarrhoea|Obeticholic Acid Treatment in Patients With Bile Acid Diarrhoea: an Open-label, Pilot Study of Mechanisms, Safety and Symptom Response.|Completed||Phase 2|28|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 03:02:17.26216|2017-10-11 03:02:17.26216
NCT01585012|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-05-04|||January 2012||2012-01-01|May 2015|2015-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|Ib2C||Usability Study of the Focus Touch™ Conception System: Semen Collection|Phase 2 Human Factors Usability Study of the Focus Touch™ Conception System: Semen Collection|Completed||Early Phase 1|30|Actual|Rinovum Women's Health, Inc.||1|||f||||t||||||||||2017-10-11 03:02:17.39319|2017-10-11 03:02:17.39319
NCT01584999|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-05-21|||February 2011||2011-02-01|May 2012|2012-05-01||||February 2012|Actual|2012-02-01||Interventional|||Effects on Septic Patient's Microcirculation of the Transfusion of Different Types of Concentrated RBCs.|Effects on the Septic Patient's Microcirculation of the Transfusion of Three Different Types of Concentrated Red Blood Cells.|Completed||Phase 4|30|Actual|Università Politecnica delle Marche||3|||f||||f||||||||||2017-10-11 03:02:17.485867|2017-10-11 03:02:17.485867
NCT01584986|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-24|||May 2008||2008-05-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery Disease|Autologous Stem Cell Therapy for the Treatment of Patients With Peripheral Artery Disease|Completed||Phase 2|22|Actual|Salus Ltd.||2|||f||||f||||||||||2017-10-11 03:02:17.576583|2017-10-11 03:02:17.576583
NCT01584973|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-24|||April 2012||2012-04-01|April 2012|2012-04-01||||||||Observational|||Changes in Inter-joint Coordination and Muscle Activation After Cruciate Ligament Injury of the Knee Joint|Changes in Inter-joint Coordination and Muscle Activation After Cruciate Ligament Injury of the Knee Joint|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 03:02:17.677536|2017-10-11 03:02:17.677536
NCT01584960|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2013-11-29|||April 2008||2008-04-01|November 2013|2013-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Endurance Training in Patients With Prostate Cancer|The Effect of Endurance Training on PSA Doubling Time, Body Composition, Insulin Sensitivity and Inflammation in Patients With Prostate Cancer|Completed||N/A|30|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 03:02:17.76871|2017-10-11 03:02:17.76871
NCT01584947|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-02-17|||April 2012||2012-04-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Interventional|||Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Chronic Oral Pain|Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Oral Mucosal Pain in Burning Mouth Syndrome, Sjögrens Syndrome and Lichen Planus.|Terminated||Phase 2|31|Actual|Hvidovre University Hospital||2||Because of a very slow patient recruitment.|f||||t||||||||||2017-10-11 03:02:17.868052|2017-10-11 03:02:17.868052
NCT01584934|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-12-04|||June 2013||2013-06-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Sodium Oxybate in Patients With Chronic Fatigue Syndrome.|The Effect of Sodium Oxybate in Patients With Chronic Fatigue Syndrome.|Unknown status|Recruiting|Phase 4|65|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 03:02:17.971315|2017-10-11 03:02:17.971315
NCT01584921|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2013-11-04|||March 2012||2012-03-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|EPO 2012||Renal Effects of Erythropoietin in Humans|Renal Effects of Erythropoietin in Humans|Completed||Phase 1|16|Actual|University of Copenhagen||3|||f||||t||||||||||2017-10-11 03:02:18.106242|2017-10-11 03:02:18.106242
NCT01584908|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-12-31|||August 2012||2012-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Observational|||Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients|Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients(AdVEnTR)|Completed||Phase 4|68|Actual|University of Alberta|||1||f||||f||||||||||2017-10-11 03:02:18.20444|2017-10-11 03:02:18.20444
NCT01584895|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-08-17|||May 2011||2011-05-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|RehabVAD||Cardiac Rehabilitation in Patients With Continuous Flow Left Ventricular Assist Devices:Rehab VAD Trial|Cardiac Rehabilitation in Patients With Continuous Flow Left Ventricular Assist Devices:Rehab VAD Trial|Completed||N/A|26|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-10-11 03:02:18.267323|2017-10-11 03:02:18.267323
NCT01584882|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-07-15|||October 2009||2009-10-01|July 2014|2014-07-01|July 2012|Actual|2012-07-01|April 2011|Actual|2011-04-01||Interventional|CATI||Computer-Assisted Tobacco Interventions in Dental Offices|Computer-Assisted Guidance for Tobacco Dependence Interventions in Dental Offices|Completed||N/A|548|Actual|HealthPartners Institute||2|||f||||f||||||||||2017-10-11 03:02:18.348083|2017-10-11 03:02:18.348083
NCT01584869|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-01-28|||December 2011||2011-12-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Emergency Capsule Endoscopy in Severe GI-bleeding|Emergency Capsule Endoscopy in Severe GI-bleeding|Completed||Phase 2/Phase 3|20|Anticipated|Technische Universität München||1|||f||||f||||||||||2017-10-11 03:02:18.43388|2017-10-11 03:02:18.43388
NCT01584856|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-25|||May 2006||2006-05-01|April 2012|2012-04-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Small Dense Low-density Lipoprotein in Patients With Prediabetes and Type 2 Diabetes||Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 03:02:18.514457|2017-10-11 03:02:18.514457
NCT01584843|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-07-02|2014-06-26||May 2012||2012-05-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus|A Multicenter, Randomized, Evaluator-masked, Parallel-group, Non-treatment-controlled Study Followed by an Open-label Study to Evaluate Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus|Completed||Phase 3|41|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 03:02:18.656971|2017-10-11 03:02:18.656971
NCT01584830|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2016-02-05|||April 2012||2012-04-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2013|Actual|2013-11-01||Interventional|CONCUR||Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy|A Randomized, Double-blind, Placebo-controlled Phase III Study of Regorafenib Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Asian Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy|Completed||Phase 3|204|Actual|Bayer||2|||f||||t||||||||||2017-10-11 03:02:20.954845|2017-10-11 03:02:20.954845
NCT01584817|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2013-12-01|||February 2012||2012-02-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Repeated Instruction by Telephone on the Day Before Colonoscopy to Patients Undergoing Colonoscopy|A Repeated Instruction by Telephone on the Day Before Colonoscopy Improves the Quality of Bowel Preparation and Colonoscopy Procedure : a Prospective Randomized, Controlled Trial|Completed||N/A|605|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 03:02:21.103014|2017-10-11 03:02:21.103014
NCT01584804|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-11-15|||June 2012||2012-06-01|November 2012|2012-11-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|||Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma|Randomised, Double-blinded, Placebo-Controlled Study of Therapeutic Effect of Su-Huang Antitussive Capsule on Cough Variant Asthma(CVA)|Unknown status|Recruiting|Phase 4|60|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 03:02:21.199111|2017-10-11 03:02:21.199111
NCT01584791|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-24|||October 2010||2010-10-01|April 2012|2012-04-01||||February 2012|Actual|2012-02-01||Interventional|||Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting||Completed||Phase 4|148|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:02:21.320525|2017-10-11 03:02:21.320525
NCT01584778|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-25|||January 2002||2002-01-01|April 2012|2012-04-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Observational|||Behçet's Disease and Eosinophil Cationic Protein|The Serum Eosinophil Cationic Protein Levels in Behçet's Disease and Its Relation to the Clinical Activity|Completed||N/A|47|Actual|Cukurova University|||3||f||||f||||||||||2017-10-11 03:02:21.40993|2017-10-11 03:02:21.40993
NCT01584765|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2014-07-03|||February 2012||2012-02-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Rechallenge, Potential Drug Induced Liver Injury (Kaiser)|Rechallenge Analysis: Detection of Potential Drug-Induced Liver Injury Using Kaiser California Database|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-10-11 03:02:21.499501|2017-10-11 03:02:21.499501
NCT01584752|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2014-11-21|||November 2011||2011-11-01|April 2012|2012-04-01|November 2015|Anticipated|2015-11-01|December 2014|Anticipated|2014-12-01|12 Months|Observational [Patient Registry]|||Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas|Clinical Multicenter Study of the Efficacy of Gore-BioA Fistula Plug in High Transsphincteric Perianal Fistulas|Terminated||Phase 3|60|Actual|Central Finland Hospital District|||1||f||||f||||||||||2017-10-11 03:02:21.597753|2017-10-11 03:02:21.597753
NCT01584739|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-11-30|||June 2012||2012-06-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients|A Phase I, Single Centre, Double-Blind, Randomised, Placebo- Controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Inhaled Doses of AZD8683 in Healthy Volunteers and COPD Patients|Terminated||Phase 1|30|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:02:21.789719|2017-10-11 03:02:21.789719
NCT01584726|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2014-01-27|||December 2012||2012-12-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|March 2015|Anticipated|2015-03-01||Interventional|||Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma|Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: A Randomized, Double-Blind, Controlled Trial (RCT)|Unknown status|Recruiting|N/A|400|Anticipated|Hamad Medical Corporation||2|||f||||t||||||||||2017-10-11 03:02:21.918704|2017-10-11 03:02:21.918704
NCT01584713|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2012-04-23|||December 2011||2011-12-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|July 2012|Anticipated|2012-07-01||Interventional|HULPUTC||Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC)|A Phase II Clinical Trial to Study the Feasibility and Safety of Stromal Vascular Derived From Adipose Tissue for the Treatment of Enterocutaneous Fistula|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Instituto de Investigación Hospital Universitario La Paz||1|||f||||f||||||||||2017-10-11 03:02:22.063911|2017-10-11 03:02:22.063911
NCT01584700|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-08-22|||January 2011||2011-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|REACH-Pilot||Renal Artery Denervation in Chronic Heart Failure|Renal Artery Denervation in Chronic Heart Failure- Pilot|Completed||Phase 1|7|Actual|Imperial College London||1|||f||||t||||||||Undecided|waiting|2017-10-11 03:02:22.232852|2017-10-11 03:02:22.232852
NCT01584687|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-04-24|||June 2012||2012-06-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||mRNA Expression as a Biomarker of Omalizumab Response|mRNA Expression as a Biomarker of Xolair (Omalizumab) Response|Unknown status|Not yet recruiting|Phase 4|6|Anticipated|Instituto de Investigação em Imunologia||1|||f||||t||||||||||2017-10-11 03:02:22.348441|2017-10-11 03:02:22.348441
NCT01584674|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2013-05-15|||March 2012||2012-03-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne|A Prospective Clinical Trial Evaluating the Efficacy of the KLOX Biophotonic System (KLOX KLGA0105-01 and KLOX THERA LAMP) On Moderate to Severe Acne|Completed||Phase 3|98|Actual|KLOX Technologies Inc.||2|||f||||f||||||||||2017-10-11 03:02:22.460356|2017-10-11 03:02:22.460356
NCT01584661|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-24|||July 2012||2012-07-01|April 2012|2012-04-01||||August 2013|Anticipated|2013-08-01||Observational|||The Continuity of Nutritional Care Among Elderly Patients|The Continuity of Nutritional Care From the Hospital to the Community and Its Impact on Health and Functional Indicators Among Elderly Patients|Unknown status|Not yet recruiting|N/A|||Bait Balev Hospital|||1||f||||t||||||||||2017-10-11 03:02:22.586098|2017-10-11 03:02:22.586098
NCT01584648|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-08-31|2014-04-10||May 1, 2012|Actual|2012-05-01|August 2017|2017-08-01|July 15, 2018|Anticipated|2018-07-15|August 1, 2013|Actual|2013-08-01||Interventional|||A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma|A Phase III, Randomized, Double-blinded Study Comparing the Combination of the BRAF Inhibitor, Dabrafenib and the MEK Inhibitor, Trametinib to Dabrafenib and Placebo as First-line Therapy in Subjects With Unresectable (Stage IIIC) or Metastatic (Stage IV) BRAF V600E/K Mutation-positive Cutaneous Melanoma|Active, not recruiting||Phase 3|422|Actual|Novartis||2|||f||||t|t|f||||||||2017-10-11 03:02:22.849065|2017-10-11 03:02:22.849065
NCT01584635|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-10-27|||January 2012||2012-01-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|POEM||The Role That Peroral Endoscopic Myotomy (POEM) Could Play in the Treatment of Achalasia|Peroral Endoscopic Myotomy (POEM) for Treatment of Achalasia|Completed||N/A|20|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 03:02:25.244927|2017-10-11 03:02:25.244927
NCT01584622|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-06-27|||July 2012||2012-07-01|June 2013|2013-06-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|CADENCE||Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases|Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases|Withdrawn||N/A|0|Actual|AUM Cardiovascular, Inc.||1|||f||||f||||||||||2017-10-11 03:02:25.34788|2017-10-11 03:02:25.34788
NCT01584609|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-12-22|||April 2012||2012-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke|A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke|Active, not recruiting||Phase 2/Phase 3|230|Anticipated|Penumbra Inc.||2|||f||||t||||||||||2017-10-11 03:02:25.45446|2017-10-11 03:02:25.45446
NCT01584596|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2016-02-04|||March 2012||2012-03-01|February 2016|2016-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Steps Ahead, Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population|Steps Ahead, Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population|Completed||Phase 1/Phase 2|129|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||No||2017-10-11 03:02:25.565058|2017-10-11 03:02:25.565058
NCT01584583|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-24|2012-04-24|||February 2012||2012-02-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|||||Observational|||Blood Pressure Monitor Clinical Test (Cuff Range: 22 Cm-36cm)||Completed||N/A|85|Actual|Andon Health Co., Ltd|||2||f||||f||||||||||2017-10-11 03:02:25.674913|2017-10-11 03:02:25.674913
NCT01584570|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2014-07-13|||January 2012||2012-01-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||The Effects of Dexmedetomidine and Tracheal Intubation on Heart Rate Variability and QTc Interval||Unknown status|Recruiting|N/A|66|Anticipated|Yonsei University||3|||f||||f||||||||||2017-10-11 03:02:25.73897|2017-10-11 03:02:25.73897
NCT01584544|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-04-17|2015-04-07||January 2011||2011-01-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer|Phase I Study of Preoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients|Completed||Phase 1|24|Actual|Chinese Academy of Medical Sciences||5|||f||||t||||||||||2017-10-11 03:02:26.026221|2017-10-11 03:02:26.026221
NCT01584531|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-06-22||2016-06-28|May 2012||2012-05-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|ONTARGET||Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome|A Phase II, Multicenter, Single-arm Study to Assess the Efficacy and Safety of Oral Rigosertib in Transfusion-dependent Low or Intermediate-1 (Any Cytogenetics) or Trisomy 8 Intermediate-2 Myelodysplastic Syndrome Patients Based on IPSS Classification|Completed||Phase 2|82|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 03:02:26.692684|2017-10-11 03:02:26.692684
NCT01584518|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-04-28|2016-01-04||July 2012||2012-07-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading|B-type Natriuretic Peptide (BNP) as a Surrogate Marker Guiding Post-operative Fluid Off-loading|Completed||N/A|50|Actual|Creighton University||2|||f||||t||||||||||2017-10-11 03:02:26.813716|2017-10-11 03:02:26.813716
NCT01584505|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-03-28|||April 2012||2012-04-01|March 2017|2017-03-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|CARSAF||Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD|Randomized, Double-Blind, Active Controlled, 3-Arm Parallel Group, Multi-National, Multi-Centre Study To Evaluate The Cardiac Safety Of Two Doses Of CHF5993 BID Delivered Via HFA PMDI Both Combined With CHF1535 BID Delivered Via HFA PMDI Versus CHF1535 BID Delivered Via HFA PMDI In Patients With Moderate To Severe COPD|Completed||Phase 2|191|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||||2017-10-11 03:02:27.031524|2017-10-11 03:02:27.031524
NCT01584492|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-03-28|||December 2011||2011-12-01|March 2017|2017-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|PAED3||Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children|Double Blind, Double Dummy, Cross-over Study to Compare the Bronchodilator Effect of CHF1535 pMDI (Fixed Combination of Beclometasone 50 µg + Formoterol 6 µg) Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children|Completed||Phase 2|59|Actual|Chiesi Farmaceutici S.p.A.||5|||f||||t||||||||||2017-10-11 03:02:27.162121|2017-10-11 03:02:27.162121
NCT01584479|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-06-17|2014-06-13||December 2010||2010-12-01|June 2015|2015-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational||See Giannobile et al 2013 manuscript included|Periodontal Disease Prevention Study|Periodontal Disease Prevention Study:A Retrospective Cohort Study to Assess the Effect of Genetics and Dental Preventive Care on Periodontal Disease|Completed||N/A|5117|Actual|University of Michigan|||4||f||||f||||||Samples With DNA|"     buccal swabs   "|||2017-10-11 03:02:28.834546|2017-10-11 03:02:28.834546
NCT01584466|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2014-01-27|||January 2014||2014-01-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study|Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study|Withdrawn||N/A|0|Actual|University of Maryland||1|||f||||f||||||||||2017-10-11 03:02:29.178781|2017-10-11 03:02:29.178781
NCT01584453|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-08-18|||April 2012||2012-04-01|July 2015|2015-07-01|November 2015|Anticipated|2015-11-01|November 2013|Actual|2013-11-01||Interventional|NITRITE-AMI||Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction|A Randomised, Double-blind, Placebo-controlled Trial Assessing the Safety and Efficacy of Intracoronary Nitrite Infusion During Acute Myocardial Infarction|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|Barts & The London NHS Trust||2|||f||||t||||||||||2017-10-11 03:02:29.280327|2017-10-11 03:02:29.280327
NCT01584440|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-09-18|||June 2012||2012-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients|A Phase 2, Randomized, Double-dummy, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of AVP-923 (Dextromethorphan/Quinidine) for the Treatment of Symptoms of Agitation in Patients With Alzheimer's Disease.|Completed||Phase 2|220|Actual|Avanir Pharmaceuticals||2|||f||||t||||||||||2017-10-11 03:02:29.380672|2017-10-11 03:02:29.380672
NCT01584427|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-06-06|||April 2012||2012-04-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ButCoIns||ButCoIns - Metabolic Effects of Resistent Starch and Arabinoxylans in Subjects With Metabolic Syndrome|ButCoIns - Metabolic Effects of Resistent Starch and Arabinoxylans in Subjects With Metabolic Syndrome|Completed||N/A|22|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 03:02:29.593562|2017-10-11 03:02:29.593562
NCT01584414|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2012-04-24|||October 2007||2007-10-01|April 2012|2012-04-01|April 2010|Actual|2010-04-01|||||Observational|||Evaluation of the Zetiq Histological and Cytological Staining Technique for the Detection Cervical Cancer|Evaluation of the Zetiq Histological and Cytological Staining Technique for the Detection Cervical Cancer|Completed||Phase 1|210|Actual|Meir Medical Center|||2||f||||||||||||||2017-10-11 03:02:29.686986|2017-10-11 03:02:29.686986
NCT01584388|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2017-05-31|2015-12-14||April 2012||2012-04-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional||Covient sample|Rituximab in IgG4-RD: A Phase 1-2 Trial|Rituximab (RTX) for IgG4-related Disease (IgG4-RD): a Prospective,Open-label Trial|Completed||Phase 1/Phase 2|30|Actual|Massachusetts General Hospital||1|||f||||t|t|f||||||||2017-10-11 03:02:30.978966|2017-10-11 03:02:30.978966
NCT01584375|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2014-10-30|||April 2012||2012-04-01|November 2013|2013-11-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|||The Risk of Intraventricular Hemorrhage With Flat Midline Versus Right-Tilted Flat Lateral Head Positions|The Risk of Intraventricular Hemorrhage With Flat Midline Versus Right-Tilted Flat Lateral Head Positions in Preterm Infant Less Than 30 Weeks of Gestation: a Multicenter Randomized Control Trial|Terminated||N/A|71|Actual|King Abdul Aziz General Hospital||2||Due to low patient recruitment|f||||f||||||||||2017-10-11 03:02:31.352258|2017-10-11 03:02:31.352258
NCT01584362|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-08-29|||August 2016||2016-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|OXFEND-02||Single Ascending Dose Safety Study of Oxfendazole|Phase I Study of Oxfendazole (Toward the Treatment of Neurocysticercosis)|Withdrawn||Phase 1|0|Actual|Johns Hopkins Bloomberg School of Public Health||7||study conducted under Clinical Trials Agreement as NIAID registration NCT02234570|f||||f||||||||||2017-10-11 03:02:31.477136|2017-10-11 03:02:31.477136
NCT01584336|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2014-02-05|||October 2012||2012-10-01|February 2014|2014-02-01|March 2014|Anticipated|2014-03-01|February 2014|Actual|2014-02-01||Interventional|KLASS-03||Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03)|Prospective Multi-center Study of Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03)|Unknown status|Recruiting|Phase 2|168|Anticipated|Soonchunhyang University Hospital||1|||f||||t||||||||||2017-10-11 03:02:31.58226|2017-10-11 03:02:31.58226
NCT01584323|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-04-22|||April 2012||2012-04-01|April 2012|2012-04-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|||Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes|Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes|Unknown status|Recruiting|N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-11 03:02:31.74637|2017-10-11 03:02:31.74637
NCT01584310|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-04-10|||October 2012||2012-10-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Interventional|STAMP2||Validation of the STAMP Screening Tool|Validation of the STAMP Screening Tool For Pediatric Nutritional Risk To Be Used in the Ambulatory Setting.|Completed||N/A|60|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 03:02:31.955108|2017-10-11 03:02:31.955108
NCT01584297|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2015-01-19|||October 2012||2012-10-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|GreKo||Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary|Open Phase II Study of Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary. GreKo Study.|Terminated||Phase 2|6|Actual|Grupo Español de Tumores Huérfanos e Infrecuentes||1||Insufficient recruitment rate|f||||f||||||||||2017-10-11 03:02:32.048429|2017-10-11 03:02:32.048429
NCT01584284|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2015-08-21|||April 2012||2012-04-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer|Phase I Trial Of Attenuated Vaccinia Virus (GL-ONC1) Delivered Intravenously With Concurrent Cisplatin and Radiotherapy in Patients With Locoregionally Advanced Head and Neck Carcinoma|Completed||Phase 1|19|Actual|Genelux Corporation||1|||f||||t||||||||||2017-10-11 03:02:32.176341|2017-10-11 03:02:32.176341
NCT01584271|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-07-07|||July 2011||2011-07-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Study of Ear Comfort Ear Drops to Treat AOE Cases Compared to DexOtic & Otidin(R)|Phase II 3 Arm Double Blinded Clinical Study Evaluating the Pain Killing and Healing Time of Botanical Ear Drops, Ear Comfort(TM), in Severe External Ear Infection (AOE) Patients, Compared to Dex-Otic(R) and Otidin(R)|Unknown status|Recruiting|Phase 2|75|Anticipated|Assuta Hospital Systems||3|||f||||t||||||||||2017-10-11 03:02:32.268698|2017-10-11 03:02:32.268698
NCT01584258|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-22|2015-04-24|||April 2012||2012-04-01|April 2015|2015-04-01|September 2026|Anticipated|2026-09-01|September 2021|Anticipated|2021-09-01||Interventional|PACE||Prostate Advances in Comparative Evidence|International Randomised Study of Laparoscopic Prostatectomy vs Stereotactic Body Radiotherapy (SBRT) and Conventionally Fractionated Radiotherapy vs SBRT for Early Stage Organ-Confined Prostate Cancer|Recruiting||Phase 3|1716|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:02:32.39063|2017-10-11 03:02:32.39063
NCT01584245|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-09-15|||February 2012||2012-02-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of the Efficacy of an Amino Acid Based Formula in Infants|Evaluation of the Efficacy of an Amino Acid Based Formula in Infants|Terminated||N/A|32|Actual|Mead Johnson Nutrition||||Enough participants enrolled to provide adequate statistical power|f||||f||||||||||2017-10-11 03:02:32.536995|2017-10-11 03:02:32.536995
NCT01584232|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2014-10-14|2014-10-03|2013-09-27|April 2012||2012-04-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||All randomized participants who received at least 1 dose of LY2189265 or insulin glargine.|A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus|A Phase 3 Study of LY2189265 Compared to Insulin Glargine in Patients With Type 2 Diabetes Mellitus on a Sulfonylurea and/or Biguanide|Completed||Phase 3|361|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:02:32.665341|2017-10-11 03:02:32.665341
NCT01584219|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-05-07|||April 2012||2012-04-01|April 2012|2012-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||The Role of Placental Myeloid Cells During Gestation, Labor and Disease|The Role of Placental Myeloid Cells During Gestation, Labor and Disease|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||4||f||||f||||||||||2017-10-11 03:02:33.649638|2017-10-11 03:02:33.649638
NCT01584206|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-03-09|||April 2012||2012-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|August 2013|Actual|2013-08-01||Interventional|STAIR7002||Sitosterolemia Metabolism|Assessment of Sterol Metabolism in Sitosterolemia: A Pilot Study of Patients Treated With Ezetimibe|Active, not recruiting||N/A|8|Actual|University of Manitoba||1|||f||||t||||||||||2017-10-11 03:02:33.733658|2017-10-11 03:02:33.733658
NCT01584193|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2015-06-23|||June 2013||2013-06-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection for Venous Access Port Implantation|Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection for Totally Implantable Venous Access Port Implementation: a Single-center Controlled Randomized Superiority Trial|Withdrawn||N/A|0|Actual|University of Lausanne Hospitals||2||Logistical reasons (institutional reorganization of ambulatory surgery)|f||||f||||||||||2017-10-11 03:02:33.931185|2017-10-11 03:02:33.931185
NCT01584180|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2012-08-14|||January 2012||2012-01-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|iCOOL 3||A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Brain.Pad (iCOOL 3)|iCOOL 3 (Induction of COOLing 3): A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Brain.Pad|Completed||Phase 2|20|Anticipated|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-11 03:02:34.03212|2017-10-11 03:02:34.03212
NCT01584167|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2013-06-21|||January 2012||2012-01-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|iCOOL 2||A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Flex.Pads (iCOOL 2)|iCOOL 2 (Induction of COOLing 2): A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Flex.Pads|Unknown status|Recruiting|Phase 2|20|Anticipated|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-11 03:02:34.14271|2017-10-11 03:02:34.14271
NCT01584154|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2015-09-03|||March 2012||2012-03-01|September 2015|2015-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|CRYOABLATE||Comparative Study Between Cryoablation and Radiofrequency Ablation in the Treatment of Supraventricular Tachycardia|CRYOthermy and Radiofrequency ABLation For AVNRT TrEatment|Unknown status|Recruiting|Phase 4|520|Anticipated|Princess Margaret Hospital, Hong Kong||2|||f||||f||||||||||2017-10-11 03:02:34.890401|2017-10-11 03:02:34.890401
NCT01584141|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2017-07-18|||July 3, 2011||2011-07-03|July 10, 2017|2017-07-10||||||||Observational|||Study of Lymphoma in Asia|A Multi-Center International Hospital-Based Case-Control Study of Lymphoma in Asia (AsiaLymph)|Recruiting||N/A|13600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:02:35.034795|2017-10-11 03:02:35.034795
NCT01584128|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2017-05-02|||April 2012||2012-04-01|May 2017|2017-05-01|March 1, 2013|Actual|2013-03-01|March 1, 2013|Actual|2013-03-01||Observational|||Oxidized Regenerated Cellulose to Decrease Vaginal Cuff Complications|Use of Structured Non-woven Absorbable Hemostat (or Oxidized Regenerated Cellulose) to Decrease Vaginal Cuff Dehiscence Rate in Laparoscopic Hysterectomy|Completed||N/A|101|Actual|Milton S. Hershey Medical Center|||1||f||||t||||||||||2017-10-11 03:02:35.166738|2017-10-11 03:02:35.166738
NCT01584115|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-21|2012-04-24|||July 2012||2012-07-01|April 2012|2012-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)|Phase I Clinical Trial of a Therapeutic Vaccine for Malignancies, Comprising the Tumor Antigen NY-ESO-1 in Combination With the Adjuvant MPLA of Bordetella Pertussis. Evaluation of Toxicity and Immunogenicity|Unknown status|Not yet recruiting|Phase 1/Phase 2|15|Anticipated|Instituto de Investigação em Imunologia||1|||f||||t||||||||||2017-10-11 03:02:35.265451|2017-10-11 03:02:35.265451
NCT01584102|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-04-23|||January 2011||2011-01-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Randomized Controlled Trial Targeting Obesity-related Behaviors|Better Together Healthy Caswell County: Randomized Controlled Trial Targeting Obesity-related Behaviors|Completed||N/A|91|Actual|Virginia Polytechnic Institute and State University||2|||f||||f||||||||||2017-10-11 03:02:35.376018|2017-10-11 03:02:35.376018
NCT01584076|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2017-02-07|||August 2012||2012-08-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Treatment of Residual Amblyopia With Donepezil|Recovery From Amblyopia With Cholinesterase Inhibitors|Recruiting||Phase 1|20|Anticipated|Boston Children’s Hospital||1|||f||||f||||||||No||2017-10-11 03:02:35.475838|2017-10-11 03:02:35.475838
NCT01584063|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-04-23|||February 2004||2004-02-01|April 2012|2012-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|Healthy MOMs||Healthy Mothers on the Move||Completed||N/A|276|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:02:35.60259|2017-10-11 03:02:35.60259
NCT01584050|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-08-09|||May 2012||2012-05-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Relative Bioavailability of Folic Acid and L-5-Methlytetrahydrofolate|Relative Bioavailability of Folic Acid and L-5-Methlytetrahydrofolate|Completed||N/A|150|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-11 03:02:35.686843|2017-10-11 03:02:35.686843
NCT01584037|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2014-04-17|||December 2011||2011-12-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01|12 Months|Observational [Patient Registry]|||Adenovirus Vaccine Pregnancy Registry|Adenovirus Vaccine Pregnancy Registry|Withdrawn||N/A|0|Actual|Teva Pharmaceutical Industries|||1||f||||t||||||||||2017-10-11 03:02:35.827505|2017-10-11 03:02:35.827505
NCT01584024|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-07-08|||March 2013||2013-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Resin Infiltration to Arrest Early Tooth Decay|Radiographic Progression of Early Caries Lesions After Resin Infiltration|Active, not recruiting||N/A|42|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:02:35.92889|2017-10-11 03:02:35.92889
NCT01584011|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-05-07|||January 2010||2010-01-01|April 2012|2012-04-01||||December 2015|Anticipated|2015-12-01||Observational|||Taste Disorders in Middle Ear Disease and After Middle Ear Surgery|Taste Disorders in Middle Ear Disease and After Middle Ear Surgery|Unknown status|Recruiting|N/A|310|Anticipated|Uppsala University|||1||f||||t||||||Samples Without DNA|"     Samples of nerve tissue   "|||2017-10-11 03:02:36.026233|2017-10-11 03:02:36.026233
NCT01583998|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-05-21|||June 2011||2011-06-01|April 2012|2012-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|e-MBC||Electronic-Measurement Based Care for Major Depressive Disorder|Electronic-Measurement Based Care (e-MBC) for Major Depressive Disorder (MDD)|Unknown status|Active, not recruiting|N/A|80|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 03:02:36.133423|2017-10-11 03:02:36.133423
NCT01583985|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-06-07|||June 1, 2013|Actual|2013-06-01|June 2017|2017-06-01|May 31, 2017|Actual|2017-05-31|January 31, 2017|Actual|2017-01-31||Interventional|SPACE||Strategies for Prescribing Analgesics Comparative Effectiveness Trial|Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) Trial|Completed||N/A|265|Actual|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-11 03:02:36.277414|2017-10-11 03:02:36.277414
NCT01583972|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-14|2014-08-22|||January 2012||2012-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function|Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function|Completed||N/A|300|Actual|USDA, Western Human Nutrition Research Center||2|||f||||t||||||||||2017-10-11 03:02:36.432469|2017-10-11 03:02:36.432469
NCT01583959|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-02-05|||April 2012||2012-04-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|FOLVARI||Study of Different Doses of Folic Acid in Combination With Methotrexate in Rheumatoid Arthritis|Randomized Trial of 10 mg Versus 30 mg Per Week of Folic Acid in Combination With Methotrexate in Rheumatoid Arthritis|Completed||Phase 4|100|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 03:02:37.070173|2017-10-11 03:02:37.070173
NCT01583946|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-06-07|||April 2012||2012-04-01|December 2015|2015-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|LIFT||Temporally-Oriented Subjective Well-being Across Transitions—Resources & Outcomes|Temporally-Oriented Subjective Well-being Across Transitions—Resources & Outcomes|Completed||N/A|793|Actual|University of Pittsburgh|||8||f||||t||||||||||2017-10-11 03:02:37.173113|2017-10-11 03:02:37.173113
NCT01583933|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-04-26|||September 2011||2011-09-01|April 2012|2012-04-01|May 2012|Anticipated|2012-05-01|January 2012|Actual|2012-01-01||Interventional|retainer||Essix Retainer vs Hawley Retainer|PHASE 3 STUDY OF THE EFFECTIVITY OF TWO RETAINERS IN THE DENTAL AND OCCLUSAL STABILITY|Unknown status|Recruiting|Phase 3|46|Anticipated|CES University||2|||f||||f||||||||||2017-10-11 03:02:37.266927|2017-10-11 03:02:37.266927
NCT01583920|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-10-03|||July 2012||2012-07-01|October 2017|2017-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer|Pilot Study of Focal Salvage HDR Prostate Brachytherapy|Recruiting||Phase 1/Phase 2|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 03:02:37.360014|2017-10-11 03:02:37.360014
NCT01583907|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-04-24|||March 2012||2012-03-01|April 2012|2012-04-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Observational|||Nutrition in Children With Food Allergy||Unknown status|Recruiting|Early Phase 1|70|Anticipated|Federico II University|||1||f||||f||||||Samples Without DNA|"     blood sampling to measure laboratory parameters useful to asses nutritional status   "|||2017-10-11 03:02:37.488599|2017-10-11 03:02:37.488599
NCT01583894|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-03-09|2014-12-18||June 2012||2012-06-01|November 2013|2013-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|MAP|Patients suffering from chronic intractable pain of the trunk and/or limbs for a duration of at least 6 months|Multiple Areas of Pain (MAP)|Multiple Areas of Pain (MAP): Epidemiology of Multisite Pain in the Chronic Pain Population|Completed||N/A|828|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 03:02:37.603199|2017-10-11 03:02:37.603199
NCT01583881|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-10-30|||April 2012||2012-04-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|DIASTOLE||Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction|Sympathetic Renal Denervation in Heart Failure With Normal LV Ejection Fraction: Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction|Unknown status|Active, not recruiting|Phase 2/Phase 3|60|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-11 03:02:37.778862|2017-10-11 03:02:37.778862
NCT01583868|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2012-08-10|||April 2012||2012-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:02:37.863909|2017-10-11 03:02:37.863909
NCT01583855|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-03-03|||April 2012||2012-04-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MAST-AF||Manual vs Amigo SmartTouch Atrial Fibrillation Study|Manual vs Amigo SmartTouch Atrial Fibrillation Study|Active, not recruiting||N/A|50|Anticipated|University of Leicester||2|||f||||t||||||||||2017-10-11 03:02:37.906143|2017-10-11 03:02:37.906143
NCT01583842|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-01-09|||June 2012||2012-06-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study|124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study|Unknown status|Recruiting|N/A|20|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:02:37.992989|2017-10-11 03:02:37.992989
NCT01583829|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-07-06|||May 2009||2009-05-01|July 2017|2017-07-01|November 2013|Actual|2013-11-01|December 2012|Actual|2012-12-01||Interventional|CATS||Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder|Randomized Control Trial of Two Computer-Based Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder (ADHD)|Completed||N/A|104|Actual|Tufts Medical Center||3|||f||||t||||||||||2017-10-11 03:02:38.154749|2017-10-11 03:02:38.154749
NCT01583816|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2015-12-14|||May 2012||2012-05-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Interventional|||Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions|Prospective, Randomized, Partly Blinded, in Part Placebo-controlled, Multicenter, Dose-finding Trial Exploring Safety, Tolerability and Efficacy of a Topical Resiquimod Gel in Patients With Multiple Actinic Keratosis Lesions|Completed||Phase 2|218|Actual|Spirig Pharma Ltd.||5|||f||||f||||||||||2017-10-11 03:02:38.397249|2017-10-11 03:02:38.397249
NCT01583803|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-12-20|||June 2012||2012-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|January 2014|Actual|2014-01-01||Observational|||Sex Differences in Oral Bacteria|Investigation of the Sex Differences in Oral Microbiota and Their Effect on Circulating Nitrite Levels|Active, not recruiting||N/A|24|Anticipated|Queen Mary University of London|||2||f||||f||||||Samples Without DNA|"     Urine, saliva and plasma   "|||2017-10-11 03:02:38.51528|2017-10-11 03:02:38.51528
NCT01583790|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-23|2015-04-13|||January 2012||2012-01-01|March 2012|2012-03-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Factors Influencing the Positive Outcome of Bariatric Surgery for Morbidly Obese Patients|A Prospective Trial for Laparoscopic Adjustable Gastric Banding in Morbidly Obese Patients: Report on Weight Loss, Metabolic Changes and Quality of Life|Unknown status|Recruiting|N/A|2000|Anticipated|Assuta Hospital Systems|||1||f||||f||||||||||2017-10-11 03:02:38.615937|2017-10-11 03:02:38.615937
NCT01583777|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-07-20|||September 2013||2013-09-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer|A Phase 1 Study for the Evaluation of Excretion (Mass Balance) and Pharmacokinetics of 14C-Labeled Belinostat in Patients With Advanced Cancer|Completed||Phase 1|6|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-11 03:02:38.741822|2017-10-11 03:02:38.741822
NCT00005692|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1992||1992-04-01|March 2005|2005-03-01|November 2002|Actual|2002-11-01|||||Observational|||Inflammation Markers Over Time in Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.740039|2017-10-11 04:28:53.740039
NCT01583725|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-01-10|||July 2010||2010-07-01|January 2014|2014-01-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|||fMRI and Appetite-Related Hormones Pre and Post Obesity Surgery|Functional Brain Imaging and Appetite-Related Hormones Pre and Post Obesity Surgery|Unknown status|Enrolling by invitation|N/A|160|Anticipated|New York Obesity and Nutrition Research Center||5|||f||||t||||||||||2017-10-11 03:02:39.086554|2017-10-11 03:02:39.086554
NCT01583712|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2015-07-19|||April 2012||2012-04-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Endomicroscopy and Graft-versus-host Disease|Diagnosis of Acute Gastrointestinal Graft-versus-Host Disease by Early Endomicroscopic Features of the Small Intestine|Unknown status|Recruiting|N/A|40|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 03:02:39.2189|2017-10-11 03:02:39.2189
NCT01583699|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2015-07-19|||April 2012||2012-04-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Endomicroscopy and Gastric MALT-lymphoma|Confocal Laser Endomicroscopy as Diagnostic Tool for Gastrointestinal MALT-lymphoma|Completed||N/A|50|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 03:02:39.348152|2017-10-11 03:02:39.348152
NCT01583686|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-10-03|||March 30, 2012||2012-03-30|September 19, 2017|2017-09-19|December 31, 2029|Anticipated|2029-12-31|December 4, 2028|Anticipated|2028-12-04||Interventional|||CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer|Phase I/II Study of Metastatic Cancer Using Lymphodepleting Conditioning Followed by Infusion of Anti-mesothelin Gene Engineered Lymphocytes|Recruiting||Phase 1/Phase 2|136|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:02:39.46934|2017-10-11 03:02:39.46934
NCT01583673|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-10-20|||May 2012||2012-05-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Growth of Infants Fed an Amino Acid Infant Formula|Assessment of Growth of Infants Fed an Amino Acid Based Formula|Completed||N/A|225|Actual|Nestlé||2|||f||||t||||||||||2017-10-11 03:02:39.587852|2017-10-11 03:02:39.587852
NCT01583660|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-04-21|||January 2012||2012-01-01|April 2012|2012-04-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Observational|||Clinical Research of the Prognostic Influence of NSAIDS's Anti-inflammatory Effect on Senior Patients With Hip Fracture|Clinical Research of the Prognostic Influence of NSAIDS's Anti-inflammatory Effect on Senior Patients With Hip Fracture|Unknown status|Recruiting|N/A|800|Anticipated|Beijing Army General Hospital|||1||f||||t||||||Samples Without DNA|"     Peripheral blood serum   "|||2017-10-11 03:02:39.689274|2017-10-11 03:02:39.689274
NCT01583647|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-11-02|2013-10-07||June 2012||2012-06-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158)|A Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ER Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia|Terminated||Phase 1|10|Actual|Merck Sharp & Dohme Corp.||2||"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a   significant increase in incidence of some types of non-fatal SAEs."|f||||f||||||||||2017-10-11 03:02:39.780905|2017-10-11 03:02:39.780905
NCT01583634|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2014-10-02|||September 2014||2014-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin|Accuracy of Oximeters With Hypoxia and Methemoglobin or Carboxyhemoglobin|Completed||N/A|9|Actual|Mespere Lifesciences Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 03:02:40.006366|2017-10-11 03:02:40.006366
NCT01583621|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-02-08|||November 2011||2011-11-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|November 2012|Actual|2012-11-01||Interventional|D-SUNNY||Vitamin D Supplementation in Overweight/Obese African American Adults and Youth (D-SUNNY)|Vitamin D Supplementation in Overweight/Obese African American Adults and Youth (D-SUNNY)|Completed||N/A|74|Actual|Augusta University||4|||f||||||||||||||2017-10-11 03:02:40.132995|2017-10-11 03:02:40.132995
NCT01583608|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-12-08|||April 2012||2012-04-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|March 2013|Actual|2013-03-01||Observational|ASSURE||ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease|ABSORB: Initial Clinical Experience With the Everolimus-eluting Bioresorbable Vascular Scaffold (BVS) System in the Treatment of de Novo Native Coronary Artery Lesions - a Surveillance Registry|Completed||N/A|183|Actual|Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.|||1||f||||t||||||||||2017-10-11 03:02:40.224291|2017-10-11 03:02:40.224291
NCT01583595|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-04-01|||December 2011||2011-12-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease|Determining the Relationships Between Self-efficacy for Walking Ability, Gate Speed and Physical Activity in Patients With Chronic Lung Disease|Completed||N/A|70|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:02:40.37099|2017-10-11 03:02:40.37099
NCT01583582|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-01-30|||March 2012||2012-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|MARE||Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp|Assessment on Antihypertensive Effect and Safety of Bioactive Peptides Derived From Coldwater Shrimp (Pandalus Borealis) in Healthy Subjects With Mild or Moderate Hypertension|Completed||Phase 2|74|Actual|Marealis AS||3|||f||||f||||||||||2017-10-11 03:02:40.455802|2017-10-11 03:02:40.455802
NCT01583569|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-10-05|||November 2011||2011-11-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||Complex Dynamic Systems in Mood Disorders|Complex Dynamic Systems in Mood Disorders|Completed||N/A|20|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 03:02:40.590699|2017-10-11 03:02:40.590699
NCT01583556|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-04-06|||July 2012||2012-07-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Optional Follow-up Visits for Common, Low-risk Arm Fractures|Optional Follow-up Visits for Common, Low-risk Arm Fractures|Completed||N/A|120|Actual|Massachusetts General Hospital|||2||f||||t||||||None Retained|"     n.a.   "|||2017-10-11 03:02:40.689427|2017-10-11 03:02:40.689427
NCT01583543|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-04-11|2016-03-09||May 2012||2012-05-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|January 2014|Actual|2014-01-01||Interventional|||Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma|Phase II Study of the PARP Inhibitor, Olaparib, in Adult Patients With Recurrent/Metastatic Ewing's Sarcoma Following Failure of Prior Chemotherapy|Completed||Phase 2|12|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-11 03:02:40.799649|2017-10-11 03:02:40.799649
NCT01583530|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-08-01|2012-05-22||February 2011||2011-02-01|August 2013|2013-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Study of Belimumab Administered Subcutaneously to Healthy Subjects|A Randomized, Parallel-Group, Open-Label Study to Evaluate the Absolute Bioavailability, Pharmacokinetics, Tolerability and Safety of a High Concentration Formulation of Belimumab (HGS1006), a Fully Human Monoclonal Anti-BLyS Antibody, Administered Subcutaneously to Healthy Subjects|Completed||Phase 1|118|Actual|Human Genome Sciences Inc.||6|||f||||f||||||||||2017-10-11 03:02:41.169595|2017-10-11 03:02:41.169595
NCT01583517|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2014-10-08|||September 1997||1997-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|April 2012|Actual|2012-04-01||Interventional|||ERCP in Idiopathic Recurrent Acute Pancreatitis|Defining the Role of ERCP in the Evaluation and Treatment of Idiopathic Recurrent Acute Pancreatitis|Completed||N/A|89|Actual|Indiana University||4|||f||||f||||||||||2017-10-11 03:02:43.379183|2017-10-11 03:02:43.379183
NCT01583504|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-04-23|||March 2012||2012-03-01|April 2012|2012-04-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Interventional|||High Volume Saline Injections for Achilles Tendinopathy|A Double Blind, Randomised Controlled Trial of High Volume Saline Injections for Chronic Midportion Achilles Tendinopathy|Unknown status|Recruiting|N/A|44|Anticipated|Leeds Comunity Healthcare NHS Trust||2|||f||||f||||||||||2017-10-11 03:02:43.508247|2017-10-11 03:02:43.508247
NCT01583491|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-04-24|||December 2011||2011-12-01|April 2012|2012-04-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Interventional|||Evaluation of Platelet Rich Fibrin on Reduction of Periodontal Problems After Surgical Removal of Mandibular Third Molar|Evaluation of Platelet Rich Fibrin Efficacy on Reduction of Periodontal Problems|Unknown status|Active, not recruiting|Phase 4|30|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:02:43.619575|2017-10-11 03:02:43.619575
NCT01583478|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2014-09-27|||September 2014||2014-09-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids|An Open-Label Pilot Study to Compare the Efficacy of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids|Unknown status|Recruiting|Phase 4|15|Anticipated|The Maas Clinic||5|||f||||f||||||||||2017-10-11 03:02:43.700076|2017-10-11 03:02:43.700076
NCT01583465|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-04-23|||October 2009||2009-10-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|Aquamantys||Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty|Open Label, Randomized, Blinded Study to Evaluate the Efficacy of Aquamantys System for Reducing the Transfusion Requirements Associated With the Anterior-Supine Intermuscular (ASI) Approach for Total Hip Arthroplasty (THA)|Completed||N/A|200|Actual|Joint Implant Surgeons, Inc.||2|||f||||t||||||||||2017-10-11 03:02:43.828673|2017-10-11 03:02:43.828673
NCT01583452|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-06-27|2015-03-19||April 2012||2012-04-01|June 2015|2015-06-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Chewing Gum Use to Reduce Post-operative Ileus in Pediatric Patients|Use of Chewing Gum to Reduce Postoperative Ileus in Pediatric Patients After Gastrointestinal Surgery|Completed||Phase 1|41|Actual|Instituto Tecnologico y de Estudios Superiores de Monterey|We had a small number of participants because of time limitations. We included only patients with diagnosis of appendicitis and post-op appendectomy.|2|||f||||t||||||||||2017-10-11 03:02:43.979066|2017-10-11 03:02:43.979066
NCT01583439|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2015-03-18|||September 2012||2012-09-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Interventional|||The Mochudi Prevention Project ART Protocol|An Evaluation of the Uptake and Safety of, and Adherence to Antiretroviral Treatment Among Individuals With CD4 ≥ 250 Cells/mm3 and HIV Virus Load ≥ 50,000 cp/mL|Terminated||N/A|11|Actual|Harvard School of Public Health||1||Low Accrual.|f||||t||||||||||2017-10-11 03:02:44.387859|2017-10-11 03:02:44.387859
NCT01583426|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-10-11|||July 2012||2012-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|GeparSepto||Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)|A Randomized Phase III Trial Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto)|Active, not recruiting||Phase 3|1200|Anticipated|German Breast Group||2|||f||||t||||||||||2017-10-11 03:02:44.48064|2017-10-11 03:02:44.48064
NCT01583413|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-10-10|||May 2012||2012-05-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||CDC Prevention Epicenters Wake Up and Breathe Collaborative|CDC Prevention Epicenters Wake Up and Breathe Collaborative|Completed||N/A|3342|Actual|Harvard Pilgrim Health Care||1|||f||||f||||||||||2017-10-11 03:02:44.634863|2017-10-11 03:02:44.634863
NCT01583400|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2014-09-17|||September 2011||2011-09-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial|Development and Evaluation of Enhanced Digital Health Coaching Program for Depressive Symptoms to Support Collaborative Depression Treatment in Primary Care: The RESPECT-D-E (Enhanced) Trial|Completed||N/A|131|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 03:02:44.744818|2017-10-11 03:02:44.744818
NCT01583387|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-10-07|||February 2011||2011-02-01|October 2016|2016-10-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Water Intake on the DNA Adducts Formation|Proof of Concept of the Effect of Water Intake on the DNA Adducts Formation|Completed||N/A|65|Actual|Danone Research||2|||f||||||||||||||2017-10-11 03:02:44.862688|2017-10-11 03:02:44.862688
NCT01583374|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-09-28|2015-02-24||May 2, 2012|Actual|2012-05-02|September 2017|2017-09-01|October 2, 2018|Anticipated|2018-10-02|February 24, 2014|Actual|2014-02-24||Interventional|POSTURE|Modified Intent to Treat (mITT) were all participants who were randomized and received at least one dose of investigational product (IP)|Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis|A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF APREMILAST (CC-10004) IN THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS|Active, not recruiting||Phase 3|490|Actual|Celgene||3|||f||||t||||||||||2017-10-11 03:02:44.963598|2017-10-11 03:02:44.963598
NCT01583361|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-23|||March 2012||2012-03-01|April 2012|2012-04-01|January 2017|Anticipated|2017-01-01|September 2014|Anticipated|2014-09-01||Interventional|RESONANCE||SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer|Phase III, Randomized, Multicenter, Controlled Evaluation of S‐1 and Oxaliplatin as Neoadjuvant Chemotherapy for Advanced Gastric Cancer Patients|Unknown status|Recruiting|Phase 3|772|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 03:02:45.932839|2017-10-11 03:02:45.932839
NCT01583348|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-04-28|||April 2012||2012-04-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Observational|||Technical Feasibility of Routine Intraoperative Cholangiography During Elective Rigid-hybrid Transvaginal Natural Orifice Transluminal Endoscopic Cholecystectomy|An Open Case Series About Technical Feasibility of Routine Intraoperative Cholangiography (IOC) During Elective Rigid-hybrid Transvaginal Natural Orifice Transluminal Endoscopic Cholecystectomy (tvNCC)|Completed||N/A|33|Actual|Cantonal Hosptal, Baselland|||1||f||||f||||||||||2017-10-11 03:02:46.071916|2017-10-11 03:02:46.071916
NCT01583335|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2015-01-27|||May 2009||2009-05-01|January 2015|2015-01-01|December 2020|Anticipated|2020-12-01|August 2012|Actual|2012-08-01||Interventional|||The Healthy Start Project: Primary Prevention of Overweight in Preschool Children Predisposed to Future Overweight|Prevention of Weight Gain Among Normal Weight, High Risk, Pre-school Children - a Randomized Controlled Interventions Study.|Active, not recruiting||N/A|1100|Anticipated|Bispebjerg Hospital||3|||f||||f||||||||||2017-10-11 03:02:46.180787|2017-10-11 03:02:46.180787
NCT01583322|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-03-15|||June 2012||2012-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|May 2015|Actual|2015-05-01||Interventional|CHIVA||Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer|Randomized Double Blind Placebo-controlled Phase II Trial of Vargatef® (Nintedanib) in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Adenocarcinoma of the Ovary, the Fallopian Tube or Serous Adenocarcinoma of the Peritoneum|Completed||Phase 2|188|Actual|ARCAGY/ GINECO GROUP||2|||f||||t||||||||||2017-10-11 03:02:46.295087|2017-10-11 03:02:46.295087
NCT01583309|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-04-23|||November 2003||2003-11-01|April 2012|2012-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|ECTDP||Effects of Convective Therapies in Dialysis Patients|Effects of Convective Therapies in Dialysis Patients|Completed||Phase 3|146|Actual|A. Manzoni Hospital||3|||f||||f||||||||||2017-10-11 03:02:46.418773|2017-10-11 03:02:46.418773
NCT01583296|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-01-12|||July 2010||2010-07-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|LUCHAR||LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction|Adaptation of a Behavioral Treatment for Latinos With Panic Disorder and Asthma|Completed||N/A|53|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 03:02:46.569562|2017-10-11 03:02:46.569562
NCT01583283|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-07-21|||July 12, 2012|Actual|2012-07-12|July 2017|2017-07-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma|A Phase I/II, Open Label, Multicenter Study of ACY-1215 in Combination With Lenalidomide and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|38|Actual|Celgene||1|||f||||f||||||||||2017-10-11 03:02:46.645389|2017-10-11 03:02:46.645389
NCT01583270|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-06-18|||April 2012||2012-04-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Arabinoxylan and Rye Kernels on Second Meal Responses|Effect of Arabinoxylan and Rye Kernels on Second Meal Responses in Subjects With the Metabolic Syndrome|Completed||N/A|15|Actual|Aarhus University Hospital||4|||f||||f||||||||||2017-10-11 03:02:46.738172|2017-10-11 03:02:46.738172
NCT01583257|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-05-14|||June 2012||2012-06-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pilot Study: Active Video Gaming to Facilitate Physical Activity and Quality of Life in Kidney Transplant Recipients|Pilot Study: Active Video Gaming to Facilitate Physical Activity and Quality of Life in Kidney Transplant Recipients|Completed||Phase 1/Phase 2|10|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 03:02:46.832859|2017-10-11 03:02:46.832859
NCT01583244|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-05-10|||March 2010||2010-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Korean Post-marketing Surveillance for Orencia®|Korean Post-marketing Surveillance for Orencia®|Completed||N/A|701|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 03:02:47.007661|2017-10-11 03:02:47.007661
NCT01583231|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-12-18|||May 2012||2012-05-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy of the Brushless Scrub|Efficacy of the Brushless Scrub|Completed||N/A|100|Actual|Winthrop University Hospital||2|||f||||f||||||||||2017-10-11 03:02:47.09301|2017-10-11 03:02:47.09301
NCT01583218|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-09-18|2017-07-19||March 2012||2012-03-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|APEX|All randomized subjects|Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)|(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients|Completed||Phase 3|7513|Actual|Portola Pharmaceuticals||2|||f||||t||||||||||2017-10-11 03:02:47.282436|2017-10-11 03:02:47.282436
NCT01583205|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-11-07|||April 2012||2012-04-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Coping Effectiveness Training for ALS|Coping Effectiveness Training for Recently Diagnosed ALS Patients and Care Partners|Withdrawn||N/A|0|Actual|Research Foundation for Mental Hygiene, Inc.||1||The study was not funded.|f||||f||||||||||2017-10-11 03:02:51.252435|2017-10-11 03:02:51.252435
NCT01583192|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2014-06-06|||March 2013||2013-03-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Chloridehexidine Versus Povidine Jodine Both Soluted in Alcohol in Forefoot Surgery|Prospective Study of Chloridehexidine/Alcohol Versus Jodine/Povidine in Forefoot Surgery|Completed||Phase 3|52|Actual|St. Antonius Hospital||2|||f||||f||||||||||2017-10-11 03:02:51.418038|2017-10-11 03:02:51.418038
NCT01583179|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-01-06|||April 2012||2012-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|March 2014|Actual|2014-03-01||Interventional|||Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic Solution|Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic Solution|Terminated||N/A|22|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 03:02:51.520182|2017-10-11 03:02:51.520182
NCT01583166|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-06-08|||March 2012||2012-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|URINE&ME||Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial|Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial|Completed||N/A|50|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 03:02:51.615316|2017-10-11 03:02:51.615316
NCT01583153|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-04-13|||June 2012||2012-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HIHO||The HIHO Study: Hospital Inpatient vs Home Rehabilitation After Total Knee Replacement|Randomised Controlled Trial Comparing Hospital Inpatient vs Home Rehabilitation After Total Knee|Completed||N/A|165|Actual|South West Sydney Local Health District||2|||f||||t||||||||||2017-10-11 03:02:51.718751|2017-10-11 03:02:51.718751
NCT01583140|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-01-24|||October 2009||2009-10-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Seamos Saludables - Physical Activity Intervention Study for Latinas|Culturally and Linguistically Adapted Physical Activity Intervention for Latinas (Seamos Saludables)|Completed||N/A|312|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 03:02:51.834279|2017-10-11 03:02:51.834279
NCT01583127|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-02-23|||September 2002||2002-09-01|February 2016|2016-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Examining Variation in the Impact of School-Wide Positive Behavioral Interventions and Supports (PBIS)|Examining Variation in the Impact of School-Wide Positive Behavioral Interventions and Supports (PBIS)|Completed||N/A|32986|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 03:02:51.936264|2017-10-11 03:02:51.936264
NCT01583114|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-02-23|||December 2011||2011-12-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PRECARDIA||PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors|Preventive Effect of ACE Inhibitor Perindopril)on the Onset or Progression of Left Ventricular Dysfoction in Subjects at a Preclinical Stage From Families With Dilated Cardiomyopathy|Terminated||Phase 3|6|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2||recruitement problem|f||||t||||||||||2017-10-11 03:02:52.031171|2017-10-11 03:02:52.031171
NCT01583101|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-04-10|2016-12-08||April 2012||2012-04-01|April 2017|2017-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Child Health Improvement Through Computer Automation (CHICA) Highlighting Study|Increasing Prompt Response Rates in the CHICA System|Completed||N/A|2237|Actual|Indiana University||2|||f||||f||||||||No||2017-10-11 03:02:52.158886|2017-10-11 03:02:52.158886
NCT01583088|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-12-21|||September 2012||2012-09-01|April 2015|2015-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|RespiStimALS||Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation|Can Diaphragm Pacing Delay Non Invasive Ventilation in Amyotrophic Lateral Sclerosis ? a Randomized Controlled Study|Terminated||Phase 3|74|Actual|Assistance Publique - Hôpitaux de Paris||2||"in the absence of benefits and because of a statistically significant excess mortality in the   group of patients receiving active stimulation."|f||||t||||||||||2017-10-11 03:02:52.366182|2017-10-11 03:02:52.366182
NCT01583075|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-04-23|||December 2009||2009-12-01|April 2012|2012-04-01||||March 2011|Actual|2011-03-01||Interventional|||Pulmonary Vein Ablation of Atrial Fibrillation Using Magnetic Navigation: Single Ring Versus Circumferential Techniques|"Pulmonary Vein Ablation With Magnetic Navigation in Patients With Therapy-refractory Symptomatic Atrial Fibrillation: Comparison of Single Ring and Circumferential Ablation Techniques"|Completed||N/A|80|Actual|University Medical Center Goettingen||2|||f||||f||||||||||2017-10-11 03:02:52.459575|2017-10-11 03:02:52.459575
NCT01583062|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2013-07-12|||January 2006||2006-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures|Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures (Mandibular Fractures, Zygomaticoorbital Fractures, Isolated Orbital Blow-out Fractures and LeFort I/II/III Fractures): 1 Day vs. 5 Days: a Prospective, Randomized, Double Blind and Placebo Controlled Study (Phase IV)|Terminated||Phase 4|217|Actual|University Hospital Inselspital, Berne||2||Limited number of patients|f||||t||||||||||2017-10-11 03:02:52.552938|2017-10-11 03:02:52.552938
NCT01583049|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-09-08|||March 2012|Actual|2012-03-01|September 2017|2017-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children|Observational Post Authorisation Safety Study to Describe the Safety Profile of the Diphtheria, Tetanus, Acellular Pertussis Combination Vaccine, Reduced Antigen Content (Triaxis) as a 5th Dose in 4-6 Year Old Spanish Children|Completed||N/A|556|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 03:02:52.684213|2017-10-11 03:02:52.684213
NCT01583036|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-06-09|||January 16, 2012|Actual|2012-01-16|June 2017|2017-06-01|April 17, 2012|Actual|2012-04-17|April 17, 2012|Actual|2012-04-17||Interventional|||An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed|An Interaction Study to Assess the Effect of the Ezogabine/Retigabine and the Main Metabolite NAMR on the Pharmacokinetics of Digoxin in Healthy Volunteers|Completed||Phase 1|30|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:02:52.792392|2017-10-11 03:02:52.792392
NCT01583023|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2014-03-31|||April 2014||2014-04-01|March 2014|2014-03-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Bipolar Depression|Assessing the Efficacy of Left Repetitive Transcranial Magnetic Stimulation (rTMS) as an Adjunctive Treatment to Mood Stabilizers for the Treatment of Bipolar Depression|Unknown status|Not yet recruiting|Phase 4|45|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-10-11 03:02:52.882654|2017-10-11 03:02:52.882654
NCT01583010|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-04-20|||December 2011||2011-12-01|April 2012|2012-04-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Improvement of Needle Visibility in Ultrasound Guided Regional Anaesthesia|"Improvement of Needle Visibility in In-line Regional Anaesthesia by Advanced Needle Visualization Technology ®"|Unknown status|Recruiting|N/A|100|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 03:02:52.987529|2017-10-11 03:02:52.987529
NCT01582997|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-11-12|||May 2012||2012-05-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|||A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors|An Open-label, Dose Escalation, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of GSK2118436 in Japanese Subjects With BRAF V600 Mutation Positive Solid Tumors.|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:02:53.090492|2017-10-11 03:02:53.090492
NCT01582971|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-08-15|2017-03-21||April 17, 2012||2012-04-17|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|May 1, 2016|Actual|2016-05-01||Interventional|||Home-Based Symptom Management Via Reflexology for Breast Cancer Patients|Home-Based Symptom Management Via Reflexology for Breast Cancer Patients|Active, not recruiting||N/A|256|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 03:02:53.291184|2017-10-11 03:02:53.291184
NCT01582958|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-14|2015-10-06|||April 2013||2013-04-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of OMT on Patients With COPD: Correlating Pulmonary Function Tests With Biochemical Alterations|The Effect of Osteopathic Manipulative Treatment on Patients With Chronic Obstructive Pulmonary Disease:Correlating Pulmonary Function Tests With Biochemical Alterations|Completed||N/A|45|Actual|Michigan State University||3|||f||||f||||||||||2017-10-11 03:02:53.749674|2017-10-11 03:02:53.749674
NCT01582945|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-04-18|2017-03-02||April 2012||2012-04-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Ketamine Infusion for Treatment-resistant Major Depressive Disorder|N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation|Completed||N/A|14|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:02:54.045922|2017-10-11 03:02:54.045922
NCT01582932|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-05-18|||April 2013||2013-04-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Evaluate the Safety and Tolerability of Calcipotriene Foam, 0.005%, in Pediatric Subjects (Ages 2 to 11 Years, Inclusive) With Mild to Moderate Plaque Psoriasis.|A Multicenter, Open-label, Phase 1 Study of the Safety, Tolerability, Systemic Exposure, Pharmacodynamics, and Treatment Effect of Calcipotriene Foam, 0.005%, in Pediatric Subjects (Ages 2 to 11 Years) With Plaque Psoriasis|Recruiting||Phase 1|75|Anticipated|Mayne Pharma International Pty Ltd||1|||f||||f|t|||||||||2017-10-11 03:02:54.235953|2017-10-11 03:02:54.235953
NCT01582919|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-03-31|||September 2012|Actual|2012-09-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|AMIMAGE 2||Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study|STUDY OF IMAGING MARKERS IN THE VERY EARLY STAGES OF DEMENTIA AMONG RETIRED RURAL FARM IN THE GIRONDE AND PARTICIPATING IN THE AMI COHORT EPIDEMIOLOGY: A LONGITUDINAL STUDY.|Completed||N/A|304|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 03:02:54.398951|2017-10-11 03:02:54.398951
NCT01582906|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2012-04-20|||August 2011||2011-08-01|April 2012|2012-04-01||||August 2013|Anticipated|2013-08-01||Observational|||A Survivorship Care Plan for Gynaecological Cancer Patients|Does a Post Treatment Survivorship Care Plan Improve Gynaecological Cancer Patient's Quality of Life and Self Efficacy? A Mixed Methods Pilot Study.|Unknown status|Recruiting|N/A|75|Anticipated|Royal Marsden NHS Foundation Trust|||2||f||||f||||||||||2017-10-11 03:02:54.482857|2017-10-11 03:02:54.482857
NCT01582893|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-04-04|||April 2012||2012-04-01|April 2017|2017-04-01|July 2013|Actual|2013-07-01|October 2012|Actual|2012-10-01||Interventional|PERCI||Permeability Enhancement to Reduce Chronic Inflammation|Permeability Enhancement to Reduce Chronic Inflammation|Completed||N/A|50|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-10-11 03:02:54.575034|2017-10-11 03:02:54.575034
NCT01582880|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-09-14|2017-03-21||March 2012||2012-03-01|September 2017|2017-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis|The Use of Riboflavin/Ultraviolet A Cross-linked Human Donor Corneas as Carriers for the Boston Keratoprosthesis|Completed||Phase 1/Phase 2|1|Actual|Massachusetts Eye and Ear Infirmary||1|||f||||f||||||||||2017-10-11 03:02:54.670352|2017-10-11 03:02:54.670352
NCT01582867|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-04-19|||May 2012||2012-05-01|March 2017|2017-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SOCRATHE||HemoControl System Activated in Hemodiafiltration Treatments|Studio Cross-Over Controllato Randomizzato Sul Dispositivo ArTis Con Hemocontrol in Emodiafiltrazione - SOCRATHE|Completed||N/A|7|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-10-11 03:02:55.044028|2017-10-11 03:02:55.044028
NCT01582854|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-01-23|2016-01-23||June 2012||2012-06-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|ARTEMIDA||Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)|A 12-month, International, Parallel Group, Randomised, Multi-centre, Double-blind, Placebo-controlled Trial to Examine the Effect of Actovegin® Treatment Given First Intravenously and Subsequently Orally Over 6 Months, in Subjects With Post-stroke Cognitive Impairment (PSCI).|Completed||Phase 3|503|Actual|Takeda||2|||f||||f||||||||||2017-10-11 03:02:55.183163|2017-10-11 03:02:55.183163
NCT01582841|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-08-29|||February 2012||2012-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|HNPCC||Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting|Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting|Completed||N/A|247|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 03:02:56.664766|2017-10-11 03:02:56.664766
NCT01582828|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2016-07-06|||August 2012||2012-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|SHAFT||Serial Hybrid Atrial Fibrillation Ablation|Serial Hybrid Atrial Fibrillation Ablation|Recruiting||N/A|162|Anticipated|Medisch Spectrum Twente||2|||f||||f||||||||||2017-10-11 03:02:56.770696|2017-10-11 03:02:56.770696
NCT01582815|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-06-15|||September 2012||2012-09-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms|A Multicenter, Double-Blind, Placebo-Controlled Study of JNJ-40411813 as Adjunctive Treatment to an Antidepressant in Adults With Major Depressive Disorder With Anxiety Symptoms|Completed||Phase 2|121|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 03:02:56.879427|2017-10-11 03:02:56.879427
NCT01582802|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-06-09|||July 2011||2011-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Determinants of Neonatal Anemia in Women Carrying Multiples|Determinants of Neonatal Iron Homeostasis in Women Carrying Multiples|Active, not recruiting||N/A|350|Anticipated|Cornell University|||1||f||||f||||||Samples With DNA|"     maternal and cord blood, placental tissue and RNA   "|No||2017-10-11 03:02:57.036527|2017-10-11 03:02:57.036527
NCT01582789|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2016-03-30|2016-02-25||April 2012||2012-04-01|March 2016|2016-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||All subjects prior to dispense of first set of study lenses|Comparative Study of Two Marketed Spherical Soft Contact Lenses|Comparative Study of Two Marketed Spherical Soft Contact Lenses|Completed||Phase 4|61|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 03:02:57.120843|2017-10-11 03:02:57.120843
NCT01582776|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-01-09|||October 2012||2012-10-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma|A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma|Recruiting||Phase 1/Phase 2|315|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-11 03:02:57.595199|2017-10-11 03:02:57.595199
NCT01582763|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-01-04|||May 2012||2012-05-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|June 2017|Anticipated|2017-06-01||Observational|IGOS||International Guillain-Barré Syndrome Outcome Study|International GBS Outcome Study (IGOS): A Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).|Recruiting||N/A|4000|Anticipated|Erasmus Medical Center|||4||f||||f||||||Samples With DNA|"     serum, cerebrospinal fluid, samples with DNA   "|Undecided||2017-10-11 03:02:57.997155|2017-10-11 03:02:57.997155
NCT01582737|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2017-08-14|||May 30, 2012|Actual|2012-05-30|August 2017|2017-08-01|March 31, 2019|Anticipated|2019-03-31|March 31, 2019|Anticipated|2019-03-31||Observational|||Xarelto [SPAF] Post-marketing Surveillance in Japan|Special Drug Use Investigation of Xarelto [SPAF]|Active, not recruiting||N/A|11311|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:02:59.241486|2017-10-11 03:02:59.241486
NCT01582724|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2015-08-03|||December 2012||2012-12-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Interventional|AKUD||Effectiveness of Additional Self-care Acupressure for Women With Menstrual Pain Compared to Usual Care Alone|Randomized Pragmatic Trial for Women With Menstrual Pain Comparing Additional Self-care Acupressure to Usual Care Alone|Completed||N/A|220|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:02:59.347675|2017-10-11 03:02:59.347675
NCT01582711|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2015-07-30|||September 2012||2012-09-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|iAdhere||Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT|TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.|Completed||Phase 3|1002|Actual|Centers for Disease Control and Prevention||3|||f||||t||||||||||2017-10-11 03:02:59.457982|2017-10-11 03:02:59.457982
NCT01582698|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-20|2015-06-23|||April 2012||2012-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||TBE Seropersistence up to 10 Years After First Booster in Adults|Open-label Phase 4 Study to Investigate the Seropersistence of Tick-borne Encephalitis (TBE) Virus Antibodies From 7 to 10 Years After the First Booster and the Response to a Second Booster Vaccination With FSME-IMMUN 0.5ml in Adults|Completed||Phase 4|243|Actual|Baxter Healthcare Corporation||1|||f||||t||||||||||2017-10-11 03:02:59.615447|2017-10-11 03:02:59.615447
NCT01582685|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2014-12-01|||April 2012||2012-04-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Exercise in Breast Cancer Survivors|Exercise in Breast Cancer Survivors: Analysis of Angiogenic Profile|Withdrawn||N/A|0|Actual|University of Mississippi Medical Center||2||no patients enrolled|f||||f||||||||||2017-10-11 03:02:59.710747|2017-10-11 03:02:59.710747
NCT01582672|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-06-06|||November 2012||2012-11-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|ADAPT||Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma|An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)|Active, not recruiting||Phase 3|450|Anticipated|Argos Therapeutics||2|||f||||t||||||||No||2017-10-11 03:02:59.820917|2017-10-11 03:02:59.820917
NCT01582659|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-12-04|||June 2012||2012-06-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Outpatient Treatment of Constipation in Children|Outpatient Treatment of Constipation in Children - a Randomized Interventions Study|Completed||N/A|239|Actual|Vejle Hospital||3|||f||||f||||||||||2017-10-11 03:03:00.222327|2017-10-11 03:03:00.222327
NCT01582646|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-09-07|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|Bêtapain||Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain|Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain|Terminated||Phase 2|20|Actual|University Hospital, Strasbourg, France||2||difficulty of recruitment|f||||f||||||||||2017-10-11 03:03:01.061159|2017-10-11 03:03:01.061159
NCT01582633|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-06-20|||July 2012||2012-07-01|June 2012|2012-06-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|||Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine|Assessment of Dose-sparing of Pandemic A/California/7/2009 H1N1 Influenza Vaccine Administered Intradermally by Needle-free Disposable-syringe Jet Injector (DSJI)|Unknown status|Not yet recruiting|Phase 2/Phase 3|300|Anticipated|University of Sao Paulo General Hospital||4|||f||||f||||||||||2017-10-11 03:03:01.182398|2017-10-11 03:03:01.182398
NCT01582620|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2012-04-19|||August 2011||2011-08-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|Telestroke||Telestroke in Nordland Hospital. A Study of a Telemedicine Network in Rural Hospitals|Telestroke in Nordland Hospital: Improved Treatment of Cerebral Stroke in Small Hospitals|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital of North Norway||1|||f||||f||||||||||2017-10-11 03:03:01.298195|2017-10-11 03:03:01.298195
NCT01582607|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-14|2012-04-19|||January 2010||2010-01-01|April 2012|2012-04-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Interventional|||Subarachnoid Administration of Levobupivacaine for Cesarean Section|Intrathecal Plain Bupivacaine, Ropivacaine and Levo-bupivacaine With or Without Fentanyl for Elective c Section.|Unknown status|Recruiting|Phase 2/Phase 3|130|Anticipated|University of Patras||6|||f||||t||||||||||2017-10-11 03:03:01.394198|2017-10-11 03:03:01.394198
NCT00004664|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||June 1995||1995-06-01|December 2001|2001-12-01||||||||Interventional|||Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting||Completed||N/A|69||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.885448|2017-10-11 04:26:55.885448
NCT01582594|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2013-06-27|||February 2012||2012-02-01|May 2012|2012-05-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Observational|||A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection|A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection|Terminated||Phase 3|795|Actual|Johnson & Johnson Medical, China|||1|Sponsor's decision|f||||f||||||Samples With DNA|"     A minimum of 1000 qualified specimens shall be collected, including at least 350 anti-HCV     seropositive specimens.      To further evaluate RIBA test specificity in HAV IgG positive, HBsAg positive, HEV IgG     positive and anti-HIV positive specimens, approximately 30 specimens of each viral infection     will be included in the study.      A minimum of 60 matched plasma and serum specimens will be collected to evaluate the     applicability of the investigational product on different types of samples, including at     least 30% of anti-HCV seropositive specimens.   "|||2017-10-11 03:03:01.529192|2017-10-11 03:03:01.529192
NCT01582581|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-04-29|||March 2012||2012-03-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|iTAD||Study of Technology-assisted Treatment of Adolescent Depression|Information Technology Enabled Treatment of Adolescent Depression|Completed||N/A|45|Actual|iHope Network, Inc.||2|||f||||t||||||||||2017-10-11 03:03:01.614548|2017-10-11 03:03:01.614548
NCT01582568|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-02-17|||June 2011||2011-06-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|EUS||EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment|EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment|Terminated||Phase 4|1|Actual|Baylor College of Medicine|||1|Not enough subjects to reach accrual goals.|f||||t||||||||No||2017-10-11 03:03:01.73479|2017-10-11 03:03:01.73479
NCT01582555|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-04-19|||June 2012||2012-06-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Postoperative Nasal Irrigation Using Mucolytic Agents|Postoperative Nasal Irrigation Using Mucolytic Agents in Patients Undergoing Endoscopic Sinus Surgery|Unknown status|Not yet recruiting|N/A|44|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 03:03:01.866799|2017-10-11 03:03:01.866799
NCT01582542|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-19|||April 2012||2012-04-01|April 2012|2012-04-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction|Usage of Desmopressin fo Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Orthotopic Bladder Reconstruction|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-11 03:03:02.008545|2017-10-11 03:03:02.008545
NCT01582529|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-02-10|||June 2012||2012-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||SVRII Family Factors Study|The Impact of Family Factors on Developmental and Psychosocial Outcomes in Children With Hypoplastic Left Heart Syndrome (HLHS) at 6 Years of Age - Pediatric Heart Network Single Ventricle Reconstruction Extension (SVR II) Ancillary Study|Recruiting||N/A|250|Anticipated|Medical College of Wisconsin|||1||f||||t||||||||||2017-10-11 03:03:02.23426|2017-10-11 03:03:02.23426
NCT01582516|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-03-06|||June 2010||2010-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma|A Phase I/II Trial of a Conditionally Replication-competent Adenovirus (Delta-24-rgd) Administered by Convection Enhanced Delivery in Patients With Recurrent Glioblastoma|Completed||Phase 1/Phase 2|20|Actual|Erasmus Medical Center||1|||f||||t||||||||||2017-10-11 03:03:02.365906|2017-10-11 03:03:02.365906
NCT01582503|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-11-01||2016-08-09|April 2012||2012-04-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)|A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Dosing Regimens of MEMP1972A in Adults With Allergic Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids and a Second Controller (COSTA)|Completed||Phase 2|578|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 03:03:02.490416|2017-10-11 03:03:02.490416
NCT01582490|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2014-05-31|2014-04-29||April 2012||2012-04-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||19 subjects were enrolled, 9 in the Infiltration - EXPAREL group and 10 in the Instillation - EXPAREL group.|Study of EXPAREL in Patients Undergoing Breast Augmentation|Evaluation of the Safety and Efficacy of EXPAREL® (Bupivacaine Liposome Injectable Suspension) When Administered Via Infiltration Versus Instillation in Subjects Undergoing Bilateral Augmentation Mammoplasty|Completed||Phase 4|19|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-10-11 03:03:02.868452|2017-10-11 03:03:02.868452
NCT01582477|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2013-05-05|2013-02-26||March 2012||2012-03-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|TAP||TAP-patients With Robotic Assisted Lap Prostatectomy|Evaluation of the Safety and Efficacy of EXPAREL When Administered by Infiltration Into the Transversus Abdominis Plane (TAP) for Prolonged Postsurgical Analgesia in Subjects Undergoing Robot-assisted Laparoscopic Prostatectomy|Completed||Phase 4|24|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-10-11 03:03:03.297931|2017-10-11 03:03:03.297931
NCT01582464|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-05-06|||May 2012||2012-05-01|May 2016|2016-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|AAIU-PHOA||Addressing Attitudes to Improve Use of Protective Headwear in Older Adults|Effect of Social Marketing on Attitudes Towards Protective Headwear in Older Adults to Reduce Traumatic Brain Injury|Completed||N/A|37|Actual|University of California, Los Angeles|||1||f||||f||||||||No|all data shared will be de-identified|2017-10-11 03:03:05.179485|2017-10-11 03:03:05.179485
NCT01582451|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2014-04-14||2014-04-14|April 2012||2012-04-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|IMAGINE 5||A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus|A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study|Completed||Phase 3|426|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:03:05.268911|2017-10-11 03:03:05.268911
NCT01582438|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-03-07|||November 2012||2012-11-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Expanded Access|||An Open Label Access Study For Subjects Who Completed A1481156|A Local, Multicentre, Open Label Access Study, To Provide Sildenafil Therapy For Subjects Who Completed A1481156 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil For Subjects In India|No longer available||N/A|||Pfizer|||||f||||||||||||||2017-10-11 03:03:05.470086|2017-10-11 03:03:05.470086
NCT01582425|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-06-28|||April 2012||2012-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Drug Interaction Study of Isavuconazole and Methadone|A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Methadone in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:03:05.54081|2017-10-11 03:03:05.54081
NCT01582412|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-08-31|||March 2012||2012-03-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Drug Interaction Study of Isavuconazole and Digoxin|A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Digoxin in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:03:05.636339|2017-10-11 03:03:05.636339
NCT01582399|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-12-07|||February 2012||2012-02-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240|A Phase 1 Single-Dose, Parallel Group, Randomized, Open-Label Study to Determine the Absolute Bioavailability of ASKP1240 After Intravenous and Subcutaneous Administration in Healthy Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 03:03:05.717914|2017-10-11 03:03:05.717914
NCT01582386|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-09-26|||October 2012||2012-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:03:05.906322|2017-10-11 03:03:05.906322
NCT01582373|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2014-12-01|||May 2012||2012-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|May 2013|Actual|2013-05-01||Interventional|||Pilot Study to Assess the Efficacy of Cognitive-behavioral Couple Therapy for Provoked Vestibulodynia|Pilot Study to Assess the Efficacy of an Experimental 12-week Cognitive-behavioral Couple Therapy in the Treatment of Provoked Vestibulodynia|Completed||N/A|9|Actual|Université de Montréal||1|||f||||f||||||||||2017-10-11 03:03:05.952319|2017-10-11 03:03:05.952319
NCT01582360|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2015-10-14|||May 2013||2013-05-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|PharmacoCRRT||2012_PharmacoCRRT-study:Pharmacokinetics of Anti-infectives in Critically Ill Patients in Need of Continuous Renal Replacement Therapy (CRRT)|Pharmacokinetics of Anti-infectives in Critically Ill Patients in Need of Continuous Renal Replacement Therapy (CRRT) or Without CRRT|Recruiting||N/A|640|Anticipated|Oslo University Hospital|||8||f||||t||||||||||2017-10-11 03:03:06.052723|2017-10-11 03:03:06.052723
NCT01582347|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-01-19||2015-08-07|March 2012||2012-03-01|January 2017|2017-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Transfer of Subjects From Subutex/Suboxone to RBP-6300|A Randomized, Double-blind, Double-dummy, Active-drug-controlled, Parallel-group, Multicentre Acceptability and Safety Study of the Transfer From Subutex/Suboxone to RBP-6300 in Opioid-dependent Subjects|Completed||Phase 2|143|Actual|Indivior Inc.||2|||f||||t||||||||||2017-10-11 03:03:06.168851|2017-10-11 03:03:06.168851
NCT01582334|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-04-20|||March 2013||2013-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS ARG||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina|"Easypod Connect: A National, Multicentre, Observational Registry to Evaluate Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Argentina"|Completed||N/A|68|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 03:03:06.33867|2017-10-11 03:03:06.33867
NCT01582321|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-06-12|||March 2012||2012-03-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Investigation of the Influence of Gender on Cardiovascular Function|Investigation of the Influence of Gender on Cardiovascular Function and Inflammation|Completed||Early Phase 1|56|Anticipated|Queen Mary University of London||4|||f||||f||||||||||2017-10-11 03:03:06.4321|2017-10-11 03:03:06.4321
NCT01582308|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-04-28|2013-12-04||June 21, 2012|Actual|2012-06-21|April 2017|2017-04-01|December 14, 2012|Actual|2012-12-14|December 4, 2012|Actual|2012-12-04||Interventional|||A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)|A Study to Assess and Compare the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|22|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:03:06.565133|2017-10-11 03:03:06.565133
NCT01582295|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-05-23|||June 2012|Actual|2012-06-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease|Dose Finding Pilot Study of Cabozantinib (XL184) Administered Orally as Monotherapy for the Treatment of Patients With Relapsed or Relapsed/Refractory Multiple Myeloma With Bone Disease|Completed||Phase 1|4|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:03:07.219732|2017-10-11 03:03:07.219732
NCT01582282|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-11-08|2012-10-03||May 1988||1988-05-01|November 2012|2012-11-01|January 1990|Actual|1990-01-01|January 1990|Actual|1990-01-01||Interventional|||Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects|A Clinical Study to Determine the Ability of Metamucil to Reduce Fasting Blood Glucose and HbA1c Levels in Type II NIDDM|Terminated||Phase 4|37|Actual|Procter and Gamble||3||due to slow enrollment|f||||f||||||||||2017-10-11 03:03:07.314247|2017-10-11 03:03:07.314247
NCT01582269|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-08-01||2014-09-29|April 2012||2012-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2014|Actual|2014-07-01||Interventional|||A Study in Recurrent Glioblastoma (GB)|A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma|Active, not recruiting||Phase 2|180|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:03:08.127051|2017-10-11 03:03:08.127051
NCT01582256|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-04-19|||August 2012||2012-08-01|April 2012|2012-04-01|July 2015|Anticipated|2015-07-01|||||Observational|||Behavior, Neuropsychology, Neuroimage and Electrophysiology in Autistic Individuals With and Without CNVs|Behavior, Neuropsychology, Neuroimage and Electrophysiology in Autistic Individuals With and Without Copy Number Variation and Their Unaffected Siblings|Unknown status|Not yet recruiting|N/A|132|Anticipated|National Taiwan University Hospital|||6||f||||t||||||Samples With DNA|"     The subjects will receive blood withdrawal. The blood sample will be used for establishing     lymphoblastoid cell lines, which will be used for molecular genetic experiments.   "|||2017-10-11 03:03:08.311176|2017-10-11 03:03:08.311176
NCT01582243|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-09-15|2016-09-15||April 2013||2013-04-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Baseline characteristics used the Intent to Treat (ITT) population: all enrolled patients who took at least one tablet of vildagliptin plus metformin 50/500 mg, and had Baseline and at least one post treatment evaluation for efficacy measurement|Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients|A Prospective, Open-label, Interventional Study to Assess the HbA1c Change an 24-hr Glucose Fluctuation After Vildagliptin Plus Metformain (SPC) Treatment in Metformin Monotherapy Uncontrolled Type 2 Diabetes Mellitus Patients|Completed||Phase 4|40|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:03:08.406325|2017-10-11 03:03:08.406325
NCT01582230|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-08-29|||April 2012||2012-04-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus|A 24-week, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|293|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:03:08.7327|2017-10-11 03:03:08.7327
NCT01582217|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2015-12-22|||March 2012||2012-03-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|TRIAGE||Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition|TRIAGE: Patients Undergoing Percutaneous Coronary Interventions to Improve Clinical Outcomes Through Optimal Platelet Inhibition|Completed||N/A|318|Actual|Icahn School of Medicine at Mount Sinai|||3||f||||t||||||||||2017-10-11 03:03:08.879|2017-10-11 03:03:08.879
NCT01582204|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-06-30|||April 2012||2012-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma|Pilot Trial To Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma|Recruiting||N/A|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:03:08.965859|2017-10-11 03:03:08.965859
NCT01582191|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-08-02|||May 2012|Actual|2012-05-01|August 2017|2017-08-01|May 2026|Anticipated|2026-05-01|May 2026|Anticipated|2026-05-01||Interventional|||A Phase 1 Trial of Vandetanib (a Multi-kinase Inhibitor of EGFR, VEGFR and RET Inhibitor) in Combination With Everolimus (an mTOR Inhibitor) in Advanced Cancer|A Phase 1 Trial of Vandetanib (a Multi-kinase Inhibitor of EGFR, VEGFR and RET Inhibitor) in Combination With Everolimus (an mTOR Inhibitor) in Advanced Cancer|Recruiting||Phase 1|174|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:03:09.103503|2017-10-11 03:03:09.103503
NCT01582178|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-09-19|2013-06-02||June 2012||2012-06-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Warm Water Versus Room Temperature Water Immersion Colonoscopy|Warm Water Versus Room Temperature Water Immersion Colonoscopy - a Prospective, Randomized, Double-blind, Single-center Trial|Completed||N/A|212|Actual|Vitkovice Hospital||2|||f||||f||||||||||2017-10-11 03:03:09.248657|2017-10-11 03:03:09.248657
NCT01582165|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-09-26|||June 2012||2012-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Women With Chest Pain and no Significant Coronary Artery Stenosis; A Study on Microvascular Resistance|Microvascular Resistance in Women With Chest Pain and no or Minimal Coronary Artery Disease|Completed||Phase 4|66|Actual|Oslo University Hospital||2|||f||||f||||||||Undecided|Analyses of the study will start within a few weeks or months. Publication planned in 2017|2017-10-11 03:03:09.543329|2017-10-11 03:03:09.543329
NCT01582139|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2014-07-28|2014-06-27||May 2012||2012-05-01|July 2014|2014-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker|Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker|Completed||N/A|12|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 03:03:09.75132|2017-10-11 03:03:09.75132
NCT01582126|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-03-26|||August 2012||2012-08-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Group Balance Training for People With Multiple Sclerosis|Group Balance Training for People With Multiple Sclerosis|Completed||N/A|87|Actual|Örebro County Council||2|||f||||f||||||||||2017-10-11 03:03:10.078416|2017-10-11 03:03:10.078416
NCT01582113|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-05-24|||June 2012||2012-06-01|May 2017|2017-05-01|May 24, 2017|Actual|2017-05-24|May 24, 2017|Actual|2017-05-24||Interventional|||Cognizin Citicoline Dosing in a Healthy Adolescent Male Population||Completed||N/A|84|Actual|University of Utah||3|||f||||t||||||||||2017-10-11 03:03:10.182583|2017-10-11 03:03:10.182583
NCT01582100|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2014-11-05|2014-11-05||March 2012||2012-03-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||two subjects with GERD and nausea|Reletex for Nausea in GERD Patients|Reletex ™ Band as an Adjunct to Standard Therapy in Patients With GERD, Nausea With or Without Vomiting- A Pilot Study|Terminated||N/A|2|Actual|Northwestern University|The study was terminated due to low enrollment. One subject withdrew due to minor wrist discomfort and the other withdrew after determining the study schedule was undesirable.|1||study was terminated by investigator due to low enrollment|f||||f||||||||||2017-10-11 03:03:10.25641|2017-10-11 03:03:10.25641
NCT01582087|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-05-10|||February 2012||2012-02-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Observational|||Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic Failure|Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic Failure|Active, not recruiting||N/A|20|Anticipated|The University of Texas Medical Branch, Galveston|||1||f||||t||||||Samples Without DNA|"     Samples previously collected for diagnostic use which could include blood, urine, bile,     cerebral spinal fluid, feces, liver tissue, brain tissue.   "|||2017-10-11 03:03:10.414299|2017-10-11 03:03:10.414299
NCT01582074|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-06-30|||July 3, 2011||2011-07-03|December 16, 2016|2016-12-16||||||||Observational|||The Ultrasound Study of Tamoxifen|The Ultrasound Study of Tamoxifen|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:03:10.54113|2017-10-11 03:03:10.54113
NCT01582061|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-08-25|||August 16, 2011|Actual|2011-08-16|August 2017|2017-08-01|January 26, 2017|Actual|2017-01-26|January 26, 2017|Actual|2017-01-26||Interventional|||An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.|An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease (Seascape).|Completed||Phase 3|104|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:03:10.706884|2017-10-11 03:03:10.706884
NCT01582048|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2014-12-03|||April 2012||2012-04-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning|Multicenter Phase II Study of Peritransplantation Immunosuppression Using ATG, Rituximab, Sirolimus and Mycophenolate Mofetil in Patient Receiving Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning With Fludarabine and Treosulfan|Unknown status|Recruiting|Phase 2|30|Anticipated|University Hospital Tuebingen||1|||f||||t||||||||||2017-10-11 03:03:10.957106|2017-10-11 03:03:10.957106
NCT01582035|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2014-02-14|||April 2012||2012-04-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir|A Phase I, Open Label Trial in Genotype 1 HCV-Infected Subjects to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Repeated Doses of TMC647055 Given in Combination With Telaprevir|Completed||Phase 1|7|Actual|Janssen R&D Ireland||2|||f||||f||||||||||2017-10-11 03:03:11.120892|2017-10-11 03:03:11.120892
NCT01582022|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2012-04-19||||||April 2012|2012-04-01||||||||Interventional|||Evaluation of The Effect of Bupivacaine (Marcaine) in Reducing Early Post Tonsillectomy Pain|The Effect of Bupivacaine (Marcaine) in Reducing Early Post Tonsillectomy Pain|Unknown status|Not yet recruiting|Phase 4|||King Saud University||2|||f||||t||||||||||2017-10-11 03:03:11.265031|2017-10-11 03:03:11.265031
NCT01582009|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-15|2017-05-17|2017-04-07||March 2010||2010-03-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional||All treated and eligible patients|Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate|A Phase I/II Study of the HDAC Inhibitor LBH-589 in Combination With the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma|Terminated||Phase 1/Phase 2|26|Actual|Roswell Park Cancer Institute||1||pts off study, PI left institute|f||||t||||||||||2017-10-11 03:03:11.375277|2017-10-11 03:03:11.375277
NCT01581996|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2017-05-08|||March 2012||2012-03-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|||Fosrenol and Phosphorus Balance - Lanthanum Carbonate|Effect of Lanthanum Carbonate (Fosrenol) on Fecal Phosphorus Excretion and Phosphorus Balance|Completed||N/A|9|Actual|Los Angeles Biomedical Research Institute||1|||f||||t||||||||||2017-10-11 03:03:11.92614|2017-10-11 03:03:11.92614
NCT01581983|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2015-07-09|||April 2012||2012-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Mindfulness Meditation Format Pilot Study|Mindfulness Meditation Format Pilot Study|Completed||Phase 1|8|Actual|Oregon Health and Science University||2|||f||||||||||||||2017-10-11 03:03:12.045833|2017-10-11 03:03:12.045833
NCT01581970|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2015-07-15|||June 2012||2012-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer|Potentiation of Cetuximab by Tregs Depletion With Metronomic Cyclophosphamide in Metastatic Squamous Cell Cancers of Head and Neck|Completed||Phase 2|8|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-10-11 03:03:12.119567|2017-10-11 03:03:12.119567
NCT01581957|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2014-06-26|||December 2012||2012-12-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|SPIRIT||Pilot Study on Gastro-intestinal (GI) Enteral Nutrition (EN) Tolerance in Intensive Care Unit Patients|A Pilot Study to Evaluate the Effect of a Specific Enteral Formulation Designed to Improve Gastrointestinal Tolerance in the Critically Ill Patient|Completed||N/A|90|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 03:03:12.228645|2017-10-11 03:03:12.228645
NCT01581944|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-04-18|||January 2008||2008-01-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Gonadotropin-releasing Hormone Agonist Prior to Myomectomy|Phase 3 Study of Experience With a Gonadotropin-releasing Hormone Agonist Prior to Myomectomy - Comparison of 2 Versus 3 Monthly Doses.|Completed||Phase 3|68|Actual|Mt. Hope Maternity Hospital||3|||f||||t||||||||||2017-10-11 03:03:12.35885|2017-10-11 03:03:12.35885
NCT01581931|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2013-06-14|2013-06-14||April 2012||2012-04-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets|Bioequivalence of Metformin Under Fed Conditions After Administration of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Male and Female Volunteers, (an Open-label, Randomised, Single Dose, Two-way Crossover, Phase I Trial)|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:03:12.493087|2017-10-11 03:03:12.493087
NCT01581918|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-23|||December 2011||2011-12-01|April 2012|2012-04-01||||March 2012|Actual|2012-03-01||Interventional|||Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting|PHASE II STUDY TO EVALUATE EFFICACY AND SAFETY OF CARBAMAZEPINE FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING.|Unknown status|Recruiting|Phase 2|43|Anticipated|Faculdade de Medicina do ABC||1|||f||||t||||||||||2017-10-11 03:03:12.831192|2017-10-11 03:03:12.831192
NCT01581905|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-01-19|||March 2012||2012-03-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution|A Randomized Controlled Trial Comparing Conventional Laparoscopic Hysterectomy With Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution|Terminated||N/A|98|Actual|Milton S. Hershey Medical Center||2||Trial was redesigned as a new trial|f||||f||||||||||2017-10-11 03:03:12.939783|2017-10-11 03:03:12.939783
NCT01581892|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2015-08-24|||December 2011||2011-12-01|August 2015|2015-08-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Use of Adult Bone Marrow Mononuclear Cells in Patients With Long Bone Nonunion|Treatment of Long Bone Nonunion With Autologous Bone Marrow Stem Cells. Phase I/II Study|Completed||Phase 1/Phase 2|7|Actual|Hospital Universitario Central de Asturias||1|||f||||f||||||||||2017-10-11 03:03:13.043257|2017-10-11 03:03:13.043257
NCT01581879|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-19|||November 2004||2004-11-01|April 2012|2012-04-01|January 2005|Actual|2005-01-01|November 2004|Actual|2004-11-01||Interventional|||Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions|Randomized, 2-way Crossover, Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg in Healthy Subjects Under Fed Conditions.|Completed||Phase 1|38|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:03:13.132129|2017-10-11 03:03:13.132129
NCT01581866|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-19|||November 2004||2004-11-01|April 2012|2012-04-01|January 2005|Actual|2005-01-01|November 2004|Actual|2004-11-01||Interventional|||Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions|Randomized, 2-way Crossover, Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg in Healthy Subjects Under Fasting Conditions.|Completed||Phase 1|56|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:03:13.224762|2017-10-11 03:03:13.224762
NCT01581853|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-10-05|||May 2012||2012-05-01|April 2013|2013-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily|Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily|Completed||Phase 4|21|Actual|Hospital Universitari de Bellvitge||1|||f||||f||||||||||2017-10-11 03:03:13.321223|2017-10-11 03:03:13.321223
NCT01581840|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2016-08-02|||June 2012||2012-06-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus|Phase I-II on Radiochemotherapy Combined With Panitumumab in the Treatment of Localised Epidermoid Carcinoma of the Anus|Recruiting||Phase 1/Phase 2|45|Anticipated|Federation Francophone de Cancerologie Digestive||1|||f||||t||||||||||2017-10-11 03:03:13.420477|2017-10-11 03:03:13.420477
NCT01581827|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-04-09|||January 2009||2009-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Observational|SHF-L||SCREEN-HFL (SCReening Evaluation of the Evolution of New Heart Failure) - a Longitudinal Study|SCREEN-HFL (SCReening Evaluation of the Evolution of New Heart Failure) - a Longitudinal Study|Active, not recruiting||N/A|3500|Anticipated|Monash University|||1||f||||f||||||Samples Without DNA|"     Blood samples to measure BNP and NT-proBNP   "|||2017-10-11 03:03:13.672131|2017-10-11 03:03:13.672131
NCT01581814|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2012-04-19|||October 2008||2008-10-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|July 2011|Actual|2011-07-01||Interventional|||Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome||Completed||Phase 3|99|Actual|Catholic University of the Sacred Heart||3|||f||||t||||||||||2017-10-11 03:03:13.765393|2017-10-11 03:03:13.765393
NCT01581801|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-02-04|||October 2012||2012-10-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|||Bariatric Surgery and Reactive Hypoglycemia|RANDOMIZED CLINICAL STUDY COMPARING THE EFFECT OF ROUX-en-Y GASTRIC BYPASS AND SLEEVE GASTRECTOMY ON REACTIVE HYPOGLYCEMIA|Completed||N/A|120|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 03:03:13.864811|2017-10-11 03:03:13.864811
NCT01581788|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-19|||January 2011||2011-01-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions|Open Label, Balanced, Randomized, Single-dose, Crossover Oral Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's and Depakote ER 500 mg Tablets of Abbott Laboratories, in Healthy Subjects Under Fed Conditions.|Completed||Phase 1|54|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:03:13.971352|2017-10-11 03:03:13.971352
NCT01581775|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-19|||January 2011||2011-01-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting Conditions|Open Label, Balanced, Randomized, Single-dose, Crossover Oral Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's and Depakote ER 500 mg Tablets of Abbott Laboratories, in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|54|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:03:14.189998|2017-10-11 03:03:14.189998
NCT01581762|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-10-11|||June 2012||2012-06-01|October 2016|2016-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||EUS-FNA With 22G Procore Needles vs 22G Conventional Needles|Prospective Comparative Study on Endoscopic Ultrasonography (EUS) - Guided Fine-Needle Aspiration (FNA) Using the 22G Conventional Needles or Procore Needles Without Immediate On-site Cytopathologic Examination|Completed||Phase 3|42|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 03:03:14.322139|2017-10-11 03:03:14.322139
NCT01581749|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-03-22|||October 2011||2011-10-01|March 2016|2016-03-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer|Prospective Evaluation of Truebeam STX Stereotactic Body Radiosurgery for Low and Intermediate Risk Prostate Cancer|Recruiting||Phase 4|50|Anticipated|Main Line Health||1|||f||||f||||||||||2017-10-11 03:03:14.454872|2017-10-11 03:03:14.454872
NCT01581736|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-05-06|||April 2012||2012-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Molecular Regulation of Muscle Glucose Metabolism|Molecular Regulation of Muscle Glucose Metabolism|Terminated||N/A|48|Actual|Mayo Clinic||1||PI job change|f||||f||||||||||2017-10-11 03:03:14.570119|2017-10-11 03:03:14.570119
NCT01581723|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-02-02|||May 2012||2012-05-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor|Using Biploar Technology for Transurethral Resection of Bladder Tumor - a Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|150|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:03:14.680103|2017-10-11 03:03:14.680103
NCT01581697|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-04-19||||||April 2012|2012-04-01||||||||Interventional|||Impact of Consumption of Oats in Lipid Profile of Children and Adolescents With Dyslipidemia|Impact of Consumption of Oats in Lipid Profile of Children and Adolescents With Dyslipidemia at the Outpatient Clinic of Reference in Preventive Pediatric Cardiology at the Institute of Cardiology of Rio Grande do Sul|Unknown status|Recruiting|Phase 1/Phase 2|||Instituto de Cardiologia do Rio Grande do Sul||1|||f||||||||||||||2017-10-11 03:03:14.9378|2017-10-11 03:03:14.9378
NCT01581684|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-07-05|2014-03-13||April 1, 2012|Actual|2012-04-01|July 2017|2017-07-01|August 1, 2012|Actual|2012-08-01|August 1, 2012|Actual|2012-08-01||Interventional|||Safety Tolerability and Pharmacokinetic of BI 411034|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 411034 (PIB) in Healthy Male Volunteers (Randomised, Single-blind, Placebocontrolled Within Dose Groups, Phase I Study)|Completed||Phase 1|62|Actual|Boehringer Ingelheim||9|||f||||||||||||||2017-10-11 03:03:15.082972|2017-10-11 03:03:15.082972
NCT01581671|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-06-24|||September 2010||2010-09-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|April 2012|Actual|2012-04-01||Observational|||Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography|Non-Invasive Peripheral Arterial Tonometry (EndoPAT) Increases Diagnostic Yield of Coronary Artery Disease by Coronary Angiography|Completed||N/A|201|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:03:16.203286|2017-10-11 03:03:16.203286
NCT01581658|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-07-04|2014-05-16||April 1, 2012|Actual|2012-04-01|July 2017|2017-07-01|November 1, 2012|Actual|2012-11-01|November 1, 2012|Actual|2012-11-01||Interventional|||Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes|A Phase I, Open-label, Parallel-group Study to Investigate Pharmacokinetics, Pharmacodynamics and Safety of a Single 25 mg Dose of Empagliflozin in Japanese Type 2 Diabetes Patients With Different Degrees of Renal Impairment in Comparison to Type 2 Diabetes Patients With Normal Renal Function|Completed||Phase 1|32|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 03:03:16.295771|2017-10-11 03:03:16.295771
NCT01581645|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2015-12-30|||May 2012||2012-05-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Mobilaser Study to Help With People Who Are Having Problems With Their Gait|Increasing Mobility in Parkinsonian Patients With Freezing of Gait and Gait Hypokinesia With an Adjustable, Attachable Laser (Mobilaser)|Completed||Early Phase 1|11|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 03:03:16.725553|2017-10-11 03:03:16.725553
NCT01581632|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-09-22|||January 2010||2010-01-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Assessment of Coronary Plaque Composition|Assessment of Coronary Plaque Composition Using Near Infrared Spectroscopy During Inhibition of LpPLA2 Activity|Completed||N/A|39|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 03:03:16.853751|2017-10-11 03:03:16.853751
NCT01581619|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-08-29|2017-08-29||May 2012||2012-05-01|August 2017|2017-08-01|August 2024|Anticipated|2024-08-01|August 2016|Actual|2016-08-01||Interventional|||External-Beam Partial-Breast Irradiation for Early Breast Cancer 40 Gy QD Over 2 Weeks|A Phase I Study of Once-Daily External-Beam Partial-Breast Irradiation (PBI) for Selected Patients With Early Invasive N0 or Non-Invasive Breast Cancer|Active, not recruiting||N/A|54|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:03:16.963321|2017-10-11 03:03:16.963321
NCT01581606|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-18|||November 2011||2011-11-01|April 2012|2012-04-01|November 2013|Anticipated|2013-11-01|November 2012|Anticipated|2012-11-01||Observational|||Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes|Evaluation of TeleOphthalmology in Age-related Macular Degeneration (AMD) - TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes.|Unknown status|Recruiting|N/A|212|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||||2017-10-11 03:03:17.474822|2017-10-11 03:03:17.474822
NCT01581580|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-10-05|||July 12, 2011||2011-07-12|June 1, 2017|2017-06-01|March 1, 2021|Anticipated|2021-03-01|January 1, 2020|Anticipated|2020-01-01||Interventional|||Deep Brain Stimulation Surgery for Movement Disorders|Deep Brain Stimulation Surgery for Movement Disorders|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:03:17.734583|2017-10-11 03:03:17.734583
NCT01581567|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-08-22|||July 14, 2011||2011-07-14|August 4, 2017|2017-08-04||||||||Observational|||Neuroimmunology Branch Repository|NIB Repository Protocol|Completed||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:03:17.836941|2017-10-11 03:03:17.836941
NCT01581554|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-06-30|||April 26, 2011||2011-04-26|March 31, 2017|2017-03-31||||||||Observational|||Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B|Withdrawal of Therapy After Long-Term Oral Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B|Active, not recruiting||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:03:17.925134|2017-10-11 03:03:17.925134
NCT01581541|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2017-09-06|2017-07-28||April 26, 2011|Actual|2011-04-26|September 2017|2017-09-01|September 3, 2014|Actual|2014-09-03|September 3, 2014|Actual|2014-09-03||Interventional|||PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment|Phase I Study of the Hsp90 Inhibitor, PU-H71, in Patients With Refractory Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma|Terminated||Phase 1|17|Actual|National Institutes of Health Clinical Center (CC)||1||The study closed prematurely due to discontinuation of drug supply.|f||||f|t|f||||||||2017-10-11 03:03:18.108857|2017-10-11 03:03:18.108857
NCT01581528|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-19|2016-05-17|||April 2012||2012-04-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia|Metabolic Pathways in T-Cell Acute Lymphoblastic Leukemia (T-ALL)|Completed||N/A|15|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:03:21.10771|2017-10-11 03:03:21.10771
NCT01581515|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-04-17|||January 2012||2012-01-01|April 2012|2012-04-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|ANCHOR||Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation|2-phased Randomized Comparison Between PromusTMElementTM Versus Xience PRIME® Stent|Unknown status|Recruiting|Phase 4|100|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 03:03:21.196171|2017-10-11 03:03:21.196171
NCT01581502|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-08-31|||September 2011||2011-09-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Observational|SAMURAI-NVAF||SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)|Stroke Acute Management With Urgent Risk-factor Assessment and Improvement (SAMURAI) Study on Anticoagulant Therapy in Nonvalvular Atrial Fibrillation (NVAF)|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Ministry of Health, Labour and Welfare, Japan|||1||f||||f||||||||||2017-10-11 03:03:21.324473|2017-10-11 03:03:21.324473
NCT01581489|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-06-11|||April 2012||2012-04-01|June 2015|2015-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Early Versus Delayed Cord Clamping at Term: Neurodevelopmental Outcomes in Swedish Infants at 4 Years of Age|Early Versus Delayed Cord Clamping at Term: Neurodevelopmental Outcomes in Swedish Infants at 4 Years of Age|Completed||N/A|263|Actual|Uppsala University|||2||f||||f||||||||||2017-10-11 03:03:21.499652|2017-10-11 03:03:21.499652
NCT01581476|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-10-26|||January 2009||2009-01-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|AdDIT||Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial|Randomised, Double Blind, Placebo Controlled Trial of Angiotensin Converting Enzyme Inhibitors and Statins in the Prevention of Long Term Complications in Young People With Type 1 Diabetes|Active, not recruiting||Phase 3|500|Anticipated|University of Cambridge||4|||f||||t||||||||||2017-10-11 03:03:21.61933|2017-10-11 03:03:21.61933
NCT01581463|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-08-03|||April 2012||2012-04-01|August 2012|2012-08-01||||August 2012|Actual|2012-08-01||Interventional|||A Study of Sustained-Release Liothyronine Sodium (T3) in Healthy Subjects|Phase 1 Single-Dose Study of the Pharmacokinetics of Sustained-Release Liothyronine Sodium (T3) in Healthy Subjects|Completed||Phase 1|12|Actual|Ipe, LLC||1|||f||||t||||||||||2017-10-11 03:03:21.73332|2017-10-11 03:03:21.73332
NCT01581450|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2012-04-19|||January 2012||2012-01-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Hyperalgesia and Pain|Evaluation of Antihyperalgesic and Analgesic Effects of 35% Nitrous Oxide in a Human Model of Electrically Evoked Hyperalgesia and Pain|Completed||Phase 1|20|Actual|Air Liquide Santé International||2|||f||||||||||||||2017-10-11 03:03:21.802373|2017-10-11 03:03:21.802373
NCT01581437|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2016-03-09|2015-06-05||October 2011||2011-10-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CONFIRM|48 patients with persistent AF, 7=longstanding AF, 23 paroxysmal AF|Recording for Potential AF Drivers and Patient Specific Atrial Anatomy & Atrial Electrogram Maps|Recording for Potential AF Drivers and Patient Specific Atrial Anatomy and Atrial Electrogram Maps Using an FDA Approved 64-Pole Basket Catheter (CONFIRM)|Completed||N/A|78|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 03:03:21.921046|2017-10-11 03:03:21.921046
NCT01581424|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2015-12-01|||October 2010||2010-10-01|December 2015|2015-12-01|September 2020|Anticipated|2020-09-01|July 2020|Anticipated|2020-07-01||Observational|LDN6702||Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study|Natural History and Structural Functional Relationships in Fabry Renal Disease Natural History, Structural Functional Relationships and Determinants of Renal Structural Responses (Changes) With Enzyme Replacement Therapy in Fabry Disease|Recruiting||N/A|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     Serum and Plasma samples as well as urine samples from an overnight collection.   "|||2017-10-11 03:03:22.276818|2017-10-11 03:03:22.276818
NCT01581398|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-10-06|||April 2012||2012-04-01|April 2012|2012-04-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients|A Phase 3, Randomized, Multi-center, Active-Controlled, Open-label Study to Evaluate the Efficacy and Safety of Peginterferon Alfa-2b (40kD, Y Shape) in Combination With Ribavirin in Chinese Chronic Hepatitis C Patients|Completed||Phase 3|770|Actual|Xiamen Amoytop Biotech Co., Ltd.||4|||f||||t||||||||||2017-10-11 03:03:22.561573|2017-10-11 03:03:22.561573
NCT01581385|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-04-18|||April 2012||2012-04-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Acoustic Radiation Force Impulse (ARFI) Ultrasound for Noninvasive, Diagnostic Atherosclerosis Imaging|Acoustic Radiation Force Impulse (ARFI) Ultrasound for Noninvasive, Diagnostic Atherosclerosis Imaging; Independent Scientist: ARFI and RWI Ultrasound for Improved Atherosclerosis Imaging|Active, not recruiting||N/A|25|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples Without DNA|"     Plaque specimens extracted during clinically indicated carotid endarterectomy surgery will be     sectioned and histochemically processed.   "|||2017-10-11 03:03:22.758913|2017-10-11 03:03:22.758913
NCT01581372|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-04-25|||December 2011||2011-12-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|RxACT||A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets|A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets (RxACT Study)|Completed||N/A|100|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 03:03:22.837795|2017-10-11 03:03:22.837795
NCT01581359|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-10-21|||March 2012||2012-03-01|April 2014|2014-04-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|ENDOFIV||The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis|A Comparative Study, Randomized, Blinded, About the Effect of Pre-treatment With GnRH Analogues Versus Placebo in Infertile Patients With Endometriosis Undergoing in Vitro Fertilization Treatment|Completed||Phase 4|200|Actual|Instituto de Investigacion Sanitaria La Fe||2|||f||||t||||||||||2017-10-11 03:03:22.924154|2017-10-11 03:03:22.924154
NCT01581346|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-04-18|||March 2011||2011-03-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|POSITIVE||Exercise Study in Patients With Lung Cancer|Pilot Study to Establish an Exercise Intervention in Patients With Lung Cancer|Completed||Phase 2|40|Actual|German Cancer Research Center||1|||f||||f||||||||||2017-10-11 03:03:23.067294|2017-10-11 03:03:23.067294
NCT01581333|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-06-16|||April 2012||2012-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|HOWLONG||Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia|Randomized Open Label Clinical Trial Directed to Optimize the Duration of Empirical Antimicrobial Therapy in Haematologic Patients With Febrile Neutropenia|Completed||Phase 4|157|Actual|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f||||||||||2017-10-11 03:03:23.156066|2017-10-11 03:03:23.156066
NCT01580956|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-05-28|||April 2012||2012-04-01|April 2012|2012-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||"VARIABLE-PSV Study"|"Evaluation a New Ventilatory Modes: VARIABLE-PSV: a Randomized Controlled Cross-over Study: the  VARIABLE-PSV Study"|Completed||Phase 3|20|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 03:03:29.191475|2017-10-11 03:03:29.191475
NCT01581320|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2016-10-31|||December 2011||2011-12-01|April 2012|2012-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|DIOS||Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis|A Multicenter, Randomized, Double-blind, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R206 and Bonviva for the Improvement of Vitamin D in Postmenopausal Women With Osteoporosis|Completed||Phase 3|201|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-11 03:03:23.301531|2017-10-11 03:03:23.301531
NCT01581307|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-01-20|2016-11-09||April 2012||2012-04-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional||All participants. Outcome Measures may reference participants evaluable at time of analysis.|Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets|A Phase II Clinical Trial Evaluating Overall Survival With Therasphere® In Conjunction With 2nd-Line FOLFOX In Patients With Gemcitabine-Refractory Pancreatic Carcinoma With Liver Metastases|Completed||Phase 2|9|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 03:03:23.422925|2017-10-11 03:03:23.422925
NCT01581294|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2016-08-06|||April 2012||2012-04-01|August 2016|2016-08-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|NOR-DMARD||The Norwegian Antirheumatic Drug Register|Long-term Safety and Effectiveness of Disease Modifying Therapies in Inflammatory Arthropathies: a Multicentre, Phase IV, Longitudinal Observational Study|Recruiting||N/A|15000|Anticipated|Diakonhjemmet Hospital|||1||f||||t||||||Samples With DNA|"     Samples (including serum, plasma and full blood) for biomarker or DNA/RNA discovery and     validation will be collected and stored in a freezer at -70 C at visits at baseline and at     the 3-month assessment.   "|||2017-10-11 03:03:24.045984|2017-10-11 03:03:24.045984
NCT01581281|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-07-11|2016-11-16||June 2012||2012-06-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|April 2015|Actual|2015-04-01||Interventional|CHAMP||The Childhood and Adolescent Migraine Prevention Study|Amitriptyline and Topiramate in the Prevention of Childhood Migraine|Terminated||Phase 3|488|Actual|Children's Hospital Medical Center, Cincinnati||3||Interim assessment provided sufficient data to answer study questions|f||||t||||||||||2017-10-11 03:03:24.211017|2017-10-11 03:03:24.211017
NCT01581255|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-09-10|||February 2012||2012-02-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||The Effect of High Frequency Oscillation on Biological Markers of Lung Injury|The Effect of High Frequency Oscillation on Biological Markers of Lung Injury|Terminated||N/A|2|Actual|Canadian Critical Care Trials Group|||2|Parent study (OSCILLATE) stopped by the Data Monitoring Committee|f||||f||||||Samples Without DNA|"     Blood samples will be drawn to measure the following biomarkers of ventilator-induced lung     injury: IL-1β, IL-6, IL-8, IL-10, IFN-γ, TGF-β, TNF-α, VEGF, sICAM-1, surfactant protein D     (SP-D), Krebs von den Lungen protein (KL-6), Clara cell 16 kD protein (CC16), Angiopoietin-1,     Angiopoietin-2, and vWF.   "|||2017-10-11 03:03:25.122683|2017-10-11 03:03:25.122683
NCT01581242|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-09-16|||April 2012||2012-04-01|September 2012|2012-09-01||||June 2012|Actual|2012-06-01||Interventional|BKP-1003-101||A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects|A Randomized, Open-label, Three-sequence, Three-period, Three-treatment Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects|Completed||Phase 1|42|Anticipated|Bukwang Pharmaceutical||3|||f||||f||||||||||2017-10-11 03:03:25.204508|2017-10-11 03:03:25.204508
NCT01581229|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-07-05|||June 2012||2012-06-01|July 2012|2012-07-01||||June 2013|Anticipated|2013-06-01||Interventional|||Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury||Unknown status|Recruiting|N/A|200|Anticipated|Beijing Hospital||2|||f||||f||||||||||2017-10-11 03:03:25.311023|2017-10-11 03:03:25.311023
NCT01581216|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2015-08-10|||December 2011||2011-12-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Fatigue Before and After Exercise in Patients With Advanced Cancer Stage|The Use of Physical Activity to Control Fatigue and Improve the Quality of Life in Patients With Advanced Cancer Stage|Unknown status|Recruiting|N/A|50|Anticipated|Barretos Cancer Hospital||3|||f||||f||||||||||2017-10-11 03:03:25.4016|2017-10-11 03:03:25.4016
NCT01581203|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2015-09-23||2015-09-23|May 2012||2012-05-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|October 2013|Actual|2013-10-01||Interventional|Hallmark DUAL||Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)|A Phase 3 Study With Asunaprevir and Daclatasvir (DUAL) for Null or Partial Responders to Peginterferon Alfa and Ribavirin (P/R), Intolerant or Ineligible to P/R Subjects and Treatment-Naive Subjects With Chronic Hepatitis C Genotype 1b Infection|Completed||Phase 3|748|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 03:03:25.930118|2017-10-11 03:03:25.930118
NCT01581190|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-14|2012-04-18|||September 2011||2011-09-01|April 2012|2012-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Bananas as an Energy Source During Exercise: a Metabolomics Approach|Comparison of Bananas and Gatorade on Performance and Exercise-induced Inflammation, Oxidative Stress, and Changes in Immune Function in Endurance Athletes|Completed||N/A|14|Actual|Appalachian State University||1|||f||||f||||||||||2017-10-11 03:03:26.30514|2017-10-11 03:03:26.30514
NCT01581177|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-05-18||2017-04-17|April 2012||2012-04-01|May 2017|2017-05-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation|A Randomized, Double- or Evaluator-blind, Active- and Placebo-controlled, Single Dose, Seven-arm, Crossover Dose-ranging Study of A006 in Adult Asthma Patients|Completed||Phase 2|23|Actual|Amphastar Pharmaceuticals, Inc.||7|||f||||f||||||||||2017-10-11 03:03:26.389521|2017-10-11 03:03:26.389521
NCT01581164|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-05-07|||December 2011||2011-12-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation|Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation|Completed||N/A|12|Actual|University of California, San Francisco|||1||f||||t||||||Samples With DNA|"     Serum will be collected and stored for immunologic analysis after vaccination. Samples will     be cryopreserved. No cell lines will be created using samples procured on this protocol.   "|||2017-10-11 03:03:26.598881|2017-10-11 03:03:26.598881
NCT01581151|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-02-19|||September 2011||2011-09-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion|Dexamethasone Implant With Rescue Ranibizumab for Treating Macular Edema Secondary to Retinal Vein Occlusion|Unknown status|Recruiting|N/A|30|Anticipated|Wills Eye||2|||f||||f||||||||||2017-10-11 03:03:26.708757|2017-10-11 03:03:26.708757
NCT01581138|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2014-07-02||2014-07-02|July 2012||2012-07-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C|A Multicenter, Randomized, Open-label, Phase 2b Study to Evaluate the Efficacy and Safety of Two Regimens of All-oral Triple Therapy (VX-222 in Combination With Telaprevir [Incivek™] and Ribavirin [Copegus®]) in Treatment-Naïve Subjects With Genotype 1a Chronic Hepatitis C|Completed||Phase 2|64|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-11 03:03:26.833285|2017-10-11 03:03:26.833285
NCT01581125|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-07-15|||April 2012||2012-04-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Sleep Duration Required to Restore Performance During Chronic Sleep Restriction|Sleep Duration Required to Restore Performance During Chronic Sleep Restriction|Completed||N/A|19|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:03:27.019386|2017-10-11 03:03:27.019386
NCT01581112|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2013-09-17|||September 2012||2012-09-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Microbial Community Transplantation on the Armpit/Foot|Microbial Community Transplantation on the Armpit/Foot in Order to Reduce the Malodour Generation on Armpit/Foot|Completed||N/A|4|Actual|University Ghent||2|||f||||f||||||||||2017-10-11 03:03:27.108028|2017-10-11 03:03:27.108028
NCT01581099|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-05-01|||April 2013||2013-04-01|May 2017|2017-05-01|April 20, 2017|Actual|2017-04-20|March 2016|Actual|2016-03-01||Observational|ADIII||"Effect of Bariatric Surgery Digestive Adaptations III on Cardiovascular Risk"|"Effect of Bariatric Surgery Digestive Adaptations III on Clinical, Laboratory and Cardiovascular Risk Factors"|Completed||N/A|30|Actual|University of Sao Paulo|||3||f||||f||||||Samples Without DNA|"     Whole blood samples will be retained for future exams.   "|||2017-10-11 03:03:27.207307|2017-10-11 03:03:27.207307
NCT01581086|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-06-20|||January 2012||2012-01-01|May 2016|2016-05-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Observational|VAST||Vascular Subphenotypes of Lung Disease in HIV & COPD|Identify and Characterize Populations at Risk for Developing Pulmonary Arterial Hypertension (PAH)|Completed||N/A|30|Actual|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 03:03:27.292347|2017-10-11 03:03:27.292347
NCT01581073|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-07-13|||December 2011||2011-12-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PREDICT||PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease|Prevention of End Stage Kidney Disease by Darbepoetin Alfa In CKD Patients With Non-diabetic Kidney Disease|Active, not recruiting||Phase 3|476|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||||||||||||2017-10-11 03:03:27.368089|2017-10-11 03:03:27.368089
NCT01581060|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2014-05-15|||March 2012||2012-03-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours|A Phase I/II, Open-label, Dose-escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor WX-554 in Patients With Solid Tumours|Terminated||Phase 1/Phase 2|41|Actual|Wilex||1||Study terminated for business reasons|f||||f||||||||||2017-10-11 03:03:27.455686|2017-10-11 03:03:27.455686
NCT01581047|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-12-04|||March 2012||2012-03-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Observational|AMOCEF||Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units|Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Ghent|||2||f||||f||||||Samples Without DNA|"     8 serum samples will be taken per patient.   "|||2017-10-11 03:03:27.551042|2017-10-11 03:03:27.551042
NCT01581034|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-07-31|||April 2012||2012-04-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PADMA 28||Effect of PADMA 28 on Endothelial Function, Autonomic Nervous System and Biomarkers in Patients With Coronary Artery Disease|A Randomized, Placebo-controlled, Double-blinded Trial on the Effect of PADMA 28 on Endothelial Function, Biomarkers and the Autonomic Nervous System in Patients With Coronary Artery Disease|Completed||Phase 2|80|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 03:03:27.649292|2017-10-11 03:03:27.649292
NCT01581021|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-12-13|2013-04-14||August 2005||2005-08-01|December 2013|2013-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Pedicle Screw Usage in Conventional Fixation Pattern Constructs Compared to Thoracic Hook Constructs in Scoliosis|Pedicle Screw Usage in Conventional Fixation Pattern Constructs Compared to Thoracic Hook Constructs in Adolescent Idiopathic Scoliosis Patients and Neuromuscular Ambulators|Completed||N/A|58|Actual|University of Mississippi Medical Center|The design of this study is a computer-generated randomized trial. Initially, the first 3 participants were not computer-randomized and therefore, these subjects had to be removed from the study.|2|||f||||f||||||||||2017-10-11 03:03:27.746705|2017-10-11 03:03:27.746705
NCT01581008|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-04-27|2014-11-03||October 2011||2011-10-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|CASA||Improving Symptoms and Quality of Life in Chronic Heart Failure: Pilot Study|Implementing Collaborative Care to Alleviate Symptoms and Adjust to Heart Failure: A Pilot Study|Completed||N/A|31|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 03:03:28.254085|2017-10-11 03:03:28.254085
NCT01580995|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-08-01|2016-06-13||April 2012||2012-04-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|HSV1/HCV||Herpes Simplex Type 1 Suppression in Hepatitis C|HSV-1 Suppression in HCV Infected Veterans Who Are Seronegative for HSV-2|Completed||Phase 2|19|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 03:03:28.617312|2017-10-11 03:03:28.617312
NCT01580982|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-08-18|||January 23, 2012|Actual|2012-01-23|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer|Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung and Other Thoracic Cancers|Recruiting||N/A|175|Anticipated|University of Colorado, Denver|||1||f||||f||||||Samples With DNA|"     Tumor tissue will be acquired from either archival or de novo biopsy material   "|||2017-10-11 03:03:28.97257|2017-10-11 03:03:28.97257
NCT01580969|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-08-17|||July 2012||2012-07-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Interventional|RAMBO||Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma|A Phase 1b/2 Study of Repeat rAdiation, Minocycline, and Bevacizumab in Patients With Recurrent gliOma (RAMBO)|Recruiting||Phase 1/Phase 2|18|Anticipated|University of Utah||1|||f||||t||||||||||2017-10-11 03:03:29.074708|2017-10-11 03:03:29.074708
NCT01580943|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-04-20|||October 2011||2011-10-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy of Two Commercially Available Chlorhexidine Mouthrinses Non-alcohol Base|Efficacy of Two Commercially Available Chlorhexidine Mouthrinses Non-alcohol Base - a Randomized Clinical Trial|Completed||Phase 1/Phase 2|50|Actual|Universidade do Porto||2|||f||||t||||||||||2017-10-11 03:03:29.31537|2017-10-11 03:03:29.31537
NCT01580930|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-19|||March 2010||2010-03-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|START||Changes in Habitual Physical Activity and Inactivity|Changes in Physical Activity and Inactivity During a 12-week Exercise Training and/or Sedentary Time Intervention|Completed||N/A|57|Actual|University of Massachusetts, Amherst||4|||f||||f||||||||||2017-10-11 03:03:29.603759|2017-10-11 03:03:29.603759
NCT01580917|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-12-14|||November 2007||2007-11-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|ILH||Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study|Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control|Completed||N/A|18|Actual|Temple University|||2||f||||f||||||||||2017-10-11 03:03:29.740668|2017-10-11 03:03:29.740668
NCT01580904|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-12-19|2016-03-11||September 2009||2009-09-01|December 2016|2016-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|IPCD||Impact of Pharmaceutical Care in Diabetics Patients|Popular Pharmacy of Brazil: Impact of Pharmaceutical Care in Diabetics Patients|Completed||N/A|100|Actual|Universidade Estadual da Paraiba||2|||f||||t||||||||No||2017-10-11 03:03:29.847368|2017-10-11 03:03:29.847368
NCT01580891|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2014-05-05|||May 2012||2012-05-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis|Randomized, Double-Blind, Placebo-Controlled, Multiple-Site, Parallel Design Study to Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis.|Completed||Phase 1|1053|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 03:03:30.264059|2017-10-11 03:03:30.264059
NCT01580878|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-05-03|||January 2012||2012-01-01|May 2017|2017-05-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis|A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of a Generic Butenafine Hydrochloride Cream, 1% and Reference Listed Lotrimin Ultra® (Butenafine Hydrochloride Cream, 1%) and Compare Both Active Treatments to a Vehicle Control in the Treatment of Interdigital Tinea Pedis.|Completed||Phase 1|707|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 03:03:30.345466|2017-10-11 03:03:30.345466
NCT01580865|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-11-02|||May 2012||2012-05-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis|Comparison Between Tacrolimus and Mycophenolate Mofetil for Induction of Remission in Lupus Nephritis|Recruiting||N/A|90|Anticipated|Ramathibodi Hospital||2|||f||||t||||||||||2017-10-11 03:03:30.440948|2017-10-11 03:03:30.440948
NCT01580852|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-04-18|||July 2012||2012-07-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||The Effects of Immersion in Dead Sea Water on Glucose Levels in Type 2 Diabetes Mellitus Patients|The Effects of Immersion in Dead Sea Water on Glucose Levels in Type 2 Diabetes Mellitus Patients|Unknown status|Not yet recruiting|N/A|40|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-10-11 03:03:30.548299|2017-10-11 03:03:30.548299
NCT01580839|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-09-21|||June 2012||2012-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EXTEND||EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International)|Extending the Time for Thrombolysis in Emergency Neurological Deficits|Recruiting||Phase 3|200|Anticipated|Neuroscience Trials Australia||2|||f||||t||||||||||2017-10-11 03:03:30.638324|2017-10-11 03:03:30.638324
NCT01580826|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-04-18|||March 2006||2006-03-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|February 2010|Actual|2010-02-01||Interventional|||Pasteurization of Mother's Own Milk for Preterm Infants|Pasteurization of Mother's Own Milk for Preterm Infants : a Randomized Trial.|Completed||N/A|303|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 03:03:30.746721|2017-10-11 03:03:30.746721
NCT01580813|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-05-04|||June 2011||2011-06-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|AcT2||Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes|Effects of Serum Fatty Acid Lowering on Insulin Sensitivity, Cardiovascular Function, And Exercise Capacity in Non-Insulin Dependent Diabetes|Recruiting||N/A|50|Anticipated|University of Colorado, Denver||2|||f||||t||f||||||||2017-10-11 03:03:30.900818|2017-10-11 03:03:30.900818
NCT01580800|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-10-13|||September 2011||2011-09-01|October 2016|2016-10-01|December 2025|Anticipated|2025-12-01|September 2021|Anticipated|2021-09-01||Observational|||National Breast Cancer and Lymphedema Registry|National Breast Cancer and Lymphedema Registry|Recruiting||N/A|1000|Anticipated|Stanford University|||1||f||||t||||||||Undecided||2017-10-11 03:03:31.013232|2017-10-11 03:03:31.013232
NCT01580774|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-08-28|||July 2012||2012-07-01|August 2017|2017-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Effect of Post-discharge Phone Calls on Patient Outcomes|Effect of Post-discharge Phone Calls on Patient Outcomes for General Internal Medicine Patients Discharged From a Teaching Hospital.|Completed||N/A|334|Actual|Mount Sinai Hospital, Canada|||2||f||||f||||||||||2017-10-11 03:03:31.193456|2017-10-11 03:03:31.193456
NCT01580761|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-08-22|||July 2012||2012-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Sleep Restriction and Obesity|Sleep Restriction and Obesity|Recruiting||N/A|20|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:03:31.2668|2017-10-11 03:03:31.2668
NCT01577615|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2015-11-10|||February 2012||2012-02-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|PEPI||Patterned Experience for Preterm Infants|Patterned Experience for Preterm Infants|Completed||N/A|121|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 03:04:26.246309|2017-10-11 03:04:26.246309
NCT01580748|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-04-18|||May 2012||2012-05-01|April 2012|2012-04-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|||Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients||Unknown status|Not yet recruiting|Phase 2|25|Anticipated|Seoul National University Bundang Hospital||1|||f||||||||||||||2017-10-11 03:03:31.362855|2017-10-11 03:03:31.362855
NCT01580735|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-08-16|||May 2012||2012-05-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer|A Phase 2, Multicenter, Open-label, Single-arm Study of ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer|Completed||Phase 2|40|Anticipated|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-11 03:03:31.45473|2017-10-11 03:03:31.45473
NCT01580722|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-04-18|||March 2012||2012-03-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Comparison of Early Versus Delay Reconstruction in Anterior Cruciate Ligament Tearing|Study of Surgical Methods for Anterior Cruciate Ligament Tearing|Completed||Phase 2|202|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:03:31.555144|2017-10-11 03:03:31.555144
NCT01580709|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2016-09-19|||April 2012||2012-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures|Optimizing the Role of ERCP in Evaluating Indeterminate Bile Duct Strictures|Completed||N/A|48|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:03:31.652817|2017-10-11 03:03:31.652817
NCT01580696|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-11-16|||April 2012||2012-04-01|November 2015|2015-11-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer|Phase I/IIa Trial of Folate Binding Protein (FBP) Peptide (E39) Vaccine in Ovarian and Endometrial Cancer Patients|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|San Antonio Military Medical Center||2|||f||||f||||||||||2017-10-11 03:03:31.749021|2017-10-11 03:03:31.749021
NCT01580683|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-05-11|||July 2012||2012-07-01|May 2015|2015-05-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Vitamin C and Atrial Fibrillation After Cardiac Surgery|Effect of Ascorbic Acid on the Incidence of Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery|Withdrawn||Phase 3|0|Actual|Regional Hospital of Scranton||2||No funding obtained to support patient recruitment|f||||t||||||||||2017-10-11 03:03:31.84589|2017-10-11 03:03:31.84589
NCT01580670|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-04-09|||March 2012||2012-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease|Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Pediatric Patients With Moderate to Severe Crohn's Disease|Completed||Phase 3|14|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 03:03:31.960975|2017-10-11 03:03:31.960975
NCT01580657|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-17|||September 2006||2006-09-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Experimental Analysis of HIV Risk Assessment Reactivity in South African Clinics|Experimental Analysis of HIV Risk Assessment Reactivity in South African Clinics|Completed||N/A|1728|Actual|Medical College of Wisconsin||6|||f||||f||||||||||2017-10-11 03:03:32.070689|2017-10-11 03:03:32.070689
NCT01580644|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-04-19|||January 2012||2012-01-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Bioavailability Study of Prodrug of GLPG0187 in Healthy Volunteers|Bioavailability Study of Two Formulations of the Isopropyl Malonate Prodrug of GLPG0187 in Healthy Male Subjects|Completed||Phase 1|12|Actual|Galapagos NV||4|||f||||f||||||||||2017-10-11 03:03:32.185698|2017-10-11 03:03:32.185698
NCT01580631|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-05-24|||October 2012||2012-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Narrow Band Imaging Project on Barrett's Esophagus|Assessment of a Consensus Driven Narrow Band Imaging (NBI) Pattern Classification System in Barrett's Esophagus (BE)|Recruiting||N/A|50|Anticipated|Midwest Biomedical Research Foundation|||2||f||||f||||||||||2017-10-11 03:03:32.27386|2017-10-11 03:03:32.27386
NCT01580618|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-17|2015-01-02|2013-06-24||January 2008||2008-01-01|January 2015|2015-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy|TNK for Loculated Pleural Effusions in Patients With Malignancy|Terminated||Phase 2/Phase 3|20|Actual|Kaiser Permanente|Results are limited due to the small numbers of patients enrolled|2||Unable to accrue patients at a reasonable rate|f||||f||||||||||2017-10-11 03:03:32.417265|2017-10-11 03:03:32.417265
NCT01580605|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2014-04-29|||July 2003||2003-07-01|April 2014|2014-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin|Prospective, Longitudinal and National Follow-up Program of Adult Patients With Somatotropic Hormone Deficiency for Whom Substituting Treatment by Norditropin SimpleXx Was Started|Completed||N/A|331|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:03:32.78131|2017-10-11 03:03:32.78131
NCT01580592|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-02-23|2015-10-27||April 2012||2012-04-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|CUTEX|Intention-to-treat|Cold Urticaria Treatment With Xolair|A Two-center, Double Blind, Placebo-controlled Study in Parallel Design to Assess the Efficacy and Safety of 150 and 300 mg Omalizumab in Subjects With Antihistamine-resistant Cold Contact Urticaria (CCU)|Completed||Phase 2|31|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 03:03:32.869452|2017-10-11 03:03:32.869452
NCT01580579|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-03-01|||July 2012||2012-07-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Observational|||Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation|Clinical, Biochemical, Dosimetric and Functional Respiratory Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer (Stages IIIa and IIIb) Treated With Chemotherapy and Radiotherapy|Completed||N/A|62|Actual|Instituto Nacional de Cancerologia de Mexico|||1||f||||f||||||||Yes||2017-10-11 03:03:33.273816|2017-10-11 03:03:33.273816
NCT01580566|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-04-09|||March 2012||2012-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Renal Acute MI Study|Renal Structural, Functional and Cytokine Responses to Acute Myocardial Injury in Man|Recruiting||N/A|160|Anticipated|Monash University|||4||f||||f||||||Samples With DNA|"     Blood samples to measure bio-markers   "|||2017-10-11 03:03:33.358867|2017-10-11 03:03:33.358867
NCT01580553|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-04-26|||January 2011||2011-01-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure|The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure —A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study|Completed||Phase 2/Phase 3|268|Actual|Lee's Pharmaceutical Limited||2|||f||||f||||||||||2017-10-11 03:03:33.453136|2017-10-11 03:03:33.453136
NCT01580540|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-08-03|||March 2012||2012-03-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Head to Head Study Epi proColon and FIT|Comparison of the Performance of the Epi proColon and Fecal ImmunochemicalTest Post Colonoscopy in Subjects With Colorectal Cancer and Pre Colonoscopy in Subjects From a Guideline-Eligible Screening Population|Completed||N/A|336|Actual|Epigenomics, Inc|||2||f||||f||||||Samples With DNA|"     Plasma   "|||2017-10-11 03:03:33.55671|2017-10-11 03:03:33.55671
NCT01580527|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-04-17|||March 2011||2011-03-01|April 2012|2012-04-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|Nutri-DPC||Postoperative Artificial Nutrition After Pancreaticoduodenectomy|A Prospective, Multicentric, Randomized Trial Comparing Early Enteral Nutrition Versus Parenteral Nutrition After Pancreaticoduodenectomy|Unknown status|Recruiting|N/A|220|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:03:33.740347|2017-10-11 03:03:33.740347
NCT01580514|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-04-18|||September 2009||2009-09-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|EMPIRE||Myocardial Protection of Exenatide in AMI|Cardioprotective Effects of Exenatide in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention ; Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study|Completed||Phase 4|127|Actual|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-11 03:03:33.826425|2017-10-11 03:03:33.826425
NCT01580501|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2014-01-27|||March 2012||2012-03-01|January 2014|2014-01-01||||March 2013|Actual|2013-03-01||Interventional|||PDE Inhibitors in DMD Study (Acute Dosing Study)|Functional Muscle Ischemia and PDE5 Inhibition in Duchenne Muscular Dystrophy: Acute Dosing Study|Completed||Phase 1|12|Anticipated|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-10-11 03:03:33.930485|2017-10-11 03:03:33.930485
NCT01580488|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-11-08|2013-08-19||April 2012||2012-04-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris|A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris|Completed||Phase 1|24|Actual|LEO Pharma|This was an exploratory study in which each of the 24 subjects received all 6 treatments on 2 cm diameter dermal test sites. Regarding Adverse Events, only local dermal reactions could be potentially attributed to a specific treatment.|1|||f||||f||||||||||2017-10-11 03:03:34.034904|2017-10-11 03:03:34.034904
NCT01580475|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2012-04-18|||September 2008||2008-09-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|September 2008|Actual|2008-09-01||Interventional|||Training, Detraining, Retraining and Glycemic Control in Patients With Type 2 Diabetes|Training, Detraining and Retraining Effects on Glycemic Control and Physical Fitness in Patients With Type 2 Diabetes|Completed||N/A|13|Actual|Democritus University of Thrace||1|||f||||f||||||||||2017-10-11 03:03:34.723911|2017-10-11 03:03:34.723911
NCT01580462|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2012-04-18|||April 2012||2012-04-01|April 2012|2012-04-01|October 2012|Anticipated|2012-10-01|June 2012|Anticipated|2012-06-01||Observational|ADHERENCE||The ADHERENCE Index - the Indicator of Effective Coping With the Requirements of the Disease of Children and Adolescents With Type 1 Diabetes|The ADHERENCE Index - the Indicator of Effective Coping With the Requirements of the Disease of Children and Adolescents With Type 1 Diabetes. Prospective Study|Unknown status|Recruiting|N/A|200|Anticipated|Institution of Mother and Child, Warsaw, Poland|||1||f||||||||||||||2017-10-11 03:03:34.808686|2017-10-11 03:03:34.808686
NCT01580436|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2014-10-23|||August 2011||2011-08-01|October 2014|2014-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Prophylactic Tricuspid Valve Annuloplasty in Patients Undergoing Mitral Valve Surgery|Prospective, Randomized Evaluation of Prophylactic Tricuspid Valve Annuloplasty in Patients Undergoing Mitral Valve Surgery|Recruiting||N/A|300|Anticipated|Hasselt University||2|||f||||t||||||||||2017-10-11 03:03:34.892067|2017-10-11 03:03:34.892067
NCT01580423|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-05-24|2013-05-24||April 2012||2012-04-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|SP-RLB||The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing|The Role of Substance P on Perception of Breathlessness|Completed||N/A|16|Actual|Dartmouth-Hitchcock Medical Center|"single dose of aprepitant used
clinical diagnosis of chronic bronchitis phenotype of chronic obstructive pulmonary disease"|2|||f||||t||||||||||2017-10-11 03:03:34.987359|2017-10-11 03:03:34.987359
NCT01580410|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-12-28|||May 2009||2009-05-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|October 2015|Actual|2015-10-01||Interventional|||Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix|A Multi-Center, Open-Label, Randomized Phase II Trial to Evaluate Hematologic Toxicities After HIPEC With Oxaliplatin or Mitomycin C in Patients With Appendiceal Tumors|Active, not recruiting||Phase 2|116|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 03:03:35.237244|2017-10-11 03:03:35.237244
NCT01580397|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-06-27|||May 2012||2012-05-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer|A Multicenter, Open-Label Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) in Subjects With Advanced or Unresectable Pancreatic Ductal Carcinoma Whose Tumors Have Progressed Following Prior Treatment With Gemcitabine and Fluoropyrimidine-Based Chemotherapy|Completed||Phase 2|14|Actual|CytRx||1|||f||||f||||||||||2017-10-11 03:03:35.355815|2017-10-11 03:03:35.355815
NCT01580384|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-03-02|||February 2012||2012-02-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome||Completed||N/A|90|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:03:35.560532|2017-10-11 03:03:35.560532
NCT01580371|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-10-04|||May 2012||2012-05-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Interventional|CKD-581||Safety and Pharmacokinetic Profile of CKD-581|Phase I Clinical Trial to Assess the Safety and Pharmacokinetic Profile of CKD-581 in Patients With Lymphoma or Multiple Myeloma Failed to Standard Therapy|Completed||Phase 1|39|Actual|Chong Kun Dang Pharmaceutical||1|||f||||f||||||||No||2017-10-11 03:03:35.726663|2017-10-11 03:03:35.726663
NCT01580358|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-06-19|||October 2009||2009-10-01|June 2012|2012-06-01|September 2012|Anticipated|2012-09-01|June 2012|Anticipated|2012-06-01||Interventional|||Therapeutic Effects of Traditional Chinese Medicine, Shen-Mai San in Cancer Patient Undergoing Chemotherapy or Radiotherapy|Changhua Christian Hospital|Unknown status|Recruiting|N/A|60|Anticipated|Changhua Christian Hospital||2|||f||||t||||||||||2017-10-11 03:03:35.834975|2017-10-11 03:03:35.834975
NCT01580345|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-18|2017-02-20|||December 2015||2015-12-01|February 2017|2017-02-01|December 9, 2016|Actual|2016-12-09|December 6, 2016|Actual|2016-12-06||Interventional|DHANI||Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India.|Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India (DHANI)|Completed||Phase 3|600|Actual|Centre for Chronic Disease Control, India||2|||f||||t||||||||No||2017-10-11 03:03:35.957249|2017-10-11 03:03:35.957249
NCT01580332|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2014-07-22|||January 2012||2012-01-01|April 2012|2012-04-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Observational|ISRUSAL01||Non-Invasive Biomarkers For Early Detection Of Lung Cancers|NON-INVASIVE BIOMARKERS FOR EARLY DETECTION OF LUNG CANCERS: ELEMENT 1: NON-RANDOMIZED PHASE II EVALUATION AND VALIDATION IN NEWLY DIAGNOSED LUNG CANCER PATIENTS|Completed||N/A|50|Anticipated|Baptist Cancer Institute|||1||f||||f||||||Samples With DNA|"     serum; sputum   "|||2017-10-11 03:03:36.090553|2017-10-11 03:03:36.090553
NCT01580319|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2012-05-07|||April 2009||2009-04-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Primary Prevention of Cardiovascular Diseases in Childhood and Adolescence: the Role of Physical Activity|Outpatient Strategy of Primary Prevention of Cardiovascular Diseases in Childhood and Adolescence: the Role of Physical Activity|Terminated||N/A|27|Actual|Instituto de Cardiologia do Rio Grande do Sul||2||Difficulty in selecting the sample and follow-up lost.|f||||f||||||||||2017-10-11 03:03:36.180959|2017-10-11 03:03:36.180959
NCT01580306|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-07-03|2015-07-03||April 2012||2012-04-01|July 2015|2015-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment|Pharmacokinetics, Safety and Tolerability of BI 201335 in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function in a Monocentric, Open-label, Parallel-group, Phase I Trial|Completed||Phase 1|32|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:03:36.30471|2017-10-11 03:03:36.30471
NCT01580293|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-09-12||2015-06-09|April 23, 2012|Actual|2012-04-23|September 2017|2017-09-01|January 15, 2019|Anticipated|2019-01-15|June 13, 2014|Actual|2014-06-13||Interventional|PROTECT-VIII||A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A|A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A|Active, not recruiting||Phase 2/Phase 3|141|Actual|Bayer||4|||f||||t|t|f||||||||2017-10-11 03:03:36.863718|2017-10-11 03:03:36.863718
NCT01580280|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2014-11-12|||April 2012||2012-04-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Manual Therapy and Exercise in Patients With Cervicogenic Headache|Effect of Upper Cervical and Upper Thoracic Thrust Manipulation Versus Mobilization and Exercise in Patients With Cervicogenic Headache|Completed||N/A|112|Anticipated|Alabama Physical Therapy & Acupuncture||2|||f||||t||||||||||2017-10-11 03:03:37.235141|2017-10-11 03:03:37.235141
NCT01580267|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2014-04-24|||June 2012||2012-06-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Hepcidin and Anemia in Trauma|Hepcidin and Anemia in Trauma|Completed||N/A|74|Actual|University of Michigan|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 03:03:37.339818|2017-10-11 03:03:37.339818
NCT01580254|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-04-17|||June 2011||2011-06-01|April 2012|2012-04-01|July 2012|Anticipated|2012-07-01|June 2012|Anticipated|2012-06-01||Interventional|LATANOPROST||Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma|Phase 4 Study to Evaluate Efficacy And Safety of Three Different Preparations of Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma|Unknown status|Recruiting|Phase 4|120|Anticipated|University of Cantanzaro||3|||f||||f||||||||||2017-10-11 03:03:37.403607|2017-10-11 03:03:37.403607
NCT01580241|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-08-21|||October 2010||2010-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2015|Actual|2015-07-01||Observational|||Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer|Expression Patterns of Stem Cell Marker Doublecortin and CaM Kinase-Like-1 (DCAMKL-1) in Human Pancreatic Adenocarcinoma|Active, not recruiting||N/A|60|Anticipated|University of Oklahoma|||4||f||||f||||||||||2017-10-11 03:03:37.506085|2017-10-11 03:03:37.506085
NCT01580228|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-02-17|||August 2012||2012-08-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714)|A Phase 3 Study to Evaluate the Efficacy and Safety of Dinaciclib or Ofatumumab in Subjects With Refractory Chronic Lymphocytic Leukemia|Completed||Phase 3|44|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 03:03:37.563523|2017-10-11 03:03:37.563523
NCT01580215|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2017-04-06|||July 2012||2012-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|August 2017|Anticipated|2017-08-01||Observational|LIVE||Long Term Follow up Investigation of Endobronchial Valves in Emphysema|Long Term Follow up Investigation of Endobronchial Valves in Emphysema|Terminated||N/A|628|Actual|Pulmonx, Inc.|||1||f||||t||||||||||2017-10-11 03:03:37.65338|2017-10-11 03:03:37.65338
NCT01580202|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-06-28|||April 2012||2012-04-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine|A Randomized, Open Labeled, Multicenter Study Comparing Entecavir Versus Lamivudine as Antiviral Prophylaxis for Patients With Hepatitis B Infection Undergoing Cytotoxic Chemotherapy for Malignant Tumors|Completed||Phase 3|180|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:03:37.734844|2017-10-11 03:03:37.734844
NCT01580189|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-12-07|||October 2011||2011-10-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|October 2012|Actual|2012-10-01||Interventional|||Whole Milk Versus Whey Protein Supplement and Resistance Exercise|Effects of Whole Milk Versus Whey Protein Supplementation With Resistance Exercise on Body Composition, Muscle Hypertrophy and Strength Changes in Healthy Individuals|Completed||N/A|32|Actual|University of Manitoba||3|||f||||t||||||||||2017-10-11 03:03:37.82907|2017-10-11 03:03:37.82907
NCT01574794|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2014-12-01|||April 2012||2012-04-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Interventional|||Exercise Intervention and Running Biomechanics in Older Adults|Changes in Running Gait Biomechanics Following an Intervention Program in Older Runners|Completed||N/A|105|Actual|University of Calgary||3|||f||||f||||||||||2017-10-11 03:05:10.213324|2017-10-11 03:05:10.213324
NCT01580176|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2013-12-19|||March 2012||2012-03-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|ContAssGlu||Continuous GlucoseMonitor for Measurement of Blood Glucose Level|A Prospective Clinical Trial on Agreement to Evaluate the GlucoseMonitor, a Novel Device for Continuous Assessment of Blood Glucose Levels, in Comparison With the RAPIDLab® 1265 Blood Gas Analyser (ContAssGlu)|Completed||N/A|100|Actual|University Hospital Heidelberg||1|||f||||f||||||||||2017-10-11 03:03:37.90746|2017-10-11 03:03:37.90746
NCT01580163|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-11-16|||September 2009||2009-09-01|November 2015|2015-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification|Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification|Completed||N/A|554|Actual|Shanghai Mental Health Center||3|||f||||f||||||||||2017-10-11 03:03:37.97386|2017-10-11 03:03:37.97386
NCT01580150|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-04-16|||November 2009||2009-11-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|SOMA||Effects of Berries on Post-meal Blood Sugar|Effects of Berries on Postprandial Glycemic Responses to Sucrose and Starch|Completed||N/A|20|Actual|University of Eastern Finland||2|||f||||f||||||||||2017-10-11 03:03:38.289361|2017-10-11 03:03:38.289361
NCT01580137|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2013-10-29|||February 2012||2012-02-01|October 2013|2013-10-01|April 2014|Anticipated|2014-04-01|April 2012|Actual|2012-04-01||Observational|||Acute Upper Respiratory Tract Infection - When is Bacteria Involved?|Acute Upper Respiratory Tract Infection - When is Bacteria Involved?|Unknown status|Active, not recruiting|N/A|48|Anticipated|Oulu University Hospital|||2||f||||f||||||||||2017-10-11 03:03:38.386879|2017-10-11 03:03:38.386879
NCT01580124|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-01-26|||November 2010||2010-11-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Interventional|CHASE-AF||CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation Versus Defragmentation. The CHASE-AF Study|CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation Versus Defragmentation. The CHASE-AF Study.|Completed||N/A|150|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||No||2017-10-11 03:03:38.466788|2017-10-11 03:03:38.466788
NCT01580111|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2012-04-17|||December 2010||2010-12-01|April 2012|2012-04-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Blood Storage Age on the Resolution of Lactic Acidosis in Children With Severe Malarial Anemia at Mulago Hospital|Effect of Blood Storage Age on the Resolution of Lactic Acidosis in Children With Severe Malarial Anemia at Mulago Hospital|Completed||N/A|74|Actual|Makerere University||2|||f||||t||||||||||2017-10-11 03:03:38.54603|2017-10-11 03:03:38.54603
NCT01580098|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-08-21|2015-04-08||February 2010||2010-02-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|August 2013|Actual|2013-08-01||Interventional|RenewingHealth||Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus|Regions of Europe Working Together for Health (Renewing Health)|Completed||N/A|193|Actual|Landeskrankenanstalten-Betriebsgesellschaft||3|||f||||t||||||||||2017-10-11 03:03:38.636666|2017-10-11 03:03:38.636666
NCT01580085|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-04-17|||November 2009||2009-11-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Obstructive Sleep Apnea in Pulmonary Embolism|Obstructive Sleep Apnea is Prevalent in Patients With Pulmonary Embolism|Completed||N/A|75|Actual|University of Gaziantep|||2||f||||f||||||||||2017-10-11 03:03:39.130961|2017-10-11 03:03:39.130961
NCT01580072|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2015-07-01|2015-04-08||February 2010||2010-02-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Interventional|RenewingHealth||Telemonitoring of Patients With COPD in Carinthia|REgions of Europe WorkiNg toGether for HEALTH (Renewing Health)|Completed||N/A|65|Actual|Landeskrankenanstalten-Betriebsgesellschaft||3|||f||||||||||||||2017-10-11 03:03:39.251838|2017-10-11 03:03:39.251838
NCT01580046|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-10-14|||April 2012||2012-04-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|RIPE||Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction|Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction—a Multicentre, Single Blind, Randomized Controlled, Prospective Trial|Unknown status|Recruiting|Phase 4|200|Anticipated|Peking University First Hospital||2|||f||||f||||||||||2017-10-11 03:03:39.78084|2017-10-11 03:03:39.78084
NCT01580033|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-17|2013-05-07|||April 2012||2012-04-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine|Immunogenicity and Safety Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Aged 3-5 Months: A Phase 3 Clinical Trial|Completed||Phase 3|900|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 03:03:39.944973|2017-10-11 03:03:39.944973
NCT01580020|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-04-11|2015-09-28||May 2012||2012-05-01|April 2016|2016-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO|An Open-label, Multi-center, 6-month Extension Study Comparing the Long-term Efficacy and Safety of Lucentis (Ranibizumab) Intravitreal Injections Versus Ozurdex (Dexamethasone) Intravitreal Implant in Patients With Visual Impairment Due to Macular Edema Following Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO) Who Have Completed the Respective Core Study (CRFB002EDE17 or CRFB002EDE18)|Completed||Phase 4|175|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:03:40.090653|2017-10-11 03:03:40.090653
NCT01579994|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-03-13|||April 2012|Actual|2012-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers|A Phase I Study of Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers|Active, not recruiting||Phase 1|55|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:03:43.546167|2017-10-11 03:03:43.546167
NCT01577030|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-02-10|||January 2012||2012-01-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Hypotensive Effects of Conventional Dairy Products: Role of Arterial Stiffness|Hypotensive Effects of Conventional Dairy Products: Role of Arterial Stiffness|Completed||N/A|49|Actual|University of Texas at Austin||2|||f||||f||||||||||2017-10-11 03:04:34.506144|2017-10-11 03:04:34.506144
NCT01579981|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-02-09|||April 2012||2012-04-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects|The Exaggerated Glucagon-like Peptide-1 Response is Important for the Improved β-cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes|Completed||N/A|9|Actual|Hvidovre University Hospital||1|||f||||f||||||||||2017-10-11 03:03:43.645599|2017-10-11 03:03:43.645599
NCT01579968|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-02-23|||March 10, 1999|Actual|1999-03-10|February 2017|2017-02-01|March 9, 2010|Actual|2010-03-09|March 9, 2010|Actual|2010-03-09||Observational|||Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery|Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery|Completed||N/A|86|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:03:43.730941|2017-10-11 03:03:43.730941
NCT01579955|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-02-22|||March 10, 1999|Actual|1999-03-10|February 2017|2017-02-01|March 9, 2010|Actual|2010-03-09|March 9, 2010|Actual|2010-03-09||Observational|||Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice|Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice|Completed||N/A|321|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:03:43.832985|2017-10-11 03:03:43.832985
NCT01579942|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-03-02|||April 2012||2012-04-01|March 2017|2017-03-01||||||||Observational|||Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression|Potential Use Of Brain Network Activation Analysis Using Evoked Response Potentials to Diagnose Major Depression and Assess Response to Antidepressant Treatment|Terminated||N/A|70|Anticipated|Massachusetts General Hospital|||2|The study was ultimately not funded by the sponsor. No subjects were enrolled.|f||||f||||||||||2017-10-11 03:03:43.935334|2017-10-11 03:03:43.935334
NCT01579929|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2017-08-14|||April 2012||2012-04-01|August 2017|2017-08-01|August 11, 2017|Actual|2017-08-11|August 11, 2017|Actual|2017-08-11||Interventional|||Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)|A Phase I Trial of the Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)|Completed||Phase 1|19|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:03:44.018085|2017-10-11 03:03:44.018085
NCT01579916|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-12-16|2013-12-16||May 2012||2012-05-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults|A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults|Completed||Phase 4|303|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 03:03:44.152403|2017-10-11 03:03:44.152403
NCT01579903|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-02-07|||August 2012||2012-08-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)|An Open-Label, Randomized, Two-period Crossover Study To Compare Relative Bioavailability of Two Formulations of Moroctocog Alfa (Af-cc) In Subjects With Moderately Severe Or Severe Hemophilia A (FVIII:C </=2%)|Completed||Phase 1|16|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:03:44.783165|2017-10-11 03:03:44.783165
NCT01578915|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2017-05-14|||May 2011||2011-05-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||A Case Control Study of Women With Multiple Sexual Partners|A Case Control Study of Women With Multiple Sexual Partners Attending the Jefferson County Department of Health Sexually Transmitted Diseases Clinic|Completed||N/A|213|Actual|University of Alabama at Birmingham|||2||f||||f|f|f||||||No||2017-10-11 03:03:44.87599|2017-10-11 03:03:44.87599
NCT01578889|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-12-12|||May 2012||2012-05-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|September 2014|Actual|2014-09-01||Interventional|||Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults|A Phase 1 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an IL-12 pDNA Enhanced HIV-1 Multiantigen pDNA Vaccine Delivered Intramuscularly With Electroporation, With an HIV-1 rVSV Vaccine Boost, in Healthy HIV-Uninfected Adult Participants|Completed||Phase 1|100|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||t||||||||||2017-10-11 03:03:45.067997|2017-10-11 03:03:45.067997
NCT01578876|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2012-04-17|||December 2008||2008-12-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|May 2011|Actual|2011-05-01||Interventional|||Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease|To Prove up the Effect of CSWT in Vivo and to Evaluate the Feasibility and Efficiency of CSWT for Treatment of CAD and to Establish the Inclusion and Exclusion Criteria and Summarize the Methodological Outlines of CSWT in China.|Completed||Phase 3|55|Actual|Kunming Medical University||3|||f||||t||||||||||2017-10-11 03:03:45.197071|2017-10-11 03:03:45.197071
NCT01578863|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-04-13|||June 2012||2012-06-01|May 2014|2014-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Predictors of Success in an Intervention Program for the Treatment of Childhood Obesity|Predictors of Success in a Multidisciplinary Intervention Program for Obese Children and Adolescence|Completed||N/A|176|Actual|Meir Medical Center||3|||f||||f||||||||||2017-10-11 03:03:45.298304|2017-10-11 03:03:45.298304
NCT01578850|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2016-05-25|2016-02-16||July 2012||2012-07-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||The Full Analysis Set for Period 2 (Double Blind FAS) included all randomized participants who met the period 2 DAS28-ESR inclusion criteria, had at least one dose of study drug during Period 2 (ie, ETN, MTX or placebo) and have at least one valid efficacy (DAS28-ESR) evaluation after randomization.|Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening|A Randomized, Double-blind Placebo-controlled Study Of The Maintenance Of Efficacy Of Etanercept Plus Dmard(s) Compared With Dmard(s) Alone In Subjects With Rheumatoid Arthritis After Achieving An Adequate Response With Etanercept Plus Dmard(s)|Completed||Phase 4|491|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:03:45.63601|2017-10-11 03:03:45.63601
NCT01578837|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2014-02-18|||April 2012||2012-04-01|February 2014|2014-02-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|R-KAT||Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes|Efficacy and Safety of Combined Rg3-enriched Korean Red Ginseng (Panax Ginseng C.A. Meyer) and American Ginseng (Panax Quinquefolius) as Poly-therapy in the Management of Concomitant Hypertension in Type 2 Diabetes|Unknown status|Recruiting|Phase 1/Phase 2|90|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 03:03:48.818404|2017-10-11 03:03:48.818404
NCT01578824|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-06-12|||March 2011||2011-03-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Assessment Of Vitamin D Role In The Pathogenesis Of Asthma In Vitamin D Resistent Patients|Assessment Of Vitamin D Role In The Pathogenesis Of Asthma In Vitamin D Resistent Patients|Completed||N/A|26|Actual|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-11 03:03:48.9223|2017-10-11 03:03:48.9223
NCT01579890|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-04-17||||||April 2012|2012-04-01||||||||Expanded Access|||Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis|A Non-blinded, Non-placebo Controlled, Compassionate Use, Open Treatment, Open-ended Program of the Safety of Pennsaid Topical Lotion (Diclofenac) in the Treatment of Osteo or Rheumatoid Arthritis|Approved for marketing||N/A|||Mallinckrodt|||||f||||||||||||||2017-10-11 03:03:49.003843|2017-10-11 03:03:49.003843
NCT01579877|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-05-12|||April 2012||2012-04-01|May 2013|2013-05-01|November 2013|Anticipated|2013-11-01|September 2013|Anticipated|2013-09-01||Interventional|||Treatment of Xerostomia by Herbal Preparation|Efficacy of Yukmijihwang-tang on Xerostomia in the Elderly: A Randomized,Double-blind, Placebo-controlled, Two-center Trial|Unknown status|Recruiting|N/A|96|Anticipated|Korea Health Industry Development Institute||2|||f||||f||||||||||2017-10-11 03:03:49.063037|2017-10-11 03:03:49.063037
NCT01579864|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-11-02|||January 2012||2012-01-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Broncho-SR||Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia|Interventional Rigid Bronchoscopy Under General Anesthesia: Influence of the Muscle Relaxant, Succinylcholine or Rocuronium, on the Quality of the Surgical Procedure|Terminated||Phase 4|6|Actual|Hopital Foch||2||recent publication (Ghezel-Ahmadi. Thorac Cardiovasc Surg. 2014 Nov 21)|f||||f||||||||||2017-10-11 03:03:49.167165|2017-10-11 03:03:49.167165
NCT01579851|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-05-19|||January 2012||2012-01-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|Sugammadex2||Recovery After Sugammadex(Propofol vs Sevoflurane)|Recovery After Sugammadex(TIVA Using Propofol vs Inhalation Anesthesia Using Sevoflurane)|Completed||Phase 4|71|Actual|Hopital Foch||2|||f||||f||||||||||2017-10-11 03:03:49.257111|2017-10-11 03:03:49.257111
NCT01579838|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-04-17|||February 2012||2012-02-01|April 2012|2012-04-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||An Open Label Study of the Effects of Eculizumab in CD59 Deficiency|An Open Label Study of the Effects of Eculizumab in CD59 Deficiency|Unknown status|Recruiting|Phase 1/Phase 2|5|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 03:03:49.334727|2017-10-11 03:03:49.334727
NCT01579825|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-04-24|||April 2012||2012-04-01|April 2012|2012-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of Buffer on Immune Response to Oral Polio Vaccine (OPV) in Bangladesh|Evaluation of the Effect of Buffer on the Immune Response to Oral Poliovirus Vaccine in Bangladesh: a Randomized Controlled Trial|Completed||N/A|300|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 03:03:49.423697|2017-10-11 03:03:49.423697
NCT01579812|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-07-03|||October 2011||2011-10-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients|A Phase II Evaluation of Metformin, Targeting Cancer Stem Cells for the Prevention of Relapse in Patients With Stage IIC/III/IV Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Active, not recruiting||Phase 2|90|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 03:03:49.49775|2017-10-11 03:03:49.49775
NCT01579799|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-05-27|||April 2012||2012-04-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||The Effect of L-lysine on Human Gastrointestinal Secretion: A Dose-finding Study Applying Magnetic Resonance Imaging (MRI)||Completed||N/A|6|Actual|University of Zurich||4|||f||||||||||||||2017-10-11 03:03:49.680856|2017-10-11 03:03:49.680856
NCT01579786|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-02-19|||May 2011||2011-05-01|February 2014|2014-02-01|February 2014|Anticipated|2014-02-01|December 2012|Actual|2012-12-01||Interventional|||Treatment of Post Operative Pain in Thyroid Surgery Patients: Perspective Study Acupuncture Versus Drugs|The Treatment of Post Operative Pain in Thyroid Surgery Patients: Perspective Study Acupuncture Versus Pharmacological Treatment|Unknown status|Active, not recruiting|N/A|121|Actual|University of Padova||2|||f||||t||||||||||2017-10-11 03:03:49.769102|2017-10-11 03:03:49.769102
NCT01579773|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-12-08|||April 2010||2010-04-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|DEXA||Comparison of Body Composition & Weight Change in Users of Progestin-only Contraception During the First Year of Use|Comparison of Body Composition & Weight Change in Users of Progestin-only Contraception During the First Year of Use|Completed||N/A|345|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 03:03:49.86791|2017-10-11 03:03:49.86791
NCT01579760|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-05-10|||November 2012||2012-11-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Intravitreal Aflibercept Injection for Radiation Retinopathy|Treatment of Radiation Retinopathy With Intravitreal Aflibercept Injection 2.0mg|Active, not recruiting||Phase 1|20|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:03:49.947555|2017-10-11 03:03:49.947555
NCT01579747|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-12-18|2013-08-19||July 2012||2012-07-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Does Ultrasound Improve Procedural Time in the Lateral Popliteal Approach to the Sciatic Nerve in Obese Patients|Does Ultrasound Improve Procedural Time in the Lateral Popliteal Approach to the Sciatic Nerve in Obese Patients|Completed||Phase 4|25|Actual|University of New Mexico|We attempted to minimize performance bias by only involving staff anesthesiologists with years of experience in peripheral nerve blockade using both guidance modalities.|2|||f||||f||||||||||2017-10-11 03:03:50.195249|2017-10-11 03:03:50.195249
NCT01577602|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2013-03-13|||October 2011||2011-10-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Standard Medication Reconciliation Protocol in the Primary Care Office-based Setting|Standard Medication Reconciliation Protocol in the Primary Care Office-based Setting: A Focused Investigation of Two Interventions|Completed||N/A|424|Actual|The Cleveland Clinic||4|||f||||f||||||||||2017-10-11 03:04:26.380782|2017-10-11 03:04:26.380782
NCT01579734|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-08-09|||March 2002||2002-03-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|HOT||Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users|The HOT Study: Hormone Replacement Therapy Opposed by Low Dose Tamoxifen. A Phase III Trial of Breast Cancer Prevention With Low Dose Tamoxifen in HRT Users.|Active, not recruiting||Phase 3|1884|Actual|European Institute of Oncology||2|||f||||t||||||||||2017-10-11 03:03:50.503604|2017-10-11 03:03:50.503604
NCT01579721|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-02-03|||September 2011||2011-09-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Prospective Randomized Study of SILS Versus CLS for Rectal Cancer|Prospective Randomized Study of Single Incision Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Rectal Cancer|Completed||Phase 4|40|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 03:03:50.619947|2017-10-11 03:03:50.619947
NCT01579708|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2012-04-17|||September 2011||2011-09-01|April 2012|2012-04-01|June 2014|Anticipated|2014-06-01|June 2012|Anticipated|2012-06-01||Interventional|Preschool_PSI!||Evaluation of the Program SI! for Preschool Education: A School-Based Randomized Controlled Trial|Evaluation of the Program SI! for Preschool Education: A School-Based Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 3|2060|Actual|Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III||2|||f||||||||||||||2017-10-11 03:03:50.696216|2017-10-11 03:03:50.696216
NCT01579695|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2016-08-12|||February 2013||2013-02-01|August 2016|2016-08-01|March 2030|Anticipated|2030-03-01|December 2029|Anticipated|2029-12-01||Observational|||Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®|A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®|Recruiting||N/A|3190|Anticipated|Theratechnologies|||2||f||||t||||||||||2017-10-11 03:03:50.78968|2017-10-11 03:03:50.78968
NCT01579682|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-04-12|||September 2011||2011-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Adaptive Family Treatment for Adolescent Anorexia Nervosa|Adaptive Family Treatment for Adolescent Anorexia Nervosa|Completed||N/A|90|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 03:03:51.012907|2017-10-11 03:03:51.012907
NCT01579669|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-10-30|2015-08-18||September 2013||2013-09-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Baseline characteristics are presented for the autistic participants who completed the pre-intervention survey and the primary care providers who completed the PCP survey.|Partnering With Autistic Adults to Improve Healthcare|Partnering With Autistic Adults to Develop Tools to Improve Primary Healthcare|Completed||N/A|237|Actual|Oregon Health and Science University|This study was designed as a single-arm trial to assess feasibility and acceptability and to explore potential mechanisms of action. As such, there was no control group. PCPs are not a separate arm, but were included to assess acceptability.|1|||f||||f||||||||||2017-10-11 03:03:51.116378|2017-10-11 03:03:51.116378
NCT01579656|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2014-03-06|||February 2011||2011-02-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Flax, Poppy, Sesame & Salba on Postprandial Blood Glucose Response, Vascular, Appetite & Sensory Parameters|The Effects of Four Commonly Consumed Seeds (Flax, Poppy, Sesame & Salba) on Postprandial Blood Glucose Response, Vascular, Appetite and Sensory Parameters in Healthy Individuals|Completed||Phase 1|21|Actual|St. Michael's Hospital, Toronto||5|||f||||f||||||||||2017-10-11 03:03:51.76765|2017-10-11 03:03:51.76765
NCT01579643|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-04-21|||January 2012||2012-01-01|April 2015|2015-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|LALAK||OCT-guided LALAK in Children|Randomized Clinical Trial of OCT-guided Laser-assisted Lamellar Anterior Keratoplasty in Children|Unknown status|Recruiting|N/A|10|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 03:03:51.861522|2017-10-11 03:03:51.861522
NCT01579617|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-12-16|||August 2012||2012-08-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|eSiHLE||e-SiHLE: An Internet Pregnancy Prevention for Older Teenage Girls|e-SiHLE: An Internet Pregnancy Prevention for Older Teenage Girls|Completed||N/A|637|Actual|Tulane University||2|||f||||f||||||||No||2017-10-11 03:03:52.019901|2017-10-11 03:03:52.019901
NCT01579604|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-12-10|||June 2012||2012-06-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nerve Transfer Reconstruction in the Tetraplegic Upper Extremity|Early Nerve Reconstruction Approach in Tetraplegic Patients With Dysfunctional Upper Extremity: a Randomized Controlled Trial.|Recruiting||Phase 4|10|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:03:52.123107|2017-10-11 03:03:52.123107
NCT01579591|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-17|||March 2012||2012-03-01|April 2012|2012-04-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Interventional|||VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer|A Phase III, Randomized, Double-Blind Placebo Controlled Study of the Probiotic Preparation VSL#3® Versus Placebo in Increasing the Pathological Major Response Rate in Patients Receiving Concurrent Chemotherapy and Pelvic Radiation Therapy|Unknown status|Recruiting|Phase 3|160|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 03:03:52.214821|2017-10-11 03:03:52.214821
NCT01579578|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2014-09-11|2014-03-20||April 2012||2012-04-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer|A Phase IIa Multi-centre Randomised Double-Blind Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Metastatic, Gastric or Gastro-oesophageal Junction, Cancer Who Progress Following First Line Therapy and Are Ineligible for Treatment With Trastuzumab by HER2 Status (SAGE)|Terminated||Phase 2|39|Actual|AstraZeneca||2||AstraZeneca sponsored trials of AZD8931 have been halted|f||||||||||||||2017-10-11 03:03:52.321438|2017-10-11 03:03:52.321438
NCT01579565|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-05-19|2014-07-02|2013-07-10|April 2012||2012-04-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|OMS302-ILR-004||Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification|A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study of the Pharmacokinetics of OMS302 and the Effect of OMS302 on Intraoperative Pupil Diameter and Early Postoperative Pain in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification|Completed||Phase 3|416|Actual|Omeros Corporation||2|||f||||f||||||||||2017-10-11 03:03:53.218364|2017-10-11 03:03:53.218364
NCT01579552|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-08-08|||July 2010||2010-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer|EMPOWER Study: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer|Active, not recruiting||Phase 3|360|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 03:03:53.900594|2017-10-11 03:03:53.900594
NCT01579539|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-12-01|||June 2013||2013-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy|The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy|Recruiting||Phase 3|24|Anticipated|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 03:03:53.988195|2017-10-11 03:03:53.988195
NCT01579526|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2012-05-16|||April 2012||2012-04-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers|A Randomized, Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers|Completed||Phase 1|40|Actual|Cerecor Inc||4|||f||||f||||||||||2017-10-11 03:03:54.082502|2017-10-11 03:03:54.082502
NCT01579513|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-08-28|||June 2012||2012-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass|Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass|Recruiting||N/A|190|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:03:54.152701|2017-10-11 03:03:54.152701
NCT01579500|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-04-23|||April 2012||2012-04-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients|The Effect of Botulinum Toxin A in Post Spinal Cord Injury Neuropathic Pain|Completed||Phase 4|40|Actual|Catholic University of Korea Saint Paul's Hospital||2|||f||||t||||||||||2017-10-11 03:03:54.278232|2017-10-11 03:03:54.278232
NCT01579487|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-06-20|||March 2012||2012-03-01|March 2012|2012-03-01|February 2013|Actual|2013-02-01|April 2012|Actual|2012-04-01||Interventional|JUNO||Extended Follow-Up Study for Subjects Who Participated in 2010 Study|Non-Invasive Reduction of Abdominal Fat Utilizing the JUNO Applicator|Completed||N/A|10|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 03:03:54.365325|2017-10-11 03:03:54.365325
NCT01579474|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-07-03|2015-07-03||April 2012||2012-04-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||FAS (All patients who were randomized and received at least 1 dose of the trial medication)|Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial|Safety, Efficacy and Pharmacokinetics of BI 201335 NA in Patient With Genotype 1 Chronic Hepatitis C Virus Infection in Combination With Pegylated Interferon Alfa-2b and Ribavirin - Cohort 1 for Treatment-naive Patients: Randomised, Double-blind Part of BI 201335 NA for 12 or 24 Weeks - Cohort 2 for Treatment-experienced Patients: Open-label Part of BI 201335 NA for 24 Weeks|Completed||Phase 3|131|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 03:03:54.478676|2017-10-11 03:03:54.478676
NCT01579461|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-09-04|||November 2008||2008-11-01|September 2013|2013-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects|An Open Label Single Dose Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of YM178 Compared With Healthy Subjects|Completed||Phase 1|32|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 03:03:56.001883|2017-10-11 03:03:56.001883
NCT01579448|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2013-09-24|||December 2012||2012-12-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Boost||Evaluation of a Boosting Regimen With Oral Cholera Vaccine|A Open Labeled Controlled Trial to Evaluate the Immune Response of a Boosting Regimen With Shanchol™, a Killed Whole Cell Oral Cholera Vaccine (WC-OCV), in Previously Immunized Adults and Children in Eastern Kolkata, India|Completed||Phase 4|426|Actual|International Vaccine Institute||3|||f||||t||||||||||2017-10-11 03:03:56.108316|2017-10-11 03:03:56.108316
NCT01579435|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-04-10|||April 2012||2012-04-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ELECTRE||Experimental Therapeutics in Essential Tremor Using Transcranial Direct Current Stimulation|Thérapeutique expérimentale du Tremblement Essentiel Par la Stimulation Trans-crânienne Par Courant Direct (tDCS) du Cortex cérébelleux et du Cortex Moteur. Etude Exploratoire.|Completed||N/A|12|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-11 03:03:56.19076|2017-10-11 03:03:56.19076
NCT01579422|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-01-11|||May 2012||2012-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Social Cognitive Training for Psychosis: Treatment Development|Social Cognitive Training for Psychosis: Phase I Treatment Development|Completed||Phase 1|77|Actual|Yale University||1|||f||||f||||||||||2017-10-11 03:03:56.265477|2017-10-11 03:03:56.265477
NCT01579409|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2012-04-16|||November 2011||2011-11-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|NUTRIVASC||The Impact of the French PNNS Guidelines on Vascular Function Following a Standardised Breakfast.|The Impact of the French National Program for Nutrition and Health Guidelines on Vascular Function Following a Standardised Breakfast:The Nutri-Vasc Study|Unknown status|Enrolling by invitation|Phase 4|94|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-11 03:03:56.414419|2017-10-11 03:03:56.414419
NCT01579396|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-04-04|||April 2012||2012-04-01|April 2017|2017-04-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|HICOSIRS||High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery|The Effects of High-cutoff (HCO) Hemofiltration in the Immediate Postoperative Period on Systemic Inflammatory Response Syndrome (SIRS) and Renal Recovery in Cardiac Surgery Patients With a High Risk for Renal Failure. (HICOSIRS)|Withdrawn||N/A|0|Actual|Baxter Healthcare Corporation||2||Study halted prematurely, prior to enrollment of first patient, due to recruiting problems.|f||||f||||||||||2017-10-11 03:03:56.502374|2017-10-11 03:03:56.502374
NCT01579383|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-04-25|||April 2012||2012-04-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Safety Tolerability and Pharmacokinetics of ALD403|A Single Dose, Placebo-Controlled, Ascending Dose Study to Determine the Safety, Tolerability and Pharmacokinetics of ALD403, a Humanized Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody Administered by Intravenous Infusion and Subcutaneous Injection|Completed||Phase 1|104|Actual|Alder Biopharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 03:03:56.606583|2017-10-11 03:03:56.606583
NCT01579370|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-11-15|||April 2012||2012-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|July 2014|Actual|2014-07-01||Interventional|||Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)|A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes|Completed||N/A|21395|Actual|Duke University||4|||f||||f||||||||||2017-10-11 03:03:56.711305|2017-10-11 03:03:56.711305
NCT01579344|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2012-04-16|||January 2012||2012-01-01|April 2012|2012-04-01||||March 2014|Anticipated|2014-03-01||Interventional|||Lacrimal Drainage System Obstruction Associated to Radioactive Iodine Therapy for Thyroid Carcinoma|Lacrimal Drainage System Obstruction Associated to Radioactive Iodine Therapy for Thyroid Carcinoma|Unknown status|Enrolling by invitation|N/A|100|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:03:56.992187|2017-10-11 03:03:56.992187
NCT01579331|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2012-11-25|||July 2011||2011-07-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|DCT||Reliability of Dynamic Contour Tonometry (DCT)|Study of Test-retest Reliability of Dynamic Contour Tonometry and Its Correlation With Goldmann Applanation Tonometry|Completed||Phase 4|102|Actual|University of Cantanzaro||1|||f||||f||||||||||2017-10-11 03:03:57.521759|2017-10-11 03:03:57.521759
NCT01579318|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2016-12-12|||July 2012||2012-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|CTCL||Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma|A Multicenter Phase II Trial of Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma|Completed||Phase 2|2|Actual|OncoSec Medical Incorporated||1|||f||||t||||||||||2017-10-11 03:03:57.637464|2017-10-11 03:03:57.637464
NCT01579305|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2015-04-30|2014-06-27||April 2012||2012-04-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional||Baseline characteristics are based on the “modified Intent-to-Treat” population: subjects randomized to receive treatment and treated.|Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement||Completed||N/A|285|Actual|Allergan||2|||f||||||||||||||2017-10-11 03:03:57.777915|2017-10-11 03:03:57.777915
NCT01579292|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2014-07-16|||May 2012||2012-05-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Mobile Based Diabetes Prevention Program|mDPP Pilot RCT of a Motivational Mobile Diabetes Prevention Program (mDPP)|Completed||N/A|61|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:03:58.063171|2017-10-11 03:03:58.063171
NCT01579279|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2013-09-24|||April 2012||2012-04-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain|A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain|Terminated||Phase 2|1|Actual|AbbVie||5||Study Stopped|f||||t||||||||||2017-10-11 03:03:58.151286|2017-10-11 03:03:58.151286
NCT01579266|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-14|2017-06-30|||March 21, 2012||2012-03-21|October 25, 2016|2016-10-25|October 25, 2016||2016-10-25|||||Observational|||Validating a New Writer s Cramp Scale|Validating a New Writer's Cramp Scale|Completed||N/A|16|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:03:58.269918|2017-10-11 03:03:58.269918
NCT01579253|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-15|2012-12-17|||April 2012||2012-04-01|December 2012|2012-12-01||||||||Observational|||Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients|Untersuchungen Zur Verlaufskontrolle Bei Re-Bestrahlung Von Glioblastompatienten Mittels Kombinierter [18F]FET-PET-Kernspintomographie|Unknown status|Recruiting|N/A|10|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||f||||||||||2017-10-11 03:03:58.338774|2017-10-11 03:03:58.338774
NCT01579240|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-04-16|||February 2006||2006-02-01|December 2006|2006-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Internet Intervention Promotes Physical Activity in Sedentary Older Adults|Internet Intervention Promotes Physical Activity|Completed||N/A|368|Actual|Oregon Center for Applied Science, Inc.||1|||f||||f||||||||||2017-10-11 03:03:58.429299|2017-10-11 03:03:58.429299
NCT01579227|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-01-20|||January 2012||2012-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|TOP/OTOP||Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound|Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound.|Active, not recruiting||N/A|101|Anticipated|Ohio State University|||6||f||||f||||||Samples With DNA|"     Tissue biopsy will be collected twice in the study period.   "|||2017-10-11 03:03:58.521748|2017-10-11 03:03:58.521748
NCT01579201|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-02-12|||March 2012||2012-03-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery|ED90 Determination of Carbetocin for the Prevention of Postpartum Uterine Atony in Women Undergoing an Elective Cesarean Delivery|Unknown status|Recruiting|Phase 4|40|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||||2017-10-11 03:03:58.729962|2017-10-11 03:03:58.729962
NCT01579188|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-04-18|||May 2012||2012-05-01|April 2012|2012-04-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|LucaVax||Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer|A Double-blind, Multicenter, Randomized Phase III Study of the Telomerase Vaccine, GV1001 Administered After Curative Intent Chemo-radiotherapy in Patients With Inoperable Stage III Non-small Cell Lung Cancer Compared to Best Supportive Care|Unknown status|Not yet recruiting|Phase 3|600|Anticipated|Kael-GemVax Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:03:58.867879|2017-10-11 03:03:58.867879
NCT01579175|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-03-13|||January 2010||2010-01-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|GumGyn||The Effect of Gum Chewing on Postoperative Ileus After Gynecologic Surgery|The Effect of Gum Chewing on Postoperative Ileus After Gynecologic Surgery.|Completed||Phase 1/Phase 2|294|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:03:58.960573|2017-10-11 03:03:58.960573
NCT01579149|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-03-19|||September 2011||2011-09-01|March 2015|2015-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese Descent|A Phase 1, Randomized, Single-center, Single-dose, Double-blind, Placebo-controlled Pharmacokinetic, Safety, and Pharmacodynamic Study of Subcutaneous Injection of 160 μg/kg, 240 μg/kg, and 400 μg/kg Plerixafor in Healthy Adult Volunteers of Japanese Descent|Completed||Phase 1|24|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:03:59.185695|2017-10-11 03:03:59.185695
NCT01579136|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-12-20|||December 2011||2011-12-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Do Home Monitors Improve Blood Pressure Control?||Terminated||N/A|26|Actual|Exempla Saint Joseph Hospital||2||Lack of subjects|f||||f||||||||||2017-10-11 03:03:59.269014|2017-10-11 03:03:59.269014
NCT01579123|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-06-19|||February 2012||2012-02-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Laser Atherectomy Versus Angioplasty for the Treatment of Critical Limb Ischemia|Prospective Trial Comparing Laser Atherectomy to Angioplasty With/Without Stenting for Infrageniculate Peripheral Disease|Unknown status|Recruiting|N/A|200|Anticipated|Baylor Research Institute||2|||f||||t||||||||||2017-10-11 03:03:59.354057|2017-10-11 03:03:59.354057
NCT01579110|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-04-18|||April 2012||2012-04-01|April 2012|2012-04-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.|Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Institute of Hematology & Blood Diseases Hospital||2|||f||||t||||||||||2017-10-11 03:03:59.456776|2017-10-11 03:03:59.456776
NCT01579097|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-01-31|||December 2011||2011-12-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation|A Randomized, Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-Chamber Parenteral Nutrition Formulation (Oliclinomel N4)|Completed||Phase 3|458|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-10-11 03:03:59.547504|2017-10-11 03:03:59.547504
NCT01579084|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-09-12|2013-09-12||April 2012||2012-04-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea||Completed||Phase 1|64|Actual|Allergan||10|||f||||f||||||||||2017-10-11 03:03:59.659219|2017-10-11 03:03:59.659219
NCT01579071|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-02-08|||April 2012||2012-04-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy and Safety of CO2 vs Room Air Insufflation During ESD for Gastric Tumor|A Randomized, Controlled, Double-blind Trial of the Efficacy and Safety of CO2 vs Room Air Insufflation During ESD for Gastric Tumor|Completed||Phase 4|110|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 03:04:00.995318|2017-10-11 03:04:00.995318
NCT01579058|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-14|2014-05-08|||July 2012||2012-07-01|May 2014|2014-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|BLAST||Effect of Bisoprolol on Progression of Aortic Stenosis|A Randomized Trial of Beta-blocker Therapy in Aortic Stenosis|Terminated||Phase 4|150|Anticipated|Asan Medical Center||2||The sponsor discontinued to support the study.|f||||t||||||||||2017-10-11 03:04:01.064094|2017-10-11 03:04:01.064094
NCT01579045|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-05-05|2014-08-28||August 2012||2012-08-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Twenty-four subjects were screened, enrolled and completed each of the two arms of the study. No subjects were deemed ineligible on screening.|Effect of Head and Gaze Position on Soft Toric Contact Lens Performance|Effect of Head and Gaze Position on Soft Toric Contact Lens Performance|Completed||N/A|24|Actual|Johnson & Johnson Vision Care, Inc.||12|||f||||f||||||||||2017-10-11 03:04:01.200601|2017-10-11 03:04:01.200601
NCT01579032|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-04-16|||January 2004||2004-01-01|February 2012|2012-02-01||||January 2012|Actual|2012-01-01||Observational|||PULSE WAVE ANALYSIS AND VELOCITY IN PATIENTS WITH CHRONIC RENAL FAILURE|PULSE WAVE ANALYSIS AND VELOCITY IN PATIENTS WITH CHRONIC RENAL FAILURE: A CROSS-SECTIONAL OBSERVATIONAL STUDY TO ASSESS ASSOCIATION WITH LEFT VENTRICULAR HYPERTROPY, UREMIC TOXINS AND INFLAMMATION.|Completed||N/A|90|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 03:04:01.48218|2017-10-11 03:04:01.48218
NCT01579019|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-11-01|||July 2012||2012-07-01|November 2016|2016-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor Treatment||Withdrawn||Phase 2|0|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 03:04:01.548198|2017-10-11 03:04:01.548198
NCT01579006|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-16|2016-02-04|2015-12-08||May 2012||2012-05-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||Full Analysis Set (FAS) population included all recruited participants who received at least one dose of TCZ.|Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis|A Multi National, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab (Actemra)|Completed||N/A|184|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:04:01.699719|2017-10-11 03:04:01.699719
NCT01578993|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2016-02-18|2014-05-21||August 2012||2012-08-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Observational|PRISM-1||Observational Study of Complications Related to Use of Peripherally Inserted Central Catheters|A Phase IV, Prospective Clinical Evaluation of Complications Related to the Use of Peripherally Inserted Central Catheters (PICC) - An Observational Baseline Multicenter Study.|Completed||N/A|101|Actual|Teleflex|Further comparative studies standarizing the management of PICC line flushing solutions and type if PICC line required to provide comparative and evidence based clinical practice recommendations.||1||f||||f||||||||||2017-10-11 03:04:03.104547|2017-10-11 03:04:03.104547
NCT01578980|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2014-09-05|2014-08-08||April 2012||2012-04-01|August 2014|2014-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Outpatient Control-to-Range: System and Monitoring Testing|Outpatient Control-to-Range: System and Monitoring Testing|Completed||N/A|20|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:04:03.276527|2017-10-11 03:04:03.276527
NCT01578954|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-08-18|||June 2012||2012-06-01|August 2017|2017-08-01|April 2023|Anticipated|2023-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction|LCCC 1111: An Open-Label Dose-Finding Study of Lenalidomide as Reinduction/ Consolidation Followed by Lenalidomide Maintenance Therapy for Adults ≥ 60 Years of Age With Acute Myeloid Leukemia (AML) in Partial or Complete Response Following Conventional Induction Therapy|Recruiting||Phase 1|26|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:04:03.604291|2017-10-11 03:04:03.604291
NCT01578941|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-10-31|||January 2011||2011-01-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine||Completed||Phase 4|12|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 03:04:03.701938|2017-10-11 03:04:03.701938
NCT01578928|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-03-02|||May 2012||2012-05-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers|A Phase I, Open-label, Multicenter, Single Dose Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous (s.c.) Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to a Matched Control Group of Healthy Volunteers|Completed||Phase 1|50|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:04:03.80163|2017-10-11 03:04:03.80163
NCT01578811|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-03-14|||August 2011||2011-08-01|December 2010|2010-12-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis||Completed||Phase 2|102|Actual|SK Chemicals Co.,Ltd.||3|||f||||t||||||||||2017-10-11 03:04:03.887771|2017-10-11 03:04:03.887771
NCT01578798|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-10-29|||March 2012||2012-03-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Detection of Immune Changes as a Result of Surgical Trauma in Human Subject|Detection of Immune Changes as a Result of Surgical Trauma in Human Subject|Completed||N/A|50|Actual|Stanford University|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 03:04:03.963726|2017-10-11 03:04:03.963726
NCT01578785|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2014-02-19|2014-02-19||March 2012||2012-03-01|February 2014|2014-02-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|GLOW||An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)|A Multinational, Multicenter, Randomized, Parallel Group, Double Blind, Placebo Controlled Study Performed in Subjects With Relapsing-Remitting Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate 20mg/0.5ml New Formulation Administered Daily by Subcutaneous Injection|Terminated||Phase 3|178|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 03:04:04.064262|2017-10-11 03:04:04.064262
NCT01578772|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-12-02|2014-09-04||August 2012||2012-08-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||HIV-infected individual >50 years old with HIV-1 RNA <50 copies /mL on stable ART and >=1 CVD risk factor.|A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease|Telmisartan and Flow-Mediated Dilatation in Older HIV-Infected Patients at Risk for Cardiovascular Disease|Completed||Phase 2|17|Actual|University of California, Los Angeles|Given the limited size of the study population, the study was underpowered.|1|||f||||f||||||||||2017-10-11 03:04:05.106156|2017-10-11 03:04:05.106156
NCT01578759|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-04-21|||April 2012||2012-04-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effects of Salpingectomy During Laparoscopic Hysterectomy on Ovarian Function|Effects of Salpingectomy During Laparoscopic Hysterectomy on Ovarian Function|Completed||N/A|30|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 03:04:05.307081|2017-10-11 03:04:05.307081
NCT01578746|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-06-13|||January 2012||2012-01-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison Between Anterior and Direct Lateral Approach in Total Hip Arthroplasty|Comparison Between Minimally Invasive Anterior Approach and Direct Lateral Approach in Total Hip Arthroplasty - A Prospective Randomized Trial|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Sorlandet Hospital HF||2|||f||||t||||||||||2017-10-11 03:04:05.40869|2017-10-11 03:04:05.40869
NCT01578733|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2013-08-16|||November 2011||2011-11-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Determination of Protein Requirement in Elderly Female Subjects 65-75 Yrs Old|Use of Indicator Amino Acid Oxidation Technique to Determine Protein Requirement of Elderly Female Subjects 65-75 Yrs Old|Completed||N/A|14|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 03:04:05.533913|2017-10-11 03:04:05.533913
NCT01578720|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-07-24|||June 2012||2012-06-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|April 2014|Actual|2014-04-01||Interventional|||Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome|Treatment of CNV Secondary to Presumed Ocular Histoplasmosis With EYLEA 2.0mg (Intravitreal Aflibercept Injection)|Unknown status|Active, not recruiting|Phase 1|5|Anticipated|Retina Research Institute, LLC||1|||f||||f||||||||||2017-10-11 03:04:05.615143|2017-10-11 03:04:05.615143
NCT01578707|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-12-22|2015-06-23||June 2012||2012-06-01|December 2016|2016-12-01|November 2018|Anticipated|2018-11-01|November 2013|Actual|2013-11-01||Interventional|RESONATE™||A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Active, not recruiting||Phase 3|391|Actual|Pharmacyclics LLC.||2|||f||||t||||||||||2017-10-11 03:04:05.732276|2017-10-11 03:04:05.732276
NCT01578694|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-19|2017-05-09|||July 2007||2007-07-01|May 2017|2017-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Characterization of Proteoglycan Depletion in Femoroacetabular Impingement With T1ρ Magnetic Resonance Imaging (MRI)|Characterization of Proteoglycan Depletion in Femoroacetabular Impingement With T1ρ MRI|Completed||N/A|26|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 03:04:08.804276|2017-10-11 03:04:08.804276
NCT01578681|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-09-21|||September 2011||2011-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|September 2011|Actual|2011-09-01||Interventional|ELTGOLBQ||ELTGOL and Bronchiectasis. Respiratory Therapy|Multicenter Randomized Placebo-controlled Trial to Evaluate the Efficacy of the ELTGOL Technique in the Drainage of Secretions in Patients With Bronchiectasis|Unknown status|Active, not recruiting|N/A|154|Anticipated|Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta||2|||f||||f||||||||||2017-10-11 03:04:08.902236|2017-10-11 03:04:08.902236
NCT01578668|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2015-01-23|||January 2012||2012-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases|Phase 2 Study of Erlotinib Plus Pemetrexed/Cisplatin Treating Lung Adenocarcinoma With Brain Metastases|Completed||Phase 2|69|Actual|Guangzhou Medical University||2|||f||||t||||||||||2017-10-11 03:04:09.002993|2017-10-11 03:04:09.002993
NCT01578655|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2016-10-11||2016-10-07|August 2012||2012-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|AFFINITY||Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer|A Randomized Phase 3 Study Comparing Cabazitaxel/Prednisone in Combination With Custirsen (OGX-011) to Cabazitaxel/Prednisone for Second-Line Chemotherapy in Men With Metastatic Castrate Resistant Prostate Cancer (AFFINITY)|Completed||Phase 3|630|Actual|Achieve Life Sciences||2|||f||||t||||||||||2017-10-11 03:04:09.129631|2017-10-11 03:04:09.129631
NCT01578642|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2014-02-11|||September 2010||2010-09-01|January 2013|2013-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease|A Feasibility Study: An Evaluation of the Effect of Long-Term Electrical Stimulation on Lower Esophageal Sphincter (LES) Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 2|24|Actual|EndoStim Inc.||1|||f||||f||||||||||2017-10-11 03:04:09.42457|2017-10-11 03:04:09.42457
NCT01578629|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-01-20|||March 2012||2012-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|November 2016|Actual|2016-11-01||Interventional|NUTRITION||NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event|Human Blood Outcomes Following Tocotrienol Supplementation - NUTRITION Phase I and Phase IIA|Active, not recruiting||Phase 1/Phase 2|210|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-11 03:04:09.508027|2017-10-11 03:04:09.508027
NCT01578616|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2015-08-05|||July 2010||2010-07-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Endothelial Dysfunction and Plaque Vulnerability|Association of Endothelial Function With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Acute Coronary Syndrome|Completed||N/A|100|Actual|Yokohama City University Medical Center|||2||f||||f||||||||||2017-10-11 03:04:09.614472|2017-10-11 03:04:09.614472
NCT01578603|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2012-05-09|||January 2011||2011-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Two Sugar Substituted Chewing Gums on Caries and Gingivitis Variables|Effects of Two Sugar Substituted Chewing Gums Plus Tooth Brushing on Different Caries and Gingivitis Related Variables: a Double Blind, Randomized Controlled Clinical Trial|Completed||Phase 4|130|Actual|Universidad de Antioquia||2|||f||||f||||||||||2017-10-11 03:04:09.686346|2017-10-11 03:04:09.686346
NCT01578590|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-11-26|||May 2012||2012-05-01|November 2014|2014-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|Meat-Milk||Post-exercise Recovery After Dietary Protein Ingestion in Healthy Young Men (Meat-Milk Study)|Post-exercise Recovery After Dietary Protein Ingestion in Healthy Young Men|Completed||N/A|12|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:04:09.774269|2017-10-11 03:04:09.774269
NCT01578577|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-03-26|||April 2012||2012-04-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|NAMES||Northwestern University and Access Community Health Network Medication Education Study|EHR-based Health Literacy Strategy to Promote Medication Therapy Management|Unknown status|Active, not recruiting|N/A|1680|Anticipated|Northwestern University||3|||f||||t||||||||||2017-10-11 03:04:09.857589|2017-10-11 03:04:09.857589
NCT01578564|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-06-21|||July 2012||2012-07-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|July 2015|Actual|2015-07-01||Interventional|||Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel|Phase I, Open-label, Dose Escalation Study to Assess Safety and Tolerability of SOR-C13 in Subjects With Advanced Solid Tumors Commonly Known to Express the TRPV6 Ion Channel|Completed||Phase 1|23|Actual|Soricimed Biopharma Inc||1|||f||||t||||||||||2017-10-11 03:04:09.955377|2017-10-11 03:04:09.955377
NCT01578551|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-10-12|||April 2012||2012-04-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2015|Actual|2015-11-01||Interventional|NA_00052073||A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.|A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Previously Untreated Advanced/Metastatic Pulmonary Adenocarcinoma|Active, not recruiting||Phase 2|60|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 03:04:10.039269|2017-10-11 03:04:10.039269
NCT01578538|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-04-16|||February 2012||2012-02-01|April 2012|2012-04-01|June 2016|Anticipated|2016-06-01|June 2014|Anticipated|2014-06-01||Interventional|hernia||Safety of Mesh Used Repairs in Emergency Abdominal Wall Hernias. Prospective Randomized Multicenter Trial|Mesh Used Repairs in Emergency Abdominal Wall Hernias|Unknown status|Recruiting|N/A|200|Anticipated|SB Istanbul Education and Research Hospital||2|||f||||f||||||||||2017-10-11 03:04:10.267839|2017-10-11 03:04:10.267839
NCT01578525|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2015-10-29|||April 2012||2012-04-01|May 2012|2012-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Medication Safety of Elderly Patients in Hospital and Ambulatory Setting|Medication Safety of Elderly Patients in Hospital and Ambulatory Setting Considering the Transitions of Care for Home-cared Patients and Nursing Home Residents|Completed||N/A|61|Actual|RWTH Aachen University||2|||f||||||||||||||2017-10-11 03:04:10.364321|2017-10-11 03:04:10.364321
NCT01578512|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-16|||February 2012||2012-02-01|March 2012|2012-03-01|November 2012|Anticipated|2012-11-01|August 2012|Anticipated|2012-08-01||Interventional|SPARK||SPARK a Healthy and Fit Lifestyle|SPARK a Healthy and Fit Lifestyle|Unknown status|Recruiting|N/A|45|Anticipated|The Miriam Hospital||3|||f||||f||||||||||2017-10-11 03:04:10.490721|2017-10-11 03:04:10.490721
NCT01578499|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-02-07||2017-02-02|August 2012||2012-08-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|May 2016|Actual|2016-05-01||Interventional|||A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma|A Randomized, Open-Label, Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma|Active, not recruiting||Phase 3|132|Actual|Takeda||2|||f||||t||||||||||2017-10-11 03:04:10.623928|2017-10-11 03:04:10.623928
NCT01578473|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-04-08|||April 2012||2012-04-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|PD+||Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease|An Open-Label, Nine-Month Randomized Controlled Study of Testosterone (Testopel) Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease|Unknown status|Active, not recruiting|Phase 1|75|Anticipated|Men's Health Boston||2|||f||||t||||||||||2017-10-11 03:04:11.087733|2017-10-11 03:04:11.087733
NCT01578460|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-03-09|||May 2012|Actual|2012-05-01|March 2017|2017-03-01|August 29, 2014|Actual|2014-08-29|August 29, 2014|Actual|2014-08-29||Interventional|HMHB||Healthy Moms, Healthy Babies|Healthy Moms, Healthy Babies: A Strategy to Improve the Care and OUtcome of Diabetes in Pregnancy in On-Reserve First Nations Women|Completed||N/A|18|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:04:11.194203|2017-10-11 03:04:11.194203
NCT01578447|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2014-09-16|||April 2012||2012-04-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda|Acceptability of Depo-subQ Provera 104 in Uniject Versus Intramuscular Depo-Provera Among HIV-positive Women and Family Planning Providers in Rakai, Uganda|Completed||N/A|356|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 03:04:11.313001|2017-10-11 03:04:11.313001
NCT01578434|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-17|||November 2007||2007-11-01|April 2012|2012-04-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|ROCAVINR||Role of Calcium And Vitamin D In Nutritional Rickets And It's Management|Role of Calcium And Vitamin D In Nutritional Rickets And It's Management|Completed||Phase 4|67|Actual|Lady Hardinge Medical College||3|||f||||f||||||||||2017-10-11 03:04:11.424186|2017-10-11 03:04:11.424186
NCT01578421|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2013-08-06|||February 2012||2012-02-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser|Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser|Completed||N/A|31|Actual|Kantonsspital Aarau||3|||f||||f||||||||||2017-10-11 03:04:11.586064|2017-10-11 03:04:11.586064
NCT01578408|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2015-05-28|||May 2010||2010-05-01|May 2015|2015-05-01|December 2023|Anticipated|2023-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Cemented Versus Uncemented Stems in Total Hip Arthroplasty in Patients With Femoral Neck Fractures|Corail-SP Study - A Prospective Randomized Comparison Between Cemented and Uncemented Hydroxyapatite Coated Prosthesis Stems in Total Hip Arthroplasty in Patients With Femoral Neck Fractures|Recruiting||N/A|100|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-11 03:04:11.684546|2017-10-11 03:04:11.684546
NCT01578395|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-12-05|||April 2012||2012-04-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Impact of Antioxidant Agents on the Number of DNA Double-strand Breaks After Radiation-based Cardiac Examinations|Randomized, Double-blinded, Placebo-controlled, Single Center, and Prospective Phase II Clinical Trial to Analyze the Effects of Antioxidant Agents on DNA Double-strand Breaks in Patients After Radiation-based Cardiac Examinations|Completed||Phase 2|102|Actual|University of Zurich||3|||f||||t||||||||||2017-10-11 03:04:11.831653|2017-10-11 03:04:11.831653
NCT01578382|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2016-10-27|||September 2011||2011-09-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)|Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU): A Comparison of Martorell HYTILU, Calciphylaxis and Venous Ulcer (Control)|Recruiting||N/A|50|Anticipated|University of Zurich|||3||f||||f||||||Samples With DNA|"     Blood serum (2 tubes); blood plasma in citrate (2 tubes); blood plasma in heparin (2 tubes)     Diseased skin tissue in formalin for paraffin embedded H-E histology; Diseased skin tissue     snap frozen Diseased skin tissue in RNA later tube (1 tube)   "|||2017-10-11 03:04:11.937729|2017-10-11 03:04:11.937729
NCT01578369|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-04-13|||September 2009||2009-09-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effect of Pelvic Floor Muscle Training Included in General Fitness Classes During Pregnacy|Pelvic Floor Muscle Training Included in General Fitness Classes is Effective in Primary Prevention of Urinary Incontince in Pregnancy. A Randomized Controlled Trial|Completed||N/A|169|Actual|Universidad Politecnica de Madrid||2|||f||||f||||||||||2017-10-11 03:04:12.0405|2017-10-11 03:04:12.0405
NCT01578356|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2014-12-04|||February 2013||2013-02-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery|Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Ghent|||2||f||||f||||||||||2017-10-11 03:04:12.135172|2017-10-11 03:04:12.135172
NCT01578343|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-04-13|||June 2012||2012-06-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|ZOLINZA||Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma|A Phase II Investigation of Vorinostat in Combination With Intravenous Fludarabine, Mitoxantrone, and Dexamethasone in Patients With Relapsed or Refractory Mantle Cell Lymphoma|Terminated||Phase 2|20|Actual|Samsung Medical Center||1||"we collected data of a total of 19 patients for an interim analysis. but there are less than 7   responses out of the initial 19 patients."|f||||f||||||||Yes|we will share collected data with principal investigator in Korea|2017-10-11 03:04:12.236609|2017-10-11 03:04:12.236609
NCT01578330|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-04-29|2016-04-29||October 2012||2012-10-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720|A 12 -Month, Open-label, Multi-center Pilot Study to Explore the Health Outcomes of FTY720 in RRMS Patients Who Have Previously Been Treated With Other Disease Modifying Therapies (DMT)- Fine|Completed||Phase 4|42|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:04:12.338968|2017-10-11 03:04:12.338968
NCT01578304|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-13|||December 2010||2010-12-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder|Phase IV Study to Evaluate the Efficacy and Safety Imidafenacin Versus Fesoterodine in Patients With Overactive Bladder|Completed||Phase 4|207|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 03:04:12.820587|2017-10-11 03:04:12.820587
NCT01578291|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-13|||December 2011||2011-12-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Parent Education and Medical Play: A Comparison of Psychological Preparation Strategies for Voiding Cystourethrogram|Parent Education and Medical Play: A Comparison of Psychological Preparation Strategies for Voiding Cystourethrogram|Unknown status|Recruiting|Phase 1|100|Anticipated|Johns Hopkins University||3|||f||||f||||||||||2017-10-11 03:04:12.905489|2017-10-11 03:04:12.905489
NCT01578278|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-04-04||2013-08-23|December 2011||2011-12-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis||Completed||Phase 2|606|Actual|Bausch & Lomb Incorporated||4|||f||||f||||||||||2017-10-11 03:04:12.995305|2017-10-11 03:04:12.995305
NCT01578265|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-13|||May 2011||2011-05-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Ondansetron Tablets USP 8 mg With Zofran® 8 mg in Normal, Healthy, Adult, Human Subjects Under Fed Condition.|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 03:04:13.223887|2017-10-11 03:04:13.223887
NCT01578252|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-13|||May 2011||2011-05-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Ondansetron Tablets USP 8 mg With Zofran® 8 mg in Normal, Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|48|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 03:04:13.320454|2017-10-11 03:04:13.320454
NCT01578239|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-08-29|2017-08-29||September 2012||2012-09-01|July 2017|2017-07-01|February 2021|Anticipated|2021-02-01|July 2015|Actual|2015-07-01||Interventional|NETTER-1|All patients who were randomized in the study.|A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours|A Multicentre, Stratified, Open, Randomized, Comparator-controlled, Parallel-group Phase III Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours|Active, not recruiting||Phase 3|231|Actual|Advanced Accelerator Applications||2|||f||||t||||||||||2017-10-11 03:04:13.443934|2017-10-11 03:04:13.443934
NCT01578226|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-04-13|||October 2009||2009-10-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Observational|||Procalcitonin in Cirrhotic Patients at High Risk for Sepsis|Role of Procalcitonin (PCT) for the Diagnosis of Sepsis in Ascitic Cirrhotic Patients|Completed||N/A|75|Actual|University of Modena and Reggio Emilia|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 03:04:14.464132|2017-10-11 03:04:14.464132
NCT01578213|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-05-09|||November 2011||2011-11-01|May 2017|2017-05-01|May 2019|Anticipated|2019-05-01|November 2018|Anticipated|2018-11-01||Interventional|ISAV||Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients|Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients (ISAV)|Active, not recruiting||Phase 4|100|Anticipated|University of Milano Bicocca||1|||f||||f||||||||||2017-10-11 03:04:14.545658|2017-10-11 03:04:14.545658
NCT01578200|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-09-27|||December 2011||2011-12-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|LANDMARK||Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study|Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate on Cardiovascular Mortality and Morbidity in Patients With Chronic Kidney Disease on Hemodialysis (CKD5D)|Active, not recruiting||Phase 3|2309|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||||||||||||2017-10-11 03:04:14.714303|2017-10-11 03:04:14.714303
NCT01578187|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-11-27|2013-04-04||March 2012||2012-03-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|OHR6-LCU||Hair2Go Label Comprehension and Usability Study|Evaluating Label Comprehension and Usability of the Hair2Go System|Completed||N/A|63|Actual|Syneron Medical||1|||f||||t||||||||||2017-10-11 03:04:14.819891|2017-10-11 03:04:14.819891
NCT01578174|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-10-31|||April 2012||2012-04-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Effect of Dexmedetomidine in the Management of Pain After Uterine Artery Embolization||Completed||N/A|66|Anticipated|Severance Hospital||2|||f||||f||||||||||2017-10-11 03:04:15.029445|2017-10-11 03:04:15.029445
NCT01578161|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2012-04-13|||January 2012||2012-01-01|April 2012|2012-04-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Interventional|||The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia|The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia|Unknown status|Recruiting|Phase 4|116|Anticipated|Seoul National University Hospital||4|||f||||f||||||||||2017-10-11 03:04:15.114603|2017-10-11 03:04:15.114603
NCT01578148|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2013-04-23|||April 2012||2012-04-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Noxipoint Therapy Versus Standard Physical Therapy Using Electrical Stimulation for Chronic Pain|Noxipoint Therapy vs. Standard Physical Therapy Using Electrical Stimulation for Chronic Pain|Completed||N/A|34|Actual|Pain Cure Center, California||2|||f||||t||||||||||2017-10-11 03:04:15.239818|2017-10-11 03:04:15.239818
NCT01578135|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-07-31|||March 19, 2007|Actual|2007-03-19|July 2017|2017-07-01|April 28, 2022|Anticipated|2022-04-28|April 28, 2022|Anticipated|2022-04-28||Observational|||French National Registry of Children Born Small for Gestational Age Treated With Somatropin|French National Longitudinal Prospective Follow-up of Children Born Small for Gestational Age and Treated With Norditropin SimpleXx (French Health Authorities Commitment)|Active, not recruiting||N/A|400|Anticipated|Novo Nordisk A/S|||2||f||||f|t|f||||||||2017-10-11 03:04:15.360831|2017-10-11 03:04:15.360831
NCT01578122|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-09-19|||June 2012|Actual|2012-06-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Interventional|CELEST||Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome|Evaluation of the Efficacy of Elastic Compression in Preventing Post-thrombotic Syndrome. Randomised Non-inferiority Study for Ankle Pressure Targeted at 25 mm Hg Versus 35 mm Hg|Active, not recruiting||N/A|350|Actual|Laboratoires Innothera||2|||f||||t||||||||||2017-10-11 03:04:15.484364|2017-10-11 03:04:15.484364
NCT01578109|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2017-09-12|||January 13, 2012|Actual|2012-01-13|September 2017|2017-09-01||||December 31, 2018|Anticipated|2018-12-31||Interventional|||Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia|A Pilot Study of Sorafenib in Patients With Acute Myeloid Leukemia as Peri-transplant Remission Maintenance|Active, not recruiting||N/A|45|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 03:04:15.74413|2017-10-11 03:04:15.74413
NCT01578096|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-08-20|||May 2012||2012-05-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|CALMS-D||Stress Management Among Latinos With Type 2 Diabetes|Stress Management Among Latinos With Type 2 Diabetes Mellitus|Completed||N/A|107|Actual|Yale University||2|||f||||||||||||||2017-10-11 03:04:15.877108|2017-10-11 03:04:15.877108
NCT01578083|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2013-02-25|||April 2012||2012-04-01|April 2012|2012-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|CICI||Chemotherapy-Induced Cognitive Impairment|The Neurobiology of Chemotherapy-Induced Cognitive Impairment|Completed||N/A|28|Actual|Washington University School of Medicine|||2||f||||f||||||||||2017-10-11 03:04:15.957954|2017-10-11 03:04:15.957954
NCT01578070|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2013-08-29|||March 2012||2012-03-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|VSG-2011-101||Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine|A Single-centre Study Evaluating the Safety of ViscoGel® and Its Safety and Efficacy as an Adjuvant in Act-HIB® Vaccine Administered by Intramuscular Injection to Healthy Volunteers in a Single-blind Randomised, Parallel-group Design|Completed||Phase 1/Phase 2|130|Actual|Viscogel AB||5|||f||||t||||||||||2017-10-11 03:04:16.026166|2017-10-11 03:04:16.026166
NCT01578057|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2014-02-14|||April 2012||2012-04-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol|A Randomized, Double-mask, Four-period Crossover Study in Healthy Subjects to Evaluate the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol|Completed||Phase 1|28|Actual|Vanda Pharmaceuticals||4|||f||||f||||||||||2017-10-11 03:04:16.117709|2017-10-11 03:04:16.117709
NCT01578044|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-05-28|2015-04-27||January 2012||2012-01-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Dabigatran Adherence Pilot Intervention for Patients With Atrial Fibrillation|Pilot Intervention to Improve Adherence to Dabigatran for Patients With Atrial Fibillation|Completed||N/A|12|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 03:04:16.211661|2017-10-11 03:04:16.211661
NCT01578031|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-04-12|2017-04-12||March 2009||2009-03-01|April 2017|2017-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|PISA||The Effects of Treating Obese and Lean Patients With Sleep Apnea|Responses to CPAP Treatment in Obese and Lean Sleep Apnea Patients|Completed||N/A|450|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 03:04:16.670114|2017-10-11 03:04:16.670114
NCT01578018|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-08-08|||December 2011||2011-12-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Tumor Markers in Lung Cancer: DCAMLK-1LK-1|Tumor Markers in Lung Cancer: DCAMLK-1LK-1: A Pilot Study|Completed||N/A|49|Actual|University of Oklahoma||2|||f||||f||||||||||2017-10-11 03:04:17.291782|2017-10-11 03:04:17.291782
NCT01578005|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-02-21|||March 2011||2011-03-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|OPTIVUS||IVUS Assessment of Atheroma Burden After Acute Coronary Syndrome|Intravascular Ultrasound (IVUS) Assessment of the Atherosclerotic Plaque Causing an Acute Coronary Syndrome: One-year Changes Under Optimal Secondary Prevention Drug Treatment|Recruiting||N/A|150|Anticipated|University Hospital, Toulouse|||1||f||||f||||||Samples With DNA|"     bioanalysis on DNA, searching genes involving coronary disease   "|No||2017-10-11 03:04:17.39846|2017-10-11 03:04:17.39846
NCT01577992|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2013-11-08|||December 2011||2011-12-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|MSA-DOUL||Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy|Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy|Completed||N/A|42|Actual|University Hospital, Toulouse||3|||f||||f||||||||||2017-10-11 03:04:17.512344|2017-10-11 03:04:17.512344
NCT01577979|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-02-24|||August 2012||2012-08-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Adolescent Vaccination in the Medical Home: Established and Innovative Strategies|Adolescent Vaccination in the Medical Home: Established and Innovative Strategies|Completed||N/A|34581|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 03:04:17.63538|2017-10-11 03:04:17.63538
NCT01577966|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-10-16|2016-07-19||January 2012||2012-01-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma|A Pilot Study to Determine the Effect of Sulfasalazine on Glutamate Levels Detected by Magnetic Resonance Spectroscopy(MRS) in Patients With Glioma|Completed||N/A|9|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 03:04:17.747147|2017-10-11 03:04:17.747147
NCT01577953|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2014-04-28|||April 2012||2012-04-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma|Phase-Ib Study in Male Patients With Stable Allergic Asthma With Airway Hyperresponsiveness to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Inhaled Single Doses of SB010, a Human GATA-3-specific DNAzyme Solution for Nebulisation - A Randomised, Double-blind, Placebo-controlled, Parallel-group (Per Dose Level) Dose-escalation Study in Asthmatic Patients|Completed||Phase 1|24|Actual|Sterna Biologicals GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 03:04:17.958378|2017-10-11 03:04:17.958378
NCT01577940|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-05-03|||January 2011||2011-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Method Study: Bilateral TAP Block With 24 Hours Infusion|Method Study of Bilateral Transversus Abdominis Plane (TAP) Block With 24 Hours Infusion. Extent of Sensory Block, Analgetic Effect and Lung Function in Healthy Volunteers|Completed||Phase 4|8|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-11 03:04:18.058862|2017-10-11 03:04:18.058862
NCT01577927|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-06-04|||July 2011||2011-07-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|UTIR||Feasibility Study of a Home Rehabilitative Network to Treat Prolonged Weaned Patients|Feasibility and Efficacy of a Home Rehabilitative Network for Prolonged Weaned Patients Discharged From a Weaning Unit|Completed||N/A|60|Actual|Fondazione Salvatore Maugeri||2|||f||||t||||||||||2017-10-11 03:04:18.174649|2017-10-11 03:04:18.174649
NCT01577914|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-07-05|||July 2011||2011-07-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Carvedilol Tablets USP 12.5 mg With Coreg® 12.5 mg in Normal, Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|42|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 03:04:18.291205|2017-10-11 03:04:18.291205
NCT01577888|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2014-08-06|||August 2012||2012-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Feasibility Study of the Shockwave Lithoplasty System|Safety and Feasibility Study of the Shockwave Lithoplasty System|Completed||N/A|6|Actual|Shockwave Medical, Inc.||1|||f||||t||||||||||2017-10-11 03:04:18.477999|2017-10-11 03:04:18.477999
NCT01577875|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-11-18|||April 2012||2012-04-01|April 2012|2012-04-01|March 2013|Actual|2013-03-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Narrow Band Imaging With or Without Magnifying Colonoscopy|A Prospective Clinical Study to Evaluate Narrow Band Imaging and Magnifying Colonoscopy for the Histologic Prediction of Colorectal Polyps|Completed||N/A|122|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:04:18.570963|2017-10-11 03:04:18.570963
NCT01577862|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-12|||November 2008||2008-11-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|CoRAb||Colistin and Rifampicin for MDR-Acinetobacter|Randomised, Open-Label Clinical Trial on The Efficacy of Colistin Plus Rifampicin Treatment Versus Colistin Alone for Severe Infections Due to Multidrug-Resistant Acinetobacter Baumannii|Completed||Phase 3|210|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||t||||||||||2017-10-11 03:04:18.651998|2017-10-11 03:04:18.651998
NCT01577849|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-10-31|||March 2012||2012-03-01|April 2012|2012-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety and Pharmacokinetic Characteristics of DP-R206(Vitamin D3) in Healthy Adult Volunteers|Randomized, Open-label Crossover Study to Evaluate Comparative Pharmacokinetics of Vitamin D3 Between DP-R206(150mg Ibandronate / 24,000 IU Vitamin D3 Tablet) and a 24,000 IU Vitamin D3 in Healthy Adult Volunteers|Completed||Phase 1|36|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-11 03:04:18.737556|2017-10-11 03:04:18.737556
NCT01577836|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-13|2016-05-19|||November 2012||2012-11-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|RoboProstate||Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via Laparotomy|Medico-economic Comparison of Robot-assisted Radical Prostatectomy Using the da Vinci System Versus Radical Prostatectomy Via Laparotomy|Active, not recruiting||N/A|90|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 03:04:18.821539|2017-10-11 03:04:18.821539
NCT01577823|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-04-08||||||April 2013|2013-04-01||||||||Interventional|||Utility of Indwelling Catheter in Orthopaedic Patients Receiving Spinal Anesthesia||Completed||N/A|||Rothman Institute Orthopaedics||2|||f||||f||||||||||2017-10-11 03:04:18.943085|2017-10-11 03:04:18.943085
NCT01577810|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-06-06|||June 2013||2013-06-01|June 2013|2013-06-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment.|Near Infrared Spectroscopy (NIRS) for Heart Failure Assessment in the Outpatient Setting|Unknown status|Recruiting|N/A|100|Anticipated|Phoenix Children's Hospital||1|||f||||f||||||||||2017-10-11 03:04:19.032963|2017-10-11 03:04:19.032963
NCT01577797|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-07-08|||April 2012||2012-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence|A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence|Completed||Phase 1|25|Actual|New Leaf Treatment Center||2|||f||||f||||||||||2017-10-11 03:04:19.155451|2017-10-11 03:04:19.155451
NCT01577407|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-12-10|||September 2011||2011-09-01|October 2011|2011-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|Nefopel||Non Opioid Treatment for Experimental Dyspnea|Non Opioid Treatment for Experimental Dyspnea|Completed||Phase 3|15|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:04:28.51|2017-10-11 03:04:28.51
NCT01577784|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-03-11|||April 2012||2012-04-01|March 2014|2014-03-01|October 2015|Anticipated|2015-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Pazopanib in Second-line Therapy in Renal Cell Carcinoma|A Phase II, Opened, Not Controlled and Multicentric Clinical Trial of Pazopanib in Monotherapy to Determine Efficiency and Safety in Second-line of Treatment in Patients With Carcinoma of Advanced Renal Cells That Have Progressed or Have Not Tolerated the First Line of Treatment With Tyrosine Kinase Inhibitor|Unknown status|Active, not recruiting|Phase 2|27|Anticipated|Associació per a la Recerca Oncologica, Spain||1|||f||||f||||||||||2017-10-11 03:04:19.272211|2017-10-11 03:04:19.272211
NCT01577771|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-03-03|||February 2013||2013-02-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|PCV13-Bobo||Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso|Immunogenicity and Reactogenicity of 13-valent Pneumococcal Conjugate Vaccine Among Infants, Toddlers and Children in Bobo-Dioulasso, Burkina Faso: a Phase 4 Randomized Trial|Completed||Phase 4|663|Actual|Agence de Médecine Préventive, France||5|||f||||f||||||||||2017-10-11 03:04:19.449896|2017-10-11 03:04:19.449896
NCT01577758|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-09-06|2015-02-12||June 2012||2012-06-01|September 2016|2016-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Safety population included all participants who received at least 1 dose of study drug. A total of 41 participants participated in the study. There were 3 participants who participated in both phases of the study and are only counted once.|Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C|An Open-Label, Dose Escalation, Phase 1, First-in-Human Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C|Completed||Phase 1|41|Actual|Takeda||1|||f||||f||||||||||2017-10-11 03:04:19.609036|2017-10-11 03:04:19.609036
NCT01577745|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-03-21|2017-01-23||April 2012||2012-04-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||Safety Population included all participants who received at least one dose of MEDI0639.|A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors|A Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Adult Subjects With Advanced Solid Tumors|Completed||Phase 1|58|Actual|MedImmune LLC|OMs relationship modulation of DLL4-Notch signaling pathway in tumor and clinical response analysis was not conducted due to low number of evaluable tumor samples and low response rate. Study was terminated early due to lack of clinical activity.|6|||f||||f||||||||||2017-10-11 03:04:21.285265|2017-10-11 03:04:21.285265
NCT01577732|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-04-24|2014-04-03||December 8, 2012||2012-12-08|April 2017|2017-04-01|April 9, 2013|Actual|2013-04-09|April 9, 2013|Actual|2013-04-09||Interventional|||Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers|Safety and Reactogenicity of GlaxoSmithKline Biologicals' DTPa-IPV/Hib (Infanrix-IPV+HibTM) in Healthy Vietnamese Toddlers|Completed||Phase 3|321|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:04:24.314149|2017-10-11 03:04:24.314149
NCT01577719|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-06-08|||June 2009||2009-06-01|June 2016|2016-06-01||||November 2012|Actual|2012-11-01||Interventional|SAHARA-Pilot||South Asian HeArt Risk Assessment Project - Pilot|South Asian HeArt Risk Assessment Project - Pilot|Active, not recruiting||N/A|400|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 03:04:24.565687|2017-10-11 03:04:24.565687
NCT01577706|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-03-24|2014-09-25||June 2013|Actual|2013-06-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CEBRA2|Healthy male volunteers receiving drug and undergoing 1H-MRSI scanning|Spectroscopic Imaging at 4T: A Drug Challenge Study|Spectroscopic Imaging of GABA and Glutamate/Glutamine in Healthy Volunteers at 4T: A Double Blind, Crossover Drug Challenge Study|Terminated||N/A|7|Actual|Mclean Hospital||3||lack of enrollment|f||||f||||||||Undecided|At present, there is no plan to share IPD data.|2017-10-11 03:04:24.692356|2017-10-11 03:04:24.692356
NCT01577693|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-06-21|||May 12, 2011|Actual|2011-05-12|June 2017|2017-06-01|August 31, 2011|Actual|2011-08-31|August 31, 2011|Actual|2011-08-31||Interventional|ARI115148||Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects|An Open-label, Single Dose, Randomized, Two-period Crossover Study to Investigate the Bioavailability of a Novel Dosage Form of Dutasteride in Healthy Male Subjects|Completed||Phase 1|35|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:04:25.315112|2017-10-11 03:04:25.315112
NCT01577680|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-07-24|||March 5, 2012|Actual|2012-03-05|July 2017|2017-07-01|June 29, 2012|Actual|2012-06-29|June 29, 2012|Actual|2012-06-29||Interventional|||A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers|An Open-label, Non-randomized, Pharmacokinetic and Safety Study of Single Dose GSK573719 + GW643444 (VI) Combination and Repeat Doses of GSK573719 in Healthy Subjects and in Subjects With Moderate Hepatic Impairment|Completed||Phase 1|18|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:04:25.400638|2017-10-11 03:04:25.400638
NCT01577667|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-12-05|||February 2011||2011-02-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|Intellivent||Intellivent Versus Conventional Ventilation|Comparative Monocenter RCT Comparing Safety and Efficacy of an Automated Closed-loop Oxygenation and Ventilation(IntelliVent® System - HAMILTON MEDICAL AG) With Non-automated Conventional Ventilation and Oxygenation|Completed||Phase 3|80|Actual|Hamilton Medical AG||2|||f||||t||||||||||2017-10-11 03:04:25.563974|2017-10-11 03:04:25.563974
NCT01577654|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2015-08-03|||March 2011||2011-03-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2013|Actual|2013-12-01||Interventional|TARGET||Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer|A Randomized, Open-label Phase 2 Study of EC145 Single-agent and the Combination of EC145 Plus Docetaxel Versus Docetaxel Alone in Participants With Folate-receptor Positive [FR(++)] Second Line NSCLC|Completed||Phase 2|203|Actual|Endocyte||3|||f||||t||||||||||2017-10-11 03:04:25.652697|2017-10-11 03:04:25.652697
NCT01577628|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-03-23|2016-02-23||June 2012||2012-06-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis|Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis|Terminated||N/A|2|Actual|Cosmetique Active International||2||Sponsor Decision|f||||f||||||||No||2017-10-11 03:04:25.765484|2017-10-11 03:04:25.765484
NCT01577589|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-09-01|||April 2012||2012-04-01|September 2017|2017-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy Subjects|A Phase I, Single-center, 2-part, Randomized, 2-way Crossover Study to Assess the Local Tolerability and Safety (Multiple-dose) and to Assess the Pharmacokinetics, Safety, and Tolerability (Single-dose) of Ceftaroline in Healthy Subjects When Ceftaroline Fosamil is Diluted in Various Infusion Volume|Completed||Phase 1|34|Actual|Pfizer||6|||f||||||||||||||2017-10-11 03:04:26.496563|2017-10-11 03:04:26.496563
NCT01577576|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2015-11-27|||September 2012||2012-09-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|MediaSport||Mechanical Stress Effects on the Cardiovascular Adaptations of Peripheral Arterial Calcifications Among Athletes|Morphological, Biomechanical and Functional Properties of the Arterial Wall of Athletes: Impact and Consequences of Mechanical Stress on the Cardiovascular Adaptations of Peripheral Arterial Calcifications|Terminated||N/A|56|Actual|Centre Hospitalier Universitaire de Nīmes|||3|Inclusion curve too slow.|f||||f||||||Samples Without DNA|"     A non-fasting venous blood sample is required for the following cofactors:        -  serum protein        -  serum calcium        -  phosphorus        -  PTH        -  Vitamin D2 and D3      Left-over serum will be stored in the Nîmes University Hospital Sérotheque (serum     collection).   "|||2017-10-11 03:04:26.621528|2017-10-11 03:04:26.621528
NCT01577563|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-05-13|||May 2012||2012-05-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|RATIONAL||Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).|Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis Receiving Treatment With Non- Steroidal Anti- Inflammatory Drugs.|Completed||N/A|5383|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 03:04:26.765119|2017-10-11 03:04:26.765119
NCT01577550|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-11-15|||April 2012||2012-04-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional|||Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis|Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)|Completed||Phase 1|39|Actual|AbbVie||4|||f||||||||||||||2017-10-11 03:04:27.016356|2017-10-11 03:04:27.016356
NCT01577537|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2013-10-27||2012-10-17|March 2012||2012-03-01|October 2013|2013-10-01||||December 2012|Actual|2012-12-01||Interventional|||A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis|A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Assess the Efficacy and Safety of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis|Completed||Phase 3|251|Actual|Starpharma Pty Ltd||2|||f||||t||||||||||2017-10-11 03:04:27.163295|2017-10-11 03:04:27.163295
NCT01577524|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-07-13|||January 2012||2012-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||The Use of Diluted Povidone Iodine Irrigation in Spine Surgery|The Use of Diluted Povidone Iodine Irrigation in Spine Surgery|Terminated||Phase 2|58|Actual|Attabib, Najmedden, M.D.||2||"We had very low recruitment rates that would have resulted in several years being added to the   study to achieve an appropriate sample size."|f||||f||||||||||2017-10-11 03:04:27.247131|2017-10-11 03:04:27.247131
NCT01577511|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-06-16|||June 2012||2012-06-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2015|Actual|2015-10-01||Observational|||Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer|Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer: Molecular Characterization and Implications for Therapeutic Strategies|Active, not recruiting||N/A|60|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||Samples Without DNA|"     Peroperative blood sample plus primary and metastatic tumor biopsies.   "|||2017-10-11 03:04:27.689857|2017-10-11 03:04:27.689857
NCT01577498|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-06-09|||May 2012||2012-05-01|May 2016|2016-05-01|March 2014|Actual|2014-03-01|April 2013|Actual|2013-04-01||Observational|AGE-ADO||Age Estimation of Adolescents for Legal Purposes|Age Estimation of Adolescents for Legal Purposes: Determining the Medical Response|Completed||N/A|500|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-10-11 03:04:27.817536|2017-10-11 03:04:27.817536
NCT01577485|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2013-01-03|||August 2012||2012-08-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||LGG/BB12-pastille Study|LGG/BB12-pastille Study|Completed||Phase 1|60|Actual|University of Turku||2|||f||||f||||||||||2017-10-11 03:04:27.906945|2017-10-11 03:04:27.906945
NCT01577472|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-09-28|||August 2013||2013-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CANTAPOR||Efficacy Study Comparing the Effect of Clomiphencitrate to an Antagonist Protocol|Prospective Randomized Phase IV Study Comparing the Effect of Adding Clomiphencitrate Versus Placebo to a High Dose Versus a Minimal Dose GnRH Antagonist Protocol on the Number of Oocytes Collected From Women That Are Poor Responders|Recruiting||Phase 4|120|Anticipated|University Hospital, Basel, Switzerland||4|||f||||t||||||||||2017-10-11 03:04:27.993277|2017-10-11 03:04:27.993277
NCT01577459|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-10-04|||April 23, 2012|Actual|2012-04-23|October 2017|2017-10-01|June 15, 2012|Actual|2012-06-15|June 15, 2012|Actual|2012-06-15||Interventional|||A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response|A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response to Pseudoephedrine Concurrent With Placebo or TR 701 FA|Completed||Phase 1|18|Actual|Trius Therapeutics LLC||2|||f||||f||||||||||2017-10-11 03:04:28.10928|2017-10-11 03:04:28.10928
NCT01577446|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-10-15|||January 2008||2008-01-01|October 2016|2016-10-01||||August 2012|Actual|2012-08-01||Interventional|NARROW-CRT||Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy (NARROW CRT)|Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy|Completed||N/A|120|Actual|Ospedale Santa Maria di Loreto Mare||2|||f||||||||||||||2017-10-11 03:04:28.19355|2017-10-11 03:04:28.19355
NCT01577433|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-12-06|||May 2012||2012-05-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|SSI||Driveline Silicone Skin Interface Registry|Driveline Silicone Skin Interface (SSI) Registry|Active, not recruiting||N/A|400|Anticipated|St. Jude Medical|||2||f||||f||||||||||2017-10-11 03:04:28.269141|2017-10-11 03:04:28.269141
NCT01577420|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2012-04-12|||August 2005||2005-08-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|April 2010|Actual|2010-04-01||Interventional|||Reflexology: An Intervention for Advanced Breast Cancer|Reflexology: An Intervention for Advanced Breast Cancer|Completed||N/A|451|Actual|Michigan State University||3|||f||||t||||||||||2017-10-11 03:04:28.380314|2017-10-11 03:04:28.380314
NCT01577394|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-05-20|||June 2011||2011-06-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|February 2016|Actual|2016-02-01||Interventional|OculoMacl||Oculomotor Testing in the Differential Diagnosis of Dementia|Oculomotor Recording in the Contribution to the Early Differential Diagnosis of Dementia With Lewy Bodies and Alzheimer's Disease|Completed||Phase 3|65|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-11 03:04:28.67481|2017-10-11 03:04:28.67481
NCT01577381|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-02-16|2015-12-09|2015-11-06|August 2012||2012-08-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration|A Phase 2 Multi-center, Randomized, Double-masked, Placebo-controlled, Multi-dose Study To Investigate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of Rn6g (Pf-04382923) In Subjects With Geographic Atrophy Secondary To Age-related Macular Degeneration|Terminated||Phase 2|10|Actual|Pfizer|The study was terminated early due to an organizational decision, which was not based on safety or efficacy concerns. As only 10 participants enrolled at the time of termination, there were not enough subjects or data to perform meaningful analyses.|2||See termination reason in detailed description.|f||||t||||||||||2017-10-11 03:04:28.816958|2017-10-11 03:04:28.816958
NCT01577368|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-09-19|||May 2011||2011-05-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|January 2014|Actual|2014-01-01||Interventional|PiperTazo||Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa|Efficacy and Safety of Piperacillin-Tazobactam Continuous Infusion vs Intermittent Infusion for Complicated or Nosocomial Pseudomonas Aeruginosa Infection or Suspected Infection|Completed||Phase 3|76|Actual|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla||2|||f||||f||||||||||2017-10-11 03:04:30.112898|2017-10-11 03:04:30.112898
NCT01577355|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-07-02|||April 2012||2012-04-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of LY2784544 in Healthy Male Subjects|Disposition of [14C]-LY2784544 Following Oral Administration in Healthy Male Subjects|Completed||Phase 1|8|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:04:30.229437|2017-10-11 03:04:30.229437
NCT01577342|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-04-12|||November 2010||2010-11-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora|Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora|Completed||N/A|56|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:04:30.328869|2017-10-11 03:04:30.328869
NCT01577329|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-04-21|2016-11-22||October 2011||2011-10-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|May 2013|Actual|2013-05-01||Interventional|||Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD)|Mindfulness Mediation Intervention in COPD|Completed||N/A|41|Actual|University of Michigan||2|||f||||f||||||||Undecided||2017-10-11 03:04:30.430579|2017-10-11 03:04:30.430579
NCT01577316|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-04-12|||April 2012||2012-04-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|VACINFL2011||Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant Women|Clinical Trial to Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant Women|Unknown status|Not yet recruiting|Phase 2/Phase 3|240|Anticipated|Instituto Nacional de Salud Publica, Mexico||2|||f||||t||||||||||2017-10-11 03:04:30.727827|2017-10-11 03:04:30.727827
NCT01577303|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-10-29|||April 2012||2012-04-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Treatment of Social Phobia With Cognitive Bias Modification|Reduction of Social Phobia Symptoms With Internet-Based Cognitive Bias Modification|Completed||N/A|129|Actual|Umeå University||6|||f||||f||||||||||2017-10-11 03:04:30.827715|2017-10-11 03:04:30.827715
NCT01577290|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-10-29|||March 2012||2012-03-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|June 2013|Actual|2013-06-01||Interventional|||An Internet-administered, Mindfulness Training Program for the Treatment of Anxiety|An Internet-administered, Mindfulness Training Program for the Treatment of Anxiety|Completed||N/A|91|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 03:04:30.930844|2017-10-11 03:04:30.930844
NCT01577277|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-03-03|||May 2011||2011-05-01|March 2017|2017-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||OPUS School Meal Study - Cross Sectional Analyses From Baseline Investigations|OPUS(Optimal Well-being, Development and Health for Danish Children Through a Healthy New Nordic Diet) School Meal Study - - Cross Sectional Analyses From Baseline Investigations|Completed||N/A|834|Actual|University of Copenhagen|||1||f||||f||||||Samples With DNA|"     serum and white cells   "|||2017-10-11 03:04:31.267828|2017-10-11 03:04:31.267828
NCT01577264|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2015-11-09|||August 2011||2011-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)|Observational Study to Evaluate the Safety and Effectiveness of Cimzia in Rheumatoid Arthritis and Crohn's Disease Patients When Using a Comprehensive Program of Tuberculosis Screening and Monitoring|Terminated||N/A|199|Actual|UCB Pharma|||1|"Study is replaced by some Risk Manag. Activities covering the whole Russian Federation. Primary   objectives could not be met due to critical missing information."|f||||f||||||||||2017-10-11 03:04:31.384272|2017-10-11 03:04:31.384272
NCT01577251|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2016-09-23|||June 2008||2008-06-01|September 2016|2016-09-01||||June 2018|Anticipated|2018-06-01||Observational|||Registry and Biosample Repository|Registry and Biosample Repository|Recruiting||N/A|2500|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-11 03:04:31.589729|2017-10-11 03:04:31.589729
NCT01577238|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2013-10-27||2012-10-17|March 2012||2012-03-01|October 2013|2013-10-01||||December 2012|Actual|2012-12-01||Interventional|||A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis|A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Assess the Efficacy and Safety of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis|Completed||Phase 3|250|Actual|Starpharma Pty Ltd||2|||f||||t||||||||||2017-10-11 03:04:31.670215|2017-10-11 03:04:31.670215
NCT01577225|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2017-04-24|||November 2011||2011-11-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|OPOV||OPSITE Post-Op Visible Wound Dressings in Treatment of Surgical Incisions|A Prospective, Open, Randomised Controlled Trial to Compare OPSITE Post-Op Visible Wound Dressings With Standard Therapy in the Treatment of Surgical Incisions.|Completed||N/A|100|Actual|Smith & Nephew Medical (Shanghai) Ltd||2|||f||||f||||||||No||2017-10-11 03:04:31.774648|2017-10-11 03:04:31.774648
NCT01577212|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-11-06|||March 2012||2012-03-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|IDEAL-VMAT||Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy|Individualized Dose Escalation for Non-small Cell Lung Cancer (NSCLC) Using Volumetric Modulated Arc Therapy (VMAT)|Terminated||Phase 2|6|Actual|Radboud University||1||Lack of accrual|f||||t||||||||||2017-10-11 03:04:31.889111|2017-10-11 03:04:31.889111
NCT01577199|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-12-15|||April 2012||2012-04-01|December 2016|2016-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|CLOVANT||RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders|Randomized Prospective Controlled Non-inferiority Trial of Low-dose Clomiphene Based Antagonist Protocol vs. High Dose Gonadotropin/Antagonist Protocol for IVF Poor Responders|Withdrawn||Phase 4|0|Actual|Weill Medical College of Cornell University||2||no subjects recruited|f||||f||||||||No||2017-10-11 03:04:32.000831|2017-10-11 03:04:32.000831
NCT01577186|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2013-12-02|2013-12-02||July 2008||2008-07-01|December 2013|2013-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)|Symptomatic Remission and Social Function in Patients Treated With Paliperidone ER|Completed||Phase 4|480|Actual|Johnson & Johnson Taiwan Ltd|Some Adverse Events summaries were reported based on estimates due to the fact that they were not prepared in the original study report and the relevant definitions of the data elements were not available for these summaries to be regenerated.|1|||f||||f||||||||||2017-10-11 03:04:32.20463|2017-10-11 03:04:32.20463
NCT01577173|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-11-01||2016-07-12|July 2012||2012-07-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck|A Phase II, Open-Label, Randomized Study of MEDH7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck Who Have Progressed During or Following Platinum-based Chemotherapy|Completed||Phase 2|122|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:04:32.580175|2017-10-11 03:04:32.580175
NCT01577160|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2013-11-25|2013-11-25||May 2008||2008-05-01|November 2013|2013-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia|An Open Label, Prospective, Non-Comparative Study to Evaluate Flexible Dose of Paliperidone ER and Clinical Response in the Treatment of Subjects With Schizophrenia|Completed||Phase 4|353|Actual|Johnson & Johnson Taiwan Ltd|Some Adverse Events summaries were reported based on estimates due to the fact that they were not prepared in the original study report and the relevant definitions of the data elements were not available for these summaries to be regenerated.|1|||f||||f||||||||||2017-10-11 03:04:32.884101|2017-10-11 03:04:32.884101
NCT01577147|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-04-18|||January 2012|Actual|2012-01-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|March 2017|Actual|2017-03-01||Interventional|EPS||Early Pregnancy Sample Collection Study|Generic Protocol for the Collection of Early Pregnancy Urines|Active, not recruiting||N/A|4025|Actual|SPD Development Company Limited||1|||f||||f||||||||||2017-10-11 03:04:33.261377|2017-10-11 03:04:33.261377
NCT01577134|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-03-26|||April 2012||2012-04-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|August 2013|Actual|2013-08-01||Interventional|PREFER||Personal Resources of Elderly People With Multimorbidity|Personal Resources of Elderly People With Multimorbidity: Fortification of Effective Health Behaviour|Completed||N/A|310|Actual|German Centre of Gerontology||3|||f||||t||||||||||2017-10-11 03:04:33.353646|2017-10-11 03:04:33.353646
NCT01577121|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-10-20|||April 2012||2012-04-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|INDOGEST||Evaluation of the Use of Indomethacin as Co-treatment in Women With Preterm Labor and High Risk of Intraamniotic Inflammation|Evaluation of the Utility of Indomethacin as Support Treatment in Women With Preterm Labor With Intact Membranes and High Risk of Intraamniotic Inflammation|Completed||Phase 2|16|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||f||||||||||2017-10-11 03:04:33.476794|2017-10-11 03:04:33.476794
NCT01577108|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-02-13|2016-03-06||April 2011||2011-04-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|September 2012|Actual|2012-09-01||Interventional|||Oral Probiotics Reduce Group B Streptococci Colonization in Pregnant Women|Oral Probiotics Lactobacillus Rhamnosus GR-1 and Lactobacillus Reuteri RC-14 Reduce Group B Streptococci Colonization in Pregnant Women|Completed||N/A|110|Actual|China Medical University Hospital||2|||f||||t||||||||No||2017-10-11 03:04:33.607918|2017-10-11 03:04:33.607918
NCT01577095|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-04-12|||April 2006||2006-04-01|April 2012|2012-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy|A Randomized Controlled Trial Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy on Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|49|Actual|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 03:04:33.985178|2017-10-11 03:04:33.985178
NCT01577082|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2017-03-28|||April 2012||2012-04-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients|A 12-week, Multinational, Multicentre, Randomised, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of CHF 1535 200/6µg Versus Beclomethasone Dipropionate in Adult Asthmatic Patients Not Adequately Controlled on High Dose of Inhaled Corticosteroids or on Medium Dose of Inhaled Corticosteroids Plus Long-acting β2 Agonists|Completed||Phase 3|542|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 03:04:34.103011|2017-10-11 03:04:34.103011
NCT01577069|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-12|2016-06-21|||February 2011||2011-02-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|GENUPI||Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir|Predictive Factors of the Treatment Failure in HCV Mono-infected Patients Treated With Pegylated-interferon/Ribavirin/Telaprevir.|Completed||N/A|73|Anticipated|Association HGE CHU Bordeaux Sud|||1||f||||f||||||||||2017-10-11 03:04:34.204321|2017-10-11 03:04:34.204321
NCT01577056|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-11|||April 2012||2012-04-01|April 2012|2012-04-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|FIFH||Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils|Effect of Fish Oil Supplementation on Postprandial Lipid Metabolism in Familial Hypercholesterolaemia|Unknown status|Not yet recruiting|N/A|30|Anticipated|The University of Western Australia||2|||f||||f||||||||||2017-10-11 03:04:34.283729|2017-10-11 03:04:34.283729
NCT01577017|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-06-13|||May 2008||2008-05-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|May 2009|Actual|2009-05-01||Interventional|||The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)|Study On The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)|Completed||Phase 3|150|Actual|University of Science Malaysia||1|||f||||t||||||||||2017-10-11 03:04:34.6034|2017-10-11 03:04:34.6034
NCT01577004|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-04-11|||July 2009||2009-07-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Do Apolipoprotein E Polymorphisms Influence Risk of Cognitive Decline by Modulating Omega-3 Fatty Acid Metabolism?|Do Apolipoprotein E Polymorphisms Influence Risk of Cognitive Decline by Modulating Omega-3 Fatty Acid Metabolism?|Completed||N/A|40|Actual|Université de Sherbrooke||1|||f||||t||||||||||2017-10-11 03:04:34.693879|2017-10-11 03:04:34.693879
NCT01576991|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2013-08-09|||June 2009||2009-06-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Telomeres and Reproduction in Women|Telomeres and Reproduction in Women|Completed||N/A|145|Actual|University of South Florida|||1||f||||t||||||Samples With DNA|"     Blood, Follicle cells, and or polar body of eggs   "|||2017-10-11 03:04:34.774323|2017-10-11 03:04:34.774323
NCT01576978|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-04-11|||June 2009||2009-06-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Hatha Yoga Exercises in Pelvic and Lumbar Back Pain in Pregnant Woman|Hatha Yoga Exercises in Pelvic and Lumbar Back Pain in Pregnant Woman|Completed||N/A|60|Actual|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-11 03:04:34.856126|2017-10-11 03:04:34.856126
NCT01576965|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-03-10|||April 2012||2012-04-01|February 2015|2015-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Mechanical Bowel Preparation Before Laparoscopic Hysterectomy and Laparoscopic Sacrocolpopexy: a Randomized Controlled Trial|Mechanical Bowel Preparation Before Laparoscopic Hysterectomy and and Laparoscopic Sacrocolpopexy: a Randomized Controlled Trial|Completed||N/A|160|Actual|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-11 03:04:34.945463|2017-10-11 03:04:34.945463
NCT01576952|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-06-02|2016-04-26|2014-06-19|July 2012||2012-07-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|ISV-303|Modified Intent-to-Treat: subjects who were randomized into the trial, underwent cataract surgery, and received at least one dose of study drug.|Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects|A Randomized Double-Masked Study to Compare the Ocular Safety, Tolerability, and Efficacy of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects|Completed||Phase 3|268|Actual|InSite Vision||2|||f||||||||||||||2017-10-11 03:04:35.060328|2017-10-11 03:04:35.060328
NCT01576939|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-05-16|2016-12-08||August 2011||2011-08-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|January 2014|Actual|2014-01-01||Interventional|||Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer|A Feasibility Study of IMRT (Intensity Modulated Radiotherapy) Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer Patients|Completed||N/A|30|Actual|Stanford University||1|||f||||t||||||||No||2017-10-11 03:04:35.31444|2017-10-11 03:04:35.31444
NCT01576926|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2012-04-11|||March 2009||2009-03-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Observational|||Evolution of Swallowing in Patients Undergoing Lateral Pharyngoplasty With Preservation Stylopharyngeal Muscle|Evolution of Swallowing in Patients Undergoing Lateral Pharyngoplasty With Preservation Stylopharyngeal Muscle|Completed||N/A|1|Actual|Hospital do Servidor Publico Estadual|||1||f||||t||||||||||2017-10-11 03:04:35.669556|2017-10-11 03:04:35.669556
NCT01576913|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2014-11-22|||April 2012||2012-04-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Music Pacing in Pediatric Exercise Testing|Music Pacing in Pediatric Exercise Testing|Completed||N/A|20|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 03:04:35.959821|2017-10-11 03:04:35.959821
NCT01576900|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-11-19|||April 2012||2012-04-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia||Completed||N/A|124|Actual|Seoul National University Hospital|||2||f||||t||||||||||2017-10-11 03:04:36.044441|2017-10-11 03:04:36.044441
NCT01576887|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-11-01|||July 2012||2012-07-01|November 2012|2012-11-01|October 2013|Anticipated|2013-10-01|October 2012|Actual|2012-10-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis||Withdrawn||Phase 2|0|Actual|Reata Pharmaceuticals, Inc.||2||IDMC recommendation for safety concerns|f||||||||||||||2017-10-11 03:04:36.143451|2017-10-11 03:04:36.143451
NCT01576874|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-03-07|||June 2012||2012-06-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|SCOR-III||The Gender-Sex Hormone Interface With Craving & Stress-Related Changes in Smoking|The Gender-Sex Hormone Interface With Craving & Stress-Related Changes in Smoking|Recruiting||N/A|180|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:04:36.234216|2017-10-11 03:04:36.234216
NCT01576861|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-10-17|||January 2007||2007-01-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure||Completed||Phase 2|28|Actual|Federico II University||2|||f||||||||||||||2017-10-11 03:04:36.338174|2017-10-11 03:04:36.338174
NCT01576848|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2012-04-12|||August 2011||2011-08-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|PRO-CARB||Impact of Carbohydrate Co-ingestion on the Post-prandial Anabolic Response of Protein in Young and Elderly Men|Impact of Carbohydrate Co-ingestion on the Post-prandial Anabolic Response of Protein in Young and Elderly Men|Completed||N/A|48|Actual|Maastricht University Medical Center||4|||f||||f||||||||||2017-10-11 03:04:36.419569|2017-10-11 03:04:36.419569
NCT01576835|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2015-08-24|||February 2012||2012-02-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|REACT||Renal Artery Contrast-Free Trial|Comparison of Non-contrast Renal Artery Magnetic Resonance Angiography With Contrast-enhanced CT Angiography|Completed||Phase 4|75|Actual|Central Coast Cardiovascular Research|||1||f||||t||||||||||2017-10-11 03:04:36.516291|2017-10-11 03:04:36.516291
NCT01576822|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-10-29|||November 2011||2011-11-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Sauna Detoxification Study: Pilot Feasibility|Complementary and Alternative Medicine Detoxification: Safety and Efficacy|Completed||Phase 1|10|Actual|Bastyr University||2|||f||||t||||||||||2017-10-11 03:04:36.592658|2017-10-11 03:04:36.592658
NCT01576809|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-10-18|2013-04-17||March 2012||2012-03-01|October 2013|2013-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI)|An Open Label, In-use Study to Assess the Warming Sensation, Acceptability and Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup Given as a 30 ml Single Dose in Subjects Suffering From Symptoms of an Upper Respiratory Tract Infection|Completed||Phase 3|51|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:04:36.696251|2017-10-11 03:04:36.696251
NCT01576796|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-07-27|||March 2012||2012-03-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|March 2016|Actual|2016-03-01||Interventional|RTEP-5||Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer|Phase II Study of the Efficacy and Safety of a Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Identified by F-miso PET/CT in Patients With Stage III Non-small-cell Lung Cancer (NSCLC) Not Amenable to Curative Surgical Resection Who Are Candidate for Curative Radio-chemotherapy|Active, not recruiting||Phase 2|75|Anticipated|Centre Henri Becquerel||1|||f||||f||||||||||2017-10-11 03:04:37.045808|2017-10-11 03:04:37.045808
NCT01576783|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-07-11|||April 2012||2012-04-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|April 2017|Actual|2017-04-01||Interventional|||Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes|Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes|Active, not recruiting||Phase 4|377|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 03:04:37.140537|2017-10-11 03:04:37.140537
NCT01576757|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-06-28|||April 2011||2011-04-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Harvest, Isolation and Culture of Cardiac Stem Cells From Endomyocardial Biopsies|Harvest, Isolation and Culture of Cardiac Stem Cells From Endomyocardial Biopsies|Enrolling by invitation||N/A|30|Anticipated|University of Louisville|||1||f||||f||||||Samples With DNA|"     Biopsy samples are taken at the time of right heart catheterization. They are frozen in a GMP     facility at the University of Louisville. The tissue is shipped either to the Institue of     Molecular Caridology, Louisville, KY or shipped overnight to the Brigham and Women's Hospital     in Boston, MA. The tissue is enzymatically dissociated, and cardiac stem cells are isolated     and maintained in culture for 6-8 passages (point of clinical utility). During that time     period, experimentation is carried out to charcterize the biological attributes of these cell     populations. After this experimentation is complete, the cultures are destroyed in accordance     with the biohazard handling policies of the individual institution.   "|||2017-10-11 03:04:37.398517|2017-10-11 03:04:37.398517
NCT01576744|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-06-01|||March 2010||2010-03-01|June 2012|2012-06-01||||June 2012|Anticipated|2012-06-01||Observational|FHE4||Serum Biomarker HE4 During IVF Treatment|Serum Concentration of HE4, a New Marker for Ovarian Cancer, Changes Little Throughout IVF Stimulation|Unknown status|Active, not recruiting|N/A|20|Actual|Turku University Hospital|||1||f||||f||||||Samples Without DNA|"     Repeated serum samples   "|||2017-10-11 03:04:37.490358|2017-10-11 03:04:37.490358
NCT01576731|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-03-31|||July 2012||2012-07-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|RAL-PEP||Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)|Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir|Completed||Phase 4|240|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 03:04:37.562032|2017-10-11 03:04:37.562032
NCT01576718|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-05-02|2017-02-28|2015-03-19|April 2012||2012-04-01|May 2017|2017-05-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional||Intent to treat analysis set|A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications|A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fp Spiromax® (Fluticasone Propionate Inhalation Powder) Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Severe Persistent Asthma Uncontrolled on High Dose Inhaled Corticosteroid Therapy|Completed||Phase 2|889|Actual|Teva Pharmaceutical Industries||6|||f||||f||||||||||2017-10-11 03:04:37.754341|2017-10-11 03:04:37.754341
NCT01576692|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-03-30|||April 2012||2012-04-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|October 2014|Actual|2014-10-01||Interventional|||Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma|A Safety/Feasibility Trial of the Addition of the Humanized Anti-GD2 Antibody (hu14.18K322A) With and Without Natural Killer Cells to Chemotherapy in Children and Adolescents With Recurrent/Refractory Neuroblastoma|Active, not recruiting||Phase 1|34|Actual|St. Jude Children's Research Hospital||1|||f||||f|t|t|t|f||||||2017-10-11 03:04:40.891401|2017-10-11 03:04:40.891401
NCT01576315|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-04-11|||June 2014||2014-06-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|ATCF||ATCF (Azole Therapy in Cystic Fibrosis)|Efficacy of Itraconazole and of Voriconazole in Patients With Cystic Fibrosis and Presenting With Persistent Positive Sputums for Aspergillus.|Completed||Phase 2|11|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 03:04:47.995044|2017-10-11 03:04:47.995044
NCT01576679|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-05-02|||March 2012||2012-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study|A Double Blind, Randomized Controlled Trial Examining the Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-abdominal Collections in Children - a Prospective Study|Suspended||Phase 3|50|Anticipated|The Hospital for Sick Children||2||Slow accrual. Interim analysis|f||||t||||||||No||2017-10-11 03:04:40.994323|2017-10-11 03:04:40.994323
NCT01576666|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-02-18|||July 2012||2012-07-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors|A Phase Ib, Multi-center, Open Label, Dose Escalation Study of Oral LDE225 in Combination With BKM 120 in Patients With Advanced Solid Tumors|Completed||Phase 1|120|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:04:41.094069|2017-10-11 03:04:41.094069
NCT01576653|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-09-20|||June 2011||2011-06-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|||Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL|Prospective Clinical Evaluation of Bata-D-Glucan Assay for Diagnosis of Invasive Fungal Infection in Blood and Bronchoalveolar Lavage|Recruiting||N/A|100|Anticipated|Medical University of Graz||2|||f||||f||||||||||2017-10-11 03:04:43.025595|2017-10-11 03:04:43.025595
NCT01576640|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2015-05-19|||December 2005||2005-12-01|May 2015|2015-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia|An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia|Terminated||Phase 4|17|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:04:43.13606|2017-10-11 03:04:43.13606
NCT01576627|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2013-01-03|||March 2012||2012-03-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|||Zinc Absorption From Zinc Citrate, Zinc Gluconate and Zinc Oxide|Zinc Absorption From Zinc Supplements Comparing Zinc Citrate to Zinc Gluconate and Zinc Oxide in Young Adults|Completed||N/A|15|Actual|Swiss Federal Institute of Technology||3|||f||||f||||||||||2017-10-11 03:04:43.230463|2017-10-11 03:04:43.230463
NCT01576614|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2013-09-24|||August 2011||2011-08-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|||The Role of Off-shift Robotic Telerounding Between Physicians and Nurses in the Surgical Intensive Care Unit|A Prospective Randomized Study on the Role of Off-shift Robotic Telerounding on the Collaboration Between Physicians and Nurses in the Surgical Intensive Care Unit|Completed||N/A|35|Actual|Lahey Clinic|||2||f||||f||||||||||2017-10-11 03:04:43.325037|2017-10-11 03:04:43.325037
NCT01576601|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-11|||August 2011||2011-08-01|April 2012|2012-04-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||The Management of Postoperative Craniotomy Pain in Pediatric Patients|The Management of Postoperative Craniotomy Pain in Pediatric Patients: A Prospective Cohort Study|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Johns Hopkins University|||3||f||||f||||||||||2017-10-11 03:04:43.412642|2017-10-11 03:04:43.412642
NCT01576588|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-12-09|||October 2011||2011-10-01|December 2014|2014-12-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||Rituximab in Pretreated Elderly or Unfit B-CLL Patients|Study of Rituximab in Addition to Glucocorticoid in Pretreated Elderly or Unfit Patients With Chronic B Lymphocytic Leukemia|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Vilnius University||1|||f||||f||||||||||2017-10-11 03:04:43.491397|2017-10-11 03:04:43.491397
NCT01576575|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-06-16|||June 2010||2010-06-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BUP||Buprenorphine Disposition and Clinical Effects|Influence of CYP3A Modulation on Buprenorphine Disposition and Clinical Effects|Recruiting||N/A|25|Anticipated|Washington University School of Medicine||7|||f||||t||||||||||2017-10-11 03:04:43.578926|2017-10-11 03:04:43.578926
NCT01576562|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-08-07|||February 2014|Actual|2014-02-01|August 2017|2017-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Implantable Cardioverter Defibrillator (ICD) Function During Ventricular Assist Device (VAD) Implantation|Implantable Cardioverter Defibrillator (ICD) Function During Ventricular Assist Device (VAD) Implantation|Completed||N/A|37|Actual|Virginia Commonwealth University|||1||f||||f||||||||||2017-10-11 03:04:43.704001|2017-10-11 03:04:43.704001
NCT01576549|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2013-09-27||2013-09-27|May 2012||2012-05-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of LY2127399 in Rheumatoid Arthritis|An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies|Completed||Phase 2|36|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:04:43.775056|2017-10-11 03:04:43.775056
NCT01576536|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-05-08|||July 2012||2012-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Genetic Variation in Platelet Aggregation|Genetic Variation in Platelet Aggregation|Active, not recruiting||N/A|118|Actual|Vanderbilt University Medical Center|||1||f||||f||||||Samples With DNA|"     Blood samples for DNA and plasma/serum for subsequent biomarker analysis if required.   "|||2017-10-11 03:04:44.004952|2017-10-11 03:04:44.004952
NCT01576523|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-07-27||2014-01-28|April 2012||2012-04-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route|An Open-label, Cross-over, Dose-ranging Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of the Subcutaneous Administration of a Human Plasma-derived C1-esterase Inhibitor in Subjects With Hereditary Angioedema|Completed||Phase 1/Phase 2|18|Actual|CSL Behring||6|||f||||||||||||||2017-10-11 03:04:44.114013|2017-10-11 03:04:44.114013
NCT01576510|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-06-23|||August 2010||2010-08-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||fMRI Predictors of Treatment Response in Posttraumatic Stress Disorder (PTSD)|Brain Circuitry and Psychosocial Predictors of PTSD|Completed||N/A|95|Actual|Research Foundation for Mental Hygiene, Inc.||2|||f||||f||||||||||2017-10-11 03:04:44.290886|2017-10-11 03:04:44.290886
NCT01576497|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2014-05-28|||April 2012||2012-04-01|April 2012|2012-04-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||Optimal Number of To-and-fro Motion in EUS-guided Fine Needle Aspiration for Pancreatic Masses|Optimal Number of To-and-fro Motion in EUS-guided Fine Needle Aspiration for Pancreatic Masses in Terms of Suction or Without Suction: Prospective Randomized Single Blinded Trial|Completed||Phase 3|193|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 03:04:44.400701|2017-10-11 03:04:44.400701
NCT01576484|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-01-19|||March 2012||2012-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Open-Label Extension of Study R727-CL-1003 to Evaluate the Long-Term Safety and Efficacy of REGN727 (SAR236553) in Patients With Hypercholesterolemia|A Phase 2, Open-Label Extension of Study R727-CL-1003 to Evaluate the Long-Term Safety and Efficacy of REGN727 Administered by Subcutaneous Injection in Patients With Heterozygous Familial Hypercholesterolemia|Completed||Phase 2|58|Actual|Regeneron Pharmaceuticals||1|||f||||t||||||||||2017-10-11 03:04:44.540498|2017-10-11 03:04:44.540498
NCT01576471|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-05-30|2017-04-03||July 2012||2012-07-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|TRUST-I||Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo|A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease|Completed||Phase 2|250|Actual|Coronado Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 03:04:44.731331|2017-10-11 03:04:44.731331
NCT01576458|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2012-04-11|||January 1998||1998-01-01|April 2012|2012-04-01|December 1998|Actual|1998-12-01|December 1998|Actual|1998-12-01||Interventional|||Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy|Randomised Placebo-controlled Study of Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy|Completed||Phase 3|20|Actual|Turku University Hospital||2|||f||||t||||||||||2017-10-11 03:04:45.438599|2017-10-11 03:04:45.438599
NCT01576445|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-10|||March 2010||2010-03-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Functional Outcome in Two Types of Total Knee Replacement Surgery for People With Osteoarthritis|Randomised Controlled Trial to Compare the Speed of Recovery and Functional Outcome Following Total Knee Replacement (TKR) Using a Quadriceps Sparing Approach to the Knee Against a Standard Medial Parapatellar Surgical Exposure|Completed||Phase 2|30|Actual|Queen Margaret University||2|||f||||f||||||||||2017-10-11 03:04:45.541881|2017-10-11 03:04:45.541881
NCT01576432|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-04-10|||January 2011||2011-01-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Interventional|||Non-pharmacological Analgesia During Heel Prick|Non-pharmacological Analgesia During Heel Prick: A Randomized, Controlled Trial|Terminated||N/A|136|Actual|Puerta de Hierro University Hospital||4||The data showed that pain was higher for our standardized method of sampling|f||||f||||||||||2017-10-11 03:04:45.634564|2017-10-11 03:04:45.634564
NCT01576419|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-10|||January 2010||2010-01-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Interventional|||Active Drug Comparative, Multi-center, phase3 Clinical Study to Evaluate the Efficacy and Safety of PG201 in Osteoarthritis Patients|Double Blinded, Randomized, Active Drug Comparative, Multi-center, phase3 Clinical Study to Evaluate the Efficacy and Safety of PG201 in Osteoarthritis Patients|Completed||Phase 3|309|Actual|PMG Pharm Co., Ltd||2|||f||||t||||||||||2017-10-11 03:04:45.764917|2017-10-11 03:04:45.764917
NCT01576393|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2015-09-20|||August 2009||2009-08-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional|||Adolescent Involvement in Parental Substance Abuse Treatment|Adolescent Involvement in Parental Substance Abuse Treatment: Evaluation of EBFT|Completed||Phase 1/Phase 2|183|Anticipated|Ohio State University||3|||f||||f||||||||||2017-10-11 03:04:46.213843|2017-10-11 03:04:46.213843
NCT01576380|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-02-23|||June 2012||2012-06-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients|A Single-arm, Multi-center, Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Adult Patients With Advanced Scirrhous Gastric Carcinoma That Have Progressed After One or Two Prior Systemic Treatments|Completed||Phase 2|11|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:04:46.31669|2017-10-11 03:04:46.31669
NCT01576367|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-06-22|2016-06-22||January 2012||2012-01-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease|An Open-label Extension Study to Assess Efficacy, Safety and Tolerability of Canakinumab and the Efficacy and Safety of Childhood Vaccinations in Patients With Cryopyrin Associated Periodic Syndromes (CAPS)|Completed||Phase 3|17|Actual|Novartis||1|||f||||t||||||||||2017-10-11 03:04:46.499497|2017-10-11 03:04:46.499497
NCT01576354|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-12-03|||March 2012||2012-03-01|December 2015|2015-12-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|FAMPKIN||Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis|A Phase IIb, Double-blind, Randomized, Mono-center, Placebo-controlled Study With Crossover Design Characterizing the Effects of Prolonged-release Fampridine Treatment on Ambulatory Function in Patients With Multiple Sclerosis Using Detailed Gait Analysis Based on Kinematic and Kinetic Parameters|Active, not recruiting||Phase 2|70|Anticipated|University of Zurich||2|||f||||||||||||||2017-10-11 03:04:47.015779|2017-10-11 03:04:47.015779
NCT01576341|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-04-04|2017-04-03||April 2012||2012-04-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|SENSE|Safety population: The safety population consists of all patients that received at least one dose of study drug|HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)|Open Label, Single Arm, Multicenter Study to Evaluate the Safety and Immunogenicity of HX575 Epoetin Alfa in the Treatment of Anemia Associated With Chronic Kidney Disease in Pre-dialysis and Dialysis Patients|Completed||Phase 3|417|Actual|Sandoz||1|||f||||f||||||||||2017-10-11 03:04:47.135522|2017-10-11 03:04:47.135522
NCT01576328|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2016-10-12|||April 2012||2012-04-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes|A Randomized, Placebo-Controlled Dose-Escalation Study to Assess the Safety and Tolerability of a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Type 2 Diabetes Sub-optimally Controlled on Metformin|Completed||Phase 1/Phase 2|61|Actual|Mesoblast, Ltd.||3|||f||||t||||||||||2017-10-11 03:04:47.866287|2017-10-11 03:04:47.866287
NCT01576302|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2014-12-08|||April 2012||2012-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Diaphragmatic Breathing and Muscle Relaxation for Rumination|Diaphragmatic Breathing and Progressive Muscle Relaxation: Behavioral Interventions for Gastrointestinal Rumination|Completed||Phase 3|13|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:04:48.126316|2017-10-11 03:04:48.126316
NCT01576289|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2012-07-23|||November 2011||2011-11-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|histoGERD||Analysis of Biopsies From the Upper Gastrointestinal Tract|Clinical Evaluation and Histological Analysis of Biopsies From the Upper Gastrointestinal Tract of Patients With and Without Symptoms of Reflux Disease (histoGERD Trial)|Completed||N/A|600|Anticipated|Medical University of Graz|||1||f||||f||||||Samples With DNA|"     Biopsy specimens (formalin fixed and paraffin embedded) which are routinely obtained during     the endoscopic procedure are retained according to legal requirements.   "|||2017-10-11 03:04:48.314586|2017-10-11 03:04:48.314586
NCT01576276|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-08-18|||April 2012|Actual|2012-04-01|August 2017|2017-08-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||A Brain Imaging Study of Opioid (Morphine) and Non-opioid (Ketorolac) Conditioning Effects|A Brain Imaging Study of Opioid (Morphine) and Non-opioid (Ketorolac) Conditioning Effects|Completed||N/A|86|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 03:04:48.40956|2017-10-11 03:04:48.40956
NCT01576263|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-04-09|||March 2010||2010-03-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Observational|||Autologous Blood Transfusion After Local Infiltration|Autologous Blood Transfusion After Local Infiltration Analgesia With Ropivacaine in Total Knee and Hip Arthroplasty|Completed||Phase 2|52|Actual|Northern Orthopaedic Division, Denmark|||2||f||||f||||||Samples Without DNA|"     Venous blood to collect an analysis of total ropivacaine concentrations.   "|||2017-10-11 03:04:48.507559|2017-10-11 03:04:48.507559
NCT01576250|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2015-05-27|||April 2012||2012-04-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of Lowered Physical Activity on Insulin Sensitivity and Lipid and Glucose Metabolism|The Effect of Lowered Physical Activity (Induced by Lower Limb Suspension (ULLS)) on Insulin Sensitivity and Lipid and Glucose Metabolism|Completed||N/A|13|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 03:04:48.605992|2017-10-11 03:04:48.605992
NCT01576237|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2015-02-24|||February 2012||2012-02-01|April 2012|2012-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Multinational Haemapheresis Vigilance Study|Open Prospective Multi-national Long-term Study to Register Adverse Events Related to Hemaphereses by Means of an Internet-based Haemapheresis Vigilance Questionnaire|Unknown status|Active, not recruiting|N/A|50000|Anticipated|DGTI - Haemapheresis Vigilance Working Party|||1||f||||t||||||||||2017-10-11 03:04:48.698673|2017-10-11 03:04:48.698673
NCT01576224|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2017-01-23|||January 2012||2012-01-01|January 2017|2017-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|E-MOB||Early Mobilization After Volar Plate Osteosynthesis of Distal Radius Fractures|Early Mobilization After Volar Plate Osteosynthesis of Distal Radius Fractures. A Prospective Randomized Study.|Completed||N/A|100|Actual|Zealand University Hospital||2|||f||||t||||||||No||2017-10-11 03:04:48.779718|2017-10-11 03:04:48.779718
NCT01576211|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-05-17|||April 2012||2012-04-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor|Investigating the Frequency of Loss of Imprinting Across a Birth Cohort and the Link DNA Methylation Plays|Completed||N/A|40|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     blood and tissue   "|||2017-10-11 03:04:48.878576|2017-10-11 03:04:48.878576
NCT01576198|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-07-13|||April 2012||2012-04-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Studying Biomarkers in Samples From Younger Patients With Wilms Tumor|Validation of Copy Number Changes by MLPA as Predictors of Relapse in Wilms Tumor|Completed||N/A|2227|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:04:48.955761|2017-10-11 03:04:48.955761
NCT01576185|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2016-05-13|||May 2012||2012-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia|Development of Pediatric Acute Myeloid Leukemia Xenograft Models for the Testing of Targeted Therapeutic Agents|Completed||N/A|10|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     tissue   "|||2017-10-11 03:04:49.057784|2017-10-11 03:04:49.057784
NCT01576172|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-11|2017-09-12|||May 21, 2012|Actual|2012-05-21|September 2017|2017-09-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer|A Randomized Gene Fusion Stratified Phase 2 Trial of Abiraterone With or Without ABT-888 for Patients With Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 2|148|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 03:04:49.166397|2017-10-11 03:04:49.166397
NCT01576159|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2015-06-09|2012-05-02||January 2008||2008-01-01|June 2015|2015-06-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Serum Cartilage Oligomeric Matrix Protein Levels After 12 Weeks of Different Exercises|The Effect of Mechanical Loading During Sports Exercises on Degradation of Human Articular Cartilage|Completed||Early Phase 1|48|Actual|Middle East Technical University||4|||f||||t||||||||||2017-10-11 03:04:49.338697|2017-10-11 03:04:49.338697
NCT01576146|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-03-01|2017-03-01|2015-07-21|March 2012||2012-03-01|March 2017|2017-03-01|May 1, 2014|Actual|2014-05-01|May 1, 2014|Actual|2014-05-01||Interventional||Baseline was defined as the baseline of the parent study, 20120331.|Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism|A Multicenter Open-label Extension Study to Assess the Long-term Safety and Efficacy of KAI-4169 (Also Known as AMG 416) in the Treatment of Chronic Kidney Disease-Mineral and Bone Disorder in Patients With Secondary Hyperparathyroidism|Terminated||Phase 2|30|Actual|KAI Pharmaceuticals||1||Study was terminated early to allow subjects to roll over to study NCT02102204.|f||||f|t|f||||||||2017-10-11 03:04:49.871714|2017-10-11 03:04:49.871714
NCT01576133|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-08-16|||April 2012||2012-04-01|August 2017|2017-08-01|May 2017|Actual|2017-05-01|April 2017|Actual|2017-04-01||Interventional|CAPABLE||Reducing Disability Via a Bundled Bio-Behavioral-Environmental Approach|Reducing Disability Via a Bundled Bio-Behavioral-Environmental Approach|Completed||Phase 2|300|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 03:04:50.359549|2017-10-11 03:04:50.359549
NCT01576120|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-10-05|2014-10-05||March 2012||2012-03-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|RD-207||Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients|Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients- Pivotal Study|Completed||Phase 1/Phase 2|40|Actual|Given Imaging Ltd.||2|||f||||f||||||||||2017-10-11 03:04:50.461662|2017-10-11 03:04:50.461662
NCT01576107|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-04-22|||April 2012||2012-04-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||MOTIVACTION - Study|Motivational Intervention Enhancing Physical Activity In Oncology Patients (MOTIVACTION)|Completed||N/A|76|Actual|German Cancer Research Center||2|||f||||||||||||||2017-10-11 03:04:50.691415|2017-10-11 03:04:50.691415
NCT01576094|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2012-04-11|||November 2009||2009-11-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Two Inodilators Postsurgery in Neonates|Phase I Study of Two Inodilators in Neonates Undergoing Cardiovascular Surgery|Completed||Phase 1/Phase 2|20|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz||2|||f||||t||||||||||2017-10-11 03:04:50.778021|2017-10-11 03:04:50.778021
NCT01576081|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-08-15|||April 2011||2011-04-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|HEP||"The Novel Unloading Device HEPHAISTOS and Its Effects Upon Bone, Muscle and Vasculature"|The Effects of a 56day Unilateral Muscular Unloading Intervention With a Novel Device That Allows Normal Ambulation While Reducing Muscle Activation Drastically, on Muscles, Bones and Vessels.|Completed||N/A|11|Actual|DLR German Aerospace Center||1|||f||||t||||||||||2017-10-11 03:04:50.879375|2017-10-11 03:04:50.879375
NCT01576068|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-04-11|||October 2010||2010-10-01|April 2012|2012-04-01|June 2013|Anticipated|2013-06-01|July 2012|Anticipated|2012-07-01||Interventional|FARMAEPOC||Chronic Obstructive Pulmonary Disease Case Finding in Community-pharmacies by Spirometry|Efficiency of COPD Case Finding Program by Spirometry in High-risk Customers of Urban Community Pharmacies|Unknown status|Active, not recruiting|Early Phase 1|3600|Anticipated|Col·legi de Farmacèutics de la Província de Barcelona||1|||f||||f||||||||||2017-10-11 03:04:50.958186|2017-10-11 03:04:50.958186
NCT01576042|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-10-06|2014-09-18||May 2012||2012-05-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|CALYPSO||Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator|Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator (CALYPSO) PILOT TRIAL|Terminated||N/A|27|Actual|Duke University||2||"Main objectives of the study were met; consensus among investigators that continuing the study   would not add new information beyond that already learned."|f||||t||||||||||2017-10-11 03:04:52.239983|2017-10-11 03:04:52.239983
NCT01576029|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2013-12-23|||August 2012||2012-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SWITCH||Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer|Phase II Randomized Study of Continuing Treatment With Docetaxel Versus Switching to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in the First Line Treatment of Patients With Castration-Resistant Metastatic Prostate Cancer.|Completed||Phase 2|2|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:04:52.95675|2017-10-11 03:04:52.95675
NCT01576016|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2016-07-20|||March 2012||2012-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|October 2014|Actual|2014-10-01||Interventional|||Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead|Accent Magnetic Resonance Imaging Pacemaker and Tendril Magnetic Resonance Imaging™ Lead Investigational Device Exemption Study|Active, not recruiting||N/A|800|Anticipated|St. Jude Medical||2|||f||||f||||||||||2017-10-11 03:04:53.087908|2017-10-11 03:04:53.087908
NCT01576003|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2015-07-28|||April 2012||2012-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants|Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants|Completed||N/A|48|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-10-11 03:04:53.358166|2017-10-11 03:04:53.358166
NCT01575990|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-05-27|||March 2012||2012-03-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|EPIC-D||Elders Preferences in Care Decisions|Improving Appropriate Colorectal Cancer Screening in Elderly Patients|Completed||N/A|424|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 03:04:53.474262|2017-10-11 03:04:53.474262
NCT01575977|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-09-25|||February 2011||2011-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Stress Analysis of Hip Dysplasia|Stress Analysis of Hip Dysplasia After Corrective Surgery|Enrolling by invitation||N/A|24|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 03:04:53.599142|2017-10-11 03:04:53.599142
NCT01575964|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-09-25|||January 2012||2012-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|FAI||Biomechanical Assessment of Femoroacetabular Impingement|Biomechanical Assessment of Femoroacetabular Impingement|Enrolling by invitation||N/A|36|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 03:04:53.689231|2017-10-11 03:04:53.689231
NCT01575951|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-04-11|||February 2010||2010-02-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection|Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection|Active, not recruiting||N/A|16|Anticipated|University of Utah||1|||f||||t|f|f||||||||2017-10-11 03:04:53.790947|2017-10-11 03:04:53.790947
NCT01575938|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-06-01|||March 2012|Actual|2012-03-01|June 2017|2017-06-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Interventional|LifeSkills||HIV Prevention Intervention for Young Transgender Women|HIV Prevention Intervention for Young Transgender Women|Completed||N/A|300|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||3|||f||||t||||||||Undecided||2017-10-11 03:04:53.887058|2017-10-11 03:04:53.887058
NCT01575925|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-07-25|||June 1, 2012|Actual|2012-06-01|July 2017|2017-07-01|June 11, 2021|Anticipated|2021-06-11|June 11, 2021|Anticipated|2021-06-11||Interventional|POM Renal||Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)|A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function|Active, not recruiting||Phase 1|25|Actual|Celgene||2|||f||||f||||||||||2017-10-11 03:04:53.987971|2017-10-11 03:04:53.987971
NCT01575912|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-06-09|2017-01-31||March 2012||2012-03-01|June 2017|2017-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Past Pain Experience and Perception of Experimental Pain|Past Pain Experience and Perception of Experimental Pain|Completed||N/A|92|Actual|Centre Hospitalier Esquirol|||3||f||||f||||||||No||2017-10-11 03:04:54.1322|2017-10-11 03:04:54.1322
NCT01575899|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-07-28|2012-04-19||December 2007||2007-12-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori|Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori.|Terminated||Phase 4|208|Actual|Buddhist Tzu Chi General Hospital|The limitation of this study is the local primary resistance of Hp to levofloxacin and to amoxicillin/clavulanate is unknown. We are currently engaged in an on-going investigation of the influence of CYP2C19 genotypes on this new regimen.|2||Early termination due to efficacy|f||||t||||||||||2017-10-11 03:04:54.441706|2017-10-11 03:04:54.441706
NCT01575886|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2012-04-10|||July 2009||2009-07-01|April 2012|2012-04-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Enhancing Teachable Moment Communication for Smoking Cessation and Weight Management|Enhancing Teachable Moment Communication for Smoking Cessation and Weight|Unknown status|Enrolling by invitation|N/A|1152|Anticipated|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 03:04:54.933403|2017-10-11 03:04:54.933403
NCT01575873|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-07-06||2017-05-17|March 28, 2012|Actual|2012-03-28|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|June 21, 2016|Actual|2016-06-21||Interventional|GIOP||A Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids|A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals|Completed||Phase 3|795|Actual|Amgen||2|||f||||t||||||||||2017-10-11 03:04:55.073975|2017-10-11 03:04:55.073975
NCT01575860|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-04-26|||April 2012||2012-04-01|April 2016|2016-04-01||||April 2017|Anticipated|2017-04-01||Interventional|||Maintenance Lenalidomide in Lymphoma|Maintenance Lenalidomide in Lymphoma|Recruiting||Phase 1/Phase 2|28|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:04:55.351797|2017-10-11 03:04:55.351797
NCT01575847|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-01-03|||August 2011||2011-08-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Observational|||Adduct Dipstick for Diagnosis of Acetaminophen Toxicity|Adduct Dipstick for Diagnosis of Acetaminophen Toxicity|Completed||N/A|120|Anticipated|Arkansas Children's Hospital Research Institute|||2||f||||f||||||Samples Without DNA|"     Acetaminophen Adduct Samples   "|||2017-10-11 03:04:55.567408|2017-10-11 03:04:55.567408
NCT01575834|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-05-09||2016-03-07|March 15, 2012|Actual|2012-03-15|April 2017|2017-04-01|December 28, 2016|Actual|2016-12-28|December 14, 2015|Actual|2015-12-14||Interventional|FRAME||Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis|A Multicenter, International, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis|Completed||Phase 3|7180|Actual|Amgen||2|||f||||t||||||||||2017-10-11 03:04:55.717185|2017-10-11 03:04:55.717185
NCT01575821|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2012-04-11|||January 2009||2009-01-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Effect of Honey on Nocturnal Cough and Sleep Quality|The Effect of Honey on Nocturnal Cough and Sleep Quality: a Double-blind, Randomized,Placebo-controlled Study|Completed||N/A|300|Actual|Meir Medical Center||4|||f||||f||||||||||2017-10-11 03:04:56.705549|2017-10-11 03:04:56.705549
NCT01575795|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2013-04-09|||April 2012||2012-04-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)|Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI): a Multi-center Randomized Parallel Pharmacodynamic Study.|Completed||Phase 4|83|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 03:04:56.96097|2017-10-11 03:04:56.96097
NCT01575782|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-07-13|||May 2014|Actual|2014-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|Chloroquine||Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer|Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer (SCLC) Patients: a Phase I Trial.|Terminated||Phase 1|5|Actual|Maastricht Radiation Oncology||1||Poor accrual|f||||f||||||||||2017-10-11 03:04:57.072095|2017-10-11 03:04:57.072095
NCT01575769|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2015-12-03|2015-08-17||March 2012||2012-03-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Safety Population included all participants who entered the study, took at least one dose of study drug, and with at least one safety follow-up, regardless of premature withdrawal.|An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis|Long-term, Interventional, Open Label Extension Study Evaluating the Safety of Tocilizumab Treatment in Patients With Polyarticular-course Juvenile Idiopathic Arthritis From Poland and Russia Who Completed the Global, Multinational Trial (WA19977).|Terminated||Phase 3|41|Actual|Hoffmann-La Roche|The study was terminated prior to the planned final on-treatment efficacy assessments due to commercial availability of tocilizumab in Russia and Poland.|1|||f||||||||||||||2017-10-11 03:04:57.249795|2017-10-11 03:04:57.249795
NCT01575756|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2016-10-05|2016-10-05||June 2013||2013-06-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Full analysis set: All randomised participants who received at least 1 infusion of study medication (Octafibrin and/or any part of an infusion of Haemocomplettan® P/RiaSTAPTM) and for whom any post-treatment data were available.|Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap|A Prospective, Controlled, Randomised, Crossover Study Investigating the Pharmacokinetic Properties, Surrogate Efficacy and Safety of Octafibrin Compared to Haemocomplettan® P/RiaSTAPTM in Patients With Congenital Fibrinogen Deficiency|Completed||Phase 2|22|Actual|Octapharma||2|||f||||f||||||||||2017-10-11 03:04:58.290961|2017-10-11 03:04:58.290961
NCT01575743|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-04-10|||March 2008||2008-03-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Aerobic Exercise on Occupational Burnout|Effects of Aerobic Exercise on Occupational Burnout|Completed||N/A|24|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 03:04:58.610794|2017-10-11 03:04:58.610794
NCT01575730|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2014-12-04|||June 2012||2012-06-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis|Phase II Study Comparing Normothermic Versus Hyperthermic Intraoperative Chemoperfusion With Oxaliplatin in Patients With Peritoneal Metastases From Appendiceal or Colon Cancer|Unknown status|Recruiting|Phase 2|24|Anticipated|University Hospital, Ghent||3|||f||||t||||||||||2017-10-11 03:04:58.681981|2017-10-11 03:04:58.681981
NCT01575704|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-03-31|||January 2011||2011-01-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|BISON||Physical Exercise Therapy in Pediatric Stem Cell Transplantation|Physical Exercise Therapy in Pediatric Stem Cell Transplantation (BISON- Bewegungstherapie in Der Pädiatrischen Stammzelltransplantation)|Completed||N/A|68|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 03:04:58.89622|2017-10-11 03:04:58.89622
NCT01575691|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2012-04-10|||July 2005||2005-07-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||Phase I 5-Azacytidine Plus VPA Plus ATRA|Phase I Study of the Combination of 5-azacytidine With Valproic Acid and All-trans Retinoic Acid in Patients With High Risk Myelodysplastic Syndrome and Acute Myelogenous Leukemia|Completed||Phase 1|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:04:58.979609|2017-10-11 03:04:58.979609
NCT01575678|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-11-01|||January 2012||2012-01-01|November 2012|2012-11-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||The Effect of Melatonin on Nocturnal Enuresis|The Effect of Melatonin on Nocturnal Enuresis|Unknown status|Recruiting|Phase 2|40|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:04:59.307104|2017-10-11 03:04:59.307104
NCT01575665|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-05-18|||February 2011||2011-02-01|May 2016|2016-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|HVMASKE||Normalizing CO2 in Chronic Hyperventilation by a Novel Breathing Mask: A Pilot Study|CO2 Rebreathing by a Partial Rebreathing Mask as a Treatment of Chronic Idiopathic Hyperventilation - a Pilot Study|Completed||N/A|6|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 03:04:59.405287|2017-10-11 03:04:59.405287
NCT01575652|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-10|||June 2008||2008-06-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients|Effects of Angiotensin Converting Enzyme Inhibitors on Peritoneal Protein Loss and Solute Transport in Peritoneal Dialysis Patients|Completed||Phase 4|43|Actual|Turkish Nephrology Association||2|||f||||f||||||||||2017-10-11 03:04:59.492947|2017-10-11 03:04:59.492947
NCT01575639|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2013-04-07|||February 2012||2012-02-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Prednisolone in Infantile Spasms- High Dose Versus Usual Dose|Randomized Trial of High Dose (4mg/kg) Versus Usual Dose (2mg/kg) Oral Prednisolone in the Treatment of Infantile Spasms.|Completed||Phase 3|63|Actual|Lady Hardinge Medical College||2|||f||||||||||||||2017-10-11 03:04:59.577808|2017-10-11 03:04:59.577808
NCT01575626|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-04-10|||May 2012||2012-05-01|April 2012|2012-04-01||||May 2013|Anticipated|2013-05-01||Interventional|||The Effect of Different Sevoflurane Concentrations on Intraocular Pressure in Patients Undergoing Ocular Surgery Under General Anesthesia||Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center||4|||f||||||||||||||2017-10-11 03:04:59.664771|2017-10-11 03:04:59.664771
NCT01575613|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-11-26|||April 2012||2012-04-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|REDHOT||Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission|Reducing the Burden of Malaria by Targeting Hotspots of Transmission and Improving Malaria Control Measures in the Highlands of Western Kenya: Simultaneous Rollout of Four Malaria Control Interventions and Evaluation by Cross-sectional Surveys|Completed||N/A|17506|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 03:04:59.752905|2017-10-11 03:04:59.752905
NCT01575600|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-05-08|||July 2010||2010-07-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Intravenous Fluid Therapy on Postoperative Vomiting in Children Undergoing Otorhinolaryngological Surgery|Effect of Intravenous Fluid Therapy on Postoperative Vomiting in Children Undergoing Otorhinolaryngological Surgery|Completed||Phase 3|100|Actual|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 03:04:59.851521|2017-10-11 03:04:59.851521
NCT01575587|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-01-09|||January 2012||2012-01-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Men|A Single-Dose, Open-Label, Randomized, 4-Way Crossover Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Male Subjects|Completed||Phase 1|51|Actual|Janssen Research & Development, LLC||4|||f||||f||||||||||2017-10-11 03:04:59.936404|2017-10-11 03:04:59.936404
NCT01575574|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-08-21|||July 2012||2012-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PRIGA||Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis|Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis|Completed||Phase 4|74|Actual|Fundacion Clinic per a la Recerca Biomédica||1|||f||||f||||||||||2017-10-11 03:05:00.068464|2017-10-11 03:05:00.068464
NCT01575561|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-07-11|2016-07-11||June 2012||2012-06-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PERSISTExt||This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296|A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder|Completed||Phase 3|377|Actual|Sunovion||1|||f||||f||||||||||2017-10-11 03:05:00.249277|2017-10-11 03:05:00.249277
NCT01575535|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2015-03-05|||April 2012||2012-04-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia|S0106B, Stem Cell Origin in AML: Prognostic and Therapeutic Implications|Completed||N/A|100|Actual|Southwest Oncology Group|||1||f||||t||||||||||2017-10-11 03:05:02.818174|2017-10-11 03:05:02.818174
NCT01575522|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2016-02-23|2015-11-12||March 2012||2012-03-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer|A Phase 2 Study of ARQ 197 in Metastatic Triple-negative Breast Cancer|Completed||Phase 2|22|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:05:02.935608|2017-10-11 03:05:02.935608
NCT01575509|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-06-14|||March 2012||2012-03-01|April 2012|2012-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Comparative Study of Effects of Berry and Grain Products on Postprandial Glycemic Response in Healthy Subjects|A Clinical, Randomized, Comparative Study of Effects of Berry and Grain Products on Postprandial Glycemic Response in Healthy Subjects|Completed||N/A|14|Actual|Clinical Life Sciences Ltd.||1|||f||||f||||||||||2017-10-11 03:05:03.235921|2017-10-11 03:05:03.235921
NCT01575496|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-08-01|||April 2012||2012-04-01|August 2012|2012-08-01||||January 2015|Anticipated|2015-01-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) for the Treatment of Tinnitus|Transcranial Direct Current Stimulation (tDCS) for the Treatment of Chronic Subjective Tinnitus|Unknown status|Enrolling by invitation|Phase 2|40|Anticipated|Centre Hospitalier Universitaire Vaudois||2|||f||||||||||||||2017-10-11 03:05:03.31324|2017-10-11 03:05:03.31324
NCT01575483|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2017-08-07|||March 1, 2012|Actual|2012-03-01|August 2017|2017-08-01|September 7, 2016|Actual|2016-09-07|September 7, 2016|Actual|2016-09-07||Observational|||Korean Post-marketing Surveillance for Onglyza®|Korean Post-marketing Surveillance for Onglyza®|Completed||N/A|3433|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:05:03.422491|2017-10-11 03:05:03.422491
NCT01575470|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2016-07-11||2016-07-07|March 2012||2012-03-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells|Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells|Completed||Phase 1/Phase 2|25|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 03:05:03.502497|2017-10-11 03:05:03.502497
NCT01575457|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2015-04-05|||June 2009||2009-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|January 2013|Actual|2013-01-01||Interventional|HF||Harriet Lane Healthy Futures Program|The Harriet Lane Clinic Healthy Futures Program is to Increase Academic or Workforce Development Success Among Adolescents and Young Adults|Completed||N/A|202|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:05:03.599356|2017-10-11 03:05:03.599356
NCT01575444|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2014-05-15|||June 2012||2012-06-01|May 2014|2014-05-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||Cervical Cancer Screening Project Part C|Minnesota Community Networks Center for Eliminating Cancer Disparities: Cervical Cancer Screening Project Part C Quantitative|Unknown status|Recruiting|N/A|60|Anticipated|Masonic Cancer Center, University of Minnesota|||2||f||||f||||||Samples With DNA|"     Home based or clinic based HPV test (Pap) collection   "|||2017-10-11 03:05:03.677343|2017-10-11 03:05:03.677343
NCT01575431|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2013-03-06|||April 2012||2012-04-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2014|Anticipated|2014-12-01||Observational|PROCREATION||Progenitor Cells Role in Restenosis and Atherosclerosis|PROgenitor Cells Role in Restenosis and Progression of Coronary ATherosclerosis After Percutaneous Coronary Intervention (PROCREATION) Study|Recruiting||N/A|200|Anticipated|University of Roma La Sapienza|||1||f||||f||||||||||2017-10-11 03:05:03.937905|2017-10-11 03:05:03.937905
NCT01575418|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-05-06|||March 2013||2013-03-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations|An Exploratory, Double-Blinded, Randomized, Pharmacokinetic and Safety Study of Three Rectally-Applied Tenofovir 1% Microbicide Gel Formulations|Completed||Phase 1|9|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 03:05:04.018285|2017-10-11 03:05:04.018285
NCT01575405|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2013-11-06|||March 2013||2013-03-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally|A Randomized, Double Blind Phase 1 Safety, Acceptability, and Pharmacokinetic Study Comparing Three Formulations of Tenofovir 1% Gel Administered Rectally to HIV-1 Seronegative Adults|Completed||Phase 1|13|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 03:05:04.120357|2017-10-11 03:05:04.120357
NCT01575210|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2013-11-25|||June 2012||2012-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:05:05.759519|2017-10-11 03:05:05.759519
NCT01575392|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-04-10|||June 2010||2010-06-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Quality Assessment Creatinines in Plasma and Urine|Quality Assessment of Creatinines in Plasma and Urine|Completed||N/A|181|Actual|Medical Research Foundation, The Netherlands|||1||f||||f||||||Samples Without DNA|"     All patients presenting at the laboratory facility for a 24-hour creatinine clearance and     patients in the dialysis population of the Isala Clinics who came for their periodical KT/V     control, were informed about the study and asked to participate. From the 24-hour urine (and     for peritoneal dialysis population also from the 24-hour peritoneal dialysate fluid) 4     samples of 4 ml were collected. Moreover, extra blood samples (16 ml in total) were drawn on     top of the samples that were necessary for the (routine) 24-hour creatinine clearance.   "|||2017-10-11 03:05:04.208528|2017-10-11 03:05:04.208528
NCT01575379|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2016-02-22|||September 2012||2012-09-01|February 2016|2016-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|PERL||A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes|A Pilot Study of Allopurinol to Prevent GFR Loss in Type 1 Diabetes.|Terminated||Phase 4|30|Actual|Joslin Diabetes Center||2||"The pivotal trial was funded by NIH. Participants were transferred to that study   (NCT02017171).."|f||||t||||||||||2017-10-11 03:05:04.275288|2017-10-11 03:05:04.275288
NCT01575366|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2013-08-16|||February 2010||2010-02-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Movement Velocity Effect on Cortical Reorganization and Finger Function in Stroke|Movement Velocity Effect on Cortical Reorganization and Finger Function in Stroke|Completed||Phase 1|5|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 03:05:04.374261|2017-10-11 03:05:04.374261
NCT01575353|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-13|2014-02-27|||December 2010||2010-12-01|February 2014|2014-02-01|November 2011|Actual|2011-11-01|May 2011|Actual|2011-05-01||Interventional|||Nasal High-flow Versus Venturi Mask Oxygen Therapy in the Post-extubation Period|Nasal High-flow Oxygen Therapy vs Standard Oxygen Therapy Via Venturi Mask in the Post-extubation Period|Completed||N/A|105|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 03:05:04.4542|2017-10-11 03:05:04.4542
NCT01575340|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2012-09-05|||July 2011||2011-07-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer|Markers of the Inflammatory Response (IL-1β, IL-10, IL-17A and TNF-α) in Patients With Colorectal Cancer in Chemotherapy Supplemented With Fish Oil|Completed||N/A|11|Actual|Universidade Federal de Santa Catarina||2|||f||||f||||||||||2017-10-11 03:05:04.537799|2017-10-11 03:05:04.537799
NCT01575327|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-01-27|||July 2012||2012-07-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|FreeO2-rehab||Closed-loop System for Oxygen Delivery and Exercise in Chronic Obstructive Pulmonary Disease|Using a Closed-loop System for Oxygen Delivery (FreeO2) to Optimize Exercise Tolerance During Walk in Patients With COPD, Oxygen Therapy and Hypercapnia|Completed||N/A|15|Actual|AGIR à Dom||2|||f||||t||||||||||2017-10-11 03:05:04.618862|2017-10-11 03:05:04.618862
NCT01575314|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2016-02-01|||November 2011||2011-11-01|February 2016|2016-02-01|July 2013|Actual|2013-07-01|September 2012|Actual|2012-09-01||Interventional|||Cost-consequence Analysis of Parenchymal Stapling Device Versus Hand-sewing for Pulmonary Lobectomy in Lung Disease|Cost-consequence Analysis of Parenchymal Stapling Device Versus Hand-sewing for Pulmonary Lobectomy in Lung Disease: A Randomized Controlled Trial|Completed||N/A|53|Actual|Chiang Mai University||2|||f||||t||||||||No||2017-10-11 03:05:04.706681|2017-10-11 03:05:04.706681
NCT01575301|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-04-11|||March 2011||2011-03-01|April 2012|2012-04-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|DIRECTGLP||DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists|DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists|Unknown status|Recruiting|N/A|800|Anticipated|University of Dundee||1|||f||||f||||||||||2017-10-11 03:05:04.876307|2017-10-11 03:05:04.876307
NCT01575288|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2015-12-09|||May 2012||2012-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults|Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults|Completed||N/A|110|Actual|University of Colorado, Boulder||2|||f||||t||||||||||2017-10-11 03:05:05.015849|2017-10-11 03:05:05.015849
NCT01575262|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-10|||March 2011||2011-03-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|PAL||The Physical Activity Loyalty Card Scheme|The Physical Activity Loyalty Card Scheme: A Randomised Controlled Trial to Encourage Physical Activity|Completed||Phase 2/Phase 3|406|Actual|Queen's University, Belfast||2|||f||||t||||||||||2017-10-11 03:05:05.266494|2017-10-11 03:05:05.266494
NCT01575249|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2012-04-10|||July 2012||2012-07-01|April 2012|2012-04-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Observational|ENIGMAS||Identification of Parameters in rapId-proGression Subgroup Patients With Moderate Aortic Stenosis|Prospective Study Focused on idEntification of cliNical, Biological and Imagistic Parameters in rapId-proGression Subgroup Patients With Moderate Aortic Stenosis|Unknown status|Not yet recruiting|N/A|200|Anticipated|Carol Davila University of Medicine and Pharmacy|||2||f||||t||||||Samples Without DNA|"     standard blood count, c-reactive protein, urea, creatinin, hepatic standard biology, serum     calcium, cholesterol and tryglicerides.   "|||2017-10-11 03:05:05.379234|2017-10-11 03:05:05.379234
NCT01575236|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-08-06|||March 2012||2012-03-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||A Randomized Non Crossover Study of the GuardianTM Versus SupremeTM Laryngeal Mask Airway|A Randomized Non Crossover Study of the GuardianTM Versus SupremeTM Laryngeal Mask Airway|Completed||Phase 3|120|Actual|Schulthess Klinik||2|||f||||t||||||||||2017-10-11 03:05:05.513526|2017-10-11 03:05:05.513526
NCT01575223|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2014-04-22|||March 2012||2012-03-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|HVSI||Saline Irrigation After Surgery in Patients With Chronic Sinusitis|The HVSI STUDY: High Volume Saline Irrigation in the Post-operative Management of Chronic Rhinosinusitis: A Multicenter Randomized Single-Blind Controlled Trial|Completed||Phase 4|86|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 03:05:05.61695|2017-10-11 03:05:05.61695
NCT01575197|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2015-05-13|2015-04-28||September 2012||2012-09-01|April 2015|2015-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||All enrolled subjects who received at least one rotavirus vaccine dose and are IgA seronegative (< 20 U/mL) at 6 (Groups 1 and 3) or 10 (Group 2) weeks of age at baseline.|Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana|Immunogenicity of the Human Rotavirus Vaccine (Rotarix™) at Varying Schedules, Doses, and Ages in Rural Ghana|Completed||Phase 4|456|Actual|PATH||3|||f||||||||||||||2017-10-11 03:05:05.825432|2017-10-11 03:05:05.825432
NCT01575184|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-12|||August 2011||2011-08-01|April 2012|2012-04-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Effect of Shoulder Traction on Size and Relative Position of Internal Jugular Vein to Carotid Artery|Effect of Shoulder Position and Head Rotation on Size and Relative Position of Internal Jugular Vein to Carotid Artery in Infants and Children|Unknown status|Recruiting|N/A|25|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 03:05:06.258059|2017-10-11 03:05:06.258059
NCT01575171|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-07-31|||September 2010||2010-09-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Using Nudges to Implement Comparative Effectiveness|Using Nudges to Implement Comparative Effectiveness: Behavioral Economics and Statins|Completed||N/A|19|Actual|New York University School of Medicine|||1||f||||t||||||||||2017-10-11 03:05:06.357585|2017-10-11 03:05:06.357585
NCT01575158|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2012-04-10|||October 1997||1997-10-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Citalopram vs Clomipramine vs Placebo in Recurrent Depression||Completed||N/A|59|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 03:05:06.443095|2017-10-11 03:05:06.443095
NCT01575145|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2016-01-08|||May 2012||2012-05-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Helping Hospitalized Patients Quit Smoking|Helping Hospitalized Patients Quit Smoking|Completed||Phase 4|600|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:05:06.525563|2017-10-11 03:05:06.525563
NCT01575132|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-10|2013-12-10|||November 2012||2012-11-01|November 2012|2012-11-01|September 2015|Anticipated|2015-09-01|April 2014|Anticipated|2014-04-01||Observational|||Deep Brain Stimulation Follow-up After 10 Years|STN-DBS Retrospective/Prospective Study With a Follow-up Time of Minimum 10 Years|Unknown status|Enrolling by invitation|N/A|15|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-10-11 03:05:06.611631|2017-10-11 03:05:06.611631
NCT01575119|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-12-16|||May 2012||2012-05-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Decision Aid for Cigarette Smokers Undergoing Surgery|Decision Aid Development for Cigarette Smokers Undergoing Surgery: Specific Aim 2|Completed||Phase 3|130|Actual|Mayo Clinic||4|||f||||f||||||||||2017-10-11 03:05:06.690866|2017-10-11 03:05:06.690866
NCT01575093|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2012-07-04|||March 2012||2012-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety Evaluation of Bowel Cleansing Regimen for PillCam® COLON 2 Capsule Endoscopy||Completed||Phase 1/Phase 2|25|Actual|Given Imaging Ltd.||1|||f||||f||||||||||2017-10-11 03:05:06.849595|2017-10-11 03:05:06.849595
NCT01575080|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2016-01-29|2013-04-26||April 2012||2012-04-01|January 2016|2016-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Performance Evaluation of Blood Glucose Monitoring System Using ISO Study Design|Performance Evaluation of the Contour TS BGMS Using ISO/DIS 15197:2011 Section 8 Study Design and Performance Criteria|Completed||N/A|102|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 03:05:06.93456|2017-10-11 03:05:06.93456
NCT01575067|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2012-04-10|||February 2012||2012-02-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Blood Pressure Monitor Clinical Test (Cuff Range: 22 Cm-42cm)||Completed||N/A|85|Actual|Andon Health Co., Ltd|||2||f||||f||||||||||2017-10-11 03:05:07.198445|2017-10-11 03:05:07.198445
NCT01575054|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2016-08-22|2015-10-01||May 2012||2012-05-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|September 2014|Actual|2014-09-01||Interventional|||BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity||Completed||Phase 3|468|Actual|Allergan||2|||f||||f||||||||||2017-10-11 03:05:07.293544|2017-10-11 03:05:07.293544
NCT01575041|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-08-09|||January 2012||2012-01-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|KaNa||The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function|Study on the Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function in Untreated (Pre)Hypertensive Subjects|Completed||N/A|40|Actual|Wageningen University||3|||f||||f||||||||||2017-10-11 03:05:07.74789|2017-10-11 03:05:07.74789
NCT01575028|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-07-29|2015-05-14||October 2012||2012-10-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies|A Prospective, Double Blinded, Randomized Comparison of Transversus Abdominis Plane Block Versus Local Anesthetic Infiltration for Laparoscopic Appendectomy in the Pediatric Population|Terminated||Phase 2|3|Actual|Nationwide Children's Hospital||2||"The study was allowed to expire due to changes in standard care for the patient population   within the NCH institution."|f||||t||||||||||2017-10-11 03:05:08.060425|2017-10-11 03:05:08.060425
NCT01575015|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2017-02-04|||May 2012||2012-05-01|February 2017|2017-02-01|December 11, 2015|Actual|2015-12-11|December 11, 2015|Actual|2015-12-11||Interventional|INCEPTION||Intraoperative Dialysis in Liver Transplantation|Intra-Operative Continuous Renal Replacement Therapy in Liver Transplantation: A Phase II Randomized Controlled Trial (INCEPTION)|Terminated||N/A|32|Actual|University of Alberta||2||Insufficient funding.|f||||f||||||||||2017-10-11 03:05:08.368357|2017-10-11 03:05:08.368357
NCT01575002|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-03-17|||January 2012||2012-01-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Effects of Transcranial Direct Current Stimulation (tDCS) in Chronic Corneal Pain|Neural Correlates of Pain-related Cognitive Processing in Chronic Pain of the Cornea: an ERP and Electrical Stimulation Study.|Completed||N/A|26|Actual|Spaulding Rehabilitation Hospital||2|||f||||f|f|f||||||||2017-10-11 03:05:08.474445|2017-10-11 03:05:08.474445
NCT01574989|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-04-24|||May 2011||2011-05-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of rTMS and tDCS on Motor Function in Stroke|Effects of Repetitive Transcranial Magnetic Stimulation and Transcranial DC Stimulation on Motor Function in Stroke Patients|Completed||N/A|14|Actual|Spaulding Rehabilitation Hospital||5|||f||||f|f|f||||||||2017-10-11 03:05:08.578215|2017-10-11 03:05:08.578215
NCT01574976|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2015-11-16|||May 2015||2015-05-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Feedback and Practice on Probabilistic Decision Making in Attention Deficit and Hyperactivity Disorder|Effect of Feedback and Practice on Probabilistic Decision Making in Attention Deficit and Hyperactivity Disorder|Completed||N/A|80|Actual|Shaare Zedek Medical Center||4|||f||||f||||||||||2017-10-11 03:05:08.689057|2017-10-11 03:05:08.689057
NCT01574963|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-09|||July 2010||2010-07-01|April 2012|2012-04-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Observational|||Graz Osteoprotegerin as a Risk Factor (GORF) Study|Graz Osteoprotegerin as a Risk Factor (GORF) Study: THE ROLE of OSTEOPROTEGERIN (OPG) and the RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-Kb LIGAND (RANKL) IN PATIENTS REQUIRING SURGERY FOR CORONARY HEART DISEASE|Unknown status|Recruiting|N/A|150|Anticipated|Medical University of Graz|||2||f||||t||||||||||2017-10-11 03:05:08.782329|2017-10-11 03:05:08.782329
NCT01574950|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-10-23|||March 2012||2012-03-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Impact of Impaired Cerebral Autoregulation on Postoperative Delirium in Elderly Patients Undergoing Spine Surgery|The Impact of Impaired Cerebral Autoregulation on the Development of Postoperative Delirium in Elderly Patients Undergoing Spine Surgery|Completed||N/A|99|Actual|Johns Hopkins University|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 03:05:08.907202|2017-10-11 03:05:08.907202
NCT01574937|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2017-03-07|||September 2012||2012-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|||XL-184+Abiraterone in Post-Chemo CRPC|A Dose Finding Clinical Trial of Cabozantinib (XL 184) Administered in Combination With Abiraterone in Castration Resistant Prostate Cancer|Active, not recruiting||Phase 1|27|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||Undecided||2017-10-11 03:05:08.994586|2017-10-11 03:05:08.994586
NCT01574924|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-04-12|||April 2012||2012-04-01|April 2012|2012-04-01||||October 2018|Anticipated|2018-10-01||Observational|||Personality Change During Medical Residency|Personality Change During Medical Residency Across Different Medical Specialties|Not yet recruiting||N/A|600|Anticipated|University of Coimbra|||1||f||||t||||||||||2017-10-11 03:05:09.185656|2017-10-11 03:05:09.185656
NCT01574911|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2012-04-19|||April 2012||2012-04-01|April 2012|2012-04-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Observational|||Validation of a New Method of Limb Volumetry|Development and Validation of a Limb Volumetry Technique Applicable in Daily Clinical Practice Using Self Positioning 3D Laser Scanning:Reproductibility and Comparison to the Reference Method|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Montpellier|||3||f||||t||||||None Retained|"     Validation study an innovative non-invasive diagnostic technique. Biomedical research     conducted with the help of Montpellier University Hospital Clinical Investigation Center     (CIC) for the recruitment of healthy controls, and vascular Medicine clinics for the     recruitment of patients with chronic venous insufficiency or lymphedema   "|||2017-10-11 03:05:09.295043|2017-10-11 03:05:09.295043
NCT01574898|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-07-06|||March 2012||2012-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations|Pilot Pharmacokinetic Study of Three New Nicotine Lozenge Formulations (V0474) Versus Two Reference Formulations (V0018 B mg and Niquitin® Fresh Mint, 4mg) After Single Oral Administration in Healthy Male Smokers.|Completed||Phase 1|13|Actual|Pierre Fabre Medicament||5|||f||||||||||||||2017-10-11 03:05:09.383426|2017-10-11 03:05:09.383426
NCT01574885|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-11-07|||February 2012||2012-02-01|November 2012|2012-11-01|April 2013|Anticipated|2013-04-01|February 2013|Anticipated|2013-02-01||Interventional|||Efficacy of Aerosal® in the Treatment of Sub-Obstructive Adenotonsillar Hypertrophy and Related Diseases|Double-blind, Randomized, Placebo Controlled Study Evaluating the Efficacy of Aerosal® in the Treatment of Sub-Obstructive Adenotonsillar Hypertrophy and Related Diseases|Terminated||Phase 2|45|Actual|Tecno Sun SRL||2|||f||||t||||||||||2017-10-11 03:05:09.491769|2017-10-11 03:05:09.491769
NCT01574872|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2014-11-17|||March 2012||2012-03-01|November 2014|2014-11-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Interventional|||Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis|Double-blind, Randomized, Placebo Controlled Study Evaluating the Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis|Withdrawn||Phase 2|0|Actual|Tecno Sun SRL||2||Changes in the sponsorship, design and locations of the study|f||||t||||||||||2017-10-11 03:05:09.604799|2017-10-11 03:05:09.604799
NCT01574859|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2013-03-30|||April 2012||2012-04-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Observational|||Central Hypothyroidism and Cardiovascular Risk|Central Hypothyroidism and Cardiovascular Risk Factors|Completed||N/A|200|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 03:05:09.735833|2017-10-11 03:05:09.735833
NCT01574846|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-10-15|||January 2011||2011-01-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|Vantas||Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer|Prospective, Multicentre, Non-interventional (Observational) Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer.|Completed||N/A|142|Actual|Orion Corporation, Orion Pharma|||1||f||||f||||||||||2017-10-11 03:05:09.83538|2017-10-11 03:05:09.83538
NCT01574833|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2012-04-09|||March 2007||2007-03-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Early Application of Pulsed Electromagnetic Field in the Treatment of Postoperative Delayed Union|Phase 4 Study of Early Applied Pulsed Electromagnetic Field in the Treatment of Postoperative Delayed Union of Long-bone Fractures|Completed||Phase 4|92|Actual|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||||2017-10-11 03:05:09.916799|2017-10-11 03:05:09.916799
NCT01574820|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-10|||November 2006||2006-11-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|||Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease|Role of Rosiglitazone Treatment and Secondary Prevention of Cardiovascular Events in Patients With Pre-Diabetes Mellitus and Coronary Artery Disease|Completed||Phase 3|105|Actual|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-11 03:05:10.012096|2017-10-11 03:05:10.012096
NCT01574781|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-06-28|||September 2011||2011-09-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|NIPD||Non-invasive Prenatal Diagnostic Validation Study|Development of Non-invasive Prenatal Diagnostic Test Based on Fetal DNA Isolated From Maternal Blood|Completed||N/A|1781|Actual|Natera, Inc.|||6||f||||f||||||Samples With DNA|"     Maternal blood, paternal blood or cheek swab, paternal relative blood or cheek swab, fetal     blood or tissue, POC tissue, and child cord blood or saliva.   "|||2017-10-11 03:05:10.299593|2017-10-11 03:05:10.299593
NCT01574768|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2012-04-07|||November 2011||2011-11-01|April 2012|2012-04-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|||LATERAL PHARYNGOPLASTY OUTCOMES IN THE TREATMENT OF SNORE AND OBSTRUCTIVE SLEEP APNEA|LATERAL PHARYNGOPLASTY OUTCOMES IN THE TREATMENT OF SNORE AND OBSTRUCTIVE SLEEP APNEA|Unknown status|Active, not recruiting|N/A|300|Anticipated|Hospital do Servidor Publico Estadual||1|||f||||f||||||||||2017-10-11 03:05:10.419787|2017-10-11 03:05:10.419787
NCT01574755|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2013-06-29|||September 2011||2011-09-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|ACHAT FU||Long Term Outcome of Argon Plasma Coagulation of Cervical Heterotopic Gastric Mucosa as an Alternative Treatment for Globus Sensations|Long Term Outcome of Argon Plasma Coagulation of Cervical Heterotopic Gastric Mucosa as an Alternative Treatment for Globus Sensations|Completed||N/A|49|Actual|Technische Universität München|||1||f||||f||||||Samples Without DNA|"     biopsy of gastric inlet patches   "|||2017-10-11 03:05:10.497094|2017-10-11 03:05:10.497094
NCT01574742|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-09|2012-07-03|||June 2012||2012-06-01|April 2012|2012-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Open Study Assessing the Feasibility of Minocycline in Patients With Unipolar Depression|A Single Center, Open Label Study Assessing the Feasibility, Safety and Therapeutic Effect of Minocycline in Adult Patients With Diagnosis of Unipolar Depression.|Unknown status|Recruiting|Phase 1|30|Anticipated|Shalvata Mental Health Center||1|||f||||t||||||||||2017-10-11 03:05:10.551088|2017-10-11 03:05:10.551088
NCT01574729|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2012-06-27|||August 2012||2012-08-01|June 2012|2012-06-01|October 2015|Anticipated|2015-10-01|August 2015|Anticipated|2015-08-01||Interventional|rAd-p53||Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma|Phase II Study of Surgery Combined With Recombinant Adenoviral Human p53 Gene Therapy in Treatment Advanced Non-small-cell Carcinoma|Unknown status|Not yet recruiting|Phase 2|120|Anticipated|Shenzhen SiBiono GeneTech Co.,Ltd||2|||f||||f||||||||||2017-10-11 03:05:10.640794|2017-10-11 03:05:10.640794
NCT01574716|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2016-11-29||2016-11-04|May 2012||2012-05-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|November 2015|Actual|2015-11-01||Interventional|SOURCE||Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation. (SOURCE)|A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel in Metastatic Soft Tissue Sarcoma|Completed||Phase 2|209|Actual|Morphotek||2|||f||||||||||||||2017-10-11 03:05:10.742147|2017-10-11 03:05:10.742147
NCT01574703|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2016-10-31|2016-07-07||May 2012||2012-05-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|CATS|The term Baseline visit refers to the Baseline (Week 0) visit of the parent study NCT01456936. The safety population included all participants who received at least one dose of study drug in NCT01456936 parent study. The below Baseline characteristics (age, gender) are presented for all participants who entered study NCT01574703.|Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.|A Phase 4, Non-treatment Follow-up For Cardiac Assessments Following Use Of Smoking Cessation Treatments In Subjects With And Without A History Of Psychiatric Disorders|Completed||Phase 4|4595|Actual|Pfizer||4|||f||||t||||||||||2017-10-11 03:05:10.954977|2017-10-11 03:05:10.954977
NCT01574690|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-02-07|||April 2012||2012-04-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Correlation of Physical Exam Versus Non-invasive Assessment Versus Invasive Assessment of Central Venous Pressure|Correlation of Physical Exam Versus Non-invasive Near-infrared Spectroscopy Versus Invasive Hemodynamic Assessment of Central Venous Pressure|Completed||N/A|50|Actual|Mespere Lifesciences Inc.|||1||f||||f||||||||||2017-10-11 03:05:13.491881|2017-10-11 03:05:13.491881
NCT01574677|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2014-08-01|||June 2012||2012-06-01|August 2014|2014-08-01||||||||Observational|||Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test|Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test|Withdrawn||N/A|0|Actual|Epigenomics, Inc|||1||f||||t||||||||||2017-10-11 03:05:13.60641|2017-10-11 03:05:13.60641
NCT01574664|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-12-10|||September 2012||2012-09-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|June 2015|Anticipated|2015-06-01||Observational|||Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions|A Prospective, Single-Arm, Multicenter Clinical Study to Evaluate the Safety and Performance of the Health Beacons Radiofrequency Identification (RFID) Localization System for Marking and Retrieving Non-Palpable Breast Lesions|Unknown status|Active, not recruiting|N/A|60|Anticipated|Health Beacons|||1||f||||f||||||||||2017-10-11 03:05:13.694758|2017-10-11 03:05:13.694758
NCT01574651|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2014-05-19|2014-03-27||May 2012||2012-05-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|QUANTIFY||The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A 26-week Treatment, Multicenter, Randomized, Parallel Group, Blinded Study to Assess the Efficacy and Safety of QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Using Tiotropium Plus Formoterol as Control|Completed||Phase 3|934|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:05:13.886789|2017-10-11 03:05:13.886789
NCT01574638|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2015-10-13|||June 2012||2012-06-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults|Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers|Completed||Phase 1|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-11 03:05:15.481419|2017-10-11 03:05:15.481419
NCT01574625|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2017-04-17|||April 2001||2001-04-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Post-Approval Study for the MOSAIC® Bioprostheses|Post-Approval Study for the MOSAIC® Bioprostheses: A Long Term Follow Up Study.|Active, not recruiting||N/A|178|Actual|Medtronic Cardiovascular|||1||f||||f||||||||||2017-10-11 03:05:15.647038|2017-10-11 03:05:15.647038
NCT01574612|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-04-28|2014-02-25||March 2012||2012-03-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old|An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children|Completed||Phase 3|54|Actual|Meda Pharmaceuticals||1|||f||||f||||||||||2017-10-11 03:05:15.748936|2017-10-11 03:05:15.748936
NCT01574599|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2017-03-21|||April 2012||2012-04-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Use of Repetitive Facilitative Exercise Program in Established Stroke|A Randomized Controlled Evaluation of a Repetitive Facilitative Exercise Program for Adults With an Established Stroke and Upper Extremity Impairment|Terminated||N/A|15|Actual|Mayo Clinic||2||poor subject recruitment|f||||f||||||||||2017-10-11 03:05:16.017409|2017-10-11 03:05:16.017409
NCT01574586|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2015-04-06|||April 2012||2012-04-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|May 2014|Actual|2014-05-01||Interventional|BEGIN||Bifurcation Stenting Using 2 Link Stent Nobori Versus 3 Link Stent Xience|A Multicenter, Randomized Trial to Compare 2 Link Nobori and 3 Link Xience Stents in Bifurcation Stenting|Unknown status|Active, not recruiting|N/A|240|Anticipated|Kurashiki Central Hospital||2|||f||||||||||||||2017-10-11 03:05:16.123488|2017-10-11 03:05:16.123488
NCT01574573|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2017-05-24|||June 2009||2009-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study|Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study|Terminated||N/A|52|Actual|Midwest Biomedical Research Foundation||2||Closed due to lack of recruitment|f||||f||||||||||2017-10-11 03:05:16.200946|2017-10-11 03:05:16.200946
NCT01574560|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-08-05|||January 2011||2011-01-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||P60 Program Project Grant-Outreach for Smoke-Free Homes|Community Outreach and Biomarker Feedback for Smoke-Free Homes|Completed||N/A|212|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 03:05:16.291729|2017-10-11 03:05:16.291729
NCT01574547|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2012-04-09|||September 2007||2007-09-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|CSC||Risk Factors of Cat Scratch Colon Developing.|Risk Factors of Cat Scratch Colon Developing.|Completed||N/A|10715|Actual|University Hospital of the Nuestra Señora de Candelaria|||2||f||||t||||||||||2017-10-11 03:05:16.368375|2017-10-11 03:05:16.368375
NCT01574534|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2017-01-23|||April 2012||2012-04-01|January 2017|2017-01-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|BASKET-SMALL2||Basel Stent Kosten Effektivitäts Trial Drug Eluting Balloons vs. Drug Eluting Stents in Small Vessel Interventions|A Prospective, Randomized, Controlled, Open Label, Multicenter Trial to Test the Non-inferiority of Drug Eluting Balloon vs. Drug Eluting Stent Treatment in de Novo Stenoses of Small Native Vessels Regarding Efficacy and Safety|Recruiting||N/A|758|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 03:05:16.440373|2017-10-11 03:05:16.440373
NCT01574521|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2012-04-09|||January 2008||2008-01-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Observational|||Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV)|A Fetal Seroepidemiologic Study in Hepatitis B Virus Transmitted Via Male Germ Line|Completed||N/A|407|Actual|Taizhou Hospital|||3||f||||f||||||Samples With DNA|"     whole blood, serum,amniotic fluid   "|||2017-10-11 03:05:16.573429|2017-10-11 03:05:16.573429
NCT01574508|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2013-05-03|||December 2011||2011-12-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|CAMACS||Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy||Unknown status|Recruiting|Phase 4|120|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-11 03:05:16.68425|2017-10-11 03:05:16.68425
NCT01574495|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-09-23|||January 2008||2008-01-01|September 2015|2015-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|VREA||Evaluating Error Augmentation for Neurorehabilitation|Evaluating Error Augmentation for Neurorehabilitation|Completed||N/A|40|Actual|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 03:05:16.783549|2017-10-11 03:05:16.783549
NCT01574482|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2016-11-23|||January 2007||2007-01-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Italy)|Effects of the Consumption of a Plant Sterols-enriched Dairy Fermented Product on Hypercholesterolemia Management in Hypercholesterolemic Adults|Completed||N/A|116|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 03:05:16.879807|2017-10-11 03:05:16.879807
NCT01574469|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-07|2016-12-06|||September 2004||2004-09-01|December 2016|2016-12-01|August 2005|Actual|2005-08-01|December 2004|Actual|2004-12-01||Interventional|||Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (France)|Effect of Low-fat, Fermented Milk Enriched With Plant Sterols on Serum Lipid Profile in Moderate Hypercholesterolemia|Completed||N/A|194|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 03:05:17.115477|2017-10-11 03:05:17.115477
NCT01574456|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-12-09|||March 2012||2012-03-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Blood-brain Barrier Permeability in Alzheimer's Disease||Completed||N/A|39|Actual|Maastricht University Medical Center|||3||f||||||||||||||2017-10-11 03:05:17.212255|2017-10-11 03:05:17.212255
NCT01574443|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-02-16|||August 2011|Actual|2011-08-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|ECOG||Brain Dynamics in Different Stages of Arousal and Anesthesia|Brain Dynamics in Different Stages of Arousal and Anesthesia|Active, not recruiting||N/A|50|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-10-11 03:05:17.275|2017-10-11 03:05:17.275
NCT01574430|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2016-08-15|||December 2010||2010-12-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)|A Randomized, Double-masked, Multicenter, Controlled Study of Photodynamic Therapy in Patients With Central Serous Chorioretinopathy|Completed||Phase 4|131|Anticipated|Peking University People's Hospital||2|||f||||f||||||||||2017-10-11 03:05:17.340758|2017-10-11 03:05:17.340758
NCT01574417|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-10-24|||March 2012||2012-03-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Plant Stanols and Gene Expression Profile|The Effects of Plant Stanol Esters on Intestinal Mucosal Gene Expression Profiles and Microbiota Composition in Healthy Human Subjects|Completed||N/A|20|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:05:17.418724|2017-10-11 03:05:17.418724
NCT01574404|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-06-10|||September 2011||2011-09-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|July 2012|Actual|2012-07-01||Interventional|Polar Body||Polar Body Biopsy for Preimplantation Genetic Screening|Polar Body Biopsy (PB) for Preimplantation Genetic Screening|Completed||N/A|33|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 03:05:17.498524|2017-10-11 03:05:17.498524
NCT01574391|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-08|2015-04-13|||March 2012||2012-03-01|April 2015|2015-04-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||A Comparison Study Of Two Different Techniques For Identifying The Epidural Space In Parturients In Labour|A COMPARISON STUDY OF TWO DIFFERENT TECHNIQUES FOR IDENTIFYING THE EPIDURAL SPACE IN PARTURIENTS IN LABOUR: A PILOT PROSPECTIVE RANDOMIZED STUDY.|Completed||N/A|300|Actual|National Maternity Hospital, Ireland||2|||f||||t||||||||||2017-10-11 03:05:17.582574|2017-10-11 03:05:17.582574
NCT01574378|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-04-08|||August 2010||2010-08-01|April 2012|2012-04-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Effectiveness of Wound Closure Using V-Loc™ 90 Sutures in Lipoabdominoplasty Patients|Cost Effectiveness and Clinical Outcomes of Wound Closure Using V-Loc™ 90 Sutures.|Unknown status|Active, not recruiting|Phase 4|30|Actual|Grigoryants Medical Corporation||2|||f||||f||||||||||2017-10-11 03:05:17.653691|2017-10-11 03:05:17.653691
NCT01574365|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-02-28|||February 2012||2012-02-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus|A Phase 2 Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus|Terminated||Phase 2|53|Actual|Kyowa Hakko Kirin Co., Ltd||4|||f||||f||||||||||2017-10-11 03:05:17.728672|2017-10-11 03:05:17.728672
NCT01574352|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2014-07-02|||April 2012||2012-04-01|July 2014|2014-07-01|July 2017|Anticipated|2017-07-01|July 2014|Actual|2014-07-01||Interventional|OOIS||The Odense Overweight Intervention Study|The Odense Overweight Intervention Study (OOIS): A Randomized Controlled Trial on Overweight Prevention in Children.|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 03:05:17.809145|2017-10-11 03:05:17.809145
NCT01574339|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-03-17|||August 2011||2011-08-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of Long-Term Electrical Stimulation on LES Pressure and Esophageal Acid Exposure in Patients With GERD|An Investigation of the Effect of Long-Term Electrical Stimulation on Lower Esophageal Sphincter (LES) Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD)|Unknown status|Active, not recruiting|Phase 3|42|Actual|EndoStim Inc.||1|||f||||t||||||||||2017-10-11 03:05:17.916449|2017-10-11 03:05:17.916449
NCT01574326|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2016-06-14|2016-06-14||May 2012||2012-05-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease|A 2-Week, Randomized, Placebo-Controlled, Fixed Dose Period Followed by a 6-Month, Single-Arm, Open-Label, Dose Titration Period Study to Investigate the Efficacy and Safety of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease|Completed||Phase 2|101|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 03:05:18.03835|2017-10-11 03:05:18.03835
NCT01574313|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2012-04-10|||April 2010||2010-04-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|April 2011|Actual|2011-04-01||Interventional|||Effect of Stellate Ganglion Block on Meniere's Disease|Effect of Stellate Ganglion Block on Meniere's Disease|Completed||Phase 4|20|Actual|Chi Mei Medical Hospital||2|||f||||t||||||||||2017-10-11 03:05:18.831472|2017-10-11 03:05:18.831472
NCT01574300|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-03-16|||November 2010||2010-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CASTLE||Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network|Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network|Recruiting||N/A|200|Anticipated|Addario Lung Cancer Medical Institute|||1||f||||f|f|f||||||Undecided||2017-10-11 03:05:20.55383|2017-10-11 03:05:20.55383
NCT01574287|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2016-10-25|||August 2012||2012-08-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas|Amino Acid Transport Imaging of Parathyroid Adenomas With Anti-3-[18F]FACBC|Recruiting||N/A|12|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 03:05:20.657258|2017-10-11 03:05:20.657258
NCT01574274|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-09-25|||April 2012||2012-04-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Interventional|||SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma|Randomized Study of Intravenous Calaspargase Pegol (SC-PEG Asparaginase) and Intravenous Oncaspar in Children and Adolescents With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|Active, not recruiting||Phase 2|240|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 03:05:20.748441|2017-10-11 03:05:20.748441
NCT01574261|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2012-04-09|||March 2012||2012-03-01|April 2012|2012-04-01||||August 2012|Anticipated|2012-08-01||Interventional|||Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical Trial||Unknown status|Recruiting|Early Phase 1|70|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 03:05:20.859677|2017-10-11 03:05:20.859677
NCT01574248|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-12-22|2016-10-28||August 2011||2011-08-01|December 2016|2016-12-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema|Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema - a Mulitcenter Trial|Terminated||Phase 4|33|Actual|Vanderbilt University Medical Center||2||DSMC recommended discontinuation for futility and feasibility|f||||t||||||||||2017-10-11 03:05:20.963681|2017-10-11 03:05:20.963681
NCT01574235|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2015-07-27|||October 2011||2011-10-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents|Safety of Nivestim® in Patients Treated With Neutropenia-inducing Anticancer Chemotherapy in Routine Practice|Completed||N/A|2114|Actual|Hospira, now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-10-11 03:05:21.467302|2017-10-11 03:05:21.467302
NCT01574222|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-04-21|||October 1, 2011|Actual|2011-10-01|April 2017|2017-04-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|VTNSCLC||A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer|Intratumoral Genetic Therapy for Lung Cancer|Terminated||Phase 1|16|Actual|VA Office of Research and Development||1||"Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome   measure)"|f||||f||||||||No||2017-10-11 03:05:22.796145|2017-10-11 03:05:22.796145
NCT01574209|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-11-08|||April 2012||2012-04-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|PPCD||Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome|Gut Peptides and Intestinal Permeability in Celiac Patients, Healthy Subjects and IBS Patients: a Comparative Study|Completed||N/A|70|Actual|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis|||3||f||||f||||||||||2017-10-11 03:05:22.889745|2017-10-11 03:05:22.889745
NCT01574196|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2015-03-30|||September 2012||2012-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|SALTO-SNA||Assessment of Cardiac Autonomic Function in Adulthood After Chemotherapy or Radiotherapy in Childhood|"Assessment of Cardiac Autonomic Function in Adulthood After Chemotherapy or Radiotherapy in Childhood. Ancillary Study of the Long-term Follow-up of Childhood Cancer Survivors in the Rhône-Alpes and Auvergne Regions of France Study"|Completed||N/A|83|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 03:05:22.972472|2017-10-11 03:05:22.972472
NCT01574183|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-07-08|2015-09-21||August 2012||2012-08-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|||Vilazodone Treatment for Marijuana Dependence|Vilazodone Treatment for Marijuana Dependence|Completed||Phase 2|76|Actual|Medical University of South Carolina|Limitations included small sample size, significant attrition, and difficulty with UCT (urine cannabinoid test) interpretation due to long excretion half-life of cannabis in urine.|2|||f||||f||||||||||2017-10-11 03:05:23.075101|2017-10-11 03:05:23.075101
NCT01574170|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-05-26|||May 2012||2012-05-01|September 2014|2014-09-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|METAL3||Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival|Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival|Recruiting||Phase 4|270|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||||2017-10-11 03:05:23.561392|2017-10-11 03:05:23.561392
NCT01574157|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-06-05|||November 5, 2012|Actual|2012-11-05|June 2017|2017-06-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|||Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.|Investigations of the Optimum Serum Bicarbonate Level in Renal Disease|Recruiting||N/A|74|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||No||2017-10-11 03:05:23.794078|2017-10-11 03:05:23.794078
NCT01574131|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-02-09|||May 2012||2012-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients|Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients|Terminated||Phase 4|3|Actual|The University of Texas Medical Branch, Galveston||2||lost funding|f||||t||||||||||2017-10-11 03:05:24.022649|2017-10-11 03:05:24.022649
NCT01574118|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-01-22|||April 2012||2012-04-01|January 2015|2015-01-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Enhancing Exposure Therapy for Post-traumatic Stress Disorder|Enhancing Exposure Therapy for PTSD: An Investigation of Non-Pharmacological Augmentation Strategies|Recruiting||Phase 2|54|Anticipated|University of Texas at Austin||3|||f||||f||||||||||2017-10-11 03:05:24.12507|2017-10-11 03:05:24.12507
NCT01574105|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-07-03|2013-06-18||May 2012||2012-05-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Heparin Dose and Post Operative Bleeding in Cardiopulmonary Bypass Patients|Heparin Dose and Post Operative Bleeding in Cardiopulmonary Bypass Patients|Completed||N/A|66|Actual|University of Saskatchewan|||2||f||||f||||||||||2017-10-11 03:05:24.288237|2017-10-11 03:05:24.288237
NCT01574092|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-08-21|||November 2009||2009-11-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Interventional|||Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas|Phase II, Single Arm, Open Label Clinical Trial With Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas|Completed||Phase 2|39|Actual|Hospital Sant Joan de Deu||1|||f||||f||||||||||2017-10-11 03:05:24.603852|2017-10-11 03:05:24.603852
NCT01574079|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-09-04|2013-06-25||November 2010||2010-11-01|September 2014|2014-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Mirror Therapy on Lower Extremity Motor Control and Gait in Patients With Stroke|Effect of Mirror Therapy on Lower Extremity Motor Control and Gait in Patients With Stroke|Completed||N/A|33|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-10-11 03:05:24.805355|2017-10-11 03:05:24.805355
NCT01574066|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-08-01|||November 2011||2011-11-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|PACSCAN||Chest CT-scan for the Diagnosis of Community-acquired Pneumonia|Chest CT-scan for the Diagnosis of Community-acquired Pneumonia in Patients Visiting the Emergency Department|Completed||N/A|339|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 03:05:25.242296|2017-10-11 03:05:25.242296
NCT01574053|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2015-06-01|||July 2012||2012-07-01|June 2015|2015-06-01|||||||1 Year|Observational [Patient Registry]|||Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort|Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort|Unknown status|Recruiting|N/A|15000|Anticipated|CHDI Foundation, Inc.|||1||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-11 03:05:25.378761|2017-10-11 03:05:25.378761
NCT01574040|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-04-05|||February 2012||2012-02-01|April 2012|2012-04-01||||April 2012|Anticipated|2012-04-01||Interventional|LUDIC||The Lifestyle moDIfCation Study|A Before-and-after Study to Evaluate Effects of Low-cost Interventions for Promoting Healthy Lifestyle Modifications|Unknown status|Active, not recruiting|N/A|11000|Anticipated|UMC Utrecht||1|||f||||f||||||||||2017-10-11 03:05:26.251352|2017-10-11 03:05:26.251352
NCT01574027|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-04-05|||April 2008||2008-04-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy of Vitamin D in Colorectal Cancer Chemoprevention||Completed||Phase 2|55|Actual|University of Illinois at Chicago||2|||f||||||||||||||2017-10-11 03:05:26.36185|2017-10-11 03:05:26.36185
NCT00004665|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||June 1995||1995-06-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.953264|2017-10-11 04:26:55.953264
NCT01574001|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2013-05-14|||April 2012||2012-04-01|April 2012|2012-04-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Smoking Cessation Interventions in Stroke Patients|Comparison of Smoking Cessation Interventions of Different Intensities in Patients With First Ever Ischemic Stroke.|Unknown status|Recruiting|N/A|240|Anticipated|Institute of Psychiatry and Neurology, Warsaw||3|||f||||t||||||||||2017-10-11 03:05:26.578904|2017-10-11 03:05:26.578904
NCT01573988|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-09-26|||August 2010||2010-08-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|SAFRAN||Satiety, Meal Frequency and Nutritional Aspects|Behavioural and Metabolic Consequences of Increasing Eating Frequency|Terminated||N/A|37|Actual|Hospices Civils de Lyon||2||Difficulties in recruiting of volunteers with a BMI (Body Mass Index) between 30 and 35 kg/m2|f||||f||||||||||2017-10-11 03:05:26.716338|2017-10-11 03:05:26.716338
NCT01573975|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-09|||January 2009||2009-01-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori|Comparison Between Ten Days Sequential Treatment (With Metronidazole or Tetracycline) and Ten Days Standard Triple Therapy of Helicobacter Pylori|Completed||Phase 4|345|Actual|Buddhist Tzu Chi General Hospital||3|||f||||t||||||||||2017-10-11 03:05:26.808128|2017-10-11 03:05:26.808128
NCT01573962|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2014-10-13|||April 2012||2012-04-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury|A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury|Completed||N/A|420|Actual|Astute Medical, Inc.|||1||f||||f||||||||||2017-10-11 03:05:26.929515|2017-10-11 03:05:26.929515
NCT01573949|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-06-20|||December 2011||2011-12-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)|A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)|Completed||N/A|8|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 03:05:27.036421|2017-10-11 03:05:27.036421
NCT01573936|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-04-06|||January 2008||2008-01-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Quality of Life in Adult Neurological Patients|The Influence of Rehabilitation on Quality of Life in Adult Patients With Neurological Disorders|Completed||N/A|70|Actual|Associação de Assistência a Criança Deficiente||1|||f||||t||||||||||2017-10-11 03:05:27.114448|2017-10-11 03:05:27.114448
NCT01573923|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2015-04-12|||July 2014||2014-07-01|April 2012|2012-04-01|October 2015|Anticipated|2015-10-01|July 2015|Anticipated|2015-07-01||Interventional|LC||Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis|Clinical Trial of Umbilical Mesenchymal Stem Cells Transplantation for Liver Cirrhosis-Phase I/II|Unknown status|Recruiting|Phase 1/Phase 2|320|Anticipated|Alliancells Bioscience Corporation Limited||2|||f||||f||||||||||2017-10-11 03:05:27.182843|2017-10-11 03:05:27.182843
NCT01573910|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2015-04-27|2015-04-27||May 2012||2012-05-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||This analysis population includes all participants who were administered study medication or potentially used study medication.|An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients|An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients|Completed||Phase 3|985|Actual|Alcon Research||2|||f||||t||||||||||2017-10-11 03:05:27.298733|2017-10-11 03:05:27.298733
NCT01573897|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2017-01-31|||May 2012||2012-05-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|SAS-FOOT||Impact of Sleep Apnea on Diabetic Foot Wound|Influence of Sleep Apnea Syndrome and Its Treatment by Positive Airway Pressure Therapy on Transcutaneous Oxygen Tension (PtcO2)in Patients With Foot Wound or at Risk for Foot Wound|Recruiting||N/A|60|Anticipated|AGIR à Dom|||2||f||||f||||||||Undecided||2017-10-11 03:05:27.538466|2017-10-11 03:05:27.538466
NCT01573884|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2012-04-06|||September 2011||2011-09-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Observational|||Ex Vivo Exploratory Analysis in Healthy Full-term Infants|Ex Vivo Exploratory Analysis in Healthy Full-term Infants|Completed||N/A|54|Actual|Abbott Nutrition|||1||f||||f||||||||||2017-10-11 03:05:27.610261|2017-10-11 03:05:27.610261
NCT01573871|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2013-02-14|||February 2012||2012-02-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula|Tolerance and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula|Completed||Phase 3|25|Actual|Abbott Nutrition||1|||f||||t||||||||||2017-10-11 03:05:27.791891|2017-10-11 03:05:27.791891
NCT01573858|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2013-02-01|||April 2012||2012-04-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|PCOSAct||Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome|Effect of Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial (PCOSAct)|Unknown status|Recruiting|N/A|1000|Anticipated|Heilongjiang University of Chinese Medicine||4|||f||||t||||||||||2017-10-11 03:05:27.874656|2017-10-11 03:05:27.874656
NCT01573845|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-03-23|||September 2011||2011-09-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|June 2012|Actual|2012-06-01||Interventional|||The GREEN Project Lunch Box Study|The GREEN (Growing Right: Eating Eco-Friendly & Nutritious) Project Lunch Box Study|Completed||N/A|979|Actual|Tufts University||3|||f||||f||||||||||2017-10-11 03:05:28.104194|2017-10-11 03:05:28.104194
NCT01573832|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-07-14|||June 2012||2012-06-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|ICCP-WC||Integrated Client Care Project Trial: Wound Care Evaluation|Integrated Client Care Project Randomized Control Trial: Wound Care Evaluation|Completed||N/A|13999|Actual|Sunnybrook Health Sciences Centre||4|||f||||f||||||||||2017-10-11 03:05:28.207945|2017-10-11 03:05:28.207945
NCT01573637|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-08-21|||July 2011||2011-07-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women|Six Month, Double Blind, Placebo-controlled Trial of the Efficacy of Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women|Completed||Phase 3|78|Actual|Fundació Sant Joan de Déu||2|||f||||f||||||||||2017-10-11 03:05:30.823287|2017-10-11 03:05:30.823287
NCT01573819|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-06-13|||November 24, 2011|Actual|2011-11-24|June 2017|2017-06-01|April 2, 2012|Actual|2012-04-02|April 2, 2012|Actual|2012-04-02||Interventional|||A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278|A Randomised, Placebo Controlled, Ascending, Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278|Completed||Phase 1|36|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:05:28.311832|2017-10-11 03:05:28.311832
NCT01573806|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-10-03|||October 2012||2012-10-01|October 2017|2017-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|PEPS||Pharmacology of Exenatide in Pediatric Sepsis|Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis|Withdrawn||Phase 1/Phase 2|0|Actual|Seattle Children's Hospital||2||No funding|f||||t||||||||||2017-10-11 03:05:28.458115|2017-10-11 03:05:28.458115
NCT01573793|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2014-03-24|||April 2012||2012-04-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|May 2016|Anticipated|2016-05-01||Interventional|||Promoting Optimal Parenting (Bright Start)|Promoting Optimal Parenting|Unknown status|Recruiting|N/A|500|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 03:05:28.577929|2017-10-11 03:05:28.577929
NCT01573780|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2014-01-14|||April 2012||2012-04-01|January 2014|2014-01-01||||September 2013|Actual|2013-09-01||Interventional|||Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors|A Phase I Study of TL32711 In Combination With Gemcitabine in Patients With Advanced Solid Tumors|Terminated||Phase 1|21|Actual|Roswell Park Cancer Institute||1||Sponsor did not have funds to continue study|f||||f||||||||||2017-10-11 03:05:28.6917|2017-10-11 03:05:28.6917
NCT01573767|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-11-18|2014-12-18||April 2012||2012-04-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children|A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy|Completed||Phase 2|463|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:05:28.856853|2017-10-11 03:05:28.856853
NCT01573754|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-02-05|||April 2003||2003-04-01|February 2016|2016-02-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda|A Prospective Comparison of Low Dose Hydroxychloroquine and Phlebotomy in the Treatment of Porphyria Cutanea Tarda. IRB 02-435|Recruiting||Phase 2|100|Anticipated|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 03:05:29.972772|2017-10-11 03:05:29.972772
NCT01573741|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-05-02|||February 2012||2012-02-01|April 2012|2012-04-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|||Study of Ketamine as an Antidepressant in Major Depressive Disorder|Department of AnesthesiologyJinling Hospital, Nanjing University School of Medicine, Nanjing, China|Unknown status|Recruiting|Phase 1/Phase 2|35|Anticipated|Jinling Hospital, China||1|||f||||t||||||||||2017-10-11 03:05:30.06322|2017-10-11 03:05:30.06322
NCT01573728|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-03-31|||May 2012||2012-05-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|RED||Role of Exercise in Depression in Middle Aged and Older Adults|Role of Exercise in Depression Among Middle Aged and Older Adults|Completed||N/A|20|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 03:05:30.145193|2017-10-11 03:05:30.145193
NCT01573715|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-08-29|||April 2012||2012-04-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)|Effects of NMBA on the Alteration of Transpulmonary Pressures at the Early Phase of ARDS|Unknown status|Recruiting|Phase 4|40|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-11 03:05:30.2225|2017-10-11 03:05:30.2225
NCT01573702|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-09-20|||January 2012||2012-01-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)|Phase II Study of Stereotactic Radiosurgery or Other Local Ablation Followed by Erlotinib for Patients With Epidermal Growth Factor Receptor(EGFR) Mutation Who Have Previously Progressed on an Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)|Active, not recruiting||Phase 2|32|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:05:30.31243|2017-10-11 03:05:30.31243
NCT01573689|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-05-07|||September 2012||2012-09-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Bereaving, But Not Alone : the Development and Actualization of a Mutual Aid Group for Children Who Have Lost a Parent.|Bereaving, But Not Alone : the Development and Actualization of a Mutual Aid Group for Children Who Have Lost a Parent.|Completed||N/A|4|Actual|Université de Montréal||1|||f||||f||||||||||2017-10-11 03:05:30.408184|2017-10-11 03:05:30.408184
NCT01573676|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-04-06|||May 2012||2012-05-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|July 2012|Anticipated|2012-07-01||Observational|OSA||The Influence of Bariatric Surgery on Patients With Obstructive Sleep Apnea (OSA)|The Influence of Bariatric Surgery on Patients With Obstructive Sleep Apnea (OSA)|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 03:05:30.480762|2017-10-11 03:05:30.480762
NCT01573663|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-07-18|||February 2012||2012-02-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Drug-Drug Interaction Study of Ambroxol and Levodropropizine|Open Label, Randomized, 3-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Ambroxol HCl and Levodropropizine in Healthy Male Volunteers|Completed||Phase 1|21|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 03:05:30.543694|2017-10-11 03:05:30.543694
NCT01573650|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-10-13|||March 2015||2015-03-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|March 2018|Anticipated|2018-03-01||Observational|||Optimization of Peripheral Nerve Reconstruction: A Non-inferiority Trial|Optimization of Peripheral Nerve Reconstruction: A Non-inferiority Trial|Recruiting||N/A|48|Anticipated|University Hospital, Basel, Switzerland|||2||f||||t||||||||||2017-10-11 03:05:30.682954|2017-10-11 03:05:30.682954
NCT01506908|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-02-06|2013-12-12||September 2011||2011-09-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Provoked Craving Assessment|Evaluation of the Nicotine Mini Lozenge in Relief of Provoked Acute Craving|Completed||Phase 2|323|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:25:29.896397|2017-10-11 03:25:29.896397
NCT01573624|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-09-07|2017-05-18|2013-07-25|April 3, 2012|Actual|2012-04-03|September 2017|2017-09-01|February 4, 2013|Actual|2013-02-04|February 4, 2013|Actual|2013-02-04||Interventional|ILA115938||Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma|A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma|Completed||Phase 2|421|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:05:31.006989|2017-10-11 03:05:31.006989
NCT01573611|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-12-02|||April 2012||2012-04-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|April 2013|Actual|2013-04-01||Interventional|||Impact of Grape Consumption on Brain Metabolism and Cognitive Function|Examining the Impact of Grape Consumption on Brain Metabolism and Cognitive Function in Patients With Mild Cognitive Impairment|Completed||Phase 1|12|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:05:32.232466|2017-10-11 03:05:32.232466
NCT01573585|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-06-27|||November 2012||2012-11-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Interventional|FAST||Fast Muscle Activation and Stepping Training (FAST) Post-stroke|Effectiveness of Fast Muscle Activation and Stepping Training (FAST) on Balance and Mobility Post-stroke|Recruiting||N/A|60|Anticipated|University of British Columbia||2|||f||||f||||||||No||2017-10-11 03:05:32.597348|2017-10-11 03:05:32.597348
NCT01573572|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-04|2017-04-25|||April 2010|Actual|2010-04-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium|A Phase IV, Open Label, Multi-center Study to Assess the Effect of Intravitreal Injections of Macugen (Pegaptanib Sodium Injection)Administered Every 6 Weeks for 48 Weeks on the Corneal Endothelium.|Recruiting||Phase 4|125|Anticipated|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 03:05:32.710991|2017-10-11 03:05:32.710991
NCT01573559|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-04-05|||September 2011||2011-09-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||ClearView Predicate Comparison Testing|ClearView Predicate Comparison Testing|Completed||N/A|31|Actual|Epic Research & Diagnostics, Inc.|||1||f||||f||||||||||2017-10-11 03:05:32.828735|2017-10-11 03:05:32.828735
NCT01573546|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-07-25|||December 2011||2011-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|ENLIGHTEN||ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement|Lifestyle, CVD Risk, and Cognitive Impairment|Active, not recruiting||N/A|160|Actual|Duke University||4|||f||||t||||||||||2017-10-11 03:05:32.901364|2017-10-11 03:05:32.901364
NCT01573520|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-01-28|||January 2010||2010-01-01|January 2016|2016-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|MEMS-cinac||Treatment Adhesion in Dialysis Patients Treated With Cinacalcet|A Randomized Trial Comparing an Integrated Care Approach Using Electronic Cinacalcet Adherence Data Versus Usual Care to Improve Secondary Hyperparathyroidism in Hemodialysis Patients|Completed||Phase 4|50|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-10-11 03:05:33.131869|2017-10-11 03:05:33.131869
NCT01573507|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2016-12-05|||March 2012||2012-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|November 2017|Anticipated|2017-11-01||Interventional|LS_TCC||Lactate Therapy After Traumatic Brain Injury|Neuroprotective Role of Lactate Therapy in Humans With Traumatic Brain Injury|Recruiting||Phase 2|30|Anticipated|Centre Hospitalier Universitaire Vaudois||1|||f||||t||||||||No||2017-10-11 03:05:33.249367|2017-10-11 03:05:33.249367
NCT01573494|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2014-06-25|||May 2012||2012-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Interventional|||Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma|Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma.|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 03:05:33.351087|2017-10-11 03:05:33.351087
NCT01573481|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-08-03|||January 2012||2012-01-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|REVENTIL||Comparison of Two Ventilator Mode During the Night: New Strategy of Mechanical Ventilation Weaning|Pressure Controlled Ventilation Versus Pressure Support Ventilation During the Night: New Strategy of Mechanical Ventilation Weaning?|Completed||N/A|19|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-11 03:05:33.433691|2017-10-11 03:05:33.433691
NCT01573468|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-07-20|||April 2012||2012-04-01|July 2012|2012-07-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|TESEGAST||Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer|A Randomized, Double-blind Study of Capecitabine Plus Tesetaxel Versus Capecitabine Plus Placebo as Second-line Therapy in Subjects With Gastric Cancer|Unknown status|Recruiting|Phase 2|580|Anticipated|Genta Incorporated||2|||f||||t||||||||||2017-10-11 03:05:33.534195|2017-10-11 03:05:33.534195
NCT01573442|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-06|2017-09-29|||August 2013||2013-08-01|September 2017|2017-09-01||||November 2017|Anticipated|2017-11-01||Interventional|||Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment|Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias|Recruiting||Phase 3|224|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 03:05:33.823387|2017-10-11 03:05:33.823387
NCT01573416|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-10-08|||December 2011||2011-12-01|April 2012|2012-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."|"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."|Completed||Phase 3|400|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 03:05:36.627641|2017-10-11 03:05:36.627641
NCT01573403|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-02-12|||April 2012||2012-04-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy and Safety of DLBS2411 in Healthy Volunteers|Effect of DLBS2411 on Gastric pH Regulation in Healthy Volunteers : Comparison With Placebo|Completed||Phase 1/Phase 2|54|Actual|Dexa Medica Group||3|||f||||f||||||||||2017-10-11 03:05:36.772211|2017-10-11 03:05:36.772211
NCT01573390|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-01-20|||August 2011||2011-08-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Non Invasive and Non-Contact Dual-modal Imaging Of Tissue Oxygenation and Vascular Reactivity Dynamic Imaging Of Tissue Metabolism and Vascular Function.|Non Invasive and Non-Contact Dual-modal Imaging Of Tissue Oxygenation and Vascular Reactivity Dynamic Imaging Of Tissue Metabolism and Vascular Function.|Active, not recruiting||N/A|50|Anticipated|Ohio State University|||1||f||||f||||||None Retained|"     there is no biospecimen collection require in this protocol.   "|||2017-10-11 03:05:36.851861|2017-10-11 03:05:36.851861
NCT01573377|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2013-12-26|||February 2012||2012-02-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial|Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial|Completed||N/A|40|Actual|Chongqing Medical University||2|||f||||t||||||||||2017-10-11 03:05:36.932297|2017-10-11 03:05:36.932297
NCT01573364|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2012-04-05|||February 2011||2011-02-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Observational|Dist'air2||Prevalence and Reversibility of Lung Hyperinflation in Asthma|Evaluation of the Prevalence and the Reversibility of the Lung Hyperinflation in Uncontrolled Persistent Asthmatic Patients With Dyspnea|Completed||N/A|450|Actual|Chiesi Farmaceutici S.p.A.|||1||f||||f||||||||||2017-10-11 03:05:37.015355|2017-10-11 03:05:37.015355
NCT01573351|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-09-23||2015-09-23|May 2012||2012-05-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|Hallmark QUAD||Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)|A Phase 3, Open-Label Study With Asunaprevir and Daclatasvir Plus Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) (P/R) (QUAD) for Subjects Who Are Null or Partial Responders to Peginterferon Alfa 2a or 2b Plus Ribavirin With Chronic Hepatitis C Genotypes 1 or 4 Infection|Completed||Phase 3|398|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 03:05:37.208338|2017-10-11 03:05:37.208338
NCT01573338|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-04-25|||February 25, 2013|Actual|2013-02-25|April 2017|2017-04-01|June 23, 2016|Actual|2016-06-23|March 25, 2016|Actual|2016-03-25||Interventional|||Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)|Phase Ib / II Study of BAY 1000394 in Combination With Cisplatin / Etoposide or Carboplatin / Etoposide as First-line Therapy in Subjects With Extensive Disease Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|43|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:05:37.458195|2017-10-11 03:05:37.458195
NCT01573325|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-02-27|2012-12-26||March 2012||2012-03-01|February 2014|2014-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|LowMELD||HRQoL in the Low MELD Pre-tx Population|Health-Related Quality of Life in the Low Model for End-Stage Liver Disease (MELD) Pre Transplant Patient Candidate: A Pilot Study|Completed||N/A|50|Actual|Northwestern University|The small sample size and convenience sampling were limitations of this study. Additionally, since subjects were recruited from only one site, generalizability of findings is limited.||1||f||||f||||||||||2017-10-11 03:05:37.573986|2017-10-11 03:05:37.573986
NCT01573312|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-01-09|||June 2012||2012-06-01|July 2013|2013-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||H5N1 Vaccination With and Without AS03: Systems Biology Analysis|A Randomized, Double-Blinded, Controlled, Phase I Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of Intramuscular Subvirion Inactivated Monovalent Influenza A/H5N1 Virus Vaccine Administered With and Without AS03 Adjuvant: Standard & Systems Biology Analyses|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 03:05:37.79665|2017-10-11 03:05:37.79665
NCT01573299|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-12-16|||November 2011||2011-11-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|SEVEL||Ischemic Stroke and Early Vertical Positioning (SEVEL)|Ischemic Stroke and Early Vertical Positioning, the SEVEL Study: a Randomised Controlled Trial Comparing the 3 Months Rankin Score Outcome in Ischemic Stroke Patients; in Whom Early or Delayed Mobilization is Performed|Terminated||N/A|167|Actual|Nantes University Hospital||2||"The required number of patients was not reached. The sites were not able to include more   patients.Despite several actions the stop of the study has been decided"|f||||t||||||||||2017-10-11 03:05:37.889187|2017-10-11 03:05:37.889187
NCT01573286|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2014-12-19|||January 2012||2012-01-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2014|Actual|2014-08-01||Interventional|GLP-2-01||Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure|Phase 1-2 Trial of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure|Terminated||Phase 1/Phase 2|13|Actual|Alberta Children's Hospital||2||GLP-2 Drug product stability concerns|f||||t||||||||||2017-10-11 03:05:38.001029|2017-10-11 03:05:38.001029
NCT01573273|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-09-12|||October 2012||2012-10-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Oxytocin in Cocaine Dependence||Recruiting||N/A|152|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:05:38.114862|2017-10-11 03:05:38.114862
NCT01573260|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2015-12-21|2015-04-15||April 2012||2012-04-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|||Tango for Treatment of Motor and Non-motor Manifestations in Parkinson's Disease.|Tango for Treatment of Motor and Non-motor Manifestations in Parkinson's Disease: A Randomized Control Study.|Completed||Early Phase 1|33|Actual|McGill University Health Center|This was a relatively small study, and many of our negative results could be related to inadequate power. The higher baseline activity rate in the controls may have affected responsiveness to change.|2|||f||||t||||||||||2017-10-11 03:05:38.251335|2017-10-11 03:05:38.251335
NCT01573247|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-03-24|||December 2011||2011-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia|A Phase 1/2, Open-Label, Multi-Center Dose Escalation, Safety and Tolerability Study of AKN-028 in Patients With Acute Myelogenous Leukemia (AML)|Terminated||Phase 1/Phase 2|25|Actual|Akinion Pharmaceuticals AB||1||"During the study two patients have experienced serious liver events related to AKN-028. The   risk-benefit balance was judged to be negative."|f||||t||||||||||2017-10-11 03:05:38.830124|2017-10-11 03:05:38.830124
NCT01573234|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2014-01-10|||April 2012||2012-04-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of MySkin Patch for the Healing of Cut Injuries and Abrasions|Efficacy of MySkin Patch for the Healing of Cut Injuries and Abrasions: a Randomised Controlled Trial|Completed||Phase 3|180|Actual|Associazione Infermieristica per lo studio delle Lesioni Cutanee||2|||f||||t||||||||||2017-10-11 03:05:38.9314|2017-10-11 03:05:38.9314
NCT01573221|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2013-01-04||||||January 2013|2013-01-01||||||||Observational|||Stroke and PMSI (Medicalisation Information Systems Programm)|Stroke and PMSI Evaluation of the Sensitivity and Specificity|Unknown status|Recruiting|N/A|||Centre Hospitalier Universitaire Dijon|||1||f||||f||||||||||2017-10-11 03:05:39.018201|2017-10-11 03:05:39.018201
NCT01573208|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-05-17|||February 2011||2011-02-01|May 2016|2016-05-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Custom Guides for Total Knee Arthroplasty (TKA)|Prospective Cohort of FIRST TKA With Custom Guides|Recruiting||Phase 4|80|Anticipated|University of Lausanne Hospitals||1|||f||||||||||||||2017-10-11 03:05:39.105818|2017-10-11 03:05:39.105818
NCT01573195|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2014-12-16|||March 2011||2011-03-01|December 2014|2014-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Merck IISP Stewardship Grant for Antibiotic Best Practices|Implementation of Antimicrobial Stewardship and Decision Support Into the EPIC Electronic Medical Record|Completed||Phase 4|1285|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-10-11 03:05:39.18079|2017-10-11 03:05:39.18079
NCT01573182|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-05-02|||April 2012||2012-04-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|VZV-Zostavax||Herpes Zoster Vaccine for Bone Marrow Transplant Donors|A Phase II Clinical Trial of Vaccination of Stem Cell Donors With Zostavax to Reduce the Incidence of Herpes Zoster in Transplant Recipients - A Pilot Study|Recruiting||Phase 2|10|Anticipated|University of Sydney||1|||f||||f||||||||||2017-10-11 03:05:39.274285|2017-10-11 03:05:39.274285
NCT01573156|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2013-07-01|||May 2013||2013-05-01|July 2013|2013-07-01|June 2015|Anticipated|2015-06-01|May 2014|Anticipated|2014-05-01||Interventional|KCM201||Vascular Targeted Photodynamic Therapy T1a Renal Tumours|Vascular Targeted Photodynamic Therapy With WST11 for T1a Renal Tumours. PHASE IIa Histological Follow up Trial|Unknown status|Recruiting|Phase 1/Phase 2|12|Anticipated|University of Oxford||1|||f||||t||||||||||2017-10-11 03:05:39.455037|2017-10-11 03:05:39.455037
NCT01573143|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-09-16|||September 2011||2011-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|STICS||Statin Therapy In Cardiac Surgery|Statin Therapy In Cardiac Surgery|Completed||Phase 4|1922|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 03:05:39.54493|2017-10-11 03:05:39.54493
NCT01573130|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2016-10-29|||March 2012||2012-03-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Treating Depression With Physical Exercise|An Internet-administered, Therapist-supported Physical Exercise Program for the Treatment of Depression|Completed||N/A|128|Anticipated|Umeå University||2|||f||||f||||||||||2017-10-11 03:05:39.656864|2017-10-11 03:05:39.656864
NCT01573117|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2012-04-25|||September 2010||2010-09-01|April 2012|2012-04-01||||November 2011|Actual|2011-11-01||Interventional|iCOOL 1||A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1)|iCOOL 1 (Induction of COOLing 1): A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill|Completed||Phase 2|20|Actual|University Hospital Heidelberg||2|||f||||f||||||||||2017-10-11 03:05:39.759837|2017-10-11 03:05:39.759837
NCT01573104|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-05-26|||November 2012||2012-11-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluating Novel Biomarkers in Acute Kidney Injury|Evaluating the Utility of Urinary Proteomics and Novel Biomarkers in Acute Kidney Injury|Completed||N/A|87|Actual|University of Glasgow||1|||f||||f||||||||||2017-10-11 03:05:39.857814|2017-10-11 03:05:39.857814
NCT01573091|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-02-22|||December 2011||2011-12-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|CRT-MORE||Cardiac Resynchronization Therapy Modular Registry|Cardiac Resynchronization Therapy Modular Registry|Completed||N/A|500|Actual|University of Florence|||1||f||||||||||||No||2017-10-11 03:05:39.948691|2017-10-11 03:05:39.948691
NCT01573078|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-09-29|||May 2012||2012-05-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Psychology of Crohn's Disease|Will The Real Psychology Of Crohn's Disease Please Stand Up?|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of British Columbia|||1||f||||||||||||||2017-10-11 03:05:40.068432|2017-10-11 03:05:40.068432
NCT01573065|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-08-09|||March 2010||2010-03-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|May 2010|Actual|2010-05-01||Interventional|||HIV Testing and Brief Alcohol Intervention for Young Drinkers in the Emergency Department|Addressing HIV Risk in Young Unhealthy Alcohol Drinkers in the Emergency Department With Rapid HIV Testing and Brief Intervention|Completed||N/A|85|Actual|Yale University||1|||f||||f||||||||||2017-10-11 03:05:40.148532|2017-10-11 03:05:40.148532
NCT01505972|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2012-01-06|||March 2011||2011-03-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Time Schedules for Sending Invitations to Colonoscopy Screening||Completed||N/A|1600|Actual|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||f||||||||||2017-10-11 03:25:42.924951|2017-10-11 03:25:42.924951
NCT01573039|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2014-04-03|||November 2011||2011-11-01|January 2013|2013-01-01|July 2013|Actual|2013-07-01|November 2012|Actual|2012-11-01||Observational|||Cut Off for the Diagnosis of Cytomegalovirus (CMV) Disease in Serum-positive Kidney Transplant Recipients|Definition of Cut Off for PCR - Quantitative and Antigenemia in the Diagnosis of Cytomegalovirus (CMV) Disease in Serum-positive Kidney Transplant Recipients|Completed||N/A|120|Actual|University of Sao Paulo General Hospital|||1||f||||t||||||||||2017-10-11 03:05:40.308307|2017-10-11 03:05:40.308307
NCT01573026|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-05|||August 2011||2011-08-01|April 2012|2012-04-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Observational|Genesis Dental||Five Year Survival Study Evaluating the Genesis Dental Implant System|Clinical Analysis of a Biomimetic Implant System: Five Year Survival Rates, Marginal Bone-level Changes, and Soft Tissue Aesthetics.|Unknown status|Active, not recruiting|N/A|120|Anticipated|Keystone Dental, Inc.|||1||f||||f||||||||||2017-10-11 03:05:40.371477|2017-10-11 03:05:40.371477
NCT01573013|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-05-09|||September 2011||2011-09-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Iron Fortification Trail Using NaFeEDTA in Iron Deficient Lead-exposed Children|Interactions of Lead Intoxication and Iron Deficiency in Morocco: The Effects of Iron Fortification With and Without NaEDTA on Lead Burden, Iron Status and Cognition in Children|Completed||N/A|457|Actual|Swiss Federal Institute of Technology||4|||f||||t||||||||||2017-10-11 03:05:40.634335|2017-10-11 03:05:40.634335
NCT01573000|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-11-30|2012-04-12||September 1998||1998-09-01|November 2016|2016-11-01|April 2010|Actual|2010-04-01|April 2001|Actual|2001-04-01||Interventional|||A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)|Phase II a Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|78|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:05:40.821886|2017-10-11 03:05:40.821886
NCT01572987|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-05-24|||September 2011||2011-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Interventional|ERADICATE||Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus|Endoscopic Resection or Ablation for Patients With Dysplasia or Intramucosal Cancer in Barrett's Esophagus|Terminated||N/A|12|Actual|Midwest Biomedical Research Foundation||2||Recruitment goals not being met|f||||t||||||||||2017-10-11 03:05:45.676488|2017-10-11 03:05:45.676488
NCT01572974|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2015-10-19|||January 2010||2010-01-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|September 2016|Anticipated|2016-09-01||Observational|||Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease|Quality of Life in Barrett's Esophagus and GERD:GERD Symptoms, Perception of Cancer Risk, and Actual Cancer Risk|Terminated||N/A|384|Anticipated|Midwest Biomedical Research Foundation|||4|Lack of recruitment|f||||f||||||||||2017-10-11 03:05:45.797344|2017-10-11 03:05:45.797344
NCT01572961|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2016-02-11|||November 2010||2010-11-01|February 2016|2016-02-01|May 2013|Actual|2013-05-01|March 2012|Actual|2012-03-01||Interventional|MICROTEC||Microvascular Function Assessment in Healthy Subjects|Amélioration Des Techniques d'étude de la Micro-cirulation cutanée Chez Des Sujets Sains|Completed||N/A|16|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 03:05:45.907798|2017-10-11 03:05:45.907798
NCT01572948|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2015-09-28|2015-05-29||June 2012||2012-06-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)|A Placebo-controlled Trial of Roflumilast (Daliresp) on Markers of Inflammation in Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|27|Actual|University of Alabama at Birmingham|small sample size and limited follow-up|2|||f||||f||||||||||2017-10-11 03:05:46.025765|2017-10-11 03:05:46.025765
NCT01572935|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-09-18|||February 2012||2012-02-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Observational|||Body Weight Assessment in Swiss Primary School Children: Trend Analysis Over 10 Years|Body Weight Assessment in Swiss Primary School Children: Trend Analysis Over 10 Years|Completed||N/A|2979|Actual|Swiss Federal Institute of Technology|||1||f||||f||||||||||2017-10-11 03:05:46.596279|2017-10-11 03:05:46.596279
NCT01572922|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-10-03|||June 11, 2012|Actual|2012-06-11|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Massive Iron Deposit Assessment|Massive Iron Deposit Assessment|Recruiting||N/A|235|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|f|t|f|f||||||2017-10-11 03:05:46.872847|2017-10-11 03:05:46.872847
NCT01572909|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-11-11||2015-11-11|April 2012||2012-04-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|EMBRACE||Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia (MTP-131) on Reperfusion Injury in Patients Treated With Standard Therapy Including Primary PCI and Stenting for ST-segment Elevation Myocardial Infarction|Completed||Phase 2|300|Actual|Stealth BioTherapeutics Inc.||2|||f||||t||||||||||2017-10-11 03:05:46.982104|2017-10-11 03:05:46.982104
NCT01572896|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-03-31|||April 2012||2012-04-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2016|Actual|2016-03-01||Interventional|||An Internet-based Self-management Program for Adolescents With Arthritis|An Internet-based Self-management Program for Adolescents With Arthritis: A Randomized Controlled Trial|Completed||N/A|333|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 03:05:47.133914|2017-10-11 03:05:47.133914
NCT01572883|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2014-10-15|||December 2011||2011-12-01|October 2014|2014-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast Cancer|Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast Cancer|Completed||N/A|175|Actual|Institute of Oncology Ljubljana|||1||f||||f||||||||||2017-10-11 03:05:47.250013|2017-10-11 03:05:47.250013
NCT01572870|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2016-06-27|||December 2010||2010-12-01|June 2016|2016-06-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Observational|||Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients|Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients|Completed||N/A|40|Actual|Rambam Health Care Campus|||3||f||||||||||||||2017-10-11 03:05:47.321004|2017-10-11 03:05:47.321004
NCT00004667|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||October 1993||1993-10-01|December 2001|2001-12-01||||||||Interventional|||Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease||Completed||Phase 1|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:56.02167|2017-10-11 04:26:56.02167
NCT01572857|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-04-11|||April 2012||2012-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Observational|RCP-MM||Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple Myeloma|Correlation Between the Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple Myeloma.|Recruiting||N/A|50|Anticipated|Rennes University Hospital|||2||f||||f||||||Samples Without DNA|"     -  Proteinuria        -  Albuminuria        -  Urinary FLC (Freelite ™)        -  Urine creatinine   "|||2017-10-11 03:05:47.41154|2017-10-11 03:05:47.41154
NCT01572831|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2015-05-22|||May 2012||2012-05-01|April 2012|2012-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||PCT and Clinical Algorithm for Determination of Duration of Antibiotics|A Pilot Study to Evaluate a Procalcitonin-Based Algorithm for Duration of Antibiotic Therapy in Critically Ill Patients|Completed||Phase 3|1|Actual|Fraser Health||2|||f||||f||||||||||2017-10-11 03:05:47.766729|2017-10-11 03:05:47.766729
NCT01572818|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2016-06-14|||October 2010||2010-10-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|SAINPOS||Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients|Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients|Completed||N/A|13|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 03:05:47.857627|2017-10-11 03:05:47.857627
NCT01572805|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-10-10|||February 2012||2012-02-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of Melatonin's Effect on Pain and Blood Loss After Cesarean Section||Completed||Phase 1/Phase 2|120|Actual|Qazvin University Of Medical Sciences||3|||f||||t||||||||||2017-10-11 03:05:47.978862|2017-10-11 03:05:47.978862
NCT01572792|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-03-09|2016-12-23|2015-02-27|April 2012||2012-04-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||The Extension Safety Population defined as all patients from the lead-in study (LAC-MD-31) who signed informed consent at Visit 1 of this extension study (last visit of the lead-in study) and who took at least 1 dose of double-blind investigational product in this extension study|Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)|A Phase III, Long-term, Randomized, Double-blind, Extension Study of the Efficacy, Safety, and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28- Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|921|Actual|AstraZeneca|The objective of this extension study was to assess long-term safety and tolerability. Thus efficacy assessments were considered only supportive to the lead-in study (LAC-MD-31), and were not categorized as primary, secondary, or additional|5|||f||||f||||||||||2017-10-11 03:05:48.132703|2017-10-11 03:05:48.132703
NCT01572779|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-03-23|||November 2009||2009-11-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study to Investigate the Effect of a New Postural Bio-feedback Device on Low Back Pain|A Multicentre, Cluster Randomised, Placebo-controlled, Open-label Pilot Study of Back Strain Monitor (BSM) With Feedback Compared With the BSM Without Feedback in Subjects With Moderate Lower Back Pain.|Completed||Phase 2|112|Actual|Pro-Active Medical Pty Ltd||2|||f||||t||||||||||2017-10-11 03:05:50.403635|2017-10-11 03:05:50.403635
NCT01572766|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-05|||February 2010||2010-02-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors|Impact of the FRAX Assessment on Physician and Patient Treatment Behavior|Completed||N/A|90|Actual|Duquesne University||2|||f||||f||||||||||2017-10-11 03:05:50.507311|2017-10-11 03:05:50.507311
NCT01572753|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-02-23|||April 12, 2012|Actual|2012-04-12|February 2017|2017-02-01|September 8, 2012|Actual|2012-09-08|September 8, 2012|Actual|2012-09-08||Interventional|||Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects|A Single Centre, Multiple Dose, Open Label Randomised Trial to Evaluate the Effect of Post Dose Meal Timings and the Effect of Volume of Water With Dosing on the Pharmacokinetic Properties of Oral Semaglutide in Healthy Male Subjects|Completed||Phase 1|161|Actual|Novo Nordisk A/S||8|||f||||f||||||||||2017-10-11 03:05:50.697173|2017-10-11 03:05:50.697173
NCT01572740|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-01-26|2014-03-27||April 2012||2012-04-01|January 2017|2017-01-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes|A 36-week, Randomised, Multi-centre, Double-blind, Parallel Group Trial to Investigate the Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Monotherapy in Japanese Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|257|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:05:50.834562|2017-10-11 03:05:50.834562
NCT01572727|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-01-27|2016-05-31||August 2012||2012-08-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|BELLE-4|The Full Analysis Set (FAS) included all patients who were randomized to study treatment.|A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation|A Randomized, Double-blind, Placebo Controlled, Phase II/III Study of BKM120 Plus Paclitaxel in Patients With HER2 Negative Inoperable Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Pathway Activation.|Completed||Phase 2/Phase 3|416|Actual|Novartis|Safety set: all randomized pts who received at least 1 dose of the study treatment (either buparlisib + paclitaxel or matching placebo + paclitaxel) & had at least 1 post-baseline safety assessment;13 of 416 pts didn't meet this criteria; safety =403|2|||f||||t||||||||||2017-10-11 03:05:51.68345|2017-10-11 03:05:51.68345
NCT01572714|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2016-07-12|||July 2011||2011-07-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Examining the Effects of a Telehealth Self-management Intervention in Multiple Sclerosis|Examining the Effects of Physical Activity Promotion, Fatigue Management Education, and Social Support Using a Telehealth Intervention Approach Among Adults With Multiple Sclerosis|Active, not recruiting||N/A|215|Anticipated|Case Western Reserve University||3|||f||||f||||||||||2017-10-11 03:05:53.174179|2017-10-11 03:05:53.174179
NCT01572701|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-11-23|||January 2012||2012-01-01|November 2015|2015-11-01||||June 2012|Actual|2012-06-01||Interventional|||Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection|A Phase 1 Pilot Study of 99mTc-MIP-1404 Single Photon Emission Computed Tomography (SPECT)/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection (PLND)|Completed||Phase 1|8|Actual|Molecular Insight Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:05:53.300399|2017-10-11 03:05:53.300399
NCT01572688|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-08-01|||November 2011||2011-11-01|April 2012|2012-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|MM||Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma|A Multicenter, Single Arm, Open Label Study of Autologous Stem Cell Transplantation With High Dose Melphalan in Patients With Multiple Myeloma|Unknown status|Recruiting|N/A|60|Anticipated|Shandong Lanjin Pharmaceuticals Co.,Ltd||1|||f||||t||||||||||2017-10-11 03:05:53.380583|2017-10-11 03:05:53.380583
NCT01572675|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-04-15|2016-04-15||June 2012||2012-06-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|COXIBUS||A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)|Pharmacoepidemiological Study on the Use of Arcoxia® Under Actual Conditions of Use in France|Completed||N/A|547|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-10-11 03:05:53.529339|2017-10-11 03:05:53.529339
NCT01572662|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2016-12-19|||April 2012||2012-04-01|December 2016|2016-12-01||||April 2018|Anticipated|2018-04-01||Interventional|||Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning|Phase II Study of Timed Sequential Busulfan in Combination With Fludarabine in Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 2|200|Anticipated|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 03:05:55.666301|2017-10-11 03:05:55.666301
NCT01572649|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2014-05-22|||May 2012||2012-05-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes|A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Paediatric (10 - 17 Years Old) and Adult Patients With Type 2 Diabetes|Completed||Phase 1|24|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:05:55.783502|2017-10-11 03:05:55.783502
NCT01572636|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-09-14|||March 28, 2012|Actual|2012-03-28|September 2017|2017-09-01|July 17, 2018|Anticipated|2018-07-17|July 17, 2018|Anticipated|2018-07-17||Observational|||Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome|MT2011-21C Laronidase (Aldurazyme TM) Enzyme Replacement Therapy (ERT) With Hematopoietic Stem Cell Transplantation (HSCT) for Hurler Syndrome (MPS IH).|Active, not recruiting||N/A|20|Actual|Masonic Cancer Center, University of Minnesota|||1||f||||f||||||||||2017-10-11 03:05:55.883262|2017-10-11 03:05:55.883262
NCT01572623|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-05|||July 2011||2011-07-01|April 2012|2012-04-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|ARMYDA-CARO||Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting|Efficacy of Two Different Pre-Intervention Therapeutic Strategies With Clopidogrel and Atorvastatin for the Prevention of Cerebral Damage During Carotid Artery Stenting. Armyda-Caro Randomized Trial.|Unknown status|Recruiting|Phase 4|150|Anticipated|Campus Bio-Medico University||2|||f||||f||||||||||2017-10-11 03:05:55.97172|2017-10-11 03:05:55.97172
NCT01572610|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-02-28|||February 2012|Actual|2012-02-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus|A Phase 2 GFR Measuring Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus|Terminated||Phase 2|11|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-11 03:05:56.08451|2017-10-11 03:05:56.08451
NCT01572597|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-04-05|||June 2011||2011-06-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy|Increased Second-line Eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Conventional Triple Therapy.|Unknown status|Recruiting|Phase 4|120|Anticipated|Buddhist Tzu Chi General Hospital||2|||f||||t||||||||||2017-10-11 03:05:56.176232|2017-10-11 03:05:56.176232
NCT01572584|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2013-12-18|||December 2011||2011-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|LUS-PNXsize||Lung Ultrasound in the Evaluation of Pneumothorax Size|Accuracy of Lung Ultrasound in the Prediction of Pneumothorax Volume Assessed by CT Scan|Completed||N/A|115|Actual|San Luigi Gonzaga Hospital|||1||f||||f||||||||||2017-10-11 03:05:56.282643|2017-10-11 03:05:56.282643
NCT01572571|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2013-12-18|||December 2011||2011-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|US-UHP||Ultrasound in Undifferentiated Hypotension|Focused Multiorgan Ultrasound in the Emergency Evaluation of Undifferentiated Hypotension|Completed||N/A|100|Actual|San Luigi Gonzaga Hospital|||1||f||||f||||||||||2017-10-11 03:05:56.358153|2017-10-11 03:05:56.358153
NCT01572558|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-10-15|||February 2012||2012-02-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|CONSAPP Pilot||Conservative Treatment of Acute Appendicitis in Children|Conservative Treatment of Acute Appendicitis in Children Pilot Trial|Completed||N/A|51|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 03:05:56.432675|2017-10-11 03:05:56.432675
NCT01572545|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2013-01-15|||April 2012||2012-04-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|DenoZol||Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass|Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin Levels of Postmenopausal Women With Low Bone Mass: A Multicenter, Randomized, Head-to-head Clinical Trial|Completed||N/A|91|Actual|Aristotle University Of Thessaloniki||2|||f||||t||||||||||2017-10-11 03:05:56.676122|2017-10-11 03:05:56.676122
NCT01572532|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-08-18|||August 2010||2010-08-01|December 2011|2011-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Maternal Genitourinary Infections and Adverse Perinatal Outcomes|Maternal Genitourinary Infections and Adverse Perinatal Outcomes in Sylhet District, Bangladesh|Unknown status|Recruiting|Phase 3|9000|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 03:05:56.790877|2017-10-11 03:05:56.790877
NCT01503333|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-05-02|||September 2011||2011-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls|Girls on the Move Intervention|Completed||Phase 3|1543|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 03:26:19.221488|2017-10-11 03:26:19.221488
NCT01572519|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-06-22|||June 1, 2012|Actual|2012-06-01|June 2017|2017-06-01|August 13, 2013|Actual|2013-08-13|August 13, 2013|Actual|2013-08-13||Interventional|||A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma|An Open-label, Multicenter, Phase 1/2 Study of JNJ-40346527, an FMS Inhibitor, in Subjects With Relapsed or Refractory Hodgkin Lymphoma|Completed||Phase 1|21|Actual|Janssen Research & Development, LLC||1|||f||||t||f||||||||2017-10-11 03:05:56.881192|2017-10-11 03:05:56.881192
NCT01572506|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2017-06-30|||March 27, 2012||2012-03-27|June 23, 2017|2017-06-23|July 30, 2015|Actual|2015-07-30|July 30, 2015|Actual|2015-07-30||Interventional|||Mechanisms Accounting for Unexplained Anemia in the Elderly|Assessing Mechanisms Accounting for Unexplained Anemia in the Elderly|Completed||N/A|128|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-11 03:05:56.98398|2017-10-11 03:05:56.98398
NCT01572467|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-05|2016-07-13|||April 2012||2012-04-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors|DICER1 Mutations and miRNA in Ovarian and Testicular Sex Cord Stromal Tumors of Childhood|Completed||N/A|50|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:05:57.297493|2017-10-11 03:05:57.297493
NCT01572454|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2013-12-24|||March 2012||2012-03-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Dexmedetomidine and Remifentanil Infusion During CABG|The Comparison of Serum Potassium Concentration, Antiarrhythmic Effect, and Myocardial Protective Effect Between Dexmedetomidine and Remifentanil Infusion in Patients Undergoing Coronary Artery Bypass Surgery|Completed||N/A|77|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 03:05:57.378521|2017-10-11 03:05:57.378521
NCT01572441|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-02-23|||September 2009||2009-09-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|PAIT||Parent-Adolescent Interactions and Adolescent Development|Responses During Parent-child Interactions and Alcohol Use Behavior in Adolescents.|Active, not recruiting||N/A|250|Anticipated|George Mason University|||1||f||||t||||||Samples With DNA|"     Retain saliva sample.   "|No|We will make data from the proposed laboratory study available to other researchers, after de-identifying study data and after publishing the main manuscripts on the study.|2017-10-11 03:05:57.485247|2017-10-11 03:05:57.485247
NCT01572428|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-03-15|||April 2011||2011-04-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|||Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon|Randomized Controlled Trial Comparing the Use of Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon|Active, not recruiting||N/A|950|Anticipated|Indiana University||2|||f||||f||||||||||2017-10-11 03:05:57.653291|2017-10-11 03:05:57.653291
NCT01572415|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-12-03|||September 2011||2011-09-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Observational|||Evaluation of SCOUT DS Device in the Diagnosis of Diabetes Mellitus|Evaluation of SCOUT DS Device in the Diagnosis of Diabetes Mellitus|Completed||N/A|409|Actual|VeraLight, Inc.|||1||f||||f||||||||||2017-10-11 03:05:57.737761|2017-10-11 03:05:57.737761
NCT01572402|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-05-09|||January 2012||2012-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Postprandial Insulin Secretion, Oxidative Stress and Gastrointestinal Peptides in Patients With Type 2 Diabetes Versus Healthy Subjects||Completed||N/A|100|Actual|Institute for Clinical and Experimental Medicine||2|||f||||t||||||||||2017-10-11 03:05:57.811561|2017-10-11 03:05:57.811561
NCT01572376|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-08-24|||November 2007||2007-11-01|August 2015|2015-08-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment|Treatment of Pressure Ulcers With Autologous Bone Marrow Stem Cells in Spinal Cord Injury Patients.Phase I/II Study.|Completed||Phase 1/Phase 2|30|Actual|Hospital Universitario Central de Asturias||1|||f||||f||||||||||2017-10-11 03:05:58.022719|2017-10-11 03:05:58.022719
NCT01572363|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-03-04|||April 2012||2012-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Fontan Patients: Comprehensive Evaluation of Pulmonary Circulation and Ventricular Function|Fontan Patients: Comprehensive Evaluation of the Pulmonary Circulation to Identify Pulmonary Vascular Disease and Its Influence on Ventricular Hemodynamics.|Completed||N/A|10|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 03:05:58.108652|2017-10-11 03:05:58.108652
NCT01572350|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-07|2012-04-04|||October 2010||2010-10-01|April 2011|2011-04-01||||October 2012|Anticipated|2012-10-01||Interventional|ALBA||Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema|Randomized Multicenter Clinical Trial of Three Parallel Groups to Estimate the Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema.|Unknown status|Recruiting|Phase 3|105|Anticipated|Hospital Universitario de Canarias||3|||f||||||||||||||2017-10-11 03:05:58.199559|2017-10-11 03:05:58.199559
NCT01570439|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-10|||January 2012||2012-01-01|December 2013|2013-12-01||||December 2014|Anticipated|2014-12-01||Observational|||To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore||Unknown status|Recruiting|N/A|10|Anticipated|National University Hospital, Singapore|||1||f||||t||||||||||2017-10-11 03:06:27.019647|2017-10-11 03:06:27.019647
NCT01572337|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-03-08|||April 2012||2012-04-01|March 2017|2017-03-01||||April 2018|Anticipated|2018-04-01||Interventional|e-NIV||Early Non-invasive Ventilation Outside the Intensive Care Unit|Reducing the Need for Intensive Care Unit in Hospitalized Patients With Early Respiratory Failure Using the Non-invasive Ventilation Technique. A Multicentre Randomized Study.|Recruiting||Phase 4|520|Anticipated|Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-10-11 03:05:58.30845|2017-10-11 03:05:58.30845
NCT01572324|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-01-02|||March 2012||2012-03-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|October 2015|Actual|2015-10-01||Interventional|||Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas|Phase II Study of Hepatic Arterial Infusion With Oxaliplatin and Fluorouracil in Patients With Unresectable Biliary Tract Carcinomas|Completed||Phase 2|37|Actual|Peking University||1|||f||||t||||||||||2017-10-11 03:05:58.415598|2017-10-11 03:05:58.415598
NCT01572311|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-10-24|||June 2012||2012-06-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional|HM2||Dual Task Aerobic Exercise for Older Adults With Cognitive Impairment (HM2)|Study of Community Based Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults Without Dementia|Completed||N/A|44|Actual|Parkwood Hospital, London, Ontario||2|||f||||f||||||||||2017-10-11 03:05:58.50363|2017-10-11 03:05:58.50363
NCT01572298|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-10-01|2014-10-01||April 2012||2012-04-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Prospective Study: Alveolar Ridge Augmentation Using Tenting Screws, Acellular Dermal Matrix and Combination Particulate Grafts|A Prospective Study: Alveolar Ridge Augmentation Using Tenting Screws, Acellular Dermal Matrix and Combination Particulate Grafts.|Completed||N/A|34|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 03:05:58.63071|2017-10-11 03:05:58.63071
NCT01572285|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-04-05|||October 2011||2011-10-01|March 2012|2012-03-01|November 2012|Anticipated|2012-11-01|May 2012|Anticipated|2012-05-01||Interventional|||Transforaminal Epidural Steroid Injection to Treat Hemiplegic Shoulder Pain|Transforaminal Epidural Steroid Injection to Treat Hemiplegic Shoulder Pain : A Randomized, Sham-Controlled, Proof of Principle Trial|Unknown status|Recruiting|N/A|20|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 03:05:58.855931|2017-10-11 03:05:58.855931
NCT01572272|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2016-11-01|||August 2012||2012-08-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Comparison of Open Versus Masked Distal EtCO2 Monitoring of Neonates Ventilated With Conventional Ventilation|Comparison of Open Versus Masked Distal EtCO2 Monitoring of Neonates Ventilated With Conventional Ventilation. A Randomized, Multi-Center Study|Completed||N/A|66|Actual|Medtronic - MITG|||2||f||||f||||||||||2017-10-11 03:05:58.972412|2017-10-11 03:05:58.972412
NCT01572259|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2015-11-16|||September 2011||2011-09-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism|Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism|Unknown status|Recruiting|Phase 3|40|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 03:05:59.046036|2017-10-11 03:05:59.046036
NCT01572246|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-02-23|||May 2012||2012-05-01|August 2016|2016-08-01|September 14, 2016|Actual|2016-09-14|September 14, 2016|Actual|2016-09-14||Observational|||Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators|Effects of Surgical Monopolar Electrocautery and Optimal Electrosurgery Unit Return Pad Placement on Implantable Cardioverter Defibrillators Protocol|Completed||N/A|167|Actual|Oregon Health and Science University|||3||f||||f||||||||||2017-10-11 03:05:59.13683|2017-10-11 03:05:59.13683
NCT01572233|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2012-12-26|||December 2011||2011-12-01|November 2012|2012-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection|Effects of Personalized Physical Activity and Psycho-Education Program on Patients With Chronic Hepatitis C Infection|Recruiting||N/A|300|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 03:05:59.228839|2017-10-11 03:05:59.228839
NCT01572220|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-10-24|||April 2012||2012-04-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|August 2014|Actual|2014-08-01||Interventional|SECURE||Stress Echo Ultrasound Contrast in an Urban Safety Net Hospital to Refine Ischemia Evaluation|Stress Echo Ultrasound Contrast in an Urban Safety Net Hospital to Refine Ischemia Evaluation|Active, not recruiting||N/A|240|Actual|Denver Health and Hospital Authority||2|||f||||f||||||||||2017-10-11 03:05:59.334024|2017-10-11 03:05:59.334024
NCT01572207|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-01-22|2013-08-07||July 2011||2011-07-01|January 2015|2015-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Promoting Physical Activity Behavior in Persons With Multiple Sclerosis|Using Targeted Print-material to Promote Physical Activity Behavior in Adults With Multiple Sclerosis|Completed||N/A|30|Actual|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 03:05:59.440178|2017-10-11 03:05:59.440178
NCT01572194|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-05-31|||April 2012||2012-04-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|MUCO-IRC||Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC)|Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation.|Terminated||N/A|45|Actual|Nantes University Hospital||1||no more recruitment in the centers|f||||f||||||||||2017-10-11 03:05:59.743048|2017-10-11 03:05:59.743048
NCT01572181|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-06-26|||April 2012|Actual|2012-04-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|FB4-PEDIA||Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens|Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens|Active, not recruiting||Phase 2|50|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 03:05:59.819686|2017-10-11 03:05:59.819686
NCT01572168|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-02-03|||September 2011||2011-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Acupuncture for the Treatment of Cancer Related Fatigue|A Phase II Study of Acupuncture for the Treatment of Cancer Related Fatigue in Children and Adolescents With Central Nervous System Tumors|Terminated||Phase 2|7|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||1||slow accrual|f||||f||||||||||2017-10-11 03:06:00.217921|2017-10-11 03:06:00.217921
NCT01572155|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-12-03|||March 2012||2012-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Pilot Study: Anti-inflammatory Effect of Peroperative Stimulation of the Vagus Nerve|Pilot Study: Anti-inflammatory Effect of Peroperative Stimulation of the Vagus Nerve: Potential New Therapeutic Intervention to Shorten Postoperative Ileus|Completed||N/A|24|Actual|Katholieke Universiteit Leuven||3|||f||||f||||||||||2017-10-11 03:06:00.33159|2017-10-11 03:06:00.33159
NCT01572142|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-09-27|||August 2010||2010-08-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|OLF||Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson's Disease|Hyposmia, Cholinergic Denervation and Incipient Cognitive Decline in PD|Completed||N/A|74|Actual|University of Michigan|||1||f||||f||||||Samples With DNA|"     saliva   "|||2017-10-11 03:06:00.431444|2017-10-11 03:06:00.431444
NCT01572129|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-04-04|||November 2011||2011-11-01|April 2012|2012-04-01||||May 2012|Anticipated|2012-05-01||Interventional|||Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy|Clopidogrel Reloading in Patients With Non-ST Elevation Acute Coronary Syndrome Undergoing PCI on Chronic Clopidogrel Therapy. Results of the ARMYDA RELOAD ACS (Antiplatelet Therapy for Reduction of MYocardial Damage During Angioplasty in Acute Coronary Syndrome) Randomized Trial.|Unknown status|Recruiting|Phase 4|240|Anticipated|Campus Bio-Medico University||2|||f||||f||||||||||2017-10-11 03:06:00.500858|2017-10-11 03:06:00.500858
NCT01572116|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2012-04-04|||January 2010||2010-01-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Effect of Sufentanil on the Rate of Anesthesia|Comparison the Effect of Lidocaine (With Epinephrine) With and Without Sufentanil on the Rate of Anesthesia of Intra-ligamentary Injection in Teeth With Irreversible Pulpitis|Completed||Phase 2|60|Actual|Islamic Azad University, Tehran||2|||f||||t||||||||||2017-10-11 03:06:00.620894|2017-10-11 03:06:00.620894
NCT01572103|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-04-04|||January 2010||2010-01-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Coffee Effect in HCV-related Hepatitis|Coffee Consumption and Oxidative DNA Damage, Apoptosis and Collagen Synthesis in HCV-related Liver Disease: a Prospective Randomized Trial.|Completed||Phase 3|40|Actual|Azienda Ospedaliera di Padova||2|||f||||f||||||||||2017-10-11 03:06:00.711594|2017-10-11 03:06:00.711594
NCT01572090|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-10-24|||January 2006||2006-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of Weight Loss Induced by Bariatric Surgery vs Conventional Treatment|Comparison of Weight Loss Induced by Bariatric Surgery vs Conventional Treatment on Body Composition, Adipokines, Gastro-intestinal Hormones and Cardiometabolic Risk Factors|Active, not recruiting||N/A|600|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||6|||f||||f||||||||No||2017-10-11 03:06:00.778232|2017-10-11 03:06:00.778232
NCT01572077|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-06-30|||January 2011||2011-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|RVMET||Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension|Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension|Active, not recruiting||N/A|20|Actual|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 03:06:00.886726|2017-10-11 03:06:00.886726
NCT01572064|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-09-17|||May 2009||2009-05-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|Mrker||Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis|Magnetic Resonance Imaging in the Evaluation of Hepatic Fibrosis: Search for MRI Biomarker|Completed||N/A|134|Actual|University of Nottingham||1|||f||||f||||||||||2017-10-11 03:06:00.970377|2017-10-11 03:06:00.970377
NCT01572051|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-01-14|||October 2011||2011-10-01|October 2013|2013-10-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|PARQVE||Project Osteoarthritis: Recovering Quality of Life Through Education|Project Osteoarthritis: Recovering Quality of Life Through Education|Completed||N/A|228|Actual|University of Sao Paulo General Hospital||8|||f||||f||||||||||2017-10-11 03:06:01.135211|2017-10-11 03:06:01.135211
NCT01572038|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-07-20|||June 1, 2012|Actual|2012-06-01|July 2017|2017-07-01|September 28, 2019|Anticipated|2019-09-28|September 28, 2019|Anticipated|2019-09-28||Interventional|PERUSE||A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer|A Multicenter, Open-Label, Single-Arm Study of Pertuzumab in Combination With Trastuzumab and a Taxane in First Line Treatment of Patients With HER2-Positive Advanced (Metastatic or Locally Recurrent) Breast Cancer|Active, not recruiting||Phase 3|1436|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:06:01.291569|2017-10-11 03:06:01.291569
NCT01572025|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-12-08|||May 2012||2012-05-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|DITTO||Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging|Efficacy of Dehydroepiandrosterone to Overcome the Effect of Ovarian Aging - A Pilot Double Blinded Randomised Controlled Trial|Completed||Phase 3|60|Actual|University of Nottingham||2|||f||||t||||||||||2017-10-11 03:06:02.571785|2017-10-11 03:06:02.571785
NCT01572012|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-01-22|||February 2012||2012-02-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers|Phase 1 Open-Label Randomized 4 Period Crossover Study Comparing Safety, Tolerability and PK of Ondansetron Given Subcutaneously With Hylenex Recombinant and Given Alone Intramuscularly, Intravenously and Orally in Healthy Volunteers|Completed||Phase 1|12|Actual|Halozyme Therapeutics||4|||f||||f||||||||||2017-10-11 03:06:02.666877|2017-10-11 03:06:02.666877
NCT01571999|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-07-24|||March 29, 2012|Actual|2012-03-29|July 2017|2017-07-01|June 22, 2012|Actual|2012-06-22|June 22, 2012|Actual|2012-06-22||Interventional|||Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment|A Single-blind, Non-randomized Pharmacokinetic and Safety Study of Single Dose of GSK573719 and GSK573719 + GW642444 Combination in Healthy Subjects and in Subjects With Severe Renal Impairment|Completed||Phase 1|17|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:06:02.778044|2017-10-11 03:06:02.778044
NCT01571986|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-03-08|||February 2012||2012-02-01|March 2017|2017-03-01||||February 2018|Anticipated|2018-02-01||Observational|Improving NIV||Improving Non-invasive Ventilation|Improving Non Invasive Ventilation|Recruiting||N/A|750|Anticipated|Università Vita-Salute San Raffaele|||1||f||||f||||||||||2017-10-11 03:06:02.885143|2017-10-11 03:06:02.885143
NCT01571973|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-04-04|||March 2010||2010-03-01|June 2011|2011-06-01|May 2012|Anticipated|2012-05-01|March 2012|Actual|2012-03-01||Interventional|depression||Evaluation of Pharmaceutical Care in Depressed Outpatients|EVALUATION OF THE EFFECTIVENESS OF PHARMACEUTICAL CARE (DÁDER PROGRAM) IN DEPRESSED OUTPATIENTS TREATED WITH PSYCHOTROPIC|Unknown status|Active, not recruiting|N/A|60|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:06:02.989166|2017-10-11 03:06:02.989166
NCT01571960|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-01-23|||April 2012||2012-04-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|August 2014|Actual|2014-08-01||Interventional|||Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults|A Phase 1 Placebo Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of a Prime-Boost Vaccine Regimen of GEO-D03 DNA and MVA/HIV62B Vaccines in Healthy, HIV-1-Uninfected Vaccinia Naive Adult Participants|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-11 03:06:03.070065|2017-10-11 03:06:03.070065
NCT01571947|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-07-22|||November 2011||2011-11-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2012|Actual|2012-06-01||Interventional|||Acute Effects of Dietary Fats and Carbohydrate in Subjects With Metabolic Syndrome|Acute Effects of Dietary Fats and Carbohydrate on Insulinaemia, Lipaemia, Inflammatory Responses and Gastrointestinal Peptide Secretion in Subjects With Metabolic Syndrome|Completed||N/A|30|Actual|Malaysia Palm Oil Board||4|||f||||t||||||||||2017-10-11 03:06:03.203526|2017-10-11 03:06:03.203526
NCT01571934|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-04-24|||November 2011||2011-11-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Observational|PASs||Inhibitor Development in Patients With Hemophilia A Undergoing Surgery|Inhibitor Development in Patients With Hemophilia A Undergoing Surgery|Completed||N/A|30|Actual|Emory University|||1||f||||f|f|f||||Samples With DNA|"     Blood drawn during study includes 15 ml within 7 days prior to surgery and 15 ml drawn on     post-operative days 1, 14 and 90.      Samples for DNA storage will be generated from blood draw study samples.   "|Undecided||2017-10-11 03:06:03.380609|2017-10-11 03:06:03.380609
NCT01571921|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-09-13|||January 2013||2013-01-01|September 2016|2016-09-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|GEMM1a||Gamma-delta Tocotrienol as Potential Maintenance Treatment in Women With Metastatic Breast Cancer|Phase 1a: A Randomized, 2-period Cross-over Study to Compare the Bioavailability of Gamma-Delta Tocotrienol (GDT) With That of Tocotrienol Rich Fraction (TRF) in Twelve Healthy Subjects|Completed||Phase 1|12|Actual|Malaysia Palm Oil Board||2|||f||||||||||||||2017-10-11 03:06:03.494648|2017-10-11 03:06:03.494648
NCT01571908|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-07-17|||September 2012||2012-09-01|May 2015|2015-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|MagInRoc||Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study|Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study|Completed||Phase 2|280|Actual|University Hospital, Geneva||2|||f||||t||||||||||2017-10-11 03:06:03.60339|2017-10-11 03:06:03.60339
NCT01571895|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2014-06-25|||July 2011||2011-07-01|June 2014|2014-06-01||||July 2012|Actual|2012-07-01||Interventional|||Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid|A Phase 2, Multicentre, Single Arm, Pilot Study to Assess the Efficacy and the Safety of 150 mg Twice a Day Oral DF2156A in Patients With Active Bullous Pemphigoid.|Terminated||Phase 2|4|Actual|Dompé Farmaceutici S.p.A||1||Limited efficacy response observed at 1/3 enrollment at investigated dosage.|f||||t||||||||||2017-10-11 03:06:03.73549|2017-10-11 03:06:03.73549
NCT01571882|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-11-23|||June 2007||2007-06-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Fermented Milk Product Enriched With Plant Sterols and Policosanols in Mild Hypercholesterolaemic Adults|Effects of the Consumption of a no Added Sugar Fermented Milk Product Enriched With Plant Sterols and Policosanols on Hypercholesterolaemia Management in Moderately Hypercholesterolaemic Adults|Completed||N/A|72|Actual|Danone Research||3|||f||||f||||||||||2017-10-11 03:06:03.885052|2017-10-11 03:06:03.885052
NCT01571869|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-12-06|||April 2005||2005-04-01|December 2016|2016-12-01|April 2006|Actual|2006-04-01|December 2005|Actual|2005-12-01||Interventional|||Pilot Study in the Cholesterol Absorption Reduction After Consumption of Low-fat, Drinkable Fermented Milk Enriched With Plant Sterols|Influence of a Meal on the Efficacy of Plant Sterol Given at Different Times of the Day in Management of Hypercholesterolemia|Completed||N/A|30|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 03:06:03.979297|2017-10-11 03:06:03.979297
NCT01571856|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2013-05-05|||July 2011||2011-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants|Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants Under Six Months.|Completed||Phase 4|52|Actual|Centro Pediatrico Albina de Patino||2|||f||||f||||||||||2017-10-11 03:06:04.068692|2017-10-11 03:06:04.068692
NCT01571843|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-04-07|||February 2010||2010-02-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Radius Loading in Primary Hyperparathyroidism|Effect of Mechanical Loading on Radius Bone Density and Microarchitecture in Primary Hyperparathyroidism|Completed||N/A|12|Actual|Columbia University||4|||f||||f||||||||||2017-10-11 03:06:04.187077|2017-10-11 03:06:04.187077
NCT01571830|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-08-05|||December 2011||2011-12-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Improving Nutrient Intake and Growth in Children With Multiple Food Allergies|Improving Nutrient Intake and Growth in Children With Multiple Food Allergies|Completed||N/A|43|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-10-11 03:06:04.303763|2017-10-11 03:06:04.303763
NCT01571817|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2013-08-07|||April 2012||2012-04-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Pancreatic Islet Transplantation Into the Gastric Submucosa|Treatment of Type I Diabetes by Pancreatic Islet Transplantation Into The Gastric Submucosa|Unknown status|Enrolling by invitation|Phase 1|4|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 03:06:04.396964|2017-10-11 03:06:04.396964
NCT01571804|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2012-05-04|||December 2011||2011-12-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Pregabalin Reduce the Sevoflurane Requirement|Does Pregabalin Reduce the Sevoflurane Requirement During Laparoscopic Cholecystectomy? Mansoura University Hospitals Experience.|Completed||Phase 2|42|Actual|Mansoura University||3|||f||||t||||||||||2017-10-11 03:06:04.465131|2017-10-11 03:06:04.465131
NCT01502930|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-05-15|||January 2012||2012-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|MARI||Treatment of Nightmares Via the Internet|MARI - Treatment of Nightmares Via the Internet - a Randomized Controlled Trial|Completed||Phase 3|175|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 03:26:25.648503|2017-10-11 03:26:25.648503
NCT01571791|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2015-03-15|||June 2012||2012-06-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery|A Randomized Study of the Effects of Perioperative i.v. Ketorolac-lidocaine on the Hemodynamic Response in the Patients With Valvular Heart Diseases During Cesarean Delivery|Unknown status|Recruiting|Phase 2|90|Anticipated|Mansoura University||2|||f||||t||||||||||2017-10-11 03:06:04.570418|2017-10-11 03:06:04.570418
NCT01571778|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-11-30|||April 2012||2012-04-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Hand Hygiene Before Non-sterile Glove Use|The Utility of Hand Hygiene Before Non-sterile Glove Use|Completed||N/A|230|Actual|University of Maryland||2|||f||||||||||||||2017-10-11 03:06:04.671854|2017-10-11 03:06:04.671854
NCT01571765|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-05-04|||April 2012||2012-04-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|July 2014|Actual|2014-07-01||Interventional|HCUM||MNCH Programming in Southwest Uganda Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA|Scaling Up Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA|Completed||N/A|10985|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 03:06:04.738918|2017-10-11 03:06:04.738918
NCT01571752|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-10-05|||March 8, 2012||2012-03-08|September 27, 2017|2017-09-27||||||||Observational|||Health Outcomes by Neighborhood - Baltimore|Health Outcomes by Neighborhood - HON Study Baltimore|Recruiting||N/A|1550|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:06:04.841729|2017-10-11 03:06:04.841729
NCT01571739|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-06-30|||January 2, 2012||2012-01-02|May 20, 2014|2014-05-20|May 20, 2014||2014-05-20|||||Observational|||Determining Risk in Latent Tuberculosis|Risk Stratification in Latent Tuberculosis: PET/CT Findings in TB Contacts|Terminated||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:06:04.912981|2017-10-11 03:06:04.912981
NCT01571726|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-04|2017-07-06|||March 27, 2012||2012-03-27|April 16, 2014|2014-04-16|April 23, 2014|Actual|2014-04-23|April 23, 2014|Actual|2014-04-23||Interventional|||Imaging Studies and the Development of Multiple Myeloma|Novel Imaging Modalities to Characterize Angiogenesis in the Bone Marrow Microenvironment in Multiple Myeloma (MM) and Its Precursor Disease|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:06:05.007436|2017-10-11 03:06:05.007436
NCT01571713|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-10-14|||August 2011||2011-08-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Side Effects of Pulmonary Hypertension Medications|Patient Reported Side Effects of Pulmonary Hypertension (PH) Medications|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||t||||||||No||2017-10-11 03:06:05.099263|2017-10-11 03:06:05.099263
NCT01571700|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-10-14|||September 2006||2006-09-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Investigation of Dysynchrony in Patients With Pulmonary Hypertension|Investigation of Dysynchrony in Patients With Pulmonary Hypertension|Recruiting||N/A|100|Anticipated|Stanford University|||2||f||||t||||||||Yes|Publication|2017-10-11 03:06:05.172944|2017-10-11 03:06:05.172944
NCT01571687|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-04-03|||April 2009||2009-04-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|PLHARE||Pik Lenin High Altitude Research Expedition 2009|Pik Lenin High Altitude Research Expedition 2009, a Follow-up Project of the Muztagh Ata High Altitude Research Expedition 2005|Completed||N/A|30|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 03:06:05.257271|2017-10-11 03:06:05.257271
NCT01571674|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-05-13|||January 2012||2012-01-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Validation of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation: A Randomized Clinical Trial|Validation of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation: A Randomized Clinical Trial|Completed||Phase 2/Phase 3|140|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 03:06:05.350564|2017-10-11 03:06:05.350564
NCT01571661|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-04-03|||September 2004||2004-09-01|April 2012|2012-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus|A Double Blind, Randomized, Placebo Controlled, Single-dose Escalation, First-time-in-human Crossover Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|16|Actual|GlaxoSmithKline||8|||f||||f||||||||||2017-10-11 03:06:05.748455|2017-10-11 03:06:05.748455
NCT01571648|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2013-06-14|||April 2012||2012-04-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azacitidine in Japanese Patients With Myelodysplastic Syndromes|A Phase 1, Multicenter, Open-label Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azacitidine in Japanese Subjects With Myelodysplastic Syndromes|Completed||Phase 1|5|Actual|Celgene||1|||f||||f||||||||||2017-10-11 03:06:05.842561|2017-10-11 03:06:05.842561
NCT01571635|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-01-19||2015-12-11|October 2012||2012-10-01|January 2017|2017-01-01|February 2020|Anticipated|2020-02-01|July 2015|Actual|2015-07-01||Interventional|||Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.|A Phase 2A, Open-label Dose Finding Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With BETA(b)-THALASSEMIA.|Active, not recruiting||Phase 2|46|Actual|Celgene||6|||f||||f||||||||||2017-10-11 03:06:05.943983|2017-10-11 03:06:05.943983
NCT01571622|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-03-27|||April 2012||2012-04-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|WheyGLP-1||Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes|Effect of Whey Protein Concentrate on Postprandial Glycemic Insulin, Active and Intact GLP-1and GIP, and DPP-4 Response in Type 2 Diabetic Patients|Completed||N/A|19|Actual|Tel Aviv University||2|||f||||t||||||||||2017-10-11 03:06:06.06319|2017-10-11 03:06:06.06319
NCT01571609|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2014-12-01|||August 2012||2012-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|July 2013|Actual|2013-07-01||Interventional|||Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders|Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders|Completed||N/A|40|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:06:06.148689|2017-10-11 03:06:06.148689
NCT01571596|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-06-10||2015-01-12|February 2012||2012-02-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|||An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia|An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia|Completed||Phase 1/Phase 2|23|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||f||||||||||2017-10-11 03:06:06.232113|2017-10-11 03:06:06.232113
NCT01571583|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-06-29|||February 2012||2012-02-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|REPLACE||An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation|Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects|Completed||Phase 3|74|Actual|Janssen-Cilag International NV||1|||f||||t||||||||||2017-10-11 03:06:06.330847|2017-10-11 03:06:06.330847
NCT01571570|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2013-06-24|||March 2012||2012-03-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.|A Phase I, Open-Label, Randomized, 3-Panel, 3-way Crossover Trial in Healthy Adult Subjects to Assess the Relative Bioavailability of TMC435 Following Administration of 2 Liquid Formulations or 2 Different Capsule Concept Formulations Compared ot the Phase III 150 mg Capsule, and to Assess the Effect of Food on the Bioavailability of TMC435 Following Administration of the Liquid Formulations.|Completed||Phase 1|72|Actual|Janssen R&D Ireland||9|||f||||f||||||||||2017-10-11 03:06:06.599228|2017-10-11 03:06:06.599228
NCT01571557|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2015-06-22|2015-06-22||April 2012||2012-04-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Observational|||A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)||Completed||N/A|573|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:06:06.740029|2017-10-11 03:06:06.740029
NCT01571544|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-01-03|||November 2012||2012-11-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|April 2013|Actual|2013-04-01||Interventional|||The Use of Thermal Suits as Preventing Hypothermia During Surgery|The Use of Thermal Suits as Preventing Hypothermia During Surgery|Completed||Phase 4|100|Actual|Tampere University Hospital||2|||f||||t||||||||||2017-10-11 03:06:06.981841|2017-10-11 03:06:06.981841
NCT01571531|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-05-03|||April 2004||2004-04-01|May 2017|2017-05-01|August 2026|Anticipated|2026-08-01|August 2026|Anticipated|2026-08-01||Observational|||European Multicentre Study of Human Spinal Cord Injury|European Multicentre Study of Human SCI|Recruiting||N/A|5500|Anticipated|University of Zurich|||1||f||||t||||||||||2017-10-11 03:06:07.059772|2017-10-11 03:06:07.059772
NCT01571518|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-04-03|||April 2012||2012-04-01|April 2012|2012-04-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy|Optimal Timing and Duration of Daily G-CSF With Adjuvant TAC Chemotherapy in Node-positive Breast Cancer;Multicenter, Randomized, Open Label, Clinically IV Phase|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Sunchonhang University||2|||f||||t||||||||||2017-10-11 03:06:07.139767|2017-10-11 03:06:07.139767
NCT01571505|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-08-30|||March 1, 2012|Actual|2012-03-01|August 2017|2017-08-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Interventional|||Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)|Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA|Completed||Phase 1|372|Actual|International Vaccine Institute||2|||f||||f||||||||||2017-10-11 03:06:07.247975|2017-10-11 03:06:07.247975
NCT01571492|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-06-05|||June 2009||2009-06-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|October 2010|Actual|2010-10-01||Interventional|||Continuous L2 Paravertebral Block Versus Continuous Lumbar Plexus Block for Postoperative Analgesia|Continuous L2 Paravertebral Block Versus Continuous Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty|Completed||N/A|60|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 03:06:07.356987|2017-10-11 03:06:07.356987
NCT01571466|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-03-31|||September 2011||2011-09-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|2009-016578-34||A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART|A Double-blind Phase I Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART|Completed||Phase 1|30|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 03:06:07.567487|2017-10-11 03:06:07.567487
NCT01571453|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2014-10-06|2014-10-06||May 2012||2012-05-01|October 2014|2014-10-01||||October 2013|Actual|2013-10-01||Interventional||"The all-patients-treated set (APTS) comprises all randomized patients who took at least one dose of IMP.
Baseline age and gender is based on the APTS. Baseline efficacy outcome measures is based on the full-analysis set (FAS)."|Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries|Randomised, Double-blind, Parallel-group, Active-comparator (Venlafaxine Extended Release), Fixed-dose Study of [Vortioxetine] Lu AA21004 in Major Depressive Disorder in Asian Countries|Completed||Phase 3|437|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 03:06:07.667068|2017-10-11 03:06:07.667068
NCT01571440|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-12|2014-02-07|||February 2010||2010-02-01|February 2014|2014-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Soluble Corn Fiber and Calcium Utilization in Adolescents|The Effect of Soluble Corn Fiber on Calcium Utilization and Retention and Gut Microflora in Adolescents|Completed||N/A|24|Actual|Purdue University||2|||f||||f||||||||||2017-10-11 03:06:08.140739|2017-10-11 03:06:08.140739
NCT01571427|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-08-08|||February 2012||2012-02-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|conversation||Conversations as a Means to Delay the Onset of Alzheimer's Disease|Conversational Engagement as a Means to Delay Alzheimer's Disease Onset|Completed||Early Phase 1|96|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 03:06:08.241495|2017-10-11 03:06:08.241495
NCT01571011|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-07-31|||March 2012||2012-03-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CURB||Chicago Urban Resiliency Building (CURB)|Chicago Urban Resiliency Building (CURB): Phase 3 Clinical Trial in Primary Care to Engage Adolescents With a Web-based Depression Prevention Intervention|Completed||N/A|10|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 03:06:20.632|2017-10-11 03:06:20.632
NCT01571414|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-04-02|||May 2012||2012-05-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin|A Phase I, Three-Arm Safety, Tolerability, and Pharmacokinetic Interaction Study of PA-824, an Investigational Nitroimidazole for the Treatment of Tuberculosis, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin|Completed||Phase 1|52|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-10-11 03:06:08.331019|2017-10-11 03:06:08.331019
NCT01571401|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-06-17|||April 2012||2012-04-01|April 2012|2012-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|TRACKS||Trying Activity in Kidney Cancer Survivors (TRACKS) Trial|Trying Activity in Kidney Cancer Survivors (TRACKS) Trial: A Randomized Controlled Trial Comparing the Effects of Supervised Physical Activity Versus Supervised Physical Activity Plus Behavioural Counselling|Completed||Phase 2|32|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 03:06:08.448205|2017-10-11 03:06:08.448205
NCT01571388|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2013-12-16|||April 2012||2012-04-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study To Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic Impairment|A Phase 1 Study To Evaluate The Single Dose Pharmacokinetics Of Dacomitinib (PF-00299804) In Subjects With Impaired Hepatic Function|Completed||Phase 1|25|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:06:08.542927|2017-10-11 03:06:08.542927
NCT01571375|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-10-20|||June 2012||2012-06-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|November 2020|Anticipated|2020-11-01||Observational|||The Effect of Different Emergency Medical Systems on the Prognosis of Traumatic Brain Injury - a Prospective Study|The Differences Between Out-of-hospital Severe Traumatic Brain Injury (TBI) Treatment in a Physician-staffed Versus Paramedic-staffed Emergency Medical Service (EMS) Unit and Its Effect on Patient Prognosis|Suspended||N/A|400|Anticipated|Tampere University Hospital|||2||f||||f||||||||||2017-10-11 03:06:08.640246|2017-10-11 03:06:08.640246
NCT01571362|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-02-17|2016-10-06|2014-08-04|June 2012||2012-06-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain|A Multicenter, 12 Week, Double-blind, Placebo-controlled, Randomized Withdrawal Study To Determine The Efficacy And Safety Of Alo-02 (Oxycodone Hydrochloride And Naltrexone Hydrochloride) Extended-release Capsules In Subjects With Moderate To Severe Chronic Low Back Pain|Completed||Phase 3|410|Actual|Pfizer||2|||f||||f|t|f||||||||2017-10-11 03:06:09.000348|2017-10-11 03:06:09.000348
NCT01571349|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2013-12-24|||April 2012||2012-04-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura|Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura|Completed||N/A|20|Actual|Samsung Medical Center|||2||f||||t||||||||||2017-10-11 03:06:14.096815|2017-10-11 03:06:14.096815
NCT01571336|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2016-09-26|||April 2012||2012-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Observational|||Photodynamic Therapy of Actinic Keratoses With Alacare®|Non-interventional Observational Study on Photodynamic Therapy of Actinic Keratoses With Alacare®|Completed||N/A|388|Actual|photonamic GmbH & Co. KG|||1||f||||t||||||||||2017-10-11 03:06:15.827469|2017-10-11 03:06:15.827469
NCT01571323|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-10-10|||February 2012||2012-02-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section||Completed||Phase 1/Phase 2|150|Actual|Qazvin University Of Medical Sciences||3|||f||||t||||||||||2017-10-11 03:06:15.9866|2017-10-11 03:06:15.9866
NCT01571297|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-09-21||2014-11-06|April 2012||2012-04-01|September 2016|2016-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis|Completed||Phase 2|204|Actual|Motus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 03:06:16.148763|2017-10-11 03:06:16.148763
NCT01571284|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2017-02-28|||May 2012||2012-05-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen|A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen|Completed||Phase 3|780|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:06:16.290576|2017-10-11 03:06:16.290576
NCT01571271|ClinicalTrials.gov processed this data on October 10, 2017|2009-12-23|2017-03-28|||January 2010||2010-01-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|EHLvlaser||Electrohydraulic Versus Laser Lithotripsy for Treatment of Difficult to Remove Biliary Stones|Electrohydraulic Versus Laser Lithotripsy for Treatment of Difficult to Remove Biliary Stones|Completed||N/A|25|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-11 03:06:17.88735|2017-10-11 03:06:17.88735
NCT01571258|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-03|2012-04-04|||September 2010||2010-09-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|Text4Diet||Text4Diet: A Text Messaging Program for Weight Loss|Text4Diet: A Text Messaging Program for Weight Loss|Completed||N/A|170|Actual|Santech, Inc||2|||f||||f||||||||||2017-10-11 03:06:17.992702|2017-10-11 03:06:17.992702
NCT01571245|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-12-14|||April 2012||2012-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Predicting Treatment Response Using Psychophysiologic Reactivity Measures|Predicting Treatment Response Using Psychophysiologic Reactivity Measures|Completed||N/A|9|Actual|Central Arkansas Veterans Healthcare System|||1||f||||f||||||||||2017-10-11 03:06:18.209095|2017-10-11 03:06:18.209095
NCT01571232|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-04-26|2017-04-26||April 2012||2012-04-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|February 2014|Actual|2014-02-01||Interventional|||Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema|Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema.|Completed||Phase 2|20|Actual|Retina Macula Institute||2|||f||||f||||||||||2017-10-11 03:06:18.300996|2017-10-11 03:06:18.300996
NCT01571219|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-07-30|||March 2012||2012-03-01|July 2017|2017-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1|An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-Administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab(Remicade or CP-P13) in Study CT-P13 3.1|Completed||Phase 3|302|Actual|Celltrion||1|||f||||f||||||||||2017-10-11 03:06:18.630006|2017-10-11 03:06:18.630006
NCT01571206|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-07-30|||March 2012||2012-03-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1|An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1|Completed||Phase 1|174|Actual|Celltrion||1|||f||||f||||||||||2017-10-11 03:06:18.733294|2017-10-11 03:06:18.733294
NCT01571193|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-10-04|||November 2011||2011-11-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Twelve-Month Study of Pomegranate Extract in Normal Aging|Twelve-Month, Double-blind, Placebo-Controlled Study of Pomegranate Extract in Normal Aging|Unknown status|Recruiting|Phase 1/Phase 2|212|Anticipated|POM Wonderful LLC||2|||f||||t||||||||||2017-10-11 03:06:18.830317|2017-10-11 03:06:18.830317
NCT01571180|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-05-17|||April 2012||2012-04-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|INOGMA||Influence of Obesity and Gastric Bypass on Medication Absorption|Influence of Obesity and Gastric Bypass on Medication Absorption: Prospective Follow-up of Patients|Active, not recruiting||N/A|100|Anticipated|Katholieke Universiteit Leuven|||1||f||||t||||||||||2017-10-11 03:06:18.939297|2017-10-11 03:06:18.939297
NCT01571167|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2013-06-12|||January 2011||2011-01-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|Varenicline||Varenicline as a Treatment for Methamphetamine Dependence|A Human Laboratory Assessment of the Safety and Potential Efficacy of Varenicline in Methamphetamine-Dependent Volunteers Receiving Methamphetamine|Completed||Phase 1|17|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-10-11 03:06:19.061743|2017-10-11 03:06:19.061743
NCT01571141|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-04-18||||||June 2011|2011-06-01||||||||Interventional|||Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection||Completed||Phase 4|||AGUNCO Obstetrics and Gynecology Centre||2|||f||||f||||||||||2017-10-11 03:06:19.189271|2017-10-11 03:06:19.189271
NCT01571128|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-03-14|||November 2014|Actual|2014-11-01|March 2017|2017-03-01|March 23, 2016|Actual|2016-03-23|March 23, 2016|Actual|2016-03-23||Interventional|MP3-Youth||Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)|Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)|Completed||Phase 4|1215|Actual|New York University||5|||f||||f||||||||||2017-10-11 03:06:19.298345|2017-10-11 03:06:19.298345
NCT01571115|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-08-12|||January 2012||2012-01-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|IER||Effects of Resistance Physical Exercise in Patients With Chronic Primary Insomnia|Effects of Resistance Physical Exercise in Patients With Chronic Primary|Completed||N/A|30|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-10-11 03:06:19.483744|2017-10-11 03:06:19.483744
NCT01571102|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2014-12-04|||February 2013||2013-02-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Impact of Physiotherapy on Short-term Outcome After Meniscectomy|Study of Impact of Physiotherapy on Short-term Outcome After Meniscectomy.|Unknown status|Recruiting|N/A|180|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-10-11 03:06:19.603438|2017-10-11 03:06:19.603438
NCT01571089|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2015-05-19|||March 2012||2012-03-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Anxiety Treatment Inspired by Dialectical Behavior Therapy (DBT)|Anxiety Treatment Inspired by Dialectical Behavior Therapy (DBT) - An Alternative for Patients Who Previously Received Exposure-based Treatment for Anxiety Without Sustained Improvements.|Completed||N/A|5|Actual|Örebro County Council||1|||f||||f||||||||||2017-10-11 03:06:19.733672|2017-10-11 03:06:19.733672
NCT01571076|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-07-10|||June 2012||2012-06-01|November 2013|2013-11-01|February 2015|Anticipated|2015-02-01|September 2014|Anticipated|2014-09-01||Interventional|||Preimplantation Genetic Screening (PGS) in Advanced Female Age and Male Severe Factor|Prospective and Randomized Study of the Use of Comparative Genomic Hybridization (CGH) Arrays to Study Embryo Aneuploidies in Female Advanced Age and Male Factor In Vitro Fertilization (IVF) Patients.|Unknown status|Recruiting|N/A|240|Anticipated|Igenomix||4|||f||||f||||||||||2017-10-11 03:06:19.835401|2017-10-11 03:06:19.835401
NCT01571063|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-10-24|||January 2013||2013-01-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D||Completed||Phase 2|22|Actual|University of Zurich||2|||f||||||||||||||2017-10-11 03:06:19.946545|2017-10-11 03:06:19.946545
NCT01571050|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-04-02|||January 2011||2011-01-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Systemic Fluoride Bioavailability From Toothpastes Containing Calcium Carbonate or Silica as Abrasives||Completed||Phase 1|20|Actual|University of Campinas, Brazil||5|||f||||f||||||||||2017-10-11 03:06:20.198549|2017-10-11 03:06:20.198549
NCT01571037|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2014-02-28|||April 2012||2012-04-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|||Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study|Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study|Completed||Phase 1|10|Actual|University of Nebraska||1|||f||||t||||||||||2017-10-11 03:06:20.36124|2017-10-11 03:06:20.36124
NCT01571024|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-04-24|||May 2012||2012-05-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|May 2015|Actual|2015-05-01||Interventional|||BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer|A Phase I Study of BKM120 With mFOLFOX6 in Patients With Advanced Solid Tumors With Expansion Cohort in Metastatic Pancreatic Cancers.|Completed||Phase 1|17|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:06:20.493727|2017-10-11 03:06:20.493727
NCT01569672|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-11-01|||November 2006||2006-11-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2010|Actual|2010-12-01||Interventional|OPNRP||Ohio Patient Navigator Research Program|Ohio Patient Navigation Research Program|Active, not recruiting||Phase 4|941|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-11 03:06:39.191952|2017-10-11 03:06:39.191952
NCT01570998|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-04-28|||May 2012||2012-05-01|April 2017|2017-04-01||||June 2017|Anticipated|2017-06-01||Interventional|||Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery|Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery|Recruiting||Phase 4|750|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:06:20.753889|2017-10-11 03:06:20.753889
NCT01570985|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-05-26|||February 2010||2010-02-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2013|Actual|2013-12-01||Interventional|FSS||Treatment Study of Frozen Shoulder: Corticosteroid Injection in Joint Versus Wait and See Policy|Outcome in Shoulder Capsulitis (Frozen Shoulder) Between Corticosteroid and Corticosteroid With Distension Compared to Wait and See Policy, a Randomised Controlled Trial|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|University of Bergen||3|||f||||t||||||||||2017-10-11 03:06:21.022526|2017-10-11 03:06:21.022526
NCT01570972|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-04-24|||February 2010|Actual|2010-02-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis|Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis|Completed||N/A|103|Actual|University of Arizona||1|||f||||f||||||||||2017-10-11 03:06:21.152391|2017-10-11 03:06:21.152391
NCT01570959|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-04-02|||April 2007||2007-04-01|April 2012|2012-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions|A Two Period, Two Treatment, Two Way, Steady State Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Fasting Conditions|Completed||N/A|56|Actual|Roxane Laboratories||1|||f||||f||||||||||2017-10-11 03:06:21.290156|2017-10-11 03:06:21.290156
NCT01570946|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2015-12-29|||May 2012||2012-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Use of Mobile Technology to Promote Sustained Lifestyle Changes to Prevent Type 2 Diabetes in India and the UK|A Pragmatic and Scalable Strategy Using Mobile Technology to Promote Sustained Lifestyle Changes to Prevent Type 2 Diabetes in India and the UK|Completed||N/A|1171|Actual|India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals||2|||f||||t||||||||||2017-10-11 03:06:21.388024|2017-10-11 03:06:21.388024
NCT01570933|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-12-06|||November 2011||2011-11-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|NIVNAVA||Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.|Feasibility Study Over the Neurally Adjusted Ventilatory Assist (NAVA) Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.|Completed||Phase 4|10|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 03:06:21.506012|2017-10-11 03:06:21.506012
NCT01570920|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-30|2012-04-02|||September 2009||2009-09-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Regular Brisk Walking in Chronic Stroke Patients|Effects of Regular Brisk Walking in Chronic Stroke Patients|Completed||N/A|34|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-10-11 03:06:21.631089|2017-10-11 03:06:21.631089
NCT01570907|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-04-02|||June 2007||2007-06-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Quetiapine Fumarate 25 mg Tablets Under Fasting Conditions|Completed||N/A|42|Actual|Roxane Laboratories||1|||f||||f||||||||||2017-10-11 03:06:21.734211|2017-10-11 03:06:21.734211
NCT01570894|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-04-02|||July 2007||2007-07-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions|Completed||N/A|42|Actual|Roxane Laboratories||1|||f||||f||||||||||2017-10-11 03:06:21.809375|2017-10-11 03:06:21.809375
NCT01570881|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2012-04-03|||April 2010||2010-04-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Association of Plasma Melatonin Levels With Delirium|Association of Plasma Melatonin Levels With Delirium After Sevoflurane Anesthesia|Completed||N/A|33|Actual|Okayama University|||1||f||||f||||||||||2017-10-11 03:06:21.89963|2017-10-11 03:06:21.89963
NCT01570855|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-04-25|||October 2011||2011-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|May 2014|Actual|2014-05-01||Observational|||Chemotherapy Resistance and Sensitivity Testing in Lung Tumors|Chemotherapy Resistance and Sensitivity Testing in Lung Tumors|Completed||N/A|45|Actual|Marshall University|||1||f||||f||||||||||2017-10-11 03:06:22.086521|2017-10-11 03:06:22.086521
NCT01570842|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2014-03-28|||October 2011||2011-10-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury|The Role of Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury|Completed||N/A|100|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 03:06:22.155161|2017-10-11 03:06:22.155161
NCT01570829|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-02-07|||December 2011||2011-12-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial of Safety and Efficiency of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients|Multicentric Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Safety and Efficiency of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients|Completed||Phase 3|332|Actual|Materia Medica Holding||2|||f||||f||||||||||2017-10-11 03:06:22.257924|2017-10-11 03:06:22.257924
NCT01570816|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-09-13|||April 2012||2012-04-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Improving Ambulatory Community Access After Paralysis|Improving Ambulatory Community Access After Paralysis|Active, not recruiting||Phase 1|6|Anticipated|Louis Stokes VA Medical Center||1|||f||||t||||||||||2017-10-11 03:06:22.370669|2017-10-11 03:06:22.370669
NCT01502540|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2013-01-13|||October 2010||2010-10-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Pain Prevalence After Major Craniotomy|Pain Prevalence After Major Craniotomy in Siriraj Hospital|Completed||N/A|302|Actual|Mahidol University|||1||f||||f||||||||||2017-10-11 03:26:29.976536|2017-10-11 03:26:29.976536
NCT01570803|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-04-24|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|SENS-FP||Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease|Efficacy of Self-Expanding Nitinol S.M.A.R.T-CONTROL Stent Versus Complete SE Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease : Prospective, Multicenter, Randomized, Controlled Trial (SENS-FP Trial)|Recruiting||N/A|346|Anticipated|Korea University Guro Hospital||2|||f||||t||||||||No||2017-10-11 03:06:22.460472|2017-10-11 03:06:22.460472
NCT01570790|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2012-04-03|||May 2003||2003-05-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration|An Open Label, Pilot (Phase I/II), Dose-Escalation Safety and Tolerability Study of Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration.|Completed||Phase 1/Phase 2|8|Actual|Johns Hopkins University||3|||||||f||||||||||2017-10-11 03:06:22.567998|2017-10-11 03:06:22.567998
NCT01570777|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-11-03|||April 2012||2012-04-01|October 2015|2015-10-01|April 2018|Anticipated|2018-04-01|May 2014|Actual|2014-05-01||Interventional|DENER-HTN||Renal Denervation in Hypertension|Renal Denervation in Patients With Resistant Hypertension|Active, not recruiting||Phase 4|121|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:06:22.662107|2017-10-11 03:06:22.662107
NCT01570764|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-09-14|||January 2013||2013-01-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|SCLEROCYC||Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease|Intravenous Cyclophosphamide for the Treatment of Systemic Sclerosis Associated Interstitial Lung Disease|Recruiting||Phase 3|50|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-10-11 03:06:22.938396|2017-10-11 03:06:22.938396
NCT01570751|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-01-24|2015-10-16|2014-01-24|April 2012||2012-04-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||For 4 subjects baseline fasting plasma glucose (FPG) values were missing, hence did not contribute to the FPG summary.|A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin|A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin|Completed||Phase 3|145|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:06:23.081861|2017-10-11 03:06:23.081861
NCT01570738|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-03-08|||July 2012||2012-07-01|April 2014|2014-04-01||||August 2017|Anticipated|2017-08-01||Observational|||Validation of Home Sleep Testing (WP200) Compared to an Overnight Sleep Testing in the Sleep Laboratory|Validation of Home Sleep Testing (WP200) Compared to an Overnight Sleep Testing in the Sleep Laboratory|Unknown status|Recruiting|N/A|150|Anticipated|Itamar-Medical, Israel|||1||f||||f||||||||||2017-10-11 03:06:23.628581|2017-10-11 03:06:23.628581
NCT01570725|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-22|2012-04-02|||October 2008||2008-10-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|VRSurg||Virtual Reality to Reduce Anxiety in Ambulatory Surgical Operations|A Portable Virtual Reality System as an Alternative Medical Treatment to Reduce Anxiety in Ambulatory Surgical Operations: a Randomized Controlled Study|Withdrawn||N/A|0|Actual|Istituto Auxologico Italiano||2||Difficulty in recruiting the selected subjects|f||||t||||||||||2017-10-11 03:06:23.693149|2017-10-11 03:06:23.693149
NCT01570712|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2014-08-29|||August 2011||2011-08-01|August 2014|2014-08-01|February 2015|Anticipated|2015-02-01|August 2014|Anticipated|2014-08-01||Interventional|||"Evaluation of the Housing First Program in Patients With Severe Mental Disorders in France"|"Evaluation of the Housing First Program in Patients With Severe Mental Disorders in France: a Multicentric Randomized Controlled Study"|Unknown status|Recruiting|N/A|600|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 03:06:23.778971|2017-10-11 03:06:23.778971
NCT01570699|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-09-28|||December 2012||2012-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|COM-ON||Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients|COMT Val158Met Polymorphism in Opiate-using Subjects Without Lifetime Opiate Dependence|Completed||N/A|87|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||Samples With DNA|"     We will compare polymorphism COMT between COM-ON patients and METHADOSE patients. Samples may     be blood sample or salivary sample.   "|||2017-10-11 03:06:23.869677|2017-10-11 03:06:23.869677
NCT01570686|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2014-01-15|2013-11-10||April 2012||2012-04-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||All Randomized patients (including one mis-randomized patient in Aliskiren:Fed arm).|8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension|An 8-week Randomized, Open-label, Multi-center Study to Evaluate the Efficacy and Safety of Oral Aliskiren 300 mg Once Daily Under Light Meal Versus Fasted Condition in Patients With Hypertension|Completed||Phase 4|589|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:06:23.991892|2017-10-11 03:06:23.991892
NCT01570673|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-06-11|||May 2012||2012-05-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Group Versus Individual Urotherapy for Children|Group Versus Individual Urotehrapy in Children With Non-neurogenic Lower Urinary Tract Dysfunction|Completed||N/A|60|Actual|Hamilton Health Sciences Corporation||2|||f||||f||||||||||2017-10-11 03:06:24.68426|2017-10-11 03:06:24.68426
NCT01570660|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-04-02|||February 2002||2002-02-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Phielix et al.: Hepatic Fat Content and Adipokines|Effects of Glimepiride Monotherapy Versus Combined Neteglinide-Pioglitazone Therapy on Insulin Sensitivity in Type 2 Diabetic Patients|Completed||N/A|24|Actual|German Diabetes Center||1|||f||||f||||||||||2017-10-11 03:06:24.760125|2017-10-11 03:06:24.760125
NCT01570647|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2013-10-08|||February 2012||2012-02-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|StromaTorque||Automated Connective Tissue Torque Sensor|Automated Connective Tissue Torque Sensor|Completed||N/A|165|Actual|Stromatec, Inc.|||5||f||||t||||||||||2017-10-11 03:06:24.844403|2017-10-11 03:06:24.844403
NCT01570452|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2012-04-03|||September 2005||2005-09-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|September 2008|Actual|2008-09-01||Observational|MMP7||Matrilysin Expression in Different Stages of Colorectal Tumors|Matrilysin Expression in Different Stages of Colorectal Tumors|Completed||N/A|38|Actual|University of Roma La Sapienza|||4||f||||f||||||Samples With DNA|"     normal mucosa, cancer tissue, lymph nodes and serum from cancer patients serum from healty     volunteers   "|||2017-10-11 03:06:26.920529|2017-10-11 03:06:26.920529
NCT01570634|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2013-02-03|2012-12-29||March 2012||2012-03-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection|Proof-of-Concept, CASAD for Treatment of Clostridium Difficile Infection|Terminated||Phase 2|2|Actual|Salient Pharmaceuticals Incorporated|This study was terminated early for slow enrollment. Only 2 patients were enrolled during the open period. One of the two took less than 50% of the prescribed study drug. The results are not meaningful.|1||Study was stopped for slow enrollment - only 2 patients, no evaluable results|f||||t||||||||||2017-10-11 03:06:24.919741|2017-10-11 03:06:24.919741
NCT01570608|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-01|2012-04-03|||March 2007||2007-03-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Lucentis KAV Study|Comparison of Ranibizumab (Lucentis) Monotherapy Versus Combination of Ranibizumab (Lucentis) With Photodynamic Therapy (Verteporfin) in Patients With Subfoveal Choroidal Neovascularisation Due to Age-Related Macular Degeneration - a Pilot Study|Completed||Phase 3|51|Actual|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||2|||f||||f||||||||||2017-10-11 03:06:25.219466|2017-10-11 03:06:25.219466
NCT01570595|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-05-09|||September 2011||2011-09-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|PSFW||Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV|A Pilot Study of Positively Smoke Free on the Web (PSFW) for HIV-infected Smokers|Completed||Phase 1/Phase 2|138|Actual|Georgetown University||2|||f||||||||||||||2017-10-11 03:06:25.31041|2017-10-11 03:06:25.31041
NCT01570582|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-04-03|||March 2010||2010-03-01|April 2012|2012-04-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|A Phase II Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Unknown status|Active, not recruiting|Phase 2|314|Anticipated|Korean Gynecologic Oncology Group||1|||f||||f||||||||||2017-10-11 03:06:25.408835|2017-10-11 03:06:25.408835
NCT01570569|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-04-01|||January 2011||2011-01-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Development of Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in Human|Development of High-throughput Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in Human|Completed||Phase 1|26|Actual|Inje University||5|||f||||f||||||||||2017-10-11 03:06:25.497403|2017-10-11 03:06:25.497403
NCT01570556|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-04-03|||December 2011||2011-12-01|March 2012|2012-03-01||||December 2013|Anticipated|2013-12-01||Interventional|||Clinical Impact of Bacteriuria on Chronic Inflammation in Asymptomatic Hemodialysis Patients|Clinical Impact of Bacteriuria on Chronic Inflammation in Asymptomatic Hemodialysis Patients|Unknown status|Recruiting|Phase 4|120|Anticipated|Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-10-11 03:06:25.60284|2017-10-11 03:06:25.60284
NCT01570543|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-09-27|||March 2012||2012-03-01|October 2012|2012-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|MRI||MRI Scanning of People With MR Safe Orthopedic Implants That Are Made of Metal|Development of MR Systems, Accessories, and Software for Imaging Subjects With Metallic Orthopedic Implants.|Withdrawn||N/A|0|Actual|GE Healthcare|||1|After over a year no subjects were identified|f||||f||||||||||2017-10-11 03:06:25.687911|2017-10-11 03:06:25.687911
NCT01570530|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-09-15|||January 2011||2011-01-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|PROFACE||Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery|Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery|Terminated||Phase 3|90|Actual|Fundación General Universidad de Valladolid||2||End of finantial support|f||||f||||||||||2017-10-11 03:06:25.770666|2017-10-11 03:06:25.770666
NCT01570517|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-08-03|||May 2012||2012-05-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Feasibility Trial of the DC Devices Interatrial Septal Device (IASD) System|Evaluation of the DC Devices IASD System in the Treatment of Patients With Heart Failure With Preserved Ejection Fraction|Completed||Phase 1/Phase 2|11|Actual|Corvia Medical||1|||f||||f||||||||||2017-10-11 03:06:25.954854|2017-10-11 03:06:25.954854
NCT01570504|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-05-24|||March 2013|Actual|2013-03-01|May 2017|2017-05-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|STRONGTREAT||Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis|Randomized, Open-label, Multi Centre Phase III Clinical Trial on Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis|Active, not recruiting||Phase 3|312|Actual|Centro per le Malattie Tropicali||2|||f||||t||||||||No||2017-10-11 03:06:26.036827|2017-10-11 03:06:26.036827
NCT01570478|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-03-28|||July 2012||2012-07-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|NELSON||A Study in Patients With Asthma|A 12-week, Multicenter, Randomized, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster® NEXThaler® (Beclomethasone Dipropionate 100 µg Plus Formoterol 6 µg/Actuation), 2 Inhalations b.i.d., Versus Seretide® Accuhaler® (Fluticasone 250 µg Plus Salmeterol 50 µg/Actuation), 1 Inhalation b.i.d., on Small Airway Derived Parameters in Patients With Asthma|Completed||Phase 3|108|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 03:06:26.27407|2017-10-11 03:06:26.27407
NCT01570465|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-05-25|||September 2012||2012-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|AML1411||Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients|Prospective Survey on Severe Infections During a Multicenter Study of Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia.|Recruiting||N/A|237|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||No||2017-10-11 03:06:26.406585|2017-10-11 03:06:26.406585
NCT01570426|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-07-18|||July 2007||2007-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|BBPP||Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy Controls|Brain/Behavior Alterations in Pediatric Psychopathology|Recruiting||N/A|240|Anticipated|Bradley Hospital|||4||f||||f||||||Samples With DNA|"     Spit samples are collected for DNA/RNA extraction.Genetic tests will be performed at the     Brown University affiliated Molecular Genetics Laboratory located at the Providence VA     Medical Center. For privacy purposes, all genetic samples will be assigned a study code     number to ensure that there is no identifiable information with them. After this study is     over, genetic samples will be disposed.   "|||2017-10-11 03:06:27.104051|2017-10-11 03:06:27.104051
NCT01570413|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-05-03|||February 2012||2012-02-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PEP||Pelvic Examination in Pregnancy|Utility of Pelvic Examination in the Evaluation of Threatened Abortion|Completed||N/A|220|Actual|Boston Medical Center||2|||f||||t||||||||||2017-10-11 03:06:27.230426|2017-10-11 03:06:27.230426
NCT01570400|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-10-29|||September 2012||2012-09-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|SOFIE13a||Treatment of Social Phobia With Combined Cognitive Bias Modification and iCBT|Reduction of Social Phobia Symptoms With Combined Internet-Based Cognitive Bias Modification and Cognitive Behavioral Therapy|Completed||N/A|133|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 03:06:27.347767|2017-10-11 03:06:27.347767
NCT01570387|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-01-03|||June 2012||2012-06-01|January 2017|2017-01-01|February 2030|Anticipated|2030-02-01|October 2017|Anticipated|2017-10-01||Interventional|||A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis|A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis|Active, not recruiting||Phase 1/Phase 2|27|Actual|Boston Medical Center||1|||f||||t||||||||No||2017-10-11 03:06:27.51147|2017-10-11 03:06:27.51147
NCT01570374|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-31|2016-10-31|||January 2012||2012-01-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Internet-based Treatment of Generalized Anxiety Disorder|Internet-based Treatment of Generalized Anxiety Disorder|Completed||N/A|103|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 03:06:27.623372|2017-10-11 03:06:27.623372
NCT01570361|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-06-27|||February 2012||2012-02-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|ATTEST||Atrial Fibrillation Progression Trial|Atrial Fibrillation Progression Trial|Recruiting||Phase 4|330|Anticipated|Biosense Webster, Inc.||2|||f||||f||||||||||2017-10-11 03:06:27.739425|2017-10-11 03:06:27.739425
NCT01570348|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-08-02|||July 2012||2012-07-01|August 2017|2017-08-01|February 2022|Anticipated|2022-02-01|February 2018|Anticipated|2018-02-01||Interventional|CATS||Crohn's Allogeneic Transplant Study|Allogeneic Hematopoietic Cell Transplantation for Patients With Treatment-Refractory Crohn's Disease: A Phase 2 Study|Suspended||Phase 2|2|Actual|Fred Hutchinson Cancer Research Center||1||Temporarily closed to enrollment|f||||t||||||||||2017-10-11 03:06:28.00031|2017-10-11 03:06:28.00031
NCT01570335|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-12-01|||April 2012||2012-04-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||The SBAR Effect on Safety Attitudes in the Perinatal Department||Completed||N/A|40|Actual|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-10-11 03:06:28.147629|2017-10-11 03:06:28.147629
NCT01570322|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2016-06-08||||||June 2016|2016-06-01||||||||Observational|||Determinants of Quality of Life Related to Health in Alzheimer Disease||Recruiting||N/A|400|Anticipated|CHU de Reims|||1||f||||f||||||||||2017-10-11 03:06:28.21633|2017-10-11 03:06:28.21633
NCT01570309|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2013-08-05|2012-09-23||August 2008||2008-08-01|August 2013|2013-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Vitamin D Repletion in Coronary Artery Disease|The Effects of Vitamin D Repletion on Endothelial Function and Inflammation in Patients With Coronary Artery Disease|Completed||N/A|96|Actual|New York City Health and Hospitals Corporation||2|||f||||f||||||||||2017-10-11 03:06:28.306445|2017-10-11 03:06:28.306445
NCT01570296|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-07-31|||October 3, 2011|Actual|2011-10-03|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|February 22, 2016|Actual|2016-02-22||Interventional|BKM120||A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR|A Phase Ib Trial of Gefitinib (EGFR Tyrosine Kinase Inhibitor, Iressa™) in Combination With BKM120, an Oral Pan-class I PI3K Inhibitor in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR|Active, not recruiting||Phase 1|38|Actual|National Cancer Centre, Singapore||1|||f||||f||||||||||2017-10-11 03:06:28.768401|2017-10-11 03:06:28.768401
NCT01570283|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-07-05||2016-01-21|September 2012||2012-09-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|April 2014|Actual|2014-04-01||Interventional|ARMS||ARMS - Rapidly Generated Multivirus-Specific CTLs for the Prophylaxis And Treatment of EBV, CMV, Adenovirus, HHV6, and BK Virus|ARMS - Administration Of Rapidly Generated Multivirus-Specific Cytotoxic T-Lymphocytes For The Prophylaxis And Treatment Of EBV, CMV, Adenovirus, HHV6, And BK Virus Infections Post Allogeneic Stem Cell Transplant|Active, not recruiting||Phase 1/Phase 2|43|Anticipated|ViraCyte||1|||f||||t||||||||||2017-10-11 03:06:28.864199|2017-10-11 03:06:28.864199
NCT01570270|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-04-03|||May 2009||2009-05-01|April 2012|2012-04-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Cheese Intake and Hypercholesterolemia||Completed||Phase 1/Phase 2|42|Actual|Azienda Ospedaliera Brotzu||1|||f||||f||||||||||2017-10-11 03:06:28.958914|2017-10-11 03:06:28.958914
NCT01570257|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2016-08-02|||September 2003||2003-09-01|March 2012|2012-03-01|October 2007|Actual|2007-10-01|December 2006|Actual|2006-12-01||Interventional|||A Trial of High and Low Pressure Level Settings on a Programmable Ventriculoperitoneal Shunt Valve for Idiopathic Normal Pressure Hydrocephalus|A Randomized Trial of High and Low Pressure Level Settings on a Programmable Ventriculoperitoneal Shunt Valve for Idiopathic Normal Pressure Hydrocephalus. Results of the Dutch Evaluation Program Strata Shunt (DEPSS) Trial|Completed||N/A|58|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 03:06:29.023432|2017-10-11 03:06:29.023432
NCT01570244|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2015-07-03|2015-07-03||April 2012||2012-04-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Drug-drug Interaction of BI 201335 and Microgynon|An Open-label, Two-period, Fixed-sequence, Phase I Trial to Evaluate the Effect of Multiple Doses of 240 mg BI 201335 QD on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Premenopausal Female Volunteers|Completed||Phase 1|16|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:06:29.138694|2017-10-11 03:06:29.138694
NCT01570231|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2012-07-26|||January 2008||2008-01-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Feasibility, Safety and Efficacy of Remote Ischemic Preconditioning for Symptomatic Intracranial Arterial Stenosis in Octogenarians|Feasibility, Safety and Efficacy of RIPC for Symptomatic Intracranial Arterial Stenosis in Octogenarians|Completed||Phase 1|58|Actual|Capital Medical University||2|||f||||||||||||||2017-10-11 03:06:29.610383|2017-10-11 03:06:29.610383
NCT01570218|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2012-04-01|||February 2010||2010-02-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy|Randomized Clinical Trial Testing Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy.|Completed||Phase 3|164|Actual|Universidade Federal de Goias||2|||f||||f||||||||||2017-10-11 03:06:29.690184|2017-10-11 03:06:29.690184
NCT01570205|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-04-03|||July 2011||2011-07-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers|The Safety, Tolerability and Pharmacokinetics of a Single Intravenous Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Male Volunteers in a Randomized, Double Blind, Placebo Controlled, Dose Escalating Phase I Study|Completed||Phase 1|24|Actual|Xigen SA||4|||f||||f||||||||||2017-10-11 03:06:29.789404|2017-10-11 03:06:29.789404
NCT01570179|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2013-01-23|||May 2012||2012-05-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|SugReBaCh-1||Sugammadex-dosing in Bariatric Patients|Sugammadex in Patients Undergoing Bariatric Surgery: An Equivalence Trial Comparing Real and Ideal Body Weight-based Dosing|Completed||Phase 3|34|Actual|Central Hospital, Nancy, France||4|||f||||t||||||||||2017-10-11 03:06:30.884148|2017-10-11 03:06:30.884148
NCT01570166|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-04-03|||November 2011||2011-11-01|March 2012|2012-03-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma|Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|180|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:06:31.011957|2017-10-11 03:06:31.011957
NCT01570153|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-03-21|||March 2012||2012-03-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|July 2012|Actual|2012-07-01||Observational|BIONICS-HF||Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial|Biomarkers Plus Bioimpedance Vector Analysis to Predict Cardiorenal Syndrome Onset and Prognosis in Patients With Acutely Decompensated Heart Failure: Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial|Completed||N/A|100|Actual|Massachusetts General Hospital|||1||f||||t||||||Samples Without DNA|"     10 ml sample of blood will be draw into a tube containing ethylenediaminetetraacetic acid,     spun for 15 minutes, and aliquoted to freezer tubes for biomarker measurement following the     completition of the trial   "|||2017-10-11 03:06:31.133946|2017-10-11 03:06:31.133946
NCT01570140|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-11-29|||May 2012||2012-05-01|November 2013|2013-11-01|October 2015|Anticipated|2015-10-01|February 2015|Anticipated|2015-02-01||Observational|LSD||Large Scale Demonstrator, Webportal Diabetes|Large Scale Demonstrator, Webportal Diabetes|Unknown status|Recruiting|N/A|10000|Anticipated|Medical Research Foundation, The Netherlands|||1||f||||f||||||||||2017-10-11 03:06:31.262578|2017-10-11 03:06:31.262578
NCT01570127|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-04-05|||October 2010||2010-10-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Interventional|||Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Low Back Pain|Clinical Trial to Evaluate and Compare the Efficacy and Safety of Individualized and Standardized Acupuncture for Low Back Pain Patients: Randomized, Double-blind, Controlled Study|Unknown status|Recruiting|Phase 2|276|Anticipated|Kyunghee University Medical Center||4|||f||||t||||||||||2017-10-11 03:06:31.390185|2017-10-11 03:06:31.390185
NCT01570114|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-30|||January 2011||2011-01-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Observational|||Covered Metallic Stent and Benign Colonic Strictures|EFFICACY OF A SELF EXPANDABLE FULLY COVERED METALLIC STENT IN THE TREATMENT OF BENIGN COLONIC STRICTURES|Completed||Phase 2|43|Actual|Société Française d'Endoscopie Digestive|||1||f||||f||||||||||2017-10-11 03:06:31.500059|2017-10-11 03:06:31.500059
NCT01570101|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-04-29|||December 2011||2011-12-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|July 2013|Actual|2013-07-01||Interventional|eSCOPE||European Sapheon™ Closure System Observational ProspectivE (eSCOPE) Study|"Post Market Study - European Observational Study of the Sapheon™ Closure System for the Definitive Treatment of Incompetent Great Saphenous Veins: A Prospective Single Arm Multicenter Clinical Observational Study"|Completed||N/A|70|Actual|Medtronic Endovascular||1|||f||||f||||||||No||2017-10-11 03:06:31.594404|2017-10-11 03:06:31.594404
NCT01570088|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-12-12|||April 2012||2012-04-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bioavailability of Folic Acid Fortified Bread|Bioavailability of Folic Acid and L-5-methyltetrahydrofolic Acid in Fortified Bread: a Randomized Placebo-controlled Trial|Completed||Phase 2|45|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-11 03:06:31.695373|2017-10-11 03:06:31.695373
NCT01570075|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-03-30|||November 2011||2011-11-01|March 2012|2012-03-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria|Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria|Unknown status|Recruiting|Phase 4|180|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:06:31.815873|2017-10-11 03:06:31.815873
NCT01570062|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-04-10|||November 2011||2011-11-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|CLEAR||Cardiovascular Effects of Aerosols in Residences Study|Subclinical Cardiovascular Health Benefits of Interventions to Reduce Exposure to Combustion-Derived Particulate Air Pollution|Completed||Phase 2|83|Actual|Simon Fraser University||2|||f||||t||||||||||2017-10-11 03:06:31.918472|2017-10-11 03:06:31.918472
NCT01570049|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-08-01|||April 2010||2010-04-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma|A Multicenter, Single Arm Clinical Trial in Patients With Rituximab Refractory B-cell Indolent Lymphoma|Unknown status|Recruiting|Phase 3|100|Anticipated|Shandong Lanjin Pharmaceuticals Co.,Ltd||1|||f||||t||||||||||2017-10-11 03:06:32.016699|2017-10-11 03:06:32.016699
NCT01570036|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2017-08-14|||January 2013||2013-01-01|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax|Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2-expressing Breast Cancer Patients to Prevent Recurrence|Recruiting||Phase 2|300|Anticipated|Cancer Insight, LLC||2|||f||||t||||||||||2017-10-11 03:06:32.160409|2017-10-11 03:06:32.160409
NCT01570023|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-10-09|||April 2012||2012-04-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study of Tongue Strengthening for Swallowing Problems|Comparison Between Isometric Lingual Strengthening Exercises and Standard Clinical Care for the Treatment of Dysphagia|Completed||N/A|34|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 03:06:32.468205|2017-10-11 03:06:32.468205
NCT01570010|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-12-04|||March 2012||2012-03-01|December 2015|2015-12-01|March 2040|Anticipated|2040-03-01|March 2040|Anticipated|2040-03-01||Interventional|NFS||Effect of the New Norwegian Food Based Dietary Guidelines on Chronic Diseases in Colorectal Cancer Survivors|Effect of the New Norwegian Food Based Dietary Guidelines on Chronic Diseases in Colorectal Cancer Survivors|Recruiting||N/A|500|Anticipated|University of Oslo||2|||f||||t||||||||||2017-10-11 03:06:32.5784|2017-10-11 03:06:32.5784
NCT01569997|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2015-08-21|||May 2010||2010-05-01|August 2015|2015-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|IDEM||Impact of Systematic Tracking of Dementia Cases on the Rate of Hospitalization in Emergency Care Units|Interest of Systematic Tracking of Dementia Cases in Nursing Homes: Analysing the Contribution of MultiDisciplinary Team Meeting (MDTM) in Alzheimer's Disease and Related Diseases|Completed||N/A|1428|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 03:06:32.703024|2017-10-11 03:06:32.703024
NCT01569984|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-10-12|||March 2012||2012-03-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SBRT-Avastin||Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis|An Open Label, Single-Centre, Phase II Study for Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy (SBRT) for Colorectal Liver Metastasis (SBRT Avastin)|Completed||Phase 2|11|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 03:06:32.93414|2017-10-11 03:06:32.93414
NCT01569971|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2014-06-23|||March 2012||2012-03-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program|Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program|Completed||N/A|55|Actual|St. Jude Children's Research Hospital|||3||f||||f||||||||||2017-10-11 03:06:33.01018|2017-10-11 03:06:33.01018
NCT01569958|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-10-08|||July 2012||2012-07-01|October 2012|2012-10-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Transcranial Direct Current Stimulation as a Novel Therapeutic Approach in Amyotrophic Lateral Sclerosis|Transcranial Direct Current Stimulation as a Novel Therapeutic Approach in Amyotrophic Lateral Sclerosis|Unknown status|Recruiting|Phase 2|54|Anticipated|Università degli Studi 'G. d'Annunzio' Chieti e Pescara||2|||f||||t||||||||||2017-10-11 03:06:33.142032|2017-10-11 03:06:33.142032
NCT01569945|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2014-09-09|||September 2004||2004-09-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur||Completed||N/A|371|Actual|University Hospital, Gasthuisberg||2|||f||||f||||||||||2017-10-11 03:06:33.233917|2017-10-11 03:06:33.233917
NCT01569932|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-02-25|||February 2011||2011-02-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|CFCC||Cognitive Changes in Adult Cancer Survivors|Cognitive and Functional Changes With Chemotherapy in Adult Cancer|Completed||N/A|13|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 03:06:33.310942|2017-10-11 03:06:33.310942
NCT01569919|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2013-03-11|||December 2012||2012-12-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|SKOPOS||A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma|A Phase II Trial to Assess the Safety, Immunological Activity of TroVax® Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma|Unknown status|Recruiting|Phase 2|26|Anticipated|Wales Cancer Trials Unit||1|||f||||t||||||||||2017-10-11 03:06:33.381838|2017-10-11 03:06:33.381838
NCT01569906|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-04-03|||April 2009||2009-04-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Narrowband UVB for Children With Moderate to Severe Atopic Eczema|Narrowband Ultraviolet B Phototherapy in Children With Moderate to Severe Atopic Eczema- an Observational Prospective Controlled Study|Completed||N/A|58|Actual|Royal Victoria Infirmary|||2||f||||f||||||Samples With DNA|"     saliva   "|||2017-10-11 03:06:33.487252|2017-10-11 03:06:33.487252
NCT01569893|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-10-27|||March 2012||2012-03-01|January 2014|2014-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Life-Long Monitoring of Diabetes Mellitus in Veneto Region|RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring of Diabetes Mellitus|Completed||N/A|598|Actual|Regione Veneto||2|||f||||t||||||||||2017-10-11 03:06:33.572129|2017-10-11 03:06:33.572129
NCT01569880|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-03-30|||January 2006||2006-01-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Pre-flight Evaluation of Adult Patients With Cystic Fibrosis|Pre-flight Evaluation of Adult Patients With Cystic Fibrosis|Completed||N/A|30|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 03:06:33.653|2017-10-11 03:06:33.653
NCT01569867|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-09-26|||March 2012||2012-03-01|September 2016|2016-09-01|March 2022|Anticipated|2022-03-01|June 2020|Anticipated|2020-06-01||Observational|||Genetic Influence on Statin Pharmacokinetics|An Observational Study Investigating Genetic Influences on Statin Plasma Concentrations in Adults Taking Atorvastatin, Simvastatin, or Lovastatin|Recruiting||N/A|800|Anticipated|Ohio State University|||1||f||||f||||||Samples With DNA|"     Frozen plasma and frozen nuclear pellet   "|||2017-10-11 03:06:33.717042|2017-10-11 03:06:33.717042
NCT01569854|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-09-26|||March 2012||2012-03-01|September 2016|2016-09-01|March 2022|Anticipated|2022-03-01|March 2016|Anticipated|2016-03-01||Observational|||Genetic Influence on Statin Pharmacodynamics|An Observational Study Investigating Genetic Influences on Clinical Outcomes and Change in Carotid Intimal Thickness in Adults Taking Atorvastatin, Simvastatin, or Lovastatin|Withdrawn||N/A|0|Actual|Ohio State University|||1|Insufficient recruitment|f||||f||||||Samples With DNA|"     nuclear pellet   "|||2017-10-11 03:06:33.795751|2017-10-11 03:06:33.795751
NCT01569841|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-01-21|2015-10-16|2012-12-19|April 2012||2012-04-01|January 2016|2016-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes|A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes|Completed||Phase 3|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:06:33.863051|2017-10-11 03:06:33.863051
NCT01569828|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-08-27|2015-07-30||March 2009||2009-03-01|August 2015|2015-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function|An Open Label, Parallel-group Study to Determine Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment Compared to Matched Healthy Subjects With Normal Renal Function|Completed||Phase 2|12|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:06:35.795192|2017-10-11 03:06:35.795192
NCT01569815|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-09-25|2015-07-30||February 2009||2009-02-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function|An Open Label, Parallel-group Study to Determine Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Mild and Moderate Renal Impairment Compared to Matched Healthy Subjects With Normal Renal Function|Completed||Phase 1|32|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:06:36.307907|2017-10-11 03:06:36.307907
NCT01569802|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-30|||January 2012||2012-01-01|March 2012|2012-03-01||||||||Observational|||A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population|A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population|Unknown status|Recruiting|N/A|10000|Anticipated|Rose Imaging Specialists, P.A.|||1||f||||f||||||||||2017-10-11 03:06:37.590957|2017-10-11 03:06:37.590957
NCT01569789|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-04-14|||January 2012||2012-01-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Auricular Vagus Nerve Stimulation on the Pro-inflammatory Cytokine Response in Healthy Adults|Effects of Auricular Vagus Nerve Stimulation on the Pro-inflammatory Cytokine Response in Healthy Adults|Completed||Phase 1|24|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 03:06:37.66524|2017-10-11 03:06:37.66524
NCT01569776|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2013-06-24|||April 2012||2012-04-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Elemental Formula Hypoallergenicity|Evaluation of Hypoallergenicity of an Amino Acid-Based Infant Formula|Completed||N/A|37|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 03:06:37.75432|2017-10-11 03:06:37.75432
NCT01569763|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-09-05|2016-04-01||March 2012||2012-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|January 2015|Actual|2015-01-01||Interventional||Enrolled Subjects|Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation|Minerva Pivotal Study|Active, not recruiting||N/A|153|Actual|Minerva Surgical, Inc.||2|||f||||t||||||||||2017-10-11 03:06:37.897358|2017-10-11 03:06:37.897358
NCT01569750|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-08-18|||June 14, 2012|Actual|2012-06-14|August 2017|2017-08-01|September 4, 2014|Actual|2014-09-04|September 4, 2014|Actual|2014-09-04||Interventional|||A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma|A Phase 1b Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects With CD20-Positive B-Cell Non Hodgkin Lymphoma (NHL)|Completed||Phase 1|33|Actual|Janssen Research & Development, LLC||1|||f||||t||f||||||||2017-10-11 03:06:38.327796|2017-10-11 03:06:38.327796
NCT01569737|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-06-06|||January 2012||2012-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ellipse II||Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella|Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella|Recruiting||N/A|100|Anticipated|HRA Pharma|||1||f||||t||||||||||2017-10-11 03:06:38.462727|2017-10-11 03:06:38.462727
NCT01569724|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-07-19|||January 2012||2012-01-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|December 2016|Actual|2016-12-01||Interventional|TgBEX||Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma|Estimation of Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene Treatment of Cutaneous T Cell Lymphoma - Pilote Study|Completed||Phase 4|10|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 03:06:38.554828|2017-10-11 03:06:38.554828
NCT01569711|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2015-05-26|||February 2009||2009-02-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|PRESTHYM||Deep Brain Stimulation of Nucleus Accumbens for Chronic and Resistant Major Depressive Disorder|Preliminary Study Evaluating Deep Brain Stimulation of Nucleus Accumbens in Patients Suffering From Chronic and Resistant Major Depressive Disorder|Completed||N/A|6|Actual|Rennes University Hospital|||1||f||||f||||||||||2017-10-11 03:06:38.642197|2017-10-11 03:06:38.642197
NCT01569698|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-09-06|||June 2012||2012-06-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|June 2016|Actual|2016-06-01||Observational|EPURE||Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury|Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury|Recruiting||N/A|600|Anticipated|Rennes University Hospital|||1||f||||f||||||||||2017-10-11 03:06:38.872977|2017-10-11 03:06:38.872977
NCT01569685|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-03-03|||April 2012||2012-04-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PTF3||The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy|The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy - a Randomised Clinical Study|Completed||Phase 4|207|Actual|Psychiatric Center Ballerup||2|||f||||t||||||||||2017-10-11 03:06:39.09966|2017-10-11 03:06:39.09966
NCT01569646|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-02|2012-03-30|||April 2008||2008-04-01|March 2012|2012-03-01||||||||Observational|||Monocytosis and Culprit Vessel in STEMI Patients|Significance of Monocytosis and Culprit Vessel in Patients With Acute ST Elevation Myocardial Infarction|Completed||N/A|226|Actual|Northwell Health|||1||f||||t||||||||||2017-10-11 03:06:39.38361|2017-10-11 03:06:39.38361
NCT01569633|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-02-13|||October 2011||2011-10-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|February 2014|Actual|2014-02-01||Interventional|||Use of Prokinetics in Early Enteral Feeding in Preterm Infants|Pilot Study for Use of Prokinetics in Early Enteral Feeding of Preterm Infants ; Double Blind; Cross Over Study Comparing Eryththromycin, Metoclopramide and Placebo|Terminated||N/A|3|Actual|East Tennessee State University||3||very poor enrollment|f||||t||||||||||2017-10-11 03:06:39.461213|2017-10-11 03:06:39.461213
NCT01569620|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-01-28|||April 2012||2012-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Improving Colorectal Cancer Screening for Diverse Hispanics in Urban Primary Care|Improving Colorectal Cancer (CRC) Screening for Diverse Hispanics in an Urban Primary Care Setting|Completed||N/A|386|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||f||||||||||2017-10-11 03:06:39.566131|2017-10-11 03:06:39.566131
NCT01569594|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-06-28|||April 2012||2012-04-01|June 2017|2017-06-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||CorMatrix ECM for Carotid Repair Following Endarterectomy Registry|CorMatrix® ECM® for Carotid Repair Following Endarterectomy Registry|Completed||N/A|230|Actual|Aziyo Biologics, Inc.|||1||f||||f||||||||||2017-10-11 03:06:39.78569|2017-10-11 03:06:39.78569
NCT01569581|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2013-03-10|||March 2012||2012-03-01|March 2012|2012-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children|A Phase III Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants and Children|Completed||Phase 3|12000|Actual|Chinese Academy of Medical Sciences||8|||f||||t||||||||||2017-10-11 03:06:39.877723|2017-10-11 03:06:39.877723
NCT01569568|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-04-12|2015-06-30||September 2010||2010-09-01|April 2017|2017-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI|Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI|Completed||N/A|49|Actual|Children's Research Institute|||2||f||||t||||||||Yes|Final data is on the UCDC website|2017-10-11 03:06:40.014837|2017-10-11 03:06:40.014837
NCT01569555|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-03-30|||May 2012||2012-05-01|March 2012|2012-03-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Observational|||Significant Pathology Associated With Crossed Leg Sign|Crossed Leg Sign and it's Correlation With Significant Pathology|Unknown status|Not yet recruiting|N/A|400|Anticipated|Uelk, J. Daniel, D.O.|||1||f||||t||||||||||2017-10-11 03:06:40.54716|2017-10-11 03:06:40.54716
NCT01569542|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-03-30|||May 2012||2012-05-01|March 2012|2012-03-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Observational|||Crossed Leg Sign and it's Correlation With Significant Pathology|Crossed Leg Sign and it's Correlation With Significant Pathology|Unknown status|Not yet recruiting|N/A|400|Anticipated|Uelk, J. Daniel, D.O.|||1||f||||t||||||||||2017-10-11 03:06:40.623366|2017-10-11 03:06:40.623366
NCT01569529|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-02-28|2013-10-31||May 2012||2012-05-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Young Adult Smoker's Treatment Demand|Increasing Young Adult Smoker's Demand for Internet-based Cessation Treatment|Completed||N/A|3070|Actual|University of Illinois at Chicago|||2||f||||t||||||||||2017-10-11 03:06:40.696596|2017-10-11 03:06:40.696596
NCT01569516|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-04-06|||June 2011||2011-06-01|May 2011|2011-05-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Interventional|||Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease|A Phase II, Double Blind, Placebo-controlled, Randomized, Multi-Center, Parallel Group Dose Exploring Study to Evaluate the Efficacy and Safety of Octohydroaminoacridine Succinate Tablets in Patient With Mild to Moderate Alzheimer's Disease|Unknown status|Recruiting|Phase 2|288|Anticipated|Changchun Huayang High-tech Co., Ltd||4|||f||||t||||||||||2017-10-11 03:06:40.941295|2017-10-11 03:06:40.941295
NCT01569503|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-08-16|||March 2012|Actual|2012-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|March 30, 2017|Actual|2017-03-30||Interventional|VNS||Vagus Nerve Stimulation a New Approach in the Treatment of Crohn's Disease|The Anti-inflammatory Effect of Vagus Nerve Stimulation (VNS): a New Approach in the Treatment of Crohn's Disease|Terminated||Phase 3|9|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 03:06:41.095365|2017-10-11 03:06:41.095365
NCT01569490|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-02-28|||September 2012||2012-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|STQ FB||Striving to Quit: First Breath|Striving to Quit: First Breath Tobacco Cessation Research|Completed||N/A|3100|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 03:06:41.17959|2017-10-11 03:06:41.17959
NCT01569477|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-12-05|||September 2012||2012-09-01|December 2016|2016-12-01|March 2013|Actual|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Striving to Quit-Wisconsin Tobacco Quit Line|Striving to Quit: Wisconsin Tobacco Quit Line Tobacco Cessation Research|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison||2||Not able to recruit participants|f||||f||||||||Yes||2017-10-11 03:06:41.249898|2017-10-11 03:06:41.249898
NCT01569295|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-06-09||2016-05-24|June 26, 2012|Actual|2012-06-26|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 15, 2015|Actual|2015-06-15||Interventional|Tugela||A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 3|416|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-11 03:06:44.23918|2017-10-11 03:06:44.23918
NCT01569464|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2014-08-13|2014-04-15||March 2012||2012-03-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|RESTORE|The demographics section consists of the Full Analysis Set (FAS), which includes all randomized, treated subjects having valid Baseline measurements for both primary efficacy variables.|Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)|A Phase 3B, Double-Blind, Randomized, Placebo-Controlled Study of Rotigotine and Its Effect on All-Day Functioning and Quality of Life in Subjects With Moderate to Severe Idiopathic Restless Legs Syndrome|Completed||Phase 3|150|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:06:41.44466|2017-10-11 03:06:41.44466
NCT01569438|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-04-14|2016-09-23||March 31, 2012|Actual|2012-03-31|April 2017|2017-04-01|May 31, 2014|Actual|2014-05-31|May 31, 2014|Actual|2014-05-31||Interventional||Titration Population|The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome||Completed||Phase 2|74|Actual|Afferent Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-11 03:06:42.191686|2017-10-11 03:06:42.191686
NCT01569425|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-04-07|||March 2012||2012-03-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|June 2012|Actual|2012-06-01||Interventional|M-PCOS||Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome|Influence of Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome|Unknown status|Active, not recruiting|N/A|60|Anticipated|Tel Aviv University||2|||f||||t||||||||||2017-10-11 03:06:43.216797|2017-10-11 03:06:43.216797
NCT01569412|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-05-04|||March 2012||2012-03-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Open Label, Dose Escalating Study With Ertumaxomab In Patients With HER-2/Neu Expressing Advanced Solid Tumors|Phase I/II, Open Label, Dose Escalating Study To Investigate Safety, Tolerability, And Preliminary Efficacy Of The Trifunctional Anti-HER-2/Neu x Anti-CD3 Antibody Ertumaxomab In Patients With HER-2/Neu Expressing (1+/SISH Positive, 2+ and 3+) Solid Tumors Progressing After Standard Therapy|Terminated||Phase 1/Phase 2|14|Actual|Krankenhaus Nordwest||1|||f||||||||||||||2017-10-11 03:06:43.358281|2017-10-11 03:06:43.358281
NCT01569399|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-02-05|||February 2011||2011-02-01|February 2015|2015-02-01||||February 2011|Actual|2011-02-01||Interventional|||Efficacity of rTMS in Alcohol Dependance|Evaluation de l'efficacité thérapeutique de la Stimulation magnétique transcrânienne répétée Sur le Traitement du Craving à l'Alcool et la prévention de la Rechute Alcoolique à 6 Mois Chez Les Sujets dépendants et Des Facteurs génétiques déterminant la réponse thérapeutique|Unknown status|Recruiting|N/A|150|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-11 03:06:43.458782|2017-10-11 03:06:43.458782
NCT01569386|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-04-02|||June 2004||2004-06-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2007|Actual|2007-02-01||Interventional|LIPA||Low Intensity Physical Activity Leads to Improvement in Brachial-ankle Pulse Wave Velocity of Hemiplegics|Low Intensity Physical Activity Leads to Improvement in Brachial-ankle Pulse Wave Velocity in the Affected Leg of Hemiplegics|Completed||Phase 2|54|Actual|Gunma PAZ College||2|||f||||t||||||||||2017-10-11 03:06:43.556792|2017-10-11 03:06:43.556792
NCT01569373|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-05-26|||March 2012||2012-03-01|May 2014|2014-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)|Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD).|Unknown status|Enrolling by invitation|N/A|75|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:06:43.693754|2017-10-11 03:06:43.693754
NCT01569360|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2013-12-18|||March 2012||2012-03-01|February 2012|2012-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|Garchoise||Study of the Impact of the Use of a Corset on the Respiratory Function of Patients With Spinal Cord Injury|Randomised Open Study of the Efficiency and Tolerance of the Use of a Corset on the Respiratory Function of Spinal Cord Injury Patients|Withdrawn||Phase 3|0|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:06:43.782447|2017-10-11 03:06:43.782447
NCT01569347|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-12-07|||April 2012||2012-04-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|PSYCHOCOKE||Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers|Multicentric Descriptive Cross-sectional Study Evaluating Cocaine Users in Treatment Center|Completed||N/A|417|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"     -  Hair sampling: cocain and metabolit dosage (last 3 months)        -  Blood sampling : plasmatic DBH activity, polymorphisms of several genes (DBH,D2R, DAT,          COMT)   "|||2017-10-11 03:06:43.875329|2017-10-11 03:06:43.875329
NCT01569334|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-14|2014-08-28|||February 2011||2011-02-01|August 2014|2014-08-01|November 2014|Anticipated|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Identification of Non Invasive Biomarkers of Immune Endothelial Injury and Repair Associated With Cardiac Allograft Vasculopathy|Identification of Non Invasive Biomarkers of Immune Endothelial Injury and Repair Associated With Cardiac Allograft Vasculopathy|Unknown status|Active, not recruiting|N/A|170|Anticipated|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-10-11 03:06:43.970574|2017-10-11 03:06:43.970574
NCT01569321|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-04-20|||March 2012||2012-03-01|April 2015|2015-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study|Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study|Terminated||N/A|10|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-10-11 03:06:44.046237|2017-10-11 03:06:44.046237
NCT01569308|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-04-02|||May 2006||2006-05-01|March 2012|2012-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Pulse Pressure Variation Helps to Predict Fluid Responsiveness in Patients Ventilated With Low Tidal Volumes|Pulse Pressure Variation Helps to Predict Fluid Responsiveness in Patients Ventilated With Low Tidal Volumes|Completed||N/A|38|Actual|Hospital de Clinicas de Porto Alegre|||1||f||||t||||||||||2017-10-11 03:06:44.134528|2017-10-11 03:06:44.134528
NCT00004669|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||June 1996||1996-06-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia||Completed||Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:56.08456|2017-10-11 04:26:56.08456
NCT01569282|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-04-20|||October 2011||2011-10-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Interventional|||Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer|Double Bypass vs Stent Strategy in Peroperatively Diagnosed Irresectable Pancreatic Cancer - A Prospective Randomized Multicenter Study|Withdrawn||N/A|0|Actual|Göteborg University||2||Difficulties to recruit patients|f||||f||||||||||2017-10-11 03:06:44.569687|2017-10-11 03:06:44.569687
NCT01569269|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-04-02|||May 2010||2010-05-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Reiki, Yoga, Meditation, on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral Neuropathy|A Randomized, Four-Arm Study Comparing Reiki, Yoga, Meditation, or Patient Education Group for Addressing Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)|Completed||N/A|36|Actual|George Mason University||4|||f||||f||||||||||2017-10-11 03:06:44.678636|2017-10-11 03:06:44.678636
NCT01569256|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-04-03|||March 2008||2008-03-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Ovarian Hyperstimulation Syndrome and Cabergoline|The Effect Of Cabergoline On Follicular Microenvironment Profile In Patients With High Risk Of Ohss|Completed||N/A|40|Actual|Etlik Zubeyde Hanim Womens' Health and Teaching Hospital||2|||f||||t||||||||||2017-10-11 03:06:44.898479|2017-10-11 03:06:44.898479
NCT01569243|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2014-02-04|||June 2012||2012-06-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|TTM||Text to Move (TTM)Study|Using Activity Monitoring and Text Messaging For Behavior Change in a Diabetes Self-Management Program|Completed||Phase 2|126|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:06:45.0061|2017-10-11 03:06:45.0061
NCT01569230|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-04-02|||October 2010||2010-10-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Interventional|||Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Knee Osteoarthritis|Clinical Trial to Evaluate and Compare the Efficacy and Safety of Individualized and Standardized Acupuncture for Knee Osteoarthritis Patients: Randomized, Single-blind, Controlled Study|Unknown status|Recruiting|N/A|250|Anticipated|DongGuk University||4|||f||||t||||||||||2017-10-11 03:06:45.120487|2017-10-11 03:06:45.120487
NCT01569217|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-04-28|||June 2011||2011-06-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|DREM||Regional Distribution of Ventilation to Assess Respiratory Muscle Dysfunction|Construction of a Database to Identify Early Indicators of Respiratory Muscle Dysfunction in Neuromuscular Patients From the Optoelectronic Plethysmography Assessment of the Thoracoabdominal Motion|Enrolling by invitation||N/A|200|Anticipated|Centre d'Investigation Clinique et Technologique 805|||2||f||||t||||||||||2017-10-11 03:06:45.250279|2017-10-11 03:06:45.250279
NCT01569204|ClinicalTrials.gov processed this data on October 10, 2017|2012-04-02|2017-05-10|||October 2012||2012-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|March 2014|Actual|2014-03-01||Interventional|||Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma||Active, not recruiting||Phase 2|100|Anticipated|University of Cologne||2|||f||||t||||||||||2017-10-11 03:06:45.364771|2017-10-11 03:06:45.364771
NCT01569178|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-06-07|||September 2013||2013-09-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|BAMI||BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction|The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.|Recruiting||Phase 3|350|Anticipated|Queen Mary University of London||2|||f||||t|f|f||||||||2017-10-11 03:06:45.588474|2017-10-11 03:06:45.588474
NCT01569165|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-30|||February 2011||2011-02-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Water Rinsing After Topical Fluoride Application on Dental Plaque pH|Effect of Water Rinsing After APF Application on Dental Plaque Acidogenicity|Completed||N/A|25|Actual|Mashhad University of Medical Sciences||5|||f||||f||||||||||2017-10-11 03:06:45.829745|2017-10-11 03:06:45.829745
NCT01569152|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-03-14|2017-01-19||May 2012||2012-05-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||All randomized participants|Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Worldwide, Dose-Ranging Clinical Trial With a Proof-of-Concept Lead Cohort to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 + MTX in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Terminated||Phase 2|82|Actual|Merck Sharp & Dohme Corp.|This study was terminated early (12 September 2013) based on preliminary analysis of data. The results of this study need to be interpreted with caution given the small sample size (82 participants) resulting from the early termination of the study.|3|||f||||f||||||||||2017-10-11 03:06:45.95405|2017-10-11 03:06:45.95405
NCT01569139|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2015-10-01|||December 2011||2011-12-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Comparison of Information Recorded in MINAP, GPRD and HES: a CALIBER Study|Comparison of the Information Recorded in the Myocardial Ischaemia National Audit Project, the General Practice Research Database and Hospital Episode Statistics: a CALIBER Study|Completed||N/A|21000|Actual|London School of Hygiene and Tropical Medicine|||3||f||||t||||||||||2017-10-11 03:06:47.031391|2017-10-11 03:06:47.031391
NCT01569126|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2014-01-14|2013-09-20||April 2012||2012-04-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||All randomized participants.|A Study of LY110140 in Healthy Japanese Male Participants|A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY110140 in Healthy Japanese Male Subjects|Completed||Phase 1|56|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 03:06:47.165509|2017-10-11 03:06:47.165509
NCT01569113|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2013-06-12|||March 2012||2012-03-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.|A Prospective, Randomized, Double-blind Parallel-arm, Placebo-controlled Study to Assess the Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® (Ulipristal Acetate 30 mg) or Placebo.|Completed||Phase 4|76|Actual|HRA Pharma||2|||f||||f||||||||||2017-10-11 03:06:48.335285|2017-10-11 03:06:48.335285
NCT01569100|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-03-30|||December 2005||2005-12-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Atorvastatin After Aneurysmal Subarachnoid Hemorrhage|Atorvastatin Effect in Incidence and Ischemic Complications of Vasospasm After Subarachnoid Aneurysmal Hemorrhage: a Cohort Study|Completed||N/A|278|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||f||||||||||2017-10-11 03:06:48.448892|2017-10-11 03:06:48.448892
NCT01569087|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2016-10-24|2015-02-05||May 2012||2012-05-01|October 2016|2016-10-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer|Randomized Multicenter Open-label Phase II Clinical Study Comparing the Efficacy and Safety of the Single Dose of Extimia® Versus Daily Filgrastim for Neutropenia Prophylaxis in Breast Cancer Patients Receiving Myelosuppressive Chemotherapy|Completed||Phase 2|60|Actual|Biocad||3|||f||||f||||||||||2017-10-11 03:06:48.559112|2017-10-11 03:06:48.559112
NCT01569074|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2014-02-27|2013-11-21||April 2012||2012-04-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|OSKIRA-Asia-1||Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis|(OSKIRA-Asia-1): A Multi-centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose Ranging Study in Asia Evaluating Efficacy and Safety of Fostamatinib in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate Therapy|Terminated||Phase 2|163|Actual|AstraZeneca||5||"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to   Rigel Pharmaceuticals."|f||||t||||||||||2017-10-11 03:06:49.508898|2017-10-11 03:06:49.508898
NCT01569061|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-03-29|||February 2012||2012-02-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|PLTOAB||Painless Laser Therapy for Overactive Bladder|A Double-blind, Randomized, Sham-controlled, Multicenter Clinical Trial to Assess the Effectiveness of Therapeutic Class IV Laser LCT-1000TM Treatment for Overactive Bladder Syndrome.|Unknown status|Recruiting|N/A|200|Anticipated|Zipper Urogynecology Associates||2|||f||||f||||||||||2017-10-11 03:06:51.475714|2017-10-11 03:06:51.475714
NCT01569048|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2014-03-04|||March 2012||2012-03-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Randomized Controlled Trial to Evaluate of Dexmedetomidine for the Effect on Operative Visibility in Patients Undergoing Endoscopic Sinus Surgery||Completed||Phase 4|66|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 03:06:51.610186|2017-10-11 03:06:51.610186
NCT01569035|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2012-09-20|||January 2009||2009-01-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Warfarine in Unexplained Oligohydramnios|a Randomized Clinical Trial Using Oral Anti Coagulant in the Management of Unexplained Oligohydramnios|Completed||Phase 4|200|Actual|Woman's Health University Hospital, Egypt||1|||f||||t||||||||||2017-10-11 03:06:51.739272|2017-10-11 03:06:51.739272
NCT01569009|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2013-07-24|||June 2012||2012-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|PhAB||Physical Activity in Bronchiectasis|Patterns of Physical Activity Levels in Patients With Bronchiectasis: Cross Sectional Study Using Quantitative Methodology|Completed||N/A|63|Actual|University of Ulster|||1||f||||t||||||||||2017-10-11 03:06:52.009922|2017-10-11 03:06:52.009922
NCT01568996|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-06-22|||August 2012||2012-08-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|March 2016|Actual|2016-03-01||Interventional|||Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions|A Pilot Study Evaluation of Sulforaphane in Atypical Nevi--Precursor Lesions: Assessment of STAT1 and STAT3 Risk Markers of Melanoma|Active, not recruiting||Early Phase 1|17|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 03:06:52.128555|2017-10-11 03:06:52.128555
NCT01568983|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-06-29|||December 2011||2011-12-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Effects of Polyphenol-rich Berry Juice on Blood Pressure in Hypertensive Subjects|The Effects of Polyphenol-rich Berry Juice on Blood Pressure and Additional CVD Related Parameters in Pre-hypertensive Subjects|Completed||Phase 3|153|Actual|University of Oslo||3|||f||||f||||||||||2017-10-11 03:06:52.251288|2017-10-11 03:06:52.251288
NCT01568970|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-06-12|||January 2012|Actual|2012-01-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|June 2014|Actual|2014-06-01||Interventional|||Multidisciplinary Return-to-work Rehabilitation and Return-to Work Follow-up|Multidisciplinary Return-to-work Rehabilitation and Return-to-work Follow-up, a Randomized Study of Patients With Complex Symptom Disorders|Active, not recruiting||N/A|214|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-10-11 03:06:52.396207|2017-10-11 03:06:52.396207
NCT01568957|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2017-07-05|||September 2011||2011-09-01|December 2016|2016-12-01|September 30, 2017|Anticipated|2017-09-30|March 29, 2017|Actual|2017-03-29||Interventional|||Training Dual-Task Walking After Stroke|Training Dual-Task Walking After Stroke: Effects on Attentional and Locomotor Control|Active, not recruiting||N/A|37|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 03:06:52.522123|2017-10-11 03:06:52.522123
NCT01568944|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-01-27|||March 2012||2012-03-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Role of Infected Blood Dendritic Cells in Heart Disease Risk|Peripheral Blood Dendritic Cells and Periodontitis|Completed||N/A|19|Actual|Augusta University||2|||f||||t||||||||||2017-10-11 03:06:52.62592|2017-10-11 03:06:52.62592
NCT01568931|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|March 2017|Anticipated|2017-03-01|March 2015|Anticipated|2015-03-01||Interventional|DISSOLUTION||Local Thrombolytics Before Thrombectomy in STEMI|Local Delivery of thrombolytIcs Before Thrombectomy in patientS With ST-elevatiOn myocardiaL Infarction Undergoing Primary percuTaneous Coronary interventION - The DISSOLUTION Randomized Trial|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 03:06:52.769332|2017-10-11 03:06:52.769332
NCT01568918|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-10-14|||May 2012||2012-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery|The Use of an Uroselective Alpha-1-antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery|Recruiting||Phase 3|350|Anticipated|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 03:06:52.885862|2017-10-11 03:06:52.885862
NCT01568905|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-01-17|2015-12-02||February 2011||2011-02-01|January 2017|2017-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||Daily cigarette smokers|Palatability of Experimental Cigarettes - Study 2|Palatability of Experimental Cigarettes|Completed||N/A|36|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-11 03:06:53.023502|2017-10-11 03:06:53.023502
NCT01568892|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-01-02|2013-08-15||April 2012||2012-04-01|December 2013|2013-12-01|June 2015|Anticipated|2015-06-01|October 2012|Actual|2012-10-01||Interventional|VIKING-4||Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir|A Phase III Randomized, Double-blind Trial Investigating the Activity of Dolutegravir 50 mg BID vs Placebo Over 7 Days in HIV-1-infected Subjects With RAL/ELV Resistance, Followed by an Open-label Phase With an Optimized Background Regimen|Unknown status|Active, not recruiting|Phase 3|30|Actual|ViiV Healthcare||3|||t||||f||||||||||2017-10-11 03:06:53.651459|2017-10-11 03:06:53.651459
NCT01568879|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-03-04|||January 2012||2012-01-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Evaluating the Effectiveness of a Chronic Disease Management Program for Gout|Evaluating the Effectiveness of a Chronic Disease Management Program for Gout|Completed||N/A|104|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-11 03:06:54.882562|2017-10-11 03:06:54.882562
NCT01568866|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-04-18|2015-11-06||June 2012||2012-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2014|Actual|2014-11-01||Interventional|ENDEAVOR|Intent-to-treat population (all randomized participants)|Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients|A Randomized, Open-label, Phase 3 Study of Carfilzomib Plus Dexamethasone vs. Bortezomib Plus Dexamethasone in Patients With Relapsed Multiple Myeloma|Active, not recruiting||Phase 3|929|Actual|Amgen||2|||f||||t||||||||||2017-10-11 03:06:55.094285|2017-10-11 03:06:55.094285
NCT01568853|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-04-05|||November 2011||2011-11-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Prospective Study of The Complement Depletion in Patients With Severe Abdominal Sepsis|The Complement C3 Depletion in Patients With Severe Abdominal Sepsis: Risk Prediction and the Association With Down-regulated Adaptive Immunity|Completed||N/A|75|Actual|Jinling Hospital, China||1|||f||||t||||||||||2017-10-11 03:06:58.005086|2017-10-11 03:06:58.005086
NCT01568840|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-03-29|||July 2010||2010-07-01|March 2012|2012-03-01|February 2011||2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Global Postural Reeducation and Segmental Exercises in Patients With Scapular Dyskinesis and Cervicalgia|Effectiveness of Global Postural Reeducation and Segmental Exercises on Function, Pain, and Quality of Life of Patients With Scapular Dyskinesis and Cervicalgia: A Randomized Clinical Study|Completed||Phase 1|30||Irmandade da Santa Casa de Misericordia de Sao Paulo||2|||f||||t||||||||||2017-10-11 03:06:58.111682|2017-10-11 03:06:58.111682
NCT01568827|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-09-26|2015-09-25||March 2012||2012-03-01|September 2016|2016-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||older obese and overweight males|Inflammation, Polyphenols, and Genetics|Inflammation, Polyphenols, and Genetics: A Pilot Study in Overweight and Obese Adult Males to Determine Whether Black-Raspberry Consumption Affects Markers of Inflammation in Study Participants Fed a High-Fat, High-Calorie Challenge Meal|Completed||Phase 1/Phase 2|10|Actual|Ohio State University||2|||f||||f||||||||No||2017-10-11 03:06:58.215425|2017-10-11 03:06:58.215425
NCT01568814|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-30|||January 2012||2012-01-01|January 2012|2012-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|LOWPEG||Low Volume PEG With Low Residue Test Meals Versus High Volume Split-dose PEG Bowel Preparation|Efficacy and Tolerability of Morning (AM) Only Low Volume (2L) PEG With Low Residue Test Meals Versus High Volume (4L) Split-dose (PM/AM) PEG Bowel Preparation With Standard Meals: A Prospective Randomized, Investigator Blinded Trial|Completed||Phase 3|188|Actual|Inje University||2|||f||||f||||||||||2017-10-11 03:06:58.524083|2017-10-11 03:06:58.524083
NCT01568801|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-04-15|||August 2011||2011-08-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|SingaPACE||Evaluation of the Singapura Program of All Inclusive Care for the Elderly (SingaPACE) Demonstration Project|Evaluation of the Singapura Program of All Inclusive Care for the Elderly|Completed||N/A|80|Anticipated|National University, Singapore||2|||f||||f||||||||||2017-10-11 03:06:58.65317|2017-10-11 03:06:58.65317
NCT01568788|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-06-18|||December 2008||2008-12-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine|Post-marketing Clinical Observation of Hualan's Inactivated Influenza Vaccine: A Single Center, Parallelled, Controlled, Randomised Clinical Trial|Completed||N/A|600|Actual|Hualan Biological Engineering, Inc.||3|||f||||t||||||||||2017-10-11 03:06:58.741038|2017-10-11 03:06:58.741038
NCT01568775|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-29|||June 2010||2010-06-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects|An Open-label, Parallel Group, Single-sequence Study to Evaluate Pharmacokinetics, Safety, and Tolerability of a Single Dose Administration of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects|Completed||Phase 1|12|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:06:58.84168|2017-10-11 03:06:58.84168
NCT01568762|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-30|||October 2010||2010-10-01|March 2012|2012-03-01||||July 2011|Actual|2011-07-01||Interventional|||To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma|A Randomized, Double-blind, Placebo Controlled Study to Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 (Sequential Administration of a Fixed Dose of VAK694 and Single Ascending Doses of QAX576) in Patients With Well-controlled Mild to Moderate Asthma|Completed||Phase 1|50|Actual|Novartis||4|||f||||||||||||||2017-10-11 03:06:58.934763|2017-10-11 03:06:58.934763
NCT01568749|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-11-20|||December 2008||2008-12-01|June 2014|2014-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations|A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations|Completed||Phase 1|14|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 03:06:59.042064|2017-10-11 03:06:59.042064
NCT01568736|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-30|||March 2012||2012-03-01|March 2012|2012-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|HIDS-MKD||B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency|B7 Coreceptor Molecules as Clinically-Relevant Surrogate Biomarkers in the Hyper IgD Syndrome (HIDS) Form of Mevalonate Kinase Deficiency (MKD)|Unknown status|Recruiting|N/A|10|Anticipated|Michigan Technological University|||1||f||||t||||||Samples With DNA|"     Blood Urine   "|||2017-10-11 03:06:59.123757|2017-10-11 03:06:59.123757
NCT01568723|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-08-02|||January 2012||2012-01-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|BetrnetRF||Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation|Stem Cells And The Origins Of Barrett's Esophagus:Identification Of Novel Biomarkers And Gene Signatures In Barrett's Esophagus|Active, not recruiting||N/A|125|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     biopsy samples, serum, plasma, buffycoat, cytology brushings   "|||2017-10-11 03:06:59.201725|2017-10-11 03:06:59.201725
NCT01568710|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-09-02|||March 19, 2012||2012-03-19|November 25, 2016|2016-11-25||||||||Observational|||Blood Flow and Pain Crises in People With Sickle Cell Disease|Measurement of the Reactive Hyperemia Index in Sickle Cell Patients During Pain Crisis and After Recovery|Completed||N/A|94|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:06:59.298768|2017-10-11 03:06:59.298768
NCT01568697|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-06-30|||March 12, 2012||2012-03-12|June 13, 2017|2017-06-13||||||||Observational|||Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)|Oral Microbial and Immunological Characterization of Patients With Immune Dysfunction|Recruiting||N/A|650|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:06:59.37459|2017-10-11 03:06:59.37459
NCT01568684|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-06-30|||March 12, 2012||2012-03-12|December 11, 2012|2012-12-11|December 11, 2012|Actual|2012-12-11|December 11, 2012|Actual|2012-12-11||Interventional|||Brain Imaging, Genetics and Treatment for Major Depression|Pharmacogenetics and Neuroimaging in Major Depressive Disorder (PAN-D)|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:06:59.462812|2017-10-11 03:06:59.462812
NCT01568671|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-08-04|||March 13, 2012||2012-03-13|July 26, 2017|2017-07-26||||||||Observational|||Energy Expenditure Responses to Different Temperatures|Energy Expenditure Responses to Different Temperatures|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:06:59.543668|2017-10-11 03:06:59.543668
NCT01568658|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-06-30|||March 12, 2012||2012-03-12|June 6, 2017|2017-06-06||||||||Observational|||Genetic and Physical Study of Childhood Nerve and Muscle Disorders|Clinical and Molecular Manifestations of Neuromuscular and Neurogenetic Disorders of Childhood|Recruiting||N/A|5625|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:07:01.372889|2017-10-11 03:07:01.372889
NCT01568645|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2017-07-06|||March 2, 2012||2012-03-02|December 11, 2012|2012-12-11|December 11, 2012|Actual|2012-12-11|December 11, 2012|Actual|2012-12-11||Interventional|||Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease|A Pilot Study of Treatment of Adults With Sickle Cell Disease Associated Pulmonary Hypertension Based on Hemodynamic Stratification: Safety and Tolerability Study of Imatinib and Carvedilol|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:07:01.447667|2017-10-11 03:07:01.447667
NCT01568632|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-30|2012-11-20|||March 2012||2012-03-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|||||Interventional|||Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma|A Phase 1 Study of Imetelstat, a Telomerase Inhibitor, in Children With Refractory or Recurrent Solid Tumors and Lymphomas|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:07:01.519676|2017-10-11 03:07:01.519676
NCT01568619|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-01-15|||March 2012||2012-03-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Validation of Electrical Cardiometry Versus Fick Method in Cardiac Output Measurement|Validation of Electrical Cardiometry Versus Fick Method to Measure Stroke Volume and Cardiac Output in Patients With or Suspected of Having Heart Failure|Completed||N/A|30|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 03:07:01.593176|2017-10-11 03:07:01.593176
NCT01568606|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2012-03-30|||January 2011||2011-01-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Safety of Body Composition Analysis in Heart Failure Patients With Implantable Cardioverter Defibrillators (ICDs)|Safety of Body Composition Analysis Using Bioimpedance in Heart Failure Patients With Implantable Cardioverter Defibrillators (ICDs)|Completed||N/A|20|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 03:07:01.665281|2017-10-11 03:07:01.665281
NCT01568593|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-03-07|2014-10-07||March 2012||2012-03-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome|Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome|Completed||Phase 3|93|Actual|Laboratoires Thea||2|||f||||f||||||||||2017-10-11 03:07:01.761394|2017-10-11 03:07:01.761394
NCT01568580|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-29|||December 2004||2004-12-01|March 2012|2012-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A|Open-label, Non-comparative, Multicenter, Phase III for Evaluation of Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Previously Treated Patients With Hemophilia A|Completed||Phase 3|71|Actual|Green Cross Corporation||1|||f||||f||||||||||2017-10-11 03:07:02.015987|2017-10-11 03:07:02.015987
NCT01568567|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-07-03|||March 2012||2012-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|BSSII||Study to Demonstrate the Safety of a Novel Powder Formulation of Lactobacilli in Adults|To Demonstrate That a Novel Powder Formulation of Lactobacillus Reuteri DSM 17938 is Safe in Adults, a Randomized, Placebo Controlled Double-blind Study|Completed||Phase 1/Phase 2|32|Actual|Good Food Practice, Sweden||3|||f||||f||||||||||2017-10-11 03:07:02.089354|2017-10-11 03:07:02.089354
NCT01568554|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-09-23|||December 2011||2011-12-01|September 2013|2013-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Clinical Diagnosis of Acute Porphyria|Clinical Diagnosis of Acute Porphyria|Recruiting||N/A|600|Anticipated|University of California, San Francisco|||3||f||||t||||||||||2017-10-11 03:07:02.168353|2017-10-11 03:07:02.168353
NCT01568541|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-09-14|||October 2007||2007-10-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|July 2008|Actual|2008-07-01||Interventional|F||Fluoride Intake From Toothbrushig With Children's or Regular Toothpastes|Fluoride Intake From Tooth Brushing With Children's and Regular Toothpastes: a Study With Preschooler Children|Completed||N/A|208|Actual|Federal University of Minas Gerais||2|||f||||t||||||||||2017-10-11 03:07:02.409065|2017-10-11 03:07:02.409065
NCT01568528|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-09-20|||March 2013||2013-03-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|June 2018|Anticipated|2018-06-01||Interventional|||Oxytocin as Adjunctive Treatment of Schizophrenia|Oxytocin as Adjunctive Treatment of Schizophrenia|Active, not recruiting||N/A|40|Anticipated|Emory University||2|||f||||t||||||||||2017-10-11 03:07:02.519175|2017-10-11 03:07:02.519175
NCT01568515|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-10-31|||October 2011||2011-10-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students|A Randomized Longitudinal Intervention Study to Assess Whether Electronic Messaging Can Increase HPV Vaccine Utilization and Adherence Among College Students in Eastern North Carolina.|Completed||Early Phase 1|283|Actual|East Carolina University||2|||f||||f||||||||||2017-10-11 03:07:02.62491|2017-10-11 03:07:02.62491
NCT01568502|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-30|||January 2001||2001-01-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Dobutamine Stress Cardiac Magnetic Resonance Versus Echocardiography for the Assessment of Outcome. Are the Two Imaging Modalities Comparable?||Completed||N/A|5008|Actual|University Hospital Heidelberg|||2||f||||f||||||||||2017-10-11 03:07:02.745775|2017-10-11 03:07:02.745775
NCT01568489|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-09-21|||March 2012||2012-03-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis|A Randomized, Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of HL-009 Liposomal Gel in Adult Patients With Mild to Moderate Atopic Dermatitis|Completed||Phase 2|120|Actual|HanAll BioPharma Co., Ltd.||4|||f||||f||||||||||2017-10-11 03:07:02.823658|2017-10-11 03:07:02.823658
NCT01568476|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-29|||July 2011||2011-07-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|||Does Interneural Local Anesthetic Spread at the Site of Sciatic Nerve Bifurcation Shorten Block Onset Time?|Does Interneural Local Anesthetic Spread at the Site of Sciatic Nerve Bifurcation Shorten Block Onset Time?|Unknown status|Recruiting|Phase 3|88|Anticipated|University Health Network, Toronto||2|||f||||||||||||||2017-10-11 03:07:02.926141|2017-10-11 03:07:02.926141
NCT01568463|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-30|||February 2012||2012-02-01|March 2012|2012-03-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Observational|||Distance for Interscalene Block|What is the Maximal Effective Distance for Interscalene Block?|Unknown status|Recruiting|N/A|25|Anticipated|University Health Network, Toronto|||1||f||||||||||||||2017-10-11 03:07:03.023328|2017-10-11 03:07:03.023328
NCT01568450|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2013-01-25|||March 2012||2012-03-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|GL2907-101||A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers|A Randomized, Open-label, Single-dose, Crossover Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers|Completed||Phase 1|24|Actual|GL Pharm Tech Corporation||3|||f||||f||||||||||2017-10-11 03:07:03.104474|2017-10-11 03:07:03.104474
NCT01568437|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-12-07|||January 2012||2012-01-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Transversus Abdominis Plane (TAP) Block in Laparoscopic Gastric-bypass Surgery|Is the Analgesic Effect of the Transversus Abdominis Plane (TAP) Block in Laparoscopic Gastric-bypass Surgery Useful?|Completed||Phase 3|70|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:07:03.210357|2017-10-11 03:07:03.210357
NCT01568424|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-04-21|2017-03-03||September 2009||2009-09-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|CMagRVAS|This study includes data from 25 consecutive patients with acute right ventricular failure from any cause requiring use of the CentriMag RVAS to sustain life.|CentriMag RVAS U.S. Post-approval Study Protocol|CentriMag RVAS U.S. Post-approval Study Protocol|Completed||N/A|25|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 03:07:03.321864|2017-10-11 03:07:03.321864
NCT01568411|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-03-05|||April 2012||2012-04-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Fixed−Sequence, Two−Period, Open−Label Drug−Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD−1211|A Phase 1, Fixed−Sequence, Two−Period, Open−Label Drug−Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD−1211|Completed||Phase 1|20|Actual|Theravance Biopharma R & D, Inc.||2|||f||||f||||||||||2017-10-11 03:07:03.749201|2017-10-11 03:07:03.749201
NCT01568398|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-02-07|||May 2012||2012-05-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy||Completed||Phase 3|27|Actual|Takeda||1|||f||||||||||||||2017-10-11 03:07:03.82086|2017-10-11 03:07:03.82086
NCT01568385|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-02-07|||April 2012||2012-04-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy||Completed||Phase 3|30|Actual|Takeda||1|||f||||||||||||||2017-10-11 03:07:03.922713|2017-10-11 03:07:03.922713
NCT01568372|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-10-03|||May 2010||2010-05-01|October 2017|2017-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy of a Nurse Telephone Follow-up on Pain Intensity After Removal of Tonsils in Children|Efficacy of a Nurse Telephone Follow-up on Post-tonsillectomy Pain Management and Complications in Children: A Randomized Clinical Trial|Completed||N/A|52|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 03:07:04.136964|2017-10-11 03:07:04.136964
NCT01568359|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-12-04|||December 2011||2011-12-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors|Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.|Completed||N/A|49|Actual|Emory University|||1||f||||f||||||Samples Without DNA|"     Blood and urine samples obtained from subjects.   "|||2017-10-11 03:07:04.227412|2017-10-11 03:07:04.227412
NCT01568346|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-08-01|||February 2012||2012-02-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy|Randomized Trail of Breast MRI for Newly Diagnosed Early Stage Breast Cancer: Impact on Re-excision Lumpectomy|Terminated||Phase 3|9|Actual|Dana-Farber Cancer Institute||2||Slow Accural|f||||t||||||||No||2017-10-11 03:07:04.336334|2017-10-11 03:07:04.336334
NCT01568333|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-07-26|||June 2015||2015-06-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia|A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia|Recruiting||Phase 2|30|Anticipated|Shandong University||1|||f||||t||||||||||2017-10-11 03:07:04.436136|2017-10-11 03:07:04.436136
NCT01568320|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-02-27||2017-02-27|August 2012||2012-08-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|February 2015|Actual|2015-02-01||Interventional|||Zenith® Dissection Clinical Trial|Use of the Zenith® Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissection|Active, not recruiting||N/A|73|Actual|Cook Group Incorporated||1|||t||||||||||||||2017-10-11 03:07:04.589932|2017-10-11 03:07:04.589932
NCT01568307|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2013-12-16|||May 2012||2012-05-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|MDD||Major Depressive Disorder - Understanding The Link Between The Brain And The Heart|Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder - Understanding The Link Between The Brain And The Heart|Unknown status|Recruiting|Phase 4|80|Anticipated|Baker IDI Heart and Diabetes Institute||1|||f||||f||||||||||2017-10-11 03:07:04.799319|2017-10-11 03:07:04.799319
NCT01568294|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-08-19|||April 2012||2012-04-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple Myeloma|A Phase 1, Multicenter, Open-label, Dose-escalation Study in Japan to Determine the Tolerated Dose and to Evaluate the Safety, Efficacy, and Pharmacokinetics of Pomalidomide Alone or in Combination With Dexamethasone in Patients With Refractory or Relapsed and Refractory Multiple Myeloma|Completed||Phase 1|12|Actual|Celgene||1|||f||||f||||||||||2017-10-11 03:07:05.006838|2017-10-11 03:07:05.006838
NCT01568281|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-06-22|||April 2012||2012-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects|A Randomised, Open Label, Single Centre, 2 Way Crossover Bioequivalence Study Comparing Arimidex Tablet 1 mg and Anastrozole Orally Rapid Disintegration Film Formula 1 mg After Single Oral Administration in Japanese Healthy Male Subjects|Completed||Phase 1|58|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 03:07:05.10942|2017-10-11 03:07:05.10942
NCT01568268|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-12-24|||January 2012||2012-01-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting|A Randomized, Double Blind, Multicenter Phase III Trial to Evaluate the Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting|Completed||Phase 3|384|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 03:07:05.213035|2017-10-11 03:07:05.213035
NCT01568255|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-03-23|||March 2012||2012-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Is Treatment of Vitamin D Deficiency Associated With Resolution of Statin-Induced Muscular Symptoms|Is Treatment of Vitamin D Deficiency Associated With Resolution of Statin-Induced Muscular Symptoms|Recruiting||Phase 4|40|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||Yes||2017-10-11 03:07:05.329943|2017-10-11 03:07:05.329943
NCT01568242|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-03-29|||February 2012||2012-02-01|March 2012|2012-03-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Changes in Vitreous Temperature During Phacoemulsification|Changes in Vitreous Temperature During Phacoemulsification|Unknown status|Recruiting|N/A|15|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||t||||||||||2017-10-11 03:07:05.443971|2017-10-11 03:07:05.443971
NCT01568229|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2014-09-19||2014-05-13|May 2012||2012-05-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms|Terminated||Phase 2|111|Actual|Amgen||4||Toxic Epidermal Necrolysis|f||||f||||||||||2017-10-11 03:07:05.55036|2017-10-11 03:07:05.55036
NCT01568216|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-07-08||2014-05-08|May 2012||2012-05-01|July 2015|2015-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms|"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"|Terminated||Phase 2|121|Actual|Amgen||4||Toxic Epidermal Necrolysis|f||||f||||||||||2017-10-11 03:07:05.746792|2017-10-11 03:07:05.746792
NCT01568203|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-10-05|||September 2011||2011-09-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia|Phase I, Randomized, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 579 in Healthy Adult Subjects and Patients With Stable Schizophrenia or Schizoaffective Disorder|Terminated||Phase 1|50|Actual|Amgen||2||Amgen decision (business)|f||||f||||||||||2017-10-11 03:07:05.914032|2017-10-11 03:07:05.914032
NCT01568190|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-01-05|||December 2011||2011-12-01|January 2015|2015-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|AV-M-01||An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy|An Open Trial to Asses the Tolerability of AVANZ Mite Mix Immunotherapy|Completed||Phase 2/Phase 3|102|Actual|ALK-Abelló A/S||1|||f||||f||||||||||2017-10-11 03:07:06.010063|2017-10-11 03:07:06.010063
NCT01568177|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-07-19|||February 2011||2011-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cardiac Autonomic Function in Women With Microvascular Coronary Dysfunction|Cardiac Autonomic Function in Women With Microvascular Coronary Dysfunction|Recruiting||N/A|60|Anticipated|Cedars-Sinai Medical Center||3|||f||||f||||||||||2017-10-11 03:07:06.08459|2017-10-11 03:07:06.08459
NCT01568164|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-09-30|||March 2012||2012-03-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|CONFIGURE-HF||Safety and Efficacy Study of the BioVentrix PliCath HF System|Phase II Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy|Active, not recruiting||N/A|120|Anticipated|BioVentrix||1|||f||||t||||||||||2017-10-11 03:07:06.186498|2017-10-11 03:07:06.186498
NCT01568151|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-05-08|||April 2009||2009-04-01|May 2017|2017-05-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2013|Actual|2013-12-31||Interventional|TIME||Testing Interventions to Motivate and Educate|Testing Interventions to Motivate and Educate|Active, not recruiting||N/A|551|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-11 03:07:06.303841|2017-10-11 03:07:06.303841
NCT01567787|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-02-09|||June 2013||2013-06-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|NF01||Proton Radiation Therapy for Spinal Tumors|Spinal Tumor Proton Protocol|Withdrawn||N/A|0|Actual|University of Florida||2||Feasibility issues|f||||t|f|f|||f|||No||2017-10-11 03:07:16.855286|2017-10-11 03:07:16.855286
NCT01568138|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-04-02|||August 2010||2010-08-01|April 2012|2012-04-01|March 2013|Anticipated|2013-03-01|August 2012|Anticipated|2012-08-01||Interventional|CONFIGURE-HF||Prospective Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy|This Study is a Multi-center, Prospective, Single-armed, Study Designed to Evaluate the Safety and Feasibility of the BioVentrix PliCath HF System for Left Ventricular (LV) Volume and Radius Reduction Through Scar Exclusion in Patients Whose Systolic HF is Due to Ischemic Cardiomyopathy.|Unknown status|Active, not recruiting|N/A|26|Actual|BioVentrix||1|||f||||t||||||||||2017-10-11 03:07:06.387744|2017-10-11 03:07:06.387744
NCT01568125|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-30|||January 2010||2010-01-01|March 2012|2012-03-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes Mellitus|Effect of Incretin-related Drugs on Energy and Contents of Dietary Intake in Japanese Patients With Type 2 Diabetes Mellitus|Unknown status|Active, not recruiting|N/A|100|Anticipated|Nagaoka Red Cross Hospital|||1||f||||f||||||||||2017-10-11 03:07:06.638762|2017-10-11 03:07:06.638762
NCT01568112|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-05-04|2016-05-04||April 2012||2012-04-01|May 2016|2016-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||All randomized and treated participants|Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate|A Randomized, Double-Blind, Phase 3b Study to Evaluate Effects of Aspirin or Dose Titration on Flushing and Gastrointestinal Events Following Oral Administration of BG00012 Dosed at 240 mg BID|Completed||Phase 3|173|Actual|Biogen||4|||f||||f||||||||||2017-10-11 03:07:06.940148|2017-10-11 03:07:06.940148
NCT01568099|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-08-14|||February 2012||2012-02-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease|A Randomized, Controlled, Parallel Group, Patient-blinded, Single-center, Phase I Pilot Study to Assess Tolerability and Safety of Repeated Subcutaneous Administration of Two Doses of AFFITOPE® PD01A Formulated With Adjuvant to Patients With Parkinson's Disease|Completed||Phase 1|32|Actual|Affiris AG||3|||f||||t||||||||||2017-10-11 03:07:10.656106|2017-10-11 03:07:10.656106
NCT01568086|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2013-11-05|||December 2011||2011-12-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Observational|||Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A|Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD03 Applied During AFFiRiS 005A|Terminated||N/A|16|Actual|Affiris AG|||2|The study could not be performed as planned for organizational reasons.|f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-11 03:07:10.737366|2017-10-11 03:07:10.737366
NCT01568073|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-09-01|2014-11-26||March 2011||2011-03-01|September 2015|2015-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||"Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With Wearing-off Phenomenon"|"Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With Wearing-off Phenomenon Treated With Levodopa Plus a Dopa Decarboxylase Inhibitor (DDCI): a Double-blind, Randomised, Placebo- and Active-controlled, Parallel-group, Multicentre Clinical Study"|Completed||Phase 3|600|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 03:07:10.83008|2017-10-11 03:07:10.83008
NCT01568060|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-04-21|||May 2012||2012-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea|Assessment of Safety of GlaxoSmithKline (GSK) Biologicals' Combined Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus Vaccine, Infanrix-IPV When Administered According to the Approved Prescribing Information in Korea|Completed||N/A|645|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:07:11.85781|2017-10-11 03:07:11.85781
NCT01568047|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-11-23|2014-02-05||February 2010||2010-02-01|November 2015|2015-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients|"Multicentre, Double-blind, Randomised, Placebo-controlled Study in Four Parallel Groups of PD Patients Treated With Standard-release Levodopa/Carbidopa 100/25 mg (Sinemet®) or Levodopa/Benserazide 100/25 mg (Madopar®/Restex®) and With Motor Fluctuations (Wearing-off Phenomenon)"|Completed||Phase 2|40|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 03:07:11.962182|2017-10-11 03:07:11.962182
NCT01568034|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2014-12-19|2014-02-05||April 2009||2009-04-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067|A Double-blind, Randomised, Placebo-controlled, Cross-over Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067 on the Levodopa Pharmacokinetics, Motor Response, and Erythrocyte Soluble Catechol-O-methyltransferase Activity in Parkinson's Disease Patients Concomitantly Treated With Levodopa/Dopa-decarboxylase Inhibitor|Completed||Phase 2|10|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 03:07:12.589795|2017-10-11 03:07:12.589795
NCT01568021|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-01-27|2015-01-27||October 2011||2011-10-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)||Completed||N/A|100|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:07:13.102773|2017-10-11 03:07:13.102773
NCT01568008|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-07-18|2013-07-18||October 2011||2011-10-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)||Completed||N/A|933|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:07:13.309459|2017-10-11 03:07:13.309459
NCT01567995|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-12-17|||February 2008||2008-02-01|March 2012|2012-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety|Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate Cream in Patients With Eczema for Two Weeks to Evaluate the Efficacy and Safety|Completed||Phase 3|240|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:07:13.540123|2017-10-11 03:07:13.540123
NCT01567982|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-07-14|||March 2011||2011-03-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Interventional|tDCSsmokers||Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms|Phase 1 Study of Effects of tDCS on Tobacco Withdrawal Symptoms|Completed||Phase 1|60|Actual|Yale University||1|||f||||f||||||||||2017-10-11 03:07:13.639503|2017-10-11 03:07:13.639503
NCT01567969|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-10-12|||May 2011||2011-05-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|FHDP||Family Health and Development Project|Family Health and Development Project: Intensive In-home Child and Adolescent Psychiatric Service (IICAPS) vs. Home-based Child Treatment Coordination (Home-based CTC) for Seriously Emotionally Disturbed Children|Completed||Phase 3|110|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:07:13.717206|2017-10-11 03:07:13.717206
NCT01567956|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-11-04|||April 2012||2012-04-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study|Phase III Randomized Multicenter International Study to Investigate the Safety and Efficacy of Propionyl-L-Carnitine Hydrochloride Modified Release Tablets in Patients Affected by Mild Ulcerative Colitis Under Oral Stable Treatment|Terminated||Phase 3|150|Actual|sigma-tau i.f.r. S.p.A.||2||Evidence of very low probability to success. No safety issues|f||||t||||||||No||2017-10-11 03:07:13.922365|2017-10-11 03:07:13.922365
NCT01567943|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-01-05|2016-11-07||March 2012||2012-03-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|CMETG||Contingency Management of Alcohol Abuse in the Severely Mentally ILL|Novel EtG-Based Contingency Management for Alcohol in the Severely Mentally Ill|Completed||N/A|123|Actual|University of Washington||2|||f||||t||||||||No||2017-10-11 03:07:14.136539|2017-10-11 03:07:14.136539
NCT01567930|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-12-13|||February 2010||2010-02-01|March 2012|2012-03-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Temsirolimus as Second-line Therapy in HCC|A Phase II Study of Temsirolimus as Second-line Therapy in Patients With Advanced, Unresectable Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|25|Anticipated|University of Tennessee Cancer Institute||1|||f||||t||||||||||2017-10-11 03:07:14.438027|2017-10-11 03:07:14.438027
NCT01567917|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-03-29|||June 2011||2011-06-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Observational|||Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal Cancer|Incidence of Venous Thromboembolism Following Surgery in Korean Patients With Colorectal Cancer; a Prospective Study|Unknown status|Recruiting|N/A|600|Anticipated|Seoul National University Bundang Hospital|||2||f||||f||||||||||2017-10-11 03:07:14.521086|2017-10-11 03:07:14.521086
NCT01567904|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-04-04||2016-04-04|May 2012||2012-05-01|April 2016|2016-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line|An Open-label, Pharmacokinetic, Pharmacodynamic, and Tolerability Study of AVE5026 Administered at Weight-adjusted Doses to Patients Less Than 18 Years of Age With a Central Venous Line (CVL)|Terminated||Phase 2|2|Actual|Sanofi||5||"Decision from Sanofi to withdraw on a worldwide basis the Marketing Authorisation Applications   for Semuloparin sodium in the adult indication"|f||||t||||||||||2017-10-11 03:07:14.625263|2017-10-11 03:07:14.625263
NCT01567891|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-08-04|||June 2013||2013-06-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|||CT Antigen TCR-redirected T Cells for Ovarian Cancer.|A Phase I/IIa, Open Label Clinical Trial Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs Specific for NY-ESO-1 in Patients With Recurrent or Treatment Refractory Ovarian Cancer.|Recruiting||Phase 1/Phase 2|10|Anticipated|Adaptimmune||1|||f||||t||||||||||2017-10-11 03:07:14.746064|2017-10-11 03:07:14.746064
NCT01567878|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2014-12-01|||May 2009||2009-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Ultrasound of Enthesis in Patients With Ankylosing Spondylitis: a Comparative Study With Health Subjects|Ultrasound of Enthesis in Patients With Ankylosing Spondylitis: a Comparative Study With Health Subjects|Completed||N/A|80|Actual|University of Sao Paulo|||2||f||||f||||||Samples With DNA|"     Blood sample   "|||2017-10-11 03:07:14.861248|2017-10-11 03:07:14.861248
NCT01567865|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2013-08-02|||May 2012||2012-05-01|March 2012|2012-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Lot-to-lot Consistency Trial of JE Live Attenuated SA 14-14-2 Vaccine|A Clinical Trial in Healthy Infants to Assess Lot-to-lot Consistency of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine Manufactured in a New Good Manufacturing Practices Facility and Non-inferiority With Respect to an Earlier Product.|Completed||Phase 4|||PATH||1|||f||||||||||||||2017-10-11 03:07:14.938594|2017-10-11 03:07:14.938594
NCT01567852|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2014-12-15|2014-05-21||August 2011||2011-08-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time|The Use of Ketamine Versus Methohexital for Electroconvulsive Therapy: A Cross-Over Comparative Study on Patient Recovery and Re-Orientation Time|Completed||N/A|20|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-11 03:07:15.128711|2017-10-11 03:07:15.128711
NCT01567839|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2013-11-07|2013-06-24||May 2012||2012-05-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional||No difference.|Testing the Anesthetic Effectiveness of Three Different Dental Local Anesthetics Injected Next to a Lower First Molar|Anesthetic Efficacy of 4% Articaine With 1:100,000 Epinephrine, 4% Prilocaine With 1:200,000 Epinephrine, and 4% Lidocaine With 1:100,000 Epinephrine as a Primary Buccal Infiltration in the Mandibular First Molar.|Completed||Phase 4|60|Actual|Ohio State University|No adverse events.|3|||f||||f||||||||||2017-10-11 03:07:15.530178|2017-10-11 03:07:15.530178
NCT01567826|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-04-11|2016-05-10||May 2010||2010-05-01|April 2017|2017-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|YELLOW||Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy|Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy. (YELLOW Trial)|Completed||Phase 4|87|Actual|Icahn School of Medicine at Mount Sinai|Limitations - small sample size and short duration of follow-up.|2|||f||||t||||||||||2017-10-11 03:07:15.7917|2017-10-11 03:07:15.7917
NCT01567813|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-09-28|||June 23, 2011|Actual|2011-06-23|September 2017|2017-09-01|June 23, 2018|Anticipated|2018-06-23|June 23, 2018|Anticipated|2018-06-23||Observational|||Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)|Post-Licensure Observational Study of the Safety of GARDASIL™ in Males|Active, not recruiting||N/A|44000|Anticipated|Merck Sharp & Dohme Corp.|||3||f||||t||||||||||2017-10-11 03:07:16.653356|2017-10-11 03:07:16.653356
NCT01567800|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-09-19|||April 2012||2012-04-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Prostate Hypoxia FAZA|A Feasibility Study of Hypoxia Imaging in Patients With Prostate Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)|Recruiting||N/A|20|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 03:07:16.733802|2017-10-11 03:07:16.733802
NCT01567774|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2013-05-03|||April 2012||2012-04-01|May 2013|2013-05-01|June 2015|Anticipated|2015-06-01|March 2014|Anticipated|2014-03-01||Interventional|PEARL||Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity|Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on pLatelet Reactivity in Stable Patients With Coronary Artery Disease Treated With Dual Antiplatelet Therapy|Unknown status|Recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 03:07:17.045604|2017-10-11 03:07:17.045604
NCT01567761|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-03-29|||May 2012||2012-05-01|March 2012|2012-03-01||||||||Observational|||The Effect of Two Different Artificial Respiration Methods on the Intraocular Pressure During Surgery Under General Anesthesia|A Prospective, Randomized and Double Blind Study on The Effect of Two Different Artificial Respiration Methods on the Intraocular Pressure During Surgery Under General Anesthesia|Unknown status|Not yet recruiting|N/A|50|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||f||||||||||2017-10-11 03:07:17.412355|2017-10-11 03:07:17.412355
NCT01567748|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2014-12-03|||January 2012||2012-01-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||In-human Validation of a Technique for Measuring Central Aortic Hemodynamics With Peripheral Arterial Waveforms|In-human Validation of a Technique for Measuring Central Aortic Hemodynamics With Peripheral Arterial Waveforms|Completed||N/A|40|Actual|University of Alberta|||1||f||||t||||||||||2017-10-11 03:07:17.494683|2017-10-11 03:07:17.494683
NCT01567735|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-07-05|||March 27, 2012|Actual|2012-03-27|July 2017|2017-07-01|March 20, 2014|Actual|2014-03-20|March 20, 2014|Actual|2014-03-20||Interventional|RESTORE||A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients|An Open-Label, Single-Arm Phase III Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Subjects|Completed||Phase 3|107|Actual|Janssen R&D Ireland||1|||f||||t||f||||||||2017-10-11 03:07:17.598899|2017-10-11 03:07:17.598899
NCT01567722|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2016-11-09|||July 2012||2012-07-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies|Tissue Acquisition for Analysis of Prognostic Factors, Immunology, and Genetic Progression of HIV-1 Associated Malignancies|Recruiting||N/A|300|Anticipated|AIDS Malignancy Consortium|||1||f||||f||||||Samples With DNA|"     Fresh-frozen tissue, Peripheral blood mononuclear cells   "|Yes|Results will be submitted to dBGaP|2017-10-11 03:07:17.765808|2017-10-11 03:07:17.765808
NCT01567709|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2017-09-12|||April 16, 2012|Actual|2012-04-16|September 2017|2017-09-01||||December 31, 2017|Anticipated|2017-12-31||Interventional|||Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma|Phase I Study of the Aurora Kinase a Inhibitor MLN8237 in Combination With the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies|Active, not recruiting||Phase 1|60|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:07:17.98922|2017-10-11 03:07:17.98922
NCT01567696|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-03-29|||June 2011||2011-06-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Clinical, Radiographic and Laboratory Analysis of Failures of Joint Replacements|Defining the Inflammatory Cytokines in Patients With Adverse Reactions to Metal-on-Metal Hip Replacements|Unknown status|Recruiting|N/A|100|Anticipated|University of California, San Diego|||1||f||||f||||||||||2017-10-11 03:07:18.132367|2017-10-11 03:07:18.132367
NCT01567683|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2012-05-25||||||May 2012|2012-05-01||||||||Interventional|Limsafe||A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects||Completed||Phase 1|||Moberg Pharma AB||1|||f||||||||||||||2017-10-11 03:07:18.223887|2017-10-11 03:07:18.223887
NCT01567670|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-29|||August 2011||2011-08-01|March 2012|2012-03-01||||June 2012|Anticipated|2012-06-01||Interventional|BED||Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray|Clinical Controlled Trial on Extinction of Opioidergic Binge Eating Disorder (BED) With Intranasal Naloxone Administration|Unknown status|Active, not recruiting|Phase 2/Phase 3|138|Anticipated|Lightlake Sinclair Ltd.||2|||f||||t||||||||||2017-10-11 03:07:18.292671|2017-10-11 03:07:18.292671
NCT01567657|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-01-25|||January 2012||2012-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety Study of Two Regimen for Sedation for Transesophageal Echocardiography|Phase II Study of Comparison of Two Sedation Regimen for Transesophageal Echocardiography in Point of View of Blood Pressure Response, Safety and Patient Comfort|Completed||Phase 2|200|Actual|Kantonsspital Münsterlingen||2|||f||||f||||||||||2017-10-11 03:07:18.377148|2017-10-11 03:07:18.377148
NCT01567644|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-15|2012-04-01|||January 2008||2008-01-01|April 2012|2012-04-01|September 2012|Anticipated|2012-09-01|April 2012|Anticipated|2012-04-01||Interventional|||Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris|Clinical Trial Evaluating the Treatment of Patients With Refractory Chronic Angina Pectoris With Low Intensity Extracorporeal Shockwave Therapy Device|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|Medispec||1|||f||||f||||||||||2017-10-11 03:07:18.547359|2017-10-11 03:07:18.547359
NCT01567631|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-01-29|||January 2012||2012-01-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LAHIGA||Classical Procedure Versus Intrahepatic Glisson's Approach|Laparoscopic Anatomical Hepatectomy With Intrahepatic Glisson's Approach Versus Laparoscopic Anatomical Hepatectomy With Classical Procedure|Recruiting||N/A|80|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 03:07:18.673426|2017-10-11 03:07:18.673426
NCT01567618|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-11-06|||March 2012||2012-03-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|DaeMon||Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer|A Phase II Trial Evaluating Biweekly Docetaxel and DeGramont Regimen in First-Line Treatment of Unresectable or Metastatic Gastric Adenocarcinoma (DaeMon)|Completed||Phase 2|39|Actual|Sixth Affiliated Hospital, Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 03:07:18.806178|2017-10-11 03:07:18.806178
NCT01567605|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-04-26|||March 2012||2012-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bowel Care and Cardiovascular Function After Spinal Cord Injury|Bowel Care and Cardiovascular Function After Spinal Cord Injury|Recruiting||Phase 4|13|Anticipated|Simon Fraser University||2|||f||||f||||||||No||2017-10-11 03:07:18.901762|2017-10-11 03:07:18.901762
NCT01567592|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-04-01|||March 2009||2009-03-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris|Clinical Trial Evaluating the Treatment of Patients With Refractory Angina Pectoris With Low Intensity Extracorporeal Shockwave Therapy Device|Suspended||Phase 1|20|Anticipated|Medispec||1|||f||||f||||||||||2017-10-11 03:07:19.036561|2017-10-11 03:07:19.036561
NCT01567579|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-05-15|||January 2009||2009-01-01|May 2017|2017-05-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease|An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease|Recruiting||N/A|1000|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-10-11 03:07:19.156005|2017-10-11 03:07:19.156005
NCT01567566|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-03-28|||June 2011||2011-06-01|March 2012|2012-03-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|LBP-RCT||An Efficacy Study of Exercise Rehabilitation on Pain and Disability for Patients With Non-specific Low Back Pain|The Effect of Hip Stabilizer Muscle Strengthening on Pain and Disability for Patients With Non-specific Low Back Pain: an Outcome-based Randomized Controlled Trial|Unknown status|Recruiting|N/A|80|Anticipated|Running Injury Clinic||2|||f||||f||||||||||2017-10-11 03:07:19.267374|2017-10-11 03:07:19.267374
NCT01567553|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2015-10-27|||April 2009||2009-04-01|January 2015|2015-01-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Observational|USPIO-CIS||The Inflammatory Process and the Medical Imaging in Patients With an Inflammatory Disease of the Central Nervous System.|Early Neuroinflammatory Changes as a Prognostic Marker in Clinically Isolated Syndromes Patients.|Terminated||N/A|37|Actual|Rennes University Hospital|||2|terminated ( Halted prematurely,expiration of investigationnal product)|f||||f||||||||||2017-10-11 03:07:19.405789|2017-10-11 03:07:19.405789
NCT01567540|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2014-01-17|||March 2013||2013-03-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients|A Pilot Study to Evaluate the Clinical and Biological Tolerance of Sitagliptin With Pegylated Interferon alfa2a Plus Ribavirin Combination Therapy in Chronic Hepatitis C Patients|Terminated||Phase 1|3|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1||New treatments available, which prevents additional recruitment.|f||||t||||||||||2017-10-11 03:07:19.53701|2017-10-11 03:07:19.53701
NCT01567501|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-11-30|||February 2012||2012-02-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Levocetirizine Dihydrochloride 5 mg Tablets With Xyzal® 5 mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fed Condition|Completed||Phase 1|28|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 03:07:20.080009|2017-10-11 03:07:20.080009
NCT01567488|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-05-29|||June 8, 2011|Actual|2011-06-08|May 2017|2017-05-01|June 7, 2017|Anticipated|2017-06-07|September 1, 2014|Actual|2014-09-01||Interventional|EVERLAR||Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET|A Phase II Study on Everolimus, an mTOR Inhibitor (Oral Formulation), With Octreotide LAR® in Adult Patients With Advanced, Non-functioning, Well-differentiated Gastrointestinal Neuroendocrine Tumours (GI NET)|Active, not recruiting||Phase 2|43|Actual|Grupo Espanol de Tumores Neuroendocrinos||1|||f||||t||||||||Undecided|As per Spanish local regulations|2017-10-11 03:07:20.197843|2017-10-11 03:07:20.197843
NCT01567475|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2016-03-14|||December 2011||2011-12-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|June 2013|Actual|2013-06-01||Interventional|(RAD001-R)||The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's Lymphomas|A Phase I/II Study Investigating the Combination of RAD001 and Rituximab in Patients With Non-Hodgkin's Lymphomas|Completed||Phase 1|21|Actual|The Lymphoma Academic Research Organisation||1|||f||||f||||||||||2017-10-11 03:07:20.348036|2017-10-11 03:07:20.348036
NCT01567436|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-09-26|||February 2012||2012-02-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings|A Prospective Study of Male Circumcision Using the Shang Ring in Routine Clinical Settings in Kenya & Zambia|Completed||Phase 4|1200|Actual|FHI 360||1|||f||||f||||||||||2017-10-11 03:07:20.702517|2017-10-11 03:07:20.702517
NCT01567423|ClinicalTrials.gov processed this data on October 10, 2017|2009-01-27|2012-03-28|||April 2008||2008-04-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria|Efficacy of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Childhood Plasmodium Falciparum Malaria in Pweto, Democratic Republic of Congo, 2008|Completed||N/A|301|Actual|Epicentre||2|||f||||f||||||||||2017-10-11 03:07:20.833857|2017-10-11 03:07:20.833857
NCT01567410|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2014-10-22|||March 2012||2012-03-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of an E-learning Program for Assessing Pressure Ulcer Risk and Pressure Ulcer Classification - a Pilot Study|Randomized Controlled Trial to Evaluate the Effect of E-learning on Nurses Ability to Assess Patient Risk for Pressure Ulcers and Pressure Ulcer Classification|Completed||N/A|68|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 03:07:20.969199|2017-10-11 03:07:20.969199
NCT01567397|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-12-20|||December 2011||2011-12-01|December 2016|2016-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|ReDuCTO||Registry of Dupuytren's Contracture Treatment Outcomes|Registry of Dupuytren's Contracture Treatment Outcomes|Completed||N/A|87|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 03:07:21.067747|2017-10-11 03:07:21.067747
NCT01567384|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-11-19|||May 2012||2012-05-01|November 2013|2013-11-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies|A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies|Withdrawn||Phase 1|0|Actual|Emory University||1||The sponsor withdrew support for the study before any patients were enrolled.|f||||t||||||||||2017-10-11 03:07:21.153496|2017-10-11 03:07:21.153496
NCT01567371|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-03-16|2016-03-16||March 2012||2012-03-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||LiDCO Monitor Study|Use of the LiDCORapid Monitor in Patients During Graded Phlebotomy and the Removal of Autologous Blood|Completed||N/A|30|Actual|Nationwide Children's Hospital||1|||f||||f||||||||||2017-10-11 03:07:21.24191|2017-10-11 03:07:21.24191
NCT01567358|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-06-18|||February 2012||2012-02-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis|A Randomized, Double-Blind, Repeated Dose, Active Control Drug, Parallel-group and Single-center Phase I Study of the Safety of Intravenous Administration of NI-071 in Comparison With Remicade® in Japanese Patients With Rheumatoid Arthritis Inadequately Treated With Methotrexate|Completed||Phase 1|14|Actual|Nichi-Iko Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:07:21.434286|2017-10-11 03:07:21.434286
NCT01567345|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-28|||January 2009||2009-01-01|March 2012|2012-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|PITAC||Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow|Comparison of Two Types of Intrathecal Morphine Administration by Pump for Analgesia in Cancer Patients With Failure of Conventional Analgesic Therapy.|Completed||Phase 2|54|Actual|ICO Paul Papin||2|||f||||t||||||||||2017-10-11 03:07:21.684603|2017-10-11 03:07:21.684603
NCT01567332|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-08-05|||September 2011||2011-09-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|rTMS||Evaluation of Walking After Repetitive Transcranial Magnetic Stimulation (rTMS) Inhibitory 1Hz in Vascular Hemiplegia|Evaluation of Walking After Repetitive Transcranial Magnetic Stimulation (rTMS) Inhibitory 1Hz in Vascular Hemiplegia.|Terminated||N/A|10|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 03:07:21.787026|2017-10-11 03:07:21.787026
NCT01567319|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-04-28|||February 2012||2012-02-01|April 2017|2017-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts|Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts in Patients Sensitized to Them.|Completed||Phase 1|177|Actual|Roxall Medicina España S.A||3|||f||||f||||||||||2017-10-11 03:07:21.897086|2017-10-11 03:07:21.897086
NCT01567306|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-04-28|||October 2011||2011-10-01|April 2017|2017-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense|Phase II, Multicenter, Randomized, Double Blind Study, With Subcutaneous Immunotherapy At Different Doses, in Parallel Groups and Placebo-Controlled, in Patients With Rhinoconjunctivitis ± Asthma Sensitized to Phleum Pratense|Completed||Phase 2|151|Actual|Roxall Medicina España S.A||6|||f||||f||||||||||2017-10-11 03:07:22.042137|2017-10-11 03:07:22.042137
NCT01567280|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-29|2015-01-19|||May 2012||2012-05-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Observational|LIAISON||International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)|International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)|Completed||N/A|8111|Actual|Chiesi Farmaceutici S.p.A.|||2||f||||t||||||||||2017-10-11 03:07:22.197466|2017-10-11 03:07:22.197466
NCT01567267|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-03-01|||February 2010||2010-02-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|September 2018|Anticipated|2018-09-01||Interventional|||Evaluation of Educational Intervention to Teach Principles of Evidence-based Medicine (EbM) in Biology Classes|Phase II Study of a Short Term Educational Intervention for Upcoming Biology Teachers to Teach Principles of Evidence-based Medicine (EbM) in Biology Classes at High-school|Active, not recruiting||N/A|87|Actual|Goethe University||2|||f||||f||||||||||2017-10-11 03:07:22.264847|2017-10-11 03:07:22.264847
NCT01567254|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2015-01-01|||April 2012||2012-04-01|January 2015|2015-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Guided Imagery in Children With Type 1 Diabetes Mellitus on Glucose Levels and on Glycemic Control|Subject: A Blinded Randomized Trial: the Effect of Guided Imagery in Children With Type 1 Diabetes Mellitus on Glucose Levels and on Glycemic Control|Completed||N/A|13|Actual|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 03:07:22.379307|2017-10-11 03:07:22.379307
NCT01567241|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-30|||March 2012||2012-03-01|March 2012|2012-03-01|March 2014|Anticipated|2014-03-01|August 2013|Anticipated|2013-08-01||Interventional|||Clinical Hypnosis During Insemination or Embryotransfer|Prospective Off-center Randomised Trial of Clinical Hypnosis Versus Relaxation Music|Unknown status|Recruiting|N/A|282|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 03:07:22.481103|2017-10-11 03:07:22.481103
NCT01567228|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-09-14|||September 2012||2012-09-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|CHICA GIS||Delivering Geospatial Intelligence to Health Care Providers|Delivering Geospatial Intelligence to Health Care Providers|Completed||N/A|1076|Anticipated|Indiana University||2|||f||||t||||||||||2017-10-11 03:07:22.58897|2017-10-11 03:07:22.58897
NCT01567215|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-06-30|||May 2012||2012-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Treatment of Granuloma Umbilical in Newborn Babies|Treatment of Granuloma Umbilical in Newborn Babies - Comparison of Treatment With Silver Nitrate Versus Alcohol Swaps Versus Steroid Creme Group IV|Completed||Phase 2|90|Actual|Hvidovre University Hospital||1|||f||||t||||||||||2017-10-11 03:07:22.701023|2017-10-11 03:07:22.701023
NCT01567202|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2015-05-19|||March 2012||2012-03-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of DC Vaccination Against Glioblastoma|A Triple-blind Randomized Clinical Study of Vaccination With Dendritic Cells Loaded With Glioma Stem-like Cells Associated Antigens Against Brain Glioblastoma Multiform|Unknown status|Recruiting|Phase 2|100|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-11 03:07:22.809031|2017-10-11 03:07:22.809031
NCT01567189|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-03-28|||April 2012||2012-04-01|March 2012|2012-03-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|CERC1||Cost-effectiveness of Outpatient Versus Hospital Cardiac Rehabilitation|Outpatient Cardiac Rehabilitation Versus Hospital. Cost-effectiveness Study|Unknown status|Not yet recruiting|N/A|138|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-11 03:07:22.960757|2017-10-11 03:07:22.960757
NCT01567176|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-01-17|||March 2012||2012-03-01|February 2012|2012-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|Sirt6||Circulating SIRT6 Expression, Effect on Aging Quality|Circulating Expression Measurement of a Sirtuin Protein Isoform, Sirt6, as an Early Marker of Aging Quality|Completed||N/A|60|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 03:07:23.057131|2017-10-11 03:07:23.057131
NCT01567163|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2014-10-03|2014-05-16|2014-04-14|July 2012||2012-07-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|December 2012|Actual|2012-12-01||Interventional||All participants who received at least 1 dose of ramucirumab or docetaxel.|A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors|A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Docetaxel in Patients With Advanced Malignant Solid Tumors|Completed||Phase 2|22|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:07:23.167521|2017-10-11 03:07:23.167521
NCT01567150|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-10-04|2015-09-22||February 2012||2012-02-01|October 2016|2016-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Wound Fluid Protease Levels During Use of Novel Wound Dressing|Wound Fluid Protease Levels During Use of Novel Wound Dressing|Completed||Phase 4|35|Actual|Hollister Incorporated||2|||f||||f||||||||No||2017-10-11 03:07:25.364178|2017-10-11 03:07:25.364178
NCT01567137|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-06-14|||November 2007||2007-11-01|June 2016|2016-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||MR Characterisation/Localisation of Breast Cancer|Using Magnetic Resonance Techniques to Improve the Characterisation and Localisation of Breast Cancer|Completed||N/A|16|Actual|Institute of Cancer Research, United Kingdom|||1||f||||f||||||||||2017-10-11 03:07:25.613514|2017-10-11 03:07:25.613514
NCT01567124|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2013-12-16|||May 2012||2012-05-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Alleviating the Metabolic Side Effects of Antipsychotic Medications|A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia|Unknown status|Recruiting|Phase 4|90|Anticipated|Baker IDI Heart and Diabetes Institute||2|||f||||f||||||||||2017-10-11 03:07:25.690803|2017-10-11 03:07:25.690803
NCT01567111|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-02-28|||February 2012||2012-02-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|August 2015|Actual|2015-08-01||Interventional|MIA||11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism|Functional Imaging With 11C-Metomidate Positron Emission Tomography Versus Adrenal Vein Sampling in Differential Diagnosis of Unilateral and Bilateral Aldosterone Secretion in Primary Aldosteronism|Active, not recruiting||N/A|40|Anticipated|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-11 03:07:25.865568|2017-10-11 03:07:25.865568
NCT01567098|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-05-28|||June 2012||2012-06-01|May 2012|2012-05-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Single Incision Versus Conventional 3-Port Laparoscopic Appendectomy|Single Incision Versus Conventional 3-Port Laparoscopic Appendectomy: A Single Center Prospective Randomized Trial|Unknown status|Not yet recruiting|N/A|120|Anticipated|Hospital Authority, Hong Kong||2|||f||||f||||||||||2017-10-11 03:07:25.958357|2017-10-11 03:07:25.958357
NCT01567085|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-09-12|||May 2012||2012-05-01|September 2017|2017-09-01|May 24, 2017|Actual|2017-05-24|June 2015|Actual|2015-06-01||Interventional|||Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor|An Open-Label, Single-Arm, Multicenter Trial to Determine Safety and Efficacy of Eculizumab in the Prevention of Antibody Mediated Rejection (AMR) in Sensitized Recipients of a Kidney Transplant From a Deceased Donor.|Completed||Phase 2|80|Actual|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-10-11 03:07:26.054084|2017-10-11 03:07:26.054084
NCT01567072|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-09-03|||April 2012||2012-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|CHIP||Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture|Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture|Completed||Phase 3|192|Actual|Aalborg Universitetshospital||3|||f||||t||||||||||2017-10-11 03:07:26.14848|2017-10-11 03:07:26.14848
NCT01567059|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2017-02-13||2017-02-13|May 2012||2012-05-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome|A Phase II Study of Tosedostat in Combination With Either Cytarabine or Decitabine in Newly Diagnosed AML or High-Risk MDS|Completed||Phase 2|34|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 03:07:27.478119|2017-10-11 03:07:27.478119
NCT01567046|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-05-13|||May 2016||2016-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas|Observational - Potentially Actionable Mutations in Archived Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)|Completed||N/A|70|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Tissue   "|||2017-10-11 03:07:27.601231|2017-10-11 03:07:27.601231
NCT01567033|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-06-02|||July 2011||2011-07-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|HEALTH||Healthy Eating and Active Living Taught at Home|Translating a Weight Loss Intervention Through a National Home Visiting Program|Unknown status|Active, not recruiting|N/A|512|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 03:07:27.721039|2017-10-11 03:07:27.721039
NCT01567020|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-12-15|2016-12-15||May 2012||2012-05-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01|99 Years|Observational [Patient Registry]|CAPD Blast||Central Auditory Processing Deficits Associated With Blast Exposure|Central Auditory Processing Deficits Associated With Blast Exposure|Completed||N/A|105|Actual|VA Office of Research and Development|||4||f||||f||||||None Retained|"     None collected.   "|Yes|Data sharing will be through an established data repository overseen by the VA Portland HCS IRB.|2017-10-11 03:07:27.823547|2017-10-11 03:07:27.823547
NCT01567007|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-27|||March 2011||2011-03-01|March 2012|2012-03-01|August 2012|Anticipated|2012-08-01|April 2012|Anticipated|2012-04-01||Interventional|||Change in Physical Activity Levels in Women at Working Place|Impact of Different Interventions in Physical Activity Level and Co-morbidities in Women: Randomized, Controlled Study|Unknown status|Active, not recruiting|N/A|195|Actual|University of Sao Paulo General Hospital||4|||f||||t||||||||||2017-10-11 03:07:28.21612|2017-10-11 03:07:28.21612
NCT01566994|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-09-16|||March 2010||2010-03-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparing Population Cessation Services|Comparing Population Cessation Services With Emphasis on Unmotivated Smokers|Completed||N/A|2500|Actual|University of Rhode Island||3|||f||||t||||||||||2017-10-11 03:07:28.327021|2017-10-11 03:07:28.327021
NCT01566981|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2014-10-28|2014-07-27||March 2012||2012-03-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|EHDI||E-health Care Process Support for Diabetes Type II Patients|E-support for Healthcare Processes - DIABETES|Completed||N/A|120|Actual|University of Primorska||2|||f||||f||||||||||2017-10-11 03:07:28.411197|2017-10-11 03:07:28.411197
NCT01566968|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-04-05|||January 2011||2011-01-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|NEAT||Novel Endpoints in Cough Challenge Testing|Novel Endpoints in Cough Challenge Testing.|Completed||N/A|98|Actual|University Hospital of South Manchester NHS Foundation Trust|||5||f||||f||||||||||2017-10-11 03:07:28.784042|2017-10-11 03:07:28.784042
NCT01566955|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-05-26|||April 2012||2012-04-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TG-Adnex||Feasability Study of Removing the Ovaries and Fallopian Tubes|Feasability of Transgastric Adnexectomy|Completed||N/A|6|Actual|Heidelberg University||1|||f||||f||||||||||2017-10-11 03:07:28.888688|2017-10-11 03:07:28.888688
NCT01566942|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-03-27|||June 2012||2012-06-01|March 2012|2012-03-01|June 2017|Anticipated|2017-06-01|May 2014|Anticipated|2014-05-01||Interventional|||FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer|FOLFIRI or mFOLFOX6 as Adjuvant Chemotherapy Regiment After Neo-adjuvant Chemotherapy With FOLFIRI in Patients With Advanced Colorectal Cancer: a Randomized, Multicenter Clinical Trial|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:07:28.996593|2017-10-11 03:07:28.996593
NCT01566929|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-12-11|||October 2010||2010-10-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|January 2016|Actual|2016-01-01||Interventional|||Weight Management Intervention for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF)|Weight Management Interventions for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF): a Randomized Controlled Trial|Active, not recruiting||N/A|317|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-10-11 03:07:29.097353|2017-10-11 03:07:29.097353
NCT01566916|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-02-10||||||February 2014|2014-02-01||||||||Interventional|||Medium Term Survivorship of Cementless THA Performed Using the Bone Preservation Tri-Lock Femoral Stem||Unknown status|Not yet recruiting|N/A|||Rothman Institute Orthopaedics||2|||f||||||||||||||2017-10-11 03:07:29.25012|2017-10-11 03:07:29.25012
NCT01566903|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-05-24|||June 2012||2012-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|NCE MRA||Neurovascular Non Contrast-Enhanced MR Angiography at 3T|Morphological and Dynamic Non Contrast-enhanced MR Angiography in the Exploration of Neurovascular Diseases|Recruiting||N/A|100|Anticipated|Rennes University Hospital|||3||f||||||||||||||2017-10-11 03:07:29.345043|2017-10-11 03:07:29.345043
NCT01566890|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2016-07-18|||July 2012||2012-07-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Microvascular Blood Flow in Sickle Cell Anemia|Effect of Adenosine 2A Receptor Agonist Regadenoson on Microvascular Blood Flow in Sickle Cell Anemia|Recruiting||N/A|200|Anticipated|Blood Center of Wisconsin||5|||f||||t||||||||||2017-10-11 03:07:29.432028|2017-10-11 03:07:29.432028
NCT01566877|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-05-06|||May 2013||2013-05-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers|Completed||Phase 1|40|Actual|Sarepta Therapeutics||2|||f||||t||||||||||2017-10-11 03:07:29.556952|2017-10-11 03:07:29.556952
NCT01566864|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-02-22|||April 2011||2011-04-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Multi-Method Health System Quality Improvement Intervention to Reduce Hypertension Disparities|Multi-Method Health System QI Intervention to Reduce Hypertension Disparities|Active, not recruiting||N/A|66570|Actual|Johns Hopkins University||1|||f||||t||||||||No||2017-10-11 03:07:29.650966|2017-10-11 03:07:29.650966
NCT01566851|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-03-28|||May 2012||2012-05-01|March 2012|2012-03-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Observational|||Application of EULAR Recommendations for Cardiovascular Risk Management in Patients With Rheumatoid Arthritis|Application of EULAR Recommendations for Cardiovascular Risk Management in Patients With Rheumatoid Arthritis in France in the Entire Population of the RSI (Other Branches of the Universal Healthcare Insurance Agency)|Unknown status|Not yet recruiting|N/A|7000|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||||2017-10-11 03:07:29.765695|2017-10-11 03:07:29.765695
NCT01566838|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-07-06|2016-01-04||October 2012||2012-10-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Continuous Subpleural Infusion of Bupivacaine|A Randomized Controlled Trial of Continuous Subpleural Infusion of Bupivacaine After Thoracoscopy|Completed||N/A|83|Actual|Inova Health Care Services|This study limited by a low power and reliance on patient self-reporting.|2|||f||||f||||||||||2017-10-11 03:07:29.845435|2017-10-11 03:07:29.845435
NCT01566825|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-03-27|||August 2008||2008-08-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Influence of Amitriptyline on Learning in a Visual Discrimination Task|The Influence of Amitriptyline (Amitriptylin-CT 25 mg®) on Learning in a Visual Discrimination Task (Karni-Sagi-paradigm)|Completed||N/A|32|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 03:07:30.319938|2017-10-11 03:07:30.319938
NCT01566812|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-03-05|||June 2012||2012-06-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|BRAVO||Effect of Breastfeeding Optimization on Early Vascular Development|BReast Feeding Attitude and Volume Optimization (BRAVO) Trial: A Randomized Breast Feeding Optimization Experiment|Active, not recruiting||N/A|1000|Actual|Indonesia University||2|||f||||f||||||||||2017-10-11 03:07:30.411475|2017-10-11 03:07:30.411475
NCT01566799|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-29|||April 2012||2012-04-01|March 2012|2012-03-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer|Clinical Phase II, Randomized, Double Blind Trial, to Evaluate the Efficacy of Metformin and Chemotherapy Versus Placebo Nad Chemotherapy in Neoadjuvant Setting for Locally Advanced Breast Cancer|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Instituto Nacional de Cancerologia de Mexico||1|||f||||t||||||||||2017-10-11 03:07:30.501558|2017-10-11 03:07:30.501558
NCT01566786|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-01-11|||August 2001||2001-08-01|January 2017|2017-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage|Randomised, Double-Blind, Placebo-Controlled, Multicentre, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of Activated Recombinant Factor VII (NovoSeven®) in Acute Intracerebral Haemorrhage|Completed||Phase 2|48|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:07:30.584274|2017-10-11 03:07:30.584274
NCT01566760|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-08-17|||May 2012||2012-05-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers|Open-Label, Single-Dose, Randomized, Crossover Study To Estimate The Effects Of Food On The Pharmacokinetics Of Two Fesoterodine Sustained-Release Beads-In-Capsule Formulations And To Estimate The Relative Bioavailability Of One Or Both Formulations Compared To Commercial Tablet Formulation In Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 03:07:30.914922|2017-10-11 03:07:30.914922
NCT01566747|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-05-30|||March 2011||2011-03-01|May 2017|2017-05-01||||August 13, 2015|Actual|2015-08-13||Interventional|||Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5|A Phase II Study of Pazopanib in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC) Who Have Failed Prior Sunitinib Therapy|Active, not recruiting||Phase 2|43|Actual|Cancer Trials Ireland||1|||f||||||||||||||2017-10-11 03:07:31.008286|2017-10-11 03:07:31.008286
NCT01566734|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-10-12|||December 2010||2010-12-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Cefazolin and Normal Saline Irrigation on Surgical Site Infections (SSIs)|Comparison of the Effect of Cefazolin and Normal Saline Irrigation With no Irrigation on the Incidence of Surgical Site Infections|Completed||N/A|200|Actual|Hormozgan University of Medical Sciences||3|||f||||t||||||||||2017-10-11 03:07:31.091718|2017-10-11 03:07:31.091718
NCT01566721|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-03-06|2017-03-06||May 2012||2012-05-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|March 2015|Actual|2015-03-01||Interventional|SafeHER|Intent-to-Treat (ITT) Population: All participants enrolled into the study regardless of whether treatment was received.|A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer|A Phase III Prospective, Two-Cohort Non-Randomized, Multi-Centre, Multinational, Open-Label Study to Assess the Safety of Assisted- and Self-Administered Subcutaneous Trastuzumab as Therapy in Patients With Operable HER2-Positive Early Breast Cancer|Active, not recruiting||Phase 3|2577|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 03:07:31.294053|2017-10-11 03:07:31.294053
NCT01566708|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-04-24|||January 2012||2012-01-01|April 2013|2013-04-01|September 2013|Anticipated|2013-09-01|April 2013|Actual|2013-04-01||Interventional|||Neuro-Music Therapy for Recent Onset Tinnitus: Evaluation of a Therapy Concept|Diagnostic and Interventional Study of Neuro-Music Therapy for Recent Onset Tinnitus: Evaluation of a Therapy Concept Using Psychological Assessment and Functional Neuroimaging|Unknown status|Active, not recruiting|N/A|60|Anticipated|German Center for Music Therapy Research||3|||f||||f||||||||||2017-10-11 03:07:34.058537|2017-10-11 03:07:34.058537
NCT01566695|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-10-02|||April 26, 2013|Actual|2013-04-26|October 2017|2017-10-01|October 31, 2021|Anticipated|2021-10-31|October 31, 2021|Anticipated|2021-10-31||Interventional|||The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)|A Phase 3, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Subjects With Red Blood Cell Transfusion-dependent Anemia and Thrombocytopenia Due to IPSS Lower-risk Myelodysplastic Syndromes.|Recruiting||Phase 3|386|Anticipated|Celgene||2|||f||||f||||||||||2017-10-11 03:07:34.917135|2017-10-11 03:07:34.917135
NCT01566682|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-07-19|||October 2012||2012-10-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||A Multi-Center Trial of the ProLung Test™|A Multi-Center Trial of the ProLung Test™ (Transthoracic Bioconductance Measurement) as an Adjunct to CT Chest Scans for the Risk Stratification of Patients With Pulmonary Lesions Suspicious for Lung Cancer|Recruiting||N/A|350|Anticipated|Fresh Medical Laboratories|||1||f||||f||||||||||2017-10-11 03:07:35.746381|2017-10-11 03:07:35.746381
NCT01566669|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2012-09-20|||June 2009||2009-06-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|PCEA||Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery|A Multicenter, Randomised, Double-blinded, Placebo-controlled Trial Comparing the Efficacy and Safety of Intravenous Parecoxib Sodium on Morphine Patient-controlled Epidural Analgesia After Gynecologic Surgery|Completed||N/A|294|Actual|First Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-11 03:07:35.957711|2017-10-11 03:07:35.957711
NCT01566474|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2013-01-23|||April 2012||2012-04-01|January 2013|2013-01-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study|Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study|Unknown status|Recruiting|Phase 3|80|Anticipated|Aragon Institute of Health Sciences||2|||f||||t||||||||||2017-10-11 03:07:41.711119|2017-10-11 03:07:41.711119
NCT01566656|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-10-10|||March 2012||2012-03-01|October 2016|2016-10-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|TLI-ATG||Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies|Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies|Recruiting||Phase 2|30|Anticipated|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 03:07:36.10749|2017-10-11 03:07:36.10749
NCT01566643|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-04-04|||January 2011||2011-01-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections|Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections|Unknown status|Recruiting|Phase 4|231|Anticipated|Buddhist Tzu Chi General Hospital||3|||f||||t||||||||||2017-10-11 03:07:36.295178|2017-10-11 03:07:36.295178
NCT01566630|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-10-12|2015-08-06||May 2013||2013-05-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia|An Adaptive Multicentre, Randomized, Partially Double-blind, Placebo-controlled Study to Assess the Safety, PK and PD/Efficacy of RLX030 in Women With Pre-eclampsia|Terminated||Phase 2|3|Actual|Novartis||2||Novartis terminated this study due to internal, strategic decisions.|f||||||||||||||2017-10-11 03:07:36.475004|2017-10-11 03:07:36.475004
NCT01566617|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-01-20|||October 2012||2012-10-01|January 2016|2016-01-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|ChagasCare||Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease|Impact of The Pharmaceutical Care on the Quality of Life of Patients With Chagas Disease and Heart Failure: Randomized Clinical Trial|Recruiting||N/A|88|Anticipated|Evandro Chagas Institute of Clinical Research||2|||f||||f||||||||||2017-10-11 03:07:38.147846|2017-10-11 03:07:38.147846
NCT01566604|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-07-16|2014-06-03||March 2012||2012-03-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|GLOW7||Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease|A 26-week Treatment, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of NVA237 (50 µg o.d.) in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|460|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:07:38.335232|2017-10-11 03:07:38.335232
NCT01566591|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-02-05|||May 2012||2012-05-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression|A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-Coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction With Mood Stabilizers in Subjects With Bipolar Depression|Recruiting||Phase 3|120|Anticipated|Brainsway||2|||f||||t||||||||||2017-10-11 03:07:39.249338|2017-10-11 03:07:39.249338
NCT01566578|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-08-02|||April 2012||2012-04-01|August 2012|2012-08-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|EGFR||A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF|A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF|Unknown status|Recruiting|Phase 1|24|Anticipated|Ennar Pharmaceuticals AF||2|||f||||f||||||||||2017-10-11 03:07:39.570949|2017-10-11 03:07:39.570949
NCT01566565|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2013-02-22|||March 2012||2012-03-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension|The Safety Evaluation of Theophylline and Bambuterol When Administered Orally Alone and in Combination to Healthy Volunteers|Completed||Phase 1|20|Actual|Norwegian Armed Forces Medical Service||2|||f||||t||||||||||2017-10-11 03:07:39.682437|2017-10-11 03:07:39.682437
NCT01566552|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-01-21|||June 2014||2014-06-01|March 2012|2012-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis|Point of Care Diagnosis and Treatment With Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India.|Not yet recruiting||Phase 4|1300|Anticipated|Banaras Hindu University||1|||f||||t||||||||||2017-10-11 03:07:39.769357|2017-10-11 03:07:39.769357
NCT01566539|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-09-08|2017-07-21||April 2008||2008-04-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Biological Basis of Individual Variation in Social Cooperation|The Biological Basis of Individual Variation in Social Cooperation|Completed||N/A|707|Actual|Emory University||11|||f||||t||||||||||2017-10-11 03:07:39.893991|2017-10-11 03:07:39.893991
NCT01566526|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2013-03-27|2013-03-27||March 2012||2012-03-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion||Completed||N/A|26|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:07:41.094994|2017-10-11 03:07:41.094994
NCT01566513|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2015-01-22|||August 2011||2011-08-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|Project PEP||Effectiveness and Cost Effectiveness of Peer Mentors in Reducing Hospital Use|Effectiveness and Cost Effectiveness of Peer Mentors in Reducing Hospital Use|Completed||N/A|285|Actual|Yale University||4|||f||||t||||||||||2017-10-11 03:07:41.382996|2017-10-11 03:07:41.382996
NCT01566500|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2015-07-29|2015-04-28||September 2011||2011-09-01|July 2015|2015-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational||Adults with self-reported epilepsy.|Medication Adherence in Individuals With Epilepsy|Best Practices and Challenges in Medication Adherence for Individuals With Epilepsy|Completed||N/A|140|Actual|Columbia University|||1||f||||t||||||||||2017-10-11 03:07:41.482446|2017-10-11 03:07:41.482446
NCT01566487|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-28|2012-03-28|||June 2010||2010-06-01|April 2010|2010-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition|Randomized, Open-Label, Balanced, Two-treatment, Two-period, Two-sequence, Crossover, Multicentric Experimental Bioequivalence Study of Quetiapine Fumarate Film-coated Tablets 300 mg (Test)and Seroquel Film-coated Tablets 300 mg (Reference) Under Fasting Condition|Completed||Phase 1|54|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:07:41.633028|2017-10-11 03:07:41.633028
NCT01566266|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2013-05-13|||March 2012||2012-03-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Gut Flora and Lipid Metabolism||Completed||N/A|77|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:07:46.941138|2017-10-11 03:07:46.941138
NCT01566461|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-01-03|2015-02-18||March 2012||2012-03-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|February 2014|Actual|2014-02-01||Interventional|INPACT SFA II|The randomized data (n=331) from both phases have been pooled and comprise the pivotal trial data.|IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA)|Randomized Trial of IN.PACT (Paclitaxel) Admiral Drug-Coated Balloon (DCB) vs. Standard Percutaneous Transluminal Angioplasty (PTA) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)|Active, not recruiting||Phase 2|331|Actual|Medtronic Endovascular||2|||f||||t||||||||||2017-10-11 03:07:41.842795|2017-10-11 03:07:41.842795
NCT01566448|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-12-11|||February 2012||2012-02-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash|Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash|Completed||Phase 2|30|Actual|West Virginia University||1|||f||||t||||||||||2017-10-11 03:07:43.335286|2017-10-11 03:07:43.335286
NCT01566435|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-06-29|2015-09-08||August 9, 2012|Actual|2012-08-09|June 2017|2017-06-01|October 31, 2023|Anticipated|2023-10-31|October 31, 2013|Actual|2013-10-31||Interventional|||Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer|Phase II Trial of Nab-Paclitaxel, Cisplatin, and 5-FU (ACF) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)|Active, not recruiting||Phase 2|30|Actual|Washington University School of Medicine||1|||f||||t|t|f|||f|||||2017-10-11 03:07:43.478663|2017-10-11 03:07:43.478663
NCT01566422|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-12-08|||June 2012||2012-06-01|December 2014|2014-12-01||||December 2015|Anticipated|2015-12-01||Interventional|||Comparative Effectiveness and Cost-Benefit Analysis of Vancomycin Powder in High Risk Spine Surgery Patients|Comparative Effectiveness and Cost-Benefit Analysis of Vancomycin Powder in High Risk Spine Surgery Patients|Unknown status|Recruiting|N/A|160|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-10-11 03:07:44.673597|2017-10-11 03:07:44.673597
NCT01566409|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-08-04|2016-08-04||September 2013||2013-09-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|April 2015|Actual|2015-04-01||Interventional|||Maintenance Treatment for Children With Constipation|Maintenance Treatment With Polyethylene Glycol 3350 for Children With Constipation. A Randomized, Placebocontrolled Intervention Study|Completed||N/A|115|Actual|Vejle Hospital||2|||f||||f||||||||||2017-10-11 03:07:44.764607|2017-10-11 03:07:44.764607
NCT01566383|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-02-21|||March 2012||2012-03-01|February 2017|2017-02-01|August 27, 2013|Actual|2013-08-27|August 27, 2013|Actual|2013-08-27||Interventional|||Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population|Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population|Terminated||N/A|19|Actual|Vanderbilt University Medical Center||1||unable to meet recruitment goals|f||||f|f|f||||||No||2017-10-11 03:07:45.197708|2017-10-11 03:07:45.197708
NCT01566370|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-11-17|2016-03-22||May 2012||2012-05-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|ZNSBP|Heavy drinkers with bipolar disorder|Zonisamide for Heavy Drinkers With Bipolar Disorder|Zonisamide for Heavy Drinkers With Bipolar Disorder|Terminated||Phase 2|3|Actual|Yale University||2||recruitment infeasible|f||||t||||||||||2017-10-11 03:07:45.316391|2017-10-11 03:07:45.316391
NCT01566357|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2013-07-17|||January 2012||2012-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Impact of Milk on Erosion/Abrasion of Enamel and Dentin - an in Situ Study|Impact of Milk and Casein Phosphopeptide-amorphous Calcium Phosphate on Erosion/Abrasion of Enamel and Dentin - an in Situ Study|Completed||N/A|15|Actual|University of Zurich||7|||f||||f||||||||||2017-10-11 03:07:45.847424|2017-10-11 03:07:45.847424
NCT01566344|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-04-09|||May 2012||2012-05-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes|Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes - A Prospective Randomized Clinical Trial|Unknown status|Recruiting|N/A|70|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:07:45.976661|2017-10-11 03:07:45.976661
NCT01566331|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-10-17|2014-05-19||January 2011||2011-01-01|October 2016|2016-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|SDB||Safe Delivery Using a Belt on the Belly of Pregnant Woman|Safe Natural Delivery by Using a New Inflatable Ergonomic Three Chambers Belt|Completed||Phase 2|80|Actual|University of Padua||2|||f||||t||||||||No||2017-10-11 03:07:46.171716|2017-10-11 03:07:46.171716
NCT01566318|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-12-11|||March 2012||2012-03-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|February 2016|Actual|2016-02-01||Interventional|||Depression Agency-Based Collaboration|Depression Agency-Based Collaborative (Depression ABC)|Completed||N/A|104|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:07:46.489842|2017-10-11 03:07:46.489842
NCT01566305|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-03-27|||October 2010||2010-10-01|March 2012|2012-03-01||||July 2012|Anticipated|2012-07-01||Interventional|||Effects of Buttermilk on Serum LDL Cholesterol Concentrations|The Effects of Buttermilk With or Without Lutein-enriched Egg Yolk on the Serum LDL Cholesterol Concentration of Slightly Hypercholesterolaemic Volunteers|Unknown status|Active, not recruiting|N/A|108|Actual|Maastricht University Medical Center||4|||f||||f||||||||||2017-10-11 03:07:46.580459|2017-10-11 03:07:46.580459
NCT01566292|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-03-27|||September 2009||2009-09-01|March 2012|2012-03-01||||September 2010|Actual|2010-09-01||Interventional|||"Intraprostatic Botulinum Toxin Type A Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy"|"Intraprostatic Botulinum Toxin Type A Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy: a Randomised, Double-blind, Controlled Trial Using Subjective and Objective Outcomes"|Completed||Phase 2/Phase 3|33|Actual|Catholic University of the Sacred Heart||1|||f||||t||||||||||2017-10-11 03:07:46.702744|2017-10-11 03:07:46.702744
NCT01566279|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-02-23|||August 2012||2012-08-01|February 2014|2014-02-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|CPCT-03||A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)|A Two Parts, Biomarker Study to Identify Genetic Aberrations Predictive for Response on Everolimus in Solid Tumors Without Regular Treatment Options (CPCT-03)|Unknown status|Recruiting|N/A|60|Anticipated|UMC Utrecht||1|||f||||f||||||||||2017-10-11 03:07:46.803113|2017-10-11 03:07:46.803113
NCT01566253|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2013-04-03|||March 2012||2012-03-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Oral Self Medication Versus IV Administration of Pain Killers After Caesarian Delivery|Comparison of a Patient Controlled Oral Administration (PCOA) of Analgesic Protocol With an IV Administration After Planned Caesarian Section : Monocentric, Randomised and Controlled Study|Completed||Phase 4|80|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 03:07:47.028348|2017-10-11 03:07:47.028348
NCT01566240|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-05-17|||September 2012||2012-09-01|June 2016|2016-06-01|September 2021|Anticipated|2021-09-01|December 2017|Anticipated|2017-12-01||Interventional|INTERLACE||Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer|A Phase III Multicentre Trial of Weekly Induction Chemotherapy Followed by Standard Chemoradiation Versus Standard Chemoradiation Alone in Patients With Locally Advanced Cervical Cancer|Recruiting||Phase 3|770|Anticipated|University College, London||2|||f||||f||||||||||2017-10-11 03:07:47.13688|2017-10-11 03:07:47.13688
NCT01566227|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-03-26|||February 2012||2012-02-01|March 2012|2012-03-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Within-subject Comparison of Mandibular Overdentures Retained by 1,2,or 3 Implants|Within-subject Comparison of Mandibular Overdentures Retained by 1,2,or 3 Implants|Unknown status|Recruiting|N/A|30|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-10-11 03:07:47.4226|2017-10-11 03:07:47.4226
NCT01566214|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-09-01|||April 30, 2012|Actual|2012-04-30|September 2017|2017-09-01|October 31, 2012|Actual|2012-10-31|June 30, 2012|Actual|2012-06-30||Interventional|VHPI||Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease|Representational Telehealth Nursing Intervention for Veterans With CHD|Completed||Phase 2|14|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 03:07:47.54055|2017-10-11 03:07:47.54055
NCT01566201|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-12-01|||March 2011||2011-03-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|April 2012|Actual|2012-04-01||Interventional|||Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease|The Effect of Inhibition of Interleukin-1 Activity on Vascular and Left Ventricular Function in Patients With Coronary Artery Disease and Coexistent Rheumatoid Arthritis|Completed||N/A|80|Actual|University of Athens||2|||f||||t||||||||||2017-10-11 03:07:47.655644|2017-10-11 03:07:47.655644
NCT01566188|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2014-09-01|||January 2011||2011-01-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CARDIOMEGA||Vascular Impact of Omega-3 in Metabolic Syndrome|Cardiovascular Impact of Omega-3 Dietary Supplement From Vegetal Origin in Hypertension Associated With Metabolic Syndrome|Completed||N/A|95|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 03:07:47.763903|2017-10-11 03:07:47.763903
NCT01566175|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-02-28|||August 2011||2011-08-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Reducer||Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization|Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Angina Class 3-4 Who Are Not Candidates for Revascularization|Recruiting||N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 03:07:47.854797|2017-10-11 03:07:47.854797
NCT01566162|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-11-12|2014-10-21||April 2012||2012-04-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Twelve Week, Open Label Extension Study in Patients With Schizophrenia|A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia|Completed||Phase 3|191|Actual|Sunovion||1|||f||||f||||||||||2017-10-11 03:07:47.978453|2017-10-11 03:07:47.978453
NCT01566149|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-03-17|2013-05-28||March 2012||2012-03-01|March 2017|2017-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)|An Open-Label Study to Assess the Safety and Tolerability of Zenhale® (a Fixed-Dose Combination of Mometasone Furoate/Formoterol Fumarate Delivered by Metered Dose Inhaler) in 40 Subjects With Persistent Asthma (Protocol No. 206-00 [P08212])|Completed||Phase 3|49|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:07:48.652864|2017-10-11 03:07:48.652864
NCT01566136|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-04-23|||August 2009||2009-08-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||An Inpatient Rehabilitation Model of Care Targeting Patients With Cognitive Impairment|An Inpatient Rehabilitation Model of Care Targeting Patients With Cognitive|Completed||Phase 2/Phase 3|198|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:07:48.99486|2017-10-11 03:07:48.99486
NCT01566123|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-28|||March 2007||2007-03-01|March 2012|2012-03-01|February 2020|Anticipated|2020-02-01|January 2020|Anticipated|2020-01-01||Interventional|||Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS)|Clinical Phase I/II Trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in Patients With Retroperitoneal Soft Tissue Sarcoma|Recruiting||Phase 1/Phase 2|37|Anticipated|University Hospital Heidelberg||1|||f||||t||||||||||2017-10-11 03:07:49.100958|2017-10-11 03:07:49.100958
NCT01566110|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-04-12|||March 2012||2012-03-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CD-DIET||Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial|A Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Gluten-Free Diet in Patients With Asymptomatic Celiac Disease and Type 1 Diabetes, Celiac Disease and Diabetes - Dietary Intervention and Evaluation Trial (CD-DIET)|Active, not recruiting||N/A|50|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 03:07:49.189436|2017-10-11 03:07:49.189436
NCT01566097|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-03-25|||April 2012||2012-04-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||Intervention Trial of Culturally-Appropriate Decision Aids for Smoking Cessation|Development and Application of Culturally-Appropriate Decision Aids for Smoking Cessation in Korea: a Single Arm Intervention Trial With Historical Control|Unknown status|Active, not recruiting|N/A|400|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:07:49.281062|2017-10-11 03:07:49.281062
NCT00004670|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||October 1994||1994-10-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Pallidotomy for Parkinson Disease||Completed||Phase 2|60||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:56.161716|2017-10-11 04:26:56.161716
NCT01566084|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-12-04|2014-05-20||February 2009||2009-02-01|December 2015|2015-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||11 Men and 6 post-menopausal women were enrolled.|Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults|Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults|Completed||N/A|17|Actual|University of Colorado, Boulder|Due to the complexity, burden, and, in some cases, invasiveness of the study design and procedures, only a limited number of subjects could be studied.|2|||f||||t||||||||||2017-10-11 03:07:49.376175|2017-10-11 03:07:49.376175
NCT01566071|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-06-08|||July 2012||2012-07-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|||||Interventional|DRIVE COG||Ability to Drive of Early Stage Alzheimer Disease||Completed||N/A|60|Actual|CHU de Reims|||||f||||f||||||||||2017-10-11 03:07:49.6616|2017-10-11 03:07:49.6616
NCT01566058|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-04-29|||January 2013||2013-01-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|January 2014|Actual|2014-01-01||Interventional|BBBox||Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and Mother-child Relationships|Pilot Study Evaluating the Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and the Establishment of a Mother-child Relationship in the Context of a Premature Birth|Completed||N/A|59|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 03:07:49.721439|2017-10-11 03:07:49.721439
NCT01566045|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-05-28|||May 2012||2012-05-01|May 2013|2013-05-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer|MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer. A Phase III Study|Unknown status|Recruiting|N/A|980|Anticipated|Philips Healthcare||2|||f||||t||||||||||2017-10-11 03:07:49.805027|2017-10-11 03:07:49.805027
NCT01566032|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-07-05|||January 2012||2012-01-01|July 2017|2017-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|DiVA||Digital Versus Analog Pleural Drainage in Patients With Pulmonary Air Leak|Digital Versus Analog Pleural Drainage in Patients With Pulmonary Air Leak|Completed||N/A|30|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-11 03:07:49.888261|2017-10-11 03:07:49.888261
NCT01566019|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-07-11|||October 2011||2011-10-01|July 2016|2016-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|MOSCATO 02||Molecular Screening for Cancer Treatment Optimization|Molecular Screening Analysis Used as Decision Tool for Targeted Molecular Treatment|Recruiting||N/A|1050|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 03:07:49.948363|2017-10-11 03:07:49.948363
NCT01566006|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-15|2012-03-28|||April 2012||2012-04-01|March 2012|2012-03-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Interventional|Myridian||Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration|Mycophenolate Mofetil (MMF) ,Carnitine and Phosphodiesterase Type 5 Inhibitor, Three Potential Treatments for Resistant Proteinuria and for Slowing the Deterioration of Diabetic Nephropathy in Patients With Type II Diabetes Mellitus|Unknown status|Not yet recruiting|N/A|80|Anticipated|The Nazareth Hospital, Israel||4|||f||||t||||||||||2017-10-11 03:07:50.032903|2017-10-11 03:07:50.032903
NCT01565993|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-04-25|2012-03-28||July 2007||2007-07-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||The Use of Prophylactic Hemoclips in the Endoscopic Resection of Large Pedunculated Polyps|Is the Use of Prophylactic Hemoclips in the Endoscopic Resection of Large Pedunculated Polyps Useful? A Prospective and Randomized Study|Terminated||N/A|108|Actual|Hospital Severo Ochoa|Not to reach the sample size established previously in the initial design, implies bias and decreases the strength of the study.|2||The unexpected increase in morbidity of the hemoclip group|f||||f||||||||||2017-10-11 03:07:51.840199|2017-10-11 03:07:51.840199
NCT01565980|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-11-14|2014-07-13||March 2012||2012-03-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Mindfulness Therapy for Individuals With Lung Cancer|A Mindfulness Intervention for Symptom Management in Lung Cancer|Completed||N/A|40|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 03:07:52.202648|2017-10-11 03:07:52.202648
NCT01565967|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-10-28|||December 2011||2011-12-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Registry AutoLog Lipid Removal and Blood Component Characterization|Registry AutoLog Lipid Removal and Blood Component Characterization|Completed||N/A|199|Actual|Medtronic Cardiovascular|||1||f||||f||||||Samples With DNA|"     Whole blood and washed blood will be collected from each patient   "|||2017-10-11 03:07:53.048921|2017-10-11 03:07:53.048921
NCT01565954|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-09-28|||January 2014||2014-01-01|March 2012|2012-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|SOMMEDREP||Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children|Systematic Evaluation of Sleep Respiratory Disorders During Sleep in Children With Sickle Cell Disease|Recruiting||N/A|120|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 03:07:53.200118|2017-10-11 03:07:53.200118
NCT01565941|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-06-12|||March 2012||2012-03-01|June 2017|2017-06-01|November 2017|Anticipated|2017-11-01|September 2016|Actual|2016-09-01||Interventional|HALF-PINT||Heart And Lung Failure - Pediatric INsulin Titration Trial|Heart And Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT)|Active, not recruiting||Phase 3|713|Actual|Boston Children’s Hospital||2|||f||||t||||||||Undecided||2017-10-11 03:07:53.289413|2017-10-11 03:07:53.289413
NCT01565915|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2013-08-20|||March 2012||2012-03-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit||Unknown status|Active, not recruiting|N/A|221|Actual|Medicis Global Service Corporation||2|||f||||||||||||||2017-10-11 03:07:53.580252|2017-10-11 03:07:53.580252
NCT01565902|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2015-01-08|2014-12-12||October 2012||2012-10-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacokinetics of BAF312 in Patients With Hepatic Impairment|A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Control Subjects.|Completed||Phase 1|40|Actual|Novartis||4|||f||||f||||||||||2017-10-11 03:07:53.717265|2017-10-11 03:07:53.717265
NCT01565889|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-09-25|2014-08-28||March 2012||2012-03-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional||Safety Analysis Set: participants who enrolled and received at least one dose of study drug(s)|Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.|Part A: Drug Interaction Study Between GS-7977 and Antiretroviral Therapy (ARV) Combinations of Efavirenz, Tenofovir and Emtricitabine; Efavirenz, Zidovudine and Lamivudine; Atazanavir/Ritonavir, Tenofovir and Emtricitabine; Darunavir/Ritonavir, Tenofovir and Emtricitabine; Raltegravir, Tenofovir and Emtricitabine in Human Immunodeficiency Virus and Hepatitis C Virus (HIV/HCV) Co-infected Patients. Part B: A Phase 2, Open-Label Study to Investigate the Efficacy and Safety of GS-7977 With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naïve HIV/HCV Co-infected Patients.|Completed||Phase 1/Phase 2|52|Actual|Gilead Sciences||6|||f||||f||||||||||2017-10-11 03:07:54.216896|2017-10-11 03:07:54.216896
NCT01565876|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2012-03-28|||December 2012||2012-12-01|March 2012|2012-03-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|minkal||Auxiliary Device to Alleviate Soldiers' Backload|Auxiliary Device to Alleviate Soldiers' Backload|Unknown status|Not yet recruiting|N/A|12|Anticipated|Medical Corps, Israel Defense Force||1|||f||||||||||||||2017-10-11 03:07:55.533564|2017-10-11 03:07:55.533564
NCT01565863|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-03-27|||February 2012||2012-02-01|March 2012|2012-03-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|PGAP for Vets||Progressive Goal Attainment Program for Veterans|The Progressive Goal Attainment Program for Veterans Project|Unknown status|Recruiting|Phase 1|200|Anticipated|MDRC||2|||f||||f||||||||||2017-10-11 03:07:55.643255|2017-10-11 03:07:55.643255
NCT01565850|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2016-03-11|2016-03-11|2013-11-25|April 2012||2012-04-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|January 2013|Actual|2013-01-01||Interventional||Safety Analysis Set: participants who were randomized and received at least one dose of study drug|D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults|A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of Darunavir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Cobicistat-boosted Darunavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed Dose Combination in HIV-1 Infected, Antiretroviral Treatment Naive Adults|Completed||Phase 2|153|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||t||||||||||2017-10-11 03:07:55.8993|2017-10-11 03:07:55.8993
NCT01565837|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-01-28|||August 2012||2012-08-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|SART||Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma|Phase II Evaluation of Concurrent Ipilimumab Therapy and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Malignant Melanoma|Recruiting||Phase 2|50|Anticipated|Comprehensive Cancer Centers of Nevada||1|||f||||t||||||||||2017-10-11 03:07:56.834724|2017-10-11 03:07:56.834724
NCT01565824|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-08-04|||November 2011||2011-11-01|August 2017|2017-08-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|MODIAB-web||Web-based Support During Pregnancy and Early Motherhood in Women With Type 1 Diabetes (MODIAB-web)|Web-based Support During Pregnancy and Early Motherhood in Women With Type 1 Diabetes (MODIAB-web)|Completed||N/A|174|Actual|Göteborg University||2|||f||||t||||||||||2017-10-11 03:07:56.952686|2017-10-11 03:07:56.952686
NCT01565811|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2015-08-28|||August 2010||2010-08-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|March 2012|Actual|2012-03-01||Observational|LN||Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis|Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis|Completed||Phase 2|30|Actual|Gachon University Gil Medical Center|||1||f||||t||||||||||2017-10-11 03:07:57.02466|2017-10-11 03:07:57.02466
NCT01565798|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-03-23|||July 2010||2010-07-01|December 2011|2011-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy Of Copper To Reduce Acquisition Of Microbes and Healthcare-acquired Infections|Copper Antimicrobial Research Program: Environmental and Patient Sampling For Indicator Organisms To Determine The Efficacy Of Copper To Reduce Acquisition Of Microbes From The Patient Care Environment|Completed||N/A|614|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:07:57.107483|2017-10-11 03:07:57.107483
NCT01565785|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2015-11-16|||February 2012||2012-02-01|November 2015|2015-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Evaluating a New Way to Prepare Parents of Hospitalized Children for Discharge and Management of Child at Home|Self-Management Guided Discharge Teaching for Parents of Hospitalized Children: A Pilot Study|Completed||N/A|104|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 03:07:57.197393|2017-10-11 03:07:57.197393
NCT01565772|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-02-12|||March 2012||2012-03-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer|A Phase I Trial of Hypofractionated Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer|Terminated||Phase 1|4|Actual|Massachusetts General Hospital||1||Slow accrual|f||||t||||||||||2017-10-11 03:07:57.283185|2017-10-11 03:07:57.283185
NCT01565759|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-02-11|||May 2012||2012-05-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||In Vivo Lithium Treatment Effects on Gene Expression Levels in Lymphoblastoid Cell Lines From Human Healthy Subjects|Investigation of the Effects of in Vivo Lithium Treatment on Gene Expression Levels Using Lymphoblastoid Cell Lines From Human Healthy Subjects|Recruiting||Phase 1|20|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 03:07:57.377289|2017-10-11 03:07:57.377289
NCT01565746|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-10-14|||March 2012||2012-03-01|October 2016|2016-10-01|April 2016|Actual|2016-04-01|October 2012|Actual|2012-10-01||Interventional|||Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients|Uncontrolled, Open-label, Non-randomized Phase I Study to Investigate Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics of a Single Dose of BAY88-8223 in Japanese Patients With Castration-resistant Prostate Cancer and Bone Metastases|Completed||Phase 1|19|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:07:57.487579|2017-10-11 03:07:57.487579
NCT01564667|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-01-13|||April 2012||2012-04-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Attention Bias Modification Treatment for Warzone-Related Posttraumatic Stress Disorder (PTSD)|Attention Bias Modification Treatment for Warzone-Related PTSD: A Randomized Clinical Trial Magnetoencephalography Study|Completed||N/A|51|Actual|Creighton University||2|||f||||f||||||||||2017-10-11 03:08:18.585061|2017-10-11 03:08:18.585061
NCT01565733|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-10-27|||January 2007||2007-01-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes|Multicenter, Open Label, Non-randomized, Non-interventional Observational Study of Safety of Treatment Initiation With a Biphasic Insulin Aspart (NovoMix® 30) in Hospitalized Patients With Type 2 Diabetes Mellitus|Completed||N/A|2223|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:07:57.60879|2017-10-11 03:07:57.60879
NCT01565720|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-07-05|||March 2012||2012-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization|A Phase 1, Randomized, Double Blind, Placebo and Active Controlled, Parallel Study to Evaluate the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization in Healthy Adult Subjects|Completed||Phase 1|161|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 03:07:57.695441|2017-10-11 03:07:57.695441
NCT01565707|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-02-27|2016-12-05|2014-12-18|June 2012||2012-06-01|February 2017|2017-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|LION|Baseline values provided are based on the Safety Analysis Set (SAF) population and the Full Analysis Set (FAS). Population analysis is defined within each baseline measure.|A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug|A Phase 3, Double-Blind, Randomized, Multi-center, Placebo-Controlled Sequential Dose Titration Study to Assess Efficacy, Safety and Population Pharmacokinetics of Solifenacin Succinate Suspension in Pediatric Subjects From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)|Completed||Phase 3|189|Actual|Astellas Pharma Inc||4|||f||||t||||||||||2017-10-11 03:07:57.835848|2017-10-11 03:07:57.835848
NCT01565694|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-04-18||2017-04-18|August 14, 2012||2012-08-14|April 2017|2017-04-01|April 28, 2016|Actual|2016-04-28|April 28, 2016|Actual|2016-04-28||Interventional|||A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Patients 5 to 18 Years of Age With Neurogenic Detrusor Overactivity|A Phase 3, Open-Label, Baseline-controlled, Multicenter, Sequential Dose Titration Study to Assess the Long-Term Efficacy and Safety, and the Pharmacokinetics of Solifenacin Succinate Suspension in Patients From 5 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (NDO)|Completed||Phase 3|82|Actual|Astellas Pharma Inc||1|||f||||t||||||||Undecided||2017-10-11 03:08:00.113668|2017-10-11 03:08:00.113668
NCT01565681|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2012-12-07|||January 2009||2009-01-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects|A Phase 1 Single Ascending Dose Study of ASKP1240 in Healthy Male and Female Volunteers|Completed||Phase 1|109|Actual|Astellas Pharma Inc||13|||f||||f||||||||||2017-10-11 03:08:00.902058|2017-10-11 03:08:00.902058
NCT01565668|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2017-04-06||2017-04-06|April 2012||2012-04-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 2, Randomized, Open-Label Study of the Safety and Efficacy of Two Doses of Quizartinib (AC220; ASP2689) in Subjects With FLT3-ITD Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)|Completed||Phase 2|76|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 03:08:01.076581|2017-10-11 03:08:01.076581
NCT01565655|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-27|2014-12-01||2014-12-01|June 2012||2012-06-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis|A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects|Completed||Phase 2|289|Actual|Astellas Pharma Inc||5|||f||||t||||||||||2017-10-11 03:08:01.308943|2017-10-11 03:08:01.308943
NCT01565642|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-03-01|||May 2012||2012-05-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|GOC||Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia|Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia|Completed||N/A|302|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 03:08:01.508686|2017-10-11 03:08:01.508686
NCT01565629|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-10-25|||February 2012||2012-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|CCAL||Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders|Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders|Completed||N/A|40|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-11 03:08:01.61167|2017-10-11 03:08:01.61167
NCT01565616|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-08-29|2017-08-29||March 2012|Actual|2012-03-01|August 2017|2017-08-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|STRIDE|Individuals with severe sickle cell disease receiving hematopoietic cell transplantation (HCT) from a human leukocyte antigen (HLA)-identical sibling donor or an unrelated HLA-matched donor|Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease|A Phase II Study of Hematopoietic Stem Cell Therapy for Young Adults With Severe Sickle Cell Disease|Completed||Phase 2|22|Actual|Emory University||1|||f||||t|t|f||||||||2017-10-11 03:08:01.791235|2017-10-11 03:08:01.791235
NCT01565603|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-03-29|||July 2011||2011-07-01|March 2012|2012-03-01|October 2012|Anticipated|2012-10-01|October 2011|Actual|2011-10-01||Observational|VALLOT 2011||Sleep and Cerebral Responses to High Altitude|Intolerance Mechanisms and Exercise Performance Limitation During a High Altitude Stay: Investigation of Sleep and Cerebral Responses|Unknown status|Active, not recruiting|N/A|12|Actual|University Hospital, Grenoble|||1||f||||f||||||Samples Without DNA|"     Venous blood   "|||2017-10-11 03:08:02.581286|2017-10-11 03:08:02.581286
NCT01565590|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-03-05|||February 2012||2012-02-01|March 2015|2015-03-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage|Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage|Terminated||Phase 3|4|Actual|University of Cincinnati||2||Slow enrollment along with new competing studies, investigators decided to stop study|f||||t||||||||||2017-10-11 03:08:02.649058|2017-10-11 03:08:02.649058
NCT01565213|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-03-26|||January 2006||2006-01-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|September 2008|Actual|2008-09-01||Interventional|||Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care|Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care: A Randomized Controlled Trial|Completed||Phase 3|245|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 03:08:07.911248|2017-10-11 03:08:07.911248
NCT01565577|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2014-09-05|||April 2012||2012-04-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|Exten MenbVac||Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac)|Phase 3, Vaccinal Activity Assessment of MenBVac Against Nesseiria Menigitidis B:14,P1.7,16 Strain in Child Vaccinated With MenBVac®|Completed||Phase 3|117|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 03:08:02.761717|2017-10-11 03:08:02.761717
NCT01565564|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-06-09|2015-05-21||September 2010||2010-09-01|June 2015|2015-06-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes|A Randomized Translational Study to Examine the Effects of Shared Care Versus Usual Care in Management of Gestational Diabetes in a Three-tier Prenatal Care Network in Tianjin, China|Completed||N/A|948|Actual|Tianjin Women and Children's Health Center|Exclusion of 242 women with GDM diagnosed from 10 Nov 2011 to 31 Jul 2012 due to potential contaminations due to logistic reasons.|2|||f||||t||||||||||2017-10-11 03:08:02.844932|2017-10-11 03:08:02.844932
NCT01565551|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2014-01-03|2014-01-03||April 2010||2010-04-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|August 2012|Actual|2012-08-01||Observational|||Transforming Research and Clinical Knowledge in TBI Pilot|Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot|Completed||N/A|650|Actual|University of California, San Francisco|Enrolling patients representative of the TBI population created challenges for follow-up (e.g. homelessness, substance abuse); limited access to research MRI scanner; lack of validated outcome measures for non-English-speaking and pediatric patients.||2||f||||f||||||Samples With DNA|"     Whole blood for genetic analysis. Plasma for proteomic analysis.   "|||2017-10-11 03:08:03.211192|2017-10-11 03:08:03.211192
NCT01565538|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-09-11|2014-09-03||December 2008||2008-12-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|||Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma|A Randomized Phase II Trial of Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced EGFR Wild-Type and EGFR FISH-Positive Lung Adenocarcinoma|Completed||Phase 2|123|Actual|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 03:08:03.752072|2017-10-11 03:08:03.752072
NCT01565525|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-03-27|||June 2005||2005-06-01|March 2012|2012-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|MOMS||Anticipatory Guidance to Prevent Childhood Obesity|Can Changing How Moms Eat Prevent Obesity in Toddlers?|Completed||N/A|306|Actual|Nationwide Children's Hospital||3|||f||||f||||||||||2017-10-11 03:08:04.225583|2017-10-11 03:08:04.225583
NCT01565512|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2015-03-03|||November 2011||2011-11-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort|Randomized Trial to Determine the Effect of Dorsal Penile Block on Post-Robotic Prostatectomy Foley Discomfort|Withdrawn||Phase 1/Phase 2|0|Actual|Columbia University||2||Lack of funding, PI left the institution, poor enrollment|f||||t||||||||||2017-10-11 03:08:04.339075|2017-10-11 03:08:04.339075
NCT01565499|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2013-06-07|||June 2013||2013-06-01|November 2012|2012-11-01|August 2019|Anticipated|2019-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer|Phase II, Open-label, Non-randomized Study of Nab-paclitaxel for the Neoadjuvant Treatment of Patients With Stage II and III Luminal Breast Cancer|Active, not recruiting||Phase 2|78|Anticipated|Spanish Breast Cancer Research Group||1|||f||||f||||||||||2017-10-11 03:08:04.454763|2017-10-11 03:08:04.454763
NCT01565486|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2012-12-04|||August 2011||2011-08-01|December 2012|2012-12-01|August 2017|Anticipated|2017-08-01|January 2013|Anticipated|2013-01-01||Interventional|UCBEST||Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System|Comparison of Surgical Outcomes Between Papillary Thyroid Cancer Patients Treated With the Harmonic ACE® Scalpel and LigaSure Precise™ Instrument During Conventional Thyroidectomy: A Single-blind Prospective Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|304|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-11 03:08:04.578908|2017-10-11 03:08:04.578908
NCT01565473|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2014-12-01|||September 2008||2008-09-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||PET Study of Non-Motor Symptoms of Parkinson Disease|PET Study of Biochemistry and Metabolism of the CNS: Parkinson Disease|Completed||N/A|242|Actual|University of Michigan|||2||f||||f||||||Samples With DNA|"     Whole blood Saliva   "|||2017-10-11 03:08:04.711595|2017-10-11 03:08:04.711595
NCT01565460|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-03-29|||February 2012||2012-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Bile and Bile Duct/Pancreatic Duct Brushings Database for Patients With Pancreato-biliary Stricture|Bile and Bile Duct/Pancreatic Duct Brushings Database for Patients With Pancreato-biliary Stricture|Completed||N/A|200|Actual|The Cleveland Clinic|||1||f||||f||||||Samples With DNA|"     Bile and bile duct/pancreatic duct brushings   "|No||2017-10-11 03:08:04.826158|2017-10-11 03:08:04.826158
NCT01565447|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-10-14|||December 2011||2011-12-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study|Temporal and Spatial Gait Parameters of Children Undergoing Treatment for and Surviving Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Oregon Health and Science University|||1||f||||t||||||||||2017-10-11 03:08:04.952235|2017-10-11 03:08:04.952235
NCT01565434|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-06-08|||February 2012||2012-02-01|March 2012|2012-03-01|April 2015|Actual|2015-04-01|||||Interventional|||Erythrocyte Complement Receptor 1 and Alzheimer Disease||Completed||N/A|200|Actual|CHU de Reims|||||f||||f||||||||||2017-10-11 03:08:05.043042|2017-10-11 03:08:05.043042
NCT01565421|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-04-18|||September 2008||2008-09-01|April 2017|2017-04-01|May 2010|Actual|2010-05-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy Study of Maintenance Therapy for Ovarian Cancer Patients|A Phase II Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of Maintenance IT-101 in Platinum Sensitive Ovarian Cancer Patients Who Received 4-6 Cycles of a 2nd Line Platinum-Based Regimen Without Disease Progression.|Withdrawn||Phase 2|0|Actual|NewLink Genetics Corporation||3||By previous sponsor|f||||t||||||||||2017-10-11 03:08:05.125936|2017-10-11 03:08:05.125936
NCT01565408|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-02-06|||March 2012||2012-03-01|February 2017|2017-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis|Safety and Tolerability of NNC0114-0006 Following Multiple s.c. Dosing at Escalating Dose Levels in Subjects With Rheumatoid Arthritis|Completed||Phase 1|32|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:08:05.26908|2017-10-11 03:08:05.26908
NCT01565395|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-02-03|||March 2012||2012-03-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Xeomin||Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)|Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)|Withdrawn||Phase 2|0|Actual|Beth Israel Deaconess Medical Center||2||Could not recruit ALS participants, hence ALS arm discontinued|f||||||||||||No||2017-10-11 03:08:05.387906|2017-10-11 03:08:05.387906
NCT01565382|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-05-23|2012-04-06||February 2011||2011-02-01|May 2012|2012-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)|Evaluation of Physician Training for Interpretation of Florbetapir-PET Scans: Evaluation of Inter-reader Reliability Using Images From Subjects With a Clinical Presentation of AD or MCI|Completed||N/A|40|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:08:05.533233|2017-10-11 03:08:05.533233
NCT01565369|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-05-03|2012-04-06||January 2011||2011-01-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Evaluation of Physician Training Methods to Read Florbetapir-PET Scans|Evaluation of Physician Training for Interpretation of Florbetapir-PET Scans: Validation of Binary Image Rating Methodology Using Amyloid Histopathology at Autopsy as the Reference Standard.|Completed||N/A|35|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:08:05.749586|2017-10-11 03:08:05.749586
NCT01565356|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-05-03|2012-04-06||March 2010||2010-03-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of PET Scan Timing Relative to AV-45 Injection Time|Comparison of PET Images Acquired at 30 Min and 50 Min Post Injection of 18F-AV-45 in Healthy Volunteers and Alzheimer's Disease Patients|Completed||N/A|41|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:08:05.982799|2017-10-11 03:08:05.982799
NCT01565343|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-05-08|2012-04-06||April 2008||2008-04-01|May 2012|2012-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers|Test-retest Reproducibility of 18F-AV-45 for Brain Imaging of Amyloid in Healthy Volunteers and Alzheimer's Disease Patients|Completed||Phase 1|25|Actual|Avid Radiopharmaceuticals||3|||f||||f||||||||||2017-10-11 03:08:06.189555|2017-10-11 03:08:06.189555
NCT01565330|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-06-14|2012-04-06||March 2008||2008-03-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers|An Open Label, Parallel Group, Dose Comparison of Safety and Imaging Characteristics of 111 and 370 MBq (3 and 10 mCi) of 18F-AV-45 for Brain Imaging of Amyloid in Healthy Volunteers and Patients With Alzheimer's Disease (AD)|Completed||Phase 1|20|Actual|Avid Radiopharmaceuticals||4|||f||||f||||||||||2017-10-11 03:08:06.578155|2017-10-11 03:08:06.578155
NCT01565317|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-02-22|||April 2012||2012-04-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy|Evaluation of the Effect of Intensive Diabetes Control Through Non-Surgical Intensive Lifestyle Modifications and Weight Reduction on Diabetic Peripheral Neuropathy|Completed||N/A|50|Actual|Joslin Diabetes Center||2|||f||||f||||||||||2017-10-11 03:08:06.990703|2017-10-11 03:08:06.990703
NCT01565304|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-09-22|||January 2012||2012-01-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of the Effectiveness of the POWER Through Choices Program|Evaluation of the Effectiveness of the POWER Through Choices Program|Completed||N/A|1039|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-11 03:08:07.092386|2017-10-11 03:08:07.092386
NCT01565291|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2012-05-11|2012-04-06||June 2007||2007-06-01|May 2012|2012-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers|A Preliminary Evaluation of the Amyloid Binding Properties, Pharmacokinetics and Safety of 18F-AV-45 in Healthy Elderly Volunteers and Patients With Alzheimer's Disease|Completed||Early Phase 1|32|Actual|Avid Radiopharmaceuticals||2|||f||||f||||||||||2017-10-11 03:08:07.200492|2017-10-11 03:08:07.200492
NCT01565278|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-05-10|||February 2012||2012-02-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition|Effect of n-3 Polyunsaturated Fatty Acid Lipid Emulsion on Parenteral Nutrition Associated Liver Disease|Terminated||Phase 3|2|Actual|University Health Network, Toronto||2||No more eligible patients could be identified.|f||||f||||||||||2017-10-11 03:08:07.468981|2017-10-11 03:08:07.468981
NCT01565265|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-04-27|||April 2012||2012-04-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|Pergoveris||Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression|Prospective Randomized Study Comparing Ovarian Stimulation With Pergoveris Supported by a GnRH Agonist in a Long Protocol Versus Multidose GnRH Antagonist Regimen in Young Infertile Women Treated With ICS|Completed||N/A|5|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 03:08:07.577463|2017-10-11 03:08:07.577463
NCT01565252|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2013-11-21|||April 2014||2014-04-01|February 2013|2013-02-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|PisNShMiGSL-01||Assessment of the Effect of n-3(Omega 3) Fortified Egg in Healthy Subjects|Assessment of the Effect of n-3(Omega 3) Fortified Egg Compared to Omega-6 Israeli Regular Egg on Metabolic, Inflammation and Other Physiologic Parameters Prospective, Crossover, Compared Study in Healthy Subjects|Unknown status|Not yet recruiting|N/A|20|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 03:08:07.673211|2017-10-11 03:08:07.673211
NCT01565239|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-09-08|||March 2012||2012-03-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|Fiix||Fiix-prothrombin Time for Monitoring Warfarin|"Clinical Outcome During Warfarin Anticoagulation Monitored With Fiix-INR Compared to Standard Monitoring With INR.A Prospective Randomized Double-blinded Trial."|Completed||Phase 2|1156|Actual|Landspitali University Hospital||2|||f||||t||||||||||2017-10-11 03:08:07.755049|2017-10-11 03:08:07.755049
NCT01565226|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2016-11-01|||August 2012||2012-08-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Capnography in Neonates Ventilated With High Frequency Ventilation: Prospective, Observational Multi-Center Study|Capnography in Neonates Ventilated With High Frequency Ventilation: Prospective, Observational Multi-Center Study|Completed||N/A|25|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 03:08:07.840664|2017-10-11 03:08:07.840664
NCT01565200|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-09-01|||May 2012||2012-05-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ZEPHIR||HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1|Phase II Prospective Imaging Study Evaluating the Utility of Pre-treatment zr89 Labelled Trastuzumab PET/CT and an Early FDG-PET/CT Response to Identify Patients With Advanced HER2+ BC Unlikely to Benefit From a Novel antiHER2 Therapy: TDM1|Recruiting||Phase 2|105|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 03:08:08.008098|2017-10-11 03:08:08.008098
NCT01565187|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-05-10|||February 2012||2012-02-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Development of a Psychosocial Assessment Database for Reconstructive Hand Transplantation|Development of a Psychosocial Assessment Database for Reconstructive Hand Transplantation|Enrolling by invitation||N/A|100|Anticipated|Mayo Clinic|||1||f||||f||||||None Retained|"     No biospecimens to be gathered and used for this study.   "|||2017-10-11 03:08:08.143985|2017-10-11 03:08:08.143985
NCT01565174|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-04-01|||October 2012||2012-10-01|April 2012|2012-04-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Observational|||The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced Psychosis|The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced Psychosis|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||2||f||||f||||||Samples With DNA|"     Samples of DNA will be taken from saliva of participants   "|||2017-10-11 03:08:08.401117|2017-10-11 03:08:08.401117
NCT01565161|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-03-27|||September 2009||2009-09-01|March 2012|2012-03-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|HH||Healthy Habits, Happy Homes: An Intervention to Improve Household Routines for Obesity Prevention|Healthy Habits, Happy Homes: An Intervention to Improve Household Routines for Obesity Prevention|Unknown status|Active, not recruiting|N/A|117|Actual|Harvard Pilgrim Health Care||2|||f||||f||||||||||2017-10-11 03:08:08.505928|2017-10-11 03:08:08.505928
NCT01565148|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-07-28|2016-10-11||February 2012|Actual|2012-02-01|July 2017|2017-07-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|iDEAL||A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)|A Randomized, Multi-center, Phase II Study of the Safety, Tolerability, and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema With Involvement of the FoveAL Center (the iDEAL Study)|Terminated||Phase 2|185|Actual|Johns Hopkins University||4||Patient's disease progressed and Vision Dropped which led to exit from the study|f||||t||||||||||2017-10-11 03:08:08.635443|2017-10-11 03:08:08.635443
NCT01565135|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-01-04|||September 2012||2012-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|October 2015|Actual|2015-10-01||Interventional|||Immunization Delivery in Obstetrics and Gynecology Settings|Immunization Delivery in Obstetrics and Gynecology Settings|Active, not recruiting||N/A|225000|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 03:08:09.284186|2017-10-11 03:08:09.284186
NCT01565122|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-11-01|||March 2012||2012-03-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)|An Observational, Non-interventional, Multi-national Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab|Completed||N/A|51|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:08:09.382776|2017-10-11 03:08:09.382776
NCT01565109|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-13|2012-12-20|||March 2009||2009-03-01|December 2012|2012-12-01|March 2018|Anticipated|2018-03-01|March 2013|Anticipated|2013-03-01||Interventional|||NESC: Neoadjuvant Treatment Of Gastric Adenocarcinoma|Phase II Multicenter Study in the Preoperative Treatment of Gastric Adenocarcinoma Consisting of Chemotherapy Using Docetaxel-cisplatin-5FU + Lenograstim Followed by Chemoradiation Based 5FU and Oxaliplatin|Recruiting||Phase 2|34|Anticipated|Institut Sainte Catherine||1|||f||||t||||||||||2017-10-11 03:08:09.523928|2017-10-11 03:08:09.523928
NCT01565096|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-03-26|||November 2011||2011-11-01|March 2012|2012-03-01||||November 2012|Anticipated|2012-11-01||Interventional|||Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy|Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy|Unknown status|Recruiting|Phase 4|44|Anticipated|ikfe-CRO GmbH||2|||f||||f||||||||||2017-10-11 03:08:09.631588|2017-10-11 03:08:09.631588
NCT01565083|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-09-30|2016-09-30||April 2012||2012-04-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|VELVET|Intent-to-treat (ITT) population included all participants enrolled into the study.|A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer|A Two-cohort, Open-label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in First Line Patients With HER2-positive Advanced (Metastatic or Locally Advanced) Breast Cancer|Completed||Phase 2|213|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:08:09.796981|2017-10-11 03:08:09.796981
NCT01565070|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2014-07-09|||April 2012||2012-04-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Osteoarthritis in Older Adults: Recovery of Mobility and Pain With a Topical Analgesic|Osteoarthritis in Older Adults: Recovery of Mobility and Pain With a Topical Analgesic|Withdrawn||Phase 3|0|Actual|University of Chile||2||The local authorities did not authorize the use of biofreeze in Chile.|f||||t||||||||||2017-10-11 03:08:10.991947|2017-10-11 03:08:10.991947
NCT01565057|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-05-04|||August 2011||2011-08-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Gastric Layering Study|A Study on the Effect of Gastric Layering and Emptying Induced by a Food Emulsion|Completed||N/A|10|Actual|Quadram Institute||1|||f||||t||||||||||2017-10-11 03:08:11.071363|2017-10-11 03:08:11.071363
NCT01565044|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-08-22|||March 2012||2012-03-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|AUTOTAB||Automatic Versus Intentional Movement Exercises to Enhance Arm Functions After Stroke|Automatic Versus Intentional Movement Exercises to Enhance Arm Functions After Stroke|Recruiting||N/A|32|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:08:11.147097|2017-10-11 03:08:11.147097
NCT01565031|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-03-27|||May 2012||2012-05-01|March 2012|2012-03-01|June 2015|Anticipated|2015-06-01|May 2015|Anticipated|2015-05-01||Observational|||Prediction of Future Risk in Patients With Controlled Asthma|A Simple Prognostic Score for Future Risk Assessment in Patients With Controlled Asthma Who Undergo a Step-down Guidelines-based Strategy|Unknown status|Not yet recruiting|N/A|338|Anticipated|Hospital Universitario Lucus Augusti|||1||f||||f||||||||||2017-10-11 03:08:11.238889|2017-10-11 03:08:11.238889
NCT01565018|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-07-05|||March 2012||2012-03-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects|Single-site, Open-label, Randomized, Cross-over Study in Healthy Japanese Subjects to Evaluate the Bioequivalence of Single Dose Rotigotine Transdermal Patch (2 mg/24 h) Comparing 2 Different Formulations|Completed||Phase 1|55|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:08:11.309293|2017-10-11 03:08:11.309293
NCT01565005|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-07-24|||October 2013|Actual|2013-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MICROFANC||Microcephaly Genetic Deficiency in Neural Progenitors|Microcephaly Genetic Deficiency in Neural Progenitors: Genotyping, Phenotyping and Functional Neuro-anatomy and Neurobiology Comparative Primitive Microcephaly (MCPH) and the Fanconi Anemia (FA)|Recruiting||N/A|135|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-11 03:08:11.402705|2017-10-11 03:08:11.402705
NCT01564992|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-06-27|||May 2009||2009-05-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Observational|DIGPD||Drug Interaction With Genes in Parkinson's Disease|Drug Interaction With Genes in Parkinson's Disease|Recruiting||N/A|600|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     blood   "|No||2017-10-11 03:08:11.477097|2017-10-11 03:08:11.477097
NCT01564966|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2012-03-28|||April 2008||2008-04-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|||Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation|Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation|Completed||N/A|46|Actual|Istanbul University|||1||f||||t||||||||||2017-10-11 03:08:11.706283|2017-10-11 03:08:11.706283
NCT01564953|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2017-01-13|2015-05-31||February 2012||2012-02-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Observational|||Magnesium is Associated With QoL in COPD: A Cross-sectional Study|Serum Magnesium and Nit Vitamin D is Associated With Better QoL in COPD: A Cross-sectional Study|Completed||N/A|143|Actual|University of Aarhus|The cross-sectional design. Some data (e.g. number of exacerbations past one year and smoking history) were self-reported and therefore, a risk of recall-bias cannot be excluded.||1||f||||f||||||Samples Without DNA|"     Blood samples:      p-creatinine p-potassium p-sodium p-albumine p-phosphate p-magnesium p-calcium-ion     p-parathyrine p-25-hydroxy-vitamin D2 + D3   "|Yes|Publish as paper in Scientific journal|2017-10-11 03:08:11.779657|2017-10-11 03:08:11.779657
NCT01564940|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2012-03-27|||September 2011||2011-09-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Human Factors Usability Study of Ib2C Conception System|Human Factors Usability Study of Abbreviated Functional Use of the Intimate Bridge 2 Conception, Inc. Conception System|Completed||N/A|15|Actual|Rinovum Women's Health, Inc.|||1||f||||t||||||||||2017-10-11 03:08:11.9756|2017-10-11 03:08:11.9756
NCT01564927|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-27|||March 2012||2012-03-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Physiological Changes Associated With Deqi During Electroacupuncture to Right LI4 and LI11|Physiological Changes Associated With Deqi During Electroacupuncture to Right LI4 and LI11|Unknown status|Recruiting|N/A|36|Anticipated|The Hong Kong Polytechnic University||3|||f||||t||||||||||2017-10-11 03:08:12.037504|2017-10-11 03:08:12.037504
NCT01564914|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2014-07-16|||May 2012||2012-05-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|105GM201||A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab for the Treatment Of Recurrent or Progressive Glioblastoma That Has Progressed on Bevacizumab|A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab for the Treatment Of Recurrent or Progressive Glioblastoma That Has Progressed on Bevacizumab|Unknown status|Active, not recruiting|Phase 2|22|Anticipated|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||||2017-10-11 03:08:12.126245|2017-10-11 03:08:12.126245
NCT01564901|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-11-01|||January 2012||2012-01-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With Glucocorticoids|A Prospective Observational Study to Assess the Impact of RoActemra® on the Use of Glucocorticoids in Patients With Rheumatoid Arthritis Treated With the Standard of Care.|Completed||N/A|23|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:08:12.229734|2017-10-11 03:08:12.229734
NCT01564888|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2016-02-16|||January 2011||2011-01-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PROPHET-II||Prevention of Radial Artery Occlusion: Prophylactic Hyperperfusion Evaluation Trial|Prevention of Radial Artery Occlusion: Prophylactic Hyperperfusion Evaluation Trial|Completed||Phase 4|3000|Actual|Total Cardiovascular Solutions||2|||f||||f||||||||No||2017-10-11 03:08:12.320629|2017-10-11 03:08:12.320629
NCT01564875|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-03-26|||December 2010||2010-12-01|March 2012|2012-03-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|HM-SIM4||Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia|Efficacy and Safety of Morning Intake of Simvast Controlled Release (CR) Tablet Versus Evening Intake of Zocor Tablet in Chronic Kidney Disease Stage(CKD)3, 4 and 5 Patients With Hyperlipidemia: A Randomized, Double-blind, Multicenter Phase 4 Trial (HM-SIM4)|Unknown status|Active, not recruiting|Phase 4|122|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 03:08:13.973073|2017-10-11 03:08:13.973073
NCT01564862|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2015-02-04|2015-01-13||April 2012||2012-04-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Flexible Dose Study on the Efficacy of Lu AA21004 on Cognitive Dysfunction in Adult Subjects With Major Depressive Disorder (MDD)|Completed||Phase 2|602|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:08:14.117782|2017-10-11 03:08:14.117782
NCT01564849|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2016-11-13|||April 2012||2012-04-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||The Clinical Efficacy of Topical Nasal Pomegranate Fruit Extract for Patients With Chronic Rhinosinusitis|The Clinical Efficacy of Topical Nasal Pomegranate Fruit Extract (PFE) for Patients With Chronic Rhinitis, Chronic Sinusitis With or Without Nasal Polyps|Recruiting||N/A|198|Anticipated|Hillel Yaffe Medical Center|||6||f||||f||||||||||2017-10-11 03:08:15.61507|2017-10-11 03:08:15.61507
NCT01564836|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2014-01-10|||June 2010||2010-06-01|January 2014|2014-01-01||||June 2015|Anticipated|2015-06-01||Interventional|||Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib|A Multi-center Study of the Discontinuation of Imatinib in Adult Patients With Ph+ CML in CP Who Have a Complete Molecular Response to Imatinib|Unknown status|Recruiting|N/A|50|Anticipated|Seoul St. Mary's Hospital||1|||f||||t||||||||||2017-10-11 03:08:15.715769|2017-10-11 03:08:15.715769
NCT01564823|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-03-15|||June 2012||2012-06-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|APPRECIA||Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease|Adalimumab on Preventing Postoperative Recurrence of Crohn's Disease|Completed||Phase 3|86|Actual|Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa||2|||f||||f||||||||||2017-10-11 03:08:15.839355|2017-10-11 03:08:15.839355
NCT01564810|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-10-23|||September 2006||2006-09-01|October 2012|2012-10-01|September 2015|Anticipated|2015-09-01|June 2012|Actual|2012-06-01||Interventional|||Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer|Study of Cetuximab in Combination With Chemotherapy for the First Treatment of Metastatic Colorectal Cancer|Unknown status|Recruiting|Phase 4|150|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 03:08:16.076985|2017-10-11 03:08:16.076985
NCT01564797|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-03-04|||July 2008||2008-07-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Partnership for a Hispanic Diabetes Prevention Program|Partnership for a Hispanic Diabetes Prevention Program|Completed||N/A|430|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 03:08:16.191356|2017-10-11 03:08:16.191356
NCT01564771|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2014-08-20|||January 2011||2011-01-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|B1851065||Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year.|Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year.|Completed||Phase 4|320|Actual|Pfizer|||1||f||||f||||||Samples Without DNA|"     Urine Samples   "|||2017-10-11 03:08:16.997029|2017-10-11 03:08:16.997029
NCT01564758|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-06-27|2012-06-27||February 2004||2004-02-01|June 2012|2012-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Observational|A5951090||Post Marketing Surveillance Study on Linezolid|Post Marketing Surveillance on the Efficacy, Safety and Tolerability of Linezolid (Zyvox) in the Treatment of Gram Positive Infections|Completed||N/A|99|Actual|Pfizer|Protocol did not indicate primary or secondary endpoints and all determination of primary or secondary endpoints were arbitrary.||1||f||||f||||||||||2017-10-11 03:08:17.1335|2017-10-11 03:08:17.1335
NCT01564745|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2014-02-03|||March 2012||2012-03-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|Extu-Cough||Cough Determinants in Mechanically Ventilated Patients|Cough Determinants in Mechanically Ventilated Patients: a Physiological Study|Unknown status|Recruiting|N/A|180|Anticipated|University Hospital, Caen||1|||f||||t||||||||||2017-10-11 03:08:17.358664|2017-10-11 03:08:17.358664
NCT01564732|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-06-03|2016-04-25||September 2013||2013-09-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding|Multicenter Prospective Randomized Clinical Trial of Plicated Laparoscopic Adjustable Gastric Banding|Terminated||N/A|17|Actual|Duke University||2||Sponsor withdrew funding.|f||||t||||||||||2017-10-11 03:08:17.477697|2017-10-11 03:08:17.477697
NCT01564719|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-02-09|||October 2010|Actual|2010-10-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|SpiritedLife||Study of a Holistic Health Program for United Methodist Clergy|A Randomized Multiple Baseline Intervention Study of Metabolic Syndrome, Mental Health, and Spiritual Well-Being of United Methodist Clergy in North Carolina|Completed||N/A|1114|Actual|Duke Clergy Health Initiative||3|||f||||f||||||||No||2017-10-11 03:08:17.835272|2017-10-11 03:08:17.835272
NCT01564706|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-25|2012-05-11|2012-04-03||October 2007||2007-10-01|May 2012|2012-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of 18F-AV-45 in Healthy Volunteers|Positron Emission Tomography Whole Body Biodistribution Using 18F-AV-45|Completed||Phase 1|9|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:08:17.966349|2017-10-11 03:08:17.966349
NCT01564693|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-07-28|2015-04-23||April 2010||2010-04-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Observational|||Cancer Anorexia and the Central Nervous System|Neuroimaging of Hypothalamic Activity During Cancer Anorexia|Completed||N/A|15|Actual|University of Roma La Sapienza|||3||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 03:08:18.218093|2017-10-11 03:08:18.218093
NCT01564680|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-26|2012-03-27|||March 2009||2009-03-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Lornoxicam vs. Paracetamol After Lower Abdominal Surgery|Intravenous Lornoxicam is More Effective Than Paracetamol as a Supplemental Analgesic After Lower Abdominal Surgery; A Randomized Controlled Trial|Completed||Phase 4|60|Actual|Dammam University||3|||f||||t||||||||||2017-10-11 03:08:18.495562|2017-10-11 03:08:18.495562
NCT01564641|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2017-07-13|||May 2012|Actual|2012-05-01|July 2017|2017-07-01|March 2025|Anticipated|2025-03-01|August 2016|Actual|2016-08-01||Observational|||Study of the ConforMIS iDuo(R) G2|A Prospective, Multicenter Study of the ConforMIS iDuo(R) G2 Bicompartmental Knee Repair System|Active, not recruiting||N/A|150|Anticipated|ConforMIS, Inc.|||1||f||||f|f|t|f|f|t|||||2017-10-11 03:08:18.744292|2017-10-11 03:08:18.744292
NCT01564628|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-26|||March 2012||2012-03-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Observational|||Data Acquisition for Optimization of Coronary Artery Disease (CAD) Algorithm|Data Acquisition for Optimization of Coronary Artery Disease Algorithm|Unknown status|Enrolling by invitation|N/A|250|Anticipated|Coloplast A/S|||3||f||||f||||||||||2017-10-11 03:08:18.965737|2017-10-11 03:08:18.965737
NCT01564615|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-03-27|||July 2007||2007-07-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||AgION Catheter for Preventing Catheter-Related Bloodstream Infections|Reduction of Catheter-Related Bloodstream Infections in Preterm Infants by the Use of Catheters With the AgION Antimicrobial System|Completed||N/A|86|Actual|University of Florence||2|||f||||t||||||||||2017-10-11 03:08:19.077525|2017-10-11 03:08:19.077525
NCT01564602|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-03-28|||January 2011||2011-01-01|March 2012|2012-03-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Interventional|||To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy|Prospective Cohort Study to Compare to 2-channel and Multiple Channel Single Port Laparoscopic-assisted Vaginal Hysterectomy|Unknown status|Recruiting|N/A|200|Anticipated|Taipei Veterans General Hospital, Taiwan||1|||f||||f||||||||||2017-10-11 03:08:19.195278|2017-10-11 03:08:19.195278
NCT01564589|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-08-25|||March 2012||2012-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:08:19.301844|2017-10-11 03:08:19.301844
NCT01564576|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-27|||April 2012||2012-04-01|March 2012|2012-03-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|Sugamadex||Neuromuscular Blockade and Surgical Conditions|The Influence of the Magnitude of Neuromuscular Blockade on the Surgical Conditions During Laparoscopic Sleeve Gastrectomy|Unknown status|Not yet recruiting|N/A|40|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 03:08:19.347879|2017-10-11 03:08:19.347879
NCT01564563|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-02-23|||June 28, 2002|Actual|2002-06-28|February 2017|2017-02-01|October 27, 2003|Actual|2003-10-27|October 27, 2003|Actual|2003-10-27||Interventional|||Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation|A Multi-center, Randomized, Double-blind, Parallel Groups, Placebo-controlled Trial on Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in the Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation (HSCT)|Terminated||Phase 2|11|Actual|Novo Nordisk A/S||3||Trial enrollment was prematurely terminated due to excessively slow patient recruitment|f||||f||||||||||2017-10-11 03:08:19.454276|2017-10-11 03:08:19.454276
NCT01564550|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-12-05|||November 2012||2012-11-01|November 2012|2012-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism|The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism|Completed||N/A|30|Actual|University of Aarhus|||2||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-11 03:08:19.566509|2017-10-11 03:08:19.566509
NCT01564537|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-09-04|2015-12-19||August 1, 2012|Actual|2012-08-01|September 2017|2017-09-01|December 1, 2020|Anticipated|2020-12-01|October 1, 2014|Actual|2014-10-01||Interventional||Intent-to-Treat (ITT) population was defined as all randomized participants.|A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma|A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral Ixazomib (MLN9708) Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma|Active, not recruiting||Phase 3|722|Actual|Takeda||2|||f||||t||||||||||2017-10-11 03:08:19.738595|2017-10-11 03:08:19.738595
NCT01564524|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-10-24|||April 2011||2011-04-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Effect of Concentrating Endogenous Stromal Cells in the Fat Graft|Structural Fat Grafting for Craniofacial Trauma: Effect of Concentrating Endogenous Stromal Cells in the Fat Graft|Terminated||N/A|3|Actual|University of Pittsburgh|||1|Funding ended|f||||t||||||||||2017-10-11 03:08:21.849759|2017-10-11 03:08:21.849759
NCT01564511|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-09-09|||November 2011||2011-11-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Electromechanical Gait Trainer in Patients With Multiple Sclerosis|Effects of Electromechanical Gait Trainer on Endurance, Fatigue and Daily Life Autonomy in Patients With Multiple Sclerosis: a Randomized Control Trial|Completed||N/A|50|Actual|Universita di Verona||2|||f||||t||||||||||2017-10-11 03:08:21.928933|2017-10-11 03:08:21.928933
NCT01564498|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-10-24|||April 2012||2012-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk Factors|A Pilot Study of the Effects of Replacing Orange Carrots and White Potatoes With Purple Varieties, on Risk Factors for Cardiovascular Disease|Recruiting||Phase 1|60|Anticipated|University of Guelph||4|||f||||f||||||||No||2017-10-11 03:08:22.02207|2017-10-11 03:08:22.02207
NCT01564485|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-12-07|||July 2008||2008-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CTRAD||Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome|Role of Cardiac CT in Risk Factor Control in Asymptomatic Patients With Diabetes|Completed||N/A|198|Actual|University of California, Irvine||2|||f||||t||||||||Undecided||2017-10-11 03:08:22.139337|2017-10-11 03:08:22.139337
NCT01564472|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-11-30|||February 2013||2013-02-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Observational|||Validation of Sleepware G3 Autoscoring Algorithm|Validation of Sleepware G3 Autoscoring Algorithm|Unknown status|Not yet recruiting|N/A|100|Anticipated|Philips Respironics|||1||f||||f||||||||||2017-10-11 03:08:22.346564|2017-10-11 03:08:22.346564
NCT01564459|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-05-31|2016-05-02||March 26, 2012|Actual|2012-03-26|May 2017|2017-05-01|April 18, 2013|Actual|2013-04-18|April 18, 2013|Actual|2013-04-18||Interventional|||Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)|A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients With Painful Diabetic Neuropathy|Completed||Phase 2|170|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 03:08:22.435735|2017-10-11 03:08:22.435735
NCT01564446|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-03-26|||April 2011||2011-04-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|April 2013|Actual|2013-04-01||Interventional|SMMRT||Interactive Medication Reconciliation By Secure Messaging|Interactive Medication Reconciliation by Secure Messaging|Unknown status|Active, not recruiting|Phase 1|152|Actual|VA Boston Healthcare System||1|||f||||t||||||||||2017-10-11 03:08:23.050416|2017-10-11 03:08:23.050416
NCT01564433|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-06-13|||November 2011||2011-11-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Electromechanical Gait Trainer in Patients With Cerebral Palsy|The Effects of an Electromechanical Gait Trainer in Gait Impairments and Endurance in Patients With Cerebral Palsy: a Randomized Control Trial|Completed||Early Phase 1|20|Actual|Universita di Verona||2|||f||||t||||||||||2017-10-11 03:08:23.196605|2017-10-11 03:08:23.196605
NCT01564420|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-23|||January 2003||2003-01-01|March 2012|2012-03-01||||December 2006|Actual|2006-12-01||Observational|||Morphine Postoperative Analgesia and Pharmacokinetic/Pharmacodynamic Modeling|Pharmacokinetic/Pharmacodynamic Modeling of Morphine for Postoperative Analgesia Through a Patient Controlled Device After Coronary Artery Bypass Grafting. Intrathecal Morphine Significantly Reduces Drug Consumption|Completed||N/A|36|Actual|University of Sao Paulo|||2||f||||f||||||Samples Without DNA|"     For pharmacokinetic analysis, a serial of blood samples of patients was collected     postoperatively after the extubation from a venous catheter (5mL each) into an EDTA tube (BD,     Sao Paulo/Brazil) in the periods as follows: 0, 0.08, 0.25, 0.5, 1, 3, 6, 12, 18, 24 and 36     hrs. Blood samples were centrifuged at 2800 g for 20 minutes, plasma was transferred to     labeled polyethylene vials and frozen at -80ºC until drug plasma assay.   "|||2017-10-11 03:08:23.316859|2017-10-11 03:08:23.316859
NCT01564407|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-06-09|2016-02-18||January 2011||2011-01-01|June 2017|2017-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures|A Phase I/II Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures|Terminated||Phase 1/Phase 2|15|Actual|University of Pittsburgh||5||Study Terminated due to lack of Funding|f||||t||||||||Undecided||2017-10-11 03:08:23.427688|2017-10-11 03:08:23.427688
NCT01564394|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-11-09|2013-06-12||October 2011||2011-10-01|November 2015|2015-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Body Mind Training Project|Effects of Qigong on Fatigue & Quality of Life in Elderly Prostate Cancer Survivors|Completed||N/A|60|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 03:08:24.246038|2017-10-11 03:08:24.246038
NCT01564381|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2017-07-13|||March 2012||2012-03-01|July 2017|2017-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women|Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women|Completed||Phase 1/Phase 2|64|Actual|University of California, Davis||3|||f||||f||||||||||2017-10-11 03:08:24.657561|2017-10-11 03:08:24.657561
NCT01564368|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2017-03-16|||August 2012||2012-08-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|July 2017|Anticipated|2017-07-01||Interventional|ACRIN6698||DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy|Diffusion Weighted MR Imaging Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: A Sub-study of the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And MoLecular Analysis)|Active, not recruiting||N/A|304|Anticipated|American College of Radiology Imaging Network||1|||f||||t||||||||Yes|See ACRIN data sharing Policy https://www.acrin.org/RESEARCHERS/POLICIES/DATAANDIMAGESHARINGPOLICY.aspx|2017-10-11 03:08:24.757736|2017-10-11 03:08:24.757736
NCT01564355|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-12-01|||April 2012||2012-04-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Spacer Following Endoscopic Sinus Surgery|The Role of Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Middle Meatal Spacer Following Endoscopic Sinus Surgery: A Randomized, Double-Blind, Placebo Controlled Trial|Completed||N/A|80|Actual|University of Calgary||2|||f||||||||||||||2017-10-11 03:08:24.89403|2017-10-11 03:08:24.89403
NCT01564342|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-23|||June 1994||1994-06-01|March 2012|2012-03-01|June 1996|Actual|1996-06-01|June 1996|Actual|1996-06-01||Interventional|||Tap Water Versus Normal Saline for Wound Irrigation|A Prospective Double-Blind Randomized Clinical Trial Comparing Tap Water Irrigation With Normal Saline for Wound Management|Completed||N/A|660|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 03:08:24.977904|2017-10-11 03:08:24.977904
NCT01564329|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-23|||March 2012||2012-03-01|March 2012|2012-03-01|July 2013|Anticipated|2013-07-01|April 2013|Anticipated|2013-04-01||Interventional|||The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar|The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar|Unknown status|Recruiting|Phase 2|20|Anticipated|Simcere Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-10-11 03:08:25.089762|2017-10-11 03:08:25.089762
NCT01564316|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2016-04-14|||May 2005||2005-05-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients|Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients|Terminated||Early Phase 1|22|Actual|Seoul National University Hospital|||1|The study has been terminated due to difficulties in gathering the patient samples.|f||||t||||||Samples With DNA|"     serum:10ml      WHO: neurodegeneration patients and control group include dementia patients visited the part     of neurology.   "|||2017-10-11 03:08:25.201659|2017-10-11 03:08:25.201659
NCT01564303|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-24|||May 2012||2012-05-01|March 2012|2012-03-01|February 2013|Anticipated|2013-02-01|November 2012|Anticipated|2012-11-01||Interventional|||Nephroprotective Effects of Carnitine and (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN)|Potentially Nephroprotective Effects of Carnitine and Phosphodiesterase Type 5 (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN): A Double Blind Randomized Study|Unknown status|Not yet recruiting|N/A|80|Anticipated|The Nazareth Hospital, Israel||4|||f||||t||||||||||2017-10-11 03:08:25.278828|2017-10-11 03:08:25.278828
NCT01564290|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-29|2012-03-26|||February 2011||2011-02-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|August 2011|Actual|2011-08-01||Interventional|||Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children|Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children: A Randomized Double-blind Trial|Completed||Phase 4|54|Actual|Centro Pediatrico Albina de Patino||2|||f||||f||||||||||2017-10-11 03:08:25.394363|2017-10-11 03:08:25.394363
NCT01564264|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2014-08-29|||November 2012||2012-11-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Sentinel Node Biopsy in Endometrial Cancer|Prospective Cohort Study Evaluating Identification Rate of Sentinel Node in the Management of Endometrial Cancer Utilizing a Combined Method of Cervical and Myometrial Injections|Unknown status|Recruiting|N/A|50|Anticipated|Hamilton Health Sciences Corporation||1|||f||||f||||||||||2017-10-11 03:08:25.632464|2017-10-11 03:08:25.632464
NCT01564251|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-08-14|||March 31, 2012|Actual|2012-03-31|August 2017|2017-08-01|June 2, 2018|Anticipated|2018-06-02|June 2, 2018|Anticipated|2018-06-02||Interventional|||A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma|An Open-label, Phase I, Dose Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0575 Administered Alone and in Combination With Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma|Active, not recruiting||Phase 1|104|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 03:08:25.7456|2017-10-11 03:08:25.7456
NCT01564238|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-04-03|||June 1999||1999-06-01|April 2012|2012-04-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Effect of Sodium Intake on Calcium Retention in Girls|Effect of Sodium Intake on Calcium Retention in Black and White Adolescent Girls.|Completed||N/A|67|Actual|Purdue University||2|||f||||f||||||||||2017-10-11 03:08:25.885748|2017-10-11 03:08:25.885748
NCT01564225|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-11-25|||May 2012||2012-05-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200|A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200, an Ectodysplasin-A1 Replacement Molecule, in X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Adults|Completed||Phase 1|6|Actual|Edimer Pharmaceuticals||1|||f||||t||||||||||2017-10-11 03:08:25.994568|2017-10-11 03:08:25.994568
NCT01564212|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-12-29|||March 2012||2012-03-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Quantitative Heat Loss With Laminar Air Flow||Active, not recruiting||N/A|10|Anticipated|The Cleveland Clinic||4|||f||||f||||||||||2017-10-11 03:08:26.07152|2017-10-11 03:08:26.07152
NCT01564199|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-06-25|||April 2012||2012-04-01|March 2012|2012-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|SALBLOCK||Phase I Pharmacokinetic Study (SALBLOCK)|Effect of Charcoal on Gastrointestinal Absorption of Salmeterol and Fluticasone Propionate.|Completed||Phase 1|20|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-11 03:08:26.162385|2017-10-11 03:08:26.162385
NCT01564186|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2014-04-08|||April 2012||2012-04-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|November 2012|Actual|2012-11-01||Observational|||Characterization of Cardiac Hemodynamics During MultiSite Pacing|Characterization of Cardiac Hemodynamics by Pressure-Volume Loop Analysis During MultiPoint Pacing|Completed||N/A|44|Actual|St. Jude Medical|||2||f||||t||||||||||2017-10-11 03:08:26.237525|2017-10-11 03:08:26.237525
NCT01564173|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2016-03-23|||June 2012||2012-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Dependence of LV Hemodynamics on Pacing Site|Characterization of LV Hemodynamics During Epicardial and Endocardial Pacing|Completed||N/A|13|Actual|St. Jude Medical|||1||f||||t||||||||||2017-10-11 03:08:26.316911|2017-10-11 03:08:26.316911
NCT01564160|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-11-30|||April 2012||2012-04-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Assessment of PCSO-524 Relative to a Comparator Product|Assessment of the Acute and Chronic Bioavailability of Marine Lipid Fraction PCSO-524 Relative to a Comparator Product.|Completed||Early Phase 1|10|Anticipated|Nutrasource Diagnostics Inc.||2|||f||||f||||||||||2017-10-11 03:08:26.399776|2017-10-11 03:08:26.399776
NCT01564147|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-08-05|||September 2011||2011-09-01|August 2016|2016-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|ETP-PR||More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis (ETP-PR)|More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis|Terminated||N/A|62|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 03:08:26.509133|2017-10-11 03:08:26.509133
NCT01564134|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-07-09|||August 2011||2011-08-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Dose of Hepatitis B Vaccines in Non/Low-response Populations|Effect of Dose of Hepatitis B Vaccines in Non/Low-response Populations|Completed||N/A|537|Actual|Centers for Disease Control and Prevention, China||4|||f||||t||||||||||2017-10-11 03:08:26.606034|2017-10-11 03:08:26.606034
NCT01564121|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-08-29|||January 2006||2006-01-01|August 2013|2013-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|Zometa||Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa|Phase 2 Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone|Terminated||Phase 1/Phase 2|24|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 03:08:26.862014|2017-10-11 03:08:26.862014
NCT01564108|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-07-04|||February 2012||2012-02-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema|An Exploratory Study of Ranibizumab (Lucentis) for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema Which Has Proven Refractory or Ineligible to Standard Treatment.|Completed||Phase 2|10|Actual|Moorfields Eye Hospital NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 03:08:26.936479|2017-10-11 03:08:26.936479
NCT01564095|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-03-21|||October 2011|Actual|2011-10-01|March 2017|2017-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|TOP||TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion|TOP-Study (Tacrolimus Organ Perfusion): A Prospective Multicenter Trial for Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion|Terminated||Phase 2/Phase 3|25|Actual|Ludwig-Maximilians - University of Munich||2||Missing evidence of the effectiveness of the study medication|f||||t|t|f|||f|||No||2017-10-11 03:08:27.059038|2017-10-11 03:08:27.059038
NCT01501006|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-08-15|||October 2010||2010-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|SBI||Social and Behavioral Influence (SBI)|Social and Behavioral Influences on Clinical Care|Enrolling by invitation||N/A|120|Anticipated|University of Rochester|||1||f||||t||||||||||2017-10-11 03:26:47.287932|2017-10-11 03:26:47.287932
NCT01564082|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-04-09|||April 2012||2012-04-01|April 2015|2015-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of Early Endotracheal Tube Insertion With GlideScope Use|Comparison of Early Endotracheal Tube Insertion With GlideScope Use|Completed||N/A|160|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:08:27.186046|2017-10-11 03:08:27.186046
NCT01564069|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-03-05|||July 2009||2009-07-01|March 2013|2013-03-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy|Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy|Unknown status|Recruiting|N/A|90|Anticipated|Brigham and Women's Hospital|||3||f||||f||||||||||2017-10-11 03:08:27.27197|2017-10-11 03:08:27.27197
NCT01564056|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-08-31|||March 2012||2012-03-01|August 2015|2015-08-01|March 2026|Anticipated|2026-03-01|March 2020|Anticipated|2020-03-01||Interventional|ASTER 70s||Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment|Adjuvant Systemic Treatment for Oestrogen-receptor (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) Multicentre Phase III Trial|Recruiting||Phase 3|2000|Anticipated|UNICANCER||2|||f||||f||||||||||2017-10-11 03:08:27.365891|2017-10-11 03:08:27.365891
NCT01564043|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-03-26|||February 2011||2011-02-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Internet Walking Program and Pedometer in Chronic Obstructive Pulmonary Disease||Completed||N/A|31|Actual|VA Boston Healthcare System||1|||f||||f||||||||||2017-10-11 03:08:27.76781|2017-10-11 03:08:27.76781
NCT01564030|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-11-08|||February 2012||2012-02-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Gastric Ultrasound in Pregnant Women at Term|Qualitative Ultrasound Assessment of the Gastric Content of Pregnant Women at Term|Completed||N/A|32|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||3|||f||||f||||||||||2017-10-11 03:08:27.836948|2017-10-11 03:08:27.836948
NCT01564017|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-04-28|||May 2012||2012-05-01|April 2017|2017-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract|Phase II, Multicenter, Randomized, Double-blind Study, With Subcutaneous Immunotherapy, in Parallel Groups and Placebo-controlled, in Patients With Rhinoconjunctivitis ± Asthma Sensitized to Dermatophagoides Pteronyssinus.|Completed||Phase 2|150|Actual|Roxall Medicina España S.A||6|||f||||f||||||||||2017-10-11 03:08:27.921525|2017-10-11 03:08:27.921525
NCT01564004|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2012-03-26|||February 2011||2011-02-01|March 2012|2012-03-01|September 2014|Anticipated|2014-09-01|February 2014|Anticipated|2014-02-01||Interventional|||Clinical Hypnosis Before External Cephalic Version (ECV)|Clinical Hypnosis Versus Neuro-linguistic Programming Before External Cephalic Version (ECV) - a Prospective Off-centre Randomised Controlled Trial|Unknown status|Recruiting|N/A|716|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 03:08:28.04833|2017-10-11 03:08:28.04833
NCT01563991|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2017-03-28|||February 2007||2007-02-01|March 2017|2017-03-01|April 18, 2012|Actual|2012-04-18|April 18, 2012|Actual|2012-04-18||Interventional|||Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes|Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes Following Elective Open Colorectal Surgery|Completed||N/A|186|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-11 03:08:28.148069|2017-10-11 03:08:28.148069
NCT01563978|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2014-04-23|2013-11-08||April 2012||2012-04-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Oskira ABPM||Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis|OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis|Completed||Phase 2|266|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 03:08:28.263892|2017-10-11 03:08:28.263892
NCT01563965|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-24|2012-03-26|||March 2010||2010-03-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Carbohydrates and Proteins 3h Before Surgery|Effects of the Abbreviation of Preoperative Fasting With Carbohydrates and Hydrolized Proteins on the Inflammatory Response and Insulin Resistance After Major Abdominal Operations|Completed||Phase 3|30|Actual|Federal University of Mato Grosso do Sul||2|||f||||t||||||||||2017-10-11 03:08:29.254118|2017-10-11 03:08:29.254118
NCT01563952|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-26|||October 2010||2010-10-01|March 2012|2012-03-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|CTO||Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents|Impact of IVUS-guided Chronic Total Occlusion InterVention With DrUg-eluting Stents on Mid-term Angiographic and Clinical Outcomes (CTO-IVUS Study)|Unknown status|Recruiting|Phase 4|400|Anticipated|Yonsei University||4|||f||||t||||||||||2017-10-11 03:08:29.354527|2017-10-11 03:08:29.354527
NCT01563939|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-09-02|||February 2012||2012-02-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Patient-controlled Intravenous Analgesia With Remifentanil Infusion for Labour|Patient-controlled Intravenous Analgesia With Remifentanil Infusion for Labour: is Demand Bolus Required for Optimal Analgesia|Terminated||N/A|2|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2||Difficult recruitment.|f||||f||||||||||2017-10-11 03:08:29.493689|2017-10-11 03:08:29.493689
NCT01563926|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-02-23|||October 23, 2000|Actual|2000-10-23|February 2017|2017-02-01|October 10, 2002|Actual|2002-10-10|October 10, 2002|Actual|2002-10-10||Interventional|||Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency|An Open, Multi-Centre Trial Evaluating Acceptance of the New Liquid Growth Hormone Formulation - Norditropin Simplexx™ in Children With GH Deficiency|Completed||Phase 3|168|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:08:29.581642|2017-10-11 03:08:29.581642
NCT01563900|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-04-16|||February 2012||2012-02-01|April 2013|2013-04-01|February 2016|Anticipated|2016-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA)|Continuous Positive Airway Pressure for Fatigue Treatment in Patients With Multiple Sclerosis and Obstructive Sleep Apnea|Withdrawn||N/A|0|Actual|Northwestern University||2||Was unable to recruit subjects|f||||f||||||||||2017-10-11 03:08:29.769573|2017-10-11 03:08:29.769573
NCT01563887|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-12-04|||February 2012||2012-02-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)|Identifying Driving Risk Factors in T1DM and Their Reduction Via Behavioral Intervention|Completed||N/A|568|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 03:08:29.944212|2017-10-11 03:08:29.944212
NCT01563874|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-10-05|||May 26, 2009||2009-05-26|June 19, 2017|2017-06-19||||||||Observational|||Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins|Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:08:30.065183|2017-10-11 03:08:30.065183
NCT01563861|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-12-16|||February 2012||2012-02-01|December 2016|2016-12-01||||March 2012|Actual|2012-03-01||Observational|||S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma|Determining the Cell of Origin and Prognostic Gene Signatures in SWOG Trials of Diffuse Large B-Cell Lymphoma|Active, not recruiting||N/A|397|Actual|Southwest Oncology Group|||1||f||||f||||||||||2017-10-11 03:08:30.160084|2017-10-11 03:08:30.160084
NCT01563848|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-09-21|||September 2011||2011-09-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|June 2015|Actual|2015-06-01||Interventional|CIAFL||Cryoablation in Patients With Atrial Flutter|Cryoablation in Patients With Atrial Flutter|Unknown status|Recruiting|Phase 2|80|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 03:08:30.251267|2017-10-11 03:08:30.251267
NCT01563835|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2014-10-09|||March 2012||2012-03-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Analgesia for 2nd Trimester Termination of Pregnancy|Analgesia for 2nd Trimester Termination of Pregnancy: a Randomized Controlled Trial of Intravenous Versus Epidural Patient Controlled Analgesia|Terminated||N/A|42|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2||Recruitment difficulty|f||||f||||||||||2017-10-11 03:08:30.355667|2017-10-11 03:08:30.355667
NCT01563822|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-10-06|||December 2011||2011-12-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Does Flushing the Uterine Cavity With Follicular Fluid After Ovum Pick-up Improve Implantation Rates in ICSI Cycles?|Phase I Study of the Effect of Flushing the Uterine Cavity With Follicular Fluid After Ovum Pick-up on Implantation Rates in ICSI Cycles|Completed||Phase 1|100|Actual|Kasr El Aini Hospital||2|||f||||t||||||||||2017-10-11 03:08:30.464558|2017-10-11 03:08:30.464558
NCT01563809|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-04-21|||December 2008||2008-12-01|April 2015|2015-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Basal Androgens and LH Needing for Ovarian Stimulation for in Vitro Fertilization|The Relationship Between Basal Androgen Levels and the Needing of LH for Controlled Ovarian Stimulation for in Vitro Fertilization|Completed||Phase 3|400|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||4|||f||||f||||||||||2017-10-11 03:08:30.560136|2017-10-11 03:08:30.560136
NCT01563796|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-09-22|||March 2012||2012-03-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|March 2014|Actual|2014-03-01||Observational|||Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer|A Multi-Center Study to Evaluate the Safety and Efficacy of a Urine DEK ELISA in Diagnosis of Subjects With Bladder Cancer|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Medical Diagnostic Laboratories, LLC|||2||f||||f||||||None Retained|"     urine   "|||2017-10-11 03:08:30.65902|2017-10-11 03:08:30.65902
NCT01563783|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-06-30|||December 2012||2012-12-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|September 2017|Anticipated|2017-09-01||Interventional|TRUST||Post Market TRUST Study|The Trust (Treatment Results of Uterine Sparing Technologies) Study|Active, not recruiting||N/A|260|Anticipated|Acessa Health, Inc.||2|||f||||t||||||||||2017-10-11 03:08:30.76234|2017-10-11 03:08:30.76234
NCT01563770|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-05-23|||April 2012||2012-04-01|January 2012|2012-01-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Cardiovascular Effects of Salvia Miltiorrhiza Extract (Danshen)|A Double Blind, Randomized Placebo-controlled Cross-over Study on the Cardiovascular Effects of Salvia Miltiorrhiza Extract (Danshen) in Patients With Hypertension and Hyperlipidemia.|Unknown status|Recruiting|N/A|20|Anticipated|Radboud University||2|||f||||t||||||||||2017-10-11 03:08:30.954492|2017-10-11 03:08:30.954492
NCT01563757|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-10-28|||March 2012||2012-03-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology|An Investigation Into The Potential Roles Of Vasoactive Intestinal Peptide And Substance P In The Pathophysiology Of Plastic Bronchitis And Protein Losing Enteropathy In Children With Palliated Single Ventricle Physiology|Completed||N/A|20|Actual|Medical College of Wisconsin|||4||f||||f||||||||||2017-10-11 03:08:31.129086|2017-10-11 03:08:31.129086
NCT01563744|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2016-04-15|||August 2009||2009-08-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||EGD-assisted Bowel Preparation for Colonoscopy|EGD-assisted Bowel Preparation for Colonoscopy|Completed||N/A|82|Actual|Rockford Gastroenterology Associates||2|||f||||f||||||||No||2017-10-11 03:08:31.238861|2017-10-11 03:08:31.238861
NCT01563731|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-03-02|||April 2013||2013-04-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|September 2018|Anticipated|2018-09-01||Interventional|ESH-CHL-SHOT||Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives|European Society of Hypertension and Chinese Hypertension League Stroke in Hypertension Optimal Treatment Trial|Recruiting||Phase 4|7500|Anticipated|Istituto Auxologico Italiano||6|||f||||t||||||||||2017-10-11 03:08:31.375758|2017-10-11 03:08:31.375758
NCT01563718|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2015-10-21|||March 2012||2012-03-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Pre-Release VIVITROL for Opioid Dependent Inmates|VIVITROL® (Naltrexone for Extended Release Injectable Suspension (XR-NTX)) for Opioid Dependent Inmates Released From Prison|Completed||Phase 4|26|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-10-11 03:08:31.528887|2017-10-11 03:08:31.528887
NCT01563705|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-12-19|||February 2011||2011-02-01|December 2012|2012-12-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|PRO GSDIII||Prospective Follow-up of Patients With Glycogen Storage Disease Type III|Prospective Follow-up of Patients With Glycogen Storage Disease Type III|Unknown status|Recruiting|N/A|30|Anticipated|Institut de Myologie, France||1|||f||||f||||||||||2017-10-11 03:08:31.620511|2017-10-11 03:08:31.620511
NCT01563692|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-11-06|||March 2012||2012-03-01|November 2015|2015-11-01||||August 2012|Actual|2012-08-01||Observational|||Immune Response to Respiratory Syncytial Virus (RSV) in Health Care Workers|Analysis of the Immune Response to Respiratory Syncytial Virus (RSV) Infection in Health Care Personnel|Completed||N/A|30|Actual|University of Oxford|||2||f||||f||||||Samples With DNA|"     The humoral and cellular immune response to RSV exposure. To characterise these further some     analysis of HLA typing my occur.   "|||2017-10-11 03:08:31.73896|2017-10-11 03:08:31.73896
NCT01563679|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-05-23|||February 2012||2012-02-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Analysis of Percutaneous Ablations for Cancer Treatment|Prospective Analysis of Percutaneous Ablations for Cancer Treatment|Completed||N/A|26|Actual|Emory University|||1||f||||t||||||||||2017-10-11 03:08:31.841641|2017-10-11 03:08:31.841641
NCT01563653|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-06-16|||February 20, 2014|Actual|2014-02-20|June 2017|2017-06-01|February 23, 2017|Actual|2017-02-23|February 23, 2017|Actual|2017-02-23||Interventional|IEUF||Development and Evaluation of a New Diagnostic Test in Female Urinary Stress Incontinence|Development and Evaluation of a New Diagnostic Test in Female Urinary Stress Incontinence|Terminated||N/A|7|Actual|Centre Hospitalier Universitaire de Nīmes||1||Not enough inclusions.|f||||t||||||||||2017-10-11 03:08:31.926371|2017-10-11 03:08:31.926371
NCT01563640|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-08-31|||March 2012||2012-03-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|June 2013|Actual|2013-06-01||Interventional|DengueTools||Insecticidal School Uniforms for Dengue Prevention in Thailand|Can Insecticide-treated School Uniforms Reduce Dengue Infections in School-aged Children in Thailand|Terminated||N/A|1825|Actual|Umeå University||2||Insecticidal treatment of school uniforms did not last through a dengue season|f||||t||||||||||2017-10-11 03:08:32.056011|2017-10-11 03:08:32.056011
NCT01563627|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-05-31|||October 2011||2011-10-01|May 2016|2016-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Serum Profile of Inflammatory Factors, Immune and Angiogenic in Temporal Lobe Epilepsy|Serum Profile of Inflammatory Factors, Immune and Angiogenic in Temporal Lobe Epilepsy: New Targets for Diagnosis and Prediction of Drug Resistance|Completed||N/A|70|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 03:08:32.172535|2017-10-11 03:08:32.172535
NCT01563614|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-04-18|||March 2012||2012-03-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain|Safety and Efficacy of Liposomal Cytarabine in Combination With Radiotherapy (RT) and Lomustine for the Treatment of Leptomeningeal Metastasis From Malignant Melanoma|Terminated||Phase 1|1|Actual|University Hospital, Bonn||1||"No patients can be recruited for this trial anymore due to other therapeutical approaches that   became available."|f||||f||||||||||2017-10-11 03:08:32.2735|2017-10-11 03:08:32.2735
NCT01563601|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-08-14|||August 2012||2012-08-01|August 2012|2012-08-01|January 2018|Anticipated|2018-01-01|May 2016|Anticipated|2016-05-01||Interventional|||Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer|A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer|Withdrawn||Phase 3|0|Actual|Teva Pharmaceutical Industries||2||Business Decision|f||||t||||||||||2017-10-11 03:08:32.391523|2017-10-11 03:08:32.391523
NCT01563588|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-12-23|||December 2008||2008-12-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2010|Actual|2010-10-01||Interventional|||Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After Chemotherapy|Post Therapeutic Support and Rehabilitation Protocol in Hydrothermal Centers for Breast Cancer Patients in Complete Remission: a Multicenter Prospective Randomized Trial Testing the Intervention Versus Best Supportive Care|Terminated||N/A|251|Actual|Centre Jean Perrin||2||"Enrollment lasted longer than expected and expected number of patients could not be matched in   time."|f||||f||||||||||2017-10-11 03:08:32.523889|2017-10-11 03:08:32.523889
NCT01563575|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-04-05|||January 2012||2012-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RP||WHO-HPH Recognition Project on Fast-Track Implementation of Clinical Health Promotion|WHO-HPH Recognition Project on Fast-Track Implementation of Clinical Health Promotion - a Multi-Centre RCT|Active, not recruiting||N/A|48|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 03:08:32.651979|2017-10-11 03:08:32.651979
NCT01563562|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2013-04-09|||April 2012||2012-04-01|October 2012|2012-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function|A Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function|Completed||Phase 1|34|Actual|Reata Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-11 03:08:32.79952|2017-10-11 03:08:32.79952
NCT01563536|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2014-12-29|2014-12-29|2013-04-25|February 2012||2012-02-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|April 2012|Actual|2012-04-01||Interventional|||Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects|An Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects|Completed||Phase 2|12|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 03:08:32.918263|2017-10-11 03:08:32.918263
NCT01563523|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-01-12|||March 2002||2002-03-01|January 2017|2017-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients|A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven®/ Niastase®) in the Treatment of Bleeding in Severely Injured Trauma Subjects|Completed||Phase 2|283|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:08:33.804084|2017-10-11 03:08:33.804084
NCT01563510|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-10-08|||January 2012||2012-01-01|October 2012|2012-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Research of the Key Technology and Standardization of Minimal Invasive Treatment for Hepatolithiasis|Comparison of Laparoscopic Versus Open Operation for Hepatolithiasis|Enrolling by invitation||N/A|100|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 03:08:33.909568|2017-10-11 03:08:33.909568
NCT01563497|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2012-03-23|||February 2012||2012-02-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State|A Phase 1, Open-Label, Single Dose, Bioavailability Study In Healthy Volunteers Comparing PF-05089771 TS Tablet To PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And The Fed State|Completed||Phase 1|12|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:08:34.005173|2017-10-11 03:08:34.005173
NCT01563484|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-30|||March 2012||2012-03-01|March 2012|2012-03-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|||Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media|Comparison of Liver and Renal Function After TACE for PHC With Iso-osmolar and Low-osmolar Contrast Media|Unknown status|Active, not recruiting|Phase 2/Phase 3|50|Anticipated|Southeast University, China|||2||f||||t||||||||||2017-10-11 03:08:34.086595|2017-10-11 03:08:34.086595
NCT01563471|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-01-12|||October 2001||2001-10-01|January 2017|2017-01-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers|Single-centre, Randomised, Placebo-controlled, Double-blind, Dose Escalation Trial Investigating Pharmacokinetics, Pharmacodynamics and Tolerability of Three Different Single Intravenous Doses of Activated Recombinant Factor VIIa (rFVIIa/NovoSeven®) in Healthy Caucasian and Japanese Subjects|Completed||Phase 1|39|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:08:34.161501|2017-10-11 03:08:34.161501
NCT01563458|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-01-12|||August 2001||2001-08-01|January 2017|2017-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation|A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Dose Exploratory Trial Evaluating the Safety and Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in the Reduction of Bleeding in Subjects Undergoing Orthotopic Liver Transplantation|Completed||Phase 2|208|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:08:34.247177|2017-10-11 03:08:34.247177
NCT01563445|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-23|2017-01-12|||November 2001||2001-11-01|January 2017|2017-01-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage|Multi-center, Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of Activated Recombinant Factor VII (NovoSeven®) for Preventing Early Hematoma Growth in Acute Intracerebral Hemorrhage (ICH)|Completed||Phase 2|40|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:08:34.37381|2017-10-11 03:08:34.37381
NCT01563432|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-03-26|||January 2012||2012-01-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers|Open Label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Characteristics of Febuxostat Between TMX-67 40mg 2 Tablets and Feburic® 80mg 1 Tablet in Healthy Male Volunteers|Completed||Phase 1|30|Actual|SK Chemicals Co.,Ltd.||2|||f||||t||||||||||2017-10-11 03:08:34.45933|2017-10-11 03:08:34.45933
NCT01563419|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-26|||October 2011||2011-10-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Clinical Usefulness of a Magnifier for Insulin Pen||Completed||N/A|50|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:08:34.629347|2017-10-11 03:08:34.629347
NCT01563406|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-04-14|2015-08-14||March 2012||2012-03-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|HUC-PHIN|140 participants, 149 separate MICU admissions, 509 hubs total. Each MICU admission is treated as a separate enrollment.|Hub Cleansing to Prevent Hub Infection|Hub Cleansing to Prevent Hub Infection|Completed||N/A|149|Actual|Rush University Medical Center|"Single MICU
Large number of eligible hubs not evaluated
Unbalanced hub collection among study arms
Studied hub contamination only; unable to collect catheter tips
Did not study central-line associated bloodstream infection itself"|4|||f||||f||||||||Yes|Rush University Medical Center adheres to the NIH Grant Policy on Sharing of Unique Research Resources including the Sharing of Biomedical Research Resources Principles and Guidelines for Recipients of NIH Grants and Contracts. Our response to requests for research resources from academic and other non-profit investigators will be timely and will be based on the Simple Letter Agreement for the Transfer of Materials as described in the Guidelines for Disseminating Research Resources Arising Out of NIH-Funded Research (Federal Register, Vol. 64, No 246, p.72094), and will not be more restrictive than the Uniform Biological Materials Transfer Agreement (UBMTA). Any intellectual property resulting from this study that can be patented will remain easily and widely available to the researchers in accordance with the NIH Principles and Guidelines. Distribution of resources to for-profit entities may occur under material transfer agreements or non-exclusive license arrangements.|2017-10-11 03:08:34.764185|2017-10-11 03:08:34.764185
NCT01563393|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-04-10|||May 2012||2012-05-01|April 2016|2016-04-01||||November 2016|Anticipated|2016-11-01||Interventional|STAMP||Validation of a STAMP in Hospitalized Children and the Effect of Its Use on the Awareness of the Medical Staff|Validation of a Nutritional Risk Screening Tool- STAMP in Hospitalized Children and the Effect of Its Use on the Awareness of the Medical Staff|Recruiting||N/A|464|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 03:08:35.83568|2017-10-11 03:08:35.83568
NCT01563380|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-26|||January 2010||2010-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|PRPTKA2012||Role of Autologous Platelet Rich Plasma in Total Knee Arthroplasty|Efficacy of Autologous Platelet Rich Plasma on Blood Loss, Pain, Wound Healing and Functional Outcome After Total Knee Arthroplasty by a Single Surgeon A Randomized, Prospective, Controlled, Double-blinded Study|Completed||N/A|40|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 03:08:35.972914|2017-10-11 03:08:35.972914
NCT01563367|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-04-28|||January 2012||2012-01-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|CABG-01||A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof|A Randomized, Prospective, Double-Blind, Comparative Placebo-Controlled Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute CABG, Valve Replacement or a Combination Thereof|Completed||Phase 3|74|Actual|Pharmacosmos A/S||2|||f||||t||||||||||2017-10-11 03:08:36.074655|2017-10-11 03:08:36.074655
NCT01563354|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-08-22|||August 16, 2013|Actual|2013-08-16|August 2017|2017-08-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|LUNA||3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial|Multicenter 3-arm Trial to Evaluate the Efficacy and Safety of Pasireotide LAR or Everolimus Alone or in Combination in Patients With Well Differentiated Neuroendocrine Carcinoma of the Lung and Thymus - LUNA Trial|Active, not recruiting||Phase 2|124|Actual|Novartis||3|||f||||t||||||||||2017-10-11 03:08:36.175204|2017-10-11 03:08:36.175204
NCT01563341|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-04-24|||April 2012||2012-04-01|April 2013|2013-04-01|January 2015|Anticipated|2015-01-01|December 2013|Anticipated|2013-12-01||Interventional|||Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation|Tandem DBS for Parkinson&Apos;s Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation|Unknown status|Enrolling by invitation|Phase 2|6|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-10-11 03:08:36.360473|2017-10-11 03:08:36.360473
NCT01563328|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-03-27|||March 1, 2012||2012-03-01|March 2017|2017-03-01|May 1, 2012|Actual|2012-05-01|May 1, 2012|Actual|2012-05-01||Interventional|||A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).|A Phase I, Open Label, Randomized, Two Cohort, Two Period, Oneway Study to Evaluate the Effect of Boceprevir and Telaprevir onDolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697)|Completed||Phase 1|32|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 03:08:36.428835|2017-10-11 03:08:36.428835
NCT01563315|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-23|||January 2008||2008-01-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|||Community-acquired Pneumonia in Buskerud County in Norway|Community-acquired Pneumonia: A Prospective Observational Study to Explore Etiology, Risk Factors and Potential Predictors for re- Admittance to Hospital and All-cause Mortality|Completed||N/A|270|Actual|Vestre Viken Hospital Trust|||1||f||||t||||||Samples With DNA|"     whole blood, serum, plasma, blood culture, airways specimens, urine   "|||2017-10-11 03:08:36.537893|2017-10-11 03:08:36.537893
NCT01563302|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-12-31|||February 2012||2012-02-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers|A Phase 1/2 Study of ISIS 481464, an Antisense Oligonucleotide Inhibitor of STAT3, Administered to Patients With Advanced Cancers|Active, not recruiting||Phase 1/Phase 2|80|Anticipated|Ionis Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:08:36.637774|2017-10-11 03:08:36.637774
NCT01563289|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2013-05-07|||February 2012||2012-02-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries|A Randomised, Multicentre, Two-arm, Parallel Group, Double-blind, Placebo-controlled, Comparative Efficacy and Safety Clinical Study of Ibuprofen in Patients With Pain Related to Uncomplicated Ankle Injuries|Completed||Phase 3|62|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-11 03:08:36.734163|2017-10-11 03:08:36.734163
NCT01563276|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-23|||December 2011||2011-12-01|March 2012|2012-03-01||||||||Observational|||Postural Instability in Progressive Supranuclear Palsy|Postural Instability in Progressive Supranuclear Palsy: Why do Patients With PSP Fall?|Unknown status|Recruiting|N/A|40|Anticipated|Oregon Health and Science University|||3||f||||||||||||||2017-10-11 03:08:36.809984|2017-10-11 03:08:36.809984
NCT01563263|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-03-29|||March 2012||2012-03-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43|A Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43 Recombinant Pseudomonas Vaccine Intensive Care Patients|Completed||Phase 2/Phase 3|803|Actual|Valneva Austria GmbH||2|||f||||t||||||||||2017-10-11 03:08:36.910654|2017-10-11 03:08:36.910654
NCT01563250|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-04-03|||June 2011||2011-06-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|RACE||Improving the Management of Acute Coronary Syndromes in the Emergency Department|Improving the Management of Acute Coronary Syndromes in the Emergency Department Using a Rapid Acute Cardiac Evaluation Pathway|Completed||Phase 4|705|Actual|Integrated Medical Research LLC||2|||f||||f||||||||||2017-10-11 03:08:37.275723|2017-10-11 03:08:37.275723
NCT01563237|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-01-10|||June 2011||2011-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant|Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) to Relieve Glaucoma Symptoms|Completed||Phase 2|72|Actual|InnFocus Inc.||1|||f||||f||||||||||2017-10-11 03:08:37.356384|2017-10-11 03:08:37.356384
NCT01563224|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-06-03|||July 2013||2013-07-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||GABA-B Receptor Function in Healthy Volunteers|GABA-B Receptor Function in Healthy Volunteers: a Pilot, Double Blind Crossover Study of the Effects of 2 Doses of Baclofen and Placebo on Objective and Subjective Measurements of Brain Function|Completed||N/A|8|Actual|Imperial College London||1|||f||||f||||||||||2017-10-11 03:08:37.419162|2017-10-11 03:08:37.419162
NCT01563211|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2015-03-25|||February 2012||2012-02-01|March 2012|2012-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Predictive Model of Therapy Outcomes in Breast Cancer Patients|Predictive Modelling of Short Term Outcomes Following Systemic Neo-adjuvant and Adjuvant Therapy in Breast Cancer Patients|Completed||N/A|70|Actual|Imperial College London|||2||f||||f||||||Samples With DNA|"     plasma/serum urine buffy coat - for purposes of DNA extraction   "|||2017-10-11 03:08:37.492405|2017-10-11 03:08:37.492405
NCT01562860|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-04-14|||July 2010||2010-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Influence of Pronator Teres Release on Treatment of Median Nerve Compression Neuropathy|The Influence of Pronator Teres Release in the Treatment of Median Nerve Compression Neuropathy: A Randomized Prospective Study|Recruiting||Phase 2|100|Anticipated|Christine M. Kleinert Institute for Hand and Microsurgery||2|||f||||f||||||||||2017-10-11 03:08:48.421787|2017-10-11 03:08:48.421787
NCT01563198|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-04-12|2017-04-12||August 2011||2011-08-01|April 2017|2017-04-01|February 17, 2016|Actual|2016-02-17|July 2015|Actual|2015-07-01||Interventional||We obtained cumulative data from patients completion rates, thus no individual patient data on age, gender, ethnicity are available. MR departments per se do not have personal characteristics.|Reduction of Claustrophobia and Patient Motion After Training of MRI Personnel in Comfort TalkTM|Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging|Completed||N/A|97712|Actual|Hypnalgesics, LLC||1|||f||||f||||||||No||2017-10-11 03:08:37.578211|2017-10-11 03:08:37.578211
NCT01563185|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-11-19|2015-07-17||April 2012||2012-04-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis|A Multicenter, Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis|Completed||Phase 4|12|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||1|||f||||f||||||||||2017-10-11 03:08:37.819273|2017-10-11 03:08:37.819273
NCT01563172|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-08-15|2017-04-27||January 1, 2009|Actual|2009-01-01|July 2017|2017-07-01|June 1, 2009|Actual|2009-06-01|June 1, 2009|Actual|2009-06-01||Interventional||Safety population: The overall Safety Population included all the participants who were randomized and used at least one of the treatment dentifrices during the study and had at least one safety assessment (e.g. assessment of adverse events [AEs] or had an oral soft tissue examination) after using the treatment dentifrices.|Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride|A Study to Measure the Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride Using an In Situ Caries Model|Completed||Phase 4|65|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-10-11 03:08:38.270523|2017-10-11 03:08:38.270523
NCT01563159|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-09-01|||March 31, 2015|Actual|2015-03-31|September 2017|2017-09-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|||Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011|Assessing the Rotavirus Positive Test Results in 11 Hospitals in Belgium From 2005 to 2013: the RotaBIS Study (Rotavirus Belgian Impact Study)|Active, not recruiting||N/A|1|Anticipated|GlaxoSmithKline|||1||f|||||f|f||||||||2017-10-11 03:08:40.73999|2017-10-11 03:08:40.73999
NCT01563146|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-12-27|||February 2016||2016-02-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007|Assessing the Number of Rotavirus Related Hospitalizations in 11 Hospitals in Belgium - Season 2006-2007|Active, not recruiting||N/A|1|Anticipated|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:08:40.830428|2017-10-11 03:08:40.830428
NCT01563133|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-08-28|||June 2012||2012-06-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2, 2016|Actual|2016-03-02||Interventional|CONTACT||Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas|Clinical Evaluation Of NCLE in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas|Active, not recruiting||N/A|330|Actual|Mauna Kea Technologies||1|||f||||f||||||||||2017-10-11 03:08:40.899137|2017-10-11 03:08:40.899137
NCT01563120|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2016-10-30|||January 2012||2012-01-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus||Completed||Phase 4|108|Actual|HaEmek Medical Center, Israel||2|||f||||||||||||||2017-10-11 03:08:41.020341|2017-10-11 03:08:41.020341
NCT01563107|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-08-09|||March 2012||2012-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome|Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome|Active, not recruiting||N/A|40|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 03:08:41.089496|2017-10-11 03:08:41.089496
NCT01563094|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-10-24|||January 2003||2003-01-01|October 2016|2016-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Bone Accrual and Hormones in Response to Lactation|Bone Accrual and Hormones in Response to Lactation|Completed||N/A|141|Actual|University of Virginia|||1||f||||f||||||Samples Without DNA|"     Blood samples.   "|Yes|Deidentified IPD may be available by direct request of Principal Investigator.|2017-10-11 03:08:41.198923|2017-10-11 03:08:41.198923
NCT01563081|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-01-16|2013-03-07||April 2012||2012-04-01|January 2017|2017-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics|A Multi-Center, Open-labelled Study to Evaluate the Safety of Levocetirizine Hydrochloride Oral Solution in Children Aged 6 Months to 2 Years With Allergic Rhinitis or Pruritus Associated With the Skin Diseases.|Completed||Phase 3|60|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:08:41.277428|2017-10-11 03:08:41.277428
NCT01563068|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-05-15|||April 2012||2012-04-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis|A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005%, Applied Under Maximal-Use Conditions in Adolescent Subjects (Ages 12 to 16 Years) With Plaque Psoriasis|Recruiting||Phase 1|30|Anticipated|Mayne Pharma International Pty Ltd||1|||f||||f|t|||||||||2017-10-11 03:08:41.908214|2017-10-11 03:08:41.908214
NCT01563055|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-07-16|2015-05-28||April 2012||2012-04-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia|A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|10|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:08:42.10273|2017-10-11 03:08:42.10273
NCT01563042|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-06-19|||February 13, 2012|Actual|2012-02-13|June 2017|2017-06-01|May 23, 2012|Actual|2012-05-23|May 23, 2012|Actual|2012-05-23||Interventional|||A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers|An Exploratory First Time in Human (FTIH) Study Investigating the Pharmacokinetics (PK), Immunogenicity, Safety and Tolerability of GSK2434735 Administered as a Single Low Dose in Healthy Male Subjects|Completed||Phase 1|5|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:08:44.63304|2017-10-11 03:08:44.63304
NCT01563029|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-04-25|2015-04-09||March 28, 2012|Actual|2012-03-28|April 2017|2017-04-01|September 24, 2014|Actual|2014-09-24|September 24, 2014|Actual|2014-09-24||Interventional|||A Dose-ranging Study of Fluticasone Furoate (FF)|A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma|Completed||Phase 2|597|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:08:44.788006|2017-10-11 03:08:44.788006
NCT01563016|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-23|||April 2012||2012-04-01|March 2012|2012-03-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia|Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia: A Randomized Controlled Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|The University of Hong Kong||4|||f||||f||||||||||2017-10-11 03:08:46.277331|2017-10-11 03:08:46.277331
NCT01563003|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-04-15|2015-04-01||June 2011||2011-06-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism|Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism|Completed||N/A|31|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 03:08:46.375367|2017-10-11 03:08:46.375367
NCT01562990|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-05-20|||December 2012||2012-12-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|August 2014|Actual|2014-08-01||Interventional|||Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse|A Multi-center, Phase IB/II, Open Label, Single Arm Study of Inotuzumab Ozogamicin Plus Rituximab (R-CMC544) Alternating With Gemcitabine-oxaliplatin Plus Rituximab(R-GEMOX)in Patients Aged From 18 to 80 Years With CD20 and CD22 Positive Diffuse Large B-cell Lymphoma (DLBCL) in Relapse After/Refractory to 1ST or 2ND Line Treatment, Who Are no Candidates for Autologous Transplant.|Completed||Phase 1/Phase 2|11|Actual|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-11 03:08:46.714269|2017-10-11 03:08:46.714269
NCT01562977|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2013-08-22|||April 2011||2011-04-01|August 2013|2013-08-01|April 2017|Anticipated|2017-04-01|April 2015|Anticipated|2015-04-01||Interventional|RGemOx||Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL|Prospective, Open-label, Multicentric, ph. II Study of R-GemOx and Dexametasone in Patients With Agressive Lymphomas Refractory or Relapsed to Previous Treatment and Non Eligible for High-dose Chemotherapy Followed by Autologous Stem Cell Transplanted|Unknown status|Recruiting|Phase 2|129|Anticipated|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||||||||||||2017-10-11 03:08:46.823445|2017-10-11 03:08:46.823445
NCT01562964|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-09-08||||||August 2015|2015-08-01||||||||Interventional|||Hypnotherapy in Patients With Chest Pain & Unobstructed Coronaries|The Impact of Hypnotherapy on Symptoms, Psychological Morbidity and Quality of Life in Postmenopausal Women With Chest Pain and Unobstructed Coronary Arteries|Withdrawn||N/A|0|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 03:08:47.068485|2017-10-11 03:08:47.068485
NCT01562951|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-05-03|||October 2012||2012-10-01|May 2016|2016-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ADACAL||Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants|cAlprotectin and hsCRP as Markers of a New Diagnostic-therapeutic strAtegy That Assesses muCosal Activity to individuaLize Treatment and Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants|Terminated||Phase 3|15|Actual|Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa||2||Not enough patient population according to selection criteria to complete the study|f||||f||||||||No||2017-10-11 03:08:47.168469|2017-10-11 03:08:47.168469
NCT01562938|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-10-04|||March 2012||2012-03-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|CD-1092||MEDI-557 Adult Dosing|A Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of MEDI-557, a Humanized Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus (RSV), Administered to Healthy Adults|Completed||Phase 1|42|Actual|MedImmune LLC||3|||f||||f||||||||||2017-10-11 03:08:47.321702|2017-10-11 03:08:47.321702
NCT01562925|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2013-07-04|||March 2012||2012-03-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|RenPro-II-WINE||Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury|Randomized Controlled Study for Evaluation of the Impact of Red Wine, White Wine and Beer Intake on Contrast-Medium Induced Acute Kidney Injury|Completed||Phase 3|260|Actual|University of Cologne||4|||f||||t||||||||||2017-10-11 03:08:47.407917|2017-10-11 03:08:47.407917
NCT01562912|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-09-14|||February 2012||2012-02-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|CAPCOST||Efficiency Study Evaluating the Use of PVAC Catheter Technology for Performing Ablation in Pts With Atrial Fibrillation|The Prospective, Multicenter Canadian Atrial Fibrillation PVAC Cohort Study|Active, not recruiting||N/A|230|Actual|Newmarket Electrophysiology Research Group Inc||2|||f||||f||||||||||2017-10-11 03:08:47.494258|2017-10-11 03:08:47.494258
NCT01562899|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-02-14||2017-02-14|August 2012||2012-08-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors|A Phase Ib/II Open-label, Multi-center Study of the Combination of MEK162 Plus AMG 479 (Ganitumab) in Adult Patients With Selected Advanced Solid Tumors|Terminated||Phase 2|77|Actual|Array BioPharma||4||Study was withdrawn due to scientific and business considerations.|f||||||||||||||2017-10-11 03:08:47.605412|2017-10-11 03:08:47.605412
NCT01562886|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-05-19|2014-05-19||March 2012||2012-03-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||The Rilpivirine Cerebrospinal-fluid (CSF) Study|A Phase I Pharmacokinetic Study to Assess the Cerebrospinal-fluid (CSF) Exposure of Rilpivirine in HIV-infected Subjects Switching From TDF/FTC/Nevirapine to TDF/FTC/Rilpivirine|Completed||Phase 1|14|Actual|Imperial College London||1|||f||||f||||||||||2017-10-11 03:08:47.760253|2017-10-11 03:08:47.760253
NCT01562873|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-01-03|2016-10-05||June 2012||2012-06-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional||The analysis dataset is comprised of all treated patients.|Ruxolitinib in Patients With Breast Cancer|Phase II Study of Ruxolitinib (INCB018424) in Patients With PSTAT3+ Breast Cancer|Terminated||Phase 2|21|Actual|Dana-Farber Cancer Institute||2||Not enough responses to continue treatment.|f||||t||||||||No||2017-10-11 03:08:47.994718|2017-10-11 03:08:47.994718
NCT01561612|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-10-09|||June 1996||1996-06-01|October 2013|2013-10-01||||December 1998|Actual|1998-12-01||Interventional|PROBIT||Promotion of Breastfeeding Intervention Trial|Breastfeeding Promotion RCT and Child Metabolic Syndrome|Completed||N/A|17046|Actual|Harvard Pilgrim Health Care||2|||f||||f||||||||||2017-10-11 03:09:14.544203|2017-10-11 03:09:14.544203
NCT01562847|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-01-10|||July 2011||2011-07-01|January 2014|2014-01-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Observational|AMICAN||Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib|Dynamics of ABL Mutations in Imatinib Failed Ph Positive or Bcr-Abl Positive CML CP or AP Patients Who Treated With Nilotinib as Second-line TKI Therapy (AMICAN-Prospective)in Asia|Unknown status|Active, not recruiting|Phase 2|125|Anticipated|Seoul St. Mary's Hospital|||1||f||||t||||||Samples Without DNA|"     RNA analysis for mutation and Bcr-Abl gene quantification using mainly peripheral blood   "|||2017-10-11 03:08:48.55261|2017-10-11 03:08:48.55261
NCT01562834|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-02-23|||October 21, 1998|Actual|1998-10-21|February 2017|2017-02-01|December 1, 2002|Actual|2002-12-01|December 1, 2002|Actual|2002-12-01||Interventional|||Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients|Randomized Cross Over Double Blind Versus Placebo Trial Followed by an Open Phase Studying Effect of Norditropin® on Left Ventricular Mass of Growth Hormone Deficient Adult Patients|Completed||Phase 4|22|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:08:48.658442|2017-10-11 03:08:48.658442
NCT01562821|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-01-12|||July 2001||2001-07-01|January 2017|2017-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy|A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial Evaluating the Safety and Efficacy of A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial Evaluating the Safety and Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in Cirrhotic Patients Scheduled to Undergo Partial Hepatectomy Due to Liver Cancer or Benign Tumours|Completed||Phase 2|235|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:08:48.815673|2017-10-11 03:08:48.815673
NCT01562808|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-23|||January 2009||2009-01-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|May 2010|Actual|2010-05-01||Interventional|||Change in Brain Metabolism and Cognitive Function by Aripiprazole|The Relationship Between D2 Occupancy and Change in Frontal Metabolism and Working Memory Induced by Aripiprazole|Completed||N/A|15|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 03:08:48.919028|2017-10-11 03:08:48.919028
NCT01562795|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-01-02|||March 2012||2012-03-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease|Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease|Completed||N/A|48|Actual|Wenzhou Medical University||4|||f||||t||||||||||2017-10-11 03:08:48.997227|2017-10-11 03:08:48.997227
NCT01562782|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-07-20|||March 2012||2012-03-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Change of Fructose to Fat in South Asians|Fructose-induced Hepatic De Novo Lipogenesis in South Asians|Active, not recruiting||N/A|36|Anticipated|The Rogosin Institute||1|||f||||f||||||||||2017-10-11 03:08:49.103284|2017-10-11 03:08:49.103284
NCT01562769|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-08-20|||March 2012||2012-03-01|May 2015|2015-05-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Observational|ISOL/STAND||Interest of Contact Precautions for Preventing Micro-organisms Acquisition in Patients Hospitalized in Infectious Disease Unit of University-affiliated Hospital in Rennes|Interest of Contact Precautions for Preventing Micro-organisms Acquisition in Patients Hospitalized in Infectious Disease Unit of University-affiliated Hospital in Rennes|Terminated||N/A|400|Actual|Rennes University Hospital|||2|enrollment difficulties|f||||||||||||||2017-10-11 03:08:49.214939|2017-10-11 03:08:49.214939
NCT01562756|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-05-05|2017-03-21||February 2012||2012-02-01|May 2017|2017-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PRiSM||Patient Response to Spinal Manipulation - Pilot Study|Pilot for Patient Response to Spinal Manipulation (PRiSM)|Completed||N/A|6|Actual|Palmer College of Chiropractic||1|||f||||f||||||||No|Feasibility/pilot study|2017-10-11 03:08:49.289631|2017-10-11 03:08:49.289631
NCT01562743|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-03-26|2014-02-03||August 2008||2008-08-01|March 2014|2014-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|RLS||A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome|An Open-label Long-term Extension Trial From Late Phase II of SPM 962 (243-07-003) in Patients With Restless Legs Syndrome|Completed||Phase 2|185|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 03:08:49.519573|2017-10-11 03:08:49.519573
NCT01562730|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-04-30|||April 2012||2012-04-01|April 2012|2012-04-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Observational|||Myovista iECG for Detecting Ischemic Heart Disease: Comparison With Computed Tomography Coronary Angiography|Incremental Value of Signal Processed Surface Electrocardiography (IECG) for Detecting Ischemic Heart Disease: Comparison With Computed Tomography Coronary Angiography (CTCA)|Unknown status|Recruiting|Phase 2|1000|Anticipated|Cardiocentro Ticino|||2||f||||f||||||||||2017-10-11 03:08:49.903104|2017-10-11 03:08:49.903104
NCT01562717|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2013-05-07|||February 2012||2012-02-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries|A Randomised, Multicentre, Two-arm, Parallel Group, Double-blind, Placebo-controlled, Comparative Efficacy and Safety Clinical Study of Ibuprofen in Patients With Pain Related to Uncomplicated Ankle Injuries|Completed||Phase 3|62|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-11 03:08:49.997401|2017-10-11 03:08:49.997401
NCT01562704|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2013-01-11|||January 2012||2012-01-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|IRMf||Visualisation of the Central Analgesic Effect of Paracetamol in Functional MRI|Visualisation of the Central Analgesic Effect of Paracetamol in Functional MRI|Completed||Phase 1|21|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 03:08:50.104078|2017-10-11 03:08:50.104078
NCT01562691|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-23|||June 2009||2009-06-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Effect of Airway Integrated Nasal Packing With Different Material|Comparison of Nasal Packing Methods:Nasal Packing Was Done With Nasopore@, Airway-integrated Nasopore@ and Airway-integrated Vaseline Gauze|Completed||Phase 4|60|Actual|Chi Mei Medical Hospital||3|||f||||t||||||||||2017-10-11 03:08:50.185778|2017-10-11 03:08:50.185778
NCT01562678|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-04-26|2015-12-22||March 2012||2012-03-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI|Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI|Completed||Phase 4|28|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-11 03:08:50.29808|2017-10-11 03:08:50.29808
NCT01562665|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-05-23|||June 2012||2012-06-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|Lung-EPICLIN/G||Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf|Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA|Completed||N/A|25|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 03:08:50.579316|2017-10-11 03:08:50.579316
NCT01562652|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-23||||||March 2012|2012-03-01||||||||Interventional|||AposTherapy for Singaporean Patients With Knee Osteoarthritis (OA)||Completed||N/A|60|Actual|Apos Medical and Sports Technology Ltd.||1|||f||||||||||||||2017-10-11 03:08:50.660193|2017-10-11 03:08:50.660193
NCT01562639|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-10-30|||April 2012||2012-04-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Nexium Capsules RE Maintenance Specific Clinical Experience Investigation|Nexium Capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis|Completed||N/A|647|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 03:08:50.738266|2017-10-11 03:08:50.738266
NCT01562626|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-02-16|||September 2012||2012-09-01|February 2017|2017-02-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors|A Phase I/II Safety, Pharmacokinetic, and Pharmacodynamic Study of APS001F With Flucytosine and Maltose for the Treatment of Advanced and/or Metastatic Solid Tumors|Recruiting||Phase 1/Phase 2|75|Anticipated|Anaeropharma Science, Inc.||1|||f||||||||||||||2017-10-11 03:08:50.889472|2017-10-11 03:08:50.889472
NCT01562613|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-08-08|2014-03-27||March 2012||2012-03-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With Eprosartan|Stroke Estimation (According to Framingham Profile ParameterS) in Patients Under medicAtion Due to Essential Hypertension. (NASA)|Completed||N/A|533|Actual|Abbott|No important limitations apply. Missing data and drop-out rate was very low; but some factors required for patient CV (cardiovascular) risk classification were unknown and may have resulted in CV risk underestimation in a limited number of patients.||1||f||||f||||||||||2017-10-11 03:08:50.999018|2017-10-11 03:08:50.999018
NCT01562600|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-06-20|||April 19, 2012|Actual|2012-04-19|June 2017|2017-06-01|August 27, 2015|Actual|2015-08-27|August 27, 2015|Actual|2015-08-27||Observational|||Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation|Nexium Capsules Specific Clinical Experience Investigation for Long-term Use Concerning Prevention of Recurrence of Gastric Ulcer or Duodenal Ulcer With NSAIDs|Completed||N/A|1634|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 03:08:51.494457|2017-10-11 03:08:51.494457
NCT01562587|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-01-11|||September 2002||2002-09-01|January 2017|2017-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State|Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non-Bleeding State|Completed||Phase 1|18|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:08:51.668534|2017-10-11 03:08:51.668534
NCT01562574|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-01-11|||January 2002||2002-01-01|January 2017|2017-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease|A Randomised, Double-blind, Parallel Group, Placebo-controlled Comparison of Recombi-nant Factor VIIa (rFVIIa/ NovoSeven®) With Standard Haemostatic Replacement Therapy, and Standard Haemostatic Replacement Ther-apy Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease|Completed||Phase 3|82|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:08:51.782344|2017-10-11 03:08:51.782344
NCT01562561|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-02-17|||June 1, 2001|Actual|2001-06-01|February 2017|2017-02-01|December 20, 2002|Actual|2002-12-20|December 20, 2002|Actual|2002-12-20||Interventional|||Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes|Multi-centre, Multinational, Open-labelled, Randomised, Parallel, Controlled Trial in Type 2 Diabetic Subjects Inadequately Controlled on Repaglinide, to Compare the Efficacy and Safety of Repaglinide Combined With Bedtime NPH Insulin Versus Twice Daily NPH Insulin|Completed||Phase 3|213|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:08:51.865259|2017-10-11 03:08:51.865259
NCT01562548|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2014-05-01|2014-03-06||February 2012||2012-02-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Exploratory Efficacy Study of Guaifenesin in Upper Back Pain|A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain|Completed||N/A|78|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:08:52.008806|2017-10-11 03:08:52.008806
NCT01562535|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-23|||June 2012||2012-06-01|March 2012|2012-03-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Interventional|||A Clinical Trial of Pronation Versus Supination Maneuvers for the Reduction of the Pulled Elbow|A Randomized Clinical Trial of Pronation Versus Supination Maneuvers for the Reduction of the Pulled Elbow|Unknown status|Not yet recruiting|N/A|90|Anticipated|Instituto Tecnologico y de Estudios Superiores de Monterey||2|||f||||t||||||||||2017-10-11 03:08:53.207921|2017-10-11 03:08:53.207921
NCT01562522|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-03-22|||March 2012||2012-03-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|EXPEDIENT||Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.|Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.|Terminated||Phase 2|6|Actual|Ipsen||2||Poor enrolment; only 6 subjects enrolled and they were all screen failures.|f||||f||||||||||2017-10-11 03:08:53.30551|2017-10-11 03:08:53.30551
NCT01562509|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-11-12|||October 2012||2012-10-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||PEARL Study: Improvement of Non-Hodgkin's Lymphoma Care|Improvement of Hospital Care for Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|N/A|418|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 03:08:53.395275|2017-10-11 03:08:53.395275
NCT01562496|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-11-12|||January 2012||2012-01-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The ParkCycle Study: Aerobic Exercise in PD|The ParkCycle Study: Effects of Aerobic Exercise on Cognitive and Adaptive Plasticity in Parkinson's Disease|Completed||N/A|35|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 03:08:53.505495|2017-10-11 03:08:53.505495
NCT01562483|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2014-10-27|||October 2012||2012-10-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain|The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain; a Randomized, Double Blinded, Placebo-controlled, Experiment|Completed||Phase 2|36|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 03:08:53.606572|2017-10-11 03:08:53.606572
NCT01562470|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-03-23|||June 2011||2011-06-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Clinical Trial to Assess the Efficacy and Safety of a Novel Cellulite Cream|Clinical Trial to Assess the Efficacy and Safety of a Novel Cellulite Cream in Reducing the Appearance of Cellulite in Human Subjects|Completed||Phase 1|23|Actual|Nutrasource Diagnostics Inc.||1|||f||||f||||||||||2017-10-11 03:08:53.71289|2017-10-11 03:08:53.71289
NCT01562457|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-05-11|||November 2005||2005-11-01|May 2016|2016-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State|A Randomised, Open-label, Multi-centre Trial Investigating the Intra-subject Variability of ROTEM® and TEG® Parameters Following Two Intravenous Administrations of the Same Dose of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in Haemophilia Patients in a Non-bleeding State|Completed||Phase 1|30|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:08:53.8076|2017-10-11 03:08:53.8076
NCT01562431|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-01-23|||October 2011||2011-10-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics|The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics|Completed||N/A|246|Actual|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-11 03:08:54.008562|2017-10-11 03:08:54.008562
NCT01562418|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2012-03-22|||September 2009||2009-09-01|March 2012|2012-03-01|February 2013|Anticipated|2013-02-01|March 2012|Anticipated|2012-03-01||Interventional|||Multi Dimensional System for Evaluating a Preventive Program for Upper Extremity Disorders Among Computer Operators|Multi Dimensional System for Evaluating a Preventive Program for Upper Extremity Disorders Among Computer Operators|Unknown status|Recruiting|N/A|108|Anticipated|Medical Corps, Israel Defense Force||3|||f||||f||||||||||2017-10-11 03:08:54.095506|2017-10-11 03:08:54.095506
NCT01562405|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2017-05-23|||May 2012||2012-05-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma|Phase 1, Multicenter, Open-label, Dose-escalation Study of Sotatercept (ACE-011) in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma|Recruiting||Phase 1|34|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:08:54.236743|2017-10-11 03:08:54.236743
NCT01562392|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-02-26|||September 2011||2011-09-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Berries and Vegetables on Cardiometabolic Risk Markers and Cognitive Functions|Effects of 5 w Daily Intake of Berries and Vegetables on Cardiometabolic Risk Markers and Cognitive Functions|Completed||N/A|40|Anticipated|Lund University||2|||f||||||||||||||2017-10-11 03:08:54.424078|2017-10-11 03:08:54.424078
NCT01562379|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-04-23|||September 2012||2012-09-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Complementary Food Supplements for Reducing Childhood Undernutrition|Evaluation of Complementary Food Supplements For Reducing Childhood Undernutrition: The JiVitA-4 Study|Completed||Phase 2/Phase 3|5449|Actual|Johns Hopkins Bloomberg School of Public Health||5|||f||||t||||||||||2017-10-11 03:08:54.550004|2017-10-11 03:08:54.550004
NCT01562366|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-05-23|||April 2012||2012-04-01|May 2017|2017-05-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Research Study to Compare the Addition of Topaz Micro Debridement to the Standard of Care Surgery|A Randomised, Controlled, Double-blind Clinical Investigation on the Efficacy and Safety of Radiofrequency Micro Debridement, Topaz, in Recalcitrant Greater Trochanteric Pain Syndrome (GTPS) vs. Standard of Care|Completed||N/A|66|Actual|Smith & Nephew, Inc.||2|||f||||f||||||||||2017-10-11 03:08:54.655788|2017-10-11 03:08:54.655788
NCT01562353|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2013-09-13|||April 2012||2012-04-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction|A Pilot Study to Determine the Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction in Patients Treated for Pain Using a Comparative Transcriptomic Analysis of Gene Expression in Peripheral Blood Cells|Unknown status|Recruiting|N/A|30|Anticipated|Analgesic Solutions|||2||f||||f||||||Samples With DNA|"     One tube (2.5-5.0 mL) of blood will be drawn from each subject during the visit for mRNA     testing   "|||2017-10-11 03:08:54.767383|2017-10-11 03:08:54.767383
NCT01562340|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-05-26|||March 2012||2012-03-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|POM Pilot||Pomegranate and Hemodialysis Pilot Trial|A Pilot Trial Assessing the Effect of Pomegranate Juice and Extract on Biomarkers of Oxidative Stress, Systemic Inflammation, and Monocyte Function in Hemodialysis Patients|Completed||N/A|24|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 03:08:54.868827|2017-10-11 03:08:54.868827
NCT01562327|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-10-18|2016-06-29||February 2012||2012-02-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis|A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab Actemra|Completed||N/A|50|Actual|Hoffmann-La Roche|||1||f||||t||||||||||2017-10-11 03:08:55.025266|2017-10-11 03:08:55.025266
NCT01557465|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-04-06|||November 2009||2009-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|MAS||Mechanical Alternans Study|Study of Mechanical Alternans for Prediction of Ventricular Tachyarrhythmias|Completed||N/A|134|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 03:10:20.897966|2017-10-11 03:10:20.897966
NCT01562314|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-07-17|2015-06-22||February 2012||2012-02-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|GWID10160||A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)|A Randomised, Double-blind, Placebo-controlled Parallel Group, Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis.|Completed||Phase 2|60|Actual|GW Research Ltd||2|||f||||f||||||||||2017-10-11 03:08:55.910193|2017-10-11 03:08:55.910193
NCT01562301|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-06-05|||June 2014||2014-06-01|June 2015|2015-06-01||||June 2016|Anticipated|2016-06-01||Interventional|||Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)|A Phase I Study of the Combination of Carboplatin, Docetaxel, and Increasing Doses of Sublingual Anvirzel (Nerium Oleander) in Advance Non-Small Cell Lung Cancer|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 03:08:57.92827|2017-10-11 03:08:57.92827
NCT01562288|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-08-07|||February 2012||2012-02-01|August 2017|2017-08-01||||January 2100|Anticipated|2100-01-01||Observational|||Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab|Adjuvant Chemotherapy Combined With Trastuzumab in the Randomized Phase III Trial N9831 Actively Immunizes Patients Against Tumor Antigens|Active, not recruiting||N/A|1576|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Serum and DNA extracted from peripheral blood mononuclear cell samples   "|||2017-10-11 03:08:58.035893|2017-10-11 03:08:58.035893
NCT01562275|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-02-25|2016-02-25||April 2012||2012-04-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||All enrolled participants.|A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors|A Phase Ib, Open-Label, Dose-Escalation Study of the Safety, Tolerability and Pharmacokinetics of GDC-0973 and GDC-0068 in Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|67|Actual|Genentech, Inc.|As per changes in the planned analysis, PFS and duration of response outcome measures were not analyzed as only few participants experienced a measurable response.|3|||f||||||||||||||2017-10-11 03:08:58.281209|2017-10-11 03:08:58.281209
NCT01562262|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-24|||October 2011||2011-10-01|March 2012|2012-03-01|March 2013|Anticipated|2013-03-01|March 2012|Actual|2012-03-01||Observational|||Comparison of RT in Patients With Sleep Apnea With and Without Complaints of Daytime Sleepiness|Behavior of Psychomotor Vigilance Task Performance in Subjects With Obstructive Sleep Apnea With and Without Complaints of Daytime Sleepiness|Unknown status|Recruiting|N/A|30|Anticipated|Federal University of São Paulo|||3||f||||t||||||||||2017-10-11 03:09:07.626073|2017-10-11 03:09:07.626073
NCT01562249|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-21|||March 2009||2009-03-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|February 2010|Actual|2010-02-01||Interventional|||Rehabilitative Management of Mastication|Rehabilitative Management of Mastication After Orthognathic Surgery: A Randomized Controlled Trial|Completed||Phase 2|17|Actual|University of Sao Paulo General Hospital||3|||f||||t||||||||||2017-10-11 03:09:07.696029|2017-10-11 03:09:07.696029
NCT01562236|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-22|||January 2000||2000-01-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|December 2002|Actual|2002-12-01||Observational|||Gender-specific aEEGs and Outcome in Preterms|Gender-related Differences in Early Amplitude-integrated Electroencephalography in Newborns < 30 Weeks' Gestational Age and Their Correlation With Neurodevelopment Outcome at Three Years Corrected Age|Completed||N/A|148|Actual|Medical University of Vienna|||1||f||||t||||||||||2017-10-11 03:09:07.781718|2017-10-11 03:09:07.781718
NCT01562223|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-03-16|||August 2012||2012-08-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|A6701QIBA||Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer|Repeatability Assessment of Quantitative DCE-MRI and DWI: A Multicenter Study of Functional Imaging Standardization in the Prostate|Active, not recruiting||N/A|30|Anticipated|American College of Radiology Imaging Network||1|||f||||t||||||||Yes|"See ACRIN data Sharing Policy:
https://www.acrin.org/RESEARCHERS/POLICIES/DATAANDIMAGESHARINGPOLICY.aspx"|2017-10-11 03:09:07.834215|2017-10-11 03:09:07.834215
NCT01562210|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-12-07|||April 2012||2012-04-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|November 2017|Anticipated|2017-11-01||Interventional|olaparib||Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC|Olaparib Dose Escalating Trial in Patients Treated With Radiotherapy With or Without Daily Dose Cisplatin for Locally Advanced Non-small Cell Lung Carcinoma|Recruiting||Phase 1|60|Anticipated|The Netherlands Cancer Institute||1|||f||||f||||||||||2017-10-11 03:09:07.924104|2017-10-11 03:09:07.924104
NCT01562197|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-05-23|||April 2014||2014-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AxiGII||A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma|A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma|Active, not recruiting||Phase 2|52|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-10-11 03:09:08.024108|2017-10-11 03:09:08.024108
NCT01562184|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-11-30|||June 2012||2012-06-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Investigating tDCS as a Treatment for Unipolar and Bipolar Depression|A Controlled Trial of Transcranial Direct Current Stimulation as a Treatment for Unipolar and Bipolar Depression|Completed||Phase 2/Phase 3|120|Actual|The University of New South Wales||2|||f||||t||||||||||2017-10-11 03:09:08.11447|2017-10-11 03:09:08.11447
NCT01562171|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-12-11|||March 2012||2012-03-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|LEN-0-2012||Lentils as a Functional Food to Improve Glucose and Decrease Cardiovascular Risk|Lentils as a Functional Food to Improve Glucose Tolerance and Decrease Cardiovascular Disease Risk in Hypercholesterolemic Overweight Individuals|Completed||N/A|102|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 03:09:08.237512|2017-10-11 03:09:08.237512
NCT01562158|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2017-01-10|||April 2001||2001-04-01|January 2017|2017-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation|A Multi-centre, Randomised, Double-blind, Parallel Groups, Placebocontrolled Trial on Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in Treatment of Bleeding in Patients Following Stem Cell Transplantation (SCT)|Completed||Phase 2|100|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:09:08.352345|2017-10-11 03:09:08.352345
NCT01562145|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-23|||January 2009||2009-01-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Elevated Plasma Levels of TIMP-1 in Patients With Rotator Cuff Tear|Elevated Plasma Levels of TIMP-1 in Patients With Rotator Cuff Tear|Completed||N/A|34|Actual|University Hospital, Linkoeping|||2||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 03:09:08.719121|2017-10-11 03:09:08.719121
NCT01562132|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-07-31|2015-07-31||September 2013||2013-09-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|SToP-Crypto||Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection|An Open Label Randomized Controlled Phase IIb Trial to Determine the Safety of Oral Fluconazole in Combination With Flucytosine as Compared to Fluconazole Alone|Terminated||Phase 2|6|Actual|Yale University||2||Stopped in accordance with pre-specified stopping rules for poor recruitment.|f||||t||||||||||2017-10-11 03:09:08.803702|2017-10-11 03:09:08.803702
NCT01562119|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2013-04-17|||January 2011||2011-01-01|April 2013|2013-04-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|ADM||Long Term Evaluation of Human Acellular Dermal Matrix Allograft For Coverage of the Wound After Extensive Deep Burn|Long Term Evaluation of Human Acellular Dermal Matrix Allograft For Coverage of the Wound After Extensive Deep Burn|Unknown status|Active, not recruiting|N/A|30|Actual|Tang-Du Hospital|||1||f||||t||||||Samples With DNA|"     The skin with ADM inplant and the nomal skin as control group   "|||2017-10-11 03:09:09.074706|2017-10-11 03:09:09.074706
NCT01562106|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-11-16|||February 2012||2012-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|September 2015|Actual|2015-09-01||Interventional|||Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery|A Prospective Investigation of the Use of Fluorescence Imaging on the da Vinci Surgical System for Ultrastaging of Endometrial Cancer by Sentinel Node Assessment|Completed||N/A|123|Actual|Swedish Medical Center||1|||f||||f||||||||||2017-10-11 03:09:09.140868|2017-10-11 03:09:09.140868
NCT01562093|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-08-30|||January 2012||2012-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion|Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion, a Randomized Controlled Trial|Terminated||N/A|14|Actual|St. Olavs Hospital||2||Investigational drugs no longer available|f||||f||||||||||2017-10-11 03:09:09.250563|2017-10-11 03:09:09.250563
NCT01562080|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2013-02-27|||January 2012||2012-01-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|ARM-PLUS-LDL||Combined Effects of Bioactive Compounds in Lipid Profile|Combined Effects of Bioactive Compounds (ARMOLIPID PLUS ®) on Lipid Profile and Clinical Criteria of Metabolic Syndrome in Patients With Serum Elevated LDL-C|Completed||Phase 2/Phase 3|118|Actual|Rottapharm Spain||2|||f||||f||||||||||2017-10-11 03:09:09.378052|2017-10-11 03:09:09.378052
NCT01562067|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2012-03-22|||March 2012||2012-03-01|March 2011|2011-03-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Observational|||Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy|Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy|Unknown status|Not yet recruiting|N/A|40|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples Without DNA|"     pap smear   "|||2017-10-11 03:09:09.501142|2017-10-11 03:09:09.501142
NCT01562054|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-08-08|||February 2012||2012-02-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|||||Observational|||Evaluation of a Rating Tool for Measuring General Surgeons' Non-technical Performance in the Operating Room|Evaluation of a Rating Tool for Measuring General Surgeons' Non-technical Performance in the Operating Room|Completed||N/A|20|Anticipated|Herlev Hospital|||1||f||||f||||||||||2017-10-11 03:09:09.600662|2017-10-11 03:09:09.600662
NCT01562041|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-04-15|||March 2012||2012-03-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease|Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease|Terminated||Phase 2|11|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:09:09.675911|2017-10-11 03:09:09.675911
NCT01562028|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2016-11-11|||June 2012||2012-06-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|BELIEF||BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)|An Open-label Phase II Trial of Erlotinib and Bevacizumab in Patients With Advanced Non-small Cell Lung Cancer and Activating EGFR Mutations|Active, not recruiting||Phase 2|110|Actual|European Thoracic Oncology Platform||1|||f||||t||||||||||2017-10-11 03:09:10.013754|2017-10-11 03:09:10.013754
NCT01562015|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-05-18|||April 2012||2012-04-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|CHIARA||A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)|A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)|Completed||Phase 2|12|Actual|Synta Pharmaceuticals Corp.||1|||f||||f||||||||||2017-10-11 03:09:10.267553|2017-10-11 03:09:10.267553
NCT01562002|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2015-01-07|||March 2012||2012-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome|Advanced Therapy for Ocular Surface Reconstruction. Allogenic Limbus Epithelial Stem-cell Transplant vs Bone Marrow Mesenchymal Stem-cell Transplant in Limbus Insufficiency Syndrome. Double-masked Randomized Trial|Completed||Phase 1/Phase 2|27|Actual|Instituto Universitario de Oftalmobiología Aplicada||2|||f||||||||||||||2017-10-11 03:09:10.344435|2017-10-11 03:09:10.344435
NCT01561963|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-11-21|||February 2012||2012-02-01|November 2016|2016-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast|A Phase 1, Open-label, Three-period, Fixed-sequence Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects|Completed||Phase 1|21|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 03:09:10.592189|2017-10-11 03:09:10.592189
NCT01561950|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-11-22|||May 2008||2008-05-01|November 2016|2016-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding|Use of Recombinant FVIIa to Mitigate Clopidogrel Anti-platelet Therapy-Mediated Bleeding in a Single Centre, Randomized, Placebo-controlled, Double-blind Clinical Trial|Terminated||Phase 1|91|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:09:10.680575|2017-10-11 03:09:10.680575
NCT01561937|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-11-23|||January 2007||2007-01-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment|Use of Recombinant FVIIa to Mitigate Warfarin Anticoagulation Therapy-Mediated Bleeding in a Single Centre, Randomized, Placebo-controlled, Double-blind Clinical Trial|Completed||Phase 1|127|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:09:10.841752|2017-10-11 03:09:10.841752
NCT01561924|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-11-22|||November 2005||2005-11-01|November 2016|2016-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography|An Exploratory Non-interventional Study of Ex-vivo Spiking Followed by Thromboelastography as a Method for Predicting the Efficacy of Recombinant Activated Human FVII (rFVIIa, NovoSeven®) in Adult Congenital Haemophilia A or B Patients With Inhibitors|Completed||Phase 1|17|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:09:10.928686|2017-10-11 03:09:10.928686
NCT01561911|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-12-01|||July 2007||2007-07-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment|A Phase I Clinical Research Study Evaluating the Safety, Tolerability and Biological Effects of the Chimeric Anti-CD40 Monoclonal Antibody Chi Lob 7/4 Given Intravenously, Weekly for Four Weeks in the Treatment of Patients With Advanced Malignancies Refractory to Conventional Anti-cancer Treatment.|Completed||Phase 1|29|Actual|Cancer Research UK|||||f||||||||||||||2017-10-11 03:09:11.037582|2017-10-11 03:09:11.037582
NCT01561898|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-09-14|2012-08-08||June 2006||2006-06-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Long-Term Study of JNS007ER in Patients With Schizophrenia|A Long-Term Study of JNS007ER in Patients With Schizophrenia|Completed||Phase 3|228|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 03:09:11.158878|2017-10-11 03:09:11.158878
NCT01561885|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2017-04-04|||March 2012||2012-03-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CHAMP-Path||Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways|A Pragmatic Randomized Controlled Trial of Patient-Centered Integrated Clinical Pathways Based Versus Usual Care in an Academic Center: National Guard Health Affairs Western Region Experience|Completed||N/A|341|Actual|King Abdullah International Medical Research Center||2|||f||||t||||||||||2017-10-11 03:09:11.58199|2017-10-11 03:09:11.58199
NCT01561872|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-02-12|||April 2012||2012-04-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Observational|GET-BETTER||Assessment of an Automated Telesurveillance System on Serious Falls Prevention in an Elderly Suffering From Dementia Specialized Care Unit: the URCC|Assessment of an Automated Telesurveillance System on Serious Falls Prevention in an Elderly Suffering From Dementia Specialized Care Unit: the URCC. GET-BETTER Study (Geriatric Environmental Telecare - Behavioral Engineering Technology To Enhance Rehabilitation)|Completed||N/A|350|Actual|University Hospital, Limoges|||2||f||||f||||||||||2017-10-11 03:09:11.707822|2017-10-11 03:09:11.707822
NCT01561859|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-08-18|||June 2012||2012-06-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|BICEPS||Brain Imaging, Cognitive Enhancement and Early Schizophrenia|Brain Imaging, Cognitive Enhancement and Early Schizophrenia|Active, not recruiting||N/A|102|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 03:09:11.775741|2017-10-11 03:09:11.775741
NCT01561846|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-22|2012-03-22|||June 2008||2008-06-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|CASU||Cheese Intake,CLA and Hypercholesterolemia|Randomized, Double Blind, Controlled, Cross Over Clinical Trial on Intake of CLA Enriched Cheese in Hypercholesterolemic Patients|Completed||Phase 1/Phase 2|42|Actual|Azienda Ospedaliera Brotzu||2|||f||||f||||||||||2017-10-11 03:09:11.885126|2017-10-11 03:09:11.885126
NCT01561820|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-03-07|||November 2011||2011-11-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study|Community-based, Buddy-supported Exercise in Patients With MCI: a Pilot Trial|Completed||N/A|15|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 03:09:12.04633|2017-10-11 03:09:12.04633
NCT01561807|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-08-31||2014-01-08|March 2012||2012-03-01|August 2016|2016-08-01||||October 2012|Actual|2012-10-01||Interventional|||A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus|A Phase 2a, Randomized, Double-Blind,Placebo-Controlled Study to Investigate the Effects of VX-787 Administered to Adult Volunteers Experimentally Inoculated With Live Influenza Virus|Completed||Phase 2|140|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||f||||||||||2017-10-11 03:09:12.14118|2017-10-11 03:09:12.14118
NCT01561599|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-02-18|||August 2011||2011-08-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|February 2016|Anticipated|2016-02-01||Interventional|||Study on Delayed Graft Function Using Paired Kidneys|Pilot Study of BB3 to Improve Renal Function in Patients With Signs and Symptoms of Significant Renal Injury After Kidney Transplantation From Donors After Cardiac Death|Active, not recruiting||Phase 2|12|Actual|Angion Biomedica Corp||2|||f||||t||||||||||2017-10-11 03:09:14.708252|2017-10-11 03:09:14.708252
NCT01561794|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2015-04-24|||May 2012||2012-05-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia|A Prospective, Non-randomized, Open-label, Non-controlled, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics/ Pharmacodynamics of BAYQ3939 (400 mg BID and TID) in Hospitalized Patients With Bacterial Pneumonia or Secondary Infection of Chronic Respiratory Disease With Severe Disease or a Poor Response to Other Antimicrobials|Completed||Phase 3|44|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:09:12.225987|2017-10-11 03:09:12.225987
NCT01561781|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-08-26|||March 2012||2012-03-01|August 2016|2016-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|Vandetanib||Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib|A Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of Digoxin in Healthy Subjects When Administered Alone and in Combination With a Single Dose of Vandetanib (CAPRELSA) 300 mg|Completed||Phase 1|14|Actual|Sanofi||1|||f||||||||||||||2017-10-11 03:09:12.334931|2017-10-11 03:09:12.334931
NCT01561768|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2013-07-16||2013-07-16|March 2012||2012-03-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults|A Phase 2 Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Quadrivalent Seasonal Virus-Like Particle (VLP) Influenza Vaccine (Recombinant) in Healthy Young (18-64) Adults|Completed||Phase 2|500|Actual|Novavax||5|||f||||f||||||||||2017-10-11 03:09:12.414594|2017-10-11 03:09:12.414594
NCT01561755|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2016-09-14|||February 2012||2012-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy|A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy|Terminated||Phase 4|17|Actual|Icahn School of Medicine at Mount Sinai||2||Difficulty with enrollment|f||||f||||||||||2017-10-11 03:09:12.50284|2017-10-11 03:09:12.50284
NCT01561742|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-22|||February 2012||2012-02-01|March 2012|2012-03-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Minocycline Augmentation in Schizophrenia|Minocycline Augmentation in Early-Course Schizophrenia|Unknown status|Recruiting|N/A|120|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 03:09:12.586646|2017-10-11 03:09:12.586646
NCT01561729|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-11-03|||January 2012||2012-01-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Nasogastric/Orogastric Tube Placement Verification Study Using RightSpot pH Indicator to Verify Gastric Acidity|Evaluation of RightBio Metrics', RightSpot pH Indicator, for Rapid Bedside Verification of Proper Nasogastric/ Orogastric Tube Placement in Emergency Department & Intensive Care Unit Patients|Unknown status|Recruiting|N/A|30|Anticipated|RightBio Metrics||1|||f||||f||||||||||2017-10-11 03:09:12.836262|2017-10-11 03:09:12.836262
NCT01561716|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-09-16|2012-03-29||September 2009||2009-09-01|September 2015|2015-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||An Evaluation of the Energy Expenditure From Wii Fit Games|Is the Wii Fit / Wii Fit Plus Good Enough? A Comparison of the Energy Expenditure From Interactive Physical Activity Promoting Technology to Walking and Running|Completed||N/A|30|Actual|University of Rochester|The lab staffs that administrated the tests were not blinded to the order of the randomization, nor were they blinded to the results of the test. Thus, our study is subjected to observer and measurement biases.|6|||f||||f||||||||||2017-10-11 03:09:12.928659|2017-10-11 03:09:12.928659
NCT01561703|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-11-22|2015-10-28||March 2012||2012-03-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01||Interventional|||Comparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic Use|Postoperative Healthcare Utilization in Adenotonsillectomy Patients With Postoperative Antibiotic Administration Compared to Patients Without Antibiotic Administration|Completed||N/A|58|Actual|University of Missouri-Columbia||2|||f||||f||||||||||2017-10-11 03:09:13.396767|2017-10-11 03:09:13.396767
NCT01561690|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2013-06-06||2013-06-06|March 2012||2012-03-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of ARRY-502 in Patients With Persistent Asthma||Completed||Phase 2|184|Actual|Array BioPharma||2|||f||||f||||||||||2017-10-11 03:09:13.663121|2017-10-11 03:09:13.663121
NCT01561677|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-21|||September 2011||2011-09-01|March 2012|2012-03-01||||March 2014|Anticipated|2014-03-01||Interventional|||Consequences of Obstructive Sleep Apnea Syndrome (OSAS) on the Outcome and the Survival After Ischemic Subtentorial Stroke. Impact of the Treatment With Continuous Positive Airway Pressure (CPAP)|Consequences of Obstructive Sleep Apnea Syndrome (OSAS) on the Outcome and the Survival After Ischemic Subtentorial Stroke. Impact of the Treatment With Continuous Positive Airway Pressure (CPAP)|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Montpellier||5|||f||||f||||||||||2017-10-11 03:09:13.842288|2017-10-11 03:09:13.842288
NCT01561664|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-09-17|||November 2011||2011-11-01|March 2012|2012-03-01|December 2013|Actual|2013-12-01|November 2011|Actual|2011-11-01||Interventional|||Inflammation Regulation in Obese Patients|Relations Between Obesity and Insulin Resistance: Role of Inflammation Regulatory Mechanisms in Obese Patients Without Associated Comorbidity|Completed||N/A|30|Actual|University Hospital, Montpellier||3|||f||||f||||||||||2017-10-11 03:09:14.046437|2017-10-11 03:09:14.046437
NCT01561651|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-09-08|||July 2012||2012-07-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|LAAOS III||Left Atrial Appendage Occlusion Study III|Left Atrial Appendage Occlusion Study III|Recruiting||N/A|4700|Anticipated|McMaster University||2|||f||||t||||||||||2017-10-11 03:09:14.204959|2017-10-11 03:09:14.204959
NCT01561638|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-03-15|||June 2013||2013-06-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Pulsed Radiofrequency Versus Pulsed Dose for Shoulder Pain|"Pulsed Radiofrequency Versus New Technique Pulsed Dose in Treatment of Chronic Shoulder Pain"|Completed||Phase 1/Phase 2|38|Actual|Mansoura University||3|||f||||t||||||||||2017-10-11 03:09:14.331379|2017-10-11 03:09:14.331379
NCT01561625|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-05-03|||October 2009||2009-10-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|SIM||Signaling Pathway Activation After Exercise in Patients With Chronic Obstructive Pulmonary Disease|Signaling Pathway Activation in the Quadriceps of Patients With COPD After an Acute Bout of Resistance|Completed||N/A|21|Actual|Laval University||1|||f||||t||||||||||2017-10-11 03:09:14.457181|2017-10-11 03:09:14.457181
NCT01561586|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-02-24|||March 2012||2012-03-01|February 2016|2016-02-01|March 2020|Anticipated|2020-03-01|March 2017|Anticipated|2017-03-01||Interventional|TACO||Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer|Randomized Phase III Clinical Trial of Weekly Versus Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer|Recruiting||Phase 3|590|Anticipated|Korea Cancer Center Hospital||2|||f||||t||||||||||2017-10-11 03:09:14.849251|2017-10-11 03:09:14.849251
NCT01561573|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-04-21|||April 2012||2012-04-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Ultrasound Assisted Distal Radius Fracture Reduction|Ultrasound Assisted Distal Radius Fracture Reduction|Unknown status|Recruiting|Phase 1/Phase 2|136|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 03:09:15.311529|2017-10-11 03:09:15.311529
NCT01561560|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2013-11-19|2013-11-19||May 2012||2012-05-01|November 2013|2013-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||All participants enrolled and exposed to Test Article|Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses|Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses|Completed||N/A|123|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:09:15.472533|2017-10-11 03:09:15.472533
NCT01561547|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-09-17|||June 2012||2012-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|March 2016|Actual|2016-03-01||Interventional|TRAKC||Trial of Repeated Analgesia With Kangaroo Care|Maternal Analgesia for Procedural Pain in Preterm Neonates: Does It Remain Efficacious?|Completed||Phase 3|242|Actual|IWK Health Centre||3|||f||||f||||||||No|Aggregate data will be available but no individual data will be provided.|2017-10-11 03:09:15.693096|2017-10-11 03:09:15.693096
NCT01561534|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-21|||February 2012||2012-02-01|March 2012|2012-03-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Observational|||Vascularized Free Fibula Flap and Computer-guided Implant Surgery|Long-term Results of Mandibular/Maxillary Reconstruction With Vascularized Free Fibula Flap and Computer-guided Implant Surgery|Unknown status|Recruiting|N/A|5|Anticipated|University of Bari|||1||f||||t||||||||||2017-10-11 03:09:15.812274|2017-10-11 03:09:15.812274
NCT01561521|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2013-07-16||2013-07-16|March 2012||2012-03-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis||Completed||Phase 3|90|Actual|Akorn, Inc.||3|||f||||f||||||||||2017-10-11 03:09:15.927467|2017-10-11 03:09:15.927467
NCT01561508|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-12-21|||June 2012||2012-06-01|December 2012|2012-12-01||||April 2013|Anticipated|2013-04-01||Interventional|GABA||Effect of GABA Supplementation in the Progression of Type 1 Diabetes in Children|Double Blinded, Placebo Controlled Trial on the Effect of GABA Supplementation in the Progression of Type 1 Diabetes in Children|Withdrawn||Phase 2|0|Actual|University of Alabama at Birmingham||2||Unable to obtain IND currently|f||||f||||||||||2017-10-11 03:09:16.038396|2017-10-11 03:09:16.038396
NCT01561495|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-10-10|||June 2010||2010-06-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Proton Radiotherapy for Extremity Soft Tissue Sarcoma|Proton Radiotherapy for Extremity Soft Tissue Sarcoma|Completed||Phase 2|124|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 03:09:16.175183|2017-10-11 03:09:16.175183
NCT01561482|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-07-20|||January 2012||2012-01-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study of Metformin With Simvastatin for Men With Prostate Carcinoma|Open-Label Study Of Metformin In Combination With Simvastatin For Men With Prostate Carcinoma And A Rising Serum Prostate-Specific Antigen Level After Radical Prostatectomy And/Or Radiation Therapy|Withdrawn||Phase 2|0|Actual|Baylor College of Medicine||1||Study closed due to slow/low enrollment; no subjects were enrolled.|f||||t||||||||||2017-10-11 03:09:16.304894|2017-10-11 03:09:16.304894
NCT01561469|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-06-09|2014-06-09||November 2008||2008-11-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational||Analysis population included all participants who met the eligibility criteria for this study.|Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin|Multicenter, Retrospective, Observational Study to Evaluate Clinical and Economic Outcomes of Patients With MRSA Hospital-Acquired Pneumonia Treated With Linezolid Or Vancomycin|Completed||N/A|188|Actual|Pfizer|Prioritization of endpoints as primary or secondary was not specified in protocol and was based on study team's inputs.||2||f||||f||||||||||2017-10-11 03:09:16.444928|2017-10-11 03:09:16.444928
NCT01561456|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-12-04|||December 2011||2011-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung|Phase II, Randomized, Open-label Study of the IGF-1R Inhibitor AXL1717 Compared to Docetaxel in Patients With Previously Treated, Locally Advanced, or Metastatic Squamous Cell Carcinoma or Adenocarcinoma of the Lung|Completed||Phase 2|100|Actual|Axelar AB||2|||f||||t||||||||||2017-10-11 03:09:16.854763|2017-10-11 03:09:16.854763
NCT01561443|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-01-08|||May 2012||2012-05-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|LINE||LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer|LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer|Completed||N/A|153|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:09:17.022687|2017-10-11 03:09:17.022687
NCT01561430|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-01-07||2014-01-07|March 2012||2012-03-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease|Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease|Terminated||Phase 1/Phase 2|128|Anticipated|Eli Lilly and Company||4||Study terminated due to abnormal liver biochemical tests in some participants.|f||||f||||||||||2017-10-11 03:09:17.154515|2017-10-11 03:09:17.154515
NCT01561417|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-01-18|||April 2006||2006-04-01|January 2017|2017-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects|A Single-centre, Randomised, Double-blind, Two-way Cross-over Trial Investigating the Bio-equivalence in Healthy Male Subjects of NovoSeven (CP-rFVIIa) and a Formulation of NovoSeven Stable at 25°C (VII25)|Completed||Phase 1|28|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:09:17.545131|2017-10-11 03:09:17.545131
NCT01484392|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2016-03-07|||August 2006||2006-08-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Determinants of Compliance With Glaucoma Therapy|Determinants of Compliance With Glaucoma Therapy|Completed||N/A|60|Actual|Legacy Health System|||1||f||||f||||||||||2017-10-11 03:32:10.648594|2017-10-11 03:32:10.648594
NCT01561404|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-04-27|||September 2011||2011-09-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EXETOR||Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise|Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise.|Terminated||Phase 4|3|Actual|Hospital Universitari de Bellvitge||1||lack of potential patients|f||||f||||||||||2017-10-11 03:09:17.643798|2017-10-11 03:09:17.643798
NCT01561391|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-01-11|||April 1998||1998-04-01|January 2017|2017-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery|An Open-Label, Randomized, Parallel, Multicenter Trial Comparing the Safety and Efficacy of rFVIIa When Administered as i.v. Bolus or i.v. Continuous Infusion to Hemophiliacs With Inhibitors During and After Major Surgery|Completed||Phase 4|36|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:09:17.730842|2017-10-11 03:09:17.730842
NCT01561378|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-01-13|||August 2012||2012-08-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CNS-Elders||Cardiac Surgery Neuroprotection Study in Elders|Intranasal Insulin for Neuroprotection in Elderly Cardiac Surgery Patients|Completed||Phase 2|22|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 03:09:17.851746|2017-10-11 03:09:17.851746
NCT01561365|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2012-03-21|||October 2003||2003-10-01|March 2012|2012-03-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Applicability of the Ottawa Ankle Rules|Applicability of the Ottawa Ankle Rules to Exclude Fractures of the Ankle and Midfoot - Comparison to Orthopedic Residents Routine.|Completed||N/A|92|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 03:09:17.958518|2017-10-11 03:09:17.958518
NCT01561352|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2017-01-11|||September 2001||2001-09-01|January 2017|2017-01-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis|An Open Label Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven®) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy|Completed||Phase 2|7|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:09:18.065301|2017-10-11 03:09:18.065301
NCT01561326|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-21|||May 2005||2005-05-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|TC3||Facilitating Follow-Up Adherence for Abnormal Pap Smears|Facilitating Follow-Up Adherence for Abnormal Pap Smears|Completed||N/A|211|Actual|Fox Chase Cancer Center||3|||f||||t||||||||||2017-10-11 03:09:18.158749|2017-10-11 03:09:18.158749
NCT01561313|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-21|2014-01-23|2013-11-08||March 2012||2012-03-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||63 participants received at least one dose of the study drug, and 62 participants were analyzed for injection site-related pain. 63 participants were analyzed for other safety analyses.|Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.|A Multicenter, Randomized, Single-Blind Crossover Study of the Safety and Tolerability of Two Adalimumab Formulations in Adult Subjects With Rheumatoid Arthritis.|Completed||Phase 2|64|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 03:09:18.273435|2017-10-11 03:09:18.273435
NCT01561300|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-02-16|2016-12-21||March 2012||2012-03-01|February 2017|2017-02-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Efficacy of Brooke Bond Black Tea Extract on Flow Mediated Dilation in Indian Males|Efficacy of Standardized Brooke Bond Black Tea Extract on Flow-Mediated Dilation After an Acute Dose as Well as After One Week of Consumption in Healthy Adult Indian Males|Completed||N/A|30|Actual|Unilever R&D||2|||f||||f||||||||No||2017-10-11 03:09:18.767889|2017-10-11 03:09:18.767889
NCT01561287|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-05-10|||July 2011||2011-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction|A Comparison of Dermal Autograft to Commercially Available Dermal Allograft in Breast Reconstruction|Completed||Phase 4|48|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-11 03:09:19.125113|2017-10-11 03:09:19.125113
NCT01561274|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2014-06-20|||March 2012||2012-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|ET-50||ET 50 for Post Caesarean Section Spinal Hypotension|The Time Required to Remain Sitting After Spinal Anesthesia for 50% of Patients to Not Experience Hypotension|Completed||Phase 2|50|Actual|McGill University Health Center||2|||f||||t||||||||||2017-10-11 03:09:19.231991|2017-10-11 03:09:19.231991
NCT01561261|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-04-15|||October 2012||2012-10-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Interventional|PACS||Predicting Acute Compartment Syndrome (PACS)|Predicting Acute Compartment Syndrome (PACS) Using Optimized Clinical Assessment, Continuous Pressure Monitoring, and Continuous Tissue Oximetry|Completed||N/A|194|Actual|Major Extremity Trauma Research Consortium||1|||f||||t||||||||||2017-10-11 03:09:19.376456|2017-10-11 03:09:19.376456
NCT01561248|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-03-21|||May 2011||2011-05-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Interventional|EHEC-PEG||Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis|Repetitive Intestinal Lavage Using Polyethylene Glycol Solution in Patients With EHEC O104:H4 Infection During the German 2011 Outbreak for Prevention of Severe Thrombocytopenia With Subsequently Following Therapeutic Plasmapheresis|Completed||N/A|33|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 03:09:19.507891|2017-10-11 03:09:19.507891
NCT01561235|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-06-20|||February 2008||2008-02-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|Protein||Protein Dose-repsonse Effect on GLP-1, PYY and Appetite in Male Subjects|The Contribution of Gastrointestinal Appetite Hormones to Protein-induced|Completed||N/A|25|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 03:09:19.620419|2017-10-11 03:09:19.620419
NCT01561222|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-06-05|||July 2015||2015-07-01|June 2015|2015-06-01||||March 2016|Anticipated|2016-03-01||Interventional|||Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2||Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Taixing People's Hospital||2|||f||||||||||||||2017-10-11 03:09:19.726065|2017-10-11 03:09:19.726065
NCT01561209|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-08-26|||March 2012||2012-03-01|August 2017|2017-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Low Doses Amitriptyline & Chronic Neck Pain|Prospective Randomized & Controlled Study of the Role of Low Doses Amitriptyline in the Management of Chronic Neck Pain|Completed||Phase 4|212|Actual|St Joseph University, Beirut, Lebanon||2|||f||||f||||||||||2017-10-11 03:09:19.844984|2017-10-11 03:09:19.844984
NCT01561196|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-01-30|||February 2012||2012-02-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Conventional Verses Ultrasound Guided Arteria Cannulation, With and Without Local Anesthesia|Conventional vs. Ultrasound Guided Arteria Cannulation, With and Without Local Anesthesia|Completed||Phase 3|20|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 03:09:19.975074|2017-10-11 03:09:19.975074
NCT01561183|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-04-26|||March 2012||2012-03-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|March 2014|Actual|2014-03-01||Interventional|||Vital Pulp Therapy (VPT) Using Calcium Enriched Mixture (CEM) to Treat Irreversible Pulpitis|Vital Pulp Therapy for Management of Irreversible Pulpitis in Human Permanent Teeth: A Randomized Clinical Trial.|Completed||N/A|302|Actual|Shahid Beheshti University of Medical Sciences||4|||f||||t||||||||||2017-10-11 03:09:20.124995|2017-10-11 03:09:20.124995
NCT01561170|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-04-09|||October 2011||2011-10-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Electromagnetic Field Therapy to Improve Healing of Chronically Venous Ulcer|The Effect of Electromagnetic Field Therapy to Improve Healing of Chronically Venous Ulcer in Lower Extremities|Unknown status|Active, not recruiting|Early Phase 1|36|Anticipated|Northern Orthopaedic Division, Denmark|||1||f||||f||||||||||2017-10-11 03:09:20.227025|2017-10-11 03:09:20.227025
NCT01561157|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-08-24|||November 2010||2010-11-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|September 2019|Anticipated|2019-09-01||Observational|||Longitudinal Study of the Porphyrias|Longitudinal Study of the Porphyrias|Recruiting||N/A|800|Anticipated|Icahn School of Medicine at Mount Sinai|||9||f||||t||||||Samples With DNA|"     whole blood, plasma/serum, red blood cells, white cells, urine, stool, tissue, DNA   "|||2017-10-11 03:09:20.317018|2017-10-11 03:09:20.317018
NCT01561144|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-04-08|||August 2011||2011-08-01|April 2014|2014-04-01||||August 2016|Anticipated|2016-08-01||Observational|UMBRELLA||UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic Implantable Cardiac Defibrillator Implant|UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic ICD Implant|Unknown status|Recruiting|N/A|10000|Anticipated|Medtronic Bakken Research Center|||1||f||||||||||||||2017-10-11 03:09:20.487187|2017-10-11 03:09:20.487187
NCT01561131|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-02-06|||January 2012|Actual|2012-01-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|PROKA||The Effect of Protein and Calcium on Weight Change and Blood Lipid Profile|The Effect of Protein and Calcium on Weight Change and Blood Lipid Profile|Completed||N/A|223|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-11 03:09:20.642648|2017-10-11 03:09:20.642648
NCT01561118|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-10-28|||September 2012||2012-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|DiaSport||DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis|DiaSport - Ausdauerorientiertes Trainingsprogramm Mit Kindern Und Jugendlichen an Der Dialyse (DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis)|Active, not recruiting||N/A|66|Actual|University Hospital, Bonn||2|||f||||t||||||||||2017-10-11 03:09:20.735932|2017-10-11 03:09:20.735932
NCT01561105|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-26|||January 1999||1999-01-01|March 2012|2012-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|IMPACT||Improving Depression Care for Elders: Coordinating Center|This Was a Five-year Seven-site Trial to Study the Cost-effectiveness of a Population Based Disease Management Program for Late Life Depression in Primary Care.|Completed||N/A|1801|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:09:21.052636|2017-10-11 03:09:21.052636
NCT01561092|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-06-18||||||June 2012|2012-06-01||||||||Interventional|ESTIAS||Escitalopram Treatment In Acute Stroke|Efficacy of Escitalopram Treatment in Acute Stroke and the Role of SERT Genotype in Stroke|Withdrawn||Phase 4|0|Actual|University of Aarhus||2||Study medication could not be supplied. An alternative project will be conducted|f||||t||||||||||2017-10-11 03:09:21.171864|2017-10-11 03:09:21.171864
NCT01561079|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-08-28|2017-03-08||February 2012||2012-02-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Fetal and Infant Effects of Maternal Buprenorphine Treatment|Fetal and Infant Effects of Maternal Buprenorphine Treatment|Completed||Phase 2/Phase 3|127|Actual|Johns Hopkins University|Small sample size|1|||f||||t||||||||||2017-10-11 03:09:21.298398|2017-10-11 03:09:21.298398
NCT01561066|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2013-02-23|||January 2008||2008-01-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Autologous Fibrin Glues for Fistulas Closure|Adjuvant Use of Autologous Platelet-rich Fibrin Glue in the Treatment of Fistulas and Anastomotic Leakages of the Digestive Tract|Completed||Phase 1|122|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 03:09:21.916275|2017-10-11 03:09:21.916275
NCT01561053|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-08-01|||March 2012||2012-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AMBAR||A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease|A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD|Active, not recruiting||Phase 2/Phase 3|350|Anticipated|Grifols Biologicals Inc.||4|||f||||f||||||||||2017-10-11 03:09:22.010066|2017-10-11 03:09:22.010066
NCT01561040|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-03-22|||March 2012||2012-03-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|ONIT||Oral Nutrition Impact on Tear Film|Eight Week Feasibility Study Enrolling Dry Eye Subjects Confirmed by Four of Seven Dianostic Markers Responding to Nutritional Therapy|Unknown status|Recruiting|Phase 4|80|Anticipated|Eye and Vision Technologies and Research Institute||1|||f||||f||||||||||2017-10-11 03:09:22.179294|2017-10-11 03:09:22.179294
NCT01560845|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2012-03-21|||June 2010||2010-06-01|March 2012|2012-03-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|||ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis|Autologous Bone Marrow Stem Cells Infusion Through Hepatic Artery in Open Abdominal Portal Hypertension Surgery for the Treatment of Liver Cirrhosis: a Prospective, Non-randomized, Controlled Study|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Wenzhou Medical University||2|||f||||f||||||||||2017-10-11 03:09:26.02355|2017-10-11 03:09:26.02355
NCT01561014|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-04-17|||April 2007|Actual|2007-04-01|April 2017|2017-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction|A Phase I Study of Preoperative Chemoradiation With Oxaliplatin, 5-Fluorouracil, Erlotinib and Radiation Followed by Resection and Consolidative Erlotinib for Patients With Locally Advanced Cancer of the Esophagus and Gastroesophageal Junction|Completed||Phase 1|9|Actual|Wake Forest University Health Sciences||1|||f||||t|t|f||||||||2017-10-11 03:09:22.412891|2017-10-11 03:09:22.412891
NCT01561001|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-05-19|||April 2012||2012-04-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy With Collagen Implant|24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Primary Open Angle Glaucoma Before and After Deep Sclerectomy With Collagen Implant|Terminated||N/A|3|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 03:09:22.539671|2017-10-11 03:09:22.539671
NCT01560988|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-07-11|2017-02-15||February 2013||2013-02-01|July 2017|2017-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Borage|Patients with physician diagnosed asthma between 18 and 65 years of age|Borage and Echium Seed Oils for Asthma|Treatment of Bronchial Asthma With Borage and Echium Seed Oils|Completed||Phase 3|62|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:09:22.612775|2017-10-11 03:09:22.612775
NCT01560975|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2015-12-21|2014-11-18||March 2012||2012-03-01|December 2015|2015-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure|A Prospective, Explorative, Open Label Study to Assess the 24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Moderate to Severe Obstructive Sleep Apnea Syndrome Using Continuous Positive Airway Pressure With or Without Primary Open Angle Glaucoma|Completed||N/A|10|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 03:09:24.750308|2017-10-11 03:09:24.750308
NCT01560962|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-05-28|||January 2012||2012-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis|Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis|Terminated||N/A|||Southern California Institute for Research and Education||4||research staffs unable to continue.|f||||||||||||||2017-10-11 03:09:25.096402|2017-10-11 03:09:25.096402
NCT01560949|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-05-24|||June 14, 2012|Actual|2012-06-14|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas|A Phase II Study of Preoperative Systemic Chemotherapy (Modified FOLFIRINOX) Followed by Radiation Therapy for Patients With High Risk Resectable and Borderline Resectable Adenocarcinoma of the Pancreas|Active, not recruiting||Phase 2|34|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:09:25.195101|2017-10-11 03:09:25.195101
NCT01560936|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2013-05-13|||June 2012||2012-06-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU|Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU and the Effectiveness of an Antimicrobial Gel in Reducing Transmission to the Hands|Completed||N/A|50|Actual|Mednax Center for Research, Education and Quality|||1||f||||f||||||||||2017-10-11 03:09:25.312735|2017-10-11 03:09:25.312735
NCT01560923|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-11-07|||October 2012||2012-10-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|February 2017|Anticipated|2017-02-01||Interventional|||Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer|A Randomized, Double-Blind Phase II Study of Sipuleucel-T (Provenge®) Followed by Indoximod or Placebo in the Treatment of Patients With Asymptomatic or Minimally Symptomatic Metastatic Castration Resistant Prostate Cancer|Active, not recruiting||Phase 2|47|Actual|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-10-11 03:09:25.378111|2017-10-11 03:09:25.378111
NCT01560910|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-21|||January 2010||2010-01-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Detection of Minimal Change Esophagitis by I-scan||Completed||N/A|48|Actual|Maharaj Nakorn Chiang Mai Hospital|||1||f||||f||||||||||2017-10-11 03:09:25.472045|2017-10-11 03:09:25.472045
NCT01560897|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-07-30|||January 2012||2012-01-01|July 2012|2012-07-01||||December 2012|Anticipated|2012-12-01||Interventional|PIL001||"Investigating Project of the Functional C13 Test Pilot Study"|Investigating Project of the Functional C13 Test|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-11 03:09:25.547417|2017-10-11 03:09:25.547417
NCT01560884|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-11-06|||April 2012||2012-04-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|SPI-014||Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb|A Double Blind, Dose-Ranging, Phase 1 Study In Healthy Volunteers to Assess Safety and the Phosphate Binding Capacity of Lanthanum Dioxycarbonate (SPI-014, Renazorb)|Completed||Phase 1|32|Actual|Spectrum Pharmaceuticals, Inc||4|||f||||f||||||||||2017-10-11 03:09:25.625381|2017-10-11 03:09:25.625381
NCT01560871|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-10-19|||March 2012||2012-03-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Effects of a Walking Program and Inspiratory Muscle Training on Individuals With Chronic Heart Failure|Effects of a Walking Program and Inspiratory Muscle Training on Individuals With Chronic Heart Failure - A Pilot Study|Recruiting||N/A|30|Anticipated|Texas Woman's University||2|||f||||t||||||||||2017-10-11 03:09:25.710206|2017-10-11 03:09:25.710206
NCT01560858|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-06-19|||April 2012||2012-04-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State|A Retrospective Observational Study to Describe Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State, in Routine Clinical Practice in Spain.|Completed||N/A|407|Actual|Ipsen|||1||f||||f||||||||||2017-10-11 03:09:25.87463|2017-10-11 03:09:25.87463
NCT01560832|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2014-03-04|||December 2011||2011-12-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region||Completed||N/A|188|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 03:09:26.162416|2017-10-11 03:09:26.162416
NCT01560819|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-12-04|2013-07-15||March 2012||2012-03-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|GMT||Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases|Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases|Completed||Phase 1|20|Actual|Spectrum Health Hospitals|This short-term pilot study is limited by its small sample size; therefore, studies with a larger sample size and longer follow-up period will be required to determine true efficacy of GMT in patients with ulcerative colitis (UC).|1|||f||||t||||||||||2017-10-11 03:09:26.256197|2017-10-11 03:09:26.256197
NCT01560806|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-03-20|||December 2006||2006-12-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Intervention Study on Hypertension Management Combined With Health Promotion at Commune Level|Quasi-experimental Intervention Study on Hypertension Management Combined With Comprehensive Healthy Lifestyle Promotion at Commune Level|Completed||N/A|2400|Actual|Vietnam National Heart Institute||2|||f||||t||||||||||2017-10-11 03:09:26.649347|2017-10-11 03:09:26.649347
NCT01560793|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2014-09-22|||June 2012||2012-06-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years|Phase I Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years|Completed||Phase 1|224|Actual|VaxInnate Corporation||1|||f||||t||||||||||2017-10-11 03:09:26.817661|2017-10-11 03:09:26.817661
NCT01560780|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-03-22|||February 1, 2013|Actual|2013-02-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis|Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis|Recruiting||Phase 3|120|Anticipated|VA Office of Research and Development||2|||f||||t||||||||No||2017-10-11 03:09:26.930222|2017-10-11 03:09:26.930222
NCT01560767|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-03-20|||October 2010||2010-10-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|PAKA||Perioperative Analgesia for Knee Arthroplasty (PAKA)|Can Periarticular Knee Injection of Multimodal Agents Levobupivicaine, Morphine, Ketorolac and Adrenaline Improve Postoperative Pain and Function Following Primary Total Knee Arthroplasty?|Completed||Phase 4|46|Actual|University of Warwick||2|||f||||f||||||||||2017-10-11 03:09:27.075826|2017-10-11 03:09:27.075826
NCT01560754|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-09-28|||October 2012||2012-10-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|NIC-PD||Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease|A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA|Unknown status|Active, not recruiting|Phase 2|160|Anticipated|University of Vermont||2|||f||||t||||||||||2017-10-11 03:09:27.195858|2017-10-11 03:09:27.195858
NCT01560741|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-10-03|||July 2012||2012-07-01|October 2012|2012-10-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|TeleMotiNIV||Telemedicine and Ventilator Titration in Chronic Respiratory Patients Initiating Non-invasive Ventilation|Randomized Trial Comparing Telemedicine Monitoring and Titration in Patients Initiating Non-invasive Ventilation With Usual Care (TELEMOTINIV Study)|Unknown status|Recruiting|Phase 1|128|Anticipated|Hospital Sao Joao||2|||f||||f||||||||||2017-10-11 03:09:27.386456|2017-10-11 03:09:27.386456
NCT01560728|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-03-15|||November 2012||2012-11-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Bringing What Works to Youth in Corrections: A Trauma Intervention|Bringing What Works to Youth in Prison: An Evidence-Based Trauma Intervention|Completed||Phase 1/Phase 2|57|Actual|University of Texas at Austin||2|||f||||t||||||||||2017-10-11 03:09:27.494209|2017-10-11 03:09:27.494209
NCT01560715|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-07-18|||June 2011||2011-06-01|July 2017|2017-07-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|RETICELL||Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa|Phase 2 Study Of Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa|Completed||Phase 2|50|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 03:09:27.600717|2017-10-11 03:09:27.600717
NCT01560702|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-09-24|||March 2012||2012-03-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers|Endoscopic Injection of Autologous Blood Versus Diluted Epinephrine for Control of Actively Bleeding Gastroduodenal Ulcers|Completed||N/A|100|Actual|Zagazig University||2|||f||||t||||||||||2017-10-11 03:09:27.689814|2017-10-11 03:09:27.689814
NCT01560689|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-09-06|||June 2008||2008-06-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|alloforb||Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation|Open-labeled Trial to Evaluate the Therapeutic Effects of Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans After Allogeneic Stem Cell Transplantation|Completed||Phase 2|32|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:09:27.790777|2017-10-11 03:09:27.790777
NCT01560676|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-20|||September 2009||2009-09-01|March 2012|2012-03-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|HEALTH[e]TEEN||Reducing Obesity and Type 2 Diabetes in High Risk Youth|A School-based Internet Obesity Prevention Program for Adolescents|Completed||Phase 2/Phase 3|384|Actual|Yale University||2|||f||||f||||||||||2017-10-11 03:09:27.890829|2017-10-11 03:09:27.890829
NCT01560663|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-03-07|||January 2012||2012-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|March 2017|Anticipated|2017-03-01||Observational|||Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer|Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer|Recruiting||N/A|185|Anticipated|Hospital General Universitario Gregorio Marañon|||1||f||||f||||||||||2017-10-11 03:09:27.982465|2017-10-11 03:09:27.982465
NCT01560650|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-01-17|||March 2011||2011-03-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Effect of the Intensity of Continuous Renal Replacement Therapy in Patients With Acute Kidney Injury|Effect of the Intensity of Continuous Renal Replacement Therapy in Patients With Cardiac Surgery Associated Acute Kidney Injury (CRITERIA STUDY)|Completed||Phase 4|211|Actual|Guangdong General Hospital||2|||f||||t||||||||||2017-10-11 03:09:28.133357|2017-10-11 03:09:28.133357
NCT01559909|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2014-05-08|||June 2012||2012-06-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Socket Wall Height With Vacuum Suspension for Above Knee Amputees|Effect of Brim Height Using Vacuum Assisted Technology With Transfemoral Amputees|Completed||Phase 1|10|Anticipated|Stony Brook University||1|||f||||f||||||||||2017-10-11 03:09:39.722155|2017-10-11 03:09:39.722155
NCT01560637|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-11-15|||May 2012||2012-05-01|November 2016|2016-11-01|August 2021|Anticipated|2021-08-01|May 2021|Anticipated|2021-05-01||Interventional|||An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension|Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310|Recruiting||Phase 3|850|Anticipated|United Therapeutics||1|||f||||t||||||||||2017-10-11 03:09:28.350046|2017-10-11 03:09:28.350046
NCT01560624|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-01-24|||July 2012||2012-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|FREEDOM-Ev||Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension|A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy|Recruiting||Phase 3|850|Anticipated|United Therapeutics||2|||f||||t||||||||||2017-10-11 03:09:29.20764|2017-10-11 03:09:29.20764
NCT01560611|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-21|||March 2012||2012-03-01|March 2012|2012-03-01||||||||Observational|||A New Non-invasive Marker to Detect Silent Hypoxia in Patients Undergoing Cardiac Surgery|The Somatic-to-cerebral Oxygen Saturation Gradient as a Non-invasive Index of Anaerobic Threshold in High-risk Cardiac Surgical Patient|Unknown status|Not yet recruiting|N/A|60|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-10-11 03:09:30.125191|2017-10-11 03:09:30.125191
NCT01560598|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-21|||June 2012||2012-06-01|March 2012|2012-03-01||||June 2013|Anticipated|2013-06-01||Observational|||Adipokines and the Risk of Reflux Esophagitis|Adipokines and the Risk of Reflux Esophagitis : Prospective Case-control Study|Unknown status|Not yet recruiting|N/A|600|Anticipated|Seoul National University Hospital|||2||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 03:09:30.224599|2017-10-11 03:09:30.224599
NCT01560585|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-08-27|||April 2012||2012-04-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease|Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease|Terminated||Phase 1/Phase 2|10|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-10-11 03:09:30.326347|2017-10-11 03:09:30.326347
NCT01560572|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-12-31|||April 2011||2011-04-01|December 2014|2014-12-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Interventional|Allegro||Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen|Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen|Unknown status|Active, not recruiting|Phase 4|300|Anticipated|University Medical Center Groningen||3|||f||||t||||||||||2017-10-11 03:09:30.481036|2017-10-11 03:09:30.481036
NCT01560559|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-05-22|||March 2012||2012-03-01|March 2012|2012-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TAMEO||Peroral Endoscopic Myotomy for Primary Esophageal Achalasia|Peroral Endoscopic Myotomy for Primary Esophageal Achalasia|Completed||Phase 3|16|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 03:09:30.656138|2017-10-11 03:09:30.656138
NCT01560546|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-11-13|||March 2012||2012-03-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)|Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) - a Randomised, Doubleblinded and Placebocontrolled Trial of Men With Subnormal Testosterone Levels and T2DM.|Completed||Phase 4|43|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-11 03:09:30.790279|2017-10-11 03:09:30.790279
NCT01560533|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2014-01-29|||November 2011||2011-11-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|CORCAN||Representation of the Body for Patients With Cancer|Representation of the Body and Treatment of Peritoneal Cancer by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - A Collaborative Approach Between Professionals of Health / Patients / Researchers|Completed||N/A|21|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:09:30.924345|2017-10-11 03:09:30.924345
NCT01560520|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-10-17|||November 2011||2011-11-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Physical Activity Immediately After Acute Cerebral Ischemia|Physical Activity Immediately After Acute Cerebral Ischemia: Too Little or Too Much?|Completed||N/A|100|Actual|Hillerod Hospital, Denmark|||1||f||||f||||||Samples Without DNA|"     Interleukin (IL)-6, IL-1beta, Tumor Nekrosis Factor(TNF)-alpha, C-Reactive Proteine (CRP),     IL-1ra, IL-10, fasting-insuline, fasting-glucose   "|||2017-10-11 03:09:31.015643|2017-10-11 03:09:31.015643
NCT01560507|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2014-12-05|2013-09-09||May 2012||2012-05-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|LiveForLife2||Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants|Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants|Terminated||Phase 2/Phase 3|19|Actual|Duke University|Early termination of the study because of recruitment difficulties lead to insufficient data collection and analysis of primary and secondary outcome measures.|3||Low Recruitment|f||||t||||||||||2017-10-11 03:09:31.114092|2017-10-11 03:09:31.114092
NCT01560494|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-20|||July 2008||2008-07-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Validation of a Curriculum (STAC) for Technical Skill Acquisition in Minimally Invasive Surgery|Validation of a Structured Training and Assessment Curriculum (STAC) for Technical Skill Acquisition in Minimally Invasive Surgery. A Randomized Controlled Study|Completed||N/A|20|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 03:09:31.545008|2017-10-11 03:09:31.545008
NCT01560481|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2014-02-12|||December 2011||2011-12-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|NTC00940472||Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers|Open Crossover Randomized Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic-pharmacodynamic Profile of Metformin Glycinate 620 mg,1240 mg, 2480 mg and Metformin Chlorhydrate 1000 mg After Administration of One Single Dose, Multiple Dose and After Food Intake in Healthy Volunteers|Completed||Phase 1|49|Actual|Laboratorios Silanes S.A. de C.V.||7|||f||||f||||||||||2017-10-11 03:09:31.649436|2017-10-11 03:09:31.649436
NCT01560468|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-01-27|||March 2012||2012-03-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection|Phase I Study of Hepatitis C Virus (HCV) Entry Inhibitor (ITX 5061) in Liver Transplant Recipients With HCV Infection|Active, not recruiting||Phase 1|10|Anticipated|Schiano, Thomas D., MD||1|||f||||t||||||||||2017-10-11 03:09:31.795791|2017-10-11 03:09:31.795791
NCT01560455|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2016-03-11|||May 2011||2011-05-01|March 2016|2016-03-01||||September 2014|Actual|2014-09-01||Interventional|EBC TWO||European Bifurcation Club Trial - Two-stent Versus One-stent Technique for Large Bifurcation Lesions|The European Bifurcation Coronary Study; A Randomised Comparison Of Provisional T-Stenting Versus A Systematic Two Stent Strategy In Large Calibre True Bifurcations|Completed||Phase 3|200|Anticipated|Royal Sussex County Hospital||2|||f||||t||||||||||2017-10-11 03:09:31.895498|2017-10-11 03:09:31.895498
NCT01560442|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-01-11|||February 2012||2012-02-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|July 2013|Anticipated|2013-07-01||Observational|PUPIDOL||Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine|Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine.|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-10-11 03:09:32.011229|2017-10-11 03:09:32.011229
NCT01560429|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-06-09|2013-06-12||June 2009||2009-06-01|June 2016|2016-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Efficacy of Patient Controlled Epidural Anesthesia Versus Continuous Epidural Analgesia for Post-thoracotomy Pain|Efficacy of Patient Controlled Epidural Anesthesia (PCEA) Versus Continuous Epidural Analgesia (CEA) for Post-thoracotomy Pain.|Completed||Phase 4|52|Actual|Queen's University||2|||f||||f||||||||No||2017-10-11 03:09:32.133248|2017-10-11 03:09:32.133248
NCT01560416|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-10-02|||May 2012||2012-05-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fulvestrant With or Without Ganetespib in HR+ Breast Cancer|Randomized Phase II Study of Fulvestrant With or Without Ganetespib in Patients With Hormone Receptor-Positive, Metastatic Breast Cancer|Active, not recruiting||Phase 2|50|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-11 03:09:32.432877|2017-10-11 03:09:32.432877
NCT01560403|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-11-10|2014-12-16||May 2012||2012-05-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|STEPS3||A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021|A One-Year, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition-dependent Short Bowel Syndrome Who Completed Study CL0600-021|Completed||Phase 3|14|Actual|Shire|This study provided further long-term safety and efficacy data on the 14 US subjects who enrolled in the CL0600-020 and the CL0600-021 study. Given the small number of subjects in this study, only descriptive statistics were employed and presented.|1|||f||||t||||||||||2017-10-11 03:09:32.538152|2017-10-11 03:09:32.538152
NCT01560390|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2013-01-11|||October 2011||2011-10-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|KetaRea||Use of Ketamine Associate With an Opioid for Sedation in ICU|Use of Ketamine Associate With an Opioid for Sedation in ICU : a Randomized Controlled Double Blind Study|Completed||Phase 4|164|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 03:09:32.875893|2017-10-11 03:09:32.875893
NCT01560364|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2014-11-28|||May 2011||2011-05-01|November 2014|2014-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|BEERT||Bundle Evaluation in Extra Renal Epuration, Incidence of Thrombosis|Bundle Evaluation in Extra Renal Epuration, Incidence of Thrombosis|Completed||N/A|100|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 03:09:33.083521|2017-10-11 03:09:33.083521
NCT01560351|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-03-09|||March 2012||2012-03-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|STIMJEU||Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study|Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study|Terminated||N/A|31|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 03:09:33.258073|2017-10-11 03:09:33.258073
NCT01560338|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2017-04-05|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|HIP||Hypothermia's Impact on Pharmacology|Impact of Hypothermia on Midazolam and Morphine Pharmacokinetics|Recruiting||N/A|41|Anticipated|Children's Hospital of Philadelphia|||1||f||||f||||||Samples With DNA|"     Whole blood   "|Undecided||2017-10-11 03:09:33.347554|2017-10-11 03:09:33.347554
NCT01560325|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-09-15|||June 2012||2012-06-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers|Phase I Clinical Trial to Assess the Safety and Pharmacokinetic Profile of CKD-516 Inj. Administered on A Twice-Weekly Schedule in Patients With Advanced Solid Cancers Failed to Standard Therapy|Completed||Phase 1|21|Actual|Chong Kun Dang Pharmaceutical||1|||f||||f||||||||||2017-10-11 03:09:33.480789|2017-10-11 03:09:33.480789
NCT01560312|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-02-27|||October 2011||2011-10-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PRAGUE-15||Renal Denervation in Refractory Hypertension|Renal Denervation - Hope for Patients With Refractory Hypertension?|Terminated||Phase 3|106|Actual|Charles University, Czech Republic||2||"Based on analysis of our data after the Symplicity-3 trial announcement, decision for study   termination was done."|f||||f||||||||||2017-10-11 03:09:33.575998|2017-10-11 03:09:33.575998
NCT01560299|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-20|||February 2010||2010-02-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients||Completed||N/A|150|Actual|Mashhad University of Medical Sciences||3|||f||||f||||||||||2017-10-11 03:09:33.68151|2017-10-11 03:09:33.68151
NCT01560286|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-08-17||2017-08-17|May 2012||2012-05-01|August 2017|2017-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks|A Phase II, Multi-center, Open-label, Dose-finding Study to Evaluate Safety, Efficacy and Tolerability of Subcutaneously (SC) Administered rAvPAL-PEG in Patients With PKU for 24 Weeks|Completed||Phase 2|24|Actual|BioMarin Pharmaceutical||2|||f||||t||||||||||2017-10-11 03:09:33.770356|2017-10-11 03:09:33.770356
NCT01560273|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-03-14|||February 2012||2012-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Aspen Spinous Process Fixation System for Use in PLF in Patients With Spondylolisthesis|A Multi-Center Prospective Study Evaluation Aspen Spinous Process Fixation System for Use in Posterolateral Fusion (PLF) in Patients With Spondylolisthesis|Terminated||Phase 4|25|Actual|Zimmer Biomet|||1|Will answer study question through other research means.|f||||f||||||||Undecided||2017-10-11 03:09:33.878041|2017-10-11 03:09:33.878041
NCT01560260|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-11-18|2016-11-18||March 2012||2012-03-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors|A Phase 2 Study of Linsitinib (OSI-906) in Pediatric and Adult Wild Type Gastrointestinal Stromal Tumors|Completed||Phase 2|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:09:33.999653|2017-10-11 03:09:33.999653
NCT01560247|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-04-03|||January 2012||2012-01-01|April 2012|2012-04-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Observational|PRIISM2||Percutaneous Recanalization in Ischemic Stroke Management in Europe Observational Registry|Percutaneous Recanalization in Ischemic Stroke Management in Europe Observational Registry|Unknown status|Active, not recruiting|N/A|1000|Anticipated|MindFrame, Inc.|||1||f||||f||||||||||2017-10-11 03:09:34.441309|2017-10-11 03:09:34.441309
NCT01560234|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-05-05|2015-07-30||May 2012||2012-05-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||All available data were used for the baseline analysis|AZD8848 Single Ascending Dose Study|A Double-blind, Placebo-controlled, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Inhaled Doses of AZD8848 in Healthy Subjects|Completed||Phase 1|47|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:09:34.570169|2017-10-11 03:09:34.570169
NCT01560221|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-12-10|||October 2012||2012-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution|Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution|Completed||Phase 1|38|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 03:09:35.946377|2017-10-11 03:09:35.946377
NCT01560208|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-12-18|||April 2012||2012-04-01|December 2012|2012-12-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Observational|ACSIKS||The Asia Cornea Society Infectious Keratitis Study|The Asia Cornea Society Infectious Keratitis Study|Unknown status|Recruiting|N/A|6750|Anticipated|Asia Cornea Society|||1||f||||f||||||Samples Without DNA|"     Positive bacterial and fungal growth obtained from the cornea samples of ACSIKS patients will     be retained and stored.   "|||2017-10-11 03:09:36.053654|2017-10-11 03:09:36.053654
NCT01560195|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2012-11-04|||April 2012||2012-04-01|November 2012|2012-11-01||||January 2013|Anticipated|2013-01-01||Interventional|||A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy|A Double-Blind, Placebo-Controlled, Multicenter, Randomized Study Evaluating the Prophylactic Use of Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (rhG-CSF) on the Incidence of Neutropenia in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Myelosuppressive Chemotherapy|Unknown status|Recruiting|Phase 3|150|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||f||||||||||2017-10-11 03:09:36.179266|2017-10-11 03:09:36.179266
NCT01560182|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-03-22|||May 2010||2010-05-01|March 2017|2017-03-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|TIGET-MLD||Gene Therapy for Metachromatic Leukodystrophy|A Phase I/II Clinical Trial of Hematopoietic Stem Cell Gene Therapy for the Treatment of Metachromatic Leukodystrophy|Active, not recruiting||Phase 2|14|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-10-11 03:09:36.272742|2017-10-11 03:09:36.272742
NCT01560169|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-10-09|||March 2012||2012-03-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients|Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients|Completed||N/A|110|Actual|Alvine Pharmaceuticals Inc.|||2||f||||f||||||||||2017-10-11 03:09:36.369477|2017-10-11 03:09:36.369477
NCT01560156|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2014-01-10|||March 2012||2012-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:09:36.452789|2017-10-11 03:09:36.452789
NCT01560143|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2016-12-16|2016-10-11||March 2012||2012-03-01|December 2016|2016-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects|Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects|Completed||Phase 4|12|Actual|University of Michigan|Small study sample size|1|||f||||f||||||||No|The data have been published as a manuscript J Antimicrob Chemother. 2014 Jan;69(1):190-9.|2017-10-11 03:09:36.510734|2017-10-11 03:09:36.510734
NCT01560130|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-04-23|||January 2012||2012-01-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|SHARE||State-wide Health Approach to Increase Reach and Effectiveness: Study 2|Using a State-wide Initiative to Disseminate Effective Behavioral Weight Loss Strategies|Completed||Phase 3|300|Actual|The Miriam Hospital||3|||f||||f||||||||||2017-10-11 03:09:36.657117|2017-10-11 03:09:36.657117
NCT01560117|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-03-20|||January 2004||2004-01-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma|Multicenter Study to Evaluate the Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy Und Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma|Completed||Phase 2|29|Actual|Arbeitsgemeinschaft medikamentoese Tumortherapie|||||f||||f||||||||||2017-10-11 03:09:36.871715|2017-10-11 03:09:36.871715
NCT01560104|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-09-30||2015-09-30|February 2012||2012-02-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer|Randomized, Double-Blind, Multicenter, Phase 2 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|160|Actual|AbbVie||2|||f||||t||||||||||2017-10-11 03:09:36.943424|2017-10-11 03:09:36.943424
NCT01560091|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-02-16|||March 2012||2012-03-01|February 2017|2017-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy|Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After ESWL|Withdrawn||Phase 3|0|Actual|Albert Einstein Healthcare Network||3||accrual of subjects did not occur as anticipated|f||||t|t|f||||||Undecided||2017-10-11 03:09:37.042521|2017-10-11 03:09:37.042521
NCT01560078|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2013-07-11|||September 2006||2006-09-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|October 2011|Actual|2011-10-01||Observational|||Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion|Evaluation of Efficacy of Thrice Weekly DOTS Regimen in Tubercular Pleural Effusion at 6 Months|Completed||N/A|360|Actual|All India Institute of Medical Sciences, New Delhi|||1||f||||f||||||||||2017-10-11 03:09:37.13806|2017-10-11 03:09:37.13806
NCT01560065|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-20|2012-03-21||||||January 2012|2012-01-01||||||||Interventional|||Effect of Treatment With Myo-inositol on Human Semen Parameters in Patients Undergoing In Vitro Fertilization Cycles||Completed||Phase 4|||AGUNCO Obstetrics and Gynecology Centre||3|||f||||||||||||||2017-10-11 03:09:37.211403|2017-10-11 03:09:37.211403
NCT01560052|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-02-01|||April 2012||2012-04-01|February 2017|2017-02-01|June 2023|Anticipated|2023-06-01|June 2022|Anticipated|2022-06-01||Interventional|TESTING||Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)|Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study|Recruiting||N/A|500|Anticipated|The George Institute||2|||f||||t||||||||||2017-10-11 03:09:37.309142|2017-10-11 03:09:37.309142
NCT01560039|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-19|||April 2012||2012-04-01|March 2012|2012-03-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Electroencephalography Based Neurofeedback in Chronic Neuropathic Pain|Voluntary Modulation of M1 Motor Cortex Activity Using EEG Neurofeedback for the Treatment of Resistant Chronic Neuropathic Pain - a Clinical and fMRI Study|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||||||||||||2017-10-11 03:09:37.741523|2017-10-11 03:09:37.741523
NCT01560026|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2012-03-24|||August 2000||2000-08-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2011|Actual|2011-12-01||Observational|ECWOP||Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma|Study for Elevate the Feasibility of Ovarian Preservation With Endometrial Carcinoma|Unknown status|Recruiting|N/A|300|Anticipated|Taipei Veterans General Hospital, Taiwan|||2||f||||t||||||||||2017-10-11 03:09:37.878444|2017-10-11 03:09:37.878444
NCT01560013|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-03|2012-03-20|||October 2012||2012-10-01|March 2012|2012-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients|Brain Imaging Study on the Effects of Treatment With Naltrexone on Cue-induced Craving and Brain's Metabolic Changes in Alcohol and Cannabis-dependent Patients|Unknown status|Not yet recruiting|N/A|24|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 03:09:37.970001|2017-10-11 03:09:37.970001
NCT01560000|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-03-13|||March 2012||2012-03-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite|Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite|Completed||N/A|40|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-11 03:09:38.062028|2017-10-11 03:09:38.062028
NCT01559987|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-01-18|||February 2012||2012-02-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PAU2||Dental Plaque Removal Study|A Randomized Parallel Method Development Study Comparing Clinical to Subclinical Effects From Oral Cleaning Modalities|Completed||N/A|270|Actual|University of North Carolina, Chapel Hill||3|||f||||f|f|f||||||||2017-10-11 03:09:38.131158|2017-10-11 03:09:38.131158
NCT01559974|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2013-03-08|||November 2011||2011-11-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Vitamin D and Walking Ability in Patients With Peripheral Artery Occlusive Disease|Phase 4 Study of 25-hydroxy-vitamin D in Patients With Peripheral Artery Occlusive Disease and Walking Ability|Terminated||Phase 4|4|Actual|University Hospital, Basel, Switzerland||2||Insufficient recruitment|f||||t||||||||||2017-10-11 03:09:38.23461|2017-10-11 03:09:38.23461
NCT01559961|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2013-06-24|||March 2012||2012-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome|A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome|Completed||Phase 1|28|Actual|Trillium Therapeutics Inc.||1|||f||||t||||||||||2017-10-11 03:09:38.315469|2017-10-11 03:09:38.315469
NCT01559935|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-05-01|2017-02-01||March 2012|Actual|2012-03-01|May 2017|2017-05-01|March 2022|Anticipated|2022-03-01|June 7, 2016|Actual|2016-06-07||Interventional|CarBiRD|72 subjects started the Car Phase of the CarBiRD therapy. 58 subjects started the BiRD Phase of the CarBiRD therapy. 54 subjects started the Maintenance Phase of the CarBiRD therapy. A detailed explanation of those numbers is provided in the participant flow.|Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma|A Phase II Study of Sequential Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|74|Actual|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-10-11 03:09:38.503129|2017-10-11 03:09:38.503129
NCT01559922|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-12-21|2014-10-02||February 2012||2012-02-01|December 2016|2016-12-01|February 2014|Actual|2014-02-01|April 2013|Actual|2013-04-01||Interventional|||Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction|A Phase 3 Randomized Placebo-Controlled Double-Blind Study of the Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction|Completed||Phase 3|175|Actual|Suneva Medical, Inc.||2|||f||||f||||||||No||2017-10-11 03:09:39.295317|2017-10-11 03:09:39.295317
NCT01479452|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-11-23|||January 1987||1987-01-01|November 2011|2011-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|SOS||Effects of Bariatric Surgery in Swedish Obese Subjects|Effects of Bariatric Surgery in Swedish Obese Subjects|Completed||N/A|4047|Actual|Göteborg University||2|||f||||t||||||||||2017-10-11 03:33:50.270749|2017-10-11 03:33:50.270749
NCT01559896|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-08-04|||September 2011||2011-09-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||Egg Protein Hydrolysate and Vascular Function|The Effect of Egg Protein Hydrolysate on Arterial Stiffness in Overweight or Moderately Obese Subjects With Impaired Glucose Tolerance or Diabetes Type 2|Completed||N/A|40|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 03:09:39.807421|2017-10-11 03:09:39.807421
NCT01559883|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-08-14|||February 2012||2012-02-01|November 2013|2013-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Study on Thrombosis Therapy in German Cancer Patients|Study on Thrombosis Therapy in German Cancer Patients|Completed||N/A|76|Actual|LEO Pharma|||1||f||||f||||||||||2017-10-11 03:09:39.881839|2017-10-11 03:09:39.881839
NCT01559870|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-11-10|||August 2011||2011-08-01|March 2012|2012-03-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Observational|||Peri-operative Prediction of Prolonged Stay in the Cardiac Intensive Care Unit for Adult Cardiac Surgery|Peri-operative Prediction of Prolonged Stay in the Cardiac Intensive Care Unit for Adult Cardiac Surgery With Cardiopulmonary Bypass|Completed||N/A|164|Actual|Khon Kaen University|||1||f||||f||||||Samples Without DNA|"     whole blood taken from arterial line   "|||2017-10-11 03:09:39.965245|2017-10-11 03:09:39.965245
NCT01559857|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-03-30|2016-10-19||November 2011||2011-11-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Pioglitazone in Patients With Mood Disorders|Pioglitazone Treatment for Insulin Resistant Patients With Mood Disorders|Completed||Phase 4|37|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 03:09:40.073455|2017-10-11 03:09:40.073455
NCT01559844|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-06-16|2015-05-12||March 2012||2012-03-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional||Safety Analysis Set: participants who were enrolled and received at least 1 dose of study drug|Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant|An Open-Label Study to Explore the Clinical Efficacy of GS-7977 With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant|Completed||Phase 2|61|Actual|Gilead Sciences||1|||f||||t||||||||||2017-10-11 03:09:40.458043|2017-10-11 03:09:40.458043
NCT01559831|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2013-03-07|||June 2012||2012-06-01|March 2013|2013-03-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination|Immune Responses to Revaccination After Potentially Insufficient Priming With the Japanese Encephalitis Vaccine IXIARO Batch JEV09L37|Withdrawn||Phase 1|0|Actual|Valneva Austria GmbH||1|||f||||f||||||||||2017-10-11 03:09:41.292275|2017-10-11 03:09:41.292275
NCT01559818|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-03-04|||February 2012||2012-02-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001|An Open Label Long Term Follow up Study for Patients With Melanoma Who Were Previously Enrolled in the Phase I Study IMM-101-001|Active, not recruiting||Phase 1/Phase 2|12|Anticipated|Immodulon Therapeutics Ltd||1|||f||||f||||||||No||2017-10-11 03:09:41.406938|2017-10-11 03:09:41.406938
NCT01559805|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-03-23|||November 2012||2012-11-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Interventional|||Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men|Efficacy Trial of a Brief Health Enhancement Intervention for Newly Diagnosed Men|Recruiting||N/A|440|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-11 03:09:41.537975|2017-10-11 03:09:41.537975
NCT01559792|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-03-20|||December 2011||2011-12-01|March 2012|2012-03-01||||December 2012|Anticipated|2012-12-01||Observational|||Band to Bypass - Metabolism Kinetics in Gastric Bypass and Banding|Gastric Banding to Bypass - Metabolism Kinetics in Gastric Bypass and Banding|Unknown status|Recruiting|N/A|18|Anticipated|Hvidovre University Hospital|||1||f||||t||||||Samples With DNA|"     blood   "|||2017-10-11 03:09:41.662195|2017-10-11 03:09:41.662195
NCT01559779|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-06-09|||November 2010||2010-11-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Observational|AB-CD-10||Effect of Gastric Bypass Surgery on Pancreatic Islets and Incretin Function|The Effect of Gastric Bypass Surgery on the Beta- and Alpha Cells Secretory Function and the Insulinotropic Effect of the Incretin Hormones|Completed||N/A|11|Actual|Hvidovre University Hospital|||1||f||||f||||||Samples Without DNA|"     Plasma and serum specimens are retained   "|||2017-10-11 03:09:41.739967|2017-10-11 03:09:41.739967
NCT01559766|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-03-20|||July 2009||2009-07-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Observational|||Dietary Vitamin A Requirement in Chinese Children and the New Technology of Dietary Assessment|Estimating Dietary Vitamin A Requirement in Chinese Children by Stable-isotope Dilution Technique|Completed||N/A|403|Actual|Huazhong University of Science and Technology|||2||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 03:09:41.821524|2017-10-11 03:09:41.821524
NCT01559753|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2012-03-19|||January 1998||1998-01-01|March 2012|2012-03-01|November 2002|Actual|2002-11-01|September 2002|Actual|2002-09-01||Interventional|||Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment|Comparison of Two Lengths of Treatment in Early-onset Ventilated Associated Pneumonia|Completed||Phase 4|225|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-10-11 03:09:41.910834|2017-10-11 03:09:41.910834
NCT01559740|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-19|||July 2010||2010-07-01|March 2012|2012-03-01||||August 2010|Actual|2010-08-01||Interventional|||Transversus Abdominis Plane Blocks for Infants and Children for Postoperative Pain Control|Transversus Abdominis Plane Blocks for Infants and Children for Postoperative Pain Control: Is it the Concentration or Volume of Local Anesthetic Solution That Improves Analgesia?|Completed||Phase 2|36|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 03:09:42.030802|2017-10-11 03:09:42.030802
NCT01559727|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2013-08-27|||March 2012||2012-03-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Dose-comparison Study of Prednisone in Heart Failure|Randomized Dose-comparison Study of Prednisone in Patients With Symptomatic Heart Failure|Completed||Phase 3|40|Actual|Hebei Medical University||4|||f||||t||||||||||2017-10-11 03:09:42.144188|2017-10-11 03:09:42.144188
NCT01559714|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-08-15|||April 2012||2012-04-01|August 2016|2016-08-01||||December 2020|Anticipated|2020-12-01||Observational|BE STRONG HCM||A Biomarker and MRI Study on Troponin Release After Exercise in Hypertrophic Cardiomyopathy|BE STRONG HCM: Biomarkers, Exercise Stress Testing, and mRi to Obtain New insiGhts in Hypertrophic CardioMyopathy Study|Active, not recruiting||N/A|81|Actual|Heartcenter, University Medical Center St. Radboud|||2||f||||f||||||||||2017-10-11 03:09:42.267193|2017-10-11 03:09:42.267193
NCT01559701|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-08-28||2012-10-01|April 2006||2006-04-01|August 2015|2015-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Long-term Safety of PF-00345439 (Oxycodone)|A Long-Term, Open-Label, Safety Study Of PTI-821 In Patients With Moderate To Severe Chronic Low Back Pain Or With Moderate To Severe Chronic Pain Due To Osteoarthritis Of The Hip Or Knee|Completed||Phase 3|823|Actual|Pain Therapeutics||1|||f||||f||||||||||2017-10-11 03:09:42.344396|2017-10-11 03:09:42.344396
NCT01559688|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2013-10-29|||July 2011||2011-07-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Accelerated Resolution Therapy (ART) for Psychological Trauma||Completed||N/A|80|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-11 03:09:42.45835|2017-10-11 03:09:42.45835
NCT01559675|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-08-18|2014-08-18||September 2010||2010-09-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||We assumed that patients treated with HDS would have no postural hypotension on POD1 95% of the time. The noninferiority margin was 10%. We calculated that a sample size of 118 patients (59 patients per study arm) was needed to establish clinical equivalency with a 1-sided α level of 0.05 and 80% power.|Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery|Randomized Controlled Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery|Completed||N/A|121|Actual|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-10-11 03:09:42.592829|2017-10-11 03:09:42.592829
NCT01559662|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-08-14|||August 2010||2010-08-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Sugared Chewing Gum on Gastrointestinal Recovery After Major Colorectal Surgery|A Prospective Randomized Controlled Trial of Sugared Chewing Gum on Gastrointestinal Recovery After Major Colorectal Surgery in Patients Managed With Early Enteral Feeding|Completed||N/A|114|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 03:09:42.955831|2017-10-11 03:09:42.955831
NCT01559649|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-06-24|2016-06-24||October 2012||2012-10-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Observational|SSST|N=250 stroke patients with data analyzed|Stroke Swallowing Screening Tool Validation|Development and Validation of a VA Stroke Swallowing Screening Tool|Completed||N/A|284|Actual|VA Office of Research and Development|Large number of individuals excluded from participation due to stringent inclusion/exclusion criteria to ensure that stroke-related aspiration was being measured. Small number of women recruited. Inability to screen in the emergency department.||2||f||||f||||||None Retained|"     no samples will be collected   "|No||2017-10-11 03:09:43.115288|2017-10-11 03:09:43.115288
NCT01559636|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-10-13|||August 2012||2012-08-01|October 2015|2015-10-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Diarrhea and Bivalent Oral Polio Vaccine Immunity|Effect of Diarrheal Disease on Bivalent Oral Polio Vaccine (bOPV) Immune Response in Infants in Nepal|Completed||N/A|699|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 03:09:44.329165|2017-10-11 03:09:44.329165
NCT01559623|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-12-15|||January 2009||2009-01-01|December 2014|2014-12-01|February 2013|Actual|2013-02-01|December 2011|Actual|2011-12-01||Observational|||Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms||Completed||N/A|766|Actual|University of Zurich|||1||f||||||||||||||2017-10-11 03:09:44.452283|2017-10-11 03:09:44.452283
NCT01559610|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-03-19|||August 2008||2008-08-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Preoperatively Orientation in Cardiac Surgery: Nurses Intervention on Patients Recovery|Preoperatively Orientation in Cardiac Surgery: Nurses Intervention on Patients Recovery|Completed||N/A|180|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||t||||||||||2017-10-11 03:09:44.540808|2017-10-11 03:09:44.540808
NCT01559597|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2013-05-01|||November 2012||2012-11-01|February 2013|2013-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain|Etude Comparative de Deux stratégies de Vaccination antitétanique en Situation réelle: Vaccin conservé en chaîne de Froid Versus en chaîne de température contrôlée.|Completed||N/A|2129|Actual|Epicentre||2|||f||||||||||||||2017-10-11 03:09:44.641733|2017-10-11 03:09:44.641733
NCT01559584|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-04-05|||March 2012||2012-03-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata|A Clinical and Immunological Study of Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata: A Randomized Controlled Clinical Trial|Completed||N/A|40|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 03:09:44.741092|2017-10-11 03:09:44.741092
NCT01559571|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-12-16|||May 2012||2012-05-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Observational|||Registry for Severe ROP and Treatment on Visual Outcomes|Study Registry for Severe Retinopathy and Treatment on Visual Outcomes of Premature Neonates|Active, not recruiting||N/A|324|Actual|Mednax Center for Research, Education and Quality|||1||f||||f||||||||||2017-10-11 03:09:44.843145|2017-10-11 03:09:44.843145
NCT01559558|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-19|||March 2012||2012-03-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Changes of Pad Weight Results and Urethral Pressure Profiles After Reduction of Cystocele by Vaginal Gauze Packing||Completed||N/A|140|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 03:09:44.91281|2017-10-11 03:09:44.91281
NCT01559545|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2013-06-06|||March 2012||2012-03-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis|A Randomized, Open Label, Active Control, Safety, Tolerability and Pharmacokinetics Study of Two Dr. Reddy's Formulations of Metronidazole Versus Immediate Release Metronidazole (Flagyl) in Patients With Mild to Moderate C. Difficile Associated Diarrhea (CDAD)|Completed||Phase 2|60|Actual|Dr. Reddy's Laboratories Limited||3|||f||||f||||||||||2017-10-11 03:09:45.00395|2017-10-11 03:09:45.00395
NCT01559532|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-19|||February 2008||2008-02-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Observational|||Influence of Tourniquet Use and Surgery Duration on the Incidence of Deep Vein Thrombosis in Total Knee Arthroplasty|Influence of Tourniquet Use and Surgery Duration on the Incidence of Deep Vein Thrombosis in Total Knee Arthroplasty|Completed||N/A|78|Actual|University of Sao Paulo General Hospital|||1||f||||f||||||||||2017-10-11 03:09:45.13277|2017-10-11 03:09:45.13277
NCT00004682|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||March 1995||1995-03-01|March 1999|1999-03-01|March 1999||1999-03-01|||||Interventional|||Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis||Terminated||N/A|100||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.227093|2017-10-11 04:26:56.227093
NCT01559519|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-12-16|||September 2012||2012-09-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy|Effect of Albumine Infusion in the Prevention of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt|Completed||Phase 4|20|Actual|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-11 03:09:45.215349|2017-10-11 03:09:45.215349
NCT01559506|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-03-16|2015-02-25||November 2011||2011-11-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Air Barrier System Device to Reduce Contamination in Posterior Spine Surgery|ABS to Reduce Contamination in Spine Surgery|Completed||N/A|41|Actual|Nimbic Systems, LLC||2|||f||||t||||||||||2017-10-11 03:09:45.314695|2017-10-11 03:09:45.314695
NCT01559493|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-03-19|||January 2012||2012-01-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Fractional Flow Reserve (FFR) Versus Instant Wave-Free Ratio (iFR)|Comparison of Fractional Flow Reserve Versus Instant Wave-Free Ratio for Assessment of Coronary Artery Stenosis Severity in Routine Practice|Completed||N/A|200|Actual|NHS National Waiting Times Centre Board|||1||f||||f||||||||||2017-10-11 03:09:45.642378|2017-10-11 03:09:45.642378
NCT01559480|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-04-08|||January 2012||2012-01-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Postoperative Desogestrel for Endometriosis Related Pain|A Prospective Double Blind Randomized Controlled Trial to Study the Effectiveness of a Desogestrel for the Treatment of Pelvic Pain or Dysmenorrhea in the Patients Undergone Conservative Surgery for Pelvic Endometriosis|Completed||N/A|40|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 03:09:45.736359|2017-10-11 03:09:45.736359
NCT01559467|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2017-07-03|||April 2012||2012-04-01|July 2016|2016-07-01|June 19, 2017|Actual|2017-06-19|May 2017|Actual|2017-05-01||Interventional|CARMENTA||The Supplementary Role of Non-invasive Imaging to Routine Clinical Practice in Suspected Non-ST-elevation Myocardial Infarction|The Supplementary Role of Cardiovascular Magnetic Resonance Imaging and Computed Tomography Angiography to Routine Clinical Practice in Suspected Non-ST Elevation Myocardial Infarction - A Randomized Controlled Trial|Completed||N/A|300|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 03:09:45.826778|2017-10-11 03:09:45.826778
NCT01559454|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-02-17|2016-01-22||February 2012||2012-02-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients|A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients|Completed||Phase 4|19|Actual|State University of New York at Buffalo|Early termination due to human subject concerns|2|||f||||t||||||||Undecided|We are preparing a de-identified data set that could be shared.|2017-10-11 03:09:45.962468|2017-10-11 03:09:45.962468
NCT01559441|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2013-07-15|||March 2012||2012-03-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Beetroot Juice and Postprandial Vascular Activity|The Effects of Beetroot Juice on Postprandial Vascular Activity After a High-fat Meal in Overweight and Slightly Obese Men|Completed||N/A|20|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:09:48.280763|2017-10-11 03:09:48.280763
NCT01559428|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-19|||May 2010||2010-05-01|March 2012|2012-03-01||||April 2012|Anticipated|2012-04-01||Interventional|||Phytosterols and Oxyphytosterol Concentrations|The Effects of Plant Sterol and Stanol Esters on Serum Oxyphytosterol Concentrations in Healthy Human Subjects|Unknown status|Active, not recruiting|N/A|48|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 03:09:48.391431|2017-10-11 03:09:48.391431
NCT01559415|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-12-22|||March 2012||2012-03-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|ADIPOSTRESS||An Adipocyte-Driven Mechanism For Weight Regain After Weight Loss: The Yo-Yo Effect|An Adipocyte-Driven Mechanism For Weight Regain After Weight Loss: The Yo-Yo Effect|Completed||N/A|58|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:09:48.475216|2017-10-11 03:09:48.475216
NCT01559402|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-08-31|||March 2012||2012-03-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Oxygenation Test During General Anesthesia|Application of Protective Ventilation Improves Oxygenation During and After Anesthesia. Is it Possible That a Special Procedure, an Oxygenation Test, Can Replace Arterial Blood Gases When Evaluating Oxygenation?|Completed||N/A|40|Actual|Landstinget Västmanland||3|||f||||t||||||||||2017-10-11 03:09:48.618884|2017-10-11 03:09:48.618884
NCT01559389|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-07-27|||March 2012||2012-03-01|July 2017|2017-07-01|March 2017|Actual|2017-03-01|December 2016|Actual|2016-12-01||Interventional|IIMPACT||Incontinence & Intimate Partners: Assessing the Contribution of Treatment|Incontinence & Intimate Partners: Assessing the Contribution of Treatment|Completed||N/A|69|Actual|Loyola University||1|||f||||f||||||||||2017-10-11 03:09:48.706224|2017-10-11 03:09:48.706224
NCT01559376|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-08-25|||February 2012||2012-02-01|March 2012|2012-03-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Observational|||Long Term Follow-up of Open Versus Endoscopic Radial Artery Harvest With CT Angiography|Long Term Follow-up of Open Versus Endoscopic Radial Artery Harvest With CT Angiography|Completed||N/A|118|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||||2017-10-11 03:09:48.787583|2017-10-11 03:09:48.787583
NCT01559363|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-08-10|||September 2012||2012-09-01|June 2016|2016-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)|A Phase 1b/2a, Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease|Active, not recruiting||Phase 1/Phase 2|120|Anticipated|Kadmon Corporation, LLC||7|||f||||f||||||||||2017-10-11 03:09:48.867486|2017-10-11 03:09:48.867486
NCT01559350|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-04-13|||January 2012||2012-01-01|March 2012|2012-03-01|December 2022|Anticipated|2022-12-01|December 2015|Actual|2015-12-01||Observational|||Graft Patency Analysis of the Right Coronary Artery System|Graft Patency of the Right Coronary Artery System in OPCAB: Saphenous Vein Graft Versus Right Gastroepiploic Artery|Terminated||N/A|50|Actual|Samsung Medical Center|||2|Poor recruiting rate|f||||t||||||||||2017-10-11 03:09:48.977674|2017-10-11 03:09:48.977674
NCT01559337|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2012-03-20|||May 2007||2007-05-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|June 2009|Actual|2009-06-01||Interventional|||Nerve Transfer for Finger Sensory Reconstruction With Dorsal Branch of the Digital Nerve||Completed||N/A|17|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 03:09:49.226651|2017-10-11 03:09:49.226651
NCT01559324|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-07-08|||August 2009||2009-08-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Electroconvulsive Therapy (ECT) for Elderly Patients With Major Depression|Randomized Controlled Comparison of Bifrontal and Right Unilateral ECT as to Effects on Depression, Global Cognitive Function and Biomarkers.|Completed||Phase 4|92|Actual|Diakonhjemmet Hospital||2|||f||||f||||||||||2017-10-11 03:09:49.320558|2017-10-11 03:09:49.320558
NCT01559311|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-11-17|2016-09-07||February 2012||2012-02-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|November 2015|Actual|2015-11-01||Interventional|ENHANCE|Age = (the year of visit - year of birth)|ENHANCE-Efficacy of the Presence of Right Ventricular Apical Pacing Induced Ventricular Dyssynchrony as a Guiding Parameter for Biventricular Pacing in Patients With Bradycardia and Normal Ejection Fraction|Efficacy of the Presence of Right Ventricular Apical Pacing Induced Ventricular Dyssynchrony as a Guiding Parameter for Biventricular Pacing in Patients With Bradycardia and Normal Ejection Fraction|Completed||N/A|98|Actual|St. Jude Medical|Sample size was not reached due to difficulty in enrollment.|3|||f||||f||||||||||2017-10-11 03:09:49.461545|2017-10-11 03:09:49.461545
NCT01559298|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-05-10|||March 2012|Actual|2012-03-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|ARTE||Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial|Aspirin Versus Aspirin + ClopidogRel as Antithrombotic Treatment Following Transcatheter Aortic Valve Implantation With the Edwards SAPIEN XT Valve. A Randomized Pilot Study (the ARTE Trial)|Completed||Phase 4|178|Actual|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec||2|||f||||f||||||||||2017-10-11 03:09:50.786952|2017-10-11 03:09:50.786952
NCT01559285|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-08-28|||November 16, 2011|Actual|2011-11-16|August 2017|2017-08-01|April 19, 2013|Actual|2013-04-19|April 19, 2013|Actual|2013-04-19||Interventional|PNU||Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters|Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters|Completed||Phase 4|120|Actual|Pusan National University Hospital||3|||f||||f||||||||||2017-10-11 03:09:50.905436|2017-10-11 03:09:50.905436
NCT01559272|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-09-15|||February 21, 2008|Actual|2008-02-21|September 2017|2017-09-01|May 24, 2014|Actual|2014-05-24|April 9, 2014|Actual|2014-04-09||Interventional|||A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia|A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Paliperidone Palmitate 3-Month Formulation in Subjects With Schizophrenia|Completed||Phase 1|328|Actual|Janssen Research & Development, LLC||4|||f||||f||f||||||||2017-10-11 03:09:51.02216|2017-10-11 03:09:51.02216
NCT01559259|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-07-25||2014-07-25|April 2012||2012-04-01|July 2014|2014-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of the Efficacy of Novel Ibuprofen Acetaminophen Combination Formulations in the Treatment of Post-surgical Dental Pain|Evaluation of the Efficacy of Novel Ibuprofen Acetaminophen Combination Formulations in the Treatment of Post-surgical Dental Pain|Completed||Phase 2|394|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 03:09:51.402474|2017-10-11 03:09:51.402474
NCT01559246|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-11-05|||April 2012||2012-04-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Observational|TCEM||True Continuous ECG Monitoring (TCEM Study)|Comparison of Short Term Holter Monitoring vs. Long Term Zio(R)Patch True Continuous ECG Monitoring (TCEM Study)|Unknown status|Active, not recruiting|N/A|150|Anticipated|iRhythm Technologies, Inc.|||1||f||||f||||||||||2017-10-11 03:09:51.538145|2017-10-11 03:09:51.538145
NCT01559233|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2012-03-20|||February 2011||2011-02-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Clinical Study to Determine Safety and Efficacy of FPlus for Wrinkle Treatment|Clinical Study to Determine Safety and Efficacy of FPlus for Wrinkle Treatment|Completed||N/A|69|Actual|Invasix||1|||f||||f||||||||||2017-10-11 03:09:51.654922|2017-10-11 03:09:51.654922
NCT01559220|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-03-28|||March 2012||2012-03-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Deep Brain Stimulation for the Treatment of Alzheimer's Disease|Deep Brain Stimulation (DBS) for Treatment of the Cognitive, Behavioral, and Functional Disability of Alzheimer's Disease|Completed||N/A|3|Actual|Ohio State University||1|||f||||f|f|t|f|||||No||2017-10-11 03:09:51.735597|2017-10-11 03:09:51.735597
NCT01559207|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-03-25|||April 2013||2013-04-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism|Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism|Completed||N/A|120|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||Samples With DNA|"     EDTA, CTAD and dry tubes; Biological collection at the Nîmes University Hospital.   "|||2017-10-11 03:09:51.827476|2017-10-11 03:09:51.827476
NCT01559194|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-04-10|||May 2005||2005-05-01|April 2014|2014-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|LEAF||Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk|A Randomized Comparison of a Low Fat or Low Carbohydrate Dietary Pattern for Weight Loss and Impact on Biomarkers Associated With Breast Cancer Risk in Overweight and Obese Premenopausal Women: Lifestyle Eating and Fitness|Completed||Phase 3|82|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 03:09:51.993765|2017-10-11 03:09:51.993765
NCT01559181|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-10-13|||April 2012||2012-04-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|April 2015|Actual|2015-04-01||Observational|EPICOM||Study of Offspring of Women With Type 1 Diabetes|Environmental Versus Genetic and Epigenetic Influences on Growth, Metabolism and Cognitive Function in Offspring of Mothers With Type 1 Diabetes|Unknown status|Active, not recruiting|N/A|584|Actual|Odense University Hospital|||2||f||||f||||||Samples With DNA|"     Whole blood, serum and plasma. Tissue biopsies from m. vastus lateralis and subcutaneous     abdominal fat (only selected subgroup of participants)   "|||2017-10-11 03:09:52.096952|2017-10-11 03:09:52.096952
NCT01559168|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-01-31|||October 2012||2012-10-01|January 2017|2017-01-01|July 15, 2016|Actual|2016-07-15|July 15, 2016|Actual|2016-07-15||Interventional|||Uphold Mesh for the Surgical Treatment of Uterine-predominant Prolapse|Clinical Evaluation of the Uphold Mesh for the Surgical Treatment of Uterine-predominant Prolapse: a Prospective, Multicenter Trial|Completed||N/A|121|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-10-11 03:09:52.205902|2017-10-11 03:09:52.205902
NCT01555788|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2014-12-02|||February 2012||2012-02-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||DiaPort Closed-Loop Artificial Pancreas|Closed Loop Artificial Pancreas Using Intraperitoneal (IP) Insulin Via DiaPort®|Completed||Phase 2|10|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 03:10:50.478999|2017-10-11 03:10:50.478999
NCT01559155|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-03-30|||November 2013||2013-11-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid|Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid|Recruiting||N/A|130|Anticipated|Centre Hospitalier Universitaire de Nīmes|||3||f||||f||||||Samples With DNA|"     All left over plasma samples will be incorporated into the biological collection at the Nîmes     University Hospital.   "|||2017-10-11 03:09:52.352829|2017-10-11 03:09:52.352829
NCT01559129|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-04-05|||August 9, 2012|Actual|2012-08-09|April 2017|2017-04-01|November 3, 2016|Actual|2016-11-03|November 3, 2016|Actual|2016-11-03||Interventional|||Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease|A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease|Completed||Phase 2|23|Actual|Celgene||2|||f||||t||||||||||2017-10-11 03:09:52.570963|2017-10-11 03:09:52.570963
NCT01559116|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-06-19|2015-06-19|2014-04-03|March 2012||2012-03-01|June 2015|2015-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Treated Set (TS): This patient set includes all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease|Randomised, Double-blind, Placebo-controlled, 6 Treatment, 4 Period, Incomplete Cross-over Trial to Characterise the 24-hour Lung Function Profiles of Tiotropium + Olodaterol Fixed Dose Combination (2.5/5 µg, 5/5 µg), Tiotropium (2.5 µg, 5 µg) and Olodaterol (5 µg) (Oral Inhalation, Delivered by the Respimat® Inhaler) After 6 Weeks Once Daily Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD) [VIVACITOTM]|Completed||Phase 3|219|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 03:09:52.925198|2017-10-11 03:09:52.925198
NCT01559103|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2015-02-19|||May 2012||2012-05-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients|A Double-blind, Placebo-controlled, Randomized Study in Rheumatoid Arthritis Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of MEDI5117 (Anti-IL-6)|Terminated||Phase 1|39|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:09:54.831491|2017-10-11 03:09:54.831491
NCT01559090|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2017-03-07|||April 20, 2012|Actual|2012-04-20|March 2017|2017-03-01|February 21, 2017|Actual|2017-02-21|August 19, 2014|Actual|2014-08-19||Interventional|||Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus|A Phase 2, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Intravenous Dose of MEDI-546, a Human Monoclonal Antibody Directed Against Type I Interferon Receptor (IFNAR), in Japanese Subjects With Active Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|20|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 03:09:54.928314|2017-10-11 03:09:54.928314
NCT01559077|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2013-01-14|||March 2012||2012-03-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|||Trial to Evaluate Safety, Tolerability, and Parmacokinetics of ALN-TTR02 in Healthy Volunteer Subjects|A Phase 1, Randomized, Single-blind, Placebo-Controlled, Single Ascending Dose, Safety, Tolerability and Pharmacokinetics Study of ALN-TTR02 in Healthy Volunteers|Completed||Phase 1|17|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:09:55.038954|2017-10-11 03:09:55.038954
NCT01559064|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2014-10-06|2013-03-21||February 2012||2012-02-01|June 2014|2014-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face|A Prospective, Observational Study of the Volumizing Effect of Open-Label Aesthetic Use of VOLUMA® in the Mid-Face Area|Completed||N/A|115|Actual|Allergan|||3||f||||f||||||||||2017-10-11 03:09:55.127074|2017-10-11 03:09:55.127074
NCT01559051|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-19|2016-09-19|||March 2014||2014-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous and Inhalation Implantation of Autologous Adipose-Derived Stromal Vascular Fraction Cells in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||Phase 1/Phase 2|100|Anticipated|Ageless Regenerative Institute||1|||f||||f||||||||Undecided||2017-10-11 03:09:55.522976|2017-10-11 03:09:55.522976
NCT01559025|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-05-13|||March 2014||2014-03-01|May 2014|2014-05-01|March 2017|Anticipated|2017-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus|Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in Residual β-cell Function and Inflammatory Markers in New-onset Type 1 Diabetes Mellitus.|Unknown status|Recruiting|Phase 3|44|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:09:55.963716|2017-10-11 03:09:55.963716
NCT01559012|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-03-31|2014-02-12||February 2012||2012-02-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CLONEMESI|"Baseline biophysical and demographic data were reported:
age, race, ethnicity, parity, HG in previous pregnancy, smoking, BMI, weight loss, concurrent diseases, concurrent treatment,gestational age at start of symptoms, gestational age at enrollment, PUQE score at enrollment"|Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum|The CLONEMESI Study: a Randomized Placebo-controlled Study With Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum.|Completed||Phase 3|13|Actual|Azienda Ospedaliera Città della Salute e della Scienza di Torino|"Efficacy and safety issues are represented by maternal exposure in a critical period for organogenesis and hypotensive effect of the drug.
Findings based on a very limited number of women limit the reliability of results"|2|||f||||f||||||||||2017-10-11 03:09:56.082814|2017-10-11 03:09:56.082814
NCT01558999|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2014-07-22||2013-08-30|March 2012||2012-03-01|July 2014|2014-07-01||||July 2012|Actual|2012-07-01||Interventional|||A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye||Completed||Phase 2|150|Actual|Seikagaku Corporation||3|||f||||||||||||||2017-10-11 03:09:56.693695|2017-10-11 03:09:56.693695
NCT01558986|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-19|||December 2007||2007-12-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Routine Preoperative Antibiotic Prophylaxis in Modified Radical Mastectomy|A Randomized, Double Blinded Placebo-Controlled Trial on the Routine Use of Preoperative Antibiotic Prophylaxis in Modified Radical Mastectomy|Completed||Phase 3|254|Actual|University of the Philippines||2|||f||||t||||||||||2017-10-11 03:09:56.791669|2017-10-11 03:09:56.791669
NCT01558973|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2016-11-28|||August 2005||2005-08-01|November 2016|2016-11-01||||December 2015|Actual|2015-12-01||Observational|||FMRI of Stress and Addictive Disorders|Functional Magnetic Resonance Imaging of Stress and Addictive Disorders|Completed||N/A|108|Actual|Yale University|||6||f||||t||||||||||2017-10-11 03:09:56.87701|2017-10-11 03:09:56.87701
NCT01558960|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-08-19|||March 2012||2012-03-01|March 2012|2012-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Intravitreal Injections of Melphalan for Retinoblastoma|Intravitreal Injections of Melphalan for Retinoblastoma|Terminated||N/A|10|Anticipated|Hadassah Medical Organization||1||Sufficient findings to draw conclusions|f||||f||||||||||2017-10-11 03:09:56.955703|2017-10-11 03:09:56.955703
NCT01558947|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-18|||January 2011||2011-01-01|March 2012|2012-03-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer|Peri-operative Chemotherapy With ECX (Epirubicin + Cisplatin + Capecitabine) or XP (Capecitabine + Cisplatin) in the Treatment of Advanced Gastric Cancer: a Randomized, Multicenter, Parallel Control|Unknown status|Recruiting|Phase 2|2|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-11 03:09:57.030717|2017-10-11 03:09:57.030717
NCT01558934|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-05-01|||February 2012||2012-02-01|May 2017|2017-05-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients|A Pilot, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Electrocardiographic Effects of Lofexidine When Administered Orally to Methadone Maintained Adult Subjects|Completed||Phase 1|6|Actual|US WorldMeds LLC||1|||f||||f||||||||||2017-10-11 03:09:57.128025|2017-10-11 03:09:57.128025
NCT01558921|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2017-05-08|||June 21, 2011|Actual|2011-06-21|May 2017|2017-05-01|June 8, 2022|Anticipated|2022-06-08|March 8, 2020|Anticipated|2020-03-08||Interventional|RAPIDO||Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial|Randomized Multicentre Phase III Study of Short Course Radiation Therapy Followed by Prolonged Pre-operative Chemotherapy and Surgery in Primary High Risk Rectal Cancer Compared to Standard Chemoradiotherapy and Surgery and Optional Adjuvant Chemotherapy.|Active, not recruiting||Phase 3|920|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-10-11 03:09:57.225161|2017-10-11 03:09:57.225161
NCT01558908|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2012-03-18|||May 2012||2012-05-01|March 2012|2012-03-01|July 2013|Anticipated|2013-07-01|May 2013|Anticipated|2013-05-01||Interventional|||Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia|Allogeneic,Unrelated, Menstrual Derived, Mesenchymal Stem Cell-Like, Endometrial Cells; Administered Intramuscular|Unknown status|Not yet recruiting|Phase 1/Phase 2|15|Anticipated|Medistem Inc.||1|||f||||||||||||||2017-10-11 03:09:57.455233|2017-10-11 03:09:57.455233
NCT01558895|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2012-03-20|||March 2012||2012-03-01|March 2012|2012-03-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Interventional|||Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites|Infrared Ray Heat Treatment in Hepatic Area in Liver Cirrhosis Patients With Refractory Ascites|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|First People's Hospital of Foshan||2|||f||||t||||||||||2017-10-11 03:09:57.553829|2017-10-11 03:09:57.553829
NCT01558882|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2017-06-16|||January 21, 2014|Actual|2014-01-21|June 2017|2017-06-01|November 28, 2014|Actual|2014-11-28|November 28, 2014|Actual|2014-11-28||Observational|||Impact of Essure Tubal Sterilization Devices on the Endometrium|Impact of Essure Tubal Sterilization Devices on the Endometrium|Terminated||N/A|2|Actual|Centre Hospitalier Universitaire de Nīmes|||1|Trouble with recruting|f||||f||||||Samples With DNA|"     All left over samples will be included in the hematology biological collection at the Nîmes     University Hospital.      Endometrial flushing samples will also be included in the Nîmes University Hospital biobank.   "|||2017-10-11 03:09:57.639632|2017-10-11 03:09:57.639632
NCT01558869|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2017-05-06|||April 2012||2012-04-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma|An Open-label, Single-centre, Single-arm Phase II Study of Capecitabine Combined With Oxaliplatin and Irinotecan (Xeloxiri) as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma|Completed||Phase 2|37|Actual|The University of Hong Kong||1|||f||||f||||||||||2017-10-11 03:09:57.749425|2017-10-11 03:09:57.749425
NCT01558856|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-18|2016-10-12|||October 2012||2012-10-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|HAVIR Bi||Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder|Prospective Randomized Trial Comparing Unilateral and Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder|Recruiting||N/A|55|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 03:09:58.034691|2017-10-11 03:09:58.034691
NCT01558843|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2012-03-27|||February 2012||2012-02-01|March 2012|2012-03-01||||||||Observational|SANI||Sodium Management in Acute Neurological Injury|Sodium Management in Patients With Acute Neurological Injury|Unknown status|Recruiting|N/A|400|Anticipated|Washington University School of Medicine|||4||f||||f||||||||||2017-10-11 03:09:58.158042|2017-10-11 03:09:58.158042
NCT01558804|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-09-09|||November 2011||2011-11-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|GRASP||GRoup A StrePtococcus|Gene Expression in Isolates of Group A Streptococci Recovered From Patients Who Are Carriers|Recruiting||N/A|80|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||Samples With DNA|"     Throat swab specimens   "|No||2017-10-11 03:09:58.438397|2017-10-11 03:09:58.438397
NCT01558791|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-04-06|2014-11-03||September 2011||2011-09-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|TBI|All veterans screened for TBI|A Brief Educational Intervention to Improve Traumatic Brain Injury (TBI) Screening Outcomes|A Brief Educational Intervention to Improve TBI Screening Outcomes|Completed||Phase 1|1236|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 03:09:58.548984|2017-10-11 03:09:58.548984
NCT01558778|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-07-05|||May 2012||2012-05-01|July 2012|2012-07-01||||June 2012|Actual|2012-06-01||Interventional|||Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant|Pilot Study of Mechanical Stimulation for Prevention of Hematopoietic Cell Transplant Associated Bone Density Loss|Withdrawn||N/A|0|Actual|Roswell Park Cancer Institute||1||device not available|f||||t||||||||||2017-10-11 03:09:59.206148|2017-10-11 03:09:59.206148
NCT01558765|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-11-12|||March 2012||2012-03-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|CopenHeartVR||CopenHeartVR - Integrated Rehabilitation of Patients After Heart Valve Surgery|CopenHeartVR - A Randomized Clinical Trial Investigating the Effect of Integrated Rehabilitation Versus Usual Care Without Physical Exercise After Heart Valve Surgery.|Completed||Phase 2|147|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 03:09:59.374536|2017-10-11 03:09:59.374536
NCT01558752|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-08-04|||April 2010||2010-04-01|August 2016|2016-08-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Clinical Trial of a Metal on Poly Component Versus CORAIL Stem: A Bone Mineral Density Study|A Randomized Clinical Trial of a Modular Cementless Acetabular Metal on Poly Component Versus a Monoblock Cementless Titanium Shell With Ceramic on Ceramic Bearing and CORAIL Stem: A Bone Mineral Density Study|Recruiting||Phase 4|108|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 03:09:59.480639|2017-10-11 03:09:59.480639
NCT01558739|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-03-01|2015-01-26||May 2012||2012-05-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|MACS2030|All enrolled patients were included in the Full Analysis Set and the Safety Set.|Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)|A UK Open-label, Multicentre, Exploratory Phase II Study of INC424 for Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)|Completed||Phase 4|48|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:09:59.598363|2017-10-11 03:09:59.598363
NCT01558726|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2012-03-17|||October 2011||2011-10-01|March 2012|2012-03-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Case Management for Crack Users Who Seek Treatment in CAPSad in Brazil|Effectiveness of Case Management for Crack Users Who Seek Treatment in CAPSad in Six Brazilian Capitals|Unknown status|Recruiting|N/A|600|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 03:10:00.217936|2017-10-11 03:10:00.217936
NCT01558713|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-04-26|||January 2010||2010-01-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Epidural Volume Extension and Intrathecal Use of Local Anesthetics in Cesarean Sections|Assessment of Sensory and Motor Block After Intrathecal Administration of Bupivacaine, Ropivacaine and Levo-bupivacaine Combined With Small Doses of Fentanyl, Followed by Administration of Normal Saline Epidurally:a Clinical Trial in Parturients Scheduled for C-section|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|University of Patras||6|||f||||f||||||||||2017-10-11 03:10:00.332378|2017-10-11 03:10:00.332378
NCT01558700|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-12-16|2014-12-05||March 2012||2012-03-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Duloxetine in Osteoarthritis (OA) Pain|Brain Morphometries in OA Patients Treated With Duloxetine|Completed||Phase 4|40|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 03:10:00.46346|2017-10-11 03:10:00.46346
NCT01558687|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-02-03|||August 2012||2012-08-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Cilengitide Imaging Trial in Glioblastoma|A Multi-center, Open-label, Randomized, Controlled Phase I Trial to Investigate the Effects of Cilengitide (EMD 121974) Using Dynamic MR and FET-PET Imaging as a Pharmacodynamic Measure of Response in Subjects With Newly Diagnosed Glioblastoma|Terminated||Phase 1|1|Actual|Merck KGaA||2||Discontinuation of development program|f||||f||||||||||2017-10-11 03:10:00.739508|2017-10-11 03:10:00.739508
NCT01558674|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-03-27|2017-01-11||May 2014||2014-05-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)|A Two Part, Open-label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-7145 in Patients With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II)|Terminated||Phase 1|11|Actual|Merck Sharp & Dohme Corp.|Study terminated early due to lack of efficacy.|7||Lack of efficacy|f||||t||||||||||2017-10-11 03:10:00.843186|2017-10-11 03:10:00.843186
NCT01558648|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-04-03|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer|Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer|Active, not recruiting||N/A|265|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 03:10:01.545541|2017-10-11 03:10:01.545541
NCT01558635|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-04-28|||September 2012||2012-09-01|April 2017|2017-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Subjects With Longstanding Persistent Atrial Fibrillation Requiring Mitral Valve Surgery|Cryo-AF Clinical Study|Completed||N/A|17|Actual|Medtronic Cardiovascular||1|||f||||f||||||||No||2017-10-11 03:10:01.831306|2017-10-11 03:10:01.831306
NCT01558609|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-03-19|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:10:02.028388|2017-10-11 03:10:02.028388
NCT01558596|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-02-01|2016-10-12||September 2011||2011-09-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|December 2015|Actual|2015-12-01||Interventional|CRIPES||Remote Ischemic Preconditioning Prior to Vascular Surgery|Cardiac Remote Ischemic Preconditioning Prior to Elective Major Vascular Surgery|Completed||Phase 1/Phase 2|201|Actual|VA Office of Research and Development||2|||f||||t||||||||No||2017-10-11 03:10:02.087351|2017-10-11 03:10:02.087351
NCT01558583|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-04-21|||July 2011||2011-07-01|July 2012|2012-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|CARR2||Online Study of Colorectal Cancer and Prostate Cancer Screening Decision Making|A Comparison of the Effect of a Conjoint Analysis Based Values Clarification Exercise, Rating and Ranking Exercise, and Balance Sheet for Colorectal Cancer Screening and Prostate Cancer Screening Decision Making|Completed||N/A|1831|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 03:10:02.372526|2017-10-11 03:10:02.372526
NCT01558570|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2012-03-17|||July 2011||2011-07-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin|Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin|Completed||N/A|100|Actual|University of Maryland|||1||f||||f||||||Samples With DNA|"     Laboratory Measures:      Zonulin and gliadin antibodies will be sent to the lab of Dr. Alessio Fasano for assay.      Genetic and Biochemical analysis will be sent for analysis and storage of blood sample at the     Maryland Psychiatric Research Center Neurogenetics laboratory under the direction of Dr.     Ikwunga Wonodi. Analysis will include kynurenic acid metabolites, inflammatory markers from     Peripheral Blood Mononuclear Cells (PBMC) and future genetic analysis including but not     limited to human leukocyte antigen (HLA) haplotypes (DQ2 and DQ8).      Cytokines will be analyzed by the Cytokine Core Laboratory at the University of Maryland     using Luminex Technology.      Other standard laboratories will be done by Lab Corp or other contract laboratory.   "|||2017-10-11 03:10:02.464763|2017-10-11 03:10:02.464763
NCT01558557|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-01-27|||June 2008||2008-06-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Gluten Free Diet in People With Schizophrenia: A Pilot Study|Gluten Free Diet in People With Schizophrenia: A Pilot Study|Completed||N/A|3|Actual|University of Maryland||1|||f||||f||||||||||2017-10-11 03:10:02.537974|2017-10-11 03:10:02.537974
NCT01558544|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-02-21|||April 1997|Actual|1997-04-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cryopreservation of Ovarian Tissue|Cryopreservation of Ovarian Tissue for Potential In Vitro Maturation or Autologous Transplantation|Recruiting||N/A|100|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 03:10:02.631649|2017-10-11 03:10:02.631649
NCT01558531|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2015-02-02|||January 2010||2010-01-01|February 2015|2015-02-01||||December 2011|Actual|2011-12-01||Observational|DEBATE-ISR||Drug Eluting Balloon in Peripheral Intervention for In-Stent Restenosis|Drug Eluting Balloon in peripherAl inTErvention for In-Stent Restenosis: the DEBATE-ISR Study|Suspended||Phase 4|44|Actual|Ospedale San Donato|||2|slow enrollment|f||||f||||||||||2017-10-11 03:10:02.717401|2017-10-11 03:10:02.717401
NCT01558518|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2013-07-09|||September 2012||2012-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Handheld Echocardiography in Clinical Practice|Handheld Echocardiography in Clinical Practice|Completed||N/A|200|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:10:02.795142|2017-10-11 03:10:02.795142
NCT01558505|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2013-01-26|||November 2010||2010-11-01|January 2013|2013-01-01||||September 2012|Actual|2012-09-01||Interventional|DEBATE-BTK||Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation|Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation: the DEBATE-BTK Study|Completed||Phase 4|142|Actual|Ospedale San Donato||2|||f||||f||||||||||2017-10-11 03:10:02.930043|2017-10-11 03:10:02.930043
NCT01558492|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-05-05|2017-02-28||March 2011|Actual|2011-03-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|June 2012|Actual|2012-06-01||Interventional|||Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer|A Phase II Trial of Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer Previously Treated With Docetaxel|Terminated||Phase 2|3|Actual|Weill Medical College of Cornell University||1||Poor accrual|f||||t||||||||No||2017-10-11 03:10:03.014896|2017-10-11 03:10:03.014896
NCT01558479|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-05-28|||September 2009|Actual|2009-09-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|PaGeR||The Parkinson's Genetic Research Study|The Parkinson's Genetic Research Study (PaGeR)|Recruiting||N/A|5000|Anticipated|University of Washington|||3||f||||f||||||Samples With DNA|"     Blood or saliva   "|||2017-10-11 03:10:03.219966|2017-10-11 03:10:03.219966
NCT01558466|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2012-09-23|||November 2011||2011-11-01|September 2012|2012-09-01|June 2015|Anticipated|2015-06-01|November 2014|Anticipated|2014-11-01||Interventional|Sildeno||Sildenofil in Persistent Pulmonary Hypertension in Newborns|Early Combined Use of Inhaled Nitric Oxide and Oral Sildenafil on the Outcome of Pulmonary Hypertension in New Born Infants|Unknown status|Recruiting|Phase 3|100|Anticipated|Hamad Medical Corporation||2|||f||||f||||||||||2017-10-11 03:10:03.362503|2017-10-11 03:10:03.362503
NCT01558453|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2013-03-25|||March 2011||2011-03-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Oxaliplatin for Children With Solid Tumors|Phase II Study With Oxaliplatin In Children With Relapsed/Refractory Solid Tumors|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Hospital Santa Marcelina||1|||f||||f||||||||||2017-10-11 03:10:03.486669|2017-10-11 03:10:03.486669
NCT01558245|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2013-09-11|||December 2011||2011-12-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis|Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis|Unknown status|Recruiting|Phase 2|99|Anticipated|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 03:10:08.000076|2017-10-11 03:10:08.000076
NCT01558440|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-07-26|||January 2012||2012-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Rehabilitation of Malnourished Infants With F-100 or Diluted F-100|Rehabilitation of Severely Malnourished Infants Aged <6months: a Randomised, Controlled Comparison of Three Recovery Diets (Infant Formula, F-100 and Diluted F-100)|Completed||Phase 2|132|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||t||||||||||2017-10-11 03:10:03.572318|2017-10-11 03:10:03.572318
NCT01558427|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-06-01|||May 2012||2012-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer|Salvage Treatment or Active Clinical Surveillance for Oligometastatic Prostate Cancer: a Randomized Phase II Trial|Active, not recruiting||Phase 2|54|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 03:10:03.665914|2017-10-11 03:10:03.665914
NCT01558414|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2013-03-11|||April 2011||2011-04-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|October 2011|Actual|2011-10-01||Interventional|||Single Incision Laparoscopic Surgery vs Flexible Single Incision Surgery for Cholecystectomy|Prospective Randomized Clinical Trial Comparing Single Incision Laparoscopic Surgery vs Flexible Single Incision Surgery on Cholecystectomy|Completed||Phase 3|60|Actual|Hospital Son Llatzer||3|||f||||f||||||||||2017-10-11 03:10:03.745429|2017-10-11 03:10:03.745429
NCT01558401|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-19|||April 2010||2010-04-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Efficiency of Physical Activity on the Physical Condition of Elderly Women|Effects of an Adapted Physical Activity Program on the Physical Condition of Elderly Women: an Analysis of Efficiency|Completed||N/A|120|Actual|Universidade Federal de Sao Carlos||1|||f||||t||||||||||2017-10-11 03:10:03.839234|2017-10-11 03:10:03.839234
NCT01558388|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-16|||September 2009||2009-09-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy|Randomised Control Trial of Probiotics Versus Placebo as Adjuvant to Oral Clindamycin Treatment for Bacterial Vaginosis During Pregnancy|Unknown status|Recruiting|Phase 4|100|Anticipated|Università degli Studi di Brescia||2|||f||||f||||||||||2017-10-11 03:10:03.921073|2017-10-11 03:10:03.921073
NCT01558375|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-05-26|||March 2012||2012-03-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Anakinra in Hidradenitis Suppurativa|A Double-blind, Randomized, Placebo-controlled Clinical Trial of the Safety and Efficacy of Anakinra in Patients With Hidradenitis Suppurativa|Completed||Phase 2|20|Actual|University of Athens||2|||f||||t||||||||||2017-10-11 03:10:03.996693|2017-10-11 03:10:03.996693
NCT01558362|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-04-21|||April 2012||2012-04-01|April 2017|2017-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|CMICE||A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers|A Phase 1 Study of Safety, Tolerance, Pharmacokinetics and Nuclear Medicine Imaging of 123I-CMICE-013 Administered Intravenously in Healthy Adult Volunteers|Completed||Phase 1|12|Actual|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 03:10:04.10065|2017-10-11 03:10:04.10065
NCT01558349|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-17|2017-01-31|||June 2013||2013-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques|Circulating Tumor Cells and Melanoma: Comparing the EPISPOT (EPithelial ImmunoSPOT) and CellSearch Techniques|Recruiting||N/A|82|Anticipated|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||||||2017-10-11 03:10:04.189763|2017-10-11 03:10:04.189763
NCT01558336|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2013-01-16|||August 2008||2008-08-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Schistosoma Haematobium Infections and Praziquantel|Schistosoma Haematobium Infections Among Schoolchildren in Central Sudan One Year After Treatment With Praziquantel|Completed||Phase 3|520|Actual|University of Khartoum||1|||f||||t||||||||||2017-10-11 03:10:04.285929|2017-10-11 03:10:04.285929
NCT01558323|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-01-14|||May 2012||2012-05-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Pharmacokinetics of LCQ908 in Patients With Renal Impairment|An Open-label, Parallel-group, Single Dose Study to Assess the Pharmacokinetics of LCQ908 in Patients With Mild, Moderate and Severe Renal Impairment Compared to Age, Gender and Weight-matched Healthy Volunteers.|Completed||Phase 1|58|Actual|Novartis||3|||f||||||||||||||2017-10-11 03:10:04.379433|2017-10-11 03:10:04.379433
NCT01558310|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-07-17|||August 2012||2012-08-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis|A Double - Blind, Placebo Controlled Crossover Study to Evaluate The Efficacy and Tolerability of Stelara ™ (Ustekinumab) in The Treatment of Scalp Psoriasis|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Yamauchi, Paul Steven, M.D., Ph.D.||2|||f||||f||||||||||2017-10-11 03:10:04.500162|2017-10-11 03:10:04.500162
NCT01558297|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-06-03|2015-05-19||April 2012||2012-04-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Chi-square for categorical variables and ANOVAs for continuous variables.|Internet Treatment for Weight Loss in Primary Care|Internet Treatment for Weight Loss in Primary Care|Completed||N/A|89|Actual|Yale University|Treatment as Usual (TAU) was subsequently referred to as Usual Care (UC) when the study results were disseminated because the literature evolved regarding treatment terms. UC more accurately reflect the condition.|3|||f||||t||||||||||2017-10-11 03:10:04.617188|2017-10-11 03:10:04.617188
NCT01558284|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-02-04|||February 2012||2012-02-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Observational|Neu-P11||The Effect of Neu-P11 on Symptoms in Patients With D-IBS|Clinical Study on the Effect of Neu-P11 on Symptoms in Patients With Diarrhea- Irritable Bowel Syndrome (D-IBS)|Completed||N/A|40|Actual|Ludwig-Maximilians - University of Munich|||1||f||||t||||||||||2017-10-11 03:10:05.174656|2017-10-11 03:10:05.174656
NCT01558271|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-05-20|2014-10-22|2014-04-25|March 2012||2012-03-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional||Participants who received at least 1 dose of study medication.|A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus|A Phase 3 Study of LY2189265 Monotherapy Compared to Placebo and Liraglutide in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|492|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:10:05.361238|2017-10-11 03:10:05.361238
NCT01558258|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-04-08|||April 2011||2011-04-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|||A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors|A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors|Completed||Phase 2|71|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 03:10:07.929695|2017-10-11 03:10:07.929695
NCT01558232|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-07-05|||March 2012||2012-03-01|July 2012|2012-07-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|Acute Effects||A Prospective Study to Evaluate Use of the Tibion Bionic Leg in Sub-Acute Post-stroke Patients|A Prospective, Experimental ABA Study to Evaluate Use of the Tibion Bionic Leg in Subacute Post-stroke Patients Undergoing Physical Therapy|Terminated||N/A|10|Actual|Tibion Bionics, Inc.||1||Study was terminated base on Sponsor's decision.|f||||f||||||||||2017-10-11 03:10:08.151407|2017-10-11 03:10:08.151407
NCT01558219|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2016-10-20|||November 2011||2011-11-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ProstyII||Second-line Chemotherapy in Castration Resistant Prostate Cancer|Open, Single-arm, Multicenter, Phase II Trial Investigating the Safety of Biweekly Cabazitaxel in Metastatic Castration Resistant Prostate Cancer Patients Previously Treated With a Docetaxel-containing Regimen|Completed||Phase 2|60|Actual|Tampere University Hospital||1|||f||||f||||||||||2017-10-11 03:10:08.250213|2017-10-11 03:10:08.250213
NCT01558206|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2012-03-16|||March 2012||2012-03-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Observational|||Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE|Bedside Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in the Patients Who Came to Emergency Department of Alzahra General Hospital With Respiratory Symptoms and Signs in Favor of Pulmonary Thromboemboli.|Unknown status|Enrolling by invitation|N/A|76|Anticipated|Isfahan University of Medical Sciences|||1||f||||t||||||||||2017-10-11 03:10:08.357357|2017-10-11 03:10:08.357357
NCT01558193|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-05-02|||March 2011||2011-03-01|May 2017|2017-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Impact of Supplementation With Multi-vitamins/Minerals, With and Without Fatty Acids, on Impulsivity and Aggression|The Impact of Supplementation With Multi-vitamins/Minerals, With and Without Fatty Acids, on Impulsivity and Aggression|Completed||N/A|202|Actual|Swansea University||4|||f||||f||||||||||2017-10-11 03:10:08.487667|2017-10-11 03:10:08.487667
NCT01558180|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-02-02|||April 2012||2012-04-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Telephone Care Management to Address Sleep Problems in Young Children With Autism|Telephone Care Management to Address Sleep Problems in Young Children With Autism|Completed||Phase 2|60|Anticipated|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 03:10:08.605735|2017-10-11 03:10:08.605735
NCT01558167|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-09-23|||February 2011||2011-02-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|October 2013|Actual|2013-10-01||Interventional|CLL2P||A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia|A phaseI/II Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide (BRL) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|22|Actual|German CLL Study Group||1|||f||||f||||||||No||2017-10-11 03:10:08.704806|2017-10-11 03:10:08.704806
NCT01558154|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-16|||March 2012||2012-03-01|March 2012|2012-03-01|July 2014|Anticipated|2014-07-01|March 2014|Anticipated|2014-03-01||Interventional|||Comparison of Treatment Effect of Chinese Medicine and Western Medicine on Depression in China and America|Comparison of Treatment Effect of Chinese Medicine and Western Medicine on Depression in China and America|Unknown status|Not yet recruiting|N/A|160|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||4|||f||||t||||||||||2017-10-11 03:10:08.839834|2017-10-11 03:10:08.839834
NCT01558141|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-06-10|||September 2011||2011-09-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Follicular Flushing|Follicular Flushing on Cycle Outcomes in Poor Responders|Completed||N/A|50|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 03:10:08.971158|2017-10-11 03:10:08.971158
NCT01558128|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-04-21|2017-02-16||March 2012||2012-03-01|April 2017|2017-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery|Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery|Terminated||N/A|1|Actual|Weill Medical College of Cornell University||1||Insufficient Recruitment|f||||f||||||||No|There is no plan to share IPD|2017-10-11 03:10:09.079483|2017-10-11 03:10:09.079483
NCT01558115|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-04-07|||January 2012||2012-01-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Denosumab in Primary Hyperparathyroidism|Denosumab in Primary Hyperparathyroidism|Completed||Phase 4|8|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 03:10:09.248185|2017-10-11 03:10:09.248185
NCT01558102|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-11-20|||March 2012||2012-03-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|IntrePED||International Retrospective Study of Pipeline Embolization Device|International Retrospective Study of Pipeline Embolization Device|Completed||N/A|793|Actual|ev3|||1||f||||f||||||||||2017-10-11 03:10:09.345109|2017-10-11 03:10:09.345109
NCT01558089|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-09-21|2016-05-25||March 2013||2013-03-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|EARLY RA||Good EULAR Response In Patients With Early Rheumatoid Arthritis|Ability To Achieve A Good Eular Response In Patients With Moderate-to-severe Active Early Rheumatoid Arthritis Who Satisfy The New Acr/Eular Classification Criteria Receiving Etanercept + Mtx In Real World Clinical Practice In Greece|Completed||N/A|76|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:10:09.501358|2017-10-11 03:10:09.501358
NCT01558076|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-09-21|||January 2012||2012-01-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia|Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia|Unknown status|Recruiting|N/A|90|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||t||||||||||2017-10-11 03:10:09.828907|2017-10-11 03:10:09.828907
NCT01558063|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-12-20|||February 2012||2012-02-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Ketamine in the Treatment of Depression|The Antidepressant Action of Ketamine: Brain Chemistry|Active, not recruiting||Phase 2|76|Anticipated|Columbia University||6|||f||||t||||||||Undecided||2017-10-11 03:10:09.926068|2017-10-11 03:10:09.926068
NCT01558050|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2012-09-13|||March 2012||2012-03-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||the Effect of a Red Rice Nutrition Supplement on Cholesterol Levels|The Effect of a Commercially Available Red Rice Nutrition Supplement on Serum Lipids|Completed||Phase 4|52|Actual|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-11 03:10:10.036094|2017-10-11 03:10:10.036094
NCT01558037|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2013-04-03|||April 2010||2010-04-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Observational|ViracorCMI||Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients|A Study to Correlate CMV-Specific Cell Mediated Immunity With Risk of CMV Disease and With Clinical Response to Therapy Following Solid Organ Transplantation|Completed||N/A|113|Actual|Northwestern University|||2||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 03:10:10.112853|2017-10-11 03:10:10.112853
NCT01558024|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-05-19|||July 2014||2014-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|MACIVC||The Effects of Compression Stockings on Pressure Parameters in Patients With Chronic Venous Insufficiency|The Effects of Compression Stockings on Pressure Parameters in Patients With Chronic Venous Insufficiency|Completed||N/A|111|Actual|Centre Hospitalier Universitaire de Nīmes|||6||f||||f||||||||||2017-10-11 03:10:10.180398|2017-10-11 03:10:10.180398
NCT01558011|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-05-03|||March 2012||2012-03-01|October 2013|2013-10-01|December 2015|Actual|2015-12-01|October 2014|Actual|2014-10-01||Interventional|||Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study|Using Genetic Polymorphisms of Drug Metabolism and Immunohistochemical Stain to Predict the Efficacy and Toxicity in Patients With Gastric Adenocarcinoma - A Phase II Study|Terminated||Phase 2|51|Actual|National Health Research Institutes, Taiwan||1||The budget issues.|f||||t||||||||||2017-10-11 03:10:10.259196|2017-10-11 03:10:10.259196
NCT01557998|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-07-11|||March 2012||2012-03-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|TLCIDU Kenya||Testing and Linkage to Care for Injecting Drug Users in Kenya|Testing and Linkage to Care for IDUs in Kenya|Recruiting||N/A|10000|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 03:10:10.359422|2017-10-11 03:10:10.359422
NCT01557985|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-03-19|||July 2010||2010-07-01|March 2013|2013-03-01||||October 2011|Actual|2011-10-01||Interventional|||Single Dose Pharmacokinetics and Pharmacodynamics of Bupivacaine Following Transversus Abdominis Plane (TAP) Block in Neonates|Single Dose Pharmacokinetics and Pharmacodynamics of Bupivacaine Following Transversus Abdominis Plane (TAP) Block in Neonates|Completed||Phase 2|13|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||t||||||||||2017-10-11 03:10:10.450482|2017-10-11 03:10:10.450482
NCT01557972|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2012-03-16|||November 1999||1999-11-01|March 2012|2012-03-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Observational|||Long-term of 10 Years Results of a Prospective Longitudinal Study|Usefulness of Home Blood Pressure Measurement in the Morning in Type 2 Diabetic Patients : Long-term (10 Years) Results of a Prospective Longitudinal Study|Unknown status|Active, not recruiting|N/A|400|Anticipated|Nagaoka Red Cross Hospital|||2||f||||f||||||||||2017-10-11 03:10:10.530499|2017-10-11 03:10:10.530499
NCT01557959|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-07-28|2013-05-01||July 2007|Actual|2007-07-01|November 2013|2013-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Sequential Dose-Dense Chemotherapy and Dose-Intense Erlotinib for the Initial Treatment of Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|45|Actual|Wake Forest University Health Sciences||1|||f||||t|t|f||||||||2017-10-11 03:10:10.623288|2017-10-11 03:10:10.623288
NCT01557946|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-08-10|2017-01-20||March 2012||2012-03-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression|Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression|Completed||Phase 4|32|Actual|Mclean Hospital|"Modest sample size due to participant attrition and the cost and logistical challenges of the study design.
Multiple comparisons, increasing the likelihood of type I errors. Open-label design which leaves open the possibility of a placebo effect."|2|||f||||f||||||||||2017-10-11 03:10:11.366256|2017-10-11 03:10:11.366256
NCT01557933|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-11-28|||April 2011||2011-04-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Effects of Electroconvulsive Therapy (ECT) in Bipolar Depression|A Study of the Acute and Chronic Effects of Electroconvulsive Therapy on Glutamatergic Neurotransmission in Bipolar Depression|Withdrawn||N/A|0|Actual|Mclean Hospital|||1|Due to a lack of participants, this study has been closed.|f||||f||||||||||2017-10-11 03:10:11.787102|2017-10-11 03:10:11.787102
NCT01557920|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-08-01|2015-04-12||January 2013||2013-01-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||The Effects of General Anesthetics on Upper Airway Collapsibility in Healthy Subjects|The Effects of Sevoflurane, Propofol, and Carbon Dioxide 'Reversal' on Upper Airway Collapsibility in Healthy, Adult Subjects|Completed||Phase 4|18|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:10:11.872694|2017-10-11 03:10:11.872694
NCT01557907|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-07-25|||February 2012||2012-02-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion|Multi-day (3) In-patient Evaluation of Intradermal vs Subcutaneous Basal/Bolus Insulin Infusion|Completed||Phase 1/Phase 2|23|Actual|Becton, Dickinson and Company||2|||f||||f||||||||||2017-10-11 03:10:12.371048|2017-10-11 03:10:12.371048
NCT01557894|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-09-05|2013-10-09||April 2012||2012-04-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|iSOFIE-Ro||Internet Treatment for Social Phobia in Romania|Internet Treatment for Social Phobia in Romania: A Randomized Controlled Trial|Completed||N/A|76|Actual|Babes-Bolyai University|1) An active control condition matched for clients’ expectations, time, and therapist involvement was not included, 2)Due to personnel constrains, post-intervention SCID interviews were not blinded regarding the study conditions etc.|2|||f||||f||||||||||2017-10-11 03:10:12.462125|2017-10-11 03:10:12.462125
NCT01557881|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-08-12|||February 2012||2012-02-01|August 2015|2015-08-01||||April 2015|Actual|2015-04-01||Interventional|||Positron Emission Tomography/Magnetic Resonance Imaging in Patients|Evaluating Attenuation Correction Methods Applied to PET/MRI|Terminated||N/A|98|Actual|Case Comprehensive Cancer Center||1||Funding unavailable|f||||t||||||||||2017-10-11 03:10:12.849629|2017-10-11 03:10:12.849629
NCT01557868|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-02-19|2014-01-07||October 2008||2008-10-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis|Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis|Completed||Phase 4|198|Actual|American Orthopaedic Society for Sports Medicine||2|||f||||f||||||||||2017-10-11 03:10:12.935194|2017-10-11 03:10:12.935194
NCT01557842|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-05-13|2014-12-19||June 1, 2012|Actual|2012-06-01|May 2017|2017-05-01|March 19, 2014|Actual|2014-03-19|March 19, 2014|Actual|2014-03-19||Interventional|ASPIRE|All enrolled subjects|Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators|Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators|Terminated||Phase 4|15|Actual|Biosense Webster, Inc.|Please note that this study was terminated early and only 15 subjects were enrolled. As a result the reported results might be unreliable (unmonitored) and limited.|2|||f||||f||||||||||2017-10-11 03:10:15.595383|2017-10-11 03:10:15.595383
NCT01557829|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-04-03|||February 2012||2012-02-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|January 2016|Actual|2016-01-01||Interventional|SNAP||Valeo OL Interbody Fusion Devices for Posterior Lumbar Interbody Fusion SNAP Trial|Clinical Study of the Amedica Corporation Valeo OL Interbody Fusion Devices for Posterior Lumbar Interbody Fusion|Completed||N/A|100|Actual|Amedica Corporation||2|||f||||t||||||||No||2017-10-11 03:10:16.207292|2017-10-11 03:10:16.207292
NCT01557816|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-03-21|||December 2011||2011-12-01|February 2012|2012-02-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Trial of Naproxen to Evaluate Various Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee|A Randomized, Double-Blind, Placebo-controlled Cross-over, Exploratory Trial of Naproxen to Evaluate Methods of Measuring Analgesic Effect in Osteoarthritis Pain of the Knee|Unknown status|Recruiting|N/A|70|Anticipated|Analgesic Solutions||2|||f||||t||||||||||2017-10-11 03:10:16.343459|2017-10-11 03:10:16.343459
NCT01557803|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-01-13|||January 2012||2012-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Observational|IRIS||Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome|Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome in Lambaréné, Gabon|Completed||N/A|107|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples Without DNA|"     Plasma, Paxgene RNA tubes and urine   "|||2017-10-11 03:10:16.471058|2017-10-11 03:10:16.471058
NCT01557790|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-09-23|||March 2012||2012-03-01|July 2016|2016-07-01||||February 2015|Actual|2015-02-01||Interventional|||Proton Radiotherapy for Stage I, IIA, and IIB Seminoma|A Phase II Study of Adjuvant Proton Radiation Therapy for the Treatment of Stage I, IIA and IIB Seminoma|Active, not recruiting||Phase 2|5|Actual|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:10:16.594225|2017-10-11 03:10:16.594225
NCT01557777|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-07-02||2014-07-02|June 2012||2012-06-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)|An Extension Study of Navitoclax (ABT-263) in Subjects With Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|17|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 03:10:16.673553|2017-10-11 03:10:16.673553
NCT01557764|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2013-07-02|||September 2012||2012-09-01|July 2013|2013-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer|A Phase II Study of Lapatinib in Combination With Trastuzumab in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 03:10:16.929077|2017-10-11 03:10:16.929077
NCT01557751|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-06-05|||February 2010||2010-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Acute Pain Genomic Study|Preliminary Studies for Whole Genome Association Study (WGAS) in Acute Perioperative Pain|Active, not recruiting||N/A|400|Anticipated|University of Pittsburgh||1|||f||||t||||||||Undecided||2017-10-11 03:10:17.032563|2017-10-11 03:10:17.032563
NCT01557738|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-06-24|||December 2012||2012-12-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Role of Flavanols in Exercise and Aging|Acute and Long-term Effects of Dietary Flavanols on Local Control of Skeletal Muscle Blood Flow During Exercise in Young and Old Humans|Completed||N/A|20|Actual|University of Texas at Austin||4|||f||||f||||||||||2017-10-11 03:10:17.125266|2017-10-11 03:10:17.125266
NCT01557725|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2015-12-14|||February 2010||2010-02-01|December 2015|2015-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|FETA||Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty.|Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty|Completed||N/A|4924|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 03:10:17.232867|2017-10-11 03:10:17.232867
NCT01557712|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-02-23|||March 2012|Actual|2012-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|KETADEP||Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks|Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks.|Completed||Phase 3|25|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 03:10:17.33008|2017-10-11 03:10:17.33008
NCT01557699|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2014-11-29|2014-06-14||March 2012||2012-03-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Interventional|PMV-001|60 healthy adult males of 18 to 45 years|A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices|An Open-Label, Randomized, Phase I Study in Healthy Male Adults to Evaluate the Safety of a Measles Vaccine (Dry Powder)Administered by Two Devices|Completed||Phase 1|60|Actual|Serum Institute of India Pvt. Ltd.||3|||f||||f||||||||||2017-10-11 03:10:17.448976|2017-10-11 03:10:17.448976
NCT01557686|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-16|||May 2010||2010-05-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|PACE-AL||Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study|Patient Activation Through Counseling and Exercise - Acute Leukemia - Pilot Trial|Completed||Early Phase 1|20|Actual|Universitetshospitalernes Center for Sygepleje||1|||f||||t||||||||||2017-10-11 03:10:18.091056|2017-10-11 03:10:18.091056
NCT01557673|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2013-05-03|||January 2012||2012-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Bolus and Continuous Nasogastric Feeding on Small Bowel Water Content and Blood Flow|Effects of Bolus and Continuous Nasogastric Feeding on Small Bowel Water Content and Blood Flow|Completed||Phase 1/Phase 2|12|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-11 03:10:18.206411|2017-10-11 03:10:18.206411
NCT01550198|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-10-12|||May 2013||2013-05-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|Edscini||Early Detection of Neonatal Shock|Early Detection of Shock in Critically Ill Newborn Infants. The Impact of Advanced Hemodynamic Monitoring|Recruiting||N/A|70|Anticipated|Radboud University|||1||f||||t||||||||||2017-10-11 03:12:20.574423|2017-10-11 03:12:20.574423
NCT01557660|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-23|||June 2012||2012-06-01|March 2012|2012-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|INTREPID - OL||Inhaled Treprostinil for PAH: Open-label Extension|Inhaled Treprostinil in Subjects With Pulmonary Arterial Hypertension: An Open-Label, Phase III, International, Multi-Center Study|Withdrawn||Phase 3|0|Actual|United Therapeutics||1|||f||||t||||||||||2017-10-11 03:10:18.316681|2017-10-11 03:10:18.316681
NCT01557647|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-23|||June 2012||2012-06-01|March 2012|2012-03-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|INTREPID||Safety and Efficacy of Inhaled Treprostinil in Patients With PAH|Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension: A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil.|Withdrawn||Phase 3|0|Actual|United Therapeutics||2|||f||||t||||||||||2017-10-11 03:10:18.384415|2017-10-11 03:10:18.384415
NCT01557634|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2013-04-01|||December 2012||2012-12-01|March 2012|2012-03-01||||December 2013|Anticipated|2013-12-01||Interventional|||Closing the Loop in Young Children With Type 1 Diabetes|An Open-label, Single-centre, Randomised, 2-period Cross-over Study to Assess the Efficacy and Safety of Overnight Closed-loop Insulin Delivery Using Diluted Insulin in Comparison With Closed-loop With Non-diluted Insulin in Children With Type 1 Diabetes Aged 2 to 6 Years|Unknown status|Recruiting|Phase 2|12|Anticipated|University of Cambridge||2|||f||||f||||||||||2017-10-11 03:10:18.459856|2017-10-11 03:10:18.459856
NCT01557621|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-12-15|||September 2012||2012-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Comparative Effectiveness Trial of Two Reminder/Recall Methods to Increase Immunization Rates in Young Children|Center for Research in Implementation Science and Prevention (CRISP): Project 1: Comparative Effectiveness Trial of Two Reminder/Recall Methods to Increase Immunization Rates in Young Children|Completed||N/A|68000|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-10-11 03:10:18.59748|2017-10-11 03:10:18.59748
NCT01557608|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-03-29|||April 2012||2012-04-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|CIN||Characterization and Treatment of Chemotherapy Neuropathy|Characterization of and Treatment for Chemotherapy-Induced Neuropathy|Active, not recruiting||Phase 2|131|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:10:18.716944|2017-10-11 03:10:18.716944
NCT01557595|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-04-04|2014-04-08||September 2011||2011-09-01|April 2017|2017-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|ADHD||Blue Wavelength Light-blocking Glasses in ADHD-Insomnia|Evening Use of Polarized Glasses Designed to Filter Out Blue Light in Attention Deficit Hyperactivity Disorder - Delayed Circadian Rhythm Disorder Patients|Completed||N/A|22|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-11 03:10:18.800591|2017-10-11 03:10:18.800591
NCT01557582|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-03-25|2015-03-25||April 2012||2012-04-01|October 2012|2012-10-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional||Demographic information was not available for 2 patients. One subject failed to disclose metal in his abdomen and the other was due to user error.|Assessmet of Patients With PAH Right Ventricular Volume|Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Pulmonary Arterial Hypertension|Completed||N/A|103|Actual|VentriPoint Diagnostics Ltd.||1|||f||||f||||||||||2017-10-11 03:10:19.000818|2017-10-11 03:10:19.000818
NCT01557569|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-12-16|2016-10-24||April 2012||2012-04-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|ATM|those that received at least one dose of study medication|Clinical Efficacy of Atomoxetine for Methamphetamine Dependence||Completed||Phase 1/Phase 2|20|Actual|University of Arkansas|Recruitment and retention was much more difficult than anticipated. Because of, this too few (3 in ATM and 1 in PLA) were retained through the residential stay to determine efficacy.|2|||f||||t||||||||||2017-10-11 03:10:19.460065|2017-10-11 03:10:19.460065
NCT01557556|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-06-30|||February 24, 2012||2012-02-24|December 16, 2013|2013-12-16|December 16, 2013||2013-12-16|||||Observational|||Pexacerfont to Reduce Stress-induced Tobacco Craving|Pexacerfont for Reduction of Stress-induced Tobacco Craving, Nicotine Reinforcement, and Brain Activation in Humans|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:10:19.779754|2017-10-11 03:10:19.779754
NCT01557543|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-09-12|||February 27, 2012||2012-02-27|August 21, 2017|2017-08-21|July 25, 2017|Actual|2017-07-25|July 25, 2017|Actual|2017-07-25||Interventional|||Stem Cell Injection to Treat Heart Damage During Open Heart Surgery|Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD With Depressed Left Ventricular Function|Completed||Phase 1|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:10:19.837135|2017-10-11 03:10:19.837135
NCT01557517|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-08-25|||January 25, 2012||2012-01-25|August 24, 2017|2017-08-24|August 24, 2017|Actual|2017-08-24|June 9, 2017|Actual|2017-06-09||Interventional|||Clobetasol for Oral Graft-Versus-Host Disease|A Randomized Double-Blind Pilot Study of Topical Clobetasol 0.05% Oral Rinse for Oral Chronic Graft-Versus-Host-Disease|Completed||Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:10:19.920711|2017-10-11 03:10:19.920711
NCT01557504|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-04-06|2015-04-06||July 18, 2012|Actual|2012-07-18|April 2017|2017-04-01|April 29, 2014|Actual|2014-04-29|April 29, 2014|Actual|2014-04-29||Interventional|||A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)|A Study to Assess the Pharmacokinetics and the Ability for Pediatric Patients With Type 2 Diabetes to Swallow MK-0431A XR Tablets|Completed||Phase 1|25|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:10:20.044859|2017-10-11 03:10:20.044859
NCT01557491|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-16|||May 2012||2012-05-01|March 2012|2012-03-01||||November 2013|Anticipated|2013-11-01||Interventional|||Hair Regrowth After Bicoronal Incision|A Randomized Blinded Comparison of Hair Growth Following Either Bevelled or Standard Bi-coronal Scalp Incisions.|Unknown status|Not yet recruiting|N/A|26|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||||||||||||2017-10-11 03:10:20.671376|2017-10-11 03:10:20.671376
NCT01557478|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-01-06|||March 2012||2012-03-01|January 2015|2015-01-01||||September 2016|Anticipated|2016-09-01||Interventional|MIQOL-B||Melatonin as Adjuvant Therapy in Breast Cancer Patients|Melatonin in Improving the Quality of Life of Breast Cancer Patients and Reduction of Postoperative Pain and Chemotherapy Induced Toxicity|Unknown status|Active, not recruiting|Phase 2/Phase 3|166|Actual|Khon Kaen University||2|||f||||f||||||||||2017-10-11 03:10:20.796513|2017-10-11 03:10:20.796513
NCT01557452|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-02-26|||December 2011||2011-12-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||An Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis (JIA)|An Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Polyarticular Course Juvenile Idiopathic Arthritis (Poly JIA) JIA|Terminated||N/A|1|Actual|Italfarmaco||1||"Previous study DSC/08/2357/36 did not show efficacy for Givinostat in JIA. Decision wasn't   related to any tolerability concerns"|f||||f||||||||||2017-10-11 03:10:20.979593|2017-10-11 03:10:20.979593
NCT01557439|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-11-30|||February 2012||2012-02-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition|A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Levocetirizine Dihydrochloride 5 mg Tablets With Xyzal® 5 mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fasting Condition|Completed||Phase 1|28|Actual|IPCA Laboratories Ltd.||2|||f||||t||||||||||2017-10-11 03:10:21.063222|2017-10-11 03:10:21.063222
NCT01557426|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-04-28|||March 2012||2012-03-01|March 2012|2012-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Soft Tissue Ultrasound of Infections|Soft Tissue Ultrasound of Infections|Completed||Phase 1|15|Actual|Rhode Island Hospital||1|||f||||f||||||||||2017-10-11 03:10:21.155547|2017-10-11 03:10:21.155547
NCT01557413|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-02-20|||February 2012|Actual|2012-02-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|HUMERUS||Randomised Study Between Intramedullary Locking Nails and Locking Plates for Treatment of Proximal Humerus Fractures|Randomised Study Between Intramedullary Locking Nails and Locking Plates for Treatment of Proximal Humerus Fractures in Patients After 40-year-old|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-11 03:10:21.226692|2017-10-11 03:10:21.226692
NCT01557400|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-09-18|||May 2012||2012-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Ataluren for Previously Treated Patients With nmDBMD in Europe, Israel, Australia, and Canada|An Open-Label Study for Previously Treated Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy|Active, not recruiting||Phase 3|95|Actual|PTC Therapeutics||1|||f||||f||||||||||2017-10-11 03:10:21.34888|2017-10-11 03:10:21.34888
NCT01557387|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-12-27|||September 2011||2011-09-01|December 2014|2014-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Real-time Diagnosis of Pseudopolyps During Colonoscopy|Real-time Diagnosis of Pseudopolyps During Colonoscopy Using Noninvasive Advanced Endoscopic Techniques - a Prospective Study|Completed||N/A|75|Actual|University of Miami|||1||f||||f||||||||||2017-10-11 03:10:21.50676|2017-10-11 03:10:21.50676
NCT01557374|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2016-06-20|||April 2012||2012-04-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|TOLEDO||TOward the Lowest Effective DOse of Abatacept or Tocilizumab|Tapering Abatacept or Tocilizumab in Rheumatoid Arthritis in Remission. An Evaluation of Disease Activity, Relapse Risk, Structural Progression and the Economic Impact of a Tapering Strategy|Active, not recruiting||Phase 4|232|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-10-11 03:10:21.635296|2017-10-11 03:10:21.635296
NCT01557361|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2014-09-11|||May 2012||2012-05-01|August 2013|2013-08-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|STARRT-AKI||Standard Versus Accelerated Initiation of Dialysis in Acute Kidney Injury|STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI)|Completed||Phase 2|100|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-10-11 03:10:21.763526|2017-10-11 03:10:21.763526
NCT01557348|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-11-28|2016-11-28||June 2009||2009-06-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational||The primary effectiveness population included all participants who received at least one dose of a second biologic therapy at baseline (day of change in biologic therapy [<=Day 1]), had only one previous biologic therapy, and contributed for 24-week disease activity score 28 (DAS28)-erythrocyte sedimentation rate (ESR) for primary analysis.|An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor|A Global Multi-centre Observational Study in RA Patients Who Are Non Responders or Intolerant to a Single TNF Inhibitor.|Completed||N/A|1239|Actual|Hoffmann-La Roche|||2||f||||||||||||||2017-10-11 03:10:22.133229|2017-10-11 03:10:22.133229
NCT01557335|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-15|||November 2010||2010-11-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540|A Randomized, Open-Label, Cross-Over, Study to Evaluate the Inhibitory Effect of Clopidogrel, EC Aspirin 81 mg and EC Omeprazole 40 mg All Dosed Concomitantly and PA32540 and Clopidogrel Dosed Separately on Platelet Aggregation in Healthy Volunteers|Completed||Phase 1|30|Actual|POZEN||2|||f||||f||||||||||2017-10-11 03:10:24.374268|2017-10-11 03:10:24.374268
NCT01557322|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2013-08-26|2013-08-26||October 2011||2011-10-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)|Evaluation of the Clinical Characteristics, Real-world Treatment Pathways, and Outcomes of Patients With Moderate Rheumatoid Arthritis|Completed||N/A|1754|Actual|Pfizer|Since this study was a retrospective registry analysis of de-identified participants’ data, only SAEs pre specified in analysis were reported with preferred terms and all other SAEs were reported under the preferred term Other Serious Event.||2||f||||f||||||||||2017-10-11 03:10:24.545177|2017-10-11 03:10:24.545177
NCT01557309|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-08-16|||November 2010||2010-11-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Observational|||Clinical and Structural Outcome After Early Repair of the Traumatic Rotator Cuff Tear|Arthroscopic Repair of Traumatic Rotator Cuff Tears. A Prospective Trial|Completed||N/A|60|Actual|Helsingborgs Hospital|||1||f||||||||||Samples Without DNA|"     Peroperatively retained rotator cuff biopsy.   "|||2017-10-11 03:10:27.14521|2017-10-11 03:10:27.14521
NCT01557296|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-02-01|||September 2007||2007-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis|Comparing Treatment With Food of Small Particle Size and Food of Large Particle Size in Subjects With Diabetic Gastroparesis. Evaluation of Diagnostic Methods. Determination of the Motility of Gastric Emptying After Intervention|Recruiting||Phase 2|50|Anticipated|Göteborg University||2|||f||||f||||||||||2017-10-11 03:10:27.227713|2017-10-11 03:10:27.227713
NCT01557283|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-05-28|2014-05-28||September 2011||2011-09-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|BEFLEX|Per protocol (PP) population included participants who completed at least 1 treatment cycle, for whom study conclusion was duly filled in, and who had not deviated from protocol.|An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria|An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria - Beflex Study|Completed||N/A|140|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:10:27.403607|2017-10-11 03:10:27.403607
NCT01557270|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-12-03|||March 2012||2012-03-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety Study of Dexmedetomidine as an Additive to Local Anesthetics in Shoulder Surgery|The Efficacy and Safety of Dexmedetomidine as an Additive to Ropivacaine for Interscalene Brachial Plexus Blocks for Shoulder Surgery|Completed||Phase 3|62|Actual|Paracelsus Medical University||2|||f||||t||||||||||2017-10-11 03:10:27.808275|2017-10-11 03:10:27.808275
NCT01557257|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-06-26|||March 2012||2012-03-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pharmacokinetics Study of ALO-02 and OxyContin|An Open-label, Single-dose and Multiple-dose, Randomized, Crossover Study to Evaluate Pharmacokinetics, Safety and Tolerability After Administration of ALO-02 40 Mg Twice Daily Compared to ALO-02 80 Mg Once Daily and to Oxycontin 40 Mg Twice Daily in Healthy Volunteers|Completed||Phase 1|13|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:10:27.90642|2017-10-11 03:10:27.90642
NCT01557244|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-10-02|||July 2, 2012|Actual|2012-07-02|October 2017|2017-10-01|November 14, 2019|Anticipated|2019-11-14|November 14, 2019|Anticipated|2019-11-14||Interventional|||A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition|A 24-week Randomized, Open-label, Study To Evaluate The Safety And Efficacy Of Fesoterodine In Subjects Aged 6 To 17 Years With Symptoms Of Detrusor Overactivity Associated With A Neurological Condition (Neurogenic Detrusor Overactivity)|Recruiting||Phase 3|192|Anticipated|Pfizer||5|||f||||t|t|f||||||||2017-10-11 03:10:28.059855|2017-10-11 03:10:28.059855
NCT01557231|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-12-16|||March 2012||2012-03-01|December 2016|2016-12-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|||Epidemiology of Osteoarthritis (OA) Pain|Epidemiology of OA Pain|Active, not recruiting||N/A|60|Anticipated|Northwestern University|||1||f||||f||||||||||2017-10-11 03:10:28.370655|2017-10-11 03:10:28.370655
NCT01557218|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2013-02-14|||January 2011||2011-01-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Increasing the Variety of Vegetables and Fruits Served to Preschool Children at a Snack||Completed||N/A|61|Actual|Penn State University||8|||f||||f||||||||||2017-10-11 03:10:28.44282|2017-10-11 03:10:28.44282
NCT01557205|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-16|||March 2012||2012-03-01|March 2012|2012-03-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Observational|||Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging|Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging|Unknown status|Not yet recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||f||||||None Retained|"     No biospecimen to be retained.   "|||2017-10-11 03:10:28.541169|2017-10-11 03:10:28.541169
NCT01557192|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-04-12|||May 2010||2010-05-01|April 2016|2016-04-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|LFMS6tx||Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments|Low Field Magnetic Stimulation in Mood Disorders in Six Visits|Suspended||Phase 1|200|Anticipated|Mclean Hospital||2||on hold indefinitely due to lack of funding|f||||f||||||||||2017-10-11 03:10:28.597965|2017-10-11 03:10:28.597965
NCT01557179|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-16|||May 2009||2009-05-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional|||Evaluation of the Efficacy and Safety of Hyaluronic Acid Vaginal Gel to Ease Vaginal Dryness|Evaluation of the Efficacy and Safety of Hyaluronic Acid Vaginal Gel to Ease Vaginal Dryness. A Multicenter, Randomized, Controlled, Open-label, Parallel-group, Clinical Trial|Completed||Phase 2|144|Actual|Lee's Pharmaceutical Limited||2|||f||||f||||||||||2017-10-11 03:10:28.683783|2017-10-11 03:10:28.683783
NCT01557166|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-05-17|2015-01-22|2014-06-10|June 7, 2012|Actual|2012-06-07|May 2017|2017-05-01|June 17, 2013|Actual|2013-06-17|June 1, 2013|Actual|2013-06-01||Interventional|||Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea|Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial|Completed||Phase 3|359|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:10:28.935354|2017-10-11 03:10:28.935354
NCT01557153|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-16|||April 2012||2012-04-01|March 2012|2012-03-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|VALUeD||Vascular Augmentation of Late-life Unremitted Depression (VALUeD)|Vascular Augmentation of Late-life Unremitted Depression (VALUeD)|Unknown status|Not yet recruiting|Phase 3|80|Anticipated|Gateshead Health NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:10:29.640644|2017-10-11 03:10:29.640644
NCT01557140|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-08-10|||May 2003||2003-05-01|August 2015|2015-08-01|December 2006|Actual|2006-12-01|March 2004|Actual|2004-03-01||Interventional|||A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy|A Randomized Trial of Carvedilol After Renin-angiotensin System Inhibition in Chronic Chagas Cardiomyopathy|Completed||Phase 4|42|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-11 03:10:29.771591|2017-10-11 03:10:29.771591
NCT01557127|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-16|2017-03-24|||November 1, 2011|Actual|2011-11-01|March 2017|2017-03-01|March 31, 2016|Actual|2016-03-31|May 16, 2014|Actual|2014-05-16||Observational|NEXST||"Nexavar Dosing in Renal Cancer Patients in Real-life Setting"|Nexavar Dose Evaluation Study in Patients With Advanced Renal Cell Carcinoma|Completed||N/A|205|Actual|Bayer|||1||f||||f||||||||No||2017-10-11 03:10:29.919408|2017-10-11 03:10:29.919408
NCT01557114|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-16|2016-06-08|||March 2011||2011-03-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|Mel-Ipi-Rx||Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma|A Dose Escalation Phase I Study of Radiotherapy Administered in Combination With Anti-CTLA4 Monoclonal Antibody (Ipilimumab) in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma|Terminated||Phase 1|19|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1||New compounds available in the indication (nivolumab/pembrolizumab), toxicity of ipilimumab|f||||t||||||||||2017-10-11 03:10:30.062299|2017-10-11 03:10:30.062299
NCT01557101|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2014-01-08|||April 2012||2012-04-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|CRIBADO||Comparison Colon Capsule Endoscopy vs Optical Colonoscopy for Colorectal Cancer Screening in Familiar-Risk Population|Effectiveness of Colon Capsule Endoscopy as Colorectal Cancer Method of Screening in The Familiar-Risk Population|Completed||Phase 4|200|Actual|Hospital Universitario de Canarias||2|||f||||f||||||||||2017-10-11 03:10:30.181486|2017-10-11 03:10:30.181486
NCT01557088|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-09-22|||February 2009||2009-02-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|AIM 1 and II||Lp-PLA2 and Coronary Atherosclerosis in Humans|Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans|Completed||N/A|166|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 03:10:30.278813|2017-10-11 03:10:30.278813
NCT01557075|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-16|||July 2010||2010-07-01|March 2012|2012-03-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|statin||Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation|Effects of High-dose Statin Treatments on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Drug-eluting Stents Implantation: a Randomized Controlled Study|Unknown status|Recruiting|Phase 4|2000|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 03:10:30.36325|2017-10-11 03:10:30.36325
NCT01557062|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-03-15|||March 2009||2009-03-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Passive Body Heating, Sleep and Fibromyalgia|Passive Body Heating Improves The Sleep Pattern In Women Patients Fibromyalgia|Completed||N/A|25|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-10-11 03:10:30.479223|2017-10-11 03:10:30.479223
NCT01557049|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-15|||June 2008||2008-06-01|April 2010|2010-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|GPR||Global Postural Reeducation in Chronic Low Back Pain|Global Postural Reeducation in Chronic Low Back Pain: an Randomized Controlled Trial|Completed||N/A|61|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 03:10:30.58446|2017-10-11 03:10:30.58446
NCT01557036|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-01-19|||May 2012||2012-05-01|January 2015|2015-01-01||||May 2014|Actual|2014-05-01||Observational|ASPIRE||Aneurysm Study of Pipeline in an Observational Registry|Aneurysm Study of Pipeline in an Observational Registry|Terminated||N/A|200|Actual|ev3|||1||f||||t||||||||||2017-10-11 03:10:30.692287|2017-10-11 03:10:30.692287
NCT01557023|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-09-19|||July 1, 2013|Anticipated|2013-07-01|March 2012|2012-03-01|December 1, 2014|Anticipated|2014-12-01|December 1, 2014|Anticipated|2014-12-01||Interventional|||Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol||Withdrawn||Phase 3|0|Actual|Eurofarma Laboratorios S.A.||2||Change Company strategy|f||||t||||||||||2017-10-11 03:10:30.832899|2017-10-11 03:10:30.832899
NCT01557010|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-02-19|||March 2012||2012-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia|The Clinical Trial for Evaluation of Efficacy and Safety of DWP05195 in Postherpetic Neuralgia: Double-blind, Placebo-controlled, Randomized, Multi-center, Exploratory Clinical Trial|Completed||Phase 2|140|Actual|Daewoong Pharmaceutical Co. LTD.||4|||f||||||||||||||2017-10-11 03:10:30.903983|2017-10-11 03:10:30.903983
NCT01556997|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-09-08|2015-07-28||February 2012||2012-02-01|August 2015|2015-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|PATH||Perindopril Amlodipine for the Treatment of Hypertension|Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension|Completed||Phase 3|837|Actual|Symplmed Pharmaceuticals LLC||3|||f||||f||||||||||2017-10-11 03:10:30.997754|2017-10-11 03:10:30.997754
NCT01556984|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-06-12|||October 2012||2012-10-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Observational|||Changes of Endothelial Function Before and After DSA in Patients With Diabetes|Changes of Endothelial Function Before and After DSA in Patients With Diabetes|Completed||N/A|200|Anticipated|Wuhan General Hospital of Guangzhou Military Command|||2||f||||||||||||||2017-10-11 03:10:31.976982|2017-10-11 03:10:31.976982
NCT01556971|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-15|||February 2011||2011-02-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Efficacy Study of Botox for Depression|A Controlled Study of the Efficacy of Botulinum Toxin A (Botox) for the Treatment of Major Depressive Disorder (MDD)|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Capital Clinical Research Associates, LLC||2|||f||||f||||||||||2017-10-11 03:10:32.075448|2017-10-11 03:10:32.075448
NCT01556958|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2013-08-16|||March 2012||2012-03-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||WheezoMeter® Correlation Study|Prospective Comparative Study of WheezeRATE™ (Wz%) Readings With Spirometry, Symptoms, and Auscultatory Findings in Children With Wheezing.|Terminated||N/A|19|Actual|iSonea|||3|Device revised|f||||||||||||||2017-10-11 03:10:32.185333|2017-10-11 03:10:32.185333
NCT01556945|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-05-01|||April 2001||2001-04-01|May 2014|2014-05-01||||February 2002|Actual|2002-02-01||Interventional|MAL019||Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S|Phase I/IIa Safety, Immunogenicity, and Preliminary Efficacy of an Administration Schedule of FMP1 and SmithKlineBeecham Biologicals' Candidate Malaria Vaccine RTS,S Each Adjuvanted With SBAS2, Given Concomitantly in Separate Injections|Completed||Phase 1/Phase 2|72|Actual|U.S. Army Medical Research and Materiel Command||5|||f||||f||||||||||2017-10-11 03:10:32.286387|2017-10-11 03:10:32.286387
NCT01556932|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-10-15|2015-03-03||March 2012||2012-03-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional||Patients who were eligible were randomly assigned to two sequences: one group used ABH gel first and then the placebo; and the other group used the placebo first and then ABH gel. We assumed there was no carry-over effect from the first treatment to the second. In total, 22 patients were enrolled but 20 subjects completed the study.|"Randomized Trial of the Effectiveness of Topical ABH Gel vs. Placebo in Cancer Patients With Nausea"|"A Randomized Trial of the Effectiveness of Topical ABH Gel (Ativan®, Lorazepam; Benadryl®, Diphenhydramine; and Haldol®, Haloperidol Gel) Versus Placebo in Patients With Nausea"|Completed||N/A|22|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 03:10:32.392152|2017-10-11 03:10:32.392152
NCT01556919|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2017-05-10|||March 2012||2012-03-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Esophageal Monitoring Device for Assessing Mucosal Impedance|Development of an Esophageal Monitoring Device for the Assessment of Esophageal Epithelium Integrity With Mucosal Impedance|Recruiting||N/A|750|Anticipated|Vanderbilt University Medical Center|||1||f||||f||f||||||||2017-10-11 03:10:32.733176|2017-10-11 03:10:32.733176
NCT01556906|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-04-04|2013-01-18||June 2003||2003-06-01|April 2013|2013-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor|A Phase II Open Label, Dose-Escalation Study to Determine the Safety, Tolerability and Efficacy of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor BMS-201038 in Patients With Homozygous Familial Hypercholeterolemia|Completed||Phase 2|6|Actual|Aegerion Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 03:10:32.866799|2017-10-11 03:10:32.866799
NCT01556893|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-10-23|||April 2012||2012-04-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Creating LASIK Flaps With the LenSx Femtosecond Laser|Prospective, Single-center Clinical Trial of Subjects Scheduled to Undergo LASIK Surgery Requiring an Initial Corneal Flap.|Completed||Phase 1|20|Actual|Alcon LenSx, Inc.||1|||f||||f||||||||||2017-10-11 03:10:33.369956|2017-10-11 03:10:33.369956
NCT01556880|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-02-04|||May 2009||2009-05-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|May 2010|Actual|2010-05-01||Interventional|||RCT of SMS for Drivers With Pre-DM|A Randomized Controlled Trial of Short Message Service by Cellular Phone for Professional Drivers With Pre-diabetes|Completed||N/A|104|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:10:33.455038|2017-10-11 03:10:33.455038
NCT01556867|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-08-05|||March 2011||2011-03-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|NEOCORD||Evaluation of Two Strategies for Umbilical Cord Care : Dry Cord Care Versus Antiseptic on the Incidence of Omphalitis in Healthy Term Newborn|Evaluation of Two Strategies for Umbilical Cord Care : Dry Cord Care Versus Antiseptic on the Incidence of Omphalitis in Healthy Term Newborn|Terminated||N/A|8698|Actual|Nantes University Hospital||2|||f||||||||||||||2017-10-11 03:10:33.594823|2017-10-11 03:10:33.594823
NCT01556854|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-15|||July 2011||2011-07-01|March 2012|2012-03-01|June 2014|Anticipated|2014-06-01|November 2013|Anticipated|2013-11-01||Observational|CER||Comparative Effectiveness of Neuroprotectants on Acute Ischemic Stroke|Comparative Effectiveness of Different Neuroprotectants Among Patients With Acute Ischemic Stroke in Clinical Practice|Unknown status|Recruiting|N/A|20000|Anticipated|Ministry of Science and Technology of the People´s Republic of China|||1||f||||||||||||||2017-10-11 03:10:33.890627|2017-10-11 03:10:33.890627
NCT01556841|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-06-03|||November 2013||2013-11-01|June 2016|2016-06-01|October 2018|Anticipated|2018-10-01|May 2017|Anticipated|2017-05-01||Interventional|TRIOC||The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer|A Randomised Parallel Group Double-Blind Phase II Study to Assess the Activity of TroVax® (MVA-5T4) Versus Placebo in Patients With Relapsed Asymptomatic Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Recruiting||Phase 2|75|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 03:10:34.00827|2017-10-11 03:10:34.00827
NCT01556828|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-06-22|||June 2011||2011-06-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing|Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing|Terminated||N/A|70|Actual|Stanford University|||1||f||||t||||||Samples With DNA|"     whole blood tissue   "|||2017-10-11 03:10:34.279238|2017-10-11 03:10:34.279238
NCT01556815|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-04-24|||May 2012||2012-05-01|April 2012|2012-04-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma|Phase II Trail of Sorafenib Combined With Transarterial Chemoembolization in HBV-infected Patients With Intermediate Hepatocellular Carcinoma|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Shandong Cancer Hospital and Institute||2|||f||||f||||||||||2017-10-11 03:10:34.382007|2017-10-11 03:10:34.382007
NCT01556802|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-15|||October 2011||2011-10-01|March 2012|2012-03-01|January 2013|Anticipated|2013-01-01|November 2011|Actual|2011-11-01||Interventional|||Use of Minocicline in Patients With Stroke|Effect of Minocicline Use in Less Neurologic Sequels in Patients With Stroke|Unknown status|Recruiting|Phase 1|134|Anticipated|Hospital Universitario Hernando Moncaleano Perdomo||2|||f||||t||||||||||2017-10-11 03:10:34.546466|2017-10-11 03:10:34.546466
NCT01556789|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-09-15|||March 2013||2013-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Phase 1 Study of ONT-10 in Patients With Solid Tumors|Phase 1 Study of ONT-10, a Liposomal MUC1 Cancer Vaccine, in Patients With Solid Tumors|Completed||Phase 1|85|Actual|Cascadian Therapeutics Inc.||1|||f||||t||||||||||2017-10-11 03:10:34.675161|2017-10-11 03:10:34.675161
NCT01556776|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-09-20|||July 2012||2012-07-01|September 2016|2016-09-01|July 2021|Anticipated|2021-07-01|March 2016|Actual|2016-03-01||Interventional|||A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy|CLLM1-Protocol of the German CLL-Study Group (GCLLSG) A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) as Maintenance Therapy for High-risk Patients With Chronic Lymphocytic Leukemia Following First-line Therapy|Terminated||Phase 3|89|Actual|German CLL Study Group||2||Low recruitment rate|f||||t||||||||||2017-10-11 03:10:34.793851|2017-10-11 03:10:34.793851
NCT01556763|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-05-21|2012-04-18||April 2008||2008-04-01|May 2012|2012-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia|A Double-Blind, Placebo-Controlled Randomized Study to Assess the Safety, Tolerability, and Pharmacokinetics of EVP-6124 in Participants With Schizophrenia on Stable Monotherapy With Selected Antipsychotics|Completed||Phase 1|21|Actual|FORUM Pharmaceuticals Inc||3|||f||||f||||||||||2017-10-11 03:10:34.949154|2017-10-11 03:10:34.949154
NCT01556750|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2013-02-27|||March 2012||2012-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:10:35.817001|2017-10-11 03:10:35.817001
NCT01556737|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-10-30|||November 2011||2011-11-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|ISOII||Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal Women|Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal Women|Completed||N/A|72|Actual|Wageningen University||2|||f||||f||||||||||2017-10-11 03:10:35.865425|2017-10-11 03:10:35.865425
NCT01556724|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-03-23|2016-03-23||January 2010||2010-01-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|May 2011|Actual|2011-05-01||Interventional|||A Comparison of Postoperative Analgesic Nerve Block Ropivacaine Concentrations|A Comparison of 0.1 and 0.2% Ropivacaine in Lumbar Plexus Catheters After Primary Total Hip Arthroplasty: a Comparison of Postoperative Analgesia and Motor Function.|Completed||N/A|41|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 03:10:35.985182|2017-10-11 03:10:35.985182
NCT01556711|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-12-07|||August 2012||2012-08-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|B-AHEAD II||Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology|Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology|Completed||N/A|816|Actual|BrainScope Company, Inc.|||2||f||||f||||||||||2017-10-11 03:10:36.328468|2017-10-11 03:10:36.328468
NCT01556698|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-15|||July 2011||2011-07-01|March 2012|2012-03-01||||December 2011|Actual|2011-12-01||Interventional|||Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris||Completed||Phase 1/Phase 2|||Novan, Inc.||2|||f||||||||||||||2017-10-11 03:10:36.441872|2017-10-11 03:10:36.441872
NCT01556685|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2013-09-12|||March 2011||2011-03-01|March 2012|2012-03-01||||October 2011|Actual|2011-10-01||Interventional|MATRIX||MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia|Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia|Completed||Phase 4|180|Actual|Biogen||2|||f||||f||||||||||2017-10-11 03:10:36.523531|2017-10-11 03:10:36.523531
NCT01556672|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-06-28|||April 2012||2012-04-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||Adalimumab-psoriasis and Small Bowel Lesions|Open-label Study on Small Bowel Lesions Suggestive of Crohn's Disease in Patients With Moderate to Severe Plaque Psoriasis Treated With Adalimumab|Completed||Phase 4|100|Actual|Innovaderm Research Inc.||1|||f||||f||||||||No||2017-10-11 03:10:36.620703|2017-10-11 03:10:36.620703
NCT01556659|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-19|||March 2012||2012-03-01|March 2012|2012-03-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||LV Thrombus After Acute AMI: A Randomized Controlled Trial|Left Ventricular Thrombus Formation After Acute Myocardial Infarction - a Randomized Multi-center Trial Comparing Two Different Anti-thrombotic Regimens|Unknown status|Recruiting|N/A|250|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 03:10:36.709885|2017-10-11 03:10:36.709885
NCT01556646|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-02-06|||April 2011||2011-04-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Tolvaptan on Cognitive Function in Cirrhosis|Effects of Tolvaptan on Cognitive Function, Brain Metabolism and Quality of Life in Hyponatremic Cirrhotics With Hepatic Encephalopathy: A Prospective Clinical Trial|Completed||Phase 3|25|Actual|Hunter Holmes Mcguire Veteran Affairs Medical Center||1|||f||||f||||||||||2017-10-11 03:10:36.79946|2017-10-11 03:10:36.79946
NCT01556633|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-05-26|2015-11-30||March 2012||2012-03-01|May 2016|2016-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Safety population: All participants who received the study drug, whether prematurely withdrawn from the study or not, were included.|A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance|An Open Label, Prospective, Single Oral Dose Study Evaluating the Pharmacokinetics, Safety, and Tolerability of Oseltamivir in Adult Subjects on Peritoneal Dialysis (PD) Using a Rapid Cycle Regimen to Simulate APD and in Adult Subjects With Creatinine Clearance From 10 to 30 mL/Min Not on Dialysis|Completed||Phase 1|16|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:10:36.904125|2017-10-11 03:10:36.904125
NCT01556620|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-03-15|||November 2011||2011-11-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|NIRS||Is NIRS Able to Detect Ischemia Following Brain Insult|The New 4 Wavelengths EQUANOX NIRS Sensor: Correlation and Detection of Ischemic Episodes. An Observational Comparative Study Versus PtiO2|Completed||N/A|8|Actual|Direction Centrale du Service de Santé des Armées|||1||f||||f||||||||||2017-10-11 03:10:37.528263|2017-10-11 03:10:37.528263
NCT01556607|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-05-21|||March 2012||2012-03-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma|A Double-Blind, Randomized, 3 Period Crossover, Single Ascending Dose Study to Assess the Safety, and Tolerability of Inhaled MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma|Completed||Phase 1|10|Anticipated|MicroDose Therapeutx, Inc||2|||f||||||||||||||2017-10-11 03:10:37.593165|2017-10-11 03:10:37.593165
NCT01556594|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-04-26|2013-03-18||March 2012||2012-03-01|April 2016|2016-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|AMG102|Healthy volunteers|Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia|Phase II Study to Investigate the Safety and Efficacy of 2 Dose Levels of a Novel Glucagon Formulation Compared to Commercially Available Glucagon in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia|Completed||Phase 2|18|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 03:10:37.698702|2017-10-11 03:10:37.698702
NCT01556581|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-09-11|||February 2012|Actual|2012-02-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|July 27, 2016|Actual|2016-07-27||Interventional|COMPETE||Comparative Effectiveness of Early Physical Therapy Versus Usual Care for Low Back Pain|Effectiveness and Subsequent Healthcare Use Associated With Early Physical Therapy Access Compared With a Stepped Usual Care Approach for Treatment of Low Back Pain.|Completed||N/A|119|Actual|Madigan Army Medical Center||2|||f||||f||||||||||2017-10-11 03:10:38.285735|2017-10-11 03:10:38.285735
NCT01556568|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-12-28|||February 2012||2012-02-01|December 2015|2015-12-01||||May 2017|Anticipated|2017-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy|An Open Label Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy|Withdrawn||Phase 2|0|Actual|Array BioPharma||1||Study was withdrawn due to scientific and business considerations.|f||||f||||||||||2017-10-11 03:10:38.417255|2017-10-11 03:10:38.417255
NCT01556555|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-15|||September 2008||2008-09-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Observational|||Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)|Prospective Evaluation of the Clinical Utility of Peroral Cholangiopancreatoscopy With the Spyglass System in Patients With Sclerosing Cholangitis|Completed||N/A|46|Actual|Karolinska University Hospital|||1||f||||f||||||||||2017-10-11 03:10:38.575156|2017-10-11 03:10:38.575156
NCT01556542|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-01-26|||November 2010||2010-11-01|January 2013|2013-01-01||||September 2012|Actual|2012-09-01||Interventional|DEBATE SFA||Drug Eluting Balloon in peripherAl inTErvention SFA|Drug Eluting Balloon in peripherAl inTErvention: the DEBATE SFA Study|Completed||Phase 4|104|Actual|Ospedale San Donato||2|||f||||f||||||||||2017-10-11 03:10:38.685793|2017-10-11 03:10:38.685793
NCT01556529|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-03-20|||June 2007||2007-06-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|CDRM_DMP||CDRM Study: Computer-assisted Diabetes Risk Management-for Secondary and Tertiary Prevention of T2DM Complications|CDRM Study: Computer-assisted Diabetes Risk Management-evaluation of a Medical Care Approach to Support Secondary and Tertiary Prevention of Type 2 Diabetes Mellitus and Its Complications|Completed||N/A|405|Actual|Philipps University Marburg Medical Center||2|||f||||t||||||||||2017-10-11 03:10:38.842003|2017-10-11 03:10:38.842003
NCT01556516|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-09-27|||February 2012||2012-02-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|October 2014|Actual|2014-10-01||Observational|||Pregnancy and Birth Outcome in Women With Pompe Disease|Pregnancy and Birth Outcome in Women With Pompe Disease|Completed||N/A|20|Actual|O & O Alpan LLC|||1||f||||f||||||||||2017-10-11 03:10:40.49904|2017-10-11 03:10:40.49904
NCT01556503|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-04-21|||April 2011||2011-04-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis|Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis|Completed||N/A|24|Actual|OHSU Knight Cancer Institute|||1||f||||f||||||||||2017-10-11 03:10:40.593047|2017-10-11 03:10:40.593047
NCT01556490|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-08-22|||March 2012||2012-03-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|July 2019|Anticipated|2019-07-01||Interventional|STOP-HCC||Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer|A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC)|Recruiting||Phase 3|390|Anticipated|BTG International Inc.||2|||f||||t||||||||||2017-10-11 03:10:40.704698|2017-10-11 03:10:40.704698
NCT01556477|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-14|||March 2012||2012-03-01|March 2012|2012-03-01|November 2014|Anticipated|2014-11-01|July 2014|Anticipated|2014-07-01||Interventional|||The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).|A Multicentre Open Randomized Phase II Study of the Efficacy and Safety of Azacitidine Alone or in Combination With Lenalidomide in High-risk Myeloid Disease (High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia) With a Karyotype Including Del(5q)|Unknown status|Recruiting|Phase 2|72|Anticipated|Nordic MDS Group||2|||f||||t||||||||||2017-10-11 03:10:41.442076|2017-10-11 03:10:41.442076
NCT01556464|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-11-20|||February 2012||2012-02-01|November 2014|2014-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Initiation of Auto-adjusting CPAP for Newly Diagnosed OSA in Hospitalized Patients|Initiation of Auto-adjusting Continuous Positive Airway Pressure (CPAP) for Management of Newly Diagnosed Obstructive Sleep Apnea (OSA) in Hospitalized Patients: A Pilot Study|Terminated||Phase 2/Phase 3|5|Actual|MetroHealth Medical Center||2||Difficulty with enrollment. Study stopped after first 5 patients.|f||||f||||||||||2017-10-11 03:10:41.57091|2017-10-11 03:10:41.57091
NCT01556451|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-03-14|2013-07-19||April 2012||2012-04-01|March 2017|2017-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)|An Open-label, Single-arm, Multi-center, Phase IV Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX™ in Healthy Adults in Korea|Completed||Phase 4|180|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:10:41.679205|2017-10-11 03:10:41.679205
NCT01556438|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-02-09|||July 2012||2012-07-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|||Study of LY2127399 in Japanese Participants With Relapsed or Refactory Multiple Myeloma|A Phase 1 Study of LY2127399 in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|10|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:10:41.871969|2017-10-11 03:10:41.871969
NCT01556425|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-04-07|||May 2012|Actual|2012-05-01|April 2017|2017-04-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence|The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence|Active, not recruiting||Phase 2|84|Actual|Johns Hopkins University||4|||f||||f||||||||No|We will publish the results in a peer-reviewed journal.|2017-10-11 03:10:41.974763|2017-10-11 03:10:41.974763
NCT01556412|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2014-10-19|||March 2009||2009-03-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Observational|||Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis|Pilot Study of Endoscopic Ultrasound as an Early Diagnostic Tool for Evaluation of Suspected Primary Sclerosing Cholangitis|Completed||N/A|32|Actual|Tischendorf, Jens, M.D.|||1||f||||f||||||||||2017-10-11 03:10:42.058986|2017-10-11 03:10:42.058986
NCT01556399|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2015-12-15|||November 2011||2011-11-01|December 2015|2015-12-01|November 2021|Anticipated|2021-11-01|November 2020|Anticipated|2020-11-01||Observational|DUO/AMP-LST||Endoscopic Characteristics of Duodenal and Ampullary Lesions|A Correlation of the Endoscopic Characteristics of Duodenal and Ampullary Laterally Spreading Tumours With Their Somatic or Germline Mutations.|Recruiting||N/A|350|Anticipated|Western Sydney Local Health District|||1||f||||t||||||Samples With DNA|"     Adenoma tissue sample and control regular tissue sample   "|||2017-10-11 03:10:42.128294|2017-10-11 03:10:42.128294
NCT01556386|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-07-11|||June 2006||2006-06-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Observational|||Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia|Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia|Completed||N/A|200|Anticipated|Seoul National University Hospital|||1||f||||f||||||Samples With DNA|"     1. Candidate genes exhibit polymorphisms and encodes proteins that are involved in the          pharmacokinetics and pharmacodynamics of antileukemic agents             -  Priority was given to polymorphism that were demonstrated to be associated with               phenotypes in both clinical and preclinical studies.             -  Candidate genes : CYP3A4*1B, CYPA5*3, GSTM1 deletion, GSTP1 313, GSTT1 deletion,               MDR exon 21, MDR exon 26, MTHFR 677, MTHFR 1298, NR3C1 1088, RFC 80, TPMT-1 238,               TPMT-1 460, TPMT-1 719, VDR intron 8, VDR FokI, ITPA        2. Blood sample at complete remission→DNA extraction        3. Total-Plex (multiplex) PCR amplification        4. Luminex system analysis   "|||2017-10-11 03:10:42.201577|2017-10-11 03:10:42.201577
NCT01546727|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-12-27|||March 2012||2012-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|LAUNCH||Behavioral Treatment for Obese Preschoolers|Clinic and Home Family Based Behavioral Treatment for Obese Preschoolers|Completed||Phase 3|167|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-10-11 03:13:14.241197|2017-10-11 03:13:14.241197
NCT01556373|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-02-10|||February 2012||2012-02-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|IRIGA||Effects of Acute Systemic Inflammation on Arterial Stiffness and Microcirculation.|Effects of Acute Systemic Inflammation on Arterial Stiffness and Microcirculation.|Recruiting||N/A|40|Anticipated|Rennes University Hospital|||2||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 03:10:42.270039|2017-10-11 03:10:42.270039
NCT01556360|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-05-26|||July 2008||2008-07-01|May 2015|2015-05-01||||August 2014|Actual|2014-08-01||Observational|FEROS||Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study|Bone Status on Patients With Genetic Hemochromatosis : a 3 Years Descriptive and Evolutionary Study.|Completed||N/A|100|Actual|Rennes University Hospital|||1||f||||f||||||Samples With DNA|"     -  serum        -  urine        -  DNA   "|||2017-10-11 03:10:42.372488|2017-10-11 03:10:42.372488
NCT01556347|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2016-12-21|||July 2012||2012-07-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Multi-Drug Desensitization Protocol for Heart Transplant Candidates|Multi-Drug Desensitization Protocol for Heart Transplant Candidates|Terminated||Phase 2|2|Actual|Providence Health & Services||1||Lack of efficacy|f||||t||||||||||2017-10-11 03:10:42.457594|2017-10-11 03:10:42.457594
NCT01556334|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-03-04|||April 2010||2010-04-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|PEACE||Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes|Preterm Premature Rupture of Membranes: Erythromycin Versus Azithromycin a Randomized Trial Comparing Their Efficacy to Prolong Latency (PEACE Trial)|Withdrawn||Phase 3|0|Actual|Indiana University||2||Terminated before starting due to need for IND determined by FDA.|f||||t||||||||||2017-10-11 03:10:42.647394|2017-10-11 03:10:42.647394
NCT01556321|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-03-17|||June 2012||2012-06-01|May 2013|2013-05-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Long-term Effects of Green Tea on Gut Flora, Fat Absorption, Body Composition and Resting Energy Expenditure|Long-term Effects of Green Tea on Gut Flora, Fat Absorption, Body Composition and Resting Energy Expenditure|Completed||N/A|70|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-11 03:10:42.735635|2017-10-11 03:10:42.735635
NCT01556308|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2014-07-28|||March 2012||2012-03-01|March 2012|2012-03-01|October 2013|Actual|2013-10-01|March 2012|Actual|2012-03-01||Interventional|||Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara|Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara|Completed||N/A|6|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 03:10:42.827715|2017-10-11 03:10:42.827715
NCT01556295|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-16|||March 2012||2012-03-01|March 2012|2012-03-01|April 2013|Anticipated|2013-04-01|August 2012|Anticipated|2012-08-01||Observational|||Gesture Behavior and Knowledge on Low Back Pain Among Nurses|Assessment of Gesture Behavior and Knowledge on Low Back Pain Among Nurses|Unknown status|Recruiting|N/A|100|Anticipated|Federal University of São Paulo|||2||f||||t||||||||||2017-10-11 03:10:42.911746|2017-10-11 03:10:42.911746
NCT01556282|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-05-23|||March 2009||2009-03-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis|A Humanitarian Device Exemption Treatment Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma in Patients With Portal Vein Thrombosis|Completed||N/A|35|Actual|Emory University||1|||f||||f||||||||||2017-10-11 03:10:42.999878|2017-10-11 03:10:42.999878
NCT01556256|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-01-05|||April 2012||2012-04-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents|Music Video for AYA-Parent Communication and Resilience|Completed||N/A|123|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 03:10:43.083284|2017-10-11 03:10:43.083284
NCT01556243|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2017-03-06|||July 2012||2012-07-01|March 2017|2017-03-01||||July 2020|Anticipated|2020-07-01||Interventional|||Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer|Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients With Multiple Ipsilateral Breast Cancers (MIBC)|Active, not recruiting||Phase 2|270|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 03:10:43.239627|2017-10-11 03:10:43.239627
NCT01556230|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-01-30|||November 2010||2010-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PAPS||Prospective Study of Clinically Nonfunctioning Pituitary Adenomas|Prospective Study of Clinically Nonfunctioning Pituitary Adenomas|Recruiting||N/A|350|Anticipated|Columbia University|||2||f||||f||||||Samples Without DNA|"     Blood Serum and Plasma samples   "|Undecided||2017-10-11 03:10:44.594787|2017-10-11 03:10:44.594787
NCT01556217|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2013-07-23|||September 2010||2010-09-01|July 2013|2013-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Pharmacokinetic Study to Characterize JNJ-39393406 in the Cerebrospinal Fluid of Healthy Volunteers|A Double-blind, Placebo-controlled, Single Dose, Pharmacokinetic Study to Characterize the Central Brain Penetrance of JNJ-39393406 Using Cerebrospinal Fluid in Healthy Male and Female Subjects|Completed||Phase 1|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-10-11 03:10:44.708578|2017-10-11 03:10:44.708578
NCT01556204|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-12-22|2016-05-16||March 2012||2012-03-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|LAROSE||Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial|Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial|Completed||N/A|73|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-11 03:10:44.798605|2017-10-11 03:10:44.798605
NCT01556191|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-09-19|||May 2012||2012-05-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|LADIE||Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR|Phase II Randomised Clinical Trial Evaluating an EGFR Tyrosine Kinase Inhibitor (EGFR-TKI) Versus an EGFR-TKI Combined With an Anti-oestrogen Treatment (Fulvestrant) in Women With Advanced Stage Non-squamous Lung Cancer|Active, not recruiting||Phase 2|394|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||4|||f||||f||||||||||2017-10-11 03:10:45.150769|2017-10-11 03:10:45.150769
NCT01556178|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-02-03|||July 2011||2011-07-01|February 2016|2016-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research|Collection of Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research|Completed||N/A|5|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||Samples Without DNA|"     whole blood and cerebrospinal fluid   "|||2017-10-11 03:10:45.384541|2017-10-11 03:10:45.384541
NCT01556165|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2014-12-22|2014-12-04||April 2012||2012-04-01|December 2014|2014-12-01||||December 2013|Actual|2013-12-01||Interventional||The all-patients-treated set (APTS) comprises all randomised patients who took at least one dose of IMP.|Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China|Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China|Completed||Phase 3|130|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 03:10:45.494885|2017-10-11 03:10:45.494885
NCT01556152|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-15|2012-11-09||||||November 2012|2012-11-01||||||||Interventional|||A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)|A Phase II, 4 Week Randomized, Double-Blind, Parallel Group, Placebo Controlled Proof of Concept Study to Evaluate Efficacy, Safety and Tolerability of GRC 17536 in Patients With Painful Diabetic Neuropathy|Withdrawn||Phase 2|0|Actual|Glenmark Pharmaceuticals Ltd. India||3||"Due to new scientific evidence assessment, the study design was revised before the study   started recruitment"|f||||t||||||||||2017-10-11 03:10:46.001005|2017-10-11 03:10:46.001005
NCT01556139|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-07-06|||June 2011||2011-06-01|July 2015|2015-07-01|February 2016|Anticipated|2016-02-01|November 2015|Anticipated|2015-11-01||Interventional|||Effectiveness of Respiratory Muscle Training by Spirotiger in Chronic Patients|Evaluation of the Effectiveness of Respiratory Muscle Training by the Technique of Hypocapnia Hyperpnea (Spirotiger) in COPD and CHF Patients|Unknown status|Active, not recruiting|N/A|40|Anticipated|Fondazione Salvatore Maugeri||2|||f||||t||||||||||2017-10-11 03:10:46.173794|2017-10-11 03:10:46.173794
NCT01556126|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-03-15|||February 2012||2012-02-01|March 2012|2012-03-01|February 2018|Anticipated|2018-02-01|August 2013|Anticipated|2013-08-01||Interventional|PARTICIPATE||Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population|Prove ART (Abluminal Reservoir Technology) Clinical Benefit in Alla Comers Patients|Recruiting||Phase 4|1000|Anticipated|CID - Carbostent & Implantable Devices||1|||f||||f||||||||||2017-10-11 03:10:46.293685|2017-10-11 03:10:46.293685
NCT01556113|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2017-04-26|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease|The Genetic Effect on Omega 3 Fatty Acid Supplementation for the Treatment of Non Alcoholic Fatty Liver Disease in Obese Children and Adolescents|Completed||N/A|17|Actual|Yale University||2|||f||||t||||||||No||2017-10-11 03:10:46.573401|2017-10-11 03:10:46.573401
NCT01556087|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-09-09|||March 2012||2012-03-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|February 2014|Actual|2014-02-01||Interventional|TRUST||Distress Tolerance and Buprenorphine|Distress Tolerance and Reducing Early Relapse in Buprenorphine Patients|Completed||Phase 3|59|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-11 03:10:46.753664|2017-10-11 03:10:46.753664
NCT01556074|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-08-01|||June 2012||2012-06-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of Yoga for Sleep Disturbances in Post Traumatic Stress Disorder (PTSD)|Evaluation of Yoga for Sleep Disturbances in Insomnia and Posttraumatic Stress Disorder|Completed||N/A|50|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-11 03:10:46.841896|2017-10-11 03:10:46.841896
NCT01556061|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-04-25|2013-07-27||June 2011||2011-06-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients|Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients - A Prospective Randomized Crossover Trial|Completed||Phase 4|50|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 03:10:46.952564|2017-10-11 03:10:46.952564
NCT01556048|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-12-01|||February 2009||2009-02-01|December 2014|2014-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pilot Study of Behavioral Activation for Prolonged Grief||Completed||Phase 1|25|Actual|University of Nevada, Las Vegas||2|||f||||f||||||||||2017-10-11 03:10:47.31367|2017-10-11 03:10:47.31367
NCT01556035|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-09-22|||July 2012||2012-07-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|REV-LEG||Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma|A Multicentre Prospective Phase II Single Arm Trial Evaluating the Benefit of Therapy With Lenalidomide (Revlimid®) in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) After First Line Treatment by Chemotherapy Plus Rituximab for the French Study Group of Cutaneous Lymphoma (GFELC)|Completed||Phase 2|19|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-10-11 03:10:47.415087|2017-10-11 03:10:47.415087
NCT01556022|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-10-26|||June 2012||2012-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2015|Actual|2015-08-01||Interventional|ATHENA||Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia|Adipose-derived Regenerative Cells in the Treatment of Patients With Chronic Ischemic Heart Disease Not Amenable to Surgical or Interventional Revascularization.|Completed||Phase 2|28|Actual|Cytori Therapeutics||2|||f||||t||||||||||2017-10-11 03:10:47.576566|2017-10-11 03:10:47.576566
NCT01556009|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2016-01-13|||April 2012||2012-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|Vismodegib||Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas|A Phase II Randomized, Open Label Trial Comparing the Effects of Intermittent Vismodegib Versus PDT on the Maintenance of Benefit Following 7 Months of Continuous Vismodegib Treatment in Patients With Multiple Basal Cell Carcinomas|Completed||Phase 2|24|Actual|Children's Hospital & Research Center Oakland||2|||f||||t||||||||||2017-10-11 03:10:47.711339|2017-10-11 03:10:47.711339
NCT01555996|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2014-05-19|||April 2011||2011-04-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Early Occupational Therapy for Delirium Prevention in Older Patients Admitted to Critical Care Unit|Early Occupational Therapy (OT) for Delirium Prevention in Older Patients Admitted to Critical Care Unit (CCU)|Completed||N/A|126|Actual|University of Chile||2|||f||||f||||||||||2017-10-11 03:10:47.828459|2017-10-11 03:10:47.828459
NCT01555983|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-03-20|2015-12-03||July 2012||2012-07-01|February 2017|2017-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Consented subjects with at least one study visit|Vaporized Cannabis and Spinal Cord Injury Pain|The Effect of Vaporized Cannabis on Neuropathic Pain in Spinal Cord Injury|Completed||Phase 2/Phase 3|42|Actual|University of California, Davis||3|||f||||f||||||||Yes|email Barth Wilsey at bwilsey@ucsd.edu|2017-10-11 03:10:47.974279|2017-10-11 03:10:47.974279
NCT01555970|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-10-23|||March 2012||2012-03-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|NACTOC||Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder|Serotonin Reuptake Inhibitor Augmentation With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder: a Double-blind, Randomized and Controlled Study|Completed||Phase 2|40|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:10:48.300765|2017-10-11 03:10:48.300765
NCT01555957|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2017-08-14|||February 2012||2012-02-01|August 2017|2017-08-01|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis|Effect of Lipid Intake on Direct Hyperbilirubinemia in Late Preterm and Term Infants With Gastrointestinal Surgical Problems.|Recruiting||Phase 3|40|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-11 03:10:48.406824|2017-10-11 03:10:48.406824
NCT01555931|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-08-21|2014-07-14||March 2012||2012-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PPIUD1|Baseline characteristics of women allocated to immediate or late LNG-IUS placement after delivery.|Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding|Immediate vs. 4-8 Week Postpartum Levonorgestrel-releasing Intrauterine System Placement: A Randomized Clinical Trial (Short Title: PPIUD1)|Completed||Phase 4|61|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 03:10:48.693299|2017-10-11 03:10:48.693299
NCT01555918|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2013-01-31|||August 2012||2012-08-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers|A Phase I, Open-Label, Single and Multiple Dose Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers|Completed||Phase 1|36|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 03:10:49.012176|2017-10-11 03:10:49.012176
NCT01555892|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-09-16|||January 2013||2013-01-01|September 2016|2016-09-01|July 2022|Anticipated|2022-07-01|September 2017|Anticipated|2017-09-01||Interventional|GRALE||Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE|Administration of Rapidly Generated LMP, BARF1 And EBNA1 Specific Cytotoxic T-Lymphocytes To Patients With EBV-Positive Lymphoma|Recruiting||Phase 1|136|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 03:10:49.226921|2017-10-11 03:10:49.226921
NCT01555879|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-03-16|||March 2012||2012-03-01|March 2012|2012-03-01|April 2012|Anticipated|2012-04-01|March 2012|Anticipated|2012-03-01||Observational|||Real-world Clinical Efficacy of Abatacept in the T3 Data Registry|Abatacept in T3: A Characterization of Abatacept's Efficacy and Outcomes From a Real-Word Clinical Practice Information Hub on Novel Patient Sub-Groups|Unknown status|Active, not recruiting|N/A|200|Anticipated|Arthritis Northwest PLLC|||1||f||||f||||||||||2017-10-11 03:10:49.379738|2017-10-11 03:10:49.379738
NCT01555866|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-08-31|||March 2012||2012-03-01|August 2015|2015-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.|A Phase 1 Open Label, 2 Part, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole|Completed||Phase 1|49|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-10-11 03:10:49.499576|2017-10-11 03:10:49.499576
NCT01555853|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-12-05|||July 2012||2012-07-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma|A Phase I/II Institutional Study of Abraxane in Recurrent and Refractory Lymphoma|Terminated||Phase 1|20|Actual|Washington University School of Medicine||4||"completed accrual to phase I but drug did not show activity, so halted before initiation of   phase II"|f||||f||||||||||2017-10-11 03:10:49.736843|2017-10-11 03:10:49.736843
NCT01555840|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-12-17|||November 2011||2011-11-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Comparative Study of the Magnetically Guided Capsule Endoscopy Versus High Definition Gastroscopy|"EVALUATION CLINIQUE D'UNE CAPSULE A GUIDAGE MAGNETIQUE POUR L'EXPLORATION GASTRIQUE Capsule Dirigée Versus Gastroscopie à Haute Définition"|Completed||N/A|189|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-10-11 03:10:49.893534|2017-10-11 03:10:49.893534
NCT01555827|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2014-11-12|||April 2012||2012-04-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|SIGNAL||Retinal Neurodegenerative Signs in Alzheimer's Diseases|Retinal Neurodegenerative Signs in Alzheimer's Diseases|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 03:10:49.987294|2017-10-11 03:10:49.987294
NCT01555814|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2016-10-25|||May 2011||2011-05-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen|Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): the Effects of D2 Antagonism on Candidate Endophenotypes|Completed||N/A|56|Actual|University of Copenhagen||1|||f||||t||||||||||2017-10-11 03:10:50.201972|2017-10-11 03:10:50.201972
NCT01555801|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-01-23|||February 2012||2012-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Endoscopic Ultrasound Plus Submucosal Injection for Early Esophageal Cancer|Efficacy Study of Endoscopic Ultrasound Combining With Submucosal Saline Injection for Pretreatment Staging of T1a and T1b in Patients With Early Esophageal Cancer|Recruiting||N/A|80|Anticipated|Sun Yat-sen University||2|||f||||t||||||||Yes||2017-10-11 03:10:50.337067|2017-10-11 03:10:50.337067
NCT01555775|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-01-15|||March 2012||2012-03-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Recovery After Resistance Exercise|Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Muscle Damage, Inflammation, Oxidative Stress and Functional Recovery, After Resistance Exercise|Completed||N/A|13|Actual|Universidade do Porto||2|||f||||f||||||||||2017-10-11 03:10:50.587075|2017-10-11 03:10:50.587075
NCT01555749|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-02-23|||March 12, 2012|Actual|2012-03-12|February 2017|2017-02-01|May 8, 2012|Actual|2012-05-08|May 8, 2012|Actual|2012-05-08||Interventional|||Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects|A Randomised, Double-blind, Placebo-controlled, Single Centre, Single Dose Trial, Assessing the Pharmacokinetics of NNC172-2021, Administered Subcutaneously at Two Different Dose Levels, in Healthy Japanese Subjects|Completed||Phase 1|8|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:10:51.195636|2017-10-11 03:10:51.195636
NCT01555736|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-19|||January 2003||2003-01-01|March 2012|2012-03-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy|A Randomised Double-blind Clinical Trial for Evaluation of Efficacy and Safety of Perennial in Comparison to Preseasonal Grass/Rye Pollen Immunotherapy in Patients Suffering From Seasonal Allergic Rhinitis|Completed||Phase 4|120|Actual|Medical Universtity of Lodz||2|||f||||f||||||||||2017-10-11 03:10:51.307181|2017-10-11 03:10:51.307181
NCT01555723|ClinicalTrials.gov processed this data on October 10, 2017|2008-06-02|2015-09-29||||||September 2015|2015-09-01||||||||Observational|RELATES||Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring|HIV (Human Immunodeficiency Virus) Subtype and ARV Response in African Children|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison|||1|New study created.|f||||f||||||Samples With DNA|"     Plasma obtained fron participants   "|||2017-10-11 03:10:51.42642|2017-10-11 03:10:51.42642
NCT01555710|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2013-05-20|||May 2012||2012-05-01|May 2013|2013-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)|A Multi-center, Open-Label, Adaptive, Randomized Study of Palifosfamide-tris, a Novel DNA Crosslinker, in Combination With Carboplatin and Etoposide (PaCE) Chemotherapy Versus Carboplatin and Etoposide (CE) Alone in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer. The MATISSE Study|Unknown status|Active, not recruiting|Phase 3|548|Anticipated|Ziopharm||2|||f||||t||||||||||2017-10-11 03:10:51.498252|2017-10-11 03:10:51.498252
NCT01555697|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-05-12|||July 2014||2014-07-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|Swerdlow-R34||Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia|Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia|Recruiting||Phase 1/Phase 2|60|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-11 03:10:51.830142|2017-10-11 03:10:51.830142
NCT01555684|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-12-01|||April 2012||2012-04-01|December 2015|2015-12-01|December 2012|Anticipated|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Functional Changes Following Percutaneous Venoplasty in Multiple Sclerosis Patients|The Effect of Percutaneous Venoplasty on Muscular Function, Mobility and Fatigue of Multiple Sclerosis (MS) Patients With Chronic Cerebrospinal Venous Insufficiency (CCSVI).|Withdrawn||N/A|0|Actual|University of Stirling||2|||f||||t||||||||||2017-10-11 03:10:51.98126|2017-10-11 03:10:51.98126
NCT01555671|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2012-12-13|||January 2012||2012-01-01|December 2012|2012-12-01|January 2013|Anticipated|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Study of the Effectiveness of Administration of Meperidine on the Length of Active Phase of Labor in Women|Is There Any Effect of Meperidine on the Length of Duration of Labor? A Prospective Randomized Controlled Trial.|Unknown status|Recruiting|Phase 4|440|Anticipated|Kanuni Sultan Suleyman Training and Research Hospital||2|||f||||t||||||||||2017-10-11 03:10:52.117577|2017-10-11 03:10:52.117577
NCT01555658|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-13|||April 2012||2012-04-01|March 2012|2012-03-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Interventional|BILLION||Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial|Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial|Unknown status|Not yet recruiting|Phase 3|204|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 03:10:52.254308|2017-10-11 03:10:52.254308
NCT01555645|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-12-03|||May 2009||2009-05-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|March 2014|Actual|2014-03-01||Interventional|||Stress Management in Breast Cancer Patients|How Can Health Care Help Female Breastcancer Patients Reduce Their Stress Symptoms? A Randomized Intervention Study With Stepped-care|Completed||N/A|466|Actual|Uppsala University||2|||f||||t||||||||||2017-10-11 03:10:52.357824|2017-10-11 03:10:52.357824
NCT01555632|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-06-17|||March 2012||2012-03-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Atorvastatin Calcium in Preventing Metabolic Syndrome in Patients With Prostate Cancer Receiving Long-Term Androgen-Deprivation Therapy|A Pilot Study of Atorvastatin on Prevention of Metabolic Syndrome in Subjects With Prostate Cancer on Long Term Androgen-deprivation Therapy|Withdrawn||N/A|0|Actual|University of Nebraska||2||Other more favorable treatments are now available.|f||||t||||||||||2017-10-11 03:10:52.441646|2017-10-11 03:10:52.441646
NCT01555619|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-06-20|||February 15, 2012||2012-02-15|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Observational|Quad PAS||Quadripolar Pacing Post Approval Study|Quadripolar Pacing Post Approval Study|Active, not recruiting||N/A|1971|Actual|St. Jude Medical|||1||f||||f|f|t|f|f||||No||2017-10-11 03:10:52.548359|2017-10-11 03:10:52.548359
NCT01555606|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-07-20|||June 2011||2011-06-01|July 2015|2015-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis|A Multicenter, Observational, Noninterventional, Narrative Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis|Completed||Phase 4|108|Actual|Janssen Biotech, Inc.|||1||f||||f||||||||||2017-10-11 03:10:52.803716|2017-10-11 03:10:52.803716
NCT01555593|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-10-28|||March 2012||2012-03-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Prolonged Decubitus on Nitric Oxide Concentration in Chronic Obstructive Pulmonary Disease|Effect of Prolonged Decubitus on Bronchial Inflammation in COPD Patients Evaluated by Expired NO Concentration Assessment|Completed||Phase 4|30|Actual|University of Milan||1|||f||||t||||||||||2017-10-11 03:10:52.915552|2017-10-11 03:10:52.915552
NCT01555580|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-14|||April 2012||2012-04-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis|A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Symptomatic Autoimmune Generalized Myasthenia Gravis|Unknown status|Not yet recruiting|Early Phase 1|12|Anticipated|Muscular Dystrophy Association||1|||f||||f||||||||||2017-10-11 03:10:53.001389|2017-10-11 03:10:53.001389
NCT01555567|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-05-13|2015-04-26||August 2009||2009-08-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury|Quadriceps Inhibition After ACL Injury: Neuromuscular and Functional Consequences|Completed||N/A|43|Actual|University of Michigan||4|||f||||f||||||||||2017-10-11 03:10:53.205154|2017-10-11 03:10:53.205154
NCT01555554|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-08-29|||May 2012||2012-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Perioperative Propranolol in Patients With Post Traumatic Stress Disorder (PTSD)|Effect of Prophylactic, Perioperative Propranolol on Peri- and Postoperative Complications in Patients With Post Traumatic Stress Disorder|Recruiting||N/A|110|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:10:53.747374|2017-10-11 03:10:53.747374
NCT01555541|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-06-07|||June 2012||2012-06-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma|A Phase II Study of Intensive Consolidation and Stem Cell Mobilization Therapy With Ofatumumab, Etoposide, and High-dose Ara-C (OVA), Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma|Recruiting||Phase 2|24|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:10:53.919474|2017-10-11 03:10:53.919474
NCT01555528|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-04-20|||April 2012||2012-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS MEX||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico|"Easypod Connect: A National, Multicentre, Observational Registry to Evaluate Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Mexico"|Completed||N/A|193|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 03:10:54.099162|2017-10-11 03:10:54.099162
NCT01555515|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-09-12|||March 2012||2012-03-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Interventional|||Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant|Safety and Efficacy of Sustained Erythropoietin Therapy of Anemia in End Stage Renal Disease (ESRD) Dialysis Patients Using EPODURE Biopump|Terminated||Phase 1/Phase 2|4|Actual|Medgenics Medical Israel Ltd.||1||New protocol to start with improved product|f||||f||||||||No|Early phase study.|2017-10-11 03:10:54.218024|2017-10-11 03:10:54.218024
NCT01555502|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-05-26|||March 2011||2011-03-01|May 2015|2015-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Health Related Quality of Life After Video Assisted Thoracoscopic Lobectomy for Lung Cancer||Completed||N/A|50|Actual|University of Alberta|||2||f||||t||||||||||2017-10-11 03:10:54.312116|2017-10-11 03:10:54.312116
NCT01555489|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2017-01-31|||October 2011||2011-10-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca|Phase II, Open Label Study of Intravenous Ascorbic Acid in Combination With Gemcitabine and Erlotinib in the Treatment of Metastatic Pancreatic Cancer|Completed||Phase 2|11|Actual|Thomas Jefferson University||1|||f||||t||||||||No||2017-10-11 03:10:54.383679|2017-10-11 03:10:54.383679
NCT01555476|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-07-06|||February 2012||2012-02-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores|Bioequivalence Between an Ibuprofen Suspension and a Reference Formulation. A Study in Healthy Volunteers.|Completed||Phase 1|32|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 03:10:54.491857|2017-10-11 03:10:54.491857
NCT01555463|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-12-28|2014-12-28||September 2012||2012-09-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea|A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea|Completed||Phase 3|961|Actual|Bayer||2|||f||||||||||||||2017-10-11 03:10:54.66764|2017-10-11 03:10:54.66764
NCT01555450|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-02-23|||March 2011||2011-03-01|March 2012|2012-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|PRADO||Study of Patient Navigation to Reduce Social Inequalities|The Patient Navigator to Reduce Social Inequalities. A French Interventional Trial in Public Health|Completed||N/A|28929|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-11 03:10:56.206374|2017-10-11 03:10:56.206374
NCT01555437|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-11-18|||October 2008||2008-10-01|November 2013|2013-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Assessment of Capsule Endoscopy Scoring Index (CESI), Harvey-Bradshaw Index (HBI) and Biological Markers in Small Bowel Crohn's Disease (SBCD)|Assessment of Capsule Endoscopy Scoring Index, Clinical Disease Activity and Biological Markers in Small Bowel Crohn's Disease|Completed||N/A|58|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples Without DNA|"     serum of small bowel Crohn's disease patients   "|||2017-10-11 03:10:56.331043|2017-10-11 03:10:56.331043
NCT01555424|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-14|||February 2012||2012-02-01|March 2012|2012-03-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Vitamin D Fortified Cheese and Well-being in the Institutionalized Elderly|Bioavailability of Casein-bound Vitamin D From Fortified Cheese and Its Effects on the Well-being of the Institutionalized Elderly|Unknown status|Active, not recruiting|N/A|28|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 03:10:56.431897|2017-10-11 03:10:56.431897
NCT01555411|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-06-15|||September 2012||2012-09-01|June 2015|2015-06-01|December 2050|Anticipated|2050-12-01|May 2015|Actual|2015-05-01||Observational|ACE1950||Akershus Cardiac Examination (ACE) 1950 Study|Akershus Cardiac Examination 1950 Study - a Cohort Study on Cardio- and Cerebrovascular Disease in 62-65-year-old Subjects|Active, not recruiting||N/A|4000|Anticipated|Vestre Viken Hospital Trust|||1||f||||t||||||Samples With DNA|"     Blood samples, including for genetic testing, and urine.   "|||2017-10-11 03:10:56.559427|2017-10-11 03:10:56.559427
NCT01555398|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-04-05|||February 2012||2012-02-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule|Open-label, Randomized Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Fenofibric Acid for HIP0901 Capsule in Healthy Male Subjects|Completed||Phase 1|48|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 03:10:56.769428|2017-10-11 03:10:56.769428
NCT01555385|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2013-03-05|||September 2011||2011-09-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|April 2012|Actual|2012-04-01||Interventional|AivoPro1||The Effects of Breakfast on Mental Workload|The Effects of Nutritive and Non-nutritive Breakfast on Subjective Mental Workload During Multitasking - a Pilot Study in Healthy Volunteers|Completed||N/A|13|Actual|Helsinki University||3|||f||||f||||||||||2017-10-11 03:10:56.870479|2017-10-11 03:10:56.870479
NCT01555372|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2012-03-14|||May 2012||2012-05-01|March 2012|2012-03-01|May 2014|Anticipated|2014-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Treatment of Unstable Distal Clavicular Fractures (Neer 2b): Hook Plate vs Locking Plate|Treatment of Unstable Distal Clavicular Fractures (Neer 2b): Hook Plate vs Locking Plate|Unknown status|Not yet recruiting|N/A|40|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 03:10:56.966082|2017-10-11 03:10:56.966082
NCT01555359|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-14|||February 2012||2012-02-01|January 2012|2012-01-01|February 2013|Anticipated|2013-02-01|||||Observational|||Telomerase Activity as a Marker For Mobilization Quality|Telomerase Activity Of CD34+ Cells - Marker For Mobilization Quality And Predictor For Engraftment After Autologous Hematopoietic Cell Transplantation|Unknown status|Recruiting|N/A|50|Anticipated|Rabin Medical Center|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 03:10:57.084535|2017-10-11 03:10:57.084535
NCT01555346|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-04-18|||March 2012||2012-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|October 2014|Actual|2014-10-01||Observational|||Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies|A Clinical Study to Evaluate the Clinical Performance of the SEQureDx Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted From a Maternal Blood Sample Obtained From Pregnant Women With One or More High Risk Indicators for Fetal Chromosome 21 Aneuploidy|Completed||N/A|3062|Actual|Sequenom, Inc.|||2||f||||f||||||Samples With DNA|"     Whole blood specimens will be collected and processed to plasma. DNA will be extracted from     the plasma.   "|||2017-10-11 03:10:57.177303|2017-10-11 03:10:57.177303
NCT01555333|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-07-30|||November 2011||2011-11-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|209FX303||An Open Label Extension Study in Subjects With Fragile X Syndrome|An Open-Label Extension Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subject With Fragile X Syndrome|Terminated||Phase 3|357|Actual|Seaside Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 03:10:57.326081|2017-10-11 03:10:57.326081
NCT01555320|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2013-03-19|||March 2012||2012-03-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|CACT-IHF||Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure|Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure (CACT-IHF) A Randomized, Double-blind, Multicenter, Placebo-controlled Trial|Unknown status|Recruiting|N/A|640|Anticipated|State Administration of Traditional Chinese Medicine of the People's Republic of China||2|||f||||t||||||||||2017-10-11 03:10:57.471673|2017-10-11 03:10:57.471673
NCT01555307|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-03-14|||June 2007||2007-06-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|May 2009|Actual|2009-05-01||Interventional|||Effectiveness of Exercise Programs Following Total Hip and Knee Joint Arthroplasty|Effectiveness of Exercise Programs Following Total Hip and Knee Joint Arthroplasty|Completed||N/A|82|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:10:59.436842|2017-10-11 03:10:59.436842
NCT01555294|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2012-03-14|||May 2005||2005-05-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|NIMA||Evaluation of Non-invasive Measurements of Atherosclerosis in Cardiovascular Risk Stratification|Evaluation of Non-invasive Measurements of Atherosclerosis in Cardiovascular Risk Stratification: a Study in a Population-based Cohort and Familial Combined Hyperlipidemia|Completed||N/A|1960|Actual|Radboud University|||2||f||||f||||||||||2017-10-11 03:10:59.542606|2017-10-11 03:10:59.542606
NCT01555281|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-08-02|||April 2012||2012-04-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma|Nelfinavir and Lenalidomide/Dexamethasone in Patients With Progressive Multiple Myeloma That Have Failed Lenalidomide-containing Therapy - A Single Arm Phase I/II Trial|Active, not recruiting||Phase 1/Phase 2|33|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 03:10:59.663266|2017-10-11 03:10:59.663266
NCT01555268|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-02-14|||October 31, 2011|Actual|2011-10-31|February 2017|2017-02-01|August 3, 2016|Actual|2016-08-03|September 24, 2013|Actual|2013-09-24||Interventional|||Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia|A Phase lb Study of the Safety, Feasibility, and Pharmacokinetics of AMG 386 Alone and in Combination With Low Dose Cytarabine in Acute Myeloid Leukemia (AML) Patients|Completed||Phase 1|24|Actual|Roswell Park Cancer Institute||2|||f||||f||||||||||2017-10-11 03:10:59.916681|2017-10-11 03:10:59.916681
NCT01555255|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-14|2015-04-22|||November 2010||2010-11-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|March 2012|Actual|2012-03-01||Observational|||Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental Malaria|Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental Malaria|Unknown status|Active, not recruiting|N/A|1205|Anticipated|Foundation for Innovative New Diagnostics, Switzerland|||1||f||||f||||||Samples With DNA|"     Red cell pellets, dried whole blood on filter paper, and fixed blood and placental tissue   "|||2017-10-11 03:11:00.090386|2017-10-11 03:11:00.090386
NCT01554514|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-09-18|||August 2012||2012-08-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura|Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency|Recruiting||Phase 2|20|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 03:11:12.842266|2017-10-11 03:11:12.842266
NCT01555242|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-04-07|||August 2012||2012-08-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas|A Phase I, Open-Label, Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Aneustat™ (OMN54) Administered on a Daily Oral Regimen in Patients With Advanced Cancer and Lymphomas|Completed||Phase 1|22|Actual|Omnitura Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 03:11:00.228584|2017-10-11 03:11:00.228584
NCT01555229|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2015-09-16|||August 2011||2011-08-01|April 2015|2015-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|ASPIRE||Effect of Intermittent Versus Continuous Subglottic Secretion Drainage on Tracheal Mucosa Damages|Randomized, Single Blind Study Comparing the Effect of Intermittent Versus Continuous Subglottic Secretion Drainage on Tracheal Mucosa Damages in Intensive Care Patients Requiring Prolonged Mechanical Ventilation|Terminated||Phase 3|80|Actual|Rennes University Hospital||2||Enrolment difficulties|f||||f||||||||||2017-10-11 03:11:00.358236|2017-10-11 03:11:00.358236
NCT01555216|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2016-05-25|||October 2011||2011-10-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Continuous Tibial Nerve Block Versus Single Shot Tibial Nerve Block|A Randomized Comparison of a Continuous Posterior Tibial Nerve Block and Single Injection Posterior Tibial Nerve Block in Patients Undergoing Forefoot Surgery|Withdrawn||N/A|0|Actual|Northwestern University||2||Lack of participant recruitment|f||||f||||||||No||2017-10-11 03:11:00.491417|2017-10-11 03:11:00.491417
NCT01555203|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-04-27|||November 2009||2009-11-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Multiple Health Behavior Change Internet Program for College Students|A Multiple Health Behavior Change Internet Program for College Students|Completed||Phase 2|1877|Actual|Pro-Change Behavior Systems||1|||f||||f||||||||||2017-10-11 03:11:00.607214|2017-10-11 03:11:00.607214
NCT01555190|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2012-03-14|||January 2012||2012-01-01|March 2012|2012-03-01||||||||Interventional|||Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone|Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone: Effects of Six Months Treatment on Clinical, Endocrine and Metabolic Features in Obese Women With Polycystic Ovary Syndrome|Unknown status|Recruiting|N/A|50||Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-11 03:11:00.806714|2017-10-11 03:11:00.806714
NCT01555177|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-11-03|||April 2012||2012-04-01|November 2014|2014-11-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|OPTIMUS||Study of Coronary Plaque Rupture in Heart Attack Following Surgery Using Optical Coherence Tomography (OCT)|OCT Plaque and Thrombus IMaging in Patients Who Underwent Non-cardiac Surgery|Unknown status|Recruiting|N/A|60|Anticipated|Hamilton Health Sciences Corporation|||2||f||||t||||||||||2017-10-11 03:11:00.921594|2017-10-11 03:11:00.921594
NCT01555164|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2014-09-17|2014-09-17|2014-01-17|June 2012||2012-06-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional||Safety Analysis Set: randomized participants who received at least one dose of study treatment.|A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone|A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Metformin in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|442|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 03:11:01.055439|2017-10-11 03:11:01.055439
NCT01555151|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-04-10|2014-07-06||July 2012||2012-07-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma|A Randomized, Double-blind, Double-dummy, 4-week Treatment, Parallel-group Study to Evaluate the Efficacy and Safety of Two Doses of Mometasone Furoate Delivered Via Concept1 or Twisthaler® in Adult and Adolescent Patients With Persistent Asthma|Completed||Phase 2|739|Actual|Novartis||4|||f||||f||||||||||2017-10-11 03:11:02.106142|2017-10-11 03:11:02.106142
NCT01555138|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-04-08|2015-02-10||February 2012||2012-02-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|INSTEAD||Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)|A Randomized, Double-blind, Parallel-group, 26-week Study Comparing the Efficacy and Safety of Indacaterol (Onbrez® Breezhaler® 150 mcg o.d.) With Salmeterol/Fluticasone Propionate (Seretide® Accuhaler® 50 mcg/500 mcg b.i.d.) in Patients With Moderate Chronic Obstructive Pulmonary Disease|Completed||Phase 4|581|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:11:03.721937|2017-10-11 03:11:03.721937
NCT01555125|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-02-28|||May 2012||2012-05-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|FEATURE||First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks|A Randomized, Double-blind, Placebo Controlled, Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate Efficacy After Twelve Weeks of Treatment, and to Assess the Safety, Tolerability, Usability and Long-term Efficacy in Subjects With Chronic Plaque-type Psoriasis|Completed||Phase 3|177|Actual|Novartis||3|||f||||t||||||||||2017-10-11 03:11:04.737988|2017-10-11 03:11:04.737988
NCT01555112|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2013-08-14|||March 2012||2012-03-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy Study to Test Topical AS101 for External Genital Warts|A Phase I/II, Open Labeled, Uncontrolled, Single Center Study of Topical AS101 for External Genital Warts|Completed||Phase 1/Phase 2|12|Actual|BioMAS Ltd||1|||f||||t||||||||||2017-10-11 03:11:04.91409|2017-10-11 03:11:04.91409
NCT01555086|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-01-23|||August 2011||2011-08-01|January 2017|2017-01-01||||August 2017|Anticipated|2017-08-01||Interventional|SEAL||Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy|Prospective Randomized Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy|Recruiting||N/A|500|Anticipated|Association of Urogenital Oncology (AUO)||2|||f||||t||||||||||2017-10-11 03:11:05.247477|2017-10-11 03:11:05.247477
NCT01555073|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-06-29|2014-09-11||October 2011||2011-10-01|June 2016|2016-06-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional||Baseline Analysis population description|Preemptive Analgesia Following Uterine Artery Embolization|A Prospective Randomized Blinded Placebo Controlled Comparison of Multimodal Pre-emptive Analgesia on Long Term Outcome Following Uterine Artery Embolization|Terminated||Phase 4|23|Actual|Northwestern University|Early termination due to lost of follow-up for primary outcome at 3 months|4||Subjects did not meet inclusion criteria|f||||f||||||||||2017-10-11 03:11:05.388699|2017-10-11 03:11:05.388699
NCT01555060|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-01-22|||March 2012||2012-03-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|HEIRS||Hemoglobin and Iron Recovery Study|Hemoglobin and Iron Recovery Study|Completed||Phase 2|215|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-10-11 03:11:05.765064|2017-10-11 03:11:05.765064
NCT01555047|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2013-04-08|||September 2011||2011-09-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Correlation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their Partner||Unknown status|Active, not recruiting|Phase 4|200|Anticipated|Nanjing Medical University||3|||f||||t||||||||||2017-10-11 03:11:05.868926|2017-10-11 03:11:05.868926
NCT01555034|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-04-13|||April 2012||2012-04-01|March 2014|2014-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Movement Therapy and Childhood Obesity|The Effect of Movement Therapy on the Success in a Multidisciplinary Intervention for the Treatment of Childhood Obesity|Completed||N/A|26|Actual|Meir Medical Center||2|||f||||f||||||||||2017-10-11 03:11:05.948403|2017-10-11 03:11:05.948403
NCT01555008|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-09-06|||March 2012||2012-03-01|September 2013|2013-09-01||||August 2013|Actual|2013-08-01||Interventional|||Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes Mellitus and Moderate to Severe Renal Impairment|Completed||Phase 1|31|Actual|Lexicon Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:11:06.187126|2017-10-11 03:11:06.187126
NCT01554995|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-11-13|||March 2012||2012-03-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study|A Phase I Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCB01-0371 in Healthy Male Subjects|Completed||Phase 1|70|Actual|LegoChem Biosciences, Inc||2|||f||||t||||||||||2017-10-11 03:11:06.285339|2017-10-11 03:11:06.285339
NCT01554982|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-06-02|2015-09-24||August 2012||2012-08-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional||Note: two subjects randomized did not receive study drug, therefore not included in Safety Assessment Population|A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis|A Long-Term Safety Extension Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) on Dialysis|Completed||Phase 3|168|Actual|Keryx Biopharmaceuticals||1|||f||||t||||||||||2017-10-11 03:11:06.426564|2017-10-11 03:11:06.426564
NCT01554969|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-02-19|||May 2012||2012-05-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer|Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer|Completed||Phase 1|16|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:11:07.732479|2017-10-11 03:11:07.732479
NCT01554956|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-07-26|||September 2012||2012-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients|A Historically Controlled Phase II/III Study to Evaluate Efficacy and Safety of Kedrion Human Plasminogen Eye Drop Preparation in Patients Diagnosed With Ligneous Conjunctivitis|Active, not recruiting||Phase 2/Phase 3|12|Anticipated|Kedrion S.p.A.||1|||f||||f||||||||||2017-10-11 03:11:07.855449|2017-10-11 03:11:07.855449
NCT01554943|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-08-29|||July 2010||2010-07-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients|Late Cardiac Evaluation of the Three Arm Belgian Trial A Phase III Randomized Trial Involving Node-positive Early Breast Cancer Patients With a Long Median Follow-up (~ 15 Years)|Completed||Phase 2|73|Actual|Jules Bordet Institute||3|||f||||f||||||||||2017-10-11 03:11:07.973837|2017-10-11 03:11:07.973837
NCT01554930|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2012-03-14|||May 2010||2010-05-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|November 2010|Actual|2010-11-01||Interventional|||Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease|A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Severe Type of Hand, Foot, and Mouth Disease|Completed||N/A|230|Actual|Jiangxi Qingfeng Pharmaceutical Co. Ltd.||2|||f||||t||||||||||2017-10-11 03:11:08.121316|2017-10-11 03:11:08.121316
NCT01554917|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-02-22|||May 2012||2012-05-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study of Iguratimod in Patients With Active Rheumatoid Arthritis|A Phase IV Study of Iguratimod in Patients With Active Rheumatoid Arthritis (RA)|Completed||Phase 4|1759|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||No||2017-10-11 03:11:08.294941|2017-10-11 03:11:08.294941
NCT01554904|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-04-29|2013-02-24||February 2012||2012-02-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Number completing study|Study Will Test the Theory That Training With the Facial-Flex Exercise Device Will Improve Snoring in Patients|Facial-Flex as a Treatment for Snoring|Completed||N/A|18|Actual|Facial Concepts, Inc.|This was not a sham controlled trial. The number of participants was somewhat limited.|1|||f||||f||||||||||2017-10-11 03:11:08.40016|2017-10-11 03:11:08.40016
NCT01554891|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-03-02|2015-09-21||February 2012||2012-02-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|September 2014|Actual|2014-09-01||Observational|SAFE-TBI||INTRuST Structured Assessment For Evaluation of TBI (SAFE-TBI)|Reliability and Initial Validation of the INTRuST Structured Assessment For Evaluation of TBI (SAFE-TBI)|Completed||N/A|305|Actual|INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium|||3||f||||t||||||||||2017-10-11 03:11:08.663854|2017-10-11 03:11:08.663854
NCT01554878|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-09-30|||January 2012||2012-01-01|May 2014|2014-05-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01||Observational|LOGIC||Observational Study on the Treatment of Knee Osteochondral Lesions of Grade III-IV|Observational Studies, Prospective, Multicenter, to Evaluate the Effect of Treatment of Knee Osteochondral Lesions of Outerbridge Grade III-IV|Completed||N/A|20|Actual|Ettore Sansavini Health Science Foundation|||1||f||||f||||||||No||2017-10-11 03:11:08.955692|2017-10-11 03:11:08.955692
NCT01554865|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2015-07-27|||December 2010||2010-12-01|July 2015|2015-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Diet-induced Weight Loss in Obese Men|The Effects of Diet-induced Weight Loss on Metabolic and Inflammatory Profile, Endothelial, Sexual and Urinary Function, and Quality of Life in Obese Men|Completed||Phase 4|70|Actual|Changi General Hospital||2|||f||||f||||||||||2017-10-11 03:11:09.050022|2017-10-11 03:11:09.050022
NCT01554852|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-06-10|||May 2010||2010-05-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|September 2017|Anticipated|2017-09-01||Interventional|Myeloma XI||Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients|Randomised Comparisons, in Myeloma Patients of All Ages, of Thalidomide, Lenalidomide, Carfilzomib and Bortezomib Induction Combinations, and of Lenalidomide and Combination Lenalidomide Vorinostat as Maintenance (Myeloma XI)|Active, not recruiting||Phase 3|4420|Actual|University of Leeds||2|||f||||t||||||||||2017-10-11 03:11:09.146101|2017-10-11 03:11:09.146101
NCT01554839|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-02-09|||October 2011||2011-10-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Family of Heroes: an Evaluation of an Online Educational Tool|The Family of Heroes Program for Veterans and Their Families: An Evaluation of an Online Educational Tool for Helping Veterans.|Completed||N/A|206|Actual|Department of Veterans Affairs, New Jersey||2|||f||||f||||||||||2017-10-11 03:11:09.27897|2017-10-11 03:11:09.27897
NCT01554826|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-09-04|||March 2009||2009-03-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)|A Double - Blind, Randomized, - Controlled Clinical Trial With Inactivated Influenza Vaccine (Split Virion)(0.25ml Formulation for Pediatric Use)|Completed||Phase 3|810|Actual|Hualan Biological Engineering, Inc.||2|||f||||t||||||||||2017-10-11 03:11:09.366304|2017-10-11 03:11:09.366304
NCT01554813|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-09-04|||May 2006||2006-05-01|March 2012|2012-03-01|October 2006|Actual|2006-10-01|July 2006|Actual|2006-07-01||Interventional|||Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)|A Single - Blind, Randomized, - Controlled Clinical Trial With Inactivated Influenza Vaccine (Split Virion) (0.5ml Formulation)|Completed||Phase 3|900|Actual|Hualan Biological Engineering, Inc.||3|||f||||t||||||||||2017-10-11 03:11:09.484281|2017-10-11 03:11:09.484281
NCT01554800|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-01-10|||March 2012||2012-03-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease|An Intravenous, Open-label, Single-dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of rhLCAT in Subjects With Coronary Artery Disease|Completed||Phase 1|16|Actual|Alphacore Pharma, LLC||1|||f||||f||||||||||2017-10-11 03:11:09.583169|2017-10-11 03:11:09.583169
NCT01554787|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-13|||January 2012||2012-01-01|March 2012|2012-03-01||||December 2013|Anticipated|2013-12-01||Interventional|||Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue||Unknown status|Recruiting|Phase 4|90|Anticipated|China Medical University Hospital||2|||f||||||||||||||2017-10-11 03:11:09.668728|2017-10-11 03:11:09.668728
NCT01554774|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2015-02-06|||March 2012||2012-03-01|February 2015|2015-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|PVR-COPD||Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease|Observational Study of Comparison of Echocardiographic Markers of Right Ventricular Function and Electrocardiographic Signs of Chronic Cor Pulmonale in Elderly Patient With COPD|Completed||N/A|60|Actual|Hospital Viamed Valvanera, Spain|||3||f||||t||||||||||2017-10-11 03:11:09.800189|2017-10-11 03:11:09.800189
NCT01554761|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-13|||February 2012||2012-02-01|March 2012|2012-03-01||||May 2012|Anticipated|2012-05-01||Interventional|||Effect of Posterior Corneal Toricity on Refractive Outcome of Pseudophakia|Effect of Posterior Corneal Toricity on Refractive Outcome of Pseudophakia|Unknown status|Recruiting|Phase 4|30|Anticipated|China Medical University, China||1|||f||||t||||||||||2017-10-11 03:11:09.934452|2017-10-11 03:11:09.934452
NCT01554748|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-08-18|||January 2008||2008-01-01|August 2015|2015-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Improvement of Implant Survival in Total Joint Arthroplasty of the Trapeziometacarpal Joint|Improvement of Implant Survival in Total Joint Arthroplasty of the Trapeziometacarpal Joint|Recruiting||Phase 4|100|Anticipated|Regional Hospital Holstebro||1|||f||||t||||||||||2017-10-11 03:11:10.113459|2017-10-11 03:11:10.113459
NCT01554735|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-07-27|||July 2010||2010-07-01|July 2015|2015-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men|The Effects of Lifestyle-modification Induced Weight Loss on Metabolic and Inflammatory Profile, Endothelial, Sexual and Urinary Function, and Quality of Life in Obese Men|Completed||Phase 4|70|Actual|Changi General Hospital||1|||f||||f||||||||||2017-10-11 03:11:10.230174|2017-10-11 03:11:10.230174
NCT01554722|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-13|||November 2011||2011-11-01|March 2012|2012-03-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Needle Nerve Contact in Ultrasound Guided Femoral Block|Incidence of Intraneural Needle Insertion in Ultrasound Guided Femoral Block: Out of Plane Versus in Plane Approach|Unknown status|Recruiting|N/A|44|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 03:11:10.353917|2017-10-11 03:11:10.353917
NCT01554709|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2014-09-23|||March 2012||2012-03-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Performance Study of the CardioGard Cannula|A Study to Collect Additional Information Related to the Safety and Performance of the CardioGard Cannula|Completed||Phase 2/Phase 3|71|Actual|CardioGard Medical Ltd.||2|||f||||f||||||||||2017-10-11 03:11:10.557845|2017-10-11 03:11:10.557845
NCT01554501|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-11-28|||November 2007||2007-11-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Role of Stress in Self-Control, Coping, and Emotion Regulation|The Role of Stress in Self-Control, Coping and Emotion Regulation|Completed||N/A|855|Actual|Yale University|||1||f||||t||||||Samples With DNA|"     Blood taken for understanding genetic factors.   "|||2017-10-11 03:11:12.994856|2017-10-11 03:11:12.994856
NCT01554696|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2014-12-01||2014-12-01|June 2012||2012-06-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate|A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate|Completed||Phase 2|379|Actual|Astellas Pharma Inc||5|||f||||t||||||||||2017-10-11 03:11:10.682724|2017-10-11 03:11:10.682724
NCT01554683|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-02-23|||February 2012||2012-02-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Seizure Activity in Alzheimer's Disease|Seizure-like Hippocampal Activity in Alzheimer's Disease Neurodegeneration|Active, not recruiting||N/A|20|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||t||||||||||2017-10-11 03:11:10.918515|2017-10-11 03:11:10.918515
NCT01554670|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-18|||January 2009||2009-01-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|RF||Radio-frequency (RF)-Based Plasma Micro-tenotomy for the Treatment of Shoulder Impingement Syndrome|A Prospective Randomized Controlled Study of Radio-frequency Treatment for Shoulder Impingement Syndrome|Completed||Phase 4|65|Actual|Beijing Hospital||2|||f||||f||||||||||2017-10-11 03:11:11.008896|2017-10-11 03:11:11.008896
NCT01554657|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-14|||January 2011||2011-01-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit||Completed||N/A|46|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:11:11.092914|2017-10-11 03:11:11.092914
NCT01554644|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-07-15|||March 2012||2012-03-01|July 2013|2013-07-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Interventional|||Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients|A Randomized, Double-Blind Exploratory Pilot Study Comparing Prontosan(TM) Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients|Withdrawn||N/A|0|Actual|B. Braun Medical Inc.||2||Lack of Enrollment|f||||f||||||||||2017-10-11 03:11:11.178728|2017-10-11 03:11:11.178728
NCT01554631|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-06-13|||March 2012||2012-03-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg|Randomized, Non-blinded, 3-fold Crossover Study to Investigate the Bioequivalence Between Glucobay ODT 100 mg Taken Without and With Water and the Glucobay Standard Tablet 100 mg Following Single Oral Dosing in Healthy Male Subjects|Completed||Phase 1|34|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:11:11.270309|2017-10-11 03:11:11.270309
NCT01552811|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-02-04|||March 2012||2012-03-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Studies of Pancreatic Islet Mass by Positron Emission Tomography (PET)|Open Study to Investigate Pancreatic Islet Mass by Positron Emission Tomography Using the Tracer [11C]5-hydroxytryptophane|Completed||N/A|20|Actual|Uppsala University Hospital|||2||f||||||||||||||2017-10-11 03:11:11.676911|2017-10-11 03:11:11.676911
NCT01554605|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-03-14|||March 2012||2012-03-01|March 2012|2012-03-01||||||||Observational|||Gait Disturbances and Hips Bone Mineral Density||Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||||||||||||2017-10-11 03:11:11.73832|2017-10-11 03:11:11.73832
NCT01554592|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-05-30|||March 2012||2012-03-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Polypharmacy in the Heart Failure Patient: Are All Prescribed Drug Classes Required? Statin Withdrawal Study|Polypharmacy in the Heart Failure Patient: Are All Prescribed Drug Classes Required? Statin Withdrawal Study.|Completed||N/A|13|Actual|The Alfred||2|||f||||f||||||||||2017-10-11 03:11:11.7867|2017-10-11 03:11:11.7867
NCT01554579|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2017-04-14|2016-09-23||March 31, 2012|Actual|2012-03-31|April 2017|2017-04-01|November 30, 2013|Actual|2013-11-30|November 30, 2013|Actual|2013-11-30||Interventional|||A Four-Week Multicenter Study Evaluating the Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Subjects With Osteoarthritis of the Knee||Completed||Phase 2|171|Actual|Afferent Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 03:11:11.882511|2017-10-11 03:11:11.882511
NCT01554566|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2012-03-14|||January 2010||2010-01-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Metabolic Effects of Honey in Type 1 Diabetes Mellitus|Metabolic Effects of Honey in Type 1 Diabetes Mellitus: a Cross Over Randomised Controlled Pilot Study|Completed||Phase 2|20|Actual|Ain Shams University||1|||f||||t||||||||||2017-10-11 03:11:12.41812|2017-10-11 03:11:12.41812
NCT01554553|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-05-10|||January 2012||2012-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Longitudinal Sleeve Gastrectomy Study Comparing Posterior Crural Repair Versus No Repair|A Prospective Randomized Clinical Trial Comparing Patients Who Have Had Longitudinal Sleeve Gastrectomy With Posterior Crural Repair Versus Without Posterior Crural Repair|Active, not recruiting||N/A|100|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 03:11:12.506641|2017-10-11 03:11:12.506641
NCT01554540|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-07-17|||February 2012||2012-02-01|July 2013|2013-07-01|February 2014|Anticipated|2014-02-01|October 2013|Anticipated|2013-10-01||Interventional|TIPPS||Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study|Pharmacodynamic and Pharmacokinetic Assessment of Treprostinil Iontophoresis on the Forearm and the Fingers|Unknown status|Active, not recruiting|Phase 1/Phase 2|40|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 03:11:12.604105|2017-10-11 03:11:12.604105
NCT01554527|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-08-14|||March 2012||2012-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|July 2017|Actual|2017-07-01||Interventional|||Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children|Sleep-Disordered Breathing and CPAP After Adenotonsillectomy in Children|Active, not recruiting||N/A|120|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 03:11:12.721855|2017-10-11 03:11:12.721855
NCT00004685|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||January 1998||1998-01-01|March 1999|1999-03-01|September 2000||2000-09-01|||||Interventional|||Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy||Completed||N/A|90||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.311117|2017-10-11 04:26:56.311117
NCT01554488|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-02-24|||March 2013||2013-03-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|InFLOW||Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease|Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease|Terminated||N/A|58|Anticipated|VA Office of Research and Development||2||Low subject accrual|f||||t||||||||||2017-10-11 03:11:13.062453|2017-10-11 03:11:13.062453
NCT01554475|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-02-16|||March 2012||2012-03-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction|Use of Alternative Medicine Among Patients With Dementia and Mild Cognitive Dysfunction|Completed||N/A|151|Actual|University Hospital of North Norway|||1||f||||f||||||||||2017-10-11 03:11:13.154505|2017-10-11 03:11:13.154505
NCT01554462|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-12-10|||January 2009||2009-01-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD|The Effects of Eicosapentaenoic Acid (EPA)/ Docosahexaenoic Acid (DHA) Supplementation on Cognitive Control in Children With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|79|Actual|Unilever R&D||4|||f||||f||||||||||2017-10-11 03:11:13.230482|2017-10-11 03:11:13.230482
NCT01554449|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-11-23|||September 2011||2011-09-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|MARGAUT||Upper Arm Reahabilitation After Stroke and Video Game|Effect of Early Upper Arm Rehabilitation After Stroke Using Adaptative Video Games|Recruiting||Phase 3|62|Anticipated|University Hospital, Montpellier||3|||f||||f||||||||||2017-10-11 03:11:13.331764|2017-10-11 03:11:13.331764
NCT01554436|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-12-30|||December 2008||2008-12-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|May 2011|Actual|2011-05-01||Interventional|||Neuropsychological Prognosis Factors of Smoking Cessation|Neuropsychological and Psychopathological Prognosis Factors of Smoking Cessation|Completed||Phase 4|135|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 03:11:13.436966|2017-10-11 03:11:13.436966
NCT01554423|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-07-18|||July 2010||2010-07-01|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|January 31, 2017|Actual|2017-01-31||Interventional|SA R01||Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa|Four-Arm RCT of Brief MI vs. Couples-Based HIV/STI Prevention in South Africa|Completed||N/A|464|Actual|The City College of New York||4|||f||||t||||||||||2017-10-11 03:11:13.520463|2017-10-11 03:11:13.520463
NCT01554410|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-12-01|||August 2010||2010-08-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma|A Phase I Trial of Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Escalating Gemcitabine for Locally Advanced Cervical Carcinoma|Unknown status|Recruiting|Phase 1|19|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 03:11:13.611026|2017-10-11 03:11:13.611026
NCT01554397|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-12-01|||September 2011||2011-09-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer|Phase II/III Clinical Trial of Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage I-IVA Cervical Carcinoma|Recruiting||Phase 2/Phase 3|425|Anticipated|University of California, San Diego||3|||f||||t||||||||||2017-10-11 03:11:13.75388|2017-10-11 03:11:13.75388
NCT01554384|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2013-06-04|||October 2010||2010-10-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|TBNEATXpert||Trial of Point-of-treatment Xpert MTB/RIF Assay|Multicentre Randomised Control Trial of Point-of-treatment (Clinic-based) Xpert MTB/RIF Assay|Completed||N/A|1472|Actual|University of Cape Town||2|||f||||t||||||||||2017-10-11 03:11:13.92647|2017-10-11 03:11:13.92647
NCT01554371|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-08-08|||March 2012||2012-03-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies|A Phase Ib/II Study of Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies|Recruiting||Phase 1/Phase 2|58|Anticipated|University of California, San Francisco||1|||f||||t|t|f||||||||2017-10-11 03:11:14.033143|2017-10-11 03:11:14.033143
NCT01554358|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-11-03|||August 2009||2009-08-01|November 2015|2015-11-01||||July 2011|Actual|2011-07-01||Interventional|GDM||Tianjin Gestational Diabetes Prevention Program (TGDPP)|Lifestyle and Genetic Factors on Diabetes Risk in Women With GDM After Delivery: Tianjin Gestational Diabetes Prevention Program (TGDPP)|Recruiting||N/A|1180|Anticipated|Tianjin Women and Children's Health Center||2|||f||||t||||||||||2017-10-11 03:11:14.163374|2017-10-11 03:11:14.163374
NCT01554345|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2012-03-13|||June 2011||2011-06-01|March 2012|2012-03-01||||August 2012|Anticipated|2012-08-01||Interventional|||Effect of Vitamin E+Selenium on Kidney Function in Controlled Hypotension|Assessment of Preventive Effect of Vitamin E +Selenium on Acute Kidney Injury Through NGAL in Patients Undergoing Controlled Hypotension During Neurosurgery Operations|Unknown status|Recruiting|Phase 2|60|Anticipated|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:11:14.264041|2017-10-11 03:11:14.264041
NCT01554332|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-04-24|||October 2012||2012-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Motor Cortex Stimulation for Chronic Neuropathic Pain|A Clinical Evaluation for the Management of Patients With Chronic Neuropathic Pain With Cortical Stimulation|Active, not recruiting||N/A|38|Actual|St. Jude Medical||2|||f||||f||||||||||2017-10-11 03:11:14.373535|2017-10-11 03:11:14.373535
NCT01554319|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2012-11-22|||April 2012||2012-04-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects|Phase-I Study in Healthy Male Subjects to Investigate Safety, Tolerability and Pharmacokinetics of Orally Inhaled Multiple Doses of SB010, a Human GATA-3-specific DNAzyme Solution for Nebulisation|Completed||Phase 1|36|Actual|Sterna Biologicals GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 03:11:14.463931|2017-10-11 03:11:14.463931
NCT01554306|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-10-28|||March 2012||2012-03-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease|Observational Study on the Effecst of Continuous Dopaminergic Stimulation on Nocturnal Hypokinesia in Parkinson's Disease|Terminated||N/A|2|Actual|Sleep Medicine Centre Kempenhaeghe|||1|difficulty to include enough subjects|f||||t||||||||||2017-10-11 03:11:14.546169|2017-10-11 03:11:14.546169
NCT01554293|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2013-05-15|||July 2012||2012-07-01|May 2013|2013-05-01|September 2013|Anticipated|2013-09-01|July 2013|Anticipated|2013-07-01||Interventional|||Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled Phase I Study To Determine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers|Unknown status|Recruiting|Phase 1|48|Anticipated|Panacea Biotec Ltd||2|||f||||t||||||||||2017-10-11 03:11:14.61542|2017-10-11 03:11:14.61542
NCT01554280|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2014-12-03|||January 2012||2012-01-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|CBE-001-SEOS||Fully Coated, Removable, Self-expanding Oesophageal Stents for Preventing Strictures Following Complete Barretts Excision.|Fully, Coated, Removable, Self-expanding Oesophageal Stents for the Prevention of Oesophageal Stricture Following Endoscopic Mucosal Resection of Short Segment Barrett's With High Grade Dysplasia and Early Cancer.|Completed||N/A|12|Actual|Western Sydney Local Health District||1|||f||||f||||||||||2017-10-11 03:11:14.702443|2017-10-11 03:11:14.702443
NCT01554267|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-05-12|||January 2014||2014-01-01|May 2014|2014-05-01|May 2015|Anticipated|2015-05-01|January 2015|Anticipated|2015-01-01||Interventional|ICG||The Use of Laser-Assisted Indocyanine Green Dye Angiography to Predict Mastectomy Skin Flap Viability|The Use of Laser-Assisted Indocyanine Green Dye Angiography to Predict Intraoperative Mastectomy Skin Flap Viability During Breast Reconstruction|Unknown status|Recruiting|N/A|45|Anticipated|Stony Brook University||1|||f||||f||||||||||2017-10-11 03:11:14.770936|2017-10-11 03:11:14.770936
NCT01554254|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-08-29|||March 2012||2012-03-01|August 2016|2016-08-01||||December 2013|Actual|2013-12-01||Interventional|||Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation|Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation|Withdrawn||Phase 2|0|Actual|Tarix Pharmaceuticals||1||Lack of enrollment|f||||||||||||||2017-10-11 03:11:14.865102|2017-10-11 03:11:14.865102
NCT01554241|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-02-13|2015-01-23||September 2012||2012-09-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Elderly (>65 yr) clinically stable long-term stay nursing home residents with no contraindications or allergy to D, osteoporosis or a history of fractures and receiving over 800 IU/day D, treatment for severe D deficiency or investigational agent in the prior six months on no D or had stable D doses for over two months .|Optimizing Vitamin D in the Elderly|Optimizing Vitamin D in the Elderly|Completed||N/A|86|Actual|University of California, San Francisco||4|||f||||t||||||||||2017-10-11 03:11:14.959446|2017-10-11 03:11:14.959446
NCT01554228|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-12-20|||August 2011||2011-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|Obesity||Change in Cognitive Function in Obese Patients After Bariatric Surgery - an Observational Study|Change in Cognitive Function in Obese Patients After Bariatric Surgery - an Observational Study|Active, not recruiting||N/A|64|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 03:11:15.503548|2017-10-11 03:11:15.503548
NCT01554215|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-03-31|||September 2011||2011-09-01|March 2012|2012-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|MP||Mom Power is an Attachment Based Parenting Program for Families and Their Children|Phase 1 of Mom Power: Attachment Based Parenting and Self-Care Skills Program|Completed||Phase 2|419|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 03:11:15.571999|2017-10-11 03:11:15.571999
NCT01554202|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2013-03-05|||January 2008||2008-01-01|March 2013|2013-03-01||||December 2021|Anticipated|2021-12-01||Interventional|IMAP||Multi-modal Neuroimaging in Alzheimer's Disease|Study of the Predictive Markers and the Pathophysiological Mechanisms of Alzheimer's Disease: Transverse and Longitudinal Approach in Anatomical and Functional Multimodal Imaging|Active, not recruiting||N/A|295|Anticipated|University Hospital, Caen||9|||f||||t||||||||||2017-10-11 03:11:15.663992|2017-10-11 03:11:15.663992
NCT01554189|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-07-20|||April 2012||2012-04-01|July 2015|2015-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002)|A Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C Infected Males|Terminated||Phase 1|37|Actual|Merck Sharp & Dohme Corp.||11|||f||||f||||||||||2017-10-11 03:11:15.798368|2017-10-11 03:11:15.798368
NCT01554176|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2017-08-29|2016-09-15||May 18, 2012|Actual|2012-05-18|August 2017|2017-08-01|September 3, 2013|Actual|2013-09-03|September 3, 2013|Actual|2013-09-03||Interventional|||Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)|A Phase IIa, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 for Treatment Augmentation in Patients With Major Depressive Disorder|Terminated||Phase 2|129|Actual|Merck Sharp & Dohme Corp.||5||Low Enrollment|f||||f||||||||||2017-10-11 03:11:16.083649|2017-10-11 03:11:16.083649
NCT01554163|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2015-10-08|2013-09-25||March 2012||2012-03-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis|A Phase III, 12-Week, Randomized, Active-Comparator-Controlled, Parallel-Group, Double Blind Study in Korea to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Patients With Osteoarthritis|Completed||Phase 3|239|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 03:11:16.822236|2017-10-11 03:11:16.822236
NCT01554150|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-07-18|||February 2012||2012-02-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Randomised Controlled Trial of Method of Levels Cognitive Therapy|A Randomised Controlled Trial Comparing Method of Levels Cognitive Therapy With a Contact Service for Improving Outcomes in Primary Care|Completed||N/A|55|Actual|University of Manchester||2|||f||||f||||||||||2017-10-11 03:11:17.424217|2017-10-11 03:11:17.424217
NCT01554137|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-05-31|||October 2010||2010-10-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Interests of Strengthening Isokinetic Upper Extremity Hemiparetic Sequelae in Patients|Interests of Strengthening Isokinetic Upper Extremity Hemiparetic Sequelae in Patients|Terminated||N/A|20|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 03:11:17.542092|2017-10-11 03:11:17.542092
NCT01553929|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-08-13|||March 2012||2012-03-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|March 2012|Actual|2012-03-01||Interventional|EPAC-M||Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient|Physical Trainig and Cognitive Activity on the MCI Patient|Terminated||N/A|5|Actual|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 03:11:19.260514|2017-10-11 03:11:19.260514
NCT01554124|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-02-12|||February 2013||2013-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NeoMero-2||Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis|Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age (Inclusive) With Probable and Confirmed Meningitis: A European Multicenter Phase I-II Trial|Completed||Phase 1/Phase 2|51|Actual|PENTA Foundation||1|||f||||t||||||||||2017-10-11 03:11:17.630924|2017-10-11 03:11:17.630924
NCT01554111|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-09-23|||March 2012||2012-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparing Bowel Preparation Regimens for Flexible Sigmoidoscopy|A Randomized Controlled Study Comparing PicoSalax, Versus PicoSalax and Fleet Enema Versus Fleet Enema Alone for Sigmoidoscopy|Completed||Phase 4|120|Actual|Queen's University||3|||f||||t||||||||||2017-10-11 03:11:17.73917|2017-10-11 03:11:17.73917
NCT01554098|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-03-27|||February 2012||2012-02-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Comparison of Two Colonoscopic Withdrawal Techniques|A Comparison of Two Colonoscopic Withdrawal Techniques on Colonic Polyp Detection: an Open, Randomised, Cross Over Trial|Completed||Phase 4|130|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 03:11:17.845701|2017-10-11 03:11:17.845701
NCT01554085|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-09-26|||December 2011||2011-12-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1|A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-Part Study of Orally Administered ALS-002158 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dosing and Food-effect in Healthy Volunteers, and Multiple Ascending Dosing in Subjects With Chronic Hepatitis C Genotype 1 Infection|Terminated||Phase 1|78|Actual|Alios Biopharma Inc.||2||"ALS-2158 showed insufficient antiviral activity to warrant proceeding with further clinical   development."|f||||f||||||||||2017-10-11 03:11:17.98212|2017-10-11 03:11:17.98212
NCT01554072|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2013-06-24|||January 2012||2012-01-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|HBCOPD||Home-based in Chronic Obstructive Pulmonary Disease|Home-based Pulmonary Rehabilitation in COPD|Completed||N/A|30|Actual|University of Nove de Julho||2|||f||||t||||||||||2017-10-11 03:11:18.088579|2017-10-11 03:11:18.088579
NCT01554059|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2014-11-07|||March 2012||2012-03-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|May 2013|Actual|2013-05-01||Interventional|New Beat||Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients|Phase II Trial of Neoadjuvant Chemoradiation With Bevacizumab for Chinese Locally Advanced Rectal Adenocarcinoma|Completed||Phase 2|25|Actual|Sixth Affiliated Hospital, Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 03:11:18.221197|2017-10-11 03:11:18.221197
NCT01554046|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-03-11|||October 2011||2011-10-01|March 2012|2012-03-01|December 2022|Anticipated|2022-12-01|March 2022|Anticipated|2022-03-01||Interventional|||The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)|The Effect of Methylphenidate (Ritalin IR) Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)|Recruiting||N/A|400|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 03:11:18.346999|2017-10-11 03:11:18.346999
NCT01554033|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2012-03-16|||May 2009||2009-05-01|March 2012|2012-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)|Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN).|Unknown status|Recruiting|N/A|200|Anticipated|Seoul National University Hospital|||2||f||||t||||||Samples With DNA|"     serum-60ml urine-60ml Formation study of Lymphoblast and diagnosis of a Huntington gene   "|||2017-10-11 03:11:18.478228|2017-10-11 03:11:18.478228
NCT01554020|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-03-11|||June 2012||2012-06-01|March 2013|2013-03-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||Blood Sugar Take Care and Glucose Metabolism|Effect of Blood Sugar Take Care on Glucose Metabolism, Determinants of Metabolic Syndrome, and Quality of Life in Prediabetic Adults: A Randomized, Double-blind, Placebo-controlled Study|Withdrawn||Phase 2|0|Actual|NewChapter, Inc.||2||Change of CRO|f||||f||||||||||2017-10-11 03:11:18.586511|2017-10-11 03:11:18.586511
NCT01554007|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-10-25|||December 2012||2012-12-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Clinical Course of Korean Crohn's Disease Cohort|Clinical Course of Crohn's Disease: a Prospective Multicenter Long-term Follow-up Study in Korea|Enrolling by invitation||N/A|2000|Anticipated|Kyunghee University Medical Center|||1||f||||t||||||Samples With DNA|"     Whole blood, DNA, and serum will be retained for central biobank   "|No||2017-10-11 03:11:18.701716|2017-10-11 03:11:18.701716
NCT01553994|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2013-03-15|||June 2006||2006-06-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Effectiveness Study of Gardasil on Condyloma|Gardasil® Population-Based Condyloma Effectiveness Study In Swedish Women Including Condyloma Incidence Estimations For Swedish Men And Women|Completed||N/A|500000|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 03:11:18.821373|2017-10-11 03:11:18.821373
NCT01553981|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2015-04-20|||March 2012||2012-03-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma|A Double Blind Randomized Control Trial of Tadalafil in Interstitial Lung Disease of Scleroderma|Completed||Phase 3|40|Actual|Sanjay Gandhi Postgraduate Institute of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:11:18.905563|2017-10-11 03:11:18.905563
NCT01553968|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-09-19|||April 2012||2012-04-01|July 2012|2012-07-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained Subjects|Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained Subjects|Completed||N/A|9|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:11:19.015402|2017-10-11 03:11:19.015402
NCT01553955|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-07-22|||January 2012||2012-01-01|March 2012|2012-03-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy of Training in Manual Preparation of Platelet Rich Plasma|Efficacy of Training in Preparation of Platelet Rich Plasma Using a Standard Centrifuge and Manual Pipetting Methods|Completed||N/A|28|Actual|Peterson, Noel, N.D.||1|||f||||t||||||||||2017-10-11 03:11:19.092978|2017-10-11 03:11:19.092978
NCT01553942|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-09-19|||April 2012||2012-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Afatinib With CT and RT for EGFR-Mutant NSCLC|Afatinib Sequenced With Concurrent Chemotherapy and Radiation in EGFR-Mutant Non-Small Cell Lung Tumors: The ASCENT Trial|Recruiting||Phase 2|30|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:11:19.158477|2017-10-11 03:11:19.158477
NCT01553903|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-06-03|||December 2011||2011-12-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|OXYTAM||Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not|Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not|Completed||Phase 4|29|Actual|Institut Claudius Regaud||4|||f||||f||||||||||2017-10-11 03:11:19.434931|2017-10-11 03:11:19.434931
NCT01553890|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-13|||March 2012||2012-03-01|January 2012|2012-01-01|March 2013|Anticipated|2013-03-01|November 2012|Anticipated|2012-11-01||Interventional|SSc||Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples|Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at SSc Patients Compared Healthy Peoples|Unknown status|Not yet recruiting|N/A|30|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-11 03:11:19.51337|2017-10-11 03:11:19.51337
NCT01553877|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2013-01-01|||January 2012||2012-01-01|March 2012|2012-03-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||Development and Acceptability Testing of Ready-to-use-complementary Food Supplement (RUCFS) for Children in Bangladesh|Development and Acceptability Testing of Ready-to-use-complementary Food Supplement (RUCFS) for Children in Bangladesh|Completed||Phase 2/Phase 3|90|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||f||||||||||2017-10-11 03:11:19.582077|2017-10-11 03:11:19.582077
NCT01553851|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-10-31|2016-09-06||February 2013||2013-02-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer|A Phase II Window of Opportunity Trial With GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer|Completed||Phase 2|20|Actual|Washington University School of Medicine|Small number of treated patients. Short duration of GSK1120212 administration. Biopsy limitations precluded analysis of all patients.|1|||f||||f||||||||||2017-10-11 03:11:19.736482|2017-10-11 03:11:19.736482
NCT01553838|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-08-18|||January 2012||2012-01-01|March 2012|2012-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values|A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values|Completed||N/A|185|Actual|Heinrich-Heine University, Duesseldorf||1|||f||||f||||||||||2017-10-11 03:11:20.376297|2017-10-11 03:11:20.376297
NCT01553825|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2017-08-18|||March 2012|Actual|2012-03-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Assessment of Patient Experience During Treatment for Cancer|Assessment of Patient Experience During Treatment for Cancer|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||t||||||||||2017-10-11 03:11:20.445504|2017-10-11 03:11:20.445504
NCT01553812|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-12|||January 2010||2010-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||The Assessment of Airway Resistance and Airtrapping in Elderly COPD Patients by Forced Oscillation Technique (FOT)|The Assessment of Airway Resistance and Airtrapping in Elderly COPD Patients by Forced Oscillation Technique (FOT)|Completed||N/A|158|Actual|Kwong Wah Hospital|||1||f||||f||||||||||2017-10-11 03:11:20.508654|2017-10-11 03:11:20.508654
NCT01552798|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-01-14|||March 2012||2012-03-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|Tarot Headache||Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache|A Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single Dose of Fast Release Aspirin 1000 mg and Acetaminophen 1000 mg in Tension Type Headache Pain|Terminated||Phase 3|9|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:11:20.561497|2017-10-11 03:11:20.561497
NCT01552785|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-06-21|||March 2012||2012-03-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||A Comparison of Measurements of Peripheral Tissue Oxygenation by NONIN EQUANOX 7600, INVOS 5100c, and FORE-SIGHT||Completed||N/A|10|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 03:11:22.268975|2017-10-11 03:11:22.268975
NCT01552772|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-10-08|2014-09-02||January 2012||2012-01-01|October 2014|2014-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole|An Open-label, Safety and Tolerability Trial of Aripiprazole IM Depot Treatment Initiation in Adult Subjects With Schizophrenia Stabilized on Atypical Oral Antipsychotics Other Than Aripiprazole|Completed||Phase 1|60|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 03:11:22.400402|2017-10-11 03:11:22.400402
NCT01552759|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2013-03-08|||May 2007||2007-05-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Appetite Hormones in Binge Eating Disorder|Appetite Hormones in Binge Eating Disorder|Completed||N/A|96|Actual|New York Obesity and Nutrition Research Center||3|||f||||t||||||||||2017-10-11 03:11:22.863084|2017-10-11 03:11:22.863084
NCT01552746|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2014-06-16|||January 2012||2012-01-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|FACTS2||From ACute To Chronic Postoperative Shoulder Pain in Patients for Elective Lobectomy|From Acute to Chronic Postoperative Shoulder Pain in Patients for Elective Lobectomy|Completed||N/A|60|Actual|Odense University Hospital|||1||f||||f||||||||||2017-10-11 03:11:22.99069|2017-10-11 03:11:22.99069
NCT01552733|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-01-26|||March 1, 2012|Actual|2012-03-01|January 2017|2017-01-01|March 16, 2016|Actual|2016-03-16|March 16, 2016|Actual|2016-03-16||Interventional|R-TEASE||Robotic Therapy Early After Stroke Events|Robotic Therapy Early After Stroke Events|Completed||N/A|80|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 03:11:23.059461|2017-10-11 03:11:23.059461
NCT01552720|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-12|||January 2011||2011-01-01|March 2012|2012-03-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Observational|CCMOCPAAD||Clinical Characteristics, Management and Outcomes of Chinese Patients With Acute Aortic Dissection|Clinical Investigation of Chinese Patients With Aortic Dissection|Unknown status|Recruiting|N/A|5000|Anticipated|Xijing Hospital|||1||f||||t||||||||||2017-10-11 03:11:23.260782|2017-10-11 03:11:23.260782
NCT01552707|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-03-16|||June 2012||2012-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety Study of Mesenchymal Stem Cells and Spinal Fusion|"Ex Vivo Expanded Autologous Bone Marrow Mesenchymal Stem Cells Fixed in Allogenic Human Bone Tissue for Spinal Fusion in Spine Degenerative Disease"|Active, not recruiting||Phase 1/Phase 2|62|Anticipated|Banc de Sang i Teixits||2|||f||||f||||||||||2017-10-11 03:11:23.357993|2017-10-11 03:11:23.357993
NCT01552694|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-05-13|2015-02-05||October 2012||2012-10-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Sitagliptin and HIV|A Double Blind, Randomized, Placebo Controlled Study to Determine the Physiological Effectiveness of Januvia (100 mg/d) for Reducing Inflammation and Increasing Endothelial Progenitor Cell Number in Human Immunodeficiency Virus (HIV) Infected Men and Women With Insulin Resistance and Central Adiposity.|Completed||Phase 3|38|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 03:11:23.493024|2017-10-11 03:11:23.493024
NCT01552681|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-03-22|2016-02-21||July 2012||2012-07-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional||The Modified Intent-to-Treat population included all randomized subjects who received at least one dose of either baminercept or placebo and had a screening stimulated salivary flow assessment|Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome|A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial of Baminercept, a Lymphotoxin-beta Receptor Fusion Protein, for the Treatment of Primary Sjögren's Syndrome (ASJ02)|Terminated||Phase 2|52|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Randomization was prematurely stopped in July 2014 due to study product expiration. 52 of the 72 planned subjects were randomized.|2||Expired experimental study agent, no additional supply available.|f||||t||||||||Yes|The plan is to share data in ImmPort, a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools that are available to researchers who register online and subsequently receive DAIT approval.|2017-10-11 03:11:24.085956|2017-10-11 03:11:24.085956
NCT01552668|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-05-27|||September 2012||2012-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Fidaxomicin to Prevent Clostridium Difficile Colonization|The Effect of a Twice Daily, 200 mg Dose of Oral Fidaxomicin Compared to Placebo on Risk of Acquiring C. Difficile and Developing C. Difficile Infection (CDI) in High Risk Patients|Withdrawn||Phase 4|0|Actual|Washington University School of Medicine||2||Study not performed|f||||f||||||||||2017-10-11 03:11:25.313426|2017-10-11 03:11:25.313426
NCT01552655|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-04-20|||December 2011||2011-12-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|BREAC-AUT||Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT|Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT|Completed||N/A|101|Actual|Odense University Hospital||1|||f||||f||||||||||2017-10-11 03:11:25.500805|2017-10-11 03:11:25.500805
NCT01552642|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-07-27|||February 2013||2013-02-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||An Interactive Web-based Intervention to Achieve Healthy Weight in Young Children|An Interactive Web-based Intervention to Achieve Healthy Weight in Young Children|Completed||Phase 3|77|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 03:11:25.6009|2017-10-11 03:11:25.6009
NCT01553799|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-12|||April 2012||2012-04-01|March 2012|2012-03-01||||||||Observational|||Use of Ultrasound Technology to Check Proper Placement of Tracheal and Endobronchial Tubes||Unknown status|Not yet recruiting|N/A|40|Anticipated|King Saud University|||2||f||||||||||||||2017-10-11 03:11:25.71919|2017-10-11 03:11:25.71919
NCT01553786|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-07-11|||November 2011|Actual|2011-11-01|July 2017|2017-07-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)|STUDY OF THE EFFICACY AND SAFETY OF FIRST LINE TREATMENT WITH CHOP AND LENALIDOMIDE (Rev-CHOP) IN PATIENTS AGED FROM 60 TO 80 YEARS WITH PREVIOUSLY UNTREATED ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL)|Recruiting||Phase 2|70|Anticipated|The Lymphoma Academic Research Organisation||1|||f||||f||||||||||2017-10-11 03:11:25.79656|2017-10-11 03:11:25.79656
NCT01553773|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-13|||July 2004||2004-07-01|March 2012|2012-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment|Hyaluronic Acid Concentration in Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment: Double-blind and Randomized Clinical Trial of Efficacy|Completed||Phase 2|30|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:11:26.051773|2017-10-11 03:11:26.051773
NCT01553760|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2012-03-13|||March 2012||2012-03-01|March 2012|2012-03-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||The Use of an Anterior Chamber Maintainer as a Sole Fluid Source in Micro Incision Cataract Surgery as Compared to a Standard Phacoemulsification Procedure||Unknown status|Not yet recruiting|N/A|20|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 03:11:26.153327|2017-10-11 03:11:26.153327
NCT01553747|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-04-26||2014-03-25|May 2012||2012-05-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol JNJ-27018966IBS3002)|A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome|Completed||Phase 3|1150|Actual|Furiex Pharmaceuticals, Inc||3|||f||||f||||||||||2017-10-11 03:11:26.325399|2017-10-11 03:11:26.325399
NCT01553734|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-11|2016-08-30|||March 2012||2012-03-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?|Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?|Completed||N/A|148|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||No||2017-10-11 03:11:27.032041|2017-10-11 03:11:27.032041
NCT01553721|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2016-04-15|||August 2011||2011-08-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)|A Placebo-controlled, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)|Completed||Phase 2|63|Actual|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:11:27.218519|2017-10-11 03:11:27.218519
NCT00004686|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||February 1994||1994-02-01|March 1999|1999-03-01|September 1999||1999-09-01|||||Interventional|||Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis||Completed||Phase 2|300||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.390523|2017-10-11 04:26:56.390523
NCT01553708|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-03-19|2012-07-01||December 2011||2011-12-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of EGF With Silver Sulfadiazine Cream Compared With Silver Zinc Sulfadiazine Cream for Treatment of Burn Wound|The Clinical Efficacy of Epidermal Growth Factor With Silver Sulfadiazine Cream Compared With Silver Zinc Sulfadiazine Cream on Acceleration of Partial Thickness Burn Wound Healing|Completed||Phase 2/Phase 3|34|Actual|Chulalongkorn University|Early termination leading to small numbers of subjects analyzed and all samples have 18-60 years of age, this data cannot be applied for pediatrics.|2|||f||||t||||||||||2017-10-11 03:11:27.381492|2017-10-11 03:11:27.381492
NCT01553695|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-07-28|||March 2012||2012-03-01|January 2012|2012-01-01|February 2014|Actual|2014-02-01|March 2012|Actual|2012-03-01||Interventional|||Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French|Validation of a Clinical Interview for a Diagnosis of ADHD in Adults. Cross-validity of Screening Instruments ADHD in Adults. Estimation of Prevalence in France|Completed||N/A|110|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 03:11:27.800812|2017-10-11 03:11:27.800812
NCT01553682|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-06-24|||December 2011||2011-12-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Project N-Liten- HIV Prevention for African American Women|Reducing Alcohol-Related HIV Risk in African American Females|Completed||N/A|560|Actual|Emory University||3|||f||||f||||||||||2017-10-11 03:11:27.937887|2017-10-11 03:11:27.937887
NCT01553669|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-05-14|||October 2011||2011-10-01|May 2012|2012-05-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Reminiscence Therapy on Depression, Self Esteem, Life Satisfaction, and Loneliness of the Elderly|The Effects of Reminiscence Therapy on Depression, Self Esteem, Life Satisfaction, and Loneliness of the Elderly in China|Unknown status|Recruiting|Phase 2|60|Anticipated|Chinese Academy of Sciences||2|||f||||t||||||||||2017-10-11 03:11:28.050387|2017-10-11 03:11:28.050387
NCT01553656|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-08-19|||February 2011||2011-02-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer|Phase 1 Multiple Ascending Dose Study of XL184 Monotherapy in Japanese Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|85|Anticipated|Exelixis||1|||f||||f||||||||||2017-10-11 03:11:28.176592|2017-10-11 03:11:28.176592
NCT01553643|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-13|||January 2010||2010-01-01|March 2012|2012-03-01||||November 2012|Anticipated|2012-11-01||Interventional|||A Randomized Double Blind Placebo Control Study of Huang-Chi-Wu-Wu- Tang in Patients With Intracranial Arterial Stenosis||Unknown status|Recruiting|Phase 4|80|Anticipated|China Medical University Hospital||2|||f||||||||||||||2017-10-11 03:11:28.313717|2017-10-11 03:11:28.313717
NCT01553630|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-11-10|||May 2010||2010-05-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Reamed Locked Plating - Metaphyseal Fractures of the Distal Femur and Tibia|Reamed Locked Plating - Metaphyseal Fractures of the Distal Femur and Tibia|Terminated||N/A|6|Actual|Florida Orthopaedic Institute||2||Low enrollment.|f||||f||||||||||2017-10-11 03:11:28.431065|2017-10-11 03:11:28.431065
NCT01553617|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2014-06-25|||October 2012||2012-10-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||VolulyteTM in Cardiac Surgery|Efficacy and Safety of Perioperative Infusion of 6 % Hydroxyethyl Starch 130/0.4 in an Isotonic Electrolyte Solution (VolulyteTM) vs. 5% HSA as Volume Replacement Therapy During Cardiac Surgery for Adult Patients|Completed||Phase 4|133|Actual|Fresenius Kabi||2|||f||||f||||||||||2017-10-11 03:11:28.555305|2017-10-11 03:11:28.555305
NCT01553604|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2016-02-10|||July 2013||2013-07-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||Dressing Wear Time After Breast Augmentation With Prosthesis|Influence of Dressing Wear Time on Skin Colonization After Breast Augmentation With Prosthesis: a Randomized Controlled Trial|Completed||N/A|80|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 03:11:28.664187|2017-10-11 03:11:28.664187
NCT01553591|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-04-26||2014-03-25|May 2012||2012-05-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol JNJ-27018966IBS3001)|A Randomized, Double-blind, Placebo-controled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome|Completed||Phase 3|1282|Actual|Furiex Pharmaceuticals, Inc||3|||f||||f||||||||||2017-10-11 03:11:28.80668|2017-10-11 03:11:28.80668
NCT01553578|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-05-25|||February 2012||2012-02-01|May 2015|2015-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy|The Efficacy of Healing Touch Versus Guided Imagery on Pain, Fatigue, Nausea, and Anxiety in Patients' Receiving Outpatient Chemotherapy|Completed||N/A|244|Actual|Wake Forest University Health Sciences||3|||f||||f|f|f||||||||2017-10-11 03:11:29.58684|2017-10-11 03:11:29.58684
NCT01553565|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-10|2014-08-13|||March 2012||2012-03-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prospective Comparison of Cold Polypectomy and Conventional Polypectomy for Small Colorectal Polyps in Patients Taking Antithrombotic Agents||Completed||N/A|160|Anticipated|Showa Inan General Hospital||2|||f||||f||||||||||2017-10-11 03:11:29.772277|2017-10-11 03:11:29.772277
NCT01553552|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-13|||October 2011||2011-10-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|SchistoVAN||Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal|Comparison of Schistosomiasis Diagnostic Techniques and Study of Schistosoma Infection on Children's Immune Response to Childhood Vaccines, on Anaemia and on Nutritional Status|Completed||N/A|99|Actual|Biomedical Research Center EPLS|||2||f||||t||||||Samples Without DNA|"     Whole blood Sera Urine Stool   "|||2017-10-11 03:11:29.868967|2017-10-11 03:11:29.868967
NCT01553539|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-09-01|2013-11-15||October 2009||2009-10-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery|A Phase II Clinical Trial of Angiotensin 1-7 For the Second or Third Line Treatment of Patients With Metastatic or Unresectable Sarcomas|Completed||Phase 2|20|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 03:11:29.979146|2017-10-11 03:11:29.979146
NCT00004688|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||August 1996||1996-08-01|March 1999|1999-03-01|July 1998||1998-07-01|||||Interventional|||Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms||Completed||Phase 2|35||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.449234|2017-10-11 04:26:56.449234
NCT01553526|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-08-29|||August 2011||2011-08-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|March 2013|Actual|2013-03-01||Observational|BIOFLOW-III||BIOFLOW-III All-comers Orsiro Safety and Performance Registry|BIOTRONIK - Safety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III|Active, not recruiting||N/A|1356|Actual|Biotronik AG|||1||f||||f||||||||||2017-10-11 03:11:30.426281|2017-10-11 03:11:30.426281
NCT01553513|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-10|2012-03-13|||June 2012||2012-06-01|March 2012|2012-03-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|QAEK||PET/CT for the Quantification of Atherosclerotic Plaque Inflammation|PET/CT for the Quantification of Atherosclerotic Plaque Inflammation in Patients With Coronary Heart Disease: The QAEK Trial|Unknown status|Not yet recruiting|N/A|140|Anticipated|Ludwig-Maximilians - University of Munich|||4||f||||f||||||Samples With DNA|"     A 20 ml blood sample will be obtained from each patient. The following biomarkers will be     assessed: glucose level, HBA1C, cholesterol levels, LDL cholesterol, HDL cholesterol,     triglycerides, fibrinogen, factor XIII, plasminogen, complement C3, TNF-alpha, IL-6, CRP,     resistin, adiponectin, CD40, 5-lipoxygenase, MMP-9, MMP-1, osteopontin, osteoprotegerin,     fetuin, FGF21.      ELISA and/or calorimetric assays will be used for the biochemical analyses of the serum     markers.   "|||2017-10-11 03:11:30.607718|2017-10-11 03:11:30.607718
NCT01553500|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2014-04-01|||June 2011||2011-06-01|March 2012|2012-03-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|GC-NASH||Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease|Study of the Efficacy and Tolerability of Glucomannan on Children Affected by NAFLD|Completed||Phase 2|66|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||||||||||||2017-10-11 03:11:30.741254|2017-10-11 03:11:30.741254
NCT01553487|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-08-13|||September 2013||2013-09-01|August 2013|2013-08-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|Vib-Frx||Effects Of Unilateral Forearm Vibration On The Loss Of Muscle And Bone Of Contralateral Forearm|Effects Of Unilateral Forearm Vibration On The Loss Of Muscle Strength And Bone Of The Contralateral Forearm Due to Forearm/Elbow Fracture|Withdrawn||N/A|0|Actual|Bagcilar Training and Research Hospital||2||We did not found voluntary subjects|f||||f||||||||||2017-10-11 03:11:30.837339|2017-10-11 03:11:30.837339
NCT01553474|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-06-30|||February 24, 2012||2012-02-24|February 5, 2013|2013-02-05|February 5, 2013||2013-02-05|||||Observational|||Blood and Saliva Sample Collection for AREDS 2|Blood and Saliva Sample Collection and Submission to the Age-Related Eye Disease Study 2 (AREDS2) Genetic Repository|Completed||N/A|56|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:11:30.920844|2017-10-11 03:11:30.920844
NCT01553461|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2017-06-30|||February 1, 2012||2012-02-01|June 15, 2017|2017-06-15|October 20, 2036|Anticipated|2036-10-20|October 20, 2036|Anticipated|2036-10-20||Interventional|||Transplants With Unlicensed Preserved Cord Blood|A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications|Recruiting||Phase 1/Phase 2|500|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:11:30.988576|2017-10-11 03:11:30.988576
NCT01553448|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-13|2016-05-17|||March 2012||2012-03-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Gene Expression in Samples From Younger Patients With Neuroblastoma|The Role of Stroma-Derived Soluble TßRIII in Neuroblastoma|Completed||N/A|75|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:11:31.08386|2017-10-11 03:11:31.08386
NCT01553435|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-04-12|||January 2011||2011-01-01|April 2015|2015-04-01||||January 2015|Actual|2015-01-01||Interventional|||Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients|Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients|Unknown status|Active, not recruiting|N/A|36|Anticipated|King Abdullah International Medical Research Center||2|||f||||t||||||||||2017-10-11 03:11:31.175477|2017-10-11 03:11:31.175477
NCT01553422|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-12-03|||March 2012||2012-03-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Relation Between Intrabdominal Pressure and Collapsibility Index of Inferior Vena Cava Before and After Fluid Therapy|Assessment of Relation Between Intrabdominal Pressure and Collapsibility Index of Inferior Vena Cava by Emergency Ultrasonography Before and After Fluid Therapy|Completed||Phase 4|82|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:11:31.279127|2017-10-11 03:11:31.279127
NCT01553409|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-05-07|||February 2012||2012-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Effect of Blood Donation on Blood Pressure, Iron Metabolism, Oxidative Stress|Prospective Observational Study on the Effects of Blood Donation on Blood Pressure, Iron Metabolism and Oxidative Stress|Completed||N/A|300|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples Without DNA|"     regular blood donation is done and from blood, that is taken for blood tests by the blood     donation center any there are made blood tests of lipid metabolism, iron metabolism and     antioxidative stress   "|||2017-10-11 03:11:31.36223|2017-10-11 03:11:31.36223
NCT01553396|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-13|||January 2009||2009-01-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Observational|||Muscle Strength and Functional Autonomy of Elderly Women|Muscle Strength and Functional Autonomy of Normo-IGF-1 Elderly Women With Skeletal Muscle Dysfunctions|Completed||N/A|35|Actual|Euro-American Network of Human Kinetics|||1||f||||f||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 03:11:31.434808|2017-10-11 03:11:31.434808
NCT01553383|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-04-05|||February 2012||2012-02-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of Nasal Positive End Expiratory Pressure Valve to Dental Device as an Alternative Treatment for Obstructive Sleep Apnea|Comparison of Nasal Positive End Expiratory Pressure Valve to Dental Device as an Alternative Treatment for OSA|Completed||N/A|200|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:11:31.488036|2017-10-11 03:11:31.488036
NCT01553370|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2012-03-13|||April 2012||2012-04-01|March 2012|2012-03-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|||Randomized Controlled Trial of Milk Products and Physical Activity on Body Composition and Health in Overweight Young Males|Randomized Controlled Trial of Milk Products and Physical Activity on Body Composition and Health in Overweight Young Males|Unknown status|Not yet recruiting|N/A|54|Anticipated|Brock University||2|||f||||f||||||||||2017-10-11 03:11:31.565849|2017-10-11 03:11:31.565849
NCT01553357|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2012-03-13|||March 2009||2009-03-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia|A Pilot Study of Lenalidomide and Dexamethasone in Patients With Primary Plasma Cell Leukemia|Completed||Phase 2|23|Actual|IRCCS Centro di Riferimento Oncologico della Basilicata||1|||f||||t||||||||||2017-10-11 03:11:31.669675|2017-10-11 03:11:31.669675
NCT01553344|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-12|2014-12-22|||March 2012||2012-03-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Observational|OMSOST||Serum Sclerostin Level & Treatment of Vitamin D Deficiency|Serum Sclerostin Level in Patients With Vitamin D Deficiency|Completed||N/A|26|Actual|Bagcilar Training and Research Hospital|||1||f||||f||||||||||2017-10-11 03:11:31.760944|2017-10-11 03:11:31.760944
NCT01553331|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-10|2014-12-10|||March 2012||2012-03-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Day Case Laparoscopic Cholecystectomy: Fundus First With Ultrasonic Dissection or Conventional Diathermy Hook|Day Case Laparoscopic Cholecystectomy: Comparison of Fundus First With Ultrasonic Dissection or Conventional Diathermy Hook, Randomized Trial|Completed||N/A|169|Actual|Central Finland Hospital District||2|||f||||t||||||||||2017-10-11 03:11:31.832937|2017-10-11 03:11:31.832937
NCT01553318|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-09-28|2016-04-26||March 2012||2012-03-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|KetoforFMS||Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study|Novel Use of Ketotifen (Mast Cell Stabilizer) in Fibromyalgia: A Pilot Study|Completed||Phase 3|51|Actual|Indiana University|Just tested one dose (low dose). Would be better if we tested higher dosages|2|||f||||t||||||||||2017-10-11 03:11:31.936787|2017-10-11 03:11:31.936787
NCT01553305|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2013-07-03|||January 2012||2012-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study of the Effect of Supervised Exercise Programme in Patients With Rheumatoid Arthritis|The Effect of 6-weeks Supervised Exercise Programme Followed by 6-weeks Unsupervised Exercise Programme Versus 12 Weeks Unsupervised Exercise Programme in Patients With Rheumatoid Arthritis.|Completed||N/A|52|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 03:11:32.277854|2017-10-11 03:11:32.277854
NCT01553292|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-06-18|2012-10-05||April 2012||2012-04-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|ECALMIST||Early CPAP And Large Volume Minimally Invasive Surfactant (ECALMIST) in Preterm Infants With RDS|Feasibility of Using Early CPAP (Continuous Positive Airway Pressure) And Large Volume Minimal Invasive Surfactant Therapy (ECALMIST) in Preterm Infants With Respiratory Distress Syndrome (RDS)|Completed||N/A|21|Actual|University of Manitoba|This is non randomized interventional feasibility trial, small sample size and in one center|1|||f||||t||||||||||2017-10-11 03:11:32.373814|2017-10-11 03:11:32.373814
NCT01553279|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-02-27|||March 2012||2012-03-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Immunogenicity and Safety of V419 Given at 2, 3 and 4 Months of Age With Meningococcal Serogroup C Conjugate Vaccines|A Phase III Open-label Randomised Study, to Evaluate the Immunogenicity and Safety of the Concomitant Administration of V419 (PR5I) Given at 2, 3 and 4 Months of Age With Two Types of Meningococcal Serogroup C Conjugate (MCC) Vaccines Given at 3 and 4 Months of Age, and Followed by the Administration at 12 Months of Age of a Combined Haemophilus Influenzae Type b-MCC Vaccine|Completed||Phase 3|284|Actual|MCM Vaccines B.V.||2|||f||||f||||||||||2017-10-11 03:11:32.855703|2017-10-11 03:11:32.855703
NCT01553266|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-04-17|||March 1, 2012|Actual|2012-03-01|December 2013|2013-12-01|April 12, 2017|Actual|2017-04-12|March 12, 2014|Actual|2014-03-12||Observational|||Mobile Diabetes Education Teams in Primary Care|Mobile Diabetes Education Teams in Primary Care|Completed||N/A|900|Actual|Ryerson University|||2||f||||f||||||||||2017-10-11 03:11:32.977682|2017-10-11 03:11:32.977682
NCT01553253|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2014-06-16|||April 2010||2010-04-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|FACTS1||From ACute To Chronic Postoperative Pain in Patients for Elective Cholecystectomy|From Acute To Chronic Postoperative Pain in Patients for Elective Cholecystectomy: The Significance of Components of Pain|Completed||N/A|100|Actual|Odense University Hospital|||1||f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 03:11:33.155529|2017-10-11 03:11:33.155529
NCT01553240|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-01-12|2017-01-12||June 2007||2007-06-01|January 2017|2017-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||P.I. has left the institution and NYSPI has no access to the data. Results will not be analyzed or presented.|Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies|Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies|Terminated||N/A|8|Actual|New York State Psychiatric Institute||1||Principal Investigator (Dr. Sporn) left the sponsoring institution.|f||||t||||||||||2017-10-11 03:11:33.237857|2017-10-11 03:11:33.237857
NCT01553227|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2012-11-26|||August 2011||2011-08-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Treatment for Obstructive Sleep Apnea Hypopnea Syndrome and Obesity Hypoventilation Syndrome (OHS)|Effect of Auto-trilevel Ventilator on Patients With Obstructive Sleep Apnea Hypopnea Syndrome and Obesity|Completed||N/A|24|Actual|Nanjing Medical University||1|||f||||f||||||||||2017-10-11 03:11:33.428884|2017-10-11 03:11:33.428884
NCT01553214|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-10|2017-06-30|||March 6, 2012||2012-03-06|November 21, 2016|2016-11-21|January 1, 2030|Anticipated|2030-01-01|January 1, 2030|Anticipated|2030-01-01||Interventional|||Improving White Blood Cell Collection From Healthy Donors|Collection of Granulocytes by Apheresis of Healthy Donors Stimulated With Filgrastim (G-CSF) and Dexamethasone|Recruiting||Phase 1|1000|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-11 03:11:33.531058|2017-10-11 03:11:33.531058
NCT01553201|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-10|2017-09-21|||February 24, 2012||2012-02-24|September 18, 2017|2017-09-18|December 31, 2019|Anticipated|2019-12-31|January 1, 2019|Anticipated|2019-01-01||Interventional|||Botulinum Toxin for Pelvic Pain in Women With Endometriosis|The Effectiveness of Botulinum Toxin on Persistent Pelvic Pain in Women With Endometriosis|Recruiting||Phase 1/Phase 2|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:11:33.647273|2017-10-11 03:11:33.647273
NCT01553188|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-10|2017-07-26|||February 7, 2012||2012-02-07|July 17, 2017|2017-07-17|January 1, 2018|Anticipated|2018-01-01|April 20, 2017|Actual|2017-04-20||Interventional|||AMG 386 and Abiraterone for Advanced Prostate Cancer|A Phase II Multicenter Study of AMG 386 and Abiraterone in Metastatic Castration Resistant Prostate Cancer|Active, not recruiting||Phase 2|23|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 03:11:33.797491|2017-10-11 03:11:33.797491
NCT00005693|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||April 1992||1992-04-01|July 2000|2000-07-01|March 1995|Actual|1995-03-01|||||Observational|||Computer Assisted Instruction Weight Management for Low Literacy Populations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.810036|2017-10-11 04:28:53.810036
NCT01553162|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-10|2016-05-17|||April 2012||2012-04-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia|B-precursor Acute Lymphoblastic Leukemia (ALL): Studying the Mechanisms Behind Dexamethasone and Prednisone Sensitivity in High-Risk Patients|Completed||N/A|20|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:11:34.062125|2017-10-11 03:11:34.062125
NCT01553136|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-08-31|||September 2012||2012-09-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Varenicline Treatment of Alcohol Dependence in Smokers|1/2-Multi-site Study: Varenicline Treatment of Alcohol Dependent Smokers|Completed||Phase 2|59|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:11:34.598427|2017-10-11 03:11:34.598427
NCT01553123|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2013-02-05|||April 2012||2012-04-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma|A Randomized, Placebo Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ulipristal Acetate in Women With Anemia Associated With Uterine Leiomyomas|Withdrawn||Phase 3|0|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:11:34.723141|2017-10-11 03:11:34.723141
NCT01553110|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-02-21|||March 2012||2012-03-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|February 2018|Anticipated|2018-02-01||Observational|||An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms|An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms in Acute Rhinosinusitis.|Recruiting||N/A|62|Anticipated|Virginia Commonwealth University|||2||f||||t|f|f||||Samples With DNA|"     Nasal Secretions   "|||2017-10-11 03:11:34.90374|2017-10-11 03:11:34.90374
NCT01553097|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-12-12|||March 2012||2012-03-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty|Neurocognitive Impairment in Women With Early Stage Breast Cancer|Completed||N/A|51|Actual|Virginia Commonwealth University|||3||f||||t||||||Samples Without DNA|"     3 cc of blood in a BD Vacutainer® tube preserved with 5.4mg K2 EDTA for the cytokine assay   "|||2017-10-11 03:11:35.000557|2017-10-11 03:11:35.000557
NCT01553084|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-10-26|||May 2012||2012-05-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|NHLBI-RO1||A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers|A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers|Active, not recruiting||Phase 4|1500|Anticipated|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 03:11:35.110718|2017-10-11 03:11:35.110718
NCT01553071|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies|Phase I Trial of Intravenous Fenretinide (4-HPR) Plus Intravenous Safingol for Patients With Relapsed Malignancies|Recruiting||Phase 1|8|Anticipated|South Plains Oncology Consortium||1|||f||||t||||||||||2017-10-11 03:11:35.23456|2017-10-11 03:11:35.23456
NCT01553045|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-12-02|||November 2011||2011-11-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|May 2014|Actual|2014-05-01||Observational|SMURF||Reasons for Variations in Health Related Quality of Life and Symptom Burden in Patients With Atrial Fibrillation|Observational Study of the Variation in Health-related Quality of Life and Symptom Burden in Patients Accepted for Catheter Ablation of Atrial Fibrillation in Relation to Biomarkers, Intracardiac Pressures and Echocardiography.|Unknown status|Active, not recruiting|N/A|200|Anticipated|University Hospital, Linkoeping|||1||f||||t||||||Samples Without DNA|"     Blood samples will be drawn from femoral vein, CS and LA (baseline sampling).      Concerning sub-study: After the induction of AF and after the patient has maintained AF in 30     minutes blood samples will be drawn in the exact same way as before the induction in the     intervention group.      Patients who are going to be randomized to control group after the baseline blood sampling,     are going to be monitored in about 30 minutes to examine whether they maintain sinus rhythm     (SR) under that time. No intervention, clinical or experimental is going to be made during     that time. After those 30 minutes, blood samples are going to be drawn in the exact same way     as before.      Blood to be analyzed for biomarkers will be froozen to -70 degress and analyzed when the     study is completed.   "|||2017-10-11 03:11:35.465064|2017-10-11 03:11:35.465064
NCT01553032|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2013-08-01|||May 2011||2011-05-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Interventional|HICARE||Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)|Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux®|Unknown status|Recruiting|Phase 4|500|Anticipated|University of Heidelberg Medical Center||2|||f||||t||||||||||2017-10-11 03:11:35.551442|2017-10-11 03:11:35.551442
NCT01553019|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-09-01|||October 2011||2011-10-01|September 2017|2017-09-01|August 31, 2017|Actual|2017-08-31|August 31, 2017|Actual|2017-08-31||Interventional|PC03||Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer|A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 2|2|Actual|University of Florida||3|||f||||t|f|f||||||||2017-10-11 03:11:35.678748|2017-10-11 03:11:35.678748
NCT01553006|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-03-13|||January 2012||2012-01-01|March 2012|2012-03-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|RS||Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis|A Comparison of Cefditoren Pivoxil 10 mg/kg/Day and Cefditoren Pivoxil 20 mg/kg/Day in Treatment of Childhood With Acute Rhinosinusitis|Unknown status|Recruiting|Phase 4|120|Anticipated|Thammasat University||2|||f||||t||||||||||2017-10-11 03:11:35.79733|2017-10-11 03:11:35.79733
NCT01552993|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-04-21|||March 2012||2012-03-01|April 2016|2016-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Registration and Treatment of Pain During Eye Examination of Prematurity|Registration and Treatment of Pain During Eye Examination of Prematurity|Terminated||N/A|5|Actual|St. Olavs Hospital||2||the chosen intervention was obviously ineffective|f||||f||||||||||2017-10-11 03:11:35.918278|2017-10-11 03:11:35.918278
NCT01552980|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-27|||March 2012||2012-03-01|March 2012|2012-03-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|mSOX||Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma|A Phase II Trial Evaluate a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma|Unknown status|Recruiting|Phase 2|30|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 03:11:36.042237|2017-10-11 03:11:36.042237
NCT01552967|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-27|||March 2012||2012-03-01|March 2012|2012-03-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|mXELOX||Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma|A Phase II Trial Evaluating a Modified Regimen of Oxaliplatin and Capecitabine in First-Line Treatment of Metastatic Colorectal Adenocarcinoma|Unknown status|Recruiting|Phase 2|30|Anticipated|Sixth Affiliated Hospital, Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 03:11:36.14302|2017-10-11 03:11:36.14302
NCT01552954|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-12-10|2013-10-30||February 2012||2012-02-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|ESPECIAL||Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan|Effects of Low Sodium Intake on the Anti-proteinuric Efficacy of Olmesartan in Hypertensive Patients With Albuminuria Through Open-label Randomized Trial|Completed||Phase 4|269|Actual|Seoul National University Bundang Hospital|The major limitation of this study is that we used a 24-hour volume urine collected at a single time point for each follow-up visit. Urine excretion can be influenced by the sodium intake of individual patients at certain point.|2|||f||||f||||||||||2017-10-11 03:11:36.244599|2017-10-11 03:11:36.244599
NCT01552941|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-10-28|||July 2011||2011-07-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid Arthritis|Pilot Study of the Safety and Efficacy of Neurostimulation of the Cholinergic Anti-Inflammatory Pathway Using an Active Implantable Vagal Nerve Stimulation Device in Patients With Rheumatoid Arthritis|Completed||N/A|18|Actual|SetPoint Medical Corporation||1|||f||||f||||||||No||2017-10-11 03:11:36.876818|2017-10-11 03:11:36.876818
NCT01552928|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-03-12|2013-09-20||March 2012||2012-03-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy Volunteers|A Phase 1, Randomized, Double-blind, Placebo- and Positive-controlled, 4-Period Crossover Trial to Assess the Effect of Anagrelide Hydrochloride on QT/QTc Interval in Healthy Men and Women.|Completed||Phase 1|60|Actual|Shire||4|||f||||f||||||||||2017-10-11 03:11:37.018466|2017-10-11 03:11:37.018466
NCT01552915|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-12-10|2014-12-03||April 2012||2012-04-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Safety Set: All subjects in the Randomized Set who took at least 1 dose of investigational product.|Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder|A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Dose-optimization Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 4|464|Actual|Shire||3|||f||||f||||||||||2017-10-11 03:11:38.181381|2017-10-11 03:11:38.181381
NCT01552902|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-03-04|2015-03-04||April 2012||2012-04-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||The Safety set consisted of all participants in the Randomized set (all screened participants for whom a randomization number was generated) who took at least 1 dose of investigational product.|Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder|A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared With OROS-MPH (CONCERTA®) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 4|549|Actual|Shire||3|||f||||f||||||||||2017-10-11 03:11:39.101963|2017-10-11 03:11:39.101963
NCT01552889|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-03-16|2017-01-25||January 2012||2012-01-01|March 2017|2017-03-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|DOCS||Depression Outpatient Cardiology Screening Study|Randomized Controlled Trial of Screening for Depression in Cardiac Outpatients|Completed||N/A|201|Actual|Washington University School of Medicine||2|||f||||t||||||||No||2017-10-11 03:11:39.978683|2017-10-11 03:11:39.978683
NCT01552876|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-05-06|2013-10-30||February 2012||2012-02-01|May 2015|2015-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||All enrolled subjects.|Comparative Clinical Evaluation of Soft Toric Lens Designs|Comparative Clinical Evaluation of Soft Toric Lens Designs|Completed||N/A|42|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 03:11:40.480567|2017-10-11 03:11:40.480567
NCT01552863|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-08-28|||March 2012||2012-03-01|August 2015|2015-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers|Open-Label, Single-Dose, Randomized, Crossover Study To Evaluate The Pharmacokinetics Of Oxycodone Following Oral Administration Of PF-00345439 Under Fed Conditions In Healthy Volunteers|Completed||Phase 1|21|Actual|Pain Therapeutics||6|||f||||f||||||||||2017-10-11 03:11:40.805928|2017-10-11 03:11:40.805928
NCT01552850|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-08-28|||April 2012||2012-04-01|August 2015|2015-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pharmacokinetics And Relative Bioavailability Study Of Oxycodone|An Open-Label, Single-Dose, Randomized, Crossover Pharmacokinetics And Relative Bioavailability Study Of Three Modified 40 Mg Oxycodone Formulations Compared With 40 Mg Pf-00345439 Capsule Formulation In Healthy Volunteers|Completed||Phase 1|18|Actual|Pain Therapeutics||5|||f||||f||||||||||2017-10-11 03:11:40.914835|2017-10-11 03:11:40.914835
NCT01552837|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-09|||December 2007||2007-12-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology|Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology|Completed||N/A|33|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-10-11 03:11:41.015454|2017-10-11 03:11:41.015454
NCT01552824|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-05-09|||June 2015||2015-06-01|May 2015|2015-05-01|June 2018|Anticipated|2018-06-01|May 2017|Anticipated|2017-05-01||Interventional|CYSTUO||Fetal Cystoscopy Versus Vesico-amniotic Shunting in Severe Lower Urinary Tract Obstructions|Randomized Controlled Trial of Fetal Cystoscopy Versus Vesico-amniotic Shunting in Severe Lower Urinary Tract Obstructions|Not yet recruiting||Phase 2|60|Anticipated|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-10-11 03:11:41.117743|2017-10-11 03:11:41.117743
NCT01552629|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-02-20|||January 5, 2012|Actual|2012-01-05|February 2017|2017-02-01|August 28, 2013|Actual|2013-08-28|August 28, 2013|Actual|2013-08-28||Interventional|||A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients|A Randomized, Double-blind, Placebo Controlled, Parallel Group, Proof of Concept Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of QGE031 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis|Completed||Phase 2|22|Actual|Novartis||3|||f||||||||||||||2017-10-11 03:11:41.211661|2017-10-11 03:11:41.211661
NCT01552616|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2013-04-05|||February 2012||2012-02-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Safety and Performance of Muscle Activation for Critical Care Patients|Evaluation of Thermal-aided Muscle Activation in Intensive Care Unit (ICU) Patients - A PILOT Study|Terminated||N/A|5|Actual|Niveus Medical, Inc.||2||Enrollment|f||||f||||||||||2017-10-11 03:11:41.32216|2017-10-11 03:11:41.32216
NCT01552603|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-04-27|2014-09-08||March 2012||2012-03-01|April 2016|2016-04-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Artificial Pancreas Control System in an Inpatient Setting|Sensor-controlled Insulin- and Glucagon Delivery in Subjects With Type 1 Diabetes: Testing of an Automated System in a Supervised Inpatient Setting|Completed||Phase 2|14|Actual|Legacy Health System||1|||f||||t||||||||||2017-10-11 03:11:41.442385|2017-10-11 03:11:41.442385
NCT01552590|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-01-03|||April 2012||2012-04-01|January 2013|2013-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|ECF||Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites|Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites|Unknown status|Recruiting|Phase 4|74|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:11:41.631005|2017-10-11 03:11:41.631005
NCT01552577|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-03-10|||October 2010||2010-10-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|August 2015|Actual|2015-08-01||Observational|RETINA||The RETINA Project: Reliable Eye Tracking in Neurocognitive Assessment of Traumatic Brain Injury|Eye Tracking Indicators of Neurocognitive Status After Traumatic Brain Injury|Terminated||N/A|183|Actual|Uniformed Services University of the Health Sciences|||2|Expiration of funding|f||||t||||||||||2017-10-11 03:11:41.724258|2017-10-11 03:11:41.724258
NCT01552564|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-10-27|||March 2012||2012-03-01|October 2014|2014-10-01||||January 2014|Actual|2014-01-01||Observational|Micro-AMI||The Microcirculation in Acute Myocardial Infarction (Micro-AMI)|The Microcirculation in Acute Myocardial Infarction (Micro-AMI)|Completed||N/A|50|Actual|University of Bristol|||1||f||||t||||||||||2017-10-11 03:11:41.811576|2017-10-11 03:11:41.811576
NCT01552551|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-12-29|||May 2012||2012-05-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||Assessment and Referral Versus Exercise in Primary Prevention of Falls: PA Healthy Steps Program|Assessment and Referral Versus Exercise in Primary Prevention of Falls: PA Healthy Steps Program|Completed||N/A|189|Actual|University of Pittsburgh||3|||f||||t||||||||Yes|Deidentified research data will be made available to qualified investigators|2017-10-11 03:11:41.885353|2017-10-11 03:11:41.885353
NCT01552538|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-10-28|||January 2012||2012-01-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|May 2018|Anticipated|2018-05-01||Interventional|||Long Term Extension Study For SPM-005 Participants|Long Term Observational Study of the Safety and Efficacy of an Active Implantable Vagal Nerve Stimulation Device in Patients With Rheumatoid Arthritis|Active, not recruiting||Phase 1/Phase 2|18|Anticipated|SetPoint Medical Corporation||1|||f||||f||||||||No||2017-10-11 03:11:43.501121|2017-10-11 03:11:43.501121
NCT01552525|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-03-02|||January 2011||2011-01-01|March 2012|2012-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||L-Arginine, Symmetrical and Asymmetrical Dimethylarginine (SDMA/ADMA) in Acute Kidney Injury (AKI)|Regulation of L-Arginine Und Its Derivatives of Asymmetrical and Symmetrical Dimethylarginine and L-NG Monomethylarginine (ADMA/SDMA/L-NMMA) in Acute Kidney Injury and Correlation to Cardiac, Renal and Vascular Function and Mortality|Completed||N/A|300|Anticipated|Wuerzburg University Hospital|||1||f||||f||||||Samples With DNA|"     Blood and urine samples will be centrifuged. One ml aliquots of plasma, serum, urine and a     whole blood sample will be stored at -80°C.   "|||2017-10-11 03:11:43.5823|2017-10-11 03:11:43.5823
NCT01552512|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-03-08|||June 2011||2011-06-01|March 2012|2012-03-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|NPPU||Nutributter Programming to Prevent Undernutrition: an Evaluation|Randomized Control Trial of Complementary Food to Prevent Undernutrition Among At-Risk Infants in Fort San Michel, Haiti|Unknown status|Active, not recruiting|N/A|612|Anticipated|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 03:11:43.668466|2017-10-11 03:11:43.668466
NCT01552499|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-08-13|||March 2012||2012-03-01|August 2015|2015-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers|A Prospective, Randomized, Comparative Parallel Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers|Completed||N/A|25|Actual|MiMedx Group, Inc.||2|||f||||||||||||||2017-10-11 03:11:43.752431|2017-10-11 03:11:43.752431
NCT01552486|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-11-02|||June 2012||2012-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Chiropractic Spinal Manipulative Therapy for Acute Sciatica Secondary to Lumbar Disc Herniation|Biology and Clinical Outcomes of Chiropractic Spinal Manipulative Therapy in the Treatment of Patients With Acute Inflammatory Radiculopathy Secondary to Lumbar Disc Herniation: a Pilot Study|Active, not recruiting||N/A|40|Actual|Vancouver General Hospital||2|||f||||t||||||||||2017-10-11 03:11:43.828766|2017-10-11 03:11:43.828766
NCT01552460|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-04-02|||April 2011||2011-04-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Brain Genomics Superstruct Project|Brain Genomics Superstruct Project|Completed||N/A|61|Actual|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     Saliva   "|||2017-10-11 03:11:44.090064|2017-10-11 03:11:44.090064
NCT01552447|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-03-14|||March 2012||2012-03-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers|A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.|Completed||N/A|98|Actual|MiMedx Group, Inc.||3|||f||||f||||||||Undecided||2017-10-11 03:11:45.331133|2017-10-11 03:11:45.331133
NCT01552434|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-03-28|||March 2012|Actual|2012-03-01|March 2017|2017-03-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid or Cetuximab in Patients With Advanced Malignancy and Other Indications|A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid or Cetuximab in Patients With Advanced Malignancy and Other Indications|Recruiting||Phase 1|216|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-11 03:11:45.485859|2017-10-11 03:11:45.485859
NCT01552421|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-09-23|||September 2012||2012-09-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|TRAVAKOL||The Effect of Transvaginal vs. Conventional Laparoscopic Cholecystectomy on the Postoperative Course|The Effect of Transvaginal vs. Conventional Laparoscopic Cholecystectomy on the Postoperative Course|Terminated||N/A|50|Anticipated|Herlev Hospital||2||For logistic reasons in the department and due to very low inclusion rates.|f||||t||||||||||2017-10-11 03:11:45.637399|2017-10-11 03:11:45.637399
NCT01552408|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-02-27|||March 2012|Actual|2012-03-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|DAVE||Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE)|A Phase I/II, Randomized, Study for Diabetic Macular Edema Using 0.3mg Ranibizumab Combined With Targeted PRP Monthly for 4 Months,Then PRN vs. 0.3mg Ranibizumab 4 Months Monotherapy, Then as Needed(DME-AntiVEgf) DAVE|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Greater Houston Retina Research||2|||f||||f||||||||No||2017-10-11 03:11:45.987886|2017-10-11 03:11:45.987886
NCT01552395|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-05-23|||March 2012||2012-03-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia|A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic|Completed||N/A|4136|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 03:11:46.188148|2017-10-11 03:11:46.188148
NCT01552382|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-08-10|||March 2012||2012-03-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|Vitop||Vitamin D, Cardiac Surgery and Outcome|Vitamin D and Clinical Outcome in Cardiac Surgical Patients|Completed||N/A|4418|Actual|Heart and Diabetes Center North-Rhine Westfalia|||1||f||||f||||||||No||2017-10-11 03:11:46.435195|2017-10-11 03:11:46.435195
NCT01552369|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-09-26|||October 2012||2012-10-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|June 2018|Anticipated|2018-06-01||Interventional|CAPSIL||Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in Liver Transplant Recipients|Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in High-Risk R-D+ Liver Transplant Recipients|Active, not recruiting||Phase 4|180|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:11:46.545297|2017-10-11 03:11:46.545297
NCT01552356|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-09-04|||March 19, 2012|Actual|2012-03-19|July 2017|2017-07-01||||December 31, 2015|Actual|2015-12-31||Interventional|||Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors|Pharmacokinetic-Driven Individualization of Pazopanib Therapy in Patients With Solid Tumors: A Phase I Study|Active, not recruiting||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:11:46.68835|2017-10-11 03:11:46.68835
NCT01552343|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-06-15|2016-11-21|2013-05-31|March 2012||2012-03-01|June 2017|2017-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|IMPACT||Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary|A Double-blind, Randomized, Placebo-controlled Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary|Completed||Phase 3|56|Actual|Ferring Pharmaceuticals|This was a patient reported outcome (PRO) validation study on a highly selective population (responders on active treatment and non-responsers on placebo from CS40/CS41) and not powered to look at efficacy.|4|||f||||f||||||||||2017-10-11 03:11:46.832731|2017-10-11 03:11:46.832731
NCT01552330|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-08-27|||May 2012||2012-05-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Pharmacokinetic Study of Primaquine and Pyronaridine-Artesunate in Healthy Subjects|Open-Label Study to Evaluate Potential Pharmacokinetic Interaction of Orally Administered Primaquine and Pyronaridine-Artesunate in Healthy Adult Subjects|Completed||Phase 1|17|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 03:11:47.481732|2017-10-11 03:11:47.481732
NCT01552317|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-12-02|||April 2012||2012-04-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|OxCKD1||OxCKD1 -Empowering Healthy Lifestyle Choices in Chronic Kidney Disease|OxCKD1 - a Randomised Controlled Trial of the OxSalt1 Care Bundle to Help Renal Patients Learn How to Lower the Salt Content of Their Diets.|Completed||N/A|201|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 03:11:47.579912|2017-10-11 03:11:47.579912
NCT01552304|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-05-03|||February 2012||2012-02-01|May 2016|2016-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Oxygen Supplementation Study in Obstructive Sleep Apnea (OSA) Patients|The Benefit and Risk of Oxygen Supplementation in Perioperative Management of Obstructive Sleep Apnea|Completed||N/A|196|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:11:47.79078|2017-10-11 03:11:47.79078
NCT01552291|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-09-04|||May 2012||2012-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Glutaminprojec||The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies|The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies - A Randomized, Placebo-controlled Pilot Study|Active, not recruiting||Phase 4|42|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 03:11:47.906249|2017-10-11 03:11:47.906249
NCT01552265|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-09-17|||February 2012||2012-02-01|September 2015|2015-09-01||||June 2017|Anticipated|2017-06-01||Observational|||Shanghai Mild Cognitive Impairment Cohort Study|Shanghai Cohort Study on Mild Cognitive Impairment for Early Detection of Alzheimer's Disease|Unknown status|Active, not recruiting|N/A|400|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||f||||||||||2017-10-11 03:11:48.014576|2017-10-11 03:11:48.014576
NCT01552252|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-08|||March 2010||2010-03-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2010|Actual|2010-03-01||Interventional|||Evaluation of an Apple Juice Drink With POs-Ca|Development and Evaluation of a Low Erosive Apple Juice Drink With Phosphoryl Oligosaccharides of Calcium (POs-Ca)|Completed||Early Phase 1|30|Actual|Tokyo Medical and Dental University||5|||f||||||||||||||2017-10-11 03:11:48.096053|2017-10-11 03:11:48.096053
NCT01552239|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-09-19|||August 2011||2011-08-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|PREMISS||Preoperative Radiotherapy for Sarcomas of the Extremities With Intensity-Modulation, Image-Guidance and Small Safety-margins|Phase II Study of Preoperative Radiotherapy for Sarcomas of the Extremities With Intensity-Modulation, Image-Guidance, Small Safety-margins and Brachytherapy Conditioned by Resection Margin|Recruiting||Phase 2|50|Anticipated|Technische Universität München||1|||f||||||||||||||2017-10-11 03:11:48.192152|2017-10-11 03:11:48.192152
NCT01552226|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2014-07-22|||January 2010||2010-01-01|July 2014|2014-07-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal Surgery|Prospective Randomized Clinical Trial to Compare Continuous Preperitoneal Analgesia to Continuous Epidural Analgesia for Pain Control After Colon and Rectal Surgery|Unknown status|Active, not recruiting|N/A|137|Anticipated|Saint Joseph Mercy Health System||2|||f||||f||||||||||2017-10-11 03:11:48.295403|2017-10-11 03:11:48.295403
NCT01552200|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-04-06|||June 2012||2012-06-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Performance Evaluation of the NaviAid™ G-Eye System|Performance Evaluation of the NaviAid™ G-Eye System|Completed||N/A|126|Actual|Smart Medical Systems Ltd.||2|||f||||f||||||||||2017-10-11 03:11:48.541505|2017-10-11 03:11:48.541505
NCT01552187|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-06-29|||March 2012||2012-03-01|June 2014|2014-06-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|COPPS-2||COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)|COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial).|Unknown status|Active, not recruiting|Phase 3|360|Anticipated|Maria Vittoria Hospital||2|||f||||t||||||||||2017-10-11 03:11:48.653877|2017-10-11 03:11:48.653877
NCT01552174|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-08-31|||March 2012||2012-03-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|MEIBUM||Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice||Completed||N/A|185|Actual|Laboratoires Thea|||1||f||||f||||||||||2017-10-11 03:11:48.774995|2017-10-11 03:11:48.774995
NCT01552161|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-01-26|||April 2010||2010-04-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Observational|||Prevalence of Allergic Diseases and Atopy in Subjects With Coronary Artery Disease|Prevalence of Allergic Diseases and Atopy in Patients With Angiographically Confirmed Coronary Artery Disease|Completed||N/A|300|Anticipated|Medical Universtity of Lodz|||2||f||||f||||||Samples With DNA|"     Blood samples for total IgE, specific IgE and markers of inflammation.   "|||2017-10-11 03:11:48.85604|2017-10-11 03:11:48.85604
NCT01552148|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-02-14|||March 2012||2012-03-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Transversus Abdominis Plane Block for Laparoscopic Hysterectomy|Randomized, Controlled, Observer-blinded Study on the Efficacy of TAP Block With 0.375% Levobupivacaine in Terms of PCA Morphine Postoperative Consumption in Patients Undergoing Laparoscopic Hysterectomy|Completed||Phase 4|52|Actual|Istituti Ospitalieri di Cremona||2|||f||||||||||||||2017-10-11 03:11:48.938178|2017-10-11 03:11:48.938178
NCT01552135|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-05-29|||January 2012||2012-01-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|May 2012|Actual|2012-05-01||Observational|||Pilot Study - Putative Penetration of Nanoparticles in Sunscreen in Intact or Sunburned Skin|Pilot Study - Does Nanoparticles in Sunscreen Penetrate Intact or Sunburned Skin?|Unknown status|Active, not recruiting|N/A|2|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 03:11:49.026777|2017-10-11 03:11:49.026777
NCT01552122|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-08-26|||May 2012||2012-05-01|August 2015|2015-08-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)|A Phase III Randomized, Double-Blind, Active Comparator-Controlled Study to Evaluate the Effects of Odanacatib (MK-0822) on Bone Mineral Density, Tolerability, and Safety in the Treatment of Postmenopausal Women With Osteoporosis Previously Treated With Alendronate|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 03:11:49.129029|2017-10-11 03:11:49.129029
NCT01552109|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-10-03|||January 2012||2012-01-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|August 2012|Actual|2012-08-01||Observational|STAR||Stable Angina Observational Registry|STable Angina obseRvational Registry|Completed||N/A|2079|Actual|Medtronic Vascular|||1||f||||f||||||||||2017-10-11 03:11:49.239901|2017-10-11 03:11:49.239901
NCT01552096|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2014-03-15|||December 2011||2011-12-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Tramadol Versus Lidocaine Infiltration for Tonsillectomy|A Comparative Study of the Effects of Pre-incisional Infiltration of Tramadol or Lidocaine on the Inflammatory Response After Tonsillectomy.|Completed||Phase 2|90|Actual|Dammam University||3|||f||||t||||||||||2017-10-11 03:11:49.314669|2017-10-11 03:11:49.314669
NCT01552083|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-03-12|||January 2012||2012-01-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||A Community Pharmacist-led Intervention to Improve Screening of Sleep Apnea in Primary Care|A Community Pharmacist-led Intervention to Improve Screening of Sleep Apnea in Primary Care|Unknown status|Recruiting|N/A|400|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||||||||||||2017-10-11 03:11:49.464293|2017-10-11 03:11:49.464293
NCT01552070|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-09-13|||September 2010||2010-09-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Recruitment on Extravascular Lung Water in Acute Respiratory Distress Syndrome (ARDS)|Impact of Alveolar Recruitment Maneuver on Extravascular Lung Water of Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome.|Completed||Phase 2|30|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 03:11:49.564916|2017-10-11 03:11:49.564916
NCT01552057|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-01-07|2014-12-12||March 2012||2012-03-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Randomized participants who received at least 1 dose of study drug who had at least 1 post-baseline measurement of primary efficacy [Brief Pain Inventory (BPI) 24-hour average pain severity].|A Study of Duloxetine in Fibromyalgia|A Phase III Clinical Trial of Duloxetine in Participants With Fibromyalgia|Completed||Phase 3|393|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:11:49.710545|2017-10-11 03:11:49.710545
NCT01552044|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2016-02-24|||January 2012||2012-01-01|February 2016|2016-02-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis|Evaluation de la Spironolactone Dans le Traitement Des choriorétinites séreuses Centrales Non résolutives à Trois Mois|Completed||Phase 1/Phase 2|17|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-11 03:11:51.096776|2017-10-11 03:11:51.096776
NCT01552031|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-03-03|||November 2011||2011-11-01|March 2017|2017-03-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Monitoring Chronic Obstructive Pulmonary Disease Patients at Home by a Forced Oscillation Technique Device|Monitoring COPD Patients at Home by a Forced Oscillation Technique Device|Recruiting||N/A|80|Anticipated|Politecnico di Milano|||1||f||||f||||||||||2017-10-11 03:11:51.194134|2017-10-11 03:11:51.194134
NCT01552018|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-06-17|||March 2012||2012-03-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|SAXATH||Saxagliptin and Atherosclerosis|Saxagliptin and Atherosclerosis. A Possible Role for Saxagliptin in the Prevention of Atherosclerosis Beyond Glucose Metabolism.|Completed||Phase 4|12|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 03:11:51.329787|2017-10-11 03:11:51.329787
NCT01552005|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-06-06|||May 2012||2012-05-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|DIAPAZON||Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France|Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France|Completed||N/A|1000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:11:51.412807|2017-10-11 03:11:51.412807
NCT01551992|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-09-15|||November 2010||2010-11-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|QUILL-LSC||Affixing Polypropylene Mesh Using Barbed Suture (Quill™ Srs) During Laparoscopic Sacrocolpopexy Randomized Controlled Trial (Quill Lsc)|Affixing Polypropylene Mesh Using Barbed Suture (Quill™ Srs) During Laparoscopic Sacrocolpopexy Randomized Controlled Trial|Completed||N/A|32|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 03:11:51.516867|2017-10-11 03:11:51.516867
NCT01551979|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-05-01|2017-03-15||February 2012||2012-02-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia|Therapeutic Efficacy of Cerebellar Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia|Completed||N/A|22|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 03:11:51.611182|2017-10-11 03:11:51.611182
NCT01551966|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-07-26|||October 2011||2011-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|PREVOCAP||Esophageal Capsule Endoscopy in Children|Evaluation of Wireless Capsule Endoscopy for the Detection and the Control of the Esophageal Varices in Children|Completed||N/A|100|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 03:11:52.133999|2017-10-11 03:11:52.133999
NCT01551953|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-02-23|||February 2011||2011-02-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|BEAM COPD||BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD)|BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease|Completed||Phase 2|124|Actual|Beth Israel Deaconess Medical Center||3|||f||||t||||||||||2017-10-11 03:11:52.240687|2017-10-11 03:11:52.240687
NCT01551940|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2015-08-13|||February 2012||2012-02-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ALS-TOX||Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea|Evaluation of Efficacy of Botulinum Toxin Type A in the Treatment of Sialorrhea in the Patient Affected by Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|18|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 03:11:52.368335|2017-10-11 03:11:52.368335
NCT01551927|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2014-02-17|||March 2011||2011-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Observational|TAPE||Patients Expectations for Future Examination and Treatment|What Are the Expectations for Future Examination and Treatment in Patients Undergoing Evaluation and Treatment of Coronary Heart Disease?|Completed||N/A|754|Actual|Göteborg University|||1||f||||f||||||Samples Without DNA|"     Blood samples NtProBNP   "|||2017-10-11 03:11:52.569725|2017-10-11 03:11:52.569725
NCT01551914|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-06-30|||March 2012||2012-03-01|June 2014|2014-06-01|March 2015|Anticipated|2015-03-01|October 2014|Anticipated|2014-10-01||Interventional|FOThyr||Medico-economic Evaluation Comparing the Use of Ultrasonic Scissors to the Conventional Techniques of Haemostasis in Thyroid Surgery by Cervicotomy|Medico-economic Evaluation Comparing the Use of Ultrasonic Scissors to the Conventional Techniques of Haemostasis in Thyroid Surgery by Cervicotomy|Unknown status|Active, not recruiting|Phase 3|1350|Anticipated|Nantes University Hospital||2|||f||||||||||||||2017-10-11 03:11:52.693505|2017-10-11 03:11:52.693505
NCT01551901|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-09-18|||January 2012||2012-01-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|LIFT||Luna Interbody System for Fusion Trial|LIFT: Luna Interbody System for Fusion Trial|Unknown status|Active, not recruiting|N/A|100|Anticipated|Benvenue Medical, Inc.||1|||f||||f||||||||||2017-10-11 03:11:52.819781|2017-10-11 03:11:52.819781
NCT01551888|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-12-22|2016-10-04|2012-08-22|January 2012||2012-01-01|December 2016|2016-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Phase 2a, Randomized, Open-Label, 2-Way Crossover Study To Determine The Pharmacokinetics, Safety, And Tolerability Of Aclidinium/Formoterol 400/12 µg Fixed Dose Combination Via Almirall Inhaler And Formoterol 12 µg Via Foradil® Aerolizer® In Patients With Moderate To Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 2|24|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 03:11:52.920702|2017-10-11 03:11:52.920702
NCT00005694|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1992||1992-07-01|July 2000|2000-07-01|June 1996|Actual|1996-06-01|||||Observational|||Worksites, Occupational Nurses and Cholesterol Change||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.970754|2017-10-11 04:28:53.970754
NCT01551875|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-07-08|||May 2012||2012-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|Score-India||A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors|A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors in Asymptomatic Nationwide Indian Population (SCORE India)|Completed||N/A|1200|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-11 03:11:53.199841|2017-10-11 03:11:53.199841
NCT01551862|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-12|||January 2007||2007-01-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Observational|||Complications in Lower Body Lifts|Prospective Study on Complications Following a Lower Body Lift After Massive Weight Loss|Completed||N/A|50|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 03:11:53.311783|2017-10-11 03:11:53.311783
NCT01551849|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2017-07-19|||January 1, 2012|Actual|2012-01-01|July 2017|2017-07-01|December 30, 2016|Actual|2016-12-30|December 30, 2016|Actual|2016-12-30||Observational|||Echocardiographic Assessment of Function During ECMO Support|Echocardiographic Assessment of Function During ECMO Support|Completed||N/A|5|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 03:11:53.377603|2017-10-11 03:11:53.377603
NCT01551836|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-03-08|||June 2009||2009-06-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations|A Randomised, Two Way Crossover Study to Determine the Time at Which Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations|Completed||Phase 1|12|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:11:53.447165|2017-10-11 03:11:53.447165
NCT01551823|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-09|2016-07-31|||March 2012||2012-03-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug）|The Phase Ⅲ Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)（Children Forms of Drug）|Completed||Phase 3|1200|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:11:53.517081|2017-10-11 03:11:53.517081
NCT01551810|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-07-31|||March 2012||2012-03-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|IVV||The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)|The Phase Ⅲ Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)|Completed||Phase 3|1200|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:11:53.603247|2017-10-11 03:11:53.603247
NCT01551797|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-12-06|||May 2010||2010-05-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.|A Proof of Principal Study to Investigate the Pharmacokinetic Profiles of Sustained Release and Standard Paracetamol Formulations|Completed||Phase 1|14|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:11:53.698909|2017-10-11 03:11:53.698909
NCT01551784|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-10-14|||March 2012||2012-03-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|SIRIUS||An Observational Study of Statin Treatment Induced HDL Changes|An Observational Study of Statin Treatment Induced HDL Changes - Effect on Cardiovascular Disease|Completed||N/A|120000|Actual|AstraZeneca|||1||f||||f|||||||"     Cholesterol values (HDL-C, LDL-C, TC)   "|||2017-10-11 03:11:53.966093|2017-10-11 03:11:53.966093
NCT01551771|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-07-24|||February 1, 2012|Actual|2012-02-01|July 2017|2017-07-01|April 12, 2012|Actual|2012-04-12|April 12, 2012|Actual|2012-04-12||Interventional|||GW824575 First Time in Human|A Single-centre, Masked, Placebo-controlled Four Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of the CC-chemokine Receptor 3 (CCR3) Antagonist, GW824575, Coadministered With or Without Food in Healthy Male Subjects|Terminated||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:11:54.058779|2017-10-11 03:11:54.058779
NCT01551758|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-05-03|2016-09-05||March 13, 2012|Actual|2012-03-13|May 2017|2017-05-01|November 24, 2015|Actual|2015-11-24|November 24, 2015|Actual|2015-11-24||Interventional|||A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)|A 12-month, Open Label, Randomised, Effectiveness Study to Evaluate Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) Inhalation Powder Delivered Once Daily Via a Novel Dry Powder Inhaler (NDPI) Compared With the Existing COPD Maintenance Therapy Alone in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|2802|Actual|GlaxoSmithKline||2|||f||||t|f|f||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:11:54.289814|2017-10-11 03:11:54.289814
NCT01551745|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-08-02|||March 2012||2012-03-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Salvage Ovarian FANG™ Vaccine + Bevacizumab|Phase II Trial of Adjuvant Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Vaccine (FANG™) Integrated With Bevacizumab for Patients With Recurrent/Refractory Ovarian Cancer Participating in Study CL-PTL 105|Completed||Phase 2|5|Actual|Gradalis, Inc.||1|||f||||t||||||||||2017-10-11 03:11:57.991738|2017-10-11 03:11:57.991738
NCT01551732|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-08-11|||July 2011||2011-07-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Anger Control Therapy (ACT) With RAGE-Control: An Outpatient Videogame-assisted Therapy for the Treatment of Anger|Anger Control Therapy (ACT) With RAGE-Control: An Outpatient Videogame-assisted Therapy for the Treatment of Anger|Active, not recruiting||N/A|40|Anticipated|Gonzalez-Heydrich, Joseph, M.D.||2|||f||||f||||||||||2017-10-11 03:11:58.110585|2017-10-11 03:11:58.110585
NCT01551719|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-12-28|||March 2012||2012-03-01|December 2012|2012-12-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation|Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation|Withdrawn||N/A|0|Actual|Federico II University||2|||f||||f||||||||||2017-10-11 03:11:58.196638|2017-10-11 03:11:58.196638
NCT01551706|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-07-03|||February 2012||2012-02-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Pilot Study to Evaluate the Effect of ENI Patented Whole Grape Extract on Antioxidant Status|A Randomized, Double-blind, Placebo-controlled, Pilot Study to Evaluate the Effect of ENI Patented Whole Grape Extract on Antioxidant Status|Completed||Phase 1|26|Actual|Ethical Naturals, Inc.||2|||f||||t||||||||||2017-10-11 03:11:58.284733|2017-10-11 03:11:58.284733
NCT01551693|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2017-03-01|2016-12-21||September 2011||2011-09-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||The analysis dataset is comprised of all treated patients.|STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma|This Trial is an Open Label, Parallel Cohort, Phase II Study Evaluating the Efficacy of the Heat Shock Protein 90 (Hsp90) Inhibitor STA-9090 in Patients With Unresectable Stage III or Stage IV Melanoma Who Were Intolerant of, or Progressed on, Prior Tyrosine Kinase Inhibitor Treatment. Two Cohorts Will Enroll Concurrently. One Cohort Will be Composed of Patients With Melanoma Expressing a Mutation in the Protein BRAF and the Other Cohort Will be Composed of Patients With Melanoma Expressing Wild-type BRAF.|Terminated||Phase 2|3|Actual|Dana-Farber Cancer Institute|The study was terminated early due to weak accrual.|2||due to weak accrual|f||||t|t|f||||||No||2017-10-11 03:11:58.559194|2017-10-11 03:11:58.559194
NCT01551680|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-08-16|||September 2012||2012-09-01|August 2017|2017-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|RAPIBE||A Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib in Multiple Non Operable Brain Metastases|A Phase I Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib (BSI-201) in Multiple Non Operable Brain Metastases|Terminated||Phase 1|3|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||1||end of study of this product|f||||t||||||||||2017-10-11 03:11:58.912036|2017-10-11 03:11:58.912036
NCT01551667|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-04-05|||November 2012||2012-11-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|ORISA||Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds|Observational and Comparative Study on the Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds (Localized Infections Versus Bacteremia)|Completed||N/A|69|Actual|Centre Hospitalier Universitaire de Nīmes|||2||f||||f||||||Samples Without DNA|"     Left over blood/serum/plasma specimens will be incorporated into the biobank at the     Bacteriology Laboratory of the Nîmes University Hospital   "|||2017-10-11 03:11:59.022522|2017-10-11 03:11:59.022522
NCT01551654|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-19|||September 2009||2009-09-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Electrical Stimulation Over Acupuncture Points in Reduction of Rectal Discomfort Distension|Non-invasive Acu-point Stimulation (Acu-TENS) in Reduction of Discomfort Associated With Barostat-induced Rectal Distension - a Randomized Controlled Study|Completed||N/A|40|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:11:59.128864|2017-10-11 03:11:59.128864
NCT01551641|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-02-14|||January 2012||2012-01-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer|A Phase II Clinical Trial on VEGF Expression Interfered by Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer|Recruiting||Phase 2|180|Anticipated|Changzhou No.2 People's Hospital||3|||f||||t||||||||||2017-10-11 03:11:59.221481|2017-10-11 03:11:59.221481
NCT01551628|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-07-27|||April 2012||2012-04-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma|A Pilot Study of the Safety and Preliminary Efficacy of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma|Terminated||Phase 1|1|Actual|Bio-Cancer Treatment International Limited||1||slow patient recruitment|f||||t||||||||||2017-10-11 03:11:59.345785|2017-10-11 03:11:59.345785
NCT01551615|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-08-26|||March 2012||2012-03-01|August 2016|2016-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|Vandetanib||A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib|A Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of Metformin, an OCT2 Substrate, in Healthy Subjects When Administered Alone and in Combination With a Single Oral Dose of Vandetanib (CAPRELSA) 800 mg|Completed||Phase 1|14|Actual|Sanofi||1|||f||||||||||||||2017-10-11 03:11:59.44015|2017-10-11 03:11:59.44015
NCT01551602|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-07-21|||March 2012||2012-03-01|January 2012|2012-01-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Clinical Study of AK159 in Healthy Postmenopausal Women||Completed||Phase 1|132|Actual|Asahi Kasei Pharma Corporation||11|||f||||||||||||||2017-10-11 03:11:59.538265|2017-10-11 03:11:59.538265
NCT01551589|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2017-07-25|||March 2012||2012-03-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal Cancer|Multicenter Prospective Randomized Phase III Trial Comparing Elective to Prophylactic Regional Lymph Node Irradiation for Thoracic Esophageal Cancer|Completed||N/A|220|Actual|The Second People's Hospital of Sichuan||2|||f||||t||||||||||2017-10-11 03:11:59.754634|2017-10-11 03:11:59.754634
NCT01551576|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-01-27|||February 2014||2014-02-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study|Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study|Recruiting||N/A|20|Anticipated|Stanford University|||1||f||||t||||||||||2017-10-11 03:11:59.86156|2017-10-11 03:11:59.86156
NCT01551563|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-08-26|||April 2012||2012-04-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|SUSI||Stavanger University Hospital Inflammatory Bowel Disease Trial|Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue|Recruiting||N/A|300|Anticipated|Helse Stavanger HF|||1||f||||f||||||Samples With DNA|"     Plasma and mucosal biopsies   "|No||2017-10-11 03:11:59.935107|2017-10-11 03:11:59.935107
NCT01551550|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-01-27|||June 2013||2013-06-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|STEPS||Shunt Tube Exposure Prevention Study|Amniotic Membrane Versus Pericardium in Reducing Glaucoma Drainage Tube Exposure: A Randomized Clinical Trial|Active, not recruiting||N/A|96|Anticipated|Tissue Tech Inc.||2|||f||||t||||||||||2017-10-11 03:12:00.025578|2017-10-11 03:12:00.025578
NCT01551537|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-09-05|||April 2013||2013-04-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka|Post-marketing Surveillance (PMS) of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) -16/18 Vaccine, Cervarix™ When Administered to Healthy Females According to the Prescribing Information in Sri Lanka|Withdrawn||N/A|0|Actual|GlaxoSmithKline|||1|"Lack of clarity regarding the PMS study requirement from the RA and Ethics committee hence it   was concluded GSK will submit local PSURs"|f||||||||||||||2017-10-11 03:12:00.196283|2017-10-11 03:12:00.196283
NCT01551524|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-05-05|||March 2012||2012-03-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Phase I Study of mPEG-R-Crisantaspase Given IV|A Dose Escalation Phase I Study of Asparec®(mPEG-R-Crisantaspase) Administered as Intravenous (IV) Infusion in Patients With Relapsed or Refractory Hematological Malignancies|Completed||Phase 1|36|Anticipated|Jazz Pharmaceuticals||1|||f||||f||||||||||2017-10-11 03:12:00.311895|2017-10-11 03:12:00.311895
NCT01551511|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2014-10-27|||October 2012||2012-10-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain|Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain: a Randomized, Double-blinded, Placebo-controlled, Parallel Design|Completed||Phase 2|29|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 03:12:00.449945|2017-10-11 03:12:00.449945
NCT01551498|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-10-29|||March 2012||2012-03-01|October 2015|2015-10-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|ASAP||Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Potential Effects of the Dietary Supplement Anatabloc on Antithyroid Autoantibodies and Thyroid Function in Autoimmune Thyroiditis|Completed||Phase 2|165|Actual|Rock Creek Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:12:00.61033|2017-10-11 03:12:00.61033
NCT01551485|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-08-07|||February 2012||2012-02-01|August 2012|2012-08-01|October 2012|Anticipated|2012-10-01|August 2012|Anticipated|2012-08-01||Interventional|||Postoperative Sleep Disturbances After Zolpidem Treatment in Fast-track Hip and Knee Replacement|Postoperative Sleep Disturbances After Zolpidem Treatment in Fast-track Hip and Knee Replacement|Unknown status|Active, not recruiting|N/A|20|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 03:12:00.746227|2017-10-11 03:12:00.746227
NCT01551472|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-07-26|||April 2012||2012-04-01|July 2017|2017-07-01|June 2024|Anticipated|2024-06-01|June 2020|Anticipated|2020-06-01||Observational|e-plus||Post Market Study of the 3DKnee™ With E-plus Insert|Prospective Multicenter Open Label Study Examining the Mid- and Long-term Safety and Efficacy of the 3DKnee™ System With Vitamin E UHMWPE Tibial Inserts (3DKnee™ With E-plus Insert)|Recruiting||N/A|300|Anticipated|Encore Medical, L.P.|||1||f||||f||||||||||2017-10-11 03:12:00.848203|2017-10-11 03:12:00.848203
NCT01551459|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-07-25|||October 2010||2010-10-01|January 2016|2016-01-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|SUAVE||A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma|A Randomised Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma|Active, not recruiting||Phase 2|124|Anticipated|The Clatterbridge Cancer Centre NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:12:01.028998|2017-10-11 03:12:01.028998
NCT01551446|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-11-01|||April 2012||2012-04-01|November 2012|2012-11-01|October 2013|Anticipated|2013-10-01|November 2012|Anticipated|2012-11-01||Interventional|||Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes|Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes|Withdrawn||Phase 1|0|Actual|Reata Pharmaceuticals, Inc.||1||IDMC recommendation for safety concerns|f||||||||||||||2017-10-11 03:12:01.178495|2017-10-11 03:12:01.178495
NCT01551433|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-08-17|||February 2012||2012-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy|A Prospective Trial to Evaluate Whether Variations in Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy|Completed||N/A|166|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:12:01.28503|2017-10-11 03:12:01.28503
NCT01551420|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-07-05|||April 1, 2012|Actual|2012-04-01|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|December 29, 2017|Anticipated|2017-12-29||Observational|||Home Study of an Advanced Upper Limb Prosthesis|Home Study of an Advanced Upper Limb Prosthesis|Recruiting||N/A|100|Anticipated|VA Office of Research and Development|||1||f||||f|f|t|f|f|f|||||2017-10-11 03:12:01.407231|2017-10-11 03:12:01.407231
NCT01551407|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-10-24|||December 2011||2011-12-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Detection of Bladder Tumors After 30 Min Instillation of Hexvix|Open Prospective Within Patient, Phase IIa Study of Hexvix Flexible Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer After 30 Minutes Instillation of Hexvix in Patients With Known or Suspicion of Bladder Cancer|Terminated||Phase 2|38|Actual|Photocure||1||slow inclusion rate|f||||f||||||||||2017-10-11 03:12:01.601363|2017-10-11 03:12:01.601363
NCT01551394|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-02-12|||September 2012||2012-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NeoMero-1||Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset Sepsis|Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age (Inclusive) With Clinical or Confirmed Late-onset Sepsis : a European Multicenter Randomised Phase III Trial|Completed||Phase 3|272|Actual|PENTA Foundation||2|||f||||t||||||||||2017-10-11 03:12:01.707461|2017-10-11 03:12:01.707461
NCT01551381|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-06-14|||January 2012||2012-01-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects|Double-blind, Controlled Study in Healthy and Type 2 Diabetic Subjects to Assess Safety, Tolerability and Pharmacokinetics of 28 Days EV-077 Treatment, and the Effects on Platelet Function, Vascular Inflammation and Oxidative Stress.|Terminated||Phase 2|33|Actual|Evolva SA||2||Interim review indicated that the dose selected was too high for diabetics|f||||t||||||||||2017-10-11 03:12:01.844099|2017-10-11 03:12:01.844099
NCT01551368|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-05-04|||December 2012||2012-12-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|April 2014|Actual|2014-04-01||Interventional|nimodipine||Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients|Using Nimodipine, a Calcium Channel Blocker, to Prevent the LH Surge and Ovulation in Women Undergoing Assisted Reproduction|Terminated||Phase 2|12|Actual|Mount Sinai Hospital, Canada||2||small number of patients got recruited|f||||f||||||||||2017-10-11 03:12:01.967636|2017-10-11 03:12:01.967636
NCT01540890|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-03-17|||November 2011||2011-11-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Observational|||Impairment of Sleep and Pattern of Breathing Before and After Opioid Withdrawal in Comparison to Patients Without Opioid Withdrawal||Completed||N/A|40|Actual|Ruhr University of Bochum|||3||f||||f||||||||||2017-10-11 03:15:03.570294|2017-10-11 03:15:03.570294
NCT01551355|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-11-10|2014-08-04||July 2009||2009-07-01|November 2016|2016-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Promoting Heart Health in Preschool Children|Evaluation of an Intervention to Promote Healthy Heart Habits in Pre-School Children|Completed||Phase 3|2279|Actual|Icahn School of Medicine at Mount Sinai|minimal participation of teachers in initial planning stage. small number of teachers evaluated has limited the statistical power in this group.|2|||f||||f||||||||||2017-10-11 03:12:02.383237|2017-10-11 03:12:02.383237
NCT01551342|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2014-03-20|||January 2012||2012-01-01|August 2013|2013-08-01||||||||Observational|||Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology|Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology|Unknown status|Recruiting|N/A|500|Anticipated|Zetiq Technologies|||1||f||||f||||||Samples With DNA|"     urine samples   "|||2017-10-11 03:12:02.86208|2017-10-11 03:12:02.86208
NCT01551329|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-12-01|||March 2012||2012-03-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|KetamineDep||Ketamine for Depression and Alcohol Dependence|A Randomized Controlled Trial of the N-methyl-D-aspartate (NMDA) Receptor Antagonist Ketamine in Comorbid Depression and Alcohol Dependence.|Completed||Phase 1|5|Actual|Yale University||1|||f||||t||||||||||2017-10-11 03:12:02.97296|2017-10-11 03:12:02.97296
NCT01551316|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-05-17|||March 2012||2012-03-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients|A Phase Ib Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of Repeated Administration, Intravenous MN-221 in Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients|Completed||Phase 1|19|Actual|MediciNova||2|||f||||||||||||||2017-10-11 03:12:03.063409|2017-10-11 03:12:03.063409
NCT01551303|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-05-29|2014-03-26||February 2009||2009-02-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety|Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety|Completed||N/A|47|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:12:03.162965|2017-10-11 03:12:03.162965
NCT01551290|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-10-28|||April 2012||2012-04-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Infliximab in Chinese Subjects With Active Ulcerative Colitis|Completed||Phase 3|99|Actual|Xian-Janssen Pharmaceutical Ltd.||2|||f||||f||||||||||2017-10-11 03:12:03.39978|2017-10-11 03:12:03.39978
NCT01551277|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2012-03-09|||March 2010||2010-03-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Use of Breath Stacking Technique on Regional Ventilation in Box Chest in Women With Morbid Obesity|Use of Breath Stacking Technique on Regional Ventilation in Box Chest in Women With Morbid Obesity: Clinical Trial Controlled and Randominzado|Completed||N/A|32|Actual|Universidade Federal de Pernambuco||2|||f||||t||||||||||2017-10-11 03:12:03.508586|2017-10-11 03:12:03.508586
NCT01551264|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-12-21|||May 2012||2012-05-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|FAB24||Duration of Brace Wear in Clubfoot Treatment - A Prospective Randomized Trial|Duration of Brace Wear in Clubfoot Treatment - A Prospective Randomized Trail|Active, not recruiting||N/A|124|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:12:03.694893|2017-10-11 03:12:03.694893
NCT01551251|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-07-27|||January 2006||2006-01-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer|Tumor-Associated Macrophages Correlate With Response and Outcomes in Advanced Non-Small Cell Lung Cancer After First Line Treatment.|Completed||N/A|107|Actual|Chang Gung Memorial Hospital|||2||f||||t||||||Samples With DNA|"     All specimens were fixed in 10% buffered formalin and embedded in paraffin according to     standard procedures. All of the tissues were fixed immediately after biopsy, with time from     tissue acquisition to fixation as short as possible. Serial sections (4 μm thickness) placed     on positively charged slides (Menzel-Glasser, German) were used for immuno-histochemistry.   "|||2017-10-11 03:12:03.816152|2017-10-11 03:12:03.816152
NCT01551238|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2013-05-02|||March 2012||2012-03-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Energy Expenditure, Sleep and Macronutrients|Energy Expenditure and Sleep in Response to Protein/Carbohydrate and Fat Ratio|Unknown status|Recruiting|N/A|40|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:12:03.924978|2017-10-11 03:12:03.924978
NCT01551225|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-01-11|||January 2012||2012-01-01|July 2016|2016-07-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder|Randomized Controlled Trial of Escitalopram Versus Placebo for Patients With Irritable Bowel Syndrome and Panic Disorder|Completed||Phase 4|32|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 03:12:04.04498|2017-10-11 03:12:04.04498
NCT01551212|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-08-02|||January 2012||2012-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|HEPHAISTOS||Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients|A 12-month, Multi-center, Open-label, Randomized, Controlled Study to Evaluate Efficacy/Safety and Evolution of Renal Function of Everolimus in Co-exposure With Tacrolimus in de Novo Liver Transplant Recipients|Recruiting||Phase 4|330|Anticipated|Novartis||2|||f||||f||||||||||2017-10-11 03:12:04.140472|2017-10-11 03:12:04.140472
NCT01551199|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-01-04|2014-12-08||March 2012||2012-03-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)|Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)|Completed||Phase 1|7|Actual|VA Office of Research and Development||1|||f||||t||||||||No||2017-10-11 03:12:04.29497|2017-10-11 03:12:04.29497
NCT01551186|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2014-01-23|||February 2012||2012-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria|The Use of the Probiotic, Lactobacillus Rhamnosus GG to Evaluate Colonization With Antimicrobial Resistant Bacteria in High Risk Patients|Completed||Phase 4|104|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 03:12:04.504002|2017-10-11 03:12:04.504002
NCT01551173|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-08-10|2014-05-13||January 2012||2012-01-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Randomized Set (RAN)|Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia|A 12-week, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group Study to Assess the Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily Compared to Fluvastatin Sodium Immediate Release Capsules 40 mg Twice Daily (BID) in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia at Moderate or High Cardiovascular Risk Who Did Not Achieve Their Lipid Goals When Treated With Fluvastatin Sodium Immediate Release Capsules 40 mg QD|Completed||Phase 4|436|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:12:04.619219|2017-10-11 03:12:04.619219
NCT01551160|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2016-11-23|||July 2014||2014-07-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|IMPACT||Impact of a Communication and Team-working Intervention on Performance and Effectiveness of a Medical Emergency Team|Impact of a Communication and Team-working Intervention on Performance and Effectiveness of a Medical Emergency Team|Completed||N/A|1500|Actual|Lyell McEwin Hospital||1|||f||||f||||||||No||2017-10-11 03:12:05.198981|2017-10-11 03:12:05.198981
NCT01551147|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-04-29|||June 2012||2012-06-01|April 2013|2013-04-01||||April 2013|Actual|2013-04-01||Interventional|||A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma|A Double-blind, Placebo-controlled, Three-way Crossover Study to Compare the Safety and Efficacy of 8 Days of Therapy With ONO-6950 Versus Placebo and Montelukast (Singulair®) on Asthmatic Responses and Airway Hypersensitivity Following Allergen Challenge in Patients With Asthma|Completed||Phase 2|25|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||f||||||||||2017-10-11 03:12:05.325283|2017-10-11 03:12:05.325283
NCT01551134|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2012-03-09|||January 2003||2003-01-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Is Laparoscopic Fundoplication Better Than Open Fundoplication in Children ?|IS Laparoscopic Fundoplication Superior to Open Fundoplication in Children - a Randomized Study|Terminated||N/A|88|Actual|Oslo University Hospital||2||Fewer patients than anticipated were referred|f||||f||||||||||2017-10-11 03:12:05.452222|2017-10-11 03:12:05.452222
NCT01551121|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-08-19|||March 2012||2012-03-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Observational|TELEHPAD||Assessment of an Automated Telesurveillance System on the Incidence of Serious Falls in Nursing Homes|Assessment of an Automated Telesurveillance System on the Incidence of Serious Falls in Nursing Homes|Recruiting||N/A|216|Anticipated|University Hospital, Limoges|||2||f||||f||||||||||2017-10-11 03:12:05.542084|2017-10-11 03:12:05.542084
NCT01551108|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-05-02|||March 2012||2012-03-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Parent-targeted Mobile Phone Based Intervention to Increase Physical Activity in Children (P-Mobile)|Parent-targeted Mobile Phone Based Intervention to Increase Physical Activity in Children (P-Mobile)|Completed||N/A|27|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 03:12:05.635687|2017-10-11 03:12:05.635687
NCT01551095|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-03-02|2016-08-21||January 2012||2012-01-01|March 2017|2017-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J)|Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J): A Pilot Study|Terminated||Phase 2|7|Actual|Johns Hopkins University|Small number of patients and short follow-up|1||Proof of principle was achieved after inclusion of 7 patients|f||||t||||||||||2017-10-11 03:12:05.762711|2017-10-11 03:12:05.762711
NCT01551082|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-10-18|2016-07-13||March 2012||2012-03-01|October 2016|2016-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational||patients older than 18 years old who underwent lung resection and were sent home with chest tubes|Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes|Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes|Terminated||N/A|12|Actual|Alliance of Cardiothoracic and Vascular Surgeons|||1|Poor accrual|f||||t||||||||No||2017-10-11 03:12:05.960337|2017-10-11 03:12:05.960337
NCT01551069|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2014-05-12|||March 2012||2012-03-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion|A Randomized, Double Blind, Baseline Controlled Study Using Placebo as Reference for Assessing the Efficacy and Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus in the Presence of Active Lupus Erythematosus Specific Skin Lesion|Completed||Phase 3|103|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:12:06.121464|2017-10-11 03:12:06.121464
NCT01551056|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-09-06|2017-06-27|2015-04-30|March 2012||2012-03-01|September 2017|2017-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)|A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Evaluation of the Onset and Duration of Action of Cetirizine 0.24% Ophthalmic Solution (Formula AFH-002) Compared to Vehicle (Formula AFH-001) in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis|Completed||Phase 3|91|Actual|Aciex Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 03:12:06.300041|2017-10-11 03:12:06.300041
NCT01551043|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-09-27|||September 2010||2010-09-01|September 2016|2016-09-01||||May 2015|Actual|2015-05-01||Interventional|||Allo CART-19 Protocol|Pilot Study of Donor Lymphocyte Infusions Using Donor T Cells Engineered to Contain Anti-CD19 Attached To TCR And 4-1BB Signaling Domains in Patients With Relapsed CD19+ All After Allogeneic Stem Cell Transplantation|Completed||Phase 1|2|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 03:12:07.503149|2017-10-11 03:12:07.503149
NCT01551030|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-04-17|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium|Phase II Study of Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium|Active, not recruiting||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:12:07.575079|2017-10-11 03:12:07.575079
NCT01551017|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-04-21|||December 2011||2011-12-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|June 2015|Anticipated|2015-06-01||Observational|FARP||Fast Track Recovery Knee Arthroplasty Project|Postoperative Cryotherapy: Fast Track Recovery Knee Arthroplasty Project|Unknown status|Recruiting|N/A|80|Anticipated|Medical University of Graz|||2||f||||f||||||||||2017-10-11 03:12:07.664841|2017-10-11 03:12:07.664841
NCT01551004|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-09-21|||May 22, 2012|Actual|2012-05-22|September 26, 2014|2014-09-26|April 21, 2014|Actual|2014-04-21|April 7, 2014|Actual|2014-04-07||Interventional|||Phase I Trial of a Single Dose of CRS3123|Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123 Administered Orally to Healthy Adults|Completed||Phase 1|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f|||||t|f|||f|||||2017-10-11 03:12:07.754234|2017-10-11 03:12:07.754234
NCT01550978|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-02-17|||February 2012||2012-02-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Evaluation of the Safety and Efficacy of the AnapnoGuard 100 System|The Safety of Using the AnapnoGuard 100 System in Intubated Critical Care Patients|Completed||N/A|60|Actual|Hospitech Respiration||2|||f||||f||||||||||2017-10-11 03:12:07.932206|2017-10-11 03:12:07.932206
NCT01550965|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-09-14|2016-04-01||May 2012||2012-05-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|InspirAda|Intention to Treat (ITT) population: all participants who had received at least one dose of study drug and had data for at least one post-baseline assessment of any effectiveness measurement [up to and including Week 26] while receiving treatment with adalimumab.|A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting|An Open-Label Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting|Completed||Phase 3|463|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 03:12:08.061092|2017-10-11 03:12:08.061092
NCT01550952|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-03-01|2016-01-29||December 2011||2011-12-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Interscalene Dynamometer Pilot Study|Interscalene Dynamometer Pilot Study|Completed||N/A|10|Actual|Hospital for Special Surgery, New York|||1||f||||||||||||||2017-10-11 03:12:08.992764|2017-10-11 03:12:08.992764
NCT01550926|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2013-01-24|||February 2009||2009-02-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms|A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms|Completed||Phase 1|48|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:12:09.362775|2017-10-11 03:12:09.362775
NCT01550913|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-03-29|||July 2011||2011-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression|Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression|Completed||Phase 1|59|Actual|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||||2017-10-11 03:12:09.488317|2017-10-11 03:12:09.488317
NCT01550900|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2013-04-04|||July 2013||2013-07-01|April 2013|2013-04-01||||July 2020|Anticipated|2020-07-01||Interventional|||Prospective Trial of Metformin - Chemoprevention Role|A Prospective Placebo-control Double-blind Randomized Trial of Metformin in Chemoprevention of Metachronous Colonic Neoplastic Polyps|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 03:12:09.570167|2017-10-11 03:12:09.570167
NCT01550887|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-08-10|||April 2012||2012-04-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of Impulsivity on Cocaine and Crack Addicts|Evaluation of Impulsivity on Cocaine and Crack Addicts|Completed||N/A|60|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 03:12:09.655917|2017-10-11 03:12:09.655917
NCT01550874|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2015-09-22|||April 2012||2012-04-01|September 2015|2015-09-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|STEP||STEP: Enhanced Physical Activity in Children and Youth With Epilepsy|STEP: Enhanced Physical Activity in Children and Youth With Epilepsy: Developing Evidence of Impacts on Health, Functioning, Psychological Wellbeing, and Quality of Life|Recruiting||N/A|200|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 03:12:09.741189|2017-10-11 03:12:09.741189
NCT01550861|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-06-10|||February 2012||2012-02-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|IVM||In Vitro Maturation (IVM) of Human Oocytes|IN VITRO MATURATION (IVM) OF HUMAN OOCYTES|Unknown status|Active, not recruiting|N/A|40|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 03:12:09.856661|2017-10-11 03:12:09.856661
NCT01550848|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-09-08|||January 2012||2012-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|July 2014|Actual|2014-07-01||Interventional|||A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer|A Phase II Study of Abraxane Combined With Gemcitabine in the Patients With Metastatic Breast Cancer|Completed||Phase 2|84|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 03:12:09.960646|2017-10-11 03:12:09.960646
NCT01550835|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-04-17|||February 2012||2012-02-01|April 2015|2015-04-01||||February 2016|Anticipated|2016-02-01||Interventional|||Impact of Aspiration Thrombectomy During Carotid Stenting|Impact of Aspiration Thrombectomy During Carotid Stenting on New Ischemic Lesions Identified by Diffusion-Weighted Magnetic Resonance Imaging|Unknown status|Recruiting|N/A|80|Anticipated|Fogarty Clinical Research Inc.||2|||f||||f||||||||||2017-10-11 03:12:10.070788|2017-10-11 03:12:10.070788
NCT01550822|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2017-03-09|||April 2012||2012-04-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||HEALS (Healthy Eating And Lifestyle After Stroke)|HEALS (Healthy Eating And Lifestyle After Stroke): A Pilot Trial of a Multidisciplinary Lifestyle Intervention Program|Completed||N/A|100|Actual|Los Amigos Research and Education Institute||2|||f||||f||||||||||2017-10-11 03:12:10.191845|2017-10-11 03:12:10.191845
NCT01550809|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-08-20|2012-06-05||February 2010||2010-02-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||New Strategies for Postprandial Glycemic Control Using Insulin Pump Therapy|New Strategies for Postprandial Glycemic Control Using Insulin Pump Therapy: Feasibility of Insulin Dosing Based on Information From Continuous Glucose Monitoring|Completed||Phase 3|12|Actual|Fundación para la Investigación del Hospital Clínico de Valencia||2|||f||||f||||||||||2017-10-11 03:12:10.290794|2017-10-11 03:12:10.290794
NCT00005695|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-21|||January 1995||1995-01-01|April 2002|2002-04-01|December 1997||1997-12-01|||||Observational|||Physical Training and Blood Pressure in High Risk Youths||Completed||N/A|||Augusta University|||||f||||||||||||||2017-10-11 04:28:54.023507|2017-10-11 04:28:54.023507
NCT01550796|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2013-05-21|||January 2012||2012-01-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Treatment of Chronic Bothersome Tinnitus Using Cognitive Training and D-cycloserine|Treatment of Chronic Bothersome Tinnitus Using Cognitive Training and D-cycloserine|Completed||Phase 2|37|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 03:12:10.792967|2017-10-11 03:12:10.792967
NCT01550783|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-01-23|||March 2012||2012-03-01|January 2017|2017-01-01||||May 2018|Anticipated|2018-05-01||Interventional|||Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening|Cytology vs. at Home HPV Screening for Detection of CIN 2,3,CIS|Active, not recruiting||N/A|2000|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-11 03:12:10.891322|2017-10-11 03:12:10.891322
NCT01550770|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-07-20|||February 2012||2012-02-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Exploratory Study of Propofol and Fentanyl Pharmacodynamics|An Open Label, Exploratory Study of Propofol and Fentanyl Pharmacodynamics|Completed||Phase 1|20|Actual|Ethicon Endo-Surgery||1|||f||||||||||||||2017-10-11 03:12:11.017858|2017-10-11 03:12:11.017858
NCT01550744|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-08|2016-12-15|2016-04-25||March 2012||2012-03-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|PSTELLAR|The “enrolled subject data set” was defined as all participants enrolled at Week 0 who received at least 1 dose of ustekinumab during the study.|"A Study of Ustekinumab to Evaluate a Subject-tailored Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis"|"A Phase 3b, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate a Subject-tailored Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis"|Completed||Phase 3|478|Actual|Janssen Biotech, Inc.||2|||f||||t||||||||||2017-10-11 03:12:11.192373|2017-10-11 03:12:11.192373
NCT01550731|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-07-26|||July 2012||2012-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PREPARE||Preparing Older Veterans With Serious and Chronic Illness for Decision Making|Preparing Older Veterans With Serious and Chronic Illness for Decision Making|Completed||Early Phase 1|414|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 03:12:12.075486|2017-10-11 03:12:12.075486
NCT01550718|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-06-08|||February 2012||2012-02-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial|Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial|Completed||N/A|152|Actual|University of Washington||3|||f||||f||||||||||2017-10-11 03:12:12.159663|2017-10-11 03:12:12.159663
NCT01550705|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-11-19|2016-11-19||March 2012||2012-03-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|INHEPP||Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria|Quantification of the Effects of Isoniazid Treatment on Erythrocyte and Plasma Protoporphyrin IX Concentration and Plasma Aminolevulinic Acid in Patients With Erythropoietic Protoporphyria|Terminated||N/A|11|Actual|University of Utah||1||Interim analysis demonstrated the treatment was not effective|f||||t||||||||No||2017-10-11 03:12:12.248401|2017-10-11 03:12:12.248401
NCT01550679|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-07-19|||October 2010||2010-10-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Observational|MARKO||Early Detection of COPD Patients in GOLD 0 (Smokers) Population|Early Detection of COPD Patients in GOLD 0 (Smokers) Population|Recruiting||N/A|600|Anticipated|Children's Hospital Srebrnjak|||1||f||||t||||||Samples With DNA|"     whole blood, serum, plasma   "|||2017-10-11 03:12:12.455023|2017-10-11 03:12:12.455023
NCT01550666|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-01-08|||January 2011||2011-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|MOVE||Treatment Development Targeting Severe and Persistent Negative Symptoms|Treatment Development Targeting Severe and Persistent Negative Symptoms|Completed||N/A|96|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 03:12:14.214228|2017-10-11 03:12:14.214228
NCT01550653|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-02-26|||May 2012||2012-05-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Liraglutide Effects on Memory in Healthy Subjects|Liraglutide Effects on Memory in Healthy Subjects|Completed||Phase 1|40|Actual|University of Luebeck||2|||f||||t||||||||||2017-10-11 03:12:14.305193|2017-10-11 03:12:14.305193
NCT01550640|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-11-14|||March 2011||2011-03-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia|Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia|Completed||N/A|149|Actual|Charles University, Czech Republic||2|||f||||f||||||||||2017-10-11 03:12:14.404996|2017-10-11 03:12:14.404996
NCT01550627|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-03-09|||November 2007||2007-11-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy|Study of Possible Effects of Intravenous Fluid Supplementation on Serum Bilirubin Levels and Cardiorespiratory Parameters in Preterm Infants During Phototherapy|Completed||Early Phase 1|60|Actual|University of Jena||2|||f||||t||||||||||2017-10-11 03:12:14.537571|2017-10-11 03:12:14.537571
NCT01550614|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-09-27|||March 2012||2012-03-01|September 2016|2016-09-01||||May 2016|Actual|2016-05-01||Interventional|ASPIRE||Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease|A Randomized, Controlled, Parallel Group, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Ad5FGF-4 Using SPECT Myocardial Perfusion Imaging in Patients With Stable Angina Pectoris|Terminated||Phase 3|11|Actual|Cardium Therapeutics||2|||f||||t||||||||No||2017-10-11 03:12:14.625425|2017-10-11 03:12:14.625425
NCT01550601|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-09|||September 2011||2011-09-01|March 2012|2012-03-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Interventional|QUALISLEEVE||Impact of the Preservation of the Gastric Antrum in the Technique of Sleeve Gastrectomy for the Treatment of the Morbid Obesity|Impact of the Preservation of the Gastric Antrum in the Technique of Sleeve Gastrectomy for the Treatment of the Morbid Obesity: a Prospective,Controlled, Randomized, Multicentrique Study.|Unknown status|Recruiting|Phase 4|346|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 03:12:14.739855|2017-10-11 03:12:14.739855
NCT01550588|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2017-06-28|||February 2012||2012-02-01|June 2017|2017-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)|Device Closure Versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale : DEFENSE-PFO|Recruiting||Phase 4|210|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 03:12:14.862156|2017-10-11 03:12:14.862156
NCT01550575|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-02-19|||March 2012||2012-03-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Observational|PRO||Precision Retrospective Outcomes|Precision Retrospective Outcomes|Recruiting||N/A|2000|Anticipated|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 03:12:14.96911|2017-10-11 03:12:14.96911
NCT01550562|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2013-05-08|||February 2012||2012-02-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effects of Programming Parameters on Back Pain Relief in Subthreshold Spinal Cord Stimulation|Precision™ High-Rate Sub-perception Spinal Cord Stimulation for the Treatment of Chronic Intractable Pain|Terminated||N/A|1|Actual|Boston Scientific Corporation||3||"In >9 months only 1 patient enrolled. Study stopped because design was too cumbersome and   subjects not willing to participate"|f||||f||||||||||2017-10-11 03:12:15.074258|2017-10-11 03:12:15.074258
NCT01550549|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-05-03|2012-04-06||August 2011||2011-08-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans|Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans|Completed||N/A|151|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:12:15.272382|2017-10-11 03:12:15.272382
NCT01550536|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-09|||January 2008||2008-01-01|March 2012|2012-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Physical Activity and Basal Metabolic Rate in Postmenopausal Women|Aging and Basal Metabolic Rate in Postmenopausal Women: Effects of Long-Term and Short-Term Physical Activity|Completed||N/A|49|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 03:12:15.671377|2017-10-11 03:12:15.671377
NCT01550523|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2013-12-02|||January 2012||2012-01-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pilot Immunotherapy Trial for Recurrent Malignant Gliomas|Phase 1 Study in Humans Evaluating the Safety of Rectus Sheath Implantation of Diffusion Chambers Encapsulating Autologous Malignant Glioma Cells Treated With Insulin-Like Growth Factor Receptor-1 Antisense Oligodeoxynucleotide in 12 Patients With Recurrent Malignant Glioma|Completed||Phase 1|12|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 03:12:15.768539|2017-10-11 03:12:15.768539
NCT01550510|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-01-31|||December 2011||2011-12-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA|Phase I/II Study of Intravenous Ascorbic Acid in Combination With Irinotecan Versus Irinotecan Alone for Advanced Colorectal Cancer|Terminated||Phase 1/Phase 2|4|Actual|Thomas Jefferson University||1||Closed: low enrollment, many treatment options available for Colorectal Cancer|f||||t||||||||No||2017-10-11 03:12:15.878906|2017-10-11 03:12:15.878906
NCT01550497|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-12-17|||March 2012||2012-03-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|LBPAIS||Spinal Stabilization Exercises for Low Back Pain in Adolescents With Idiopathic Scoliosis|Effectiveness of Spinal Stabilization Exercises for Low Back Pain in Adolescents With Idiopathic Scoliosis|Completed||N/A|45|Actual|Texas Scottish Rite Hospital for Children||2|||f||||t||||||||||2017-10-11 03:12:15.991848|2017-10-11 03:12:15.991848
NCT01550484|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-02-08||2017-02-08|April 2012||2012-04-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders|An Open Label, Multicenter Study, Evaluating the Safety and Efficacy of 18F-AV-133 PET Imaging to Identify Subjects With Dopaminergic Degeneration Among Subjects Presenting to a Movement Disorders Specialty Clinic With an Uncertain Diagnosis|Completed||Phase 2/Phase 3|170|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:12:16.094159|2017-10-11 03:12:16.094159
NCT01550458|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-07-11|||February 2012||2012-02-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers|A Study of the Pharmacokinetic and Safety Profile of QID Dosing of Mibefradil in Normal Human Volunteers|Completed||Phase 1|30|Actual|Cavion LLC||2|||f||||f||||||||||2017-10-11 03:12:16.315176|2017-10-11 03:12:16.315176
NCT01550445|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-03-07|||May 2008||2008-05-01|March 2012|2012-03-01|July 2012|Anticipated|2012-07-01|October 2009|Actual|2009-10-01||Interventional|||Steroid Withdrawal Immunosuppression After Renal Transplantation|Prospective Controlled Protocol for 3 Months Steroid Withdrawal With Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients|Unknown status|Recruiting|Phase 4|30|Anticipated|Ajou University School of Medicine||1|||f||||f||||||||||2017-10-11 03:12:16.415341|2017-10-11 03:12:16.415341
NCT01550432|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-05-24|||June 2011||2011-06-01|May 2017|2017-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation|Effects of GSH and N-Acetylcysteine on Inflammatory Markers Among Adults With CVD Risk|Completed||N/A|78|Actual|Stanford University||5|||f||||f|f|f||||||No||2017-10-11 03:12:16.544369|2017-10-11 03:12:16.544369
NCT01550419|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2013-02-24|||March 2012||2012-03-01|February 2013|2013-02-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke|Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke|Unknown status|Recruiting|Early Phase 1|100|Anticipated|Shanghai Minhang Central Hospital||2|||f||||t||||||||||2017-10-11 03:12:16.639789|2017-10-11 03:12:16.639789
NCT01550406|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2016-06-06|||November 2011||2011-11-01|June 2016|2016-06-01||||April 2015|Actual|2015-04-01||Interventional|||Use of Polyethylene Glycolic Acid or Tachocomb to Prevent Pancreatic Fistula Following Distal Pancreatectomy|Use of Polyethylene Glycolic Acid or Tachocomb to Prevent Pancreatic Fistula Following Distal Pancreatectomy: Prospective Multicenter Randomized Study|Completed||Phase 4|150|Actual|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 03:12:16.754596|2017-10-11 03:12:16.754596
NCT01550393|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-07-07|||March 2012||2012-03-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Biomarkers in Urine Samples From Patients With Wilms Tumor|Discovery and Validation of Wilms Tumor Markers Using Urine Proteomics|Completed||N/A|100|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Urine   "|||2017-10-11 03:12:16.848164|2017-10-11 03:12:16.848164
NCT01550380|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-07-28|||May 2014||2014-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|BKM120||BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers|A Study of BKM120 as a Single Agent in First Line Therapy in Advanced, Metastatic, or Recurrent Endometrial Cancers|Withdrawn||Phase 2|0|Actual|University of Utah||1|||f||||t||||||||||2017-10-11 03:12:16.927742|2017-10-11 03:12:16.927742
NCT01550367|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-12-22|||March 2012||2012-03-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)|Inhibiting the Systemic Autophagic Syndrome - A Phase I/II Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC). A Cytokine Working Group (CWG) Study|Recruiting||Phase 1/Phase 2|39|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 03:12:17.005787|2017-10-11 03:12:17.005787
NCT01550354|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-02-04|||February 2012||2012-02-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Comparison Among Propofol, Alfentanil and Rocuronium as Adjunct to Sevoflurane Anesthesia for Endotracheal Intubation in Children With Frenectomy||Completed||N/A|114|Actual|Yonsei University||3|||f||||t||||||||||2017-10-11 03:12:17.22549|2017-10-11 03:12:17.22549
NCT01550328|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-01-14|||April 2012||2012-04-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Observational|BSOS||Bias Source of Signal in SCOUT DS|Bias Source of Signal in SCOUT DS|Terminated||N/A|25|Actual|VeraLight, Inc.|||1|Protocol no longer meets sponsor objectives|f||||f||||||||||2017-10-11 03:12:17.412887|2017-10-11 03:12:17.412887
NCT01550315|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-04-03|||April 2012||2012-04-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Dietary Sodium Intake on Vascular Endothelium|A Pilot Study of the Effect of Dietary Sodium Intake on Assessments of Vascular Endothelium|Active, not recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 03:12:17.488282|2017-10-11 03:12:17.488282
NCT01550302|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-06-14|2017-03-23||October 2013||2013-10-01|June 2017|2017-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|SCPB||Superficial Cervical Plexus Block for Shoulder Pain After Lung Surgery|The Effect of Superficial Cervical Plexus Block on Post-Thoracotomy/Scopy Ipsilateral Shoulder Pain|Terminated||Phase 4|10|Actual|University of Washington||2||"Unable to continue enrollment due to lack of resources (research coordinator no longer   available)."|f||||t||||||||||2017-10-11 03:12:17.615773|2017-10-11 03:12:17.615773
NCT01550289|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-11-06|2016-09-14||March 2012||2012-03-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India|Immunogenicity and Safety of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India.|Completed||Phase 2|189|Actual|Sanofi||2|||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-11 03:12:18.176629|2017-10-11 03:12:18.176629
NCT01550276|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-03-08|||January 2010||2010-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Tension-type Headache With Articulatory and Suboccipital Soft Tissue Therapy|Treatment of Tension-type Headache With Articulatory and Suboccipital Soft Tissue Therapy: a Double-blind, Randomized, Placebo-controlled Clinical Trial|Completed||N/A|84|Actual|University of Valencia||4|||f||||t||||||||||2017-10-11 03:12:19.804971|2017-10-11 03:12:19.804971
NCT01550263|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-10-04|||January 2012||2012-01-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|Hip||Psychological Distress and Outcomes in Hip Preservation Patients|Pre-Operative Psychological Distress and Post-Operative Outcomes in Hip Preservation Patients|Active, not recruiting||N/A|200|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 03:12:19.923913|2017-10-11 03:12:19.923913
NCT01550250|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2014-07-16|||April 2012||2012-04-01|July 2012|2012-07-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Night-time Compression Systems for Breast Cancer Related Lymphedema|Feasibility of Night-time Compression Systems for Breast Cancer Related Lymphedema: a Pilot Study|Completed||Phase 1|30|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 03:12:19.984636|2017-10-11 03:12:19.984636
NCT01550237|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-08-22|||October 2012||2012-10-01|August 2017|2017-08-01|September 2025|Anticipated|2025-09-01|September 2015|Actual|2015-09-01||Interventional|RIC||Curative Image Guided Radiotherapy for Prostate Cancer|A Randomised, Two Centre Trial on Daily Cone-beam vs Standard Weekly Orthogonal Image Guided Radiotherapy (IGRT) for Prostate Cancer|Active, not recruiting||N/A|260|Actual|St. Olavs Hospital||2|||f||||t||||||||||2017-10-11 03:12:20.217811|2017-10-11 03:12:20.217811
NCT01550224|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-07-31|||May 1, 2013|Actual|2013-05-01|July 2017|2017-07-01|December 31, 2019|Anticipated|2019-12-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Phase II Temozolomide + Vorinostat in Patients With Relapse/Refractory AML|A Phase 2 Study of Temozolomide Plus Vorinostat in Patients With Relapse/Refractory Acute Myeloid Leukemia (AML)|Suspended||Phase 2|45|Anticipated|Stanford University||2||Review|f||||t||||||||||2017-10-11 03:12:20.325566|2017-10-11 03:12:20.325566
NCT01550185|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-04-04|||May 2012||2012-05-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia|Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia|Terminated||Phase 1|10|Actual|Roswell Park Cancer Institute||1||Sponsor wanted study rewritten|f||||f||||||||||2017-10-11 03:12:20.703704|2017-10-11 03:12:20.703704
NCT01550172|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-10-24|||April 2012||2012-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Improving Dementia Caregiver Sleep & the Effect on Heart Disease Biomarkers|Improving Dementia Caregiver Sleep & the Effect on Heart Disease Biomarkers|Completed||N/A|80|Actual|University of South Florida||2|||f||||t||||||||||2017-10-11 03:12:20.858645|2017-10-11 03:12:20.858645
NCT01550159|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-03-06|||April 2009||2009-04-01|March 2012|2012-03-01|April 2013|Anticipated|2013-04-01|February 2013|Anticipated|2013-02-01||Observational|||Correlation Between Markers of Neuronal Injury and Cognitive Dysfunction After Coronary Artery Bypass Surgery|Study of Correlation Between Serum Levels of Markers of Neuronal Injury and Cognitive Dysfunction After Coronary Artery Bypass Graft Surgery|Unknown status|Recruiting|N/A|88|Anticipated|University of Sao Paulo|||1||f||||t||||||||||2017-10-11 03:12:20.9637|2017-10-11 03:12:20.9637
NCT01550133|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-10-04|||September 2012||2012-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|April 2016|Actual|2016-04-01||Interventional|||Effects of Food Form on Cephalic Phase Responses|Effects of Nutritive and Non-Nutritive Food Form and Learning on Cephalic Phase Responses|Active, not recruiting||N/A|60|Anticipated|Purdue University||8|||f||||f||||||||||2017-10-11 03:12:21.146148|2017-10-11 03:12:21.146148
NCT01550120|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-11-21|||March 2012||2012-03-01|March 2013|2013-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Free Fatty Acids: Threshold Repeatability Study|Free Fatty Acids: Threshold Repeatability Study|Completed||N/A|48|Anticipated|Purdue University|||1||f||||f||||||||||2017-10-11 03:12:21.280774|2017-10-11 03:12:21.280774
NCT01550107|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-05-01|||December 2014||2014-12-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Allopurinol in Functional Impairment (ALFIE) Trial: 'Improving Muscle Strength'|A Prospective Study to Evaluate the Effect of Allopurinol on Muscle Energetics in Primary Sarcopenia|Enrolling by invitation||Phase 4|124|Anticipated|University of Dundee||2|||f||||f||||||||||2017-10-11 03:12:21.364564|2017-10-11 03:12:21.364564
NCT01550094|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-10-13|||March 2012||2012-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||A Comparison of Two Injection Locations in Obese Patients Having Lower Leg/Foot Surgery|Evaluation of Ultrasound-Guided Popliteal Sciatic Nerve Blockade in the Severely and Morbidly Obese Populations|Completed||N/A|60|Actual|Ochsner Health System|||1||f||||f||||||||||2017-10-11 03:12:21.486232|2017-10-11 03:12:21.486232
NCT01550081|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-11-27|||March 2012||2012-03-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|August 2012|Actual|2012-08-01||Interventional|||Target Heart Rate and Aerobic Interval Training|Exercise Intensity and Target Heart Rate During Aerobic Interval Training in Cardiac Rehabilitation|Completed||N/A|10|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 03:12:21.560042|2017-10-11 03:12:21.560042
NCT01550068|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-09-20|||December 2012||2012-12-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Rheumatic Heart Disease School Project|A Population-Based Study of Prevalence of Rheumatic Heart Disease and Cardiovascular Outcomes Among Schoolchildren in Nepal|Recruiting||N/A|5476|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-11 03:12:21.652814|2017-10-11 03:12:21.652814
NCT01550055|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-02-08|||March 2009||2009-03-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CRC009||Study of Cetuximab to Treat KRAS Wild Type Metastatic Colorectal Cancer|Phase II/III Trial of Cetuximab Plus Irinotecan Synchronously/Subsequently in Patients With KRAS Wild-type Metastatic Colorectal Cancer: an Randomized, Open-label, Multicenter, Prospective Study|Completed||Phase 2/Phase 3|512|Actual|Shanghai Zhangjiang Biotechnology Limited Company||2|||f||||t||||||||||2017-10-11 03:12:21.760882|2017-10-11 03:12:21.760882
NCT01550042|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-07-06|||September 2011||2011-09-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|April 2015|Actual|2015-04-01||Observational|SCARF||Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients|Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients|Active, not recruiting||N/A|50|Actual|Medisch Spectrum Twente|||1||f||||t||||||||||2017-10-11 03:12:21.893351|2017-10-11 03:12:21.893351
NCT01550029|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2014-01-03|||July 2010||2010-07-01|January 2014|2014-01-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Targeted Intervention for Bipolar Smokers|Targeted Intervention for Bipolar Smokers|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-10-11 03:12:21.970239|2017-10-11 03:12:21.970239
NCT01550016|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-10-10|||October 2011||2011-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|June 2016|Actual|2016-06-01||Observational|IDAMS||International Research Consortium on Dengue Risk Assessment, Management, and Surveillance|Clinical Evaluation of Dengue and Identification of Risk Factors for Severe Disease (WP1)|Completed||N/A|7411|Actual|University of Heidelberg Medical Center|||1||f||||f||||||Samples With DNA|"     Blood samples   "|No||2017-10-11 03:12:22.070803|2017-10-11 03:12:22.070803
NCT01550003|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2017-08-17|||March 2012||2012-03-01|August 2017|2017-08-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|PASCAL||Pediatric Arthritis Study of Certolizumab Pegol|A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-course Juvenile Idiopathic Arthritis (JIA)|Active, not recruiting||Phase 3|163|Actual|UCB Pharma||1|||f||||t||||||||||2017-10-11 03:12:22.189677|2017-10-11 03:12:22.189677
NCT01549990|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-01-26|||February 2012||2012-02-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||A Comparison of Kidney Function After Nephrectomy in Living Donors Under Sevoflurane and Desflurane Anesthesia||Completed||N/A|236|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 03:12:22.36421|2017-10-11 03:12:22.36421
NCT01549977|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-10-30|2013-10-30||July 2012||2012-07-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina|A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Exercise Tolerance in Subjects With Chronic Stable Angina|Terminated||Phase 2|1|Actual|Takeda||2||Business Decision (please see below)|f||||t||||||||||2017-10-11 03:12:22.475026|2017-10-11 03:12:22.475026
NCT01549964|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-04-20|2015-03-25||April 2012||2012-04-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Placebo and Sitagliptin 100 mg When Used in Combination With Metformin in Subjects With Type 2 Diabetes|Terminated||Phase 3|916|Actual|Takeda||4||Due to concerns about potential liver safety (See Detailed Description)|f||||t||||||||||2017-10-11 03:12:22.861554|2017-10-11 03:12:22.861554
NCT01549951|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-04-24|2016-02-29||May 2012||2012-05-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Safety analysis set was defined as all participants who received at least 1 dose of any study drug.|Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer|A Phase 2, Open-Label, Single-Arm, Multidose Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer|Completed||Phase 2|50|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:12:24.868393|2017-10-11 03:12:24.868393
NCT01549925|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-12-21|2015-10-02||January 2011||2011-01-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand|A Prospective Randomized Surgical Trial Comparing the Efficacy of LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Standard Surgical Resection in Women With Stage IIIC or Stage IVA Epithelial Ovarian Cancer|Completed||N/A|50|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 03:12:25.788214|2017-10-11 03:12:25.788214
NCT01549912|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-08-05|||February 2012||2012-02-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Results of Rotator Cuff Repair|Results of Rotator Cuff Repair Following Acute Shoulder Dislocation|Completed||N/A|2|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 03:12:26.034808|2017-10-11 03:12:26.034808
NCT01549899|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2016-05-05|||March 2012||2012-03-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Comparing Internet and In-Person Brief Cognitive Behavioral Therapy of Insomnia|Comparing Internet and In-Person Brief Cognitive Behavioral Therapy of Insomnia|Completed||Phase 3|187|Actual|University of North Texas, Denton, TX||3|||f||||t||||||||||2017-10-11 03:12:26.119968|2017-10-11 03:12:26.119968
NCT01549873|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-02-24|2015-02-04||January 2012||2012-01-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Anesthesia During Neurophysiologic Monitoring in Scoliosis Patients|Anesthesia During Neurophysiologic Monitoring in Scoliosis Patients: Volatile Agents Versus Total Intravenous Anesthesia|Completed||N/A|30|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-10-11 03:12:26.351334|2017-10-11 03:12:26.351334
NCT01549860|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-07-02|2015-04-27||April 2012||2012-04-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional||Eligible subjects randomized|Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers|IN-BALANCE VLU Inflammation, Bacteria, & Angiogenesis Effects in Launching Venous Leg Ulcer Healing|Completed||N/A|156|Actual|Celleration, Inc.||2|||f||||t||||||||||2017-10-11 03:12:26.63844|2017-10-11 03:12:26.63844
NCT01549847|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2015-11-16||||||November 2015|2015-11-01||||February 2013|Anticipated|2013-02-01||Interventional|||A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome|A Phase III, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Therapeutic Effect of the Association of L-carnitine and Piracetam as an Adjuvant Therapy in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome|Withdrawn||Phase 3|0|Actual|Biolab Sanus Farmaceutica||2||Study was not approved by Health Surveillance Agency|f||||f||||||||||2017-10-11 03:12:27.06303|2017-10-11 03:12:27.06303
NCT01549834|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2014-10-24||2014-10-24|March 2012||2012-03-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors|Completed||Phase 2|434|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 03:12:27.162162|2017-10-11 03:12:27.162162
NCT01549808|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-08|||February 2011||2011-02-01|March 2012|2012-03-01|April 2014|Anticipated|2014-04-01|January 2014|Anticipated|2014-01-01||Interventional|MIT||Early Mobilization in Intensive Therapy|Early Mobilisation in Intensive Therapy|Unknown status|Recruiting|Phase 1/Phase 2|200|Anticipated|Region Zealand||1|||f||||f||||||||||2017-10-11 03:12:27.408384|2017-10-11 03:12:27.408384
NCT00005696|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||January 1994||1994-01-01|May 2005|2005-05-01|December 1996|Actual|1996-12-01|||||Observational|||Early Atherosclerosis Change in Two Clinical Trials||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.075766|2017-10-11 04:28:54.075766
NCT01549795|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-07-17|||January 2012||2012-01-01|July 2012|2012-07-01||||July 2013|Anticipated|2013-07-01||Interventional|||Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy|Trapianto di Fegato Per Colangiocarcinoma (CCA) Ilare in Associazione a Radio e Chemioterapia Neoadiuvante|Unknown status|Recruiting|N/A|33|Anticipated|Azienda Ospedaliera di Padova||1|||f||||t||||||||||2017-10-11 03:12:27.520722|2017-10-11 03:12:27.520722
NCT01549782|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-08|||June 2005||2005-06-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy.|Effect of a Mixture of Inulin and Fructo-oligosaccharide on Lactobacillus and Bifidobacterium Intestinal Microbiota of Patients Receiving Radiotherapy: a Randomised, Double-blind, Placebo-controlled Trial.|Completed||N/A|40|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-11 03:12:27.632519|2017-10-11 03:12:27.632519
NCT01549769|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-04-28|||April 2012||2012-04-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes|A Multiple-Dose, Open-Label Pharmakokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes|Terminated||Phase 1|24|Actual|Reata Pharmaceuticals, Inc.||1||IDMC recommendation for safety concerns|f||||||||||||||2017-10-11 03:12:27.717897|2017-10-11 03:12:27.717897
NCT01549756|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-08|||March 2012||2012-03-01|March 2012|2012-03-01||||April 2012|Anticipated|2012-04-01||Observational|||Qualitative Research for Stage 4 Stomach Cancer and Their Caregivers|Qualitative Research for Stage 4 Stomach Cancer and Their Caregivers|Unknown status|Recruiting|N/A|30|Anticipated|Find A Cure Panel|||1||f||||f||||||||||2017-10-11 03:12:27.781341|2017-10-11 03:12:27.781341
NCT01549743|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-08|||May 2012||2012-05-01|March 2012|2012-03-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||The Pharmacokinetic Interaction Between Celecoxib and Rebamipide|Clinical Trial to Assess the Pharmacokinetic Interaction Between Celecoxib and Rebamipide in Healthy Male Volunteers|Unknown status|Not yet recruiting|Phase 1|30|Anticipated|Hanlim Pharm. Co., Ltd.||3|||f||||||||||||||2017-10-11 03:12:27.859147|2017-10-11 03:12:27.859147
NCT01549730|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-09-19|||May 2011||2011-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Cervix Hypoxia FAZA|A Feasibility Study of Hypoxia Imaging in Patients With Cervix Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)|Recruiting||N/A|30|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 03:12:27.947468|2017-10-11 03:12:27.947468
NCT01549717|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2014-02-11|||December 2012||2012-12-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|LISTEN||Feasibility And Efficacy Of Continuous In-Hospital Patient Monitoring|Feasibility And Efficacy Of Continuous In-Hospital Patient Monitoring|Completed||N/A|300|Anticipated|Guy's and St Thomas' NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 03:12:28.037029|2017-10-11 03:12:28.037029
NCT01549704|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-01-07|||February 2012||2012-02-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Adductor-Canal-Blockade on High Pain Responders After Total Knee Arthroplasty|Effect of Adductor-Canal-Blockade on High Pain Responders the 1. or 2. Postoperative Day After Total Knee Arthroplasty|Completed||Phase 4|50|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-11 03:12:28.273096|2017-10-11 03:12:28.273096
NCT01549691|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2013-09-24|||March 2012||2012-03-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|PREMED||Reassessment of Premedication in Surgery|Assessment of Two Modes of Premedication in Surgery - PREMED Study|Completed||Phase 4|455|Anticipated|University Hospital, Angers||3|||f||||t||||||||||2017-10-11 03:12:28.3786|2017-10-11 03:12:28.3786
NCT01549678|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-07|||August 2010||2010-08-01|November 2010|2010-11-01|August 2012|Anticipated|2012-08-01|April 2012|Anticipated|2012-04-01||Interventional|||Plantar Fasciitis Foot Insole|Effect of Plantar Fasciitis Foot Insole|Unknown status|Recruiting|N/A|74|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:12:28.509505|2017-10-11 03:12:28.509505
NCT01549665|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-03-14|||January 2012||2012-01-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|GVHD-MSC||Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease|Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:12:28.639429|2017-10-11 03:12:28.639429
NCT01549639|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-07-18|||January 2012||2012-01-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Blood Propofol Measurement During Anaesthesia Using Propofol Target Controlled Infusion|Use of a Novel Point of Care Device to Measure Blood Propofol Levels During Propofol Based General Anesthesia by Target Controlled Infusion Using the Marsh Model in Effect Site Mode|Completed||N/A|50|Actual|University Hospital Birmingham NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 03:12:28.844444|2017-10-11 03:12:28.844444
NCT01549626|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-03-08|||March 2009||2009-03-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||Effects of Flaxseed Flour in Appetite Sensations, Lipid Profile and Pressure Levels Among Overweighed and Obese Women|Effects of Flaxseed Flour - Whole Brown Flaxseed Flour, Brown Defatted Flaxseed Flour and Golden Flaxseed Flour in Appetite Sensations Satiety, Lipid Profile, Pressure Levels and Associated Costs Among Overweighed and Obese Women|Completed||N/A|54|Actual|Universidade Federal do Rio de Janeiro||3|||f||||t||||||||||2017-10-11 03:12:28.919172|2017-10-11 03:12:28.919172
NCT01549431|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2016-12-01|||January 2012||2012-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|February 2016|Actual|2016-02-01||Interventional|||Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma|A Phase I Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed and/or Refractory Multiple Myeloma|Active, not recruiting||Phase 1|22|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:12:31.295736|2017-10-11 03:12:31.295736
NCT01549613|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-07-07|2014-07-07||May 2012||2012-05-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||161 patients were screened;104 were initially enrolled. 3 patients were withdrawn prior to randomization; 1 patient was transferred to OR, 1 patient was admitted prior to randomization, 1 patient was prescribed a different antibiotic;1 patient was withdrawn not meet inclusion criteria. 39 patients in each treatment group completed follow-up.|Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections|Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections|Completed||Phase 4|104|Actual|University of Cincinnati||2|||f||||t||||||||||2017-10-11 03:12:29.099158|2017-10-11 03:12:29.099158
NCT01549600|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-10-27|||February 2012||2012-02-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose|A Randomized, Controlled Study To Compare the Effects of 2 Types of Dietary Fiber, Psyllium and Microcrystalline Cellulose, on Glycemic Measures in Subjects With Pre-type 2 Diabetes|Completed||N/A|18|Actual|Procter and Gamble||2|||f||||f||||||||||2017-10-11 03:12:29.632234|2017-10-11 03:12:29.632234
NCT01549587|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-06-18|||February 2012||2012-02-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|OHMOM||Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM)|A Randomized Controlled Clinical Trial to Evaluate Late First to Mid-Second Trimester Introduction of Advanced Daily Oral Hygiene on Gingivitis and Maternity Outcomes|Completed||N/A|746|Actual|Procter and Gamble||2|||f||||t||||||||||2017-10-11 03:12:29.769742|2017-10-11 03:12:29.769742
NCT01549574|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-25|2012-06-01|||May 2012||2012-05-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Drug Drug Interaction Study Of Crizotinib With Esomeprazole.|A Phase 1, Open Label, Single Dose, Randomized, Cross-Over Study To Estimate The Effect Of Esomeprazole On The Pharmacokinetics Of Crizotinib In Healthy Volunteers|Completed||Phase 1|16|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:12:29.953352|2017-10-11 03:12:29.953352
NCT01549561|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-04-07|||November 2006||2006-11-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|KEEP2||Preventing Behavior and Health Problems in Foster Teens|Preventing Behavior and Health Problems in Foster Teens|Completed||N/A|259|Actual|Oregon Social Learning Center||3|||f||||f||||||||||2017-10-11 03:12:30.10323|2017-10-11 03:12:30.10323
NCT01549548|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-03-13||||||March 2013|2013-03-01||||||||Expanded Access|||Compassionate Use Ponatinib|Treatment Plan for the Compassionate Use of Ponatinib (AP24534) in Patients With Imatinib-, Dasatinib-, and Nilotinib- Resistant/Intolerant Philadelphia Chromosome Positive Leukemias.|No longer available||N/A|||OHSU Knight Cancer Institute|||||||||||||||||||2017-10-11 03:12:30.25041|2017-10-11 03:12:30.25041
NCT01549535|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-11-22|||February 2012||2012-02-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||Polyp Detection With The Peerscope System™|Polyp Detection With The Peerscope System™: A Randomized Tandem Colonoscopy Study|Completed||Phase 2|197|Actual|PeerMedical Ltd.||2|||f||||||||||||||2017-10-11 03:12:30.33591|2017-10-11 03:12:30.33591
NCT01549522|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2012-03-08|||March 2012||2012-03-01|March 2012|2012-03-01||||April 2012|Anticipated|2012-04-01||Observational|||Qualitative Research for Stage 4 Liver Cancer Patients and Their Caregivers|Phase 1 0 Qualitative Research for Stage 4 Liver Cancer Patients and Their Caregivers.|Unknown status|Recruiting|N/A|30|Anticipated|Find A Cure Panel|||1||f||||f||||||||||2017-10-11 03:12:30.472027|2017-10-11 03:12:30.472027
NCT01549509|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2014-10-15|||April 2007||2007-04-01|October 2014|2014-10-01|October 2009|Actual|2009-10-01|April 2008|Actual|2008-04-01||Interventional|||Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 Recombinant Adenovirus-5 Vector Vaccine, VRC-HIVADV014-00-VP Administered Alone or Administered as a Boost to a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, in Uninfected Adult Volunteers in Uganda|Completed||Phase 1|18|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-11 03:12:30.595086|2017-10-11 03:12:30.595086
NCT01549496|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-01-07|||May 2012||2012-05-01|January 2015|2015-01-01||||September 2012|Anticipated|2012-09-01||Interventional|||A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers|A Drug Interaction Study Investigating the Effect of Boceprevir on the Pharmacokinetics of the Calcium Channel Blockers Amlodipine and Diltiazem and Vice Versa in Healthy Volunteers|Withdrawn||Phase 1|0|Actual|Ottawa Hospital Research Institute||1||Investigator left this hospital|f||||f||||||||||2017-10-11 03:12:30.726507|2017-10-11 03:12:30.726507
NCT01549483|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-01-15|||May 2012||2012-05-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Observational|ABHR||Small Airways Disease in Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness (AHR)|Differences in Small Airways Disease Between Asymptomatic and Symptomatic Subjects With Airway Hyperresponsiveness|Completed||N/A|45|Anticipated|University Medical Center Groningen|||3||f||||f||||||Samples With DNA|"     Nasal epithelium brushes for mRNA expression   "|||2017-10-11 03:12:30.865296|2017-10-11 03:12:30.865296
NCT01549470|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-12||||||March 2012|2012-03-01|March 2006|Actual|2006-03-01|||||Interventional|||Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, in Uninfected Adult Volunteers in Uganda|Completed||Phase 1|31|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 03:12:30.979468|2017-10-11 03:12:30.979468
NCT01549457|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-10-07|||April 2012||2012-04-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment|The Effect of Weekly Text-message Communication on Treatment Completion Among Patients With Latent Tuberculosis Infection: a Randomised Controlled Trial (WelTel LTBI)|Unknown status|Active, not recruiting|Early Phase 1|350|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:12:31.118982|2017-10-11 03:12:31.118982
NCT01549444|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-10-21|||March 2012||2012-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Observational|||Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension|Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension (RENAL HIT Study)|Completed||N/A|76|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||Samples Without DNA|"     Serum samples for Renin and Alsosterone, to be discarded when study is complete.   "|||2017-10-11 03:12:31.216965|2017-10-11 03:12:31.216965
NCT01549418|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-08|||September 2012||2012-09-01|March 2012|2012-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|ASAPOL||The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin|The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Continuing or Discontinuing on Aspirin: a Multicenter, Double-blind, Placebo-controlled, Randomized Clinical Trial|Unknown status|Not yet recruiting|Phase 4|760|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||t||||||||||2017-10-11 03:12:31.397297|2017-10-11 03:12:31.397297
NCT01549405|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2013-04-01|2013-02-21||February 2012||2012-02-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Ultrasound-Guided Intercostal Nerve Block for Postoperative Pain Relief in Percutaneous Nephrolitotomy||Completed||N/A|40|Actual|Diskapi Teaching and Research Hospital||2|||f||||t||||||||||2017-10-11 03:12:31.503368|2017-10-11 03:12:31.503368
NCT01549392|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-09-11|2014-04-02||February 2012||2012-02-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||patients with recurrent glioblastoma|Imaging Study of Glioblastomas Treated With Avastin|Feasibility Study of Magnetic Resonance Spectroscopy and Dynamic Enhanced Cat Scan Imaging in Glioblastomas Treated With and Without Avastin|Terminated||N/A|3|Actual|London Health Sciences Centre||2||insufficient accrual|f||||f||||||||||2017-10-11 03:12:31.790282|2017-10-11 03:12:31.790282
NCT01549379|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-10-14|||July 2013||2013-07-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Dynamic Contrast Enhanced Computed Tomography (CT) for Head and Neck Cancer|Dynamic Contrast Enhanced Computed Tomography (DCE-CT) to Assess Lymph Node Metastases in Head and Neck Cancer: A Prospective Study|Terminated||N/A|1|Actual|Lawson Health Research Institute||2||Poor Accrual|f||||f||||||||||2017-10-11 03:12:32.010589|2017-10-11 03:12:32.010589
NCT01549366|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-03-15|||February 2012||2012-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion|A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)|Recruiting||Phase 4|144|Anticipated|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-10-11 03:12:32.093686|2017-10-11 03:12:32.093686
NCT01549353|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-12-01|||July 2011||2011-07-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Gum Chewing After Gynecologic Laparoscopy|Does Gum Chewing After Gynecologic Laparoscopy Stimulate Earlier Return of Bowel Motility?|Completed||N/A|200|Anticipated|Klinikum Klagenfurt am Wörthersee||1|||f||||f||||||||||2017-10-11 03:12:32.247379|2017-10-11 03:12:32.247379
NCT01549340|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-01-18|2014-01-23||November 2011||2011-11-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)|Evaluation of Patient Initiation and Persistence With Advised Allergen Immunotherapy|Completed||N/A|8790|Actual|ALK-Abelló A/S|||1||f||||f||||||||||2017-10-11 03:12:32.332726|2017-10-11 03:12:32.332726
NCT01549327|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-03-22|||May 2012||2012-05-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Effect of a Virtual Navigator on Colorectal Cancer Patient Empowerment|A Web-Based Person-Centred Navigation Tool for Newly Diagnosed Colorectal Cancer Patients: A Randomized Clinical Trial (RCT) to Assess Effects on Empowerment and Cost-Effectiveness (The TEN-C Study: Together to Enhance Navigation in Cancer)|Completed||N/A|129|Actual|McGill University||2|||f||||f||||||||No||2017-10-11 03:12:32.665137|2017-10-11 03:12:32.665137
NCT01549314|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-09-12|||April 2012||2012-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Cystic Fibrosis Related Bone Disease: the Role of CFTR|Cystic Fibrosis Related Bone Disease: the Role of CFTR|Active, not recruiting||N/A|80|Actual|Massachusetts General Hospital|||3||f||||f||||||Samples Without DNA|"     Plasma and urine   "|||2017-10-11 03:12:32.794006|2017-10-11 03:12:32.794006
NCT01549301|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-06|||August 2012||2012-08-01|March 2012|2012-03-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.||Unknown status|Not yet recruiting|Phase 1|128|Anticipated|Azidus Brasil||4|||f||||||||||||||2017-10-11 03:12:32.90817|2017-10-11 03:12:32.90817
NCT01549288|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-04-07|||February 2012||2012-02-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy|Evaluation of the Modified Atkins Diet in Children With Infantile Spasms Refractory to Hormonal Therapy: a Randomized Controlled Trial|Withdrawn||Phase 2/Phase 3|0|Actual|Lady Hardinge Medical College||2|||f||||||||||||||2017-10-11 03:12:33.037379|2017-10-11 03:12:33.037379
NCT01549275|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-09-07|2013-07-15||April 2010||2010-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Observational|||Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration|Kaohsiung Medical University Hospital|Completed||N/A|105|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||t||||||Samples With DNA|"     cancer cells and cancer-associated fibroblasts   "|||2017-10-11 03:12:33.11685|2017-10-11 03:12:33.11685
NCT01549262|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-08-04|||February 2012||2012-02-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Clinical Validation of Embryo Cinematography|Clinical Validation of Embryo Culture and Selection by Morphokinetic Analysis; a Randomized Controlled Trial by Time-lapse System|Completed||N/A|843|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-10-11 03:12:35.453947|2017-10-11 03:12:35.453947
NCT01549249|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-11-12|||June 2008||2008-06-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|||Evaluation of the Cone Outer Segment Tips Line After Epiretinal Membrane Surgery|Evaluation of the Cone Outer Segment Tips Line After Epiretinal Membrane Surgery|Completed||N/A|333|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 03:12:35.535168|2017-10-11 03:12:35.535168
NCT01549236|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-08-27|||May 2011||2011-05-01|August 2012|2012-08-01|October 2012|Anticipated|2012-10-01|August 2012|Actual|2012-08-01||Interventional|Pop PK Chagas||Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease|Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Drugs for Neglected Diseases||1|||f||||f||||||||||2017-10-11 03:12:35.608862|2017-10-11 03:12:35.608862
NCT01549223|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2017-06-27|2017-02-24||April 2011||2011-04-01|June 2017|2017-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Oxytocin And Uterotonic Agent Use For Cesarean Delivery|A Randomized Controlled Trial of Standardized Versus Conventional Oxytocin and Uterotonic Agent Use for Cesarean Delivery|Completed||Phase 4|60|Actual|Brigham and Women's Hospital||2|||f||||f|t|f|||t|||No||2017-10-11 03:12:35.717314|2017-10-11 03:12:35.717314
NCT01549210|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-03-09|||April 2011||2011-04-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|KING||Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life|Multicentre Prospective Observational Study for Identification of Determinants of Disability and Quality of Life in Patients With Gout.|Completed||N/A|450|Actual|Italian Society for Rheumatology|||1||f||||t||||||||||2017-10-11 03:12:36.049816|2017-10-11 03:12:36.049816
NCT01549197|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-11-19|||August 2011||2011-08-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|CAESAR||Quality of Dying in the Intensive Care Unit: Validation of the CAESAR Scale|End-of-life in French Intensive Care Units: Perception of the Quality of Dying and Experience of Physicians, Nurses and Relatives. Validation of the CAESAR Scale|Completed||N/A|475|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 03:12:36.144518|2017-10-11 03:12:36.144518
NCT01549184|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-20|||December 2010||2010-12-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|HCQITP||Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia|Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia Among 40 Patients|Completed||N/A|40|Actual|Henri Mondor University Hospital|||1||f||||f||||||||||2017-10-11 03:12:37.059232|2017-10-11 03:12:37.059232
NCT01549158|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-04-24|||February 2012||2012-02-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure|Randomized, Open-Label, Blinded-Endpoint, Crossover, Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg, in Patients With Compensated Heart Failure (CHF).|Terminated||Phase 4|8|Actual|Ferrer Internacional S.A.||3||Slow recruitment|f||||f||||||||||2017-10-11 03:12:37.276856|2017-10-11 03:12:37.276856
NCT01549145|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-08-28|||June 2010||2010-06-01|August 2012|2012-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression||Completed||N/A|14|Actual|EstimME Ltd.||1|||f||||f||||||||||2017-10-11 03:12:37.394077|2017-10-11 03:12:37.394077
NCT01549132|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-08|||April 2012||2012-04-01|March 2012|2012-03-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Observational|||Retinal Oximtery Following Treatment for Diabetic Maculopathy|Non-invasive Retinal Oximetry Using Oxymap in Patients With Diabetic Maculopathy Receiving Laser/Intravitreal Anti-VEGF Therapy|Unknown status|Not yet recruiting|N/A|45|Anticipated|East Kent Hospitals University NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 03:12:37.484537|2017-10-11 03:12:37.484537
NCT01549119|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2015-01-30|||February 2012||2012-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|February 2013|Actual|2013-02-01||Interventional|||Phase I/IIa Dose-escalation Clinical Study of VAC-3S|Multicentre, Randomized, Placebo-controlled, Double-blind, Phase I/IIa Dose-escalation Clinical Study of a Therapeutic Vaccine (VAC-3S) Intended to Confer Protection Against Immunopathological Effects of HIV-1 in Infected Patients|Completed||Phase 1/Phase 2|33|Actual|InnaVirVax||5|||f||||t||||||||||2017-10-11 03:12:37.58621|2017-10-11 03:12:37.58621
NCT01549106|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-07-31|||August 2011||2011-08-01|July 2017|2017-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study|A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food and Ketoconazole on the Pharmacokinetics of IPI-145 When Administered to Healthy Adult Subjects|Completed||Phase 1|106|Actual|Verastem, Inc.||2|||f||||f||||||||||2017-10-11 03:12:37.723086|2017-10-11 03:12:37.723086
NCT01549080|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-07|||July 2011||2011-07-01|June 2011|2011-06-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Observational|thalessemia||Study of Effects of YisuiShengxueGranules on Thalassemia|A Double-blind, Placebo-controlled, Randomized, Parallel-group Study of the Safety and Effects of YisuiShengxueGranules on Thalassemia Presenting the Syndrome of Deficiency of Liver/Kidney-yin, and Asthenia of Essence/Blood.|Completed||N/A|2|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|||2||f||||t||||||Samples With DNA|"     Peripheral blood and bone marrow cells   "|||2017-10-11 03:12:37.949376|2017-10-11 03:12:37.949376
NCT01549067|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-13|||September 2011||2011-09-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|Sprit||The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey|The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey|Unknown status|Recruiting|N/A|3700|Anticipated|Chinese Medical Doctor Association|||1||f||||t||||||||||2017-10-11 03:12:38.057776|2017-10-11 03:12:38.057776
NCT01549054|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-10-31|||January 2012||2012-01-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501|A Single-center, Randomized, Open-label, Two-part Study to Evaluate Bioavailability of Prototype Third-generation Formulations of E5501 Relative to Second-generation Tablet Formulation in Healthy Subjects|Completed||Phase 1|28|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-11 03:12:38.147032|2017-10-11 03:12:38.147032
NCT01549041|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2014-04-23|2014-01-24||April 2012||2012-04-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|||Once-Daily Asenapine for Schizophrenia|A Randomized Comparison of Twice-Daily Versus Once-Daily Asenapine for Schizophrenia|Completed||Phase 4|30|Actual|Duke University|Small sample size Open label design|2|||f||||f||||||||||2017-10-11 03:12:38.24258|2017-10-11 03:12:38.24258
NCT01549028|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-07|||September 2011||2011-09-01|March 2012|2012-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD)|The Prevalence, Correlations and Effectiveness of Intervention of Osteoporosis in COPD Patients|Unknown status|Recruiting|N/A|60|Anticipated|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-10-11 03:12:38.623991|2017-10-11 03:12:38.623991
NCT01549015|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-06-25|||January 2012||2012-01-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|July 2012|Actual|2012-07-01||Interventional|||Study in Healthy Subjects, Patients With Urea Cycle Disorders (UCD) and Carriers of UCD Mutations to Evaluate Urea Cycle Function|Open, Prospective, Diagnostic, Multicentre Study in Healthy Subjects, Patients With Urea Cycle Disorders (UCD), and Carriers of UCD Mutations, to Evaluate in Vivo Ureagenesis Measured After a Single Application of Sodium [1,2-13C]-Acetate|Completed||N/A|37|Actual|Cytonet GmbH & Co. KG||1|||f||||f||||||||||2017-10-11 03:12:38.715173|2017-10-11 03:12:38.715173
NCT01549002|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-08-20|2015-02-02||January 2012||2012-01-01|August 2015|2015-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children|Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children|Completed||Phase 3|20|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 03:12:38.803558|2017-10-11 03:12:38.803558
NCT01548989|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-03-25|||April 2012||2012-04-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Validation of a New Sexuality Questionnaire for Patients With Urinary Incontinence or Pelvic Organ Prolapse|Validation of a New Sexuality Questionnaire: a Tool for Evaluating the Sexuality of Patients With Urinary Incontinence or Pelvic Organ Prolapse|Completed||N/A|25|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 03:12:39.099988|2017-10-11 03:12:39.099988
NCT01548976|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-03-25|||April 2012||2012-04-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Validation of a French Version of the PISQ-R|Validation of a French Version of the PISQ-R: a Tool for Evaluating the Sexuality of Patients With Urinary Incontinence or Pelvic Organ Prolapse|Completed||N/A|25|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 03:12:39.198404|2017-10-11 03:12:39.198404
NCT01548963|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-25|2015-05-15|||January 2007||2007-01-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Interventional|||Perioperative Versus Postoperative Glycemia Control in Cardiac Surgery Patients|Perioperative Versus Postoperative Glycemia Control in Cardiac Surgery Patients|Completed||N/A|2384|Actual|Charles University, Czech Republic||2|||f||||f||||||||||2017-10-11 03:12:39.468341|2017-10-11 03:12:39.468341
NCT01548950|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-06-17|||September 2011||2011-09-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|January 2014|Actual|2014-01-01||Interventional|||Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension|Combined Clinical and Surgical Approaches to Congenital Heart Disease Associated With Pulmonary Arterial Hypertension (PAH-CHD)|Unknown status|Recruiting|N/A|50|Anticipated|University of Sao Paulo General Hospital||1|||f||||t||||||||||2017-10-11 03:12:39.619118|2017-10-11 03:12:39.619118
NCT01548937|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2016-01-27|||May 2010||2010-05-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Serotonin Transporter Density in Late-life Depression With and Without Dementia|Serotonin Transporter Density in Late-life Depression With and Without Dementia|Completed||Phase 2|39|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 03:12:39.783559|2017-10-11 03:12:39.783559
NCT01548924|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-01-07|||April 2012||2012-04-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|||Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors|Phase I/II Randomized Clinical Trial of Neoadjuvant Paclitaxel Versus Priming With BIBF 1120 BIBF 1120 Followed by Plus Paclitaxel in Breast Cancer With HER-2 Negative Correlative Proteomic Studies. and Dynamic Image|Terminated||Phase 1|24|Anticipated|Centro Nacional de Investigaciones Oncologicas CARLOS III||2||Drug toxicity|f||||t||||||||||2017-10-11 03:12:39.884446|2017-10-11 03:12:39.884446
NCT01548911|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-07-28|||May 2012||2012-05-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia|Safety and Efficacy of Gemtuzumab Ozogamicin (Mylotarg®) as for Treatment of Patients With CD33-Positive Acute Myeloid Leukemia (AML)|Withdrawn||Phase 2|0|Actual|Wake Forest University Health Sciences||1|||f||||f|t|f||||||||2017-10-11 03:12:40.032211|2017-10-11 03:12:40.032211
NCT01548898|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-03-06|||January 2008||2008-01-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||The Efficacy of Laser Assisted Hair Removal in the Treatment of Acne Keloidalis Nuchae; a Pilot Study||Completed||Phase 4|16|Actual|Cairo University||1|||f||||t||||||||||2017-10-11 03:12:40.214307|2017-10-11 03:12:40.214307
NCT01548885|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-01-29|2013-03-27||March 2012||2012-03-01|January 2016|2016-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||Per protocol|Comparison Evaluation of Blood Glucose Meter Systems|Evaluation of Blood Glucose Meter Systems - NACT Study|Completed||N/A|146|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 03:12:40.310568|2017-10-11 03:12:40.310568
NCT01548872|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-06|||December 2011||2011-12-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Comparison of the Effects of Crystalloid Cardioplegia and HTK Solution for Postoperative Troponin-I and CK-MB Levels After Pediatric Cardiac Surgery||Unknown status|Recruiting|Phase 4|60|Anticipated|Baskent University||2|||f||||t||||||||||2017-10-11 03:12:40.583794|2017-10-11 03:12:40.583794
NCT01548859|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2012-03-06|||July 2011||2011-07-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Comparison of the Effects of Sevoflurane and Midazolam Used for the Maintenance of Anaesthesia on the Levels of Postoperative Cardiac Troponin I in Pediatric Cardiac Surgery||Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Baskent University||2|||f||||t||||||||||2017-10-11 03:12:40.756998|2017-10-11 03:12:40.756998
NCT01540877|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-02-28|||April 2011||2011-04-01|February 2012|2012-02-01||||September 2011|Actual|2011-09-01||Interventional|||A Human Experimental Model for Neuropathic Pain Using Combined Application of Capsaicin and Local Anesthetics||Completed||N/A|28|Actual|Ruhr University of Bochum||4|||f||||f||||||||||2017-10-11 03:15:03.633835|2017-10-11 03:15:03.633835
NCT01548846|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-03-12|||May 2012||2012-05-01|March 2014|2014-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TOQUAL||Impact of Tomotherapy on Xerostomia and Quality of Life of Patients With Cancer of the Upper Aero-digestive Tract|Impact of Tomotherapy on Xerostomia and Quality of Life of Patients With Cancer of the Upper Aero-digestive Tract|Terminated||Phase 2|11|Actual|Centre Francois Baclesse||1||lack of recrutment|f||||f||||||||||2017-10-11 03:12:40.893348|2017-10-11 03:12:40.893348
NCT01548833|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-06-06|2013-04-22||March 2012||2012-03-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||All enrolled participants|Pre-Lens Tear Film Performance of Silicone Hydrogel Daily Disposable Contact Lenses|Randomized Cross-Over Evaluation of Silicone Hydrogel Daily Disposable Soft Contact Lenses|Completed||N/A|39|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 03:12:41.044188|2017-10-11 03:12:41.044188
NCT01548820|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2013-09-08|||June 2010||2010-06-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Observational|||Resistance to Lamivudine in HBV Egyptian Patients|Pretreatment and On-treatment Indicators of Virologic Breakthrough in Chronic HBV Egyptian Patients Receiving Lamivudine Therapy|Completed||N/A|230|Actual|Ain Shams University|||1||f||||t||||||Samples With DNA|"     blood samples +/- tissue biopsy   "|||2017-10-11 03:12:41.2865|2017-10-11 03:12:41.2865
NCT01548807|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2016-09-23|||September 2010||2010-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy|Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy|Recruiting||Phase 1|33|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:12:41.378568|2017-10-11 03:12:41.378568
NCT01548794|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-04-21|||March 2012||2012-03-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Recovery of Bupivacaine or Bupivacaine-Lidocaine Spinal Anesthesia and Infiltration Anesthesia in Herniorrhaphy|A Comparison of the Recovery Profiles of Bupivacaine or Bupivacaine Mixed With Lidocaine Spinal Anesthesia and Local Infiltration Anesthesia for Outpatient Herniorrhaphy|Completed||Phase 4|93|Actual|Diskapi Teaching and Research Hospital||3|||f||||f||||||||||2017-10-11 03:12:41.501367|2017-10-11 03:12:41.501367
NCT01548781|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-10-05|||March 2012||2012-03-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||The Effect of Resistance to Participant-Supported Reaching on Workspace of the Hand in Severe Chronic Stroke|The Effect of Resistance to Participant-Supported Reaching on Workspace of the Hand in Severe Chronic Stroke|Completed||N/A|38|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 03:12:41.680714|2017-10-11 03:12:41.680714
NCT01548768|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-03-13|||October 10, 2011|Actual|2011-10-10|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|RHYTHM||RHYTHM (Formerly Escape II Myocardium)|RHYTHM (RHeumatoid Arthritis studY of THe Myocardium): How Rheumatoid Arthritis (RA) and Tumor Necrosis Factor (TNF) Inhibitors Affect the Myocardial Structure and Function.|Recruiting||Phase 4|175|Anticipated|Columbia University||3|||f||||t|t|f||||||No||2017-10-11 03:12:41.811984|2017-10-11 03:12:41.811984
NCT01548755|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-12|||April 2012||2012-04-01|March 2012|2012-03-01|January 2015|Anticipated|2015-01-01|||||Observational|||The Western Galilee Hospital in Nahariya Home Monitoring Registry|Workload Assessment of a Home Monitoring Based Follow up for Biotronik ICD and CRTD Patients.|Unknown status|Not yet recruiting|N/A|20|Anticipated|Western Galilee Hospital-Nahariya|||1||f||||t||||||||||2017-10-11 03:12:41.95842|2017-10-11 03:12:41.95842
NCT01548742|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-11-04|2015-09-29||March 2012||2012-03-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|VMP||Meditation Interventions for Treatment of PTSD in Veterans|Meditation Interventions for Treatment of PTSD in Veterans|Completed||N/A|116|Actual|VA Office of Research and Development|Initial analyses did not account for clustering effects. However, when we re-analyzed data using a multilevel model including a random effect for therapy group, we found that the results were essentially unchanged.|2|||f||||t||||||||||2017-10-11 03:12:42.053975|2017-10-11 03:12:42.053975
NCT01548729|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-03-16|||March 2012||2012-03-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PIM||Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis|Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis : a Pilot Study|Recruiting||Phase 1/Phase 2|15|Anticipated|University Hospital, Strasbourg, France||1|||f||||t||||||||||2017-10-11 03:12:42.735541|2017-10-11 03:12:42.735541
NCT01548716|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-03-05|||September 2011||2011-09-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|October 2011|Actual|2011-10-01||Observational|||A Study of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients|A Cross-sectional Analysis of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients|Completed||N/A|50|Actual|Winthrop University Hospital|||1||f||||f||||||||||2017-10-11 03:12:42.932046|2017-10-11 03:12:42.932046
NCT01548703|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-05-07|||February 2012||2012-02-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of BCI 838 in Healthy Adult Subjects|Completed||Phase 1|30|Actual|BrainCells Inc.||3|||f||||f||||||||||2017-10-11 03:12:43.009385|2017-10-11 03:12:43.009385
NCT01548690|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-02-04|||June 2012||2012-06-01|February 2016|2016-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|STOP-ALF||Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure|A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure|Recruiting||Phase 2|36|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||Yes|De-identified data for the overall study will be shared once the study is completed.|2017-10-11 03:12:43.124029|2017-10-11 03:12:43.124029
NCT01548677|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-10-25|||April 2013||2013-04-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|March 2017|Anticipated|2017-03-01||Interventional|TREAT-CTC||Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer|"TRastuzumab in HER2-negative Early Breast Cancer as Adjuvant Treatment for Circulating Tumor Cells (CTC) (TREAT CTC Trial)"|Active, not recruiting||Phase 2|2175|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 03:12:43.450546|2017-10-11 03:12:43.450546
NCT01548664|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2014-02-25|||May 2009||2009-05-01|February 2014|2014-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The Utilization of Nintendo Wii™ in Outpatient Rehabilitation Following Total Knee Replacement|The Utilization of Nintendo Wii™ in Outpatient Rehabilitation Following Total Knee Replacement|Completed||Phase 2|50|Actual|St. John's Rehab Hospital||2|||f||||f||||||||||2017-10-11 03:12:43.77027|2017-10-11 03:12:43.77027
NCT01548651|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-05-31|||February 2012||2012-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation|Effect of Saxagliptin Treatment on Myocardial Fat Content, Left Ventricular Function, and Monocyte Inflammation in Patients With Impaired Glucose Tolerance|Recruiting||Phase 4|40|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 03:12:43.910225|2017-10-11 03:12:43.910225
NCT01548638|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2014-07-01|2013-10-30||February 2012||2012-02-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|August 2012|Actual|2012-08-01||Interventional|||Effect of Galantamine on Smoking Abstinence|The Effect of the Acetylcholinesterase Inhibitor, Galantamine, on Short-term Abstinence|Completed||Phase 2|13|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 03:12:44.039426|2017-10-11 03:12:44.039426
NCT01548625|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-07|||July 2007||2007-07-01|March 2012|2012-03-01||||November 2008|Actual|2008-11-01||Observational|||Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers||Completed||N/A|6|Actual|Environmental Protection Agency (EPA)|||1||f||||f||||||||||2017-10-11 03:12:44.332167|2017-10-11 03:12:44.332167
NCT01548612|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-03-07|||February 2006||2006-02-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|June 2009|Actual|2009-06-01||Interventional|||Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia|Randomised Double Blind Placebo Controlled Study of Sodium Nitroprusside Added to Treatment as Usual in Patients With Schizophrenia|Completed||Phase 2|20|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:12:44.414839|2017-10-11 03:12:44.414839
NCT01548599|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2014-08-19|||April 2012||2012-04-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Shamba||Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya|Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya|Completed||N/A|140|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:12:44.505749|2017-10-11 03:12:44.505749
NCT01548586|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-10-05|||January 2012||2012-01-01|March 2012|2012-03-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Transcranial Direct Current Stimulation (tDCS) on the Excitability of the Diaphragmatic Primary Motor Cortex|Modulation de l'excitabilité Des Aires Corticales Motrices Primaires Correspondant Aux hémi Diaphragmes à l'Aide de la tDCS (Transcranial Direct Current Stimulation)|Completed||Phase 1|12|Actual|Institut National de la Santé Et de la Recherche Médicale, France||3|||f||||f||||||||||2017-10-11 03:12:44.597591|2017-10-11 03:12:44.597591
NCT01548573|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-05-19|2017-04-04||May 2012|Actual|2012-05-01|May 2017|2017-05-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|||Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment|Tandem Autotransplantation for Multiple Myeloma in Participants With Less Than 12 Months of Preceding Therapy, Incorporating Velcade (Bortezomib) With the Transplant Chemotherapy and During Maintenance|Terminated||Phase 2|19|Actual|University of Iowa|Enrollment halted prematurely. Study met stopping rules. Outcomes will not be tracked and published|1||Met study stopping rules|f||||t|t|f|||f|||No||2017-10-11 03:12:44.731306|2017-10-11 03:12:44.731306
NCT01548560|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-09-05|||August 2012||2012-08-01|September 2017|2017-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Assessing the Safety of Dapivirine Gel and Film Formulations||Completed||Phase 1|60|Actual|International Partnership for Microbicides, Inc.||4|||f||||||||||||||2017-10-11 03:12:46.143044|2017-10-11 03:12:46.143044
NCT01548547|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-07|||June 2008||2008-06-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|POISE||Patient Outcomes in Simulation Education (POISE) Intravenous (IV) and Lumbar Puncture (LP) Multi-institution Protocol|Patient Outcomes in Simulation Education (POISE) Intravenous (IV) and Lumbar Puncture (LP) Multi-institution Protocol|Completed||N/A|210|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 03:12:46.246814|2017-10-11 03:12:46.246814
NCT01548534|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-07-28|||February 2012||2012-02-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DHALYA||A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer|A Phase III Randomized, Multicenter, Two Arms Double-blind Trial Versus Placebo, Evaluating the Interest of a Dietary Supplementation With Docosahexaenoic Acid (DHA) During Chemotherapy for Metastatic Breast Cancer|Terminated||Phase 3|65|Actual|University Hospital, Tours||2||Judicial liquidation of the society providing dietary supplementation.|f||||f||||||||||2017-10-11 03:12:46.353308|2017-10-11 03:12:46.353308
NCT01548521|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-02-21|||July 2011||2011-07-01|February 2017|2017-02-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Interventional|OTBB||Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies|Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies and Effect on Suck and Food Intake.|Completed||Phase 1/Phase 2|5|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-11 03:12:46.490515|2017-10-11 03:12:46.490515
NCT01548508|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-05-10|||July 2008||2008-07-01|May 2017|2017-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|EMSICA||Evaluation of Functionnal ElectromyoStimulation on Leg In Advanced Chronic Heart Failure After Hospitalisation for Acute Decompensation|Evaluation of Functionnal ElectromyoStimulation on Leg In Advanced Chronic Heart Failure After Hospitalisation for Acute Decompensation|Completed||N/A|46|Actual|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-11 03:12:46.583071|2017-10-11 03:12:46.583071
NCT01548495|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-03-08|||May 2012||2012-05-01|March 2012|2012-03-01|September 2013|Anticipated|2013-09-01|May 2013|Anticipated|2013-05-01||Observational|MDS||Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients|Investigating Recombinant Human Erythropoietin (rHuEPO) Treatment Efficacy Depending on the Presence of Erythropoietin Autoantibodies in Myelodysplatic Syndrome (MDS) Patients|Unknown status|Not yet recruiting|N/A|100|Anticipated|Meir Medical Center|||4||f||||f||||||||||2017-10-11 03:12:46.6917|2017-10-11 03:12:46.6917
NCT01548482|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2015-10-05|||March 2012||2012-03-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|A Phase I Trial of AMG 386 and Temsirolimus in Advanced Solid Tumors With an Expansion Cohort in Uterine Cancer, Renal Cell Carcinoma and Carcinoid Tumor|Completed||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:12:46.797392|2017-10-11 03:12:46.797392
NCT01548469|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-02-05|||March 2012||2012-03-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study to Evaluate Clinical Efficacy and Safety of Bio Mineral Toothpaste in Patients With Mild Periodontitis|Single Blind, Randomized, Active-controlled Comparative Clinical Trial to Evaluate Clinical Efficacy and Safety Following the Application for 4 Weeks of Bio Mineral Toothpaste in Patients With Mild Periodontitis|Completed||Phase 4|60|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-11 03:12:46.927156|2017-10-11 03:12:46.927156
NCT01548456|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-05-16|||July 2012||2012-07-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Nails Versus Plates for Femur Fractures in Dar es Salaam, Tanzania|Intramedullary Nailing Versus Plates for Femoral Shaft Fractures in Dar es Salaam, Tanzania With Minimum 1-Year Follow-up|Completed||N/A|332|Actual|University of California, San Francisco|||2||f||||f||||||||||2017-10-11 03:12:47.049797|2017-10-11 03:12:47.049797
NCT01548443|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-02-05|||March 2012||2012-03-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|Medifoam H||"Study to Evaluate Clinical Efficacy and Safety of Medifoam H in Wound Healing"|The Wound Healing Efficacy and Safety of Medifoam H in Patients With Minor, Acute Trauma: a Single-center, Randomized, Active-controlled, Open-label, Phase IV|Completed||Phase 4|66|Actual|Seoul St. Mary's Hospital||2|||f||||f||||||||||2017-10-11 03:12:47.182975|2017-10-11 03:12:47.182975
NCT01548430|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-02-11|||October 2011||2011-10-01|February 2015|2015-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Safety Study of TTP4000 in Subjects With Alzheimer's Disease|A Double-blind, Randomized, Placebo-controlled, Phase 1 Study of 2 Escalating, Single Subcutaneous Doses to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of TTP4000 in Subjects With Alzheimer's Disease With Mild Cognitive Impairment|Completed||Phase 1|8|Actual|vTv Therapeutics||3|||f||||f||||||||||2017-10-11 03:12:47.317405|2017-10-11 03:12:47.317405
NCT01548417|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-05-24|2016-02-02||March 2012||2012-03-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists|Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists|Completed||Phase 2|56|Actual|The Scripps Research Institute||2|||f||||f||||||||No||2017-10-11 03:12:47.466142|2017-10-11 03:12:47.466142
NCT01548391|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-07|||March 2012||2012-03-01|March 2012|2012-03-01||||||||Interventional|||A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects||Unknown status|Not yet recruiting|Phase 1|66|Anticipated|Biotoxtech Co., Ltd||9|||f||||t||||||||||2017-10-11 03:12:48.244489|2017-10-11 03:12:48.244489
NCT01548378|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-03-23|||March 2012||2012-03-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|NL003CLI-II||Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia|A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of NL003 in Subject With Critical Limb Ischemia|Completed||Phase 2|200|Actual|Beijing Northland Biotech. Co., Ltd.||4|||f||||t||||||||||2017-10-11 03:12:48.344685|2017-10-11 03:12:48.344685
NCT01548365|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2013-09-20|||March 2012||2012-03-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|ETI||Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices|Impact of an Infusion Therapy Nursing Expert Service on Length of Stay, Clinical Results of Venous Access Devices and Satisfaction on Patients With Long Intravenous Therapy Prescription.|Completed||N/A|82|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 03:12:48.494289|2017-10-11 03:12:48.494289
NCT01548352|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-07-26|||April 2010||2010-04-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Observational|||BAsel Syncope EvaLuation (BASEL IX) Study|BAsel Syncope EvaLuation (BASEL IX) Study|Recruiting||N/A|720|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     EDTA Plasma; Heparin; Serum   "|||2017-10-11 03:12:48.596805|2017-10-11 03:12:48.596805
NCT01548339|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-12-29|||February 2009||2009-02-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|||Laparoscopic Cholecystectomy for Acute Cholecystitis After 72 Hours of Symptoms|Laparoscopic Cholecystectomy for Acute Cholecystitis: is the Rule of 72 Hours Still Actual?|Terminated||N/A|86|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-11 03:12:48.764894|2017-10-11 03:12:48.764894
NCT01548326|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-06|||September 2011||2011-09-01|March 2012|2012-03-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine|Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine|Unknown status|Enrolling by invitation|Phase 4|52|Anticipated|Baqiyatallah Medical Sciences University||2|||f||||t||||||||||2017-10-11 03:12:48.866703|2017-10-11 03:12:48.866703
NCT01548313|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2015-01-30|||May 2010||2010-05-01|January 2015|2015-01-01|May 2015|Anticipated|2015-05-01|May 2013|Actual|2013-05-01||Observational|MYMILK||The Role of Human Milk in Development of Breast Fed Child's Intestinal Microbiota|The Role of Human Milk in Development of Breast Fed Child's Intestinal Microbiota|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Ljubljana|||3||f||||f||||||Samples With DNA|"     colostrum, meconium, milk, child's faeces, urine, venous blood   "|||2017-10-11 03:12:48.97834|2017-10-11 03:12:48.97834
NCT01548300|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-04-21|||February 2011||2011-02-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|AIRCMD||Environmental Triggers Of Cardiometabolic Disease|Environmental Triggers Of Cardiometabolic Disease|Completed||N/A|66|Actual|University of Maryland|||1||f||||f||||||||||2017-10-11 03:12:49.076756|2017-10-11 03:12:49.076756
NCT01548287|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-12-14|2015-01-26||April 2012||2012-04-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment|A Phase IIa Safety and Tolerability Study to Investigate the Effect on Sleep of 3 Doses of AZD5213 and Placebo in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment During 4 Weeks of Treatment, Placebo-Controlled|Completed||Phase 2|164|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 03:12:49.213858|2017-10-11 03:12:49.213858
NCT01548274|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-05|||October 2010||2010-10-01|March 2012|2012-03-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells|Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells|Unknown status|Recruiting|N/A|20|Anticipated|Aichi Gakuin University||1|||f||||t||||||||||2017-10-11 03:12:50.110645|2017-10-11 03:12:50.110645
NCT01548261|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2012-03-07|||January 2012||2012-01-01|March 2012|2012-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Donating Oral Mucosal Cells for the Study of ex Vivo Culture of Cells Sheets||Unknown status|Recruiting|N/A|1|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     Donating oral mucosal cells for the study of ex vivo culture of cells sheets.   "|||2017-10-11 03:12:50.20148|2017-10-11 03:12:50.20148
NCT01548248|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-01-30|||January 2006||2006-01-01|January 2017|2017-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Efficacy and Safety of Levemir® Used as Basal Insulin|An Observational 3-months Study to Evaluate Efficacy and Safety of Insulin Levemir® Used as Basal Insulin on the Glycaemic Control, Weight and Incidence of Hypoglycaemic Events in Insulin Treated Subjects With Type 1 or Type 2 Diabetes|Completed||N/A|631|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:12:50.288831|2017-10-11 03:12:50.288831
NCT01548235|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2017-01-05|||February 2006||2006-02-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment|A Multicentre, Open Label, Non-randomised, Non-interventional, Observational Safety Study in Subjects With Type 2 Diabetes Mellitus, Starting or Switching to NovoMix® 30 Treatment|Completed||N/A|423|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:12:50.393286|2017-10-11 03:12:50.393286
NCT01548222|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-08-23|||February 2012||2012-02-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target|CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target|Completed||N/A|20|Actual|Diabetes Care Center|||1||f||||f||||||||||2017-10-11 03:12:50.47753|2017-10-11 03:12:50.47753
NCT01548209|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-01-30|||September 2011||2011-09-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery|Effects of a Single Dose Dexmedetomidine on Postoperative Nausea and Vomiting (PONV) and Quality of Recovery 40 (QoR 40) in Breast Cancer Surgery|Completed||N/A|97|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 03:12:50.560919|2017-10-11 03:12:50.560919
NCT01548196|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2015-03-12|||February 2008||2008-02-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Standard Percutaneous Nephrolithotomy Percutaneous Nephrolithotomy (PNL) Versus Tubeless PNL Versus Tubeless Stentless PNL|A Prospective, Randomized Controlled Pilot Study Of Standard Percutaneous Nephrolithotomy (PNL) Versus Tubeless PNL Versus Tubeless Stentless PNL|Completed||Phase 3|60|Actual|Duke University||4|||f||||t||||||||||2017-10-11 03:12:50.658751|2017-10-11 03:12:50.658751
NCT01548183|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-05-26|||August 2011||2011-08-01|May 2015|2015-05-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|StARSS||Text-message Program to Reduce Risky Sexual Behavior in Young Adult Female Emergency Department (ED) Patients|Mobile Phone Text-message Program to Reduce Risky Sexual Behavior in Young Females Discharged From the Emergency Department|Completed||Phase 2|52|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:12:50.743274|2017-10-11 03:12:50.743274
NCT01548170|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2012-03-05|||April 2011||2011-04-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib|A Phase I, Pilot, Dose Finding Clinical Trial to Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib for National Health System|Completed||Phase 1|12|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||5|||f||||f||||||||||2017-10-11 03:12:50.827095|2017-10-11 03:12:50.827095
NCT01548157|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-06-03|||March 2012||2012-03-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule|A Randomized, Open Label, Single Dose, 2X2 Cross-over Study to Compare Pharmacokinetics Between Rosuvastatin 10mg and Omega-3 1g Co-administration and HCP1007 in Healthy Male Volunteers|Completed||Phase 1|28|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||t||||||||||2017-10-11 03:12:50.939856|2017-10-11 03:12:50.939856
NCT01548144|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-12-22|||April 2012||2012-04-01|December 2016|2016-12-01||||April 2018|Anticipated|2018-04-01||Interventional|||Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer|A Two Steps Phase I Trial of Pazopanib or Pemetrexed in Combination With Crizotinib Followed by the Triplet, Crizotinib Plus Pazopanib Plus Pemetrexed in Patients With Advanced Malignancies|Active, not recruiting||Phase 1|364|Anticipated|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-10-11 03:12:51.019745|2017-10-11 03:12:51.019745
NCT01548131|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2012-03-15|||November 2007||2007-11-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|LINNEA||A Randomized Longitudinal Trial About Treatment for Severe Fear of Childbirth|A Randomized Longitudinal Trial About Treatment for Severe Fear of Childbirth|Completed||N/A|370|Actual|Helsinki University Central Hospital||2|||f||||t||||||||||2017-10-11 03:12:51.154407|2017-10-11 03:12:51.154407
NCT01548105|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2014-10-15|||March 2012||2012-03-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Observational|||Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse|Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse|Completed||N/A|96|Actual|TriHealth Inc.|||4||f||||f||||||||||2017-10-11 03:12:51.354837|2017-10-11 03:12:51.354837
NCT00005697|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||January 1993||1993-01-01|April 2001|2001-04-01|December 1996||1996-12-01|||||Observational|||Intervention for Resistant Pregnant Smokers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.16635|2017-10-11 04:28:54.16635
NCT01548092|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2012-03-05|||December 2011||2011-12-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|July 2012|Anticipated|2012-07-01||Interventional|HULPCIR||Stromal Vascular Fraction (SVF) for Treatment of Recto-vaginal Fistula|A Phase II Clinical Trial to Study the Feasibility and Safety of Stromal Vascular Derived From Adipose Tissue for the Treatment of Recto-vaginal Fistula|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Instituto de Investigación Hospital Universitario La Paz||1|||f||||f||||||||||2017-10-11 03:12:51.447863|2017-10-11 03:12:51.447863
NCT01548066|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2012-10-05|||September 2011||2011-09-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss|The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss|Completed||Phase 2|40|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:12:51.673737|2017-10-11 03:12:51.673737
NCT01548053|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-04-13|||March 2012||2012-03-01|April 2017|2017-04-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Interventional|PC-DATA||The Primary Care - Dementia Assessment and Treatment Algorithm|A Study Evaluating the Effects of a Primary Care - Dementia Assessment Treatment Algorithm on the Quality of Care Provided to Older Adults With Dementia in Primary Care Settings|Completed||N/A|55|Actual|Queen's University||1|||f||||f||||||||||2017-10-11 03:12:51.773484|2017-10-11 03:12:51.773484
NCT01548040|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-09-06|||March 2012||2012-03-01|September 2017|2017-09-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Compare the Effects of a Standard Therapy Protocol With a 12-week Peri-Operative Program of Kneehab XP Neuromuscular Electrical Stimulation Compared to a Control Treatment in Patients Undergoing Total Knee Replacement|A Randomised Controlled Study To Compare the Effects of a Standard Therapy Protocol With a 12-week Peri-Operative Program of Kneehab XP Neuromuscular Electrical Stimulation Compared to a Control Treatment in Patients Undergoing Total Knee Replacement|Completed||N/A|111|Actual|Theragen Inc.||2|||f||||f||||||||||2017-10-11 03:12:51.882118|2017-10-11 03:12:51.882118
NCT01548027|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2014-07-30|||July 2012||2012-07-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|December 2013|Actual|2013-12-01||Interventional|TAP||Surgical Transversus Abdominis Plane Block in Pediatric Patients|Efficacy of Surgical Transversus Abdominis Plane Block for Postoperative Pain Relief Following Abdominal Surgery in Pediatric Patients.|Completed||N/A|54|Actual|Mahidol University||3|||f||||t||||||||||2017-10-11 03:12:51.976771|2017-10-11 03:12:51.976771
NCT01548014|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-03-07|||January 2010||2010-01-01|March 2012|2012-03-01|January 2016|Anticipated|2016-01-01|September 2012|Anticipated|2012-09-01||Interventional|||The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease|Reduction in Frequency of Infliximab Administration From q 8 Weeks to q 12 Weeks in Children With Crohn's Disease Receiving Probiotic VSL#3 Supplementation: A Pilot Study|Unknown status|Recruiting|Phase 3|1|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 03:12:52.082774|2017-10-11 03:12:52.082774
NCT01548001|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-02-22|||May 2012||2012-05-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|November 2016|Anticipated|2016-11-01||Interventional|||Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis|A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Iguratimod Alone or Iguratimod in Combination With Methotrexate Versus Methotrexate Alone in Patients With Rheumatoid Arthritis|Active, not recruiting||Phase 4|910|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||3|||f||||f||||||||Undecided||2017-10-11 03:12:52.150167|2017-10-11 03:12:52.150167
NCT01547988|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-03-05|||October 2001||2001-10-01|March 2012|2012-03-01|August 2003|Actual|2003-08-01|February 2003|Actual|2003-02-01||Interventional|||Training Improves Balance Control|Improving Balance Control and Self-Reported Lower Extremity Function in Community Dwelling Older Adults - A Randomized Control Study|Completed||N/A|66|Actual|Boston University||2|||f||||f||||||||||2017-10-11 03:12:52.228745|2017-10-11 03:12:52.228745
NCT01547975|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2012-04-01|||April 2010||2010-04-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Retrospective Analysis of Surgical Outcomes After Corneal Transplantation|Retrospective Analysis of Surgical Outcomes After Corneal Transplantation|Completed||N/A|1000|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 03:12:52.298294|2017-10-11 03:12:52.298294
NCT01547962|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-04-06|||September 2005||2005-09-01|April 2012|2012-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva|A Pilot Clinical Trial to Assess the Safety and Efficacy of Gintuit (TM) (Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen) in Establishing a Functional Zone of Attached Gingiva|Completed||N/A|25|Actual|Organogenesis||2|||f||||f||||||||||2017-10-11 03:12:52.362789|2017-10-11 03:12:52.362789
NCT01547949|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-08-09|||March 2012||2012-03-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy of Tart Cherry Juice in Reducing Muscle Injury and Biomarkers of Muscle Damage Among Healthy Adults|Efficacy of Tart Cherry Juice in Reducing Muscle Injury and Biomarkers of Muscle Damage Among Healthy Adults|Completed||Phase 4|15|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 03:12:52.44801|2017-10-11 03:12:52.44801
NCT01547936|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-03-05|||February 2012||2012-02-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Effect of Controlled Adverse Environment (CAE) on Tear Film Stability|A Single-Center Study Evaluating the Effect of the Controlled Adverse Environment (CAE) on Tear Film Stability Using the OPI 2.0 System, Ocular Protection Index (OPI), Tear Film Break-Up Time (TFBUT) and Mean Break up Area by Region (MBA) in Patients Diagnosed With Dry Eye Evaluated During Their Natural Blink Pattern|Completed||N/A|33|Actual|ORA, Inc.|||1||f||||f||||||||||2017-10-11 03:12:52.540902|2017-10-11 03:12:52.540902
NCT01547923|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-03-05|||June 2008||2008-06-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|DPD côlon||Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines|The Medical-financial Evaluation of Pre-therapeutic Screening by a Joint Phenotypic-pharmacogenetic Approach for Metabolic Fluoropyrimidine Enzyme Deficiency in Terms of Serious Toxicity Risk Prevention : a Multicentric Case Study|Unknown status|Recruiting|Phase 3|2296|Anticipated|ICO Paul Papin||2|||f||||t||||||||||2017-10-11 03:12:52.607715|2017-10-11 03:12:52.607715
NCT01547910|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-08-19|||August 2007||2007-08-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in Children|Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in Children - a Randomized, Double Blind, Placebo Controlled, Multicenter Study|Completed||Phase 2|76|Actual|Children's Memorial Health Institute, Poland||2|||f||||t||||||||||2017-10-11 03:12:53.063823|2017-10-11 03:12:53.063823
NCT01547897|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-02-21|||March 2012||2012-03-01|September 2013|2013-09-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria|A Phase IIa Study to Characterize the Effects of CCL2 Inhibition With the Spiegelmer® NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria|Completed||Phase 2|76|Actual|NOXXON Pharma AG||2|||f||||f||||||||||2017-10-11 03:12:53.161452|2017-10-11 03:12:53.161452
NCT01547884|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-10-05|||February 7, 2012||2012-02-07|August 31, 2017|2017-08-31||||||||Observational|||Effect of Filarial Infection on Immune Responses in Latent Tuberculosis|Effect of Filarial Infection on Antigen-Specific Immune Responses in Latent Tuberculosis|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:53.306644|2017-10-11 03:12:53.306644
NCT01547871|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-06-30|||February 7, 2012||2012-02-07|April 14, 2016|2016-04-14|April 14, 2016||2016-04-14|||||Observational|||Infants With Spinal Muscular Atrophy Type I|A Pilot Study of the Natural History of Infants With Spinal Muscular Atrophy (SMA) Type 1|Terminated||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:53.386505|2017-10-11 03:12:53.386505
NCT01547858|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-06-30|||February 7, 2012||2012-02-07|November 28, 2016|2016-11-28||||||||Observational|||Studying Blood Toxicity in Workers Exposed to Formaldehyde|A Cross-Sectional Study of Hematotoxicity in Workers Exposed to Formaldehyde|Completed||N/A|720|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:53.456104|2017-10-11 03:12:53.456104
NCT01547845|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-06-30|||February 7, 2012||2012-02-07|June 2, 2017|2017-06-02||||||||Observational|||Cancer Symptom Data From Multiple Treatment Centers|The NCl Community Cancer Center Program Patients Reported Symptom Surveillance and Disparities Study|Completed||N/A|2550|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:53.547581|2017-10-11 03:12:53.547581
NCT01547832|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-10-03|||February 24, 2012||2012-02-24|September 22, 2017|2017-09-22||||||||Observational|||Mutations Associated With Parkinson s Disease|Metabolic Phenotyping of Subjects With Mutations Associated With Hereditary Parkinson's Disease|Completed||N/A|42|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:53.681335|2017-10-11 03:12:53.681335
NCT01547819|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-06-30|||February 16, 2012||2012-02-16|December 18, 2013|2013-12-18|December 18, 2013||2013-12-18|||||Observational|||Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder|Imaging the GABAergic System Using 11C-flumazenil PET to Assess the Role of Mild Traumatic Brain Injury in the Development of Post Traumatic Stress Disorder|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:53.76264|2017-10-11 03:12:53.76264
NCT01547806|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-07-27|2017-06-22||February 22, 2012|Actual|2012-02-22|July 2017|2017-07-01|December 1, 2017|Anticipated|2017-12-01|June 17, 2014|Actual|2014-06-17||Interventional|||Collection of Transplant Stem Cells for Plasma Cell Myeloma|Mobilization and Collection of Autologous Stem Cell for Transplantation (ASCT) for Plasma Cell Myeloma (PCM)|Active, not recruiting||Phase 2|49|Actual|National Institutes of Health Clinical Center (CC)|The sample size in outcome measure number 6 was inadequate. Results were not conclusive and the information is determined to be too preliminary to present. No conclusion should be drawn from the reported data for this outcome.|1|||f||||f|t|f||||||||2017-10-11 03:12:53.856051|2017-10-11 03:12:53.856051
NCT01547793|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-06-30|||January 26, 2012||2012-01-26|November 4, 2015|2015-11-04|November 4, 2015||2015-11-04|||||Observational|||Carbon Monoxide Levels and Sickle Cell Disease Severity|End-Alveolar Carbon Monoxide as a Measure of Erythrocyte Survival and Hemolytic Severity in Sickle Cell Disease|Completed||N/A|106|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:54.456792|2017-10-11 03:12:54.456792
NCT01547780|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-09-29|||January 20, 2012||2012-01-20|September 28, 2017|2017-09-28|September 28, 2017|Actual|2017-09-28|September 28, 2017|Actual|2017-09-28||Interventional|||Translocator Protein and Inflammation After Traumatic Brain Injury|PET Imaging of Translocator Protein in Subjects With Traumatic Brain Injury|Completed||Phase 1/Phase 2|52|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:12:54.572393|2017-10-11 03:12:54.572393
NCT01547767|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-06-30|||January 30, 2012||2012-01-30|June 9, 2017|2017-06-09||||||||Observational|||Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy|Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy|Active, not recruiting||N/A|2|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:54.689527|2017-10-11 03:12:54.689527
NCT01547754|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2017-06-30|||January 9, 2012||2012-01-09|August 25, 2014|2014-08-25|August 25, 2014||2014-08-25|||||Observational|||Mild Neurocognitive Disorder in HIV Infection of the Brain|Inflammation and Function of P-gp in HIV Infection of Brain|Terminated||N/A|8|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:12:54.793804|2017-10-11 03:12:54.793804
NCT01547741|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-06|2015-10-21|||April 2012||2012-04-01|October 2015|2015-10-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer|A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer|Active, not recruiting||Phase 3|1871|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-10-11 03:12:55.203799|2017-10-11 03:12:55.203799
NCT01547728|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-07-13|2015-04-21||February 2012||2012-02-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery|Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery|Terminated||Phase 4|42|Actual|Mayo Clinic|The study was terminated because there were too many barriers to enroll participants.|1||Too many barriers to enroll participants.|f||||f||||||||||2017-10-11 03:13:00.039248|2017-10-11 03:13:00.039248
NCT01546324|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2013-08-08|||February 2012||2012-02-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|May 2012|Actual|2012-05-01||Observational|||Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing|Prenatal Diagnosis of Fetal DNA Isolated From Maternal Plasma|Completed||N/A|16|Actual|Natera, Inc.|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 03:13:29.179007|2017-10-11 03:13:29.179007
NCT01547715|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-12-18|2014-12-18||March 2012||2012-03-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India|A Phase 3, Multi-center, Open-label Study to Evaluate Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) in Healthy Subjects From 2 to 75 Years of Age in India.|Completed||Phase 3|180|Actual|Novartis||3|||f||||f||||||||||2017-10-11 03:13:00.287413|2017-10-11 03:13:00.287413
NCT01547702|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-03-27|||February 2012||2012-02-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder|Randomized-controlled Trial of a Classroom-based Distance Intervention for Teachers of Elementary School-aged Children With ADHD|Completed||Phase 2|116|Actual|Dalhousie University||2|||f||||t||||||||||2017-10-11 03:13:02.674824|2017-10-11 03:13:02.674824
NCT01547689|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-02-18|||March 2012||2012-03-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|SEMAD||Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease|Open-Label, Single-Center, Self Control, Phase Ⅰ/Ⅱ Clinical Trial to Evaluate the Safety and the Efficacy of UC-MSC in Patients With Alzheimer's Disease|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Affiliated Hospital to Academy of Military Medical Sciences||1|||f||||t||||||||||2017-10-11 03:13:02.809836|2017-10-11 03:13:02.809836
NCT01547676|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2015-03-25|||December 2011||2011-12-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|||Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer|Prospective Randomized Comparison of Clamped Versus Unclamped Partial Nephrectomy|Terminated||N/A|28|Actual|University of Southern California||2||P.I. decided to terminate study due to multiple unresolved issues|f||||t||||||||||2017-10-11 03:13:02.899597|2017-10-11 03:13:02.899597
NCT01547663|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-04|2012-03-07|||March 2012||2012-03-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||A Comparison of Pain Scales in Patients With Disorder of Consciousness Following Craniotomy|A Comparison of Pain Scales in Patients With Disorder of Consciousness Following Craniotomy|Unknown status|Not yet recruiting|N/A|40|Anticipated|Mahidol University|||1||f||||f||||||||||2017-10-11 03:13:02.988202|2017-10-11 03:13:02.988202
NCT01547650|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-03-13|||February 2012||2012-02-01|March 2012|2012-03-01|February 2023|Anticipated|2023-02-01|February 2022|Anticipated|2022-02-01||Observational|||Evaluation of Plasma Volume Using Ultrasound in Disorders of Fluid With Sodium|Evaluation of Plasma Volume Using Ultrasound in Disorders of Fluid With Sodium|Active, not recruiting||N/A|42|Anticipated|Nagaoka Red Cross Hospital|||1||f||||f||||||None Retained|"     There is no biospeciment.   "|||2017-10-11 03:13:03.060839|2017-10-11 03:13:03.060839
NCT01547637|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-01-17|||May 2012||2012-05-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Preventing the Obturator Nerve Reflex|Preventing the Obturator Nerve Reflex: A Comparison of Ultrasound Guided Obturator Nerve Block and Classic Anatomic Block Technique.|Recruiting||N/A|45|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 03:13:03.135678|2017-10-11 03:13:03.135678
NCT01547624|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-03-10|||February 2011||2011-02-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Neck Muscle Activation in Patients With Long Standing Problems After a Whiplash Trauma Registered With Ultrasound With Speckle Tracking||Completed||N/A|60|Anticipated|Linkoeping University||3|||f||||t||||||||Undecided||2017-10-11 03:13:03.226192|2017-10-11 03:13:03.226192
NCT01547611|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-03-06|||January 2009||2009-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|||Outcome of Physiotherapy After Surgery for Cervical Disc Disease: a Prospective Multi-Centre Trial|Outcome of Physiotherapy After Surgery for Cervical Disc Disease: a Prospective Randomised Multi-Centre Trial|Active, not recruiting||N/A|200|Anticipated|Linkoeping University||2|||f||||t||||||||No||2017-10-11 03:13:03.333447|2017-10-11 03:13:03.333447
NCT01547598|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-07-28|2014-07-28||December 2011||2011-12-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction||Completed||Phase 4|135|Actual|Allergan||2|||f||||f||||||||||2017-10-11 03:13:03.471676|2017-10-11 03:13:03.471676
NCT01547572|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-07|||September 2010||2010-09-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Psychological Preparation for Colorectal Surgery: Impact of Video Education|Psychological Preparation for Colorectal Surgery: Impact of Video Education. A Randomised Trial|Completed||N/A|60|Actual|Ihedioha, Ugo, M.D.||2|||f||||t||||||||||2017-10-11 03:13:03.985285|2017-10-11 03:13:03.985285
NCT01547559|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-07|2014-10-20|||June 2007||2007-06-01|October 2014|2014-10-01||||November 2014|Anticipated|2014-11-01||Interventional|||Research for Prevention and Treatment of NSAIDs Related Gastrointestinal Side Effects|Evaluation of Preventive and Treatment Effects of Hp Eradication and Teprenone in Patients Taking NSAIDs|Unknown status|Active, not recruiting|N/A|369|Actual|Sun Yat-sen University||7|||f||||t||||||||||2017-10-11 03:13:04.074527|2017-10-11 03:13:04.074527
NCT01547546|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-05|2016-11-01|||April 2012||2012-04-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma|An Open-label, Phase I, Dose-escalation Study Evaluating the Safety and Tolerability of GDC-0084 Administered to Patients With Progressive or Recurrent High-grade Glioma|Completed||Phase 1|29|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:13:04.203326|2017-10-11 03:13:04.203326
NCT01547533|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-03-17|||August 2011||2011-08-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|LACTBENZ||Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease|Study of Benznidazole Transfer Into Breastmilk in Lactating Women Treated for Chagas Disease|Completed||N/A|10|Actual|Hospital de Niños R. Gutierrez de Buenos Aires|||1||f||||t||||||Samples Without DNA|"     breastmilk; plasma   "|||2017-10-11 03:13:04.282309|2017-10-11 03:13:04.282309
NCT01547507|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-05-29|||March 2012||2012-03-01|May 2012|2012-05-01||||December 2012|Anticipated|2012-12-01||Interventional|||Performance Evaluation of AirWay Medix Closed Suction System Compared With a Standard Closed Suction System|Performance Evaluation of AirWay Medix Closed Suction System Compared With a Standard Closed Suction System|Unknown status|Recruiting|N/A|26|Anticipated|Biovo Technologies Ltd||2|||f||||f||||||||||2017-10-11 03:13:04.547146|2017-10-11 03:13:04.547146
NCT01547494|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-05-13|||September 2011||2011-09-01|May 2013|2013-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Nutritional Intervention for Migraines|A Nutritional Intervention for Migraines|Completed||N/A|16|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-10-11 03:13:04.625772|2017-10-11 03:13:04.625772
NCT01547481|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-04-10|||December 2011||2011-12-01|April 2017|2017-04-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Observational|||MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.|Statistical Mapping of the Brain in Progressive Supranuclear Palsy, Essential Tremor, Parkinson Disease, Parkinsonism, and REM Behavior Disorder|Completed||N/A|50|Actual|University of Alabama at Birmingham|||6||f||||f||||||||Yes|Patient data has now been collated as a de-identified dataset, that can be shared if requested.|2017-10-11 03:13:04.708873|2017-10-11 03:13:04.708873
NCT01547468|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-03-14|||March 2012||2012-03-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||A Comparison of Two Pain Control Techniques on Deliruim in Hip Fracture Patients|Does Femoral Nerve Catheterization Reduce the Incidence of Post-Operative Delirium in Patients Presenting for Hip Fracture Repair?|Unknown status|Recruiting|N/A|270|Anticipated|Ochsner Health System||2|||f||||f||||||||||2017-10-11 03:13:04.796324|2017-10-11 03:13:04.796324
NCT01547455|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2013-07-24|||April 2012||2012-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficiency Study of Loading Dose Atorvastatin in Cardiac Surgery|Anti-inflammatory and Renoprotective Effect of Pretreatment Loading Dose Atorvastatin in CABG|Completed||N/A|96|Actual|Peking Union Medical College||2|||f||||t||||||||||2017-10-11 03:13:04.914381|2017-10-11 03:13:04.914381
NCT01547442|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2016-01-31|||January 2012||2012-01-01|January 2016|2016-01-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Artisan Aphakia Lens for the Correction of Aphakia in Children|Artisan Aphakia Lens for the Correction of Aphakia in Children|Recruiting||Phase 3|300|Anticipated|Ophtec USA||1|||f||||f||||||||||2017-10-11 03:13:05.023572|2017-10-11 03:13:05.023572
NCT01547429|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2016-01-31|||January 2012||2012-01-01|January 2016|2016-01-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Artisan Aphakia Lens for the Correction of Aphakia (Secondary) in Adults|Artisan Aphakia Lens for the Correction of Aphakia in Adults|Recruiting||Phase 3|300|Anticipated|Ophtec USA||1|||f||||f||||||||||2017-10-11 03:13:05.173441|2017-10-11 03:13:05.173441
NCT01547416|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-07-09|||November 2011||2011-11-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function|The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function After Robot-assisted Prostatectomy|Completed||Phase 4|50|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 03:13:05.275955|2017-10-11 03:13:05.275955
NCT01547403|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-01-14|||August 2012||2012-08-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|CUSTOM||Customer Support Response Study|Evaluation of Customer Support Issues, Questions, or Alleged Complaints Regarding Use of Approved Commercially Distributed Scout DS Product in the Field|Withdrawn||N/A|0|Actual|VeraLight, Inc.|||1|Protocol no longer meeting sponsor objectives|f||||f||||||||||2017-10-11 03:13:05.386382|2017-10-11 03:13:05.386382
NCT01547390|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-06-02|||March 2012||2012-03-01|June 2017|2017-06-01|July 20, 2015|Actual|2015-07-20|July 20, 2015|Actual|2015-07-20||Interventional|EPAPP||Early Prevention of Preeclampsia Study|Early Prediction and Aspirin for Prevention of Preeclampsia|Completed||N/A|104|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:13:05.483201|2017-10-11 03:13:05.483201
NCT01547377|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-03-02|||January 2008||2008-01-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|||Zinc and Selenium Supplementation in Atherosclerosis|Effect of Zinc and Selenium Supplementation in Patients With Atherosclerosis Treated With Statins|Completed||N/A|76|Actual|Universidade Federal do Rio Grande do Norte||2|||f||||f||||||||||2017-10-11 03:13:05.610585|2017-10-11 03:13:05.610585
NCT01547364|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-11-18|||February 2012||2012-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|October 2013|Actual|2013-10-01||Interventional|||Caudal Epidural Injection of Dextrose For Low Back Pain|Blinded Analgesic Effect and 1 Year Outcome of Caudal D5W Injection in All-Comers With Chronic Low Back Pain and Either Buttock or Leg Pain|Completed||Phase 2|35|Actual|Smigel, Liza, M.D.||2|||f||||t||||||||||2017-10-11 03:13:05.757911|2017-10-11 03:13:05.757911
NCT01547351|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-10-18|||December 2011||2011-12-01|October 2016|2016-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|ARMS||Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire|Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire - A Phase 4 Pilot Study|Completed||N/A|103|Actual|Mallinckrodt|||1||f||||||||||||||2017-10-11 03:13:05.871111|2017-10-11 03:13:05.871111
NCT01547338|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-04-13|||June 2012||2012-06-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Photography or Video in Assessing Breast Reconstruction?|Comparison of Static Photography and Real Time Digital Video in the Assessment of Aesthetic Outcomes Following Breast Reconstruction|Completed||N/A|35|Actual|NHS Greater Glasgow and Clyde|||1||f||||f||||||||||2017-10-11 03:13:05.9704|2017-10-11 03:13:05.9704
NCT01547325|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-03-09|||May 2012||2012-05-01|March 2017|2017-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds|Double-Blind, Single-Site, Pilot Study of NanoDOX Hydrogel Versus Placebo Hydrogel for Dehisced Surgical Wounds.|Withdrawn||N/A|0|Actual|NanoSHIFT LLC||2|||f||||f||||||||||2017-10-11 03:13:06.05487|2017-10-11 03:13:06.05487
NCT01547312|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-10-13|||May 2012||2012-05-01|October 2015|2015-10-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022)|A Randomized Clinical Trial Using Fine Needle Aspiration For Evaluation of Hepatic Pharmacokinetics of MK-5172 in Participants With Chronic Hepatitis C|Withdrawn||Phase 1|0|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-10-11 03:13:06.132454|2017-10-11 03:13:06.132454
NCT01547286|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-04-20|2015-05-08||May 2012||2012-05-01|April 2017|2017-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||7 Subjects were enrolled and 5 subjects completed the study. Demographics and metacholine challenge test were obtained from all 7 subjects.|Imaging Study of the Lungs During an Allergic Asthma Attack|Redistribution of Pulmonary Perfusion During Bronchoconstriction in Asthma|Completed||N/A|7|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:13:07.548565|2017-10-11 03:13:07.548565
NCT01547273|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-09-26|||March 2012||2012-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Bone Grafts on Facial Gingival Profile in Maxillary Anterior Single Tooth Replacement|The Effect of Bone and Connective Tissue Grafts on Facial Gingival Profile in Single Maxillary Anterior Immediate Implant Placement and Provisionalization: A 1-Year Prospective Study|Active, not recruiting||N/A|30|Anticipated|Loma Linda University||3|||f||||f||||||||||2017-10-11 03:13:07.767412|2017-10-11 03:13:07.767412
NCT01547260|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2014-11-26|||October 2009||2009-10-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|January 2014|Actual|2014-01-01||Interventional|LENAGEM||Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer|Phase I/II Study of Lenalidomide and Gemcitabine as First-line Treatment in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|34|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 03:13:07.973391|2017-10-11 03:13:07.973391
NCT01547247|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2015-10-04|2012-12-20||January 2012||2012-01-01|October 2015|2015-10-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Cap-assisted Water Immersion Versus Water Immersion Colonoscopy|Cap-assisted Water Immersion Versus Water Immersion Minimal Sedation Colonoscopy - a Prospective, Randomized, Single-center Trial|Completed||N/A|208|Actual|Vitkovice Hospital|There were no complications recorded in the study.|2|||f||||f||||||||||2017-10-11 03:13:08.089239|2017-10-11 03:13:08.089239
NCT01547234|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-06-26|||February 2013||2013-02-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis|Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis|Completed||N/A|47|Actual|Carmel Medical Center|||1||f||||f||||||||||2017-10-11 03:13:08.375217|2017-10-11 03:13:08.375217
NCT01547221|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-04-27|||March 2012||2012-03-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients|Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients: a Randomized Controlled Trial|Completed||N/A|120|Actual|Khon Kaen Hospital||2|||f||||t||||||||||2017-10-11 03:13:08.451782|2017-10-11 03:13:08.451782
NCT01547208|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-09-29|||September 2012||2012-09-01|September 2017|2017-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|PARTITA||Does Timing of VT Ablation Affect Prognosis in Patients With an Implantable Cardioverter-defibrillator?||Recruiting||N/A|590|Anticipated|IRCCS San Raffaele||2|||f||||f||||||||||2017-10-11 03:13:08.553737|2017-10-11 03:13:08.553737
NCT01547195|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-03-28|||January 2012||2012-01-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|January 2012|Actual|2012-01-01||Interventional|ESTF||Effects of Swimming in the Treatment of Fibromyalgia|Assessment of the Effects of Swimming in the Treatment of Patients With Fibromyalgia.|Unknown status|Recruiting|Phase 1|75|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:13:08.780947|2017-10-11 03:13:08.780947
NCT01547182|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-03-21|||March 2012||2012-03-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|CLIP-II||Cooperative Lifestyle Programs (CLIP-II)|Cooperative Lifestyle Programs (CLIP-II)|Completed||N/A|249|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||No||2017-10-11 03:13:08.895641|2017-10-11 03:13:08.895641
NCT01547169|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-12-17|||March 2011||2011-03-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SNIFF-LONG 21||Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days|Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days|Completed||Phase 2|60|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 03:13:08.996566|2017-10-11 03:13:08.996566
NCT01547156|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-03-09|||May 2011||2011-05-01|March 2016|2016-03-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Mobile Sipoo - Telemonitoring With Combined With Active Assistance Technology|Mobile Sipoo a Randomized Controlled Trial|Completed||N/A|56|Actual|VTT Technical Research Centre of Finland||2|||f||||f||||||||||2017-10-11 03:13:09.106143|2017-10-11 03:13:09.106143
NCT01547143|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-05-22|||March 2012||2012-03-01|May 2016|2016-05-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|HELA2012||Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis|Pilot Study of First-line Immunosuppressive Therapy Combined With Etoposide and Allogeneic Hematopoietic Cell Transplantation in Refractory/Reactivated Cases for Hemophagocytic Lymphohistiocytosis (HLH) in Adult Patients|Terminated||N/A|12|Actual|Asan Medical Center||1||"The PI resigned the institute, and the rest investigators at the institute decided to terminate   the study."|f||||f||||||||||2017-10-11 03:13:09.225026|2017-10-11 03:13:09.225026
NCT01546948|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2017-04-11|||August 2011||2011-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Intraoperative Opioids and Postoperative Recovery After Hepatobiliary or Foregut Surgery|Intraoperative Opioids and Postoperative Recovery After Hepatobiliary or Foregut Surgery|Active, not recruiting||Phase 4|60|Anticipated|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||||2017-10-11 03:13:11.693739|2017-10-11 03:13:11.693739
NCT01547130|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2015-02-17|2015-01-17||May 2008||2008-05-01|February 2015|2015-02-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Yoga and Bolus Lukewarm Saline as Rapid Colonoscopy Preparation|A Single Blind, Parallel Group, Randomized Controlled Trial Comparing Solution PEG Based Colon Preparation (HalfLytely) Versus Bolus Luke Warm Saline (Shudh) and Yoga Exercise for Large Bowel Cleansing Prior to Colonoscopy|Completed||Phase 1/Phase 2|133|Actual|Arya, Vijaypal, M.D., P.C.|Shudh Colon Cleanse (SCC) is suitable to only 30% of patients who are undergoing colonoscopy. A multi-center study is warranted to confirm these results.|2|||f||||t||||||||||2017-10-11 03:13:09.376413|2017-10-11 03:13:09.376413
NCT01547117|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-04-03|||March 2012||2012-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Dietary Salt in Postural Tachycardia Syndrome|Dietary Salt in Postural Tachycardia Syndrome|Active, not recruiting||N/A|30|Anticipated|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 03:13:09.760348|2017-10-11 03:13:09.760348
NCT01547104|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-04-10|||April 2012||2012-04-01|April 2012|2012-04-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus|Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus|Unknown status|Recruiting|Phase 4|40|Anticipated|ikfe-CRO GmbH||2|||f||||f||||||||||2017-10-11 03:13:09.866667|2017-10-11 03:13:09.866667
NCT01547078|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2015-03-17|||January 2015||2015-01-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Clinical Study of Lyophilized Plasma in Patients With Liver Disease|A Phase 2 Clinical Study of Lyophilized Plasma in Patients With Acquired Coagulopathy Due to Liver Disease|Withdrawn||Phase 2|0|Actual|HemCon Medical Technologies, Inc||2|||f||||t||||||||||2017-10-11 03:13:10.135756|2017-10-11 03:13:10.135756
NCT01547065|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2015-04-23|||August 2011||2011-08-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Use of Transesophageal Echocardiography to Measure Intraoperative Renal Resistive Index and Predict Acute Renal Injury|Use of Transesophageal Echocardiography to Measure Intraoperative Renal Resistive Index and Predict Acute Renal Injury|Terminated||N/A|13|Actual|Rutgers, The State University of New Jersey|||1|Enrollment lower than anticipated|f||||f||||||||||2017-10-11 03:13:10.215512|2017-10-11 03:13:10.215512
NCT01547039|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-08|||June 2012||2012-06-01|March 2012|2012-03-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Observational|||Platelet Reactivity and MES During CEA|Platelet Reactivity Testing in Association With Perioperative Microembolic Signals During Carotid Endarterectomy|Unknown status|Not yet recruiting|N/A|200|Anticipated|UMC Utrecht|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 03:13:10.394963|2017-10-11 03:13:10.394963
NCT01547026|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2013-02-12|||April 2012||2012-04-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients|Self-regulation Strategies to Improve Exercise Behavior: A Randomized Clinical Trial in Persons With Schizophrenia Spectrum Disorders|Completed||N/A|42|Actual|University of Konstanz||1|||f||||f||||||||||2017-10-11 03:13:10.471756|2017-10-11 03:13:10.471756
NCT01547000|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-01-23|||April 2012||2012-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Guanfacine in Children With Tic Disorders|Guanfacine in Children With Tic Disorders: A Multi-site Study|Completed||Phase 4|34|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:13:10.629595|2017-10-11 03:13:10.629595
NCT01546987|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2017-05-18|||May 2012|Actual|2012-05-01|May 2017|2017-05-01||||June 2020|Anticipated|2020-06-01||Interventional|||Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer|Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) With a GNRH Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT With a GNRH Agonist and TAK-700 For Men With High Risk Prostate Cancer|Active, not recruiting||Phase 3|239|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 03:13:10.793019|2017-10-11 03:13:10.793019
NCT01546974|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2012-03-06|||November 2011||2011-11-01|January 2012|2012-01-01|February 2014|Anticipated|2014-02-01|November 2013|Anticipated|2013-11-01||Interventional|||Ventilator-associated Pneumonia (VAP) and Humidification System|Prospective Analysis of the Incidence of Ventilator-associated Pneumonia Related to the Humidification System: Heat and Moisture Exchanger Versus Heated Humidification|Unknown status|Recruiting|Phase 4|306|Anticipated|Hospital Sao Domingos||2|||f||||t||||||||||2017-10-11 03:13:11.49258|2017-10-11 03:13:11.49258
NCT01546961|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-01-04|||June 2011||2011-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KCP||Chloroquine Population Pharmacokinetics in Pre and Post-partum Women|The Population Pharmacokinetics of Chloroquine for the Treatment of Uncomplicated P.Vivax Malaria in Pre- and Post-partum Women.|Recruiting||N/A|160|Anticipated|University of Oxford||1|||f||||f||||||||||2017-10-11 03:13:11.583798|2017-10-11 03:13:11.583798
NCT01546935|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-07-26|||December 2012||2012-12-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One|SEA022 Oseltamivir Treatment in Children Under One Year of Age With Moderate or Severe Influenza Lower Respiratory Tract Infection - a Clinical and Pharmacokinetic Study.|Withdrawn||Phase 2/Phase 3|0|Actual|University of Oxford||1||Study drugs (Oseltamivir suspension from Roche) were unavailable|f||||t||||||||||2017-10-11 03:13:11.799148|2017-10-11 03:13:11.799148
NCT01546922|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2014-06-10|2014-04-25||February 2012||2012-02-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|SUPREME CORT|The 47 participants completing both study periods were used for further analysis.|Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)|A Randomized Double Blind Cross-over Study of the Effects of Low Dose and High Dose Hydrocortisone Replacement Therapy on Cognition, Quality of Life, Metabolic Profile and Somatosensation in Patients With Secondary Adrenal Insufficiency|Completed||Phase 4|63|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 03:13:11.961675|2017-10-11 03:13:11.961675
NCT01546909|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-09-08|||February 2012|Actual|2012-02-01|September 2017|2017-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE|Antibody Persistence in 11 to 13-year-old Children Previously Vaccinated at 6 Years Old With Either REVAXIS or DT Polio, and Immune Response to a Booster Dose of TETRAVAC-ACELLULAIRE|Completed||Phase 4|278|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:13:12.717509|2017-10-11 03:13:12.717509
NCT01546896|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2015-05-19|||March 2012||2012-03-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder||Withdrawn||Phase 4|0|Actual|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 03:13:12.899049|2017-10-11 03:13:12.899049
NCT01546883|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-09-10|2015-08-11||February 2012||2012-02-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|DEPAF||Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation|Dabigatran-related Effect on Progression of Atrial Fibrosis in Patients With Atrial Fibrillation|Terminated||Phase 4|14|Actual|University of Utah||1||Not enough patients in time period allotted for study|f||||t||||||||||2017-10-11 03:13:12.995498|2017-10-11 03:13:12.995498
NCT01546870|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-03|2016-06-16|||April 2012||2012-04-01|June 2016|2016-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|CAS-POHT||Coronary Artery Study in Pediatric Heart Transplantation||Withdrawn||N/A|0|Actual|Arkansas Children's Hospital Research Institute|||1|never approved by IRB|f||||f||||||||||2017-10-11 03:13:13.173985|2017-10-11 03:13:13.173985
NCT01546844|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-09-04|||March 2012||2012-03-01|September 2012|2012-09-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|Care4Life||Mobile Health Technology as an Intervention for Diabetes Self-Management|Use of Mobile Health Technology as an Intervention for Type II Diabetes Self-Management|Unknown status|Enrolling by invitation|N/A|500|Anticipated|HealthInsight||2|||f||||f||||||||||2017-10-11 03:13:13.336208|2017-10-11 03:13:13.336208
NCT01546831|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-10-12|||August 2011||2011-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:13:13.507422|2017-10-11 03:13:13.507422
NCT01546818|ClinicalTrials.gov processed this data on October 10, 2017|2009-06-09|2013-09-05|||March 2012||2012-03-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients|A Phase I, Randomized, Observer-blinded, Placebo-controlled Clinical Study to Assess the Safety, Tolerability, and Immune Response of Killed-Whole HIV-1 Vaccine (SAV001-H) Administered Intramuscularly to Chronic HIV-1 Infected Patients Currently Under Treatment With Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1|33|Actual|Sumagen||1|||f||||f||||||||||2017-10-11 03:13:13.548662|2017-10-11 03:13:13.548662
NCT01546805|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-03-01|||April 2012||2012-04-01|March 2012|2012-03-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm|The Effect of Zinc Supplementation on the Efficacy and Duration of Botulinum Toxin for the Treatment of Oculofacial Spasm Disorders|Unknown status|Not yet recruiting|N/A|40|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-11 03:13:13.636185|2017-10-11 03:13:13.636185
NCT01546792|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-01|||January 2010||2010-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Lifestyle Intervention in Obstructive Sleep Apnoea|Effects of a Lifestyle Intervention on Quality of Life, Weight Loss and Cardiovascular Risk in Patients With Obstructive Sleep Apnoea Established on Continuous Positive Airway Pressure|Completed||Phase 2/Phase 3|60|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 03:13:13.741072|2017-10-11 03:13:13.741072
NCT01546779|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2012-03-01|||December 2008||2008-12-01|March 2012|2012-03-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||The Use of Visual Feedback in Airway Clearance|"The Immediate Effect of Resistive Expiration Via Volumetric Incentive Spirometer on Lung Function in Patients With Cystic Fibrosis."|Completed||N/A|40|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 03:13:13.860354|2017-10-11 03:13:13.860354
NCT01546766|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-11-16|||February 2007||2007-02-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)|Developing a Non-invasive Method and Device for Assessing the Degree of Midperipheral Retinal Ischemia in Diabetic Retinopathy.|Recruiting||N/A|315|Anticipated|University of California, Los Angeles|||3||f||||f||||||||||2017-10-11 03:13:13.936355|2017-10-11 03:13:13.936355
NCT01546753|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-06-28|||April 2012||2012-04-01|June 2017|2017-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|WOIT||Walnut Oral Immunotherapy for Tree Nut Allergy|Walnut Oral Immunotherapy for Tree Nut Allergy|Active, not recruiting||Phase 1/Phase 2|15|Anticipated|University of Arkansas||2|||f||||t||||||||||2017-10-11 03:13:14.04827|2017-10-11 03:13:14.04827
NCT01546714|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-02-06|||August 2011||2011-08-01|February 2017|2017-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|WSHP||Sexually Transmitted Infections Among African American Women Who Have Sex With Women|Sexually Transmitted Infections Among African American Women Who Have Sex With Women|Completed||N/A|165|Actual|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"     One vaginal swab and one endocervical swab to be stored for future studies.   "|Yes|De-identified data will be shared with investigators at the Harvard School of Public Health for secondary data analysis.|2017-10-11 03:13:14.324187|2017-10-11 03:13:14.324187
NCT01546701|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-12-06|||March 2011||2011-03-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Buprenorphine in Acute Renal Colic Pain Management||Completed||Phase 4|80|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:13:14.399827|2017-10-11 03:13:14.399827
NCT01546688|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-01-06|2012-11-12||November 2008||2008-11-01|November 2015|2015-11-01|August 2011|Actual|2011-08-01|November 2010|Actual|2010-11-01||Interventional|||A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures|A Randomised, Double Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability and to Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures|Terminated||Phase 4|41|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 03:13:14.488776|2017-10-11 03:13:14.488776
NCT01546675|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-11-17|2014-10-17||January 2012||2012-01-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional||Cross-over design. Each subject participated under each condition. Total of 2 subjects.|Interface Kinematics of Transhumeral Prosthetic Sockets Using XROMM|Interface Kinematics of Transhumeral Prosthetic Sockets Using XROMM|Completed||N/A|2|Actual|VA Office of Research and Development|These results cannot be generalized outside of this small sample and may have been different if the intervention socket had been optimized. Additional research is needed to expand our understanding of the impact of prosthetic socket designs.|2|||f||||f||||||||||2017-10-11 03:13:14.9908|2017-10-11 03:13:14.9908
NCT01546662|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-02|||October 2011||2011-10-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|May 2012|Anticipated|2012-05-01||Interventional|EB-RH-02-11||A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.|A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.|Unknown status|Recruiting|N/A|54|Anticipated|Enovate Biolife Pvt Ltd||3|||f||||f||||||||||2017-10-11 03:13:15.732884|2017-10-11 03:13:15.732884
NCT01546649|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-10-22|2015-10-22||April 2012||2012-04-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Full analysis set (FAS) included all randomized participants who had received at least a single dose of study treatment.|A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer||Completed||Phase 3|167|Actual|Takeda||2|||f||||||||||||||2017-10-11 03:13:15.899086|2017-10-11 03:13:15.899086
NCT01546636|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2015-03-11|2013-07-16||November 2010||2010-11-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||The number of participants was determined by performing a sample size calculation.|The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position|The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position|Completed||Phase 4|70|Actual|NorthShore University HealthSystem Research Institute|There were no technical limitations to the trial|2|||f||||f||||||||||2017-10-11 03:13:18.32103|2017-10-11 03:13:18.32103
NCT01546623|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-06-24|2015-04-02||March 2012||2012-03-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||The population included all participants who were randomized to treatment.|A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy|A Phase 3, Multi-center, Randomized, Open-label, Parallel-group, Comparative Study of TAP-144-SR (3M) to Evaluate Hormone Dynamics, Pharmacokinetics, Safety and Efficacy of TAP-144-SR (6M) 22.5 mg Subcutaneous Injection for 48 Weeks in Prostate Cancer Patients Previously Treated With Hormonal Therapy|Completed||Phase 3|160|Actual|Takeda||2|||f||||f||||||||||2017-10-11 03:13:18.65946|2017-10-11 03:13:18.65946
NCT01546610|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-08|||November 2011||2011-11-01|March 2012|2012-03-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Rheumatoid Foot Insole|Effect of Rheumatoid Foot Insole|Unknown status|Recruiting|N/A|80|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:13:21.644571|2017-10-11 03:13:21.644571
NCT01546597|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-07-09|||February 2012||2012-02-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine|A Phase 1, Open-Label, Single Cohort, Four-period Sequential Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|24|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 03:13:21.78583|2017-10-11 03:13:21.78583
NCT01545479|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-03-01|||January 2010||2010-01-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Increased Renal Oxygenation and Angiotensin Converting Enzyme Inhibition|Renal Oxygen Content is Increased in Healthy Subjects After Angiotensin Converting Enzyme Inhibition|Completed||Phase 4|5|Actual|Instituto de Cardiologia do Rio Grande do Sul||1|||f||||f||||||||||2017-10-11 03:13:21.89032|2017-10-11 03:13:21.89032
NCT01545453|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-11-01||2016-08-09|March 2012||2012-03-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication|Completed||Phase 2|205|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 03:13:22.067134|2017-10-11 03:13:22.067134
NCT01545440|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-03-03|||March 2012||2012-03-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication|Completed||Phase 2|258|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 03:13:22.324527|2017-10-11 03:13:22.324527
NCT01545427|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-06|||April 2008||2008-04-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma|A Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma|Terminated||Phase 2|10|Actual|Lawson Health Research Institute||2||Frequent adverse events occurred early in treatment with poor tolerability.|f||||t||||||||||2017-10-11 03:13:22.786161|2017-10-11 03:13:22.786161
NCT01545414|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-02-12|||February 2012||2012-02-01|February 2015|2015-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease|Internet-based CBT for Depression and Anxiety in Parkinson's Disease: a Pilot Study and Randomized Controlled Trial|Completed||Phase 3|150|Anticipated|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 03:13:22.918692|2017-10-11 03:13:22.918692
NCT01545401|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-09-18|||January 2012||2012-01-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Empowering Primary Care Providers and Patients to Improve Chronic Disease Outcomes: The EMPOWER Participatory Action Research (EMPOWER - PAR)|Empowering Primary Care Providers and Patients to Improve Chronic Disease Outcomes: The EMPOWER Participatory Action Research (EMPOWER - PAR)|Completed||Early Phase 1|1545|Actual|Ministry of Health, Malaysia||2|||f||||t||||||||||2017-10-11 03:13:23.023484|2017-10-11 03:13:23.023484
NCT01545388|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-03-24|2014-02-10||February 23, 2012|Actual|2012-02-23|March 2017|2017-03-01|March 12, 2013|Actual|2013-03-12|March 12, 2013|Actual|2013-03-12||Interventional||All participants as treated population defined as all randomized participants.|Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)|A Phase III, Randomized, Placebo and Active-Controlled, Double-Blind Clinical Trial to Study the Efficacy and Safety of the Addition of Metformin in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy and Sitagliptin Monotherapy|Completed||Phase 3|337|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:13:23.128672|2017-10-11 03:13:23.128672
NCT01545375|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-08-11|2017-07-11||May 21, 2012|Actual|2012-05-21|July 2017|2017-07-01|July 26, 2016|Actual|2016-07-26|July 26, 2016|Actual|2016-07-26||Interventional|||Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children|Study to Determine Protective Efficacy Against Otitis Media and Assess Safety of an Investigational Pneumococcal Vaccine 2189242A in Healthy Infants|Completed||Phase 2|1806|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 03:13:23.664014|2017-10-11 03:13:23.664014
NCT01545362|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-01-11|||November 2011||2011-11-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Arthroplasty|The Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Replacements Performed Within One Week|Completed||N/A|50|Actual|Heekin Orthopedic Research Institute|||1||f||||f||||||||||2017-10-11 03:13:25.488108|2017-10-11 03:13:25.488108
NCT01545349|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-01-10|||February 2012||2012-02-01|January 2017|2017-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|LAIV||Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine|Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine|Completed||Phase 1|30|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:13:25.577953|2017-10-11 03:13:25.577953
NCT01546584|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-10-12|||October 2011||2011-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:13:25.698583|2017-10-11 03:13:25.698583
NCT01546571|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2017-09-06|||April 2012|Actual|2012-04-01|September 2017|2017-09-01|June 30, 2019|Anticipated|2019-06-30|January 1, 2019|Anticipated|2019-01-01||Interventional|MAVIS||Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients|A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients With a High Risk of Recurrence|Active, not recruiting||Phase 3|1059|Anticipated|Polynoma LLC||2|||f||||f||||||||||2017-10-11 03:13:25.767629|2017-10-11 03:13:25.767629
NCT01546558|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-07-09|||February 2012||2012-02-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg|A Phase 1, Open-label, Single Cohort, Two-Period Fixed Sequence Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Twice Daily in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|25|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 03:13:25.993011|2017-10-11 03:13:25.993011
NCT01546532|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2015-05-20||2015-05-20|February 2012||2012-02-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)|A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Renal Hemodynamic Effects of RLX030 and Placebo Infused for 24 Hours in Subjects With Chronic Heart Failure (CHF)|Completed||Phase 2|118|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:13:26.158648|2017-10-11 03:13:26.158648
NCT01546311|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-02|||January 2012||2012-01-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Observational|PADS||Evaluation of a Pro-Active Dynamic Accommodating Socket||Unknown status|Recruiting|N/A|5|Anticipated|Infoscitex Corporation|||1||f||||||||||||||2017-10-11 03:13:29.372347|2017-10-11 03:13:29.372347
NCT01546519|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-04-14|2015-10-13||March 2012||2012-03-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function|A Phase Ib Open-Label Pharmacokinetics and Safety Study of the Hedgehog Pathway Inhibitor Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic Function|Completed||Phase 1|31|Actual|Genentech, Inc.||5|||f||||f||||||||||2017-10-11 03:13:26.303044|2017-10-11 03:13:26.303044
NCT01546506|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2015-01-07|||February 2012||2012-02-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|FLUMED||Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells|Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells|Completed||Phase 2|79|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 03:13:27.613997|2017-10-11 03:13:27.613997
NCT01546493|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-19|2016-08-04|||September 2010||2010-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2015|Actual|2015-09-01||Interventional|||Hip Impingement - Understanding Cartilage Damage|Femoroacetabular Impingement: Correlating Hip Morphology to Changes in Cartilage and Subchondral Bone|Active, not recruiting||N/A|75|Anticipated|Ottawa Hospital Research Institute||3|||f||||f||||||||||2017-10-11 03:13:27.784405|2017-10-11 03:13:27.784405
NCT01546480|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2014-06-16|||November 2011||2011-11-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||From Acute to Chronic Postoperative Pain in Patients for Elective Cholecystectomy. Immunological Tests|From Acute to Chronic Postoperative Pain in Patients for Elective Cholecystectomy. Immunological Tests|Completed||N/A|18|Actual|Odense University Hospital|||3||f||||f||||||Samples With DNA|"     Whole blood Serum Plasma Cerebrospinal fluid Saliva   "|||2017-10-11 03:13:27.889708|2017-10-11 03:13:27.889708
NCT01546467|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-03-01|||September 2009||2009-09-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Cognitive Remediation in Early Phase Psychosis|Cognitive Remediation in Early Phase Psychosis|Unknown status|Recruiting|N/A|50|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 03:13:27.970295|2017-10-11 03:13:27.970295
NCT01546454|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2017-02-17|2014-04-11||February 2012||2012-02-01|February 2017|2017-02-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional||Healthy premenopausal women from the Portland, OR metro area|Relationship Between the Menstrual Cycle and Heart Disease in Women|Identification of the Menstrual Cycle-Associated Factors That Modulate Circulating Lipid Levels in Premenopausal Women|Completed||N/A|5|Actual|Oregon Health and Science University||3|||f||||f||||||||||2017-10-11 03:13:28.06376|2017-10-11 03:13:28.06376
NCT01546441|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-06|||April 2012||2012-04-01|March 2012|2012-03-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||IMPACT Plus: The Integrated Complex Care Clinic|IMPACT Plus: The Integrated Complex Care Clinic|Unknown status|Not yet recruiting|N/A|350|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 03:13:28.276178|2017-10-11 03:13:28.276178
NCT01546428|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2016-06-17|||February 2012||2012-02-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors|A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors|Completed||Phase 1|44|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:13:28.359913|2017-10-11 03:13:28.359913
NCT01546415|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-10-27|||October 2011||2011-10-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia|A Single Arm, Multicenter, Open Label Study of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia|Completed||Phase 4|64|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:13:28.432149|2017-10-11 03:13:28.432149
NCT01546402|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2014-06-17|2014-04-15||May 2011||2011-05-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema|Intraoperative Dexamethasone Implant (Ozurdex®) Improves Outcome of Cataract Surgery in Patients With Diabetic Macular Edema|Completed||Phase 4|20|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 03:13:28.528847|2017-10-11 03:13:28.528847
NCT01546389|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2013-09-12|||April 2012||2012-04-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Sanaria™ PfSPZ Challenge Vaccine|A Phase I, Randomized Malaria Challenge Study of Intradermally-Administered Infectious (Replication-intact), Cryopreserved Plasmodium Falciparum Sporozoites (PfSPZ Challenge) in Malaria-Naïve Adults|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-10-11 03:13:28.741794|2017-10-11 03:13:28.741794
NCT01546376|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-06|||August 2009||2009-08-01|January 2009|2009-01-01||||||||Observational|||Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients|Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients|Unknown status|Recruiting|N/A|100|Anticipated|Rajavithi Hospital|||1||f||||f||||||||||2017-10-11 03:13:28.840981|2017-10-11 03:13:28.840981
NCT01546363|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-05-05|||February 2012||2012-02-01|May 2017|2017-05-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2019|Anticipated|2019-01-01||Observational|||Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer|Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer|Recruiting||N/A|100|Anticipated|Stanford University|||2||f||||t||||||Samples With DNA|"     Blood Tissue   "|||2017-10-11 03:13:28.90736|2017-10-11 03:13:28.90736
NCT01546350|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2013-08-20|||March 2012||2012-03-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH|Comparison of Standard ART Practice vs. Trophectoderm Biopsy, Array CGH Analysis, and Day-6 Replacement of a Single Euploid Embryo|Suspended||Phase 2|200|Anticipated|Reprogenetics||2||not enough patients recruited on time|f||||t||||||||||2017-10-11 03:13:28.99045|2017-10-11 03:13:28.99045
NCT01546337|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-06|||May 2008||2008-05-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Observational|EPO||Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome|Search for Predictive Markers of Efficacy of Epoetin Beta (NEORECORMON) in the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Chemotherapy or Myelodysplastic Syndrome|Terminated||N/A|30|Actual|Rennes University Hospital|||1||f||||f||||||||||2017-10-11 03:13:29.105416|2017-10-11 03:13:29.105416
NCT01546298|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2017-06-06|||January 2012||2012-01-01|June 2017|2017-06-01|November 2026|Anticipated|2026-11-01|November 2026|Anticipated|2026-11-01||Observational|||Immune Reactions in Contact Dermatitis Affected Skin|Analysis of Immune Reactions Occurring Upon Administration of Patch Tests and Contact Dermatitis Affected Skin|Enrolling by invitation||N/A|120|Anticipated|Rockefeller University|||1||f||||f||||||Samples With DNA|"     Patch tests of skin   "|Undecided||2017-10-11 03:13:29.473282|2017-10-11 03:13:29.473282
NCT01546285|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-05-02|2013-01-16||March 2012||2012-03-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||B40 Non-Invasive Blood Pressure Equivalency Study|B40 Non-Invasive Blood Pressure Equivalency Study|Completed||N/A|66|Actual|GE Healthcare||1|||f||||f||||||||||2017-10-11 03:13:29.564829|2017-10-11 03:13:29.564829
NCT01546272|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-03-07|||March 2012||2012-03-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|May 2014|Actual|2014-05-01||Interventional|S2CARA||Medico-economic Evaluation of Subcutaneous Automatic Resorbable Staples Device|Medico-economic Evaluation of Subcutaneous Automatic Resorbable Staples Device|Completed||Phase 3|664|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 03:13:29.799423|2017-10-11 03:13:29.799423
NCT01546259|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-03-24|||November 2011||2011-11-01|March 2016|2016-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Water Method in Low-body Mass Index (BMI) Female Patients With Unsedated Colonoscopy|Water Method With Water Exchange Versus Air Insufflation in Low-BMI Female Patients Undergoing Unsedated Colonoscopy: a Prospective Randomized, Controlled Trial|Withdrawn||N/A|0|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 03:13:29.951977|2017-10-11 03:13:29.951977
NCT01546246|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-03-24|||November 2011||2011-11-01|March 2016|2016-03-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Water Method in Patients With Incomplete Colonoscopy|Water Method With Water Exchange Versus Air Insufflation in Patients With Incomplete Colonoscopy: a Prospective Randomized, Controlled Trial|Withdrawn||N/A|0|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 03:13:30.081138|2017-10-11 03:13:30.081138
NCT01546233|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-07-04|||March 2012||2012-03-01|March 2012|2012-03-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|||Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment|Outcome of Multidisciplinary Education Programme in Self-care in Fatigue Lung Cancer Patients Who Receiving Chemotherapy Treatment|Completed||N/A|60|Actual|Rajavithi Hospital|||2||f||||f||||||||Yes|๋Journal of the medical association of Thailand|2017-10-11 03:13:30.207724|2017-10-11 03:13:30.207724
NCT01546220|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-03-24|||November 2011||2011-11-01|March 2016|2016-03-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Water Method in Elder Patients With Unsedated Colonoscopy|Water Method With Water Exchange Versus Air Insufflation in Elder Patients Undergoing Unsedated Colonoscopy: a Prospective Randomized, Controlled Trial|Withdrawn||N/A|0|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 03:13:30.343836|2017-10-11 03:13:30.343836
NCT01546207|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-06-28|2013-08-20||September 2011||2011-09-01|June 2016|2016-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|STRATUM VT||Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia|Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia|Terminated||N/A|4|Actual|Icahn School of Medicine at Mount Sinai|Early termination due to poor enrollment. Data analysis not done - there is not enough data for meaningful analysis.|1||low enrollment|f||||t||||||||No||2017-10-11 03:13:30.462961|2017-10-11 03:13:30.462961
NCT01546194|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-03-30|2015-08-26||September 2009||2009-09-01|March 2016|2016-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||A Survey of Patient's Attitudes Towards Consent For Clinical Research In Anesthesiology|A Survey of Patient's Attitudes Towards Consent For Clinical Research In Anesthesiology|Completed||N/A|200|Actual|NorthShore University HealthSystem Research Institute|||2||f||||f||||||||||2017-10-11 03:13:30.757931|2017-10-11 03:13:30.757931
NCT01546181|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-02-23|||October 2010||2010-10-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|iPhot||Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases|Observational, Follow-up Study of Adaptive Optics Retinal Imaging in Controls and During Retinal or General Diseases|Recruiting||N/A|300|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||8||f||||t||||||||||2017-10-11 03:13:30.95442|2017-10-11 03:13:30.95442
NCT01546155|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-02-27|2017-01-06||December 2011||2011-12-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|October 2012|Actual|2012-10-01||Interventional|||The Influence of Pressure Pain on [11C]Diprenorphine Binding Potentials|The Influence of Pressure Pain on [11C]Diprenorphine Binding Potentials|Completed||N/A|11|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:13:31.15234|2017-10-11 03:13:31.15234
NCT01546142|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2015-05-28|2015-05-28|2014-05-30|March 2012||2012-03-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional||Intention-to-treat population|Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area|Completed||Phase 3|516|Actual|Kythera Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 03:13:31.365783|2017-10-11 03:13:31.365783
NCT01546129|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-06|||April 2012||2012-04-01|January 2012|2012-01-01||||December 2012|Anticipated|2012-12-01||Interventional|||Effect of Dianatal Obstetric Gel (Cross-linked Polyacrylic Acid) on Outcomes in Vaginal Delivery|Effect of Dianatal Obstetric Gel (Cross-linked Polyacrylic Acid) on Outcomes in Vaginal Delivery|Unknown status|Not yet recruiting|Phase 3|180|Anticipated|Rabin Medical Center||2|||f||||||||||||||2017-10-11 03:13:32.254608|2017-10-11 03:13:32.254608
NCT01546116|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-02-14|||February 2010||2010-02-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2012|Actual|2012-02-01||Interventional|ALTER||Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)|Efficacy of Adefovir and Lamivudine Combination Therapy in Patients With Entecavir Resistance|Completed||Phase 4|20|Actual|Korea University||1|||f||||t||||||||||2017-10-11 03:13:32.356327|2017-10-11 03:13:32.356327
NCT01546103|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-01-22|||August 2011||2011-08-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Vitamin D3 Supplementation Pilot Study|Pilot Study of Vitamin D3 Supplementation and Outcomes in Vitamin D Deficient Obese, African American Adolescents|Completed||N/A|39|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 03:13:32.500563|2017-10-11 03:13:32.500563
NCT01546090|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-06|||March 2011||2011-03-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Alprazolam on the Success of Inferior Alveolar Nerve (IAN) Block|Effect of Preoperative Alprazolam on the Success of Inferior Alveolar Nerve Block for Teeth With Irreversible Pulpitis|Completed||Phase 4|60|Actual|Isfahan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:13:32.654852|2017-10-11 03:13:32.654852
NCT01546077|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-11-09|||January 2012||2012-01-01|November 2012|2012-11-01||||March 2013|Anticipated|2013-03-01||Interventional|||Placement of Perineural Catheters in the Popliteal Region|Comparison of Techniques for Placement of Perineural Catheters in the Popliteal Region|Unknown status|Recruiting|Phase 4|40|Anticipated|Attikon Hospital||2|||f||||||||||||||2017-10-11 03:13:32.80588|2017-10-11 03:13:32.80588
NCT01546064|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2012-03-01|||May 2008||2008-05-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Interventional|||Study to Establish Whether the Use of T-Tube in Bile Duct Anastomosis in Liver Transplantation Decreases Morbidity|Prospective and Randomized Trial on the Usefulness of T-Tube in the Bile Duct Anastomosis in Liver Transplantation Procedure.|Completed||N/A|200|Actual|Hospital Universitario La Fe||2|||f||||f||||||||||2017-10-11 03:13:32.930788|2017-10-11 03:13:32.930788
NCT01546051|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-03-06|||October 2011||2011-10-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetic and Food Effect of BCI-838; and, An Open-Label Minidose Bioavailability Study to Compare Several BCI-632 Pro-drug Candidates in Healthy Male Subjects|Completed||Phase 1|31|Actual|BrainCells Inc.||4|||f||||f||||||||||2017-10-11 03:13:33.058232|2017-10-11 03:13:33.058232
NCT01546038|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-09-28|||June 27, 2012|Actual|2012-06-27|September 2017|2017-09-01|October 17, 2019|Anticipated|2019-10-17|January 3, 2017|Actual|2017-01-03||Interventional|||A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome|A Phase 1b/2 Study To Evaluate The Safety And Efficacy Of Pf-04449913, An Oral Hedgehog Inhibitor, In Combination With Intensive Chemotherapy, Low Dose Ara-c Or Decitabine In Patients With Acute Myeloid Leukemia Or High-risk Myelodysplastic Syndrome|Active, not recruiting||Phase 2|255|Actual|Pfizer||5|||f||||t||||||||||2017-10-11 03:13:33.172196|2017-10-11 03:13:33.172196
NCT01546025|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-03-02|||June 2010||2010-06-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Brief Alcohol Intervention for School-to-Work Transitions|Brief Alcohol Intervention for School-to-Work Transitions|Completed||N/A|163|Actual|Brown University||2|||f||||||||||||||2017-10-11 03:13:33.640685|2017-10-11 03:13:33.640685
NCT01546012|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2015-08-31||||||August 2015|2015-08-01||||||||Interventional|||Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials||Withdrawn||N/A|0|Actual|Laboratoires Thea||2||Too difficult to select patient according to the investigator|f||||f||||||||||2017-10-11 03:13:33.748046|2017-10-11 03:13:33.748046
NCT01545999|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-04-04|||March 2012||2012-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia|Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia: a Combined Transcranial Magnetic Stimulation and Electroencephalography Study Across the Life Span|Active, not recruiting||N/A|72|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-10-11 03:13:33.874566|2017-10-11 03:13:33.874566
NCT01545986|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2012-03-01|||September 2009||2009-09-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Comparative Analysis of Two Types of Exercise on Outcomes Following Total Knee Arthroplasty|A Comparative Analysis of High Velocity and Standard Low Velocity Exercise Training on Rehabilitation Outcomes Following Total Knee Arthroplasty|Completed||N/A|38|Actual|Helen Hayes Hospital||2|||f||||f||||||||||2017-10-11 03:13:33.985766|2017-10-11 03:13:33.985766
NCT01545973|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-02|||August 2011||2011-08-01|March 2012|2012-03-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||Understanding the Physiological Implications of Scanning Kelvin Probe Measurements|Measuring Skin Electrical Potential With the Kelvin Probe: Underlying Physiology|Suspended||N/A|24|Anticipated|Massachusetts General Hospital|||1|Repair of minor software glitches|f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 03:13:34.093185|2017-10-11 03:13:34.093185
NCT01545960|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2012-03-02|||August 2011||2011-08-01|March 2012|2012-03-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||Evaluating Acupuncture Points With Scanning Kelvin Probe|Scanning Kelvin Probe Measurements of Acupuncture Point|Suspended||N/A|24|Anticipated|Massachusetts General Hospital|||1|Adjusting minor software glitches|f||||f||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 03:13:34.184483|2017-10-11 03:13:34.184483
NCT01545947|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2016-11-04|||May 2012||2012-05-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer|A PHASE 1B, MULTI-CENTER, OPEN-LABEL STUDY OF THE MTOR KINASE INHIBITOR CC-223 IN COMBINATION WITH ERLOTINIB OR ORAL AZACITIDINE IN ADVANCED NON-SMALL CELL LUNG CANCER|Completed||Phase 1|76|Actual|Celgene Corporation||3|||f||||f||||||||||2017-10-11 03:13:34.26303|2017-10-11 03:13:34.26303
NCT01545934|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-07-25|||November 2012||2012-11-01|July 2016|2016-07-01|June 2021|Anticipated|2021-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Preventing Excessive Gestational Weight Gain in Obese Women|Preventing Excessive Gestational Weight Gain in Obese Women|Active, not recruiting||N/A|350|Anticipated|California Polytechnic State University-San Luis Obispo||2|||f||||t||||||||||2017-10-11 03:13:34.384911|2017-10-11 03:13:34.384911
NCT01545921|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-16|2012-03-06|||December 2010||2010-12-01|March 2012|2012-03-01|April 2014|Anticipated|2014-04-01|November 2013|Anticipated|2013-11-01||Interventional|CEOLE||Cancer End Of Life Evaluation|Evaluation and Validation of Quality Of Life Scales in Palliative Advanced Cancer|Unknown status|Recruiting|Phase 3|402|Anticipated|ICO Paul Papin||4|||f||||f||||||||||2017-10-11 03:13:34.487652|2017-10-11 03:13:34.487652
NCT01545908|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-03-17|||March 2012||2012-03-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis|A Randomized Controlled Trial of Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis|Completed||Phase 2|130|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f||||||||||2017-10-11 03:13:34.648209|2017-10-11 03:13:34.648209
NCT01545882|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-07-22|||May 2011||2011-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|October 2011|Actual|2011-10-01||Interventional|OTT 10-06||A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer|A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer|Terminated||Phase 2|5|Actual|Ottawa Hospital Research Institute||1||Negative study; Principal Investigator chose to prematurely terminate the study.|f||||f||||||||||2017-10-11 03:13:34.757292|2017-10-11 03:13:34.757292
NCT01545869|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-02|2014-04-04|||March 2012||2012-03-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy and Safety of Fractional Carbon Dioxide Laser for Treatment of Facial Freckles.|Efficacy and Safety of Fractional Carbon Dioxide Laser for Treatment of Facial Freckles|Completed||N/A|20|Actual|Cairo University||1|||f||||t||||||||||2017-10-11 03:13:34.843239|2017-10-11 03:13:34.843239
NCT01545856|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-05-15|||September 2011||2011-09-01|May 2017|2017-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Cardiovascular Events in Parkinson's Disease Patients|Background Incidence of Cardiovascular Ischaemic Events in Treated Parkinson's Disease Patients in the Impact Database|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:13:34.928137|2017-10-11 03:13:34.928137
NCT01545843|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2015-01-19|2015-01-13||March 2009||2009-03-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression|Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression|Completed||Phase 2|68|Actual|University of Michigan|Sample is largely young, healthy adults|3|||f||||t||||||||||2017-10-11 03:13:35.019796|2017-10-11 03:13:35.019796
NCT01545830|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-08-30|||March 2012||2012-03-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|MISURA||Metabolic Syndrome and Insulin Resistance at Allina|Randomized, Controlled Trial of Vitamin D Replenishment in Metabolic Syndrome|Completed||Phase 2|84|Actual|Allina Health System||2|||f||||f||||||||||2017-10-11 03:13:35.360102|2017-10-11 03:13:35.360102
NCT01545817|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-09-26|||April 2012||2012-04-01|September 2017|2017-09-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|CATChEz||Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma|Continuous Access to Advanced and Metastatic Renal Cell Carcinoma Therapy With Everolimus Post Pazopanib Treatment|Terminated||Phase 2|74|Actual|Novartis||1||"Due to changes in the RCC treatment landscape, info gained is no longer clinically relevant to   patients. Data collected is deemed sufficient to meet objectives."|f||||f|f|f||||||||2017-10-11 03:13:35.469581|2017-10-11 03:13:35.469581
NCT01545804|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-02-07|||August 2011|Actual|2011-08-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma|Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma (HCC): a Phase II Clinical Trial|Completed||Phase 2|55|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 03:13:35.62269|2017-10-11 03:13:35.62269
NCT01545791|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-10-27|||May 2006||2006-05-01|October 2016|2016-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|PREDICTIVE™||Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes|A Multicentre, Open Label, Nonrandomised, Non-interventional, Observational, Safety Study in Patients Using Insulin Detemir for the Treatment of Type 1 or Type 2 Diabetes Mellitus: The PREDICTIVE™ Study - Predictable Results and Experience in Diabetes Through Intensification and Control to Target: An International Variability Evaluation|Completed||N/A|1037|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:13:35.710797|2017-10-11 03:13:35.710797
NCT01545778|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-10-26|||February 2010||2010-02-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)|Risk of Shopping Behavior of Tapentadol IR Immediate-Release (IR) Compared to Oxycodone IR Immediate-Release (IR)|Completed||N/A|646620|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||2||f||||||||||||||2017-10-11 03:13:35.847215|2017-10-11 03:13:35.847215
NCT01545765|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2013-06-25|2013-06-25||May 2012||2012-05-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||No sample size determination as a standard sample size for this type of study is about 30 subjects.|Anesthetic Effect Duration Assessment|Anesthetic Effect Duration Produced by Lidocaine 7% + Tetracaine 7% Cream on 2 Different Body Areas|Completed||Phase 4|30|Actual|Galderma|No limitation or caveat on this study|1|||f||||f||||||||||2017-10-11 03:13:35.959295|2017-10-11 03:13:35.959295
NCT01545752|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-07-11|||October 2009||2009-10-01|March 2012|2012-03-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Comparing Interactive and Non-interactive CD-based Method|Comparing Interactive and Non-interactive CD-based Method in Teaching Medical Terminology|Terminated||Phase 2/Phase 3|180|Actual|Mashhad University of Medical Sciences||3|||f||||f||||||||||2017-10-11 03:13:36.24051|2017-10-11 03:13:36.24051
NCT01545739|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-10-15|||April 2012||2012-04-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Evia/Entovis HF-T Master Study|Master Study of the Evia/Entovis HF-T Pacemaker|Completed||N/A|122|Actual|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 03:13:36.313854|2017-10-11 03:13:36.313854
NCT01545726|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2013-10-08|||February 2012||2012-02-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma|A Double-blind, Placebo-controlled Study Examining the Effect of Orally Administered QAW039 on Sputum Eosinophil Levels and Other Efficacy Outcomes in Patients With Sputum Eosinophilia and Persistent Asthma|Completed||Phase 2|61|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:13:36.384775|2017-10-11 03:13:36.384775
NCT01545713|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-09-19|||June 2011||2011-06-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|February 2012|Actual|2012-02-01||Observational|||Correlation of Donor-specific Anti-endothelial Cells|A Phase II, Prospective, Single-center Study: Correlation of Donor-specific Anti-precursor Endothelial Cells With Transplant Outcome for Recipients of Living-donor Kidney Transplants, Are Auto-antibodies Important.|Active, not recruiting||N/A|16|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"     A total of 40 cc/3 tablespoons of blood will be drawn once.   "|||2017-10-11 03:13:36.492538|2017-10-11 03:13:36.492538
NCT01545700|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-01-15|2012-11-09||September 2009||2009-09-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery|Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery|Completed||Phase 4|200|Actual|NorthShore University HealthSystem Research Institute||6|||f||||f||||||||||2017-10-11 03:13:36.575865|2017-10-11 03:13:36.575865
NCT01545687|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-08-04|||April 2012||2012-04-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy|A Phase III, Randomized, Double-Blind Study of Lactobacillus Brevis CD2 Lozenges Versus Placebo in the Prevention of Acute Oral Mucositis (OM) in Patients With Head and Neck Cancer Receiving Concurrent Radiotherapy and Chemotherapy|Withdrawn||Phase 3|0|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 03:13:37.403316|2017-10-11 03:13:37.403316
NCT01545674|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-04-12|||January 2012||2012-01-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|April 2014|Actual|2014-04-01||Observational|PreNATUS||Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial|Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)|Active, not recruiting||N/A|1000|Anticipated|Natera, Inc.|||1||f||||t||||||Samples With DNA|"     Plasma Sample Prepared DNA   "|No|A peer reviewed publication is planned from this study.|2017-10-11 03:13:37.541317|2017-10-11 03:13:37.541317
NCT01545661|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2012-12-21|||August 2009||2009-08-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|SINET||Utility of Sputum Induction and Novel Technologies to Improve TB Diagnosis in a High HIV Prevalence Primary Care Setting|A Randomised Control Trial of Sputum Induction, and New and Emerging Technologies in a High HIV Prevalence Primary Care Setting|Completed||N/A|517|Actual|University of Cape Town||2|||f||||t||||||||||2017-10-11 03:13:37.729907|2017-10-11 03:13:37.729907
NCT01545648|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-09-14|||November 2012||2012-11-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|October 29, 2014|Actual|2014-10-29||Interventional|||Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer|Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer|Active, not recruiting||Phase 2|45|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:13:37.843018|2017-10-11 03:13:37.843018
NCT01545635|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-03-22|||March 2012||2012-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma|RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma|Terminated||Phase 3|100|Actual|Medical University Innsbruck||2||"The Interim analysis (100 patients) revealed a possible harm to patients randomised to the   fresh frozen plasma (FFP) treatment arm."|f||||t||||||||||2017-10-11 03:13:37.924098|2017-10-11 03:13:37.924098
NCT01545622|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-08-30|||March 2008|Actual|2008-03-01|August 2017|2017-08-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Observational|||Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid Disease|Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid Disease|Completed||N/A|61|Actual|University of Arkansas|||1||f||||f||||||||||2017-10-11 03:13:38.007764|2017-10-11 03:13:38.007764
NCT01545609|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-12-20|||March 2012||2012-03-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|BC 2U||A Trial Assessing the Effectiveness of Text Messages in Improving Continuation of Birth Control|A Text Message Support System for Effective Continuation of a Birth Control Method in Female Adolescents: 'BC 2U'|Completed||Phase 1|220|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 03:13:38.087595|2017-10-11 03:13:38.087595
NCT01545596|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2014-05-23|||January 2011||2011-01-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Will a Real Time Advisory for Double Low State Change Clinical Behavior and Impact Outcomes|A Randomized Effectiveness Trial of Early Hemodynamic Support in Patients Demonstrating a Double and Triple Low Combination of Mean Arterial Pressure, and Either End-tidal Anesthetic Concentration or Bispectral Index.|Completed||N/A|20237|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 03:13:38.197369|2017-10-11 03:13:38.197369
NCT01545570|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-07-24|||November 7, 2011|Actual|2011-11-07|July 2017|2017-07-01|December 23, 2012|Actual|2012-12-23|December 23, 2012|Actual|2012-12-23||Interventional|||A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers|A Single-blinded, Randomized, Placebo-controlled, Staggered-parallel, Escalating Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2374697 in Healthy Volunteers|Completed||Phase 1|82|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:13:38.564541|2017-10-11 03:13:38.564541
NCT01545557|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-03-24|||February 2012||2012-02-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pan Facial Volume Restoration|Pan Facial Volume Restoration With a New Hyaluronic Acid Dermal Filler|Completed||Phase 4|60|Actual|Galderma||1|||f||||f||||||||||2017-10-11 03:13:38.679232|2017-10-11 03:13:38.679232
NCT01545544|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-02-06|||November 2006||2006-11-01|June 2013|2013-06-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Observational|Lympho C||Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)|Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) in Patients With Hepatitis C Virus|Unknown status|Active, not recruiting|N/A|138|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||t||||||Samples With DNA|"     whole blood and bone marrow   "|||2017-10-11 03:13:38.792376|2017-10-11 03:13:38.792376
NCT01545531|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-12-30|||September 2008||2008-09-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance||Completed||N/A|54|Actual|University of Washington|||1||f||||f||||||Samples Without DNA|"     blood sample for iohexol level, serum creatinine, cystatin C, and hematocrit at baseline,     prior to iohexol infusion, 2 hours and 5 hours post iohexol infusion.   "|||2017-10-11 03:13:38.880819|2017-10-11 03:13:38.880819
NCT01545518|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-08-21|2014-08-21||November 2011||2011-11-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional||18-50 years of age, both male and female|IVIG Treatment for Refractory Immune-Related Adult Epilepsy|IVIG Treatment for Refractory Immune-Related Adult Epilepsy|Terminated||Phase 2|20|Actual|Emory University|Study was terminated early. Subject eligibility for phase 2 not available.|1||Futility criteria, unable for Phase 2 of study, & phase 1 was terminated.|f||||f||||||||||2017-10-11 03:13:38.987295|2017-10-11 03:13:38.987295
NCT01545505|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-02-20|||October 2012||2012-10-01|February 2013|2013-02-01|July 2014|Anticipated|2014-07-01|October 2013|Anticipated|2013-10-01||Interventional|||Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse|Early Diagnosis of Risk of Post-Traumatic Stress Disorder (PTSD) Relapse in Children and Their Families|Unknown status|Recruiting|N/A|120|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 03:13:39.202955|2017-10-11 03:13:39.202955
NCT01545492|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-03-01|||January 2012||2012-01-01|March 2012|2012-03-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|CHIPS-Child||Testing the Developmental Origins Hypothesis|CHIPS-Child:Testing the Developmental Origins Hypothesis|Recruiting||N/A|626|Anticipated|Children's & Women's Health Centre of British Columbia|||2||f||||t||||||Samples With DNA|"     1. ~150 strands of hair        2. Four buccal swabs   "|||2017-10-11 03:13:39.332161|2017-10-11 03:13:39.332161
NCT01545336|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-09-20|2016-06-29||October 2012||2012-10-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|AIPH||Anastrozole in Patients With Pulmonary Arterial Hypertension|A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension|Completed||Phase 2|18|Actual|University of Pennsylvania|"Small sample size
No changes in echo parameters
Unclear mechanism for impact on 6MWD"|2|||f||||t||||||||||2017-10-11 03:13:39.546228|2017-10-11 03:13:39.546228
NCT01545323|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-10-18|||April 2014||2014-04-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Gene Therapy for Netherton Syndrome|Phase I Study of Ex-vivo Lentiviral Gene Therapy for the Inherited Skin Disease Netherton Syndrome|Recruiting||Phase 1|5|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 03:13:40.090267|2017-10-11 03:13:40.090267
NCT01545310|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-09-14|||May 2011||2011-05-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia|An Open-Label, Positron Emission Tomography (PET) Study to Evaluate the Brain 5 HT6 Receptor Occupancy by Single Doses of SLV354 in Healthy Male Subjects and Subjects With Stable Schizophrenia|Completed||Phase 1|18|Actual|Abbott||1|||f||||f||||||||||2017-10-11 03:13:40.191834|2017-10-11 03:13:40.191834
NCT01545297|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-07-05|||November 2012||2012-11-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Dexmedetomidine and Propofol-Remifentanil Conscious Sedation for Awake Craniotomy for Tumor Surgery|Comparison of Dexmedetomidine and Propofol-Remifentanil Conscious Sedation for Awake Craniotomy for Tumor Surgery: a Randomized Controlled Trial|Completed||N/A|50|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:13:40.270519|2017-10-11 03:13:40.270519
NCT01545284|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-07-23|||March 2012||2012-03-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis|Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis|Completed||Phase 2/Phase 3|9|Actual|Innovaderm Research Inc.||1|||f||||f||||||||||2017-10-11 03:13:40.376299|2017-10-11 03:13:40.376299
NCT01545271|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-10-30|||May 2012||2012-05-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|October 2013|Actual|2013-10-01||Interventional|CoolXenon2||Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth|Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth: A Randomised Pilot Study|Unknown status|Active, not recruiting|Phase 1/Phase 2|32|Actual|University Hospitals Bristol NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:13:40.469344|2017-10-11 03:13:40.469344
NCT01545258|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2016-12-01|||March 2012||2012-03-01|December 2016|2016-12-01||||March 2013|Actual|2013-03-01||Interventional|||Exercise and Pain Sensitivity in Knee Osteoarthritis|Exercise and Changes in Pain Sensitivity in Patients With Knee Osteoarthritis|Completed||N/A|60|Actual|Frederiksberg University Hospital||2|||f||||||||||||||2017-10-11 03:13:40.561582|2017-10-11 03:13:40.561582
NCT01545245|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-12-05|||July 2010||2010-07-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants|Cohort Study to Evaluate Effects of Prophylactic Treatment for Respiratory Syncytial (RS) Virus Infection in Respiratory Tract During Infancy on Subsequent Atopic Asthma in Preterm Infants|Completed||N/A|343|Actual|Tokai University|||2||f||||f||||||Samples Without DNA|"     The serum samples   "|||2017-10-11 03:13:40.643006|2017-10-11 03:13:40.643006
NCT01545232|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-05-29|2015-04-22||August 2012||2012-08-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PROPPR||Pragmatic, Randomized Optimal Platelet and Plasma Ratios|Pragmatic, Randomized Optimal Platelet and Plasma Ratios|Completed||Phase 3|680|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 03:13:40.73485|2017-10-11 03:13:40.73485
NCT01545219|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-03-06|||September 2008||2008-09-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|XOS||A Study of a Prebiotic, a Probiotic and a Synbiotic Upon the Gut Microbiota and Immune Response of Healthy Volunteers|A Double-blind, Placebo-controlled, Randomized Crossover Study to Determine the Effects of Xylooligosaccharides (XOS), B. Lactis (BI07) and XOS + BI07 Upon the Gut Microbiota and Immune Response of Healthy Volunteers|Completed||N/A|44|Actual|University of Reading||4|||f||||f||||||||||2017-10-11 03:13:41.396709|2017-10-11 03:13:41.396709
NCT01545206|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-05|||February 1997||1997-02-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Dose Reducing Door-to-balloon Time in ST-elevation Myocardial Infarction Cause Less Cost?|Better Quality With Less Cost? A Single Hospital Experience on Reducing Door-to-balloon Time in ST-elevation Myocardial Infarction|Completed||N/A|215|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 03:13:41.491888|2017-10-11 03:13:41.491888
NCT01538836|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-03-22|||January 2012|Actual|2012-01-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|CRPS||Calorie Restriction, Protein Supplementation and Metabolic Health|Calorie Restriction and Metabolic Health|Completed||N/A|75|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 03:15:36.594276|2017-10-11 03:15:36.594276
NCT01545193|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2015-04-03|2015-03-17||June 2011||2011-06-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Observational|||The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade|The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade|Completed||N/A|300|Actual|NorthShore University HealthSystem Research Institute|||2||f||||f||||||||||2017-10-11 03:13:41.563757|2017-10-11 03:13:41.563757
NCT01545180|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-02-12|||February 2012||2012-02-01|February 2015|2015-02-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|PH-HF||Observatory: Search for Prognostic Factors of Pulmonary Hypertension Post-capillary in Heart Failure|Observatory: Search for Prognostic Factors of Pulmonary Hypertension Post-capillary in Heart Failure.|Recruiting||N/A|520|Anticipated|French Cardiology Society|||1||f||||f||||||Samples With DNA|"     -  3 tubes of 6 blood for analysis of biomarkers        -  2 tubes of 6 mL blood for DNA analysis   "|||2017-10-11 03:13:41.89801|2017-10-11 03:13:41.89801
NCT01545167|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-09-14|||September 2008||2008-09-01|September 2017|2017-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|NAPS||The North American Pancreatitis Study|The North American Pancreatitis Study|Completed||N/A|2980|Actual|University of Pittsburgh|||2||f||||t||||||Samples With DNA|"     Blood samples and extracted biomarkers and genetic material.   "|||2017-10-11 03:13:42.013538|2017-10-11 03:13:42.013538
NCT01545154|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-03-27|||February 2012||2012-02-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate Cancer|Phase II Study of The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate Cancer|Completed||N/A|17|Actual|University of Vermont Medical Center|||1||f||||||||||||||2017-10-11 03:13:42.092745|2017-10-11 03:13:42.092745
NCT01545141|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-02-02|||October 2012||2012-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer|Randomized Phase 1/2 Evaluation of Neoadjuvant Administration of a Chemokine-Modulatory Regimen in Patients With Recurrent Resectable Colorectal Cancer|Recruiting||Phase 1/Phase 2|50|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:13:42.182845|2017-10-11 03:13:42.182845
NCT01545128|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2012-03-05|||January 2009||2009-01-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|||||Observational|||Impact of Pulmonary Rehabilitation on Direct Healthcare Costs in Chronic Obstructive Pulmonary Disease (COPD)|A Retrospective Case-control Study Comparing the Direrct Healthcare Costs of Conventionally Managed COPD Patients With Those Who Have Completed a Pulmonary Rehabilitation Programme|Completed||N/A|70|Actual|East and North Hertfordshire NHS Trust|||1||f||||f||||||||||2017-10-11 03:13:42.295763|2017-10-11 03:13:42.295763
NCT01545115|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-03-12|||October 2008||2008-10-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|AnoPalAnoVac||Study of the Environmental Factors Modulating Children Immune Response in Northern Senegal|Study of the Environmental Factors Modulating Children Immune Response in Northern Senegal|Completed||N/A|410|Actual|Biomedical Research Center EPLS|||1||f||||t||||||Samples Without DNA|"     Sera, culture supernatants   "|||2017-10-11 03:13:42.353218|2017-10-11 03:13:42.353218
NCT01545102|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-03-06|||April 2012||2012-04-01|March 2012|2012-03-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Observational|||Assessment of Exercise Intensity in Cardiac Rehabilitation Programmes for Patients With Chronic Heart Failure|Assessment of Exercise Intensity in Cardiac Rehabilitation Programmes for Patients With Chronic Heart Failure|Unknown status|Not yet recruiting|N/A|21|Anticipated|Eastbourne General Hospital|||1||f||||f||||||||||2017-10-11 03:13:42.452077|2017-10-11 03:13:42.452077
NCT01545089|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-03-25|||July 2012||2012-07-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Use of a Fabric Mattress Cover for Patient Comfort|Use of a Fabric Mattress Cover for Patient Comfort|Completed||N/A|174|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 03:13:42.519046|2017-10-11 03:13:42.519046
NCT01545076|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-09-27||2017-09-20|March 2012||2012-03-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)|Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Phase III Study to Investigate the Efficacy, Safety, and Tolerability of 2 Different Doses of IgPro20 (Subcutaneous Immunoglobulin) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - the PATH Study|Completed||Phase 3|172|Actual|CSL Behring||3|||f||||t||||||||||2017-10-11 03:13:42.609826|2017-10-11 03:13:42.609826
NCT01545063|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-07-18|||May 2012|Actual|2012-05-01|July 2017|2017-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|CAPANAH||CAre of Patients With PArenteral Nutrition At Home|Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate the Quality of Care for Adult Patients on Home Parenteral Nutrition (HPN)|Completed||N/A|39|Actual|Katholieke Universiteit Leuven|||1||f||||t|f|f||||||||2017-10-11 03:13:44.582157|2017-10-11 03:13:44.582157
NCT01545050|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-09-13||2015-07-24|June 2012||2012-06-01|September 2017|2017-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease|A Phase IIb, Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Dose-Ranging Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-945429 in Subjects With Moderate to Severe Crohn's Disease|Terminated||Phase 2|72|Actual|Vitaeris INC||9|||f||||t||||||||||2017-10-11 03:13:44.691888|2017-10-11 03:13:44.691888
NCT01545037|ClinicalTrials.gov processed this data on October 10, 2017|2012-03-01|2017-07-27|||July 2012||2012-07-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome|Effect of Lactobacillus Acidophilus CL1285®, L. Casei LBC80R® and L. Rhamnosus CLR2® on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study|Completed||Phase 2|117|Actual|Bio-K Plus International Inc.||2|||f||||f||||||||||2017-10-11 03:13:45.0671|2017-10-11 03:13:45.0671
NCT01545024|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-03-13|||September 2011||2011-09-01|February 2012|2012-02-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Observational|||Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus|Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus|Unknown status|Recruiting|N/A|60|Anticipated|Nagaoka Red Cross Hospital|||1||f||||f||||||||||2017-10-11 03:13:45.176963|2017-10-11 03:13:45.176963
NCT01545011|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-09-18|||October 2011||2011-10-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|April 2012|Actual|2012-04-01||Interventional|IMT||Effects of Inspiratory Muscle Training on Dyspnea in Subjects With Chronic Obstructive Pulmonary Disease|Effects of Inspiratory Muscle Training Combined With a Pulmonary Rehabilitation Program Versus a Program of Pulmonary Rehabilitation Alone on Dyspnea: a Randomized Trial|Completed||N/A|38|Actual|University Hospital, Brest||2|||f||||f||||||||||2017-10-11 03:13:45.291505|2017-10-11 03:13:45.291505
NCT01544998|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-10-01|2014-12-15||February 2012||2012-02-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2013|Actual|2013-08-01||Interventional||Baseline analysis population description includes only those subjects who completed the study.|Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure|To Define the Role of PDEV in Mediating the Decreased GFR and Attenuated Renal Sodium and cGMP Excretory Response to Acute Saline Volume Expansion in PSD and PDD With Renal Dysfunction.|Completed||Phase 1/Phase 2|43|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 03:13:45.86336|2017-10-11 03:13:45.86336
NCT01544985|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-12-21|||April 2012||2012-04-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Bladder Catheterization|A Randomized Double-blind Trial Comparing the Effect on Pain of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Bladder Catheterization|Completed||Phase 4|84|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 03:13:46.179928|2017-10-11 03:13:46.179928
NCT01544972|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-12-13|||February 2012||2012-02-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants|Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen|Unknown status|Recruiting|Phase 4|80|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-11 03:13:46.263815|2017-10-11 03:13:46.263815
NCT01544959|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-09|2016-10-25|||January 2010||2010-01-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2013|Actual|2013-01-01||Interventional|PAINFree||Postoperative Analgesia Impact of Narcotic Free Anesthesia|The Impact on Postoperative Pain of Substituting Opioids by Beta Blockers for Peroperative Hemodynamic Control in Patients Undergoing Mastectomy|Active, not recruiting||N/A|84|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 03:13:46.361805|2017-10-11 03:13:46.361805
NCT01544946|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2015-12-21|||February 2012||2012-02-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Nasopharyngeal Aspiration|A Randomized Double-blind Trial Comparing the Effect on Pain of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Nasopharyngeal Aspiration|Completed||Phase 4|80|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 03:13:46.474367|2017-10-11 03:13:46.474367
NCT01544933|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-03-05|||February 2011||2011-02-01|August 2011|2011-08-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Observational|||The Influence of the Ribs on the Gravity of Burst Thoracic Spine Fractures|The Influence of the Ribs on the Gravity of Burst Thoracic Spine Fractures|Completed||N/A|2|Actual|Universidade de Passo Fundo|||2||f||||t||||||||||2017-10-11 03:13:46.556844|2017-10-11 03:13:46.556844
NCT01544920|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-03-10|2016-04-22||May 2012||2012-05-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)|A Phase 3, Safety and Efficacy Study of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Chronic HCV Genotype 1 IL28B CC Subjects|Completed||Phase 3|737|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:13:46.664483|2017-10-11 03:13:46.664483
NCT01544907|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-03-04|||January 2012||2012-01-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|DEBAPTA||Prospective Randomized Trial Comparing DEB Versus Conventional PTA for the Treatment of Hemodialysis AVF or AVG Stenoses|Prospective Randomized Trial Comparing Drug Eluting Balloon Angioplasty Versus Conventional Percutaneous Transluminal Angioplasty Balloon for the Treatment of Hemodialysis Arterio-Venous Fistula or Arterio-Venous Graft Stenoses|Completed||N/A|125|Actual|Singapore General Hospital||2|||f||||t||||||||||2017-10-11 03:13:47.485772|2017-10-11 03:13:47.485772
NCT01544894|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-08-31|||September 2009||2009-09-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis|Comparison of Raloxifene and Strontium Ranelate on Compliance and Efficacy in Women With Postmenopausal Osteoporosis|Completed||Phase 4|80|Actual|University of Valencia||2|||f||||f||||||||||2017-10-11 03:13:47.593395|2017-10-11 03:13:47.593395
NCT01544881|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2013-01-24|||March 2012||2012-03-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes|A Phase 1, Single-center, Open-label, Randomized, Crossover Design Clinical Study in Subjects With Type 1 Diabetes Comparing Insulin Exposure & Response Following Inhalation of Technosphere Insulin Inhalation Powder Using the Gen2C Inhaler Vs Subcutaneous Rapid-Acting Analog|Completed||Phase 1|17|Actual|Mannkind Corporation||2|||f||||f||||||||||2017-10-11 03:13:47.727182|2017-10-11 03:13:47.727182
NCT01544868|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2014-08-19|||November 2011||2011-11-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|TEE||Total Energy Expenditure, Protein Kinetics, and Body Composition in Recovering Burn Children.|Total Energy Expenditure, Protein Kinetics and Body Composition During Recovery From Severe Burn Injury in Children.|Completed||N/A|12|Actual|Shriners Hospitals for Children||1|||f||||f||||||||||2017-10-11 03:13:47.845189|2017-10-11 03:13:47.845189
NCT01544855|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-02-27|||February 2011||2011-02-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Does Incorporation of EPA and DHA in Lipoproteins Differ According to Apolipoprotein E Genotype?|Does Incorporation of EPA and DHA in Lipoproteins Differ According to Apolipoprotein E Genotype?|Completed||N/A|80|Actual|Université de Sherbrooke||1|||f||||t||||||||||2017-10-11 03:13:47.934882|2017-10-11 03:13:47.934882
NCT01544842|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-07-15|||August 2004||2004-08-01|December 2014|2014-12-01|July 2015|Actual|2015-07-01|February 2015|Actual|2015-02-01||Interventional|||Tacrolimus Ointment in Oral Lichen Planus|Comparison of Topical Tacrolimus, Triamcinolone and Placebo in the Treatment of Symptomatic Oral Lichen Planus|Terminated||N/A|28|Actual|University of Oulu||3||Lack of resources|f||||f||||||||||2017-10-11 03:13:48.0103|2017-10-11 03:13:48.0103
NCT01544829|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-11-30|||February 2012||2012-02-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||The Acute Effect of 2 Different Serving Regimens of Theobromine on Physiological Effects|The Acute Effect of 2 Different Serving Regimens of Theobromine on Theobromine Concentration in the Blood & Physiological Effects|Completed||N/A|12|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-11 03:13:48.118982|2017-10-11 03:13:48.118982
NCT01544816|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2013-05-06|||February 2012||2012-02-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Evaluating the Effects of Snack Products on Energy||Completed||N/A|49|Actual|Mondelēz International, Inc.||3|||f||||f||||||||||2017-10-11 03:13:48.22084|2017-10-11 03:13:48.22084
NCT01544803|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-03-05|||September 2009||2009-09-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||Randomized Controlled Trial of eScreen for Problematic Alcohol Use|Randomized Controlled Trial of eScreen for Problematic Alcohol Use|Completed||Phase 2|633|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 03:13:48.333036|2017-10-11 03:13:48.333036
NCT01544790|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-04-04|||January 2012||2012-01-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|ROBOT||Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy|Robot-assisted Minimally Invasive Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer. The ROBOT-trial: a Monocenter Randomized Controlled Trial.|Completed||Phase 3|112|Actual|UMC Utrecht||2|||f||||t||||||||Undecided||2017-10-11 03:13:48.432973|2017-10-11 03:13:48.432973
NCT01544777|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-03-23|||February 2012||2012-02-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|751||Visual Quality Following Aspheric Intraocular Lens (IOL) Implantation - a Comparative Clinical Study|Visual Quality Following Aspheric and Monovision Lens Implantation - a Comparative Clinical Study|Completed||N/A|42|Actual|Hoya Surgical Optics, Inc.||3|||f||||f||||||||||2017-10-11 03:13:48.543047|2017-10-11 03:13:48.543047
NCT01544764|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2013-12-16|||April 2011||2011-04-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|AFIX||Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX) in North Carolina|Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX)|Completed||N/A|91|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 03:13:48.644136|2017-10-11 03:13:48.644136
NCT01544751|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-05-27|||September 2011||2011-09-01|May 2014|2014-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin|Metformin Versus Atorvastatin in Nonalcoholic Hepatic Steatosis: a Randomized Study|Unknown status|Recruiting|N/A|150|Anticipated|University Magna Graecia||3|||f||||f||||||||||2017-10-11 03:13:48.774568|2017-10-11 03:13:48.774568
NCT01544738|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-03-05|||November 2008||2008-11-01|February 2012|2012-02-01||||May 2009|Actual|2009-05-01||Interventional|||Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease|Aponeurotic Stimulation Effect on Parkinson Bradykinesia|Completed||N/A|11|Actual|Université Libre de Bruxelles||2|||f||||||||||||||2017-10-11 03:13:48.887189|2017-10-11 03:13:48.887189
NCT01544725|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-11-30|||April 2012||2012-04-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Ketamine-propofol Versus Ketamine Alone for Procedural Sedation in Adults|Ketamine-propofol Versus Ketamine Alone for Procedural Sedation in Adults : a Blinded, Randomized Controlled Trial|Completed||Phase 4|150|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 03:13:48.972226|2017-10-11 03:13:48.972226
NCT01544712|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-03-05|||August 2004||2004-08-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow|Treatment of Stage 3 Osteonecrosis of the Femoral Head by Autologous Transplantation of Bone Marrow Cells: a Randomized, Controlled Double Blind Study|Completed||N/A|50|Actual|University Hospital of Liege||2|||f||||f||||||||||2017-10-11 03:13:49.068438|2017-10-11 03:13:49.068438
NCT01544699|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-10-25|||January 2012||2012-01-01|October 2016|2016-10-01|January 2030|Anticipated|2030-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Impact of Non-invasive Brain Stimulation on Motor Recuperation|Impact of Non-invasive Brain Stimulation on Motor Recuperation|Active, not recruiting||N/A|200|Anticipated|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-10-11 03:13:49.150966|2017-10-11 03:13:49.150966
NCT01544686|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-12-08|||February 2012||2012-02-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|COAT||Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients|Chlorhexidine Containing Iv-securement Dressings for the Prevention of Central Venous Catheter-related Blood Stream Infections in Neutropenic Patients: a Randomized Trial|Completed||N/A|630|Actual|University of Cologne||2|||f||||t||||||||||2017-10-11 03:13:49.244304|2017-10-11 03:13:49.244304
NCT01544673|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-04-26|||March 2012||2012-03-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Males|An Open-label, Placebo-controlled Phase 1 Study to Evaluate the Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Male Subjects|Completed||Phase 1|18|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:13:49.357998|2017-10-11 03:13:49.357998
NCT01544660|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2014-04-15|||April 2012||2012-04-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|Interscanner||Bone Quality by vQCT and HR-pQCT:Translation to Multi-center Clinical Research|Bone Quality by vQCT and HR-pQCT:Translation to Multi-center Clinical Research|Completed||N/A|60|Actual|University of California, San Francisco|||2||f||||f||||||||||2017-10-11 03:13:49.481341|2017-10-11 03:13:49.481341
NCT01544647|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-08-13|||February 2012||2012-02-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|May 2013|Actual|2013-05-01||Interventional|Nancythermal||Spa Therapy in Knee Osteoarthritis (OA): Nancy-thermal|Comparison of 2 Spa Therapy Protocols in Symptomatic Knee Osteoarthritis : a Randomised Trial|Completed||N/A|283|Actual|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-11 03:13:49.595651|2017-10-11 03:13:49.595651
NCT01544634|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-06-11|||March 2012||2012-03-01|June 2012|2012-06-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|ANDA1||Beta Blocker Therapy in Mild to Moderate Asthmatics|Evaluation of Any Steroid Sparing Effect of Beta Blocker Therapy on Airway Hyper-responsiveness in Stable, Mild to Moderate Asthmatics|Unknown status|Recruiting|Phase 2|16|Anticipated|University of Dundee||2|||f||||f||||||||||2017-10-11 03:13:49.735732|2017-10-11 03:13:49.735732
NCT01544621|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2013-05-20|||November 2011||2011-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|ESCAPE SMOKE||Escape Smoke Project: Non-Intervention Non-Drug Multicenter Study on the Real-life Effectiveness of Smoking Cessation in General Practice in Denmark|Escape Smoke Project: Non-Intervention Multicenter Study On the Real-Life Effectiveness of Smoking Cessation in General Practice in Denmark|Completed||N/A|544|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:13:49.901428|2017-10-11 03:13:49.901428
NCT01544608|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2013-06-19|||July 2012||2012-07-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|RECONNECT-S||Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia|A Non- Interventional Study to Observe Real Life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia.|Completed||N/A|1076|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 03:13:50.209185|2017-10-11 03:13:50.209185
NCT01544595|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-04-20|||June 19, 2012|Actual|2012-06-19|April 2017|2017-04-01|June 26, 2017|Anticipated|2017-06-26|June 26, 2017|Anticipated|2017-06-26||Interventional|||Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab|A Multicenter, Double-blind, Randomized Withdrawal Extension Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate Long-term Efficacy, Safety, and Tolerability up to 2 Years in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab|Active, not recruiting||Phase 3|1150|Actual|Novartis||2|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 03:13:50.398679|2017-10-11 03:13:50.398679
NCT01544582|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-07-28|2016-05-24||May 2012||2012-05-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational||Analysis Population: All CHC genotype-1 participants included in study meeting eligibility criteria and receiving boceprevir plus peginterferon and ribavirin (PR), telaprevir plus PR, or PR alone.|Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518)|An Observational Post-Authorization Safety Study (PASS) of Victrelis™ (Boceprevir) Among Chronic Hepatitis C Patients|Completed||N/A|713|Actual|Merck Sharp & Dohme Corp.|This was a non-interventional study that collected data on both boceprevir and telaprevir treatment regimens within routine medical practice. No individual administration of any therapeutic or prophylactic agent was assigned in this protocol.||3||f||||f||||||||||2017-10-11 03:13:51.144648|2017-10-11 03:13:51.144648
NCT01544569|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2016-05-17|||March 2012||2012-03-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors|Endogenous DNA Transposition in Rhabdoid Tumors|Completed||N/A|50|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:13:53.133436|2017-10-11 03:13:53.133436
NCT01544556|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2012-03-05|||July 2009||2009-07-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Use of PrineoTM (Dermabond Protape) Skin Adhesive for Wound Closure Following Abdominoplasty|Use of PrineoTM (Dermabond Protape) Skin Adhesive for Wound Closure Following Abdominoplasty: An Open, Prospective, Controlled, Randomized Clinical Study|Completed||N/A|1|Actual|Medical University of Graz|||2||f||||||||||||||2017-10-11 03:13:53.219272|2017-10-11 03:13:53.219272
NCT01544543|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-03-05|||February 2010||2010-02-01|February 2012|2012-02-01||||||||Observational|VESALIO||Validation of HealthCare Standards in Chronic Obstructive Pulmonary Disease|Validation of HealthCare Standards in COPD|Completed||N/A|600|Actual|Sociedad Española de Neumología y Cirugía Torácica|||1||f||||f||||||||||2017-10-11 03:13:53.308236|2017-10-11 03:13:53.308236
NCT01544530|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-05-05|||March 2012||2012-03-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|COOLDonor||Cooling to Optimize Organ Life in Donor Study|Feasibility of Mild-to-moderate Therapeutic Hypothermia as an In-vivo Organ Preservation Strategy in Brain-dead Donors|Terminated||Phase 2|4|Actual|University of Pittsburgh||2||Lack of funding and other logistic reasons|f||||t||||||||||2017-10-11 03:13:53.387837|2017-10-11 03:13:53.387837
NCT01544517|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-03-05|||January 2011||2011-01-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection|Five-day Concomitant Versus 10-day Sequential Therapy for Eradication of Helicobacter Pylori Infection: a Randomized Trial of Levofloxacin-based Regimens|Completed||Phase 3|180|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||t||||||||||2017-10-11 03:13:53.492973|2017-10-11 03:13:53.492973
NCT01544504|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-05-25|||March 2012||2012-03-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy|Exploratory Study of Topical Norepinephrine in Post-Surgical Breast Cancer Patients Receiving Radiotherapy|Withdrawn||Phase 1/Phase 2|0|Actual|ProCertus BioPharm, Inc||1||"The principal investigator withdrew from the study. The study was withdrawn because a qualified   replacement was not available."|f||||f||||||||||2017-10-11 03:13:53.588409|2017-10-11 03:13:53.588409
NCT01544491|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-02-28|||August 17, 2012|Actual|2012-08-17|February 2017|2017-02-01|October 5, 2018|Anticipated|2018-10-05|October 5, 2018|Anticipated|2018-10-05||Interventional|||Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients||Active, not recruiting||Phase 3|131|Actual|Novartis||2|||f||||t||||||||||2017-10-11 03:13:53.673775|2017-10-11 03:13:53.673775
NCT01544478|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2017-06-08|2017-06-08||November 25, 2011|Actual|2011-11-25|June 2017|2017-06-01|August 27, 2016|Actual|2016-08-27|August 27, 2016|Actual|2016-08-27||Interventional|||V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)|A Phase IV Open-Label, Descriptive Study to Evaluate the Safety and Effectiveness on the Incidence of HPV 6, 11, 16 and 18 Related CIN 2/3 or Worse of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in 16- to 26-Year-Old Japanese Women|Completed||Phase 4|1030|Actual|Merck Sharp & Dohme Corp.||1|||f||||f|t|f|||t|||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:13:54.010113|2017-10-11 03:13:54.010113
NCT01544465|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-03-20|||August 2011||2011-08-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease|Effect of a Structured Physical Activity Program on Sleep Quality and Sleepiness in Parkinson's Disease|Terminated||N/A|1|Actual|Northwestern University||2||Difficulty recruiting, funding lapsed|f||||f||||||||||2017-10-11 03:13:54.288537|2017-10-11 03:13:54.288537
NCT01544452|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-11-26|||August 2010||2010-08-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Total Preoperative MR Diagnostic Evaluation Versus Standard Diagnostic Evaluation in Patients With Rectal Cancer|Prospective Randomized Study of Total Preoperative MR Diagnostic Evaluation Versus Standard Diagnostic Evaluation in Patients With Rectal Cancer|Terminated||N/A|75|Actual|Herlev Hospital||2||Lack of MR scanning capacity|f||||f||||||||||2017-10-11 03:13:54.457916|2017-10-11 03:13:54.457916
NCT01544439|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-05-15|||March 2012||2012-03-01|March 2012|2012-03-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|||Occlusal Splint and Counseling to Temporomandibular Disorder|The Efficacy of Occlusal Stabilization Appliance Associated to Counseling in the Management of Myofascial Pain Chronic and in the Improvement of the Quality of Life of Patients With Temporomandibular Disorders|Unknown status|Recruiting|Phase 3|40|Anticipated|Federal University of Juiz de Fora||2|||f||||t||||||||||2017-10-11 03:13:54.598941|2017-10-11 03:13:54.598941
NCT01544426|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2014-12-27|||February 2012||2012-02-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Office Hysteroscopy and Endometrial Snip Improve Intrauterine Insemination Outcome|Does Office Hysteroscopy and Endometrial Snip Improve IUI Outcome? : a Randomized Controlled Trial|Completed||Phase 3|332|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 03:13:54.757741|2017-10-11 03:13:54.757741
NCT01544413|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-12-14|||February 2012||2012-02-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer|Quality Control Study for Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy and Stomach Preserving Surgery in Early Gastric Cancer|Completed||N/A|112|Actual|National Cancer Center, Korea||1|||f||||t||||||||||2017-10-11 03:13:54.900686|2017-10-11 03:13:54.900686
NCT01544400|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-08-05|||June 2010||2010-06-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|TCA SHN||Description and Evaluation of Eating Disorders in Elite Athletes (TCA SHN)|Description and Evaluation of Eating Disorders in Elite Athletes|Terminated||N/A|386|Actual|Nantes University Hospital|||1||f||||||||||||||2017-10-11 03:13:55.081134|2017-10-11 03:13:55.081134
NCT01544387|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-02-26|||July 2010||2010-07-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|BRAT||Preterm Premature Rupture of Membranes (PPROM): Bed Rest Versus Activity Trial|PPROM: Bed Rest Versus Activity Trial (BRAT)|Completed||N/A|36|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 03:13:55.207242|2017-10-11 03:13:55.207242
NCT01544374|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-06-07|||October 2012||2012-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities|Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities|Completed||N/A|198|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 03:13:55.346605|2017-10-11 03:13:55.346605
NCT01544361|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-06-23|2014-06-23||January 2012||2012-01-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers|A Phase 1, Randomized, Placebo-controlled, Single-dose Study to Evaluate the Safety of MEDI7814 in Adult Volunteers|Completed||Phase 1|125|Actual|MedImmune LLC|Analyses of PK parameters and immunogenicity were not performed as the clinical development of MEDI7814 had been discontinued because the indication was no longer being pursued.|5|||f||||f||||||||||2017-10-11 03:13:55.476417|2017-10-11 03:13:55.476417
NCT01544348|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-12-18|2014-12-18||January 2012||2012-01-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Safety population included all participants who received any amount of investigational product and had safety data available.|A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL|A Phase 1 Randomized, Placebo-controlled, Dose-escalation Study to Evaluate the Safety of MEDI4212 in Subjects With IgE >= 30 IU/mL|Completed||Phase 1|295|Actual|MedImmune LLC||8|||f||||t||||||||||2017-10-11 03:13:56.280007|2017-10-11 03:13:56.280007
NCT01544335|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2017-03-28|||December 2011||2011-12-01|March 2017|2017-03-01||||January 2018|Anticipated|2018-01-01||Observational|||Evaluation of BIS for Quantification of Lymphedema|Evaluation of the Validity of BIS as a Tool for Quantification of Lymphedema Through Comparison With Perometry and Self-Report|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-11 03:13:58.196553|2017-10-11 03:13:58.196553
NCT01544322|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-06-17|||May 2012||2012-05-01|April 2014|2014-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|ME-344-001||Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors|Phase 1 Open Label Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 as a Single Agent in Patients With Refractory Solid Tumors|Completed||Phase 1|24|Anticipated|MEI Pharma, Inc.||1|||f||||t||||||||||2017-10-11 03:13:58.296291|2017-10-11 03:13:58.296291
NCT01544309|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-03-04|2014-11-10||March 2012||2012-03-01|March 2015|2015-03-01||||June 2014|Actual|2014-06-01||Interventional|LISTEN|Full analysis set (FAS) - All participants who received at least 1 dose of open-label study drug except the ones who had no HbA1c or non-HDL-C data or a protocol deviation of the administration of study drugs.|LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts|Study on Effect of Highly Potent Statins on Lipid Lowering Effect and Glucose Metabolism in Hypercholesterolemia Patients With Diabetes Mellitus|Completed||N/A|1049|Actual|Listen Trial Group||2|||f||||||||||||||2017-10-11 03:13:58.474811|2017-10-11 03:13:58.474811
NCT01544296|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-10-08|||February 2012||2012-02-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Comparative Study of KHK6188|Phase II Study of KHK6188 (A Placebo-controlled, Double Blind, Crossover Study of KHK6188 in Postherpetic Neuralgia)|Completed||Phase 2|42|Anticipated|Kyowa Hakko Kirin Co., Ltd||3|||f||||f||||||||||2017-10-11 03:14:00.993752|2017-10-11 03:14:00.993752
NCT01543009|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-10-28|||March 2012||2012-03-01|October 2015|2015-10-01|October 2016|Anticipated|2016-10-01|October 2015|Actual|2015-10-01||Interventional|||Use of Local Warming in Children Venipuncture|Use of Local Warming in Children to Facilitate Venipuncture. A Randomized Controlled Trial.|Suspended||Early Phase 1|72|Anticipated|University of Florence||2||Difficulty in recruiting|f||||t||||||||||2017-10-11 03:14:30.798205|2017-10-11 03:14:30.798205
NCT01544270|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-04-24|||September 2011||2011-09-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|AivoPro2||The Effects of Dietary Factors on Physiological Subjective Stress Responses|The Effects of Dietary Factors on Physiological Subjective Stress Responses in Cronically Stressed Subjects: a Randomised Clinical Trial|Completed||N/A|101|Actual|Helsinki University||3|||f||||f||||||||||2017-10-11 03:14:01.213992|2017-10-11 03:14:01.213992
NCT01544257|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-02-28|||August 2008||2008-08-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Osteopathic Manipulative Treatment on Length of Stay in Preterms|Effect of OMT on Length of Stay in a Population of Preterm Infants: RCT Study|Completed||Phase 4|100|Actual|European Institute for Evidence Based Osteopathic Medicine||2|||f||||t||||||||||2017-10-11 03:14:01.295024|2017-10-11 03:14:01.295024
NCT01544244|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-06-02|||October 2012||2012-10-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis|Comparison of the Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis: a Prospective, Randomized Study|Terminated||N/A|40|Actual|Centre Hospitalier Universitaire de Nīmes||2||Inclusion curve too slow.|f||||f||||||||||2017-10-11 03:14:01.381791|2017-10-11 03:14:01.381791
NCT01544231|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-12-11|||August 2013||2013-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis|Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) Levels During Emergency Management of Rhabdomyolysis: Predicting Renal Failure|Completed||N/A|197|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 03:14:01.509789|2017-10-11 03:14:01.509789
NCT01544218|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-06-19|||September 2012||2012-09-01|June 2017|2017-06-01|June 30, 2016|Actual|2016-06-30|July 20, 2015|Actual|2015-07-20||Observational|||Validating NIAAA Screen Guide in YCMC|Validating NIAAA's Brief Screening Guide in Youth With Chronic Medical Conditions|Completed||N/A|521|Actual|Boston Children’s Hospital|||1||f||||f||||||||||2017-10-11 03:14:01.639331|2017-10-11 03:14:01.639331
NCT01544205|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-12-13|||March 2012||2012-03-01|December 2016|2016-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|NFD||Neurofeedback as a Treatment Tool for Depression|fMRI Based Neurofeedback as a Treatment Method for Depression|Completed||N/A|43|Actual|Cardiff University||2|||f||||||||||||||2017-10-11 03:14:01.733727|2017-10-11 03:14:01.733727
NCT01544192|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2012-03-02|||April 2008||2008-04-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|November 2009|Actual|2009-11-01||Interventional|||Impact of Oral Versatile Antioxidants on Glaucoma Progression|Impact of Oral Versatile Antioxidants on Glaucoma Progression:Comparative Early Results|Completed||Phase 3|60|Actual|Bagcilar Training and Research Hospital||5|||f||||f||||||||||2017-10-11 03:14:01.891106|2017-10-11 03:14:01.891106
NCT01544179|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-04-18|2015-04-29||March 15, 2012|Actual|2012-03-15|April 2017|2017-04-01|December 29, 2017|Anticipated|2017-12-29|May 5, 2014|Actual|2014-05-05||Interventional|IMPRESS||A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone|A Phase III Randomised, Double Blind, Placebo Controlled, Parallel, Multicentre Study to Assess the Efficacy and Safety of Continuing IRESSA 250 mg in Addition to Chemotherapy Versus Chemotherapy Alone in Patients Who Have Epidermal Growth Factor Receptor (EGFR) Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) and Have Progressed on First Line IRESSA|Active, not recruiting||Phase 3|287|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 03:14:02.063492|2017-10-11 03:14:02.063492
NCT01544166|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-06-03|2014-11-18||May 2012||2012-05-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)|Open-label, Multicenter, Pharmacokinetic, and Safety Study in Children (Term Newborn Infants to 23 Months of Age) Undergoing a Contrast-enhanced MRI With an Intravenous Injection of 0.1 mmol/kg BW Gadobutrol 1.0 M|Completed||Phase 1|44|Actual|Bayer|Results for Typical PK parameters were provided by the median value of the population together with the min-max range (individual PK). Typical PK parameter as described in study protocol was reflected by the Median PK parameter in the study report.|1|||f||||f||||||||||2017-10-11 03:14:03.051316|2017-10-11 03:14:03.051316
NCT01544153|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-12-19|2016-10-25||February 2012||2012-02-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|December 2015|Actual|2015-12-01||Interventional||Includes baseline characteristics of participants who completed participation in the full study.|Improving Adherence to Web-Based Cessation Programs: A Social Network Approach|Improving Adherence to Web-Based Cessation Programs: A Social Network Approach|Active, not recruiting||N/A|5292|Actual|Truth Initiative||4|||f||||f||||||||No|No current plans, but interested researchers may contact Principal Investigator for additional discussion.|2017-10-11 03:14:05.247951|2017-10-11 03:14:05.247951
NCT01544140|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-08-26|||April 2012||2012-04-01|August 2016|2016-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|Vandetanib||Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib|A Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, in Healthy Subjects When Administered Alone and in Combination With a Single Dose of 800-mg Vandetanib (CAPRELSA)|Completed||Phase 1|16|Actual|Sanofi||1|||f||||||||||||||2017-10-11 03:14:06.339829|2017-10-11 03:14:06.339829
NCT01544127|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-04-11|||July 30, 2012|Actual|2012-07-30|April 2017|2017-04-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Motivational Interviewing to Prevent Suicide in High Risk Veterans|Motivational Interviewing to Prevent Suicide in High Risk Veterans|Active, not recruiting||N/A|132|Actual|VA Office of Research and Development||3|||f||||t||||||||Undecided||2017-10-11 03:14:06.450657|2017-10-11 03:14:06.450657
NCT01543555|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-12-30|||November 2012||2012-11-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|LOAD||Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose|Multicenter Randomized Controlled Trial of Loading Dose Statins for the Prevention of Cardiovascular Complications in High-Risk Non-Cardiac Surgery|Completed||Phase 3|648|Actual|Hospital do Coracao||2|||f||||t||||||||||2017-10-11 03:14:18.651082|2017-10-11 03:14:18.651082
NCT01544114|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-09-07|2017-08-04|2016-02-11|April 2012||2012-04-01|September 2017|2017-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)|A 6-month, Multicenter, Open-label, Safety Study of VIMOVO (250 mg/20 mg, 375 mg/20 mg, and 500 mg/20 mg Naproxen/Esomeprazole) in Adolescents Aged 12 to 16 Years, Inclusive, With Juvenile Idiopathic Arthritis (JIA)|Completed||Phase 4|46|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||1|||f||||f||||||||||2017-10-11 03:14:06.589966|2017-10-11 03:14:06.589966
NCT01544101|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-10-18|||September 2011||2011-09-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Nutritional Intervention for Arthritis|A Nutritional Intervention for Arthritis|Completed||N/A|32|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-10-11 03:14:08.068637|2017-10-11 03:14:08.068637
NCT01544088|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-08-29|||July 1, 2012|Actual|2012-07-01|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|August 23, 2017|Actual|2017-08-23||Interventional|GCBT||Group CBT for PTSD|Group CBT for Chronic PTSD: RCT With Veterans|Active, not recruiting||N/A|198|Actual|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 03:14:08.159015|2017-10-11 03:14:08.159015
NCT01544075|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-06-02|||February 2012||2012-02-01|June 2015|2015-06-01||||September 2015|Anticipated|2015-09-01||Interventional|||Efficacy of Pain Neurophysiology Education in Combination With Psychologic Inoculation in Chronic Whiplash|Efficacy of Pain Neurophysiology Education in Combination With Psychologic Inoculation in Chronic Whiplash Associated Disorders : a Double-blind Randomised Controlled Trial|Unknown status|Enrolling by invitation|Early Phase 1|36|Anticipated|Vrije Universiteit Brussel||2|||f||||f||||||||||2017-10-11 03:14:08.2497|2017-10-11 03:14:08.2497
NCT01544062|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-05-12|2015-11-30||July 2012||2012-07-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional|CarDolMev||IV Acetaminophen as an Adjunct Analgesic in Cardiac Surgery|Efficacy of Perioperative Intravenous Acetaminophen as an Adjunct Analgesic in Cardiac Surgery Patients|Completed||Phase 4|68|Actual|University of Washington|"several subjects received intraoperative hydromorphone while others only received intraoperative fentanyl
significantly greater proportion of females in the placebo group"|2|||f||||t||||||||No||2017-10-11 03:14:08.402741|2017-10-11 03:14:08.402741
NCT01544049|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-04-10|||December 2011||2011-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study|Patients Salpingectomy as a Method of Ovarian Cancer Prevention: A Descriptive Study|Active, not recruiting||N/A|24|Actual|University of Washington|||1||f||||f||||||||||2017-10-11 03:14:09.399555|2017-10-11 03:14:09.399555
NCT01544036|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-12-18|||February 2012||2012-02-01|December 2013|2013-12-01||||February 2014|Anticipated|2014-02-01||Interventional|||Monitoring Renal Blood Flow With Contrast Enhanced Ultrasound During Coronary Angiogram|Monitoring Renal Blood Flow Using Contrast Enhanced Ultrasound in Predicting Acute Kidney Injury After Exposure to Iodinated Contrast Agent|Unknown status|Recruiting|N/A|150|Anticipated|University of Virginia||1|||f||||||||||||||2017-10-11 03:14:11.070176|2017-10-11 03:14:11.070176
NCT01544023|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-12-26|2015-11-30||January 2010||2010-01-01|December 2016|2016-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||TiLoop® Bra for Breast Reconstruction|Multicenter Observational Study of Implant Based Breast Reconstruction Using a Titanium-coated Polypropylene Mesh|Completed||N/A|207|Actual|University of Rostock|||1||f||||f||||||||||2017-10-11 03:14:11.288467|2017-10-11 03:14:11.288467
NCT01544010|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-05-26|||February 2009||2009-02-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|STAR||Optimal TTM Tailoring for Population Cessation|Optimal TTM Tailoring for Population Cessation|Completed||N/A|3006|Actual|University of Rhode Island||5|||f||||t||||||||||2017-10-11 03:14:11.459439|2017-10-11 03:14:11.459439
NCT01543997|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2016-11-16|||January 2012||2012-01-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|March 2015|Actual|2015-03-01||Interventional|||Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms|Investigating Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms: An Exploratory Randomized Controlled Trial|Completed||Phase 2|75|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 03:14:11.574079|2017-10-11 03:14:11.574079
NCT01543984|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2015-11-19|||January 2012||2012-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Interventional|||"Efficacy of Tailored Physical Activity in Health Care Workers"|"Efficacy of Tailored Physical Activity on the Number of Sick Days: a Randomized Controlled Trial in Health Care Workers That Have Experienced Pain Related to the Spine or Upper Body"|Completed||Phase 1/Phase 2|54|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 03:14:11.675984|2017-10-11 03:14:11.675984
NCT01543971|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-10|2016-08-29|||December 2009||2009-12-01|August 2016|2016-08-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs)|Phase I Double-Blinded Comparison Study Using TXA127 and/or Neupogen to Increase Peripheral Blood Stem Cell (CD34+) Counts|Completed||Phase 1|18|Actual|Tarix Pharmaceuticals||3|||f||||f||||||||||2017-10-11 03:14:11.765263|2017-10-11 03:14:11.765263
NCT01543958|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-29|2013-12-04|2013-09-23||November 2011||2011-11-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Sevelamer for Reducing Endotoxemia and Immune Activation|Sevelamer Carbonate for Reducing Endotoxemia and Immune Activation: A Proof of Concept Study|Completed||Phase 2|40|Actual|AIDS Clinical Trials Group||1|||f||||t||||||||||2017-10-11 03:14:11.902332|2017-10-11 03:14:11.902332
NCT01543945|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-07-29|||March 2008||2008-03-01|July 2012|2012-07-01||||December 2011|Actual|2011-12-01||Interventional|||Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy||Completed||Phase 2|340|Actual|Prince of Songkla University||2|||f||||t||||||||||2017-10-11 03:14:13.010571|2017-10-11 03:14:13.010571
NCT01543932|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-12-10|||July 2012||2012-07-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|TRIPLETE RESET||High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients|Comparison of Therapy With TICAGRELOR, Prasugrel and High Clopidogrel Dose in PCI Patients With High on Treatment Platelet Reactivity and Genotype Variation|Completed||Phase 3|81|Actual|University of Roma La Sapienza||3|||f||||t||||||||||2017-10-11 03:14:13.115063|2017-10-11 03:14:13.115063
NCT01543191|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-07-18|||February 2012||2012-02-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis|A Phase 1 Dose-escalation Study TO Evaluate the Safety and Tolerability of PUR118 and Placebo in Subjects With CF|Completed||Phase 1|10|Actual|Pulmatrix Inc.||2|||f||||f||||||||||2017-10-11 03:14:25.806762|2017-10-11 03:14:25.806762
NCT01543919|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2014-10-15||2014-10-15|April 2012||2012-04-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide|A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide|Completed||Phase 2|730|Actual|Pfizer||6|||f||||t||||||||||2017-10-11 03:14:13.24684|2017-10-11 03:14:13.24684
NCT01543906|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-12-11|||February 2012||2012-02-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)|An Open-Label, Phase 1b, Safety/Proof-of-Concept Study to Evaluate the Effects of Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)|Completed||Phase 1|5|Actual|QLT Inc.||1|||f||||f||||||||||2017-10-11 03:14:13.729299|2017-10-11 03:14:13.729299
NCT01543893|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-06-27|||March 2012||2012-03-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|IRMA05||Effect of Personal Versus Video Instruction in Elastic Resistance Exercise on Technical Execution (IRMA05)|Danish: Integreret Motion på Arbejdspladsen (IRMA) English: Implementation of Exercise at the Workplace|Completed||N/A|38|Actual|National Research Centre for the Working Environment, Denmark||2|||f||||f||||||||||2017-10-11 03:14:13.840773|2017-10-11 03:14:13.840773
NCT01543880|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-04-28|||July 2003||2003-07-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|NordiWIN||Safety and Efficacy of Long-term Somatropin Treatment in Adults|Non-interventional Study of Safety and Efficacy of Long-term Somatropin Treatment in Adults|Completed||N/A|752|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:14:13.940369|2017-10-11 03:14:13.940369
NCT01543867|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2015-03-27|||January 2001||2001-01-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|GrowthWIN II||Safety and Efficacy of Long-term Somatropin Treatment in Children|Non-interventional Study of the Safety and Efficacy of Long-term Somatropin Treatment in Children (GrowthWIN II / GrowthWIN II SGA)|Completed||N/A|5442|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:14:14.045014|2017-10-11 03:14:14.045014
NCT01543854|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2014-08-04|||March 2012||2012-03-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure|A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-controlled Study to Evaluate the Hemodynamic Responses to Intravenous RLX030 Infusion in Subjects With Acute Heart Failure|Completed||Phase 2|71|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:14:14.138864|2017-10-11 03:14:14.138864
NCT01543841|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-04-16|||August 2012||2012-08-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood|A Laboratory Evaluation of Tie-2 Expressing Monocytes (TEMs) in Healthy Volunteers and Patients With Advanced Cancer|Completed||N/A|20|Actual|University Health Network, Toronto|||2||f||||f||||||None Retained|"     One tube of whole blood   "|||2017-10-11 03:14:14.281208|2017-10-11 03:14:14.281208
NCT01543828|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-05-06|2013-03-19||January 2012||2012-01-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Phase IV, Randomized, Double-blind, Placebo-controlled, Multicenter, Exploratory, Single-dose Crossover Study With Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 4|40|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:14:14.369367|2017-10-11 03:14:14.369367
NCT01543815|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-03-04|||January 2006||2006-01-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|February 2009|Actual|2009-02-01||Interventional|WELL-ME||Well-Being Therapy by Personalized Mobile Technology Program for Psychological Distress and Promote Healthy Behaviors|Well-Being Therapy for Psychological Distress and Enhancing Healthy Behaviors With Personalized Mobile Technology in Cardiac Patients: a Randomized Controlled-trial Study Protocol|Completed||N/A|400|Actual|University of Bergamo||3|||f||||t||||||||||2017-10-11 03:14:14.655746|2017-10-11 03:14:14.655746
NCT01543802|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2015-05-26|||April 2013||2013-04-01|May 2015|2015-05-01|June 2018|Anticipated|2018-06-01|June 2015|Anticipated|2015-06-01||Interventional|NOPASS||Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma|A Phase II Window-of-opportunity Study of Preoperative Therapy With Pazopanib (Votrient®) in High-risk Soft Tissue Sarcoma|Recruiting||Phase 2|35|Anticipated|Heidelberg University||1|||f||||f||||||||||2017-10-11 03:14:14.758026|2017-10-11 03:14:14.758026
NCT01543789|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2015-06-02|||March 2012||2012-03-01|June 2015|2015-06-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|FUN||The Flemish Umbilical Nitinol Mesh Trial, a Multicenter Trial|The Flemish Umbilical Nitinol Mesh Trial, a Multicenter Randomized Controlled Trial.|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 03:14:14.935487|2017-10-11 03:14:14.935487
NCT01543776|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-06-19|||January 2012||2012-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|January 2017|Actual|2017-01-01||Interventional|||Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer|A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer|Active, not recruiting||Phase 2|72|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 03:14:15.06611|2017-10-11 03:14:15.06611
NCT01543763|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-07-28|||May 2012||2012-05-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Phase I Tolerability, Efficacy, and Safety Study of Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors|Phase I Study to Evaluate the Tolerability, Efficacy, and Safety of Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors|Active, not recruiting||Phase 1|52|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:14:15.166165|2017-10-11 03:14:15.166165
NCT01543750|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2014-02-07|||April 2013||2013-04-01|February 2014|2014-02-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|4AP in EA2||4-Aminopyridine in Episodic Ataxia Type 2|Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2|Unknown status|Enrolling by invitation|Phase 2|20|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:14:15.26679|2017-10-11 03:14:15.26679
NCT01543737|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-02-11|||February 2012||2012-02-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee|Single-blind Randomised Pragmatic Trial Comparing the Effectiveness of Two Hyaluronic Acid Viscosupplements, DUROLANE® (Single Injection) Versus HYALGAN® (Three Injections) for Symptomatic Tibiofemoral Osteoarthritis of the Knee.|Terminated||N/A|290|Actual|Bioventus LLC||2||post transfer of company ownership from Smith & Nephew to Bioventus LLC|f||||f||||||||Undecided||2017-10-11 03:14:15.384552|2017-10-11 03:14:15.384552
NCT01543724|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-03-02|||August 2008||2008-08-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder|A Brain Imaging Study to Investigate Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder: Glycogen Synthase Kinase 3β Polymorphism (-50T/C) and Gray Matter Volume Increase Following Lithium Treatment in Bipolar Disorder|Unknown status|Recruiting|Phase 4|50|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 03:14:15.505137|2017-10-11 03:14:15.505137
NCT01543711|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-06-05|||January 2012||2012-01-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment|Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment|Completed||N/A|2411|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 03:14:15.629861|2017-10-11 03:14:15.629861
NCT01543698|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-02-17|||May 2012||2012-05-01|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|January 2018|Anticipated|2018-01-01||Interventional|||A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors|A Phase Ib/II, Multicenter, Open-label, Dose Escalation Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF V600 - Dependent Advanced Solid Tumors|Active, not recruiting||Phase 1/Phase 2|179|Anticipated|Array BioPharma||2|||f||||f||||||||||2017-10-11 03:14:15.715412|2017-10-11 03:14:15.715412
NCT01543685|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2014-01-02|2013-02-27||February 2012||2012-02-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Study of Indomethacin Capsules to Treat Pain Following Bunionectomy|A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin [Test] Capsules for the Treatment of Acute Postoperative Pain After Bunionectomy|Completed||Phase 3|462|Actual|Iroko Pharmaceuticals, LLC||5|||f||||f||||||||||2017-10-11 03:14:15.965358|2017-10-11 03:14:15.965358
NCT01543672|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-09-26|||October 2011||2011-10-01|December 2016|2016-12-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|VOLUMES||Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously|VOLUMES Treatment of Larger Tumor Volumes or ≥ 2 Lung Tumors Simultaneously in Lung Cancer Patients Using SBRT in a Mean-lung Dose Escalation Study|Recruiting||Phase 1/Phase 2|60|Anticipated|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-10-11 03:14:17.191819|2017-10-11 03:14:17.191819
NCT01543659|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2017-03-13|||February 2012||2012-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer|A Phase I/II Study of Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|77|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:14:17.35868|2017-10-11 03:14:17.35868
NCT01543646|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-03-02|||March 2011||2011-03-01|March 2012|2012-03-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|RIAL||Multiparametric MR for Rapid Imaging Assessment of the Liver|Rapid Imaging Assessment of the Liver Using Multiparametric Magnetic Resonance|Unknown status|Recruiting|N/A|60|Anticipated|University of Oxford|||1||f||||f||||||Samples With DNA|"     Fresh frozen plasma, frozen serum, and whole blood for DNA analysis   "|||2017-10-11 03:14:17.488313|2017-10-11 03:14:17.488313
NCT01543633|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-12-01|||August 2005||2005-08-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||EEG Studies of Induction and Recovery From Propofol Induced General Anesthesia|Electroencephalogram Studies of Induction and Recovery From Propofol Induced General Anesthesia|Active, not recruiting||N/A|20|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:14:17.59498|2017-10-11 03:14:17.59498
NCT01543620|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2014-12-08|||February 2012||2012-02-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis|Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis|Unknown status|Recruiting|N/A|150|Anticipated|Foundation for the National Institutes of Health|||2||f||||f||||||Samples Without DNA|"     urine and blood   "|||2017-10-11 03:14:17.681878|2017-10-11 03:14:17.681878
NCT01543607|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-03-13|2017-03-13||February 2012|Actual|2012-02-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Endoscopic Therapy of Malignant Bile Duct Strictures|Endoscopic Therapy of Malignant Bile Duct Strictures: A Pilot Study|Terminated||N/A|1|Actual|Massachusetts General Hospital||1||Lack of enrollment|f||||t||||||||||2017-10-11 03:14:17.807683|2017-10-11 03:14:17.807683
NCT01543594|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2012-03-02|||January 2009||2009-01-01|February 2012|2012-02-01||||||||Observational|GISEA||Italian Registry of Arthritis on Biologic Therapy|Study of Efficacy and Safety of Biologic Drugs in the Therapy of Rheumatoid Arthritis and Spondyloarthritis|Unknown status|Recruiting|N/A|10000|Anticipated|Gruppo Italiano Studio Early Arthritis|||1||f||||t||||||||||2017-10-11 03:14:18.059717|2017-10-11 03:14:18.059717
NCT01543581|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2014-09-24|2013-09-19||May 2012||2012-05-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|Erivedge||Vismodegib for Treatment of Basal Cell Carcinoma|Placebo-controlled, Double Blind Study to Assess Efficacy and Safety of Oral Vismodegib for the Treatment of Basal Cell Carcinoma Preceding Excision by Mohs Micrographic Surgery (MMS)|Completed||Phase 2|3|Actual|Loma Linda University||2|||f||||t||||||||||2017-10-11 03:14:18.155597|2017-10-11 03:14:18.155597
NCT01543568|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2016-11-03|2016-02-05||February 2012||2012-02-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|TURF||Study for Recalcitrant Age Related Macular Degeneration|AflibercepT for Subjects Who Are Incomplete Responders to mUltiple Intravitreal Injections of Ranibizumab, Anti-VegF (The TURF Study)|Completed||Phase 4|46|Actual|Greater Houston Retina Research||1|||f||||t||||||||||2017-10-11 03:14:18.374827|2017-10-11 03:14:18.374827
NCT01543542|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-05-05|||April 2010||2010-04-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|TOMOSIBII||A Phase II Multi-institutional Study Assessing Simultaneous In-field Boost Helical Tomotherapy for 1-3 Brain Metastases|A Phase II Multi-institutional Study Assessing Simultaneous In-Field Boost Helical Tomotherapy for 1-3 Brain Metastases|Completed||Phase 2|91|Actual|Lawson Health Research Institute||1|||f||||t||||||||||2017-10-11 03:14:18.763198|2017-10-11 03:14:18.763198
NCT01543529|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-05-09|||February 28, 2012|Actual|2012-02-28|May 2017|2017-05-01|June 4, 2012|Actual|2012-06-04|June 4, 2012|Actual|2012-06-04||Interventional|||A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers|A Single Center, Randomized, Double-blind, Single-dose, Four Period, Crossover Study to Investigate Pharmacodynamics and Pharmacokinetics of RO4917838 Alone or With Concomitant Administration of Alcohol in Healthy Volunteers|Completed||Phase 1|25|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 03:14:18.852901|2017-10-11 03:14:18.852901
NCT01543516|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-06-29|||November 2011||2011-11-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|||Cell Distribution in Induced Sputum in Patients With Asthma|Cell Distribution in Induced Sputum in Healthy Subjects and Patients With Asthma After Different Techniques for Sputum Induction|Completed||N/A|40|Actual|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples With DNA|"     whole blood, serum, and sputum   "|||2017-10-11 03:14:18.937296|2017-10-11 03:14:18.937296
NCT01543503|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2016-01-12|2016-01-12||February 2012||2012-02-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational||Baseline characteristics were described for the safety population. All enrolled participants who received at least one dose of a TNF inhibitor or tocilizumab during the study were included in the safety population.|An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis|A Global Comparative Observational Study In Rheumatoid Arthritis (RA) Patients Who Are Treated With A TNF Inhibitor Or Tocilizumab As The First Biologic Therapy|Completed||N/A|1225|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:14:19.098076|2017-10-11 03:14:19.098076
NCT01543490|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2017-08-22|||September 2017|Anticipated|2017-09-01|June 2017|2017-06-01|October 2018|Anticipated|2018-10-01|August 2018|Anticipated|2018-08-01||Interventional|ISV-305||Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects|A Phase 3, Multicenter, Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-305 (0.1% Dexamethasone) Compared to Vehicle in the Treatment of Subjects With Blepharitis|Not yet recruiting||Phase 3|550|Anticipated|InSite Vision||2|||f||||f|t|f||||||||2017-10-11 03:14:21.377511|2017-10-11 03:14:21.377511
NCT01543477|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-10-03|||July 2010|Actual|2010-07-01|October 2017|2017-10-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Observational|PASCO II||Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia|Post-authorisation Safety Cohort Observation Of Retacrit (tm) (Epoetin Zeta) Administered Subcutaneously For The Treatment Of Renal Anaemia (Pasco Ii)|Recruiting||N/A|6700|Anticipated|Pfizer|||1||f||||f||||||Samples Without DNA|"     Pre-dose serum samples   "|||2017-10-11 03:14:21.495792|2017-10-11 03:14:21.495792
NCT01543464|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2015-08-17|||May 2012||2012-05-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients|Combination of IDO/Survivin Peptide Vaccine, GM-CSF, Imiquimod and Temozolomide Chemotherapy for Patients With Metastatic Malignant Melanoma|Terminated||Phase 2|41|Actual|Herlev Hospital||1||Diminished rectruitment|f||||t||||||||||2017-10-11 03:14:21.930847|2017-10-11 03:14:21.930847
NCT01543451|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-02-27||2014-02-27|February 2012||2012-02-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|January 2013|Actual|2013-01-01||Interventional|||Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea|Phase II, Double-blind, Randomized, Two-stage, Placebo-controlled Proof of Concept Study in Colorectal Cancer Patients Receiving 5-FU Based Chemotherapy to Assess the Efficacy of Elsiglutide (ZP1846)Administered s.c. in the Prevention of Chemotherapy Induced Diarrhea(CID)|Completed||Phase 2|138|Actual|Helsinn Healthcare SA||2|||f||||t||||||||||2017-10-11 03:14:22.031076|2017-10-11 03:14:22.031076
NCT01543438|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-01-02|||January 2012||2012-01-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Using Point-of-Care Video Prescriptions to Improve Aftercare Following Discharge From a Pediatric Emergency Department|Optimizing Emergency Aftercare With Mobile Video Prescriptions|Unknown status|Recruiting|N/A|5000|Anticipated|healthEworks LLC||2|||f||||t||||||||||2017-10-11 03:14:22.275284|2017-10-11 03:14:22.275284
NCT01543425|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-28|2013-05-13|||March 2012||2012-03-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Observational|HORMONES||Adrenocorticotropic Axis and Neuropathic Pain|Status of the Hypothalamic-pituitary-gonado- Adrenal Axis (HHSG) in Patients With Neuropathic Pain|Completed||N/A|120|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||None Retained|"     Day of inclusion: Blood sample for analysis of several hormones (cortisol, ACTH, SHBG, total     testostérone et S-DHEA, βœstradiol et progestérone for women, LH, FSH).      Day +1: salivary samples (at wake-up, 30 minutes after wake-up, at lunch, at 06:00 pm and     before sleep).      Day +2: salivary samples (at wake-up, 30 minutes after wake-up).   "|||2017-10-11 03:14:22.419047|2017-10-11 03:14:22.419047
NCT01543412|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-07|2012-03-02|||January 2010||2010-01-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|SLAP||Second Line Chemotherapy for Advanced Pancreatic Cancer|Folfiri as Second-Line Chemotherapy for Advanced Pancreatic Cancer. A GISCAD Phase II Study|Completed||Phase 2|50|Actual|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente||1|||f||||f||||||||||2017-10-11 03:14:22.516693|2017-10-11 03:14:22.516693
NCT01543399|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-04-02|||March 2012||2012-03-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TDILA||Vascular Effect of Tibolone in the Brachial Artery|Vascular Effect of Tibolone Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery|Completed||N/A|60|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-11 03:14:22.635956|2017-10-11 03:14:22.635956
NCT01543386|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-07-04|||February 2012||2012-02-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|CURCUMIN||Effects of Curcumin on Vascular Reactivity|Effects of Curcumin Loading Dose on Vascular Reactivity of Healthy Middle-aged Smokers|Completed||Phase 1/Phase 2|21|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 03:14:22.757645|2017-10-11 03:14:22.757645
NCT01543373|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-02-27|||January 2012||2012-01-01|February 2012|2012-02-01|June 2013|Anticipated|2013-06-01|September 2012|Anticipated|2012-09-01||Interventional|DEMONSTRATE||Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS|Randomized Comparison Between a DES and a BMS to Assess Neointimal Coverage by OCT Evaluation|Unknown status|Recruiting|Phase 4|40|Anticipated|CID - Carbostent & Implantable Devices||2|||f||||f||||||||||2017-10-11 03:14:22.85881|2017-10-11 03:14:22.85881
NCT01543360|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-03-25|||June 2012||2012-06-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Axillary Versus Subclavian Vein Strategies for Central Venous Catheterization Under Continuous Ultrasound Guidance|Comparison of Axillary Versus Subclavian Vein Strategies for Central Venous Catheterization Under Continuous Ultrasound Guidance: a Prospective, Randomized, Non-inferiority Study|Completed||N/A|132|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 03:14:22.981923|2017-10-11 03:14:22.981923
NCT01543347|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-01-28|||February 2012||2012-02-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|TEA||Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae|Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL) Producing and AmpC Hyperproducing Enterobacteriaceae in United Kingdom|Withdrawn||Phase 4|0|Actual|Belpharma s.a.||1||No patient has been included in 9 months because of strict incl/excl criteria|f||||f||||||||||2017-10-11 03:14:23.085465|2017-10-11 03:14:23.085465
NCT01543334|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-03-25|||March 2012||2012-03-01|March 2015|2015-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|DALI||Antibiotic Concentrations Among Critically Ill Patients|Antibiotic Concentrations Among Critically Ill Patients|Completed||N/A|98|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 03:14:23.197551|2017-10-11 03:14:23.197551
NCT01543321|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2017-09-11|||May 14, 2012|Actual|2012-05-14|September 2017|2017-09-01|August 2017|Actual|2017-08-01|May 18, 2017|Actual|2017-05-18||Interventional|Xeladys||Xenazine in Late Dyskinetic Syndrome With Neuroleptics|Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial|Completed||Phase 3|54|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||t||||||||||2017-10-11 03:14:23.33458|2017-10-11 03:14:23.33458
NCT01543308|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-05-16|||February 2012||2012-02-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|October 2013|Anticipated|2013-10-01||Observational|||The Alteration of HDL Protein Composition in Patients With Coronary Heart Disease Before and After Statins Treatment|Phase 1 Study of Coronary Heart Disease Proteomics Research|Unknown status|Active, not recruiting|N/A|400|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||2||f||||f||||||Samples With DNA|"     frozen in -80C   "|||2017-10-11 03:14:23.491209|2017-10-11 03:14:23.491209
NCT01543295|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-07-27|||July 2011||2011-07-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Evaluation of the Performance of Chembio's DPP(R) Syphilis Screen & Confirm Rapid Test System|Qualitative Evaluation of the DPP Syphilis Screen and Confirm Rapid Test to Detect the Presence of Antibodies Against Non-Treponemal and Treponema Pallidum Antigens in Fingerstick Whole Blood, Venous Whole Blood, Serum and Plasma Specimens.|Withdrawn||N/A|0|Actual|Chembio Diagnostic Systems, Inc.|||3||f||||t||||||||||2017-10-11 03:14:23.567179|2017-10-11 03:14:23.567179
NCT01543282|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-08-02|||December 2011||2011-12-01|February 2013|2013-02-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|||Endoscopic Ultrasonography (EUS) Guided Fine Needle Aspiration Using Free Stylet 22g and 25 g Needles|Randomized Controlled Study Comparing Endoscopic Ultrasonography Guided Fine Needle Aspiration Using Free Stylet 22g and 25 g Needles in Solid Lesions|Completed||N/A|120|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 03:14:23.649899|2017-10-11 03:14:23.649899
NCT01543269|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-11-20|||February 2010||2010-02-01|November 2015|2015-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers|A Randomized, Double Blind, Placebo Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZYT1, a Selective Thyroid Receptor (TR) ß Agonist, Following the Oral Administrations in Healthy Volunteers.|Terminated||Phase 1|24|Actual|Cadila Healthcare Limited||2||Safety concerns|f||||t||||||||||2017-10-11 03:14:23.802739|2017-10-11 03:14:23.802739
NCT01543256|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-06-26|||September 2012||2012-09-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study|A Multi-Center, Prospective, Randomized Study Comparing Removable, Self-Expanding Metal Stents to Plastic Stents for the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis|Recruiting||Phase 4|164|Anticipated|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 03:14:23.930666|2017-10-11 03:14:23.930666
NCT01543243|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-06-11|||November 2011||2011-11-01|June 2016|2016-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Application of Whole-body Vibration With Stochastic Resonance in Frail Elderly: The Effects on Postural Control|Application of Whole-body Vibration With Stochastic Resonance in Frail Elderly: The Effects on Postural Control: a Pilot Study|Completed||Phase 2|30|Actual|Bern University of Applied Sciences||2|||f||||f||||||||||2017-10-11 03:14:24.14687|2017-10-11 03:14:24.14687
NCT01543230|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-04-07|||February 2012||2012-02-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||CoMplete™ Acetabular Hip System|Ceramic on Metal Total Hip System, CoMplete™ Acetabular Hip System|Terminated||N/A|58|Actual|DePuy Orthopaedics||1||Sponsor withdrew PMA|f||||f||||||||||2017-10-11 03:14:24.261209|2017-10-11 03:14:24.261209
NCT01543217|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-10-06|||July 2012||2012-07-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Respiratory Disease Management|Use of a Respiratory Care Practitioner Disease Management (RCP-DM) Program for Patients Hospitalized With COPD|Completed||N/A|428|Actual|Barnes-Jewish Hospital||2|||f||||t||||||||||2017-10-11 03:14:24.380228|2017-10-11 03:14:24.380228
NCT01543204|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-06-29|2016-05-18||February 2012||2012-02-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab|Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Lost a Satisfactory Response to Adalimumab|Terminated||Phase 4|64|Actual|Amgen||1||Business decision due to slow enrollment|f||||f||||||||||2017-10-11 03:14:24.516442|2017-10-11 03:14:24.516442
NCT01543178|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-04-26|2015-06-15||February 2012||2012-02-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|TARGET3|Baseline results were summarized for the safety population, defined as patients who received at least 1 dose of study drug. Results are presented for patients in the open-label period only (1943) and for patients who eventually were randomized to rifaximin (329) or placebo (308) (ie, participated in both open-label and double-blind periods).|Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study|A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)|Completed||Phase 3|2583|Actual|Valeant Pharmaceuticals International, Inc.||3|||f||||f||||||||||2017-10-11 03:14:27.584134|2017-10-11 03:14:27.584134
NCT01543165|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-12-13|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy of Nefopam and Morphine in Balanced Analgesia for Acute Ureteric Colic|A Single Center, Prospective Randomized Double-blind Trial: Efficacy of Nefopam and Morphine in Balanced Analgesia for Acute Ureteric Colic|Unknown status|Recruiting|Phase 4|111|Anticipated|Seoul National University Hospital||3|||f||||||||||||||2017-10-11 03:14:28.931362|2017-10-11 03:14:28.931362
NCT01543139|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-06-06|||October 2009||2009-10-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Trial of Combined Cytidine and Creatine in the Treatment of the Bipolar Depression|A Double-Blind, Placebo-Controlled Trial of Combined Cytidine and Creatine in the Treatment of the Bipolar Depression: A Magnetic Resonance Spectroscopy Study|Unknown status|Recruiting|N/A|75|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-10-11 03:14:29.163369|2017-10-11 03:14:29.163369
NCT01543126|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-07-24|||February 2011||2011-02-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer|A Prospective Study Assessing the Correlation Between Disease Prognosis and the Level of IL-6 and IL-8 Level in Blood and Pleural Effusion Before and After Chemotherapy in Patients With Metastatic Breast Cancer|Terminated||N/A|9|Actual|Fudan University|||1|it's too slow to enroll suitable patients into this study|f||||f||||||Samples With DNA|"     pleural effusion   "|||2017-10-11 03:14:29.271576|2017-10-11 03:14:29.271576
NCT01543113|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-02-21|||January 2011||2011-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|March 2012|Actual|2012-03-01||Interventional|KitMel||cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project|cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project|Completed||N/A|288|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 03:14:29.348211|2017-10-11 03:14:29.348211
NCT01543100|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2014-01-03|||November 2010||2010-11-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PACMoG||Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy|Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy|Completed||N/A|60|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 03:14:29.456302|2017-10-11 03:14:29.456302
NCT01543074|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-08-10|2015-06-01||February 2013||2013-02-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Dietary Histone Deacetylase Inhibitors (HDAC)|Dietary Histone Deacetylase (HDAC) Inhibitors|Terminated||N/A|23|Actual|Texas A&M University|Early termination (23/80) due to small numbers of subjects recruited.|4||Poor recruitment|f||||f||||||||||2017-10-11 03:14:29.95354|2017-10-11 03:14:29.95354
NCT01543061|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-09-26|||February 2012||2012-02-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints|Evaluation of the Effect of Repeated Usage of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints|Completed||Phase 4|35|Anticipated|Optometric Technology Group Ltd||3|||f||||f||||||||||2017-10-11 03:14:30.389292|2017-10-11 03:14:30.389292
NCT01543048|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-08-22|||March 6, 2012|Actual|2012-03-06|August 2017|2017-08-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Observational|SUIVICOL||Prognostic Value of Human Papillomavirus (HPV) Detection in Cervical Intra-epithelial Neoplasia (CIN) Recurrence After Conization|Prognostic Value of Human Papillomavirus (HPV) Detection in Cervical Intra-epithelial Neoplasia (CIN) Recurrence After Conization: Prospective Study With Virological Follow-up on 24 Months (SUIVICOL)|Terminated||N/A|106|Actual|University Hospital, Bordeaux|||1|Lack of recruitment|f||||f||||||Samples With DNA|"     Cervical samples   "|||2017-10-11 03:14:30.485768|2017-10-11 03:14:30.485768
NCT01543035|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-12-11|||December 2011||2011-12-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|ETRALL||Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs|Phase III Prospective Multicentric Trial Evaluating Etravirine for HIV Infected Patients in Need of Lipid Lowering Drugs: the ETRALL Trial|Completed||Phase 3|34|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-10-11 03:14:30.594482|2017-10-11 03:14:30.594482
NCT01543022|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-05-01|||November 2011||2011-11-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|Symphony||Symphony: The Implantable Counter Pulsation Device (CPD) Safety and Feasibility Trial|First in Man Study - a Prospective, Multicenter, Single Arm Trial to Investigate the Safety and Feasibility of the Symphony Device|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Abiomed Inc.||1|||f||||t||||||||||2017-10-11 03:14:30.713016|2017-10-11 03:14:30.713016
NCT01542983|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2013-02-05|||March 2012||2012-03-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy|Feasibility of Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy for Breast Cancer|Completed||N/A|10|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-11 03:14:30.874961|2017-10-11 03:14:30.874961
NCT01542970|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-02|||February 2012||2012-02-01|March 2012|2012-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PROOM-3||Can Supplementation With Lactobacillus Reuteri and Omega-3 Fatty Acids During Pregnancy and Lactation Reduce the Risk of Allergic Disease in Infancy?|Combined Dietary Supplementation With Lactobacillus Reuteri and Omega-3 PUFA During Pregnancy and Postnatally in Relation to Development of IgE-associated Disease During Infancy|Unknown status|Recruiting|N/A|496|Anticipated|Ostergotland County Council, Sweden||4|||f||||t||||||||||2017-10-11 03:14:30.96611|2017-10-11 03:14:30.96611
NCT01542957|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2017-02-17|2016-10-25||November 2011||2011-11-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention|Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention|Completed||N/A|128|Actual|University of Barcelona||2|||f||||f||||||||||2017-10-11 03:14:31.101476|2017-10-11 03:14:31.101476
NCT01542944|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2016-04-19|||February 2012||2012-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||TevaGastrim for Stem Cell Mobilization Sibling Donors|TevaGastrim for Stem Cell Mobilization of HLA Matched Sibling Donors for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Completed||Phase 2|24|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 03:14:31.491996|2017-10-11 03:14:31.491996
NCT01542931|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2017-08-16|||January 2008||2008-01-01|February 2012|2012-02-01|December 31, 2015|Actual|2015-12-31|December 2015|Actual|2015-12-01||Interventional|||TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma|Study of TPF (Docetaxel, Cisplatin, 5-fluorouracil) Induction Chemotherapy Followed by Surgery and Radiotherapy in Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma|Completed||Phase 2/Phase 3|256|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 03:14:31.581564|2017-10-11 03:14:31.581564
NCT01542918|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-09-15|||December 17, 2012|Actual|2012-12-17|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|April 7, 2016|Actual|2016-04-07||Interventional|||Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma|Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma|Active, not recruiting||Phase 1|14|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:14:31.661961|2017-10-11 03:14:31.661961
NCT01542905|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2015-05-23|||May 2010||2010-05-01|May 2015|2015-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Stress Relief Effect of Korean Red Ginseng|Effects of Korean Red Ginseng on Stress Relief and Cognitive and Mental Function Enhancement Using Neuroimaging: Double-Blind, Randomized, Placebo-Controlled Clinical Trial|Completed||N/A|51|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:14:31.74785|2017-10-11 03:14:31.74785
NCT01542892|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-11-14|||October 2011||2011-10-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy of Nutritional Supplementation on Physical-activity Mediated Changes in Physical Functioning Older Adults at Risk for Mobility Disability (The VIVE2 Study)|Efficacy of Nutritional Supplementation on Physical-activity Mediated Changes in Physical Functioning Older Adults at Risk for Mobility Disability (The VIVE2 Study)|Completed||N/A|150|Actual|Tufts University||3|||f||||f||||||||||2017-10-11 03:14:31.825847|2017-10-11 03:14:31.825847
NCT01542879|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-05-02|||February 2012||2012-02-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer|Development of Radiation Free Whole Body MR Imaging Technique for Staging of Children With Cancer.|Recruiting||N/A|100|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 03:14:31.924491|2017-10-11 03:14:31.924491
NCT01542866|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2016-11-16|||June 2011||2011-06-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)|A 16 Week Evaluation of the Novartis Health Management Tool in Assessing Self-test Visual Function in Patients With AMD Treated With Ranibizumab|Completed||Phase 4|160|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:14:32.027531|2017-10-11 03:14:32.027531
NCT01542853|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-02-15|||March 2012||2012-03-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|||||Observational|||The Value of PET/CT in Diagnosing Residual Disease in Patients With Spinal Infection|Preliminary Study. The Value of 18F-FDG PET/CT Compared to MRI in Diagnosing Residual Disease in Patients With Spondylodiscitis|Suspended||N/A|10|Anticipated|Odense University Hospital|||1|problems with recruitment and funding|f||||||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:14:32.339784|2017-10-11 03:14:32.339784
NCT01542840|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-03-20|||May 2014||2014-05-01|March 2014|2014-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Onset Time of Nerve Block: A Comparison of Two Injection Locations in Patients Having Lower Leg/ Foot Surgery|Onset Time of Ultrasound-Guided Popliteal Sciatic Nerve Block: Comparing Circumferential Injection of Local Anesthetic to Injection That Separates the Nerve in Its Two Components|Unknown status|Not yet recruiting|N/A|76|Anticipated|Ochsner Health System|||1||f||||f||||||||||2017-10-11 03:14:32.445051|2017-10-11 03:14:32.445051
NCT01542827|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2016-09-22|||January 2016||2016-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|IRMA04||Acute Effect of Topical Menthol on Neck Pain|Danish: Integreret Motion på Arbejdspladsen (IRMA) English: Implementation of Exercise at the Workplace|Terminated||N/A|20|Anticipated|National Research Centre for the Working Environment, Denmark||2||Lack of resources to perform the study|f||||f||||||||||2017-10-11 03:14:32.557536|2017-10-11 03:14:32.557536
NCT01542814|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2013-10-23|||February 2012||2012-02-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|3DM||Collection of FUJIFILM's 3Dimensional Mammograms|Acquisition of Mammography Images for Clinical Evaluation of FUJIFILM 3Dimensional Mammography|Completed||Phase 3|600|Actual|Fujifilm Medical Systems USA, Inc.|||2||f||||f||||||||||2017-10-11 03:14:32.669312|2017-10-11 03:14:32.669312
NCT00005698|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|July 2000|2000-07-01|August 1997|Actual|1997-08-01|||||Observational|||IN CONTROL--Hypertension Reduction in Inner City Seattle||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.225057|2017-10-11 04:28:54.225057
NCT01542801|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2016-12-27|||August 2011||2011-08-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|July 2015|Actual|2015-07-01||Interventional|||Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention|Comparison of Daily Norfloxacin Versus Weekly Ciprofloxacin for the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients|Completed||Phase 4|124|Actual|Korea University||2|||f||||t||||||||||2017-10-11 03:14:32.777182|2017-10-11 03:14:32.777182
NCT01542788|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-05-08|2014-01-06||March 2012||2012-03-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|POSITRON|Participants in the Safety Analysis Set (randomized and received at least 1 dose of study drug) were analyzed for baseline characteristics.|Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GS-7977 + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 HCV Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon|Completed||Phase 3|278|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 03:14:32.990325|2017-10-11 03:14:32.990325
NCT01542775|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-03-01|||January 2010||2010-01-01|February 2012|2012-02-01||||December 2011|Actual|2011-12-01||Interventional|||Effects of Exercise on sRAGE Levels and Cardiometabolic Risk Factors||Completed||N/A|80|Actual|Korea University||2|||f||||||||||||||2017-10-11 03:14:34.097163|2017-10-11 03:14:34.097163
NCT01542762|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2016-10-10|||March 2012||2012-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|Pot-Cast||Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation|Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation: Determining the Balance Between Benefits and Risks|Completed||N/A|1500|Actual|Leiden University Medical Center||2|||f||||t||||||||Undecided||2017-10-11 03:14:34.181099|2017-10-11 03:14:34.181099
NCT01542749|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-03-01|||January 2009||2009-01-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|August 2010|Actual|2010-08-01||Observational|||Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer|Pilot Research Study to Asses Total Body Albumin Levels|Completed||N/A|20|Actual|Daxor Corporation|||1||f||||t||||||||||2017-10-11 03:14:34.299757|2017-10-11 03:14:34.299757
NCT01542736|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-09-19|||May 2007||2007-05-01|September 2017|2017-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)|Feasibility of Using Concurrent Carboplatin and Reduced Dose Craniospinal Radiation (24Gy) for Metastatic Medulloblastoma, High-Risk Supratentorial PNET and Metastatic PNET|Completed||Phase 2|8|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 03:14:34.37034|2017-10-11 03:14:34.37034
NCT01542723|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2016-10-10|||May 2012||2012-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|Pot-Kast||Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy|Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy: Determining the Balance Between Benefits and Risks|Completed||N/A|1500|Actual|Leiden University Medical Center||2|||f||||t||||||||Undecided||2017-10-11 03:14:34.457111|2017-10-11 03:14:34.457111
NCT01542710|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-03-01|||January 2011||2011-01-01|January 2011|2011-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Bimatoprost/Timolol Versus Travoprost/Timolol|Bimatoprost/Timolol Versus Travoprost/Timolol Fixed Combinations in an Egyptian Population: A Hospital-Based Prospective Randomized Study|Completed||N/A|80|Actual|Kasr El Aini Hospital||1|||f||||f||||||||||2017-10-11 03:14:34.574007|2017-10-11 03:14:34.574007
NCT01542697|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-02-27|||June 2011||2011-06-01|February 2012|2012-02-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Effect of Intraperitoneal Nebulisation of Magnesium Sulphate for Analgesia Following Laparoscopic Cholecystectomy|Phase IV Recruiting|Unknown status|Recruiting|Phase 4|60|Anticipated|B.P. Koirala Institute of Health Sciences||2|||f||||f||||||||||2017-10-11 03:14:34.688269|2017-10-11 03:14:34.688269
NCT01542684|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2014-03-28|2014-03-28||March 2012||2012-03-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)|Phase II Study of Azacytidine Followed by GM-CSF in Patients With Low- or Intermediate-1- Risk Myelodysplastic Syndrome (MDS)|Terminated||Phase 2|8|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f||||||||||2017-10-11 03:14:34.78715|2017-10-11 03:14:34.78715
NCT01542658|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2012-03-01|||February 2012||2012-02-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Comparison of Robot-assisted Laparoscopic Myomectomy With Traditional Laparoscopic Myomectomy||Completed||N/A|42|Actual|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 03:14:35.170021|2017-10-11 03:14:35.170021
NCT01542645|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2014-09-23|2014-03-26||September 2010||2010-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|November 2013|Actual|2013-11-01||Interventional|||The Effect of Choice of Intraoperative Opioid on Postoperative Pain|The Effect of Choice of Intraoperative Opioid on Postoperative Pain|Completed||Phase 4|164|Actual|NorthShore University HealthSystem Research Institute||2|||f||||f||||||||||2017-10-11 03:14:35.240804|2017-10-11 03:14:35.240804
NCT01542632|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-07-20|2014-12-31||February 1, 2012|Actual|2012-02-01|July 2017|2017-07-01|January 10, 2014|Actual|2014-01-10|January 1, 2014|Actual|2014-01-01||Interventional|||A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers|A Randomized, Phase 1b Study to Investigate the Safety and Immunogenicity of Various Schedules of Tetravalent Chimeric Dengue Vaccine in Healthy Adult Volunteers Between the Ages of 18 - 45 Years|Completed||Phase 1|140|Actual|Takeda||6|||f||||f||||||||||2017-10-11 03:14:35.508249|2017-10-11 03:14:35.508249
NCT01542619|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-26|2017-04-19|||March 2012||2012-03-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||A Safety and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor VIIa With Albumin (rVIIa-FP) in Healthy Male Volunteers|A Randomized, Placebo-controlled, Single Center, 5 Cohort Dose Escalation Trial to Investigate Safety and Pharmacokinetics of rVIIa-FP (CSL689) in Comparison to Placebo in Healthy Male Human Volunteers|Completed||Phase 1|40|Actual|CSL Behring||2|||f||||||||||||||2017-10-11 03:14:37.117686|2017-10-11 03:14:37.117686
NCT01542606|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-03-01|||March 2012||2012-03-01|November 2011|2011-11-01|November 2012|Anticipated|2012-11-01|September 2012|Anticipated|2012-09-01||Interventional|||Performance Proof of Product Developed to Detect Abnormal Vaginal pH|Performance Proof of The Norma-Sense Gen 3 - Wearing Study|Unknown status|Not yet recruiting|Phase 3|256|Anticipated|Common Sense||1|||f||||t||||||||||2017-10-11 03:14:37.201796|2017-10-11 03:14:37.201796
NCT01542593|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-04-29|||February 2012||2012-02-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|URO-Y-2||Evaluating Ureteral Length Using Computed Tomography (CT)|Evaluation of Ureteral Length Measurement by Computed Tomography (CT) to Actual Ureteral Length Measured by Ureteral Catheterization|Completed||N/A|53|Actual|Carmel Medical Center||1|||f||||f||||||||||2017-10-11 03:14:37.288188|2017-10-11 03:14:37.288188
NCT01542580|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2017-03-28|||March 2012||2012-03-01|July 2016|2016-07-01|December 2027|Anticipated|2027-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee|A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee|Enrolling by invitation||N/A|255|Anticipated|Zimmer Biomet|||3||f||||f||||||||No||2017-10-11 03:14:37.358668|2017-10-11 03:14:37.358668
NCT01542567|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-05-20|||May 2012||2012-05-01|May 2012|2012-05-01||||May 2014|Anticipated|2014-05-01||Interventional|DIC-2011||Efficacy of Diclofenac BCG Irrigations|Efficacy of Diclofenac Suppositories in Prevention of Immediate Side Effects of BCG Bladder Irrigations. A Double Blind Placebo Controlled Randomized Study|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|Carmel Medical Center||2|||f||||f||||||||||2017-10-11 03:14:37.462168|2017-10-11 03:14:37.462168
NCT01542554|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-27|2012-08-22|||March 2012||2012-03-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Effect of Low Glycaemic Index Diet on Blood Glucose Control in Chinese Type 2 Diabetic Patients|Effect of Low Glycaemic Index Diet on Blood Glucose Control in Chinese Type 2 Diabetic Patients: Randomized Controlled Trial|Unknown status|Recruiting|N/A|44|Anticipated|Hospital Authority, Hong Kong||2|||f||||f||||||||||2017-10-11 03:14:37.543657|2017-10-11 03:14:37.543657
NCT01542528|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-07-28|2016-09-08||March 2012||2012-03-01|July 2017|2017-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|IBBS||Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)|Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|117|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:14:37.876122|2017-10-11 03:14:37.876122
NCT01542515|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-07-24|||March 2009||2009-03-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Allograft Meniscal Arthroplasty for the Treatment of Basal Joint Arthritis of the Thumb|Allograft Meniscal Arthroplasty for the Treatment of Basal Joint Arthritis of the Thumb|Completed||N/A|22|Actual|William Beaumont Hospitals|||1||f||||f||||||||||2017-10-11 03:14:38.28503|2017-10-11 03:14:38.28503
NCT01542502|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-12-12|2014-08-19||February 2012||2012-02-01|December 2016|2016-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||This is a cross-over trial, so all patients have been treated with anakinra and with placebo at different times.|Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction|Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction|Completed||N/A|12|Actual|Virginia Commonwealth University|This is a pilot study to estimate the effects of targeted anti-inflammatory treatment on aerobic exercise capacity in patients with Heart Failure and Preserved Ejection Fraction. All findings should therefore be considered hypothesis generating.|2|||f||||f||||||||||2017-10-11 03:14:38.378264|2017-10-11 03:14:38.378264
NCT01542489|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-01-30|||October 2006||2006-10-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos|An Observational 3 Months Study to Evaluate the Effect of Insulin Levemir® on Glycaemic Control, Weight and Incidence of Hypoglycaemic Events in Insulin Treated Subjects With Type 1 or Type 2 Diabetes|Completed||N/A|480|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-10-11 03:14:38.634702|2017-10-11 03:14:38.634702
NCT01542476|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-03-02|||August 2006||2006-08-01|March 2016|2016-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|CONFIDENCE||The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction|An Observational Study in Dutch Type 1 and Type 2 Diabetes Patients: The Impact of Initiation of/Switching to Levemir® on Emotional Well-being, Insulin Perceptions and Treatment Satisfaction - CONFIDENCE (Clinical ObservatioNs oF Levemir® In Dutch ExperieNCE)|Completed||N/A|299|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:14:38.732845|2017-10-11 03:14:38.732845
NCT01542463|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-03-02|||September 2004||2004-09-01|March 2016|2016-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes|Levemir®: the Physiological Basal Insulin. Documentation of Safety Aspects, Glycaemic Control and Weight|Completed||N/A|4464|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:14:38.819415|2017-10-11 03:14:38.819415
NCT01542450|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-01-26|||August 2002||2002-08-01|January 2017|2017-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes|A Randomised, Open-labelled, Single-centre, Two-period Crossover Trial Investigating the Pharmacodynamics and Pharmacokinetics of Single s.c. Doses of NN304 (Insulin Detemir) and NPH Human Insulin in Japanese Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|23|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:14:38.915838|2017-10-11 03:14:38.915838
NCT01542437|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-03-01|||January 2012||2012-01-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2014|Actual|2014-06-01||Interventional|NSCLC||Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer|Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer in Advanced Stage, Which Have Progressed to Chemotherapy. Analysis of Mutations in EGFR and Number of Copies of HER-2|Active, not recruiting||Phase 2|66|Actual|Instituto Nacional de Cancerologia de Mexico||1|||f||||t||||||||No||2017-10-11 03:14:39.020648|2017-10-11 03:14:39.020648
NCT01542424|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-01-30|||March 2006||2006-03-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus|A Prospective, Multicentre, Open Label, Non-controlled, Observational, 24-week Study in Patients Using NovoMix® 30 (Biphasic Insulin Aspart 30) or Levemir® (Insulin Detemir) for Treatment of Type 1 or Type 2 Diabetes Mellitus in Macedonia|Completed||N/A|1889|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-10-11 03:14:39.129809|2017-10-11 03:14:39.129809
NCT01542411|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-25|2012-03-01|||April 2008||2008-04-01|February 2012|2012-02-01||||||||Observational|||Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment||Completed||N/A|520|Actual|Yazd Medical University|||3||f||||t||||||||||2017-10-11 03:14:39.218686|2017-10-11 03:14:39.218686
NCT01542385|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-08-28|||April 2014||2014-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|November 2017|Anticipated|2017-11-01||Interventional|PRIMACY||Primary Reperfusion Secondary Stenting Trial|Immediate vs. Delayed Stenting After Primary Percutaneous Reperfusion in ST Elevation Myocardial Infarction|Active, not recruiting||N/A|307|Actual|Montreal Heart Institute||2|||f||||t||||||||||2017-10-11 03:14:39.364741|2017-10-11 03:14:39.364741
NCT01542372|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-04-10|2017-02-20||April 2012|Actual|2012-04-01|April 2017|2017-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Patients who meet inclusion criteria for Step 1 such as PTSD and impairment.|Two Stepped Care Models for Posttraumatic Stress Disorder (PTSD) Among Cambodian Refugees With PTSD|Two Stepped Care Models for PTSD Among Cambodian Refugees With PTSD|Terminated||Phase 4|114|Actual|Massachusetts General Hospital|Owing to lack of recruitment sites the study was ended early. In addition, many more patients than anticipated had no PTSD after Step I and hence could not be randomized to participate in Step II. This greatly impacted on flow.|2||Inadequate flow of patients|f||||t|t|f|||t|||Undecided||2017-10-11 03:14:39.474094|2017-10-11 03:14:39.474094
NCT01542359|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2013-01-08|||September 2011||2011-09-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effectiveness of Yoga on Ambulatory Blood Pressure in Patients With Pre- and Stage I Hypertension|Effectiveness of Yoga on Ambulatory Blood Pressure in Patients With Pre- and Stage I Hypertension|Completed||N/A|90|Actual|Long Island University||2|||f||||f||||||||||2017-10-11 03:14:39.839862|2017-10-11 03:14:39.839862
NCT01542346|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-25|2013-07-11|||March 2012||2012-03-01|July 2013|2013-07-01||||||||Interventional|||Subcutaneous Adaption and Cosmetic Outcome Following Caesarean Delivery||Completed||N/A|116|Anticipated|Klinikum Klagenfurt am Wörthersee||1|||f||||||||||||||2017-10-11 03:14:39.940757|2017-10-11 03:14:39.940757
NCT01542333|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-05-17|||February 2012||2012-02-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Biomarkers in Samples From Younger Patients With Wilms Tumor|Biological Analysis of Ethnic Variations in Wilms Tumor|Completed||N/A|20|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:14:40.051389|2017-10-11 03:14:40.051389
NCT01542320|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-03-05|||March 2012||2012-03-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ProBoost||Effect of Probiotic Supplementation on Immune Function in Healthy Infants|Application of Therapeutic Microbiology to Improve Immunogenicity|Completed||N/A|15|Actual|Emory University||2|||f||||t||||||||||2017-10-11 03:14:40.174691|2017-10-11 03:14:40.174691
NCT01542307|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-02-03|2016-10-16||July 2012||2012-07-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Enrolled subjects|Normobaric Oxygen (NBO) Therapy in Acute Migraine|Normobaric Oxygen (NBO) Therapy in Acute Migraine|Completed||Phase 2|22|Actual|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-11 03:14:40.306757|2017-10-11 03:14:40.306757
NCT01542294|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2016-06-12|||June 2011||2011-06-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|September 2014|Actual|2014-09-01||Interventional|||SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer|Phase I/II Study of Oral S-1 Plus f Oxaliplatin as an Adjuvant Chemotherapy After Curative Resection of Stage II-IV(M0) Gastric Cancer|Active, not recruiting||Phase 1/Phase 2|71|Actual|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 03:14:40.955348|2017-10-11 03:14:40.955348
NCT01542281|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-02-24|||January 2012||2012-01-01|February 2012|2012-02-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer|Improving Outcomes in Patients With Hepatobiliary Cancers With a Nutritional and Physical Conditioning Pre-habilitation Program|Unknown status|Recruiting|N/A|64|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 03:14:41.081077|2017-10-11 03:14:41.081077
NCT01542268|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2012-03-05|||March 2012||2012-03-01|March 2012|2012-03-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|IBS-PTX||Effect of Pentoxifylline on Tight Junctions (TJs) of Intestinal Mucosa in Patients With Irritable Bowel Syndrome(IBS)|Effect of Pentoxifylline on Tight Junctions of Intestinal Mucosa in Patients With Irritable Bowel Syndrome|Unknown status|Not yet recruiting|Phase 4|59|Anticipated|Hospital Universitario de Canarias||2|||f||||t||||||||||2017-10-11 03:14:41.203633|2017-10-11 03:14:41.203633
NCT01542255|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-09-08|2014-08-28||June 2010||2010-06-01|September 2014|2014-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||patients with metastatic melanoma|Metronomic Therapy in Patients With Metastatic Melanoma|Metronomic Therapy in Patients With Metastatic Melanoma: A Phase II Study of Low Dose Vinblastine, Cyclophosphamide, and Dacarbazine|Terminated||Phase 2|7|Actual|Dartmouth-Hitchcock Medical Center|terminated early due to difficulty with scheduling three times per week office treatment|1||Low accrual not allowing to support statistical endpoints|f||||t||||||||||2017-10-11 03:14:41.317938|2017-10-11 03:14:41.317938
NCT01542242|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-12-08|||February 2012||2012-02-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Liraglutide Use in Prader-Willi Syndrome||Terminated||Phase 4|1|Actual|Vancouver General Hospital||1||Subject withdrew|f||||||||||||||2017-10-11 03:14:41.512061|2017-10-11 03:14:41.512061
NCT01542229|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-02-23|||May 3, 2012|Actual|2012-05-03|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|PTSD/SMI||PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)|Improving PTSD Service Delivery for Veterans With Severe Mental Illness|Completed||Phase 2|156|Anticipated|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 03:14:41.636911|2017-10-11 03:14:41.636911
NCT01542216|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-11-04|||February 2012||2012-02-01|November 2015|2015-11-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||Evaluation of Nutrition and Metabolism in Breast Cancer Patients|Evaluation of Nutrition and Metabolism in Breast Cancer Patients|Withdrawn||N/A|0|Actual|University of Waterloo||2||Recruitment challenges|f||||f||||||||||2017-10-11 03:14:41.783948|2017-10-11 03:14:41.783948
NCT01542203|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-02-29|||March 2012||2012-03-01|January 2012|2012-01-01||||||||Observational|||Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer|Impact of Body Weight on the Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide in Breast Cancer Patients|Unknown status|Not yet recruiting|N/A|18|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-10-11 03:14:41.898092|2017-10-11 03:14:41.898092
NCT01542190|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2014-12-02|||February 2011||2011-02-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery|A Randomized, Masked Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery.|Completed||Phase 4|80|Anticipated|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 03:14:41.985003|2017-10-11 03:14:41.985003
NCT01542177|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-06-21|||February 2012||2012-02-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer|The Evaluation of Hypoxia Imaging in Patients With Pancreatic Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)|Recruiting||N/A|30|Anticipated|University Health Network, Toronto|||1||f||||f||||||None Retained|"     2 tubes of whole blood   "|||2017-10-11 03:14:42.087441|2017-10-11 03:14:42.087441
NCT01542164|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-26|2017-02-06|||June 2010|Actual|2010-06-01|February 2017|2017-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|KIFU/B266||Calcium Intake and Fat Excretion|Calcium Intake and Fat Excretion - an Observational Study|Completed||N/A|158|Actual|University of Copenhagen|||1||f||||f||||||Samples With DNA|"     Whole blood, urine and faeces   "|||2017-10-11 03:14:42.184442|2017-10-11 03:14:42.184442
NCT01542151|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-03-24|||October 2011||2011-10-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Sleep, Fatigue, and Timing of Post-dates Inductions Among Nulliparas|Effects of Sleep, Fatigue, and Timing of Post-dates Inductions Among Nulliparas|Completed||N/A|72|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:14:42.271946|2017-10-11 03:14:42.271946
NCT01542138|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-11-27|||July 2011||2011-07-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation|A Double Blind, Randomized Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation|Completed||Phase 4|28|Actual|Universidad Autonoma de San Luis Potosí||3|||f||||f||||||||||2017-10-11 03:14:42.39238|2017-10-11 03:14:42.39238
NCT01542125|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-06-10|2015-06-05||September 2008||2008-09-01|June 2016|2016-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||The Effect of Liposomal Lidocaine on Perceived Pain in Children During Percutaneous Interosseous Pin Removal in the Outpatient Setting|The Effect of Liposomal Lidocaine on Perceived Pain in Children During Percutaneous Interosseous Pin Removal in the Outpatient Setting: A Triple Blinded, Randomized Placebo-controlled Clinical Trial|Completed||Phase 4|281|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 03:14:42.503412|2017-10-11 03:14:42.503412
NCT01542112|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2013-03-05|||March 2012||2012-03-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||An Innovational Model to Manage Patient Expectations and Improve Patient Satisfaction: An Intervention Study|An Innovational Model to Manage Patient Expectations and Improve Patient Satisfaction: An Intervention Study|Completed||N/A|835|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 03:14:42.713975|2017-10-11 03:14:42.713975
NCT01542099|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-04-19|||November 2011||2011-11-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||The EC50 of Remifentanil Blunting Hemodynamic Response to Double Lumen Tube Intubation|The Effect Site Concentration of Remifentanil Blunting Hemodynamic Responses to Tracheal Intubation: Single Versus Double Lumen Tube|Completed||N/A|80|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:14:42.798566|2017-10-11 03:14:42.798566
NCT01542086|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-02-24|||September 2011||2011-09-01|February 2012|2012-02-01||||||||Interventional|CARE-CCTA||Comparison of the Cost-Effectiveness of Coronary CT Angiography Versus Myocardial SPECT in Patients With Intermediate Risk of Coronary Heart Disease|Comparison of the Cost-Effectiveness of Coronary CT Angiography Versus Myocardial SPECT in Patients With Intermediate Risk of Coronary Heart Disease|Unknown status|Recruiting|N/A|1050|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:14:42.876209|2017-10-11 03:14:42.876209
NCT01542073|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-04-06|||February 2012||2012-02-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GRGDMI||68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction|68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Angiogenesis of Myocardial Infarction and the Comparison With Cardiac Perfusion and Metabolism|Recruiting||Early Phase 1|50|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-11 03:14:42.977704|2017-10-11 03:14:42.977704
NCT01542060|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-04-11|||January 2004||2004-01-01|April 2012|2012-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus|A Clinical Experience Programme to Collect Data on the Safety and Efficacy of NovoMix® 30 in the Treatment of Patients With Type 2 Diabetes in Jordan|Completed||N/A|298|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:14:43.069505|2017-10-11 03:14:43.069505
NCT01542047|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2015-06-17|||August 2012||2012-08-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies|A Phase I Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies|Terminated||Phase 1|3|Actual|New Mexico Cancer Care Alliance||1||Low rate of accrual|f||||t||||||||||2017-10-11 03:14:43.187823|2017-10-11 03:14:43.187823
NCT01542034|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2015-05-28|2015-05-28|2014-05-30|February 2012||2012-02-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|REFINE-1|Intention-to-treat population|Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area|Completed||Phase 3|506|Actual|Kythera Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 03:14:43.551149|2017-10-11 03:14:43.551149
NCT01542021|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-03-01|||February 2012|Actual|2012-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer|Establishing a Neo-Adjuvant Platform for Developing Targeted Agents: Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer|Active, not recruiting||N/A|41|Actual|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-11 03:14:44.346876|2017-10-11 03:14:44.346876
NCT01542008|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-01-30|||April 2012||2012-04-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|July 2017|Anticipated|2017-07-01||Interventional|CAE RCT||Treatment Adherence Enhancement in Bipolar Disorder|Treatment Adherence Enhancement in Bipolar Disorder|Active, not recruiting||N/A|184|Actual|Case Western Reserve University||2|||f||||f||||||||||2017-10-11 03:14:44.448213|2017-10-11 03:14:44.448213
NCT01541995|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2013-09-27|||April 2012||2012-04-01|September 2013|2013-09-01||||August 2013|Actual|2013-08-01||Observational|||Evaluation of Contrast Medium Enhanced Post-mortem CT in Virtual Autopsy||Completed||N/A|50|Actual|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f||||||Samples Without DNA|"     Histology   "|||2017-10-11 03:14:44.527395|2017-10-11 03:14:44.527395
NCT01541982|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2015-06-16|||April 2012||2012-04-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Observational|||Virtual Autopsy for Quality Control on Intensive Care Medicine|Virtual Autopsy for Quality Control on Intensive Care Medicine|Completed||N/A|160|Actual|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f||||||||||2017-10-11 03:14:44.682433|2017-10-11 03:14:44.682433
NCT01541969|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-07-21|2015-04-18||August 2012||2012-08-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|RESET2||Evaluation of the CR Neuromodulation Treatment for Tinnitus|Systematic Evaluation of the Acoustic CR ® Neuromodulation Treatment for Tinnitus|Completed||Phase 2/Phase 3|100|Actual|Nottingham University Hospitals NHS Trust|Clinical Trial Protocol inadequately specified, particularly (i) device fitting, (ii) tolerance for pitch matching shifts and (iii) monitoring research audiologists after training. Specification of placebo algorithm is not evidenced by published data|2|||f||||t||||||||||2017-10-11 03:14:44.775114|2017-10-11 03:14:44.775114
NCT01541956|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-11-16|||February 2012||2012-02-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)|An Open-labeled, Randomized, Multicenter, Prospective, Parallel Group, Interventional Study to Demonstrate the Effectiveness of 24 Weeks Treatment With Vildagliptin 50mg Bid as Add on to Metformin 500 mg Bid Compared to Metformin up to 1000 mg Bid in Chinese Patients With Type 2 Diabetes Inadequately Controlled on Metformin 500 mg Bid Monotherapy .|Completed||Phase 4|3091|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:14:45.416186|2017-10-11 03:14:45.416186
NCT01541943|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2015-09-21|||March 2012||2012-03-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia|A Phase 3, Randomized, Double- Blind, Multi-center, Double Dummy, Clinical Trial Comparing HL-040XC With Single Component Therapies(Atorvastatin, Losartan) to Assess the Efficacy and Safety of HL-040XC in Patients With Essential Hypertension and Hyperlipidemia|Completed||Phase 3|356|Actual|HanAll BioPharma Co., Ltd.||4|||f||||f||||||||||2017-10-11 03:14:46.204004|2017-10-11 03:14:46.204004
NCT01541930|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2014-01-07|2013-11-13||April 2012||2012-04-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|GK567|All patients who received the treatment at least once (Safety population) were included in all efficacy and safety analyses.|An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours|An Open, Uncontrolled Study Investigating the Safety and Efficacy of GK567 in the Deodorization of Malodorous Infected Cutaneous Fungating Neoplastic Tumours, Over 14 Days of Treatment|Completed||Phase 3|21|Actual|Galderma R&D||1|||f||||f||||||||||2017-10-11 03:14:46.366285|2017-10-11 03:14:46.366285
NCT01541917|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-01-18|2016-11-21||July 2012||2012-07-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|WebSMART||Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis|WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis|Completed||Phase 3|305|Actual|Children's Mercy Hospital Kansas City||2|||f||||t||||||||Yes|A deidentified dataset is available for secondary analyses per our Resource Sharing Plan.|2017-10-11 03:14:47.211074|2017-10-11 03:14:47.211074
NCT01541904|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-06-03|||March 2011||2011-03-01|June 2013|2013-06-01||||February 2012|Actual|2012-02-01||Interventional|PRO-118||Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis|STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PRO-118 OPHTHALMIC SOLUTION IN ALLERGIC CONJUNCTIVITIS|Suspended||Phase 2|35|Anticipated|Laboratorios Sophia S.A de C.V.||5||Reformulation|f||||t||||||||||2017-10-11 03:14:48.03364|2017-10-11 03:14:48.03364
NCT01541878|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2012-02-29|||January 2012||2012-01-01|February 2012|2012-02-01||||||||Observational|||Breast Cancer Registry in Thailand|Pilot Study of Breast Cancer Registry in Thailand|Unknown status|Recruiting|N/A|300|Anticipated|Siriraj Hospital|||1||f||||f||||||||||2017-10-11 03:14:48.237885|2017-10-11 03:14:48.237885
NCT01541865|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-10-23|2015-09-15||February 2012||2012-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|November 2013|Actual|2013-11-01||Interventional|REDUCE-HTN||Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter|Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter (REDUCE-HTN) - POST MARKET APPROVAL CLINICAL SURVEILLANCE STUDY|Completed||N/A|146|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-10-11 03:14:48.314168|2017-10-11 03:14:48.314168
NCT01541852|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-03-15|||June 2012||2012-06-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|EVOLUTION||Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen.|An Evaluation Of Losmapimod in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Systemic Inflammation Stratified Using Fibrinogen (EVOLUTION)|Completed||Phase 2|72|Actual|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 03:14:49.055231|2017-10-11 03:14:49.055231
NCT01541826|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-04-12|2016-12-12||February 2012||2012-02-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|August 2015|Actual|2015-08-01||Interventional|||Study of Chokeberry to Reduce Cardiovascular Disease Risk in Former Smokers|The Effect of Chokeberry Polyphenols on Biomarkers of Cardiovascular Disease and Antioxidant Defenses in Former Smokers|Completed||N/A|62|Actual|University of Connecticut||3|||f||||f||||||||||2017-10-11 03:14:49.291106|2017-10-11 03:14:49.291106
NCT01541813|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2015-03-09|||March 2011||2011-03-01|August 2014|2014-08-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|HEPCIDEF||Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.|Clinical, Biological, Genetic and Functional Characterization of Rare Iron Overload Phenotypes Associated With Hepcidin Deficiency Except C282Y Homozygosity.|Terminated||N/A|62|Actual|Rennes University Hospital|||1|rare overload and low recruitment|f||||||||||||||2017-10-11 03:14:52.357821|2017-10-11 03:14:52.357821
NCT01541800|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2016-02-03|||March 2010||2010-03-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Circulating microRNAs as Disease Markers in Pediatric Cancers|A Feasibility Study of Circulating microRNAs as Disease Markers in Pediatric Cancers|Recruiting||N/A|20|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||Samples Without DNA|"     whole blood and cerebral spinal fluid   "|||2017-10-11 03:14:52.455894|2017-10-11 03:14:52.455894
NCT01541774|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-04|2014-01-29|||August 2010||2010-08-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|EASE||Endovascular Atherectomy Safety and Effectiveness Study|A Prospective, Multicenter Clinical Evaluation of the Safety and Effectiveness of the Phoenix Atherectomy™ System in Atherectomy of the Peripheral Vasculature|Completed||Phase 3|128|Actual|AtheroMed, Inc||1|||f||||t||||||||||2017-10-11 03:14:52.55221|2017-10-11 03:14:52.55221
NCT01541748|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-07-19|||November 2011||2011-11-01|July 2017|2017-07-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Observational|||Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study|Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study|Active, not recruiting||N/A|74|Actual|Coloplast A/S|||1||f||||f||||||||||2017-10-11 03:14:52.770846|2017-10-11 03:14:52.770846
NCT01541735|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2014-01-07|2013-07-27||January 2012||2012-01-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|IBP||Pantoprazole on Insulin Secretion in Diabetes|Effect of Pantoprazole on Insulin Secretion in Patients With Type 2 Diabetes|Completed||Phase 2/Phase 3|14|Actual|Coordinación de Investigación en Salud, Mexico|The intervention time was short to evaluate a total change in the primary outcome variables|2|||f||||t||||||||||2017-10-11 03:14:52.857185|2017-10-11 03:14:52.857185
NCT01541722|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2015-10-01|||February 2012||2012-02-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Observational|||Oxidative Stress, Inflammation and Acute Decompensation in Urea Cycle Disorders|Oxidative Stress, Inflammation and Acute Decompensation in Urea Cycle Disorders|Terminated||N/A|10|Actual|Children's Research Institute|||1|DSMB suggested closure due to low enrollment|f||||t||||||||||2017-10-11 03:14:53.333591|2017-10-11 03:14:53.333591
NCT01541709|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-24|2017-07-13|||March 2012|Actual|2012-03-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation|A Phase II Study of Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation|Recruiting||Phase 2|44|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:14:53.460461|2017-10-11 03:14:53.460461
NCT01541696|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-03-06|||June 2010||2010-06-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|December 2011|Actual|2011-12-01||Observational|||Exchangeable Zinc Pool Size and Zn Absorption From Sprinkles and Traditional Foods in Pakistani Infants /Toddlers|Exchangeable Zn Pool Size and Zn Absorption From Sprinkles and Traditional Foods in Pakistani Infants/Toddlers|Unknown status|Active, not recruiting|N/A|40|Actual|Aga Khan University|||2||f||||t||||||||||2017-10-11 03:14:53.577699|2017-10-11 03:14:53.577699
NCT01541683|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-08-05|||January 2012||2012-01-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Mentholyptus Drops on the Palatability of PEG-Electrolyte Solution|The Effect of Mentholyptus Drops (Halls®) on the Palatability of PEG-Electrolyte Solution (FORTRANS®) in Colonoscopy Preparation: A Randomized Controlled Trial|Completed||N/A|99|Actual|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-11 03:14:53.683397|2017-10-11 03:14:53.683397
NCT01541670|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-06-26|||November 2011||2011-11-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis|A Study to Assess the Safety and Tolerability of Anti-MIF Antibody in Subjects With Lupus Nephritis|Terminated||Phase 1|4|Actual|Baxalta US Inc.||1|||f||||t||||||||||2017-10-11 03:14:53.789218|2017-10-11 03:14:53.789218
NCT01541657|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2014-09-12|||December 2011||2011-12-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|STARS||Sensory-Targeted Ankle Rehabilitation Strategies (STARS)|Sensory-Targeted Ankle Rehabilitation Strategies|Completed||Phase 2|80|Actual|University of Kentucky||4|||f||||t||||||||||2017-10-11 03:14:53.942744|2017-10-11 03:14:53.942744
NCT01541644|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-11-02|2015-04-21||May 2011||2011-05-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|June 2012|Actual|2012-06-01||Interventional|||1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma|A Pilot Study to Evaluate the Efficacy and Explore the Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma Patients|Completed||N/A|27|Actual|University of Maryland|TNSc results deemed invalid as original validation of TNSc was performed by 2 neuromuscular trained physicians & the TNSc in our trial was performed by a research nurse. The reliability & validity of research nurse's TNSc not established pre-trial.|1|||f||||t||||||||||2017-10-11 03:14:54.058118|2017-10-11 03:14:54.058118
NCT01541631|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-03-02|||May 2012||2012-05-01|March 2012|2012-03-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes|Epidemiology of Human Immunodeficiency Virus (HIV-1) and Schistosoma Mansoni Co-infections and Its Impact on Anthelminthic Treatment Outcome Among HIV-1 Infected Individuals in Fishing Communities in Mwanza Region, Northwestern Tanzania.|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Catholic University of Health and Allied Sciences||4|||f||||f||||||||||2017-10-11 03:14:54.230066|2017-10-11 03:14:54.230066
NCT01541618|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-02-29|||January 2012||2012-01-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|||A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis|A Longitudinal Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis|Unknown status|Recruiting|N/A|15|Anticipated|MSDx, Inc.|||1||f||||f||||||Samples With DNA|"     Blood remaining after the biomarker test is completed will be retained for possible     evaluation of additional biomarkers   "|||2017-10-11 03:14:54.345689|2017-10-11 03:14:54.345689
NCT01541605|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-06-09|||March 2012||2012-03-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Methylphenidate for the Treatment of Acute Mania|International Randomised Double-blind Placebo-controlled Study on the Initial Treatment of Acute Mania With Methylphenidate|Completed||Phase 3|42|Actual|University of Leipzig||2|||f||||t||||||||||2017-10-11 03:14:54.425056|2017-10-11 03:14:54.425056
NCT01541592|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-11-24|||March 2012||2012-03-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Does Class of Dietary Fat Affect Insulin Resistance?|Insulin Resistance and Dietary Fat|Completed||N/A|24|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 03:14:54.526803|2017-10-11 03:14:54.526803
NCT01541579|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-11-30|||July 2012||2012-07-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|July 2015|Actual|2015-07-01||Interventional|ADMIRE-CD||Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease|A Phase III, Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess Efficacy and Safety of Expanded Allogeneic Adipose-derived Stem Cells (eASCs) for the Treatment of Perianal Fistulising Crohn's Disease Over a Period of 24 Weeks and an Extended Follow-up Period up to 104 Weeks.|Active, not recruiting||Phase 3|278|Anticipated|Cellerix||2|||f||||f||||||||||2017-10-11 03:14:54.620037|2017-10-11 03:14:54.620037
NCT01541566|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-02-25|||November 2007||2007-11-01|February 2016|2016-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|TELEBPMET||Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring and Assessment of Psychological Determinants|Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring|Completed||N/A|254|Actual|Italian Institute of Telemedicine|||2||f||||f||||||||||2017-10-11 03:14:54.835935|2017-10-11 03:14:54.835935
NCT01541553|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-07-26|2014-02-13||March 2012||2012-03-01|July 2016|2016-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp|A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp|Completed||Phase 3|367|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 03:14:55.131673|2017-10-11 03:14:55.131673
NCT01541540|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-10-06|||February 2012||2012-02-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|REACH||e-Counseling Promotes Blood Pressure Reduction and Therapeutic Lifestyle Change in Hypertension|Reducing Risk With E-based Support for Adherence to Lifestyle Change in Hypertension|Completed||N/A|264|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 03:14:55.559272|2017-10-11 03:14:55.559272
NCT01541527|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-12-30|||February 2012||2012-02-01|February 2012|2012-02-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Observational|||Non Neutralizing Antibodies: Prevalence and Characterization|Prevalence and Epitope Specificity of Non-neutralizing Antibodies in Haemophilia A Patients Without Inhibitors, Immunogenicity of B Domain: A Prospective Study|Withdrawn||N/A|0|Actual|University Hospital, Montpellier|||1|Promoter's change|f||||f||||||||||2017-10-11 03:14:55.658441|2017-10-11 03:14:55.658441
NCT01541514|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-12-02|||July 2011||2011-07-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|April 2012|Actual|2012-04-01||Observational|||Evaluating the Patient-Ventilator Synchrony During Mechanical Ventilation in Patients With Acute Lung Injury||Completed||N/A|30|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 03:14:55.752144|2017-10-11 03:14:55.752144
NCT01541501|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-09-02|||September 2011||2011-09-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|||||Observational|||Comparison of Three Different No-contact Pachymetries|Phase 4 Study of Comparison Among 3 Different No-contact Instruments to Valuate Central Corneal Thickness|Unknown status|Recruiting|N/A|150|Anticipated|University of Cantanzaro|||1||f||||f||||||||||2017-10-11 03:14:55.813329|2017-10-11 03:14:55.813329
NCT01541488|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-10-30|||February 2012||2012-02-01|October 2013|2013-10-01||||May 2012|Actual|2012-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Early Pharmacodynamics of Single Rising Oral Doses of BI 1021958 Tablets in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses (1 mg as Drinking Solution, and 5, 20, 60, 150, 300, 500 mg as Tablets) of BI 1021958 in Healthy Male Volunteers (Placebo-controlled, Randomised and Single Blind Within Dose Groups), Including Investigation of the Effect of Food on the Bioavailability of BI 1021958 (Open-label, Randomised, Two-way Cross-over)|Completed||Phase 1|66|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:14:55.904575|2017-10-11 03:14:55.904575
NCT00004689|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||January 1991||1991-01-01|February 1999|1999-02-01|September 1998||1998-09-01|||||Interventional|||Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease||Completed||Phase 2|50||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.519499|2017-10-11 04:26:56.519499
NCT01541475|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-04-09|||March 2009||2009-03-01|April 2014|2014-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder|Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder|Completed||Phase 4|60|Actual|Ewha Womans University||2|||f||||f||||||||||2017-10-11 03:14:55.990353|2017-10-11 03:14:55.990353
NCT01541462|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-02-23|||October 2000||2000-10-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|June 2010|Actual|2010-06-01||Interventional|||Weaning From Prolonged Mechanical Ventilation|Weaning From Prolonged Mechanical Ventilation|Completed||N/A|500|Actual|RML Specialty Hospital||2|||f||||f||||||||||2017-10-11 03:14:56.095675|2017-10-11 03:14:56.095675
NCT01541449|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-29|||January 2012||2012-01-01|January 2012|2012-01-01|April 2012|Anticipated|2012-04-01|||||Observational|||Plaqenil Role in Prevention of Age Related Macular Degeneration|Observational Study Between People That Use Plaquenil and Those Who do Not in Prevention of AMD.|Unknown status|Recruiting|N/A|30|Anticipated|Ziv Hospital|||2||f||||t||||||||||2017-10-11 03:14:56.186859|2017-10-11 03:14:56.186859
NCT01541436|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-06-02|||March 2012|Actual|2012-03-01|June 2017|2017-06-01|April 30, 2017|Actual|2017-04-30|March 2016|Actual|2016-03-01||Interventional|||Remote Ischemic Preconditioning Mechanism Study|Remote Ischemic Preconditioning Effects on Central and Peripheral Sensitization in Healthy Volunteers-A Pilot Study|Completed||N/A|20|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 03:14:56.278309|2017-10-11 03:14:56.278309
NCT01541423|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-10-20|||March 2012||2012-03-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema|A European Multi-Center, Multi-Country, Post-Authorisation, Observational Study (Registry) Of Patients With Hereditary Angioedema (HAE) Who Are Administered CINRYZE® (C1 Inhibitor [Human]) For The Treatment Or Prevention Of HAE Attacks|Completed||N/A|83|Actual|Shire|||1||f||||f||||||||||2017-10-11 03:14:56.393991|2017-10-11 03:14:56.393991
NCT01541410|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2013-07-12|||May 2010||2010-05-01|July 2013|2013-07-01||||August 2011|Actual|2011-08-01||Interventional|||Evaluation of the Vascutek Hybrid Graft for Use in the Replacement of the Aortic Arch and Concomitant Treatment of an Aneurysm/Dissection of the Descending Aorta in the Frozen Elephant Trunk Procedure||Completed||Phase 1/Phase 2|34|Actual|Vascutek Ltd.||1|||f||||t||||||||||2017-10-11 03:14:56.517998|2017-10-11 03:14:56.517998
NCT01541397|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-06-11|2015-06-11||June 2011||2011-06-01|June 2015|2015-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy|Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy|Terminated||N/A|6|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 03:14:56.588484|2017-10-11 03:14:56.588484
NCT01541384|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-08-10|2017-07-12||February 2012||2012-02-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Medication Adherence in Kidney Transplant Recipients Using Automated Reminders and Provider Notification|Medication Adherence in Kidney Transplant Recipients Using Automated Reminders and Provider Notification|Completed||N/A|120|Actual|University of Pennsylvania|The study did not assess clinical end points. Participants and study coordinators were not blinded to intervention arm.|3|||f||||f||||||||||2017-10-11 03:14:56.847513|2017-10-11 03:14:56.847513
NCT01541371|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2013-07-03|2013-02-28||July 2008||2008-07-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia|An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Non Acute Episode Subjects With Schizophrenia|Completed||Phase 3|405|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||||||||||2017-10-11 03:14:57.277506|2017-10-11 03:14:57.277506
NCT01541358|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-05-12|2017-02-14||May 2012||2012-05-01|May 2017|2017-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer|Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer|Terminated||N/A|2|Actual|Stanford University|Low participant enrollment. The uptake of fluoride ions is better in bone remodeling processes, while purely bone lytic processes have a lower uptake, or no uptake at all, which is a limitation of F-18 NaF PET/CT bone scan.|1||Low accrual and no funding|f||||t||||||||No||2017-10-11 03:14:57.881699|2017-10-11 03:14:57.881699
NCT01541345|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-12-01|||February 2011||2011-02-01|December 2015|2015-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2|A Phase III, Randomized, Controlled Clinical Trial of Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2|Active, not recruiting||Phase 3|24|Anticipated|University of Zurich||2|||f||||f||||||||||2017-10-11 03:14:58.136897|2017-10-11 03:14:58.136897
NCT01541332|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-03-08|||February 2012||2012-02-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma|A Phase 1/2 Study of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|70|Actual|Oncotherapeutics||1|||f||||f||||||||||2017-10-11 03:14:58.225982|2017-10-11 03:14:58.225982
NCT01541319|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-09-07|||July 2012||2012-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|MARS||Mechanism and Repository Study for the Red Cell Storage Duration Study|Mechanism and Repository Study for the Red Cell Storage Duration Study|Completed||N/A|92|Actual|New England Research Institutes|||4||f||||t||||||Samples With DNA|"     plasma, pRBCs, PBMCs   "|||2017-10-11 03:14:58.356255|2017-10-11 03:14:58.356255
NCT01541306|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-04-13|||February 2012||2012-02-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||C-Type Natriuretic Peptide and Achondroplasia|C-Type Natriuretic Peptide and Achondroplasia|Completed||N/A|91|Actual|Nemours Children's Clinic|||1||f||||f||||||Samples Without DNA|"     Plasma and serum samples are stored for potential future research.   "|||2017-10-11 03:14:58.496301|2017-10-11 03:14:58.496301
NCT01541293|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-05-13|||September 2012||2012-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Intrauterine Lidocaine for Laminaria|Intrauterine Lidocaine for Pain Control During Laminaria Insertion Prior to Dilation & Evacuation (D&E)|Completed||Phase 1|72|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 03:14:58.578895|2017-10-11 03:14:58.578895
NCT01541280|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-03-17|||November 2011||2011-11-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|VIDAZA-DLI||VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome|Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome|Completed||Phase 2|30|Actual|Nantes University Hospital||1|||f||||||||||||||2017-10-11 03:14:58.672772|2017-10-11 03:14:58.672772
NCT01541267|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2012-02-28|||December 2009||2009-12-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|May 2011|Actual|2011-05-01||Interventional|||The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria|The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria in Chronic Non-diabetic Kidney Disease: a Double-blind Cross-over Randomised Controlled Study|Completed||Phase 4|20|Actual|Medical University of Gdansk||3|||f||||t||||||||||2017-10-11 03:14:58.791244|2017-10-11 03:14:58.791244
NCT01541254|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-09-06|2014-09-05||March 2012||2012-03-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|LVIS||Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device|A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms|Completed||Phase 2/Phase 3|30|Actual|Microvention-Terumo, Inc.||1|||f||||t||||||||||2017-10-11 03:14:58.887365|2017-10-11 03:14:58.887365
NCT01541241|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-02-28|||January 2012||2012-01-01|February 2012|2012-02-01|May 2012|Anticipated|2012-05-01|January 2012|Actual|2012-01-01||Observational|IUD||Study About Patients Using Copper Intrauterine Device|Uterine Haemodynamic Changes in Patients With Copper Intrauterine Device Induced Bleeding|Unknown status|Recruiting|N/A|100|Anticipated|Egymedicalpedia|||1||f||||t||||||||||2017-10-11 03:14:59.15944|2017-10-11 03:14:59.15944
NCT01541228|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2013-09-02|||April 2010||2010-04-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|April 2011|Actual|2011-04-01||Interventional|||Photodynamic Treatment of Actinic Keratoses With Different Light Doses|Clinical Effect of Photodynamic Treatment When Treating Actinic Keratoses With Different Light Doses|Completed||N/A|38|Actual|Lithuanian University of Health Sciences||2|||f||||t||||||||||2017-10-11 03:14:59.253232|2017-10-11 03:14:59.253232
NCT01541215|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-08-18|||November 13, 2012|Actual|2012-11-13|August 2017|2017-08-01|May 20, 2020|Anticipated|2020-05-20|June 28, 2018|Anticipated|2018-06-28||Interventional|Ellipse™||Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes|Efficacy and Safety of Liraglutide in Combination With Metformin Versus Metformin Monotherapy on Glycaemic Control in Children and Adolescents With Type 2 Diabetes|Active, not recruiting||Phase 3|150|Anticipated|Novo Nordisk A/S||2|||f||||f|t|f||||||||2017-10-11 03:14:59.384245|2017-10-11 03:14:59.384245
NCT01541202|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-02-28|||February 2012||2012-02-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients|A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Survival of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure|Unknown status|Recruiting|Phase 3|1600|Anticipated|Zensun Sci. & Tech. Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:14:59.870106|2017-10-11 03:14:59.870106
NCT01541189|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-03-17|||February 2012||2012-02-01|March 2017|2017-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.|A 8-week, Multi Center(10),Single Arm, Open-labeled Prospective Study of Valsartan 160 mg in 200 Mild to Moderate Chinese Hypertension Patients Forced Titrated From 2-week Therapy of Valsartan 80 mg.|Completed||Phase 4|200|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:15:00.258366|2017-10-11 03:15:00.258366
NCT01541176|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-01-05|||April 2012||2012-04-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|Astronef||Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation|Impact of the Absence of Steroids on the Evolution of Renal Function and on the Progression of Graft Fibrosis, Quantified by Numerical Method, in Patients With Renal Transplant|Active, not recruiting||Phase 4|193|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 03:15:00.531793|2017-10-11 03:15:00.531793
NCT01541163|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-05-02|||September 2010||2010-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|HISTORY||Heart and Ischemic STrOke Relationship studY|Assessment of Relationship Between Acute Ischemic Stroke and Heart Disease|Recruiting||N/A|500|Anticipated|University Hospital Olomouc|||1||f||||t||||||||||2017-10-11 03:15:00.696433|2017-10-11 03:15:00.696433
NCT01541150|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-12-30|||August 2011||2011-08-01|February 2012|2012-02-01|January 2017|Anticipated|2017-01-01|August 2015|Anticipated|2015-08-01||Interventional|||Impaired Decision Making in Pedophilic Offenders|Neuropsychological Approach of Pedophilic Behaviors, a Pilot Study in a Population of Inmates Pedophilic Offenders|Unknown status|Recruiting|Phase 4|128|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 03:15:00.84975|2017-10-11 03:15:00.84975
NCT01541137|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2012-02-28|||March 2004||2004-03-01|February 2012|2012-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||NSAIDs With Morphine-PCA Compared to Epidural Analgesia in Thoracotomy Pain|NSAID With IV-PCA Morphine is an Alternative to Thoracic Epidural Analgesia in Post-thoracotomy Pain|Completed||N/A|30|Actual|Helsinki University Central Hospital||3|||f||||f||||||||||2017-10-11 03:15:00.981356|2017-10-11 03:15:00.981356
NCT01541124|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-02-28|||August 2008||2008-08-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||Morphine as First Drug for Cancer Pain|Morphine as the First Drug for the Treatment of Cancer Pain|Completed||N/A|60|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 03:15:01.084716|2017-10-11 03:15:01.084716
NCT01541111|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-07-27|||January 2011||2011-01-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Magnesium Associated With Morphine for Cancer Pain Relief|Evaluation of Analgesic Effect of Magnesiun Associated With Morphine for Cancer Pain Relief|Completed||N/A|40|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-10-11 03:15:01.162919|2017-10-11 03:15:01.162919
NCT01541098|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-03-17|||January 2015||2015-01-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||A Clinical Study of Lyophilized Plasma in Patients on Warfarin|A Phase II Clinical Study of Lyophilized Plasma in Patients on Warfarin|Withdrawn||Phase 2|0|Actual|HemCon Medical Technologies, Inc||2|||f||||t||||||||||2017-10-11 03:15:01.241134|2017-10-11 03:15:01.241134
NCT01541085|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2013-11-25|||December 2011||2011-12-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART|Ex Vivo Study of Immune-Reconstitution Kinetics in HIV-infected ARV-naive Subjects, With Advanced Disease, Starting a Darunavir/Ritonavir or Efavirenz Based HAART (IMMUNO Study)|Completed||Phase 4|33|Actual|Janssen-Cilag S.p.A.|||2||f||||f||||||||||2017-10-11 03:15:01.321481|2017-10-11 03:15:01.321481
NCT01541072|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-10-31|||February 2012||2012-02-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|PALM2||Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation|Lymphocyte Reconstitution in a Randomized Study After Administration of Pegfilgrastim Versus Filgrastim in Patients With B-cell Non-Hodgkin Lymphoma Treated With High-dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation|Terminated||N/A|34|Actual|Centre Leon Berard||2||Number of enrolled patients was insufficient during planned inclusion time.|f||||f||||||||||2017-10-11 03:15:01.418964|2017-10-11 03:15:01.418964
NCT01541059|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-10-21|||June 2012||2012-06-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|RopiMol||Postoperative Analgesia Following Wisdom Teeth Removal: Ropivacaine Versus Placebo|Postoperative Analgesia in Third Molar Surgery Under General Anesthesia: Ropivacaine Versus Placebo|Completed||Phase 4|100|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 03:15:01.56825|2017-10-11 03:15:01.56825
NCT01541046|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-11-19|||November 2011||2011-11-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic|Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic: A Randomized Double-blind Controlled Trial|Completed||Phase 2|55|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 03:15:01.688333|2017-10-11 03:15:01.688333
NCT01541033|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-08-17|||November 2009||2009-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2016|Actual|2016-05-01||Observational|||Biomarker of Children With Familial Autoimmune History|Biomarker Discovery In Children With Autism Plus Familial Autoimmune History|Completed||N/A|58|Actual|Le Bonheur Children's Hospital|||3||f||||f||||||Samples With DNA|"     Blood   "|Undecided||2017-10-11 03:15:01.785222|2017-10-11 03:15:01.785222
NCT01541020|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-12-04|||January 2011||2011-01-01|January 2012|2012-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Inspiratory Resistive Loading and Proprioceptive Postural Control|Inspiratory Resistive Loading and Proprioceptive Postural Control in Healthy Individuals and Individuals With Recurrent Low Back Pain|Completed||N/A|40|Actual|Katholieke Universiteit Leuven|||2||f||||t||||||||||2017-10-11 03:15:01.91364|2017-10-11 03:15:01.91364
NCT01541007|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-10-30|||April 2012||2012-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ConCab||A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer|A Randomized, Open Label, Multicenter, Phase II Trial Comparing The Conventional 3 Weekly Schedule Of Cabazitaxel With A Weekly Regimen In Patients With Metastatic Castration Resistant Prostate Cancer|Completed||Phase 2|100|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 03:15:02.047896|2017-10-11 03:15:02.047896
NCT01540994|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-04-27|||January 2011||2011-01-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer|Phase I/II Trial of Stereotactic Hypofractionated Radiotherapy of the Prostate|Recruiting||Phase 1/Phase 2|10|Anticipated|Sharp HealthCare||1|||f||||t||||||||||2017-10-11 03:15:02.196301|2017-10-11 03:15:02.196301
NCT01540981|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2015-01-06|2014-10-06||February 2012||2012-02-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Deep Tissue Injury Treatment With MIST Therapy Versus Standard Care: REVERSE DTI Study|Multi-Center Study of the Effects of MIST Therapy on the Treatment of Deep Tissue Injury|Terminated||N/A|12|Actual|Celleration, Inc.|Follow-up limited by discharge from hospital.|2||Lack of enrollment|f||||t||||||||||2017-10-11 03:15:02.372983|2017-10-11 03:15:02.372983
NCT01540968|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-06-25|||March 2012||2012-03-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Nutrition and Physical Exercise Study|Influence of a Combined Intervention by Nutritional Support and Physical Exercise on Quality of Life in Cancer Out-patients Treated in Palliative Intention.|Completed||N/A|58|Actual|Kantonsspital Winterthur KSW||2|||f||||f||||||||||2017-10-11 03:15:03.047491|2017-10-11 03:15:03.047491
NCT01540955|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-04-08|||April 2012||2012-04-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors|Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors|Completed||Phase 2|48|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 03:15:03.13276|2017-10-11 03:15:03.13276
NCT01540942|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-03-20|||November 2011||2011-11-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease|A Randomized, Controlled, Open-label Study to Investigate the Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease|Completed||N/A|91|Actual|Jinling Hospital, China||2|||f||||||||||||||2017-10-11 03:15:03.210839|2017-10-11 03:15:03.210839
NCT01540929|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-05-25|||December 2008||2008-12-01|May 2016|2016-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel|A Phase IV Post-licensure DOD Screening Accuracy Study in Military Personnel|Completed||N/A|5001|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 03:15:03.29444|2017-10-11 03:15:03.29444
NCT01540916|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-11-07|||February 2012||2012-02-01|November 2015|2015-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Respiratory Alterations of Acid-base Equilibrium: Acute and Chronic Renal Response|Respiratory Alterations of Acid-base Equilibrium: Acute and Chronic Renal Response|Active, not recruiting||N/A|50|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||||||||||||2017-10-11 03:15:03.370091|2017-10-11 03:15:03.370091
NCT01540903|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-09-09|||February 2012||2012-02-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|September 2012|Actual|2012-09-01||Interventional|||Controlled Human Malaria Infection by Intradermal Injection of Plasmodium Falciparum Sporozoites in Tanzanian Adults|Controlled Human Malaria Infection by Intradermal Injection of Plasmodium Falciparum Sporozoites (PfSPZ Challenge)in Tanzanian Adults|Completed||Phase 1|30|Actual|Sanaria Inc.||3|||f||||t||||||||||2017-10-11 03:15:03.45884|2017-10-11 03:15:03.45884
NCT01540864|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-08-19||2015-08-19|May 2012||2012-05-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects|A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects|Terminated||Phase 2|126|Actual|High Point Pharmaceuticals, LLC.||3|||f||||f||||||||||2017-10-11 03:15:03.707323|2017-10-11 03:15:03.707323
NCT01540851|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-01-22|2015-12-16||July 2011||2011-07-01|January 2016|2016-01-01|November 2018|Anticipated|2018-11-01|May 2014|Actual|2014-05-01||Interventional|AViKA||Adding Value in Knee Arthroplasty Post-total Knee Replacement (TKR) Care Navigator Trial|Adding Value in Knee Arthroplasty Post TKR Care Navigator Trial|Active, not recruiting||N/A|308|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:15:03.838253|2017-10-11 03:15:03.838253
NCT01540838|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-02-26|||February 2012|Actual|2012-02-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|INFU/PARA||Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis|Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis, Especially of Pneumococcal Meningitis, in Angola.|Completed||Phase 4|375|Actual|Helsinki University||2|||f||||t||||||||Undecided|We are working on an agreement to share data with all the participants,|2017-10-11 03:15:04.132655|2017-10-11 03:15:04.132655
NCT01540825|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-11-23|2016-11-23||February 2012||2012-02-01|November 2016|2016-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Treated set which included all randomised subjects who received 1 dose of the study drug.|First in Man Trial of BI 113608|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113608 in Healthy Male Volunteers (Randomised, Double-blind, Placebo-controlled Within Dose Groups)|Completed||Phase 1|80|Actual|Boehringer Ingelheim||11|||f||||||||||||||2017-10-11 03:15:04.253662|2017-10-11 03:15:04.253662
NCT01540812|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-01-11|||February 2012||2012-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS||Recruiting||Phase 4|200|Anticipated|PETHEMA Foundation|||1||f||||t||||||||||2017-10-11 03:15:06.67633|2017-10-11 03:15:06.67633
NCT01540799|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-05-23|||February 2012||2012-02-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|Pathway M-1||Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache|Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache|Active, not recruiting||N/A|80|Anticipated|Autonomic Technologies, Inc.||2|||f||||t||||||||||2017-10-11 03:15:06.924574|2017-10-11 03:15:06.924574
NCT01540786|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-10-14|||March 2012||2012-03-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics|"An Exploratory Study to Evaluate Bladder Contractions in the Storage Phase (Non Voiding Activities) and Related Bladder Sensation in Healthy Females and Untreated Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics"|Terminated||Phase 1|6|Actual|Astellas Pharma Inc||3||It was decided to discontinue the study due to insufficient recruitment|f||||t||||||||||2017-10-11 03:15:07.096539|2017-10-11 03:15:07.096539
NCT01540773|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-01-31|2014-11-14||October 2011||2011-10-01|December 2016|2016-12-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Single Low-Dose of Supplement Amino Acid|Growth Hormone 120 Minutes Following a Single Low-dose of Amino Acids in Healthy Subjects.|Completed||N/A|16|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 03:15:07.244334|2017-10-11 03:15:07.244334
NCT01540760|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-11-01|||March 2012||2012-03-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of MCAF5352A in Healthy Volunteers|A Phase Ib, Single-Center, Randomized, Placebo-Controlled, Double-Blind Multiple Ascending-Dose Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers|Completed||Phase 1|23|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:15:07.667555|2017-10-11 03:15:07.667555
NCT01540747|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-02-23||||||January 2009|2009-01-01||||||||Interventional|||Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome||Completed||Phase 4|||AGUNCO Obstetrics and Gynecology Centre||2|||f||||||||||||||2017-10-11 03:15:07.778424|2017-10-11 03:15:07.778424
NCT01540734|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-11-20|||December 2009||2009-12-01|June 2014|2014-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®|A Single Dose PK Study Investigating the Extent of Paracetamol Absorption From Two Sustained Release Paracetamol Formulations|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:15:07.904288|2017-10-11 03:15:07.904288
NCT01540721|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-11-20|||December 2009||2009-12-01|June 2014|2014-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend|A Single Dose PK Study Investigating the Extent of Paracetamol Absorption From Two Different Sustained Released Paracetamol Formulations|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:15:08.022449|2017-10-11 03:15:08.022449
NCT01540708|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-06-27|||January 16, 2012|Actual|2012-01-16|June 2017|2017-06-01|September 4, 2012|Actual|2012-09-04|September 4, 2012|Actual|2012-09-04||Interventional|||A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol|An Open-label, Randomised, Cross-over, Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation andROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol.|Completed||Phase 1|36|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:15:08.149864|2017-10-11 03:15:08.149864
NCT01540695|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2014-10-10|||February 2012||2012-02-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology|Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H&E Histology|Completed||N/A|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-11 03:15:08.294424|2017-10-11 03:15:08.294424
NCT01540682|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-07-27|||February 2012||2012-02-01|July 2017|2017-07-01||||November 2015|Actual|2015-11-01||Interventional|||MLN8237 in Head and Neck Cancer|Phase I Study of MLN8237 in Combination With Cetuximab and Definitive Radiation in Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 1|9|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:15:08.411549|2017-10-11 03:15:08.411549
NCT01540669|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-01-21|||March 2012||2012-03-01|January 2016|2016-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|PDX-Transit||Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time|Dose-ranging Efficacy of 2-week Polydextrose Supplementation on Whole Gut Transit Time and Gastrointestinal Symptoms in Adults With Functional Constipation: A Double-blind, Randomized, Placebocontrolled Trial|Terminated||N/A|59|Actual|Danisco||4||Slow recruitment|f||||f||||||||No|Terminated|2017-10-11 03:15:08.514474|2017-10-11 03:15:08.514474
NCT01540656|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2013-05-23|||June 2012||2012-06-01|May 2013|2013-05-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence|Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence|Unknown status|Active, not recruiting|Phase 3|39|Actual|Copenhagen University Hospital at Herlev||2|||f||||f||||||||||2017-10-11 03:15:08.635522|2017-10-11 03:15:08.635522
NCT01540643|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2017-01-19|||March 2012||2012-03-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry|Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry|Completed||N/A|600|Actual|Cook Group Incorporated|||1||f||||||||||||||2017-10-11 03:15:08.728815|2017-10-11 03:15:08.728815
NCT01540630|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-10-29|||March 2012||2012-03-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|||A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia|A Phase IIa Placebo-Controlled, Double-Blind Randomized Withdrawal Study to Evaluate the Safety and Efficacy of CNV1014802 in Patients With Trigeminal Neuralgia|Completed||Phase 2|67|Actual|Convergence Pharmaceuticals||2|||f||||t||||||||||2017-10-11 03:15:08.859446|2017-10-11 03:15:08.859446
NCT01540617|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-04-11|||April 2012||2012-04-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||The Neural Basis of Lumbosacral Proprioceptive Impairment in Recurrent Low Back Pain|The Neural Basis of Lumbosacral Proprioceptive Impairment in Recurrent Low Back Pain|Completed||N/A|36|Actual|Katholieke Universiteit Leuven|||2||f||||t||||||||||2017-10-11 03:15:08.93857|2017-10-11 03:15:08.93857
NCT01540604|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2012-10-01||||||October 2012|2012-10-01||||||||Interventional|||CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers|An Open-label, Un-controlled, Single-centre Trial Investigating the Efficacy and Safety of CRD007 in Children With Duchenne Muscular Dystrophy (DMD) or Becker Muscular Dystrophy (BMD) or Children Being Symptomatic Carriers for DMD or BMD|Completed||Phase 2|||RSPR Pharma AB||1|||f||||||||||||||2017-10-11 03:15:09.017145|2017-10-11 03:15:09.017145
NCT01540591|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-09-14|||February 2012||2012-02-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|Intralipid||Intralipid for Repeated Implantation Failure|Does Intralipid Infusion Improve the Implantation Rate in Repeated Implantation Failure: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|200|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 03:15:09.099743|2017-10-11 03:15:09.099743
NCT01540578|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-05-17|||February 2012||2012-02-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia|OBSERVATIONAL: Replication Profiling as a Diagnostic Tool in B-cell Acute Lymphoblastic Leukemia (ALL)|Completed||N/A|70|Actual|Children's Oncology Group|||1||f||||t||||||Samples With DNA|"     Fresh and frozen bone marrow cells   "|||2017-10-11 03:15:09.180628|2017-10-11 03:15:09.180628
NCT01540565|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2017-09-13|||April 9, 2012|Actual|2012-04-09|September 2017|2017-09-01||||April 24, 2018|Anticipated|2018-04-24||Interventional|||Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Evaluation of the Poly (ADP-Ribose) Polymerase (PARP)-1 and -2 Inhibitor Veliparib (ABT-888) (NSC#737664) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Who Carry a Germline BRCA1 or BRCA2 Mutation|Active, not recruiting||Phase 2|51|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 03:15:09.278821|2017-10-11 03:15:09.278821
NCT01540552|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-01-24|||February 2012||2012-02-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung Cancer|Evolution of Undetermined Ld-CT Detected Lung Nodules Among a Randomized Phase II Trial With Inhaled Budesonide|Completed||N/A|320|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-10-11 03:15:09.706987|2017-10-11 03:15:09.706987
NCT01540539|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-01-23|||March 2012||2012-03-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers||Completed||Phase 1|44|Actual|Regeneron Pharmaceuticals||8|||f||||t||||||||||2017-10-11 03:15:09.789521|2017-10-11 03:15:09.789521
NCT01540526|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-12-11|||March 2012||2012-03-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib|Pharmacodynamic Study Using FLT-PET/CT in Patients With Prostate and Other Solid Malignancies Treated With an Interrupted High-dose Axitinib Schedule|Completed||Phase 1|24|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 03:15:09.873555|2017-10-11 03:15:09.873555
NCT01540500|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-02-14|||February 2012||2012-02-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine|An Open-label, Single-sequence Study in Healthy Subjects to Evaluate the Single-dose Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP1A2 Inhibitor, Fluvoxamine|Completed||Phase 1|24|Actual|Vanda Pharmaceuticals||1|||f||||f||||||||||2017-10-11 03:15:10.225232|2017-10-11 03:15:10.225232
NCT01540487|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2013-06-06|2013-06-06||February 2012||2012-02-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin|Characterisation of Fixed Dose Combination Tablets of Linagliptin 2.5 mg/Metformin 850 mg or Linagliptin 2.5 mg/Metformin 500 mg and Relative Oral Bioavailability Compared With Single Linagliptin 2.5 mg and Metformin 850 mg or 500 mg Tablets Administered Together to Healthy Chinese Male and Female Volunteers in an Open Label, Randomised, Single-dose, Two-way Crossover, Phase I Study|Completed||Phase 1|48|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:15:10.352141|2017-10-11 03:15:10.352141
NCT01540474|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-01-14|||February 2012||2012-02-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults|Phase 1 Study With the Vaccine Candidate Plasmodium Falciparum Malaria Protein (FMP012), an E.Coli-expressed Cell-Traversal Protein, Administered Intramuscularly in Healthy Malaria-Naive Adults|Completed||Phase 1|30|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||f||||||||||2017-10-11 03:15:10.85683|2017-10-11 03:15:10.85683
NCT01540461|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2014-07-04|||March 2012||2012-03-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)|A Phase 1 Study to Determine the Safety and Pharmacokinetics of Brivanib in Chinese Subjects With Advanced Hepatocellular Carcinoma (HCC)|Completed||Phase 1|17|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 03:15:10.969956|2017-10-11 03:15:10.969956
NCT01540448|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-02-22|||January 2010||2010-01-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|3DCT||Role of CT Angiography With Three-dimensional Reconstruction of Mesenteric Vessels in Planning and Performing of Laparoscopic Colorectal Resections||Completed||Phase 3|100|Actual|University of Roma La Sapienza||2|||f||||||||||||||2017-10-11 03:15:11.094593|2017-10-11 03:15:11.094593
NCT01540435|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-05-28|||September 2012||2012-09-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PERIMAX||Perioperative Treatment of Resectable Liver Metastases|Perioperative FOLFOXIRI and Bevacizumab Compared With Postoperative FOLFOX in Patients With Resectable Liver Metastases From Colorectal Cancer (PERIMAX). A Randomized, Multidisciplinary DGAV(CAO-V/CALGP)/AIO Phase II Trial|Withdrawn||Phase 2|0|Actual|University of Regensburg||2||insufficient recruitment|f||||t||||||||||2017-10-11 03:15:11.194918|2017-10-11 03:15:11.194918
NCT01540422|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2015-03-12|||October 2010||2010-10-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique|OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques|Completed||N/A|93|Actual|Baylor Research Institute|||1||f||||f||||||||||2017-10-11 03:15:11.314505|2017-10-11 03:15:11.314505
NCT01540409|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2016-11-22|||February 2012||2012-02-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|April 2016|Actual|2016-04-01||Interventional|||Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy|Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201|Active, not recruiting||Phase 2|12|Actual|Sarepta Therapeutics||1|||f||||f||||||||||2017-10-11 03:15:11.450233|2017-10-11 03:15:11.450233
NCT01540396|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-02-02|||February 2012||2012-02-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|February 2013|Actual|2013-02-01||Interventional|GD2M||Gestational Diabetes Diagnostic Methods|GD2M Study:Gestational Diabetes Diagnostic Methods|Completed||N/A|47|Actual|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 03:15:11.577958|2017-10-11 03:15:11.577958
NCT01540383|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-09-25|||April 2012||2012-04-01|September 2017|2017-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|FCET2EC||Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions|From Controlled Experimental Trial to Everyday Communication: How Effective is Intensive Aphasia Therapy Under Routine Clinical Conditions?|Completed||N/A|156|Actual|University Hospital Muenster||2|||f||||t||||||||||2017-10-11 03:15:11.692549|2017-10-11 03:15:11.692549
NCT01540370|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-23|2013-07-16|2013-07-16||February 2012||2012-02-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)||Completed||N/A|102|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:15:11.830564|2017-10-11 03:15:11.830564
NCT01540357|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-09-26|||May 2010||2010-05-01|September 2013|2013-09-01|January 2012|Actual|2012-01-01|October 2010|Actual|2010-10-01||Interventional|||Mindfulness-based Therapy in Chronic Tinnitus|Mindfulness-based Therapy For the Treatment of Chronic Tinnitus: A Randomized Controlled Pilot Study|Completed||N/A|36|Actual|University of Regensburg||2|||f||||f||||||||||2017-10-11 03:15:12.013304|2017-10-11 03:15:12.013304
NCT01540344|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2014-12-10|||October 2010||2010-10-01|December 2014|2014-12-01|October 2017|Anticipated|2017-10-01|July 2015|Anticipated|2015-07-01||Interventional|COMBATAC||Combined Anticancer Treatment of Advanced Colon Cancer|Multimodality Treatment Including Pre- and Postoperative Systemic Chemotherapy Plus Cetuximab, Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis Arising From Wild Type K-ras Colon Cancer: A Prospective Multicenter Phase II Study.|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|University of Regensburg||1|||f||||f||||||||||2017-10-11 03:15:12.130149|2017-10-11 03:15:12.130149
NCT01540331|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-02-27|||June 2009||2009-06-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy And Safety of Pneumatic Trabeculoplasty|Phase 4 Study to Evaluate Efficacy And Safety of Pneumatic Trabeculoplasty (PNT) in Subjects Affected by Primary Open Angle Glaucoma|Completed||Phase 4|27|Actual|University of Cantanzaro||1|||f||||f||||||||||2017-10-11 03:15:12.242063|2017-10-11 03:15:12.242063
NCT01540318|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-06-19|||February 2012||2012-02-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|February 2016|Actual|2016-02-01||Interventional|||Utility of Abdominal Ultrasound in the Evaluation of Children With Blunt Trauma|Utility of Abdominal Ultrasound in the Evaluation of Children With Blunt Trauma|Active, not recruiting||N/A|925|Actual|University of California, Davis||2|||f||||t||||||||||2017-10-11 03:15:12.320485|2017-10-11 03:15:12.320485
NCT01532583|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2012-12-12|||January 2009||2009-01-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Observational|||The Outcome of the Transobturator Tape (TOT) Procedure|The Outcome of the Transobturator Tape (TOT) Procedure During the Follow-up of 6.5 Years|Completed||N/A|139|Actual|Turku University Hospital|||1||f||||||||||||||2017-10-11 03:17:35.830773|2017-10-11 03:17:35.830773
NCT01540305|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-27|||May 2011||2011-05-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Efficacy Study of Transcranial Magnetic Stimulation for Treatment of Obsessive-Compulsive Disorder|A Randomized Double-blind Trial of Repetitive Transcranial Magnetic Stimulation in Obsessive -Compulsive Disorder With Three Months Follow-up|Completed||Phase 2|22|Actual|University of Brasilia||2|||f||||f||||||||||2017-10-11 03:15:12.404633|2017-10-11 03:15:12.404633
NCT01540292|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-01-17|||March 2012||2012-03-01|January 2013|2013-01-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders|Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|University Hospital of Liege||1|||f||||f||||||||||2017-10-11 03:15:12.509534|2017-10-11 03:15:12.509534
NCT01540279|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-03-17|||July 2011||2011-07-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Clinical Outcome in View of Surgical Site Infection (SSI) With Antibacterial Skin Sutures|Do Antibacterial Skin Sutures Reduce Surgical Site Infections After Open Abdominal Surgery?|Terminated||N/A|52|Actual|University Hospital, Basel, Switzerland|||2|insufficient enrollment|f||||||||||||||2017-10-11 03:15:12.628275|2017-10-11 03:15:12.628275
NCT01540266|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-03-17|2015-03-02||July 2011||2011-07-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|BACOP||Basel Discharge Communication Project|BACOP - Basel Discharge Communication Project - Study 3|Completed||N/A|242|Actual|University Hospital, Basel, Switzerland||6|||f||||t||||||||||2017-10-11 03:15:12.723157|2017-10-11 03:15:12.723157
NCT01540253|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-06-29|||May 2012||2012-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic|A Phase I Study of the PI3-Kinase Inhibitor BKM120 in Combination With Docetaxel in Patients With Advanced Solid Tumors.|Completed||Phase 1|38|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 03:15:13.434098|2017-10-11 03:15:13.434098
NCT01540240|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-02-27|||August 2011||2011-08-01|February 2012|2012-02-01||||December 2012|Anticipated|2012-12-01||Interventional|AZTlowdose||Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients|Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients: A Randomized Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|136|Anticipated|University Hospital, Geneva||2|||f||||t||||||||||2017-10-11 03:15:13.570997|2017-10-11 03:15:13.570997
NCT01540227|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-10-03|||September 2011||2011-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Penicillin Therapeutic Drug Monitoring in the Treatment of Infectious Syphilis.|Penicillin Therapeutic Drug Monitoring in the Treatment of Infectious Syphilis. Do Low Serum Penicillin Levels Correlate With Treatment Failure?|Enrolling by invitation||N/A|120|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-11 03:15:13.715245|2017-10-11 03:15:13.715245
NCT01540214|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2013-01-04|||February 2012||2012-02-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Observational|SOAP||Study of Overactive Bladder in Women With Prolapse|Prevalence of Overactive Bladder (OAB) in Patients With Pelvic Organ Prolapse (POP) and Predictors of Symptoms of OAB After Surgical Correction of POP|Unknown status|Recruiting|N/A|100|Anticipated|Radboud University|||1||f||||f||||||Samples With DNA|"     Urine   "|||2017-10-11 03:15:13.818222|2017-10-11 03:15:13.818222
NCT01540201|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-12-24|||February 2012||2012-02-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing One-lung Ventilation for Lung Surgery|The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing One-lung Ventilation for Lung Surgery|Completed||N/A|110|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 03:15:13.93903|2017-10-11 03:15:13.93903
NCT01540188|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-02-16|||July 2010||2010-07-01|February 2016|2016-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Development of a Family Intervention to Address Drug Use and HIV in Vietnam|Development of a Family Intervention to Address Drug Use and HIV in Vietnam|Completed||Phase 1/Phase 2|230|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:15:14.036747|2017-10-11 03:15:14.036747
NCT01540175|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-07-13|||March 2012||2012-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|IROPAST||Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant|Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant|Completed||N/A|31|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 03:15:14.143121|2017-10-11 03:15:14.143121
NCT01540162|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-08-12|2015-08-12||March 2011||2011-03-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Observational|EMSUP||Experience of Mutaflor Suspension Use in Preterm Infants for Immunity Improvement|Open-labelled, Controlled, Parallel Group Study to Assess the Efficacy and Safety of MUTAFLOR in 3 Weeks Treatment for Immunity Improvement in Preterm Infants With 1 Year Follow-up Period|Completed||N/A|62|Actual|Odessa National Medical University|||2||f||||f||||||||||2017-10-11 03:15:14.26808|2017-10-11 03:15:14.26808
NCT01540149|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-07-06|||August 2012||2012-08-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|October 2014|Actual|2014-10-01||Observational|||Tel Aviv Sourasky MC Home Monitoring Clinic Registry|Tel Aviv Sourasky MC Home Monitoring Registry|Completed||N/A|45|Actual|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||||No||2017-10-11 03:15:14.660546|2017-10-11 03:15:14.660546
NCT01540136|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-10-27|||February 2012||2012-02-01|March 2013|2013-03-01|July 2016|Actual|2016-07-01|May 2014|Actual|2014-05-01||Interventional|||Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma|A Randomized Phase III Non-inferiority Study of Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma|Completed||Phase 3|402|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:15:14.756998|2017-10-11 03:15:14.756998
NCT01540123|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-06-20|||February 2012||2012-02-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Time Effects of a Berry Extract Upon Cerebral Blood Flow.|The Time Effects of a Berry Extract Upon Cerebral Blood Flow.|Completed||N/A|20|Actual|Northumbria University||2|||f||||t||||||||||2017-10-11 03:15:14.928189|2017-10-11 03:15:14.928189
NCT00005723|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-28|||January 1991||1991-01-01|March 2016|2016-03-01|September 1996|Actual|1996-09-01|January 1996|Actual|1996-01-01||Observational|||Worksite Issues in Organizational Health Promotion (Take Heart)||Completed||N/A|||Oregon Research Institute|||||f||||f||||||||Undecided||2017-10-11 04:28:55.783476|2017-10-11 04:28:55.783476
NCT01540110|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-09-02|||August 2010||2010-08-01|September 2016|2016-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses|Phase 2 Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses|Active, not recruiting||Phase 2|41|Anticipated|National Cancer Centre, Singapore||1|||f||||t||||||||||2017-10-11 03:15:15.099173|2017-10-11 03:15:15.099173
NCT01540084|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-02-27|||December 2006||2006-12-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP)|Cocktail Sedation Containing Propofol Versus Conventional Sedation for ERCP: a Prospective, Randomized Controlled Study|Completed||Phase 4|205|Actual|King Chulalongkorn Memorial Hospital||2|||f||||f||||||||||2017-10-11 03:15:15.209343|2017-10-11 03:15:15.209343
NCT01540071|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2016-02-23|||August 2011||2011-08-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer|A Phase II Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer|Completed||Phase 2|38|Actual|Io Therapeutics||1|||f||||t||||||||||2017-10-11 03:15:15.461961|2017-10-11 03:15:15.461961
NCT01540058|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-02-09|||March 2012||2012-03-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|March 2016|Anticipated|2016-03-01||Interventional|GEFCAPI04||Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP|A Randomised Phase III Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With Carcinoma of an Unknown Primary (CUP)|Recruiting||Phase 3|223|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t||||||||||2017-10-11 03:15:15.620983|2017-10-11 03:15:15.620983
NCT01540045|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-03-06|2013-07-23||December 2010||2010-12-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Observational||We invited to participate 72 patients with NSCLC newly diagnosed, but only 40 patients completed their baseline evaluation and their follow up after two cycles of chemotherapy using paclitaxel (175 mg/m2) and cisplatin (75 mg/m2). The main reason of exclusion was death followed by not returning to the institution.|Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer|Effect of Chemotherapy With Paclitaxel and Cisplatin on Development Dysgeusia in Non-small Cell Lung Cancer Patients|Completed||N/A|40|Actual|Instituto Nacional de Cancerologia de Mexico|No analysis of serum zinc was performed and a small number of subjects analyzed.||1||f||||t||||||||||2017-10-11 03:15:15.774732|2017-10-11 03:15:15.774732
NCT01540032|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-02-22|||February 2012||2012-02-01|February 2012|2012-02-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Low Salicylate Diet in Aspirin Exacerbated Respiratory Disease||Unknown status|Not yet recruiting|N/A|80|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f||||||||||2017-10-11 03:15:16.959925|2017-10-11 03:15:16.959925
NCT01540006|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-10-29|||January 2009||2009-01-01|October 2015|2015-10-01||||December 2016|Anticipated|2016-12-01||Observational|||Outpatient Cardiac Rehabilitation in Austria||Unknown status|Recruiting|N/A|1000|Anticipated|Paracelsus Medical University|||1||f||||f||||||||||2017-10-11 03:15:17.283929|2017-10-11 03:15:17.283929
NCT01539993|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-05-23|||November 2008||2008-11-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Prospective Liver Study|Prospective Analysis of Liver Cancer Treatment and Interventions|Completed||N/A|400|Actual|Emory University|||1||f||||f||||||||||2017-10-11 03:15:17.406939|2017-10-11 03:15:17.406939
NCT01539980|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-04-01|2015-03-10||August 2012||2012-08-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment|Clinical Efficacy of Wound Dressing Containing Silk Sericin for Split-thickness Skin Graft Donor Site Treatment|Completed||Phase 1/Phase 2|30|Actual|Chulalongkorn University||1|||f||||t||||||||||2017-10-11 03:15:17.537249|2017-10-11 03:15:17.537249
NCT01539967|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-04-05|||August 2009||2009-08-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|GASTROMANCH||Impact of the Residual Gastric Volume in Laparoscopic Sleeve Gastrectomy's Failure|Is the Residual Gastric Volume After Sleeve Gastrectomy an Objective Criterion to Adapt the Treatment Strategy After Failure?|Completed||N/A|90|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 03:15:17.856399|2017-10-11 03:15:17.856399
NCT01539954|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-10-06|||September 2012||2012-09-01|October 2016|2016-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|cASCA||Computerized Alcohol Screening for Children and Adolescents|Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care|Withdrawn||N/A|0|Actual|Boston Children’s Hospital|||1|The project was not funded.|f||||f||||||||No||2017-10-11 03:15:17.970542|2017-10-11 03:15:17.970542
NCT01539941|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-08-03|||August 2011||2011-08-01|February 2012|2012-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care|Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care|Completed||Phase 1|14|Actual|The National Center on Addiction and Substance Abuse at Columbia University||1|||f||||t||||||||||2017-10-11 03:15:18.090183|2017-10-11 03:15:18.090183
NCT01539928|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-06-24|||March 2012||2012-03-01|June 2013|2013-06-01|March 2015|Anticipated|2015-03-01|March 2014|Anticipated|2014-03-01||Observational|DILUCE||Dual PET/CT Imaging in Lung Cancer|Dual PET/CT Imaging in Lung Cancer (Danish Title: En og Tre Timers FDG-PET/CT Ved Lungecancer)|Unknown status|Recruiting|N/A|216|Anticipated|Odense University Hospital|||1||f||||t||||||Samples With DNA|"     Fresh frozen sample of primary lung cancer tumor   "|||2017-10-11 03:15:18.20953|2017-10-11 03:15:18.20953
NCT01539915|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-02-27|||April 2007||2007-04-01|February 2012|2012-02-01||||November 2007|Actual|2007-11-01||Interventional|||Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients|A Single Center, Open Label Exploratory Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Topically Administered BCT194 in Dermal Interstitial Fluid in Psoriatic Patients Using Open Flow Microperfusion|Completed||Phase 1|12|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:15:18.33858|2017-10-11 03:15:18.33858
NCT01539902|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-03-05|||February 2012||2012-02-01|March 2012|2012-03-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|hUC-MSC-SLE||Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis|A Randomized, Double Blind, Parallel Group, Placebo Controlled Research of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis|Unknown status|Recruiting|Phase 2|25|Anticipated|CytoMed & Beike||2|||f||||t||||||||||2017-10-11 03:15:18.468091|2017-10-11 03:15:18.468091
NCT01539889|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-09-30|||December 2011||2011-12-01|September 2014|2014-09-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|||Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation|Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation|Completed||Phase 1|20|Actual|Montreal Heart Institute||1|||f||||t||||||||||2017-10-11 03:15:18.618818|2017-10-11 03:15:18.618818
NCT01539876|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-03-24||||||March 2014|2014-03-01||||||||Interventional|TNFactor||Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel|Assessing Serial Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neo-adjuvant Taxane Chemotherapy|Withdrawn||Phase 1|0|Actual|Lawson Health Research Institute||1||Disease Site Team changed research focus unlikely to have sufficient support to complete study|f||||f||||||||||2017-10-11 03:15:18.730505|2017-10-11 03:15:18.730505
NCT01539863|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2017-08-15|||March 2012||2012-03-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Chiropractic Maintenance Care of Persistent or Recurrent Low Back Pain|Chiropractic Maintenance Care of Persistent or Recurrent Low Back Pain. A Randomized Controlled Trial With 1 Year Follow up|Completed||N/A|321|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:15:18.876987|2017-10-11 03:15:18.876987
NCT01539850|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-02-27|||March 2010||2010-03-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|||Safety Evaluation of the LGL102 in Obese Subjects Treated With OMS102|Safety Evaluation of the LGL102 in Obese Subjects Treated With OMS102. A Prospective Multicenter Study|Completed||N/A|34|Actual|IntraPace, Inc||1|||f||||f||||||||||2017-10-11 03:15:18.981884|2017-10-11 03:15:18.981884
NCT01539837|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-10-16|||February 2012||2012-02-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|DeferipronPD||A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease|A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease|Unknown status|Recruiting|Phase 2|36|Anticipated|Imperial College London||3|||f||||t||||||||||2017-10-11 03:15:19.121964|2017-10-11 03:15:19.121964
NCT01539824|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-12-01|||February 2012||2012-02-01|December 2016|2016-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer|A Phase II, Single Arm, Investigative Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Patients With Previously Treated Colorectal Cancer|Completed||Phase 2|12|Actual|Immodulon Therapeutics Ltd||1|||f||||t||||||||No||2017-10-11 03:15:19.305914|2017-10-11 03:15:19.305914
NCT01539811|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-04-13|2015-04-13||February 2012||2012-02-01|April 2015|2015-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Diabetic Foot Infection Antibiotic Study|Surgical Management of Diabetic Foot Infections - The Role of Post-Operative Antibiotics|Terminated||N/A|2|Actual|Greenville Health System||2||Principal investigator decided to terminate the study.|f||||f||||||||||2017-10-11 03:15:19.482537|2017-10-11 03:15:19.482537
NCT01539798|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2012-02-27|||August 2011||2011-08-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Body Composition and Serum Biochemistry After Intravenous Infusion or Oral Intake of Saline in Healthy Volunteers|Changes in Body Composition, Hematological Parameters, and Serum Biochemistry and After Rapid Intravenous Infusion or Oral Intake of 2L of 0.9% Saline Solution in Young Healthy Volunteers. A Randomized Cross-over Study|Completed||N/A|10|Actual|Federal University of Mato Grosso do Sul||2|||f||||t||||||||||2017-10-11 03:15:19.77702|2017-10-11 03:15:19.77702
NCT01539785|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2014-08-21|||September 2012||2012-09-01|August 2014|2014-08-01||||September 2018|Anticipated|2018-09-01||Interventional|HORSE||Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence|Surgery Plus Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) Versus Surgery Alone in Patients With Platinum-sensitive First Recurrence of Ovarian Cancer: a Prospective Randomized Multicenter Trial.|Recruiting||N/A|158|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 03:15:19.905233|2017-10-11 03:15:19.905233
NCT01539772|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2017-01-23|||April 2012||2012-04-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping|PITT0112: Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping|Active, not recruiting||N/A|85|Actual|Cooperative International Neuromuscular Research Group|||1||f||||t||||||||||2017-10-11 03:15:20.014677|2017-10-11 03:15:20.014677
NCT01539746|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-01-30|||January 2013||2013-01-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|SIMPLIFy TAVI||Transcatheter Aortic Valve Implantation Without Predilation|Use of the Self-Expanding Medtronic CoreValve Prosthesis Without Predilation in Patients With Severely IMPaired Left-VentrIcular Ejection Fraction for TAVI Trial - The SIMPLIFy TAVI Trial|Unknown status|Recruiting|N/A|110|Anticipated|University Hospital, Bonn||2|||f||||f||||||||||2017-10-11 03:15:20.528316|2017-10-11 03:15:20.528316
NCT01539733|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-04-06|||March 2010||2010-03-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer|Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer|Completed||N/A|101|Actual|VU University Medical Center||2|||f||||f||||||||||2017-10-11 03:15:20.691529|2017-10-11 03:15:20.691529
NCT01539720|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-12-09|||December 2012||2012-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|LIFE||Levonorgestrel Intrauterine System For Emergency Contraception|Levonorgestrel Intrauterine System For Emergency Contraception: a Randomized Control Trial|Recruiting||N/A|532|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:15:20.811265|2017-10-11 03:15:20.811265
NCT01539707|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-10-29|||March 2012||2012-03-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder|A Multicenter, Open-label, Single-dose Study to Evaluate Pharmacokinetics, Safety and Tolerability of Solifenacin Succinate Suspension in Pediatric Subjects From 5 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (NDO)|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:15:20.930415|2017-10-11 03:15:20.930415
NCT01539694|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-09-28|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:15:21.035129|2017-10-11 03:15:21.035129
NCT01539681|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-02-16|||February 2012||2012-02-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|January 2014|Actual|2014-01-01||Observational|STELLA||Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy|Sorafenib Treatment Modalities for HEpatoceLLular Carcinoma Patients in ItAly|Completed||N/A|234|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:15:21.097912|2017-10-11 03:15:21.097912
NCT01539668|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2014-02-25|||March 2012||2012-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|December 2012|Actual|2012-12-01||Observational|careHPV||Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas|CareHPV - Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas|Completed||Early Phase 1|5079|Actual|Barretos Cancer Hospital|||1||f||||f||||||Samples With DNA|"     Cervical cell samples (cytology)   "|||2017-10-11 03:15:21.17499|2017-10-11 03:15:21.17499
NCT01539655|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-04-28|||February 2012||2012-02-01|April 2017|2017-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|Vandetanib||Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib|A Phase I, Randomized, Open-label, Single-center Study to Assess the Pharmacokinetics of Vandetanib (CAPRELSA) in Healthy Subjects When a Single Oral Dose of Vandetanib 300 mg is Administered Alone and in Combination With Omeprazole or Ranitidine|Completed||Phase 1|34|Actual|Sanofi||4|||f||||||||||||||2017-10-11 03:15:21.241348|2017-10-11 03:15:21.241348
NCT01539642|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-09-30|2013-10-24||February 2012||2012-02-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery|Completed||Phase 3|172|Actual|AcelRx Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:15:21.33374|2017-10-11 03:15:21.33374
NCT01539629|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2012-12-04|||March 2012||2012-03-01|October 2012|2012-10-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Observational|ELEVATE 3||ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0|Evaluation of Left Ventricular Autothreshold|Completed||N/A|50|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 03:15:21.658903|2017-10-11 03:15:21.658903
NCT01539616|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2013-10-25|||November 2011||2011-11-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia|A Multicentric Prospective Randomized Double Blind Parallel Group Active Controlled Study to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia|Completed||Phase 2|109|Actual|Cadila Healthcare Limited||4|||f||||t||||||||||2017-10-11 03:15:23.369902|2017-10-11 03:15:23.369902
NCT01539603|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-06-11|||April 2011||2011-04-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|DEBfirst||Comparison of Drug Eluting Balloon and Drug Eluting Stent|Comparison of Drug-Eluting Balloon First and Then Bare Metal Stent With Drug-eluting Stent for Treatment of de Novo Lesions (DEB First): A Randomized Controlled Single Center Clinical Trial|Completed||Phase 2|180|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 03:15:23.498091|2017-10-11 03:15:23.498091
NCT01539590|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2014-11-07|2014-10-29||July 2012||2012-07-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack|A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to Percutaneous Coronary Intervention (PCI) in Subjects Presenting With Acute ST Segment Elevation Myocardial Infarction (STEMI)|Terminated||Phase 2|5|Actual|Angion Biomedica Corp|Five subjects were enrolled into the study; 3 subjects were randomized to BB3 and 2 subjects to placebo. All the 3 subjects randomized to BB3 discontinued the study prematurely. The 2 subjects randomized to placebo completed study treatment.|2|||f||||t||||||||||2017-10-11 03:15:23.62254|2017-10-11 03:15:23.62254
NCT01539577|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2016-04-18|||March 2012||2012-03-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||A Long-Term Safety Study of OZURDEX® in Clinical Practice||Completed||N/A|875|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:15:24.02063|2017-10-11 03:15:24.02063
NCT01539564|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-06-25|||April 2012||2012-04-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Arestin - Use in Subjects With Peri-Implantitis|Multi-Center Phase 3 Trial of Minocycline HCl 1mg Microspheres for the Use in Subjects With Peri-Implantitis|Completed||Phase 3|215|Actual|OraPharma||2|||f||||f||||||||||2017-10-11 03:15:24.102343|2017-10-11 03:15:24.102343
NCT01539551|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-11-12|||February 2012||2012-02-01|March 2012|2012-03-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Investigation of the Role of Brain Natriuretic Peptide and Lactate in Early Goal-directed Therapy for Patients With Severe Sepsis and Septic Shock|Investigation of the Role of Brain Natriuretic Peptide and Lactate in Early Goal-directed Therapy for Patients With Severe Sepsis and Septic Shock|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     blood(serum/plasma)   "|||2017-10-11 03:15:24.295905|2017-10-11 03:15:24.295905
NCT01539369|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-05-21|||April 2011||2011-04-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|LWW||The Leeds Women's Wellbeing (LWW) Study|A Study to Investigate the Short and Long Term Effects of Two 12-week Healthy Eating Interventions on Body Weight, Body Composition, Appetite Control, Biomarkers of Health and Subjective Wellbeing in Overweight Women|Completed||N/A|80|Actual|University of Leeds||2|||f||||f||||||||||2017-10-11 03:15:28.623678|2017-10-11 03:15:28.623678
NCT01539538|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-22|2015-09-16|2013-11-25||April 2012||2012-04-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain|A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain|Completed||Phase 3|357|Actual|AcelRx Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:15:24.405175|2017-10-11 03:15:24.405175
NCT01539525|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-03-02|2016-09-29||September 5, 2011|Actual|2011-09-05|March 2017|2017-03-01|January 28, 2015|Actual|2015-01-28|January 28, 2015|Actual|2015-01-28||Interventional|ProjectSTART||Screening to Augment Referral to Treatment- Project START|Screening to Augment Referral to Treatment- Project START|Completed||N/A|439|Actual|Yale University|"Results may not be generalizable to populations differing from population from which sample was drawn.
Outcomes relied upon self-report, although we did try to verify through lab results for substance use and medical records/ provider for treatment."|3|||f||||f||||||||No|We will require data request with delineation of variables of interest. Only de-identified data will be released after evaluation of the request|2017-10-11 03:15:24.965527|2017-10-11 03:15:24.965527
NCT01539512|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2015-04-20|2014-10-09||April 2012||2012-04-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional||ITT Analysis Set: randomized participants with treatment group designated according to initial randomization.|A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia|Completed||Phase 3|220|Actual|Gilead Sciences|Following a recommendation by an independent Data Monitoring Committee (DMC), the study was stopped early due to highly statistically significant results for the primary efficacy endpoint of progression-free survival.|2|||f||||t||||||||||2017-10-11 03:15:25.956007|2017-10-11 03:15:25.956007
NCT01539499|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-08-30|||January 2010||2010-01-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Complications of Endocrine Surgery: Data From the United HealthSystem Consortium|Complications of Endocrine Surgery: Data From the United Health System Consortium|Completed||N/A|1000|Actual|University of Arkansas|||1||f||||f||||||||||2017-10-11 03:15:27.698525|2017-10-11 03:15:27.698525
NCT01539486|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-06-12|||January 2010||2010-01-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy|Relationship of Preoperative PTH and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy|Active, not recruiting||N/A|200|Anticipated|University of Arkansas|||1||f||||f||||||||||2017-10-11 03:15:27.778755|2017-10-11 03:15:27.778755
NCT01539473|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-05-02|||February 2012||2012-02-01|May 2016|2016-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge|A Phase 1, Blinded, Placebo-Controlled, Crossover TR-701 FA Study of Blood Pressure Response Post-Tyramine Challenge|Completed||Phase 1|30|Actual|Trius Therapeutics LLC||2|||f||||f||||||||||2017-10-11 03:15:27.872507|2017-10-11 03:15:27.872507
NCT01539460|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-05-11|||February 2012||2012-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||A Minimally Invasive Surgery for Axillary Osmidrosis: Combined Liposuction With Subcutaneous Pruning|A Refined Minimally Invasive Procedure for Radical Treatment of Axillary Osmidrosis: Combined Tumescent Liposuction With Subcutaneous Pruning Through a Small Incision|Enrolling by invitation||N/A|30|Anticipated|Tang-Du Hospital||1|||f||||f||||||||||2017-10-11 03:15:27.973807|2017-10-11 03:15:27.973807
NCT01539447|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-10-04|||January 2012||2012-01-01|October 2017|2017-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy|Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy|Active, not recruiting||Early Phase 1|342|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-11 03:15:28.07789|2017-10-11 03:15:28.07789
NCT01539434|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-05-18|||September 2010|Actual|2010-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|COPD||Behavioral Intervention to Maintain Physical Capacity and Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Behavioral Medicine Intervention to Maintain Physical Capacity and Level of Physical Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Recruiting||Phase 2|100|Anticipated|Uppsala University||2|||f||||t||||||||||2017-10-11 03:15:28.182097|2017-10-11 03:15:28.182097
NCT01539421|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-02-27|||June 2010||2010-06-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Use of Wii Home Computer in Patients With Chronic Obstructive Pulmonary Disease: Effects on Quality of Life|The Use of Home Exercise Program Based on Interactive Entertainment Computer System in Patients With Moderate to Severe COPD: Its Feasibility and Effects on Exercise Performance, Physical Activity, Dyspnea, and Quality of Life|Completed||N/A|20|Actual|Saint Francis Care||1|||f||||f||||||||||2017-10-11 03:15:28.29136|2017-10-11 03:15:28.29136
NCT01539408|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-02-21|||August 2009||2009-08-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria|Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion|Completed||Phase 1|90|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 03:15:28.374578|2017-10-11 03:15:28.374578
NCT01539395|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-02-24|||January 2012||2012-01-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|April 2012|Anticipated|2012-04-01||Observational|||A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis|A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis|Unknown status|Recruiting|N/A|65|Anticipated|MSDx, Inc.|||3||f||||f||||||Samples With DNA|"     Blood remaining after testing for MSDx Complex-1 will be retained for evaluation for other MS     biomarkers   "|||2017-10-11 03:15:28.455906|2017-10-11 03:15:28.455906
NCT01539382|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-10-22|||November 2011||2011-11-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Measuring and Treating Brain Oxygen Levels in Open Heart Surgery|Optimizing Cerebral Oxygenation in Cardiac Surgery|Completed||N/A|140|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 03:15:28.542303|2017-10-11 03:15:28.542303
NCT01539343|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-04-15|||April 2013||2013-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)|Phase II Pilot Study to Estimate the Adverse Events Associated With the Lock Solution When Used to Salvage Central Venous Catheter (CVC) in the Setting of a Central Line Associated Bloodstream Infection (CLABSI)|Completed||Phase 2|31|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:15:28.80941|2017-10-11 03:15:28.80941
NCT01539330|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-10-31|||February 2009||2009-02-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|VORTarget-site||Assessment of Target Site Pharmacokinetics of Voriconazole in Healthy Volunteers During Sequence Therapy|Assessment of Target Site Pharmacokinetics of Voriconazole in Healthy Volunteers During Sequence Therapy|Completed||Phase 4|9|Actual|Martin-Luther-Universität Halle-Wittenberg||1|||f||||f||||||||||2017-10-11 03:15:28.893663|2017-10-11 03:15:28.893663
NCT01539317|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-04-12|2015-06-05||December 2011||2011-12-01|April 2017|2017-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Therapy to Prevent Sexual Pain in Breast Cancer Survivors|Therapy to Prevent Sexual Pain in Menopausal Survivors of Breast Cancer|Completed||Phase 3|50|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-10-11 03:15:29.011533|2017-10-11 03:15:29.011533
NCT01539304|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-02-26|||September 2010||2010-09-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||"Clinical Trial to Evaluate the Safety and Efficacy of CITUS Dry Syrup in Children With Perennial Allergic Rhinitis"|"Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of CITUS Dry Syrup in Children With Perennial Allergic Rhinitis: Double Blinded, Randomized, Placebo Controlled, Parallel Designed, Multi-centered, Phase III Study"|Completed||Phase 3|245|Actual|SamA Pharmaceutical Co., Ltd||2|||f||||||||||||||2017-10-11 03:15:29.860015|2017-10-11 03:15:29.860015
NCT01539291|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2016-12-13|||October 2012||2012-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116|A Phase 3, Double-Blind Extension Study Evaluating the Efficacy and Safety of Two Different Dose Levels of Single-Agent Idelalisib (GS-1101) for Previously Treated Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 3|160|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 03:15:29.984588|2017-10-11 03:15:29.984588
NCT01539278|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-08-04|||February 2011||2011-02-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea|Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea|Completed||N/A|113|Actual|Eastern Virginia Medical School||2|||f||||f||||||||||2017-10-11 03:15:30.265016|2017-10-11 03:15:30.265016
NCT01539265|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2013-10-29||||||October 2013|2013-10-01||||||||Interventional|||A Dose-finding Study of Silodosin in Patients With Urinary Calculi|A Randomized, Double-blind, Placebo-controlled, Phase II Study of Silodosin in Patients With Urinary Calculi|Completed||Phase 2|300||Kissei Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 03:15:30.377381|2017-10-11 03:15:30.377381
NCT01539252|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-12-07|||January 2013||2013-01-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Examining the Impact of Using Two Dialysers in Parallel on Dialysis Adequacy in Hemodialysis Patients|Examining the Impact of Using Two Dialysers in Parallel on Dialysis Adequacy in Hemodialysis Patients|Completed||N/A|33|Actual|University of Alberta||2|||f||||f||||||||No||2017-10-11 03:15:30.481352|2017-10-11 03:15:30.481352
NCT01539239|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-09-05|||January 2012||2012-01-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2017|Actual|2017-06-01||Interventional|||Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery|The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial|Active, not recruiting||N/A|1143|Actual|Ivantis, Inc.||2|||f||||t||||||||||2017-10-11 03:15:30.594915|2017-10-11 03:15:30.594915
NCT01539226|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2016-12-14|||March 2012||2012-03-01|December 2015|2015-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women|A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women|Completed||N/A|1950|Actual|International Partnership for Microbicides, Inc.||2|||f||||t||||||||No||2017-10-11 03:15:30.76795|2017-10-11 03:15:30.76795
NCT01539213|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2015-02-04|||February 2012||2012-02-01|February 2015|2015-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|OFM ISF||Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg|An Exploratory Study to Investigate the Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid Using Open Flow Microperfusion After a Single Subcutaneous Administration of 300 mg in Healthy Subjects and Psoriatic Patients|Completed||Phase 1|16|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:15:30.86206|2017-10-11 03:15:30.86206
NCT01539200|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-03-25|||March 2012||2012-03-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|NUDAL||Effects of Daily Nutritional Supplementation in Combination With a Eurhythmics Training (NUDAL)|Effects of 6-months Once Daily Nutritional Supplementation in Combination With a Once Weekly Jacques-Delacroze Eurhythmics Training (NUDAL) on Functionality, Probability of Independence and/or Functional Reserve Among Community-dwelling Seniors|Completed||Phase 3|80|Anticipated|Nestlé||2|||f||||f||||||||||2017-10-11 03:15:30.943186|2017-10-11 03:15:30.943186
NCT01539187|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-03-13|||June 2012||2012-06-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|FAST-L||Fibroid Ablation Study - Large Fibroids|Symptom Effectiveness Study of VizAblate® Intrauterine Ultrasound-Guided RF Ablation (IUUSgRFA) in the Ablation of Large Uterine Fibroids|Terminated||N/A|6|Actual|Gynesonics||1||Investigational device changes|f||||f||||||||||2017-10-11 03:15:31.020556|2017-10-11 03:15:31.020556
NCT01539174|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-03-01||||||March 2016|2016-03-01||||||||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma|A Phase II Study of Rituximab Intense Dosing With CHOP-21 (RID-CHOP) in Patients With Previously Untreated High or High-Intermediate Risk IPI (3-5) Diffuse Large B-Cell Lymphoma (DLBCL)|Withdrawn||Phase 2|0|Actual|Fox Chase Cancer Center||1||No Funding Source and Competing Trials|f||||t||||||||||2017-10-11 03:15:31.156678|2017-10-11 03:15:31.156678
NCT01539161|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-10-10|||July 2013||2013-07-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease|Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease|Terminated||Phase 4|12|Actual|Medtronic Cardiac Rhythm and Heart Failure||2||Extremely low enrollment rate|f||||f||||||||||2017-10-11 03:15:31.31464|2017-10-11 03:15:31.31464
NCT01539148|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-05-01|||March 2010||2010-03-01|May 2013|2013-05-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Observational|IPTLD||A Five-Year Quality of Life Study for Cancer Patients|A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLDSM ) Chemotherapy and Nutrition Therapy in the Treatment of Cancer - The IPTLDSM QoL Broad Study|Unknown status|Recruiting|N/A|50|Anticipated|The Kotsanis Institute|||1||f||||f||||||||||2017-10-11 03:15:31.428282|2017-10-11 03:15:31.428282
NCT01539135|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2015-08-05|2015-04-30||April 2012||2012-04-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Influence of Endotracheal Tube Design on Fluid Leakage Into the Lungs During Surgery|The Influence of Endotracheal Tube Cuff Design on Intraoperative Microaspiration and Postoperative Respiratory Complications|Completed||N/A|80|Actual|Medtronic - MITG|This was a feasibility study and based on the results, we do not believe that a larger, multicenter randomized controlled trial would be appropriate. The study wasn’t powered to find any significant differences.|2|||f||||f||||||||||2017-10-11 03:15:31.529123|2017-10-11 03:15:31.529123
NCT01539122|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-11-18|||April 2012||2012-04-01|November 2015|2015-11-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Interventional|TMGlenoid||Clinical Experience With the Zimmer Trabecular Metal (TM) Glenoid in Total Shoulder Arthroplasty|A Multi-Centre, Randomized Controlled Study on the Zimmer TM Glenoid Component Compared to Cemented Glenoid Component|Active, not recruiting||N/A|104|Anticipated|Joint Preservation Centre of BC||2|||f||||f||||||||||2017-10-11 03:15:31.918499|2017-10-11 03:15:31.918499
NCT01539109|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-01-04|||November 2011||2011-11-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Directing Neuroplasticity to Improve Rehabilitative Outcomes of the Upper Limb in Incomplete Quadriplegia|Directing Neuroplasticity to Improve Rehabilitative Outcomes of the Upper Limb in Incomplete Quadriplegia|Recruiting||N/A|10|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No|We will not be sharing or releasing any study data to third parties outside the Cleveland Clinic|2017-10-11 03:15:32.029806|2017-10-11 03:15:32.029806
NCT01539096|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-01-04|||July 2011||2011-07-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Brain Stimulation-aided Stroke Rehabilitation: Neural Mechanisms of Recovery|Brain Stimulation-aided Stroke Rehabilitation: Neural Mechanisms of Recovery|Recruiting||Phase 1/Phase 2|30|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No|We will not be sharing or releasing any study data to third parties outside the Cleveland Clinic.|2017-10-11 03:15:32.152307|2017-10-11 03:15:32.152307
NCT01539083|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-08-08|2016-12-16||January 13, 2012|Actual|2012-01-13|August 2017|2017-08-01|February 28, 2018|Anticipated|2018-02-28|December 30, 2015|Actual|2015-12-30||Interventional|VCAT|Baseline population was defined as all enrolled participants who received at least 1 non-zero dose of any study drug in the induction phase.|Velcade (Bortezomib) Consolidation After Transplant|An Open-label, Randomised Trial of Bortezomib Consolidation (With Thalidomide and Prednisolone) Vs Thalidomide and Prednisolone Alone in Previously Untreated Subjects With Multiple Myeloma After Receiving Bortezomib, Cyclophosphamide, Dexamethasone (VCD) Induction and Autologous Stem Cell Transplant|Active, not recruiting||Phase 3|242|Actual|Janssen Scientific Affairs, LLC||3|||f||||t|f|f||||||||2017-10-11 03:15:32.304583|2017-10-11 03:15:32.304583
NCT01539070|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2014-03-19|2013-07-01||March 2012||2012-03-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Intervention for the Prevention of Obesity in Preschool|Design and Feasibility of a Clinical-based Intervention to Prevent Obesity in Preschool Children|Completed||N/A|306|Actual|Coordinación de Investigación en Salud, Mexico|35% of families did not complete follow-up at 3 months, our primary endpoint. To address the resulting bias from missing data we performed multiple imputation of missing information on covariates and behavioral and BMI outcomes.|2|||f||||f||||||||||2017-10-11 03:15:33.759553|2017-10-11 03:15:33.759553
NCT01539057|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-12-03|||July 2012||2012-07-01|December 2014|2014-12-01|January 2015|Anticipated|2015-01-01|September 2013|Actual|2013-09-01||Interventional|FibstudLT||The Efficacy of the Administration of Fibrinogen in Liver Transplantation|A Multicenter, Placebo Controlled Study to Evaluate the Efficacy of the Administration of Fibrinogen on Blood Product Requirements in Liver Transplantation|Unknown status|Active, not recruiting|Phase 3|132|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 03:15:34.299557|2017-10-11 03:15:34.299557
NCT01539044|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-08-06|||February 2012||2012-02-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ProjectO5Rs||Optimal Relaxation Technique for Laparotomies With Rocuronium Infusion Followed by Sugammadex Reversal|Phase 4 Study of Optimal Relaxation With Rocuronium Infusion Followed by Rapid Reliable Reversal With Sugammadex: A Comparison With Conventional Practice|Completed||Phase 4|49|Actual|Hospital Sultanah Aminah Johor Bahru||2|||f||||t||||||||||2017-10-11 03:15:34.419573|2017-10-11 03:15:34.419573
NCT01539031|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-09-16|||March 2012||2012-03-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease|Randomized, Multicenter, Double-blind, Double-dummy, Parallel-Group Study With an Open-label Extension Phase to Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease|Completed||Phase 3|351|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 03:15:34.54979|2017-10-11 03:15:34.54979
NCT01539018|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2015-08-03|||January 2012||2012-01-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE|A Phase II Trial of Sorafenib Plus Tegafur-uracil (UFT) vs. Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation &/or TACE|Terminated||Phase 2|77|Actual|Egyptian Society of Liver Cancer||2||After interim results data showed no evidence of a difference between both groups|f||||t||||||||||2017-10-11 03:15:34.77196|2017-10-11 03:15:34.77196
NCT01539005|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-02-01|||November 2009||2009-11-01|February 2017|2017-02-01|April 23, 2014|Actual|2014-04-23|April 23, 2014|Actual|2014-04-23||Observational|TRuTH||Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy|Is Tuberculosis Recurrence in Treated Tuberculosis-Human Immunodeficiency Virus (HIV) Co-Infected Patients Relapse or Re-infection?|Completed||N/A|402|Actual|Centre for the AIDS Programme of Research in South Africa|||1||f||||t||||||Samples With DNA|"     Stored Plasma/Serum/PBMCs: Participants who consent to have additional samples stored for     future testing will have serum, plasma and PBMCs stored . Possible uses of plasma include     assessment of host genetics profiles, including HLA profile, additional viral load     assays.Possible uses of serum include additional safety serology and evaluation of suspected     IRIS on participants where indicated. The PBMCs will be used to test for IRIS/PR when     suspected.      Other potential tests that may be performed on the stored specimens include new generation     assays of immunity.      Stored Sputum Isolates :RFLP testing will be performed from stored bacterial isolates on all     positive cultures in which recurrence is suspected and compared to the initial positive     culture used to diagnose the TB initially.   "|||2017-10-11 03:15:34.905292|2017-10-11 03:15:34.905292
NCT01538992|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-07-23|||April 2013||2013-04-01|July 2013|2013-07-01|April 2014|Anticipated|2014-04-01|January 2014|Anticipated|2014-01-01||Interventional|||Renal Denervation in Patients With Advanced Heart Failure|Phase 3 Study of Renal Denervation That Improves Symptoms of Heart Failure and Enhances Life Quality in Advanced Heart Failure|Withdrawn||Phase 3|0|Actual|Bursa Postgraduate Hospital||2||we could not fined enough patients for the study|f||||f||||||||||2017-10-11 03:15:34.991177|2017-10-11 03:15:34.991177
NCT01538979|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-12-17|||March 2012||2012-03-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Phase II Study of Grass Pollen Allergy Vaccine BM32|Phase IIb Study on the Safety and Efficacy of BM32, a Recombinant Hypoallergenic Vaccine for Immunotherapy of Grass Pollen Allergy|Completed||Phase 2|181|Actual|Biomay AG||3|||f||||t||||||||||2017-10-11 03:15:35.096195|2017-10-11 03:15:35.096195
NCT01538966|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-07-23|||January 2012||2012-01-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Acromegaly Combination Treatment Study|Comparison of Combination Low-Dose SRL + Daily Pegvisomant Therapy and High-Dose SRL + Weekly Pegvisomant Therapy|Recruiting||N/A|51|Anticipated|Cedars-Sinai Medical Center||3|||f||||t||||||||||2017-10-11 03:15:35.243312|2017-10-11 03:15:35.243312
NCT01538953|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-02-24|||March 2003||2003-03-01|February 2012|2012-02-01|January 2004|Actual|2004-01-01|December 2003|Actual|2003-12-01||Interventional|||Pakistan Flocculent Health Outcome Study|Pakistan Flocculent Health Outcome Study|Completed||N/A|8949|Actual|Centers for Disease Control and Prevention||5|||f||||f||||||||||2017-10-11 03:15:35.393968|2017-10-11 03:15:35.393968
NCT01538940|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-09-10|||November 2011||2011-11-01|September 2012|2012-09-01||||July 2013|Anticipated|2013-07-01||Interventional|||Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand|Randomized Controlled Trial to Compare the Immunogenicity of Intramuscular Versus Intradermal Trivalent Inactivated Split Virion Influenza Vaccine in HIV-infected Men Who Have Sex With Men in Bangkok, Thailand|Unknown status|Recruiting|Phase 4|480|Anticipated|Centers for Disease Control and Prevention||6|||f||||f||||||||||2017-10-11 03:15:35.521713|2017-10-11 03:15:35.521713
NCT01538927|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-12-22|||April 2012||2012-04-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|FS||Effect of Fibrin Sealant on Early Wound Healing|Evaluation of Early Wound Healing Following Use of Fibrin Sealant (FS) in Periodontal Surgery. A Controlled Randomized Clinical Trial.|Completed||Phase 4|15|Anticipated|Chhattisgarh Dental College and Research Institute||2|||f||||f||||||||||2017-10-11 03:15:35.666789|2017-10-11 03:15:35.666789
NCT01538914|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-04-19|||February 2013||2013-02-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|||Analgesic Effect of Intravenous Patient-Controlled Analgesia (IV PCA) Versus Paravertebral Block After Video Assisted Thoracic Surgery (VATS)|A Comparison Between the Analgesic Effect of Intravenous Patient-controlled Analgesia and of Paravertebral Block After Video Assisted Thoracoscopic Surgery|Completed||N/A|76|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:15:35.784656|2017-10-11 03:15:35.784656
NCT01538901|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2017-09-11|||September 2012||2012-09-01|September 2017|2017-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|AKtransplant||Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients|Topical Imiquimod 5% Cream Therapy Versus Photodynamic Therapy With Methyl-aminolaevulinate 16% Cream of Actinic Keratoses in Organ Transplant Recipients|Terminated||Phase 4|10|Actual|Medical University of Vienna||2||prolonged recruitment phase|f||||t||||||||||2017-10-11 03:15:35.886761|2017-10-11 03:15:35.886761
NCT01538888|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-02-18|||February 2011||2011-02-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|EWBVEPQL||Effects Whole Body Vibration in Ergospirometrics Parameters and Quality of Life|Effects Whole Body Vibration in Ergospirometrics Parameters, Strength And Quality of Life: A Randomised Controlled Trial|Completed||Phase 1/Phase 2|35|Actual|Universidade Federal de Pernambuco||1|||f||||t||||||||||2017-10-11 03:15:36.022407|2017-10-11 03:15:36.022407
NCT01538875|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2013-05-16|||July 2012||2012-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy|Hydralazine vs. Labetalol for the Management of Hypertensive Crisis in Patients With Hypertensive Disorders of Pregnancy. A Randomized Controlled Trial.|Completed||Phase 3|261|Actual|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-11 03:15:36.124039|2017-10-11 03:15:36.124039
NCT01538862|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-05-30|2016-04-01||February 2012||2012-02-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa|Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa|Completed||Phase 2|7|Actual|Vanderbilt University Medical Center||1|||f||||f||||||||No||2017-10-11 03:15:36.248435|2017-10-11 03:15:36.248435
NCT01538849|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2014-07-08|||December 2012||2012-12-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional|||Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis|Randomized, Double-blind, Active-controlled, Multi-center Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis|Completed||Phase 2|154|Actual|Yuhan Corporation||5|||f||||f||||||||||2017-10-11 03:15:36.472857|2017-10-11 03:15:36.472857
NCT01538823|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-04-04|||February 2012||2012-02-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|UP||Urine Proteome of Surgical Patients and Healthy Volunteers|Urine Proteome of Surgical Patients and Healthy Volunteers.|Active, not recruiting||N/A|836|Actual|Washington University School of Medicine|||7||f||||t||||||||||2017-10-11 03:15:36.70014|2017-10-11 03:15:36.70014
NCT01538810|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-06-16|||February 2012||2012-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Biomarker Correlates of Radiologic Imaging|Biomarker Correlates of Radiologic Imaging|Completed||N/A|751|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 03:15:36.784201|2017-10-11 03:15:36.784201
NCT01538797|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-20|||July 1996||1996-07-01|February 2012|2012-02-01|August 1996|Actual|1996-08-01|August 1996|Actual|1996-08-01||Interventional|||Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed States|YF476: Effects of a Single Dose at 3 Dose Levels on 24-hour Ambulatory Gastric pH Compared With Placebo and Ranitidine in Healthy Volunteers|Completed||Phase 1|22|Actual|Trio Medicines Ltd.|||||f||||f||||||||||2017-10-11 03:15:36.851751|2017-10-11 03:15:36.851751
NCT01538784|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-20|||May 1996||1996-05-01|February 2012|2012-02-01|June 1996|Actual|1996-06-01|June 1996|Actual|1996-06-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men|A Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of YF476, a Novel, Potent and Selective Gastrin/Cholecystokinin-B Antagonist, in Healthy Male Volunteers|Completed||Phase 1|15|Actual|Trio Medicines Ltd.|||||f||||f||||||||||2017-10-11 03:15:36.94253|2017-10-11 03:15:36.94253
NCT01538771|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-06-18|||November 2009||2009-11-01|June 2015|2015-06-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||Intracoronary Darbepoetin-alpha to Reduce The Infarct Size and Post-Infarct Remodeling|The Efficacy of IntraCoronary Erythropoietin Delivery BEfore Reperfusion: Gauging Infarct Size in Patients With Acute ST-segment Elevation Myocardial Infarction (ICEBERG).|Completed||Phase 2|80|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 03:15:37.017922|2017-10-11 03:15:37.017922
NCT01538758|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2012-07-11|||July 2012||2012-07-01|July 2012|2012-07-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Interventional|BARB-01||Ultrasound Guided Needling Versus Ultrasound Guided Corticosteroid Injection Alone, a Randomized Controlled Trial.|Treatment of Calcifying Tendinitis of the Shoulder: Ultrasound Guided Needling With Subacromial Corticosteroid Injection Versus Ultrasound Guided Subacromial Corticosteroid Injection Only, a Randomized Controlled Trial.|Unknown status|Recruiting|N/A|80|Anticipated|Medisch Spectrum Twente||2|||f||||t||||||||||2017-10-11 03:15:37.140874|2017-10-11 03:15:37.140874
NCT01538732|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-03-19|||March 2012||2012-03-01|March 2012|2012-03-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Lichen Planus Mucosae at USZ, Efficacy of Oral Alitretinoin|Single-Center, Prospective, Open Label, Single-arm Pilot Study Investigating the Efficacy and Safety of Alitretinoin in Patients Suffering From Severe Mucosal Lichen Planus.|Unknown status|Recruiting|Phase 2|20|Anticipated|University of Zurich||1|||f||||t||||||||||2017-10-11 03:15:37.4027|2017-10-11 03:15:37.4027
NCT01538719|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-03-29|||December 2011||2011-12-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|January 2017|Actual|2017-01-01||Interventional|||IL1-TRAP, Rilonacept, in Systemic Sclerosis|Randomized, Double-Blind, Placebo-Controlled Trial if IL1-TRAP, Rilonacept, in Systemic Sclerosis -A Phase I/II Biomarker Trial|Active, not recruiting||Phase 1/Phase 2|19|Actual|Boston University||2|||f||||t|t|f||||||Undecided||2017-10-11 03:15:37.653363|2017-10-11 03:15:37.653363
NCT01538706|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-02-23|||August 2008||2008-08-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Hospital-based Home Care for Children With Cancer|Hospital-based Home Care for Children With Cancer|Completed||N/A|75|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 03:15:37.742934|2017-10-11 03:15:37.742934
NCT01538667|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-08-20|||April 2012||2012-04-01|August 2014|2014-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases|Non-blinded, Single Dose, Single Centre Trial to Assess the Pulmonary Deposition as Well as Pharmacokinetics, Safety and Tolerability of 99mTc Labeled Ciprofloxacin When Delivered as a Single Dose From a Dry Powder Inhaler to Healthy Subjects With and Without Charcoal Block and Patients Suffering From Bronchiectasis and COPD|Completed||Phase 1|24|Actual|Bayer||4|||f||||f||||||||||2017-10-11 03:15:39.080584|2017-10-11 03:15:39.080584
NCT01538654|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-02-23|||March 2011||2011-03-01|February 2012|2012-02-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Interventional|EMF||Enteroprotein Modified Fast ( EMF )|Enteroprotein Modified Fast ( EMF ) : Clinical Safety and Efficacy. A Six Months Pilot RCT|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||2|||f||||f||||||||||2017-10-11 03:15:39.170332|2017-10-11 03:15:39.170332
NCT01538056|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2016-05-16|||March 2011||2011-03-01|May 2016|2016-05-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Interventional|PMEG||Physician Modified Endovascular Grafts|Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study|Recruiting||N/A|150|Anticipated|University of Washington||1|||f||||t||||||||Undecided||2017-10-11 03:15:44.181248|2017-10-11 03:15:44.181248
NCT01538641|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-07-11|||October 2003||2003-10-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|August 2007|Actual|2007-08-01||Interventional|||Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive Lymphomas|Phase II Evaluation Of GROC (Gemcitabine- Rituximab-Oxaliplatin Combination) Given Every 14 Days For The Treatment Of Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|43|Actual|Auxilio Mutuo Cancer Center||1|||f||||t||||||||||2017-10-11 03:15:39.252163|2017-10-11 03:15:39.252163
NCT01538628|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2014-11-21|||January 2012||2012-01-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||SpaceOAR System Pivotal Study|Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study|Completed||Phase 3|222|Actual|Augmenix, Inc.||2|||f||||f||||||||||2017-10-11 03:15:39.31858|2017-10-11 03:15:39.31858
NCT01538602|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2012-02-23||||||February 2012|2012-02-01||||||||Observational|||Mean Platelet Volume and TXA2 Levels in Patients With Polycystic Ovary Syndrome (PCOS)||Completed||N/A|||AGUNCO Obstetrics and Gynecology Centre|||2||f||||||||||||||2017-10-11 03:15:39.589148|2017-10-11 03:15:39.589148
NCT01538589|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-03-03|||December 2003||2003-12-01|March 2016|2016-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Special Survey for Patients With Type 1 or Type 2 Diabetes|Special Survey for Type 1 or Type 2 Diabetic Patients|Completed||N/A|1582|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:15:39.665212|2017-10-11 03:15:39.665212
NCT01538576|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-03-03|||December 2003||2003-12-01|March 2016|2016-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Paediatric Subjects - Special Survey|Special Survey for Paediatric Subjects|Completed||N/A|71|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:15:39.758915|2017-10-11 03:15:39.758915
NCT01538563|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-06-22|||June 2006||2006-06-01|June 2017|2017-06-01|November 2011|Actual|2011-11-01|July 2010|Actual|2010-07-01||Interventional|||Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer|Phase I Dose Escalation Study of ON 01910.Na by 24 Hour Continuous Infusion Per Week in Patients With Advanced Cancer|Completed||Phase 1|42|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 03:15:39.861633|2017-10-11 03:15:39.861633
NCT01538550|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-04-13|||March 2012||2012-03-01|April 2015|2015-04-01|December 2030|Anticipated|2030-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Pilot Study of a National Screening Programme for Bowel Cancer in Norway|Colorectal Cancer Screening in Norway: Pilot Study of a National Screening Programme With Randomised Comparison of Different Screening Strategies to Provide the Best Possible Service to the Population|Enrolling by invitation||Phase 3|140000|Anticipated|Norwegian Department of Health and Social Affairs||2|||f||||t||||||||||2017-10-11 03:15:39.967882|2017-10-11 03:15:39.967882
NCT01538537|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-06-22|||August 2006||2006-08-01|June 2017|2017-06-01|January 2012|Actual|2012-01-01|October 2010|Actual|2010-10-01||Interventional|||Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer|Phase I Dose Escalation Study of ON 01910.Na by 3-day Continuous Infusion in Patients With Advanced Cancer|Completed||Phase 1|29|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 03:15:40.092311|2017-10-11 03:15:40.092311
NCT01538524|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-02-23|||February 2012||2012-02-01|January 2012|2012-01-01|February 2014|Anticipated|2014-02-01|||||Observational|||Analysis of Patient Seeking Second Opinion Who Are Undergoing Full Mouth Orthodontic Treatment|Analysis of Patient Seeking Second Opinion Who Undergoing Full Mouth Orthodontic Treatment|Unknown status|Not yet recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 03:15:40.203702|2017-10-11 03:15:40.203702
NCT01538511|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-10-04|||June 5, 2006|Actual|2006-06-05|October 2017|2017-10-01|March 13, 2007|Actual|2007-03-13|March 13, 2007|Actual|2007-03-13||Interventional|||Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers|A Two-centre, Randomised, Open-labelled, Four-week, Parallel-group Pharmacokinetics Trial in Japanese Type 2 Diabetic Subjects Characterising the Insulin Profile of Thrice Daily Regimen With Biphasic Insulin Aspart 70 (NN2000-Mix70) With Reference to That of Twice Daily Regimen With Biphasic Insulin Aspart 30 (NN-X14Mix30) and Physiological Insulin Profile in Japanese Healthy Volunteers|Completed||Phase 1|59|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:15:40.267442|2017-10-11 03:15:40.267442
NCT01538498|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2013-03-26|||April 2008||2008-04-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Observational|||Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer|A Clinical Trial to Develop a Peritoneal Carcinomatosis Index (PCI) in Ovarian|Completed||N/A|134|Actual|National Cancer Center, Korea|||1||f||||||||||||||2017-10-11 03:15:40.375722|2017-10-11 03:15:40.375722
NCT01538485|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-10-09|||January 2012||2012-01-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUT|Pilot Study to Assess the Effects of Vitamin D Supplementation on the Number of Regulatory FoxP3+ T Cells in the Gastrointestinal Mucosa in Healthy Women and Men: Step 3 in the Austrian Diabetes Prevention Programme|Completed||Phase 4|16|Actual|Medical University of Graz||1|||f||||t||||||||||2017-10-11 03:15:40.441328|2017-10-11 03:15:40.441328
NCT01538472|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2014-09-04|2014-09-04||September 2003||2003-09-01|September 2014|2014-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma|Y Zevalin, BEAM and Rituximab In Autologous Stem Cell Transplantation (ASCT) For Lymphoma|Completed||Phase 1/Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:15:40.534979|2017-10-11 03:15:40.534979
NCT01538459|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2013-05-17|||November 2012||2012-11-01|May 2013|2013-05-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block|Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block|Withdrawn||Phase 3|0|Actual|Lifespan||2|||f||||f||||||||||2017-10-11 03:15:40.84149|2017-10-11 03:15:40.84149
NCT01537666|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-03-03|2013-10-30||November 2011||2011-11-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics|Phase I, Reference-controlled, Dose Escalating Study to Examine the Pharmacokinetics and Safety of AeroVanc Inhalation Powder.|Completed||Phase 1|25|Actual|Savara Inc.||6|||f||||t||||||||||2017-10-11 03:15:49.404835|2017-10-11 03:15:49.404835
NCT01538446|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-01-10|||March 2012||2012-03-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ANTARCTIC||Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel|The ANTARCTIC Study - Assessment of a Normal Versus Tailored Dose of Prasugrel After Stenting in Patients Aged > 75 Years to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications|Completed||Phase 4|880|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:15:41.001207|2017-10-11 03:15:41.001207
NCT01538433|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2015-08-17|||February 2012||2012-02-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy|A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy: an Observational Study|Completed||N/A|603|Actual|Guangdong General Hospital|||1||f||||t||||||||||2017-10-11 03:15:41.107453|2017-10-11 03:15:41.107453
NCT01538420|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-04-18|||January 2012||2012-01-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||GLPG0492 Pharmacodynamics|Assessment of the Muscle Protein Fractional Synthesis Rate Induced by Repeated Administrations of GLPG0492 to Healthy Male Subjects and Assessment of the Safety, Tolerability and Pharmacokinetics of Repeated Administrations of GLPG0492 to Healthy Postmenopausal Women.|Completed||Phase 1|26|Actual|Galapagos NV||2|||f||||f||||||||||2017-10-11 03:15:41.16548|2017-10-11 03:15:41.16548
NCT01538407|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2014-01-21|||March 2012||2012-03-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Strengthening Exercise and Quadriceps Force During Walking|A Study of Strengthening Exercise on Quadriceps Force During Walking|Completed||N/A|30|Actual|Frederiksberg University Hospital||2|||f||||f||||||||||2017-10-11 03:15:41.237926|2017-10-11 03:15:41.237926
NCT01538394|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2013-10-17|||January 2012||2012-01-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|COMBIVAR||Clinical Trial to Evaluate the Efficacy of Smoking Cessation|Randomized Double-blind Trial of Two Parallel Groups Design to Evaluate the Efficacy of Smoking Cessation With Combined (Varenicline Plus Nicotine Patches) Versus Monotherapy (Varenicline Plus Placebo Patches)|Completed||Phase 4|322|Actual|Hospital Universitari de Bellvitge||2|||f||||f||||||||||2017-10-11 03:15:41.316873|2017-10-11 03:15:41.316873
NCT01538381|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-10-11|||July 2012||2012-07-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck|Neoadjuvant Afatinib Based Treatment Strategies Followed by Surgery in Squamous Cell Carcinoma of the Head and Neck: an EORTC NOCI-HNCG Window Study.|Completed||Phase 2|30|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 03:15:41.597524|2017-10-11 03:15:41.597524
NCT01538368|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-02-23|||January 2007||2007-01-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|||Magnetic Resonance Cholangio-pancreatography (MRCP) for Suspected Bilio-pancreatic Disease|Magnetic Resonance Cholangio-pancreatography (MRCP) for Suspected Bilio-pancreatic Disease: Should the Endoscopist Take a Second Look?|Completed||N/A|155|Actual|Deutsche Klinik fuer Diagnostik|||1||f||||f||||||||||2017-10-11 03:15:41.694827|2017-10-11 03:15:41.694827
NCT01538355|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-02-15|||December 2011||2011-12-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|February 2013|Actual|2013-02-01||Interventional|IGEL||A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis|A Randomised Controlled Pilot Study to Compare the Effects of Prolonged Fasting and Ketogenic Low Glycemic Load Treatment on Health Related Quality of Life in Relapsing-remitting Multiple Sclerosis.|Completed||N/A|48|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-10-11 03:15:41.753139|2017-10-11 03:15:41.753139
NCT01538342|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-04-22|||July 2012||2012-07-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis|Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis|Recruiting||N/A|170|Anticipated|Centre Hospitalier Universitaire de Nice||5|||f||||f||||||||||2017-10-11 03:15:41.846444|2017-10-11 03:15:41.846444
NCT01538329|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-05-06|||March 2012||2012-03-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|April 2017|Anticipated|2017-04-01||Interventional|PREMANDYSK||Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease|Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)|Recruiting||Phase 2|202|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 03:15:41.982054|2017-10-11 03:15:41.982054
NCT01538316|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-05-13|||March 2012||2012-03-01|May 2012|2012-05-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|QUERGEN||Prostate Cancer Prevention Trial With Quercetin and Genistein|Clinical Trial on the Effectiveness of the Flavonoids Genistein and Quercetin in Men With Rising Prostate-specific Antigen|Unknown status|Recruiting|N/A|60|Anticipated|University of Hohenheim||3|||f||||f||||||||||2017-10-11 03:15:42.148992|2017-10-11 03:15:42.148992
NCT01538303|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-07-09|||March 2012||2012-03-01|July 2012|2012-07-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Observational|||Microvascular Dysfunction in Acute Myocardial Infarction (AMI) and Its Relation to Outcome|Microvascular Dysfunction in AMI and Its Relation to Outcome|Unknown status|Recruiting|N/A|25|Anticipated|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||||2017-10-11 03:15:42.270584|2017-10-11 03:15:42.270584
NCT01538290|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2012-06-11|||November 2011||2011-11-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|IMPRESS||Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic Patients|Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic|Completed||N/A|34|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 03:15:42.359017|2017-10-11 03:15:42.359017
NCT01538277|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-10-27|||February 2012||2012-02-01|March 2012|2012-03-01|October 2016|Actual|2016-10-01|September 2014|Actual|2014-09-01||Interventional|CFC-PVAI||A Pilot Study of a Contact Force Catheter for Pulmonary Vein Antrum Isolation|A Pilot Study of a Contact Force Catheter for Pulmonary Vein Antrum Isolation (CFC-PVAI)|Completed||Phase 2|50|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 03:15:42.425814|2017-10-11 03:15:42.425814
NCT01538264|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-03-10|||June 2006||2006-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|Glioma||Blood Flow MRI for Monitoring Brain Tumors|Blood Flow MRI for Monitoring of Glioma Angiogenesis|Recruiting||N/A|125|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||||No||2017-10-11 03:15:42.618795|2017-10-11 03:15:42.618795
NCT00005749|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-11|||July 1996||1996-07-01|August 2004|2004-08-01|December 2002||2002-12-01|||||Observational|||Project Andale--Increasing Exercise in Hispanic Women||Completed||N/A|||San Diego State University|||||f||||||||||||||2017-10-11 04:28:57.656525|2017-10-11 04:28:57.656525
NCT01538251|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-11-04|||April 2012||2012-04-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis|Randomized Multicenter International Study to Investigate the Safety and Efficacy of Propionyl-L-Carnitine Hydrochloride Modified Release Tablets in Patients Affected by Mild Ulcerative Colitis Under Oral Stable Treatment|Terminated||Phase 3|147|Actual|sigma-tau i.f.r. S.p.A.||2||Evidence of very low probability to success. No safety issues.|f||||t||||||||No||2017-10-11 03:15:42.702098|2017-10-11 03:15:42.702098
NCT01538238|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2017-04-24|||May 2, 2012|Actual|2012-05-02|April 2017|2017-04-01|November 14, 2015|Actual|2015-11-14|February 28, 2015|Actual|2015-02-28||Interventional|||pazopanib_NCRCC,Ph2 STUDY||Completed||Phase 2|10|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:15:42.91541|2017-10-11 03:15:42.91541
NCT01538225|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2014-01-17|||April 2012||2012-04-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|NS-MSS||Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity|Neurophysiologic Study on Effects of Sativex® on Spasticity in Progressive Multiple Sclerosis|Completed||Phase 3|45|Actual|Almirall, S.A.||2|||f||||t||||||||||2017-10-11 03:15:42.992175|2017-10-11 03:15:42.992175
NCT01538212|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-20|2016-04-15|||January 2012||2012-01-01|April 2016|2016-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|ACT||Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease|Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease|Completed||N/A|55|Actual|Accera, Inc.|||1||f||||f||||||||||2017-10-11 03:15:43.083752|2017-10-11 03:15:43.083752
NCT01538186|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-02-23|||January 2008||2008-01-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|August 2011|Actual|2011-08-01||Observational|||Treatment Of Coronary Bifurcation Lesions: Stentcovering Of The Side Branch With And Without PCI Of The Side Branch: A Retrospective Analysis Of All Consecutive Patients|Treatment Of Coronary Bifurcation Lesions: Stentcovering Of The Side Branch With And Without PCI Of The Side Branch: A Retrospective Analysis Of All Consecutive Patients|Completed||N/A|98|Actual|Krankenhaus Hetzelstift|||2||f||||f||||||||||2017-10-11 03:15:43.244638|2017-10-11 03:15:43.244638
NCT01538173|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2015-11-30|||January 2007||2007-01-01|November 2015|2015-11-01|February 2012|Actual|2012-02-01|October 2011|Actual|2011-10-01||Interventional|||Increased Microcirculation for Preventing Postoperative Wound Infections in Patients Undergoing Reduction Mammoplasty|Prospective Study Investigating the Role of Increased Microcirculation for Preventing Postoperative Surgical Side Infections in Patients Undergoing Reduction Mammoplasty|Completed||Phase 4|334|Actual|University of Rostock||2|||f||||f||||||||||2017-10-11 03:15:43.307907|2017-10-11 03:15:43.307907
NCT01538160|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-02-22|||February 2012||2012-02-01|February 2012|2012-02-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|rFVIIa||A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery||Unknown status|Not yet recruiting|N/A|15|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 03:15:43.389418|2017-10-11 03:15:43.389418
NCT01538147|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2015-01-01|||August 2014||2014-08-01|January 2015|2015-01-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Observational|||Restless Leg Syndrome and Severe Preeclampsia|Association Between Restless Leg Syndrome and Severe Preeclampsia. A Case Control Study.|Unknown status|Recruiting|N/A|310|Anticipated|Saint Thomas Hospital, Panama|||2||f||||f||||||||||2017-10-11 03:15:43.474596|2017-10-11 03:15:43.474596
NCT01538134|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2015-01-01|||June 2015||2015-06-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|February 2016|Anticipated|2016-02-01||Observational|||Antiphospholipid Antibodies and Fetal Growth Restriction|Antiphospholipid Antibodies and Early Fetal Growth Restriction (<34 Weeks of Gestation). A Case Control Study.|Unknown status|Not yet recruiting|N/A|90|Anticipated|Saint Thomas Hospital, Panama|||2||f||||f||||||||||2017-10-11 03:15:43.556028|2017-10-11 03:15:43.556028
NCT01538121|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2015-01-01|||June 2015||2015-06-01|January 2015|2015-01-01|August 2016|Anticipated|2016-08-01|July 2016|Anticipated|2016-07-01||Observational|||Antiphospholipid Antibodies and Early Severe Preeclampsia.|Antiphospholipid Antibodies and Early Severe Preeclampsia (< 34 Weeks of Gestation). A Case-Control Study.|Unknown status|Not yet recruiting|N/A|310|Anticipated|Saint Thomas Hospital, Panama|||2||f||||f||||||||||2017-10-11 03:15:43.634457|2017-10-11 03:15:43.634457
NCT01538108|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-22|||July 2012||2012-07-01|February 2012|2012-02-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae|The Use of NMB Drug Ejecting Balloon for Arteriovenous (AV) Dialysis Fistulae|Unknown status|Not yet recruiting|N/A|40|Anticipated|N.M.B. Medical Applications Ltd||2|||f||||||||||||||2017-10-11 03:15:43.708064|2017-10-11 03:15:43.708064
NCT01538095|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2016-09-30|||February 2012||2012-02-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors|A Phase 1 Study of AMG 386, an Angiopoietin Neutralizing Peptibody, in Children With Relapsed or Refractory Solid Tumors, Including CNS Tumors|Completed||Phase 1|37|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 03:15:43.808014|2017-10-11 03:15:43.808014
NCT01538082|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-19|2012-02-19|||December 2008||2008-12-01|February 2012|2012-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|STREX||Role of the Stress in the Development of the Metabolic Syndrome|Role of Anxiety, Depression, Quality of Life and Stressful Vital Events in the Development of the Metabolic Syndrome. StreX Project.|Unknown status|Recruiting|N/A|738|Anticipated|Jordi Gol i Gurina Foundation|||2||f||||f||||||||||2017-10-11 03:15:43.956216|2017-10-11 03:15:43.956216
NCT01538069|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2013-08-06|||March 2012||2012-03-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Interventional|CPAP||Heart Failure and Sleep Apnea: Exercise Training and Continuous Positive Airway Pressure|Comparison Between Exercise Training and CPAP Treatment for Patients With Heart Failure and Sleep Apnea.|Unknown status|Recruiting|N/A|80|Anticipated|Associação Fundo de Incentivo à Pesquisa||4|||f||||t||||||||||2017-10-11 03:15:44.068279|2017-10-11 03:15:44.068279
NCT01538030|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2012-08-13|||May 2012||2012-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Perinatal Outcome After Premature Rupture of Membranes|Perinatal Outcomes According to Amniotic Fluid Indez After Premature Rupture of Membranes. A Prospective Cohort Study.|Completed||N/A|80|Actual|Saint Thomas Hospital, Panama|||2||f||||f||||||||||2017-10-11 03:15:44.409817|2017-10-11 03:15:44.409817
NCT01538017|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2016-10-03|||February 2012||2012-02-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture|Comparing Injectable Collagenase (CI) and Percutaneous Needle Fasciotomy (PNF) for Dupuytren's Contracture (DC) Affecting Proximal Interphalangeal Joints (PIP). A Randomised Controlled Trial|Completed||N/A|50|Actual|Regionshospitalet Silkeborg||2|||f||||f||||||||||2017-10-11 03:15:44.501254|2017-10-11 03:15:44.501254
NCT01538004|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-04-02|||March 2014||2014-03-01|April 2014|2014-04-01|November 2014|Anticipated|2014-11-01|September 2014|Anticipated|2014-09-01||Observational|||Where Should Automated Blood Pressures be Done in Primary Care Offices?|Where Should Automated Blood Pressures be Done? RCT of BpTRU Measurement in Private or Non-private Areas of Primary Care Offices|Withdrawn||N/A|0|Actual|North Toronto Primary Care Research Network|||2|Not funded|f||||f||||||||||2017-10-11 03:15:44.605312|2017-10-11 03:15:44.605312
NCT01537991|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-02-17|||January 2012||2012-01-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|I-START||ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial|A Phase I/II Trial of Isotoxic Accelerated Radiotherapy in the Treatment of Patients With Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 1/Phase 2|121|Anticipated|Wales Cancer Trials Unit||3|||f||||t||||||||||2017-10-11 03:15:44.706567|2017-10-11 03:15:44.706567
NCT01537978|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-12-08|||February 2012||2012-02-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Use of Interactive Gaming for Enhanced Function After Spinal Cord Injury|Use of Interactive Gaming After Spinal Cord Injury|Completed||Phase 1|21|Actual|VA Palo Alto Health Care System||1|||f||||f||||||||||2017-10-11 03:15:44.841177|2017-10-11 03:15:44.841177
NCT01537965|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-02-21|||January 2012||2012-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|FIBRECHO||Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Viral Hepatitis B or C||Completed||N/A|96|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-10-11 03:15:44.944538|2017-10-11 03:15:44.944538
NCT01537952|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2012-02-22|||May 2007||2007-05-01|February 2012|2012-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Microbiologic Findings of Acute Facial Palsy in Children|Microbiologic Findings of Acute Facial Palsy in Children|Completed||N/A|46|Actual|Helsinki University|||1||f||||f||||||||||2017-10-11 03:15:45.21103|2017-10-11 03:15:45.21103
NCT01537939|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2012-02-22|||March 2009||2009-03-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|ASUKI-Step||ASUKI Step Pedometer Worksite Intervention|ASUKI Step Pedometer Worksite Intervention|Completed||Phase 4|2018|Actual|Arizona State University||1|||f||||f||||||||||2017-10-11 03:15:45.26373|2017-10-11 03:15:45.26373
NCT01537926|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-05-01|||January 2012||2012-01-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|HALT||Hypertrophic Regression With N-Acetylcysteine in HCM|Pilot Feasibility Study With N-acetylcystein (NAC) in Patients With HCM Caused by Sarcomere Proteins Mutations|Completed||Phase 1|42|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 03:15:45.344569|2017-10-11 03:15:45.344569
NCT01537913|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-18|2012-02-22|||June 2009||2009-06-01|February 2012|2012-02-01|June 2010|Actual|2010-06-01|||||Observational|||FOUR Score in Children With Non-traumatic Impairment of Consciousness|Comparison of the Full Outline of UnResponsiveness (FOUR) Score With Glasgow Coma Scale (GCS) in Children With Non-traumatic Impairment of Consciousness.|Completed||N/A|70|Actual|All India Institute of Medical Sciences, New Delhi|||1||f||||f||||||||||2017-10-11 03:15:45.433153|2017-10-11 03:15:45.433153
NCT01537900|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-03-01|2016-02-03||October 2013||2013-10-01|March 2017|2017-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Multiple Dose Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Participants (MK-5172-010)|A Multiple Dose Study to Evaluate Pharmacokinetics and Hepatitis C Virus RNA Dynamics Following Administration of MK-5172 in Hepatitis C Infected Patients|Completed||Phase 1|4|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:15:45.493919|2017-10-11 03:15:45.493919
NCT01537887|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-06-25|||February 2012||2012-02-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of LY2484595 on the Electrical Activity of the Heart|A Placebo- and Positive-Controlled Study of the Effect of LY2484595 on QT Interval in Healthy Subjects|Completed||Phase 1|72|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:15:45.74372|2017-10-11 03:15:45.74372
NCT01537874|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2014-05-19|||May 2010||2010-05-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||MassCONECT (Massachusetts Community Networks to Eliminate Cancer Disparities Through Education) 4 Kids: Promoting Smoke-free Homes|MassCONECT 4 Kids: Promoting Smoke-free Homes MassCONECT (Massachusetts Community Networks to Eliminate Cancer Disparities Through Education)|Completed||N/A|138|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-11 03:15:45.844603|2017-10-11 03:15:45.844603
NCT01537861|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-01-21|||June 2012||2012-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma|A Pilot Study of G-CSF to Disrupt the Bone Marrow Microenvironment in Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma|Terminated||Early Phase 1|7|Actual|Washington University School of Medicine||1||Unexpected toxicity (2 early deaths)|f||||f||||||||||2017-10-11 03:15:46.875806|2017-10-11 03:15:46.875806
NCT00005750|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-08|||April 1996||1996-04-01|July 2001|2001-07-01|March 2001||2001-03-01|||||Observational|||School and Family-Based Obesity Prevention for Children||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 04:28:57.753455|2017-10-11 04:28:57.753455
NCT01537848|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-02-23|||January 2002||2002-01-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Observational|||Retrospective Study of Endoscopic Ultrasound (EUS) Guided Transmural Drainage of Post-operative Abdominal Collections|Retrospective Study of Endoscopic Ultrasound Guided Transmural Drainage of Post-operative Collections|Completed||N/A|43|Actual|Erasme University Hospital|||1||f||||f||||||||||2017-10-11 03:15:47.161214|2017-10-11 03:15:47.161214
NCT01537835|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-02-09|2014-12-17||November 2011||2011-11-01|February 2015|2015-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Please note two participants in the standard scrub group and two participants in the antimicrobial scrub group A were excluded from analysis.|Bacterial Contamination of Healthcare Worker Uniforms|Bacterial Contamination of Healthcare Worker Uniforms: A Study of Antimicrobial Uniforms on Occupationally Acquired Bacterial Contamination: A Randomized Controlled Trial|Completed||N/A|109|Actual|Denver Health and Hospital Authority||3|||f||||f||||||||||2017-10-11 03:15:47.307556|2017-10-11 03:15:47.307556
NCT01537822|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-12-04|||May 2011||2011-05-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|HM||The Hysteroscopic Morcellator (HM).|The Hysteroscopic Morcellator Versus the Bipolar Resectoscope for Removal of Lager Intrauterine Polyps, Removal of Submucous Myomas and Removal of Residual Placental Tissue: a Randomized Controlled Trial.|Unknown status|Recruiting|Phase 4|222|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 03:15:47.882483|2017-10-11 03:15:47.882483
NCT01537809|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2013-12-12|||June 2011||2011-06-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]|The Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors in Schoolchildren|Completed||N/A|691|Actual|Tufts University||3|||f||||t||||||||||2017-10-11 03:15:48.069767|2017-10-11 03:15:48.069767
NCT01537796|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-08-04|||February 2012||2012-02-01|August 2015|2015-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese|Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese|Completed||N/A|39|Actual|University of Pittsburgh||3|||f||||f||||||||||2017-10-11 03:15:48.187786|2017-10-11 03:15:48.187786
NCT01537783|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-03-15|2017-01-23||September 2011||2011-09-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess|A Randomized Trial to Evaluate a Staphylococcus Eradication Protocol for Patients Who Present to the Emergency Department With Cutaneous Abscess|Completed||Phase 4|50|Actual|Tufts Medical Center|There were so many lost to follow-up patients in the intervention group that it is difficult to draw conclusions from this study.|2|||f||||f||||||||||2017-10-11 03:15:48.299069|2017-10-11 03:15:48.299069
NCT01537770|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-09-10|||February 2012||2012-02-01|October 2014|2014-10-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|VOPE||Vertebroplasty Compared With a Sham-procedure for Painful Acute Osteoporotic Vertebral Fractures|Prospective, Randomized Study for Comparison of Percutaneous Vertebroplasty Opposite - Infiltration of the Periost and Vertebral Body With Lidocaine - as Pain Palliative Treatment of Osteoporotic Vertebral Fractures of the Thoracic and Lumbar Spine|Completed||Phase 4|52|Actual|Sygehus Lillebaelt||2|||f||||t||||||||||2017-10-11 03:15:48.617805|2017-10-11 03:15:48.617805
NCT01537757|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-01-23|||March 2012||2012-03-01|January 2015|2015-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])|An Open-Label, Two-Part, Single-Dose Study to Investigate the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (Protocol No. MK-8931-009 [P08535])|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 03:15:48.718766|2017-10-11 03:15:48.718766
NCT01537744|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-03-21|||February 2012||2012-02-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|March 2016|Actual|2016-03-01||Interventional|||A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma|Phase I Trial of Oral 5-azacitidine With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma|Completed||Phase 1|18|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:15:48.815943|2017-10-11 03:15:48.815943
NCT01537731|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2013-10-08|||April 2009||2009-04-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Vaginal or Laparoscopic Hysterectomy, Persistent Postsurgical Pain|Chronic Pain After Vaginal or Laparoscopic Hysterectomy for Benign Conditions|Completed||N/A|225|Anticipated|Tampere University Hospital|||1||f||||f||||||||||2017-10-11 03:15:48.917889|2017-10-11 03:15:48.917889
NCT01537718|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2013-07-16|||March 2012||2012-03-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|DREAM||Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Function in Pacemaker|Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Function in Pacemaker|Completed||Phase 3|40|Actual|LivaNova||1|||f||||f||||||||||2017-10-11 03:15:48.988694|2017-10-11 03:15:48.988694
NCT01537705|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-17|||March 2012||2012-03-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|Neuron012703||A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy|A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy|Unknown status|Not yet recruiting|Phase 2|24|Anticipated|Targeted Medical Pharma||1|||f||||f||||||||||2017-10-11 03:15:49.083934|2017-10-11 03:15:49.083934
NCT01537692|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-22|||March 2009||2009-03-01|February 2012|2012-02-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol|A Randomized, Open-Label, 3-Period Crossover Study to Investigate the Pharmacokinetics, Safety and Tolerability of BDP HFA Nasal Aerosol in Healthy Volunteers|Completed||Phase 1|30|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 03:15:49.18971|2017-10-11 03:15:49.18971
NCT01537679|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-11-23|||March 2010||2010-03-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|August 2010|Actual|2010-08-01||Interventional|Meditation||Meditation to Reduce Caregiver Stress|Meditation or Relaxation Used to Reduce Stress Response and Improve Cognitive Functioning in Older Family Dementia Caregivers|Completed||N/A|40|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:15:49.270758|2017-10-11 03:15:49.270758
NCT01537653|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2013-12-05|||March 2012||2012-03-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects|A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Single Subcutaneous Doses of SAR231893/REGN668 in Healthy Japanese Adult Male Subjects|Completed||Phase 1|32|Actual|Sanofi||5|||f||||||||||||||2017-10-11 03:15:50.299095|2017-10-11 03:15:50.299095
NCT01537640|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2013-12-05|||February 2012||2012-02-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy Subjects|A Randomized, Double-Blind, Parallel Group Study of the Pharmacokinetics, Safety, and Tolerability of Two Different SAR231893 Drug Products After Administration of a Single Subcutaneous Dose to Healthy Subjects|Completed||Phase 1|30|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:15:50.434001|2017-10-11 03:15:50.434001
NCT01537627|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-05-02|||November 2009||2009-11-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Long-term Physical Training in Chronic Obstructive Pulmonary Disease|Effects of a Long-term Physical Training Program on Pulmonary and Systemic Aspects in Patients With Chronic Obstructive Pulmonary Disease|Recruiting||N/A|82|Anticipated|Universidade Estadual de Londrina||2|||f||||f||||||||||2017-10-11 03:15:50.517349|2017-10-11 03:15:50.517349
NCT01537614|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2016-10-10|||October 2011||2011-10-01|October 2016|2016-10-01||||February 2013|Actual|2013-02-01||Interventional|COLI-VLM||Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis||Completed||Phase 1|7|Actual|Poitiers University Hospital||2|||f||||||||||||||2017-10-11 03:15:50.624959|2017-10-11 03:15:50.624959
NCT01537601|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-07-28|||August 2012||2012-08-01|July 2015|2015-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|CIRCUP||CIRCumcision and Urinary Tract Infections in Boys With Posterior Urethral Valves|Effect of Circumcision on the Risk of Febrile Urinary Tract Infections in Children With Posterior Urethral Valves.|Recruiting||N/A|90|Anticipated|Centre Hospitalier Universitaire de la Réunion||2|||f||||f||||||||||2017-10-11 03:15:50.704843|2017-10-11 03:15:50.704843
NCT01537588|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2015-03-09|||July 2009||2009-07-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Changes in Muscle Morphology Resulting From Anterior Cruciate Ligament Reconstruction|Changes in Muscle Morphology Resulting From ACL Reconstruction: Impact on Strength and Function|Completed||N/A|30|Actual|Panam Clinic||3|||f||||f||||||||||2017-10-11 03:15:50.855609|2017-10-11 03:15:50.855609
NCT01537575|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-02-23|||January 2008||2008-01-01|February 2012|2012-02-01||||December 2009|Actual|2009-12-01||Interventional|||Intravenous Immunoglobulins for Post-Polio Syndrome||Completed||Phase 3|50|Actual|Azienda Ospedaliera Universitaria Integrata Verona||2|||f||||f||||||||||2017-10-11 03:15:50.962555|2017-10-11 03:15:50.962555
NCT01537562|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-22|||February 2007||2007-02-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|April 2010|Actual|2010-04-01||Interventional|||Intrauterine Contraception (IUC) After Medical Abortion|Early Versus Delayed Insertion of Intrauterine Contraception After Medical Abortion- a Randomized Controlled Trial|Completed||N/A|129|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 03:15:51.056307|2017-10-11 03:15:51.056307
NCT01537549|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-04-24|2017-02-28||September 14, 2010|Actual|2010-09-14|April 2017|2017-04-01|April 7, 2015|Actual|2015-04-07|September 24, 2013|Actual|2013-09-24||Interventional|||Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy|An Open-label Trial of Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy (PSP): Effect Upon Oxidative Damage and Mitochondrial Biomarkers|Completed||Phase 1/Phase 2|11|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 03:15:51.152286|2017-10-11 03:15:51.152286
NCT01537536|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-06-14|||November 2011||2011-11-01|February 2012|2012-02-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|EndoTAG-1||Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer|An Open-label Phase II Trial Evaluating the Efficacy and Safety of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in Patients With HER2-negative Breast Cancer|Completed||Phase 2|18|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 03:15:51.629795|2017-10-11 03:15:51.629795
NCT01537523|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-02-17|||February 2012||2012-02-01|February 2012|2012-02-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Interventional|||To Investigate the Effect of Early Community-care Program on Fracture Hip Patient|To Investigate the Effect of Early Community-care Program on Physical and Depressive Aspects for Discharged Hospital Patient Suffered From Hip Fracture.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hong Kong Healthcare Volunteer Organization||2|||f||||f||||||||||2017-10-11 03:15:51.710123|2017-10-11 03:15:51.710123
NCT01537510|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-09-25|||December 2010||2010-12-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|STAR||Study of Technology to Accelerate Research|Accelerating Adoption of Childhood Obesity Comparative Effectiveness Research|Completed||N/A|549|Actual|Harvard Pilgrim Health Care||3|||f||||||||||||||2017-10-11 03:15:51.790104|2017-10-11 03:15:51.790104
NCT01537497|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2012-07-06|||March 2012||2012-03-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers|Phase 1 Four-Arm Parallel Group, Placebo-Controlled Study To Evaluate The Effects Of Single Doses Of PF- 05175157 At Three Dose Levels On Pharmacodynamic And Metabolic Parameters In Healthy Volunteers|Completed||Phase 1|31|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 03:15:51.868346|2017-10-11 03:15:51.868346
NCT01537484|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-04-18|||June 2012||2012-06-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|EMBARK||Exploring Massage Benefits for Arthritis of the Knee|Multisite RCT Investigating the Efficacy of Massage in Osteoarthritis|Completed||N/A|222|Actual|Duke University||3|||f||||t||||||||||2017-10-11 03:15:51.956273|2017-10-11 03:15:51.956273
NCT01537471|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2013-01-15|||January 2012||2012-01-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PPI||The Effects of Antihistamines on Pre-Pulse Inhibition|A Pilot Study of the Effects of Meclizine on Pre-Pulse Inhibition|Completed||Phase 1|117|Actual|Duke University||2|||f||||f||||||||||2017-10-11 03:15:52.057183|2017-10-11 03:15:52.057183
NCT01537458|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-02-22|||March 2012||2012-03-01|February 2012|2012-02-01||||June 2012|Anticipated|2012-06-01||Observational|||Long-term Outcome After Isolated Tricuspid Valve Repair||Unknown status|Not yet recruiting|N/A|50|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 03:15:52.161891|2017-10-11 03:15:52.161891
NCT01537445|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-02-22|||February 2012||2012-02-01|February 2012|2012-02-01|August 2015|Anticipated|2015-08-01|February 2015|Anticipated|2015-02-01||Observational|MERFAP||MR-Evaluation of Renal Function-After-Pancreas-transplantation|MR-Evaluation of Renal Function-After-Pancreas-transplantation|Unknown status|Not yet recruiting|N/A|40|Anticipated|Uppsala University|||1||f||||t||||||||||2017-10-11 03:15:52.238851|2017-10-11 03:15:52.238851
NCT01537432|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2015-12-01|2015-12-01||January 2012||2012-01-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients|Phase II Randomized Double Blinded Placebo Controlled, Multiple-dose Regimen Study to Assess the Rate of Histological Clearance and Effect on Molecular Pathways as Well as on Biomarkers of 12 Months Secukinumab 300 mg s.c. Treated Patients With Chronic Plaque-type Psoriasis|Completed||Phase 2|36|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:15:52.332984|2017-10-11 03:15:52.332984
NCT01537419|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-03-31|||March 2012|Actual|2012-03-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Attachment Based Family Therapy for Suicidal Adolescents|Attachment Based Family Therapy (ABFT) for Suicidal Adolescents|Completed||N/A|129|Actual|Drexel University||2|||f||||t||||||||||2017-10-11 03:15:52.871499|2017-10-11 03:15:52.871499
NCT01537406|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-03-07|||March 2012||2012-03-01|March 2012|2012-03-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|BIMRT||Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy|Long Term Outcomes of A Multicentre Controlled Clinical Trial of Breast Irradiation Using Intensity-Modulated Radiation Therapy|Unknown status|Enrolling by invitation|N/A|314|Anticipated|British Columbia Cancer Agency|||1||f||||t||||||||||2017-10-11 03:15:52.984605|2017-10-11 03:15:52.984605
NCT01537393|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-01-02|||March 2012||2012-03-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|March 2017|Anticipated|2017-03-01||Interventional|CPTS||Cornea Preservation Time Study|Effect of Corneal Preservation Time on Long-Term Graft Success|Active, not recruiting||Phase 4|1330|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-10-11 03:15:53.104379|2017-10-11 03:15:53.104379
NCT01537380|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-17|2017-07-18|||March 2012||2012-03-01|July 2017|2017-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Cefasleeve||Tissue and Plasma Pharmacokinetics of Cefazolin in Antibiotic Prophylaxis in Bariatric Surgery|Tissue and Plasma Pharmacokinetics of Cefazolin in Antibiotic Prophylaxis in Bariatric Surgery, an Open Label, Prospective, Single Center Trial|Completed||Phase 4|117|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 03:15:53.351563|2017-10-11 03:15:53.351563
NCT01537367|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2013-08-22|2013-08-07||July 2010||2010-07-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|Phase II|The transgendered particpants were all males at birth, so we added the transgendered to the male count in the gender field.|Intervention to Retain HIV-positive Patients in Medical Care|Intervention Trials to Retain HIV-positive Patients in Medical Care|Completed||N/A|1838|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-11 03:15:53.476428|2017-10-11 03:15:53.476428
NCT01537354|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-01-07|||June 2012||2012-06-01|January 2014|2014-01-01||||December 2013|Actual|2013-12-01||Interventional|||Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome|A Comparison of Immediate Changes in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome|Withdrawn||N/A|0|Actual|University of Michigan||2||Sponsor discontinued clinical trial before enrollment of subjects.|f||||f||||||||||2017-10-11 03:15:53.979404|2017-10-11 03:15:53.979404
NCT01537341|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2013-07-18|||April 2012||2012-04-01|July 2013|2013-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Asymmetric Locomotor Training in the Elderly to Restore Physical Function|Asymmetric Locomotor Training in the Elderly to Restore Physical Function|Withdrawn||N/A|0|Actual|University of Florida||2||Funding was not received for this study.|f||||f||||||||||2017-10-11 03:15:54.08363|2017-10-11 03:15:54.08363
NCT01537328|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-06-22|||July 2011||2011-07-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|May 2016|Actual|2016-05-01||Interventional|PROG||Progressive Rehabilitation Following Total Knee Arthroplasty|Progressive Rehabilitation Following Total Knee Arthroplasty|Active, not recruiting||Phase 1|162|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 03:15:54.205056|2017-10-11 03:15:54.205056
NCT01537315|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-11-18|2014-10-31||February 2012||2012-02-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study|Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study|Terminated||Phase 2|8|Actual|University of Arkansas||2||lack of funding|f||||t||||||||||2017-10-11 03:15:54.314038|2017-10-11 03:15:54.314038
NCT01537302|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-03-17|2015-03-05||February 2012||2012-02-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|CONNECTII|All enrolled subjects.|Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II|A Non-randomized Study of the Avinger Ocelot System Used to Cross Chronic Total Occlusions in the Superficial Femoral and Popliteal Arteries|Completed||Phase 1|201|Actual|Avinger, Inc.||1|||f||||t||||||||||2017-10-11 03:15:54.601496|2017-10-11 03:15:54.601496
NCT01537276|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2012-02-22|||January 2010||2010-01-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Improve Hysterosalpingographic Accuracy by Real-time Fluoroscopy|Improve Hysterosalpingographic Accuracy by Real-time Fluoroscopy|Completed||N/A|263|Actual|Taizhou Hospital||2|||f||||f||||||||||2017-10-11 03:15:55.226191|2017-10-11 03:15:55.226191
NCT01537263|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-04-05|||January 2012||2012-01-01|April 2012|2012-04-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|PSAB||Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage|Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage|Unknown status|Recruiting|N/A|30|Anticipated|Asklepios Kliniken Hamburg GmbH|||1||f||||f||||||||||2017-10-11 03:15:55.332389|2017-10-11 03:15:55.332389
NCT01537250|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2012-02-16|||August 2009||2009-08-01|February 2012|2012-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)|A Multi-center, Randomized, Double-blind, Double-dummy Parallel-controlled Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)|Completed||Phase 2|192|Actual|TaiGen Biotechnology Co., Ltd.||3|||f||||f||||||||||2017-10-11 03:15:55.427067|2017-10-11 03:15:55.427067
NCT01537237|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-11-24|||August 2011||2011-08-01|March 2012|2012-03-01|November 2014|Actual|2014-11-01|August 2013|Actual|2013-08-01||Observational|3DATGvsCT||Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation|Randomized Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation|Completed||N/A|37|Actual|Steward St. Elizabeth's Medical Center of Boston, Inc.|||2||f||||t||||||||||2017-10-11 03:15:55.742136|2017-10-11 03:15:55.742136
NCT01537224|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-11-30|||September 2011||2011-09-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|EMOPHYSIO||Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information|Study of the Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information in Patients With Parkinson's Disease|Unknown status|Recruiting|N/A|25|Anticipated|Rennes University Hospital||1|||f||||||||||||||2017-10-11 03:15:55.841475|2017-10-11 03:15:55.841475
NCT01537211|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-04-12|||August 2011||2011-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|CLEG||Functional Outcomes in Dysvascular Transfemoral Amputees|Microprocessor Knee Versus Mechanical Knee: Impact on Functional Outcomes in Dysvascular Transfemoral Amputees|Active, not recruiting||N/A|40|Anticipated|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 03:15:55.928715|2017-10-11 03:15:55.928715
NCT01537198|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2015-06-18|2015-06-18||January 2012||2012-01-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Surveillance of Synagis in Korean Pediatric Patients|"Post-Marketing Surveillance of Synagis in Korean Pediatric Patients Under the New Drug Re-Examination"|Completed||N/A|618|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 03:15:56.017669|2017-10-11 03:15:56.017669
NCT01537185|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2014-05-06|2014-03-28||February 2012||2012-02-01|February 2012|2012-02-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|||Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults|A Phase 1 Randomized, Double-Blind, Dose-Escalation Study to Assess the Safety, Tolerability and Immunogenicity of Inactivated Streptococcus Pneumoniae Whole Cell Vaccine Formulated With Alum (SPWCV+Alum) in Healthy Adults|Completed||Phase 1|42|Actual|PATH||4|||f||||t||||||||||2017-10-11 03:15:56.271076|2017-10-11 03:15:56.271076
NCT01537172|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-12-07|||January 2012||2012-01-01|June 2012|2012-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers|A Phase 1, Single Centre, Three-part, Randomised, Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Single and Multiple Ascending Doses of Oral ONO-4053 and the Effects of Food in Healthy Males and Females|Completed||Phase 1|80|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 03:15:56.805349|2017-10-11 03:15:56.805349
NCT01537159|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-08-02|||May 2012||2012-05-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||MRI Assessment of Leukemia Response to Therapy|Quantitative DCE-MRI as a Predictor of Therapeutic Response in Acute Leukemia|Recruiting||N/A|30|Anticipated|OHSU Knight Cancer Institute|||1||f||||t||||||||||2017-10-11 03:15:56.914561|2017-10-11 03:15:56.914561
NCT01537146|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-01-21|||April 2010||2010-04-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HTO_pains||Local Infiltration Versus Block Against Pains After High Tibial Osteotomy|Examination of the LIA (Local Infiltration) Versus Regional Blockade as Pain Management for Open-wedge High Tibial Osteotomy|Completed||Phase 4|60|Actual|Northern Orthopaedic Division, Denmark||2|||f||||t||||||||||2017-10-11 03:15:57.020646|2017-10-11 03:15:57.020646
NCT01537133|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-11-17|2016-03-11||October 2012||2012-10-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment|Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment|Completed||N/A|84|Actual|Milton S. Hershey Medical Center||4|||f||||t||||||||||2017-10-11 03:15:57.126565|2017-10-11 03:15:57.126565
NCT01537120|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-08-17|2013-09-25||December 2011||2011-12-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2)|Evaluation of Continuous Glucose Monitoring as a Tool to Measure Glucoregulatory Effects of a Twice Daily Oral Insulin Secretagogue|Completed||Phase 1|25|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-10-11 03:15:57.654604|2017-10-11 03:15:57.654604
NCT01537107|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-03-21|||March 2012|Actual|2012-03-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery|Phase I Trial of The Combination of Vismodegib and Sirolimus|Suspended||Phase 1|32|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 03:15:59.449657|2017-10-11 03:15:59.449657
NCT01537094|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2013-12-11|||December 2013||2013-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Vitamin C on Growth Hormone Secretion|The Effect of Vitamin C on Growth Hormone Secretion|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||3||Unable to obtain funding to initiate the study. No subjects were enrolled.|f||||f||||||||||2017-10-11 03:15:59.55582|2017-10-11 03:15:59.55582
NCT01537081|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-10-22|2013-07-03||September 2011||2011-09-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional||Based on the Safety population, defined as all patients who received at least one dose of the study medication, excluding patients who later return all the dispensed study medication to the site unused.|Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections|Randomized, Double-Blind, Double Dummy, Placebo-Controlled Study of the Safety and Efficacy Mucinex (2400 mg/d) and Immediate-Release Guaifenesin (800 mg/d) in the Treatment of Symptoms of Acute Upper Respiratory Tract Infections For 7 Days|Completed||Phase 2/Phase 3|2810|Actual|Reckitt Benckiser LLC||3|||f||||f||||||||||2017-10-11 03:15:59.661655|2017-10-11 03:15:59.661655
NCT01537068|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-09-07|2017-06-12||February 2012|Actual|2012-02-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|August 2016|Actual|2016-08-01||Interventional||59 met inclusion criteria and started with study medication.|Desvenlafaxine vs. Placebo Treatment of Chronic Depression|Desvenlafaxine (Pristiq) vs. Placebo in the Treatment of Chronic Depression|Completed||Phase 4|59|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 03:16:00.18295|2017-10-11 03:16:00.18295
NCT01537055|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-01-30|||February 2012||2012-02-01|January 2015|2015-01-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy|Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection- A Multi-center Randomized Trial|Unknown status|Recruiting|Phase 4|600|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 03:16:00.808028|2017-10-11 03:16:00.808028
NCT01537042|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-10-31|2014-10-01||April 2012||2012-04-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||The baseline analysis population consisted of the Safety Set (SS), which is all subjects who were randomized and had at least 1 patch applied during the Treatment Period.|A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis|Completed||Phase 3|30|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:16:01.038287|2017-10-11 03:16:01.038287
NCT01537029|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-11-09|||February 2012||2012-02-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide|Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide|Recruiting||Phase 4|18|Anticipated|Texas Tech University Health Sciences Center||1|||f||||f||||||||No||2017-10-11 03:16:02.143196|2017-10-11 03:16:02.143196
NCT01537016|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-07-04|||July 2013||2013-07-01|May 2013|2013-05-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test on DFU|WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Diabetic Foot Ulcers|Unknown status|Recruiting|N/A|250|Anticipated|Systagenix Wound Management||4|||f||||f||||||||||2017-10-11 03:16:02.275649|2017-10-11 03:16:02.275649
NCT01537003|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-07-04|||October 2012||2012-10-01|May 2013|2013-05-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Interventional|||WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test|WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Venous Leg Ulcers|Unknown status|Recruiting|N/A|250|Anticipated|Systagenix Wound Management||4|||f||||f||||||||||2017-10-11 03:16:02.415402|2017-10-11 03:16:02.415402
NCT01536990|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-02-21|||May 2007||2007-05-01|February 2012|2012-02-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Observational|||Sensitivity to Change of the Lower Extremity Functional Scale in Patients With Stroke|Sensitivity to Change of the Lower Extremity Functional Scale and a Single-Item Functional Assessment Tool in Patients With Neurological Impairments Secondary to Stroke|Completed||N/A|39|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:16:02.559729|2017-10-11 03:16:02.559729
NCT01536977|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-05-29|||March 2012||2012-03-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)|Early Behavioral Intervention in BMT Recipients With Sleep Disturbance: Assessing Its Impact on Quality of Life, Fatigue and Cognitive Function|Completed||N/A|29|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 03:16:02.645359|2017-10-11 03:16:02.645359
NCT01536964|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-04-02|||April 2012||2012-04-01|February 2013|2013-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Morphine on Prasugrel Absorption in STEMI Patients||Completed||Phase 4|12|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:16:02.744435|2017-10-11 03:16:02.744435
NCT01536951|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-05-15|2017-03-10||February 2012||2012-02-01|May 2017|2017-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Participants who received at least 1 dose of LY3009104, moxifloxacin, or placebo and had at least 1 postdose safety assessment.|A Study of LY3009104 in Healthy Participants|A Placebo-Controlled, Single Dose, Dose Escalation (Part A) and a Placebo- and Positive-Controlled Study of the Effect on the Electrocardiographic QT Interval of a Single Dose (Part B) of LY3009104 in Healthy Subjects|Completed||Phase 1|62|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:16:02.969934|2017-10-11 03:16:02.969934
NCT01536938|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-04-04|2015-11-02|2013-10-22|May 2012||2012-05-01|April 2016|2016-04-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||LEO 90100 in the Treatment of Psoriasis Vulgaris||Completed||Phase 2|303|Actual|LEO Pharma||3|||f||||f||||||||||2017-10-11 03:16:04.070573|2017-10-11 03:16:04.070573
NCT01536925|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-04-20|||December 2011||2011-12-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|YHO||Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects|Biobehavioral Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects|Completed||N/A|21|Actual|Wayne State University|||1||f||||t||||||||||2017-10-11 03:16:04.477891|2017-10-11 03:16:04.477891
NCT01536912|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-07-29|||February 2012||2012-02-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|MMS||Medical Marijuana Use in HIV+ Patients: Probability Survey|Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients: Probability Survey|Completed||N/A|218|Actual|Wayne State University|||1||f||||f||||||||||2017-10-11 03:16:04.57743|2017-10-11 03:16:04.57743
NCT01536899|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-04-20|||February 2012||2012-02-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|MMC-1||Medical Marijuana Use in HIV+ Patients Prospective Cohort Study|Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study|Active, not recruiting||N/A|150|Anticipated|Wayne State University|||1||f||||f||||||||||2017-10-11 03:16:04.667555|2017-10-11 03:16:04.667555
NCT01535430|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-09-15|||January 2012||2012-01-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Observational|||Assessment of Eloquent Function in Brain Tumor Patients|Assessment of Reorganization and Plasticity of Eloquent Function in Patients With Brain Tumors|Recruiting||N/A|10|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-10-11 03:16:37.774274|2017-10-11 03:16:37.774274
NCT01536886|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-08-09|2015-11-02|2013-10-22|May 2012||2012-05-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris|A Phase 2 Study Comparing Treatment With LEO 90100 With Calcipotriol Plus Betamethasone Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris.|Completed||Phase 2|376|Actual|LEO Pharma||4|||f||||f||||||||||2017-10-11 03:16:04.762051|2017-10-11 03:16:04.762051
NCT01536873|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-01-16|||June 2012||2012-06-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|DEAP||Dolutegravir Expanded Access Study|A Dolutegravir Open Label Protocol for HIV Infected, Adult and Adolescent Patients With Integrase Resistance|Recruiting||Phase 3|200|Anticipated|ViiV Healthcare|||||f||||f||||||||Undecided||2017-10-11 03:16:05.31943|2017-10-11 03:16:05.31943
NCT01536860|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-11-05|2012-09-11||February 2012||2012-02-01|November 2013|2013-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Glycemic Response Testing|Glycaemic Response Testing|Completed||N/A|12|Actual|Mondelēz International, Inc.||3|||f||||f||||||||||2017-10-11 03:16:05.752345|2017-10-11 03:16:05.752345
NCT01536847|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-09-07|||December 2011||2011-12-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Glycaemic Response Testing|Glycaemic Response Testing|Completed||N/A|12|Actual|Mondelēz International, Inc.||3|||f||||f||||||||||2017-10-11 03:16:06.024257|2017-10-11 03:16:06.024257
NCT01536821|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2013-12-13|||May 2011||2011-05-01|April 2013|2013-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|PROGENI||PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)|PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study|Completed||N/A|81|Actual|Indiana University|||1||f||||t||||||Samples With DNA|"     DNA, plasma and serum will be obtained and stored from a blood sample. In addition, a whole     blood and urine samples will be obtained and stored.   "|||2017-10-11 03:16:06.189054|2017-10-11 03:16:06.189054
NCT01536808|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-08-02|||April 2009||2009-04-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|R2D2||Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?|Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?|Completed||N/A|150|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 03:16:06.296527|2017-10-11 03:16:06.296527
NCT01536782|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-02-02|||February 2015|Actual|2015-02-01|February 2017|2017-02-01|February 2017|Anticipated|2017-02-01|December 2016|Actual|2016-12-01||Interventional|||Optimal Tube Feeding Method in Head and Neck Cancer Patients|The Optimal Tube Feeding Method in Head and Neck Cancer Patients: A Comparison Between Bolus, Gravity, and Tube Feeding Pump.|Suspended||N/A|60|Anticipated|Baylor Research Institute||3||PI left the company|f||||f||||||||||2017-10-11 03:16:06.535713|2017-10-11 03:16:06.535713
NCT01536769|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-11-11|||November 2011||2011-11-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Observational|||Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease|Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease|Completed||N/A|150|Actual|Helsinki University Central Hospital|||2||f||||f||||||Samples With DNA|"     Nasal and oral bacterial swabs and stool samples   "|||2017-10-11 03:16:06.651236|2017-10-11 03:16:06.651236
NCT01536756|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-02-23|||February 2012||2012-02-01|February 2012|2012-02-01|May 2014|Anticipated|2014-05-01|October 2013|Anticipated|2013-10-01||Interventional|||Effectiveness of a Structured Physical Rehabilitation Program for Chinese Patients With Depressive Disorders|A Single Blind Randomized Controlled Study Investigating the Effectiveness of a Structured Physical Rehabilitation Program on the Physical Fitness and Negative Psychological Symptoms for Chinese Patients With Mild to Severe Depressive Disorders|Unknown status|Recruiting|N/A|84|Anticipated|Kowloon Hospital, Hong Kong||2|||f||||f||||||||||2017-10-11 03:16:06.734522|2017-10-11 03:16:06.734522
NCT01536743|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-06-12|||December 15, 2011||2011-12-15|August 2016|2016-08-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression|A Open Label Phase II Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression|Active, not recruiting||Phase 2|26|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:16:06.862873|2017-10-11 03:16:06.862873
NCT01536730|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-03-23|||January 2012||2012-01-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Self-Guided Intervention to Promote Condom Use Among African American Males|A Self-Guided Intervention to Promote Condom Use Among African American Males|Completed||N/A|193|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 03:16:06.945714|2017-10-11 03:16:06.945714
NCT01536717|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-05-31|||March 2012||2012-03-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Comparison of the Local Anaesthetics Articaine and Bupivacaine in Treatment of Acute Sternum Pain After Heart Surgery|Comparison of Periosteal and Subcutaneous Infusions of Articaine and Bupivacaine in Treatment of Acute Pain After Sternotomy|Unknown status|Recruiting|Phase 4|60|Anticipated|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 03:16:07.050502|2017-10-11 03:16:07.050502
NCT01536704|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-03-14|2013-03-14||July 2011||2011-07-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Nicotine Lozenge Bioequivalence Study|A Single Dose Bioequivalence Study of 2 Different Doses of Mini Cherry Nicotine Lozenges|Completed||Phase 1|50|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:16:07.24466|2017-10-11 03:16:07.24466
NCT01536691|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2012-10-02|||June 2011||2011-06-01|February 2012|2012-02-01|February 2013|Anticipated|2013-02-01|November 2012|Anticipated|2012-11-01||Interventional|ROAD||Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone|To Assess the Efficacy and Safety of Ramosetron, Aprepitant and Dexamethasone Therapy vs Ondansetron, Aprepitant and Dexamethasone Therapy for Preventing of Nausea and Vomiting in Highly Emetogenic Chemotherapy (ROAD Study)|Unknown status|Recruiting|Phase 3|338|Anticipated|Hallym University Medical Center||2|||f||||t||||||||||2017-10-11 03:16:07.896031|2017-10-11 03:16:07.896031
NCT01536665|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-02-06|||February 2012||2012-02-01|February 2017|2017-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes|The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes|Completed||Phase 1|45|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:16:08.113761|2017-10-11 03:16:08.113761
NCT01536652|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-03-03|||January 2006||2006-01-01|March 2016|2016-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|ProMix||Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes|Prandial Oriented NovoMix 30® - the Physiological Insulin Therapy of Diabetes Type 2|Completed||N/A|4994|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:16:08.20001|2017-10-11 03:16:08.20001
NCT01536639|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-01-06|||January 2006||2006-01-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes|Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes|Completed||N/A|454|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:16:08.284981|2017-10-11 03:16:08.284981
NCT01536626|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-02-22|||June 9, 2006|Actual|2006-06-09|February 2017|2017-02-01|April 10, 2007|Actual|2007-04-10|April 10, 2007|Actual|2007-04-10||Observational|SWITCH||Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands|SWITCH Mixtard® 30 NovoLet® to NovoMix® 30 FlexPen®. An Observational Study|Completed||N/A|211|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:16:08.374853|2017-10-11 03:16:08.374853
NCT01536613|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-03-03|||September 2004||2004-09-01|March 2016|2016-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Post Marketing Surveillance Study of Biphasic Insulin Aspart 30|NovoMix® 30 FlexPen, Post Marketing Surveillance Study|Completed||N/A|5346|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:16:08.459913|2017-10-11 03:16:08.459913
NCT01536600|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-01-05|||September 2004||2004-09-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|PRESENT||Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes|A Multi-center, Prospective, Non-interventional Evaluation of Efficacy, Safety and Convenience of Using NovoMix 30 as Monotherapy, or in Combination With OHAs, in the Treatment of Type 2 Diabetic Patients in Routine Clinical Practice|Completed||N/A|33010|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:16:08.542228|2017-10-11 03:16:08.542228
NCT01536587|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-03-13|2013-07-30||July 2012||2012-07-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|ESAN||Effects of Salmeterol on Autonomic Nervous System|Effects of Bronchodilatation With Salmeterol on the Autonomic Nervous System|Completed||Phase 4|32|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:16:08.678537|2017-10-11 03:16:08.678537
NCT01536574|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-01-16|2012-11-15||September 2010||2010-09-01|January 2017|2017-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528|An Open Label Extension Study With REQUIP PR for Subjects From Study ROP111528|Completed||Phase 3|295|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:16:09.542832|2017-10-11 03:16:09.542832
NCT01536561|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-08-01|2012-02-23||April 24, 1990|Actual|1990-04-24|August 2017|2017-08-01|October 16, 2009|Actual|2009-10-16|July 2, 1997|Actual|1997-07-02||Interventional|||Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma|Phase I Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas|Completed||Phase 1|59|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-10-11 03:16:10.481342|2017-10-11 03:16:10.481342
NCT01536548|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-02-10|||March 2012||2012-03-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Interventional|||Indicating Direction and Angle for Cannulating of AV-fistula in Hemodialysis Patients|Indicating Direction and Angle for Button-hole Cannulating of AV-fistula in Hemodialysis Patients - a Randomized Controlled Study|Completed||N/A|83|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 03:16:11.94589|2017-10-11 03:16:11.94589
NCT01536535|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-05-12|||July 2012||2012-07-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|April 2016|Actual|2016-04-01||Interventional|PROTECT||Predicting Response to Standardized Pediatric Colitis Therapy|Multicenter Open-label Study Evaluating the Safety and Efficacy of Standardized Initial Therapy Using Either Mesalamine or Corticosteroids Then Mesalamine to Treat Children and Adolescents With Newly Diagnosed Ulcerative Colitis.|Active, not recruiting||Phase 4|467|Actual|Connecticut Children's Medical Center||2|||f||||t||||||||Yes|Baseline data will plan to be shared two years after recruitment is complete (last initial visit) or within 6 months of publication date (whichever is first)|2017-10-11 03:16:12.08669|2017-10-11 03:16:12.08669
NCT01536522|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-05-12|||October 2011||2011-10-01|May 2017|2017-05-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|AIR||Asthma Inflammation Research|Asthma Inflammation Research|Active, not recruiting||N/A|200|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-10-11 03:16:12.24333|2017-10-11 03:16:12.24333
NCT01536509|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-09-21|||February 2012||2012-02-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Interventional|TEAM||Improving Medication Adherence in Pediatric Inflammatory Bowel Disease|Telehealth Enhancement of Adherence to Medication in Pediatric Inflammatory Bowel Disease|Active, not recruiting||Phase 3|140|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-10-11 03:16:12.33978|2017-10-11 03:16:12.33978
NCT01536496|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-01-20|2015-06-16||September 2010||2010-09-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma|A Prospective, Randomized Comparison Of Rapid Thrombelastography (r-TEG) And Conventional Coagulation Testing For Guiding The Diagnosis And Haemostatic Resuscitation Of Trauma Patients At Risk For Post-Injury Coagulopathy|Completed||N/A|114|Actual|Denver Health and Hospital Authority||2|||f||||f||||||||||2017-10-11 03:16:12.460841|2017-10-11 03:16:12.460841
NCT01536483|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2016-05-10|||February 2012||2012-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|NEOTRANS||Effects of Recto-colic Enemas of Butyrate on the Digestive Disorders of Very Low Birth Weight Preterms <1250 Grams|Effects of Recto-colic Enemas of Butyrate on the Digestive Disorders of Very Low Birth Weight Preterms <1250 Grams. Clinical Trial Prospective, Monocentric, Randomized in Double-blinded.|Terminated||Phase 2/Phase 3|61|Actual|Nantes University Hospital||2||The second intermediary analysis showed no significant difference between both arms|f||||||||||||||2017-10-11 03:16:13.312655|2017-10-11 03:16:13.312655
NCT01536470|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-09-30|||March 2012||2012-03-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|INPRESS||Intraoperative Noradrenaline to Control Arterial Pressure (INPRESS Study)|Effectiveness of Noradrenaline to Control Intraoperative Arterial Pressure in High-risk Surgical Patients: A Multicentre Prospective Randomized Controlled Trial|Completed||Phase 4|300|Actual|University Hospital, Clermont-Ferrand||2|||f||||f||||||||||2017-10-11 03:16:13.416711|2017-10-11 03:16:13.416711
NCT01536457|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2015-02-10|||July 2011||2011-07-01|February 2015|2015-02-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Observational|||Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only|Data Analysis of a Randomized, Double-Blind, Placebo- Controlled Study of Gastroesophageal Reflux Disease Therapy (Lansoprazole; Solutab™) in the Management of Childhood Asthma|Completed||N/A|59|Actual|Children's Center for Digestive Health Care|||1||f||||f||||||||||2017-10-11 03:16:13.540948|2017-10-11 03:16:13.540948
NCT01536444|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-02-21|||January 2012||2012-01-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer|Use of the Epidermal Expansion System to Harvest and Place Suction Blister Epidermal Grafts on Wounds in Patients After Mohs or Excisional Surgery for Skin Cancer|Unknown status|Recruiting|N/A|12|Anticipated|Momelan Technologies||1|||f||||f||||||||||2017-10-11 03:16:13.630371|2017-10-11 03:16:13.630371
NCT01536431|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2015-07-27|||January 2012||2012-01-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|MonoPepT1De||Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes|Phase 1b Study of Proinsulin (PI) Peptide Immunotherapy in New-Onset Type 1 Diabetes|Completed||Phase 1/Phase 2|27|Actual|Cardiff University||3|||f||||t||||||||||2017-10-11 03:16:13.754323|2017-10-11 03:16:13.754323
NCT01536418|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-07-19|2017-04-06|2014-03-06|November 11, 2011|Actual|2011-11-11|April 2017|2017-04-01|October 17, 2013|Actual|2013-10-17|October 17, 2013|Actual|2013-10-17||Interventional|SHIELD-4||An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease|A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Moderately-to-Severely Active Crohn's Disease|Terminated||Phase 3|255|Actual|GlaxoSmithKline||2|||f||||t|t|f||||||||2017-10-11 03:16:13.930654|2017-10-11 03:16:13.930654
NCT01536405|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-03-15|2014-05-30||June 2012||2012-06-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)|A Phase III Double-Blind, Randomized, Multicenter, Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)|Completed||Phase 3|1412|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:16:15.472029|2017-10-11 03:16:15.472029
NCT01536392|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-10-05|||March 2012|Actual|2012-03-01|October 2017|2017-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation|Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation|Active, not recruiting||Phase 3|150|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 03:16:16.619022|2017-10-11 03:16:16.619022
NCT01536379|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-03-14|2016-10-05||September 2013||2013-09-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study of Belimumab in the Prevention of Kidney Transplant Rejection|BEL114424: A Phase 2 Pilot, Multicentered, Randomised, Double Blind, Placebo-Controlled Study to Evaluate the Potential for Efficacy and the Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in the Prevention of Allograft Rejection in Adult Subjects After Renal Transplantation|Completed||Phase 2|30|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:16:16.818165|2017-10-11 03:16:16.818165
NCT01536366|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-07-22|2015-07-22||June 2009||2009-06-01|July 2015|2015-07-01|January 2011|Actual|2011-01-01|July 2009|Actual|2009-07-01||Interventional|||Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide|Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide in Healthy Volunteers|Completed||Phase 1|27|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 03:16:18.67464|2017-10-11 03:16:18.67464
NCT01536353|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-11-24|||January 2012||2012-01-01|February 2012|2012-02-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301|A Single Dose, Randomized, Open-label, 2x2 Crossover Study to Evaluate the Bioavailability and Safety of AGSAV301 Tablet in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Ahn-Gook Pharmaceuticals Co.,Ltd||2|||f||||||||||||||2017-10-11 03:16:19.281392|2017-10-11 03:16:19.281392
NCT01536340|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-05-22|||September 2011||2011-09-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2012|Actual|2012-10-01||Observational|||Identifying Adverse Events After Discharge From a Community Hospital|Identifying Adverse Events After Discharge From a Community Hospital|Completed||N/A|684|Actual|Florida State University|||1||f||||f||||||||||2017-10-11 03:16:19.378163|2017-10-11 03:16:19.378163
NCT01536327|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-21|2017-05-03|||September 2011||2011-09-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|September 2018|Anticipated|2018-09-01||Observational|BioMeta||Biomarker for Metachromatic Leukodystrophy Disease|Biomarker for Metachromatic Leukodystrophy Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|80|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry 10ml EDTA     blood, sputum tube and a dry blood spot filter card are taken. To proof the correct diagnosis     in those patients where up to the enrollment in the study no genetic testing has been done,     sequencing will be done. The analyses are done in the Albrecht-Kossel-Institute for     Neuroregeneration (AKos), POB 100 888, Gehlsheimer Str. 20, 18055 Rostock (Germany)   "|No||2017-10-11 03:16:19.47551|2017-10-11 03:16:19.47551
NCT01536314|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-06-30|||February 2012||2012-02-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|MEMANTINE||Prophylaxis of Neuropathic Pain by mémantine|Preventing the Development of Neuropathic Pain Post-mastectomy/Tumorectomy by Pre-emptive or Post-operative Memantine Administration|Completed||Phase 3|43|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 03:16:19.607677|2017-10-11 03:16:19.607677
NCT01536301|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-01-30|||June 2012||2012-06-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|July 2016|Actual|2016-07-01||Interventional|||Oxycodone Versus Intravenous Morphine for Postoperative Analgesia After Hip Surgery|Evaluation of Oxycodone Hydrochloride Versus Intravenous Morphine Hydrochloride for Postoperative Analgesia After Hip Prosthetic Surgery|Active, not recruiting||Phase 4|246|Anticipated|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||||2017-10-11 03:16:19.706345|2017-10-11 03:16:19.706345
NCT01536288|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2012-02-21|||October 2010||2010-10-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness|Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness.|Completed||Phase 2|125|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 03:16:19.845762|2017-10-11 03:16:19.845762
NCT01536275|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2017-06-21|||June 2012||2012-06-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|October 2018|Anticipated|2018-10-01||Interventional|PEPaNIC||Early Versus Late Parenteral Nutrition in the Pediatric Intensive Care Unit|Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Paediatric Critically Ill Patients|Recruiting||N/A|1440|Anticipated|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 03:16:19.981262|2017-10-11 03:16:19.981262
NCT01536262|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2015-06-19|2015-06-19|2014-04-03|February 2012||2012-02-01|June 2015|2015-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Treated Set (TS): This patient set included all patients who received at least 1 dose of treatment.|Japan Long-term Safety for Tiotropium Plus Olodaterol|A Randomised, Double-blind, Parallel-group Study to Assess the Safety and Efficacy of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed-dose Combination (2.5µg / 5µg, 5µg / 5µg ) and Olodaterol (5 µg) Delivered by the RESPIMAT Inhaler in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|122|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:16:20.192293|2017-10-11 03:16:20.192293
NCT01536249|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-16|2014-11-24|||March 2012||2012-03-01|November 2014|2014-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)|An Open-Label Study to Assess the Effect of Cimetidine on the Pharmacokinetics of Dexpramipexole (BIIB050) in Healthy Volunteers|Completed||Phase 1|14|Actual|Knopp Biosciences||2|||f||||||||||||||2017-10-11 03:16:20.971827|2017-10-11 03:16:20.971827
NCT01536236|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-03-20|||October 2011||2011-10-01|March 2015|2015-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Spinal Cord Stimulation for Diabetic Polyneuropathy|A Randomized, Comparison Study of the Safety and Efficacy of Spinal Cord Stimulation Versus Standard of Care Medical Management in the Treatment of Diabetic Polyneuropathy|Withdrawn||N/A|0|Actual|St. Jude Medical||3|||f||||f||||||||||2017-10-11 03:16:21.085652|2017-10-11 03:16:21.085652
NCT01536223|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2013-03-03|||April 2012||2012-04-01|April 2012|2012-04-01|February 2015|Anticipated|2015-02-01|December 2013|Anticipated|2013-12-01||Interventional|ESNCCT||Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma|Cisplatin and 5-fluorouracil(PF) or Docetaxel,Cisplatin and 5-fluorouracil (TPF) Neoadjuvant Chemotherapy With Chemoradiation Therapy for Locally Advanced Nasopharyngeal Carcinoma--A Randomised Prospective Multicenter Phase 3 Study|Unknown status|Recruiting|Phase 3|400|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-11 03:16:21.248175|2017-10-11 03:16:21.248175
NCT01536210|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-02-15|||December 2011||2011-12-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Interventional|ADHD||Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder)|Randomized, Double-Blind, Placebo-control, Multicenter Study, the Efficacy and Safety of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD(Attention Deficit Hyperactivity Disorder)in 8 Weeks|Unknown status|Recruiting|Phase 3|144|Anticipated|Yuyu Pharma, Inc.||2|||f||||t||||||||||2017-10-11 03:16:21.388059|2017-10-11 03:16:21.388059
NCT01536197|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2014-07-02|2014-06-02||September 2009||2009-09-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Observational|RBtaste||Taste Perception Pre and Post Bariatric Surgery|Effect of Bariatric Surgery-induced Weight Loss on Taste Perception|Completed||N/A|27|Actual|Washington University School of Medicine|||2||f||||t||||||Samples With DNA|"     Tongue tissue   "|||2017-10-11 03:16:21.548579|2017-10-11 03:16:21.548579
NCT01536184|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-08-16|2016-08-16||March 2012||2012-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Evaluating the Effectiveness of an Attachment-Focused Intervention in Preschool Children With FASD|Evaluating the Effectiveness of an Attachment-Focused Intervention in Preschool Children With Fetal Alcohol Spectrum Disorder (FASD) or At-risk for FASD: A Randomized Controlled Field Trial|Completed||N/A|12|Actual|University of Manitoba|While we set out to conduct an RCT to evaluate the effectiveness of COS delivered in a home-visiting model vs. a behavioral TAU intervention, the limitations we faced did not allow for this.|2|||f||||f||||||||No||2017-10-11 03:16:21.922317|2017-10-11 03:16:21.922317
NCT01536171|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2014-03-17|2013-12-13||September 2011||2011-09-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational||Healthy young active adults|Peak Impact Forces and Metabolic Cost During Mid-Forefoot Striking in Shod Versus Barefoot Runners|Peak Impact Forces and Metabolic Cost During Mid-Forefoot Striking in Shod Versus Barefoot Runners: A Pilot Study|Completed||N/A|22|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 03:16:22.573994|2017-10-11 03:16:22.573994
NCT01536158|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-12-24|||February 2012||2012-02-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial|Oral Paracetamol Versus Oral Ibuprofen Treatment|Completed||Phase 4|80|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-11 03:16:22.869486|2017-10-11 03:16:22.869486
NCT01536145|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2013-03-12|2013-01-18||December 2003||2003-12-01|March 2013|2013-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||CP-751,871 Treatment For Patients With Multiple Myeloma|An Open Label Phase I Study Of CP-751,871 In Patients With Multiple Myeloma|Completed||Phase 1|47|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:16:23.035595|2017-10-11 03:16:23.035595
NCT01536132|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-02-13|||April 2010||2010-04-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|October 2013|Actual|2013-10-01||Interventional|LION-HEART||Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients|Multicenter, Double-blind, Placebo-controlled Randomized Trial to Evaluate the Efficacy and Safety of Intravenous Administration of Intermittent Doses of Levosimendan in Ambulatory Patients With Advanced CHF: the LION-HEART Study|Completed||Phase 4|70|Actual|Parc de Salut Mar||2|||f||||f||||||||No||2017-10-11 03:16:24.148993|2017-10-11 03:16:24.148993
NCT01536119|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2013-12-18|2013-07-04||February 2012||2012-02-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|COSI|The baseline participants consisted of 214 participants 107*2=214 107 couples per group (107 mothers and 107 fathers).|Evaluating a Coparenting Breastfeeding Support Intervention|Evaluating the Effectiveness of a Coparenting Breastfeeding Support Intervention on Exclusive Breastfeeding Rates at 12 Weeks Postpartum|Completed||N/A|428|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 03:16:24.275349|2017-10-11 03:16:24.275349
NCT01536106|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-16|2013-09-03|||December 2013||2013-12-01|September 2013|2013-09-01|March 2015|Anticipated|2015-03-01|January 2015|Anticipated|2015-01-01||Interventional|AMIRST||Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients.|Intracoronary Infusion of Concentrated Autologous Bone Marrow Mononuclear Cells in Acute Myocardial Infarction Patients Utilizing a Novel Point-of-Care Device for Rapid-Delivery of Stem Cells (AMIRST)|Unknown status|Not yet recruiting|Phase 1/Phase 2|30|Anticipated|TotipotentRX Cell Therapy Pvt. Ltd.||2|||f||||t||||||||||2017-10-11 03:16:25.071307|2017-10-11 03:16:25.071307
NCT01536093|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-08-11|2014-07-17||January 2012||2012-01-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Oropharyngeal Administration of Colostrum to Extremely Low Gestational Age Newborns||Completed||Phase 2|48|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:16:25.251632|2017-10-11 03:16:25.251632
NCT01536080|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-02-15|||July 2008||2008-07-01|February 2012|2012-02-01||||||||Observational|||Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life|Comparison of Risk Factors, GERD Symptoms and PPI Responses in the Reflux Esophagitis, Non-erosive Reflux Disease and Functional Heartburn Using GERD Impact Scale Questionnaire|Completed||N/A|207|Actual|Seoul National University Bundang Hospital|||3||f||||f||||||||||2017-10-11 03:16:25.658807|2017-10-11 03:16:25.658807
NCT01536067|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-05-03|2016-05-03||April 2012||2012-04-01|May 2016|2016-05-01||||April 2014|Actual|2014-04-01||Interventional||All treated and eligible patients|Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia|A Multicenter Phase II Study of Ofatumumab and Bortezomib (OB) in Previously Untreated Patients With Waldenstrom Macroglobulinemia|Terminated||Phase 2|3|Actual|Roswell Park Cancer Institute||1||funding was withdrawn|f||||t||||||||||2017-10-11 03:16:25.753978|2017-10-11 03:16:25.753978
NCT01536054|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-03-28|||August 20, 2012|Actual|2012-08-20|March 2017|2017-03-01|April 1, 2018|Anticipated|2018-04-01|April 21, 2015|Actual|2015-04-21||Interventional|||Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer|A Phase I Clinical Trial of mTOR Inhibition With Sirolimus for Enhancing ALVAC(2)-NY-ESO-1(M)/TRICOM Vaccine Induced Anti-Tumor Immunity in Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|Active, not recruiting||Phase 1|7|Actual|Roswell Park Cancer Institute||1|||f||||f||||||||||2017-10-11 03:16:26.308571|2017-10-11 03:16:26.308571
NCT01536041|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-01-21||2014-01-21|March 2012||2012-03-01|January 2014|2014-01-01||||November 2012|Actual|2012-11-01||Interventional|||A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients|A Double-blind, Placebo-controlled, Four-way Crossover Study to Compare the Safety and Efficacy of ONO-6950 20 mg and 200 mg QD Versus Placebo and Montelukast (Singulair) in Asthmatic Patients Who Experience Exercise-induced Bronchoconstriction|Completed||Phase 2|59|Actual|Ono Pharmaceutical Co. Ltd||4|||f||||f||||||||||2017-10-11 03:16:26.456684|2017-10-11 03:16:26.456684
NCT01536028|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-01-05|||April 2006||2006-04-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes|A Double-blind, Randomised, Four-Period Crossover Trial Comparing the Pharmacodynamics and Pharmacokinetics After Single Dose of Biphasic Insulin Aspart 30, Biphasic Insulin Aspart 50, Biphasic Insulin Aspart 70 and Insulin Aspart in Subjects With Type 1 Diabetes|Completed||Phase 1|32|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:16:26.621189|2017-10-11 03:16:26.621189
NCT01536015|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-07-07|2014-07-07||January 2012||2012-01-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|ROADMAP|The Analysis Population Description refers to the Safety Set (SS) which consists of all randomized subjects who received at least one dose of study medication.|Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction|Terminated||Phase 3|25|Actual|UCB Pharma||2||The study was stopped due to low enrollment.|f||||f||||||||||2017-10-11 03:16:26.779432|2017-10-11 03:16:26.779432
NCT01536002|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-05-26|||June 7, 2011|Actual|2011-06-07|May 2017|2017-05-01|May 7, 2014|Actual|2014-05-07|May 7, 2014|Actual|2014-05-07||Interventional|||Pharmacokinetics of Propofol in Morbidly Obese Patients|Pharmacokinetics (PK) of Propofol in Bariatric (Morbidly Obese) Patients|Completed||Phase 4|69|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 03:16:27.56105|2017-10-11 03:16:27.56105
NCT00005751|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||December 1998||1998-12-01|July 2004|2004-07-01|November 2003|Actual|2003-11-01|||||Observational|||Endothelial Vasomotor Function in the Framingham Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:57.860354|2017-10-11 04:28:57.860354
NCT01535989|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-06-06|||December 2011||2011-12-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|IOSI-LND-001||Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma|A Phase I Study of Inotuzumab Ozogamicin (CMC-544) in Combination With Temsirolimus (CCI-779) in Patients With Relapsed or Refractory CD22-positive B-cell Non Hodgkin's Lymphomas|Completed||Phase 1|25|Actual|Oncology Institute of Southern Switzerland||1|||f||||t||||||||||2017-10-11 03:16:27.707522|2017-10-11 03:16:27.707522
NCT01535976|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2014-02-18|2013-11-11||August 2011||2011-08-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Ketamine Infusion and Hypoventilation|The Effect of Ketamine in The Prevention of Hypoventilation in Patients With and Without a Positive Berlin Questionnaire Undergoing Deep Sedation|Completed||N/A|54|Actual|Northwestern University|We did not use depth of anesthesia monitor guided protocol due to controversial effects of ketamine of the correlation of processed EEG monitor and clinical levels of sedation. We did not use opioids as part of the protocol.|2|||f||||f||||||||||2017-10-11 03:16:27.836391|2017-10-11 03:16:27.836391
NCT01535963|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-02-07|||June 2012||2012-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Patient Satisfaction in Cutaneous Surgery|A Pilot Study of Patient Satisfaction After Cutaneous Surgery|Active, not recruiting||N/A|354|Actual|Northwestern University|||1||f||||f||||||||||2017-10-11 03:16:28.142424|2017-10-11 03:16:28.142424
NCT01535950|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-03-22||2016-03-22|February 2012||2012-02-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)|A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration|Completed||Phase 2|43|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:16:28.260756|2017-10-11 03:16:28.260756
NCT01535937|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-08-07|||February 2012|Actual|2012-02-01|August 2017|2017-08-01|April 2017|Actual|2017-04-01|February 2017|Actual|2017-02-01||Interventional|||The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence||Terminated||Phase 1/Phase 2|55|Actual|New York State Psychiatric Institute||2||An analysis demonstrated that running the final participants was unnecessary.|f||||t||||||||||2017-10-11 03:16:28.415637|2017-10-11 03:16:28.415637
NCT01535924|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-07-10|||February 9, 2012|Actual|2012-02-09|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase I/II Study Of Gemcitabine And Bendamustine In Patients With Relapsed Or Refractory Hodgkin's Lymphoma|Active, not recruiting||Phase 1/Phase 2|26|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-11 03:16:28.530005|2017-10-11 03:16:28.530005
NCT01535911|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-07-18|||April 2012||2012-04-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|Ketones||Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors|Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors|Recruiting||N/A|12|Anticipated|Michigan State University||1|||f||||t||||||||||2017-10-11 03:16:28.647954|2017-10-11 03:16:28.647954
NCT01535898|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-05-04|||February 2012||2012-02-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers|Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers|Completed||N/A|10|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:16:28.747251|2017-10-11 03:16:28.747251
NCT01535885|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-08-10|||February 2012||2012-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|ACE||Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus|A Phase I Study Of Using Multi-virus Cytotoxic T-cells Following T-cell Depleted Allogeneic Hematopoietic Progenitor Cell Transplantation For Prophylaxis Against Specific Pathogens- Epstein Barr Virus, Adenovirus, And Cytomegalovirus (ACE TRIAL)|Recruiting||Phase 1|18|Anticipated|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 03:16:28.845699|2017-10-11 03:16:28.845699
NCT01535872|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-06-14|||February 2012||2012-02-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|October 2014|Actual|2014-10-01||Interventional|||Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients|Dehydroepiandrosterone Treatment for Poor Responders in IVF Patients: A Prospective Randomised Controlled Trial.|Active, not recruiting||Phase 3|280|Anticipated|KK Women's and Children's Hospital||2|||f||||t||||||||||2017-10-11 03:16:28.954115|2017-10-11 03:16:28.954115
NCT01535859|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-06-14|||April 2012||2012-04-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Interventional|||Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers|A Randomised Controlled Trial of Cabergoline Prophylaxis for Ovarian Hyperstimulation Syndrome in IVF Cycles and Derivation of Biomarkers for OHSS.|Active, not recruiting||Phase 3|540|Anticipated|KK Women's and Children's Hospital||2|||f||||t||||||||||2017-10-11 03:16:29.051693|2017-10-11 03:16:29.051693
NCT01535846|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2013-04-24|||January 2011||2011-01-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|Flaveur||Awakening to the Taste of Food Among Restrained Women|Awakening to the Taste of Food: What Are the Effects on Cognitions and Behaviors About Food and Eating Among Restrained Women?|Completed||N/A|50|Actual|Laval University||2|||f||||f||||||||||2017-10-11 03:16:29.166017|2017-10-11 03:16:29.166017
NCT01535833|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-05-10|||February 2012||2012-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Robotic Assisted Sacral Colpopexy : A Prospective Study Assessing Outcomes With Learning Curves|Robotic Assisted Sacral Colpopexy : A Prospective Study Assessing Subjective and Objective Outcomes With Learning Curves in the Development of a New Pelvic Floor Robotics Program|Recruiting||N/A|100|Anticipated|Kaiser Permanente||1|||f||||t||||||||||2017-10-11 03:16:29.250338|2017-10-11 03:16:29.250338
NCT01535820|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2013-03-19|||March 2011||2011-03-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women|A Bioequivalence Study to Evaluate the Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women|Completed||Phase 1|54|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 03:16:29.373627|2017-10-11 03:16:29.373627
NCT01535807|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-11-19|2015-11-19||January 2012||2012-01-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|February 2013|Actual|2013-02-01||Interventional|CorMatrix||CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM|CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without CorMatrix's Extra Cellular Matrix (ECM)|Active, not recruiting||N/A|44|Actual|Inova Health Care Services||2|||f||||f||||||||||2017-10-11 03:16:29.468076|2017-10-11 03:16:29.468076
NCT01535794|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-08-07|||February 2012||2012-02-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||HPV Vaccine Acceptability Among Young Men Who Have Sex With Men|Exploring the Potential for Social Network Site-delivered Interventions to Increase HPV Vaccine Uptake Among Men Who Have Sex With Men|Completed||N/A|2000|Actual|Indiana University|||1||f||||t||||||||||2017-10-11 03:16:29.953339|2017-10-11 03:16:29.953339
NCT01535781|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2015-02-03|||September 2011||2011-09-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?|Effect of Tranexamic Acid on Blood Loss and Transfusion Need in Patients Operated With a Short Intramedullary Nail, for Pertrochanteric Fractures .|Terminated||N/A|72|Actual|Hvidovre University Hospital||2||Recruiting slower than expected.|f||||t||||||||||2017-10-11 03:16:30.047903|2017-10-11 03:16:30.047903
NCT01535768|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-07-19|||February 2012||2012-02-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves|Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves|Recruiting||Phase 4|150|Anticipated|Credit Valley EyeCare||2|||f||||t||||||||||2017-10-11 03:16:30.168189|2017-10-11 03:16:30.168189
NCT01535755|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2013-07-15|||July 2010||2010-07-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Protocol to Wean From Noninvasive Mechanical Ventilation|A Protocol to Wean From Noninvasive Mechanical Ventilation|Terminated||N/A|80|Actual|Chongqing Medical University||2||Enough patients has been enrolled.|f||||t||||||||||2017-10-11 03:16:30.265576|2017-10-11 03:16:30.265576
NCT01535729|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2015-10-01|2015-10-01||May 2011||2011-05-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational||Safety Analysis Set (SAF), included participants who received at least one dose of Tarceva®.|An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer|Erlotinib (Tarceva®) in Routine Clinical Practice in Patients With Advanced Non Small Cell Lung Cancer (NSCLC) After Failure of at Least One Prior Chemotherapy Regimen With Focus on the Elderly Patient.|Completed||N/A|465|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:16:30.512537|2017-10-11 03:16:30.512537
NCT01535716|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-04-16|||February 2012||2012-02-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|ECOMIII||Effects of a Goal-directed Hemodynamic Therapy Driven by ECOM on Morbidity and Mortality After Cardiac Surgery?|Does Goal-directed Hemodynamic Therapy Driven by Endotracheal Cardiac Output Monitoring System During Surgical Intervention Reduce Hospital Stay and Major Adverse Cardiac Events Following Cardiac Surgery?|Completed||Phase 4|100|Actual|University Hospital, Caen||2|||f||||t||||||||||2017-10-11 03:16:33.126541|2017-10-11 03:16:33.126541
NCT01535703|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-04-03|||November 2011||2011-11-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Observational|PANEX||Comparison of Cardiac Output Measurement Between Transpulmonary Thermodilution and Photoplethysmography|Comparison of Cardiac Output Measurement Between Invasive Method (Transpulmonary Thermodilution) and Non Invasive Method (Photoplethysmography) : an Observational Study|Completed||N/A|50|Actual|University Hospital, Caen|||1||f||||f||||||||||2017-10-11 03:16:33.282751|2017-10-11 03:16:33.282751
NCT01535690|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2012-02-17|||March 2008||2008-03-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|October 2009|Actual|2009-10-01||Interventional|||Photodynamic Therapy Associated With Full-mouth Ultrasonic Debridement in the Treatment of Severe Chronic Periodontitis|Photodynamic Therapy Associated With Full-mouth Ultrasonic Debridement in the Treatment of Severe Chronic Periodontitis: a Randomized-controlled Clinical Trial Running Title: Photodynamic Therapy Associated With Periodontal Debridement|Completed||N/A|22|Actual|Escola Bahiana de Medicina e Saude Publica||1|||f||||t||||||||||2017-10-11 03:16:33.3543|2017-10-11 03:16:33.3543
NCT01535677|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-07-08|||April 2013||2013-04-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately|A Bioequivalence Study of the Fixed Dose Combination Dapagliflozin/Metformin Tablet (5 mg/850 mg) Relative to a 5 mg Dapagliflozin Tablet and an 850 mg Metformin (Glucophage® Marketed in Canada by Sanofi-Aventis) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States|Completed||Phase 1|71|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 03:16:33.44157|2017-10-11 03:16:33.44157
NCT01535664|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-08-08|2013-05-28||January 2012||2012-01-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|||An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)|An Open-label, Proof of Concept Study to Evaluate Multiple Gait and Balance Parameters After Withdrawal of Dalfampridine-ER 10mg in Subjects With MS|Completed||Phase 2|20|Actual|Acorda Therapeutics|||1||f||||f||||||||||2017-10-11 03:16:33.553931|2017-10-11 03:16:33.553931
NCT01535651|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-07-27|||September 2011||2011-09-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|TOP4ME||Using Social Media to Enhance the Impact of the Teen Outreach Program|Using Social Media to Enhance the Impact of the Teen Outreach Program|Completed||Phase 2/Phase 3|852|Actual|Colorado School of Public Health||2|||f||||f||||||||||2017-10-11 03:16:33.88955|2017-10-11 03:16:33.88955
NCT01535638|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2016-03-09|2016-01-21||February 2012||2012-02-01|March 2016|2016-03-01||||March 2012|Actual|2012-03-01||Interventional|||Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers|Relative Bioavailability of BI 207127 FF Tablets, BI 207127 FF Modified Tablets and BI 207127 TFII Tablets Administered Orally as Three Tablets (Single Dose) to Healthy Male Volunteers, an Open-label, Randomised Three-way Crossover Study|Completed||Phase 1|18|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:16:33.968443|2017-10-11 03:16:33.968443
NCT01535625|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-17|||February 2012||2012-02-01|February 2012|2012-02-01|July 2013|Anticipated|2013-07-01|January 2013|Anticipated|2013-01-01||Interventional|||Safety and Effectiveness of the Coronary Momo Stent|Clinical Evaluation of the Momo Cobalt-Chromium Coronary Stent System for the Treatment of Patients With Coronary Artery Disease|Unknown status|Recruiting|Phase 4|100|Anticipated|be Medical||1|||f||||t||||||||||2017-10-11 03:16:35.52552|2017-10-11 03:16:35.52552
NCT01535612|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-07-25|||March 2012||2012-03-01|July 2016|2016-07-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus|A Study Evaluating the Feasibility of Use and Performance of PaQ™ in Patients With Type 2 Diabetes Mellitus Who Are Currently Treated With Basal/Bolus Insulin Therapy|Completed||N/A|20|Actual|CeQur Corporation||1|||f||||f||||||||Yes|Published in Diabetes Care - Volume 37, May 2014, pages 1476-1479|2017-10-11 03:16:35.628174|2017-10-11 03:16:35.628174
NCT01535599|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2014-06-24|2014-05-19||March 2012||2012-03-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||This reporting group includes all randomized participants who were treated with study medication (686). Note: 6 participants were randomized in error and did not receive study medication (3 in AL-60371 and 3 in Vehicle). Additionally 1 participant randomized to Vehicle exited the study at Visit 2 without dosing the study medication.|Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa|Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa|Completed||Phase 3|768|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:16:35.737871|2017-10-11 03:16:35.737871
NCT01535586|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-02-16|||April 2012||2012-04-01|February 2012|2012-02-01||||March 2015|Anticipated|2015-03-01||Interventional|||A Randomized Cross Over Trial of Two Treatments for Obstructive Sleep Apnea in Veterans With Post Traumatic Stress Disorder||Unknown status|Not yet recruiting|Phase 4|42|Anticipated|The VA Western New York Healthcare System||2|||f||||f||||||||||2017-10-11 03:16:36.072455|2017-10-11 03:16:36.072455
NCT01535573|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-05-03|||December 2010||2010-12-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Citalopram for Cocaine Dependence|Clinical Trial of Serotonin Medication Combination in Cocaine Dependence|Completed||Phase 2|122|Actual|The University of Texas Health Science Center, Houston||3|||f||||t||||||||||2017-10-11 03:16:36.167998|2017-10-11 03:16:36.167998
NCT01535560|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2013-10-18|2013-10-18||April 2012||2012-04-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||This reporting group includes all randomized participants who received the study drug (ie, 548). Note: 1 participant in the Vehicle arm was randomized in error and did not receive the study drug.|Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa|Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa|Completed||Phase 3|589|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:16:36.273869|2017-10-11 03:16:36.273869
NCT01535547|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2012-02-15|||December 2011||2011-12-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Drug Interaction Study of Isavuconazole and Tacrolimus|Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Tacrolimus: A Phase 1, Open Label, Sequential Study in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:16:36.810062|2017-10-11 03:16:36.810062
NCT01535534|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2016-11-22|||January 2012||2012-01-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|||||Observational|MaSep||Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis|Evaluation of Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis|Recruiting||N/A|400|Anticipated|Universitätsmedizin Mannheim|||1||f||||f||||||Samples Without DNA|"     Peripheral blood samples   "|||2017-10-11 03:16:36.930901|2017-10-11 03:16:36.930901
NCT01535521|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2013-06-19||||||June 2013|2013-06-01||||February 2013|Actual|2013-02-01||Interventional|SupPos||Sleep Positional Trainer for Positional Sleep Apnea After Mandibular Advancement Device (MAD) Therapy|Evaluation of Sleep Position Trainer for Positional Sleep Apnea Patients After Therapy With Mandibular Advancement Device (MAD)|Completed||N/A|||University Hospital, Antwerp||1|||f||||||||||||||2017-10-11 03:16:37.036653|2017-10-11 03:16:37.036653
NCT01535508|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2016-11-04|||February 2012||2012-02-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Open Label Clinical Trial of Vitamin D in Children With Autism|Open Label Clinical Trial of Vitamin D Dosage Tolerability, and Effect on Behavioral Measures in Children With Autism|Completed||Phase 2/Phase 3|10|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:16:37.123142|2017-10-11 03:16:37.123142
NCT01535495|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-03-29|||February 2012||2012-02-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Propranolol for Diabetic Retinopathy|Propranolol for Diabetic Retinopathy|Completed||Phase 1|9|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 03:16:37.225389|2017-10-11 03:16:37.225389
NCT01535482|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-06-07|||September 2011||2011-09-01|June 2017|2017-06-01|April 6, 2017|Actual|2017-04-06|April 6, 2017|Actual|2017-04-06||Interventional|||Cognitive Therapy for Suicidal Older Men|Cognitive Therapy for Suicidal Older Men|Completed||N/A|110|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 03:16:37.332054|2017-10-11 03:16:37.332054
NCT01535469|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-04-19|||July 1, 2012|Actual|2012-07-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ORCAS||Operational Research for Cryptococcal Antigen Screening|Operational Research for Cryptococcal Antigen Screening to Improve ART Survival|Completed||Phase 4|3049|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t|f|f|||f|||Yes|After publication, data to be shared upon request to the Infectious Disease Institute Research Department as per the institutional data sharing policy.|2017-10-11 03:16:37.42775|2017-10-11 03:16:37.42775
NCT01535456|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2015-04-29|||July 2012||2012-07-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||FLT-PET Imaging for MDS|A Pilot Study for Using 18F-FLT PET Imaging To Assess Response In Patients With Myelodysplastic Syndrome (MDS) Being Treated With 5-azacitidine|Terminated||N/A|1|Actual|University of Wisconsin, Madison||1||funding|f||||t||||||||||2017-10-11 03:16:37.562319|2017-10-11 03:16:37.562319
NCT01535417|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2012-02-14|||May 2009||2009-05-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of Shinbaro Capsule|A 12 Weeks, Randomized, Double-blind, Multi-centers, Phase III Study to Evaluate the Efficacy and Safety of Shinbaro Capsule Compared With Celebrex Capsule in Patients With Osteoarthritis of Knee|Completed||Phase 3|198|Actual|Green Cross Corporation||2|||f||||f||||||||||2017-10-11 03:16:37.882782|2017-10-11 03:16:37.882782
NCT01535404|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-05-11|||January 2012||2012-01-01|October 2014|2014-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|RIVELA||Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ventricular Systolic Function Study|Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ventricular Systolic Function (RIVELA) Study|Terminated||N/A|36|Actual|University Hospital, Geneva||2||Slow enrollment|f||||t||||||||||2017-10-11 03:16:37.975977|2017-10-11 03:16:37.975977
NCT01535391|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-08-31|||January 2012|Actual|2012-01-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2014|Actual|2014-11-01||Interventional|CML0811||Nilotinib in PH+, BCR-, ABL+ CML Patients|The Protein Tyrosine Kinase Inhibitor Nilotinib as First-line Treatment of Ph+, BCR-, ABL+ Chronic Myeloid Leukemia (CML) in Early Chronic Phase: a Phase IIIb, Multicenter Study to Assess the Complete Molecular Response|Active, not recruiting||Phase 3|109|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-11 03:16:38.090829|2017-10-11 03:16:38.090829
NCT01535378|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2014-07-21|||March 2012||2012-03-01|July 2014|2014-07-01||||||||Observational|PARADYSAM||Interest of Behavioural Reeducation in Dysfunctions of Masticatory Apparatus. Relations Between Parafunctions and Dysfunctions of Mastixatory Apparatus|Interest of Behavioural Reeducation in Dysfunctions of Masticatory Apparatus. Relations Between Parafunctions and Dysfunctions of Mastixatory Apparatus|Completed||N/A|32|Actual|Rennes University Hospital|||1||f||||||||||||||2017-10-11 03:16:38.298607|2017-10-11 03:16:38.298607
NCT01535365|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-05|2012-02-16|2010-11-05||March 2008||2008-03-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Heat Versus Ice in the Acute Management of Neck and Back Strain Injuries|Heat Versus Ice in the Acute Management of Neck and Back Strain Injuries|Completed||N/A|60|Actual|Stony Brook University||2|||f||||f||||||||||2017-10-11 03:16:38.384204|2017-10-11 03:16:38.384204
NCT01535339|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2016-03-31|||February 2012||2012-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Sport Concussion Assessment - Test Stability and Effect of Concussion|Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Sport Concussion Assessment - Test Stability and Effect of Concussion|Completed||N/A|114|Actual|ElMindA Ltd|||4||f||||f||||||||||2017-10-11 03:16:38.98507|2017-10-11 03:16:38.98507
NCT01535326|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2014-07-28|2014-03-16||February 2012||2012-02-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||patients underwent endoscopy by YHH|Comparing Water Immersion and Water Exchange Methods During Minimally Sedated Colonoscopy|Comparing Air Insufflation, Water Immersion and Water Exchange Methods During Minimal Sedated Colonoscopy, a Randomized, Controlled Trial|Completed||N/A|270|Actual|Dalin Tzu Chi General Hospital|Single center; single endoscopist|3|||f||||f||||||||||2017-10-11 03:16:39.197054|2017-10-11 03:16:39.197054
NCT01535313|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-02-16|||May 2011||2011-05-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of a Powered Bone Marrow Biopsy Device With a Manual System|a Prospective Randomized Controlled Trial Comparing a Powered Bone Marrow Biopsy Device With a Manual System|Completed||N/A|60|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 03:16:39.622409|2017-10-11 03:16:39.622409
NCT01535300|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-02-14|||August 2010||2010-08-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Ultrasound and Paediatric Endotracheal Tube Size|Role of Ultrasound Compared to Age-related Formulas for Uncuffed Endotracheal Intubation in a Paediatric Population|Completed||N/A|50|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-11 03:16:39.750104|2017-10-11 03:16:39.750104
NCT01535274|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2014-09-19|||September 2012||2012-09-01|July 2013|2013-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Ventilation Strategies, Anesthetic Techniques and Cerebral Oxygenation in the Beach Chair Position|The Influence of Basic Ventilation Strategies and Anesthetic Techniques on Cerebral Oxygenation in the Beach Chair Position|Completed||N/A|54|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 03:16:40.163159|2017-10-11 03:16:40.163159
NCT01535261|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2016-09-21|2016-03-16||February 2012||2012-02-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CRYSTAL||Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion|A 24-month, Phase IIIb, Open-label, Single Arm, Multicenter Study Assessing the Efficacy and Safety of an Individualized, Stabilization-criteria-driven PRN Dosing Regimen With 0.5-mg Ranibizumab Intravitreal Injections Applied as Monotherapy in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal|Completed||Phase 3|357|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:16:40.311944|2017-10-11 03:16:40.311944
NCT01535248|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-11-30|||March 2012||2012-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Echo Detection of Endoscopic Retrograde Cholangiopancreatography (ERCP) Air Embolus|Echocardiographic Surveillance of Patients Undergoing Scheduled Endoscopic Retrograde Cholangiopancreatography for the Presence of Intracardiac Air Embolus|Completed||N/A|17|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 03:16:41.2233|2017-10-11 03:16:41.2233
NCT00005752|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-08|||April 1999||1999-04-01|August 2004|2004-08-01|March 2002||2002-03-01|||||Observational|||Overweight Adults--Ethnic, SES and Behavioral Influences||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 04:28:57.930914|2017-10-11 04:28:57.930914
NCT01535235|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-05-12|2016-03-01||February 2012||2012-02-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study|ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study|Completed||Phase 4|31|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:16:41.326405|2017-10-11 03:16:41.326405
NCT01535222|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-06-14|2012-06-14||November 2010||2010-11-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery|A Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective CABG Surgery|Completed||Phase 2|32|Actual|The Medicines Company||6|||f||||t||||||||||2017-10-11 03:16:41.676655|2017-10-11 03:16:41.676655
NCT01535209|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-02-16|||January 2012||2012-01-01|February 2012|2012-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus Whole-Brain Radiotherapy After Resection|Phase 3 Study of Stereotactic Radiotherapy of the Postoperative Resection Cavity Versus Whole-Brain Irradiation After Surgical Resection of Single Brain Metastasis|Unknown status|Recruiting|Phase 3|100|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||t||||||||||2017-10-11 03:16:42.40006|2017-10-11 03:16:42.40006
NCT01535196|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-02-18|||December 2012||2012-12-01|February 2014|2014-02-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Vitamine D Treatment in Chronic Heart Failure|Effects of 25-OH-D3 Vitamin Substitution in Congestive Heart Failure. Controlled, Randomized, Double Blind Trial|Suspended||Phase 3|300|Anticipated|Semmelweis University||2||financial reasons|f||||t||||||||||2017-10-11 03:16:42.5126|2017-10-11 03:16:42.5126
NCT01535183|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2014-07-11|||January 2012||2012-01-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents|Irinotecan, Vincristine, Etoposide, Carboplatin, and Cyclophosphamide for Refractory or Relapsed Brain Tumor in Children and Adolescents|Unknown status|Recruiting|Phase 2|40|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 03:16:42.74423|2017-10-11 03:16:42.74423
NCT01535170|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-02-14|||September 2010||2010-09-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|LFasSDD||Bovine Lactoferrin as a Natural Regimen of Selective Decontamination of the Digestive Tract in Patients With Prolonged Mechanical Ventilation|Bovine Lactoferrin as a Natural Regimen of Selective Decontamination of the Digestive Tract in Patients With Prolonged Mechanical Ventilation|Unknown status|Recruiting|N/A|280|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 03:16:42.857629|2017-10-11 03:16:42.857629
NCT01535157|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-07-28|||February 2012||2012-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer|Phase I/II Trial of Fenretinide/LXS Oral Powder (NSC 374551) Plus Ketoconazole in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|South Plains Oncology Consortium||1|||f||||t||||||||||2017-10-11 03:16:42.98105|2017-10-11 03:16:42.98105
NCT01535144|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-02-29|||February 2010||2010-02-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Comparative Study of Osteosynthesis for Chevron Osteotomy of Hallux Valgus Using Degradable Versus Non-degradable Metallic Device||Completed||N/A|26|Actual|Syntellix AG||2|||f||||f||||||||||2017-10-11 03:16:43.106254|2017-10-11 03:16:43.106254
NCT01535131|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-01-10|||February 2012||2012-02-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Furlow Palatoplasty With Tensor Tenopexy|Furlow Palatoplasty With Tensor Tenopexy for Otitis Media|Recruiting||Phase 2|120|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 03:16:43.214922|2017-10-11 03:16:43.214922
NCT01535118|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-01-18|2013-12-09||January 2012||2012-01-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|AIRS||A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)|National Allergies, Immunotherapy and RhinoConjunctivitis Survey in America|Completed||N/A|2765|Actual|ALK-Abelló A/S|||1||f||||f||||||||||2017-10-11 03:16:43.383091|2017-10-11 03:16:43.383091
NCT01535105|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2013-03-13|||August 2012||2012-08-01|February 2012|2012-02-01|April 2017|Anticipated|2017-04-01|April 2013|Anticipated|2013-04-01||Observational|||Impairment in Glucose Homeostasis Among Obese Adolescents in High Risk Diabetes Prone Population - Jisr Az-Zarqa Village||Unknown status|Recruiting|N/A|300|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 03:16:43.74416|2017-10-11 03:16:43.74416
NCT01535079|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-11-09|||February 2012||2012-02-01|October 2012|2012-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Acute Sore Throat Pain Study|Analgesic Profile of 3 New Ibuprofen Lozenges (V0498TA01A 15 mg, 25 mg, 35 mg) After Single Administration in Acute Sore Throat Pain|Completed||Phase 2|186|Actual|Pierre Fabre Medicament||5|||f||||||||||||||2017-10-11 03:16:43.995394|2017-10-11 03:16:43.995394
NCT01535066|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-07-12|||March 2012||2012-03-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer|Randomized Blinded Sham- and Waitlist-Controlled Trial of Acupuncture for Joint Symptoms Related to Aromatase Inhibitors in Women With Early Stage Breast Cancer|Active, not recruiting||N/A|228|Anticipated|Southwest Oncology Group||3|||f||||t||||||||||2017-10-11 03:16:44.137286|2017-10-11 03:16:44.137286
NCT01534650|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-02-22|||February 2012||2012-02-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Movement Disorder Quantification Algorithm Development||Completed||N/A|17|Actual|Great Lakes NeuroTechnologies Inc.|||1||f||||||||||||||2017-10-11 03:16:52.633841|2017-10-11 03:16:52.633841
NCT01535053|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-08-23|||June 18, 2012|Actual|2012-06-18|August 2017|2017-08-01||||May 31, 2018|Anticipated|2018-05-31||Interventional|||Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia|A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia|Active, not recruiting||Phase 3|384|Anticipated|Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 03:16:44.420543|2017-10-11 03:16:44.420543
NCT01535040|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-05-25|2015-01-12||August 2012||2012-08-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||All randomized participants|Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking|Randomized Placebo-Controlled Phase 2 Pilot Study of Memantine (Namenda) for Smoking Cessation Among Cancer Survivors|Completed||Phase 2|130|Actual|Wake Forest University Health Sciences||2|||f||||t|t|f||||||||2017-10-11 03:16:45.372154|2017-10-11 03:16:45.372154
NCT01535027|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-12-30|||March 2006||2006-03-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|Confors||Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis|Phase IV Study Teriparatide and Antiresorptive Combination Treatment Subsequent to 9 Months of Teriparatide Monotherapy|Completed||Phase 4|125|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-10-11 03:16:46.42006|2017-10-11 03:16:46.42006
NCT01535014|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-02-07|||December 2011||2011-12-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial of Safety and Efficiency of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients|Multicentric Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Safety and Efficiency of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients|Completed||Phase 3|493|Actual|Materia Medica Holding||4|||f||||f||||||||||2017-10-11 03:16:46.556725|2017-10-11 03:16:46.556725
NCT01534962|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-07-29|2014-07-29||January 2012||2012-01-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|RAFFAELLO|ITT-population (excluding 3 randomized patients who never started study drug)|Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Dose-ranging Phase II Study Assessing Ranolazine in the Maintenance of Sinus Rhythm After Electrical Cardioversion in Patients With Non-permanent Atrial Fibrillation.|Completed||Phase 2|241|Actual|Menarini Group|Most of the Kaplan-Meier estimates could not be calculated due to the lower than expected number of observed events and the high variability of data.|4|||f||||f||||||||||2017-10-11 03:16:47.961106|2017-10-11 03:16:47.961106
NCT01534949|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-07-21|||February 2012||2012-02-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|Triad-DLBCL||Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial|A Phase 1, Multicenter, Open-Label, Single-Arm Study to Evaluate the Initial Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of CT-P10 Given in Combination With Dexamethasone, Cytosine Arabinoside, and Cisplatin (DHAP) in Patients With Diffuse Large B-Cell Lymphoma as Second-Line Chemotherapy|Terminated||Phase 1|1|Actual|Celltrion||1|||f||||t||||||||||2017-10-11 03:16:48.93287|2017-10-11 03:16:48.93287
NCT01534936|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-12-19|||February 2012||2012-02-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|AFFECT||Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary|Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary.|Completed||N/A|2153|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:16:49.028218|2017-10-11 03:16:49.028218
NCT01534923|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-02-02|||February 2012||2012-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Doctor-Patient Communication About Colorectal Cancer Screening|Doctor-Patient Communication About Colorectal Cancer Screening|Active, not recruiting||N/A|225|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:16:49.23205|2017-10-11 03:16:49.23205
NCT01534910|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-03-09|2015-02-20||May 2012||2012-05-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Garlic4||Effect of Aged Garlic Extract on Atherosclerosis|Effect of Aged Garlic Extract on Atherosclerosis|Completed||Phase 4|65|Actual|Los Angeles Biomedical Research Institute||2|||f||||f||||||||No||2017-10-11 03:16:49.335857|2017-10-11 03:16:49.335857
NCT01534897|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-01-24|2015-06-23||July 2012||2012-07-01|January 2017|2017-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436|Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436|Completed||N/A|10|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-10-11 03:16:49.649707|2017-10-11 03:16:49.649707
NCT01534884|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2015-05-20|||February 2012||2012-02-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|August 2013|Actual|2013-08-01||Interventional|Triad RA||Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis|Phase 1, Randomized, Controlled, Multicenter, 2-Arm, Parallel-Group, Double-Blind Study to Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis|Completed||Phase 1|154|Actual|Celltrion||2|||f||||t||||||||||2017-10-11 03:16:50.105255|2017-10-11 03:16:50.105255
NCT01534871|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-02-06|||October 2013||2013-10-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effects of Cardiac Rehabilitation on Cardiovascular Disease Risk in Rheumatoid Arthritis Patients|The Effects of a 12-week Cardiovascular Rehabilitation Exercise Program on Inflammatory Markers and Traditional Coronary Artery Disease Risk Factors in Patients With Rheumatoid Arthritis|Recruiting||N/A|60|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||No||2017-10-11 03:16:50.203558|2017-10-11 03:16:50.203558
NCT01534858|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2015-09-21|||March 2012||2012-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Prospective, Descriptive Cohort Study With Prontosan® Wound Gel X in Partial and Full Thickness Burns Requiring Split Thickness Skin Grafts|A Prospective, Descriptive Cohort Study With Prontosan® Wound Gel X in Partial and Full Thickness Burns Requiring Split Thickness Skin Grafts|Completed||N/A|51|Actual|B. Braun Ltd. Centre of Excellence Infection Control||1|||f||||f||||||||||2017-10-11 03:16:50.336124|2017-10-11 03:16:50.336124
NCT01534845|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2015-07-07|||March 2012||2012-03-01|July 2015|2015-07-01|February 2017|Anticipated|2017-02-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion|A Randomized Phase 2 Study to Evaluate the Efficacy Between Only Radiotherapy Versus CCRT With Temozolomide in Newly Diagnosed Grade III Gliomas Without 1p/19q Codeletion|Unknown status|Active, not recruiting|Phase 2|90|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 03:16:50.439034|2017-10-11 03:16:50.439034
NCT01534832|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-08-14|||April 2012||2012-04-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|Innervision||Assessment of a New Surgical Smoke Clearing Technology in Laparoscopic Cholecystectomy|"Assessment of a New Surgical Smoke Clearing Technology, Innervision, in Laparoscopic Cholecystectomy"|Completed||Phase 1/Phase 2|30|Actual|Asalus Medical Instruments Limited||1|||f||||f||||||||||2017-10-11 03:16:50.541358|2017-10-11 03:16:50.541358
NCT01534819|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-05-22|||April 2012|Actual|2012-04-01|January 2017|2017-01-01|April 2024|Anticipated|2024-04-01|April 2020|Anticipated|2020-04-01||Observational|ANCHOR||ANCHOR (Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry)|Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry|Recruiting||N/A|2000|Anticipated|Medtronic Endovascular|||2||f||||f||||||||No||2017-10-11 03:16:50.708074|2017-10-11 03:16:50.708074
NCT01534806|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-06-23|||January 2012||2012-01-01|June 2014|2014-06-01||||January 2012|Actual|2012-01-01||Interventional|||Prochlorperazine Versus Prochlorperazine & Ketorolac in Treatment of Pediatric Migraine in the Emergency Department|A Randomized Double Blinded Study Comparing Use of Prochlorperazine Versus Prochlorperazine and Ketorolac in the Treatment of Pediatric Migraine in the Emergency Department|Withdrawn||Phase 4|0|Actual|Akron Children's Hospital||2||Drug is backordered;|f||||t||||||||||2017-10-11 03:16:51.062895|2017-10-11 03:16:51.062895
NCT01534793|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2015-02-24|||February 2012||2012-02-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|May 2013|Actual|2013-05-01||Observational|QUAPELLA||QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser)|Observational Study Evaluating the Quality of Laser Enucleation of the Prostate Using a LUMENIS Laser Device|Completed||N/A|100|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 03:16:51.188863|2017-10-11 03:16:51.188863
NCT01534780|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-02-18|||April 2013||2013-04-01|February 2016|2016-02-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Interventional|FS||3 Fixation Devices in Laparoscopic Ventral Herniotomy|A Controlled Randomized Study of Protack, Securestrap and Glubran Glue as Fixation Devices in Laparoscopic Ventral Herniotomy|Recruiting||Phase 2|75|Anticipated|Horsens Hospital||3|||f||||t||||||||||2017-10-11 03:16:51.297023|2017-10-11 03:16:51.297023
NCT01534754|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2012-02-14|||January 2009||2009-01-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Mesalazine and/or Lactobacillus Casei in the Diverticular Disease of the Colon|Mesalazine and/or Lactobacillus Casei in Maintaining Remission of Symptomatic Uncomplicated Diverticular Disease of the Colon: a Double-blind, Double-dummy, Placebo-controlled Study|Completed||Phase 4|250|Actual|Hospital Cristo Re||4|||f||||f||||||||||2017-10-11 03:16:51.409601|2017-10-11 03:16:51.409601
NCT01534741|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-04-08|||January 2012||2012-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Comparison FX CorDiax 60 in Relation to the FX 60-Dialyzer|Investigation on the Middle Size Molecule Elimination Characteristics of the FX CorDiax 60 in Relation to the FX 60-Dialyzer|Completed||Phase 4|30|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 03:16:51.534686|2017-10-11 03:16:51.534686
NCT01534728|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2015-01-12|||February 2012||2012-02-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|TETRA||Identification of Hepatitis C Virus (HCV) Specific T Cells|Identification of HCV Specific T Cells Using Tetramer Technology - TETRA Study|Completed||N/A|40|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||Samples Without DNA|"     PBMCs   "|||2017-10-11 03:16:51.627434|2017-10-11 03:16:51.627434
NCT01534715|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2016-08-24|||January 2012||2012-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia|A Phase I, Multi-center, Open-label Study of IMGN529 Administered Intravenously in Adult Patients With Relapsed or Refractory Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia|Completed||Phase 1|49|Actual|ImmunoGen, Inc.||1|||f||||f||||||||No||2017-10-11 03:16:51.702724|2017-10-11 03:16:51.702724
NCT01534702|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2012-02-17|||January 2012||2012-01-01|February 2012|2012-02-01|September 2015|Anticipated|2015-09-01|April 2013|Anticipated|2013-04-01||Interventional|CIARA||Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML|Phase I/II Study on Cytarabine and Idarubicin Combined With Escalating Doses of Clofarabine as Induction Therapy in Patients With Acute Myeloid Leukemia and High Risk for Induction Failure (AMLSG 17-10)|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Hannover Medical School||1|||f||||f||||||||||2017-10-11 03:16:51.789986|2017-10-11 03:16:51.789986
NCT01534689|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2015-11-07|2015-07-13||April 2011||2011-04-01|November 2015|2015-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus|An Evaluation of the Effect of the Erchonia FX-405™ on Treating Toenail Onychomycosis Clinical Study|Completed||N/A|105|Actual|Erchonia Corporation||1|||f||||f||||||||||2017-10-11 03:16:51.969289|2017-10-11 03:16:51.969289
NCT01534676|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2016-08-11|2016-08-11||February 2012||2012-02-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Transfusion of Older Stored Red Cells|Harmful Effects of Transfusion of Older Stored Red Cells: Iron and Inflammation|Terminated||N/A|3|Actual|Columbia University||4||Difficulty recruiting donors and recipients, looking for alternative sites|f||||f||||||||Undecided||2017-10-11 03:16:52.234839|2017-10-11 03:16:52.234839
NCT01534663|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2014-07-05|||November 2011||2011-11-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|GLUTFISH-HF||Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure|Effects of Glutamine and Fish Oil on Muscle Function in Heart Failure (GlutFish-HF)|Completed||Phase 2/Phase 3|31|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 03:16:52.536462|2017-10-11 03:16:52.536462
NCT01534637|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-14|2017-07-28|2012-08-29||August 2006||2006-08-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|December 2009|Actual|2009-12-01||Interventional|||Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer|A Feasibility Study to Discern the Tolerability of 5-FU/Gemcitabine Based Chemotherapy Concurrent With Upper Abdominal Radiation and the Utility of Aprepitant/5HT-3 Antagonist (EMEND) for the Prevention of ChemoRadiation-Induced Nausea and Vomiting (CRINV)|Completed||N/A|22|Actual|Wake Forest University Health Sciences||1|||f|||||t|f||||||||2017-10-11 03:16:52.738649|2017-10-11 03:16:52.738649
NCT01534624|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-06-30|||February 7, 2012||2012-02-07|July 30, 2014|2014-07-30|July 30, 2014||2014-07-30|||||Observational|||Stem Cell Study of Genetics and Drug Addiction|Development of Induced Pluripotent Stem Cells Carrying Monoamine Transporter Polymorphisms|Completed||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:16:53.084655|2017-10-11 03:16:53.084655
NCT01534598|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-15|2017-07-06|||January 20, 2012||2012-01-20|June 26, 2017|2017-06-26|April 28, 2020|Anticipated|2020-04-28|April 25, 2018|Anticipated|2018-04-25||Interventional|||FdCyd and THU for Advanced Solid Tumors|Phase I Trial of Oral 5-Fluoro-2'-Deoxycytidine With Oral Tetrahydrouridine in Patients With Advanced Solid Tumors|Recruiting||Phase 1|68|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:16:53.179146|2017-10-11 03:16:53.179146
NCT01534585|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-02-16|||February 2012||2012-02-01|February 2012|2012-02-01|February 2015|Anticipated|2015-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma|Phase Ⅰ/Ⅱ Study of Icotinib Hydrochloride Combined With Intensity-modulated Radiotherapy in Nasopharyngeal Cancer|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Taizhou Hospital||1|||f||||t||||||||||2017-10-11 03:16:53.32414|2017-10-11 03:16:53.32414
NCT01534572|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-02-15|||January 2006||2006-01-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|March 2006|Actual|2006-03-01||Interventional|||Significance of Synbiotics on Inflammation and Proliferation of Colonic Mucosa|Significance of Synbiotics on Inflammation and Proliferation of Colonic Mucosa|Completed||N/A|12|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 03:16:53.453743|2017-10-11 03:16:53.453743
NCT01534559|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-04-06|||November 2014||2014-11-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MMC||Pharmacist-led Medicines Management Outpatient Service|A Pharmacist-led Medicines Management Outpatient Service for Patients at High Risk of Medication Related Problems|Recruiting||Phase 4|268|Anticipated|Queen's University, Belfast||2|||f||||f||||||||||2017-10-11 03:16:53.540727|2017-10-11 03:16:53.540727
NCT01534546|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-02-04|||March 2012||2012-03-01|February 2016|2016-02-01|September 2019|Anticipated|2019-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection|A Randomized, Multicenter, Controlled Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection|Recruiting||Phase 3|1059|Anticipated|Peking University||3|||f||||t||||||||No||2017-10-11 03:16:53.671946|2017-10-11 03:16:53.671946
NCT01534533|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2013-06-18|2012-07-26||June 2010||2010-06-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Effects of Lutein Supplementation on Subclinical Atherosclerosis|The Effects of Lutein Supplementation on Subclinical Atherosclerosis|Completed||Phase 2/Phase 3|192|Actual|Peking University||4|||f||||t||||||||||2017-10-11 03:16:53.798908|2017-10-11 03:16:53.798908
NCT01534520|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-10-27|2016-05-20||June 2012||2012-06-01|October 2016|2016-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|LIVIIN|Randomization is blinded.|Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women|Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women: a Randomized Controlled Trial|Completed||N/A|61|Actual|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 03:16:54.558999|2017-10-11 03:16:54.558999
NCT01534507|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-08-12|||November 2011||2011-11-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Small and Large Bowel Transit Tests Using MRI (Study 1)|Optimising Measurement of Small and Large Bowel Transit During MRI Scanning and Characterising IBS Subtypes and Their Response to Stress Using MRI (Study 1)|Completed||N/A|108|Actual|University of Nottingham|||5||f||||f||||||Samples Without DNA|"     Study 1: no samples Study 2: no samples   "|||2017-10-11 03:16:54.870863|2017-10-11 03:16:54.870863
NCT01534494|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-02-06|||January 2012||2012-01-01|February 2014|2014-02-01|March 2014|Anticipated|2014-03-01|September 2013|Actual|2013-09-01||Interventional|||Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence|Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|University of New Mexico||1|||f||||t||||||||||2017-10-11 03:16:54.946946|2017-10-11 03:16:54.946946
NCT01534481|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-06-19|||August 2012|Actual|2012-08-01|June 2017|2017-06-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants|Neurodevelopmental Effects of Donor Human Milk vs. Preterm Formula in Extremely Low Birth Weight (ELBW) Infants|Recruiting||Phase 3|670|Anticipated|NICHD Neonatal Research Network||2|||f||||t||||||||Yes|NIH has had a long-standing policy to share and make available to the public the results and accomplishments of the activities that it funds. The NRN plans to share de-identified data after final publication in an NIH supported data repository such as the NICHD Data and Specimen Hub (https://dash.nichd.nih.gov)|2017-10-11 03:16:55.041591|2017-10-11 03:16:55.041591
NCT01534468|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-12-14|||March 2012||2012-03-01|December 2015|2015-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults|Evaluation of Priming by Pandemic Live Attenuated Influenza Vaccine (LAIV) on the Subsequent Response to Inactivated H7N7 Vaccine in Healthy Adults: A Non-Randomized, Open Label Study|Completed||Phase 1|45|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||f||||||||||2017-10-11 03:16:55.386377|2017-10-11 03:16:55.386377
NCT01534273|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-08-09|||February 2012||2012-02-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study of LY2886721 in Healthy Participants|Single- and Multiple-Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects|Completed||Phase 1|39|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 03:16:57.528428|2017-10-11 03:16:57.528428
NCT01534455|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2016-02-09|||February 2012||2012-02-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)|A Randomized Phase II Study to Determine the Efficacy and Tolerability of Two Doses of Eribulin Plus Lapatinib in Trastuzumab Pre-treated Patients With HER2-positive Metastatic Breast Cancer (E-VITA)|Terminated||Phase 2|43|Actual|German Breast Group||2||very slow patient recruitment and concerns about the actuality of the study design|f||||t||||||||||2017-10-11 03:16:55.526144|2017-10-11 03:16:55.526144
NCT01534442|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2012-12-06|||September 2011||2011-09-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin Response|The Significances of Atropin Administration for the GLP-1 Potentiation of Glucose Induced Insulin Secretion and the Cephalic Insulin Response|Unknown status|Recruiting|N/A|10|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-10-11 03:16:55.68038|2017-10-11 03:16:55.68038
NCT01534429|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-07-07|||February 2011||2011-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Observational|||Quantitative Sensory Testing and Analysis of Post Inguinal Hernia Surgery Pain|Quantitative Sensory Testing and Neurophysiologic Analysis of Post-Herniorraphy Pain in Patients Undergoing Selective Neurectomy and Mesh Removal|Completed||N/A|10|Actual|University of California, Los Angeles|||1||f||||f||||||||No||2017-10-11 03:16:55.867152|2017-10-11 03:16:55.867152
NCT01534403|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-04-11||2016-04-11|January 2012||2012-01-01|April 2016|2016-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects|A Phase 2, Multicenter, Open-label, Long-term, Extension Study to Assess the Safety of Epratuzumab Treatment in Japanese Subjects With Systemic Lupus Erythematosus|Completed||Phase 2|17|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 03:16:56.100514|2017-10-11 03:16:56.100514
NCT01534390|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2015-05-31|||April 2012||2012-04-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2013|Actual|2013-04-01||Interventional|||Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients|The Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients: A Prospective, Randomized, Controlled Trial|Completed||Phase 2|504|Actual|University of Salzburg||2|||f||||f||||||||||2017-10-11 03:16:56.243558|2017-10-11 03:16:56.243558
NCT01534377|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-07-20|||July 2011||2011-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|IPT||Interpersonal Psychotherapy for Adolescent Girls|Prevention of Depression in Maltreated and Nonmaltreated Adolescents|Active, not recruiting||N/A|328|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 03:16:56.381473|2017-10-11 03:16:56.381473
NCT01534364|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-03-24|||January 2012||2012-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|CR_KCH||Brief Title:Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery|Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery|Completed||N/A|82|Actual|University of Cologne||2|||f||||t||||||||||2017-10-11 03:16:56.494372|2017-10-11 03:16:56.494372
NCT01534351|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-05-26|2015-10-29||August 1, 2013|Actual|2013-08-01|May 2017|2017-05-01|November 18, 2013|Actual|2013-11-18|November 18, 2013|Actual|2013-11-18||Interventional|||Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)|A Phase III, Randomized Clinical Trial to Study the Safety and Efficacy of MK-906 (Finasteride) and Tamsulosin Administered Either Alone or Concomitantly in Patients With Benign Prostatic Hyperplasia (BPH)|Terminated||Phase 3|1|Actual|Merck Sharp & Dohme Corp.|The trial was terminated for business reasons.|3||Business Reasons|f||||t||||||||||2017-10-11 03:16:56.632088|2017-10-11 03:16:56.632088
NCT01534338|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-12-10|||February 2012||2012-02-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|MAPS||Effect of Mindfulness Training on Sleep and Inflammation Among Older Adults With Sleep Problems|A Randomized Controlled Trial Testing the Effect of Mindfulness Practices Versus Sleep Education on Sleep and Inflammation Among Older Adults With Sleep Problems|Completed||Phase 1/Phase 2|48|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:16:56.959717|2017-10-11 03:16:56.959717
NCT01534325|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-01-21|||July 2012||2012-07-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy Study for SD Device|Efficacy Study of SD Device for Overweight and Obesity Treatment|Recruiting||N/A|150|Anticipated|Beck Medical Ltd.||3|||f||||t||||||||||2017-10-11 03:16:57.071871|2017-10-11 03:16:57.071871
NCT01534312|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-11-20|||January 2012||2012-01-01|December 2012|2012-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)|Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)|Completed||N/A|24|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:16:57.187505|2017-10-11 03:16:57.187505
NCT01534299|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-04-12|||February 2012||2012-02-01|April 2017|2017-04-01|April 2021|Anticipated|2021-04-01|November 2017|Anticipated|2017-11-01||Observational|||Global SYMPLICITY Registry|Global proSpective registrY for syMPathetic renaL denervatIon in seleCted IndicatIons Through 3 Years Registry|Recruiting||N/A|3000|Anticipated|Medtronic Vascular|||1||f||||f||||||||||2017-10-11 03:16:57.297759|2017-10-11 03:16:57.297759
NCT01534286|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-05-04|||August 2012||2012-08-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics|A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics|Terminated||Phase 4|8|Actual|Targeted Medical Pharma||2||Unable to recruit patients|f||||f||||||||No|Too small data set to draw any conclusions|2017-10-11 03:16:57.416193|2017-10-11 03:16:57.416193
NCT01528904|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-02-05|||January 2001||2001-01-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Observational|||Maternal Autoimmune Thyroid Disease and Fetal Thyroxin|Fetal Thyroid Hormones Concentration In Hyperthyroid or Hypothyroid Pregnant Women|Completed||N/A|83|Actual|University of Belgrade|||3||f||||t||||||||||2017-10-11 03:18:31.513517|2017-10-11 03:18:31.513517
NCT01534260|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-01-30|||February 10, 2012|Actual|2012-02-10|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype|Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype|Recruiting||Phase 1/Phase 2|38|Anticipated|Indiana University||1|||f||||t|t|f||||||||2017-10-11 03:16:57.628574|2017-10-11 03:16:57.628574
NCT01534247|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-09-01|||February 2012||2012-02-01|September 2017|2017-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately|A Phase I, Open-Label, 3-way Crossover, Pharmacokinetic and Drug-Drug Interaction Study of Ceftazidime Avibactam (CAZ-AVI) and Metronidazole When Administered Alone and in Combination in Healthy Subjects|Completed||Phase 1|28|Actual|Pfizer||3|||f||||||||||||||2017-10-11 03:16:57.738395|2017-10-11 03:16:57.738395
NCT01534234|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-11-10|||January 2012||2012-01-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|RESPOND CRT||Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D|Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D|Unknown status|Active, not recruiting|Phase 3|1039|Actual|LivaNova||2|||f||||t||||||||||2017-10-11 03:16:57.870825|2017-10-11 03:16:57.870825
NCT01534221|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-02-15|||March 2012||2012-03-01|February 2012|2012-02-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|COPERNICOS||The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting|Randomized Comparison of Outcome of Stenting in Unselected Patients in Everyday Clinical Practice|Not yet recruiting||Phase 4|5100|Anticipated|Zealand University Hospital||5|||f||||f||||||||||2017-10-11 03:16:58.470038|2017-10-11 03:16:58.470038
NCT01534208|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2014-06-27|2014-06-27||May 2012||2012-05-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Safety population|Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism|An Open Label, Escalating Dose, 6 Month Phase III Safety Study Of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism|Completed||Phase 3|499|Actual|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 03:16:58.661426|2017-10-11 03:16:58.661426
NCT01534195|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-07-10|||January 2012||2012-01-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model|A Phase 4, Randomized, Double-Masked, Single Center, Placebo-Controlled Adaptive Clinical Trial, Using Prednisolone Sodium Phosphate Ophthalmic Solution, 1%, in Subjects With Allergic Conjunctivitis to Evaluate a Modified Conjunctival Allergen Challenge (CAC) Model|Completed||Phase 4|9|Actual|ORA, Inc.||2|||f||||f||||||||||2017-10-11 03:16:59.182679|2017-10-11 03:16:59.182679
NCT01534182|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-08-07|2014-06-11||January 2012||2012-01-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|EPOC||Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)|A 6-month, Randomized, Active Comparator, Open-label, Multi-Center Study to Evaluate Patient Outcomes, Safety and Tolerability of (Fingolimod) 0.5 mg/Day in Patients With Relapsing Remitting Multiple Sclerosis Who Are Candidates for Multiple Sclerosis (MS) Therapy Change From Previous Disease Modifying Therapy (DMT)|Completed||Phase 4|298|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:16:59.279911|2017-10-11 03:16:59.279911
NCT01534169|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-11-08|||March 2012||2012-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|March 2012|Actual|2012-03-01||Interventional|||Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients|Function of Regulatory T Cells Improved by Treatment With an Intrathyroid Injection of Dexamethasone in Graves' Patients|Completed||Phase 1|50|Actual|Nanjing Medical University||1|||f||||t||||||||||2017-10-11 03:16:59.737595|2017-10-11 03:16:59.737595
NCT01534143|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2017-03-08|2013-10-22||February 2012||2012-02-01|March 2017|2017-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant|A Pilot Study Using High Dose Busulfan and Bortezomib as Part of Allogeneic Transplant Conditioning Regimen for High Risk Multiple Myeloma Patients.|Terminated||Phase 2|1|Actual|Barbara Ann Karmanos Cancer Institute|Data was not collected, because funding was unavailable to continue study.|1||Data was not collected, because funding was unavailable to continue study.|f||||t||||||||||2017-10-11 03:17:01.507395|2017-10-11 03:17:01.507395
NCT01534130|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2012-08-06|||April 2011||2011-04-01|August 2012|2012-08-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Acupuncture for the Sleep Disorder of Chronic Fatigue Syndrome|Acupuncture for the Sleep Disorder of Chronic Fatigue Syndrome|Unknown status|Recruiting|N/A|72|Anticipated|Chengdu University of Traditional Chinese Medicine||2|||f||||f||||||||||2017-10-11 03:17:01.901352|2017-10-11 03:17:01.901352
NCT01534117|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-02-15|||October 2009||2009-10-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|ASA/Plavix||Platelet Function Analysis in Head Trauma: ASA/Plavix|Platelet Function Analysis in Head Trauma: ASA/CLOPIDOGREL|Completed||N/A|97|Actual|Chang, Steve S., M.D.||2|||f||||t||||||||||2017-10-11 03:17:02.014154|2017-10-11 03:17:02.014154
NCT01534104|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-08-08|||February 2012|Actual|2012-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning|Using Functional MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning|Recruiting||N/A|175|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:17:02.097896|2017-10-11 03:17:02.097896
NCT01534091|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-04-13|||May 2012||2012-05-01|October 2013|2013-10-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Enhancing the Amount of Physical Activity Carried Out by Overweight Children at Leisure Time|Enhancing the Amount of Physical Activity Carried Out by Overweight Children at Leisure Time|Terminated||N/A|25|Actual|Meir Medical Center||3||Lack of cooperation by the participants|f||||f||||||||||2017-10-11 03:17:02.19492|2017-10-11 03:17:02.19492
NCT01534078|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-08-01|2017-06-07||March 2012|Actual|2012-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2015|Actual|2015-01-01||Interventional|||Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma|Brentuximab Vedotin Plus AVD in Non-bulky Limited Stage Hodgkin Lymphoma|Active, not recruiting||Phase 2|34|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:17:02.302188|2017-10-11 03:17:02.302188
NCT01534065|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-11-07|||April 2009||2009-04-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Barricaid EU Post Market Study for Primary Lumbar Disc Herniation|A Multi-center, Post Marketing Surveillance Study to Monitor the Safety and Performance of the Barricaid® ARD in the Treatment of Back and Radicular Pain Caused by Primary Lumbar Disc Herniation|Completed||Phase 4|45|Actual|Intrinsic Therapeutics||1|||f||||t||||||||||2017-10-11 03:17:03.1362|2017-10-11 03:17:03.1362
NCT01534052|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-07-25|||October 26, 2011|Actual|2011-10-26|July 2017|2017-07-01|April 18, 2017|Actual|2017-04-18|April 18, 2017|Actual|2017-04-18||Interventional|||A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100|A Phase 2 Open-label Extension Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100|Completed||Phase 2|52|Actual|Astellas Pharma Inc||1|||f||||f|t|f||||||||2017-10-11 03:17:03.220582|2017-10-11 03:17:03.220582
NCT01534039|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-09-23|||December 2011||2011-12-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Clinical Comparison of Two Marketed Skin Barriers on Healthy Volunteers|Phase 4-A Clinical Comparison of a Marketed Moldable Skin Barrier Versus a Marketed Stretch-to-Fit Skin Barrier in Healthy Volunteers|Completed||Phase 4|60|Actual|Independent Nurse Consultants LLC||2|||f||||f||||||||||2017-10-11 03:17:03.32682|2017-10-11 03:17:03.32682
NCT01534026|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-05-30|||March 2012||2012-03-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study|Polypharmacy in the Heart Failure Patient: Are All Prescribed Drug Classes Required? Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study|Completed||Phase 4|12|Actual|The Alfred||2|||f||||f||||||||||2017-10-11 03:17:03.442491|2017-10-11 03:17:03.442491
NCT01534013|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-02-15|||August 2011||2011-08-01|February 2012|2012-02-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Clinical Assessment of a Closed-loop Insulin Delivery System|Clinical Assessment of a Closed-loop Insulin Delivery System|Unknown status|Recruiting|N/A|20|Anticipated|Imperial College London||1|||f||||t||||||||||2017-10-11 03:17:03.564816|2017-10-11 03:17:03.564816
NCT01534000|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-06-18|||January 2010||2010-01-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CATCH||Cardiac-CT in the Treatment of Acute Chest Pain|Cardiac-CT in the Treatment of Acute Chest Pain|Completed||N/A|600|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 03:17:03.718041|2017-10-11 03:17:03.718041
NCT01533987|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2012-02-15|||July 2009||2009-07-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Juice Plus+® Supplementation on Endothelial Function in Overweight Men|Effects of Juice Plus+® Supplementation on Endothelial Function in Overweight Men: A Randomized, Controlled Trial|Completed||N/A|70|Actual|Griffin Hospital||2|||f||||f||||||||||2017-10-11 03:17:03.828667|2017-10-11 03:17:03.828667
NCT01533974|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2016-05-13|2016-04-05||June 2011||2011-06-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|PATH||PATH Partnering to Achieve Tobacco-free Health|Acceptance & Commitment Therapy for Smoking Cessation (Aka PATH Study - Partnering to Achieve Tobacco-free Health)|Completed||Phase 1/Phase 2|450|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-11 03:17:03.918878|2017-10-11 03:17:03.918878
NCT01533961|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-09-17|||February 2012||2012-02-01|February 2012|2012-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158|Randomized, Double-blind, Placebo-controlled Sequential Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SCYX-7158 After Single Oral Ascending Doses in Healthy Male Volunteers|Completed||Phase 1|136|Actual|Drugs for Neglected Diseases||2|||f||||f||||||||||2017-10-11 03:17:04.154557|2017-10-11 03:17:04.154557
NCT01533948|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-05-31|||January 2012||2012-01-01|May 2016|2016-05-01||||July 2015|Actual|2015-07-01||Interventional|||Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery|Predictive Markers of Response in a Phase II Trial of Axitinib in Advanced Melanoma|Terminated||Phase 2|25|Actual|Roswell Park Cancer Institute||1||low accrual|f||||t||||||||||2017-10-11 03:17:04.265861|2017-10-11 03:17:04.265861
NCT01533935|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-08-12|2015-06-19|2014-04-30|February 2012||2012-02-01|August 2015|2015-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Treated Set (TS) : This patient set included all patients of the Randomised Set (RS : patients who signed the informed consent form and were also randomised, regardless of whether the patient was treated with study medication or not) who were dispensed study medication and were documented to have taken at least 1 dose of study medication.|Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.|A Randomised, Double-blind, 5 Treatment Arms, 4-period, Incomplete Cross-over Study to Determine the Effect of 6 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (FDC) (2.5 / 5 µg; and 5 / 5 µg) (Delivered by the Respimat® Inhaler) Compared With Tiotropium (5 µg), Olodaterol (5 µg ) and Placebo (Delivered by the Respimat® Inhaler) on Lung Hyperinflation and Exercise Endurance Time During Constant Work Rate Cycle Ergometry in Patients With Chronic Obstructive Pulmonary Disease (COPD) [MORACTO TM 2]|Completed||Phase 3|291|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 03:17:04.410099|2017-10-11 03:17:04.410099
NCT01533922|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-08-12|2015-06-19|2014-04-30|March 2012||2012-03-01|August 2015|2015-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Treated Set (TS) : This patient set included all patients of the Randomised Set (RS : patients who signed the informed consent form and were also randomised, regardless of whether the patient was treated with study medication or not) who were dispensed study medication and were documented to have taken at least 1 dose of study medication.|Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients|A Randomised, Double-blind, 5 Treatment Arms, 4-period, Incomplete Cross-over Study to Determine the Effect of 6 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (FDC) (2.5 / 5 µg; and 5 / 5 µg) (Delivered by the Respimat® Inhaler) Compared With Tiotropium (5 µg), Olodaterol (5 µg ) and Placebo (Delivered by the Respimat® Inhaler) on Lung Hyperinflation and Exercise Endurance Time During Constant Work Rate Cycle Ergometry in Patients With Chronic Obstructive Pulmonary Disease (COPD) [MORACTO TM 1]|Completed||Phase 3|295|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 03:17:05.751964|2017-10-11 03:17:05.751964
NCT00004690|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||September 1996||1996-09-01|March 1999|1999-03-01|September 1998||1998-09-01|||||Interventional|||Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis||Completed||Phase 3|90||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.590536|2017-10-11 04:26:56.590536
NCT01533909|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-12-02|||March 2012||2012-03-01|March 2012|2012-03-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Observational|||Development of a Screening Tool to Detect and Stage Cachectic Cancer Patients|Development of a Screening Tool to Detect and Stage Cachectic Cancer Patients|Completed||N/A|56|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"     The blood sample that will be collected is part of the routine hospital assessment. The     biomarkers that will be measured are albumine, creatine, CRP, hemoglobin and Lactate     dehydrogenase (LDH).   "|||2017-10-11 03:17:06.765929|2017-10-11 03:17:06.765929
NCT01533896|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-02-14|||June 2010||2010-06-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Can a Brief Primary Care Intervention Affect Healthy Weight Habits|Can a Brief Primary Care Intervention Affect Healthy Weight Habits|Completed||N/A|221|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 03:17:06.866819|2017-10-11 03:17:06.866819
NCT01533883|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-08-28|||September 2011||2011-09-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|July 2016|Actual|2016-07-01||Observational|||Cardioband Adjustable Annuloplasty System for Minimally Invasive Mitral Valve Repair|Cardioband Adjustable Annuloplasty System for Minimally Invasive Mitral Valve Repair|Active, not recruiting||N/A|16|Actual|Valtech Cardio Ltd|||1||f||||t||||||||||2017-10-11 03:17:06.966034|2017-10-11 03:17:06.966034
NCT01533870|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-10-13|||March 2012||2012-03-01|October 2014|2014-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118|An Open-label, Fixed-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Rifampin on Pharmacokinetics of NKTR-118 in Healthy Subjects|Completed||Phase 1|22|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 03:17:07.07081|2017-10-11 03:17:07.07081
NCT01533857|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2013-08-12|||February 2012||2012-02-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|February 2012|Actual|2012-02-01||Interventional|||Pharmacokinetic Behavior of Phenolic Acids Derived From Black Tea|Pharmacokinetic Behavior of Phenolic Acids Derived From Black Tea|Completed||N/A|12|Actual|Unilever R&D||2|||f||||f||||||||||2017-10-11 03:17:07.200693|2017-10-11 03:17:07.200693
NCT01533844|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2015-03-03|||March 2012||2012-03-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|DAISY||To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis|An Observational, Non-interventional Study to Determine the Role of Clostridium Difficile in the Pathogenesis of Disease Observed in Neonates and to Investigate the Feasibility of a Potential Study to Evaluate Safety, Efficacy and Pharmacokinetics of Fidaxomicin Oral Suspension in Neonates With Clostridium Difficile Associated Disease (CDAD)|Terminated||N/A|1|Actual|Astellas Pharma Inc|||1|Terminated due to the fact that the required number of trial subjects was not met.|f||||f||||||Samples Without DNA|"     Stool Sample   "|||2017-10-11 03:17:07.300496|2017-10-11 03:17:07.300496
NCT01533831|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2013-02-12|||February 2012||2012-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:17:07.405324|2017-10-11 03:17:07.405324
NCT01533818|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-13|2014-06-02|||May 2012||2012-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|MAT-YI||Community Based Management of Fast Breathing in Infants Aged < 60 Days in Low-income Settlements of Karachi|Community Based Management of Fast Breathing in Infants Aged < 60 Days: A Double-Blind, Randomized Placebo-Controlled Trial in Low-income Settlements of Karachi|Terminated||Phase 4|963|Actual|Aga Khan University||2||"The study was stopped by DSMB based on high treatment failure rate in placebo compared to   active drug."|f||||t||||||||||2017-10-11 03:17:07.465933|2017-10-11 03:17:07.465933
NCT01533805|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-14|||February 2012||2012-02-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Effects of Different Techniques of the Method Pilates in Chronic Low Back Pain|Effects of Different Techniques of the Method Pilates in Chronic Low Back Pain in Women 46 to 60 Years|Unknown status|Not yet recruiting|N/A|40|Anticipated|Universidade Gama Filho||2|||f||||t||||||||||2017-10-11 03:17:07.818417|2017-10-11 03:17:07.818417
NCT01533792|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2012-02-15|||March 2010||2010-03-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|EONSPT||Effect of Non-surgical Periodontal Treatment|Effect of Non-surgical Periodontal Treatment on Pregnant Women With Periodontitis: a Randomized Clinical Trial|Completed||Phase 2|40|Actual|Universidade Federal do Maranhão||2|||f||||f||||||||||2017-10-11 03:17:07.960264|2017-10-11 03:17:07.960264
NCT01533779|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2012-02-14|||February 2012||2012-02-01|February 2012|2012-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Observational|||Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity|Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy for Pediatric Hematological and Solid Tumors, and Its Relation to Other Neutrophil Functions and the Role of NETs in Antitumor Activity|Unknown status|Recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 03:17:08.058389|2017-10-11 03:17:08.058389
NCT01533766|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-02-15|||August 2011||2011-08-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|OMEGA||A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition|A Randomized, Open, Multicenter, Compared Phase III Trial to Evaluate the Safety, Efficacy of CombiflexOmega and SmofKabiven in Postoperative Patients Requiring Parenteral Nutrition|Completed||Phase 3|50|Anticipated|JW Pharmaceutical||2|||f||||||||||||||2017-10-11 03:17:08.154231|2017-10-11 03:17:08.154231
NCT01533753|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-09-10|2014-08-25||February 2012||2012-02-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer|Randomized, Open-Label Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer|Terminated||Phase 2|5|Actual|University of Wisconsin, Madison|The study was terminated due to slow accrual. The data was uninterpretable due to the small numbers of subjects analyzed.|2||Slow accrual|f||||||||||||||2017-10-11 03:17:08.279676|2017-10-11 03:17:08.279676
NCT01533740|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-02-01|||March 2012||2012-03-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients|Observational Study of the Impact of Circulating T Regulatory Cells (Tregs) on Clinical Outcome of Metastatic Colorectal Cancer (MCRC) Patients Treated With Standard Fluorouracil/Irinotecan/Bevacizumab First Line Therapy|Completed||N/A|31|Actual|University of Rome Tor Vergata|||1||f||||f||||||Samples With DNA|"     whole blood sample   "|||2017-10-11 03:17:08.722677|2017-10-11 03:17:08.722677
NCT01533727|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2013-12-05|||August 2011||2011-08-01|February 2012|2012-02-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)|A Phase 2,Open-label Study of Autologous Cytokine-Induced Killer Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Sun Yat-sen University||2||"Few patients would like to participate ,since CIK cell transfusion was a new treatment and its   efficacy was doubted."|f||||t||||||||||2017-10-11 03:17:08.853899|2017-10-11 03:17:08.853899
NCT01533701|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-02-10|||January 2012||2012-01-01|February 2012|2012-02-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|FBS||Scalp Sampling for Fetal Surveillance|Biosampling for Markers of Hypoxia in Fetal Blood Scalp Sampling During Labor|Unknown status|Recruiting|N/A|60|Anticipated|Uppsala University Hospital||1|||f||||f||||||||||2017-10-11 03:17:09.177826|2017-10-11 03:17:09.177826
NCT01533688|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-03-24|||October 2011||2011-10-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Study of Efficacy and Tolerability of Various Bowel Preps in Diabetic Patients|Efficacy and Tolerability of Various Bowel Preparations in Diabetic Patients: A Randomized Controlled Trial|Active, not recruiting||N/A|244|Anticipated|University of Oklahoma||3|||f||||f||||||||||2017-10-11 03:17:09.309987|2017-10-11 03:17:09.309987
NCT01533675|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-05-09|||May 2010||2010-05-01|May 2017|2017-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Comparison Study of the Tensile Strength of Sutures Used in Dermatologic Surgery on the Day of Suture Removal, Following Wound Care With Two Different Products|A Comparison Study of the Tensile Strength of Sutures Used in Dermatologic Surgery on the Day of Suture Removal, Following Wound Care With Two Different|Completed||N/A|40|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 03:17:09.430716|2017-10-11 03:17:09.430716
NCT01533662|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2014-06-20|||March 2011||2011-03-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|PPSA||Prophylactic Phenylephrine Infusion for Preventing Hypotension During Spinal Anesthesia|Phase 2 Study Evaluating the Prophylactic Phenylephrine Infusion for Preventing Hypotension During Spinal Anesthesia for Lower Limb Orthopedic Surgery in the Elderly Patients|Completed||Phase 2|64|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 03:17:09.543473|2017-10-11 03:17:09.543473
NCT01533649|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-02-10|||April 2012||2012-04-01|February 2012|2012-02-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|PHOENICS||Personalizing Health Outcome in Epilepsy Now - An Introduction to Clinical Services|Pilot Trial: Personalizing Health Outcome in Epilepsy Now - An Introduction to Clinical Services|Unknown status|Not yet recruiting|N/A|30|Anticipated|University Health Network, Toronto||3|||f||||t||||||||||2017-10-11 03:17:09.665407|2017-10-11 03:17:09.665407
NCT01533636|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-05-09|||July 2012||2012-07-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|CADET||CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment|CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment to Lung Mucin|Recruiting||N/A|50|Anticipated|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     Samples of induced and expectorated sputum and blood for DNA and RNA extraction, plasma, and     serum will be banked in the UCSF Airway Tissue Bank.   "|||2017-10-11 03:17:09.810921|2017-10-11 03:17:09.810921
NCT01533623|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-06-19||||||June 2013|2013-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The 1 Year Follow-up Objective Oral Appliance Compliance|The 1 Year Follow-up of Objective Measures of Oral Appliance Compliance for Treatment of Sleep-disordered Breathing (SDB): a Clinical Trial|Completed||N/A|51|Actual|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-11 03:17:09.915105|2017-10-11 03:17:09.915105
NCT01533610|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2012-02-14|||February 2012||2012-02-01|February 2012|2012-02-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||The Efficacy of Stellate Ganglion Block as Post-traumatic Stress Disorder (PTSD) Therapy: A Pilot Study|The Efficacy of Stellate Ganglion Block as PTSD Therapy: A Pilot Study|Unknown status|Recruiting|Phase 2|12|Anticipated|Southern California Institute for Research and Education||1|||f||||f||||||||||2017-10-11 03:17:10.007277|2017-10-11 03:17:10.007277
NCT01533597|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-01-24|2015-01-11||December 2010||2010-12-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)|Comparison of the Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With OAB: A Prospective Randomized Multicenter Study|Completed||Phase 4|70|Actual|Soonchunhyang University Hospital|small study population|2|||f||||f||||||||||2017-10-11 03:17:10.143334|2017-10-11 03:17:10.143334
NCT01533584|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-09-09|||March 2012||2012-03-01|September 2012|2012-09-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Observational|||Evaluation of Nocturnal Hypertension and Correlation With Target-Organ Damage|Evaluation of Nocturnal Hypertension With 24-hour Ambulatory or Home Blood Pressure Measurement: Correlation With Target-Organ Damage|Unknown status|Recruiting|N/A|100|Anticipated|University of Athens|||1||f||||f||||||||||2017-10-11 03:17:10.54408|2017-10-11 03:17:10.54408
NCT01533571|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-03-06|||January 2014||2014-01-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||Immediate Implant Placement in the Esthetic Zone|Immediate Implant Placement After Tooth Extraction in the Esthetic Zone: Extraction Socket Morphology-Guided Treatment Modalities and Esthetic Outcome|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Lithuanian University of Health Sciences||2|||f||||f||||||||||2017-10-11 03:17:10.61943|2017-10-11 03:17:10.61943
NCT01533558|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2013-08-28|||January 2012||2012-01-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Observational|CASCADE||Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates|Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates|Completed||N/A|20|Actual|Radboud University|||1||f||||f||||||Samples Without DNA|"     Plasma samples for determination of caspofungin   "|||2017-10-11 03:17:10.743213|2017-10-11 03:17:10.743213
NCT01533545|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-04-15|||September 2012||2012-09-01|April 2014|2014-04-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients|Effect of Epinephrine on Systemic Absorption of Mepivacaine Administered for Brachial Plexus Block in Patients With Chronic Renal Insufficiency|Terminated||N/A|16|Actual|Rigshospitalet, Denmark||2||Slow recruitment|f||||t||||||||||2017-10-11 03:17:10.844723|2017-10-11 03:17:10.844723
NCT01533532|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2014-05-29||||||May 2014|2014-05-01||||||||Interventional|||A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)|A Multicenter, Randomized, Placebo-controlled, Double-blind Phase II Study of KLH-2109 in Patients With Endometriosis(2)|Completed||Phase 2|100||Kissei Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-11 03:17:10.940059|2017-10-11 03:17:10.940059
NCT01533519|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-04-13|||December 2012||2012-12-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)|A Dose Escalation Study of Intranasal Neuropeptide Y in PTSD|Completed||Phase 1|26|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 03:17:11.041043|2017-10-11 03:17:11.041043
NCT01533506|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-02-26|||February 2012||2012-02-01|February 2013|2013-02-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Expanded Access|||Stiripentol in Dravet Syndrome|Compassionate Use of Stiripentol in Intractable Epilepsy Due to Dravet Syndrome|No longer available||N/A|||Mayo Clinic|||||||||f||||||||||2017-10-11 03:17:11.132334|2017-10-11 03:17:11.132334
NCT01533493|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-03-10|2013-11-04||May 2012||2012-05-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study|Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study|Completed||N/A|33|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:17:11.23351|2017-10-11 03:17:11.23351
NCT01533480|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-03-30|||January 2012||2012-01-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis|A Prospective, Double-masked, Placebo Controlled Comparison of Topical 0.15% Ganciclovir Gel (Zirgan®) Versus 0.3% Hypromellose Gel (Genteal Gel®; Placebo) for the Treatment of Adenovirus Conjunctivitis|Unknown status|Recruiting|Phase 4|80|Anticipated|Lifelong Vision Foundation||2|||f||||f||||||||||2017-10-11 03:17:11.554714|2017-10-11 03:17:11.554714
NCT01533467|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-02-12|||November 2010||2010-11-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Device Designed to Protect the Perineum During Labor|Study of Perineal Protection Device|Completed||Phase 2|1200|Actual|Helsingborgs Hospital||2|||f||||f||||||||||2017-10-11 03:17:11.676228|2017-10-11 03:17:11.676228
NCT01533454|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2016-01-03|||September 2012||2012-09-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Randomized Incentive-Based Weight Loss Trial in Singapore|A Randomized Incentive-Based Weight Loss Trial in Singapore|Completed||N/A|161|Actual|Duke-NUS Graduate Medical School||2|||f||||f||||||||||2017-10-11 03:17:11.843163|2017-10-11 03:17:11.843163
NCT01533441|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2014-04-07|||February 2012||2012-02-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|SAFEK||Vitamin K2 Intervention in Patients With Vitamin K Antagonists|Study of the Effect of Food Vitamin K2 Intake in Association With a Fermented Dairy Product on Patients Treated With Vitamin K Antagonist (VKA)|Completed||Phase 2|50|Actual|Danisco||4|||f||||f||||||||||2017-10-11 03:17:12.047369|2017-10-11 03:17:12.047369
NCT01533428|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-12|2015-10-12|2015-02-06||February 2012||2012-02-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|STEP|Safety Analysis Set|A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)|A Phase III, Double-blind, Randomized, Placebo-controlled, Multicenter Study Evaluating the Efficacy and Safety of QUTENZA® in Subjects With Painful Diabetic Peripheral Neuropathy|Completed||Phase 3|369|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||f||||||||||2017-10-11 03:17:12.209999|2017-10-11 03:17:12.209999
NCT01533415|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2013-04-05|||February 2012||2012-02-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Use of Alpha-Stim Cranial-electrotherapy Stimulation (CES) in the Treatment of Anxiety|The Efficacy of Cranial-electrotherapy Stimulation (CES) Using Alpha-Stim Technology in The Treatment of Anxiety Disorders|Completed||Phase 4|115|Actual|Wyndhurst Counseling Center||2|||f||||f||||||||||2017-10-11 03:17:13.684932|2017-10-11 03:17:13.684932
NCT01533402|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2014-09-08|||February 2012||2012-02-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|||Internet-delivered Cognitive Behavior Therapy (CBT) for Children Age 8-12 Years With Anxiety Disorders|Internet-delivered Cognitive Behavior Therapy (CBT) Treatment for Anxiety Disorders in Children Age 8-12 Years - a Randomised Controlled Trial|Completed||N/A|128|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:17:13.824378|2017-10-11 03:17:13.824378
NCT01533389|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2013-11-18|||October 2011||2011-10-01|November 2013|2013-11-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|STONE||Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones|A 4-week, Double-blind, Randomized, Comparative and Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones.|Completed||Phase 4|114|Actual|JW Pharmaceutical||2|||f||||f||||||||||2017-10-11 03:17:13.937608|2017-10-11 03:17:13.937608
NCT01533376|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2017-05-12|||February 2012||2012-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol|Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol|Recruiting||Phase 1|10|Anticipated|Wills Eye||2|||f||||t||||||||No||2017-10-11 03:17:14.058307|2017-10-11 03:17:14.058307
NCT01533363|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2012-02-11|||July 2000||2000-07-01|February 2012|2012-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study About Patient Comfort and Long-term Outcome After Stapled Hemorrhoidopexy|Patient Comfort After Stapled Hemorrhoidopexy Long Term Results of a Randomized Controlled Trial|Completed||Phase 3|130|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 03:17:14.207898|2017-10-11 03:17:14.207898
NCT01533350|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-15|||September 2010||2010-09-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Receptivity Assessment of Homogeneous Endometrium in Late Follicle Phase|Receptivity Assessment of Homogeneous Endometrium in Late Follicle Phase of Infertile Women With Natural Cycles|Completed||Phase 1|28|Actual|Shen-Zhen City Maternity and Child Healthcare Hospital|||2||f||||t||||||Samples Without DNA|"     The specimen was divided into three parts after washing with sterilized saline, and one was     ﬁxed by 2.5% glutaraldehyde solution immediately ，then coated with palladium gold for     electron microscopic examination;one was fixed by 2.5% glutaraldehyde arsenate ,then embedded     in Epon for transmission electron microscopy ; one was ﬁxed by 4% formalin, then embedded in     parafﬁn for immunohistochemical analysis.   "|||2017-10-11 03:17:14.293023|2017-10-11 03:17:14.293023
NCT01533337|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-02-14|||May 2007||2007-05-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|May 2009|Actual|2009-05-01||Interventional|||Use of the Free Dorsal Digital Flap Including Both Dorsal Branches of the Proper Digital Nerves for Reconstruction of Volar Soft Tissue Defect of Digits||Completed||N/A|12|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 03:17:14.383352|2017-10-11 03:17:14.383352
NCT01533324|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-02-14|||November 2011||2011-11-01|February 2012|2012-02-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)|Phase II Study of S-1 Combined With Calcium Folinate to Treat Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|32|Anticipated|Second Military Medical University||1|||f||||t||||||||||2017-10-11 03:17:14.462131|2017-10-11 03:17:14.462131
NCT01533311|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2012-02-14|||January 2009||2009-01-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Prevalence and Characteristics of Nonpolypoid Colorectal Neoplasms - A Chinese Cohort Study|Prevalence and Characteristics of Nonpolypoid Colorectal Neoplasms - A Chinese Cohort Study|Completed||N/A|1342|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples Without DNA|"     All the lesions will be removed endoscopically or surgically and examined histologically by     an independent gastrointestinal pathologist.      Histological diagnosis is determined according to the World Health Organization (WHO)     criteria.Pedunculated lesions are categorized according to Haggitt's classification.   "|||2017-10-11 03:17:14.574584|2017-10-11 03:17:14.574584
NCT01533298|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-02-15|||July 2011||2011-07-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|OMEGA||A Safety, Efficacy Study of CombiflexOmega Peri Versus SmofKabiven Peripheral in Patients With Parenteral Nutrition|A Randomized, Open, Multicenter, Compared Phase III Trial to Evaluate the Safety, Efficacy of CombiflexOmega Peri and SmofKabiven Peripheral in Postoperative Patients Requiring Parenteral Nutrition|Completed||Phase 3|50|Anticipated|JW Pharmaceutical||2|||f||||||||||||||2017-10-11 03:17:14.630679|2017-10-11 03:17:14.630679
NCT01533285|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-03-27|||May 2012||2012-05-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients|A 2-way Crossover Study to Explore the Effect of an Inflammatory and Psychosocial Stressor and a Combination Thereof on the Mood and Cytokine Levels in Young and Elderly Healthy Female Subjects and Female Subjects With Major Depressive Disorder|Completed||Early Phase 1|40|Actual|Janssen Pharmaceutica N.V., Belgium||6|||f||||f||||||||||2017-10-11 03:17:14.724837|2017-10-11 03:17:14.724837
NCT01533272|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2015-03-31|||February 2012||2012-02-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)|Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: TENOFOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC|Completed||Phase 4|240|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 03:17:14.849999|2017-10-11 03:17:14.849999
NCT01533259|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-01-16|2015-01-16|2013-11-19|January 2012||2012-01-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|November 2012|Actual|2012-11-01||Interventional||Safety Analysis Set: participants who received at least one dose of study drug.|Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients|A Phase 3B Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination (FTC/TDF) to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate (EVG/COBI/FTC/TDF) Single-Tablet Regimen (STR) in Virologically Suppressed, HIV-1 Infected Patients|Completed||Phase 3|48|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 03:17:14.948806|2017-10-11 03:17:14.948806
NCT01533246|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2015-03-02|2015-03-02||February 2012||2012-02-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||Patients that received treatment.|Linsitinib in Treating Patients With Asymptomatic or Mildly Symptomatic Metastatic Prostate Cancer|A Phase 2 Study of OSI-906 in Patients With Asymptomatic or Mildly Symptomatic (Non-Opioid Requiring) Metastatic Castrate Resistant Prostate Cancer (CRPC)|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:17:15.385187|2017-10-11 03:17:15.385187
NCT01533233|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-15|2013-10-27|||February 2011||2011-02-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients|Safety and Results of Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients.|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 03:17:15.825074|2017-10-11 03:17:15.825074
NCT01533220|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-09-24|||June 2013||2013-06-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal|A Randomized, Double-blind, Prospective, Monocentric, Superior Efficacy and Safety of Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal Due to Colds or Other Upper Respiratory Allergies|Unknown status|Active, not recruiting|Phase 3|212|Anticipated|EMS||2|||f||||t||||||||||2017-10-11 03:17:15.919733|2017-10-11 03:17:15.919733
NCT01533207|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2017-08-23|||June 4, 2012|Actual|2012-06-04|August 2017|2017-08-01||||June 30, 2018|Anticipated|2018-06-30||Interventional|||Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery|A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) Versus Observation for Uterus-Limited, High-Grade Uterine Leiomyosarcoma|Active, not recruiting||Phase 3|216|Anticipated|Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 03:17:16.074548|2017-10-11 03:17:16.074548
NCT01533194|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2015-04-14|||April 2012||2012-04-01|December 2014|2014-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase 1 Study of Reolysin Alone in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:17:17.642776|2017-10-11 03:17:17.642776
NCT01533181|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2015-12-10|2015-12-10||February 2012||2012-02-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||All participants|Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer|Randomized Phase II Study of Single Agent OSI-906, an Oral, Small Molecule, Tyrosine Kinase Inhibitor (TKI) of the Insulin Growth Factor-1 Receptor (IGF-1R) Versus Topotecan for the Treatment of Patients With Relapsed Small Cell Lung Cancer (SCLC)|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 03:17:17.773768|2017-10-11 03:17:17.773768
NCT01533168|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-05-17|||February 2012||2012-02-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia|Next-Generation Sequencing of Immunoglobulin Heavy Chain Variable Region to Identify Previously Undetectable Minimal Residual Disease in Children With Acute Lymphoblastic Leukemia With Prognostic Significance|Completed||N/A|12|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     cell samples   "|||2017-10-11 03:17:18.780025|2017-10-11 03:17:18.780025
NCT01533155|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-10-13|||March 2012||2012-03-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118|A Randomized, 2-Part, Crossover, Single Center Study to Evaluate Effect of Quinidine on the Pharmacokinetics of NKTR-118 and the Concomitant Effect of Quinidine and NKTR-118 on Morphine-induced Miosis|Completed||Phase 1|214|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 03:17:18.870915|2017-10-11 03:17:18.870915
NCT01533142|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-02-17|||February 2012||2012-02-01|February 2016|2016-02-01||||December 2016|Anticipated|2016-12-01||Observational|FatWest||Bariatric Surgery on the West Coast of Norway (Vestlandet)|Bariatric Surgery on the West Coast of Norway (Vestlandet): Prospective Study of Overweight People Undergoing Bariatric Surgery|Recruiting||N/A|400|Anticipated|Helse Fonna|||2||f||||f||||||Samples With DNA|"     Plasma, serum, urine and biopsi from fat   "|||2017-10-11 03:17:18.965948|2017-10-11 03:17:18.965948
NCT01533129|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-02-14|||August 2008||2008-08-01|February 2012|2012-02-01||||April 2011|Actual|2011-04-01||Interventional|||The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism|Phase 4 Study That Evaluates the Effects of Two Different Testosterone Replacement Regiments on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Subjects With Hypogonadotrophic Hypogonadism.|Completed||Phase 4|106|Actual|Gulhane School of Medicine||2|||f||||f||||||||||2017-10-11 03:17:19.059892|2017-10-11 03:17:19.059892
NCT01533116|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-10-14|2015-07-22||March 2009||2009-03-01|October 2015|2015-10-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide|Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa and 100/25 mg Levodopa/Benserazide in Healthy Subjects|Completed||Phase 1|52|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 03:17:19.160237|2017-10-11 03:17:19.160237
NCT01532336|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2015-05-26|||May 2012||2012-05-01|July 2014|2014-07-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|BAYnovation™||Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis|A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis|Completed||Phase 2|500|Actual|NovaBay Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:17:21.623506|2017-10-11 03:17:21.623506
NCT01532323|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-09-18|||December 2011||2011-12-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|ORALISENS||Oral Sphere: Salivary Markers and Food. A Prospective Study in Children Expressing Oral Disorders|Oral Sphere: Salivary Markers and Food. A Prospective Study in Children Expressing Oral Disorders|Completed||N/A|44|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:17:21.849535|2017-10-11 03:17:21.849535
NCT01532310|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-08-08|||July 16, 2012|Actual|2012-07-16|August 2017|2017-08-01|November 26, 2021|Anticipated|2021-11-26|November 26, 2021|Anticipated|2021-11-26|9 Years|Observational [Patient Registry]|||Belimumab (BENLYSTA®) Pregnancy Registry|WEUKBRE6076: Belimumab (BENLYSTA) Pregnancy Registry Protocol|Recruiting||N/A|500|Anticipated|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 03:17:21.964587|2017-10-11 03:17:21.964587
NCT01532297|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-06-05|||October 2011||2011-10-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Application of Citrate Dialysate in Chronic Haemodialysis|Application of Citrate Dialysate in Chronic Haemodialysis|Completed||N/A|95|Actual|Fresenius Medical Care Deutschland GmbH||6|||f||||f||||||||||2017-10-11 03:17:22.079991|2017-10-11 03:17:22.079991
NCT01532284|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-11-23|||February 2012||2012-02-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|December 2016|Anticipated|2016-12-01||Interventional|ESTEEM||The Eshre Study Into The Evaluation of Oocyte Euploidy by Microarray Analysis|The Eshre Study Into The Evaluation of Oocyte Euploidy by Microarray Analysis|Recruiting||N/A|600|Anticipated|European Society of Human Reproduction and Embryology||2|||f||||t||||||||||2017-10-11 03:17:22.199098|2017-10-11 03:17:22.199098
NCT01532271|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2014-04-03|||February 2012||2012-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Observational|||Comparison of Brain Network Activation (BNA™) Analysis, Clinical Symptoms and Neuro-cognitive Performance in Concussed Children and Young Adults|Comparison of Brain Network Activation Analysis (BNA™) Using Evoked Response Potentials, Clinical Symptoms and Neuro-cognitive Performance and Symptoms in Concussed Children, Young Adults and Matched Controls|Completed||N/A|146|Actual|ElMindA Ltd|||2||f||||f||||||||||2017-10-11 03:17:23.823764|2017-10-11 03:17:23.823764
NCT01532258|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2013-07-29|||April 2012||2012-04-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effectiveness of an Eight Week Online Mediterranean Based Diet|Effectiveness of an Eight Week Online Mediterranean Based Diet in an Overweight or Obese Outpatient Primary Care Population|Withdrawn||N/A|0|Actual|The Cleveland Clinic||3||Online program required re-design|f||||f||||||||||2017-10-11 03:17:23.944147|2017-10-11 03:17:23.944147
NCT01532245|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-12-15|||December 2011||2011-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||The Use of Constant-flow Technique for Determining the Lower Inflexion Point of Pressure-volume Curve and Intrinsic PEEP During One-lung Ventilation||Active, not recruiting||N/A|40|Anticipated|The Cleveland Clinic||3|||f||||||||||||||2017-10-11 03:17:24.027191|2017-10-11 03:17:24.027191
NCT01532232|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2015-12-22|||February 2012||2012-02-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)|Treatment of Tobacco Dependence in Breast Cancer Patients: A Randomized Trial of Varenicline (Chantix)|Terminated||N/A|7|Actual|Memorial Sloan Kettering Cancer Center|||2|Lack of accrual|f||||||||||Samples Without DNA|"     saliva samples   "|||2017-10-11 03:17:24.101268|2017-10-11 03:17:24.101268
NCT01532219|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-04-23|||February 2012||2012-02-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ATLAS||Internet-delivered Psychodynamic Therapy for Depression and Anxiety Disorders|Internet-delivered Psychodynamic Therapy for Depression and Anxiety Disorders: A Randomized Controlled Trial|Completed||N/A|100|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-11 03:17:24.187659|2017-10-11 03:17:24.187659
NCT01533103|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2013-08-20|||March 2012||2012-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:17:24.268316|2017-10-11 03:17:24.268316
NCT01533090|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-11|||April 2010||2010-04-01|March 2010|2010-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|LowVolumePEG||Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy|Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy|Completed||N/A|162|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-10-11 03:17:24.303748|2017-10-11 03:17:24.303748
NCT01533077|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-11-18|2015-07-22||March 2009||2009-03-01|November 2015|2015-11-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|||Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa|Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa in Healthy Subjects|Completed||Phase 1|18|Actual|Bial - Portela C S.A.||4|||f||||f||||||||||2017-10-11 03:17:24.395745|2017-10-11 03:17:24.395745
NCT01533064|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-11|2012-02-14|||March 2011||2011-03-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|||||Observational|||Response of Psychiatric Outpatients to the Great East Japan Earthquake|Response of Psychiatric Outpatients to the Great East Japan Earthquake|Completed||N/A|328|Actual|Ashikaga Red Cross Hospital|||1||f||||t||||||||||2017-10-11 03:17:25.308525|2017-10-11 03:17:25.308525
NCT01533051|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-05-07|||February 2012||2012-02-01|May 2012|2012-05-01|March 2016|Anticipated|2016-03-01|March 2015|Anticipated|2015-03-01||Observational|||Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B|Phase IV Study of Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B|Unknown status|Recruiting|N/A|100|Anticipated|Yonsei University|||1||f||||t||||||Samples Without DNA|"     Initially, 30ml of heparinized peripheral blood will be obtained from each subjects. After     then, 10ml of heparinized peripheral blood will be additionaly obtained at every 3 months     follow-up visit.   "|||2017-10-11 03:17:25.382562|2017-10-11 03:17:25.382562
NCT01533038|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-06-22|2015-10-22||February 2012||2012-02-01|June 2017|2017-06-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|BPH-6||BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia|BPH-6: A UroLift® System Post Market Multi-Center Randomized Study|Completed||N/A|80|Actual|NeoTract, Inc.||2|||f||||f||||||||No||2017-10-11 03:17:25.485239|2017-10-11 03:17:25.485239
NCT01533025|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-02-14|||August 2008||2008-08-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Single Bundle Anterior Cruciate Ligament Reconstruction in Active Young Men|Single Bundle Anterior Cruciate Ligament Reconstruction in Active Young Men: Free Tendon Achilles Allograft vs. Bone-tendon Achilles Allograft|Completed||N/A|72|Actual|National Police Hospital||2|||f||||t||||||||||2017-10-11 03:17:25.82875|2017-10-11 03:17:25.82875
NCT01533012|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-14|||November 2011||2011-11-01|February 2012|2012-02-01||||April 2012|Anticipated|2012-04-01||Interventional|||Initial Positioning of Left Sided Double Lumen Endobronchial Tubes Using Peak Inspiratory Pressures Difference Between Two Lungs|Initial Positioning of Left Sided Double Lumen Endobronchial Tubes Using Peak Inspiratory Pressures Difference Between Two Lungs|Unknown status|Recruiting|N/A|100|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 03:17:25.905904|2017-10-11 03:17:25.905904
NCT01532999|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-04-06|2015-03-06||January 2012||2012-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Multisite Randomized Controlled Trial of Mindfulness Meditation Therapy for PTSD|A Multisite Randomized Controlled Trial of Mindfulness Meditation Therapy for PTSD|Completed||N/A|254|Actual|VA Office of Research and Development|Limitations: PCGT may be more active than originally anticipated and is thus an active control rather than neutral control|2|||f||||t||||||||||2017-10-11 03:17:25.993983|2017-10-11 03:17:25.993983
NCT01532986|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-08-02|||July 9, 2012|Actual|2012-07-09|August 2017|2017-08-01|April 30, 2017|Actual|2017-04-30|January 31, 2017|Actual|2017-01-31||Interventional|CHAPS||"Randomized Trial to Test the Coordinated Care for Health Promotion and Activities in Parkinson's Disease Intervention in the Veterans Administration"|Improving Quality of Care in Parkinson's Disease: A Randomized Controlled Trial|Completed||N/A|345|Actual|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 03:17:26.500161|2017-10-11 03:17:26.500161
NCT01532973|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-10-03|2016-10-03||February 2012||2012-02-01|October 2016|2016-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||All enrolled participants who received at least one dose of study drug. Participants who received placebo in Part 1, 2, or 3 are grouped together regardless of HCV GT or randomly assigned panel. 2 Panels (Panel D in Part 1 and Panel H in Part 2) were planned but not performed. No participants were enrolled in either of these panels.|Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002)|A Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8742 in Hepatitis C Infected Males|Completed||Phase 1|48|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-10-11 03:17:26.777878|2017-10-11 03:17:26.777878
NCT01532960|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2016-08-11|||July 2012||2012-07-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|Breast 41||Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer|A Pilot Study of the Immunogenicity of a 9-Peptide Breast Cancer Vaccine Plus Poly-ICLC in Stage I-IV Breast Cancer|Terminated||Phase 1|11|Actual|University of Virginia||1||"Futility for immune responses to the vaccine. Also, a component of study drug was in short   supply."|f||||t||||||||||2017-10-11 03:17:28.172225|2017-10-11 03:17:28.172225
NCT01532947|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2012-02-10|||January 2003||2003-01-01|February 2012|2012-02-01||||June 2005|Actual|2005-06-01||Interventional|||Randomized Controlled Trial of Fiber Post Restorations|Survival of Endodontically Treated and Restored Premolars: A Randomized Controlled Trial|Completed||N/A|360|Actual|University of Siena||2|||f||||f||||||||||2017-10-11 03:17:28.271398|2017-10-11 03:17:28.271398
NCT01532934|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-10-19|2015-10-06||August 2009||2009-08-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Participants were adults in an urban pretrial jail diversion program in Upstate New York recruited between 2009 and 2014 subsequent to being charged with a crime.|The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention|The Impact of Psychopathic Traits on the Efficacy of a Brief Intervention for Substance Use|Completed||Phase 2|105|Actual|University of Rochester||2|||f||||t||||||||No||2017-10-11 03:17:28.350207|2017-10-11 03:17:28.350207
NCT01532908|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-04-24||2016-07-13|May 2012||2012-05-01|April 2017|2017-04-01|August 27, 2015|Actual|2015-08-27|August 27, 2015|Actual|2015-08-27||Interventional|MBL-HCV1||Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C|A Phase II Open-Label Study of the Clinical Effectiveness of a Human Monoclonal Antibody Against Hepatitis C Virus E2 Glycoprotein (MBL-HCV1) Combined With Oral Direct-Acting Antivirals in Hepatitis C Infected Patients Undergoing Liver Transplantation|Terminated||Phase 2|10|Actual|MassBiologics||2||The study was terminated due to funding constraints|f||||f||||||||||2017-10-11 03:17:29.090324|2017-10-11 03:17:29.090324
NCT01532895|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-03-15|||September 2011||2011-09-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|||Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid|Clinical Usefulness and Quality of Life of OROS Hydromorphone in Strong Opioid-Naïve Cancer Pain Patients; Multicenter, Prospective, Open-Label and Observational Study|Completed||Phase 4|400|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-10-11 03:17:29.24934|2017-10-11 03:17:29.24934
NCT01532882|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2013-04-26|||January 2012||2012-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|EDEN||Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs|Assessment of the Efficacy and Safety of Diosmin 600mg on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs: a Multicentric, Randomised, Double-blind, Placebo-controlled Trial in Parallel Groups|Completed||Phase 3|378|Actual|Laboratoire Innotech International||2|||f||||f||||||||||2017-10-11 03:17:29.423197|2017-10-11 03:17:29.423197
NCT01532869|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-08-02|2015-10-08||March 2012||2012-03-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|January 2014|Actual|2014-01-01||Interventional||Safety population included all participants who received any study drug and provided at least one post-dose safety assessment (withdrawal, adverse event [AE], death, laboratory assessment, vital signs).|A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis|A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-controlled Study To Assess The Efficacy And Safety Of Tocilizumab Versus Placebo In Patients With Systemic Sclerosis|Completed||Phase 3|87|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 03:17:29.582275|2017-10-11 03:17:29.582275
NCT01532856|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-02-14|||January 2007||2007-01-01|February 2012|2012-02-01|June 2012|Anticipated|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years|Iberoamerican Phase III International Study, Open, Multicenter, Randomized, Comparative of Thalidomide / Cyclophosphamide / Dexamethasone Versus Thalidomide / Dexamethasone Versus Thalidomide / Melphalan / Prednisone as Induction Therapy Followed by Maintenance Therapy With Thalidomide + Prednisone Versus Thalidomide Alone in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65years.|Unknown status|Active, not recruiting|Phase 3|64|Actual|Grupo de Estudos Multicentricos em Onco-Hematologia||3|||f||||t||||||||||2017-10-11 03:17:31.792095|2017-10-11 03:17:31.792095
NCT01532843|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-01-22|||June 2012||2012-06-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|PEGON||Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B|Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B (PEGON-study)|Completed||Phase 4|82|Actual|Foundation for Liver Research||2|||f||||f||||||||No||2017-10-11 03:17:31.890059|2017-10-11 03:17:31.890059
NCT01532830|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2014-08-04|||February 2012||2012-02-01|August 2014|2014-08-01||||July 2012|Actual|2012-07-01||Interventional|||Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine|Non-Invasive Neurostimulation of the Vagus Nerve With the GammaCore Device For the Relief of Symptoms Associated With Migraine|Completed||N/A|30|Actual|ElectroCore LLC|||||f||||||||||||||2017-10-11 03:17:31.999941|2017-10-11 03:17:31.999941
NCT01532817|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2012-05-25|||January 2012||2012-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Device|Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore™ Device, for the Relief of Acute Bronchoconstriction Due to Asthma|Completed||Phase 2|30|Actual|ElectroCore LLC||1|||f||||||||||||||2017-10-11 03:17:32.074195|2017-10-11 03:17:32.074195
NCT01532609|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-02-09|||March 2009||2009-03-01|March 2009|2009-03-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|MMT1||Methadone Maintenance and HIV Prevention: A Window of Opportunity in China|Methadone Maintenance and HIV Prevention: A Window of Opportunity in China Version|Completed||N/A|220|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:17:35.357415|2017-10-11 03:17:35.357415
NCT01532804|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-08-16|||July 2011||2011-07-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|BEVATOMOX||2nd-line Treatment of Metastatic Colorectal Cancer|A Multicenter Randomized Phase 2 Trial to Evaluate the Triplet Combination of Raltitrexed, Oxaliplatin and Bevacizumab Versus FOLFOX6 Plus Bevacizumab in Second-line Treatment of Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|83|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||t||||||||||2017-10-11 03:17:32.145912|2017-10-11 03:17:32.145912
NCT01532791|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-08-10|||July 2004||2004-07-01|August 2016|2016-08-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Observational|||Natural History Study - Mitochondrial Disease|Mitochondrial Encephalomyopathies and Mental Retardation: Investigations of Clinical Syndromes Associated With MtDNA Point Mutations|Recruiting||N/A|300|Anticipated|Columbia University|||2||f||||f||||||None Retained|"     skin fibroblast blood urine buccal cells hair samples   "|Yes|When applicable, manuscript(s) regarding data will be submitted for publication|2017-10-11 03:17:32.242427|2017-10-11 03:17:32.242427
NCT01532778|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-09-22|||January 2011||2011-01-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|SensInFat||Saliva Modification Related to Fat Perception in Human|Perception Ortho-nasale du Gras Chez l'Homme Sain : Relations Entre Typages olfactométriques, Sensoriels et Composition de la Salive.|Completed||N/A|40|Actual|Centre des Sciences du Goût et de l'Alimentation|||1||f||||f||||||||No||2017-10-11 03:17:32.340384|2017-10-11 03:17:32.340384
NCT01532765|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-12-03|||September 2011||2011-09-01|December 2015|2015-12-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|||Randomized Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Removal|A Multicentre Randomized Clinical Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Peeling|Recruiting||N/A|80|Anticipated|Sunnybrook Health Sciences Centre||4|||f||||f||||||||||2017-10-11 03:17:32.406181|2017-10-11 03:17:32.406181
NCT01532752|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2013-07-31|||December 2011||2011-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:17:32.563513|2017-10-11 03:17:32.563513
NCT01532739|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2016-08-08|||April 2012||2012-04-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Making Memory Better for Seniors With Mild Cognitive Impairment|Neuropsychological Intervention for a Seniors Mental Health Population With Mild Cognitive Impairment|Active, not recruiting||N/A|40|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 03:17:32.610537|2017-10-11 03:17:32.610537
NCT01532726|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-10|2017-01-05|||March 2012||2012-03-01|January 2017|2017-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)|A Non-Interventional, Prospective Study to Assess Seizure Control and Tolerability of Eslicarbazepine Acetate as Adjunctive Therapy to One Baseline Antiepileptic Drug, in Adults With Partial-Onset Seizures With or Without Secondary Generalization|Completed||N/A|56|Actual|Bial - Portela C S.A.|||1||f||||f||||||||||2017-10-11 03:17:32.713001|2017-10-11 03:17:32.713001
NCT01532713|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-03-04|||January 2012||2012-01-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of Oxygen Administration on Regional Cerebral Oxygen Saturation (rSO2) in the Non-block Side After Stellate Ganglion Block||Completed||N/A|38|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 03:17:32.814068|2017-10-11 03:17:32.814068
NCT01532700|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-10-31|||February 2012||2012-02-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|||An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)||Active, not recruiting||Phase 2|28|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 03:17:32.893349|2017-10-11 03:17:32.893349
NCT01532687|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-05-01|||March 2012||2012-03-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma|A Randomized, Double-Blind Phase II, Study of Gemcitabine Alone or in Combination With Pazopanib for Refractory Soft Tissue Sarcoma|Recruiting||Phase 2|80|Anticipated|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-10-11 03:17:33.142395|2017-10-11 03:17:33.142395
NCT01532661|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2014-11-17|||April 2008||2008-04-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|NOVO7||National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology|National Registry of rFVIIa (Novoseven) in Haemorrhagic Traumatology|Completed||N/A|114|Actual|University Hospital, Grenoble|||1||f||||t||||||||||2017-10-11 03:17:33.441857|2017-10-11 03:17:33.441857
NCT01532648|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-03-27|||February 2012||2012-02-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Randomized Placebo Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 mg in Patients With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA).||Completed||Phase 3|509|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 03:17:33.656839|2017-10-11 03:17:33.656839
NCT01532635|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-10-19|2014-11-03||March 2012||2012-03-01|October 2016|2016-10-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives|A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using Two Related Donors|Terminated||Phase 2|4|Actual|Thomas Jefferson University|Study was terminated due to poor accrual. No reportable data has been collected.|1||Slow accrual|f||||t||||||||||2017-10-11 03:17:34.016146|2017-10-11 03:17:34.016146
NCT01532622|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2013-10-18|||January 2012||2012-01-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Impact of Blueberries on Uric Acid and Quality of Life|Impact of Blueberries on Uric Acid and Quality of Life|Completed||N/A|30|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-10-11 03:17:34.562674|2017-10-11 03:17:34.562674
NCT01532570|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-10-25|2016-06-15||January 2012||2012-01-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions|To Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Patients With Behcet's Disease ( BD ) With Special Lesions After the Administration of TA-650|Completed||Phase 3|18|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 03:17:35.958657|2017-10-11 03:17:35.958657
NCT01532544|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-04-21|||June 2012||2012-06-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis|Double-blinded, Randomized Trial in Severe Pneumonia Patients With Severe Sepsis Investigating the Safety and Efficacy of Co-administration of Iloprost and Ascending Doses of Eptifibatide Compared to Low-molecular-weight Heparin|Terminated||Phase 2|5|Actual|Thrombologic ApS||2||Difficulty recruiting patients, company closed down|f||||t||||||||Undecided||2017-10-11 03:17:38.098114|2017-10-11 03:17:38.098114
NCT01532531|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-08-14|||March 2011||2011-03-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||The Effects of Collateral Meridian Therapy for Knee Osteoarthritis Pain Management||Completed||N/A|28|Actual|Taichung Armed Forces General Hospital||2|||f||||t||||||||||2017-10-11 03:17:38.254873|2017-10-11 03:17:38.254873
NCT01532505|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-02-13|||February 2012||2012-02-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Effect of Vasopressin on Tissue Oxygen Saturation in Cardiac Surgery Patients During Cardiopulmonary Bypass|A Randomized Study Comparing Low Dose Vasopressin Infusion or Placebo on Near Infrared Spectroscopy Tissue Oxygen Saturation and the Vascular Occlusion Test in Cardiac Surgery Patients During Cardiopulmonary Bypass: A Pilot Study|Unknown status|Not yet recruiting|N/A|40|Anticipated|London Health Sciences Centre|||1||f||||t||||||||||2017-10-11 03:17:38.474992|2017-10-11 03:17:38.474992
NCT01532492|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2014-04-30|||November 2011||2011-11-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|WORC||Validation of the Western Ontario Rotator Cuff Index in Patients With Arthroscopic Rotator Cuff Repair|Validation of the Western Ontario Rotator Cuff Index in Patients With Arthroscopic Rotator Cuff Repair|Completed||N/A|118|Actual|St. Antonius Hospital|||3||f||||f||||||||||2017-10-11 03:17:38.571496|2017-10-11 03:17:38.571496
NCT01532479|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-04-25|||August 2015||2015-08-01|April 2017|2017-04-01|January 2022|Anticipated|2022-01-01|August 2021|Anticipated|2021-08-01||Observational|SHOTGUN||Saliva, Hyperbaric Oxygen Therapy, & Gland Function: A Prospective Study|Saliva, Hyperbaric Oxygen Therapy, & Gland Function: A Prospective Study|Withdrawn||N/A|0|Actual|Loma Linda University|||3||f||||f||||||||||2017-10-11 03:17:38.665445|2017-10-11 03:17:38.665445
NCT01532466|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-09|||March 2011||2011-03-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||The Effect of Priming Intravenous Rocuronium on Fentanyl-Induced Coughing||Completed||N/A|260|Actual|Taichung Armed Forces General Hospital||2|||f||||t||||||||||2017-10-11 03:17:38.764414|2017-10-11 03:17:38.764414
NCT01532453|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2015-12-03|2015-07-16||November 2010||2010-11-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients|Open, Multicentre, Randomised, Comparative, Prospective Trial With MD-3511356 Versus Standard Sun Protection Measures in Immunosuppressed Solid Organ Transplanted Patients for Prevention of UV-induced Carcinogenic Skin Alterations|Terminated||Phase 3|244|Actual|Spirig Pharma Ltd.|Trial was terminated early for futility reasons (outcome would not be changed, if trial pursued up completion) and potential “loss of chance” (which could neither be confirmed nor rejected at the time) for patients included in the MD 3511356 group.|2||"For futility reasons and potential loss of chance for MD 3511356 group"|f||||t||||||||||2017-10-11 03:17:38.87797|2017-10-11 03:17:38.87797
NCT01532440|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2013-07-31|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:17:39.323375|2017-10-11 03:17:39.323375
NCT01532427|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-06-12|||June 2012|Actual|2012-06-01|June 2017|2017-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01|2 Years|Observational [Patient Registry]|2011-AAR-004||ALFApump System Post Marketing Surveillance Registry|ALFApump System Post Marketing Surveillance Registry, In Support of the Following Indication: Automated Removal of Excess Peritoneal Fluid Into the Urinary Bladder in Patients With Cirrhosis or Malignancy, With Persistent or Refractory Ascites|Active, not recruiting||N/A|100|Actual|Sequana Medical AG|||1||f||||f||||||||||2017-10-11 03:17:39.372783|2017-10-11 03:17:39.372783
NCT01532414|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2015-05-07|2014-06-13||August 2012||2012-08-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Analyses were conducted on the following populations: ITT (all subjects enrolled), mITT (all ITT subjects except site 09), PP (all ITT subjects who completed Week 12) and Safety (all subjects who received any study drug)|Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism|A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration|Completed||Phase 3|151|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-10-11 03:17:39.501773|2017-10-11 03:17:39.501773
NCT01532401|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-10-10|||March 2011||2011-03-01|February 2012|2012-02-01||||September 2014|Actual|2014-09-01||Interventional|PLADSEL||Oral Sodium Blood Pressure in Normal Weight, Overweight and Obese Volunteers|Simplification of the Test of Sensibility in the Salt: Preliminary Study at the Child and the Adult|Completed||Phase 2|51|Actual|Poitiers University Hospital||2|||f||||||||||||||2017-10-11 03:17:40.344236|2017-10-11 03:17:40.344236
NCT01532362|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2016-01-12|2016-01-12||November 2011||2011-11-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer|Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer|Terminated||N/A|1|Actual|Jonsson Comprehensive Cancer Center|Early termination of study when sponsor withdrew drug from market due to toxicities revealed from other studies.|2||Drug sponsor stopped drug manufacture due to toxicity issues from other studies|f||||t||||||||||2017-10-11 03:17:40.591803|2017-10-11 03:17:40.591803
NCT01532349|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-05-16|2017-03-09||May 2012||2012-05-01|May 2017|2017-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|D-fense||Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease|Cholecalciferol as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease|Completed||Phase 2|34|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 03:17:40.833729|2017-10-11 03:17:40.833729
NCT01532206|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-03-24|||March 2013||2013-03-01|March 2013|2013-03-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction|Interleukin-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction.|Terminated||N/A|1|Actual|Johns Hopkins University||2||Lack of funding|f||||f||||||||||2017-10-11 03:17:41.252293|2017-10-11 03:17:41.252293
NCT01532193|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2015-08-25|||November 2009||2009-11-01|August 2015|2015-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates|A Randomized Controlled Trial Evaluation the Effect of Low Oxygen Tension on the Pregnancy Rate After Day 3 Embryo Transfer in an Egg Donation Programme.|Completed||N/A|380|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-10-11 03:17:41.355378|2017-10-11 03:17:41.355378
NCT01532180|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-02-09|||November 2009||2009-11-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA)|A Pilot Study and Follow Up of the Use of a Hypoglossal Nerve Implant for Treatment of Obstructive Sleep Apnea|Completed||Phase 2/Phase 3|14|Actual|ImThera Medical, Inc.||1|||f||||f||||||||||2017-10-11 03:17:41.449413|2017-10-11 03:17:41.449413
NCT01532167|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-03-23|||February 2010||2010-02-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu Arteritis|Impact and Utility of Positron Emission Tomography (PET) for the Assessment of Inflammatory Activity Arteritis Versus Clinical Score and Laboratory Values in Takayasu Arteritis: a Cohort Study|Completed||N/A|26|Actual|Instituto Nacional de Cardiologia Ignacio Chavez|||1||f||||f||||||||||2017-10-11 03:17:41.566393|2017-10-11 03:17:41.566393
NCT01532154|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-10-17|||August 2015||2015-08-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01|12 Weeks|Observational [Patient Registry]|||Fampridine Pregnancy Exposure Registry|Fampridine Pregnancy Exposure Registry|Terminated||N/A|1|Actual|Biogen|||1|Due to low enrollment, registration closed in agreement with the Regulatory Agency|f||||f||||||||||2017-10-11 03:17:41.654238|2017-10-11 03:17:41.654238
NCT01532141|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-07-22|2015-07-22||November 2009||2009-11-01|July 2015|2015-07-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Interventional|||Effect of Rasagiline on BIA 9-1067 Pharmacokinetics|Effect of Rasagiline on BIA 9-1067 Pharmacokinetics in Healthy Subjects|Completed||Phase 1|25|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 03:17:41.760535|2017-10-11 03:17:41.760535
NCT01532128|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-07-22|2015-07-22||November 2009||2009-11-01|July 2015|2015-07-01|July 2010|Actual|2010-07-01|February 2010|Actual|2010-02-01||Interventional|||Effect of BIA 9-1067 on Rasagiline Pharmacokinetics|Effect of BIA 9-1067 on Rasagiline Pharmacokinetics in Healthy Subjects|Completed||Phase 1|24|Actual|Bial - Portela C S.A.||3|||f||||f||||||||||2017-10-11 03:17:42.272219|2017-10-11 03:17:42.272219
NCT01532102|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-01-22|||February 2012||2012-02-01|January 2016|2016-01-01||||May 2013|Actual|2013-05-01||Interventional|||Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts|A Double-blind, Placebo Controlled, Randomized, Phase IIa Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of Repeated Topical Applications Over 42 Days of AP611074 5% Gel in Condyloma Patients|Completed||Phase 1/Phase 2|24|Actual|Aviragen Therapeutics||2|||f||||f||||||||||2017-10-11 03:17:42.824638|2017-10-11 03:17:42.824638
NCT01532076|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2014-09-16|||June 2012||2012-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ROBUST||Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts|Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts Versus Acellular Bone Graft Substitutes for Augmentation in the Treatment of Proximal Humeral Fractures as Model for Fractures of Osteoporotic Bone - a Prospective Randomized First in Men Proof of Principle Trial|Terminated||Phase 2|8|Actual|University Hospital, Basel, Switzerland||2||Slow recruitment|f||||f||||||||||2017-10-11 03:17:43.10656|2017-10-11 03:17:43.10656
NCT01532063|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-04-20|||October 2011||2011-10-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|FRIDA-Rea||Risk Factors of Difficult Intubation and Related Complications in Adults in Intensive Care Units: FRIDA-Rea|Risk Factors of Difficult Intubation and Related Complications in Adults in Intensive Care Units(ICU)|Completed||N/A|1400|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 03:17:43.203126|2017-10-11 03:17:43.203126
NCT01532050|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-04-01|||February 2012||2012-02-01|April 2014|2014-04-01||||December 2014|Anticipated|2014-12-01||Interventional|PROMAD||PROMAD: Predicting Therapeutic Outcome of Mandibular Advancement Device Treatment in Obstructive Sleep Apnea|PROMAD : Predicting Therapeutic Outcome of Mandibular Advancement Device Treatment in Obstructive Sleep Apnea|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-11 03:17:43.288865|2017-10-11 03:17:43.288865
NCT01532037|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-06-20|||June 2012||2012-06-01|June 2012|2012-06-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Self Help for Fatigue in Multiple Sclerosis|A Randomised Controlled Trial of Cognitive Behavioural Therapy Based Self Help for Fatigue in Multiple Sclerosis|Unknown status|Recruiting|N/A|96|Anticipated|University of Edinburgh||3|||f||||t||||||||||2017-10-11 03:17:43.363025|2017-10-11 03:17:43.363025
NCT01532024|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-01-19|||October 2014||2014-10-01|January 2016|2016-01-01||||May 2016|Anticipated|2016-05-01||Interventional|NAP||Exploratory Clinical Study of Neutrophil Activation Probe (NAP) for Optical Molecular Imaging in Human Lungs|Phase 1 Exploratory Clinical Study of Microdosing NAP for Optical Molecular Imaging in Human Lungs in Healthy Volunteers and in Patients With Acute Lung Injury in Intensive Care|Recruiting||Early Phase 1|15|Anticipated|University of Edinburgh||3|||f||||t||||||||||2017-10-11 03:17:43.460415|2017-10-11 03:17:43.460415
NCT01532011|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-07-01|||March 2012||2012-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Erlotinib in Combination With Pralatrexate in Advanced Malignancies|A Phase I Dose-Escalation Study of Erlotinib in Combination With Pralatrexate in Subjects With Advanced Cancer|Completed||Phase 1|72|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:17:43.573592|2017-10-11 03:17:43.573592
NCT01531998|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2015-06-02|2015-06-02||May 2012||2012-05-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)|An Open Label, Single-Arm, Phase 1b/2 Study of the Safety and Efficacy of Combination Treatment With Lenalidomide, Bortezomib, Dexamethasone and Siltuximab (CNTO 328) in Subjects With Newly Diagnosed, Previously Untreated Multiple Myeloma Requiring Systemic Chemotherapy|Completed||Phase 1/Phase 2|14|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:17:43.685585|2017-10-11 03:17:43.685585
NCT01531985|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-05-07|||April 2010||2010-04-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Urine and Serum Biomarkers for Early Detection of Acute Kidney Injury|Urine and Serum Biomarkers for Early Detection of Acute Kidney Injury Following Cardiopulmonary Bypass Surgery for Congenital Heart Disease in Children and Adults: A Pilot Study|Completed||N/A|20|Actual|Medical College of Wisconsin|||1||f||||f||||||Samples Without DNA|"     Urine samples will be collected after the operation at 6 hours, 12 hours, 24 hours and 72     hours. The urine samples will be collected from your/your child's urinary catheter if one is     in place for your/your child's regular hospital care, or by urine collected in a cup if     you/your child do not have a urinary catheter. This study requires one blood samples of about     1 teaspoon, before surgery. The blood sample will be collected when other blood samples are     drawn, to avoid extra needle sticks for blood. The extra blood collected, totaling about 1     teaspoon, is a safe amount for children over 2 years old.   "|||2017-10-11 03:17:44.050821|2017-10-11 03:17:44.050821
NCT01531972|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2013-12-06|||February 2012||2012-02-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects|A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects|Completed||Phase 1|30|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 03:17:44.106787|2017-10-11 03:17:44.106787
NCT01531959|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-02-23|||April 2012||2012-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Midodrine for the Treatment of Refractory Hypotension|Midodrine for the Treatment of Refractory Hypotension in Patients Otherwise Ready for Discharge From the ICU|Recruiting||Phase 3|120|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:17:44.182753|2017-10-11 03:17:44.182753
NCT01531946|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2014-07-15|||January 2012||2012-01-01|July 2014|2014-07-01||||December 2014|Anticipated|2014-12-01||Observational|||Acute MRI in Transient Ischemic Attack|Acute MRI-techniques for the Detection of Ischemic Lesions After Transient Ischemic Attack|Unknown status|Recruiting|N/A|300|Anticipated|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-11 03:17:44.283744|2017-10-11 03:17:44.283744
NCT01531933|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-08-06|||November 2011||2011-11-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|DIPPER-DM||Efficacy and Safety of DLBS3233 in Prediabetic Patients|Phase III Clinical Study : DLBS3233 in Primary Prevention of Type 2 Diabetes Mellitus [DIPPER-DM]|Completed||Phase 3|80|Actual|Dexa Medica Group||2|||f||||f||||||||||2017-10-11 03:17:44.554244|2017-10-11 03:17:44.554244
NCT01531920|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-02-10|||May 2010||2010-05-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel|A Phase 1 Study in Healthy Subjects to Determine the Safety, Tolerability, Psychomotor Function and Cognitive Effects of Perampanel When Administered With Alcohol|Completed||Phase 1|59|Actual|Eisai Inc.||4|||f||||f||||||||||2017-10-11 03:17:44.68008|2017-10-11 03:17:44.68008
NCT01531907|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-12-14|||September 2011||2011-09-01|December 2012|2012-12-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Observational|GLP-2||Relationships Between GLP-2 and Markers of Bone Turnover Following Feeding|Relationships Between GLP-2 and Markers of Bone Turnover Following Feeding: the Influence of Obesity and Cellular Mechanisms of Action|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||2||f||||f||||||Samples Without DNA|"     On completion of the study, serum and plasma aliquots will be moved to the Human Tissue     Authority (HTA) licensed biorepository housed in the Centre for Biomedical Research.   "|||2017-10-11 03:17:44.767083|2017-10-11 03:17:44.767083
NCT01531894|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2017-09-15|||February 8, 2012||2012-02-08|September 2017|2017-09-01|April 18, 2018|Anticipated|2018-04-18|April 18, 2018|Anticipated|2018-04-18||Interventional|||Continuation Study of the Oral AKT Inhibitor GSK2110183|An Open Label Continuation Study of the Oral AKT Inhibitor GSK2110183 in Subjects With Solid Tumors and Hematologic Malignancies|Active, not recruiting||Phase 2|200|Anticipated|Novartis||3|||f||||t|t|f||||||||2017-10-11 03:17:44.853821|2017-10-11 03:17:44.853821
NCT01531881|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-06-12|||March 2006||2006-03-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|January 2014|Actual|2014-01-01||Observational|||Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression|Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression|Active, not recruiting||N/A|240|Actual|Roswell Park Cancer Institute|||1||f||||t||||||Samples With DNA|"     saliva, oral mucosal and tongue brushings.   "|||2017-10-11 03:17:44.946519|2017-10-11 03:17:44.946519
NCT01531868|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-04-07|||February 2012||2012-02-01|April 2016|2016-04-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Alternative Sensory Presentation Formats in Asymptomatic Carotid Stenosis|A Randomized Trial of Alternative Sensory Presentation Formats in Asymptomatic Carotid Stenosis|Withdrawn||N/A|0|Actual|Rhode Island Hospital||6|||f||||f||||||||||2017-10-11 03:17:45.017157|2017-10-11 03:17:45.017157
NCT01531855|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2014-08-01|||February 2012||2012-02-01|August 2014|2014-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Post-exercise Insulin Reductions in Type 1 Diabetes|The Metabolic and Glycaemic Responses to Reductions in Rapid-acting Insulin Dose After Running Exercise in People With Type 1 Diabetes Mellitus.|Completed||N/A|13|Actual|Northumbria University||1|||f||||t||||||||||2017-10-11 03:17:45.114775|2017-10-11 03:17:45.114775
NCT01531829|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-02-11|||July 2009||2009-07-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|||Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD|Low Dose Rt-PA Plus LMWH Compared With LMWH Alone for the Treatment of Normotensive Pulmonary Embolism Patients With Acute RV Dysfunction: A Randomized，Multi-Center，Controlled Trial|Unknown status|Recruiting|Phase 4|460|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-11 03:17:45.304627|2017-10-11 03:17:45.304627
NCT01531816|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-11-04|||February 2012||2012-02-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|WeeHab in PCCU||Early Rehabilitation in Critically Ill Children Pilot Study|Early Rehabilitation in Critically Ill Children, a Pilot Study|Completed||Phase 1|20|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 03:17:45.746455|2017-10-11 03:17:45.746455
NCT01531803|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2015-10-22|||September 2012||2012-09-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Study to Evaluate the Safety of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients|A Prospective, Randomized, Multi-Center, Controlled, Open-Label Study to Evaluate the Safety of Kedbumin 25% Compared to Normal Saline Solution in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients Undergoing Major Elective Surgery.|Terminated||Phase 2/Phase 3|3|Actual|Kedrion S.p.A.||2||"Per FDA CBER letter dated July 15, 2015, Kedrion SpA was released from the PMC to perform the   study with Kedbumin 25 % in pediatric patients"|f||||t||||||||||2017-10-11 03:17:45.833488|2017-10-11 03:17:45.833488
NCT01531790|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-01-15|||September 2011||2011-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients|A Phase I Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced NSCLC Patients|Completed||Phase 1|19|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 03:17:45.920808|2017-10-11 03:17:45.920808
NCT01531777|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-04-02|||April 2011||2011-04-01|February 2012|2012-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer|A Random, Open, Dose Finding and Pharmacokinetics/Pharmacodynamics(PK/PD) Phase II Study of Apatinib Tablets in the Treatment of Advanced Colorectal Cancer|Completed||Phase 2|40|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:17:46.027074|2017-10-11 03:17:46.027074
NCT01531764|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-10-17|||July 2012||2012-07-01|February 2012|2012-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||BIBW 2992 (Afatinib) and Vinorelbine|Single-arm, Open-label, Multicentre Phase II Study Evaluating the Efficacy and Safety of BIBW 2992 (Afatinib) in Combination With Vinorelbine for the Treatment of Patients With Metastatic Breast Cancer With Intermediate HER2 Expression (HER2 2+ by Immunohistochemistry, Fluorescence In-situ Hybridisation (FISH) Negative) After Failure of First-line Therapy in the Metastatic Setting and Having Been Pre-treated With Anthracyclines|Terminated||Phase 2|2|Actual|University of Magdeburg||1||The recruitment was discontinued because of failure to meet expected enrolment goals|f||||f||||||||||2017-10-11 03:17:46.156984|2017-10-11 03:17:46.156984
NCT01531751|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2015-09-01|||February 2015||2015-02-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DIACAL||High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease|An Open Label Phase II Trial of Free Light Chain Removal by Extended High Cut-Off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End-Stage Renal Disease.|Suspended||Phase 2|16|Anticipated|IRCCS Policlinico S. Matteo||1|||f||||t||||||||||2017-10-11 03:17:46.270035|2017-10-11 03:17:46.270035
NCT01531738|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-11-01|||July 2010||2010-07-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Investigation of the Effects of Bariatric Surgery on Taste Reward in Humans|Investigation of the Effects of Bariatric Surgery on Taste Reward in Humans|Recruiting||N/A|20|Anticipated|Imperial College London|||3||f||||t||||||||No||2017-10-11 03:17:46.36815|2017-10-11 03:17:46.36815
NCT01525381|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-03-29|||November 2011||2011-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|April 2015|Actual|2015-04-01||Observational|||Strategies to Improve Asthma and Treatment of Asthma in Canadians|Strategies to Improve Diagnosis and Treatment of Asthma in Canadians|Completed||N/A|701|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-11 03:19:38.779816|2017-10-11 03:19:38.779816
NCT01531725|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2013-03-19|2013-02-14||February 2007||2007-02-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|April 2008|Actual|2008-04-01||Interventional|MULTIBENE|197 patients were considered for baseline analysis. 5 patients with protocol violation were excluded.|MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study|6 Months Evaluation of the BIOTRONIK PRO-Kinetic Coronary Stent System|Completed||N/A|202|Actual|Biotronik AG|"Limitations:
missing comparators
permission to conduct follow up visits by telephone
limited number of 197 patients allows an insight of the safety and efficacy of the device."|1|||f||||t||||||||||2017-10-11 03:17:46.476023|2017-10-11 03:17:46.476023
NCT01531712|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-08-28|||February 10, 2011||2011-02-10|August 2017|2017-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable|Phase II Study of Neoadjuvant Treatment With Gemcitabine, Tarceva and Oxaliplatin Followed by Chemotherapy With Tarceva and Gemcitabine in Patients With Pancreas Adenocarcinoma With Borderline Resectability.|Terminated||Phase 2|6|Actual|Institut Català d'Oncologia||1||Due to a low recruitment rate since start of recruitment period.|f||||f||||||||||2017-10-11 03:17:46.721563|2017-10-11 03:17:46.721563
NCT01531699|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2012-12-10|||February 2012||2012-02-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Antimicrobial Efficacy of ALT005 Ophthalmic Prep Solution in Healthy Volunteers|An Open-label Study to Assess the Antimicrobial Efficacy of ALT005 Ophthalmic Prep Solution (ALT005) Compared to Control (Sterile Saline) Following Dermal Administration in Healthy Volunteers|Completed||Phase 3|54|Actual|Altacor Ltd.||3|||f||||f||||||||||2017-10-11 03:17:46.853573|2017-10-11 03:17:46.853573
NCT01531686|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-12-05|||March 2012||2012-03-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route|An Observational Study to Determine the Safety and Effectiveness of Intraosseous Vascular Access for the Delivery of CT Contrast Dye|Terminated||N/A|8|Actual|Vidacare Corporation|||1|Slow rate of enrollment|f||||f||||||||||2017-10-11 03:17:46.970471|2017-10-11 03:17:46.970471
NCT01531673|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2015-05-05||2015-05-05|February 2012||2012-02-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation|A Phase 2, Multicenter, Double-Blinded, Placebo Controlled Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-661 Monotherapy and VX-661/Ivacaftor Cotherapy in Subjects With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation|Completed||Phase 2|194|Actual|Vertex Pharmaceuticals Incorporated||22|||f||||t||||||||||2017-10-11 03:17:47.623493|2017-10-11 03:17:47.623493
NCT01531660|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-03-07|||April 2004||2004-04-01|March 2012|2012-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Active Over 45: A Step-up Jogging Program in Inactive Female Hospital Staff Aged 45+|Active Over 45: A Step-up Jogging Program in Inactive Female Hospital Staff Aged 45+: Feasability, Role of Motivation and Sustained Benefit|Completed||N/A|68|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 03:17:47.848123|2017-10-11 03:17:47.848123
NCT01531647|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-11-01|||January 2012||2012-01-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers|A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir When Given With Raltegravir in Healthy Adult Volunteers|Completed||Phase 1|20|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:17:47.92146|2017-10-11 03:17:47.92146
NCT01531634|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-08||||||February 2012|2012-02-01||||||||Interventional|||Promoting Recovery Processes in Women With Borderline Personality Disorder Using a Dynamic Cognitive Intervention|Promoting Recovery Processes in Women Diagnosed With Borderline Personality Disorder Using a Dynamic Cognitive Intervention|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center||2|||f||||f||||||||||2017-10-11 03:17:48.016395|2017-10-11 03:17:48.016395
NCT01531621|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2015-03-25|||February 2012||2012-02-01|March 2015|2015-03-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|RAXO||A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland|A Population-based Prospective Study to Evaluate Clinical Behaviour, Resectability and Survival in 1st Line Metastatic Colorectal Cancer (CRC) Patients in Finland|Recruiting||N/A|1000|Anticipated|Helsinki University Central Hospital|||1||f||||f||||||||||2017-10-11 03:17:48.111434|2017-10-11 03:17:48.111434
NCT01531608|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-04-20|||March 2011||2011-03-01|April 2015|2015-04-01||||February 2012|Actual|2012-02-01||Observational|Mel54||Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma|Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma Independent Of Fixed Gamma Camera Imaging|Completed||N/A|20|Actual|University of Virginia|||1||f||||t||||||||||2017-10-11 03:17:48.20638|2017-10-11 03:17:48.20638
NCT01531595|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2015-03-25|||February 2012||2012-02-01|March 2015|2015-03-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer|Phase 2 Study of Bevacizumab in Combination With Alternating Xeliri and Xelox as First-line Treatment of Patients With Metastatic Colorectal Cancer|Recruiting||Phase 2|100|Anticipated|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-11 03:17:48.28655|2017-10-11 03:17:48.28655
NCT01531569|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-10-25|||December 2011||2011-12-01|October 2016|2016-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|SOD||Single Oral Dose of BeneFlax to Healthy Young and Older Adults|Community Alliance for Quality of Life in Long Term Care: Single Oral Dose of BeneFlax to Healthy Young and Older Adults|Completed||Phase 2|22|Actual|University of Saskatchewan||1|||f||||f||||||||||2017-10-11 03:17:48.466081|2017-10-11 03:17:48.466081
NCT01531556|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-02-10|||January 2012||2012-01-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||A Study of How Tutin and Hyenanchin, Two Toxins Found in Honey, Are Absorbed and Processed by the Body|An Open-label, Non-randomised Study to Investigate the Pharmacokinetics of Tutin and Hyenanchin, Following Single Dose Administration of Honey Containing Tutin and Hyenanchin to Healthy Male Subjects.|Unknown status|Recruiting|Phase 1|6|Anticipated|Food Standards Australia New Zealand||1|||f||||||||||||||2017-10-11 03:17:48.559768|2017-10-11 03:17:48.559768
NCT01531543|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-10|||July 2008||2008-07-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Prospective Comparison of Primary Abdominal Closure and Vacuum Assisted Laparostomy in Treatment of Severe Peritonitis|Phase 4 Study of Primary Use of the Vacuum Assisted Laparostomy in Treatment of Severe Peritonitis|Completed||Phase 4|57|Actual|The Faculty Hospital Na Bulovce||2|||f||||f||||||||||2017-10-11 03:17:48.64893|2017-10-11 03:17:48.64893
NCT01531530|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-01-14|||July 2011||2011-07-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP|Safety, Clinical Tolerance, and Immunogenicity of CVD 1208S, a Delta guaBA, Delta Sen, Delta Set, Live, Oral Shigella Flexneri 2a Vaccine Manufactured Using cGMP|Completed||Phase 1|26|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 03:17:48.936295|2017-10-11 03:17:48.936295
NCT01531517|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2015-02-19|||July 2011||2011-07-01|February 2012|2012-02-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|PED111||Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers|Study of the Efficacy of Topical Application of Royal Jelly and Panthenol (PedyPhar® Ointment) on the Diabetic Foot Ulcers, An Open Label, Randomized, Non-placebo-controlled Study|Terminated||Phase 3|47|Actual|European Egyptian Pharmaceutical Industries||2||inability to recruit patients|f||||t||||||||||2017-10-11 03:17:49.036509|2017-10-11 03:17:49.036509
NCT01531491|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2015-02-12|||January 2012||2012-01-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effects of Hypercapnia on Emergence From General Anesthesia Under Propofol|Effects of Hypercapnia on Emergence From General Anesthesia Under Propofol: a Pilot Study|Completed||N/A|30|Actual|DongGuk University||2|||f||||t||||||||||2017-10-11 03:17:49.246119|2017-10-11 03:17:49.246119
NCT01531478|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-03-30|||May 2011||2011-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|SALTO||Long-term Follow-up of Childhood Cancer Survivors in the Rhône-Alpes and Auvergne Regions of France|Long-term Follow-up of Childhood Cancer Survivors in the Rhône-Alpes and Auvergne Regions of France|Completed||N/A|147|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 03:17:49.346551|2017-10-11 03:17:49.346551
NCT01531465|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2013-06-03|||June 2011||2011-06-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure|Pulmonary Function Testing in Infants With Respiratory Insufficiency While Receiving High Flow Nasal Cannula (HFNC) Versus Nasal Continuous Positive Airway Pressure (nCPAP)|Completed||N/A|20|Actual|Christiana Care Health Services||2|||f||||f||||||||||2017-10-11 03:17:49.448595|2017-10-11 03:17:49.448595
NCT01531452|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2014-12-03|||June 2011||2011-06-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|November 2012|Actual|2012-11-01||Interventional|||The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer|a Phase II Study of Oxaliplatin Plus S-1 (SOX) as First-line Treatment for Patients With Advanced Gastric Cancer|Completed||Phase 2|43|Actual|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 03:17:49.549208|2017-10-11 03:17:49.549208
NCT01531439|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-07-18|||November 2011|Actual|2011-11-01|July 2017|2017-07-01|December 1, 2016|Actual|2016-12-01|May 1, 2015|Actual|2015-05-01||Interventional|||Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion Surgery|Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion Surgery|Completed||N/A|84|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-10-11 03:17:49.653309|2017-10-11 03:17:49.653309
NCT01531426|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2013-02-22|||January 2012||2012-01-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|CoCaHYp||Cerebral Oxygenation in Cardiac Arrest and Hypothermia|Cerebral Oxygen Saturation as Outcome Predictor in Cardiac Arrest Patients Undergoing Mild Therapeutic Hypothermia|Completed||N/A|94|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 03:17:49.763496|2017-10-11 03:17:49.763496
NCT01531413|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-08|||March 2006||2006-03-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|AppyO2||Oxygen Insufflation To Reduce Postoperative Abscess In Laparoscopic Appendectomy|Single-Blind, Randomized, Controlled Trial of Oxygen Insufflation to Reduce Incidence of Postoperative Abscess in Laparoscopic Appendectomy|Completed||N/A|100|Actual|Chang, Steve S., M.D.||1|||f||||t||||||||||2017-10-11 03:17:49.85675|2017-10-11 03:17:49.85675
NCT01531400|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-29|2012-03-18|||December 2002||2002-12-01|March 2012|2012-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Investigation of Pain and Anxiety During Electrodiagnostic Examination Using Self-selected Music|Investigation of Pain and Anxiety During Electrodiagnostic Examination Using Self-selected Music|Completed||N/A|61|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-11 03:17:49.95237|2017-10-11 03:17:49.95237
NCT01531387|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-01-13|2015-06-19||May 2012||2012-05-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|SCATE||Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)|Sparing Conversion to Abnormal TCD Elevation (SCATE) - a Phase III Clinical Trial to Compare Standard Care (Observation) With Alternative Therapy (Hydroxyurea) for Reducing the Risk of Converting to an Abnormal TCD Velocity in Children With Sickle Cell Anemia and Conditional Pre-treatment TCD Velocities.|Terminated||Phase 3|38|Actual|Children's Hospital Medical Center, Cincinnati||2||inability to reach a satisfactory endpoint with respect to adequate recruitment|f||||t||||||||||2017-10-11 03:17:50.049636|2017-10-11 03:17:50.049636
NCT01531374|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-06-29|2016-09-01||February 2012||2012-02-01|June 2017|2017-06-01|October 2019|Anticipated|2019-10-01|November 2015|Actual|2015-11-01||Interventional||A total of 1658 Extreme Risk subjects were enrolled; 1257 Iliofemoral and 367 Non-Iliofemoral had an attempted implant procedure. A total of 1119 High Risk subjects were enrolled; however, 1108 subjects had an attempted implant procedure. The baseline data presented are for subjects with an attempted implant.|Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement|Medtronic CoreValve® Continued Access Study|Active, not recruiting||N/A|2777|Actual|Medtronic Cardiovascular||3|||f||||t||||||||||2017-10-11 03:17:50.63127|2017-10-11 03:17:50.63127
NCT01531361|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-03-27|||February 2012|Actual|2012-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Sorafenib or Crizotinib and Vemurafenib in Advanced Cancer|A Phase I Trial of Sorafenib (CRAF, BRAF, KIT, RET, VEGFR, PDGFR Inhibitor) or Crizotinib (MET, ALK, ROS1 Inhibitor) in Combination With Vemurafenib (BRAF Inhibitor) in Patients With Advanced Malignancies|Recruiting||Phase 1|183|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 03:17:57.222973|2017-10-11 03:17:57.222973
NCT01531348|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-08-28|||February 2012||2012-02-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa|Feasibility and Safety of Adult Human Bone Marrow-Derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa|Enrolling by invitation||Phase 1|10|Anticipated|Mahidol University||1|||f||||t||||||||||2017-10-11 03:17:57.334859|2017-10-11 03:17:57.334859
NCT01531335|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-11-07|2013-12-16||August 2011||2011-08-01|November 2015|2015-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|RuRaL||Hypocaloric Nutrition in Critically Ill Patients|Effectiveness of Hypocaloric Nutrition Compared With Standard Care in Critically Ill Adults Patients, a Randomized Controlled Trial|Completed||Phase 3|80|Actual|Lafrancol S.A.|No surgical patients included Wide variety of patients Caloric needs were not estimated with a gold standard|2|||f||||t||||||||||2017-10-11 03:17:57.420398|2017-10-11 03:17:57.420398
NCT01531322|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-02-15|||October 2011||2011-10-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects|A Phase 1 Open-label Study to Assess the Safety and Tolerability of a Single Dose of 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Adults, Children and Infants|Completed||Phase 1|72|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:17:57.744684|2017-10-11 03:17:57.744684
NCT01531309|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2013-03-06||2013-02-18|February 2011||2011-02-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Pharmacokinetics of Agomelatine in Patients With Liver Impairment|An Open-label, Parallel-group Study to Compare the Pharmacokinetics, Safety and Tolerability of a Single Sublingual 1 mg Dose of AGO178 in Subjects With Mild and Moderate Hepatic Impairment With That in Matched Healthy Control Subjects|Completed||Phase 1/Phase 2|32|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:17:57.852829|2017-10-11 03:17:57.852829
NCT01531296|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2016-01-13|||October 2011||2011-10-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||To Assess Rotation for Femoral Version and Tibial Torsion|Correlation Between MRI and Clinical Measurements of Lower Extremity Rotational Profile: Reliability of MRI to Assess Rotation for Femoral Version and Tibial Torsion|Completed||N/A|37|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 03:17:57.941171|2017-10-11 03:17:57.941171
NCT01531283|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-11-13|||February 2011||2011-02-01|November 2012|2012-11-01||||April 2013|Anticipated|2013-04-01||Interventional|UAG||Deacylated Ghrelin and Beta Cell Function|Impact of Unacylated Ghrelin on Beta-cell Function in Humans|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Cincinnati||4|||f||||t||||||||||2017-10-11 03:17:58.020256|2017-10-11 03:17:58.020256
NCT01531257|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-09-19|||April 2010||2010-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|"Mini-Kidney"||Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients|Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients|Recruiting||N/A|1000|Anticipated|Northwestern University|||1||f||||f||||||Samples With DNA|"     Urine Collection: Approximately one cup of urine (200 mL) will be taken for research tests on     the day of a routine care biopsy, if possible.      Blood Draws: About 1.5 tablespoons of blood (20.5 mL) will be taken for research tests before     the biopsy.      Kidney Biopsy: A kidney biopsy is a procedure to remove and examine a small piece of kidney     tissue. For this study, one biopsy will be taken from the new kidney and used specifically     for research. The biopsy will be done at the same time as the biopsies done for routine care.     If there are any complications during the routine care biopsies, the tissue for this research     study will not be taken.   "|||2017-10-11 03:17:58.119413|2017-10-11 03:17:58.119413
NCT01531244|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-07-17|||December 2014||2014-12-01|July 2014|2014-07-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma|A Phase I/II Study of Isolated Limb Infusion and Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma|Withdrawn||Phase 1/Phase 2|0|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 03:17:58.20777|2017-10-11 03:17:58.20777
NCT01531231|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2013-07-23|||January 2012||2012-01-01|July 2013|2013-07-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Observational|||Typical Daily Experiences, Ischemia and Repolarization in Coronary Artery Disease|Typical Daily Emotions, Ischemia and Repolarization in Coronary Artery Disease|Unknown status|Recruiting|N/A|300|Anticipated|University of Arizona|||4||f||||f||||||||||2017-10-11 03:17:58.332063|2017-10-11 03:17:58.332063
NCT01531218|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-07-03|||March 2012||2012-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Concisus2012||Trial Of Azithromycin In Campylobacter Concisus Patients With Diarrhea|Randomized, Double-Blind, Placebo-Controlled Trial Of Azithromycin In Campylobacter Concisus Positive Patients With Diarrhea|Completed||Phase 3|100|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:17:58.419581|2017-10-11 03:17:58.419581
NCT01531205|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-11-04|2014-07-08||May 2012||2012-05-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional||All participants|Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA|Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA Failure With Biopsy Proven Local Recurrence After Initial Definitive Radiotherapy|Terminated||Phase 2|2|Actual|H. Lee Moffitt Cancer Center and Research Institute|Study was closed early due to low accrual. Investigators had planned to follow 25 participants from On Study through End of Follow-up, up to 10 years.|1||low accrual|f||||t||||||||||2017-10-11 03:17:58.515988|2017-10-11 03:17:58.515988
NCT01531192|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2013-07-13|||June 2012||2012-06-01|February 2012|2012-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants|Zekai Tahir Burak Maternity Teaching Hospital, Ankara/Turkey|Completed||Phase 4|300|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||t||||||||||2017-10-11 03:17:58.829368|2017-10-11 03:17:58.829368
NCT01531179|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2013-05-08|||February 2012||2012-02-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants|Role Of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis in Very Low Birth Weight Infants|Completed||Phase 3|400|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-11 03:17:59.050694|2017-10-11 03:17:59.050694
NCT01531166|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-08-16|||September 2011||2011-09-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|August 2014|Actual|2014-08-01||Observational|||A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon|An Observational, Multi-Center, Cohort Study Evaluating the Antiviral Efficacy, Safety, and Tolerability in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon-alpha 2a (Pegasys®): TRACES STUDY|Completed||N/A|500|Actual|Yonsei University|||1||f||||t||||||||||2017-10-11 03:17:59.146231|2017-10-11 03:17:59.146231
NCT01531153|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2016-08-04|||September 2011||2011-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Cognitive Enhancement as a Target for Cocaine Pharmacotherapy|Cognitive Enhancement as a Target for Cocaine Pharmacotherapy|Completed||N/A|95|Actual|Yale University||2|||f||||t||||||||Undecided||2017-10-11 03:17:59.231678|2017-10-11 03:17:59.231678
NCT01531140|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-02-09|||November 2010||2010-11-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy|High-volume Polyethylene Glycol Solution (PEG) Versus Low-volume PEG Plus Stimulant Laxative Versus Sennosides for Colon Cleansing Before Colonoscopy: a Randomized, Single Blinded Study|Completed||Phase 4|240|Actual|Medical University of Warsaw||3|||f||||f||||||||||2017-10-11 03:17:59.33811|2017-10-11 03:17:59.33811
NCT01531127|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-02-09|||March 2012||2012-03-01|February 2012|2012-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||Executive Function in Learning in Children With Attention Deficit Hyperactivity Disorder (ADHD) Receiving Medical Treatment Alone Compared to Children Receiving Additional Treatment to Improve Learning Strategies||Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-10-11 03:17:59.427243|2017-10-11 03:17:59.427243
NCT01531114|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-06-27|||May 2013||2013-05-01|June 2017|2017-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|RESET 2D||PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus|Prasugrel Or Ticagrelor In ST-Elevation Myocardial Infarction Patients With Diabetes Mellitus|Completed||Phase 3|50|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 03:17:59.485407|2017-10-11 03:17:59.485407
NCT01531088|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-01-04|||January 2012||2012-01-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|||Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes|Enhancing the Detection and Management of Adverse Drug Events in the Nursing Home|Completed||N/A|36|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:17:59.694068|2017-10-11 03:17:59.694068
NCT01531075|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-06-06|||May 2012||2012-05-01|June 2012|2012-06-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|HBV VIP||Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease|Assessment of Hepatitis B Vaccination Efficacy in Patients With Inflammatory Bowel Diseases|Unknown status|Recruiting|N/A|75|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-10-11 03:17:59.767113|2017-10-11 03:17:59.767113
NCT01531062|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-02-08|||September 2011||2011-09-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Nigella Sativa on Lipid Profiles in Elderly|Effect of Nigella Sativa on Lipid Profiles in Elderly: a Randomized Double-blinded Clinical Trial|Completed||Phase 2|96|Actual|Indonesia University||2|||f||||t||||||||||2017-10-11 03:17:59.867923|2017-10-11 03:17:59.867923
NCT01531049|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-06-02|||May 2012||2012-05-01|June 2017|2017-06-01|September 2, 2016|Actual|2016-09-02|December 31, 2015|Actual|2015-12-31||Interventional|||Smoking Habits and Smoking Cessation in Young Adults|Smoking Cessation in Young Adults in Northern Finland|Completed||Phase 2/Phase 3|300|Actual|University of Oulu||4|||f||||f||||||||||2017-10-11 03:17:59.94754|2017-10-11 03:17:59.94754
NCT01531036|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2016-02-24|||December 2010||2010-12-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||3D Breast Ultrasound Elastography in Patients Under Neoadjuvant Chemotherapy|Imagerie 3D d'élasticité du Sein Par échographie Ultrarapide au Cours d'un Traitement Par chimiothérapie néoadjuvante.|Completed||N/A|33|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-10-11 03:18:00.087949|2017-10-11 03:18:00.087949
NCT01531023|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-10-28|||April 2013||2013-04-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice|What is the Outcome of Treatment of Urinary Tract Infections Caused by Bacteria Producing Extended Spectrum Betalactamase in a Primary Care Setting?|Completed||N/A|168|Actual|University of Oslo|||2||f||||f||||||Samples With DNA|"     Urinesamples   "|||2017-10-11 03:18:01.827699|2017-10-11 03:18:01.827699
NCT01531010|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-02-08|||July 2010||2010-07-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Pressure-limited Ventilation Versus Volume-targeted Ventilation in Preterm Newborns|Randomised Controlled Trial of Pressure-limited Ventilation Versus Volume-targeted Ventilation in Prematurely Born Infants|Completed||N/A|40|Actual|King's College London||2|||f||||f||||||||||2017-10-11 03:18:01.937687|2017-10-11 03:18:01.937687
NCT01530815|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-02-09|||August 2011||2011-08-01|February 2012|2012-02-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Bupivicaine to Reduce Postoperative Pain in Laparoscopic Ventral Hernia Repair|Intraoperative Local Anesthesia for Management of Postoperative Pain Following Laparoscopic Ventral Hernia Repair: a Prospective Double-blind Randomized Trial|Unknown status|Recruiting|N/A|80|Anticipated|Chang, Steve S., M.D.||1|||f||||t||||||||||2017-10-11 03:18:04.42294|2017-10-11 03:18:04.42294
NCT01524276|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-09-13|||January 2012||2012-01-01|September 2017|2017-09-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|PSR||Product Surveillance Registry|Medtronic Product Surveillance Registry|Recruiting||N/A|55000|Anticipated|Medtronic|||1||f||||f||||||||||2017-10-11 03:19:56.998924|2017-10-11 03:19:56.998924
NCT01530997|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-07-10|2017-03-30||November 2011||2011-11-01|July 2017|2017-07-01|January 2022|Anticipated|2022-01-01|November 2014|Actual|2014-11-01||Interventional||Sixty-nine patients were eligible for enrollment, of whom 45 were accrued. One patient had a cerebrovascular accident during de-intensified CRT and was taken off the study leaving 44 patients included in the baseline characteristics.|De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca|Phase II Study of De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal Squamous Cell Carcinoma|Active, not recruiting||Phase 2|45|Actual|UNC Lineberger Comprehensive Cancer Center|Per the protocol, affiliate sites will only report grade 3/4 and all fatal (grade 5) toxicities. 1/2 toxicities were not reported for affiliate sites.|1|||f||||t||||||||||2017-10-11 03:18:02.04619|2017-10-11 03:18:02.04619
NCT01530984|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-10-01|||June 2015||2015-06-01|October 2015|2015-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Ipilimumab and GMCSF Immunotherapy for Prostate Cancer|Anti-CTLA4 Blockade Alone or Combined With Systemic GM-CSF for Prostate Cancer Immunotherapy|Withdrawn||Phase 2|0|Actual|University of California, San Francisco||2||Unable to execute contract|f||||t||||||||||2017-10-11 03:18:02.958268|2017-10-11 03:18:02.958268
NCT01530971|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2013-07-01|||March 2012||2012-03-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effect of Maternal and Neonatal Oxygenation|Effects of Neonate and Maternal Oxygenation in Low-dose Oxygen Supplement by Oxygen Cannula or Non- Supplement in Elective Cesarean Section: a Randomized Controlled Trial|Completed||Phase 3|325|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 03:18:03.073258|2017-10-11 03:18:03.073258
NCT01530958|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-10-26|||April 2013||2013-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|KARE||Kidney Awareness Registry and Education|The Kidney Awareness Registry and Education Study|Recruiting||Phase 3|100|Anticipated|University of California, San Francisco||4|||f||||t||||||||Undecided|Data may be available upon contact of study PI.|2017-10-11 03:18:03.16544|2017-10-11 03:18:03.16544
NCT01530945|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-09-02|||March 2012||2012-03-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease|Mapping Multidimensional Illness Trajectories of Patients With ESKD|Completed||N/A|227|Actual|University of North Carolina, Chapel Hill|||1||f||||||||||||||2017-10-11 03:18:03.280979|2017-10-11 03:18:03.280979
NCT01530932|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-10-20|||February 2012||2012-02-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal Origin|Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal Origin|Completed||N/A|20|Anticipated|Universitätsmedizin Mannheim|||1||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-11 03:18:03.376092|2017-10-11 03:18:03.376092
NCT01530919|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-05-01|||September 1998||1998-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|December 2009|Actual|2009-12-01||Observational|MIRP||Minimally Invasive Radioguided Parathyroidectomy|Minimally Invasive Radioguided Parathyroidectomy|Completed||N/A|856|Actual|University of Louisville|||1||f||||f||||||Samples With DNA|"     Small portion of abnormal parathyroid gland that is removed during surgery is frozen and     stored for future research.   "|||2017-10-11 03:18:03.46863|2017-10-11 03:18:03.46863
NCT01530906|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-12-02|||January 2012||2012-01-01|February 2012|2012-02-01|September 2015|Anticipated|2015-09-01|March 2015|Anticipated|2015-03-01||Interventional|rTMS&bulimia||Efficiency of Repetitive Transcranial Magnetic Stimulation (rTMS) in Bulimia|Efficiency of rTMS in Bulimia: a Controlled Randomized Study|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 03:18:03.594039|2017-10-11 03:18:03.594039
NCT01530893|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-02-27|||February 2012||2012-02-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|FASTCHECK||Flavonoids, Blood Pressure and Blood Vessel Function|Are the Cardiovascular Responses of Individuals at Mild to Moderate Cardiovascular Risk Influenced by Dietary Flavonoid Sub-class and Dietary Form?|Completed||N/A|64|Actual|University of East Anglia||4|||f||||f||||||||||2017-10-11 03:18:03.713905|2017-10-11 03:18:03.713905
NCT01530880|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-08-15|2017-07-14||October 2012||2012-10-01|August 2017|2017-08-01|March 17, 2016|Actual|2016-03-17|March 17, 2016|Actual|2016-03-17||Interventional||Includes subjects from both arms as this information is only available for all subjects and not per arm.|Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage|Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage|Terminated||Phase 4|35|Actual|Columbia University||2||PI no longer at institution|f||||f||||||||||2017-10-11 03:18:03.832422|2017-10-11 03:18:03.832422
NCT01530867|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2013-06-05|||November 2011||2011-11-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Physician-Patient Communication Project|Physician-Patient Communication Project|Completed||N/A|456|Actual|University of California, Los Angeles|||1||f||||t||||||||||2017-10-11 03:18:04.099013|2017-10-11 03:18:04.099013
NCT01530854|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-03-15|||February 2008||2008-02-01|March 2017|2017-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Plasma Free Fatty Acids in Risk Assessment of Sepsis in the Emergency Department: A Prospective Pilot Study|Plasma Free Fatty Acids in Risk Assessment of Sepsis in the Emergency Department: A Prospective Pilot Study|Completed||N/A|74|Actual|The Cleveland Clinic|||2||f||||f||||||Samples With DNA|"     Blood samples (10 cc. total) are to be collected in non-heparinized tubes upon initial     presentation to the ED as well as 3-6hours and 24(+/-3) hours after the initial blood draw.     The 3-6hour and 24-hour blood draw will be optional depending on patient location and the     availability of study personnel. The plasma samples will be aliquoted and frozen at -70°C for     later assays. These samples will be assayed for plasma FFA, plasma glucose, plasma insulin,     and future cytokines including IL-1 and TNF.   "|||2017-10-11 03:18:04.17615|2017-10-11 03:18:04.17615
NCT01530841|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2017-03-08|||July 2012||2012-07-01|March 2017|2017-03-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy|Prospective Randomized Controlled Single Blind Study of Efficacy and Tolerance of AVAPS Mode Compared to Bilevel Pressure Ventilation un Adult Patients With Myotonic Dystrophy|Completed||N/A|32|Actual|Centre d'Investigation Clinique et Technologique 805||2|||f||||f||||||||||2017-10-11 03:18:04.261331|2017-10-11 03:18:04.261331
NCT01530828|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2013-08-07|||August 2010||2010-08-01|August 2013|2013-08-01|August 2014|Anticipated|2014-08-01|September 2013|Anticipated|2013-09-01||Observational|||IRT in Infants With Intestinal Perforation|Immunoreactive Trypsinogen in Infants With Intestinal Perforation|Unknown status|Recruiting|N/A|300|Anticipated|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||||2017-10-11 03:18:04.341638|2017-10-11 03:18:04.341638
NCT01530802|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-01|2012-02-09|||January 2007||2007-01-01|June 2010|2010-06-01|December 2009||2009-12-01|||||Interventional|||Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy|Reduction of Intraoperative Blood Loss During Laparoscopic Myomectomy by Temporary Clipping of the Uterine Arteries|Completed||N/A|166|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:18:04.509134|2017-10-11 03:18:04.509134
NCT01530789|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2015-08-05|||May 2011||2011-05-01|October 2012|2012-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Paramedical Consultation in Telemedicine|Evaluation of Paramedical Consultation in Type 1 Diabetic Patients in Telemedicine|Terminated||N/A|50|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète|||1||f||||||||||||||2017-10-11 03:18:04.587775|2017-10-11 03:18:04.587775
NCT01530776|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-05-05|||January 2012||2012-01-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Healthy4Baby: Preventing Postpartum Weight Retention Among Low-Income, Black Women|Preventing Postpartum Weight Retention Among Low-Income, Black Women|Completed||Phase 2|66|Actual|Temple University||2|||f||||f||||||||||2017-10-11 03:18:04.639038|2017-10-11 03:18:04.639038
NCT01530763|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2015-01-12|||September 2012||2012-09-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)|A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline Versus Ceftriaxone in Pediatric Subjects With Community-acquired Bacterial Pneumonia Requiring Hospitalization|Completed||Phase 2/Phase 3|161|Actual|Forest Laboratories||2|||f||||t||||||||||2017-10-11 03:18:04.713505|2017-10-11 03:18:04.713505
NCT01530750|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2012-08-31|||March 2012||2012-03-01|August 2012|2012-08-01|February 2014|Anticipated|2014-02-01|February 2013|Anticipated|2013-02-01||Observational|||READ-POAF Pilot Studies Postoperative Atrial Fibrillation After Cardiac Surgery|READ-POAF Pilot Study. The Use of the Reveal XT as Device for Postoperative Atrial Fibrillation Detection After Cardiac Surgery|Unknown status|Recruiting|N/A|40|Anticipated|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||||2017-10-11 03:18:05.04375|2017-10-11 03:18:05.04375
NCT01530737|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-01-06|||November 2011||2011-11-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery|Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery|Completed||Phase 3|18|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 03:18:05.144177|2017-10-11 03:18:05.144177
NCT01530724|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2015-09-29|||October 2012||2012-10-01|September 2015|2015-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CENTRAL||Diet and Body Composition|Effect of Weight-loss Diet Strategies and Exercise on Dynamics of Body Fat Depots and Metabolic Rate|Completed||Phase 3|224|Actual|Ben-Gurion University of the Negev||2|||f||||t||||||||||2017-10-11 03:18:05.221645|2017-10-11 03:18:05.221645
NCT01530711|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-09|2016-08-17|||April 2012||2012-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|AMELIORATE||Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response|Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response|Active, not recruiting||Phase 4|40|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-11 03:18:05.287869|2017-10-11 03:18:05.287869
NCT01530698|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-31|2017-04-13|||April 2010||2010-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients|Single-step Antigen Loading and TLR Activation of Dendritic Cells by mRNA Electroporation for Vaccination in Stage III and IV Melanoma Patients|Completed||Phase 1/Phase 2|28|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 03:18:05.368494|2017-10-11 03:18:05.368494
NCT01530685|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-02-09|||November 2011||2011-11-01|February 2012|2012-02-01|August 2012|Anticipated|2012-08-01|April 2012|Anticipated|2012-04-01||Interventional|||Gycabiane and Glycemic Control of Prediabetic Subjects|Effect of Glycabiane, a Dietary Supplement, on Glycemic Control of Prediabetic Subjects|Unknown status|Recruiting|Phase 3|60|Anticipated|Pileje||2|||f||||||||||||||2017-10-11 03:18:05.454484|2017-10-11 03:18:05.454484
NCT01530672|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2014-10-27|||January 2012||2012-01-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional|MBIO||Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test|Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test|Completed||N/A|2900|Actual|PATH||1|||f||||f||||||||||2017-10-11 03:18:05.540648|2017-10-11 03:18:05.540648
NCT01530659|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-10-26|||January 2012||2012-01-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa|Photoreceptor Structure in A Phase 2 Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants With Retinitis Pigmentosa Using Rates of Change in Cone Spacing and Density|Active, not recruiting||Phase 2|30|Anticipated|Neurotech Pharmaceuticals||1|||f||||t||||||||||2017-10-11 03:18:05.628254|2017-10-11 03:18:05.628254
NCT01530646|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2015-06-06|||February 2012||2012-02-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Impact of Whey and Soy Protein Ingestion in Conjunction With Energy Restriction in Overweight/Obese Individuals|Molecular Events Underpinning Changes in Tissue Metabolism With Whey and Soy Ingestion in Energy Restriction in Overweight/Obese Adults|Completed||N/A|42|Actual|McMaster University||3|||f||||t||||||||||2017-10-11 03:18:05.724225|2017-10-11 03:18:05.724225
NCT01530620|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-09|||December 2004||2004-12-01|February 2012|2012-02-01|July 2006|Actual|2006-07-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity|Efficacy and Tolerability of Propiverine Hydrochloride Extended Release (ER) Compared to Immediate Release (IR) in Patients With Neurogenic Detrusor Overactivity. A Randomized, Double Blind, Parallel Group, Multicenter Clinical Trial|Completed||Phase 3|66|Actual|APOGEPHA Arzneimittel GmbH||2|||f||||f||||||||||2017-10-11 03:18:05.897956|2017-10-11 03:18:05.897956
NCT01530243|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-02-15|2015-01-21||January 2012||2012-01-01|February 2015|2015-02-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms|Phase One of Study on Urinary Stent Complications and Treatment|Completed||Phase 2/Phase 3|104|Actual|Urmia University of Medical Sciences|Applying stents with the same size and length|4|||f||||t||||||||||2017-10-11 03:18:10.735752|2017-10-11 03:18:10.735752
NCT01530607|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-02-24|||November 2009||2009-11-01|February 2012|2012-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer|Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer|Completed||Phase 3|416|Actual|King Faisal Specialist Hospital & Research Center||2|||f||||||||||||||2017-10-11 03:18:06.007428|2017-10-11 03:18:06.007428
NCT01530594|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-02-24|||January 2009||2009-01-01|February 2012|2012-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma|Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma|Completed||Phase 3|440|Actual|King Faisal Specialist Hospital & Research Center||2|||f||||||||||||||2017-10-11 03:18:06.086972|2017-10-11 03:18:06.086972
NCT01530581|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-01-04|||November 2008||2008-11-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2012|Actual|2012-06-01||Interventional|||Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation|A Randomized Multicentre Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation for Hematologic Malignancies|Completed||Phase 3|230|Actual|King Faisal Specialist Hospital & Research Center||2|||f||||||||||||||2017-10-11 03:18:06.190273|2017-10-11 03:18:06.190273
NCT01530568|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-01-06|||August 2010||2010-08-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Gene Xpert Diagnosis of TB Using Tracheal Aspirates From Intensive Care Unit (ICU) Patients|A Randomised Control Trial of a Standardised and User-friendly Real-time PCR Assay for the Diagnosis of TB Using Tracheal Aspirates Obtained From Patients in the ICU|Completed||N/A|341|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-11 03:18:06.271079|2017-10-11 03:18:06.271079
NCT01530555|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-02-24|||April 2008||2008-04-01|February 2012|2012-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia|Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia|Completed||Phase 2|35|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-10-11 03:18:06.368642|2017-10-11 03:18:06.368642
NCT01530542|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-02-22|||July 2010||2010-07-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers|Open-Label, Single-Dose, Randomized, 5-Period, 5-Way Crossover Study To Evaluate The Dose Proportionality And The Effects Of Food On The Bioavailability Of Acurox Tablets In Healthy Volunteers|Completed||Phase 1|35|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 03:18:06.446419|2017-10-11 03:18:06.446419
NCT01530529|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-04-29|||January 2012||2012-01-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999|A Phase 1, Cross-Over, Single-Dose, Open-Label Study to Estimate the Relative Bioavailability of a Modified-Release Formulation of PF-05180999 Under Fed and Fasted Conditions in Healthy Adult Subjects|Completed||Phase 1|12|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 03:18:06.569742|2017-10-11 03:18:06.569742
NCT01530516|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-05-03|||October 2012||2012-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Crossbow Versus Forsus Springs in Mild to Moderate Class II Malocclusion Cases|3D Changes Comparing the Crossbow Appliance and Later Full Fixed Brackets Against Simultaneous Use of Full Fixed Brackets Plus Forsus Springs Among Mild to Moderate Class II Malocclusion Cases: A Randomized Clinical Trial.|Active, not recruiting||N/A|54|Actual|University of Alberta, Graduate Orthodontic Program||2|||f||||f||||||||No||2017-10-11 03:18:06.682317|2017-10-11 03:18:06.682317
NCT01530503|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-02-24|||November 2011||2011-11-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|BIT-2||Second Line Therapy in Advanced Biliary Tract Cancer|A Randomized Phase II Trial of Second Line Therapy in Advanced Biliary Tract Cancer: Capecitabine or Capecitabine Plus Mitomycin C|Completed||Phase 2|52|Actual|IRCCS San Raffaele||2|||f||||t||||||||||2017-10-11 03:18:06.792962|2017-10-11 03:18:06.792962
NCT01530490|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-02-09|||August 2007||2007-08-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|August 2008|Actual|2008-08-01||Interventional|||Cabergoline and Hydroxyethyl Starch in Ovarian Hyperstimulation Syndrome Prevention|Prevention of Ovarian Hyperstimulation Syndrome in GnRH Agonist IVF Cycles: Randomized Study Comparing Hydroxyethyl Starch Versus Cabergoline and Hydroxyethyl Starch|Completed||Early Phase 1|80|Actual|Hospital de Cruces||2|||f||||t||||||||||2017-10-11 03:18:06.932329|2017-10-11 03:18:06.932329
NCT01530477|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-08-08|2013-06-26||January 2012||2012-01-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|DXA P&A||DXA Precision and Accuracy Comparison Study|DXA Precision and Accuracy Comparison Study|Terminated||N/A|82|Actual|GE Healthcare||3||Early termination due to inability to meet enrollment for >350lb weight class|f||||f||||||||||2017-10-11 03:18:07.046459|2017-10-11 03:18:07.046459
NCT01530464|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2013-11-28|2013-09-01||February 2012||2012-02-01|November 2013|2013-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|GQ01||The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers|The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers|Completed||Phase 1|18|Actual|Duke University||3|||f||||||||||||||2017-10-11 03:18:07.437079|2017-10-11 03:18:07.437079
NCT01530451|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-02-02|||March 2012||2012-03-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients|Prospective, Randomized, Double-blind Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients|Terminated||Phase 3|9|Actual|Chinese University of Hong Kong||2||Insufficient funding|f||||f||||||||||2017-10-11 03:18:08.044735|2017-10-11 03:18:08.044735
NCT01530438|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-22|2014-04-08|||April 2009||2009-04-01|March 2014|2014-03-01|May 2015|Anticipated|2015-05-01|December 2014|Anticipated|2014-12-01||Interventional|SLAMEM||Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis|Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis : Neuropsychological, Imaging and Neuropathological Study|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Caen||3|||f||||||||||||||2017-10-11 03:18:08.142955|2017-10-11 03:18:08.142955
NCT01530412|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-18|2012-02-09|||June 2007||2007-06-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Long Term Evaluation of Activity Levels Post Pulmonary Rehabilitation|Long Term Evaluation of Activity Levels Post Pulmonary Rehabilitation: 1 Year Follow-up|Completed||N/A|65|Actual|Beaumont Hospital||2|||f||||f||||||||||2017-10-11 03:18:08.317924|2017-10-11 03:18:08.317924
NCT01530399|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2015-11-04|2015-11-04||March 2012||2012-03-01|November 2015|2015-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery|A Phase II, Double-blind, Parallel Group, Dose-selection Study to Compare Antifibrinolytic MDCO-2010 vs. Placebo and Tranexamic Acid in Reducing Blood Loss in Patients Undergoing Primary Cardiac Surgery|Terminated||Phase 2|44|Actual|The Medicines Company||6||Safety|f||||t||||||||||2017-10-11 03:18:08.421666|2017-10-11 03:18:08.421666
NCT01530386|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-08-16|||January 2012||2012-01-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects|A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects|Completed||Phase 1|25|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 03:18:09.26519|2017-10-11 03:18:09.26519
NCT01530373|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-02-13|||February 2012||2012-02-01|February 2017|2017-02-01|September 2021|Anticipated|2021-09-01|July 2021|Anticipated|2021-07-01||Interventional|||Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients|A Phase II Randomized Study of Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients Receiving Adjuvant Hormonal Therapy|Recruiting||Phase 2|110|Anticipated|University of Arkansas||2|||f||||t||||||||||2017-10-11 03:18:09.365408|2017-10-11 03:18:09.365408
NCT01530360|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-12-07|||September 2011||2011-09-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|SafeBoosC-p||Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants|Safeguarding the Brains of Our Smallest Children - a Pilot Study|Completed||Phase 1|10|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-10-11 03:18:09.497818|2017-10-11 03:18:09.497818
NCT01530347|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-02-09|||March 2012||2012-03-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Non Invasive Breath Based Acetone-meter- Easy Check|Assessing Feasibility of Non-invasive Breath Based Acetone Meter -Easy Check- Relative to Finger Capillary Blood Glucose and Beta Hydroxybutyrate Reference|Suspended||Phase 1|20|Anticipated|Rabin Medical Center||1||sponsor wish to amend the protocol before proceeding to segment 2 of the study|f||||f||||||||||2017-10-11 03:18:09.588636|2017-10-11 03:18:09.588636
NCT01530334|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-01-26|2015-07-27||July 2012||2012-07-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ICARUS|The overall number of patients was 61 (FAS population). FAS population was defined as all screened patients enrolled in the study|Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment|A Phase II Open Label, Multicentre, Single Arm Study to Characterise the Efficacy, Safety and Tolerability of Gefitinib 250 mg (IRESSA) as 3rd Line Treatment Re-challenge in Patients, Who Have Epidermal Growth Factor Receptor (EGFR) Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) and Who Responded to Gefitinib in 1st Line and Progressed After 2nd Line Chemotherapy|Completed||Phase 2|61|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 03:18:09.683204|2017-10-11 03:18:09.683204
NCT01530321|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-09-07|||August 2012||2012-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|CGH D-R||Cervicogenic Headache Dose-Response|Dose-Response of Manipulation for Cervicogenic Headache|Completed||Phase 1/Phase 2|256|Actual|University of Western States||4|||f||||t||||||||||2017-10-11 03:18:10.02961|2017-10-11 03:18:10.02961
NCT01530308|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-11-25|||November 2012||2012-11-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|HARPOON||Haloperidol Prophylaxis in Older Emergency Department Patients|Early Pharmacological Intervention to Prevent Delirium: Haloperidol Prophylaxis in Older Emergency Department Patients|Completed||Phase 4|242|Actual|VU University Medical Center||2|||f||||t||||||||||2017-10-11 03:18:10.23678|2017-10-11 03:18:10.23678
NCT01530295|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2012-02-07|||July 2008||2008-07-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer|Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant in Patients With High Risk Locallized Prostate Cancer|Unknown status|Recruiting|N/A|70|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 03:18:10.366234|2017-10-11 03:18:10.366234
NCT01530282|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-02-08|||February 2012||2012-02-01|February 2012|2012-02-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|ERNI||Non-invasive Measurements of Elastance and Resistance|Non-invasive Respiratory Mechanics Assessment During Spontaneous / Assisted Breathing: The ERNI (Elastance, Resistance, Non Invasive Measurements) Study|Unknown status|Not yet recruiting|Phase 2|15|Anticipated|University of Turin, Italy||1|||f||||f||||||||||2017-10-11 03:18:10.468585|2017-10-11 03:18:10.468585
NCT01530269|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2017-04-03|||April 2012||2012-04-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma|C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma|Recruiting||Phase 2|300|Anticipated|Phoenix Molecular Imaging||1|||f||||f||||||||No||2017-10-11 03:18:10.541438|2017-10-11 03:18:10.541438
NCT01530256|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-09-13||2014-06-23|March 2012||2012-03-01|September 2017|2017-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|ALD518-010||Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)|An Exploratory Phase 1/2 Clinical Trial Evaluating ALd518 in Subjects With Glucocorticoid-Refractory Acute Graft vs. Host Disease (GVHD) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT)|Completed||Phase 1/Phase 2|3|Actual|Vitaeris INC||1|||f||||t||||||||||2017-10-11 03:18:10.636932|2017-10-11 03:18:10.636932
NCT01530230|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-02-10|||November 2005||2005-11-01|February 2012|2012-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||ST- Depression on Electrocardiogram During Caesarean Section in Regional Anaesthesia in Women With Preeclampsia|Randomised Study on Cardiac Effects of Oxytocin During Caesarean Section in Preeclamptic Women|Completed||N/A|25|Actual|Uppsala University Hospital||2|||f||||||||||||||2017-10-11 03:18:11.14488|2017-10-11 03:18:11.14488
NCT01530217|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-02-08|||March 2011||2011-03-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Assessing of Tooth Sensitivity Using Ibuprofen Before in Office-tooth Bleaching|Assessing of Tooth Sensitivity Using Ibuprofen Before in Office-tooth Bleaching: a Randomized, Triple-blind Clinical Trial|Completed||N/A|30|Actual|Universidade Estadual de Ponta Grossa||1|||f||||t||||||||||2017-10-11 03:18:11.230766|2017-10-11 03:18:11.230766
NCT01530204|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-10-26|||July 2011||2011-07-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|RAPID||RAPID: Reducing Pain; Preventing Depression|RAPID: Reducing Pain; Preventing Depression|Completed||Phase 4|135|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 03:18:11.311884|2017-10-11 03:18:11.311884
NCT01530191|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2013-10-15|||September 2011||2011-09-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Factors Affecting Perioperative Outcomes|Factors Affectign Perioperative Outcomes After Surgery for Pelvic Organ Prolapse|Withdrawn||N/A|0|Actual|University of Oklahoma|||2|No subject accrual|f||||f||||||||||2017-10-11 03:18:11.409134|2017-10-11 03:18:11.409134
NCT01530165|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-01-03|||December 2011||2011-12-01|January 2014|2014-01-01|October 2015|Anticipated|2015-10-01|October 2014|Anticipated|2014-10-01||Interventional|PDPP||(Pakistan Diabetes Prevention Program PDPP)|A Translation Randodomized Trial of Culturally Specific and Cost Effective Life Style Intervention for the Prevention of Type 2 Diabetes in Pakistan|Unknown status|Active, not recruiting|N/A|20000|Anticipated|Aga Khan University||2|||f||||t||||||||||2017-10-11 03:18:11.594173|2017-10-11 03:18:11.594173
NCT01530152|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-06-18|||January 2012||2012-01-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Method Evaluation Study of Truview Picture Capture Device(PCD) Versus MacIntosh Laryngoscope|Method Evaluation Study of Truview PCD Versus MacIntosh Laryngoscope|Completed||N/A|56|Actual|Aalborg Universitetshospital||1|||f||||f||||||||||2017-10-11 03:18:11.673878|2017-10-11 03:18:11.673878
NCT01530139|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-02-25|||August 2012||2012-08-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|Food4Me||Strategies for Personalised Nutrition|Personalised Nutrition: An Integrative Analysis of Opportunities and Challenges|Completed||N/A|1607|Actual|Newcastle University||4|||f||||f||||||||Yes|Data will be available upon request from the Project leader Professor Mike Gibney and Professor John Mathers.|2017-10-11 03:18:11.741966|2017-10-11 03:18:11.741966
NCT01530126|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-01-06|||January 2000||2000-01-01|January 2016|2016-01-01|January 2007|Actual|2007-01-01|January 2005|Actual|2005-01-01||Interventional|||Platelet Derived Growth Factor Stimulates Bone Fill and Rate of Attachment Level Gain|Platelet Derived Growth Factor Stimulates Bone Fill and Rate of Attachment Level Gain|Completed||N/A|180|Actual|University of Michigan||3|||f||||f||||||||||2017-10-11 03:18:11.863418|2017-10-11 03:18:11.863418
NCT01530113|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-02-08|||March 2012||2012-03-01|January 2012|2012-01-01|March 2015|Anticipated|2015-03-01|March 2014|Anticipated|2014-03-01||Observational|CSA-V-LD||Childhood Sexual Abuse, Vaginismus and Labor Dystocia|Childhood Sexual Abuse, Vaginismus and Labor Dystocia: Towards a Theoretical Model|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 03:18:11.960133|2017-10-11 03:18:11.960133
NCT01530100|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2014-12-01|||February 2012||2012-02-01|February 2012|2012-02-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Observational|||Lower Laser Therapy in Orthognathics Surgery|Lower Laser Therapy in Orthognathics Surgery - Double Blind Study.|Completed||N/A|10|Actual|Universidade Federal de Goias|||1||f||||f||||||||||2017-10-11 03:18:12.035456|2017-10-11 03:18:12.035456
NCT01530087|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-02-22|2015-09-22||January 2012||2012-01-01|September 2015|2015-09-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Preliminary Evaluation of CASTLE Barrier Prototype UK|Peristomal Skin Irritation: A Preliminary Evaluation of the CASTLE Barrier Prototype for People With Intestinal Stomas|Terminated||N/A|3|Actual|Hollister Incorporated||1||Inability of site to recruit/enroll target population|f||||f||||||||||2017-10-11 03:18:12.10642|2017-10-11 03:18:12.10642
NCT01530074|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-08|||March 2012||2012-03-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Quantitative Sensory Testing of the Lower Lip After Inferior Alveolar Nerve Block, and Evaluation of the Role of the Contra-lateral Inferior Alveolar Nerve||Unknown status|Not yet recruiting|N/A|60|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 03:18:12.260157|2017-10-11 03:18:12.260157
NCT01530061|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-08-16|||February 2012||2012-02-01|August 2012|2012-08-01|April 2013|Anticipated|2013-04-01|August 2012|Actual|2012-08-01||Interventional|||The Satiating Effect of Eggs in Children|The Satiating Effect of Eggs in Children|Unknown status|Active, not recruiting|N/A|30|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 03:18:12.328546|2017-10-11 03:18:12.328546
NCT01530048|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-10-14|||March 2006||2006-03-01|October 2016|2016-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)|A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial, Assessing the Bioequivalence Between Insulin Aspart 100 U/mL and Insulin Aspart 200 U/mL in Healthy Individuals|Completed||Phase 1|34|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:18:12.417932|2017-10-11 03:18:12.417932
NCT01530035|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-05-04|||March 2011||2011-03-01|May 2017|2017-05-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Cardiovascular and Muscular Adaptations to Recreational Soccer and Strength Training in Elderly Healthy 65-75-year-old Men|Cardiovascular and Muscular Adaptations to Recreational Soccer and Strength Training in Elderly Healthy 65-75-year-old Men|Completed||N/A|41|Actual|University of Copenhagen||4|||f||||f||||||||||2017-10-11 03:18:12.518436|2017-10-11 03:18:12.518436
NCT01524263|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-01-30|||July 2009||2009-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:19:57.594106|2017-10-11 03:19:57.594106
NCT01530022|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2014-01-23|||May 2012||2012-05-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects|A Multicenter, Randomized, Double-blind, Double-dummy, 2-period Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects|Completed||Phase 1|60|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:18:12.607658|2017-10-11 03:18:12.607658
NCT01530009|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-07-24|||January 2012||2012-01-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children|The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children|Active, not recruiting||N/A|26|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-11 03:18:12.696365|2017-10-11 03:18:12.696365
NCT01529996|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-09-14|||January 2012||2012-01-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness|Comparison of the Efficacy Between Pulsed Dye Laser (PDL) and the Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness: A Pilot, Prospective Randomized Trial.|Completed||N/A|16|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 03:18:12.797766|2017-10-11 03:18:12.797766
NCT01529983|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-02-07|||February 2012||2012-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Fractional Laser vs. Ultrasound for Periorbital Wrinkles|A Comparison of 1550-nm Fractional Photothermolysis Versus Intense Focused Ultrasound for Treatment of Periorbital Wrinkles: A Pilot, Prospective Randomized Control Trial|Active, not recruiting||N/A|20|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 03:18:12.874448|2017-10-11 03:18:12.874448
NCT01529970|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-08|||January 2012||2012-01-01|February 2012|2012-02-01||||||||Observational|||Genetic Study in Young Onset Parkinson's Disease||Unknown status|Active, not recruiting|N/A|60|Anticipated|China Medical University Hospital|||2||f||||||||||||||2017-10-11 03:18:12.94892|2017-10-11 03:18:12.94892
NCT01529957|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-16|||September 2008||2008-09-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion|A Phase I Clinical Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion|Completed||Phase 1|176|Actual|TaiGen Biotechnology Co., Ltd.||10|||f||||f||||||||||2017-10-11 03:18:13.007006|2017-10-11 03:18:13.007006
NCT01529944|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-04-29|||September 2008||2008-09-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658|Genetic Testing of Noonan Subjects Previously Treated With Norditropin® in the GHNOO-1658 Trial|Completed||Phase 3|22|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:18:13.140582|2017-10-11 03:18:13.140582
NCT01529931|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-10-13|||January 2012||2012-01-01|October 2016|2016-10-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|OHR-8-FU-1Y||Long Term Efficiency of the Hair2Go Device|Follow Up Study: The Effect Of Hair2Go Maintenance Treatments on Long Term Hair Removal|Completed||N/A|5|Actual|Syneron Medical||1|||f||||f||||||||No|Only 5 subjects enrolled into this protocol. Data was combined with OHR2-1Y protocol and reported under that study.|2017-10-11 03:18:13.237384|2017-10-11 03:18:13.237384
NCT01529918|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-08|||November 2009||2009-11-01|October 2009|2009-10-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Detecting Diabetes Sooner With a Risk Survey for the Family Doctor:Comparing Internet and Traditional Methods of Communication for Patients and Doctors|e-Diabetes:Uptake, Patient Preferences and Clinical Outcomes Regarding Self-screening and Clinical Follow-up Using Web-based Technologies in a Large Team-based Primary Care Setting|Unknown status|Active, not recruiting|N/A|2000|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 03:18:13.327884|2017-10-11 03:18:13.327884
NCT01529905|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2012-02-08|||June 1999||1999-06-01|June 2005|2005-06-01|June 2014|Anticipated|2014-06-01|September 2009|Actual|2009-09-01||Observational|||Longitudinal Study of People Presenting for First Treatment of a Mood Disorder|Longitudinal Study of Individuals Presenting With a First Treated Episode of Depression of Mania (First Episode Project)|Unknown status|Recruiting|N/A|200|Anticipated|McMaster University|||1||f||||||||||||||2017-10-11 03:18:13.3988|2017-10-11 03:18:13.3988
NCT01529892|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-05-29||||||May 2013|2013-05-01||||||||Interventional|||The Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine|An Open-Label Study to Evaluate the Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine in Healthy Adults|Withdrawn||Phase 4|0|Actual|California Pacific Medical Center Research Institute||2|||f||||t||||||||||2017-10-11 03:18:13.635342|2017-10-11 03:18:13.635342
NCT01529879|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-03-30|||August 2011||2011-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Polaris||Assessment of the Effect of an Implant System With a Novel Abutment Attachment Design on Crestal Bone Preservation|A Prospective Randomized-Controlled Evaluation of an Implant System With a Novel Abutment Attachment Design for the Preservation of Crestal Bone|Completed||N/A|49|Actual|Zimmer Biomet||2|||f||||f||||||||No||2017-10-11 03:18:13.715962|2017-10-11 03:18:13.715962
NCT01529866|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-03-30|||August 2011||2011-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Bridge||Study of the Integration Success of an Implant System With a Novel Abutment Attachment Design in Immediate Loading Cases|A Prospective Randomized-controlled Study of the Integration Success Rate of an Implant System With a Novel Abutment Attachment in Cases Loaded Immediately|Completed||N/A|60|Actual|Zimmer Biomet||2|||f||||f||||||||No||2017-10-11 03:18:13.80015|2017-10-11 03:18:13.80015
NCT01529853|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-01-22||2016-01-22|January 2012||2012-01-01|January 2016|2016-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)|Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Repeated Doses of SAR156597 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 1/Phase 2|24|Actual|Sanofi||4|||f||||t||||||||||2017-10-11 03:18:13.88773|2017-10-11 03:18:13.88773
NCT01529658|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-10-25|||September 2012||2012-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Renal Hypothermia During Partial Nephrectomy|A Randomized Controlled Trial of Renal Hypothermia During Partial Nephrectomy|Active, not recruiting||N/A|184|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||No||2017-10-11 03:18:15.906092|2017-10-11 03:18:15.906092
NCT01529840|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2017-01-17|||June 1990||1990-06-01|January 2017|2017-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome|Norditropin Treatment in Subjects With Noonan Syndrome. Effects on Linear Growth and Final Height - Data Collection and Follow-up Visit|Completed||Phase 3|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:18:14.016731|2017-10-11 03:18:14.016731
NCT01529827|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-09-08|2017-06-30||February 28, 2012|Actual|2012-02-28|September 2017|2017-09-01|May 1, 2018|Anticipated|2018-05-01|May 28, 2015|Actual|2015-05-28||Interventional||All treated and eligible patients|Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies|A Phase II Trial of Reduced Intensity Allogeneic Stem Cell Transplantation With Fludarabine, Melphalan and Low Dose Total Body Irradiation|Active, not recruiting||Phase 2|94|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 03:18:14.109442|2017-10-11 03:18:14.109442
NCT01529814|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-03-30|||July 2011||2011-07-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Comet||Assessment of Integration Success of an Implant System With a Novel Abutment Attachment Design in Early Loaded Cases|A Prospective Randomized-controlled Study of the Integration Success Rate of an Implant System With a Novel Abutment Attachment in Cases Loaded Early|Completed||N/A|49|Actual|Zimmer Biomet||2|||f||||f||||||||No||2017-10-11 03:18:14.566653|2017-10-11 03:18:14.566653
NCT01529801|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-03-30|||February 2011||2011-02-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|Luna||Assessment of the Effect of a Novel Surface Roughness Treatment on Dental Implants on Integration Success|A Prospective Randomized-controlled Study of the Effect of Surface Topographies on Implant Integration Rates and Clinical Success|Completed||N/A|80|Actual|Zimmer Biomet||3|||f||||f||||||||No||2017-10-11 03:18:14.694179|2017-10-11 03:18:14.694179
NCT01529788|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2014-09-29|||September 2009||2009-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2012|Actual|2012-09-01||Interventional|||Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study|"A Double Blinded Randomized Controlled Trial to Compare the Efficacy, Time to Onset, and Duration of Two Botulinum Type A Exotoxins (Onabotulinum Toxin A and Abobotulinum Toxin A) in the Treatment of Crow's Feet."|Completed||Phase 4|90|Actual|The Maas Clinic||1|||f||||f||||||||||2017-10-11 03:18:14.828806|2017-10-11 03:18:14.828806
NCT01529775|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-03-28|||November 2010||2010-11-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Bolivar||Randomized Study of Osseotite Certain Tapered Prevails vs. Osseotite Certain Tapered|A Prospective Randomized-controlled Evaluation of the Osseotite Certain Tapered Prevail Implant for the Preservation of Crestal Bone|Completed||N/A|92|Actual|Zimmer Biomet||2|||f||||f||||||||No||2017-10-11 03:18:14.959909|2017-10-11 03:18:14.959909
NCT01529762|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-03-20|||January 2011||2011-01-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|Carrera||Observational Study of Osseotite Certain Tapered Implants in Immediate Loading Cases|A Prospective, Observational Study of Immediate Loading Cases Using Osseotite Certain Tapered Implants|Completed||N/A|47|Actual|Zimmer Biomet|||1||f||||f||||||||No||2017-10-11 03:18:15.080163|2017-10-11 03:18:15.080163
NCT01529749|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-08|2016-02-18|||February 2012||2012-02-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|March 2012|Actual|2012-03-01||Interventional|||Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated|Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation|Completed||Phase 4|48|Actual|Hospital Clinic of Barcelona||4|||f||||f||||||||||2017-10-11 03:18:15.165499|2017-10-11 03:18:15.165499
NCT01529736|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2017-03-20|||December 2010||2010-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Pegasus||Randomized Study of Integration Success of Osseotite Dental Implants Placed Using Different Insertion Procedures|Prospective Randomized-controlled Study of the Integration Success of Osseotite Implants Placed With Different Insertion Procedures|Completed||N/A|60|Actual|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-10-11 03:18:15.26956|2017-10-11 03:18:15.26956
NCT01529723|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-04-07|||February 2012||2012-02-01|April 2016|2016-04-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Observational|||Validity of a New Stroke Dysphagia Screening Tool|Validity of a New Stroke Dysphagia Screening Tool|Withdrawn||N/A|0|Actual|Rhode Island Hospital|||1||f||||f||||||||||2017-10-11 03:18:15.384435|2017-10-11 03:18:15.384435
NCT01529710|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2015-02-19|||December 2011||2011-12-01|February 2015|2015-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PHAR0211||Safety and Efficacy of Mirazid for Schistosomiasis Treatment|Safety and Efficacy of Mirazid for Schistosomiasis Treatment as Compared to Praziquantel: An Open-label Randomized Non-placebo-Controlled Study|Completed||Phase 3|200|Actual|Pharco Pharmaceuticals||2|||f||||t||||||||||2017-10-11 03:18:15.461983|2017-10-11 03:18:15.461983
NCT01529697|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2016-01-11|||February 2012||2012-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|INCA||Prospective Study of the Feedback From an Adherence Monitor on Asthma Control|Prospective Study of the Feedback From an Adherence Monitor on Asthma Control|Completed||N/A|220|Actual|Beaumont Hospital||2|||f||||f||||||||||2017-10-11 03:18:15.564503|2017-10-11 03:18:15.564503
NCT01529684|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-07|2013-04-12|||January 2012||2012-01-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body|A Phase 1, Open-label Study to Investigate the Absorption, Metabolism, and Excretion of 14C-OSI-906 in Subjects With Advanced Solid Tumors With an Optional Treatment Phase|Completed||Phase 1|5|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:18:15.666123|2017-10-11 03:18:15.666123
NCT01529671|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-12-10|||January 2012||2012-01-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee|An Investigator And Subject Blinded, Sponsor Open, Randomized, Placebo Controlled, Multiple Dose Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of Pf-05089771 In Healthy Subjects And In Subjects With Osteoarthritis Of The Knee|Completed||Phase 1|80|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 03:18:15.774924|2017-10-11 03:18:15.774924
NCT00005753|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||June 1997||1997-06-01|February 2005|2005-02-01|May 2002|Actual|2002-05-01|||||Observational|||Pharmacological and Behavioral Treatment of Insomnia||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:57.985984|2017-10-11 04:28:57.985984
NCT01529645|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-03-03|2014-04-30||March 2012||2012-03-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional||Analysis was done on the all enrolled set, ie, all subjects who have signed an informed consent, undergone screening procedures and were randomized.|Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years|Phase I, Randomized, Controlled, Observer-Blind, Dose-Ranging Study of Acellular Pertussis and Tetanus-Diptheria-Acellular Pertussis Booster Vaccine in Adults Ages 18 to 40 Years.|Completed||Phase 1|420|Actual|Novartis||10|||f||||||||||||||2017-10-11 03:18:16.082161|2017-10-11 03:18:16.082161
NCT01529632|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2014-01-16|2013-12-02||May 2012||2012-05-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|BEACON||Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Study to Compare the Efficacy and Safety of Once Daily QVA149 Versus the Once Daily Concurrent Administration of QAB149 Plus NVA237 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 3|193|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:18:18.515549|2017-10-11 03:18:18.515549
NCT01529619|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-11-16|||March 2012||2012-03-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors|A 24-week, Open-label, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease (MMSE 10-23) Switched From Cholinesterase Inhibitors (Donepezil, Galantamine)|Completed||Phase 4|52|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:18:18.975475|2017-10-11 03:18:18.975475
NCT01529606|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2014-09-23|||September 2012||2012-09-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Cold Plasma for Dental Restoration and Caries Prevention|Development of a Miniature Plasma Brush for Dental Clinical Applications|Completed||Phase 1/Phase 2|102|Actual|Nanova, Inc||2|||f||||t||||||||||2017-10-11 03:18:19.085409|2017-10-11 03:18:19.085409
NCT01529593|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-10-31|||March 2012||2012-03-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Temsirolimus in Combination With Metformin in Patients With Advanced Cancers|Phase I Study of Temsirolimus in Combination With Metformin in Patients With Advanced Cancers|Recruiting||Phase 1|104|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:18:19.170576|2017-10-11 03:18:19.170576
NCT01529580|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-04-14|||January 2012||2012-01-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||School-Age Children With Autism With Limited Expressive Language Skills|School-Age Children With Autism With Limited Expressive Language Skills: An Intervention Study|Completed||N/A|13|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||3|||f||||f||||||||||2017-10-11 03:18:19.279376|2017-10-11 03:18:19.279376
NCT01529567|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2013-02-14|||November 2011||2011-11-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel Syndrome||Completed||N/A|311|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:18:19.396239|2017-10-11 03:18:19.396239
NCT01529554|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2015-08-19|||December 2014||2014-12-01|August 2015|2015-08-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|CLEVER-ACS||Controlled Level EVERolimus in Acute Coronary Syndromes|Phase I-II Randomized Prospective Double-blind Multi-center Trial on the Effects of a Short Course of Oral Everolimus on Infarct Size, Left Ventricular Remodeling and Inflammation in Patients With Acute ST-Elevation Myocardial Infarction|Unknown status|Recruiting|Phase 1/Phase 2|150|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 03:18:19.48194|2017-10-11 03:18:19.48194
NCT01529541|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2014-05-12|||May 2011||2011-05-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|CWP-DIANA-302||Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone|A Multicenter, Randomized, Double-blind, Double Dummy, Active-controlled, Therapeutic Confirmatory Trial(Phase 3) to Evaluate the Efficacy and Safety of CWP-0403 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 DM Insufficiently Controlled With Metformin Alone|Completed||Phase 3|200|Anticipated|JW Pharmaceutical||2|||f||||f||||||||||2017-10-11 03:18:19.578684|2017-10-11 03:18:19.578684
NCT01529528|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2013-01-02|||May 2011||2011-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|CWP-DIANA-301||A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients|A Multicenter, Randomized, Double Blind, Placebo Controlled, Therapeutic Confirmatory Trial(Phase 3) to Evaluate Efficacy and Safety of CWP-0403 in Type 2 DM Patients|Completed||Phase 3|117|Actual|JW Pharmaceutical||3|||f||||f||||||||||2017-10-11 03:18:19.657869|2017-10-11 03:18:19.657869
NCT01529515|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-05-02|2015-04-07||May 2012||2012-05-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia|A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia|Completed||Phase 3|509|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 03:18:19.751409|2017-10-11 03:18:19.751409
NCT01529502|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-04-17|2016-10-26||March 2012||2012-03-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting|Effects of Stored Red Blood Cell Transfusion in Overweight Subjects With Endothelial Dysfunction: Influence of Inhaled Nitric Oxide (iNO)|Completed||Phase 2|14|Actual|Massachusetts General Hospital||3|||f||||t||||||||No||2017-10-11 03:18:22.238948|2017-10-11 03:18:22.238948
NCT01529489|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-06|||January 2008||2008-01-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|BVPS-123||Effect of Two Physical Training Programs on Oxygen Uptake and Heart Rate On-kinetics in Patients COPD|Effect of the Combined (Aerobic/Resisted) and Interval Physical Training on Oxygen Uptake and Heart Rate On-kinetics Responses in Patients With Moderate to Very Severe COPD: Double-blind, Randomized, Controlled Trial|Completed||N/A|40|Actual|Universidade Federal de Sao Carlos||4|||f||||f||||||||||2017-10-11 03:18:22.708803|2017-10-11 03:18:22.708803
NCT00004694|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||January 1994||1994-01-01|April 1999|1999-04-01|September 1998||1998-09-01|||||Interventional|||Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations||Completed||N/A|24||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.655842|2017-10-11 04:26:56.655842
NCT01529476|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-06-17|||April 2011||2011-04-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP|A Randomized, Double-Blind, Comparative, Multi-Center Study of the Safety and Efficacy of TG-873870(Nemonoxacin) Versus Levofloxacin in Adult Patients With Community-Acquired Pneumonia (CAP)|Completed||Phase 3|540|Actual|TaiGen Biotechnology Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:18:22.968935|2017-10-11 03:18:22.968935
NCT01529463|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-25|2013-02-28|||January 2011||2011-01-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Observational|||Effect of Post Discharge Follow-up on Readmission Rates for Congestive Heart Failure Patients|Effect of Post Discharge Follow-up on Readmission Rates for Congestive Heart Failure Patients|Completed||N/A|21|Actual|Saint Francis Care|||1||f||||f||||||||||2017-10-11 03:18:23.179502|2017-10-11 03:18:23.179502
NCT01529450|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-11-23|2016-03-11||February 2012||2012-02-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Participants with evaluable data are included for Baseline Characteristics|Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors|A Pilot Open-Label Study to Examine the Safety and Efficacy of Oral LDE225 in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma Who Have Been Previously Treated With Non-LDE225 Smoothened Inhibitor(s)|Completed||N/A|11|Actual|Stanford University||2|||f||||t||||||||No||2017-10-11 03:18:23.274048|2017-10-11 03:18:23.274048
NCT01529437|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-11-24|||January 2005||2005-01-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|SLIT||Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies|Phase 1 Single Center, Randomized, Controlled Study Using Sublingual Immunotherapy for Timothy Grass and Dust Mite Allergies|Completed||Phase 1|31|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 03:18:23.660999|2017-10-11 03:18:23.660999
NCT01529424|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-06-14||2016-06-14|February 2012||2012-02-01|June 2016|2016-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in Hypertriglyceridemia|A Randomized, Double-Blind, Placebo-Controlled, Dose Response, Phase 2 Study of ISIS 304801 Administered Subcutaneously to Patients With Severe or Uncontrolled Hypertriglyceridemia|Completed||Phase 2|89|Actual|Ionis Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-10-11 03:18:23.745343|2017-10-11 03:18:23.745343
NCT01529411|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2014-12-17|||February 2012||2012-02-01|February 2012|2012-02-01|December 2014|Actual|2014-12-01|February 2013|Actual|2013-02-01||Interventional|MAJA||Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer|Randomized Phase II Study of Vinflunine as Maintenance Monotherapy in Patients With Advanced or Metastatic Urothelial Cancer That Obtains Clinical Benefit of the First Line With Cisplatin-gemcitabine Combination|Completed||Phase 2|86|Actual|Spanish Oncology Genito-Urinary Group||2|||f||||f||||||||||2017-10-11 03:18:23.855712|2017-10-11 03:18:23.855712
NCT01529398|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2012-02-08|||March 2008||2008-03-01|February 2012|2012-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Sensorimotor Training Versus Resistance Training in Patients With Knee Osteoarthritis|Efficacy of a Sensorimotor Training in Patients With Knee Osteoarthritis: a Randomized Clinical Trial|Completed||Phase 2/Phase 3|96|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-10-11 03:18:23.971405|2017-10-11 03:18:23.971405
NCT01529385|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-05-13|2016-04-07||February 2012||2012-02-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes|Efficacy of a Mild Compression Diabetic Sock Versus A Non- Compression Diabetic Sock in the Control of Lower Extremity Edema in Patients With Diabetes: A Randomized Controlled Trial|Completed||N/A|80|Actual|Rosalind Franklin University of Medicine and Science||2|||f||||f||||||||No||2017-10-11 03:18:24.103503|2017-10-11 03:18:24.103503
NCT01529372|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-04-04|||May 2012||2012-05-01|November 2014|2014-11-01|June 2016|Anticipated|2016-06-01|February 2015|Actual|2015-02-01||Interventional|REALISE||REnAL denervatIon by ultraSound Transcatheter Emission|REnAL denervatIon by ultraSound Transcatheter Emission|Unknown status|Active, not recruiting|N/A|20|Actual|ReCor Medical, Inc.||1|||f||||f||||||||||2017-10-11 03:18:25.054533|2017-10-11 03:18:25.054533
NCT01529359|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-02-06|||April 2010||2010-04-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|||Irritable Bowel Syndrome and Lactibiane Tolerance|Effect of Lactibiane Tolerance on Symptoms Severity of Irritable Bowel Syndrome|Unknown status|Recruiting|Phase 3|94|Anticipated|Pileje||2|||f||||f||||||||||2017-10-11 03:18:25.151374|2017-10-11 03:18:25.151374
NCT01529346|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-08-01|||December 2011||2011-12-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy Of PF-05089771 In Treating Postoperative Dental Pain|A Randomized, Double-Blind, Double-Dummy, Parallel Group, Placebo Controlled Study Assessing The Efficacy Of Single Doses Of PF-05089771 For The Treatment Of Postoperative Dental Pain Using Ibuprofen 400 mg As Positive Control|Completed||Phase 2|235|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 03:18:25.270068|2017-10-11 03:18:25.270068
NCT01529333|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-06|||May 2012||2012-05-01|February 2012|2012-02-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||Middle-Ear Implant With MET V Transducer (Aka MET V System)|Middle Ear Implant With MET V for Mixed Hearing Loss|Unknown status|Not yet recruiting|N/A|130|Anticipated|Otologics LLC||1|||f||||f||||||||||2017-10-11 03:18:25.413562|2017-10-11 03:18:25.413562
NCT01529320|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-05-11|||February 2012||2012-02-01|May 2016|2016-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers|Pilot, Phase I, Single Blind Trial to Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers. (PRURITUS- Nimpa Study).|Completed||Phase 1|18|Actual|Fundacion IMIM||1|||f||||f||||||||||2017-10-11 03:18:25.481511|2017-10-11 03:18:25.481511
NCT01529307|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-12-10|||June 2012||2012-06-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||First in Human Trial of TAS266 in Patients With Advanced Solid Tumors|A Phase I, Open-label Dose Escalation Study With Safety Expansion of TAS266 Administered by IV Infusion to Patients With Advanced Solid Tumors|Terminated||Phase 1|6|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:18:25.568711|2017-10-11 03:18:25.568711
NCT01529294|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2013-03-13|||August 2010||2010-08-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers|Open-label, Single-dose, Parallel-group Study to Compare the PKs of Iloperidone in Subjects With Mild or Moderate Hepatic Impairment With That in Matched Healthy Control Subjects|Completed||Phase 1|90|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:18:25.656666|2017-10-11 03:18:25.656666
NCT01529281|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-06|||June 2011||2011-06-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Exercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino Acids|Exercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino Acids|Completed||N/A|12|Actual|Northumbria University||2|||f||||f||||||||||2017-10-11 03:18:25.746278|2017-10-11 03:18:25.746278
NCT01529268|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-08-02|2017-04-10||June 2012||2012-06-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|CyNCh||Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children|Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)|Completed||Phase 2/Phase 3|169|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t|t|f||||||||2017-10-11 03:18:25.869904|2017-10-11 03:18:25.869904
NCT01529255|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-06-17|||August 2011||2011-08-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|EFFORT-Ex||EFFORT Extension Study|A 3-year, Open-label, Multi-center Extension Trial of Telbivudine Therapy for Patients Previously Treated in EFFORT Clinical Trial|Unknown status|Active, not recruiting|Phase 4|576|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 03:18:27.242858|2017-10-11 03:18:27.242858
NCT01529242|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-02-15|||February 2014|Actual|2014-02-01|February 2017|2017-02-01|October 20, 2016|Actual|2016-10-20|August 2016|Actual|2016-08-01||Interventional|||Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment|A Double-blind, Randomized, Multicenter Parallel-group Study on Efficacy of Desloratadine and Prednisolone Association Compared to Dexchlorpheniramine and Betamethasone Association in Children (2-12 Years) With Acute Cutaneous Rash|Terminated||Phase 3|17|Actual|EMS||2||By sponsor decision due to difficulty of recruitment|f||||t|f|f||||||||2017-10-11 03:18:27.527726|2017-10-11 03:18:27.527726
NCT01529216|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-03-15|||May 2012||2012-05-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|RUBY||Efficacy Study of the DIAMOND System to Treat Type 2 Diabetes Mellitus|An Advanced Configuration (The Third Generation) of the DIAMOND System for the Treatment of T2DM Patients - A Randomized, Double Blind Study|Completed||N/A|2|Actual|Metacure||2|||f||||f||||||||||2017-10-11 03:18:27.719261|2017-10-11 03:18:27.719261
NCT01529203|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-09-16|2014-03-24||February 2012||2012-02-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|FIRST||Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range|Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range|Completed||Phase 3|60|Actual|Galderma||1|||f||||f||||||||||2017-10-11 03:18:27.827412|2017-10-11 03:18:27.827412
NCT01529190|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-02-07|||March 2011||2011-03-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pregabalin on Interleukin-6 Levels in Living Donor Kidney|Effect of Preoperative Pregabalin on Pain Intensity and Interleukin-6 Levels in Living Donor Kidney|Completed||Phase 2|40|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:18:28.078073|2017-10-11 03:18:28.078073
NCT01529177|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2015-08-05|||February 2012||2012-02-01|August 2015|2015-08-01|February 2017|Anticipated|2017-02-01|September 2016|Anticipated|2016-09-01||Interventional|||Metformin for the Treatment of Unexplained Oligozspermia|Metformin for the Treatment of Unexplained Oligozspermia and Azoospermia|Unknown status|Recruiting|Phase 4|600|Anticipated|The Egyptian IVF-ET Center||2|||f||||t||||||||||2017-10-11 03:18:28.166473|2017-10-11 03:18:28.166473
NCT01529164|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2013-11-26|||October 2011||2011-10-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer|Phase II Study of Recombinant Endostatin Combined With Modified FOLFOX6 in Advanced Colorectal Cancer|Unknown status|Recruiting|Phase 2|51|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 03:18:28.26351|2017-10-11 03:18:28.26351
NCT01529151|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-06-08|||January 2012||2012-01-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) in Individuals With Vertigo|Effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) Alone or in Combination on Balance and Visual Function in Individuals With Vertigo and Somatic Dysfunction|Completed||N/A|26|Actual|Western University of Health Sciences||4|||f||||t||||||||||2017-10-11 03:18:28.367931|2017-10-11 03:18:28.367931
NCT01529138|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-04-10|||October 2011||2011-10-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of Axitinib and Temsirolimus in Solid Tumors|Phase I Study of Axitinib and Temsirolimus in Solid Tumors|Completed||Phase 1|13|Actual|Emory University||2|||f||||t||||||||||2017-10-11 03:18:28.473672|2017-10-11 03:18:28.473672
NCT01529125|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2014-01-22|||July 2011||2011-07-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|ARMAM||Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV|ART Pharmacokinetics, Mitochondrial Integrity, and Antioxidant Capacity in Severely Malnourished HIV-infected Malawian Children|Completed||N/A|42|Actual|Washington University School of Medicine|||3||f||||f||||||||||2017-10-11 03:18:28.553335|2017-10-11 03:18:28.553335
NCT01529112|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-08-28|2016-02-17|2015-10-05|November 2011|Actual|2011-11-01|August 2017|2017-08-01|June 27, 2015|Actual|2015-06-27|January 21, 2014|Actual|2014-01-21||Interventional|||A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral E7080 in Addition to Best Supportive Care (BSC) Versus BSC Alone in Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Who Have Failed at Least Two Systemic Anticancer Regimens|Completed||Phase 2|135|Actual|Eisai Inc.||2|||f||||t||||||||||2017-10-11 03:18:28.659288|2017-10-11 03:18:28.659288
NCT01529099|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-05-27|||January 2009||2009-01-01|June 2015|2015-06-01|July 2015|Actual|2015-07-01|January 2015|Actual|2015-01-01||Interventional|||Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEM|A Prospective, Non-comparative, Single Centre Study to Determine the Performance & Survivorship of the SIGMA HP® PARTIAL KNEE SYSTEM.|Completed||Phase 4|64|Actual|DePuy International||1|||f||||f||||||||||2017-10-11 03:18:29.664071|2017-10-11 03:18:29.664071
NCT01529086|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-08-22|||February 2012||2012-02-01|August 2016|2016-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||For Cause Prostate Biopsy in REDUCE Population Trial|Determining the Likelihood of Prostate Cancer Detection in Men Taking Dutasteride When Biopsy is Performed 'for Cause'.|Completed||N/A|6608|Actual|The Cleveland Clinic|||2||f||||f||||||||No||2017-10-11 03:18:29.754321|2017-10-11 03:18:29.754321
NCT01529073|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2015-01-13|||February 2012||2012-02-01|January 2015|2015-01-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection|Phase II Clinical Trial to Evaluate the Antiviral Activity of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in Individuals With Chronic Hepatitis Due to HCV Genotype 4 and Coinfected by HIV|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|Andaluz Health Service||1|||f||||t||||||||||2017-10-11 03:18:29.826715|2017-10-11 03:18:29.826715
NCT01529047|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2013-12-10|||February 2010||2010-02-01|December 2013|2013-12-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling|RTC of Web Versus In-Person SUD and Comorbidity Treatment|Unknown status|Enrolling by invitation|Phase 2|375|Anticipated|University of Washington||3|||f||||t||||||||||2017-10-11 03:18:30.00791|2017-10-11 03:18:30.00791
NCT01529034|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-09-19|||July 2012|Actual|2012-07-01|May 2017|2017-05-01||||April 2017|Actual|2017-04-01||Interventional|||Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters|An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters|Terminated||Phase 3|175|Actual|Proximagen, LLC||1|||f||||||||||||||2017-10-11 03:18:30.081002|2017-10-11 03:18:30.081002
NCT01529021|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-07|||October 2011||2011-10-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Reducing Children's Distress Towards Flu Vaccinations||Completed||N/A|57|Actual|University of Calgary|||2||f||||t||||||||||2017-10-11 03:18:30.414726|2017-10-11 03:18:30.414726
NCT01529008|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-05-23|||November 2011||2011-11-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Phase 3 Study on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head|Phase 3, Pivotal, Multicentre, Randomised, Double-blind Controlled Study to Evaluate the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB®) Implantation in Early Stage Non Traumatic Osteonecrosis of the Femoral Head|Recruiting||Phase 3|130|Anticipated|Bone Therapeutics S.A||2|||f||||t||||||||||2017-10-11 03:18:30.4908|2017-10-11 03:18:30.4908
NCT01528995|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-06-20|||February 2012||2012-02-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|KISS||Treatment of Fecal Incontinence After Obstetric Anal Sphincter Injuries|A Blinded Randomized Controlled Clinical Trial Comparing Sacral Nerve Modulation and Anal Bulking Injections as Treatment for Fecal Incontinence After Obstetric Anal Sphincter Injuries (OASIS).|Completed||N/A|68|Actual|University Hospital of North Norway||3|||f||||t||||||||||2017-10-11 03:18:30.6572|2017-10-11 03:18:30.6572
NCT01528982|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-07-28|||November 2008||2008-11-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Susceptibility to Pathological Gambling|Susceptibility to Pathological Gambling|Recruiting||N/A|600|Anticipated|University of Chicago||3|||f||||t||||||||||2017-10-11 03:18:30.739268|2017-10-11 03:18:30.739268
NCT01528969|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-07-14|2015-03-30||March 2012||2012-03-01|July 2015|2015-07-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Xylitol on Oral Microbiota in Children|The Effect of the Frequent Xylitol Chewing Gum Use on the Oral Microbiota in Children With High MS Counts|Completed||Phase 1/Phase 2|122|Actual|Kuwait University||2|||f||||f||||||||||2017-10-11 03:18:30.843577|2017-10-11 03:18:30.843577
NCT01528956|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2016-05-17|||February 2012||2012-02-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Genes in Samples From Younger Patients With Adrenocortical Tumor|Using New Approaches for Genomics Studies in Pediatric Adrenocortical Tumors: Whole Genome Sequencing; Deep Sequencing; miRNA; methDNA and SNP 6.0|Completed||N/A|10|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:18:31.17149|2017-10-11 03:18:31.17149
NCT01528943|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2012-02-07|||March 2012||2012-03-01|February 2012|2012-02-01||||March 2013|Anticipated|2013-03-01||Interventional|||Effect of Prostacyclin on Haemostasis in Abdominal Surgery|The Effect of Prostacyclin on Haemostasis as Evaluated by Thrombelastography and Endothelial Markers in Patients Undergoing Major Abdominal Surgery. A Pilot Study|Unknown status|Not yet recruiting|Phase 1|40|Anticipated|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 03:18:31.254648|2017-10-11 03:18:31.254648
NCT01528930|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-12-14|||February 2012||2012-02-01|December 2012|2012-12-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|||Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease|Inhaled Amikacin for Treatment of Intractable Nontuberculous Mycobacterial Lung Disease|Withdrawn||Phase 2|0|Actual|Samsung Medical Center||1||"Although this study was approved at the Institutional Review Board, Korea Food & Drug   Administration (KFDA) did not approve this study due to safety concern."|f||||f||||||||||2017-10-11 03:18:31.331261|2017-10-11 03:18:31.331261
NCT01528917|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-07-19|||June 2011||2011-06-01|April 2013|2013-04-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Observational|||An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype|An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype|Completed||N/A|49|Actual|Alexion Pharmaceuticals|||1||f||||f||||||||No||2017-10-11 03:18:31.41617|2017-10-11 03:18:31.41617
NCT01528891|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2015-12-15|2015-09-16||January 2012||2012-01-01|February 2012|2012-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation|Dexmedetomidine as a Rapid Bolus for Treatment and Prophylactic Prevention of Emergence Agitation in Anesthetized Children|Completed||Phase 3|418|Actual|Children's Hospital of Pittsburgh||2|||f||||f||||||||||2017-10-11 03:18:31.622574|2017-10-11 03:18:31.622574
NCT01528878|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-03-17|||April 2009||2009-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases|A Dose-finding, Safety and Preliminary Efficacy Study of Stereotactic Radiosurgery for Hepato-cellular Carcinoma and Metastatic Disease to the Liver.|Active, not recruiting||N/A|30|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 03:18:32.135088|2017-10-11 03:18:32.135088
NCT01528865|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-03-10|||December 2015||2015-12-01|March 2016|2016-03-01||||August 2017|Anticipated|2017-08-01||Interventional|||Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma|A Phase I/II Study of Safety and Efficacy of Lamivudine (EPIVIR®) and Tenofovir Disoproxil Fumarate (VIREAD®) Used to Lower the Plasma Level of Viral RNA of HERV-K(HML2) in Patients With Lymphoma|Withdrawn||Phase 1/Phase 2|0|Actual|University of Michigan Cancer Center||1||Funding was removed.|f||||t||||||||||2017-10-11 03:18:32.219991|2017-10-11 03:18:32.219991
NCT01528852|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-07|||October 2010||2010-10-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|CHX-Pemba||Chlorhexidine Cordcare for Reduction in Neonatal Mortality and Omphalitis|Efficacy of Use of Chlorhexidine to Clean Umbilical Cord of Neonates in First 10 Days for Reduction in Neonatal Mortality and Omphalitis - A Community Based Randomized, Double Masked Controlled Trial in Pemba Tanzania|Unknown status|Recruiting|Phase 3|28000|Anticipated|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-10-11 03:18:32.303445|2017-10-11 03:18:32.303445
NCT01528826|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-29|2012-02-07|||December 2011||2011-12-01|February 2012|2012-02-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|NVBOX||Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial|A Prospective Phase II Trial of Vinorelbine Plus Oxaliplatin in Pretreated Metastatic Triple-negative Breast Cancer|Unknown status|Recruiting|Phase 2|35|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 03:18:32.485752|2017-10-11 03:18:32.485752
NCT01528813|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2013-08-05|||February 2012||2012-02-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis|AVALIAÇÃO DO USO DO LASER ERBIUM-DOPED YTTRIUM ALUMINIUM GARNET (Er:YAG) ASSOCIADO AO ESMALTE DE AMOROLFINA NO TRATAMENTO DA ONICOMICOSE|Unknown status|Recruiting|Phase 2|30|Anticipated|Brasilia University Hospital||2|||f||||f||||||||||2017-10-11 03:18:32.582891|2017-10-11 03:18:32.582891
NCT01528800|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-07-24|||November 2012||2012-11-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|iPACKHD||Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients|Inhibit Progression of Coronary Artery Calcification With Vitamin K in HemoDialyis Patients: iPACKHD Study|Recruiting||Phase 2|80|Anticipated|Clinical Evaluation Research Unit at Kingston General Hospital||2|||f||||f||||||||||2017-10-11 03:18:32.718415|2017-10-11 03:18:32.718415
NCT01528787|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-05|2016-06-08||2014-02-17|March 2012||2012-03-01|June 2016|2016-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study of Netarsudil (AR-13324) in Patients With Elevated Intraocular Pressure|A Phase 2, Double-masked, Randomized, Placebo-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of Three Doses of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Elevated Intraocular Pressure|Completed||Phase 2|85|Actual|Aerie Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:18:32.839203|2017-10-11 03:18:32.839203
NCT01528774|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-07-24|||June 2016||2016-06-01|July 2017|2017-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|CTC||Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers|Culture and Characterization of Circulating Tumor Cells (CTC) From Patients With Malignant Melanoma and Other Cancers|Completed||N/A|150|Actual|Comprehensive Cancer Centers of Nevada|||5||f||||f||||||Samples With DNA|"     Whole blood (up to 40 cc) collected in four 7.5 - 10 ml tubes. Serum samples may be stored     frozen in a coded, de-identified format until DNA or RNA is extracted for assays to allow for     batch processing. Samples will be consumed in the course of the research studies. Viable     tumor cells may be grown as long-term cell lines.   "|||2017-10-11 03:18:32.944953|2017-10-11 03:18:32.944953
NCT01528761|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-04-19|||August 15, 2011|Actual|2011-08-15|April 2017|2017-04-01|March 28, 2017|Actual|2017-03-28|March 28, 2017|Actual|2017-03-28||Interventional|||Prosocial Behavior and Volunteerism to Promote Physical Activity in Older Adults|Prosocial Behavior and Volunteerism to Promote Physical Activity in Older Adults|Completed||N/A|317|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 03:18:33.035552|2017-10-11 03:18:33.035552
NCT01528748|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2016-10-25|||April 2011||2011-04-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2015|Actual|2015-12-01||Observational|||Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence|Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence|Active, not recruiting||N/A|8|Actual|University of Virginia|||1||f||||f||||||||||2017-10-11 03:18:33.117901|2017-10-11 03:18:33.117901
NCT01528735|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2016-03-14|2016-01-21|2014-04-30|February 2012||2012-02-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Treated Set which included all patients who were dispensed study medication and were documented to have taken at least one dose of study medication.|This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C|An Open-label, Ascending Dose, Phase II Study to Evaluate Tolerability, Safety, Antiviral Activity, and Pharmacokinetics of BI 207127 NA in Combination With BI 201335 NA and Ribavirin for 8 Weeks in Treatment-naïve Japanese Patients With Genotype 1chronic Hepatitis C Virus Infection|Completed||Phase 2|25|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:18:33.273039|2017-10-11 03:18:33.273039
NCT01528722|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-04|2012-02-07|||January 2009||2009-01-01|February 2012|2012-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Randomized Control Trial of Intraperitoneal Bupivacaine During Cholecystectomy|Double Blind Sham Controlled Randomised Trial of Intraperitoneal Bupivacaine During Acute Laparoscopic Cholecystectomy|Completed||N/A|42|Actual|University Hospitals Coventry and Warwickshire NHS Trust||2|||f||||f||||||||||2017-10-11 03:18:35.777461|2017-10-11 03:18:35.777461
NCT01528709|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2017-01-31|||March 2012||2012-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|ACTIVE||Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)|Aggressive Cholesterol Therapy to Inhibit Vein Graft Events (ACTIVE Trial): Does High-Dose Postoperative Statin Therapy Improve Graft Patency After Coronary Bypass?|Completed||Phase 3|173|Actual|Boca Raton Regional Hospital||2|||f||||f|f|f||||||Undecided||2017-10-11 03:18:35.895158|2017-10-11 03:18:35.895158
NCT01528696|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-02-15|2016-12-22||February 2012||2012-02-01|February 2017|2017-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section|Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section|Terminated||Phase 4|37|Actual|University of Michigan||2||Insufficient Recruitment|f||||f||||||||||2017-10-11 03:18:36.046736|2017-10-11 03:18:36.046736
NCT01528683|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-31|2013-02-18|||December 2012||2012-12-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PANDORA||Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer|Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer|Unknown status|Recruiting|Phase 1/Phase 2|45|Anticipated|University Hospital Heidelberg||1|||f||||t||||||||||2017-10-11 03:18:36.477079|2017-10-11 03:18:36.477079
NCT01528670|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2013-02-18|||December 2011||2011-12-01|February 2013|2013-02-01||||February 2014|Anticipated|2014-02-01||Observational|MIRANDA||Monitoring of Patients Treated With Particle Therapy Using Positron-Emission-Tomography (PET): The MIRANDA Study|Monitoring of Patients Treated With Particle Therapy Using Positron-Emission-Tomography (PET): The MIRANDA Study.|Unknown status|Recruiting|N/A|240|Anticipated|University Hospital Heidelberg|||8||f||||f||||||||||2017-10-11 03:18:36.603128|2017-10-11 03:18:36.603128
NCT01528657|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-06|2015-10-21|||December 2011||2011-12-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|VIPERS||Ventricular Pace Suppression Versus Intrinsic Rhythm Support Study||Completed||N/A|230|Actual|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-10-11 03:18:36.688868|2017-10-11 03:18:36.688868
NCT01528644|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2013-02-28|||February 2012||2012-02-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Iron & Alginate Study|Study to Measure the Absorption of Iron From Ferrous Gluconate Incorporated Into Alginate Beads.|Completed||N/A|16|Actual|University of East Anglia||4|||f||||f||||||||||2017-10-11 03:18:36.828842|2017-10-11 03:18:36.828842
NCT01528631|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-07-24|||February 2012||2012-02-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||The Effects of D-Fagomine on Glycaemic Response to Sucrose in Men|Randomized Controlled Double-blind Nutritional Intervention Trial to Evaluate the Effects of D-fagomine on Glycaemic Response to Sucrose in Men|Completed||N/A|12|Actual|Bioglane||2|||f||||f||||||||||2017-10-11 03:18:36.960555|2017-10-11 03:18:36.960555
NCT01528618|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-01-09|||October 2015||2015-10-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma|A Randomized, Multicenter Phase III Clinical Trial Comparing Gemcitabine and Cisplatin With 5-Fluorouracil and Cisplatin in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)|Active, not recruiting||Phase 3|362|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:18:37.096358|2017-10-11 03:18:37.096358
NCT01528605|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2014-08-18|2014-07-20||June 2010||2010-06-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional||4 participants was excluded during the analysis since they did not finish the intervention.|Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration|The Effects of Lutein and Zeaxanthin Supplementations on Early Age-related Macular Degeneration|Completed||N/A|168|Actual|Peking University||6|||f||||t||||||||||2017-10-11 03:18:37.230598|2017-10-11 03:18:37.230598
NCT01528579|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-22|2017-03-06|||March 2011||2011-03-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Different Exercise Programs for People With Chronic Whiplash Associated Disorders|Effects of Different Exercise Programs for People With Chronic Whiplash Associated Disorders: a Prospective Randomized Study|Completed||N/A|216|Actual|Linkoeping University||3|||f||||t||||||||||2017-10-11 03:18:38.130868|2017-10-11 03:18:38.130868
NCT01528566|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-02-03|||January 2008||2008-01-01|February 2012|2012-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Tai Chi on Osteoarthritic Knee Pain in Elders With Mild Dementia|Effect of Tai Chi on Osteoarthritic Knee Pain in Elders With Mild Dementia|Completed||N/A|55|Actual|University of Arkansas||2|||f||||f||||||||||2017-10-11 03:18:38.24593|2017-10-11 03:18:38.24593
NCT01528553|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-02-03|||August 2009||2009-08-01|February 2012|2012-02-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Stapling Versus 8plate for Correction of Genu Valgus|Stapling Versus 8plate for Correction of Genu Valgus. A Randomised Clinical Study|Unknown status|Active, not recruiting|N/A|20|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 03:18:38.344709|2017-10-11 03:18:38.344709
NCT01528540|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2015-09-08|||April 2012||2012-04-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluation of Efficacy of Combination of Pregabalin and Antioxidant in Reducing Pain in Chronic Pancreatitis: a Randomized Control Trial|Evaluation of Efficacy of Combination of Pregabalin and Antioxidant in Reducing Pain in Chronic Pancreatitis: a RCT|Completed||N/A|87|Actual|Asian Institute of Gastroenterology, India||2|||f||||t||||||||||2017-10-11 03:18:38.444737|2017-10-11 03:18:38.444737
NCT01527604|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-11-18|||December 2012||2012-12-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Avenanthramide-enriched Oats on Inflammation|Effects of Avenanthramide-enriched Oats on Inflammation in Obese Adults With Central Adiposity: A Randomized Clinical Trial|Completed||N/A|16|Actual|Tufts University||2|||f||||||||||||||2017-10-11 03:18:51.763164|2017-10-11 03:18:51.763164
NCT01528514|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-07|||September 2009||2009-09-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|September 2011|Actual|2011-09-01||Interventional|CUPID||Effects of CUrcuminoids on Coronary Artery byPass graftIng-related myocarDial Infarction Study|The Effects of CUrcuminoids on Coronary Artery byPass graftIng-related myocarDial Infarction Study|Unknown status|Recruiting|Phase 3|200|Anticipated|Thailand Research Fund||2|||f||||t||||||||||2017-10-11 03:18:38.547149|2017-10-11 03:18:38.547149
NCT01528501|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2013-04-30|||June 2009||2009-06-01|December 2012|2012-12-01||||February 2013|Actual|2013-02-01||Interventional|HDAC||Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)|An Open-label, Uncontrolled Phase II Trial of HDAC-Inhibitor LBH589 in Patients With Chemo-refractory Metastatic Gastric Cancer Overexpressing Histone Deacetylases (HDACs) - CLBH589BDE03T|Terminated||Phase 2|28|Anticipated|Technische Universität München||1||medical/ethical reasons|f||||||||||||||2017-10-11 03:18:38.642286|2017-10-11 03:18:38.642286
NCT01528488|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2013-11-04|||December 2011||2011-12-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC|A Randomized, Double-blind, Prospective Trial of Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in Non-small Cell Lung Cancer|Completed||Phase 2/Phase 3|118|Actual|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 03:18:38.736813|2017-10-11 03:18:38.736813
NCT01528475|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-12-16|||July 2012||2012-07-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Initiation of Cooling by EMS to Promote Adoption of In-hospital Hypothermia in Cardiac Arrest Survivors|Initiation of Cooling by Emergency Medical Services to Promote the Adoption of In-hospital Therapeutic Hypothermia in Cardiac Arrest Survivors: the ICE-PACS Trial|Completed||N/A|585|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-11 03:18:38.827196|2017-10-11 03:18:38.827196
NCT01528462|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-11-21|||October 2011||2011-10-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|SMARTIES||Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke|Does Acute Management of Sleep Disorders Improve Outcomes After Non-disabling Cerebrovascular Events?|Completed||N/A|97|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-10-11 03:18:40.753398|2017-10-11 03:18:40.753398
NCT01528449|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-09-11|||December 2011||2011-12-01|September 2017|2017-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Babesia Testing in Blood Donors|Blood Donation Screening for Babesia Microti by Real-time Polymerase Chain Reaction (PCR) and by Indirect Flourescent Antibody (IFA) Assays|Completed||Phase 3|90116|Actual|Imugen||2|||f||||f||||||||||2017-10-11 03:18:40.869914|2017-10-11 03:18:40.869914
NCT01528436|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-07-17|||February 2012||2012-02-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Umbilical Cord Blood Therapy for Cerebral Palsy|Umbilical Cord Blood Therapy for Cerebral Palsy: a Randomized,Double-blind, Placebo-controlled Trial|Completed||Phase 2|37|Actual|Bundang CHA Hospital||2|||f||||f||||||||||2017-10-11 03:18:40.96963|2017-10-11 03:18:40.96963
NCT01528423|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-06-14|||May 2009||2009-05-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|XtremeCT||Evaluation of the XtremeCT Device for the Assessment of Bone|Evaluation of the XtremeCT Device for the Assessment of Bone|Completed||N/A|180|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||6||f||||f||||||Samples Without DNA|"     Serum samples taken for measurement of PINP, CTX, PTH, calcium, creatinine, albumin,     testosterone, IGF-1, IGFBP-3 and SHBG   "|||2017-10-11 03:18:41.084449|2017-10-11 03:18:41.084449
NCT01528410|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-06-12|||August 17, 2012|Actual|2012-08-17|June 2017|2017-06-01|September 21, 2016|Actual|2016-09-21|September 21, 2016|Actual|2016-09-21||Interventional|||ALFApump System Versus Standard of Care in Ascites Treatment|ALFApump® System Versus Large Volume Paracentesis in the Treatment of Refractory Ascites. A Multicentre Randomised Controlled Study.|Completed||Phase 3|58|Actual|Sequana Medical AG||2|||f||||t||||||||||2017-10-11 03:18:41.181275|2017-10-11 03:18:41.181275
NCT01528397|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-07|||May 2005||2005-05-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|September 2009|Actual|2009-09-01||Interventional|||Reconstruction of Proper Digital Nerve Defects in the Thumb Using a Pedicled Nerve Graft||Completed||N/A|14|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 03:18:41.280413|2017-10-11 03:18:41.280413
NCT01528384|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-14|2014-04-08|||December 2011||2011-12-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Ph 1 Study of ADI PEG 20 in Pediatric Subjects Who Are Argininosuccinate Synthetase (ASS) Deficient|A Phase 1 Study of ADI PEG 20 in Pediatric Subjects Who Are Argininosuccinate Synthetase (ASS) Deficient and Have Failed Prior Systemic Therapy|Completed||Phase 1|8|Actual|Polaris Group||1|||f||||f||||||||||2017-10-11 03:18:41.356559|2017-10-11 03:18:41.356559
NCT01528371|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-10-01|||October 2010||2010-10-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Midazolam on White-coat Hypertensive Dental Patients|The Effect of Low Dose of Midazolam on Blood Pressure and Anxiety Scale in White-coat Hypertensive Dental Patients|Completed||N/A|40|Anticipated|Okayama University||2|||f||||f||||||||||2017-10-11 03:18:41.428368|2017-10-11 03:18:41.428368
NCT01528358|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-09-19|||February 2012||2012-02-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Tissue Near InfraRed Spectroscopy (NIRS) in Critically Ill Patients|Tissue NIRS in the Assessment and Management of Critically Ill Patients|Recruiting||N/A|1000|Anticipated|Lawson Health Research Institute|||2||f||||f||||||Samples Without DNA|"     Blood: inflammatory markers   "|Undecided||2017-10-11 03:18:41.519281|2017-10-11 03:18:41.519281
NCT01528345|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-05-26|2016-04-01||April 2012||2012-04-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Full Analysis Set (FAS): Consisted of all randomized patients. Following the intent-to-treat principle, patients were analyzed according to the treatment and stratum to which they were assigned at randomization.|Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer|A Multicenter, Randomized, Double Blind, Placebo Controlled, Phase II Trial Evaluating the Safety and Efficacy of Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer That Have Evidence of Disease Progression on or After Prior Endocrine Therapy|Terminated||Phase 2|97|Actual|Novartis||2||Slow and low enrollment|f||||t||||||||||2017-10-11 03:18:41.629656|2017-10-11 03:18:41.629656
NCT01527409|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-02-06|||February 2012||2012-02-01|February 2012|2012-02-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||The Efficacy of Health Partnership Program for Cancer Patients|The Efficacy of Health Partnership Program for Cancer Patients|Unknown status|Recruiting|N/A|248|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 03:18:54.924911|2017-10-11 03:18:54.924911
NCT01528332|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-02-07|2013-09-09||February 2012||2012-02-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PAINCT02||Blue Light Device for Pain Therapy|A Prospective, Randomized, Controlled, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Blue Light Therapy for Relief of Chronic Musculoskeletal Back Pain|Completed||Phase 3|171|Actual|Philips Light and Health||2|||f||||f||||||||||2017-10-11 03:18:42.620766|2017-10-11 03:18:42.620766
NCT01528319|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2014-07-14|2014-01-26||December 2011||2011-12-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|MG-1||Open-Label Study for Shoulder Dislocation Using MG-1|Open Clinical Trial of Arthroscopic Bankart Repair Using MG-1 for Dislocation of the Shoulder|Completed||N/A|24|Actual|Johnson & Johnson K.K. Medical Company||1|||f||||f||||||||||2017-10-11 03:18:42.923851|2017-10-11 03:18:42.923851
NCT01528306|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-05-15|||March 2012||2012-03-01|May 2012|2012-05-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Interventional|||A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa|An Exploratory, Cross-Over Study of the Safety of HP802-247 Applied to Open Wounds of Subjects With Dystrophic Epidermolysis Bullosa|Withdrawn||Phase 2|0|Actual|Healthpoint||2|||f||||f||||||||||2017-10-11 03:18:43.217969|2017-10-11 03:18:43.217969
NCT01528293|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-12-21|2015-04-14||July 2012||2012-07-01|December 2016|2016-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||ActiV.A.C.+ Compression Therapy Versus Compression Therapy Alone for the Treatment of Chronic Venous Ulcerations|A Prospective, Randomized, Comparative Effectiveness Trial of the ActiV.A.C.+ Compression Therapy Versus Compression Therapy Alone for the Treatment of Chronic Venous Ulcerations|Terminated||N/A|2|Actual|Georgetown University|Enrollment was insufficient to support statistical analyses. Three subjects were screened and only one completed the study. The study was terminated due to insufficient enrollment.|2||slow recruitment - unable to meet enrollment goals|f||||f||||||||No||2017-10-11 03:18:43.319293|2017-10-11 03:18:43.319293
NCT01528280|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-08-11|||January 2013||2013-01-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Humoral and Cellular Response in Shift Workers|Vaccination Against Hepatitis A Virus in Shift Workers: Evaluation of the Humoral and Cellular Immune Response|Unknown status|Recruiting|N/A|75|Anticipated|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 03:18:43.650137|2017-10-11 03:18:43.650137
NCT01528267|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2013-12-19|||November 2009||2009-11-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Bronchoscopic Lung Volume Reduction Using Blood|A Randomised, Double Blind, Sham Controlled Trial of Autologous Blood Lung Volume Reduction|Completed||Phase 2|10|Actual|Chelsea and Westminster NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 03:18:43.949248|2017-10-11 03:18:43.949248
NCT01528254|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-08-18|||March 30, 2012|Actual|2012-03-30|August 2017|2017-08-01|April 18, 2019|Anticipated|2019-04-18|April 18, 2019|Anticipated|2019-04-18||Interventional|||VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus|A 5-year Study to Compare the Durability of Glycemic Control of a Combination Regimen With Vildagliptin & Metformin Versus Standard-of-care Monotherapy With Metformin, Initiated in Treatment-naïve Patients With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 4|1986|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:18:44.114996|2017-10-11 03:18:44.114996
NCT01528241|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-03|||August 2008||2008-08-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)|A Multi-center, Open-label Study in Elderly Healthy Volunteers and Elderly Patients With Major Depressive Disorder to Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)|Completed||Phase 1|42|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:18:44.950268|2017-10-11 03:18:44.950268
NCT01528228|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-01-27|||July 2011||2011-07-01|January 2017|2017-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|TENS||Effects of TENS Therapy Following Arthroscopic Knee Surgery|Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on Postoperative Pain and Function Following Arthroscopic Knee Surgery: A Prospective Randomized Clinical Trial Pilot Study|Completed||N/A|20|Actual|A.T. Still University of Health Sciences||2|||f||||f||||||||||2017-10-11 03:18:45.062097|2017-10-11 03:18:45.062097
NCT01528215|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-02-03|2016-03-15||November 2011||2011-11-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2014|Actual|2014-12-01||Interventional|||Multicenter Study Comparing OsseoSpeed TX With OsseoSpeed EV.|An Open, Prospective, Randomized, Multicenter Study Comparing OsseoSpeed™ EV With OsseoSpeed™ TX in Partially Edentulous Maxillae and Mandibles. A 5-year Follow-up Study.|Active, not recruiting||N/A|120|Actual|Dentsply Sirona Implants||2|||f||||||||||||||2017-10-11 03:18:45.169685|2017-10-11 03:18:45.169685
NCT01528202|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-03|||April 2010||2010-04-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Tart Cherries and Melatonin Content|Effect of Tart Cherry Juice (Prunus Cerasus) on Melatonin Levels and Sleep Quality|Completed||N/A|20|Actual|Northumbria University||4|||f||||f||||||||||2017-10-11 03:18:45.42948|2017-10-11 03:18:45.42948
NCT01528189|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-03-25|||February 2012||2012-02-01|March 2016|2016-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Effect of High Dose Insulin on Infectious Complications Following Major Surgery|Effect of Hyperinsulinemic Normoglycemic Clamp (HINC) on Infectious Complications Following Major Abdominal Surgery. A Randomized Controlled Trial.|Recruiting||N/A|540|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-11 03:18:45.53266|2017-10-11 03:18:45.53266
NCT01528176|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-13|||November 2010||2010-11-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Vitamin D Metabolism in Chronic Kidney Disease Patients|Vitamin D Metabolism in Chronic Kidney Disease Patients With Vitamin D Deficiency Treated With Cholecalciferol|Unknown status|Active, not recruiting|N/A|70|Actual|Memphis VA Medical Center||1|||f||||t||||||||||2017-10-11 03:18:45.653029|2017-10-11 03:18:45.653029
NCT01528163|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-06-12|||February 2012||2012-02-01|June 2017|2017-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|RACATREX||Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-based Therapy.|Completed||Phase 2|101|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-10-11 03:18:45.763777|2017-10-11 03:18:45.763777
NCT01528150|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-07-19|2015-12-02||February 2012||2012-02-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01|12 Months|Observational [Patient Registry]|TendrilMRI™||Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing Indication|Clinical Investigation to Assess the Safety and Efficacy of the Tendril MRI™ Leads, as a Part of the Accent MRI™ System, in Patients With Standard Bradycardia Pacing Indication.|Completed||N/A|466|Actual|St. Jude Medical|||1||f||||f||||||||No||2017-10-11 03:18:45.997432|2017-10-11 03:18:45.997432
NCT01528137|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-07-30|||May 2012||2012-05-01|July 2016|2016-07-01|July 2013|Actual|2013-07-01|August 2012|Actual|2012-08-01||Interventional|||Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer|A Phase Ib Immunomodulatory Study of Single Agent Talactoferrin in Patients With Select Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) and Squamous Head and Neck Cancer (HNSCC)|Terminated||Phase 1|4|Actual|Stanford University||1||Negative data from another trial led to termination of this trial by sponsor.|f||||t||||||||||2017-10-11 03:18:46.320385|2017-10-11 03:18:46.320385
NCT01528111|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2015-08-31||2015-08-31|March 2012||2012-03-01|August 2015|2015-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension|A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)|Completed||Phase 1/Phase 2|63|Actual|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-10-11 03:18:46.601327|2017-10-11 03:18:46.601327
NCT01528098|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-20|||March 2012||2012-03-01|February 2012|2012-02-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Observational|PEG||Comparison of Bowel Cleansing Methods for Colonoscopy in Hospitalized Patients|Efficacy of Bisacodyl Given as Part of a Polyethylene Glycol-based Bowel Preparation Prior to Colonoscopy in Hospitalized Patients|Unknown status|Not yet recruiting|N/A|600|Anticipated|Kangbuk Samsung Hospital|||2||f||||t||||||||||2017-10-11 03:18:46.745844|2017-10-11 03:18:46.745844
NCT01528085|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2015-09-29|||January 2012||2012-01-01|September 2015|2015-09-01|November 2018|Anticipated|2018-11-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Efficacy and Safety of Nilotinib in Combination With Chemotherapy in Elderly Patients With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|An Open Label Phase II Study to Evaluate the Efficacy and Safety of Induction and Consolidation Therapy With Nilotinib in Combination With Chemotherapy in Patients Aged 55 Years and Over With Philadelphia Chromosome Positive (Ph+ or BCR-ABL+) Acute Lymphoblastic Leukemia (ALL)|Active, not recruiting||Phase 2|79|Actual|Johann Wolfgang Goethe University Hospital||1|||f||||t||||||||||2017-10-11 03:18:46.877406|2017-10-11 03:18:46.877406
NCT01528072|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-07-14|||March 2012||2012-03-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Dynesys Spinal System Post Market 522 Study|Post Market Surveillance for the Dynesys Spinal System, Assessing Safety and Fusion.|Recruiting||N/A|168|Anticipated|Zimmer Biomet||1|||f||||t||||||||Undecided||2017-10-11 03:18:47.159137|2017-10-11 03:18:47.159137
NCT01528059|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-06|||February 2012||2012-02-01|February 2012|2012-02-01|March 2013|Anticipated|2013-03-01|February 2012|Anticipated|2012-02-01||Interventional|||Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes|A Prospective Randomised Study Comparing Billroth II With Roux-en-Y Reconstruction After Radical Distal Subtotal Gastrectomy for Gastric Cancer Comorbid With Type 2 Diabetes|Unknown status|Recruiting|Phase 2/Phase 3|110|Anticipated|Xiamen University||2|||f||||t||||||||||2017-10-11 03:18:47.797421|2017-10-11 03:18:47.797421
NCT01528046|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-08-02|||April 25, 2012|Actual|2012-04-25|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Metformin in Children With Relapsed or Refractory Solid Tumors|A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors|Recruiting||Phase 1|25|Anticipated|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t|t|f|||f|||||2017-10-11 03:18:47.921356|2017-10-11 03:18:47.921356
NCT01528033|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-08-08|||August 2011||2011-08-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|SAWHI||Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments|Treatment of Subcutaneous Abdominal Wound Healing Impairment After Surgery Without Fascial Dehiscence by Vacuum Assisted Closure™(SAWHI-V.A.C.® Study) Versus Standard Conventional Wound Therapy|Recruiting||N/A|550|Anticipated|University of Witten/Herdecke||2|||f||||t||||||||||2017-10-11 03:18:48.133481|2017-10-11 03:18:48.133481
NCT01528020|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2016-05-16|||January 2012||2012-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|August 2015|Actual|2015-08-01||Interventional|CARES||Collaborative Adolescent Research on Emotions and Suicide|Treatment of Suicidal and Self-Injurious Adolescents With Emotional Dysregulation|Completed||N/A|173|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 03:18:48.484427|2017-10-11 03:18:48.484427
NCT01528007|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2013-12-04|||January 2011||2011-01-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention|Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention - a Placebo Controlled Trial|Completed||Phase 4|100|Actual|National Institute for Health and Welfare, Finland||2|||f||||f||||||||||2017-10-11 03:18:48.594136|2017-10-11 03:18:48.594136
NCT01527994|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-04-13|||January 2012||2012-01-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional|||Aprepitant Effects in Intravenous Heroin Dependence|Clinical Laboratory Evaluations of Aprepitant for the Treatment of Opioid Dependence: Inpatient Test|Completed||Phase 1|64|Actual|New York University||2|||f||||t||||||||||2017-10-11 03:18:48.692447|2017-10-11 03:18:48.692447
NCT01527981|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-03|||March 2008||2008-03-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Cognitive Behavioral Therapy (CBT) for Adherence and Depression in Type 1 Diabetes|CBT for Adherence and Depression in Type 1 Diabetes|Completed||Phase 2|9|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:18:48.778854|2017-10-11 03:18:48.778854
NCT01527968|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2016-07-22|||April 2012||2012-04-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty|A Prospective, Randomized, Double Blind, Double-Dummy Study Comparing the Safety and Efficacy of Epsilon Aminocaproic Acid (eACA) Versus Tranexamic Acid (TXA) Versus Placebo for Prevention of Blood Loss in Total Knee Arthroplasty|Active, not recruiting||N/A|54|Actual|Heekin Orthopedic Research Institute||3|||f||||f||||||||||2017-10-11 03:18:48.857119|2017-10-11 03:18:48.857119
NCT01527955|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-06|||September 2008||2008-09-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Interventional|||Kelee® Meditation: A Distinctive and Effective Therapeutic Intervention for Stress, Anxiety, and Depression|Troubleshooting the Mind Through Kelee® Meditation: A Distinctive and Effective Therapeutic Intervention for Stress, Anxiety, and Depression|Completed||N/A|47|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 03:18:48.926345|2017-10-11 03:18:48.926345
NCT01527942|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-11-13|2015-03-17||March 2012||2012-03-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients|Effect of Intravenous Acetaminophen on Postoperative Pain of Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized, Placebo-Controlled Trial|Terminated||N/A|34|Actual|Saint Francis Care||2||Study Terminated per Principal Investigator's request|f||||t||||||||||2017-10-11 03:18:49.018607|2017-10-11 03:18:49.018607
NCT01527929|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2013-12-03|||April 2012||2012-04-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment|An Open-label Pharmacokinetic and Safety Study of Cabazitaxel in Patients With Solid Tumors With Moderately and Severely Impaired and With Normal Renal Function|Completed||Phase 1|25|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:18:49.255934|2017-10-11 03:18:49.255934
NCT01527916|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2014-11-06||2014-11-06|February 2012||2012-02-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo and Active-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|438|Actual|AbbVie||5|||f||||t||||||||||2017-10-11 03:18:49.347511|2017-10-11 03:18:49.347511
NCT01527903|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-08-16|||September 2009||2009-09-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|ICU||A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit|Sedation of Surgical Patients in the Intensive Care Unit: A Randomized Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation|Completed||Phase 4|77|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 03:18:49.591292|2017-10-11 03:18:49.591292
NCT01527890|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-02-02|||February 2012||2012-02-01|February 2012|2012-02-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Observational|||Effect of Intravenous Patient-controlled Analgesia (IV-PCA) With Fentanyl in Adults for Acute Postoperative Pain Control||Unknown status|Recruiting|N/A|2000|Anticipated|Yonsei University|||1||f||||||||||||||2017-10-11 03:18:49.678165|2017-10-11 03:18:49.678165
NCT01527877|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-10-04|||September 2012||2012-09-01|October 2012|2012-10-01|August 2014|Anticipated|2014-08-01|December 2013|Anticipated|2013-12-01||Interventional|||Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck|An Open Label, Single Arm, Multicenter Phase II Study of BKM120 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy|Unknown status|Recruiting|Phase 2|53|Anticipated|Yonsei University||1|||f||||t||||||||||2017-10-11 03:18:49.7586|2017-10-11 03:18:49.7586
NCT01527864|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2012-02-06|||May 2011||2011-05-01|February 2012|2012-02-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|||Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or With Pegylated Endostatin for Advanced Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|300|Anticipated|Protgen Ltd||2|||f||||t||||||||||2017-10-11 03:18:49.855526|2017-10-11 03:18:49.855526
NCT01527851|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-05-01|||February 2012||2012-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Excess Skin and Physical Activity|Impact of Excess Skin on the Practice of Physical Activity in Women Who Underwent Bariatric Surgery and Exploration of the Benefits of Plastic Surgery|Active, not recruiting||N/A|30|Anticipated|Université de Sherbrooke|||1||f||||f||||||||||2017-10-11 03:18:49.942543|2017-10-11 03:18:49.942543
NCT01527838|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-09-09|||January 2012||2012-01-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit|A Phase I Trial of a Single FT1050 (16,16-Dimethyl Prostaglandin E2) Ex Vivo-Modulated Umbilical Cord Blood (CB) Unit Following a Reduced Intensity Conditioning Regimen For Adults With Hematologic Malignancies|Completed||Phase 1|10|Actual|Fate Therapeutics||1|||f||||t||||||||||2017-10-11 03:18:50.018068|2017-10-11 03:18:50.018068
NCT01527825|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-01-09|||September 2012||2012-09-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women|Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women: a Randomized Controlled Trial|Completed||Phase 3|800|Actual|University of Witwatersrand, South Africa||3|||f||||t||||||||||2017-10-11 03:18:50.121587|2017-10-11 03:18:50.121587
NCT01527812|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-03-31|||December 2009||2009-12-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Optimal Positioning of Local Anaesthetic in Femoral Nerve Block Prior to Hip Surgery|Optimal Positioning of Local Anaesthetic in Femoral Nerve Block Prior to Operative Fixation of Fractured Neck of Femur|Completed||N/A|60|Actual|Cork University Hospital||3|||f||||f||||||||||2017-10-11 03:18:50.244528|2017-10-11 03:18:50.244528
NCT01527799|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-02-03|||June 2009||2009-06-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Exercise Capacity in Pediatric Sickle Cell Anemia|The Physiologic Assessment of Exercise Capacity in Pediatric Sickle Cell Anemia|Completed||N/A|60|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||t||||||Samples Without DNA|"     Plasma is collected and stored to be analyzed   "|||2017-10-11 03:18:50.354268|2017-10-11 03:18:50.354268
NCT01527786|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-14|2015-01-26|||November 2010||2010-11-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine|A Pilot Study of Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine|Completed||Phase 3|25|Actual|BC Women's Hospital & Health Centre||1|||f||||f||||||||||2017-10-11 03:18:50.443384|2017-10-11 03:18:50.443384
NCT01527773|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-08-09|||May 2011||2011-05-01|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|TOPDOCS||Phenotypes and Vascular Damage in Chronic Obstructive Pulmonary Disease (COPD)|The Obstructive Pulmonary Disease Outcomes Cohort of Switzerland (TOP DOCS): Phenotypes and Vascular Damage in COPD|Completed||N/A|313|Actual|University of Zurich|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 03:18:50.529749|2017-10-11 03:18:50.529749
NCT01527760|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-14|||February 2011||2011-02-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension|Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension. One Group Pretest Posttest Design|Completed||N/A|37|Actual|Fr Muller Homoeopathic Medical College||1|||f||||t||||||||||2017-10-11 03:18:50.610097|2017-10-11 03:18:50.610097
NCT01527747|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-10-13|||January 2012||2012-01-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|||Effects of DPP-4 Inhibition on Triglycerides|Effects of Dipeptidyl Peptidase-4 Inhibition With Saxagliptin on Fasting and Postprandial Triglyceride Concentrations|Unknown status|Recruiting|Phase 4|30|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 03:18:50.687019|2017-10-11 03:18:50.687019
NCT01527734|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-02-07|||December 2011||2011-12-01|February 2012|2012-02-01||||January 2012|Actual|2012-01-01||Interventional|||Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers|COMPARISON OF THE PHARMACOKINETICS AND SAFETY OF LIQUID (30 µg) AND LYOPHILIZED TETRODOTOXIN (15 µg AND 30 µg) FOLLOWING SINGLE AND TWICE DAILY SUBCUTANEOUS DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS—DETERMINATIONS IN BLOOD AND URINE|Completed||Phase 1|44|Actual|Wex Pharmaceuticals Inc.||2|||f||||||||||||||2017-10-11 03:18:50.829489|2017-10-11 03:18:50.829489
NCT01527721|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2017-01-14|||September 2010||2010-09-01|January 2017|2017-01-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CxL Combined With Photorefractive Keratectomy (PRK) in Keratoconus|Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CXL Combined With Photorefractive Keratectomy (PRK) in Keratoconus.|Completed||N/A|32|Actual|Democritus University of Thrace||2|||f||||f||||||||||2017-10-11 03:18:50.920007|2017-10-11 03:18:50.920007
NCT01527708|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-03|||September 2011||2011-09-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Observational|||Accuracy of Curvature and Wavefront Aberrations of Posterior Corneal Surface, in Keratoconic and Post-CXL Corneas|Repeatability, Reliability and Reproducibility of Pentacam-derived Curvature and Wavefront Aberrations of Posterior Corneal Surface, in Keratoconic and Cross-linked Corneas|Completed||N/A|129|Actual|Democritus University of Thrace|||3||f||||t||||||||||2017-10-11 03:18:51.013325|2017-10-11 03:18:51.013325
NCT01527695|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2013-01-30|||April 2012||2012-04-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||PET Study in Parkinson's Disease Patients|A Phase IIA, Multi Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Effect of 8 Weeks Treatment With Oral AZD3241 on Microglia Activation, as Measured by Positron Emission Tomography (PET), in Patients With Parkinson's Disease|Completed||Phase 2|24|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:18:51.133898|2017-10-11 03:18:51.133898
NCT01527682|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-16|2015-08-31|||July 2009||2009-07-01|August 2015|2015-08-01|July 2017|Anticipated|2017-07-01|January 2017|Anticipated|2017-01-01||Interventional|||Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric Glaucoma|Efficacy and Safety of Prostaglandin Analogue and Carbonic Anhydrase Inhibitor for the Treatment of Pediatric Glaucoma|Unknown status|Active, not recruiting|Phase 2|69|Actual|Azienda Ospedaliera Spedali Civili di Brescia||1|||f||||t||||||||||2017-10-11 03:18:51.242315|2017-10-11 03:18:51.242315
NCT01527669|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-07-09|||February 2012||2012-02-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||The Pharmacokinetic Study of Red Yeast Rice Capsule Compared to Lovastatin Tablet in Healthy Subjects|The Pharmacokinetic Study of Red Yeast Rice Capsule Compared to Lovastatin Tablet in Healthy Subjects.|Completed||Phase 4|12|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 03:18:51.355521|2017-10-11 03:18:51.355521
NCT01527656|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-01-05|||December 2003||2003-12-01|January 2017|2017-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects|Single-Centre, Randomised, Balanced, Double-Blind, Cross-Over Trial Investigating the Bioequivalence of Formulation 2 and Formulation 4 of Biphasic Insulin Aspart 70 in Healthy Male Subjects|Completed||Phase 1|40|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:18:51.4388|2017-10-11 03:18:51.4388
NCT01527643|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-02-22|||November 11, 2003|Actual|2003-11-11|February 2017|2017-02-01|December 17, 2003|Actual|2003-12-17|December 17, 2003|Actual|2003-12-17||Interventional|||Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects|Single-Centre, Randomised, Balanced, Double- Blind, Cross-Over Trial Investigating the Bioequivalence of Formulation 2 and Formulation 4 of Biphasic Insulin Aspart 50 in Healthy Male Subjects|Completed||Phase 1|30|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:18:51.513937|2017-10-11 03:18:51.513937
NCT01527630|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-02-22|||November 16, 2002|Actual|2002-11-16|February 2017|2017-02-01|January 8, 2003|Actual|2003-01-08|January 8, 2003|Actual|2003-01-08||Interventional|||Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects|A Randomised, Double-blind, Single-centre, Two-Period Crossover Trial Testing the Bioequivalence of Two Formulations of NN-X14Mix50 in Healthy Japanese Subjects|Completed||Phase 1|30|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:18:51.593513|2017-10-11 03:18:51.593513
NCT01527617|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-06-01|||February 2012||2012-02-01|June 2016|2016-06-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress|The Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress in Healthy But Overweight/Obese Subjects: A Randomized Clinical Trial|Completed||N/A|79|Actual|Tufts University||2|||f||||||||||||||2017-10-11 03:18:51.684903|2017-10-11 03:18:51.684903
NCT01527591|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-11-30|||February 2012||2012-02-01|November 2015|2015-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)|Safety And Long-Term Immunogenicity Of The 13-Valent Pneumococcal Conjugate Vaccine In Children Who Are Solid Organ Transplant Recipients|Recruiting||N/A|45|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 03:18:51.84816|2017-10-11 03:18:51.84816
NCT01527578|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-05-08|||September 2011||2011-09-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Observational|||Simons Variation in Individuals Project, Functional Common Acquisition Protocol|Functional Common Acquisition Protocol Phase of the Simons VIP|Completed||N/A|120|Anticipated|University of California, San Francisco|||1||f||||t||||||||||2017-10-11 03:18:51.951968|2017-10-11 03:18:51.951968
NCT01527565|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-02-22|||January 20, 2003|Actual|2003-01-20|February 2017|2017-02-01|February 26, 2003|Actual|2003-02-26|February 26, 2003|Actual|2003-02-26||Interventional|||Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects|A Single-Centre, Randomised, Balanced, Double-Blind, Cross-Over Trial Investigating the Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects|Completed||Phase 1|30|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:18:52.036393|2017-10-11 03:18:52.036393
NCT01527552|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-02-22|||November 5, 2002|Actual|2002-11-05|February 2017|2017-02-01|December 18, 2002|Actual|2002-12-18|December 18, 2002|Actual|2002-12-18||Interventional|||Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects|A Single-Centre, Randomised, Balanced, Double-Blind, Cross-Over Trial Investigating the Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects|Completed||Phase 1|30|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:18:52.146547|2017-10-11 03:18:52.146547
NCT01527539|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-02-22|||November 23, 2001|Actual|2001-11-23|February 2017|2017-02-01|October 12, 2004|Actual|2004-10-12|October 12, 2004|Actual|2004-10-12||Interventional|||Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes|A Multi-centre, Non-comparative, Open-labelled, Extension Trial to Assess the Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes (Extension to BIAsp-1237)|Completed||Phase 3|25|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:18:52.252839|2017-10-11 03:18:52.252839
NCT01527526|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2015-06-03|||February 2011||2011-02-01|June 2015|2015-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|DMPA||Depot-medroxyprogesterone Acetate (DMPA) Contraceptive Method and Metabolism|Prospective Study for Evaluation of the Insulin Resistance, Lipid Metabolism and Sub Clinical Cardiovascular Disease in Women Who Initiate the Depot-medroxyprogesterone Acetate (DMPA) Contraceptive Method With in Follow-up for Two Years|Completed||N/A|54|Actual|University of Campinas, Brazil|||1||f||||f||||||Samples Without DNA|"     Serum samples for determination of lipid profile, insulin, glucose, coagulation factors,     neuropeptide Y and factors related to bone mineral density.   "|||2017-10-11 03:18:52.520453|2017-10-11 03:18:52.520453
NCT01527513|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2014-10-23|2014-01-10||August 2010||2010-08-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|March 2012|Actual|2012-03-01||Interventional|||Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures|Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures: an add-on, Double-blind, Randomised, Placebo-controlled, Parallel Group, Multicentre Clinical Trial|Completed||Phase 2|123|Actual|Bial - Portela C S.A.||2|||f||||f||||||||||2017-10-11 03:18:52.64496|2017-10-11 03:18:52.64496
NCT01527487|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-10-03|2016-03-18||June 2012||2012-06-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|September 2014|Actual|2014-09-01||Interventional||Analysis population for ErC includes 10 lead-in and 44 randomized patients.|Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer|A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer|Completed||Phase 2|76|Actual|SCRI Development Innovations, LLC||2|||f||||t||||||||||2017-10-11 03:18:53.690322|2017-10-11 03:18:53.690322
NCT01527474|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-09|||April 2008||2008-04-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Escitalopram in the Treatment of Postpartum Depression|An Open-label Study of Escitalopram in the Treatment of Postpartum Depression|Completed||N/A|20|Actual|BC Women's Hospital & Health Centre||1|||f||||f||||||||||2017-10-11 03:18:54.371118|2017-10-11 03:18:54.371118
NCT01527461|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2013-06-02|||February 2012||2012-02-01|June 2013|2013-06-01||||||||Observational|||Identifying Unique Scent Signature of Lung Cancer Through Body Odor||Unknown status|Recruiting|N/A|100|Anticipated|Sheba Medical Center|||2||f||||f||||||Samples Without DNA|"     sweat samples   "|||2017-10-11 03:18:54.475536|2017-10-11 03:18:54.475536
NCT01527448|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-09|||April 2008||2008-04-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II|An Open Label Dose Titration Study of Quetiapine XR in the Treatment of Postpartum Depression in Nonlactating Women Diagnosed With Bipolar Disorder (BD), Type II.|Completed||N/A|26|Actual|BC Women's Hospital & Health Centre||1|||f||||f||||||||||2017-10-11 03:18:54.593771|2017-10-11 03:18:54.593771
NCT01527435|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-04-05|||December 2011||2011-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ARMD||Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)|Zeaxanthin as an Adjuvant to Combination Therapy for Treatment of Choroidal Neovascularization (CNV) in Exudative Age Related Macular Degeneration (ARMD)|Completed||N/A|200|Actual|The Retina Center of St. Louis County, PC|||1||f||||f||||||||||2017-10-11 03:18:54.712963|2017-10-11 03:18:54.712963
NCT01527422|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-03|2012-02-03|||January 2006||2006-01-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|November 2010|Actual|2010-11-01||Interventional|CHOP-R||Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL|"Protocol CCAM 05-02  Phase I-II Study of Dose Dense of PEG Filgrastim and GM-CSF as Support for Dose Desnse CHOP-R Front Line Therapy for Aggressive Non Hodgkin's Lymphoma"|Completed||Phase 1/Phase 2|60|Actual|Auxilio Mutuo Cancer Center||1|||f||||t||||||||||2017-10-11 03:18:54.824201|2017-10-11 03:18:54.824201
NCT01527396|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-10-27|||December 2011||2011-12-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Observational|PALME||Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer|Multi-center Prospective Observational Study for the Validation of Preoperative Low-risk Criteria for Lymph Node Metastasis in Endometrial Cancer|Completed||N/A|529|Actual|National Cancer Center, Korea|||1||f||||t||||||||||2017-10-11 03:18:55.117652|2017-10-11 03:18:55.117652
NCT01527383|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-02-13|||February 2012||2012-02-01|February 2015|2015-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)|A Phase II Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Immunogenicity of V212 in Adult Patients With Autoimmune Disease|Completed||Phase 2|354|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 03:18:55.196928|2017-10-11 03:18:55.196928
NCT01527370|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-03-14|2013-11-11||October 2012||2012-10-01|March 2017|2017-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)|A Phase III Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of ZOSTAVAX™ in Healthy Adults in India|Completed||Phase 3|250|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:18:55.298887|2017-10-11 03:18:55.298887
NCT01527357|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-06-06||2014-04-14|May 2012||2012-05-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|FINISH-3||Phase 3 Study of Fibrocaps™ in Surgical Bleeding|A Phase 3, Randomized, Single-blind, Controlled Trial of Topical Fibrocaps™ in Intraoperative Surgical Hemostasis|Completed||Phase 3|719|Actual|Mallinckrodt||2|||f||||t||||||||||2017-10-11 03:18:55.499699|2017-10-11 03:18:55.499699
NCT01527344|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-05-08|||August 2011||2011-08-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|CAV-OCT-IVUS||Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography|Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography as Compared to Intravascular Ultrasound-Virtual Histology|Completed||N/A|82|Actual|Mayo Clinic|||1||f||||t||||||||||2017-10-11 03:18:55.725083|2017-10-11 03:18:55.725083
NCT01527331|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-04-28|||June 2011||2011-06-01|April 2012|2012-04-01||||December 2012|Anticipated|2012-12-01||Interventional|||A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced Cancer||Unknown status|Recruiting|N/A|150|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:18:55.805039|2017-10-11 03:18:55.805039
NCT01527318|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-05-13|||August 2011||2011-08-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|NLSDM||The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)|The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)|Completed||Phase 4|6|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 03:18:55.911512|2017-10-11 03:18:55.911512
NCT01527305|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-12-24|||June 2012||2012-06-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PREVAIL||A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia|An Open-Label, Prospective, Non-Comparative Study to Evaluate the Efficacy and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia|Completed||Phase 4|212|Actual|Johnson & Johnson Pte Ltd||1|||f||||f||||||||||2017-10-11 03:18:56.005386|2017-10-11 03:18:56.005386
NCT01527292|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-04-04|||February 2012|Actual|2012-02-01|January 2016|2016-01-01|September 2, 2015|Actual|2015-09-02|May 2, 2015|Actual|2015-05-02||Interventional|||Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis|Randomized Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis|Terminated||Phase 2|3|Actual|James Graham Brown Cancer Center||2||Unable to enroll|f||||t||||||||||2017-10-11 03:18:56.153935|2017-10-11 03:18:56.153935
NCT01527279|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-05-21|||November 2012||2012-11-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|AnPAF||Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation|Clinical Efficacy of Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation - a Single Centre, Randomized, Double-blind, Placebo-controlled Study (the AnPAF Study)|Completed||Phase 4|74|Actual|Institute of Cardiology, Warsaw, Poland||2|||f||||t||||||||||2017-10-11 03:18:56.265354|2017-10-11 03:18:56.265354
NCT01527266|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-10-16|||February 2012||2012-02-01|October 2012|2012-10-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|CHO rinse||Carbohydrate Mouth-rinse|The Impact of a Sucrose Mouth-rinse in the Fasted and Fed-state on Time Trial Performance|Unknown status|Recruiting|N/A|15|Anticipated|Maastricht University Medical Center||4|||f||||f||||||||||2017-10-11 03:18:56.401982|2017-10-11 03:18:56.401982
NCT01527253|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-05-22|||September 2011||2011-09-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Effect of a Synergistic Food Basket on Metabolic Syndrome Risk|Effects of a Synergistic Food Basket on Markers of Metabolic Syndrome Risk in Healthy Mature Women|Completed||N/A|52|Actual|Lund University||2|||f||||f||||||||||2017-10-11 03:18:56.488295|2017-10-11 03:18:56.488295
NCT01527240|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-05-15|||October 2009||2009-10-01|January 2012|2012-01-01|December 2013|Actual|2013-12-01|October 2009|Actual|2009-10-01||Interventional|CsAStroke||Neuroprotection Impact of Cyclosporin A in Cerebral Infarction|Cyclosporin A Combined to Intravenous Thrombolysis. Multicenter Randomized Placebo-controlled|Completed||Phase 2|126|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 03:18:56.592491|2017-10-11 03:18:56.592491
NCT01527227|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-02-02|||January 2010||2010-01-01|January 2012|2012-01-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Observational|||Parentification Among Children Whose Parents Cope With a Serious Mental Illness|Parentification Among Children Whose Parents Cope With a Serious Mental Illness|Unknown status|Recruiting|N/A|130|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 03:18:56.680389|2017-10-11 03:18:56.680389
NCT01527214|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2013-08-05|||November 2011||2011-11-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Effect of Direct Referral for Fast CT Scan in Early Lung Cancer Detection in General Practice|The Effect of Direct Referral for Fast CT Scan in Early Lung Cancer Detection in General Practice. Clinical, Randomised Trial|Completed||N/A|650|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 03:18:56.769478|2017-10-11 03:18:56.769478
NCT01527201|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-10-14|||January 2012||2012-01-01|July 2015|2015-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||The ChAMP (Chondral Lesions And Meniscus Procedures) Trial|Design of a Randomized Controlled Trial Examining the Effects of Arthroscopic Debridement on Chondral Lesions in Patients Undergoing Partial Meniscectomy: The ChAMP (Chondral Lesions And Meniscus Procedures) Trial|Completed||N/A|190|Actual|State University of New York at Buffalo||2|||f||||t||||||||||2017-10-11 03:18:56.863062|2017-10-11 03:18:56.863062
NCT01527188|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2013-08-01|||January 2011||2011-01-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite (HDM) Tablets in Allergic Rhinitis Environment Exposure Chamber Model|A Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase II Study to Assess the Efficacy and Safety of 100IR, 300IR and 500IR Sublingual Tablets of House Dust Mite Allergen for the Treatment of Allergic Rhinitis in an Environmental Exposure Chamber Model|Completed||Phase 2|355|Actual|Stallergenes Greer||4|||f||||f||||||||||2017-10-11 03:18:57.428272|2017-10-11 03:18:57.428272
NCT01527175|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2012-03-30|||November 2011||2011-11-01|March 2012|2012-03-01||||February 2012|Actual|2012-02-01||Interventional|SuCVC||Ultrasound-guided Subclavian Venous Catheterization in Children|Comparision of Ultrasound-guided Supraclavicular and Infraclavicular Approach for Central Venous Catheterization in Children|Completed||N/A|98|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:18:57.533726|2017-10-11 03:18:57.533726
NCT01527162|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-02-03|2015-11-16||January 2012||2012-01-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|SAFO|ages 3.0 to 5.8 years, mean age 4.3 years, spastic diplegia cerebral palsy, all wearing current AFO bilaterally to enhance walking activity|Orthotics in Ambulatory Cerebral Palsy|Relationship of Orthotics to Activity and Participation in Children With Cerebral Palsy|Completed||Phase 3|11|Actual|Seattle Children's Hospital||2|||f||||f||||||||No||2017-10-11 03:18:57.866285|2017-10-11 03:18:57.866285
NCT01527149|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-07-08|||December 6, 2011|Actual|2011-12-06|July 2017|2017-07-01|October 5, 2021|Anticipated|2021-10-05|October 5, 2020|Anticipated|2020-10-05||Interventional|||Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma|Ofatumumab (O) in Combination With Chemotherapy: Hyper-Fractionated Cyclophosphamide, Doxorubicin, Vincristine and Dexamethasone (O-HyperCVAD) Alternating With Ofatumumab High-Dose Cytarabine and Methotrexate (O-MA) for Patients With Newly Diagnosed Mantle Cell Lymphoma|Recruiting||Phase 2|37|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 03:18:58.223005|2017-10-11 03:18:58.223005
NCT01527136|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-01-11|||January 2012||2012-01-01|January 2016|2016-01-01||||October 2014|Actual|2014-10-01||Interventional|||Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery|A Phase 1 Study to Evaluate the Safety and Pharmacokinetic Profile of CBLB502 in Patients With Advanced Cancers|Completed||Phase 1|25|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 03:18:58.512013|2017-10-11 03:18:58.512013
NCT01527123|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-07-24|||February 28, 2012|Actual|2012-02-28|July 2017|2017-07-01|June 1, 2012|Actual|2012-06-01|June 1, 2012|Actual|2012-06-01||Interventional|||A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris|A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 03:18:58.620144|2017-10-11 03:18:58.620144
NCT01527097|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2015-11-16|||August 2012||2012-08-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Influence of Atorvastatin on Psoriasis Severity and Endothelial Function|Atorvastatin to Reduce Psoriasis Severity and Improve Endothelial Function in Patients With Severe Psoriasis and Non-Elevated LDL Levels: A Randomized, Double Blind, Placebo-Controlled Study.|Withdrawn||Phase 3|0|Actual|Rabin Medical Center||2||"We strongly feel that the ability to recruit the required number of patients is very low and   thus decided to stop the study."|f||||f||||||||||2017-10-11 03:18:58.832291|2017-10-11 03:18:58.832291
NCT01527084|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2014-11-08|||July 2011||2011-07-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Timing of Surgical Intervention After Percutaneous Catheter Drainage in STEP UP Approach for Severe Acute Pancreatitis|Timing of Surgical Intervention After Percutaneous Catheter Drainage in STEP UP Approach for Severe Acute Pancreatitis: a Randomized Controlled Stud|Completed||N/A|40|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 03:18:59.003967|2017-10-11 03:18:59.003967
NCT01527058|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-04-05|||December 2011||2011-12-01|November 2014|2014-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GRGDLC||68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients|Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Diagnostic Performance of 68Ga-BNOTA-PRGD2 in Healthy Volunteers and Lung Cancer Patients|Recruiting||Early Phase 1|100|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-11 03:18:59.119852|2017-10-11 03:18:59.119852
NCT01527045|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-09-12|||September 25, 2012|Actual|2012-09-25|September 2017|2017-09-01||||May 26, 2018|Anticipated|2018-05-26||Interventional|||Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies|Donor Statin Treatment for Prevention of Severe Acute GVHD After Nonmyeloablative Hematopoietic Cell Transplantation|Recruiting||Phase 2|100|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t|t|f||||||||2017-10-11 03:18:59.244783|2017-10-11 03:18:59.244783
NCT01527032|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-03-24|||September 2002||2002-09-01|July 2011|2011-07-01|September 2005|Actual|2005-09-01|||||Interventional|||Risk-adapted Therapy for Primary Systemic (AL) Amyloidosis|Risk-adapted Therapy for AL Amyloidosis|Completed||Phase 2|||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 03:18:59.402088|2017-10-11 03:18:59.402088
NCT01527019|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-07-24|||October 2012||2012-10-01|February 2012|2012-02-01||||October 2012|Actual|2012-10-01||Interventional|CECI||Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)|A Phase III Non-Inferiority Open-label Multicenter Randomized Clinical Trial to Compare CEPHALOSPORIN to NORFLOXACIN in the Treatment of Acute Cystitis|Withdrawn||Phase 3|0|Actual|Eurofarma Laboratorios S.A.||3||the company suspended the persecution of this combination|f||||t||||||||||2017-10-11 03:18:59.45609|2017-10-11 03:18:59.45609
NCT01527006|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-06-13|2015-07-31||January 2012||2012-01-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional|||Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs|An Open-label Pilot Study With an Extension Phase to Evaluate the Pharmacokinetics, and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Pediatric Subjects From 2 to Less Than 12 Years of Age With Epilepsy|Completed||Phase 2|63|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 03:18:59.602027|2017-10-11 03:18:59.602027
NCT01526980|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-01-04|||May 2002||2002-05-01|January 2017|2017-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes|A Single-Centre, Randomised, Open-Labelled, Two-Period, Crossover Trial In Subjects With Type 2 Diabetes Comparing the Glycaemic Control of Two Treatment Regimens: A Thrice Daily Regimen With Biphasic Insulin Aspart 70 and - 30 and a Twice Daily Regimen With Biphasic Human Insulin 30|Completed||Phase 2|31|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:19:01.757714|2017-10-11 03:19:01.757714
NCT01526954|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-12-03|||April 2012||2012-04-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Cohera TissuGlu® Surgical Adhesive in the Management of Wound Drainage|A Prospective, Randomized, Controlled, Single-blind, Multicenter Clinical Trial Evaluating the Safety and Efficacy of the Cohera TissuGlu® Surgical Adhesive in the Management of Wound Drainage as Compared to the Standard of Care Closure Techniques Following Abdominoplasty|Completed||Phase 2/Phase 3|150|Actual|Cohera Medical, Inc.||2|||f||||||||||||||2017-10-11 03:19:01.969322|2017-10-11 03:19:01.969322
NCT01526941|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-01-04|||May 2001||2001-05-01|January 2017|2017-01-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes|A Double-blind, Randomised, Two-Period Crossover Trial Comparing the Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Insulin Aspart 70 in Subjects With Type 1 Diabetes|Completed||Phase 1|27|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:19:02.273284|2017-10-11 03:19:02.273284
NCT01526928|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-07-26|||March 2012||2012-03-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|||Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients|A Phase 1/2, Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of Oral Rociletinib in Patients With Previously Treated Mutant EGFR Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1/Phase 2|605|Anticipated|Clovis Oncology, Inc.||1|||f||||f||||||||||2017-10-11 03:19:02.400845|2017-10-11 03:19:02.400845
NCT01526915|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-04-06|||September 2011||2011-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|OCN/PRF||Assessment of Platelet Rich Fibrin Efficiency on Healing Delay and on Jawbone Osteochemonecrosis Provoked by Bisphosphonates|Contribution of Platelet Rich Fibrin (PRF) After Tooth Avulsion in the Prevention of Healing Delay and of Jawbone Osteochemonecrosis Induced by Bisphosphonates|Suspended||N/A|270|Anticipated|Centre Hospitalier Régional Metz-Thionville||2|||f||||t||||||||||2017-10-11 03:19:02.591206|2017-10-11 03:19:02.591206
NCT01526902|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2014-03-07|2013-11-01||February 2012||2012-02-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Proclear 1-D Multifocal Nondispensing Study|Proclear 1-D Multifocal Nondispensing Study|Completed||N/A|49|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 03:19:02.692953|2017-10-11 03:19:02.692953
NCT01526889|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-09-22|||December 20, 2012|Actual|2012-12-20|September 2017|2017-09-01|August 24, 2017|Actual|2017-08-24|February 16, 2017|Actual|2017-02-16||Interventional|||Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,|A Randomized, Active-controlled, Open-label, Multicenter proof-of Concept Study of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, Posterior-, or Panuveitis Requiring Systemic Immunosuppressive Therapy|Completed||Phase 2|24|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:19:03.003942|2017-10-11 03:19:03.003942
NCT01526876|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-07-13|||November 2011||2011-11-01|July 2017|2017-07-01|December 19, 2012|Actual|2012-12-19|November 2012|Actual|2012-11-01||Interventional|||The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients|Effect of Clevidipine on Intracranial Pressure, Cerebral Blood Flow, Brain Tissue Oxygenation and Brain Cellular Metabolism in Severely Hypertensive Patients With Acute Brain Injury|Withdrawn||Phase 4|0|Actual|Columbia University||1||Terminated by Sponsor|f||||f||||||||||2017-10-11 03:19:03.115926|2017-10-11 03:19:03.115926
NCT01526863|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-01-15|||October 2012||2012-10-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Hydrolyzed Egg and Tolerance Induction|Assessment of the Effect of an HA Egg Administration for 6 Months on the Tolerance Induction to Egg in Children Allergic to Egg as Compared to a Placebo|Completed||N/A|29|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 03:19:03.193811|2017-10-11 03:19:03.193811
NCT01526850|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-08-01|||February 2012||2012-02-01|February 2012|2012-02-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|MSCsTcGVHD||Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease|Phase Ⅱ/Ⅲ Clinical Trial, Multicenter, Randomized, Controlled, for the Evaluation of Efficacy and Safety of Therapy With Allogenic Mesenchymal Stem Cells in Patients With Chronic Graft Versus Host Disease|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:19:03.280796|2017-10-11 03:19:03.280796
NCT01526837|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2017-07-11|||October 2011||2011-10-01|July 2017|2017-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence|A Dose-Escalating Phase I Study for Safety and Tolerability of Bevacizumab in Collagen Delivery Vehicle Administered Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence|Terminated||Phase 1|1|Actual|Brain & Spine Surgeons of New York||1||Investigators decision|f||||f||||||||||2017-10-11 03:19:03.38419|2017-10-11 03:19:03.38419
NCT01526824|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-01|||September 2011||2011-09-01|February 2012|2012-02-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Lovaza's Effect on Clopidogrel in a Neuro Population|The Effects of Polyunsaturated Omega-3 Fatty Acids (Lovaza) on Patients Taking Clopidogrel +/- Aspirin Who Have Suffered an Ischemic Stroke/TIA and/or Are Candidates for Neuroendovascular Stenting.|Unknown status|Recruiting|Early Phase 1|60|Anticipated|Millard Fillmore Gates Hospital||2|||f||||f||||||||||2017-10-11 03:19:03.46197|2017-10-11 03:19:03.46197
NCT01526811|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-01-03|||March 2012||2012-03-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)|Post-market Study on Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms|Active, not recruiting||N/A|180|Actual|Medtronic Endovascular|||1||f||||f||||||||||2017-10-11 03:19:03.572404|2017-10-11 03:19:03.572404
NCT01526798|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2017-04-19|||March 2012||2012-03-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|CIEPO-PILOT||Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammation by High Cut-off Hemodialysis|Improvement of EPO-resistance in HD Patients With Chronic Inflammation by High Cut-off Hemodialysis - Pilot Study (CIEPO-PILOT)|Completed||N/A|24|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-10-11 03:19:03.688102|2017-10-11 03:19:03.688102
NCT01526785|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-02|2015-11-09|2015-09-29||March 2012||2012-03-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Full analysis population defined as all participants who receive at least 1 infusion of 4000 L alglucosidase alfa during the study.|A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease|A Phase 4 Open Label, Prospective Study in Patients With Pompe Disease to Evaluate The Efficacy and Safety of Alglucosidase Alfa Produced at the 4000L Scale|Terminated||Phase 4|113|Actual|Sanofi||1||Terminated due to approved label expansion|f||||t||||||||||2017-10-11 03:19:05.452449|2017-10-11 03:19:05.452449
NCT01526772|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-04-17|||September 2011||2011-09-01|April 2017|2017-04-01|July 7, 2014|Actual|2014-07-07|July 7, 2014|Actual|2014-07-07||Observational|||A Prospective Study Evaluating The Utility of Transnasal Endoscopy With Roux en Y Gastric Bypass|A Prospective Study Evaluating The Utility of Transnasal Endoscopy With Roux en Y Gastric Bypass Referred for Upper Endoscopy|Completed||N/A|11|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-10-11 03:19:07.161011|2017-10-11 03:19:07.161011
NCT01526759|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2012-03-09|||December 2011||2011-12-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|FLiTS||Fiber Longer Term Study on Energy Intake|The Effect of 2 Weeks of Supplementation of a High-gelling, High-viscous Dietary Fibre on Energy Intake|Completed||N/A|35|Actual|Wageningen University||2|||f||||t||||||||||2017-10-11 03:19:07.242068|2017-10-11 03:19:07.242068
NCT01526746|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-02-14|||February 2012||2012-02-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function|An Open-Label, Single-Dose, Parallel-Group Study to Compare the Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment With That in Matched Control Subjects With Relatively Normal Renal Function|Completed||Phase 1|32|Actual|Vanda Pharmaceuticals||3|||f||||f||||||||||2017-10-11 03:19:07.334406|2017-10-11 03:19:07.334406
NCT01526733|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-09-23|2014-09-23||December 2011||2011-12-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|August 2012|Actual|2012-08-01||Interventional||All enrolled participants.|Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase|A Phase 4, Randomized, Double-Blind, 2-Way Crossover Study of Continuous Subcutaneous Insulin Infusion (CSII) With, Compared to Without, Pretreatment With Recombinant Human Hyaluronidase (rHuPH20)|Completed||Phase 4|25|Actual|Halozyme Therapeutics||2|||f||||f||||||||||2017-10-11 03:19:07.43466|2017-10-11 03:19:07.43466
NCT01526720|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-02-03|||October 2003||2003-10-01|February 2012|2012-02-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|VNDS||The Verona Newly Diagnosed Type 2 Diabetes Study|The Verona Newly Diagnosed Type 2 Diabetes Study. Construction of a Biobank of Diabetes Related Genotypes and Phenotypes|Recruiting||N/A|1500|Anticipated|Universita di Verona|||2||f||||t||||||Samples With DNA|"     Whole blood Serum Plasma Urine   "|||2017-10-11 03:19:07.905466|2017-10-11 03:19:07.905466
NCT01526707|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-10-08|||June 2011||2011-06-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Use of FKBP51 in the Identification of Non-adherence to Inhaled Corticosteroids in Difficult Asthma|The Use of FKBP51 in the Identification of Non-adherence to Inhaled Corticosteroids in Difficult Asthma|Completed||N/A|40|Actual|Belfast Health and Social Care Trust||1|||f||||t||||||||||2017-10-11 03:19:08.123197|2017-10-11 03:19:08.123197
NCT01526694|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-07-14|||October 2011||2011-10-01|July 2016|2016-07-01|August 2017|Anticipated|2017-08-01|December 2015|Actual|2015-12-01||Interventional|||Multicenter Clinical Trial to Investigate the Efficacy and Safety of Bendamustine, Dexamethasone and Thalidomide in Relapsed or Refractory Multiple Myeloma Patients After Treatment With Lenalidomide and Bortezomib or Which Are Ineligible to One of These Drugs|Phase II Multicenter Clinical Trial to Investigate the Efficacy and Safety of Bendamustine, Dexamethasone and Thalidomide in Relapsed or Refractory Multiple Myeloma Patients After Treatment With Lenalidomide and Bortezomib or Which Are Ineligible to One of These Drugs|Recruiting||Phase 2|30|Anticipated|Azienda Ospedaliera di Bolzano||1|||f||||f||||||||||2017-10-11 03:19:08.201134|2017-10-11 03:19:08.201134
NCT01526681|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-01-24|||November 2008||2008-11-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|RANGER||Registry of Avance Nerve Graft Evaluating Utilization and Outcomes for the Reconstruction of Peripheral Nerve Discontinuities|Registry Study: A Multicenter, Retrospective Study of Avance Nerve Graft Utilization, Evaluations and Outcomes in Peripheral Nerve Injury Repair|Recruiting||N/A|500|Anticipated|AxoGen, Inc|||2||f||||f||||||||Yes||2017-10-11 03:19:08.328322|2017-10-11 03:19:08.328322
NCT01526668|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-02-20|||October 2011||2011-10-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|POSTHYSTREC||Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy|A Randomized Study Comparing Four Different Postoperative Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy|Recruiting||N/A|600|Anticipated|University Hospital, Linkoeping||4|||f||||t||||||||||2017-10-11 03:19:08.480437|2017-10-11 03:19:08.480437
NCT01526655|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2016-02-20|||January 2012||2012-01-01|February 2016|2016-02-01|August 2016|Anticipated|2016-08-01|June 2016|Anticipated|2016-06-01||Interventional|||Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer|A Randomized Open Controlled Trial Comparing Robot Assisted Laparoscopic Hysterectomy and Abdominal Hysterectomy for Endometrial Cancer in a Fast Track Program|Recruiting||N/A|50|Anticipated|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-11 03:19:08.658052|2017-10-11 03:19:08.658052
NCT01526642|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-08-21|||December 2011||2011-12-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|NIVOLD||Home Non-invasive Ventilation for Chronic Obstructive Pulmonary Disease Patients|Home Non-invasive Ventilation Versus Long-term Oxygen Therapy in COPD Survivors of Acute Hypercapnic Respiratory Failure. A Multicenter Randomized Controlled Trial|Terminated||N/A|12|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 03:19:08.806795|2017-10-11 03:19:08.806795
NCT01526629|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-04-18|2017-02-14||May 2011||2011-05-01|February 2017|2017-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Full Automaticity and Remote Follow-up|Identification of Implantable Cardioverter Defibrillator Patients With Remote Follow up That Requires an Onsite Visit|Completed||N/A|354|Actual|Medtronic Bakken Research Center|||1||f||||f||||||||||2017-10-11 03:19:08.904851|2017-10-11 03:19:08.904851
NCT01526616|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-02-03|||May 2010||2010-05-01|February 2012|2012-02-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Spironolactone Plus Metformin in Polycystic Ovary Syndrome|Metformin Versus Metfotmin Plus Low-dose Spironolactone in the Treatment of Overweight/Obese Patients With Polycystic Ovary Syndrome: a Randomized Study|Completed||N/A|56|Actual|University Magna Graecia||2|||f||||f||||||||||2017-10-11 03:19:09.104999|2017-10-11 03:19:09.104999
NCT01526603|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-02-17|||March 28, 2012|Actual|2012-03-28|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||High Dose Chemotherapy and Autologous Transplant for Neuroblastoma|High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell (PBSC) Rescue for Neuroblastoma: Standard of Care Considerations|Recruiting||N/A|20|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||f|f|f||||||||2017-10-11 03:19:09.212279|2017-10-11 03:19:09.212279
NCT01526590|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2015-06-03|||July 2012||2012-07-01|June 2015|2015-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Contrast Enhanced Endoscopic Ultrasound for Vascular Involvement in Pancreatic Lesions|A Pilot Study of the Effects of Contrast Enhanced Endoscopic Ultrasound on Determining Vascular Involvement in Pancreatic Lesions|Withdrawn||N/A|0|Actual|University of Vermont||1||Lack of support|f||||f||||||||||2017-10-11 03:19:09.333506|2017-10-11 03:19:09.333506
NCT01526564|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-14|2013-11-07|||August 2008||2008-08-01|February 2012|2012-02-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|||Clinical Study on Acetyl-L-Carnitine|Phase III Study of Acetyl-L-Carnitine (ALC) Hydrochloride Enteric-coated Tablets in Treatment of Peripheral Sensory Neuropathy in Anti-cancer Chemotherapeutics Induce|Completed||Phase 3|239|Actual|Lee's Pharmaceutical Limited||2|||f||||t||||||||||2017-10-11 03:19:09.569599|2017-10-11 03:19:09.569599
NCT01526551|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-02-19|2015-02-19||August 2012||2012-08-01|February 2015|2015-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates|A Study to Compare the Impact of a School Based HPV Vaccination Program on Vaccination Uptake and Completion Rates Among High School Students in Rural, Southeastern Kentucky|Completed||N/A|935|Actual|Lake Cumberland District Health Department||1|||f||||f||||||||||2017-10-11 03:19:09.697052|2017-10-11 03:19:09.697052
NCT01526538|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-12-22|2015-09-10||September 2011||2011-09-01|December 2016|2016-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Improving Learning-based Treatment of Cocaine Dependence With Medication|Improving Learning-based Treatment of Cocaine Dependence With Medication|Completed||Phase 2|52|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:19:09.961729|2017-10-11 03:19:09.961729
NCT01526525|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2014-02-20|||July 2009||2009-07-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|September 2011|Actual|2011-09-01||Interventional|||Perioperative Electroacupuncture on Postoperative Analgesia in Prostatectomy|Effect of Perioperative Electroacupuncture With Tramadol and Ketamine on Postoperative Analgesia in Prostatectomy: a Randomized Placebo-controlled Trial|Completed||Phase 4|70|Actual|G.Gennimatas General Hospital||2|||f||||f||||||||||2017-10-11 03:19:10.285039|2017-10-11 03:19:10.285039
NCT01526512|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-29|2012-02-05|||December 2011||2011-12-01|February 2012|2012-02-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer||Unknown status|Recruiting|Phase 2|72|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 03:19:10.414468|2017-10-11 03:19:10.414468
NCT01526499|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-29|2012-02-05|||December 2011||2011-12-01|February 2012|2012-02-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer||Unknown status|Recruiting|Phase 2|60|Anticipated|Fudan University||2|||f||||f||||||||||2017-10-11 03:19:10.542876|2017-10-11 03:19:10.542876
NCT01526486|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2015-05-04|||June 2009||2009-06-01|May 2015|2015-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer|Videoscopic Versus Open Inguinal Lymphadenectomy for Sentinel Node Positive Cutaneous Malignancies and Genitourinary Staging Procedures|Completed||N/A|29|Actual|Emory University||2|||f||||f||||||||||2017-10-11 03:19:10.656976|2017-10-11 03:19:10.656976
NCT01526473|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-03-23|||February 2012||2012-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Interventional|||A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901|A Phase I Study To Evaluate The Antitumor Activity And Safety Of DUKE-002-VRP(HUHER2-ECD+TM), An Alphaviral Vector Encoding The HER2 Extracellular Domain And Transmembrane Region, In Patient With Locally Advanced Or Metastatic Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Cancers Including Breast Cancer|Active, not recruiting||Phase 1|22|Actual|Duke University||1|||f||||f||||||||||2017-10-11 03:19:10.763522|2017-10-11 03:19:10.763522
NCT01526460|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-03-05|||August 2011||2011-08-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|STATIPLAT||Evaluation of Platelet Function After Statin Loading Dose in Patients Before Percutaneous Coronary Intervention|Prospective, Randomized, Single Center, Open Label Study Designed to Evaluate the Effect on Platelet Reactivity in Response to High Doses of Atorvastatin or Rosuvastatin Administered Before Percutaneous Coronary Intervention (PCI)|Completed||Phase 2|146|Actual|IRCCS San Raffaele||3|||f||||f||||||||||2017-10-11 03:19:10.853687|2017-10-11 03:19:10.853687
NCT01526447|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-02-20|||February 2012||2012-02-01|February 2017|2017-02-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|CranioS||Effects of Craniosacral Therapy on Chronic Neck Pain|Effects of Craniosacral Therapy on Chronic Neck Pain: A Randomized Controlled Trial|Completed||N/A|54|Actual|Universität Duisburg-Essen||2|||f||||t||||||||||2017-10-11 03:19:10.965517|2017-10-11 03:19:10.965517
NCT01526434|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-03-18|||January 2012||2012-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|SONAR-12||Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol|An Open-label, Observational 12-week Study to Assess Health-related Quality of Life and Patient-reported Outcomes in Patients With Rheumatoid Arthritis Treated With Certolizumab Pegol|Completed||N/A|81|Actual|UCB Pharma|||1||f||||f||||||||||2017-10-11 03:19:11.154772|2017-10-11 03:19:11.154772
NCT01526421|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-12-18|||February 2012||2012-02-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|Incentives-1||Use of Incentives to Engage Drug Users in HIV Therapy|A Randomized Clinical Trial Evaluating the Role of Contingent Reinforcement in the Engagement of and Retention of Drug Users in HAART Programs - Part 1|Completed||N/A|301|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 03:19:11.395524|2017-10-11 03:19:11.395524
NCT01526408|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-08-27|||December 2011||2011-12-01|October 2013|2013-10-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|Famvir||Famvir for Treatment of Hearing in Unilateral Meniere's Disease|Treatment of Hearing Fluctuation in Unilateral Meniere's Disease: A Randomized, Placebo-controlled Clinical Trial of Famciclovir|Terminated||Phase 3|11|Actual|House Research Institute||2||HRI no longer conducting research.|f||||f||||||||||2017-10-11 03:19:11.49334|2017-10-11 03:19:11.49334
NCT01526395|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2013-04-01|||August 2011||2011-08-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital|Decreasing the Use of Unmodified ECT in an Indian Hospital|Completed||N/A|99|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:19:11.580347|2017-10-11 03:19:11.580347
NCT01526382|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2015-04-30|||January 2012||2012-01-01|September 2012|2012-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PiCCO||Use of PiCCO System in Critically Ill Patients With Septic Shock and Acute Respiratory Distress Syndrome|Use of PiCCO System in Critically Ill Patients With Septic Shock and Acute Respiratory|Completed||Phase 1/Phase 2|350|Actual|Jinhua Central Hospital||2|||f||||||||||||||2017-10-11 03:19:11.682411|2017-10-11 03:19:11.682411
NCT01526369|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-05-30|||January 2012||2012-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2015|Actual|2015-11-01||Interventional|TH V THL||A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer|A Phase III Randomized Study of TH (Paclitaxel and Trastuzumab) Versus THL (Paclitaxel, Trastuzumab and Lapatinib) in First Line Treatment of HER2-positive Metastatic Breast Cancer|Terminated||Phase 3|75|Actual|Cancer Trials Ireland||2|||f||||||||||||||2017-10-11 03:19:11.798447|2017-10-11 03:19:11.798447
NCT01526356|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2015-06-09|||May 2012||2012-05-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|Treatment||Topical Rapamycin to Erase Angiofibromas in TSC|Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy|Completed||Phase 2|177|Actual|The University of Texas Health Science Center, Houston||3|||f||||t||||||||||2017-10-11 03:19:11.967441|2017-10-11 03:19:11.967441
NCT01526343|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-08-01|2017-05-08||June 2011||2011-06-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Medtronic Reveal XT Study|A Comparison of Traditional Arrhythmia Assessment With the Use of Continuous Monitoring to Quantify Postoperative Arrhythmia Burden Following Surgical Treatment of Atrial Fibrillation- Medtronic Reveal XT Study|Completed||Phase 2|47|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 03:19:12.088377|2017-10-11 03:19:12.088377
NCT01526330|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-05-27|||May 2012||2012-05-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease|A Double-blind, Randomized, Parallel, Placebo Controlled, Phase I/II Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH14618 Following Single Intradiscal Injection in Patients With Degenerative Disc Disease|Completed||Phase 1/Phase 2|48|Actual|Yuhan Corporation||4|||f||||t||||||||||2017-10-11 03:19:12.293582|2017-10-11 03:19:12.293582
NCT01526317|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-07-31|||December 2011||2011-12-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers|A Randomized, Open Label, Cross-over Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers|Completed||Phase 1|36|Actual|Yuhan Corporation||6|||f||||f||||||||||2017-10-11 03:19:12.382663|2017-10-11 03:19:12.382663
NCT01526304|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-02|||January 2012||2012-01-01|January 2012|2012-01-01|January 2014|Anticipated|2014-01-01|||||Observational|||The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers|A Cross-Sectional Study To Investigate The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers|Unknown status|Recruiting|Phase 4|150|Anticipated|University of Zurich|||1||f||||f||||||Samples Without DNA|"     Whole Blood   "|||2017-10-11 03:19:12.48011|2017-10-11 03:19:12.48011
NCT01526291|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-02-13|||August 2011||2011-08-01|February 2014|2014-02-01||||||||Observational|PROWL-1||Patient-Reported Outcomes With LASIK:PROWL-1|Patient-Reported Outcomes With LASIK:PROWL-1|Completed||N/A|550|Anticipated|Food and Drug Administration (FDA)|||1||f||||t||||||||||2017-10-11 03:19:12.553437|2017-10-11 03:19:12.553437
NCT01526278|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-02-13|||October 2011||2011-10-01|February 2012|2012-02-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Interventional|YY_PK_2011||Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women|Pharmacokinetics of a Single Oral Dose of Maxmarvil® in Healthy Postmenopausal Women Without a Previous History of Fractures|Unknown status|Recruiting|Phase 1|20|Anticipated|Yuyu Pharma, Inc.||1|||f||||t||||||||||2017-10-11 03:19:12.627764|2017-10-11 03:19:12.627764
NCT01526265|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-05-10|||February 2012||2012-02-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures|Way to Quit - Comparative Efficacy, Acceptance and Effectiveness of Health Incentive Structures|Completed||N/A|2185|Anticipated|University of Pennsylvania||5|||f||||t||||||||||2017-10-11 03:19:12.730366|2017-10-11 03:19:12.730366
NCT01526252|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-04-21|||December 2011||2011-12-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|July 2012|Actual|2012-07-01||Observational|STE Normal||Reference Population for Speckle Tracking Imaging|Establishing a Reference Population for Normal Left Ventricular Function Parameters to Validate the Use of Two Dimensional Speckle Tracking Imaging Software in the Scar Study|Completed||N/A|91|Actual|Ottawa Heart Institute Research Corporation|||1||f||||f||||||||No|The objective of the trial was to establish a normal database for comparison. The database has not produced a specific study result. There is no publication as the sample size was not adequate.|2017-10-11 03:19:12.88885|2017-10-11 03:19:12.88885
NCT01526239|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-02-02|||November 2008||2008-11-01|January 2012|2012-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Reminding Patients of the Important of Colorectal Cancer Screening Results in Patient-Initiated Promoting Colorectal Cancer Screening Via Colonoscopy|Patient-Reminder Results in Patient-Initiated Promoting Colorectal Cancer Screening Via Colonoscopy|Completed||N/A|274|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-11 03:19:12.947994|2017-10-11 03:19:12.947994
NCT01526226|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2017-06-23|||February 2012||2012-02-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Patient Comfort During High Flow Nasal Cannula Versus Nasal Continuous Airway Pressure (CPAP)|Patient Comfort During High Flow Nasal Cannula (HFNC)Versus Nasal Continuous Airway Pressure (CPAP): a Cross Over Randomised Trial|Completed||N/A|24|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 03:19:13.021345|2017-10-11 03:19:13.021345
NCT01526213|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-04-21|2012-03-03||September 2009||2009-09-01|December 2012|2012-12-01|April 2011|Actual|2011-04-01|April 2010|Actual|2010-04-01||Interventional|||Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?|Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?|Completed||N/A|18|Actual|University of North Carolina, Chapel Hill||6|||f||||f||||||||||2017-10-11 03:19:13.134688|2017-10-11 03:19:13.134688
NCT01526200|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-02-02|||October 2007||2007-10-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Observational|CEIOUSCLM||Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases|Factors Influencing the Impact of Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases|Completed||N/A|127|Actual|University of Milan|||1||f||||f||||||||||2017-10-11 03:19:13.580131|2017-10-11 03:19:13.580131
NCT01526187|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-10-13|||February 2012||2012-02-01|March 2013|2013-03-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Observational|VOYAG-R||Travel in the Tropics and Acquisition of Multidrug-resistant Bacteria (VOYAG-R)|Acquisition of Multidrug-resistant Bacteria After Travel in the Tropics : Prevalence, Determinants and Length of Carriage|Completed||N/A|750|Anticipated|Assistance Publique - Hôpitaux de Paris|||3||f||||t||||||Samples Without DNA|"     Stool   "|||2017-10-11 03:19:13.681796|2017-10-11 03:19:13.681796
NCT01526174|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2013-10-10|||March 2012||2012-03-01|October 2013|2013-10-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Interventional|AIED||Intratympanic Injection for Autoimmune Inner Ear Disease|Safety and Efficacy of Intratympanically Delivered Golimumab for Stabilization of Hearing in Patients With Autoimmune Inner Ear Disease: An Open-label Proof-of-concept Clinical Trial|Terminated||Phase 1/Phase 2|16|Actual|House Research Institute||2||House Research no longer conducting research.|f||||f||||||||||2017-10-11 03:19:13.776211|2017-10-11 03:19:13.776211
NCT01526148|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-07-18|2015-07-30||January 2012||2012-01-01|July 2017|2017-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Gao Bipolar Spectrum Lithium/Quetiapine Study|Comparative Safety, Tolerability, and Effectiveness of Lithium Versus Quetiapine in Patients Across the Spectrum of Bipolar Disorder|Terminated||Phase 4|42|Actual|University Hospitals Cleveland Medical Center||2||Ran out of funding|f||||t||||||||||2017-10-11 03:19:14.029793|2017-10-11 03:19:14.029793
NCT01526135|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-01-24|||January 2012||2012-01-01|January 2017|2017-01-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma|Multicentric Randomized Phase III Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus 5-fluorouracil, Leucovorin, Irinotecan and Oxaliplatin (mFolfirinox) in Patients With Resected Pancreatic Adenocarcinoma|Active, not recruiting||Phase 3|490|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-11 03:19:14.473812|2017-10-11 03:19:14.473812
NCT01526122|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2014-09-29|||September 2011||2011-09-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration|A PhaseⅠ Study to Compare the Pharmacokinetic Characteristics and Safety After Oral Administration of G0041(75/100mg) With Those of Clopidogrel 75mg & Aspirin 100mg Coadministration in Healthy Male Volunteers|Completed||Phase 1|65|Actual|Dong-A ST Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:19:14.688068|2017-10-11 03:19:14.688068
NCT01526109|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-12-03|||January 2012||2012-01-01|February 2012|2012-02-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Strength Training and Whole Body Vibration in Healthy Elderly|Effect of Strength Training and Whole Body Vibration on Cognitive Function, Behavioral and Functional Capacity in Healthy Elderly.|Withdrawn||N/A|0|Actual|Universidade Gama Filho||3||The study was finished since the University has been closed|f||||t||||||||||2017-10-11 03:19:14.917942|2017-10-11 03:19:14.917942
NCT01526096|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-04-18|||July 2011||2011-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stem Cell Transplantation for Patients With Multiple Myeloma|Pilot Study T Cell Depletion in the Setting of Autologous Stem Cell Transplantation for Patients With Multiple Myeloma|Recruiting||Phase 1|30|Anticipated|University of Chicago||3|||f||||f||||||||||2017-10-11 03:19:15.033302|2017-10-11 03:19:15.033302
NCT01526083|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-05-04|||January 2012||2012-01-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males|Single-center, Open-label, Randomized 2-way Crossover Study of the Effect of Lacosamide 200 mg Twice Daily on the Single-dose Pharmacokinetics and Pharmacodynamics of Warfarin (25 mg) in Healthy Male Volunteers|Completed||Phase 1|16|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:19:15.186758|2017-10-11 03:19:15.186758
NCT01526070|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-11-17|||January 2012||2012-01-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration|Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Standard Therapy for Exudative Age-Related Macular Degeneration|Completed||N/A|142|Actual|Stanford University|||1||f||||f||||||||||2017-10-11 03:19:15.330518|2017-10-11 03:19:15.330518
NCT01526057|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-09-09||2014-09-09|March 2012||2012-03-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional|REFLECTIONS||A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)|A Randomized, Double-Blind, Study Comparing The Pharmacokinetics And Pharmacodynamics, And Assessing The Safety Of PF-05280586 And Rituximab In Subjects With Active Rheumatoid Arthritis On A Background Of Methotrexate Who Have Had An Inadequate Response To One Or More TNF Antagonist Therapies|Completed||Phase 1/Phase 2|222|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 03:19:15.447255|2017-10-11 03:19:15.447255
NCT01526044|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-06-26|||December 2010||2010-12-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|RESCUEII||Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill Patients|Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill Patients; a Randomized Controlled Trial (RESCUEII)|Completed||N/A|178|Actual|Onze Lieve Vrouwe Gasthuis||2|||f||||f||||||||||2017-10-11 03:19:15.717961|2017-10-11 03:19:15.717961
NCT01526031|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-02-01|||January 2010||2010-01-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Bee Venom Acupuncture for the Treatment of Frozen Shoulder|Randomized Controlled Double Blind Study of Bee Venom Therapy on Adhesive Capsulitis of the Shoulder|Completed||Phase 2|68|Actual|Kyunghee University Medical Center||3|||f||||f||||||||||2017-10-11 03:19:15.83978|2017-10-11 03:19:15.83978
NCT01526018|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-08-14|||January 2012||2012-01-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||The Bottle Study: Infant Weight Gain During Use of Novel Versus Typical Infant Feeding Bottles||Terminated||N/A|5|Actual|University of Alabama at Birmingham|||1|Inadequate recruitment|f||||f||||||||||2017-10-11 03:19:15.944797|2017-10-11 03:19:15.944797
NCT01526005|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2015-01-26|||March 2012||2012-03-01|January 2015|2015-01-01||||January 2014|Actual|2014-01-01||Observational|||Brain Nicotine Receptor Density & Response to Nicotine Patch|Brain Nicotine Receptor Density & Response to Nicotine Patch|Completed||Phase 3|50|Actual|Brentwood Biomedical Research Institute|||2||f||||f||||||||||2017-10-11 03:19:16.02192|2017-10-11 03:19:16.02192
NCT01525992|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-04-16|||March 2012||2012-03-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||A Community Pharmacy-based Program to Improve Management of Diabetes|A Community Pharmacy-based Intervention on Type 2 Diabetic Patients to Improve Medications Adherence and Disease Outcomes; a Randomized Controlled Trial.|Completed||N/A|101|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:19:16.097929|2017-10-11 03:19:16.097929
NCT01525979|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-06-04|||January 2011||2011-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Comparative Efficacy Research of Uni- vs Bi-lateral Arm Training Poststroke|Comparative Efficacy Research of Uni- vs Bi-lateral Arm Training Poststroke: Task-Related or Robotic|Completed||N/A|42|Actual|Chang Gung Memorial Hospital||5|||f||||f||||||||||2017-10-11 03:19:16.191863|2017-10-11 03:19:16.191863
NCT01525966|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-09-06|||February 15, 2012|Actual|2012-02-15|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer|Phase II Trial of Neoadjuvant Chemotherapy With Carboplatin and NAB-Paclitaxel in Patients With Locally Advanced and Inflammatory Triple Negative Breast Cancer|Recruiting||Phase 2|69|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 03:19:16.310964|2017-10-11 03:19:16.310964
NCT01525953|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-02-01|||January 2012||2012-01-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|CRCRT-EC||Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis|Predictors of Survival for Complete Clinical Responders to Definite Chemoradiation or Radiation Therapy for Esophageal Cancer|Completed||N/A|110|Actual|Centre Oscar Lambret|||1||f||||f||||||||||2017-10-11 03:19:16.422554|2017-10-11 03:19:16.422554
NCT01525940|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2015-11-09|||November 2011||2011-11-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||PillCam Colon Capsule and CT-colonography in the Evaluation of Patients With Incomplete Conventional Colonoscopy|PillCam Colon Capsule and CT-colonography in the Evaluation of Patients With Incomplete Conventional Colonoscopy|Completed||N/A|100|Actual|Catholic University of the Sacred Heart||1|||f||||f||||||||||2017-10-11 03:19:16.493164|2017-10-11 03:19:16.493164
NCT01525927|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-01-29|2015-08-28||August 2010||2010-08-01|January 2016|2016-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||data was not collected for Baseline Characteristics due to premature termination of this study|Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity|Phase II Trial of Neoadjuvant Chemotherapy for HPV-Associated Squamous Cell Carcinoma of the Oropharynx Followed by Reduced Dose Radiotherapy/Chemoradiotherapy for Responders or Standard Dose Chemoradiotherapy for Non-Responders|Terminated||Phase 2|2|Actual|Northwell Health|Study terminated , PI left the institution, no data analyzed|2||Principal Investigator left institution. IRB approval lapsed.|f||||t||||||||||2017-10-11 03:19:16.58045|2017-10-11 03:19:16.58045
NCT01525914|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2012-02-02|||May 2010||2010-05-01|February 2012|2012-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Response of Patients on Surveillance for Prostate Cancer to Dutasteride|Assessment of Response of Patients on Surveillance for Favorable Risk Prostate Cancer to Dutasteride|Completed||N/A|100|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||Samples With DNA|"     prostate biopsy tissue stored on site   "|||2017-10-11 03:19:16.810157|2017-10-11 03:19:16.810157
NCT01525901|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-01-10|||February 2012||2012-02-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)|A Double-Blind Placebo-Controlled Crossover Trial of Insulin-Like Growth Factor-1 (IGF-1) in Children and Adolescents With 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)|Completed||Phase 2|20|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 03:19:16.944398|2017-10-11 03:19:16.944398
NCT01525862|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2013-02-12|||December 2011||2011-12-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||XprESS Maxillary Balloon Dilation Study|XprESS Maxillary Sinus Balloon Dilation Study|Completed||N/A|30|Anticipated|Entellus Medical, Inc.||1|||f||||f||||||||||2017-10-11 03:19:17.291594|2017-10-11 03:19:17.291594
NCT01525849|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-01-04|2016-11-01||December 2011||2011-12-01|January 2017|2017-01-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|REMODEL|All treated participants|Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up|Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up|Completed||N/A|151|Actual|Entellus Medical, Inc.||2|||f||||f||||||||No||2017-10-11 03:19:17.378793|2017-10-11 03:19:17.378793
NCT01525836|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2016-04-18|||May 2011||2011-05-01|May 2013|2013-05-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP|Recombinant Human Thrombopoietin in Combination With Rituximab Versus Low-dose Rituximab for the Treatment of Refractory ITP.|Completed||Phase 3|123|Actual|Shandong University||2|||f||||t||||||||||2017-10-11 03:19:17.918106|2017-10-11 03:19:17.918106
NCT01525823|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-06-13|||February 2012||2012-02-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|NHV||Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin|Effects of Metformin on Glucose Homeostasis Following Administration of BMS-754807 in Healthy Volunteer Subjects|Completed||Phase 1|26|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 03:19:18.029738|2017-10-11 03:19:18.029738
NCT01525810|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2015-03-25|||March 2012||2012-03-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial|A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in Which Peginterferon Lambda-1a (BMS-914143) Was Administered for the Treatment of Chronic Hepatitis C|Completed||N/A|218|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 03:19:18.121607|2017-10-11 03:19:18.121607
NCT01525797|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-03-13|||October 2002||2002-10-01|March 2015|2015-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Blood Draw Study for Liver Transplant Patients|Immunomonitoring of Transplant Patients|Unknown status|Active, not recruiting|N/A|200|Anticipated|Baylor Research Institute|||2||f||||f||||||||||2017-10-11 03:19:18.359182|2017-10-11 03:19:18.359182
NCT01525784|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-02-01|||February 2012||2012-02-01|February 2012|2012-02-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Observational|||Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients|Prospective Short and Long Term Follow up of Pediatric Diabetes Mellitus Patients Receiving RT-CGMS as Part of National Clinical Care|Unknown status|Not yet recruiting|N/A|300|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||||||2017-10-11 03:19:18.424312|2017-10-11 03:19:18.424312
NCT01525771|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-06-26|||February 2011||2011-02-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|XPID||Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer|A Phase I-II Study of Systemic Capecitabine, Cisplatin and Intraperitoneal Docetaxel (XPID) in Patients With Advanced Stomach Cancer With Peritoneal Seeding|Completed||Phase 1/Phase 2|37|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:19:18.517013|2017-10-11 03:19:18.517013
NCT01525758|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-08-12|||January 2012||2012-01-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Study of SI000413 in Knee Osteoarthritis Patients|Eight-week, Multi-centre, Dose-response, Double Blind, Placebo-controlled, Randomized, Parallel-group, PhaseⅡ Trial to Evaluate Efficacy and Safety of SI000413 in Patients With Knee Osteoarthritis|Unknown status|Recruiting|Phase 2|152|Anticipated|Dong-A ST Co., Ltd.||4|||f||||f||||||||||2017-10-11 03:19:18.599827|2017-10-11 03:19:18.599827
NCT01525745|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-01-23|2015-09-03||January 2012||2012-01-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis|Randomized Ph II Study of Stereotactic Body Radiotherapy (SBRT) Versus Conventional Radiation for Spine Metastasis|Terminated||Phase 2|6|Actual|Beth Israel Deaconess Medical Center||2||Local IRB decision due to poor accrual|f||||t||||||||||2017-10-11 03:19:18.711361|2017-10-11 03:19:18.711361
NCT01525732|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-04-27|||June 2010||2010-06-01|April 2017|2017-04-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|POEM||Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Esophageal Motility Disorders|Prospective Study on the Feasibility and Effectiveness of Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders|Completed||N/A|50|Actual|Chinese University of Hong Kong||1|||f||||||||||||||2017-10-11 03:19:18.963498|2017-10-11 03:19:18.963498
NCT01525719|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-02|||January 2012||2012-01-01|January 2012|2012-01-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|CRAD001T||Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma|A Phase II Single Arm Study to Evaluate the Safety and Efficacy of RAD001 as Monotherapy in Treatment naïve Advanced Cholangiocarcinoma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|Ratchavithi Hospital||1|||f||||f||||||||||2017-10-11 03:19:19.189514|2017-10-11 03:19:19.189514
NCT01525706|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-11-01|||September 2012||2012-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm|EUS Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm|Terminated||Phase 1|1|Actual|Lawson Health Research Institute||1||Poor recruitment|f||||f||||||||||2017-10-11 03:19:19.299033|2017-10-11 03:19:19.299033
NCT01525693|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2013-02-13|||April 2012||2012-04-01|February 2012|2012-02-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Observational|NEW2D||Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China|Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China (NEW2D STUDY) A Study Of China Cardiometabolic Registries (CCMR)|Unknown status|Active, not recruiting|N/A|5000|Anticipated|China Cardiometabolic Registries|||1||f||||f||||||||||2017-10-11 03:19:19.451077|2017-10-11 03:19:19.451077
NCT01525680|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2013-11-27|||April 2011||2011-04-01|November 2013|2013-11-01||||September 2015|Anticipated|2015-09-01||Interventional|||A Randomized Clinical Trial of Hydrocortisone Augmentation of Prolonged Exposure|"Improving PTSD Outcomes in OIF/OEF Returnees: A Randomized Clinical Trial of Hydrocortisone Augmentation of Prolonged Exposure Therapy"|Unknown status|Recruiting|N/A|60|Anticipated|Bronx VA Medical Center||2|||f||||f||||||||||2017-10-11 03:19:19.632837|2017-10-11 03:19:19.632837
NCT01525667|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-09-07|2015-01-01||November 2012||2012-11-01|January 2015|2015-01-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty|A Phase I/II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty|Completed||Phase 1/Phase 2|20|Actual|Pluristem Ltd.||3|||f||||t||||||||||2017-10-11 03:19:19.760127|2017-10-11 03:19:19.760127
NCT01525654|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-03-16|||March 2009||2009-03-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|PARASS||Patient Rheumatoid Arthritis Social Support Study|Rheumatoid Arthritis Patient-to-Patient Connection Program|Enrolling by invitation||N/A|65|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:19:20.398129|2017-10-11 03:19:20.398129
NCT01525641|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2015-07-17|2015-06-04||February 2012||2012-02-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational||Safety set: included all patients who had received treatment with Mirapex®-LA Tablets except those who were found to have no observation after enrolment, invalid registration, or invalid contract.|Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease|Special Survey on Long-term Drug Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease|Completed||N/A|615|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 03:19:20.533297|2017-10-11 03:19:20.533297
NCT01525628|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-05-04|2016-01-21||April 2012||2012-04-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional||The treated set (TRT) included all patients who were dispensed trial medication and were documented to have taken at least one dose of trial drug.|Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients|A Multi-centre, Open Label, Parallel Group Trial to Evaluate the Pharmacokinetic Interactions Between BI 207127 (600 mg t.i.d. or 600 mg b.i.d.) and BI 201335 (120 mg q.d.) Given in Combination With Ribavirin for 24 Weeks, and Their Combined Effect on the Pharmacokinetics of Tenofovir, Raltegravir, Caffeine (the Probe Drug Substrate for CYP1A2), Tolbutamide (the Probe Drug Substrate for CYP2C9) and Midazolam (the Probe Drug Substrate for CYP3A4) in Treatment naïve Patients and Prior Treatment Relapse or Partial Responder Patients With Genotype 1 Chronic Hepatitis C Infection|Completed||Phase 1|72|Actual|Boehringer Ingelheim|BI decided to stop the further development of the interferon-free combination therapy for Hepatitis C in December 2013 so the recruitment was stopped after 7 patients had entered Group E also PK analyses for Groups C to E were not performed.|5|||f||||||||||||||2017-10-11 03:19:21.314476|2017-10-11 03:19:21.314476
NCT01525615|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2016-07-28|2015-06-19|2014-04-03|February 2012||2012-02-01|July 2016|2016-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Treated set included all randomised patients who were dispensed study medication and were documented to have taken any dose of study medication.|A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD|A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Determine the Effect of 12 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (2.5/5 µg and 5/5 µg) Delivered by the Respimat® Inhaler, on Exercise Endurance Time During Constant Work Rate Cycle Ergometry in Patients With Chronic Obstructive Pulmonary Disease (COPD)[Torracto (TM)]|Completed||Phase 3|404|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:19:26.417915|2017-10-11 03:19:26.417915
NCT01525602|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-09-18|||May 2012||2012-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors|A Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|90|Anticipated|Plexxikon||3|||f||||f||||||||||2017-10-11 03:19:27.679333|2017-10-11 03:19:27.679333
NCT01525589|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-08-21|||December 2012||2012-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer|A Multicenter Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer|Recruiting||Phase 2|110|Anticipated|PharmaMar||1|||f||||f||||||||||2017-10-11 03:19:27.792481|2017-10-11 03:19:27.792481
NCT01525576|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-07-30|||February 2012||2012-02-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Booster as an Adjunct to Internet-based Cognitive Behavior Therapy (CBT)|Efficacy of an Internet-based Booster Program for Obsessive-compulsive Disorder: A Randomized Controlled Trial|Completed||Phase 2|98|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:19:27.904852|2017-10-11 03:19:27.904852
NCT01525563|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2014-12-17|2014-12-17||April 2012||2012-04-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study|Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study|Completed||N/A|1000|Actual|Abbott|||1||f||||f||||||||||2017-10-11 03:19:27.997938|2017-10-11 03:19:27.997938
NCT01525550|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-04-07|2017-03-08||June 6, 2012|Actual|2012-06-06|April 2017|2017-04-01|June 29, 2018|Anticipated|2018-06-29|March 19, 2016|Actual|2016-03-19||Interventional||Full analysis set (FAS) included all participants who were enrolled into the study regardless of whether participants received study drug or not.|A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors|A Single-arm Open-label International Multi-center Study Of The Efficacy And Safety Of Sunitinib Malate (su011248, Sutent (Registered)) In Patients With Progressive Advanced Metastatic Well-differentiated Unresectable Pancreatic Neuroendocrine Tumors|Active, not recruiting||Phase 4|106|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:19:29.104349|2017-10-11 03:19:29.104349
NCT01525537|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-06-14|||March 2009||2009-03-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|February 2010|Actual|2010-02-01||Interventional|||Surgical Pleth Index (SPI) Guided Analgesia During Sevoflurane Anesthesia|Comparison of Surgical Pleth Index Guided Analgesia With Standard Clinical Practise During Balanced Anesthesia|Completed||N/A|82|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-11 03:19:37.056903|2017-10-11 03:19:37.056903
NCT01525524|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2014-09-07|||January 2012||2012-01-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional|||Treatment of Major Depressive Disorder Post Stroke With Transcranial Direct Current Stimulation|Treatment of Major Depressive Disorder Post Stroke With Transcranial Direct Current Stimulation (TDCS): Randomized, Double-Blind, Clinical Trial|Completed||Phase 2|48|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:19:37.15515|2017-10-11 03:19:37.15515
NCT01525511|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-08-27|||June 2012||2012-06-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Pharmacokinetic Study of Primaquine and Dihydroartemisinin-Piperaquine in Healthy Subjects|Open-Label Study to Evaluate Potential Pharmacokinetic Interaction of Orally Administered Primaquine and Dihydroartemisinin-Piperaquine in Healthy Adult Subjects|Completed||Phase 1|16|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 03:19:37.267211|2017-10-11 03:19:37.267211
NCT01525498|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2013-10-15|||August 2011||2011-08-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Foley Catheterization Following Sacrocolpopexy|Urinary Bladder Catheterization Following Sacrocolpopexy|Withdrawn||N/A|0|Actual|University of Oklahoma|||2|No subject accrual|f||||f||||||||||2017-10-11 03:19:37.377937|2017-10-11 03:19:37.377937
NCT01525485|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-06-08|||March 2011||2011-03-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|Estim||Vaginal Electrical Stimulation Versus Neuromodulation|Vaginal Electrical Stimulation Versus Sacral Neuromodulation for the Treatment of Refractory Overactive Bladder: A Pilot Study|Completed||N/A|34|Actual|University of Oklahoma|||2||f||||f||||||||||2017-10-11 03:19:37.47739|2017-10-11 03:19:37.47739
NCT01525472|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2015-02-05|||February 2012||2012-02-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|June 2015|Anticipated|2015-06-01||Observational|SENAPID||Accelerated Aging of the Cells of Visceral Adipose Tissue in Morbid Obese Subjects|Accelerated Aging of the Cells of Visceral Adipose Tissue in Morbid Obese Subjects: Involvement in Diseases Associated With Obesity (Viellissement accéléré Des Cellules du Tissu Adipeux viscéral Chez Les obèses Morbides: Implication Dans Les Pathologies associées à l'obésité)|Unknown status|Recruiting|N/A|225|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||t||||||Samples Without DNA|"     adipose tissue   "|||2017-10-11 03:19:37.554018|2017-10-11 03:19:37.554018
NCT01525459|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-02-06|||December 2010||2010-12-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Observational|||Gene Expression, Immunological Status and Metabolome in Glioma Patients|Monitoring and Analysis of Gene Expression, Immunological Status and Metabolome in Peripheral Blood Mononuclear Cells and Their Specific Subpopulations (CD4+ T Cells and CD56+ NK Cells) in Surgically Treated Glioma Patients|Unknown status|Recruiting|N/A|16|Anticipated|National Institute of Biology, Slovenia|||1||f||||f||||||Samples With DNA|"     Whole blood, blood plasma, peripheral blood mononuclear cells, CD4+ T cells, CD56+ NK cells   "|||2017-10-11 03:19:37.651919|2017-10-11 03:19:37.651919
NCT01525446|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-02-12|||September 2011||2011-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer|Proton Stereotactic Body Radiation Therapy (SBRT) for Medically Inoperable, Peripheral Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Pilot Study|Terminated||Early Phase 1|7|Actual|Massachusetts General Hospital||1||Slow accrual|f||||t||||||||||2017-10-11 03:19:37.784808|2017-10-11 03:19:37.784808
NCT01525433|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-09-26|||September 2011||2011-09-01|September 2017|2017-09-01|July 2019|Anticipated|2019-07-01|September 2015|Actual|2015-09-01||Interventional|||Cervical Cancer Screening Among Hispanic Women|Cervical Cancer Screening and Adherence to Follow-up Among Hispanic Women|Active, not recruiting||N/A|451|Actual|Fred Hutchinson Cancer Research Center||3|||f||||f||||||||||2017-10-11 03:19:37.882972|2017-10-11 03:19:37.882972
NCT01525420|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-05-07|2014-03-10||March 2012||2012-03-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|TALK||Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy|Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy|Completed||N/A|121|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 03:19:37.971596|2017-10-11 03:19:37.971596
NCT01525407|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-07-18|2017-04-11||May 2012||2012-05-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|September 2015|Actual|2015-09-01||Interventional|||Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation|Donor Statin Treatment for Prevention of Severe Acute GVHD After Myeloablative Hematopoietic Cell Transplantation|Completed||Phase 2|83|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 03:19:38.214576|2017-10-11 03:19:38.214576
NCT01525394|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-03-03|||December 2010||2010-12-01|April 2012|2012-04-01||||August 2011|Actual|2011-08-01||Interventional|||A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval|A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval|Completed||Phase 1|52|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-11 03:19:38.693687|2017-10-11 03:19:38.693687
NCT01525368|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2014-11-11|||September 2010||2010-09-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|OutPreC MCI||Outcome Predictors of a Cognitive Intervention in aMCI|Outcome Predictors of a Complex Cognitive Intervention in Amnestic Mild Cognitive Impairment (aMCI)|Completed||N/A|110|Actual|Ludwig-Maximilians - University of Munich|||2||f||||f||||||||||2017-10-11 03:19:38.830305|2017-10-11 03:19:38.830305
NCT01525355|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-04-17|||October 2010|Actual|2010-10-01|April 2017|2017-04-01|June 7, 2016|Actual|2016-06-07|June 7, 2016|Actual|2016-06-07||Observational|||EUS Prior to ERCP in the Positive Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy|"A Prospective Study Evaluation the Role of EUS Prior to ERCP in the Positive Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy"|Completed||N/A|34|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-10-11 03:19:38.973205|2017-10-11 03:19:38.973205
NCT01525316|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-01-16|||May 2012||2012-05-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|NEOLACTO||Lactoferrin for Prevention of Sepsis in Infants|Lactoferrin for Prevention of Sepsis in Infants|Completed||Phase 3|414|Actual|Universidad Peruana Cayetano Heredia||2|||f||||t||||||||||2017-10-11 03:19:39.135477|2017-10-11 03:19:39.135477
NCT01525303|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2013-01-14|||December 2011||2011-12-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||Effects of Aerobic Exercise Within a Behavioral Treatment Program for Chronic Headaches|Additive Effects of Aerobic Exercise to a Standard Behavioral Self-Management Program for Chronic Headaches|Completed||N/A|5|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-10-11 03:19:39.303763|2017-10-11 03:19:39.303763
NCT01525290|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-07-18|||September 2012||2012-09-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|WAKE-UP||Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke|Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke: a Randomised, Double-blind, Placebo-controlled Trial|Active, not recruiting||Phase 3|501|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-11 03:19:39.402082|2017-10-11 03:19:39.402082
NCT01525277|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-04-11|||March 2012||2012-03-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|June 2014|Anticipated|2014-06-01||Observational|||The Side of Implantable Central Vascular Catheters and Complications|The Side of Implantable Central Vascular Catheters and Complications in Cancer Patients: A Randomization Observational Study|Unknown status|Recruiting|N/A|246|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 03:19:39.52266|2017-10-11 03:19:39.52266
NCT01525264|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2016-08-17|||August 2008||2008-08-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Breast Cancer Screening Intervention|Korean Immigrants & Mammography—Culture-Specific Health Intervention (KIM-CHI)|Completed||N/A|434|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 03:19:39.616314|2017-10-11 03:19:39.616314
NCT01525251|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-02-01|||August 2009||2009-08-01|January 2012|2012-01-01||||||||Observational|NCMM||Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty|The Effect of Nurse Case Manager Model on Caregiver's Adaptation of Disease Uncertainty About Their Child With Neuroblastoma|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 03:19:39.70043|2017-10-11 03:19:39.70043
NCT01525238|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-04-26|2016-09-29||July 1, 2012|Actual|2012-07-01|April 2017|2017-04-01|September 1, 2014|Actual|2014-09-01|September 1, 2014|Actual|2014-09-01||Interventional||All treated participants|PK Study of Dapagliflozin in Pediatric Subjects With T2DM|A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus|Completed||Phase 1|53|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 03:19:39.797381|2017-10-11 03:19:39.797381
NCT01525225|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-05-27|2014-08-11||September 2012||2012-09-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||All participants who received at least one dose of study drug.|Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM|Evaluation of the Pharmacokinetics of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus Following Oral Administration of Saxagliptin and Metformin XR Fixed Dose Combination Tablet and Co-Administration of Saxagliptin and Glucophage® (Metformin) IR Tablets|Terminated||Phase 1|4|Actual|AstraZeneca|Due to the small number of participants (2), the primary endpoints, pharmacokinetic parameters, were not calculated.|1||Release of Post Marketing Requirement for this study. Terminated November 2013.|f||||f||||||||||2017-10-11 03:19:40.681457|2017-10-11 03:19:40.681457
NCT01525212|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-06-19|||April 2012||2012-04-01|June 2013|2013-06-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients|Double-Blinded, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Antiviral Activity, Safety, Tolerability, and Pharmacokinetics of BMS-929075 in Treatment Naive Subjects Infected With Hepatitis C Virus Genotype 1|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 03:19:40.919926|2017-10-11 03:19:40.919926
NCT01525199|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-04-11|||May 2012||2012-05-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|IDENTIFY||Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.|Study of Cases and Controls on Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.|Completed||N/A|450|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-10-11 03:19:41.043259|2017-10-11 03:19:41.043259
NCT01525186|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-01|||September 2009||2009-09-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Observational|||Observational Study of Parental Feeding Practices to Improve Child's Food Intake and Weight Status|The Relationship of Parental Feeding Control Practices to Food Intake of 3-5Yr Children in Families With Limited Incomes|Completed||N/A|660|Actual|Michigan State University|||1||f||||t||||||||||2017-10-11 03:19:41.148508|2017-10-11 03:19:41.148508
NCT01525173|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2013-10-07|2013-10-07||January 2012||2012-01-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension||Completed||Phase 4|137|Actual|Allergan||2|||f||||f||||||||||2017-10-11 03:19:41.209762|2017-10-11 03:19:41.209762
NCT01525160|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-04-08|||October 2011||2011-10-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Observational|||New Markers to Measure Clotting in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome|Novel Biomarkers for Haemostasis in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome|Completed||N/A|66|Actual|Hywel Dda Health Board|||1||f||||f||||||Samples Without DNA|"     Frozen aliquots of citrated plasma   "|||2017-10-11 03:19:41.834151|2017-10-11 03:19:41.834151
NCT01525147|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-07-08|||December 2011||2011-12-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|||Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers|A Block-randomized, Double-blind, Placebo-controlled, Single-dose Escalating, Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers|Completed||Phase 1|49|Actual|Yuhan Corporation||5|||f||||t||||||||||2017-10-11 03:19:41.951497|2017-10-11 03:19:41.951497
NCT01525134|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-02-01|||January 2011||2011-01-01|January 2012|2012-01-01|April 2012|Anticipated|2012-04-01|February 2012|Anticipated|2012-02-01||Interventional|||Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis|Feasibility of Using the Inverness Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in HIV-Positive TB Suspects|Unknown status|Active, not recruiting|N/A|504|Actual|Tuberculosis Clinical Diagnostics Research Consortium||1|||f||||f||||||||||2017-10-11 03:19:42.0923|2017-10-11 03:19:42.0923
NCT01525121|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2012-02-01|||July 2008||2008-07-01|February 2012|2012-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Expiratory Rib Cage Compression in Mechanically Ventilated Patients|Expiratory Rib Cage Compression Does Not Improve Secretion Clearance and Respiratory Mechanics in Mechanically Ventilated Patients|Completed||N/A|20|Actual|Centro Universitário Augusto Motta||2|||f||||f||||||||||2017-10-11 03:19:42.224175|2017-10-11 03:19:42.224175
NCT01525108|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2013-06-10|||March 2012||2012-03-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||A Home-based Blood Pressure Monitoring Program to Promote Better Management of Hypertension|A Home-based Blood Pressure Measurement Program in Hypertensive Patients to Promote Medications Adherence and Blood Pressure Status.|Completed||N/A|196|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:19:42.316879|2017-10-11 03:19:42.316879
NCT01525095|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2014-06-06|||January 2012||2012-01-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|DIRECT||Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)|Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)-Part 1 (Prospective Collection and Freezing of Whole Blood Specimens)|Completed||N/A|700|Anticipated|T2 Biosystems|||2||f||||f||||||Samples With DNA|"     Whole Blood specimens, in addition to bacterial and fungal species isolates   "|||2017-10-11 03:19:42.41552|2017-10-11 03:19:42.41552
NCT01525082|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-09-21|||December 2012||2012-12-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors|A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors|Active, not recruiting||Phase 2|20|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 03:19:42.514003|2017-10-11 03:19:42.514003
NCT01525069|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-06-29|||April 3, 2012|Actual|2012-04-03|June 2017|2017-06-01|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma|Pilot Study of Hepatic Arterial Infusion Therapy in Patients With Unresectable or Borderline Resectable Intrahepatic Cholangiocarcinoma|Recruiting||Phase 1|18|Anticipated|Washington University School of Medicine||3|||f||||t|t|f|||f|||||2017-10-11 03:19:42.630799|2017-10-11 03:19:42.630799
NCT01525056|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2014-09-08|||March 2012||2012-03-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI|Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Node Metastases Using PET-CT, CT-Perfusion and 3T MRI: A Prospective Feasibility Study|Completed||Phase 2|30|Actual|London Health Sciences Centre||1|||f||||f||||||||||2017-10-11 03:19:42.867874|2017-10-11 03:19:42.867874
NCT01525017|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-10-09|||February 2012||2012-02-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer|A Phase I Open-label Study to Evaluate Safety and Immunologic Response of COMBIG-DC Administered Intratumorally in Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1|12|Actual|Immunicum AB||1|||f||||t||||||||||2017-10-11 03:19:43.095629|2017-10-11 03:19:43.095629
NCT01525004|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-08-12|||September 2011||2011-09-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients|Randomized, Double Blind, Comparison of Standard Dose Trivalent Inactivated Influenza Vaccine in Pediatric Solid Organ Transplant Patients|Completed||Phase 1|38|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 03:19:43.210488|2017-10-11 03:19:43.210488
NCT01524991|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-09-06|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|July 15, 2017|Actual|2017-07-15||Interventional|||First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma|Phase II Trial of Gemcitabine, Cisplatin, Plus Ipilimumab as First-line Treatment for Patients With Metastatic Urothelial Carcinoma: Hoosier Cancer Research Network GU10-148|Active, not recruiting||Phase 2|36|Anticipated|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-10-11 03:19:43.332555|2017-10-11 03:19:43.332555
NCT01524965|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-22|2017-01-03|||May 2011||2011-05-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||The Effect of the Timing of Postoperative Mobilisation After Locking Plate Osteosynthesis of Fractures of the Surgical Neck of the Humerus|The Effect of the Timing of Postoperative Mobilisation After Locking Plate Osteosynthesis of Fractures of the Surgical Neck of the Humerus.|Recruiting||N/A|100|Anticipated|Helsinki University||2|||f||||f||||||||||2017-10-11 03:19:43.667684|2017-10-11 03:19:43.667684
NCT01524952|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-01-31|||December 2010||2010-12-01|January 2012|2012-01-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||The Effect of Combined Thermal and Electrical Muscle Stimulation (cTEMS) on Obesity|The Effect of Combined Thermal and Electrical Muscle Stimulation (cTEMS) on Cardiorespiratory Fitness and Adipose Tissue in Obese Individuals|Completed||N/A|12|Actual|Haukeland University Hospital||1|||f||||f||||||||||2017-10-11 03:19:43.78643|2017-10-11 03:19:43.78643
NCT01524939|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-09-19|||January 2012||2012-01-01|January 2012|2012-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||"Study of Combined Therapy of Aspirin and IVIG-SN in Kawasaki Disease"|"Multicenter, Single-arm, Phase IV Study to Evaluate the Efficacy, Safety of Combined Therapy of Aspirin and High Dose IVIG-SN in Pediatric Patients With Kawasaki Disease"|Completed||Phase 4|45|Actual|Green Cross Corporation||1|||f||||f||||||||||2017-10-11 03:19:43.900773|2017-10-11 03:19:43.900773
NCT01524926|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-08-04|||September 2012||2012-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CREATE||CREATE: Cross-tumoral Phase 2 With Crizotinib|"Cross-tumoral Phase 2 Clinical Trial Exploring Crizotinib (PF-02341066) in Patients With Advanced Tumors Induced by Causal Alterations of ALK and/or MET (CREATE)"|Active, not recruiting||Phase 2|582|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||6|||f||||t||||||||||2017-10-11 03:19:44.032407|2017-10-11 03:19:44.032407
NCT01524913|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-29|2017-03-27|2017-01-12||January 2012||2012-01-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional||The Baseline Analysis Population includes all participants who met eligibility criteria, were randomized to a study arm, and received their assigned study treatment.|A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction|A Double Blind Randomised Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint Dysfunction|Completed||Phase 4|102|Actual|Emory University||3|||f||||t||||||||||2017-10-11 03:19:44.213574|2017-10-11 03:19:44.213574
NCT01524900|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2015-06-01|2015-05-15||March 2012||2012-03-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||Patients from the Treated Set (TS): This patient set includes all HIV-1 infected patients who were dispensed Viramune® and were documented to have taken at least one dose of Viramune®and of a antiretroviral combination partner.|Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice|Observational Study Assessing the Safety, Efficacy and Treatment Adherence of Nevirapine Extended Release (Combined With Other Antiretroviral Drugs) in HIV Infected Patients in Daily Clinical Practice|Completed||N/A|398|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 03:19:45.065469|2017-10-11 03:19:45.065469
NCT01524887|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-06-26|2015-02-03||January 2012||2012-01-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||The baseline analysis population comprises treated subjects (=safety analysis set).|Phase 3 IGIV, 10% in Alzheimer´s Disease|A Phase 3 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% Solution (IGIV, 10%) for the Treatment of Mild to Moderate Alzheimer's Disease|Terminated||Phase 3|508|Actual|Baxalta US Inc.|The primary and secondary outcome measures were originally planned to be assessed at 18 months. However, as the study was terminated early, an analysis was completed at 9 months instead, in a subset of subjects who had received 9 months of treatment.|3||"The study was terminated because the first Phase 3 did not demonstrate efficacy on the   co-primary endpoints. The known safety profile remained unchanged."|f||||t||||||||||2017-10-11 03:19:45.807243|2017-10-11 03:19:45.807243
NCT01524874|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2012-01-31|||August 2010||2010-08-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|CEDARS||Comparative Effectiveness of Vitamin D and Repletion Strategies|A Comparative Effectiveness Trial of High-quality Vitamin D3 Nutritional Supplements to Replete Serum Vitamin D|Completed||N/A|66|Actual|Bastyr University||3|||f||||f||||||||||2017-10-11 03:19:47.254567|2017-10-11 03:19:47.254567
NCT01524861|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-01-26|||December 2011||2011-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy|Sympathetic Heart Innervation in Patients With Previous Experience of Transient Stress-induced Cardiomyopathy (Tako-Tsubo): Effects of α-lipoic Acid and L-acetyl Carnitine Therapies.|Completed||Phase 4|90|Actual|"University of Campania Luigi Vanvitelli"||3|||f||||t||||||||||2017-10-11 03:19:47.952915|2017-10-11 03:19:47.952915
NCT01524848|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-05-09|||February 2012||2012-02-01|May 2016|2016-05-01|November 2016|Actual|2016-11-01|January 2015|Actual|2015-01-01||Interventional|PAGIST||Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib|Pazopanib in Advanced GISTs Refractory to Imatinib and Sunitinib - A Non-comparative Phase II Multicenter Study by the Scandinavian Sarcoma Group|Completed||Phase 2|72|Anticipated|Scandinavian Sarcoma Group||1|||f||||t||||||||||2017-10-11 03:19:48.122726|2017-10-11 03:19:48.122726
NCT01524835|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-03-23|||August 2010||2010-08-01|March 2017|2017-03-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|||Live Lung Donor Cross-sectional Cohort Study|Live Lung Donor Cross-sectional Cohort Study|Completed||N/A|192|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 03:19:48.280706|2017-10-11 03:19:48.280706
NCT00005754|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-06-08|||September 1999||1999-09-01|June 2015|2015-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Coronary Artery Calcification in Type 1 Diabetes||Completed||N/A|1420|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 04:28:58.072485|2017-10-11 04:28:58.072485
NCT01524822|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-08-30|||January 20, 2012||2012-01-20|August 28, 2017|2017-08-28||||||||Observational|||The Effects of Chronic Exposure to Low-Level Blasts|Experienced Breacher Study: Evaluation of the Effects From Chronic Exposure to Low-Level Blast|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:19:48.432108|2017-10-11 03:19:48.432108
NCT01524809|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-01-04|||January 2001||2001-01-01|January 2017|2017-01-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes|A Single-Centre, Randomised, Double-Blind, 2- Period Crossover Trial Investigating the Steady State Pharmacokinetics of Biphasic Insulin Aspart 30 and Biphasic Insulin Aspart 70 in Subjects With Type 1 Diabetes|Completed||Phase 1|26|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:19:48.590389|2017-10-11 03:19:48.590389
NCT01524796|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-03-25|2015-03-11||January 2012||2012-01-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|NEP-TUNE|Safety analysis set included all participants who received at least one dose of the drug under study.|NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark|NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions In Denmark|Completed||Phase 4|128|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:19:48.755886|2017-10-11 03:19:48.755886
NCT01524783|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-05-04|2016-03-26||March 30, 2012|Actual|2012-03-30|May 2017|2017-05-01|December 28, 2020|Anticipated|2020-12-28|November 28, 2014|Actual|2014-11-28||Interventional|RADIANT-4|The full analysis set (FAS) consists of all randomized patients. Following the intent-to-treat principle, patients were analyzed according to the treatment arm and stratification factors they were assigned to at randomization.|Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)|A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced NET of GI or Lung Origin|Active, not recruiting||Phase 3|302|Actual|Novartis|Two patients randomized to everolimus were not treated due to withdrawal of consent and protocol deviation and one patient randomized to everolimus inadvertently received placebo treatment.|2|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 03:19:49.535938|2017-10-11 03:19:49.535938
NCT01524770|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2014-10-21|2014-10-03||March 2012||2012-03-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Participants who received at least 1 dose of dulaglutide.|A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe|Comparative Pharmacokinetics of Dulaglutide After Administration Via an Auto-injector and a Manual Syringe in Healthy Subjects|Completed||Phase 1|50|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:19:50.951858|2017-10-11 03:19:50.951858
NCT01524757|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-01|||March 2012||2012-03-01|January 2012|2012-01-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|He-ppi||Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis|Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis|Unknown status|Not yet recruiting|N/A|48|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:19:51.197134|2017-10-11 03:19:51.197134
NCT01524744|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-02-01|||March 2009||2009-03-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus||Unknown status|Enrolling by invitation|Phase 2|40|Anticipated|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:19:51.299046|2017-10-11 03:19:51.299046
NCT01524731|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2014-09-02|||May 2012||2012-05-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Prophylactic Antiemetic Dexamethasone on Plasma Cortisol Levels|The Effect of Prophylactic Antiemetic Dexamethasone on Plasma Cortisol Levels After Gynecologic Laparotomy|Completed||N/A|63|Anticipated|McGill University Health Center||3|||f||||t||||||||||2017-10-11 03:19:51.380494|2017-10-11 03:19:51.380494
NCT01524718|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-09-02|||September 2012||2012-09-01|September 2012|2012-09-01|March 2013|Anticipated|2013-03-01|October 2012|Anticipated|2012-10-01||Interventional|||Internal Fixation of Hip Fractures Using Intraoperative Simultaneous Two Axis View||Unknown status|Not yet recruiting|N/A|60|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 03:19:51.481731|2017-10-11 03:19:51.481731
NCT01524692|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-10-26|||March 2012||2012-03-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|ACC||Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma|A Phase II Pilot Study of Dovitinib (TKI258) in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.|Completed||Phase 2|36|Actual|University of Virginia||1|||f||||t||||||||||2017-10-11 03:19:51.715053|2017-10-11 03:19:51.715053
NCT01524679|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2017-08-21|||August 2012||2012-08-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|PADD-ON||Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen|A Prospective, Randomised, Open-label Phase IIb Clinical Trial Assessing the Effect of Pegylated Interferon Alfa-2a (Pegasys®)180 μg Once Weekly for 48 Weeks in Addition to an Ongoing Nucelos(t)Ide Based Treatment on Quantitative HBsAg Levels in Patients With Chronic HBeAg-negative Hepatitis B|Active, not recruiting||Phase 2|170|Anticipated|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-11 03:19:51.795123|2017-10-11 03:19:51.795123
NCT01524666|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-12-01|||February 2012||2012-02-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy|Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy|Recruiting||N/A|15|Anticipated|JFK Medical Center|||1||f||||f||||||Samples Without DNA|"     Skin Biopsy   "|||2017-10-11 03:19:51.920924|2017-10-11 03:19:51.920924
NCT01524653|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-12-27|||March 2012||2012-03-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|DISOLVE||Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)|Impact of Rosuvastatin on Risk Markers of Venous Thromboembolism During Systemic Therapy for Advanced Cancer|Active, not recruiting||Phase 2|30|Anticipated|University of Vermont||2|||f||||t||||||||||2017-10-11 03:19:51.993435|2017-10-11 03:19:51.993435
NCT01524640|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2015-05-01|||December 2012||2012-12-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Bridging Study for Killed Oral Cholera Vaccine in Ethiopia|A Randomized, Double-blind, Controlled Trial to Evaluate the Safety and Immunogenicity of Killed Bivalent (o1 and o139) Whole-cell Based Oral Cholera Vaccine (Shanchol®) in Healthy Individuals in Ethiopia|Completed||Phase 4|216|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-10-11 03:19:52.090278|2017-10-11 03:19:52.090278
NCT01524627|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-08-15|2017-04-21||December 2011||2011-12-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|VSMK||Effects of Varenicline on Smoking Reminders|Characterizing a Cue-vulnerable Pharmaco-responsive Endophenotype in Smokers|Completed||Phase 2|124|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 03:19:54.038201|2017-10-11 03:19:54.038201
NCT01524614|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-01-15|||October 2011||2011-10-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety Study of Continuous Positive Airway Pressure Via a Nasal Mask|Effect of Continuous Positive Airway Pressure Ventilation Through Nasal Mask on Upper Airway Patency During Induction of Anesthesia|Completed||N/A|80|Actual|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-11 03:19:54.372815|2017-10-11 03:19:54.372815
NCT01524601|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-10-11|||February 2012||2012-02-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|RITA||The Rosuvastatin In TrAnsplant Recipients Study|The RITA-study -- An Open Study to Evaluate the Blood Lipid Lowering Effect of Rosuvastatin Versus Fluvastatin and the Bilateral Interaction Between Everolimus and Rosuvastatin in Renal Transplant Recipients|Completed||Phase 4|20|Actual|University of Oslo School of Pharmacy||1|||f||||f||||||||||2017-10-11 03:19:54.451126|2017-10-11 03:19:54.451126
NCT01524588|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-10-19|||April 2008||2008-04-01|October 2012|2012-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||C Terminal Variants of FSH Receptor|C Terminal Peptide Variants of the Fsh Receptor in Women Involved in an Assisted Reproduction Programm : Mechanistic Approach|Completed||N/A|814|Actual|University Hospital, Tours|||1||f||||f||||||||||2017-10-11 03:19:54.546744|2017-10-11 03:19:54.546744
NCT01524575|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-01-30|||January 2012||2012-01-01|January 2012|2012-01-01|January 2014|Anticipated|2014-01-01|July 2013|Anticipated|2013-07-01||Interventional|||Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1|Phase II Study of Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1 (Excision Repair Cross-complementation Group 1)|Unknown status|Recruiting|Phase 2|50|Anticipated|University of Hawaii||2|||f||||t||||||||||2017-10-11 03:19:54.612836|2017-10-11 03:19:54.612836
NCT01524562|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-10-05|||December 20, 2011||2011-12-20|March 28, 2017|2017-03-28||||||||Observational|||HIV Accelerated Liver Disease in Uganda|HIV-Accelerated Liver Disease in Uganda|Completed||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:19:54.706523|2017-10-11 03:19:54.706523
NCT01524549|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-06-30|||January 13, 2012||2012-01-13|June 14, 2017|2017-06-14||||||||Observational|||Blood Vessel Study|The Role of the Functionally Relevant Single Nucleotide Polymorphisms CYP2J2 -50G>T (CYP2J2 7) and EPHX2 9846A>G (EPHX2 K55R) in Human Endothelial Function|Enrolling by invitation||N/A|172|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:19:54.782584|2017-10-11 03:19:54.782584
NCT01524536|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-07-13|||November 22, 2011||2011-11-22|July 12, 2017|2017-07-12|December 31, 2019|Anticipated|2019-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Steroid Treatment for Hypereosinophilic Syndrome|Assessment of Glucocorticoid Responsiveness and Mechanisms of Resistance in Hypereosinophilic Syndromes|Recruiting||Phase 4|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:19:54.865186|2017-10-11 03:19:54.865186
NCT01524523|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2017-06-30|||December 2, 2011||2011-12-02|June 27, 2013|2013-06-27|June 27, 2013||2013-06-27|||||Observational|||Bone Marrow Aspiration Pain Study|Biochemical and Genetic Mechanisms of Acute Clinical Pain During Bone Marrow Aspiration|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:19:54.964382|2017-10-11 03:19:54.964382
NCT01524510|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-05-27|||February 2011||2011-02-01|May 2015|2015-05-01||||April 2016|Anticipated|2016-04-01||Interventional|||Validation of Functional Imaging as Predictive Tool for Outcome of Mandibular Replacement Appliance Therapy in Obstructive Sleep Apnea Hypopnea Syndrome Patients|Open, Prospective Study for the Validation of the Predictive Value of Upper Airway Segmentation and CFD Analysis on Outcome Parameters of the Mandibular Replacement Appliance (MRA) Therapy in Obstructive Sleep Apnea Hypopnea Syndrome OSAHS) Patients|Unknown status|Recruiting|Phase 4|40|Anticipated|University Hospital, Antwerp||1|||f||||f||||||||||2017-10-11 03:19:55.175164|2017-10-11 03:19:55.175164
NCT01524497|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-10-14|||November 2011||2011-11-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression|A Clinical Study on Efficacy And Safety of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression A Multicenter, Randomized, Double-Blind, Parallel Controlled Study|Completed||Phase 2/Phase 3|382|Actual|Lee's Pharmaceutical Limited||2|||f||||t||||||||||2017-10-11 03:19:55.273903|2017-10-11 03:19:55.273903
NCT01524484|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2014-10-21|||November 2011||2011-11-01|October 2014|2014-10-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Observational|QoQ||Quality of Quality Data|Quality of Quality Data - A Retrospective Study on Routine Quality Data Reporting in Anesthesia|Completed||N/A|255|Actual|Klinik Hirslanden, Zurich|||2||f||||f||||||||||2017-10-11 03:19:55.36006|2017-10-11 03:19:55.36006
NCT01524471|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-02-01|||July 2010||2010-07-01|January 2012|2012-01-01||||March 2012|Anticipated|2012-03-01||Interventional|||Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders||Unknown status|Recruiting|Phase 2|20|Anticipated|Chinese University of Hong Kong||1|||f||||||||||||||2017-10-11 03:19:55.439659|2017-10-11 03:19:55.439659
NCT01524055|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2013-11-25|||December 2011||2011-12-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|||CO2 Insufflation During Single-Balloon-Enteroscopy|CO2 Insufflation During Single-Balloon-Enteroscopy|Completed||Phase 3|107|Actual|University Hospital Muenster||2|||f||||||||||||||2017-10-11 03:19:59.640588|2017-10-11 03:19:59.640588
NCT01524458|ClinicalTrials.gov processed this data on October 10, 2017|2012-02-01|2012-02-01|||July 2010||2010-07-01|October 2010|2010-10-01||||||||Interventional|POEM||Prospective Study on the Feasibility and Effectiveness of Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders|Prospective Study on the Feasibility and Effectiveness of Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders|Unknown status|Recruiting|Phase 1/Phase 2|8|Anticipated|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 03:19:55.523208|2017-10-11 03:19:55.523208
NCT01524445|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-06-11|||March 2011||2011-03-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|||||Observational|||Retrospective Survey of Re-treatment With Bortezomib|Retrospective Evaluation of Re-Treatment With Bortezomib in Subjects With First Relapse After Bortezomib First-Line Therapy|Completed||Phase 4|35|Actual|Janssen Pharmaceutica N.V., Belgium|||1||f||||f||||||||||2017-10-11 03:19:55.609482|2017-10-11 03:19:55.609482
NCT01524432|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-03-31|||January 2012||2012-01-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis|Phase III Study in Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis|Completed||Phase 1|42|Actual|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-10-11 03:19:55.69977|2017-10-11 03:19:55.69977
NCT01524419|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-05-02|||March 2012||2012-03-01|January 2012|2012-01-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Observational|||Women's Involvement In Decision Making At Labor And Its Effect on Their Perceived Labor Process|Women's Involvement In Decision Making At Labor And Its Effect on Their Perceived Labor Process|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-10-11 03:19:55.791798|2017-10-11 03:19:55.791798
NCT01524406|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2014-07-14|||January 2012||2012-01-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety Study of HPP593 in Subjects During and After Limb Immobilization|A Randomized, Double-blind, Placebo Controlled, Phase I Study to Evaluate the Safety and Tolerability of 28 Day Treatment With HPP593 Capsules in Healthy Volunteers During and After Limb Immobilization|Terminated||Phase 1|24|Actual|High Point Pharmaceuticals, LLC.||2|||f||||f||||||||||2017-10-11 03:19:55.870334|2017-10-11 03:19:55.870334
NCT01524393|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2012-02-01|||January 1990||1990-01-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Observational|||Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization|Estimation of the Risk of Pulmonary Embolism and Venous Thromboembolism in Pregnancy After in Vitro Fertilization.|Completed||N/A|140458|Actual|Danderyd Hospital|||1||f||||f||||||||||2017-10-11 03:19:55.951568|2017-10-11 03:19:55.951568
NCT01524380|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2016-07-10|||September 2011||2011-09-01|July 2016|2016-07-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Ginkgo Biloba Extract for Schizophrenia|A Double-blind and Randomized Trial of Ginkgo Biloba Extract Added to Risperidone in Treatment-naive First-episode Schizophrenia|Completed||N/A|124|Actual|Beijing HuiLongGuan Hospital||2|||f||||t||||||||||2017-10-11 03:19:56.03033|2017-10-11 03:19:56.03033
NCT01524367|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2015-02-04|||October 2011||2011-10-01|February 2015|2015-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery|Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery|Completed||Phase 4|74|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 03:19:56.118523|2017-10-11 03:19:56.118523
NCT01524354|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-09-11|||March 2010||2010-03-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Depth of Anesthesia in Cardiac Surgery|Monitoring of Anesthetic Depth During Surgical Correction of Acquired Valvular Disorders|Completed||N/A|28|Actual|Northern State Medical University||2|||f||||f||||||||||2017-10-11 03:19:56.19312|2017-10-11 03:19:56.19312
NCT01524341|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2013-05-09|||January 2012||2012-01-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection|A Proof-of-concept, Open Label, 3-day Repeated Dose Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection|Completed||Phase 2|27|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:19:56.266868|2017-10-11 03:19:56.266868
NCT01524328|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-01-30|||October 2009||2009-10-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. A Cross Sectional Study in Norway.|Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. A Cross Sectional Study in Norway.|Completed||N/A|460|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 03:19:56.342385|2017-10-11 03:19:56.342385
NCT01524315|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2013-05-14|||February 2012||2012-02-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery|Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery - a Pilot Study|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 03:19:56.403135|2017-10-11 03:19:56.403135
NCT01524302|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-03-14|2015-10-12||February 2012||2012-02-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|May 2014|Actual|2014-05-01||Interventional|||Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia|Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (CABP)|Completed||Phase 4|12|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 03:19:56.510507|2017-10-11 03:19:56.510507
NCT01524289|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-07-27|||February 3, 2012|Actual|2012-02-03|July 2017|2017-07-01|October 20, 2018|Anticipated|2018-10-20|February 12, 2014|Actual|2014-02-12||Interventional|REALIZE||Study to Assess the Tolerability and Efficacy of Anacetrapib Co-administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)|A 1-Year, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo- Controlled Study to Assess the Efficacy and Tolerability of Anacetrapib When Added to Ongoing Statin Therapy With or Without Other Lipid Modifying Medication(s) in Patients With Heterozygous Familial Hypercholesterolemia|Active, not recruiting||Phase 3|306|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 03:19:56.837328|2017-10-11 03:19:56.837328
NCT00005755|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||May 1999||1999-05-01|January 2006|2006-01-01|April 2003|Actual|2003-04-01|||||Observational|||Community Based Study on Occupational Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:58.185592|2017-10-11 04:28:58.185592
NCT01524250|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-09-01|||March 2012||2012-03-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Optic Neuritis Recovery After Oral or IV Corticosteroids|Recovery of Demyelinating Optic Neuritis After Treatment With Equivalent High Doses of Oral vs. Intravenous Corticosteroids: a Randomized Single Blinded Clinical Trial|Completed||Phase 2/Phase 3|51|Actual|London Health Sciences Centre||2|||f||||f||||||||||2017-10-11 03:19:57.646774|2017-10-11 03:19:57.646774
NCT01524237|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2013-07-31|||April 2012||2012-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study of LY2979165 and LY2140023 in Healthy Volunteers|Biomarker Study: Impact of Single Doses of LY2979165 and LY2140023 on the Ketamine-Challenge Pharmacological MRI Assay in Healthy Male Subjects|Completed||Phase 1|52|Anticipated|Eli Lilly and Company||7|||f||||f||||||||||2017-10-11 03:19:57.755157|2017-10-11 03:19:57.755157
NCT01524224|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-02-08|||January 2008||2008-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|November 2012|Actual|2012-11-01||Interventional|||A Dose-Escalation Study in Participants With Advanced Cancer|A Phase 1 Dose-Escalation Study of LY2495655, an Anti-Myostatin Monoclonal Antibody, in Patients With Advanced Cancer|Completed||Phase 1|32|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:19:57.857206|2017-10-11 03:19:57.857206
NCT01524211|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-04-02|||January 2012||2012-01-01|April 2017|2017-04-01|January 2022|Anticipated|2022-01-01|September 2021|Anticipated|2021-09-01||Interventional|||Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms|Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms|Recruiting||Phase 2|125|Anticipated|Lee, W. Anthony, M.D. FACS||1|||f||||f||||||||No||2017-10-11 03:19:57.97421|2017-10-11 03:19:57.97421
NCT01524198|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-02-12|2013-11-02||November 2010||2010-11-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room|The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room|Completed||Phase 2/Phase 3|945|Actual|King Saud University||2|||f||||t||||||||||2017-10-11 03:19:58.076133|2017-10-11 03:19:58.076133
NCT01524185|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-05-18|||February 2009||2009-02-01|May 2016|2016-05-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||FamilyLive Feasibility and Effectiveness Study|FamilyLive Feasibility and Effectiveness Study|Active, not recruiting||Early Phase 1|300|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||||2017-10-11 03:19:58.410526|2017-10-11 03:19:58.410526
NCT01524172|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-05-18|||January 2009||2009-01-01|May 2016|2016-05-01|November 2021|Anticipated|2021-11-01|November 2021|Anticipated|2021-11-01||Interventional|||Yoga Based Psychotherapy Group Feasibility and Efficacy Study|Yoga Based Psychotherapy Group Feasibility and Efficacy Study|Recruiting||Early Phase 1|300|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||||2017-10-11 03:19:58.496698|2017-10-11 03:19:58.496698
NCT01524159|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-09-20|||June 2011||2011-06-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|BRCARDIO||Bromelain and Cardiovascular Risk Factors in Diabetes|Bromelain and Cardiovascular Risk Factors in Diabetes|Completed||N/A|72|Actual|Hebei Yiling Hospital||2|||f||||t||||||||||2017-10-11 03:19:58.604772|2017-10-11 03:19:58.604772
NCT01524146|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-02-16|||November 2011||2011-11-01|February 2017|2017-02-01|December 30, 2018|Anticipated|2018-12-30|December 1, 2018|Anticipated|2018-12-01||Observational|PDTRegistry||Photodynamic Therapy (PDT) Cholangiocarcinoma Registry|To Establish a Multicenter Registry to Evaluate the Impact of Photodynamic Therapy in the Management of Patients With Unresectable Cholangiocarcinoma.|Recruiting||N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|No IPD Sharing|2017-10-11 03:19:58.710228|2017-10-11 03:19:58.710228
NCT01524133|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-06-16|||November 2011||2011-11-01|June 2017|2017-06-01|May 2017|Actual|2017-05-01|December 2016|Actual|2016-12-01||Interventional|PROGrESS||PROlonGed ExpoSure Sertraline|Randomized Trial of Sertraline, Prolonged Exposure, and Their Combination for Post-traumatic Stress Disorder (PTSD) in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF).|Completed||Phase 4|223|Actual|VA Ann Arbor Healthcare System||3|||f||||t||||||||||2017-10-11 03:19:58.821552|2017-10-11 03:19:58.821552
NCT01524120|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2013-01-23|||April 2012||2012-04-01|January 2013|2013-01-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Observational|||Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD)||Unknown status|Not yet recruiting|N/A|96|Anticipated|University of Erlangen-Nürnberg Medical School|||4||f||||t||||||Samples With DNA|"     Biopsies were taken from every patient for subsequent histological analysis.   "|||2017-10-11 03:19:58.929824|2017-10-11 03:19:58.929824
NCT01524107|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-12-18|||January 2012||2012-01-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Observational|||Complications: Urgent C Section VS Elective C Section|Comparison of Maternal and Fetal Complications After Urgent Caesarian Section for Prolapsed Cord Versus Elective Caesarian Section.|Recruiting||N/A|240|Anticipated|Hadassah Medical Organization|||2||f||||f||||||||||2017-10-11 03:19:59.183565|2017-10-11 03:19:59.183565
NCT01524094|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-31|||June 2003||2003-06-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis|A Randomised Phase-III Study Comparing Cytoreductive Surgery Plus Intraperitoneal Chemotherapy Versus Modern Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis.|Completed||Phase 3|49|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 03:19:59.275057|2017-10-11 03:19:59.275057
NCT01524081|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-02-07|||July 2008||2008-07-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|||Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures|Phase 3 Study of Antibiotic Prophylaxis Use Prior Emergent Surgery, Because of Acute Appendicitis|Completed||Phase 3|187|Actual|The Faculty Hospital Na Bulovce||6|||f||||f||||||||||2017-10-11 03:19:59.391811|2017-10-11 03:19:59.391811
NCT01524068|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-01-04|||September 2012||2012-09-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations|A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations|Withdrawn||Phase 2|0|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:19:59.514413|2017-10-11 03:19:59.514413
NCT00004695|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||September 1997||1997-09-01|May 1999|1999-05-01|March 2000||2000-03-01|||||Interventional|||Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency||Completed||N/A|48||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.726263|2017-10-11 04:26:56.726263
NCT01524042|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-29|||January 2012||2012-01-01|January 2012|2012-01-01|July 2012|Anticipated|2012-07-01|June 2012|Anticipated|2012-06-01||Interventional|||Patient Satisfaction With Novel Double Pants Compared to Conventional Single Pants for Outpatient Colonoscopy|Patient Satisfaction With Novel Double Pants Compared to Conventional Single Pants for Outpatient Colonoscopy: Prospective Randomized Study|Unknown status|Enrolling by invitation|N/A|160|Actual|Yonsei University||1|||f||||t||||||||||2017-10-11 03:19:59.763158|2017-10-11 03:19:59.763158
NCT01524029|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-29|2012-01-31|||January 2012||2012-01-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Observational|||Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial|Digital Breast Tomosynthesis vs. Digital Mammography: A National Multicenter Trial|Unknown status|Recruiting|N/A|600|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-10-11 03:19:59.858924|2017-10-11 03:19:59.858924
NCT01524016|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-29|2017-04-05|||December 2011||2011-12-01|July 2014|2014-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia|68Ga-DOTATATE PET/CT for Detection and Evaluation of the Causative Tumor of Oncogenic Osteomalacia|Recruiting||Early Phase 1|100|Anticipated|Peking Union Medical College Hospital||1|||f||||t||||||||No||2017-10-11 03:19:59.95215|2017-10-11 03:19:59.95215
NCT01524003|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2015-05-06|||November 2011||2011-11-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|CHICAPS||Chinese Cancer Prevention Study(CHICAPS)|Chinese Cancer Prevention Study(CHICAPS) Mass Population Based Cervical Cancer Screening|Completed||N/A|8382|Actual|Preventive Oncology International, Inc.||2|||f||||f||||||||||2017-10-11 03:20:00.067901|2017-10-11 03:20:00.067901
NCT01523990|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-12-18|||October 2011||2011-10-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients|A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of Single and Multiple Ascending Oral Doses of TG-2349, and Followed by a Dose-Ranging Study in Hepatitis C Genotype 1 Infected Patients|Completed||Phase 1|135|Actual|TaiGen Biotechnology Co., Ltd.||27|||f||||f||||||||||2017-10-11 03:20:00.163046|2017-10-11 03:20:00.163046
NCT01523977|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-03-13|||November 2011||2011-11-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|CRAD001NUS175T||Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL|A Feasibility Trial of Everolimus (RAD001),an mTOR Inhibitor, Given in Combination With Multiagent Re-Induction Chemotherapy in Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia (ALL)|Active, not recruiting||Phase 1|42|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 03:20:00.298463|2017-10-11 03:20:00.298463
NCT01523964|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2013-10-16|2013-08-09||February 2012||2012-02-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls|A Phase I, Multi-Center, Controlled, Prospective Correlative Study of Electrical Impedance Myography in Males With Duchenne Muscular Dystrophy and In Healthy Males|Completed||N/A|92|Actual|Dart Therapeutics. LLC||4|||f||||f||||||||||2017-10-11 03:20:00.429365|2017-10-11 03:20:00.429365
NCT01523951|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-29|2012-03-19|||January 2012||2012-01-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|LACCA||Topical Local Anaesthesia and Cooling During Capsaicin 8% Patch Application|A Comparison of Topical Local Anaesthesia and Cooling to Reduce the Burning Pain During Capsaicin 8% Patch Application|Completed||N/A|12|Actual|Medical University of Vienna|||1||f||||f||||||Samples Without DNA|"     Skin biopsy   "|||2017-10-11 03:20:00.807253|2017-10-11 03:20:00.807253
NCT01523938|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-08-09|||March 2012||2012-03-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|April 2014|Actual|2014-04-01||Interventional|HYPNOC||Influence of Perioperative Hypnotherapy on Postoperative Improvement in Cognitive Performance|Influence of Perioperative Hypnotherapy on Postoperative Improvement in Cognitive Performance. A Randomized-controlled Open Clinical Monocentric Interventional Study.|Terminated||N/A|72|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:20:00.920642|2017-10-11 03:20:00.920642
NCT01523925|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-02-10|||January 2012||2012-01-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Combined Behavioral Approaches With Functional Electrical Therapy in Stroke Rehabilitation|Combined Behavioral Approaches With Functional Electrical Therapy in Stroke Rehabilitation: Effects on Motor Control, Motor Impairment, Daily Function and Community Reintegration|Withdrawn||N/A|0|Actual|Chang Gung Memorial Hospital||5|||f||||f||||||||||2017-10-11 03:20:01.006088|2017-10-11 03:20:01.006088
NCT01523912|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2016-02-18|||January 2011||2011-01-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Radiofrequency Ablation for the Treatment of Gastric Dysplasia|Ablation of Gastric Dysplastic Mucosa by a Novel Endoscopic Radiofrequency Device.|Completed||Phase 4|10|Actual|Hospital Sao Joao||1|||f||||f||||||||||2017-10-11 03:20:01.178129|2017-10-11 03:20:01.178129
NCT01523899|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-08-04|2017-02-23||May 2011||2011-05-01|August 2017|2017-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses|A Randomized Clinical Trial Comparing Use of Rapid Molecular Testing for Staphylococcus Aureus for Patients With Cutaneous Abscesses in the Emergency Department With Standard of Care.|Completed||N/A|252|Actual|George Washington University||2|||f||||f||||||||||2017-10-11 03:20:01.310883|2017-10-11 03:20:01.310883
NCT01523886|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-03-16|2014-01-16||March 2012||2012-03-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||The Muscle Relaxation-study|Optimization of Surgical Conditions During Laparoscopic Cholecystectomy With Deep or Moderate Neuromuscular Blockade|Completed||Phase 4|49|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 03:20:01.647269|2017-10-11 03:20:01.647269
NCT01523873|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-01-10|2015-12-14||November 2008||2008-11-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)|Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)|Completed||N/A|35921|Actual|Guerbet|||1||f||||||||||||||2017-10-11 03:20:02.029355|2017-10-11 03:20:02.029355
NCT01523678|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-07-28|||February 2012||2012-02-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|May 2014|Actual|2014-05-01||Interventional|||Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers|Phase II Study of Weekly Paclitaxel/Carboplatin in Combination With Prophylactic G-CSF in the Treatment of Gynaecological Cancers|Active, not recruiting||Phase 2|108|Anticipated|Belgian Gynaecological Oncology Group||1|||f||||||||||||||2017-10-11 03:20:04.594686|2017-10-11 03:20:04.594686
NCT01523860|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-02-29|||June 2009||2009-06-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|FLE09||Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma|Brief Induction Chemoimmunotherapy With Rituximab + Bendamustine + Mitoxantrone Followed by Rituximab in Elderly Patients With Advanced Stage Previously Untreated Follicular Lymphoma|Completed||Phase 2|76|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-11 03:20:02.566156|2017-10-11 03:20:02.566156
NCT01523847|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-08-03|||November 2010||2010-11-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|HD0803||A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL)|A Phase II Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL)|Completed||Phase 2|50|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-10-11 03:20:02.759484|2017-10-11 03:20:02.759484
NCT01523834|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-08-03|||February 2011||2011-02-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|FIL_PanAL10||Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT|A Phase II Study of Oral Panobinostat in Adult Patients With Diffuse Large B-cell Lymphoma Relapsed/Refractory After High-dose Chemotherapy With Autologous Stem Cell Transfusion (ASCT) or Not Eligible for ASCT|Completed||Phase 2|35|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||t||||||||||2017-10-11 03:20:02.922907|2017-10-11 03:20:02.922907
NCT01523821|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-05-22|||October 11, 2013|Actual|2013-10-11|May 2017|2017-05-01|January 15, 2017|Actual|2017-01-15|January 15, 2017|Actual|2017-01-15||Interventional|||Alpha 1 Anti-Trypsin in Treating Patients With Acute Graft-Versus-Host Disease|Treatment of Steroid Non-responsive Acute GVHD With Alpha 1 Antitrypsin (AAT). A Phase I/II Study|Completed||Phase 1/Phase 2|14|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 03:20:03.035584|2017-10-11 03:20:03.035584
NCT01523808|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-03-07|||June 2009||2009-06-01|March 2013|2013-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer|Phase I, Dose Escalation Clinical Trial of GRASPA (Red Blood Cells Encapsulating L-Asparaginase) in Patients With Pancreatic Carcinoma|Completed||Phase 1|12|Actual|ERYtech Pharma||4|||f||||t||||||||||2017-10-11 03:20:03.15132|2017-10-11 03:20:03.15132
NCT01523795|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-01-31|||October 2010||2010-10-01|January 2012|2012-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||PRESENCE 2: Predicting Sedentary Entertainment Choices and Effects|PRESENCE 2: Predicting Sedentary Entertainment Choices and Effects|Completed||N/A|120|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 03:20:03.24295|2017-10-11 03:20:03.24295
NCT01523769|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2012-01-30|||September 2009||2009-09-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants|The Efficacy of Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants Born Between 24 and 28 6/7 Weeks Gestation, a Randomized Controlled Trial.|Completed||N/A|113|Actual|Eastern Virginia Medical School||2|||f||||t||||||||||2017-10-11 03:20:03.421102|2017-10-11 03:20:03.421102
NCT01523756|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2014-01-28|2013-11-21||February 2012||2012-02-01|January 2014|2014-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Clinical Investigation of New Ostomy Appliances|An Open-labelled Randomized Cross-over and Controlled Exploratory Investigation Comparing Several Variants of a Newly Developed Ostomy Appliance With Regard to Performance in 20 Patients With Ileostomy|Completed||N/A|20|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 03:20:03.531931|2017-10-11 03:20:03.531931
NCT01523743|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-08-23|2013-08-06||November 2011||2011-11-01|August 2016|2016-08-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional||The ITT population consistsed of 118 subjects.|Quality of Life Intermittent Catheter Study|Quality of Life Intermittent Catheter Study - A Prospective, Randomized, Cross-over, Multicenter Study Comparing Quality of Life Using Compact Versus Standard Urinary Intermittent Catheters|Completed||Phase 4|125|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 03:20:03.810415|2017-10-11 03:20:03.810415
NCT01523730|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2015-09-08|||April 2012||2012-04-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|rTMSsmokelab||Effects of rTMS on Cigarette Smoking and Cognition in Schizophrenia|Effects of Repetitive Transcranial Magnetic Stimulation on Cigarette Smoking and Cognitive Function in Smokers With and Without Schizophrenia|Completed||N/A|27|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 03:20:04.166255|2017-10-11 03:20:04.166255
NCT01523717|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-03-13|||December 2011||2011-12-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|MOSES||Procalcitonin Monitoring Sepsis Study|Procalcitonin Decrease Over 72 Hours and Outcome in Patients With Severe Sepsis or Septic Shock|Completed||N/A|858|Actual|Brahms AG|||1||f||||||||||Samples Without DNA|"     EDTA plasma and serum samples   "|||2017-10-11 03:20:04.294786|2017-10-11 03:20:04.294786
NCT01523704|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-02-03|||January 2012||2012-01-01|February 2017|2017-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Safety and Efficacy Study of IPG Patient With Home Monitoring|Comparison of the Safety and Efficacy of the Management of Pacemaker Patients Followed-up Via Home Monitoring vs. Conventional In-Office Follow-up|Completed||N/A|1333|Actual|Biotronik Japan, Inc.||2|||f||||||||||||||2017-10-11 03:20:04.406726|2017-10-11 03:20:04.406726
NCT01523691|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-03-10|||August 2011||2011-08-01|March 2017|2017-03-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Repeating Patterns of Sleep Restriction and Recovery|Repeating Patterns of Sleep Restriction and Recovery - do we Get Used to it?|Completed||N/A|17|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 03:20:04.496866|2017-10-11 03:20:04.496866
NCT01463813|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-05-13|||September 2012||2012-09-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|FIND||Finnish Vitamin D Trial (FIND)|Finnish Vitamin D Trial (FIND)|Active, not recruiting||N/A|2495|Actual|University of Eastern Finland||3|||f||||t||||||||||2017-10-11 03:40:02.807258|2017-10-11 03:40:02.807258
NCT01523665|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2013-11-26|||October 2011||2011-10-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System|Evaluation of Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System|Completed||N/A|508|Actual|B. Braun Melsungen AG|||1||f||||f||||||||||2017-10-11 03:20:04.731401|2017-10-11 03:20:04.731401
NCT01523652|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-01-30|||November 2007||2007-11-01|January 2012|2012-01-01|November 2008|Actual|2008-11-01|||||Observational|||Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients|Studio Pilota Farmacocinetico-clinico Sulla Somministrazione di Eparina a Basso Peso Molecolare e Dosaggio Sierico di HGF Nelle Pazienti Operate Affette da Patologie Ginecologiche|Completed||N/A|29|Actual|Azienda Ospedaliera San Giovanni Battista|||2||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 03:20:04.830511|2017-10-11 03:20:04.830511
NCT01523639|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-03-07|||April 2012||2012-04-01|March 2014|2014-03-01|May 2014|Anticipated|2014-05-01|November 2013|Actual|2013-11-01||Interventional|G-LUCAS||A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis|A Randomized, Placebo-controlled, Double-blind Multicenter Phase II Study to Investigate the Protectivity and Efficacy of Metformin Against Steatosis in Combination With FOLFIRI and Cetuximab in Subjects With First-line Palliative Treated, KRAS-Wild-Type, Metastatic Colorectal Cancer|Terminated||Phase 2|8|Actual|Austrian Breast & Colorectal Cancer Study Group||2||"Prematurely due to slow recruitment (07/08/2013). Newly defined study end=LPLV=05/11/2013.   ABCSG guaranteed completed treatment period for ethical reasons."|f||||t||||||||||2017-10-11 03:20:04.940246|2017-10-11 03:20:04.940246
NCT01523626|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2014-12-23|||April 2011||2011-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|REACT-2||A Multicenter, Randomized Study of Early Assessment by CT Scanning in Severely Injured Trauma Patients|Randomized Study of Early Assessment by CT Scanning in Trauma Patients|Completed||N/A|1083|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 03:20:05.162847|2017-10-11 03:20:05.162847
NCT01523613|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-09-05|2017-07-15||November 2011||2011-11-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|ROCK||High-strength Glass-ionomer Dental Restorations|Clinical Performance of High-Viscous Glass-Ionomer Restorative Systems In Class II Lesions|Completed||N/A|93|Actual|University of Michigan|Current study was not designed to investigate wear behavior as final surface treatment was different between the two materials.|3|||f||||f||||||||||2017-10-11 03:20:05.350647|2017-10-11 03:20:05.350647
NCT01523600|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-05-10|||October 2011||2011-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|March 2014|Actual|2014-03-01||Interventional|VAREX||Whole Body Vibration Training Among Older People Using Sheltered Housing|Effect of Whole Body Vibration Training on Physical Functioning and Risk of Falling in Older People Using Sheltered Housing|Terminated||Phase 4|130|Actual|UKK Institute||2||Lack of funding|f||||f||||||||||2017-10-11 03:20:05.930247|2017-10-11 03:20:05.930247
NCT01523587|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-09-06|2014-10-06||March 5, 2012|Actual|2012-03-05|September 2017|2017-09-01|September 21, 2017|Anticipated|2017-09-21|October 7, 2013|Actual|2013-10-07||Interventional||All patients who were randomised, regardless of whether they received investigational treatment, are defined as the Randomised Set.|LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy|LUX-Lung 8: A Randomized, Open-label Phase III Trial of Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung as Second-line Therapy Following First-line Platinum-based Chemotherapy|Active, not recruiting||Phase 3|795|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:20:06.082644|2017-10-11 03:20:06.082644
NCT01523561|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-07-14|||October 2009||2009-10-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|May 2012|Actual|2012-05-01||Interventional|||Influencing Adolescent Girls´ With Creative Dance Twice Weekly|Influencing Adolescent Girls With Internalizing Problems With Creative Dance Twice Weekly. A Randomised, Controlled Study|Completed||Phase 3|150|Actual|Örebro County Council||2|||f||||f||||||||||2017-10-11 03:20:08.182548|2017-10-11 03:20:08.182548
NCT01523548|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-06-08|||July 2012||2012-07-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CO in PAH||Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension|Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension|Withdrawn||Phase 1/Phase 2|0|Actual|University of Illinois at Chicago||1||Lack of funding and subject acuity|f||||t||||||||||2017-10-11 03:20:08.264981|2017-10-11 03:20:08.264981
NCT01523535|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2017-04-12|||August 2011|Actual|2011-08-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|September 2014|Actual|2014-09-01||Interventional|||Repeated Challenge of Insufficient Sleep: Endothelial Effects|Repeated Challenge of Insufficient Sleep: Effects on Endothelial Function|Active, not recruiting||N/A|52|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-10-11 03:20:08.342698|2017-10-11 03:20:08.342698
NCT01523522|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-10-22|||February 2012||2012-02-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|MIAS||Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence|Etude de l'efficacité et de la sécurité d'Injections Intra-sphinctériennes de Myoblastes Autologues Chez Des Patients Atteints d'Incontinence Anale sévère Par Insuffisance sphinctérienne|Completed||Phase 2/Phase 3|24|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 03:20:08.414166|2017-10-11 03:20:08.414166
NCT01523509|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-06-15|||August 2012||2012-08-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Use of Radiographic Contrast to Detect Dental Caries|The Use of Radiographic Contrast to Differentiate Cavitated From Non-cavitated Dental Caries|Completed||Phase 1|33|Actual|Creighton University||1|||f||||f||||||||||2017-10-11 03:20:08.509125|2017-10-11 03:20:08.509125
NCT01523496|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-02-09|||December 2011||2011-12-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Vitamin D Supplementation in HIV Youth|Vitamin D Supplementation and HIV-related Complications in Children and Young Adults|Completed||Phase 2/Phase 3|295|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 03:20:08.577998|2017-10-11 03:20:08.577998
NCT01523483|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2015-04-21|||March 2012||2012-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm Labor|Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm Labor|Completed||N/A|30|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-11 03:20:08.670683|2017-10-11 03:20:08.670683
NCT01523470|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-14|2012-01-31|||November 2010||2010-11-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Withdrawal of Non-invasive Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Acute Hypercapnic Respiratory Failure|A Pilot Randomised Controlled Trial of Withdrawal of Non-invasive Ventilation in COPD Patients With Acute Hypercapnic Respiratory Failure|Completed||Phase 3|60|Actual|United Christian Hospital||2|||f||||t||||||||||2017-10-11 03:20:08.757148|2017-10-11 03:20:08.757148
NCT01523457|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-08-28|2016-09-01||October 2011||2011-10-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|FOLFIRINOX|75 patients, including 44 with MPC and 31 with LAPC, were enrolled. The demographics and disease characteristics of the 37 evaluable patients in the MPC cohort in this study are presented here. Seven of 44 patients with MPC were excluded from efficacy analysis due to voluntary withdrawal.|Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer|Phase II Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer|Completed||Phase 2|75|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:20:08.848574|2017-10-11 03:20:08.848574
NCT01523444|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2015-07-14|||September 2013||2013-09-01|July 2015|2015-07-01|November 2017|Anticipated|2017-11-01|February 2016|Anticipated|2016-02-01||Interventional|||Advancing Adolescent Screening and Brief Intervention Protocols in Primary Care Settings|Advancing Adolescent Screening and Brief Intervention Protocols in Primary Care Settings|Withdrawn||Phase 3|0|Actual|Treatment Research Institute||3||Study not funded.|f||||t||||||||||2017-10-11 03:20:09.38912|2017-10-11 03:20:09.38912
NCT01523431|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-03-29|||March 8, 2012|Actual|2012-03-08|March 2017|2017-03-01|April 27, 2016|Actual|2016-04-27|November 23, 2015|Actual|2015-11-23||Interventional|||Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients|Influence of Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype on Clinical Outcomes and Pharmacokinetics in Chinese Patients With Metastatic Colorectal Cancer|Completed||Phase 2/Phase 3|583|Actual|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||3|||f||||f|t|f|||f|||||2017-10-11 03:20:09.487492|2017-10-11 03:20:09.487492
NCT01523418|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2016-02-02|||October 2014||2014-10-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|XYRIS||Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)|Xarelto in the Prophylaxis of Post Surgical Venous Thromboembolism After Elective Major Orthopedic Surgery or Hip or Knee in Indian Patients|Withdrawn||N/A|0|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:20:09.595995|2017-10-11 03:20:09.595995
NCT01523405|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-09-05|||March 2012||2012-03-01|September 2014|2014-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|INSIGHT||A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM|A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In Type 2 Diabetes Patients On Pharmacotherapy (INSIGHT)|Completed||N/A|4911|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:20:09.686831|2017-10-11 03:20:09.686831
NCT01523392|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-09-30|2014-09-22||March 2012||2012-03-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Randomized Analysis Set for demography (N=34) - included all patients who signed informed consent and were randomized into the study.|A Pharmacodynamic Study With Ticagrelor in African American Patients|A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease|Completed||Phase 4|50|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:20:11.692666|2017-10-11 03:20:11.692666
NCT01523379|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-31|2012-04-24||||||April 2012|2012-04-01||||||||Expanded Access|||Efficacy of Parecoxib on Patients With CRPS|Efficiacy of the Selctive COX-2-inhibitor Parecoxibe on the Pathological Low Pressure Pain Threshold (PPT) of Patients With Complex Regional Pain Syndrome (CRPS)|No longer available||N/A|||Ruhr University of Bochum|||||f||||||||||||||2017-10-11 03:20:12.214478|2017-10-11 03:20:12.214478
NCT01523366|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2014-08-14|2014-05-10||April 2012||2012-04-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Randomized Analysis Set for demography (N=40) - included all patients who signed informed consent and were randomized into the study. Pharmacodynamic (PD) Analysis Set for outcomes (N=38) - included all patients for whom PD data was available with no major protocol deviations thought to significantly affect the PD of ticagrelor or clopidogrel|A Pharmacodynamic Study With Ticagrelor in Hispanic Patients|A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease|Completed||Phase 4|53|Actual|AstraZeneca|Total N for the secondary outcome analysis after multiple doses and for PK measures was not the same for 2 hours, 8 hours and end of dosing. Only the first time point total N can be reported via the form. Row titles indicate N's where they differ.|2|||f||||f||||||||||2017-10-11 03:20:12.287684|2017-10-11 03:20:12.287684
NCT01523353|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2013-12-16|||July 2011||2011-07-01|February 2012|2012-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Prehabilitation in Liver Surgery|Feasibility Study of Preoperative Exercise Intervention in the Resection of Colorectal Liver Metastasis.|Completed||Phase 1|37|Actual|Aintree University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 03:20:13.016937|2017-10-11 03:20:13.016937
NCT01523340|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2013-01-30|||December 2011||2011-12-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|MENTOR||A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response|Phase 4 Study of Response to EGFR-TKI and Correlation With C-met Expression and EGFR Gene Mutation in NSCLC Patients Treated With Erlotinib|Unknown status|Recruiting|N/A|200|Anticipated|Chonnam National University Hospital|||1||f||||t||||||Samples Without DNA|"     NSCLC tumor tissue for c-MET expression by immuohistochemistry c-MET amplification by silver     in situ hybridization EGFR mutation by realtime PCR   "|||2017-10-11 03:20:13.1488|2017-10-11 03:20:13.1488
NCT01419886|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-05-31|||October 2010||2010-10-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Observational|||Testing of a New Scale Measuring Medical Outcomes of Dysphagia (MOD) in Adult Patients With Swallowing Disorders||Recruiting||N/A|500|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 03:54:44.098431|2017-10-11 03:54:44.098431
NCT01523327|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-01-31|||October 2011||2011-10-01|January 2012|2012-01-01|October 2012|Anticipated|2012-10-01|November 2011|Actual|2011-11-01||Observational|||Study of Association Between Maternal Uric Acid , Maternal and Fetal Outcome in Pregnant Women With Hypertension|Association of Maternal Uric Acid With Maternal Condition and Fetal Outcome in Pregnant Women With Hypertension|Unknown status|Recruiting|N/A|80|Anticipated|Ain Shams Maternity Hospital|||2||f||||t||||||||||2017-10-11 03:20:13.281573|2017-10-11 03:20:13.281573
NCT01523314|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-28|2012-01-31|||March 2012||2012-03-01|January 2012|2012-01-01|February 2013|Anticipated|2013-02-01|August 2012|Anticipated|2012-08-01||Interventional|DECEDE||Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema|Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema|Unknown status|Not yet recruiting|Phase 2/Phase 3|40|Anticipated|King Saud University||2|||f||||t||||||||||2017-10-11 03:20:13.408729|2017-10-11 03:20:13.408729
NCT01523301|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2015-11-16|2015-10-12||April 2012||2012-04-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Baseline Characteristics refer to the Randomized Set (RS), which consists of all randomized subjects.|Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients|Double Blind, Placebo-controlled, Parallel, Multicenter, Randomized Interventional Phase IV Study to Evaluate the Efficacy of Rotigotine on Depressive Symptoms in Idiopathic Parkinson's Disease Patients|Completed||Phase 4|380|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:20:13.573802|2017-10-11 03:20:13.573802
NCT01523288|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2012-01-31|||February 2011||2011-02-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||The Intestinal Function in People With Prader-Willi Syndrome|The Intestinal Function in People With Prader-Willi Syndrome|Completed||N/A|21|Actual|Aarhus University Hospital|||2||f||||t||||||||||2017-10-11 03:20:14.322032|2017-10-11 03:20:14.322032
NCT01523275|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-05-12|||January 2012||2012-01-01|May 2016|2016-05-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Study of Mitomycin-C Application in Laryngotracheal Stenosis|A Randomized Study of Mitomycin-C Application in the Endoscopic Surgical Treatment of Patients With Laryngotracheal Stenosis|Recruiting||N/A|60|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:20:14.410435|2017-10-11 03:20:14.410435
NCT01523262|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-01-12|||January 2011||2011-01-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Preventing Myocardial Ischemia by Preconditioning in Elective Operation for Abdominal Aortic Aneurysm|The Effect of Preconditioning to Prevent Perioperative Myocardial Ischemia in Elective Operation of Abdominal Aortic Aneurysm|Unknown status|Recruiting|Phase 1|200|Anticipated|Aarhus University Hospital||2|||f||||f||||||||||2017-10-11 03:20:14.527224|2017-10-11 03:20:14.527224
NCT01523236|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-01-27|||December 2011||2011-12-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation|A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Furoate Anhydrous, 50 Mcg/Actuation Nasal Spray (Teva Pharmaceuticals USA) Compared to Nasonex® (Mometasone Furoate Monohydrate) 50 Mcg/Actuation Nasal Spray (Schering) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis|Completed||Phase 1/Phase 2|800|Actual|Teva Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 03:20:14.717937|2017-10-11 03:20:14.717937
NCT01523223|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-11-17|||January 2012||2012-01-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies|A Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematolymphoid Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell Transplantation|Active, not recruiting||Phase 1|16|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 03:20:14.815731|2017-10-11 03:20:14.815731
NCT01523210|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-07|2012-11-12|||November 2011||2011-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle|Influence of Physiotherapy on the Spastic Musculus Biceps Brachii Under Routine Botulinum Toxin Injection. - An Explorative MRI Study|Completed||N/A|5|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 03:20:15.130746|2017-10-11 03:20:15.130746
NCT01523197|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-11-26|||August 2011||2011-08-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Auto-trilevel Ventilator for Patients With Overlap Syndrome|Effect of Auto-Trilevel Ventilation on Patients With Overlap Syndrome|Completed||N/A|17|Actual|Nanjing Medical University||1|||f||||f||||||||||2017-10-11 03:20:15.245255|2017-10-11 03:20:15.245255
NCT01523184|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2014-07-02||2014-07-01|March 2012||2012-03-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation|A Phase II, Single-Center, Randomized, Parallel Group, Multiple Administration, Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation|Completed||Phase 2|57|Actual|SK Life Science||4|||f||||f||||||||||2017-10-11 03:20:15.334088|2017-10-11 03:20:15.334088
NCT01523171|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-02-17||2016-02-17|April 2012||2012-04-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|JAKARTA2||Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib|A Phase II, Multicenter, Open Label, Single Arm Study of SAR302503 in Subjects Previously Treated With Ruxolitinib and With a Current Diagnosis of Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis|Completed||Phase 2|97|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:20:15.436449|2017-10-11 03:20:15.436449
NCT01523158|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-09-21|||April 2012||2012-04-01|September 2012|2012-09-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||Mechanisms of Allergen Immunotherapy|An Open Study to Investigate the Effects of Injection Immunotherapy on Allergen-specific T and B Cell Responses in Adult Patients With Seasonal Allergic Rhinitis.|Terminated||N/A|2|Actual|Royal Sussex County Hospital||1||R and D approval not forthcoming|f||||f||||||||||2017-10-11 03:20:15.636595|2017-10-11 03:20:15.636595
NCT01523145|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-04-18|||December 2011||2011-12-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Interventional|||CopenHeartRFA - Integrated Rehabilitation of Patients Treated for Atrial Fibrillation With Radio Frequency Ablation|CopenHeartRFA - A Randomized Clinical Trial Investigating the Effect and Meaning of Integrated Rehabilitation Versus Usual Follow-up of Patients Treated for Atrial Fibrillation With Radio Frequency Ablation|Completed||N/A|210|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||No||2017-10-11 03:20:15.752372|2017-10-11 03:20:15.752372
NCT01523132|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-04-05|||November 2011||2011-11-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms|Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms|Completed||N/A|545|Actual|Rigshospitalet, Denmark|||1||f||||t||||||Samples With DNA|"     blood   "|||2017-10-11 03:20:15.874583|2017-10-11 03:20:15.874583
NCT01523119|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-02-08|||July 2006||2006-07-01|February 2012|2012-02-01|October 2006|Actual|2006-10-01|July 2006|Actual|2006-07-01||Interventional|||Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions|An Open Label, Balanced, Randomised, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover Bioavailability Study Comparing Ondansetron 8 mg Orally Disintegrating Tablets of Ohm Laboratories (A Subsidiary of Ranbaxy Pharmaceuticals USA) With Zofran 8 mg ODT® Orally Disintegrating Tablets (Containing 8 mg of Ondansetron) Manufactured by Cardinal Health, UK for GlaxoSmithKline USA, in Healthy, Adult, Human, Male Subjects Under Fed Condition.|Completed||N/A|35|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 03:20:15.991912|2017-10-11 03:20:15.991912
NCT01523106|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-01-16|||August 2013||2013-08-01|January 2014|2014-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||L-carnitine to Treat Fatigue Associated With Crohn's Disease|L-carnitine to Treat Fatigue Associated With Crohn's Disease|Withdrawn||N/A|0|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:20:16.104732|2017-10-11 03:20:16.104732
NCT01523093|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-02-08|||July 2006||2006-07-01|February 2012|2012-02-01|October 2006|Actual|2006-10-01|July 2006|Actual|2006-07-01||Interventional|||Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions|An Open Label, Balanced, Randomised, Two-treatment, Two-period, Two-sequence, Single-dose, Crossover Bioavailability Study Comparing Ondansetron 8 mg Orally Disintegrating Tablets of OHM Laboratories Inc (A Subsidiary of Ranbaxy Pharmaceuticals Inc,) With Zofran ODT® 8 mg Orally Disintegrating Tablets (Containing 8 mg of Ondansetron) of GlaxoSmithKline in Healthy, Adult, Human, Male Subjects Under Fasting Condition.|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 03:20:16.211711|2017-10-11 03:20:16.211711
NCT01523080|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-02-08|||May 2006||2006-05-01|February 2012|2012-02-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fasting Condition|An Open Label, Balanced, Randomised, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover Bioavailability Study Comparing Acetaminophen 650 mg Extended Release Gel Tabs (Containing Acetaminophen 650 mg) of OHM Laboratories Inc. (Subsidiary of Ranbaxy) With Tylenol 8 Hour Extended Release Gel Tabs (Containing Acetaminophen 650 mg) of McNeil Consumer & Speciality Pharmaceuticals in Healthy, Adult, Human, Male Subjects Under Fasting Condition|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 03:20:16.308748|2017-10-11 03:20:16.308748
NCT01523067|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2013-01-03|||January 2012||2012-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension|Phase 1, Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Adult Subjects With Stage 1 or Stage 2 Essential Hypertension|Completed||Phase 1|68|Actual|PhaseBio Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 03:20:16.399523|2017-10-11 03:20:16.399523
NCT01523054|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-01-30|||February 2000||2000-02-01|January 2012|2012-01-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Metoprolol in Acute Myocardial Infarction. A PK/PD Study|A Pharmacokinetic and Pharmacodynamic Study Comparing Metoprolol IR and Metoprolol CR/XL Subsequent to Initial Treatment With Intravenous and/or Oral Metoprolol in Patients With Suspected Acut Myocardial Infarction|Completed||Phase 1|27|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:20:16.507725|2017-10-11 03:20:16.507725
NCT01523041|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-02-22|||November 3, 1999|Actual|1999-11-03|February 2017|2017-02-01|November 30, 1999|Actual|1999-11-30|November 30, 1999|Actual|1999-11-30||Interventional|||Comparison of Two Formulations of Biphasic Insulin Aspart 70|A Randomised, Double Blind, Single Centre, Three Period Crossover Trial Testing the Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 and Characterising the Pharmacokinetics of Biphasic Insulin Aspart 50 in Healthy Male Subjects|Completed||Phase 1|24|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:20:16.622779|2017-10-11 03:20:16.622779
NCT01523028|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2013-06-04|||September 2011||2011-09-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Influence of Breakfast Consumption on Chlorogenic Acid Metabolism in Humans||Completed||N/A|14|Actual|Nestlé||3|||f||||t||||||||||2017-10-11 03:20:16.761764|2017-10-11 03:20:16.761764
NCT01523015|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2013-02-02|||January 2012||2012-01-01|February 2013|2013-02-01|December 2020|Anticipated|2020-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction|Efficacy and Safety Study of the Combined Modality Therapy in Patients With Potentially Resectable, Locally Advanced Adenocarcinoma of the Esophago-gastric Junction With Preoperative Chemo- and Chemoradiation Followed by Surgical Resection|Recruiting||Phase 2/Phase 3|100|Anticipated|Medical University of Lublin||2|||f||||t||||||||||2017-10-11 03:20:16.839702|2017-10-11 03:20:16.839702
NCT01523002|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2013-01-25|||January 2012||2012-01-01|January 2012|2012-01-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Drug Interaction Study of Pyronaridine-artesunate and Metoprolol and Pyronaridine-artesunate Re-dosing Study in Healthy Volunteers|Open-label, Drug Interaction Study of Pyramax (Pyronaridine:Artesunate) and Metoprolol in Healthy Volunteers and Pyramax Re-dosing Study in Healthy Volunteers|Completed||Phase 1|56|Actual|Medicines for Malaria Venture||2|||f||||t||||||||||2017-10-11 03:20:16.995054|2017-10-11 03:20:16.995054
NCT00004696|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||August 1994||1994-08-01|May 1999|1999-05-01|July 1998||1998-07-01|||||Interventional|||Study of Morphine in Postoperative Infants to Allow Normal Ventilation||Completed||N/A|100||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:56.785322|2017-10-11 04:26:56.785322
NCT01522989|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-04-21|||December 2011||2011-12-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies|A Phase I Study of the CDK4/6 Inhibitor PD-0332991, 5-Fluorouracil, and Oxaliplatin in Patients With Advanced Solid Tumor Malignancies|Active, not recruiting||Phase 1|37|Actual|Georgetown University||1|||f||||t||||||||||2017-10-11 03:20:17.122337|2017-10-11 03:20:17.122337
NCT01522976|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-06-06|2016-02-18||March 1, 2012|Actual|2012-03-01|May 2017|2017-05-01||||June 1, 2015|Actual|2015-06-01||Interventional||Analysis includes eligible patients only.|Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia|A Randomized Phase II/III Study of Azacitidine in Combination With Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination With Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)|Active, not recruiting||Phase 2|282|Actual|National Cancer Institute (NCI)||3|||f||||f||||||||||2017-10-11 03:20:17.414297|2017-10-11 03:20:17.414297
NCT01522963|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-07-20|2017-02-13||December 2011||2011-12-01|July 2017|2017-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Only those that completed the entire cross-over study were included in the analysis|Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms|Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms|Completed||N/A|98|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||||2017-10-11 03:20:20.469556|2017-10-11 03:20:20.469556
NCT01522950|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-03-13|||May 2010||2010-05-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|EVIDENCE||A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function|A Double-blind, Placebo-controlled, Randomized Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function and Cardiovascular Risk in Patients With Early Vascular Disease|Completed||Phase 2|75|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-11 03:20:20.874386|2017-10-11 03:20:20.874386
NCT01522937|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-01-18|2017-01-18||October 2009||2009-10-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer|A Phase II Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer|Completed||Phase 2|94|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 03:20:20.967912|2017-10-11 03:20:20.967912
NCT01522924|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-04-12|2013-01-07||February 2012||2012-02-01|April 2017|2017-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||There were 94 dental students who provided linkable surveys. There were 42 in the intervention group and 52 in the control group.|Tobacco Dependence Treatment Education for Dental Students|Tobacco Dependence Treatment Education for Dental Students Using Standardized Patients|Completed||N/A|94|Actual|University of Louisville|One participant in the intervention group did not provide gender information. The total number of participants in the intervention group did not equal the number of male and female participants.|2|||f||||f||||||||No||2017-10-11 03:20:21.608736|2017-10-11 03:20:21.608736
NCT01522911|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-01-30|||May 2010||2010-05-01|January 2012|2012-01-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage|Interventional Study to Investigate the Effects of Percutaneous Closure of the Left Atrial Appendage on Atrial and Brain Natriuretic Peptide Secretion|Unknown status|Active, not recruiting|N/A|50|Anticipated|University of Leipzig||1|||f||||f||||||||||2017-10-11 03:20:21.992412|2017-10-11 03:20:21.992412
NCT01522898|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-06-08|||March 2013||2013-03-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|CAAN-AF||Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF)|Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation|Recruiting||N/A|590|Anticipated|University of Adelaide||2|||f||||t||||||||||2017-10-11 03:20:22.086504|2017-10-11 03:20:22.086504
NCT01522885|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2014-08-19|||April 2012||2012-04-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|KatGuide||KatGuide Method Versus Conventional Method at Insertion of Chest Tube|KatGuide-trial. KatGuide Method Versus Conventional Method at Insertion of Chest Tube. A Randomized, Parallel Group, Controlled Trial.|Completed||Phase 3|109|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 03:20:22.342378|2017-10-11 03:20:22.342378
NCT01522872|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-06-01|||February 2012||2012-02-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma|A Phase 1/2 Open-label Study to Assess the Safety, Tolerability and Preliminary Efficacy of TH-302, A Hypoxia-Activated Prodrug, and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|98|Anticipated|Threshold Pharmaceuticals||4|||f||||||||||||||2017-10-11 03:20:22.44854|2017-10-11 03:20:22.44854
NCT01522859|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-27|||August 2009||2009-08-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Telehealth Monitoring in Chronic Obstructive Pulmonary Disease|The Efficacy of Telehealth Monitoring in the Management of Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|110|Actual|South Eastern Health and Social Care Trust||2|||f||||f||||||||||2017-10-11 03:20:22.590743|2017-10-11 03:20:22.590743
NCT01522846|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-08-28|||January 2012||2012-01-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Heparin Solution and INTEM/HEPTEM Analysis|Influence by Heparinized Flush Solution of the Radial Artery Catheter: INTEM and HEPTEM Analysis.|Completed||N/A|25|Actual|Seoul National University Bundang Hospital|||1||f||||f||||||||||2017-10-11 03:20:22.680272|2017-10-11 03:20:22.680272
NCT01522651|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-08-08||2014-08-07|January 2012||2012-01-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation (HARMONY)|A Phase 2, Proof of Concept, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination on Atrial Fibrillation Burden in Subjects With Paroxysmal Atrial Fibrillation|Completed||Phase 2|134|Actual|Gilead Sciences||5|||f||||f||||||||||2017-10-11 03:20:24.498861|2017-10-11 03:20:24.498861
NCT01522833|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2016-03-04|||October 2012||2012-10-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer|Non-Small-Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer: Demographics, Treatment and Outcome Characteristics of Patient Cases in a Community-Based Setting|Completed||N/A|27|Actual|SCRI Development Innovations, LLC|||2||f||||f||||||Samples With DNA|"     Tissue-testing will be performed or test results will be reviewed to identify EGFR-wt and     EGFR mutation positive advanced non small cell lung cancer (NSCLC) patient cases with an     erlotinib-treatment duration of six months or longer (as 2nd/3rd line and/or maintenance     single-agent therapy) in a community-based setting.      Biopsy specimens from enrolled patient cases who are EGFR-wt will be evaluated via     exploratory genetic analysis for correlated biomarkers.   "|||2017-10-11 03:20:22.755322|2017-10-11 03:20:22.755322
NCT01522820|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2016-10-03|||March 2012||2012-03-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors|A Phase I Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced Anti-tumor Immunity in Patients With NY-ESO-1 Expressing Solid Tumors|Completed||Phase 1|18|Actual|Roswell Park Cancer Institute||5|||f||||f||||||||||2017-10-11 03:20:22.825441|2017-10-11 03:20:22.825441
NCT01522807|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2012-01-27|||September 2011||2011-09-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study Of Three PF-05190457 Formulations In Healthy Volunteers|A Phase I, Cross-Over, Single Dose, Double-Blind Study To Estimate The Relative Bioavailability Of Three Different Formulations Of PF-05190457 In Healthy Adult Volunteers|Completed||Phase 1|16|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:20:22.960063|2017-10-11 03:20:22.960063
NCT01522794|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-11-07|||January 2012||2012-01-01|November 2014|2014-11-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model|Randomized Double Blind Placebo Controlled PK/PD Study on the Effects of a Single Intravenous Dose of NOX-H94 on Serum Iron During Experimental Human Endotoxemia|Completed||Phase 1|24|Actual|NOXXON Pharma AG||2|||f||||t||||||||||2017-10-11 03:20:23.056383|2017-10-11 03:20:23.056383
NCT01522781|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-27|||October 1998||1998-10-01|January 2012|2012-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||10 Year Outcome of Total Knee Replacement (TKR) Using Sigma Prosthesis|10 Year Outcome of Total Knee Replacement (TKR) Using Sigma Prosthesis|Completed||N/A|234|Actual|NHS Fife|||1||f||||f||||||||||2017-10-11 03:20:23.146001|2017-10-11 03:20:23.146001
NCT01522768|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-04-14|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer|A Phase II Study of Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab Refractory Advanced Esophagogastric Cancer|Recruiting||Phase 2|48|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:20:23.374719|2017-10-11 03:20:23.374719
NCT01522742|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-03-15|||February 2012||2012-02-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|MMAPPS||Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study|Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study|Terminated||N/A|29|Actual|Massachusetts General Hospital|||2||f||||f||||||Samples Without DNA|"     Plasma, serum.   "|||2017-10-11 03:20:23.642003|2017-10-11 03:20:23.642003
NCT01522729|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-01-27|||October 2010||2010-10-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Impact of Muscle Afferent Feedback During Exercise in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Impact of Somatosensory Feedback on Peripheral Muscle Fatigue and Exercise Tolerance in Patients With COPD|Completed||N/A|8|Actual|Laval University||2|||f||||t||||||||||2017-10-11 03:20:23.730866|2017-10-11 03:20:23.730866
NCT01522716|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-05-30|||August 2011||2011-08-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2016|Actual|2016-03-01||Interventional|||Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease|Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease|Active, not recruiting||Phase 1|11|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 03:20:23.826931|2017-10-11 03:20:23.826931
NCT01522703|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-11-24|2016-08-08||March 2012||2012-03-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of Whole Sprouts on Airway Allergic Inflammation|Dietary Interventions and Asthma Treatment: A Pilot Study of the Effects of Whole Sprouts on Airway Allergic Inflammation|Completed||N/A|51|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 03:20:23.90148|2017-10-11 03:20:23.90148
NCT01522690|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-04-14|||December 2011||2011-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ACCELERIX||Assessment of Accelerometric Measurement Devices for Gait Analysis|Assessment of Accelerometric Measurement Devices for Gait Analysis|Completed||N/A|300|Anticipated|Institut de Myologie, France||1|||f||||f||||||||||2017-10-11 03:20:24.12841|2017-10-11 03:20:24.12841
NCT01522677|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-11-30|||August 2012||2012-08-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer|A Phase I/II Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|University of California, Irvine||1||Slow accrual|f||||t||||||||||2017-10-11 03:20:24.200643|2017-10-11 03:20:24.200643
NCT01522664|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2016-11-01|||March 2012||2012-03-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma|A Phase I, Open-Label Study of the Safety and Pharmacokinetics of Escalating Doses of DEDN6526A in Patients With Metastatic or Unresectable Melanoma|Completed||Phase 1|53|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:20:24.294599|2017-10-11 03:20:24.294599
NCT01522274|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-07-28|||January 2012||2012-01-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|QFH||Quit Smoking With Nicotine Patch and Exercise/Health Education (Females Only)|Efficacy of Brisk Walking as a Smoking Cessation Treatment Adjunct Among Women|Completed||N/A|113|Actual|Brown University||2|||f||||f||||||||||2017-10-11 03:20:29.149013|2017-10-11 03:20:29.149013
NCT01522638|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2012-01-27|||December 2011||2011-12-01|January 2012|2012-01-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Observational|||Advanced Characterization of Autosomal Dominant Optic Atrophy|Cross Sectional Study of Autosomal Dominant Opticus Atrophy|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Glostrup University Hospital, Copenhagen|||2||f||||f||||||||||2017-10-11 03:20:24.739378|2017-10-11 03:20:24.739378
NCT01522625|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-03-20|||January 2012||2012-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||Tenofovir in Chronic Hepatitis B With Mild ALT Elevation|Efficacy of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients With High Viral Load But Slight Aminotransferase Elevation|Active, not recruiting||Phase 4|160|Anticipated|E-DA Hospital||2|||f||||f||||||||||2017-10-11 03:20:24.816517|2017-10-11 03:20:24.816517
NCT01522612|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-06-09|||April 2013||2013-04-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Colorectal Cancer (CRC) Cetuximab Elderly Frail|Treatment of Patients With KRAS Wild Type Advanced Colorectal Cancer (CRC) With 5-Fluorouracil (5-FU) or 5- FU Plus an Epidermal Growth Factor Receptor (EGFR) Inhibitor (Cetuximab) Based on a Comprehensive Geriatric Assessment (CGA).|Terminated||Phase 2|5|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2||poor accrual|f||||t||||||||||2017-10-11 03:20:24.923211|2017-10-11 03:20:24.923211
NCT01522599|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-06-16|||April 2012||2012-04-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ELP||Flow-flow ECCO2-R and 4 ml/kg Tidal Volume vs. 6 ml/kg Tidal Volume to Enhance Protection From VILI in Acute Lung Injury|Flow-flow ECCO2-R and 4 ml/kg Tidal Volume vs. 6 ml/kg Tidal Volume to Enhance Protection From Ventilator Induced Lung Injury in Acute Lung Injury (ELP)|Terminated||Phase 3|230|Actual|University of Turin, Italy||2||Financial hardship|f||||t||||||||||2017-10-11 03:20:25.045667|2017-10-11 03:20:25.045667
NCT01522586|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2014-02-12|||January 2012||2012-01-01|January 2012|2012-01-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031|A Dose Block-randomized, Double-blind, Placebo-controlled, Single/Multiple Dosing, Dose-escalation Clinical Phase 1 Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031|Terminated||Phase 1|74|Actual|Daewoong Pharmaceutical Co. LTD.||2||change development strategy|f||||t||||||||||2017-10-11 03:20:25.155412|2017-10-11 03:20:25.155412
NCT01522573|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-02-16|||November 2011||2011-11-01|February 2017|2017-02-01|December 30, 2018|Anticipated|2018-12-30|December 30, 2018|Anticipated|2018-12-30||Observational|EUSERCPReg||T-EUS for Gastrointestinal Disorders: A Multicenter Registry|Therapeutic Endoscopic Ultrasound (T-EUS) Guided Procedures in the Management of Gastrointestinal Disorders: A Multicenter Registry.|Recruiting||N/A|1000|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-10-11 03:20:25.232751|2017-10-11 03:20:25.232751
NCT01522560|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-08-10|||July 2011||2011-07-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Multiscore Feedback in Professionalism for Anesthesia||Recruiting||N/A|80|Anticipated|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 03:20:25.346599|2017-10-11 03:20:25.346599
NCT01522547|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2013-12-24|||August 2007||2007-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|October 2012|Actual|2012-10-01||Interventional|SCD-001||Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease|A Prospective, Multi-Center, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety and Effect on Induction of Fetal Hemoglobin of CC-4047 In Subjects With Sickle Cell Disease|Completed||Phase 1|12|Anticipated|Celgene||5|||f||||f||||||||||2017-10-11 03:20:25.449573|2017-10-11 03:20:25.449573
NCT01522534|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2012-01-30|||January 2012||2012-01-01|January 2012|2012-01-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|BPOP||Randomized Double Blind Controlled Trial Comparing a Blind Sciatic Nerve Block in the Popliteal Fossa to Intravenous Morphine for Traumatic Severe Acute Pain in the Prehospital Setting||Unknown status|Recruiting|Phase 3|66|Anticipated|Centre Hospitalier de la Région d'Annecy||2|||f||||t||||||||||2017-10-11 03:20:25.54945|2017-10-11 03:20:25.54945
NCT01522521|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2015-10-01|||February 2012||2012-02-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study of AK156 in Primary Osteoporosis Patients|Phase 3 Study of AK156 in Primary Osteoporosis Patients|Completed||Phase 3|600|Anticipated|Asahi Kasei Pharma Corporation||2|||f||||||||||||||2017-10-11 03:20:25.683941|2017-10-11 03:20:25.683941
NCT01522508|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-06-14|||June 2011||2011-06-01|June 2012|2012-06-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Observational|||Evaluation of Analgesia Nociception Index (ANI) During Propofol/Remifentanil and Sevoflurane/Remifentanil Anesthesia|Detection of Nociceptive Stimulation by Analgesia Nociception Index (ANI) During Anesthesia With Propofol or Sevoflurane and Varying Remifentanil Concentrations.|Unknown status|Recruiting|N/A|50|Anticipated|University of Schleswig-Holstein|||2||f||||f||||||||||2017-10-11 03:20:25.830463|2017-10-11 03:20:25.830463
NCT01522495|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-07-27|||April 2013||2013-04-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging|Pilot Study for: Eye vs. Spy - A Prospective, Randomized Study Evaluating Patient Outcomes With the Use of SPY Imaging During Amputations or Debridements|Recruiting||N/A|160|Anticipated|Georgetown University||4|||f||||t||||||||||2017-10-11 03:20:25.933458|2017-10-11 03:20:25.933458
NCT01522482|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-01-31|||March 2009||2009-03-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|||Apolipoprotein (APO)E Genotype, Meal Fatty Acids, Postprandial Lipaemia|Effects of Meal Fatty Acid Composition on Postprandial Lipaemia in Men According to APOE Genotype|Completed||N/A|31|Actual|University of Reading||3|||f||||t||||||||||2017-10-11 03:20:26.048282|2017-10-11 03:20:26.048282
NCT01522469|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-30|2015-03-18|||July 2012||2012-07-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Phase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating Mutations|A Phase II Study of Crenolanib Besylate in Subjects With Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations|Completed||Phase 2|20|Actual|Arog Pharmaceuticals, Inc.||1|||f||||||||||||||2017-10-11 03:20:26.153838|2017-10-11 03:20:26.153838
NCT01522092|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-03-28||||||March 2017|2017-03-01||||||||Interventional|||Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations|The Effect of Escitalopram on Exacerbation Rates and Quality of Life in Patients With Anxiety Associated With Severe COPD|Withdrawn||Phase 3|0|Actual|Hull and East Yorkshire Hospitals NHS Trust||1||Study was not given ethical approval- a alternative protocol required|f||||f||||||||||2017-10-11 03:20:31.086083|2017-10-11 03:20:31.086083
NCT01522456|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-08-10|2013-03-11||April 2012||2012-04-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel|Split-face Tolerability Comparison Between Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Versus Retin-A Micro® (Tretinoin Gel) Microsphere, 0.1% in Subjects With Acne Vulgaris|Completed||Phase 4|73|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||||2017-10-11 03:20:26.269567|2017-10-11 03:20:26.269567
NCT01522430|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-01-27|||January 2012||2012-01-01|January 2012|2012-01-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|DEPART||Study of Catheter Based Renal Denervation Therapy in Hypertension|DENERVATION OF RENAL SYMPATHETIC ACTIVITY AND HYPERTENSION STUDY|Unknown status|Recruiting|Phase 3|120|Anticipated|Erasme University Hospital||2|||f||||t||||||||||2017-10-11 03:20:27.787756|2017-10-11 03:20:27.787756
NCT01522417|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2015-04-06|||April 2012||2012-04-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|SAVI-PCI||Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention|A Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy of Tirofiban Using a High-Dose Bolus Plus a Shortened Infusion Duration Versus Label-Dosing Eptifibatide in Patients Undergoing Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 2|675|Anticipated|Medicure||3|||f||||f||||||||||2017-10-11 03:20:27.871443|2017-10-11 03:20:27.871443
NCT01522391|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-01-27|||March 2008||2008-03-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060|A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060|Completed||Phase 1/Phase 2|41|Actual|DermaGen AB||2|||f||||||||||||||2017-10-11 03:20:28.168713|2017-10-11 03:20:28.168713
NCT01522378|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2017-04-24|||February 2012||2012-02-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging|Cardiac Resynchronization and MIBG Imaging|Terminated||Phase 1|14|Actual|Mayo Clinic||1||The study was terminated because the funding was withdrawn.|f||||f|t|f|||t|||No||2017-10-11 03:20:28.260884|2017-10-11 03:20:28.260884
NCT01522365|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-08-24|||November 2011||2011-11-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|XiCC||XiVE® CAD/CAM Bridges (Abutment-supported/ Implant-supported)|A Randomized, Prospective, International, Multi-center Clinical Study to Evaluate the Peri-implant Tissue Outcome of Abutment-supported XiVE® CAD/CAM Supra-structures and Directly Implant-supported XiVE® CAD/CAM Supra-structures (Split-mouth) in Partly Edentulous Human Subjects.|Active, not recruiting||N/A|20|Anticipated|Dentsply Implants Manufacturing GmbH||2|||f||||f||||||||||2017-10-11 03:20:28.360118|2017-10-11 03:20:28.360118
NCT01522352|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-09-02|||March 2012||2012-03-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Comparison Between Three Types of Stented Pericardial Aortic Valves|Comparison of Short and Mid-term Hemodynamic Performance Between Three Types of Stented Pericardial Aortic Valves|Unknown status|Recruiting|N/A|165|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 03:20:28.445768|2017-10-11 03:20:28.445768
NCT01522339|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-09-23|2013-08-08||February 2012||2012-02-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|NICU MRI||Pilot Study: Safety of a Customized MRI System for Neonatal Imaging|Pilot Study: Safety of a Customized MRI System for Neonatal Imaging|Completed||N/A|15|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 03:20:28.542815|2017-10-11 03:20:28.542815
NCT01522326|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2016-09-12|||March 2012||2012-03-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness|Acute Mountain Sickness Treatment: A Double-blind Comparison of Metoclopramide vs. Ibuprofen|Recruiting||N/A|300|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-11 03:20:28.758215|2017-10-11 03:20:28.758215
NCT01522313|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-10-08|||January 2006||2006-01-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|NEPHRANEST||Influence of Perioperative Kidney Function on Postoperative Outcome|Retrospective Data Analysis of the Impact of Perioperative Kidney Function on Postoperative Outcome|Completed||N/A|39369|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 03:20:28.892809|2017-10-11 03:20:28.892809
NCT01522300|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-11-20|||January 2012||2012-01-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity Search|Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité|Terminated||Phase 2|81|Actual|Centre Jean Perrin||1||No more inclusions since august 2013|f||||f||||||||||2017-10-11 03:20:28.968547|2017-10-11 03:20:28.968547
NCT01522287|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2014-03-13|||January 2012||2012-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Computer Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: A Comprehensive Stepped-Care Approach|Computer Assisted CBT for OCD: A Comprehensive Stepped-Care Approach|Completed||Phase 1|88|Actual|Center for Psychological Consultation||3|||f||||t||||||||||2017-10-11 03:20:29.046589|2017-10-11 03:20:29.046589
NCT01522261|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-04-17|||January 2012||2012-01-01|April 2015|2015-04-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|MBP||The Surgical Benefit and Pt.Tolerability Between Two Different Bowel Cleansing Regimens Performed Prior to Pelvic Reconstructive Surgery. Does One Bowel Cleansing Regimen Improve the Surgeons Visual Field Significantly Better Than the Other.|The Use of Mechanical Bowel Preparation in Pelvic Reconstructive Surgery (MBP)|Unknown status|Recruiting|Phase 1|176|Anticipated|Boston Urogynecology Associates||2|||f||||f||||||||||2017-10-11 03:20:29.244057|2017-10-11 03:20:29.244057
NCT01522248|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-27|2015-09-17|||January 2012||2012-01-01|September 2015|2015-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study|A Pilot Study to Examine the Early Cytokine Responses After Inactivated Influenza Vaccination in Adults 18-50.|Completed||N/A|20|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 03:20:29.366977|2017-10-11 03:20:29.366977
NCT01522235|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-06-02|2017-04-14||February 2012||2012-02-01|June 2017|2017-06-01|September 2015|Actual|2015-09-01|May 2014|Actual|2014-05-01||Interventional|||Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy|A Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy.|Completed||Phase 2/Phase 3|6|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||Yes|The investigators will adhere to the NIH Grant Policy on Sharing of Unique Research Resources including the Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources.|2017-10-11 03:20:29.456383|2017-10-11 03:20:29.456383
NCT01522222|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-12-28|||July 2010||2010-07-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PEEP||Study to Determine if Using Ventilation During Open Heart Surgery Improves Lung Outcomes|Effect of Continuous Mechanical Ventilation During Cardiopulmonary Bypass on The Lung Mechanics: A Prospective Evaluation|Completed||N/A|40|Actual|Aurora BayCare Medical Center||2|||f||||f||||||||||2017-10-11 03:20:29.837884|2017-10-11 03:20:29.837884
NCT01522209|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-01-14|||December 2011||2011-12-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|CEIOUS-Liver||Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging|Value of Contrast Enhanced Intraoperative Ultrasound Compared to Preoperative CEUS, CT and MRT in the Treatment of Colorectal Liver Metastases.|Completed||N/A|59|Actual|Asklepios Kliniken Hamburg GmbH||1|||f||||t||||||||||2017-10-11 03:20:29.912261|2017-10-11 03:20:29.912261
NCT01522196|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-01-30||2014-01-30|February 2012||2012-02-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|IMPACTS-2||A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.|A Randomized, Double-blind, Placebo-Controlled Study With Varespladib Infusion (A-001) in Subjects With Sickle Cell Disease and Vaso-Occlusive Crisis for the Prevention of Acute Chest Syndrome At-Risk Subjects.|Terminated||Phase 2|2|Actual|Anthera Pharmaceuticals||2||change in company plans|f||||f||||||||||2017-10-11 03:20:30.007789|2017-10-11 03:20:30.007789
NCT01522183|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-08-23|||April 2012||2012-04-01|August 2017|2017-08-01|December 2025|Anticipated|2025-12-01|December 2023|Anticipated|2023-12-01||Observational|||Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry|An Observational, Non-Interventional, Multi-Center, Multi-National Study of Patients With aTypical Hemolytic-Uremic Syndrome (aHUS Registry)|Recruiting||N/A|2000|Anticipated|Alexion Pharmaceuticals|||1||f||||f||||||||||2017-10-11 03:20:30.118774|2017-10-11 03:20:30.118774
NCT01522170|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-02-22|||March 2012|Actual|2012-03-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01|5 Years|Observational [Patient Registry]|LTFU||aHUS Observational Long Term Follow-Up|An Observational, Multi-Center, Multi-National, Long Term Follow-Up Study of Atypical Hemolytic Uremic Syndrome (aHUS) Patients Treated With Eculizumab in a Prior Clinical Study|Terminated||N/A|94|Actual|Alexion Pharmaceuticals|||1|"Remaining patients were offered a similar observational study (Alexion M11-001) to allow for   robust, high quality data collection in a larger, single database"|f||||f||||||||||2017-10-11 03:20:30.189206|2017-10-11 03:20:30.189206
NCT01522157|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2013-11-29|||January 2012||2012-01-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Randomized Cross-over Trial of the Postprandial Effects of Three Different Diets in Patients With Type 2 Diabetes|A Randomized Cross-over Trial of the Postprandial Effects of Three Different Diets in Patients With Type 2 Diabetes|Completed||N/A|19|Actual|Vårdcentralen Lyckorna||1|||f||||||||||||||2017-10-11 03:20:30.336399|2017-10-11 03:20:30.336399
NCT01522144|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-01-27|||July 2006||2006-07-01|January 2012|2012-01-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||An Electronic Decision Support Tool to Improve Outpatient Asthma Care|EHR Decision Support to Improve Outpatient Asthma Care|Completed||N/A|1030|Actual|Agency for Healthcare Research and Quality (AHRQ)||1|||f||||f||||||||||2017-10-11 03:20:30.574674|2017-10-11 03:20:30.574674
NCT01522131|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2014-05-13|2014-01-14||December 2011||2011-12-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Laser Use on Guided Tissue Regeneration in Treatment of Molar Teeth With Class 2 Furcation Affected by Periodontitis|Treatment of Class II Furcation Defects in the Maxillary and Mandibular Molars With Bioresorbable Collagen Membrane and Laser|Completed||N/A|33|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 03:20:30.666566|2017-10-11 03:20:30.666566
NCT01522118|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2013-02-25|||January 2011||2011-01-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease|Focal Therapy With Magnetic Resonance Guided Focused Ultrasound Treatment of Locally Non-Advanced Prostate Cancer: Phase 1 Study|Completed||Phase 1|12|Actual|University of Roma La Sapienza||1|||f||||f||||||||||2017-10-11 03:20:30.915781|2017-10-11 03:20:30.915781
NCT01522105|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-06-07|||April 2012|Actual|2012-04-01|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|December 31, 2017|Anticipated|2017-12-31||Interventional|||Daptomycin in Pediatric Patients With Bacterial Meningitis|Evaluation of Cerebrospinal Fluid Concentration of Daptomycin (Cubicin¬) in Pediatric Patients With Gram-positive Bacterial Meningitis, Concurrently Receiving Standard Antimicrobial Therapy|Recruiting||Phase 1|5|Anticipated|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-10-11 03:20:30.986787|2017-10-11 03:20:30.986787
NCT01522079|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-26|||January 2011||2011-01-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||Spinal Muscular Atrophy and Cardiac Autonomic Function|Spinal Muscular Atrophy and Cardiac Autonomic Function|Completed||N/A|9|Actual|Centro Universitário Augusto Motta||1|||f||||t||||||||||2017-10-11 03:20:31.196431|2017-10-11 03:20:31.196431
NCT01522066|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-12-17|||January 2012||2012-01-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Catheter-over Needle: Outpatient Study|Comparison of the Effectiveness of Single-shot Local Anesthetic Delivery Versus Double-shot Local Anesthetic Delivery Via a Perineural Catheter|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 03:20:31.291912|2017-10-11 03:20:31.291912
NCT01522053|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-12-17|||January 2012||2012-01-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Catheter-over-needle: Inpatient Study|Comparison of the Catheter-over-needle and Catheter-through-needle Methods for Continuous Delivery of Local Anesthetic During Peripheral Nerve Blockade|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 03:20:31.372848|2017-10-11 03:20:31.372848
NCT01522040|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-03-29|||January 2012||2012-01-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Pilot Study of Magnesium Infusions in Pediatric Asthma|A Pilot Study of Magnesium Infusions (Drips) for Moderate-to-Severe Pediatric Asthma Exacerbations|Withdrawn||Phase 2/Phase 3|0|Actual|University of Louisville||2|||f||||t||||||||||2017-10-11 03:20:31.453917|2017-10-11 03:20:31.453917
NCT01522027|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-12-17|||May 2012||2012-05-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|||Electrically Guided Needle Insertion: ICU Study|Use of Nerve Stimulation Technology to Aid in Percutaneous Tracheostomy in Intensive Care Patients.|Unknown status|Active, not recruiting|N/A|20|Anticipated|University of Alberta||1|||f||||f||||||||||2017-10-11 03:20:31.537682|2017-10-11 03:20:31.537682
NCT01522014|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2013-02-19|||November 1997||1997-11-01|February 2012|2012-02-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||Randomized Clinical Trial of Ceramic Bearing Primary Total Hip Arthroplasty|Five-Year Outcome of Ceramic on Ceramic Bearing Versus Ceramic on Crossfire® Highly Cross-Linked Polyethylene Bearing in Primary Total Hip Arthroplasty: A Randomized Trial|Completed||Phase 4|92|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 03:20:31.623209|2017-10-11 03:20:31.623209
NCT01522001|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-05-28|||October 2011||2011-10-01|September 2012|2012-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SHARED-REHAB||Shared Care Rehabilitation After Acute Coronary Syndrome|Shared Care Rehabilitation After Acute Coronary Syndrome|Completed||Phase 4|212|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 03:20:31.707241|2017-10-11 03:20:31.707241
NCT01521988|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-12-06|||June 2012||2012-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PAF CRIOBLAF||Cryoballoon Pulmonary Venous Isolation in Patients Referred for Typical Atrial Flutter Ablation|Prevention of Atrial Fibrillation by Combined Right Isthmus Ablation and cryoBalloon Pulmonary Vein Isolation in Patients With Typical Atrial Flutter|Active, not recruiting||N/A|76|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 03:20:31.81019|2017-10-11 03:20:31.81019
NCT01521975|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-01-30|||September 2011||2011-09-01|January 2012|2012-01-01|May 2014|Anticipated|2014-05-01|February 2013|Anticipated|2013-02-01||Interventional|STEN||A Two-year Study of Telbivudine in HBeAg Negative Hepatitis|A Two-year, Open-label, Virological Response Adaptive Design, Multicenter Study to Evaluate Efficacy of Telbivudine in HBeAg Negative Adult CHB Patients With Roadmap Strategy|Unknown status|Recruiting|Phase 4|360|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||||2017-10-11 03:20:31.907335|2017-10-11 03:20:31.907335
NCT01521962|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2013-11-12|||February 2012||2012-02-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Study of Combination Therapy With SYR-322|A Phase 3 Study to Investigate the Efficacy and Safety of SYR-322 When Used in Combination With Insulin Preparation in Subjects With Type 2 Diabetes in Japan|Completed||Phase 3|67|Actual|Takeda||2|||f||||||||||||||2017-10-11 03:20:31.992354|2017-10-11 03:20:31.992354
NCT01521949|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-07-06|||November 4, 2011|Actual|2011-11-04|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|October 3, 2012|Actual|2012-10-03||Interventional|||Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA|A Phase 2 Study Acai Juice Product in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising Prostate Specific Antigen (PSA)|Active, not recruiting||Phase 2|21|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-10-11 03:20:32.133317|2017-10-11 03:20:32.133317
NCT01521936|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-06-18|||December 2011||2011-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|March 2013|Actual|2013-03-01||Interventional|||Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy|Vitamin D3 Supplementation in Acute Myeloid Leukemia: Pharmacokinetic Study|Terminated||Phase 2|4|Actual|Roswell Park Cancer Institute||2||Lack of funding|f||||t||||||||||2017-10-11 03:20:32.2112|2017-10-11 03:20:32.2112
NCT01521923|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-11-10|2016-07-06||January 2012||2012-01-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|C-early|Baseline refers to Baseline from Period 1. Only subjects who entered Period 2 are included. Characteristics refer to the Safety Set 2 (SS2).|A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis|A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate for Inducing and Sustaining Clinical Response in the Treatment of DMARD-Naïve Adults With Early Active Rheumatoid Arthritis|Completed||Phase 3|359|Actual|UCB Pharma||3|||f||||f||||||||||2017-10-11 03:20:34.161232|2017-10-11 03:20:34.161232
NCT01521910|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-30|||April 1995||1995-04-01|January 2012|2012-01-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|LPD||Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy|Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy|Completed||N/A|82|Actual|Steno Diabetes Center||2|||f||||f||||||||||2017-10-11 03:20:36.147303|2017-10-11 03:20:36.147303
NCT01521897|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-12-14|2015-12-14||September 2010||2010-09-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|January 2013|Actual|2013-01-01||Observational||In total, 1143 participants were enrolled in this study. Of the 1143 participants, 23 participants were excluded from the baseline analysis for the reasons of protocol violation and lost to follow-up.|Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)|Prevenar Special Use-result Surveillance (Multi-center, Prospective Observational Safety Surveillance For Prevenar In Japan)|Completed||N/A|1143|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:20:36.537099|2017-10-11 03:20:36.537099
NCT01521884|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2015-02-03|2015-02-03||November 2010||2010-11-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational||Intention to treat (ITT) population included all participants for whom the primary endpoint or one of the secondary endpoints could be determined at baseline. Here “N” (Overall Number of Baseline Participants) includes participants with non-missing baseline data.|Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy|Longitudinal Changes In Fatigue And Health Status (aims2) In Ra Patients Treated With Sc Anti-tnf-alpha Therapy|Completed||Phase 4|62|Actual|Pfizer|Designation of primary and secondary endpoints was based on study team's inputs, as the endpoints were not prioritized in the study protocol.||1||f||||f||||||||||2017-10-11 03:20:38.406925|2017-10-11 03:20:38.406925
NCT01521871|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2014-11-03|2013-12-13||January 2012||2012-01-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|TG-CYANO||Tissue Glue (Cyanoacrylate) Versus Conventional Suture in Kidney Donors|A Prospective, Randomised Study on Tissue Glue (Cyanoacrylate) Versus Conventional Suture for Skin Closure in Laparoscopic Living Donor Nephrectomy|Completed||Phase 4|64|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 03:20:38.96859|2017-10-11 03:20:38.96859
NCT01521858|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-08-28|||January 2012||2012-01-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||THRA_hematologic Variables|Relations Between Hematologic Variables and Postoperative Bleeding in Total Hip Replacement Arthroplasty|Completed||N/A|73|Actual|Seoul National University Bundang Hospital|||1||f||||f||||||||||2017-10-11 03:20:39.526756|2017-10-11 03:20:39.526756
NCT01521845|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-12-06|2012-05-31||January 2012||2012-01-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)|Phase 3 Study of Poly Unsaturated Fatty Acids of Omega 3 as an Anti Platelet Agent on Biomarkers of Cardiac Necrosis Including CKMB and Troponin I and Inflammation Marker CRP|Completed||Phase 3|104|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:20:39.6005|2017-10-11 03:20:39.6005
NCT01521832|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-02-06|||October 2009||2009-10-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Escalating Dose Study in Healthy Volunteers With SEN0014196|A Phase I, Randomised, Double-Blind, Placebo-Controlled, Two-Part Study Consisting of Single and Multiple Oral Dose Escalation to Determine, Safety, Tolerability and Pharmacokinetics of SEN0014196|Completed||Phase 1|88|Actual|Siena Biotech S.p.A.||11|||f||||f||||||||||2017-10-11 03:20:39.880956|2017-10-11 03:20:39.880956
NCT01521819|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-10-24|||August 2012||2012-08-01|October 2012|2012-10-01|August 2014|Anticipated|2014-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration|A Pilot, Single-center, Interventional Clinical Trial in Which Subjects With Vascularized Pigment Epithelial Detachment (V-PED) Secondary to AMD With Serous Component Superior to 50% of the Lesion Will Receive Low Voltage Stereotactic Radiotherapy (IRay®) Treatment and Lucentis Treatment as Needed.|Unknown status|Active, not recruiting|N/A|12|Anticipated|Oraya Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 03:20:39.97596|2017-10-11 03:20:39.97596
NCT01521793|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-07-25|||January 2012||2012-01-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)|An Open-Label Study to Evaluate the Effects of Repeated Treatments of Oral QLT091001 on Safety and Vision Outcome in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT) (Extension of Study RET IRD 01)|Completed||Phase 1|27|Actual|QLT Inc.||1|||f||||t||||||||||2017-10-11 03:20:40.175019|2017-10-11 03:20:40.175019
NCT01521780|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-10-30|2013-08-14||April 2012||2012-04-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)|A Clinical Study to Characterize Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma for Utilization of Target Engagement and Pharmacodynamic Biomarkers in Future Phase I Trials|Terminated||Phase 1|12|Actual|Merck Sharp & Dohme Corp.|The study was terminated early.|3|||f||||f||||||||||2017-10-11 03:20:40.258006|2017-10-11 03:20:40.258006
NCT01521767|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-26|||October 2011||2011-10-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Pharmacokinetics and Relative Bioavailability Study|A Single-Dose Pharmacokinetics And Relative Bioavailability Study Of Tolterodine From Two Microspheres In Powder Blend Extended Release Formulations Compared To The Commercial Extended Release Capsules|Completed||Phase 1|16|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 03:20:40.539879|2017-10-11 03:20:40.539879
NCT01521754|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-06-30|||March 6, 2012|Actual|2012-03-06|June 2017|2017-06-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Observational|MORE||Product Surveillance Registry- Deep Brain Stimulation for Epilepsy|Medtronic Registry for Epilepsy (MORE)|Active, not recruiting||N/A|192|Actual|Medtronic International Trading Sarl|||2||f||||t||||||||||2017-10-11 03:20:40.640852|2017-10-11 03:20:40.640852
NCT01521741|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-04-05|||August 2009||2009-08-01|April 2017|2017-04-01|December 2023|Anticipated|2023-12-01|August 2019|Anticipated|2019-08-01||Observational|||Prospective Analysis of Symptoms and Lymphedema in Patients Following Treatment for Breast Cancer|Prospective Analysis of Symptoms, Functionality and Quality of Life Questionnaires to Evaluate Lymphedema in Patients Following Treatment for Breast Cancer.|Recruiting||N/A|2500|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||No||2017-10-11 03:20:40.873034|2017-10-11 03:20:40.873034
NCT01521728|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-04-18|||January 2012||2012-01-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)|Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)|Completed||N/A|60|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 03:20:40.960061|2017-10-11 03:20:40.960061
NCT01521715|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-08-22|||January 24, 2012|Actual|2012-01-24|August 2017|2017-08-01|July 31, 2017|Actual|2017-07-31|June 30, 2017|Actual|2017-06-30||Interventional|FLIPPER||First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma|A Single Arm Multicentre Study Evaluating Pazopanib in First-line Treatment of Poor-risk Patients With Locally Advanced or Metastatic Renal Cell Carcinoma|Completed||Phase 4|44|Actual|iOMEDICO AG||1|||f||||f||||||||||2017-10-11 03:20:41.066713|2017-10-11 03:20:41.066713
NCT01521702|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-03-19|||December 2011||2011-12-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|NEOPAC||NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer|Adjuvant Gemcitabine Versus NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer: a Randomized Multicenter Phase III Study|Completed||Phase 3|2|Actual|Institut Paoli-Calmettes||2|||f||||f||||||||||2017-10-11 03:20:41.172811|2017-10-11 03:20:41.172811
NCT01521689|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-03-19|||December 2011||2011-12-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|LLCRlowdoz||Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment|Phase II Study of Tolerance and Efficacy of Subcutanous Low Doses Rituximab Given as Consolidation Treatment to Chronic Lymphocytic Leukaemia (CLL) Patients Responding to Induction Therapy|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-11 03:20:41.255298|2017-10-11 03:20:41.255298
NCT01521676|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-09-01|||December 2010||2010-12-01|September 2017|2017-09-01|December 2029|Anticipated|2029-12-01|December 2019|Anticipated|2019-12-01||Interventional|BC-BIO||Predictive Clinical and Biological Parameters in Breast Cancer|Research of Predictive Clinical and Biological Parameters in Breast Cancer|Recruiting||N/A|750|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-11 03:20:41.341923|2017-10-11 03:20:41.341923
NCT01521663|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-01-31||2013-09-27|November 2011||2011-11-01|January 2017|2017-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)|A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)|Completed||Phase 2|159|Actual|IMPAX Laboratories, Inc.||2|||f||||f|t|f||||||No||2017-10-11 03:20:41.445961|2017-10-11 03:20:41.445961
NCT01521650|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-10-02|||January 2012||2012-01-01|October 2017|2017-10-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Probiotics Against Pathogenic Bacteria in Connection With Anaesthesia|Probiotics for Reduction of Colonisation With Pathogenic Bacteria in the Oropharynx in Connection With Anaesthesia|Active, not recruiting||N/A|102|Anticipated|Region Skane||2|||f||||f||||||||||2017-10-11 03:20:41.61618|2017-10-11 03:20:41.61618
NCT01521637|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-08-17|||January 2012||2012-01-01|August 2015|2015-08-01||||April 2015|Actual|2015-04-01||Interventional|||The Efficacy of Neuromuscular Electrical Stimulation to Attenuate Muscle Loss|The Efficacy of Neuromuscular Electrical Stimulation to Attenuate Skeletal Muscle Loss in ICU Patients|Completed||N/A|15|Anticipated|Hasselt University||2|||f||||f||||||||||2017-10-11 03:20:41.701822|2017-10-11 03:20:41.701822
NCT01521624|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-01-28|||October 2010||2010-10-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Interventional|||Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients|Comparing Effects of Metformin Plus Life Style Modification Compared With Life Style Modification Alone in Lowering Parameters of Oxidative Stress in Newly Diagnosed Type 2 Diabetes Patients|Completed||N/A|108|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:20:41.776161|2017-10-11 03:20:41.776161
NCT01521611|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-10-14|||March 2002||2002-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy|Radiolabelled Anti-CD66 Monoclonal Antibody in the Conditioning Regimen Prior to Haematopoietic Stem Cell Transplantation: Phase I Study in Patients With Poor-risk Disease.|Recruiting||Phase 1/Phase 2|55|Anticipated|University Hospital Southampton NHS Foundation Trust||1|||f||||f||||||||Yes|Trial still recruiting. Data will be summarised upon completion of study.|2017-10-11 03:20:41.848715|2017-10-11 03:20:41.848715
NCT01521598|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-05-18||2013-07-12|January 2012||2012-01-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy|A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of SKL11197 for the Pain of Diabetic Peripheral Neuropathy|Completed||Phase 2|128|Actual|SK Life Science||2|||f||||f||||||||||2017-10-11 03:20:41.958579|2017-10-11 03:20:41.958579
NCT01521585|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-11-24|||November 2011||2011-11-01|November 2015|2015-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase II Safety and Tolerability Study With SEN0014196|A Double-blind, Placebo-controlled Study in Huntington's Disease Patients to Determine the Safety and Tolerability of SEN0014196|Completed||Phase 2|144|Actual|Siena Biotech S.p.A.||3|||f||||f||||||||||2017-10-11 03:20:42.07702|2017-10-11 03:20:42.07702
NCT01521572|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-01-31|||June 2011||2011-06-01|January 2012|2012-01-01|September 2012|Anticipated|2012-09-01|January 2012|Anticipated|2012-01-01||Interventional|||Effect of the Salbutamol on Mechanical Properties of Respiratory System|Effect of the Use of Salbutamol on the Mechanical Properties of the Respiratory System of Healthy Individuals, Smokers and COPD Patients|Unknown status|Recruiting|N/A|200|Anticipated|Rio de Janeiro State University||1|||f||||t||||||||||2017-10-11 03:20:42.16881|2017-10-11 03:20:42.16881
NCT01521559|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-11-05|2014-11-05|2014-07-10|April 2012||2012-04-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|August 2013|Actual|2013-08-01||Interventional|VIBRANT|Full analysis set (FAS): All enrolled subjects who received any investigational product, had a baseline best corrected visual acuity (BCVA) assessment, and at least 1 post-baseline BCVA assessment.|Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)|A Double-Masked, Randomized, Active-Controlled Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]) in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion|Completed||Phase 3|183|Actual|Regeneron Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:20:42.301513|2017-10-11 03:20:42.301513
NCT01521546|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-10-04|2015-04-21||February 2012||2012-02-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|E-SCAR DMD|Males with Duchenne Muscular Dystrophy|Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy|Early Treatment With Aldosterone Antagonism Attenuates Cardiomyopathy in Duchenne Muscular Dystrophy|Completed||N/A|42|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 03:20:43.055497|2017-10-11 03:20:43.055497
NCT01521533|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-10-05|||March 2012||2012-03-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma|A Multi-center, Open Label, Uncontrolled, Phase IIA Clinical Trial Evaluating the Safety and Efficacy of NOX A12 in Combination With a Background Therapy of Bortezomib and Dexamethasone (VD) in Previously Treated Patients With Multiple Myeloma (MM)|Completed||Phase 2|28|Actual|NOXXON Pharma AG||1|||f||||t||||||||||2017-10-11 03:20:43.359516|2017-10-11 03:20:43.359516
NCT01521520|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-04-06|||January 2012||2012-01-01|April 2017|2017-04-01||||||||Observational|||Imaging of Type 1 Diabetes Progression|Ferumoxytol Enhanced Magnetic Resonance Imaging of Type 1 Diabetes Progression|Active, not recruiting||N/A|65|Anticipated|Massachusetts General Hospital|||4||f||||f||||||||||2017-10-11 03:20:43.485748|2017-10-11 03:20:43.485748
NCT01521507|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-02-04|2015-02-04||January 2012||2012-01-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye|Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye|Completed||N/A|200|Actual|TearScience, Inc.||2|||f||||f||||||||||2017-10-11 03:20:43.595464|2017-10-11 03:20:43.595464
NCT01521494|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-11-29||||||January 2012|2012-01-01||||||||Interventional|||PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia||Completed||Phase 2|150|Anticipated|Kissei Pharmaceutical Co., Ltd.||5|||f||||f||||||||||2017-10-11 03:20:44.389113|2017-10-11 03:20:44.389113
NCT01521481|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2014-02-03|||April 2011||2011-04-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|October 2011|Actual|2011-10-01||Interventional|U-IFB||Ultrasound-guided Inguinal Field Block (Genitofemoral, Iliohypogastric and Ilioinguinal Nerve Block) for Inguinal Hernia Surgery|Analgesic Efficacy of Ultrasound-guided Inguinal Field Block (Genitofemoral, Iliohypogastric and Ilioinguinal Nerve Block) for Inguinal Hernia Surgery.|Completed||Phase 4|87|Actual|Azienda Ospedaliera San Gerardo di Monza||2|||f||||t||||||||||2017-10-11 03:20:44.490052|2017-10-11 03:20:44.490052
NCT01521468|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2014-12-08|||January 2012||2012-01-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|PACIFIC||Comparison of Cardiac Imaging Techniques for Diagnosing Coronary Artery Disease|Prospective Comparison of Cardiac PET/CT, SPECT/CT Perfusion Imaging and CT Coronary Angiography With Invasive Coronary Angiography|Completed||N/A|210|Actual|VU University Medical Center|||1||f||||t||||||Samples With DNA|"     Urine and whole blood.   "|||2017-10-11 03:20:44.589981|2017-10-11 03:20:44.589981
NCT01521455|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2013-08-22|||February 2012||2012-02-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients|A Phase I, Randomized, Open, Multi-center, Cross Over Study to Evaluate the Therapeutic Equivalence of Repeated Dose of HCP0910 250/50 μg to SeretideTM 250 DiskusTM in Asthmatic Patients|Completed||Phase 1|56|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 03:20:44.686608|2017-10-11 03:20:44.686608
NCT01521442|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-12-18|||April 2013||2013-04-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|||Mindful Yoga Therapy as an Adjunctive Treatment for PTSD Among OEF/OIF Veterans|Mindful Yoga Therapy as an Adjunctive Treatment for PTSD Among OEF/OIF Veterans: A Pilot Study|Withdrawn||Phase 1/Phase 2|0|Actual|VA Connecticut Healthcare System||2||Did not have funding or resources to carry out study|f||||f||||||||||2017-10-11 03:20:44.780047|2017-10-11 03:20:44.780047
NCT01521429|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2017-05-03|||August 2009||2009-08-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Longitudinal Study of Bone Disease in Children With Mucopolysaccharidoses (MPS) I, II, and VI|Longitudinal Study of Bone and Endocrine Disease in Children With MPS I, II, and VI: A Multicenter Study of the Lysosomal Disease Network.|Active, not recruiting||N/A|55|Actual|Los Angeles Biomedical Research Institute|||3||f||||f||||||Samples With DNA|"     Serum, plasma, white cells for DNA extraction, and urine will be retained.   "|||2017-10-11 03:20:44.864354|2017-10-11 03:20:44.864354
NCT01521416|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2013-08-29|||June 2011||2011-06-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Cost of Illness Associated With Influenza in the UK|The Cost of Illness Associated With Influenza in the UK|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:20:44.954709|2017-10-11 03:20:44.954709
NCT01521403|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-05-10|||November 2012||2012-11-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Is it Effective to Treat Patients With Blastocystis Hominis Infection?|Is it Effective to Treat Patients With Blastocystis Hominis Infection? A Double-blind Placebo Controlled Randomized Trial|Active, not recruiting||Phase 4|200|Anticipated|University of Lausanne Hospitals||2|||f||||t||||||||No||2017-10-11 03:20:45.05126|2017-10-11 03:20:45.05126
NCT01521390|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-06-19|||October 12, 2011|Actual|2011-10-12|June 2017|2017-06-01|December 16, 2011|Actual|2011-12-16|December 16, 2011|Actual|2011-12-16||Interventional|||Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler.|Randomized, Double-blind, 5 Period Cross Over Study Assessing Lung Function in Healthy Volunteers Following Single Inhalations of GSK573719 Inhalation Powder From Two Configurations of the Novel Dry Powder Inhaler|Completed||Phase 1|15|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:20:45.136825|2017-10-11 03:20:45.136825
NCT01521377|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-06-09|||December 19, 2011|Actual|2011-12-19|June 2017|2017-06-01|June 5, 2012|Actual|2012-06-05|June 5, 2012|Actual|2012-06-05||Interventional|||QTc Study GSK573719+GW642444|A Randomised, Placebo-controlled, Incomplete Block, Four Period Crossover , Repeat Dose Study to Evaluate the Effect of the Inhaled GSK573719/Vilanterol Combination and GSK573719 Monotherapy on Electrocardiographic Parameters, With Moxifloxacin as a Positive Control, in Healthy Subjects.|Completed||Phase 1|100|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:20:45.241045|2017-10-11 03:20:45.241045
NCT01521364|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2013-05-27|2013-01-17||December 2011||2011-12-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients|The Pharmacokinetic Effect of Clarithromycin on the AUC0-12h of Linezolid in Multidrug-resistant and Extensively Drug-resistant Tuberculosis (MDR/XDR-TB) Patients|Completed||Phase 4|7|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-11 03:20:45.360763|2017-10-11 03:20:45.360763
NCT01521338|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-05-08|||January 2014||2014-01-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|GOAL- e2||G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)|G551D Observational Study (GOAL)-Expanded to Additional Genotypes and Extended for Long Term Follow up (GOAL-e2)|Active, not recruiting||N/A|120|Actual|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"     Blood, Sputum, Urine   "|||2017-10-11 03:20:45.740102|2017-10-11 03:20:45.740102
NCT01521325|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-07|2016-09-28|||September 2011||2011-09-01|September 2016|2016-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers|A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers|Completed||Phase 1|6|Actual|Morphotek||1|||f||||f||||||||||2017-10-11 03:20:45.915325|2017-10-11 03:20:45.915325
NCT01521312|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-02-02|||September 2012||2012-09-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ACCES||ACute and Chronic Effects of Saxagliptin|A Randomized, Double Blind, Placebo Controlled, Pilot Study to Evaluate ACute and Chronic Effects of Saxagliptin on Impaired Glucose Tolerance and micro-and Macro-vascular Integrators|Completed||Phase 2|24|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:20:46.018036|2017-10-11 03:20:46.018036
NCT01521299|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2012-08-24|||March 2012||2012-03-01|August 2012|2012-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors|A Phase I Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors|Withdrawn||Phase 1|0|Actual|Dartmouth-Hitchcock Medical Center||1||Insufficient population of eligible patients.|f||||t||||||||||2017-10-11 03:20:46.108938|2017-10-11 03:20:46.108938
NCT01521286|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2015-09-24|||March 2012||2012-03-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Observational|||Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain|Population Based Surveillance to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain|Completed||N/A|552|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:20:46.193813|2017-10-11 03:20:46.193813
NCT01521273|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-11-07|||March 2012||2012-03-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Iron Absorption From Biofortified Beans With Different Levels of Phytic Acid|A Multiple Meal Study to Evaluate the Role of Phytic Acid From Beans on Human Iron Absorption|Completed||N/A|25|Actual|Swiss Federal Institute of Technology||6|||f||||f||||||||||2017-10-11 03:20:46.295712|2017-10-11 03:20:46.295712
NCT01521260|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-06-28|2013-05-03||October 2009||2009-10-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Implant Surface Decontamination in Peri-implantitis Treatment|Microbiological and Clinical Evaluation of Different Implant Surface Decontaminating Procedures in the Surgical Treatment of Peri-implantitis; a Double Blind Placebo Controlled Randomized Clinical Study|Completed||N/A|30|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 03:20:46.386391|2017-10-11 03:20:46.386391
NCT01521247|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-09-08|||April 2010||2010-04-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Interventional|||Implementation of a Pediatric-to-adult Asthma Transition Program||Completed||N/A|30|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 03:20:46.701663|2017-10-11 03:20:46.701663
NCT01521234|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-05-11|||October 2012||2012-10-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Using Wireless-technology for Feedback of Daily Walking Activity Post-stroke|Using Wireless Technology in Clinical Practice: Does Feedback of Daily Walking Activity Improve Walking Outcomes of Individuals Receiving Rehabilitation Post-stroke?|Completed||N/A|63|Actual|Toronto Rehabilitation Institute||2|||f||||f||||||||||2017-10-11 03:20:46.784608|2017-10-11 03:20:46.784608
NCT01521221|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2012-01-25|||April 2012||2012-04-01|January 2012|2012-01-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Assessment of Hand-grip in the Prevention of Postural Orthostatic Hypotension|Assessment of Hand-grip in the Prevention of Postural Orthostatic Hypotension|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-11 03:20:46.889652|2017-10-11 03:20:46.889652
NCT01521208|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-25|2012-02-03|||January 2012||2012-01-01|February 2012|2012-02-01|April 2014|Anticipated|2014-04-01|February 2014|Anticipated|2014-02-01||Interventional|LUCAT||LUCAS Chest Compressor Versus Manual Chest Compression in Out-of-hospital Sudden Cardiac Arrest. LUCAT Trial|LUcas Continuous Chest Compressions in Out-of-hospital Cardiac Arrest Treatment. The LUCAT Trial|Unknown status|Recruiting|Phase 3|400|Anticipated|Sistema d’Emergències Mèdiques||2|||f||||f||||||||||2017-10-11 03:20:46.994343|2017-10-11 03:20:46.994343
NCT01521195|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-08-15|||October 2011||2011-10-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Oxygen Consumption In Critically Ill Children|A Pilot Study of the Relationship Between Oxygen Delivery and Consumption During Extracorporeal Membrane Oxygenation.|Unknown status|Recruiting|Phase 2|10|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 03:20:47.128154|2017-10-11 03:20:47.128154
NCT01521182|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-09-19|||September 2011||2011-09-01|September 2016|2016-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effect of the Consumption of a Fermented Dairy Drink on the Immune Function||Completed||N/A|550|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 03:20:47.229437|2017-10-11 03:20:47.229437
NCT01521169|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-10-26|||February 2010||2010-02-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Long-term Effectiveness Study on Cholesterol-reducing Activity|Clinical Study for Evaluating the Plasma Cholesterol-reducing Activity of a Plant Sterol-enriched Yoghurt Drink - Effectiveness and Long-term Safety Study|Completed||N/A|138|Actual|Danone Research||3|||f||||f||||||||||2017-10-11 03:20:47.313748|2017-10-11 03:20:47.313748
NCT01521156|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-10-26|||July 2009||2009-07-01|October 2016|2016-10-01|February 2010|Actual|2010-02-01|November 2009|Actual|2009-11-01||Interventional|||Effect of the Consumption of a Fermented Dairy Product Enriched With Plant Sterols|Cholesterol Lowering Effects of a Drinkable Low Fat Dairy Product Enriched With Plant Sterols|Completed||N/A|128|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 03:20:47.399308|2017-10-11 03:20:47.399308
NCT01520246|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-07-07|||January 2012||2012-01-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia|Signaling in Tumorigenesis and Immunity|Completed||N/A|20|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     tissue, blood, and bodily fluids   "|||2017-10-11 03:21:08.933414|2017-10-11 03:21:08.933414
NCT01521143|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-12-09|2016-11-16||January 2012||2012-01-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CANVAS|"Part A - Safety population: All randomized participants who received at least 1 dose of Cvac or placebo.
Part B - Safety population: All randomized participants who received at least 1 dose of Cvac (Cvac group) or were evaluated at least once (observational standard of care group)."|Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment|A Randomized Trial of Cvac (Autologous Dendritic Cells Pulsed With Recombinant Human Fusion Protein [Mucin 1-glutathione S-transferase] Coupled to Oxidized Polymannose) as Maintenance Treatment in Patients With Epithelial Ovarian Cancer (EOC) in Complete Remission Following First-line Chemotherapy (A) and Patients With EOC in Second Remission (B)|Terminated||Phase 2|91|Actual|Prima BioMed Ltd||4||"The study was terminated due to company restructuring and changes in drug development   priorities."|f||||t||||||||||2017-10-11 03:20:48.209181|2017-10-11 03:20:48.209181
NCT01521130|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-02-17|||January 2012||2012-01-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|FIRST||Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children|Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children|Active, not recruiting||Phase 1|144|Anticipated|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-10-11 03:20:49.264506|2017-10-11 03:20:49.264506
NCT01521117|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-01-25|||December 2011||2011-12-01|January 2012|2012-01-01|July 2012|Anticipated|2012-07-01|April 2012|Anticipated|2012-04-01||Interventional|||The Effect of Donepezil on Gait and Balance in Parkinson's Disease|A Randomized, Double-blind, Placebo Controlled, Crossover Study to Evaluate the Effect of Donepezil on Gait and Balance in Parkinson's Disease|Unknown status|Recruiting|Phase 4|12|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 03:20:49.398538|2017-10-11 03:20:49.398538
NCT01521104|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-01-27|||January 2009||2009-01-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||The Value of Narrow Band Imaging in Stratifying Patients for Endoscopic Resection or Surgery|The Value of NBI in Stratifying Patients for Endoscopic Resection or Surgery|Completed||N/A|565|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples Without DNA|"     All the lesions will be removed endoscopically or surgically and examined histologically by     an independent gastrointestinal pathologist.      Histological diagnosis is determined according to the World Health Organization (WHO)     criteria.Pedunculated lesions are categorized according to Haggitt's classification.   "|||2017-10-11 03:20:49.652581|2017-10-11 03:20:49.652581
NCT01521091|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-27|||January 2009||2009-01-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Comparison of Diagnostic Accuracy for Predicting Histology of Colorectal Lesions|Comparison of Diagnostic Accuracy for Predicting Histology of Colorectal Lesions Using Magnifying Colonoscopy With Narrow Band Imaging, Indigo Carmine, and Acetic Acid Staining|Completed||N/A|565|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples Without DNA|"     All the lesions will be removed endoscopically or surgically and examine histologically by an     independent gastrointestinal pathologist.      Histological diagnosis is determined according to the World Health Organization (WHO)     criteria. Pedunculated lesions are categorized according to Haggitt's classification.   "|||2017-10-11 03:20:49.733052|2017-10-11 03:20:49.733052
NCT01521078|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2012-05-24|||January 2012||2012-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Web-based Personalized Feedback for University Students|Randomized Controlled Trial of a Brief Personalized Feedback Intervention in University Students|Completed||N/A|425|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 03:20:49.84801|2017-10-11 03:20:49.84801
NCT01521065|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-04-24|||September 2012||2012-09-01|April 2013|2013-04-01|October 2016|Anticipated|2016-10-01|October 2014|Anticipated|2014-10-01||Interventional|ENDEAVOUR||An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration|A Multicenter, Open-label Study to Evaluate the Clinical and Economic Benefits of Low Voltage Stereotactic Radiotherapy in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)|Unknown status|Recruiting|Phase 2|500|Anticipated|Oraya Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 03:20:49.977334|2017-10-11 03:20:49.977334
NCT01521052|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-01-27|||January 2012||2012-01-01|January 2012|2012-01-01||||December 2012|Anticipated|2012-12-01||Interventional|||Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for Treatment of Major Depressive Episode in the Elderly||Unknown status|Not yet recruiting|Phase 2|27|Anticipated|Shalvata Mental Health Center||1|||f||||t||||||||||2017-10-11 03:20:50.122494|2017-10-11 03:20:50.122494
NCT01521039|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-02-03|||February 13, 2012|Actual|2012-02-13|February 2017|2017-02-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease|Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease|Recruiting||N/A|240|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 03:20:50.233357|2017-10-11 03:20:50.233357
NCT01521026|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-22|2013-11-15|2013-07-01||September 2003||2003-09-01|November 2013|2013-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Cognitive Training for Patients With Schizophrenia|Cognitive Training for Patients With Schizophrenia|Completed||Phase 2|69|Actual|University of California, San Diego|"small sample size
relatively short follow-up period
significant dropout rate
did not use an active control condition that matched CCT for therapist time or group involvement"|2|||f||||t||||||||||2017-10-11 03:20:50.395462|2017-10-11 03:20:50.395462
NCT01521013|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-04-07|||February 2012||2012-02-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DIRECT-sc||Effectiveness of a Self-care Intervention for Depression in Primary Care Patients With Chronic Physical Illnesses|Effectiveness of a Supported Self-Care Intervention for Depression Compared to an Unsupported Intervention in Older Adults With Chronic Physical Illnesses (DIRECT-sc)|Completed||N/A|223|Actual|McGill University||2|||f||||||||||||||2017-10-11 03:20:50.783603|2017-10-11 03:20:50.783603
NCT01521000|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-09|2012-01-25|||July 2010||2010-07-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|L-Dex||The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient|The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient|Unknown status|Recruiting|N/A|200|Anticipated|Main Line Health||2|||f||||f||||||||||2017-10-11 03:20:50.950276|2017-10-11 03:20:50.950276
NCT01520987|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-05-12|2015-07-22||May 2011||2011-05-01|May 2016|2016-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects|Randomized, Double-Blinded, Placebo-Controlled, Multiple Ascending Dose Study to Compare the Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|105|Actual|Bial - Portela C S.A.||8|||f||||t||||||||||2017-10-11 03:20:51.112038|2017-10-11 03:20:51.112038
NCT01520974|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-05-01|||January 2012||2012-01-01|May 2012|2012-05-01||||August 2012|Anticipated|2012-08-01||Interventional|||Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)|ProBiora3 Oral Care Probiotics Usage|Unknown status|Recruiting|N/A|48|Anticipated|Oragenics, Inc.||2|||f||||f||||||||||2017-10-11 03:20:52.56172|2017-10-11 03:20:52.56172
NCT01520961|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-02-06|||January 2012||2012-01-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|AYNF||Functional Recovery After Partial Hip Arthroplasty: Anterior or Posterolateral Approach?|Approach Your Neck Fracture|Completed||N/A|82|Actual|Hospital Ambroise Paré Paris|||2||f||||f||||||||||2017-10-11 03:20:52.68546|2017-10-11 03:20:52.68546
NCT01520948|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-01-23|||September 2012||2012-09-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Interventional|BETTUR PD||Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease|Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease|Recruiting||Phase 3|60|Anticipated|Atlanta VA Medical Center||2|||f||||f||||||||||2017-10-11 03:20:52.768712|2017-10-11 03:20:52.768712
NCT01520935|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-09-06|||September 2011||2011-09-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Influenza Burden Assessment in the United Kingdom, 1996-2008|Burden of Influenza in the United Kingdom, 1996-2008|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:20:52.856058|2017-10-11 03:20:52.856058
NCT01520922|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-11-22|2013-10-10||March 2012||2012-03-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|February 2013|Actual|2013-02-01||Interventional|||Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)|A Phase II, Multi-centre Study Investigating the Safety and Efficacy of Ofatumumab and Bendamustine Combination in Patients With Untreated or Relapsed Chronic Lymphocytic Leukaemia (CLL)|Completed||Phase 2|99|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:20:52.999203|2017-10-11 03:20:52.999203
NCT01520909|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-02-19|2014-08-21||March 2012||2012-03-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PETIT2||Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.|A Two Part, Double-blind, Randomized, Placebo-controlled and Open-label Study to Investigate the Efficacy, Safety and Tolerability of Eltrombopag, a Thrombopoietin Receptor Agonist, in Pediatric Patients With Previously Treated Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP). PETIT2: Eltrombopag in PEdiatric Patients With Thrombocytopenia From ITP|Completed||Phase 3|92|Actual|GlaxoSmithKline||3|||f||||t||||||||||2017-10-11 03:20:56.816592|2017-10-11 03:20:56.816592
NCT01520896|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2014-10-13|||February 2012||2012-02-01|October 2014|2014-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118|An Open-label, 1-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118 in Healthy Subjects|Completed||Phase 1|22|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 03:21:00.492084|2017-10-11 03:21:00.492084
NCT01520883|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2013-05-24|||March 2011||2011-03-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Observational|||Evaluation of Decisional Conflict and Needs Assessment in Asthma Management|Decisional Conflict and Needs Assessment in Shared Decision Making in Asthma Management|Completed||N/A|50|Actual|Laval University|||1||f||||f||||||||||2017-10-11 03:21:00.580803|2017-10-11 03:21:00.580803
NCT01520870|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-08-10|||February 2012||2012-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|August 2015|Actual|2015-08-01||Interventional|||Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.|Phase II Pilot, Prospective, Open Label, Multicenter CT, to Evaluate the Safety and Efficacy of PF299804, a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation|Active, not recruiting||Phase 2|64|Anticipated|Grupo Español de Investigación en Neurooncología||1|||f||||f||||||||||2017-10-11 03:21:00.644755|2017-10-11 03:21:00.644755
NCT01520857|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-03-15|||October 2011||2011-10-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Spinal Versus General Anesthesia for Transabdominal Preperitoneal (TAPP) Repair of Inguinal Hernia|A Controlled Randomized Trial Comparing Spinal Versus General Anesthesia for Transabdominal Preperitoneal (TAPP) Repair of Inguinal Hernia|Completed||N/A|140|Actual|Larissa University Hospital||2|||f||||f||||||||||2017-10-11 03:21:00.802579|2017-10-11 03:21:00.802579
NCT01520844|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-03-21|||February 2012||2012-02-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|February 2018|Anticipated|2018-02-01||Interventional|CODEX||"the ANRS CO21  Extreme  Cohort (CODEX)"|Multicentric Cohort of HIV Patient With Extrem Profil|Recruiting||N/A|300|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-11 03:21:00.982435|2017-10-11 03:21:00.982435
NCT01520831|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-01-03|||April 1999||1999-04-01|January 2017|2017-01-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects|A Randomised, Four-period Cross-over Trial in Healthy Subjects, Investigating the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, Biphasic Insulin Aspart 50, Biphasic Insulin Aspart 70 and Soluble Insulin Aspart|Completed||Phase 1|35|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:21:01.07714|2017-10-11 03:21:01.07714
NCT01520818|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-01-03|||March 2000||2000-03-01|January 2017|2017-01-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes|A Multinational, Randomised, Open-labelled, Parallel Group Four Months Comparison of Twice Daily Biphasic Human Insulin 30 and Thrice Daily Biphasic Insulin Aspart 50 and 70 in Subjects With Type 1 or Type 2 Diabetes|Completed||Phase 3|666|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:21:01.188408|2017-10-11 03:21:01.188408
NCT00005756|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-12|||August 1999||1999-08-01|January 2016|2016-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Epidemiology of Coronary Calcification in the Elderly||Completed||N/A|||University of Pittsburgh|||||f||||t||||||||Yes||2017-10-11 04:28:58.264739|2017-10-11 04:28:58.264739
NCT01520805|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2016-12-27|||January 2016||2016-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome|A Phase 2a Open-Label Clinical Trial Evaluating Efficacy & Safety of CPI-613 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML), and in Patients With Myelodysplastic Syndrome (MDS) Who Failed Hypomethylating Agents|Withdrawn||Phase 2|0|Actual|Cornerstone Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:21:01.457767|2017-10-11 03:21:01.457767
NCT01520792|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-05-13|||November 2011||2011-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Paracetamol and Pharmacogenetic|Paracétamol and Pharmacogenetic in Healthy Volunteers|Completed||Phase 1|100|Actual|University Hospital, Clermont-Ferrand||1|||f||||f||||||||||2017-10-11 03:21:01.553337|2017-10-11 03:21:01.553337
NCT01520779|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2013-09-29|||January 2012||2012-01-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||Recurrence of Hepatocellular Carcinoma|Risk Factors for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation|Completed||N/A|99|Actual|Ain Shams University|||2||f||||t||||||||||2017-10-11 03:21:01.645383|2017-10-11 03:21:01.645383
NCT01520766|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-30|||January 2003||2003-01-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|April 2004|Actual|2004-04-01||Interventional|||Prefabricated Endodontic Posts: Glass Fiber Versus Titanium - A Randomized Controlled Pilot- Trial||Completed||Phase 4|91|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:21:01.72937|2017-10-11 03:21:01.72937
NCT01520753|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-01-03|||March 1999||1999-03-01|January 2017|2017-01-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes|A Randomised, Double-blind, 4-week, Crossover Trial on Two Treatment Regimens With Biphasic Insulin Aspart 70 and 50 in Patients With Type 2 Diabetes|Completed||Phase 3|16|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:21:01.827591|2017-10-11 03:21:01.827591
NCT01520740|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2013-11-13|||February 2012||2012-02-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|CV+/-||Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema|Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema|Terminated||Phase 4|100|Anticipated|Aeris Therapeutics||2|||f||||f||||||||||2017-10-11 03:21:01.951423|2017-10-11 03:21:01.951423
NCT01520727|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-12-29|2014-12-29||October 2007||2007-10-01|December 2014|2014-12-01|April 2009|Actual|2009-04-01|December 2007|Actual|2007-12-01||Interventional|||A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects|A Single Oral Ascending Dose Study to Investigate the Safety, Pharmacokinetics and Catechol-O-methyltransferase (COMT) Inhibition Profiles of BIA 9-1067 in Healthy Male Subjects|Completed||Phase 1|64|Actual|Bial - Portela C S.A.||9|||f||||f||||||||||2017-10-11 03:21:02.084933|2017-10-11 03:21:02.084933
NCT01520714|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-22|2014-04-30|2013-08-09||December 2009||2009-12-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|EXPECT||Effect of Posture on Left Ventricular (LV) Transvenous Lead Capture Thresholds (EXPECT)|Effect of Posture on LV Transvenous Lead Capture Thresholds (EXPECT)|Terminated||N/A|11|Actual|Baylor Research Institute|Early termination leading to small numbers of subjects; Non-efficacy of treatment leading to no data summary and analysis.|2||Lower enrollment rate than expected|f||||f||||||||||2017-10-11 03:21:02.873422|2017-10-11 03:21:02.873422
NCT01520701|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-07-13|||February 2012||2012-02-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|February 2018|Anticipated|2018-02-01||Interventional|IPAC||Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy|Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy|Recruiting||Phase 3|125|Anticipated|Centre Francois Baclesse||2|||f||||f||||||||||2017-10-11 03:21:03.139032|2017-10-11 03:21:03.139032
NCT01520675|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-06-27|||July 2010|Actual|2010-07-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Endoscopic Versus Surgical Treatment of Chronic Pancreatitis|Endoscopic Versus Surgical Treatment of Chronic Pancreatitis - A Randomized Controlled Trial|Active, not recruiting||N/A|50|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 03:21:03.407419|2017-10-11 03:21:03.407419
NCT01520662|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-01-26|||September 2007||2007-09-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|July 2008|Actual|2008-07-01||Interventional|||Impact of a Wellness Portal on The Delivery of Patient-Centered Preventive Care|Impact of a Wellness Portal on The Delivery of Patient-Centered Preventive Care|Completed||N/A|540|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||t||||||||||2017-10-11 03:21:03.624258|2017-10-11 03:21:03.624258
NCT01520649|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2014-04-01|||May 2012||2012-05-01|November 2012|2012-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects|A Phase 1B, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects|Completed||Phase 1|26|Actual|Neuralstem Inc.||2|||f||||t||||||||||2017-10-11 03:21:03.705421|2017-10-11 03:21:03.705421
NCT01520636|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-05-02|||July 2012||2012-07-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|AMOBES||Active MOBility Early After Stroke : What Should be the Best Physiotherapy Early After Stroke ?|What Should be the Best Physiotherapy Early After Stroke ?|Completed||Phase 3|104|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:21:03.785919|2017-10-11 03:21:03.785919
NCT01520623|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2015-04-09|||April 2010||2010-04-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||Complement and Graft-versus-host Disease|Role of Complement System in Human Allogeneic Haematopoietic Stem Cell Transplantation|Completed||N/A|70|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 03:21:03.881677|2017-10-11 03:21:03.881677
NCT01520610|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-09-14|||November 2011||2011-11-01|February 2016|2016-02-01|May 2016|Actual|2016-05-01|November 2014|Actual|2014-11-01||Observational|||TAKO-TSUBO Cardiomyopathy and Genetic|Genetic Polymorphisms in Catecholamine Pathway Responsible for the Tako-TSUBO Cardiomyopathy Susceptibly (TAKO-GENE)|Completed||N/A|530|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||t||||||Samples With DNA|"     20 ml of blood sample will be collected from all patients enrolled in order to DNA analysis.   "|||2017-10-11 03:21:03.981407|2017-10-11 03:21:03.981407
NCT01520597|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-07-31|||November 2009||2009-11-01|July 2016|2016-07-01|April 2019|Anticipated|2019-04-01|October 2018|Anticipated|2018-10-01||Observational|MONALISA||National Study on Listeriosis and Listeria|Multicentric Observational NAtional Study on LISteriosis and ListeriA|Recruiting||N/A|1200|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     blood sample   "|||2017-10-11 03:21:04.051737|2017-10-11 03:21:04.051737
NCT01520584|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-14|2012-01-25|||January 2012||2012-01-01|January 2012|2012-01-01|January 2016|Anticipated|2016-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Supplement Intake in Infertile Men;the Effect on Sperm Parameters,Fertilization Rate and Embryo Quality|Vitamins ,Minerals and Amino Acids Supplement Intake in Infertile Men;the Effect on Sperm Parameters,Fertilization Rate and Embryo Quality. A Double Blind Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hillel Yaffe Medical Center||2|||f||||f||||||||||2017-10-11 03:21:04.221277|2017-10-11 03:21:04.221277
NCT01520571|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-01-25|||January 2000||2000-01-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2001|Actual|2001-12-01||Interventional|||Do We Need Computer Assistance To Improve the Survival of Primary Total Knee Arthroplasty. A Minimum Ten Years Follow-up||Completed||Phase 4|520|Actual|Ewha Womans University||2|||f||||f||||||||||2017-10-11 03:21:04.303795|2017-10-11 03:21:04.303795
NCT01520558|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-05-30|2017-04-18||December 2012||2012-12-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|March 2016|Actual|2016-03-01||Interventional|||CNDO-109-AANK for AML in First Complete Remission (CR1)|A Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Patients With High Risk Acute Myeloid Leukemia in First Complete Remission (CR1)|Active, not recruiting||Phase 1/Phase 2|12|Actual|Coronado Biosciences, Inc.||3|||f||||f||||||||||2017-10-11 03:21:04.408751|2017-10-11 03:21:04.408751
NCT01520545|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-10-18|||December 2012||2012-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump|Study to Assess the Safety of 3 mg/mL Gablofen® (Baclofen Injection) Delivered by Intrathecal Administration Using the Synchromed® II Programmable Infusion System|Completed||Phase 3|153|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-11 03:21:05.119561|2017-10-11 03:21:05.119561
NCT01520532|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2013-09-10|2012-12-10||March 2012||2012-03-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|ERACE||Evaluation of the Incidence of Cerebral Lesions Post Pulmonary Vein Ablation Catheter (PVAC)|Evaluate Reduction in Asymptomatic Cerebral Embolism|Completed||N/A|60|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||f||||||||||2017-10-11 03:21:05.234782|2017-10-11 03:21:05.234782
NCT01520519|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-08-11|||February 2012|Actual|2012-02-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients|A Phase 2 Study of the Combination of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients|Active, not recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:21:05.455028|2017-10-11 03:21:05.455028
NCT01520506|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2015-08-14|2015-07-31||May 2012||2012-05-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Interventional|RAPID||Rapid Renal Sympathetic Denervation for Resistant Hypertension|Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot™ Ablation System|Completed||Phase 2|50|Actual|Medtronic Endovascular||1|||f||||f||||||||||2017-10-11 03:21:05.576326|2017-10-11 03:21:05.576326
NCT01520493|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2013-04-16|||June 2011||2011-06-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Interventional|||Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension|Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension|Unknown status|Recruiting|N/A|40|Anticipated|Laval University||1|||f||||f||||||||||2017-10-11 03:21:05.978315|2017-10-11 03:21:05.978315
NCT01520480|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-01-29|||January 1999||1999-01-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Pathological Subtrochanteric Fractures in 194 Patients|Pathological Subtrochanteric Fractures in 194 Patients. A Comparison of Outcome After Surgical Treatment of Pathological and Non-pathological Fractures.|Completed||N/A|281|Actual|Karolinska University Hospital|||2||f||||f||||||||||2017-10-11 03:21:06.114359|2017-10-11 03:21:06.114359
NCT01520467|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2016-08-23|||April 2012||2012-04-01|August 2016|2016-08-01|October 2016|Anticipated|2016-10-01|July 2016|Actual|2016-07-01||Interventional|ANASILPRA||Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome|Efficacy and Tolerance of Treatment With an Aromatase Inhibitor (Anastrozole) to Limit the Progression of Bone Maturation Related to Pathological Adrenarche in Children With Silver-Russell or Prader-Willi Syndrome|Active, not recruiting||N/A|27|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:21:06.182198|2017-10-11 03:21:06.182198
NCT01520454|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-03-16|2015-12-29||November 2011||2011-11-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Increased Free Fatty Acids on Leptin Function|Differential Effects of Oral and Intravenous Lipid Administration on Leptin Signaling|Completed||N/A|26|Actual|Beth Israel Deaconess Medical Center||4|||f||||f||||||||||2017-10-11 03:21:06.296315|2017-10-11 03:21:06.296315
NCT01520441|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-06-01|||March 2011||2011-03-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)|H-25362: Effect of Botulinum Neurotoxin Type A Prostate Injections on Neurogenesis and Gene Profile Expression in Men With Localized Prostate Cancer and Lower Urinary Tract Symptoms/BPH (Protocol # 05-09-30-03)|Withdrawn||Early Phase 1|0|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 03:21:06.921778|2017-10-11 03:21:06.921778
NCT00004697|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||November 1997||1997-11-01|March 1999|1999-03-01|March 1999||1999-03-01|||||Interventional|||Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition||Completed||N/A|15||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:57.053322|2017-10-11 04:26:57.053322
NCT01520428|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-09-26|||June 2010||2010-06-01|September 2012|2012-09-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Interventions to Prevent Adolescents With Type 1 Diabetes From Long-term Complications|Interventions to Prevent Adolescents With Type 1 Diabetes From Long-term Complications. A Multicenter Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|120|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 03:21:07.046669|2017-10-11 03:21:07.046669
NCT01520415|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2013-07-26|||January 2012||2012-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients|A Prospective, Randomized, Double-blind, Clinical Trial of Trigger Point Injection Therapy for the Treatment of Myofascial Pain Syndrome|Completed||Phase 2|40|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 03:21:07.167325|2017-10-11 03:21:07.167325
NCT01520402|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-02-06|2012-10-24||June 2009||2009-06-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Genetic Response to Warfarin in Healthy Subjects|Quantitative Pharmacogenomics of the Anticoagulant Response to Warfarin in Healthy Subjects|Completed||N/A|35|Actual|Icahn School of Medicine at Mount Sinai|Small number of subjects, which prevented detection of modest effects; relied on self-reported race and self-reported adherance to vitamin K restricted diet without objective markers such as ancestry informative markers and serum vitamin k levels.|1|||f||||t||||||||||2017-10-11 03:21:07.286291|2017-10-11 03:21:07.286291
NCT01520389|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-03-14|||January 2012||2012-01-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment|A Phase 1 and Pharmacologic Study of MM-151 in Patients With Refractory Advanced Solid Tumors|Completed||Phase 1|112|Actual|Merrimack Pharmaceuticals||3|||f||||||||||||||2017-10-11 03:21:07.703026|2017-10-11 03:21:07.703026
NCT01520376|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2015-08-11|||October 2011||2011-10-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|ADPHA-EPOC||Anxiety and Depression in Patients Hospitalizes for an Acute Exacerbation of COPD|A Prospective Randomized Trial to Asses the Efficacy of an Early Psychiatric Counseling Compared to Usual Care in a Cohort of Patients Hospitalized for an Acute Exacerbation of COPD in Prevention of Re-exacerbation|Completed||N/A|169|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||t||||||||||2017-10-11 03:21:07.823204|2017-10-11 03:21:07.823204
NCT01520363|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-05-15|||March 2012|Actual|2012-03-01|May 2017|2017-05-01|October 26, 2016|Actual|2016-10-26|October 26, 2016|Actual|2016-10-26||Interventional|PCTDMRTT||Placebo Controlled Trial of Dextromethorphan in Rett Syndrome|Placebo Controlled Trial of Dextromethorphan in Rett Syndrome|Completed||Phase 2|50|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||t||||||||No||2017-10-11 03:21:07.902575|2017-10-11 03:21:07.902575
NCT01520350|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2014-07-28|||February 2012||2012-02-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study|Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study|Terminated||Phase 3|2|Actual|Douglas Mental Health University Institute||2||recruitment issues|f||||f||||||||||2017-10-11 03:21:08.006347|2017-10-11 03:21:08.006347
NCT01520337|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2014-02-10|||January 2012||2012-01-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|March 2013|Actual|2013-03-01||Observational|||Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy|Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy|Completed||N/A|170|Actual|Cosmo Technologies Ltd|||1||f||||t||||||Samples Without DNA|"     mucosal biopsy   "|||2017-10-11 03:21:08.201076|2017-10-11 03:21:08.201076
NCT01520324|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2014-01-27|||January 2012||2012-01-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy|Intraepithelial Neoplasia Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Patients With Long Standing Ulcerative Colitis Undergoing Colonoscopy.|Completed||N/A|50|Actual|Cosmo Technologies Ltd|||1||f||||t||||||Samples Without DNA|"     mucosal biopsy   "|||2017-10-11 03:21:08.317449|2017-10-11 03:21:08.317449
NCT01520311|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-06-28|||January 2012||2012-01-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The eSVS® Mesh Post-Marketing Trial|Post-market Study to Evaluate Post-implant Patency Rates of the eSVS Mesh in the Treatment of Saphenous Vein Graphs During Coronary Artery Bypass Grafting Versus Saphenous Vein Grafts Without the eSVS Mesh Via Coronary Angiography and Duplex Ultra-Sonography Results|Terminated||N/A|8|Actual|Kips Bay Medical, Inc.||1||Company closed|f||||f||||||||||2017-10-11 03:21:08.438345|2017-10-11 03:21:08.438345
NCT01520298|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2014-09-29|||December 2011||2011-12-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Intravenous Acetaminophen as Adjuvant Therapy for Pain Control in Geriatric Hip Fracture Patients|Intravenous Acetaminophen as Adjuvant Therapy for Pain Control in Geriatric Hip Fracture Patients|Withdrawn||Phase 3|0|Actual|Lancaster General Hospital||2||Difficulty in recruiting subjects for the trial.|f||||f||||||||||2017-10-11 03:21:08.550416|2017-10-11 03:21:08.550416
NCT01520285|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-10-14|||December 2011||2011-12-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01||Interventional|Zanidip||Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension|A Multi-center, Randomized, Open-label, Parallel-group Clinical Study to Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for the Treatment of Patients With Mild-to-Moderate Hypertension|Completed||Phase 4|281|Actual|Lee's Pharmaceutical Limited||2|||f||||f||||||||||2017-10-11 03:21:08.667353|2017-10-11 03:21:08.667353
NCT01520272|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-06-30|||January 2, 2012||2012-01-02|June 28, 2017|2017-06-28|June 28, 2017||2017-06-28|||||Observational|||HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda|Immunogenicity of Bivalent HPV Vaccine Among Partially Vaccinated Young Adolescent Girls in Uganda|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:21:08.766979|2017-10-11 03:21:08.766979
NCT01520259|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2017-08-04|||January 2, 2012||2012-01-02|July 28, 2017|2017-07-28||||||||Observational|||Initial Study of Gallbladder Cancer in Chile|A Pilot Study of Gallbladder Cancer in Chile|Completed||N/A|446|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:21:08.85246|2017-10-11 03:21:08.85246
NCT01520233|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-26|2016-05-13|||January 2012||2012-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma|Genome Based Outcome Prediction in High Risk Neuroblastoma|Completed||N/A|100|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:21:09.002721|2017-10-11 03:21:09.002721
NCT01520220|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-04-10|||June 11, 2012|Actual|2012-06-11|April 2017|2017-04-01|February 24, 2017|Actual|2017-02-24|June 26, 2015|Actual|2015-06-26||Interventional|||Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms|A Phase 1 Study of LY2784544 Testing Alternative Dosing Regimens in Patients With Myeloproliferative Neoplasms|Completed||Phase 1|100|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 03:21:09.084724|2017-10-11 03:21:09.084724
NCT01520194|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2016-05-08|||January 2012||2012-01-01|May 2016|2016-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|GWburden||The Psychosocial and Economic Burden of Genital Warts|The Psychosocial and Economic Burden of Genital Warts for Women Attending Six Reproductive Health Clinics in Brazil|Completed||N/A|224|Actual|BEMFAM-Bem Estar Familiar|||2||f||||t||||||||No||2017-10-11 03:21:09.256129|2017-10-11 03:21:09.256129
NCT01520181|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2015-10-06|||March 2012||2012-03-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment||Completed||N/A|200|Anticipated|Meir Medical Center||1|||f||||||||||||||2017-10-11 03:21:09.323742|2017-10-11 03:21:09.323742
NCT01520168|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-03-12|||October 2003||2003-10-01|March 2012|2012-03-01|March 2012|Anticipated|2012-03-01|July 2011|Actual|2011-07-01||Observational|||Composix Kugel Mesh Recall Leaves Unresolved Problems of Patient Management|The 2005 Composix Kugel Mesh Recall Leaves Unresolved Problems of Patient Management: Taking Stock After 5-year Follow up|Suspended||N/A|21|Actual|University of Wuerzburg|||1|Because of the product recall 2005/2006.|f||||f||||||Samples Without DNA|"     Explanted meshes   "|||2017-10-11 03:21:09.39415|2017-10-11 03:21:09.39415
NCT01520155|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-12-20|||December 2011||2011-12-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|CASTLE||CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)|CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE): Studie Zur Detektion Des kardiovaskulären Risikos in Patienten Mit Systemischem Lupus Erythematodes|Completed||N/A|90|Actual|Johann Wolfgang Goethe University Hospital|||3||f||||f||||||Samples Without DNA|"     Every participant will provide 20 ml Serum for further laboratory analysis   "|||2017-10-11 03:21:09.480712|2017-10-11 03:21:09.480712
NCT01520142|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2013-06-21|||November 2011||2011-11-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male Participants|A Two-Part, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male Subjects Employing the Intravenous Endotoxin-Induced Model of Acute Inflammation|Completed||Phase 1|19|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 03:21:09.553704|2017-10-11 03:21:09.553704
NCT01520129|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-01-28|||March 2012||2012-03-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pilot Study of Interpersonal and Social Rhythm Therapy for Subthreshold Bipolar|Pilot Study of Interpersonal and Social Rhythm Therapy for Subthreshold Bipolar|Completed||N/A|16|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-10-11 03:21:09.645784|2017-10-11 03:21:09.645784
NCT01520116|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-10-30|||January 2012||2012-01-01|October 2012|2012-10-01||||December 2012|Anticipated|2012-12-01||Interventional|||Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension|A Phase 1/2a Randomized, Investigator-masked, Placebo- and Active-controlled, Dose-ranging Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension|Unknown status|Active, not recruiting|Phase 1/Phase 2|180|Anticipated|Altheos, Inc.||8|||f||||f||||||||||2017-10-11 03:21:09.738108|2017-10-11 03:21:09.738108
NCT01520103|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-08-08|||January 2012|Actual|2012-01-01|August 2017|2017-08-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Interventional|VicTORia||Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer|Randomized Phase II Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer|Completed||Phase 2|139|Actual|AIO-Studien-gGmbH||2|||f||||f||||||||||2017-10-11 03:21:09.881898|2017-10-11 03:21:09.881898
NCT01520090|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-01-26|||January 2012||2012-01-01|January 2012|2012-01-01|April 2012|Anticipated|2012-04-01|March 2012|Anticipated|2012-03-01||Observational|||Egyptian Women Knowledge and Use of Different Contraceptive Methods|Egyptian Women Knowledge and Use of Different Contraceptive Methods|Unknown status|Recruiting|N/A|1200|Anticipated|Ain Shams University|||1||f||||f||||||||||2017-10-11 03:21:10.000179|2017-10-11 03:21:10.000179
NCT01520077|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-03-16|||July 2011||2011-07-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Vytorin in the Treatment of Alopecia Areata|A Pilot Study To Evaluate the Efficacy of Vytorin (Simvastatin +Ezetimibe) In the Treatment of Alopecia Areata|Completed||Phase 1|29|Actual|University of Miami||1|||f||||t||||||||||2017-10-11 03:21:10.103285|2017-10-11 03:21:10.103285
NCT01520064|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2013-11-13|||February 2012||2012-02-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01|2 Years|Observational [Patient Registry]|||Post Market Registry Study of the AeriSeal System|Post Market Registry Study of the AeriSeal System|Terminated||N/A|25|Anticipated|Aeris Therapeutics|||1||f||||f||||||||||2017-10-11 03:21:10.218722|2017-10-11 03:21:10.218722
NCT01520051|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2012-02-06|||January 2012||2012-01-01|February 2012|2012-02-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|MATERIAL||Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations|The Efficacy of Mepolizumab Treatment on Rhinovirus Induced Asthma Exacerbations|Unknown status|Recruiting|Phase 3|48|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 03:21:10.343418|2017-10-11 03:21:10.343418
NCT01520038|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2017-07-31|||January 2012||2012-01-01|July 2017|2017-07-01||||December 2013|Actual|2013-12-01||Interventional|||Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer|Feasibility and Phase 1/II Trial of Adjuvant Radiation Therapy for the Treatment of Urothelial Bladder Cancer Using Proton Therapy or IMRT|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:21:10.46104|2017-10-11 03:21:10.46104
NCT01520025|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2017-04-21|||December 2011||2011-12-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA|Direct Imaging of Ischemia With 18F-FDG PET Imaging Combined With Coronary Anatomy From CT Coronary Angiography|Terminated||Phase 4|18|Actual|Ottawa Heart Institute Research Corporation||1||Continued recruitment of study participants was not feasible|f||||f||||||||||2017-10-11 03:21:10.559988|2017-10-11 03:21:10.559988
NCT01520012|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-07-23|||February 2012||2012-02-01|May 2012|2012-05-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Food Effect on Pharmacokinetics of YH4808 in Healthy Male Subjects|Clinical Trial to Investigate the Influence of Food on Safety/Tolerability and Pharmacokinetics of YH4808 After Oral Administration in Healthy Male Subjects|Completed||Phase 1|44|Actual|Yuhan Corporation||5|||f||||t||||||||||2017-10-11 03:21:10.656789|2017-10-11 03:21:10.656789
NCT01519999|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-09-05|||May 2012||2012-05-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CRCS-WISDM||Colorectal Cancer Screening With Improved Shared Decision Making|Colorectal Cancer Screening With Improved Shared Decision Making (CRCS-WISDM)|Active, not recruiting||N/A|5842|Anticipated|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 03:21:10.748953|2017-10-11 03:21:10.748953
NCT01519986|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-24|||September 2011||2011-09-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|VITD_100484||The Effect of Fat on Vitamin D Absorption|The Effect of Fat on Vitamin D Absorption After a Single Oral Dose|Completed||N/A|64|Actual|Federal University of Rio Grande do Sul||3|||f||||t||||||||||2017-10-11 03:21:10.85922|2017-10-11 03:21:10.85922
NCT01519973|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2017-04-21|||August 2008||2008-08-01|April 2017|2017-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|OSCARS||Optimization of SPECT Imaging|Optimization of SPECT Cardiac Imaging Through Compensation for Attenuation, Resolution Loss and Scatter - The OSCARS|Terminated||N/A|64|Actual|Ottawa Heart Institute Research Corporation||1||Recruitment base changed due to change in clinical acquisition procedures|f||||f||||||||No|This trial has concluded and the investigators have published from the available data.|2017-10-11 03:21:10.991541|2017-10-11 03:21:10.991541
NCT01519960|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-08-03|2016-07-08||July 2012||2012-07-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|July 2015|Actual|2015-07-01||Interventional||Full Analysis Population: All participants who were randomized into the study and who were included in any of the study analyses.|A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B|A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon Alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children With HBeAg Positive Chronic Hepatitis B|Active, not recruiting||Phase 3|165|Actual|Hoffmann-La Roche|Results presented above include final analyses of the primary endpoint and most secondary endpoints. Group D had not reached FU Week 24 at time of analysis, so basic safety data were reported. New/updated data will be reported in the final results.|4|||f||||||||||||||2017-10-11 03:21:11.199648|2017-10-11 03:21:11.199648
NCT01519934|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-03-19|2013-12-30||October 2011||2011-10-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Observational||Subjects who had received a dual depth Ulthera treatment to the face and upper neck prior to enrollment and met all entrance criteria.|A Retrospective Study to Evaluate the Effectiveness of the Ulthera System|Retrospective Evaluation of the Ulthera System for Lifting and Tightening of the Face and Neck|Completed||N/A|48|Actual|Ulthera, Inc|||1||f||||f||||||||||2017-10-11 03:21:14.131954|2017-10-11 03:21:14.131954
NCT01519921|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-03-22|2015-12-17||October 2005||2005-10-01|March 2016|2016-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional||Baseline characteristics were analysed on Intent-to-treat (ITT) population which included all participants who received at least one dose of study drug. The ITT and the safety populations were identical.|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B.|An Open Label Phase IV Multicenter Study for Efficacy and Safety of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Patients With HBeAg Positive Chronic Hepatitis B|Completed||Phase 4|150|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:21:14.403789|2017-10-11 03:21:14.403789
NCT01519908|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-11-30|||February 2012||2012-02-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|MARC||Markers and Response to Cardiac Resynchronization Therapy|Markers and Response to Cardiac Resynchronization Therapy|Completed||N/A|240|Actual|University Medical Center Groningen|||1||f||||t||||||Samples With DNA|"     Whole blood, serum, plasma   "|||2017-10-11 03:21:15.128835|2017-10-11 03:21:15.128835
NCT01519895|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2015-04-14|||June 2011||2011-06-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Effectiveness of Telephone Intervention for Colorectal Cancer Caregivers|Effectiveness of Telephone-based Intervention on Distress, Burden and Quality of Life of Chinese Caregivers of Colorectal Cancer Patients|Completed||Phase 2|140|Actual|Hospital Authority, Hong Kong||2|||f||||f||||||||||2017-10-11 03:21:15.227047|2017-10-11 03:21:15.227047
NCT01519882|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2014-01-29|2013-12-10||March 2012||2012-03-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|REFRESH-PD||Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease|A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of Rotigotine on Sleep Efficiency in Patients With Advanced Parkinson's Disease.|Terminated||Phase 4|1|Actual|UCB Pharma|"Despite many attempts by study sites to recruit subjects, only 1 subject was randomized by Oct 2012. The decision to terminate the study was taken in Nov 2012. The subject completed in Jan 2013.
No planned efficacy/safety analyses were performed."|2||Due to major recruitment issues, a decision was made to terminate this trial|f||||f||||||||||2017-10-11 03:21:15.348308|2017-10-11 03:21:15.348308
NCT01519869|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-11-22|||March 2012||2012-03-01|November 2016|2016-11-01|November 2020|Anticipated|2020-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma|Neoadjuvant Platinum-based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol|Active, not recruiting||N/A|28|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-10-11 03:21:15.758509|2017-10-11 03:21:15.758509
NCT01519856|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-12|2016-01-28|||June 2009||2009-06-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|PIR-008/K||PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy|Efficacy and Safety of Long-term Therapy With Piribedil (CLARIUM) in Patients With M. Parkinson Under Consideration of Quality of Life Parameters and Cognitive Function|Completed||N/A|908|Actual|Desitin Arzneimittel GmbH|||1||f||||f||||||||||2017-10-11 03:21:15.829868|2017-10-11 03:21:15.829868
NCT01519843|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-05-12|||September 2010||2010-09-01|May 2017|2017-05-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Post Stroke Motor Learning|Post-stroke Procedural Learning: From Neural Substrates to Therapeutic Modulation by Non-invasive Brain Stimulation|Recruiting||N/A|100|Anticipated|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-10-11 03:21:15.915548|2017-10-11 03:21:15.915548
NCT01519830|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-02-27|||January 2012||2012-01-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|ISUB||Iron Substitution in Blood Donors|Significance of Iron Deficiency in Transfusion Medicine: Effects of Iron Substitution on Fatigue Und General Well Being in Healthy Blood Donors|Completed||Phase 4|405|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 03:21:15.995011|2017-10-11 03:21:15.995011
NCT01519817|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-05-30|2017-02-27||January 5, 2012|Actual|2012-01-05|May 2017|2017-05-01|January 1, 2018|Anticipated|2018-01-01|March 3, 2016|Actual|2016-03-03||Interventional|||Cancer Vaccine Targeting Brachyury Protein in Tumors|An Open Label Phase I Study to Evaluate the Safety and Tolerability of GI-6301 Vaccine Consisting of Whole, Heat-Killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express Brachyury Protein in Adults With Solid Tumors|Active, not recruiting||Phase 1|34|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t|t|f||||||No||2017-10-11 03:21:16.140854|2017-10-11 03:21:16.140854
NCT01519804|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-09-01||2016-06-29|April 2012||2012-04-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer|A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Onartuzumab (Metmab) in Combination With Paclitaxel + Cisplatin or Carboplatin as First-Line Treatment for Patients With Stage IIIb (T4 Disease) or IV Squamous Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|108|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:21:20.342462|2017-10-11 03:21:20.342462
NCT01519791|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-01-20|2015-07-08||January 2012||2012-01-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|July 2014|Actual|2014-07-01||Interventional|C-early|Baseline Charactersitics refer to the Randomized Set (RS).|A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis|A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate for Inducing and Sustaining Clinical Response in the Treatment of DMARD-Naïve Adults With Early Active Rheumatoid Arthritis|Completed||Phase 3|880|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:21:20.776057|2017-10-11 03:21:20.776057
NCT01519778|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-03-21|2015-02-27|2014-04-02|February 1, 2012|Actual|2012-02-01|March 2017|2017-03-01|August 1, 2012|Actual|2012-08-01|August 1, 2012|Actual|2012-08-01||Interventional|||A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study|Phase 2 Open-Label Safety and Exploratory Skin Lesion Measurement Study of 6-Day Oral TR-701 FA in Skin Abscess and Cellulitis Patients|Completed||Phase 2|200|Actual|Trius Therapeutics LLC||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:21:22.898674|2017-10-11 03:21:22.898674
NCT01519765|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-08-03|2016-03-04||July 2011||2011-07-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||73 participants were recruited to the study. 5 participants were excluded.|Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor|Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor: Randomized Control Trial|Terminated||Phase 4|73|Actual|University of California, Los Angeles|Limitations to the trial were termination of study due to poor recruitment, leading to small numbers of subjects analyzed.|2||Poor Enrollment|f||||t||||||||||2017-10-11 03:21:23.186035|2017-10-11 03:21:23.186035
NCT01519752|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-01-19|||November 2011||2011-11-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis|A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-Site, Study Comparing Oxiconazole Nitrate Cream 1% (Taro Pharmaceuticals,Inc) to Oxistat® (Oxiconazole Nitrate Cream) Cream 1% (PharmaDerma) in the Treatment of Tinea Pedis|Completed||Phase 1|661|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 03:21:24.068496|2017-10-11 03:21:24.068496
NCT01519739|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-07-19|||January 2012||2012-01-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|||Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (CRT) Implants|Clinical Evaluation of Mediguide System in CRT Implants|Completed||N/A|15|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 03:21:24.151935|2017-10-11 03:21:24.151935
NCT01519726|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-24|||December 2011||2011-12-01|January 2012|2012-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|MEMO||CYP3A4 Metabolism Before and After Surgery Induced Weight Loss Using Midazolam as Model Drug|CYP3A4 Metabolism Before and After Surgery Induced Weight Loss in Morbidly Obese Patients Using Midazolam as a Model Drug|Unknown status|Recruiting|Phase 4|20|Anticipated|St. Antonius Hospital||1|||f||||||||||||||2017-10-11 03:21:24.25404|2017-10-11 03:21:24.25404
NCT01519713|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2013-05-22|2013-04-04||January 2012||2012-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects|Immunogenicity and Safety of a Single Dose of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects|Completed||Phase 3|200|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:21:24.603378|2017-10-11 03:21:24.603378
NCT01519700|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-04-14|2015-03-25||December 2011||2011-12-01|April 2015|2015-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PIONEER|The safety set consists of all patients who received at least one dose of study drug and had at least one post-baseline safety assessment|Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim|A Randomized, Double-blind, Parallel-group, Multi-center Phase III Study Comparing the Efficacy and Safety of EP2006 and Neupogen® in Breast Cancer Patients Treated With Myelosuppressive Chemotherapy|Completed||Phase 3|218|Actual|Sandoz||2|||f||||t||||||||||2017-10-11 03:21:25.427728|2017-10-11 03:21:25.427728
NCT01519687|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-26|||January 2012||2012-01-01|January 2012|2012-01-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout|Open-Label, Inpatient Study of Levotofisopam 50 mg TID Administered for 7 Days to Men and Postmenopausal Women With Hyperuricemia and Gout|Unknown status|Recruiting|Phase 2|20|Anticipated|Pharmos||1|||f||||f||||||||||2017-10-11 03:21:26.715029|2017-10-11 03:21:26.715029
NCT01519674|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-01-10|2014-10-17||June 2012||2012-06-01|January 2017|2017-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|SIT2MIX||Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin|A 24 Week Randomised, Open Label, 3 Parallel-group Comparison of Once and Twice Daily Biphasic Insulin Aspart (BIAsp) 30 Plus Sitagliptin and Twice Daily BIAsp 30, All in Combination With Metformin in Insulin naïve Type 2 Diabetic Subjects Inadequately Controlled on Sitagliptin and Metformin|Completed||Phase 4|582|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:21:26.849797|2017-10-11 03:21:26.849797
NCT01519661|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-02-08|2014-12-17||January 2012||2012-01-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis|A Single Arm, Open-label, Multicenter, Phase IV Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis|Completed||Phase 4|157|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:21:27.962146|2017-10-11 03:21:27.962146
NCT01519648|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2014-07-18|2014-06-18||January 2012||2012-01-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Observational|||A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation|A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation|Completed||N/A|808|Actual|National Hematological Society, Russia|||2||f||||f||||||||||2017-10-11 03:21:28.830076|2017-10-11 03:21:28.830076
NCT01519622|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-26|||February 2012||2012-02-01|January 2012|2012-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Impact of Disease on the Concept of End-of-life Decisions of the Elderly in the Community||Unknown status|Not yet recruiting|N/A|88|Anticipated|Meir Medical Center|||1||f||||t||||||||||2017-10-11 03:21:29.324717|2017-10-11 03:21:29.324717
NCT01519609|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2012-11-20|||September 2011||2011-09-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Trial Comparing Moviprep and Phosphoral as Bowel Prep Before Colonoscopy|Double Blind Randomised Trial Comparing Moviprep and Phosphoral as Bowel Prep Before|Completed||N/A|400|Actual|Randers Regional Hospital||2|||f||||f||||||||||2017-10-11 03:21:29.427837|2017-10-11 03:21:29.427837
NCT01519596|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-05-30|||October 2012||2012-10-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy|Minimizing Physical Function Decline in Older Adults Receiving Chemotherapy|Active, not recruiting||N/A|70|Anticipated|Wake Forest University Health Sciences||2|||f||||f|f|f||||||||2017-10-11 03:21:29.512887|2017-10-11 03:21:29.512887
NCT01519583|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-05-04|||May 2012||2012-05-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women|Title: Comparative Effectiveness of Pedometer-Based Walking Interventions: WalkMore|Unknown status|Active, not recruiting|N/A|120|Anticipated|Pennington Biomedical Research Center||3|||f||||f||||||||||2017-10-11 03:21:29.620682|2017-10-11 03:21:29.620682
NCT01519570|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-01-24|||March 2011||2011-03-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates|Use of an Electronic Medical Record to Improve Standard Practice in the Primary Care Setting: A Randomized-Controlled Study of Herpes Zoster Vaccination Rates|Completed||N/A|2589|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 03:21:29.743315|2017-10-11 03:21:29.743315
NCT01519557|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-03-03|||April 2011||2011-04-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders|Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders|Completed||Early Phase 1|68|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 03:21:29.820899|2017-10-11 03:21:29.820899
NCT01519544|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-04-22|||March 2012||2012-03-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|July 2012|Actual|2012-07-01||Interventional|||Comparison of Temazepam and Acetazolamide to Treat Difficulty Sleeping at High Altitude|Treatment of High-altitude Sleep Disturbance: A Double-blind Comparison of Temazepam Versus Acetazolamide.|Completed||N/A|34|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:21:29.898056|2017-10-11 03:21:29.898056
NCT01519531|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-12-04|||January 2012||2012-01-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects|A Randomized, Double-blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of VIA-3196 in Healthy Subjects|Completed||Phase 1|48|Actual|Madrigal Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:21:30.109765|2017-10-11 03:21:30.109765
NCT01519518|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-04-24|2015-04-07||February 2012||2012-02-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|HEAT-PPCI||How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention|A Randomised Controlled Trial to Compare Unfractionated Heparin Versus Bivalirudin in the Treatment of Patients With a Clinical Diagnosis of ST-Segment Elevation Myocardial Infarction Events - For Planned Management With Primary PCI|Completed||Phase 4|1829|Actual|Liverpool Heart and Chest Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:21:30.199113|2017-10-11 03:21:30.199113
NCT01519505|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-26|||March 2005||2005-03-01|January 2012|2012-01-01|March 2012|Anticipated|2012-03-01|March 2006|Actual|2006-03-01||Interventional|DE-PLAN-CAT||Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention in Catalonia|Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention in Catalonia(DE-PLAN-CAT).|Unknown status|Active, not recruiting|N/A|2082|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-10-11 03:21:30.583606|2017-10-11 03:21:30.583606
NCT01519492|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-08-03|||February 2012||2012-02-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci|A Phase 2, Open-Label, Multi-Center Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococci|Completed||Phase 2|103|Actual|Affinium Pharmaceuticals, Ltd||1|||f||||f||||||||||2017-10-11 03:21:30.680259|2017-10-11 03:21:30.680259
NCT01519479|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-03-27|||April 2012||2012-04-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Palliative Care for Heart Failure Patients|An Examination of Palliative Care as Standard Practice for Heart Failure Patients|Completed||N/A|232|Actual|Abbott Northwestern Hospital||2|||f||||f||||||||||2017-10-11 03:21:30.837982|2017-10-11 03:21:30.837982
NCT01519466|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-03-03|2015-11-12||January 2012||2012-01-01|March 2016|2016-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||A total of 55 subjects consented and enrolled into the study. Six of these withdrew before randomisation or failed screening. Forty-nine (49) subjects were randomised and completed the study.|Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Study|Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Study|Completed||N/A|55|Actual|Abbott Diabetes Care||2|||f||||f||||||||||2017-10-11 03:21:31.003342|2017-10-11 03:21:31.003342
NCT01519453|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-04-13|||September 2011||2011-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|November 2016|Actual|2016-11-01||Interventional|ABC-HS||Reducing Asthma Morbidity In High Risk Minority Preschool Children|Reducing Asthma Morbidity In High Risk Minority Preschool Children|Active, not recruiting||N/A|401|Actual|Johns Hopkins University||2|||f||||t|f|f||||||No|We will not be sharing individual participant data with other researchers|2017-10-11 03:21:31.532899|2017-10-11 03:21:31.532899
NCT01519440|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-10-21|||March 2011||2011-03-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Observational|||Randomized Comparison of Sharp Versus Blunt Techniques at Cesarean|Unintended Extension of the Lower Segment Uterine Incision at Cesarean Delivery;A Randomized Comparison of Sharp Versus Blunt Techniques|Completed||N/A|1076|Actual|Istanbul Bakirkoy Maternity and Children Diseases Hospital|||2||f||||||||||||||2017-10-11 03:21:31.641608|2017-10-11 03:21:31.641608
NCT01519427|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-25|2014-05-16|2013-11-27||January 2012||2012-01-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||2 consented patients were not eligible for the trial|Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib|A Phase II Trial of MAP Kinase Inhibition With AZD6244 Hydrogen Sulfate in Combination With MK-2206 (Akt Inhibitor) in Patients With BRAF V600-Mutant Advanced Melanoma Whose Disease Has Progressed on Prior Therapy With a Selective BRAF Inhibitor (i.e., Vemurafenib, Dabrafenib, LGX818)|Terminated||Phase 2|2|Actual|National Cancer Institute (NCI)|Because this study terminated early due to slow accrual, data were available for only the two eligible patients that enrolled before study closure.|1||Study terminated due to slow accrual|f||||t||||||||||2017-10-11 03:21:31.733569|2017-10-11 03:21:31.733569
NCT01519401|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-01-23|||February 2010||2010-02-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|||||Interventional|||Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.|Clinical Efficacy and Metabolic Impact of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Normal-weight Women With Polycystic Ovary Syndrome: a Randomized Study.|Completed||N/A|||Catholic University of the Sacred Heart||2|||f||||||||||||||2017-10-11 03:21:32.236023|2017-10-11 03:21:32.236023
NCT01519388|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2013-07-09|||February 2012||2012-02-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|February 2012|Actual|2012-02-01||Interventional|OPTIDEG||Evaluation of the Impact on Swallowing of Non Invasive Ventilation|Evaluation of Nasal Ventilation on Optimizing Swallowing in Ventilated Neuromuscular Patients|Completed||N/A|10|Actual|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||||2017-10-11 03:21:32.323486|2017-10-11 03:21:32.323486
NCT01519375|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-05-28|||March 2012||2012-03-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|CONVOY||Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)|Cross-sectional, Observational Real Life Study on NSAIDs Treated Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis: Assessment of Patient Adherence to PPI Treatment|Completed||N/A|102|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:21:32.412934|2017-10-11 03:21:32.412934
NCT01519362|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-25|||October 2011||2011-10-01|January 2012|2012-01-01||||||||Observational|||A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis||Completed||N/A|1|Actual|First Hospital of Jilin University|||1||f||||f||||||||||2017-10-11 03:21:32.508928|2017-10-11 03:21:32.508928
NCT01519180|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-09-05|||January 2012||2012-01-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis|Study of the Antro-pyloro-duodenal Motor Dysfunction in Idiopathic Gastroparesis|Completed||N/A|32|Actual|University Hospital, Rouen|||2||f||||t||||||||||2017-10-11 03:21:36.644558|2017-10-11 03:21:36.644558
NCT01519349|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-01-26|||January 2012||2012-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis|Phase I Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis.|Active, not recruiting||Phase 1|15|Actual|Nationwide Children's Hospital||3|||f||||t||||||||||2017-10-11 03:21:32.559524|2017-10-11 03:21:32.559524
NCT01519336|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-11-01|||February 2012||2012-02-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers|A Study to Evaluate the Potential Drug-Drug Interaction Between Darunavir and Danoprevir When Administered Together With Low-Dose Ritonavir in Healthy Volunteers|Completed||Phase 1|40|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:21:32.910283|2017-10-11 03:21:32.910283
NCT01519323|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2016-08-25|2016-06-17||January 2013||2013-01-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations|An Open-label, Multicenter, Single-arm, Phase I Dose-escalation With Efficacy Tail Extension Study of Vemurafenib (RO5185426) in Pediatric Patients With Surgically Incurable and Unresectable Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations|Terminated||Phase 1|6|Actual|Hoffmann-La Roche|The study was prematurely terminated on 18 December 2015 by the Sponsor due to recruitment challenges and therefore low enrollment.|1||Study was terminated due to low enrollment.|f||||t||||||||||2017-10-11 03:21:33.034246|2017-10-11 03:21:33.034246
NCT01519310|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-03-01|||April 2010||2010-04-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Glory||Gut Flora Dependent Metabolism of Dietary Phosphatidylcholine and Cardiovascular Disease|Gut Flora Dependent Metabolism of Dietary Phosphatidylcholine and Cardiovascular Disease|Completed||Early Phase 1|4|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-10-11 03:21:33.569358|2017-10-11 03:21:33.569358
NCT01519297|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-12-23|||May 2012||2012-05-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Preeclampsia: A Marker for Future Cardiovascular Risk in Women|Preeclampsia: A Marker for Future Cardiovascular Risk in Women|Recruiting||N/A|150|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-11 03:21:33.660328|2017-10-11 03:21:33.660328
NCT01519284|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-07-22|2015-07-22||November 2009||2009-11-01|July 2015|2015-07-01|June 2011|Actual|2011-06-01|February 2010|Actual|2010-02-01||Interventional|||Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic|A Double-blind, Randomised, Placebo- and Active-controlled Multiple-dose Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetics Following a Levodopa/Carbidopa 100/25 mg Single-dose in Healthy Subjects|Completed||Phase 1|82|Actual|Bial - Portela C S.A.||5|||f||||f||||||||||2017-10-11 03:21:33.832513|2017-10-11 03:21:33.832513
NCT01519271|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-02-22|2016-05-24||December 2011||2011-12-01|February 2017|2017-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Mild Cognitive Impairment in Parkinson's Disease|A Phase IV Randomized, Double-Blind, Placebo-Controlled, Crossover Single Site Study Of Exelon® Patch (Rivastigmine Transdermal System) For Mild Cognitive Impairment In Parkinson's Disease|Completed||Phase 4|28|Actual|University of Pennsylvania|"The small sample size may have limited our power to detect a treatment effect.
When the study was conducted, the maximum strength of the rivastigmine patch was 9.5 mg/24 h. Since then, a higher dose has been approved by the FDA."|2|||f||||f||||||||||2017-10-11 03:21:34.812192|2017-10-11 03:21:34.812192
NCT01519258|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2013-09-13|||October 2012||2012-10-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Mechanical Ventilation With Neurally-Adjusted Ventilatory Assist in Patients With ARDS|Performance of NAVA as Lung Protective Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome|Unknown status|Recruiting|N/A|20|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 03:21:35.157629|2017-10-11 03:21:35.157629
NCT01519245|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2013-05-27|2012-12-06||December 2011||2011-12-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery|Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery|Completed||Phase 3|44|Actual|University of Saskatchewan|"Small sample size
Low-risk CABG patients enrolled only
Break in protocol, with pre-pump TXA not given to 2 participants, and post-pump TXA given to 8 participants
Short study period, with no long-term follow-up data"|2|||f||||f||||||||||2017-10-11 03:21:35.280807|2017-10-11 03:21:35.280807
NCT01519232|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2015-05-14|||August 2008||2008-08-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|June 2012|Actual|2012-06-01||Observational|||A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)|A Pilot Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary SPECT|Completed||N/A|23|Actual|University of Michigan Cancer Center|||1||f||||t||||||||||2017-10-11 03:21:35.896253|2017-10-11 03:21:35.896253
NCT01519219|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-07-03|||January 2003||2003-01-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|IC-Green||Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation|Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation|Recruiting||N/A|240|Anticipated|University of Michigan Cancer Center|||1||f||||t||||||||||2017-10-11 03:21:35.970508|2017-10-11 03:21:35.970508
NCT01519206|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2014-05-22|2014-03-20||August 2011||2011-08-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|February 2012|Actual|2012-02-01||Interventional|||Lifting and Tightening of the Face and Neck Following an Increased Density Treatment|Evaluation of the Efficacy and Safety of the Ulthera® System for Lifting and Tightening of the Face and Neck Following an Increased Density Treatment.|Completed||N/A|32|Actual|Ulthera, Inc|3-D digital imaging was not completed, thus quantitative measure of submental skin lift was not obtained.|1|||f||||f||||||||||2017-10-11 03:21:36.078068|2017-10-11 03:21:36.078068
NCT01519193|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2012-11-06|||January 2011||2011-01-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Treatment of Aggressive Behavior and Post-Traumatic Stress Disorder|Treatment of Aggressive Behavior and Post-Traumatic Stress Disorder in Former Street Children and Vulnerable Children in Burundi With Narrative Exposure Therapy for Violent Offenders|Completed||Phase 2|42|Actual|University of Konstanz||2|||f||||t||||||||||2017-10-11 03:21:36.422251|2017-10-11 03:21:36.422251
NCT01519167|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-03-16|2015-05-05||October 2012||2012-10-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Safety Evaluable Population: All subjects who receive any amount of study drug. All safety analyses will be performed on this population.|Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation|Phase IV, Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation|Completed||Phase 4|91|Actual|Hospira, now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-10-11 03:21:36.739743|2017-10-11 03:21:36.739743
NCT01519154|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-11-26|||March 2012||2012-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Sedation MRI - Propofol Versus Propofol-Ketamin in Children|Untersuchung Unterschiedlicher Sedationstechniken für Elektive Magnetresonanztomographie (MRT)-Diagnostik Bei Kindern Anhand Klinischer Und MRT-basierter Outcomeparameter (Propofol Versus Propofol-Ketamin)|Completed||Phase 3|347|Actual|University Children's Hospital, Zurich||2|||f||||t||||||||||2017-10-11 03:21:37.401879|2017-10-11 03:21:37.401879
NCT01519141|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-05-03|||July 2003||2003-07-01|May 2017|2017-05-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Observational|||Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection|Immunologic and Inflammatory Factors and Cardiovascular Risk in Patients With HIV Infection or Autoimmune Diseases|Active, not recruiting||N/A|400|Anticipated|University of California, San Francisco|||2||f||||f||||||||||2017-10-11 03:21:37.49407|2017-10-11 03:21:37.49407
NCT01519128|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2013-03-01|||January 2012||2012-01-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin|A Phase I, Open Label, Randomized, Crossover Trial in Healthy Subjects to Investigate the Effect of Steady-state TMC278 on the Pharmacokinetics of a Single Dose of Digoxin|Completed||Phase 1|22|Actual|Janssen R&D Ireland||2|||f||||f||||||||||2017-10-11 03:21:37.574014|2017-10-11 03:21:37.574014
NCT01519115|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-01-09|||July 2013||2013-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ACF||Comparison of Outcomes Between Early Physical Therapy Intervention and Usual Care Following Anterior Cervical Fusion Surgery|A Comparison of Clinic Outcomes Between Early Physical Therapy Intervention and Usual Care in Individuals Following Anterior Cervical Fusion|Completed||N/A|40|Actual|Texas Woman's University||2|||f||||t||||||||||2017-10-11 03:21:37.670161|2017-10-11 03:21:37.670161
NCT01519102|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-12-07|||January 2012||2012-01-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|CLASS02||Comparison of Closed-loop Operation After Morning Meal With and Without Carbohydrate Counting|An Open-label, Randomized Two-way, Cross-over Study to Compare Meal-and-carbohydrate-announcement Strategy Versus Meal-announcement Strategy During Closed-loop Regulation of Glucose Levels in a Morning Meal in Adults With Type-1 Diabetes.|Completed||Phase 2|12||Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||||2017-10-11 03:21:37.756366|2017-10-11 03:21:37.756366
NCT01519089|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-08-06|2015-01-08||March 2012||2012-03-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis|A Phase 3, Multi Site, Randomized, Double Blind Study Of The Long-term Safety, Tolerability And Efficacy Of 2 Oral Doses Of Cp 690,550 In Subjects With Moderate To Severe Plaque Psoriasis And/or Psoriatic Arthritis|Completed||Phase 3|95|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 03:21:37.935286|2017-10-11 03:21:37.935286
NCT01519076|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-12-08|||June 2012||2012-06-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||A Safety Evaluation of the Use of Magnetic-guided Iron Particles|A Feasibility Study: A Safety Evaluation of the Use of Magnetic-guided Iron Particles Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)|Terminated||Phase 1|7|Actual|Pulse Therapeutics||1||Sponsor Request|f||||t||||||||||2017-10-11 03:21:44.322043|2017-10-11 03:21:44.322043
NCT01519063|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-05-16|||January 2012|Actual|2012-01-01|May 2017|2017-05-01|May 1, 2017|Actual|2017-05-01|March 29, 2017|Actual|2017-03-29||Interventional|||Naltrexone and Memantine Effects on Alcohol Drinking Behaviors|Glutamate-opioid Interactions in Alcohol Drinking Behaviors|Completed||Phase 2|75|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:21:44.40849|2017-10-11 03:21:44.40849
NCT01519050|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-01-25|||November 2011||2011-11-01|January 2012|2012-01-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||Predictors of Postoperative Left Ventricular Function in Patients Undergoing Mitral Valve Repair for Severe Degenerative Mitral Regurgitation||Unknown status|Recruiting|Phase 3|100|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 03:21:44.511756|2017-10-11 03:21:44.511756
NCT01519037|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-01-28|||January 2012||2012-01-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2012|Actual|2012-06-01||Interventional|||Interaction Between a Calcimimetic Agent and the Renin Angiotensine Aldosterone System|Evaluation of the Interaction Between a Calcimimetic Agent (Cinacalcet) and the Renin Angiotensine Aldosterone System in Healthy Volunteers|Completed||N/A|18|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||Yes|Publication|2017-10-11 03:21:44.591786|2017-10-11 03:21:44.591786
NCT01519024|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-01-25|||April 2010||2010-04-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|February 2011|Actual|2011-02-01||Observational|||Postural Control in Breast Hypertrophy|Poorer Postural Control in Women With Breast Hypertrophy.|Completed||N/A|28|Actual|University of Sao Paulo General Hospital|||2||f||||f||||||||||2017-10-11 03:21:44.742171|2017-10-11 03:21:44.742171
NCT01519011|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-03-24|||February 2012||2012-02-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine|A PHASE 1, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS AND EFFECT OF FOOD OF A NEW TABLET FORMULATION OF ORAL AZACITIDINE, AND TO EVALUATE THE SAFETY AND EFFICACY OF ORAL AZACITIDINE IN SUBJECTS WITH MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA|Completed||Phase 1|34|Actual|Celgene Corporation||7|||f||||f||||||||||2017-10-11 03:21:44.840477|2017-10-11 03:21:44.840477
NCT01518998|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-06-29|||August 2011||2011-08-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension||Completed||Phase 2|420|Actual|Boryung Pharmaceutical Co., Ltd||9|||f||||t||||||||||2017-10-11 03:21:44.979289|2017-10-11 03:21:44.979289
NCT01518985|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-04-17|||January 2012||2012-01-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking|A Phase 1, Placebo-Controlled Trial to Evaluate the Impact of Intravenous (IV) Bendavia™ (MTP-131) on Endothelial Reactivity Dysfunction Induced by Cigarette Smoking|Completed||Phase 1|6|Actual|Stealth BioTherapeutics Inc.||2|||f||||f||||||||||2017-10-11 03:21:45.111868|2017-10-11 03:21:45.111868
NCT01518972|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-08-13|||September 2009||2009-09-01|August 2012|2012-08-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Prazosin for Alcohol Dependence and Posttraumatic Stress Disorder|A Placebo-Controlled Trial of Prazosin in Individuals With Co-occurring Alcohol Dependence and PTSD Seeking Abstinence|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|Seattle Institute for Biomedical and Clinical Research||2|||f||||t||||||||||2017-10-11 03:21:45.201438|2017-10-11 03:21:45.201438
NCT01518959|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-11-18|||January 2012||2012-01-01|November 2014|2014-11-01||||January 2017|Anticipated|2017-01-01||Interventional|D-HEM||The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases|Phase III, Controlled, Double-blind, Randomized Study of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases|Unknown status|Recruiting|Phase 3|50|Anticipated|Semmelweis University||2|||f||||f||||||||||2017-10-11 03:21:45.318957|2017-10-11 03:21:45.318957
NCT01518946|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-10-10|2014-07-03||May 2012||2012-05-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Randomized Safety Analysis Set defined as all subjects who received at least 1 dose of randomized investigational product.|Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension|A Phase 4, Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Clinical Benefit of Midodrine Hydrochloride in Male and Female Subjects With Symptomatic Orthostatic Hypotension|Completed||Phase 4|24|Actual|Shire||2|||f||||t||||||||||2017-10-11 03:21:45.438664|2017-10-11 03:21:45.438664
NCT01518933|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-03-04|||August 2011||2011-08-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|LEG-SIL-LTX-02||Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted Patients|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of LEGALON SIL for the Treatment of HCV Recurrence in Stable Liver Transplanted Patients|Terminated||Phase 2|20|Actual|Rottapharm||2||when a blind review highlighted that at least 43% of patients had a virological response|f||||f||||||||||2017-10-11 03:21:45.800447|2017-10-11 03:21:45.800447
NCT01518920|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2013-04-01|||December 2011||2011-12-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss|A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-04958242 In Subjects With Age-Related Sensorineural Hearing Loss|Completed||Phase 1|44|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:21:45.884965|2017-10-11 03:21:45.884965
NCT01518907|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2015-03-17|||January 2012||2012-01-01|March 2015|2015-03-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)|A Phase 1b, Open-label, Dose-escalation Study of the Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy Commonly Known as Cellulite|Completed||Phase 1|99|Actual|Endo Pharmaceuticals||11|||f||||f||||||||||2017-10-11 03:21:45.99218|2017-10-11 03:21:45.99218
NCT01518894|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-05-05|||November 2011||2011-11-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia|A Randomized, Double-Blind, Placebo Controlled, Sponsor Open, Phase 1b Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia|Completed||Phase 1|30|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:21:46.203162|2017-10-11 03:21:46.203162
NCT01518881|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-01-08|||January 2012||2012-01-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion|A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With Additional Multiple-Ascending Dose Cohorts to Evaluate the Safety, Tolerability and Pharmacokinetics of TKM-100201 in Healthy Human Volunteers|Terminated||Phase 1|24|Actual|Arbutus Biopharma Corporation||2||Corporate decision to reformulate the investigational product.|f||||t||||||||||2017-10-11 03:21:46.28689|2017-10-11 03:21:46.28689
NCT01518868|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-08-10|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:21:46.366463|2017-10-11 03:21:46.366463
NCT01518855|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-24|||March 2004||2004-03-01|January 2012|2012-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension|Clinical Effect and Cost Effectiveness of Ca Antagonist in Combination With AII Receptor Antagonist in Patient With Essential Hypertension (PMS Study)|Completed||Phase 4|514|Actual|Bayer||2|||f||||f||||||||||2017-10-11 03:21:46.414236|2017-10-11 03:21:46.414236
NCT01518842|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-22|2017-07-18|||September 2011||2011-09-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|June 2014|Actual|2014-06-01||Interventional|RetinaCell||Effect of Intravitreal Bone Marrow Stem Cells on Ischemic Retinopathy|Effect of Intravitreal Bone Marrow Stem Cells on Ischemic Retinopathy|Active, not recruiting||N/A|30|Anticipated|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 03:21:46.583875|2017-10-11 03:21:46.583875
NCT01518829|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2013-09-29|||April 2012||2012-04-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|||Procalcitonin in Hepatocellular Carcinoma|Role of Procalcitonin in Differantiation Between Bacerial Infection and Non Infectious Inflammation in Febrile Hepatocellular Carcinoma Patients After Locoregional Treatment|Completed||N/A|42|Actual|Ain Shams University|||2||f||||t||||||Samples Without DNA|"     Serum   "|||2017-10-11 03:21:46.662575|2017-10-11 03:21:46.662575
NCT01518816|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2012-01-26|||October 2011||2011-10-01|January 2012|2012-01-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Observational|||Role of Serum Total Antioxidant Level in Preterm Labor|the Role of Serum Total Antioxidant Level in Preterm Labor|Unknown status|Recruiting|N/A|70|Anticipated|Ain Shams Maternity Hospital|||2||f||||t||||||None Retained|"     serum   "|||2017-10-11 03:21:46.734293|2017-10-11 03:21:46.734293
NCT01518803|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-09-20|||May 2010||2010-05-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Mediterranean-style Breakfast and Postprandial Lipid Disorders in Obese Pre-adolescents and Adults|Influence of a Mediterranean-style Breakfast on Postprandial Lipid Disorders and Inflammatory Processes in Obese Pre-adolescents and Adults|Completed||N/A|48|Actual|National Research Council, Spain||2|||f||||f||||||||||2017-10-11 03:21:46.818929|2017-10-11 03:21:46.818929
NCT01518777|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-02-08|||January 2012||2012-01-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Reducing Radioisotope Dose: the Half-Dose CZT Study|Reducing Radioisotope Dose in Regadenoson SPECT Myocardial Perfusion Imaging: Comparison of Half-Dose Scans Using a Novel Solid-State-Detector Dedicated Cardiac Camera to Full Dose Scans Acquired On Standard Equipment|Recruiting||N/A|50|Anticipated|The Methodist Hospital System||1|||f||||f||||||||Undecided|To be determined.|2017-10-11 03:21:46.988399|2017-10-11 03:21:46.988399
NCT01518764|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-11-24|||May 2012||2012-05-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||The Effects of Red Wine Polyphenols on Microvascular Dysfunction|The Effects of Red Wine Polyphenols on Microvascular Dysfunction|Completed||N/A|29|Actual|VU University Medical Center||2|||f||||||||||||||2017-10-11 03:21:47.090607|2017-10-11 03:21:47.090607
NCT01518751|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2015-09-29|||December 2011||2011-12-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease - Evolution|Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease - Evolution A Monocentric Study to Investigate the Development of Symptoms of Autonomic Dysregulation in Parkinson`s Disease|Completed||N/A|27|Actual|University of Zurich|||1||f||||t||||||||||2017-10-11 03:21:47.168793|2017-10-11 03:21:47.168793
NCT01518738|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-06-03|||February 2012||2012-02-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Attention Training|Attention Training|Completed||N/A|94|Actual|University of Wisconsin, Madison||3|||f||||f||||||||||2017-10-11 03:21:47.244026|2017-10-11 03:21:47.244026
NCT01518725|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-04-27|||January 2012||2012-01-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of Vitamin D Supplementation on Muscle Power in Elite Cyclist|The Effect of Vitamin D Supplementation on Muscle Power in Elite Cyclist|Completed||Phase 4|103|Actual|Oklahoma State University||2|||f||||t||||||||||2017-10-11 03:21:47.316235|2017-10-11 03:21:47.316235
NCT01518712|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2012-08-28|||September 2011||2011-09-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagl|Completed||Phase 1|64|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-10-11 03:21:47.415405|2017-10-11 03:21:47.415405
NCT01518699|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2013-07-22|||January 2012||2012-01-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers|A Randomized, Double-Blind, Placebo- and Active-Controlled Crossover Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Male and Female Adult Subjects, Preceded by a Dose-Escalation Study to Determine the Supratherapeutic Dose of Ha44|Completed||Phase 1|81|Actual|Hatchtech Pty Ltd||6|||f||||f||||||||||2017-10-11 03:21:47.508375|2017-10-11 03:21:47.508375
NCT01518686|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-12-10|||June 2006||2006-06-01|December 2013|2013-12-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|Norm-Oct900||Age-related Normative Values for the Octopus 900 Perimeter|Normal Values for the Full Visual Field, Corrected for Age- and Reaction Time, Using Semi-automated Kinetic Testing on the Octopus 900 Perimeter|Completed||N/A|86|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-11 03:21:47.630589|2017-10-11 03:21:47.630589
NCT01518673|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2014-12-04|||February 2012||2012-02-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|January 2015|Anticipated|2015-01-01||Observational|PedCTBe||Low Dose Effects of X-rays in Pediatric Patients Undergoing a CT Examination.|National Study of Low Dose Effects of X-rays in Pediatric Patients Undergoing a CT Examination.|Unknown status|Recruiting|N/A|120|Anticipated|University Ghent|||1||f||||f||||||Samples With DNA|"     Blood lymphocytes   "|||2017-10-11 03:21:47.716251|2017-10-11 03:21:47.716251
NCT01518660|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-12-01|||February 2012||2012-02-01|April 2013|2013-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Multiple Sclerosis and Progressive Resistance Training|Multiple Sclerosis - Inflammatory, Neurological and Muscular Adaptations to Progressive Resistance Training|Completed||N/A|35|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:21:49.442979|2017-10-11 03:21:49.442979
NCT01518647|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-05-08|||January 25, 2012|Actual|2012-01-25|May 2017|2017-05-01|February 9, 2016|Actual|2016-02-09|August 25, 2015|Actual|2015-08-25||Interventional|Stress-4||Acceptance and Commitment Therapy for Patients With Multi-organ Bodily Distress Syndrome (Stress-4)|Treatment of Multi-organ Bodily Distress Syndrome. A Randomized Controlled Trial of the Effects of Acceptance and Commitment Therapy Given as Group Therapy or Workshop Compared to Standard Treatment (Stress-4)|Completed||N/A|180|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 03:21:49.557898|2017-10-11 03:21:49.557898
NCT01518634|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-05-08|||January 2012||2012-01-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01||Interventional|Stress-3||Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome|Treatment of Multi-organ Bodily Distress Syndrome. A Double-blinded Placebo Controlled Trial of the Effects of Imipramine (Stress-3)|Completed||Phase 2|138|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:21:49.650367|2017-10-11 03:21:49.650367
NCT00005757|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-11-23|||September 1997||1997-09-01|November 2016|2016-11-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Observational|||Racial Variation in ACE--Genetic and Physiologic Bases||Completed||N/A|293|Actual|Vanderbilt University|||8||f||||||||||||||2017-10-11 04:28:58.356873|2017-10-11 04:28:58.356873
NCT01518621|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-06-22|||May 2012||2012-05-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RadEr||Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer|Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer|Terminated||Phase 2|25|Actual|Oslo University Hospital||2||Slow accrual|f||||f||||||||||2017-10-11 03:21:49.766317|2017-10-11 03:21:49.766317
NCT01518608|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2012-01-25|||September 2009||2009-09-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Alfentanil and the Elimination of Sympathetic Responses to Tracheal Intubation During Rapid Sequence Induction of Anesthesia: A Probability-based Approach|Alfentanil and the Elimination of Sympathetic Responses to Tracheal Intubation During Rapid Sequence Induction of Anesthesia: A Probability-based Approach|Completed||Phase 4|84|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 03:21:49.865169|2017-10-11 03:21:49.865169
NCT01518595|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2016-09-27|||October 2011||2011-10-01|September 2016|2016-09-01||||April 2014|Actual|2014-04-01||Interventional|||Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis|Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis - a Prospective Double Blind Randomized Controlled Clinical Study|Terminated||Phase 2|6|Actual|Medical University of Vienna||2||too slow patient recruitment|f||||||||||||||2017-10-11 03:21:49.940882|2017-10-11 03:21:49.940882
NCT01518582|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-06-27|||August 2012||2012-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||GRANVIA®-C Cervical Disc Prosthesis Multicenter European Pilot Study|The GRANVIA®-C Cervical Disc Prosthesis to Treat Symptomatic Degenerative Disc Diseases|Completed||N/A|70|Actual|Medicrea International|||1||f||||f||||||||||2017-10-11 03:21:50.060326|2017-10-11 03:21:50.060326
NCT01518569|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-01-25|||March 2008||2008-03-01|January 2012|2012-01-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|ulistin||Ulinastatin's Anti-inflammatory Reaction in Cardiac Surgery|Effect of Ulinastatin on Postoperative Systemic Inflammatory Response in Cardiac Surgery|Completed||Phase 4|26|Actual|Konkuk University Medical Center||2|||f||||t||||||||||2017-10-11 03:21:50.171341|2017-10-11 03:21:50.171341
NCT01518556|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2016-09-01|||July 2011||2011-07-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|IDAML||Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia|Phase I/II Clinical Study of Idarubicin Dose Intensification for Remission Induction Therapy in Acute Myeloid Leukemia Patients Age of 65 Years or Less|Recruiting||Phase 1/Phase 2|67|Anticipated|Konkuk University Medical Center||1|||f||||t||||||||||2017-10-11 03:21:50.272147|2017-10-11 03:21:50.272147
NCT01518543|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2014-09-10|||April 2010||2010-04-01|September 2014|2014-09-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Observational|||Follow-up of Patient Implanted With the Staple ASTUS®|Follow-up of Patient Implanted With the Staple ASTUS®|Terminated||N/A|5|Actual|Integra LifeSciences Services|||1||f||||f||||||||||2017-10-11 03:21:50.419794|2017-10-11 03:21:50.419794
NCT01518530|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-08-22|2013-05-07||February 2012||2012-02-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||One patient dropped out of the experiment due to lack of necessary documentation required for inclusion.|Tailored Computerized Mobilization of the Cervical Spine Utilizing the Occiflex Device for the Treatment of Chronic Neck Pain||Completed||Phase 2|10|Actual|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-10-11 03:21:50.522799|2017-10-11 03:21:50.522799
NCT01518517|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-02-06|||December 2009|Actual|2009-12-01|March 2016|2016-03-01|October 2016|Actual|2016-10-01|September 2014|Actual|2014-09-01||Interventional|GRASPIVOTALL||GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia|Phase 2/3 Study Evaluating Efficacy and Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA)Versus Reference L-asparaginase Treatment in Combination With Standard Polychemotherapy in Patient With First Recurrence of Philadelphia Negative Acute Lymphoblastic Leukemia|Completed||Phase 2/Phase 3|80|Actual|ERYtech Pharma||2|||f||||t||||||||Undecided||2017-10-11 03:21:50.696917|2017-10-11 03:21:50.696917
NCT01518504|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2012-11-19|||December 2011||2011-12-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effects of Thoracic Mobilization on Shoulder Range of Motion|Effects of Thoracic Mobilization on Shoulder Range of Motion|Completed||N/A|40|Actual|Creighton University||2|||f||||f||||||||||2017-10-11 03:21:50.835218|2017-10-11 03:21:50.835218
NCT01518491|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-06-21|||April 2012||2012-04-01|June 2017|2017-06-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Open Label Trial of NanoDOX Hydrogel in Orthopedic Trauma Wounds With and Without Vacuum Assisted Closure Therapy|A Prospective, Randomized, Open Label Trial of NanoDOX™ Hydrogel Plus Vacuum Assisted Closure Therapy Versus Vacuum Assisted Closure Therapy Alone in Orthopedic Trauma Wounds.|Withdrawn||Phase 2|0|Actual|NanoSHIFT LLC||2|||f||||f||||||||||2017-10-11 03:21:51.023397|2017-10-11 03:21:51.023397
NCT01518478|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-02-27|||November 2011||2011-11-01|February 2017|2017-02-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot|An Open Label Study in Adults With Atopic Dermatitis to Assess Variability in Immune Response to Fluzone® Intradermal Vaccine|Completed||Early Phase 1|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||f||||||||||2017-10-11 03:21:51.130288|2017-10-11 03:21:51.130288
NCT01518465|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-03-02|||January 9, 2012|Actual|2012-01-09|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma|A Phase 2 Study of Lenalidomide and Low-dose Dexamethasone in Combination With Dalteparin in Previously Untreated Multiple Myeloma|Terminated||Phase 2|13|Actual|University of Southern California||2||Insufficient Accrual|f||||t||||||||||2017-10-11 03:21:51.215798|2017-10-11 03:21:51.215798
NCT01518452|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-06-13|||April 2011|Actual|2011-04-01|June 2017|2017-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Computerized Working Memory Training in Very-low-birth-weight Children at Preschool Age|Computerized Working Memory Training Evaluated With Clinical Assessments and Quantitative EEG in Very-low-birth-weight (VLBW) Children at Preschool Age|Completed||N/A|20|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 03:21:51.358886|2017-10-11 03:21:51.358886
NCT01518439|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2013-07-18|||January 2012||2012-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|January 2012|Actual|2012-01-01||Interventional|OPTICOUGH||Instrumental and Manual Increase of Couch in Neuromuscular Patients|Instrumental and Manual Increase of Couch in Neuromuscular Patients: Effects of Different Techniques on the Generated Flow|Completed||N/A|20|Actual|Centre d'Investigation Clinique et Technologique 805||1|||f||||f||||||||||2017-10-11 03:21:51.450855|2017-10-11 03:21:51.450855
NCT01518426|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-05-05|||June 2012||2012-06-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|3Electrods||Evaluation of Evoked Potentials Recording Modalities in Healthy Volunteer Population|Evaluation of Evoked Potentials Recording Modalities in Healthy Volunteer Population.|Completed||Early Phase 1|10|Actual|Centre d'Investigation Clinique et Technologique 805||1|||f||||t||||||||||2017-10-11 03:21:51.629952|2017-10-11 03:21:51.629952
NCT01518413|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-02-26|||December 2011||2011-12-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors|Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors|Completed||Phase 1|17|Actual|Children's Research Institute||1|||f||||t||||||||||2017-10-11 03:21:51.719655|2017-10-11 03:21:51.719655
NCT01518400|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-02-02|||February 2009||2009-02-01|February 2017|2017-02-01|December 2050|Anticipated|2050-12-01|January 2050|Anticipated|2050-01-01||Observational|||LIFE Cancer Survivorship Database for Pediatric Cancer|A Research Database for Survivors of Childhood Cancer|Recruiting||N/A|5000|Anticipated|Children's Hospital Los Angeles|||1||f||||f||||||||||2017-10-11 03:21:51.832113|2017-10-11 03:21:51.832113
NCT01518387|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-03-10|||January 2006||2006-01-01|March 2016|2016-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients|Phase III Open Study of BAY 77 1931 (Lanthanum Carbonate) in Patients With Hyperphosphatemia Undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD)|Completed||Phase 3|43|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:21:51.920115|2017-10-11 03:21:51.920115
NCT01518374|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-06-09|||December 2009||2009-12-01|June 2017|2017-06-01|May 3, 2017|Actual|2017-05-03|May 3, 2017|Actual|2017-05-03||Interventional|||Clinical Evaluation of Florbetapir F 18 (18F-AV-45)|Clinical Evaluation of Florbetapir F 18 (18F-AV-45)|Completed||Phase 2|1772|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:21:52.045568|2017-10-11 03:21:52.045568
NCT01518348|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-16|2013-02-26|||December 2012||2012-12-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|PREAII||Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents|Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents|Withdrawn||Phase 3|0|Actual|Allerderm||1||Study has been updated with new protocol number|f||||f||||||||||2017-10-11 03:21:52.17897|2017-10-11 03:21:52.17897
NCT01518335|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-05-08|||June 2009||2009-06-01|May 2017|2017-05-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|PRP||Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department|A Double-Blind, Randomized, Placebo Controlled Study Evaluating the Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department.|Completed||N/A|38|Actual|Albert Einstein Healthcare Network||2|||f||||t||||||||No||2017-10-11 03:21:52.274154|2017-10-11 03:21:52.274154
NCT01518322|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2013-06-11|2013-03-16||November 2011||2011-11-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational||A total of 235 subjects were included in the All Subjects Population. 13 of the 235 subjects were missing the FeNO measurement.|Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms|An Observational, Multi-Center, Single-Visit Study to Assess the Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms|Completed||N/A|235|Actual|Aerocrine AB|Physicians were blinded to FeNO results during the study, therefore asthma diagnoses and ICS prescriptions were made without knowledge of FeNO results.||1||f||||f||||||||||2017-10-11 03:21:52.377551|2017-10-11 03:21:52.377551
NCT01518309|ClinicalTrials.gov processed this data on October 10, 2017|2008-12-16|2017-04-18|||November 2004||2004-11-01|April 2017|2017-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients||Completed||Phase 2|39|Actual|ACADIA Pharmaceuticals Inc.||1|||f||||||||||||||2017-10-11 03:21:52.664232|2017-10-11 03:21:52.664232
NCT01518296|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-22|2013-03-28|||January 2012||2012-01-01|March 2013|2013-03-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Rating Pelvic Organs Prolapse in Women According to the POPQ Method Before and After Emptying the Urinary Bladder|Rating the Degree of Pelvic Organs Prolapse in Women According to the POPQ Method Before and After Emptying the Urinary Bladder|Unknown status|Recruiting|N/A|80|Anticipated|Carmel Medical Center||1|||f||||f||||||||||2017-10-11 03:21:52.742495|2017-10-11 03:21:52.742495
NCT01518283|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-06-29|||May 2012||2012-05-01|November 2015|2015-11-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Study of Weekly Cabazitaxel for Advanced Prostate Cancer|"Phase II Study of Weekly Cabazitaxel for Advanced Prostate Cancer in Unfit Hormone-Refractory Patients Previously Treated With Docetaxel"|Completed||Phase 2|74|Actual|Spanish Oncology Genito-Urinary Group||1|||f||||f||||||||||2017-10-11 03:21:52.843587|2017-10-11 03:21:52.843587
NCT01518270|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-11-09|2012-11-09||December 2011||2011-12-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women||Completed||N/A|179|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:21:52.96895|2017-10-11 03:21:52.96895
NCT01518257|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2014-07-15|2014-07-15|2014-01-27|January 2012||2012-01-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin Type A as Treatment for Osteoarthritis Knee Pain||Completed||Phase 1/Phase 2|121|Actual|Allergan||2|||f||||f||||||||||2017-10-11 03:21:53.156702|2017-10-11 03:21:53.156702
NCT01518244|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-07-17|2014-02-25||December 2011||2011-12-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||The analysis population includes all participants who received AZARGA® and with at least one on-therapy study visit (V2 or V3). Of the 50 enrolled, 1 participant discontinued after V1 and before V2.|Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America|Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America|Completed||Phase 4|50|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:21:53.576982|2017-10-11 03:21:53.576982
NCT01518231|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-24|||January 2012||2012-01-01|January 2012|2012-01-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|AHSCTIS||Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke|Phase 1 Study of Autologous Peripheral Hematopoietic Stem Cell Transplantation in Ischemic Stroke|Unknown status|Recruiting|Phase 1|40|Anticipated|Zhejiang Hospital||2|||f||||f||||||||||2017-10-11 03:21:53.752247|2017-10-11 03:21:53.752247
NCT01518218|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2015-04-09|||March 2006||2006-03-01|January 2012|2012-01-01|December 2009|Actual|2009-12-01|March 2007|Actual|2007-03-01||Interventional|||Effectiveness of Laying-on-of-hands for Sickle Cell Disease|Effectiveness of Laying-on-of-hands for Patients With Sickle Cell Disease in Africa|Completed||Phase 2|40|Actual|MOA Health Science Foundation||2|||f||||t||||||||||2017-10-11 03:21:53.855603|2017-10-11 03:21:53.855603
NCT01518205|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-22|2017-01-02|||February 2012||2012-02-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|HADIF||HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F)|HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F): a RCTrial to Evaluate the Effect of LDL-apheresis on the Recovery of Diabetic Ulcers in Patients With Peripheral Vasculopathy Not Susceptible to Revascularization.|Completed||N/A|13|Actual|Universita di Verona||2|||f||||f||||||||No||2017-10-11 03:21:53.934585|2017-10-11 03:21:53.934585
NCT01518192|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-28|2011-12-18|2010-06-28||June 2006||2006-06-01|December 2011|2011-12-01|January 2009|Actual|2009-01-01|November 2007|Actual|2007-11-01||Interventional|||Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome|Risk Factors for Failure of Erythema Migrans Treatment - Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Adult Patients With Erythema Migrans: Clinical and Microbiological Outcome.|Completed||Phase 4|544|Actual|University Medical Centre Ljubljana|Medical explanation besides Lyme disease of the symptoms in patients was based on history and physical examination, therefore some other medical explanations might have been missed. With regard to controls this was even more likely.|2|||f||||f||||||||||2017-10-11 03:21:54.033826|2017-10-11 03:21:54.033826
NCT01518179|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2017-07-18|||April 2012||2012-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Compression Gloves for Distal Radius Fracture|The Effect of Wearing Made-to-Measure Compression Gloves on Rehabilitation Following DRF.|Recruiting||N/A|120|Anticipated|Clalit Health Services||2|||f||||f||||||||||2017-10-11 03:21:54.443458|2017-10-11 03:21:54.443458
NCT01518166|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-01-24|||May 2006||2006-05-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH|A Two-way Cross-over, Placebo-controlled Interaction Trial in Two Parts (in Healthy Subjects), Studying Liraglutide's Potential Influence on the Absorption Pharmacokinetics of Lisinopril, Atorvastatin, Griseofulvin and Digoxin, and Liraglutide's Potential Influence on Intragastric pH|Completed||Phase 1|70|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:21:54.547229|2017-10-11 03:21:54.547229
NCT01518153|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-02-18|2016-01-22||February 2012||2012-02-01|February 2016|2016-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)|Phase 2 Study of Planned Donor Lymphocyte Infusion After Reduced Intensity Allogeneic Stem Cell Transplantation|Terminated||Phase 2|16|Actual|M.D. Anderson Cancer Center||2||Objectives not met.|f||||f||||||||||2017-10-11 03:21:54.657282|2017-10-11 03:21:54.657282
NCT01518140|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2013-08-12|||December 2013||2013-12-01|August 2013|2013-08-01||||December 2019|Anticipated|2019-12-01||Interventional|||BiPAP-Vapotherm RCT|Novel Oxygen Delivery Modalities for Refractory Dyspnea in Patients With Advanced Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-10-11 03:21:55.367698|2017-10-11 03:21:55.367698
NCT01518127|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-07-18|||August 2011||2011-08-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|September 2013|Actual|2013-09-01||Interventional|AMDCELL||Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration|Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration|Completed||N/A|20|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 03:21:55.448099|2017-10-11 03:21:55.448099
NCT01518114|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-26|||December 2011||2011-12-01|January 2012|2012-01-01||||January 2013|Anticipated|2013-01-01||Interventional|||Exercise Training in Patients With Hypertrophic Cardiomyopathy||Unknown status|Recruiting|N/A|60|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 03:21:55.522511|2017-10-11 03:21:55.522511
NCT01518101|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-22|2017-02-23|||January 2012||2012-01-01|February 2017|2017-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|PREFER||Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications|A Randomized, Open-label, Cross-over Study to Evaluate Patient Preferences for Eucreas® Versus Victoza® as add-on to Metformin in Type 2 Diabetes Mellitus Patients Who Did Not Have Adequate Glycaemic Control With Metformin.|Completed||Phase 4|62|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:21:55.611643|2017-10-11 03:21:55.611643
NCT01518088|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2016-04-20|||February 2012||2012-02-01|January 2012|2012-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of a Dietary Fiber on Fecal Microbiota and Metabolism|Effects of a Dietary Fiber on Human Gut Microbiota, Bioactive Metabolites and Blood Glucose Control|Completed||N/A|20|Actual|Ingredion Incorporated||3|||f||||f||||||||||2017-10-11 03:21:55.814888|2017-10-11 03:21:55.814888
NCT01518075|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2012-09-14|||January 2012||2012-01-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Breathing-swallowing Interaction in Chronic Obstructive Pulmonary Disease Patients - Impact of Non Invasive Ventilation|Breathing-swallowing Interaction in Chronic Obstructive Pulmonary Disease (COPD) Patients Hospitalized in Intensive Care Unit for an Acute Exacerbation: Impact of Non Invasive Ventilation. Physiological Evaluation|Completed||N/A|16|Actual|University Hospital, Caen||2|||f||||t||||||||||2017-10-11 03:21:55.908727|2017-10-11 03:21:55.908727
NCT01518062|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-01-17|||November 1989||1989-11-01|January 2017|2017-01-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome|Dose Response Trial of Biosynthetic Authentic Human Growth Hormone and Induction of Puberty With 17b Oestradiol in Girls With Turner's Syndrome|Completed||Phase 4|65|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:21:56.012445|2017-10-11 03:21:56.012445
NCT01518049|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2015-10-12|||February 2012||2012-02-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Observational|||Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)||Completed||N/A|50|Actual|Aarhus University Hospital|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-11 03:21:56.132005|2017-10-11 03:21:56.132005
NCT01518036|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-02-27|||September 14, 1987|Actual|1987-09-14|February 2017|2017-02-01|April 11, 2004|Actual|2004-04-11|April 11, 2004|Actual|2004-04-11||Interventional|||Use of Somatropin in Turner Syndrome|The Use of Norditropin® in Turner's Syndrome|Completed||Phase 3|57|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:21:56.212157|2017-10-11 03:21:56.212157
NCT01518023|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-01-24|||January 2011||2011-01-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy|Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy|Completed||N/A|240|Actual|University of Sao Paulo|||3||f||||f||||||||||2017-10-11 03:21:56.321495|2017-10-11 03:21:56.321495
NCT01518010|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2012-01-24|||June 2012||2012-06-01|January 2012|2012-01-01|January 2014|Anticipated|2014-01-01|December 2012|Anticipated|2012-12-01||Interventional|||Multi-player Online Video Games for Cognitive Rehabilitation|Multi-player Online Video Games for Cognitive Rehabilitation|Unknown status|Not yet recruiting|N/A|10|Anticipated|University of Portsmouth||1|||f||||f||||||||||2017-10-11 03:21:56.458252|2017-10-11 03:21:56.458252
NCT01517997|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-10-08|||August 2011||2011-08-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|IDEAS-I||Infrapopliteal Drug Eluting Angioplasty Versus Stenting|Infrapopliteal Drug Eluting Angioplasty Versus Stenting for the Treatment of Long-segment Arterial Disease: The IDEAS-I Randomized Controlled Trial.|Completed||Phase 2/Phase 3|50|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 03:21:56.568903|2017-10-11 03:21:56.568903
NCT01517984|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-08-10|2016-06-16||November 2010||2010-11-01|August 2017|2017-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Intent-to-treat|Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation|Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation|Terminated||Phase 2|52|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|After meeting protocol stopping rules, this trial was closed to new enrollment and randomization. No additional prespecified withdrawal of tacrolimus was allowed. Those already enrolled or randomized were followed for up to 24 months post-transplant.|2||Absence of equipoise on the basis of predetermined stopping rules.|f||||t||||||||||2017-10-11 03:21:56.712778|2017-10-11 03:21:56.712778
NCT01517971|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-08-07|||January 2012||2012-01-01|August 2017|2017-08-01||||June 2100|Anticipated|2100-06-01||Observational|||Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer|Validation of Molecular Prognostic Tests in NSCLC|Recruiting||N/A|1060|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Tissue samples   "|||2017-10-11 03:21:57.731347|2017-10-11 03:21:57.731347
NCT01517958|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2016-03-24|||October 2011||2011-10-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates|The Use of Lung Ultrasound to Diagnose RDS vs. TTN in Neonates Greater Than or Equal to 28 Weeks Gestation|Completed||N/A|36|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||t||||||||No||2017-10-11 03:21:57.85659|2017-10-11 03:21:57.85659
NCT01517945|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-02-06|||January 2012||2012-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Attention and Interpretation Modification (AIM) for Fear of Breast Cancer Recurrence: An Intervention Development Study|Attention and Interpretation Modification (AIM) for Fear of Breast Cancer Recurrence: An Intervention Development Study|Active, not recruiting||N/A|127|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||t||||||Samples Without DNA|"     salvia   "|||2017-10-11 03:21:57.998354|2017-10-11 03:21:57.998354
NCT01517932|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-22|2013-03-18|||June 2011||2011-06-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia|Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia in Patients Undergoing Thoracotomy During Anesthesia Recovery Period|Completed||Phase 4|60|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-10-11 03:21:58.107225|2017-10-11 03:21:58.107225
NCT01517919|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-09-08|||January 2010||2010-01-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||"Peer-Led Self-Management Support in Real World Clinical and Community Settings"|"Peer-Led Self-Management Support in Real World Clinical and Community Settings"|Completed||N/A|241|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:21:58.184663|2017-10-11 03:21:58.184663
NCT01517906|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-20|||April 2002||2002-04-01|January 2012|2012-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Developing Identity: An Eating Disorder Randomized Clinical Trial|Developing Identity: An Eating Disorder Nursing Therapy|Completed||N/A|69|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:21:58.293143|2017-10-11 03:21:58.293143
NCT01517893|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-03-11|2015-02-19||January 2012||2012-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Clinical Trial of Simvastatin to Treat Generalized Vitiligo|A Phase-II, Randomized, Placebo-controlled Trial of Simvastatin in Generalized Vitiligo|Completed||Phase 2|15|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 03:21:58.422043|2017-10-11 03:21:58.422043
NCT01517880|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-06-14||2016-06-14|May 2012||2012-05-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|GNE Myopathy||A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy|A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy|Completed||Phase 2|46|Actual|Ultragenyx Pharmaceutical Inc||3|||f||||t||||||||||2017-10-11 03:21:58.701835|2017-10-11 03:21:58.701835
NCT01517854|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-10-27|||October 2012||2012-10-01|October 2016|2016-10-01||||November 2017|Anticipated|2017-11-01||Interventional|RePo1||Revatio Portal-Pulmonary Arterial Hypertension Trial|Revatio Portal-Pulmonary Arterial Hypertension Trial (RePo1 Trial): A Randomized, Double-blinded, Placebo-controlled, Multi-center Study to Evaluate the Effects of Sildenafil Citrate (Revatio) 20 mg TID on Patients With Portal Pulmonary Arterial Hypertension (PPAH)|Enrolling by invitation||Phase 2|44|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 03:21:58.874537|2017-10-11 03:21:58.874537
NCT01517841|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-01-24|||January 2012||2012-01-01|January 2012|2012-01-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Observational|||Barriers to Peritoneal Dialysis Selection|Barriers to Selection and Initiation of Peritoneal Dialysis in the United States|Unknown status|Not yet recruiting|N/A|180|Anticipated|MetroHealth Medical Center|||1||f||||f||||||||||2017-10-11 03:21:58.958864|2017-10-11 03:21:58.958864
NCT01517828|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2014-12-02|||January 2012||2012-01-01|December 2014|2014-12-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room|Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room.|Unknown status|Active, not recruiting|Phase 3|62|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 03:21:59.131951|2017-10-11 03:21:59.131951
NCT01517815|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-11-28|||February 2012||2012-02-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pharmacokinetic of Doripenem and Piperacillin/Tazobactam in More Than 120 kg Critically Ill Patients|Pharmacokinetic of Doripenem and Piperacillin/Tazobactam in More Than 120 kg Critically Ill Patients|Completed||N/A|50|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 03:21:59.229986|2017-10-11 03:21:59.229986
NCT01517802|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2017-08-24|||March 28, 2012|Actual|2012-03-28|August 2017|2017-08-01|April 9, 2018|Anticipated|2018-04-09|April 9, 2018|Anticipated|2018-04-09||Interventional|||A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate|A Phase 3b Multicenter, Open-label Abiraterone Acetate Long-term Safety Study|Recruiting||Phase 3|300|Anticipated|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 03:21:59.326156|2017-10-11 03:21:59.326156
NCT01517789|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-03-04|||January 2012||2012-01-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|VISUOPEV||Advantage of Using Intraoperative Visual Evoked Potentials to Preserve Visual Function During Surgical Procedures Near the Optical Pathways|Advantage of Using Intraoperative Visual Evoked Potentials to Preserve Visual Function During Surgical Procedures Near the Optical Pathways|Completed||N/A|40|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-11 03:21:59.511657|2017-10-11 03:21:59.511657
NCT01517763|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-09-28|||January 2012||2012-01-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Comparison Study of the ICON™ Auto Series With and Without SensAwake™ and ThermoSmart™ and Conventional Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients||Terminated||N/A|25|Actual|Fisher and Paykel Healthcare||3||The site closed down, therefore the study has been terminated.|f||||f||||||||||2017-10-11 03:21:59.707385|2017-10-11 03:21:59.707385
NCT01517750|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-06-21|2015-03-10||January 2012||2012-01-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study to Predict the Need for Humidification Use and Comparison of the Effect of ThermoSmart™ and no Humidification on Adherence||Completed||N/A|80|Actual|Fisher and Paykel Healthcare||2|||f||||f||||||||||2017-10-11 03:21:59.796283|2017-10-11 03:21:59.796283
NCT01517737|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-02-08|||January 2012||2012-01-01|February 2012|2012-02-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Immunology of Failing Metal-on-Metal Hip Replacement|Immune Cell Involvement in the Tissue Response to Metallosis in Patients With Failed Metal-on-metal Hip Replacements|Unknown status|Recruiting|N/A|105|Anticipated|University of East Anglia|||1||f||||t||||||Samples With DNA|"     blood from all patients; joint fluid, soft tissue and bone on operated patients   "|||2017-10-11 03:22:00.246826|2017-10-11 03:22:00.246826
NCT01517724|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-05-17|||December 2009||2009-12-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2014|Actual|2014-12-01||Interventional|BCT||Bortezomib Consolidation Trial|Phase II Study of Bortezomib Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Multiple Myeloma|Active, not recruiting||Phase 2|40|Actual|University College, London||1|||f||||t||||||||||2017-10-11 03:22:00.310113|2017-10-11 03:22:00.310113
NCT01517698|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2016-07-06||2016-07-06|May 2012||2012-05-01|July 2016|2016-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of RO4917523 in Patients With Fragile X Syndrome|A Randomized, Double-blind, 12-week, Parallel Group, Placebo-controlled Study of Efficacy and Safety of RO4917523 in Patients With Fragile X Syndrome.|Completed||Phase 2|185|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:22:02.268016|2017-10-11 03:22:02.268016
NCT01517685|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-02-17|||January 2012||2012-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Hallelujah Acres Omega 3 Fat Study|Hallelujah Acres Omega 3 Fat Study|Completed||N/A|13|Actual|Hallelujah Acres||1|||f||||f||||||||||2017-10-11 03:22:02.434074|2017-10-11 03:22:02.434074
NCT01517672|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-21|||January 2008||2008-01-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Imaging Outcomes of Cognitive Behavioral Therapy (CBT) for Battered Women With Posttraumatic Stress Disorder|Neurobiology of Severe Psychological Trauma in Women|Completed||N/A|41|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 03:22:02.518651|2017-10-11 03:22:02.518651
NCT01517659|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-06-20|||November 2012||2012-11-01|November 2012|2012-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Non-Invasive Reduction of Fat in the Inner Thighs|Non-Invasive Reduction of Fat in the Inner Thighs With the Zeltiq Coolsculpting System|Completed||N/A|45|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 03:22:02.599484|2017-10-11 03:22:02.599484
NCT01517646|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-06-20|||February 2012||2012-02-01|January 2012|2012-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pilot Study of CoolTXT for Non-Invasive Fat Reduction|Pilot Study of CoolTXT for Non-Invasive Fat Reduction|Completed||N/A|18|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 03:22:02.683933|2017-10-11 03:22:02.683933
NCT01517633|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2012-01-24|||January 2012||2012-01-01|January 2012|2012-01-01||||January 2013|Anticipated|2013-01-01||Interventional|||Study of a Diagnostic Device for Identifying Between Amniotic Fluid to Urine|Study of a Diagnostic Device for Identifying Between Amniotic Fluid to Urine|Unknown status|Active, not recruiting|Phase 2/Phase 3|100|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-10-11 03:22:02.766491|2017-10-11 03:22:02.766491
NCT01517620|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2013-12-12|||November 2011||2011-11-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy||Completed||Phase 4|38|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:22:02.860773|2017-10-11 03:22:02.860773
NCT01517607|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-09-30|||February 2012||2012-02-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|MUKOSA||Mesalazine (PENTASA®) in Ulcerative Colitis|Mesalazine (PENTASA®) in Ulcerative Colitis: Correlation of the Information Level With Patient's Compliance in Everyday Practice|Completed||N/A|506|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 03:22:03.072507|2017-10-11 03:22:03.072507
NCT01517594|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2013-10-18|||October 2011||2011-10-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis|Tolerability of Pentasa® Sachet in Patients With Ulcerative Colitis Under Conditions of Standard Practice in the Czech Republic|Completed||N/A|568|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 03:22:03.511813|2017-10-11 03:22:03.511813
NCT01517581|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-01-24|||October 2008||2008-10-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Brown Fat Activity and White Fat Accumulation|Study on the Association Between Brown Adipose Tissue Activation and White Adipose Tissue Accumulation in Successfully Treated Pediatric Malignancy|Completed||N/A|32|Actual|Children's Hospital Los Angeles|||1||f||||f||||||||||2017-10-11 03:22:03.656162|2017-10-11 03:22:03.656162
NCT01517568|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2017-01-25|||November 2006||2006-11-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Metabolism and Excretion of Liraglutide in Healthy Male Volunteers|A Single-Centre, Open Label Trial Investigating the Metabolites in Plasma, Urine and Faeces After a Single Subcutaneous Dose of [3H]-Liraglutide to Healthy Subjects|Completed||Phase 1|7|Anticipated|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:22:03.753873|2017-10-11 03:22:03.753873
NCT01517555|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2017-01-25|||October 2006||2006-10-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes|A Single Centre, Randomised, Double-blind, Placebo Controlled Trial to Evaluate the Possible Drug-drug Interaction Between Liraglutide and Paracetamol and the Effects of Liraglutide on Postprandial Glucose and Insulin, Gastric Emptying, Appetite Sensations and Energy Intake in Subjects With Type 2 Diabetes|Completed||Phase 1|18|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:22:03.884214|2017-10-11 03:22:03.884214
NCT01517542|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-08-12|||February 2010||2010-02-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of Effectiveness of Nutritional Counseling in Patients After Stroke|Evaluation on the Effectiveness of Nutritional Counseling on an Adapted DASH Diet in Patients After Stroke: a Randomized Clinical Trial|Unknown status|Recruiting|N/A|128|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 03:22:03.99419|2017-10-11 03:22:03.99419
NCT01517529|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2015-10-20|2015-08-25||January 2012||2012-01-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Observational||chronically HCV-infected patients who fail the standard peg-IFN and Ribavirin (RBV) therapy (NR)|Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations|Evaluating the Role of the Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy|Completed||N/A|10|Actual|University of Cincinnati|||1||f||||f||||||Samples With DNA|"     Blood lymphocytes from enrolled subjects will be retained until all investigations will be     performed and publications are generated. After that remaining samples will be discarded     properly according to the Biosafety instructions.   "|||2017-10-11 03:22:04.122833|2017-10-11 03:22:04.122833
NCT01517516|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-01-12|||March 2011||2011-03-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|MMI||Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.|A Magnetic Resonance Imaging (MRI) Study to Investigate Differences in the Structure and the Function of the Brain at Rest; Between Persons With Functional Pain Conditions Such as IBS or Vulvodynia, IBD and Healthy Controls|Completed||N/A|165|Actual|University of California, Los Angeles|||2||f||||f||||||||||2017-10-11 03:22:04.416248|2017-10-11 03:22:04.416248
NCT01517503|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2012-12-02|||December 2011||2011-12-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Acceptance and Commitment Therapy Versus Cognitive Therapy for the Treatment of Major Depressive Disorder|Acceptance and Commitment Therapy vs. Cognitive Therapy for the Treatment of Major Depressive Disorder|Unknown status|Recruiting|N/A|98|Anticipated|VU University of Amsterdam||2|||f||||t||||||||||2017-10-11 03:22:04.618091|2017-10-11 03:22:04.618091
NCT01517490|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2015-03-10|||August 2011||2011-08-01|March 2015|2015-03-01||||December 2016|Anticipated|2016-12-01||Observational|||Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes|Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes|Unknown status|Recruiting|N/A|100|Anticipated|Glostrup University Hospital, Copenhagen|||6||f||||f||||||||||2017-10-11 03:22:04.757597|2017-10-11 03:22:04.757597
NCT01517477|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2016-03-23|||January 2012||2012-01-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects|A Prospective, Randomized, Controlled Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications, Implanted With One, Two, or Three Trabecular Micro-Bypass Stents|Active, not recruiting||Phase 4|251|Actual|Glaukos Corporation||3|||f||||f||||||||Yes|18 month results published in Clinical Ophthalmology 2015:9 2313-2320.|2017-10-11 03:22:04.892764|2017-10-11 03:22:04.892764
NCT01517464|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-04-24|||January 2012||2012-01-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SGT94-01||A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors|A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors|Completed||Phase 1|13|Actual|SynerGene Therapeutics, Inc.||1|||f||||t||||||||Undecided||2017-10-11 03:22:05.001724|2017-10-11 03:22:05.001724
NCT01517451|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2016-01-28|||May 2013||2013-05-01|January 2016|2016-01-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Radiation and Androgen Ablation for Prostate Cancer|Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate|Recruiting||Phase 1/Phase 2|105|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||Undecided||2017-10-11 03:22:05.123999|2017-10-11 03:22:05.123999
NCT01517438|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-20|||March 2011||2011-03-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Serotonin Inhibitors on Patient-controlled Analgesia Related Nausea and Vomiting||Completed||N/A|21|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 03:22:05.255608|2017-10-11 03:22:05.255608
NCT01517425|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-09-05|||November 2012||2012-11-01|September 2017|2017-09-01||||July 2020|Anticipated|2020-07-01||Observational|iPSC||Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells|Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells|Enrolling by invitation||N/A|200|Anticipated|Scripps Translational Science Institute|||2||f||||f||||||||||2017-10-11 03:22:05.334861|2017-10-11 03:22:05.334861
NCT01517412|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2016-08-22|2016-08-22|2014-05-06|February 2012||2012-02-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin|A 24-week, Open-label, Randomized, 2-arm Parallel Group, Multinational, Multi-center Clinical Trial to Compare the Efficacy and Safety of Lixisenatide Injected Prior to the Main Meal of the Day Versus Lixisenatide Injected Prior to Breakfast in Type 2 Diabetic Patients Not Adequately Controlled on Metformin|Completed||Phase 3|451|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 03:22:05.497133|2017-10-11 03:22:05.497133
NCT01517399|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-10-22|||December 2011||2011-12-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects|A Phase 1, Open-Label, Single-Sequence Crossover Study Assessing the Effect of Tivantinib (ARQ 197) on the Pharmacokinetics of Omeprazole/S-Warfarin/Caffeine/Midazolam and Digoxin in Cancer Subjects|Completed||Phase 1|28|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-11 03:22:06.397096|2017-10-11 03:22:06.397096
NCT01517386|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2012-12-03|||January 2012||2012-01-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|OTS-PS||Photonic Needle and Paravertebral Space Detection|Optical Tissue Stylet (OTS) - Descriptive Observational Study Into Paravertebral Space (PS) Detection in Humans|Completed||N/A|10|Actual|Philips Healthcare|||1||f||||f||||||||||2017-10-11 03:22:06.500892|2017-10-11 03:22:06.500892
NCT01517373|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2016-12-06|2016-12-06|2014-04-21|February 2012||2012-02-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Baseline analysis population included all randomized participants who received at least 1 dose of study treatment.|Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin|A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose-ranging, Parallel Group Study To Evaluate Safety And Efficacy Of Pf-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin|Completed||Phase 2|304|Actual|Pfizer||5|||f||||t||||||||||2017-10-11 03:22:06.698266|2017-10-11 03:22:06.698266
NCT01517360|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2013-03-27|||January 2012||2012-01-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Pharmacological Approach to Improve the Outcome of Social Cognition Training|Pharmacological Approach to Improve the Outcome of Social Cognition Training|Completed||Phase 1|27|Actual|VA Greater Los Angeles Healthcare System||2|||f||||f||||||||||2017-10-11 03:22:09.816479|2017-10-11 03:22:09.816479
NCT01517347|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-10-20|||January 2012||2012-01-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation|Low Dose of Interleukin-2 Following Allogeneic Unmanipulated Blood and Marrow Transplantation in Treating Patients With Standard Risk Hematologic Malignancy|Terminated||N/A|90|Actual|Peking University People's Hospital||2||"Because the conditional power was 0.083, the Data and Safety Monitoring Board recommended   halting the study due to futility after the 1st interim analysis."|f||||t||||||||||2017-10-11 03:22:09.917474|2017-10-11 03:22:09.917474
NCT01517334|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2015-08-25|||May 2012||2012-05-01|April 2014|2014-04-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)|Multi-Center Phase 3 Trial of Minocycline HCl 1 mg Microspheres for the Use in Subjects With Peri-Implantitis: Clinical and Microbiological Evaluations|Completed||Phase 3|208|Actual|OraPharma||2|||f||||f||||||||||2017-10-11 03:22:10.046706|2017-10-11 03:22:10.046706
NCT01517321|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2013-07-07||||||July 2013|2013-07-01||||||||Interventional|||MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes|MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes|Completed||Phase 3|||Ono Pharmaceutical Co. Ltd||2|||f||||||||||||||2017-10-11 03:22:10.154921|2017-10-11 03:22:10.154921
NCT01517308|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-03-16|||May 2012||2012-05-01|March 2012|2012-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C|24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C, RELAPSERS TO PEG-IFN + RIBAVIRIN TREATMENT. A RANDOMIZED CONTROLLED TRIAL|Withdrawn||Phase 3|0|Actual|Federico II University||2||"Time elapsed to require permissions and a recent paper showed a high efficacy of a 48-week   regimen in this setting. It seems non-ethical to start this trial"|f||||f||||||||||2017-10-11 03:22:10.404802|2017-10-11 03:22:10.404802
NCT01517295|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-06-17|2016-05-04||February 2012||2012-02-01|June 2016|2016-06-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients|Evaluating the Pharmacokinetic Profile of Hydromorphone in Chronic Pain Patients Taking Hydrocodone/APAP|Completed||Phase 4|30|Actual|NEMA Research, Inc.|Sensitivity of the lab test used to determine plasma hydromorphone concentrations was not sufficient. Failure to meet the lowest level of detection, all subjects plasma hydromorphone concentrations were recorded as zero at all time points.|2|||f||||t||||||||||2017-10-11 03:22:10.51838|2017-10-11 03:22:10.51838
NCT01517087|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-08-28|||January 6, 2012||2012-01-06|July 11, 2017|2017-07-11||||||||Observational|||Studying Motor Neuron Tests|Structural and Functional Brain Imaging Markers of Upper Motor Neuron Function|Recruiting||N/A|55|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:22:14.397923|2017-10-11 03:22:14.397923
NCT01517282|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2014-11-09|2014-10-08||January 2012||2012-01-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional||All subjects who received 1 or more dose of placebo or MOR103 (safety population).|Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis|A Randomized, Double-blind, Placebo-controlled Phase Ib Study to Evaluate the Safety and Pharmacokinetics of MOR103, a Human Antibody to GM-CSF, in Patients With Multiple Sclerosis|Completed||Phase 1/Phase 2|32|Actual|MorphoSys AG|Key limitations of this trial include its small sample size and limited duration. Efficacy assessments were not made in this study. Larger clinical trials will be required to evaluate the potential of MOR103 in treating patients with MS.|4|||f||||t||||||||||2017-10-11 03:22:11.019718|2017-10-11 03:22:11.019718
NCT01517269|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-03-06|||April 2010||2010-04-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||PETS-D (Parent Education Thru Simulation-Diabetes)|PETS-D (Parent Education Thru Simulation-Diabetes)|Completed||Phase 3|191|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 03:22:12.584812|2017-10-11 03:22:12.584812
NCT01517256|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-20|||November 2009||2009-11-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|LEAP||A Pilot Study Evaluating a Multidisciplinary Chronic Pain Group Therapy in a Primary Care Setting|Living Everyday Above-and-beyond Pain Research (LEAP): A Pilot Study Evaluating a Multidisciplinary Chronic Pain Group Therapy in a Primary Care Setting|Completed||Phase 3|60|Actual|McMaster University||2|||f||||||||||||||2017-10-11 03:22:12.671729|2017-10-11 03:22:12.671729
NCT01517243|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-05-31|||June 2010||2010-06-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase II Study of Alternating Sunitinib and Temsirolimus|Alternating Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma: A Phase II Study of Alternating Sunitinib and Temsirolimus|Unknown status|Active, not recruiting|Phase 2|37|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 03:22:12.780891|2017-10-11 03:22:12.780891
NCT01517230|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-05-19|||March 2012||2012-03-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Can Mass Media Campaigns Reduce Child Mortality|Can Mass Media Campaigns Reduce Child Mortality|Completed||N/A|100000|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 03:22:12.884373|2017-10-11 03:22:12.884373
NCT01517217|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-01-20|||April 2011||2011-04-01|January 2012|2012-01-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Effect of Postoperative Girdle Following Abdominal Surgery on Pulmonary Function, Mobilisation and Postoperative Pain|Randomised Trial Evaluating the Effect of Postoperative Girdle Following Major Abdominal Surgery|Unknown status|Recruiting|N/A|50|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:22:12.995134|2017-10-11 03:22:12.995134
NCT01517204|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2012-09-16|||May 2011||2011-05-01|May 2011|2011-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Efficacy of Trachway (R) Intubating Stylet in the Insertion of the Double Lumen Endobronchial Tube|The Comparison of Direct Laryngoscope and Trachway (R) Intubating Stylet in the Insertion of the Double Lumen Endobronchial Tube|Completed||N/A|60|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-10-11 03:22:13.125306|2017-10-11 03:22:13.125306
NCT01517191|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-20|||November 2011||2011-11-01|January 2012|2012-01-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01||Observational|SOS-VE01||Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults|Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults|Unknown status|Recruiting|N/A|2400|Anticipated|Dalhousie University|||2||f||||f||||||Samples Without DNA|"     Serum and Nasopharyngeal swabs   "|||2017-10-11 03:22:13.225024|2017-10-11 03:22:13.225024
NCT01517178|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2015-03-03|2015-03-03||May 2011||2011-05-01|March 2015|2015-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care|An Open-labelled, Randomised, Controlled, Comparative, Multi-national, Cross-over Study Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared to 2-piece Standard Care Ostomy Products|Terminated||Phase 3|33|Actual|Coloplast A/S|Early termination leading to small number of subjects analyzed.|2|||f||||f||||||||||2017-10-11 03:22:13.371661|2017-10-11 03:22:13.371661
NCT01517165|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-06-30|||January 4, 2012||2012-01-04|February 2, 2015|2015-02-02|February 2, 2015|Actual|2015-02-02|February 2, 2015|Actual|2015-02-02||Interventional|||Pioglitazone to Treat Opioid Withdrawal Symptoms|Pioglitazone as an Aid During Buprenorphine Taper|Terminated||Phase 1|120|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:22:13.691645|2017-10-11 03:22:13.691645
NCT01517139|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-10-05|||December 22, 2011||2011-12-22|July 28, 2017|2017-07-28||||||||Observational|||Diet and Nutrition Pilot Study for Chinese Adolescents and Their Mothers|Pilot Study to Test the Methods for the Diet, Nutrition and Physical Activity Feasibility Study of Early Life Determinants of Adult Cancers in a Chinese Cohort of Adolescents and Their Mothers|Completed||N/A|360|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:22:14.017409|2017-10-11 03:22:14.017409
NCT01517126|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-08-22|||January 2, 2012||2012-01-02|August 15, 2017|2017-08-15||||||||Observational|||Assessing Suicide Risk in Adolescents With Developmental Delays|Assessing Suicide Risk in Adolescents With Developmental Delays: Development of a Screening Tool|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:22:14.100131|2017-10-11 03:22:14.100131
NCT01517113|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-06-30|||January 2, 2012||2012-01-02|October 20, 2016|2016-10-20||||||||Observational|||Age-Related Changes in Body Composition|Age-Associated Changes in Regional Adiposity and Novel Cardiovascular Risk Factors|Completed||N/A|350|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:22:14.161805|2017-10-11 03:22:14.161805
NCT01517100|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-06-30|||January 2, 2012||2012-01-02|December 8, 2016|2016-12-08|October 6, 2014|Actual|2014-10-06|October 6, 2014|Actual|2014-10-06||Interventional|||The Role of Endocannabinoids in Insulin Production and Action|The Roles of Endocannabinoids in Insulin Secretion and Action|Completed||Phase 1|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:22:14.233501|2017-10-11 03:22:14.233501
NCT01517074|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2016-08-31|2014-05-12||January 2012||2012-01-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Interventional|ISAS||Sirolimus Injections for Autoimmune Scleritis|A Phase I/II Study to Investigate Subconjunctival Sirolimus for the Treatment of Active Autoimmune Non-Necrotizing Anterior Scleritis|Completed||Phase 1/Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 03:22:14.530058|2017-10-11 03:22:14.530058
NCT01517061|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-06-30|||January 3, 2012||2012-01-03|July 30, 2014|2014-07-30|July 30, 2014||2014-07-30|||||Observational|||Genetics and Phantom Limb Pain|Integrative Genomic Analysis In Phantom Limb Pain|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:22:14.882504|2017-10-11 03:22:14.882504
NCT01517048|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-06-30|||January 9, 2012||2012-01-09|December 12, 2014|2014-12-12|December 12, 2014||2014-12-12|||||Observational|||Brain-Derived Neurotrophic Factor in Obesity and Brain Function|Brain-Derived Neurotrophic Factor in Obesity and Neurocognitive Function|Completed||N/A|59|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:22:14.963761|2017-10-11 03:22:14.963761
NCT01517035|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-24|2017-06-30|||January 13, 2012||2012-01-13|March 29, 2017|2017-03-29|March 29, 2017|Actual|2017-03-29|March 29, 2017|Actual|2017-03-29||Interventional|||Improving Blood Stem Cell Collection and Transplant Procedures|Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using Ex Vivo CD3, CD19 Depletion and CD34 Selection|Completed||Phase 1/Phase 2|43|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:22:15.071244|2017-10-11 03:22:15.071244
NCT01517009|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2013-06-25|||June 2008||2008-06-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|DoCCS||A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer|A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer|Completed||Phase 2|50|Anticipated|Jeroen Bosch Ziekenhuis||1|||f||||t||||||||||2017-10-11 03:22:15.304087|2017-10-11 03:22:15.304087
NCT01516996|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-03-18|||March 2012||2012-03-01|March 2012|2012-03-01|March 2018|Anticipated|2018-03-01|September 2013|Anticipated|2013-09-01||Interventional|||Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer|Neoadjuvant and Concurrent Chemoradiotherapy Plus Nimotuzumab in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Oropharynx and Hypopharynx|Recruiting||Phase 2|80|Anticipated|The Second People's Hospital of Sichuan||2|||f||||t||||||||||2017-10-11 03:22:15.412976|2017-10-11 03:22:15.412976
NCT01516983|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2014-02-13|||December 2011||2011-12-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation|A Single Center, Open Label, Dose-Finding Study to Determine the Safety of Icotinib in Combination With Whole Brain Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation.|Completed||Phase 1/Phase 2|15|Actual|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 03:22:15.558368|2017-10-11 03:22:15.558368
NCT01516970|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-06-21|2016-06-20|2014-06-27|November 25, 2011|Actual|2011-11-25|June 2017|2017-06-01|September 28, 2013|Actual|2013-09-28|August 1, 2013|Actual|2013-08-01||Interventional|PEPDar|The safety population included all participants who received at least 1 dose of randomized HIV PEP.|Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)|HIV Postexposure Prophylaxis With Darunavir/r (PEPDar)|Completed||Phase 3|312|Actual|Janssen-Cilag G.m.b.H||2|||f||||f||f||||||||2017-10-11 03:22:15.671656|2017-10-11 03:22:15.671656
NCT01516931|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2014-07-17|||December 2011||2011-12-01|July 2014|2014-07-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Depression|A Study to Evaluate the Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of the Symptoms of Depression.|Unknown status|Recruiting|Phase 3|540|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 03:22:16.517921|2017-10-11 03:22:16.517921
NCT01516918|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-10-09||2014-10-09|February 2012||2012-02-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis|A Multicenter, Open-Label Phase 2b Pilot Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir, Peginterferon-Alfa-2, and Ribavirin) in Subjects With Genotype 1 Chronic Hepatitis C With Compensated Cirrhosis|Completed||Phase 2|103|Actual|Vertex Pharmaceuticals Incorporated||1|||f||||t||||||||||2017-10-11 03:22:16.649552|2017-10-11 03:22:16.649552
NCT01516905|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-03-16|||December 2011||2011-12-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||PET/CT Imaging of Malignant Brain Tumors With 124I-NM404|PET/CT Imaging of Malignant Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue 124I-NM404|Active, not recruiting||N/A|19|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-10-11 03:22:17.132821|2017-10-11 03:22:17.132821
NCT01516892|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2016-11-09|2016-11-09||December 2011||2011-12-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||All enrolled participants.|A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine||Completed||Phase 4|716|Actual|Allergan||1|||f||||f||||||||||2017-10-11 03:22:17.244401|2017-10-11 03:22:17.244401
NCT01516879|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-08-28|2015-08-28|2014-05-15|January 2012||2012-01-01|August 2015|2015-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|DESCARTES||Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study|A Double-Blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Long-Term Tolerability and Durable Efficacy of AMG 145 (Evolocumab) on LDL-C in Hyperlipidemic Subjects|Completed||Phase 3|905|Actual|Amgen||2|||f||||t||||||||||2017-10-11 03:22:18.034651|2017-10-11 03:22:18.034651
NCT01516866|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-03-16|||November 2011||2011-11-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|September 2015|Actual|2015-09-01||Observational|NaFl PET/CT||Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy|NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients With Metastatic Castrate-resistant Prostate Cancer to Bone Treated With Either an Antimicrotubule Directed Agent or Androgen Receptor (AR)-Directed Therapies|Active, not recruiting||N/A|58|Actual|University of Wisconsin, Madison|||2||f||||t||||||||||2017-10-11 03:22:19.490689|2017-10-11 03:22:19.490689
NCT01516853|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2015-06-16|||January 2012||2012-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Non-invasive Quantification of Liver Iron With MRI|Non-invasive Quantification of Liver Iron With MRI|Completed||N/A|50|Actual|University of Wisconsin, Madison||1|||f||||||||||||||2017-10-11 03:22:19.60186|2017-10-11 03:22:19.60186
NCT01516840|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-01-17|||March 2012||2012-03-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients|Randomized, Open-label (Double Blind Among Rivaroxaban Groups in the Initial 3 Weeks), Parallel-group, Active-controlled Study of Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis Without Symptomatic Pulmonary Embolism|Completed||Phase 3|60|Actual|Bayer||4|||f||||t||||||||||2017-10-11 03:22:19.698063|2017-10-11 03:22:19.698063
NCT01516827|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-07-11|||February 2012||2012-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TCT||Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder (TreatChildTrauma)|Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder|Completed||N/A|159|Actual|University of Ulm||2|||f||||t||||||||||2017-10-11 03:22:19.882352|2017-10-11 03:22:19.882352
NCT01516814|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-01-19|||February 2012||2012-02-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients|Randomized, Open-label, Parallel-group, Active-controlled Study of Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism, With or Without Symptomatic Deep Vein Thrombosis|Completed||Phase 3|40|Actual|Bayer||3|||f||||t||||||||||2017-10-11 03:22:20.061842|2017-10-11 03:22:20.061842
NCT01516801|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-24|||October 2009||2009-10-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Pragmatic Trial of the Effect of a Mailed Patient Flyer About Prostate Specific Antigen (PSA) Testing Prior to an Annual Exam|A Pragmatic Randomized Trial of the Effect of a Mailed Patient Flyer About PSA Testing Prior to an Annual Exam|Completed||N/A|303|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 03:22:20.264587|2017-10-11 03:22:20.264587
NCT01516788|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-09-08|||December 2011||2011-12-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Photoprovocation Testing in Subjects With Cutaneous Lupus|Photoprovocation Testing in Subjects With Cutaneous Lupus|Recruiting||N/A|50|Anticipated|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 03:22:20.353848|2017-10-11 03:22:20.353848
NCT01516775|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-09-28|||January 2012||2012-01-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Gastric pH in Intubated Children|Untersuchung Des Magen-pH in Intubationsanästhesie Bei Kindern|Completed||N/A|150|Actual|University Children's Hospital, Zurich||2|||f||||f||||||||||2017-10-11 03:22:20.437865|2017-10-11 03:22:20.437865
NCT01516762|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2014-07-11||||||July 2014|2014-07-01||||||||Expanded Access|||Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases|Radium-223 Chloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases|No longer available||N/A|||Bayer|||||||||||||||||||2017-10-11 03:22:20.725416|2017-10-11 03:22:20.725416
NCT01516749|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2014-08-15|2014-07-11||October 2012||2012-10-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional||Eligible per protocol criteria|Anakinra as a Treatment for Hydradenitis Suppurativa|An Open Label Non-randomized Study Assessing the Efficacy and Tolerability of Fixed-dose Regimen Daily Subcutaneous Anakinra for the Treatment of Moderate to Severe Hidradenitis Suppurativa|Completed||Phase 2|6|Actual|University of California, San Francisco|Limitations of the study include early termination leading to small numbers of subjects analyzed, and lack of control group.|1|||f||||f||||||||||2017-10-11 03:22:20.938252|2017-10-11 03:22:20.938252
NCT01516736|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-08-01|2017-03-28|2014-11-20|March 2012||2012-03-01|August 2017|2017-08-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|PROTECT2|Patient demographics (FAS set)|Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim|Pivotal Study in Breast Cancer Patients Investigating Efficacy and Safety of LA-EP2006 and Neulasta®|Completed||Phase 3|308|Actual|Sandoz||2|||f||||t||||||||||2017-10-11 03:22:21.32424|2017-10-11 03:22:21.32424
NCT01516723|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-03-27|||February 2012||2012-02-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|February 2016|Actual|2016-02-01||Interventional|PRISON-IV||Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions|Hybrid Sirolimus-eluting Stent With Bioresorbable Polymer Versus Everolimus-eluting Stent With Durable Polymer for Total Coronary Occlusions in Native Coronary Arteries (PRISON-IV)|Active, not recruiting||Phase 3|330|Anticipated|R&D Cardiologie||2|||f||||t||||||||||2017-10-11 03:22:22.852197|2017-10-11 03:22:22.852197
NCT01515293|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-23|||September 2009||2009-09-01|May 2011|2011-05-01||||December 2010|Actual|2010-12-01||Interventional|||Single Incision Versus Conventional Laparoscopic Appendectomy|Prospective Randomised Study Comparing Single Incision Transumbilical Versus Conventional Laparoscopic Appendectomy|Completed||Phase 3|184|Actual|Hospital Universitario Virgen de la Arrixaca||2|||f||||f||||||||||2017-10-11 03:22:58.899821|2017-10-11 03:22:58.899821
NCT01516710|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-01-04|||January 2012||2012-01-01|January 2017|2017-01-01|December 2025|Anticipated|2025-12-01|April 2016|Actual|2016-04-01||Interventional|Oslo-CoMet||Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study|Prospective Randomized Study of Laparoscopic Versus Open Liver Resection for Colorectal Metastases|Active, not recruiting||N/A|280|Actual|Oslo University Hospital||2|||f||||f||||||||Yes|Not decided yet but results will be public no matter the outcome of the trial|2017-10-11 03:22:23.03599|2017-10-11 03:22:23.03599
NCT01516697|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-01-15|||October 2011||2011-10-01|January 2017|2017-01-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Non-invasive Cardiac Output Monitoring in Obstetric Patients|Using Thoracic Electrical Bioimpedance to Measure Stroke Volume and Cardiac Output in Patients Under Spinal Anesthesia for Cesarean Section|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||2||unable to enrollment subjects due to early departure of study personele|f||||f||||||||||2017-10-11 03:22:23.186346|2017-10-11 03:22:23.186346
NCT01516684|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-20|2017-05-25|||January 2012||2012-01-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Local Anesthetic Cream in Younger Patients Undergoing Lumbar Punctures|A Randomized, Double Blind Trial of Pediatric Lumbar Puncture Under Sedation/Total Intravenous Anesthesia (TIVA) With and Without EMLA Cream|Suspended||Phase 2|40|Anticipated|Wake Forest University Health Sciences||2||Resource Issues|f||||f|t|f||||||||2017-10-11 03:22:23.278494|2017-10-11 03:22:23.278494
NCT01516671|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-11-11|||November 2011||2011-11-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Neuroinflammation and Bispectral Index After Subarachnoid Hemorrhage|Pilot Study on the Role of Neuroinflammation in the Pathophysiology of Subarachnoid Hemorrhage and the Value of the Bilateral Bispectral Index for Early Diagnosis of Cerebral Ischemia After Subarachnoid Hemorrhage.|Unknown status|Active, not recruiting|N/A|40|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||f||||||Samples With DNA|"     Cerebrospinal fluid Blood   "|||2017-10-11 03:22:23.381585|2017-10-11 03:22:23.381585
NCT01516658|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2012-09-05|||February 2012||2012-02-01|September 2012|2012-09-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Interventional|HYBRID||HYdrogel Coil Versus Bare Platinum Coil in Recanalization Imaging Data Study|Efficacy of Hydrogel Coil on Endovascular Treatment for Intracranial Aneurysms; Multi-center, Prospective, Randomized, Open-label Blind-endpoint Trial|Unknown status|Enrolling by invitation|Phase 4|500|Anticipated|Kobe City General Hospital||2|||f||||t||||||||||2017-10-11 03:22:23.46133|2017-10-11 03:22:23.46133
NCT01516645|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-03-14|||January 2012|Actual|2012-01-01|March 2017|2017-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors|Phase 1, Open-Label, Dose Escalation Study of Anti-CD98 Monoclonal Antibody KHK2898 as Monotherapy in Subjects With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or For Whom No Standard Therapy Is Available|Terminated||Phase 1|14|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-10-11 03:22:23.577855|2017-10-11 03:22:23.577855
NCT01516632|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-15|2016-04-28|2016-03-29||June 2009||2009-06-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SMS USA||Smoking Cessation Via Text Messaging: Feasibility Testing of Stop My Smoking USA|Smoking Cessation Via Text Messaging: Feasibility Testing of SMS USA|Completed||N/A|164|Actual|Center for Innovative Public Health Research|The main limitation of the study is its small sample size. Also, it is unclear how young adult smokers recruited on Craigslist compared with young adult smokers who would be recruited through other ways.|2|||f||||f||||||||No||2017-10-11 03:22:23.678698|2017-10-11 03:22:23.678698
NCT01516619|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2012-01-24|||November 2011||2011-11-01|January 2012|2012-01-01|September 2014|Anticipated|2014-09-01|November 2013|Anticipated|2013-11-01||Interventional|ProRom||Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia|Pilot Phase II Trial on Safety and Activity of Secondary Prophylaxis With Romiplostim in Patients With Non-Hodgkin Lymphoma and Chemotherapy-induced Thrombocytopenia|Unknown status|Recruiting|Phase 2|20|Anticipated|IRCCS San Raffaele||1|||f||||f||||||||||2017-10-11 03:22:24.386973|2017-10-11 03:22:24.386973
NCT01516606|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-19|||January 2012||2012-01-01|January 2012|2012-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|HD-K||Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma|Phase II Clinical Trial on the Activity of Salvage Therapy With High Dose Oral Clarithromycin in Patients With Relapsed or Refractory Extranodal Marginal Zone Lymphoma|Unknown status|Recruiting|Phase 2|19|Anticipated|IRCCS San Raffaele||1|||f||||f||||||||||2017-10-11 03:22:24.653229|2017-10-11 03:22:24.653229
NCT01516593|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-24|||November 2011||2011-11-01|January 2012|2012-01-01|August 2015|Anticipated|2015-08-01|April 2013|Anticipated|2013-04-01||Interventional|CARMEN||Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma|Phase II Study on Safety and Activity of a Short Term Intensified Chemo-immunotherapy Combination in HIV-positive Patients Affected by Burkitt Lymphoma|Unknown status|Recruiting|Phase 2|19|Anticipated|IRCCS San Raffaele||1|||f||||f||||||||||2017-10-11 03:22:24.776969|2017-10-11 03:22:24.776969
NCT01516580|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-06-13|||December 2011||2011-12-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|June 13, 2017|Actual|2017-06-13||Interventional|||Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients|Intergroup Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Evaluation of Rituximab Efficacy and Safety in High Risk Patients - Phase III Trial|Active, not recruiting||Phase 3|482|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t||||||||||2017-10-11 03:22:24.927969|2017-10-11 03:22:24.927969
NCT01516567|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-08-01|||December 1, 2011|Actual|2011-12-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2016|Actual|2016-04-01||Interventional|||Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation|Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients - Phase II Trial of DA-EPOCH-Rituximab in PMLBL|Active, not recruiting||Phase 2|47|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||t||||||||||2017-10-11 03:22:25.081844|2017-10-11 03:22:25.081844
NCT01516554|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-07-04|||February 2012||2012-02-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients|A Randomized, Controlled Crossover Trial Evaluating Oral Testosterone in the Treatment of Fatigue in Male Multiple Sclerosis Patients|Terminated||Phase 2|3|Actual|Health Sciences Centre, Winnipeg, Manitoba||2||Poor recruitment|f||||f||||||||||2017-10-11 03:22:25.189786|2017-10-11 03:22:25.189786
NCT01516541|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-11-01||2016-07-08|January 2012||2012-01-01|November 2016|2016-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease|A Phase 3b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Effect of Dalcetrapib 600 mg on Cardiovascular (CV) Events in Adult Patients With Stable Coronary Heart Disease (CHD), CHD Risk Equivalents or at Elevated Risk for Cardiovascular Disease (CVD).|Completed||Phase 3|2220|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:22:25.321221|2017-10-11 03:22:25.321221
NCT01516528|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-09-18|||November 17, 2011||2011-11-17|September 2017|2017-09-01|June 12, 2015|Actual|2015-06-12|May 1, 2015|Actual|2015-05-01||Observational|ACCESS||Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care|Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care|Completed||N/A|3500|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:22:27.732421|2017-10-11 03:22:27.732421
NCT01516502|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2012-01-24|||February 2011||2011-02-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||The Efficacy of Low-level Laser on Cervical Myofascial Pain Syndrome|Is Low-level Laser on Traditional Acupoint as Effective as That on Trigger Point in the Management of Cervical Myofascial Pain Syndrome?|Completed||N/A|100|Actual|Chang Gung Memorial Hospital||4|||f||||f||||||||||2017-10-11 03:22:28.608464|2017-10-11 03:22:28.608464
NCT01516489|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-10-23|||February 2012||2012-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|October 2013|Actual|2013-10-01||Interventional|||Improving Fecal Occult Blood Test Completion Rates Among Veterans|Improving Fecal Occult Blood Test Completion Rates Among Veterans|Completed||Phase 1/Phase 2|1549|Actual|Corporal Michael J. Crescenz VA Medical Center||8|||f||||f||||||||||2017-10-11 03:22:28.718985|2017-10-11 03:22:28.718985
NCT01516476|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-11-01||2016-07-08|November 2011||2011-11-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of RO6807952 in Patients With Diabetes Mellitus Type 2|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of RO6807952 in Type 2 Diabetic Patients Inadequately Controlled With Metformin Alone|Terminated||Phase 2|2|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 03:22:28.830069|2017-10-11 03:22:28.830069
NCT01516463|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-05-15|||March 2012||2012-03-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Using Santyl or Bacitracin on Second Degree Burns|Comparison of Collagenase Santyl® Ointment With Antibiotic Ointment in the Outpatient Care of Minor Partial Thickness Burns|Withdrawn||Phase 4|0|Actual|Healthpoint||2|||f||||f||||||||||2017-10-11 03:22:28.940129|2017-10-11 03:22:28.940129
NCT01516450|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-06-09|||December 26, 2011|Actual|2011-12-26|June 2017|2017-06-01|April 11, 2012|Actual|2012-04-11|April 11, 2012|Actual|2012-04-11||Interventional|||Japanese phase1 Study of Belimumab (IV vs SC)|An Open Label, Randomized, Parallel, Single Dose Study to Investigate Safety and Pharmacokinetics Following Intravenous Administration and Subcutaneous Administration of GSK1550188 in Healthy Japanese Males|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:22:29.062244|2017-10-11 03:22:29.062244
NCT01516437|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-04-12|2017-01-10||February 1, 2012|Actual|2012-02-01|April 2017|2017-04-01|December 20, 2012|Actual|2012-12-20|June 28, 2012|Actual|2012-06-28||Interventional|||A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD|A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD) Aged Between 45-75 Years|Completed||N/A|73|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-10-11 03:22:29.184057|2017-10-11 03:22:29.184057
NCT01516411|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-12-08|||October 2010||2010-10-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Promoting Healthy Lifestyles Using Mobile Phones|Promoting Healthy Lifestyles Using Mobile Phones|Completed||N/A|130|Actual|Stanford University||4|||f||||f||||||||||2017-10-11 03:22:30.602876|2017-10-11 03:22:30.602876
NCT01516398|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-10-12|||July 2011||2011-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2013|Actual|2013-06-01||Observational|||Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia|Endothelin-1 (ET-1) Levels as Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia (BPD)|Active, not recruiting||N/A|60|Anticipated|Stanford University|||1||f||||f||||||||Yes|Publication|2017-10-11 03:22:30.707827|2017-10-11 03:22:30.707827
NCT01516385|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-01-26|||January 2012||2012-01-01|January 2012|2012-01-01||||||||Observational|||Detection of Peripheral Blood Biomarkers in Intermediate Phase Spinal Cord Injury: Correlation With Neurological and Functional Outcomes, and Comparison to Other Central and Peripheral Neurological Conditions.||Unknown status|Not yet recruiting|N/A|150|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 03:22:30.804011|2017-10-11 03:22:30.804011
NCT01516372|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2013-07-15|||January 2012||2012-01-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers|A Randomized, Double-blind, Single Dose Crossover Study to Assess the Effect of Gabapentin Enacarbil on Cardiac Conduction as Compared With Placebo and Moxifloxacin in Healthy Volunteers|Completed||Phase 1|52|Actual|XenoPort, Inc.||4|||f||||f||||||||||2017-10-11 03:22:30.896926|2017-10-11 03:22:30.896926
NCT01516359|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||October 2011||2011-10-01|January 2012|2012-01-01|November 2012|Anticipated|2012-11-01|October 2012|Anticipated|2012-10-01||Observational|||Incidence and Predictive Factors of Intestinal Injury in Patients Undergoing Heart Valve Replacements|Official Title is Required by the WHO and ICMJE|Unknown status|Recruiting|N/A|1000|Anticipated|First Affiliated Hospital, Sun Yat-Sen University|||1||f||||t||||||Samples With DNA|"     Blood samples are retained for the detections of some biomarkers and gene polymorphism.   "|||2017-10-11 03:22:31.02256|2017-10-11 03:22:31.02256
NCT01516346|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-08-09|||January 2012||2012-01-01|September 2015|2015-09-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Vasodilator Therapy for Heart Failure and Preserved Ejection Fraction|Effect of Organic Nitrates and Hydralazine on Wave Reflections and Left Ventricular Structure and Function in Heart Failure With Preserved Ejection Fraction|Unknown status|Active, not recruiting|Phase 2|54|Anticipated|Corporal Michael J. Crescenz VA Medical Center||3|||f||||f||||||||||2017-10-11 03:22:31.114653|2017-10-11 03:22:31.114653
NCT01516333|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2015-12-17|||February 2007||2007-02-01|December 2015|2015-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Replace Glycemic Load and Satiety Study|Response of Energy Peak Levels After Carbohydrates Are Eaten Glycemic Load and Satiety Study - Phase 1|Completed||Phase 1|26|Actual|Pennington Biomedical Research Center||4|||f||||f||||||||||2017-10-11 03:22:31.240808|2017-10-11 03:22:31.240808
NCT01516320|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-01-30|||May 13, 2009|Actual|2009-05-13|January 2017|2017-01-01|September 1, 2014|Actual|2014-09-01|September 1, 2014|Actual|2014-09-01||Interventional|LAF26||Mechanisms of Diabetes Relapse After Bariatric Surgery|Mechanisms of Diabetes Relapse After Bariatric Surgery|Completed||N/A|56|Actual|Columbia University||3|||f||||t|f|f||||||No||2017-10-11 03:22:31.360835|2017-10-11 03:22:31.360835
NCT01516307|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-03-02||2017-03-02|December 2011||2011-12-01|March 2017|2017-03-01|August 2019|Anticipated|2019-08-01|August 2016|Actual|2016-08-01||Interventional|||Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects|A Double-blind, Randomized Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Subjects With Metastatic Breast Cancer|Active, not recruiting||Phase 2|349|Actual|OBI Pharma, Inc||2|||f||||t|f|f||||||No||2017-10-11 03:22:31.493999|2017-10-11 03:22:31.493999
NCT01516294|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-10-31|||January 2012||2012-01-01|October 2012|2012-10-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Interventional|||IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD|A Pilot, Single-center, Interventional Clinical Trial in Which Subjects With Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD) Will Receive Low Voltage Stereotactic Radiotherapy (IRay®) Treatment and Lucentis® Treatment as Needed.|Unknown status|Active, not recruiting|N/A|12|Anticipated|Oraya Therapeutics, Inc.||1|||f||||t||||||||||2017-10-11 03:22:31.706955|2017-10-11 03:22:31.706955
NCT01516281|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-01-22|||March 2012||2012-03-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury|Imaging Biomarkers of Delayed Sequelae in Mild to Moderate Traumatic Brain Injury|Completed||N/A|67|Actual|NorthShore University HealthSystem Research Institute|||2||f||||f||||||Samples With DNA|"     Collect blood and extract and store plasma and DNA from 100 mTBI and 100 mTBI- subjects     undergoing clinical assessments and DaTscan studies.   "|||2017-10-11 03:22:31.807088|2017-10-11 03:22:31.807088
NCT01516268|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2013-02-19|2013-02-19||January 2012||2012-01-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|TAP|25 & 25|The Effect of Adding Sufentanyl to Bupivacaine in Transversus Abdominis Plane Block to Reduce the Narcotic Dosage and Pain After Cesarean Delivery|the Effect of Adding Sufentanyl to Bupivacaine in Transversus Abdominis Plane (TAP) Block Under the Guide of Ultrasound to Reduce the Narcotic Dosage, Side Effects and Pain in the First 24 Hours After Cesarean Delivery|Completed||Phase 4|50|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:22:31.898155|2017-10-11 03:22:31.898155
NCT01516255|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-01-24|||July 2006||2006-07-01|January 2017|2017-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Effect of Liraglutide on Heart Frequency in Healthy Volunteers|A Thorough QTc Evaluation of the Effect of Liraglutide on Cardiac Repolarization in Healthy Volunteers: A Randomized, Double-blind, Placebo-controlled, Two Period Crossover Study Followed by Open-label Moxifloxacin (Positive Control) Administration|Completed||Phase 1|64|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:22:32.171911|2017-10-11 03:22:32.171911
NCT01516242|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-11-04|||October 2006||2006-10-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Evaluation of Safety and Parameters of Application Technique|Monitoring of Expected Parameters of the Application Technique and Safety of the Therapy|Completed||N/A|4819|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:22:32.285297|2017-10-11 03:22:32.285297
NCT01516229|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-02-23|||May 1, 1997|Actual|1997-05-01|February 2017|2017-02-01|March 31, 2007|Actual|2007-03-31|March 31, 2007|Actual|2007-03-31||Observational|||Special Survey for Long Term Application|Specific Survey of Norditropin® in Achondroplasia: Survey for Long-term Application|Completed||N/A|395|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:22:32.508318|2017-10-11 03:22:32.508318
NCT01516216|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-02-07|||March 2012||2012-03-01|February 2017|2017-02-01||||July 2017|Anticipated|2017-07-01||Interventional|||Study of Vitamin D in Untreated Metastatic Colorectal Cancer|Randomized, Double-Blind, Phase II Trial of Vitamin D Supplementation in Patients With Previously Untreated Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|120|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 03:22:32.611937|2017-10-11 03:22:32.611937
NCT01516203|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-12-16||2014-04-16|December 2012||2012-12-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Phase 2a EBA Trial of AZD5847|Randomized, Open Label, Multiple Dose Phase 2a Study of the Early Bactericidal Activity of AZD5847 in Adults With Pulmonary Tuberculosis|Completed||Phase 2|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-10-11 03:22:32.76469|2017-10-11 03:22:32.76469
NCT01516190|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-06-01|||August 2011||2011-08-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|April 2017|Anticipated|2017-04-01||Interventional|PreHab||The Preoperative Health & Body Study|The Preoperative Health & Body Study|Recruiting||N/A|50|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 03:22:32.884602|2017-10-11 03:22:32.884602
NCT01512121|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-09-08|||September 2011|Actual|2011-09-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Spinal Cord Stimulation and Functional MRI|Investigating the Cortical Correlates of Spinal Cord Stimulation Using Functional Magnetic Resonance Imaging|Completed||N/A|10|Actual|Ohio State University|||1||f||||f||||||||||2017-10-11 03:23:54.948662|2017-10-11 03:23:54.948662
NCT01516177|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2016-12-16|||September 2010||2010-09-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|ARTIST||Associating Renal Transplantation With the ITN Signature of Tolerance|An Observational Study to Assess the Prevalence of a Tolerance Signature in Renal Transplant Recipients (ITN524ST/CTOT-12)|Completed||N/A|250|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     Whole blood Isolation PBMC isolated RNA specimens   "|||2017-10-11 03:22:32.994724|2017-10-11 03:22:32.994724
NCT01516164|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-10-03|||March 2012||2012-03-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Comparison of the Ease of Tracheal Intubation Using a McGrath MAC Laryngoscope and a Standard MacIntosh Laryngoscope|A Comparison of the Ease of Tracheal Intubation Using a McGrath MAC Laryngoscope and a Standard MacIntosh Laryngoscope|Completed||N/A|158|Actual|NHS Tayside||3|||f||||f||||||||||2017-10-11 03:22:33.113017|2017-10-11 03:22:33.113017
NCT01516151|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-01-07|||December 2011||2011-12-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|||Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia|A Randomized Open-label Dose-ranging, Multi-center Trial to Assess the Safety and Efficacy of NKPL66(CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia|Completed||Phase 2|289|Actual|Acasti Pharma Inc.||5|||f||||f||||||||||2017-10-11 03:22:33.234269|2017-10-11 03:22:33.234269
NCT01516138|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2014-10-30|||February 2012||2012-02-01|July 2014|2014-07-01|February 2022|Anticipated|2022-02-01|March 2013|Actual|2013-03-01||Interventional|||Benefits of GIK in Cardiac Surgery Patients|Myocardial Protection of Glucose - Insulin - Potassium in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Active, not recruiting||Phase 2|930|Actual|Xijing Hospital||2|||f||||t||||||||||2017-10-11 03:22:33.466936|2017-10-11 03:22:33.466936
NCT01516125|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-05-18|||September 2011||2011-09-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Observational|||Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing|Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing|Recruiting||N/A|800|Anticipated|Wake Forest University Health Sciences|||1||f||||t||||||Samples With DNA|"     A small saliva sample for screening purposes will be collected. If documentation from a     personal physician of blood glucose and lipid levels are unavailable, we will collect a small     tube (10-12 ml) of blood to determine these measurements.   "|No|This is a screening (one visit) to recruit healthy people for genotyping and re-contact for future studies|2017-10-11 03:22:33.59567|2017-10-11 03:22:33.59567
NCT01516112|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-01-19|||February 2012||2012-02-01|July 2011|2011-07-01||||||||Observational|||Meir Medical Center Home Monitoring Clinic Registry|Meir Medical Center Home Monitoring Clinic Registry|Unknown status|Not yet recruiting|N/A|20|Anticipated|Meir Hospital, Kfar Saba, Israel|||1||f||||f||||||||||2017-10-11 03:22:33.700829|2017-10-11 03:22:33.700829
NCT01516099|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-08-12|||April 2012||2012-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||A Structural Approach to Implement the Role of 'Physical Activity Counselors' in Sports and Exercise Promotion|Pilot Study: A Structural Approach to Implement the Role of 'Physical Activity Counselors' in Sports and Exercise Promotion in Flanders|Completed||Phase 4|110|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 03:22:33.792212|2017-10-11 03:22:33.792212
NCT01516086|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-11-24||2014-11-24|March 2012||2012-03-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A 12-Week Study in Adult Subjects With Asthma|A 12-week Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled, Parallel-Group Study to Replicate Efficacy of Nebulized Fluticasone Propionate (FP) in Adult Subjects With Partly Controlled and Uncontrolled Asthma|Completed||Phase 2|498|Actual|Dey||6|||f||||f||||||||||2017-10-11 03:22:33.884763|2017-10-11 03:22:33.884763
NCT01516073|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-11-24||2014-11-24|March 2012||2012-03-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||12-Week Study in Adult Subjects With Asthma|A 12-week Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Nebulized Fluticasone Propionate (FP) Dose Response in Adult Subjects With Partly Controlled and Uncontrolled Asthma|Completed||Phase 2|629|Actual|Dey||6|||f||||f||||||||||2017-10-11 03:22:33.992964|2017-10-11 03:22:33.992964
NCT01516060|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2013-09-18|||January 2012||2012-01-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Neurocognitive Sub-study of Encore1|The Neurocognitive Sub Study of Encore1:A Randomised, Double‐Blind, Placebo‐Controlled, Clinical Trial to Compare the Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus 2N(t)RTI in Antiretroviral‐naïve HIV‐Infected Individuals Over 96 Weeks A Randomised, Double-blind, Placebo-controlled, Clinical Trial to Compare the Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals Over 96 Weeks|Completed||Phase 3|71|Actual|Kirby Institute||2|||f||||t||||||||||2017-10-11 03:22:34.115893|2017-10-11 03:22:34.115893
NCT01516047|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-06-24|||January 2012||2012-01-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic Function|An Open-Label Pharmacokinetic Study of Abiraterone Acetate Suspension in Subjects With Severe Hepatic Impairment Compared to Matched Control Subjects With Normal Hepatic Function|Completed||Phase 1|16|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 03:22:35.860721|2017-10-11 03:22:35.860721
NCT01516034|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-11-22|2012-11-09||November 2011||2011-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||The Efficacy of the Cupola Ultrasonic Tattoo Removal Device|The Efficacy of the Cupola Ultrasonic Tattoo Removal Device: A Prospective Single Blinded, Before-After Study Design|Terminated||N/A|8|Actual|Cupola Medical Ltd||1||Sponsor decided that the results were not significant enough to continue.|f||||f||||||||||2017-10-11 03:22:36.054663|2017-10-11 03:22:36.054663
NCT01516021|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-01-18|||January 2011||2011-01-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||How Fat Influences the Brain|Fat Intake Modulates Cerebral Blood Flow in Homeostatic and Gustatory Brain Areas in Humans|Completed||N/A|11|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-11 03:22:36.26413|2017-10-11 03:22:36.26413
NCT01511744|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-08-13|||November 2011||2011-11-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Interventional|||Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine|A Randomised, Controlled Phase IV Clinical Trial With an Inactivated Influenza Vaccine(Split Virion)|Completed||Phase 4|6000|Actual|Hualan Biological Engineering, Inc.||2|||f||||t||||||||||2017-10-11 03:24:03.249127|2017-10-11 03:24:03.249127
NCT01516008|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-03-28|2014-01-24||January 2012||2012-01-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From Bunionectomy|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Tapentadol Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy; Bridging Study for Korea|Completed||Phase 3|353|Actual|Janssen Research & Development, LLC||3|||f||||f||||||||||2017-10-11 03:22:37.047743|2017-10-11 03:22:37.047743
NCT01515995|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-05-03|||January 2012||2012-01-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation|Nebulized Magnesium Sulfate Versus Normal Saline as a Vehicle for Albuterol in Children With Moderate to Severe Asthma Exacerbation: a Randomized Controlled Trial|Completed||Phase 4|50|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 03:22:38.418296|2017-10-11 03:22:38.418296
NCT01515982|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2014-12-01|||February 2010||2010-02-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Physical Exercise as an Additional Treatment for Alzheimer Disease||Completed||N/A|20|Actual|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-11 03:22:38.520482|2017-10-11 03:22:38.520482
NCT01515969|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-07-11|||July 2012||2012-07-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|February 2013|Actual|2013-02-01||Interventional|||Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)|A Phase I Study of Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer|Terminated||Phase 1|9|Actual|Stanford University||1||Patient safety - Unacceptable toxicity|f||||t||||||||||2017-10-11 03:22:38.636375|2017-10-11 03:22:38.636375
NCT01515956|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-07-12|2017-04-13||October 2011||2011-10-01|July 2017|2017-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)|A Phase 2, Open-label, Multinational Clinical Study to Evaluate the Safety and Efficacy of BMN 110 in Pediatric Patients Less Than 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)|Completed||Phase 2|15|Actual|BioMarin Pharmaceutical||1|||f||||t||||||||||2017-10-11 03:22:38.766461|2017-10-11 03:22:38.766461
NCT01515943|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2017-04-11|2016-05-02||June 2012||2012-06-01|April 2017|2017-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Convergence Insufficiency Treatment Study (CITS)|Effectiveness of Home-Based Therapy for Symptomatic Convergence Insufficiency|Completed||N/A|204|Actual|Jaeb Center for Health Research|"Differential loss to follow-up (HB-C 8%, HB-PU 19%, and HB-P 30%).
Did not formally assess whether participants remained masked to their treatment group during the study.
Assessment of compliance was not completely objective."|3|||f||||t||||||||Yes|In accordance with the NIH data sharing policy, a de-identified database is placed in the public domain on the PEDIG public website after the completion of each protocol and publication of the primary manuscript.|2017-10-11 03:22:39.58718|2017-10-11 03:22:39.58718
NCT01515930|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-06-01|||April 2011||2011-04-01|June 2017|2017-06-01|September 9, 2014|Actual|2014-09-09|March 3, 2014|Actual|2014-03-03||Interventional|||Computerized Intervention of Parental Involvement in Diabetes Care of Their Child|Computer-Delivered Motivational Intervention to Improve Teen Diabetes Management|Completed||N/A|145|Actual|Wayne State University||3|||f||||t|f|f||||||No||2017-10-11 03:22:40.345224|2017-10-11 03:22:40.345224
NCT01515917|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-01-15|||November 2013||2013-11-01|January 2015|2015-01-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)|Citicoline and Omega-3 Fatty Acid Effects in Veterans With TBI|Withdrawn||N/A|0|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 03:22:40.44478|2017-10-11 03:22:40.44478
NCT01515904|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-11-07|||April 2011||2011-04-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|STOMP||Evaluation of the SickKids Team Obesity Management Program|Evaluation of the SickKids Team Obesity Management Program (STOMP)|Recruiting||N/A|400|Anticipated|The Hospital for Sick Children|||2||f||||f||||||||||2017-10-11 03:22:40.539728|2017-10-11 03:22:40.539728
NCT01515891|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-12-30|2014-12-30||May 2009||2009-05-01|December 2014|2014-12-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|||Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites|An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites Following a Single-dose Oral Administration|Completed||Phase 1|4|Actual|Bial - Portela C S.A.||1|||f||||f||||||||||2017-10-11 03:22:40.69733|2017-10-11 03:22:40.69733
NCT01515878|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2012-07-04|||February 2012||2012-02-01|July 2012|2012-07-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|HERACLES||Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS|Hemocontrol's Effectiveness in a RAndomized Controlled Trial on the Reduction of Cardiovascular Long-term EventS|Unknown status|Recruiting|Phase 4|396|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||||2017-10-11 03:22:40.983359|2017-10-11 03:22:40.983359
NCT01515865|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-11-10|2014-10-16||May 2012||2012-05-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||The Enrolled Population consisted of all subjects who participated in Part A baseline procedures starting at Day -1.|Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension|A Phase 4, Randomized-withdrawal, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Clinical Benefit of Midodrine Hydrochloride in Male and Female Subjects With Symptomatic Orthostatic Hypotension|Completed||Phase 4|67|Actual|Shire||2|||f||||t||||||||||2017-10-11 03:22:41.143565|2017-10-11 03:22:41.143565
NCT01515852|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-23|2013-02-20|||January 2012||2012-01-01|February 2013|2013-02-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|GALAXY||General Anesthesia vs. Local Anesthesia in Stereotaxy|General Anesthesia vs. Local Anesthesia in Stereotaxy|Unknown status|Recruiting|N/A|80|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 03:22:41.506423|2017-10-11 03:22:41.506423
NCT01515839|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-01|2012-01-23|||May 2009||2009-05-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players|Brain Single Photon Emission Computed Tomography and Quantitative Electroencephalography In Former NFL Players: A Single-Site Exploratory Pilot Study|Completed||N/A|100|Actual|Amen Clinics, Inc.||1|||f||||t||||||||||2017-10-11 03:22:41.635452|2017-10-11 03:22:41.635452
NCT01515826|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-19|2014-03-24|||March 2014||2014-03-01|March 2014|2014-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery|Evaluation of the Safety and Efficacy of VIGADEXA Ophthalmic Gel Compared to VIGADEXA Ophthalmic Solution in Preventing Inflammation and Infection Following Cataract Surgery|Withdrawn||Phase 3|0|Actual|Alcon Research||2||Management decision|f||||f||||||||||2017-10-11 03:22:41.753767|2017-10-11 03:22:41.753767
NCT01515813|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2016-01-29|||November 2011||2011-11-01|January 2016|2016-01-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation|A Randomized Controlled Trial to Compare the Effects of Highly Active Antiretroviral Therapy (HAART) Versus Statin Therapy on Endothelial Function and Markers of Inflammation/Coagulation In HIV-Infected Individuals With High CD4 Cell Counts|Withdrawn||Phase 2|0|Actual|AIDS Clinical Trials Group||3||On 05/08/12, team working on revising protocol and re-open study under version 2.0|f||||t||||||||||2017-10-11 03:22:41.857514|2017-10-11 03:22:41.857514
NCT01515800|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-21|2016-11-04|||May 2012||2012-05-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer|S1105, Randomized Trial Of Text-Messaging Intervention To Reduce Early Discontinuation Of Adjuvant Aromatase Inhibitor Therapy In Women With Early Stage Breast Cancer|Active, not recruiting||N/A|692|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 03:22:41.994235|2017-10-11 03:22:41.994235
NCT01515787|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-09-29|||January 2012|Actual|2012-01-01|September 2017|2017-09-01||||January 2021|Anticipated|2021-01-01||Interventional|||PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery|A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)|Recruiting||Phase 2/Phase 3|1060|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 03:22:43.211442|2017-10-11 03:22:43.211442
NCT01515761|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-01-23|||September 2010||2010-09-01|January 2012|2012-01-01||||March 2013|Anticipated|2013-03-01||Interventional|POLAR||POsition of Leads in Advanced heaRt Failure: the POLAR Study|POsition of Leads in Advanced heaRt Failure: the POLAR Study - A 6 Month, Observational, Mult-centered, Blinded, Randomized Study to Determine if Lead Positioning in the Lateral Wall of LV in Patients Meeting Criteria for CRT Plays a Role in Determining Myocardial Function and Affect the Severity of Mitral Regurgitation|Unknown status|Recruiting|N/A|60|Anticipated|Southern Arizona VA Health Care System||2|||f||||t||||||||||2017-10-11 03:22:48.228055|2017-10-11 03:22:48.228055
NCT01515748|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-04-12|||January 2012||2012-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|PRODIGY||Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer|A Phase III, Open-labelled, Randomised Study of Neoadjuvant Docetaxel+Oxaliplatin+S-1 (DOS) + Surgery + Adjuvant S-1 Versus Surgery + Adjuvant S-1 in Patients With Resectable Advanced Gastric Cancer|Active, not recruiting||Phase 3|640|Anticipated|Sanofi||2|||f||||t||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-11 03:22:48.330834|2017-10-11 03:22:48.330834
NCT01515735|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-23|||December 2011||2011-12-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||LOXL1 Polymorphism in Pseudoexfoliation Syndrome|Evaluation of LOXL1 Polymorphism in Pseudoexfoliation Syndrome in the Korean Population|Unknown status|Recruiting|N/A|60|Anticipated|Samsung Medical Center|||1||f||||t||||||Samples With DNA|"     Peripheral blood sample   "|||2017-10-11 03:22:48.415141|2017-10-11 03:22:48.415141
NCT01515722|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2012-01-23|||December 2010||2010-12-01|January 2012|2012-01-01|June 2012|Anticipated|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder|Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder : 6-month, Randomized, Open-label, Multi-center Trial|Unknown status|Recruiting|N/A|692|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 03:22:48.519585|2017-10-11 03:22:48.519585
NCT01515709|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-05-11|||April 2011|Actual|2011-04-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2013|Actual|2013-09-01||Observational|||Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease|Is the Short Physical Performance Battery a Useful Outcome Measure in Patients With Chronic Obstructive Pulmonary Disease ?|Active, not recruiting||N/A|445|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 03:22:48.670801|2017-10-11 03:22:48.670801
NCT01515696|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2014-06-17|2013-10-29||October 2007||2007-10-01|June 2014|2014-06-01|February 2011|Actual|2011-02-01|October 2010|Actual|2010-10-01||Interventional|||Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants|Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants- a Phase 4 Study|Completed||Phase 4|96|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 03:22:48.871688|2017-10-11 03:22:48.871688
NCT01515683|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-05-05|||December 2008||2008-12-01|May 2014|2014-05-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|STØB||Behavioral Support Before Anesthesia|Behavioral Support to Cancer Patients Before Anesthesia|Completed||Phase 2|350|Actual|Odense University Hospital||4|||f||||t||||||||||2017-10-11 03:22:50.069969|2017-10-11 03:22:50.069969
NCT01510483|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2016-07-19|||January 2010||2010-01-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|HS||Clinician Promotion of Healthy Diet and Activity to Reduce Obesity Among Adolescents: HEALTHY SMILES|Clinician Promotion of Healthy Diet and Activity to Reduce Obesity Among Adolescents|Completed||N/A|693|Actual|San Diego State University||2|||f||||t||||||||||2017-10-11 03:24:22.509849|2017-10-11 03:24:22.509849
NCT01515670|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-07-30|||February 2010||2010-02-01|July 2017|2017-07-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01|90 Days|Observational [Patient Registry]|||Length of Stay and Complications in High-risk Patients Receiving Fast-track Total Hip (THA) or Knee- Alloplasty (TKA)|Length of Stay and Complications in High-risk Patients Receiving Fast-track Total Hip (THA) or Knee- Alloplasty (TKA).|Recruiting||N/A|30000|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 03:22:50.204039|2017-10-11 03:22:50.204039
NCT01515657|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-02-11|2015-06-22||January 2012||2012-01-01|February 2016|2016-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients|A Randomized, Actively Controlled, Crossover Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Patients With Type II Diabetes|Completed||Phase 3|40|Actual|PLx Pharma||3|||f||||f||||||||||2017-10-11 03:22:50.38222|2017-10-11 03:22:50.38222
NCT01515644|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2013-04-22|||October 2011||2011-10-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|STAR-IFFO||Study on the Effect of Inulin in Infant Formula on Gut Health|A Randomized, Double-blind, Controlled Study on the Effect of Inulin on Gut Health of Infants|Completed||Phase 3|164|Actual|PT. Sari Husada||3|||f||||f||||||||||2017-10-11 03:22:50.683095|2017-10-11 03:22:50.683095
NCT01515631|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-10-14|||April 2007||2007-04-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Observational|||Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review|Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record|Recruiting||N/A|25|Anticipated|Stanford University|||1||f||||f||||||||No||2017-10-11 03:22:50.785773|2017-10-11 03:22:50.785773
NCT01515618|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-08-30|||February 2012||2012-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:22:50.897086|2017-10-11 03:22:50.897086
NCT01515605|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-10-12|||January 2011||2011-01-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Observational|MoMoTxRes||Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation|Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation|Recruiting||N/A|1000|Anticipated|Odense University Hospital|||1||f||||f||||||Samples With DNA|"     Blood, urine, tissue   "|No||2017-10-11 03:22:50.945092|2017-10-11 03:22:50.945092
NCT01515592|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-01-24|||January 2006||2006-01-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers|A Randomised, Double-blind Within Dose Group, Single Centre, Placebo-controlled, Dose Escalation, Multiple s.c. Dose Study to Assess the Safety and Tolerability of Liraglutide 20 ug/kg and 25 ug/kg in Healthy Japanese Male Subjects|Completed||Phase 1|24|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:22:51.047776|2017-10-11 03:22:51.047776
NCT01515579|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-01-29|||April 2006||2006-04-01|January 2015|2015-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Comparison of Two Liraglutide Formulations in Healthy Subjects|A Randomized, Double-blind, Single-centre, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between the Phase 2 Formulation of Liraglutide at pH 7.7 (Formulation 3) and the Phase 3 Formulation at pH 8.15 (Formulation 4)|Completed||Phase 1|22|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:22:51.151413|2017-10-11 03:22:51.151413
NCT01515566|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-08-07|2014-08-07||April 2012||2012-04-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Breakthrough Dyspnea Fentanyl Study in Cancer Patients|Effects of Prophylactic Subcutaneous Fentanyl on Exercise-Induced Breakthrough Dyspnea in Cancer Patients: A Preliminary Double-Blind, Randomized Controlled Trial|Completed||Phase 1/Phase 2|26|Actual|M.D. Anderson Cancer Center|The small sample size means findings are susceptible to random errors and regression to the mean.|2|||f||||t||||||||||2017-10-11 03:22:51.249598|2017-10-11 03:22:51.249598
NCT01515553|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-01-12|||January 2007||2007-01-01|January 2015|2015-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers|A Randomized, Double-blind, Single-centre, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between the Phase 3a Formulation of Liraglutide (Formulation 4) and the Planned Phase 3b Formulation (Final Formulation 4)|Completed||Phase 1|22|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:22:51.570132|2017-10-11 03:22:51.570132
NCT01515540|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-07-23|2012-10-16||January 2004||2004-01-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Brain Imaging of Lidoderm for Chronic Back Pain|Brain Imaging of Lidoderm for Chronic Back Pain|Completed||Phase 4|38|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 03:22:51.674778|2017-10-11 03:22:51.674778
NCT01515527|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-02-14|||February 2012|Actual|2012-02-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)|Phase II Study of Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed By Consolidation With Cladribine Plus LDAC Alternating With Decitabine in Patients With Untreated Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)|Recruiting||Phase 2|160|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:22:51.916959|2017-10-11 03:22:51.916959
NCT01515514|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2013-05-15|||August 2012||2012-08-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Confocal Endomicroscopy for GI Neoplasia Study|Confocal Endomicroscopy for GI Neoplasia Study|Completed||N/A|40|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:22:52.225214|2017-10-11 03:22:52.225214
NCT01515501|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-03-22|||October 2007||2007-10-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|January 2020|Anticipated|2020-01-01||Interventional|EDGE||Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)|Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:22:52.31506|2017-10-11 03:22:52.31506
NCT01515488|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-09-13|2012-08-14||January 2012||2012-01-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Kiosk-Model Self-Triage System in the Pediatric Emergency Department|"Assessing Utility of a Kiosk Model Self-Triage System in the Pediatric Emergency Department of A Tertiary Care Teaching Hospital"|Completed||N/A|400|Actual|Maricopa Integrated Health System||2|||f||||f||||||||||2017-10-11 03:22:52.440506|2017-10-11 03:22:52.440506
NCT01515475|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-04-11|||February 23, 2012|Actual|2012-02-23|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|HTS1||Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation|Glasses Versus Observation for Moderate Hyperopia in Young Children (HTS1)|Active, not recruiting||N/A|672|Anticipated|Jaeb Center for Health Research||2|||f||||t||||||||Yes|In accordance with the NIH data sharing policy, a de-identified database is placed in the public domain on the PEDIG public website after the completion of each protocol and publication of the primary manuscript.|2017-10-11 03:22:52.800455|2017-10-11 03:22:52.800455
NCT01515462|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2017-04-22|||April 20, 2010|Actual|2010-04-20|April 2017|2017-04-01|March 31, 2023|Anticipated|2023-03-31|April 30, 2018|Anticipated|2018-04-30||Interventional|TIGET-WAS||Gene Therapy for Wiskott-Aldrich Syndrome|A Phase I/II Clinical Trial of Hematopoietic Stem Cell Gene Therapy for the Wiskott-Aldrich Syndrome|Active, not recruiting||Phase 2|8|Anticipated|GlaxoSmithKline||1|||f||||f|f|f||||||||2017-10-11 03:22:52.931707|2017-10-11 03:22:52.931707
NCT01515449|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-23|||October 1998||1998-10-01|January 2012|2012-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Predictors of Poor Outcomes in 1038 Sigma Knees|Predictors of Poor Outcomes in 1038 Sigma Knees|Completed||N/A|1038|Actual|NHS Fife|||1||f||||f||||||||||2017-10-11 03:22:53.092456|2017-10-11 03:22:53.092456
NCT01515436|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-23|||February 2004||2004-02-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|May 2004|Actual|2004-05-01||Interventional|||The Effect of Music Periodicity on Interictal Epileptiform Discharges|A Randomized, Single-Blinded Clinical Trial: The Effect of Music Periodicity on Interictal Epileptiform Discharges|Completed||N/A|10|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 03:22:53.209893|2017-10-11 03:22:53.209893
NCT01515423|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-04-28|2016-02-01||May 2012||2012-05-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional||The safety analysis set included all participants who were randomly assigned to treatment during the Double-blind Phase and received at least 1 dose study drug.|Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia|A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia|Completed||Phase 3|1429|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 03:22:53.355202|2017-10-11 03:22:53.355202
NCT01515410|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2014-01-27|2013-11-20||January 2012||2012-01-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations|A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations|Completed||Phase 2|34|Actual|Depomed||2|||f||||f||||||||||2017-10-11 03:22:56.824061|2017-10-11 03:22:56.824061
NCT01515397|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2013-11-26|||December 2011||2011-12-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparison of Two Gelatine Solutions|Efficacy and Safety of a Balanced Gelatine Solution in Combination With a Balanced Electrolyte Solution Versus a Standard Gelatine Solution in Combination With a Non-balanced Electrolyte Solution in Patients Scheduled for Abdominal Surgery|Completed||Phase 3|40|Actual|B. Braun Melsungen AG||2|||f||||f||||||||||2017-10-11 03:22:57.272804|2017-10-11 03:22:57.272804
NCT01515384|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-21|2012-11-08|||June 2010||2010-06-01|November 2012|2012-11-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||A Trial of 18F-AV-133 Positron Emission Tomography (PET)|A Preliminary Evaluation of the Safety and Pancreas Imaging Properties of 18F-AV-133 in Healthy Volunteers and in Patients With Type 1 or Type 2 Diabetes|Suspended||Phase 1|35|Anticipated|Avid Radiopharmaceuticals||3|||f||||f||||||||||2017-10-11 03:22:57.360731|2017-10-11 03:22:57.360731
NCT01515371|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-06-18|||January 2012||2012-01-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring|Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, 3-stage Dose-finding Study to Identify a Safe and Effective Dose of NT 201 for Unilateral Injection Into the Soft Palate for Treatment of Habitual Snoring|Terminated||Phase 2|8|Actual|Merz Pharmaceuticals GmbH||2||Due to lack of sufficient eligible subjects, no safety concerns|f||||t||||||||||2017-10-11 03:22:57.457575|2017-10-11 03:22:57.457575
NCT01515358|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-05-30|||February 2012||2012-02-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants|A Single-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Subjects|Completed||Phase 1|18|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:22:57.554997|2017-10-11 03:22:57.554997
NCT01515345|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-03-24|2013-02-03||July 2011||2011-07-01|March 2017|2017-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|IDEAL-PCI||Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry|Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry|Completed||Phase 3|1008|Actual|Kaiser Franz Josef Hospital||2|||f||||f||||||||||2017-10-11 03:22:57.643097|2017-10-11 03:22:57.643097
NCT01515332|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2015-09-08|||March 2011||2011-03-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|March 2011|Actual|2011-03-01||Observational|||Energy Expenditure Methodology|Energy Expenditure Methodology|Completed||N/A|15|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-10-11 03:22:57.978609|2017-10-11 03:22:57.978609
NCT01515319|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2013-03-27|||April 2012||2012-04-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|Y242-01||Safety and Pharmacokinetic Study of Y242 in Adult Subjects|A Randomised, Placebo Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Y242 in Adult Subjects|Completed||Phase 1|68|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 03:22:58.036825|2017-10-11 03:22:58.036825
NCT01515306|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-05-25|2014-05-16|2014-04-25|July 2012||2012-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|March 2013|Actual|2013-03-01||Interventional||All participants who received at least 1 dose of study drug.|A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors|A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Paclitaxel in Patients With Advanced Malignant Solid Tumors|Active, not recruiting||Phase 2|40|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:22:58.161938|2017-10-11 03:22:58.161938
NCT01515280|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-12-11|||January 2012||2012-01-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Hull Airway Reflux Questionnaire Scores Following Cough Treatment|"Supplementary Study of Hull Airway Reflux Questionnaire Scores Before and After Treatment Study: A Multicentre, Double-Blind, Placebo-Controlled, Pivotal Study of the Efficacy and Safety of Oral Theobromine in the Management of Cough."|Completed||N/A|57|Actual|Hull and East Yorkshire Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 03:22:58.960284|2017-10-11 03:22:58.960284
NCT01515267|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-23|||November 2011||2011-11-01|January 2012|2012-01-01||||||||Observational|LVivoEF||Automated Left Ventricular Function Evaluation by LVivoEF|Automated Left Ventricular Function Evaluation by LVivoEF|Unknown status|Active, not recruiting|N/A|100|Anticipated|Diacardio LTD|||1||f||||t||||||||||2017-10-11 03:22:59.027839|2017-10-11 03:22:59.027839
NCT01515254|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-07-21|||February 2012||2012-02-01|July 2014|2014-07-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|FeeDIn||The Feeding Dynamic Intervention: Self Regulation of Intake in Preschoolers|The Feeding Dynamic Intervention Study|Unknown status|Active, not recruiting|N/A|84|Anticipated|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-11 03:22:59.134831|2017-10-11 03:22:59.134831
NCT01515241|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-01-29||2014-01-29|January 2012||2012-01-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|EXPRESS||Exploratory Study of Plaque Regression|EXPLORATORY STUDY OF PLAQUE REGRESSION:A Phase II Single Center Open-Label Exploratory Trial of the Effect of CER 001 in Subjects With Familial Hypercholesterolemia|Completed||Phase 2|10|Actual|Cerenis Therapeutics, SA||1|||f||||f||||||||||2017-10-11 03:22:59.300079|2017-10-11 03:22:59.300079
NCT01515228|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-01-08|||January 2012||2012-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)|Randomized Comparison of Dual Drug-Eluting Cilotax Stent and Everolimus -Eluting Stent Implantation for DE Novo Coronary Artery DisEase in Patients With DIABETES Mellitus|Completed||Phase 4|291|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-10-11 03:22:59.393561|2017-10-11 03:22:59.393561
NCT01515215|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-10-31|||July 2008||2008-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder|Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder|Completed||N/A|107|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||No||2017-10-11 03:22:59.539505|2017-10-11 03:22:59.539505
NCT01515202|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-12-04|||March 2012||2012-03-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Japanese Phase 1 Multiple Ascending Dose Study|A Randomized, Placebo-Controlled, Double-Blinded, Multiple Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-823778 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|40|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-10-11 03:22:59.66072|2017-10-11 03:22:59.66072
NCT01515189|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-08-21|2017-02-03||February 17, 2012|Actual|2012-02-17|August 2017|2017-08-01|October 1, 2017|Anticipated|2017-10-01|February 6, 2016|Actual|2016-02-06||Interventional||All randomized participants|Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab|A Randomized Double-Blind Phase III Study of Ipilimumab Administered at 3 mg/kg Versus at 10 mg /kg in Subjects With Previously Treated or Untreated Unresectable or Metastatic Melanoma|Active, not recruiting||Phase 4|831|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-11 03:22:59.857497|2017-10-11 03:22:59.857497
NCT01515163|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-01-12|||May 2010||2010-05-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||Exercise and Systemic Lupus Erythematosus||Active, not recruiting||N/A|90|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 03:23:02.289649|2017-10-11 03:23:02.289649
NCT01515150|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-01-23|||February 2012||2012-02-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Observational|P-VOD||The Out-patient, Non Antibiotic Management of Patients With Acute Uncomplicated Colonic Diverticulitis|Management of Patients With Uncomplicated Diverticulitis as Out-patient and Without Antibiotics|Completed||N/A|161|Actual|Uppsala University|||1||f||||t||||||||||2017-10-11 03:23:02.371402|2017-10-11 03:23:02.371402
NCT01515137|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-01-28|||November 2005||2005-11-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma|Phase II Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma With Evaluation of Neoadjuvant Biomarker Modulation With TARCEVA vs. TARCEVA Plus Sulindac|Completed||Phase 1|47|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 03:23:02.452931|2017-10-11 03:23:02.452931
NCT01515124|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-02-13|||January 2012||2012-01-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Women In Steady Exercise Research (WISER) Survivor Trial|The Women In Steady Exercise Research (WISER) Survivor Trial & Cost of Illness and Cost Effectiveness of Alternative Management Strategies|Active, not recruiting||N/A|555|Anticipated|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 03:23:02.730205|2017-10-11 03:23:02.730205
NCT01515111|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-18|||April 2011||2011-04-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|August 2011|Actual|2011-08-01||Observational|||Guatemala Internal Medicine Physicians' Knowledge of Non-communicable Disease Clinical Preventive Services|Knowledge and Recommendations on Tobacco Cessation and Other Preventive Interventions Among Internal Medicine Staff in Guatemala Teaching Hospitals|Completed||N/A|394|Actual|Unidad de Cirugía Cardiovascular|||1||f||||f||||||||||2017-10-11 03:23:02.920025|2017-10-11 03:23:02.920025
NCT01515098|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-05-13|||January 2012||2012-01-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|BERRY||Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline|The Effect of Blueberry Consumption on Cognition and Body Composition in Elderly Who Are Experiencing Mild Cognitive Decline|Completed||Phase 2|123|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 03:23:03.022807|2017-10-11 03:23:03.022807
NCT01515085|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2014-05-20|||August 2011||2011-08-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|LITT||MRI-Guided Laser Induced Thermal Therapy|MRI-Guided Laser-Induced Thermal Therapy for Cytoreduction of Inoperable Grade III/IV GLiomas Prior to Chemotherapy and Radiation|Terminated||N/A|1|Actual|Rutgers, The State University of New Jersey|||1|PI elected to close study|f||||f||||||||||2017-10-11 03:23:03.131207|2017-10-11 03:23:03.131207
NCT01515072|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-04-06|2016-04-28||July 2011||2011-07-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|July 2014|Actual|2014-07-01||Interventional|RIPNOD|All donors enrolled in both groups were included in the in-between group comparisons of baseline characteristics|Remote Ischemic Preconditioning in Neurological Death Organ Donors|Remote Ischemic Preconditioning in Neurological Death Organ Donors|Completed||N/A|321|Actual|Rutgers, The State University of New Jersey|1) Bias from variation in the intervention between two sites; 2) Lack of blinding; 3) Inadequate data precludes analyses of ejection fraction; 4) Data on some of the other secondary outcomes were not available for all donors.|2|||f||||f||||||||No||2017-10-11 03:23:03.29098|2017-10-11 03:23:03.29098
NCT01515059|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-12-14|||September 2012||2012-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ADIPOSE||Analysing Differences in Glycaemic Control Immediately Post Obesity SurgEry (The ADIPOSE Study)|A Prospective Pilot Study Investigating the Effects of Bariatric Surgery on Measures of Glycaemic Control and Incretin Levels|Terminated||N/A|16|Actual|University of Leicester|||1|Slow recruitment and sufficient data available to analyse|f||||f||||||||||2017-10-11 03:23:04.862718|2017-10-11 03:23:04.862718
NCT01515046|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-05-11|2017-02-10||September 2012||2012-09-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|July 2015|Actual|2015-07-01||Interventional|PACMAN-II||Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer|Pharmacological Ascorbate for the Control of Metastatic and Node-Positive Pancreatic Cancer (PACMAN): A Phase II Trial|Terminated||Phase 2|1|Actual|University of Iowa|There was only one treated participant. Conclusions cannot be drawn from these data due to limited sampling size.|1||Standard of care changed to FOLFIRINOX; poor accrual.|f||||t||||||||No||2017-10-11 03:23:04.981062|2017-10-11 03:23:04.981062
NCT01515033|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-20|||September 2010||2010-09-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Aerobic Exercise on PETCO2 Response in Coronary Artery Disease Patients|Effect of Continuous and Interval Exercise Training on PETCO2 Response During Graded Exercise Test in Patients With Coronary Artery Disease|Completed||Phase 2|37|Actual|Hospital TotalCor||2|||f||||t||||||||||2017-10-11 03:23:05.313064|2017-10-11 03:23:05.313064
NCT01515020|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-08-25|||May 2012||2012-05-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|June 2013|Actual|2013-06-01||Interventional|DAVASAB||Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia|A Randomized, Multicenter Trial of Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated Methicillin-resistant Staphylococcus Aureus Bacteremia|Terminated||Phase 3|10|Actual|Assistance Publique - Hôpitaux de Paris||2||lack of inclusion|f||||f||||||||||2017-10-11 03:23:05.408033|2017-10-11 03:23:05.408033
NCT01515007|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-12-02|||April 2014||2014-04-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|ORBIT-3||Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Time to First Pulmonary Exacerbation, Safety and Efficacy of ARD-3150 (Dual Release Ciprofloxacin for Inhalation-DRCFI) Compared With Placebo in the Management of Chronic Lung Infections With Pseudomonas Aeruginosa in Patients With Non-Cystic Fibrosis Bronchiectasis|Completed||Phase 3|278|Actual|Aradigm Corporation||2|||f||||f||||||||||2017-10-11 03:23:05.547106|2017-10-11 03:23:05.547106
NCT01514994|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-04-15|||June 2012||2012-06-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Interventional|||Valvuloplasty Scoring Balloon Catheter First-in-Man Study|Treatment of Critical Aortic Valve Stenosis Using a Novel Valvuloplasty Scoring Balloon Catheter: a First-in-Man Study|Completed||N/A|25|Actual|Spectranetics Corporation||1|||f||||f||||||||||2017-10-11 03:23:05.844155|2017-10-11 03:23:05.844155
NCT01514981|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-04-16|||December 2011||2011-12-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||AMG 761 in Adults With Asthma|A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 761 in Subjects With Asthma|Terminated||Phase 1|7|Actual|Amgen||2||Administrative decision|f||||f||||||||||2017-10-11 03:23:05.919439|2017-10-11 03:23:05.919439
NCT01514968|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2016-11-01|||December 2011||2011-12-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers|A Drug-Drug Interaction Study Between Danoprevir/Low-dose Ritonavir and Cyclosporine, a Potent Inhibitor of OATP, in Healthy Subjects|Completed||Phase 1|18|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:23:06.011283|2017-10-11 03:23:06.011283
NCT01514955|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-02-24|||November 2009||2009-11-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|IMRT||An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer|An Initial Feasibility Study to Integrate High-precision, Image Guided, Radiotherapy(MRI Based Brachytherapy and CT/MRI Fused Dynamic IMRT Planning) in the Treatment Planning of 10 Patients With Locally Advanced Carcinoma of the Cervix|Withdrawn||Phase 1|0|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 03:23:06.101007|2017-10-11 03:23:06.101007
NCT01514942|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-18||||||January 2012|2012-01-01||||||||Interventional|||Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters||Completed||Phase 4|||AGUNCO Obstetrics and Gynecology Centre||2|||f||||||||||||||2017-10-11 03:23:06.159954|2017-10-11 03:23:06.159954
NCT01514929|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-05-08|||October 2011||2011-10-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|||||Interventional|||A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers|A Randomized, Double-Blind, Placebo and Positive-Controlled, Crossover Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers|Completed||Phase 1|64|Actual|Achaogen, Inc.||4|||f||||t||||||||||2017-10-11 03:23:06.426456|2017-10-11 03:23:06.426456
NCT01514916|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-02-08||||||February 2012|2012-02-01||||||||Interventional|VJ||New Anastomotic Device for End to End Vascular Anastomosis in the Treatment of Peripheral Vascular Disease|Evaluation of a Mechanical System (Vascular Join) Facilitating Arterial Anastomoses During Peripheral Vascular Surgery (Bypass).|Unknown status|Recruiting|N/A|30|Anticipated|Ab Medica Spa||1|||f||||t||||||||||2017-10-11 03:23:06.535787|2017-10-11 03:23:06.535787
NCT01514903|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-10-11|||December 2011||2011-12-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers||Completed||Phase 1|54|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||t||||||||||2017-10-11 03:23:06.628029|2017-10-11 03:23:06.628029
NCT01514890|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-01-23|||February 2011|Actual|2011-02-01|January 2017|2017-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|CUPIC||French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin|Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) Included in the French Early Access Program for the Use of Protease Inhibitors in Genotype 1 Patients Who Failed to Eradicate HCV With a Previous Standard PEG-IFN and RBV Combination.|Completed||N/A|675|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||2||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:23:06.738246|2017-10-11 03:23:06.738246
NCT01514877|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-07-22|||January 2012||2012-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer|Phase II Study of Icotinib Combined With Whole Brain Radiotherapy in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer|Completed||Phase 2|20|Actual|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-10-11 03:23:06.849257|2017-10-11 03:23:06.849257
NCT01514864|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-11-02|2015-07-23||May 2012||2012-05-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||All participants who received at least 1 dose of study drug|Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation|Phase II Trial of Dasatinib in Subjects With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation|Terminated||Phase 2|19|Actual|Bristol-Myers Squibb|The study was terminated due to lack of efficacy and slow enrollment of patients.|2||Lack of efficacy and slow accrual|f||||f||||||||||2017-10-11 03:23:06.998564|2017-10-11 03:23:06.998564
NCT01514851|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-06-07|||January 2006||2006-01-01|June 2012|2012-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate|Phase III Double-blind Comparative Study of BAY 77 1931 (Lanthanum Carbonate) With a Calcium Carbonate in Patients With Hyperphosphatemia Undergoing Hemodialysis|Completed||Phase 3|259|Actual|Bayer||2|||f||||f||||||||||2017-10-11 03:23:07.938005|2017-10-11 03:23:07.938005
NCT01514838|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2016-01-19|||January 2012||2012-01-01|January 2016|2016-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus|A Phase III, Double-Blind, Randomized, Active Controlled, Monotherapy Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 3|46|Actual|Astellas Pharma Inc||2||Discontinued due to company's strategic reason|f||||f||||||||Undecided||2017-10-11 03:23:08.114208|2017-10-11 03:23:08.114208
NCT01514825|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-23|||November 2006||2006-11-01|January 2012|2012-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects|YM150 Clinical Pharmacology Study - Repeated Oral Administration to Elderly Subjects|Completed||Phase 1|36|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 03:23:08.270696|2017-10-11 03:23:08.270696
NCT01514812|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-01-23|||February 2006||2006-02-01|January 2012|2012-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy Subjects|A Double Blind, Randomized, Two Period Crossover Study To Determine The Effect of Multiple Doses of 120 MG Modified Release Formulation of YM150 on the Steady State Pharmacokinetics of Digoxin in Healthy Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 03:23:08.376059|2017-10-11 03:23:08.376059
NCT01514799|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2015-03-16|||June 2011||2011-06-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study|Randomized Study Comparing the Effects of Gastric Bypass Using a Long BP-limb vs. a Long Alimentary Limb in Morbid Obesity|Unknown status|Recruiting|N/A|200|Anticipated|Aleris Obesity||2|||f||||f||||||||||2017-10-11 03:23:08.480908|2017-10-11 03:23:08.480908
NCT01514786|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-09-10|2017-03-14||May 2012||2012-05-01|September 2017|2017-09-01|April 2015|Actual|2015-04-01|September 2014|Actual|2014-09-01||Interventional|DATES||Decision Aid to Technologically Enhance Shared Decision Making|Decision Aid to Technologically Enhance Shared Decision Making|Completed||N/A|570|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 03:23:08.590319|2017-10-11 03:23:08.590319
NCT01514773|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-03-15|||August 2011|Actual|2011-08-01|March 2017|2017-03-01|August 30, 2013|Actual|2013-08-30|August 30, 2013|Actual|2013-08-30||Observational|||Patient and Physician Survey Determinants of Appropriate ICD Utilization|Patient and Physician Knowledge and Attitudes Toward Defibrillator Therapy Survey Study|Completed||N/A|452|Actual|University of Michigan|||2||f||||f||||||||||2017-10-11 03:23:08.927189|2017-10-11 03:23:08.927189
NCT01514747|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2017-03-10|||October 2011||2011-10-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||A MRI Study of Visual and Motor Pathways in Premature Infants||Active, not recruiting||N/A|40|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-10-11 03:23:09.33736|2017-10-11 03:23:09.33736
NCT01514734|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2013-08-15|2013-08-15||March 2012||2012-03-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil|Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Brazil|Terminated||Phase 4|9|Actual|Alcon Research||1||Low recruitment rate|f||||f||||||||||2017-10-11 03:23:09.421091|2017-10-11 03:23:09.421091
NCT01514721|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2014-12-02|||June 2012||2012-06-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy|Assessing the Efficacy and Tolerability of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Prior Prostaglandin Fixed Combination|Terminated||Phase 4|37|Actual|Alcon Research||1||low enrollment|f||||f||||||||||2017-10-11 03:23:09.621924|2017-10-11 03:23:09.621924
NCT01514708|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-18|2012-12-27|||November 2011||2011-11-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||The Safety and Immune Response to Influenza Vaccination in Pregnant Women|The Safety and Immune Response to Influenza Vaccination in Pregnant Women|Completed||Phase 4|46|Actual|Adimmune Corporation||1|||f||||f||||||||||2017-10-11 03:23:09.716786|2017-10-11 03:23:09.716786
NCT01514695|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2013-01-28|||February 2012||2012-02-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|FUSE||Fentanyl Use for Sedation in Esophagogastroduodenoscopy|Fentanyl Use for Sedation in Esophagogastroduodenoscopy (FUSE): a Phase 4, Randomized, Double-blind, Placebo-controlled Trial of Fentanyl Added to Midazolam Compared to Midazolam Alone for Sedation in Routine Upper Endoscopy|Completed||Phase 4|139|Actual|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-11 03:23:09.804431|2017-10-11 03:23:09.804431
NCT01514682|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-05-01|||June 2012|Actual|2012-06-01|May 2017|2017-05-01|April 17, 2017|Actual|2017-04-17|April 17, 2017|Actual|2017-04-17||Interventional|||Anti-Inflammatory Treatment of Schizophrenia|Anti-Inflammatory Combination Therapy for the Treatment of Schizophrenia|Completed||N/A|51|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 03:23:09.916352|2017-10-11 03:23:09.916352
NCT01514669|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-03-06|||January 2012||2012-01-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer|Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer|Active, not recruiting||N/A|75|Anticipated|University of Arkansas|||1||f||||f||||||Samples With DNA|"     Tear Sample collection; serum sample collection   "|||2017-10-11 03:23:10.005531|2017-10-11 03:23:10.005531
NCT01514656|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-05-02|||November 2011||2011-11-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|July 2015|Actual|2015-07-01||Interventional|||CPR Training: Video Self-Instruction Kit or Video-Only|Hospital-based CPR Training for At-risk Family Members Using a Video-self Instruction Kit or Video-only|Completed||N/A|1870|Actual|University of Pennsylvania||6|||f||||t||||||||No||2017-10-11 03:23:10.08492|2017-10-11 03:23:10.08492
NCT01514643|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-06-16|||October 2011||2011-10-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PTOA||Inflammatory Response Following Intraarticular Fracture|Inflammatory Response Following Intraarticular Fracture|Recruiting||N/A|60|Anticipated|University of Utah|||1||f||||f||||||Samples Without DNA|"     Synovial fluid and blood serum   "|||2017-10-11 03:23:10.187261|2017-10-11 03:23:10.187261
NCT01514630|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2015-06-09|2015-05-14||January 2013||2013-01-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Creatine as a Treatment Option for Depression in Methamphetamine Using Females|Creatine as a Treatment Option for Depression in Methamphetamine Using Females|Completed||Phase 4|14|Actual|University of Utah||1|||f||||t||||||||||2017-10-11 03:23:10.275807|2017-10-11 03:23:10.275807
NCT01514617|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2015-12-01|||January 2012||2012-01-01|October 2011|2011-10-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization|Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization|Unknown status|Active, not recruiting|N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 03:23:10.513002|2017-10-11 03:23:10.513002
NCT01514604|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-04-29|||March 2012||2012-03-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Constructing a Learning Curve in Ultrasound Guided Needling|Constructing a Learning Curve in Ultrasound Guided Needling - an Observational Study Using Cumulative Sum (Cusum) Analysis|Completed||N/A|21|Actual|University of Aberdeen|||3||f||||f||||||||||2017-10-11 03:23:10.588498|2017-10-11 03:23:10.588498
NCT01514591|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2013-06-19|||August 2011||2011-08-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Thromboelastography in Non-elective Cesarean Delivery|Thromboelastography to Assess Hemostatic Changes in Laboring Patients Undergoing Non-elective (Intrapartum) Cesarean Delivery|Completed||N/A|33|Actual|Stanford University|||1||f||||t||||||Samples With DNA|"     Blood samples for TEG analysis.   "|||2017-10-11 03:23:10.669659|2017-10-11 03:23:10.669659
NCT01514578|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-08-23|||January 2012||2012-01-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males|A Multi-Part, Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TRV130A in Healthy Adult Males|Completed||Phase 1|74|Actual|Trevena Inc.||2|||f||||t||||||||||2017-10-11 03:23:10.94853|2017-10-11 03:23:10.94853
NCT01514565|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2015-03-17|||December 2011||2011-12-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01||Observational|||Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer|Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer.|Recruiting||N/A|70|Anticipated|Thomas Jefferson University|||1||f||||f||||||||||2017-10-11 03:23:11.086081|2017-10-11 03:23:11.086081
NCT01514552|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-04-07|||November 2010||2010-11-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|January 2018|Anticipated|2018-01-01||Interventional|||The Use of Functional Confections in Promoting Oral Health|A Pilot Phase I Study of the Use of Functional Confections in Promoting Oral Health in Men and Women|Active, not recruiting||Phase 1|36|Anticipated|Ohio State University||2|||f||||f||||||||||2017-10-11 03:23:11.221317|2017-10-11 03:23:11.221317
NCT01514539|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-01-07|||August 2009||2009-08-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk|Role of Ghrelin and PYY in Postpartum Body Weight Regulation and Presence in Human Milk|Completed||N/A|44|Actual|University of Wyoming||2|||f||||t||||||||||2017-10-11 03:23:11.377166|2017-10-11 03:23:11.377166
NCT01514526|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-04-24|||January 2012||2012-01-01|April 2016|2016-04-01|November 2016|Actual|2016-11-01|July 2013|Actual|2013-07-01||Interventional|||Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma|Phase II Clinical Trial of Dovitinib (TKI-258) in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma|Completed||Phase 2|17|Actual|Spanish Oncology Genito-Urinary Group||1|||f||||f||||||||||2017-10-11 03:23:11.480034|2017-10-11 03:23:11.480034
NCT01514513|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2014-12-18|2014-12-03||August 2011||2011-08-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin|A Comparative Study to Demonstrate the Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin in Head Lice Infested Individuals|Completed||N/A|42|Actual|South Florida Family Health and Research Centers||2|||f||||t||||||||||2017-10-11 03:23:11.611686|2017-10-11 03:23:11.611686
NCT01514500|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-02-23|||January 16, 2012|Actual|2012-01-16|February 2017|2017-02-01|March 18, 2013|Actual|2013-03-18|March 18, 2013|Actual|2013-03-18||Interventional|||First Human Dose Trial of NNC0195-0092 in Healthy Subjects|First Human Dose Trial of NNC0195-0092 in Healthy Subjects|Completed||Phase 1|105|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:23:12.252919|2017-10-11 03:23:12.252919
NCT01514487|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-02-28|||January 13, 2005|Actual|2005-01-13|February 2017|2017-02-01|March 30, 2005|Actual|2005-03-30|March 30, 2005|Actual|2005-03-30||Interventional|||Comparison of Three Liraglutide Formulations in Healthy Volunteers|A Randomised, Double-blind, Single-centre, Three-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Each of the Two New Liraglutide Formulations at pH 7.9 and 8.15 and the Planned Phase 3 Formulation at pH 7.7|Completed||Phase 1|24|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:23:12.379298|2017-10-11 03:23:12.379298
NCT01514461|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-05-15|2015-05-15||July 2012||2012-07-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Full analysis set (FAS) consisted of all randomized patients, except for those who were mis-randomized.|A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome|A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome|Completed||Phase 3|45|Actual|Novartis||3|||f||||||||||||||2017-10-11 03:23:12.518238|2017-10-11 03:23:12.518238
NCT01514448|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-07-17|2017-03-31||May 21, 2012|Actual|2012-05-21|July 2017|2017-07-01|April 1, 2016|Actual|2016-04-01|April 1, 2016|Actual|2016-04-01||Interventional||Demographic and other baseline data (including disease characteristics) were summarized descriptively for all patients for the FAS. The full analysis set (FAS) consisted of all patients who received at least one dose of everolimus.|Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib|An Open Label, Single Arm Trial to Evaluate Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus After Failure of First Line Therapy With Sunitinib or Pazopanib|Completed||Phase 4|29|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:23:13.912218|2017-10-11 03:23:13.912218
NCT01514435|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-17|||May 2006||2006-05-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|May 2009|Actual|2009-05-01||Interventional|||Changes in Cerebral Glucose Metabolism After Electroconvulsive Therapy (ECT)|Clinical Effects of Electroconvulsive Therapy in Severe Depression and Concomitant Changes in Cerebral Glucose Metabolism - an Exploratory Study|Completed||N/A|13|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-11 03:23:14.893917|2017-10-11 03:23:14.893917
NCT01514422|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-12-06|2016-09-29||May 2011||2011-05-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Minocycline for Bipolar Depression|Minocycline for Bipolar Disorder|Completed||Phase 4|20|Actual|Icahn School of Medicine at Mount Sinai|Limitations are this is an open label study with no placebo and low number of subjects.|1|||f||||f||||||||||2017-10-11 03:23:14.988248|2017-10-11 03:23:14.988248
NCT01514409|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-20|||May 2011||2011-05-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Sub-chronic Effects of 5-hydroxytryptophan on Mood and Emotional Processing in Healthy Volunteers|Sub-chronic Effects of 5-hydroxytryptophan on Mood and Emotional Processing in Healthy Volunteers: A Randomised Trial|Completed||N/A|33|Actual|Northumbria University||2|||f||||f||||||||||2017-10-11 03:23:15.219001|2017-10-11 03:23:15.219001
NCT01514370|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-09-02|||April 2012||2012-04-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|CONTAIN||Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a|ProspeCtive Study to Evaluate Efficacy, Safety and tOlerability of Dietary supplemeNT of Curcumin (BCM95) in Subjects With Active Relapsing MultIple Sclerosis Treated With subcutaNeous Interferon Beta 1a 44 mcg Three Times a Week (TIW)|Completed||Phase 2|80|Actual|Merck KGaA||2|||f||||||||||||||2017-10-11 03:23:15.543362|2017-10-11 03:23:15.543362
NCT01514344|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-17|||December 2011||2011-12-01|January 2012|2012-01-01|October 2015|Anticipated|2015-10-01|October 2014|Anticipated|2014-10-01||Interventional|IRIS||Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma|Phase II Study on Activity and Tolerability of Intralesional Rituximab in Patients With Relapsed or Refractory CD20+ Indolent Lymphomas of Conjunctiva; Activity of Supplemental Autologous Serum in Patients Not Responsive to Rituximab Alone|Unknown status|Recruiting|Phase 2|20|Anticipated|IRCCS San Raffaele||1|||f||||f||||||||||2017-10-11 03:23:17.445414|2017-10-11 03:23:17.445414
NCT01514331|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-11-19|||January 2012||2012-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Ventilatory Parameters and Inflammatory Responses of Neonates Ventilated by Different Modes of Ventilation|Determination of Ventilatory Parameters and Inflammatory Responses of Neonates Who Are Ventilated by Volume Guarantee Combined With Synchronized Intermittent Mandatory Ventilation or Pressure Support Ventilation|Completed||N/A|40|Actual|Gazi University||2|||f||||f||||||||||2017-10-11 03:23:17.579715|2017-10-11 03:23:17.579715
NCT01514318|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-10-31|2012-07-18||February 2012||2012-02-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Encore Revelation Hip Stem|A Long-term Follow Up Study of the Revelation™ Hip Stem|Completed||N/A|8|Actual|Encore Medical, L.P.|Small patient population to choose from and difficulty in locating people who have not been seen by the doctor in almost 10 years.||1||f||||f||||||||||2017-10-11 03:23:17.718868|2017-10-11 03:23:17.718868
NCT01514305|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-01-20|||November 2011||2011-11-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System|Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System|Completed||N/A|21|Actual|DexCom, Inc.|||1||f||||f||||||||||2017-10-11 03:23:17.895035|2017-10-11 03:23:17.895035
NCT01514292|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2015-09-10|2014-02-03||December 2011||2011-12-01|August 2015|2015-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Type 1 Diabetes and Type 2 Diabetes with Insulin treatment.|Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System|PTL-900590 Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System|Completed||N/A|72|Actual|DexCom, Inc.||1|||f||||f||||||||||2017-10-11 03:23:17.951451|2017-10-11 03:23:17.951451
NCT01514279|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-01-26|||February 2011||2011-02-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|IMPACT||Ideas Moving Parents and Adolescents to Change Together (IMPACT)|Targeting Obesity and Blood Pressure in Urban Youth(Consortium Title: Childhood Obesity Prevention and Treatment Research [COPTR] and Site Project Name IMPACT (Ideas Moving Parents and Adolescents to Change Together).|Enrolling by invitation||N/A|360|Anticipated|Case Western Reserve University||3|||f||||t||||||||Yes|Conducted in conjunction with the Research Coordinating Unit (UNC Chapel Hill) of the COPTR Consortium.|2017-10-11 03:23:18.145064|2017-10-11 03:23:18.145064
NCT01514266|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-01-20|||April 2005||2005-04-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|May 2007|Actual|2007-05-01||Interventional|||Effect of Curcumin on Lung Inflammation|Effect of Curcumin on Lung Inflammation|Completed||N/A|57|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 03:23:18.234237|2017-10-11 03:23:18.234237
NCT01514253|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-20|||February 2012||2012-02-01|January 2012|2012-01-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|glucose||Reduced Infant Response to a Routine Care Procedure After Glucose 25% Analgesia in Comparison to Materna RTF Stage 1|Reduced Infant Response to a Routine Care Procedure After Glucose 25% Analgesia in Comparison to Materna RTF Stage 1|Unknown status|Not yet recruiting|N/A|180|Anticipated|The Baruch Padeh Medical Center, Poriya||3|||f||||f||||||||||2017-10-11 03:23:18.367316|2017-10-11 03:23:18.367316
NCT01514240|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-09-08|2015-03-04||February 2012||2012-02-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan|A Multicentre, Double-blind, Randomised, Parallel-group, Phase III Study to Assess Efficacy and Safety of D9421-C 9 mg Versus Mesalazine 3 g in Patients With Active Crohn's Disease (CD) in Japan|Completed||Phase 3|123|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:23:18.594842|2017-10-11 03:23:18.594842
NCT01514227|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-01-26|||December 2011||2011-12-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Nobori Dual Antiplatelet Therapy as Appropriate Duration|Nobori Dual Antiplatelet Therapy as Appropriate Duration.|Completed||Phase 4|3773|Actual|Associations for Establishment of Evidence in Interventions||2|||f||||f||||||||No||2017-10-11 03:23:19.748355|2017-10-11 03:23:19.748355
NCT01514214|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-04-07|||January 2012||2012-01-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct Obstruction|A Randomized Trial Comparing a Winged Perimeter Stent and Traditional Polyethylene Plastic Stent in the Management of Malignant Distal Biliary Strictures|Unknown status|Recruiting|Phase 4|100|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 03:23:19.820207|2017-10-11 03:23:19.820207
NCT01514201|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2017-09-04|||November 17, 2011|Actual|2011-11-17|April 2017|2017-04-01||||August 1, 2019|Anticipated|2019-08-01||Interventional|||Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas|A Phase I/II Study of ABT-888, An Oral Poly(ADP-ribose) Polymerase Inhibitor, and Concurrent Radiation Therapy, Followed by ABT-888 and Temozolomide, in Children With Newly Diagnosed Diffuse Pontine Gliomas (DIPG)|Active, not recruiting||Phase 1/Phase 2|66|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 03:23:19.911552|2017-10-11 03:23:19.911552
NCT01514188|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-09-12|||December 2011||2011-12-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|December 2013|Anticipated|2013-12-01||Interventional|||Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma|A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma|Unknown status|Active, not recruiting|Phase 2|105|Anticipated|CytRx||2|||f||||t||||||||||2017-10-11 03:23:20.054086|2017-10-11 03:23:20.054086
NCT01514175|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2012-05-15|||January 2012||2012-01-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac|A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac|Unknown status|Enrolling by invitation|Phase 4|50|Actual|Culpeper Surgery Center||1|||f||||f||||||||||2017-10-11 03:23:20.373771|2017-10-11 03:23:20.373771
NCT01514162|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-05-02|2016-10-14||February 2012||2012-02-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve|Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve|Completed||N/A|245|Actual|St. Jude Medical||1|||f||||f||||||||No||2017-10-11 03:23:20.468852|2017-10-11 03:23:20.468852
NCT01514149|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-06-21|2017-05-02||September 2011||2011-09-01|June 2017|2017-06-01|March 2013|Actual|2013-03-01|May 2012|Actual|2012-05-01||Interventional||Intent to Treat population|Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2 Dose-Ranging Study to Evaluate the Efficacy and Safety of 17 Weeks of Weekly Injections of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus on Metformin Monotherapy|Terminated||Phase 2|73|Actual|ConjuChem||5||Business decision|f||||f||||||||||2017-10-11 03:23:20.767607|2017-10-11 03:23:20.767607
NCT01514136|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2015-02-20|2015-01-19||September 2011||2011-09-01|February 2015|2015-02-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||An Investigation of Ostomy Devices|CP216: An Exploratory Investigation of Convex Ostomy Devices|Completed||N/A|32|Actual|Coloplast A/S|This was an exploratory investigation where the participating subjects had to test 8 different test products. A small number of subjects were analysed from two different populations (convex product/flat product users).|1|||f||||f||||||||||2017-10-11 03:23:21.426005|2017-10-11 03:23:21.426005
NCT01514123|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-07-21|||January 2012||2012-01-01|July 2017|2017-07-01|November 2017|Anticipated|2017-11-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors|A Phase I, Open Label, Dose Escalation Study of the VEGF-C Human Monoclonal Antibody VGX-100 Administered by Intravenous Infusion Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced or Metastatic Solid Tumors|Active, not recruiting||Phase 1|40|Anticipated|Circadian Technologies Ltd.||2|||f||||f||||||||||2017-10-11 03:23:22.150745|2017-10-11 03:23:22.150745
NCT01514110|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-07-26|||January 2008||2008-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Gastric Cancer RAD001 Study|Phase I/II Study of Paclitaxel / Carboplatin / RAD001 as First Line Therapy for Advanced Adenocarcinoma of the Stomach|Active, not recruiting||Phase 1/Phase 2|35|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 03:23:22.249089|2017-10-11 03:23:22.249089
NCT01514097|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2015-07-29|||February 2012||2012-02-01|April 2014|2014-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Adequacy of Pain Management for Upper Extremity Fracture After Discharge From a Pediatric Emergency Depart||Unknown status|Recruiting|N/A|300|Anticipated|Children's Hospitals and Clinics of Minnesota|||2||f||||||||||||||2017-10-11 03:23:22.337786|2017-10-11 03:23:22.337786
NCT01514084|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2014-04-21|||February 2012||2012-02-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Cosmetic Outcomes and Patient Satisfaction After Facial Laceration Repair in the Emergency Department||Completed||N/A|160|Anticipated|Children's Hospitals and Clinics of Minnesota|||4||f||||||||||||||2017-10-11 03:23:22.402846|2017-10-11 03:23:22.402846
NCT01514071|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-07-30|||February 2012||2012-02-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Animated Picture to Improve Provider Adherence to CT Scan for Head Injury Rule||Completed||N/A|746|Anticipated|Children's Hospitals and Clinics of Minnesota||1|||f||||||||||||||2017-10-11 03:23:22.4858|2017-10-11 03:23:22.4858
NCT01514058|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-05-25|||November 2011||2011-11-01|July 2015|2015-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction|A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction|Terminated||N/A|8|Actual|Wake Forest University Health Sciences||2||new clinical strategies have rendered the question posed by this study less relevant|f||||f|f|f||||||||2017-10-11 03:23:22.569404|2017-10-11 03:23:22.569404
NCT01514045|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-08-08|||April 2011||2011-04-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Observational|||The Gastric Cancer Foundation: A Gastric Cancer Registry|The Gastric Cancer Foundation: A Gastric Cancer Registry|Recruiting||N/A|500|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"     Blood samples with DNA Paraffin embedded tissue will be stored in the Stanford Tissue Bank     for 100 years.   "|||2017-10-11 03:23:22.666576|2017-10-11 03:23:22.666576
NCT01514032|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||October 2011||2011-10-01|January 2012|2012-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones|TOP-Stone: Treatment of Patients With Small Kidney Stones - Randomized Head-to-head Trial Comparing Extracorporal Shockwave Lithotripsy With Retrograde Intrarenal Surgery|Unknown status|Recruiting|N/A|230|Anticipated|University of Zurich||2|||f||||||||||||||2017-10-11 03:23:22.762138|2017-10-11 03:23:22.762138
NCT01514019|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-06-19|||January 2012||2012-01-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers|An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers|Completed||Phase 4|16|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:23:22.852282|2017-10-11 03:23:22.852282
NCT01514006|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2015-03-06|||January 2012||2012-01-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty|Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty - a Prospective Observational Study|Completed||N/A|125|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 03:23:22.939698|2017-10-11 03:23:22.939698
NCT01513993|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2015-10-27|||October 2011||2011-10-01|January 2012|2012-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Remote Monitoring of Chronic Heart Failure in Veneto Region|RENEWING HEALTH - Large Scale Pilot in Veneto Region: Remote Monitoring of Chronic Heart Failure|Completed||N/A|315|Actual|Regione Veneto||2|||f||||t||||||||||2017-10-11 03:23:23.02674|2017-10-11 03:23:23.02674
NCT01513980|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-04-13|||November 2011||2011-11-01|January 2012|2012-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Life-long Monitoring of COPD in Veneto Region|RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring in COPD|Completed||N/A|750|Actual|Regione Veneto||3|||f||||t||||||||No||2017-10-11 03:23:23.370173|2017-10-11 03:23:23.370173
NCT01513967|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-12-05|||January 2012||2012-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease|A Randomized Single and Multiple Dose Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease|Completed||Phase 1/Phase 2|36|Actual|Regenera Pharma Ltd||14|||f||||t||||||||||2017-10-11 03:23:23.518838|2017-10-11 03:23:23.518838
NCT01513954|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-17|||January 2012||2012-01-01|January 2012|2012-01-01|June 2013|Anticipated|2013-06-01|January 2013|Anticipated|2013-01-01||Observational|||Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration|Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration|Unknown status|Recruiting|N/A|450|Anticipated|Red Rock Fertility Center|||2||f||||t||||||||||2017-10-11 03:23:23.686296|2017-10-11 03:23:23.686296
NCT01513941|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2016-05-04|||April 2012||2012-04-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|INSIGHT||An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)|Open-Label, Phase 3b Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Virus Treatment-Naïve and Treatment-Experienced Subjects With Genotype 1 Chronic Hepatitis C and Human Immunodeficiency Virus Type 1 (HCV-1/HIV-1) Coinfection|Completed||Phase 3|163|Actual|Janssen-Cilag International NV||1|||f||||f||||||||||2017-10-11 03:23:23.814922|2017-10-11 03:23:23.814922
NCT01513928|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-03-08|||January 2012||2012-01-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects|A Phase 1, Cross-Over, Single-Dose, Open-Label Study To Estimate The Relative Bioavailability Of Three Different Formulations Of PF-04937319 In Overweight And Obese Otherwise Healthy Subjects|Completed||Phase 1|12|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 03:23:23.992424|2017-10-11 03:23:23.992424
NCT01513915|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2016-04-23|||July 2008||2008-07-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||A Parent-only Group Cognitive Behavioral Intervention for Children With Anxiety Disorders: a Control Group Study|A Parent-only Group Cognitive Behavioral Intervention for Children With Anxiety Disorders: a Control Waiting List Group Study|Completed||N/A|40|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:23:24.070951|2017-10-11 03:23:24.070951
NCT01513902|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-05-24|2016-05-24||March 2013||2013-03-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||The safety analysis population included all participants who received at least 1 dose of study drug.|Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)|An Open-label Multiple Dose Study To Evaluate The Pharmacokinetics, Safety And Tolerability Of CP-690,550 In Pediatric Patients From 2 To Less Than 18 Years Of Age With Juvenile Idiopathic Arthritis (JIA)|Completed||Phase 1|26|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:23:24.185185|2017-10-11 03:23:24.185185
NCT01513863|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-12-19|||August 2011||2011-08-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|MTZG||A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea|A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site Clinical Study to Compare the Bioequivalence of Two Metronidazole 1% Topical Gel Formulations in Patients With Moderate to Severe Rosacea|Completed||Phase 1|602|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 03:23:24.779145|2017-10-11 03:23:24.779145
NCT01513850|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-05-29|||October 2010||2010-10-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients|A 52-week, Multi-center, Open Label, Single Arm, Phase 3 Study to Evaluate the Efficacy and Safety of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients|Completed||Phase 3|87|Actual|SK Chemicals Co.,Ltd.||1|||f||||f||||||||||2017-10-11 03:23:24.899339|2017-10-11 03:23:24.899339
NCT01513837|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-09-07|||March 2011||2011-03-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|February 2012|Actual|2012-02-01||Observational|IRIS-ASMA||Rinitis y Sinusitis según la Gravedad Del Asma|PREVALENCIA, GRAVEDAD E IMPACTO DE LA RINITIS Y DE LA SINUSITIS SEGÚN EL NIVEL DE GRAVEDAD Y CONTROL DEL ASMA (PROYECTO IRIS-ASMA)|Completed||N/A|450|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||||||||||||2017-10-11 03:23:24.974423|2017-10-11 03:23:24.974423
NCT01513824|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-02-25|||November 2011||2011-11-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|SongHeart||Stress and Ischemic Heart Disease. The Effect of Bio Feedback Guided Stress Management on Life Quality Including Signs of Depression and Stress|Stress, Ongoing Self Monitoring and Ischemic Heart Disease Rehabilitation, a Randomized Controlled Trial (SongHeart)|Completed||N/A|216|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 03:23:25.038939|2017-10-11 03:23:25.038939
NCT01513811|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-04-17|||February 2010||2010-02-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Itopride as an Adjuvant for Bowel Preparation in Patients With Chronic Constipation is Effective|High Dose of Itopride: a Valid Adjuvant for Bowel Preparation in Patients With Chronic Constipation|Completed||Phase 2|115|Actual|Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||||2017-10-11 03:23:25.117874|2017-10-11 03:23:25.117874
NCT01513798|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-02-25|||January 2012||2012-01-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||Diet and Exercise in Type 2 Diabetes - a Randomized Controlled Trial|Diet and Exercise in Type 2 Diabetes - a Randomized Controlled Trial|Completed||N/A|40|Actual|Umeå University||2|||f||||||||||||||2017-10-11 03:23:25.206908|2017-10-11 03:23:25.206908
NCT01513785|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||April 2011||2011-04-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot Study|New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot Study|Completed||Phase 2|40|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||f||||||||||2017-10-11 03:23:25.298249|2017-10-11 03:23:25.298249
NCT01513772|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-08-07|||February 2012||2012-02-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Effect of Dexmedetomidine on the Emergence Agitation in Nasal Surgery||Completed||N/A|100|Actual|Severance Hospital||2|||f||||||||||||||2017-10-11 03:23:25.386944|2017-10-11 03:23:25.386944
NCT01513759|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2013-06-11|||May 2012||2012-05-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|SEATTLE II||A Prospective, Single-arm, Multi-center Trial of EkoSonic® Endovascular System and Activase for Treatment of Acute Pulmonary Embolism (PE).|Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy|Completed||Phase 3|150|Actual|EKOS Corporation||1|||f||||f||||||||||2017-10-11 03:23:25.463035|2017-10-11 03:23:25.463035
NCT01513746|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2014-08-25|||December 2011||2011-12-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity|Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity|Completed||N/A|83|Actual|Duke University|||1||f||||t||||||||||2017-10-11 03:23:25.624727|2017-10-11 03:23:25.624727
NCT01513733|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-08-11|||January 2012||2012-01-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|CATCH||The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer|The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Castration-Resistant Heavily Pre-treated Prostate Cancer|Completed||Phase 1|25|Actual|Duke University||3|||f||||t||||||||||2017-10-11 03:23:25.696939|2017-10-11 03:23:25.696939
NCT01513720|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-17|||December 2002||2002-12-01|October 2002|2002-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition|Single Dose, Two-way, Crossover, Oral Bioequivalence Study of Lamotrigine Tablets 200 mg With Lamictal® Tablets 200 mg in Healthy, Volunteers Under Fasting Condition.|Completed||Phase 1|20|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:23:25.786454|2017-10-11 03:23:25.786454
NCT01513707|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2017-04-25|||December 22, 2011|Actual|2011-12-22|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|PDMP||The Effects of Pre-transplant Dialysis Modality on Post-transplant Events|The Effects of Pre-transplant Dialysis Modality on Post-transplant Events|Recruiting||N/A|1040|Anticipated|Samsung Medical Center|||2||f||||f||||||||Undecided||2017-10-11 03:23:25.87422|2017-10-11 03:23:25.87422
NCT01513694|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2017-06-01|||January 2010||2010-01-01|May 2017|2017-05-01|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Interventional|||Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease|Clinical Trial Phase I / II Prospective, Open, Non-randomized for Treatment of Lumbar Intervertebral Degenerative Disc Disease With Posterolateral Instrumented and Autologous Mesenchymal Stem Cells.|Completed||Phase 1/Phase 2|15|Anticipated|Red de Terapia Celular||1|||f||||t||||||||||2017-10-11 03:23:25.958452|2017-10-11 03:23:25.958452
NCT01513681|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-17|||November 2002||2002-11-01|October 2002|2002-10-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition|Single Dose, Two-way, Crossover, Oral Bioequivalence Study of Lamotrigine Tablets 200 mg With Lamictal® Tablets 200 mg in Healthy, Volunteers Under Fed Condition.|Completed||Phase 1|20|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:23:26.039866|2017-10-11 03:23:26.039866
NCT01513668|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-27|||May 2006||2006-05-01|January 2012|2012-01-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fed Condition|An Open Label, Balanced, Randomised, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover Bioavailability Study Comparing Acetaminophen 650 mg Extended Release Gel Tabs (Containing Acetaminophen 650 mg) of OHM Laboratories (Subsidiary of Ranbaxy) With Tylenol 8 Hour 650 mg Gel Tabs (Containing Acetaminophen 650 mg) of Mc Neil, Consumer & Speciality Pharmaceuticals in Healthy, Adult, Human, Male Subjects Under Fed Condition|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 03:23:26.11902|2017-10-11 03:23:26.11902
NCT01513655|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-11-23|||July 2013||2013-07-01|November 2015|2015-11-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation|Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation|Recruiting||Phase 4|150|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-11 03:23:26.195031|2017-10-11 03:23:26.195031
NCT01513642|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||March 2009||2009-03-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|February 2010|Actual|2010-02-01||Interventional|||Respiratory Physiotherapy After Cardiac Surgery|Inspiratory Volume and Muscle Recruitment During Breath-stacking and Incentive Spirometry Techniques in Postoperative Cardiac Patients|Completed||N/A|16|Actual|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-10-11 03:23:26.44957|2017-10-11 03:23:26.44957
NCT01513629|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||October 2010||2010-10-01|January 2012|2012-01-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|||Structural Connectivity as Imaging Endophenotypes of Autism Spectrum Disorders||Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 03:23:26.540523|2017-10-11 03:23:26.540523
NCT01513616|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-12-14|||November 2006||2006-11-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Impact of Pulmonary Rehabilitation on Dyspnea in Chronic Obstructive Pulmonary Disease|Mechanisms of Dyspnea Relief Following Exercise Training in COPD|Completed||N/A|48|Actual|Queen's University||2|||f||||f||||||||||2017-10-11 03:23:26.616944|2017-10-11 03:23:26.616944
NCT01513603|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-19|||January 2012||2012-01-01|January 2012|2012-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia|Phase II Trial of CLAG-M in Relapsed ALL|Unknown status|Recruiting|Phase 2|50|Anticipated|New York Medical College||1|||f||||f||||||||||2017-10-11 03:23:26.710024|2017-10-11 03:23:26.710024
NCT01513590|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2017-02-09|2015-10-19||January 2012||2012-01-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|BOOST™||A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes|A 26-week, Randomised, Open-label, Multinational, Treat-to-target Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) Twice Daily (BID) and BIAsp 30 BID Both With Metformin in Insulin naïve Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Monotherapy or Metformin in Combination With One Additional Oral Antidiabetic Drug (OAD)|Completed||Phase 3|394|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:23:26.859483|2017-10-11 03:23:26.859483
NCT01513577|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2014-09-12|||January 2003||2003-01-01|September 2014|2014-09-01|June 2006|Actual|2006-06-01|December 2004|Actual|2004-12-01||Interventional|||Percutaneous Minimal Invasive Pedicular Screw and Rod Insertion in Circumferential Lumbar Fusion|Percutaneous Minimal Invasive Pedicular Screw and Rod Insertion Reduces Hospital Stay and Morbidity Compared to Open Midline Approach in Circumferential Lumbar Fusion. A Randomized Study With 2 Years Follow-up|Completed||N/A|16|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 03:23:27.569721|2017-10-11 03:23:27.569721
NCT01513564|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-05-27|||January 2001||2001-01-01|May 2015|2015-05-01|June 2006|Actual|2006-06-01|December 2003|Actual|2003-12-01||Interventional|||Multimodal Perioperative Pain Management|Multimodal Perioperative Pain Management of Circumferential Lumbar Fusion Improves Recovery|Completed||N/A|120|Actual|Northern Orthopaedic Division, Denmark||1|||f||||f||||||||||2017-10-11 03:23:27.651169|2017-10-11 03:23:27.651169
NCT01513551|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2015-02-26|||March 2012||2012-03-01|February 2015|2015-02-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||A Study to Compare the Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in Healthy Volunteers (V114-002)|A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of a Pneumococcal Conjugate Vaccine (V114) Compared to Pneumococcal Polysaccharide Vaccine (PNEUMOVAX 23) and Prevnar 13 (Pneumococcal 13-Valent Conjugate Vaccine [Diphtheria CRM197 Protein]) in Healthy Adults 50 Years of Age or Older|Completed||Phase 2|692|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 03:23:27.761469|2017-10-11 03:23:27.761469
NCT01513525|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2017-01-25|||February 2007||2007-02-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers|A Randomised, Open-label, Single Centre, Three Period Cross-over Trial in Healthy Subjects Comparing the Pharmacokinetic Profiles After Single Dose Administration of Liraglutide at Three Different Injection Sites|Completed||Phase 1|21|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:23:27.974082|2017-10-11 03:23:27.974082
NCT01513512|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-12-26|||October 2011||2011-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:23:28.083357|2017-10-11 03:23:28.083357
NCT01513499|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-04-28|||January 2012||2012-01-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effect of Intranasal Oxytocin on Appetite and Caloric Intake in Men and Women|Effect of Intranasal Oxytocin on Appetite and Caloric Intake in Humans|Active, not recruiting||Early Phase 1|140|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||Undecided||2017-10-11 03:23:28.13041|2017-10-11 03:23:28.13041
NCT01513486|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2013-05-20|||March 2012||2012-03-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|ESDIM||Electrical Stimulation During Immobilization|The Effects of Daily Neuromuscular Electrical Stimulation on Muscle Mass During Short-term One-legged Knee Immobilization in Healthy Young Men|Completed||N/A|24|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:23:28.225851|2017-10-11 03:23:28.225851
NCT01513473|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2017-01-19|2015-10-12|2013-11-07|January 2012||2012-01-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|BEGIN™|Full Analysis set (FAS) included all randomised subjects.|A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus|A 26-week, Multinational, Multi-centre, Open-Labelled, Randomised, Parallel, Efficacy and Safety Comparison of Insulin Degludec and Insulin Detemir in Children and Adolescents 1 to Less Than 18 Years With Type 1 Diabetes Mellitus on a Basal-bolus Regimen With Insulin Aspart as Bolus Insulin, Followed by a 26-week Extension Investigating Long Term Safety (BEGIN™: Young 1)|Completed||Phase 3|350|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:23:28.351499|2017-10-11 03:23:28.351499
NCT01513460|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2014-12-23|2014-12-10||April 2012||2012-04-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease|A Multicenter, Randomized, Blinded, Active-controlled, Parallel-group Study to Compare the Efficacy, Tolerability and Safety of NVA237 Compared to Tiotropium Added on to Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|773|Actual|Novartis||3|||f||||||||||||||2017-10-11 03:23:29.335175|2017-10-11 03:23:29.335175
NCT01513447|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-02-23|2015-01-30||December 2011||2011-12-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Laboring women requesting labor analgesia|Intracutaneous Sterile Water Injections|Intracutaneous Sterile Water Injection as an Adjunct to Neuraxial Labor Analgesia: A Randomized Controlled Trial|Terminated||N/A|8|Actual|Northwestern University|Early termination leading to small numbers of subjects analyzed; Subjects recruitment unsuccessful because of low number of subjects that were eligible for study inclusion.|2||low qualified candidate enrollment|f||||f||||||||||2017-10-11 03:23:30.488916|2017-10-11 03:23:30.488916
NCT01513434|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||July 2008||2008-07-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Femoral Tunnel Position on Conventional MRI After Anterior Cruciate Ligament Reconstruction-Transtibial Technique Versus Transportal Technique||Completed||N/A|64|Actual|National Police Hospital||2|||f||||t||||||||||2017-10-11 03:23:30.865247|2017-10-11 03:23:30.865247
NCT01513421|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-20|||January 2012||2012-01-01|January 2012|2012-01-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Observational|||Active Versus Non Active Drainage for the Treatment of Infected Intra-abdominal Collection|Active Versus Non Active Drainage for the Treatment of Infected Intra-abdominal Collection: a Randomized Prospective Trial|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire Vaudois|||2||f||||f||||||||||2017-10-11 03:23:30.967248|2017-10-11 03:23:30.967248
NCT01512901|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2014-07-17||||||July 2014|2014-07-01||||||||Interventional|||Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)|A Randomized, Sham Controlled, Multicenter, Double-Masked, Phase 2/3 Study Assessing Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion|Completed||Phase 2/Phase 3|||Santen Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 03:23:42.948684|2017-10-11 03:23:42.948684
NCT01513408|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-06-20|||May 2012|Actual|2012-05-01|June 2017|2017-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|PRIMUNEO||Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy|Prospective Study of the Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as a New imMUne Prognostic Biomarker in Breast Cancer Treated by NEOadjuvant Chemotherapy|Completed||N/A|500|Anticipated|Centre Georges Francois Leclerc||1|||f||||f||||||||||2017-10-11 03:23:31.068203|2017-10-11 03:23:31.068203
NCT01513382|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-07-23|||January 2012||2012-01-01|July 2016|2016-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|BAVUGC-2||Effectiveness of Methylene Blue Guidance in Total Excision of Pilonidal Sinus.|Does Intraoperative Methylene Blue Guidance in Pilonidal Sinus Surgery Really Effective in Total Excision of the Nest ?|Completed||N/A|30|Actual|Bezmialem Vakif University||1|||f||||t||||||||||2017-10-11 03:23:31.267014|2017-10-11 03:23:31.267014
NCT01513369|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-12-12|||August 2012||2012-08-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|CLEVER||Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency|Intravenous Ferric Carboxymaltose for Improvement of Metabolic Parameters and Vascular Function in T2DM-patients With Iron Deficiency|Recruiting||Phase 3|152|Anticipated|GWT-TUD GmbH||2|||f||||f||||||||||2017-10-11 03:23:31.370871|2017-10-11 03:23:31.370871
NCT01513356|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-04-01|||October 2012||2012-10-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pharmacodynamic Study of BKM120 in Breast Cancer|Evaluation of PI3K/AKT/mTOR Signaling Pathway Using BKM120 in Early Breast Cancer|Completed||Early Phase 1|20|Actual|Grupo Hospital de Madrid||1|||f||||f||||||||||2017-10-11 03:23:31.521093|2017-10-11 03:23:31.521093
NCT01513343|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2017-01-30|||August 2014||2014-08-01|January 2017|2017-01-01|January 31, 2018|Anticipated|2018-01-31|December 2017|Anticipated|2017-12-01||Interventional|SEEDs||Promoting The Self-Regulation Of Energy Intake|Promoting The Self-Regulation Of Energy Intake In African American And Latino Preschoolers: A Family Focused Obesity Prevention Program|Active, not recruiting||N/A|330|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 03:23:31.626524|2017-10-11 03:23:31.626524
NCT01513330|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2013-11-21|2013-08-06||November 2011||2011-11-01|November 2013|2013-11-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||Performance Study of Newly Developed Ostomy Products|An Open-labelled, Randomised, Controlled, Crossover Investigation Evaluating Performance of a Newly Developed Ostomy Care Product Compared to Standard Care.|Completed||Phase 4|122|Actual|Coloplast A/S||2|||f||||f||||||||||2017-10-11 03:23:31.734957|2017-10-11 03:23:31.734957
NCT01513317|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2014-09-24|2014-09-24|2013-10-04|November 2011||2011-11-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome|A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Subjects With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome|Terminated||Phase 2|76|Actual|Janssen Research & Development, LLC||2||"The study was stopped after the interim analysis based on lack of sufficient efficacy. There   were no safety concerns."|f||||t||||||||||2017-10-11 03:23:32.028661|2017-10-11 03:23:32.028661
NCT01513304|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2012-01-19|||September 2007||2007-09-01|January 2012|2012-01-01||||May 2011|Actual|2011-05-01||Interventional|||Chiropractic Manual Therapy in Infantile Colic||Completed||N/A|||Anglo-European College of Chiropractic||1|||f||||f||||||||||2017-10-11 03:23:32.771383|2017-10-11 03:23:32.771383
NCT01513291|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2016-07-28|2016-06-08||February 2012||2012-02-01|July 2016|2016-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Baseline characteristics are reported for all randomized participants|A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)|A Phase IIa, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Patients With Episodic Migraine|Completed||Phase 2|237|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 03:23:32.86868|2017-10-11 03:23:32.86868
NCT01513278|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2013-07-12|||January 2012||2012-01-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer|Randomized, Double-blind, Split-body, Placebo-controlled Phase Ib Study of APN201 (Liposomal Recombinant Human Cu/Zn-superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer|Completed||Phase 1/Phase 2|20|Actual|Apeiron Biologics||2|||f||||f||||||||||2017-10-11 03:23:33.401224|2017-10-11 03:23:33.401224
NCT01513265|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2014-05-21|||December 2011||2011-12-01|December 2011|2011-12-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|RASP||Rationalisation of Polypharmacy in the Elderly by the RASP Instrument|Rationalisation of Polypharmacy in the Elderly by the RASP Instrument (Rationalisation of Home Medication by an Adjusted STOPP-list in Older Patients): a Prospective, Clinical Trial.|Completed||N/A|172|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 03:23:33.485208|2017-10-11 03:23:33.485208
NCT01513252|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2015-08-18|||December 2011||2011-12-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|February 2016|Anticipated|2016-02-01||Interventional|MAPT-PLUS||Long-term Effects of Interventional Strategies to Prevent Cognitive Decline in Elderly.|A 2-years Extension Study of MAPT Trial : Evaluation of the Long Term Effects of Interventional Strategies to Prevent the Decline in Cognitive Functioning in Frail Older Adults|Unknown status|Recruiting|N/A|1150|Anticipated|University Hospital, Toulouse||1|||f||||t||||||||||2017-10-11 03:23:33.589007|2017-10-11 03:23:33.589007
NCT01512706|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2012-04-26|||July 2011||2011-07-01|June 2011|2011-06-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants|A Phase II Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants|Completed||Phase 2|660|Actual|Chinese Academy of Medical Sciences||15|||f||||t||||||||||2017-10-11 03:23:45.485332|2017-10-11 03:23:45.485332
NCT01513239|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2017-02-28|2016-10-24||February 2012||2012-02-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MODIFY II|All Randomized Participants|A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of a Single Infusion of MK-6072 (Human Monoclonal Antibody to Clostridium Difficile Toxin B), and MK-3415A (Human Monoclonal Antibodies to Clostridium Difficile Toxin A and B) in Patients Receiving Antibiotic Therapy for Clostridium Difficile Infection (MODIFY II)|Completed||Phase 3|1203|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:23:33.782761|2017-10-11 03:23:33.782761
NCT01513226|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-19|||June 2006||2006-06-01|January 2012|2012-01-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Interventional|||Cycled Light and Crying of Preterm Infants|Cycled Light Exposure Reduces Fussing and Crying in Very Preterm Infants|Completed||N/A|37|Actual|University Children's Hospital, Zurich||1|||f||||f||||||||||2017-10-11 03:23:38.603811|2017-10-11 03:23:38.603811
NCT01513213|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-01-20|||October 2011||2011-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|May 2014|Actual|2014-05-01||Observational|O2 Fraction||Correlation of PaCO2 to the Inspired and Expired Oxygen Gradient|Correlation of PaCO2 to the Inspired and Expired Oxygen Gradient|Completed||N/A|65|Actual|Swedish Medical Center|||1||f||||f||||||||||2017-10-11 03:23:38.670824|2017-10-11 03:23:38.670824
NCT01513200|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-04-17|||January 2012||2012-01-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia|A Two Part Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers and the Effects of Bendavia™ and Unfractionated Heparin When Administered Concurrently|Completed||Phase 1|12|Actual|Stealth BioTherapeutics Inc.||2|||f||||f||||||||||2017-10-11 03:23:38.737849|2017-10-11 03:23:38.737849
NCT01513187|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-04-19|||September 2010||2010-09-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|December 2015|Actual|2015-12-01||Interventional|||Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma|Phase I/II Prospective, Open Label and Multicentric Clinical Trial to Determine the Recommended Dose (Phase I) and Efficacy of Pazopanib in Combination With Interferon Alfa 2-A (Phase II), in Patients With Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|53|Actual|Spanish Oncology Genito-Urinary Group||1|||f||||f||||||||||2017-10-11 03:23:38.827931|2017-10-11 03:23:38.827931
NCT01513174|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2017-04-25|||August 2011||2011-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|GOAL||Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone|Multicenter, Randomized, Phase Ib/IIb Study to Evaluate the Efficacy and Tolerability of Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone, in Patients With EGFR Mutation Positive Advanced Non-small-cell Lung Cancer|Completed||Phase 1/Phase 2|186|Actual|Spanish Lung Cancer Group||2|||f||||t||||||||||2017-10-11 03:23:39.056527|2017-10-11 03:23:39.056527
NCT01513161|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-23|2012-01-19|||April 2008||2008-04-01|January 2012|2012-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|TRK-820||Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis|A 14 Day, Multi-center, Randomized, Double Blinded, Placebo-controlled, Parallel Group, Fixed Dose, Phase III Clinical Trial to Assess the Efficacy and Safety of TRK-820 in Treating Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis|Completed||Phase 3|104|Actual|SK Chemicals Co.,Ltd.||3|||f||||f||||||||||2017-10-11 03:23:39.172328|2017-10-11 03:23:39.172328
NCT01513148|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-07-10|2012-06-11||June 2006||2006-06-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Light Emitting Diode Irradiation on the Conduction Parameters of the Superficial Radial Nerve|The Effect of Light Therapy on Superficial Radial Nerve Conduction Using a Clustered Array of Infrared Super Luminous and Red Light Emitting Diodes|Completed||N/A|32|Actual|Shenandoah University|4 subjects were terminated early in the project, two from the light therapy group and two from the sham therapy group. All cases, we were unable to achieve an appropriate baseline temperature of 30 degrees celsius to allow continued participation|2|||f||||f||||||||||2017-10-11 03:23:39.275298|2017-10-11 03:23:39.275298
NCT01513135|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-17|2016-03-03|||March 2012||2012-03-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|ISS T-003||A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers|A Phase Il, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Immunogenicity and Safety of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers|Completed||Phase 2|200|Actual|Istituto Superiore di Sanità||2|||f||||t||||||||||2017-10-11 03:23:39.869799|2017-10-11 03:23:39.869799
NCT01513122|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-12-01|2013-12-01||February 2010||2010-02-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|September 2012|Actual|2012-09-01||Interventional|||Bone and Body Comp: A Sub Study of the SECOND-LINE Study||Completed||Phase 4|211|Actual|Kirby Institute||2|||f||||t||||||||||2017-10-11 03:23:39.983007|2017-10-11 03:23:39.983007
NCT01513109|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||December 2011||2011-12-01|January 2012|2012-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|ASCI||Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia|A Phase I/II Study to Assess the Safety and Immunogenicity of WT1-A10 + AS01B Antigen-Specific Cancer Immunotherapeutic (ASCI) Combined With Infusions of ex Vivo Regulatory T Cells Depleted T Lymphocytes in in Vivo Regulatory T Cells Depleted Patients as Post-consolidation Therapy for Adult Patients With WT1-positive Acute Myeloid Leukemia (AML) in CR1 (for High Risk Patients) or in CR2 or CR3 Who Are Not Eligible for Allogeneic Stem Cell Transplantation (SCT).|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 03:23:40.351827|2017-10-11 03:23:40.351827
NCT01513096|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-03-30|||November 2011||2011-11-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|PSPEG||Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel Preparation|Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel Preparation: A Randomized, Controlled Trial|Completed||Phase 3|152|Actual|Inje University||2|||f||||f||||||||||2017-10-11 03:23:40.486423|2017-10-11 03:23:40.486423
NCT01513083|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2016-11-01|||February 2012||2012-02-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function|A Phase I, Open Label, Parallel Group, Pharmacokinetic Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function|Completed||Phase 1|28|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:23:40.571836|2017-10-11 03:23:40.571836
NCT01513070|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2014-08-03|||April 2012||2012-04-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|July 2012|Actual|2012-07-01||Interventional|||A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis|A Randomized Double-blind Placebo-controlled Clinical Trials of the Blood-quickening Stasis-transforming Formula Quick-Acting Heart Reliever for Patients With Moderate Coronary Stenosis|Completed||Phase 4|120|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||f||||||||||2017-10-11 03:23:40.700728|2017-10-11 03:23:40.700728
NCT01513057|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||January 2009||2009-01-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed Conditions|An Open-label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Bioequivalence Study in Healthy, Adult,Human, Male Subjects Under Fed Conditions.|Completed||Phase 1|61|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:23:40.84728|2017-10-11 03:23:40.84728
NCT01513044|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||January 2009||2009-01-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting Conditions|An Open-label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Bioequivalence Study in Healthy, Adult,Human, Male Subjects Under Fasting Conditions.|Completed||Phase 1|68|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:23:40.963718|2017-10-11 03:23:40.963718
NCT01513031|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-06-28|||January 2012||2012-01-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation|Pilot Project to Determine Rates and Reasons for Non-Adherence in Patients Receiving Chronic Oral Antiarrhythmic Therapy for Atrial Fibrillation in the State of Nebraska|Terminated||Phase 4|9|Actual|Creighton University||1||Low enrollment|f||||f||||||||||2017-10-11 03:23:41.061|2017-10-11 03:23:41.061
NCT01513018|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2012-01-19|||June 2009||2009-06-01|January 2012|2012-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effects of High and Low Tidal Volumes on Arterial Oxygenation and Pulmonary Shunt During One-Lung Ventilation||Completed||N/A|100|Actual|The Cleveland Clinic||2|||f||||||||||||||2017-10-11 03:23:41.155572|2017-10-11 03:23:41.155572
NCT01513005|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2014-02-04|||May 2011||2011-05-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|GASTRAMBU||Feasibility of Laparoscopic Sleeve Gastrectomy in Day Case Surgery|Feasibility of Day Case Management by Laparoscopic Sleeve Gastrectomy for Obesity: a Pilot Study|Completed||N/A|30|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 03:23:41.235059|2017-10-11 03:23:41.235059
NCT01512992|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2013-09-04|||April 2012||2012-04-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Home Telehealth Follow-up After Hospital Discharge for Chronic Obstructive Pulmonary Disease (COPD) Patients|Renewing Health RCT in Catalonia for the Evaluation of Home Telehealth Follow-up After Hospital Discharge for COPD Patients|Unknown status|Active, not recruiting|N/A|380|Anticipated|Catalan Agency for Health Information, Assessment and Quality||2|||f||||t||||||||||2017-10-11 03:23:41.436089|2017-10-11 03:23:41.436089
NCT01512979|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2014-05-12|2014-04-08||January 2012||2012-01-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Patients from Treated Set (TS): All patients treated with at least 1 dose of study drug.|Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes|A 24-week, Randomized, Double-blind, Active-controlled, Parallel Group Trial to Assess the Superiority of Oral Linagliptin and Metformin Compared to Linagliptin Monotherapy in Newly Diagnosed, Treatment-naïve, Uncontrolled Type 2 Diabetes Mellitus Patients|Completed||Phase 4|316|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:23:41.714109|2017-10-11 03:23:41.714109
NCT01512966|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2014-10-08|||January 2012||2012-01-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|VIVID-Japan||Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)|An Open-label Phase III Study Evaluating the Safety and Tolerability of Repeated Doses of Intravitreal VEGF Trap-Eye in Japanese Subjects With Diabetic Macular Edema|Completed||Phase 3|73|Actual|Bayer||1|||f||||t||||||||||2017-10-11 03:23:42.393687|2017-10-11 03:23:42.393687
NCT01512953|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2012-01-19|||January 2011||2011-01-01|January 2012|2012-01-01|August 2013|Anticipated|2013-08-01|August 2012|Anticipated|2012-08-01||Interventional|GENIOUS||Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata|Randomized Comparison of PPI Versus no PPI on Top of Standard Dose Clopidogrel Therapy in Patients Stratified Based on CYC2C19 Activity Via a Genetic Point of Care System.|Unknown status|Recruiting|Phase 4|522|Anticipated|Università degli Studi di Ferrara||2|||f||||f||||||||||2017-10-11 03:23:42.540917|2017-10-11 03:23:42.540917
NCT01512940|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2012-03-11|||October 2011||2011-10-01|March 2012|2012-03-01|October 2014|Anticipated|2014-10-01|October 2012|Anticipated|2012-10-01||Interventional|LGCP||Resolution of Comorbidities, Safety and Efficacy of Greater Curvature Plication in Obese Patients.|Laparoscopic Greater Curvature Plication for Weight Loss and Resolution of Diabetes and Other Comorbidities.|Unknown status|Recruiting|N/A|50|Anticipated|Singh, Kuldeep, M.D., P.A.||1|||f||||t||||||||||2017-10-11 03:23:42.641176|2017-10-11 03:23:42.641176
NCT01512927|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2012-01-18|||January 2012||2012-01-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Observational|||Electro Stethoscope in Detect Arteriovenous Fistula (AVF) Stenosis|Electronic Stethoscope and Computer-aided Diagnostic System in Detecting Arteriovenous Fistula (AVF) Stenosis|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 03:23:42.73112|2017-10-11 03:23:42.73112
NCT01512914|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2012-01-18|||May 2008||2008-05-01|January 2012|2012-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery|Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery|Completed||Phase 3|120|Actual|San Gerardo Hospital||4|||f||||f||||||||||2017-10-11 03:23:42.828858|2017-10-11 03:23:42.828858
NCT01512888|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-04-11|||August 17, 2016|Actual|2016-08-17|March 2017|2017-03-01|August 31, 2034|Anticipated|2034-08-31|August 31, 2025|Anticipated|2025-08-31||Interventional|LVXSCID-ND||Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants|A Pilot Feasibility Study of Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Using a Self-Inactivating Lentiviral Vector to Transduce Autologous CD34+ Hematopoietic Cells|Recruiting||Phase 1/Phase 2|28|Anticipated|St. Jude Children's Research Hospital||1|||f||||t|t|t|f|||||||2017-10-11 03:23:43.076291|2017-10-11 03:23:43.076291
NCT01512875|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-11-16|||December 2011||2011-12-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Observational|||S1119 Peruvian H. Pylori Water Contamination Study|Gastric Cancer and Helicobacter Pylori Infection in Lima, Peru: The Role of Water Contamination|Completed||N/A|107|Actual|Southwest Oncology Group|||1||f||||f||||||Samples With DNA|"     tissue   "|||2017-10-11 03:23:43.2493|2017-10-11 03:23:43.2493
NCT01512862|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-04-09|||January 2012||2012-01-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients|Additive Renoprotective Effects of Oral Calcitriol in Nondiabetic Chronic Kidney Disease Patients|Unknown status|Recruiting|Phase 4|240|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:23:43.346228|2017-10-11 03:23:43.346228
NCT01512849|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-05-13|2014-03-25||January 2012||2012-01-01|May 2014|2014-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment|An Open-Label, Randomized, 2 Way Crossover, Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment|Completed||Phase 1|24|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 03:23:43.48526|2017-10-11 03:23:43.48526
NCT01512836|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2015-03-31|||July 2012||2012-07-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Randomized Controlled Trial to Determine Outcome and Cost Effectiveness of Case Management of Chronic Obstructive Pulmonary Disease (COPD) Patients|A Randomized Controlled Trial to Determine Outcome and Cost Effectiveness of Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease (COPD) in a Danish Setting|Completed||N/A|150|Actual|Kronikerenheden Nordjylland||2|||f||||t||||||||||2017-10-11 03:23:43.994719|2017-10-11 03:23:43.994719
NCT01512823|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-02-03|||November 2007||2007-11-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|January 2009|Actual|2009-01-01||Interventional|OTEBP||Randomised Trial of Two Educational Intervention for Improving Evidence-based Practice Knowledge, Atttitudes and Practice|Randomised Trial of the Effectiveness of Two Educational Interventions to Improve Evidence-based Practice Knowledge, Attitudes and Behaviour in Occupational Therapists|Completed||N/A|58|Actual|University of Cape Town||2|||f||||f||||||||||2017-10-11 03:23:44.086037|2017-10-11 03:23:44.086037
NCT01512810|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-01-09|||January 2012||2012-01-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|September 2017|Anticipated|2017-09-01||Interventional|||Treatment of Endometrial Cancer|Treatment of Endometrial Cancer Utilizing Pathology Intraoperative Consultation to Determine Extent of Surgical Staging|Active, not recruiting||Phase 2|200|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-10-11 03:23:44.173219|2017-10-11 03:23:44.173219
NCT01512797|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-10-11|||July 2012||2012-07-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|LAF33||Treatment of Diabetes After Gastric Bypass With Sitagliptin|A Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Assess Efficacy, Safety and Tolerability of Sitagliptin Phosphate 100 mg as Treatment for Recurrent, Persistent or Newly Diagnosed Type 2 Diabetes After Gastric Bypass|Completed||N/A|37|Actual|Columbia University||2|||f||||t||||||||Undecided||2017-10-11 03:23:44.280945|2017-10-11 03:23:44.280945
NCT01512784|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-18|||October 2011||2011-10-01|January 2012|2012-01-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults|Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults vs. Healthy Adolescents and Young Adults: Non-randomized Controlled Clinical Trial|Unknown status|Recruiting|Phase 3|100|Anticipated|University of Milan||2|||f||||||||||||||2017-10-11 03:23:44.384053|2017-10-11 03:23:44.384053
NCT01512771|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-09-23|||March 2010||2010-03-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|PTSD||The Effect of Nasal Continuous Positive Airway Pressure Treatment on PTSD Symptoms.|The Effect of Nasal Continuous Positive Airway Pressure (Nasal CPAP) Treatment on Post Traumatic Stress Disorder (PTSD) Symptoms.|Completed||N/A|18|Actual|Northport Veterans Affairs Medical Center|||1||f||||t||||||||||2017-10-11 03:23:44.478103|2017-10-11 03:23:44.478103
NCT01512758|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-10-15|||February 2012||2012-02-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||A Study of Alisertib (MLN8237) in Adult East Asian Patients With Advanced Solid Tumors or Lymphomas|A Phase 1 Dose Escalation and Pharmacokinetic Study of Alisertib (MLN8237), an Aurora A Kinase Inhibitor, in Adult East Asian Patients With Advanced Solid Tumors or Lymphomas|Completed||Phase 1|36|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:23:44.609897|2017-10-11 03:23:44.609897
NCT01512745|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-08-30|2015-08-06||January 2011||2011-01-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||5 participants in the apatinib group and 1 in the placebo group withdrew from the study before receiving the assigned treatments.As a result,267 randomly assigned participants were included in Full Analysis Set （FAS），with 176 assigned to the apatinib group and 91 assigned to the placeo group.|Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer|A Randomized, Double Blinded, Placebo Controlled Multicenter Phase III Study of Apatinib Mesylate Tablets in the Treatment of Advanced or Metastatic Gastric Cancer|Completed||Phase 3|267|Actual|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:23:44.80594|2017-10-11 03:23:44.80594
NCT01512732|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2012-01-22|||February 2012||2012-02-01|January 2012|2012-01-01||||||||Observational|||Validation of the Hebrew Version of the Montreal Affective Voices.||Unknown status|Not yet recruiting|N/A|120|Anticipated|Hadassah Medical Organization|||3||f||||||||||||||2017-10-11 03:23:45.274251|2017-10-11 03:23:45.274251
NCT01512719|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-15|2016-04-12|||January 2013||2013-01-01|April 2016|2016-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|POEM||POEM- Peroral Endoscopic Myotomy for Esophageal Motility Disorders|POEM a Novel Endoscopic Treatment for Achalasia|Recruiting||N/A|25|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-10-11 03:23:45.353157|2017-10-11 03:23:45.353157
NCT01512680|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-11-28|||November 2011||2011-11-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Interventional|IFOPI||Evaluation of Functional Insulin Therapy in Type 1 Diabetic Patients|Evaluation of Functional Insulin Therapy on Blood Glucose Control in Type 1 Diabetic Patients Treated by Insulin Pumps|Completed||Phase 2|52|Actual|University Hospital, Montpellier||1|||f||||f||||||||||2017-10-11 03:23:45.757363|2017-10-11 03:23:45.757363
NCT01512654|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-12-02|||September 2008||2008-09-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|February 2009|Actual|2009-02-01||Interventional|||Personalized Glucose Predictive and Therapy Advisory System - DIAdvisor 2|Assessment of an Enhanced Version of a Personalized Glucose Predictive and Therapy Advisory System (DIAdvisor-2) for Diabetic Patients Treated by Basal-Bolus Insulin Regimens|Completed||Phase 2|60|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 03:23:45.989099|2017-10-11 03:23:45.989099
NCT01512641|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-01-31|||December 2011||2011-12-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Prevalence of Dissociative Disorders in Children|Prevalence of Dissociative Disorders in Children in a Population Supported in the Medico-social and Health Structures in Provence Alpes Cote d'Azur|Completed||N/A|301|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 03:23:46.10531|2017-10-11 03:23:46.10531
NCT01512628|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-01-26|||January 2012||2012-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement Arthroplasty|Hemostatic Changes After Colloid Fluid Administration During Total Hip Replacement Arthroplasty|Completed||N/A|75|Actual|Seoul National University Bundang Hospital||3|||f||||f||||||||||2017-10-11 03:23:46.240215|2017-10-11 03:23:46.240215
NCT01512615|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-11-28|||December 2011||2011-12-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|May 2017|Anticipated|2017-05-01||Interventional|||CopenHeart IE - Integrated Rehabilitation of Patients Treated for Infective Endocarditis|CopenHeart IE - A Randomized Clinical Trial Investigating the Effect and Meaning of Integrated Rehabilitation Versus Usual Follow-up of Patients Treated for Infective Endocarditis|Recruiting||Phase 2|150|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 03:23:46.339927|2017-10-11 03:23:46.339927
NCT01512602|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-04-25|||January 2012||2012-01-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|DiaS||Efficacy of Dialectical Behavior Therapy Versus CAMS-informed Supportive Psychotherapy on Self Harming Behavior|Efficacy of Dialectical Behavior Therapy in Patient With Self Harming Behavior and Traits Within the Spectrum of Borderline Personality Disorder.|Completed||N/A|108|Actual|Mental Health Services in the Capital Region, Denmark||2|||f||||f||||||||||2017-10-11 03:23:46.459548|2017-10-11 03:23:46.459548
NCT01512589|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-03-09|||April 2012|Actual|2012-04-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial|Phase IIB Randomized Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for the Treatment of Esophageal Cancer|Recruiting||Phase 2|180|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 03:23:46.571311|2017-10-11 03:23:46.571311
NCT01512576|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-15|||January 2011||2011-01-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Does Acupuncture Activate Endogenous Pain Inhibition in Chronic Whiplash?|Does Acupuncture Activate Endogenous Pain Inhibition in Chronic Whiplash Associated Disorders? A Randomized Cross-over Trial|Completed||Phase 2|39|Actual|Vrije Universiteit Brussel||2|||f||||f||||||||||2017-10-11 03:23:46.712481|2017-10-11 03:23:46.712481
NCT01512563|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-15|||February 2007||2007-02-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|MIRA-cover||Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent|Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent(Niti-S Mira-Cover Biliary Stent ) to the Common Covered Metallic Biliary Stent(Niti-S Biliary Stent)|Completed||Phase 3|106|Actual|Taewoong Medical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:23:46.825033|2017-10-11 03:23:46.825033
NCT01512550|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-09-26|||January 2010||2010-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|December 2011|Actual|2011-12-01||Interventional|||Importance of Restoring Biomechanical Correct Hip Anatomy During Total Hip Arthroplasty|Evaluation of the Importance in Restoring Biomechanical Correct Hip Anatomy During THA. A Prospective, Randomized and Controlled Study Evaluated by RSA, CT and Gait Analysis|Completed||N/A|75|Actual|Region Skane||3|||f||||f||||||||||2017-10-11 03:23:46.936982|2017-10-11 03:23:46.936982
NCT01512537|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-01-15|||February 2010||2010-02-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|April 2011|Actual|2011-04-01||Interventional|||Alternative Treatments of Vitamin D Deficiency|Comparison of UVB and Vitamin D Supplementation in Treatment of Vitamin D Deficiency|Completed||N/A|32|Actual|Lund University||2|||f||||f||||||||||2017-10-11 03:23:47.069585|2017-10-11 03:23:47.069585
NCT01512524|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2014-03-21|||November 2011||2011-11-01|March 2014|2014-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|INSPIRE-TC||Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury|Long Term Follow-up of Moderate and Severe Traumatic Bain Injury and Assessment of Involvement of Hormonal Deficiency in the Quality of Life|Recruiting||N/A|140|Anticipated|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 03:23:47.172574|2017-10-11 03:23:47.172574
NCT01512511|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-15|||November 2010||2010-11-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Comparing Nitrous Oxide and Carbon Dioxide for Laparoscopic Cholecystectomy|Prospective Randomized Trial Comparing Nitrous Oxide and Carbon Dioxide for Laparoscopic Cholecystectomy|Completed||N/A|64|Actual|Ahvaz Jundishapur University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:23:47.283928|2017-10-11 03:23:47.283928
NCT01512498|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-02-22|||December 2012||2012-12-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Observational|||Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After Menarche|Vulvovaginal Graft Versus Host Disease in Women Who Underwent Transplantation Before and After Menarche|Recruiting||N/A|50|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||No||2017-10-11 03:23:47.386991|2017-10-11 03:23:47.386991
NCT01512485|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-13|||October 2006||2006-10-01|January 2012|2012-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions|Randomized, Open-label, 2-Way Crossover, Bioequivalence Study of Clopidogrel 75 mg Tablet With Plavix® 75 mg In Healthy Subjects Under Fed Conditions|Completed||Phase 1|51|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:23:47.491646|2017-10-11 03:23:47.491646
NCT01512472|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-10-13|||January 2012||2012-01-01|November 2012|2012-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|FIT||Firmagon (Degarelix) Intermittent Therapy|Randomized, Multicentre Efficacy and Safety Study Comparing 10 Mons vs 4 Mons Degarelix Therapy in Prolonging the Off Treatment Interval in Men With Localized Prostate Cancer Receiving Intermittent ADT for Biochemical Recurrence Following Radical Local Therapy|Terminated||Phase 4|144|Actual|Canadian Urology Research Consortium||2||acrrual target was not being met|f||||f||||||||||2017-10-11 03:23:47.59824|2017-10-11 03:23:47.59824
NCT01512459|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-18|||May 2006||2006-05-01|January 2012|2012-01-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-sequence Two-period, Single Dose Sprinkled on Apple Sauce, Crossover and Relative Bioavailability Study in Healthy Adult, Human Subjects Under Fed Conditions|Completed||Phase 1|33|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:23:47.732782|2017-10-11 03:23:47.732782
NCT01512446|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-07-10|||February 2012|Actual|2012-02-01|July 2017|2017-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|BILANZ||Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy|Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy|Terminated||Phase 3|436|Actual|Evangelisches Krankenhaus Lutherhaus gGmbH||2||low recruitment rate|f||||t||||||||||2017-10-11 03:23:47.826574|2017-10-11 03:23:47.826574
NCT01512433|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2013-03-21|||August 2011||2011-08-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|March 2012|Actual|2012-03-01||Interventional|||The Clinical Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts|The Clinical Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts: A Randomized Controlled Trial|Completed||N/A|60|Actual|China Medical University, Taiwan||2|||f||||t||||||||||2017-10-11 03:23:47.926692|2017-10-11 03:23:47.926692
NCT01512420|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-11-01|||November 2011||2011-11-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)|A Multicenter, Prospective, Observational Study to Identify Different Prognostic Factors Related to Survival in Patients With Previously Treated Advanced NSCLC With Wild-type Epidermal Growth Factor Receptor (EGFR) Gene.|Completed||N/A|355|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:23:48.036358|2017-10-11 03:23:48.036358
NCT01512407|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-14|2015-02-02|||January 2012||2012-01-01|February 2015|2015-02-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|A-TECH||RCT on Adjuvant TACE After Hepatectomy for HCC|Randomised Controlled Trial on Adjuvant Transarterial Chemoembolisation After Curative Hepatectomy for Hepatocellular Carcinoma|Recruiting||Phase 3|144|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:23:48.187657|2017-10-11 03:23:48.187657
NCT01512394|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-01-27|||November 2011||2011-11-01|January 2016|2016-01-01|December 2013|Anticipated|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Pre-op Bowel Prep Before Abdominal Surgery|Effects of Preoperative Bowel Preparation Prior to Elective Bowel Resection or Ostomy Closure in the Pediatric Patient Population|Withdrawn||N/A|0|Actual|Children's Mercy Hospital Kansas City||2||Study was never started.|f||||f||||||||||2017-10-11 03:23:48.328682|2017-10-11 03:23:48.328682
NCT01512381|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-08-10|||December 2010||2010-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|VISTA||Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure|Variant of Stimulation in Atrioventricular Node Ablation (VISTA) in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure|Recruiting||Phase 4|60|Anticipated|Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health||2|||f||||f||||||||||2017-10-11 03:23:48.418763|2017-10-11 03:23:48.418763
NCT01512368|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2013-01-09|2012-01-20||March 2010||2010-03-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Changes in Serum Fibroblast Growth Factor 21 (FGF21) Levels Correlated With Exercise|Changes in Serum Fibroblast Growth Factor 21 (FGF21) Levels After a Cardiorespiratory Exercise Program|Completed||N/A|82|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|We cannot fully control other potential sources of physical activity. The results may not be applicable to men. We did not register the caloric consumption during the study.|1|||f||||t||||||||||2017-10-11 03:23:48.535205|2017-10-11 03:23:48.535205
NCT01512355|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-07-15|||September 2011||2011-09-01|July 2015|2015-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of Dexmedetomidine on Decreasing Emergence Agitation and Delirium in Pediatric Patients Undergoing Strabismus Surgery||Completed||N/A|88|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 03:23:49.098087|2017-10-11 03:23:49.098087
NCT01512342|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2015-12-16|||August 2011||2011-08-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Pacing Activity Self-management for Patients With Chronic Fatigue Syndrome|Pacing Activity Self-management for Patients With Chronic Fatigue Syndrome: Randomized Controlled Clinical Trial|Completed||Phase 2|33|Actual|Vrije Universiteit Brussel||2|||f||||f||||||||||2017-10-11 03:23:49.22024|2017-10-11 03:23:49.22024
NCT01512329|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2015-12-16|||October 2011||2011-10-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|||Pacing Activity Self-management for Patients With Multiple Sclerosis|Pacing Activity Self-management for Patients With Multiple Sclerosis: Randomized Controlled Clinical Trial|Completed||Phase 2|31|Actual|Vrije Universiteit Brussel||2|||f||||f||||||||||2017-10-11 03:23:50.326366|2017-10-11 03:23:50.326366
NCT01512303|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-03-30|||April 2012||2012-04-01|March 2017|2017-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Complementary and Alternative Interventions for Veterans With Posttraumatic Stress Disorder|Complementary and Alternative Interventions for Veterans With Posttraumatic Stress Disorder: Community Program Evaluation Study|Suspended||N/A|200|Anticipated|University of Wisconsin, Madison||4||Study on hold due to funding issues|f||||f||||||||||2017-10-11 03:23:50.586146|2017-10-11 03:23:50.586146
NCT01512290|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-09-24|||March 2012||2012-03-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations|Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations; a Placebo-controlled Trail|Completed||N/A|71|Actual|UMC Utrecht||2|||f||||t||||||||||2017-10-11 03:23:50.719666|2017-10-11 03:23:50.719666
NCT01512277|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-08-26|||September 1998||1998-09-01|August 2013|2013-08-01|September 1999|Actual|1999-09-01|March 1999|Actual|1999-03-01||Interventional|Bilhvax1a||Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis|Phase 1 Study Evaluating Safety and Immunological Criteria of Efficacy of the Recombinant Vaccine Candidate Bilhvax Against Schistosomiasis|Completed||Phase 1|24|Actual|University Hospital, Lille||3|||f||||f||||||||||2017-10-11 03:23:50.823913|2017-10-11 03:23:50.823913
NCT01512264|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-04-03|||January 2012||2012-01-01|April 2017|2017-04-01|June 30, 2018|Anticipated|2018-06-30|January 31, 2018|Anticipated|2018-01-31||Interventional|PART||Post-Stroke Aphasia and Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment Study|Post-Stroke Aphasia and rTMS Treatment Study|Recruiting||N/A|80|Anticipated|University of Alabama at Birmingham||5|||f||||t||||||||||2017-10-11 03:23:50.977905|2017-10-11 03:23:50.977905
NCT01512251|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-09-14|||June 9, 2012|Actual|2012-06-09|September 2017|2017-09-01|March 21, 2017|Actual|2017-03-21|December 13, 2013|Actual|2013-12-13||Interventional|||BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma|A Phase 1/2 Trial of BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma (Novartis Study Number CBKM120ZUS21T)|Completed||Phase 1/Phase 2|8|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:23:51.110987|2017-10-11 03:23:51.110987
NCT01512238|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-09-30|||February 2010||2010-02-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|January 2011|Actual|2011-01-01||Observational|||Improvement of Intentional and Unintentional Non-adherence in the Elderly|Improvement of Intentional and Unintentional Non-adherence in the Elderly. Importance of Pharmaceutical Care, Generic Substitution, Non-prescription Drugs, Herbal Medicine and Dietary Supplements|Completed||N/A|630|Actual|University of Aarhus|||2||f||||f||||||||||2017-10-11 03:23:51.215803|2017-10-11 03:23:51.215803
NCT01512225|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-03-08|2016-11-07||May 2012||2012-05-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|EMPOWER||Enhancing Breast Milk Production With Domperidone in Mothers of Preterm Neonates|Enhancing Breast Milk Production With Domperidone in Mothers of Preterm Neonates|Completed||Phase 2|90|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||No||2017-10-11 03:23:51.342195|2017-10-11 03:23:51.342195
NCT01512212|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-13|||January 2012||2012-01-01|January 2012|2012-01-01|September 2012|Anticipated|2012-09-01|June 2012|Anticipated|2012-06-01||Interventional|fnab||New Thyroid Fine Needle Aspiration Biopsy Apparatus|New Thyroid Fine Needle Biopsy Apparatus|Unknown status|Recruiting|N/A|40|Anticipated|SB Istanbul Education and Research Hospital||1|||f||||f||||||||||2017-10-11 03:23:51.930815|2017-10-11 03:23:51.930815
NCT01512199|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-02-25|||January 2012||2012-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|July 2015|Actual|2015-07-01||Interventional|||Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)|Randomized, Placebo Controlled, Double Blind Phase 1b/2 Study of U3-1287 (AMG 888) in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed HER2 Positive Metastatic Breast Cancer (MBC)|Active, not recruiting||Phase 1/Phase 2|29|Anticipated|Daiichi Sankyo, Inc.||3|||f||||t||||||||||2017-10-11 03:23:52.063117|2017-10-11 03:23:52.063117
NCT01512186|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-06-11|||July 2010||2010-07-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|February 2014|Actual|2014-02-01||Observational|Panther||A Phase II Study Investigating Upfront Pazopanib In Metastatic Renal Cancer Renal Cancer (Panther)|A Phase II Study Investigating Upfront Pazopanib In Metastatic Clear Cell Renal Cancer (Panther)|Unknown status|Active, not recruiting|N/A|95|Anticipated|Queen Mary University of London|||1||f||||t||||||Samples With DNA|"     Pre-treatment biopsy and post treatment nephrectomy samples will be obtained   "|||2017-10-11 03:23:52.239372|2017-10-11 03:23:52.239372
NCT01512173|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-10-29|||January 2012||2012-01-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo|A Randomised, Double Blind, Controlled, Multicentre Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo.|Completed||Phase 2|82|Actual|Pierre Fabre Dermatology||2|||f||||||||||||||2017-10-11 03:23:52.35986|2017-10-11 03:23:52.35986
NCT01512160|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-05-23|2013-03-14||October 2011||2011-10-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain|A Randomized, Double-Blind Third Party Open, Double-Dummy, Parallel Group, Placebo Controlled Study Assessing The Efficacy Of Single Doses Of Pf-04531083 For The Treatment Of Post-Surgical Dental Pain Using Ibuprofen 400 Mg As A Positive Control|Terminated||Phase 2|90|Actual|Pfizer|Study was terminated for futility based on results of interim analysis.|4||See termination reason in detailed description.|f||||t||||||||||2017-10-11 03:23:52.562121|2017-10-11 03:23:52.562121
NCT01512147|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-09-26|||December 2011||2011-12-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Dexmedetomidine on Intraoperative Somatosensory and Motor Evoked Potential Monitoring During Neurosurgery in Pediatric Patients|Measuring the Effects of Dexmedetomidine on Somatosensory Evoked and Muscular Evoked Potential During Neurosurgery in Pediatric Patients|Recruiting||N/A|20|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-10-11 03:23:54.753804|2017-10-11 03:23:54.753804
NCT01512134|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2017-03-28|||January 2012||2012-01-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Deep Brain Stimulation for the Treatment of Obesity|Deep Brain Stimulation For Morbid, Treatment-Refractory, Obesity|Completed||N/A|3|Actual|Ohio State University||1|||f||||f||||||||No||2017-10-11 03:23:54.862039|2017-10-11 03:23:54.862039
NCT01413217|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2012-02-07|||July 2010||2010-07-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Which is a Better Breakfast? Egg or Cereal?|"Which is a Better Breakfast? Egg or Cereal?"|Completed||N/A|20|Actual|Pennington Biomedical Research Center|||2||f||||f||||||||||2017-10-11 03:56:27.490531|2017-10-11 03:56:27.490531
NCT01512108|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-01-26|2014-04-25||January 2012||2012-01-01|January 2017|2017-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone|A 52-week, Multi-centre, Open-labelled, Randomised (2:1), Parallel-group Trial With an Active Control (Two OADs Combination Therapy) to Evaluate the Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Monotherapy|Completed||Phase 3|363|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:23:55.129935|2017-10-11 03:23:55.129935
NCT01512095|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-09-13|||August 2013||2013-08-01|September 2013|2013-09-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers|A Trial to Examine the Bioequivalence of Norditropin® Versus Nutropin AQ® in Healthy Adult Volunteers|Withdrawn||Phase 1|0|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:23:55.901273|2017-10-11 03:23:55.901273
NCT01512082|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2015-04-09|||August 2011||2011-08-01|April 2015|2015-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Reducing Soreness in Marathon Runners|The Effect of Pulsed Electromagnetic Field Therapy in Reducing Delayed Onset Muscle Soreness in Marathon Runners. A Double-blind Randomized Placebo-controlled Study.|Completed||N/A|47|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 03:23:55.995937|2017-10-11 03:23:55.995937
NCT01512069|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-04-23|||October 2011||2011-10-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy of a Web-based Tailored Self-management Program|Efficacy of a Web-based Self-management Exercise and Diet Intervention Program With Tailored Motivation and Action Planning for Breast Cancer Survivors: A Randomized Controlled Trial|Completed||N/A|59|Actual|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 03:23:56.095209|2017-10-11 03:23:56.095209
NCT01512056|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-01-13|||October 2011||2011-10-01|January 2012|2012-01-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients|Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients|Unknown status|Recruiting|Phase 4|300|Anticipated|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-11 03:23:56.226433|2017-10-11 03:23:56.226433
NCT01512043|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2014-05-05|||July 2011||2011-07-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD) Intervention With Device-guided Breathing Control in COPD|Completed||N/A|150|Actual|Lovisenberg Diakonale Hospital||3|||f||||t||||||||||2017-10-11 03:23:56.356509|2017-10-11 03:23:56.356509
NCT01512030|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-09-06|||December 2011||2011-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study|Prospective Study of Peripherla Neuropathy in Diabetic Type I|Completed||N/A|35|Actual|Landeskrankenhaus Feldkirch|||1||f||||f||||||||||2017-10-11 03:23:56.478112|2017-10-11 03:23:56.478112
NCT01512017|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-14|2012-01-24|||June 2008||2008-06-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Clinical Study on Veloderm for the Treatment of Split-thickness Skin Graft Donor Sites|A Clinical Study to Evaluate the Safety and Efficacy on Veloderm (a Crystalline Cellulose Simple Occlusive Dressing) for the Split-thickness Skin Graft Donor Sites in Burn and Plastic Surgery|Completed||Phase 3|96|Actual|Lee's Pharmaceutical Limited||2|||f||||t||||||||||2017-10-11 03:23:56.565676|2017-10-11 03:23:56.565676
NCT01512004|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-24|2012-01-24|||January 2010||2010-01-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|January 2010|Actual|2010-01-01||Interventional|||Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder|Phase III Study of Propiverine Hydrochloride Extended-Release Capsule in the Treatment of Overactive Bladder (OAB) in Chinese Population With Urgent Micturition, Frequent Micturition and/or Urge Urinary Incontinence|Completed||Phase 3|324|Actual|Lee's Pharmaceutical Limited||2|||f||||t||||||||||2017-10-11 03:23:56.660492|2017-10-11 03:23:56.660492
NCT01511978|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-24|2017-07-07|2017-06-07||January 2012||2012-01-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|February 2014|Actual|2014-02-01||Interventional|DAPPER||Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome|Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome|Completed||Phase 2|32|Actual|Jacobus Pharmaceutical||2|||||||f|t|f||||||||2017-10-11 03:23:56.928907|2017-10-11 03:23:56.928907
NCT01511965|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-01-31|||May 2011||2011-05-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|Viticell||Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo||Completed||Phase 1/Phase 2|23|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 03:23:58.275525|2017-10-11 03:23:58.275525
NCT01511952|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-16|2015-03-19|||January 2007||2007-01-01|March 2015|2015-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Multi-Site Study of Music Therapy Interventions on Vitals, Feeding and Sleep in Premature Infants|A Multi-Site Study of Music Therapy Interventions on Vitals, Feeding and Sleep in Premature Infants|Completed||N/A|272|Actual|Beth Israel Medical Center||3|||f||||t||||||||||2017-10-11 03:23:58.365741|2017-10-11 03:23:58.365741
NCT01511939|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-06-24|2014-03-26||February 2012||2012-02-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|ATCCTCP-1|One subject in the warfarin group and one subject in the dabigatran group were also taking aspirin. For the Outcome measures, these two subjects were also included in the aspirin and/or clopidogrel group.|Trial to See if Topical Pennsaid for Knee Pain Affects Coagulation Values in Patients Who Are Also Taking Anticoagulants|Single Center, Open-label Study of Effect of PENNSAID (Diclofenac Sodium Solution Topical) on Coagulation Parameters (PT, PTT, INR and Platelet Function) in Patients With Moderate to Severe Osteoarthritis Pain of the Knee Taking Anticoagulant Medication|Completed||Phase 3|22|Actual|Arthritis Treatment Center, Maryland||3|||f||||f||||||||||2017-10-11 03:23:58.47851|2017-10-11 03:23:58.47851
NCT01511926|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2015-03-09|||January 2012||2012-01-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|CHARACTERIZE||Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns|European Study in Patients With Osteoarthritis, Rheumatoid Arthritis, or Ankylosing Spondylitis at Gastrointestinal Risk: A Retrospective, Non-interventional Study of Vimovo™ Prescribing Patterns|Completed||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:23:58.979464|2017-10-11 03:23:58.979464
NCT01511913|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-08-31|||April 30, 2012|Actual|2012-04-30|August 2017|2017-08-01|March 30, 2020|Anticipated|2020-03-30|March 29, 2018|Anticipated|2018-03-29||Observational|IMAGE||A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma|A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma|Recruiting||N/A|1800|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 03:23:59.250591|2017-10-11 03:23:59.250591
NCT01511900|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2012-06-07|||December 2011||2011-12-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CAT-1004 in Patients With Type 2 Diabetes|Completed||Phase 1|44|Actual|Catabasis Pharmaceuticals||5|||f||||f||||||||||2017-10-11 03:24:01.565157|2017-10-11 03:24:01.565157
NCT01511887|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-19|||January 2011||2011-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)|Evaluation of the Safety and Efficacy of Oral Ibuprofen in Term 20-28 Days Old Newborns Referred to Bandar Abbass Children Hospital in 2011|Completed||N/A|40|Actual|Hormozgan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:24:01.669426|2017-10-11 03:24:01.669426
NCT01511874|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-09-21|||January 2011||2011-01-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer|Non-comparative, Opened Multicenter Study to Assess the Efficacy and Safety of ELIGARD 22.5mg in the Treatment of Subjects With Prostate Cancer|Completed||Phase 4|42|Actual|HanAll BioPharma Co., Ltd.||1|||f||||f||||||||||2017-10-11 03:24:01.77501|2017-10-11 03:24:01.77501
NCT01511861|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-11-30|||November 2010||2010-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2012|Actual|2012-12-01||Observational|||Assessing the Reliability of Non-invasive Blood Glucose Monitoring Device|Assessing the Reliability of Non-invasive Blood Glucose Monitoring Device|Active, not recruiting||N/A|137|Anticipated|GlucoVista|||1||f||||f||||||||||2017-10-11 03:24:01.867586|2017-10-11 03:24:01.867586
NCT01511848|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-02-03|||February 2012||2012-02-01|February 2012|2012-02-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload|A Prospective Randomized Comparative Study of Efficacy and Safety of Combined Deferiprone (DFP) and Deferasirox Versus DFP and Desferrioxamine (DFO) Therapy in Diseases With Severe Iron Overload|Unknown status|Not yet recruiting|Phase 2/Phase 3|60|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 03:24:01.931531|2017-10-11 03:24:01.931531
NCT01511835|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-01-13||||||January 2012|2012-01-01||||||||Interventional|||Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women||Unknown status|Recruiting|Phase 4|||AGUNCO Obstetrics and Gynecology Centre||3|||f||||||||||||||2017-10-11 03:24:02.048422|2017-10-11 03:24:02.048422
NCT01511822|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-18||||||January 2012|2012-01-01||||||||Interventional|||Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance||Completed||Phase 4|||AGUNCO Obstetrics and Gynecology Centre||3|||f||||||||||||||2017-10-11 03:24:02.166584|2017-10-11 03:24:02.166584
NCT01511809|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-01-08|2014-11-07||September 2010||2010-09-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression|Efficacy of Atazanavir / Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression. Randomized, Open Label Non Inferiority Trial. A Phase 3 Study.|Completed||Phase 3|117|Actual|Ospedale San Raffaele||2|||f||||t||||||||||2017-10-11 03:24:02.27855|2017-10-11 03:24:02.27855
NCT01511796|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-17|||January 2012||2012-01-01|January 2012|2012-01-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Examining the Effectiveness of Combined Rehabilitation and Botulinum Toxin Injection on Functional Improvement of the Upper Limb After Stroke|Effectiveness of Botulinum Toxin Combined With Upper Limb Rehabilitation on Arm Function|Unknown status|Enrolling by invitation|Phase 3|38|Anticipated|Toronto Rehabilitation Institute||1|||f||||t||||||||||2017-10-11 03:24:02.859807|2017-10-11 03:24:02.859807
NCT01511783|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2015-11-02|||December 2011||2011-12-01|November 2015|2015-11-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|||Evaluation of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of E2609 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E2609 in Healthy Subjects|Completed||Phase 1|50|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 03:24:02.953312|2017-10-11 03:24:02.953312
NCT01511770|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-18|||August 2002||2002-08-01|January 2012|2012-01-01|September 2002|Actual|2002-09-01|August 2002|Actual|2002-08-01||Interventional|||Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions|Comparative,Randomized,Single-dose,2-way Crossover Bioavailability Study of Dr.Reddy's Laboratories Limited Fluconazole Tablets 200 mg and PFIZER (DIFLUCAN) 200 MG in Healthy Males Under Fasting Condition.|Completed||Phase 1|17|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:24:03.049869|2017-10-11 03:24:03.049869
NCT01511757|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-18|||June 2002||2002-06-01|January 2012|2012-01-01|July 2002|Actual|2002-07-01|June 2002|Actual|2002-06-01||Interventional|||Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions|Comparative,Randomized,Single-dose,2-way Crossover Bioavailability Study of Dr.Reddy's Laboratories Limited Fluconazole Tablets 200 mg and PFIZER (DIFLUCAN) 200 MG in Healthy Males Under Fed Condition.|Completed||Phase 1|15|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:24:03.15312|2017-10-11 03:24:03.15312
NCT01509885|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-11-16|||July 2010||2010-07-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Cyproheptadine and Chlorpromazine Effects on Spasticity|Phase 3 Study of Cyproheptadine and Chlorpromazine Effects on Spasticity After Spinal Cord Injury|Completed||N/A|20|Actual|University of Alberta|||2||f||||||||||||||2017-10-11 03:24:33.695337|2017-10-11 03:24:33.695337
NCT01511731|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-01-18|||October 1998||1998-10-01|January 2012|2012-01-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions|Open-label, Randomized, 2-way Crossover Study to Compare the Bioavailability of Reddy Cheminor and Merck &Co, Pepcid Famotidine Tablets 40 mg Under Fasting Conditions.|Completed||Phase 1|30|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:24:03.347779|2017-10-11 03:24:03.347779
NCT01511718|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-18|||October 2006||2006-10-01|October 2006|2006-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condition|Open Label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Oral Bioequivalence Study of Ondansetron Hydrochloride Tablets 8 mg With Zofran® (Containing Ondansetron Hydrochloride Dihydrate) Tablets 8 mg in Healthy, Adult, Human Subjects Under Fed Condition.|Completed||Phase 1|26|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:24:03.440727|2017-10-11 03:24:03.440727
NCT01511705|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-01-18|||October 2006||2006-10-01|October 2006|2006-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition|Open Label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Oral Bioequivalence Study of Ondansetron Hydrochloride Tablets 8 mg With Zofran® (Containing Ondansetron Hydrochloride Dihydrate) Tablets 8 mg in Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|26|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:24:03.55991|2017-10-11 03:24:03.55991
NCT01511692|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-01-24|||November 2005||2005-11-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes|A 4 Week Single Center, Double-dummy, Randomised Double-blind, Balanced Incomplete Latin Square Design Study to Evaluate the Effects of Liraglutide on Appetite in Subjects With Type 2 Diabetes Compared to Glimepiride and Placebo|Completed||Phase 1|43|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:24:03.701137|2017-10-11 03:24:03.701137
NCT01511679|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2013-01-02|||September 2012||2012-09-01|January 2013|2013-01-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Observational|BANC||Brain-imaging and Adolescent Neuroscience Consortium|Brain-imaging and Adolescent Neuroscience Consortium|Withdrawn||N/A|0|Actual|Boston Children’s Hospital|||3|The project was not funded.|f||||f||||||Samples With DNA|"     Saliva DNA samples for future analyses.   "|||2017-10-11 03:24:03.819334|2017-10-11 03:24:03.819334
NCT01511666|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-01-29|||March 2013|Actual|2013-03-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Hyperinvasive Approach in Cardiac Arrest|"Hyperinvasive Approach to out-of Hospital Cardiac Arrest Using Mechanical Chest Compression Device, Prehospital Intraarrest Cooling, Extracorporeal Life Support and Early Invasive Assessment Compared to Standard of Care. A Randomized Parallel Groups Comparative Study. Prague OHCA Study"|Recruiting||Phase 4|170|Anticipated|Charles University, Czech Republic||2|||f||||t|f|f||||||Undecided||2017-10-11 03:24:03.905869|2017-10-11 03:24:03.905869
NCT01511653|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-06-24|||October 2011||2011-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|GLNE010||Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma|Validation and Comparison of Biomarkers for the Early Detection of Colorectal Adenocarcinoma|Completed||N/A|5230|Actual|University of Michigan|||1||f||||f||||||Samples With DNA|"     Two 10 ml red top (serum) tubes Two 7 ml purple top (EDTA)tubes 100 ml of urine 2 Fecal     Immunohistochemical Tests (FIT)      1 stool bucket   "|||2017-10-11 03:24:04.022803|2017-10-11 03:24:04.022803
NCT01511640|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-05-01|||February 1, 2017|Actual|2017-02-01|May 2017|2017-05-01|December 31, 2019|Anticipated|2019-12-31|June 30, 2019|Anticipated|2019-06-30||Interventional|||Behavioral Effects of Pregabalin and Cannabis|Behavioral Effects of Drugs (Outpatient)(43)|Recruiting||Early Phase 1|13|Anticipated|University of Kentucky||2|||f||||f|t|f||||||No||2017-10-11 03:24:04.109572|2017-10-11 03:24:04.109572
NCT01511627|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-11-10|||January 2012||2012-01-01|November 2016|2016-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Randomized Controlled Trial Comparing Postoperative Pain Following TAH With GA vs. Combined GA + SAB|A Randomized Controlled Trial Comparing Postoperative Pain Following Total Abdominal Hysterectomy With General Anesthetic vs. Combined General and Spinal Anesthetic|Withdrawn||N/A|0|Actual|University of Saskatchewan||2||Research question was answered by Acta Anaesthesiol Scand 2012; 56: 102-109.|f||||f||||||||||2017-10-11 03:24:04.20707|2017-10-11 03:24:04.20707
NCT01511601|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-10-05|||December 20, 2011||2011-12-20|July 28, 2016|2016-07-28|July 28, 2016||2016-07-28|||||Observational|||Apheresis to Obtain Plasma and White Blood Cells in Malies|Apheresis to Obtain Plasma and Leukocytes in Mali for In Vitro Studies|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:24:04.394219|2017-10-11 03:24:04.394219
NCT01511588|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-09-22|||December 15, 2011||2011-12-15|September 21, 2017|2017-09-21||||||||Observational|||Hormonal Regulation of Puberty and Fertility|Hormonal Regulation of Puberty and Fertility|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:24:04.457489|2017-10-11 03:24:04.457489
NCT01511575|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2016-05-13|||February 2012||2012-02-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder|Analysis of MicroRNA Expression in Down Syndrome Acute Myeloid Leukemia and the Transient Myeloproliferative Disorder|Completed||N/A|60|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:24:04.677759|2017-10-11 03:24:04.677759
NCT01511562|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-05-02|||September 2012||2012-09-01|May 2017|2017-05-01||||October 2026|Anticipated|2026-10-01||Interventional|||Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma|A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma|Active, not recruiting||Phase 2|113|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 03:24:04.795899|2017-10-11 03:24:04.795899
NCT01511549|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-09-28|||January 2012||2012-01-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis|A Randomized, Double-blind, Placebo-controlled Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SAR113945 (IKK Inhibitor) Following Intra-articular Administration in Japanese Patients With Knee Osteoarthritis|Completed||Phase 1|24|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 03:24:05.227898|2017-10-11 03:24:05.227898
NCT01511536|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-06-28|2015-10-02||March 2012||2012-03-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional||All treated/safety population defined as all registered participants exposed to both investigational medicinal product (IMP) components, regardless of the amount of treatment administered.|Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer|A Phase I/II Study of Cabazitaxel Combined With Abiraterone Acetate and Prednisone in Patients With Metastatic Castrate-Resistant Prostate Cancer (CRPC) Whose Disease Has Progressed After Docetaxel Chemotherapy|Completed||Phase 1/Phase 2|38|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:24:05.376276|2017-10-11 03:24:05.376276
NCT01511523|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2012-03-15|||January 2012||2012-01-01|January 2012|2012-01-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD).|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Biovil Research Group, LLC||2|||f||||f||||||||||2017-10-11 03:24:06.494853|2017-10-11 03:24:06.494853
NCT01511510|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-01-17|||June 2011||2011-06-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers|A Phase I, Randomized, Subject And Investigator Blind, Sponsor Open, Multiple Escalating Dose Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Healthy Adult Volunteers|Completed||Phase 1|39|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:24:06.583804|2017-10-11 03:24:06.583804
NCT01511497|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2013-02-20|||October 2011||2011-10-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers|A Randomized, Placebo Controlled, Double-Blind, Third Party Open, Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Female Adult Volunteers|Completed||Phase 1|31|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:24:06.690329|2017-10-11 03:24:06.690329
NCT01511484|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2012-01-12|||February 2011||2011-02-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||You Are What You Eat: A Randomised Controlled Trial of an Appearance-based Dietary Intervention||Completed||N/A|73|Actual|Perception Lab||3|||f||||f||||||||||2017-10-11 03:24:06.800931|2017-10-11 03:24:06.800931
NCT01511471|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-02-02|||January 2012||2012-01-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis|Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis|Completed||Phase 3|20|Actual|University of Patras||1|||f||||f||||||||||2017-10-11 03:24:06.911041|2017-10-11 03:24:06.911041
NCT01511458|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2014-07-11|||March 2012||2012-03-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Observational|NEXT||Non-invasive Chromosomal Examination of Trisomy Study|Non-invasive Chromosomal Examination of Trisomy|Completed||N/A|18955|Actual|Roche Sequencing Solutions|||2||f||||t||||||||||2017-10-11 03:24:07.012045|2017-10-11 03:24:07.012045
NCT01511445|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-03-27|2017-01-26||December 2011||2011-12-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|October 2014|Actual|2014-10-01||Interventional|CASCADE||Interbody Fusion Devices in the Treatment of Cervicobrachial Syndrome|Interbody Fusion Devices in the Treatment of Cervicobrachial Syndrome; a Blinded Randomised Trial of Cancellous Structured Ceramic (CSC) Versus PEEK Cages.|Completed||N/A|100|Actual|Amedica Corporation||2|||f||||t||||||||No||2017-10-11 03:24:07.32904|2017-10-11 03:24:07.32904
NCT01511432|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-07-03|||January 2012||2012-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects|A Two-Part, Phase 1, Randomized, Open-Label, Crossover Study to Evaluate the Relative Bioavailability of 3 Novel Oral Formulations of Telaprevir Relative to Incivek 375-mg Tablets When Administered as a Single 1125-mg Dose to Healthy Subjects|Completed||Phase 1|64|Actual|Vertex Pharmaceuticals Incorporated||2|||f||||f||||||||||2017-10-11 03:24:07.747068|2017-10-11 03:24:07.747068
NCT01511419|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-07-10|||April 2012||2012-04-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Safety Trial of Live Attenuated Influenza (H7N3) Vaccine|Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/Mallard/Netherlands/00/95 (H7N3) Influenza Vaccine|Completed||Phase 1|40|Actual|PATH||2|||f||||t||||||||||2017-10-11 03:24:07.855436|2017-10-11 03:24:07.855436
NCT01511406|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2014-10-22|||January 2011||2011-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Cognitive Behavioral Therapy for Patients With an Early Psychosis|Does Cognitive Behavioral Therapy Improve Depressive Symptoms and Self-Esteem in Patients With a First Episode Psychosis? A Randomized Controlled Study|Completed||Phase 2|60|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 03:24:07.953879|2017-10-11 03:24:07.953879
NCT01511393|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-02-17|||January 2012||2012-01-01|February 2017|2017-02-01|December 2027|Anticipated|2027-12-01|December 2027|Anticipated|2027-12-01|15 Years|Observational [Patient Registry]|||An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)|Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry|Enrolling by invitation||N/A|6750|Anticipated|United BioSource Corporation|||1||f||||t||||||||Undecided|Currently this is undecided for this 15 year registry. The Data Monitoring Committee is a group of external interdisciplinary consultants who oversee the registry data to review if there are any signals or safety concerns with patients who have taken any of the long-acting GLP-1 RAs and were diagnosed with medullary thyroid carcinoma.|2017-10-11 03:24:08.088907|2017-10-11 03:24:08.088907
NCT01511380|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-05-03|||September 2008||2008-09-01|May 2013|2013-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth|Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth|Completed||Phase 2|120|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:24:08.207542|2017-10-11 03:24:08.207542
NCT01511367|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2014-02-13|||March 2012||2012-03-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients|A Double-blind, Double Dummy, Randomised, Parallel Group, Multicentre Study to Compare the Efficacy and Safety of Flutiform pMDI With Fluticasone pMDI and With Seretide pMDI in Paediatric Subjects Aged 5 to Less Than 12 Years With Moderate to Severe Persistent Reversible Asthma|Completed||Phase 3|498|Anticipated|Mundipharma Research Limited||3|||f||||||||||||||2017-10-11 03:24:08.320486|2017-10-11 03:24:08.320486
NCT01511341|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2015-02-03|||August 2011||2011-08-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Impact of a Telenursing Service on Satisfaction and Health Outcomes of Children With Inflammatory Rheumatic Diseases|Impact of a Telenursing Service on Satisfaction and Health Outcomes of Children With Inflammatory Rheumatic Diseases and Their Family: a Crossover Trial|Completed||N/A|55|Actual|University of Applied Sciences of Western Switzerland||2|||f||||f||||||||||2017-10-11 03:24:08.554276|2017-10-11 03:24:08.554276
NCT01511328|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-03-01|||January 2012||2012-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm|Randomized Implementation of Primary Human Papillomavirus (HPV) Testing in the Organized Screening for Cervical Cancer in Stockholm|Active, not recruiting||N/A|270000|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:24:08.659916|2017-10-11 03:24:08.659916
NCT01511315|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-01-13|2015-12-07||March 2012||2012-03-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Patients who did not complete the study (n=4) were not included in the baseline analysis.|The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment|A Single-Center, Open-Label Study to Assess Change in Psychosocial and Occupational Dimensions With Ustekinumab Treatment of Moderate-to-Severe Psoriasis Evaluated With the Psychological General Well Being (PGWB), Work Productivity and Activity Impairment (WPAI), Psoriasis Quality of Life-12 Items (PQOL-12), and Dermatology Life Quality Index (DLQI)|Completed||Phase 4|36|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 03:24:08.760829|2017-10-11 03:24:08.760829
NCT01511302|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2014-07-24|||June 2012||2012-06-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma|A Phase I, Single-Blinded, Randomized Study of Nebulized RNS60 in Combination With Budesonide in Adult Subjects With Mild to Moderate Asthma|Completed||Phase 1|65|Actual|Revalesio Corporation||3|||f||||||||||||||2017-10-11 03:24:09.099847|2017-10-11 03:24:09.099847
NCT01511289|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-02-22|||August 2011||2011-08-01|January 2016|2016-01-01||||February 2015|Actual|2015-02-01||Interventional|||Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients|A Phase 3 Multinational, Multi-center, Open-Label, Randomized Study of the Efficacy of Radotinib Versus Imatinib in Newly Diagnosed Ph+ CML Patients in Early Chronic Phase|Completed||Phase 3|242|Actual|Il-Yang Pharm. Co., Ltd.||3|||f||||t||||||||||2017-10-11 03:24:09.214372|2017-10-11 03:24:09.214372
NCT01511276|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-05-02|||February 2012||2012-02-01|May 2017|2017-05-01|October 2014|Actual|2014-10-01|June 2013|Actual|2013-06-01||Interventional|SHAPE-2||The Effects of Equivalent Weight Loss With or Without Exercise Training on Breast Cancer Risk (SHAPE-2)|The Effects of Equivalent Weight Loss With or Without Exercise Training on Breast Cancer Risk Biomarkers in Postmenopausal Women: the SHAPE-2 Study|Completed||N/A|243|Actual|UMC Utrecht||3|||f||||t||||||||||2017-10-11 03:24:09.362469|2017-10-11 03:24:09.362469
NCT01511263|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-02-24|||January 2012||2012-01-01|February 2016|2016-02-01||||July 2016|Anticipated|2016-07-01||Interventional|EpiCardiAL||Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis|A Phase II Open-label Randomized Study of Dietary Supplement With Epigallocatechin Gallate (EGCG) to Improve Cardiac Dysfunction in Patients With AL Amyloidosis Who do Not Require Chemotherapy (EpiCardiAL)|Recruiting||Phase 2|86|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-10-11 03:24:09.459844|2017-10-11 03:24:09.459844
NCT01511250|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-07-20||2016-11-29|November 16, 2011|Actual|2011-11-16|July 2017|2017-07-01|April 15, 2016|Actual|2016-04-15|April 15, 2016|Actual|2016-04-15||Interventional|||Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years|A Double-Blind, Randomized, Placebo-Controlled, Age Descending and Expansion Phase 2 Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years|Completed||Phase 2|360|Actual|Takeda||10|||f||||t||||||||||2017-10-11 03:24:09.595697|2017-10-11 03:24:09.595697
NCT01511237|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-11-07|||December 2011||2011-12-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|June 2015|Actual|2015-06-01||Interventional|PHPT-5||Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers|PHPT-5 Second Phase: Perinatal Antiretroviral Intensification for the Prevention of Mother-to-child Transmission of HIV in Thai Women Having Received Less Than 8 Weeks of HAART During Pregnancy|Active, not recruiting||Phase 3|1837|Anticipated|Institut de Recherche pour le Developpement||1|||f||||t||||||||||2017-10-11 03:24:09.757208|2017-10-11 03:24:09.757208
NCT01511224|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-01-17|||August 2010||2010-08-01|January 2012|2012-01-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Observational|ANTI-AB||A Prospective Observational Study of Patients With Drug Resistant Acinetobacter Baumannii Bacteremia|A Prospective Observational Study of Patients With Drug Resistant Acinetobacter Baumannii Bacteremia Treated With Antibiotics Therapy|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||5||f||||f||||||Samples With DNA|"     Blood sample will be collected on the day of enrollment (Day 0), Day 1, 2, 3 and 7 for PCR     identification and quantification of Acinetobacter species.   "|||2017-10-11 03:24:09.995505|2017-10-11 03:24:09.995505
NCT01511211|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-09-11|||September 2012||2012-09-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Duration of Leg Nerve Blocks With Dexamethasone Added to Local Anesthetic|Effect of Dexamethasone on Duration of Analgesia After Ultrasound-Guided Femoral, Obturator, and Popliteal Blocks With Ropivacaine in Total Knee Arthroplasty|Withdrawn||Phase 4|0|Actual|University of New Mexico||2||Other researchers have published results on a similar trial|f||||||||||||||2017-10-11 03:24:10.172365|2017-10-11 03:24:10.172365
NCT01511198|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-01-25|||February 2001||2001-02-01|January 2017|2017-01-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent|NNC 90-1170 Dose-response, Efficacy and Safety: A 12-week Randomized, Multicenter, Doubleblind, Double-dummy, Parallel-group Study of Metformin and Five Doses of NNC 90-1170 in Previously-treated OHA Monotherapy Obese Subjects With Type 2 Diabetes|Completed||Phase 2|223|Actual|Novo Nordisk A/S||6|||f||||f||||||||||2017-10-11 03:24:10.318856|2017-10-11 03:24:10.318856
NCT01511185|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-01-25|||February 2001||2001-02-01|January 2017|2017-01-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group|NNC 90-1170 Mechanism of Action: A Double-blind, Randomized, Single-center, Placebo Controlled, Crossover Study to Examine Beta-cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes|Completed||Phase 1|20|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:24:10.586005|2017-10-11 03:24:10.586005
NCT01511172|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2017-01-24|||August 2002||2002-08-01|January 2017|2017-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes|Effect on Glycemic Control of Individual Maximum Effective Dose of NNC 90-1170 as Add on Therapy to Metformin Compared to Monotherapy of NNC 90-1170 or Metformin or a Metformin-SU Combination Therapy in Patients With Type 2 Diabetes. A Double-blind, Double-dummy, Randomised, Parallel-group, Dose Titration Study With an Open Labelled OHA Arm|Completed||Phase 2|145|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:24:10.927084|2017-10-11 03:24:10.927084
NCT01511159|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2015-03-25|||October 2001||2001-10-01|March 2015|2015-03-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers|A Single-Centre, Open-Label, Five-Period Crossover Trial In Healthy Male Volunteers Investigating the Relative Bioavailability of NNC 90-1170 By Pulmonary Administration Compared To A Subcutaneous Injection|Completed||Phase 1|32|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:24:11.167278|2017-10-11 03:24:11.167278
NCT01511146|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2012-01-18|||July 2011||2011-07-01|January 2012|2012-01-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor|Intrahepatic and Systemic Chemotherapy Together With Antibody to Patients With Non-resectable Liver Metastases From Solid Tumors|Unknown status|Recruiting|Phase 2|100|Anticipated|Copenhagen University Hospital at Herlev||1|||f||||t||||||||||2017-10-11 03:24:11.309153|2017-10-11 03:24:11.309153
NCT01511133|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-05-15|||April 2010||2010-04-01|May 2017|2017-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™|Blinded Retrospective Laboratory Evaluations to Assess the Serologic Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in the Stool of Infants Aged 6 to 12 Weeks Following Administration of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus Vaccine (444563)|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||||||||Samples With DNA|"     Serum and stool samples   "|||2017-10-11 03:24:11.432148|2017-10-11 03:24:11.432148
NCT01511120|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2015-05-11|||November 2011||2011-11-01|August 2013|2013-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect on Fluid Balance After Cardiac Surgery After Use of Two Different Priming Protocols|Ringer`s Acetat Versus Balanced Hydroxyethyl-starch as Primesolution in the Heart-lung Maschine During Cardio-pulmonary-bypass. Postoperatively Fluid Balance and Cardiac Function|Completed||Phase 2|40|Anticipated|Haukeland University Hospital||1|||f||||t||||||||||2017-10-11 03:24:11.544301|2017-10-11 03:24:11.544301
NCT01511107|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2017-10-05|2016-09-30||January 2012||2012-01-01|October 2017|2017-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional||520 children underwent randomization; 260 were randomized to the amoxicillin-clavulante 10 days group and 260 to the amoxicillin-clavulante 5 days, placebo 5 days group. 3 and 2, respectively, were found ineligible after randomization and were withdrawn by the PI. The remaining 257 and 258 participants, respectively, were the basis for analysis.|Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance|A Phase 2b, Multicenter, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Short-Course Antimicrobial Therapy for Young Children With Acute Otitis Media (AOM) and Impact on Antimicrobial Resistance|Terminated||Phase 2|520|Actual|University of Pittsburgh||2||The primary objective of the study was met.|f||||t||||||||||2017-10-11 03:24:11.689787|2017-10-11 03:24:11.689787
NCT01511094|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2012-01-17|||June 2009||2009-06-01|January 2012|2012-01-01|January 2012|Anticipated|2012-01-01|May 2010|Actual|2010-05-01||Interventional|GC||Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications|Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications|Unknown status|Active, not recruiting|Phase 2/Phase 3|32|Actual|Federal University of Minas Gerais||1|||f||||f||||||||||2017-10-11 03:24:13.363231|2017-10-11 03:24:13.363231
NCT01511081|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-10-06|||August 2012||2012-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)|Randomized Phase II Study Comparing Stereotactic Body Radiotherapy (SBRT) With Stereotactic Body Proton Therapy (SBPT) for Centrally Located Stage I, Selected Stage II and Recurrent Non-Small Cell Lung Cancer|Terminated||Phase 2|21|Actual|M.D. Anderson Cancer Center||2||Low Accrual|f||||t||||||||||2017-10-11 03:24:13.460899|2017-10-11 03:24:13.460899
NCT01511068|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2014-06-03|||August 2012||2012-08-01|January 2013|2013-01-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Interventional|FAMPAP||Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)|Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)|Completed||Phase 2|2|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 03:24:13.557336|2017-10-11 03:24:13.557336
NCT01510678|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-07-14|||January 2012|Actual|2012-01-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||The Effect of Three Different Dietary Messages on Dietary Intake and Health in Families|The Effect of Three Different Dietary Messages on Dietary Intake and Health in Families|Active, not recruiting||N/A|45|Anticipated|University of Tennessee||3|||f||||t||||||||||2017-10-11 03:24:20.16484|2017-10-11 03:24:20.16484
NCT01511055|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2015-06-03|||January 2012||2012-01-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand|Phase II, Prospective, Non-Randomized Trial Investigating the Intra-Operative Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand|Terminated||Phase 2|21|Actual|Mayo Clinic||1||"Accrual temporarily suspended, followed by study closure due to technical problems with   investigational camera."|f||||t||||||||||2017-10-11 03:24:13.64142|2017-10-11 03:24:13.64142
NCT01511042|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-05-17|||December 1999|Actual|1999-12-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2017|Actual|2017-01-01||Interventional|||Vascular Dysfunction in Diabetes: Genes and Hormones|Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus|Active, not recruiting||N/A|500|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-11 03:24:13.716777|2017-10-11 03:24:13.716777
NCT01511029|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-11-24|||January 2012||2012-01-01|November 2014|2014-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)|A Single-Center, Randomized, Blinded, Placebo- and Active-Controlled Crossover Study to Evaluate the Effect of Dexpramipexole (BIIB050) on the QTc Interval in Healthy Volunteers|Completed||Phase 1|68|Actual|Knopp Biosciences||3|||f||||f||||||||||2017-10-11 03:24:13.795029|2017-10-11 03:24:13.795029
NCT01511016|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2015-12-21|2013-08-13||February 2003||2003-02-01|December 2015|2015-12-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome|The Effect of Leptin Therapy on Abnormal Lipid Kinetics in Subjects With HIV Lipodystrophy Syndrome|Completed||N/A|17|Actual|Baylor College of Medicine|"Relatively small sample size.
Early drop-out of 3 subjects (2 in placebo arm, 2 in metreleptin arm).
Possible confounders in phenotypic hetereogeneity of HIV lipodystrophy, and differences in antiretroviral drugs."|2|||f||||f||||||||||2017-10-11 03:24:13.87487|2017-10-11 03:24:13.87487
NCT01511003|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-07-17|||December 5, 2011|Actual|2011-12-05|July 2017|2017-07-01|May 11, 2015|Actual|2015-05-11|May 11, 2015|Actual|2015-05-11||Interventional|TREASURE||A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)|An Open- Label, Single-arm, Phase 4 Study to Assess the Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Shown Unsuccessful Response Against DMARDs|Completed||Phase 4|128|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:24:14.200096|2017-10-11 03:24:14.200096
NCT01510990|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2013-01-26|||April 2012||2012-04-01|January 2013|2013-01-01|November 2015|Anticipated|2015-11-01|June 2013|Anticipated|2013-06-01||Interventional|||First Line Gefitinib by FDG-PET Metabolic Response|First Line Gefitinib Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) by the FDG-PET Metabolic Response|Unknown status|Recruiting|Phase 2|60|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:24:14.305488|2017-10-11 03:24:14.305488
NCT01510977|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-02-11|||November 2011||2011-11-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Second Bowel Preparation for Colonoscopy Failure|The Outcome of a Second Preparation for Colonoscopy After Preparation Failure in the First Procedure: a Prospective Randomized Controlled Study|Terminated||Phase 4|150|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 03:24:14.410902|2017-10-11 03:24:14.410902
NCT01510964|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2013-08-09|||June 2011||2011-06-01|December 2011|2011-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|INCA||The Involvement of Breast Cancer Patients During Oncological Consultations|The Involvement of Breast Cancer Patients During Oncological Consultations. A Multi-centre Randomized Controlled Trial. The Study Protocol|Completed||N/A|300|Actual|Azienda Ospedaliera Universitaria Integrata Verona||2|||f||||t||||||||||2017-10-11 03:24:14.491808|2017-10-11 03:24:14.491808
NCT01510951|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-03-25|||August 2011||2011-08-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis|A Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Moderate to Severe Psoriasis|Completed||Phase 1|9|Actual|Amgen||2|||f||||||||||||||2017-10-11 03:24:14.574836|2017-10-11 03:24:14.574836
NCT01510938|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-12-25|||January 2012||2012-01-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Probiotics in Respiratory Tract Infections in Children|Role of Probiotics in Prevention of Respiratory Tract Infections in Preschool and Primary School Children|Completed||Phase 2|242|Actual|Lviv National Medical University||2|||f||||t||||||||||2017-10-11 03:24:14.782423|2017-10-11 03:24:14.782423
NCT01510912|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2014-04-08|2014-04-08||January 2012||2012-01-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||The safety population included all subjects who were treated with at least 1 dose of trial drug. Of the 602 subjects who started the study, 601 received at least 1 dose of trial drug.|Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain|A Multicenter, Open-Label, Safety Study of Diclofenac [Test] Capsules in Subjects With Osteoarthritis of the Knee or Hip|Completed||Phase 3|602|Actual|Iroko Pharmaceuticals, LLC||1|||f||||f||||||||||2017-10-11 03:24:14.914356|2017-10-11 03:24:14.914356
NCT01510899|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-11-01|||October 2011||2011-10-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838|A Multiple Center, Open-label, Single Dose, Parallel-group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of RO4917838|Completed||Phase 1|12|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:24:15.451962|2017-10-11 03:24:15.451962
NCT01510886|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2014-08-12|||June 2012||2012-06-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|PismaEP||Assessment of MDD Management in Andalusia|Assessment of MDD Management Strategies in Andalusia: A Sub-analysis of the PismaEP Study|Completed||N/A|5309|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:24:15.546415|2017-10-11 03:24:15.546415
NCT01510873|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2014-01-22|||December 2011||2011-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)|Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP).|Completed||N/A|424|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto|||3||f||||f||||||||||2017-10-11 03:24:15.644951|2017-10-11 03:24:15.644951
NCT01510860|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-01-17|||November 2008||2008-11-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis|Double-blind, Double-dummy, Randomised, Crossover, Multicentre Phase IV Clinical Study Comparing the Effect of Ursofalk 500 mg Tablets od Versus Ursofalk 250 mg Capsules od on Liver Enzymes in the Treatment of Primary Biliary Cirrhosis|Completed||Phase 4|65|Actual|Dr. Falk Pharma GmbH||2|||f||||t||||||||||2017-10-11 03:24:15.836247|2017-10-11 03:24:15.836247
NCT01510847|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-01-05|||October 2011||2011-10-01|January 2016|2016-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|OTEST||The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM)|The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes: OTEST|Terminated||Phase 4|19|Actual|Singapore Clinical Research Institute||1||Unable to reach the target recruitment within timeline|f||||t||||||||||2017-10-11 03:24:15.928333|2017-10-11 03:24:15.928333
NCT01510834|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2013-07-02|2013-03-05||July 2011||2011-07-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Interventional|CTI-PTSD||Computerized Tailored Intervention for Behavioral Sequelae of PTSD in Veterans|Computerized Tailored Intervention for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans|Completed||N/A|90|Actual|VA Pacific Islands Health Care System|N.A.|1|||f||||f||||||||||2017-10-11 03:24:16.055731|2017-10-11 03:24:16.055731
NCT01510821|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2013-09-30|||November 2011||2011-11-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Investigation of Endothelium in Saphenous Vein Grafts|A Prospective Trial to Investigate Endothelial Dysfunction in Saphenous Vein Grafts Subjected to the Maquet Vasoshield Pressure Limiting Syringe Versus Non-Regulated Vessel Dilation in Patients Undergoing Coronary Artery Bypass Grafting|Completed||N/A|30|Actual|Emory University||2|||f||||t||||||||||2017-10-11 03:24:16.38119|2017-10-11 03:24:16.38119
NCT01510808|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-15|||January 2012||2012-01-01|January 2012|2012-01-01||||||||Observational|||The Affect of Orthodontic Treatment on the Periodontal Status of Patients With Aggressive Periodontitis||Unknown status|Recruiting|N/A|25|Anticipated|Hadassah Medical Organization|||2||f||||f||||||||||2017-10-11 03:24:16.496225|2017-10-11 03:24:16.496225
NCT01510795|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2012-01-17|||January 2012||2012-01-01|January 2012|2012-01-01|January 2014|Anticipated|2014-01-01|June 2013|Anticipated|2013-06-01||Interventional|||Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology|Impact of a Mineralocorticoid Receptor Antagonist on Chronic Histological Changes in Renal Allograft|Unknown status|Enrolling by invitation|Phase 4|40|Anticipated|Clinical Hospital Merkur||2|||f||||f||||||||||2017-10-11 03:24:16.614928|2017-10-11 03:24:16.614928
NCT01510782|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-10-31|||January 2012||2012-01-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses (0.2 mg to 120 mg Administered by Intravenous Infusion and 40 mg to 120 mg Administered by Subcutaneous Injection) of BI 655064 (Buffer Solution for Injection) in Healthy Male Volunteers (Randomised, Single-blind, Placebo-controlled Within Dose Groups, Clinical Phase I Study)|Completed||Phase 1|72|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 03:24:16.745593|2017-10-11 03:24:16.745593
NCT01510769|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2016-04-20|2016-01-14|2015-03-23|January 2012||2012-01-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|CRYSTAL||Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat|A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Febuxostat Compared to Febuxostat Alone at Lowering Serum Uric Acid and Resolving Tophi in Subjects With Tophaceous Gout|Completed||Phase 3|330|Actual|Ardea Biosciences, Inc.||3|||f||||t||||||||||2017-10-11 03:24:16.91448|2017-10-11 03:24:16.91448
NCT01510756|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2015-12-16|2015-08-21||December 2011||2011-12-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)|A Phase II Translational Study of Sorafenib for the Treatment of Chronic Lymphocytic Leukemia Patients|Terminated||Phase 2|4|Actual|University of California, San Diego||1||slow enrollment|f||||t||||||||||2017-10-11 03:24:18.1606|2017-10-11 03:24:18.1606
NCT01510743|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-10-27|||January 2012||2012-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Ultrasound Guided Central Vein Catheterization and Complications|Incidence of Complication Depending on the Cannulation Site in US Guided Central Vein Catheterization|Recruiting||N/A|1484|Anticipated|Seoul National University Bundang Hospital|||2||f||||f||||||||||2017-10-11 03:24:18.48729|2017-10-11 03:24:18.48729
NCT01510730|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-03-13|||January 2005||2005-01-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors|Effect of Helicobacter Pylori Eradication on the New Tumor Development After Endoscopic Resection of Gastric Tumors|Completed||Phase 3|855|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:24:18.585335|2017-10-11 03:24:18.585335
NCT01510717|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2015-05-08|2015-05-08||February 2012||2012-02-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||This analysis population includes all participants with successful IOL implantation in at least 1 eye.|Clinical Investigation of AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0]|Clinical Investigation of AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2|Completed||N/A|409|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:24:18.710051|2017-10-11 03:24:18.710051
NCT01510704|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-12|2013-05-15|2013-05-15||January 2012||2012-01-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase II Dose-ranging Study of APD421 in PONV|Randomised, Double-blind, Placebo-controlled, Dose-ranging Phase II Study of APD421 for the Prevention of Post-operative Nausea and Vomiting|Completed||Phase 2|215|Actual|Acacia Pharma Ltd||4|||f||||f||||||||||2017-10-11 03:24:19.654662|2017-10-11 03:24:19.654662
NCT01510691|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2015-04-14|||October 2011||2011-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Vitrectomy Retinal Oxygenation|The Influence of Retinal Oxygenation on the Clinical Outcomes in Eyes With Different Vitreoretinal Pathologies After a Successful Vitrectomy|Completed||N/A|7|Anticipated|Medical University of Vienna|||3||f||||||||||||||2017-10-11 03:24:20.084858|2017-10-11 03:24:20.084858
NCT00010686|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17||||||August 2006|2006-08-01|December 2005||2005-12-01|||||Interventional|||Dietary Phytoestrogens and Bone Metabolism|Dietary Phytoestrogens and Bone Metabolism|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:08.106948|2017-10-11 04:29:08.106948
NCT01510665|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2013-06-12|||January 2012||2012-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Magnesium Supplementation in the Second Trimester of Pregnancy to Overweight and Obese Individuals|Magnesium Supplementation in the Second Trimester of Pregnancy for Overweight Individuals|Completed||N/A|28|Actual|University of California, Los Angeles||3|||f||||f||||||||||2017-10-11 03:24:20.302362|2017-10-11 03:24:20.302362
NCT01510652|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-10-22|2015-08-14||November 2011||2011-11-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|MORE-CRT||More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges|More Options Available With a Quadripolar Left Ventricular (LV) Lead pRovidE In-clinic Solutions to Cardiac Resynchronization Therapy (CRT) Challenges|Completed||N/A|1078|Actual|St. Jude Medical|Patients were followed for only 6 months, studies with longer follow-up would add to the body of evidence.|2|||f||||f||||||||||2017-10-11 03:24:20.437893|2017-10-11 03:24:20.437893
NCT01510639|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-04-30|||July 2010||2010-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|July 2013|Actual|2013-07-01||Interventional|PRP||The Influence of Growth Factors (PDGF), Applied as Autologous Thrombocyte Concentrate, on Functional Recovery|Results of Subacromial Surgery; The Influence of Growth Factors (PDGF), Applied as Autologous Thrombocyte Concentrate, on Functional Recovery|Completed||Phase 3|73|Actual|St. Antonius Hospital||4|||f||||f||||||||||2017-10-11 03:24:21.14689|2017-10-11 03:24:21.14689
NCT01510626|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-12-09|||November 2011||2011-11-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|April 2014|Actual|2014-04-01||Interventional|||Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center|Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center|Completed||Phase 1|35|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 03:24:21.227802|2017-10-11 03:24:21.227802
NCT01510613|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-02-24|||February 2012||2012-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis|An Open-label, Phase II Study of Pomalidomide and Dexamethasone (PDex) for Previously Treated Patients With AL Amyloidosis.|Active, not recruiting||Phase 2|28|Anticipated|IRCCS Policlinico S. Matteo||1|||f||||t||||||||||2017-10-11 03:24:21.310652|2017-10-11 03:24:21.310652
NCT01510600|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-05-17|||January 2012||2012-01-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma|Alternative Lengthening of Telomeres (ALT) in Neuroblastoma|Completed||N/A|99|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:24:21.413929|2017-10-11 03:24:21.413929
NCT01510587|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-07|2015-01-28|||July 2010||2010-07-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|4-Health||Family Influences to Prevent Childhood Obesity|Family Influences to Prevent Childhood Obesity: An Integrated Research and Outreach Program for Parents of Montana 4-H Youth|Completed||N/A|194|Actual|Montana State University||2|||f||||f||||||||||2017-10-11 03:24:21.485797|2017-10-11 03:24:21.485797
NCT01510574|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-03-11|||May 2012||2012-05-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)||Completed||N/A|749|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 03:24:21.585179|2017-10-11 03:24:21.585179
NCT01510561|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2015-02-12|||March 2012||2012-03-01|February 2015|2015-02-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|||A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.|A Ph Ib Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|Immunomedics, Inc.||2|||f||||f||||||||||2017-10-11 03:24:21.675636|2017-10-11 03:24:21.675636
NCT01510548|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2013-10-10|||March 2007||2007-03-01|October 2013|2013-10-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||ADALISKIAS: Adalimumab for Acute Disc Prolapse|Adalimumab (Anti TNF Alfa) in the Management of Acute Lumbar Disc Prolapses - a One Year, Randomized, Placebo Controlled, Double Blind, Single Center Trial|Unknown status|Active, not recruiting|Phase 3|90|Anticipated|Kuopio University Hospital||3|||f||||f||||||||||2017-10-11 03:24:21.972957|2017-10-11 03:24:21.972957
NCT01510535|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2013-01-16|||December 2011||2011-12-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis|An Double-blind, Active-controlled, Parallel-group, Randomized, Multi-center Study to Compare Efficacy and Safety of LBSA0103 Once Versus Hyruan Plus Injection Once Weekly for 3weeks in the Treatment of Patients With Osteoarthritis of the Knee|Completed||Phase 3|287|Actual|LG Life Sciences||2|||f||||||||||||||2017-10-11 03:24:22.077432|2017-10-11 03:24:22.077432
NCT01510522|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2014-02-03|||June 2012||2012-06-01|February 2014|2014-02-01||||June 2012|Actual|2012-06-01||Interventional|||Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets|Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients, Previously Treated With Metformin Tablets|Withdrawn||Phase 4|0|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-11 03:24:22.172018|2017-10-11 03:24:22.172018
NCT01510509|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-13|||January 2009||2009-01-01|December 2008|2008-12-01||||||||Interventional|TITANIC-XV||The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients|TITANIC-XV Trial: Prospective, Multicenter and Randomized Trial (Bioactive Bare Metal Titanium Stent Versus Everolimus Drug Eluting Stent)|Unknown status|Active, not recruiting|Phase 4|||Hospital Universitario Infanta Cristina||2|||f||||t||||||||||2017-10-11 03:24:22.279639|2017-10-11 03:24:22.279639
NCT01510496|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2015-12-29|||January 2009||2009-01-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|December 2012|Actual|2012-12-01||Observational|||Transition From Acute to Chronic Pain After Inguinal Hernia, Hysterectomy and Thoracotomy: Analysis of Risk Factors and Association With Genetic Polymorphisms|Transition From Acute to Chronic Pain After Inguinal Hernia, Hysterectomy and Thoracotomy : Analysis of Risk Factors and Association With Genetic Polymorphisms|Completed||N/A|3979|Actual|Fundacion IMIM|||3||f||||f||||||Samples With DNA|"     Sample collection Five milliliters of venous blood will be extracted from each patient with     chronic pain; control samples will come from a DNA bank. All patients must have given their     written consent to testing and storage.      - Plasma DNA will be extracted with a BioRobot EZ1 Workstation (Qiagen).   "|||2017-10-11 03:24:22.376434|2017-10-11 03:24:22.376434
NCT01510470|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-01-13|||January 2012||2012-01-01|January 2012|2012-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Clinical and Radiological Outcomes Study on Astra Tech Osseospeed Tx Profile Implant|Clinical and Radiological Outcomes Study on Astra Tech Osseospeed Tx Profile Implant|Unknown status|Enrolling by invitation|N/A|15|Anticipated|Hong Kong Brånemark Osseointegration Center|||1||f||||t||||||||||2017-10-11 03:24:22.629982|2017-10-11 03:24:22.629982
NCT01510457|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-05-26|2014-11-05||November 2010||2010-11-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|KOA||Milnacipran for Chronic Pain in Knee Osteoarthritis|Milnacipran for the Pain, Sensory Sensitization and Mood Changes in Knee Osteoarthritis|Completed||Phase 4|46|Actual|Shirley Ryan AbilityLab||2|||f||||f||||||||||2017-10-11 03:24:22.799295|2017-10-11 03:24:22.799295
NCT01510431|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-10-12|||May 2009||2009-05-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease|An Open-label Compassionate Treatment Protocol to Evaluate the Safety and Treatment Outcomes of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease|Completed||N/A|11|Actual|Mesoblast, Ltd.||1|||f||||f||||||||||2017-10-11 03:24:23.333679|2017-10-11 03:24:23.333679
NCT01510418|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2016-08-01|||May 2011||2011-05-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|PWBCD||Socialization of Adult Men With Congenital Hemophilia A or B|Socialization of Adult Men With Congenital Hemophilia A or B: A Study to Examine Socialization Measures, the Role of Spouse/Significant Other and Health Related Quality of Life|Completed||N/A|27|Actual|Dana-Farber Cancer Institute|||2||f||||t||||||||||2017-10-11 03:24:23.438185|2017-10-11 03:24:23.438185
NCT01510405|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-03-23|||July 2010||2010-07-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Observational|||Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer|Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer|Active, not recruiting||N/A|42|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||||2017-10-11 03:24:23.545567|2017-10-11 03:24:23.545567
NCT01510392|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-08-29|||January 2012||2012-01-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||CEI Van Outreach Screening Study|Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases|Unknown status|Active, not recruiting|N/A|200|Anticipated|Oregon Health and Science University|||1||f||||t||||||||||2017-10-11 03:24:23.662301|2017-10-11 03:24:23.662301
NCT01510379|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2014-02-24|2013-11-15||August 2011||2011-08-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|Reletex||Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery|Median Nerve Acustimulation Plus Medical Anti-emetic Therapy for Control Post-operative Nausea in Patients Undergoing Foregut Surgery: A Randomized Control Trial|Completed||N/A|100|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 03:24:23.765576|2017-10-11 03:24:23.765576
NCT01510366|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2015-09-13|||January 2012||2012-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|IPV||The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)|The Phase Ⅲ Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains|Completed||Phase 3|1200|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:24:24.229253|2017-10-11 03:24:24.229253
NCT01510353|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-07-02|||January 2012||2012-01-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization|Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization|Completed||Phase 3|505|Actual|North Texas Veterans Healthcare System||2|||f||||||||||||||2017-10-11 03:24:24.406025|2017-10-11 03:24:24.406025
NCT01510340|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-08-03|||January 2012||2012-01-01|July 2016|2016-07-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|HIVMediconline||Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management||Recruiting||Phase 3|234|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-10-11 03:24:24.522896|2017-10-11 03:24:24.522896
NCT01510327|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-02-02|2012-01-16||October 2009||2009-10-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|February 2010|Actual|2010-02-01||Interventional|PLATINUM PK||PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)|PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Pharmacokinetics Sub-trial|Completed||Phase 3|22|Actual|Boston Scientific Corporation||1|||f||||t||||||||No|Primary endpoint data uploaded|2017-10-11 03:24:24.649283|2017-10-11 03:24:24.649283
NCT01510314|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-13|2017-04-13|||November 2011|Actual|2011-11-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|||||Interventional|IMACORS||Inflammatory Markers After COloRectal Surgery)|Comparison of C-reactive Protein and Procalcitonin to Detect Infectious Complications After Elective Colorectal Surgery|Completed||N/A|552|Actual|Centre Hospitalier Universitaire Dijon|||||f||||t||||||||||2017-10-11 03:24:25.36418|2017-10-11 03:24:25.36418
NCT01510301|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-09-14|||March 2012||2012-03-01|September 2016|2016-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Mobile Phone in Hypertension Management|Mastery and Autonomy in Management of Hypertension With a Mobile Self-report System|Completed||N/A|51|Actual|Göteborg University||1|||f||||t||||||||||2017-10-11 03:24:25.437713|2017-10-11 03:24:25.437713
NCT01510288|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-10|||November 2004||2004-11-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|December 2007|Actual|2007-12-01||Interventional|||Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer|A Phase 1 Dose Escalation Trial of Ipilimumab in Combination With CG1940 and CG8711 in Patients With Metastatic Hormone-Refractory Prostate Cancer|Terminated||Phase 1|28|Actual|VU University Medical Center||1||The study was terminated because Cell Genesys stopped all activities for GVAX.|f||||t||||||||||2017-10-11 03:24:25.513193|2017-10-11 03:24:25.513193
NCT01510275|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-10-25|||October 2010||2010-10-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Combined Use of Respiratory Devices After Thoracic Surgery|Efficacy on Combined Use of Respiratory Devices RESPILIFT® and RESPIVOL® in Adult Cardio-thoracic Surgery Patients. Randomized-controlled Study|Completed||N/A|60|Actual|Villa Pineta Hospital||2|||f||||f||||||||||2017-10-11 03:24:25.6015|2017-10-11 03:24:25.6015
NCT01510262|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-13|||April 2012||2012-04-01|January 2012|2012-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk|Repeat STI Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk|Unknown status|Not yet recruiting|N/A|500|Anticipated|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-10-11 03:24:25.68985|2017-10-11 03:24:25.68985
NCT01510249|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2012-01-13|||January 2010||2010-01-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Observational|||A Comparison of the Analgesic Efficacies of Ultrasound and Shock Wave Therapy in the Patients With Calcaneal Spur|A Comparison of the Analgesic Efficacies of Ultrasound and Shock Wave Therapy in the Patients With Calcaneal Spur|Completed||N/A|3|Actual|Medical Universtity of Lodz|||1||f||||t||||||||||2017-10-11 03:24:25.822031|2017-10-11 03:24:25.822031
NCT01510236|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-05-27|||January 2013||2013-01-01|May 2015|2015-05-01|May 2018|Anticipated|2018-05-01|July 2015|Anticipated|2015-07-01||Interventional|U-CARE:TeenCan||Self-help Program Via Internet for Adolescents With Cancer|A Randomized Controlled Study of the Clinical Efficacy and Cost-effectiveness of a Self-help Program Via Internet on Psychosocial Function Among Adolescents With Cancer|Withdrawn||Phase 2|0|Actual|Uppsala University||2||a feasibility study showed low recruitment and adherence|f||||||||||||||2017-10-11 03:24:25.88477|2017-10-11 03:24:25.88477
NCT01510223|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-10|||August 2010||2010-08-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||The Effect of Macronutrients in the Diet on Digestive and Cardiovascular Health|Effect of a 5-day Adaptation and Deadaptation Periods to a High-fat Diet Supplemented With Specific Fatty Acids on Gastrointestinal Transit, Appetite and Substrate Utilisation|Completed||N/A|24|Actual|University of Limerick||3|||f||||f||||||||||2017-10-11 03:24:26.185965|2017-10-11 03:24:26.185965
NCT01510210|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2016-05-10|||April 2011||2011-04-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Observational|||Risk Profile for Patients With Atrial Fibrillation|Identification of a Risk Profile to Guide Atrial Fibrillation Therapy|Active, not recruiting||N/A|500|Actual|University Medical Center Groningen|||1||f||||f||||||Samples With DNA|"     Serum and plasma stored at -80 degrees Celcius. If informed consent was obtained, DNA     extraction has been performed.   "|Undecided||2017-10-11 03:24:26.300036|2017-10-11 03:24:26.300036
NCT01510197|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2015-07-27|||September 2011||2011-09-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Risk Profile for Atrial Fibrillation|Identification of a Risk Profile in Patients With Atrial Fibrillation|Completed||N/A|503|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-11 03:24:26.389976|2017-10-11 03:24:26.389976
NCT01510184|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2015-03-17|||April 2012||2012-04-01|August 2014|2014-08-01|February 2018|Anticipated|2018-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy|A Phase 3, Open-label, Multicenter, Randomized Study of Sequential Zevalin (Ibritumomab Tiuxetan) Versus Observation in Patients at Least 60 Years of Age With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy|Terminated||Phase 3|81|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||t||||||||||2017-10-11 03:24:26.497122|2017-10-11 03:24:26.497122
NCT01510171|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2014-09-24|||January 2012||2012-01-01|September 2014|2014-09-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|RAPID||Rapid Activity of Platelet Inhibitor Drugs Study|Rapid Activity of Platelet Inhibitor Drugs Study|Completed||Phase 4|50|Actual|Careggi Hospital||2|||f||||t||||||||||2017-10-11 03:24:26.75922|2017-10-11 03:24:26.75922
NCT01510158|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-07-11|2016-01-21|2015-04-09|January 2012||2012-01-01|July 2016|2016-07-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|CLEAR 1||Combining Lesinurad With Allopurinol in Inadequate Responders|A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol.|Completed||Phase 3|607|Actual|Ardea Biosciences, Inc.||3|||f||||t||||||||||2017-10-11 03:24:26.942536|2017-10-11 03:24:26.942536
NCT01510145|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2014-05-15|2014-05-15||February 2012||2012-02-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||This analysis population includes all enrolled patients.|Efficacy of Changing to TRAVATAN® From Prior Therapy|Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy|Completed||Phase 4|191|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:24:31.421886|2017-10-11 03:24:31.421886
NCT01510132|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2012-10-16|||January 2012||2012-01-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Travacom Post Marketing Surveillance Study|Post Marketing Surveillance Study to Evaluate the Safety Profile of Travacom (Travoprost/Timolol Fixed Combination) in Patients With Open-Angle Glaucoma or Ocular Hypertension Across India|Withdrawn||Phase 4|0|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:24:31.60723|2017-10-11 03:24:31.60723
NCT01510119|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2016-12-06|||September 2011||2011-09-01|December 2016|2016-12-01||||July 2016|Actual|2016-07-01||Interventional|||Autophagy Inhibition to Augment mTOR Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine in Patients With Previously Treated Renal Cell Carcinoma|Autophagy Inhibition to Augment mTOR Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine in Patients With Previously Treated Renal Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|40|Actual|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:24:31.684596|2017-10-11 03:24:31.684596
NCT01510093|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-11|2013-01-28|||May 2012||2012-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)|Interactions Between Exogenous Insulin Aspart, Endogenous Insulin and Plasma Glucose in Type 2 Diabetes Mellitus Patients|Completed||Phase 2|10|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 03:24:31.765529|2017-10-11 03:24:31.765529
NCT01510080|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-01-19|||January 2012||2012-01-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Acceptance and Efficacy of Live Supervision|Live Supervision Put to Test - Studies of Acceptance and Efficacy of Computer-assisted Live Supervision|Completed||N/A|42|Actual|Goethe University||2|||f||||f||||||||||2017-10-11 03:24:31.857016|2017-10-11 03:24:31.857016
NCT00006322|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-02|2016-03-15|||July 1999||1999-07-01|March 2005|2005-03-01|June 2003|Actual|2003-06-01|||||Observational|||Birth Weight Effect on Blood Pressure in Late Childhood||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:30:00.732391|2017-10-11 04:30:00.732391
NCT01510067|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-10-24|||December 2006||2006-12-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus|Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus|Recruiting||N/A|400|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Blood, Skin Tissue Biopsies   "|No||2017-10-11 03:24:31.961331|2017-10-11 03:24:31.961331
NCT01510054|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-04-02|||July 2002||2002-07-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA|Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With Gonadotropin Releasing Hormone (GnRH) Antagonists: Focusing on MicroRNA Identification and Expression|Withdrawn||N/A|0|Actual|Johns Hopkins University|||1||f||||t||||||Samples With DNA|"     endometril tissue   "|||2017-10-11 03:24:32.035034|2017-10-11 03:24:32.035034
NCT01510041|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-12|||January 2011||2011-01-01|January 2012|2012-01-01|February 2013|Anticipated|2013-02-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Respiratory Muscle Training and Respiratory Exercise in Exercise Tolerance, Performing Daily Life Activities and Quality of Life of Patients With Chronic Obstructive Pulmonary Disease|Effects of Respiratory Muscle Training and Respiratory Exercise in Exercise Tolerance, Performing Daily Life Activities and Quality of Life of Patients With COPD.|Unknown status|Recruiting|N/A|40|Anticipated|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-11 03:24:32.104207|2017-10-11 03:24:32.104207
NCT01510028|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-01-31|||August 2012||2012-08-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|IDEAMLD||Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)|A Phase I/II Multicenter Open-label Dose Escalation Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy|Completed||Phase 1/Phase 2|24|Actual|Shire||4|||f||||t||||||||||2017-10-11 03:24:32.379582|2017-10-11 03:24:32.379582
NCT01510015|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2012-01-10|||January 2012||2012-01-01|January 2012|2012-01-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel|Evaluation of the Effects of Psychological and Pharmacological Treatment of Psycho-stimulant and Cannabis-dependent Users in Kfar Izun in Israel|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-10-11 03:24:32.500931|2017-10-11 03:24:32.500931
NCT01510002|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-01-10|||January 1993||1993-01-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Prophylactic Central Neck Dissection for Papillary Thyroid Cancer|Prophylactic Central Neck Dissection for Papillary Thyroid Cancer|Completed||N/A|640|Actual|Jagiellonian University||2|||f||||t||||||||||2017-10-11 03:24:32.600288|2017-10-11 03:24:32.600288
NCT01509989|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-07-05|||January 2013||2013-01-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Observational|Adherence-SLE||International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus|International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus|Completed||N/A|307|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"     blood   "|||2017-10-11 03:24:32.720082|2017-10-11 03:24:32.720082
NCT01509976|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-12|||July 2011||2011-07-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Triclosan, Triclocarban, and the Microbiota|Triclosan, Triclocarban, and the Microbiota|Unknown status|Recruiting|N/A|20|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 03:24:32.838031|2017-10-11 03:24:32.838031
NCT01509963|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-08-02|||December 2011||2011-12-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|NOTEGS||The Memorial Sloan-Kettering Cancer Center (MSKCC|Prospective Evaluation of the Reliability of the Combined Use of Two Models to Predict Non-sentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: the MSKCC Nomogram and the Tenon Score.|Completed||N/A|3194|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 03:24:32.988741|2017-10-11 03:24:32.988741
NCT01509950|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-10-13|||January 2012||2012-01-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery|Comparison of Staples Versus Nonabsorbable Subcuticular (Prolene) Suture for Skin Closure in Cesarean Deliveries: A Randomized Study|Recruiting||Phase 1|100|Anticipated|Stanford University||3|||f||||f||||||||No||2017-10-11 03:24:33.094444|2017-10-11 03:24:33.094444
NCT01509937|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-11-22|||January 2013||2013-01-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|BOCOMO||Body Composition Monitor(BCM) Guided Fluid Management in Maintenance Hemodialysis (MHD) Patients|A Randomized Controlled Trial of Long Term Effect of BCM Guided Fluid Management in MHD Patients|Completed||N/A|433|Actual|Peking University First Hospital||2|||f||||t||||||||||2017-10-11 03:24:33.218685|2017-10-11 03:24:33.218685
NCT01509924|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-09-15|||May 2010||2010-05-01|September 2014|2014-09-01|July 2015|Anticipated|2015-07-01|April 2015|Anticipated|2015-04-01||Interventional|||Cognitive and Physical Functions in Patients With Transient Ischemic Attack. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event|Cognitive and Physical Functions in Patients With TIA. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event|Unknown status|Active, not recruiting|N/A|100|Anticipated|Tiohundra AB||4|||f||||t||||||||||2017-10-11 03:24:33.346166|2017-10-11 03:24:33.346166
NCT01509911|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-02-04|||January 2012||2012-01-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Interventional|||A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment||Active, not recruiting||Phase 2|99|Actual|Tiltan Pharma Ltd.||2|||f||||||||||||||2017-10-11 03:24:33.468876|2017-10-11 03:24:33.468876
NCT01509898|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2017-09-27|||July 18, 2012|Actual|2012-07-18|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease|The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease|Recruiting||N/A|40|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-11 03:24:33.590512|2017-10-11 03:24:33.590512
NCT01509859|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-12|||December 2011||2011-12-01|January 2012|2012-01-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Interventional|||Comparing Weight Bearing After Intramedullary Fixation Devices for the Proximal Femur Fracture|Prospective Randomized Trial Comparing the Weight Bearing After Fixation of Proximal Femur Fractures With Two Different Proximal Intramedullary Devices|Unknown status|Recruiting|Phase 4|100|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 03:24:33.896742|2017-10-11 03:24:33.896742
NCT01509846|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2013-02-04|||March 2011||2011-03-01|January 2012|2012-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults|A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an Oral Inactivated Whole Cell Shigella Flexneri 2a Vaccine in Healthy Adult Subjects|Completed||Phase 1|82|Actual|PATH||4|||f||||t||||||||||2017-10-11 03:24:34.009076|2017-10-11 03:24:34.009076
NCT01509833|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-10|||October 2009||2009-10-01|August 2009|2009-08-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Efficacy of Low Dose hCG on Oocyte Maturity in Poor Responder Women Undergoing Intracytoplasmic Sperm Injection|Efficacy of Low Dose hCG on Oocyte Maturity for Ovarian Stimulation in Poor Responder Women Undergoing ICSI: a Prospective Randomized Controlled Trial|Completed||Phase 3|73|Actual|Royan Institute||3|||f||||t||||||||||2017-10-11 03:24:34.346832|2017-10-11 03:24:34.346832
NCT01509807|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-03-09|2013-11-30||January 2012||2012-01-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|IMPROVE-IR|One patient in Group 1 did not have the planned surgery. Thus, while 16 participants were enrolled in Group 1, 15 participants were in the Safety Analysis Set and had the planned surgery.|A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504|A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of BupiVacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal|Completed||Phase 4|33|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-10-11 03:24:34.442701|2017-10-11 03:24:34.442701
NCT01509794|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-03-27|||November 2011||2011-11-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Psychophysiological Indicators of Performance in Computer-Based Simulation|Psychophysiological Indicators of Performance in Computer-Based Simulation|Completed||N/A|17|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:24:34.974902|2017-10-11 03:24:34.974902
NCT01509781|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2015-10-05|||September 2011||2011-09-01|October 2015|2015-10-01||||January 2016|Anticipated|2016-01-01||Interventional|||Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study|Optimal Wound Care After Simplex or Modified Radical Mastectomy With or Without Axillary Lymphadenectomy Placement of a Drain Versus the Use of Adaptive Skin Sutures; a Prospective Randomised Study|Unknown status|Recruiting|Phase 3|400|Anticipated|National Institute of Oncology, Hungary||2|||f||||t||||||||||2017-10-11 03:24:35.098064|2017-10-11 03:24:35.098064
NCT01509768|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2014-11-24|||March 2012||2012-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)|An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)|Completed||N/A|19|Actual|Shire|||1||f||||f||||||Samples With DNA|"     blood (plasma and serum), cerebrospinal fluid (CSF), urine   "|||2017-10-11 03:24:35.203148|2017-10-11 03:24:35.203148
NCT01509755|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-01-23|||October 2000||2000-10-01|January 2017|2017-01-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes|Dose-response Relationship of Five Dose Levels of NNC90-1170 and Placebo on Glycaemic Control in Type 2 Diabetic Patients Compared to OHA Treatment. A 12-week Multi-centre, Double-blind, Randomised, Parallel Group Trial With an Open Labelled OHA Arm|Completed||Phase 2|196|Anticipated|Novo Nordisk A/S||7|||f||||f||||||||||2017-10-11 03:24:35.289301|2017-10-11 03:24:35.289301
NCT01509742|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-01-23|||April 2001||2001-04-01|January 2017|2017-01-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes|Effect of NNC 90-1170 on Hypoglycaemic Counterregulation During Stepwise Hypoglycaemic Clamp in Type 2 Diabetic Subjects. A Double-blind, Placebo-controlled, Randomised, 2-period Cross-over Trial|Completed||Phase 1|19|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:24:35.58486|2017-10-11 03:24:35.58486
NCT01509729|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-04-09|||June 2011||2011-06-01|April 2015|2015-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Topical Lidocaine After Major Arthroscopic Knee Surgery|Topical Lidocaine Patch Does Not Have an Analgesic Effect After Major Arthroscopic Knee Surgery. A Double-blind Place-controlled Randomized Study|Completed||N/A|21|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 03:24:35.700989|2017-10-11 03:24:35.700989
NCT01509716|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2015-04-14||||||April 2015|2015-04-01||||||||Observational|||Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients|Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis CKD Patients|Unknown status|Recruiting|N/A|400|Anticipated|National University, Singapore|||1||f||||f||||||||||2017-10-11 03:24:35.825747|2017-10-11 03:24:35.825747
NCT01509703|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-03-23|||December 2011||2011-12-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Respiratory Physiology Under High Flow Therapy|Respiratory Physiology Measurements Under Transnasal High Flow Therapy in Patients With Tracheostoma After Long Term Ventilation|Completed||N/A|10|Actual|Institut für Pneumologie Hagen Ambrock eV||1|||f||||f||||||||||2017-10-11 03:24:35.909976|2017-10-11 03:24:35.909976
NCT01509690|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2015-04-14||||||April 2015|2015-04-01||||||||Interventional|||Impact of a Multidisciplinary Intensive Management Clinic on Outcomes in Multi-Ethnic Asian Incident Hemodialysis Patients|Impact of a Multidisciplinary Intensive Management Clinic on Clinical, Patient-Reported and Economic Outcomes in Multi-Ethnic Asian Incident Hemodialysis Patients|Unknown status|Recruiting|Phase 2/Phase 3|150|Anticipated|National University, Singapore||1|||f||||f||||||||||2017-10-11 03:24:36.020716|2017-10-11 03:24:36.020716
NCT01509664|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-01-10|2014-01-10||August 2006||2006-08-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Baseline characteristics for participants who completed the study|Encouraging Healthy Food Shopping and Eating Behaviors by Price Reduction: A Community Supermarket Study|Encouraging Healthy Food Shopping and Eating Behaviors by Price Reduction: A Community Supermarket Study|Completed||N/A|137|Actual|New York Obesity and Nutrition Research Center||2|||f||||t||||||||||2017-10-11 03:24:36.304288|2017-10-11 03:24:36.304288
NCT01509651|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2012-04-03|||January 2012||2012-01-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Sugammadex and Heart Failure|Reversal of Rocuronium-induced Neuromuscular Block With Sugammadex in Heart Failure Patients|Completed||Phase 3|12|Actual|Onze Lieve Vrouw Hospital||1|||f||||t||||||||||2017-10-11 03:24:36.728561|2017-10-11 03:24:36.728561
NCT01509638|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-01-19|2013-11-30||March 2012||2012-03-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|IMPROVE-IR|23 patients in Group 1 and 25 patients in Group 2 were enrolled. 22 patients from Group 1 and 23 patients from Group 2 were in the Safety Analysis Set (patients who underwent planned surgery).|A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501|A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal|Completed||Phase 4|47|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-10-11 03:24:36.871495|2017-10-11 03:24:36.871495
NCT01509625|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2016-04-25|2014-06-02||January 2012||2012-01-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Observational|EFFICACY||Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)|Assessment of Treatment Response With Faslodex® (500 mg) in Standard Clinical Practice Through a Retrospective Study|Completed||N/A|272|Actual|Hospital Clinico Universitario San Cecilio|||1||f||||f||||||||Undecided||2017-10-11 03:24:37.735919|2017-10-11 03:24:37.735919
NCT01509612|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-07|2017-08-28|||January 2011||2011-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|HIC||Additive Homeopathy in Cancer Patients|"Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter Study Evaluating Quality of Life in Patients With Advanced Malignant Lung Tumors With or Without add-on Homeopathy"|Recruiting||Phase 2/Phase 3|150|Anticipated|Medical University of Vienna||3|||f||||f||||||||||2017-10-11 03:24:38.226857|2017-10-11 03:24:38.226857
NCT01509599|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-04-03|||August 2011||2011-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation|Preventing Venous Leg Ulcers With Cryotherapy: A Randomized Clinical Trial|Completed||Phase 1/Phase 2|197|Actual|Medical University of South Carolina||2|||f||||t||||||||Yes|Data may be requested via the PI and is available through REDCap.|2017-10-11 03:24:38.391487|2017-10-11 03:24:38.391487
NCT01509586|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-06-20|2016-06-20||November 2011||2011-11-01|January 2015|2015-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco|A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco|Completed||N/A|1236|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-10-11 03:24:38.553256|2017-10-11 03:24:38.553256
NCT01509573|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-08-25|||July 2011||2011-07-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Pilot Feasibility Trial of the Family Strengthening Intervention in Rwanda (FSI-R)|Family-Based Prevention of Mental Health Problems in HIV/AIDS-Affected Children (R34MH084679-01A1)|Completed||N/A|82|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 03:24:39.306964|2017-10-11 03:24:39.306964
NCT01509560|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-02-20|||November 1, 2011|Actual|2011-11-01|February 2017|2017-02-01|April 30, 2016|Actual|2016-04-30|April 30, 2016|Actual|2016-04-30||Interventional|||PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood|PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood|Completed||Phase 2|21|Actual|Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH||1|||f||||f||||||||||2017-10-11 03:24:39.46988|2017-10-11 03:24:39.46988
NCT01509547|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-03-07|||August 2012||2012-08-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Varenicline for Adolescent Smoking Cessation|A Randomized Controlled Trial of Varenicline for Adolescent Smoking Cessation|Recruiting||Phase 3|166|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:24:39.60352|2017-10-11 03:24:39.60352
NCT01509534|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-07-27|||January 2012||2012-01-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|SUP2||Guideline-based Pacing Therapy for Reflex Syncope|Guideline-based Pacing Therapy for Reflex Syncope|Completed||N/A|281|Actual|Gruppo Italiano Multidisciplinare per lo Studio della Sincope|||1||f||||t||||||||||2017-10-11 03:24:39.733787|2017-10-11 03:24:39.733787
NCT01509521|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2012-08-05|||February 2012||2012-02-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|OBDUC||The Oxygenation of the Brain During Caesarean Section|The Oxygenation of the Brain During Caesarean Section. A Comparison of Ephedrine Versus Phenylephrine|Completed||Phase 4|24|Anticipated|Naestved Hospital||2|||f||||t||||||||||2017-10-11 03:24:39.840599|2017-10-11 03:24:39.840599
NCT01509508|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-07-20|||March 2012||2012-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TasP||Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence|A Cluster Randomised Trial Comparing the Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence. The ARNS 12249 TasP (Treatment as Prevention) Trial in Hlabisa Sub-district, KwaZulu-Natal, South Africa.|Completed||N/A|28153|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-11 03:24:39.956217|2017-10-11 03:24:39.956217
NCT01509495|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2014-07-03|||December 2011||2011-12-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|SIM-HF||Impedance Measurements in Heart Failure Patients|Impedance Measurements in Heart Failure Patients|Terminated||Phase 1|20|Anticipated|Medtronic BRC||1||Enrollment rate too low; rate much under estimation of sponsor and investigators|f||||f||||||||||2017-10-11 03:24:40.086796|2017-10-11 03:24:40.086796
NCT01509482|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-11-23|||January 2012||2012-01-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Insulin Resistance in Idiopathic Oligospermia and Azoospermia|Insulin Resistance : a New Diagnosis of the Pathogenesis of Idiopathic Oligozoospermia and Non Obstructive Azoospermia|Completed||N/A|100|Actual|The Egyptian IVF-ET Center||2|||f||||t||||||||||2017-10-11 03:24:40.309137|2017-10-11 03:24:40.309137
NCT01509469|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-01-28|||March 2012||2012-03-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Different Macronutrients on Ileal Brake Activation|The Effect of Different Macronutrients on Ileal Brake Activation|Completed||N/A|15|Actual|Maastricht University Medical Center||6|||f||||f||||||||||2017-10-11 03:24:40.462228|2017-10-11 03:24:40.462228
NCT01509456|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2017-02-28|||February 2010||2010-02-01|February 2017|2017-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|NUC||The Effect of Potassium Bicarbonate on Bone and Several Physiological Systems During Immobilisation|The Effect of Potassium Bicarbonate on Bone and the Immune System During 21 Days of 6° Head- Down- Tilt Bedrest (HDT- Bedrest)|Completed||N/A|8|Actual|DLR German Aerospace Center||2|||f||||f||||||||||2017-10-11 03:24:40.610881|2017-10-11 03:24:40.610881
NCT01509443|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2016-02-10|||April 2012||2012-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Breathing & Mild Physical Exercise Therapy for Asthma|Application of Breathing Exercise Program to Improve Asthma in Obese Patients: Effects on Clinico-immunological Parameters|Recruiting||N/A|200|Anticipated|Dasman Diabetes Institute||2|||f||||f||||||||||2017-10-11 03:24:40.73934|2017-10-11 03:24:40.73934
NCT01509430|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-11-28|||October 2011||2011-10-01|November 2016|2016-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||DAHANCA 25B: Progressive Resistance Training as Intervention for Regaining Muscle Mass After Radiation Therapy in Patients With HNSCC|Progressive Resistance Training as Intervention for Regaining Muscle Mass After Radiation Therapy in Patients With HNSCC - a Randomized Controlled Trial|Completed||N/A|41|Actual|Danish Head and Neck Cancer Group||2|||f||||t||||||||||2017-10-11 03:24:40.871198|2017-10-11 03:24:40.871198
NCT01509417|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2013-05-28|||July 2010||2010-07-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Different Feeding Methods After Pyloromyotomy|Prospective Randomized Trial Evaluating the Feeding Regimen After Pyloromyotomy.|Completed||N/A|150|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-10-11 03:24:40.999676|2017-10-11 03:24:40.999676
NCT01509404|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-02-12|||November 2011||2011-11-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection|Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for CMV Infection|Completed||Phase 4|40|Actual|Medical University of South Carolina||2|||f||||||||||||||2017-10-11 03:24:41.115|2017-10-11 03:24:41.115
NCT01509391|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-10-16|||January 2012||2012-01-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|IM1||Keyhole Limpet Hemocyanin in Chronic Hepatitis C|Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - Pilot Study IM1|Completed||N/A|14|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-11 03:24:41.255958|2017-10-11 03:24:41.255958
NCT01509378|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-06-08|||November 2011||2011-11-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|4P||4P Study: Predictive Quality With Painfree Therapies|4P Study: A Prospective Study on Predictive Quality Preferring PainFree Therapies|Completed||N/A|200|Actual|Medtronic Bakken Research Center|||1||f||||t||||||||||2017-10-11 03:24:41.387874|2017-10-11 03:24:41.387874
NCT01509365|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-05-06|||December 2011||2011-12-01|October 2014|2014-10-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|PLATO-dose||Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27|Evaluation the Effect of the Double Maintenance Dose of Clopidogrel Versus Single Dose in Patients With Coronary Artery Disease With a BMI ≥ 27 kg.m-2|Completed||Phase 4|116|Actual|Les Laboratoires des Médicaments Stériles||3|||f||||t||||||||||2017-10-11 03:24:41.507285|2017-10-11 03:24:41.507285
NCT01509352|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-01-25|||February 2010||2010-02-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication|Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication.|Completed||N/A|65|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||No||2017-10-11 03:24:41.628271|2017-10-11 03:24:41.628271
NCT01509339|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-01-25|||January 2012||2012-01-01|January 2013|2013-01-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis|Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|Case Western Reserve University||1|||f||||t||||||||||2017-10-11 03:24:41.74363|2017-10-11 03:24:41.74363
NCT01509313|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2013-09-13|||June 2012||2012-06-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|MERT||A Trial Comparing Morcellation With Electrical Resection for Removal of Uterine Polyps|A Randomised Controlled Trial Comparing Morcellation With Electrical Resection for Removal of Uterine Polyps|Completed||Phase 3|121|Actual|Birmingham Women's NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 03:24:42.055089|2017-10-11 03:24:42.055089
NCT01509105|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-12-20|2016-12-20||September 2011||2011-09-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational||Safety analysis set included all participants who recieved at least 1 dose of Prevenar 13 and had the safety assessment through appropriate follow-up.|Prevenar13 Post Market Surveillance|Post Marketing Surveillance To Observe Safety Of Prevenar 13|Completed||N/A|649|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:24:43.821174|2017-10-11 03:24:43.821174
NCT01509300|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-12|||January 2012||2012-01-01|January 2012|2012-01-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors|HLA-haploidentical Allogeneic Hematopoietic Cell Transplantation Using CD3 Depletion for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors After Conditioning of TBI, Fludarabine, Cyclophosphamide and Antithymocyte Globulin|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Asan Medical Center||1|||f||||||||||||||2017-10-11 03:24:42.14901|2017-10-11 03:24:42.14901
NCT01509287|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2013-11-07|||March 2010||2010-03-01|November 2013|2013-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Metabolic Screening in Patients With Donnai-Barrow Syndrome|Metabolic Screening in Patients With Donnai-Barrow Syndrome|Unknown status|Recruiting|N/A|70|Anticipated|Massachusetts General Hospital|||2||f||||t||||||Samples With DNA|"     whole blood, saliva, urine   "|||2017-10-11 03:24:42.290208|2017-10-11 03:24:42.290208
NCT01509274|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-16|||August 2011||2011-08-01|January 2012|2012-01-01||||June 2012|Anticipated|2012-06-01||Interventional|||Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia|Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study.|Unknown status|Recruiting|Phase 4|90|Anticipated|Kolding Sygehus||3|||f||||t||||||||||2017-10-11 03:24:42.383069|2017-10-11 03:24:42.383069
NCT01509261|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-10|||July 2010||2010-07-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy Study of Ilaprazole to Treat Erosive Esophgitis|A Phase Ⅲ Multi-center, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Ilaprazole (20mg QD) in Adult Patients With Erosive Esophagitis|Completed||Phase 3|292|Actual|Il-Yang Pharm. Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:24:42.499838|2017-10-11 03:24:42.499838
NCT01509248|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-02-21|||May 2010||2010-05-01|February 2012|2012-02-01||||||||Observational|||Population Pharmacokinetics and Metabolomics of Theophylline in Preterm Infants|Population Pharmacokinetics and Metabolomic Analysis of Aminopylline/Theophylline Drug Levels in Preterm Infants With Apnea of Prematurity|Unknown status|Enrolling by invitation|N/A|110|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 03:24:42.673416|2017-10-11 03:24:42.673416
NCT01509235|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-05-07|||March 2006||2006-03-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|GYM-MUCO||Self Drainage in Pediatric Cystic Fibrosis Patients|Exercise Coupled to Self Drainage in Pediatric Cystic Fibrosis Patients: an Open Label Cross Over Randomised Clinical Trial|Completed||N/A|34|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:24:42.736905|2017-10-11 03:24:42.736905
NCT01509222|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-04-24|||September 2011||2011-09-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Changing Dietary Patterns: an Individually Tailored Nutrition Intervention (OKE-study)|Changing Dietary Patterns: an Individually Tailored Nutrition Intervention|Completed||N/A|186|Actual|Wageningen University||2|||f||||f||||||||||2017-10-11 03:24:42.809923|2017-10-11 03:24:42.809923
NCT01509209|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2013-05-22|||May 2011||2011-05-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis|Efficacy and Safety of Cossac L Tablet in Vasomotor Rhinitis Patients : A Randomized, Double-blind, Placebo-controlled, Phase 3 Clinical Trial|Completed||Phase 3|137|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 03:24:42.921684|2017-10-11 03:24:42.921684
NCT01509196|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-03-28|||November 2011||2011-11-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet|Open-label, Randomized Comparative Study to Evaluate the Pharmacokinetic Characteristics of Fenofibric Acid Between Lipidilsupra Tablet and HIP0901 Capsule in Healthy Male Subjects|Completed||Phase 1|28|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 03:24:43.038296|2017-10-11 03:24:43.038296
NCT01509183|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-07-23|||January 2012||2012-01-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|January 2013|Anticipated|2013-01-01||Interventional|||Effectiveness of the Asthmapolis Monitoring System|Effectiveness of the Asthmapolis Monitoring System|Unknown status|Recruiting|N/A|420|Anticipated|Reciprocal Labs||2|||f||||f||||||||||2017-10-11 03:24:43.147467|2017-10-11 03:24:43.147467
NCT01509170|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2012-01-10|||February 2012||2012-02-01|January 2012|2012-01-01|January 2017|Anticipated|2017-01-01|January 2015|Anticipated|2015-01-01||Observational|0597-10-HMO||The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia|Observational Cohort Study- The Clinical and Laboratory Characteristics of Recurrent Drug- Related|Unknown status|Not yet recruiting|N/A|500|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 03:24:43.26288|2017-10-11 03:24:43.26288
NCT01509157|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-25|2013-07-15|||January 2012||2012-01-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|MDRS||MDRS for Prevention of Nocturnal Hypoglycemia|Prevention of Nocturnal Hypoglycemia in Children and Young Adults With Type 1 Diabetes Using a Remote Safety and Control Diabetes Management System|Completed||Phase 1|38|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 03:24:43.337188|2017-10-11 03:24:43.337188
NCT01509144|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-05-20|||January 2012||2012-01-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine|Phase 1, Randomised, Single-centre, Observer-blind Clinical Trial of Safety and Immunogenicity of Nasal-prime and Intramuscular Boost Immunisation With EN41-FPA2 HIV Vaccine in Healthy Female Volunteers|Completed||Phase 1|48|Actual|PX'Therapeutics||5|||f||||t||||||||||2017-10-11 03:24:43.450179|2017-10-11 03:24:43.450179
NCT01509131|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-11|||March 2010||2010-03-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of a Mixed Bowel Prep (2L PEG + Bisacodyl) Versus PEG With Ascorbate|Low Volume Bowel Preparation for Colonoscopy: a Comparison Between PEG-CS Plus Bisacodyl Versus PEG-ASC|Completed||Phase 4|408|Actual|Promefarm S.r.l.||2|||f||||f||||||||||2017-10-11 03:24:43.55085|2017-10-11 03:24:43.55085
NCT01509118|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2012-01-11|||July 2011||2011-07-01|January 2012|2012-01-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Observational|||Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery|Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery|Unknown status|Recruiting|N/A|500|Anticipated|Phramongkutklao College of Medicine and Hospital|||1||f||||f||||||||||2017-10-11 03:24:43.674095|2017-10-11 03:24:43.674095
NCT01509092|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2014-10-06|||January 2012||2012-01-01|January 2012|2012-01-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Comparative Study Between Early Vitrectomy and Observation for Spontaneous Closure of Traumatic Macular Hole|Traumatic Macular Hole: Six-months Observation Versus Early Surgical Intervention, A Multicenter Clinical Trial|Completed||N/A|44|Actual|Peking University Third Hospital||2|||f||||t||||||||||2017-10-11 03:24:44.556668|2017-10-11 03:24:44.556668
NCT01509079|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-11-10|2016-08-15||March 2012||2012-03-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors|Phase 2 Study Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors|Completed||Phase 2|116|Actual|HealthPartners Institute||2|||f||||t||||||||||2017-10-11 03:24:44.684549|2017-10-11 03:24:44.684549
NCT01509066|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-09-18|||January 2012||2012-01-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|HERHealth||Healthy Eating for Reproductive Health (HERHealth)|Healthy Eating for Reproductive Health (HERHealth)|Completed||Phase 1/Phase 2|18|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-11 03:24:45.122336|2017-10-11 03:24:45.122336
NCT01509053|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-02-12|2013-11-26||January 2012||2012-01-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|ARRIVE- EU|Baseline measures are based on all enrolled participants.|Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole|Open-label Study to Assess Hospitalization Rates in Adult Schizophrenic Patients Treated With Oral Antipsychotics for 6 Months and IM Depot Aripiprazole for 6 Months, Respectively, in a Naturalistic Community Setting, Europe, Canada and Asia|Terminated||Phase 3|30|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 03:24:45.308685|2017-10-11 03:24:45.308685
NCT01509040|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-06-08|2016-06-08||January 2012||2012-01-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Interventional|||Washington Study of Hemofiltration After Out-of-Hospital Cardiac Arrest|Washington Study of Hemofiltration After Out-of-Hospital Cardiac Arrest|Completed||Phase 1/Phase 2|2|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 03:24:45.733124|2017-10-11 03:24:45.733124
NCT01509027|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-05-29|||January 2012||2012-01-01|January 2012|2012-01-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis Patients|A Randomized Controlled Trial to Evaluate the Impact of Education on the Knowledge About and Compliance With a Phosphorus Restricted Diet and Phosphate Binder Therapy in Maintenance Dialysis Patients|Unknown status|Recruiting|N/A|150|Anticipated|Universitaire Ziekenhuizen Leuven||3|||f||||f||||||||||2017-10-11 03:24:46.356433|2017-10-11 03:24:46.356433
NCT01509014|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-01-11|||March 2010||2010-03-01|January 2012|2012-01-01|January 2012|Anticipated|2012-01-01|November 2011|Actual|2011-11-01||Interventional|CPATCH||Community Pharmacy Assisting in Total Cardiovascular Health||Unknown status|Active, not recruiting|N/A|2250|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 03:24:46.460486|2017-10-11 03:24:46.460486
NCT01509001|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-01-13|||January 2011||2011-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus|Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes|Completed||Phase 4|20|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:24:46.566604|2017-10-11 03:24:46.566604
NCT01508988|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-06-12|||January 2012||2012-01-01|June 2012|2012-06-01||||April 2012|Actual|2012-04-01||Interventional|||Single Dose Escalation Study of ONO-9054 in Healthy Volunteers|A Double-masked Placebo-controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ONO-9054 in Healthy Adult Subjects|Completed||Phase 1|48|Actual|Ono Pharmaceutical Co. Ltd||7|||f||||f||||||||||2017-10-11 03:24:46.693266|2017-10-11 03:24:46.693266
NCT01508975|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-02-13|||January 2011||2011-01-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Satiety Response of White and Brown Rice Compared to Glucose Control|Satiety Response of White and Brown Rice Compared to Glucose Control|Completed||N/A|20|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-10-11 03:24:46.794633|2017-10-11 03:24:46.794633
NCT01508962|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-06-08|||November 2013||2013-11-01|June 2017|2017-06-01|December 2027|Anticipated|2027-12-01|December 2027|Anticipated|2027-12-01||Observational|PRESS-ALS||PRE-Symptomatic Studies in ALS|PRE-Symptomatic Studies in ALS|Recruiting||N/A|100|Anticipated|University of Miami|||2||f||||t||||||||||2017-10-11 03:24:46.875721|2017-10-11 03:24:46.875721
NCT01508949|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-01-24|||June 2001||2001-06-01|January 2017|2017-01-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes|NNC 90-1170 Mechanism of Action: A Single-centre, Randomised, Double-blind, Parallel-group, Placebo-controlled Trial Evaluating the Effect of NNC 90-1170 on Weight and Appetite in Obese Subjects With Type 2 Diabetes|Completed||Phase 2|35|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:24:46.94899|2017-10-11 03:24:46.94899
NCT01508936|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-05-26|2016-03-23|2014-05-08|February 2012||2012-02-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Randomized, analyzed|Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma|A 16-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) Treatment in Patients With Moderate to Severe Asthma|Completed||Phase 3|511|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 03:24:47.078783|2017-10-11 03:24:47.078783
NCT01508923|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-01-23|||May 2001||2001-05-01|January 2017|2017-01-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes|Effect of NNC 90-1170 on 24-hour Glucose and Hormonal Profiles, Gastric Emptying, and Fasting Gluconeogenesis in Type 2 Diabetic Subjects. A Double-blind, Placebo-controlled, Randomised, Cross-over Trial|Completed||Phase 2|17|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:24:48.522689|2017-10-11 03:24:48.522689
NCT01508741|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-03-18|||January 2012||2012-01-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood|Supplement 5-ALA And Sleep And Mood Study|Completed||N/A|85|Actual|University of Hawaii||2|||f||||t||||||||||2017-10-11 03:24:53.685673|2017-10-11 03:24:53.685673
NCT01508910|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-12-22|2016-12-22||April 2012||2012-04-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|RENEW|Arms for baseline characteristics based on the Safety population as randomized i.e. randomized participants prior to treatment.|Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina|A Prospective, Randomized, Double-blinded, Active-control and Unblinded Standard of Care (SOC) Controlled Study to Determine the Efficacy and Safety of Targeted Intramyocardial Delivery of Autologous CD34+ Cells (Auto-CD34+ Cells) for Increasing Exercise Capacity During Standardized Exercise Testing in Subjects With Refractory Angina Pectoris and Chronic Myocardial Ischemia|Completed||Phase 3|291|Actual|Baxalta US Inc.|Study terminated early due to business considerations. Participants in Treatment or Active Control arms who did not have injection of target cells/placebo assigned to Not Injected Arm. Not included in efficacy analysis but in safety follow-up.|3|||f||||t||||||||||2017-10-11 03:24:48.672841|2017-10-11 03:24:48.672841
NCT01508897|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-02-28|||May 28, 2004|Actual|2004-05-28|February 2017|2017-02-01|June 30, 2004|Actual|2004-06-30|June 30, 2004|Actual|2004-06-30||Interventional|||Comparison of Two Liraglutide Formulations in Healthy Volunteers|A Randomized, Single-blind, Single-centre, Two-period, Cross-over Trial Investigating the Bioequivalence Between Completed Phase 2 and Planned Phase 3 Formulations of Liraglutide in Healthy Subjects|Completed||Phase 1|22|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:24:52.223691|2017-10-11 03:24:52.223691
NCT01508884|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-12-08|||January 2012||2012-01-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intradermal Trivalent Influenza Vaccine With Imiquimod|Efficacy and Effectiveness of Intradermal Trivalent Influenza Vaccine With Topical Imiquimod, a Double Blind Randomized Controlled Trial|Completed||N/A|93|Actual|The University of Hong Kong||3|||f||||f||||||||||2017-10-11 03:24:52.320432|2017-10-11 03:24:52.320432
NCT01508871|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-01-09|||January 2011||2011-01-01|August 2011|2011-08-01||||||||Observational|||Electrical Interactions in Heart Disease||Unknown status|Recruiting|N/A|100|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 03:24:52.432712|2017-10-11 03:24:52.432712
NCT01508858|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-01-23|||November 2006||2006-11-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women|A Double-blind, Two Period Cross-over, Single Centre Trial in Healthy Subjects Investigating the Influence on the Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Drug After Multiple Dose Administration of Liraglutide|Completed||Phase 1|21|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:24:52.518721|2017-10-11 03:24:52.518721
NCT01508845|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-07-18|||January 2012||2012-01-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|MUFA/PUFA||A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption|A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption|Completed||N/A|61|Actual|Tufts University||4|||f||||f||||||||||2017-10-11 03:24:52.622987|2017-10-11 03:24:52.622987
NCT01508832|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-07-01|2013-05-23||January 2012||2012-01-01|July 2014|2014-07-01||||March 2013|Actual|2013-03-01||Interventional|||Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers|Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers|Suspended||Phase 4|12|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:24:52.725355|2017-10-11 03:24:52.725355
NCT01508819|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-10-17|||January 2012||2012-01-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|ICECUBII||Impact on Mid-term Mortality of Guidelines for ICU Admission of Elderly Patients Arriving in Emergency Departments|Impact on Mid-term Mortality of Guidelines for ICU Admission of Elderly Patients Arriving in Emergency Departments: a Cluster Randomized Controlled Trial|Completed||N/A|3036|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-11 03:24:52.9837|2017-10-11 03:24:52.9837
NCT01508806|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-01-23|||August 2005||2005-08-01|January 2017|2017-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function|A Single-centre, Open-label, Trial Investigating the Pharmacokinetics and the Tolerability of Liraglutide in Subjects With Normal Renal Function and in Subjects With Impaired Renal Function|Completed||Phase 1|30|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-10-11 03:24:53.075468|2017-10-11 03:24:53.075468
NCT01508793|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-12-02|||August 2011||2011-08-01|September 2015|2015-09-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|||Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors||Completed||N/A|103|Actual|The Miriam Hospital||2|||f||||t||||||||||2017-10-11 03:24:53.305917|2017-10-11 03:24:53.305917
NCT01508780|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-02-11|||May 2012||2012-05-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan|Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||1||Due to complex study protocol, no patients have been enrolled in the study.|f||||||||||||||2017-10-11 03:24:53.400899|2017-10-11 03:24:53.400899
NCT01508767|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-08-16|||January 2012||2012-01-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Early Post-operative Removal of Urethral Catheter in Patients Undergoing Colorectal Surgery With Epidural Analgesia|Prospective Randomized Controlled Trial of Early Post-operative Removal of Urethral Catheter in Patients Undergoing Colorectal Surgery With Epidural Analgesia|Completed||N/A|41|Actual|University College Hospital Galway||2|||f||||f||||||||||2017-10-11 03:24:53.502739|2017-10-11 03:24:53.502739
NCT01508754|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2014-09-12|||January 2012||2012-01-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy of CPAP Treatment on Blood Pressure of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome|Efficacy of Continuous Positive Airway Pressure (CPAP) on Blood Pressure Control of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome (OSAS).|Completed||Phase 4|125|Actual|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-10-11 03:24:53.588925|2017-10-11 03:24:53.588925
NCT01508715|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-04-15|||February 2012||2012-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Comparison of Exercise Interventions in Adults With Subacromial Impingement Syndrome|Comparison of an Eccentric Exercise Intervention to a Concentric Exercise Intervention in Adults With Subacromial Impingement Syndrome|Completed||N/A|36|Actual|Texas Woman's University||2|||f||||f||||||||||2017-10-11 03:24:53.878257|2017-10-11 03:24:53.878257
NCT01508702|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-10|2016-01-14|2016-01-14|2014-04-28|January 2012||2012-01-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|LIGHT||Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors|A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor|Completed||Phase 3|214|Actual|Ardea Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 03:24:54.009336|2017-10-11 03:24:54.009336
NCT01508689|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-02-17|||February 2012||2012-02-01|February 2014|2014-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Calcium-fortified Cereal Bars on Dietary Calcium Intake in Women|Effect of Calcium-fortified Cereal Bars on Dietary Calcium Intake in Women|Completed||N/A|36|Actual|Texas Woman's University||2|||f||||f||||||||||2017-10-11 03:24:54.708464|2017-10-11 03:24:54.708464
NCT01508676|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-12-13|2016-09-23||November 2011||2011-11-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Pennsaid on Clinical Neuropathic Pain|Effects of Pennsaid on Clinical Neuropathic Pain|Completed||N/A|35|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:24:54.810677|2017-10-11 03:24:54.810677
NCT01508663|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-09|||August 2010||2010-08-01|January 2012|2012-01-01||||February 2014|Anticipated|2014-02-01||Interventional|BRAVE||The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease|The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients (Age > 75 Years Old) With Coronary Artery Disease: a Randomized Controlled Study|Unknown status|Recruiting|Phase 4|1600|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 03:24:55.370573|2017-10-11 03:24:55.370573
NCT01508650|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-01-31|||October 2011||2011-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|REHAB-HF||Rehabilitation and Exercise Training After Hospitalization|Rehabilitation and Exercise Training After Hospitalization: Assessing Benefit in Acute Heart Failure (REHAB-HF) Pilot Study|Active, not recruiting||N/A|27|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 03:24:55.467138|2017-10-11 03:24:55.467138
NCT01508637|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2015-07-30|||January 2012||2012-01-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|CVDTRAP4||Diesel Exhaust and Vascular Function|Effect of Diesel Exhaust Exposures on Vascular Function in Humans: The Role of Sympathetic Activation|Unknown status|Recruiting|N/A|24|Anticipated|University of Washington||4|||f||||f||||||||||2017-10-11 03:24:55.562187|2017-10-11 03:24:55.562187
NCT01508624|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2014-05-20|||April 2012||2012-04-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Evaluation of Interventions to Improve Pain Relief, Perceived Anxiety and Recovery in Participants Receiving Office Based Surgery|Evaluation of an Intervention to Increase Pain Relief, Perceived Anxiety and Recovery in Participants Receiving Office Based Surgery|Completed||N/A|404|Actual|University of Surrey||5|||f||||t||||||||||2017-10-11 03:24:55.667544|2017-10-11 03:24:55.667544
NCT01508611|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-05-25|||February 2015||2015-02-01|May 2016|2016-05-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Cost-efficacy of Silver Diammine Fluoride in Erupting Molars|Cost-efficacy of Silver Diammine Fluoride to Control Caries Lesions in Erupting Permanent First Molars - Randomized Clinical Trial.|Recruiting||N/A|183|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:24:55.777233|2017-10-11 03:24:55.777233
NCT01508598|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-07-27|||February 2012||2012-02-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Validation of Circulating Endothelial Cells and Microparticles in Youth|Validation of Circulating Endothelial Cells and Microparticles in Youth|Recruiting||N/A|32|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f|f|f||||Samples Without DNA|"     10 mL of blood serum and 5 mL of blood plasma will be frozen in long-term storage for future     study analyses and use. 8 mL of urine will be frozen in long-term storage for future study     analyses and use.   "|||2017-10-11 03:24:55.896837|2017-10-11 03:24:55.896837
NCT01508585|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-07-14|||March 2012||2012-03-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Telephone-based Cognitive Behavioral Therapy for Bariatric Surgery Patients: A Pilot Study|Telephone-based Cognitive Behavioral Therapy for Bariatric Surgery Patients: A Pilot Study|Completed||N/A|47|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:24:56.003967|2017-10-11 03:24:56.003967
NCT01508572|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-03-29|||October 2011||2011-10-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer|Validation of Uptake of a VEGF-targeted Optical Fluorescent Imaging Tracer in Surgical Specimens of Breast Cancer and Application of Pre- and Intra-operative Human Molecular Fluorescence Imaging Techniques. A Multicenter Feasibility Study|Completed||Phase 1|20|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 03:24:56.096474|2017-10-11 03:24:56.096474
NCT01508559|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-04-10|||September 2011||2011-09-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|MSM Neurocog||Men Who Have Sex With Men (MSM) Neurocog 1&2 Study|Neurocognitive Function in a Central London Cohort of HIV Infected and Uninfected Men Who Have Sex With Men|Completed||N/A|237|Actual|St Stephens Aids Trust|||2||f||||f||||||||||2017-10-11 03:24:56.194302|2017-10-11 03:24:56.194302
NCT01508546|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-01-09|||May 1998||1998-05-01|January 2012|2012-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer||Completed||Phase 3|565|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-11 03:24:56.275905|2017-10-11 03:24:56.275905
NCT01508533|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-01-09|||July 2009||2009-07-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Observational|||Epidemiology of Rotavirus Infection in North India Community|Disease Burden Study and Site Preparation for Planning and Implementation of the Phase III Trials for the Oral Rotavirus Vaccine 116E|Completed||N/A|200|Actual|Society for Applied Studies|||2||f||||f||||||||||2017-10-11 03:24:56.367425|2017-10-11 03:24:56.367425
NCT01508520|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2012-01-11|||December 2009||2009-12-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Observational|||a Prospective Study on the Efficacy of Magnifying Endoscopy With Narrow-band Imaging in Diagnosing Gastric Lesions|a Prospective Study on the Efficacy of Magnifying Endoscopy With Narrow-band Imaging in Diagnosing Gastric Lesions|Completed||N/A|146|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||f||||||Samples Without DNA|"     Samples after biopsy or resection are to be retained.   "|||2017-10-11 03:24:56.465034|2017-10-11 03:24:56.465034
NCT01508494|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2016-12-06|||November 2011||2011-11-01|April 2015|2015-04-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|COGICRehab||Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment|Evaluation de l'efficacité de la Galantamine Versus Placebo associée à Une Revalidation Neuropsychologique Chez Des Patients présentant un Trouble Cognitif après un Premier Infarctus cérébral : étude en Neuroimagerie Fonctionnelle|Recruiting||Phase 2|30|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-11 03:24:56.658444|2017-10-11 03:24:56.658444
NCT01508481|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-10-05|||January 2007||2007-01-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes|Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes|Completed||N/A|1500|Actual|Seoul National University Bundang Hospital|||1||f||||f||||||None Retained|"     Blood sample was collected at the baseline.   "|||2017-10-11 03:24:56.750573|2017-10-11 03:24:56.750573
NCT01508468|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-08-23|||January 2012||2012-01-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|January 2015|Actual|2015-01-01||Interventional|GEMRITUX||Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy|Prospective Randomized Multicentric Open Label Study to Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy (IMN)|Active, not recruiting||Phase 3|80|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:24:56.822365|2017-10-11 03:24:56.822365
NCT01508455|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-08-10|2013-08-02||March 2012||2012-03-01|September 2015|2015-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||All subjects that received study drug.|Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age|A Phase II/III, Open-Label, Multicenter, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age|Completed||Phase 2/Phase 3|6|Actual|Hospira, now a wholly owned subsidiary of Pfizer||1|||f||||t||||||||||2017-10-11 03:24:56.931401|2017-10-11 03:24:56.931401
NCT01508429|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-07-06|||July 2012||2012-07-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home Births|Misoprostol for the Treatment of Postpartum Haemorrhage (PPH) Following Self- Administration of Misoprostol Prophylaxis in Home Deliveries.|Completed||N/A|70|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 03:24:57.175251|2017-10-11 03:24:57.175251
NCT01508416|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2015-07-27|||January 2012||2012-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|METRO||Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma|Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma: a Multicentric Study|Completed||N/A|71|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"     whole blood and serum   "|||2017-10-11 03:24:57.259772|2017-10-11 03:24:57.259772
NCT01508403|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-05-13|||January 2012||2012-01-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Observational|RSCMI-I||A Registry Study on Shuxuetong (a Chinese Medicine Injection) Used in Twenty Hospitals|A Registry Study on Shuxuetong (a Chinese Medicine Injection) Used in Twenty Hospitals|Unknown status|Active, not recruiting|N/A|30000|Anticipated|China Academy of Chinese Medical Sciences|||1||f||||t||||||||||2017-10-11 03:24:57.339939|2017-10-11 03:24:57.339939
NCT01508390|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-11-25|||June 2011||2011-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate|Phase II Study of Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate for Treatment of Localized, Non-Metastatic, High Risk Prostate Cancer|Recruiting||Phase 2|30|Anticipated|Boston Medical Center||1|||f||||t||||||||No||2017-10-11 03:24:57.407217|2017-10-11 03:24:57.407217
NCT01508377|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-01-30|||December 2011||2011-12-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of an Internet-based Intervention for Posttraumatic Stress Disorder|Additive Effect of Cognitive Restructuring in a Web-based Treatment for Traumatized Arab People|Completed||N/A|293|Actual|Berlin Center for the Treatment of Torture Victims||2|||f||||f||||||||||2017-10-11 03:24:57.515101|2017-10-11 03:24:57.515101
NCT01508364|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-01-19|||July 2012||2012-07-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|NEXTAR||Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell Carcinoma|NEXTAR - NEXavar® as First TARgeted Treatment for Patients With Advanced Renal Cell Carcinoma|Completed||N/A|20|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:24:57.616144|2017-10-11 03:24:57.616144
NCT00006323|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-02|2016-05-12|||September 1999||1999-09-01|March 2005|2005-03-01|July 2004|Actual|2004-07-01|||||Observational|||Neurobehavioral Consequences of Sleep Apnea in Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:30:00.806577|2017-10-11 04:30:00.806577
NCT01508351|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-04-28|||May 2012||2012-05-01|April 2015|2015-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||The Hypotensive Effect of Propofol: an Observational Study|The Hypotensive Effect of Propofol: an Observational Study of Hypotension With Anesthetic Induction by Propofol in the General Population Under Standard of Care Anesthesia|Completed||N/A|100|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-10-11 03:24:57.699423|2017-10-11 03:24:57.699423
NCT01508338|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-07-28|||January 2012||2012-01-01|July 2017|2017-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained Athletes|The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained Athletes|Completed||N/A|44|Actual|Metabolic Technologies Inc.||4|||f||||f||||||||||2017-10-11 03:24:57.784872|2017-10-11 03:24:57.784872
NCT01508325|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-04-28|2015-04-28||December 2011||2011-12-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|CREATIVE|Intention-to-treat (ITT) analysis population included all randomized subjects.|Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients|Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients (CREATIVE Study)|Completed||Phase 4|186|Actual|Merck KGaA||2|||f||||f||||||||||2017-10-11 03:24:57.954256|2017-10-11 03:24:57.954256
NCT01508312|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-02-14|||January 5, 2012||2012-01-05|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma|Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma|Active, not recruiting||Phase 2|46|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 03:24:58.712769|2017-10-11 03:24:58.712769
NCT01508299|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-10-06|||April 2012||2012-04-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Skin Prick Test for the Diagnosis of Food Allergy- a Comparison of Different Commercial Extracts and Raw Food|Skin Prick Test for the Diagnosis of Food Allergy- a Comparison of Different Commercial Extracts and Raw Food|Completed||N/A|200|Anticipated|Meir Medical Center||1|||f||||t||||||||||2017-10-11 03:24:58.82297|2017-10-11 03:24:58.82297
NCT01508286|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-07-22||||||July 2015|2015-07-01||||||||Expanded Access|||Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects|Multicenter, Open-label, Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Genotype 1 Chronic Hepatitis C Subjects With Severe Fibrosis and Compensated Cirrhosis|No longer available||N/A|||Janssen-Cilag International NV|||||f||||f||||||||||2017-10-11 03:24:58.91525|2017-10-11 03:24:58.91525
NCT01508273|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-12-01|||May 2012||2012-05-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Lifestyle Intervention for High Risk Cancer Survivors|Development of an Aerobic and Resistance Training Feasibility Study for a Racially and Ethnically Diverse Sample of Breast Cancer Survivors|Completed||N/A|1150|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 03:24:59.257381|2017-10-11 03:24:59.257381
NCT01508260|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-04-04|||March 2013||2013-03-01|April 2013|2013-04-01||||March 2018|Anticipated|2018-03-01||Interventional|||Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload|Ultrafiltration (Aquapheresis) in the Management of Patients With Leukemia and Severe Fluid Overload|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-10-11 03:24:59.385219|2017-10-11 03:24:59.385219
NCT01508247|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-03-27|||January 2012||2012-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months|A Multiple-center Randomized Double-blind Placebo-controlled Phase 3 Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months|Completed||Phase 3|10245|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 03:24:59.501937|2017-10-11 03:24:59.501937
NCT01508221|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2016-07-30|||June 2011||2011-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis|A Phase II Trial to Evaluate the Use of Trental and Vitamin E for Prophylaxis of Radiation Necrosis|Recruiting||Phase 2|50|Anticipated|University of Cincinnati||1|||f||||f||||||||||2017-10-11 03:24:59.647714|2017-10-11 03:24:59.647714
NCT01508208|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2015-01-01|||March 2012||2012-03-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Comparison of Urine Protein/Creatinine Ratio With 24-hour Urine Protein Excretion in Woman With Hypertensive Disorders|A Comparison of Spot Test (Urine Protein/Creatinine Ratio) With 24 - Hour Urine Protein Excretion in Woman With Hypertensive Disorders of Pregnancy|Unknown status|Recruiting|N/A|420|Anticipated|Saint Thomas Hospital, Panama||1|||f||||f||||||||||2017-10-11 03:24:59.779201|2017-10-11 03:24:59.779201
NCT01508195|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-01-30|||January 2012||2012-01-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy Volunteers|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess the Bioequivalence of 2 FDC Tablets of Canagliflozin and Metformin IR (50 mg/500 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 500 mg) in Healthy Fed Subjects|Completed||Phase 1|64|Actual|Janssen Research & Development, LLC||2|||f||||||||||||||2017-10-11 03:24:59.869452|2017-10-11 03:24:59.869452
NCT01508182|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2013-01-15|||January 2012||2012-01-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy Volunteers|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess the Bioequivalence of 2 FDC Tablets of Canagliflozin and Metformin IR (150 mg/500 mg) With Respect to the Individual Components of Canagliflozin (1x300 mg) and Metformin IR Tablets (2x500 mg) in Healthy Fed Subjects|Completed||Phase 1|64|Actual|Janssen Research & Development, LLC||2|||f||||||||||||||2017-10-11 03:24:59.986308|2017-10-11 03:24:59.986308
NCT01508169|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-03-09|2012-02-02||April 2011||2011-04-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Foot Orthoses and Elderly Women With Osteoporosis|The Effect of Foot Orthoses on the Balance of Elderly Women With Osteoporosis|Completed||N/A|94|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 03:25:00.110241|2017-10-11 03:25:00.110241
NCT01508156|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2015-04-24|||January 2012||2012-01-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)|A Phase I/IIa Study Assessing Single and Multiple Doses of HCV NS5A Inhibitor IDX719 in Healthy and HCV-Infected Subjects|Completed||Phase 1/Phase 2|130|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 03:25:00.532356|2017-10-11 03:25:00.532356
NCT01508143|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-09-30|||January 2012||2012-01-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Comparitive Study of Two Misoprostol Regimen in Early Pregnancy Termination|A Comparative Study of Vaginal Misoprostol Two Dosing Regimen for First Trimester Pregnancy Termination in Patients Admitted at Bandarabbas in Shariati Hospital in 2009|Completed||N/A|41|Actual|Hormozgan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:25:00.632587|2017-10-11 03:25:00.632587
NCT01508130|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-03-10|2015-10-19||January 31, 2012|Actual|2012-01-31|March 2017|2017-03-01|March 31, 2014|Actual|2014-03-31|March 31, 2014|Actual|2014-03-31||Observational|||An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1|Non-Interventional, Prospective Cohort Study of the Effectiveness, Safety and Utilization of Two Approved Pegylated Interferon-Based Direct Acting Antiviral Triple Therapies in the Management of Genotype 1 Chronic Hepatitis C in Routine Clinical Practice in the USA|Completed||N/A|672|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:25:00.789573|2017-10-11 03:25:00.789573
NCT01508117|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-08-18|2017-08-18||August 2011||2011-08-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients|A Phase II Window Study of Front-line Axitinib Followed by Axitinib and Radiation for Elderly Patients With Glioblastoma Multiforme (GBM)|Terminated||Phase 2|1|Actual|University of Cincinnati|Early termination due to lack of accrual.|1||transferred study sponsor|f||||t||||||||||2017-10-11 03:25:03.15885|2017-10-11 03:25:03.15885
NCT01508104|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-08-21|||January 2012||2012-01-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors|A Dose Escalation, Single Arm, Phase 1b-2 Combination Study of BEZ235 With Everolimus to Determine the Safety, Pharmacodynamics and Pharmacokinetics in Subjects With Advanced Solid Malignancies|Terminated||Phase 1|19|Actual|University of Cincinnati||1||funding|f||||t||||||||||2017-10-11 03:25:03.418042|2017-10-11 03:25:03.418042
NCT01508078|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-02-23|||May 2010||2010-05-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|CASA||Characterization of Adult Subjects for Asthmatic Research Studies|Characterization of Adult Subjects for Asthmatic Research Studies|Recruiting||N/A|2000|Anticipated|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     Samples of induced sputum and blood for DNA and RNA extraction, plasma, and serum will be     banked in the UCSF Airway Tissue Bank.   "|||2017-10-11 03:25:03.610726|2017-10-11 03:25:03.610726
NCT01508065|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-08-24|||September 2012||2012-09-01|August 2016|2016-08-01||||July 2014|Actual|2014-07-01||Observational|||Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device|Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device|Active, not recruiting||N/A|20|Anticipated|GlucoVista|||1||f||||f||||||||||2017-10-11 03:25:03.709032|2017-10-11 03:25:03.709032
NCT01508052|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-04-03|2014-02-24||December 2011||2011-12-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Sequential Compression Device on Body Temperature|The Effects of Sequential Compression Device on Body Temperature During Propofol Anaesthesia: A Comparison With Elastic Stockings|Completed||N/A|40|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 03:25:03.795501|2017-10-11 03:25:03.795501
NCT01508039|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-01-25|||April 2011||2011-04-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|INCA||Immunological Effects From Intranasal Chitin Micro-Particles|A Randomised, Double-blind,Single-dose,Placebo and Single-blind Active Controlled Cross-over Study in Healthy Volunteers to Access in Effects of Intranasal Chitin Micro-particles on the Release of Cytokines From Nasal Mucosa|Completed||N/A|14|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 03:25:04.109397|2017-10-11 03:25:04.109397
NCT01508026|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2014-03-28||2014-03-28|January 2012||2012-01-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension|A Multicenter, Randomized, Double-blind, Placebo-Controlled, 8-Week Study to Evaluate the Safety and Efficacy of Nebivolol and Valsartan Given as a Fixed Dose Combination in Patients With Stage 1 or 2 Essential Hypertension|Completed||Phase 3|4161|Actual|Forest Laboratories||8|||f||||f||||||||||2017-10-11 03:25:04.275165|2017-10-11 03:25:04.275165
NCT01508013|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-04-26|2016-01-21||May 2011||2011-05-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|iSTART|Adolescent females aged 12-18 years old who expressed interest in future indoor tanning.|An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk|An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk|Completed||N/A|443|Actual|East Tennessee State University|None noted|2|||f||||t||||||||Yes|The proposed research will include data from high school teenage women who indoor tan. The final dataset will include self-reported demographic, attitudinal, cognitive and behavioral data from surveys about private personal behaviors. The final dataset will be stripped of identifiers prior to release for sharing. We will make the data and associated documentation available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and to not attempting to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.|2017-10-11 03:25:05.304273|2017-10-11 03:25:05.304273
NCT00004699|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||August 1995||1995-08-01|March 1999|1999-03-01|January 1999||1999-01-01|||||Interventional|||Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism||Completed||N/A|8||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:57.136979|2017-10-11 04:26:57.136979
NCT01508000|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-10-11|||June 2013||2013-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|BOS2||Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases|Randomized Phase II Trial Evaluating the Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab as Perioperative Treatment in Patients With Resectable Liver Metastases From Wild Type KRAS/NRAS Colorectal Cancer|Terminated||Phase 2|44|Actual|European Organisation for Research and Treatment of Cancer - EORTC||3||Low or poor accrual|f||||||||||||||2017-10-11 03:25:05.769129|2017-10-11 03:25:05.769129
NCT01507987|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-07-06|||March 2013||2013-03-01|June 2017|2017-06-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Observational|CLAS||St.Jude Medical Cardiac Lead Assessment Study|St.Jude Medical Cardiac Lead Assessment Study|Active, not recruiting||N/A|2215|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 03:25:05.944609|2017-10-11 03:25:05.944609
NCT01507974|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-10-30|||January 2012||2012-01-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Examination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections|The Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections|Recruiting||N/A|100|Anticipated|HaEmek Medical Center, Israel||3|||f||||t||||||||||2017-10-11 03:25:06.026701|2017-10-11 03:25:06.026701
NCT01507961|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-08|2012-01-10|||February 2012||2012-02-01|December 2011|2011-12-01||||||||Observational|||Comparison of Soft and Hard Tissue Thickness in the Anterior Regions of the Upper and Lower Jaws Taken From CBCT Versus Clinical Measurements||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 03:25:06.452583|2017-10-11 03:25:06.452583
NCT01507948|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-01-19|||September 2010||2010-09-01|July 2015|2015-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)|The Neurobiology of Psychotherapy: Emotional Reactivity and Regulation in PTSD|Completed||N/A|94|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 03:25:06.509131|2017-10-11 03:25:06.509131
NCT01507935|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-09-04|||January 2012||2012-01-01|September 2012|2012-09-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|ColoR||Colonisation Resistance Study|Randomised, Controlled, Double-blind Exploratory Study to Investigate the Effect of Specific Prebiotic Oligosaccharides on Gut Microbiota Composition in Healthy Infants|Withdrawn||Phase 2|0|Actual|Danone Asia Pacific Holdings Pte, Ltd.||4||The study was withdrawn due to change of the study product formulation.|f||||f||||||||||2017-10-11 03:25:06.622211|2017-10-11 03:25:06.622211
NCT01507922|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2014-12-17|||December 2011||2011-12-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|FEN-401||Comparative Efficacy and Safety of Fenoverine|Comparative Efficacy and Safety of Fenoverine and Trimebutine Maleate in Irritable Bowel Syndrome; A Randomized Double-blind Parallel Multi-center Phase IV Trial|Completed||Phase 4|186|Anticipated|Bukwang Pharmaceutical||2|||f||||f||||||||||2017-10-11 03:25:06.731193|2017-10-11 03:25:06.731193
NCT01507909|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-07-25|||January 2012||2012-01-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Observational|||Quantitative EEG Assessment of Cue-Induced Changes in Brain Activity in Alcohol Use Disorders|Quantitative EEG Assessment of Cue-Induced Changes in Brain Activity in Alcohol Use Disorders|Terminated||N/A|11|Actual|Boston University|||1|Equipment Failure|f||||f||||||||||2017-10-11 03:25:06.836437|2017-10-11 03:25:06.836437
NCT01507896|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-12-22|2016-07-27|2015-05-07|December 2011||2011-12-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Note there were 30 unique participants with a total of 40 planned surgeries, as participants may have > 1 surgery. Baseline data reflects number of planned surgeries.|BAX 326 Surgery Study in Hemophilia B Patients|BAX 326 (Recombinant Factor IX): A Phase 3 Prospective, Multicenter Study Evaluating Efficacy and Safety in Previously Treated Patients With Severe (FIX Level < 1%) or Moderately Severe (FIX Level 1-2%) Hemophilia B Undergoing Surgical or Other Invasive Procedures|Completed||Phase 3|30|Actual|Baxalta US Inc.|Data provided for surgical procedures, treatments with BAX326 etc. and for unique participants (one unique participant could undergo more than one surgical procedure).|1|||f||||t||||||||||2017-10-11 03:25:06.927112|2017-10-11 03:25:06.927112
NCT01507883|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-01-10|||March 2011||2011-03-01|January 2012|2012-01-01|January 2012|Anticipated|2012-01-01|December 2011|Actual|2011-12-01||Observational|||Time-lapse Evaluation of Human Embryo Development in Single Versus Sequential Culture Media - a Sibling Oocyte Study|Time-lapse Evaluation of Human Embryo Development in Single Versus Sequential Culture Media - a Sibling Oocyte Study|Unknown status|Recruiting|N/A|50|Anticipated|Bahceci Health Group|||1||f||||f||||||Samples With DNA|"     Human embryos   "|||2017-10-11 03:25:07.829672|2017-10-11 03:25:07.829672
NCT01507870|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2015-07-01|||January 2010||2010-01-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Randomized Controlled Prospective Multicenter Study Primary Onlay- Mesh After Elective Median Laparotomy in Patients With BMI ≥ 27||Terminated||N/A|300|Anticipated|Austrian Hernia Study Group||2|||f||||||||||||||2017-10-11 03:25:07.906122|2017-10-11 03:25:07.906122
NCT01507857|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2013-11-27|||January 2012||2012-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine|A Multicentered, Double - Blind, Randomized, and Placebo - Controlled Clinical Trial With Inactivated Enterovirus Type 71 (EV71) Vaccines|Completed||Phase 3|10077|Actual|Sinovac Biotech Co., Ltd||2|||f||||t||||||||||2017-10-11 03:25:07.999488|2017-10-11 03:25:07.999488
NCT01507844|ClinicalTrials.gov processed this data on October 10, 2017|2009-11-02|2012-01-08|||November 2009||2009-11-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|CPAP||Continuous Positive Airway Pressure Effect on Air Trapping in Chronic Obstructive Pulmonary Disease Patients|Continuous Positive Airway Pressure Effect on Air Trapping, Endurance Time in Chronic Obstructive Pulmonary Disease Patients|Completed||N/A|24|Actual|Assaf-Harofeh Medical Center||1|||f||||f||||||||||2017-10-11 03:25:08.116196|2017-10-11 03:25:08.116196
NCT01507649|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-12-01|||July 2012||2012-07-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of a Telephone-based Intervention on Postnatal Depression|The Effect of a Telephone-based Cognitive-behavioral Intervention on Postnatal Depression: a Randomized Controlled Trial|Completed||N/A|397|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 03:25:14.092003|2017-10-11 03:25:14.092003
NCT00006404|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2014-03-25|||September 2000||2000-09-01|May 2009|2009-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Nutrition in Pregnancy, Birth Weight, and Childhood Asthma||Completed||N/A|||Harvard Pilgrim Health Care|||||f||||||||||||||2017-10-11 04:30:18.659346|2017-10-11 04:30:18.659346
NCT01507831|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2015-11-18|2015-11-18||January 2012||2012-01-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)|Long-term Safety and Tolerability of SAR236553 (REGN727) in High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Lipid Modifying Therapy: A Randomized, Double-Blind, Placebo-Controlled Study|Completed||Phase 3|2341|Actual|Sanofi|"Manual reclassification was done by the Sponsor for the other reasons of non-completion of study as specified in the electronic case report (eCRF) form."|2|||f||||t||||||||||2017-10-11 03:25:08.386922|2017-10-11 03:25:08.386922
NCT01507818|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2012-07-06|||December 2011||2011-12-01|July 2012|2012-07-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Interventional|||Effectiveness of the Ivivi Torino II, Pulsed Radio Frequency Device, on Narcotic Use, Pain and Quality of Life Following Shoulder Arthroscopic Rotator Cuff Repair.|Impact of Non-thermal Pulsed Radio Frequency (PRF)on Narcotic Use, Pain, and Health-related Quality of Life Following Shoulder Arthroscopic Rotator Cuff Repair: A Double-Blind, Randomized Sham-Controlled Trial|Terminated||N/A|37|Actual|Amp Orthopedics, Inc.||2||Sponsor decision|f||||f||||||||||2017-10-11 03:25:11.983905|2017-10-11 03:25:11.983905
NCT01507805|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-01-08|||February 2011||2011-02-01|February 2011|2011-02-01|January 2013|Anticipated|2013-01-01|June 2012|Anticipated|2012-06-01||Interventional|||Electroacupuncture Preconditioning on Geriatric Noncardiac Surgery|Effects of Electroacupuncture Preconditioning on Outcomes of the Geriatric Patients With Coronary Heart Disease Undergoing Non-cardiac Surgery|Unknown status|Recruiting|N/A|300|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 03:25:12.086454|2017-10-11 03:25:12.086454
NCT01507792|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2012-01-08|||January 2002||2002-01-01|January 2012|2012-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|CID||Iron Repletion in Chronic Cough and Iron Deficiency|Effect of Iron Repletion in Women With Chronic Cough and Iron Deficiency|Completed||N/A|22|Actual|University of Turin, Italy||1|||f||||f||||||||||2017-10-11 03:25:12.19948|2017-10-11 03:25:12.19948
NCT01507779|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2013-09-19|||April 2012||2012-04-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine|Evaluation of The Safety and Immunogenicity of an Influenza A/H1N1 Vaccine (IVACFLU), Produced by IVAC, in Healthy Adults in Vietnam|Completed||Phase 1|48|Actual|PATH||2|||f||||f||||||||||2017-10-11 03:25:12.30721|2017-10-11 03:25:12.30721
NCT01507766|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-11-15|||September 2010||2010-09-01|November 2012|2012-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis|The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis|Completed||Phase 4|60|Actual|Nanjing University School of Medicine||2|||f||||t||||||||||2017-10-11 03:25:12.409989|2017-10-11 03:25:12.409989
NCT01507753|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2016-03-04|||September 2011||2011-09-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|OATS||Omega-3 and Therapy Study for Childhood Bipolar Disorder- Not Otherwise Specified|Omega-3 Fatty Acids & Psychoeducational Psychotherapy for Childhood Bipolar Disorder- Not Otherwise Specified|Completed||Phase 1|23|Actual|Ohio State University||4|||f||||t||||||||||2017-10-11 03:25:12.509773|2017-10-11 03:25:12.509773
NCT01507740|ClinicalTrials.gov processed this data on October 10, 2017|2009-09-18|2015-04-28|||July 2009||2009-07-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|December 2012|Actual|2012-12-01||Observational|||Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients|Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients|Terminated||N/A|60|Actual|Medical University Innsbruck|||2|"Study was stopped 04.10.2014 prematurly after recruitment of HCC and RCC patients. NSCLC (2 of   10 patients planned) and CRC patients recruitment was stopped"|f||||t||||||Samples With DNA|"     Consecutive serum and blood probes will be taken and will be examined and correlated with     functional imaging and the clinical course. Following parameters have been selected: soluble     markers in the plasma (VEGF, bFGF, ICAM, sVGFR-2 IL-8, SDF1 and Dickkopf 3) and cellular     parameters like circulating endothelial cells (CEC) and circulating endothelial progenitor     cells (CEPs).   "|||2017-10-11 03:25:12.628909|2017-10-11 03:25:12.628909
NCT01507727|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-08|||January 2012||2012-01-01|January 2012|2012-01-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia|A Multicenter, Randomized, Double-blind, Placebo-controlled (Standard Therapy + Placebo) Study to Evaluate the Efficacy and Safety of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia|Unknown status|Recruiting|Phase 2/Phase 3|240|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:25:12.72889|2017-10-11 03:25:12.72889
NCT01507714|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-08|||January 2012||2012-01-01|January 2012|2012-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Anterior Vaginal Wall Repair With Mesh in Combination With TVT-O to Reduce Urinary Stress Incontinence|Anterior Vaginal Wall Repair With Mesh in Combination With TVT-O to Reduce Urinary Stress Incontinence|Unknown status|Not yet recruiting|N/A|100|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-11 03:25:12.999066|2017-10-11 03:25:12.999066
NCT01507701|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-01-12|||January 2010||2010-01-01|January 2012|2012-01-01||||March 2010|Actual|2010-03-01||Interventional|||Pilot Study for the NorCAPITAL Trial|Pilot Study for the NorCAPITAL Trial|Completed||N/A|5|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 03:25:13.134726|2017-10-11 03:25:13.134726
NCT01507688|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-06-12|||January 7, 2013|Actual|2013-01-07|June 2017|2017-06-01|December 31, 2017|Anticipated|2017-12-31|March 31, 2017|Actual|2017-03-31||Interventional|||Stroke Self-Management|Stroke Self-Management: Effect on Function and Stroke Quality of Life|Active, not recruiting||N/A|258|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||Undecided||2017-10-11 03:25:13.259641|2017-10-11 03:25:13.259641
NCT01507675|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-03-21|||October 2011||2011-10-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Observational|||Burden, Belonging, and Response to Pain in Veterans|Burden, Belonging, and Response to Pain in Veterans|Withdrawn||N/A|0|Actual|VA Eastern Colorado Health Care System|||1|Study should not have been listed on ClinicalTrials|f||||t||||||||||2017-10-11 03:25:13.391939|2017-10-11 03:25:13.391939
NCT00005264|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1990||1990-09-01|October 2002|2002-10-01|September 1996|Actual|1996-09-01|||||Observational|||Pediatric Epidemiology of Cardiovascular Disease Risk Factors (Project Heartbeat)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.663014|2017-10-11 04:26:59.663014
NCT01507636|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-05-14|||January 2012||2012-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Occupational Therapy in Patients With Multiple Sclerosis|Apraxia-specific Occupational Therapy in Patients With Multiple Sclerosis|Completed||N/A|40|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 03:25:14.205734|2017-10-11 03:25:14.205734
NCT01507623|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2012-01-10|||September 2010||2010-09-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Value of Capnography During Nurse Administered Propofol Sedation (NAPS)|The Role of Capnography in Endoscopy Patients Undergoing Nurse Administered Propofol Sedation (NAPS): A Randomized Study|Completed||N/A|591|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-10-11 03:25:14.334018|2017-10-11 03:25:14.334018
NCT01507610|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-02-28|||January 2012||2012-01-01|January 2012|2012-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects|An Open-Label, Single-Dose, Randomized, Crossover Study to Compare the Bioavailability of the Intranasal Administration of 20 mg OPTINOSE SUMATRIPTAN With 20 mg IMITREX® (Sumatriptan) Nasal Spray, 100 mg IMITREX® (Sumatriptan) Oral Tablet and 6 mg IMITREX® (Sumatriptan) Subcutaneous Injection in Healthy Subjects|Completed||Phase 1|20|Actual|Optinose US Inc.||4|||f||||f||||||||||2017-10-11 03:25:14.498206|2017-10-11 03:25:14.498206
NCT01507597|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-12-09|||December 2011||2011-12-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Effect of GLP-1 on the Inhibition of Glucagon Secretion||Completed||N/A|30|Actual|University Hospital, Gentofte, Copenhagen||3|||f||||f||||||||||2017-10-11 03:25:14.611831|2017-10-11 03:25:14.611831
NCT01507584|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2012-01-06|||August 2011||2011-08-01|January 2012|2012-01-01|September 2012|Anticipated|2012-09-01|June 2012|Anticipated|2012-06-01||Interventional|||The Effects of the Water Drinking Test on Intraocular Pressure|The Effects of the Water Drinking Test on Intraocular Pressure of Glaucoma Patients Undergoing 24 Hour Continuous Monitoring With the SENSIMED Triggerfish|Unknown status|Enrolling by invitation|Phase 3|40|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-10-11 03:25:14.715404|2017-10-11 03:25:14.715404
NCT01507571|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2012-01-10|||September 2005||2005-09-01|January 2012|2012-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|DignityDK||Implementation and Evaluation of Dignity Therapy in Denmark|Implementation and Evaluation of Dignity Therapy in Denmark|Completed||Phase 2|80|Actual|Bispebjerg Hospital||1|||f||||f||||||||||2017-10-11 03:25:14.804688|2017-10-11 03:25:14.804688
NCT01507558|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-10-20|||December 2010||2010-12-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|DANCE||Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization|Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:25:14.934655|2017-10-11 03:25:14.934655
NCT01507545|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-09-04||2015-06-25|March 2012||2012-03-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)|A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer|Completed||Phase 2|126|Actual|Morphotek||2|||f||||t||||||||||2017-10-11 03:25:15.052377|2017-10-11 03:25:15.052377
NCT01507532|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-08-28|||January 2012||2012-01-01|August 2017|2017-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients|Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients|Withdrawn||Phase 4|0|Actual|Midwestern University||1||did not enroll a patient|f||||f||||||||||2017-10-11 03:25:15.419897|2017-10-11 03:25:15.419897
NCT01507519|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-10|||April 2009||2009-04-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|||Study Safety,Efficacy of the Biomime Stent in Patients With Single, Discrete, De Novo, Non-Complex Coronary Lesions|The First-In_Man Safety and Performance Evaluation of the Biomime Sirolimus Eluting Stent System for the Treatment of Patients With Single, Discrete, De Novo, Non-Complex Coronary Lesions-The Biomime Pilot FiM Trial.|Completed||Phase 4|30|Actual|Meril Life Sciences Pvt. Ltd.||1|||f||||f||||||||||2017-10-11 03:25:15.528881|2017-10-11 03:25:15.528881
NCT01507506|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-05-26|||March 2011||2011-03-01|September 2014|2014-09-01|March 2019|Anticipated|2019-03-01|March 2016|Anticipated|2016-03-01||Interventional|SPECTRO GLIO||Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma|Phase III Randomized Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma : Standard 3D Conformational Radiotherapy Versus Intensity-modulated Radiotherapy With Simultaneous-integrated Boost Guided by Magnetic Resonance Spectroscopic Imaging|Recruiting||Phase 3|220|Anticipated|Institut Claudius Regaud||2|||f||||f||||||||||2017-10-11 03:25:15.648327|2017-10-11 03:25:15.648327
NCT01507493|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-08-31|2013-05-30||January 2011||2011-01-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||The Impact of SCN9A Gene Polymorphism on Individual Pain Perception in the General Population|The Impact of SCN9A Gene Polymorphism on Individual Pain Perception in the General Population|Completed||N/A|200|Actual|Huazhong University of Science and Technology|||2||f||||t||||||Samples With DNA|"     Heparin anti-coagulated blood (2 ml) was collected from the central venous during the     operation and all blood samples were stored at -80℃. Genomic DNA was extracted from the blood     samples using a guanidinium isothiocyanate method.   "|||2017-10-11 03:25:15.820497|2017-10-11 03:25:15.820497
NCT01507480|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-05-13|||October 2011||2011-10-01|December 2011|2011-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ELLIPSE||The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia|The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia.|Completed||Phase 1|42|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-10-11 03:25:16.182233|2017-10-11 03:25:16.182233
NCT01507259|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-07-26|||February 2012||2012-02-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|||||Observational|||Chocolate's Effect on the Cerebral Vasculature|A Randomised Trial of Effect of Chocolate Upon Cerebrovascular Reactivity in Healthy Adult Volunteers|Completed||N/A|24|Actual|NHS Greater Glasgow and Clyde|||1||f||||f||||||||||2017-10-11 03:25:18.281038|2017-10-11 03:25:18.281038
NCT01507467|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-14|2016-11-22|||March 2012||2012-03-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2014|Actual|2014-05-01||Interventional|IAEA-HypoX||IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck|IAEA-HypoX. A Randomized Multicenter Study of Accelerated Fractionated Radiotherapy With or Without the Hypoxic Radiosensitizer Nimorazole in the Treatment of Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 3|104|Actual|Danish Head and Neck Cancer Group||2||Insufficient recruitment|f||||t||||||||||2017-10-11 03:25:16.294529|2017-10-11 03:25:16.294529
NCT01507454|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-02-06|||April 2006||2006-04-01|February 2017|2017-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency|Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency|Completed||N/A|1613|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:25:16.410208|2017-10-11 03:25:16.410208
NCT01507441|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-05-17|||February 2012||2012-02-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial|Whole Exon Sequencing of Down Syndrome Acute Myeloid Leukemia|Completed||N/A|10|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:25:16.505262|2017-10-11 03:25:16.505262
NCT01507428|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-09-04|||February 22, 2012|Actual|2012-02-22|May 2017|2017-05-01||||June 8, 2019|Anticipated|2019-06-08||Interventional|||Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer|Randomized Phase II Trial of Individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT and Modern Technology in Locally Advanced Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|138|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 03:25:16.764222|2017-10-11 03:25:16.764222
NCT01507415|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-11-04|||November 2011||2011-11-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Observational|||Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?|Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?|Completed||N/A|226|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Whole blood, plasma and serum.   "|||2017-10-11 03:25:17.021562|2017-10-11 03:25:17.021562
NCT01507402|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-11-12|||January 2012||2012-01-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Assess the Safety and Tolerability of Single Ascending Doses of REGN1033(SAR391786)||Completed||Phase 1|76|Actual|Regeneron Pharmaceuticals||9|||f||||t||||||||||2017-10-11 03:25:17.112676|2017-10-11 03:25:17.112676
NCT01507389|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-12-08|||March 2006||2006-03-01|December 2014|2014-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function|A Single-centre, Open-label Trial Investigating the Pharmacokinetics and the Safety Profile After a Single Dose of Liraglutide in Subjects With Hepatic Impairment and in Subjects With Normal Hepatic Function|Completed||Phase 1|24|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:25:17.209598|2017-10-11 03:25:17.209598
NCT01507376|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-04-24|||October 2010||2010-10-01|October 2010|2010-10-01|June 2013|Actual|2013-06-01|September 2012|Actual|2012-09-01||Interventional|||Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity|Comparing the Efficacy of Urinary and Recombinant hCG on Oocyte Maturity for Ovulation Induction in Assisted Reproductive Techniques: a Randomized Clinical Trial|Completed||Phase 3|180|Actual|Royan Institute||3|||f||||t||||||||||2017-10-11 03:25:17.293741|2017-10-11 03:25:17.293741
NCT01507363|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2014-04-10|||January 2012||2012-01-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)|Analgesic Effect of Perioperative Gabapentin in Total Knee Arthroplasty: A Randomized, Double-blind, Placebo-controlled, Dose-response Study|Completed||Phase 4|300|Actual|Hvidovre University Hospital||3|||f||||t||||||||||2017-10-11 03:25:17.399813|2017-10-11 03:25:17.399813
NCT01507350|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-08-09|||June 2011||2011-06-01|August 2017|2017-08-01|August 1, 2017|Actual|2017-08-01|June 1, 2017|Actual|2017-06-01||Observational|||Effects of Obesity Surgery on Renal Function|Effects of Obesity Surgery on Renal Function|Completed||N/A|45|Actual|Imperial College London|||3||f||||t||||||||||2017-10-11 03:25:17.514574|2017-10-11 03:25:17.514574
NCT01507337|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-01-23|||April 2004||2004-04-01|January 2017|2017-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers|An Open Label, Single Dose Trial With Two Groups Comparing the Pharmacokinetics of Liraglutide in Young Versus Elderly Healthy Subjects of Both Sexes|Completed||Phase 1|32|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:25:17.69358|2017-10-11 03:25:17.69358
NCT01507311|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-01-23|||September 1999||1999-09-01|January 2017|2017-01-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes|Effect of NNC90-1170 on Pulsatile Insulin Secretion in Type 2 Diabetic Patients. A Double-blind, Placebo-controlled, Randomised, Single-dose, Cross-over Trial|Completed||Phase 1|11|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:25:17.810572|2017-10-11 03:25:17.810572
NCT01507285|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-01-23|||August 1999||1999-08-01|January 2017|2017-01-01|November 1999|Actual|1999-11-01|November 1999|Actual|1999-11-01||Interventional|||Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes|A Randomised, Double-blind, Placebo-controlled, Dose-escalation, Parallel-group, Single and Multiple Dosing Trial of NN90-1170 in Healthy Volunteers and Patients With Type 2 Diabetes to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:25:18.049117|2017-10-11 03:25:18.049117
NCT01507272|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-01-23|||March 1999||1999-03-01|January 2017|2017-01-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Safety and Tolerability of Liraglutide in Healthy Male Volunteers|A Randomised, Double-blind, Placebo-controlled, Dose Escalation Trial of Single Doses of NNC90-1170 to Assess Tolerability, Pharmacokinetics, Pharmacodynamics and Absolute Bioavailability in Healthy Male Subjects|Completed||Phase 1|34|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:25:18.150408|2017-10-11 03:25:18.150408
NCT01507246|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2013-05-06|2013-02-26||December 2011||2011-12-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|IMPROVE-Open||Adult Patients Undergoing Open Colectomy MA402S23B303|A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy|Completed||Phase 4|42|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-10-11 03:25:18.370863|2017-10-11 03:25:18.370863
NCT01507233|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-01-19|2013-11-30||May 2012||2012-05-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|IMPROVE-Open||A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302|A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy|Terminated||Phase 4|5|Actual|Pacira Pharmaceuticals, Inc||2||Slow enrollment.|f||||f||||||||||2017-10-11 03:25:18.862846|2017-10-11 03:25:18.862846
NCT01507220|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-01-19|2013-11-29||March 2012||2012-03-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|IMPROVE-Open||A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301|A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy|Terminated||Phase 4|2|Actual|Pacira Pharmaceuticals, Inc||2||Slow enrollment|f||||f||||||||||2017-10-11 03:25:19.230537|2017-10-11 03:25:19.230537
NCT01507207|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-09-18|||January 2012||2012-01-01|September 2017|2017-09-01|May 15, 2015|Actual|2015-05-15|May 15, 2015|Actual|2015-05-15||Interventional|||Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft|Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft|Completed||Phase 4|50|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-10-11 03:25:19.52347|2017-10-11 03:25:19.52347
NCT01507194|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-09-30|||February 2012||2012-02-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)|A Multicenter, Randomized, Single-blind, Active-controlled, Parallel Group, Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of a Single Intravenous (6 mg, 12 mg, 18 mg, 24 mg or 36 mg) Dose of the Neurokinin-1 Receptor Antagonist, Vestipitant (GW597599), Compared With a Single 4 mg Intravenous Ondansetron Hydrochloride Dose for the Treatment of Breakthrough Post-Operative Nausea and Vomiting After Failed Prophylaxis With an Ondansetron-Containing Regimen in Patients Undergoing Non-Emergency Surgical Procedures|Completed||Phase 2|131|Actual|Accenture||6|||f||||||||||||||2017-10-11 03:25:19.62067|2017-10-11 03:25:19.62067
NCT01507181|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-12-16|2016-04-18||January 2012||2012-01-01|December 2016|2016-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Ketamine For Suicidal Ideation|Investigating Rapid Anti-Suicidal Ideation Effects of Intravenous (IV) Ketamine in Hospitalized Patients|Completed||Phase 4|24|Actual|Icahn School of Medicine at Mount Sinai|Sample size is small, increasing the likelihood of a false negative finding due to limited power. Unknown if the lack of significant separation between the treatment and control conditions at 24 h represents a true null finding or a false negative.|2|||f||||t||||||||||2017-10-11 03:25:19.738161|2017-10-11 03:25:19.738161
NCT01507168|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-11-01|||February 2012||2012-02-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma|A Randomised, Placebo-controlled, Double-blind, Multicenter Phase II Trial of Intravenous GC33 at 1600 mg Q2W in Previously Treated Patients With Unresectable Advanced or Metastatic Hepatocellular Carcinoma (HCC)|Completed||Phase 2|186|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:25:20.486809|2017-10-11 03:25:20.486809
NCT01507155|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-05-05|2015-09-29||April 2013||2013-04-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|COM-1||An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay|An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay|Completed||N/A|685|Actual|Genomind, LLC||2|||f||||f||||||||||2017-10-11 03:25:21.009316|2017-10-11 03:25:21.009316
NCT01507142|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-07-16|||October 2011||2011-10-01|July 2012|2012-07-01|October 2013|Anticipated|2013-10-01|September 2012|Anticipated|2012-09-01||Observational|||Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients|Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients|Unknown status|Recruiting|N/A|100|Anticipated|Gaia Medical Institute|||4||f||||f||||||Samples Without DNA|"     Saliva   "|||2017-10-11 03:25:21.345326|2017-10-11 03:25:21.345326
NCT01507129|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-08-14|||October 2010||2010-10-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Biomarkers for Noninvasive Assessment of Human Hydration|Biomarkers for Noninvasive Assessment of Human Hydration|Completed||N/A|15|Actual|Gaia Medical Institute|||1||f||||t||||||Samples With DNA|"     Plasma, Serum, Urine, Saliva   "|||2017-10-11 03:25:21.444287|2017-10-11 03:25:21.444287
NCT01507116|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-01-18|||March 2012||2012-03-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|DAWN2||Diabetes Attitudes Wishes and Needs|Diabetes Attitudes Wishes and Needs (DAWN) 2 Study: A Multinational, Multi-stakeholder Survey Study of Psychosocial Issues in Diabetes and Patient-centred Diabetes Care|Completed||N/A|8985|Actual|Novo Nordisk A/S|||3||f||||f||||||||||2017-10-11 03:25:21.553047|2017-10-11 03:25:21.553047
NCT01507103|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2017-01-12|2015-09-21||February 2012||2012-02-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|SPRINT|Safety analysis set included all subjects who received at least one dose of study treatment (tecemotide [L-BLP25] or CPA).|Tecemotide (L-BLP25) in Rectal Cancer|A Multi-center, Randomized, Open-label, Mechanism of Action Trial on the Biological Effects of the Therapeutic Cancer Vaccine Stimuvax® (L-BLP25) in Rectal Cancer Subjects Undergoing Neoadjuvant Chemoradiotherapy|Completed||Phase 2|124|Actual|Merck KGaA|Not all efficacy data were analyzed as no acceptable ELISpot assay is available. The Sponsor decided to discontinue the development of tecemotide (L-BLP25) in September 2014|3|||f||||f||||||||||2017-10-11 03:25:21.748842|2017-10-11 03:25:21.748842
NCT01507090|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-02-06|2014-07-22||February 2012||2012-02-01|February 2015|2015-02-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Observational|TAPE||Validation of the Mercy TAPE|Taking the Guesswork Out of Pediatric Weight Estimation (TAPE): Validation of the Mercy TAPE|Completed||N/A|642|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-10-11 03:25:24.942478|2017-10-11 03:25:24.942478
NCT00005265|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1990||1990-09-01|November 2001|2001-11-01|May 1992|Actual|1992-05-01|||||Observational|||Natural History of Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.727652|2017-10-11 04:26:59.727652
NCT01507077|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-07-17|||December 2011||2011-12-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity|ZGN-440 (Beloranib for Subcutaneous Injection), A Novel Methionine Aminopeptidase 2 Inhibitor for Treatment of Obesity: A Randomized Double-Blind Placebo Controlled Dose Escalation Phase 1b Trial to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Initial Weight Loss|Completed||Phase 1|25|Actual|Zafgen, Inc.||2|||f||||t||||||||||2017-10-11 03:25:25.471003|2017-10-11 03:25:25.471003
NCT01507064|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-03-04|||January 2012||2012-01-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|LANEX||Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma|Randomized Controlled Phase II Trial Of Neoadjuvant Sorafenib Therapy Prior to Thermal Ablation for Hepatocellular Carcinoma More Than 4 cm in Size|Completed||Phase 2|40|Actual|Cardarelli Hospital||2|||f||||f||||||||||2017-10-11 03:25:25.582234|2017-10-11 03:25:25.582234
NCT01507051|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-01-26|2012-01-30||November 2008||2008-11-01|January 2015|2015-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Switching Study From Warfarin to Rivaroxaban|Randomized, Placebo-controlled, Parallel-group Study in Healthy Male Subjects to Investigate the Pharmacodynamics During the Switching Procedure From Warfarin to Rivaroxaban|Completed||Phase 1|96|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:25:25.776139|2017-10-11 03:25:25.776139
NCT01507038|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2015-02-16|||December 2011||2011-12-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Safety and Efficacy of YH14617 in Diabetes Mellitus|Phase II Clinical Trial to Investigate the Efficacy, Safety and Pharmacokinetics of YH14617 After Once Weekly or Biweekly Administration in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|84|Actual|Yuhan Corporation||4|||f||||t||||||||||2017-10-11 03:25:27.916285|2017-10-11 03:25:27.916285
NCT01507025|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2014-02-12|||October 2011||2011-10-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||The Effect of Hinge Location on Corneal Sensation and Dry Eye After LASIK: A Systematic Review and Meta-analysis|The Effect of Hinge Location on Corneal Sensation and Dry Eye After LASIK: A Systematic Review and Meta-analysis|Completed||N/A|400|Anticipated|Wenzhou Medical University|||2||f||||||||||||||2017-10-11 03:25:28.037575|2017-10-11 03:25:28.037575
NCT01507012|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2012-01-09|||September 2010||2010-09-01|January 2012|2012-01-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||The Effect Of Berry Polyphenols On Human Behaviour|A Double Blind, Placebo Controlled Study Measuring The Effect Of Berry Polyphenols On Mood And Cognition In Healthy Adults|Completed||N/A|36|Actual|Northumbria University||3|||f||||f||||||||||2017-10-11 03:25:28.132463|2017-10-11 03:25:28.132463
NCT01506999|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-05|||July 2006||2006-07-01|January 2012|2012-01-01|July 2012||2012-07-01|||||Observational|GENOCOR||Genetic Mapping for Cardiac Risk Assessment|GENOCOR Project-Laboratory of Genetic Mapping for Assessment of Cardiovascular Risk(GENOCOR LAB)|Unknown status|Recruiting|N/A|2000|Anticipated|"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"|||3||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:25:28.233483|2017-10-11 03:25:28.233483
NCT01506986|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-09-01|||March 2012||2012-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|HEAT||Helicobacter Eradication Aspirin Trial|Helicobacter Eradication to Prevent Ulcer Bleeding in Aspirin Users: a Large Simple Randomised Controlled Trial|Recruiting||Phase 4|33000|Anticipated|University of Nottingham||2|||f||||t||||||||||2017-10-11 03:25:28.406673|2017-10-11 03:25:28.406673
NCT01506973|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-01-24|||December 2011||2011-12-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer|A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer|Recruiting||Phase 1/Phase 2|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:25:28.591596|2017-10-11 03:25:28.591596
NCT01506960|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-10-23|2013-05-16||January 2012||2012-01-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||47 subjects did not meet angiographic criteria for participation.|Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque|Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque|Terminated||Phase 4|64|Actual|Massachusetts General Hospital||1||It was felt that a sufficient number of subjects were enrolled.|f||||f||||||||||2017-10-11 03:25:28.874091|2017-10-11 03:25:28.874091
NCT01506947|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-04-06|2017-04-06||May 10, 2012|Actual|2012-05-10|April 2017|2017-04-01|April 7, 2016|Actual|2016-04-07|April 7, 2016|Actual|2016-04-07||Interventional||The per-protocol analysis set which included participants who completed the study according to the protocol. One patient was enrolled into the study under protocol version 1.0 and was not included in the per-protocol analysis set due to subsequent major changes to the protocol.|A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients|A Prospective, Non-randomised, Single-arm, Open-Label Pilot Clinical Study Evaluating the Effect of PTH Lowering on Erythropoietin Consumption in Calcitriol-Resistant Patients|Completed||Phase 4|65|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 03:25:29.108926|2017-10-11 03:25:29.108926
NCT01506934|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2012-08-24|||October 2011||2011-10-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors|A Phase 1, Open Label, Randomized, Adaptive, Cross-Over Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors|Terminated||Phase 1|14|Actual|Abbott||1||Sponsor decision|f||||f||||||||||2017-10-11 03:25:29.709539|2017-10-11 03:25:29.709539
NCT01506921|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2012-02-20|||May 2011||2011-05-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Racemic Ketamine Versus S-ketamine With Arterial Spin Labeling (ASL)-MRI in Healthy Volunteers|A Prospective Randomised, Double-blinded Cross-over Study to Investigate the Effects of Racemic and S-ketamine on Cerebral Blood Flow on Healthy Volunteers With MRI-ASL|Completed||N/A|14|Anticipated|Lund University||2|||f||||t||||||||||2017-10-11 03:25:29.796895|2017-10-11 03:25:29.796895
NCT00005266|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1990||1990-09-01|May 2000|2000-05-01|September 1992|Actual|1992-09-01|||||Observational|||Cardiovascular Disease Mortality in The NAS-NRC Twin Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.775328|2017-10-11 04:26:59.775328
NCT01506882|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2015-11-24|2014-10-07||December 2011||2011-12-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|October 2013|Actual|2013-10-01||Interventional||Baseline Characteristics refer to the Safety Set (SS). SS consists of all subjects in the Enrolled Set, who received at least 1 dose of the Investigational Medicinal Product (IMP).|An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy|An Open-label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Levetiracetam Used as Monotherapy in Newly or Recently Diagnosed Epilepsy Patients Aged Older Than or Equal to 16 Years With Partial Seizures|Completed||Phase 3|71|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:25:30.579819|2017-10-11 03:25:30.579819
NCT01506869|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-09|||May 2011||2011-05-01|January 2012|2012-01-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Observational|REACTION||Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal Study|A Prospective Cohort Study on the Associations of Diabetes With Cancer Risk in Chinese Men and Women|Unknown status|Recruiting|N/A|200000|Anticipated|Shanghai Jiao Tong University School of Medicine|||3||f||||t||||||Samples With DNA|"     Blood and urine samples were collected and retained for biomarker analysis   "|||2017-10-11 03:25:31.313037|2017-10-11 03:25:31.313037
NCT01506856|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-07-31|||May 2010||2010-05-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|November 2019|Anticipated|2019-11-01||Interventional|iPocc||Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial|A Randomized Phase II/III Trial of Intravenous (IV) Paclitaxel Weekly Plus IV Carboplatin Once Every 3 Weeks Versus IV Paclitaxel Weekly Plus Intraperitoneal (IP) Carboplatin Once Every 3 Weeks in Women With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Active, not recruiting||Phase 2/Phase 3|654|Anticipated|Gynecologic Oncology Trial & Investigation Consortium||2|||f||||t||||||||||2017-10-11 03:25:31.423892|2017-10-11 03:25:31.423892
NCT01506830|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2016-02-23|||July 2009||2009-07-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|||Cervical Restorations Placed Under Two Isolation Methods|Influence of Operatory Field Isolation Techniques on the Clinical Performance of Class V Restorations|Completed||Phase 2/Phase 3|30|Actual|Federal University of Pelotas||2|||f||||f||||||||||2017-10-11 03:25:31.995117|2017-10-11 03:25:31.995117
NCT01506817|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-05|||December 2011||2011-12-01|January 2012|2012-01-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|||Dynamic Contrast Enhanced (DCE)-MRI in Fibromyalgia|Dynamic Contrast Enhanced MRI of the Hands in Patients With Fibromyalgia. A Pilot Study|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Frederiksberg University Hospital|||2||f||||||||||||||2017-10-11 03:25:32.115298|2017-10-11 03:25:32.115298
NCT01506804|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-08-09|||November 2010||2010-11-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Exercise Therapy and Ultrasound Guided Injections in Painful Shoulder|The Efficacy of Exercise Therapy Followed by Ultrasound Guided Injection in Patients With a Painful Shoulder - a Randomised Controlled Study With Blinded Observer|Completed||N/A|99|Actual|Frederiksberg University Hospital||2|||f||||f||||||||||2017-10-11 03:25:32.244453|2017-10-11 03:25:32.244453
NCT01506791|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-01-05|||April 2006||2006-04-01|June 2006|2006-06-01|April 2006|Actual|2006-04-01|||||Interventional|||Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed Conditions|Randomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Desloratadine and Pseudoephedrine 5 mg/240 mg Extended-Release Tablet and Clarinex-D® 24-Hour (Reference) Following a 5 mg/240 mg Dose in Healthy Subjects Under Fed Conditions|Completed||Phase 1|44|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:25:32.392894|2017-10-11 03:25:32.392894
NCT01506778|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-09|||May 2011||2011-05-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|Tenaculum||Tenaculum in Endometrial Sampling Procedure|Using a Tenaculum Which is Actually Necessary for Endometrial Sampling Procedure by Pipelle.|Completed||N/A|115|Actual|Cukurova University||2|||f||||f||||||||||2017-10-11 03:25:32.500284|2017-10-11 03:25:32.500284
NCT01506765|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-17|||August 2003||2003-08-01|January 2012|2012-01-01|September 2006|Actual|2006-09-01|December 2004|Actual|2004-12-01||Interventional|||Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia|Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia: Double-blind and Crossover Study|Completed||Phase 1|13|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||||2017-10-11 03:25:32.625719|2017-10-11 03:25:32.625719
NCT01506752|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-06-25|||July 2011||2011-07-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males|A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males|Completed||Phase 1|20|Actual|Eisai Inc.||4|||f||||||||||||||2017-10-11 03:25:32.739211|2017-10-11 03:25:32.739211
NCT01506739|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-09|||March 2011||2011-03-01|January 2012|2012-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males|A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males|Completed||Phase 1|12|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-11 03:25:32.851713|2017-10-11 03:25:32.851713
NCT01506726|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-08-31|2015-10-26||March 2012||2012-03-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia|A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6|Terminated||Phase 2|11|Actual|Duke University||2||Study drug expiration and supply shortage|f||||t||||||||||2017-10-11 03:25:32.992499|2017-10-11 03:25:32.992499
NCT01506713|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-09|||September 2006||2006-09-01|January 2012|2012-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions|Randomized, Open-label, 2-Way Crossover, Bioequivalence Study of Clopidogrel 75 mg Tablet With Plavix® 75 mg In Healthy Subjects Under Fasting Conditions|Completed||Phase 1|53|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:25:34.105009|2017-10-11 03:25:34.105009
NCT01506700|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-12-13|||May 2012||2012-05-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Observational|||Real Time Optical Coherence Tomography (OCT) of Human Tissue|Real Time Optical Coherence Tomography (OCT) of Human Tissue|Suspended||N/A|20|Anticipated|Diagnostic Photonics, Inc.|||1||f||||f||||||||||2017-10-11 03:25:34.192377|2017-10-11 03:25:34.192377
NCT01506687|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-12-02|||January 2010||2010-01-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Increasing Colorectal Cancer Screening Uptake With a Patient Navigator|Increasing Colorectal Cancer Screening Uptake With a Patient Navigator - Phase III Trial|Completed||Phase 3|750|Anticipated|Cancer Care Ontario||2|||f||||f||||||||||2017-10-11 03:25:34.265552|2017-10-11 03:25:34.265552
NCT01506674|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2017-03-08|||January 2015||2015-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Metabolomic in Critical Ill Patients||Recruiting||N/A|||Università Vita-Salute San Raffaele|||1||f||||||||||||||2017-10-11 03:25:34.375963|2017-10-11 03:25:34.375963
NCT01506661|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-09-15|||January 2012||2012-01-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Zostavax in Rheumatoid Arthritis|Immune Response to Varicella Zoster Vaccination (ZOSTAVAX) in Subjects With Rheumatoid Arthritis|Active, not recruiting||Phase 1|20|Actual|Oklahoma Medical Research Foundation||2|||f||||t||||||||||2017-10-11 03:25:34.447283|2017-10-11 03:25:34.447283
NCT01506648|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-09|2016-11-25|||January 2011||2011-01-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Observational|||Assessment of Zinc Absorption From a Phytic Acid Rich Complementary Food|Assessment of Zinc Absorption From a Phytic Acid Rich Complementary Food, Consumed by Young Children Immediately After the Addition of the Enzyme Phytase. A Randomized Single Blind Study|Completed||N/A|40|Actual|Swiss Federal Institute of Technology|||1||f||||||||||||||2017-10-11 03:25:34.540754|2017-10-11 03:25:34.540754
NCT01506635|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-09|||March 2010||2010-03-01|October 2009|2009-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial|Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After Laser in Situ Keratomileusis: A Randomized Clinical Trial|Completed||N/A|45|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:25:34.615819|2017-10-11 03:25:34.615819
NCT01506622|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-25|2015-07-14|||January 2011||2011-01-01|July 2015|2015-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparison Between Propofol and Fentanyl for Prevention of Emergence Agitation in Children After Sevoflurane Anesthesia||Completed||N/A|222|Actual|Yonsei University||3|||f||||t||||||||||2017-10-11 03:25:34.702032|2017-10-11 03:25:34.702032
NCT01506596|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2016-12-29|2016-04-18||March 2012||2012-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|October 2014|Actual|2014-10-01||Interventional|||Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma|A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma|Completed||Phase 2|42|Actual|Vector Oncology||1|||f||||f||||||||No||2017-10-11 03:25:35.267826|2017-10-11 03:25:35.267826
NCT01506583|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-06|2012-01-09|||November 2010||2010-11-01|January 2012|2012-01-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Observational|QFlu||Clinical Evaluation of QFlu Combo Test|Clinical Evaluation of QFlu Combo Test|Unknown status|Recruiting|N/A|1000|Anticipated|Cellex, Inc.|||3||f||||f||||||Samples Without DNA|"     Samples were retained in case that the testing needs to be repeated. They are to be discarded     12 months after the study is completed.   "|||2017-10-11 03:25:36.010382|2017-10-11 03:25:36.010382
NCT01506570|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2015-08-19|||December 2011||2011-12-01|August 2015|2015-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine|A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-experienced Adult Subjects|Completed||Phase 1|58|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 03:25:36.118925|2017-10-11 03:25:36.118925
NCT01506557|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-07-22|||March 2011||2011-03-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|MAVID||Vitamin D Supplementation of Lactating Mothers|Effect of Vitamin D Supplementation During Lactation on Vitamin D Status, Bone Mineralisation and Body Composition of Mother and Their Exclusively Breastfed Infants.|Completed||Phase 4|174|Actual|Children's Memorial Health Institute, Poland||2|||f||||f||||||||||2017-10-11 03:25:36.227659|2017-10-11 03:25:36.227659
NCT01506544|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-12-10|||December 2011||2011-12-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|HU||Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia|Pharmacokinetics and Relative Bioavailability of a Liquid Formulation of Hydroxyurea in Pediatric Patients With Sickle Cell Anemia|Completed||Phase 1|39|Actual|Children's Mercy Hospital Kansas City||2|||f||||t||||||||||2017-10-11 03:25:36.351588|2017-10-11 03:25:36.351588
NCT01506531|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2017-01-06|||January 2012||2012-01-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|||Silo Versus Primary Closure for Gastroschisis|Bedside Silo Versus Attempted Operative Closure for Gastroschisis|Recruiting||N/A|100|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||No||2017-10-11 03:25:36.451963|2017-10-11 03:25:36.451963
NCT01506518|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-01-12|||January 2012||2012-01-01|January 2017|2017-01-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy|Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Muscle Degeneration in Duchenne Muscular Dystrophy|Recruiting||N/A|60|Anticipated|University of North Carolina, Chapel Hill|||4||f||||f||||||||||2017-10-11 03:25:36.555267|2017-10-11 03:25:36.555267
NCT01506505|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-08-12|||July 2012||2012-07-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|TEMPUS||The Evening Versus Morning Polypill Utilization Study|A Randomised Controlled Cross-over Trial to Evaluate Evening Versus Morning Administration of a Cardiovascular Polypill|Completed||N/A|78|Actual|UMC Utrecht||3|||f||||t||||||||||2017-10-11 03:25:36.656826|2017-10-11 03:25:36.656826
NCT01506492|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-11-10|||January 2012||2012-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|CALM||Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients|Managing Cancer and Living Meaningfully (CALM): A Randomized Controlled Trial of a Psychotherapeutic Intervention for Patients With Metastatic Cancer|Completed||Phase 3|305|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 03:25:36.777284|2017-10-11 03:25:36.777284
NCT01506466|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-07-23|||September 2011||2011-09-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|March 2013|Actual|2013-03-01||Interventional|||Weight Variation During Chemotherapy in Breast Cancer Patients|Weight Variation and Mechanisms Involved, During Chemotherapy in Breast Cancer Patients|Completed||N/A|52|Actual|Centre Jean Perrin||1|||f||||f||||||||||2017-10-11 03:25:37.01746|2017-10-11 03:25:37.01746
NCT01506453|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-04-07|||January 24, 2012|Actual|2012-01-24|April 2017|2017-04-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|TINALL||Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)|Therapeutic Interventions For Peripheral Neuropathy/Neuropathic Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL) On Total XVI Protocol|Recruiting||Phase 2|80|Anticipated|St. Jude Children's Research Hospital||2|||f||||f|t|f||||||||2017-10-11 03:25:37.098932|2017-10-11 03:25:37.098932
NCT01506440|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-05-25|||October 2011|Actual|2011-10-01|February 2017|2017-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy|Feasibility Study of a Cognitive Assessment Tool During Systemic Chemotherapy for Cancer Patients|Completed||N/A|29|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-11 03:25:37.224939|2017-10-11 03:25:37.224939
NCT01506427|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2012-12-12|||September 2012||2012-09-01|December 2012|2012-12-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Interventional|||A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients|A Phase I/II, Open Label, Nonrandomized, Multi-Center Study of [F-18]HX4 Positron Emission Tomography (PET) in Head and Neck Cancer Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Siemens Molecular Imaging||1|||f||||f||||||||||2017-10-11 03:25:37.339944|2017-10-11 03:25:37.339944
NCT01506414|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-04-18|||June 2009||2009-06-01|January 2012|2012-01-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)|A Multicentre Investigation of Recombinant Human Thrombopoietin (Rh-TPO) Combine With Low-dose Rituximab in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)|Completed||Phase 3|91|Actual|Shandong University||1|||f||||t||||||||||2017-10-11 03:25:37.436414|2017-10-11 03:25:37.436414
NCT01506401|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-08-05|||June 2009||2009-06-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|OSCILLATE||The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial|The Oscillation for ARDS Treated Early (OSCILLATE) Trial|Terminated||Phase 3|548|Actual|Canadian Critical Care Trials Group||2||Enrolment halted by Steering Committee on advice from Data Monitoring Committee.|f||||t||||||||||2017-10-11 03:25:37.577252|2017-10-11 03:25:37.577252
NCT01506388|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-01-19|||February 2012||2012-02-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||A Novel Protocol for Labour Induction|Foley Catheter Plus Vaginal Isosorbide Mononitrate Versus Vaginal Misoprostol for Induction of Labour:a Randomised Controlled Trial|Completed||Phase 3|400|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 03:25:37.815107|2017-10-11 03:25:37.815107
NCT01506375|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2014-05-23|||November 2011||2011-11-01|August 2012|2012-08-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant|Safety, Clinical Tolerability and Immunogenicity of gpASIT+TM Administered Subcutaneously to Hay Fever Patients Either Alone or in Presence of DnaK Immunoregulating Adjuvant|Completed||Phase 2|24|Actual|BioTech Tools S.A.||2|||f||||f||||||||||2017-10-11 03:25:37.972944|2017-10-11 03:25:37.972944
NCT01506362|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-07-01|2014-03-31||March 2012||2012-03-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis|An Open-Label Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis|Completed||Phase 2|22|Actual|BioLineRx, Ltd.||1|||f||||f||||||||||2017-10-11 03:25:38.073944|2017-10-11 03:25:38.073944
NCT01506349|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-03-23|||June 2015||2015-06-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Assessing Neurocognitive Effects of Gluten Exposure|An Assessment of Neurocognitive Symptoms After Gluten Exposure in Adult Patients With Celiac Disease - a Pilot Study|Recruiting||N/A|60|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 03:25:38.271695|2017-10-11 03:25:38.271695
NCT01506336|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-09-25|||October 2008||2008-10-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|September 2011|Actual|2011-09-01||Interventional|||A Phase 2 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib|A Prospective, Multicenter, Randomized, Open-label, Active Controlled, 2-parallel Group, Phase II Study to Compare Efficacy and Safety of Masitinib at 12 mg/kg/Day to Sunitinib at 50 mg/Day in Treatment of Patients With Gastro-intestinal Stromal Tumor Resistant to Imatinib|Unknown status|Active, not recruiting|Phase 2|44|Actual|AB Science||2|||f||||t||||||||||2017-10-11 03:25:38.399268|2017-10-11 03:25:38.399268
NCT01506323|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2015-08-26|2015-07-08||January 2012||2012-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|March 2014|Actual|2014-03-01||Interventional|||Mantram Repetition Meditation for Veterans With PTSD|Portable Mantram Meditation for Veterans With Military Related PTSD|Completed||Phase 3|181|Actual|VA Office of Research and Development|"Study was to provide interventions for both conditions (MRP and PCT) in group format. Due to poor recruitment and after approval from Data Monitoring Committee, the study protocol was changed to provide both interventions in individual format."|2|||f||||t||||||||||2017-10-11 03:25:38.536686|2017-10-11 03:25:38.536686
NCT01506310|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2013-01-22|||July 2009||2009-07-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy of Behavioral Therapy and Exercise in Gestational Diabetes Mellitus (GDM)|Randomized Comparative Trial on the Efficacy of Behavioral Therapy, Exercise and Their Combination in Gestational Diabetes Mellitus (GDM).|Completed||Phase 3|200|Actual|University of Turin, Italy||4|||f||||f||||||||||2017-10-11 03:25:39.40971|2017-10-11 03:25:39.40971
NCT01506297|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-09-20|||July 2012|Actual|2012-07-01|September 2017|2017-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Biologic Assessment of Satiety|Biologic Assessment of Satiety|Completed||N/A|31|Actual|USDA Grand Forks Human Nutrition Research Center|||1||f||||t||||||Samples Without DNA|"     blood samples   "|||2017-10-11 03:25:39.504756|2017-10-11 03:25:39.504756
NCT01506284|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-12-08|||November 2011||2011-11-01|January 2012|2012-01-01|November 2012|Actual|2012-11-01|March 2012|Actual|2012-03-01||Observational|||Assessment of Airways Mechanical Properties by FOT and LIR During Anesthesia|Assessment of Airways Mechanical Properties by Forced Oscillatory Technique (FOT) and Laser Interferometry (LIR) During Anesthesia.|Completed||N/A|14|Actual|Uppsala University Hospital|||1||f||||f||||||||||2017-10-11 03:25:39.559815|2017-10-11 03:25:39.559815
NCT01506271|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2016-11-03|||June 2012||2012-06-01|November 2016|2016-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)|A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Intra-Abdominal Infection [cIAI]|Completed||Phase 2|351|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 03:25:39.640272|2017-10-11 03:25:39.640272
NCT01506258|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-18|||January 2012||2012-01-01|January 2012|2012-01-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Interventional|||Autologous Stem Cells in Newborns With Oxygen Deprivation|Effects of the Infusion of Autologous Non-cryopreserved CD34+ Cells in Newborns With Asphyxia|Unknown status|Recruiting|N/A|20|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||t||||||||||2017-10-11 03:25:39.789213|2017-10-11 03:25:39.789213
NCT01506245|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-31|2012-01-04|||January 2011||2011-01-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Exercise and Behavioral Therapy in Obese Children|Exercise Training and Family-based Behavioural Treatment in Pre-pubertal Obese Children and Their Mother|Unknown status|Enrolling by invitation|N/A|75|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 03:25:39.974785|2017-10-11 03:25:39.974785
NCT01506232|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2013-10-24|||March 2011||2011-03-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study|Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study|Terminated||N/A|1|Actual|Massachusetts General Hospital|||4|Due to slow enrollment and lack of funding the study was terminated prior to completion.|f||||f||||||||||2017-10-11 03:25:40.098418|2017-10-11 03:25:40.098418
NCT01506206|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-01-13|||February 2012||2012-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||ON/OFF Stimulation and Impulsivity in Patients With Deep Brain Stimulators|ON/OFF Stimulation and Impulsivity in Patients With Deep Brain Stimulators|Recruiting||N/A|60|Anticipated|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-11 03:25:40.269439|2017-10-11 03:25:40.269439
NCT01506193|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-06-01|2016-11-08|2014-05-29|February 6, 2012|Actual|2012-02-06|June 2017|2017-06-01|March 31, 2014|Actual|2014-03-31|February 17, 2014|Actual|2014-02-17||Interventional|||Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children|Immunogenicity and Safety Study of GlaxoSmithKline Biological's Live Attenuated Measles Mumps Rubella Varicella Vaccine (PriorixTetra™) When Co-administered With Conjugated Meningococcal C Vaccine (Meningitec®, Nuron Biotechs' Vaccine) in Healthy Children|Completed||Phase 3|716|Actual|GlaxoSmithKline||3|||f|||||f|f||||||||2017-10-11 03:25:40.378856|2017-10-11 03:25:40.378856
NCT01506180|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-01-06|||January 2010||2010-01-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||In-Hospital Comprehensive Geriatric Assessment in Aged Acute Medical Patients||Completed||N/A|3877|Actual|University of Aarhus|||2||f||||f||||||||||2017-10-11 03:25:41.414785|2017-10-11 03:25:41.414785
NCT01506167|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2017-06-12|||July 6, 2012|Actual|2012-07-06|November 2016|2016-11-01|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Observational|||An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)|An Observational Study of Avastin® (Bevacizumab) in Combination With Chemotherapy for Treatment of First-line Metastatic Colorectal Adenocarcinoma|Completed||N/A|719|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:25:41.495659|2017-10-11 03:25:41.495659
NCT01506154|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-10-24|||December 2011||2011-12-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder|A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Topical Patch in the Treatment of Pain Due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of Shoulder|Completed||Phase 3|210|Actual|MEDRx USA, Inc.||2|||f||||f||||||||||2017-10-11 03:25:41.661235|2017-10-11 03:25:41.661235
NCT01506141|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-02-14|||August 2010||2010-08-01|February 2017|2017-02-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Extension of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase (IT)in Conjunction With Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment|An Open Label Extension of Study HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase® in Pediatric Patients With Hunter Syndrome and Cognitive Impairment|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Shire||1|||f||||f||||||||||2017-10-11 03:25:41.806288|2017-10-11 03:25:41.806288
NCT01506128|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-03-04|||January 2012||2012-01-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Human Papillomavirus in Menstrual Blood|Exploration of Optimal Experimental Settings to Detect Human Papillomavirus From Menstrual Blood in Women With High-grade Squamous Intraepithelial Lesion or High-risk Human Papillomavirus Infection|Completed||N/A|19|Actual|Seoul National University Hospital|||1||f||||f||||||Samples With DNA|"     Menstrual blood in pad   "|||2017-10-11 03:25:41.898811|2017-10-11 03:25:41.898811
NCT01506115|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2015-11-17|||September 2009||2009-09-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma|Observational Study for Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma|Completed||N/A|11|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-10-11 03:25:41.964512|2017-10-11 03:25:41.964512
NCT01506102|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-06|||November 2011||2011-11-01|January 2012|2012-01-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Thromboelastography During and After Delivery|Determination of Thromboelastography Values in Pregnancy and After Delivery|Unknown status|Recruiting|N/A|120|Anticipated|Città di Roma Hospital||1|||f||||f||||||||||2017-10-11 03:25:42.054584|2017-10-11 03:25:42.054584
NCT01506089|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-03-25|||January 2012||2012-01-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Optimizing the Temperature for Embryo Culture in In Vitro Fertilization|Optimizing the Temperature for Embryo Culture in In Vitro Fertilization: A Randomized Controlled Trial|Completed||N/A|55|Actual|Reproductive Medicine Associates of New Jersey||2|||f||||f||||||||||2017-10-11 03:25:42.123345|2017-10-11 03:25:42.123345
NCT01506076|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-06|||December 2007||2007-12-01|January 2012|2012-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Oral Dose, Crossover, Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg With XYZAL® Tablets 5 mg in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|29|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:25:42.200024|2017-10-11 03:25:42.200024
NCT01506063|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-10|||January 2008||2008-01-01|January 2012|2012-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Oral Dose, Crossover, Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg With XYZAL® Tablets 5 mg in Healthy Subjects Under Fed Conditions|Completed||Phase 1|31|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:25:42.268025|2017-10-11 03:25:42.268025
NCT01506050|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-06|||January 2006||2006-01-01|May 2006|2006-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition|Randomized, Single Dose, 2-Way Crossover, Relative Bioavailability Study of Desloratadine Orally Disintegrating Tablet Fasting Conditions|Completed||Phase 1|35|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:25:42.357845|2017-10-11 03:25:42.357845
NCT01506037|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-10|||January 2006||2006-01-01|May 2006|2006-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition|Randomized, Single Dose, 2-Way Crossover, Relative Bioavailability Study of Desloratadine Orally Disintegrating Tablet Fed Conditions|Completed||Phase 1|36|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:25:42.437721|2017-10-11 03:25:42.437721
NCT01506024|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-01-25|||September 2011||2011-09-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|April 2014|Actual|2014-04-01||Interventional|||Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Short- and Long Term Results|Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Short- and Long Term Results|Completed||N/A|60|Actual|Norwegian University of Science and Technology||3|||f||||f|f|f||||||Undecided||2017-10-11 03:25:42.522925|2017-10-11 03:25:42.522925
NCT01506011|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-05|||March 2007||2007-03-01|January 2012|2012-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions|An Open-label Randomized, Single Dose, Two Way Crossover Oral Bioequivalence Study of Amlodipine Besylate/Benazepril HCl Capsules of Dr. Reddy's With Lotrel® Capsules of Novartis in Human Subjects Under Fasting Conditions.|Completed||Phase 1|50|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:25:42.630604|2017-10-11 03:25:42.630604
NCT01505998|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-06|||March 2007||2007-03-01|January 2012|2012-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions|An Open-label Randomized, Single Dose, Two Way Crossover Oral Bioequivalence Study of Amlodipine Besylate/Benazepril HCl Capsules of Dr. Reddy's With Lotrel® Capsules of Novartis in Human Subjects Under Fed Conditions|Completed||Phase 1|49|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:25:42.757078|2017-10-11 03:25:42.757078
NCT01505985|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2013-11-22|||January 2012||2012-01-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|HIATUS||Hip Fracture Surgery and Oral Nutritional Supplements|Effect of a Nutritional Intervention on Hip Fracture Surgery Recovery|Terminated||Phase 3|24|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 03:25:42.840655|2017-10-11 03:25:42.840655
NCT01505959|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2014-09-04|||February 2013||2013-02-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study|Blood Pressure Reduction Induced by Continuous Positive Airway Pressure (CPAP) in Sleep Apnea Patients at High Cardiovascular Risk : A Randomized Controlled Trial Comparing Usual CPAP Care Versus a Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform|Unknown status|Recruiting|Phase 4|936|Anticipated|Fédération Française de Pneumologie||2|||f||||t||||||||||2017-10-11 03:25:43.011289|2017-10-11 03:25:43.011289
NCT01505946|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2013-06-14|||March 2012||2012-03-01|June 2013|2013-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|PredicTGA||Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors|Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic Effectiveness of Factor VIII (FVIII) Concentrates in Patients Affected by Inherited Haemophilia A With FVIII Inhibitors High and Low Anamnestic Response.|Unknown status|Recruiting|N/A|25|Anticipated|Grifols Italia S.p.A|||2||f||||t||||||Samples Without DNA|"     plasma samples   "|||2017-10-11 03:25:43.22603|2017-10-11 03:25:43.22603
NCT01505933|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-02-14|||February 2012|Actual|2012-02-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Airway Dimension Study in Children Undergoing MRI Sedated With Propofol and Dexmedetomidine|Comparison of Changes in Upper Airway Dimensions With Dexmedetomidine and Propofol in Children Undergoing MRI|Recruiting||N/A|40|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||No||2017-10-11 03:25:43.377877|2017-10-11 03:25:43.377877
NCT01505920|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2013-01-13|||September 2011||2011-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial|Lidocaine Spray Compared With Submucosal Injection in Reducing Pain During Loop Electrosurgical Excision Procedure: a Randomized Controlled Trial|Completed||Phase 3|101|Actual|Chiang Mai University||2|||f||||f||||||||||2017-10-11 03:25:45.105336|2017-10-11 03:25:45.105336
NCT01505907|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2012-01-06|||December 2012||2012-12-01|January 2012|2012-01-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Pharmacokinetic Study of CXB909 in Healthy Male Subjects|Phase I, Randomized, Double-Blind, Placebo Controlled, Dose Escalation,Single Dose, Safety, Tolerance, and Pharmacokinetic Study of CXB909 in Healthy Male Volunteers|Unknown status|Not yet recruiting|Phase 1/Phase 2|40|Anticipated|CeNeRx BioPharma Inc.||5|||f||||t||||||||||2017-10-11 03:25:45.181257|2017-10-11 03:25:45.181257
NCT01505894|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2013-10-31|||January 2012||2012-01-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses|Safety, Tolerability Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 409306 Film-coated Tablets Given Orally q.d. or Bid for 14 Days in Young Healthy and Elderly Healthy Male/Female Volunteers (Randomised, Double-blind, Placebo Controlled Within Dose Groups Phase I Study)|Completed||Phase 1|83|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 03:25:45.250956|2017-10-11 03:25:45.250956
NCT01505881|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-05|2014-07-10|2014-06-06||December 2011||2011-12-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Treated set (TRT): The TRT comprised all patients who were documented to have taken at least 1 dose of study drug|Follow on Study From RE-ALIGN|Evaluation of the Long Term Safety of the Use of Dabigatran Etexilate in Patients With a Bileaflet Mechanical Heart Valve|Terminated||Phase 2|158|Actual|Boehringer Ingelheim|This study was terminated prematurely due to safety concerns arising during conduct of the trial.|2|||f||||||||||||||2017-10-11 03:25:45.354499|2017-10-11 03:25:45.354499
NCT01505868|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-05-19|||July 2012|Actual|2012-07-01|May 2017|2017-05-01|July 2029|Anticipated|2029-07-01|July 2029|Anticipated|2029-07-01||Interventional|||Study of Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer|An Open Label Phase I/II Study of Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|178|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 03:25:45.794865|2017-10-11 03:25:45.794865
NCT01505855|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-10-14|||December 2011||2011-12-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy Study of Pneumococcal Vaccination in Crohn's Disease|Serological Response to Pneumococcal Vaccination in Crohn's Disease: A Prospective Multicenter Study|Completed||Phase 4|197|Actual|Kyunghee University Medical Center||4|||f||||t||||||||||2017-10-11 03:25:46.024998|2017-10-11 03:25:46.024998
NCT01505842|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2015-08-05|||February 2011||2011-02-01|August 2015|2015-08-01|February 2017|Anticipated|2017-02-01|June 2016|Anticipated|2016-06-01||Interventional|||Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease|Randomized Controlled Trial (RCT) to Compare Dysplasia Detection Rate in Colonoscopy Without Chromoendoscopy Versus Colonoscopy With Chromoendoscopy in Detecting Dysplasia in Ulcerative Colitis and Crohn's Colitis Patients.|Unknown status|Recruiting|N/A|300|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 03:25:46.185124|2017-10-11 03:25:46.185124
NCT01505829|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-09-14|||August 2012|Actual|2012-08-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2016|Actual|2016-12-01||Observational|DISCOVAR||Diffusion-weighted Imaging Study in Cancer of the Ovary|Assessing Treatment Response of Peritoneal Metastases in Ovarian Cancer Using Diffusion Weighted Magnetic Resonance Imaging.|Active, not recruiting||N/A|134|Actual|Institute of Cancer Research, United Kingdom|||2||f||||f||||||Samples With DNA|"     Tumour samples taken at surgery for histological analysis   "|||2017-10-11 03:25:46.301585|2017-10-11 03:25:46.301585
NCT01505816|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-06|||October 2011||2011-10-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Visual Outcomes After Implantation of a New Multifocal Intraocular Lens|Visual Outcomes After Implantation of a New Refractive Toric Multifocal Intraocular Lens|Completed||Phase 4|40|Actual|Hospital Oftalmologico de Brasilia||1|||f||||t||||||||||2017-10-11 03:25:46.400238|2017-10-11 03:25:46.400238
NCT01505803|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-01-05|||July 2010||2010-07-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot Study|The Effect of a Nutritional Supplement on Cardiometabolic, Inflammatory, and Oxidative Stress Markers in Individuals With Type 2 Diabetes Mellitus: a Pilot Study|Completed||Phase 1|48|Actual|University of Sydney||4|||f||||f||||||||||2017-10-11 03:25:46.490216|2017-10-11 03:25:46.490216
NCT01505790|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2012-05-22|||July 2011||2011-07-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention|Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention|Completed||Phase 3|187|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-10-11 03:25:46.611111|2017-10-11 03:25:46.611111
NCT01505777|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-04-04|||May 2011||2011-05-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea|Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea: Double Blinded, Randomized, Placebo Drug Controlled, Parallel Designed, Multi-centered, Phase 2 Study|Completed||Phase 2|280|Anticipated|Hanmi Pharmaceutical Company Limited||5|||f||||f||||||||||2017-10-11 03:25:46.712013|2017-10-11 03:25:46.712013
NCT01505764|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2017-01-05|2017-01-05||June 2012||2012-06-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||The Role of Ghrelin in Cancer Cachexia|The Role of Ghrelin in Cancer Cachexia|Terminated||Phase 2|10|Actual|VA Office of Research and Development||2||poor recruitment|f||||f||||||||No||2017-10-11 03:25:46.826968|2017-10-11 03:25:46.826968
NCT01505751|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2016-09-04|||February 2012||2012-02-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||The Association of G9a Protein and the Outcome of Patients With Cervical Cancer||Completed||N/A|69|Actual|Far Eastern Memorial Hospital|||1||f||||||||||Samples With DNA|"     Residual pathology block after pathological exam   "|||2017-10-11 03:25:47.225892|2017-10-11 03:25:47.225892
NCT01505738|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-12-13|||January 2012||2012-01-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Observational|||Bacterial Growth in Vascular Surgery Wounds|The Effect of Bacterial Growth in Vascular Surgery Wounds to the Incidence of Postoperative Wound Infections|Completed||N/A|100|Actual|North Karelia Central Hospital|||1||f||||f||||||||||2017-10-11 03:25:47.28983|2017-10-11 03:25:47.28983
NCT01505725|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-10-05|||March 16, 2010||2010-03-16|November 29, 2013|2013-11-29|November 29, 2013||2013-11-29|||||Observational|||Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms|Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms|Completed||N/A|230|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:25:47.376976|2017-10-11 03:25:47.376976
NCT01505712|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-05-17|||December 15, 2011|Actual|2011-12-15|May 2017|2017-05-01|November 19, 2012|Actual|2012-11-19|November 19, 2012|Actual|2012-11-19||Observational|||Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial|Outcome Prediction in Hodgkin Lymphoma by Low-Density Gene Expression Profiling of Formalin Fixed Paraffin Embedded Tissues: A Correlative Study of Inter-Group Trial E2496|Completed||N/A|393|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 03:25:47.464421|2017-10-11 03:25:47.464421
NCT01505699|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-05-16|||January 6, 2012|Actual|2012-01-06|May 2017|2017-05-01|February 6, 2012|Actual|2012-02-06|February 6, 2012|Actual|2012-02-06||Observational|||Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia|Micro RNA Expression Analysis in B-Lineage Adult Acute Lymphoblastic Leukemia From ALL Trial, E2993, Including Patients With Various Cytogenetic and Molecular Abnormalities|Completed||N/A|186|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 03:25:47.535383|2017-10-11 03:25:47.535383
NCT01505686|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-06-25|||May 2012||2012-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||MRI Findings in Inguinal Hernia|MRI Findings in Inguinal Hernia|Completed||N/A|22|Actual|North Karelia Central Hospital||1|||f||||f||||||||||2017-10-11 03:25:47.623475|2017-10-11 03:25:47.623475
NCT01505660|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-04-11|||January 2012||2012-01-01|April 2015|2015-04-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Randomized Controlled Trial Using Patient Reported Outcomes and Care Managers to Improve HIV Medication Adherence in Routine Clinical Care|Randomized Controlled Trial Using Patient Reported Outcomes and Care Managers to Improve HIV Medication Adherence in Routine Clinical Care|Unknown status|Active, not recruiting|N/A|270|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-11 03:25:47.811424|2017-10-11 03:25:47.811424
NCT01505647|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-03-14|2013-04-10||April 2012||2012-04-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|||Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)|A Phase III Double-Blinded, Randomized, Multicenter, Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX™ Made With an Alternative Manufacturing Process (AMP)|Completed||Phase 3|498|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:25:47.922444|2017-10-11 03:25:47.922444
NCT01505634|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-08-10|||May 16, 2012|Actual|2012-05-16|August 2017|2017-08-01|July 28, 2015|Actual|2015-07-28|July 28, 2015|Actual|2015-07-28||Interventional|||Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)|A Phase II, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone in Patients With Complicated Urinary Tract Infection (cUTI)|Completed||Phase 2|302|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 03:25:48.483723|2017-10-11 03:25:48.483723
NCT01505426|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-01-19|||November 2011||2011-11-01|January 2016|2016-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients|A Phase III, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone|Completed||Phase 3|171|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 03:25:51.980662|2017-10-11 03:25:51.980662
NCT01505621|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-04-09|||December 2011||2011-12-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Novel Methodology to Measure Protein Accumulation|Novel Methodology to Measure Protein Accumulation|Completed||N/A|24|Actual|Mayo Clinic|||2||f||||t||||||Samples With DNA|"     On day one of the study (day of the study drink administration): blood samples and skeletal     muscle biopsy (vastus lateralis). Muscle biopsy tissue will be frozen subsequent to     collection.      Week 2 and 3 of the study: blood sample collection Week 4 of the study: blood sample and     skeletal muscle (vastus lateralis) biopsy. Muscle biopsy tissue will be frozen subsequent to     collection.   "|||2017-10-11 03:25:48.610823|2017-10-11 03:25:48.610823
NCT01505608|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-09-09|2016-05-10||December 2011||2011-12-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma|A Randomized, Phase I/II Trial of Irinotecan and Temozolomide Compared to Irinotecan and Temozolomide in Combination With TPI 287 in Patients With Primary Refractory or Early Relapsed Neuroblastoma|Terminated||Phase 1/Phase 2|14|Actual|Spectrum Health Hospitals||2||Lack of Enrollment|f||||t||||||||||2017-10-11 03:25:48.712094|2017-10-11 03:25:48.712094
NCT01505595|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-12-04|||January 2012||2012-01-01|January 2012|2012-01-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Interventional|||Proprioceptive Training and Low Back Pain||Unknown status|Recruiting|N/A|40|Anticipated|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 03:25:49.276082|2017-10-11 03:25:49.276082
NCT01505582|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-12-10|||January 2012||2012-01-01|January 2012|2012-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Inspiratory Muscle Training and Low Back Pain||Completed||N/A|28|Anticipated|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 03:25:49.404909|2017-10-11 03:25:49.404909
NCT01505569|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-10-04|||October 20, 2011|Actual|2011-10-20|September 2017|2017-09-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Auto Transplant for High Risk or Relapsed Solid or CNS Tumors|Alkylator-Intense Conditioning Followed by Autologous Transplantation for Patients With High Risk or Relapsed Solid or CNS Tumors|Recruiting||N/A|20|Anticipated|Masonic Cancer Center, University of Minnesota||3|||f||||f|f|f||||||||2017-10-11 03:25:49.538277|2017-10-11 03:25:49.538277
NCT01505556|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-12-04|||January 2014||2014-01-01|January 2012|2012-01-01|January 2015|Anticipated|2015-01-01|December 2014|Anticipated|2014-12-01||Observational|||Proprioceptive Postural Control and Diaphragm Paresis||Unknown status|Not yet recruiting|N/A|20|Anticipated|Katholieke Universiteit Leuven|||2||f||||t||||||||||2017-10-11 03:25:49.765383|2017-10-11 03:25:49.765383
NCT01505543|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-12-04|||January 2012||2012-01-01|July 2012|2012-07-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Observational|||Proprioceptive Postural Control and Chronic Obstructive Pulmonary Disease (COPD)||Completed||N/A|40|Anticipated|Katholieke Universiteit Leuven|||2||f||||t||||||||||2017-10-11 03:25:49.899444|2017-10-11 03:25:49.899444
NCT01505530|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-02-10||2015-01-16|December 2011||2011-12-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|October 2014|Actual|2014-10-01||Interventional|||A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer|A Randomized Phase 2 Placebo-Controlled Study of LY2495655 in Patients With Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy|Completed||Phase 2|125|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:25:50.058735|2017-10-11 03:25:50.058735
NCT01505517|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-12-04|||January 2011||2011-01-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Observational|||Inspiratory Resistive Loading and Diaphragm Fatigue|Inspiratory Resistive Loading and Diaphragm Fatigue in Healthy Individuals and Individuals With Recurrent Low Back Pain|Completed||N/A|20|Actual|Katholieke Universiteit Leuven|||2||f||||t||||||||||2017-10-11 03:25:50.947278|2017-10-11 03:25:50.947278
NCT01505504|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-05|||January 2004||2004-01-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Observational|||Mirtazapine in Alzheimer-associated Weight Loss|Mirtazapine in Alzheimer-associated Weight Loss: a Retrospective Phase IV Study|Completed||N/A|22|Actual|Brugmann University Hospital|||1||f||||f||||||||||2017-10-11 03:25:51.050476|2017-10-11 03:25:51.050476
NCT01505491|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-12-12|||December 2011||2011-12-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Pharmacokinetics and Safety Study of BI 695501 in Healthy Subjects|Pharmacokinetics and Safety of BI 695501 in Healthy Subjects: a Randomized, Open-label, Single Dose, Parallel Arm, Active Comparator Clinical Phase I Study|Completed||Phase 1|193|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:25:51.168161|2017-10-11 03:25:51.168161
NCT01505478|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-04-04|||July 2012||2012-07-01|January 2012|2012-01-01||||||||Observational|||Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule|Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-11 03:25:51.277481|2017-10-11 03:25:51.277481
NCT01505465|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-07-28|2017-03-23||February 2012||2012-02-01|March 2017|2017-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study of Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery|Effects of Perioperative Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery|Completed||N/A|50|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-11 03:25:51.381483|2017-10-11 03:25:51.381483
NCT01505452|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-05-05|||November 2011||2011-11-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Study of Surgical Technique With Use of Single-radius Prosthesis in Total Knee Replacement|Translational Error in Flexion-extension Gap Balancing With Singe Radius Total Knee Arthroplasty|Completed||N/A|43|Actual|Athens Orthopedic Clinic, P.A.|||1||f||||f||||||||||2017-10-11 03:25:51.785599|2017-10-11 03:25:51.785599
NCT01505439|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-06-13|||June 2011||2011-06-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence|A Prospective, Open Label, Single Arm, Multicenter Study to Estimate the Efficacy and Safety of Solifenacin in Female With Clinically Significant Stress Urinary Incontinence and Urgency Urinary Incontinence|Completed||Phase 4|311|Actual|Korea University Anam Hospital||1|||f||||f||||||||||2017-10-11 03:25:51.850712|2017-10-11 03:25:51.850712
NCT01505413|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-04-02|||January 2011||2011-01-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|GEMOX-T||Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer|Phase 2 Study of GEMOX-T in Previously Untreated Patients With Advanced Pancreatic Cancer|Completed||Phase 2|33|Actual|Soonchunhyang University Hospital||1|||f||||t||||||||||2017-10-11 03:25:52.299917|2017-10-11 03:25:52.299917
NCT01505400|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-08-19|||February 2012||2012-02-01|August 2016|2016-08-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|IMPACT||Integrated Molecular Profiling in Advanced Cancers Trial|Integrated Molecular Profiling in Advanced Cancers Trial|Active, not recruiting||N/A|3026|Actual|University Health Network, Toronto|||1||f||||f||||||Samples With DNA|"     Archival tumor tissue      1 tube of whole blood   "|||2017-10-11 03:25:52.431469|2017-10-11 03:25:52.431469
NCT01505387|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-05-13|2015-03-24||January 2012||2012-01-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Litramine in Weight Maintenance|Double-blind, Randomized, Placebo-controlled Clinical Investigation to Evaluate the Safety and Efficacy of Litramine in Maintaining Body Weight Loss in Overweight and Obese Subjects|Completed||Phase 4|50|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-11 03:25:52.537374|2017-10-11 03:25:52.537374
NCT01505374|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-03-21|2014-02-25||March 2012||2012-03-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty|Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty: A Comparative Effectiveness Study in Bilateral Total Knee Arthroplasty Patients|Completed||N/A|60|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 03:25:52.839467|2017-10-11 03:25:52.839467
NCT01505348|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-04|||July 2007||2007-07-01|January 2012|2012-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Fasting Versus Feeding on the Bone Metabolic Response to Running|Effect of Fasting Versus Feeding on the Bone Metabolic Response to Running|Completed||N/A|10|Actual|QinetiQ Ltd||2|||f||||f||||||||||2017-10-11 03:25:53.297899|2017-10-11 03:25:53.297899
NCT01505322|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-05|||August 2010||2010-08-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Observational|||Persistent Pain to Impair Daily Activities Following Thoracic Surgery|Persistent Pain to Impair Daily Activities Following Thoracic Surgery|Completed||N/A|396|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 03:25:53.507084|2017-10-11 03:25:53.507084
NCT01505309|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-12-30|||January 2008||2008-01-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Endovascular Aortic Repair for Aortic Dissection|Endovascular Aortic Repair for Aortic Dissection------XiJing Registry|Recruiting||N/A|500|Anticipated|Xijing Hospital||1|||f||||t||||||||||2017-10-11 03:25:53.593766|2017-10-11 03:25:53.593766
NCT01505296|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2014-12-13|||December 2011||2011-12-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CABAL||Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation|Randomized Comparison of Catheter Ablation Versus Anti-arrhythmic Drug Therapy in Patients With Recently Diagnosed Paroxysmal Atrial Fibrillation as Assessed by a Continuous Implantable Monitor|Withdrawn||Phase 4|0|Actual|Valley Health System||2||Never initiated|f||||f||||||||||2017-10-11 03:25:53.732318|2017-10-11 03:25:53.732318
NCT01505283|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2016-11-02|||December 2011||2011-12-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|APD-ANI||Effect of Epidural Analgesia on the Parameter ANI During Childbirth|Effect of Epidural Analgesia on the Parameter ANI During Childbirth|Terminated||N/A|42|Actual|Hopital Foch||3||recruitment difficulties|f||||f||||||||||2017-10-11 03:25:53.839952|2017-10-11 03:25:53.839952
NCT01505270|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-05|||March 2012||2012-03-01|January 2012|2012-01-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||The Prevalence of Psychological and Medical Comorbidities Among Children Suffering From Autistic Spectrum Disorder and the Differences Between Ethnic Groups in Israel||Unknown status|Not yet recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 03:25:53.945537|2017-10-11 03:25:53.945537
NCT01505257|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-10-28|||April 2010||2010-04-01|October 2014|2014-10-01|February 2015|Anticipated|2015-02-01|February 2014|Actual|2014-02-01||Interventional|END-DSD||Early Nurse Detection and Management of Delirium|Early Nurse Detection of Delirium Superimposed on Dementia|Unknown status|Active, not recruiting|N/A|390|Anticipated|Penn State University||2|||f||||t||||||||||2017-10-11 03:25:54.014832|2017-10-11 03:25:54.014832
NCT01505244|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2014-12-01|||September 2011||2011-09-01|December 2014|2014-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Before-School Physical Activity Intervention in Elementary School Children|Before-School Physical Activity Intervention in Elementary School Children: A Pilot Study|Completed||N/A|39|Actual|University of Vermont||1|||f||||f||||||||||2017-10-11 03:25:54.116743|2017-10-11 03:25:54.116743
NCT01505231|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2013-02-11|||January 2012||2012-01-01|February 2013|2013-02-01|May 2013|Anticipated|2013-05-01|February 2013|Anticipated|2013-02-01||Interventional|VaNCS||Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac Surgery||Unknown status|Recruiting|Phase 3|300|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:25:54.197287|2017-10-11 03:25:54.197287
NCT01505218|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-12-01|||October 2010||2010-10-01|December 2015|2015-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PER-projekt||Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography|Patient-controlled Propofol Sedation for Endoscopic Retrograde Cholangiopancreatography|Completed||N/A|281|Actual|University Hospital, Linkoeping||3|||f||||f||||||||||2017-10-11 03:25:54.319241|2017-10-11 03:25:54.319241
NCT01505205|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-05|||April 2011||2011-04-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Observational|||Study on the Evolution of Genes Mutation Related With Gastrointestinal Stromal Tumors||Completed||N/A|60|Actual|Guangxi Medical University|||1||f||||t||||||||||2017-10-11 03:25:54.407928|2017-10-11 03:25:54.407928
NCT00005413|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1991||1991-09-01|March 2005|2005-03-01|September 1993|Actual|1993-09-01|||||Observational|||Stroke Risk in the NAS-NRC Twin Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.048243|2017-10-11 04:27:02.048243
NCT01505192|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2012-01-05|||December 2011||2011-12-01|January 2012|2012-01-01|May 2012|Anticipated|2012-05-01|March 2012|Anticipated|2012-03-01||Interventional|||Noninvasive Continuous Measurement of SpHb After Spontaneous Vaginal Delivery|Determination of the Physiological Reference Values of Trend of Hemoglobin in the Post-partum Period After Spontaneous Vaginal Delivery. A Sequential Pilot Study Using the Noninvasive Continuous Technology of SpHb|Unknown status|Recruiting|N/A|120|Anticipated|Città di Roma Hospital||1|||f||||f||||||||||2017-10-11 03:25:54.468456|2017-10-11 03:25:54.468456
NCT01505179|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-01-11|||February 2011||2011-02-01|January 2013|2013-01-01||||December 2015|Anticipated|2015-12-01||Interventional|RAZE||The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction|The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction|Unknown status|Enrolling by invitation|N/A|40|Anticipated|University of California, San Diego||2|||f||||||||||||||2017-10-11 03:25:54.569923|2017-10-11 03:25:54.569923
NCT01505166|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-08-02|||March 2012||2012-03-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|FANG-CLM||Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver Metastases|Randomized Phase II Trial of Post-operative Adjuvant Chemotherapy ± FANG™ Autologous Tumor Cell Vaccine in Colorectal Carcinoma With Liver Metastases|Completed||Phase 2|60|Anticipated|Gradalis, Inc.||3|||f||||t||||||||||2017-10-11 03:25:54.668281|2017-10-11 03:25:54.668281
NCT01505153|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-04-24|||February 2012|Actual|2012-02-01|April 2017|2017-04-01|April 13, 2017|Actual|2017-04-13|March 2017|Actual|2017-03-01||Interventional|STMN1-LP||Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer|Phase I Trial of Intratumoral Bi-functional shRNA Stathmin 1-knockdown Lipoplex in Patients With Advanced and/or Metastatic Cancer|Completed||Phase 1|20|Actual|Strike Bio, Inc.||1|||f||||t||||||||||2017-10-11 03:25:54.766591|2017-10-11 03:25:54.766591
NCT01505140|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-31|2016-11-23|||November 2009||2009-11-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Benefits of Walnuts for Male Reproductive Health|Benefits of Walnuts for Male Reproductive Health|Completed||Phase 2|120|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 03:25:54.868637|2017-10-11 03:25:54.868637
NCT01505127|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2013-11-02|||January 2012||2012-01-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori|A Phase 3, Randomized, Double-Blind, Double Dummy, Multicenter, Parallel Group Comparison Study to Evaluate Efficacy and Safety of a Triple Therapy With TAK-438, Amoxicillin and Clarithromycin by Comparison With a Triple Therapy With AG-1749 (Lansoprazole), Amoxicillin and Clarithromycin for the First Line Eradication of H.Pylori|Completed||Phase 3|650|Actual|Takeda||2|||f||||f||||||||||2017-10-11 03:25:54.975379|2017-10-11 03:25:54.975379
NCT01505114|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-06-20|2017-05-16||June 2012||2012-06-01|June 2017|2017-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women|A Phase II Randomized, Double-Blind, Study of the Safety and Tolerability of Maraviroc (MVC), Maraviroc + Emtricitabine (MVC+FTC), Maraviroc + Tenofovir Disoproxil Fumarate (MVC+TDF), or Tenofovir Disoproxil Fumarate + Emtricitabine (TDF+FTC) For Pre-Exposure Prophylaxis (PrEP) To Prevent HIV Transmission in At-Risk Men Who Have Sex With Men and in At-Risk Women|Completed||Phase 2|594|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 03:25:55.281371|2017-10-11 03:25:55.281371
NCT01505101|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2014-08-04|||October 2011||2011-10-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy|Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy: Exploration of Cognitive, Affective, and Physiological Mechanisms|Completed||Phase 1|115|Actual|Florida State University||2|||f||||t||||||||||2017-10-11 03:25:58.697388|2017-10-11 03:25:58.697388
NCT01505088|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2013-03-28|||December 2011||2011-12-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis|A Prospective, Multi-Center, Randomized, Double-Masked, Positive-Controlled Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate Ophthalmic Suspension (1%) in Patients With Non-Infectious Anterior Segment Uveitis|Completed||Phase 3|193|Actual|Eyegate Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:25:58.810915|2017-10-11 03:25:58.810915
NCT01505075|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-04-26|||September 2011||2011-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2013|Actual|2013-01-01||Interventional|pHART8||Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer|Phase II Study of Dose-escalated, Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-Risk Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 03:25:58.99734|2017-10-11 03:25:58.99734
NCT01505062|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2017-03-15|||March 2012||2012-03-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B|A Phase I/IIa Dose Escalation Safety Study of Subretinally Injected UshStat®, Administered to Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B|Recruiting||Phase 1/Phase 2|18|Anticipated|Sanofi||5|||f||||t||||||||||2017-10-11 03:25:59.097823|2017-10-11 03:25:59.097823
NCT01505049|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-07-20|||January 2012||2012-01-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|IMAP-1||Immune Memory After Papillomavirus Vaccination|Immune Memory After Papillomavirus Vaccination (IMAP-I) Study . DMID 10-0014|Completed||N/A|203|Actual|Emory University|||3||f||||t||||||Samples With DNA|"     we will retain lymphocyte samples for testing immune function   "|||2017-10-11 03:25:59.207924|2017-10-11 03:25:59.207924
NCT01505036|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-02-05|||December 2010||2010-12-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|SMARTCARE_DM||Study to Evaluate the Effect of the Smart Care-diabetes Management System on Subjects With Diabetes|Randomized, Multi-center, Open-label, Parallel Group Study to Evaluate the Effect of the Smart Care-diabetes Management System on Subjects With Diabetes|Completed||N/A|554|Actual|SK Telecom Consortium||2|||f||||f||||||||||2017-10-11 03:25:59.31147|2017-10-11 03:25:59.31147
NCT01505023|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-04|||April 2006||2006-04-01|January 2012|2012-01-01|February 2007|Actual|2007-02-01|November 2006|Actual|2006-11-01||Interventional|||Partial Meal Replacement and Inulin in Obese Women|Evaluation of the Effectiveness of a Partial Meal Replacement With Inulin on Obesity and Dyslipidemias in Women.|Completed||Phase 2|179|Actual|Cindetec||4|||f||||f||||||||||2017-10-11 03:25:59.429483|2017-10-11 03:25:59.429483
NCT01504997|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2016-10-12|2016-04-18||December 2011||2011-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2012|Actual|2012-12-01||Interventional|RADGphaseII||Phase II Study for Robot Assisted Distal Gastrectomy|A Phase II Study of Robot Assisted Distal Gastrectomy With Nodal Dissection for Clinical Stage Ia Gastric Cancer|Active, not recruiting||Phase 2|23|Actual|Shizuoka Cancer Center||1|||f||||t||||||||||2017-10-11 03:25:59.670667|2017-10-11 03:25:59.670667
NCT01504984|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2012-06-10|||March 2012||2012-03-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers|An Open-label, Randomized, Single Dose, Crossover Phase I Clinical Trial to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab., 4T (400mg) in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Samyang Biopharmaceuticals Corporation||2|||f||||t||||||||||2017-10-11 03:25:59.873437|2017-10-11 03:25:59.873437
NCT01504971|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-08-04|2015-08-04||January 2011||2011-01-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|June 2012|Actual|2012-06-01||Observational|||Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux Disease|Diagnostic Value of Narrow-band Imaging, Autofluorescence Imaging & White-light Imaging on Gastroesophageal Reflux Disease|Unknown status|Active, not recruiting|N/A|95|Actual|Chinese PLA General Hospital|||1||f||||t||||||||||2017-10-11 03:26:00.104215|2017-10-11 03:26:00.104215
NCT01504958|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-06-05|2017-01-13||December 2010||2010-12-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Total number analyzed: 21 (1 enrolled was excluded from analysis) Real/Real: 10 Real/Sham: 5 Sham/Sham: 6|Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients|Effects of a Combined TMS and Cognitive Training in Alzheimer Patients: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study|Completed||N/A|22|Actual|Beth Israel Deaconess Medical Center||3|||f||||f||||||||||2017-10-11 03:26:00.36375|2017-10-11 03:26:00.36375
NCT01504945|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2017-03-10|||February 2010||2010-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)|Red Blood Cell Transfusion in Patients With Acute and Chronic Coronary Syndrome|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-11 03:26:00.90691|2017-10-11 03:26:00.90691
NCT01504932|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-10-04|||February 23, 2007|Actual|2007-02-23|October 2017|2017-10-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High-Risk Appalachian Patients Previously Treated With Surgery For Oral Cancer|Pilot Long-Term Oral Dose of Freeze-Dried Black Raspberries in Post-Surgical Appalachian Oral Cancer|Active, not recruiting||N/A|44|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 03:26:01.040715|2017-10-11 03:26:01.040715
NCT01504919|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-09-12|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Reducing Cancer Disparities Among Latinos in Texas|Reducing Cancer Disparities Among Latinos in Texas|Active, not recruiting||N/A|500|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 03:26:01.246226|2017-10-11 03:26:01.246226
NCT01504906|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-12-11|||January 2012||2012-01-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study to Assess Effect of Cyclosporine on the Blood Levels of Ticagrelor|A Single-Center,Open-Label,Randomized,3-Treatment,3-Period Cross-Over Study to Investigate the Potential Effect of Cyclosporine on the Pharmacokinetics, Safety, and Tolerability of Ticagrelor and the Effect of Ticagrelor on the Pharmacokinetics, Safety, and Tolerability of Cyclosporine|Completed||Phase 1|20|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 03:26:01.416831|2017-10-11 03:26:01.416831
NCT01504893|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-01-29|||September 2013||2013-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Protective Versus Conventional Ventilation During Thoracic Surgery|Multicenter Randomized Trial on Protective Ventilation Versus Conventional Ventilation During OLV in Patients Undergoing Thoracic Surgery|Recruiting||N/A|2000|Anticipated|Azienda Ospedaliera S. Maria della Misericordia||2|||f||||t||||||||||2017-10-11 03:26:01.507445|2017-10-11 03:26:01.507445
NCT01504880|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-02-17|||June 2010||2010-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Atrioventricular Valve Regurgitation Vena Contracta; Echo Versus MRI|Evaluation of Mitral and Tricuspid Regurgitation: Cardiovascular Magnetic Resonance Imaging Versus Echocardiographic Doppler Color Flow Mapping of the Vena Contracta|Active, not recruiting||N/A|3|Actual|Medical College of Wisconsin|||1||f||||f|f|f||||||Yes||2017-10-11 03:26:01.616064|2017-10-11 03:26:01.616064
NCT01504867|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-01-23|2016-08-17||January 2012|Actual|2012-01-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||400 subjects were randomized, and 10 subjects were excluded, leaving 390 in the final modified intention-to-treat analysis cohort.|LIPS-A: Lung Injury Prevention Study With Aspirin|LIPS-A: Lung Injury Prevention Study With Aspirin|Completed||Phase 2|400|Actual|Mayo Clinic||2|||f||||t||||||||Undecided||2017-10-11 03:26:01.707819|2017-10-11 03:26:01.707819
NCT01504854|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-05-06|2016-01-28||May 2012||2012-05-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Resveratrol for Alzheimer's Disease|Phase II Study to Evaluate the Impact on Biomarkers of Resveratrol Treatment in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|119|Actual|Alzheimer's Disease Cooperative Study (ADCS)|This phase 2 study has limitations. A larger study is required to determine whether resveratrol may be beneficial. More potent and bioavailable SIRT1 activators are also in development.|2|||f||||t||||||||||2017-10-11 03:26:02.357975|2017-10-11 03:26:02.357975
NCT01504841|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-09-12|||March 2012||2012-03-01|September 2017|2017-09-01|October 31, 2020|Anticipated|2020-10-31|April 30, 2018|Anticipated|2018-04-30||Interventional|||Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children|A Phase I/II, Open-Label Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine (ETR) in Antiretroviral (ARV) Treatment-Experienced HIV-1 Infected Infants and Children, Aged ≥ 2 Months to < 6 Years|Recruiting||Phase 1/Phase 2|50|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 03:26:03.111409|2017-10-11 03:26:03.111409
NCT01504828|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-03-29|||July 2012||2012-07-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Cardiac Energetics and Function in Normal Human Ageing|Cardiac Energetics and Function in Normal Human Ageing|Completed||N/A|135|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||1|||f||||f||||||||||2017-10-11 03:26:03.300433|2017-10-11 03:26:03.300433
NCT01504815|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-09-26|||March 2012||2012-03-01|September 2017|2017-09-01|September 2021|Anticipated|2021-09-01|April 2019|Anticipated|2019-04-01||Interventional|ARTFORCE||Adaptive Radiation Treatment for Head and Neck Cancer|Phase III Randomized Study With Cisplatinum and Conventional or Adaptive High Dose Radiotherapy for Advanced Head and Neck Cancer|Recruiting||Phase 3|268|Anticipated|The Netherlands Cancer Institute||2|||f||||f|f|f||||||||2017-10-11 03:26:03.472667|2017-10-11 03:26:03.472667
NCT01504802|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-09-30|||November 2010||2010-11-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|March 2013|Actual|2013-03-01||Observational|||Pharmacodynamics of CNP During Growth Hormone Treatment|Pharmacodynamics of C-Type Natriuretic Peptide During Growth Hormone Treatment in Children: A Potential Biomarker of Efficacy|Completed||N/A|22|Actual|Nemours Children's Clinic|||2||f||||f||||||Samples Without DNA|"     Serum, plasma, and urine will be saved for potential future studies.   "|||2017-10-11 03:26:03.634176|2017-10-11 03:26:03.634176
NCT01504789|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-09-28|||February 2012|Actual|2012-02-01|September 2017|2017-09-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Part II: Exercise in Hispanic Breast Cancer Survivors|Part II: Exercise in Hispanic Breast Cancer Survivors|Active, not recruiting||N/A|180|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 03:26:03.729273|2017-10-11 03:26:03.729273
NCT01504776|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2014-09-18|||April 2011||2011-04-01|January 2012|2012-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|BUS48T||Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)|A Phase I Study of Panobinostat in Combination With Bortezomib in the Treatment of Relapsed and/or Refractory Mantle Cell Lymphoma|Completed||Phase 1|3|Actual|Augusta University||1|||f||||t||||||||||2017-10-11 03:26:03.841769|2017-10-11 03:26:03.841769
NCT01504763|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2012-02-07|||October 2010||2010-10-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Measuring the Effect of Chair Massage on Stress Related Symptoms for Nurses|Measuring the Effect of Chair Massage on Stress Related Symptoms for Nurses: A Pilot Study|Completed||N/A|40|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 03:26:03.934314|2017-10-11 03:26:03.934314
NCT01504750|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-01-05|||December 2009||2009-12-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Healing Patient Rooms|Healing Patient Rooms; The Effect of Lighting on Recovery and Well-being of Patients|Completed||N/A|196|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 03:26:04.017769|2017-10-11 03:26:04.017769
NCT01504737|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2016-09-06|||September 2011||2011-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|RASP||Rehabilitation in Aortic Stenosis Patients|Rehabilitation in the Form of Exercise Training in Aortic Stenosis Patients (RASP)|Recruiting||N/A|40|Anticipated|Linkoeping University||2|||f||||f||||||||||2017-10-11 03:26:04.096999|2017-10-11 03:26:04.096999
NCT01504724|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2013-12-24|||August 2011||2011-08-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2012|Actual|2012-08-01||Interventional|IVB||Effect of the Adjunctive IVB Before PRP|Effect of Adjunctive Intravitreal Bevacizumab Before Panretinal Photocoagulation in Macular Thickness and Retinal Nerve Fiber Layer Thickness|Completed||Phase 4|30|Actual|Kyungpook National University||2|||f||||t||||||||||2017-10-11 03:26:04.198598|2017-10-11 03:26:04.198598
NCT01504711|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-08-21|||June 2012||2012-06-01|August 2017|2017-08-01|November 1, 2017|Anticipated|2017-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy|Prevention of Nausea and Vomiting Secondary to FOLFIRINOX Chemotherapy in Gastrointestinal Cancer Patients|Active, not recruiting||N/A|42|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 03:26:04.282658|2017-10-11 03:26:04.282658
NCT01504698|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-05-18|||February 2012||2012-02-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Manipulative Treatment of Children With Neck and Back Pain|Manipulative Treatment of Children With Neck and Back Pain. A Randomised Controlled Trial of 1200 Children From 3rd to 7th Grade|Completed||N/A|237|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 03:26:04.367474|2017-10-11 03:26:04.367474
NCT01504685|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-25|||May 2003||2003-05-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|March 2005|Actual|2005-03-01||Interventional|||Long-Term Results of a Randomized Trial Comparing Banded-versus-Standard Laparoscopic Roux-en-Y Gastric Bypass|Long-Term Results of a Randomized Trial Comparing Banded-versus-Standard Laparoscopic Roux-en-Y Gastric Bypass|Completed||N/A|60|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||f||||||||||2017-10-11 03:26:04.471517|2017-10-11 03:26:04.471517
NCT01504672|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-11-30|||January 2012||2012-01-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||A Randomized Controlled Pharmacist Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia|A Randomized Controlled Pharmacist Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia|Completed||N/A|460|Actual|Umeå University||2|||f||||||||||||||2017-10-11 03:26:04.557905|2017-10-11 03:26:04.557905
NCT01504659|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-03-14|||July 2012||2012-07-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|IKBP||Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder|Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder|Terminated||Phase 2/Phase 3|5|Actual|Juvenile Bipolar Research Foundation||2||Administrative issues|f||||t||||||||||2017-10-11 03:26:04.644604|2017-10-11 03:26:04.644604
NCT01504282|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-04||||||June 2010|2010-06-01||||||||Interventional|||Mitomycin-c Application for PRK|Mitomycin-c Application for Photorefractive Keratectomy|Completed||N/A|90||Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-10-11 03:26:08.031354|2017-10-11 03:26:08.031354
NCT01504646|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-04-02|||January 2012||2012-01-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma|Randomized Controlled Trial of Marine Lipid Fraction PCSO-524™ on Airway Inflammation and Hyperpnea-Induced Bronchoconstriction in Asthma|Completed||N/A|20|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 03:26:04.772685|2017-10-11 03:26:04.772685
NCT01504633|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-31|2014-02-25|||December 2011||2011-12-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|NUPICO||Nutrigenomics, PUFA, Iron and Cognition Amongst Under-two-year-old Indonesian Children|Can NUtrigenomics / Nutrigenetics Help Explain the Mixed Results on Effect of LCPUFA (DHA) and Iron on Child COgnition?|Unknown status|Active, not recruiting|N/A|240|Anticipated|Indonesia University||4|||f||||f||||||||||2017-10-11 03:26:04.908671|2017-10-11 03:26:04.908671
NCT01504620|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2012-01-03|||January 2011||2011-01-01|December 2011|2011-12-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|Polaris||Performance Evaluation of Blood Glucose Monitoring Systems|Performance Evaluation of BGStar and iBGStar in Terms of Accuracy (Polaris), Intra-assay Precision, and Hematocrit Interference (Helios Substudy) Following ISO15197 and TNO Guidelines|Completed||Phase 4|106|Actual|IKFE Institute for Clinical Research and Development||2|||f||||f||||||||||2017-10-11 03:26:05.03024|2017-10-11 03:26:05.03024
NCT01504607|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2012-01-03|||January 2011||2011-01-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Corneal Endothelial Changes Following Pediatric Cataract Surgery With IOL Implantation|Corneal Endothelial Morphologic Assessment in Pediatric Cataract Surgery With IOL Implantation: Comparison of Preoperative and Early Postoperative Specular Microscopy|Completed||N/A|106|Actual|Iladevi Cataract and IOL Research Center|||1||f||||t||||||||||2017-10-11 03:26:05.121638|2017-10-11 03:26:05.121638
NCT01504594|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-08-06|||January 2012||2012-01-01|August 2013|2013-08-01|August 2013|Anticipated|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy|Safeness and Effectiveness of Autologous Hematopoietic Cell Infusion Through Catheterization in Pediatric Patients With Dilated Cardiomyopathy|Suspended||Phase 1|10|Anticipated|Hospital Universitario Dr. Jose E. Gonzalez||1||Suspended because the lack of patients among the time this clinical trial was running.|f||||t||||||||||2017-10-11 03:26:05.189682|2017-10-11 03:26:05.189682
NCT01504581|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2014-02-06|||March 2011||2011-03-01|February 2014|2014-02-01||||September 2011|Actual|2011-09-01||Interventional|||Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects|A Randomized, Double-Blind, Placebo- And Active-Controlled Study Of The Pharmacokinetics, Pharmacodynamics And Safety Of Single Ascending Doses Of HM10660A (LAPS-INTERFERON ALPHA-2B) In Healthy Male Subjects|Completed||Phase 1|48|Actual|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 03:26:05.296846|2017-10-11 03:26:05.296846
NCT01504568|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-11-08|||January 2012||2012-01-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||The Use of Prophylactic Antibiotics in Isolated Blowout Fractures|The Use of Prophylactic Antibiotics in Isolated Blowout Fractures|Withdrawn||N/A|0|Actual|University of Arkansas||2||No subjects enrolled|f||||f||||||||||2017-10-11 03:26:05.419881|2017-10-11 03:26:05.419881
NCT01504555|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-09-23|||October 2011||2011-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|DXM||Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?|Evaluation of the Diagnostic Utility of Serum Dexamethasone Measurements in the Overnight 1mg Dexamethasone Suppression Test in Patients Investigated for Cushing's Syndrome and Incidentalomas|Recruiting||Phase 3|300|Anticipated|Haukeland University Hospital|||1||f||||f||||||Samples Without DNA|"     Blood, saliva, urine   "|||2017-10-11 03:26:05.517757|2017-10-11 03:26:05.517757
NCT01504542|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-11-20|||December 2011||2011-12-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer|A Phase 2A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Immune Response, Safety and Efficacy of HS-110 in Combination With Erlotinib vs. Erlotinib as a Single Agent in Patients With Advanced, Non-EGFR Mutated Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 2|0|Actual|Heat Biologics||3||Lack of enrollment|f||||t||||||||||2017-10-11 03:26:05.661594|2017-10-11 03:26:05.661594
NCT01504529|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-04-12|||September 2011||2011-09-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|RETO-PD||Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine|Non-Interventional, Retrospective, Multi-center Study to Evaluate Non-Motor Symptoms in Advanced PD Patients Already Treated With Rotigotine|Completed||N/A|391|Actual|UCB Pharma|||1||f||||f||||||||||2017-10-11 03:26:05.7587|2017-10-11 03:26:05.7587
NCT01504516|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-05|||October 2009||2009-10-01|September 2009|2009-09-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition|Open Label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Oral Bioequivalence Study of Donepezil Hydrochloride Tablets 10mg With ARICEPT® (Containing Donepezil Hydrochloride) Tablets 10mg in Healthy, Adult, Human Subjects Under Fed Condition.|Completed||Phase 1|25|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:26:06.132893|2017-10-11 03:26:06.132893
NCT01504503|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-05|||October 2009||2009-10-01|September 2009|2009-09-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition|Open Label, Balanced, Randomized, Two-treatment, Two-period, Two Sequence, Single Dose, Crossover, Oral Bioequivalence Study of Donepezil Hydrochloride Tablets 10mg With ARICEPT® (Containing Donepezil Hydrochloride) Tablets 10 mg in Healthy, Adult, Human Subjects Under Fasting Condition.|Completed||Phase 1|26|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 03:26:06.261897|2017-10-11 03:26:06.261897
NCT01504490|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-02-13|||December 2011||2011-12-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase I Study of CS-7017 and Bexarotene|A Phase I Study of a Combination of the Proteosome Proliferator-Activated Receptor Gamma Agonist, CS-7017 and the Retinoid X Receptor Agonist, Bexarotene|Terminated||Phase 1|9|Actual|Georgetown University||1||Drug no longer available|f||||t||||||||||2017-10-11 03:26:06.384945|2017-10-11 03:26:06.384945
NCT01504477|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-07-09|||December 2011||2011-12-01|July 2017|2017-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer|A Phase I/II Clinical Trial of the Anti-EGFR Monoclonal Antibody, Panitumumab, and the Proteosomal Inhibitor, Bortezomib, in Patients With Advanced, Refractory KRAS Wild-Type Colorectal Cancer|Terminated||Phase 1/Phase 2|6|Actual|Georgetown University||1||Low accrual--unable to meet accrual goals|f||||t||||||||||2017-10-11 03:26:06.475922|2017-10-11 03:26:06.475922
NCT01504464|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-05-15|||October 2012||2012-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis|Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells in Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial|Completed||Phase 2|40|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 03:26:06.573719|2017-10-11 03:26:06.573719
NCT01504451|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2014-06-25|||April 2012||2012-04-01|June 2014|2014-06-01|May 2015|Anticipated|2015-05-01|April 2015|Anticipated|2015-04-01||Interventional|LAAPITUP 2||Left Atrial Ablation of Paroxysmal Atrial Fibrillation With Implantable Loop Recorder Follow Up Study: The LAAPITUP 2 Study|Left Atrial Ablation of Paroxysmal Atrial Fibrillation With Implantable Loop Recorder Follow Up Study 2|Unknown status|Active, not recruiting|Phase 4|75|Anticipated|Eastbourne General Hospital||3|||f||||t||||||||||2017-10-11 03:26:06.656157|2017-10-11 03:26:06.656157
NCT01504438|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-03-23|||October 2011||2011-10-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Prospective Randomized Evaluation of a Two and Three Piece Total Ankle Replacement|Prospective Randomized Evaluation Of A Two And Three Piece Total Ankle Replacement|Active, not recruiting||N/A|100|Anticipated|Duke University||2|||f||||f||||||||||2017-10-11 03:26:06.738006|2017-10-11 03:26:06.738006
NCT01504425|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-04-06|||December 2011||2011-12-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Observational|||Difficult Colon Polypectomies|An Observational Study of Difficult Colonic Polypectomies|Completed||N/A|91|Actual|Clinical Hospital Colentina|||1||f||||||||||||||2017-10-11 03:26:06.823362|2017-10-11 03:26:06.823362
NCT01504412|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-12-11|||January 2012||2012-01-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuorpathy|An Asian, Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Pregabalin-controlled, Dose-finding Study of DS-5565 in Patients With Pain Associated With Diabetic Peripheral Neuropathy|Completed||Phase 2|450|Actual|Daiichi Sankyo, Inc.||5|||f||||||||||||||2017-10-11 03:26:06.882137|2017-10-11 03:26:06.882137
NCT01504399|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-10-10|||October 2011||2011-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Rhinological Outcomes in Endonasal Pituitary Surgery|Rhinological Outcomes in Endonasal Pituitary Surgery: A Multi-Center Observational Cohort Study|Active, not recruiting||N/A|200|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix|||2||f||||f||||||||||2017-10-11 03:26:06.979683|2017-10-11 03:26:06.979683
NCT01504386|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2013-08-21|||December 2011||2011-12-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|TAP-block||Transversus Abdominis Plane Block After Robot-assisted Laparocopic Hysterectomy|Effekt of Transversus Abdominis Plane (TAP) Block After Robot-assisted Laparocopic Hysterectomy|Terminated||Phase 4|70|Actual|Copenhagen University Hospital at Herlev||2||Due to local restructering, further recruting was not possible|f||||t||||||||||2017-10-11 03:26:07.142132|2017-10-11 03:26:07.142132
NCT01504373|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-04-04|||May 2011||2011-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Regional Distribution Differences Between Neurally Adjusted Ventilatory Assist and Pressure Support Ventilation|Regional Distribution Differences Between Neurally Adjusted Ventilatory Assist and Pressure Support Ventilation|Recruiting||N/A|25|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 03:26:07.236629|2017-10-11 03:26:07.236629
NCT01504360|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-06-09|||December 2011||2011-12-01|April 2016|2016-04-01|June 2017|Actual|2017-06-01|July 2016|Actual|2016-07-01||Interventional|SARI||Predictive Study of Radiation Induced Sarcoma|Predictive Study of Radiation Induced Sarcoma From the GSF-GETO Data Base.|Completed||N/A|360|Actual|Centre Georges Francois Leclerc||2|||f||||f||||||||||2017-10-11 03:26:07.336672|2017-10-11 03:26:07.336672
NCT01504347|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-06-26|||March 2011||2011-03-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|August 2011|Actual|2011-08-01||Interventional|||Phase 1/2 Lyme Vaccine Study|Randomized, Double-Blind, Phase 1/2 Clinical Study to Investigate the Safety and Immunogenicity of a Multivalent Recombinant OspA Lyme Borreliosis Vaccine (mv rOspA LB Vaccine) in Healthy Subjects Aged 18 to 70 Years|Completed||Phase 1/Phase 2|1630|Actual|Baxalta US Inc.||3|||f||||t||||||||||2017-10-11 03:26:07.424571|2017-10-11 03:26:07.424571
NCT01504334|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2012-02-05|||January 2012||2012-01-01|February 2012|2012-02-01|March 2013|Anticipated|2013-03-01|November 2012|Anticipated|2012-11-01||Interventional|||Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial for the Safety and Efficacy of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)|Unknown status|Recruiting|Phase 2|80|Anticipated|Beijing Kawin Technology Share-Holding Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:26:07.557785|2017-10-11 03:26:07.557785
NCT01504321|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2016-01-11|||May 2012||2012-05-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Polycystic Ovary Syndrome - Improving Outcomes|Polycystic Ovary Syndrome - Targeting the Sympathetic Nervous System to Improve Outcomes|Completed||Phase 4|42|Actual|Baker IDI Heart and Diabetes Institute||2|||f||||||||||||||2017-10-11 03:26:07.671312|2017-10-11 03:26:07.671312
NCT01504308|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-04-03|||May 2012||2012-05-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SOFIA||Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids|Philips Pivotal Clinical Trial for MRI-guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids|Terminated||Phase 2/Phase 3|49|Actual|Philips Healthcare||2||It was not possible to enroll patients into the study in a realistic timeframe.|f||||t|f|t|t|||||||2017-10-11 03:26:07.770285|2017-10-11 03:26:07.770285
NCT01504295|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2015-07-20|||April 2012||2012-04-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease|A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease|Completed||Phase 2|38|Actual|Brown University||2|||f||||t||||||||||2017-10-11 03:26:07.916815|2017-10-11 03:26:07.916815
NCT01504256|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-05-31|||October 2011||2011-10-01|May 2017|2017-05-01|July 2017|Anticipated|2017-07-01|March 2017|Actual|2017-03-01||Interventional|CatuNeo||Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas|Explorative Trial to Investigate Catumaxomab (Anti-EpCAM x Anti-CD3) for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas Prior to Gastrectomy|Active, not recruiting||Phase 2|42|Anticipated|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-10-11 03:26:08.111193|2017-10-11 03:26:08.111193
NCT01504243|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-04|2012-01-04|||May 2010||2010-05-01|December 2011|2011-12-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Observational|||Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han Population|Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han Population|Unknown status|Recruiting|N/A|400|Anticipated|Chinese PLA General Hospital|||2||f||||t||||||||||2017-10-11 03:26:08.217269|2017-10-11 03:26:08.217269
NCT01504230|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2016-12-15|||September 2011||2011-09-01|December 2016|2016-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Multi-joint Coordination Underlies Upright Balance Control in Elderly With Osteoporosis|Multi-joint Coordination Underlies Upright Balance Control in Elderly With Osteoporosis|Completed||N/A|50|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 03:26:08.289552|2017-10-11 03:26:08.289552
NCT01504217|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2015-07-07|||August 2010||2010-08-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Control of Center of Mass to Predict Balance Ability and Fall Risks in Elderly|Analysis of Muscle Strength and Control of Center of Mass Acceleration Mechanism to Predict Balance Ability and Fall Risks in Elderly|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 03:26:08.367046|2017-10-11 03:26:08.367046
NCT01504204|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-04-17|||December 2011||2011-12-01|April 2017|2017-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Samples on Acne Treatment With Epiduo® Gel|Effect of Sample Medication Use and Application Instructions on Adherence to and Efficacy of Treatment of Patients With Mild to Moderate Acne With Epiduo(R) Gel|Completed||Phase 4|20|Actual|Wake Forest University Health Sciences||2|||f||||f|t|f||||||No||2017-10-11 03:26:08.450514|2017-10-11 03:26:08.450514
NCT01504191|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2017-03-02|||September 2013||2013-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|U-CARE: Heart||Internet-based Cognitive Behavior Therapy After Myocardial Infarction|A Randomized Controlled Study of the Effects of Internet-based Cognitive Behavior Therapy on Depression and Anxiety in Patients With a Previous Myocardial Infarction|Active, not recruiting||Phase 3|239|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 03:26:08.558229|2017-10-11 03:26:08.558229
NCT01504178|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-02-21|||May 2011||2011-05-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|DOULOX||Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease|Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease|Completed||Phase 3|28|Actual|University Hospital, Toulouse||3|||f||||f||||||||Undecided||2017-10-11 03:26:08.713032|2017-10-11 03:26:08.713032
NCT01504165|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2014-02-03|||January 2012||2012-01-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Pharmacokinetics in Subjects With Renal Impairment|A Phase I, Open-label, Parallel-group, Mono-center Trial to Investigate the Pharmacokinetics of a Single Intravenous Dose of Cilengitide in Subjects With Mild, Moderate or Severe Renal Impairment Compared to Subjects With Normal Renal Function|Completed||Phase 1|32|Actual|Merck KGaA||5|||f||||f||||||||||2017-10-11 03:26:08.820129|2017-10-11 03:26:08.820129
NCT01504152|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2013-07-11|||December 2011||2011-12-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center|Survey to Assess International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center|Completed||N/A|519|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:26:08.936493|2017-10-11 03:26:08.936493
NCT01504139|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2015-03-09|||January 2012||2012-01-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||The Luteal Phase After GnRHa Trigger - a Proof of Concept Study|The Luteal Phase After GnRHa Trigger - a Proof of Concept Study|Completed||Phase 4|93|Actual|Regionshospitalet Viborg, Skive||4|||f||||t||||||||||2017-10-11 03:26:09.032419|2017-10-11 03:26:09.032419
NCT01504126|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-02-06|||March 2012|Actual|2012-03-01|February 2017|2017-02-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Feasibility Study: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients|Feasibility Study: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients|Active, not recruiting||N/A|25|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:26:09.127894|2017-10-11 03:26:09.127894
NCT01504113|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2012-01-02|||July 2011||2011-07-01|July 2011|2011-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis|The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||3||f||||||||||Samples Without DNA|"     Serum and skin scales   "|||2017-10-11 03:26:09.266246|2017-10-11 03:26:09.266246
NCT01504100|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2013-10-29|||May 2011||2011-05-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Efficiency of Patellar Taping in Treatment of Patellofemoral Pain Syndrome|The Effects of Distal Femoral Rotation on Patellofemoral Pain Syndrome Treated With Patella Taping|Completed||N/A|39|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 03:26:09.374426|2017-10-11 03:26:09.374426
NCT01504087|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-01-04|||May 2011||2011-05-01|July 2011|2011-07-01||||||||Observational|||ICU Venous Thromboembolism Incidence Study in a Chinese Population|Using Inflammatory Markers to Predict the Development and Outcome of Venous Thromboembolism in an Intensive Care Unit|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples Without DNA|"     blood   "|||2017-10-11 03:26:09.454217|2017-10-11 03:26:09.454217
NCT01504074|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2015-09-23|||November 2011||2011-11-01|September 2015|2015-09-01||||July 2014|Actual|2014-07-01||Observational|||Morphological and Functional Evaluation of Irvine-Gass Syndrome||Completed||N/A|50|Actual|Medical University of Vienna|||1||f||||||||||||||2017-10-11 03:26:09.548381|2017-10-11 03:26:09.548381
NCT00005414|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1991||1991-09-01|July 2000|2000-07-01|September 1993|Actual|1993-09-01|||||Observational|||Validation of a Historical Physical Activity Survey||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.139277|2017-10-11 04:27:02.139277
NCT01504061|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-10-23|||January 2012||2012-01-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||Mederma to Reduce Appearance of Post Surgical Scars|The Comparison of Mederma® N&I to Mederma® Ultra Gel to Reduce the Appearance of Post Surgical Scars|Completed||N/A|20|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-11 03:26:09.68274|2017-10-11 03:26:09.68274
NCT01504048|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2015-08-05|||June 2009||2009-06-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis|Prospective Study on the Usefulness of Chromoendoscopy in Detecting Microscopic Colitis in Patients Undergoing Colonoscopy Due to Chronic Watery Diarrhoea|Unknown status|Recruiting|N/A|150|Anticipated|Karolinska University Hospital||1|||f||||f||||||||||2017-10-11 03:26:09.79104|2017-10-11 03:26:09.79104
NCT01504035|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-02-08|||May 2008||2008-05-01|February 2012|2012-02-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|||Analgetic Effectiveness of a Lidocaine Loaded Hemostatic, Bioresorbable Putty|Effectiveness of the Addition of Lidocaine to a Hemostatic, Bioresorbable Putty in the Treatment of Iliac Crest Donor Site Pain|Completed||Phase 2/Phase 3|14|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 03:26:09.90844|2017-10-11 03:26:09.90844
NCT01504022|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2012-01-02|||September 2011||2011-09-01|January 2012|2012-01-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|WISH||Web Based Interactive Treatment and Self-monitoring in Hypertension|Role of Self Monitoring in Combination With Proactive Web-based Management in the Treatment of Hypertension: a Randomized Controlled Trial.|Unknown status|Recruiting|N/A|300|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-10-11 03:26:10.009113|2017-10-11 03:26:10.009113
NCT01504009|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2016-06-13|||May 2011||2011-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2012|Actual|2012-12-01||Interventional|ALS-project||Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS)|Investigating the Effect of Muscle Training in Patients With Amyotrophic Lateral Sclerosis and Looking Into the Mechanisms Behind Development of Muscle Atrophy|Completed||N/A|6|Actual|University of Southern Denmark||1|||f||||t||||||||Undecided|Data has been and will be published. Individual participant data may not be available.|2017-10-11 03:26:10.099075|2017-10-11 03:26:10.099075
NCT01503996|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2015-11-26|||October 2011||2011-10-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Drinking Habits of Glaucoma Patients and Age Matched Controls|Clinical Study to Evaluate the Drinking Habits of Glaucoma Patients and Age Matched Controls|Completed||N/A|600|Actual|Technische Universität Dresden|||2||f||||f||||||||||2017-10-11 03:26:10.190068|2017-10-11 03:26:10.190068
NCT01503983|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2015-08-26|||August 2011||2011-08-01|April 2012|2012-04-01|May 2015|Actual|2015-05-01|December 2013|Actual|2013-12-01||Interventional|HerXO||Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive|Phase II Study to Assess the Efficacy and Safety of Trastuzumab in Combination With Xelox as First-line Treatment of Patients With Advanced or Metastatic Gastric Cancer or Gastro-esophageal Junction, (HER2)-Positive.|Completed||Phase 2|45|Actual|Fundación para el Progreso de la Oncología en Cantabria||1|||f||||t||||||||||2017-10-11 03:26:10.277716|2017-10-11 03:26:10.277716
NCT01503970|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-04-11|||December 2008||2008-12-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Autologous Chondrocyte Transplantation For Articular Cartilage Regeneration|Autologous Chondrocyte Transplantation For Articular Cartilage Regeneration. Pilot Study|Completed||Phase 1/Phase 2|10|Actual|Instituto Nacional de Rehabilitacion||1|||f||||t||||||||||2017-10-11 03:26:10.439246|2017-10-11 03:26:10.439246
NCT01503957|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2012-10-25|||January 2012||2012-01-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Nasya in Allergic Rhinitis|Double-blind, Randomized, Placebo-controlled, Crossover Clinical Investigation to Evaluate Safety and Efficacy of Nasya in Reducing Symptoms of Allergic Rhinitis When Applied Before Allergen Challenge|Completed||Phase 3|20|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-11 03:26:10.523571|2017-10-11 03:26:10.523571
NCT01503944|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-14|2012-08-03||2012-08-03|March 2010||2010-03-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)|Detection of Striatal Dopaminergic Degeneration and Neocortical Amyloid Pathology in Patients With Dementia With Lewy Bodies, Alzheimer's Disease, Parkinson's Disease, and Healthy Elderly Volunteers|Completed||Phase 1/Phase 2|30|Actual|Avid Radiopharmaceuticals||4|||f||||f||||||||||2017-10-11 03:26:10.613417|2017-10-11 03:26:10.613417
NCT01503931|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2016-01-27|||June 2008||2008-06-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Observational|NGFN PLUS TP13||Endophenotyping With Functional Magnetic Resonance Imaging (fMRI)|Endophenotyping With fMRI: Genetic Modulation and Treatment Response|Completed||N/A|480|Actual|Charite University, Berlin, Germany|||2||f||||t||||||Samples With DNA|"     whole blood (EDTA)   "|||2017-10-11 03:26:10.937746|2017-10-11 03:26:10.937746
NCT01503918|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2015-01-09|||January 2012||2012-01-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|CCCC||Cytomegalovirus Control in Critical Care|Anti-viral Prophylaxis for Prevention of Cytomegalovirus (CMV) Reactivation in Immunocompetent Patients in Critical Care|Completed||Phase 2|124|Actual|University Hospital Birmingham NHS Foundation Trust||3|||f||||t||||||||||2017-10-11 03:26:11.026496|2017-10-11 03:26:11.026496
NCT01503905|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2016-05-23|||December 2011||2011-12-01|May 2016|2016-05-01|December 2021|Anticipated|2021-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients|Comparison of the Effectiveness of Neoadjuvant Chemotherapy and the Outcomes Associated With Chemo-induced Amenorrhea Between Docetaxel Plus Epirubicin, and Docetaxel Plus Epirubicin Plus Cyclophosphamide as Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients.|Recruiting||N/A|600|Anticipated|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University||2|||f||||t||||||||||2017-10-11 03:26:11.161781|2017-10-11 03:26:11.161781
NCT01503892|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2012-07-16|||December 2011||2011-12-01|July 2012|2012-07-01||||October 2013|Anticipated|2013-10-01||Interventional|SLHN2011-18||Metanx Effects on Nerve Fiber Density in Neuropathic Diabetics|Metanx Effects on Nerve Fiber Density in Neuropathic Diabetics|Unknown status|Recruiting|N/A|100|Anticipated|St. Luke's Hospital and Health Network, Pennsylvania||2|||f||||t||||||||||2017-10-11 03:26:11.359932|2017-10-11 03:26:11.359932
NCT01503697|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2012-01-03|||January 2012||2012-01-01|January 2012|2012-01-01||||||||Observational|||The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast Cancer|The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast Cancer|Unknown status|Not yet recruiting|N/A|75|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 03:26:13.633277|2017-10-11 03:26:13.633277
NCT01503879|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-31|2012-08-28|||October 2011||2011-10-01|August 2012|2012-08-01|October 2012|Anticipated|2012-10-01|||||Observational|||Evaluation of Gas Exchange by the Measurement of Lung Diffusion for Carbon Monoxide During General Anaesthesia|Effects of General Anaesthesia and Invasive Mechanical Ventilation on Alveolo-capillary Membrane: Evaluation of Gas Exchange by the Measurement of Lung Diffusion for Carbon Monoxide (DLCO) and Plasma Dosage of Surfactant Protein-B (SPB).|Unknown status|Recruiting|N/A|20|Anticipated|San Gerardo Hospital|||1||f||||f||||||Samples Without DNA|"     surfactant protein B   "|||2017-10-11 03:26:11.500754|2017-10-11 03:26:11.500754
NCT01503866|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2011-12-31|||December 2011||2011-12-01|December 2011|2011-12-01||||December 2011|Actual|2011-12-01||Interventional|||A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects|A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Bardoxolone Methyl Following a Single Oral Dose Administration in Healthy Male Subjects|Completed||Phase 1|6|Actual|Reata Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:26:11.588135|2017-10-11 03:26:11.588135
NCT01503853|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-31|2017-06-30|||April 16, 2011||2011-04-16|September 16, 2016|2016-09-16|September 16, 2016||2016-09-16|||||Observational|||Discussing Costs in the Doctor-Patient Encounter|Discussing Costs in the Doctor-Patient Encounter|Completed||N/A|264|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:26:11.669609|2017-10-11 03:26:11.669609
NCT01503840|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2014-04-20|||December 2011||2011-12-01|April 2014|2014-04-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual Paralysis|Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual Paralysis|Completed||N/A|20|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||||||||||||2017-10-11 03:26:11.748004|2017-10-11 03:26:11.748004
NCT01503827|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-02-15|||October 2007||2007-10-01|February 2017|2017-02-01|June 2022|Anticipated|2022-06-01|January 2018|Anticipated|2018-01-01||Interventional|WBRTMel||Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma|Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma - A Randomised Phase III Trial|Recruiting||N/A|220|Anticipated|Australia and New Zealand Melanoma Trials Group||2|||f||||t|f|f||||||No||2017-10-11 03:26:11.857101|2017-10-11 03:26:11.857101
NCT01503814|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-05-15|||January 2012||2012-01-01|August 2014|2014-08-01|September 2015|Actual|2015-09-01|March 2014|Actual|2014-03-01||Interventional|SimCard||Simplified Cardiovascular Management Study|Simplified Cardiovascular Management Study: A Cluster-Randomized Trial to Evaluate the Effects of a Simplified Cardiovascular Management Program in Tibet, China and Haryana, India|Completed||N/A|2086|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||f||||||||||2017-10-11 03:26:12.213822|2017-10-11 03:26:12.213822
NCT01503801|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-01-24|||May 2011||2011-05-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|NO-BPD||Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia|Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia in Preterm Infants|Completed||Phase 2/Phase 3|400|Actual|Fudan University||2|||f||||t||||||||||2017-10-11 03:26:12.332635|2017-10-11 03:26:12.332635
NCT01503788|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2012-01-03|||February 2012||2012-02-01|January 2012|2012-01-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Bedside Sedation for the Prevention of Post Dural Puncture Headache|Periprocedural Sedation for the Prevention of Post Dural Puncture Headache|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 03:26:12.466284|2017-10-11 03:26:12.466284
NCT01503775|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2017-06-19|||December 1, 2011|Actual|2011-12-01|June 2017|2017-06-01|August 1, 2014|Actual|2014-08-01|August 1, 2014|Actual|2014-08-01||Observational|TRULINE||TRUfill®'s Line in Intracranial aNeurysm Embolisation|A Prospective, Multicentric Observational Study Evaluating the Long Term Efficacy and Safety of the CODMAN TRUFILL®'s Line of Coils in the Endovascular Treatment of Intracranial Aneurysms|Completed||N/A|171|Actual|Codman & Shurtleff|||1||f||||t||||||||||2017-10-11 03:26:12.562065|2017-10-11 03:26:12.562065
NCT01503762|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2012-02-27|||January 2009||2009-01-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Mirror Therapy and Hand Rehabilitation|Mirror Therapy in Patients With Hand Orthopedic Disorders|Completed||N/A|23|Actual|Ahvaz Jundishapur University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:26:12.687845|2017-10-11 03:26:12.687845
NCT01503749|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2014-12-17|2014-11-27||January 2012||2012-01-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis|The Role of Peripheral Mononuclear Cells for Treatment of Advanced Liver Cirrhosis|Completed||Phase 1|9|Actual|Seoul National University Hospital||3|||f||||f||||||||||2017-10-11 03:26:12.799298|2017-10-11 03:26:12.799298
NCT01503736|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2013-12-23|||June 2010||2010-06-01|December 2013|2013-12-01||||June 2012|Actual|2012-06-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Definitive Phase III Study of the Effects of Ferric Citrate on Serum Phosphate in Subjects With End Stage Renal Disease|Completed||Phase 3|183|Actual|Panion & BF Biotech Inc.||3|||f||||t||||||||||2017-10-11 03:26:13.323189|2017-10-11 03:26:13.323189
NCT01503723|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-03|||August 2011||2011-08-01|September 2011|2011-09-01||||||||Observational|||Biomarkers in Exhaled Breath Condensates in Acute Lung Injury: Early Detection and Outcome Predictors|Biomarkers in Exhaled Breath Condensates in Acute Lung Injury: Early Detection and Outcome Predictors|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Exhaled breath condensate   "|||2017-10-11 03:26:13.440827|2017-10-11 03:26:13.440827
NCT01503710|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-03|||June 2011||2011-06-01|July 2011|2011-07-01|July 2012|Anticipated|2012-07-01|August 2011|Actual|2011-08-01||Observational|NSARF||Early Diagnosis of Postoperative Acute Renal Failure-using Biomarker to Predict Outcome of Cardiac Surgery Associated Acute Kidney Injury|Early Diagnosis of Postoperative Acute Renal Failure - Using Biomarker to Predict the Outcome of Cardiac Surgery Associated Acute Kidney Injury|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"     Blood samples are drawn before the first dialysis session after postcardiac sugary associated     severe AKI ( initializing RRT). Blood is drawn into Vacutainer tubes containing EDTA, and     immediately placed on ice and centrifuged within 1 h. All the samples are stored at -70°C     until analysis.   "|||2017-10-11 03:26:13.540155|2017-10-11 03:26:13.540155
NCT01503684|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-03|||August 2011||2011-08-01|September 2011|2011-09-01||||||||Observational|||Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction Syndrome|Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction Syndrome|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Exhaled breath condensate   "|||2017-10-11 03:26:13.736923|2017-10-11 03:26:13.736923
NCT01503671|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2015-08-09|||November 2011||2011-11-01|August 2015|2015-08-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|ALEVENT||Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients|Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients (ALEVENT)|Unknown status|Recruiting|Phase 4|36|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 03:26:13.839729|2017-10-11 03:26:13.839729
NCT01503658|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2012-06-18|||January 2012||2012-01-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of Clopidogrel|Clinical Trial to Evaluate the Influence of Genotype of Drug Metabolizing Enzyme or Transporter and Drug-drug Interactions on the Pharmacokinetics/Pharmacodynamics of Clopidogrel in Healthy Volunteers|Completed||Phase 4|18|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 03:26:13.933819|2017-10-11 03:26:13.933819
NCT01503645|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-11-12|||May 2006||2006-05-01|January 2012|2012-01-01||||||||Observational|||Chinese Herb Nephropathy Epidemiology and Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism|Epidemiology of Chinese Herb Nephropathy and Its Association With CYP2D6, CYP2C19, PXR, or MDR1 Polymorphism|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 03:26:14.016597|2017-10-11 03:26:14.016597
NCT01503632|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-09-27|||February 2012||2012-02-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission|A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL|Recruiting||Phase 3|608|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 03:26:14.11361|2017-10-11 03:26:14.11361
NCT01503619|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2017-06-26|||January 2012||2012-01-01|June 2017|2017-06-01||||January 2100|Anticipated|2100-01-01||Observational|||Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202|Genomics of Small Cell Lung Carcinoma|Active, not recruiting||N/A|23|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Tissue, blood   "|||2017-10-11 03:26:14.707304|2017-10-11 03:26:14.707304
NCT01503606|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-25|2015-11-24|||October 2011||2011-10-01|November 2015|2015-11-01||||August 2016|Anticipated|2016-08-01||Interventional|||Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane|Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane, Phase III Study.|Recruiting||Phase 3|206|Anticipated|Samsung Medical Center||2|||f||||||||||||||2017-10-11 03:26:14.790322|2017-10-11 03:26:14.790322
NCT01503580|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2013-10-30|||August 2008||2008-08-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|July 2010|Actual|2010-07-01||Interventional|||Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome|Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome|Completed||N/A|155|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 03:26:15.025114|2017-10-11 03:26:15.025114
NCT01503567|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2017-01-17|||January 2012||2012-01-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|HAEMOcare||Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries|Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries|Completed||N/A|282|Actual|Novo Nordisk A/S|||4||f||||f||||||||||2017-10-11 03:26:15.110552|2017-10-11 03:26:15.110552
NCT01503554|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2013-05-30|||April 2011||2011-04-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Combined Social Worker and Pharmacist Transitional Care Program|Multidisciplinary Care Transition Intervention - Cardinal Health Grant|Completed||N/A|100|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 03:26:15.210106|2017-10-11 03:26:15.210106
NCT01503541|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2015-03-05|||December 2011||2011-12-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin|The Development of Predictive Biomarker Models for Patients Receiving Standard Induction Chemotherapy With and Without Gemtuzumab Ozogamicin|Completed||N/A|365|Actual|Southwest Oncology Group|||1||f||||t||||||||||2017-10-11 03:26:15.28897|2017-10-11 03:26:15.28897
NCT01503515|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2017-01-18|||March 2013|Actual|2013-03-01|January 2017|2017-01-01||||September 2018|Anticipated|2018-09-01||Interventional|||Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant|A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)|Active, not recruiting||Phase 3|292|Actual|Children's Oncology Group||2|||f||||t|f|f||||||||2017-10-11 03:26:15.489524|2017-10-11 03:26:15.489524
NCT01503502|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2013-04-09|||August 2011||2011-08-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|June 2012|Actual|2012-06-01||Interventional|||A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia|Phase II Study of Flumatinib Versus Imatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|Unknown status|Active, not recruiting|Phase 2|150|Actual|Jiangsu HengRui Medicine Co., Ltd.||3|||f||||t||||||||||2017-10-11 03:26:15.675485|2017-10-11 03:26:15.675485
NCT01503489|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2012-01-03|||October 2005||2005-10-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|January 2010|Actual|2010-01-01||Observational|||Risk Factors for AD-Associated Switch to Mania|Risk for Antidepressant-associated Switch From Depression to Hypomania, Mania, or Mixed Episode During the 8 Weeks After the Introduction of an Antidepressant or After Increasing the Dosage of Baseline Antidepressant.|Completed||N/A|221|Actual|Hospital Clinic of Barcelona|||1||f||||t||||||||||2017-10-11 03:26:15.785535|2017-10-11 03:26:15.785535
NCT01503476|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-25|2015-07-15|||February 2012||2012-02-01|July 2015|2015-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance|RD-40 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance|Unknown status|Active, not recruiting|Phase 4|170|Anticipated|Given Imaging Ltd.||2|||f||||f||||||||||2017-10-11 03:26:15.899167|2017-10-11 03:26:15.899167
NCT01503463|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2015-03-19|||March 2011||2011-03-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|RHCluster7GR||Remote Monitoring of Patients With CHF in Central Greece|Renewing Health RCT for the Evaluation of Remote Monitoring of Patients With Congestive Heart Failure (CHF) in Central Greece|Completed||N/A|60|Actual|Regional Health Authority of Sterea & Thessaly||2|||f||||t||||||||||2017-10-11 03:26:16.019358|2017-10-11 03:26:16.019358
NCT01503450|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-04|||November 2006||2006-11-01|January 2012|2012-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-sequence, Two-period, Single-dose, Crossover Bioequivalence Study of Olanzapine 5 mg OD Tablets With Zyprexa Zydis 5 mg Tablets in Healthy Subjects Under Fed Conditions|Completed||Phase 1|26|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:26:16.151348|2017-10-11 03:26:16.151348
NCT01503437|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-04|||November 2006||2006-11-01|January 2012|2012-01-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition|An Open Label, Balanced, Randomized, Two-treatment, Two-sequence, Two-period, Single-dose, Crossover Bioequivalence Study of Olanzapine 5 mg OD Tablets With Zyprexa Zydis 5 mg Tablets in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|22|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:26:16.232148|2017-10-11 03:26:16.232148
NCT01503424|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-04|||August 2011||2011-08-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Oral Dose, Crossover, Bioequivalence Study of Olanzapine Tablets 5 mg With Zyprexa® Tablets 5 mg in Healthy Subjects Under Fed Conditions|Completed||Phase 1|48|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:26:16.311198|2017-10-11 03:26:16.311198
NCT01503411|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2014-04-08|||January 2012||2012-01-01|April 2014|2014-04-01||||March 2014|Actual|2014-03-01||Observational|||High Resolution Optical Imaging of Barrett's Esophagus Using Nvision Volumetric Laser Endomicroscopy (VLE)|High Resolution Optical Imaging of Barrett's Esophagus Using Nvision Volumetric Laser Endomicroscopy (VLE)|Completed||N/A|120|Actual|NinePoint Medical|||1||f||||f||||||||||2017-10-11 03:26:16.396312|2017-10-11 03:26:16.396312
NCT01503398|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-02|2012-01-04|||August 2011||2011-08-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Oral Dose, Crossover, Bioequivalence Study of Olanzapine Tablets 5 mg With Zyprexa® Tablets 5 mg in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|48|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 03:26:18.692786|2017-10-11 03:26:18.692786
NCT01503385|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2012-01-03|||December 2011||2011-12-01|January 2012|2012-01-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)|A Randomized Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|100|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:26:18.782979|2017-10-11 03:26:18.782979
NCT01503372|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-01-10|||November 2011||2011-11-01|January 2012|2012-01-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Interventional|PaFLO||FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer|Pazopanib With 5-Fluorouracil, Leucovorin and Oxaliplatin (FLO) as 1st-line Treatment in Advanced Gastric Cancer; a Randomized Phase-II-study of the Arbeitsgemeinschaft Internistische Onkologie|Unknown status|Recruiting|Phase 2|75|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 03:26:18.884258|2017-10-11 03:26:18.884258
NCT01503359|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2016-09-15|||January 2012||2012-01-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|February 2015|Actual|2015-02-01||Interventional|PULSAR||Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia|Effect of Sarcosine on Symptomatology, Quality of Life, Cognitive and Sexual Functioning, Blood Levels of Sarcosine, Glycine, BDNF and MMP-9, Oculomotor, Brain Metabolism and Oxidative Stress Parameters in Schizophrenia.|Completed||Phase 2|70|Anticipated|Medical Universtity of Lodz||2|||f||||f||||||||||2017-10-11 03:26:18.996123|2017-10-11 03:26:18.996123
NCT01503346|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2012-01-03|||March 2011||2011-03-01|January 2012|2012-01-01|March 2012|Anticipated|2012-03-01|September 2011|Actual|2011-09-01||Interventional|TCM||DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients|Taking Herbal Formula：DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients in Late-stage：A Clinical Control Trial Study|Unknown status|Recruiting|Phase 2|30|Anticipated|Changhua Christian Hospital||1|||f||||f||||||||||2017-10-11 03:26:19.118719|2017-10-11 03:26:19.118719
NCT01503320|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-01|2015-06-03|||January 2012||2012-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy of Enteral Glutamine Supplementation in Patients With Predicted Severe Acute Pancreatitis- A Double-Blinded Randomized Controlled Trial||Completed||N/A|60|Actual|Asian Institute of Gastroenterology, India||2|||f||||t||||||||||2017-10-11 03:26:19.32001|2017-10-11 03:26:19.32001
NCT01503307|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2015-08-19|||January 2009||2009-01-01|August 2015|2015-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Parenting After Infant Congenital Heart Defect Diagnosis|Parenting After Infant Congenital Heart Defect Diagnosis|Active, not recruiting||N/A|16|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-10-11 03:26:19.414771|2017-10-11 03:26:19.414771
NCT01503294|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2014-06-27|||February 2012||2012-02-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Observational|||Comparison of Temporal to Pulmonary Artery Temperature Measurement in Patients With Fever|Comparison of Temporal to Pulmonary Artery Temperature Measurement in Patients With Fever|Completed||N/A|60|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 03:26:19.5035|2017-10-11 03:26:19.5035
NCT01503281|ClinicalTrials.gov processed this data on October 10, 2017|2012-01-03|2012-01-11||||||January 2011|2011-01-01||||||||Interventional|||Effects of Group Vs. Home-Based Combined Exercise-Diet Program In Childhood Obesity: A Randomised Controlled Trial|Effects of Group Vs. Home-Based Combined Exercise-Diet Program In Childhood Obesity: A Randomised Controlled Trial|Completed||N/A|110|Actual|Cardenal Herrera University||3|||f||||f||||||||||2017-10-11 03:26:19.60738|2017-10-11 03:26:19.60738
NCT01503268|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2013-06-19|||November 2012||2012-11-01|June 2013|2013-06-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|ACTUAL||Atrial Fibrillation After Catheter Versus Thoracoscopic Ablation Using Patient Activated Implantable Loop Recorders: The ACTUAL Study|Atrial Fibrillation After Catheter Versus Thoracoscopic Ablation Using Patient Activated Implantable Loop Recorders|Withdrawn||Phase 4|0|Actual|Eastbourne General Hospital||3||Study methodology redesigned|f||||t||||||||||2017-10-11 03:26:19.839365|2017-10-11 03:26:19.839365
NCT01503255|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-07-13|||July 2012||2012-07-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|RAFIKI||A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention|A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention|Completed||Phase 1|614|Actual|Brown University||2|||f||||t||||||||||2017-10-11 03:26:19.937635|2017-10-11 03:26:19.937635
NCT01503242|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-09-20|||January 9, 2012|Actual|2012-01-09|September 2017|2017-09-01|December 6, 2019|Anticipated|2019-12-06|June 6, 2017|Actual|2017-06-06||Interventional|||90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma|A Phase I Study of 90Y-BC8-DOTA Monoclonal Antibody, Fludarabine and TBI Followed by HLA-Matched, Allogeneic Peripheral Blood Stem Cell Transplant for the Treatment of Multiple Myeloma|Active, not recruiting||Phase 1|15|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 03:26:20.067022|2017-10-11 03:26:20.067022
NCT01503229|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2017-08-18|||December 2012||2012-12-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer|Open Label Pharmacodynamic Study of Abiraterone Acetate in the Treatment of Metastatic, Castration Resistant Prostate Cancer|Active, not recruiting||Phase 2|30|Anticipated|University of Washington||1|||f||||||||||||||2017-10-11 03:26:20.21756|2017-10-11 03:26:20.21756
NCT01503216|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-10-07|||January 2012||2012-01-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety and Bioefficacy of Vitamin D2 and Vitamin D3|Safety and Bioefficacy of Vitamin D2 and Vitamin D3: Randomized Trial With Human Volunteers|Completed||N/A|120|Actual|Martin-Luther-Universität Halle-Wittenberg||3|||f||||t||||||||||2017-10-11 03:26:20.375849|2017-10-11 03:26:20.375849
NCT01503203|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2011-12-29|||November 2011||2011-11-01|December 2011|2011-12-01|August 2012|Anticipated|2012-08-01|April 2012|Anticipated|2012-04-01||Interventional|||Physical Virtual Training for Older Women|Physical Virtual Training Effectiveness on Nonspecific Chronic Low Back Pain, Body Balance, Functional Autonomy and Mood of Older Women|Unknown status|Recruiting|N/A|39|Anticipated|Universidade Gama Filho||2|||f||||f||||||||||2017-10-11 03:26:20.486753|2017-10-11 03:26:20.486753
NCT01503190|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-08-18|||July 21, 2009|Actual|2009-07-21|August 2017|2017-08-01|July 2021|Anticipated|2021-07-01|December 2020|Anticipated|2020-12-01||Observational|||The Immune System's Response to Young Women's Breast Cancer|A Translational Study of the Interactions Between Prior Pregnancy and the Biologic Subtype of Breast Cancer in Defining the Cancer: Host Immunologic Interaction|Recruiting||N/A|800|Anticipated|University of Colorado, Denver|||1||f||||f|f|f||||Samples With DNA|"     Tissue, Blood and urine may be collected from subjects who were recently diagnosed. Subjects     who were diagnosed after treatment begins or has ended will only be eligible for tissue     donation section of study   "|||2017-10-11 03:26:20.607442|2017-10-11 03:26:20.607442
NCT01503177|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-08-28|||November 2011|Actual|2011-11-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma|A Phase 1 Trial of Oncolytic Measles Virotherapy in Mesothelioma|Recruiting||Phase 1|36|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 03:26:20.705304|2017-10-11 03:26:20.705304
NCT01503151|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2014-12-01|||January 2012||2012-01-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|CBMSP||Cognitive Biases Modification Treatment for Social Anxiety|Cognitive Biases Modification Treatment for Social Anxiety|Completed||Phase 2|95|Actual|Tel Aviv University||4|||f||||f||||||||||2017-10-11 03:26:20.933137|2017-10-11 03:26:20.933137
NCT01503138|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2014-12-02|||December 2011||2011-12-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Intervention for Abused Chinese Immigrant Women|The Effect of a Purpose-built Intervention on Mental Health in Mainland Chinese Immigrant Women Survivors of Intimate Partner Violence: A Randomized Controlled Trial|Completed||N/A|250|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:26:21.01279|2017-10-11 03:26:21.01279
NCT01503125|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-01-26|||December 2011||2011-12-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Observational|||Giant Axonal Neuropathy Natural History Study|Clinical Study of Giant Axonal Neuropathy|Terminated||N/A|13|Actual|Columbia University|||1|PI left the institution|f||||f|f|f||||Samples With DNA|"     Skin Tissue, Blood, Cerebrospinal fluid (CSF)   "|Undecided||2017-10-11 03:26:21.100591|2017-10-11 03:26:21.100591
NCT01503112|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2014-11-04|||May 2011||2011-05-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|PRIBA||Predicting Response to Incretin Based Agents in Type 2 Diabetes|Does Urinary C-peptide Creatinine Ratio Predict Response to Incretin Based Agents in Type 2 Diabetes|Completed||N/A|957|Actual|Royal Devon and Exeter NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     Extracted DNA, stored serum/plasma   "|||2017-10-11 03:26:21.174223|2017-10-11 03:26:21.174223
NCT01503099|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2011-12-30|||October 2009||2009-10-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Observational|||Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease|Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease in Populations of High vs. Low Tuberculosis Endemicity|Unknown status|Recruiting|N/A|550|Anticipated|Lovisenberg Diakonale Hospital|||6||f||||f||||||Samples With DNA|"     Stool samples frozen at -20'C. Blood serum samples frozen at -20'C. Saliva samples stored at     room temperature. Paraffin embedded intestinal biopsies.   "|||2017-10-11 03:26:21.280785|2017-10-11 03:26:21.280785
NCT01503086|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2017-07-10|||November 2013||2013-11-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy|Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study|Recruiting||N/A|71|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 03:26:21.375844|2017-10-11 03:26:21.375844
NCT01503073|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-10-25|||January 2008||2008-01-01|October 2016|2016-10-01|December 2030|Anticipated|2030-12-01|December 2020|Anticipated|2020-12-01||Interventional|NIBSstroke||Noninvasive Brain Stimulation for Stroke|Noninvasive Brain Stimulation for Stroke Improvement|Recruiting||N/A|200|Anticipated|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-10-11 03:26:21.542745|2017-10-11 03:26:21.542745
NCT01503060|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2015-11-09|||December 2011||2011-12-01|November 2015|2015-11-01||||April 2016|Anticipated|2016-04-01||Interventional|||Effectiveness of Parent-Led Interventions in Reducing Infant Hypersensitivity to Pain|Effectiveness of Parent-Led Interventions in Reducing Infant Hypersensitivity to Pain: A Longitudinal Randomized Controlled Trial|Recruiting||Phase 3|352|Anticipated|The Hospital for Sick Children||4|||f||||f||||||||||2017-10-11 03:26:21.831312|2017-10-11 03:26:21.831312
NCT01503047|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2012-01-02|||March 2008||2008-03-01|January 2012|2012-01-01||||March 2010|Actual|2010-03-01||Interventional|CLA||Conjugated Linoleic Acid (1:1 Isomer Mixture) Intake in Overweight People|Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tonalin(R)Intake in Overweight People|Completed||Phase 4|50|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz||2|||f||||||||||||||2017-10-11 03:26:21.981116|2017-10-11 03:26:21.981116
NCT01503034|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-30|2015-05-15|||November 2010||2010-11-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Observational|||Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014|Study of Tumor Characteristics, Patient Care and Prognosis of Women With Breast Cancer During a Pregnancy Diagnosed Between 2000 and 2014|Unknown status|Recruiting|N/A|330|Anticipated|Centre Oscar Lambret|||2||f||||f||||||||||2017-10-11 03:26:22.100016|2017-10-11 03:26:22.100016
NCT01503021|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2016-09-14|2015-04-03||November 2011||2011-11-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||All participants who received at least one dose of study drug.|Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis|A Randomized, Double-Blinded, Placebo-Controlled, Crossover, Multicenter Phase III Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease Patients Receiving Chronic Hemodialysis|Completed||Phase 3|718|Actual|Rockwell Medical Technologies, Inc.||2|||f||||f||||||||||2017-10-11 03:26:22.44838|2017-10-11 03:26:22.44838
NCT01503008|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2013-03-01|||February 2012||2012-02-01|March 2013|2013-03-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Proteus Sustained Behavior Change Study|Proteus Sustained Behavior Change Study|Withdrawn||N/A|0|Actual|Proteus Digital Health, Inc.||2|||f||||f||||||||||2017-10-11 03:26:24.652065|2017-10-11 03:26:24.652065
NCT01502995|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2011-12-30|||June 2003||2003-06-01|December 2011|2011-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease|Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease|Completed||Phase 3|22|Actual|Parkinson's Disease Research, Education, and Clinical Center, Philadelphia||2|||f||||f||||||||||2017-10-11 03:26:24.759258|2017-10-11 03:26:24.759258
NCT01502982|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-09-27|||November 2004||2004-11-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional|CRY-04||Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)|CHOEP-14 + Rituximab With CNS Prophylaxis in Patients Less Than 65 Years With Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade III, Stage II-IV With Risk Factors (Age Adjusted IPI) ≥ 2. A Phase II Study|Completed||Phase 2|160|Actual|Nordic Lymphoma Group||1|||f||||f||||||||||2017-10-11 03:26:24.886165|2017-10-11 03:26:24.886165
NCT01502969|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-29|2011-12-30|||May 2010||2010-05-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|Rotavin-M1||Safety and Immunogenicity Assessment of Rotavin-M1 in Vietnamese Children|A Phase 2b Study of Rotavin-M1 Vaccine in Vietnamese Children|Completed||Phase 2/Phase 3|799|Actual|National Institute of Hygiene and Epidemiology, Vietnam||2|||f||||t||||||||||2017-10-11 03:26:25.145459|2017-10-11 03:26:25.145459
NCT01502943|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-30|||May 2011||2011-05-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index|Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index With Stable Angina Pectoris of Coronary Heart Disease as an Example|Completed||Phase 4|480|Actual|Liaoning University of Traditional Chinese Medicine||4|||f||||t||||||||||2017-10-11 03:26:25.422537|2017-10-11 03:26:25.422537
NCT01502917|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-09-21|||December 2011||2011-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy|A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy|Recruiting||Phase 1|64|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:26:25.773731|2017-10-11 03:26:25.773731
NCT01502904|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2016-07-25|||July 2010||2010-07-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents||Completed||Phase 4|120|Actual|Yonsei University||6|||f||||f||||||||||2017-10-11 03:26:25.911598|2017-10-11 03:26:25.911598
NCT01502891|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2015-12-30|||December 2011||2011-12-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|iADAPT||Making Decisions About Depression Medications|Translation of Comparative Effectiveness of Depression Medications Into Practice|Completed||N/A|301|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 03:26:26.045007|2017-10-11 03:26:26.045007
NCT01502878|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-09-12|||May 2011||2011-05-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Nut Allergy Study: Double-blind Challenge and Oral Desensitization|Nut Allergy Study: Improving Diagnosis And Treatment Of Nut Allergy|Completed||N/A|102|Actual|Helsinki University Central Hospital||3|||f||||f||||||||||2017-10-11 03:26:26.147977|2017-10-11 03:26:26.147977
NCT01502865|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2014-03-21|||December 2010||2010-12-01|March 2014|2014-03-01|December 2012|Anticipated|2012-12-01|||||Observational|CASSI||Clinician Access to Soldier Suicide Information (CASSI)|Clinician Access to Soldier Suicide Information (CASSI)|Withdrawn||N/A|0|Actual|VA Eastern Colorado Health Care System|||1|Should not have been listed on ClinicalTrials|f||||f||||||||||2017-10-11 03:26:26.25175|2017-10-11 03:26:26.25175
NCT01502852|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2014-11-24|||August 2011||2011-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Identifying the Needs of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans and Their Families: TBI and Co-Occurring Behavioral Health Issues|Identifying the Needs of OEF/OIF Veterans and Their Families: TBI and Co-Occurring Behavioral Health Issues|Completed||N/A|44|Actual|VA Eastern Colorado Health Care System|||3||f||||f||||||||||2017-10-11 03:26:26.32131|2017-10-11 03:26:26.32131
NCT01502839|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-05-12|||March 2011||2011-03-01|December 2012|2012-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Role of NSI in Differentiating Between Mild Traumatic Brain Injury And Behavioral Health Conditions|Differentiating Between Mild Traumatic Brain Injury And Behavioral Health Conditions: The Role of The Neurobehavioral Symptom Inventory|Terminated||N/A|887|Actual|VA Eastern Colorado Health Care System|||1|Unable to complete the data collection for this study.|f||||t||||||||||2017-10-11 03:26:26.394807|2017-10-11 03:26:26.394807
NCT01502826|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2012-01-18|||February 2012||2012-02-01|January 2012|2012-01-01|December 2013|Anticipated|2013-12-01|||||Observational|||Mechanisms of Atherogenesis During Post-prandial Time in Childhood Obesity|Candidate Mechanisms of Atherogenesis During the Post-prandial Period in the Obese Child/Adolescent|Unknown status|Not yet recruiting|N/A|40|Anticipated|Universita di Verona|||2||f||||t||||||Samples With DNA|"     Whole blood Serum Plasma Urine   "|||2017-10-11 03:26:26.480014|2017-10-11 03:26:26.480014
NCT01502813|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-05-24|||February 2012||2012-02-01|May 2017|2017-05-01|October 30, 2017|Anticipated|2017-10-30|October 30, 2017|Anticipated|2017-10-30||Interventional|||Citicoline, Creatine, and Omega-3 Effects in Middle Age Women||Active, not recruiting||N/A|25|Actual|University of Utah||1|||f||||t||||||||||2017-10-11 03:26:26.579955|2017-10-11 03:26:26.579955
NCT01502800|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-06-07|||December 2011||2011-12-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Trial of ARQ 761 in Advanced Solid Tumors|A Phase 1 Dose Escalation and Pharmacodynamic Study of ARQ 761 (Beta-Lapachone) in Adult Patients With Advanced Solid Tumors|Recruiting||Phase 1|30|Anticipated|University of Texas Southwestern Medical Center||4|||f||||t||||||||No||2017-10-11 03:26:26.661605|2017-10-11 03:26:26.661605
NCT01502787|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-12-29|2014-12-02||April 2009||2009-04-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients|Effects of Nebivolol Versus Metoprolol on Blood Flow Responses to Exercise and Angiotensin II in Hypertensive Patients|Completed||Phase 4|46|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 03:26:26.770088|2017-10-11 03:26:26.770088
NCT01502774|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2016-10-13|||April 2011||2011-04-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|CIRCUS||Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients|Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients|Completed||Phase 3|970|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 03:26:27.032758|2017-10-11 03:26:27.032758
NCT01502761|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-07-26|2017-06-30||March 2012||2012-03-01|July 2017|2017-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional||4 patients were enrolled (regional intra-arterial Magnesium 0.75g) before the study was stopped (not due to safety concerns). They were all enrolled in the first group|Intra-arterial Magnesium Administration for Acute Stroke|Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke|Terminated||Phase 1/Phase 2|4|Actual|University of Southern California|The trial was terminated early (with enrollment only in the first arm) by the investigators due to low enrollment (given results of relevant studies at the time) . There were no safety concerns with the trial or the agent.|4||No safety issues. Low enrollment secondary to negative stroke studies 2013|f||||t||||||||||2017-10-11 03:26:27.23351|2017-10-11 03:26:27.23351
NCT01502748|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-25|2017-07-27|||March 2012||2012-03-01|July 2017|2017-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Endovascular Magnesium Sampling in Acute Stroke|Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke|Terminated||N/A|2|Actual|University of Southern California||1||FAST-Mag study finished|f||||f|f|f||||||||2017-10-11 03:26:27.666665|2017-10-11 03:26:27.666665
NCT01502527|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-03-16|||January 2011||2011-01-01|March 2017|2017-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy|An Open Labeled Prospective Study to Investigate the Effect of Femarelle® on Vulvo-vaginal Atrophy Symptoms|Completed||N/A|12|Actual|Dr. Lila Nachtigall Rapid Medical Research, New York||1|||f||||f||||||||||2017-10-11 03:26:30.05137|2017-10-11 03:26:30.05137
NCT01502735|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-04-21|||December 2011||2011-12-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|DENV-1 PIV||Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease|A Phase 1 Trial of the Walter Reed Army Institute of Research (WRAIR) Dengue Virus Serotype-1 Purified Inactivated Vaccine (DENV-1 PIV) in Flavivirus Antibody Naïve Adults|Completed||Phase 1|20|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-10-11 03:26:27.74841|2017-10-11 03:26:27.74841
NCT01502722|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2013-01-15|||January 2012||2012-01-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Effect of Ingestion of Sugary Drinks on Thirst Sensation|Effect of Ingestion of Sugary Drinks on Thirst Sensation|Completed||N/A|24|Actual|Universidade do Porto||3|||f||||t||||||||||2017-10-11 03:26:27.834419|2017-10-11 03:26:27.834419
NCT01502709|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-04-25|2013-08-02||December 2011||2011-12-01|April 2016|2016-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|CVS||Neurostimulation in Temporomandibular Disorders (TMD) Patients|Randomized Blinded Placebo-Controlled Clinical Trial of Caloric Vestibular Neurostimulation in Patients With Chronic TMD|Terminated||N/A|5|Actual|University of North Carolina, Chapel Hill||2||recruiting difficulties|f||||f||||||||No||2017-10-11 03:26:27.949711|2017-10-11 03:26:27.949711
NCT01502696|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-02-28|||October 2012||2012-10-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Adjuvant PEG Intron in Ulcerated Melanoma|Adjuvant Pegylated-Interferon-alpha2b (SylatronTM) for 2 Years Versus Observation in Patients With an Ulcerated Primary Cutaneous Melanoma With T(2-4)bN0M0: a Randomized Phase III Trial of the EORTC Melanoma Group.|Active, not recruiting||Phase 3|1200|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 03:26:28.326876|2017-10-11 03:26:28.326876
NCT01502683|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-01-20|||December 2011||2011-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Stroke Study: Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery|Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery|Completed||N/A|193|Actual|Emory University||4|||f||||t||||||||||2017-10-11 03:26:28.616936|2017-10-11 03:26:28.616936
NCT01502670|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2013-11-18|||May 2009||2009-05-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|SPN||Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule|A Pilot Study of the Utility of the Novel Amino Acid Radiotracer Anti-[18 F]FACBC for the Noninvasive Imaging of Lung Nodules|Completed||Phase 1|10|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:26:28.723357|2017-10-11 03:26:28.723357
NCT01502657|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2011-12-30|||September 2010||2010-09-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Ultrasound Guided Percutaneous Tracheostomy|Ultrasound Guided Percutaneous Tracheostomy in the ICU|Completed||N/A|40|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||f||||||||||2017-10-11 03:26:28.806096|2017-10-11 03:26:28.806096
NCT01502644|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-06-14|2017-04-07||February 2009|Actual|2009-02-01|June 2017|2017-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Modified Intent-to-Treat Population, all participants who completed at least 50% of the opioid treatment period (at least 10 weeks of treatment).|Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms|Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms|Completed||Phase 4|81|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-11 03:26:28.889958|2017-10-11 03:26:28.889958
NCT01502631|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2016-08-23||2016-08-23|January 2012||2012-01-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury|Completed||Phase 2|62|Actual|Daiichi Sankyo, Inc.||2|||f||||t||||||||||2017-10-11 03:26:29.198632|2017-10-11 03:26:29.198632
NCT01502618|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-10|2017-02-27|||August 2010||2010-08-01|May 2016|2016-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)|Development of a Secondary Prevention Intervention Targeting HIV-Positive Black Young Men Who Have Sex With Men|Completed||N/A|18|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 03:26:29.416524|2017-10-11 03:26:29.416524
NCT01502605|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-01-03|||September 2012||2012-09-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|May 2015|Actual|2015-05-01||Interventional|||Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas|Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas|Terminated||Phase 1|6|Actual|Sidney Kimmel Comprehensive Cancer Center||1||PI leaving institution|f||||t||||||||||2017-10-11 03:26:29.50805|2017-10-11 03:26:29.50805
NCT01502592|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2016-01-04|||December 2011||2011-12-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer|A Pilot Study of Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer|Completed||Phase 1|19|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-11 03:26:29.600826|2017-10-11 03:26:29.600826
NCT01502579|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2013-08-27|||September 2011||2011-09-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data|An Observational Study of the Relationship Between Pathological Variants and Clinical Data at Presentation and Follow-up in IgA Nephropathy|Completed||N/A|603|Actual|Guangdong General Hospital|||1||f||||t||||||||||2017-10-11 03:26:29.703639|2017-10-11 03:26:29.703639
NCT01502566|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2013-07-19|||June 2010||2010-06-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|July 2011|Actual|2011-07-01||Interventional|||Educational Intervention in Preventing Early Childhood Caries|A Cluster-randomized Trial of the Effectiveness of an Educational Intervention in Preventing Early Childhood Caries|Completed||Phase 3|500|Actual|Federal University of Pelotas||2|||f||||f||||||||||2017-10-11 03:26:29.780267|2017-10-11 03:26:29.780267
NCT01502553|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2011-12-29|||October 2011||2011-10-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|BPM_S||Clinical Study of Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10|Verify the Functions of BPM LS-802 to Comply With ANSI/AAMI SP10|Completed||N/A|95|Actual|BTS International||1|||f||||f||||||||||2017-10-11 03:26:29.880755|2017-10-11 03:26:29.880755
NCT01502514|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2017-07-19|||May 2011||2011-05-01|July 2017|2017-07-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Cardiovascular Effects of Intramyocardial and Intravenous Implantation of Autologous Adipose-Derived Stem Cells in Ischemic Congestive Heart Failure Patients|Withdrawn||Phase 1|0|Actual|Ageless Regenerative Institute||1||no participants enrolled|f||||f||||||||||2017-10-11 03:26:30.138564|2017-10-11 03:26:30.138564
NCT01502501|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2017-07-19|||May 2011||2011-05-01|July 2017|2017-07-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Cardiovascular Effects of Intramyocardial and Intravenous Implantation of Autologous Adipose-Derived Stem Cells in Non-Ischemic Congestive Heart Failure Patients|Withdrawn||N/A|0|Actual|Ageless Regenerative Institute||1||no participants enrolled|f||||f||||||||||2017-10-11 03:26:30.252047|2017-10-11 03:26:30.252047
NCT01502488|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2017-07-19|||October 2016||2016-10-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Adipose Derived Stem Cell Therapy for Autism|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously in Patients With Autism|Withdrawn||Phase 1/Phase 2|0|Actual|Ageless Regenerative Institute||1|||f||||f||||||||||2017-10-11 03:26:30.347521|2017-10-11 03:26:30.347521
NCT01502475|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2014-11-25|||November 2011||2011-11-01|July 2012|2012-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|CACMAS||A Survey of Complementary and Conventional Medicine Use Patterns in the Veteran Population|A Survey of Complementary and Conventional Medicine Use Patterns in the Veteran Population|Completed||N/A|97|Actual|VA Eastern Colorado Health Care System|||1||f||||f||||||||||2017-10-11 03:26:30.452538|2017-10-11 03:26:30.452538
NCT01502462|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2016-07-11|||February 2012||2012-02-01|July 2016|2016-07-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Prospective Registry of Patients With Isolated Severe Tricuspid Regurgitation||Recruiting||N/A|200|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-11 03:26:30.530794|2017-10-11 03:26:30.530794
NCT01502449|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2012-01-11|||January 2012||2012-01-01|January 2012|2012-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|DESTRESS-T||Delivery of Self Training and Education for Stressful Situations-Telephone Version|Randomized Trial of Telephonic Psychotherapy and Case Management for Combat-Related Posttraumatic Stress Disorder|Unknown status|Not yet recruiting|N/A|91|Anticipated|Uniformed Services University of the Health Sciences||2|||f||||t||||||||||2017-10-11 03:26:30.639149|2017-10-11 03:26:30.639149
NCT01502436|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2016-01-22|||June 2008||2008-06-01|July 2012|2012-07-01|November 2014|Actual|2014-11-01|December 2010|Actual|2010-12-01||Observational|||An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans|An Exploration of the Relationship Between Chronic Pain and Suicide Attempt Among Veterans|Completed||N/A|230|Actual|VA Eastern Colorado Health Care System|||1||f||||f||||||||||2017-10-11 03:26:30.752897|2017-10-11 03:26:30.752897
NCT01502423|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2014-01-23|2013-11-07||January 2012||2012-01-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||All analyses were based on the cITT population, which included all subjects who were randomized and completed both periods and received study drug in both periods of the study (N = 60).|A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab|A Multicenter, Randomized, Single-Blind Crossover Study of the Safety and Tolerability of Two Adalimumab Formulations in Adult Subjects With Rheumatoid Arthritis|Completed||Phase 2|61|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 03:26:30.829308|2017-10-11 03:26:30.829308
NCT01502410|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2015-05-14|2015-04-14||January 2012||2012-01-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer|A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children and Young Adults With Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma|Completed||Phase 2|20|Actual|National Cancer Institute (NCI)||4|||f||||t||||||||||2017-10-11 03:26:31.279024|2017-10-11 03:26:31.279024
NCT01502397|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2014-12-29|||December 2011||2011-12-01|December 2014|2014-12-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Observational|||Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study||Unknown status|Enrolling by invitation|N/A|70|Anticipated|The University of Hong Kong|||1||f||||f||||||Samples Without DNA|"     Serum and plasma for hepatitis B virus genotypic, virologic and serologic testing   "|||2017-10-11 03:26:32.0439|2017-10-11 03:26:32.0439
NCT01502384|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2011-12-29|||January 2012||2012-01-01|December 2011|2011-12-01||||June 2015|Anticipated|2015-06-01||Observational|||A Longitudinal Study in 1st Degree Relatives of Parkinson's Disease (PD) Patients||Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-10-11 03:26:32.208797|2017-10-11 03:26:32.208797
NCT01502371|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-03-09|2015-09-01||January 2012||2012-01-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||The Baseline Analysis Population consisted of all randomized participants who received at least one dose of randomized study drug.|A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)|A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma (Phase 2; Protocol No. P04223AM3)|Completed||Phase 2|583|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:26:32.31508|2017-10-11 03:26:32.31508
NCT01502358|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-11-03|||December 2011||2011-12-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|TVDV||Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease|A Phase 1 Study To Evaluate The Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue (Serotype 1, 2, 3, and 4) Plasmid DNA Vaccine (TVDV) Formulated With and Without Vaxfectin®|Completed||Phase 1|40|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||t||||||||||2017-10-11 03:26:33.100072|2017-10-11 03:26:33.100072
NCT01502345|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2013-01-30|||January 2012||2012-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|HTNV/PUUV||Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines|Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines, pWRG/HTN-M(x) and pWRG/PUU-M(s2), for Prevention of Hemorrhagic Fever With Renal Syndrome Administered to Healthy Adult Volunteers Using the TDS-IM Electroporation Delivery Device|Completed||Phase 1|31|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||f||||||||||2017-10-11 03:26:33.250202|2017-10-11 03:26:33.250202
NCT01502332|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-10-01|2016-07-21||December 2011||2011-12-01|October 2016|2016-10-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Intensive Alveolar Recruitment Protocol After Cardiac Surgery|Comparison of Two Protective Mechanical Ventilation Strategies After Cardiac Surgery: Aggressive Versus Moderate Alveolar Recruitment Strategies|Completed||N/A|320|Actual|University of Sao Paulo||2|||f||||f||||||||No||2017-10-11 03:26:33.383168|2017-10-11 03:26:33.383168
NCT01502319|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-11-01|||September 2010||2010-09-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|MSRC||Military Suicide Research Consortium|Military Suicide Research Consortium|Active, not recruiting||N/A|1500|Anticipated|VA Eastern Colorado Health Care System|||1||f||||t||||||||||2017-10-11 03:26:33.810996|2017-10-11 03:26:33.810996
NCT01502306|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-10-27|||June 2012||2012-06-01|October 2016|2016-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline|A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline|Completed||Phase 3|3819|Actual|University of California, San Diego||3|||f||||f||||||||No||2017-10-11 03:26:33.89984|2017-10-11 03:26:33.89984
NCT01502293|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-02-24|||December 2011||2011-12-01|December 2016|2016-12-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|IL-12MEL||Trial of pIL-12 Electroporation Malignant Melanoma|A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma|Completed||Phase 2|51|Actual|OncoSec Medical Incorporated||2|||f||||t||||||||||2017-10-11 03:26:34.025182|2017-10-11 03:26:34.025182
NCT01502280|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-01-04|||November 2010||2010-11-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|BALANCE||Fluorescence-guided Surgery for Low- and High-grade Gliomas|Barrow 5-ALA Intraoperative Confocal Evaluation Trial|Recruiting||Phase 3|192|Anticipated|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||f||||||||||2017-10-11 03:26:34.142329|2017-10-11 03:26:34.142329
NCT01502267|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-24|2012-01-05|||January 2010||2010-01-01|January 2012|2012-01-01|January 2016|Anticipated|2016-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant|Phase 2 Study of Desensitization Protocol for Highly Sensitized Wait Listed Patients|Unknown status|Enrolling by invitation|Phase 2|2|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:26:34.298773|2017-10-11 03:26:34.298773
NCT01502254|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-02-11|||October 2008||2008-10-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Patients' Knowledge and Understanding of Cancer Clinical Trials - a Study of Audio Recorded Information|Patients' Knowledge and Understanding of Cancer Clinical Trials - a Randomised Study of Audio Recorded Information|Completed||N/A|130|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 03:26:34.389472|2017-10-11 03:26:34.389472
NCT01502241|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-24|2011-12-29|||January 2005||2005-01-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|Methusalem||Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly|Temozolomid (One Week on/One Week Off) Versus Strahlentherapie in Der Primärtherapie Anaplastischer Astrozytome Und Glioblastome Bei älteren Patienten: Eine Randomisierte Phase III-Studie (Methvsalem)|Completed||Phase 3|412|Actual|Heidelberg University||2|||f||||f||||||||||2017-10-11 03:26:34.505672|2017-10-11 03:26:34.505672
NCT01502228|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-28|2017-03-01|2016-11-23||October 2011||2011-10-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma|PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma|Terminated||N/A|14|Actual|Indiana University||1||No further funding|f||||t||||||||No||2017-10-11 03:26:34.677053|2017-10-11 03:26:34.677053
NCT01502215|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2012-12-04|||January 2012||2012-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|TRISOP||Transfusion Requirements in Surgical Oncologic Patient||Completed||Phase 3|198|Actual|University of Sao Paulo||2|||f||||||||||||||2017-10-11 03:26:34.947302|2017-10-11 03:26:34.947302
NCT01502202|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-06-19|||March 2012||2012-03-01|June 2012|2012-06-01|February 2015|Anticipated|2015-02-01|August 2014|Anticipated|2014-08-01||Interventional|||Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers|A Randomized Placebo-controlled Phase II Study of Intercalated Administration of Pemetrexed/Cisplatin With Iressa® (Gefitinib) or Placebo as First-line Treatment of Stage IIIB/IV Lung Adenocarcinoma in Never-smokers|Unknown status|Recruiting|Phase 2|162|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 03:26:35.048706|2017-10-11 03:26:35.048706
NCT01502189|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-12-01|||February 2012||2012-02-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|December 2012|Actual|2012-12-01||Interventional|||Information to Parents of Children With Cancer. An Exploratory Study|Information to Parents of Children With Cancer. An Exploratory Study|Completed||N/A|8|Actual|Umeå University||1|||f||||f||||||||||2017-10-11 03:26:35.165421|2017-10-11 03:26:35.165421
NCT01502176|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2011-12-29|||December 2011||2011-12-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||A Retrospective Register Study to Map the Frequency of Short Duration Atrial Fibrillation (AF) Among All Patients Admitted to Roskilde Sygehus in Denmark in 2010|A Retrospective Register Study to Map the Frequency of Short Duration Atrial Fibrillation (AF) Among All Patients Admitted to Roskilde Sygehus in Denmark in 2010|Unknown status|Recruiting|N/A|1600|Anticipated|University Hospital Roskilde|||1||f||||f||||||||||2017-10-11 03:26:35.264049|2017-10-11 03:26:35.264049
NCT01502163|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2012-03-07|||October 2011||2011-10-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy of a Convective Prewarming System in Prevention of Perioperative Hypothermia|Efficacy of a Convective Prewarming System in Prevention of Perioperative Hypothermia|Completed||N/A|90|Actual|University of Göttingen||3|||f||||f||||||||||2017-10-11 03:26:35.33816|2017-10-11 03:26:35.33816
NCT01502150|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-02-28|||June 16, 2005|Actual|2005-06-16|February 2017|2017-02-01|June 1, 2020|Anticipated|2020-06-01|June 1, 2020|Anticipated|2020-06-01||Observational|||Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics|Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics|Active, not recruiting||N/A|798|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 03:26:35.445738|2017-10-11 03:26:35.445738
NCT01502137|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-01-23|||June 2005||2005-06-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis|An Open, Non-randomized, Single-centre, Parallel Group Trial Investigating the Steady-state Blood Concentration Profile and Effects of Once Daily Subcutaneously Injected Recombinant Human Growth Hormone (Norditropin® SimpleXx®) in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis and in Matched Healthy Subjects|Completed||Phase 1|21|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:26:35.538528|2017-10-11 03:26:35.538528
NCT01502124|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2017-02-27|||May 8, 2001|Actual|2001-05-08|February 2017|2017-02-01|March 5, 2003|Actual|2003-03-05|March 5, 2003|Actual|2003-03-05||Interventional|||Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency|Norditropin® and Norditropin® Cartridges: An Open-Label, Randomized, Comparative Safety and Efficacy Trial in Children With Growth Hormone Deficiency|Completed||Phase 3|78|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:26:35.630324|2017-10-11 03:26:35.630324
NCT01502111|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2013-05-07|||January 2012||2012-01-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|AIRPORT||Airway Management Study in Physician Manned Helicopter Emergency Medical Services|Improved Knowledge Through Better Data, Implementing and Evaluating a Novel Consensus-based Template for Uniform Reporting of Data From Pre-hospital Airway Management - a Prospective Multicentre Observational Study|Completed||N/A|2333|Actual|Norwegian Air Ambulance Foundation|||1||f||||f||||||||||2017-10-11 03:26:35.862651|2017-10-11 03:26:35.862651
NCT01502098|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-24|2012-01-09|||January 2012||2012-01-01|January 2012|2012-01-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Effect of Postoperative Immobilization on Healing After Rotator Cuff Arthroscopic Repair|Effect of Postoperative Immobilization on Healing After Rotator Cuff Arthroscopic Repair With Double Row Technique in Small or Medium Ruptures. Prospective, Comparative and Randomized.|Unknown status|Recruiting|N/A|114|Anticipated|Hospital Italiano de Buenos Aires||2|||f||||t||||||||||2017-10-11 03:26:35.940893|2017-10-11 03:26:35.940893
NCT01502085|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2015-08-21|||December 2011||2011-12-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Interventional|RZD||Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens|A Phase IIb Trial of Vorinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma Patients Refractory to Previous Lenalidomide Containing Regimens|Unknown status|Active, not recruiting|Phase 1/Phase 2|92|Anticipated|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-11 03:26:36.029907|2017-10-11 03:26:36.029907
NCT01502072|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-09-05|||December 2011|Actual|2011-12-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Respiratory Syncytial Virus - RSV Protocol|An Open Label Randomized Controlled Trial To Prevent the Progression of Respiratory Syncytial Virus Upper Respiratory Tract Infection to Lower Respiratory Tract Infection in Patients After Hematopoietic Stem Cell Transplant|Active, not recruiting||Phase 2|96|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-11 03:26:36.13817|2017-10-11 03:26:36.13817
NCT01502059|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2011-12-29|||June 2008||2008-06-01|December 2011|2011-12-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|PTLBP||Pilates to Treat Low Back Pain|The Effectiveness of Pilates to Treat Low Back Pain: A Randomized Controlled Trial|Completed||Phase 3|60|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 03:26:36.251881|2017-10-11 03:26:36.251881
NCT01502046|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-29|2013-01-31|||September 2011||2011-09-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Neuroprotection by Cannabinoids in Huntington's Disease|A Double Blind, Randomized, Cross Over, Placebo Controlled Phase 2 Clinical Trial to Asses Neuroprotection by Cannabinoids in Huntington's Disease|Completed||Phase 2|25|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||2|||f||||f||||||||||2017-10-11 03:26:36.355686|2017-10-11 03:26:36.355686
NCT01502033|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2016-04-20|2015-08-06||December 2011||2011-12-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens|An Open-Label Eight-Week Trial of Repetitive Transcranial Magnetic Stimulation in Depressed Adolescents: Mechanisms of Response|Completed||N/A|10|Actual|Mayo Clinic|Please note that clinical results must be interpreted with caution due to small sample size and study design.|1|||f||||t||||||||No||2017-10-11 03:26:36.466758|2017-10-11 03:26:36.466758
NCT01502020|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2011-12-29|||February 2011||2011-02-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses|A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses|Completed||N/A|410|Actual|Actavis Mid-Atlantic LLC||3|||f||||f||||||||||2017-10-11 03:26:36.695586|2017-10-11 03:26:36.695586
NCT01502007|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-06-05|||April 2011||2011-04-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Activity Monitoring and Counseling in a Geriatric Population|Activity Monitoring and Counseling in a Geriatric Population: a Randomized Trial|Completed||N/A|50|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:26:36.808838|2017-10-11 03:26:36.808838
NCT01501994|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-06-05|||July 2009||2009-07-01|June 2014|2014-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Personalized Approach for Promoting Physical Activity in Mayo Clinic Physicians|Personalized Approach for Promoting Physical Activity in Mayo Clinic Physicians|Completed||N/A|17|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:26:36.899203|2017-10-11 03:26:36.899203
NCT01501981|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-30|2017-07-22|||February 2011||2011-02-01|July 2017|2017-07-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|MOLITOR||Impact of Therapy Optimization on the Level of Biomarkers in Patients With Decompensated Heart Failure|Impact of Therapy Optimization on the Level of Biomarkers in Patients With Acute Decompensated and Decompensated Chronic Heart Failure|Completed||N/A|150|Actual|Charite University, Berlin, Germany|||1||f||||t||||||||||2017-10-11 03:26:37.010327|2017-10-11 03:26:37.010327
NCT01501968|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-24|2011-12-29|||January 2012||2012-01-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity|Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity|Unknown status|Not yet recruiting|Phase 3|54|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 03:26:38.701308|2017-10-11 03:26:38.701308
NCT01501942|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2014-02-12|||February 2012||2012-02-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma|A Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma|Completed||Phase 2|11|Actual|AIM Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 03:26:38.890196|2017-10-11 03:26:38.890196
NCT01501929|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-12-01|||August 2010||2010-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients|Effects of Nebivolol on Microvascular Perfusion in the Skeletal Muscles During Exercise in Hypertensive Patients|Completed||Phase 4|32|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 03:26:38.98891|2017-10-11 03:26:38.98891
NCT01501916|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2013-01-08|||December 2012||2012-12-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|April 2013|Anticipated|2013-04-01||Interventional|||Effect of Vitamin D3 on Cardiovascular Risk Factors|Effect of Vitamin D3 on Cardiovascular Risk Factors: a Randomized Trial in Human|Suspended||N/A|250|Anticipated|Martin-Luther-Universität Halle-Wittenberg||2||technical problems|f||||t||||||||||2017-10-11 03:26:39.13378|2017-10-11 03:26:39.13378
NCT01501903|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-02-01|||September 2011||2011-09-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Standard Versus Fanning Techniques for Endoscopic Ultrasound-Fine Needle Aspiration (EUS-FNA)|Randomized Trial Comparing the Standard and Fanning Techniques for Fine Needle Aspiration of Pancreatic Mass Lesions at Endoscopic Ultrasound|Completed||N/A|52|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 03:26:39.219341|2017-10-11 03:26:39.219341
NCT01501890|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-10-24|||January 2012||2012-01-01|October 2016|2016-10-01|September 2014|Anticipated|2014-09-01|December 2013|Anticipated|2013-12-01||Interventional|||Progesterone for First Trimester Vaginal Bleeding|The Impact of Progesterone Treatment on Obstetrical Outcome Among Women With First Trimester Vaginal Bleeding|Withdrawn||N/A|0|Actual|Soroka University Medical Center||2||never started|f||||f||||||||||2017-10-11 03:26:39.308438|2017-10-11 03:26:39.308438
NCT01501877|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-04-10|||December 2011||2011-12-01|April 2017|2017-04-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|SSTOP||Smoking Cessation Intervention for Diabetic Patients|Smoking Cessation Intervention for Diabetic Patients|Completed||N/A|20|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-10-11 03:26:39.421953|2017-10-11 03:26:39.421953
NCT01501864|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-09-22|||July 2011|Actual|2011-07-01|September 2017|2017-09-01|March 31, 2017|Actual|2017-03-31|September 2016|Actual|2016-09-01||Interventional|||School Support as Structural HIV Prevention for Adolescent Orphans in Kenya|School Support as Structural HIV Prevention for Adolescent Orphans in Kenya|Completed||Phase 2|835|Actual|Pacific Institute for Research and Evaluation||2|||f||||f||||||||||2017-10-11 03:26:39.536915|2017-10-11 03:26:39.536915
NCT01501851|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2011-12-28|||April 2010||2010-04-01|December 2011|2011-12-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Observational|||Prediction of Low Birth Weight Infants Using Ultrasound Measurement of Placental Diameter and Thickness|Prediction of Low Birth Weight Infants Using Ultrasound Measurement of Placental Diameter and Thickness|Unknown status|Recruiting|N/A|265|Anticipated|Ain Shams Maternity Hospital|||1||f||||t||||||||||2017-10-11 03:26:39.636211|2017-10-11 03:26:39.636211
NCT01501838|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-12-16|||December 2010||2010-12-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|RIHP||Pulmonary Hypertension Institutional Registry|Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires|Recruiting||N/A|100000|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 03:26:39.829846|2017-10-11 03:26:39.829846
NCT01501825|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2012-07-03|||August 2012||2012-08-01|December 2011|2011-12-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||A Prospective, Comparative Study to Explore the Efficacy and Safety of the Five Channels Multiway Deep Transcranial Magnetic Stimulation (TMS) Device in Subjects With Major Depression Disorder (MDD)||Unknown status|Not yet recruiting|N/A|60|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 03:26:39.930939|2017-10-11 03:26:39.930939
NCT01501812|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2011-12-27|||March 2011||2011-03-01|December 2011|2011-12-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Observational|||Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders|Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders (Schizophrenia, Affective Spectrum and Anxiety Disorders) - an Open, Single Center, Longitudinal Study|Unknown status|Recruiting|N/A|180|Anticipated|Shalvata Mental Health Center|||6||f||||t||||||||||2017-10-11 03:26:40.062886|2017-10-11 03:26:40.062886
NCT01501799|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2011-12-28|||July 2011||2011-07-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris|A Multicenter, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) and Both Active Treatments to Topical Gel Placebo (Actavis Mid-Atlantic Llc) in the Treatment of Mild to Severe Acne Vulgaris|Completed||N/A|885|Actual|Actavis Mid-Atlantic LLC||3|||f||||f||||||||||2017-10-11 03:26:40.185216|2017-10-11 03:26:40.185216
NCT00005415|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1992||1992-09-01|June 2000|2000-06-01|September 1993|Actual|1993-09-01|||||Observational|||Physical Activity Effects on Health Care Utilization||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.210508|2017-10-11 04:27:02.210508
NCT01501786|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-10|2013-07-28|||January 2012||2012-01-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Does Ketamine Attenuate Depression of Respiratory and Cardiac Functions|The Effect of Small-dose Ketamine on Depression of Respiratory and Cardiac Functions Caused by Propofol in Pediatric Cardiac Catheterization|Completed||N/A|150|Actual|Ibaraki Children's Hospital||3|||f||||f||||||||||2017-10-11 03:26:40.331459|2017-10-11 03:26:40.331459
NCT01501773|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2011-12-26|||October 2008||2008-10-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke|Phase II Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke|Completed||Phase 2|120|Actual|Manipal Acunova Ltd.||2|||f||||t||||||||||2017-10-11 03:26:40.445282|2017-10-11 03:26:40.445282
NCT01501760|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2015-04-01|||January 2012||2012-01-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|BECONNEC||Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea|Effect of Bevacizumab Subconjunctival Injections on Corneal Newvessels|Unknown status|Recruiting|Phase 3|48|Anticipated|University Hospital, Limoges||2|||f||||t||||||||||2017-10-11 03:26:40.554991|2017-10-11 03:26:40.554991
NCT01501747|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2013-04-08|||February 2012||2012-02-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||The Placebo Effect May Involve Modulating Drug Bioavailability|The Placebo Effect May Involve Modulating Drug Bioavailability|Completed||N/A|162|Actual|King Faisal Specialist Hospital & Research Center||2|||f||||f||||||||||2017-10-11 03:26:40.677345|2017-10-11 03:26:40.677345
NCT01501734|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2015-04-12|||January 2012||2012-01-01|August 2012|2012-08-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Bilevel Positive Pressure Ventilation (BIPAP)in Patients With Sleep Disorders Breathing (SDB)and Congestive Heart Failure (CHF):Comparison of Two Diagnostic Methods||Unknown status|Recruiting|Phase 3|200|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 03:26:40.783828|2017-10-11 03:26:40.783828
NCT01501721|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2011-12-28|||January 2007||2007-01-01|December 2011|2011-12-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Anthropometric Changes Associated With Home-based Exercise Among School Cooks|Anthropometric and Metabolic Changes Associated With a Low-volume Home-based Exercise Program|Completed||Phase 4|95|Actual|Rio de Janeiro State University||2|||f||||t||||||||||2017-10-11 03:26:40.866824|2017-10-11 03:26:40.866824
NCT01501708|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2016-05-09|||December 2011||2011-12-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection|Phase II Study of Caspofungin Based Combined Anti-fungal Therapy for Patients With Proven or Probable Invasive Fungal Infection After Allogeneic Stem Cell Transplantation From HLA-matched Unrelated or HLA-mismatched Related Donors|Recruiting||Phase 2|55|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||No||2017-10-11 03:26:40.949781|2017-10-11 03:26:40.949781
NCT01501682|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2011-12-28|||February 2011||2011-02-01|December 2011|2011-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Long Term Complaints After Elective Repair for Small Umbilical or Epigastric Hernias|Long Term Complaints After Elective Repair for Small Umbilical or Epigastric Hernias|Unknown status|Recruiting|N/A|150|Anticipated|Zealand University Hospital|||3||f||||f||||||||||2017-10-11 03:26:41.143142|2017-10-11 03:26:41.143142
NCT01501669|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2012-07-17|||June 2011||2011-06-01|July 2012|2012-07-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|PROCEED||Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer|Phase III Multicenter Randomized Open-label Study of Irinotecan Plus Capecitabine Versus Capecitabine in Patients Previously Treated With Anthracycline and Taxane for HER2 Negative Metastatic Breast Cancer[PROCEED]|Unknown status|Recruiting|Phase 3|222|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 03:26:41.236844|2017-10-11 03:26:41.236844
NCT01501656|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2016-05-31|||May 2012||2012-05-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Epigenetic Testing for Breast Cancer Risk Stratification|Epigenetic Testing for Breast Cancer Risk Stratification|Completed||N/A|158|Actual|University of Texas Southwestern Medical Center|||1||f||||t||||||Samples With DNA|"     benign samples from unselected healthy control populations   "|No||2017-10-11 03:26:41.381666|2017-10-11 03:26:41.381666
NCT01501643|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2015-04-09|||November 2011||2011-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|VPACS||Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease|Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease With Vaso-occlusive Crisis and Morphinic Treatment|Terminated||N/A|6|Actual|Assistance Publique - Hôpitaux de Paris||2||decision of the promoter|f||||f||||||||||2017-10-11 03:26:41.471759|2017-10-11 03:26:41.471759
NCT01501630|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2015-10-13|||December 2011||2011-12-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|FLUPROSTIC||Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer|Role of PET/CT With Fluorine-18 Tracers and of Diffusion Weighted Whole-body MRI in the Early Detection of Bone Metastases in Prostate Cancer|Completed||N/A|112|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 03:26:41.566017|2017-10-11 03:26:41.566017
NCT01501604|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2015-09-16|||January 2012||2012-01-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||BKM120 in Cancers With PIK3CA Activating Mutations|An Open Label, Phase II Trial of BKM120 in Cancers With PIK3CA Activating Mutations|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||1||The study has been closed due to lack of accrual|f||||t||||||||||2017-10-11 03:26:41.903992|2017-10-11 03:26:41.903992
NCT01501591|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-25|2017-03-01|||November 2012||2012-11-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size|Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size|Completed||N/A|480|Actual|King Faisal Specialist Hospital & Research Center||3|||f||||f||||||||||2017-10-11 03:26:41.983603|2017-10-11 03:26:41.983603
NCT01501578|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-06-06|||December 2011||2011-12-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|June 2012|Actual|2012-06-01||Observational|||Pulmonary Fibrosis and Telomerase Mutation Study|Phenotype of Pulmonary Fibrosis Associated With a Mutation of Telomerase|Completed||N/A|81|Actual|Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires|||2||f||||f||||||Samples With DNA|"     one blood sample is collected for genetic analysis of telomerase mutation   "|Yes|Under analysis, publication in preparation|2017-10-11 03:26:42.072536|2017-10-11 03:26:42.072536
NCT01501565|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-11-15|||December 2011||2011-12-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery|Ultrasound-guided Analgesic Transverse Abdominal Plain Blockade in the Multimodal Pain Management for Laparoscopic Urological Surgery. Analgesic Efficacy Assessment.|Completed||Phase 4|141|Actual|Fundacio Puigvert||2|||f||||t||||||||||2017-10-11 03:26:42.160973|2017-10-11 03:26:42.160973
NCT01501552|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-09-05|||January 2012||2012-01-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|ODHIN_RCT||Trial Testing the Effect of Strategies on Performance of Brief Intervention Programmes for Harmful Alcohol Consumption|Randomised Controlled Trial Testing the Incremental Effect of Strategies That Raise Awareness, Acceptance and Performance of Identification and Brief Intervention Programmes for Harmful Alcohol Consumption in Primary Health Care|Completed||N/A|120|Actual|Fundacion Clinic per a la Recerca Biomédica||8|||f||||f||||||||||2017-10-11 03:26:42.259967|2017-10-11 03:26:42.259967
NCT01501539|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-01-20|||December 2010||2010-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement|Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement: A Randomized Controlled Trial of Hydrocolloid Dressings|Recruiting||N/A|171|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||3|||f||||f||||||||No||2017-10-11 03:26:42.430691|2017-10-11 03:26:42.430691
NCT01501526|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-25|2011-12-28|||October 2011||2011-10-01|December 2011|2011-12-01|March 2012|Anticipated|2012-03-01|||||Observational|||Unusual Clinical Findings of Herpes Esophagitis||Unknown status|Recruiting|N/A|1|Anticipated|China Medical University Hospital|||1||f||||t||||||||||2017-10-11 03:26:42.542195|2017-10-11 03:26:42.542195
NCT01501513|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-07-11||2014-07-11|December 2011||2011-12-01|July 2014|2014-07-01||||April 2013|Actual|2013-04-01||Interventional|||A Safety Study of 3 Different Bowel Cleansing Preparations|A Safety, Tolerance and Efficacy Evaluation of 3 Different Bowel Cleansing Preparations in Adult Subjects, Including the Elderly and Subjects With Hepatic or Renal Insufficiency|Completed||Phase 3|540|Anticipated|Braintree Laboratories||3|||f||||f||||||||||2017-10-11 03:26:42.645897|2017-10-11 03:26:42.645897
NCT01501500|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2013-09-05|||August 2010||2010-08-01|March 2010|2010-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effect of Botulinum Toxin to Hallux Valgus in Addition to Total Contact Insole|Therapeutic Effect of Botulinum Toxin Type A in Addition to Total Contact Insole in Treating Painful Hallux valgus-a Pilot Study|Completed||Phase 4|25|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 03:26:42.84046|2017-10-11 03:26:42.84046
NCT01501487|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-01-23|||October 2011||2011-10-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|February 2016|Actual|2016-02-01||Interventional|MINT||MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I|MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I|Active, not recruiting||Phase 4|226|Actual|Agendia||2|||f||||f||||||||||2017-10-11 03:26:42.956071|2017-10-11 03:26:42.956071
NCT01501474|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2014-07-01|||January 2012||2012-01-01|July 2014|2014-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Utility of CholangioFlex and Fluorescent in Situ Hybridization in the Diagnosis of Malignant Biliary Strictures|Utility of CholangioFlex and Fluorescent in Situ Hybridization in the Diagnosis of Malignant Biliary Strictures|Terminated||N/A|5|Actual|King Chulalongkorn Memorial Hospital|||1|No suitable case available and many techinical error|f||||f||||||Samples Without DNA|"     Brush cytology and FISH test   "|||2017-10-11 03:26:43.128833|2017-10-11 03:26:43.128833
NCT01501461|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-08-31|||May 2011||2011-05-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous Implantation of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome|Terminated||N/A|10|Anticipated|Ageless Regenerative Institute||1||Company dissolved|f||||f||||||||||2017-10-11 03:26:43.218274|2017-10-11 03:26:43.218274
NCT01501448|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2016-03-20|||January 2012||2012-01-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|May 2012|Actual|2012-05-01||Interventional|||Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients||Completed||Phase 4|118|Actual|IVI Madrid||2|||f||||||||||||||2017-10-11 03:26:43.297011|2017-10-11 03:26:43.297011
NCT01501435|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-24|2016-12-29|||December 2011||2011-12-01|December 2016|2016-12-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra|A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study to Compare the Pharmacokinetics of CJ-30039 and Lipidil Supra and to Investigate Food-effect on Pharmacokinetics of CJ-30039|Completed||Phase 1|48|Actual|CJ HealthCare Corporation||2|||f||||f||||||||No||2017-10-11 03:26:43.373111|2017-10-11 03:26:43.373111
NCT01501422|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-12-26|||July 2011||2011-07-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women|Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women at Menopause Clinic, King Chulalongkorn Memorial Hospital, Double- Blind, Randomized, Placebo-controlled Trial|Completed||Phase 3|40|Actual|Chulalongkorn University||2|||f||||f||||||||||2017-10-11 03:26:43.457996|2017-10-11 03:26:43.457996
NCT01501409|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2011-12-28|||January 2010||2010-01-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Effect of Sodium Lauryl Sulfate on Recurrent Aphthous Stomatitis|Effect of Sodium Lauryl Sulfate on Recurrent Aphthous Stomatitis : a Randomised Clinical Trial|Completed||N/A|90|Actual|Yonsei University||3|||f||||t||||||||||2017-10-11 03:26:43.587971|2017-10-11 03:26:43.587971
NCT01501396|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-01-31|||September 2013||2013-09-01|January 2014|2014-01-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite|Treatment of Cancer Anorexia-cachexia Syndrome (CACS) With Mirtazapine and Megestrol Acetate|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 03:26:43.675367|2017-10-11 03:26:43.675367
NCT01501383|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-01-15|||December 2011||2011-12-01|October 2012|2012-10-01||||August 2013|Actual|2013-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy With a 24-Week Open-Label Extension|Terminated||Phase 2|55|Actual|Vertex Pharmaceuticals Incorporated||6||Terminated by Sponsor|f||||t||||||||||2017-10-11 03:26:43.771181|2017-10-11 03:26:43.771181
NCT01501370|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-05-09|||January 2012||2012-01-01|May 2016|2016-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|ZLd_Ld||Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy|A Phase II, Multi-center, Open-label, Randomized Study of Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy|Withdrawn||Phase 2|0|Actual|University of Turin, Italy||2|||f||||t||||||||||2017-10-11 03:26:43.905089|2017-10-11 03:26:43.905089
NCT01501357|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-08-19|||July 2011||2011-07-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|toothbrushing||Effectiveness of Toothbrushing Techniques in Plaque Removal and Caries Lesion Control|Effectiveness of Toothbrushing Techniques in Plaque Removal and Caries Lesion Control in Erupting Primary Permanent Molars - Randomized Clinical Trial Abbreviated Over 24 Months|Unknown status|Recruiting|N/A|220|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:26:44.018511|2017-10-11 03:26:44.018511
NCT01501344|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2012-01-05|||January 2011||2011-01-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|YogA||Open-label Study to Evaluate the Effect of MBP-80 on Bone Remodelling|A 12-week, Open-label Study to Evaluate the Effect of MBP-80 (200g of Yogurt With Fortified Calcium Content and MBP 80 mg) on Bone Remodelling as Assessed by Bone Turnover Markers in Early Postmenopausal Women|Completed||N/A|50|Actual|Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc.||1|||f||||f||||||||||2017-10-11 03:26:44.102698|2017-10-11 03:26:44.102698
NCT01501331|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-11-16|||December 2011||2011-12-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|MULTITUDE-HF||Multiparametric Heart Failure Evaluation in Internal Cardioverter Defibrillators (ICD) Patients|Multiparametric Evaluation of Heart Failure in Device-implanted Patients.|Completed||N/A|180|Anticipated|University of Rome Tor Vergata|||1||f||||f||||||||||2017-10-11 03:26:44.189304|2017-10-11 03:26:44.189304
NCT01501318|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-09-29|||February 2012||2012-02-01|September 2016|2016-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Impact of Personalized Feedback Alone on Substance Use Behaviors|Brief Education to Reduce Health Care Consumers' Risky Substance Use Behaviors: How Brief is Brief?|Completed||N/A|40|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-10-11 03:26:44.257283|2017-10-11 03:26:44.257283
NCT01501305|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2011-12-28|||January 2012||2012-01-01|December 2011|2011-12-01|February 2013|Anticipated|2013-02-01|January 2013|Anticipated|2013-01-01||Interventional|||Influence of Carob and Probiotics on Acute Diarrhea in Children||Unknown status|Not yet recruiting|Phase 1/Phase 2|100|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 03:26:44.336801|2017-10-11 03:26:44.336801
NCT01501292|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-26|||January 2012||2012-01-01|December 2011|2011-12-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Observational|||Changes in the Distribution of Mitochondria During Oocyte Maturation||Unknown status|Not yet recruiting|N/A|20|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-10-11 03:26:44.409503|2017-10-11 03:26:44.409503
NCT01501279|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-06-10|||December 2011||2011-12-01|December 2011|2011-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Ultrasound Guided Pudendal Block in Transurethral Prostatectomies|Ultrasound Guided Pudendal Block in Transurethral Prostatectomies|Completed||N/A|40|Actual|Diskapi Teaching and Research Hospital||2|||f||||t||||||||||2017-10-11 03:26:44.592635|2017-10-11 03:26:44.592635
NCT01501266|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2016-05-09|||February 2012||2012-02-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Faslodex Specific Clinical Experience Investigation|Faslodex Specific Clinical Experience Investigation for Long-term Use|Completed||N/A|660|Anticipated|AstraZeneca|||1||f||||||||||||||2017-10-11 03:26:44.679977|2017-10-11 03:26:44.679977
NCT01501253|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2012-11-12|||August 2011||2011-08-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||CKD-828 S-Amlodipine Non-Responder Trial|Evaluate the Efficacy and Safety of a Fixed Dose Combination of S-Amlodipine and Telmisartan(CKD-828) vs. S-Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by S-Amlodipine Monotherapy.|Completed||Phase 3|187|Actual|Chong Kun Dang Pharmaceutical||3|||f||||f||||||||||2017-10-11 03:26:44.861511|2017-10-11 03:26:44.861511
NCT01501240|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-26|2014-01-26|||January 2012||2012-01-01|January 2014|2014-01-01|August 2013|Anticipated|2013-08-01|December 2012|Anticipated|2012-12-01||Observational|PriMPa||Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver|Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver: Prospective Pathologic Correlation With Explanted Liver|Withdrawn||N/A|0|Actual|Asan Medical Center|||1||f||||f||||||||||2017-10-11 03:26:44.956937|2017-10-11 03:26:44.956937
NCT01501227|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2011-12-28|||February 2012||2012-02-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients|Comparison of the Incidence of Ventilator Associated Pneumonia in Patients Intubated With the Taper Guard Endotracheal Tube Versus a Normal Endotracheal Tube|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|University of Malaya||2|||f||||t||||||||||2017-10-11 03:26:45.047655|2017-10-11 03:26:45.047655
NCT01501214|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-01-06|||December 2011||2011-12-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Use of Atosiban in in Vitro Fertilization (IVF) Treatment|A Randomized Double Blind Comparison of Atosiban in Patients Undergoing in Vitro Fertilization Treatment|Completed||Phase 4|800|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:26:45.178152|2017-10-11 03:26:45.178152
NCT01501201|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-05-17|||August 8, 2011|Actual|2011-08-08|May 2017|2017-05-01|September 2027|Anticipated|2027-09-01|September 2018|Anticipated|2018-09-01||Interventional|DIABSURG||Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients|Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients in Terms of Mortality, Glycemic Control, and Cost Effectiveness - Prospective, Multicenter, Randomized Study|Recruiting||Phase 4|490|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||No||2017-10-11 03:26:45.287719|2017-10-11 03:26:45.287719
NCT01501188|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-05-28|||September 2008||2008-09-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy Study of Kinesio Taping to Treat Muscular and Joint Problems in Chronic Venous Insufficiency|Study on the Effect of Kinesio Taping on Bioelectrical Activity of Gastrocnemius Muscles and Range of Ankle Motion in Post-menopausal Women With Chronic Venous Insufficiency|Completed||Phase 1|259|Actual|Universidad de Granada||2|||f||||f||||||||||2017-10-11 03:26:45.402634|2017-10-11 03:26:45.402634
NCT01501175|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2013-02-12|||November 2011||2011-11-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Observational|STEPH||Incidence of Superficial Vein Thrombosis|Evaluation of Annual Incidence of Superficial Vein Thrombosis in the Legs|Completed||N/A|848|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 03:26:45.500671|2017-10-11 03:26:45.500671
NCT01501162|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2015-03-24|2014-12-31||October 2010||2010-10-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|EPALD||Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease|Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease|Completed||Phase 4|130|Actual|Chuncheon Sacred Heart Hospital||2|||f||||t||||||||||2017-10-11 03:26:45.619998|2017-10-11 03:26:45.619998
NCT01501149|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-07-15|||January 2011||2011-01-01|July 2015|2015-07-01|May 2019|Anticipated|2019-05-01|December 2015|Anticipated|2015-12-01||Interventional|CTTNKTL-Ⅲ/Ⅳ||Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ|A Randomized Controlled Multi-center Clinical Trial on Treatment of Stage Ⅲ/Ⅳ NK/T Cell Lymphoma With DDGP Regiment (Gemcitabine,Pegaspargase,Cisplatin,Dexamethasone)|Recruiting||Phase 4|80|Anticipated|Zhengzhou University||2|||f||||t||||||||||2017-10-11 03:26:45.960953|2017-10-11 03:26:45.960953
NCT01501136|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2015-07-15|||January 2011||2011-01-01|July 2015|2015-07-01|May 2019|Anticipated|2019-05-01|December 2015|Anticipated|2015-12-01||Interventional|CTTNKTL-I/II||Treatment of Natural Killer/T Cell Lymphoma-I/II|A Randomized Controlled Multi-center Clinical Trial on Treatment of Stage I/II NK/T Cell Lymphoma With DDGP Regiment (Gemcitabine,Pegaspargase,Cisplatin,Dexamethasone)|Recruiting||Phase 4|200|Anticipated|Zhengzhou University||5|||f||||t||||||||||2017-10-11 03:26:46.095797|2017-10-11 03:26:46.095797
NCT01501123|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2011-12-28|||November 2011||2011-11-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|PHASR||Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient|Re-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient|Unknown status|Recruiting|N/A|162|Anticipated|Catholic Health East||2|||f||||f||||||||||2017-10-11 03:26:46.230994|2017-10-11 03:26:46.230994
NCT01501110|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2015-03-30|2014-12-03||November 2011||2011-11-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Effects of N-acetylcysteine on Low T3 Syndrome|Evaluation of the Effects of N-acetylcysteine on Thyroid Hormone Levels in the Low T3 Syndrome|Completed||Phase 4|83|Actual|Federal University of Rio Grande do Sul||2|||f||||t||||||||||2017-10-11 03:26:46.351111|2017-10-11 03:26:46.351111
NCT01501097|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2011-12-28|||December 2011||2011-12-01|December 2011|2011-12-01||||December 2013|Anticipated|2013-12-01||Interventional|CRRT||The Impact of Continuous Renal Replacement Therapy on the Outcomes of Burn Patients With Early Phase of Sepsis|A Randomized Controlled Trial on the Impact of Early Application of CRRT on the Outcomes of Burn Patients With Early Phase of Sepsis|Unknown status|Active, not recruiting|N/A|60|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 03:26:46.669643|2017-10-11 03:26:46.669643
NCT01501084|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-04-10|||December 2011||2011-12-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women|Effects of the GLP-1 Exenatide on Intrinsic Brain Activity in Lean and Obese Women|Completed||N/A|34|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 03:26:46.753739|2017-10-11 03:26:46.753739
NCT01501071|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-27|2011-12-28|||January 2009||2009-01-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|||Esophageal Calibration During Laparoscopic Fundoplication Reduces Dysphagia|Esophageal Calibration With Soft Orogastric Tube During Laparoscopic Fundoplication Reduces Postoperative Transient Dysphagia|Completed||N/A|50|Actual|Antalya Training and Research Hospital||2|||f||||f||||||||||2017-10-11 03:26:46.841929|2017-10-11 03:26:46.841929
NCT01501058|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-05-27|||December 2011||2011-12-01|May 2013|2013-05-01|September 2013|Anticipated|2013-09-01|June 2012|Actual|2012-06-01||Interventional|||Parent-supported Social Skills Training for Teens With Autism Spectrum Disorders (PEERS-K)|Parent-Assisted Social Skill Training Program in the Adolescents With Autism Spectrum Disorder|Unknown status|Active, not recruiting|N/A|40|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:26:46.933039|2017-10-11 03:26:46.933039
NCT01501045|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-10-01|||January 2011|Actual|2011-01-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Transmagnetic Stimulation on Conditioned Pain Modulation (CPM)|The Effect of Transmagnetic Stimulation on Descending Pain Modulation|Recruiting||N/A|200|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 03:26:47.019697|2017-10-11 03:26:47.019697
NCT01501032|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-03-18|||October 2013||2013-10-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MD-Logic- Cont||Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes|Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients|Withdrawn||Phase 1|0|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 03:26:47.11991|2017-10-11 03:26:47.11991
NCT01501019|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-02-17|||October 2011||2011-10-01|February 2016|2016-02-01||||July 2016|Anticipated|2016-07-01||Interventional|||Exercise in Sjogren, Myositis and Takayasu's Arteritis|Effects of Exercise Training in Primary Sjogren´s Syndrome, Myositis and Takayasu's Arteritis|Recruiting||N/A|60|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:26:47.206271|2017-10-11 03:26:47.206271
NCT00005416|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-21|||July 1992||1992-07-01|April 2002|2002-04-01|June 1995||1995-06-01|||||Observational|||Diet, Exercise, and Cardiovascular Health Among Ethnic Children||Completed||N/A|||Augusta University|||||f||||||||||||||2017-10-11 04:27:02.279214|2017-10-11 04:27:02.279214
NCT01500993|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2011-12-26|||March 2002||2002-03-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|Rektum-III||Capecitabine in the Perioperative Treatment of Rectal Cancer|5-Fluorouracil Versus Capecitabine as Perioperative Treatment for Locally Advanced Rectal Cancer. a Randomized Phase III Trial|Completed||Phase 3|401|Actual|Universitätsmedizin Mannheim||2|||f||||f||||||||||2017-10-11 03:26:47.357702|2017-10-11 03:26:47.357702
NCT01500980|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2012-12-11|||December 2011||2011-12-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|ITV||Malaria Challenge in Healthy Volunteers|Infection-Treatment-Vaccination for Plasmodium Falciparum|Completed||Phase 1|36|Actual|Seattle Biomedical Research Institute||5|||f||||t||||||||||2017-10-11 03:26:47.464|2017-10-11 03:26:47.464
NCT01500967|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2012-01-24|||December 2011||2011-12-01|January 2012|2012-01-01|May 2014|Anticipated|2014-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Shi-style Cervical Manipulations for Cervical Radiculopathy|Shi-style Cervical Manipulations for Cervical Radiculopathy-A Randomized Single Blinded Controlled Trial|Unknown status|Recruiting|N/A|648|Anticipated|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 03:26:47.564547|2017-10-11 03:26:47.564547
NCT01500954|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2012-10-15|||October 2011||2011-10-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma|Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma|Completed||N/A|7|Actual|Ruhr University of Bochum|||2||f||||f||||||Samples With DNA|"     cutaneous squamous cell carcinoma (SCC) non.lesional skin   "|||2017-10-11 03:26:47.692985|2017-10-11 03:26:47.692985
NCT01500941|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2012-01-03|||April 2010||2010-04-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Probiotics in Adults: do They Improve Atopic Dermatitis?|Evaluation of the Effects of a Combination of Probiotics in the Treatment of Adult Atopic Dermatitis: Randomized Phase III, Double-blind Placebo-controlled|Completed||Phase 3|48|Actual|ASST Fatebenefratelli Sacco||2|||f||||f||||||||||2017-10-11 03:26:47.754921|2017-10-11 03:26:47.754921
NCT01500928|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2011-12-25|||July 2011||2011-07-01|December 2011|2011-12-01||||July 2012|Anticipated|2012-07-01||Interventional|||Performance Study of the SOLO 2.0 Insulin Pump||Unknown status|Recruiting|N/A|40|Anticipated|Medingo Ltd||1|||f||||f||||||||||2017-10-11 03:26:47.823163|2017-10-11 03:26:47.823163
NCT01500915|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-03-23|||November 2010||2010-11-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|FUSION||FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration|FUSION Regimen: A Disease Activity Guided Treatment Algorithm With Ranibizumab in naïve Subjects With Exudative Age-related Macular Degeneration|Completed||Phase 4|17|Actual|Institut de la Macula y la Retina||1|||f||||f||||||||||2017-10-11 03:26:48.034034|2017-10-11 03:26:48.034034
NCT01500902|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-09-22|||September 2011||2011-09-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome|The Assessment of Novel Functional Risk Factors for the Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome|Completed||N/A|101|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 03:26:48.127695|2017-10-11 03:26:48.127695
NCT01500889|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-23|||January 2009||2009-01-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|CAF||Conventional Lateral Internal Sphincterotomy, V-Y Anoplasty and Tailored Lateral Internal Sphincterotomy With V-YF in Treatment of Chronic Anal Fissure(CAF)|Comparative Study of Conventional Lateral Internal Sphincterotomy, V-Y Anoplasty and Tailored Lateral Internal Sphincterotomy With V-Y Anoplasty in Treatment of Chronic Anal Fissure|Completed||N/A|150|Actual|Mansoura University||3|||f||||t||||||||||2017-10-11 03:26:48.222717|2017-10-11 03:26:48.222717
NCT01500876|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-11-21|||January 2012||2012-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer|A Feasibility Study Using Four-Dimensional CT Imaging to Evaluate Lung Strain in Patients Treated With External Beam Radiation Therapy for Primary Lung Cancer|Recruiting||N/A|15|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-10-11 03:26:48.332297|2017-10-11 03:26:48.332297
NCT01500863|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-10-25|||November 2011||2011-11-01|October 2016|2016-10-01||||May 2012|Actual|2012-05-01||Interventional|ERAMAD||Endometrial Receptivity After GnRH Agonist Triggering|Endometrial Receptivity After GnRH Agonist Triggering From Final Oocyte Maturation|Completed||Phase 4|35|Actual|IVI Madrid||6|||f||||f||||||||No||2017-10-11 03:26:48.429401|2017-10-11 03:26:48.429401
NCT01500850|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-23|||October 2011||2011-10-01|December 2011|2011-12-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use|Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use.|Unknown status|Recruiting|Phase 4|60|Anticipated|ikfe-CRO GmbH||4|||f||||f||||||||||2017-10-11 03:26:48.54163|2017-10-11 03:26:48.54163
NCT01500837|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2013-09-17|||October 2010||2010-10-01|September 2010|2010-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|CLINDOS||Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)|Treatment of Methicillin-sensitive Staphylococcus Aureus Orthopaedic Infections With Clindamycin in Combination With Rifampin or Levofloxacin: a Randomized Pharmacological and Clinical Study (the CLINDOS Trial)|Completed||N/A|23|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:26:48.690696|2017-10-11 03:26:48.690696
NCT01500824|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2013-02-22|||May 2014||2014-05-01|February 2013|2013-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase (ALK) Positive Advanced Non-Small Cell Lung Cancer|Phase 2 Open-label Single Arm Study Of The Efficacy And Safety Of Crizotinib In East Asian Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring A Translocation Or Inversion Involving The Anaplastic Lymphoma Kinase (ALK) Gene Locus|Withdrawn||Phase 2|0|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 03:26:48.779096|2017-10-11 03:26:48.779096
NCT01500811|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-04-24|||March 2011||2011-03-01|January 2011|2011-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Autologous Chondrocyte Intra-articular Implantation in Patients With Severe Hip Osteoarthritis|Evaluation the Side Effects of Autologous Chondrocyte Intra-articular Implantation in Patients With Severe Hip Osteoarthritis|Completed||Phase 1|6|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 03:26:48.872713|2017-10-11 03:26:48.872713
NCT01500798|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-10-27|||January 2012||2012-01-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|November 2012|Actual|2012-11-01||Interventional|||A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes|A Pharmacodynamic Study of Measured Glomerular Filtration Rate Assessed by Tc99m-DTPA in Patients With Chronic Kidney Disease and Type 2 Diabetes|Terminated||Phase 1|18|Actual|Reata Pharmaceuticals, Inc.||2||IDMC recommendation for safety concerns|f||||||||||||||2017-10-11 03:26:48.973763|2017-10-11 03:26:48.973763
NCT01500785|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2014-04-07|||January 2012||2012-01-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Intracoronary Administration of Levosimendan in Cardiac Surgery Patients|Intracoronary Administration of Levosimendan in Cardiac Surgery Patients|Unknown status|Recruiting|Phase 4|50|Anticipated|Tampere University Hospital||2|||f||||f||||||||||2017-10-11 03:26:49.053001|2017-10-11 03:26:49.053001
NCT01500772|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-06-30|2016-05-19||March 2012||2012-03-01|June 2016|2016-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||All enrolled patients|Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C|A Multicenter, Single-arm Trial Evaluating the Safety and Efficacy of DEB025/Alisporivir in Combination With Pegylated Interferon-α2a and Ribavirin (Peg-IFNα2a/RBV) in Protease Inhibitor Treatment Failure Patients With Chronic Hepatitis C Genotype 1|Terminated||Phase 3|6|Actual|Debiopharm International SA|Due to early termination of the study, none of the planned outcome measures could be evaluated.|1|||f||||||||||||||2017-10-11 03:26:49.168657|2017-10-11 03:26:49.168657
NCT01500759|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2015-08-04|||November 2007||2007-11-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01|4 Weeks|Observational [Patient Registry]|SchlaHF||Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry|Prevalence, Clinical Characteristics and Type of Sleep-disordered Breathing in Patients With Chronic, Symptomatic, Systolic Heart Failure|Completed||N/A|10775|Actual|ResMed|||1||f||||f||||||||||2017-10-11 03:26:49.548965|2017-10-11 03:26:49.548965
NCT01500746|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2014-03-10|2014-01-20||December 2011||2011-12-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|PLI2||Evaluation of the Effectiveness of Daily Pulse Lavage Therapy in Chronic Wounds|Bedside Pulse Lavage Irrigation Project|Completed||N/A|8|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 03:26:50.137813|2017-10-11 03:26:50.137813
NCT01500733|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-09-21|||November 22, 2011||2011-11-22|September 13, 2017|2017-09-13|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase II Study of PCI-32765 for Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Need Therapy and Are Older Than 65 or Have a 17p Deletion|Active, not recruiting||Phase 2|86|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:26:50.439882|2017-10-11 03:26:50.439882
NCT01500720|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-03-30|2015-03-30||March 2012||2012-03-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Randomized population included all randomized participants, and was analyzed according to the randomized treatment.|Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer|Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy|Completed||Phase 2|179|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:26:51.218201|2017-10-11 03:26:51.218201
NCT01500707|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-01-07|||January 2013||2013-01-01|January 2015|2015-01-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)|A Single Dose Study to Assess the Pharmacokinetics of SCH 900800 Administered as Oral Tablets in L-DOPA-treated Subjects With Parkinson's Disease|Withdrawn||Phase 1|0|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 03:26:52.633859|2017-10-11 03:26:52.633859
NCT01500694|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-05-30|2016-07-22||March 2012||2012-03-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional||Safety analysis set included all enrolled participants who took at least 1 dose of SPD503.|Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe|A Phase 3, Open-label, Multicentre Study to Provide Access to Guanfacine Hydrochloride Extended-release for European Subjects With Attention-deficit/Hyperactivity Disorder (ADHD) Who Participated in Study SPD503-315 or SPD503-316|Completed||Phase 3|215|Actual|Shire||1|||f||||t||||||||No||2017-10-11 03:26:52.75047|2017-10-11 03:26:52.75047
NCT01500681|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2017-03-21|||June 2012||2012-06-01|March 2017|2017-03-01||||August 2017|Anticipated|2017-08-01||Observational|MultiPLEX||Maintenance Plasma Exchange for Neuromyelitis Optica|A Prospective Observational Study of Maintenance Plasma Exchange (PLEX) for Neuromyelitis Optica Spectrum Disorders (MultiPLEX Study)|Active, not recruiting||N/A|14|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:26:53.553018|2017-10-11 03:26:53.553018
NCT01500668|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-01-03|||January 2012||2012-01-01|January 2012|2012-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Botulinum Toxin A for Treatment of Catocholamine Induced Finger Necrosis|Botulinum Toxin for Treatment of Catocholamine Induced Finger Necrosis - a Double Blind Randomized Control Prospective Study.|Unknown status|Recruiting|Phase 4|20|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 03:26:53.666467|2017-10-11 03:26:53.666467
NCT01500655|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-12-05|||April 2008||2008-04-01|December 2016|2016-12-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Ultrasound-Guided Block of the Lateral Femoral Cutaneous Nerve in Pediatric Patients|Evaluation of Ultrasound-Guided Block of the Lateral Femoral Cutaneous Nerve in Pediatric Patients for Reconstructive Surgical Procedures|Completed||N/A|19|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 03:26:53.781835|2017-10-11 03:26:53.781835
NCT01500642|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-01-04|||June 2011||2011-06-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy|Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy in Patients With Ragweed Pollinosis: a Phase III Randomized and Controlled Clinical Study|Completed||Phase 3|45|Actual|ASST Fatebenefratelli Sacco||3|||f||||f||||||||||2017-10-11 03:26:53.878692|2017-10-11 03:26:53.878692
NCT01499550|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-09-24|||August 2011||2011-08-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Nocturnal Transnasal Insufflation (nTNI)|Nocturnal Transnasal Insufflation in Patients With COPD and Hypercapnia|Completed||N/A|31|Actual|Institut für Pneumologie Hagen Ambrock eV||2|||f||||f||||||||||2017-10-11 03:27:18.229526|2017-10-11 03:27:18.229526
NCT01500629|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-01-11|2013-12-15||January 2012||2012-01-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of a Topical Nasal Spray to Ease the Symptoms of Hayfever|A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial of a Topical Nasal Spray in the the Relief of Signs and Symptoms of an Acute Response to a Nasal Allergen Challenge|Completed||Early Phase 1|21|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 03:26:54.03577|2017-10-11 03:26:54.03577
NCT01500616|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-08-16|||June 2012||2012-06-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Telaprevir Open-Label Study in Co-Infected Patients|Multicenter, Open-Label, Study of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Human Immunodeficiency Virus/Genotype 1 Chronic Hepatitis C Coinfected Subjects With Severe Fibrosis or Compensated Cirrhosis|Completed||Phase 3|122|Actual|Janssen-Cilag International NV||1|||f||||f||||||||||2017-10-11 03:26:55.507671|2017-10-11 03:26:55.507671
NCT01500603|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2014-10-07|||March 2013||2013-03-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|BALLANCE||Periurethral Pro-ACTTM Balloons vs Retrourethral AdvanceXP(TM) Male Sling for Post-prostatectomy Incontinence|Prospective, Randomized, Multicentric, Comparative Trial of Two Devices in Surgical Treatment of Post-radical Prostatectomy Stress Urinary Incontinence: Periurethral Pro-ACTTM Balloons and AdvanceXP(TM) Retrourethral Male Sling|Terminated||N/A|6|Actual|Assistance Publique - Hôpitaux de Paris||2||lack of inclusion in the study|f||||f||||||||||2017-10-11 03:26:55.635795|2017-10-11 03:26:55.635795
NCT01500590|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2016-09-02|||November 2011||2011-11-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|eGFR||Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria|Phase IV, Effect of Rennin-Angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria--- A Randomized Controlled Trial|Active, not recruiting||Phase 4|1400|Actual|Hospital Authority, Hong Kong||2|||f||||f||||||||Undecided||2017-10-11 03:26:55.729652|2017-10-11 03:26:55.729652
NCT01500577|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-23|2014-06-17|||April 2005||2005-04-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|November 2012|Actual|2012-11-01||Interventional|||A Prevention Trial in Subjects at High Risk for Breast Cancer|A Randomized Phase II Prevention Trial in Subjects at High Risk for Hormone Non-responsive Breast Cancer|Completed||Phase 2|150|Actual|European Institute of Oncology||3|||f||||f||||||||||2017-10-11 03:26:55.89636|2017-10-11 03:26:55.89636
NCT01500564|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-02-14|||January 2, 2012|Actual|2012-01-02|February 2017|2017-02-01|July 1, 2018|Anticipated|2018-07-01|July 1, 2018|Anticipated|2018-07-01||Interventional|ReSTIM||Functional Interest of Non Invasive Brain Stimulation During Physiotherapy at a Subacute Phase Post Stroke (Anodal Protocol): ReSTIM|Functional Interest of Non Invasive Brain Stimulation During Physiotherapy at a Subacute Phase Post Stroke (Anodal Protocol).|Recruiting||N/A|20|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 03:26:55.978562|2017-10-11 03:26:55.978562
NCT01500551|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-09-11|||March 18, 2013|Actual|2013-03-18|September 2017|2017-09-01|March 31, 2021|Anticipated|2021-03-31|March 31, 2021|Anticipated|2021-03-31||Interventional|||Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis|A Long-term, Open-label Follow-up Study Of Tofacitinib For Treatment Of Juvenile Idiopathic Arthritis (Jia)|Recruiting||Phase 3|340|Anticipated|Pfizer||1|||f||||t||||||||||2017-10-11 03:26:56.098101|2017-10-11 03:26:56.098101
NCT01500538|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-02-12|||October 2012||2012-10-01|October 2012|2012-10-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|VEIL||A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)|A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)|Terminated||Phase 2|1|Actual|Peter MacCallum Cancer Centre, Australia||1||Poor recruitment rate|f||||t||||||||||2017-10-11 03:26:56.368604|2017-10-11 03:26:56.368604
NCT01500512|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-24|2017-08-23|||January 3, 2012|Actual|2012-01-03|August 2017|2017-08-01||||July 1, 2015|Actual|2015-07-01||Observational|GROINSS-V||Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection|GROningen INternational Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational Study|Active, not recruiting||N/A|148|Actual|Gynecologic Oncology Group|||1||f||||||||||||||2017-10-11 03:26:56.562059|2017-10-11 03:26:56.562059
NCT01500499|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-24|2016-05-17|||December 2011||2011-12-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia|The Role of AF1q in Progression of Leukemia|Completed||N/A|20|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:26:56.743|2017-10-11 03:26:56.743
NCT01500486|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-11-16|||January 2007||2007-01-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™|Observational Study to Assess Ease of Use, Acceptability and Preference of Norditropin NordiFlex® With NordiFlex PenMate™ in Subjects on Prescribed Growth Hormone Therapy|Completed||N/A|84|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:26:56.84686|2017-10-11 03:26:56.84686
NCT01500473|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-02-13|||February 2012||2012-02-01|February 2012|2012-02-01||||December 2012|Anticipated|2012-12-01||Interventional|||Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome|Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome|Unknown status|Not yet recruiting|N/A|8|Anticipated|Children's Hospital Los Angeles||1|||f||||t||||||||||2017-10-11 03:26:56.934709|2017-10-11 03:26:56.934709
NCT01500447|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-08-03|||December 15, 2011||2011-12-15|August 2, 2017|2017-08-02||||||||Observational|||Inherited Reproductive Disorders|The Molecular Basis of Inherited Reproductive Disorders|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:26:57.023742|2017-10-11 03:26:57.023742
NCT01411462|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-09-09|||August 2011||2011-08-01|August 2011|2011-08-01||||||||Observational|VIBER||VIBE-assisted DEB Registry|Vascular Imaging Balloon Catheter-assisted Drug-eluting Balloon Angioplasty Prospective Registry|Unknown status|Recruiting|N/A|25|Anticipated|Ospedale Santa Maria Goretti|||1||f||||f||||||||||2017-10-11 03:57:02.833808|2017-10-11 03:57:02.833808
NCT01500434|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-02-02|2012-01-11||February 2009||2009-02-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|March 2011|Actual|2011-03-01||Interventional|PLATINUM LL||The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)|PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Long Lesion Sub-trial|Completed||Phase 3|102|Actual|Boston Scientific Corporation||1|||f||||t||||||||No|Primary endpoint data uploaded.|2017-10-11 03:26:57.171165|2017-10-11 03:26:57.171165
NCT01500421|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2011-12-27|||October 2008||2008-10-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safty and Feasibility Study of Therapeutic Cooling in Acute Ischemic Stroke (COOLAID Øresund)|The Øresund Copenhagen-Malmø Acute Stroke Cooling Trial|Completed||Phase 2|31|Actual|Bispebjerg Hospital||4|||f||||t||||||||||2017-10-11 03:26:58.375707|2017-10-11 03:26:58.375707
NCT01500408|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-11-16|||January 2012||2012-01-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers|A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of Interferon Beta-1a Manufactured by Two Different Processes|Completed||Phase 1|110|Actual|Biogen||2|||f||||f||||||||||2017-10-11 03:26:58.47846|2017-10-11 03:26:58.47846
NCT01500395|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-12-30|||November 2011||2011-11-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2015|Anticipated|2015-12-01|3 Years|Observational [Patient Registry]|||Hybrid Operation in Thoracic Aortic Dissection|Hybrid Operation in Thoracic Aortic Dissection---Registry of China|Recruiting||N/A|50|Anticipated|Xijing Hospital|||1||f||||t||||||||||2017-10-11 03:26:58.579813|2017-10-11 03:26:58.579813
NCT01500382|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-08-02|2016-08-02||February 2012||2012-02-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)|A Placebo and Active-Comparator Controlled Multiple-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of MK-4618 in Patients With Overactive Bladder|Terminated||Phase 1|4|Actual|Merck Sharp & Dohme Corp.|This study was terminated early due to insufficient recruitment. Only four participants in total participated in the study with three completing and one discontinuation.|4||This study was terminated early due to insufficient recruitment.|f||||f||||||||||2017-10-11 03:26:58.707702|2017-10-11 03:26:58.707702
NCT01500356|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-07-24|||December 13, 2011|Actual|2011-12-13|July 2017|2017-07-01|June 30, 2016|Actual|2016-06-30|June 30, 2016|Actual|2016-06-30||Interventional|Heart Health||Effect of Exercise and Weight Loss on Cardiovascular Health|Effect of Exercise and Weight Loss on Cardiovascular Health|Completed||N/A|383|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 03:26:59.195765|2017-10-11 03:26:59.195765
NCT01500343|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2011-12-27|||November 2008||2008-11-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|PROICA||A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA|A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients|Completed||Phase 2|20|Actual|Universidade Federal Fluminense||2|||f||||t||||||||||2017-10-11 03:26:59.287388|2017-10-11 03:26:59.287388
NCT01500330|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2013-10-08|||January 2012||2012-01-01|October 2013|2013-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|NaSK||Home Use of Cupping Massage in Chronic Neck Pain|Randomised Controlled Study on the Effectiveness of Cupping Massage for Home Use in Chronic Neck Pain [Randomisierte Kontrollierte Studie Zur Wirksamkeit Der Schröpfkopfmassage Als Heimanwendung Bei Chronischen Nackenschmerzen]|Completed||N/A|84|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-11 03:26:59.553344|2017-10-11 03:26:59.553344
NCT01500317|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-12-13|2012-11-08||May 2011||2011-05-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|tap-oxy||Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans|Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans|Completed||Phase 4|38|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 03:26:59.673366|2017-10-11 03:26:59.673366
NCT01500304|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-10-05|||June 2012||2012-06-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SAFE-MILND||Minimally Invasive Groin Dissection for Melanoma|Feasibility and Safety of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma|Completed||Phase 1|88|Actual|Mayo Clinic||1|||f||||t||||||||No|no plan to share data|2017-10-11 03:27:00.139546|2017-10-11 03:27:00.139546
NCT01500291|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-03-14|||April 2012||2012-04-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|October 2015|Actual|2015-10-01||Observational|stress||A Study Survey of Stress in Anesthesia Personnel|Principal Investigator|Enrolling by invitation||N/A|639|Anticipated|Mahidol University|||2||f||||f||||||||||2017-10-11 03:27:00.250446|2017-10-11 03:27:00.250446
NCT01500278|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-07-07|2016-11-22||December 2011||2011-12-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Interventional||Baseline Characteristics refer to the Randomized Treatment Group (RTG) that consisted of all subjects randomized into the study.|Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate|A Multicenter, Single-blind, Randomized Parallel-group Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis Responding Inadequately to Methotrexate|Completed||Phase 4|915|Actual|UCB Pharma||4|||f||||f||||||||||2017-10-11 03:27:00.377637|2017-10-11 03:27:00.377637
NCT01500265|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-02-23|||December 2011||2011-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Observational|HBVSECURE||Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus|Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus.|Completed||N/A|216|Actual|University Hospital, Limoges|||3||f||||f||||||Samples With DNA|"     Plasma and urine samples for determination of TMPi / GFR and FEUA A sample of genomic DNA     will be collected after informed consent of the patient from a saliva sample (Saliva     autocollection kits) in order to investigate genetic polymorphism in transporters responsible     for the renal elimination of TDF and ETV.   "|||2017-10-11 03:27:02.193294|2017-10-11 03:27:02.193294
NCT01500252|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2012-04-05|2012-01-03||September 1996||1996-09-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|June 2004|Actual|2004-06-01||Interventional|PROFIX||Patellar Resurfacing Versus Patellar Retention in Total Knee Arthroplasty - A Randomized Clinical Trial|A Randomized Clinical Trial Comparing Patellar Resurfacing Versus Patellar Retention in Total Knee Arthroplasty Using the PROFIX* Total Knee System|Completed||Phase 4|38|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 03:27:02.33974|2017-10-11 03:27:02.33974
NCT01500226|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-02-02|2015-10-02||February 2012||2012-02-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||"684 subjects were randomized to Rolapitant and 685 were randomized to control;
670 of those randomized to Rolapitant received study drug in C1; 674 of those who were randomized to control received study drug in C1.
4 Rolapitant subject and 8 control subject were from GCP-non-compliant sites.
MITT = 666 Rolapitant and 666 control"|Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy|Phase 3, Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy|Completed||Phase 3|1369|Actual|Tesaro, Inc.||2|||f||||f||||||||||2017-10-11 03:27:02.827085|2017-10-11 03:27:02.827085
NCT01500213|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-02-02|2015-10-02||February 2012||2012-02-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|HEC|MITT population: 278 subjects were randomized to Rolapitant and 277 were randomized to control, 272 of those randomized to Rolapitant received study drug in C1; 274 of those who were randomized to control received study drug in C1, 1 Rolapitant subject and 1 control subject were from GCP-non-compliant sites.|Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy|A Phase 3, Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy|Completed||Phase 3|555|Actual|Tesaro, Inc.||2|||f||||f||||||||||2017-10-11 03:27:03.870136|2017-10-11 03:27:03.870136
NCT01500200|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-11-21||2013-11-08|December 2011||2011-12-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)|A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy|Completed||Phase 2|142|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-10-11 03:27:04.686674|2017-10-11 03:27:04.686674
NCT01500187|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2015-01-15|||February 2012||2012-02-01|December 2013|2013-12-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Fluoride Varnish for Treatment of White Spot Lesions|Fluoride Varnish Application for Treatment of White Spot Lesion After Fixed Orthodontic Treatment. A Pilot Study.|Completed||N/A|30|Anticipated|3M||2|||f||||f||||||||||2017-10-11 03:27:04.7998|2017-10-11 03:27:04.7998
NCT01500174|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2012-09-04|||November 2007||2007-11-01|September 2012|2012-09-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||Ultraviolet-C Effectiveness in the Management of Pressure Ulcers in People With Spinal Cord Injury|Ultraviolet-C Irradiation in the Management of Pressure Ulcers in People With Spinal Cord Injury: A Randomized, Stratified, Placebo-controlled Trial|Completed||N/A|43|Actual|Toronto Rehabilitation Institute||2|||f||||f||||||||||2017-10-11 03:27:04.876564|2017-10-11 03:27:04.876564
NCT01500161|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-11-21|||November 2011||2011-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match|A Phase II Study Of Pooled Unrelated Donor Umbilical Cord Blood (UCB) Transplant For Patients With Hematologic Malignancies Needing Allogeneic Stem Cell Transplant But Do Not Have A Related HLA-Matched Donor|Terminated||Phase 2|1|Actual|Texas Oncology Cancer Center||1||Insufficient accruals|f||||t||||||||||2017-10-11 03:27:04.965504|2017-10-11 03:27:04.965504
NCT01500148|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-01-20|||December 2011||2011-12-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|SJM PMVr||St. Jude Medical Percutaneous Mitral Valve Repair Study|Clinical Assessment of the St. Jude Medical (SJM) Percutaneous Mitral Valve Repair (PMVr) Device Concept|Completed||Phase 1|2|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 03:27:05.085765|2017-10-11 03:27:05.085765
NCT01500135|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-12-15|2016-12-15|2016-08-19|March 2012||2012-03-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|VASUS|Full Analysis Set included all randomized participants.|Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery|A Randomized, Open Label, Parallel-group, Multi-center Trial to Compare Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery|Completed||Phase 3|150|Actual|Takeda||2|||f||||t||||||||||2017-10-11 03:27:06.835486|2017-10-11 03:27:06.835486
NCT01500122|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-06-20|||December 2011||2011-12-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX®|An Open-label, Non Randomized Monocentric Phase I Study Evaluation the Pharmacokinetic Profile of Novel Formulations of RHUDEX®|Completed||Phase 1|12|Anticipated|MediGene||1|||f||||f||||||||||2017-10-11 03:27:07.948863|2017-10-11 03:27:07.948863
NCT01500109|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2015-04-15|2015-03-23||November 2011||2011-11-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair|Analgesic Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair; a Randomized, Double, Blinded, Placebo Controlled Study|Completed||N/A|45|Actual|Loma Linda University||3|||f||||f||||||||||2017-10-11 03:27:08.050514|2017-10-11 03:27:08.050514
NCT01500083|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-06-29|2014-10-10||March 2012||2012-03-01|June 2017|2017-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|BENDACT|all-patients-treated set (APTS): all enrolled patients who took at least one dose of investigational medicinal product (IMP)|Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia|An Open-Label Expanded Access Trial for Bendamustine HCl in Patients With Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia|Completed||Phase 3|90|Actual|Lundbeck Canada Inc.||2|||f||||f||||||||||2017-10-11 03:27:08.670172|2017-10-11 03:27:08.670172
NCT01500070|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-08-10|||August 2012||2012-08-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PREVENT||PREVENT: Promus BTK|PREVENT: a Prospective, Multi-center, Monitored Trial Investigating the Implant of the Promus Everolimus-Eluting Stent System in Critically Ischemic Lesions BTK|Completed||Phase 2|70|Anticipated|Flanders Medical Research Program||1|||f||||t||||||||||2017-10-11 03:27:09.448851|2017-10-11 03:27:09.448851
NCT01500057|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-01-30|||December 2011||2011-12-01|January 2017|2017-01-01|October 10, 2016|Actual|2016-10-10|October 10, 2016|Actual|2016-10-10||Interventional|||Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia|An Open-Label Randomized Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia|Completed||Phase 4|60|Actual|Brooklyn Urology Research Group||2|||f||||f||||||||||2017-10-11 03:27:09.585529|2017-10-11 03:27:09.585529
NCT01500044|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-07-02|||January 2012||2012-01-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Mobilizations and Exercises Targeting the Opening of Intervertebral Foramens Following Cervical Radiculopathy|Cervical Radiculopathy: A Randomized Clinical Trial Evaluating the Effect of Mobilizations and Exercises Targeting the Opening of Intervertebral Foramens|Completed||N/A|36|Actual|Laval University||2|||f||||f||||||||||2017-10-11 03:27:09.675595|2017-10-11 03:27:09.675595
NCT01500031|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-03-10|2014-01-06||April 2012||2012-04-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|Re-ROUTE||Boston Scientific OffRoad™ Re-entry Catheter System for Subintimal Recanalization of Chronic Total Occlusions in Femoropopliteal Arteries|Boston Scientific OffRoad™ Re-entry Catheter System for Subintimal Recanalization of Chronic Total Occlusions in Femoropopliteal Arteries|Completed||Phase 4|92|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-10-11 03:27:09.790778|2017-10-11 03:27:09.790778
NCT01500018|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-03-21|||January 2012||2012-01-01|March 2012|2012-03-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|TC-5214||Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214|A Single-center, Single-dose, Double-blind, Randomized, Placebo- and Active-controlled Crossover Study to Evaluate the Abuse Potential of TC-5214 in Healthy Recreational Polydrug Users|Withdrawn||Phase 1|0|Actual|AstraZeneca||14||Sponsor decision to withdraw.|f||||||||||||||2017-10-11 03:27:10.526955|2017-10-11 03:27:10.526955
NCT01500005|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-15|2011-12-23|||August 2010||2010-08-01|December 2011|2011-12-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||The Effect of Vitamin D Supplementation on Arterial Stiffness in Diabetic Patients|The Effect of Vitamin D Supplementation on Arterial Stiffness, Blood Pressure, Oxidative Stress and Inflammation in Diabetic Patients|Completed||N/A|74|Actual|Assaf-Harofeh Medical Center||1|||f||||f||||||||||2017-10-11 03:27:10.758385|2017-10-11 03:27:10.758385
NCT01499992|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-03-18|||January 2012||2012-01-01|January 2012|2012-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Rehabilitation of Reconstructed Shoulder Rotator Cuff|Rehabilitation of Reconstructed Shoulder Rotator Cuff : Optimizing Physical Therapy Dosage and Effect of Aquatic Physical Therapy - A Randomized, Factorial Study|Completed||N/A|14|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:27:10.84803|2017-10-11 03:27:10.84803
NCT01499979|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-01-25|||February 2012||2012-02-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|||Hypothermic Perfusion During Hemihepatectomy|In Situ Hypothermic Perfusion During Right Hemihepatectomy|Completed||N/A|22|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||f||||||||Undecided||2017-10-11 03:27:10.940816|2017-10-11 03:27:10.940816
NCT01499966|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2011-12-23|||January 2011||2011-01-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|POPTuLAS||Comparison of Plaster of Paris Against Tubigrip for the Treatment of Lateral Ankle Sprains|Assessment of Tubigrip Versus Plaster of Paris in the Treatment of Grade 1 and 2 Lateral Ankle Sprains|Completed||N/A|200|Actual|Liaquat National Hospital & Medical College||2|||f||||f||||||||||2017-10-11 03:27:11.043443|2017-10-11 03:27:11.043443
NCT01499953|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-09-12|||April 2012||2012-04-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux|Superficial Vein Thrombosis (SVT) Treated for Forty-five Days With Rivaroxaban Versus Fondaparinux|Completed||Phase 3|472|Actual|GWT-TUD GmbH||2|||f||||t||||||||||2017-10-11 03:27:11.146723|2017-10-11 03:27:11.146723
NCT01499940|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-11-02|||January 2012||2012-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway|Phase II Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through the Vitamin D Pathway|Terminated||Phase 2|9|Actual|West Virginia University||1||Research cancelled - no funding identified.|f||||t||||||||||2017-10-11 03:27:11.329701|2017-10-11 03:27:11.329701
NCT01499927|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2013-12-18|||January 2012||2012-01-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|AIR||"Early Reassessment of Intravenous Antiinfective Therapy Due to Antiinfective Reminders (AIR Study)"|"Early Reassessment of Intravenous Antiinfective Therapy Due to Antiinfective Reminders (AIR Study)"|Completed||N/A|74766|Actual|University of Zurich||2|||f||||f||||||||||2017-10-11 03:27:11.424687|2017-10-11 03:27:11.424687
NCT01499914|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-08-25|||November 2009||2009-11-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|January 2011|Actual|2011-01-01||Interventional|MUCOFLU||Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination|Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination in Patients With Cystic Fibrosis and, Where Applicable, the Clinical Expression of Influenza A (H1N1)|Completed||Phase 4|439|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 03:27:11.511083|2017-10-11 03:27:11.511083
NCT01499901|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-11-16|||January 2012||2012-01-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|Cochleo||Comparison of the Bilateral Sequential and Simultaneous Cochlear Implantation in the Deaf Children|Interest of the Bilateral Cochlear Implantation in the Deep Deaf Children Respect to the Unilateral Implantation - a Randomized Test|Withdrawn||Phase 3|0|Actual|Assistance Publique - Hôpitaux de Paris||2||Recommendations of HAS have changed, the study is now useless|f||||t||||||||||2017-10-11 03:27:11.595379|2017-10-11 03:27:11.595379
NCT01499888|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-04-19|||November 11, 2011|Actual|2011-11-11|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)|Phase I/II Study of Allogeneic Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease (SCD)|Recruiting||Phase 1/Phase 2|15|Anticipated|University of Illinois at Chicago||1|||f||||t|t|f|||f|||||2017-10-11 03:27:11.677188|2017-10-11 03:27:11.677188
NCT01499875|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2014-09-30|||January 2012||2012-01-01|January 2013|2013-01-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||A Pharmacokinetic and Pharmacodynamic Study of Phenoxymethylpenicillin for Children|A Pharmacokinetic and Pharmacodynamic Study of Phenoxymethylpenicillin for Children|Completed||Phase 1|80|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 03:27:11.783893|2017-10-11 03:27:11.783893
NCT01499862|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-06-30|2012-06-18||June 2009||2009-06-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Mobility Training Using a Bionic Knee Orthosis in Patients Chronic Post-Stroke: A Case Series|Discriminatory Neurosensory Stimulation Neurological H5394-11417-15|Completed||Phase 4|3|Actual|Tibion Bionics, Inc.|These results are from a small group (n of 3) of patients and should not be assumed to be consistent across all populations. Furthermore, the inherent subjective variability of patient response in physical therapy interventions should be considered.|1|||f||||f||||||||||2017-10-11 03:27:11.890412|2017-10-11 03:27:11.890412
NCT01499849|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-04-19|2015-10-02||February 2012||2012-02-01|October 2012|2012-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||"Overall Number of Baseline Participants only included the Modified Intent to Treat (MITT) population:
266 subjects were randomized to Rolapitant and 266 were randomized to control;
264 of those randomized to Rolapitant received study drug in Cycle 1; 262 of those who were randomized to control received study drug in Cycle 1."|Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy|Phase 3, Multicenter, Randomized, Double Blind, Active-Controlled Study of the Safety & Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)|Completed||Phase 3|532|Actual|Tesaro, Inc.||2|||f||||f||||||||||2017-10-11 03:27:12.345083|2017-10-11 03:27:12.345083
NCT01499836|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-10|2014-01-14|||January 2012||2012-01-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|PQSAT||Quality Study of Anesthetic Technique on Breast Cancer Surgery|Effect of Anesthetic Technique on Pain、 Recovery and Satisfaction in Women Undergoing Breast Surgery|Completed||Phase 4|101|Actual|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 03:27:13.073075|2017-10-11 03:27:13.073075
NCT01499823|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-12-27|||December 2011||2011-12-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|December 2011|Actual|2011-12-01||Observational|||Permeability Map to Distinguish Progression From Pseudoprogression in High-Grade Glioma|Permeability Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma|Unknown status|Enrolling by invitation|N/A|74|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 03:27:13.148447|2017-10-11 03:27:13.148447
NCT01499810|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-01-26|2014-09-04||March 2010||2010-03-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy and Safety of Radiofrequency Renal Denervation in Drug Resistant Hypertension|Study of Efficacy and Safety of Radiofrequency Sympathetic Renal Denervation for Treatment of Drug Resistant Hypertension|Completed||Phase 2/Phase 3|53|Actual|Federal State Budgetary Scientific Institution, Research Institute of Cardiology||1|||f||||f||||||||Undecided||2017-10-11 03:27:13.318605|2017-10-11 03:27:13.318605
NCT01499797|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2013-06-06|||January 2011||2011-01-01|October 2011|2011-10-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|CareWell||The CareWell-programme for Community-dwelling Frail Elderly Persons.|Towards a CARE AND WELFARE STANDARD for Community-dwelling Frail Elderly People With Complex Health Problems|Completed||N/A|536|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 03:27:14.551827|2017-10-11 03:27:14.551827
NCT01499784|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-10-26|||January 2012||2012-01-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Urinary Incontinence in an Inpatient Rehab Unit|Can Urinary Incontinence be Treated in an In-patient Rehabilitation Setting?|Completed||N/A|5|Actual|Shirley Ryan AbilityLab||1|||f||||f||||||||||2017-10-11 03:27:14.690154|2017-10-11 03:27:14.690154
NCT01499771|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-07-08|||October 2009||2009-10-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions|A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions.|Completed||Phase 1|80|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 03:27:14.769202|2017-10-11 03:27:14.769202
NCT01499758|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-07-08|||October 2009||2009-10-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.|A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.|Completed||Phase 1|80|Actual|Ranbaxy Inc.||2|||f||||f||||||||||2017-10-11 03:27:14.859538|2017-10-11 03:27:14.859538
NCT01499745|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2011-12-22|||January 2012||2012-01-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients|Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients|Unknown status|Not yet recruiting|N/A|40|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 03:27:14.987014|2017-10-11 03:27:14.987014
NCT01499563|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-03-09||2014-09-03|December 2011||2011-12-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Study of a Novel Antipsychotic ITI-007 in Schizophrenia|A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Antipsychotic Efficacy of ITI-007 in Patients With Schizophrenia|Completed||Phase 2|335|Actual|Intra-Cellular Therapies, Inc.||4|||f||||f||||||||||2017-10-11 03:27:18.128985|2017-10-11 03:27:18.128985
NCT01499732|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-05-06|||December 2011||2011-12-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects|An Exploratory Trial to Evaluate Premature Endothelial Dysfunction, as Measured by Positron Emission Tomography (PET) Scan With Cold Pressor Test (CPT), in Patients With Early Rheumatoid Arthritis (RA) Compared to Patients With Established RA, and Normal Subjects. Additionally, the Relationship Between the PET Scan Findings and the Inflammatory, Cardiovascular Risk, and Endothelial Dysfunction Biomarkers Will be Analyzed|Completed||N/A|15|Actual|Orrin M Troum, M.D. and Medical Associates|||3||f||||f||||||||||2017-10-11 03:27:15.152633|2017-10-11 03:27:15.152633
NCT01499719|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-03-28|||December 2011||2011-12-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Surgery Checklist and Process Improvement Surrounding Endoscopic Sinus Surgery|Surgery Checklist and Process Improvement Surrounding Endoscopic Sinus Surgery|Completed||N/A|100|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 03:27:15.230703|2017-10-11 03:27:15.230703
NCT01499706|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2011-12-22|||November 2009||2009-11-01|December 2011|2011-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|MI||Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults|Phase I Clinical Trial of Telephone-delivered Motivational Interviewing to Reduce Sexual Risk Behavior in HIV-positive Persons 45-plus Years of Age|Completed||Phase 1|100|Actual|Ohio University College of Osteopathic Medicine||3|||f||||t||||||||||2017-10-11 03:27:15.323342|2017-10-11 03:27:15.323342
NCT01499693|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2012-09-14||||||September 2012|2012-09-01||||||||Interventional|||Magnesium Pantoprazole 20mg b.i.d. vs Magnesium Pantoprazole 40mg q.d. on Intragastric Acid Inhibition|Phase IIIb, Randomized, Triple-blinded and Crossover Study to Evaluate the Effect of Magnesium Pantoprazole 20mg Bid Versus Magnesium Pantoprazole 40mg qd on Intragastric Acid Inhibition Assessed by pHmetry, in Healthy Volunteers|Withdrawn||Phase 3|0|Actual|Takeda||2|||f||||t||||||||||2017-10-11 03:27:15.429228|2017-10-11 03:27:15.429228
NCT01499680|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-07-14|||October 2011||2011-10-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|NV in XLIF®||Multimodality Neuromonitoring in XLIF|Multimodality Neuromonitoring In eXtreme Lateral Interbody Fusion (XLIF®)|Completed||N/A|323|Actual|NuVasive|||1||f||||f||||||||||2017-10-11 03:27:15.55086|2017-10-11 03:27:15.55086
NCT01499667|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2014-08-06|2013-11-25||September 2011||2011-09-01|August 2014|2014-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|TOFIINGO|Randomized set includes all subjects who receive a randomization number, regardless of whether or not they receive study medication.|Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod|A 32-week, Patient- and Rater-blinded, Randomized, Multi-center, Parallel-group Study to Evaluate Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis Transferred From Previous Treatment With Natalizumab to Fingolimod (FTY720)|Terminated||Phase 3|142|Actual|Novartis|Study was terminated due to new data on nataluzimab washout prior to treatment with other disease modifying treatments. The power to detect statistically significant differences between the washout groups based on the (-)binomial is estimated 30-40%.|3||"Based on recent publications, determination of natalizumub washout period was no longer   relevant."|f||||f||||||||||2017-10-11 03:27:15.694354|2017-10-11 03:27:15.694354
NCT01499654|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-01-27|2015-12-18||October 2011||2011-10-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|REGA-1102||Half-Dose Radiopharmaceutical in Wide Beam Reconstruction|Feasibility of Half-Dose Radiopharmaceutical Administration Utilizing Wide-Beam Reconstruction|Terminated||N/A|64|Actual|Northwestern University|Early termination of study lead to a small numbers of subjects analyzed. Technical problems in WBR processing settings including acquisition matrix sizes and/or number of iterations.|1||Low enrollment|f||||f||||||||||2017-10-11 03:27:16.595255|2017-10-11 03:27:16.595255
NCT01499641|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-09-12|||May 2001||2001-05-01|September 2014|2014-09-01|December 2005|Actual|2005-12-01|August 2003|Actual|2003-08-01||Interventional|||Epidural Steroid Following Discectomy for Herniated Disc Reduces Morbidity|Epidural Steroid Following Discectomy for Herniated Lumbar Disc Reduces Neurological Impairment and Enhances Recovery. A Randomized Study With Two-year Follow-up|Completed||N/A|200|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 03:27:17.140878|2017-10-11 03:27:17.140878
NCT01499628|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-09-29|||April 2011||2011-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|EFFECT||EFFECT:Eccentric Fixation From Enhanced Clinical Training|Eccentric Fixation From Enhanced Clinical Training (EFFECT): A Randomised Clinical Trial for Patients With AMD|Active, not recruiting||N/A|200|Anticipated|Moorfields Eye Hospital NHS Foundation Trust||4|||f||||f||||||||||2017-10-11 03:27:17.273544|2017-10-11 03:27:17.273544
NCT01499615|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-04-07|||January 2012||2012-01-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||A Prospective Study of a New Non-Invasive Cardiac Output Monitor in Children Undergoing General Anesthesia|A Prospective Study of a New Non-Invasive Cardiac Output Monitor in Children Undergoing General Anesthesia|Completed||N/A|402|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 03:27:17.4752|2017-10-11 03:27:17.4752
NCT01499602|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2011-12-22|||May 2009||2009-05-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women|LNG-IUS or Norethisterone Acetate for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women|Completed||N/A|120|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 03:27:17.573832|2017-10-11 03:27:17.573832
NCT01499589|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2011-12-22|||October 2011||2011-10-01|December 2011|2011-12-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Observational|||Can the Usage of Regional Block Room Save the Time of Anesthesia Team|Can the Usage of Regional Block Room Save the Time of Anesthesia Team in the Main Orthopedic Operating Room?|Unknown status|Recruiting|N/A|800|Anticipated|Mahidol University|||2||f||||t||||||||||2017-10-11 03:27:17.691891|2017-10-11 03:27:17.691891
NCT01499576|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-09-20|2014-05-19||November 2011||2011-11-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|IM||Acetic Acid Chromoendoscopy to Judge Gastric Intestinal Metaplasia|Acetic Acid Chromoendoscopy for Judging Extent of Gastric Intestinal Metaplasia|Completed||N/A|126|Actual|Konyang University Hospital|Concomitant comparison with methylene blue chromoendoscopy was not performed.|1|||f||||t||||||||||2017-10-11 03:27:17.809236|2017-10-11 03:27:17.809236
NCT01499537|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2016-05-18|||January 2011||2011-01-01|February 2016|2016-02-01|March 2016|Actual|2016-03-01|February 2016|Actual|2016-02-01||Interventional|||Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct|Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct in Patients With Malignant or Post-operative Jaundice After Failure or Impossibility to Perform Endoscopic Retrograde Cholangiography|Completed||N/A|65|Actual|Institut Paoli-Calmettes||2|||f||||f||||||||||2017-10-11 03:27:18.310873|2017-10-11 03:27:18.310873
NCT01499524|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-01-09|||November 2011||2011-11-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||The Metabolic Profile in Intrahepatic Cholestasis of Pregnancy and Diabetes Mellitus|A Longitudinal Study of Alterations in Metabolic Markers and Gut Hormones in Pregnant and Non-pregnant Patients With Intrahepatic Cholestasis of Pregnancy, Gestational Diabetes Mellitus and Normal Pregnant and Non-pregnant Controls|Recruiting||Early Phase 1|160|Anticipated|Imperial College London|||1||f||||f||||||Samples Without DNA|"     Serum, whole blood, plasma.   "|No|Any results and findings will be disseminated in research publications.|2017-10-11 03:27:18.395348|2017-10-11 03:27:18.395348
NCT01499511|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-07|2011-12-22|||January 2012||2012-01-01|December 2011|2011-12-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Observational|ASCOT-10||Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study|Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study|Unknown status|Not yet recruiting|N/A|5450|Anticipated|Imperial College London|||1||f||||f||||||Samples Without DNA|"     Plasma to be stored for future measurement of biochemical markers of cardiovascular disease   "|||2017-10-11 03:27:18.472143|2017-10-11 03:27:18.472143
NCT01499498|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-10-26|2014-10-09||December 2012||2012-12-01|October 2014|2014-10-01|May 2014|Actual|2014-05-01|April 2013|Actual|2013-04-01||Interventional|||The Boceprevir and Sildenafil Pharmacokinetics Study|A Phase I Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of Boceprevir and Sildenafil When Dosed Separately and Together in Healthy Male Volunteers|Completed||Phase 1|13|Actual|Imperial College London||1|||f||||f||||||||Yes||2017-10-11 03:27:18.587065|2017-10-11 03:27:18.587065
NCT01499485|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-03-16|||November 2011||2011-11-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|TRAMA||Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.|Effects of Acetazolamide on the Duration of Mechanical Ventilation in Patients With Metabolic Alkalosis. Phase III Multicenter Double-blinded Clinical Trial.|Completed||Phase 3|140|Actual|Hospital Son Llatzer||2|||f||||f||||||||||2017-10-11 03:27:18.837649|2017-10-11 03:27:18.837649
NCT01499472|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2011-12-22|||January 2012||2012-01-01|August 2011|2011-08-01|January 2015|Anticipated|2015-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot Ulcers|ESWT Treatment of Diabetic Foot VS. Standard Care Trial|Unknown status|Not yet recruiting|N/A|300|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 03:27:18.965846|2017-10-11 03:27:18.965846
NCT01499446|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-09-13|||September 2003||2003-09-01|September 2016|2016-09-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.|A Randomised, Double-blind, Double Dummy, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening All Administered by Inhalation Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.|Completed||Phase 2|669|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:27:19.131141|2017-10-11 03:27:19.131141
NCT01499433|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2014-01-22|||January 2012||2012-01-01|January 2014|2014-01-01|November 2014|Anticipated|2014-11-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease|Prospective, Open-label Study of the Efficacy and Safety of Caspofungin for the Treatment of Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|Phase 4|40|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||1|||f||||t||||||||||2017-10-11 03:27:19.390272|2017-10-11 03:27:19.390272
NCT01499420|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-01-08||2014-01-08|February 2012||2012-02-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients|A Phase 2a, Multi-center, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of a Single Intravenous Infusion of CSL112 in Patients With Stable Atherothrombotic Disease|Completed||Phase 2|45|Actual|CSL Limited||2|||f||||||||||||||2017-10-11 03:27:19.519826|2017-10-11 03:27:19.519826
NCT01499407|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2012-01-02|||December 2011||2011-12-01|January 2012|2012-01-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|COCTAIL II||Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction|A Randomized Trial to Compare Four Different Intracoronary Modalities to Reduce Thrombus Burden and Improve Microcirculatory Function in Patients With ST-elevation Myocardial Infarction: Rationale and Design of the COCTAIL II Study|Unknown status|Recruiting|Phase 4|128|Anticipated|CLI Foundation||4|||f||||f||||||||||2017-10-11 03:27:19.626914|2017-10-11 03:27:19.626914
NCT01499394|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-06-07|||November 2010||2010-11-01|June 2016|2016-06-01|November 2025|Anticipated|2025-11-01|November 2020|Anticipated|2020-11-01||Observational|||Caris Biorepository Research Protocol|The Caris Biorepository Research Protocol|Active, not recruiting||N/A|100000|Anticipated|Caris Science, Inc.|||2||f||||f||||||Samples With DNA|"     Currently plasma with an opportunity to collect other biospecimens   "|||2017-10-11 03:27:19.709551|2017-10-11 03:27:19.709551
NCT01499381|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-06-07|||December 2011||2011-12-01|June 2016|2016-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||EMBRACE1: Prostate Biorepository|Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men With Elevated Risk for Prostate Cancer; the EMBRACE1 Study|Completed||N/A|1290|Actual|Caris Science, Inc.|||1||f||||f||||||Samples With DNA|"     Plasma   "|||2017-10-11 03:27:19.825989|2017-10-11 03:27:19.825989
NCT01499368|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2013-01-23|||November 2011||2011-11-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients|A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Koran Erosive Esophagitis Patients|Completed||Phase 3|495|Actual|Boryung Pharmaceutical Co., Ltd||3|||f||||t||||||||||2017-10-11 03:27:19.88852|2017-10-11 03:27:19.88852
NCT01499355|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-11-22|2016-11-22||July 2012||2012-07-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|ATLAS||BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis|Terminated||Phase 2|276|Actual|Biogen|Study was terminated based on the review of results following the prespecified, blinded futility analysis, which did not demonstrate sufficient efficacy to warrant continuation of the study. Study was not terminated based on safety considerations.|3||"Results from pre-specified criteria did not demonstrate sufficient efficacy to warrant   continuation of the study."|f||||t||||||||||2017-10-11 03:27:19.994075|2017-10-11 03:27:19.994075
NCT01499342|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2014-05-13|||November 2009||2009-11-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|BOSS||Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent in the Superficial Femoral Artery|Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent to Treat Atherosclerotic Lesions in the Superficial Femoral Artery|Completed||N/A|500|Anticipated|be Medical|||1||f||||f||||||||||2017-10-11 03:27:21.354716|2017-10-11 03:27:21.354716
NCT01499329|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-07-15|||December 2011||2011-12-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|EAZY||Safety and Performance of the Zeus CC Stent for the Treatment of Iliac Occlusive Disease|Endovascular Treatment of Iliac Artery Occlusions or Stenoses Using the Zeus CC Stent System|Unknown status|Recruiting|N/A|200|Anticipated|be Medical|||1||f||||f||||||||||2017-10-11 03:27:21.434106|2017-10-11 03:27:21.434106
NCT01499316|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-03-06|||March 2014||2014-03-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Investigating the Effects of Hyperoxia on Fractional Flow Reserve|Investigating the Effects of Hyperoxia on Fractional Flow Reserve in Patients With Moderate Coronary Artery Disease|Unknown status|Not yet recruiting|N/A|18|Anticipated|Bayside Health||2|||f||||f||||||||||2017-10-11 03:27:21.54551|2017-10-11 03:27:21.54551
NCT01499303|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-08-08|2014-06-17||December 2011||2011-12-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Most patients were male (69.1%). The mean age (± standard deviation) was 63.6 ± 12.6 years.|Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer|Phase II Trial to Evaluate the Efficacy of Fostamatinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma(DLBCL)|Completed||Phase 2|101|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 03:27:21.83155|2017-10-11 03:27:21.83155
NCT01499290|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2017-08-31|2015-11-06||March 2012||2012-03-01|August 2017|2017-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||The MITT analysis set includes all patients who met the disease definition for cIAI and received at least 1 dose of study drug. 15 patients excluded received at least one dose of study drug but failed the minimum disease criteria.|Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections|A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In Hospitalized Adults|Completed||Phase 3|493|Actual|Pfizer|This summary describes data collected from two identical CSPs (D4280C00001 and D4280C00005). With agreement from the EMA and the FDA the data have been combined into a single study database.|2|||f||||||||||||||2017-10-11 03:27:22.510824|2017-10-11 03:27:22.510824
NCT01499277|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-09-01|2015-06-23||May 2012||2012-05-01|September 2017|2017-09-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional||761 randomized patients who received any amount of study therapy. there are 11 patients who are randomized , but didn't receive any study therapy.|Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections|A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities|Completed||Phase 3|802|Actual|Pfizer||2|||f||||||||||||||2017-10-11 03:27:24.467317|2017-10-11 03:27:24.467317
NCT01499264|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-01-10|||January 2012||2012-01-01|January 2014|2014-01-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|||Efficacy of MySkin Patch for the Healing of Burn Wounds: a Randomised Controlled Trial|Efficacy of MySkin Patch for the Healing of Burn Wounds: a Randomised Controlled Trial|Unknown status|Recruiting|Phase 3|120|Anticipated|Associazione Infermieristica per lo studio delle Lesioni Cutanee||2|||f||||t||||||||||2017-10-11 03:27:25.622514|2017-10-11 03:27:25.622514
NCT01499251|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-05-04|||January 2012||2012-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma|A Phase 1/1b, Open-label Study in Patients With Recurrent Glioblastoma to Assess the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide|Terminated||Phase 1|75|Anticipated|Actelion||1||Results did not clearly support continuing development in recurrent GBM|f||||f||||||||||2017-10-11 03:27:25.710812|2017-10-11 03:27:25.710812
NCT01411449|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-03-16|||March 11, 2008|Actual|2008-03-11|March 2017|2017-03-01|February 18, 2015|Actual|2015-02-18|December 14, 2010|Actual|2010-12-14||Observational|PRIMOVIST||Primovist Post-marketing Surveillance in Japan|Drug Use Investigation of EOB-Primovist Inj. Syringe|Completed||N/A|2030|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:57:02.930224|2017-10-11 03:57:02.930224
NCT01499238|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2011-12-21|||December 2011||2011-12-01|December 2011|2011-12-01|March 2012|Anticipated|2012-03-01|February 2012|Anticipated|2012-02-01||Interventional|||Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn|Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn|Unknown status|Recruiting|Phase 4|40|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||t||||||||||2017-10-11 03:27:25.804747|2017-10-11 03:27:25.804747
NCT01499225|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-07-30|||December 2011||2011-12-01|July 2014|2014-07-01||||July 2013|Actual|2013-07-01||Interventional|YH14642||A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease|A Double-blind, Randomized, Parallel, Placebo-active Controlled, Multi-center Phase II Clinical Trial to Investigate the Efficacy and Safety of YH14642 Following 12-week Oral Administration in Patients With Chronic Periodontal Disease|Completed||Phase 2|162|Anticipated|Yuhan Corporation||6|||f||||f||||||||||2017-10-11 03:27:25.913271|2017-10-11 03:27:25.913271
NCT01499212|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2011-12-21|||July 2011||2011-07-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Effects of Different I:E Ratio on Intrapulmonary Shunt Fraction and Oxygenation During One Lung Ventilation in the Lateral Decubitus Position|Effects of Different Inspiratory to Expiratory Ratios on Intrapulmonary Shunt Fraction and Oxygenation During One Lung Ventilation in the Lateral Decubitus Position|Completed||N/A|58|Actual|Yonsei University||1|||f||||t||||||||||2017-10-11 03:27:27.856768|2017-10-11 03:27:27.856768
NCT01499199|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2015-01-15|2013-08-15||January 2012||2012-01-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|October 2012|Actual|2012-10-01||Interventional|||A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects|A Single-arm Study of the Safety, Efficacy and Central Nervous System and Plasma PK of GSK1349572 (Dolutegravir, DTG) 50 mg Once Daily in Combination With the Abacavir/Lamivudine Fixed Dose Combination Tablet Over 96 Weeks in HIV-1 Infected Antiretroviral Naive Adult Subjects|Completed||Phase 3|13|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-10-11 03:27:27.983566|2017-10-11 03:27:27.983566
NCT01499186|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-03-17|||January 2012||2012-01-01|December 2013|2013-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Effect of 6 Months of Local Vibration Training in Institutionalized Elderly|The Effect of 6 Months of Local Vibration Training of the Thigh and Hip on Muscle Strength, Muscle Mass, Bone Density, Bone Structure and Functionality in Institutionalized Elderly.|Completed||N/A|50|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 03:27:28.960948|2017-10-11 03:27:28.960948
NCT01499173|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-08-04|2016-12-15||December 2014||2014-12-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|August 2015|Actual|2015-08-01||Interventional|||A Community Partnership to Treat Stroke|A Community Partnership to Treat Stroke|Completed||N/A|101|Actual|University of Michigan|Because this was a pre-post design, it cannot be the basis for a conclusion that Stroke Ready caused an increase in stroke preparedness and psychological variables|1|||f||||f|f|f||||||||2017-10-11 03:27:29.124027|2017-10-11 03:27:29.124027
NCT01499147|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-05-17|2015-06-19||February 2000||2000-02-01|May 2017|2017-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies|Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies|Completed||N/A|100|Actual|University of Illinois at Chicago||2|||f||||t||||||||Yes||2017-10-11 03:27:29.7401|2017-10-11 03:27:29.7401
NCT01499134|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-12-02|2014-07-29||August 2011||2011-08-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|ENCOMPASS|Original sample size for pilot study was fixed at 40 subjects. Lagging enrollment necessitated completion at 17 subjects.|Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure|Effect of Nebivolol Compared With Metoprolol in Hypertensive Patients With Peripheral Arterial Disease|Completed||Phase 3|17|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 03:27:30.215969|2017-10-11 03:27:30.215969
NCT01499121|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-05-30|||May 2012||2012-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule|A Phase II, Multi-Centre, Study of the Efficacy and Safety of Sunitinib Given on an Individualized Schedule as First-Line Therapy for Metastatic Renal Cell Cancer|Active, not recruiting||Phase 2|110|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-10-11 03:27:30.8365|2017-10-11 03:27:30.8365
NCT01499108|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-01-30|||August 2012||2012-08-01|July 2013|2013-07-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|Liratime||Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes|Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes|Completed||Phase 4|32|Actual|Steno Diabetes Center||1|||f||||t||||||||||2017-10-11 03:27:30.948503|2017-10-11 03:27:30.948503
NCT01499095|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-09-27|2015-03-24|2014-04-08|December 2011||2011-12-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|EDITION II|Randomized population: all screened participants (who originally met inclusion criteria and signed informed consent) allocated to a treatment group and recorded in Interactive Voice/Web Response System (IVRS/IWRS) database, regardless of whether treatment was used or not. Participants were analyzed in treatment group to which they were randomized.|Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy|6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Patients With Type 2 Diabetes Mellitus With a 6-month Safety Extension Period|Completed||Phase 3|811|Actual|Sanofi||2|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-11 03:27:31.247183|2017-10-11 03:27:31.247183
NCT01499082|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-09-27|2015-03-24|2014-02-13|December 2011||2011-12-01|September 2016|2016-09-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|EDITION I|Randomized population: all screened participants (who originally met inclusion criteria and signed informed consent) allocated to a treatment group and recorded in Interactive Voice/Web Response System (IVRS/IWRS) database, regardless of whether treatment was used or not. Participants were analyzed in treatment group to which they were randomized.|Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin|6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Both Plus Mealtime Insulin in Patients With Type 2 Diabetes Mellitus With a 6-month Safety Extension Period|Completed||Phase 3|807|Actual|Sanofi||2|||f||||||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-11 03:27:32.824947|2017-10-11 03:27:32.824947
NCT01499069|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-02-12|||February 2010||2010-02-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients|Urinary NGF, PGE2 and ATP: Potential Biomarkers for Diagnosis and Prediction of Treatment Efficacy in Overactive Bladder Patients|Unknown status|Recruiting|N/A|197|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:27:34.883193|2017-10-11 03:27:34.883193
NCT01499056|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-17|2011-12-21|||June 2010||2010-06-01|January 2010|2010-01-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Mesenchymal Stem Cell Transplantation in Osteoarthritis of Hip Joint|Evaluation the Side Effect of Bone Marrow Derived Mesenchymal Stem Cell in Patients With Osteoarthritis of Hip Joint|Completed||Phase 1|6|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 03:27:35.114255|2017-10-11 03:27:35.114255
NCT01499043|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-03-23||2015-03-23|March 2012||2012-03-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)|A Pilot Study of PLX3397 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients With Bone Metastasis and High Circulating Tumor Cell (CTC)Counts|Completed||Phase 2|6|Actual|Plexxikon||1|||f||||f||||||||||2017-10-11 03:27:35.240026|2017-10-11 03:27:35.240026
NCT01499030|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2011-12-21|||November 2011||2011-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:27:35.336981|2017-10-11 03:27:35.336981
NCT01499017|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-01-27|||November 2011||2011-11-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Single Dose Study Of PF-06291874 In Healthy Adult Subjects|A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo-Controlled, Single Dose Escalating Study To Assess The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of PF-06291874 After Administration Under Fasted And Fed Conditions In Healthy Adult Subjects|Terminated||Phase 1|9|Actual|Pfizer||2||See termination reason in detailed description.|f||||f||||||||||2017-10-11 03:27:35.394837|2017-10-11 03:27:35.394837
NCT01499004|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2012-01-11|||November 2011||2011-11-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of Three Modified Release And One Immediate Release Formulations Of Tofacitinib (CP-690,550) In Healthy Volunteers|A Phase 1, Randomized, Open Label, Partial Crossover Study To Evaluate The Pharmacokinetics (PK) And Safety Of Three Modified Release (MR) And One Immediate Release (IR) Formulations Of Tofacitinib (CP-690,550) In Healthy Volunteers|Completed||Phase 1|30|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 03:27:35.526038|2017-10-11 03:27:35.526038
NCT01498991|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-11-23|||November 2011||2011-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|AMES||Spinal Cord Injury Leg Rehabilitation|Rehabilitation of the Lower Extremity With AMES Following Incomplete Spinal Cord Injury (SCI)|Completed||Phase 1/Phase 2|17|Actual|Oregon Health and Science University||1|||f||||t||||||||No||2017-10-11 03:27:35.642213|2017-10-11 03:27:35.642213
NCT01498965|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-01-20|||August 2008||2008-08-01|January 2015|2015-01-01|January 2017|Anticipated|2017-01-01|October 2016|Anticipated|2016-10-01||Observational|BASELINE||The Cork BASELINE Birth Cohort Study|BASELINE: Babies After Scope: Evaluating the Longitudinal Impact Using Neurological and Nutritional Endpoints|Unknown status|Active, not recruiting|N/A|2185|Actual|National Children's Research Centre, Ireland|||1||f||||t||||||Samples With DNA|"     MAternal DNA, plasma, serum and urine Umbilical serum, plasma, DNA, RNA At 2 years and 5     years: serum, and DNA   "|||2017-10-11 03:27:35.896889|2017-10-11 03:27:35.896889
NCT01498952|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2013-11-26|||January 2012||2012-01-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|MEDI-573-1028||MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.|A Phase 1b/2, Open-label, Randomized Study of MEDI-573 in Combination With Sorafenib Verses Sorafenib Alone in Adult Subjects With Unresectable or Metastatic Hepatocellular Carcinoma|Completed||Phase 1|6|Actual|MedImmune LLC||3|||f||||f||||||||||2017-10-11 03:27:36.014847|2017-10-11 03:27:36.014847
NCT01498939|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-10-27|||August 2007||2007-08-01|October 2016|2016-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Pharmacokinetics of Insulin Detemir in Healthy Chinese Male Subjects|A Single Centre, Randomised, Double-blind, Three-period Cross-over Trial to Investigate the 24-hour Pharmacokinetics After Single Dose of Insulin Detemir in Healthy Chinese Male Subjects|Completed||Phase 1|20|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:27:36.123882|2017-10-11 03:27:36.123882
NCT00005417|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1991||1991-09-01|May 2000|2000-05-01|September 1993|Actual|1993-09-01|||||Observational|||Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.338961|2017-10-11 04:27:02.338961
NCT01498926|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-01-13|||November 2005||2005-11-01|January 2015|2015-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Comparison of Two Insulin Detemir Formulations in Healthy Volunteers|A Randomised, Single Centre, Two-period, Cross-over, Glucose Clamp Trial to Test for Bioequivalence Between Two Insulin Detemir Formulations Containing Mannitol and Glycerol as Isotonic Agents Respectively, in Healthy Subjects|Completed||Phase 1|34|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:27:36.222382|2017-10-11 03:27:36.222382
NCT01498913|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-02-17|||August 30, 2001|Actual|2001-08-30|February 2017|2017-02-01|March 25, 2005|Actual|2005-03-25|March 25, 2005|Actual|2005-03-25||Observational|||Observational Study of NovoNorm® in Subjects With Diabetes|NovoNorm Post Marketing Surveillance Study|Completed||N/A|5841|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:27:36.343249|2017-10-11 03:27:36.343249
NCT01498900|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-10-26|||August 2004||2004-08-01|October 2016|2016-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice|A Multi-center, Prospective, Non-interventional Evaluation of Efficacy, Safety and Convenience of Using NovoNorm® in the Treatment of Type 2 Diabetic Patients in Routine Clinical Practice|Completed||N/A|30554|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:27:36.934058|2017-10-11 03:27:36.934058
NCT01498887|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2017-05-03|||December 21, 2011|Actual|2011-12-21|May 2017|2017-05-01|December 23, 2015|Actual|2015-12-23|December 23, 2015|Actual|2015-12-23||Interventional|EARLiMS||Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy|A Multi-centre, Open-label, Non-randomised, Parallel Group Clinical Trial to Assess the Efficacy of Fingolimod in Naive Patients Versus Fingolimod in Patients Previously Treated With Interferons or Glatiramer Acetate, Based on the Presence of Relapses in Patients With Relapsing-remitting Multiple Sclerosis.|Completed||Phase 4|349|Actual|Novartis||1|||f|||||f|f||||||No||2017-10-11 03:27:37.033994|2017-10-11 03:27:37.033994
NCT01498874|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-03-03|||December 2011||2011-12-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris|Completed||Phase 2|127|Actual|XOMA (US) LLC||3|||f||||f||||||||||2017-10-11 03:27:37.444002|2017-10-11 03:27:37.444002
NCT01498861|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2012-05-17|||December 2011||2011-12-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol|A Double-Blind Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol When Co-administered With Dolutegravir in Healthy Adult Female Subjects|Completed||Phase 1|16|Actual|ViiV Healthcare||3|||f||||f||||||||||2017-10-11 03:27:37.612728|2017-10-11 03:27:37.612728
NCT01498848|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2013-06-18|||June 2011||2011-06-01|June 2013|2013-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Cooking Oils on Whole Blood and Saliva Fatty Acids in Children in Bogota, Colombia|Effect of Cooking Oils on Whole Blood and Saliva Fatty Acids in Children in Bogota, Colombia|Completed||N/A|60|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:27:37.749472|2017-10-11 03:27:37.749472
NCT01498835|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-08-25|||February 2012||2012-02-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|SunRaSe||Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma|Phase 1 Trial of Concurrent Sunitinib and Radiation Therapy as Preoperative Treatment for Locally Advanced or Recurrent Soft Tissue Sarcoma.|Completed||Phase 1|9|Actual|Heidelberg University||1|||f||||t||||||||||2017-10-11 03:27:37.850429|2017-10-11 03:27:37.850429
NCT01498822|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-07-24|2015-06-25||June 2011||2011-06-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|OPTIMAL|Baseline Characteristics refer to the Randomized Set, consisting of all subjects who were randomized in this study.|Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy|A Multi-Center, Open-label, Randomized Study to Evaluate the Long Term Effectiveness of Levetiracetam as Monotherapy in Comparison With Oxcarbazepine in Subjects With Newly or Recently Diagnosed Partial Epilepsy|Completed||Phase 4|353|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:27:38.00692|2017-10-11 03:27:38.00692
NCT01498809|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-03-14|||March 2012||2012-03-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Blood Pressure and Brain Blood Flow Regulation After Midodrine Administration in Those With Spinal Cord Injury|Neural and Mechanical Baroreflex Sensitivity and Cerebral Blood Flow|Completed||N/A|22|Actual|University of British Columbia|||1||f||||t||||||||||2017-10-11 03:27:38.678678|2017-10-11 03:27:38.678678
NCT01498796|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2011-12-22||||||December 2011|2011-12-01||||||||Interventional|KITS||KITS Study -Ketorolac In Tonsillectomy Surgery: a Double Blinded, Randomized Clinical Trial|KITS Study -Ketorolac In Tonsillectomy Surgery: a Double Blinded, Randomized Clinical Trial|Unknown status|Recruiting|N/A|||University of Alberta||2|||f||||f||||||||||2017-10-11 03:27:38.758549|2017-10-11 03:27:38.758549
NCT01498783|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-02-01|||December 2011||2011-12-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|SJREFU||Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma|Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma|Completed||Phase 1|26|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 03:27:38.854734|2017-10-11 03:27:38.854734
NCT01498770|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-06-07|||April 1, 2013|Actual|2013-04-01|June 2017|2017-06-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|||An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)|An Observational Drug Utilization Study of SYCREST^® (Asenapine) in the United Kingdom|Recruiting||N/A|3000|Anticipated|Merck Sharp & Dohme Corp.|||13||f||||f||||||||||2017-10-11 03:27:38.956866|2017-10-11 03:27:38.956866
NCT01498757|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-12-28|||January 2012||2012-01-01|December 2015|2015-12-01||||June 2012|Actual|2012-06-01||Observational|||Genome-wide Association Study|Genome-wide Association Study to Predict Treatment Response for Chemotherapy in Esophageal Squamous Cell Carcinoma|Withdrawn||N/A|0|Actual|Samsung Medical Center|||1|Registration poor|f||||f||||||||||2017-10-11 03:27:39.111577|2017-10-11 03:27:39.111577
NCT01497704|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2017-09-26||2017-03-15|April 2012||2012-04-01|September 2017|2017-09-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Dose-Escalation and Safety Trial of YN968D1|Evaluation of the Safety, Pharmacokinetics and Efficacy of Four Doses of YN968D1 in Subjects With Solid Tumors|Completed||Phase 1/Phase 2|55|Actual|LSK BioPartners Inc.||1|||f||||f||||||||||2017-10-11 03:28:01.257973|2017-10-11 03:28:01.257973
NCT01498744|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-01-27|2015-11-11||February 2010||2010-02-01|January 2016|2016-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Abscess|Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Skin and Soft Tissue Abscess Undergoing Incision and Drainage|Terminated||N/A|53|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|Inadequate enrollment numbers leading to early termination of study.|2||The study was closed due to poor enrollment and lack of interest.|f||||f||||||||No||2017-10-11 03:27:39.214234|2017-10-11 03:27:39.214234
NCT01498731|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2013-06-04|||April 2011||2011-04-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|BiC-8||Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS)|The Effect of Integrating the Biomarker Copeptin Into the Process of Managing Patients With Suspected ACS|Completed||N/A|902|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:27:39.598754|2017-10-11 03:27:39.598754
NCT01498718|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-03-23|||December 2011||2011-12-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone|Double-Blind, Randomized Phase 1b Study of 2011/12 Influenza Investigational DNA Vaccine, VRC-FLUDNA061-00-VP, Followed by 2012/13 Trivalent Inactivated Vaccine (TIV) Compared to 2012/13 TIV Alone in Healthy Adults|Completed||Phase 1|131|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-11 03:27:39.751094|2017-10-11 03:27:39.751094
NCT01498705|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-01-31|||December 2011||2011-12-01|January 2014|2014-01-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Observational|||The Natural History of Procalcitonin in Hemorrhagic Stroke|The Natural History of Procalcitonin in Hemorrhagic Stroke|Withdrawn||N/A|0|Actual|CAMC Health System|||1|Anticipated grant was withdrawn and additional funding was unable to be obtained|f||||f||||||Samples Without DNA|"     3 mL of blood will be obtained for each PCT sample and will be sent to the Virology lab at     CAMC Memorial hospital where the serum will be frozen until all samples are collected. After     all samples from each of the 30 patients are obtained, the specimens will be analyzed for the     PCT value and then discarded.   "|||2017-10-11 03:27:39.893407|2017-10-11 03:27:39.893407
NCT01498692|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-02-02|2012-01-10||February 2009||2009-02-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|December 2010|Actual|2010-12-01||Interventional|PLATINUM SV||The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels|PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial|Completed||N/A|94|Actual|Boston Scientific Corporation||1|||f||||t||||||||No|Primary endpoints uploaded|2017-10-11 03:27:40.035544|2017-10-11 03:27:40.035544
NCT01498679|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-01-25|2014-02-13||January 2012||2012-01-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.|A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre Study to Evaluate the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate (FF/VI) Inhalation Powder Delivered Once Daily for 12 Weeks in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry Currently Treated With Low to Mid-strength Inhaled Corticosteroid or Low-strength Combination Therapy.|Completed||Phase 3|311|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:27:40.938053|2017-10-11 03:27:40.938053
NCT01498666|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-12-02|||December 2011||2011-12-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|LactoFAP||Efficacy of Lactobacillus Reuteri Protectis on Functional Abdominal Pain (FAP) in Children 8-14 Years Old|Efficacy of Lactobacillus Reuteri Protectis on Functional Abdominal Pain (FAP) in Children 8-14 Years Old|Terminated||Phase 4|9|Actual|BioGaia AB||2||The recruitment rate was too slow according to study protocol and agreement.|f||||f||||||||||2017-10-11 03:27:41.535099|2017-10-11 03:27:41.535099
NCT01498653|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-11-18|2013-09-19||January 2012||2012-01-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry|A Randomised, Double-blind, Double-dummy, Parallel Group Study to Evaluate the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate (FF/VI) Inhalation Powder Delivered Once Daily Compared to Fluticasone Propionate Delivered Twice Daily in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry Currently Treated With High-strength Inhaled Corticosteroids or Mid-strength ICS/LABA Combination Therapy.|Completed||Phase 3|313|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:27:41.658022|2017-10-11 03:27:41.658022
NCT01498640|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-17|2017-09-07|2015-02-04||March 2012||2012-03-01|September 2017|2017-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Retreatment of Recurrent Dupuytren's Contractures|Retreatment of Recurrent Contractures in Joints Effectively Treated With AA4500 (Collagenase Clostridium Histolyticum [XIAFLEX®/XIAPEX®]) in an Auxilium-sponsored Phase 3 Study in the United States, Australia, and Europe|Completed||Phase 4|52|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:27:42.243062|2017-10-11 03:27:42.243062
NCT01498627|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-04-02|||August 2008||2008-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|PGRx||Cervarix Long-term Safety Surveillance|Cervarix Long-term Safety Surveillance Using the PGRx Information System (PGRx Study)|Completed||N/A|2945|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-10-11 03:27:42.767244|2017-10-11 03:27:42.767244
NCT01498614|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2011-12-22|||March 2009||2009-03-01|December 2011|2011-12-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Psychological Impact in Diabetes: Intervention With Affect School and Basal Body Awareness|Psychological Impact, Metabolic Control, and Biological Stress Markers in Diabetes: Intervention Study With Affect School and Basal Body Awareness|Unknown status|Active, not recruiting|N/A|321|Actual|Lund University||2|||f||||f||||||||||2017-10-11 03:27:42.857296|2017-10-11 03:27:42.857296
NCT00005418|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||April 1992||1992-04-01|September 2001|2001-09-01|March 1994|Actual|1994-03-01|||||Observational|||Epidemiology of Cardiotoxicity in Children With Cancer||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.398048|2017-10-11 04:27:02.398048
NCT01498601|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-08-19|2015-03-30||January 2012||2012-01-01|December 2011|2011-12-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Improving Oral Care to Reduce Hospital-Acquired Pneumonia (HAP) in the Acute Neurologically Impaired Adult|Improving Oral Care to Reduce Hospital Acquired Pneumonia (HAP) in the Acute, Non-Intubated, Care Dependent, Neurologically Impaired Adult Patient Population|Completed||N/A|32|Actual|Fraser Health|This study was supported by the Fraser Health Point of Care Research Challenge.|2|||f||||f||||||||||2017-10-11 03:27:42.975878|2017-10-11 03:27:42.975878
NCT01498588|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-09-28|2016-06-21||November 2011||2011-11-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer|Phase II Neoadjuvant Trial of Eribulin Followed by Dose Dense Doxorubicin and Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer|Terminated||Phase 2|7|Actual|Emory University|Study accrual was low at 7 patients.|1||Slow accrual|f||||t||||||||||2017-10-11 03:27:43.25972|2017-10-11 03:27:43.25972
NCT01498575|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-03-03|2015-01-22||December 2011||2011-12-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||An Evaluation of a Web-based Intervention Program for Parents and Teens to Promote Safe Driving|An Evaluation of a Web-based Intervention Program for Parents and Teens to Promote Safe Driving|Completed||N/A|1024|Actual|Children's Hospital of Philadelphia|Moderate attrition (although no evidence of selective attrition); limited generalizability of results; and eight teenagers were not administered the highway module and were censored from analysis.|2|||f||||f||||||||||2017-10-11 03:27:43.559735|2017-10-11 03:27:43.559735
NCT01498562|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-11-26|||December 2011||2011-12-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|DATE||Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer|Randomized Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Patients With Advanced Non-small Cell Lung Cancer: Dual-agent Molecular Targeting of EGFR (DATE)|Completed||Phase 2|160|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 03:27:43.956267|2017-10-11 03:27:43.956267
NCT01498549|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-06-08|2017-02-08||December 2011||2011-12-01|June 2017|2017-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||The total number of people enrolled in the study before randomization to crossover assignment.|Cognitive Effects of Atomoxetine in Humans: Genetic Moderators|Cognitive Effects of Atomoxetine in Humans: Genetic Moderators|Completed||N/A|35|Actual|Yale University||2|||f||||t||||||||No||2017-10-11 03:27:44.11265|2017-10-11 03:27:44.11265
NCT01498536|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-10-29|||July 2011||2011-07-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|F4F tri neg||Effect of Diet and Exercise in Breast Cancer Survivors|Fit for the Fight: Effect of a Multidisciplinary Diet and Exercise Program on Body Weight, Quality of Life and Inflammation in Survivors of Triple-negative Breast Cancer|Completed||N/A|28|Actual|West Virginia University||1|||f||||f||||||||||2017-10-11 03:27:44.432167|2017-10-11 03:27:44.432167
NCT01498523|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-02-03|||December 2011||2011-12-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|GLUCAM||The Glycaemic and Insulinaemic Responses of Camel Milk|An Explorative Study to Characterize the Glycaemic and Insulinaemic Responses of Regular Camel Milk and Camel Milk Powder|Completed||N/A|20|Actual|Wageningen University||4|||f||||f||||||||||2017-10-11 03:27:44.518204|2017-10-11 03:27:44.518204
NCT01498510|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-05-23|||February 2012||2012-02-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|WebCBTPain||Web-based Cognitive-behavior Therapy (CBT) for Opioid-treated, Chronic Pain Patients With Aberrant Behavior|Web-based CBT for Opioid-treated, Chronic Pain Patients With Aberrant Behavior|Completed||N/A|110|Actual|National Development and Research Institutes, Inc.||2|||f||||f||||||||Undecided||2017-10-11 03:27:44.667169|2017-10-11 03:27:44.667169
NCT01498497|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-02-08|||January 2012||2012-01-01|February 2017|2017-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021|Six Month Safety Follow-up Study for PR-021 [Multicenter, Randomized, Double-blind, Placebo-controlled, Safety and Tolerability Phase 1/2a Study of Two Dosing Regimens of EUR-1100 for Oral Use, in Eosinophilic Esophagitis Subjects]|Completed||N/A|14|Actual|Forest Laboratories|||1||f||||f||||||||||2017-10-11 03:27:44.783636|2017-10-11 03:27:44.783636
NCT01498484|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-03-10|||December 2011|Actual|2011-12-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies|A Phase II Study of the Therapeutic Effects Of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies|Active, not recruiting||Phase 2|112|Anticipated|Atara Biotherapeutics||1|||t||||||||||||||2017-10-11 03:27:44.913977|2017-10-11 03:27:44.913977
NCT01498471|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2011-12-22|||January 2012||2012-01-01|December 2011|2011-12-01|February 2014|Anticipated|2014-02-01|February 2013|Anticipated|2013-02-01||Observational|||NICE Guideline 'Red Flags' to Predict Serious Outcome After Transient Loss of Consciousness|NICE Guideline 'Red Flags' to Predict Serious Outcome After Transient Loss of Consciousness: Prospective Validation Study in the Emergency Department.|Unknown status|Not yet recruiting|N/A|490|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||||||||||||2017-10-11 03:27:45.072938|2017-10-11 03:27:45.072938
NCT01498458|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-09-17|2014-07-04||October 2010||2010-10-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|December 2011|Actual|2011-12-01||Interventional|PazoX||Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer|Phase I Study to Assess the Optimal Dose for Pazopanib in Combination With Capecitabine in Patients With HER2-negative, Metastatic Breast Cancer (PazoX)|Completed||Phase 1|9|Actual|German Breast Group||1|||f||||t||||||||||2017-10-11 03:27:45.190551|2017-10-11 03:27:45.190551
NCT01498445|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-08-11|||June 12, 2012|Actual|2012-06-12|August 2017|2017-08-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357)|An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357)|Recruiting||Phase 1/Phase 2|84|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 03:27:45.571418|2017-10-11 03:27:45.571418
NCT01498432|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2011-12-22|||January 2012||2012-01-01|December 2011|2011-12-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Interventional|||Physiological Response to Heliox21 and Air O2|Phase 4, Single Centre, Single Blinded,Prospective Randomised Cross Over Comparison on the Physiological Response of Post Extubation Intensive Care Patients to Non-invasive Ventilation Using Either Air O2 or Heliox21|Unknown status|Not yet recruiting|Phase 4|38|Anticipated|University College, London||2|||f||||t||||||||||2017-10-11 03:27:45.678583|2017-10-11 03:27:45.678583
NCT01498419|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-03-15|2016-07-12||March 2012||2012-03-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional||The ages of four participants in the Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg) group and one participant in the Drug Sensitive: Rifafour group were missing and so were not included in the demographics.|Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)|A Phase II Open-Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin Plus PA-824 Plus Pyrazinamide After 8 Weeks of Treatment in Adult Patients With Newly Diagnosed Drug-Sensitive or Multi Drug-Resistant, Smear-Positive Pulmonary Tuberculosis|Completed||Phase 2|207|Actual|Global Alliance for TB Drug Development||4|||f||||t||||||||||2017-10-11 03:27:45.778708|2017-10-11 03:27:45.778708
NCT01498406|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2013-11-18|||December 2011||2011-12-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus|Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus|Terminated||Phase 2|3|Actual|Emory University||2||secondary to funding issues and low enrollment|f||||t||||||||||2017-10-11 03:27:46.806384|2017-10-11 03:27:46.806384
NCT01498393|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-02-08|||December 2011||2011-12-01|February 2017|2017-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis|A Randomized, Placebo-Controlled Study of the 1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis|Completed||Phase 1|10|Actual|University of California, Irvine||1|||f||||t||||||||||2017-10-11 03:27:46.923694|2017-10-11 03:27:46.923694
NCT01498380|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-06-30|||January 2012||2012-01-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|DexMED||The Bolus Dose of Dexmedetomidine (ED50) That Avoids Hemodynamic Compromise in Children|The Bolus Dose of Dexmedetomidine (ED50) That Avoids Hemodynamic Compromise in Children|Completed||N/A|21|Actual|University of British Columbia||1|||f||||t||||||||||2017-10-11 03:27:47.017557|2017-10-11 03:27:47.017557
NCT01498367|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-02-16|||March 2011||2011-03-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|RHCluster2GR||Life-long Tele-monitoring of Patients With Type 2 Diabetes Mellitus in Central Greece|Renewing Health RCT for the Evaluation of Life-long Tele-monitoring of Patients With Diabetes Mellitus Type 2 in Central Greece|Completed||N/A|154|Actual|Regional Health Authority of Sterea & Thessaly||2|||f||||t||||||||||2017-10-11 03:27:47.122131|2017-10-11 03:27:47.122131
NCT01498354|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2015-09-09|||August 2010||2010-08-01|September 2015|2015-09-01|February 2012|Actual|2012-02-01|October 2010|Actual|2010-10-01||Interventional|||Efficiency of Two Dimensional High Definition Versus Three Dimensional Endoscopic Systems in Transanal Endoscopic Surgery|Comparing the Efficiency of Two Dimensional High Definition (TEO) Versus Three Dimensional (TEM) Endoscopic Systems in Transanal Endoscopic Surgery; a Prospective Control Trial|Completed||Phase 3|36|Actual|Corporacion Parc Tauli||2|||f||||f||||||||||2017-10-11 03:27:47.263601|2017-10-11 03:27:47.263601
NCT01498341|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-06-30|||August 2011||2011-08-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|HypoPT||Hypoparathyroidism in Denmark|Hypoparathyroidism, Autosomal Dominant Hypocalcaemia and Pseudohypoparathyroidism in Denmark - Epidemiology, Causes, Symptoms and Prognoses|Completed||N/A|1000|Actual|University of Aarhus|||1||f||||f||||||None Retained|"     2 designs: Case-finding; Case-control   "|||2017-10-11 03:27:47.369064|2017-10-11 03:27:47.369064
NCT01498328|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-04-06||2017-04-06|December 2011||2011-12-01|April 2017|2017-04-01|May 17, 2016|Actual|2016-05-17|April 2015|Actual|2015-04-01||Interventional|ReACT||A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma|A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma|Completed||Phase 2|127|Actual|Celldex Therapeutics||3|||t||||f||||||||||2017-10-11 03:27:47.486947|2017-10-11 03:27:47.486947
NCT01498315|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-05-15|||March 2012||2012-03-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Observational|Hematoma||The Incidence of Pelvic Hematoma Following Hysterectomy|The Incidence of Pelvic Hematoma Following Hysterectomy|Completed||N/A|39|Actual|Carmel Medical Center|||1||f||||f||||||||||2017-10-11 03:27:47.815375|2017-10-11 03:27:47.815375
NCT01498302|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2016-07-07|||February 2012||2012-02-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia|Interlaboratory Comparability Study of Residual Disease in Acute Myelogenous Leukemia|Completed||N/A|10|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Bone marrow and/or peripheral blood   "|||2017-10-11 03:27:47.919735|2017-10-11 03:27:47.919735
NCT01498289|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2017-01-04|||February 2012||2012-02-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer|A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer|Active, not recruiting||Phase 2|213|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 03:27:48.126196|2017-10-11 03:27:48.126196
NCT01498276|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-06-30|||December 5, 2011||2011-12-05|June 2, 2017|2017-06-02||||||||Observational|||Family Genetics Health Education and Healthy Behaviors|The Role of the Family Genetics Health Educator in Influencing Health Promoting Behaviors|Recruiting||N/A|335|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:27:49.375349|2017-10-11 03:27:49.375349
NCT01498263|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2017-09-12|||December 5, 2011||2011-12-05|September 1, 2017|2017-09-01||||||||Observational|||Inherited Diseases, Caregiving, and Social Networks|Inherited Diseases, Caregiving, and Social Networks|Recruiting||N/A|3100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:27:49.504269|2017-10-11 03:27:49.504269
NCT00005419|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-08|||March 1992||1992-03-01|January 2016|2016-01-01|February 1994||1994-02-01|||||Observational|||Physical Activity, Hypertension, Diabetes, and Coronary Heart Disease||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 04:27:02.475027|2017-10-11 04:27:02.475027
NCT01498250|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-10-15|||November 2011||2011-11-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Microarray Analysis of microRNA Expression in Basal Cell Carcinoma|Microarray Analysis of microRNA Expression in Basal Cell Carcinoma|Completed||N/A|7|Actual|Ruhr University of Bochum|||2||f||||t||||||Samples With DNA|"     basal cell carcinoma and non-lesional skin   "|||2017-10-11 03:27:49.591926|2017-10-11 03:27:49.591926
NCT01498237|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-07-09|||January 2012||2012-01-01|July 2013|2013-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Photoacoustic Endoscopy in Endometrial Cancer|A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer|Withdrawn||Early Phase 1|0|Actual|Washington University School of Medicine||1||Need to obtain IDE prior to commencement of study|f||||t||||||||||2017-10-11 03:27:49.677022|2017-10-11 03:27:49.677022
NCT01498224|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2016-12-08|||December 2011||2011-12-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||ReSure Sealant Pivotal Study|ReSure Sealant Pivotal Study|Completed||Phase 3|488|Actual|Ocular Therapeutix, Inc.||2|||f||||f||||||||No|Data is available on FDA website for approved PMA P130004|2017-10-11 03:27:49.798063|2017-10-11 03:27:49.798063
NCT01498211|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2012-07-04|||December 2011||2011-12-01|December 2011|2011-12-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Normative Data of Intra-epidermal Nerve Fiber Density|Establishement of Normative Intra-epidermal Nerve Fiber Density Using Skin|Unknown status|Active, not recruiting|N/A|300|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 03:27:49.880061|2017-10-11 03:27:49.880061
NCT01498198|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2011-12-22|||January 2012||2012-01-01|December 2011|2011-12-01||||January 2014|Anticipated|2014-01-01||Interventional|||Workers Compensation Board: Rotator Cuff Tear Management|A Randomized Study of Non-Operative Management Versus Expedited Surgery Among WCB Patients With Small Rotator Cuff Tears: Affect Upon Time to Claim Closure in 2 Prairie Provinces|Unknown status|Not yet recruiting|N/A|144|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 03:27:49.961599|2017-10-11 03:27:49.961599
NCT01498185|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2016-12-20|2016-10-07||February 2012||2012-02-01|December 2016|2016-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||All randomized participants who received at least 1 dose of study medication|BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes|A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 2|171|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 03:27:50.111035|2017-10-11 03:27:50.111035
NCT01498159|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-02-24|||December 2011||2011-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|April 2016|Actual|2016-04-01||Interventional|||Health Promoters and Pharmacists in Diabetes Team Management|Health Promoters and Pharmacists in Diabetes Team Management|Active, not recruiting||N/A|300|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 03:27:53.003292|2017-10-11 03:27:53.003292
NCT01498146|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2014-07-15|||April 2010||2010-04-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|October 2013|Actual|2013-10-01||Observational|SURPRISE||Finding Atrial Fibrillation in Patients With Unexplained Stroke Using Longterm Cardiac Monitoring|Stroke Prior to Diagnosis of Atrial Fibrillation Using Longterm Observation With Implantable Cardiac Monitoring Apparatus Reveal(SURPRISE) -the SURPRISE Study|Unknown status|Active, not recruiting|N/A|100|Anticipated|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-11 03:27:53.135331|2017-10-11 03:27:53.135331
NCT01498133|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-12-20|||May 2008||2008-05-01|December 2011|2011-12-01||||November 2010|Actual|2010-11-01||Interventional|||Skin-to-skin Contact to Promote Bacterial Decolonization in Preterm Infants|Does Skin-to-skin Contact Promote Bacterial Decolonization in Preterm Infants in Neonatal Intensive Care Unit? A Randomized, Single-blinded Controlled Trial|Unknown status|Active, not recruiting|Phase 2|102|Actual|Universidade Federal do Maranhão||2|||f||||t||||||||||2017-10-11 03:27:53.223977|2017-10-11 03:27:53.223977
NCT01498120|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-07-06|2016-08-01||December 2011||2011-12-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||All enrolled subjects who received at least 1 dose of study medication were included in the SS.|Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome|An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome|Completed||Phase 2|14|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 03:27:53.364561|2017-10-11 03:27:53.364561
NCT01498107|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2014-01-07|||January 2012||2012-01-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Technology-enhanced Therapy: the SilverCloud Study|A Pilot Study Evaluating Engagement With a Platform Supporting Online Interventions for Common Mental Health Problems|Completed||N/A|30|Anticipated|University of Cambridge||1|||f||||f||||||||||2017-10-11 03:27:54.982594|2017-10-11 03:27:54.982594
NCT01498094|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-05-08|||December 2011||2011-12-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|Hi-Flo||Study of High-flow Oxygen Therapy Against Standard Therapy in Bronchiolitis|A Prospective Open Randomized Clinical Trial Comparing High Flow Nasal Cannula Oxygen Therapy Against Standard Therapy for Children Hospitalized With Bronchiolitis|Completed||N/A|79|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 03:27:55.257392|2017-10-11 03:27:55.257392
NCT01498081|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2012-10-25|||March 2012||2012-03-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients|A Randomised, Double-blind, Placebo and Active Controlled, Multi-centre, 6 Way Cross-over, Single-dose Phase IIa Study to Investigate the Local and Systemic Effects of 3 Different Doses of Inhaled AZD2115 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|39|Actual|AstraZeneca||6|||f||||||||||||||2017-10-11 03:27:55.349701|2017-10-11 03:27:55.349701
NCT01399567|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-07-21|||September 2006||2006-09-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Nursing Home Pain Management Algorithm Clinical Trial|Nursing Home Pain Management Algorithm Clinical Trial|Completed||Phase 2|396|Actual|Swedish Medical Center||2|||f||||t||||||||||2017-10-11 04:00:19.441287|2017-10-11 04:00:19.441287
NCT01498068|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2015-01-29|2013-09-11||January 2012||2012-01-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|April 2012|Actual|2012-04-01||Interventional|||Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C|Open-Label, Bridging Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Treatment- Naïve and Treatment-Experienced Russian Subjects With Genotype 1 Chronic Hepatitis C|Completed||Phase 3|36|Actual|Janssen-Cilag International NV||2|||f||||f||||||||||2017-10-11 03:27:55.487547|2017-10-11 03:27:55.487547
NCT01498055|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2012-03-21|||December 2011||2011-12-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|CIK||Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study|A Randomized Controlled Trail on the Efficacy and Safety of Autologous Cytokine-induced Killer (CIK) Cells Infusion Treatment in Advanced Primary Lung Cancer|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|Third Military Medical University|||2||f||||f||||||Samples With DNA|"     The one-time folic acid sodium anticoagulation vacuum picks bag, through the venous blood     sampling 60 ml. When blood alcohol on parts of the need blood disinfects processing. After     the department shows will seal in a sterile bag, 16-21 degrees Celsius save, and transported     to a cell biological treatment as soon as possible a follow-up operation center GMP     laboratory.   "|||2017-10-11 03:27:55.962576|2017-10-11 03:27:55.962576
NCT01498042|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-12-20|||January 2007||2007-01-01|December 2011|2011-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Predictors of Outcome in t-PA Treated Stroke.|Ischemic Stroke Treated With iv Thrombolysis Within 4.5 Hours: Predictors of Outcome in a Cohort With a Large Proportion of Patients Above 80 Years|Completed||N/A|162|Actual|Sorlandet Hospital HF|||1||f||||f||||||||||2017-10-11 03:27:56.062852|2017-10-11 03:27:56.062852
NCT01498029|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-03-20|||January 2012||2012-01-01|December 2011|2011-12-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|CAIS||Knee Articular Cartilage Repair: Cartilage Autograft Implantation System Versus Conventional Microfracture|A Randomised Clinical Trial Comparing a Novel Single-stage Autologous Cartilage Implantation System to Conventional Microfracture for Repair of Articular Cartilage Defects in the Knee|Unknown status|Recruiting|Phase 3|36|Anticipated|Singapore General Hospital||2|||f||||f||||||||||2017-10-11 03:27:56.31531|2017-10-11 03:27:56.31531
NCT01498016|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-05-09|||November 2011||2011-11-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia|Pharmacokinetic Study of Intravenous Busulfan as Conditioning Regimen for Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia|Recruiting||Phase 2|60|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||No||2017-10-11 03:27:56.459237|2017-10-11 03:27:56.459237
NCT01498003|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2015-07-13|||November 2011||2011-11-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PETITION||Tirofiban in Stenting for Long Coronary Lesion|Safety and Efficacy of Peri-procedural Use of Tirofiban in Elective Percutaneous Coronary Intervention for Long Coronary Lesions With Overlapping Drug-Eluting Stent|Completed||Phase 4|748|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 03:27:56.57325|2017-10-11 03:27:56.57325
NCT01497990|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-11-02|||January 2010||2010-01-01|November 2012|2012-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Pharmacokinetics Ertapenem Burns|Pharmacokinetics of Ertapenem When Used in Empiric Treatment in Burn Patients. Prospective Open Label Study.|Completed||Phase 4|8|Actual|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 03:27:56.689409|2017-10-11 03:27:56.689409
NCT01497977|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2011-12-27|||September 2008||2008-09-01|December 2011|2011-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Phytoestrogen Supplementation in Postmenopausal Women|Impact of Phytoestrogens on Serum Lipids in Postmenopausal Women|Completed||Phase 4|74|Actual|American Medical Academy, Serbia||3|||f||||t||||||||||2017-10-11 03:27:56.79285|2017-10-11 03:27:56.79285
NCT01497964|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-11-07|||December 2011||2011-12-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|GASTANA||Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy|A Phase 2, Multicenter Study of Cabazitaxel Single Agent Administered as a 1-Hour Intravenous Infusion Every 3 Weeks to Evaluate the Safety, Tolerability and Anti-tumor Activity of Cabazitaxel in Patients With Advanced Gastric Adenocarcinoma Who Have Failed Prior Chemotherapy Regimens|Completed||Phase 1/Phase 2|16|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:27:56.889274|2017-10-11 03:27:56.889274
NCT01497951|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-05-16|||May 2011||2011-05-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|PDT||Photodynamic Therapy for Oral Precursor Lesions|A Randomized Controlled Trial: Photodynamic Treatment for the Therapy of Premalignant Mucosal Oral Lesions.|Completed||Phase 3|28|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 03:27:56.988952|2017-10-11 03:27:56.988952
NCT01497938|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2014-01-31|2013-10-24||December 2011||2011-12-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ASPIRE||Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature|ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps|Completed||Phase 3|247|Actual|Medtronic Diabetes||2|||f||||t||||||||||2017-10-11 03:27:57.101725|2017-10-11 03:27:57.101725
NCT01497925|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-08-17|||May 2011||2011-05-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|September 2017|Anticipated|2017-09-01||Interventional|||Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer|Phase 1 Trial of ADI PEG 20 Plus Docetaxel in Advanced Solid Tumors With Emphasis on Castration Resistant Prostate Cancer (CRPC) and Advanced Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1|39|Anticipated|Polaris Group||1|||f||||f||||||||||2017-10-11 03:27:57.631437|2017-10-11 03:27:57.631437
NCT01497912|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-22|2011-12-22|||January 2005||2005-01-01|January 2005|2005-01-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Interventional|||Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes||Completed||Phase 4|20|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 03:27:57.708978|2017-10-11 03:27:57.708978
NCT01497353|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-10-17|||August 2011||2011-08-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Placental Transfusion and Cord Clamping|Is the Placental Transfusion Volume Influenced by the Position of the New Born at Birth?|Completed||N/A|400|Actual|Fundacion para la Salud Materno Infantil||2|||f||||t||||||||||2017-10-11 03:28:06.284948|2017-10-11 03:28:06.284948
NCT01497899|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-08-22|2015-12-04|2013-10-21|December 28, 2011|Actual|2011-12-28|August 2017|2017-08-01|August 22, 2016|Actual|2016-08-22|October 17, 2012|Actual|2012-10-17||Interventional||"E/C/F/TAF and E/C/F/TDF arms: participants who were randomized to the Double-Blind Phase and received at least 1 dose of study drug.
D/C/F/TAF to E/C/F/TAF and DRV+COBI+TVD to E/C/F/TAF arms: participants who enrolled from Gilead-sponsored Study GS-US-299-0102 in the Open-Label Extension Phase and received at least 1 dose of open-label E/C/F/TAF"|Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults|A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV-1 Infected, Antiretroviral Treatment-Naive Adults|Completed||Phase 2|279|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|3|||f||||t|t|f||||||||2017-10-11 03:27:57.822861|2017-10-11 03:27:57.822861
NCT01497886|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-01-28|||March 2011||2011-03-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Effect of Intervention to Improve Stroke Recognition|Randomized Controlled Trial Effect of Novel Intervention to Improve Stroke Symptom Recognition|Active, not recruiting||N/A|4614|Actual|Columbia University||2|||f||||t|f|f||||||Undecided||2017-10-11 03:27:59.012953|2017-10-11 03:27:59.012953
NCT01497873|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2015-09-15|||September 2010||2010-09-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients|A Phase IIb, Randomized, Open, Parallel-Group, Multi-Center Trial to Assess the Efficacy and Safety of Belotecan(CamtoBell Inj.) or Topotecan in Patients With Relapsed Small Cell Lung Cancer|Recruiting||Phase 2|176|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||t||||||||||2017-10-11 03:27:59.102974|2017-10-11 03:27:59.102974
NCT01497860|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-07-10|||July 2011||2011-07-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|January 2017|Actual|2017-01-01||Interventional|||Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas|Phase 2 Study of Weekly Vinorelbine in Children With Progressive or Recurrent Low-Grade Gliomas|Completed||Phase 2|13|Actual|Children's Research Institute||1|||f||||t||||||||||2017-10-11 03:27:59.262783|2017-10-11 03:27:59.262783
NCT01497847|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2013-04-25|||March 2010||2010-03-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|PI-IBS||Post-Infectious Irritable Bowel Syndrome (PI-IBS)|Post-Infectious Irritable Bowel Syndrome (PI-IBS)|Completed||N/A|131|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||Samples With DNA|"     whole blood, blood plasma, feces, rectal biopsy   "|||2017-10-11 03:27:59.366475|2017-10-11 03:27:59.366475
NCT01497834|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2015-09-23||2015-09-23|January 2012||2012-01-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients|A Phase 3 Japanese Study of BMS-790052 Plus BMS-650032 Combination Therapy in Chronic Hepatitis C Genotype 1b Infected Subjects Who Are Non Response to Interferon Plus Ribavirin and Interferon Based Therapy Ineligible Naive/Intolerant|Completed||Phase 3|224|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 03:27:59.450208|2017-10-11 03:27:59.450208
NCT01497821|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-03-23|||January 2012||2012-01-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|November 2014|Actual|2014-11-01||Interventional|||AMG 172 First in Human Study in Patients With Kidney Cancer|A Phase 1 First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 172 in Subjects With Relapsed / Refractory Renal Cell Carcinoma|Completed||Phase 1|37|Actual|Amgen||2|||f||||||||||||||2017-10-11 03:27:59.631064|2017-10-11 03:27:59.631064
NCT01497808|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-09-12|||December 2011||2011-12-01|August 2016|2016-08-01||||October 2015|Actual|2015-10-01||Interventional|||RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA|RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA|Active, not recruiting||Phase 1/Phase 2|23|Actual|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 03:27:59.736176|2017-10-11 03:27:59.736176
NCT01497782|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2011-12-21|||April 2011||2011-04-01|December 2011|2011-12-01|January 2012|Anticipated|2012-01-01|October 2011|Actual|2011-10-01||Interventional|Feedback||The FEEDBACK Trial, a Randomized Controlled Trial|Impact of Instructor Feedback on Performance in a Virtual Reality Simulator: A Randomized, Controlled Trial|Unknown status|Enrolling by invitation|N/A|99|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 03:27:59.846847|2017-10-11 03:27:59.846847
NCT01497769|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-07-01|||September 2011||2011-09-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|||Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route|A Phase I Trial to Compare the Safety and Immunogenicity of Candidate TB Vaccine MVA85A Administered by the Aerosol Inhaled Route and the Intradermal Route in Healthy BCG-vaccinated Adult Subjects|Completed||Phase 1|24|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 03:27:59.944211|2017-10-11 03:27:59.944211
NCT01497756|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-08-17|2012-07-02||August 2011||2011-08-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)|Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)|Completed||N/A|10|Actual|University of New Mexico||1|||f||||f||||||||||2017-10-11 03:28:00.158535|2017-10-11 03:28:00.158535
NCT01497743|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-12-20|||February 2012||2012-02-01|December 2016|2016-12-01||||February 2013|Anticipated|2013-02-01||Interventional|PRISS||Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic Sclerosis|Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic Sclerosis|Withdrawn||Phase 4|0|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:28:00.939528|2017-10-11 03:28:00.939528
NCT01497730|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-04-24|||October 1, 2011|Actual|2011-10-01|April 2017|2017-04-01|December 1, 2017|Anticipated|2017-12-01|September 29, 2017|Anticipated|2017-09-29||Interventional|10003||Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance|Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance|Active, not recruiting||N/A|840|Anticipated|DePuy Orthopaedics||1|||f||||f||||||||||2017-10-11 03:28:01.020127|2017-10-11 03:28:01.020127
NCT01497717|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-10-25|||July 2013||2013-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy of Humira in Behcet Patients With Arthritis|Efficacy of Humira in Behcet Patients With Arthritis|Completed||Phase 3|9|Actual|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-11 03:28:01.157146|2017-10-11 03:28:01.157146
NCT01497691|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-08-22|||January 2013|Anticipated|2013-01-01|August 2017|2017-08-01|November 19, 2013|Actual|2013-11-19|November 19, 2013|Actual|2013-11-19||Interventional|RCT BiPAP||Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations|A Randomized Controlled Trial of Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations|Withdrawn||N/A|0|Actual|Vanderbilt University Medical Center||3||unable to recruit participants|f||||t||||||||||2017-10-11 03:28:01.372203|2017-10-11 03:28:01.372203
NCT01497678|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-10-19|||March 2013||2013-03-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|MTURR||Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) Coordinating Center|Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury (Coordinating Center Protocol)|Withdrawn||N/A|0|Actual|University of Pittsburgh||1||Funding issues. 0 subjects enrolled|f||||t||||||||||2017-10-11 03:28:01.613216|2017-10-11 03:28:01.613216
NCT01497665|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-03-08|2015-05-12||November 2011||2011-11-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|GRABM-L|"Safety population (all patients): 16
Efficacy population (defined as the number of patients who had ≥1 intracranial lesions followed as target or non-target lesions, and who were evaluated by Overall RECIST v.1.1):10"|GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)|A Phase II, Multi-center, Open-label Study Evaluating the Efficacy and Safety of GRN1005 in Non-Small Cell Lung Cancer Patients With Brain Metastases|Terminated||Phase 2|16|Actual|Angiochem Inc||1||Slow recruitment|f||||t||||||||||2017-10-11 03:28:01.757796|2017-10-11 03:28:01.757796
NCT01497652|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-12-15|||January 2012||2012-01-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|RECOGNIZE||A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy|A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy|Completed||Phase 4|34|Actual|Georgetown University||2|||f||||f||||||||||2017-10-11 03:28:02.278308|2017-10-11 03:28:02.278308
NCT01497639|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-10-30|||March 2012||2012-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for Pallidal Deep Brain Stimulation|Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for the Deep Brain Stimulation Treatment of Primary Generalized or Segmental Dystonia|Recruiting||Phase 4|20|Anticipated|University of Pecs||2|||f||||t||||||||||2017-10-11 03:28:02.368779|2017-10-11 03:28:02.368779
NCT01497626|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-02-15|||September 2011||2011-09-01|September 2015|2015-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Lapatinib and Bortezomib in Patients With Advanced Malignancies|A Phase I Study of the HER1, HER2 Dual Kinase Inhibitor, Lapatinib Plus the Proteosomal Inhibitor Bortezomib in Patients With Advanced Malignancies|Terminated||Phase 1|15|Actual|Georgetown University||1||Drug support withdrawn|f||||t||||||||||2017-10-11 03:28:02.479033|2017-10-11 03:28:02.479033
NCT01497600|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-01-26|||February 2004||2004-02-01|January 2017|2017-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes|A Randomised, Double-blind, Six-period, Cross-over, Dose-response Trial Investigating the Pharmacodynamics and Pharmacokinetics of Single Doses of Insulin Detemir and NPH Insulin in Subjects of Blacks or African American, Whites of Hispanic or Latino Origin and Whites Not of Hispanic or Latino Origin With Type 2 Diabetes|Completed||Phase 1|50|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:28:02.690815|2017-10-11 03:28:02.690815
NCT01497587|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-01-30|||August 2005||2005-08-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan|A Single Centre, Open-labelled Trial to Investigate the Pharmacokinetics of Insulin Detemir in Healthy Taiwanese Subjects|Completed||Phase 1|20|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:28:02.810255|2017-10-11 03:28:02.810255
NCT01497574|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-01-27|||May 2005||2005-05-01|January 2017|2017-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes|A Single-centre, Randomised, Double-blind, Cross-over Trial Comparing the Within-subject Variability of the Pharmacokinetic Profiles of Insulin Detemir and Insulin Glargine in Children and Adolescents With Type 1 Diabetes|Completed||Phase 1|32|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:28:02.909779|2017-10-11 03:28:02.909779
NCT01497561|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-01-26|||March 2003||2003-03-01|January 2017|2017-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes|A Randomised, Double-blind, Four-period, Cross-over, Dose Response Trial Investigating the Pharmacodynamics and Pharmacokinetics of Single Doses of Insulin Detemir and NPH Insulin in Subjects With Type 2 Diabetes|Completed||Phase 1|15|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:28:03.009144|2017-10-11 03:28:03.009144
NCT01497548|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-24|2011-12-21|||March 2011||2011-03-01|December 2011|2011-12-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Interventional|||Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients|A Parallel-group, Double-blind, Placebo-controlled Study of Methylphenidate as an Add on Therapy for Mirtazapine in the Treatment of Major Depressive Disorder in Cancer Patients Under Palliative Care|Unknown status|Recruiting|Phase 3|120|Anticipated|University of Malaya||2|||f||||f||||||||||2017-10-11 03:28:03.118087|2017-10-11 03:28:03.118087
NCT01497535|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-02-22|||May 27, 2004|Actual|2004-05-27|February 2017|2017-02-01|October 31, 2004|Actual|2004-10-31|October 31, 2004|Actual|2004-10-31||Interventional|||Within-subject Variability of Insulin Detemir in Healthy Volunteers|A Single-centre, Parallel-group, Randomised, Double Blind Trial in Healthy Japanese Subjects Comparing the Within-subject Variability of Insulin Detemir and Insulin Glargine With Respect to Pharmacodynamic and Pharmacokinetic Properties|Completed||Phase 1|40|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:28:03.263012|2017-10-11 03:28:03.263012
NCT01497522|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-02-23|||December 2011||2011-12-01|February 2017|2017-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes|A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 12 Weeks Treatment With LAF237 50 mg Bid to Placebo as Add-On Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy|Completed||Phase 3|183|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:28:03.360563|2017-10-11 03:28:03.360563
NCT01497509|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2012-04-28|||May 2012||2012-05-01|April 2012|2012-04-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Intrapartum Epidural Fentanyl and Breastfeeding in the Immediate Postpartum Period: a Randomized, Controlled, Double-blinded Study|Effect of Intrapartum Epidural Fentanyl Upon Breastfeeding in the Immediate Postpartum Period: a Randomized, Controlled, Double-blinded Study|Unknown status|Not yet recruiting|N/A|450|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-11 03:28:03.522962|2017-10-11 03:28:03.522962
NCT01497496|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-07-28|||January 20, 2012||2012-01-20|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|Phase II Study of Ofatumumab in Combination With High Dose Methylprednisolone Followed by Ofatumumab and Lenalidomide Consolidative Therapy for the Treatment of Relapsed or Refractory CLL/SLL The HiLOG Trial|Active, not recruiting||Phase 2|29|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 03:28:03.634029|2017-10-11 03:28:03.634029
NCT01497483|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2015-01-14|||December 2011||2011-12-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Drug-Drug Interaction Study With Pravastatin and Cyclosporine|The Pharmacokinetic Interaction Between Pravastatin and Cyclosporine in Healthy Volunteers|Completed||Phase 1|21|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:28:03.766627|2017-10-11 03:28:03.766627
NCT01497470|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-10-07|||April 2012||2012-04-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen|An Open-Label, One-Arm, One-Sequence Crossover Drug-Drug Interaction Study in Advanced Solid Tumor Subjects Subjects to Evaluate the Potential Effect of Custirsen (OGX-011) on the Pharmacokinetics of Paclitaxel|Completed||Phase 1|36|Actual|Achieve Life Sciences||1|||f||||||||||||||2017-10-11 03:28:03.888367|2017-10-11 03:28:03.888367
NCT01497457|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-05-19|||December 2011||2011-12-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Interest of Saline MR Peritoneography for Pre-operative Assessment of Rectal Cancer|Interest of Saline MR Peritoneography for Pre-operative Assessment of Rectal Cancer|Completed||N/A|17|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-11 03:28:04.013402|2017-10-11 03:28:04.013402
NCT01497444|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-06-26|||May 2012||2012-05-01|June 2017|2017-06-01||||January 2018|Anticipated|2018-01-01||Interventional|||Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery|Study of Sorafenib + TH-302: Phase I in Advanced Renal Cell Carcinoma (RCC) and Advanced Hepatocellular Carcinoma (HCC) and Phase II in 1st Line Advanced HCC|Suspended||Phase 1/Phase 2|48|Anticipated|Alliance for Clinical Trials in Oncology||1||"The current dose cohort (Dose Level +1a) has met its accrual goal in the Phase I portion of the   study."|f||||t||||||||||2017-10-11 03:28:04.115996|2017-10-11 03:28:04.115996
NCT01497431|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-11-25|||November 2011||2011-11-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants|Phase I Multiple Dose Study of 12-Week Treatment by Se-Methyl-L-Cysteine(MSC) and L SeMet in Adult Males|Completed||Phase 1|66|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-10-11 03:28:04.253281|2017-10-11 03:28:04.253281
NCT01497418|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-09-18|||December 2011||2011-12-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|July 2012|Actual|2012-07-01||Observational|||Long Term Follow-up of the 23mm Portico™ Aortic Valve Implant and the St. Jude Medical Transfemoral Delivery System|Long Term Follow-up of the 23mm Portico™ Aortic Valve Implant and the SJM Transfemoral Delivery System|Completed||N/A|2|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 03:28:04.395598|2017-10-11 03:28:04.395598
NCT01497405|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-09-18|||May 2012||2012-05-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||WHC+ (Women's Health CoOp PLUS)|Combination Prevention for Vulnerable Women in South Africa|Completed||Phase 1|641|Actual|RTI International||2|||f||||t||||||||||2017-10-11 03:28:04.500753|2017-10-11 03:28:04.500753
NCT01497392|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-08|2017-02-14|||March 29, 2012|Actual|2012-03-29|February 2017|2017-02-01|February 7, 2017|Actual|2017-02-07|August 31, 2015|Actual|2015-08-31||Interventional|||Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers|Phase I Study of Dovitinib (TKI258) in Combination With Gemcitabine and Capecitabine in Advanced Solid Tumors, Pancreatic Cancer and Biliary Cancers|Completed||Phase 1|26|Actual|Roswell Park Cancer Institute||1|||f||||f||||||||||2017-10-11 03:28:04.646545|2017-10-11 03:28:04.646545
NCT01497379|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-03-28|||October 2011||2011-10-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients|Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients: A Prospective Mono- & Multicenter Clinical Study Based on Randomized Intra-individual Implant Activation in Degenerative Retinal Disease Patients.|Completed||N/A|2|Actual|Retina Implant AG||2|||f||||t||||||||||2017-10-11 03:28:04.740776|2017-10-11 03:28:04.740776
NCT01497366|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-03-04|2014-01-15|2013-11-20|December 2011||2011-12-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|FISSION|Safety Analysis Set|Phase 3 Study of Sofosbuvir and Ribavirin|A Phase 3, Multicenter, Randomized, Active-Controlled Study to Investigate the Safety and Efficacy of PSI-7977 and Ribavirin for 12 Weeks Compared to Pegylated Interferon and Ribavirin for 24 Weeks in Treatment-Naïve Patients With Chronic Genotype 2 or 3 HCV Infection|Completed||Phase 3|527|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 03:28:04.853734|2017-10-11 03:28:04.853734
NCT00005420|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-13|||April 1992||1992-04-01|January 2016|2016-01-01|March 1995||1995-03-01|||||Observational|||Prediction of Quality of Life in Cardiovascular Disease||Completed||N/A|||University of Texas at Austin|||||f||||||||||||||2017-10-11 04:27:02.549914|2017-10-11 04:27:02.549914
NCT01497340|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2011-12-21|||October 2010||2010-10-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Position at Birth,Placental Transfusion Volume and Cord Clamping|Is the Placental Transfusion Volume Influenced by the Position of the New Born at Birth? a Pilot Study|Terminated||N/A|27|Actual|Fundacion para la Salud Materno Infantil||2||difficulties with the center|f||||||||||||||2017-10-11 03:28:06.392369|2017-10-11 03:28:06.392369
NCT01497327|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2012-06-07|||July 2011||2011-07-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Open-Label Hepatic Impairment Study|An Open-Label Study to Characterize the Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of PSI-7977 or PSI-352938 in HCV-infected Subjects With Varying Degrees of Hepatic Impairment|Completed||Phase 1|24|Actual|Gilead Sciences||6|||f||||f||||||||||2017-10-11 03:28:06.503314|2017-10-11 03:28:06.503314
NCT01497314|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-05-14|||December 2011||2011-12-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Growth and Safety of a Low Lactose Milk-Based Infant Formula|An Open Label Clinical Study to Evaluate Growth and Safety of a Low Lactose Milk-Based Infant Formula in Healthy Term Infants|Completed||N/A|85|Actual|Perrigo Nutritionals||1|||f||||f||||||||||2017-10-11 03:28:06.61683|2017-10-11 03:28:06.61683
NCT01497301|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2011-12-21|||February 2012||2012-02-01|December 2011|2011-12-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Efficacy Study of Diabetes Group Visits|Initiating Diabetic Group Visits in Newly Diagnosed Diabetics in an Urban Academic Medical Practice|Unknown status|Not yet recruiting|N/A|20|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 03:28:06.71604|2017-10-11 03:28:06.71604
NCT01497288|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2012-09-28|||November 2011||2011-11-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|PK400 INFS||A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects|An Open Label, Randomised, Single-centre, Two Sequence, Cross-over Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects Using a Population PK Approach|Completed||Phase 1|20|Anticipated|Takeda||2|||f||||||||||||||2017-10-11 03:28:06.822108|2017-10-11 03:28:06.822108
NCT01497275|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-06-18|2015-05-20||February 2012||2012-02-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma|A Phase II Study Evaluating Combined Zevalin(Ibritumomab Tiuxetan)and Velcade(Bortezomib)in Relapsed/Refractory Mantle Cell Lymphoma|Terminated||Phase 2|5|Actual|Duke University|The study was closed to enrollment due to the approval of new drugs for use in Mantle Cell Lymphoma. We were not able to enroll enough subjects to answer our study questions.|1||Low accrual due to the approval of new drugs for use in Mantle cell lymphoma.|f||||t||||||||||2017-10-11 03:28:06.926382|2017-10-11 03:28:06.926382
NCT01497262|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-03-17|2015-02-26||February 2012||2012-02-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||The Enrolled Set (ENR) included all patients who signed the informed consent and enrolled in study|Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis|A 4-month, Open-label, Multi-center Study to Explore the Safety and Tolerability of Fingolimod 0.5 mg in Patients With Relapsing-remitting Multiple Sclerosis|Completed||Phase 3|162|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:28:07.330572|2017-10-11 03:28:07.330572
NCT01497249|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-02-06|||December 2011||2011-12-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|FCHO||Assessing Fermentability of a Dietary Fiber|Assessing Fermentability of a Dietary Fiber (FCHO) in Healthy Non-obese Men and Women|Active, not recruiting||N/A|29|Actual|Institute for Food Safety and Health, United States||2|||f||||f||||||||Undecided||2017-10-11 03:28:07.691167|2017-10-11 03:28:07.691167
NCT01497236|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-06-29|||March 2011||2011-03-01|June 2015|2015-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|MSF-nutcon03||Effectiveness of Nutritional Supplementation in Preventing Malnutrition in Children With Infection in Karamoja, Uganda|Effectiveness of Nutritional Supplementation (RUTF and Multi Micronutrient) in Preventing Malnutrition in Children 6-59 Months With Infection (Malaria, Pneumonia, Diarrhoea), a Randomized Controlled Trial in Kaabong, Karamoja, Uganda|Completed||N/A|2202|Actual|Medecins Sans Frontieres, Spain||3|||f||||t||||||||||2017-10-11 03:28:07.791365|2017-10-11 03:28:07.791365
NCT01497223|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-04-02|||December 2011||2011-12-01|June 2012|2012-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis|A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Fluconazole Versus Fluconazole And MGCD290 for the Treatment of Moderate to Severe Vulvovaginal Candidiasis|Completed||Phase 2|220|Actual|MethylGene Inc.||2|||f||||f||||||||||2017-10-11 03:28:07.890281|2017-10-11 03:28:07.890281
NCT01497210|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2012-04-24|||November 2011||2011-11-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||EASH Dressing on Chronic Venous Leg Ulcers|A Prospective, Multi-centre, Non-comparative Study to Evaluate the Safety and Preliminary Performance of the EASH Dressing on Chronic Venous Leg Ulcers|Completed||Phase 2|40|Actual|ConvaTec Inc.||1|||f||||f||||||||||2017-10-11 03:28:08.039919|2017-10-11 03:28:08.039919
NCT01497197|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-10-12|2015-06-15||May 2012||2012-05-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Baseline analysis population included all the subjects randomized in the study.|A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique|A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART)|Terminated||Phase 3|174|Actual|Merck KGaA|Study was terminated as per sponsor's decision.|2||Study was terminated as per sponsor's decision|f||||f||||||||||2017-10-11 03:28:08.154548|2017-10-11 03:28:08.154548
NCT01497184|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2016-12-27|||December 2011||2011-12-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood|CD19-Specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation|Active, not recruiting||Phase 1|140|Anticipated|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-10-11 03:28:08.614057|2017-10-11 03:28:08.614057
NCT01497171|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-08-06|2014-08-06||November 2011||2011-11-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||5 women were enrolled at the German site (St. Hedwig's). No subjects were enrolled at the US sites.|The ELEGANT Trial: Elevate Transvaginal Mesh vs. Anterior Colporrhaphy|Safety and Efficacy of Transvaginal Mesh Colposuspension for Anterior Vaginal Prolapse: the Elevate vs. Anterior Colporrhaphy Trial|Terminated||Phase 4|5|Actual|Mayo Clinic|Early termination of study due to changes in funding.|2||Early termination of study due to changes in funding.|f||||f||||||||||2017-10-11 03:28:08.715373|2017-10-11 03:28:08.715373
NCT01497158|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-08-21|||June 2007||2007-06-01|August 2014|2014-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Promoting Home Smoking Restrictions: Biomarker Feedback to Smoking and Non-Smoking Adults|Promoting Home Smoking Restrictions: Biomarker Feedback to Cohabitating Smoking and Non-Smoking Adults|Completed||N/A|122|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 03:28:08.959196|2017-10-11 03:28:08.959196
NCT01497145|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-03-02|||December 2011||2011-12-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome|A Phase 2, Randomized, Open-Label, Parallel, Comparative, Dose-Response Study to Evaluate the Efficacy and Safety of KRN321 in Adult Subjects With Low- or Intermediate-1-Risk Myelodysplastic Syndrome|Completed||Phase 2|45|Anticipated|Kyowa Hakko Kirin Co., Ltd|||||f||||f||||||||||2017-10-11 03:28:09.047419|2017-10-11 03:28:09.047419
NCT01497132|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2014-09-09|||January 2012||2012-01-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|EVIDENS||Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2|Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2 - EVIDENS|Completed||Phase 4|44|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:28:09.123002|2017-10-11 03:28:09.123002
NCT01497119|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2015-11-30|||October 2011||2011-10-01|November 2015|2015-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study of JNJ-39758979 in Adult Japanese Subjects With Moderate Atopic Dermatitis|Terminated||Phase 2|88|Actual|Janssen Pharmaceutical K.K.||3||This study was terminated prematurely due to 2 cases of agranulocytosis.|f||||f||||||||||2017-10-11 03:28:09.214062|2017-10-11 03:28:09.214062
NCT01497106|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2014-11-25|||December 2011||2011-12-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults|Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults|Completed||N/A|29|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:28:09.483517|2017-10-11 03:28:09.483517
NCT01497093|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-05-09|||February 15, 2012|Actual|2012-02-15|May 2017|2017-05-01|September 12, 2019|Anticipated|2019-09-12|May 1, 2013|Actual|2013-05-01||Interventional|||Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma|A Phase 1, Multicenter, Open Label, Dose-escalation Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide (POM), Bortezomib (BTZ) and Low-Dose Dexamethasone (LDDEX) in Subjects With Relapsed or Refractory Multiple Myeloma (MM)|Active, not recruiting||Phase 1|34|Actual|Celgene||1|||f||||f||||||||||2017-10-11 03:28:09.624809|2017-10-11 03:28:09.624809
NCT01497080|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-03-18|||January 2012||2012-01-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Distal Radius Fracture Prospective Database 50-80 Years Old|"Distal Radius Fracture Prospective Database 50-80 Years Old Overview: Identification of Risk of Adverse Activity Transition Following a Distal Radius Fracture."|Completed||N/A|195|Anticipated|Lawson Health Research Institute|||3||f||||f||||||||||2017-10-11 03:28:09.784398|2017-10-11 03:28:09.784398
NCT01497067|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2017-04-24|||November 21, 2011||2011-11-21||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:28:09.865498|2017-10-11 03:28:09.865498
NCT01497054|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-20|2013-07-02|||December 2011||2011-12-01|December 2011|2011-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Do Elevated BNP Levels Predict Hemodynamically Significant PDAs|Diagnostic Prediction Value of B Type Natriuretic Peptide (BNP) Levels in Hemodynamically Significant Patent Ductus Arteriosus (hsPDA) in Premature Infants.|Completed||N/A|109|Actual|Albany Medical College|||1||f||||f||||||||||2017-10-11 03:28:09.912234|2017-10-11 03:28:09.912234
NCT01497041|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2011-12-19|||February 2011||2011-02-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment|A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment|Unknown status|Recruiting|Phase 2|35|Anticipated|Korean South West Oncology Group||1|||f||||f||||||||||2017-10-11 03:28:10.008225|2017-10-11 03:28:10.008225
NCT01497028|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-04-02|||November 2011||2011-11-01|December 2011|2011-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Plicated Laparoscopic Adjustable Gastric Banding (Lap Band)|Prospective Randomized Clinical Trial of Plicated Laparoscopic Adjustable Gastric Banding|Terminated||N/A|||Jacksonville Surgical Associates|||2||f||||t||||||||||2017-10-11 03:28:10.176278|2017-10-11 03:28:10.176278
NCT01497015|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-04-11|||September 2008||2008-09-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Memory Training Intervention for Breast Cancer Survivors|Memory Training Intervention for Breast Cancer Survivors|Completed||N/A|88|Actual|Indiana University||3|||f||||f||||||||||2017-10-11 03:28:10.292362|2017-10-11 03:28:10.292362
NCT01497002|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-21|2011-12-22|||April 2005||2005-04-01|March 2011|2011-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|AML 2004||Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a|Randomized Phase III Study Comparing the OSHO Arm to the Standard Intergroup Arm. Efficacy of Allogeneic Stem Cell Transplantation in Comparison to a Second Consolidation Chemotherapy in Elderly Patients With Newly Diagnosed AML in the Age Over 60 Years|Unknown status|Recruiting|Phase 3|730|Anticipated|University of Leipzig||3|||f||||t||||||||||2017-10-11 03:28:10.430688|2017-10-11 03:28:10.430688
NCT01496989|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-08-30|||December 2011||2011-12-01|August 2013|2013-08-01||||March 2013|Actual|2013-03-01||Interventional|||Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers|A Phase 1 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate Safety and Immunogenicity of a Multiantigen HIV (HIV-MAG) pDNA Vaccine With or Without Human IL-12 pDNA GENEVAX® IL-12) and Ad35-GRIN/ENV Vaccine in HIV-Uninfected, Healthy Volunteers|Completed||Phase 1|75|Anticipated|International AIDS Vaccine Initiative||5|||f||||t||||||||||2017-10-11 03:28:10.538513|2017-10-11 03:28:10.538513
NCT01496976|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-08-16|||January 20, 2012|Actual|2012-01-20|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL|Phase II Study of Ofatumumab in Combination With High Dose Methylprednisolone Followed by Ofatumumab and Lenalidomide Consolidative Therapy for the Treatment of Untreated CLL/SLL The HiLOG Trial|Active, not recruiting||Phase 2|45|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t|t|f||||||||2017-10-11 03:28:10.675201|2017-10-11 03:28:10.675201
NCT01496963|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-08-03|||January 2012||2012-01-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|PAH2010||Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia|Observational Multicenter Study Lasting 12 Months to Determine the Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia Major and Intermedia and Verify the Suitability of Common Diagnostic Criteria in This Population|Unknown status|Active, not recruiting|N/A|1500|Anticipated|Ente Ospedaliero Ospedali Galliera|||3||f||||f||||||||||2017-10-11 03:28:10.805851|2017-10-11 03:28:10.805851
NCT01496950|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-12-19|||October 2008||2008-10-01|December 2011|2011-12-01|February 2012|Anticipated|2012-02-01|December 2011|Anticipated|2011-12-01||Interventional|TMS-CHROMIG||Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine|Double-blind Randomized Clinical Trial to Evaluate Safety and Efficacy of Repetitive Transcranial Magnetic Stimulation in the Preventive Treatment of Chronic Migraine|Unknown status|Recruiting|Phase 1|20|Anticipated|Hospital Israelita Albert Einstein||2|||f||||f||||||||||2017-10-11 03:28:10.92542|2017-10-11 03:28:10.92542
NCT01496937|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2012-04-18|||December 2011||2011-12-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||First-in-Human Exploratory Single Ascending Dose of GLPG0974|Exploratory Double-blind Placebo-controlled Study for the Assessment of Pharmacokinetics (PK), Safety, Tolerability, and Pharmacodynamics (PD) of Single Ascending Oral Doses of GLPG0974 in Healthy Subjects|Completed||Phase 1|32|Actual|Galapagos NV||2|||f||||f||||||||||2017-10-11 03:28:11.043257|2017-10-11 03:28:11.043257
NCT01496924|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-12-19|||January 2008||2008-01-01|December 2011|2011-12-01|June 2012|Anticipated|2012-06-01|January 2012|Anticipated|2012-01-01||Interventional|||Swallowing Rehabilitation of Dysphagic Tracheostomized Patients Under Mechanical Ventilation at ICU|Swallowing Rehabilitation of Dysphagic Tracheostomized Patients Under Mechanical Ventilation at Intensive Care Unit|Unknown status|Recruiting|Phase 2|30|Anticipated|Federal University of São Paulo||1|||f||||f||||||||||2017-10-11 03:28:11.158451|2017-10-11 03:28:11.158451
NCT01496911|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-11-05|||April 2012||2012-04-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving|Study to Investigate the Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving at 2 Bar and 4 Bar in Professional Navy Divers|Completed||Phase 4|24|Actual|Utrecht Institute for Pharmaceutical Sciences||3|||f||||t||||||||||2017-10-11 03:28:11.303084|2017-10-11 03:28:11.303084
NCT01496898|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2016-01-11|||January 2011||2011-01-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|December 2011|Actual|2011-12-01||Observational|||Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement|Vaginal Microflora and Inflammatory Markers Before and After Levonorgestrel Device Insertion|Completed||N/A|13|Actual|University of Utah|||1||f||||t||||||Samples With DNA|"     A total of 648 samples will be collected from 12 participants for bacterial species and human     cytokine analysis in 9 collection visits. Specimens will be collected up to one week prior to     IUD insertion and two months after IUD insertion. Vaginal and cervical specimens will be     collected using FLOQSwabs® (Copan) to maximize bacterial DNA sample collection. Uterine     samples will be collected by uterine irrigation with sterile saline using an embryo     replacement catheter.   "|||2017-10-11 03:28:11.445766|2017-10-11 03:28:11.445766
NCT01496885|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2015-10-19|||November 2011||2011-11-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke|A Multicenter Observational Study to Evaluate the Simplified STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Obtained Between 24 and 48 Hours of a Nonhemorrhagic Ischemic Stroke|Completed||N/A|120|Actual|Daiichi Sankyo, Inc.|||1||f||||f||||||||||2017-10-11 03:28:11.55805|2017-10-11 03:28:11.55805
NCT01496872|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-08-11|||August 2011||2011-08-01|November 2011|2011-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Newborn Cranial Somatic Dysfunction - An Observational Study|Newborn Cranial Somatic Dysfunction - An Observational Study|Completed||N/A|100|Actual|A.T. Still University of Health Sciences|||1||f||||f||||||||||2017-10-11 03:28:11.744723|2017-10-11 03:28:11.744723
NCT01496859|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2012-03-23|||August 2011||2011-08-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Observational Study of Baska Mask, a New Supraglottic Airway Device|Observational Study of Baska Mask, a New Supraglottic Airway Device|Completed||Phase 2|30|Actual|University College Hospital Galway||1|||f||||f||||||||||2017-10-11 03:28:11.866126|2017-10-11 03:28:11.866126
NCT01496846|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-08-09|2017-07-11||September 2011||2011-09-01|August 2017|2017-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ARTIC||Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars|Articaine Versus Lidocaine Supplemental Infiltration Efficacy in Irreversible Pulpitis Mandibular Molars After Failed Inferior Alveolar Nerve Block|Completed||Phase 4|201|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:28:12.021181|2017-10-11 03:28:12.021181
NCT01496833|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-12-30|||January 2015||2015-01-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Total Endovascular Aortic Arch Re-construction Study(TEARS)|Total Endovascular Aortic Arch Re-construction Study(TEARS)------China's Registry|Recruiting||N/A|50|Anticipated|Xijing Hospital||1|||f||||t||||||||||2017-10-11 03:28:12.49758|2017-10-11 03:28:12.49758
NCT01496820|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2013-07-15|||July 2011||2011-07-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||A Randomized Trial to Assess the Efficacy and Safety of GO2KA1(Chitosan Oligosaccharide)on Blood Glucose Control|Effect of GO2KA1(Chitosan Oligosaccharide) on Postprandial Blood Glucose in Korean Adults: a Clinical Randomized Trial|Completed||Phase 2/Phase 3|60|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 03:28:12.602391|2017-10-11 03:28:12.602391
NCT01496807|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2017-03-20|2017-01-31||February 17, 2012||2012-02-17|January 2017|2017-01-01|August 29, 2016|Actual|2016-08-29|March 16, 2016|Actual|2016-03-16||Interventional||All evaluable participants will be those who completed treatment per study criteria.|Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma|A Phase Ib Study of Yervoy With Sylatron for Patients With Unresectable Stages IIIB/C/IV Melanoma|Completed||Phase 1|31|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 03:28:12.71025|2017-10-11 03:28:12.71025
NCT01496794|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2017-02-20|||October 2011||2011-10-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|PROSPER||Endophthalmitis Cultures|Prospective Surveillance of Patients With Endophthalmitis for Multi-antibiotic Resistance (PROSPER) Study|Terminated||N/A|3|Actual|Vanderbilt University Medical Center|||1|poor enrollment|f||||f||||||||||2017-10-11 03:28:13.251347|2017-10-11 03:28:13.251347
NCT01496781|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2012-04-14|||April 2010||2010-04-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|EMR||EndoClot for Hemostasis and Preventing Post-procedure Bleeding After Endoscopic Mucosal Resection|EndoClotTM Absorbable Polysaccharide Hemostat in Comparison With Metallic Hemoclip for Hemostasis and Preventing Post-procedure Bleeding After Endoscopic Mucosal Resection: a Prospective, Randomized Trial|Completed||N/A|164|Actual|Xijing Hospital of Digestive Diseases||2|||f||||t||||||||||2017-10-11 03:28:13.32309|2017-10-11 03:28:13.32309
NCT01496768|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-02-22|||January 2012||2012-01-01|February 2013|2013-02-01|February 2013|Anticipated|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effects of Chronic Leucine Supplemetion on Glucose Homeostasis, Body Compositin, Muscle Mass and Strength of Healthy and Young Subjects|Effects of Chronic Leucine Supplemetion on Glucose Homeostasis, Body Compositin, Muscle Mass and Strength of Healthy and Young Subjects: a Randomized, Double-blind, and Placebo Controlled Trial|Suspended||N/A|24|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:28:13.415444|2017-10-11 03:28:13.415444
NCT01496755|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-11-01|||January 2012||2012-01-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of RG7667 in Healthy Volunteers|A Phase I Randomized, Double-Blind, Placebo-Controlled Trial of Single and Multiple Doses of RG7667 in Healthy Adult Volunteers|Completed||Phase 1|170|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:28:13.492732|2017-10-11 03:28:13.492732
NCT01496742|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-09-21|||April 2012||2012-04-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer|A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Metmab Vs. Placebo in Combination With Either Bevacizumab + Platinum + Paclitaxel or Pemetrexed + Platinum in Patients With Untreated Stage IIIb or IV Non-Squamous NSCLC|Completed||Phase 2|259|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 03:28:13.577293|2017-10-11 03:28:13.577293
NCT01496729|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-10-08|||January 2012||2012-01-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Interventional|||Transversus Abdominis Plane (TAP) Block After Kidney Transplantation|Single Shot Transversus Abdominis Plane (TAP) Block Versus Sham Block for Analgesia in Donors and Recipients Following Kidney Transplantation|Withdrawn||N/A|0|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:28:16.079987|2017-10-11 03:28:16.079987
NCT01496716|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2013-08-12|||November 2011||2011-11-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Obesity's Impact on the Effect of Hip Arthroplasty|Obesity's Impact on the Clinical Efficacy and Quality of Life 1 Year After Primary Total Hip Arthroplasty|Completed||N/A|102|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 03:28:16.187503|2017-10-11 03:28:16.187503
NCT01496703|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-17|2011-12-20|||January 1996||1996-01-01|December 2011|2011-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Reasons for Mycophenolate Mofetil Dose Reduction and Impact on Graft Outcome in Renal Transplant Recipients|Reasons for Dose Reduction of Mycophenolate Mofetil During the First Post-transplant Year in Renal Transplant Recipients and Its Impact on Graft Outcome: a Single-center Retrospective Analysis|Completed||N/A|749|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 03:28:16.277211|2017-10-11 03:28:16.277211
NCT01496690|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2017-01-06|||January 2012||2012-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|PACS||Pregablin for Anxiety-comorbidity in Patients With Schizophrenia|Pregablin for Anxiety-comorbidity in Patients With Schizophrenia - a Double-blinded Randomized Placebo Controlled Study|Completed||Phase 4|54|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:28:16.354141|2017-10-11 03:28:16.354141
NCT01496677|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2017-10-04|||January 17, 2012|Actual|2012-01-17|October 2017|2017-10-01|February 28, 2012|Actual|2012-02-28|February 28, 2012|Actual|2012-02-28||Interventional|||Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects|A Phase 1 Open-Label Study With Oral TR-701 Free Acid to Assess Pharmacokinetics, Safety, and Tolerability in Elderly Subjects|Completed||Phase 1|28|Actual|Trius Therapeutics LLC||2|||f||||f||||||||||2017-10-11 03:28:16.438892|2017-10-11 03:28:16.438892
NCT01496664|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2017-03-20|||September 2010||2010-09-01|March 2017|2017-03-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Coronary Hybrid Revascularisation Study|Coronary Hybrid Revascularisation Study Registry on Treatment of Significant Coronary Artery Disease by Combined Bypass Operation (CABG) and Catheter Based Treatment (PCI)|Active, not recruiting||Phase 4|2000|Anticipated|Aarhus University Hospital Skejby||1|||f||||t||||||||||2017-10-11 03:28:16.52597|2017-10-11 03:28:16.52597
NCT01496651|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2015-01-30|||November 2008||2008-11-01|January 2015|2015-01-01|December 2018|Anticipated|2018-12-01|January 2015|Actual|2015-01-01||Interventional|LeftMain/NOBLE||Coronary Artery Bypass Grafting Vs Drug Eluting Stent Percutaneous Coronary Angioplasty in the Treatment of Unprotected Left Main Stenosis|Nordic-Baltic-British Left Main Revascularization Study (NOBLE)|Active, not recruiting||Phase 4|1200|Anticipated|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 03:28:16.614728|2017-10-11 03:28:16.614728
NCT01496638|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-09-22|||December 2008||2008-12-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2012|Actual|2012-12-01||Interventional|BIF IV||The Nordic-Baltic Bifurcation Study IV|How Should Coronary Artery Stenoses With Significant Side Branch be Stented? A Strategy of Stenting Both Main Vessel and Side Branch Compared to a Strategy of Stenting the Main Vessel and Only Stenting the Side Branch if Necessary.|Active, not recruiting||Phase 4|450|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 03:28:16.713297|2017-10-11 03:28:16.713297
NCT01496625|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-17|2017-06-30|||December 1, 2011||2011-12-01|March 21, 2017|2017-03-21||||||||Observational|||National Eye Institute Biorepository for Retinal Diseases|NEI Intramural Biorepository for Retinal Diseases|Recruiting||N/A|2300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:28:16.832098|2017-10-11 03:28:16.832098
NCT01496612|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-17|2017-06-30|||November 22, 2011||2011-11-22|April 19, 2016|2016-04-19|April 19, 2016|Actual|2016-04-19|April 19, 2016|Actual|2016-04-19||Interventional|||Buspirone Therapy for Localized Epilepsy|A Phase Two Clinical Trial of Buspirone Therapy in Localization-Related Epilepsy|Terminated||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:28:16.991737|2017-10-11 03:28:16.991737
NCT01496599|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-17|2017-08-22|||November 22, 2011||2011-11-22|August 16, 2017|2017-08-16||||||||Observational|||Imaging Biomarkers in Parkinson s Disease|Imaging Biomarkers in Parkinson Disease|Recruiting||N/A|95|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:28:17.211899|2017-10-11 03:28:17.211899
NCT01496586|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-17|2017-06-30|||December 1, 2011||2011-12-01|August 3, 2015|2015-08-03|August 3, 2015||2015-08-03|||||Observational|||Service Member Fatigue and Lack of Motivation Following Concussion|Fatigue and Amotivation Following Mild Traumatic Brain Injury and Their Influence on Service Member Community Reintegration|Completed||N/A|45|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:28:17.317585|2017-10-11 03:28:17.317585
NCT01496573|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-05-17|||December 2011||2011-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma|Observational - CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)|Completed||N/A|77|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     tumor tissue   "|||2017-10-11 03:28:17.410442|2017-10-11 03:28:17.410442
NCT01496560|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2015-11-16|||November 2015||2015-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01|1 Day|Observational [Patient Registry]|||Open Prospective Study for Determination of Predictive Measures for Pain During Colonoscopy|Comparison of Procedural Sequence in Same Day Consecutive Bidirectional Endoscopy Using Moderate Sedation: A Prospective Randomized Study|Withdrawn||N/A|0|Actual|Sheba Medical Center|||1|study terminated due toTechnical issue pre -recruiting|f||||f||||||||||2017-10-11 03:28:17.505578|2017-10-11 03:28:17.505578
NCT01496547|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-05-09|||January 2011||2011-01-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML|Sequential Intensive Chemotherapy Followed by Allogeneic Stem Cell Transplantation With Reduce-intensity Conditioning for Refractory and Relapse Acute Myeloid Leukemia in Adult Patients|Recruiting||Phase 2|42|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||No||2017-10-11 03:28:17.596933|2017-10-11 03:28:17.596933
NCT01496534|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-11-26|||January 2012||2012-01-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors|Phase Ib Study of Dovitinib in Combination With Gemcitabine Plus Cisplatin or Gemcitabine Plus Carboplatin in Patients With Advanced Solid Tumors|Terminated||Phase 1|14|Actual|Icahn School of Medicine at Mount Sinai||2||toxicity of combination of medications|f||||f||||||||||2017-10-11 03:28:17.704486|2017-10-11 03:28:17.704486
NCT01496521|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-17|||January 2012||2012-01-01|December 2011|2011-12-01|January 2013|Anticipated|2013-01-01|June 2012|Anticipated|2012-06-01||Interventional|CREAT||Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols|Chemoprevention of Esophageal Squamous Cell Carcinoma With Aspirin and Tea Polyphenols: a Randomized Controlled Trial.|Unknown status|Not yet recruiting|Phase 3|600|Anticipated|Beijing Friendship Hospital||3|||f||||t||||||||||2017-10-11 03:28:17.832234|2017-10-11 03:28:17.832234
NCT01496508|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-20|||June 2007||2007-06-01|December 2011|2011-12-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional|||High-frequency Oscillatory Ventilation (HFOV) in Preterm Infants With Severe Respiratory Distress Syndrome (RDS)|Principal Investigator|Completed||Phase 2|360|Actual|Zhengzhou Children's Hospital, China||2|||f||||t||||||||||2017-10-11 03:28:17.966113|2017-10-11 03:28:17.966113
NCT01496495|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-12-27|||January 2012||2012-01-01|December 2014|2014-12-01||||December 2014|Actual|2014-12-01||Interventional|||A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes||Completed||Phase 1|71|Actual|Array BioPharma||1|||f||||||||||||||2017-10-11 03:28:18.082598|2017-10-11 03:28:18.082598
NCT01496482|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-03|2011-12-21|||September 2008||2008-09-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Comparison of Evaporimetry With the Established Methods of Tear Film Measurement|Comparison of Evaporimetry With the Established Methods of Tear Film Measurement|Completed||N/A|90|Actual|University of Zagreb|||2||f||||f||||||||||2017-10-11 03:28:18.169981|2017-10-11 03:28:18.169981
NCT01496469|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2015-07-31|2015-07-31||February 2012||2012-02-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||The Full Analysis Set (FAS) included all participants who were randomized and received at least 1 dose of double-blind study medication.|Effect of Febuxostat on Blood Pressure|A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension|Completed||Phase 2|121|Actual|Takeda||2|||f||||t||||||||||2017-10-11 03:28:18.298746|2017-10-11 03:28:18.298746
NCT01496456|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-07-09|2016-02-17||May 2010||2010-05-01|July 2017|2017-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ICON|Enrolled: 17 patients; 1 patient was not treated according to protocol. Baseline: 16 patients with 22 tooth pairs.|Radiographic Progression of Infiltrated Caries Lesions In-vivo|Radiographic Progression of Infiltrated Caries Lesions In-vivo|Completed||N/A|17|Actual|University of Michigan|Small number of subjects analyzed.|2|||f||||f||||||||||2017-10-11 03:28:19.314771|2017-10-11 03:28:19.314771
NCT00005421|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1992||1992-09-01|March 2005|2005-03-01|March 1995|Actual|1995-03-01|||||Observational|||Blood Pressure Tracking--Childhood to Young Adulthood||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.623219|2017-10-11 04:27:02.623219
NCT01496443|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2012-09-12|||January 2012||2012-01-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||TAK-875 Glimepiride Drug-Interaction Study|A Phase 1, Single-Blind, Placebo Controlled, Sequential Design Study to Evaluate the Drug Interaction Potential Between Glimepiride and TAK-875 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|28|Actual|Takeda||1|||f||||f||||||||||2017-10-11 03:28:19.866218|2017-10-11 03:28:19.866218
NCT01496430|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2015-04-20|2014-05-14||January 2012||2012-01-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Randomized Set includes all enrolled participants who were randomized via the Interactive Voice/Web Response System.|Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes|A Randomized, Double-Blind, Phase 3b Proof-of-Concept Study to Evaluate the Efficacy and Safety of TAK-491 Compared to Placebo When Used in Combination With Metformin in Subjects With Hypertension and Type 2 Diabetes|Terminated||Phase 3|105|Actual|Takeda|Because of low enrollment in the study, the sample sizes in the results data do not allow for significant interpretation of the results.|3||Business Decision; No Safety Or Efficacy Concerns. (See below)|f||||f||||||||||2017-10-11 03:28:20.044885|2017-10-11 03:28:20.044885
NCT01496417|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-08-16|||March 2012||2012-03-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores|A 12 Month, Single-center, Non-randomized, Open-label Study of Outcomes of Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores in de Novo Renal Transplant Recipients|Active, not recruiting||N/A|20|Actual|University of Maryland||1|||f||||t||||||||||2017-10-11 03:28:22.019437|2017-10-11 03:28:22.019437
NCT01496404|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2014-07-19|||January 2012||2012-01-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Electrocautery Versus Scalpel for Skin Incisions|A Randomized Controlled Trial Comparing the Cosmetic Outcome of Electrocautery Versus Scalpel for Surgical Skin Incisions|Completed||N/A|66|Actual|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 03:28:22.110356|2017-10-11 03:28:22.110356
NCT01496391|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2014-04-08|||September 2012||2012-09-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Observational|||A Single Centre Open Label Comparison of [I-123]-Ortho-Iodohippuric Acid (OIH) With [Tc-99m]-Mercaptoacetyltriglycine (MAG3) for Assessment of Renal Tubular Function|A Single Centre Open Label Comparison of [I-123]-Ortho-Iodohippuric Acid (OIH) With [Tc-99m]-Mercaptoacetyltriglycine (MAG3) for Assessment of Renal Tubular Function|Completed||N/A|6|Actual|Centre for Probe Development and Commercialization|||3||f||||t||||||None Retained|"     Whole blood (chemistry, hematology) and kidney function (eGRF, eRPF)   "|||2017-10-11 03:28:22.181304|2017-10-11 03:28:22.181304
NCT01496378|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2015-05-26|||May 2012||2012-05-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Problem Solving Skills Training For Parent Caregivers of Youth With Chronic Pain|Problem Solving Skills Training For Parent Caregivers of Youth With Chronic Pain|Completed||Phase 1|122|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 03:28:22.253842|2017-10-11 03:28:22.253842
NCT01496365|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-03-10||2014-02-07|November 2011||2011-11-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|A Randomized, Double-Blind, Placebo and Active Comparator-Controlled Study of DS-5565 for Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|Completed||Phase 2|452|Actual|Daiichi Sankyo, Inc.||6|||f||||t||||||||||2017-10-11 03:28:22.346095|2017-10-11 03:28:22.346095
NCT01496352|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-08-15|2014-08-15||February 2012||2012-02-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||DFA-02 in Patients Undergoing Colorectal Surgery|A Randomized, Double-blind, Placebo Controlled, Safety, Tolerability, and Pharmacokinetic Dose Escalation Study of DFA-02 in Patients Undergoing Colorectal Surgery|Completed||Phase 1/Phase 2|30|Actual|Dr. Reddy's Laboratories Limited|Protocol specified cohorts of 10, 20, 30 or 40 mL to be placed after closure of the fascia and prior to skin closure. Experience with 20 and 30 mL dose levels showed that even largest patients would not accommodate 40 mL so that arm was not done.|2|||f||||t||||||||||2017-10-11 03:28:22.764447|2017-10-11 03:28:22.764447
NCT01496339|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2012-06-06|||January 2012||2012-01-01|June 2012|2012-06-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients|Phase 1/2 Clinical Study of MenSCs Infusion in Type 1 Diabetes|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|S-Evans Biosciences Co.,Ltd.||2|||f||||t||||||||||2017-10-11 03:28:23.307016|2017-10-11 03:28:23.307016
NCT01496326|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-19|||February 2011||2011-02-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|ANTIPAIN||Osteoarthritis Topical Treatment|A Pilot Study to Compare the Efficacy and Safety of a Novel 10% Ibuprofen Formulation Versus Placebo Alone Applied to the Knee in Patients With Painful Osteoarthritis of the Knee|Completed||Phase 2|75|Actual|BioChemics, Inc.||2|||f||||t||||||||||2017-10-11 03:28:23.450094|2017-10-11 03:28:23.450094
NCT01496313|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2016-10-11|2015-04-01||June 2012||2012-06-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|April 2014|Actual|2014-04-01||Interventional|||To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer|An International, Randomised, Double-Blind, Two-Arm Study To Evaluate The Safety And Efficacy Of Vandetanib 150 And 300mg/Day In Patients With Unresectable Locally Advanced Or Metastatic Medullary Thyroid Carcinoma With Progressive Or Symptomatic Disease|Active, not recruiting||Phase 4|81|Actual|Sanofi||2|||f||||||||||||||2017-10-11 03:28:23.608284|2017-10-11 03:28:23.608284
NCT01496300|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-09-02|||November 2011||2011-11-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|BONARTH||Benefit of Orthopedic Navigation in the ARThroplasty of the Hip|Randomised Controlled Double-blind Monocenter Therapy Study Validating the Benefit From Information Provided by Image Free Navigation System on the Precision of the Placement of Acetabular Component in Patients Undergoing Primary THA|Completed||Phase 4|89|Actual|Aesculap AG||2|||f||||f||||||||||2017-10-11 03:28:24.483322|2017-10-11 03:28:24.483322
NCT01496287|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2014-11-04|2014-06-26||December 2011||2011-12-01|November 2014|2014-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|Inova||Tympanostomy Tube Placement in Children in the Office (Inova Study)|Tympanostomy Tube Placement in Children in the Office (Inova Study)|Completed||N/A|70|Actual|Acclarent||1|||f||||f||||||||||2017-10-11 03:28:24.597168|2017-10-11 03:28:24.597168
NCT00005422|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1992||1992-04-01|June 2000|2000-06-01|March 1995|Actual|1995-03-01|||||Observational|||Longitudinal Analysis of Spirometry in Black Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.693335|2017-10-11 04:27:02.693335
NCT01496274|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-04-03|2016-04-03|2015-09-29|February 2012||2012-02-01|April 2016|2016-04-01||||July 2014|Actual|2014-07-01||Interventional||Safety Population|A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B|A Phase II/III Open-label, Multicenter, Safety and Efficacy Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Subjects With Hemophilia B|Completed||Phase 2/Phase 3|63|Actual|CSL Behring||2|||f||||t||||||||||2017-10-11 03:28:24.85082|2017-10-11 03:28:24.85082
NCT01496261|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2011-12-20|||August 2011||2011-08-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial|Comparative Pharmacokinetics of Clopidogrel 75mg and Aspirin 100mg After Single Oral Administration as a Fixed Dose Combination Versus Separate Combination in Healthy Male Volunteers|Completed||Phase 1|60|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 03:28:25.786368|2017-10-11 03:28:25.786368
NCT01496248|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2014-10-06|2014-09-24||August 2011||2011-08-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy Study of Korean Red Ginseng to Treat Depression|The Effect of Korean Red Ginseng as Adjuvant Treatment for the Residual Symptoms of Depression|Completed||N/A|35|Actual|Korea University||1|||f||||f||||||||||2017-10-11 03:28:25.877054|2017-10-11 03:28:25.877054
NCT01496235|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-12-16|||July 2009||2009-07-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Cocoa Consumption in Cardiovascular and Immune Parameters|Randomized Clinical Trial of the Effect of Cocoa Consumption in Cardiovascular and Immune Parameters in Colombian Patients With Newly Diagnosed Stage 1 Arterial Hypertension|Terminated||N/A|69|Actual|Universidad de Antioquia||2||Difficulties with the patient recruitment|f||||t||||||||||2017-10-11 03:28:26.182559|2017-10-11 03:28:26.182559
NCT01496222|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-03-14|||January 2012||2012-01-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|October 2015|Actual|2015-10-01||Observational|MoCA||The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive Impairment in Geriatric Patients|The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive|Enrolling by invitation||N/A|582|Anticipated|Mahidol University|||1||f||||t||||||||||2017-10-11 03:28:26.440106|2017-10-11 03:28:26.440106
NCT01496209|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2014-02-10|||July 2015||2015-07-01|February 2014|2014-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|RECONSTRUCT||REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts||Withdrawn||Phase 1|0|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 03:28:26.515588|2017-10-11 03:28:26.515588
NCT01496196|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-18|2015-04-12|||January 2012||2012-01-01|December 2011|2011-12-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||The Role of Inhalations of Tranexamic Acid in Patients With Hemoptysis||Unknown status|Recruiting|Phase 3|100|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 03:28:26.631245|2017-10-11 03:28:26.631245
NCT01496183|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-11-24|2014-11-24||October 2007||2007-10-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Metabolic Effects of Olanzapine in Healthy Males|Metabolic Effects of Olanzapine in Healthy Males|Completed||N/A|24|Actual|State University of New York at Buffalo|The small sample size, the exclusion of obese subjects, and the short olanzapine exposure in the current study may limit the interpretation and generalizability of our findings.|2|||f||||f||||||||||2017-10-11 03:28:26.747906|2017-10-11 03:28:26.747906
NCT01496170|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2015-10-22|||December 2011||2011-12-01|October 2015|2015-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])|A Study to Assess the Safety, Tolerability, and Pharmacodynamics of MK-8931/SCH 900931 in Patients With Alzheimer's Disease [Phase 1b; Protocol No. 010-00 (Also Known as P07820)]|Completed||Phase 1|32|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-10-11 03:28:27.035821|2017-10-11 03:28:27.035821
NCT01496144|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2011-12-20|||December 2005||2005-12-01|December 2011|2011-12-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Manual Therapy on the Improvement of Functional Disability in Patients With Chronic Non Specific Low Back Pain|Manual Therapy Followed by Specific Active Exercises Versus a Placebo Followed by Specific Active Exercises on the Improvement of Functional Disability in Patients With Chronic Non Specific Low Back Pain: a Randomized Controlled Trial|Completed||N/A|42|Actual|University of Applied Sciences of Western Switzerland||2|||f||||f||||||||||2017-10-11 03:28:27.198116|2017-10-11 03:28:27.198116
NCT01496131|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-08-04|||October 31, 2011|Actual|2011-10-31|July 2017|2017-07-01|November 25, 2016|Actual|2016-11-25|November 25, 2016|Actual|2016-11-25||Interventional|||Tecemotide (L-BLP25) in Prostate Cancer|A Randomized Phase II Study of Tecemotide in Combination With Standard Androgen Deprivation Therapy and Radiation Therapy for Untreated, Intermediate and High Risk Prostate Cancer Patients|Completed||Phase 2|28|Actual|EMD Serono||2|||f||||f||||||||||2017-10-11 03:28:27.293391|2017-10-11 03:28:27.293391
NCT01496118|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-04-18|||December 2011||2011-12-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma|Phase I/II Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|80|Anticipated|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 03:28:27.405417|2017-10-11 03:28:27.405417
NCT01496105|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-20|||July 2011||2011-07-01|December 2011|2011-12-01|January 2012|Anticipated|2012-01-01|December 2011|Anticipated|2011-12-01||Interventional|||Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion||Unknown status|Recruiting|Phase 4|200|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 03:28:27.556278|2017-10-11 03:28:27.556278
NCT01496092|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-02-19|||April 2011||2011-04-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of Keto Acid (KA) on Insulin Resistance in Peritoneal Dialysis (PD) Patients|Effects of Regular Protein Diet Supplemented With Keto Acid on Insulin Resistance In Peritoneal Dialysis Patients|Completed||Phase 3|100|Actual|Peking University First Hospital||2|||f||||f||||||||||2017-10-11 03:28:27.664963|2017-10-11 03:28:27.664963
NCT01496079|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-04-12|||December 2011||2011-12-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|MI GIFT||Maternal Immunization: Giving Immunity For Tomorrow|The Role of Immunizing Pregnant Women In Protecting Young Infants Against Influenza|Completed||N/A|166|Actual|University of Utah|||2||f||||f||||||||||2017-10-11 03:28:27.765026|2017-10-11 03:28:27.765026
NCT01496066|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-07-25|||December 2011||2011-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:28:27.850273|2017-10-11 03:28:27.850273
NCT01496053|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2015-04-13|||December 2011||2011-12-01|December 2011|2011-12-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)|Anti-inflammatory Effect of a Mushroom Extract (AndoSan)in Patients With Inflammatory Bowel Disease. A Prospective Study|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 03:28:27.899474|2017-10-11 03:28:27.899474
NCT01496040|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2015-10-06|||September 2011||2011-09-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|RPE65||Clinical Gene Therapy Protocol for the Treatment of Retinal Dystrophy Caused by Defects in RPE65|Prospective Monocentric Open Label Non Randomized Uncontrolled Phase I/II Clinical Gene Therapy Protocol for the Treatment of Retinal Dystrophy Caused by Defects in RPE65|Completed||Phase 1/Phase 2|9|Actual|Nantes University Hospital||1|||f||||t||||||||||2017-10-11 03:28:28.008269|2017-10-11 03:28:28.008269
NCT01496027|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-10|2013-09-09|||December 2011||2011-12-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Observational|||Cerebral Tissue Oxygenation Values in Newborns Measured Using Laser and LED NIRS Oximeters|A Comparison of Cerebral Tissue Oxygenation Values in Newborns Measured Simultaneously Using Laser and LED NIRS Oximeters|Completed||N/A|30|Actual|Poznan University of Medical Sciences|||2||f||||f||||||||||2017-10-11 03:28:28.094604|2017-10-11 03:28:28.094604
NCT01496014|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-12-22|||September 2011||2011-09-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|September 2016|Actual|2016-09-01||Observational|Bioburden||Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage|Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage: Correlation With Subsequent Post-Closure Deep Wound Infection: Bioburden Study|Active, not recruiting||N/A|600|Anticipated|Major Extremity Trauma Research Consortium|||1||f||||t||||||Samples With DNA|"     Tissue   "|||2017-10-11 03:28:28.173654|2017-10-11 03:28:28.173654
NCT01496001|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-10-05|||March 2011||2011-03-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Cosmetic and Functional Outcomes After Breast Conserving Surgery|The Effect of Tumor - Breast Volume Ratio on Cosmetic and Functional Outcomes in Breast Conserving Surgery Patients; a Prospective Cohort Study|Completed||N/A|300|Actual|National Institute of Oncology, Hungary||1|||f||||t||||||||||2017-10-11 03:28:28.358643|2017-10-11 03:28:28.358643
NCT01495988|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-05-30|2017-05-30||August 2013||2013-08-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|January 2016|Actual|2016-01-01||Interventional|||Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma|Randomized Phase II Trial of Vemurafenib (PLX4032/RG7204)/Cobimetinib (GDC-0973) With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma|Terminated||Phase 2|10|Actual|Melanoma Research Foundation Breakthrough Consortium|The study was terminated prematurely on June 13, 2016. No further accrual to the study will occur.|2||Slow accrual; toxicity; change in priorities|f||||t||||||||||2017-10-11 03:28:28.486004|2017-10-11 03:28:28.486004
NCT01495975|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-09-12|2015-04-06||December 2011||2011-12-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional|DTTK||Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control|Impact of a Web-based Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control|Completed||N/A|29|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:28:29.480718|2017-10-11 03:28:29.480718
NCT01495962|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-04-25|||November 2011||2011-11-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|August 2014|Actual|2014-08-01||Interventional|||The Biomechanical Effects of Flaccid Paralysis Induced by Botulinum Toxin a After Damage Control Laparotomy|The Biomechanical Effects of Flaccid Paralysis Induced by Botulinum Toxin a After Damage Control Laparotomy: A Pilot Study|Completed||Phase 1|46|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:28:29.796852|2017-10-11 03:28:29.796852
NCT01495949|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-05-21|||December 2011||2011-12-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Cortisol Levels During Cardiac Surgery. The Comparison Between Etomidate and Thiopentone|The Changes in Cortisol Levels and Stress Responses During Cardiac Surgery. The Comparison Between Two Induction Agents: Etomidate and Thiopentone.|Completed||Phase 4|92|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 03:28:29.907198|2017-10-11 03:28:29.907198
NCT01495936|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2011-12-19|||December 2011||2011-12-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||The Effect of Two Airway Interventions, During One Lung Ventilation, on Blood Oxygen Content|The Influence Of Continuous Positive Airway Pressure and Positive End-Expiratory Pressure, With A Recruitment Maneuver, On Oxygenation During One Lung Ventilation Employing A Lung Protective Ventilation Strategy.|Unknown status|Not yet recruiting|N/A|40|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:28:30.011027|2017-10-11 03:28:30.011027
NCT01495923|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-02-28|2016-08-10||December 2011||2011-12-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Steroids Versus Gabapentin|Randomized, Double-blind, Comparative-effectiveness Study Comparing Epidural Steroid Injections to Gabapentin in Patients With Lumbosacral Radiculopathy|Completed||N/A|145|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:28:30.1349|2017-10-11 03:28:30.1349
NCT01495910|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2014-02-27|||December 2011||2011-12-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency|An Open-Label, Multiple-Dose, Dose-Finding Study of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency|Completed||Phase 1|6|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||t||||||||||2017-10-11 03:28:30.680919|2017-10-11 03:28:30.680919
NCT01495897|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-02-23|||March 2011||2011-03-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|MOUVADOC||Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study|Adaptation Sensorimotrice, Cervelet et Mouvements Anormaux: Projet d'étude Oculomotrice|Completed||N/A|14|Actual|Institut National de la Santé Et de la Recherche Médicale, France||4|||f||||f||||||||||2017-10-11 03:28:30.767853|2017-10-11 03:28:30.767853
NCT01495884|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-10-23|||March 2011||2011-03-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Myocet/Lapatinib Study. ICORG 10-03, V5|A Phase I/II Study of Lapatinib Plus Myocet TM in Patients With HER2+ve Metastatic Breast Cancer Following Disease Progression During, or After, Treatment With Trastuzumab and Taxanes|Terminated||Phase 1/Phase 2|11|Actual|Cancer Trials Ireland||1||Slower than anticipated accrual|f||||f||||||||||2017-10-11 03:28:30.848923|2017-10-11 03:28:30.848923
NCT01495871|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-02-10|||November 2011||2011-11-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TBIS||Amino Acid Supplementation in Recovery From Traumatic Brain Injury|Amino Acid Supplementation in Recovery From Traumatic Brain Injury|Withdrawn||N/A|0|Actual|The University of Texas Medical Branch, Galveston||3||PI decided not to pursue this study.|f||||f||||||||||2017-10-11 03:28:30.933899|2017-10-11 03:28:30.933899
NCT01495858|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-05-13|2014-01-24|2012-05-30|December 2011||2011-12-01|May 2015|2015-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|Morpheus/DPH||Evaluate Analgesic / Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain|A Multicenter, Randomized, Double-Blind, Parallel Group Trial Assessing the Efficacy and Safety of Naproxen Sodium and Diphenhydramine Combination in Postsurgical Dental Pain With Phase Advanced Sleep|Completed||Phase 3|267|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:28:31.226507|2017-10-11 03:28:31.226507
NCT01495845|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2012-06-07|||December 2011||2011-12-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy|Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy|Completed||Phase 1|48|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 03:28:32.925451|2017-10-11 03:28:32.925451
NCT01495832|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2014-09-24|||June 2012||2012-06-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PULSA-2011||Impact of Pulse-enriched Foods on Cognitive Function and Cardiometabolic Health in Obese Adults|Impact of Pulse-enriched Foods on Cognitive Function and Cardiometabolic Health in Obese Adults|Completed||N/A|150|Actual|University of Manitoba||2|||f||||f||||||||||2017-10-11 03:28:33.023984|2017-10-11 03:28:33.023984
NCT01495819|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2017-07-12|||January 4, 2017|Actual|2017-01-04|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Nicotine Reinforcement and Aversion in Young Adult Light Smokers|Nicotine Reinforcement and Aversion in Young Adult Light Smokers|Recruiting||N/A|64|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 03:28:33.172235|2017-10-11 03:28:33.172235
NCT01495806|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2013-06-11|||January 2010||2010-01-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood|Glucomannn for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood Randomized Double Blind Placebo Controlled Trial|Completed||Phase 4|90|Anticipated|Medical University of Warsaw||2|||f||||f||||||||||2017-10-11 03:28:33.287012|2017-10-11 03:28:33.287012
NCT01495793|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-06-17|2015-04-29||December 2011||2011-12-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Baseline Characteristics refers to the 24 treated subjects (Safety Set).|Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome|A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome|Completed||Phase 2|42|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 03:28:33.433975|2017-10-11 03:28:33.433975
NCT01495780|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2013-06-28|||January 2012||2012-01-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||eRT Remote Health Monitoring|Feasibility and Cost Effectiveness of Physiological Monitoring at Home in COPD Patients|Unknown status|Recruiting|N/A|75|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 03:28:33.967883|2017-10-11 03:28:33.967883
NCT01495767|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2011-12-22|||January 2006||2006-01-01|December 2011|2011-12-01|July 2009|Actual|2009-07-01|||||Observational|||Quality of Life in Juvenile Patients With Uveitis|The Impact of Uveitis on Health-related Quality of Life in Adolescents|Completed||N/A|37|Actual|Hospital Hietzing|||1||f||||f||||||||||2017-10-11 03:28:34.084023|2017-10-11 03:28:34.084023
NCT01495754|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2011-12-19|||January 2011||2011-01-01|December 2011|2011-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effects of Different Coffee Amounts on Energy Intake, Appetite, Glucose Metabolism and Inflammatory Markers|The Effect of Different Amounts of Coffee on Dietary Intake, Appetite-related Feeling, Appetite Hormones, Glucose Metabolism and Inflammatory Markers of Normal Weight and Overweight/Obese Individuals|Completed||N/A|33|Actual|Harokopio University||3|||f||||f||||||||||2017-10-11 03:28:34.160026|2017-10-11 03:28:34.160026
NCT01495741|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-05-08|||July 1, 2013|Actual|2013-07-01|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Observational|||Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)|An Observational Post-Authorization Safety Surveillance (PASS) Study of Sycrest® (Asenapine) Among Patients Aged 18 and Older Diagnosed With Bipolar Disorder|Recruiting||N/A|3000|Anticipated|Merck Sharp & Dohme Corp.|||3||f||||f||||||||||2017-10-11 03:28:34.274794|2017-10-11 03:28:34.274794
NCT01495728|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2011-12-19|||September 2011||2011-09-01|December 2011|2011-12-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||Thoracic Manipulation in Patients With Cervical Radiculopathy|Immediate and Short Term Effects of Thoracic Manipulation in Patients With Cervical Radiculopathy|Unknown status|Recruiting|N/A|50|Anticipated|Spine and Sport, Georgia||2|||f||||f||||||||||2017-10-11 03:28:34.365923|2017-10-11 03:28:34.365923
NCT01495715|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2014-08-21||||||August 2014|2014-08-01||||||||Interventional|||Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)||Withdrawn||Phase 3|0|Actual|Santhera Pharmaceuticals||2|||f||||||||||||||2017-10-11 03:28:34.523126|2017-10-11 03:28:34.523126
NCT01495546|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2012-09-13|||December 2011||2011-12-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|Latearly||Total Hip Arthroplasty (THA): Early Load Versus Load Late|Randomized Comparison of Quality of Life and Functional Patients Undergoing Total Hip Replacement Uncemented. Load Early X Load Late|Unknown status|Recruiting|N/A|45|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:28:40.333568|2017-10-11 03:28:40.333568
NCT00005423|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1992||1992-07-01|April 2002|2002-04-01|December 1994|Actual|1994-12-01|||||Observational|||Dietary Quality and Subsequent Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.761731|2017-10-11 04:27:02.761731
NCT01495702|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-12-01|2014-12-31|2014-08-25|December 2011||2011-12-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Interventional||Safety Analysis Set: participants were randomized and received at least one dose of study drug|Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients|A Phase 3b Randomized, Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Plus Emtricitabine (FTC) and Tenofovir DF (TDF) to the Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (EVG/COBI/FTC/TDF) in Virologically Suppressed, HIV 1 Infected Patients|Completed||Phase 3|439|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||f||||||||||2017-10-11 03:28:34.632202|2017-10-11 03:28:34.632202
NCT01495689|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-03-23|2017-03-23||November 2011||2011-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|Quit&Win||Smoking Cessation With the Ottawa Model and SmartCard in Out-patient Respirology Clinic Setting|A Pilot Randomized Control Trial of Smoking Cessation Using The Ottawa Model With the SmartCard in Out-patient Respirology Clinic Setting|Completed||N/A|50|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 03:28:37.746964|2017-10-11 03:28:37.746964
NCT01495676|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-08-10|||September 2011||2011-09-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|GETUGV04||A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer|A Randomized Phase II Trial Evaluating an Organ-conserving Strategy With Radiotherapy + CDDP + Gemcitabine vs Radiotherapy + CDDP in Muscle-infiltrative Bladder Cancer|Recruiting||Phase 2|108|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||t||||||||||2017-10-11 03:28:38.150006|2017-10-11 03:28:38.150006
NCT01495663|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-02-25|||December 2011||2011-12-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned|A Phase 1, Multi-Center, Open-Label, Dose Escalation Study of I-131-CLR1404 in Subjects With Relapsed or Refractory Advanced Solid Malignancies|Completed||Phase 1|12|Actual|Cellectar Biosciences, Inc.||1|||f||||f||||||||||2017-10-11 03:28:38.295647|2017-10-11 03:28:38.295647
NCT01495650|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-08-16|||December 2010||2010-12-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|APAD||Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment|A Randomized Controlled Trial to Evaluate the Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving Adjuvant Treatment.|Completed||Phase 3|240|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||f||||||||||2017-10-11 03:28:38.405545|2017-10-11 03:28:38.405545
NCT01495637|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-07-24|||December 2011||2011-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|GIFT||GM-CSF for Immunomodulation Following Trauma (GIFT) Study|GM-CSF for Immunomodulation Following Trauma (GIFT) Study|Recruiting||Phase 4|200|Anticipated|Nationwide Children's Hospital||1|||f||||t||||||||||2017-10-11 03:28:38.515446|2017-10-11 03:28:38.515446
NCT01495624|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-01-26|||December 2011||2011-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||The Effect of Systemic or Perineural Dexamethasone on the Duration of Interscalene Nerve Blocks With Ropivacaine||Terminated||N/A|16|Actual|The Cleveland Clinic||2||Accrual insufficient to complete study in a feasible time frame|f||||f||||||||||2017-10-11 03:28:38.783009|2017-10-11 03:28:38.783009
NCT01495611|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-01-30|||November 2010|Actual|2010-11-01|January 2017|2017-01-01|April 30, 2017||2017-04-30|January 2016|Actual|2016-01-01||Observational|||Multicenter Perioperative Opioid Pharmacogenetic Study|Predicting Perioperative Opioid Adverse Effects and Personalizing Analgesia in Children: A Multicenter Pharmacogenetic Study|Completed||N/A|1000|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||Samples With DNA|"     A database/ repository will be constructed for future research, analysis, and recruitment.     De-identified study subjects' genetic information and their responses to pain and pain     medications, side-effects will be included in the database. Blood specimens will be included     in the repository for exploring potentially important SNPs and biomarkers in future. No     patient identifiers will be included in the repository and there will be a confidential     (access limited to investigators only) code or link between the repository/database and other     information about the participant.   "|||2017-10-11 03:28:38.893974|2017-10-11 03:28:38.893974
NCT01495585|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2016-07-18|2016-04-28||December 2011||2011-12-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||"Enrolled patients were sequentially assigned into one of two dosing groups which consisted of lonafarnib 100mg in group 1 and lonafarnib 200mg in group 2, with placebo controls in each group.
Group1 placebo patients received open-label lonafarnib as group 2 participants."|Lonafarnib for Chronic Hepatitis D|Treatment of Chronic Delta Hepatitis With Lonafarnib|Completed||Phase 2|14|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||Yes|De-identified data with outside collaborators|2017-10-11 03:28:39.253269|2017-10-11 03:28:39.253269
NCT01495572|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-10-13|2014-05-08||December 2011||2011-12-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells|Phase II Study in Patients With Metastatic Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of MART-1 Reactive Peripheral Blood Lymphocytes (PBL) With or Without High Dose Aldesleukin|Terminated||Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)|Due to slow accrual, the investigator decided to close the study.|2||Due to slow accrual, the investigator decided to close the study.|f||||t||||||||||2017-10-11 03:28:39.822128|2017-10-11 03:28:39.822128
NCT01494376|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2012-03-08|||June 2011||2011-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:29:09.282689|2017-10-11 03:29:09.282689
NCT01495533|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-05-05|||December 2011||2011-12-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|December 2013|Actual|2013-12-01||Interventional|||Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter|Treatment of Coronary In-stent Restenosis by a Paclitaxel Coated AngioSculpt Scoring Balloon - a First-in-man Pilot Study|Unknown status|Active, not recruiting|Phase 3|60|Anticipated|University Hospital, Saarland||2|||f||||t||||||||||2017-10-11 03:28:40.4407|2017-10-11 03:28:40.4407
NCT01495520|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|RYPPLE||Ranolazine for Improving Symptoms of Palpitations|Ranolazine for the Treatment of sYmPtoms of PaLpitations in patiEnts With Ischemic Heart Disease - The RYPPLE Trial|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 03:28:40.549269|2017-10-11 03:28:40.549269
NCT01495507|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-19|2016-07-16|||November 2011||2011-11-01|July 2016|2016-07-01||||January 2017|Anticipated|2017-01-01||Observational|||Validation of Kujala German|Cross-cultural Adaptation and Validation of the German Version of the Kujala Score in Patients With Patellofemoral Instability - a Prospective Multi-centric Study|Recruiting||N/A|45|Anticipated|Medical University Innsbruck|||1||f||||||||||||||2017-10-11 03:28:40.663088|2017-10-11 03:28:40.663088
NCT01495494|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2014-11-20|||November 2009||2009-11-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype|A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype|Completed||Phase 1|80|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:28:40.778994|2017-10-11 03:28:40.778994
NCT01495481|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-02-07|2016-02-18||January 2012||2012-01-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Dexmedetomidine and Adenosine: Therapeutic Use for SVT|Dexmedetomidine Versus Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia|Completed||N/A|22|Actual|University of Pittsburgh||1|||f||||t||||||||No||2017-10-11 03:28:40.896888|2017-10-11 03:28:40.896888
NCT01495468|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-07-27|||March 2007||2007-03-01|December 2011|2011-12-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children|Pegylated Somatropin in the Treatment of Children With Growth Hormone Deficient：A Multicenter, Randomized, Open-label, Controlled Phase Ⅲ Clinical Trial|Completed||Phase 3|343|Actual|GeneScience Pharmaceuticals Co., Ltd.||1|||f||||t||||||||||2017-10-11 03:28:41.243403|2017-10-11 03:28:41.243403
NCT01495455|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2013-01-29|||February 2012||2012-02-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Nottingham Osteoarthritis Biomarker Study 2011|Nottingham Osteoarthritis Biomarker Study 2011|Completed||N/A|140|Actual|University of Nottingham|||2||f||||f||||||Samples With DNA|"     Serum, urine and synovial fluid.   "|||2017-10-11 03:28:41.371894|2017-10-11 03:28:41.371894
NCT01495442|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-01-20|||December 2011||2011-12-01|January 2017|2017-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|DPI||Evaluation of a Dry Powder Aerosol Dispersion Mechanism by Radiolabeling Techniques|Evaluation of a Dry Powder Aerosol Dispersion Mechanism by Radiolabeling Techniques|Completed||N/A|6|Actual|University of North Carolina, Chapel Hill||2|||f||||f|f|f||||||||2017-10-11 03:28:41.57351|2017-10-11 03:28:41.57351
NCT01495429|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-08-03|||January 2012||2012-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PICNIC||Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care|A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care Unit|Completed||Phase 3|80|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 03:28:41.651768|2017-10-11 03:28:41.651768
NCT01495403|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2015-07-29|||December 2011||2011-12-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Treatment of Muscle Cramps in Patients With Liver Cirrhosis|A Pilot Study of Hydroxychloroquine for the Treatment of Muscle Cramps in Patients With Cirrhosis|Completed||Early Phase 1|3|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 03:28:41.762057|2017-10-11 03:28:41.762057
NCT01495390|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2017-05-24|||November 2011||2011-11-01|May 2017|2017-05-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Observational|||A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers|A Multicenter Study for the Discovery and Validation of ALS Biomarkers|Completed||N/A|139|Actual|Massachusetts General Hospital|||1||f||||t||||||Samples With DNA|"     Biological samples will be collected from participants with ALS over time. These biological     samples include blood (plasma, serum, and RNA) and cerebrospinal fluid (CSF). DNA will be     collected at one time point.   "|Undecided||2017-10-11 03:28:41.862808|2017-10-11 03:28:41.862808
NCT01495377|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2012-08-21|||January 2012||2012-01-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration|Does Opioid Induced Swallowing Difficulty Lead to Elevated Risk for Pulmonary Aspiration?|Completed||Phase 4|25|Actual|Region Örebro County||4|||f||||t||||||||||2017-10-11 03:28:41.99789|2017-10-11 03:28:41.99789
NCT01495364|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-04-26|||December 2011||2011-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|June 2014|Actual|2014-06-01||Interventional|PreSERVE-AMI||NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction|A Prospective Randomized Double Blind Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients With Acute Myocardial Infarction.|Completed||Phase 2|195|Actual|Caladrius Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 03:28:42.185442|2017-10-11 03:28:42.185442
NCT01495351|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-09-21|||October 2011|Actual|2011-10-01|September 2017|2017-09-01|February 10, 2015|Actual|2015-02-10|February 2015|Actual|2015-02-01||Interventional|||Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma|Phase I Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma|Completed||Phase 1|19|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 03:28:42.419649|2017-10-11 03:28:42.419649
NCT01495338|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-09-13|||December 2011||2011-12-01|September 2017|2017-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Comparison of the Safety and Comfort of AC-170||Completed||Phase 1|60|Actual|Aciex Therapeutics, Inc.||4|||f||||f||||||||||2017-10-11 03:28:42.511276|2017-10-11 03:28:42.511276
NCT01398397|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-06-26|||April 2011||2011-04-01|June 2012|2012-06-01||||||||Observational|ECP-006||Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype|Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype|Completed||N/A|11|Actual|Edimer Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:00:33.730205|2017-10-11 04:00:33.730205
NCT01495325|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-01-23|||September 2011||2011-09-01|January 2013|2013-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|FIREWOOD||Effect of Woodsmoke on Vascular Function|Effect of Woodsmoke on Vascular Function in Healthy Firefighters|Unknown status|Recruiting|N/A|20|Anticipated|University of Edinburgh||2|||f||||t||||||||||2017-10-11 03:28:42.606544|2017-10-11 03:28:42.606544
NCT01495312|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2011-12-19|||December 2011||2011-12-01|December 2011|2011-12-01||||August 2012|Anticipated|2012-08-01||Interventional|||24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT)||Unknown status|Recruiting|N/A|20|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-10-11 03:28:42.720944|2017-10-11 03:28:42.720944
NCT01495299|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2011-12-19|||December 2011||2011-12-01|December 2011|2011-12-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Observational|||24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery||Unknown status|Recruiting|N/A|20|Anticipated|University of California, San Diego|||1||f||||f||||||||||2017-10-11 03:28:42.840016|2017-10-11 03:28:42.840016
NCT01495286|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2012-10-18|2012-09-17||December 2011||2011-12-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety of Noninvasive Electrical Stimulation of Acupuncture Points (NESAP) in Infants|Is the Use of Noninvasive Electrical Stimulation of Acupuncture Points (NESAP) During a Routine Heelstick Safe in Infants?|Completed||N/A|30|Actual|University of Arkansas|This was a small pilot study to determine safety of a TENS unit to deliver NESAP to newborn infants during routine heel sticks. The purpose was not to determine efficacy of NESAP to relieve pain during heel sticks. A large clinical trial will follow.|1|||f||||t||||||||||2017-10-11 03:28:42.9509|2017-10-11 03:28:42.9509
NCT01495273|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-10-24|||May 2017||2017-05-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Electrically Guided Needle Insertion: Transtracheal Injection|Adaptation of Nerve Stimulation Technology to Aid Transtracheal Needle Insertion and Injection|Not yet recruiting||N/A|30|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 03:28:43.234997|2017-10-11 03:28:43.234997
NCT01495260|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-09-16|||September 2011||2011-09-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants|A Clinical Trial for Adrenomyeloneuropathy (AMN): Validation of Biomarkers of Oxidative Stress, and Efficacy, Tolerance and Safety of a Mixture of the Antioxidants N-acetylcysteine, Lipoic Acid and Vitamin E|Completed||Phase 2|13|Actual|Onofre, Aurora Pujol, M.D.||1|||f||||f||||||||||2017-10-11 03:28:43.335307|2017-10-11 03:28:43.335307
NCT01495247|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-07-22|||January 2012||2012-01-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer|A Dose-finding Phase Ib Study Followed by an Open-label, Randomized Phase II Study of BEZ235 Plus Paclitaxel in Patients With HER2 Negative, Inoperable Locally Advanced or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|18|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:28:43.43522|2017-10-11 03:28:43.43522
NCT01495234|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||October 1996||1996-10-01|December 2011|2011-12-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Pilot Study of rhBMP-2/BCP in Patients With Spinal Degeneration With Instability Requiring Surgical Fusion|A Pilot Investigation of Recombinant Human Bone Morphogenetic Protein- 2/Biphasic Calcium Phosphate in Patients With Spinal Degeneration With Instability Requiring Surgical Fusion|Completed||N/A|15|Actual|Medtronic Spinal and Biologics||2|||f||||f||||||||||2017-10-11 03:28:43.537372|2017-10-11 03:28:43.537372
NCT01495208|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-08-01|||December 2011||2011-12-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment|This is an Open Label Study to Evaluate the Efficacy of Intravitreal Aflibercept Injection 2mg in Patients With a Persistent FVPED Despite at Least 6 Consecutive Injections With Ranibizumab 0.5 mg|Completed||Phase 4|6|Actual|Vitreous -Retina- Macula Consultants of New York||1|||f||||f||||||||||2017-10-11 03:28:43.698599|2017-10-11 03:28:43.698599
NCT01495195|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-12-17|||February 2012||2012-02-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SDC||Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior||Completed||Phase 2|12|Actual|Midwest Biomedical Research Foundation||4|||f||||t||||||||||2017-10-11 03:28:43.770715|2017-10-11 03:28:43.770715
NCT01495182|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-04-20|||December 2011||2011-12-01|December 2011|2011-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Dietary Fiber on Gastrointestinal Function|A Double-blind, Randomized, Crossover Trial to Assess the Gastrointestinal Tolerability of a Dietary Fiber Ingredient in Healthy Men and Women|Completed||N/A|26|Actual|Ingredion Incorporated||3|||f||||f||||||||||2017-10-11 03:28:43.885604|2017-10-11 03:28:43.885604
NCT01495169|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-06-10|||October 2011||2011-10-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients|A Multicenter, Open-label, Sequential Cohort, Dose-escalation, 14-day Study to Explore the Tolerability and Pharmacokinetics of Iloperidone 12 to 24 mg/Day Followed by 26 Weeks of Flexible Dosing (6 to 24 mg/Day) in Adolescent Patients (Aged 12 to 17 Years)|Completed||Phase 1|33|Actual|Vanda Pharmaceuticals||1|||f||||||||||||||2017-10-11 03:28:43.966497|2017-10-11 03:28:43.966497
NCT01495156|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-01-21|||September 2011||2011-09-01|January 2014|2014-01-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania|A Randomized, Double-blind, Placebo Controlled Study of the Efficacy of Adjunctive Lithium for the Treatment of Psychotic Mania Followed by an Open Label Long-term Safety Period.|Withdrawn||Phase 4|0|Actual|Northwell Health||2|||f||||f||||||||||2017-10-11 03:28:44.061361|2017-10-11 03:28:44.061361
NCT01495143|ClinicalTrials.gov processed this data on October 10, 2017|2009-12-29|2014-09-12|||January 2007||2007-01-01|September 2014|2014-09-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||Surgical Stress Measured by Microdialysis|Microdialysis of Paraspinal Muscle in Healthy Volunteers and Patients Underwent Posterior Lumbar Fusion Surgery|Completed||N/A|16|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 03:28:44.142938|2017-10-11 03:28:44.142938
NCT01495130|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-01-27|||October 2011||2011-10-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery|Mechanically-Manipulated Transrectal Ultrasound (TRUS) During Robotic-Assisted Laparoscopic Prostatectomy (RALP)|Completed||N/A|11|Actual|University of Southern California||1|||f||||t||||||||||2017-10-11 03:28:44.343974|2017-10-11 03:28:44.343974
NCT01495117|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-12-19|||October 2011||2011-10-01|December 2016|2016-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CHG||Study of Chlorhexidine Gluconate as a Preoperative Antisepsis|Comparison of Chlorhexidine Gluconate and Povidone Iodine as a Preoperative Antisepsis in Clean-contaminated Abdominal Surgery : a Randomized Prospective Trial|Completed||Phase 3|534|Actual|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 03:28:44.435112|2017-10-11 03:28:44.435112
NCT01495104|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-11-01|||October 2011||2011-10-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy Volunteers|A SINGLE CENTER, OPEN LABEL, FIXED SEQUENCE, TWO-PERIOD STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE VALPROATE ON THE PHARMACOKINETICS OF RO4917838 AND VICE VERSA IN HEALTHY MALE VOLUNTEERS|Completed||Phase 1|18|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:28:44.536052|2017-10-11 03:28:44.536052
NCT01495091|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2012-09-11|||December 2011||2011-12-01|September 2012|2012-09-01|December 2040|Anticipated|2040-12-01|December 2014|Anticipated|2014-12-01||Observational|CADENCE||Markers of Coronary Artery Disease During Exercise Testing|Markers of Coronary Artery Disease During Exercise Testing|Recruiting||N/A|600|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood, serum.   "|||2017-10-11 03:28:44.625165|2017-10-11 03:28:44.625165
NCT01495078|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-02-13|||December 2010||2010-12-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|June 2013|Actual|2013-06-01||Interventional|ICOR||Telemonitoring and Teleintervention of Heart Failure and Decrease of Non-fatal Events.|Telemonitoring and Teleintervention of Heart Failure and Decrease of Non-fatal Events.|Completed||N/A|178|Actual|Parc de Salut Mar||2|||f||||f||||||||No||2017-10-11 03:28:44.710756|2017-10-11 03:28:44.710756
NCT01495065|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-06-13|||December 19, 2011|Actual|2011-12-19|June 2017|2017-06-01|February 17, 2012|Actual|2012-02-17|February 17, 2012|Actual|2012-02-17||Interventional|||A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers|A Two Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK2251052 After Single Ascending Dosesand Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and a Repeat Dose Study to Evaluatesupratherapeutic Doses of IV GSK2251052 in Healthy Volunteers|Terminated||Phase 1|8|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 03:28:44.805698|2017-10-11 03:28:44.805698
NCT01495039|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-04-03|||November 2008||2008-11-01|April 2017|2017-04-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients|The Role of Oral Nystatin Prophylaxis in ICU Surgical/Trauma Patients|Completed||Phase 4|99|Actual|Policlinico Hospital||2|||f||||t||||||||||2017-10-11 03:28:45.023476|2017-10-11 03:28:45.023476
NCT01495026|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-07-24|||November 6, 2011|Actual|2011-11-06|July 2017|2017-07-01|April 3, 2012|Actual|2012-04-03|April 3, 2012|Actual|2012-04-03||Interventional|||A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia|An Open-label, Randomized, Single Dose, Multi-stage, Cross-over Study to Determine the Relative Bioavailability of Fixed Dose Combination Products Containing a 3-oblong Dutasteride Soft Gel Capsule and Tamsulosin (0.5 mg Dutasteride /0.2 mg Tamsulosin HCl) Pellets Having a Range of Tamsulosin Release Rates Produced by Different Mixtures of Enteric Coated and Uncoated Pellets Relative to Harnal-D Tablets, in Healthy Male Subjects of North East Asian Ancestry.|Completed||Phase 1|63|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:28:45.162266|2017-10-11 03:28:45.162266
NCT01495000|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-01-09|2013-09-12||January 2012||2012-01-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab|A Six-Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Indian Postmenopausal Women With Osteoporosis|Completed||Phase 3|250|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:28:45.624538|2017-10-11 03:28:45.624538
NCT01494987|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-11-05|2014-08-21|2013-12-12|January 2012||2012-01-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Baseline characteristics are reported for the Safety Analysis Set following randomization. The Safety Analysis Set includes randomized participants who received at least one dose of study treatment.|Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|431|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 03:28:46.634555|2017-10-11 03:28:46.634555
NCT01494974|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-04-06|||December 2011||2011-12-01|April 2014|2014-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma|Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma: a Randomized Clinical Trial.|Unknown status|Recruiting|Phase 4|40|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 03:28:47.800568|2017-10-11 03:28:47.800568
NCT01494961|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-16|||February 2009||2009-02-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|Prenahtest||Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries|The Public Health Impact of Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries|Completed||N/A|1943|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||f||||||||||2017-10-11 03:28:47.909387|2017-10-11 03:28:47.909387
NCT01494948|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-01-07|||March 2012||2012-03-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Innate Immunity and the Allergic Response|Innate Immunity and the Allergic Response|Completed||N/A|36|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 03:28:48.018784|2017-10-11 03:28:48.018784
NCT01494935|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-08-31|||April 2011||2011-04-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|May 2018|Anticipated|2018-05-01||Interventional|||"Effect of High Fat and High Glycemic Diets"|Effect of High Fat and High Glycemic Diets on Muscle Protein Synthesis in Somali Immigrants and Americans of Northern European Descent|Recruiting||N/A|24|Anticipated|Mayo Clinic||2|||f||||||||||||||2017-10-11 03:28:48.09913|2017-10-11 03:28:48.09913
NCT01494922|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-11-06||2014-10-15|December 2011||2011-12-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001|A Phase 2, Open-label Study to Provide Revision of Scars Resulting From Surgery in Prior Studies of EXC 001 (Currently Called PF-06473871)|Completed||Phase 2|14|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:28:48.193585|2017-10-11 03:28:48.193585
NCT01494909|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-04-17|||January 2011||2011-01-01|April 2017|2017-04-01|February 2018|Anticipated|2018-02-01|July 2012|Actual|2012-07-01||Interventional|||Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function|Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function|Active, not recruiting||N/A|31|Anticipated|Texas A&M University||1|||f||||f||||||||||2017-10-11 03:28:48.283507|2017-10-11 03:28:48.283507
NCT01494896|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2015-05-06|||November 2011||2011-11-01|August 2013|2013-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching|An Open-Label Study to Explore the Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching When Used for Treatment of Group 1 Pulmonary Arterial Hypertension in Patients With Concomitant Chronic Obstructive Pulmonary Disease (COPD)|Terminated||N/A|9|Actual|University of Florida|||1|due to slow enrollment. United Therapeutics and Dr. Bajwa MD decided to terminate study|f||||f||||||||||2017-10-11 03:28:48.36706|2017-10-11 03:28:48.36706
NCT01494870|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-01-07|||January 2012||2012-01-01|January 2012|2012-01-01|November 2013|Anticipated|2013-11-01|June 2013|Anticipated|2013-06-01||Interventional|||Management of Acute Myocardial Infarction in the Presence of Left Bundle Branch Block||Unknown status|Not yet recruiting|N/A|300|Anticipated|Samara Regional Cardiology Dispensary||1|||f||||f||||||||||2017-10-11 03:28:48.566073|2017-10-11 03:28:48.566073
NCT01494857|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-10-28|||January 2012||2012-01-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis|Open-Label, Non-Randomized, Single Patient Group, Multi-Center Study to Evaluate the Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Moderately to Severely Active Ulcerative Colitis|Unknown status|Recruiting|Phase 3|200|Anticipated|Clalit Health Services||1|||f||||f||||||||||2017-10-11 03:28:48.644934|2017-10-11 03:28:48.644934
NCT01494844|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-08-07|||June 2011||2011-06-01|August 2013|2013-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Comfort Evaluation of Non-Invasive Respiratory Monitor Interfaces|Comfort Evaluation of Non-Invasive Respiratory Monitor Interfaces|Completed||Early Phase 1|30|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-11 03:28:48.784639|2017-10-11 03:28:48.784639
NCT01494831|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-01-17|||May 2011||2011-05-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Randomized Control Trial of Group Intervention With Former War-affected Boys in the Democratic Republic of Congo|Evaluation of a Group-based, Cognitive-behavioural Intervention With Former Child Soldiers and Other War-affected Children in the Democratic Republic of Congo: A Randomised Controlled Trial.|Completed||Phase 2|58|Actual|Queen's University, Belfast||2|||f||||t||||||||||2017-10-11 03:28:48.868947|2017-10-11 03:28:48.868947
NCT01494818|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-07-30|2013-07-30||November 2011||2011-11-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||This reporting group includes all enrolled and dispensed participants who completed the study.|Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues|Evaluation of the Effects of Clear Care/AOSEPT Plus Hydrogen Peroxide Solution on the Eyelid Tissues - Part II: Comparative Evaluation With RENU MPS Over 3 Months of Wear|Completed||N/A|79|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:28:48.961357|2017-10-11 03:28:48.961357
NCT01494805|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-08-30|||December 2011|Actual|2011-12-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|May 2017|Actual|2017-05-01||Interventional|AMD||Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration|A Phase I/II Controlled Dose-escalating Trial to Establish the Baseline Safety and Efficacy of a Single Subretinal Injection of rAAV.sFlt-1 Into Eyes of Patients With Exudative Age-related Macular Degeneration (AMD)|Completed||Phase 1/Phase 2|40|Actual|Lions Eye Institute, Perth, Western Australia||3|||f||||t||||||||||2017-10-11 03:28:49.407248|2017-10-11 03:28:49.407248
NCT01494792|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-10-05|||November 2011||2011-11-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Sofia Strep A FIA Field Study|Sofia Strep A FIA Field Study|Terminated||N/A|2090|Actual|Quidel Corporation|||1|Performance did not meet sponsor requirements.|f||||f||||||||||2017-10-11 03:28:49.509343|2017-10-11 03:28:49.509343
NCT01494779|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-09-21|||March 2013||2013-03-01|September 2012|2012-09-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Interventional|||Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.||Unknown status|Not yet recruiting|Phase 1|32|Anticipated|Azidus Brasil||2|||f||||||||||||||2017-10-11 03:28:49.579803|2017-10-11 03:28:49.579803
NCT01494766|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-04-25|||January 2012||2012-01-01|April 2017|2017-04-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy of Tyrosine in Restless Legs Syndrome|Pilot Study of the Efficacy of Tyrosine in Restless Legs Syndrome|Completed||N/A|5|Actual|Seton Healthcare Family||1|||f||||f||||||||||2017-10-11 03:28:49.66644|2017-10-11 03:28:49.66644
NCT01494753|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2014-12-22|2014-11-12||June 2008||2008-06-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension||Completed||Phase 2|30|Actual|Laboratoires Thea||2|||f||||||||||||||2017-10-11 03:28:49.742235|2017-10-11 03:28:49.742235
NCT01494740|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-16|||December 2009||2009-12-01|October 2009|2009-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants|Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants|Completed||Phase 2|312|Actual|Shanghai Institute Of Biological Products||3|||f||||t||||||||||2017-10-11 03:28:49.948415|2017-10-11 03:28:49.948415
NCT01494727|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-04-29|||February 2012||2012-02-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg|A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet After a Single Oral Administration in Healthy Male Volunteers|Completed||Phase 1|48|Anticipated|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 03:28:50.04857|2017-10-11 03:28:50.04857
NCT01494714|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-10-30|||August 2011||2011-08-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male Participants|A Study to Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male Subjects|Completed||Phase 1|30|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 03:28:50.118685|2017-10-11 03:28:50.118685
NCT01494701|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-04-05|||November 30, 2011|Actual|2011-11-30|April 2017|2017-04-01|January 31, 2013|Actual|2013-01-31|January 31, 2013|Actual|2013-01-31||Interventional|SMNRx||An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)|An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy|Completed||Phase 1|28|Actual|Biogen||4|||t||||t||||||||||2017-10-11 03:28:50.21308|2017-10-11 03:28:50.21308
NCT01494688|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2016-11-01|||December 2011||2011-12-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors|Open-Label, Multicenter, Dose Escalation Phase Ia/Ib Study With Expansion Phase to Evaluate Safety, Pharmacokinetics and Activity of RO5509554, Administered as an Intravenous Infusion as Monotherapy and in Combination With Paclitaxel in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|217|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 03:28:50.33728|2017-10-11 03:28:50.33728
NCT01494675|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-15|||March 2008||2008-03-01|December 2011|2011-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Procalcitonin as a Tool to Shorten Antibiotic Therapy in the ICU|Clinical Impact of Procalcitonin to Shorten Antimicrobial Therapy in Septic Patients With Proven Bacterial Infection in an Intensive Care Setting|Completed||N/A|81|Actual|Hospital Israelita Albert Einstein||1|||f||||t||||||||||2017-10-11 03:28:50.471473|2017-10-11 03:28:50.471473
NCT01494662|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-05-25|||February 2012||2012-02-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||HKI-272 for HER2-Positive Breast Cancer and Brain Metastases|A Phase II Trial of HKI-272 (Neratinib) and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases|Active, not recruiting||Phase 2|96|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||Undecided||2017-10-11 03:28:50.562133|2017-10-11 03:28:50.562133
NCT01494649|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-03-21|2013-03-21||September 2011||2011-09-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity|A Pilot Clinical Study Investigating the Efficacy of a Toothpaste in Providing Immediate and Short Term Relief From Dentinal Hypersensitivity|Completed||N/A|118|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:28:50.695219|2017-10-11 03:28:50.695219
NCT01494636|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-06-19|||October 17, 2011|Actual|2011-10-17|June 2017|2017-06-01|March 15, 2012|Actual|2012-03-15|March 15, 2012|Actual|2012-03-15||Interventional|FTIH||The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects|A Two Part Study to Investigate the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2339345 in Healthy Subjects. Part A: an Open Label, Dose Escalating, Rinse, Gargle and Spit Study. Part B: a Randomised, Double-blind, Placebo Controlled, Inhaled Dose Escalating Study Using Nebulised Lidocaine for Blinding Purposes.|Completed||Phase 1|31|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:28:51.031338|2017-10-11 03:28:51.031338
NCT01494623|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2013-06-10|||May 2006||2006-05-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working Memory|Treating Working Memory Deficits in Patients With Schizophrenia Using Repetitive Transcranial Magnetic Stimulation (rTMS)|Completed||N/A|122|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 03:28:51.141027|2017-10-11 03:28:51.141027
NCT01493804|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-09-02|||November 8, 2011||2011-11-08|September 1, 2017|2017-09-01|September 1, 2017||2017-09-01|||||Observational|||Noninvasive Study of Brain Connectivity With EEG and NIRS|Non-Invasive Study of Brain Connectivity Using Combined EEG and NIRS|Completed||N/A|5|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:29:16.285284|2017-10-11 03:29:16.285284
NCT01494610|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-07-14|2012-02-16||October 25, 2010|Actual|2010-10-25|July 2017|2017-07-01|June 8, 2011|Actual|2011-06-08|June 8, 2011|Actual|2011-06-08||Interventional|||Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.|A Comparative Bioavailability Study to Compare the Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of Fluticasone Propionate and Salmeterol Delivered by Fluticasone Propionate/ Salmeterol Combination in a Capsule-based Inhaler and a Multi-dose Dry Powder Inhaler, in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.|Completed||Phase 2|60|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:28:51.303886|2017-10-11 03:28:51.303886
NCT01494597|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-16|||November 2011||2011-11-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Drug Interaction Study of Isavuconazole and Cyclosporine|Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Cyclosporine: A Phase 1, Open-Label, Sequential Study in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:28:54.478269|2017-10-11 03:28:54.478269
NCT01494584|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-04-25|2014-07-10||July 25, 2012|Actual|2012-07-25|April 2017|2017-04-01|April 29, 2013|Actual|2013-04-29|April 29, 2013|Actual|2013-04-29||Interventional|||Study in Pediatric Subjects With Epilepsy|Open-label, Multiple Dose Study to Evaluate the Parmacokinetics, Safety and Tolerability of Ezogabine/Retigabine as Adjunctive Treatment in Subjects Aged From 12 Years to Less Than 18 Years With Partial Onset Seizures or Lennox-Gastaut Syndrome|Terminated||Phase 2|5|Actual|GlaxoSmithKline||1||Terminated after placing the study on hold at the request of the FDA|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:28:54.626427|2017-10-11 03:28:54.626427
NCT01494571|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-03-06|||December 2011||2011-12-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|PharmaJet||Pediatric Optimization of the PharmaJet Needle-Free Intradermal Delivery System|Pediatric Optimization of the PharmaJet Needle-Free Intradermal Delivery System|Completed||N/A|101|Actual|University of Colorado, Denver|||7||f||||f||||||||||2017-10-11 03:28:59.325161|2017-10-11 03:28:59.325161
NCT01494558|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2011-12-16|||May 2007||2007-05-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|October 2010|Actual|2010-10-01||Interventional|||Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer|Phase 3 Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy in Patients With Unresectable Locally Advanced, Stage III Non-Small Cell Lung Cancer|Completed||Phase 2/Phase 3|200|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:28:59.407077|2017-10-11 03:28:59.407077
NCT01494545|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-07-12|2013-05-01||December 2011||2011-12-01|July 2013|2013-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||This reporting group includes all enrolled participants who were dispensed study product.|Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens Wearers|Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens Wearers|Completed||N/A|102|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:28:59.515946|2017-10-11 03:28:59.515946
NCT01494532|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-06-10|2015-07-13||April 2, 2012|Actual|2012-04-02|June 2017|2017-06-01|November 18, 2014|Actual|2014-11-18|November 18, 2014|Actual|2014-11-18||Interventional|TANDEM-569||A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease|A Fixed Dose, Dose-response Study of Ropinirole Prolonged Release (PR) as Adjunctive Treatment to L-dopa in Patients With Advanced Parkinson's Disease|Completed||Phase 4|352|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:29:00.672512|2017-10-11 03:29:00.672512
NCT01494519|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-04-20|||July 2011||2011-07-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|FIXIT||Assessment of Fixation Strategies for Severe Open Tibia Fractures|A Prospective Randomized Trial to Assess Fixation Strategies for Severe Open Tibia Fractures:Modern Ring External Fixators Versus Internal Fixation|Recruiting||Phase 3|624|Anticipated|Major Extremity Trauma Research Consortium||2|||f||||t||||||||||2017-10-11 03:29:03.423397|2017-10-11 03:29:03.423397
NCT01494506|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-06-16|2015-11-25|2014-12-23|November 2011||2011-11-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|February 2014|Actual|2014-02-01||Interventional|NAPOLI-1|All randomized patients.|Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer|A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy|Completed||Phase 3|417|Actual|Merrimack Pharmaceuticals||3|||f||||t||||||||||2017-10-11 03:29:03.671046|2017-10-11 03:29:03.671046
NCT01494493|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||September 2000||2000-09-01|December 2011|2011-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Pivotal Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease|A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease|Terminated||N/A|85|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-10-11 03:29:05.953382|2017-10-11 03:29:05.953382
NCT01494480|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-06-18|||March 2012||2012-03-01|June 2012|2012-06-01|April 2015|Anticipated|2015-04-01|January 2013|Anticipated|2013-01-01||Interventional|||The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis|The Clinical Study on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis|Unknown status|Enrolling by invitation|Phase 2|30|Anticipated|General Hospital of Chinese Armed Police Forces||1|||f||||t||||||||||2017-10-11 03:29:06.045466|2017-10-11 03:29:06.045466
NCT01494467|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-01-15|2015-01-08|2014-01-27|December 2011||2011-12-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||ITT population|Phase 3 Papulopustular Rosacea Study|A Phase 3 Randomized, Double Blind, 12 Week Vehicle Controlled, Parallel Group Study Assessing the Efficacy and Safety of CD5024 1 % Cream Versus Vehicle Cream in Subjects With Papulopustular Rosacea, Followed by a 40 Week Investigator Blinded Extension Comparing the Long Term Safety of CD5024 1% Cream Versus Azelaic Acid 15 % Gel.|Completed||Phase 3|688|Actual|Galderma||2|||f||||t||||||||||2017-10-11 03:29:06.16635|2017-10-11 03:29:06.16635
NCT01494454|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||August 1999||1999-08-01|December 2011|2011-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Clinical Study of rhBMP-2/BCP With the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease|A Clinical Study of Recombinant Human Bone Morphogenetic Protein-2 and Biphasic Calcium Phosphate With Either the TSRH® Spinal System or the CD Horizon® Spinal System for Posterolateral Lumbar Fusion in Patients With DDD|Completed||N/A|197|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-10-11 03:29:07.38201|2017-10-11 03:29:07.38201
NCT01494441|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||May 1999||1999-05-01|December 2011|2011-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Pilot Study of rhBMP/BCP With or Without the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease|A Pilot Study of Recombinant Human Bone Morphogenetic Protein-2 and Biphasic Calcium Phosphate With or Without the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic Degenerative Disc Disease|Completed||N/A|27|Actual|Medtronic Spinal and Biologics||3|||f||||f||||||||||2017-10-11 03:29:07.466715|2017-10-11 03:29:07.466715
NCT01494428|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||April 1998||1998-04-01|December 2011|2011-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||A Pilot Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease|A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease|Completed||N/A|46|Actual|Medtronic Spinal and Biologics||2|||f||||f||||||||||2017-10-11 03:29:07.553881|2017-10-11 03:29:07.553881
NCT01494415|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-12-13|||July 2012||2012-07-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|July 2016|Anticipated|2016-07-01||Interventional|||Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer|A Phase II Study of Concurrent Nab-Paclitaxel, Carboplatin and Thoracic Radiotherapy in Local Advanced Squamous Cell Lung Cancer|Recruiting||Phase 2|21|Anticipated|First People's Hospital of Hangzhou||1|||f||||t||||||||||2017-10-11 03:29:07.70123|2017-10-11 03:29:07.70123
NCT01494402|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-04-06|||January 2012||2012-01-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects|A Phase I, Open Label, Randomized, Single Center, 2 Way Crossover Bioequivalence Study Comparing D961S (a Fixed-dose Combination Capsule of Esomeprazole 20 mg and Acetylsalicylic Acid 81 mg) With a Free Combination of Esomeprazole Capsule 20 mg + Buffered Acetylsalicylic Acid Tablet 81 mg After Repeated Oral Administration in Japanese Healthy Male Subjects|Completed||Phase 1|77|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:29:07.878447|2017-10-11 03:29:07.878447
NCT01494389|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-16|2011-12-16|||August 2011||2011-08-01|July 2011|2011-07-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Observational|||The Changes of CD4+T Lymphocyte Subsets in Septic Patients|The Role of CD4+T Lymphocyte Subsets in Cell Immunity in Patients With Sepsis|Unknown status|Active, not recruiting|N/A|||Chinese PLA General Hospital|||3||f||||t||||||||||2017-10-11 03:29:07.967283|2017-10-11 03:29:07.967283
NCT01493271|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-11-01||2016-07-07|December 2011||2011-12-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma|An Adaptive, Multi-center, Randomized, Investigator-masked, Subject-masked, Multiple-dose, Placebo-controlled, Parallel Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of RO5093151 for up to 28 Days in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.|Completed||Phase 2|31|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:29:08.062551|2017-10-11 03:29:08.062551
NCT01493258|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-09-01|||August 2010||2010-08-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|iADAPT||Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination|Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination|Active, not recruiting||N/A|360|Anticipated|Johns Hopkins University||2|||f||||f||||||||No|The data contain sensitive information|2017-10-11 03:29:08.175238|2017-10-11 03:29:08.175238
NCT01493245|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2014-03-21|||October 2011||2011-10-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of JNS020QD in Patients With Chronic Pain|A Phase 3 Study of JNS020QD in Patients With Chronic Pain|Completed||Phase 3|77|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 03:29:08.270114|2017-10-11 03:29:08.270114
NCT01493219|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-09-13|||September 2011||2011-09-01|September 2017|2017-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Biomarkers for Prognosis of Glioblastoma (GBM)|MMP-2, MMP-9 and NGAL as Biomarkers for Glioblastoma (GBM) Biomarkers for the Prognosis of Glioblastoma|Active, not recruiting||N/A|30|Anticipated|University of Nebraska|||2||f||||f||||||Samples Without DNA|"     Whole Blood, Urine, and Tissue.   "|||2017-10-11 03:29:08.555847|2017-10-11 03:29:08.555847
NCT01493206|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-14|||July 2004||2004-07-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer|A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer|Completed||Phase 2|32|Actual|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-11 03:29:08.6944|2017-10-11 03:29:08.6944
NCT01493193|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-07-31|||November 2011||2011-11-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Different Endurance Training Protocols in Cardiac Rehabilitation|Effects of Different Endurance Training Protocols on Physical Performance in Cardiac Patients|Completed||Phase 4|60|Actual|Paracelsus Medical University||3|||f||||f||||||||||2017-10-11 03:29:08.794256|2017-10-11 03:29:08.794256
NCT01493180|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-02-19|2014-01-17||December 2011||2011-12-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Exploratory Study of OPC-12759 Ophthalmic Suspension|Exploratory Study of OPC-12759 Ophthalmic Suspension in Patients With Keratoconjunctiva Epithelial Disorder|Completed||Phase 2|102|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:29:08.895231|2017-10-11 03:29:08.895231
NCT01494363|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-14|||October 2011||2011-10-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer|Multicenter Phase II Study of Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) in Patients With Locally Advanced or Metastatic Biliary Tract Cancer|Unknown status|Recruiting|Phase 2|53|Anticipated|Soon Chun Hyang University||1|||f||||f||||||||||2017-10-11 03:29:09.355405|2017-10-11 03:29:09.355405
NCT01494350|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-12-18|2014-12-09||December 2011||2011-12-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||modified intent to treat (mITT)/safety subjects|WR 279,396 Open Label Treatment Protocol in Tunisia|Open-label Treatment of Non-complicated, Non-severe, Cutaneous Leishmaniasis in Tunisia With WR 279,396 (Paromomycin + Gentamicin Topical Cream) )|Terminated||Phase 2|50|Actual|U.S. Army Medical Research and Materiel Command|This study was closed prematurely due study team and travel restrictions but not due to any safety issues with the study subjects. Only a total of 50 of the 110 planned subjects were enrolled in the study.|1||This study was closed prematurely due study team travel restrictions.|f||||f||||||||||2017-10-11 03:29:09.50441|2017-10-11 03:29:09.50441
NCT01494337|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-08-25|||January 2012||2012-01-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)|Randomized Study Comparing Holmium Laser Enucleation of the Prostate (HOLEP) Versus Greenlight (XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) in the Management of Infravesical Obstruction Secondary to BPH|Completed||Phase 4|108|Actual|Royal Victoria Hospital, Canada||2|||f||||f||||||||||2017-10-11 03:29:09.843826|2017-10-11 03:29:09.843826
NCT01494324|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-05-04|||October 27, 2009||2009-10-27|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome|Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome|Recruiting||N/A|160|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:29:09.967353|2017-10-11 03:29:09.967353
NCT01494311|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-03-15|||March 2011||2011-03-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Rapydan Topical Anaesthesia for Arterial Cannulation|Lidocaine/Tetracaine Patch (Rapydan) for Topical Anaesthesia Before Arterial Access: A Double-blind, Randomized Trial|Completed||Phase 4|90|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 03:29:10.183029|2017-10-11 03:29:10.183029
NCT01494298|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-10-23|2013-06-19||December 2011||2011-12-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|LAAD|The primary objective of this project was to determine the difference in Apo B levels in African-American men with and without diabetes.To achieve a power of 80%, 48 subjects in each group were needed to detect 15 mg/dL difference in ApoB levels, assuming a standard deviation of 26 mg/dL if alpha was set at 0.05.|Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes|Preliminary Analysis of Lipoprotein Subclasses, Apoprotein Levels, and Genetic Architecture of African-American Males With Type 2 Diabetes. Lipids in African Americans With Type 2 Diabetes|Completed||N/A|111|Actual|Mercer University|||2||f||||f||||||Samples With DNA|"     We will retain a sample of serum, plasma and whole blood.   "|||2017-10-11 03:29:10.302514|2017-10-11 03:29:10.302514
NCT01494285|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-12-01|||June 2012||2012-06-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients|Multicenter, Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group, Ambulatory Safety and Efficacy Study of ARK-E021 Topical Foam of 5% and 10% in Subjects With Mild to Moderate Acne Vulgaris.|Completed||Phase 1/Phase 2|157|Actual|M. Arkin 1999 Ltd.||3|||f||||f||||||||||2017-10-11 03:29:10.749598|2017-10-11 03:29:10.749598
NCT01494272|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2015-11-23|||June 2012||2012-06-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|April 2014|Actual|2014-04-01||Observational|||Analgesia in Children Using Caudal Epidural Ropivacaine|Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study|Completed||N/A|90|Actual|Loma Linda University|||3||f||||f||||||||||2017-10-11 03:29:10.841939|2017-10-11 03:29:10.841939
NCT01494259|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-10-09|||January 2016||2016-01-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|January 2017|Anticipated|2017-01-01||Interventional|||Bupivacaine Pain Pumps to Decrease Mastectomy Post-Operative Pain|Use of Percutaneously-Placed Continuous Flow Bupivacaine Pain Pumps to Decrease Post-operative Pain Following Mastectomy With Immediate Reconstruction: A Prospective, Randomized, Double-Blind Clinical Trial|Withdrawn||Phase 4|0|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:29:10.944367|2017-10-11 03:29:10.944367
NCT01494246|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-06-18|||December 2012||2012-12-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|September 2013|Actual|2013-09-01||Interventional|TABATIC||Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption|Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption (TABATIC). A Randomized Controlled Multicentric Trial|Unknown status|Active, not recruiting|Phase 4|1064|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-10-11 03:29:11.04255|2017-10-11 03:29:11.04255
NCT01494233|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-03-03||2015-03-03|February 2012||2012-02-01|March 2015|2015-03-01||||September 2013|Actual|2013-09-01||Interventional|||A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Determine the Safety and Efficacy of Orally Administered LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|Completed||Phase 2|373|Actual|Lexicon Pharmaceuticals||4|||f||||f||||||||||2017-10-11 03:29:11.18036|2017-10-11 03:29:11.18036
NCT01494220|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-04-03|||June 2007||2007-06-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|March 2010|Actual|2010-03-01||Observational|||Validation of the Bispectral Index Monitor During Living Donor Liver Transplantation|Validation of the Bispectral Index Monitor During Living Donor Liver Transplantation|Completed||N/A|42|Actual|Mansoura University|||1||f||||t||||||||||2017-10-11 03:29:11.552547|2017-10-11 03:29:11.552547
NCT01494207|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2012-02-24|||November 2009||2009-11-01|February 2012|2012-02-01|June 2012|Anticipated|2012-06-01|May 2011|Actual|2011-05-01||Interventional|WOW||Working on Wellness (WOW) Intervention|Working on Wellness (WOW): A Worksite Health Promotion Intervention Programme|Unknown status|Active, not recruiting|N/A|800|Actual|University of Cape Town||1|||f||||f||||||||||2017-10-11 03:29:11.637102|2017-10-11 03:29:11.637102
NCT01494194|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-06-05|||December 2011||2011-12-01|June 2015|2015-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study to Evaluate the Potential of Air Structuring Protein to Elicit Allergic Reactions in Mold Sensitized People|Evaluation of the Potential of Air Structuring Protein, a Novel Protein Preparation Derived From Trichoderma Reesei, to Elicit Allergic Reactions in Mold Sensitized People|Completed||N/A|252|Actual|Unilever SEAC||3|||f||||f||||||||||2017-10-11 03:29:11.716825|2017-10-11 03:29:11.716825
NCT01494181|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-05-04|||July 2011||2011-07-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|OSA||Unrecognised Obstructive Sleep Apnea Study|Postoperative Vascular Events in Unrecognised Obstructive Sleep Apnea|Active, not recruiting||N/A|400|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 03:29:11.792206|2017-10-11 03:29:11.792206
NCT01494168|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-11-30|||December 2011||2011-12-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|January 2015|Actual|2015-01-01||Observational|BASTOD||Bariatric Surgery, Arterial Stiffness and Target Organ Damage Study (BASTOD)|Longitudinal Assessment of the Effect of Bariatric Surgery on Arterial Function and Blood Pressure Target Organs Damage|Completed||N/A|90|Actual|University Hospital, Montpellier|||1||f||||t||||||||||2017-10-11 03:29:11.872063|2017-10-11 03:29:11.872063
NCT01494155|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-07-24|||December 2011||2011-12-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer|Phase II Study of Neoadjuvant Accelerated Short Course Radiation Therapy With Proton or Photon RT Plus Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer|Active, not recruiting||Phase 2|50|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:29:12.152774|2017-10-11 03:29:12.152774
NCT01494142|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-10-17|||August 2011||2011-08-01|October 2016|2016-10-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Observational|||Registry for the Atopic Dermatitis Research Network|Registry for the Atopic Dermatitis Research Network (ADRN-02)|Recruiting||N/A|2600|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||5||f||||f||||||Samples With DNA|"     Whole blood DNA, whole blood RNA,blood cards, blood clots, serum, skin swabs, and skin swab     isolates will be retained.   "|||2017-10-11 03:29:12.313837|2017-10-11 03:29:12.313837
NCT01494116|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-02-26|||October 2011||2011-10-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Pediatric Fast Fluid Randomized Controlled Trial|Factors Affecting Pediatric Isotonic Fluid Resuscitation Efficiency: Impact of Syringe Size|Completed||N/A|48|Actual|McMaster Children's Hospital||4|||f||||f||||||||||2017-10-11 03:29:12.480977|2017-10-11 03:29:12.480977
NCT01494103|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-10-02|||November 2011||2011-11-01|October 2017|2017-10-01|May 2029|Anticipated|2029-05-01|May 2029|Anticipated|2029-05-01||Interventional|DOTTI||Administration of Donor T Cells With the Caspase-9 Suicide Gene|Administration of Haploidentical Donor T Cells Transduced With the Inducible Caspase-9 Suicide Gene|Active, not recruiting||Phase 1|15|Actual|Baylor College of Medicine||1|||f||||t|t|f||||||||2017-10-11 03:29:12.588866|2017-10-11 03:29:12.588866
NCT01494090|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-09-19|||August 2011||2011-08-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|STAFF||Statin in Hip Fracture|Efficacy and Safety of Rosuvastatin in the Prevention of Arterial and Venous Vascular Events and Mortality After Hip Fracture: A Multicenter Randomised, Double-blinded, Placebo Controlled Trial.|Terminated||Phase 3|36|Actual|University Hospital, Brest||2||Decision of the Steering Committee. Recruitment more difficult and slower than expected.|f||||t||||||||||2017-10-11 03:29:12.715693|2017-10-11 03:29:12.715693
NCT01494077|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-12-10|||April 2011||2011-04-01|December 2014|2014-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement|Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for CEA Measurement|Completed||N/A|32|Actual|University of California, Irvine|||1||f||||f||||||||||2017-10-11 03:29:12.823001|2017-10-11 03:29:12.823001
NCT01494064|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2015-12-21|||February 2011||2011-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2014|Actual|2014-10-01||Observational|STANDAREA||Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care|Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care Unit : Standardization of Critical Care Nursing|Completed||N/A|224|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-11 03:29:12.902413|2017-10-11 03:29:12.902413
NCT01494051|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2011-12-15|||January 2006||2006-01-01|December 2011|2011-12-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders|Fatty Acid Oxidation and Body Weight Regulation in Long-chain Fatty Acid Oxidation Disorders.|Completed||Phase 1/Phase 2|13|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 03:29:12.980254|2017-10-11 03:29:12.980254
NCT01494038|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-09-19|||April 2014|Actual|2014-04-01|September 2017|2017-09-01|September 6, 2017|Actual|2017-09-06|September 6, 2017|Actual|2017-09-06||Interventional|||Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women|A Phase IV Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety of Immediate (Antepartum-Initiated) Versus Deferred (Postpartum-Initiated) Isoniazid Preventive Therapy Among HIV-Infected Women in High Tuberculosis (TB) Incidence Settings|Completed||Phase 4|956|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 03:29:13.063395|2017-10-11 03:29:13.063395
NCT01494025|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2012-08-27|||October 2009||2009-10-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|FL-68||Identification of Muscle-specific Biomarkers of Fatty Acid Beta-oxidation|Identification of Muscle-specific Biomarkers of Fatty Acid Beta-oxidation|Completed||N/A|13|Actual|USDA, Western Human Nutrition Research Center||1|||f||||f||||||||||2017-10-11 03:29:13.209877|2017-10-11 03:29:13.209877
NCT01494012|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-04-26|||April 2012||2012-04-01|April 2017|2017-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer|A Phase I Study Evaluating the Efficacy and Toxicity of Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer|Terminated||Phase 1|1|Actual|Stanford University||1||low accrual|f||||t||||||||||2017-10-11 03:29:13.304443|2017-10-11 03:29:13.304443
NCT01493999|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2014-10-06|||September 2011||2011-09-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|TREAT-HPR||Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity|Prasugrel Versus Adjusted High-dose Clopidogrel to TREAT High On-clopidogrel Platelet Reactivity in Acute Coronary Syndrome Patients After PCI|Completed||Phase 4|147|Actual|University of Pecs||2|||f||||t||||||||||2017-10-11 03:29:13.419982|2017-10-11 03:29:13.419982
NCT01493986|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2012-09-09|||February 2012||2012-02-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Minimum Effective Volume of Ropivacaine 7.5 mg/ml for the Lateral and Sagittal Infraclavicular Brachial Plexus Block|Minimum Effective Volume of Ropivacaine 7.5 mg/ml for the Lateral and Sagittal Infraclavicular Brachial Plexus Block When Using Guidance by Both Ultrasound and Nerve Stimulation.|Completed||Phase 4|25|Anticipated|University Hospital of North Norway||1|||f||||f||||||||||2017-10-11 03:29:13.521794|2017-10-11 03:29:13.521794
NCT01493973|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2015-08-10|||January 2013||2013-01-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|FRIEMAX||Efficacy Study of Epoetin Alfa in Friedreich Ataxia|A Double-blind, Randomized, Placebo-controlled, Clinical Trial to Test the Efficacy of Epoetin Alfa on Physical Performance of Friedreich Ataxia Patients.|Completed||Phase 2|56|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 03:29:13.597007|2017-10-11 03:29:13.597007
NCT01493947|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2015-09-22|2015-06-29||April 2012||2012-04-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ATTRACT||CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study|Efficacy and Safety of CD5024 1% Cream Versus Metronidazole 0.75% Cream in Subjects With Papulopustular Rosacea Over 16 Weeks Treatment, Followed by a 36-week Extension Period.|Completed||Phase 3|962|Actual|Galderma R&D||2|||f||||t||||||||||2017-10-11 03:29:13.917283|2017-10-11 03:29:13.917283
NCT01493934|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-28|2016-02-23|||April 2010||2010-04-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|GLUCIMAG||Development of a Fast Measurement Technique of Insulin Resistance in Human|Development of a Fast Measurement Technique of Insulin Resistance in Human, With 123-6-deoxy-6 Iodo-D-glucose, a New Tracer of Glucose Transport|Completed||Phase 1/Phase 2|12|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-10-11 03:29:14.955569|2017-10-11 03:29:14.955569
NCT01493921|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-02-17|||October 2011||2011-10-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment|A Randomized, Double-Blind, Parallel, Vehicle-Controlled Phase III Trial to Assess the Efficacy and Safety of Topical SR-T100 Gel in the Treatment of Patients With Actinic Keratosis|Completed||Phase 3|113|Actual|G&E Herbal Biotechnology Co., LTD||2|||f||||f||||||||||2017-10-11 03:29:15.055933|2017-10-11 03:29:15.055933
NCT01493908|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-15|||January 2012||2012-01-01|December 2011|2011-12-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||The Effect of Marketing Variable on Effect of Active Drugs|The Effect of Price and Marketing Variable on the Pain Controlling Effect of Active Drugs in a Clinical Trial.|Unknown status|Not yet recruiting|N/A|220|Anticipated|Hadassah Medical Organization||5|||f||||f||||||||||2017-10-11 03:29:15.184452|2017-10-11 03:29:15.184452
NCT01493895|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-03-21||||||March 2013|2013-03-01||||||||Interventional|||Study Assessing Safety and Efficacy of B-cure Laser Treating Diabetic Chronic Wounds||Unknown status|Not yet recruiting|Phase 1/Phase 2|||Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 03:29:15.281511|2017-10-11 03:29:15.281511
NCT01493882|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2012-05-10|||March 2012||2012-03-01|May 2012|2012-05-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled Asthma|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, 2-Part Study of JNJ-39758979 in Symptomatic Adult Subjects With Uncontrolled, Persistent Asthma|Withdrawn||Phase 2|0|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4||"Study was withdrawn due to 2 cases of agranulocytosis in a different clinical trial with this   same drug."|f||||t||||||||||2017-10-11 03:29:15.360062|2017-10-11 03:29:15.360062
NCT01493869|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-09-19|||September 2011||2011-09-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|May 2014|Actual|2014-05-01||Interventional|||Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects|A Phase I, Open-Label, Parallel-Group, Single-Dose Study to Assess the Pharmacokinetics of XL184 (Cabozantinib) Capsules in Hepatic Impaired Adult Subjects|Completed||Phase 1|26|Actual|Exelixis||4|||f||||f||||||||||2017-10-11 03:29:15.446134|2017-10-11 03:29:15.446134
NCT01493856|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2012-04-02|||January 2012||2012-01-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276|A Randomized, Open Label, Single-Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 in Healthy Male Volunteers|Completed||Phase 1|58|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||f||||||||||2017-10-11 03:29:15.535842|2017-10-11 03:29:15.535842
NCT01493843|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-04-21|||January 20, 2012|Actual|2012-01-20|April 2017|2017-04-01|March 30, 2016|Actual|2016-03-30|March 30, 2016|Actual|2016-03-30||Interventional|||Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer|A Phase II, Double-Blind, Placebo-Controlled, Randomized Study Evaluating the Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer|Completed||Phase 2|501|Actual|Genentech, Inc.||6|||f|||||t|f||||||||2017-10-11 03:29:15.640098|2017-10-11 03:29:15.640098
NCT01493830|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-07-07|||December 2011||2011-12-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma|Proposed Studies on the Role of Growth Factor Receptor Trafficking in Neuroblastoma Pathogenesis|Completed||N/A|5|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Tumor samples   "|||2017-10-11 03:29:16.056987|2017-10-11 03:29:16.056987
NCT01493817|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2016-05-17|||December 2011||2011-12-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Biomarkers in Samples From Younger Patients With Wilms Tumor|Observational - Relationships Between Tumor-Associated Macrophages and Clinicopathological Factors in Wilms Tumor|Completed||N/A|30|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:29:16.119221|2017-10-11 03:29:16.119221
NCT01493791|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-06-30|||November 8, 2011||2011-11-08|July 24, 2013|2013-07-24|July 24, 2013|Actual|2013-07-24|July 24, 2013|Actual|2013-07-24||Interventional|||CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women|Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Reduce Bleeding in Premenopausal Women With Abnormal Uterine Bleeding: A Pilot Study|Withdrawn||Early Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:29:16.375694|2017-10-11 03:29:16.375694
NCT01493778|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-09-07|||September 17, 2012|Actual|2012-09-17|September 2017|2017-09-01|June 30, 2018|Anticipated|2018-06-30|February 13, 2017|Actual|2017-02-13||Interventional|guardian™4||Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A|Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients With Haemophilia A|Active, not recruiting||Phase 3|60|Anticipated|Novo Nordisk A/S||1|||f||||f|t|f||||||||2017-10-11 03:29:16.465426|2017-10-11 03:29:16.465426
NCT01493765|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-01-30|||July 2013||2013-07-01|January 2017|2017-01-01|July 1, 2016|Actual|2016-07-01|July 1, 2016|Actual|2016-07-01||Observational|||Virtual Temporal Bone Surgery: Defining and Translating Metrics|Virtual Temporal Bone Surgery: Defining and Translating Metrics|Completed||N/A|96|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 03:29:16.734285|2017-10-11 03:29:16.734285
NCT01493752|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2014-04-08|||August 2011||2011-08-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Investigation of the Effect of Dietary Nitrate Treatment on Endothelial Function and Platelet Reactivity in Hypercholesterolemics.|Investigation of the Effect of Dietary Nitrate Treatment on Endothelial Function, Platelet Reactivity in Hypercholesterolemics Without Known Cardiovascular Disease or Atherosclerosis.|Completed||Phase 1|69|Actual|Queen Mary University of London||2|||f||||f||||||||||2017-10-11 03:29:16.838649|2017-10-11 03:29:16.838649
NCT01493739|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-12-15|||January 2009||2009-01-01|December 2011|2011-12-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Observational|||EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy|EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy|Unknown status|Recruiting|N/A|100|Anticipated|Chang Gung Memorial Hospital|||1||f||||t||||||||||2017-10-11 03:29:16.920436|2017-10-11 03:29:16.920436
NCT01493726|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-11-16|||December 2011||2011-12-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia|A Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ALKS 9072 in Subjects With Chronic Stable Schizophrenia|Completed||Phase 1|88|Actual|Alkermes, Inc.||4|||f||||f||||||||||2017-10-11 03:29:17.018212|2017-10-11 03:29:17.018212
NCT01493713|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-09-16|||November 2011||2011-11-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|AVAMET||Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer|Phase 4 Study to Evaluate Correlation of Overall Response According to RECIST-conventional Imaging Techniques, Morphologic Response by CT, & Histopathologic Response in Patients With Hepatic Metastasis Secondary to Colorectal Cancer With Bevacizumab in Combination With XELOX|Active, not recruiting||Phase 4|83|Actual|Grupo Espanol Multidisciplinario del Cancer Digestivo||1|||f||||f||||||||||2017-10-11 03:29:17.139897|2017-10-11 03:29:17.139897
NCT01493700|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-06-26|||December 2011||2011-12-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Changes of Body Temperature During Shoulder Arthroscopy|Effect of Heated Humidifier on the Body Temperature During Shouler Arthroscopy|Completed||N/A|50|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 03:29:17.298932|2017-10-11 03:29:17.298932
NCT01493687|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-01-15|2015-01-08|2014-01-27|December 2011||2011-12-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional||ITT population|Phase 3 Papulopustular Rosacea Study|A Phase 3 Randomized, Double Blind, 12 Week Vehicle Controlled, Parallel Group Study Assessing the Efficacy and Safety of CD5024 1 % Cream Versus Vehicle Cream in Subjects With Papulopustular Rosacea, Followed by a 40 Week Investigator Blinded Extension Comparing the Long Term Safety of CD5024 1% Cream Versus Azelaic Acid 15 % Gel.|Completed||Phase 3|683|Actual|Galderma||2|||f||||t||||||||||2017-10-11 03:29:17.430882|2017-10-11 03:29:17.430882
NCT01493674|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-14|||January 2008||2008-01-01|December 2011|2011-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Folic Acid Supplementation in Eating Disorder|Folic Acid Supplementation for Improving Homocysteine Levels, Cognitive and Depressive Status in Eating Disorders|Completed||Phase 4|24|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz||2|||f||||t||||||||||2017-10-11 03:29:18.592395|2017-10-11 03:29:18.592395
NCT01493661|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-02-02|||December 2011||2011-12-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|CSR||Chronic Sleep Restriction|Chronic Sleep Restriction: Neurobehavioral and Physiological Responses|Completed||N/A|20|Actual|Federal University of São Paulo|||3||f||||t||||||||||2017-10-11 03:29:18.674869|2017-10-11 03:29:18.674869
NCT01493648|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-01-26|||December 2011||2011-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Muscle-Related Side Effects of Statins: Functional Impact, Mechanisms, and Potential Relief With Vitamin D Supplementation|Muscle-Related Side Effects of Statins: Functional Impact, Mechanisms, and Potential Relief With Vitamin D Supplementation|Completed||N/A|78|Actual|CHU de Quebec-Universite Laval||2|||f||||f||||||||||2017-10-11 03:29:18.759592|2017-10-11 03:29:18.759592
NCT01493635|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2017-05-16|||November 2012||2012-11-01|December 2015|2015-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|TVT||Two Step Versus the Standard Three Step Approach of the WHO Analgesic Ladder for Cancer Pain Relief.|An International, Multicentre, Open Randomised Parallel Group Trial Comparing a Two Step Approach for Cancer Pain Relief With the Standard Three Step Approach of the WHO Analgesic Ladder in Patients With Cancer Pain Requiring Step 2 Analgesia.|Completed||N/A|152|Actual|University of Edinburgh||2|||f||||f||||||||||2017-10-11 03:29:18.845935|2017-10-11 03:29:18.845935
NCT01493622|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-20|2011-12-14|||June 2010||2010-06-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia|A Double-Blind,Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Schizophrenia|Completed||Phase 4|78|Actual|Central South University||2|||f||||t||||||||||2017-10-11 03:29:18.937922|2017-10-11 03:29:18.937922
NCT01493609|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2013-11-21|||February 2012||2012-02-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Click-East||A Clinical Trial of a New Computer Based Intervention for Children With Autism.|Computer Learning in Children - the Edinburgh Autism Social-attention Trial.|Completed||Early Phase 1|54|Actual|University of Edinburgh||2|||f||||t||||||||||2017-10-11 03:29:19.027982|2017-10-11 03:29:19.027982
NCT01493596|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-05-10|||December 2011||2011-12-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|||A Safety, Tolerability and Pharmacokinetic Study of CPP-115|A Phase 1, Double-blind, Placebo-controlled, Single Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of CPP-115 Solution Administered Orally to Healthy Volunteers|Unknown status|Active, not recruiting|Phase 1|48|Anticipated|Catalyst Pharmaceuticals, Inc.||6|||f||||t||||||||||2017-10-11 03:29:19.113654|2017-10-11 03:29:19.113654
NCT01493583|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-03-06|||September 2009||2009-09-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Central Nervous Processing of Visual Food Stimuli in Severely Obese Subjects|Central Nervous Processing of Visual Food Stimuli in Severely Obese Subjects and After Roux-en Y Gastric Bypass Surgery - a fMRI Study|Completed||N/A|38|Actual|Cantonal Hospital of St. Gallen|||3||f||||f||||||||||2017-10-11 03:29:19.201736|2017-10-11 03:29:19.201736
NCT01493570|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-10-31|||December 2011||2011-12-01|October 2013|2013-10-01||||February 2012|Actual|2012-02-01||Interventional|||Assessment of Exposure of BI 409306 in Cerebrospinal Fluid (CSF) Relative to Plasma as Well as to Evaluation of the Effect of Different Doses of BI 409306 on the cGMP (Cyclic Guanosine Monophosphate) Levels in CSF in Healthy Male Volunteers|Randomised, Double-blind, Placebo-controlled Parallel-group Proof of Mechanism Study to Assess the Pharmacokinetics and to Evaluate the Pharmacodynamic Effect of Different Single Oral Doses of BI 409306 in Healthy Male Volunteers|Completed||Phase 1|20|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 03:29:19.381877|2017-10-11 03:29:19.381877
NCT01493557|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-09-02|2015-07-06||December 2011||2011-12-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Entered Set (ES): This patient set included all patients entered in the study. For those patients who were randomized to management strategies, their data prior to randomization was included in the entered set. All data from patients who were never randomized are in the entered set.|A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation|A Prospective, Open Label Study Evaluating the Efficacy of Two Management Strategies (Pantoprazole 40 mg q.a.m. and Taking Pradaxa® With Food (Within 30 Minutes After a Meal) on Gastrointestinal Symptoms (GIS) in Patients Newly on Treatment With Pradaxa® 150 mg b.i.d., 110 mg b.i.d. or 75 mg b.i.d. for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation (NVAF)|Completed||Phase 4|1067|Actual|Boehringer Ingelheim|The modest sample size,non-specific nature of symptoms,&reliance on patient self-reporting of their symptoms may contributed some bias to the final result.An open-label design may lead to patient/investigator bias in reporting symptoms.|3|||f||||||||||||||2017-10-11 03:29:19.532366|2017-10-11 03:29:19.532366
NCT01493544|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-04-25|||February 2012||2012-02-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|PUMA PROJECT||Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America|Prevalence Study and Regular Practice (Diagnosis and Treatment) Among General Practitioners in Populations at Risk of COPD in Latin America|Completed||N/A|1907|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 03:29:22.77576|2017-10-11 03:29:22.77576
NCT01493531|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-04-20|2016-01-14|2015-03-23|December 2011||2011-12-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|CLEAR 2||Combining Lesinurad With Allopurinol in Inadequate Responders|A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol|Completed||Phase 3|610|Actual|Ardea Biosciences, Inc.||3|||f||||t||||||||||2017-10-11 03:29:22.931678|2017-10-11 03:29:22.931678
NCT01493518|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2013-11-15|||November 2011||2011-11-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis|A Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Subjects With Moderate to Severe Psoriasis|Terminated||Phase 1|6|Actual|Amgen||2||Sponsor decision|f||||||||||||||2017-10-11 03:29:24.349023|2017-10-11 03:29:24.349023
NCT01493505|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-02-22||2016-11-14|January 2012||2012-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer|A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers|Terminated||Phase 3|1015|Actual|Amgen||2||Amgen Administrative Decision - termination of LTFU|f||||||||||||||2017-10-11 03:29:24.497693|2017-10-11 03:29:24.497693
NCT01493492|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2011-12-15|||May 2010||2010-05-01|December 2011|2011-12-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Observational|||Urinary Proteomics Analysis for Sepsis and Prognosis|Urinary Proteomics Analysis for Sepsis Identification and Its Prognosis in Sepsis Patient With iTRAQ Labeling and and LC-MS/MS|Unknown status|Recruiting|N/A|60|Anticipated|Chinese PLA General Hospital|||3||f||||t||||||||||2017-10-11 03:29:25.387153|2017-10-11 03:29:25.387153
NCT01493479|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2011-12-15|||June 2007||2007-06-01|December 2011|2011-12-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|FIZZ||Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma|Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin)|Unknown status|Active, not recruiting|Phase 2|76|Actual|The Christie NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 03:29:25.471747|2017-10-11 03:29:25.471747
NCT01493466|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-15|2011-12-15|||May 2010||2010-05-01|December 2011|2011-12-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Observational|||Serum Proteomics Analysis for Sepsis|Serum Proteomics Analysis for Dynamic Changes of Differential Proteins in Sepsis Patient With iTRAQ Labeling and LC-MS/MS|Unknown status|Recruiting|N/A|100|Anticipated|Chinese PLA General Hospital|||5||f||||t||||||||||2017-10-11 03:29:25.589109|2017-10-11 03:29:25.589109
NCT01493453|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2013-11-25|||March 2008||2008-03-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|May 2014|Anticipated|2014-05-01||Interventional|CD19||A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy|A Phase I Study of Adoptive Transfer of Autologous Tumour Antigen-Specific T Cells With Pre-conditioning Chemotherapy and Intravenous IL2 in Patients With CD19 Positive Malignancy|Unknown status|Recruiting|Phase 1|24|Anticipated|The Christie NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 03:29:25.679389|2017-10-11 03:29:25.679389
NCT01493440|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2011-12-16|||March 2011||2011-03-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation Failure|Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation Failure|Completed||N/A|71|Actual|An Sinh Hospital||1|||f||||f||||||||||2017-10-11 03:29:25.79406|2017-10-11 03:29:25.79406
NCT01493427|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2014-05-09|2014-02-17||December 2011||2011-12-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||This reporting group includes all subjects who instilled at least one dose of the test article|Efficacy of Changing to TRAVATAN® From Prior Therapy|Multi-Center Study Assessing the Efficacy and Tolerability of TRAVATAN® Solution Without BAK, Containing Polyquad® Preservative (0.004% Travoprost) in Patients Previously on Latanoprost 0.005% or Bimatoprost 0.01% Ophthalmic Solution Monotherapy|Completed||Phase 4|202|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:29:25.893944|2017-10-11 03:29:25.893944
NCT01493414|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-11-27||||||November 2016|2016-11-01||||||||Expanded Access|JUMP||INC424 for Patients With Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis|An Open-label, Multicenter, Expanded Access Study of INC424 for Patients With Primary Myelofibrosis (PMF) or Post Polycythemia Myelofibrosis (PPV MF) or Post-essential Thrombocythemia Myelofibrosis (PET-MF)|No longer available||N/A|||Novartis|||||f||||||||||||||2017-10-11 03:29:26.154465|2017-10-11 03:29:26.154465
NCT01493401|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-02-12|||February 2010||2010-02-01|January 2014|2014-01-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Urinary Urinary Nerve Growth Factor (NGF) as a Biomarker for Mixed Urinary Incontinence|Exploration of the Potential of Urinary Nerve Growth Factor (NGF) as a Biomarker for Diagnosis and Prognosis of Mixed Urinary Incontinence After Midurethral Slings|Unknown status|Recruiting|N/A|121|Anticipated|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:29:27.005915|2017-10-11 03:29:27.005915
NCT01493388|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-01-18|||March 2012||2012-03-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1|Observational, Cross-sectional and Retrospective Study on Diabetes Mellitus Type 1 in Tunisian Children and Adolescents Under 15 Years|Completed||N/A|402|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:29:27.109779|2017-10-11 03:29:27.109779
NCT01493375|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2015-05-27|||June 2010||2010-06-01|May 2015|2015-05-01||||December 2010|Actual|2010-12-01||Observational|||Surgical Field Bacterial Contamination in Primary Total Hip (THA) and Knee (TKA) Arthroplasty|Surgical Field Bacterial Contamination in Primary Hip and Knee Replacement Surgery|Suspended||N/A|60|Actual|Northern Orthopaedic Division, Denmark|||1|Study principal investigator left the organization|f||||t||||||||||2017-10-11 03:29:27.226042|2017-10-11 03:29:27.226042
NCT01493362|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2014-08-14|||January 2008||2008-01-01|November 2011|2011-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Imaging the Dopamine Systems in Bulimia Nervosa|Imaging the Dopamine Systems in Bulimia Nervosa|Completed||N/A|33|Actual|New York State Psychiatric Institute|||2||f||||f||||||||||2017-10-11 03:29:27.310505|2017-10-11 03:29:27.310505
NCT01493349|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2012-01-04|||January 2012||2012-01-01|January 2012|2012-01-01|October 2014|Anticipated|2014-10-01|October 2013|Anticipated|2013-10-01||Observational|||Pathophysiology of Diverticular Disease|The Role of Intestinal Microbiota Composition and Intestinal Permeability in the Development of (Complicated) Diverticular Disease.|Unknown status|Not yet recruiting|N/A|210|Anticipated|Maastricht University Medical Center|||4||f||||f||||||Samples Without DNA|"     -  1 bloodsample (14.5mL)        -  9 Colonic mucosal biopsies        -  1 Intestinal washing sample (at least 15mL)        -  1 Fecal sample   "|||2017-10-11 03:29:27.403317|2017-10-11 03:29:27.403317
NCT01493336|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2016-11-01|||May 2012||2012-05-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours|A Randomized, Open-label, Single Dose, Two-way Cross-Over Study to Investigate the Relative Bioavailability of Capecitabine in Rapid Disintegrating Tablets (RDT) Versus the Commercial Xeloda® Tablets Following Oral Administrations in Adult Patients With Solid Tumours|Completed||Phase 1|37|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:29:27.501495|2017-10-11 03:29:27.501495
NCT01493323|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-12-03|||May 2010||2010-05-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Functional Imaging of Psychic Pain|Neuro Anatomic Basis of Psychic Pain in Depression and Suicidal Behaviour|Terminated||N/A|123|Actual|University Hospital, Montpellier||2||difficult to patient inclusion|f||||f||||||||||2017-10-11 03:29:27.645791|2017-10-11 03:29:27.645791
NCT01493310|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-09-08|||November 2011||2011-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|June 2018|Anticipated|2018-06-01||Interventional|||Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer|A Randomized Phase I Trial of Nanoparticle Albumin Bound Paclitaxel (Nab-paclitaxel, Abraxane) With or Without Mifepristone for Advanced Breast Cancer|Active, not recruiting||Phase 1|32|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 03:29:27.768927|2017-10-11 03:29:27.768927
NCT01493297|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-01-22|||September 2011||2011-09-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|November 2011|Actual|2011-11-01||Interventional|||Effects of Vitamin A and Carotenoids on Iron Absorption|Effects of Vitamin A and Carotenoids on Iron Absorption|Completed||N/A|25|Actual|Swiss Federal Institute of Technology||2|||f||||f||||||||||2017-10-11 03:29:27.884573|2017-10-11 03:29:27.884573
NCT01493167|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-06-13|2016-03-30||December 2011||2011-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|WOODCAST||Study on Wood-plastic Composite for Circumferential Casting|Study on Circumferential Casting Techniques With WOODCAST|Completed||N/A|97|Actual|Onbone Oy||1|||f||||f||||||||No||2017-10-11 03:29:28.164965|2017-10-11 03:29:28.164965
NCT01493154|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2016-10-12|||April 2012||2012-04-01|October 2016|2016-10-01|October 2019|Anticipated|2019-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients|A Phase I Clinical Trial Assessing the Safety and Feasibility of Administration of pNGVL4a-CRT/E7(Detox) DNA Vaccine Using the Intramuscular TriGridTM Delivery System in Combination With Cyclophosphamide in HPV-16 Associated Head and Neck Cancer Patients|Terminated||Phase 1|2|Actual|Sidney Kimmel Comprehensive Cancer Center||4||Study Funding Terminated|f||||t||||||||||2017-10-11 03:29:28.427105|2017-10-11 03:29:28.427105
NCT01493141|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-12-14|||November 2009||2009-11-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|Metal Ions||Systemic Effects of Chronic Metal Ion Exposure From Metal-on Metal Hip Resurfacing|Systemic Effects of Chronic Metal Ion Exposure From Metal-on Metal Hip Resurfacing|Completed||N/A|46|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||2||f||||f||||||Samples With DNA|"     The following markers will be measured using the blood samples:        1. Serum, erythrocyte, and whole blood cobalt, chromium, and nickel        2. Serum iron stores:           Iron, ferritin, transferrin, and total iron binding capacity.        3. Serum biochemical markers of bone turnover:           Osteoblast activity markers (including PINP, OC, BALP) Osteoclast activity markers          (including NTX-I, CTX-I, ICTP)        4. Hypothalamo-pituitary axis hormones (in the following order of priority):           Prolactin LH/FSH + testosterone/oestradiol Growth hormone + IGF-I TSH + Free T3 ACTH +          cortisol        5. Renal function:           Urea, electrolytes, and creatinine        6. Hepatic function Liver function tests Clotting screen        7. Serum lipid profile, full blood count   "|||2017-10-11 03:29:28.551492|2017-10-11 03:29:28.551492
NCT01493128|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-03-10|||April 2010|Actual|2010-04-01|March 2017|2017-03-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Observational|||Ultrastructure of Atrial Myocytes in Patients in Sinus Rhythm and With Atrial Fibrillation|Ultrastructure of Sarcolemma, Immunofluorescence of Calcium Handling Proteins and Mitochondrial Function in Atrial Myocytes of Patients in Sinus Rhythm and With Atrial Fibrillation|Completed||N/A|45|Actual|Norwegian University of Science and Technology|||3||f||||f|f|f||||Samples Without DNA|"     Myocardial tissue from the right and left atrial appendage.   "|||2017-10-11 03:29:28.653993|2017-10-11 03:29:28.653993
NCT01493115|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2012-04-30|||November 2011||2011-11-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus|A Randomized, Double-blind, 3-sequence, 3-period Cross-over, Single-dose Study of a New Formulation of Insulin Glargine Compared to the Marketed Lantus® in Japanese Patients With Type 1 Diabetes Mellitus Using the Euglycemic Clamp Technique|Completed||Phase 1|18|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:29:28.714335|2017-10-11 03:29:28.714335
NCT01493102|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-01-28|||December 2011||2011-12-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|DOVSS||Discontinuation Order of Vasopressors in Septic Shock|Incidence of Hypotension Based on the Discontinuation Order of Vasopressors in the Management of Septic Shock|Terminated||N/A|78|Actual|Samsung Medical Center||2||Futility by interim analysis|f||||f||||||||||2017-10-11 03:29:28.811364|2017-10-11 03:29:28.811364
NCT01493089|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-08-12|2012-12-07||April 2011||2011-04-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease|A Phase III, Multi-centre, Double-blind, Double-dummy, Randomised, Study to Assess the Superiority of Zegerid® 20 mg vs. Losec® 20 mg in the Rapid Relief of Heartburn Associated With GERD as on Demand Therapy|Completed||Phase 3|239|Actual|Norgine||2|||f||||f||||||||||2017-10-11 03:29:28.935056|2017-10-11 03:29:28.935056
NCT01493076|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2011-12-14|||June 2000||2000-06-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Safety and Efficacy of a Newly Developed Baby-sphincterotome for Bile Duct Cannulation|Safety and Efficacy of a New Baby-sphincterotome for Cannulation and Pre-cut in Failed Selective Wire-guided Bile Duct Access|Completed||N/A|1886|Actual|Ruhr University of Bochum|||1||f||||f||||||||||2017-10-11 03:29:29.513686|2017-10-11 03:29:29.513686
NCT01493063|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-09-19|||October 25, 2011|Actual|2011-10-25|September 2017|2017-09-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns|"BRD/11/02-Y LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns."|Active, not recruiting||N/A|160|Actual|Nantes University Hospital|||1||f||||f|f|f||||Samples With DNA|"     Breastmilk samples et infant serum samples   "|||2017-10-11 03:29:29.764371|2017-10-11 03:29:29.764371
NCT01493037|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-07-15|||December 2011||2011-12-01|July 2014|2014-07-01||||March 2014|Actual|2014-03-01||Interventional|pRAMSES||PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention|Pressure Controlled Intermittent Coronary Sinus Occlusion in Patients With ST Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: Safety and Feasibility Study|Completed||N/A|30|Actual|Miracor Medical Systems||1|||f||||t||||||||||2017-10-11 03:29:29.994445|2017-10-11 03:29:29.994445
NCT00005424|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1993||1993-09-01|November 2001|2001-11-01|February 1996|Actual|1996-02-01|||||Observational|||Prospective Analysis of the Effect of Widowhood on CVD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.835778|2017-10-11 04:27:02.835778
NCT01493011|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-05-13|||November 2011||2011-11-01|May 2012|2012-05-01|December 2015|Anticipated|2015-12-01|December 2012|Anticipated|2012-12-01||Interventional|WBH&NSCLC||Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer|A Randomized Contrasted Polycentric Clinical Study About Chemotherapy Combined With Whole-body Hyperthermia(WBH)to Treat Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|N/A|120|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 03:29:30.255248|2017-10-11 03:29:30.255248
NCT01492998|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-23|2011-12-14|||January 2010||2010-01-01|September 2010|2010-09-01||||March 2010|Actual|2010-03-01||Interventional|GGST||Role of FXR in Hepatitis C Virus Replication|Study of the Role of the Biliary Salts Nuclear Receptor FXR in Hepatitis C Virus Replication|Terminated||N/A|15|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 03:29:30.371808|2017-10-11 03:29:30.371808
NCT01492985|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2017-01-24|||July 2013||2013-07-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2016|Actual|2016-10-01||Interventional|||Lipopeptide Immunisation With GTU-multiHIV Trial|Evaluation of a Therapeutic Immunization Strategy Associating a DNA Vaccine (GTU-MultiHIV B) Followed by a Lipopeptide Vaccine (LIPO-5) in the Control of Viral Replication Following Antiretroviral Treatment Interruption in HIV-1 Infected Patients With a CD4 Cell Count ≥ 600/mm3|Active, not recruiting||Phase 2|103|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-11 03:29:30.460173|2017-10-11 03:29:30.460173
NCT01492972|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-06-20|||January 2012||2012-01-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer|Phase III Study of Image Guided Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate|Recruiting||Phase 3|192|Anticipated|Proton Collaborative Group||2|||f||||t||||||||||2017-10-11 03:29:30.566467|2017-10-11 03:29:30.566467
NCT01492959|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-02-27|||March 23, 2004|Actual|2004-03-23|February 2017|2017-02-01|March 23, 2005|Actual|2005-03-23|March 23, 2005|Actual|2005-03-23||Observational|||Observational Study With InnoLet® in Daily Clinical Practice|A Prospective, Open, Uncontrolled, Observational Study With Innolet in Daily Clinical Situations According to the Product Labelling, Without Any Study Specific Investigations|Completed||N/A|1030|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:29:30.696856|2017-10-11 03:29:30.696856
NCT01492946|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-01-20|||May 2010||2010-05-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|November 2010|Actual|2010-11-01||Observational|PreopBIA||Impaired Preoperative Nutritional Status as a Risk Factor for Postoperative Clinical Outcome|Impaired Preoperative Nutritional Status as a Risk Factor for Postoperative Clinical Outcome (PreopBIA)|Completed||N/A|400|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 03:29:30.802488|2017-10-11 03:29:30.802488
NCT01492933|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2017-06-30|||November 22, 2011||2011-11-22|February 24, 2015|2015-02-24|February 24, 2015||2015-02-24|||||Observational|||Measuring Effects of Alcohol on Brain Chemistry|Measuring Effects of Acute Ethanol on Human Brain Metabolites Using Magnetic Resonance Spectroscopy|Terminated||N/A|34|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:29:30.893595|2017-10-11 03:29:30.893595
NCT01492920|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-14|2014-12-29|||April 2012||2012-04-01|December 2014|2014-12-01||||May 2015|Anticipated|2015-05-01||Interventional|||Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy|A Randomized, Double-Blinded, Placebo Controlled Phase III Trial Using Acetyl-L-Carnitine(ALC)(NSC# 747431) for the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Patients With Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Withdrawn||Phase 3|0|Actual|Gynecologic Oncology Group||2||Withdrawn|f||||||||||||||2017-10-11 03:29:30.995425|2017-10-11 03:29:30.995425
NCT01492907|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-08-21|||January 2012||2012-01-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer|Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer|Completed||Phase 1|8|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 03:29:31.12219|2017-10-11 03:29:31.12219
NCT01492894|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-09|2016-12-08|||January 2008||2008-01-01|December 2016|2016-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|KADWORC||Kidney Allograft Dysfunction Without Reversible Causes|A Randomized Controlled Trial of Reducing Calcineruin Inhibitor Target Level by 50% Versus Converting to Rapamycin in Chronic Kidney Dysfunction Without Reversible Causes|Withdrawn||Phase 4|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||study terminated due to low enrollment|f||||f||||||||||2017-10-11 03:29:31.251819|2017-10-11 03:29:31.251819
NCT01492881|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2012-05-09|||April 2012||2012-04-01|May 2012|2012-05-01|January 2017|Anticipated|2017-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma|A Multi-Center, Single-Arm, Phase II Study of Vorinostat (V) in Combination With Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) Followed by VB Maintenance in Patients With Relapsed and Relapsed/Refractory Multiple Myeloma|Withdrawn||Phase 2|0|Actual|UNC Lineberger Comprehensive Cancer Center||1||Doxil is currently unavailable|f||||t||||||||||2017-10-11 03:29:31.372113|2017-10-11 03:29:31.372113
NCT01492868|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-03-01|||January 2012||2012-01-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Sinusitis in Children and the Nasopharyngeal Microbiome|Sinusitis in Children and the Nasopharyngeal Microbiome|Active, not recruiting||N/A|355|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||Samples Without DNA|"     Nasopharyngeal microbiome samples   "|||2017-10-11 03:29:31.488291|2017-10-11 03:29:31.488291
NCT01492855|ClinicalTrials.gov processed this data on October 10, 2017|2008-08-14|2014-09-12|||January 2008||2008-01-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of MRI Diagnosed Meniscal Lesions|The Value of MRI in the Evaluation of Knees Suspected for Meniscal Lesions|Completed||N/A|324|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 03:29:31.587386|2017-10-11 03:29:31.587386
NCT01492842|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2017-02-27|||September 2011||2011-09-01|March 2016|2016-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV|Behavioral, Immunologic and Virologic Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV-Infection|Completed||N/A|272|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 03:29:31.703842|2017-10-11 03:29:31.703842
NCT01492829|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-02-15|||January 2012||2012-01-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|FASY||A Community-health Worker Delivered HIV/STI Prevention Intervention for Internally Displaced Women in Leogane, Haiti|Development and Evaluation of a Community Health Worker Delivered HIV/STI Prevention Intervention for Women Living in Internally Displaced Persons Camps in Leogane, Haiti|Completed||Phase 1|200|Actual|Women's College Hospital||1|||f||||f||||||||||2017-10-11 03:29:31.801906|2017-10-11 03:29:31.801906
NCT01492816|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-22|2017-02-27|||August 2011||2011-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|April 2016|Actual|2016-04-01||Interventional|||Enhancement of Connect to Protect® (C2P)|Enhancement of Connect to Protect® (C2P) to Increase Structural Change and Reduce HIV Risk: Phase IV|Completed||N/A|927|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 03:29:31.889|2017-10-11 03:29:31.889
NCT01492803|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-02-27|||December 2011||2011-12-01|February 2016|2016-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents|A Randomized Placebo-Controlled Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 03:29:31.992418|2017-10-11 03:29:31.992418
NCT01492790|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-08-12|||June 2011||2011-06-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|CCK first||Cholecystectomy First vs Sequential Common Bile Duct Imaging + Cholecystectomy|An Open Randomized Study Comparing Emergency Cholecystectomy First Versus Sequential Common Bile Duct Imaging/Cholecystectomy for the Management of Gallstone Migration|Completed||N/A|100|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 03:29:32.089837|2017-10-11 03:29:32.089837
NCT01492777|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-06-20|||November 2008||2008-11-01|June 2013|2013-06-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Observational|||Pharmacogenetics of Acenocoumarol|Stabilization of Anticoagulation by Acenocoumarol: Role of Genetic Vulnerability and Risk of Drug Interactions|Completed||N/A|115|Actual|University Hospital, Geneva|||1||f||||f||||||Samples With DNA|"     Whole blood samples   "|||2017-10-11 03:29:32.192236|2017-10-11 03:29:32.192236
NCT01492764|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-12-11|||June 2011||2011-06-01|December 2013|2013-12-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Observational|VTFIRM||Ablation of Sources for Rapid Heart Rhythms|Ventricular Tachyarrhythmia Focal Impulse and Rotor Modulation Trial|Unknown status|Recruiting|N/A|40|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-10-11 03:29:32.279402|2017-10-11 03:29:32.279402
NCT01492751|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-02-25|||April 2003||2003-04-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|May 2015|Actual|2015-05-01||Observational|E-PROSTCaT||Effectiveness of Localized Prostate Cancer Treatments|Effectiveness of Three Primary Treatments for Localized Prostate Cancer: Radical Prostatectomy, External-beam Radiotherapy, and Prostate Brachytherapy|Active, not recruiting||N/A|500|Anticipated|Fundacion IMIM|||1||f||||f||||||||||2017-10-11 03:29:32.391462|2017-10-11 03:29:32.391462
NCT01492738|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2015-04-14|||February 2011||2011-02-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Effect of Acupuncture on Anxiety and Working Memory|The Effect of Acupuncture on Anxiety and Working Memory|Completed||N/A|90|Actual|National University of Health Sciences||2|||f||||t||||||||||2017-10-11 03:29:32.524393|2017-10-11 03:29:32.524393
NCT01492725|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2015-04-20|||June 2012||2012-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|EXTEND-IA||Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial|A Randomized Controlled Trial of Intra-arterial Reperfusion Therapy After Standard Dose Intravenous t-PA Within 4.5 Hours of Stroke Onset Utilizing Dual Target Imaging Selection.|Terminated||Phase 2|70|Actual|Neuroscience Trials Australia||2||On DSMB advice, trial recruitment has been halted for efficacy. F/U continues|f||||t||||||||||2017-10-11 03:29:32.621203|2017-10-11 03:29:32.621203
NCT01492712|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-08-11|||January 2011|Actual|2011-01-01|August 2017|2017-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|VaSCoM||Validation Study of Covariates Model (VaSCoM) for Propofol|Validation Study of Covariates Model (VaSCoM) for Propofol|Completed||N/A|40|Actual|Golden Jubilee National Hospital||2|||f||||f||||||||||2017-10-11 03:29:32.724403|2017-10-11 03:29:32.724403
NCT01492673|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-04-25|||December 2011|Actual|2011-12-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma|A Phase II Trial of Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma|Active, not recruiting||Phase 2|9|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:29:32.969359|2017-10-11 03:29:32.969359
NCT01492660|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-04-19|||January 2012||2012-01-01|January 2012|2012-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Echostim1||Echogenic Versus Stimulating Needle and Catheter for Sciatic Blocks|Comparison of Visibility of Echogenic and Standard Non-echogenic Block Needles During Ultrasound Guided Sciatic Blocks. A Randomized Prospective Study|Completed||Phase 3|70|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:29:33.077385|2017-10-11 03:29:33.077385
NCT01492647|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-02-18|||August 2011||2011-08-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris|A Randomized, Double Blinded, Single Topical Dose Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Subjects With Acne Vulgaris|Completed||Phase 1|18|Actual|Janssen Pharmaceutical K.K.||2|||f||||f||||||||||2017-10-11 03:29:33.166533|2017-10-11 03:29:33.166533
NCT01492621|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2011-12-14|||November 2011||2011-11-01|December 2011|2011-12-01|November 2013|Anticipated|2013-11-01|September 2013|Anticipated|2013-09-01||Interventional|||Effect of Antidepressants on White Matter Structure|White Matter Structure and Response to Treatment With Antidepressants: a Study of Desvenlafaxine in Major Depression. A Pilot Study|Unknown status|Recruiting|Phase 4|40|Anticipated|Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine||1|||f||||f||||||||||2017-10-11 03:29:33.322374|2017-10-11 03:29:33.322374
NCT01492608|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2017-09-25|||December 2011|Actual|2011-12-01|September 2017|2017-09-01|August 2019|Anticipated|2019-08-01|December 2017|Anticipated|2017-12-01||Interventional|MASP||Magnesium Sulphate for Preterm Birth (MASP Study)|Administration of Antenatal Magnesium Sulphate for Prevention of Cerebral Palsy in Preterm Infants (MASP-STUDY)|Recruiting||Phase 3|560|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 03:29:33.584984|2017-10-11 03:29:33.584984
NCT01492595|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-02-29|||April 2012||2012-04-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|TBcontact||Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda|Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda: An Open Cohort of Children <5 Years in Contact With Newly Diagnosed Adult TB Cases in Mbarara Hospital|Completed||N/A|281|Actual|Epicentre|||1||f||||f||||||||No||2017-10-11 03:29:33.73492|2017-10-11 03:29:33.73492
NCT01492569|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2013-06-11|||May 2012||2012-05-01|June 2013|2013-06-01||||July 2013|Anticipated|2013-07-01||Interventional|||Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting|Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting|Withdrawn||N/A|0|Actual|Stanford University||2||low accrual|f||||t||||||||||2017-10-11 03:29:33.976722|2017-10-11 03:29:33.976722
NCT01492556|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-03-14|||December 2011||2011-12-01|March 2013|2013-03-01|June 2015|Anticipated|2015-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer|A Phase II, Single-arm, Multicenter Study of Etoposide Monotherapy in Treating Patients With Recurrent or Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|100|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 03:29:34.1072|2017-10-11 03:29:34.1072
NCT01492543|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-03-14|||December 2011||2011-12-01|March 2013|2013-03-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Interventional|||Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer|An Open-label, Single-arm, Multicenter, Phase II Study to Assess the Efficacy and Safety of Aiyi® (Tegafur Gimeracil Oteracil Potassium Capsule) as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 03:29:34.331881|2017-10-11 03:29:34.331881
NCT01492530|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-06-10|||August 2007||2007-08-01|June 2014|2014-06-01|March 2012|Actual|2012-03-01|May 2011|Actual|2011-05-01||Interventional|MAALES||Men of African American Legacy Empowering Self|Reducing HIV Risk Behaviors and Psychosocial Stressors Among Bisexual African American Men|Completed||Phase 2|437|Actual|Charles Drew University of Medicine and Science||2|||f||||t||||||||||2017-10-11 03:29:34.491101|2017-10-11 03:29:34.491101
NCT01492517|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-01-15|||May 2010||2010-05-01|February 2015|2015-02-01|May 2015|Actual|2015-05-01|June 2013|Actual|2013-06-01||Interventional|Lamarck||Epigenetic Effects of Diesel Exhaust and Ozone Exposure|Epigenetic Effects of Diesel Exhaust and Ozone Exposure|Completed||N/A|42|Actual|Environmental Protection Agency (EPA)||4|||f||||f||||||||||2017-10-11 03:29:34.609174|2017-10-11 03:29:34.609174
NCT01492504|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-09-27|||February 7, 2012|Actual|2012-02-07|September 2017|2017-09-01|February 16, 2021|Anticipated|2021-02-16|February 15, 2021|Anticipated|2021-02-15||Observational|||Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial|A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatitis C|Active, not recruiting||N/A|1850|Anticipated|Bristol-Myers Squibb|||1||f||||f|t|f||||||||2017-10-11 03:29:34.754368|2017-10-11 03:29:34.754368
NCT01492491|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-10|2016-06-13|||September 2011||2011-09-01|June 2016|2016-06-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|SALATO||Collaborative Research on HFR High Flux|Collaborative Study on Outcome of Antioxidant Vitamines, Microinflammation Parameters and Middle-high Toxins in ESRD Patients Treated With Online HDF, HFR and SUPRA-HFR|Completed||Phase 3|50|Actual|Azienda Sanitaria Locale di Cagliari||2|||f||||t||||||||||2017-10-11 03:29:35.261837|2017-10-11 03:29:35.261837
NCT01492478|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-14|||January 2012||2012-01-01|December 2011|2011-12-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Observational|||Psychobiological Characterization of Depression in Hepatitis C|Psychobiological Characterization of Depression in Hepatitis C|Unknown status|Not yet recruiting|N/A|200|Anticipated|Centro Hospitalar Lisboa Norte|||1||f||||f||||||||||2017-10-11 03:29:35.382705|2017-10-11 03:29:35.382705
NCT01492465|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2013-02-13|||November 2011||2011-11-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Single Ascending Dose Trial in Patients With Type 2 Diabetes|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 876 in Subjects With Type 2 Diabetes|Terminated||Phase 1|47|Actual|Amgen||2||Decision by Sponsor|f||||||||||||||2017-10-11 03:29:35.472719|2017-10-11 03:29:35.472719
NCT01492452|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-14|||December 2010||2010-12-01|December 2011|2011-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||The Anxiety of Parents of Children Undergoing Cardiac Surgery|Standard Guidelines Impact of Nursing Anxiety of Parents of Children Undergoing Cardiac Surgery: Randomized Clinical Trial|Completed||N/A|44|Actual|Instituto de Cardiologia do Rio Grande do Sul||1|||f||||f||||||||||2017-10-11 03:29:35.563127|2017-10-11 03:29:35.563127
NCT01492439|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-06-10|2014-01-22||December 2011||2011-12-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effectiveness of Cognitive Remediation in a Supported Education Setting|Examining the Effectiveness of Cognitive Remediation in a Supported Education Setting|Completed||N/A|37|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 03:29:35.69241|2017-10-11 03:29:35.69241
NCT01492426|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2016-04-28|2015-08-17||January 2012||2012-01-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|COMMAND-3||Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection|A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared With Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C|Completed||Phase 3|605|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 03:29:37.166722|2017-10-11 03:29:37.166722
NCT01492413|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2011-12-14|||October 2008||2008-10-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Impact of an Online Behavioral Weight Loss Program|Impact of an Online Behavioral Weight Loss Program Provided With or Without a Fortified Diet Beverage|Completed||N/A|572|Actual|Baylor College of Medicine||4|||f||||f||||||||||2017-10-11 03:29:38.377947|2017-10-11 03:29:38.377947
NCT01492400|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2015-01-21|2015-01-21||March 2012||2012-03-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema||Completed||Phase 2|363|Actual|Allergan||2|||f||||f||||||||||2017-10-11 03:29:38.528525|2017-10-11 03:29:38.528525
NCT01492387|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2013-12-31|||January 2012||2012-01-01|December 2013|2013-12-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|DURATION||Duration of Antibiotic Therapy in Community - Acquired Pneumonia|Individualizing Duration of Antibiotic Therapy in Hospitalized Patients With Community - Acquired Pneumonia: a Non-inferiority, Randomized, Controlled Trial.|Unknown status|Recruiting|Phase 4|892|Anticipated|University of Milan||2|||f||||t||||||||||2017-10-11 03:29:39.412156|2017-10-11 03:29:39.412156
NCT01492374|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2014-07-23|||February 2012||2012-02-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease|Completed||Phase 1|40|Actual|Bristol-Myers Squibb||4|||f||||t||||||||||2017-10-11 03:29:39.596269|2017-10-11 03:29:39.596269
NCT01492361|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-13|2017-03-15|||November 2011||2011-11-01|March 2017|2017-03-01||||December 2017|Anticipated|2017-12-01||Interventional|REDUCE-IT||A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.|Evaluation of the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients With Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events With EPA - Intervention Trial)|Active, not recruiting||Phase 3|8000|Anticipated|Amarin Pharma Inc.||2|||f||||t||||||||Undecided||2017-10-11 03:29:39.814531|2017-10-11 03:29:39.814531
NCT01492348|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-31|2017-03-10|||January 2012||2012-01-01|March 2017|2017-03-01|February 2016|Actual|2016-02-01|October 2014|Actual|2014-10-01||Interventional|STEPS UP||Stepped Enhancement of PTSD Services Using Primary Care (STEPS UP): A Randomized Effectiveness Trial|Stepped Enhancement of PTSD Services Using Primary Care (STEPS UP): A Randomized Effectiveness Trial|Completed||N/A|666|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||t|f|f||||||No||2017-10-11 03:29:42.419428|2017-10-11 03:29:42.419428
NCT01492335|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2016-01-13|||January 2006||2006-01-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|October 2011|Actual|2011-10-01||Interventional|||Cognitive Assessment of Elderly Primary Care Patients|Cognitive Assessment of Elderly Primary Care Patients|Completed||N/A|524|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:29:42.548521|2017-10-11 03:29:42.548521
NCT01492322|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2015-10-07|||November 2011||2011-11-01|December 2011|2011-12-01|October 2014|Actual|2014-10-01|July 2013|Actual|2013-07-01||Observational|DDAT||SPECT Imaging of DAT Genotype|Use of SPECT (Single-photon Emission Computed Tomography) to Examine the Role of DAT (Dopamine Transporter) Genotype in Motivated Smoking Behavior|Terminated||Phase 1|14|Actual|University of Pennsylvania|||1|UPenn suspended production of the ligand necessary to produce the tracer TRODAT.|f||||f||||||||||2017-10-11 03:29:42.620068|2017-10-11 03:29:42.620068
NCT01492296|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-12|||March 2011||2011-03-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|safendoscopy||Endoscopy With Short Fasting|Safety, Quality and Comfort of Upper Gastrointestinal Endoscopy With Conscious Sedation After Fasting for Two Hours|Completed||N/A|115|Actual|Universidade de Passo Fundo||2|||f||||f||||||||||2017-10-11 03:29:42.802685|2017-10-11 03:29:42.802685
NCT01492283|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-07-09|||December 2011||2011-12-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|May 2013|Actual|2013-05-01||Observational|||Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes|Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes|Completed||N/A|48|Actual|University Hospital, Gentofte, Copenhagen|||5||f||||t||||||Samples With DNA|"     DNA (whole blood) will be kept for 15 years   "|||2017-10-11 03:29:42.880118|2017-10-11 03:29:42.880118
NCT01492270|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-28|||December 2011||2011-12-01|December 2011|2011-12-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|PICTURE||Imaging for Significant Prostate Cancer Risk Evaluation|PICTURE - Prostate Imaging (Multi-parametric MRI and Prostate HistoScanning™) Compared to Transperineal Ultrasound Guided Biopsy for Significant Prostate Cancer Risk Evaluation.|Unknown status|Recruiting|N/A|126|Anticipated|University College London Hospitals||1|||f||||f||||||||||2017-10-11 03:29:43.043133|2017-10-11 03:29:43.043133
NCT01492257|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-12-12|||July 2011||2011-07-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|SDM||Shared Decision Making in Patients With Osteoarthritis of the Hip and Knee|Shared Decision Making in Patients With Osteoarthritis of the Hip and Knee|Completed||N/A|120|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:29:43.180207|2017-10-11 03:29:43.180207
NCT01492244|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-03-26|||December 2011||2011-12-01|March 2012|2012-03-01||||||||Observational|||Validation of an Online Knee Pain Map and Questionnaire: A Probabilistic Diagnostic Tool|Alidation of an Online Knee Pain Map and Questionnaire: A Probabilistic Diagnostic Tool|Terminated||N/A|1000|Anticipated|University of California, Los Angeles|||1||f||||t||||||||||2017-10-11 03:29:43.28627|2017-10-11 03:29:43.28627
NCT01492231|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-12-10|||November 2008||2008-11-01|December 2014|2014-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||The Clinical Impact and Outcomes of Interventional Endoscopy Procedures|The Clinical Impact and Outcomes of Interventional Endoscopy Procedures|Enrolling by invitation||N/A|3500|Anticipated|University of California, Irvine|||1||f||||t||||||||||2017-10-11 03:29:43.490205|2017-10-11 03:29:43.490205
NCT01492218|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-02-24|||March 15, 2004|Actual|2004-03-15|February 2017|2017-02-01|August 30, 2004|Actual|2004-08-30|August 30, 2004|Actual|2004-08-30||Observational|||Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction|A Prospective, Open-labelled, Non-controlled Observational Study to Assess Patient Satisfaction, Physician Acceptability and Safety of Mixtard® 30 NovoLet® for the Treatment of Diabetes Mellitus|Completed||N/A|1330|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:29:43.566887|2017-10-11 03:29:43.566887
NCT01492205|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-10-13|||September 2005||2005-09-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||NovoLet® Acceptance Study Within the Hospital Practise in Indonesia|A Doctor and Nurse Survey on Using NovoLet® Within the Hospital Practice in Indonesia|Completed||Phase 4|203|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:29:43.650866|2017-10-11 03:29:43.650866
NCT01492192|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2014-07-01|||May 2013||2013-05-01|July 2014|2014-07-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Interventional|||RGD-PET-CT in Cancer Angiogenesis|Prospective Study of 18F-RGD PET-CT in Assessment of Response to Antiangiogenic Treatment in Patients With Cancer and Comparison With Perfusion CT|Unknown status|Recruiting|Phase 2|40|Anticipated|Oxford University Hospitals NHS Trust||1|||f||||t||||||||||2017-10-11 03:29:43.735403|2017-10-11 03:29:43.735403
NCT01492179|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2014-05-25|||November 2011||2011-11-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PoPuLAR||Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.|A Comparison Between Continuous Infusion vs. Patient Controlled Intraabdominal Injection of Local Anesthetics for Treatment of Postoperative Pain After Abdominal Hysterectomy. A Randomized, Double-blind Study.|Completed||Phase 4|60|Anticipated|Örebro University, Sweden||3|||f||||t||||||||||2017-10-11 03:29:43.836928|2017-10-11 03:29:43.836928
NCT01492166|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-12-12|||November 2006||2006-11-01|December 2016|2016-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice|A Multi-center, Prospective, Non-interventional Evaluation of Efficacy, Safety and Convenience of Mixtard® 30 NovoLet® as Monotherapy, or in Combination With Oral Hypoglycaemic Agent ( OHA ), in Treatment of Subjects With Type 2 Diabetes in Routine Clinical Practice|Completed||N/A|1935|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:29:43.933861|2017-10-11 03:29:43.933861
NCT01492153|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-02-24|||February 11, 2003|Actual|2003-02-11|February 2017|2017-02-01|September 5, 2006|Actual|2006-09-05|September 5, 2006|Actual|2006-09-05||Observational|||NovoLet® Surveillance Study on Using Human Insulin System in Indonesia|A Post Marketing Surveillance on the Use of NovoLet® Human Insulin System in Indonesia|Completed||N/A|1981|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:29:44.045362|2017-10-11 03:29:44.045362
NCT01492127|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-04-22|||December 2011||2011-12-01|April 2013|2013-04-01|March 2016|Anticipated|2016-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment|Evolution of Plasma Proteasome Levels Following Curative Treatment of Hepatocellular Carcinoma in Cirrhotic Patients|Unknown status|Active, not recruiting|N/A|64|Actual|University Hospital, Montpellier||1|||f||||t||||||||||2017-10-11 03:29:44.282361|2017-10-11 03:29:44.282361
NCT01492114|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2012-07-06|||July 2011||2011-07-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Anti-inflammatory and Antioxidant Effects of Resveratrol on Healthy Adults.|Double-blind Cross-over Randomised Controlled Trial on the Anti-inflammatory and Antioxidant Effects of Resveratrol on Healthy Adults.|Completed||Phase 3|40|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-10-11 03:29:44.406736|2017-10-11 03:29:44.406736
NCT01492101|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-08-02|||December 2011||2011-12-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|BEACON||The BEACON Study (Breast Cancer Outcomes With NKTR-102)|The BEACON Study (Breast Cancer Outcomes With NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of Physician's Choice (TPC) in Patients With Locally Recurrent or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane and Capecitabine|Completed||Phase 3|852|Actual|Nektar Therapeutics||2|||f||||t||||||||||2017-10-11 03:29:44.573718|2017-10-11 03:29:44.573718
NCT01492088|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-04-05|2017-04-05|2017-02-08|April 16, 2012|Actual|2012-04-16|April 2017|2017-04-01|March 20, 2018|Anticipated|2018-03-20|October 12, 2016|Actual|2016-10-12||Interventional||Safety population is defined as participants who received at least 1 dose of study drug.|Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma|A Phase 1/2 Study of Brentuximab Vedotin (SGN-35) in Pediatric Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma|Active, not recruiting||Phase 1/Phase 2|36|Actual|Takeda||2|||f||||f|t|f||||||||2017-10-11 03:29:45.203992|2017-10-11 03:29:45.203992
NCT01492075|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2015-09-26|||January 2008||2008-01-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PoPuLAR||A Comparison Between Continuous and Intermittent Intraabdominal Analgesia Using Local Anaesthetics|Phase IV Study of Postoperative Pain Management|Completed||Phase 4|40|Actual|Örebro University, Sweden||2|||f||||t||||||||||2017-10-11 03:29:47.367462|2017-10-11 03:29:47.367462
NCT01492062|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-14|2015-03-31|||February 2011||2011-02-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Evaluate a Multiple Model Probabilistic Predictive Controller (MMPPC) for Closed Loop Insulin Delivery|A Study to Evaluate a Multiple Model Probabilistic Predictive Controller (MMPPC) for Closed Loop Insulin Delivery|Withdrawn||N/A|0|Actual|Stanford University||1||Study halted prior to enrollment of first participant.|f||||t||||||||||2017-10-11 03:29:47.452811|2017-10-11 03:29:47.452811
NCT01492049|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-05-01|||August 2012|Actual|2012-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||R-21 Colorectal Cancer Screening (CRCS) Pilot Trial|Pilot Trial - Promoting Health Literacy for Colorectal Cancer Screening|Active, not recruiting||N/A|180|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 03:29:47.571569|2017-10-11 03:29:47.571569
NCT01492036|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-06-15|||December 2011|Actual|2011-12-01|June 2017|2017-06-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|||Long-Term Follow-Up of Recipient of Gene Transfer Research|Long-Term Follow-Up Study of Recipients of Gene Transfer Research Protocols|Recruiting||N/A|130|Anticipated|M.D. Anderson Cancer Center|||1||f||||t||||||Samples With DNA|"     Study visits once a year during Years 1-5. Blood (about 2-4 tablespoons each time) drawn for     routine tests. If retroviral gene transfer therapy received, blood (up to 4 tablespoons each     time) drawn every 3 months for first year after gene transfer therapy and once a year after     that. If joining study more than a year after gene transfer therapy, RCR test performed once     a year for all 15 years of the study.   "|||2017-10-11 03:29:47.674238|2017-10-11 03:29:47.674238
NCT01492023|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2013-03-08|||November 2010||2010-11-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Observational|MSattention||The Effects of Attention Retraining in MS|The Effects of Attention Retraining on Cognitive Performance, QoL and Perceived Cognitive Impairment in MS - a Single Blind, Randomized, Controlled Study|Completed||N/A|97|Actual|Finnish MS Society|||2||f||||f||||||None Retained|"     A randomised, controlled, single-blind study   "|||2017-10-11 03:29:47.895131|2017-10-11 03:29:47.895131
NCT01492010|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2011-12-12|||June 2010||2010-06-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Role of Leucine in the Regulation of Human Myofibrillar Protein Synthesis at Rest and Following Resistance Exercise|Role of Leucine in the Regulation of Human Myofibrillar Protein Synthesis at Rest and Following Resistance Exercise|Completed||N/A|24|Actual|McMaster University||3|||f||||f||||||||||2017-10-11 03:29:48.001603|2017-10-11 03:29:48.001603
NCT01491997|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2017-09-26|||August 2011||2011-08-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Mind-Body Medicine and Ulcerative Colitis|Mind-Body Medicine and Ulcerative Colitis|Active, not recruiting||N/A|100|Anticipated|Rush University Medical Center||2|||f||||t||||||||||2017-10-11 03:29:48.08349|2017-10-11 03:29:48.08349
NCT01491984|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-02-24|2013-05-22||July 2009||2009-07-01|February 2015|2015-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effectiveness and Safety of the Levitan Scope for Laryngoscopy and Tracheal Intubation With a Simulated Difficult Airway|Effectiveness and Safety of the Levitan FPS Scope for Laryngoscopy and Tracheal Intubation With a Simulated Difficult Airway in Surgical Subjects Under General Anesthesia|Completed||Phase 4|105|Actual|IWK Health Centre||2|||f||||t||||||||||2017-10-11 03:29:48.180682|2017-10-11 03:29:48.180682
NCT01491971|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2013-11-18||2013-11-18|January 2012||2012-01-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|IM1||Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer|Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer|Completed||Phase 2|76|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-10-11 03:29:48.416656|2017-10-11 03:29:48.416656
NCT01491945|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2015-08-20|||March 2012||2012-03-01|August 2015|2015-08-01|April 2018|Anticipated|2018-04-01|March 2016|Anticipated|2016-03-01||Interventional|||Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System|Prospective, Multicenter, Single Arm Safety and Effectiveness Trial of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms|Active, not recruiting||Phase 2|122|Anticipated|Endologix||1|||f||||t||||||||||2017-10-11 03:29:48.672319|2017-10-11 03:29:48.672319
NCT01491932|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-03-20|||March 2012||2012-03-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias|An Open-label Treatment Study to Evaluate the Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias|Completed||Phase 2|129|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:29:48.820332|2017-10-11 03:29:48.820332
NCT01491919|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-06-15|2015-04-27||June 2012||2012-06-01|June 2015|2015-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|PTN_LISINO||Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant|Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients|Completed||Phase 1|26|Actual|Duke University||3|||f||||t||||||||||2017-10-11 03:29:49.016871|2017-10-11 03:29:49.016871
NCT01491906|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-07-28|||May 2011||2011-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|February 2012|Actual|2012-02-01||Interventional|||Weight Loss Among Adults in Beijing, China|Weight Loss Among Adults in Beijing, China|Completed||N/A|123|Actual|Duke University||2|||f||||f||||||||||2017-10-11 03:29:50.052102|2017-10-11 03:29:50.052102
NCT01491893|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-09-11|||April 25, 2012|Actual|2012-04-25|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|June 27, 2017|Actual|2017-06-27||Interventional|PVSRIPO||PVSRIPO for Recurrent Glioblastoma (GBM)|Dose-finding and Safety Study of an Oncolytic Polio/Rhinovirus Recombinant Against Recurrent WHO Grade IV Malignant Glioma|Active, not recruiting||Phase 1|61|Actual|Duke University||1|||f||||t|t|f||||||||2017-10-11 03:29:50.130895|2017-10-11 03:29:50.130895
NCT01491880|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2012-01-17|||November 2011||2011-11-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Treatment Study for Rural Latino Youth With Anxiety|Feasible Delivery of CBT for Rural Latino Youth With Anxiety|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-11 03:29:50.228376|2017-10-11 03:29:50.228376
NCT01491867|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-03-20|||December 2011||2011-12-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect|Evaluation of Continuous IOP Measurement and the Influence of Drug Induced IOP Decrease on the Measurement|Completed||N/A|9|Actual|Semmelweis University||1|||f||||f||||||||||2017-10-11 03:29:50.326285|2017-10-11 03:29:50.326285
NCT01491854|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-06-08|||July 2009||2009-07-01|June 2017|2017-06-01|July 2031|Anticipated|2031-07-01|July 2031|Anticipated|2031-07-01||Interventional|SGA||Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age|Long-term Safety Follow-up After Growth Hormone Treatment (rhGH) of Short Children Born Small for Gestational Age (SGA)|Recruiting||N/A|200|Anticipated|Sandoz||1|||f||||f||||||||||2017-10-11 03:29:50.414306|2017-10-11 03:29:50.414306
NCT01491828|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-10|2012-03-19|||November 2011||2011-11-01|December 2011|2011-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study to Determine Results of Vibratory Stimulus on Subject's Neck|Study to Determine Results of Vibratory Stimulus on Subject's Neck|Completed||Phase 1|100|Anticipated|Kai Medical, Inc.||1|||f||||f||||||||||2017-10-11 03:29:50.688801|2017-10-11 03:29:50.688801
NCT01491815|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-06-13|||December 2012||2012-12-01|June 2017|2017-06-01|December 2021|Anticipated|2021-12-01|March 2019|Anticipated|2019-03-01||Interventional|||Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction|A Multicenter, Randomized, Open-label, Blinded-assessor, Phase 4 Study in Patients With Early Rheumatoid Arthritis to Compare Active Conventional Therapy Versus Three Biologic Treatments, and Two De-escalation Strategies in Patients Who Respond to Treatment|Recruiting||Phase 4|800|Anticipated|Karolinska Institutet||4|||f||||t||||||||No||2017-10-11 03:29:50.756248|2017-10-11 03:29:50.756248
NCT01491802|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-05-02|2016-12-13||January 2012||2012-01-01|May 2017|2017-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPD|A 4-week Randomized, Double-blind, Crossover Study to Assess the Effect of a New LABA/LAMA Combination Versus LAMA Alone on Exertional Dyspnea, Exercise Endurance and Neuromechanical Coupling in Patients With GOLD Stage II COPD|Completed||Phase 3|17|Actual|Queen's University||2|||f||||t||||||||||2017-10-11 03:29:50.934077|2017-10-11 03:29:50.934077
NCT01491789|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-03-15|||May 2011||2011-05-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VSail||Virtual Sailing Simulator in Individuals With Spinal Cord Injury|Virtual Sailing Simulator in Individuals With Spinal Cord Injury|Recruiting||Phase 1/Phase 2|20|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||t||||||||||2017-10-11 03:29:51.457355|2017-10-11 03:29:51.457355
NCT01491776|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2012-03-07|||December 2011||2011-12-01|March 2012|2012-03-01|April 2012|Anticipated|2012-04-01|March 2012|Anticipated|2012-03-01||Observational|||Evaluation of the IND One Step Strep A Rapid Test vs. Culture|Evaluation of the IND One Step Strep A Rapid Test Versus Culture Using Clinical Throat Swab Samples From Patients With Suspected Strep A Infections, CLIA Waiver Study|Unknown status|Recruiting|N/A|315|Anticipated|IND Diagnostic Inc.|||1||f||||f||||||||||2017-10-11 03:29:52.211702|2017-10-11 03:29:52.211702
NCT01491763|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-01-11|||January 2008||2008-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE||Recruiting||Phase 4|70|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-11 03:29:52.343921|2017-10-11 03:29:52.343921
NCT01491750|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-01-02|||June 2011||2011-06-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Guided Imagery Response in Total Knee Replacement|Factors Affecting Guided Imagery Response in Total Knee Replacement|Completed||Phase 2|82|Anticipated|Kent State University||2|||f||||t||||||||||2017-10-11 03:29:52.894314|2017-10-11 03:29:52.894314
NCT01491737|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-08-09|2017-05-11||February 17, 2012|Actual|2012-02-17|August 2017|2017-08-01|October 26, 2019|Anticipated|2019-10-26|March 17, 2016|Actual|2016-03-17||Interventional|PERTAIN|Intent to treat (ITT) included all randomized participants.|A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer|A Randomized, Two-Arm, Open-Label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab Plus an Aromatase Inhibitor in First Line Patients With HER2-Positive and Hormone Receptor-Positive Advanced (Metastatic or Locally Advanced) Breast Cancer|Active, not recruiting||Phase 2|258|Actual|Hoffmann-La Roche||2|||f|||||t|f||||||||2017-10-11 03:29:53.031998|2017-10-11 03:29:53.031998
NCT01491711|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-01-30|||August 2013||2013-08-01|January 2014|2014-01-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate|Treatment of Superficial Basal Cell Carcinoma by Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Topical Photodynamic Therapy With Methylaminolevulinate|Unknown status|Recruiting|Phase 4|162|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:29:54.431731|2017-10-11 03:29:54.431731
NCT01491529|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-03-28||2016-03-28|April 2012||2012-04-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias|13-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of Modified Release AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease|Completed||Phase 2|154|Actual|Novartis||3|||f||||||||||||||2017-10-11 03:29:59.352953|2017-10-11 03:29:59.352953
NCT01491698|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2013-08-14|||December 2011||2011-12-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma|A Pilot Randomized Controlled Trial Examining the Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma|Completed||Phase 3|12|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 03:29:54.545021|2017-10-11 03:29:54.545021
NCT01491685|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-01-18|||August 2011||2011-08-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Parturient Microcirculation|An Observational Assessment of the Sublingual Microcirculation of Pregnant and Non-pregnant Women (Parturient Microcirculation - Phase 1)|Completed||N/A|36|Actual|IWK Health Centre|||2||f||||||||||||||2017-10-11 03:29:54.639634|2017-10-11 03:29:54.639634
NCT01491672|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2016-06-02|2016-04-26||November 2011||2011-11-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|RECORD-4||Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma|An Open-label, Multicenter Phase II Study to Examine the Efficacy and Safety of Everolimus as Second-line Therapy in the Treatment of Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|134|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:29:54.73523|2017-10-11 03:29:54.73523
NCT01491659|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2013-09-23|||January 2013||2013-01-01|September 2013|2013-09-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate|A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate|Withdrawn||Phase 4|0|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:29:55.91759|2017-10-11 03:29:55.91759
NCT01491646|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2015-04-14|||November 2010||2010-11-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension|Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension|Completed||N/A|25|Actual|National Jewish Health|||2||f||||f||||||Samples Without DNA|"     plasma, serum   "|||2017-10-11 03:29:56.037369|2017-10-11 03:29:56.037369
NCT01491633|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-06-14|2014-05-14||September 2011||2011-09-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Dasatinib in Advanced Squamous Cell Lung Cancer|Phase II Trial of Dasatinib in Advanced (Stage IIIB/IV) Squamous Cell Lung Cancer|Terminated||Phase 2|5|Actual|Dana-Farber Cancer Institute|Due to the toxicity of the study agent no subjects were evaluable for response|1||Safety issues/concerns per DF/HCC PI|f||||t||||||||||2017-10-11 03:29:56.136394|2017-10-11 03:29:56.136394
NCT01491620|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2013-08-05|||November 2011||2011-11-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte|A Single-Center Prospective, Open-Label Study of the Excel V 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte|Completed||N/A|24|Actual|Cutera Inc.||1|||f||||f||||||||||2017-10-11 03:29:56.491027|2017-10-11 03:29:56.491027
NCT01491607|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-09-25|2013-07-11||November 2011||2011-11-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Participants 18 to 65 years of age who received all three doses of BioThrax within the allowable time window and had a blood sample collected for immunogenicity testing on Day 63 ± 2 days. Subjects with key protocol deviations that may have impacted assessment of immune response or sample testing (as determined by Sponsor) on Day 63 were excluded.|Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults|Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults|Completed||Phase 3|200|Actual|Emergent BioSolutions||1|||f||||f||||||||||2017-10-11 03:29:56.623453|2017-10-11 03:29:56.623453
NCT01491594|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2014-04-01|||April 2012||2012-04-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia|A Phase I/II Open-label Study of Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia (CIT) in Subjects With Advanced Soft Tissue and Bone Sarcomas Receiving Gemcitabine and Docetaxel Chemotherapy|Terminated||Phase 1|1|Actual|Duke University||1||Unable to accrue subjects to the study.|f||||f||||||||||2017-10-11 03:29:58.653964|2017-10-11 03:29:58.653964
NCT01491581|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-11-20|||December 2011||2011-12-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy of a Milk-based Nutrient-rich Bar on Nutritional Status and Cognitive Performance of School Children in Vietnam|Efficacy of a Milk-based Nutrient-rich Bar on Nutritional Status and Cognitive Performance of School Children in Vietnam|Completed||N/A|415|Actual|Institut de Recherche pour le Developpement||2|||f||||f||||||||||2017-10-11 03:29:58.771024|2017-10-11 03:29:58.771024
NCT01491568|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||July 2005||2005-07-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|May 2009|Actual|2009-05-01||Interventional|||rhBMP-2/CRM/CD HORIZON® Spinal System Pilot Study (2-Level)|Pilot Study of Recombinant Human Bone Morphogenetic Protein-2 and Compression Resistant Matrix With the CD HORIZON® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic DDD at Two Adjacent Vertebral Levels|Completed||Phase 1|29|Actual|Medtronic Spinal and Biologics||1|||f||||t||||||||||2017-10-11 03:29:58.887894|2017-10-11 03:29:58.887894
NCT01491555|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-03-23|||April 2012||2012-04-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|QED||Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy|Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy|Completed||N/A|73|Actual|Boston Children’s Hospital|||2||f||||f||||||||Undecided||2017-10-11 03:29:58.983772|2017-10-11 03:29:58.983772
NCT01491542|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||April 2003||2003-04-01|December 2011|2011-12-01|March 2007|Actual|2007-03-01|November 2006|Actual|2006-11-01||Interventional|||INFUSE® Bone Graft and MASTERGRAFT® Granules With CD HORIZON® for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease - Pilot Study|A Pilot Prospective Randomized Clinical Investigation of INFUSE® Bone Graft and MASTERGRAFT® Granules With the CD HORIZON® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic Degenerative Disc Disease|Completed||N/A|46|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-10-11 03:29:59.111478|2017-10-11 03:29:59.111478
NCT01491516|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||July 2003||2003-07-01|December 2011|2011-12-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|||TELAMON P™ Implant/INFUSE® Bone Graft/CD HORIZON® Spinal System Pilot Study|A Pilot, Prospective, Non-Randomized Clinical Investigation of TELAMON P™ Implant With INFUSE® Bone Graft and the CD HORIZON® Spinal System for Posterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease|Completed||Phase 1|30|Actual|Medtronic Spinal and Biologics||1|||f||||t||||||||||2017-10-11 03:29:59.570161|2017-10-11 03:29:59.570161
NCT01491503|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2013-04-04|||November 2011||2011-11-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|MOLZ||A Drug Interaction Study of Montelukast and Levocetirizine|Open Label, Randomized, 6-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Montelukast Sodium and Levocetirizine Dihydrochloride in Health Male Volunteers|Completed||Phase 1|30|Anticipated|Hanmi Pharmaceutical Company Limited||3|||f||||f||||||||||2017-10-11 03:29:59.664842|2017-10-11 03:29:59.664842
NCT01491490|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-09-09|2013-08-28||October 2011||2011-10-01|September 2014|2014-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|GWMD09126|Only two subjects of a planned 60 were randomised due to early termination of the study due to problems with recruitment.|Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine|A Randomised, Doubleblind,Placebo Controlled, Parallel Group, Pilot Study of 40:1 Ratio of Formulated GW42003 :GW42004 in the Treatment of Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine Treatment in Subjects With Functional Psychosis|Terminated||Phase 2|2|Actual|GW Research Ltd|Early termination due to low subject recruitment meant only two subjects were randomised; one to active and the other to placebo. Only safety data of these two subjects has been reported.|2||"The Chief Investigator and the Sponsor have concluded that it will not be possible to complete   the enrolment in any meaningful timeframe."|f||||f||||||||||2017-10-11 03:29:59.779885|2017-10-11 03:29:59.779885
NCT01491477|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||April 2002||2002-04-01|December 2011|2011-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||INFUSE ® Bone Graft/CORNERSTONE-SR® Allograft Ring/ATLANTIS® Anterior Cervical Plate System Pivotal Trial|Study of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the Cornerstone-SR™ Allograft Ring and the ATLANTIS™ Anterior Cervical Plate System in Treatment of Patients With Degenerative Cervical Disc Disease|Terminated||N/A|3|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-10-11 03:30:00.105162|2017-10-11 03:30:00.105162
NCT01491464|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||March 1999||1999-03-01|December 2011|2011-12-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Pivotal Study of rhBMP-2/ACS/INTER FIX™ Device for Posterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease|A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the INTER FIX™ Device for Posterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease|Terminated||N/A|67|Actual|Medtronic Spinal and Biologics||2|||f||||f||||||||||2017-10-11 03:30:00.189569|2017-10-11 03:30:00.189569
NCT01491451|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||February 1999||1999-02-01|December 2011|2011-12-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||A Pilot Study of rhBMP-2/ACS With the INTERFIX™ Device for the AnteriorLumbar Interbody Fusion in Patients With Degenerative Disc Disease|A Pilot Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the INTERFIX™ Device for the Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease|Completed||N/A|45|Actual|Medtronic Spinal and Biologics||2|||f||||f||||||||||2017-10-11 03:30:00.273702|2017-10-11 03:30:00.273702
NCT01491438|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2013-02-06|||November 2013||2013-11-01|December 2011|2011-12-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Plasma Rich Growth Factors in Venous Ulcers|Randomized Clinical Trial to Determinate the Effectiveness and Safety of Plasma Rich Growth Factors (PRGF) in Venous Ulcers Treatment|Unknown status|Not yet recruiting|N/A|214|Anticipated|Basque Health Service||2|||f||||||||||||||2017-10-11 03:30:00.380121|2017-10-11 03:30:00.380121
NCT01491425|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||November 1998||1998-11-01|December 2011|2011-12-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||A Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease|A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease|Completed||N/A|134|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-10-11 03:30:00.501273|2017-10-11 03:30:00.501273
NCT01491412|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2012-11-29|||December 2011||2011-12-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|||||Observational|||Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia|RECONNECT-S GAMMA : A Non-interventional Study to Observe Real-life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia|Completed||N/A|503|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:30:00.576579|2017-10-11 03:30:00.576579
NCT01491399|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||September 1999||1999-09-01|December 2011|2011-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||INFUSE™ BONE GRAFT/CORNERSTONE-SR™ Allograft Ring/ATLANTIS™ Anterior Cervical Plate- Pilot Study|Study of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the CORNERSTONE-SR™Allograft Ring and ATLANTIS™ Anterior Cervical Plate System in Treatment of Patients With Degenerative Cervical Disc Disease|Completed||N/A|33|Actual|Medtronic Spinal and Biologics||2|||f||||f||||||||||2017-10-11 03:30:02.398524|2017-10-11 03:30:02.398524
NCT01491386|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||August 1998||1998-08-01|December 2011|2011-12-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease|A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease|Completed||N/A|279|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-10-11 03:30:02.508279|2017-10-11 03:30:02.508279
NCT01491373|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-08-01|||January 1997||1997-01-01|December 2011|2011-12-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Pilot Study of rhBMP-2/ACS/LT-CAGE® for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease|A Feasibility Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease|Completed||N/A|14|Actual|Medtronic Spinal and Biologics||2|||f||||f||||||||||2017-10-11 03:30:02.628759|2017-10-11 03:30:02.628759
NCT01491360|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-04-25|||December 2013||2013-12-01|April 2014|2014-04-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||LaserACE® Procedure Restore Visual Function and Range of Accommodation LaserACE® Procedure|Evaluation of the Safety & Efficacy of the LaserACE® Procedure to Restore Visual Function and Range of Accommodation|Unknown status|Enrolling by invitation|Phase 3|146|Anticipated|ACE Vision Group, Inc.||1|||f||||f||||||||||2017-10-11 03:30:02.74634|2017-10-11 03:30:02.74634
NCT01491347|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-01-30|||November 2011||2011-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Brain Derived Neurotrophic Factor Serum Levels Evolution During the Six Months After Alcohol Withdrawal|Brain Derived Neurotrophic Factor Serum Levels Evolution During the Six Months Following After Alcohol Withdrawal in Alcohol-dependent Subjects in Relation to Abstinence|Completed||N/A|389|Actual|Centre Hospitalier Esquirol|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 03:30:02.880531|2017-10-11 03:30:02.880531
NCT01491334|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2014-02-24|||December 2011||2011-12-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Observational|VTI-03||Validation of Transvaginal Tactile Imaging|A Clinical Validation Study With Transvaginal Tactile Imaging|Completed||N/A|158|Actual|Artann Laboratories|||2||f||||f||||||||||2017-10-11 03:30:03.015634|2017-10-11 03:30:03.015634
NCT01491321|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-03-20|||April 2011||2011-04-01|March 2012|2012-03-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain|Clinical Trial to Evaluate the Efficacy of Bee Venom Acupuncture on Chronic Low Back Pain|Unknown status|Recruiting|Phase 2|54|Anticipated|Kyunghee University Medical Center||2|||f||||||||||||||2017-10-11 03:30:03.141086|2017-10-11 03:30:03.141086
NCT01491308|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2011-12-12|||January 2012||2012-01-01|December 2011|2011-12-01||||January 2013|Anticipated|2013-01-01||Interventional|||Restrictive Versus Liberal Red Cell Transfusion Strategy in Orthopedic-Oncology Patients Undergoing Surgery - a Randomized Controlled Study||Unknown status|Not yet recruiting|N/A|10|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 03:30:03.251242|2017-10-11 03:30:03.251242
NCT01491295|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2016-03-31|||September 2012||2012-09-01|March 2016|2016-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients|Randomized Trial of Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients Who Have Undergone Lamivudine/Adefovir Add-on Treatment|Recruiting||Phase 4|160|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-10-11 03:30:03.332383|2017-10-11 03:30:03.332383
NCT01491282|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-30|2011-12-11|||January 2011||2011-01-01|December 2011|2011-12-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Observational|||Study of the Effect of Vagus Nerve Stimulation on Human Brown Adipose Tissue Activity|Brown Adipose Tissue After Vagus Nerve Stimulation|Unknown status|Recruiting|N/A|5|Anticipated|Maastricht University|||1||f||||f||||||||||2017-10-11 03:30:03.6068|2017-10-11 03:30:03.6068
NCT01491269|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2011-12-11|||August 2009||2009-08-01|December 2011|2011-12-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Guided Internet-delivered Cognitive-behavioral Therapy for Former Chronic Pain Patients|Guided Internet-delivered Cognitive-behavioral Therapy for Former Chronic Pain Patients: Randomised Controlled Trial|Completed||N/A|72|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-11 03:30:03.716171|2017-10-11 03:30:03.716171
NCT01491243|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|NEW-MOON||N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy|Neutrophil gElatinase-associated Lipocalin alloWs Intensive treatMent Of cOntrast Induced Nephropathy in Patients With Urgent/Emergency Percutaneous Coronary Intervention|Not yet recruiting||Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 03:30:03.975293|2017-10-11 03:30:03.975293
NCT01491230|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2011-12-12|||December 2011||2011-12-01|December 2011|2011-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|NETs post HSCT||Neutrophil Extracellular Traps Formation Post-hematopoietic Stem Cell Transplantation|Neutrophil Extracellular Traps (NETs) Formation Post-hematopoietic Stem Cell Transplantation (HSCT) and Its Relation to Chemotaxis and Creation of Reactive Oxygen Species|Unknown status|Recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"     10cc of peripheral venous blood will be collected from each patient at several time points:     Before transplant, at neutrophil engraftment, 6 weeks, 3 months, 4 months, 6 months, 9     months, 1 year, 1.5 years, 2 years, and 3 years post-transplant, or until normalization of     NETs formation in 2 consecutive examinations.   "|||2017-10-11 03:30:04.06685|2017-10-11 03:30:04.06685
NCT01491009|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-12|||May 2006||2006-05-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|February 2007|Actual|2007-02-01||Interventional|||Comparison of Remifentanil With Dexmedetomidine or Midazolam in Regards of Sedation Effectivity and Postoperative Cognitive Functions in Cystoscopies||Completed||N/A|40|Actual|Gazi University||1|||f||||||||||||||2017-10-11 03:30:10.077595|2017-10-11 03:30:10.077595
NCT01491191|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2011-12-12|||January 2012||2012-01-01|December 2011|2011-12-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|PEAforCPSP||Palmitoylethanolamide for Post-operative Pain Prevention|Perioperative Use of Palmitoylethanolamide for Prevention of Chronic Postsurgical Pain in Patients Undergoing Elective Surgery.|Unknown status|Not yet recruiting|N/A|300|Anticipated|University of Modena and Reggio Emilia||2|||f||||f||||||||||2017-10-11 03:30:04.332771|2017-10-11 03:30:04.332771
NCT01491165|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2012-10-25|||December 2011||2011-12-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Safety and Efficacy of Stem Cell Transplantation for Treatment of Liver Cirrhosis|Safety and Efficacy of Umbilical Cord Mesenchyma Stem Cell Transplantation in Liver Cirrhosis Patients|Unknown status|Recruiting|Phase 2/Phase 3|75|Anticipated|General Hospital of Chinese Armed Police Forces||1|||f||||t||||||||||2017-10-11 03:30:05.632791|2017-10-11 03:30:05.632791
NCT01491152|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-03-06|||January 2012||2012-01-01|September 2013|2013-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pilot Study of Whole Body Vibration for Children With Cerebral Palsy (CP) From 12 Months of Age|Side-alternating Whole Body Vibration in Children With Cerebral Palsy (CP) From 12 Months of Age - Pilot Study|Completed||N/A|24|Actual|University of Cologne||2|||f||||t||||||||||2017-10-11 03:30:05.732553|2017-10-11 03:30:05.732553
NCT01491139|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2012-05-29||||||May 2012|2012-05-01||||||||Interventional|ORCA||Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck|A Phase I/II Study of Olaparib in Addition to Cisplatin Based Concurrent Chemoradiotherapy for Patients With High Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)|Withdrawn||Phase 1|0|Actual|University College, London||1||Study stopped due to issues surrounding development and formulation of olaparib|f||||t||||||||||2017-10-11 03:30:05.807455|2017-10-11 03:30:05.807455
NCT01491113|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-01-13|2013-11-21||November 2011||2011-11-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||The Baseline Analysis Population refers to the Pharmacokinetic Per Protocol Set (PK-PPS) which consists of all subjects included in the Safety Set (SS), who also had a sufficient number of bioanalytical assessments (plasma or urine) to calculate reliable estimates for the PK parameters.|Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients|Single-Dose Pharmacokinetics of Orally Administered Levetiracetam (LEV) in Japanese Subjects With Normal Renal Function and Various Degrees of Renal Impairment Using a Dosing Regimen Adjusted to Renal Function (250 mg or 500 mg)|Completed||Phase 4|30|Actual|UCB Pharma||5|||f||||f||||||||||2017-10-11 03:30:06.04531|2017-10-11 03:30:06.04531
NCT01491100|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2017-05-23|||April 30, 2012|Actual|2012-04-30|May 2017|2017-05-01|April 5, 2017|Actual|2017-04-05|December 22, 2016|Actual|2016-12-22||Observational|CogniPlus||Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis|Study Assessing Cognitive Performance Plus Physical Activity in Patients With Relapsing-Remitting MS Under Treatment With Betaferon®|Completed||N/A|1085|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:30:07.535569|2017-10-11 03:30:07.535569
NCT01491087|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2013-03-28|||December 2011||2011-12-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China|Safety of the DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM®) Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China|Completed||Phase 4|900|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:30:07.696719|2017-10-11 03:30:07.696719
NCT01491074|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-05-16|||August 2011||2011-08-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|||Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction|Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction - a Randomized, Double Blind, Placebo Controlled Study.|Completed||Phase 2|120|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 03:30:07.805131|2017-10-11 03:30:07.805131
NCT01491061|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-03-06|||January 2014||2014-01-01|March 2013|2013-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|TWILIGHT||Ranolazine Loading to Prevent PCI-induced Myocardial Injury|TWice overnIght High-dose ranoLazIne Pretreatment for preventinG Myocardial iscHemic Damage in Patients With Stable Angina Undergoing percuTaneous Coronary Intervention|Not yet recruiting||Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 03:30:07.915273|2017-10-11 03:30:07.915273
NCT01491048|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2011-12-09|||July 2009||2009-07-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|Artrhosis||Evaluation of Functional Rehabilitation in Patients Undergoing Physiotherapy After Total Hip Arthroplasty|Evaluation of Functional Rehabilitation Therapy in Patients Undergoing Physiotherapy After Total Hip Arthroplasty|Completed||N/A|104|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 03:30:08.016692|2017-10-11 03:30:08.016692
NCT01491035|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-02-08|2015-12-10||April 2012||2012-04-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder|An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder|Completed||Phase 2|48|Actual|H. Lundbeck A/S||8|||f||||t||||||||||2017-10-11 03:30:08.158294|2017-10-11 03:30:08.158294
NCT01491022|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-03-01|2016-03-02||July 2012||2012-07-01|March 2017|2017-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease|A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease|Completed||Phase 1/Phase 2|22|Actual|University of Miami||2|||f||||t||||||||Yes||2017-10-11 03:30:09.715807|2017-10-11 03:30:09.715807
NCT01490996|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2017-05-23|||February 2012||2012-02-01|May 2017|2017-05-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|CUFOX||Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer|A Phase I/IIa Study Combining Curcumin (Curcumin C3-Complex, Sabinsa) With Standard Care FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer.|Active, not recruiting||Phase 1/Phase 2|51|Anticipated|University of Leicester||2|||f||||t||||||||||2017-10-11 03:30:10.175399|2017-10-11 03:30:10.175399
NCT01490983|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-04-07|||April 2009||2009-04-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Telemonitoring Study - for Chronic Myeloid Leukemia (CML)|Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Nilotinib) Therapy|Completed||N/A|14|Actual|Rex Cancer Center, Raleigh, NC||2|||f||||f||||||||||2017-10-11 03:30:10.466009|2017-10-11 03:30:10.466009
NCT01490970|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2016-01-04|||April 2008||2008-04-01|January 2016|2016-01-01||||April 2018|Anticipated|2018-04-01||Observational|||Sarcoma Database at KFSH&RC|Sarcoma Database at KFSH&RC.|Recruiting||N/A|44|Anticipated|King Faisal Specialist Hospital & Research Center|||1||f||||t||||||||||2017-10-11 03:30:10.612007|2017-10-11 03:30:10.612007
NCT01490957|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2011-12-11|||March 2008||2008-03-01|December 2011|2011-12-01||||||||Observational|FACT-BMT||Functional Assessment of Cancer Therapy - Bone Marrow Transplant|Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)|Unknown status|Recruiting|N/A|113|Anticipated|King Faisal Specialist Hospital & Research Center|||1||f||||t||||||||||2017-10-11 03:30:10.710119|2017-10-11 03:30:10.710119
NCT01490944|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2012-02-25|||January 2012||2012-01-01|January 2012|2012-01-01|January 2013|Anticipated|2013-01-01|November 2012|Anticipated|2012-11-01||Interventional|||Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls|Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls|Unknown status|Recruiting|Phase 2|360|Anticipated|Indian Council of Medical Research||2|||f||||t||||||||||2017-10-11 03:30:10.815511|2017-10-11 03:30:10.815511
NCT01490931|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2014-04-11|2014-02-24||November 2011||2011-11-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Pilot Study. No power analysis performed.|Intranasal Ketorolac for Postsurgical Pain in Dental Implant Patients|Single-dose and Multi-dose Open-label Pilot Trial of the Analgesic Efficacy and Tolerability of Intranasal Ketorolac Tromethamine (SPRIX®) in Dental Implant Surgery Patients With Postoperative Pain.|Completed||Phase 4|28|Actual|Hersh, Elliot V., DMD, MS, PhD|The major weakness of this study was its open-label design and lack of a placebo control and an active comparator drug. The study was also not powered to determine differences between the sites of implant placement and the number of implants placed.|1|||f||||t||||||||||2017-10-11 03:30:10.944173|2017-10-11 03:30:10.944173
NCT01490918|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-09-11|||April 2012||2012-04-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients|A Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Acarbose Added on Top of Metformin and Sitagliptin Combination Treatment in Type 2 Diabetes Mellitus Patients|Completed||Phase 3|165|Anticipated|The Catholic University of Korea||3|||f||||t||||||||||2017-10-11 03:30:11.451853|2017-10-11 03:30:11.451853
NCT01490905|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-12-09|||September 2010||2010-09-01|December 2011|2011-12-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain|A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain|Completed||Phase 4|127|Actual|Targeted Medical Pharma||3|||f||||t||||||||||2017-10-11 03:30:11.568114|2017-10-11 03:30:11.568114
NCT01490892|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-04-24|||November 2011||2011-11-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Quantitative Subharmonic Breast Imaging|Quantitative Subharmonic Breast Imaging|Active, not recruiting||Phase 4|236|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 03:30:11.691086|2017-10-11 03:30:11.691086
NCT01490879|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-11|2014-04-29|||July 2012||2012-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|DUNE||A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)|A Randomized, Prospective, Double-blind, Vehicle-controlled, Dose-ranging, Multi-center Study to Assess the Safety and Clinical Effect of Nexagon® in the Treatment of Subjects With a Diabetic Foot Ulcer|Completed||Phase 2|168|Actual|CoDa Therapeutics Inc.||4|||f||||t||||||||||2017-10-11 03:30:11.809672|2017-10-11 03:30:11.809672
NCT01490866|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-11-15|2016-09-21||January 2012||2012-01-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)|A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)|Completed||Phase 2|70|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 03:30:11.984588|2017-10-11 03:30:11.984588
NCT01490853|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2014-12-02|||October 2009||2009-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|January 2012|Actual|2012-01-01||Observational|||Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy|Long Term Follow-up of Ph+ CML Patients Achieving Complete Cytogenetic Remission With Interferon Based Therapy|Completed||N/A|116|Actual|Università degli Studi di Brescia|||1||f||||t||||||||||2017-10-11 03:30:12.579006|2017-10-11 03:30:12.579006
NCT01490840|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-04-07|2015-07-10||November 2011||2011-11-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|PACE||Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis|A 6-month, Multicenter, Randomized, Controlled Parallel Group Study to Evaluate the Effect of Physical Training on Fatigue in Patients With Relapsing-remitting Multiple Sclerosis Treated With Fingolimod, Followed by a 6 Month Optional Extension Phase|Terminated||Phase 4|178|Actual|Novartis||2||The study stopped due to slow enrollment and low participant compliance.|f||||||||||||||2017-10-11 03:30:12.684315|2017-10-11 03:30:12.684315
NCT00005425|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1992||1992-09-01|April 2001|2001-04-01|February 1995|Actual|1995-02-01|||||Observational|||Statistical Analysis of Vlagtwedde-Vlaardingen Data Set||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.909931|2017-10-11 04:27:02.909931
NCT01490801|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2016-05-13|||December 2011||2011-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma|Role of the IL-2 Inducible Tcell Kinase in EBV-HLH and EBV+ Hodgkin's Lymphoma|Completed||N/A|50|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Blood and Tissue   "|||2017-10-11 03:30:13.88511|2017-10-11 03:30:13.88511
NCT01490775|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2017-04-10|||April 2009||2009-04-01|April 2017|2017-04-01|June 1, 2017|Anticipated|2017-06-01|February 12, 2015|Actual|2015-02-12||Interventional|||Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy|Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Nilotinib)Therapy|Active, not recruiting||N/A|48|Anticipated|Rex Cancer Center, Raleigh, NC||2|||f||||f||||||||||2017-10-11 03:30:14.09068|2017-10-11 03:30:14.09068
NCT01490762|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-09-05|||December 2011||2011-12-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler|A Phase 1, Open-label, Randomized, Crossover Design Clinical Trial in Healthy Normal Volunteers to Evaluate Insulin Exposure and Effect Following Inhalation of Technosphere® Insulin Inhalation Powder at Multiple Doses Using the Gen2C Inhaler|Completed||Phase 1|35|Actual|Mannkind Corporation||2|||f||||f||||||||||2017-10-11 03:30:14.220392|2017-10-11 03:30:14.220392
NCT01490749|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-03-13|||February 2012||2012-02-01|March 2017|2017-03-01|May 2019|Anticipated|2019-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer|Phase I/IIB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy and Dose Escalation of RAD001 in Patients With Esophageal Cancer|Active, not recruiting||Phase 1|17|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:30:14.320125|2017-10-11 03:30:14.320125
NCT01490736|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2013-07-23|||December 2011||2011-12-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne|Phase 1/2 Study of Photodynamic Therapy (PDT) With Lemuteporfin Topical Solution (LTS) in Healthy Volunteers and in Subjects With Mild Acne|Completed||Phase 1/Phase 2|129|Actual|Dermira, Inc.||1|||f||||f||||||||||2017-10-11 03:30:14.422606|2017-10-11 03:30:14.422606
NCT01490723|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-04-14|||January 2013|Actual|2013-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)|Dose-Intense Yttrium-90 Ibritumomab Tiuxetan (Zevalin)-Containing Non-Myeloablative Conditioning for Allogeneic Stem Cell Transplantation in B-cell Malignancies|Active, not recruiting||Phase 2|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:30:14.505209|2017-10-11 03:30:14.505209
NCT01490710|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2013-09-02|||November 2011||2011-11-01|September 2013|2013-09-01||||||||Interventional|||NAVADYN11 : Hemodynamic Impact of a New Ventilatory Support Mode With Diaphragmatic Synchronization|NAVADYN11 : Hemodynamic Impact of a New Ventilatory Support Mode With Diaphragmatic Synchronization|Terminated||N/A|9|Actual|Nantes University Hospital|||||f||||f||||||||||2017-10-11 03:30:14.647703|2017-10-11 03:30:14.647703
NCT01490697|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-05-26|2017-04-06||March 2009|Actual|2009-03-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All randomized participants included in the analysis. 3 participants did not meet PTSD diagnostic criteria and are excluded.|Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments|Developing Memory Reconsolidation Blockers as Novel PTSD Treatments|Completed||Phase 4|34|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:30:14.753001|2017-10-11 03:30:14.753001
NCT01490684|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2012-08-13|||August 2012||2012-08-01|August 2012|2012-08-01|January 2014|Anticipated|2014-01-01|July 2013|Anticipated|2013-07-01||Observational|ICIP-SA||Invasive Candidiasis in ICU|Invasive Candidiasis in Critically Ill Patients in Saudi Arabia: A Prospective Cohort Study|Unknown status|Recruiting|N/A|170|Anticipated|King Abdulaziz Medical City|||1||f||||f||||||||||2017-10-11 03:30:15.06339|2017-10-11 03:30:15.06339
NCT01490671|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-05-01||||||May 2015|2015-05-01||||August 2015|Anticipated|2015-08-01||Interventional|||Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women|Phase 2 Expanded Safety Study of Tenofovir Gel in Pregnancy|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||t||||||||||2017-10-11 03:30:15.156748|2017-10-11 03:30:15.156748
NCT01490658|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-02-09|||June 2006||2006-06-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers|A Randomized, Single-Blind, Three-Period Crossover Study Examining the Single Dose Pharmacokinetics of Concomitantly Administered Repaglinide and Metformin Versus Combination Tablet Dosing (NN4440) in Fed Healthy Volunteers|Completed||Phase 1|93|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:30:15.26211|2017-10-11 03:30:15.26211
NCT01490645|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-09-04|||December 2011||2011-12-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|ProAcor||A NIS Registry of the Prospective Structured Care In Acute Coronary Syndrome|ProAcor: Prospective Structured Care In Acute Coronary Syndrome Registry|Completed||N/A|1006|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:30:15.365821|2017-10-11 03:30:15.365821
NCT01490632|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2017-06-19|2017-03-10|2013-01-11|December 2011||2011-12-01|June 2017|2017-06-01|August 2014|Actual|2014-08-01|December 2012|Actual|2012-12-01||Interventional||All randomized participants who received at least one dose of study drug.|A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase 2b Study of Baricitinib in Patients With Moderate-to-Severe Plaque Psoriasis|Completed||Phase 2|271|Actual|Eli Lilly and Company||5|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 03:30:15.593427|2017-10-11 03:30:15.593427
NCT01490619|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2017-07-20|||October 2011||2011-10-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|||Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes|Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes|Active, not recruiting||N/A|280|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 03:30:18.532196|2017-10-11 03:30:18.532196
NCT01490606|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2012-03-02|||January 2012||2012-01-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|OA||Knee Osteoarthritis (OA) Project Treatment Versus Conventional Physical Therapy in the Treatment of Knee OA Patients|A Comparative, Non Randomized Trial of Knee Osteoarthritis (OA) Project Treatment Versus Conventional Physical Therapy in the Treatment of Knee OA Patients|Unknown status|Recruiting|N/A|60|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-10-11 03:30:18.641139|2017-10-11 03:30:18.641139
NCT01490593|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-12-09|||February 2011||2011-02-01|December 2011|2011-12-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|CEIR||Canadian Eye Injury Registry|Canadian Eye Injury Registry|Unknown status|Recruiting|N/A|2500|Anticipated|Lawson Health Research Institute|||1||f||||t||||||||||2017-10-11 03:30:18.770644|2017-10-11 03:30:18.770644
NCT01490580|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-09-14|||May 2012||2012-05-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|August 2016|Actual|2016-08-01||Interventional|PRETTINEO||Premedication Trial for Tracheal Intubation of the NEOnate|"Double Blind Randomized Controlled Trial Comparing Atropine+Propofol Versus Atropine+Atracurium+Sufentanil as a Premedication Prior to Semi-urgent or Elective Endotracheal Intubation of Term and Preterm Newborns"|Active, not recruiting||Phase 2/Phase 3|173|Actual|Centre Hospitalier Intercommunal Creteil||2|||f||||t||||||||Undecided||2017-10-11 03:30:18.873409|2017-10-11 03:30:18.873409
NCT01490567|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2011-12-09|||June 2011||2011-06-01|December 2011|2011-12-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia|Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia|Unknown status|Recruiting|Phase 4|80|Anticipated|Central South University||2|||f||||t||||||||||2017-10-11 03:30:18.990039|2017-10-11 03:30:18.990039
NCT01490554|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2012-07-23|||March 2007||2007-03-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|March 2011|Actual|2011-03-01||Interventional|||Autologous Fibroblast Grafts in Facial Skin Regeneration|Effectiveness of Autologous Fibroblast Grafts in the Regeneration of Facial Ectoderm|Unknown status|Active, not recruiting|N/A|20|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 03:30:19.107571|2017-10-11 03:30:19.107571
NCT01490541|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-06-22|||October 2011||2011-10-01|June 2012|2012-06-01|October 2017|Anticipated|2017-10-01|December 2012|Anticipated|2012-12-01||Observational|||The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population||Unknown status|Recruiting|N/A|280|Anticipated|King Chulalongkorn Memorial Hospital|||1||f||||f||||||||||2017-10-11 03:30:19.327454|2017-10-11 03:30:19.327454
NCT01490528|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2011-12-12|||January 2012||2012-01-01|December 2011|2011-12-01||||||||Observational|||Durability and Tolerability of Infliximab in Pediatric Inflammatory Bowel Disease Patients: A 10 Year Single Center Experience||Unknown status|Not yet recruiting|N/A|200|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||||||2017-10-11 03:30:19.431444|2017-10-11 03:30:19.431444
NCT01490515|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2013-12-13|||April 2010||2010-04-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Embryo Selection Using Non-invasive Metabolomic Analysis Versus Morphology|Embryo Selection Using Non-invasive Metabolomic Analysis Indicates Improvement in Implantation Rates With Fetal Cardiac Activity|Completed||Phase 4|125|Actual|Eugonia||2|||f||||f||||||||||2017-10-11 03:30:19.524879|2017-10-11 03:30:19.524879
NCT01490502|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-09-27|||March 2012||2012-03-01|September 2017|2017-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Vitamin D Supplementation in Multiple Sclerosis|A Randomized Controlled Trial of Vitamin D Supplementation in Multiple Sclerosis|Recruiting||Phase 3|172|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 03:30:19.630455|2017-10-11 03:30:19.630455
NCT01490489|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-02-05|||July 2011||2011-07-01|February 2015|2015-02-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|EGEVE||EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction|EG-VEGF (Endocrine Gland-derived Vascular Endothelial Growth Factor) in Normal and Pathological Pregnancies: Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction|Unknown status|Recruiting|N/A|500|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||f||||||||||2017-10-11 03:30:19.868588|2017-10-11 03:30:19.868588
NCT01490476|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-05-22|||January 2012||2012-01-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|April 2016|Actual|2016-04-01||Interventional|AFINF2||Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients|A Single Arm, Single Center, Phase II Trial of RAD001 as Monotherapy in the Treatment of Neurofibromatosis Type 2 - Related Vestibular Schwannoma|Completed||Phase 2|10|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 03:30:19.992052|2017-10-11 03:30:19.992052
NCT01490463|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2013-01-28|||August 2011||2011-08-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|LESUIA||Brain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms|Brain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms: Incidence and Influence on Clinical Outcome in a Prospective Study.|Completed||N/A|||Johann Wolfgang Goethe University Hospital|||1||f||||||||||||||2017-10-11 03:30:20.174068|2017-10-11 03:30:20.174068
NCT01490450|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-09-13||2015-07-24|December 2011||2011-12-01|September 2017|2017-09-01|June 2015|Actual|2015-06-01|June 2013|Actual|2013-06-01||Interventional|||Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging, Multi-Center Study to Evaluate the Efficacy and Safety of BMS-945429 Subcutaneous Injection in Adults With Active Psoriatic Arthritis|Completed||Phase 2|165|Actual|Vitaeris INC||4|||f||||t||||||||||2017-10-11 03:30:20.269348|2017-10-11 03:30:20.269348
NCT01490437|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-09-22|||July 2008||2008-07-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PECULIAR||Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma|A Prospective Phase 2 Study of PEmetrexed in Combination With Cisplatin in Patients With Advanced UrotheLIal CAnceR|Completed||Phase 2|42|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:30:20.559457|2017-10-11 03:30:20.559457
NCT01490424|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-12|2011-12-12|||May 2010||2010-05-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||TREM-1 Gene Polymorphisms|Association Between TREM-1 Gene Polymorphisms and Prognosis in Sepsis Patient|Completed||N/A|160|Actual|Chinese PLA General Hospital|||2||f||||f||||||||||2017-10-11 03:30:20.660188|2017-10-11 03:30:20.660188
NCT01490411|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2014-01-23|||October 2010||2010-10-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|||Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis|A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Investigate the Relative Efficacy and Safety of Immunotherapy With rBet v1-FV Compared to Placebo in Birch Pollen-Allergic Patients With IgE-Mediated Seasonal Allergic Rhinoconjunctivitis|Completed||Phase 2|37|Actual|Allergopharma GmbH & Co. KG||5|||f||||t||||||||||2017-10-11 03:30:20.748082|2017-10-11 03:30:20.748082
NCT01490398|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-09|2014-05-08|||December 2011||2011-12-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|RESERVE||Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve|Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients|Completed||Phase 4|56|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:30:20.856295|2017-10-11 03:30:20.856295
NCT01490385|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2013-12-15|||July 2011||2011-07-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Effect of Light Emitting Diode Phototherapy on the Rate of Orthodontic Tooth Movement - A Clinical Study|The Effect of Light Emitting Diode Phototherapy on the Rate of Orthodontic Tooth Movement - A Clinical Study|Completed||N/A|11|Actual|University of Toronto||2|||f||||t||||||||||2017-10-11 03:30:20.941101|2017-10-11 03:30:20.941101
NCT01490372|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-12-22|||August 2011||2011-08-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Observational|DG3||Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring|Is Gestational Diabetes Mellitus (GDM) an Independent Risk Factor for Cardiometabolic Syndrome in Offspring?|Completed||N/A|41|Actual|Université de Sherbrooke|||2||f||||f||||||||||2017-10-11 03:30:21.010575|2017-10-11 03:30:21.010575
NCT01490346|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-06-01|||September 2008||2008-09-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Tissue Drug Levels of HIV Medications|A Compartmental Analysis of HIV Reservoirs and Immune Reconstitution|Completed||N/A|22|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     Blood & lymphatic tissue.   "|||2017-10-11 03:30:21.178792|2017-10-11 03:30:21.178792
NCT01490333|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-11-19|||July 2011||2011-07-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Sunweavers: Supporting Native American Women's Vitamin D Research|Sunweavers: Supporting Native American Women's Vitamin D Research|Completed||Phase 2|99|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 03:30:21.25374|2017-10-11 03:30:21.25374
NCT01490320|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2011-12-08|||June 2010||2010-06-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The Effect of Primary Care Interventions on Children's Media Viewing Habits and Exposure to Violence|The Effect of Primary Care Interventions on Children's Media Viewing Habits and Exposure to Violence|Completed||N/A|336|Actual|Vanderbilt University||3|||f||||f||||||||||2017-10-11 03:30:21.338873|2017-10-11 03:30:21.338873
NCT01490307|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-12-08|||February 2006||2006-02-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|January 2010|Actual|2010-01-01||Interventional|PAL-2||A Family Intervention for Adolescent Problem Behavior (AKA Project Alliance 2)|A Family Intervention for Adolescent Problem Behavior|Completed||N/A|593|Actual|University of Oregon||2|||f||||t||||||||||2017-10-11 03:30:21.433868|2017-10-11 03:30:21.433868
NCT01490294|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-05-20|2011-12-23||March 2004||2004-03-01|May 2014|2014-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Myocardial Perfusion MRI|Multicenter, Double Blind, Randomized Dose Finding Study in Myocardial Perfusion MRI With Gadavist®1.0|Completed||Phase 2|232|Actual|Bayer|Study designed for perfusion imaging, not optimized for delayed enhancement. Routine SPECT selected as standard of reference (SoR) despite known quality limitations.|4|||f||||f||||||||||2017-10-11 03:30:21.606766|2017-10-11 03:30:21.606766
NCT01490281|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-01-07|||November 2011||2011-11-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Exercise in Women With Fibromyalgia|Land- and Water-Based Exercise Intervention in Women With Fibromyalgia: The Al-Andalus Physical Activity Randomised Control Trial|Completed||Phase 2|180|Actual|Universidad de Granada||3|||f||||t||||||||||2017-10-11 03:30:24.634179|2017-10-11 03:30:24.634179
NCT01490268|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-12-05|||November 2011||2011-11-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PKPDHM-001||Pain Therapy After Elective Cardiac Surgery|Pharmacokinetic-pharmacodynamic Modeling of the Postoperative Pain Sensation During Patient-controlled Analgesia With Target-controlled Infusion of Hydromorphone, Taking Into Account the Interaction With Intraoperatively Administered Sufentanil for Elective Cardiac Surgery|Completed||Phase 4|50|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-11 03:30:24.729806|2017-10-11 03:30:24.729806
NCT00005426|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||May 1993||1993-05-01|December 2000|2000-12-01|December 1994|Actual|1994-12-01|||||Observational|||Effects of CHD Prevention on Lipoprotein Subclasses||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:02.995539|2017-10-11 04:27:02.995539
NCT01490255|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2014-03-23|||January 2012||2012-01-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|ROMAN||Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity|Comparison of the Pharmacodynamic Effects of RanOlazine Versus aMlodipine on Platelet Reactivity in Stable Patients With Coronary Artery Disease Treated With Dual ANtiplatelet Therapy - The ROMAN Randomized Study|Unknown status|Recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 03:30:24.809711|2017-10-11 03:30:24.809711
NCT01490229|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-03-06|||January 2013||2013-01-01|March 2013|2013-03-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|ECLIPSE||Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients|Randomized Trial of Ezetimibe Versus nutraCeuticals in Statin-intoLerant patIents Treated With PercutaneouS Coronary Intervention|Unknown status|Recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 03:30:26.855275|2017-10-11 03:30:26.855275
NCT01490216|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-11-12|||July 2011||2011-07-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence|Open-Label Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence|Completed||Phase 1/Phase 2|5|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-11 03:30:26.979322|2017-10-11 03:30:26.979322
NCT01490203|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2016-08-10|||December 2011||2011-12-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|February 2014|Actual|2014-02-01||Observational|LiFE||Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma|Pre-Surgical Treatment or Radio Frequency Ablation (RFA) Evaluation of Future Remnant Liver Function Using Gd-EOB-DTPA Enhanced MRI in Patients Undergoing Hepatic Resection /RFA for Hepatocellular Carcinoma|Active, not recruiting||N/A|71|Actual|Seoul National University Hospital|||2||f||||t||||||||No||2017-10-11 03:30:27.059381|2017-10-11 03:30:27.059381
NCT01490190|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-05-17|2013-11-25||December 26, 2011|Actual|2011-12-26|May 2017|2017-05-01|December 5, 2012|Actual|2012-12-05|December 5, 2012|Actual|2012-12-05||Interventional|||Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)|Contraceptive Vaginal Ring Releasing Etonogestrel and Ethinylestradiol (NuvaRing): Cycle Control, Acceptability and Tolerability Study in Indian Women|Completed||Phase 4|252|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:30:27.206891|2017-10-11 03:30:27.206891
NCT01490177|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-11-24|||November 2011||2011-11-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Single Center Food Allergy Oral Immunotherapy Study|Single Center, Phase I Food Allergy Oral Immunotherapy Study|Completed||Phase 1|50|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 03:30:29.203858|2017-10-11 03:30:29.203858
NCT01490164|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-11-12|||August 2009||2009-08-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Observational|||Transfusion Requirements During Spinal Surgery for Severe Scoliosis|An Observational Prospective Study of Transfusion Requirements During Spinal Surgery for Severe Scoliosis|Completed||N/A|50|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-10-11 03:30:29.287517|2017-10-11 03:30:29.287517
NCT01490151|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-08-31|2017-01-05||December 2011||2011-12-01|August 2017|2017-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Subjects with Type 1 Diabetes|Medtronic Treat to Range (TTR) Closed-Loop Control|Medtronic Treat to Range (TTR) Closed-Loop Control: Tuning a Treat-to-Range Controller for the Effects of High and Low Glycemic Index Meals|Completed||N/A|22|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 03:30:29.374252|2017-10-11 03:30:29.374252
NCT01490138|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2011-12-09|||January 2012||2012-01-01|December 2011|2011-12-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Observational|||Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)|Investigation of the Clinical Relevance of Serial Concentrations of β-D-Glucan Tests in the Patients With Invasive Fungal Infection|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Ruijin Hospital|||1||f||||t||||||||||2017-10-11 03:30:29.618879|2017-10-11 03:30:29.618879
NCT01490125|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2013-11-05|2013-08-09||October 2011||2011-10-01|November 2013|2013-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|BLAZE|One misrandomized participant did not receive study treatment, was discontinued and not included in the full analysis set used for demographics.|The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Multicenter, Randomized, Blinded, Double-dummy, Placebo-controlled, 3-period Cross-over Study to Evaluate the Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control|Completed||Phase 3|247|Actual|Novartis||3|||f||||f||||||||||2017-10-11 03:30:29.722505|2017-10-11 03:30:29.722505
NCT01490112|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-10-26|||January 2005||2005-01-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Surveillance Study of NovoRapid® for New Drug Re-examination|Regulatory Post Marketing Surveillance Study of NovoRapid for New Drug Re-examination|Completed||Phase 4|1239|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:30:30.836161|2017-10-11 03:30:30.836161
NCT01490099|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-02-05|||August 2006||2006-08-01|February 2016|2016-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects|A Randomised, Single Centre, Double-blind, Two-period Cross-over Glucose Clamp Trial to Demonstrate Bioequivalence Between Insulin Detemir Produced by the NN729 Process and Insulin Detemir Produced by the Current Process in Healthy Subjects|Completed||Phase 1|37|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:30:30.980966|2017-10-11 03:30:30.980966
NCT01490086|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2015-01-20|2015-01-12||December 2011||2011-12-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|REFRESH|The Baseline Analysis Population is the Safety Population (Total 233), which comprises all enrolled subjects (Total 234) who received at least one dose of study treatment. One Placebo subject was enrolled in the study but did not receive any study treatment.|RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder|REFRESH : Randomized Double-blind, Placebo-controlled, Multicenter Trial to Assess the Safety and Efficacy of RP5063 in Subjects With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder|Completed||Phase 2|234|Actual|Reviva Pharmaceuticals||5|||f||||t||||||||||2017-10-11 03:30:31.127825|2017-10-11 03:30:31.127825
NCT01490073|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-02-04|||December 2011||2011-12-01|February 2013|2013-02-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||The Effect of Nitroglycerin on the Intrauterine Device (IUD) Insertion Experience in Nulliparous Women|The Effect of Nitroglycerin on the IUD Insertion Experience in Nulliparous Women: a Pilot Study|Unknown status|Recruiting|N/A|24|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 03:30:32.686517|2017-10-11 03:30:32.686517
NCT01490060|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-03-11|2015-03-20||May 2012||2012-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Fosaprepitant in Patients Receiving Ifosfamide-based Regimen|Evaluation of Fosaprepitant's Effect on Drug Metabolism in Sarcoma Patients Receiving Ifosfamide-based Multi-day Chemotherapy Regimen|Completed||N/A|47|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 03:30:32.892012|2017-10-11 03:30:32.892012
NCT01490047|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-06-15|||January 2013||2013-01-01|June 2015|2015-06-01||||||||Interventional|||Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas|Phase I Trial of Intravenous Recombinant Human TNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas|Withdrawn||Phase 1|0|Actual|Ludwig Institute for Cancer Research||7|||f||||t||||||||||2017-10-11 03:30:33.526984|2017-10-11 03:30:33.526984
NCT01490034|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-10-14|||September 2011||2011-09-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Learning and Food Form on Intake in Humans|Effects of Learning and Food Form on Intake in Humans|Completed||N/A|120|Anticipated|Purdue University||4|||f||||f||||||||||2017-10-11 03:30:33.695428|2017-10-11 03:30:33.695428
NCT01490021|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2013-05-14|||December 2011||2011-12-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Influence of Repetitive Transcranial Magnetic Stimulation (rTMS) Challenge on Cognitive and Functional Magnetic Resonance Imaging Markers in Healthy Subjects|Influence of Repetitive Transcranial Magnetic Stimulation (rTMS) Challenge on Cognitive and Functional Magnetic Resonance Imaging Markers in Healthy Subjects|Terminated||N/A|14|Actual|Qualissima||2||"Study stopped for scientific reasons. Another study with a new design is in course of   authorization and implementation"|f||||f||||||||||2017-10-11 03:30:33.816573|2017-10-11 03:30:33.816573
NCT01490008|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2012-04-18|||December 2011||2011-12-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers|An Open-label, Single-center Triqal to Evaluate Systemic Exposure of Catechins From Commercially Available, Topically Applied Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers|Completed||Phase 1|30|Actual|MediGene||2|||f||||f||||||||||2017-10-11 03:30:33.933062|2017-10-11 03:30:33.933062
NCT01489995|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2013-12-17|||October 2011||2011-10-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Migalastat Food Effect Study|A Randomized, Open-Label, 5-Period Crossover Study to Evaluate the Effect of Meal Type and Timing on the Pharmacokinetics of Migalastat Hydrochloride in Healthy Volunteers.|Completed||Phase 1|20|Actual|Amicus Therapeutics||5|||f||||f||||||||||2017-10-11 03:30:34.040795|2017-10-11 03:30:34.040795
NCT01489982|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-04-15|||January 2011||2011-01-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Treatments for Insomnia in Patients With Parkinson's Disease|Treatments for Insomnia in Patients With Parkinson's Disease: A Pilot Study|Completed||Early Phase 1|20|Actual|McGill University Health Center||4|||f||||||||||||||2017-10-11 03:30:34.171585|2017-10-11 03:30:34.171585
NCT01489969|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-07-15|||December 2011||2011-12-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|May 2012|Actual|2012-05-01||Interventional|||Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients|A Double-blind, Parallel Group, Randomized, Placebo Controlled Sleep Laboratory Study of Efficacy and Safety of Neu-P11 in Insomnia Patients Aged 18-80|Completed||Phase 2|137|Actual|Neurim Pharmaceuticals Ltd.||3|||f||||f||||||||||2017-10-11 03:30:34.310275|2017-10-11 03:30:34.310275
NCT01489956|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-03-11|2015-12-24||December 2011||2011-12-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Enrolled Sample|A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)|Pilot Study to Determine the Immunogenicity of Immucothel® and Oral Tolerance Induction With Biosyn Native KLH in Healthy Subjects (ITN047AI)|Terminated||Early Phase 1|19|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Data from 4 of the 5 evaluable subjects in Part B was negative for tolerance to KLH as defined by a stimulation index <3 on day 42 after booster immunization. The study was terminated. Data were not collected and no analyses were performed.|3||Due to futility, identified after 5 subjects completed treatment in Part B|f||||t||||||||||2017-10-11 03:30:34.449123|2017-10-11 03:30:34.449123
NCT01489943|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-07-24|||September 19, 2011|Actual|2011-09-19|July 2017|2017-07-01|November 10, 2011|Actual|2011-11-10|November 10, 2011|Actual|2011-11-10||Interventional|||A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects|A Single Centre, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 03:30:35.154596|2017-10-11 03:30:35.154596
NCT01489930|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2011-12-09|||May 2008||2008-05-01|December 2011|2011-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effects of Resistance and Endurance Training on Synthesis of Individual Muscle Proteins in Young and Older Adults|Effects of Resistance and Endurance Training on Synthesis of Individual Muscle Proteins in Young and Older Adults|Completed||N/A|67|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 03:30:35.273239|2017-10-11 03:30:35.273239
NCT01489917|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2012-05-07|||May 2009||2009-05-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|PHARAOH||A-priori Versus Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis|Comparison of A-priori Versus Provisional Heparin Therapy on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis|Completed||N/A|428|Actual|Laval University||2|||f||||f||||||||||2017-10-11 03:30:35.386939|2017-10-11 03:30:35.386939
NCT01489748|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2015-02-18|||March 2012||2012-03-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Observational|CAPPS||Canadian Avonex PEN Productivity Study|An Open-Label, Observational, Multicenter Study to Evaluate the Impact of AVONEX PEN Autoinjector Therapy on Work Capacity of Multiple Sclerosis Patients in Canada|Completed||N/A|111|Actual|Biogen|||1||f||||f||||||||||2017-10-11 03:30:39.71672|2017-10-11 03:30:39.71672
NCT01489904|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2012-10-28|||November 2011||2011-11-01|October 2012|2012-10-01|November 2012|Anticipated|2012-11-01|November 2011|Actual|2011-11-01||Interventional|||Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy|Phase 2/3 Application of Botulinum Neurotoxin Type A in Salivary Glands as a Treatment of Chronic Drooling in Patients With Cerebral Palsy: A Controlled Clinical Trial.|Unknown status|Active, not recruiting|Phase 2/Phase 3|60|Anticipated|Hospital Vall d'Hebron||2|||f||||t||||||||||2017-10-11 03:30:35.511124|2017-10-11 03:30:35.511124
NCT01489891|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-03|2013-03-07|2012-10-29||December 2011||2011-12-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Usefulness of Lidocaine as Topical Pharyngeal Anaesthesia in Esophagogastroduodenoscopy Under Sedation With Propofol|Usefulness of Applying Lidocaine as Topical Pharyngeal Anaesthesia in Esophagogastroduodenoscopies Performed Under Sedation With Propofol- a Randomized Controlled Trial|Completed||Phase 4|120|Actual|Hospital Universitario Infanta Cristina|Unicenter study|2|||f||||t||||||||||2017-10-11 03:30:35.625009|2017-10-11 03:30:35.625009
NCT01489878|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2013-01-23|||March 2010||2010-03-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|StaphMRG||Antibiotics Use and Carriage of Methicillin-resistant Staphylococci in Community Patients|Impact of Ambulatory Antibiotics Use on Nasal Carriage of Methicillin-resistant Staphylococci in Community Patients : the StaphMRG Study|Completed||N/A|571|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||Samples Without DNA|"     Three samples of nasal flora should be obtained for each included patient: (i) the first one     before antibiotic exposure (at inclusion, by the patient's GP) (ii) the second and third ones     at the GP's office at the end and 23 to 45 days after the termination of antibiotherapy,     respectively.   "|||2017-10-11 03:30:36.112325|2017-10-11 03:30:36.112325
NCT01489865|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-03-30|||February 2011||2011-02-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer|A Phase I/II Study of ABT-888 in Combination With 5-fluorouracil and Oxaliplatin (Modified FOLFOX-6) in Patients With Metastatic Pancreatic Cancer|Recruiting||Phase 1/Phase 2|79|Anticipated|Georgetown University||1|||f||||t||||||||No||2017-10-11 03:30:36.222231|2017-10-11 03:30:36.222231
NCT01489852|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2011-12-09|||December 2006||2006-12-01|December 2011|2011-12-01|May 2011|Actual|2011-05-01|July 2010|Actual|2010-07-01||Interventional|||Estrogen Pretreatment Prior to GnRH Antagonist Protocol|Interest of a Steroid Pre-treatment Prior to IVF Protocol With Ovarian Stimulation by Recombinant FSH and With LH Surge Blockage by Daily GnRH Antagonist|Completed||Phase 4|472|Actual|Gemer||2|||f||||f||||||||||2017-10-11 03:30:36.357161|2017-10-11 03:30:36.357161
NCT01489839|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-06-16|||January 2012||2012-01-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|June 2016|Actual|2016-06-01||Observational|||Biomarkers of Periodontal Disease Progression|Biomarkers of Periodontal Disease Progression|Active, not recruiting||N/A|500|Anticipated|The Forsyth Institute|||2||f||||t||||||Samples With DNA|"     The biological samples listed below will be obtained at baseline, each 2-month assessment     visit for 12 months, and the 6-month post-therapy visit.      Blood. Ten mL of blood will be obtained by venipuncture from the antecubital fossa. Subjects     consenting to have a blood sample drawn for future DNA analysis will have an additional 7 mL     of blood drawn at the baseline visit.      Saliva. Each subject will provide a timed sample of whole saliva by expectorating into a     sterile graduated cylinder.      Gingival crevicular fluid. A GCF sample will be collected from the mesial and distal aspect     of each posterior tooth (excluding third molars) using filter strips (Periopaper®) gently     inserted 1 to 2 mm subgingivally. A total of up to 32 samples will be obtained.      Subgingival plaque samples. Two plaque samples will be taken from the mesial and distal     aspects of each posterior tooth (excluding third molars) for up to 64 samples.   "|||2017-10-11 03:30:36.448121|2017-10-11 03:30:36.448121
NCT01489826|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2016-12-16|2016-06-10||January 2012||2012-01-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours|A Phase 1, Pharmacokinetically-Guided, Dose Escalation Study to Assess the Safety and Tolerability of Dexanabinol in Patients With Advanced Solid Tumours|Completed||Phase 1|40|Actual|e-Therapeutics PLC||9|||f||||t||||||||||2017-10-11 03:30:36.71973|2017-10-11 03:30:36.71973
NCT01489813|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-05-26|||May 19, 2017|Actual|2017-05-19|May 2017|2017-05-01|May 2022|Anticipated|2022-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment|Phase II Randomized Placebo-Controlled Clinical Trial of Genistein in Reducing the Toxicity and Improving the Efficacy of Intravesical Therapy|Recruiting||Phase 2|88|Anticipated|Emory University||2|||f||||t|t|f||||||Undecided||2017-10-11 03:30:39.189648|2017-10-11 03:30:39.189648
NCT01489800|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-07-02|||November 2011||2011-11-01|July 2015|2015-07-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||The Impact of Early Feeding After Radical Cystectomy for Bladder Cancer|The Impact of Early Feeding After Radical Cystectomy for Bladder Cancer|Unknown status|Enrolling by invitation|Phase 3|164|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-11 03:30:39.305082|2017-10-11 03:30:39.305082
NCT01489787|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2017-02-02|||March 2010|Actual|2010-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|HIFU||Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases|A Phase I-II Study to Evaluate, in Patients Operated for a Hepatic Resection of Colorectal Liver Metastases, a High Intensity Focused Ultrasound (HIFU) Procedure: Feasibility, Safety and Accuracy.|Recruiting||Phase 1/Phase 2|38|Anticipated|Centre Leon Berard||3|||f||||f||||||||||2017-10-11 03:30:39.397467|2017-10-11 03:30:39.397467
NCT01489774|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-08-01|||May 2011||2011-05-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects|A Dose Block-randomized, Double-blind, Placebo-controlled, Single/Multiple Dose, Dose-escalation Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 After Oral Administration in Healthy Male Subjects, Phase I Study|Completed||Phase 1|86|Actual|CJ HealthCare Corporation||2|||f||||t||||||||||2017-10-11 03:30:39.524962|2017-10-11 03:30:39.524962
NCT01489761|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-02-23|||January 2012|Actual|2012-01-01|February 2017|2017-02-01|February 14, 2017|Actual|2017-02-14|February 14, 2017|Actual|2017-02-14||Interventional|||LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)|Percutaneous Treatment of Very LONG Native Coronary Lesions With Drug-Eluting Stent-VI: Everolimus-eluting Versus Zotarolimus-Eluting Stents|Terminated||Phase 4|302|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||No|This is not a publicly funded trial.|2017-10-11 03:30:39.603287|2017-10-11 03:30:39.603287
NCT01489735|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-01-25|||February 2012||2012-02-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|GERDq||The Use of International GerdQ Questionnaire|Observational Non-interventional Study on the Use of International GerdQ Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease in the Russian Practice|Completed||N/A|150|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:30:39.779261|2017-10-11 03:30:39.779261
NCT01489722|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-08-10|||February 2012||2012-02-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients|A Phase Ia/Ib, Open-Label, Multicentre, Two-Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 Administered Daily in Adult Patients With Recurrent or Refractory Acute Myelogenous Leukemia (AML)|Terminated||Phase 1|55|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 03:30:39.854386|2017-10-11 03:30:39.854386
NCT01489709|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2014-09-04|||June 2010||2010-06-01|September 2014|2014-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|SET-Q||Post Marketing Survey of Vesicare in Japan|Specified Drug Use Results Survey of Vesicare Tablets|Completed||N/A|1160|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 03:30:40.066419|2017-10-11 03:30:40.066419
NCT01489696|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-12-06|||August 2010||2010-08-01|December 2011|2011-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin|A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin|Completed||Phase 1|48|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 03:30:40.210409|2017-10-11 03:30:40.210409
NCT01489683|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-07-13|||May 2011||2011-05-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine|Effect of Tracheal Lidocaine on Intubating Conditions During Propofol-remifentanil TCI Without Neuromuscular Blockade|Completed||N/A|50|Actual|Ajou University School of Medicine||2|||f||||f||||||||||2017-10-11 03:30:40.302853|2017-10-11 03:30:40.302853
NCT01489670|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2014-02-13|2014-02-13||September 2011||2011-09-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension||Completed||N/A|387|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:30:40.401476|2017-10-11 03:30:40.401476
NCT01489657|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-06-07|||July 2011||2011-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2012|Actual|2012-12-01||Observational|||The Metabolite Profiling of Obese Subjects Before and After Sleeve Gastrectomy|The Impact of Sleeve Gastrectomy Surgery in Obese Subjects on Metabolite Profiling|Withdrawn||N/A|0|Actual|Wolfson Medical Center|||1|The results were not significant, therfore the study ended prematurily|f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 03:30:40.78397|2017-10-11 03:30:40.78397
NCT01489644|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-02-09|||June 2006||2006-06-01|February 2017|2017-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers|A Randomized, Single-Blind, Four-Period Crossover Study Examining the Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet Dosing (NN4440) in Fasting and Fed Healthy Volunteers|Completed||Phase 1|62|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 03:30:40.848329|2017-10-11 03:30:40.848329
NCT01489631|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-06-04|||March 2013||2013-03-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Analgesia After Total Knee Replacement Surgery|Comparison of Intra-articular Infiltration and Gabapentin With Epidural Analgesia After Total Knee Replacement Surgery|Completed||N/A|81|Actual|St. Antonius Hospital||3|||f||||f||||||||||2017-10-11 03:30:40.948301|2017-10-11 03:30:40.948301
NCT01489618|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-02-23|||June 2009||2009-06-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EVAD||"Prime Boost Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency"|"Randomised, Multicentric, Phase ii Study of the Immunogenicity of a Prime Boost Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency"|Terminated||Phase 2|45|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2||End of production|f||||t||||||||||2017-10-11 03:30:41.048841|2017-10-11 03:30:41.048841
NCT01489605|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-09-07|||July 2017||2017-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||GlideScope Groove vs. Standard GlideScope: A Non-inferiority Study|Comparison of GlideScope Groove to Standard GlideScope for Orotracheal Intubation: A Non-inferiority Study|Not yet recruiting||N/A|130|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:30:41.128685|2017-10-11 03:30:41.128685
NCT01489592|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-04-10|||October 2011||2011-10-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|CURHEP||Effect of Curcumin on Iron Metabolism in Healthy Volunteer|Effect of Curcumin on Iron Metabolism in Healthy Volunteer|Completed||Phase 2|18|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-11 03:30:41.233601|2017-10-11 03:30:41.233601
NCT01489566|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2011-12-13|||July 2011||2011-07-01|December 2011|2011-12-01|August 2013|Anticipated|2013-08-01|March 2013|Anticipated|2013-03-01||Interventional|||Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients|A Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Phase III Clinical Trial to Evaluate the Safety and Efficacy of Injectable Tyroserleutide to Treat Hepatocellular Carcinoma|Unknown status|Enrolling by invitation|Phase 3|300|Anticipated|Shenzhen Kangzhe Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:30:41.39382|2017-10-11 03:30:41.39382
NCT01489553|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2013-10-21|||January 2012||2012-01-01|October 2012|2012-10-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Egg Oral Immunotherapy|Egg Oral Immunotherapy|Completed||N/A|9|Actual|Children's Hospital of Philadelphia|||1||f||||t||||||Samples Without DNA|"     Immunocap testing (bloodwork) will be performed prior to and upon completion of the     desensitization protocol. This testing is considered standard of care in the management of     food allergies.   "|||2017-10-11 03:30:41.50926|2017-10-11 03:30:41.50926
NCT01489540|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2013-09-18|||December 2011||2011-12-01|December 2011|2011-12-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Cost-effectiveness of Laser Doppler Imaging in Burn Care|Cost-effectiveness of Laser Doppler Imaging in Burn Care in the Netherlands|Completed||N/A|200|Anticipated|Association of Dutch Burn Centres||2|||f||||f||||||||||2017-10-11 03:30:41.568438|2017-10-11 03:30:41.568438
NCT01489527|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-01-21|2015-01-05||September 2012||2012-09-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional||All treated participants|Preparedness Study - HPV Vaccine|Preparedness Study: Efficacy of HPV Vaccine to Reduce HIV Infection|Completed||N/A|406|Actual|H. Lee Moffitt Cancer Center and Research Institute|The EVRI Trial had a short duration with limited follow-up time; therefore, clinical efficacy in reducing HIV acquisition cannot be assessed.|2|||f||||t||||||||||2017-10-11 03:30:41.917886|2017-10-11 03:30:41.917886
NCT01489514|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2015-05-26|||December 2011||2011-12-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2013|Actual|2013-01-01||Observational|peanut||Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects|Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects.|Completed||N/A|22|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     Venipuncture for 30mL of blood taken for measurement of peanut IgE.   "|||2017-10-11 03:30:42.495885|2017-10-11 03:30:42.495885
NCT01489501|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-03-24||||||March 2015|2015-03-01||||||||Interventional|||Multicenter Study of CAOMECS Transplantation to Patients With Total Limbal Stem Cell Deficiency|Multicenter Study of Cultured Autologous Oral Mucosal Epithelial Cell-Sheet (CAOMECS) Transplantation to Patients With Total Limbal Stem Cell Deficiency|Withdrawn||Phase 3|0|Actual|CellSeed France S.A.R.L.||1||Change of strategic priorities in the sponsor's clinical development sector.|f||||f||||||||||2017-10-11 03:30:42.59349|2017-10-11 03:30:42.59349
NCT01489488|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2015-06-29|||January 2012||2012-01-01|June 2015|2015-06-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Relative Bioavailability and Food Effect Study|Relative Bioavailability and Food Effect Study of Two Oral Liquid Formulations in Comparison to a 1 mg Tablet of Riociguat to Characterize Its Pharmacokinetic Properties in Healthy Male and Female Adult Subjects in a Randomized, Open Label, 5-fold Crossover Design|Completed||Phase 1|32|Actual|Bayer||5|||f||||f||||||||||2017-10-11 03:30:42.71327|2017-10-11 03:30:42.71327
NCT01489475|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-02-24|||November 2011||2011-11-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass|Plasma Angiopoietin Levels in Children Undergoing Modified Ultrafiltration Following Cardiopulmonary Bypass|Completed||N/A|31|Actual|Yale University|||1||f||||f||||||Samples With DNA|"     1. Modified ultrafiltration fluid        2. Whole blood which will be spun down to plasma (cells to be discarded)   "|||2017-10-11 03:30:42.836167|2017-10-11 03:30:42.836167
NCT01489462|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-10-03|||March 2012||2012-03-01|October 2017|2017-10-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|START||Strength Training for ARthritis Trial|Strength Training for ARthritis Trial|Completed||N/A|375|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||||2017-10-11 03:30:42.924742|2017-10-11 03:30:42.924742
NCT01489449|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2016-05-11|||December 2012||2012-12-01|May 2016|2016-05-01|December 2019|Anticipated|2019-12-01|September 2017|Anticipated|2017-09-01||Interventional|PEPCADNSTEMI||Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction|Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction|Recruiting||Phase 4|1000|Anticipated|University Hospital, Saarland||2|||f||||t||||||||||2017-10-11 03:30:43.114288|2017-10-11 03:30:43.114288
NCT01489436|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2014-03-19|||July 2011||2011-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|CENoMIP||A Comparison of Single Port and Four Port Laparoscopic Gallbladder Removal|Comparative Effectiveness of Novel Minimally Invasive Procedures|Completed||N/A|118|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 03:30:43.226103|2017-10-11 03:30:43.226103
NCT01489423|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-05-16|||April 26, 2013|Actual|2013-04-26|May 2017|2017-05-01|May 26, 2013|Actual|2013-05-26|May 26, 2013|Actual|2013-05-26||Observational|||Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim|Correlative Analyses of Specimens From Eastern Cooperative Group Study E1608|Completed||N/A|270|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 03:30:43.337648|2017-10-11 03:30:43.337648
NCT01489410|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-08-30|||October 2012||2012-10-01|August 2017|2017-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma|Prospective Study Comparing Lipiodol Plus Ethanol Solution Compared With Drug-Eluting Beads for Trans-arterial Chemoembolization of Liver in Treatment of Hepatocellular Carcinoma|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Insufficient staff|f||||f||||||||||2017-10-11 03:30:43.419036|2017-10-11 03:30:43.419036
NCT01489397|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-06-09|||April 2010||2010-04-01|June 2014|2014-06-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Magnified Intelligence Chromoendoscopy Plus Probe-based Confocal Laser Endomicroscopy for Gastric Intestinal Metaplasia Diagnosis||Completed||N/A|45|Actual|King Chulalongkorn Memorial Hospital||2|||f||||f||||||||||2017-10-11 03:30:43.510842|2017-10-11 03:30:43.510842
NCT01489384|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2017-04-12|||December 2011||2011-12-01|April 2017|2017-04-01|September 2018|Anticipated|2018-09-01|August 27, 2018|Anticipated|2018-08-27||Observational|||Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s)|A Canadian Randomized Controlled Trial of DMARD Withdrawal in RA Patients Achieving Therapeutic Response With Cimzia + DMARD Combination Treatment.|Active, not recruiting||N/A|125|Actual|Pope Research Corporation|||4||f||||f||||||||||2017-10-11 03:30:43.603304|2017-10-11 03:30:43.603304
NCT01489371|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2017-08-23|||July 9, 2012|Actual|2012-07-09|August 2017|2017-08-01||||July 21, 2015|Actual|2015-07-21||Interventional|||EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase I Study of Intraperitoneal Egen-001 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered in Combination With Pegylated Liposomal-Doxorubicin (PLD, Doxil (NSC# 712227 or Lipodox (NSC#673089) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Active, not recruiting||Phase 1|16|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 03:30:43.734993|2017-10-11 03:30:43.734993
NCT00005427|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||March 1993||1993-03-01|January 2016|2016-01-01|February 1995||1995-02-01|||||Observational|||Cohort Study of Respiratory Illness in Early Childhood||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-10-11 04:27:03.090044|2017-10-11 04:27:03.090044
NCT01489358|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2016-06-09|2016-03-11||December 2011||2011-12-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||All enrolled participants|Chikungunya Virus Vaccine Trial in Healthy Adults|VRC 311: A Phase 1 Open Label, Dose-Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Virus-Like Particle (VLP) Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults|Completed||Phase 1|25|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 03:30:43.876389|2017-10-11 03:30:43.876389
NCT01489345|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-07-31|||December 2011||2011-12-01|July 2012|2012-07-01||||April 2012|Actual|2012-04-01||Interventional|||Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects|A Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects|Completed||Phase 1|36|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 03:30:45.440358|2017-10-11 03:30:45.440358
NCT01489332|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2011-12-07|||October 2011||2011-10-01|December 2011|2011-12-01|April 2018|Anticipated|2018-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer|Induction Chemotherapy, Preoperative Radiochemotherapy, Consolidation Chemotherapy, Operation and Adjuvant Chemotherapy in the Treatment of Locally Advanced Rectal Cancer- OIGIT 5-01 Phase II Trial|Recruiting||Phase 2|60|Anticipated|Institute of Oncology Ljubljana||1|||f||||f||||||||||2017-10-11 03:30:45.549187|2017-10-11 03:30:45.549187
NCT01489319|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-02-08|||February 2012||2012-02-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ELI-ROAS||Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)|Evaluation of the Ovarian Dynamic Response and the Inflammatory Response to Oral Lipid Challenge in Relation to Body Composition in Polycystic Ovary Syndrome|Terminated||Phase 1|47|Actual|Indiana University||6||"The PI left Indiana University. The findings served as preliminary data for a recently awarded   NIH R01 grant."|f||||f|t|||||||||2017-10-11 03:30:45.645115|2017-10-11 03:30:45.645115
NCT01489306|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-04-10|||December 2011||2011-12-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled MDT-637 Administered to Healthy Volunteers for 10 Days|Completed||Phase 1|36|Anticipated|MicroDose Therapeutx, Inc||2|||f||||||||||||||2017-10-11 03:30:45.728023|2017-10-11 03:30:45.728023
NCT01489293|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2013-03-03|||January 2012||2012-01-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Inhibitory Receptors in Eosinophils of Atopic Subjects|Characterization of the Expression and Activity of Inhibitory Receptors Such as CLM-1 in Eosinophils of Atopic Subjects|Unknown status|Recruiting|N/A|40|Anticipated|Meir Medical Center|||2||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:30:45.793508|2017-10-11 03:30:45.793508
NCT01489280|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2012-09-09|||May 2012||2012-05-01|September 2012|2012-09-01||||February 2014|Anticipated|2014-02-01||Observational|TTP||Temple Touch Pro (TTP) Non Invasive Continuous Temperature Measurement System|Temple Touch Pro (TTP) Non Invasive Continuous Temperature Measurement System.|Unknown status|Recruiting|N/A|800|Anticipated|Medisim Ltd|||1||f||||f||||||||||2017-10-11 03:30:45.855373|2017-10-11 03:30:45.855373
NCT01489267|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2012-06-18|||December 2011||2011-12-01|June 2012|2012-06-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Interventional|SCA||A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation|The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Transplantation in Hereditary Cerebellar Ataxia Patients|Unknown status|Enrolling by invitation|Phase 2|20|Anticipated|General Hospital of Chinese Armed Police Forces||2|||f||||t||||||||||2017-10-11 03:30:45.925677|2017-10-11 03:30:45.925677
NCT01489254|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2016-11-10|2016-04-18||October 2011||2011-10-01|November 2016|2016-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|GATE||Efficacy and Safety of GTR in Comparison to Copaxone®|Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group, 9 Month, Equivalence Trial Comparing the Efficacy and Safety and Tolerability of GTR (Synthon BV) to Copaxone® (Teva) in Subjects With Relapsing Remitting Multiple Sclerosis Followed by an Open-label 15 Month GTR Treatment Part Evaluating the Long-term GTR Treatment Effects|Completed||Phase 3|794|Actual|Synthon BV||3|||f||||t||||||||Yes||2017-10-11 03:30:46.259172|2017-10-11 03:30:46.259172
NCT01489241|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2015-02-21|||March 2011||2011-03-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|RHCluster4GR||Short-term Telehealth Follow up After Hospital Discharge for Chronic Obstructive Pulmonary Disease Exacerbation|Renewing Health RCT in Central Greece for the Evaluation of Short-term Telehealth Follow up After Hospital Discharge for COPD Exacerbation|Completed||N/A|155|Actual|Regional Health Authority of Sterea & Thessaly||2|||f||||t||||||||||2017-10-11 03:30:47.433657|2017-10-11 03:30:47.433657
NCT01489228|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-12-19|||June 2011||2011-06-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|August 2012|Anticipated|2012-08-01||Interventional|||Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease|Phase 2 Randomized, Multicenter, Placebo-controlled, Safety and Efficacy Study to Evaluate Three Oral E1224 Dosing Regimens and Benznidazole for the Treatment of Adult Patients With Chronic Indeterminate Chagas Disease|Unknown status|Recruiting|Phase 2|230|Anticipated|Drugs for Neglected Diseases||5|||f||||t||||||||||2017-10-11 03:30:47.535525|2017-10-11 03:30:47.535525
NCT01489215|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-08|2011-12-08|||February 2012||2012-02-01|December 2011|2011-12-01||||February 2015|Anticipated|2015-02-01||Interventional|||Interventions for Sleep Problems in Early Childhood|Interventions for Sleep Problems in Early Childhood:The Role of Child, Parental and Intervention Factors|Unknown status|Not yet recruiting|N/A|180|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||||||||||||2017-10-11 03:30:47.664715|2017-10-11 03:30:47.664715
NCT01489202|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-03-06|||September 2014||2014-09-01|March 2013|2013-03-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|PLATFORM||Effects of DES Platforms on Markers of Endothelial Damage and Inflammation|Randomized Comparison of the Effects of PLatinum Chromium Everolimus-eluting Stent vs. cobAlT Chromium Everolimus-eluting Stent on inFlammatOry maRkers and Endothelial daMage - The PLATFORM Trial|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 03:30:47.762675|2017-10-11 03:30:47.762675
NCT01395849|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-05-15|||October 2007||2007-10-01|May 2017|2017-05-01|March 2011|Actual|2011-03-01|September 2009|Actual|2009-09-01||Observational|||Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)|Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)|Completed||N/A|2116|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:01:18.698627|2017-10-11 04:01:18.698627
NCT01489189|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-12-08|2016-02-12||March 2012||2012-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|January 2015|Actual|2015-01-01||Interventional|Protocol S|Units in Eyes|Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy|Prompt Panretinal Photocoagulation Versus Intravitreal Ranibizumab With Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy|Active, not recruiting||Phase 3|305|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-11 03:30:47.972635|2017-10-11 03:30:47.972635
NCT01489176|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2012-09-25|||September 2012||2012-09-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Regadenoson Real Time Perfusion Imaging Trial-Optison|Regadenoson Real Time Perfusion Imaging Trial-Optison|Unknown status|Recruiting|N/A|50|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-11 03:30:52.714114|2017-10-11 03:30:52.714114
NCT01489163|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2017-07-31|||December 2011|Actual|2011-12-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|October 2015|Actual|2015-10-01||Interventional|APPLES||Lifestyle Intervention Program for Women With Gestational Diabetes or Gestational Impaired Glucose Tolerance|Translational Diabetes Prevention in GDM|Active, not recruiting||N/A|350|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 03:30:52.833646|2017-10-11 03:30:52.833646
NCT01489150|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-05-15|||December 2011||2011-12-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Observational|||Use of EtCO2 as a PaCO2 Predictor Under Non Invasive Ventilation (NIV) in Cases of Acute Hypercapnic Respiratory Failure|Use of EtCO2 and Prolonged Expiratory Maneuvers as a PaCO2 Predictor in Cases of Acute Hypercapnic Respiratory Failure|Completed||N/A|11|Actual|University of Lausanne Hospitals|||1||f||||f||||||||||2017-10-11 03:30:52.945585|2017-10-11 03:30:52.945585
NCT01489137|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-08-15|||November 2011||2011-11-01|August 2012|2012-08-01||||February 2012|Actual|2012-02-01||Interventional|||The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation|The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation in the Patients Undergoing Neurosurgery|Completed||N/A|50|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 03:30:53.030484|2017-10-11 03:30:53.030484
NCT01489124|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2011-12-08|||January 2008||2008-01-01|December 2011|2011-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia|The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia|Completed||Phase 4|9|Actual|Prince of Songkla University||3|||f||||f||||||||||2017-10-11 03:30:53.11156|2017-10-11 03:30:53.11156
NCT01489111|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-09-20|||August 2012||2012-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|pathfinder™3||Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A|Efficacy and Safety of NNC 0129-0000-1003 During Surgical Procedures in Patients With Haemophilia A|Recruiting||Phase 3|43|Anticipated|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:30:53.310141|2017-10-11 03:30:53.310141
NCT01489098|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2015-03-17|||September 2011||2011-09-01|October 2014|2014-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Effect of the Level of Dietary Protein on Body Composition|Effect of the Level of Dietary Protein on Infant Growth and Body Composition in the First Year of Life - Three and Five Year Growth and Body Composition Follow-up|Completed||N/A|178|Actual|Nestlé|||3||f||||f||||||||||2017-10-11 03:30:53.475755|2017-10-11 03:30:53.475755
NCT01489085|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-07-21|||January 2013||2013-01-01|November 2010|2010-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|intellivent||Observational Study Evaluating the Use of Intellivent® for Patients With Respiratory Distress Syndrome|Etude Clinique Observationnelle, Prospective, Ouverte, Monocentrique Sur l'Utilisation d'un Mode Ventilatoire entièrement automatisé Chez Les Patients de réanimation de l'Intubation Jusqu'au Sevrage.|Completed||N/A|100|Actual|Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer|||1||f||||t||||||||||2017-10-11 03:30:53.572557|2017-10-11 03:30:53.572557
NCT01489072|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-10-25|||April 2012||2012-04-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy of Two Bolus Doses of Remifentanil on the Incidence of Coughing During Emergence of Anesthesia|Comparison of the Efficacy of Two Bolus Doses of Remifentanil on the Incidence of Coughing During Emergence of Anesthesia.|Completed||N/A|180|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 03:30:53.666384|2017-10-11 03:30:53.666384
NCT01489059|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2014-08-28|||December 2011||2011-12-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma|A Phase I Dose Escalation Study of BMS-982470 (Recombinant Interleukin 21, rIL-21) in Combination With Ipilimumab in Subjects With Unresectable Stage III or Stage IV Melanoma|Completed||Phase 1|42|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-10-11 03:30:53.750824|2017-10-11 03:30:53.750824
NCT01489046|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2016-03-17||2016-03-17|February 2011||2011-02-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|March 2013|Actual|2013-03-01||Interventional|||Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive|A Phase IIb Randomized, Controlled, Partially Blinded Clinical Trial to Investigate Safety, Efficacy and Dose-response of BMS-986001 in Treatment-naive HIV-1-infected Subjects, Followed by an Open-label Period on the Recommended Dose|Terminated||Phase 2|297|Actual|Bristol-Myers Squibb||4|||f||||t||||||||||2017-10-11 03:30:53.898534|2017-10-11 03:30:53.898534
NCT01489033|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2017-04-28|||January 2010||2010-01-01|April 2017|2017-04-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense|Multicentre Phase I Randomized Double Blind Placebo Controlled Study of Subcutaneous Immunotherapy in Subjects With Allergic Rhinoconjunctivitis ± Asthma Sensitised to Phleum Pratense.|Completed||Phase 1|42|Actual|Roxall Medicina España S.A||6|||f||||f||||||||||2017-10-11 03:30:54.154525|2017-10-11 03:30:54.154525
NCT01489020|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-04-28|||January 2011||2011-01-01|April 2017|2017-04-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)|Multicentre Phase I Randomized Double Blind Placebo Controlled Study of Subcutaneous Immunotherapy in Subjects With Allergic Rhinoconjunctivitis ± Asthma Sensitised to Dermatophagoides Pteronyssinus.|Completed||Phase 1|48|Actual|Roxall Medicina España S.A||6|||f||||f||||||||||2017-10-11 03:30:54.268889|2017-10-11 03:30:54.268889
NCT01489007|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2015-03-25|||January 2012||2012-01-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|||Iron Absorption in Vegetarian Children|Evaluation of Iron Absorption in Healthy Vegetarian Children 4 to 10 Years of Age|Unknown status|Active, not recruiting|N/A|36|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-10-11 03:30:54.386391|2017-10-11 03:30:54.386391
NCT01488994|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-07-21|2016-03-24|2014-05-29|December 2011||2011-12-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||BAX 326 Pediatric Study|BAX 326 (Recombinant Factor IX): A Phase 2/3 Prospective, Uncontrolled, Multicenter Study Evaluating Pharmacokinetics, Efficacy, Safety, and Immunogenicity in Previously Treated Pediatric Patients With Severe (FIX Level < 1%) or Moderately Severe (FIX Level 1-2%) Hemophilia B|Completed||Phase 2/Phase 3|23|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-10-11 03:30:54.491401|2017-10-11 03:30:54.491401
NCT01488981|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2013-12-18|||February 2012||2012-02-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Feasibility of the Radio-Frequency Microstimulator System to Improve Arm Function Following Traumatic Brain Injury|A Feasibility Study to Assess the Safety and Efficacy of the Radio-Frequency Microstimulator System to Improve Function of the Arm Following Traumatic Brain Injury|Terminated||Phase 1|1|Actual|The Alfred E. Mann Foundation for Scientific Research||1||low enrollment|f||||f||||||||||2017-10-11 03:30:55.823717|2017-10-11 03:30:55.823717
NCT01488968|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-01-23|||March 2012||2012-03-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|January 2018|Anticipated|2018-01-01||Interventional|CHIRP||Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients|A Phase II Randomized Control Trial of Conventional Versus Hypofractionated Radiation Regimen in Single Phase Using IMRT Technique and Long Term Androgen Suppression Therapy in High-risk Prostate Cancer Patients.|Recruiting||N/A|134|Anticipated|AHS Cancer Control Alberta||2|||f||||t||||||||||2017-10-11 03:30:55.957762|2017-10-11 03:30:55.957762
NCT01488955|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2014-08-07|||February 2012||2012-02-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|||Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI|Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - a Comparative Effectiveness Study in General Practice (ICUTI)|Completed||Phase 4|494|Actual|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||2|||f||||f||||||||||2017-10-11 03:30:56.047693|2017-10-11 03:30:56.047693
NCT01488942|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-06-16|||December 2012||2012-12-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Incentives-2||Use of Incentives to Retain Drug Users in HIV Therapy|A Randomized Clinical Trial Evaluating the Role of Contingent Reinforcement in the Engagement of and Retention of Drug Users in HAART Programs|Recruiting||N/A|240|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 03:30:56.147936|2017-10-11 03:30:56.147936
NCT01488929|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2015-05-11||2015-05-11|December 2011||2011-12-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia|A Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to Assess Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia|Completed||Phase 2|603|Actual|Targacept Inc.||3|||f||||f||||||||||2017-10-11 03:30:56.282033|2017-10-11 03:30:56.282033
NCT01488916|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-12|||August 2011||2011-08-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Observational|||Vitamin D Inadequacy on Postprandial Glucose in Type 2 Diabetes Mellitus|Impacts of Vitamin D Inadequacy on Postprandial Glucose Excursion in Patients With Type 2 Diabetes|Unknown status|Recruiting|N/A|45|Anticipated|Taipei Veterans General Hospital, Taiwan|||3||f||||f||||||Samples Without DNA|"     Serum samples after meal challenge   "|||2017-10-11 03:30:56.883747|2017-10-11 03:30:56.883747
NCT01488903|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-12|||September 2011||2011-09-01|December 2011|2011-12-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Observational|CROWN||A Cohort Research of Genetic Susceptibility for Common Obesity in Women|A Cohort Research of Genetic Susceptibility for Common Obesity in Women (CROWN Study)|Unknown status|Recruiting|N/A|1200|Anticipated|Taipei Veterans General Hospital, Taiwan|||2||f||||f||||||Samples With DNA|"     DNA, fasting blood samples   "|||2017-10-11 03:30:56.99796|2017-10-11 03:30:56.99796
NCT01488890|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-05-01||2014-04-08|December 2011||2011-12-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|||Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine|Evaluation of the Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Administered With or Without Yellow Fever Vaccine in US Adults.|Completed||Phase 2|390|Actual|Sanofi||4|||f||||t||||||||||2017-10-11 03:30:57.108558|2017-10-11 03:30:57.108558
NCT01488877|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-09-24|2013-07-18||January 2012||2012-01-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy|A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria|Terminated||Phase 1|6|Actual|Pfizer|Study was terminated prematurely; this was based on a strategic decision by the sponsor to terminate further development of this compound for proposed indication. The study was not terminated for safety or lack of efficacy reasons.|3||See termination reason in detailed description.|f||||f||||||||||2017-10-11 03:30:57.284013|2017-10-11 03:30:57.284013
NCT01488864|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-05-10|||March 2007||2007-03-01|May 2012|2012-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Applied Relaxation for Vasomotor Symptoms|Applied Relaxation for Vasomotor Symptoms in Postmenopausal Women - a Randomized, Controlled Trial|Terminated||N/A|60|Actual|Ostergotland County Council, Sweden||2||Low drop-out rate and slow recruitment rate|f||||f||||||||||2017-10-11 03:30:57.850912|2017-10-11 03:30:57.850912
NCT01488851|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2016-01-04|||January 2012||2012-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Observational|||Study to Assess Incidence of ONJ in Pts With Bone Mets Starting Zoledronic Acid Treatment|Prospective Observational Multi Central Cohort Study to Assess the Incidence of Osteo Necrosis of Jaw in Patients With Bone Metastasis Starting Zoledronic Acid Treatment|Completed||N/A|100|Actual|King Faisal Specialist Hospital & Research Center|||1||f||||t||||||||||2017-10-11 03:30:58.024407|2017-10-11 03:30:58.024407
NCT01488838|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2016-02-24|||November 2011||2011-11-01|December 2011|2011-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors||Completed||Phase 2|120|Actual|King Faisal Specialist Hospital & Research Center||2|||f||||||||||||||2017-10-11 03:30:58.155963|2017-10-11 03:30:58.155963
NCT01488825|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-07|||January 2005||2005-01-01|December 2011|2011-12-01|June 2006|Actual|2006-06-01|February 2006|Actual|2006-02-01||Interventional|||Yoga Intervention Study on Episodic Tension Type Headache|Effect of Yoga Intervention on Episodic Tension Type Headache: A Randomized Controlled Trial|Completed||Phase 2|77|Actual|NMP Medical Research Institute||2|||f||||t||||||||||2017-10-11 03:30:58.255489|2017-10-11 03:30:58.255489
NCT01488812|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2015-04-20|||May 2010||2010-05-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Observational|||Waiting Time to Operation for Hip-fracture Patients|Waiting Time to Operation for Hip-fracture Patients|Completed||N/A|576|Actual|Danderyd Hospital|||1||f||||f||||||||||2017-10-11 03:30:58.365636|2017-10-11 03:30:58.365636
NCT01488799|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2015-12-28|||January 2012||2012-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Motivational Interviewing and Cognitive Behavioural Therapy for Generalized Anxiety Disorder|Adding Motivational Interviewing to Cognitive Behavioural Therapy for Severe Generalized Anxiety Disorder|Completed||N/A|85|Actual|York University||2|||f||||t||||||||||2017-10-11 03:30:58.43752|2017-10-11 03:30:58.43752
NCT01488786|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-08-06|||October 2011||2011-10-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind|A Study to Evaluate the Safety and Efficacy of the BrainPort® Vision Device in Subjects Who Are Blind|Completed||N/A|75|Actual|Wicab||1|||f||||t||||||||||2017-10-11 03:30:58.576395|2017-10-11 03:30:58.576395
NCT01488773|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-01-10|||April 1995||1995-04-01|January 2012|2012-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Comparison of Two Treatment Regimens in Asthmatic Patients|A Four Year Observational Study Comparing Two Treatment Regimens: Inhaled Glucocorticosteroid + Salmeterol and Inhaled Glucocorticosteroid + Montelukast.|Completed||N/A|132|Actual|Medical Universtity of Lodz|||2||f||||f||||||||||2017-10-11 03:30:58.6977|2017-10-11 03:30:58.6977
NCT01488760|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-06|||December 2009||2009-12-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Abdominal Wall Evaluation in Low Back Pain|Deep Abdominal Wall Muscle Dysfunction During Calm Respiration in Chronic Low Back Pain Patients|Completed||N/A|39|Actual|University of Sao Paulo General Hospital|||2||f||||f||||||||||2017-10-11 03:30:58.807025|2017-10-11 03:30:58.807025
NCT01488747|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-04-21|||November 2011||2011-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|October 2012|Actual|2012-10-01||Interventional|||Bioavailability of Fish Oils: Emulsified Versus Capsular Triglyceride|Bioavailability of Fish Oils: Emulsified vs. Capsular Triglyceride|Completed||N/A|19|Actual|USDA Grand Forks Human Nutrition Research Center||4|||f||||t||||||||No||2017-10-11 03:30:58.893494|2017-10-11 03:30:58.893494
NCT01488734|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-04-12|||November 2011||2011-11-01|April 2017|2017-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom|Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom|Completed||N/A|47|Actual|Icahn School of Medicine at Mount Sinai||4|||f||||f|f|f||||||||2017-10-11 03:30:58.994195|2017-10-11 03:30:58.994195
NCT01488721|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-08-16|||December 2011||2011-12-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Observational|||Clinical Evaluation of NeoPlex4 Assay and NeoPlex System|Clinical Evaluation of the xMAP® NeoPlex4™ Assay for Detection of T4, TSH, 17-OHP and IRT Using the NeoPlex System|Completed||N/A|7462|Actual|Luminex Molecular Diagnostics|||2||f||||f||||||||||2017-10-11 03:30:59.127575|2017-10-11 03:30:59.127575
NCT01488708|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-03-10||2016-03-10|January 2012||2012-01-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Illuminate-X||On Open-Label Study in Participants With Systemic Lupus Erythematosus|A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutaneous LY2127399 in Participants With Systemic Lupus Erythematosus (SLE) (Illuminate-X)|Completed||Phase 3|1518|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:30:59.222782|2017-10-11 03:30:59.222782
NCT01488695|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-09-07|||July 2017||2017-07-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||GlideScope Groove Versus Macintosh Blade for Double-Lumen Endotracheal Tube Intubation|Comparison of GlideScope Groove to Macintosh Blade for Orotracheal Intubation With Double-Lumen Endotracheal Tube: a Randomised Controlled Trial|Not yet recruiting||N/A|80|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:30:59.377806|2017-10-11 03:30:59.377806
NCT01488682|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-06|||January 2010||2010-01-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|December 2010|Actual|2010-12-01||Interventional|||The Safety and Efficacy of the Harmonic Scalpel in Neck Dissection|The Safety and Efficacy of the Harmonic Scalpel in Neck Dissection : A Prospective Randomized Study|Unknown status|Recruiting|N/A|59|Anticipated|Yonsei University||2|||f||||||||||||||2017-10-11 03:30:59.517183|2017-10-11 03:30:59.517183
NCT01488669|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-06|||January 2011||2011-01-01|December 2011|2011-12-01|September 2013|Anticipated|2013-09-01|September 2011|Actual|2011-09-01||Interventional|||Robot Assisted Supraomohyoid Neck Dissection Via Retroauricular Approach||Unknown status|Recruiting|N/A|26|Anticipated|Yonsei University||2|||f||||||||||||||2017-10-11 03:30:59.696|2017-10-11 03:30:59.696
NCT01488656|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-08-14|||November 2011||2011-11-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Effects of Dietary Supplements on Response to Air Pollution|Effect of an Antioxidant and Anti-inflammatory Dietary Supplement Pack on the Adverse Physiological Actions Associated With Acute PM2.5 Exposure|Completed||N/A|66|Actual|Utah State University||2|||f||||f||||||||||2017-10-11 03:30:59.853004|2017-10-11 03:30:59.853004
NCT01488643|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-07|||March 2011||2011-03-01|December 2011|2011-12-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Observational|||Observational Study on Obese Patients During General Anesthesia|Bronchospasm During General Anesthesia in Obese Patients|Unknown status|Recruiting|N/A|50|Anticipated|Larissa University Hospital|||2||f||||f||||||||||2017-10-11 03:30:59.967519|2017-10-11 03:30:59.967519
NCT01488630|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2015-09-15|||December 2011||2011-12-01|December 2011|2011-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|STaRS||Substance Treatment and HIV Testing and Referral System|Substance Treatment Referral System|Completed||Phase 2|60|Actual|Polaris Health Directions||2|||f||||f||||||||||2017-10-11 03:31:00.167193|2017-10-11 03:31:00.167193
NCT01488617|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-10-30|||January 2012||2012-01-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Observational|MOPS||Mainz Outcome Predictor Studies: An Observational Clinical Trial Investigating Predictors for Postoperative Outcome|Mainz Outcome Predictor Studies: An Observational Clinical Trial Investigating Physiological and Psychological Data as Predictors for Postoperative Outcome.|Completed||N/A|616|Actual|Johannes Gutenberg University Mainz|||1||f||||t||||||||||2017-10-11 03:31:00.276316|2017-10-11 03:31:00.276316
NCT01488604|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-05-08|||January 2012||2012-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold|Efficacy and Safety of an Antiviral Polymeric Nasal Spray: A Randomized, Parallel Group, Double-blind, Placebo-controlled Study in Subjects With Early Symptoms of Common Cold|Completed||N/A|163|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 03:31:00.354894|2017-10-11 03:31:00.354894
NCT01488591|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-05-30|||April 2009||2009-04-01|May 2013|2013-05-01||||||||Observational|||Biomarker Research for Personalized Medicine|Biomarker Research for Personalized Medicine in Blood Cancer Patient|Unknown status|Recruiting|N/A|1000|Anticipated|Inje University|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:31:00.46166|2017-10-11 03:31:00.46166
NCT01488578|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2012-05-11|2012-03-08||December 2006||2006-12-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|POTTOR||Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)|Postmarketing Observational Study of Tolterodine Treatment on Overactive Bladder in Real Life Setting|Completed||N/A|11157|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:31:00.551059|2017-10-11 03:31:00.551059
NCT01488565|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-02-12|||December 2010||2010-12-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|Aza-E||A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia|A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndrome / Acute Myeloid Leukaemia, With Eltrombopag Support for Thrombocytopenia.|Completed||Phase 2|25|Actual|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-11 03:31:01.306653|2017-10-11 03:31:01.306653
NCT01488552|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2016-08-17|||November 2011||2011-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|||Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer|A Phase II Study of Induction Consolidation and Maintenance Approach for Patients With Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|60|Actual|Pancreatic Cancer Research Team||1|||f||||f||||||||||2017-10-11 03:31:01.426983|2017-10-11 03:31:01.426983
NCT01488539|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2016-05-26|||January 2012||2012-01-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2016|Actual|2016-04-01||Interventional|||Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings|Implementation of an Evidence Based PTSD Treatment in Public Sector Settings|Active, not recruiting||Phase 2/Phase 3|352|Anticipated|Palo Alto Veterans Institute for Research||2|||f||||t||||||||||2017-10-11 03:31:01.543105|2017-10-11 03:31:01.543105
NCT01488526|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-06-14|||March 1, 2012|Actual|2012-03-01|June 2017|2017-06-01|October 28, 2017|Anticipated|2017-10-28|April 28, 2014|Actual|2014-04-28||Interventional|||Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus|Tenofovir Disoproxil Fumarate in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus in Highly Viremic Mothers|Active, not recruiting||Phase 4|200|Actual|New Discovery LLC||2|||f||||t||||||||||2017-10-11 03:31:01.653484|2017-10-11 03:31:01.653484
NCT01488513|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-08-19|||August 2011||2011-08-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|August 2014|Actual|2014-08-01||Interventional|ABC-101||ABC294640 in Treating Patients With Advanced Solid Tumors|A Phase I, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of ABC294640 in Patients With Advanced Solid Tumors|Completed||Phase 1|22|Actual|RedHill Biopharma Limited||1|||f||||t||||||||||2017-10-11 03:31:01.753281|2017-10-11 03:31:01.753281
NCT01488500|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2012-08-03|||November 2011||2011-11-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Woodsmoke Exposure and Cardiovascular Function|Cardiovascular Effects of Experimental Exposure to Woodsmoke in Man|Completed||N/A|20|Anticipated|University of Edinburgh||3|||f||||f||||||||||2017-10-11 03:31:01.841772|2017-10-11 03:31:01.841772
NCT01488487|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-03-08|2015-12-18||December 2011||2011-12-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Patients assigned to treatment|Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma|Phase II Single Arm Study of Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC)|Completed||Phase 2|24|Actual|UNC Lineberger Comprehensive Cancer Center|Unplanned interim analysis due to negative results from another trial found conditional probability of rejecting null hypothesis based on events in the 24 patients enrolled was 0.08. Accrual goals had been met and study was complete per protocol.|1|||f||||t||||||||No||2017-10-11 03:31:01.935187|2017-10-11 03:31:01.935187
NCT01488474|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2015-01-29|||January 2012||2012-01-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Peripheral Nerve Stimulation in Diabetic Patients|Influence of Diabetic Neuropathy on Current Settings During Peripheral Nerve Stimulation in Regional Anesthesia|Completed||N/A|124|Actual|Medical University of Graz|||2||f||||f||||||Samples With DNA|"     -  blood samples        -  any material from surgical resections   "|||2017-10-11 03:31:02.427105|2017-10-11 03:31:02.427105
NCT01488461|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2015-06-12|||January 2012||2012-01-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|ATAXIC||Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias|Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias|Completed||N/A|165|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Blood sample   "|||2017-10-11 03:31:02.510358|2017-10-11 03:31:02.510358
NCT01488448|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-01-31|2014-08-07||November 2011||2011-11-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|July 2014|Actual|2014-07-01||Interventional|||A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis|A Double-Blind, Controlled, Randomized Clinical Trial of Nebulized Hypertonic Saline for Hospitalized Infants With Viral Bronchiolitis|Completed||N/A|227|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 03:31:02.613445|2017-10-11 03:31:02.613445
NCT01488435|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-12-05|||November 2011||2011-11-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age||Completed||N/A|310|Actual|Mead Johnson Nutrition||2|||f||||f||||||||||2017-10-11 03:31:04.848017|2017-10-11 03:31:04.848017
NCT01488422|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-01-14|||December 2011||2011-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Neural Correlates of Stress Reduction|Structural and Functional Mechanisms of Stress Reduction|Completed||N/A|140|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:31:04.970862|2017-10-11 03:31:04.970862
NCT01488409|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2016-02-02|2016-01-04||May 2012||2012-05-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Acipimox on Mitochondrial Function in Obesity|The Effects of Short Term Acipimox Treatment on Skeletal Muscle Phosphocreatine Recovery in Obesity|Completed||Phase 2|39|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:31:05.097438|2017-10-11 03:31:05.097438
NCT01488396|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-08|2011-12-06|||February 2007||2007-02-01|December 2011|2011-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye|Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye|Completed||Phase 4|31|Actual|Mahidol University||1|||f||||f||||||||||2017-10-11 03:31:05.592587|2017-10-11 03:31:05.592587
NCT01488383|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-07|2015-09-07|||September 2013||2013-09-01|September 2015|2015-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Effect of Stevioside in Postpandrial Glucose in Healthy Adults|Comparison of the Effect on Postpandrial Capillary Blood Glucose Between Oral Stevioside Versus Saccharin in Healthy Adults.|Withdrawn||N/A|0|Actual|Basque Health Service||2||not i|f||||f||||||||||2017-10-11 03:31:05.684274|2017-10-11 03:31:05.684274
NCT01488370|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-04-14|2016-12-08||November 2011||2011-11-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Comparison of 2 Laryngoscopes for Endotracheal Intubation in Children Younger Than 2 Years Old|A Comparison of the Glidescope® Video Laryngoscope and the Storz DCI® Video Laryngoscope for Endotracheal Intubation in Children Younger Than Two Years of Age|Completed||N/A|65|Actual|Loma Linda University|Trainees reported more prior intubation experience using DL than the other laryngoscopes, so we were unable to equalize prior clinical experience between DL & other laryngoscopes. Assessment of learning effect limited by intubation types within study|3|||f||||f||||||||No||2017-10-11 03:31:05.79287|2017-10-11 03:31:05.79287
NCT01488357|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-04-25|||June 2012||2012-06-01|April 2017|2017-04-01|June 30, 2016|Actual|2016-06-30|February 27, 2014|Actual|2014-02-27||Observational|||Patient Preferences for Breast Reconstruction After Mastectomy|Patient Preferences for Breast Reconstruction After Mastectomy|Completed||N/A|145|Actual|UNC Lineberger Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-11 03:31:06.435481|2017-10-11 03:31:06.435481
NCT01488344|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2013-12-10|||March 2012||2012-03-01|December 2013|2013-12-01||||November 2014|Anticipated|2014-11-01||Interventional|||Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)|A Single-arm, Open Label, Multi-center Phase I/II Trial to Assess the Safety and Efficacy of BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With AML Unfit for an Intensive Induction Therapy|Unknown status|Active, not recruiting|Phase 1/Phase 2|140|Anticipated|University Hospital Muenster||1|||f||||t||||||||||2017-10-11 03:31:06.517431|2017-10-11 03:31:06.517431
NCT01488331|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2016-11-01|||June 2010||2010-06-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer|A Patient Cohort With Locally Advanced or Metastatic Non-small Cell Lung Cancer Treated With Tarceva (Erlotinib) Monotherapy and Not Progressing After at Least 9 Months|Completed||N/A|217|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:31:06.633171|2017-10-11 03:31:06.633171
NCT01488318|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2016-11-02|||October 2013||2013-10-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma|Phase II Trial of Cetuximab and Dasatinib in Patients With Cetuximab-resistant, Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck and Low Serum IL-6|Terminated||Phase 2|21|Actual|University of Pittsburgh||1||PI leaving the institution|f||||t||||||||No||2017-10-11 03:31:07.018058|2017-10-11 03:31:07.018058
NCT01488305|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-07|||October 2010||2010-10-01|December 2011|2011-12-01|March 2012|Anticipated|2012-03-01|February 2012|Anticipated|2012-02-01||Interventional|MNP||Action Against Malnutrition Through Agriculture (AAMA) Plus MNP Study|Impact of Micronutrient Powders (MNP)With Homestead Food Production and an Intensive Community Level IYCF-BCC Intervention on Reducing Anemia and Improving Growth in Young Children, Nepal|Unknown status|Active, not recruiting|N/A|334|Actual|Helen Keller International||3|||f||||t||||||||||2017-10-11 03:31:07.16946|2017-10-11 03:31:07.16946
NCT01488292|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2015-06-04|||August 2009||2009-08-01|December 2014|2014-12-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|||RECAP Multi-Component Intervention Program|Multi-Component Mental Health & Academic Intervention for Student Reintegration|Completed||Phase 2|150|Actual|Vanderbilt University||2|||f||||||||||||||2017-10-11 03:31:07.316891|2017-10-11 03:31:07.316891
NCT01488266|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2011-12-06|||November 2011||2011-11-01|December 2011|2011-12-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|||Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder|Comparison of Aripiprazole Augmentation vs Switching to Different Class of Antidepressants for Patients With MDD Who Are Partially/Minimally Responsive to Current Antidepressants:Randomized, Rater-blinded, Prospective Study|Unknown status|Active, not recruiting|N/A|90|Anticipated|Korea University||2|||f||||f||||||||||2017-10-11 03:31:07.543911|2017-10-11 03:31:07.543911
NCT01488253|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2015-03-31|||January 2012||2012-01-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|||Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants|Multicenter Trials to Evaluate the Efficacy and Toxicity of Sirolimus/Tacrolimus Combination as a GVHD Prophylaxis After HLA Matched Related PBSCT|Terminated||Phase 2|3|Actual|The Korean Society of Blood and Marrow Transplantation||1||"We could not receive the support from the national medical insurance owing to the changed   policy of the government for clincal trials."|f||||t||||||||||2017-10-11 03:31:07.684263|2017-10-11 03:31:07.684263
NCT01488240|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-11-14|||November 2012||2012-11-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars|The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars|Recruiting||Phase 1|12|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-10-11 03:31:07.821922|2017-10-11 03:31:07.821922
NCT01488227|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2013-02-22|||August 2011||2011-08-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Prospective Trial on the Effects of Vitamin D Supplementation in Collegiate Swimmers and Divers|A Prospective Trial on the Effects of Vitamin D Supplementation on 25(OH)D, Body Composition and Injury in Collegiate Swimmers and Divers|Completed||Phase 3|45|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-11 03:31:08.052934|2017-10-11 03:31:08.052934
NCT01488214|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2017-05-17|||February 16, 2011|Actual|2011-02-16|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|NeuroScS||Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic Sclerosis|Assessment of Neuropsychiatric Involvement in Systemic Sclerosis.|Recruiting||N/A|108|Anticipated|University Hospital, Lille||2|||f||||f|f|f||||||No||2017-10-11 03:31:08.192532|2017-10-11 03:31:08.192532
NCT01488201|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2012-11-01|||November 2011||2011-11-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis|A Randomized, Placebo-controlled, Ascending Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KHK4827 in Healthy Volunteers and Subjects With Moderate to Severe Psoriasis|Completed||Phase 1|48|Anticipated|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||||2017-10-11 03:31:08.339123|2017-10-11 03:31:08.339123
NCT01488188|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2013-11-05|2013-07-31||December 2011||2011-12-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route|A Controlled Study to Determine the Immunogenicity and Safety of Cold-adaptive Live Attenuated Influenza Vaccine (Flumist) Administered by the Nasal and Sublingual Route in Healthy Adult Volunteers|Completed||Phase 1|40|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-10-11 03:31:08.431873|2017-10-11 03:31:08.431873
NCT01488175|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2015-03-17|||January 2012||2012-01-01|March 2015|2015-03-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Clinical and Stereoradiological Comparison of the Results After Primary Cemented Total Knee Arthroplasty Inserted With or Without the Use of a Tourniquet|Clinical and Stereoradiological Comparison of the Results After Primary TKA Inserted With or Without the Use of a Tourniquet|Withdrawn||Phase 4|0|Actual|Hvidovre University Hospital||2||Funding problems|f||||t||||||||||2017-10-11 03:31:08.88307|2017-10-11 03:31:08.88307
NCT01488162|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-03-21|||April 4, 2011|Actual|2011-04-04|March 2017|2017-03-01|October 24, 2016|Actual|2016-10-24|October 24, 2016|Actual|2016-10-24||Observational|||An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia|Non Interventional Study Aimed to Describe the Management of Relapse or Refractory Chronic Lymphocytic Leukemia (CLL) Patients Retreated by MabThera|Completed||N/A|327|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:31:09.005791|2017-10-11 03:31:09.005791
NCT01488149|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-05-29|||February 2012||2012-02-01|May 2012|2012-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Observational|||Intrapartum Epidural Fentanyl and Breast-feeding in the Immediate Postpartum Period: a Prospective Cohort Study|Intrapartum Epidural Fentanyl and Breast-feeding in the Immediate Postpartum Period: a Prospective Cohort Study|Unknown status|Recruiting|N/A|500|Anticipated|University Hospitals Cleveland Medical Center|||2||f||||t||||||||||2017-10-11 03:31:09.266313|2017-10-11 03:31:09.266313
NCT01488123|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-10-24|||January 2012||2012-01-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|August 2014|Actual|2014-08-01||Interventional|IACS||Integrative Approaches for Cancer Survivorship|A Whole Systems Approach to the Study of Ayurveda for Cancer Survivorship, Project II|Completed||N/A|32|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 03:31:09.469261|2017-10-11 03:31:09.469261
NCT01488110|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-06-17|||January 2012||2012-01-01|June 2013|2013-06-01||||||||Interventional|||Investigation of Efficacy and Outcome of a New Medical Device for Treatment of Migraine|Undersökning av ny Behandlingsmetod Vid migränanfall (Evaluation of a New Treatment for Migraine Attacks)|Terminated||N/A|40|Anticipated|Karolinska University Hospital||2||"Too slow recruitment rate. The study has been terminated and will be re-started with an   improved and more suitable study design."|f||||f||||||||||2017-10-11 03:31:09.592023|2017-10-11 03:31:09.592023
NCT01488097|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-26|2017-01-23|2016-01-14||November 2011||2011-11-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|March 2014|Actual|2014-03-01||Interventional|||Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency|An Open Label Multicenter Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 in Adult Subjects With Liver Dysfunction Due to Lysosomal Acid Lipase Deficiency Who Previously Received Treatment in Study LAL-CL01|Active, not recruiting||Phase 2|8|Actual|Alexion Pharmaceuticals||3|||f||||t||||||||||2017-10-11 03:31:09.724968|2017-10-11 03:31:09.724968
NCT01488084|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2012-12-11|||June 2010||2010-06-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Assessing Vein Graft Properties Between Conventional & No-Touch Harvesting Technique - (PATENT SVG)|Comparative Evaluation of Vasomotor Function in Saphenous Veins Harvested Using Pedicled vs Conventional Technique|Completed||Phase 1|15|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 03:31:10.658736|2017-10-11 03:31:10.658736
NCT01488071|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-02-11|2013-12-19||January 2012||2012-01-01|February 2014|2014-02-01||||December 2012|Actual|2012-12-01||Interventional|REVIVE|"Age and Gender: All-patients-treated set (APTS) – all patients in the APRS who took at least one dose of investigational medicinal product (IMP).
Study Specific Characteristics: Full-analysis set (FAS) - all patients in the APTS who had a valid baseline assessment and at least one valid post-baseline assessment of the MADRS total score."|A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication|A Randomised, Double-blind, Parallel-group, Active-controlled, Flexible Dose Study Evaluating the Effects of [Vortioxetine] Lu AA21004 Versus Agomelatine in Adult Patients Suffering From Major Depressive Disorder With Inadequate Response to Antidepressant Treatment|Completed||Phase 3|495|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 03:31:10.820954|2017-10-11 03:31:10.820954
NCT01488058|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-09-18|||December 2011||2011-12-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Cognitive Bias Modification (CBM) and Internet Cognitive Behavioural Therapy (iCBT) for Depression- A Randomised Controlled Trial|A Randomised Controlled Trial Comparing Internet Based Cognitive Behavioural Therapy for Major Depressive Disorder Plus a Cognitive Bias Modification Intervention (OxIGen) vs. Internet Based Cognitive Behavioural Therapy for Major Depressive Disorder vs. a Waitlist Control on Symptoms of Depression and Negative Interpretation Bias.|Completed||N/A|69|Actual|St Vincent's Hospital, Sydney||2|||f||||t||||||||||2017-10-11 03:31:11.578251|2017-10-11 03:31:11.578251
NCT01488045|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2014-12-19|||June 2011||2011-06-01|December 2014|2014-12-01|June 2016|Anticipated|2016-06-01|January 2016|Anticipated|2016-01-01||Interventional|||Compare Propofol to Fentanyl and Midazolam for Colonoscopy|Randomized Trial to Compare Propofol to Fentanyl and Midazolam for Colonoscopy.|Unknown status|Active, not recruiting|N/A|290|Anticipated|Saint Joseph Mercy Health System||2|||f||||f||||||||||2017-10-11 03:31:11.693876|2017-10-11 03:31:11.693876
NCT01488032|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2011-12-08|||March 2011||2011-03-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma|Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma With Similar Structural Optic Nerve Damage|Completed||N/A|44|Actual|Technische Universität Dresden|||2||f||||f||||||||||2017-10-11 03:31:11.807359|2017-10-11 03:31:11.807359
NCT01488019|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-05-11|2017-03-21||March 2012||2012-03-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||Safety Set|Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate) Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|1071|Actual|Dey||2|||f||||f||||||||No||2017-10-11 03:31:11.948458|2017-10-11 03:31:11.948458
NCT01488006|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-07-07|||April 2001||2001-04-01|July 2015|2015-07-01|November 2012|Actual|2012-11-01|October 2009|Actual|2009-10-01||Observational|CSS||Columbia Shoulder Study (CSS)|5- Year Follow-up in Total Shoulder Arthroplasty for Primary Glenohumeral Osteoarthritis: A Prospective Multicenter Study|Completed||Phase 4|207|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 03:31:13.698094|2017-10-11 03:31:13.698094
NCT01487993|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-04-26|||August 2011||2011-08-01|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|August 2015|Actual|2015-08-01||Interventional|MetVoorMin||Metformin in Obese Children and Adolescents|An Efficacy, Safety and Pharmacokinetic Study on the Short-term and Long-term Use of Metformin in Obese Children and Adolescents|Completed||Phase 3|62|Actual|St. Antonius Hospital||2|||f||||t||||||||||2017-10-11 03:31:13.793155|2017-10-11 03:31:13.793155
NCT01487980|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-12-15|||January 2012||2012-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Delayed Cord Clamping on Haematological Status in Low Birth Weight Infants|The Effect of Delayed Cord Clamping on Haematological Status in Low Birth Weight Infants: a Randomised Controlled Trial in South Africa.|Completed||N/A|102|Anticipated|Stanger Hospital||2|||f||||f||||||||||2017-10-11 03:31:13.921399|2017-10-11 03:31:13.921399
NCT01487967|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-07-19|||January 2012||2012-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Preference and Goal Directed Attention Deficit Hyperactivity Disorder Care- Pilot Study|Preference and Goal-Directed Primary Care to Minimize Disparities and Improve Outcomes in ADHD|Completed||N/A|120|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||No||2017-10-11 03:31:14.039751|2017-10-11 03:31:14.039751
NCT01487954|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-06-01|2015-06-01||May 2010||2010-05-01|June 2015|2015-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy|Alkaline Water Consumption to Reduce Skin Radiation Toxicity in Women With Breast Cancer|Completed||Phase 2|45|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 03:31:14.228211|2017-10-11 03:31:14.228211
NCT01487941|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-11-19|||December 2011||2011-12-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|February 2013|Actual|2013-02-01||Observational|||Setrox JS Master Study|Efficacy and Safety of the Setrox JS Lead (J=J-shaped, S=Screw)|Completed||N/A|66|Actual|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 03:31:14.707634|2017-10-11 03:31:14.707634
NCT01487928|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-06-15|||December 2011||2011-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Human Milk Cream as a Caloric Supplement in Pre-Term Infants|A Randomized Study of the Use of Human Milk Cream as a Caloric Supplement in a Subset of Very Low Birth Weight Pre-Term Infants|Completed||N/A|78|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 03:31:14.799209|2017-10-11 03:31:14.799209
NCT01487915|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-09-22|||October 2010||2010-10-01|September 2014|2014-09-01||||June 2015|Anticipated|2015-06-01||Interventional|COACH||Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma|Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin Un-fit Advanced Urothelial Carcinoma: Randomized Phase II Study|Unknown status|Recruiting|Phase 2|80|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 03:31:14.924961|2017-10-11 03:31:14.924961
NCT01487902|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-07|||July 2010||2010-07-01|December 2011|2011-12-01||||October 2013|Anticipated|2013-10-01||Interventional|||The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer|Randomized Phase II Screening Trial of Docetaxel Plus Prednisolone With or Without Androgen Deprivation Treatment in Castrate-Resistant Prostatic Cancer|Unknown status|Recruiting|Phase 2|90|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 03:31:15.193764|2017-10-11 03:31:15.193764
NCT01487889|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-11-05|||April 2011||2011-04-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|PINGU||Polyunsaturated Fatty Acids in Child Nutrition|Polyunsaturated Fatty Acids in Child Nutrition - A German Multimodal Optimisation Study|Completed||N/A|214|Actual|Research Institute of Child Nutrition, Dortmund||3|||f||||f||||||||||2017-10-11 03:31:15.332543|2017-10-11 03:31:15.332543
NCT01487876|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-12-07|||September 2011||2011-09-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Interventional|||Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients|A Randomized Controlled Trial of Dual-plasmid HBV DNA Vaccine Mediated by in Vivo Electroporation in Chronic Hepatitis B Patients Under Lamivudine Chemotherapy|Unknown status|Recruiting|Phase 2|240|Anticipated|The 458 Hospital of Chinese PLA||2|||f||||t||||||||||2017-10-11 03:31:15.462038|2017-10-11 03:31:15.462038
NCT01487863|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-05-11|2017-03-27||December 2011||2011-12-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|May 2016|Actual|2016-05-01||Interventional|||Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer|A Randomized, Open-label, Phase 2 Trial of Sipuleucel-T With Concurrent Versus Sequential Administration of Abiraterone Acetate Plus Prednisone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)|Completed||Phase 2|69|Actual|Dendreon||2|||f||||f||||||||Undecided||2017-10-11 03:31:15.638096|2017-10-11 03:31:15.638096
NCT01487850|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-08|||May 2007||2007-05-01|December 2011|2011-12-01|October 2007|Actual|2007-10-01|June 2007|Actual|2007-06-01||Interventional|||Wind Instruments' Fungal Contamination|Study of Wind Reed Instruments' Fungal Contamination and Its Immunological and Clinical Consequences for Musicians.|Completed||N/A|||Centre Hospitalier Universitaire de Besancon|||||f||||f||||||||||2017-10-11 03:31:16.723512|2017-10-11 03:31:16.723512
NCT01487837|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-10-24|||January 2012||2012-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.|A Phase IV, Randomized, Single Center, Parallel Group Trial of Human Fibrinogen Concentrate (Haemocomplettan) in the Treatment of Dilutional Coagulopathy During Major Pediatric Surgery|Completed||Phase 4|57|Actual|University Children's Hospital, Zurich||2|||f||||t||||||||||2017-10-11 03:31:16.811546|2017-10-11 03:31:16.811546
NCT01487824|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-12-02|||May 2007||2007-05-01|June 2012|2012-06-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|EVS||What is the Impact of Early Life Exposures on the Cardiovascular System in Young Adulthood?|What is the Impact of Early Life Exposures on the Cardiovascular System in Young Adulthood? A 25-Year Follow-up Study of Preterm-born Individuals|Unknown status|Recruiting|N/A|250|Anticipated|University of Oxford|||2||f||||f||||||Samples With DNA|"     whole blood, serum, plasma, immortalised cell lines   "|||2017-10-11 03:31:16.982492|2017-10-11 03:31:16.982492
NCT01487811|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2017-01-05|||May 2005||2005-05-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers|Bioequivalence of Two Biphasic Insulin Aspart 30 (NovoLog® Mix 70/30) Formulations (Current and New Formulation With Glycerol): A Randomized, Double-Blind, Two-Period Crossover Study in Healthy Volunteers|Completed||Phase 1|50|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:31:17.098824|2017-10-11 03:31:17.098824
NCT01487798|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2017-01-05|||June 2002||2002-06-01|January 2017|2017-01-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|REACH||Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes|A Double-blind, Randomised, Crossover Study to Investigate the Difference in Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 Compared to Biphasic Human Insulin 30 in Patients With Well-controlled Type 2 Diabetes|Completed||Phase 4|170|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:31:17.237734|2017-10-11 03:31:17.237734
NCT01487785|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-01-24|||March 2012||2012-03-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients|A Phase Ib, Open-label, Multicenter, Dose-escalation, Safety and Tolerability Study of LDE225 in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 1|18|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:31:17.420086|2017-10-11 03:31:17.420086
NCT01487772|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-09-18|||April 2010||2010-04-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|Q-HIP||Improving Quality of Care for Hip-Fracture Patients: Studies on Fast-track Surgery|Improving Quality of Care for Hip-Fracture Patients: Studies on Fast-track Surgery|Completed||N/A|1307|Actual|Danderyd Hospital|||1||f||||f||||||||||2017-10-11 03:31:17.575252|2017-10-11 03:31:17.575252
NCT01487759|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2011-12-09|||March 2008||2008-03-01|December 2011|2011-12-01|July 2009||2009-07-01|||||Interventional|||Prebiotic Effect on Metabolites in Crohn's Disease|Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients|Completed||N/A|67|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 03:31:17.686641|2017-10-11 03:31:17.686641
NCT01487746|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-06|||December 2011||2011-12-01|December 2011|2011-12-01|September 2012|Anticipated|2012-09-01|March 2012|Anticipated|2012-03-01||Observational|||Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls|Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls.|Unknown status|Not yet recruiting|N/A|207|Anticipated|Meir Medical Center|||2||f||||f||||||Samples Without DNA|"     Serum samples of Stroke patients withdrawned within 36 hrs since stroke evoked. Healthy     controls   "|||2017-10-11 03:31:17.780189|2017-10-11 03:31:17.780189
NCT01487733|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-05-16|||December 22, 2011|Actual|2011-12-22|May 2017|2017-05-01|January 22, 2012|Actual|2012-01-22|January 22, 2012|Actual|2012-01-22||Observational|||Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301|Analysis of HPV and Other Biomarkers in Specimens From ECOG Studies in Recurrent or Metastatic Head and Neck Cancer (E1395 and E3301)|Completed||N/A|155|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 03:31:17.889729|2017-10-11 03:31:17.889729
NCT01487720|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2013-11-30|||October 2008||2008-10-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer|A Prosepctive Phase II Study of Gemcitabine and Oxaliplatin in Combination With Prednisolone for the Treatment of Hormone Refracotry Metastatic Prostate Cancer Previously Treated With Docetaxel Regimen|Completed||Phase 2|33|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:31:17.994436|2017-10-11 03:31:17.994436
NCT01487707|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2017-07-12|||December 2011||2011-12-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Community Based Strategies to Reduce Maternal Mortality in Northern Nigeria|Strengthening the Midwife Service Scheme With Community Focused Interventions: Evidence From a Randomized Controlled Field Trial in Nigeria|Completed||N/A|7200|Actual|Abdul Latif Jameel Poverty Action Lab||3|||f||||f||||||||||2017-10-11 03:31:18.114697|2017-10-11 03:31:18.114697
NCT01487694|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-24|||December 2011||2011-12-01|December 2011|2011-12-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Black Cohosh Extract for the Management of Moderate to Severe Menopausal Symptoms in Thai Women|Cimicifuga Racemosa Rhizome and Root Extract for the Management of Moderate to Severe Menopausal Symptoms in Thai Women: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|54|Anticipated|Mahidol University||2|||f||||t||||||||||2017-10-11 03:31:18.225436|2017-10-11 03:31:18.225436
NCT01487681|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2011-12-06|||November 2011||2011-11-01|December 2011|2011-12-01|October 2013|Anticipated|2013-10-01|October 2012|Anticipated|2012-10-01||Observational|||Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China|Prevaccination Distribution of Cervical Human Papillomavirus (HPV) Types and Their Associations With Invasive Cervical Cancer and Its Precursors in Yangtze River Delta Area, China|Unknown status|Recruiting|N/A|4000|Anticipated|Zhejiang University|||3||f||||f||||||Samples With DNA|"     The biospecimens are remainder tissue and exfoliated cervical cells of standard diagnosis and     surgery.   "|||2017-10-11 03:31:18.322048|2017-10-11 03:31:18.322048
NCT01487668|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2015-12-15|2015-11-10||December 2011||2011-12-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders|Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders|Completed||N/A|304|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 03:31:18.408048|2017-10-11 03:31:18.408048
NCT01487655|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2013-02-05|||September 2011||2011-09-01|September 2011|2011-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients|Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Primary Open-angle and Normal Tension Glaucoma Patients|Completed||N/A|150|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||||||2017-10-11 03:31:18.7198|2017-10-11 03:31:18.7198
NCT01487642|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-12-19|||August 2011||2011-08-01|December 2011|2011-12-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|Fristart||Comparison of Four Different Smoking Cessation Programmes|Study of the Effect of Two Different Types of Telephone Counselling Respectively and a Web-based Smoking Cessation Programme Among Adult Daily Cigarette Smokers.|Unknown status|Active, not recruiting|N/A|1600|Anticipated|University of Southern Denmark||4|||f||||t||||||||||2017-10-11 03:31:18.791087|2017-10-11 03:31:18.791087
NCT01487629|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2011-12-09|||April 2010||2010-04-01|December 2011|2011-12-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|IBERA-DME||Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema|Bevacizumab Versus Ranibizumab for Refractory Diabetic Macular Edema|Unknown status|Active, not recruiting|Phase 2|53|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:31:19.053308|2017-10-11 03:31:19.053308
NCT01487616|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-02-17|||September 2012||2012-09-01|February 2016|2016-02-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|PUMA||Prevalence of Congenital Uterine Malformations|Prevalence of Congenital Uterine Malformations in Women With a History of Preterm Delivery or Miscarriage|Recruiting||N/A|246|Anticipated|University of Nottingham|||3||f||||f||||||||No||2017-10-11 03:31:19.164019|2017-10-11 03:31:19.164019
NCT01487603|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-12-28|||October 2011||2011-10-01|December 2016|2016-12-01||||October 2017|Anticipated|2017-10-01||Observational|||Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer|Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer|Recruiting||N/A|400|Anticipated|University Health Network, Toronto|||1||f||||f|||||||"     Tissue.   "|||2017-10-11 03:31:19.277708|2017-10-11 03:31:19.277708
NCT01487590|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-01-16|||October 2006||2006-10-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|ACUVERSE||Cephalic Version by Acupuncture-Moxibustion for Breech Presentation|A Simple Blind Controlled Randomized Trial: Cephalic Version by Acupuncture-moxibustion vs Placebo for Breech Presentation|Completed||N/A|328|Actual|University Hospital, Lille||2|||f||||f||||||||||2017-10-11 03:31:19.361673|2017-10-11 03:31:19.361673
NCT01487577|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-05-13|2016-02-24||June 2010||2010-06-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Interventional||Pediatric hematopoietic stem cell recipients undergoing myeloablative conditioning therapy|Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention|A Pilot Study of Pharmacokinetics-based Mycophenolate Mofetil Dosing for Graft-Versus-Host-Disease Prophylaxis in Pediatric Blood and Marrow Transplantation|Completed||Phase 2|19|Actual|University of Pittsburgh|Our study is limited by small sample size and heterogeneity in stem cell sources. Besides targeted MMF dosing, other factors that might have affected clinical outcomes include duration of MMF and use of ATG in unrelated-donor transplants.|1|||f||||t||||||||||2017-10-11 03:31:19.485764|2017-10-11 03:31:19.485764
NCT01487564|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2013-03-01|||October 2011||2011-10-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Pharmacokinetic Profile of OROS Hydromorphone in Healthy Taiwanese Participants With Different Genotypes for the UGT2B7 Gene|A Single-Dose, Open-Label Study to Evaluate the Pharmacokinetic Profile of OROS Hydromorphone in Healthy Adult Taiwanese Subjects Having Different Genotypes for the UGT2B7 Gene|Completed||Phase 1|29|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 03:31:19.967482|2017-10-11 03:31:19.967482
NCT01487551|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-06|2014-08-26|||December 2011||2011-12-01|August 2014|2014-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)|An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)|Completed||Phase 2|9|Actual|Active Biotech AB||1|||f||||f||||||||||2017-10-11 03:31:20.127846|2017-10-11 03:31:20.127846
NCT01487538|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-02-05|||April 2012||2012-04-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Weight Maintenance Through Physical Activity and Social Support in Rural Middle-Aged Women|Weight Maintenance Through Physical Activity and Social Support in Rural Middle-Aged Women|Completed||N/A|52|Actual|University of Nebraska||2|||f||||t||||||||||2017-10-11 03:31:20.221242|2017-10-11 03:31:20.221242
NCT01487525|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-01-05|2015-06-11||November 2011||2011-11-01|January 2016|2016-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|PBFR3|Control BFR p-value Age (years) 56.1±7.7 58.4±8.7 0.377|Assessment of Efficacy of Low Intensity Resistance Training in Men at Risk for Symptomatic Knee Osteoarthritis|Assessment of Efficacy of Low Intensity Resistance Training in Men at Risk for Symptomatic Knee Osteoarthritis|Completed||N/A|44|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 03:31:20.331026|2017-10-11 03:31:20.331026
NCT01487512|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-11-15|||March 2011||2011-03-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Dose on the Pharmacokinetics of OROS Hydromorphone Under Fasted Conditions in Healthy Taiwanese Participants|A Single-Dose, Open-Label, Randomized, Crossover Dose Proportionality Study to Evaluate the Effect of Dose on the Pharmacokinetics of 8, 16, 32 and 64 mg OROS Hydromorphone Under Fasted Conditions in Healthy Adult Taiwanese Subjects|Completed||Phase 1|29|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||f||||||||||2017-10-11 03:31:20.622879|2017-10-11 03:31:20.622879
NCT01487499|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2015-05-15|2015-03-16||December 2011||2011-12-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|SCLC||Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)|Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer|Terminated||Phase 3|4|Actual|University of Florida||2||Unable to enroll adequate number of participants|f||||t||||||||||2017-10-11 03:31:20.726839|2017-10-11 03:31:20.726839
NCT01487486|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-12-05|||December 2011||2011-12-01|December 2011|2011-12-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Observational|||Proteomics & Glyco-Proteomic Analysis of Follicular Fluid|Proteomics & Glyco-Proteomic Analysis of Follicular Fluid Derived From Health Patient/Donors and Polycystic Ovary Syndrome Patients|Unknown status|Not yet recruiting|N/A|30|Anticipated|University of Cincinnati|||3||f||||f||||||Samples Without DNA|"     Follicular Fluid   "|||2017-10-11 03:31:20.936121|2017-10-11 03:31:20.936121
NCT01487473|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-02-12|||December 2011||2011-12-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||The Effects of Mindfulness-Based Stress Reduction on Attention and Pain-related Symptoms in Chronic Pain Patients|The Effects of Mindfulness-Based Stress Reduction on Attention and Pain-related Symptoms in Chronic Pain Patients: A Randomized Controlled Trial|Completed||N/A|49|Actual|York University||2|||f||||f||||||||||2017-10-11 03:31:21.054522|2017-10-11 03:31:21.054522
NCT01487460|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-04-15|||November 2011||2011-11-01|April 2016|2016-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients|A First-in-human Randomized, Double-blind, Placebo-controlled, 4-part Study to Assess Safety, Tolerability, Pharmacokinetics (Including Open Label Study of Food Effect and Interaction With Simvastatin) and Pharmacodynamics of Interwoven Single- and Multiple-ascending Doses of TAP311 in Healthy Subjects and Dyslipidemic Patients.|Completed||Phase 1|137|Actual|Novartis||4|||f||||||||||||||2017-10-11 03:31:21.169577|2017-10-11 03:31:21.169577
NCT01487447|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-07-03|||January 2010||2010-01-01|July 2013|2013-07-01||||July 2014|Anticipated|2014-07-01||Interventional|||Customized Acoustic Stimulation for the Treatment of Tinnitus||Unknown status|Active, not recruiting|Phase 2/Phase 3|60|Anticipated|University of California, Irvine||2|||f||||||||||||||2017-10-11 03:31:21.296738|2017-10-11 03:31:21.296738
NCT01487434|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2016-03-23|||September 2011||2011-09-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||A Randomized Study to Abate Truancy and Violence in Grades 3-9 in Chicago Public Schools|Preventing Truancy in Urban Schools Through Provision of Social Services by Truancy Officers|Active, not recruiting||N/A|600|Anticipated|Northwestern University||1|||f||||f||||||||||2017-10-11 03:31:21.380242|2017-10-11 03:31:21.380242
NCT01487421|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2014-06-23|||July 2003||2003-07-01|June 2014|2014-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime|The Physiological Therapy of Type 2 Diabetes - NovoRapid® FlexPen® Before Meals, Additionally Levemir® FlexPen® in the Evening or at Bedtime if Needed|Completed||N/A|2134|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:31:21.481885|2017-10-11 03:31:21.481885
NCT01487408|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-03-03|||April 2002||2002-04-01|March 2016|2016-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Special Survey for Type 1 or Type 2 Diabetic Patients|Special Survey for Type 1 or Type 2 Diabetic Patients|Completed||N/A|1463|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:31:21.565199|2017-10-11 03:31:21.565199
NCT01487395|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-04-08|||December 2011||2011-12-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|PharmacogWP3||Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development|Effect of a 15-day Donepezil Treatment on Biomarkers of AD in Healthy Volunteers|Completed||Phase 1|30|Actual|University Hospital, Lille||2|||f||||f||||||||||2017-10-11 03:31:21.656864|2017-10-11 03:31:21.656864
NCT01487382|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-03-03|||April 2002||2002-04-01|March 2016|2016-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Special Survey for Paediatric Subjects|Special Survey for Paediatric Subjects|Completed||N/A|241|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:31:21.764187|2017-10-11 03:31:21.764187
NCT01487369|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-03-03|||April 2002||2002-04-01|March 2016|2016-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Special Survey of Production of Insulin Aspart Specific Antibody|Special Survey of Production of Insulin Aspart (IAsp) Specific Antibody|Completed||N/A|204|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:31:21.881641|2017-10-11 03:31:21.881641
NCT01487356|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-12-05|||May 2008||2008-05-01|December 2011|2011-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Factors Associated With Short Withdrawal Time and Polyp Detection Rate During Colonoscopy|Factors Associated With Short Withdrawal Time and Polyp Detection Rate During Colonoscopy|Completed||N/A|802|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 03:31:22.00027|2017-10-11 03:31:22.00027
NCT01487343|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2016-11-07|||November 2011||2011-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Patient Factors Impacting Adherence to Oral Chemotherapy|A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy|Completed||N/A|79|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:31:22.128431|2017-10-11 03:31:22.128431
NCT01487330|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-08-05|||August 2011||2011-08-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Interventional|SJM TAVI FIH||First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System|First In Human Experience and Assessment of the 23mm SJM Transcatheter Aortic Valve Implant and the SJM TAVI Transfemoral Delivery System (SJM TAVI FIH)|Completed||N/A|10|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 03:31:22.241513|2017-10-11 03:31:22.241513
NCT01487317|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-07-19|||June 2011||2011-06-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|confuriv||Rivastigmine in the Management of Delirium|A Randomized, Double-blind, Placebo-controlled Study of an Acetylcholinesterase Inhibitor in the Management of Delirium in Hospitalized Patients Aged 75 Years and Over|Completed||Phase 3|23|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:31:22.365386|2017-10-11 03:31:22.365386
NCT01487304|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-10-14|||April 2005||2005-04-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy|"Impact of Professional Societies Recommendations on Practical Use of Hormone Replacement Therapy - Project WOMAN 2005"|Completed||N/A|3760|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:31:22.477256|2017-10-11 03:31:22.477256
NCT01487291|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-12-15|||January 2013||2013-01-01|December 2014|2014-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients|Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients|Completed||N/A|176|Actual|Universidade Federal do Rio de Janeiro|||1||f||||t||||||||||2017-10-11 03:31:22.556908|2017-10-11 03:31:22.556908
NCT01487278|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-01-08||||||January 2014|2014-01-01||||||||Interventional|||Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali|Preventing Postpartum Hemorrhage: Examining Two Strategies for PPH Prevention in Communities: Misoprostol and Oxytocin in UnijectTM in Mali|Withdrawn||N/A|0|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 03:31:22.651941|2017-10-11 03:31:22.651941
NCT01487252|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-04-10|||December 2011||2011-12-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||Circadian Phase Assessments at Home||Completed||N/A|73|Actual|Rush University Medical Center||2|||f||||t||||||||||2017-10-11 03:31:22.905079|2017-10-11 03:31:22.905079
NCT01487239|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-11-01|||December 2011||2011-12-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects|A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects|Completed||Phase 1|4|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:31:22.979728|2017-10-11 03:31:22.979728
NCT01487226|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2011-12-06|||January 2008||2008-01-01|December 2011|2011-12-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer|A Phase II Trial of Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in FIGO Stage IA2-IIA Cervical Cancer|Unknown status|Recruiting|Phase 2|69|Anticipated|Korean Gynecologic Oncology Group||1|||f||||f||||||||||2017-10-11 03:31:23.061825|2017-10-11 03:31:23.061825
NCT01487213|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-08-06|||September 2011||2011-09-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Routine Follow-up Versus Self-assessment in Medical Abortion|Routine Follow-up Versus Self-assessment of Complete Abortion Following Medical Abortion, Effect on Its Success and Acceptability: a Randomized Controlled Trial|Completed||N/A|929|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 03:31:23.152416|2017-10-11 03:31:23.152416
NCT01487200|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-11-16|||July 2012||2012-07-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee|A Double-Blind, Randomized, Parallel Group, Active Comparator Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects (HPA Axis) of FX006 in Patients With Osteoarthritis of the Knee|Completed||Phase 2|24|Actual|Flexion Therapeutics, Inc.||4|||f||||f||||||||||2017-10-11 03:31:23.239942|2017-10-11 03:31:23.239942
NCT01487187|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-03-07|||November 2011||2011-11-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Cord Milking on Hemodynamic Status of Preterm Infants|The Effect of Umbilical Cord Milking on Hemodynamic Status of Preterm Infants: a Randomized Controlled Trial|Active, not recruiting||N/A|73|Actual|IWK Health Centre||2|||f||||t||||||||Yes||2017-10-11 03:31:23.331914|2017-10-11 03:31:23.331914
NCT01487174|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-07-21||2014-07-21|November 2011||2011-11-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|June 2013|Actual|2013-06-01||Interventional|||KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy|A Multi-Center, Phase 3, Double-Blind, Randomized, and Controlled Trial of KD019 vs Erlotinib in Subjects With Stage IIIB/IV Non-Small Cell Lung Cancer Who Have Progressed After First- or Second-Line Chemotherapy|Terminated||Phase 3|8|Actual|Kadmon Corporation, LLC||2||"Kadmon has made a business decision to terminate the study due to slow enrollment. Note the   decision to terminate the study was not related to safety issues"|f||||||||||||||2017-10-11 03:31:23.426818|2017-10-11 03:31:23.426818
NCT01487161|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2016-05-03||2015-03-16|June 2012||2012-06-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study of FX006 in Patients With Osteoarthritis of the Knee|A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the Knee|Completed||Phase 2|229|Actual|Flexion Therapeutics, Inc.||4|||f||||f||||||||||2017-10-11 03:31:23.559147|2017-10-11 03:31:23.559147
NCT01487148|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2011-12-06|||December 2011||2011-12-01|December 2011|2011-12-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Observational|||POCARED Diagnostics, LTD, Field Study Protocol|POCARED Diagnostics, LTD, Field Study Protocol|Unknown status|Not yet recruiting|N/A|40000|Anticipated|Pocared Diagnostics|||1||f||||f||||||None Retained|"     Samples are de-identified leftover samples.   "|||2017-10-11 03:31:23.749559|2017-10-11 03:31:23.749559
NCT01487135|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-10-09|||December 2011||2011-12-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|TQT||Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects|A Randomized, Double-blind, Placebo- and Active-controlled, 3-way Crossover, Phase 1 Study to Evaluate the Effect of EVP-6124 at Therapeutic and Supratherapeutic Concentrations Following a 2-dose EVP-6124 Regimen on the QT Interval in Healthy Male and Female Subjects.|Completed||Phase 1|60|Actual|FORUM Pharmaceuticals Inc||3|||f||||f||||||||||2017-10-11 03:31:23.861059|2017-10-11 03:31:23.861059
NCT00005428|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||August 1993||1993-08-01|May 2000|2000-05-01|July 1995|Actual|1995-07-01|||||Observational|||Familial Aggregation of Stress Response||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.168786|2017-10-11 04:27:03.168786
NCT01487109|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-03-12|||January 2012||2012-01-01|July 2014|2014-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients|A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy|Completed||Phase 2|170|Actual|Concert Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:31:24.343307|2017-10-11 03:31:24.343307
NCT01487096|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-10-03|||April 2001||2001-04-01|October 2012|2012-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses|A Phase II Study of the Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses|Completed||Phase 2|179|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 03:31:24.612404|2017-10-11 03:31:24.612404
NCT01487083|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2013-01-11||2013-01-11|December 2011||2011-12-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Long-Term Study in Schizophrenia|Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia|Terminated||Phase 3|282|Anticipated|Eli Lilly and Company||1||"The decision to stop the trial was based on efficacy results in the overall schizophrenia   participant population."|f||||f||||||||||2017-10-11 03:31:24.775588|2017-10-11 03:31:24.775588
NCT01487070|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-05|||April 2011||2011-04-01|April 2011|2011-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy|A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy|Completed||Phase 1|5|Actual|Retina Institute of Hawaii||1|||f||||||||||||||2017-10-11 03:31:25.168482|2017-10-11 03:31:25.168482
NCT01487057|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2012-12-26|||February 2011||2011-02-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Observational|LITCA||Lipid Metabolic Status in Thyroid Carcinoma|"Evaluation of Lipid Metabolic Status and of Cardiovascular Risk at Patients With Thyroid Carcinoma, Radically Treated and With Chronic Thyroid Hormonal Substitution"|Completed||N/A|52|Actual|Prof. Dr. I. Chiricuta Institute of Oncology|||2||f||||f||||||||||2017-10-11 03:31:25.317442|2017-10-11 03:31:25.317442
NCT01487044|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2011-12-05||||||December 2011|2011-12-01||||||||Expanded Access|GUARDIAN||A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema|A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema|Available||N/A|||Retina Institute of Hawaii|||||||||||||||||||2017-10-11 03:31:25.467442|2017-10-11 03:31:25.467442
NCT01487031|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2013-07-31|||November 2011||2011-11-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Music Therapy on Nausea and Pain for Autologous Stem Cell|Assessment of the Use of Music Therapy on Nausea and Pain During Hospitalization for Autologous Stem Cell Transplantation|Completed||N/A|108|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 03:31:25.627793|2017-10-11 03:31:25.627793
NCT01487018|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-10-20|||December 2011||2011-12-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||Evaluation of Navigation Assisted Reconstruction of Posttraumatic Zygomatic Deformity|Evaluation of the Application of Point-to-Point Computer-Assisted Navigation for Mirroring-Reconstructing of Unilateral Posttraumatic Zygomatic Deformity: A Randomized Controlled Trial|Completed||Phase 3|103|Actual|Peking University||2|||f||||t||||||||||2017-10-11 03:31:25.791556|2017-10-11 03:31:25.791556
NCT01487005|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2012-06-08|||January 2012||2012-01-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|MOSES||Cardiovascular Effects of Exposure to Ozone|Multicenter Ozone Study in Elderly Subjects|Unknown status|Recruiting|N/A|90|Anticipated|Health Effects Institute|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 03:31:25.932724|2017-10-11 03:31:25.932724
NCT01486992|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-01-11|||November 2011||2011-11-01|November 2011|2011-11-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus||Unknown status|Recruiting|Phase 2|40|Anticipated|Peking University||1|||f||||f||||||||||2017-10-11 03:31:26.157174|2017-10-11 03:31:26.157174
NCT01486979|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2017-02-06|||January 2007||2007-01-01|February 2017|2017-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis|A Pharmacokinetic Randomized Study With a Parallel Group Design to Assess the Extent of Systemic Absorption of Estradiol During Treatment With a 10 µg or 25 µg Estradiol Vaginal Tablet Administered Once Daily for 2 Weeks Followed by 10 Weeks of Twice-Weekly Maintenance Therapy in Postmenopausal Women With Atrophic Vaginitis|Completed||Phase 1|58|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:31:26.294802|2017-10-11 03:31:26.294802
NCT01486966|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2017-02-09|2013-04-22||November 2011||2011-11-01|February 2017|2017-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes|A 2-week, Randomised, Controlled, Open-label, Two-group Parallel, Multi-centre Trial Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin Both in a Basal Bolus Regimen With or Without Metformin in Chinese Inpatients With Type 2 Diabetes Currently Treated With Insulin Qualifying for Intensified Treatment|Terminated||Phase 4|58|Actual|Novo Nordisk A/S|The size of population analysed in study was smaller than that planned in the protocol. Therefore, the superiority of experimental products to comparator could not be concluded with sufficient statistical power.|2||Trial terminated prematurely due to slow recruitment.|f||||f||||||||||2017-10-11 03:31:26.468147|2017-10-11 03:31:26.468147
NCT01486953|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-26|2013-07-22|||November 2011||2011-11-01|July 2013|2013-07-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Pulmonary Mechanics During Minimally Invasive Repair of Pectus Excavatum|Phase 4 Study of Desflurane and Sevoflurane That Affect Pulmonary Mechanics During Minimally Invasive Repair of Pectus Excavatum|Unknown status|Recruiting|Phase 4|70|Anticipated|The Catholic University of Korea||2|||f||||f||||||||||2017-10-11 03:31:27.33596|2017-10-11 03:31:27.33596
NCT01486069|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-06-12|||July 2012||2012-07-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Observational|||Mandibular Stability and Dentofacial Deformity|Evaluation of the Perioperative Mandibular Positional Stability in Subjects With Dentofacial Deformity|Completed||N/A|30|Actual|University of Sao Paulo|||1||f||||t||||||||||2017-10-11 03:31:39.577042|2017-10-11 03:31:39.577042
NCT01486940|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2017-01-26|||March 2002||2002-03-01|January 2017|2017-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes|A Multi-centre, Multinational, Open-labelled, Randomised, Parallel-Group Comparison of Insulin Detemir Plus Insulin Aspart With NPH Insulin Plus Human Soluble Insulin in Subjects With Type 1 Diabetes on a Basal-Bolus Regimen|Completed||Phase 3|598|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:31:27.438162|2017-10-11 03:31:27.438162
NCT01486927|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-19|2016-06-24|2016-06-24|2015-12-11|February 2012||2012-02-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A|A Phase I/III Open-label, Multicenter, Crossover Safety, Efficacy and Pharmacokinetic Study of Recombinant Coagulation Factor VIII (rFVIII) Compared to Recombinant Human Antihaemophilic Factor VIII (rFVIII; INN: Octocog Alfa) in Subjects With Hemophilia A, and a Repeat PK, Safety and Efficacy Study|Completed||Phase 2/Phase 3|175|Actual|CSL Behring||1|||f||||||||||||||2017-10-11 03:31:27.698469|2017-10-11 03:31:27.698469
NCT01486914|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2017-02-28|||January 19, 2003|Actual|2003-01-19|February 2017|2017-02-01|February 24, 2003|Actual|2003-02-24|February 24, 2003|Actual|2003-02-24||Interventional|||Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process|A Single Centre, Randomized, Balanced Double Blind, Cross-Over Trial Investigating the Bioequivalence of NovoRapid® Produced by the Current Process and Insulin Aspart With the Same Formulation as NovoRapid®, Produced by the NN2000 Process|Completed||Phase 1|28|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:31:28.551044|2017-10-11 03:31:28.551044
NCT01486901|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-04-27|||May 2006||2006-05-01|April 2015|2015-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Bioequivalence of Two Insulatard® Formulations in Healthy Subjects|A Randomised, Single Centre, Double-blind, Two-period Cross-over, Glucose Clamp Trial to Test for Bioequivalence Between Insulatard® (600 Nmol/ml) and Insulatard® (1998 Nmol/ml) in Healthy Subjects|Completed||Phase 1|44|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:31:28.646415|2017-10-11 03:31:28.646415
NCT01486888|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2015-03-17|||May 2006||2006-05-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects|A Randomised, Single Centre, Double-blind, Two-period Cross-over, Glucose Clamp Trial to Test for Bioequivalence Between Insulin Mixtard® 30 (600 Nmol/ml) and Insulin Mixtard® 30 (1998 Nmol/ml) in Healthy Subjects|Completed||Phase 1|45|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:31:30.397148|2017-10-11 03:31:30.397148
NCT01486875|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2017-01-05|||January 2006||2006-01-01|January 2017|2017-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|Start||Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes|NovoMix® Start - A Multicentre, Open Label, Non-randomised, Non-interventional, Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting NovoMix 30® Treatment|Completed||N/A|1155|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:31:30.505347|2017-10-11 03:31:30.505347
NCT01486862|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2014-11-13|||October 2005||2005-10-01|November 2014|2014-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs|NovoMix® 30 (Biphasic Insulin Aspart 70/30) Titrate-to-target: An Observational Study of the Efficacy of NovoMix® 30 in Subjects With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets on OADs|Completed||Phase 4|26|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:31:30.595562|2017-10-11 03:31:30.595562
NCT01486836|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2013-09-11|||November 2011||2011-11-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Lumax DX / Linox DX Evaluation|Evaluation of the Lumax DX ICD and the Linox DX Lead (ICD=Implantable Cardioverter Defibrillator, DX=Extended Diagnostics)|Completed||N/A|38|Anticipated|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 03:31:30.804666|2017-10-11 03:31:30.804666
NCT01486823|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-12-10|||November 2011||2011-11-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Bioavailability Study of MLDL1278A After Subcutaneous and Intravenous Administration in Healthy Subjects|An Open-label, Single-dose Bioavailability Study of MLDL1278A After Subcutaneous and Intravenous Administration in Healthy Subjects|Completed||Phase 1|22|Actual|BioInvent International AB||2|||f||||t||||||||||2017-10-11 03:31:30.879055|2017-10-11 03:31:30.879055
NCT01486810|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2016-10-25|||December 2011||2011-12-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Vyvance||Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence|Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence|Completed||Phase 1/Phase 2|17|Actual|New York State Psychiatric Institute||1|||f||||t||||||||No||2017-10-11 03:31:30.967646|2017-10-11 03:31:30.967646
NCT01486797|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-05-19|||March 2012||2012-03-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|November 2014|Actual|2014-11-01||Interventional|||NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)|A Multi-center, Open Label, Uncontrolled, Phase IIA Clinical Trial Evaluating the Safety and Efficacy of NOX A12 in Combination With a Background Therapy of Bendamustine and Rituximab (BR) in Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|28|Actual|NOXXON Pharma AG||1|||f||||t||||||||||2017-10-11 03:31:31.052929|2017-10-11 03:31:31.052929
NCT01486784|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-05|2017-07-28|||November 2011||2011-11-01|July 2017|2017-07-01||||November 2014|Actual|2014-11-01||Interventional|||A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia|A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 1/Phase 2|37|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 03:31:31.180057|2017-10-11 03:31:31.180057
NCT01486771|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2011-12-05|||November 2007||2007-11-01|December 2011|2011-12-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|||Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)|A Pilot Study to Determine if Intravitreal Injections of Pegaptanib Sodium (Macugen) Given Every 12 Weeks for a Year After an Induction Phase of Three Injections Every 6 Weeks Will Reduce the Progression of Proliferative Diabetic Retinopathy in Patients Without Significant Vitreous Hemorrhage in Comparison to Treatment With Retinal Photocoagulation Alone and After an Induction Phase|Unknown status|Active, not recruiting|Phase 4|30|Actual|Valley Retina Institute||3|||f||||f||||||||||2017-10-11 03:31:31.399712|2017-10-11 03:31:31.399712
NCT01486758|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-05-15|2016-04-12||December 2011||2011-12-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|APW-RSV||Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis|Pilot Study: Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis|Completed||Phase 2|40|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:31:31.536769|2017-10-11 03:31:31.536769
NCT01486745|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-03|2016-05-12|||April 2008||2008-04-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Urine Metabolomics and Colorectal Cancer Screening|Is There a Role for Using NMR Urine Metabolomics as a New Method of Screening for Colorectal Cancer?|Recruiting||N/A|1800|Anticipated|University of Alberta|||4||f||||f||||||Samples Without DNA|"     Urine sample   "|||2017-10-11 03:31:32.100285|2017-10-11 03:31:32.100285
NCT01486732|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2013-11-17|||March 2013||2013-03-01|November 2013|2013-11-01|July 2014|Anticipated|2014-07-01|April 2014|Anticipated|2014-04-01||Interventional|||FLT-PET Activity Change After Allogeneic Umbilical Cord Blood (UCB) Therapy in Cerebral Palsy|FLT(3'-Deoxy-3'-[F-18]Fluorothymidine)-PET Activity Change After Allogeneic Umbilical Cord Blood Cell Therapy in Cerebral Palsy|Withdrawn||Phase 2|0|Actual|Bundang CHA Hospital||2||Difficulty in obtaining specific isotope tracer|f||||f||||||||||2017-10-11 03:31:32.180255|2017-10-11 03:31:32.180255
NCT01486719|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2011-12-05|||February 2008||2008-02-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|May 2009|Actual|2009-05-01||Interventional|||Sensory Reconstruction of Finger Pulp Defect Using a Dorsal Digital Island Flap|Sensory Reconstruction of Finger Pulp Defect Using a Dorsal Digital Island Flap|Completed||N/A|12|Actual|The Second Hospital of Tangshan||1|||f||||t||||||||||2017-10-11 03:31:32.282458|2017-10-11 03:31:32.282458
NCT01486706|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2016-12-29|||October 2010||2010-10-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|OAB||Efficacy and Safety of Gabapentin in Treating Overactive Bladder|Efficacy and Safety of Gabapentin in Treating Overactive Bladder|Completed||Phase 2/Phase 3|94|Actual|St. Luke's Medical Center, Philippines||3|||f||||t||||||||||2017-10-11 03:31:32.348849|2017-10-11 03:31:32.348849
NCT01486693|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-12-05|||October 2011||2011-10-01|December 2011|2011-12-01|September 2012|Anticipated|2012-09-01|December 2011|Anticipated|2011-12-01||Observational|||Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis|Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 03:31:32.452043|2017-10-11 03:31:32.452043
NCT01486680|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2015-04-27|||September 2011||2011-09-01|April 2015|2015-04-01|October 2019|Anticipated|2019-10-01|October 2014|Actual|2014-10-01||Interventional|||Silastic Ring Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Obese Patients|Prospective Randomised Controlled Trial Comparing the Efficacy of Laparoscopic Silastic Ring Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy for the Management of Type 2 Diabetes Mellitus in Obese Patients|Active, not recruiting||N/A|106|Anticipated|North Shore Hospital, New Zealand||2|||f||||f||||||||||2017-10-11 03:31:32.563042|2017-10-11 03:31:32.563042
NCT01486667|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-03|2011-12-06|||October 2011||2011-10-01|December 2011|2011-12-01||||October 2013|Anticipated|2013-10-01||Interventional|||Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP|Effect of Thyroxin Treatment in Sub Clinical Hypothyroidism Patients, on the Apnea Hypopnea Index Score, Lipid Profiles and Highly Sensitive CRP : A Randomized Double Blind Controlled Trial|Unknown status|Recruiting|Phase 3|200|Anticipated|King Saud University||2|||f||||t||||||||||2017-10-11 03:31:32.71241|2017-10-11 03:31:32.71241
NCT01486654|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-05-12|||March 2010||2010-03-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Transcranial Direct Current Stimulation and Aphasia Language Therapy|Transcranial Direct Current Stimulation and Aphasia Language Therapy|Completed||Phase 1|12|Anticipated|Shirley Ryan AbilityLab||3|||f||||f||||||||||2017-10-11 03:31:32.850012|2017-10-11 03:31:32.850012
NCT01486641|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-07-31|||February 2012||2012-02-01|April 2014|2014-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|APAF||Anterolateral Versus Posterolateral Approach to the Fractured Hip Arthroplasty|Anterolateral Versus Posterolateral Approach to the Fractured Hip Arthroplasty - a Change in Approach at Sundsvall Hospital.|Completed||N/A|160|Anticipated|Sundsvall Hospital||2|||f||||t||||||||||2017-10-11 03:31:32.988382|2017-10-11 03:31:32.988382
NCT01486628|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2016-03-31|||April 2012||2012-04-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers|A Phase I, Single Dose, Single-centre, Randomized, Double-blind, Placebo-controlled Dose Escalation Study Evaluating Safety, Tolerability and Levodopa Plasma Concentration Following Administration of Subcutaneous Continuously-delivered Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers|Completed||Phase 1|36|Actual|NeuroDerm Ltd.||2|||f||||t||||||||||2017-10-11 03:31:33.113398|2017-10-11 03:31:33.113398
NCT01486615|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2012-09-06|2012-05-20||October 2011||2011-10-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Premedication With Melatonin and Alprazolam Combination Versus Alprazolam or Melatonin Alone|Premedication With Melatonin and Alprazolam Combination Versus Alprazolam or Melatonin Alone: a Randomized, Double Blind Placebo Controlled Study|Completed||Phase 4|80|Actual|B.P. Koirala Institute of Health Sciences|The study was not designed to measure drug plasma concentrations. We did not perform a battery of tests to evaluate psychomotor and amnesic performances. We only did an orientation score and assessed delayed visual episodic memory.|4|||f||||f||||||||||2017-10-11 03:31:33.248931|2017-10-11 03:31:33.248931
NCT01486056|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-08-20|||November 2011||2011-11-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||ECG Vector Determination|ECG Vector Determination for Model 106 Generator Implant Site Selection|Completed||N/A|29|Actual|Cyberonics, Inc.|||1||f||||f||||||||||2017-10-11 03:31:39.654577|2017-10-11 03:31:39.654577
NCT01486602|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-07-11|||March 2012||2012-03-01|July 2017|2017-07-01||||January 2017|Actual|2017-01-01||Interventional|||Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1|22|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 03:31:34.214797|2017-10-11 03:31:34.214797
NCT01486589|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-02-05|||October 2010||2010-10-01|February 2014|2014-02-01||||June 2013|Actual|2013-06-01||Observational|PREDICT-ER||Cardiac Autonomic Function For Risk Stratification in the Emergency Room|Risk Stratification in the Emergency Room by Cardiac Autonomic Function|Completed||N/A|6521|Actual|Thebiosignals.com|||1||f||||f||||||||||2017-10-11 03:31:34.33032|2017-10-11 03:31:34.33032
NCT01486576|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2013-05-28|||January 2012||2012-01-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|VOHO||Hydroxyethyl Starch and Renal Function After Hip Replacement Surgery|Effect of Hydroxyethyl Starch on Renal Handling of Sodium and Water, Vasoactive Hormones,Biomarkers and the Circulatory System in Patients Undergoing Hip Replacement Surgery|Completed||Phase 4|42|Actual|Regional Hospital Holstebro||2|||f||||t||||||||||2017-10-11 03:31:34.398346|2017-10-11 03:31:34.398346
NCT01486563|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2013-09-16|||January 2012||2012-01-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|VORA||Hydroxyethyl Starch and Renal Function After Radical Prostatectomy|Effect of Hydroxyethyl Starch on Renal Handling of Sodium and Water, Vasoactive Hormones,Biomarkers and the Circulatory System in Patients Undergoing Radical Prostatectomy|Completed||Phase 4|40|Actual|Regional Hospital Holstebro||2|||f||||t||||||||||2017-10-11 03:31:34.485009|2017-10-11 03:31:34.485009
NCT01486550|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2014-10-08|||December 2011||2011-12-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|VONE||Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy|Effect of Hydroxyethyl Starch on Renal Handling of Salt and Water, Blood Pressure-regulating Hormones, Proteins and Circulatory System of Patients Undergoing Kidney Removal by Keyhole Surgery|Terminated||Phase 4|14|Actual|Regional Hospital Holstebro||2||Lack of patient enrollment|f||||t||||||||||2017-10-11 03:31:34.568254|2017-10-11 03:31:34.568254
NCT01486537|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-03|2017-02-22|||December 2011||2011-12-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Observational|||Acidity Level of Blood From Primary Molar's Pulp While Undergoing Pulpotomy or Pulpectomy Procedure|Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.|Recruiting||N/A|50|Anticipated|Hadassah Medical Organization|||2||f||||t||||||None Retained|"     blood specimens which are undergoing Astrop test (acidity level .po2 pco2)   "|||2017-10-11 03:31:34.665382|2017-10-11 03:31:34.665382
NCT01486524|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2011-12-05|||October 2011||2011-10-01|December 2011|2011-12-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Observational|||Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis|A Multicenter Pharmacogenomic Biomarker Study in Matched Patients With Severe Sepsis Treated With or Without Recombinant Human Activated Protein C [Xigris®, Drotrecogin Alfa (Activated)]|Unknown status|Active, not recruiting|N/A|3000|Anticipated|Sirius Genomics Inc.|||2||f||||f||||||Samples With DNA|"     Minimum 700 ng DNA required, extracted from blood samples. Two Improved Response     Polymorphisms (IRPs) will be tested in this study. IRP A is comprised of two single     nucleotide polymorphisms (SNPs), RYR2 (ryanodine receptor 2 gene) rs684923 and ACIN1     (apoptotic chromatin condensation inducer 1 gene)rs3751501. IRP B is comprised of two SNPs,     SPATA7 (spermatogenesis associated 7 gene) rs3179969 and FLI1 (Friend leukemia virus     integration 1 gene) rs640098. An individual patient will be considered to be biomarker     positive if they have the responsive genotype for either of the SNPs or for both of the SNPs     in the IRP.   "|||2017-10-11 03:31:34.745446|2017-10-11 03:31:34.745446
NCT01486498|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-03|2011-12-05|||November 2005||2005-11-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2009|Actual|2009-11-01||Observational|SABAL||Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy|Health Economic Analyses of Treatment Strategies for Allergic Respiratory Diseases|Completed||N/A|571|Actual|Aalborg University|||1||f||||f||||||||||2017-10-11 03:31:34.963499|2017-10-11 03:31:34.963499
NCT01486485|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-02-18|||March 2012||2012-03-01|February 2013|2013-02-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)|Circuit Survival and Efficacy for Middle Molecular-weight Solute Elimination Between Nafamostat Infusion and Heparinized Saline Priming|Unknown status|Recruiting|Phase 3|160|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:31:35.020061|2017-10-11 03:31:35.020061
NCT01486472|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2011-12-06|||November 2010||2010-11-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Observational|||S-1-induced Lacrimal Drainage Obstruction|Lacrimal Drainage Obstruction in Gastric Cancer Patients Receiving Adjuvant S-1 Chemotherapy: A Prospective Study|Unknown status|Recruiting|N/A|200|Anticipated|Seoul National University Bundang Hospital|||1||f||||f||||||Samples Without DNA|"     Plasma Tears   "|||2017-10-11 03:31:35.133558|2017-10-11 03:31:35.133558
NCT01486459|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-04|2015-03-16|||November 2012||2012-11-01|August 2013|2013-08-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|TULIP||A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer|A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer|Terminated||N/A|7|Actual|Barwon Health||2||Insufficient recruits|f||||f||||||||||2017-10-11 03:31:35.23386|2017-10-11 03:31:35.23386
NCT01486264|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-04-26||2017-04-26|December 1, 2011|Actual|2011-12-01|April 2017|2017-04-01|February 28, 2017|Actual|2017-02-28|March 2016|Actual|2016-03-01||Interventional|||Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex|An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment|Completed||Phase 4|286|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-10-11 03:31:37.321415|2017-10-11 03:31:37.321415
NCT01486446|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-03-10|2014-01-21||December 2011||2011-12-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia|Phase 2a, Exploratory, Double-blind, Placebo-controlled Two-part Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of Topically Applied XPF-002 (XEN402 8% w/w Ointment) in Patients With Primary/Inherited Erythromelalgia|Completed||Phase 1/Phase 2|8|Actual|Xenon Pharmaceuticals Inc.|"This was a small trial with many exploratory efficacy measures. There was no primary outcome measure, all measures are other: pre-specified.
Only 8 subjects were enrolled (1 placebo), the actual number of Adverse Events is used, not incidence."|2|||f||||f||||||||||2017-10-11 03:31:35.342574|2017-10-11 03:31:35.342574
NCT01486433|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-04-29|||November 2011||2011-11-01|April 2015|2015-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects|An Open-Label, Randomized, 2-Way Crossover Study to Evaluate the Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects|Completed||Phase 1|52|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 03:31:35.824497|2017-10-11 03:31:35.824497
NCT01486420|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2015-10-27|||January 2012||2012-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Open Surgery Versus Corticosteroid Injections in Treatment of Trigger Finger|Open Surgery Versus Ultrasound Guided Local Corticosteroid Injections in Treatment of Trigger Finger - a Randomized Controlled Trial.|Completed||N/A|166|Actual|Regionshospitalet Silkeborg||2|||f||||f||||||||||2017-10-11 03:31:35.912702|2017-10-11 03:31:35.912702
NCT01486407|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-01-31|||February 2012||2012-02-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access.|An Observational Study of Intubating Conditions Comparing Intraosseous Vascular Access With Peripheral Intravenous Access for Drug Delivery in Rapid Sequence Intubation|Terminated||N/A|2|Actual|Vidacare Corporation|||2|For poor enrollment|f||||f||||||||||2017-10-11 03:31:35.997675|2017-10-11 03:31:35.997675
NCT01486394|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2013-08-02|||December 2011||2011-12-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Sonography in an Unselected Population of Acute Admitted Patients With Respiratory Symptoms|Focused Sonographic Examination of the Heart, Lungs and Deep Veins in an Unselected Population of Acute Admitted Patients With Respiratory Symptoms: a Randomised Clinical Trial|Completed||N/A|315|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 03:31:36.081017|2017-10-11 03:31:36.081017
NCT01486381|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-02-22|||March 20, 2002|Actual|2002-03-20|February 2017|2017-02-01|May 30, 2003|Actual|2003-05-30|May 30, 2003|Actual|2003-05-30||Interventional|||Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes|A Multi-national, Multi-centre, Open-labelled Extension Study Assessing the Long-term Safety of Biphasic Insulin Aspart 30 (BIAsp 30) in Young Diabetic Subjects With Type 1 Diabetes Mellitus Previously Treated in BIAsp-1240|Completed||Phase 3|22|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:31:36.193377|2017-10-11 03:31:36.193377
NCT01486368|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-09-16|||November 2011||2011-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|April 2014|Actual|2014-04-01||Interventional|||A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma|A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma|Completed||Phase 2|17|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-10-11 03:31:36.296441|2017-10-11 03:31:36.296441
NCT01486355|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-11-14|||August 2011||2011-08-01|November 2013|2013-11-01||||July 2016|Anticipated|2016-07-01||Interventional|||Additional Measles Vaccine at 4 Months of Age|A Randomised Trial of an Additional Measles Vaccine at 4 Months of Age to Reduce Child Mortality and to Explore the Role of Maternal Measles Antibodies for the Beneficial Non-specific Effects of Measles Vaccine|Unknown status|Recruiting|Phase 4|||Bandim Health Project||2|||f||||f||||||||||2017-10-11 03:31:36.381262|2017-10-11 03:31:36.381262
NCT01486342|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-01-03|||October 2011||2011-10-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|PET-ALI||PET Imaging in Patients at Risk for Acute Lung Injury|Positron Emission Tomography With [18F]Fluorodeoxyglucose in Patients at Risk for Acute Lung Injury|Completed||N/A|5|Actual|Washington University School of Medicine|||1||f||||t||||||||||2017-10-11 03:31:36.521126|2017-10-11 03:31:36.521126
NCT01486329|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2015-06-05|||December 2011||2011-12-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer|VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer to Examine Safety, Tolerability, and Immune Response to the Investigational VEGFR-2 DNA Vaccine VXM01|Completed||Phase 1|72|Actual|Vaximm GmbH||2|||f||||t||||||||||2017-10-11 03:31:36.684288|2017-10-11 03:31:36.684288
NCT01486303|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-12-05|||August 2011||2011-08-01|December 2011|2011-12-01||||December 2011|Anticipated|2011-12-01||Interventional|||Facial Cosmetic Acupuncture on Skin Rejuvenation|Efficacy and Safety of Facial Cosmetic Acupuncture on Skin Rejuvenation|Unknown status|Active, not recruiting|N/A|28|Actual|Kyunghee University||1|||f||||t||||||||||2017-10-11 03:31:36.909683|2017-10-11 03:31:36.909683
NCT01486290|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2014-03-26|||July 2007||2007-07-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|DISCO||Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study|Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study|Completed||N/A|52|Actual|Joslin Diabetes Center||2|||f||||t||||||||||2017-10-11 03:31:37.022987|2017-10-11 03:31:37.022987
NCT01486277|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-11-02||2015-11-04|November 2011||2011-11-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|November 2014|Actual|2014-11-01||Interventional|||A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma|A Phase 2, Single-arm, Open-label, Multicenter Study of the Histone Deacetylase Inhibitor (HDACi) JNJ-26481585 in Subjects With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma|Completed||Phase 2|26|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 03:31:37.175941|2017-10-11 03:31:37.175941
NCT01486251|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-02-09|||September 2011||2011-09-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|April 2013|Actual|2013-04-01||Interventional|AXUS||Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer|Assessment of the Tumor Vascular Effects of the Pan-vegfr Tyrosine Kinase Inhibitor Axitinib Using Dynamic Contrast-enhanced Ultrasonography (Dce-us) in Patients With Refractory Metastatic Colorectal Cancer|Completed||N/A|27|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||f||||||||||2017-10-11 03:31:37.522677|2017-10-11 03:31:37.522677
NCT01486238|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-06-12|2013-04-02||April 2009||2009-04-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|PRESERVE|"In the IVMac q6 Arm, 23 subjects started the study. Two (2) subjects withdrew early. For this reason data from the 21 remaining subjects was used.
In the IVMac q4 Arm, 49 subjects started the study. 6 subjects were lost in this arm - 2 died, 1 withdrew, & 3 were lost to follow-up. For this reason data from the 43 remaining subjects was used."|Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study|Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study|Completed||Phase 4|72|Actual|Valley Retina Institute||2|||f||||f||||||||||2017-10-11 03:31:37.623189|2017-10-11 03:31:37.623189
NCT01486225|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2014-08-07|||November 2011||2011-11-01|July 2012|2012-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Tolerance Study of the Silicone Bands on Medical Compression Stockings|Exploratory Comparative Single-blind Study Evaluating Tolerability of the Silicone Bands on Medical Compression Stockings|Terminated||Phase 4|3|Actual|Laboratoires Innothera||2|||f||||f||||||||||2017-10-11 03:31:37.986802|2017-10-11 03:31:37.986802
NCT01486212|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2012-12-11|||November 2011||2011-11-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|IROX-NH||Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers|Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers|Completed||N/A|10|Actual|Herlev Hospital|||1||f||||f||||||||||2017-10-11 03:31:38.086922|2017-10-11 03:31:38.086922
NCT01486199|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-07-24|2017-04-05||October 2011||2011-10-01|July 2017|2017-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Imaging Airway Liquid Absorption in Cystic Fibrosis|Imaging Airway Liquid Absorption in Cystic Fibrosis|Completed||N/A|20|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:31:38.171431|2017-10-11 03:31:38.171431
NCT01486186|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-12-02|||December 2011||2011-12-01|December 2011|2011-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease|Detection and Intervention on Mild/Moderate Chronic Obstructive Pulmonary Disease by Traditional Chinese Medicine Treatment and Application|Unknown status|Not yet recruiting|Phase 2|504|Anticipated|Henan University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 03:31:38.55707|2017-10-11 03:31:38.55707
NCT01486173|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2013-04-16|||June 2011||2011-06-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|EPINUTRI||Early Nutrition and Neurological Development of Very Preterm Infants|Early Nutrition and Neurological Development of Very Preterm Infants|Unknown status|Active, not recruiting|N/A|260|Anticipated|Lapillonne, Alexandre, M.D.|||2||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:31:38.669938|2017-10-11 03:31:38.669938
NCT01486160|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2012-11-28|||December 2011||2011-12-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Observational|||Respiratory Viral Infection in Nursing Home Slovenia|Etiology, Frequency and Epidemiology of Respiratory Viral Infection in Nursing Home Residents|Completed||N/A|132|Actual|University Maribor|||2||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:31:38.765235|2017-10-11 03:31:38.765235
NCT01486147|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2011-12-05|||July 2011||2011-07-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of a Visual Nutrient Profiling System on Recall of Nutrition Information||Completed||N/A|63|Actual|University of Illinois at Urbana-Champaign||2|||f||||||||||||||2017-10-11 03:31:38.878138|2017-10-11 03:31:38.878138
NCT01486134|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-08-28|||June 20, 2012|Actual|2012-06-20|August 2017|2017-08-01|June 20, 2019|Anticipated|2019-06-20|January 6, 2016|Actual|2016-01-06||Interventional|ARMTICH||Major RF Ablations of Hepatomas Under MR Thermometry Monitoring|Pilot Study of Real Time MR Temperature Monitoring of Multipolar Radiofrequency Ablation of Large Hepatocellular Carcinomas (≥ 5 CM)-ARMTICH STUDY|Active, not recruiting||N/A|15|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 03:31:38.988853|2017-10-11 03:31:38.988853
NCT01486121|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2015-12-01|||December 2011||2011-12-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Sedation Optimisation Strategy (S.O.S.) Ventilation|S.O.S. Ventilation - Sedation Optimisation Strategy For Mechanical Ventilation In Intensive Care Unit Patients|Completed||Phase 3|140|Actual|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 03:31:39.120714|2017-10-11 03:31:39.120714
NCT01486108|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-12-02|||January 2011||2011-01-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Burst Spinal Cord Stimulation for Neuropathic Pain|Burst, Tonic and Sham Spinal Cord Stimulation. A Verification of the Best Treatment Protocol|Completed||N/A|15|Actual|University Hospital, Antwerp||3|||f||||f||||||||||2017-10-11 03:31:39.252479|2017-10-11 03:31:39.252479
NCT01486095|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-05-08|||November 29, 2011||2011-11-29|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2013|Actual|2013-12-01||Interventional|COBRA||COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study|Comparison of Healing Responses After Treatment of Complex Bifurcation Lesions With a Dedicated Bifurcation Device (Axxess™ Drug Eluting Coronary Bifurcation Stent System + Biomatrix™ Drug Eluting Coronary Stent System Stents in the Distal Branches) Versus the Culotte Technique Using Xience Prime Everolimus-eluting Stents : an Optical Coherence Tomography (OCT) Analysis|Active, not recruiting||N/A|40|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 03:31:39.372519|2017-10-11 03:31:39.372519
NCT01486082|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-19|2011-12-11|||February 2011||2011-02-01|December 2011|2011-12-01|May 2012|Anticipated|2012-05-01|November 2011|Actual|2011-11-01||Observational|||Antimicrobial Susceptibility for Helicobacter Pylori Eradication|Usefulness of Antimicrobial Susceptibility in the Eradication of Helicobacter Pylori|Unknown status|Recruiting|Phase 4|1|Anticipated|Hospital Donostia|||2||f||||f||||||||||2017-10-11 03:31:39.472662|2017-10-11 03:31:39.472662
NCT00005429|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|November 2001|2001-11-01|March 1996|Actual|1996-03-01|||||Observational|||Clinical Cardiovascular Outcomes of African-Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.230182|2017-10-11 04:27:03.230182
NCT01486043|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-01-20|2015-01-13||December 2011||2011-12-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Metformin and Transient Hyperglycemia|Metformin as an Adjunctive Therapy For Transient Hyperglycemia in Patients With Acute Lymphoblastic Leukemia During Induction Chemotherapy|Terminated||N/A|4|Actual|Children's Hospital Los Angeles|Early termination leading to small numbers of subjects analyzed.|1||"The research project was terminated due to lower than projected patient recruitment within the   period of time allowed for the study."|f||||t||||||||||2017-10-11 03:31:39.759296|2017-10-11 03:31:39.759296
NCT01486017|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2011-12-02|||September 2011||2011-09-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015K|A Phase 1, Single-Dose, Open-Label, 3-Period, Randomized Crossover Study to Assess the Relative Bioavailability Across Three Strengths of a New ASP015K Tablet Formulation in Healthy Volunteers|Completed||Phase 1|30|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 03:31:40.054258|2017-10-11 03:31:40.054258
NCT01486004|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2013-01-30|||November 2011||2011-11-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen|A Phase-I, Open-label Trial in Healthy Female Subjects to Investigate the Effect of TMC435 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone|Completed||Phase 1|18|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||f||||||||||2017-10-11 03:31:40.155921|2017-10-11 03:31:40.155921
NCT01485991|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2016-03-24|2015-03-27||February 2012||2012-02-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|ATTAIN|Intent-to-treat (ITT) population included all randomized participants who took at least 1 dose of study medication.|TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy|Phase III in Partial and Null Responders|Completed||Phase 3|771|Actual|Janssen R&D Ireland||2|||f||||t||||||||||2017-10-11 03:31:40.497649|2017-10-11 03:31:40.497649
NCT01485978|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-08-07|||March 2012||2012-03-01|August 2014|2014-08-01|August 2019|Anticipated|2019-08-01|February 2019|Anticipated|2019-02-01||Interventional|||Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome|Early Prospective Therapy Trial to Delay Renal Failure in Children With Alport Syndrome|Recruiting||Phase 3|120|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||3|||f||||t||||||||||2017-10-11 03:31:41.746791|2017-10-11 03:31:41.746791
NCT01485965|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2013-03-19|||November 2011||2011-11-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease|A Phase 1b, Open-label, Parallel-group Study in Subjects With Huntington Disease to Assess the Safety, Tolerability, and Fed/Fasted Pharmacokinetics of Repeated Oral Doses of SEN0014196|Completed||Phase 1|26|Actual|Siena Biotech S.p.A.||2|||f||||f||||||||||2017-10-11 03:31:41.864693|2017-10-11 03:31:41.864693
NCT01485952|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-11-24|||March 2011||2011-03-01|November 2015|2015-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|PADDINGTON||An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196|An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients to Assess Pharmacokinetics, Candidate Pharmacodynamic Measures of Target Engagement and Disease Modulation as Well as Acute Phenotypical Effects Following Multiple Oral Doses of SEN0014196.|Completed||Phase 1|55|Actual|Siena Biotech S.p.A.||3|||f||||f||||||||||2017-10-11 03:31:41.967596|2017-10-11 03:31:41.967596
NCT01485939|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2011-12-05|||November 2011||2011-11-01|December 2011|2011-12-01|May 2012|Anticipated|2012-05-01|March 2012|Anticipated|2012-03-01||Interventional|||Lidocaine Patch for Postoperative Analgesia After Laparoscopic Cholecystectomy||Unknown status|Recruiting|Phase 4|80|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:31:42.069591|2017-10-11 03:31:42.069591
NCT01485926|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-05-30|||October 2010||2010-10-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|September 2014|Actual|2014-09-01||Interventional|TCHL Phase II||A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.|A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.|Active, not recruiting||Phase 2|120|Anticipated|Cancer Trials Ireland||2|||f||||f||||||||||2017-10-11 03:31:42.157757|2017-10-11 03:31:42.157757
NCT01485913|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-04-26|||July 1, 2011|Actual|2011-07-01|April 2017|2017-04-01|June 30, 2013|Actual|2013-06-30|December 31, 2012|Actual|2012-12-31||Interventional|||A Randomized Trial of an Intensive Education Intervention Using a Network of Involved Diabetic Patients (Peer Educators) to Improve Glycemic Control of Type 2 Diabetic Patients|A Randomized Trial of an Intensive Education Intervention Using a Network of Involved Diabetic Patients (Peer Educators) to Improve Glycemic Control of Type 2 Diabetic Patients|Completed||N/A|151|Actual|Sante Diabete Mali||2|||f||||t||||||||||2017-10-11 03:31:42.296289|2017-10-11 03:31:42.296289
NCT01485900|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2012-08-22|||November 2011||2011-11-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Hemodynamics of Ascending Repeated Oral Doses of SAR407899A in Patients With Moderate Chronic Kidney Disease on Stable Angiotensin Converting Enzyme-inhibitor (ACE-I) Treatment|Completed||Phase 1|20|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:31:42.393959|2017-10-11 03:31:42.393959
NCT01485887|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-09-30|2015-01-09||January 2012||2012-01-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)|A Open-label Long-term Extension Study To Evaluate The Safety And Efficacy Of Venlafaxine Er In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|50|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:31:42.582165|2017-10-11 03:31:42.582165
NCT01485874|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2016-08-04|||November 2011||2011-11-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer|A Phase I-II Clinical Trial of Pegylated Liposomal Doxorubicin (Doxil®) in Combination With BIBF 1120 in Patients With Ovarian Cancer: Hoosier Oncology Group GYN10-149|Terminated||Phase 1|11|Actual|Hoosier Cancer Research Network||1||Funding withdrawn due to drug unavailability|f||||t||||||||||2017-10-11 03:31:43.328662|2017-10-11 03:31:43.328662
NCT01485861|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-08-22|||January 11, 2012|Actual|2012-01-11|August 2017|2017-08-01|June 29, 2018|Anticipated|2018-06-29|September 1, 2015|Actual|2015-09-01||Interventional|||Study of Ipatasertib or GDC-0980 With Abiraterone Acetate Versus Coralie in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy|A Phase Ib/II Study of GDC-0068 or GDC-0980 With Abiraterone Acetate Versus Abiraterone Acetate in Patients With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy|Active, not recruiting||Phase 1/Phase 2|273|Actual|Genentech, Inc.||5|||f||||||||||||||2017-10-11 03:31:43.455406|2017-10-11 03:31:43.455406
NCT01485848|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2014-06-09|||February 2012||2012-02-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|ESP2011-002||EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer|EP-100, a Novel LHRH Receptor-Targeted, Membrane-Disrupting Peptide, Plus Paclitaxel Versus Paclitaxel Alone for Refractory or Recurrent Ovarian Cancer: A Phase II, Randomized, Multicenter Trial|Completed||Phase 2|49|Actual|Esperance Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-11 03:31:43.714825|2017-10-11 03:31:43.714825
NCT01485835|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2015-10-08|||January 2012||2012-01-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma|A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma|Completed||Phase 1|8|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:31:43.825736|2017-10-11 03:31:43.825736
NCT01485822|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2013-05-13|||July 2004||2004-07-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution|A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution|Terminated||Phase 4|88|Actual|Alcon Research|||2|Study objectives met|f||||f||||||||||2017-10-11 03:31:43.93759|2017-10-11 03:31:43.93759
NCT01485809|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-12-05|||October 2011||2011-10-01|December 2011|2011-12-01|February 2014|Anticipated|2014-02-01|October 2011|Actual|2011-10-01||Interventional|SIIS||Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy|A Phase II Trial of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy|Unknown status|Recruiting|Phase 2|56|Anticipated|Seoul Veterans Hospital||1|||f||||t||||||||||2017-10-11 03:31:44.027401|2017-10-11 03:31:44.027401
NCT01485796|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-05-04|2017-03-10|2014-09-08|December 1, 2011||2011-12-01|March 2017|2017-03-01|January 1, 2013|Actual|2013-01-01|January 1, 2013|Actual|2013-01-01||Interventional|||Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD|Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) Facilitated Subcutaneous Treatment With Immune Globulin Infusion (Human), 10% in Subjects With Primary Immunodeficiency Diseases (PIDD)|Completed||Phase 2/Phase 3|54|Actual|Baxalta US Inc.|Treatment with rHuPH20 was stopped as of August 2012 following discussion with the FDA. 26 subjects still active in Study Epoch 2 went into a safety follow-up period and were treated with IGI, 10% (GAMMAGARD LIQUID) intravenously or subcutaneously.|1|||f||||f||||||||||2017-10-11 03:31:44.253026|2017-10-11 03:31:44.253026
NCT01485783|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2015-09-08|||November 2011||2011-11-01|September 2015|2015-09-01|May 2015|Actual|2015-05-01|July 2013|Actual|2013-07-01||Observational|||Improving Outcomes for Hypertensive Children|Improving Outcomes for Hypertensive Children|Completed||N/A|112|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||None Retained|"     none collected   "|||2017-10-11 03:31:44.911849|2017-10-11 03:31:44.911849
NCT01485770|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2016-04-05||2013-03-08|December 2011||2011-12-01|April 2016|2016-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness|A Four-week, Double-blind, Placebo-controlled, Randomized, Cross-over Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness|Completed||Phase 2|33|Actual|Jazz Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:31:44.987691|2017-10-11 03:31:44.987691
NCT01485757|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-01-09|||July 2011||2011-07-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Prospective L-arginine Study|Effect of Chronic Oral L-arginine Supplementation on Peripheral Endothelial Function and Exercise Tolerance in a Population of Young Heart Transplant Patients.|Terminated||Phase 1|3|Actual|University of Michigan||1||Technical difficulty with Endo-PAT machine|f||||t||||||||||2017-10-11 03:31:45.14909|2017-10-11 03:31:45.14909
NCT01485744|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-04-06|||December 2011||2011-12-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer|A Phase 1b Clinical Trial of LDE225 in Combination With Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan (FOLFIRINOX) in Previously Untreated Locally Advanced or Metastatic Pancreatic Adenocarcinoma, With an Expansion Cohort at the Recommended Phase 2 Dose|Active, not recruiting||Phase 1|39|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:31:45.240083|2017-10-11 03:31:45.240083
NCT01485731|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-06-01|||January 2012||2012-01-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer|Phase 1 Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)|Completed||Phase 1|8|Actual|University of Miami||1|||f||||t||||||||||2017-10-11 03:31:45.367886|2017-10-11 03:31:45.367886
NCT01485705|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-07-01|||August 2009||2009-08-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Diabact||Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child|Frequency, Consequences and Determinants of Sub-optimal Care in the Initial Care of Severe Bacterial Infections of the Child|Completed||N/A|270|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 03:31:45.604353|2017-10-11 03:31:45.604353
NCT01485692|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2011-12-01|||February 2009||2009-02-01|February 2009|2009-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation|Safety and Efficacy of Four Intramuscular Interventions for the Management of Acute Psychomotor Agitation|Completed||N/A|120|Actual|University of Sao Paulo||4|||f||||f||||||||||2017-10-11 03:31:45.673382|2017-10-11 03:31:45.673382
NCT01485679|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2016-05-17|||January 2011||2011-01-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas|Evaluation of 18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas|Completed||N/A|126|Actual|Nantes University Hospital||1|||f||||||||||||||2017-10-11 03:31:45.773348|2017-10-11 03:31:45.773348
NCT01485666|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-04-08|||May 2012||2012-05-01|April 2016|2016-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|RESIST||Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study|Reduce Driveline Trauma Through Stabilization and Exit Site Management (RESIST) Pilot Study Protocol|Completed||N/A|50|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 03:31:45.903299|2017-10-11 03:31:45.903299
NCT01485653|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2011-12-07|||April 2010||2010-04-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Dosage of Mepivacaine in Ultrasound Axillary Block|Effective Low Dosage of Mepivacaine in Ultrasound Guided Axillary Block in Patients Undergoing Distal Upper Extremity Surgery|Completed||N/A|64|Actual|Wayne State University||1|||f||||f||||||||||2017-10-11 03:31:45.996357|2017-10-11 03:31:45.996357
NCT01485640|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-09-29|2015-02-26||June 2011||2011-06-01|September 2016|2016-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Lurasidone Extended Use Study|A Long-term, Multicenter, Open-Label, Flexible Dose Continuation Study in Subjects Who Have Completed a Prior Lurasidone Study|Completed||Phase 3|162|Actual|Sunovion||1|||f||||f||||||||||2017-10-11 03:31:46.095989|2017-10-11 03:31:46.095989
NCT01485627|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-04-30|||April 2011||2011-04-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|VOICE||VOICE: Values and Options in Cancer Care|Randomized Controlled Trial(RCT)of Patient, Caregiver and Physician Communication Coaching in Advanced Cancer|Active, not recruiting||N/A|470|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 03:31:46.508144|2017-10-11 03:31:46.508144
NCT01485601|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2012-09-19|||November 2011||2011-11-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines|A Randomised, Double-blind, Multi-centre, Phase II, Optimal Dose-finding Study to Determine the Safety and Efficacy of MT10109 (Clostridium Botulinum Toxin Type A) in Subjects With Moderate to Severe Glabellar Lines in Comparison to BOTOX®|Completed||Phase 2|121|Actual|Medy-Tox||2|||f||||t||||||||||2017-10-11 03:31:46.963565|2017-10-11 03:31:46.963565
NCT01485588|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2015-02-04||2015-02-04|December 2010||2010-12-01|February 2015|2015-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Tolerability Study for Age-Related Macular Degeneration|A Phase 1 / 2 Trial to Investigate The Safety and Tolerability of Single and Repeated Doses of hI-CON1™ Following Administration by Intravitreal Injection in Subjects With Neovascular Age-Related Macular Degeneration (AMD)|Completed||Phase 1/Phase 2|18|Actual|Iconic Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 03:31:47.040312|2017-10-11 03:31:47.040312
NCT01485575|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-04-26|||November 2011||2011-11-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Observational|||Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy|Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy|Recruiting||N/A|50|Anticipated|University Hospital, Basel, Switzerland|||1||f||||f||||||Samples Without DNA|"     Internal limiting membrane as removed during routine surgery.   "|Undecided||2017-10-11 03:31:47.120882|2017-10-11 03:31:47.120882
NCT01485562|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-03-09|||May 2012||2012-05-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home Births|Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home Births|Completed||N/A|84|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 03:31:47.217406|2017-10-11 03:31:47.217406
NCT01485549|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-03-04|||November 2012||2012-11-01|March 2015|2015-03-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|BIOAMS||Oligomeric Alpha-synuclein in Multiple System Atrophy|Oligomeric Alpha-synuclein Levels as a Biomarker for Multiple System Atrophy|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Bordeaux|||2||f||||f||||||Samples With DNA|"     -  cerebrospinal fluid (CSF)        -  whole blood        -  plasma        -  blood serum        -  urine   "|||2017-10-11 03:31:47.342837|2017-10-11 03:31:47.342837
NCT01485536|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-11-28|2016-11-28||August 2012||2012-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of the HSP90 Inhibitor AUY922|A Phase II Study of the HSP90 Inhibitor AUY922 in Patients With Relapsed and Refractory Lymphoma|Terminated||Phase 2|21|Actual|M.D. Anderson Cancer Center|Although the study surpassed the first futility endpoint for DLBCL cohort, it was terminated early due to limited responses and significant toxicities witnessed in the entire cohort of the study.|1||Study halted early due to limited response.|f||||f||||||||||2017-10-11 03:31:47.514345|2017-10-11 03:31:47.514345
NCT01485523|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2013-03-12|||January 2012||2012-01-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites|Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites|Completed||N/A|120|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||Samples Without DNA|"     Blood sample   "|||2017-10-11 03:31:49.464347|2017-10-11 03:31:49.464347
NCT01485510|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-06-10|||December 2011||2011-12-01|June 2014|2014-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|BEST?||Evaluation of the New Orleans Intervention for Infant Mental Health|Evaluation of the New Orleans Intervention for Infant Mental Health in Glasgow|Recruiting||Phase 2|100|Anticipated|University of Glasgow||2|||f||||f||||||||||2017-10-11 03:31:49.545736|2017-10-11 03:31:49.545736
NCT01485497|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-02-08|||May 2011||2011-05-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of Obstructive Sleep Apnea With Long Range 3D Endoscopic Fourier Domain Optical Coherence Tomography (FDOCT)|Evaluation of Obstructive Sleep Apnea With Long Range 3D Endoscopic Fourier Domain Optical Coherence Tomography (FDOCT)|Withdrawn||Phase 1|0|Actual|University of California, Irvine||1||no participants enrolled|f||||t||||||||||2017-10-11 03:31:49.692228|2017-10-11 03:31:49.692228
NCT01485484|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-02-08|||September 2011||2011-09-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Development and Validation of a NIRS-based Sinusitis Screening|Development and Validation of a NIRS-based Sinusitis Screening|Recruiting||N/A|170|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-10-11 03:31:49.787245|2017-10-11 03:31:49.787245
NCT01485471|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-02-08|||June 2011||2011-06-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Spectroscopic Evaluation of Middle Ear Infection|Spectroscopic Evaluation of Middle Ear Infection|Withdrawn||N/A|0|Actual|University of California, Irvine|||1|No paticipants enrolled|f||||f||||||||||2017-10-11 03:31:49.891368|2017-10-11 03:31:49.891368
NCT01485458|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-04-25|||December 2011||2011-12-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|OSCIS||Optimal Treatment for Spinal Cord Injury Associated With Cervical Canal Stenosis (OSCIS) Study|Randomized Trial of Early Versus Delayed Surgery for Acute Traumatic Cervical Spinal Cord Injury Without Bone Injury in Patients With Cervical Canal Stenosis|Recruiting||N/A|100|Anticipated|Tokyo University||2|||f||||t||||||||||2017-10-11 03:31:50.013324|2017-10-11 03:31:50.013324
NCT01485445|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-06-09|||December 21, 2011|Actual|2011-12-21|June 2017|2017-06-01|March 12, 2012|Actual|2012-03-12|March 12, 2012|Actual|2012-03-12||Interventional|||Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination|An Open-label, Randomised, Replicate, Six-way Crossover, Single Dose Study to Determine the Bioequivalence of Fluticasone Furoate (FF) Inhalation Powder (Single Strip Configuration) Compared With FF Inhalation Powder (Two Strip Configuration) and Compared With FF / Vilanterol (VI) Inhalation Powder Administered Via the Novel Dry Powder Inhaler.|Completed||Phase 1|30|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:31:50.127488|2017-10-11 03:31:50.127488
NCT01485432|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2013-01-16|||October 2011||2011-10-01|January 2013|2013-01-01|October 2015|Anticipated|2015-10-01|||||Observational|IROR||Goal Directed Hemodynamic Management and Renal Outcome After Renal Transplant Surgery|Can Goal Directed Hemodynamic Management Improve Renal Outcome After Renal Transplant Surgery?|Unknown status|Recruiting|N/A|98|Anticipated|Technische Universität München|||2||f||||t||||||||||2017-10-11 03:31:50.21306|2017-10-11 03:31:50.21306
NCT01485419|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-03-28|||January 2011||2011-01-01|March 2017|2017-03-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|||Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy|Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy|Completed||N/A|292|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-10-11 03:31:50.300202|2017-10-11 03:31:50.300202
NCT01485406|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-05-12|||December 12, 2011|Actual|2011-12-12|May 2017|2017-05-01|March 15, 2012|Actual|2012-03-15|March 15, 2012|Actual|2012-03-15||Interventional|||Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers|Safety and Immunogenicity Study of GSK Biologicals' Pneumococcal Vaccine 2830930A When Administered as a Single Dose in Healthy Toddlers Aged 12-23 Months|Completed||Phase 1|61|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 03:31:50.3687|2017-10-11 03:31:50.3687
NCT01485393|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-02-15|||January 2015||2015-01-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep|Pilot Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep|Active, not recruiting||N/A|30|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:31:50.653972|2017-10-11 03:31:50.653972
NCT01485380|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2016-06-20|2014-09-24||September 2012||2012-09-01|June 2016|2016-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Combined Electroencephalogram, Magnetic Resonance Imaging-Positron Emission Tomography of Dexmedetomidine Induced Sleep|Combined Electroencephalogram, Magnetic Resonance Imaging-Positron Emission Tomography of Dexmedetomidine Induced Sleep|Completed||N/A|20|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:31:50.744586|2017-10-11 03:31:50.744586
NCT01485367|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2012-04-19|||December 2011||2011-12-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura|Phase II Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in The Prevention and Treatment of Senile Purpura|Unknown status|Recruiting|Phase 2|20|Anticipated|Multispecialty Aesthetic Clinical Research Organization||2|||f||||t||||||||||2017-10-11 03:31:50.971169|2017-10-11 03:31:50.971169
NCT01485354|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-06-12|2017-04-05||December 2008|Actual|2008-12-01|June 2017|2017-06-01|March 2017|Actual|2017-03-01|October 2015|Actual|2015-10-01||Interventional|||Upper Arm Training With Armeo Spring for Stroke|The Effect of Repetitive Upper Arm Training in a Virtual Environment on Upper Extremity Motor Recovery in Chronic-stroke Survivors|Terminated||N/A|17|Actual|Spaulding Rehabilitation Hospital||1||Lack of funding|f||||f|f|t|f|f|f|||No||2017-10-11 03:31:51.135831|2017-10-11 03:31:51.135831
NCT01485341|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-04-12|||June 2011||2011-06-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|GS||Gluten Sensitivity in Non-Celiac Patients|Double Blind Randomized Placebo Controlled Multicenter Trial (Gluten vs Placebo) in Gluten Sensitive Subjects|Completed||Phase 3|108|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||t||||||||||2017-10-11 03:31:51.427642|2017-10-11 03:31:51.427642
NCT00005430|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|November 2001|2001-11-01|September 1995|Actual|1995-09-01|||||Observational|||Low Cholesterol and Mortality in Blacks and Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.293107|2017-10-11 04:27:03.293107
NCT01485328|ClinicalTrials.gov processed this data on October 10, 2017|2008-12-16|2011-12-05|||December 2008||2008-12-01|December 2011|2011-12-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|AMARGOL||Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics|Phase III - Efficacy Study of AMARGOL - Phytomedicine on Therapeutics|Completed||Phase 3|60|Actual|Laboratorio Saude Ltda.||2|||f||||t||||||||||2017-10-11 03:31:51.569079|2017-10-11 03:31:51.569079
NCT01485315|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-10-02|||November 2011||2011-11-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|TRISS||Transfusion-requirements in Septic Shock Trial|Effects of Red Blood Cell Transfusion on Mortality and Morbidity in Patients With Septic Shock|Completed||Phase 3|1005|Actual|Scandinavian Critical Care Trials Group||2|||f||||t||||||||||2017-10-11 03:31:51.667066|2017-10-11 03:31:51.667066
NCT01485302|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2015-03-24|||January 2012||2012-01-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients|A Multi-center, Parallel-group, Double-blind, Placebo-controlled Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability and the Pharmacokinetic Properties of SAR228810 Given as IV Infusion or as SC Injection in Patients With Mild to Moderate Alzheimer's Disease.|Completed||Phase 1|48|Actual|Sanofi||6|||f||||f||||||||||2017-10-11 03:31:51.880565|2017-10-11 03:31:51.880565
NCT01485289|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-10-03|||August 2011||2011-08-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||Stabilimax Investigational Device Exemption (IDE) Clinical Investigation Patient Followup Study|Stabilimax Study Participants Collection of Additional Follow-up Data Clinical Investigation Plan R-001|Completed||N/A|43|Actual|Rachiotek LLC|||2||f||||f||||||||||2017-10-11 03:31:52.01122|2017-10-11 03:31:52.01122
NCT01485276|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-07-06|||November 8, 2011||2011-11-08|July 30, 2014|2014-07-30|July 30, 2014|Actual|2014-07-30|||||Interventional|||Combined Deep Brain Stimulation for Parkinson's Disease|Pilot Study of Bilateral Pedunculo-Pontine Nucleus (PPN) Deep Brain Stimulation for Patients With Parkinson Disease (PD) Who Have Persistent Gait Disturbance, Despite Bilateral Subthalamic Nucleus (STN) Deep Brain Stimulation|Withdrawn||Phase 1/Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:31:52.094199|2017-10-11 03:31:52.094199
NCT01485263|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-02|2017-07-07|||May 26, 2011||2011-05-26|July 6, 2017|2017-07-06|July 6, 2017||2017-07-06|||||Observational|||Analysis of Visual-Motor Task Electrophysiological Activity During Deep Brain Stimulation for Treatment-Resistant Movement Disorders|Analysis of Visual-Motor Task Electrophysiological Activity During Deep Brain Stimulation for Treatment-Resistant Movement Disorders|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:31:52.170086|2017-10-11 03:31:52.170086
NCT01485250|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-10-05|||February 17, 2010||2010-02-17|August 23, 2017|2017-08-23||||||||Observational|||A Cross-Cultural Assessment of the Motivations of Healthy Participants in Phase I Research|A Cross-Cultural Assessment of the Motivations of Healthy Participants in Phase I Research|Completed||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:31:52.242364|2017-10-11 03:31:52.242364
NCT01485237|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2015-12-01|||October 2009||2009-10-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Observational|||Severe Pandemic H1N1 Infection in ICU: Comparative Resource Utilization|Severe Pandemic H1N1 Infection in ICU: Comparative Resource Utilization|Completed||N/A|400|Actual|University of Manitoba|||2||f||||f||||||||||2017-10-11 03:31:52.32842|2017-10-11 03:31:52.32842
NCT01485224|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-08-28|||November 2011||2011-11-01|August 2017|2017-08-01|October 11, 2016|Actual|2016-10-11|October 2014|Actual|2014-10-01||Interventional|THALI-HHT||Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia|Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)|Completed||Phase 2|31|Actual|IRCCS Policlinico S. Matteo||1|||f||||t||||||||||2017-10-11 03:31:52.430467|2017-10-11 03:31:52.430467
NCT01485211|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2011-12-02|||January 2010||2010-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Riboflavin|Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Hypo-osmolar Riboflavin Solution in Thin Corneas|Completed||Phase 4|18|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-10-11 03:31:53.178838|2017-10-11 03:31:53.178838
NCT01485198|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-26|2016-02-29|||August 2011||2011-08-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional|||Autologous Stem Cells in Osteoarthritis|Clinical Effects of Autologous Bone Marrow Mononuclear Cell Infusion in Knee Osteoarthritis.|Completed||Phase 1|61|Actual|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||t||||||||||2017-10-11 03:31:53.341302|2017-10-11 03:31:53.341302
NCT01485185|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-06-09|||October 11, 2011|Actual|2011-10-11|June 2017|2017-06-01|July 3, 2012|Actual|2012-07-03|July 3, 2012|Actual|2012-07-03||Interventional|||Gabapentin and Donepezil Combination on Experimental Human Pain Models|A Randomized, Double Blind, Placebo Controlled Study to Investigate the Effect of Donepezil and Gabapentin Combination on an Experimental Pain Model in Healthy Subjects|Completed||Phase 1|48|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:31:53.618895|2017-10-11 03:31:53.618895
NCT01485172|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-06-10|2014-12-18||January 31, 2012|Actual|2012-01-31|June 2017|2017-06-01|April 30, 2014|Actual|2014-04-30|April 30, 2014|Actual|2014-04-30||Interventional|TANDEM-662||A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease|A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release (PR) in Patients With Early Stage Parkinson's Disease|Completed||Phase 4|186|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:31:53.828531|2017-10-11 03:31:53.828531
NCT01485159|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-02-20|||October 2011||2011-10-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|ALICE||Airflow Limitation in Cardiac Diseases in Europe|Airflow Limitation in Cardiac Diseases in Europe|Completed||N/A|3000|Actual|GlaxoSmithKline|||1||f||||f||||||Samples With DNA|"     In patients that specifically consent, blood samples will be taken for future analysis of the     genetic links between COPD and cardiovascular disease   "|||2017-10-11 03:31:56.180431|2017-10-11 03:31:56.180431
NCT01485146|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-04-12|||October 2011||2011-10-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects|A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ETC-1002 at Doses Above 120 mg/Day in Healthy Subjects|Completed||Phase 1|32|Anticipated|Esperion Therapeutics||4|||f||||f||||||||||2017-10-11 03:31:56.327461|2017-10-11 03:31:56.327461
NCT01485133|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2012-11-06|||November 2011||2011-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Observational|||Water Method Colonoscopy in Patients With Prior Surgery|Water Colonoscopy Versus Air Colonoscopy for Unsedated Patients With Prior Abdominal or Pelvic Surgery: a Prospective Randomized, Controlled Trial|Completed||N/A|110|Actual|Fourth Military Medical University|||2||f||||t||||||||||2017-10-11 03:31:56.395571|2017-10-11 03:31:56.395571
NCT01485107|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2013-06-27|||June 2011||2011-06-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|||Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Décolleté|Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of the Décolleté|Completed||N/A|24|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-10-11 03:31:56.571501|2017-10-11 03:31:56.571501
NCT01485094|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-09-30|2014-09-16||February 2012||2012-02-01|September 2014|2014-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Intention-to-treat|A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain|Evaluation of the Efficacy, Tolerability, and Safety of 7 Days of Treatment With GRT6010 or Pregabalin in Comparison to Placebo in Subjects With Peripheral Neuropathic Pain.|Terminated||Phase 2|114|Actual|Grünenthal GmbH||3||"The trial was early terminated after it was concluded that there was no added benefit from   exposing further participants after an unblinded interim analysis."|f||||f||||||||||2017-10-11 03:31:56.698378|2017-10-11 03:31:56.698378
NCT01485081|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-04-07|||May 2012||2012-05-01|November 2013|2013-11-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|DEBSIDE||Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)|Assessment of the Safety and Efficacy of the Danubio Paclitaxel-Eluting Balloon for the Treatment of Side Branches of de Novo Bifurcation Lesions in Native Coronary Arteries.|Completed||N/A|52|Actual|MINVASYS||1|||f||||t||||||||||2017-10-11 03:31:58.412025|2017-10-11 03:31:58.412025
NCT01485068|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-04-07|||March 2012||2012-03-01|November 2013|2013-11-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|DEBREST||Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST)|Assessment of the Safety and Efficacy of the Danubio Paclitaxel-Eluting Balloon for the Treatment of In-Stent Restenosis Lesions in Native Coronary Arteries.|Completed||N/A|44|Actual|MINVASYS||1|||f||||t||||||||||2017-10-11 03:31:58.529009|2017-10-11 03:31:58.529009
NCT01485055|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-02-28|||December 2011||2011-12-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease|Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease|Active, not recruiting||Phase 2|10|Actual|Nationwide Children's Hospital||1|||f||||t||||||||||2017-10-11 03:31:58.653958|2017-10-11 03:31:58.653958
NCT01485042|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-08-31|||December 2011||2011-12-01|August 2017|2017-08-01|March 2014|Actual|2014-03-01|February 2013|Actual|2013-02-01||Interventional|PATH||Dose Escalation Study of Pazopanib Plus TH-302|Phase I Dose Escalation of Pazopanib Plus TH-302 in Advanced Solid Tumors|Completed||Phase 1|50|Anticipated|Duke University||1|||f||||t||||||||||2017-10-11 03:31:58.801842|2017-10-11 03:31:58.801842
NCT01485029|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2012-12-17|||January 2012||2012-01-01|December 2011|2011-12-01|January 2013|Anticipated|2013-01-01|April 2012|Actual|2012-04-01||Interventional|||Streptococcus Pneumoniae Nasopharyngeal Carriage|Streptococcus Pneumoniae Nasopharyngeal Carriage Among Children Attending Day-care Centres in the Alpes Maritimes. Substudy: Enterobacterial Intestinal Carriage and Susceptibility to 3rd Generation Cephalosporins|Unknown status|Recruiting|N/A|500|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-10-11 03:31:58.914104|2017-10-11 03:31:58.914104
NCT01485016|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-08-20|||November 2011||2011-11-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Observational|||Physiological and Biomechanical Data Collection Study in Epilepsy Subjects|Observational Study Collecting Physiological and Biomechanical Data in Ambulatory Subjects With Epilepsy|Completed||N/A|20|Actual|Cyberonics, Inc.|||1||f||||f||||||||||2017-10-11 03:31:59.025569|2017-10-11 03:31:59.025569
NCT01485003|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-08-04|||February 29, 2012|Actual|2012-02-29|August 2017|2017-08-01|November 30, 2018|Anticipated|2018-11-30|November 30, 2018|Anticipated|2018-11-30||Observational|STRIVE||Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants|A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients|Active, not recruiting||N/A|231|Actual|Biogen|||1||f||||||||||||||2017-10-11 03:31:59.141252|2017-10-11 03:31:59.141252
NCT01484990|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-12-02|||April 2010||2010-04-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease|A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease|Completed||Phase 1|19|Actual|Abbott||1|||f||||f||||||||||2017-10-11 03:31:59.367114|2017-10-11 03:31:59.367114
NCT01484977|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-07-07|2014-11-20||December 2011||2011-12-01|July 2017|2017-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|VERVE|The Baseline characteristics consist of subjects in the Safety Set (SS). The SS is all subjects who received at least 1 dose of lacosamide.|eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam|Open-label, Single Arm, Study Evaluating Tolerability and Efficacy of Lacosamide When Added to Levetiracetam With Withdrawal of Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects With Uncontrolled Partial-onset Seizures|Completed||Phase 3|120|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 03:31:59.479459|2017-10-11 03:31:59.479459
NCT01484964|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2011-12-01|||September 2011||2011-09-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New Formulation|A Phase I, Single-Dose, Open-Label, Three-Period, Randomized, Crossover Study to Compare the Relative Bioavailability Between Two Tablet Formulations of ASP015K and to Assess the Food Effect on a New Formulation in Healthy Volunteers|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 03:31:59.937572|2017-10-11 03:31:59.937572
NCT01484951|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2013-04-25|2013-03-12||May 2011||2011-05-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure|Assessing the Safety and Efficacy of Switching to AZARGA® (Brinzolamide/Timolol Fixed Combination) as Replacement Therapy in Patients With Uncontrolled Intraocular Pressure in Taiwan|Completed||Phase 4|74|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:32:00.029997|2017-10-11 03:32:00.029997
NCT01484938|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2012-10-05|2012-09-06||February 2011||2011-02-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers|Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers|Completed||N/A|175|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:32:00.455111|2017-10-11 03:32:00.455111
NCT01484925|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-01-24|||November 2011||2011-11-01|January 2017|2017-01-01||||November 2017|Anticipated|2017-11-01||Observational|||BETERNet Notch Signaling and Novel Biomarkers for Barretts Esophagus|Notch Signaling and Novel Biomarkers for Barretts Esophagus|Recruiting||N/A|60|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-11 03:32:00.727434|2017-10-11 03:32:00.727434
NCT01484912|ClinicalTrials.gov processed this data on October 10, 2017|2007-05-09|2011-12-01|2010-11-11||May 2007||2007-05-01|December 2011|2011-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Phase II Study of STA-2 in Patients With Chronic Stable Angina|A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of STA-2 in Patients With Chronic Stable Angina|Completed||Phase 2|79|Actual|Sinphar Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-11 03:32:00.848818|2017-10-11 03:32:00.848818
NCT01484899|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2013-07-04|||September 2011||2011-09-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Observational|DACH||Smoking: a Risk Factor for Pulmonary Arterial Hypertension?|Smoking: a Risk Factor for Pulmonary Arterial Hypertension? A D-A-CH Pulmonary Hypertension Study (Germany- Austria - Switzerland)|Completed||N/A|500|Actual|University of Zurich|||3||f||||f||||||||||2017-10-11 03:32:01.2181|2017-10-11 03:32:01.2181
NCT01484886|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-12|2014-09-04|||January 2012||2012-01-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Restrictive Versus Liberal Transfusion Protocol in Infants Undergoing Cardiac Surgery|Prospective Randomized Controlled Clinical Trial Comparing a Restrictive Versus Liberal Transfusion Strategy in Neonates and Infants Undergoing Surgery for Congenital Heart Disease|Completed||N/A|162|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 03:32:01.315059|2017-10-11 03:32:01.315059
NCT01484873|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-01-17|2016-02-09||June 2012||2012-06-01|January 2017|2017-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor|Effects of Exenatide on Body Weight in Patients With Hypothalamic Obesity|Completed||Phase 2|10|Actual|Vanderbilt University Medical Center||1|||f||||t||||||||No||2017-10-11 03:32:01.423759|2017-10-11 03:32:01.423759
NCT01484860|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-07-03|||January 2012||2012-01-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy|A Phase II Single Arm Study of AUY922 in Patients With Metastatic Pancreatic Adenocarcinoma Who Are Resistant to First Line Chemotherapy|Terminated||Phase 2|15|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 03:32:01.817501|2017-10-11 03:32:01.817501
NCT01484847|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2015-07-09|||December 2011||2011-12-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|March 2013|Actual|2013-03-01||Interventional|||A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma|Pharmacokinetic Assessment of PF-00299804 in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Following Administration Through a Gastrojejunostomy Feeding Tube|Completed||N/A|6|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 03:32:01.936727|2017-10-11 03:32:01.936727
NCT01484834|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-05-02|2015-12-04||August 2011||2011-08-01|May 2017|2017-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Comparison of Interventions to Promote Health in Workers|Comparison of Interventions to Promote Health in Workers: A Cluster Randomized Controled Trial|Completed||N/A|190|Actual|Universidade Metodista de Piracicaba||4|||f||||t||||||||Yes|Data are available when required|2017-10-11 03:32:02.03184|2017-10-11 03:32:02.03184
NCT01484821|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-01-12|||November 2011||2011-11-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|CAPARFI||Assessment of in Vivo Skeletal Muscle Viscoelasticity (ARFI Imaging) With Aging and Cancer||Completed||N/A|65|Actual|University Hospital, Bordeaux||3|||f||||f||||||||||2017-10-11 03:32:02.751839|2017-10-11 03:32:02.751839
NCT01484808|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2011-12-01|||January 2012||2012-01-01|November 2011|2011-11-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Observational|PSADv||The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage|Retrospective Review of Reduce Data to Determine the Utility of PSADv While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage|Unknown status|Not yet recruiting|N/A|6600|Anticipated|University Urological Associates Inc.|||1||f||||f||||||||||2017-10-11 03:32:02.872017|2017-10-11 03:32:02.872017
NCT01484795|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2011-12-01|||January 2011||2011-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||Noninvasive Ventilation in Acute Myocardial Infarction|Non Invasive Ventilation in Acute Myocardial Infarction|Completed||Phase 1|10|Actual|Centro Universitário Augusto Motta||2|||f||||t||||||||||2017-10-11 03:32:02.975351|2017-10-11 03:32:02.975351
NCT01484782|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-04-24|||May 2011||2011-05-01|April 2015|2015-04-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Developing Accessible Telehealth Programs for Hypertensive Patients in Latin America|Developing Accessible Telehealth Programs for Hypertensive Patients in Latin America|Completed||N/A|200|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:32:03.075835|2017-10-11 03:32:03.075835
NCT01484769|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-04-07|||July 2005||2005-07-01|April 2017|2017-04-01|June 2012|Anticipated|2012-06-01|June 2011|Anticipated|2011-06-01||Observational|H&N||Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells|Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells|Withdrawn||N/A|0|Actual|University of Louisville|||1||f||||f||||||Samples With DNA|"     Tissue samples from patients undergoing elective neck dissection will be collected. Primary     tumors and adjacent normal tissue from unaffected areas will be collected at the time of     surgery. All tissue dissection and removal are part of the standard of care for this type of     surgical procedure. Remaining resected tissue will be used for research.   "|||2017-10-11 03:32:03.170686|2017-10-11 03:32:03.170686
NCT01484756|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-12-05|||August 2008||2008-08-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Combined Vitamins and Minerals Decrease Incidence of Upper Respiratory Tract Infections in Older Persons|Combined Vitamins and Minerals Decrease Incidence of Upper Respiratory Tract Infections in Older Persons|Completed||Phase 3|270|Actual|Trisakti University||2|||f||||t||||||||||2017-10-11 03:32:03.246692|2017-10-11 03:32:03.246692
NCT01484743|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2011-12-01|||January 2007||2007-01-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Observational|PAHEREP||Risk Factors for Morbidity After Parastomal Hernia Repair|Nationwide Prospective Study of Surgical Risk Factors for Poor Outcome After Parastomal Hernia Repair|Completed||N/A|199|Actual|University Hospital Koge|||1||f||||f||||||||||2017-10-11 03:32:03.371034|2017-10-11 03:32:03.371034
NCT01484730|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-09-15|||November 2011||2011-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||A Pilot Study to Evaluate Multi-Spectral Imaging and Laser Speckle Imaging During Vascular Occlusion|A Pilot Study to Evaluate Multi-Spectral Imaging and Laser Speckle Imaging During Vascular Occlusion|Withdrawn||N/A|0|Actual|University of California, Irvine|||1||f||||f||||||||||2017-10-11 03:32:03.468955|2017-10-11 03:32:03.468955
NCT01484717|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-02-16|||January 2012||2012-01-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation|Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation|Completed||Phase 2|90|Actual|UConn Health||2|||f||||t|f|f||||||||2017-10-11 03:32:03.563026|2017-10-11 03:32:03.563026
NCT01484704|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2011-12-01|||February 2011||2011-02-01|November 2011|2011-11-01||||||||Observational|||The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer||Unknown status|Recruiting|N/A|100|Anticipated|Turku University Hospital|||2||f||||||||||||||2017-10-11 03:32:03.66539|2017-10-11 03:32:03.66539
NCT01484691|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-07-17|||October 2011||2011-10-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|RITA||Role of microRNAs in T Cell-Driven Inflammation in Asthma|Role of miRNAs in Th2-driven Inflammation in Asthma|Recruiting||N/A|50|Anticipated|University of California, San Francisco||3|||f||||f||||||||||2017-10-11 03:32:03.748589|2017-10-11 03:32:03.748589
NCT01484678|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-01-30|||May 2010||2010-05-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy|Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy|Recruiting||N/A|185|Anticipated|University of Florida|||2||f||||f||||||Samples With DNA|"     Blood and Skin Samples Collected   "|||2017-10-11 03:32:03.863834|2017-10-11 03:32:03.863834
NCT01484665|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-08-21|||December 2011||2011-12-01|August 2014|2014-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening|Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening|Completed||N/A|72|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-10-11 03:32:03.984829|2017-10-11 03:32:03.984829
NCT01484652|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-09-08|2014-04-11||November 2011||2011-11-01|September 2016|2016-09-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional||The analysis population for baseline characteristics includes all 329 subjects who received at least one dose of study treatment. The subjects were assigned 2 cohort classifications. Cohort 1 included 26 subjects enrolled under the original protocol and amendment 1. Cohort 2 is the remainder of the 303 subjects enrolled after amendment 1.|Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Safety and Analgesic Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain Followed by an Open-Label Extension|Completed||Phase 3|329|Actual|Mallinckrodt||2|||f||||f||||||||||2017-10-11 03:32:04.098359|2017-10-11 03:32:04.098359
NCT01484639|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2013-02-20|||January 2012||2012-01-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|TRICSII||Transfusion Requirements in Cardiac Surgery|Transfusion Requirements in Cardiac Surgery (TRICS II): A Randomized Controlled Trial|Completed||N/A|208|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-10-11 03:32:04.484482|2017-10-11 03:32:04.484482
NCT01484626|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-10-29|||May 2011||2011-05-01|October 2012|2012-10-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|BVRD||Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma|An Open-Label Phase I/II Study of Bendamustine, Weekly Bortezomib, Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma|Unknown status|Recruiting|Phase 1/Phase 2|76|Anticipated|Loyola University||1|||f||||t||||||||||2017-10-11 03:32:04.570809|2017-10-11 03:32:04.570809
NCT01484613|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-11-21|||November 2011||2011-11-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|EffaceQ||Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchronization Patients With Quadripolar Left Ventricular Leads|Effectiveness and Reliability of Selected Site Pacing for Avoidance of Phrenic Nerve Stimulation in CRT Patients With Quadripolar LV Leads|Completed||N/A|337|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 03:32:04.684724|2017-10-11 03:32:04.684724
NCT01484600|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2012-03-12|||December 2011||2011-12-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN668 Administered Subcutaneously to Healthy Volunteers||Completed||Phase 1|36|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-11 03:32:04.92539|2017-10-11 03:32:04.92539
NCT01484587|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2017-09-01|||August 22, 2011|Actual|2011-08-22|September 2017|2017-09-01|April 11, 2013|Actual|2013-04-11|April 11, 2013|Actual|2013-04-11||Interventional|||A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis|A Randomized, Double-blind, Placebo-controlled, Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CNTO 1959 Following a Single Subcutaneous Administration in Japanese Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 1|24|Actual|Janssen Pharmaceutical K.K.||2|||f||||t||f||||||||2017-10-11 03:32:05.013039|2017-10-11 03:32:05.013039
NCT00005431|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1994||1994-09-01|April 2001|2001-04-01|February 1996|Actual|1996-02-01|||||Observational|||Coronary Heart Disease Risk Factors in Blacks Vs Whites||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.345472|2017-10-11 04:27:03.345472
NCT01484574|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2016-09-12|||January 2012||2012-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|February 2014|Actual|2014-02-01||Interventional|||A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease|A Non-randomized, Open Label, Multicentric, Dose Ranging , Phase II Study Assessing the Efficacy and Safety of Intramuscular Administration of Stempeucel - CLI™ (ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients With Critical Limb Ischemia Due to Buerger's Disease|Completed||Phase 2|90|Actual|Stempeutics Research Pvt Ltd||3|||f||||t||||||||||2017-10-11 03:32:05.140756|2017-10-11 03:32:05.140756
NCT01484561|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-03-04|2014-01-11||April 2012||2012-04-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis|A Phase 1, Randomized, Placebo-Controlled, Two-Period, Fixed Sequence Study To Evaluate The Effect Of CP-690,550 On Measured Glomerular Filtration Rate In Patients With Active Rheumatoid Arthritis|Completed||Phase 1|148|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 03:32:05.316714|2017-10-11 03:32:05.316714
NCT01484548|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-02-24|||January 2012||2012-01-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|August 2012|Actual|2012-08-01||Interventional|||Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers|A Phase 1, Randomized Clinical Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of The LEISH-F3 + GLA-SE Vaccine Compared To The LEISH-F3 Protein Alone In Healthy Adult Subjects|Completed||Phase 1|36|Actual|IDRI||3|||f||||t||||||||||2017-10-11 03:32:06.782856|2017-10-11 03:32:06.782856
NCT01484535|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-07-16|||September 2011||2011-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|February 2014|Actual|2014-02-01||Interventional|||Aspiration for Pain Relief Following Ankle Fracture|Aspiration for Pain Relief Following Ankle Fracture: A Prospective Double-Blind Randomized Controlled Trial|Completed||N/A|130|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:32:06.891893|2017-10-11 03:32:06.891893
NCT01484522|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2011-11-30|||October 2009||2009-10-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|January 2010|Actual|2010-01-01||Observational|||Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth|A Laboratory Study to Assess the Immunogenicity of Three Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-1 Perinatally Infected Children and Youth|Completed||N/A|149|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|||3||f||||t||||||||||2017-10-11 03:32:07.012944|2017-10-11 03:32:07.012944
NCT01484509|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2012-05-14|||June 2011||2011-06-01|November 2011|2011-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Subjective and Objective Methods of Assessing Walking Limitation Due to Claudication|The Estimation of Ambulation Capacity by History Questionnaire (EACH-Q): An Assessment of Its Validity and Inter-day Reproducibility in Patients With Vascular-type Claudication|Completed||N/A|37|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-10-11 03:32:07.162634|2017-10-11 03:32:07.162634
NCT01484496|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-07-23|2017-01-30|2015-06-11|November 16, 2011||2011-11-16|March 2017|2017-03-01|October 1, 2015|Actual|2015-10-01|February 13, 2015|Actual|2015-02-13||Interventional|BLISS-SC||A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 3|839|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 03:32:07.30753|2017-10-11 03:32:07.30753
NCT01484483|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-08-18|||August 8, 2011|Actual|2011-08-08|August 2017|2017-08-01|October 19, 2020|Anticipated|2020-10-19|October 19, 2020|Anticipated|2020-10-19||Observational|||An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya|Breast Cancer Care (BRECC) Registry - Development of a Breast Cancer Registry to Determine the Magnitude of Breast Cancer and Current Clinical Care Patterns in Kenya|Active, not recruiting||N/A|367|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:32:09.82059|2017-10-11 03:32:09.82059
NCT01484470|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-02-23|||January 2010||2010-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|February 2017|Anticipated|2017-02-01||Interventional|||Umbilical Cord Transplantation for the Elderly Population|An Open Label,Double Arm,Single Center Pilot Study to Evaluate the Safety and Efficacy of Transplantation of Either StemEx, Umbilical Cord Blood Stem and Progenitor Cells Expanded ex Vivo, or an Unmanipulated Cord Blood Unit in the Elderly Population With Hematologic Malignancies Using Reduced Intensity Regimen|Active, not recruiting||Phase 2|18|Actual|Loyola University||2|||f||||t||||||||||2017-10-11 03:32:09.909181|2017-10-11 03:32:09.909181
NCT01484457|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2012-06-05|||July 2008||2008-07-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Controlled Insulin Delivery: Combining Technology With Treatment|Controlled Insulin Delivery: Combining Technology With Treatment|Completed||Early Phase 1|19|Actual|William Sansum Diabetes Center||1|||f||||t||||||||||2017-10-11 03:32:10.012347|2017-10-11 03:32:10.012347
NCT01484444|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-12-04|||September 2011||2011-09-01|December 2011|2011-12-01||||August 2013|Anticipated|2013-08-01||Observational|||Biomarker Analysis of Gastrointestinal Cancer|Biomarker Analysis of Gastrointestinal Cancer|Unknown status|Recruiting|N/A|500|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:32:10.176412|2017-10-11 03:32:10.176412
NCT01484431|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-08-16|||July 2012||2012-07-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|April 2017|Actual|2017-04-01||Interventional|||A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension|A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Eli Lilly and Company||1|||f||||t||||||||||2017-10-11 03:32:10.262898|2017-10-11 03:32:10.262898
NCT01484418|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-09-01|||August 2011||2011-08-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2015|Actual|2015-08-01||Interventional|ETABP||Exposure-based Treatment for Avoidant Back Pain Patients|Exposure Therapy in Chronic Low Back Pain Patients|Completed||N/A|68|Actual|Philipps University Marburg Medical Center||3|||f||||f||||||||||2017-10-11 03:32:10.417119|2017-10-11 03:32:10.417119
NCT01484405|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-11-10|||June 2010||2010-06-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|THA||Anterolateral Versus Posterior Approach for Total Hip Arthroplasty After Displaced Femoral Neck Fracture|Anterolateral Versus Posterior Approach for Total Hip Arthroplasty After Displaced Femoral Neck Fracture|Terminated||N/A|16|Actual|Florida Orthopaedic Institute||2||Low enrollment.|f||||f||||||||||2017-10-11 03:32:10.539231|2017-10-11 03:32:10.539231
NCT01484379|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-08-24|||December 2011||2011-12-01|August 2017|2017-08-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Surgical Approach for Primary Hyperparathyroidism in the Elderly|Surgical Approach for Primary Hyperparathyroidism in the Elderly - a Prospective Study|Withdrawn||N/A|0|Actual|Rambam Health Care Campus||1||difficulties in Recruiting patients|f||||f||||||||||2017-10-11 03:32:10.73925|2017-10-11 03:32:10.73925
NCT01484366|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-11-10|||September 2010||2010-09-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Forearm Shaft Fractures: Plating of Radius and Ulna Versus Plating of Radius and Nailing of Ulna|Prospective Randomized Trial for Forearm Shaft Fractures: Plating of Radius and Ulna vs. Plating of Radius and Nailing of Ulna|Terminated||N/A|13|Actual|Florida Orthopaedic Institute||2||Low enrollment. Treament no longer used by researchers.|f||||f||||||||||2017-10-11 03:32:10.858325|2017-10-11 03:32:10.858325
NCT01484353|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-03-10||||||March 2015|2015-03-01||||||||Interventional|KPTLCP||Intensive Lifestyle Intervention for Type 2 Diabetics: The KP TLC Pilot|Intensive Lifestyle Intervention for Type 2 Diabetics: The Kaiser Permanente TLC Pilot|Withdrawn||N/A|0|Actual|Kaiser Permanente||1||This study was cancelled.|f||||f||||||||||2017-10-11 03:32:10.97525|2017-10-11 03:32:10.97525
NCT01484340|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-01-30|||March 2014|Actual|2014-03-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|JHU||A Smoking Cessation Trial in HIV-infected Patients in South Africa|A Smoking Cessation Trial in HIV-infected Patients in South Africa|Active, not recruiting||N/A|500|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 03:32:11.070802|2017-10-11 03:32:11.070802
NCT01484327|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2012-08-30|||January 2009||2009-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|CARVEDIA||Carvedilol Vascular Efficacy Trial|Multicentre, Open-label, Non-interventional Observational Clinical Study Lasting 48 Weeks in Patients With Heart Failure or Reduced Left Ventricular Ejection Fraction Following Acute Myocardial Infarction Who Are Treated With Carvedilol|Completed||N/A|415|Actual|Elpen Pharmaceutical Co. Inc.|||1||f||||f||||||||||2017-10-11 03:32:11.179352|2017-10-11 03:32:11.179352
NCT01484314|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-02-01|2016-09-23||April 2012|Actual|2012-04-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma|A Phase II Study of Eltrombopag for the Treatment of Thrombocytopenia in Patients Undergoing Therapy for Relapsed Multiple Myeloma|Terminated||Phase 2|1|Actual|Dana-Farber Cancer Institute|The study is limited because it terminated early with only 1 patient enrolled.|1||Low accrual.|f||||t|t|f||||||No||2017-10-11 03:32:11.301139|2017-10-11 03:32:11.301139
NCT01484301|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2013-03-19|||February 2010||2010-02-01|March 2013|2013-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Impact of Tolerability Issues on Chronic Pain|The Impact of Opioid Tolerability Outcomes on the Management of Chronic Pain|Completed||Phase 4|165|Actual|Janssen-Ortho Inc., Canada|||1||f||||f||||||||||2017-10-11 03:32:11.47413|2017-10-11 03:32:11.47413
NCT01484288|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-12-23|||November 2011||2011-11-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|July 2013|Actual|2013-07-01||Interventional|||Baroreflex Activation Therapy in Heart Failure|Baroreflex Activation Therapy in Heart Failure|Completed||N/A|12|Actual|CVRx, Inc.||1|||f||||t||||||||||2017-10-11 03:32:11.532353|2017-10-11 03:32:11.532353
NCT01484275|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2017-08-17|||March 1, 2012|Actual|2012-03-01|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Interventional|||A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma|A Phase 2, Randomized, Blinded, Placebo-controlled, Multicenter Study of Siltuximab (Anti IL 6 Monoclonal Antibody) in Subjects With High-risk Smoldering Multiple Myeloma|Active, not recruiting||Phase 2|87|Actual|Janssen Research & Development, LLC||2|||f||||t||f||||||||2017-10-11 03:32:11.607316|2017-10-11 03:32:11.607316
NCT01484262|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-11-16|||November 2011||2011-11-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2|Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2|Completed||N/A|1344|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-10-11 03:32:11.784354|2017-10-11 03:32:11.784354
NCT01484249|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-12-02|||February 2010||2010-02-01|December 2011|2011-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Carotid Filtration During Endovascular Aortic Valve Implantation|Carotid Filtration During Endovascular Aortic Valve Implantation|Completed||N/A|38|Actual|Claret Medical||1|||f||||t||||||||||2017-10-11 03:32:11.869695|2017-10-11 03:32:11.869695
NCT01484236|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-02-22|||January 2012||2012-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|RE-LAM-CE||National Lymphangioleiomyomatosis Registry, France|National Lymphangioleiomyomatosis Registry, France|Recruiting||N/A|200|Anticipated|Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires|||1||f||||f||||||||||2017-10-11 03:32:11.935513|2017-10-11 03:32:11.935513
NCT01484223|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2012-10-10|||October 2009||2009-10-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Effectiveness of Cognitive Behavioral Intervention in Patients With Symptoms Somatization in Primary Care|Efectiveness of a Cognitive Behavioral Intervention in Patients With Symptoms Somatization, as Measure Quality of Life, Front the Clinical Practice Usual Action in Primary Health Care. A Controlled Clinical Trial With Parallel Groups|Completed||N/A|242|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||t||||||||||2017-10-11 03:32:12.053768|2017-10-11 03:32:12.053768
NCT01484210|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2012-08-30|||March 2008||2008-03-01|November 2011|2011-11-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®|Phase III Therapeutic Evaluation Study Comparing the Efficacy and Safety of the Fluticasone/Salmeterol (500/50 μg) Combination Administered With Elpenhaler® (Rolenium®) Versus the Innovative One (Seretide Diskus®) in Patients With Asthma.|Completed||Phase 3|28|Actual|Elpen Pharmaceutical Co. Inc.||1|||f||||f||||||||||2017-10-11 03:32:12.154944|2017-10-11 03:32:12.154944
NCT01484197|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2015-03-18|2013-05-17||November 2011||2011-11-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device|A Multi-centre, Randomized, Double-blind, Double-dummy, Multiple-dose, Crossover Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Orally Inhaled Indacaterol Administered as Either PulmoSphere or Lactose-blend Powder Via the Concept1 Device in Adult Patients With Persistent Asthma|Completed||Phase 2|36|Actual|Novartis||4|||f||||f||||||||||2017-10-11 03:32:12.328514|2017-10-11 03:32:12.328514
NCT01484184|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2015-08-19|||July 2013||2013-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury|Tri-therapy (SPINALON)-Elicited Spinal Locomotor Network Activation: Phase I-IIa Clinical Trial in Patients With Chronic Spinal Cord Injury|Completed||Phase 1/Phase 2|50|Actual|Nordic Life Science Pipeline Inc.||2|||f||||t||||||||||2017-10-11 03:32:16.275269|2017-10-11 03:32:16.275269
NCT01484171|ClinicalTrials.gov processed this data on October 10, 2017|2011-12-01|2016-07-12|||August 2011||2011-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia|HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia|Recruiting||Phase 3|50|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||2|||f||||f||||||||||2017-10-11 03:32:16.383603|2017-10-11 03:32:16.383603
NCT01484158|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-01-20|||October 2001||2001-10-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction|Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction|Completed||N/A|450|Actual|Yokohama City University Medical Center|||1||f||||f||||||Samples Without DNA|"     We retain only blood sample only in this study.   "|||2017-10-11 03:32:16.48405|2017-10-11 03:32:16.48405
NCT01484145|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-10-18|||December 2011||2011-12-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail|An Unblinded Clinical Trial to Evaluate the Deposition of Terbinafine in the Nail Bed After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail|Completed||Phase 2|25|Actual|Nitric BioTherapeutics, Inc||5|||f||||f||||||||||2017-10-11 03:32:16.559105|2017-10-11 03:32:16.559105
NCT01484132|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2015-07-06|2015-05-15||February 2012||2012-02-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|CUBS|98 of 101 subjects who had the pre-treatment urine sample completed the baseline interview. Therefore, 98 subjects were included in the baseline analysis.|Composites and Urinary Bisphenol-A Study|Health Effects of Dental Composites in Children|Completed||N/A|113|Actual|New England Research Institutes||1|||f||||f||||||||||2017-10-11 03:32:16.653276|2017-10-11 03:32:16.653276
NCT01484119|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2013-03-27||2013-03-27|December 2011||2011-12-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|SAR||Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis|Multi-center, Double-blind, Double-dummy, Randomized, Placebo-controlled, Active-reference, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-129968 in Adolescent, Adult & Elderly Patients With Seasonal Allergic Rhinitis|Completed||Phase 3|630|Actual|Actelion||3|||f||||f||||||||||2017-10-11 03:32:17.150928|2017-10-11 03:32:17.150928
NCT01484106|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-02-16|||November 2011||2011-11-01|September 2012|2012-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|COMMIT||Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis|Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis|Completed||N/A|65|Actual|Cheetah Medical Inc.||2|||f||||f||||||||||2017-10-11 03:32:17.262707|2017-10-11 03:32:17.262707
NCT01484093|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-09-07|||November 2011||2011-11-01|September 2017|2017-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma|Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma: A Phase I/II Trial|Active, not recruiting||Phase 1/Phase 2|96|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:32:17.382793|2017-10-11 03:32:17.382793
NCT01484080|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-04-15|||October 2011||2011-10-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|||Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates|Phase I/II Randomized Clinical Trial of Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates|Completed||Phase 1/Phase 2|140|Actual|Centro Nacional de Investigaciones Oncologicas CARLOS III||2|||f||||t||||||||||2017-10-11 03:32:17.486786|2017-10-11 03:32:17.486786
NCT01484067|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2012-09-27|||November 2011||2011-11-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study of a Cold Sore Patch for the Treatment of Herpes Labialis|A Randomized, Clinician-Blind, Clinical Study to Examine the Safety and Performance of Compeed© Total Care™ Cold Sore Patch With Zinc Sulfate for the Treatment of Herpes Labialis|Completed||N/A|472|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 03:32:17.581201|2017-10-11 03:32:17.581201
NCT01484054|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-05-05|2013-08-30||November 2011||2011-11-01|May 2015|2015-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Baseline summary was conducted on all enrolled subjects who received study lenses.|Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens|Dispensing Evaluation of Lens Comfort and Subjective Vision of an Etafilcon A With Print and PVP Lens for Dark Eyes|Completed||N/A|103|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-10-11 03:32:17.693085|2017-10-11 03:32:17.693085
NCT01484041|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-01-16|2016-03-10||April 2012||2012-04-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer|A Phase I/II Trial of TKI258 (Dovitinib) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer|Terminated||Phase 1/Phase 2|12|Actual|Georgetown University||1||Decision by company to cease development of dovitinib|f||||t||||||||No|Will not be reporting outcome data as study closed by sponsor prior to completing accrual. Will be reporting aggregate findings for correlative science project|2017-10-11 03:32:17.95629|2017-10-11 03:32:17.95629
NCT01484028|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-05-05|2013-08-30||November 2011||2011-11-01|May 2015|2015-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Baseline summary was conducted on all randomized subjects who worn at least one pair of study lenses.|Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens|Clinical Validation of Etafilcon A With Print and PVP Contact Lenses for Dark Eyes and Light Eyes|Completed||N/A|275|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||f||||||||||2017-10-11 03:32:18.245332|2017-10-11 03:32:18.245332
NCT01484015|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-05-25|||February 2011||2011-02-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia|Prolonged Infusion Compared to Standard Infusion Cefepime as Empiric Treatment of Febrile Neutropenia: A Pilot Study|Completed||Phase 1|70|Actual|Wake Forest University Health Sciences||2|||f||||f|t|f||||||||2017-10-11 03:32:18.68811|2017-10-11 03:32:18.68811
NCT01484002|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-01-23|||December 2011||2011-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Analysis of Crosslinked and Conventional Polyethylene Explants|Collaborative Analysis of UHMWPE Explants: Conventional UHMWPE With No Radiation and Marathon|Enrolling by invitation||N/A|60|Anticipated|Anderson Orthopaedic Research Institute|||2||f||||f||||||||||2017-10-11 03:32:18.931653|2017-10-11 03:32:18.931653
NCT01483989|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-11-17|||February 2011||2011-02-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients|In Vivo Measurement of Corneal Epithelial Changes in Dry Eye(DE) Patients|Completed||N/A|19|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:32:19.097889|2017-10-11 03:32:19.097889
NCT01483976|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-01-30|||October 2011||2011-10-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Comparison of Medical Nutritional Supplements|Comparison of Medical Nutritional Supplements With or Without AN777 in Elderly Men|Completed||Phase 3|27|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-10-11 03:32:19.189203|2017-10-11 03:32:19.189203
NCT01483963|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-09-07|2017-04-18|2015-03-17|November 2011||2011-11-01|September 2017|2017-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder|A Phase 2a, Open-label, Dose-ranging Study of the Safety and Effectiveness of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder|Completed||Phase 2|50|Actual|Endo Pharmaceuticals||5|||f||||f||||||||||2017-10-11 03:32:19.323926|2017-10-11 03:32:19.323926
NCT01483950|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2013-02-04|||April 2012||2012-04-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values|Non-interventional Study to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors in Bosnia and Herzegovina|Completed||N/A|800|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-11 03:32:20.978322|2017-10-11 03:32:20.978322
NCT01483937|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-06-26|2013-08-19||November 2011||2011-11-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|SEMD|4 withdrew from Conventional care physical therapy 3 withdrew from Conventional care physical therapy plus SEMD|Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium|Clinical Trial Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium|Completed||N/A|32|Actual|BalanceSense LLC|Small number of subjects recruited because of lengthy study commitment.|2|||f||||f||||||||||2017-10-11 03:32:21.11064|2017-10-11 03:32:21.11064
NCT01483924|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-02-09|2015-01-20||November 2011||2011-11-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional||A total of 60 patients were enrolled. No formal sample size calculation for this study was done, as this study was an exploratory study with main objective to assess the safety and tolerability of Apo805K1.|Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A 12-week Randomized, Double-blind, Placebo-controlled, Multicenter, Multiple Sequential Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|60|Actual|ApoPharma||4|||f||||t||||||||||2017-10-11 03:32:21.570703|2017-10-11 03:32:21.570703
NCT01483911|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2013-02-26|||December 2011||2011-12-01|October 2012|2012-10-01||||May 2012|Actual|2012-05-01||Interventional|||ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers|Phase I, Single-centre, Randomised, Placebo-controlled, Double-blinded Study, With Single Ascending Dose and Multiple Dose at Maximum Tolerated Dose, Evaluating the Safety, Tolerability and Pharmacokinetics of ALX-0171, Administered by Pulmonary Inhalation, in Healthy Male Volunteers|Completed||Phase 1|60|Actual|Ablynx||2|||f||||t||||||||||2017-10-11 03:32:22.986163|2017-10-11 03:32:22.986163
NCT01483898|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-05-31||2016-06-23|February 2012||2012-02-01|May 2017|2017-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|REVIVE||An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Ixmyelocel-T In Subjects With Critical Limb Ischemia And No Options For Revascularization|Completed||Phase 3|41|Actual|Vericel Corporation||2|||f||||t||||||||No||2017-10-11 03:32:23.094896|2017-10-11 03:32:23.094896
NCT01483885|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2011-11-29|||July 2011||2011-07-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||Comparison of the Analgesic Effects of Acupuncture and Modulated Electroanalgesia in Cold Induced Pain|Comparison of the Analgesic Effects of Acupuncture and Modulated Electroanalgesia in Cold Induced Pain.|Completed||Phase 1/Phase 2|82|Actual|Universidade Federal do Piauí||7|||f||||t||||||||||2017-10-11 03:32:23.347364|2017-10-11 03:32:23.347364
NCT01483872|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-26|2015-10-06|||March 2012||2012-03-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections|Phase II Trial of a Novel Catheter Lock Solution For Adjunctive Treatment of Hemodialysis Catheter-Associated Bacteremia.|Terminated||Phase 3|9|Actual|University of California, San Diego||2||The study was stopped due to poor enrollment.|f||||t||||||||||2017-10-11 03:32:23.427974|2017-10-11 03:32:23.427974
NCT01483859|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2015-07-14|||September 2011||2011-09-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Prediction of Intraoperative Blood Loss and Postoperative Recovery by Liver Stiffness Measurement (Fibroscan®) in Right Hepatectomy|Prediction of Intraoperative Blood Loss and Postoperative Recovery by Liver Stiffness Measurement (Fibroscan®) in Right Hepatectomy|Completed||N/A|45|Actual|Yonsei University||1|||f||||t||||||||||2017-10-11 03:32:23.504323|2017-10-11 03:32:23.504323
NCT01483846|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-12-18|||December 2011||2011-12-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers|A Phase 1b, Single-Site, Randomized, Double-Blind,Placebo-Controlled, Dose-Escalation Study: Safety, Pharmacokinetics, and Antihyperalgesic Activity of Multiple Doses of AV-101 on Capsaicin-Induced Pain in Healthy Volunteers|Completed||Phase 1|50|Actual|VistaGen Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 03:32:23.579777|2017-10-11 03:32:23.579777
NCT01483833|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2013-08-19|||September 2001||2001-09-01|November 2011|2011-11-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Efficacy Study of Iferanserin to Treat Hemorrhoids|Protocol for the Study of the Effects of S-MPEC (Iferanserin) in Patients With Hemorrhoids|Completed||Phase 2|121|Actual|Ventrus Biosciences, Inc||2|||f||||f||||||||||2017-10-11 03:32:23.68161|2017-10-11 03:32:23.68161
NCT01483820|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-09-09|2016-05-10||December 2011||2011-12-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma|A Phase I/II Trial of TPI-287 in Patients With Refractory or Recurrent Neuroblastoma and Medulloblastoma|Terminated||Phase 1/Phase 2|8|Actual|Spectrum Health Hospitals||1||Lack of enrollment|f||||t||||||||||2017-10-11 03:32:23.766462|2017-10-11 03:32:23.766462
NCT01483807|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2017-09-20|||August 1, 2011|Actual|2011-08-01|September 2017|2017-09-01|January 1, 2018|Anticipated|2018-01-01|January 31, 2017|Actual|2017-01-31||Interventional|Apraxia||Treatments of Acquired Apraxia of Speech|Treatments of Acquired Apraxia of Speech|Active, not recruiting||N/A|24|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 03:32:24.100694|2017-10-11 03:32:24.100694
NCT01483794|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2011-11-30|||November 2011||2011-11-01|November 2011|2011-11-01|April 2012|Anticipated|2012-04-01|March 2012|Anticipated|2012-03-01||Observational|||Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile|Genital Warts: Studies for Establishing Epidemiological Profile, Psychosocial Consequences and Costs of Disease in Attendants to the Sexual Health Clinic of the Public Health Service of Valparaiso and San Antonio, Chile.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Universidad de Valparaiso|||2||f||||f||||||||||2017-10-11 03:32:24.36616|2017-10-11 03:32:24.36616
NCT01483781|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-08-19|||December 2011||2011-12-01|August 2014|2014-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus|A Double-Blind, Placebo-Controlled, Randomized, Parallel-Groups Study to Investigate the Effects of JNJ-28431754 (Canagliflozin) on Plasma Volume and Renal Function in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|36|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-10-11 03:32:24.459578|2017-10-11 03:32:24.459578
NCT01483768|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2017-02-20|||September 2012|Actual|2012-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|FORBES||Study of Sleeve Gastrectomy on Iron Intestinal Absorption in Morbidly Obese Patients|Evaluation of the Impact of Bariatric Surgery by Sleeve Gastrectomy on Iron Intestinal Absorption in Morbidly Obese Patients|Completed||N/A|88|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||Undecided||2017-10-11 03:32:24.563822|2017-10-11 03:32:24.563822
NCT01483755|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2013-07-26|||July 2009||2009-07-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|PRIME||Delayed Postconditioning|Delayed Angioplasty Postconditioning in STEMI Patients|Completed||Phase 2|72|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:32:24.645766|2017-10-11 03:32:24.645766
NCT01483742|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2016-07-28||2016-07-20|April 2012||2012-04-01|July 2016|2016-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis|A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Ritonavir-Boosted DANOPREVIR and RO5024048 in Different Combinations in Null Responder or Treatment Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis|Completed||Phase 2|43|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:32:24.729178|2017-10-11 03:32:24.729178
NCT01483729|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2016-11-01|||December 2011||2011-12-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Relative Bioavailability Study of Danoprevir and Ritonavir in Healthy Volunteers||Completed||Phase 1|36|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-11 03:32:24.887532|2017-10-11 03:32:24.887532
NCT01483716|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2015-08-16|||November 2011||2011-11-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||A Trial of Rehabilitation in Obesity Hypoventilation Syndrome (OHS)||Completed||N/A|37|Actual|Guy's and St Thomas' NHS Foundation Trust||2|||f||||||||||||||2017-10-11 03:32:25.165655|2017-10-11 03:32:25.165655
NCT01483703|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-02-08|||May 2010||2010-05-01|February 2017|2017-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Noninvasive Optical Measurement of Critical Care Neonates|Noninvasive Optical Measurement of Critical Care Neonates|Completed||N/A|6|Actual|University of California, Irvine|||1||f||||f||||||||||2017-10-11 03:32:25.258466|2017-10-11 03:32:25.258466
NCT01483690|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-11-20|||December 2011||2011-12-01|September 2015|2015-09-01||||June 2015|Actual|2015-06-01||Interventional|||A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL|A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL|Terminated||Phase 1/Phase 2|23|Actual|Therapeutic Advances in Childhood Leukemia Consortium||1||Toxicity|f||||t||||||||||2017-10-11 03:32:25.373409|2017-10-11 03:32:25.373409
NCT01483677|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2011-11-30|||November 2010||2010-11-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Comparison Study of the Nintendo Wii Versus Playstation2 in Enhancing Laparoscopic Skills|Is Nintendo Wii a More Suitable Video Game Platform Than Playstation 2 for Enhancing Laparoscopic Skills?|Completed||Early Phase 1|42|Actual|Beth Israel Medical Center||2|||f||||f||||||||||2017-10-11 03:32:25.644567|2017-10-11 03:32:25.644567
NCT01483664|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-10-03|||November 2011||2011-11-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Communication Skills Intervention to Promote Transition Into Survivorship|Communication Skills Intervention to Promote Transition Into Survivorship|Active, not recruiting||N/A|314|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||t||||||||||2017-10-11 03:32:25.798634|2017-10-11 03:32:25.798634
NCT01483651|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-03-01|2014-09-08||November 2011||2011-11-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Physiologic Response to Glucagon at Varying Insulin Levels|The Hepatic Glucose Response to Glucagon at Varying Insulin Levels: Implications for Closed Loop Glycemic Control.|Completed||N/A|11|Actual|Legacy Health System||6|||f||||t||||||||||2017-10-11 03:32:25.949066|2017-10-11 03:32:25.949066
NCT01483638|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-05-11|||February 2012||2012-02-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|TTD-11-01||Axitinib as Maintenance Treatment in Patients With Metastatic CRC|A Phase II Study of Axitinib as Maintenance Treatment for Patients With Metastatic Colorectal Carcinoma|Terminated||Phase 2|84|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||2||The trial was prematurely closed due to lack of accrual|f||||f||||||||||2017-10-11 03:32:26.263939|2017-10-11 03:32:26.263939
NCT01483625|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-30|2014-06-03|2013-12-23||November 2011||2011-11-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection|A 12-week, Randomised, Placebo-controlled, Double-blind, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Tiotropium Bromide (18 µg) Delivered Via the HandiHaler® in Patients With Newly Diagnosed and/or Maintenance Treatment naïve Chronic Obstructive Pulmonary Disease (COPD) Experiencing an Acute Respiratory Infection (TICARI 1: Tiotropium In COPD Patients With an Acute Respiratory Infection 1)|Completed||Phase 4|140|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:32:26.40245|2017-10-11 03:32:26.40245
NCT01483612|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2016-10-24|||November 2011||2011-11-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|OF||Evaluation of Clinical Outcomes and Costs of a Lifestyle Intervention in Obese Infertile Women|"Evaluation of Clinical Outcomes and Costs of a Transferable Interdisciplinary Lifestyle Intervention Pre- and Per-pregnancy in Obese Infertile Women"|Active, not recruiting||N/A|130|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 03:32:26.969394|2017-10-11 03:32:26.969394
NCT01483599|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-07-05|2017-07-05|2013-10-16|November 10, 2011|Actual|2011-11-10|July 2017|2017-07-01|August 5, 2013|Actual|2013-08-05|November 27, 2012|Actual|2012-11-27||Interventional|X-PLORE|Population analyzed included all participants who were randomized.|A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis|A Phase 2 Multicenter, Randomized, Placebo- and Active-Comparator-Controlled, Dose-Ranging Trial to Evaluate CNTO 1959 for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis (X-PLORE)|Completed||Phase 2|293|Actual|Janssen Inc.||7|||f||||t||f||||||||2017-10-11 03:32:27.159596|2017-10-11 03:32:27.159596
NCT01483586|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-04-11|||November 2011||2011-11-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer|Efficacy and Safety of Oral Kanglaite (KLTc)in Men With Prostate Cancer: Randomized, Dose-Ranging Study of the Effects of KLTc on Prostate Specific Antigen (PSA) Doubling Time Among Men With Rising PSA Levels After Definitive Local Therapy|Terminated||Phase 2|90|Actual|KangLaiTe USA||2||Sponsor decision|f||||t||||||||||2017-10-11 03:32:29.252334|2017-10-11 03:32:29.252334
NCT01483573|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-07|2016-03-21|||May 2010||2010-05-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Effect of Hamstring Stretching and Neural Mobilization on Range of Motion and Low Back Pain|Effect of Hamstring Stretching and Neural Mobilization on Range of Motion and Low Back Pain|Terminated||N/A|25|Actual|Rutgers, The State University of New Jersey||2||Insufficient recruitment over time|f||||f||||||||||2017-10-11 03:32:29.353883|2017-10-11 03:32:29.353883
NCT01483560|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-04-25|||December 2011||2011-12-01|April 2017|2017-04-01|April 18, 2017|Actual|2017-04-18|March 19, 2017|Actual|2017-03-19||Interventional|REMOVAL||REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)|Phase 3 Study of Metformin in Adults With Type 1 Diabetes|Completed||Phase 3|502|Actual|University of Glasgow||2|||f||||t||||||||Yes|Site specific participant data will be made available to the site PIs later in 2017, after the main publications.|2017-10-11 03:32:29.442402|2017-10-11 03:32:29.442402
NCT01483547|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2013-02-15|||November 2011||2011-11-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Reliability of BIS Monitoring in Neurosurgical Patients|Reliability of Bispectral Index for Depth of Anesthesia Monitoring in Neurosurgical Patients|Completed||N/A|405|Actual|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta|||2||f||||t||||||||||2017-10-11 03:32:29.595963|2017-10-11 03:32:29.595963
NCT01483534|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-09-22|||October 2011||2011-10-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2013|Actual|2013-11-01||Interventional|IPS-I||Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation|Evaluation of the Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation (TLD) Therapy in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) - A Safety Study|Completed||Phase 1|22|Actual|Nuvaira, Inc.||1|||f||||t||||||||||2017-10-11 03:32:29.662397|2017-10-11 03:32:29.662397
NCT01483521|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-11-30|||April 2009||2009-04-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Infant Psychiatry Home Visitation Program|Externalizing Behavior in Early Childhood: A Randomized Control Evaluation of a Home Visitation Program|Completed||N/A|40|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 03:32:29.762907|2017-10-11 03:32:29.762907
NCT01483508|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-10-23|||February 2008||2008-02-01|October 2012|2012-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Absorption and Metabolism of Dietary Cocoa Procyanidins in Humans|Contribution of Dietary Cocoa Procyanidins to the Systemic Presence of Flavanols Metabolites in Humans|Completed||N/A|12|Actual|University of California, Davis||3|||f||||f||||||||||2017-10-11 03:32:29.931834|2017-10-11 03:32:29.931834
NCT01483495|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-02-08|||December 2011||2011-12-01|February 2017|2017-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|DOSI||Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study|Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry|Completed||N/A|78|Actual|University of California, Irvine|||1||f||||f||||||||||2017-10-11 03:32:30.047504|2017-10-11 03:32:30.047504
NCT01483482|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-03-15|||April 2011||2011-04-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Treatment of Displaced, Midshaft Clavicle Fractures. Sling or Plate?|Treatment of Displaced, Midshaft Clavicle Fractures. Sling or Plate?|Active, not recruiting||N/A|120|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 03:32:30.138052|2017-10-11 03:32:30.138052
NCT01483469|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-11-01|||December 2011||2011-12-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Human Proof of Concept Study for [11C]-RO5011232 as Radiotracer and Study of the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-State in Healthy Volunteers|Human Proof of Concept Positron Emission Tomography Study to Investigate [11C]-RO5011232 as a Radiotracer for Brain mGlu5 Receptor Occupancy and to Investigate the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-state.|Completed||Phase 1|56|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:32:30.234177|2017-10-11 03:32:30.234177
NCT01483456|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-09-16|||July 2011||2011-07-01|September 2014|2014-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|IPR||Impact of Multidisciplinary Program on Falls in Elderly Inpatients|"A Multidisciplinary Program for Preventing Falls Identify, Prevent and Get up: Impact on Falls in Elderly Inpatients"|Unknown status|Active, not recruiting|N/A|1852|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 03:32:30.331822|2017-10-11 03:32:30.331822
NCT01483443|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-08-28|||August 2008||2008-08-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|August 2012|Actual|2012-08-01||Interventional|||Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Cancer Patients|Prophylactic Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Patients With or Without Ovarian Metastasis|Completed||Phase 3|140|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 03:32:30.453246|2017-10-11 03:32:30.453246
NCT01483430|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2011-11-30|||September 2011||2011-09-01|November 2011|2011-11-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Effect of Ginseol Kg1 on Blood Pressure Lowering|Effect of Ginseol Kg1 on Blood Pressure Lowering in Prehypertensive or Stage I Hypertensive Patients: Multicenter, Randomized, Placebo-controlled, Double-blind Study|Unknown status|Recruiting|Phase 3|90|Anticipated|Seoul National University Hospital||3|||f||||f||||||||||2017-10-11 03:32:30.538083|2017-10-11 03:32:30.538083
NCT01483417|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2012-02-20|||December 2011||2011-12-01|November 2011|2011-11-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy|Multi-institution, Randomized Trial for Efficacy and Safety of Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy for the Treatment of Uterine Myoma or Adenomyosis|Unknown status|Recruiting|Phase 3|240|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 03:32:30.638029|2017-10-11 03:32:30.638029
NCT01483404|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2012-11-09|||June 2012||2012-06-01|November 2012|2012-11-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Observational|MicroFemNeck||Identification of the Microcirculation of the Caput Femoris After Fracture of the Femoral Neck|Identification of Microcirculation in Fracture of the Femural Neck: How Does the Intracapsular Hematoma Affect the Capillary Bloodflow in the Caput Femoris?|Withdrawn||N/A|0|Actual|RWTH Aachen University|||1||f||||t||||||||||2017-10-11 03:32:30.752425|2017-10-11 03:32:30.752425
NCT01483391|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-26|2016-04-19|||October 2011||2011-10-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||Early Intervention for Youth at Risk for Bipolar Disorder|Early Intervention for Youth at Risk for Bipolar Disorder|Recruiting||Phase 2/Phase 3|150|Anticipated|University of California, Los Angeles||2|||f||||t||||||||Yes|Upon completing the study we will submit a CD-ROM to the NIH Freedom of Information Act Coordinator containing all raw data, variable coding information, and copies of measures. Prior to archiving the data, we will remove all personal identifiers and other protected information. The youth's and parents' consent forms will make clear that the data, minus any identifying information, will be made available to other researchers at the end of the study.|2017-10-11 03:32:30.838808|2017-10-11 03:32:30.838808
NCT01483378|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-08-07|2013-02-19||January 2012||2012-01-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||170 patients were enrolled in the study, however 2 met FDA contraindications for herpes zoster vaccination and 2 already received the vaccine, so only 166 were included in the analysis.|Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital|Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital|Completed||N/A|170|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 03:32:30.998753|2017-10-11 03:32:30.998753
NCT01483365|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-06-15|||December 2011||2011-12-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Need for Luteal Support in NC-FET|The Use of Luteal Support After NC-FET|Unknown status|Recruiting|Early Phase 1|100|Anticipated|Wolfson Medical Center||1|||f||||t||||||||||2017-10-11 03:32:31.207296|2017-10-11 03:32:31.207296
NCT01483352|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-03-16|2015-04-24||November 2011||2011-11-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||All participants who received the implant were included in analysis.|Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes|Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes|Completed||N/A|12|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:32:31.341736|2017-10-11 03:32:31.341736
NCT01483339|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-10-05|||November 2011||2011-11-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|||Metacognitive Therapy for Patients With Obsessive-Compulsive Disorder|Metacognitive Therapy Versus Exposition With Response Prevention for Patients With Obsessive-Compulsive Disorder|Completed||N/A|37|Actual|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-10-11 03:32:32.600877|2017-10-11 03:32:32.600877
NCT01483326|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-09-27|||December 31, 2010|Actual|2010-12-31|September 2017|2017-09-01|June 19, 2017|Actual|2017-06-19|June 19, 2017|Actual|2017-06-19||Observational|||An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)|FAct: A Non-interventional Multi-center Study to Follow Patients Starting With RoActemra Assessing the Long Term Efficacy, Effectiveness and Safety of RoActemra|Completed||N/A|215|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:32:32.739327|2017-10-11 03:32:32.739327
NCT01483313|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-02-09|||November 2011||2011-11-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Observational|||Intelligence Changes Following Minor Surgery|Intelligence Performance in Adolescence After Early Exposure to Anesthesia and Minor Surgery|Withdrawn||N/A|0|Actual|RenJi Hospital|||1|No patients enrolled.|f||||t||||||||||2017-10-11 03:32:32.858107|2017-10-11 03:32:32.858107
NCT01483300|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2012-01-22|||November 2011||2011-11-01|January 2012|2012-01-01|November 2014|Anticipated|2014-11-01|August 2014|Anticipated|2014-08-01||Interventional|||Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer||Unknown status|Recruiting|Phase 2|80|Anticipated|Harbin Medical University||2|||f||||t||||||||||2017-10-11 03:32:32.940607|2017-10-11 03:32:32.940607
NCT01483287|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-11-17|||November 2011||2011-11-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS)|The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in IBS|Completed||Early Phase 1|20|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||||||||||||2017-10-11 03:32:33.053311|2017-10-11 03:32:33.053311
NCT01483105|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-05-02|||October 2011||2011-10-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|VCUG||DVD-Based Training Program in Self-Hypnosis for Children|DVD-Based Training Program in Self-Hypnosis for Children: A Randomized Clinical Trial|Recruiting||N/A|56|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 03:32:38.639697|2017-10-11 03:32:38.639697
NCT01483274|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-05-08|||March 2015||2015-03-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|AML||Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation|Pharmacologic Upregulation of Cancer Testis Antigens Followed by Vaccine Therapy for Patients With Relapsed Acute Myelogenous Leukemia (AML) Following Allogeneic Stem Cell Transplantation|Withdrawn||Phase 1|0|Actual|University of Louisville||2||Adult patient population barriers.|f||||t||||||||||2017-10-11 03:32:33.137289|2017-10-11 03:32:33.137289
NCT01483261|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2011-12-01|||May 2011||2011-05-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||An RCT of Trauma Focused-Cognitive Behavioral Therapy With Sexually Exploited, War-affected Girls in the DRC|Is Trauma-Focused Cognitive Behavioral Therapy Effective in Reducing Post-traumatic Stress and Psychosocial Distress Among Sexually Exploited, War-affected Girls in the Democratic Republic of Congo.|Completed||Phase 2|60|Actual|Queen's University, Belfast||2|||f||||f||||||||||2017-10-11 03:32:33.234312|2017-10-11 03:32:33.234312
NCT01483248|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2012-06-06|||October 2010||2010-10-01|June 2012|2012-06-01|October 2015|Anticipated|2015-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis|Phase 1/2 Study of Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation for the Evaluation of the Efficacy and Safety in Patients With Liver Cirrhosis|Unknown status|Enrolling by invitation|Phase 1/Phase 2|50|Anticipated|S-Evans Biosciences Co.,Ltd.||2|||f||||t||||||||||2017-10-11 03:32:33.343598|2017-10-11 03:32:33.343598
NCT01483235|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2011-12-01|||September 2006||2006-09-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|rCRP||Reduced Cardiac Rehabilitation Program|Design, Implementation and Evaluation of a Reduced Cardiac Rehabilitation Program|Completed||N/A|118|Actual|Simon Fraser University||2|||f||||f||||||||||2017-10-11 03:32:33.682196|2017-10-11 03:32:33.682196
NCT01483222|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-26|2014-10-14|||November 2011||2011-11-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Comparison of Inelastic and Elastic Lumbosacral Orthoses on Low Back Pain Prevention in Hospital Nurses|Comparison of Inelastic and Elastic Lumbosacral Orthoses on Low Back Pain Prevention in Hospital Nurses|Completed||N/A|300|Actual|Central South University||3|||f||||t||||||||||2017-10-11 03:32:33.822433|2017-10-11 03:32:33.822433
NCT01483209|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-02-16|2015-02-16||March 2012||2012-03-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Treatment of Vasopressor-induced Ischemia With Botulinum Toxin A|Treatment of Vasopressor-induced Ischemia With Botulinum Toxin A|Terminated||N/A|2|Actual|Duke University|Due to low accrual for this study we were unable to perform any data analysis.|1||Low accrual|f||||t||||||||||2017-10-11 03:32:33.931263|2017-10-11 03:32:33.931263
NCT01483196|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-05-25|||January 2012|Actual|2012-01-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery|Feasibility Study of Vascular and Cognitive Assessments During Adjuvant Chemotherapy for Breast Cancer (VASCOG)|Completed||N/A|30|Actual|Wake Forest University Health Sciences||1|||f||||f|f|f||||||||2017-10-11 03:32:34.147517|2017-10-11 03:32:34.147517
NCT01483183|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-02-24|2016-10-04||November 2011||2011-11-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CADENCE 215||Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation|A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation|Terminated||Phase 1|40|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|The trial was terminated after Part 1 enrollment completed. It did not progress due to many factors including slow enrollment, limited site activity in pre-screening, absence of reproducible efficacy signal and increased costs.|4||Enrollment Difficulty|f||||f||||||||||2017-10-11 03:32:34.329976|2017-10-11 03:32:34.329976
NCT01483170|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-03-29|||September 2011||2011-09-01|March 2017|2017-03-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food|Double-blind, Placebo Controlled, Randomized Multiple Ascending Dose Study in Fed Conditions for Ten Days Dosing Regimen With a Loading Dose to Evaluate the Safety, the Tolerability and the Pharmacokinetics of Oral Fexinidazole in 36 Healthy Male Sub-Saharan Volunteers.|Terminated||Phase 1|30|Actual|Drugs for Neglected Diseases||2||poor tolerability at highest dose|f||||||||||||Undecided||2017-10-11 03:32:36.754562|2017-10-11 03:32:36.754562
NCT01483157|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-02-27|||November 2011||2011-11-01|February 2014|2014-02-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Vascular Occlusion and Rheumatoid Arthritis|Effects of Strength Training With Vascular Occlusion in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial|Unknown status|Recruiting|N/A|30|Anticipated|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 03:32:37.509281|2017-10-11 03:32:37.509281
NCT01483144|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2017-08-01|||October 2013||2013-10-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|April 2019|Anticipated|2019-04-01||Interventional|||Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)|Phase III Trial of the Safety and Efficacy of Eflornithine Combined With Sulindac Compared to Eflornithine, Sulindac as Single Agents in Patients With Familial Adenomatous Polyposis|Active, not recruiting||Phase 3|171|Actual|Cancer Prevention Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-11 03:32:37.670238|2017-10-11 03:32:37.670238
NCT01483131|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-02-27|||November 2011||2011-11-01|February 2014|2014-02-01|December 2014|Anticipated|2014-12-01|November 2013|Actual|2013-11-01||Interventional|||Vascular Occlusion in Patients With Osteoarthritis|Effects of Strength Training Associated With Vascular Occlusion in Patients With Knee Osteoarthritis|Unknown status|Recruiting|N/A|45|Anticipated|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 03:32:37.870687|2017-10-11 03:32:37.870687
NCT01483118|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2017-09-05|2016-05-26||March 2011||2011-03-01|June 2017|2017-06-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Interventional|||Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)|The Effects of Oral Cinnamon Extract on Menstrual Cyclicity in PolyCystic Ovary Syndrome|Completed||Phase 3|45|Actual|Columbia University|High percentage of patients lost to follow up|2|||f||||t||||||||||2017-10-11 03:32:38.033352|2017-10-11 03:32:38.033352
NCT01482533|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2011-11-29||||||November 2011|2011-11-01||||||||Observational|||Tissue Culture Versus Swab Culture in Prosthetic Joint Infections||Unknown status|Not yet recruiting|N/A|||Rothman Institute Orthopaedics|||2||f||||f||||||||||2017-10-11 03:32:48.931601|2017-10-11 03:32:48.931601
NCT01483092|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-06-06|||August 2011||2011-08-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Effect of Inulin on Iron Absorption in Humans|Inulin Modifies Gut Microbiota, Fecal Lactate Concentration and Fecal pH But Does Not Influence Iron Absorption in Women With Low Iron Status|Completed||N/A|32|Actual|Swiss Federal Institute of Technology||2|||f||||f||||||||||2017-10-11 03:32:38.740547|2017-10-11 03:32:38.740547
NCT01483079|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-06-20|||December 2011||2011-12-01|June 2017|2017-06-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|NICU||Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the Neonatal Intensive Care Unit (NICU)|Evaluation of Post-Discharge Growth and Development of Infants Who Received Donor Human Milk Products in the NICU|Enrolling by invitation||N/A|80|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-10-11 03:32:38.814888|2017-10-11 03:32:38.814888
NCT01483066|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2014-12-22|||June 2012||2012-06-01|December 2014|2014-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Outcomes and Cost-effectiveness Analysis of ShapeMatch Technology|A Prospective, Randomized, Post-market, Multi-center Study and Cost-effectiveness Analysis of ShapeMatch Technology A Prospective, Randomized, Post-market, Multi-center Study and Cost-effectiveness Analysis of ShapeMatch Technology|Suspended||Phase 4|150|Anticipated|University of Alberta||2||FDA recall - Canadian system did voluntary suspension of study|f||||f||||||||||2017-10-11 03:32:38.881116|2017-10-11 03:32:38.881116
NCT01483053|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2013-12-16|||January 2014||2014-01-01|December 2013|2013-12-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)|A Randomised Trial Investigating the Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder.|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Baker IDI Heart and Diabetes Institute||2|||f||||f||||||||||2017-10-11 03:32:38.964763|2017-10-11 03:32:38.964763
NCT01483040|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-11-07|||September 2011||2011-09-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||PeerScope B System™ Clinical Protocol|a Prospective Clinical Study to Establish the Usability of the PeerScope B System™ When Used During Standard Colonoscopy Procedure|Completed||N/A|50|Actual|PeerMedical Ltd.||1|||f||||t||||||||||2017-10-11 03:32:39.139522|2017-10-11 03:32:39.139522
NCT01483027|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2017-08-31|||January 2012||2012-01-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|September 2018|Anticipated|2018-09-01||Interventional|EPOCH||Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer|A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy|Recruiting||Phase 3|340|Anticipated|BTG International Inc.||2|||f||||t||||||||||2017-10-11 03:32:39.250181|2017-10-11 03:32:39.250181
NCT01483014|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-11-16|||June 2008||2008-06-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|CONVERT||Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)|Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 2|30|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:32:39.972151|2017-10-11 03:32:39.972151
NCT01483001|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-01-13|||November 2011||2011-11-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|September 2012|Actual|2012-09-01||Interventional|STELLA||Feasibility Study on Stem Cells Sensitivity Assay|STELLA: a Feasibility Study on Stem Cells Sensitivity Assay|Completed||Phase 2|23|Actual|Associazione Oncologia Traslazionale||1|||f||||f||||||||||2017-10-11 03:32:40.095524|2017-10-11 03:32:40.095524
NCT01482988|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2011-11-30|||December 2011||2011-12-01|November 2011|2011-11-01||||||||Observational|Dectin-1||Role of Polymorphisms in the Dectin-1 Gene in Determining the Risk of Candida Colonization and Infection in Critically Ill Patients|Role of Polymorphisms in the Dectin-1 Gene in Determining the Risk of Candida Colonization and Infection in Critically Ill Patients|Unknown status|Not yet recruiting|N/A|600|Anticipated|Cardiff and Vale University Health Board|||1||f||||f||||||||||2017-10-11 03:32:40.173306|2017-10-11 03:32:40.173306
NCT01482975|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-05-10|||September 2007||2007-09-01|May 2016|2016-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Project BEST||Tailored Interventions to Prevent Substance Abuse|Tailored Interventions to Prevent Substance Abuse|Completed||N/A|4158|Actual|University of Rhode Island||2|||f||||f||||||||No||2017-10-11 03:32:40.245062|2017-10-11 03:32:40.245062
NCT01482962|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-03-30|||June 2012||2012-06-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|November 15, 2016|Actual|2016-11-15||Interventional|||Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma|A Phase 3, Randomized, Two-Arm, Open-Label, Multicenter, International Trial of Alisertib (MLN8237) or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma|Active, not recruiting||Phase 3|271|Actual|Takeda||2|||f||||t||||||||||2017-10-11 03:32:40.367676|2017-10-11 03:32:40.367676
NCT01482949|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-01-23|||September 2011||2011-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Rollover Protocol for Subjects Previously Treated With AGS-003|A Rollover Phase II Study Testing the Biologic Activity and Safety of AGS-003 in Renal Cell Carcinoma Subjects With Prolonged Response or Stable Disease and Ongoing AGS-003 Treatment in Protocol AGS-003-004 or AGS-003-006|Active, not recruiting||Phase 2|2|Actual|Argos Therapeutics||1|||f||||f||||||||No||2017-10-11 03:32:40.478269|2017-10-11 03:32:40.478269
NCT01482936|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-08-10|||May 2010||2010-05-01|August 2015|2015-08-01||||April 2011|Actual|2011-04-01||Interventional|||Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient|A Single Dose PK Study of Oxycodone Hydrochloride Injection 2.5, 5, and 10mg in Chinese Patients With Cancer Pain or Post-operation Patients|Completed||Phase 1|44|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||1|||f||||f||||||||||2017-10-11 03:32:40.596021|2017-10-11 03:32:40.596021
NCT01482923|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-05-01|||November 2011|Actual|2011-11-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations|Feasibility of Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations|Active, not recruiting||N/A|60|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 03:32:40.690701|2017-10-11 03:32:40.690701
NCT00005432|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||May 1995||1995-05-01|November 2001|2001-11-01|December 1997|Actual|1997-12-01|||||Observational|||Impact of Surfactant's Availability on Newborns||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.402767|2017-10-11 04:27:03.402767
NCT01482910|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-09-28|2015-03-01||December 2011||2011-12-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|||VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)|A Randomized, Double-masked, Photodynamic Therapy-controlled Phase-3 Study of the Efficacy, Safety, and Tolerability of Intravitreal VEGF Trap-Eye in Chinese Subjects With Neovascular Age-Related Macular Degeneration|Completed||Phase 3|304|Actual|Bayer||2|||f||||t||||||||||2017-10-11 03:32:40.777975|2017-10-11 03:32:40.777975
NCT01482897|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2014-12-01|||December 2011||2011-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Hiatus||Efficacy of corticoïd Infiltration Via Sacro-coccygien Hiatus in Discal Sciatica|Open Randomized Study on the Efficacy of corticoïd Infiltration Versus Physiological Solution Infiltration Versus Feigning of Infiltration Via Sacro-coccygien Hiatus Versus Natural Evolution in Discal Sciatica|Terminated||Phase 3|13|Actual|Nantes University Hospital||4||"Enrolment stopped on December 01, 2014 since after 3 years, only 13 patients were included   (instead of 274) (Date of last visit last patient : October 3, 2013)."|f||||f||||||||||2017-10-11 03:32:43.148385|2017-10-11 03:32:43.148385
NCT01482884|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2016-03-07|2015-01-20|2015-01-12|March 2012||2012-03-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional||All randomised participants.|Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis|A Phase IIa, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study to Evaluate the Efficacy and Safety of Tralokinumab (CAT-354), a Recombinant Human Monoclonal Antibody Directed Against Interleukin-13 (IL-13), as add-on Therapy, on Clinical Response in Patients With Active, Moderate-to-severe, Ulcerative Colitis|Completed||Phase 2|147|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:32:43.266292|2017-10-11 03:32:43.266292
NCT01482871|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-12-06|||January 2011||2011-01-01|December 2012|2012-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety Study of ALG- 1001 to Treat Diabetic Macular Edema|Safety Study of ALG 1001 to Treat Diabetic Macular Edema|Withdrawn||Phase 1/Phase 2|0|Actual|Allegro Ophthalmics, LLC||4|||f||||t||||||||||2017-10-11 03:32:44.325766|2017-10-11 03:32:44.325766
NCT01482858|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2011-11-30|||December 2011||2011-12-01|November 2011|2011-11-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||Analgesic Effects of the Gastrolith, in Osteoporotic Patients Suffering From Recent Skeletal Pain Caused by Vertebral Fractures|A Randomized, Double-blind, Placebo-controlled Study Evaluating the Analgesic Effects of the Gastrolith, in Osteoporotic Patients Suffering From Recent Skeletal Pain Caused by Vertebral Fractures|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|Amorphical Ltd.||2|||f||||f||||||||||2017-10-11 03:32:44.430517|2017-10-11 03:32:44.430517
NCT01482845|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-05-01|||November 2011||2011-11-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease|A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors|Completed||Phase 1|20|Actual|Abbott||2|||f||||f||||||||||2017-10-11 03:32:44.55372|2017-10-11 03:32:44.55372
NCT01482832|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2016-12-05|||December 2011||2011-12-01|December 2016|2016-12-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|REACH 2||Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers|Preventing Postpartum Depression in Adolescent Mothers|Active, not recruiting||N/A|250|Anticipated|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||No|Not at this point.|2017-10-11 03:32:44.639032|2017-10-11 03:32:44.639032
NCT01482819|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-08-21|2015-01-08||October 1, 2011|Actual|2011-10-01|August 2017|2017-08-01|December 1, 2011|Actual|2011-12-01|December 1, 2011|Actual|2011-12-01||Interventional||Subjects who were screened, gave consent, enrolled, and were randomized in the study.|Evaluation of Daytime Corneal Swelling During Wear of Galyfilcon A Lenses||Completed||N/A|21|Actual|Johnson & Johnson Vision Care, Inc.||10|||f||||f||||||||||2017-10-11 03:32:44.740102|2017-10-11 03:32:44.740102
NCT01482806|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-07-21|||February 2012||2012-02-01|July 2017|2017-07-01|May 30, 2017|Actual|2017-05-30|December 2015|Actual|2015-12-01||Interventional|||Online Treatments for Mood and Anxiety Disorders in Primary Care|Online Treatments for Mood and Anxiety Disorders in Primary Care|Completed||Phase 2/Phase 3|700|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 03:32:45.055861|2017-10-11 03:32:45.055861
NCT01482793|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2015-07-10|||November 2011||2011-11-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Controlled Trial of Vertebroplasty for Acute Painful Osteoporotic Fractures|A Controlled Trial of Vertebroplasty for Acute Painful Osteoporotic Fractures.|Completed||N/A|120|Actual|Optimus Clinical Research||2|||f||||t||||||||||2017-10-11 03:32:45.18852|2017-10-11 03:32:45.18852
NCT01482780|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-29|2015-04-06|||March 2012||2012-03-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of a Local Preconditioning Effect in Patients Undergoing Cardiac Surgery|EASY-TRIAL: Evaluation of a Local Preconditioning Effect in Patients Undergoing Cardiac Surgery|Terminated||N/A|5|Actual|Medical University of Vienna||2||Logistic reasons, lack of funding|f||||f||||||||||2017-10-11 03:32:45.28237|2017-10-11 03:32:45.28237
NCT01482767|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-06-01|2016-04-05||April 2012||2012-04-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All eligible participants enrolled (Group B participants who were found ineligible after enrollment, n=5, were excluded).|Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection|A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects|Completed||Phase 3|262|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 03:32:45.423893|2017-10-11 03:32:45.423893
NCT01482754|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2013-12-08|||May 2012||2012-05-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma|Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma|Completed||N/A|30|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-11 03:32:46.956356|2017-10-11 03:32:46.956356
NCT01482741|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2015-06-24|||November 2011||2011-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging|Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging|Completed||N/A|30|Actual|Memorial Sloan Kettering Cancer Center|||6||f||||||||||||||2017-10-11 03:32:47.055988|2017-10-11 03:32:47.055988
NCT01482728|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2016-05-11|||January 2012||2012-01-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer|A Phase 0 Pharmacodynamic Study of Dasatinib in Women With Newly Diagnosed Endometrial Cancer|Completed||Early Phase 1|12|Actual|University of Virginia||1|||f||||t||||||||||2017-10-11 03:32:47.156216|2017-10-11 03:32:47.156216
NCT01482715|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-06-13|||November 2011||2011-11-01|June 2017|2017-06-01||||April 2017|Actual|2017-04-01||Interventional|||A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)|A Phase I/II, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral Rucaparib in Patients With gBRCA Mutation Ovarian Cancer or Other Solid Tumor|Active, not recruiting||Phase 1/Phase 2|160|Anticipated|Clovis Oncology, Inc.||1|||f||||f||||||||||2017-10-11 03:32:47.246296|2017-10-11 03:32:47.246296
NCT01482702|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-12|2013-01-14|||October 2009||2009-10-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|VCC0910||Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors|Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors|Completed||N/A|72|Actual|University of Vermont||3|||f||||f||||||||||2017-10-11 03:32:47.385245|2017-10-11 03:32:47.385245
NCT01482689|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2011-11-28|||February 2005||2005-02-01|November 2011|2011-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Bioavailability of Vitamin D in Cod Liver Oil and Multivitamin Tablets in Healthy Subjects in Norway|Bioavailability of Vitamin D in Cod Liver Oil and Multivitamin Tablets in Healthy Subjects in Norway|Completed||N/A|74|Actual|University of Oslo||2|||f||||f||||||||||2017-10-11 03:32:47.486407|2017-10-11 03:32:47.486407
NCT01482676|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-06-01|||October 2010||2010-10-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction|Investigating the Role of microRNAs in the Regulation of Gene Expression and Organ Remodeling During Lower Urinary Tract Dysfunction, Including Bladder Pain Syndrome/Interstitial Cystitis (BPS), and Overactive Bladder Syndrome (OAB)|Completed||N/A|103|Actual|University Hospital Inselspital, Berne|||4||f||||f||||||Samples With DNA|"     Frozen cold-cut bladder biopsies preserved in RNAlater buffer or in SDS-PAGE sample buffer;     PFA-fixed tissue, primary cultures of urothelium and smooth muscle   "|||2017-10-11 03:32:47.577766|2017-10-11 03:32:47.577766
NCT01482663|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2014-12-02|||May 2011||2011-05-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Chronic Hand Eczema - Self-management and Prognosis|Chronic Hand Eczema - Self-management and Prognosis|Completed||N/A|306|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-10-11 03:32:47.693117|2017-10-11 03:32:47.693117
NCT01482650|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2012-06-18|||November 2011||2011-11-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Comparison of the BASKA Airway, a Novel Supraglottic Device, to the LMA Airway in Low Risk Female Patients|Comparison of the Effectiveness of the BASKA Airway, a Novel Supraglottic Device, to the LMA Airway in Low Risk Female Patients|Completed||Phase 2|92|Actual|University College Hospital Galway||2|||f||||f||||||||||2017-10-11 03:32:47.784455|2017-10-11 03:32:47.784455
NCT01482637|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-07-10|||January 2010||2010-01-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|CAS||Development of Coercion Assessment Scale|Improving Ethics in Research: Development of the Coercion Assessment Scale|Completed||Phase 3|228|Actual|Treatment Research Institute|||1||f||||t||||||||||2017-10-11 03:32:47.866572|2017-10-11 03:32:47.866572
NCT01482624|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2013-08-27|||December 2011||2011-12-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Intra-articular Hyaluronan After Arthroscopic Meniscal Surgery|Intra-articular Hyaluronan After Arthroscopic Meniscal Surgery.|Completed||N/A|64|Actual|TRB Chemedica AG||2|||f||||f||||||||||2017-10-11 03:32:47.95579|2017-10-11 03:32:47.95579
NCT01482611|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-02-18|||November 2011||2011-11-01|February 2013|2013-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382|Phase I, First-in-human, Double-blind, Randomized, Placebo-controlled Trial to Examine the Safety, Tolerability and Plasma Pharmacokinetics of Increasing Single Oral Doses of JNJ-47910382 in Healthy Caucasian and Japanese Volunteers|Completed||Phase 1|35|Actual|Janssen R&D Ireland||4|||f||||f||||||||||2017-10-11 03:32:48.070233|2017-10-11 03:32:48.070233
NCT01482598|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-03-03|||October 2011||2011-10-01|March 2016|2016-03-01|August 2018|Anticipated|2018-08-01|August 2016|Anticipated|2016-08-01||Interventional|COR-HF||Clinical Benefits in Optimized Remote HF Patient Management|COR HF - Clinical Benefits in Optimized Remote HF Patient Management|Active, not recruiting||Phase 4|438|Anticipated|St. Jude Medical||2|||f||||t||||||||||2017-10-11 03:32:48.193831|2017-10-11 03:32:48.193831
NCT01482585|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2011-11-29|||October 2011||2011-10-01|November 2011|2011-11-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Observational|||Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy|Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy|Unknown status|Recruiting|N/A|200|Anticipated|Samsung Medical Center|||1||f||||t||||||Samples With DNA|"     lung tissue, serum   "|||2017-10-11 03:32:48.321471|2017-10-11 03:32:48.321471
NCT01482572|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2015-11-17|||January 2012||2012-01-01|October 2015|2015-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Feasibility of Mutational Analysis of Non-Small Cell Lung Cancer (NSCLC) Using Low-volume Lung Aspirates|Feasibility of Gene Expression Profiling Using Low-volume Lung Aspirate|Withdrawn||N/A|0|Actual|Samsung Medical Center|||1||f||||t||||||Samples With DNA|"     lung tissue   "|||2017-10-11 03:32:48.426209|2017-10-11 03:32:48.426209
NCT01482559|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2015-01-27|||January 2015||2015-01-01|January 2015|2015-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|HIP||Management of Hypotension In the Preterm Infant|Management of Hypotension In Preterm Infants: The HIP Trial Protocol for a Randomized Controlled Trial of Hypotension Management in the Extremely Low Gestational Age Newborn|Recruiting||Phase 3|830|Anticipated|University College Cork||2|||f||||t||||||||||2017-10-11 03:32:48.510861|2017-10-11 03:32:48.510861
NCT01482546|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2017-06-26|||May 2012|Actual|2012-05-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Comparing Clinical Performance of Novice Trainee Endoscopists Using Conventional Air Insufflation Versus Warm Water Infusion Colonoscopy|Randomized Cross-Over Comparing Clinical Performance of Novice Trainee Endoscopists Using Conventional Air Insufflation Versus Warm Water Infusion Colonoscopy|Completed||N/A|6|Actual|University of California, Davis|||2||f||||t||||||||||2017-10-11 03:32:48.768593|2017-10-11 03:32:48.768593
NCT01482520|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-05-12|||August 2008||2008-08-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Observational|||Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma|Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma|Completed||N/A|200|Anticipated|Samsung Medical Center|||2||f||||f||||||||||2017-10-11 03:32:48.996675|2017-10-11 03:32:48.996675
NCT01482507|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2011-11-29|||August 2011||2011-08-01|November 2011|2011-11-01|August 2012|Anticipated|2012-08-01|||||Observational|||Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis|Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis|Unknown status|Recruiting|N/A|20|Anticipated|Optimus Clinical Research|||1||f||||f||||||||||2017-10-11 03:32:49.087923|2017-10-11 03:32:49.087923
NCT01482494|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2011-11-30|||December 2011||2011-12-01|November 2011|2011-11-01||||December 2012|Anticipated|2012-12-01||Observational|||Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emia|Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emia|Unknown status|Not yet recruiting|N/A|50|Anticipated|Hospital Vall d'Hebron|||1||f||||f||||||||||2017-10-11 03:32:49.161524|2017-10-11 03:32:49.161524
NCT01482481|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2011-11-29|||January 2008||2008-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|December 2009|Actual|2009-12-01||Observational|||Effectiveness of Nursing Care Plans Based in Nursing Diagnoses in Metabolic Control of Type 2 Diabetes Mellitus|Effectiveness of Implementing Nursing Care Plans Based on Scientific Methodology in Improving Metabolic and Blood Pressure Control of Type 2 Diabetes Mellitus Patients.|Completed||N/A|23488|Actual|Hospital Carlos III, Madrid|||1||f||||f||||||||||2017-10-11 03:32:49.228237|2017-10-11 03:32:49.228237
NCT01482468|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-03-21|||March 2012||2012-03-01|March 2012|2012-03-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting|Effect of Continuous Infusion of Palonosetron Following Single Prophylactic Injection of Palonosetron for Preventing Postoperative Nausea and Vomiting|Unknown status|Recruiting|N/A|132|Anticipated|Incheon St.Mary's Hospital||2|||f||||t||||||||||2017-10-11 03:32:49.311372|2017-10-11 03:32:49.311372
NCT01482455|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2012-09-07|||December 2011||2011-12-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|FATRAIN||Fat and Transcapillary Insulin Transport|Lipid-induced Insulin Resistance is Not Mediated by Impaired Transcapillary Transport of Insulin and Glucose in Humans|Completed||N/A|8|Actual|German Diabetes Center||4|||f||||f||||||||||2017-10-11 03:32:49.393823|2017-10-11 03:32:49.393823
NCT01482442|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-01-13|||December 2011||2011-12-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SARAH||SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma|A Prospective Randomized Open-labeled Trial Comparing RADIOEMBOLIZATION With Yttrium 90 Microspheres and Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 3|496|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:32:49.490555|2017-10-11 03:32:49.490555
NCT01482429|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2013-01-27|2013-01-12||January 2011||2011-01-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Evaluation of a Systematic Approach to Weaning From Mechanical Ventilation|Implantation of a Multidisciplinary Ventilator-weaning Protocol in a Intensive Care Unit of Teaching Hospital of Federal University of Uberlandia|Completed||N/A|235|Actual|Federal University of Uberlandia|The lack of sedation protocol in the intensive care unit.|2|||f||||t||||||||||2017-10-11 03:32:49.655091|2017-10-11 03:32:49.655091
NCT01482416|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2014-08-13|||November 2011||2011-11-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|EDILA||Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery|Flow-mediated Evaluation of the Brachial Artery of Climacteric Women Using Estradiol and Placebo. Randomized, Double Blinded, Placebo Controlled Study.|Completed||N/A|60|Actual|Federal University of Minas Gerais||2|||f||||f||||||||||2017-10-11 03:32:49.947955|2017-10-11 03:32:49.947955
NCT01482403|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-08-03||2016-07-08|November 2011||2011-11-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C|A Phase II, Randomized, Double-Blind, Multicenter, Parallel Group Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug RO5024048 in Combination With Boceprevir and Pegasys®/Copegus® in Patients With Chronic Hepatitis C Genotype 1 Virus Infection Who Were Prior Null Responders to Treatment With Pegylated Interferon/Ribavirin|Completed||Phase 2|58|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:32:50.06198|2017-10-11 03:32:50.06198
NCT01482390|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-04-21||2016-08-09|November 30, 2011|Actual|2011-11-30|April 2017|2017-04-01|January 31, 2014|Actual|2014-01-31|January 31, 2014|Actual|2014-01-31||Interventional|||A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C|A Phase II, Randomized, Double-Blind, Multicenter, Parallel Group Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug RO5024048 in Combination With Telaprevir and Pegasys®/Copegus® in Patients With Chronic Hepatitis C Genotype 1 Virus Infection Who Were Prior Null Responders to Treatment With Pegylated Interferon/Ribavirin|Completed||Phase 2|80|Actual|Hoffmann-La Roche||4|||f|||||t|f||||||||2017-10-11 03:32:50.260586|2017-10-11 03:32:50.260586
NCT01482377|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-01-26|||December 2011||2011-12-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin|Phase Ia/Ib, Open-Label, Multicenter, Dose-Escalation Study Followed by an Extension Phase to Evaluate the Safety, Pharmacokinetics and Activity of RO5479599, A Glycoengineered Antibody Against HER3, Administered Either Alone (Part A) or in Combination With Cetuximab (Part B) or in Combination With Erlotinib (Part C) in Patients With Metastatic and/or Locally Advanced Malignant HER3-Positive Solid Tumors of Epithelial Cell Origin|Completed||Phase 1|145|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 03:32:50.498205|2017-10-11 03:32:50.498205
NCT01481246|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2016-11-05|||July 2009||2009-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|NEUROAGE||Neurocognitive Study for the Aging|The Neurocognitive Study for the Aging|Recruiting||N/A|400|Anticipated|University of Cyprus|||1||f||||t||||||Samples With DNA|"     APOE phenotyping   "|||2017-10-11 03:33:07.567896|2017-10-11 03:33:07.567896
NCT01482364|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2015-03-23|||October 2011||2011-10-01|November 2011|2011-11-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional|BEAUTY||BEtter Control of Blood Pressure in Hypertensive pAtients Monitored Using the HOTMAN® sYstem|BEtter Control of Blood Pressure in Hypertensive pAtients Monitored Using the BEtter Control of Blood Pressure in Hypertensive pAtients Monitored Using the HOTMAN® sYstem|Completed||Phase 3|183|Actual|Hemo Sapiens, Inc.||2|||f||||f||||||||||2017-10-11 03:32:50.681496|2017-10-11 03:32:50.681496
NCT01482338|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-27|2012-03-13|||June 2011||2011-06-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone|A Comparative Efficacy of Low-dose Combine Oral Contraceptives Containing Desogestrel 150 mg and Drospirenone 3 mg on Premenstrual Symptoms|Completed||Phase 4|90|Actual|Chulalongkorn University||2|||f||||f||||||||||2017-10-11 03:32:50.954547|2017-10-11 03:32:50.954547
NCT01482325|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-08-08|2015-07-06||November 2011||2011-11-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SNIPE|No analysis was performed, study prematurely terminated.|SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement|SNIPE:SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement|Terminated||N/A|31|Actual|GE Healthcare||1||The business decided not to pursue the study at this time.|f||||f||||||||||2017-10-11 03:32:51.072605|2017-10-11 03:32:51.072605
NCT01482312|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2012-06-26|2012-05-22||December 2010||2010-12-01|June 2012|2012-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity Chamber||Completed||N/A|29|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 03:32:51.225585|2017-10-11 03:32:51.225585
NCT01482299|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-01-11|||November 2011||2011-11-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression|A Phase II Trial of RAD001 (Everolimus) for 2nd Line Treatment After Failure of Fluoropyrimidine Plus Platinum Chemotherapy in Patients With Metastatic or Recurrent Gastric Cancer With pS6 Ser 240/4 Expression|Completed||Phase 2|45|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:32:51.490449|2017-10-11 03:32:51.490449
NCT01482286|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-01-27|||May 2012||2012-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|PULSE||Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS|Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS|Completed||Phase 3|32|Actual|Pennington Biomedical Research Center||4|||f||||t||||||||||2017-10-11 03:32:51.583035|2017-10-11 03:32:51.583035
NCT01482273|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2015-07-16|||November 2011||2011-11-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|BERNUTIFUL||Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis|The BERN Ultrasound-enhanced Thrombolysis for Ilio-Femoral Deep Vein Thrombosis versUs Standard Catheter Directed thromboLysis Trial (BERNUTIFUL-Trial)|Completed||N/A|48|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-10-11 03:32:51.702647|2017-10-11 03:32:51.702647
NCT01482260|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-26|2012-11-05|||December 2011||2011-12-01|November 2012|2012-11-01||||January 2012|Actual|2012-01-01||Observational|||Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma|Comparative Microarray Analysis of microRNA Expression Profiles in Primary Cutaneous Malignant Melanoma, Cutaneous Malignant Melanoma Metastases and Benign Melanocytic Naevi|Completed||N/A|21|Actual|Ruhr University of Bochum|||3||f||||t||||||Samples With DNA|"     skin biopsy   "|||2017-10-11 03:32:51.825173|2017-10-11 03:32:51.825173
NCT01482247|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-07-27|||April 2012||2012-04-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||L-Arginine, Vascular Response and Mechanisms|L-Arginine, Vascular Response and Mechanisms|Completed||Phase 2|25|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:32:51.94177|2017-10-11 03:32:51.94177
NCT01482234|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2016-01-18|||February 2012||2012-02-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Text Messages and Physical Activity Among Teens|TXT Me: Texting Motivational Messages Encouraging Adolescent Physical Activity|Completed||N/A|160|Actual|Baylor College of Medicine||4|||f||||f||||||||||2017-10-11 03:32:52.040227|2017-10-11 03:32:52.040227
NCT01482221|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-04-10|2014-10-13||December 16, 2011|Actual|2011-12-16|April 2017|2017-04-01|August 26, 2013|Actual|2013-08-26|August 26, 2013|Actual|2013-08-26||Interventional|||A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder|A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants|Completed||Phase 2|542|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 03:32:52.162141|2017-10-11 03:32:52.162141
NCT01482208|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-03-28|||November 2011||2011-11-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|IHM-01||Clinical Evaluation of Ultrasonic Hydration Monitor for Infants|Study of Ultrasonic Hydration Monitor for Neonatology and Pediatric Children and Infants and/or Children up to Age 3 Years Old With Diarrhea|Completed||N/A|42|Actual|Artann Laboratories|||1||f||||f||||||||||2017-10-11 03:32:54.033202|2017-10-11 03:32:54.033202
NCT01482182|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-11-17|||November 2011||2011-11-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Observational|||Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy|Prediction of Chemotherapy Response and Patient Prognosis in Non-small Cell Lung Cancer: Dynamic Contrast-enhanced MRI and Diffusion-weighted Imaging Versus Volume-based Parameter of 18F-FDG PET|Completed||N/A|35|Actual|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 03:32:54.260003|2017-10-11 03:32:54.260003
NCT01482156|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2015-11-18|||January 2012||2012-01-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors|An Open-label, Multi-center Phase I Dose-finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors|Completed||Phase 1|46|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:32:54.469135|2017-10-11 03:32:54.469135
NCT01482143|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-09-29|||March 2012||2012-03-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)|Sequential, Two-period Study to Assess the Pharmacokinetics, Safety & Tolerability of Single and Multiple Oral Doses of AFQ056 in Patients With FXS (Fragile X Syndrome) Aged 5-11 Years (Cohort 1) and 3-4 Years (Cohort 2)|Completed||Phase 1|21|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:32:54.625934|2017-10-11 03:32:54.625934
NCT01482130|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-07-29|||November 2011||2011-11-01|July 2016|2016-07-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||High Intensity Strength Training & Bone Mineral Density in Young Women|Preventing Osteoporosis: The Effect of High Intensity Strength Training on Bone Mineral Density in Young and Healthy Women|Completed||N/A|30|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 03:32:54.744165|2017-10-11 03:32:54.744165
NCT01482117|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-26|2013-05-31|||November 2011||2011-11-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers|Randomized, Open-label, Crossover Study to Evaluate the Effect of Genetic Polymorphism on Pharmacokinetic & Pharmacodynamic Interactions of Clopidogrel and Cilostazol in Korean Healthy Adult Volunteers|Completed||N/A|28|Actual|Inje University||3|||f||||f||||||||||2017-10-11 03:32:54.85951|2017-10-11 03:32:54.85951
NCT01482104|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-06-12|||June 2012|Actual|2012-06-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)|A Randomized Controlled Blinded Multi-centre Study of Photodynamic Therapy With Methyl-aminolevulinate Comparing a Simplified Regime With the Approved Regime in Patients With Clinical Low-risk Superficial and Nodular Basal Cell Carcinoma.|Active, not recruiting||N/A|277|Anticipated|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 03:32:54.958847|2017-10-11 03:32:54.958847
NCT01482091|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-07-11|2016-03-30||December 2011||2011-12-01|July 2016|2016-07-01||||February 2015|Actual|2015-02-01||Interventional|||Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis|Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis: A Randomized, Double Blind Placebo Controlled Trial|Completed||Phase 4|124|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 03:32:55.147561|2017-10-11 03:32:55.147561
NCT01482078|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2017-02-28|||November 2011||2011-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MnMs||Magnesium for Neonatal Neuroprotection and Mothers|Prospective Observational Study, Maternal Effects of Magnesium Sulphate for Neonatal Neuroprotection in Women Having Cesarean Section Under Neuraxial Anesthesia|Recruiting||N/A|50|Anticipated|University of British Columbia|||2||f||||f||||||||||2017-10-11 03:32:56.12806|2017-10-11 03:32:56.12806
NCT01482065|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-11-01|2016-11-01||November 2011||2011-11-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|SLEEP||The Sleep, Liver Evaluation and Effective Pressure Study|The Sleep, Liver Evaluation and Effective Pressure Study (SLEEP)|Completed||Phase 2|40|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 03:32:56.247585|2017-10-11 03:32:56.247585
NCT01482052|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-01-11|||November 2011||2011-11-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis|A Double-Blind, Randomized, Controlled, Two Arm Phase 1 Clinical Trial of the Safety and Immunogenicity of Group A, C, Y & W-135 Meningococcal Polysaccharide DT Conjugate Vaccine: NmVac4-A/C/Y/W-135-DT™|Completed||Phase 1|60|Actual|JN-International Medical Corporation||2|||f||||t||||||||||2017-10-11 03:32:56.546887|2017-10-11 03:32:56.546887
NCT01482026|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2016-01-20|||November 2011||2011-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy|Sensitivity of ADHD-IV Rating Scale in the Evaluation of the Evolution of Attention Disorders Associated With Childhood Epilepsy : a Validation Study|Completed||N/A|173|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:32:56.745283|2017-10-11 03:32:56.745283
NCT01482013|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2012-08-29|||October 2011||2011-10-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease|A Double-blind, Randomized, Placebo-controlled, Phase I , Multiple-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally-administered HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease|Terminated||Phase 1|7|Actual|High Point Pharmaceuticals, LLC.||2|||f||||f||||||||||2017-10-11 03:32:56.864861|2017-10-11 03:32:56.864861
NCT01482000|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2011-11-29|||November 2011||2011-11-01|October 2011|2011-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Does Pulmonary Daoyin of China Give Additional Benefit Over Usual Therapy in Management of Stable Chronic Obstructive Pulmonary Disease?|Detection and Intervention on Mild/Moderate Chronic Obstructive Pulmonary Disease by Traditional Chinese Medicine Treatment and Application|Unknown status|Not yet recruiting|Phase 3|464|Anticipated|Henan University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 03:32:56.948362|2017-10-11 03:32:56.948362
NCT01481987|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-11-29|||January 2011||2011-01-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Microperimetry and Optical Coherence Tomography (OCT) in Idiopathic Epiretinal Membrane|Retinal Sensitivity and Optical Coherence Tomography Findings in Eyes With Idiopathic Epiretinal Membrane|Completed||N/A|76|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||f||||||||||2017-10-11 03:32:57.051286|2017-10-11 03:32:57.051286
NCT01481974|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-08-02|||December 2012||2012-12-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation|An Evaluation of the Safety and Preliminary Efficacy of Perioperative Treprostinil in Preventing Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplant Recipients|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 03:32:57.148025|2017-10-11 03:32:57.148025
NCT01481961|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2015-02-27|||November 2010||2010-11-01|February 2015|2015-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|ALSTIMAG||Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease|Feasibility Study: Cognitive Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)on add-on in Patients With Early Alzheimer's Disease|Completed||N/A|15|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||f||||||||||2017-10-11 03:32:57.27782|2017-10-11 03:32:57.27782
NCT01481948|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2016-01-18|||January 2012||2012-01-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|FFFIPG||Food, Fun, & Fitness Internet Program for Girls: Outcome Evaluation|Using Technology to Prevent Obesity Among African American Girls|Completed||N/A|342|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-10-11 03:32:57.376714|2017-10-11 03:32:57.376714
NCT01481935|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-10-25|2012-09-19||August 2011||2011-08-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Enhanced Room Cleaning in Intensive Care Units to Reduce Gown and Glove Contamination With Multi-drug-resistant Bacteria|Use of an Enhanced Room Cleaning Protocol in the Intensive Care Unit to Reduce Contamination of Disposable Isolation Gowns and Gloves With Methicillin-resistant Staphylococcus Aureus and Multi-drug Resistant Acinetobacter Baumannii|Completed||N/A|190|Actual|University of Maryland||2|||f||||f||||||||||2017-10-11 03:32:57.466898|2017-10-11 03:32:57.466898
NCT01481922|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-03-19|||November 2011||2011-11-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||What Needle Diameter Should Physician Use When They Perform Lumbar Puncture ? A Randomized Controlled Trial|Should Physicians Use a 24 Gauge Spinal Needle Instead of a 22 Gauge When Performing a Lumbar Puncture ? A Randomized Controlled Trial.|Completed||Phase 4|62|Actual|McGill University||2|||f||||f||||||||||2017-10-11 03:32:57.978521|2017-10-11 03:32:57.978521
NCT01481909|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-11-02|||September 2010||2010-09-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|SMART||Study on Mastocytosis for Rupatadine Treatment|Study on Mastocytosis for Rupatadine Treatment An Exploratory Phase IV, Randomised, Double-blind, Placebo Controlled Crossover Study to Assess the Efficacy of 20 mg Rupatadine on the Treatment of|Completed||Phase 2/Phase 3|30|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 03:32:58.134447|2017-10-11 03:32:58.134447
NCT01481896|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-08-01|2012-06-30||December 2011||2011-12-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational||The Overall Number of Baseline Participants is defined as the number of hips included in the study population instead of the number of participants since 5 participants had both hips replaced and objective of this study was to evaluated the outcome of each hip.|A Five-Year Metal-on-Metal Retrospective Clinical Study|A Five-Year Metal-on-Metal Retrospective Clinical Study|Completed||N/A|126|Actual|Anderson Orthopaedic Research Institute|||1||f||||f||||||||||2017-10-11 03:32:58.225662|2017-10-11 03:32:58.225662
NCT01481883|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-08-07|||January 2012||2012-01-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?|A Randomised Controlled Trial of Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?|Recruiting||Phase 4|180|Anticipated|The Alfred||2|||f||||t||||||||||2017-10-11 03:32:58.643706|2017-10-11 03:32:58.643706
NCT01481870|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2013-02-21|||January 2010||2010-01-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|July 2013|Anticipated|2013-07-01||Interventional|CROSS-J-RCC||Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma|Randomized Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|Yamagata University||2|||f||||t||||||||||2017-10-11 03:32:58.769523|2017-10-11 03:32:58.769523
NCT01481857|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2011-11-25|||February 2011||2011-02-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||Influence of Thoracolumbar Proprioceptive Support in the Segmental Stabilization Training|Influence of Thoracolumbar Proprioceptive Support in the Segmental Stabilization Training|Completed||Phase 1/Phase 2|24|Actual|Universidade Federal do Piauí||2|||f||||t||||||||||2017-10-11 03:32:58.885165|2017-10-11 03:32:58.885165
NCT01481844|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2015-07-05|||November 2011||2011-11-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection||Completed||Phase 3|101|Actual|Soroka University Medical Center||2|||f||||t||||||||||2017-10-11 03:32:58.971086|2017-10-11 03:32:58.971086
NCT01481831|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2012-12-28|||July 2011||2011-07-01|December 2012|2012-12-01||||August 2012|Actual|2012-08-01||Interventional|ESPNV||Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting|A Multi-center, Stratified Randomized, Controlled Study to Evaluate the Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting Associated With Moderate and Highly Emetogenic Chemotherapy in China|Completed||Phase 4|599|Actual|Shanghai Changzheng Hospital||4|||f||||||||||||||2017-10-11 03:32:59.096468|2017-10-11 03:32:59.096468
NCT01481818|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-10-27|||September 2011||2011-09-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis|Phase Ⅰ,ⅡStudy of Topically Applied Green Tea Extract for Prevention and Treatment of Radio Dermatitis and Radiation Mucositis|Enrolling by invitation||Phase 1/Phase 2|15|Anticipated|Shandong Cancer Hospital and Institute||1|||f||||f||||||||||2017-10-11 03:32:59.236129|2017-10-11 03:32:59.236129
NCT01481805|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-04-24|||January 14, 2010|Actual|2010-01-14|April 2017|2017-04-01|August 13, 2014|Actual|2014-08-13|January 13, 2014|Actual|2014-01-13||Observational|||Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients|Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients|Completed||N/A|100|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:32:59.327372|2017-10-11 03:32:59.327372
NCT01481792|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-05-10|||February 2011||2011-02-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Observational|||Efficacy and Safety of ReLEx Smile for Laser Correction of Myopia|Use of the VisuMax Femtosecond Laser for the Correction of Myopia With Small Incision Lenticular Extraction|Completed||N/A|125|Actual|University of Aarhus|||1||f||||f||||||||||2017-10-11 03:32:59.410507|2017-10-11 03:32:59.410507
NCT01481779|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-28|2014-06-19||2014-04-25|January 2012||2012-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional|IMAGINE 1||A Study in Participants With Type 1 Diabetes Mellitus|The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 1 Diabetes Mellitus Treated With Preprandial Insulin Lispro: An Open-Label, Randomized, 78-Week Study - The IMAGINE 1 Study|Completed||Phase 3|450|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:32:59.487649|2017-10-11 03:32:59.487649
NCT01481766|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-05-02|||June 2012||2012-06-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|OptEC||Iron Treatment for Young Children With Non-anemic Iron Deficiency|Optimizing Early Child Development in the Primary Care Practice Setting: Pragmatic Randomized Trial of Iron Treatment for Young Children With Non-anemic Iron Deficiency (OptEC)|Recruiting||Phase 4|230|Anticipated|The Hospital for Sick Children||4|||f||||f||||||||||2017-10-11 03:32:59.727184|2017-10-11 03:32:59.727184
NCT01481753|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-03-02|||December 2009||2009-12-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Pancreaticoduodenectomy With or Without Braun Enteroenterostomy: Comparison of Postoperative Pancreatic Fistula and Delayed Gastric Emptying||Terminated||N/A|341|Actual|Johns Hopkins University||2||"last patient recruited Feb 2015,completion of data review; study data do not meet statistical   significance to answer proposed study question"|f||||t||||||||||2017-10-11 03:32:59.883665|2017-10-11 03:32:59.883665
NCT01481740|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2016-09-14|2016-09-14||November 2010||2010-11-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)|A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients|Completed||Phase 4|170|Actual|IWK Health Centre||2|||f||||t||||||||||2017-10-11 03:32:59.98154|2017-10-11 03:32:59.98154
NCT01481727|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2015-05-22|||December 2011||2011-12-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Exacerbation Prevention GOLD IV COPD With Non Invasive Mechanical Ventilation|Exacerbation's Prevention in Patients With COPD in GOLD IV Stage (Very Severe) With Non Invasive Mechanical Ventilation|Unknown status|Active, not recruiting|Phase 4|20|Actual|National Institute of Respiratory Diseases, Mexico||2|||f||||f||||||||||2017-10-11 03:33:00.825227|2017-10-11 03:33:00.825227
NCT01481701|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2014-10-14|||October 2008||2008-10-01|September 2013|2013-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma|A Non Randomized Stratified Phase II Trial Evaluating Efficacy and Safety of Oxaliplatin in Combination With 5-Fluorouracil in Patients With Platinum-sensitive and Platinum-resistant Recurrent Ovarian Carcinoma|Completed||Phase 2|90|Anticipated|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 03:33:01.083852|2017-10-11 03:33:01.083852
NCT01481675|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-11-29|||May 2007||2007-05-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Diabetes Resolution and Hormone Changes After BPDLL and LSG|Resolution of Diabetes and Hormonal Changes Following Biliopancreatic Diversion Long Limbs and Laparoscopic Sleeve Gastrectomy. A Comparative Prospective Study.|Completed||N/A|24|Actual|University of Patras|||2||f||||f||||||||||2017-10-11 03:33:01.303826|2017-10-11 03:33:01.303826
NCT01481662|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-09-01|||November 2011||2011-11-01|August 2016|2016-08-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Observational|CARESS||Epidemiological, Clinical and Etiological Features of SUSAC's Syndrome|Epidemiological, Clinical and Etiological Features of SUSAC's Syndrome (RETINOCOCHLEOCEREBRAL Vasculopathy)|Recruiting||N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     -  serum sample        -  cerebrospinal fluid sample        -  DNA sample        -  RNA sample        -  Peripheral Blood Mononuclear Cell sample   "|Undecided||2017-10-11 03:33:01.405588|2017-10-11 03:33:01.405588
NCT01481649|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2016-04-13|||November 2011||2011-11-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Observational|||Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure|Risk of Hepatitis B Reactivation After Hematopoietic Stem Cell Transplantation in Donors and Recipients With Prior HBV Exposure|Completed||N/A|69|Actual|The University of Hong Kong|||1||f||||f||||||Samples Without DNA|"     Serum and plasma for hepatitis B virus genotypic, virologic and serologic testing   "|||2017-10-11 03:33:01.560802|2017-10-11 03:33:01.560802
NCT01481636|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2014-06-16|||November 2011||2011-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|OSA||Assessing the Symptoms of Obstructive Sleep Apnea|Association of Health Outcomes With Severity of OSA Symptomatology- a Correlation Study.|Completed||N/A|66|Actual|Bangor University|||1||f||||f||||||Samples Without DNA|"     Blood serum   "|||2017-10-11 03:33:01.655718|2017-10-11 03:33:01.655718
NCT01481623|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-06-01|||September 2012||2012-09-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|DIAGENE||Identification and Characterization of Monogenic Diabetes|Identification and Genetic, Clinical and Metabolic Characterization of Monogenic Forms of Insulin-dependent Diabetes|Unknown status|Recruiting|N/A|1000|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 03:33:01.791462|2017-10-11 03:33:01.791462
NCT01481610|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-02-11|||January 2012||2012-01-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia|Comparison of the Effects on Renal Function of Lumiracoxib and Diclofenac in Patients With Chronic Kidney Failure K/DOQI Stage III at the HCSAE PEMEX|Terminated||Phase 2|28|Actual|Hospital Central Sur de Pemex||2||Interim analysis shows harma to one of the study arms.|f||||f||||||||||2017-10-11 03:33:01.945347|2017-10-11 03:33:01.945347
NCT01481597|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-05-14|||November 2011||2011-11-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers|Tolerance and Pharmacokinetics of Single-dose Intravenous Deuteporfin in Healthy Volunteers|Completed||Phase 1|32|Actual|Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.||5|||f||||f||||||||||2017-10-11 03:33:02.057167|2017-10-11 03:33:02.057167
NCT01481584|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2015-03-04|||May 2010||2010-05-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|July 2010|Actual|2010-07-01||Interventional|||Nutritional Evaluation of Canola Protein in Comparison With Soy Protein|Comparison of the Bioavailability the of a Single Administration of Two Canola Proteins (Hydrolyzate, Isolate) and Soy Protein in Healthy Men.|Completed||N/A|28|Actual|University of Jena||4|||f||||t||||||||||2017-10-11 03:33:02.16706|2017-10-11 03:33:02.16706
NCT01481571|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2014-02-24||2013-12-27|January 2012||2012-01-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Performance Study of New Media for Vitrification of Human Oocytes|Performance Study of New Media for Vitrification of Human Oocytes|Completed||N/A|17|Actual|Vitrolife||1|||f||||f||||||||||2017-10-11 03:33:02.279843|2017-10-11 03:33:02.279843
NCT01481558|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-12-09|2013-03-20||January 2012||2012-01-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease|Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's: a Randomized, Sham-controlled Clinical Trial|Completed||Phase 2|40|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:33:02.371186|2017-10-11 03:33:02.371186
NCT01481545|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2017-09-13|||December 2006||2006-12-01|November 2015|2015-11-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|BRANCH||Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer|Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer: the BRANCH Trial|Active, not recruiting||Phase 2|46|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-10-11 03:33:02.65141|2017-10-11 03:33:02.65141
NCT01481532|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-07-18|||February 28, 2017|Actual|2017-02-28|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|June 2018|Anticipated|2018-06-01||Interventional|||Open Label Clinical Trial of Intravenous Crotoxin|Open Label Phase I Clinical Trial of Crotoxin in Patients With Advanced Cancer Using an Intravenous Route of Administration|Recruiting||Phase 1|18|Anticipated|Celtic Biotech Ltd||1|||f||||t|t|f|||t|||||2017-10-11 03:33:04.68793|2017-10-11 03:33:04.68793
NCT01481519|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2014-12-02|||December 2011||2011-12-01|December 2014|2014-12-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis|A Randomized, Double-Masked Trial of Topical Dexamethasone 0.1%/Povidone-iodine 0.4% Versus Artificial Tears for Treatment of Viral Conjunctivitis|Completed||Phase 3|100|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||||2017-10-11 03:33:04.775787|2017-10-11 03:33:04.775787
NCT01481506|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2011-11-28|||January 2010||2010-01-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|SweetAge||Multiparametric Telemonitoring In Elderly People With Chronic Obstructive Pulmonary Disease|Efficacy Of Multiparametric Telemonitoring On Respiratory Outcomes In Elderly People With Chronic Obstructive Pulmonary Disease.|Completed||N/A|100|Actual|Campus Bio-Medico University||2|||f||||t||||||||||2017-10-11 03:33:04.893653|2017-10-11 03:33:04.893653
NCT01481493|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-02-19|||December 2010||2010-12-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|||Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)|A Multi-center, Double-blind, Randomized, Placebo-controlled, Dose-finding Study in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable MTX Doses to Investigate Efficacy and Safety of SC BT061|Completed||Phase 2|127|Actual|Biotest||2|||f||||t||||||||||2017-10-11 03:33:04.966274|2017-10-11 03:33:04.966274
NCT01481480|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2016-10-24|||August 2012||2012-08-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Latissimus Dorsi Tendon Transfer or Partial Arthroscopic Repair of Massive Rotator Cuff Tears|A Multicenter, Randomized Controlled Trial Comparing Functional Outcomes After Latissimus Dorsi Tendon Transfer or Partial Arthroscopic Repair of Massive Rotator Cuff Tears|Recruiting||N/A|108|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 03:33:05.138351|2017-10-11 03:33:05.138351
NCT01481467|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-12-19|||April 2009||2009-04-01|December 2011|2011-12-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers|Evaluation of a Multi-faceted Influenza Vaccination Implementation Strategy for Health Care Workers in Hospitals|Unknown status|Recruiting|N/A|6|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 03:33:05.229362|2017-10-11 03:33:05.229362
NCT01481454|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-03-28|||March 2012||2012-03-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults|Safety and Immunogenicity of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Child/Adolescent and Adult Subjects|Completed||Phase 3|1701|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 03:33:05.327117|2017-10-11 03:33:05.327117
NCT01481233|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2013-09-26|||May 2013||2013-05-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Oral Colchicine in Men With Castrate Resistant Prostate Cancer|Phase II Trial of Oral Colchicine in Men With Castrate-Resistant Prostate Cancer Who Have Failed Taxotere-Based Chemotherapy|Withdrawn||Phase 2|0|Actual|Milton S. Hershey Medical Center||1||Due to funding|f||||t||||||||||2017-10-11 03:33:07.925914|2017-10-11 03:33:07.925914
NCT01481441|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2016-07-04|||November 2011||2011-11-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|AMC_2011_190||Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer|Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer|Terminated||N/A|208|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1||New study protocol started including targeted biopsies|f||||f||||||||||2017-10-11 03:33:05.575909|2017-10-11 03:33:05.575909
NCT01481428|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-01-06|||September 2012||2012-09-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Reducing High Risk Behavior in Treatment Court|Delivering HIV Risk Reduction Services in Treatment Court|Completed||Phase 1|371|Actual|Treatment Research Institute||2|||f||||t||||||||||2017-10-11 03:33:05.683259|2017-10-11 03:33:05.683259
NCT01481415|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2011-12-03|||November 2011||2011-11-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|November 2011|Actual|2011-11-01||Observational|||Left Atrial Volume and Function in Children Assessed by Echo 3DRT: Reference Values for Normal Children|Left Atrial Volume and Function in Healthy Children Assessed by Three Dimensional Echocardiography|Unknown status|Recruiting|N/A|145|Anticipated|Hospital Israelita Albert Einstein|||1||f||||t||||||||||2017-10-11 03:33:05.780459|2017-10-11 03:33:05.780459
NCT01481402|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2014-02-25|||July 2011||2011-07-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|LIHFA||Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)|Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Heart Function, Body Composition and Metabolic Status|Completed||N/A|21|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 03:33:05.876297|2017-10-11 03:33:05.876297
NCT01481389|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-09-17|||December 2010||2010-12-01|September 2012|2012-09-01||||January 2011|Actual|2011-01-01||Interventional|||The Effect of Theobromine on Blood Lipid Parameters in Healthy Subjects|The Effect of Theobromine on Blood Lipid Parameters in Healthy Subjects|Completed||N/A|152|Actual|Unilever R&D||4|||f||||f||||||||||2017-10-11 03:33:06.020565|2017-10-11 03:33:06.020565
NCT01481376|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-12-08|2013-12-06||October 2011||2011-10-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|October 2011|Actual|2011-10-01||Observational|||TAPP Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh|Laparoscopic Transabdominal Preperitoneal (TAPP) Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh: A Retrospective Study With 12 Month Follow-up|Completed||N/A|200|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-10-11 03:33:06.13669|2017-10-11 03:33:06.13669
NCT01481363|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-07-18|||March 2012||2012-03-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|||The Talking Sense Communication Programme for Dementia Carers|A Feasibility Study of a Psychosocial Intervention - The Talking Sense Communication Programme for Dementia Family Carers|Completed||Phase 1/Phase 2|55|Actual|University of Portsmouth||2|||f||||t||||||||||2017-10-11 03:33:06.397153|2017-10-11 03:33:06.397153
NCT01481350|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2014-12-06|||February 2012||2012-02-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|SiPaHCS||Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac Surgery|Phase 2 Use of Sildenafil for the Treatment of Post-capillary Hypertension in Patients Undergoing Cardiac Surgery|Completed||Phase 2|20|Actual|University of Turin, Italy||1|||f||||f||||||||||2017-10-11 03:33:06.551839|2017-10-11 03:33:06.551839
NCT01481337|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-04-22|||September 2011||2011-09-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|OPERA||Endoscopic Mucosal Colonic Resection and Polypectomy Under Aspirin|"Prospective Observatory of Endoscopic Mucosal Colonic Resection and Polypectomy Under Aspirin : the OPERA Study"|Completed||N/A|317|Actual|Société Française d'Endoscopie Digestive|||1||f||||f||||||||||2017-10-11 03:33:06.626206|2017-10-11 03:33:06.626206
NCT01481324|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-11-17|2014-05-13||October 2009||2009-10-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2012|Actual|2012-10-01||Observational||Number analyzed in each group|Outcomes of Compliance With Brace Wear in Clubfoot|Measurement of Compliance in Clubfoot Bracing Via a Novel Pressure Sensor|Completed||N/A|67|Actual|Shriners Hospitals for Children|As shown in the monthly completion numbers, most families complied during the first month of treatment. After the first month, not only did the wear rates drop significantly, but also the number of subjects reporting sensor and diary data.||3||f||||f||||||||||2017-10-11 03:33:06.715971|2017-10-11 03:33:06.715971
NCT01481311|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2012-10-02|||January 2012||2012-01-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Detection of Patients With Abnormal Water Distribution Based on Bioelectrical Impedance Analysis (BIA)|Detection of Patients With Abnormal Water Distribution Based on Bioelectrical Impedance Analysis (BIA)|Completed||N/A|62|Actual|Seca GmbH & Co. Kg.|||2||f||||t||||||||||2017-10-11 03:33:07.054694|2017-10-11 03:33:07.054694
NCT01481298|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2011-11-28|||December 2004||2004-12-01|November 2011|2011-11-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Observational|||Value of Cardiac Magnetic Resonance (CMR) Derived Parameters for Diagnosing Left Ventricular Non-compaction Cardiomyopathy|Value of Different Myocardial Parameters to Differentiate Left Ventricular Noncompaction Cardiomyopathy From Other Cardiomyopathies and Healthy Controls by Cardiac Magnetic Resonance|Completed||N/A|57|Actual|University of Leipzig|||4||f||||f||||||||||2017-10-11 03:33:07.141862|2017-10-11 03:33:07.141862
NCT01481285|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-10-02|||October 2011||2011-10-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Generation of Normal Ranges to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA)|Generation of Normal Ranges to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA)|Completed||N/A|992|Actual|Seca GmbH & Co. Kg.|||1||f||||t||||||||||2017-10-11 03:33:07.207159|2017-10-11 03:33:07.207159
NCT01481272|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-07-12|||November 2011||2011-11-01|July 2017|2017-07-01||||July 2017|Actual|2017-07-01||Interventional|PLRG8||Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients|A Phase II Trial on Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients Progressing or Relapsed After Prior R-CHOP Treatment Not Suitable for Autologous Stem Cell Transplant|Completed||Phase 2|77|Actual|Polish Lymphoma Research Group||1|||f||||t||||||||||2017-10-11 03:33:07.303053|2017-10-11 03:33:07.303053
NCT01481259|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-07-02|||January 2010||2010-01-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|January 2013|Anticipated|2013-01-01||Interventional|||Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer|Maintenance Immunotherapy With Autologous Cytokine-induced Killer Cells for Stage IIIb/IV Nonsquamous Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|People's Hospital of Guangxi||2|||f||||t||||||||||2017-10-11 03:33:07.469894|2017-10-11 03:33:07.469894
NCT01481220|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2013-05-02|||October 2011||2011-10-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|NMDSG10A||Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)|A Pilot Phase I Dose Finding Safety Study of a Thrombopoietin-receptor Agonist, Eltrombopag, in Patients With Myelodysplastic Syndrome Treated With Azacitidine|Completed||Phase 1|12|Actual|Nordic MDS Group||1|||f||||t||||||||||2017-10-11 03:33:08.016054|2017-10-11 03:33:08.016054
NCT01481207|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2017-01-13|||November 2011||2011-11-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Magnetic Resonance Imaging and Spectroscopy Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy|Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy|Recruiting||N/A|60|Anticipated|University Children's Hospital, Zurich|||1||f||||f||||||||No||2017-10-11 03:33:08.113594|2017-10-11 03:33:08.113594
NCT01481194|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2016-12-14|||November 2011||2011-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|May 2014|Actual|2014-05-01||Interventional|ACVDL||ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma|An Open-Label Phase II Study of the Safety and Efficacy of Doxorubicin and Cyclophosphamide in Combination With Bortezomib, Lenalidomide, and Dexamethasone for Treatment of Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|35|Anticipated|Vejle Hospital||1|||f||||t||||||||||2017-10-11 03:33:08.202579|2017-10-11 03:33:08.202579
NCT01481181|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2014-02-27|||August 2011||2011-08-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||An Efficacy Trial of a Gravity Fed Household Water Treatment Device as a Delivery System for Zinc|An Efficacy Trial of a Gravity Fed Household Water Treatment Device as a Delivery System for Zinc in Zinc Deficient Children and Women From Low Income Settings|Completed||N/A|270|Actual|Wageningen University||3|||f||||f||||||||||2017-10-11 03:33:08.319844|2017-10-11 03:33:08.319844
NCT01481168|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-02-22|||January 2012||2012-01-01|February 2012|2012-02-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Interventional|ADEPT-ILR||Adenosine Testing to DEtermine the Need for Pacing Therapy|Adenosine Testing to DEtermine the Need for Pacing Therapy With the Additional Use of an Implantable Loop Recorder (ADEPT-ILR Study). The Efficacy of Permanent Pacing in Patients With Syncope and a Positive Intravenous Adenosine Test: a Randomised, Double-blind, Placebo-controlled, Cross-over Trial.|Unknown status|Recruiting|Phase 3|180|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust||3|||f||||t||||||||||2017-10-11 03:33:08.426293|2017-10-11 03:33:08.426293
NCT01481155|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-12-07|||March 2011||2011-03-01|December 2011|2011-12-01||||December 2011|Anticipated|2011-12-01||Interventional|||Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic Keratoses|Prospective, Single-center, Investigator-blinded, Randomized, Half-side, Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic Keratoses|Unknown status|Active, not recruiting|N/A|21|Actual|Ruhr University of Bochum||1|||f||||||||||||||2017-10-11 03:33:08.540899|2017-10-11 03:33:08.540899
NCT01481142|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2015-10-16|||October 2011||2011-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|ART||Adacolumn in Refractory UC Patients Trial|Multicentre Investigation of the Efficacy and Safety of Adacolumn® GMA in Patients With Steroid-Dependent Active Ulcerative Colitis and Insufficient Response or Intolerance to Immunosuppressants and/or Biological Therapies|Completed||Phase 4|100|Actual|Otsuka Pharmaceutical Europe Ltd||1|||f||||f||||||||||2017-10-11 03:33:08.623667|2017-10-11 03:33:08.623667
NCT01481129|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2017-08-30|2016-12-02||December 2011|Actual|2011-12-01|August 2017|2017-08-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Akt Inhibitor MK2206 in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|A Phase 2 Study of MK-2206 in Patients With Relapsed or Refractory Diffuse Large-B Cell Lymphoma|Completed||Phase 2|22|Actual|National Cancer Institute (NCI)||1|||f||||t|t|f||||||||2017-10-11 03:33:08.755218|2017-10-11 03:33:08.755218
NCT01481116|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2016-04-24|2015-07-24||January 2012||2012-01-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional||The randomized set included all participants who were randomized.|Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Glimepiride When Used in Combination With Metformin in Subjects With Type 2 Diabetes|Terminated||Phase 3|2454|Actual|Takeda||3||Due to potential concerns about liver safety (See Detailed Description)|f||||t||||||||||2017-10-11 03:33:09.414099|2017-10-11 03:33:09.414099
NCT01481103|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2013-04-02|||July 2011||2011-07-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Integrating Acupuncture Into the Management of Migraines|Integrating Acupuncture Into the Management of Migraines: A Randomized, Comparative Trial|Terminated||N/A|9|Actual|National University of Health Sciences||2||PI cited personal reasons|f||||t||||||||||2017-10-11 03:33:12.546582|2017-10-11 03:33:12.546582
NCT01481090|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-04-14|||November 2010||2010-11-01|April 2015|2015-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Electro-acupuncture and Assisted Reproductive Technology|Electro-acupuncture and Assisted Reproductive Technology: Impact of EA on Endometrium During Medicated Frozen Embryo Transfer Uterine Preparation|Terminated||N/A|16|Actual|National University of Health Sciences||2||IRB violations|f||||t||||||||||2017-10-11 03:33:12.632499|2017-10-11 03:33:12.632499
NCT01481077|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2013-09-19||2013-09-16|November 2011||2011-11-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma|PPL GLAU 13: A Randomized Phase 2 Study of the Effect of Plug Placement on Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)|Completed||Phase 2|77|Actual|Mati Therapeutics Inc.||3|||f||||f||||||||||2017-10-11 03:33:12.736104|2017-10-11 03:33:12.736104
NCT01481064|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-07-22|||April 2011||2011-04-01|July 2013|2013-07-01|October 2013|Anticipated|2013-10-01|July 2013|Anticipated|2013-07-01||Interventional|||Effect and Cost Evaluation of a Multifaceted Approach With a Patient-centredness Questionnaire in Fertility Care|Effect and Cost Evaluation of a Multifaceted Approach Including Audit and Feedback With a Patient-centredness Questionnaire in Fertility Care.|Unknown status|Active, not recruiting|N/A|870|Anticipated|University Medical Center Nijmegen||2|||f||||f||||||||||2017-10-11 03:33:12.852961|2017-10-11 03:33:12.852961
NCT01481051|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2013-09-19||2013-09-16|November 2011||2011-11-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma|PPL GLAU 12: A Phase 2 Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)|Completed||Phase 2|57|Actual|Mati Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 03:33:12.933788|2017-10-11 03:33:12.933788
NCT01481038|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-05-02|||October 2011||2011-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2015|Actual|2015-12-01||Observational|||Anticipative Diagnosis of Central Venous Catheter Related Bloodstream Infections|Anticipative Diagnosis of Central Venous Catheter Related Bloodstream Infections Using Biphasic PNA FISH and Gram Stain/AOLC Tests|Completed||N/A|150|Actual|Medical University of Graz|||2||f||||f||||||Samples With DNA|"     Serum samples   "|||2017-10-11 03:33:13.013806|2017-10-11 03:33:13.013806
NCT01481025|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2011-11-28|||November 2011||2011-11-01|November 2011|2011-11-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|CH||Efficacy and Safety for Cimicifuga/Hypericum Product|Phase 3 Study - Efficacy and Tolerance for the Mixture of Dry Extracts Black Cohosh and Saint John's Worth Versus Isolated Black Cohosh Extract for the Climacteric Symptoms' Control|Unknown status|Not yet recruiting|Phase 3|210|Anticipated|Phytopharm Consulting Brazil||3|||f||||t||||||||||2017-10-11 03:33:13.100643|2017-10-11 03:33:13.100643
NCT01481012|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-23|||January 2006||2006-01-01|November 2011|2011-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices|The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices|Terminated||N/A|94|Actual|Icahn School of Medicine at Mount Sinai|||4|Slow enrollment - terminated for futility.|f||||t||||||Samples Without DNA|"     Blood for the following markers of thrombin generation and platelet function will be drawn,     spun, aliquoted and stored for later batched analysis: - Thrombo-antithrombin complex (TAT);     - Prothrombin Fragment 1+2 (F1.2); - Thromboelastrograph (TEG) (performed at the clinical     site when available); - Additional markers of coagulation and platelet activation (for future     consideration) - 4ml of plasma frozen in 1ml aliquots.   "|||2017-10-11 03:33:13.215037|2017-10-11 03:33:13.215037
NCT01480999|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-05-10|||November 2011||2011-11-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|July 2015|Actual|2015-07-01||Observational|GOC2||Comparing Robotics and Laparoscopy With Laparotomy/Open Surgery for Endometrial Cancer|A Prospective Study Evaluating Surgical and Quality of Life Outcomes in Robotics and Laparoscopy Compared to Laparotomy in Early Stage Endometrial Cancer|Active, not recruiting||N/A|550|Actual|University Health Network, Toronto|||3||f||||t||||||||||2017-10-11 03:33:13.364052|2017-10-11 03:33:13.364052
NCT01480986|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2015-05-17|||September 2011||2011-09-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|September 2012|Actual|2012-09-01||Interventional|||IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC|a Prospective Study on the Efficacy and Safety Using Sequential Therapy of Irinotecan Combined With Cisplatin (IP)and Octretide Lar in the First Line Treatment of Metastatic or Inoperable Gastrointestinal Poorly Differentiated Neuroendocrine Carcinoma: the IPO-NEC Trial|Completed||Phase 2|40|Actual|Peking University||1|||f||||f||||||||||2017-10-11 03:33:13.500812|2017-10-11 03:33:13.500812
NCT01480973|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-09-19|||June 2011||2011-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2017|Actual|2017-07-01||Interventional|||Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung Cancer|MRI Assessment of Post-Radiation Change Following Stereotactic Body RT for Non-Small Cell Lung Cancer: A Pilot Study|Active, not recruiting||N/A|30|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 03:33:13.686216|2017-10-11 03:33:13.686216
NCT01480960|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2016-02-23|||January 2012||2012-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of a Whole Body Vibration Training in Patients After Lung Transplantation|Effects of a Whole Body Vibration Training on the Exercise Performance in Patients After Lung Transplantation|Completed||N/A|140|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 03:33:13.771905|2017-10-11 03:33:13.771905
NCT01480947|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-11-28|||February 2009||2009-02-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Bio-three||The Treatment Effect of Bio-Three on Children With Enteritis|The Treatment Effect of Bio-Three on Children With Enteritis Due to Salmonella or Rotavirus or Any Unknown Reason|Completed||Phase 4|80|Actual|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-10-11 03:33:13.863165|2017-10-11 03:33:13.863165
NCT01480934|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2011-11-28|||June 2005||2005-06-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Observational|DM & PCO||Evaluation of Posterior Capsule Opacification in Eyes With Diabetes Mellitus|A Prospective Evaluation of Posterior Capsule Opacification in Eyes With Diabetes Mellitus -A Case Control Study|Completed||N/A|150|Actual|Iladevi Cataract and IOL Research Center|||2||f||||t||||||||||2017-10-11 03:33:13.953752|2017-10-11 03:33:13.953752
NCT01480921|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-11-23|||July 2003||2003-07-01|November 2011|2011-11-01|November 2007|Actual|2007-11-01|June 2006|Actual|2006-06-01||Interventional|PEAK-HF||Hospital Versus Home Based Exercise in Patients With Chronic Stable Heart Failure|The Effect of Hospital Versus Home-based Exercise on Psychosocial and Physical Outcomes in Patients With Chronic Stable Heart Failure|Completed||N/A|62|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 03:33:14.017907|2017-10-11 03:33:14.017907
NCT01480908|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2014-12-02|||June 2011||2011-06-01|August 2013|2013-08-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Right Bundle Branch Block After Surgical Closure of Ventricular Septal Defect|Postoperative Right Bundle Branch Block - Long-term Effect on the Right Ventricle in Children Operated for Ventricular Septal Defect|Completed||N/A|60|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 03:33:14.11944|2017-10-11 03:33:14.11944
NCT01480895|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-11-28|||March 2007||2007-03-01|November 2011|2011-11-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|GDM||Prevention of Diabetes Mellitus Type 2 in Women Post Gestational Diabetes Mellitus Diagnosis|Identification of Risk Factors for DM Type 2 in Women Post GDM Diagnosis and Its Prevention by Changing Life Style|Completed||N/A|180|Actual|Soroka University Medical Center||2|||f||||t||||||||||2017-10-11 03:33:14.237273|2017-10-11 03:33:14.237273
NCT01480882|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2012-12-04|||December 2011||2011-12-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|LEGA||Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory Passage|"A Prospective, Cross-over Randomized Trial to Assess the Efficacy and Safety of Mechanical Percussor LEGA Compared With Conventional Chest Physiotherapy in Adults With Chronic Bronchiectasis or Chronic Obstructive Pulmonary Disease (COPD"|Completed||Phase 2/Phase 3|20|Actual|Penang Hospital, Malaysia||2|||f||||t||||||||||2017-10-11 03:33:14.324014|2017-10-11 03:33:14.324014
NCT01480869|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2015-07-29|||July 2011||2011-07-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|VITACAL||Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients|Randomized Phase III Trial Comparing Conventional Vitamin D Supplementation vs. Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients Treated by Neoadjuvant or Adjuvant Chemotherapy.|Completed||Phase 3|264|Anticipated|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||f||||||||||2017-10-11 03:33:14.431077|2017-10-11 03:33:14.431077
NCT01480856|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2014-10-14|||September 2008||2008-09-01|October 2014|2014-10-01|February 2014|Actual|2014-02-01|January 2012|Actual|2012-01-01||Interventional|Cobedding||Cobedding in Daily Weight Gain of Neonate Twins|Evaluation of the Efficacy of Cobedding in Daily Weight Gain of Neonate Twins|Completed||N/A|64|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 03:33:14.530353|2017-10-11 03:33:14.530353
NCT01480830|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2013-12-01|||January 2012||2012-01-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|SCOPE GUIDE||The Use of Magnetic Endoscopic Imaging for Improving Quality Indicators in Outpatient Colonoscopy|The Use of Magnetic Endoscopic Imaging for Improving Quality Indicators in Outpatient Colonoscopy|Completed||N/A|633|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 03:33:14.713138|2017-10-11 03:33:14.713138
NCT01480817|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2016-04-28|||June 2012||2012-06-01|December 2013|2013-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Sorafenib VS TACE in HCC Patients With Portal Vein Invasion|An Open Label, Phase 2 Trial Comparing Sorafenib And TACE in Advanced Hepatocellular Carcinoma With Portal Vein Invasion|Terminated||Phase 2|2|Actual|Seoul National University Hospital||2||Difficulty of participant enrollment.|f||||f||||||||||2017-10-11 03:33:14.795836|2017-10-11 03:33:14.795836
NCT01480804|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2014-03-26|||November 2006||2006-11-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|DISCO||Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention Study|Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention Study|Completed||N/A|48|Actual|Joslin Diabetes Center||2|||f||||f||||||||||2017-10-11 03:33:14.9|2017-10-11 03:33:14.9
NCT01480791|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2015-05-18|||January 2012||2012-01-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries|A Double-Blind, Randomized, Parallel Design Study of Aliskiren Versus Hydrochlorothiazide in Mild-to Moderate Hypertensive Type II Diabetes Mellitus Patients on Remodeling of Resistance Arteries|Withdrawn||Phase 2|0|Actual|Sir Mortimer B. Davis - Jewish General Hospital||3||Because of results of Altitude trial, this trial was cancelled.|f||||f||||||||||2017-10-11 03:33:15.024768|2017-10-11 03:33:15.024768
NCT01480778|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-25|2016-03-02|||July 2014||2014-07-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.|Pharmacodynamic Assessment to Drug Ciclo 21 (Levonorgestrel + Ethinyl Estradiol) Market by União Química Farmacêutica Nacional S/A Compared to Drug Nordette of Wieth Indústria Farmacêutica Ltda.|Completed||Phase 3|62|Actual|Azidus Brasil||2|||f||||t||||||||Yes|The study data will be maked available after journal's approbation. The manuscript contained all of data it has been submitted.|2017-10-11 03:33:15.122258|2017-10-11 03:33:15.122258
NCT01480765|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2012-11-11|||November 2011||2011-11-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Preventing Pain After Heart Surgery|Prospective, Double-blinded, Randomised, Placebo Controlled Trial of Pre-emptive Analgesia to Prevent Pain Following Sternotomy for Cardiac Surgery.|Unknown status|Recruiting|Phase 4|150|Anticipated|Barts & The London NHS Trust||3|||f||||t||||||||||2017-10-11 03:33:15.215191|2017-10-11 03:33:15.215191
NCT01480752|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2013-01-11|||September 2011||2011-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Reduction of Post-operative Endodontic Pain|the Effect of Intraligamentary Injection of Lornoxicam on the Intensity of Post-operative Endodontic Pain in the Tooth With Symptomatic Irreversible Pulpitis|Completed||Phase 2|60|Actual|Islamic Azad University, Tehran||3|||f||||t||||||||||2017-10-11 03:33:15.324773|2017-10-11 03:33:15.324773
NCT01480739|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2015-06-24|||December 2011||2011-12-01|June 2015|2015-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||AZD5069 Neutrophil Function Study|A Randomised, Double-blind, Placebo-Controlled, Two-way Cross-over, Single Centre Study in Healthy Subjects to Assess the Effect of Oral Dosing of AZD5069 on Neutrophil Number and Function in Peripheral Blood and the Ability to Recruit Neutrophils Into the Circulation After Exercise and Subcutaneous|Completed||Phase 1|30|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:33:15.418122|2017-10-11 03:33:15.418122
NCT01480726|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-24|2015-04-13|||November 2011||2011-11-01|November 2011|2011-11-01|January 2015|Actual|2015-01-01|December 2013|Actual|2013-12-01||Observational|||Long-term Results Following Endoscopic Vein Harvesting in Coronary Artery Bypass Surgery|Endoscopic Versus Open Vein Harvest in Coronary Artery Bypass Grafting. Clinical and CT-angiographic Long-term Result From a Randomized Study.|Completed||N/A|132|Actual|Aalborg Universitetshospital|||2||f||||f||||||||||2017-10-11 03:33:15.508464|2017-10-11 03:33:15.508464
NCT01480713|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-06-27|||May 2012||2012-05-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors|Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors. A 24-week Open-label, Proof-of-concept Pilot Clinical Trial.|Completed||Phase 3|41|Actual|IrsiCaixa||1|||f||||f||||||||||2017-10-11 03:33:15.601013|2017-10-11 03:33:15.601013
NCT01480700|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2013-08-02|||October 2011||2011-10-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|ALGOVUE||Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment|Effect of Consumption of Eggs Rich in Xanthophyll Carotenoids and Omega-3 Fatty Acids on the Macular Pigment in Healthy People|Completed||N/A|99|Actual|Institut Pasteur de Lille||2|||f||||t||||||||||2017-10-11 03:33:15.9606|2017-10-11 03:33:15.9606
NCT01480687|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-11-23|||May 2011||2011-05-01|November 2011|2011-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia|Effects of Fish Oil Supplementation on Vascular Structure and Function in Hypertensive Patients With Hypertriglyceridemia|Unknown status|Recruiting|Phase 4|52|Anticipated|Hospital Universitario Pedro Ernesto||2|||f||||t||||||||||2017-10-11 03:33:16.064501|2017-10-11 03:33:16.064501
NCT01480674|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-07-07|2016-01-27||March 28, 2011|Actual|2011-03-28|June 2017|2017-06-01|November 16, 2012|Actual|2012-11-16|November 16, 2012|Actual|2012-11-16||Observational||Analyzed set population included all enrolled participants without any protocol deviation used as a primary analysis population for all efficacy outcome measures.|An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years|A Retrospective Study to Characterize Patients With HER2-positive Metastatic or Locally Advanced Breast Cancer, Treated by Herceptin® as 1st Line-therapy and Without Progression for at Least 3 Years Followed by a 1-year Prospective Study for Patients Still Alive|Completed||N/A|160|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:33:16.239668|2017-10-11 03:33:16.239668
NCT01480661|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-09-18|||December 2011||2011-12-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients|Analysis of Airway Responses in Severe COPD Patients to Daxas®, Using CT Based Functional Respiratory Imaging|Completed||Phase 4|41|Actual|FLUIDDA nv||2|||f||||f||||||||||2017-10-11 03:33:16.929797|2017-10-11 03:33:16.929797
NCT01480648|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-10-31|||November 2011||2011-11-01|October 2013|2013-10-01||||February 2012|Actual|2012-02-01||Interventional|||Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses of BI 144807 Powder in Bottle (1 to 1200 mg) in Healthy Male Volunteers in a Randomised, Single-blind, Placebo-controlled Trial|Completed||Phase 1|74|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:33:17.070237|2017-10-11 03:33:17.070237
NCT01480635|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2011-11-28|||June 2010||2010-06-01|October 2011|2011-10-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Observational|PCCE||PillCam Colon 2 Capsule Endoscopy (PCCE) After Incomplete Colonoscopy|Evaluation of the PillCam Colon Capsule Endoscopy (PCCE) After Incomplete Colonoscopy|Unknown status|Recruiting|Phase 2/Phase 3|74|Anticipated|Bethesda Krankenhaus|||1||f||||t||||||||||2017-10-11 03:33:17.184231|2017-10-11 03:33:17.184231
NCT01480622|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-06-13|||December 5, 2011|Actual|2011-12-05|June 2017|2017-06-01|December 30, 2011|Actual|2011-12-30|December 30, 2011|Actual|2011-12-30||Interventional|PK of TDF||Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects|An Open-label Single and Repeat Dose Study to Investigate the Pharmacokinetic Profiles of Tenofovir Disoproxil Fumarate 300 mg in Healthy Chinese Subjects|Completed||Phase 1|14|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:33:17.303076|2017-10-11 03:33:17.303076
NCT01480609|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-07-24|||November 30, 2011|Actual|2011-11-30|July 2017|2017-07-01|April 24, 2012|Actual|2012-04-24|April 24, 2012|Actual|2012-04-24||Interventional|||Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite|An Open Label, Single-dose, Fixed Sequence, Two Treatment Period Study to Assess the Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR).|Completed||Phase 1|8|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:33:17.445552|2017-10-11 03:33:17.445552
NCT01480596|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2016-12-15|2016-03-24||April 2013||2013-04-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||The Evaluation of Belimumab in Myasthenia Gravis (MG)|A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects With Generalized Myasthenia Gravis (MG)|Completed||Phase 2|40|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:33:17.591421|2017-10-11 03:33:17.591421
NCT01480583|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-07-11||2016-07-11|October 2011||2011-10-01|July 2016|2016-07-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|GRABM-B||GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases|A Phase II, Multi-center, Open-label Study Evaluating GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases|Completed||Phase 2|85|Actual|Angiochem Inc||2|||f||||f||||||||||2017-10-11 03:33:18.883328|2017-10-11 03:33:18.883328
NCT01479478|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-10-13|||November 2011||2011-11-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy|Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.|Recruiting||Phase 1/Phase 2|372|Anticipated|Stanford University||2|||f||||f||||||||No||2017-10-11 03:33:19.006696|2017-10-11 03:33:19.006696
NCT01479465|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-03-10||2015-03-10|December 2011||2011-12-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety of Simtuzumab With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined With FOLFIRI as Second Line Treatment for Metastatic KRAS Mutant Colorectal Adenocarcinoma That Has Progressed Following a First Line Oxaliplatin- and Fluoropyrimidine-Containing Regimen.|Completed||Phase 2|266|Actual|Gilead Sciences||4|||f||||t||||||||||2017-10-11 03:33:19.188073|2017-10-11 03:33:19.188073
NCT01480570|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2015-02-09|||November 2011||2011-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:33:19.495038|2017-10-11 03:33:19.495038
NCT01480557|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-01-14|||April 2011||2011-04-01|January 2017|2017-01-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Aqualase Versus Torsional ip. A Study on Endothelial Cells, Corneal Edema and Corneal Sensitivity|Liquefaction Versus Torsional ip. A Comparative Study on Endothelial Cells, Corneal Edema and Corneal Sensitivity|Completed||N/A|75|Actual|Democritus University of Thrace||2|||f||||f||||||||||2017-10-11 03:33:19.68976|2017-10-11 03:33:19.68976
NCT01480544|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2015-12-14|||August 2012||2012-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Interventional|IMATCHINE||Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)|Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies|Completed||N/A|14990|Anticipated|Duke University||4|||f||||f||||||||||2017-10-11 03:33:19.775949|2017-10-11 03:33:19.775949
NCT01480531|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2013-02-07|||December 2011||2011-12-01|January 2013|2013-01-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|Clevidipine||Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection|Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection.|Withdrawn||N/A|0|Actual|Duke University||1||We elected to stop this study due to our inability to recruit suitable subjects.|f||||f||||||||||2017-10-11 03:33:19.88208|2017-10-11 03:33:19.88208
NCT01480518|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-05-08|||December 2011||2011-12-01|May 2015|2015-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Biomarkers in Tissue Samples From Patients With Ewing Sarcoma|Analysis of GGAA-Microsatellites in Ewing Sarcoma|Completed||N/A|166|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Tissue   "|||2017-10-11 03:33:19.986722|2017-10-11 03:33:19.986722
NCT01480505|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-11-28|||October 1999||1999-10-01|November 2011|2011-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Primary Vitrectomy for the Treatment of Retinal Detachment in Highly Myopic||Completed||N/A|840|Actual|Centre Hospitalier Universitaire Dijon|||1||f||||f||||||||||2017-10-11 03:33:20.098755|2017-10-11 03:33:20.098755
NCT01480492|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-28|||January 2010||2010-01-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection|Study the Effect of Nucleoside on Host Immune in Patients With CHB|Completed||N/A|56|Actual|Changhai Hospital||1|||f||||t||||||||||2017-10-11 03:33:20.195885|2017-10-11 03:33:20.195885
NCT01480479|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2017-04-06||2017-04-06|November 2011||2011-11-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ACT IV||Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma|An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma|Completed||Phase 3|745|Actual|Celldex Therapeutics||2|||f||||t||||||||||2017-10-11 03:33:20.348315|2017-10-11 03:33:20.348315
NCT01480466|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-04-28|||December 2011||2011-12-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Use of Electronic Health Records for Addressing Overweight and Obesity in Primary Care|Use of Electronic Health Records for Addressing Overweight and Obesity in Primary Care|Completed||N/A|65278|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:33:21.087054|2017-10-11 03:33:21.087054
NCT01480453|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-02-21|||January 2011||2011-01-01|July 2016|2016-07-01|December 2024|Anticipated|2024-12-01|December 2023|Anticipated|2023-12-01||Observational|||Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty|Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Humeral Stem|Recruiting||N/A|120|Anticipated|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-10-11 03:33:21.226418|2017-10-11 03:33:21.226418
NCT01480440|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-01-10|||January 2011||2011-01-01|January 2017|2017-01-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|||Outcomes Study of the TM Reverse Shoulder System Used in Primary or Revision Reverse Total Shoulder Arthroplasty|Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Should System|Active, not recruiting||N/A|200|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-11 03:33:21.364685|2017-10-11 03:33:21.364685
NCT01480427|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2011-11-25|||May 2009||2009-05-01|November 2011|2011-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Assessment of Quality of Life in Food Allergic Children|Assessment of Quality of Life in Food Allergic Children|Completed||N/A|60|Actual|University of Lausanne Hospitals|||1||f||||||||||||||2017-10-11 03:33:21.462419|2017-10-11 03:33:21.462419
NCT01480414|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2012-12-25|||September 2010||2010-09-01|July 2010|2010-07-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Side Effects of 4 Times Bone Marrow Mono Nuclear Transplantation in Patients With Ischemic Lower Limb|Evaluation the Side Effects of Repeated Bone Marrow Derived Mono Nuclear Stem Cells Transplantation in Patients With Lower Limb Ischemic Ulcer|Completed||Phase 1/Phase 2|20|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 03:33:21.535773|2017-10-11 03:33:21.535773
NCT01480401|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2014-12-17|||March 2012||2012-03-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|SODIUM-HF||Study of Dietary Intervention Under 100 MMOL in Heart Failure|The Long Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients With Heart Failure|Completed||N/A|38|Actual|University of Alberta||2|||f||||t||||||||||2017-10-11 03:33:21.647417|2017-10-11 03:33:21.647417
NCT01480388|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-11-30|||December 2011||2011-12-01|November 2016|2016-11-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate|A Phase 2b Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Dose Range Finding Study of JNJ-39758979 in Subjects With Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy|Withdrawn||Phase 2|0|Actual|Janssen Research & Development, LLC||5||"Study was terminated prematurely due to 2 cases of agranulocytosis in a different clinical   trial with this same drug."|f||||t||||||||||2017-10-11 03:33:21.770051|2017-10-11 03:33:21.770051
NCT01480375|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-01-15|||September 2011||2011-09-01|January 2013|2013-01-01||||September 2013|Anticipated|2013-09-01||Interventional|NaSBxP01||A Novel 3D Navigation Technology for Improved TRUS Prostate Biopsy|A 3D Navigation Technology for Improved TRUS Prostate Biopsy|Unknown status|Recruiting|N/A|150|Anticipated|UC Care, Ltd.||1|||f||||f||||||||||2017-10-11 03:33:21.885694|2017-10-11 03:33:21.885694
NCT01480362|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-08-18|||November 2011||2011-11-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|DiaFu||Treatment Study of Negative Pressure Wound Therapy for Diabetic Foot Wounds|Randomized, Controlled Clinical Trial Evaluating the Efficacy and Clinical Effectiveness of Negative Pressure Wound Therapy for the Treatment of Diabetic Foot Wounds When Compared to Standard Wound Therapy|Completed||N/A|360|Actual|University of Witten/Herdecke||2|||f||||t||||||||||2017-10-11 03:33:21.972138|2017-10-11 03:33:21.972138
NCT01480349|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-11-14|||January 2011||2011-01-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|January 2018|Anticipated|2018-01-01||Observational|SOPHH||Shunt Outcomes of Post-Hemorrhagic Hydrocephalus|Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study|Active, not recruiting||N/A|146|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 03:33:22.199053|2017-10-11 03:33:22.199053
NCT01480336|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-03-18|||February 2011||2011-02-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot|The Pharmacokinetics and Electrocardiographic Implications of Adjunctive Amiodarone and Ranolazine Therapy in Patients on Implantable Cardioverter Defibrillators: The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot|Completed||N/A|19|Actual|Hartford Hospital||2|||f||||f||||||||||2017-10-11 03:33:22.27919|2017-10-11 03:33:22.27919
NCT01480323|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2015-07-17|||February 2012||2012-02-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional|||A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2|A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 in Pretreated Patients With Stage IV Melanoma|Completed||Phase 2|15|Actual|University Hospital Tuebingen||1|||f||||t||||||||||2017-10-11 03:33:22.364786|2017-10-11 03:33:22.364786
NCT01480310|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-11-01|||December 2011||2011-12-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers|A Phase Ia, Single-Center, Randomized, Placebo-Controlled, Double-Blind, Single Ascending-Dose Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers|Completed||Phase 1|23|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:33:22.460661|2017-10-11 03:33:22.460661
NCT01480297|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2015-04-23|2014-12-02||November 2011||2011-11-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|April 2012|Actual|2012-04-01||Interventional|SALP|adults with type 1 diabetes and painful peripheral neuropathy|Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy|A Pilot Study to Determine the Effects of 12 Weeks of Treatment With Salsalate on Measures of Peripheral Neuropathy in Type 1 Diabetes|Completed||Phase 2|8|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 03:33:22.543262|2017-10-11 03:33:22.543262
NCT01480284|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-07-07|2013-08-22||November 2011||2011-11-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|January 2013|Actual|2013-01-01||Interventional|||Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue|A Multi-center, Randomized, Active Controlled, Double-blind, Parallel Group Comparison Study and Subsequent Open-label Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue|Completed||Phase 3|166|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:33:22.963834|2017-10-11 03:33:22.963834
NCT01480271|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-06-27|||May 30, 2011|Actual|2011-05-30|June 2017|2017-06-01|September 30, 2011|Actual|2011-09-30|September 30, 2011|Actual|2011-09-30||Interventional|||An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics.|A Randomized, Double-blind, Placebo-controlled First Time Into Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intranasal Dosing With GSK2245035, a TLR7 Agonist, in Healthy Volunteers and Allergic Rhinitics|Completed||Phase 1|61|Actual|GlaxoSmithKline||16|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:33:23.788976|2017-10-11 03:33:23.788976
NCT01480258|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-02-27|||November 2011||2011-11-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)|A Phase III Randomized, Double-Blind, Active-Comparator Controlled Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months|Completed||Phase 3|1315|Actual|MCM Vaccines B.V.||2|||f||||f||||||||||2017-10-11 03:33:23.922222|2017-10-11 03:33:23.922222
NCT01480232|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-02-21|2016-12-15||December 2011||2011-12-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence|Proof-of-Concept Study of EVP-6124, an Alpha-7 Nicotinic Acetylcholine Receptor Agonist, Versus Placebo in Subjects With Nicotine Dependence|Terminated||Phase 2|345|Actual|Massachusetts General Hospital||4||Study has been put on clinical hold by FDA|f||||t||||||||||2017-10-11 03:33:26.105944|2017-10-11 03:33:26.105944
NCT01480219|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-02-04|2013-02-04||August 2011||2011-08-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g|Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009|Completed||N/A|467|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 03:33:26.921002|2017-10-11 03:33:26.921002
NCT01480206|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-05-30|||November 2011||2011-11-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR|3D Interventional Tools for Endovascular Procedures in the OR|Enrolling by invitation||N/A|140|Anticipated|Philips Healthcare|||1||f||||f||||||||||2017-10-11 03:33:27.171515|2017-10-11 03:33:27.171515
NCT01480193|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-05-30|||September 2011||2011-09-01|November 2011|2011-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||New Therapy for Patients With Severe Tinnitus|Preliminary Clinical Trial of an Integrative Therapy With Severe Tinnitus|Completed||N/A|40|Actual|Duke University||2|||f||||f||||||||||2017-10-11 03:33:27.381765|2017-10-11 03:33:27.381765
NCT01480180|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-08-16|||January 30, 2012|Actual|2012-01-30|August 2017|2017-08-01|December 3, 2018|Anticipated|2018-12-03|December 3, 2018|Anticipated|2018-12-03||Interventional|pathfinder™2||Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A|A Multi-national Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients With Haemophilia A|Active, not recruiting||Phase 3|186|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:33:27.478344|2017-10-11 03:33:27.478344
NCT01480167|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-01-18|||November 2011|Actual|2011-11-01|January 2017|2017-01-01||||December 2012|Actual|2012-12-01||Interventional|PRIORi-T||The PRIORi-T Trial--Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation|Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation (The PRIORi-T Trial)|Withdrawn||Phase 4|0|Actual|Merit Medical Systems, Inc.||2||Lack of enrollment|f||||f||||||||||2017-10-11 03:33:27.78576|2017-10-11 03:33:27.78576
NCT01480154|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-09-12|||November 23, 2011|Actual|2011-11-23|September 2017|2017-09-01||||October 1, 2017|Anticipated|2017-10-01||Interventional|||Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer|A Phase I Trial of MK-2206 and Hydroxychloroquine in Solid Tumors, Melanoma, Renal and Prostate Cancer to Examine the Role of Autophagy in Tumorigenesis|Active, not recruiting||Phase 1|62|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 03:33:27.899963|2017-10-11 03:33:27.899963
NCT01480141|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-03-25|||January 2012||2012-01-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)|A Therapeutic Trial of Afatinib in the Neoadjuvant Setting. Molecular Effects of Afatinib: A Window of Opportunity Trial In Early Stage NSCLC|Withdrawn||Phase 2|0|Actual|Medical University of South Carolina||1||PI left MUSC, no patient enrollments|f||||t||||||||||2017-10-11 03:33:28.006718|2017-10-11 03:33:28.006718
NCT01480128|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2015-10-05|||July 2011||2011-07-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|SIMPLE||Multicenter Single-port Colectomy RCT|A Multicenter Prospective Randomized Clinical Trail on the Efficacy of the Single Port Laparoscopic Surgery Compared With Multiport Laparoscopic Surgery|Enrolling by invitation||Phase 3|388|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-10-11 03:33:28.12854|2017-10-11 03:33:28.12854
NCT01480115|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2013-03-10|||April 2013||2013-04-01|November 2011|2011-11-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Observational|||A New Tool for Automatic Ovarian Follicle Count and it Abilities to Evaluate Ovarian Reserve|A New Tool for Automatic Ovarian Follicle Count and it Abilities to Evaluate Ovarian Reserve|Unknown status|Not yet recruiting|N/A|50|Anticipated|Meir Medical Center|||1||f||||t||||||Samples With DNA|"     Whole blood and serum for FSH, LH, E2, AMH, Prolactin, TSH, Testosterone, Progesterone,     17-OHP, DHEA-S.   "|||2017-10-11 03:33:28.23325|2017-10-11 03:33:28.23325
NCT01480102|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-03-28|||August 2011||2011-08-01|March 2017|2017-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|PRONE||Paravertebral Block for Percutaneous Nephrolithotomy|Paravertebral Block for Percutaneous Nephrolithotomy (PRONE)|Recruiting||N/A|82|Anticipated|Loyola University||2|||f||||f||||||||Undecided||2017-10-11 03:33:28.338289|2017-10-11 03:33:28.338289
NCT01480089|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-06-16|2016-06-16||November 2011||2011-11-01|June 2016|2016-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|SPRAY|All women randomized to treatment were included in the baseline analysis population.|Surgical Pain Control With Ropivacaine by Atomized Delivery|Surgical Pain Control With Ropivacaine by Atomized Delivery|Completed||Phase 4|56|Actual|Loyola University|There are no caveats to report.|2|||f||||f||||||||No|There is no plan to make individual participant data (IPD) available|2017-10-11 03:33:28.447068|2017-10-11 03:33:28.447068
NCT01480076|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-02-14|2016-07-11||February 2012||2012-02-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|ENABLE|Intent-to-treat population: all participants who received at least 1 dose of study treatment and who provided at least 1 efficacy assessment at Baseline and the 3-month visit.|Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis|An Open-Label, Multicenter, Multinational Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) 10 mg Twice Daily on Quality of Life as Reported by Subjects With Multiple Sclerosis|Completed||Phase 4|901|Actual|Biogen||1|||f||||||||||||||2017-10-11 03:33:29.458048|2017-10-11 03:33:29.458048
NCT01480063|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-10-02|||April 16, 2012|Actual|2012-04-16|October 2017|2017-10-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2020|Anticipated|2020-12-31||Observational|LIBERATE||An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice|A Multicenter, Multinational, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra® When Used In Routine Medical Practice (LIBERATE)|Recruiting||N/A|5000|Anticipated|Biogen|||1||f||||||||||||||2017-10-11 03:33:36.933788|2017-10-11 03:33:36.933788
NCT01480050|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2016-10-12|||April 2012||2012-04-01|October 2016|2016-10-01||||August 2015|Actual|2015-08-01||Interventional|||Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma|A Phase I Open Label Safety Study to Evaluate the Pharmacokinetic Profile and Tolerance of Mibefradil Dose Finding in Subjects With Recurrent High-Grade Glioma Undergoing Standard, Repeated Temozolomide Treatment|Completed||Phase 1|28|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 03:33:37.374073|2017-10-11 03:33:37.374073
NCT01480037|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2015-01-13|||March 2010||2010-03-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|June 2011|Actual|2011-06-01||Observational|||Genetic and Physiological Aspects of Oxidative Profile in Sleep and Well-succeed Aging|Genetic and Physiological Aspects of Oxidative Profile in Sleep and Well-succeed Aging|Completed||N/A|38|Actual|Associação Fundo de Incentivo à Pesquisa|||3||f||||t||||||Samples With DNA|"     Blood samples collected for DNA and RNA extraction, as well as for laboratory examinations   "|||2017-10-11 03:33:37.507874|2017-10-11 03:33:37.507874
NCT01480024|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-23|2017-06-28|||April 2011||2011-04-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Observational|||Effect of Body Composition and Metabolism on Oocyte Gene Expression|Effect of Body Composition and Metabolism on Oocyte Gene Expression|Active, not recruiting||N/A|70|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||Samples With DNA|"     oocytes and follicular fluid   "|||2017-10-11 03:33:37.612158|2017-10-11 03:33:37.612158
NCT01480011|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2013-02-19|||November 2011||2011-11-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation|A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation|Completed||Phase 2|31|Actual|All India Institute of Medical Sciences, New Delhi||1|||f||||f||||||||||2017-10-11 03:33:37.701059|2017-10-11 03:33:37.701059
NCT01479998|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2014-01-10|||November 2011||2011-11-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes|Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes|Terminated||Phase 1|8|Actual|Yale University||2||Reevaluating recruitment strategies|f||||t||||||||||2017-10-11 03:33:37.826335|2017-10-11 03:33:37.826335
NCT01479972|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-10-28|||November 2011||2011-11-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa|Phase II Open Label, Randomized, Controlled Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-unexposed, BCG Naive Newborn Infants in South Africa|Completed||Phase 2|48|Actual|Vakzine Projekt Management GmbH||2|||f||||t||||||||||2017-10-11 03:33:38.058218|2017-10-11 03:33:38.058218
NCT01479959|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2011-11-22|||June 2010||2010-06-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|OptiPEP||Impact of Patient Controlled Positive End-expiratory Pressure on Speech in Tracheostomized Ventilated Patients|Determination of Optimal PEEP Level Under Patient Control in Tracheostomized Ventilated Patients|Completed||N/A|14|Actual|University of Versailles||3|||f||||f||||||||||2017-10-11 03:33:38.182499|2017-10-11 03:33:38.182499
NCT01479946|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-12-08|||October 2011||2011-10-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin|An International Randomized Phase II Study Comparing Early Electrochemotherapy to Delayed or No Electrochemotherapy in Patients With Cutaneous Breast Cancer Metastases|Withdrawn||Phase 2|0|Actual|Uppsala University Hospital||2||ECT equipment not available at study center|f||||f||||||||||2017-10-11 03:33:38.32996|2017-10-11 03:33:38.32996
NCT01479933|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2013-03-03|||September 2011||2011-09-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|VitDmet||Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes|Randomized Controlled Trial of Vitamin D Supplementation on Glucose Metabolism in Subjects With Components of the Metabolic Syndrome|Completed||N/A|73|Actual|University of Eastern Finland||3|||f||||f||||||||||2017-10-11 03:33:38.444146|2017-10-11 03:33:38.444146
NCT01479920|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2015-12-04|||June 2012||2012-06-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture|The Identification of Central Neural Network for Antidepressant Effects of Dense Cranial Electroacupuncture Stimulation - a Positron Emission Topographic (PET) Study|Completed||N/A|36|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 03:33:38.587997|2017-10-11 03:33:38.587997
NCT01479907|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-05-11|||November 2010||2010-11-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|March 2012|Actual|2012-03-01||Interventional|||Synbiotics and Gastrointestinal Function Related Quality of Life After Colectomy for Cancer|Synbiotics and Gastrointestinal Function Related Quality of Life After Colectomy for Cancer|Completed||N/A|100|Actual|University of Athens||2|||f||||f||||||||No||2017-10-11 03:33:38.745381|2017-10-11 03:33:38.745381
NCT01479894|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-02-18|||November 2011||2011-11-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer||Completed||N/A|44|Actual|University of Arkansas|||1||f||||f||||||Samples With DNA|"     The Oncotype DX Colon Cancer Assay will be utilized to define the gene expression profile of     the tumor tissue.   "|||2017-10-11 03:33:38.842264|2017-10-11 03:33:38.842264
NCT01479881|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-10-31|||October 2011||2011-10-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus|A Phase I, 2-panel, Open-label, Randomized, Cross-over Trial in Healthy Subjects to Investigate the Effect of TMC435 at Steady-state on the Pharmacokinetics of the Immunosuppressants Cyclosporine and Tacrolimus|Completed||Phase 1|29|Actual|Tibotec Pharmaceuticals, Ireland||4|||f||||f||||||||||2017-10-11 03:33:38.927954|2017-10-11 03:33:38.927954
NCT01479868|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2014-10-28|2014-08-26||October 2011||2011-10-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Analysis population included all participants who received at least 1 dose of study drug.|A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1|A Phase III Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of TMC435 Plus PegIFNα-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Subjects Who Are Co-infected With Human Immunodeficiency Virus Type 1 (HIV-1)|Completed||Phase 3|109|Actual|Janssen R&D Ireland||1|||f||||f||||||||||2017-10-11 03:33:39.058317|2017-10-11 03:33:39.058317
NCT01479855|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2013-11-26|||January 2012||2012-01-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|ALZ-vit||Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type|Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type|Unknown status|Recruiting|N/A|180|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, urine, cerebrospinal fluid   "|||2017-10-11 03:33:39.782202|2017-10-11 03:33:39.782202
NCT01479491|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-10-18|||November 2011||2011-11-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan|Observational Database Study on the Incidence of Intussusception in Children Aged < 12 Months in Japan|Completed||N/A|54|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:33:50.197512|2017-10-11 03:33:50.197512
NCT01479842|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-04-05|||December 2011||2011-12-01|April 2016|2016-04-01||||March 2014|Actual|2014-03-01||Interventional|||Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma|A Phase I, Dose-escalation Trial of Rituxan and Bendamustine in Combination With Bruton's Tyrosine Kinase Inhibitor, PCI-32765, in Patients With Relapsed Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Indolent Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1|48|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:33:39.876946|2017-10-11 03:33:39.876946
NCT01479829|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-08-28|||March 2011||2011-03-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bipolar Depression and Inflammation|Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression: Role of Inflammation and Kynurenine Pathway Biomarkers|Active, not recruiting||Phase 4|80|Anticipated|Loyola University||2|||f||||t||||||||||2017-10-11 03:33:40.319818|2017-10-11 03:33:40.319818
NCT01479816|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-07-19|||September 2011||2011-09-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Observational|||Urinary Continence Index for Prediction of Urinary Incontinence in Older Women|Urinary Continence Index for Prediction of Urinary Incontinence in Older Women|Completed||N/A|702|Actual|William Beaumont Hospitals|||1||f||||f||||||||No||2017-10-11 03:33:40.437847|2017-10-11 03:33:40.437847
NCT01479803|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-04-22|||October 2011||2011-10-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|PICORE||Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS|"COMPARATIVE STUDY OF DIAGNOSTIC VALUE FOR THE ECHOTIP® PROCORE™ 22 Gauge NEEDLE VERSUS ECHOTIP® 22 Gauge IN THE DIAGNOSIS OF PANCREATIC SOLID TUMORS UNDER ENDOSCOPIC ULTRASONOGRAPHY : THE PICORE STUDY"|Completed||Phase 3|80|Actual|Société Française d'Endoscopie Digestive||2|||f||||t||||||||||2017-10-11 03:33:40.526205|2017-10-11 03:33:40.526205
NCT01479790|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2013-02-20|||June 2011||2011-06-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Repeatability and Agreement of Anterior Segment Optical Coherence Tomography (AS-OCT) and Thermography|Repeatability and Agreement of Visante and Cirrus Anterior Segment Optical Coherence Tomography and Functional Infrared Thermography|Completed||N/A|40|Actual|Singapore National Eye Centre||2|||f||||f||||||||||2017-10-11 03:33:40.611011|2017-10-11 03:33:40.611011
NCT01479777|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-09-09|2013-08-01||April 2011||2011-04-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Functional Electrical Stimulation (FES) Driven Stepping in Individuals With Spinal Cord Injury|FES Driven Stepping in Individuals With Spinal Cord Injury|Completed||Phase 1/Phase 2|12|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||t||||||||||2017-10-11 03:33:40.730705|2017-10-11 03:33:40.730705
NCT01479764|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-05-08|2013-08-26||December 2, 2011|Actual|2011-12-02|May 2017|2017-05-01|November 5, 2012|Actual|2012-11-05|October 26, 2012|Actual|2012-10-26||Interventional|||Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)|Effect of Sugammadex Compared With Usual Care for Reversal of Neuromuscular Blockade Induced by Rocuronium on Incidence of Residual Blockade at PACU Entry|Completed||Phase 3|154|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:33:41.18644|2017-10-11 03:33:41.18644
NCT01479751|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-08-24|||November 2011||2011-11-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Comparison of Methods to Facilitate Rapid Sequence Intubation|Comparison of Mg, Ketamine, Large Dose Rocuronium, and Priming on Intubating Condition in Rapid Sequence Intubation|Completed||N/A|110|Actual|Seoul National University Bundang Hospital||5|||f||||t||||||||||2017-10-11 03:33:41.718352|2017-10-11 03:33:41.718352
NCT01479738|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-19|2011-11-24|||January 2005||2005-01-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|PIPPC||Proximal Interphalangeal Joint Arthroplasty Using a Graft From the Capitate|The Second Hospital of Qinhuangdao, Qinhuangdao, Hebei, 066600, China|Completed||N/A|18|Actual|The Second Hospital of Qinhuangdao||1|||f||||t||||||||||2017-10-11 03:33:41.88167|2017-10-11 03:33:41.88167
NCT01479725|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-01-12|2016-11-13||March 2011||2011-03-01|January 2017|2017-01-01|May 2013|Actual|2013-05-01|August 2012|Actual|2012-08-01||Interventional|||Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis|A Prospective Trial Comparing the Response to Hyperbaric Oxygen Treatment in Patients With Ulcerative and Non-Ulcerative Interstitial Cystitis|Completed||Phase 2|8|Actual|William Beaumont Hospitals|A small number of patients were enrolled and treated (n=8), with only 5 patients completing the entire study. Three patients withdrew within the year following HBOT and were considered non-responders.|2|||f||||f||||||||No||2017-10-11 03:33:42.01775|2017-10-11 03:33:42.01775
NCT01479712|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-11-22|||April 2010||2010-04-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Intra-abdominal at Cesarean Section: A Randomized Controlled Trial|Intra-abdominal at Cesarean Section: A Randomized Controlled Trial|Completed||N/A|263|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 03:33:42.334322|2017-10-11 03:33:42.334322
NCT01479699|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-11-22|||June 2011||2011-06-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Absorption and Metabolism of Olive Leaf Extract and Its Effect on Vascular Reactivity and Cytokine Concentrations|Absorption and Metabolism of Olive Leaf Extract and Its Effect on Vascular Reactivity and Cytokine Concentrations|Completed||N/A|18|Actual|University of Reading||2|||f||||t||||||||||2017-10-11 03:33:42.44754|2017-10-11 03:33:42.44754
NCT01479686|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-19|2015-03-21|||September 2011||2011-09-01|March 2015|2015-03-01|July 2021|Anticipated|2021-07-01|December 2015|Anticipated|2015-12-01||Interventional|||iMRI Guided Resection in Cerebral Glioma Surgery|3.0T High-field Intraoperative MRI Guided Extent of Resection in Cerebral Glioma Surgery: a Single Center Prospective Randomized Triple-blind Controlled Clinical Trial|Recruiting||Phase 3|303|Anticipated|Huashan Hospital||2|||f||||t||||||||||2017-10-11 03:33:42.537666|2017-10-11 03:33:42.537666
NCT01479673|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2013-11-21|||November 2011||2011-11-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|P2 -RMCS||TICACOS International|Tight Caloric Balance in ICU Patients: a Multicenter, Prospective, Randomized, Controlled Study.|Unknown status|Recruiting|N/A|560|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-10-11 03:33:42.647985|2017-10-11 03:33:42.647985
NCT00005458|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||January 1991||1991-01-01|May 2000|2000-05-01|December 1991|Actual|1991-12-01|||||Observational|||Suppressed Anger, Blood Pressure and Mortality Follow-up||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.994705|2017-10-11 04:27:04.994705
NCT01479660|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-11-23|||March 2011||2011-03-01|November 2011|2011-11-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Role of Healthy Bacteria in Ulcerative Colitis|Probiotic for the Restoration of Intestinal Permeability and Reduction of Intestinal Inflammation in Active Ulcerative Colitis: A Double Blind Randomized Placebo Controlled Trial|Unknown status|Recruiting|Phase 4|100|Anticipated|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 03:33:42.7569|2017-10-11 03:33:42.7569
NCT01479647|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-02-25|||December 2011||2011-12-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study To Investigate The Effect Of Food On The Pharmacokinetics Of PH-797804|A Phase 1, Randomized, Open-Label, Single Dose, 2-Cohort Crossover Study To Determine The Effect Of Food On The Pharmacokinetics Of Orally Administered PH-797804 In Healthy Volunteers|Completed||Phase 1|28|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 03:33:42.863418|2017-10-11 03:33:42.863418
NCT01479634|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-03-03|||October 2011||2011-10-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|EARLI||Early HIV Therapy in Patients With High CD4 Cell Counts|Early Antiretroviral Therapy in Resource Limited Settings in Patients With High CD4+ Cell Counts (EARLI)|Completed||N/A|279|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:33:42.955588|2017-10-11 03:33:42.955588
NCT01479621|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-05-02|2017-02-28|2015-03-19|January 2012||2012-01-01|May 2017|2017-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Intent-to-Treat Analysis set|A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids|A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fluticasone Propionate DPI Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Persistent Asthma Uncontrolled on Non-steroidal Therapy|Completed||Phase 2|909|Actual|Teva Pharmaceutical Industries||6|||f||||f||||||||||2017-10-11 03:33:43.135508|2017-10-11 03:33:43.135508
NCT01479608|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-05-24|||November 2011||2011-11-01|May 2017|2017-05-01|December 2027|Anticipated|2027-12-01|December 2025|Anticipated|2025-12-01||Interventional|||Liver Transplantation and Colorectal Cancer|A Randomized Controlled Clinical Trial to Evaluate the Benefit and Efficacy of Liver Transplantation as Treatment for Selected Patients With Liver Metastases From ColoRectal Carcinoma|Recruiting||Phase 3|25|Anticipated|Oslo University Hospital||3|||f||||f||||||||||2017-10-11 03:33:47.303483|2017-10-11 03:33:47.303483
NCT01479595|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-06-20|2016-02-23||February 2012||2012-02-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma|A Randomized Double-blind Multiple-dose Placebo-controlled Trial to Establish the Efficacy of QBX258 (Combination of VAK694 and QAX576) in Asthma That is Inadequately Controlled With Inhaled Corticosteroids and Long Acting Beta Agonists|Completed||Phase 2|65|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:33:47.403762|2017-10-11 03:33:47.403762
NCT01479582|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-06-30|||October 27, 2011||2011-10-27|November 26, 2012|2012-11-26|November 26, 2012|Actual|2012-11-26|November 26, 2012|Actual|2012-11-26||Interventional|||Providing Access to Cord Blood Units for Transplants|A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:33:48.03606|2017-10-11 03:33:48.03606
NCT01479569|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-06-30|||November 8, 2011||2011-11-08|February 17, 2017|2017-02-17|February 17, 2017|Actual|2017-02-17|February 17, 2017|Actual|2017-02-17||Interventional|||Pericardiocentesis With Magnetic Resonance Imaging|Real-time MRI Pericardiocentesis Using Passive Needles|Terminated||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:33:48.11786|2017-10-11 03:33:48.11786
NCT01479556|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2011-11-22|||December 2011||2011-12-01|November 2011|2011-11-01|October 2014|Anticipated|2014-10-01|May 2014|Anticipated|2014-05-01||Interventional|||Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain|Assessment of Pregabalin Efficacy for the Treatment and Prevention of At-level Non-evoked and Evoked Spinal Cord Injury Neuropathic Pain|Unknown status|Not yet recruiting|Phase 4|82|Anticipated|Hospital Nacional de Parapléjicos de Toledo||2|||f||||f||||||||||2017-10-11 03:33:48.196157|2017-10-11 03:33:48.196157
NCT01479543|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2014-09-04|2014-08-19||November 2011||2011-11-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|SETOPROB|The average age was 28 years in all groups. Gender male/female in Probiotic groups 37/43 and placebo groups 9/11. Región of enrollment were Granada, Murcia and Valencia cities placed in southeast of Spain.|Effects of Probiotics in Immune System of Healthy Adults|Colonization, Safety, Tolerance, and Effects of Three Probiotic Strains on the Immune System of Healthy Adults|Completed||N/A|103|Actual|Hero Institute for Infant Nutrition||5|||f||||t||||||||||2017-10-11 03:33:48.313844|2017-10-11 03:33:48.313844
NCT01479530|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-05-23|2014-05-23||December 2011||2011-12-01|May 2014|2014-05-01||||June 2013|Actual|2013-06-01||Interventional|CHORAL||Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China|Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of [Azilect®] Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China|Completed||Phase 3|321|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-10-11 03:33:48.794702|2017-10-11 03:33:48.794702
NCT01479517|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-11-02|2016-11-02|2015-05-15|January 2012||2012-01-01|November 2016|2016-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Open-Label Study of Efficacy and Recommended Dose of Kovacaine Mist for Anesthetizing Maxillary Teeth|A Phase II, Single-Site, Open-Label Clinical Trial To Evaluate The Efficacy And Recommended Dosing Regimen Of Kovacaine Mist Administered Unilaterally For Anesthetizing Maxillary Teeth In Healthy Dental Patients|Completed||Phase 2|30|Actual|St. Renatus, LLC||3|||f||||f||||||||Undecided||2017-10-11 03:33:49.274989|2017-10-11 03:33:49.274989
NCT01479504|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-24|||November 2011||2011-11-01|October 2011|2011-10-01|December 2017|Anticipated|2017-12-01|November 2012|Anticipated|2012-11-01||Interventional|||A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|A Multicenter Trial Evaluating the Efficacy and Safety of Nedaplatin Plus Docetaxel in Neoadjuvant Chemotherapy Followed by Nedaplatin in Concurrent Chemoradiation for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 3|2|Anticipated|Guangxi Medical University||4|||f||||t||||||||||2017-10-11 03:33:49.983135|2017-10-11 03:33:49.983135
NCT01479439|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-10-04|||February 2012||2012-02-01|October 2017|2017-10-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Losartan to Reverse Sickle Nephropathy|A Phase II Trial of Losartan to Reverse Sickle Nephropathy|Completed||Phase 2|36|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 03:33:50.351301|2017-10-11 03:33:50.351301
NCT01479413|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-10|2013-09-10|||August 2009||2009-08-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|July 2012|Actual|2012-07-01||Observational|||Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs|Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs|Completed||N/A|77|Actual|Chang Gung Memorial Hospital|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 03:33:50.532741|2017-10-11 03:33:50.532741
NCT01479400|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-22|||October 2007||2007-10-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Observational|||Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study|Safety Study for Infants Who Exposed to Antipsychotics as Fetus|Completed||N/A|152|Actual|Central South University|||2||f||||t||||||||||2017-10-11 03:33:50.604243|2017-10-11 03:33:50.604243
NCT01479387|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-11-22|||August 2008||2008-08-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|||||Observational|ZEVALIN-SDUI||Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan|Special Drug Use Investigation of Zevalin|Completed||N/A|72|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:33:50.673112|2017-10-11 03:33:50.673112
NCT01479374|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2013-05-28|2013-03-28||January 2012||2012-01-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model|A Multi-Center, Randomized, Double-Masked, Vehicle and Active Controlled, Parallel-Group Efficacy and Safety Study of AL-4943A Ophthalmic Solution, 0.77% in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model|Completed||Phase 3|397|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 03:33:50.768837|2017-10-11 03:33:50.768837
NCT01479361|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-06-30|||October 31, 2011||2011-10-31|June 1, 2016|2016-06-01|February 20, 2014|Actual|2014-02-20|February 20, 2014|Actual|2014-02-20||Interventional|||Antiretroviral Drug Interaction Study in Volunteers With HIV|The Influence of Atazanavir-ritonavir and Efavirenz on Atovaquone Pharmacokinetics in HIV-infected Volunteers|Completed||Phase 1|36|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:33:51.333579|2017-10-11 03:33:51.333579
NCT01479348|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-08-05|||October 28, 2011||2011-10-28|August 4, 2017|2017-08-04|August 4, 2017|Actual|2017-08-04|August 4, 2017|Actual|2017-08-04||Interventional|||Imaging Study for FdCyd and THU Cancer Treatment|Phase 0 Trial of [F-18]-5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine|Completed||Early Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:33:51.432462|2017-10-11 03:33:51.432462
NCT01479322|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-31|2011-11-23|||January 2007||2007-01-01|November 2011|2011-11-01|July 2007|Actual|2007-07-01|||||Observational|||Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome|Correlation Between Hyperghrelinemia and Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome|Completed||N/A|51|Actual|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 03:33:51.539893|2017-10-11 03:33:51.539893
NCT01479309|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-11-23|||September 2006||2006-09-01|November 2011|2011-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study to Evaluate Sodium Stibogluconate With Interferon Alpha-2b|A Phase IIa, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sodium Stibogluconate in Combination With Interferon Alpha-2b for Patients With Advanced Malignancies|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Pharmaceutical sponsor terminated study.|f||||f||||||||||2017-10-11 03:33:51.605115|2017-10-11 03:33:51.605115
NCT01479296|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-12-05|||December 2011||2011-12-01|December 2016|2016-12-01||||May 2013|Actual|2013-05-01||Interventional|||Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults|A Phase 1b Randomized Double-Blind Clinical Trial to Examine Whether Polytopic Administration of VRC rAd5 Gag-pol/Env A/B/C Vaccine Enhances HIV-Specific Cellular Immune Responses in Humans|Active, not recruiting||Phase 1|90|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 03:33:51.703411|2017-10-11 03:33:51.703411
NCT01479283|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-05-23|||January 2013||2013-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|PARITY||Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)|Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center International Randomized Controlled Trial Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections With Endoprosthetic Replacements|Recruiting||Phase 3|600|Anticipated|McMaster University||2|||f||||t||||||||Undecided||2017-10-11 03:33:51.859428|2017-10-11 03:33:51.859428
NCT01479270|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-10-23|||May 2011||2011-05-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|TAP||Transversus Abdominal Plane Block at Total Laparoscopic Hysterectomy: Effect on Quality of Recovery|Randomized Trial of Transversus Abdominal Plane (TAP) Block at Total Laparoscopic Hysterectomy: Effect of Regional Analgesia on Quality of Recovery|Completed||N/A|58|Actual|MetroHealth Medical Center||2|||f||||f||||||||||2017-10-11 03:33:52.12266|2017-10-11 03:33:52.12266
NCT01479257|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-10-12|||January 2012||2012-01-01|October 2016|2016-10-01||||January 2022|Anticipated|2022-01-01||Observational|||Determinants of Multiple Health Risk Behaviors Among Latinos|Determinants of Multiple Health Risk Behaviors Among Latinos|Active, not recruiting||N/A|225|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 03:33:52.213431|2017-10-11 03:33:52.213431
NCT01479244|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2017-02-23|||November 2011||2011-11-01|February 2017|2017-02-01|September 21, 2016|Actual|2016-09-21|September 21, 2016|Actual|2016-09-21||Interventional|PRESENT||Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence|PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer With Low to Intermediate HER2 Expressions With NeuVax™Treatment|Completed||Phase 3|758|Actual|Galena Biopharma, Inc.||2|||f||||t||||||||||2017-10-11 03:33:52.33435|2017-10-11 03:33:52.33435
NCT01479231|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2012-04-18|||March 2012||2012-03-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis|Predictors of PPI Response in Eosinophilic Esophagitis|Withdrawn||Phase 1/Phase 2|0|Actual|Mayo Clinic||1||Souces of funding have been terminated|f||||t||||||||||2017-10-11 03:33:52.97814|2017-10-11 03:33:52.97814
NCT01479218|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2014-10-15|||November 2011||2011-11-01|May 2013|2013-05-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus|Phase 1 Study for Safety and Effectiveness of the New Occlutech PDA Occluder, for Non Surgical Closure of Patent Ductus Arteriosus|Completed||Phase 1|50|Actual|Occlutech International AB||1|||f||||f||||||||||2017-10-11 03:33:53.718156|2017-10-11 03:33:53.718156
NCT01479205|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-11-23|||July 2010||2010-07-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|November 2010|Actual|2010-11-01||Observational|ITASIT||Induction of Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy|Security of the Bronchial Allergen Provocation With Mite and Aspergillus and Predictors for a Positive Reaction.|Completed||N/A|42|Actual|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 03:33:53.812781|2017-10-11 03:33:53.812781
NCT01479192|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-01-21|||December 2009||2009-12-01|December 2015|2015-12-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|||Fenretinide in Healthy Young Women at Genetic and Familial Risk|Breast Cancer Prevention With Fenretinide in Young Women at Genetic and Familil Risk. A Phase III Randomized Clinical Trial|Terminated||Phase 3|20|Actual|European Institute of Oncology||2||very low rate of patient accrual|f||||f||||||||||2017-10-11 03:33:53.906483|2017-10-11 03:33:53.906483
NCT01479179|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2016-10-25|||November 2012||2012-11-01|October 2016|2016-10-01||||November 2015|Anticipated|2015-11-01||Interventional|||Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab|Phase I/II Study of Trastuzumab in Combination With AMG 479, A Fully Human Monoclonal Antibody Against Insulin-Like Growth Factor Type 1 Receptor (IGF-1R), in Patients With HER-2 Overexpressing Metastatic Breast Cancer Progressing on Trastuzumab-Based or Lapatinib-based Therapy|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Drug sponsor decision to discontinue study.|f||||f||||||||||2017-10-11 03:33:54.026461|2017-10-11 03:33:54.026461
NCT01479166|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2014-10-28|||June 2011||2011-06-01|October 2014|2014-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|FRA-MUKO||Bronchial Inflammation of Small Airways in Patients With Cystic Fibrosis|Bronchial Inflammation of Small Airways in Patients With Cystic Fibrosis|Completed||N/A|20|Actual|Johann Wolfgang Goethe University Hospital|||3||f||||f||||||Samples With DNA|"     whole blood, serum and Sputum   "|||2017-10-11 03:33:54.126365|2017-10-11 03:33:54.126365
NCT01479153|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-08-22|||October 2011||2011-10-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|3SITES||Venous Site for Central Catheterization|Comparison of Subclavian, Femoral and Internal Jugular Venous Catheterization in Term of Complications in the Intensive Care Unit: a Randomized Controlled Trial|Completed||N/A|3471|Actual|University Hospital, Caen||3|||f||||f||||||||||2017-10-11 03:33:54.222951|2017-10-11 03:33:54.222951
NCT01479140|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-09-24|||December 2011||2011-12-01|September 2015|2015-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|PRYME||Prevalence and Long-term Impact of Non-atherosclerotic CAD|Prospective Registry of Young Women With MI: Evaluating the Prevalence and Long-term Impact of Non-atherosclerotic CAD (PRYME)|Recruiting||N/A|200|Anticipated|Cardiology Research UBC|||1||f||||f||||||||||2017-10-11 03:33:54.335305|2017-10-11 03:33:54.335305
NCT01479127|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-03-23|2016-02-15||October 2011||2011-10-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||full safety sample|Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease|An Open-Label, Single-Arm, Baseline-Controlled, Multicenter Study to Explore the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease|Completed||Phase 2|8|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 03:33:54.485832|2017-10-11 03:33:54.485832
NCT01479114|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-11-24|||April 2009||2009-04-01|November 2011|2011-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on CD11b in Septic Neonates|In Vivo Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on Neutrophilic Expression of CD11b in Septic Neonates|Completed||Phase 4|90|Actual|Ain Shams University||3|||f||||f||||||||||2017-10-11 03:33:55.927372|2017-10-11 03:33:55.927372
NCT01479101|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2015|Actual|2015-01-01||Observational|NBRST||NBRST: Prospective Neo-adjuvant REGISTRY Trial|"Prospective Neo-adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial (NBRST) (Pronounced in Breast)"|Active, not recruiting||N/A|1142|Actual|Agendia|||1||f||||f||||||Samples With DNA|"     As part of routine breast cancer treatment, the doctor will conduct a core needle biopsy and     provide tissue from the tumor to Agendia for testing. After the diagnostic test(s) from the     Agendia Breast Cancer Suite have been performed on the tumor specimen, there might be some     remaining tissue left.   "|||2017-10-11 03:33:56.01197|2017-10-11 03:33:56.01197
NCT01479088|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2011-11-23|||March 2010||2010-03-01|November 2011|2011-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)|Twelve-month, Multicenter, Intra-subject Controlled (Retrospective-prospective), Open-label, Active-treatment Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Cinacalcet Hydrochloride for the Treatment of Secondary Hyperparathyroidism (SHPT) in Paediatric Subjects With Chronic Kidney Disease (CKD) on Dialysis, Followed by 12-month Study Extension.|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|Istituto Giannina Gaslini||1|||f||||t||||||||||2017-10-11 03:33:56.35386|2017-10-11 03:33:56.35386
NCT01479075|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2017-05-30|||August 2011||2011-08-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Interventional|Centrin||The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism|The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism|Active, not recruiting||Phase 4|30|Anticipated|German Diabetes Center||6|||f||||f||||||||||2017-10-11 03:33:56.510462|2017-10-11 03:33:56.510462
NCT01477424|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-02-14|||November 2011||2011-11-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Drug-Drug Interaction Study of Warfarin and PA21|A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Warfarin in Healthy Male and Female Adults|Completed||Phase 1|45|Actual|Vifor Inc.||3|||f||||f||||||||||2017-10-11 03:35:23.765212|2017-10-11 03:35:23.765212
NCT01479062|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2015-02-05|||February 2014||2014-02-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|October 2015|Anticipated|2015-10-01||Interventional|||Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics|Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics (ALIVE-PD)|Unknown status|Active, not recruiting|N/A|268|Anticipated|Berkeley Analytics, Inc.||2|||f||||f||||||||||2017-10-11 03:33:56.629387|2017-10-11 03:33:56.629387
NCT01479036|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2011-11-21|||October 2011||2011-10-01|November 2011|2011-11-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|CBCRT01||Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer|Phase Ⅲ Trial of Neoadjuvant Recombinant Human Endostatin, Docetaxel and Epirubicin as First-Line Therapy in Patients With Breast Cancer|Unknown status|Recruiting|Phase 3|800|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 03:33:56.802218|2017-10-11 03:33:56.802218
NCT01479023|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2013-12-19|||April 2012||2012-04-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors|A Phase 1 Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors and Determination of Tumor Receptor Occupancy by U3-1287|Terminated||Phase 1|12|Actual|Washington University School of Medicine||7||treatment was not working|f||||f||||||||||2017-10-11 03:33:56.918507|2017-10-11 03:33:56.918507
NCT01479010|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-05-20|2015-05-20||November 2011||2011-11-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Due to the small number of participants, results are not included to protect the privacy of individual participants.|Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension|Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension|Terminated||Phase 1/Phase 2|2|Actual|Virginia Commonwealth University||1||recruitment issues, critical investigators left institution|f||||t||||||||||2017-10-11 03:33:57.468738|2017-10-11 03:33:57.468738
NCT01478997|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2012-05-15|||August 2011||2011-08-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|Flexsure||A Study for Moderate Osteoarthritis of the Knee|A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi-Centric Study to Determine Whether Flexsure is Safe, Tolerable and Effective in Relieving Symptoms of Moderate Osteoarthritis of the Knee|Completed||Phase 1/Phase 2|76|Actual|Vedic Lifesciences Pvt. Ltd.||2|||f||||f||||||||||2017-10-11 03:33:57.647687|2017-10-11 03:33:57.647687
NCT01478984|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2011-11-21|||October 2011||2011-10-01|November 2011|2011-11-01||||October 2011|Actual|2011-10-01||Interventional|SMILE||Impact of Different Treatment in Multivessel Non ST Elevation Myocardial Infarction (NSTEMI) Patients: One Stage Versus Multistaged Percutaneous Coronary Intervention (PCI)|Impact of One Stage Compared With Multistaged PCI Complete Revascularization on Clinical Outcome in Multivessel NSTEMI Patients. Smile Trial|Unknown status|Recruiting|Phase 3|247|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-10-11 03:33:57.744151|2017-10-11 03:33:57.744151
NCT01478971|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-22|2016-09-16|2014-02-06||October 2011||2011-10-01|September 2016|2016-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|DIAMOND||Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis|A Phase 3b Single-Arm, Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis|Completed||Phase 3|184|Actual|Takeda||1|||f||||f||||||||||2017-10-11 03:33:57.862577|2017-10-11 03:33:57.862577
NCT01478958|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2014-06-12|2014-05-13||May 2010||2010-05-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|DIVAS||Dietary Intervention and Vascular Function|The Effects of the Substitution of Dietary SFA With n-6 PUFA or MUFA on Vascular Function|Completed||N/A|202|Actual|University of Reading||3|||f||||t||||||||||2017-10-11 03:33:59.384127|2017-10-11 03:33:59.384127
NCT01478945|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2013-08-22|||February 2012||2012-02-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|September 2012|Actual|2012-09-01||Interventional|HI-Light||HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home|Pilot Randomised Controlled Trial of Hand Held NB-UVB for the Treatment of Focal or Early Vitiligo at Home|Completed||N/A|29|Actual|University of Nottingham||3|||f||||f||||||||||2017-10-11 03:33:59.843841|2017-10-11 03:33:59.843841
NCT01478932|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2014-01-07|||December 2011||2011-12-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes|Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes|Unknown status|Recruiting|N/A|50|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-11 03:33:59.947344|2017-10-11 03:33:59.947344
NCT01478919|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-09-19|||January 2010||2010-01-01|September 2013|2013-09-01|November 2011|Actual|2011-11-01|December 2010|Actual|2010-12-01||Observational|||Risk Factors for Residual Neoplasia After Endoscopic Mucosal Resection|Risk Factors for Local Residual Neoplasia After Convetional Endoscopic Mucosal Resection of Laterally Spreading Tumors|Completed||N/A|127|Actual|Vitkovice Hospital|||1||f||||f||||||||||2017-10-11 03:34:00.062479|2017-10-11 03:34:00.062479
NCT01478906|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-05-13|||July 2011||2011-07-01|May 2012|2012-05-01|September 2012|Anticipated|2012-09-01|June 2012|Anticipated|2012-06-01||Observational|||Difference of Plasma Orexin A Levels Between Elderly and Young Patients at Emergence|To Investigate Difference of Plasma Orexin A Levels Between Elderly and Youth Patients at Emergence From Sevoflurane-fentanyl Anesthesia Undergoing Elective Lumbar Surgery|Unknown status|Recruiting|N/A|40|Anticipated|Xijing Hospital|||1||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 03:34:00.129056|2017-10-11 03:34:00.129056
NCT01478893|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2016-01-05|||November 2011||2011-11-01|January 2016|2016-01-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers|A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Pharmacodynamics of Increasing Subcutaneous Doses of SEL-068 in Healthy Non-Smoker and Smoker Adults|Completed||Phase 1|82|Actual|Selecta Biosciences, Inc.||2|||f||||||||||||||2017-10-11 03:34:00.204162|2017-10-11 03:34:00.204162
NCT01478880|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-07-13|||May 2011||2011-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|TBS-H||Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations|Efficacy and Safety of Bilateral Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation) for the Treatment of Auditory Hallucinations|Completed||Phase 2|16|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-10-11 03:34:00.281384|2017-10-11 03:34:00.281384
NCT01478867|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-11-23|||April 2011||2011-04-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|||||Observational|CELIQK2||Detection of Immunotoxic Gluten Peptides in Feces|Phase 0 Monitoring of Gluten-free Diet Compliance in Celiac Patients by Assessment of Gliadin 33-mer Equivalent Epitopes in Feces|Completed||N/A|53|Actual|University of Seville|||1||f||||f||||||Samples Without DNA|"     Fecal samples   "|||2017-10-11 03:34:59.80785|2017-10-11 03:34:59.80785
NCT01478854|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-10-05|||May 2011||2011-05-01|October 2017|2017-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide|A Prospective Trial of Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Glioblastoma Multiforme|Active, not recruiting||N/A|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:34:59.906398|2017-10-11 03:34:59.906398
NCT01478841|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-02-10|||October 2008||2008-10-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|July 2010|Actual|2010-07-01||Interventional|POLYOXRESIST||Polyphenols and Insulin Resistance|INFLUENCE OF POLYPHENOLS ON OXIDATIVE STRESS IN HEALTHY INDIVIDUALS WITH HIGH METABOLISM RISK: RELATIONSHIP WITH THE MECHANISMS OF INSULIN RESISTANCE|Completed||N/A|44|Actual|University Hospital, Montpellier||2|||f||||t||||||||||2017-10-11 03:34:59.983608|2017-10-11 03:34:59.983608
NCT01478828|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-10-13|2015-01-13||March 2012||2012-03-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|April 2013|Actual|2013-04-01||Interventional|||Pre-Prostatectomy Lovastatin on Prostate Cancer|Pharmacodynamic Trial of Pre-Prostatectomy Lovastatin on MYC (V-myc Myelocytomatosis Viral Oncogene Homolog) Down-Regulation in Localized Prostate Cancer|Suspended||N/A|2|Actual|Sidney Kimmel Comprehensive Cancer Center||1||The study was stopped due to an unanticipated serious adverse event.|f||||t||||||||||2017-10-11 03:35:00.088667|2017-10-11 03:35:00.088667
NCT01478815|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-01-15|||December 2011||2011-12-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Contingency Management for Persons With Severe Mental Illness|Contingency Management for Persons With Severe Mental Illness|Completed||Phase 2|19|Actual|UConn Health||2|||f||||t||||||||||2017-10-11 03:35:00.282537|2017-10-11 03:35:00.282537
NCT01478802|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2015-04-26|||November 2011||2011-11-01|April 2015|2015-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||High Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome (ARDS)|Effect of Intermittent High Frequency Oscillatory Ventilation on the Pathophysiology and Survival of Patients With the Acute Respiratory Distress Syndrome.|Terminated||Phase 2/Phase 3|42|Actual|University of Athens||2||Low rate of enrollment, in conjunction with inability of continuation of funding|f||||t||||||||||2017-10-11 03:35:00.373359|2017-10-11 03:35:00.373359
NCT01478789|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2011-12-20|||September 2010||2010-09-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy of Plant Sterol-Fortified Dairy Product on Plasma Lipid and Plant Sterol Concentrations in Humans|Naturalis Clinical Trial for a Novel Phytosterol Formulation|Completed||N/A|47|Actual|University of Manitoba||3|||f||||t||||||||||2017-10-11 03:35:00.539718|2017-10-11 03:35:00.539718
NCT01478763|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-09-24|||January 2011||2011-01-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Vitrous Analysis in Proliferative Diabetic Retinopathy|Analysis of Vitreous Proteins in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy|Completed||N/A|200|Actual|St. Erik Eye Hospital|||1||f||||f||||||Samples With DNA|"     Vitreous samples   "|||2017-10-11 03:35:01.115264|2017-10-11 03:35:01.115264
NCT01478750|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-10-24|||December 2009||2009-12-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Oro-gastro-intestinal Digestion of Emulsified Fat|Oro-gastro-intestinal Digestion of Emulsified Fat and How This Digestion Relates to Colloidal Stability and Physiological Responses|Completed||N/A|15|Actual|Maastricht University Medical Center||4|||f||||f||||||||||2017-10-11 03:35:01.212162|2017-10-11 03:35:01.212162
NCT01478737|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-09-24|||November 2011||2011-11-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy|A Prospective, Randomized Study on Intravitreal Ozurdex for Preventing Recurrent Vitreous Hemorrhage Following Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy|Unknown status|Recruiting|Phase 2|100|Anticipated|St. Erik Eye Hospital||2|||f||||f||||||||||2017-10-11 03:35:01.317471|2017-10-11 03:35:01.317471
NCT01478724|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2015-05-22|||November 2011||2011-11-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Effects of Proteins Fraction Derived From Milk on Osteoporosis Prevention|Effects of Proteins Fraction Derived From Milk on Bone Mineral Density and Bone Metabolism in Healthy Postmenopausal Women|Completed||Phase 1|291|Actual|Soredab||3|||f||||t||||||||||2017-10-11 03:35:01.450297|2017-10-11 03:35:01.450297
NCT01478711|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-02-25|||September 2009||2009-09-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|PreemieCDS||Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants|Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants|Completed||N/A|1517|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 03:35:01.55785|2017-10-11 03:35:01.55785
NCT01478685|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2016-03-23|||November 2011||2011-11-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors|A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors|Completed||Phase 1|169|Actual|Celgene Corporation||3|||f||||f||||||||||2017-10-11 03:35:01.73919|2017-10-11 03:35:01.73919
NCT01478672|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2011-11-21|||March 2011||2011-03-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Medium Term Health Coaching and Life-long Monitoring in Cardiovascular Disease in Norrbotten|Medium Term Health Coaching and Life-long Monitoring in Cardiovascular Disease in Norrbotten|Completed||N/A|741|Actual|Luleå Tekniska Universitet||2|||f||||t||||||||||2017-10-11 03:35:01.88959|2017-10-11 03:35:01.88959
NCT01478659|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-12-12|||August 2011||2011-08-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|FIB||The Effect of Fiber Snack Foods on Dietary Intake in Healthy Adults|The Effect of Fiber Snack Foods on Dietary Intake in Healthy Adults|Completed||N/A|97|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 03:35:02.005697|2017-10-11 03:35:02.005697
NCT01478646|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2011-11-22|||August 2011||2011-08-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV|The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea and Activity in Patients With COPD III-IV|Completed||N/A|24|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 03:35:02.105764|2017-10-11 03:35:02.105764
NCT01478633|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-03-24|||September 2011||2011-09-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil|Evaluation of Efficacy and Safety of Galantamine in Subjects With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil|Completed||Phase 4|102|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 03:35:02.197783|2017-10-11 03:35:02.197783
NCT01478620|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-10-10|2014-08-27||October 2011||2011-10-01|October 2014|2014-10-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)|An Open-label, Non-randomized, Multicenter, Interventional Study to Investigate the Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)|Completed||Phase 3|125|Actual|Bionorica SE||1|||f||||||||||||||2017-10-11 03:35:02.314749|2017-10-11 03:35:02.314749
NCT01478607|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2015-10-12|||November 2011||2011-11-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PACE||A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients|A Randomized, Controlled, Long-term Safety Study Evaluating the Effect of Repeated Applications of QUTENZATM Plus Standard of Care Versus Standard of Care Alone in Subjects With Painful Diabetic Peripheral Neuropathy|Completed||Phase 3|468|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 03:35:02.557191|2017-10-11 03:35:02.557191
NCT01478594|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2015-06-09|2015-02-19||December 2011||2011-12-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|September 2013|Actual|2013-09-01||Interventional|||A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy|A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects|Completed||Phase 2|265|Actual|AVEO Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:35:03.027896|2017-10-11 03:35:03.027896
NCT01478581|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-05-19|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma|A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase (Btk) Inhibitor, PCI-32765, in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma|Active, not recruiting||Phase 2|92|Actual|Pharmacyclics LLC.||4|||f||||f||||||||||2017-10-11 03:35:05.605355|2017-10-11 03:35:05.605355
NCT01478568|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-04-08|||October 2008||2008-10-01|July 2013|2013-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together|An Open-label, One-sequence Crossover Study to Evaluate the Effect of Multiple Doses of YM178 on the Pharmacokinetics of the CYP2D6 Substrate Desipramine in Healthy Subjects|Completed||Phase 1|28|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:35:05.892361|2017-10-11 03:35:05.892361
NCT01478555|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-08-28|||January 2018|Anticipated|2018-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|July 2018|Anticipated|2018-07-01||Interventional|ISV-101||A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease|A Dose-Finding Study To Compare The Safety, Tolerability, And Efficacy Of Differing Dosing Regimens Of ISV-101 (Bromfenac In DuraSite® Ophthalmic Solution) To Vehicle And DuraSite Alone In Dry Eye Disease Volunteers|Withdrawn||Phase 2|0|Actual|InSite Vision||5||Project postponed|f||||f|t|f||||||||2017-10-11 03:35:06.008088|2017-10-11 03:35:06.008088
NCT01478542|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-10-02|||November 2011||2011-11-01|October 2015|2015-10-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|OPTIMAL>60||OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine|Improvement of Outcome and Reduction of Toxicity in Elderly Patients With CD20+ Aggressive B-Cell Lymphoma by an Optimised Schedule of the Monoclonal Antibody Rituximab, Substitution of Conventional by Liposomal Vincristine, and FDG-PET Based Reduction of Therapy in Combination With Vitamin D Substitution|Recruiting||Phase 3|1152|Anticipated|University Hospital, Saarland||6|||f||||t||||||||||2017-10-11 03:35:06.119733|2017-10-11 03:35:06.119733
NCT01478529|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-06-25|||February 2006||2006-02-01|June 2013|2013-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation|A Single Dose, Open Label, Randomized, Two-period Cross Over Study in Healthy Male Subjects to Assess the Absolute Bioavailability of YM178 OCAS-M Formulation|Completed||Phase 1|12|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 03:35:06.633353|2017-10-11 03:35:06.633353
NCT01478516|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2011-12-01|||November 2011||2011-11-01|December 2011|2011-12-01|November 2013|Anticipated|2013-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy|Autologous Intravitreal Plasmin and Fibrinolytic System of Vitreous in Patient With Macular Edema|Unknown status|Recruiting|N/A|40|Anticipated|Hallym University Medical Center||1|||f||||t||||||||||2017-10-11 03:35:06.781225|2017-10-11 03:35:06.781225
NCT01478503|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-07-01|||May 2005||2005-05-01|July 2013|2013-07-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females|Double-blind, Randomized, Placebo-controlled, Dose-escalating, Exploratory Study to Investigate the Pharmacokinetics, Safety and Tolerability of Multiple Doses of YM178 OCAS-M in Healthy Young Male and Female Subjects and Healthy Elderly Male and Female Subjects|Completed||Phase 1|96|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 03:35:06.889165|2017-10-11 03:35:06.889165
NCT01478490|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2014-04-08|||September 2002||2002-09-01|November 2011|2011-11-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol|An Open Label, One-sequence, Parallel Study to Compare the Single Dose Pharmacokinetics of YM178 in Healthy Poor or Extensive Metabolisers for CYP2D6 and to Assess the Effect of Multiple Doses of YM178 on the Metabolism of the Model Substrate Metoprolol|Completed||Phase 1|28|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 03:35:07.004765|2017-10-11 03:35:07.004765
NCT01478477|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-08-07|||October 4, 2011|Actual|2011-10-04|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|January 9, 2014|Actual|2014-01-09||Interventional|||Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole|Prevention of Aromatase Inhibitor-Induced Joint Symptoms With Omega 3 Fatty Acid Supplementation: a Randomized Placebo Controlled Pilot Study|Active, not recruiting||N/A|40|Anticipated|Ohio State University Comprehensive Cancer Center||6|||f||||t||||||||||2017-10-11 03:35:07.142664|2017-10-11 03:35:07.142664
NCT01478464|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-06-27|||December 2011||2011-12-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|IRMA||Effect of Massage on Hamstring Muscle Soreness|Danish: Integreret Motion på Arbejdspladsen (IRMA) English: Implementation of Exercise at the Workplace|Completed||N/A|22|Actual|National Research Centre for the Working Environment, Denmark||2|||f||||f||||||||||2017-10-11 03:35:07.29746|2017-10-11 03:35:07.29746
NCT01478451|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2012-02-27|||November 2011||2011-11-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Acute Effect of Massage and Exercise on Muscle Tenderness|Danish: Integreret Motion på Arbejdspladsen (IRMA) English: Implementation of Exercise at the Workplace|Completed||N/A|20|Actual|National Research Centre for the Working Environment, Denmark||3|||f||||f||||||||||2017-10-11 03:35:07.388393|2017-10-11 03:35:07.388393
NCT01478438|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-09-12|||April 2012||2012-04-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2015|Actual|2015-12-01||Interventional|||"A Multicenter Ablate and Resect Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers"|"A Multicenter Ablate and Resect Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers"|Active, not recruiting||N/A|60|Anticipated|Novian Health Inc.||1|||f||||||||||||||2017-10-11 03:35:07.47981|2017-10-11 03:35:07.47981
NCT01478425|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-11-28|||March 2011||2011-03-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen|Study on the Efficacy and Tolerability of a Topical Microemulsion in Patients With Intermittent or Persistent Allergic Rhinitis Due to Sensitization to Birch, Olive Tree or Grass Pollen|Completed||Phase 4|110|Actual|Reig Jofre Group||2|||f||||t||||||||||2017-10-11 03:35:07.634334|2017-10-11 03:35:07.634334
NCT01478412|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-12-06|||December 2011||2011-12-01|December 2011|2011-12-01||||||||Observational|Clarity||An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer|A Prospective Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer|Unknown status|Recruiting|N/A|20|Anticipated|ProCure Proton Therapy Center|||1||f||||f||||||||||2017-10-11 03:35:07.75656|2017-10-11 03:35:07.75656
NCT01478399|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-04-12|||December 2011||2011-12-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function|Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function|Completed||Phase 1|16|Actual|PhaseBio Pharmaceuticals Inc.||2|||f||||t||||||||||2017-10-11 03:35:07.850793|2017-10-11 03:35:07.850793
NCT01478386|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-07-22|||December 2011||2011-12-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effectiveness of a Knee Brace When Combined With Viscosupplementation in the Treatment of Knee Osteoarthritis|Randomized Trail to Assess the Effectiveness of an Off-Loading Knee Brace When Combined With Viscosupplementation in the Treatment of Knee Osteoarthritis|Terminated||N/A|11|Actual|OAD Orthopaedics||3||The study was terminated due to poor enrollment|f||||f||||||||||2017-10-11 03:35:07.927856|2017-10-11 03:35:07.927856
NCT01478373|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-04-26|2015-07-14||January 2012||2012-01-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Full Analysis Set - All subjects with histologically confirmed diagnosis of GIST who received at least one dose of study drug.|Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib|DOVIGIST: Phase II Trial to Evaluate the Efficacy and Safety of Dovitinib (TKI258) in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib|Completed||Phase 2|39|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:35:08.03963|2017-10-11 03:35:08.03963
NCT01478191|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2013-03-05|||May 2010||2010-05-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|||||Observational|IIL-ProHLRec||Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT|Prognosis of Patients With Relapsed/Refractory Hl Treated With Combination of Ifosfamide, Gemcitabine and Vinorelbine(IGEV) Induction Therapy Before High-dose Chemotherapy (HDCT) With Autologous Hematopoietic Stem Cells Transplantation (AHSCT)|Completed||N/A|495|Anticipated|Fondazione Italiana Linfomi ONLUS|||1||f||||f||||||||||2017-10-11 03:35:10.555908|2017-10-11 03:35:10.555908
NCT01478360|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-10-20|2015-10-20||March 2012||2012-03-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma|A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists.|Terminated||Phase 2|46|Actual|Novartis||2||"Further investigations would require changes in study design; the use of different endpoints, a   different IL-17 antibody or a different patient population."|f||||||||||||||2017-10-11 03:35:08.614988|2017-10-11 03:35:08.614988
NCT01478347|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2015-03-06|2015-02-20||May 2013||2013-05-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|March 2014|Actual|2014-03-01||Interventional||Healthy adults (≥18 to ≤65 years), at high risk for meningococcal B disease due to routine occupational exposure to N. Meningitidis cultures, were administered two injections of rMenB + OMV NZ vaccine, 2 months apart in part I (Visit 1-Visit 3). In part II (Visit 4-Visit 7), subjects were re-enrolled for optional blood draws and safety follow-up.|A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults|A Phase 3b, Single-Center, Open-label Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-risk Adults|Completed||Phase 3|18|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:35:09.035665|2017-10-11 03:35:09.035665
NCT01478334|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-05-28|||March 2011||2011-03-01|May 2015|2015-05-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|||Exercise-induced Improvements of Inflammatory Status in Patients With Rheumatoid Arthritis|Exercise-induced Improvements of Inflammatory Status in Patients With Rheumatoid Arthritis - Improvements of Cardiovascular Risk Factors and Quality of Life|Completed||N/A|18|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 03:35:09.227137|2017-10-11 03:35:09.227137
NCT01478321|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-03-28|||November 2011||2011-11-01|March 2017|2017-03-01|November 2019|Anticipated|2019-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas|A Phase II Study of the Efficacy of Hypofractionated Radiation Therapy With Bevacizumab and Temozolomide Followed by Maintenance Temozolomide and Bevacizumab for Recurrent High-Grade Gliomas|Active, not recruiting||Phase 2|63|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 03:35:09.329592|2017-10-11 03:35:09.329592
NCT01478308|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2013-03-05|||June 2011||2011-06-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer|Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer|Withdrawn||Phase 2|0|Actual|New Mexico Cancer Care Alliance||1||No accrual in initial period, PI decided to close study.|f||||t||||||||||2017-10-11 03:35:09.45202|2017-10-11 03:35:09.45202
NCT01478295|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-02-10|||June 2013||2013-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CuidaCare||Effectiveness of Nursing Intervention on Caregivers|Effectiveness of Nursing Intervention on Quality of Life of Older Caregivers: Clinical Trial Randomised by Clusters|Completed||N/A|266|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||t||||||||||2017-10-11 03:35:09.536245|2017-10-11 03:35:09.536245
NCT01478269|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-11-22|||May 2009||2009-05-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|ProDLBCL||Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen|Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen (ProDLBCL)|Completed||N/A|1927|Actual|Fondazione Italiana Linfomi ONLUS|||1||f||||f||||||||||2017-10-11 03:35:09.758882|2017-10-11 03:35:09.758882
NCT01478256|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2013-11-20|2013-04-09||August 2011||2011-08-01|November 2013|2013-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis|A Comparative Study in the Clinical and Microbial Efficacy of Topical Besifloxocin Ophthalmic Suspension 0.6% With Erythromycin Ophthalmic Ointment 0.5% BID for the Management of Acute Blepharitis|Completed||Phase 4|30|Actual|John, George, M.D.||2|||f||||f||||||||||2017-10-11 03:35:09.90681|2017-10-11 03:35:09.90681
NCT01478243|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2016-10-17|||September 2012||2012-09-01|October 2016|2016-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Study of Psycho-Social Impact of Keloid|Study of Psycho-Social Impact of Keloid|Terminated||N/A|1000|Anticipated|Tirgan, Michael H., M.D.|||1|Lack of institutional support and IRB related issues.|f||||f||||||||||2017-10-11 03:35:10.242351|2017-10-11 03:35:10.242351
NCT01478230|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-07-06|||November 2011||2011-11-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||An Exploratory Study Comparing Two Nicotine Inhalers|A Proof of Concept With a New Nicotine Inhaler in Comparison With Nicotine Inhaler 10 mg|Completed||Early Phase 1|36|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 03:35:10.311355|2017-10-11 03:35:10.311355
NCT01478217|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2011-11-22|||October 2009||2009-10-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||PEEP Recruitment-comparison Between Ultrasonographic Assessment and LIP Assessment|Positive End-expiratory Pressure Induced Lung Recruitment -Comparison Between Ultrasonographic Assessment and Lower Inflection Point Assessment on the Pressure -Volume Loop|Completed||N/A|17|Actual|Sisters of Mercy University Hospital|||1||f||||f||||||||||2017-10-11 03:35:10.410181|2017-10-11 03:35:10.410181
NCT01478204|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-10-30|||June 2008||2008-06-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease|An Observational Epidemiological Study on Evaluation of Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease in Clinical Practice|Completed||Phase 4|925|Actual|Janssen-Cilag, S.A.|||1||f||||f||||||||||2017-10-11 03:35:10.486034|2017-10-11 03:35:10.486034
NCT01478178|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-01-19||2017-01-10|October 2011||2011-10-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|December 2015|Actual|2015-12-01||Interventional|||Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma|Open-label, Single Arm, Safety and Tolerability Dose Escalation Study of VAL-083 in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|55|Actual|DelMar Pharmaceuticals, Inc.||1|||f||||f||||||||No|The Clinical Study Report for this trial will be prepared and provided to U.S. F.D.A. as required by applicable regulatory requirement(s). Each participating trial investigator has been provided a copy their patient data captured in the electronic data base for this trial.|2017-10-11 03:35:10.703681|2017-10-11 03:35:10.703681
NCT01478165|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2011-11-22|||September 2011||2011-09-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting|Comparative Study of TIVA(Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing PONV(Postoperative Nausea and Vomiting)|Completed||N/A|100|Actual|Incheon St.Mary's Hospital||2|||f||||t||||||||||2017-10-11 03:35:10.81558|2017-10-11 03:35:10.81558
NCT01478152|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2011-11-21|||September 2009||2009-09-01|November 2011|2011-11-01|February 2010|Actual|2010-02-01|||||Interventional|||Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma|A Single Center, Dose Finding, Safety, and Feasibility Study to Investigate the Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma|Completed||Phase 2|18|Actual|Bitop AG||1|||f||||f||||||||||2017-10-11 03:35:10.894823|2017-10-11 03:35:10.894823
NCT01478139|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2013-11-26|||February 2011||2011-02-01|November 2013|2013-11-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|LIFT-plug||Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug Procedure for Anal Fistula Repair|Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug Procedure for Anal Fistula Repair: a Multicenter, Randomized, Open-label, Parallel Controlled Trial|Unknown status|Recruiting|Phase 3|240|Anticipated|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-10-11 03:35:10.979494|2017-10-11 03:35:10.979494
NCT01478126|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2013-10-30|||January 2012||2012-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass|Prospective Randomized Study of Glutamin Protective Properties in Cardiac Surgery.|Completed||Phase 3|24|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||f||||||||||2017-10-11 03:35:11.094478|2017-10-11 03:35:11.094478
NCT01478113|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-03-16|2017-01-17||February 2012||2012-02-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Interventional|||Stimulant Enhancement of Well-Being Therapy for Depression|Stimulant Enhancement of Well-Being Therapy for Depression|Terminated||N/A|5|Actual|Massachusetts General Hospital|This study was shut down due to original PI leaving the institution and due to lack of continued funding. As such, we were not able to enroll a sufficient number of patients to analyze data/answer study hypothesis/achieve study aims.|2||PI left the institution and was no funding to continue study.|f||||f||||||||No|No plan to make IPD available.|2017-10-11 03:35:11.192115|2017-10-11 03:35:11.192115
NCT01478100|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2011-11-22|||October 2011||2011-10-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Virtual Coronary Intervention and Non-invasive Fractional Flow Reserve (FFR)||Completed||N/A|20|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 03:35:11.552671|2017-10-11 03:35:11.552671
NCT01478087|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2013-02-12|2013-01-08||November 2011||2011-11-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)|Pilot Study of Immunoadsorption Therapy for Patients With Chronic Non-Ischemic Dilated Cardiomyopathy|Terminated||N/A|2|Actual|Asahi Kasei Medical Co., Ltd.||1||Sponsor terminated due to business reasons|f||||t||||||||||2017-10-11 03:35:11.616131|2017-10-11 03:35:11.616131
NCT01478074|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-01-02|||November 2011||2011-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia|A Single-center Open-label Phase I Study of ALT-801 for ex Vivo Maturation and in Vivo Retargeting of Haploidentical Natural Killer Cells Delivered Following Fludarabine, Cytarabine, and G-CSF in Patients With Relapsed/Refractory Acute Myeloid Leukemia|Withdrawn||Phase 1|0|Actual|Altor BioScience||1||"The treatment planned was determined to be of low feasibility as no subject was found eligible   and able to enroll after screening over 30 subjects"|f||||||||||||||2017-10-11 03:35:11.814222|2017-10-11 03:35:11.814222
NCT01478061|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-07-20|||April 2009||2009-04-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|January 2013|Actual|2013-01-01||Interventional|||Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device|Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device|Completed||Phase 4|115|Actual|Cardica, Inc||1|||f||||f||||||||||2017-10-11 03:35:11.933267|2017-10-11 03:35:11.933267
NCT01478048|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-09-01|2015-12-17|2015-09-23|November 30, 2011|Actual|2011-11-30|September 2017|2017-09-01|April 21, 2017|Actual|2017-04-21|May 30, 2014|Actual|2014-05-30||Interventional||All enrolled participants who were randomized to a treatment arm were summarized.|Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma|A Phase 2, Randomized Study of Bortezomib/Dexamethasone With or Without Elotuzumab in Subjects With Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|185|Actual|Bristol-Myers Squibb||2|||f||||t|t|f||||||||2017-10-11 03:35:12.145479|2017-10-11 03:35:12.145479
NCT01478035|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-21|2012-12-19|||November 2011||2011-11-01|December 2012|2012-12-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.|Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old. A Multi-center Comparative Randomized Double-blind and Placebo-controlled Clinical Trial|Unknown status|Recruiting|Phase 4|122|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 03:35:13.405884|2017-10-11 03:35:13.405884
NCT01478022|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-11-22|||October 2011||2011-10-01|November 2011|2011-11-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|ISOFEN1||To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20|Open, Randomized, 3 Period Cross-over Design, in Healthy Volunteers to Compare the Pharmacokinetics Profiles of 3 Treatments: ISO 20, IBU 200 and IBU Plus ISO Combinations (200 + 20) Administered Per os as Single Doses|Unknown status|Recruiting|Phase 1|12|Anticipated|Parent Project, Italy||3|||f||||t||||||||||2017-10-11 03:35:13.530395|2017-10-11 03:35:13.530395
NCT01478009|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-11-26|2012-07-02||November 2010||2010-11-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy of an Extract of Concentrated Korean Red Ginseng for Preventing Upper Respiratory Tract Infections|A Placebo-Controlled Trial of Korean Red Ginseng Extract to Prevent Acute Respiratory Illness in Healthy Subjects|Completed||Phase 2/Phase 3|100|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 03:35:13.635007|2017-10-11 03:35:13.635007
NCT01477996|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-01-24|||August 2011||2011-08-01|November 2011|2011-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pain After Intravitreal Therapy||Completed||N/A|200|Actual|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||2|||f||||f||||||||||2017-10-11 03:35:13.926005|2017-10-11 03:35:13.926005
NCT01477983|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-12|2017-08-15|||November 2011||2011-11-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Interventional|KPAF||Kansai Plus Atrial Fibrillation Trial|Kansai Plus Atrial Fibrillation Trial; UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate Trial; Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation Trial|Completed||Phase 4|2113|Actual|Kyoto University, Graduate School of Medicine||4|||f||||t||||||||||2017-10-11 03:35:14.018638|2017-10-11 03:35:14.018638
NCT01477970|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-11-23|||February 2009||2009-02-01|November 2011|2011-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS||Completed||N/A|38|Actual|Iakentro Fertility Centre|||1||f||||f||||||||||2017-10-11 03:35:14.145807|2017-10-11 03:35:14.145807
NCT01477957|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2017-09-13|||September 2012||2012-09-01|September 2017|2017-09-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|Bariatrix||The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism|Assessment of the Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism|Recruiting||N/A|250|Anticipated|German Diabetes Center||1|||f||||f||||||||||2017-10-11 03:35:14.198078|2017-10-11 03:35:14.198078
NCT01477944|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2012-02-20|||February 2012||2012-02-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Pattern of Statins Use in Catalonia|Pattern of Statins Use in Catalonia|Completed||N/A|180723|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:35:14.294144|2017-10-11 03:35:14.294144
NCT01477931|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-22|||November 2010||2010-11-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|WellbutrinXL||Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features|An Open-Label, 8-week Trial of Bupropion Hydrochloride Extended Release (Wellbutrin XL®) In Patients With Major Depressive Disorder (MDD) With Atypical Features.|Completed||Phase 4|50|Actual|The Catholic University of Korea||1|||f||||f||||||||||2017-10-11 03:35:14.365195|2017-10-11 03:35:14.365195
NCT01477918|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-20|2011-11-22|||December 2011||2011-12-01|November 2011|2011-11-01||||||||Observational|||Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea||Unknown status|Not yet recruiting|N/A|1000|Anticipated|Asan Medical Center|||1||f||||f||||||||||2017-10-11 03:35:14.45963|2017-10-11 03:35:14.45963
NCT01477905|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-11-22|||March 2011||2011-03-01|November 2011|2011-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Impact of Priming the Infusion System on the Performance of Target-controlled Infusion of Remifentanil|Study of Proper Operation of the Syringe Pump Used in Priming of the Syringe|Completed||N/A|48|Actual|Ajou University School of Medicine||2|||f||||f||||||||||2017-10-11 03:35:14.524239|2017-10-11 03:35:14.524239
NCT01477892|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2013-09-11|2013-04-12||December 2011||2011-12-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Evaluation of Safety and Efficacy of Remifentanil in Pediatric Population|Evaluation of Safety and Efficacy of Remifentanil in Preterm Infant|Completed||Phase 1/Phase 2|14|Actual|Seoul National University Hospital|relatively small numbers of subjects|2|||f||||t||||||||||2017-10-11 03:35:14.612049|2017-10-11 03:35:14.612049
NCT01477879|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-19|||January 2011||2011-01-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Hsv 1 and 2 Gowey Protocol Versus Placebo|Phase II Clinical Trial of Versabase/Sarracenia Purpurea Versus Placebo|Completed||Phase 1/Phase 2|33|Actual|Naturopaths International||2|||f||||f||||||||||2017-10-11 03:35:14.888143|2017-10-11 03:35:14.888143
NCT01477866|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2012-10-25|||January 2012||2012-01-01|October 2012|2012-10-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|CITOGENEX PA||Utility Of Citogenex Administration In Patients With Colon-Rectal Cancer|Utility Of Citogenex Administration In Patients With Colon-Rectal Cancer|Suspended||N/A|250|Anticipated|University of Palermo||2||because Study Chair and Director have not yet submitted it to Ethic Committee|f||||f||||||||||2017-10-11 03:35:14.971858|2017-10-11 03:35:14.971858
NCT01477853|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-19|2017-05-25|2016-06-21||October 24, 2011|Actual|2011-10-24|May 2017|2017-05-01|December 4, 2012|Actual|2012-12-04|December 4, 2012|Actual|2012-12-04||Interventional|||A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)|A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Co-administration of Sitagliptin and Atorvastatin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy|Terminated||Phase 3|166|Actual|Merck Sharp & Dohme Corp.|The study was terminated early by the Sponsor for business reasons. Due to the small number of participants included in the FAS, the results for Phase A and for the overall study should be interpreted with caution.|3||The study was terminated early by the Sponsor for business reasons.|f||||f||||||||||2017-10-11 03:35:15.102052|2017-10-11 03:35:15.102052
NCT01477840|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2011-12-12|||August 2012||2012-08-01|December 2011|2011-12-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at Cesarean|Phase 2-3 Study of Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Blood Loss at Cesarean Deliveries|Unknown status|Not yet recruiting|Phase 2/Phase 3|180|Anticipated|Kermanshah University of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:35:15.602454|2017-10-11 03:35:15.602454
NCT01477827|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-01-14|||June 2010||2010-06-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Sunlight Exposure and Vitamin D in Children|Sunlight Exposure and Vitamin D Status of Children in the UK|Completed||N/A|125|Actual|University of Manchester|||1||f||||f||||||||||2017-10-11 03:35:15.704592|2017-10-11 03:35:15.704592
NCT01475370|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-10-13|||November 2011||2011-11-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)||Active, not recruiting||Phase 1|18|Anticipated|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 03:36:02.530453|2017-10-11 03:36:02.530453
NCT01477814|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-04-20|||July 2008||2008-07-01|April 2017|2017-04-01|July 16, 2015|Actual|2015-07-16|April 27, 2010|Actual|2010-04-27||Interventional|||Interventions to Improve Colon Cancer Screening in Poor Rural Iowa Counties|Randomized Clinical Trial to Improve Colon Cancer Screening in Poor Rural Iowa Counties|Completed||N/A|743|Actual|University of Iowa||3|||f||||f||||||||Yes|Written request from an appropriate researcher to the PI|2017-10-11 03:35:15.782916|2017-10-11 03:35:15.782916
NCT01477801|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2011-11-18|||November 2011||2011-11-01|November 2011|2011-11-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Interventional|ECSPLOIT -D||Effects of Cholecalciferol Supplementation in Patients With Chronic Heart Failure and LOw vITamind D Levels|Effects of Cholecalciferol Supplementation in Patients With Chronic Heart Failure and LOw vITamind D Levels. A Phase 2 Randomized Double Blind Study|Unknown status|Recruiting|Phase 2/Phase 3|34|Anticipated|Azienda Unita' Sanitaria Locale Di Modena||2|||f||||f||||||||||2017-10-11 03:35:15.876805|2017-10-11 03:35:15.876805
NCT01477788|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2015-06-17|||May 2011||2011-05-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass|Prediction of Ovarian Malignancy, in the Presence of Sonographic Pelvic Mass Using Patient History, Sonographic Parameters and Serum Markers|Withdrawn||N/A|0|Actual|HaEmek Medical Center, Israel|||1|The researcher Left the organization|f||||f||||||||||2017-10-11 03:35:15.961672|2017-10-11 03:35:15.961672
NCT01477775|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2014-09-01|||January 2012||2012-01-01|September 2014|2014-09-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|PRU-MATRIX||Customized Choice of Oral P2Y12 Receptor Blocker|Customized Choice of P2Y12 Oral Receptor Blocker Based on Phenotype Assessment Via Point of Care Testing|Unknown status|Recruiting|Phase 4|4000|Anticipated|Italian Society of Invasive Cardiology||2|||f||||t||||||||||2017-10-11 03:35:16.035519|2017-10-11 03:35:16.035519
NCT01477762|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-03-07|2016-08-25||November 2011||2011-11-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|CSS|A total of 63 participants completed all study visits of which data were analyzed.|Cortisol Suppression and Startle Responses in Posttraumatic Stress Disorder (PTSD)|Effects of Cortisol Suppression on Fear-Potentiated Startle in Traumatized Individuals With and Without PTSD|Completed||N/A|165|Actual|Emory University||2|||f||||t||||||||||2017-10-11 03:35:16.283654|2017-10-11 03:35:16.283654
NCT01477749|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-19|2015-11-04|2015-06-10||June 2012||2012-06-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Sipuleucel-T Manufacturing Demonstration Study|An Open-Label Study Study of Sipuleucel-T in European Men With Metastatic, Castrate Resistant Prostate Cancer|Completed||Phase 2|47|Actual|Dendreon||1|||f||||f||||||||||2017-10-11 03:35:16.800511|2017-10-11 03:35:16.800511
NCT01477736|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-19|2011-11-19|||January 2009||2009-01-01|November 2011|2011-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity|A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity|Completed||N/A|68|Actual|Centro de Reabilitação e Readaptação Dr. Henrique Santillo||2|||f||||t||||||||||2017-10-11 03:35:17.29917|2017-10-11 03:35:17.29917
NCT01477723|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-19|2013-02-14|||October 2011||2011-10-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients|Evaluation of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients|Terminated||Phase 3|17|Actual|Abbott Nutrition||2||Low enrollment|f||||t||||||||||2017-10-11 03:35:17.440764|2017-10-11 03:35:17.440764
NCT01477710|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-03-11|2013-01-23||May 2011||2011-05-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Ability of Caregivers to Provide Ventilation With the SAVe Resuscitator in a Model|Ability of Caregivers to Provide Ventilation With the SAVe Resuscitator in a Model|Completed||N/A|30|Actual|University of Cincinnati||3|||f||||f||||||||||2017-10-11 03:35:17.629052|2017-10-11 03:35:17.629052
NCT01477697|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-02-22|||June 2011||2011-06-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients|Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients|Terminated||Phase 1/Phase 2|12|Actual|University of Cincinnati||2||"Terminated due to slow enrollment and interim analysis showing no difference between treatment   arms."|f||||f||||||||||2017-10-11 03:35:17.912868|2017-10-11 03:35:17.912868
NCT01477684|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2012-10-15|||October 2011||2011-10-01|October 2012|2012-10-01||||November 2011|Actual|2011-11-01||Observational|||Documentation of In-flight Medical Emergencies With Medical Incident Report Forms.||Completed||N/A|10|Actual|Ruhr University of Bochum|||1||f||||t||||||||||2017-10-11 03:35:18.028228|2017-10-11 03:35:18.028228
NCT01477671|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2014-04-25|||September 2011||2011-09-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|September 2012|Actual|2012-09-01||Observational|||Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children|Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children in India|Completed||N/A|667|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 03:35:18.093943|2017-10-11 03:35:18.093943
NCT01477658|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-05-04|||November 2007||2007-11-01|May 2013|2013-05-01|November 2013|Anticipated|2013-11-01|November 2012|Actual|2012-11-01||Observational|||Effects of Chronic Right Ventricular Pacing in Children With Advanced Atrioventricular Block|Effects of Chronic Right Ventricular Pacing in Children With Advanced Atrioventricular Block|Unknown status|Enrolling by invitation|N/A|140|Actual|University of Sao Paulo|||2||f||||t||||||Samples Without DNA|"     Blood   "|||2017-10-11 03:35:18.208588|2017-10-11 03:35:18.208588
NCT01477645|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-10-13|||November 2011||2011-11-01|October 2013|2013-10-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Observational|||Health Effects Following Use of Lead Free Ammunition Used With HK416|In Norwegian: Helseffekter av Stoff Som Avgis Ved Skyting Med HK416|Completed||N/A|55|Actual|Oslo University Hospital|||3||f||||f||||||Samples Without DNA|"     Sputum and serum   "|||2017-10-11 03:35:18.302546|2017-10-11 03:35:18.302546
NCT01477632|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2016-01-14|||March 2005||2005-03-01|January 2016|2016-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women|Single Dose, Three-way, Cross-over, Relative Bioavailability Study With 3 Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women: 0.5 mg Estradiol + 0.1 mg Norethisterone Acetate, 0.5 mg Estradiol + 0.25 mg Norethisterone Acetate, and 1.0 mg Estradiol + 0.5 mg Norethisterone Acetate|Completed||Phase 1|24|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:35:18.400918|2017-10-11 03:35:18.400918
NCT01477619|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-02-14|||November 2011||2011-11-01|February 2014|2014-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects|An Open-label, Single Dose, Parallel Group Study to Assess the Effects of Smoking Status, Age and Body Size on the Pharmacokinetics, Safety, and Tolerability of Tasimelteon in Healthy Volunteers|Completed||Phase 1|60|Actual|Vanda Pharmaceuticals||3|||f||||f||||||||||2017-10-11 03:35:18.523197|2017-10-11 03:35:18.523197
NCT01477606|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-09-07|||May 2012||2012-05-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Protocol in Acute Myeloid Leukemia With FLT3-ITD|Phase-II Study Evaluating Midostaurin in Induction, Consolidation and Maintenance Therapy Also After Allogeneic Blood Stem Cell Transplantation in Patients With Newly Diagnosed Acute Myeloid Leukemia Exhibiting a FLT3 Internal Tandem Duplication|Recruiting||Phase 2|440|Anticipated|University of Ulm||1|||f||||t||||||||||2017-10-11 03:35:18.623684|2017-10-11 03:35:18.623684
NCT01477593|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-04-08|||July 2009||2009-07-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Circumcision With a Novel Disposable Device in Chinese Children: a Hospital-based Randomized Controlled Trail||Completed||Phase 4|120|Actual|Nanjing Medical University||3|||f||||t||||||||||2017-10-11 03:35:19.114172|2017-10-11 03:35:19.114172
NCT01477580|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2015-12-16|||July 2012||2012-07-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Interventional|||Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)|A Phase I Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Tetravalent Recombinant Subunit Dengue Vaccine (V180) in Healthy Adults|Completed||Phase 1|98|Actual|Merck Sharp & Dohme Corp.||13|||f||||t||||||||||2017-10-11 03:35:19.186604|2017-10-11 03:35:19.186604
NCT01477567|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2014-10-02|2014-06-13||November 2011||2011-11-01|October 2014|2014-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||All enrolled participants.|A First-in-Human Study of LY3009385 in Healthy Participants|A Single Ascending Dose (SAD) Study of LY3009385 in Healthy Volunteers|Completed||Phase 1|40|Actual|Eli Lilly and Company||7|||f||||f||||||||||2017-10-11 03:35:19.31177|2017-10-11 03:35:19.31177
NCT01477554|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2011-11-18|||September 2009||2009-09-01|November 2011|2011-11-01|June 2013|Anticipated|2013-06-01|||||Interventional|PRONTO||PRONTO: Obstetric and Neonatal Emergency Training Program: A Cluster-Randomized Trial to Measure Impact|PRONTO: Obstetric and Neonatal Emergency Training Program: A Cluster-Randomized Trial to Measure Impact|Unknown status|Active, not recruiting|N/A|24|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||f||||||||||2017-10-11 03:35:20.820032|2017-10-11 03:35:20.820032
NCT01477541|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2011-11-18|||November 2007||2007-11-01|November 2011|2011-11-01||||March 2010|Actual|2010-03-01||Interventional|||Cluster-randomized Trial Measuring Integration of Professional Midwives and Obstetric Nurses in Rural Clinics in Mexico|Incorporation of Alternative Providers for Care During Pregnancy, Delivery and Postpartum in Rural Public Health Clinics.|Completed||N/A|27|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||||||||||||2017-10-11 03:35:20.890215|2017-10-11 03:35:20.890215
NCT01477528|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-04-18|||November 2011||2011-11-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Observational|TRACE||Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)|Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II LVAS (TRACE)|Completed||N/A|201|Actual|St. Jude Medical|||1||f||||f||||||||||2017-10-11 03:35:20.974606|2017-10-11 03:35:20.974606
NCT01477515|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2012-08-21|||February 2012||2012-02-01|August 2012|2012-08-01||||||||Observational|||Endocannabinoids in End Stage Renal Disease||Completed||N/A|30|Actual|Indiana University|||2||f||||f||||||||||2017-10-11 03:35:21.083543|2017-10-11 03:35:21.083543
NCT01477502|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-10-12|||November 2011||2011-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|August 2016|Actual|2016-08-01||Interventional|||Clinical Value of Homeopathic Prophylaxis of Recurrent Urinary Tract Infections in Persons With Spinal Cord Injury|Clinical Value of Homeopathic Assessment and Treatment for Prophylaxis of Recurrent Urinary Tract Infections in Persons With Spinal Cord Injury|Completed||N/A|46|Actual|Swiss Paraplegic Centre Nottwil||2|||f||||f||||||||||2017-10-11 03:35:21.138499|2017-10-11 03:35:21.138499
NCT01477489|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-05-02|||January 2012||2012-01-01|May 2017|2017-05-01|November 4, 2017|Anticipated|2017-11-04|October 2014|Actual|2014-10-01||Interventional|||Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer|A Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer|Active, not recruiting||Phase 1|30|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 03:35:21.21426|2017-10-11 03:35:21.21426
NCT01477476|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-06-28|||March 2012||2012-03-01|June 2017|2017-06-01|April 22, 2016|Actual|2016-04-22|March 2016|Actual|2016-03-01||Interventional|||Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes|Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes.|Terminated||Phase 2|1|Actual|University of Colorado, Denver||2||funding loss and only one subject enrolled|f||||t||||||||||2017-10-11 03:35:21.34359|2017-10-11 03:35:21.34359
NCT01477463|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-10-31|2016-06-30||September 2012||2012-09-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers|Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers|Completed||N/A|24|Actual|Stanford University||2|||f||||t||||||||Yes|Results will be submitted to scientific journal for publication.|2017-10-11 03:35:21.470451|2017-10-11 03:35:21.470451
NCT01477450|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2014-09-24|2014-01-01||October 2011||2011-10-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects|Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects|Completed||N/A|30|Actual|University of Cincinnati||3|||f||||f||||||||||2017-10-11 03:35:21.773|2017-10-11 03:35:21.773
NCT01477437|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2013-08-19|||November 2011||2011-11-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Internet-based Educational Program to Promote Self-Management for Teens With Hemophilia|Development and Evaluation of an Internet-based Educational Program to Promote Self- Management for Teens With Hemophilia|Completed||N/A|29|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 03:35:22.071664|2017-10-11 03:35:22.071664
NCT01477411|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-01-17|||November 2011||2011-11-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Drug-Drug Interaction Study of Digoxin and PA21|A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Digoxin in Healthy Male and Female Adults|Completed||Phase 1|42|Actual|Vifor Inc.||3|||f||||f||||||||||2017-10-11 03:35:23.860873|2017-10-11 03:35:23.860873
NCT01477398|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2016-08-18|||April 2010||2010-04-01|August 2016|2016-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Improved Patient Recovery After Anesthesia|Improved Patient Recovery of Spontaneous Respiration After Anesthesia With Hypercapnic Hyperpnoea|Completed||Early Phase 1|31|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 03:35:23.933413|2017-10-11 03:35:23.933413
NCT01477385|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-05-03|||January 2012||2012-01-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Treatment of Initial Caries Lesions on Proximal Surfaces of Primary and Permanent Posterior Teeth|Treatment of Initial Caries Lesions on Proximal Surfaces of Primary and Permanent Posterior Teeth: a Randomized Placebo-controlled Study.|Recruiting||N/A|183|Anticipated|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 03:35:23.992667|2017-10-11 03:35:23.992667
NCT01477372|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2012-04-10|||September 2007||2007-09-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effect of Physical Exercise Program During Pregnancy on Excessive Weight Gain and Its Consequences|Effect of Physical Exercise Program During Pregnancy on Excessive Weight Gain and Its Consequences|Completed||N/A|320|Actual|Universidad Politecnica de Madrid||2|||f||||f||||||||||2017-10-11 03:35:24.097245|2017-10-11 03:35:24.097245
NCT01477359|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-04-21|||August 2012||2012-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CHASM-CS||Cardiac Sarcoidosis Multi-Center Prospective Cohort|Cardiac Sarcoidosis Multi-Center Prospective Cohort Study|Recruiting||N/A|400|Anticipated|Ottawa Heart Institute Research Corporation|||1||f||||f||||||||||2017-10-11 03:35:24.187457|2017-10-11 03:35:24.187457
NCT01477346|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-01-04|||March 2013||2013-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Arthritis Research UK Gout Treatment Trial - Phase 2|Arthritis Research UK Gout Treatment Trial. Phase 2: Two Year Randomised Controlled Trial of a Nurse Led Package of Care|Completed||N/A|517|Actual|University of Nottingham||2|||f||||f||||||||No||2017-10-11 03:35:24.306581|2017-10-11 03:35:24.306581
NCT01477333|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-01-11|2016-08-01||October 2011||2011-10-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®|An Evaluation of the Safety and Efficacy of the Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®|Completed||Phase 2|18|Actual|United Therapeutics||1|||f||||f||||||||||2017-10-11 03:35:24.391755|2017-10-11 03:35:24.391755
NCT01477307|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-01-01|||July 2011||2011-07-01|January 2014|2014-01-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Observational|||Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver|Effect of Dietary Intervention on Intestinal Microbiota in Patients With Non-alcoholic Fatty Liver Disease|Unknown status|Recruiting|Phase 2|20|Anticipated|University Hospital, Geneva|||1||f||||t||||||||||2017-10-11 03:35:25.136159|2017-10-11 03:35:25.136159
NCT01477294|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2011-11-18|||January 2010||2010-01-01|November 2011|2011-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effects of Caffeine in Hydration and Energy Metabolism|Effects of Caffeine Ingestion in Total-body Water, Extra and Intracellular Water Distribution, and Energy Metabolism|Completed||N/A|30|Actual|Technical University of Lisbon||2|||f||||f||||||||||2017-10-11 03:35:25.261785|2017-10-11 03:35:25.261785
NCT01477281|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-11-18|||February 2012||2012-02-01|November 2011|2011-11-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||Study to Evaluate the Efficacy and Tolerability of Venaflon Use in Reducing the Symptoms Caused by Chronic Venous Insufficiency When Compared With Daflon|A Clinical Multicenter, Phase III, Prospective, Randomized, Double-blind, Comparative Study to Evaluate the Efficacy and Tolerability of Venaflon Use in Reducing the Symptoms Caused by Chronic Venous Insufficiency When Compared With Daflon|Unknown status|Not yet recruiting|Phase 3|82|Anticipated|Laboratório Teuto Brasileiro S/A||2|||f||||t||||||||||2017-10-11 03:35:25.364873|2017-10-11 03:35:25.364873
NCT01477268|ClinicalTrials.gov processed this data on October 10, 2017|2009-06-09|2011-11-18|||June 2007||2007-06-01|May 2011|2011-05-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Cognitive Correlates of Antidepressant Treatment Response in Elders|Determining the Impact of Dementia and Executive Impairment on Antidepressant Treatment Response in Older Persons|Completed||Phase 4|30|Actual|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-10-11 03:35:25.437207|2017-10-11 03:35:25.437207
NCT01477255|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-04-06|||December 2011||2011-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|DIARY1||The Feasibility Of a Daily Diary Methodology With a Pediatric Cancer Population|The Feasibility Of a Daily Diary Methodology With a Pediatric Cancer Population: A Pilot Study|Completed||N/A|154|Actual|St. Jude Children's Research Hospital|||2||f||||f||||||||||2017-10-11 03:35:25.519441|2017-10-11 03:35:25.519441
NCT01477242|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2012-01-19|||November 2011||2011-11-01|January 2012|2012-01-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||The Effect of Ondansetron During Intramuscular Ketamine Use in Children: A Trial in Emergency Department|The Effect of Oral Ondansetron During Intramuscular Ketamine Use in Children|Unknown status|Recruiting|N/A|266|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:35:25.607901|2017-10-11 03:35:25.607901
NCT01477229|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-10-12|||February 2012||2012-02-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|September 2015|Actual|2015-09-01||Observational|QoLiRECT||Quality of Life in RECTal Cancer - a Prospective Multicenter Cohort Study|Quality of Life in RECTal Cancer - A Study Within the Scandinavian Surgical Outcomes Research Group|Active, not recruiting||N/A|1500|Anticipated|Sahlgrenska University Hospital, Sweden|||4||f||||f||||||||||2017-10-11 03:35:25.701169|2017-10-11 03:35:25.701169
NCT01388751|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-10-30|||November 2008||2008-11-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||Mallet Finger Splinting Study|Night Splinting After 6 to 8 Weeks of Continuous Splinting for Mallet Finger|Completed||N/A|52|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:03:45.128303|2017-10-11 04:03:45.128303
NCT01477216|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-11-18|||January 2003||2003-01-01|November 2011|2011-11-01|December 2013|Anticipated|2013-12-01|December 2008|Actual|2008-12-01||Interventional|ELSA||Determination of Glycemic and Insulinemic Indices|The Glycemic and Insulinemic Responses of the Finnish Foods: Measurement and Modification|Unknown status|Active, not recruiting|N/A|142|Actual|National Institute for Health and Welfare, Finland||9|||f||||f||||||||||2017-10-11 03:35:25.785541|2017-10-11 03:35:25.785541
NCT01477203|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-09-13|||November 2011||2011-11-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|MAN-BIOPSY||Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders|Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders|Completed||Phase 4|289|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-10-11 03:35:25.872929|2017-10-11 03:35:25.872929
NCT01477190|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-24|||October 2010||2010-10-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program|Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program|Completed||Phase 1/Phase 2|40|Actual|McGill University Health Center||2|||f||||t||||||||||2017-10-11 03:35:25.949199|2017-10-11 03:35:25.949199
NCT01477177|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-04-08|||August 2011||2011-08-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Polar Wand Carbon Dioxide Cryotherapy for Barrett's Esophagus|Pilot Study of Polar Wand Carbon Dioxide Cryotherapy for Barrett's Esophagus With Low Grade and High Grade Dysplasia|Terminated||N/A|4|Actual|Mayo Clinic||1||enrollment much slower than anticipated, and, funding issues|f||||||||||||||2017-10-11 03:35:26.023281|2017-10-11 03:35:26.023281
NCT01477164|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-08-07|||November 2011||2011-11-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|May 2016|Actual|2016-05-01||Interventional|||Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults|Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults|Completed||N/A|72|Actual|Mayo Clinic||3|||f||||f||||||||||2017-10-11 03:35:26.092682|2017-10-11 03:35:26.092682
NCT01477151|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2015-06-03|||November 2011||2011-11-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|RISCCS||Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery|Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery: A Prospective Randomized Clinical Trial.|Completed||Phase 4|464|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 03:35:26.166436|2017-10-11 03:35:26.166436
NCT01477138|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-11-18|||July 2011||2011-07-01|November 2011|2011-11-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Observational|VOTE||RV Septal Versus Minimized RV Pacing in Sick Sinus Syndrome|Comparison of Right Ventricular Septal Pacing to Minimized Right Ventricular Septal Stimulation in Patients With Sick Sinus Syndrome|Unknown status|Recruiting|N/A|126|Anticipated|Klinikum Nürnberg|||2||f||||t||||||||||2017-10-11 03:35:26.365983|2017-10-11 03:35:26.365983
NCT01477125|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2015-09-29|||November 2013||2013-11-01|September 2015|2015-09-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Working Memory Training in Adults With ADHD|Computerised Working Memory Training in Adults With ADHD: A Randomised Controlled Trial|Unknown status|Recruiting|N/A|150|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:35:26.48643|2017-10-11 03:35:26.48643
NCT01477112|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-18|||January 2010||2010-01-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy Individuals|Effect of the Supplementation With β-carotene to Type 2 Diabetic Patients and Healthy Controls on the Iron Status and Antioxidant Capacity of Plasma|Completed||N/A|117|Actual|Instituto Venezolano de Investigaciones Cientificas||4|||f||||t||||||||||2017-10-11 03:35:26.586483|2017-10-11 03:35:26.586483
NCT01477099|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-18|||August 2010||2010-08-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Toothbrushing and Ventilator-associated Pneumonia|Efficacy of Toothbrushing for the Prevention of Ventilator-associated Pneumonia|Completed||Phase 4|436|Actual|Hospital Universitario de Canarias||2|||f||||t||||||||||2017-10-11 03:35:26.705781|2017-10-11 03:35:26.705781
NCT01477086|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-02-04|||January 2012||2012-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|PREFISSARC||Prevalence and Pathophysiology of Sarcopenia in the Elderly Patient With Hip Fracture|Prevalence and Pathophysiology of Sarcopenia in the Elderly Patient With Hip Fracture. Prospective, Observational Study on Consecutive Series|Completed||N/A|198|Actual|Hospital Viamed Valvanera, Spain|||1||f||||f||||||||||2017-10-11 03:35:26.784147|2017-10-11 03:35:26.784147
NCT01477073|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-01-02|||October 2011||2011-10-01|November 2011|2011-11-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Multiple Dose FSH-GEX(TM) in Healthy Volunteers|A Phase I, Mono-center, Placebo and Comparator Controlled, Single-blind, Randomized, Parallel Group, Clinical Study to Determine Multiple Dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FSH-GEX(TM) Administered Subcutaneously in Healthy Pituitary-suppressed Female Volunteers|Completed||Phase 1|57|Actual|Glycotope GmbH||4|||f||||f||||||||||2017-10-11 03:35:26.907025|2017-10-11 03:35:26.907025
NCT01477060|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2014-02-19|||November 2011||2011-11-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer|Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With HER2-negative, ER and/or PgR Positive Metastatic Brest Cancer With Progressive Disease After First-line Therapy|Terminated||Phase 2|32|Actual|Fondazione Michelangelo||3||The study was stopped due to insufficient accrual|f||||f||||||||||2017-10-11 03:35:27.010578|2017-10-11 03:35:27.010578
NCT01477047|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-02-24|||January 2012|Actual|2012-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Observational|||Identification of Risk Factors of Prolonged Wound Healing Following Primary Arthroplasty|Identification of Risk Factors of Prolonged Wound Healing Following Total Hip and Knee Arthroplasty|Recruiting||N/A|3000|Anticipated|Hvidovre University Hospital|||1||f||||f||||||||||2017-10-11 03:35:27.129582|2017-10-11 03:35:27.129582
NCT01477034|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-04-02|||November 2011||2011-11-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Vitamin D and Adipose Tissue Inflammation|Vitamin D and Adipose Tissue Inflammation|Completed||N/A|18|Actual|Fred Hutchinson Cancer Research Center||4|||f||||f||||||||||2017-10-11 03:35:27.216585|2017-10-11 03:35:27.216585
NCT00006142|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||December 1983||1983-12-01|August 2000|2000-08-01||||||||Interventional|||Study of a Phenylalanine Restricted Diet During Pregnancy to Prevent Symptoms in Offspring of Patients With Phenylketonuria||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:30:53.991598|2017-10-11 04:30:53.991598
NCT01477021|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-12-09|||January 2012||2012-01-01|December 2014|2014-12-01||||September 2013|Actual|2013-09-01||Interventional|||Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery|A Phase I Study To Determine the Feasibility of Using Autologous NY-ESO-1 Specific CD8+ T Cells For the Treatment of Patients With Advanced Myxoid/ Round Cell Liposarcoma and Synovial Sarcoma.|Completed||Phase 1|6|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 03:35:27.337226|2017-10-11 03:35:27.337226
NCT01477008|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2016-08-18|||October 2011||2011-10-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||BiPhasic Cartilage Repair Implant (BiCRI) IDE Clinical Trial - Taiwan|A Prospective, Multi-Center, Randomized Clinical Trial Comparing the Biphasic Cartilage Repair Implant to Marrow Stimulation in the Treatment of Focal Chondral and Osteochondral Lesions of the Knee|Recruiting||Phase 3|92|Anticipated|Exactech Taiwan, Ltd.||2|||f||||t||||||||||2017-10-11 03:35:27.432165|2017-10-11 03:35:27.432165
NCT01476995|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-11-18|||September 2010||2010-09-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|GBMC||Prognostic Indicators as Provided by the EPIC ClearView|Prognostic Indicators as Provided by the EPIC ClearView|Completed||N/A|353|Actual|Epic Research & Diagnostics, Inc.|||2||f||||f||||||||||2017-10-11 03:35:27.595236|2017-10-11 03:35:27.595236
NCT01476982|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2013-03-18|||May 2012||2012-05-01|March 2013|2013-03-01||||June 2013|Anticipated|2013-06-01||Observational|EPIC-ER||Evaluation of Patients in Chest Pain in the Emergency Room|Evaluation of Patients in Chest Pain in the Emergency Room|Unknown status|Active, not recruiting|N/A|200|Anticipated|Epic Research & Diagnostics, Inc.|||1||f||||f||||||||||2017-10-11 03:35:27.70203|2017-10-11 03:35:27.70203
NCT01476969|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-08-11|||September 2011||2011-09-01|August 2012|2012-08-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Effect of Remote Ischemic Perconditioning on Acute Kidney Injury in Adult Valve Replace|Effect of Remote Ischemic Perconditioning on Acute Kidney Injury in Adult Valve Replace|Unknown status|Recruiting|N/A|90|Anticipated|Central South University||1|||f||||t||||||||||2017-10-11 03:35:27.784365|2017-10-11 03:35:27.784365
NCT01476956|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-11-16|||October 2011||2011-10-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|||Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography|Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis|Active, not recruiting||N/A|600|Anticipated|Canadian Research & Education in Arthritis|||1||f||||f||||||Samples Without DNA|"     -  whole blood/serum        -  urine   "|||2017-10-11 03:35:27.885771|2017-10-11 03:35:27.885771
NCT01476943|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-09-18|||March 31, 2012|Actual|2012-03-31|September 2017|2017-09-01|April 30, 2018|Anticipated|2018-04-30|April 30, 2018|Anticipated|2018-04-30||Observational|CTS||Patterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant Study|Belatacept in Renal Transplantation: Patterns of Use Analysis Using the Collaborative Transplant Study (CTS)|Active, not recruiting||N/A|4335|Anticipated|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 03:35:28.037879|2017-10-11 03:35:28.037879
NCT01476930|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-11-20|||June 2008||2008-06-01|November 2014|2014-11-01|October 2011|Actual|2011-10-01|September 2009|Actual|2009-09-01||Interventional|||Cupping and Serkangabin Versus Conventional Migraine Treatment|Cupping Therapy and SERKANGABIN Versus Conventional Treatment of Migraine Headache: a Randomized Controlled Trial|Completed||Phase 4|391|Actual|Birjand University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:35:28.106176|2017-10-11 03:35:28.106176
NCT01476917|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-11-05|||November 2011||2011-11-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||The ATLAST Long-Term Study|The ATLAST Long-Term Study. A Multicenter, Prospective, Long-Term Study of the Attune Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)|Completed||Phase 2/Phase 3|39|Actual|ApniCure, Inc.||1|||f||||f||||||||||2017-10-11 03:35:28.198758|2017-10-11 03:35:28.198758
NCT01476904|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-02-10||2016-02-11|November 2011||2011-11-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Interventional|||Safety Study in Adolescent and Adult Patients With Asthma|A 3-month Safety Evaluation Extension to the 12-week E004-C Study in Asthma Patients (A Double Blinded, Placebo-controlled, Parallel, 3-month Safety Study in Adolescent and Adult Patients With Asthma)|Completed||Phase 3|208|Actual|Amphastar Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 03:35:28.30172|2017-10-11 03:35:28.30172
NCT01476891|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2013-01-17|||January 2011||2011-01-01|January 2013|2013-01-01||||August 2014|Anticipated|2014-08-01||Interventional|eCALM||The eCALM Study - An Online Mindfulness-Based Stress Reduction Program for Individuals Living With Cancer in Alberta|The eCALM Study - eTherapy for Cancer Applying Mindfulness: Online Mindfulness-Based Stress Reduction Program for Underserved Cancer Patients in Alberta: A Randomized Wait-list Controlled Trial.|Unknown status|Active, not recruiting|N/A|64|Anticipated|AHS Cancer Control Alberta||2|||f||||t||||||||||2017-10-11 03:35:28.441968|2017-10-11 03:35:28.441968
NCT01476878|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-09|2011-11-18|||January 2010||2010-01-01|August 2011|2011-08-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Frameless Stereotactic Radiosurgery for Brain Metastases|Frameless Stereotactic Radiosurgery for Brain Metastases|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 03:35:28.517943|2017-10-11 03:35:28.517943
NCT01476865|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2011-11-18|||March 2010||2010-03-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Articular Sonography: Healthy Subjects Versus Rheumatoid Arthritis Patients|Articular Sonography: Findings in Healthy Subjects Compared With Rheumatoid Arthritis Patients|Completed||N/A|190|Actual|Federal University of São Paulo|||2||f||||f||||||Samples With DNA|"     serum   "|||2017-10-11 03:35:28.699137|2017-10-11 03:35:28.699137
NCT01476839|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-05-05|||November 9, 2012|Actual|2012-11-09|May 2017|2017-05-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma|"Phase I Study of Yttrium-90 Labeled Anti-CD25 (a-Tac) Monoclonal Antibody Plus BEAM for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients With Primary Refractory or Relapsed Hodgkin Lymphoma, the a-Tac BEAM Regimen"|Recruiting||Phase 1|22|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 03:35:28.788756|2017-10-11 03:35:28.788756
NCT01476826|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2015-02-23|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:35:28.92979|2017-10-11 03:35:28.92979
NCT01476813|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-03-14|||March 2012||2012-03-01|March 2017|2017-03-01|July 2013|Actual|2013-07-01|September 2012|Actual|2012-09-01||Interventional|||Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate|A Randomized, Double-blind, Active-controlled, Cross-over Study to Assess Efficacy and Safety of 3 Free Doses of Glycopyrrolate With Beclomethasone/Formoterol pMDI for the Treatment of COPD Patients|Completed||Phase 2|281|Actual|Chiesi Farmaceutici S.p.A.||4|||f||||f||||||||||2017-10-11 03:35:28.978296|2017-10-11 03:35:28.978296
NCT01476800|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2015-08-31|||July 2006||2006-07-01|August 2015|2015-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers|A Phase 1, Open-Label, Two-Period, One-Sequence Crossover Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Male and Female Adult Volunteers|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 03:35:29.074574|2017-10-11 03:35:29.074574
NCT01476787|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2017-05-08|||December 29, 2011|Actual|2011-12-29|May 2017|2017-05-01|June 1, 2024|Anticipated|2024-06-01|April 15, 2017|Actual|2017-04-15||Interventional|RELEVANCE||Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma|A Phase 3 Open-Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy in Subjects With Previously Untreated Follicular Lymphoma|Active, not recruiting||Phase 3|255|Actual|Celgene||2|||f||||t||||||||||2017-10-11 03:35:29.177054|2017-10-11 03:35:29.177054
NCT01476774|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-07-07|||August 2009||2009-08-01|July 2015|2015-07-01||||June 2010|Actual|2010-06-01||Interventional|||NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain|NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain|Completed||Phase 3|280|Actual|Mundipharma (China) Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 03:35:29.394824|2017-10-11 03:35:29.394824
NCT01476761|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2013-08-07|||November 2011||2011-11-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|MET1||MicroCutter in Surgical Stapling - European Trial I|The Cardica MicroCutter in Surgical Stapling: A Prospective, Open-label, Multi-center Study|Completed||Phase 4|160|Actual|Cardica, Inc||1|||f||||t||||||||||2017-10-11 03:35:29.482938|2017-10-11 03:35:29.482938
NCT01476748|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2014-09-08|2013-08-23||December 2012||2012-12-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Intraoperative Trocar Slippage Study|A Pilot Study to Determine the Extent of Intraoperative Laparoscopic Trocar Slippage.|Completed||Phase 3|15|Actual|Brigham and Women's Hospital|There were no adverse events encountered during this study|3|||f||||f||||||||||2017-10-11 03:35:29.584759|2017-10-11 03:35:29.584759
NCT01476735|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2011-11-21|||August 2011||2011-08-01|November 2011|2011-11-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||Individual Approach for Bowel Preparation Before Colonoscopy|A Prospective, Randomized, Single-blind Study Evaluating Individual Approach on Bowel Preparation Quality for Colonoscopy|Unknown status|Recruiting|N/A|266|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||t||||||||||2017-10-11 03:35:29.90443|2017-10-11 03:35:29.90443
NCT01476722|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2012-11-16|2012-10-19||June 2011||2011-06-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)|Lens Wearing Experience and Biocompatibility With OPTI-FREE® PureMoist® Multi-Purpose Disinfecting Solution (OFP MPDS) in Silicone Hydrogel and Soft Contact Lens Wearers (US)|Completed||N/A|125|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:35:29.986961|2017-10-11 03:35:29.986961
NCT01476709|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2012-04-05|||November 2011||2011-11-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|PhotonicNeedle||Photonic Needle and Sleeve Study|Photonic Needle and Intraforaminal Epidural Injection (Sleeve) - Observational Study in Humans|Completed||N/A|30|Actual|Maastricht University Medical Center|||1||f||||f||||||||||2017-10-11 03:35:30.204846|2017-10-11 03:35:30.204846
NCT01476696|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-01-17|2013-10-18||November 2011||2011-11-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|Crescent|All enrolled participants.|A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease|An Open-Label, Dose-Ranging Study of Prasugrel in Pediatric Patients With Sickle Cell Disease|Completed||Phase 2|33|Actual|Eli Lilly and Company|Data for the Primary Outcome Measures 1 and 2 were collected for presentation of results in a scatter plot and were not intended to be summarized due to the limited number of participants per treatment.|2|||f||||f||||||||||2017-10-11 03:35:30.303222|2017-10-11 03:35:30.303222
NCT01476683|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2012-07-06|||December 2011||2011-12-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study to Compare the Pharmacokinetics Profiles of Four Racecadotril Products|An Open-Label, Fasting, Crossover, Single-Dose Pharmacokinetic Study of Four Formulations of Racecadotril|Completed||Phase 1|24|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||f||||||||||2017-10-11 03:35:30.89801|2017-10-11 03:35:30.89801
NCT01476670|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-18|2011-11-21|||July 2012||2012-07-01|November 2011|2011-11-01||||||||Observational|||Cerebral Blood Circulation in Patients With Posterior Fossa Brain Tumor|Cerebral Autoregulation and Carbon Dioxide Reactivity in Patients With Posterior Fossa Tumor|Unknown status|Not yet recruiting|N/A|20|Anticipated|All India Institute of Medical Sciences, New Delhi|||1||f||||f||||||||||2017-10-11 03:35:30.982474|2017-10-11 03:35:30.982474
NCT01476657|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-07-31|||October 2011||2011-10-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies|A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies|Terminated||Phase 1|210|Actual|Verastem, Inc.||1||"The scope of the program has been reduced to focus resources on studies which can potentially   enable the registration of duvelisib."|f||||f||||||||||2017-10-11 03:35:31.054089|2017-10-11 03:35:31.054089
NCT00018551|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Chemoprevention With Folic Acid|3389 Colorectal Adenoma: Chemoprevention With Folic Acid|Completed||Phase 2|||VA Office of Research and Development|||||||||||||||||||2017-10-11 04:33:12.870711|2017-10-11 04:33:12.870711
NCT01476631|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-08-02|||November 2008||2008-11-01|August 2013|2013-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Step Down Colon Cancer Risk|Step Down Colon Cancer Risk: A Pilot Intervention for Colon Cancer Risk Reduction|Terminated||N/A|17|Actual|Washington University School of Medicine||2||not enough patients consented during the funding period|f||||f||||||||||2017-10-11 03:35:31.194563|2017-10-11 03:35:31.194563
NCT01476618|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-06-08|||July 2011||2011-07-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|July 2012|Actual|2012-07-01||Observational|||Providing Mental Health Services to Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) Veterans|Providing Mental Health Services to Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) Veterans: Provider Perspectives|Completed||N/A|13|Actual|VA Eastern Colorado Health Care System|||1||f||||t||||||||||2017-10-11 03:35:31.263796|2017-10-11 03:35:31.263796
NCT01476605|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-10-09|||June 2009||2009-06-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy of Injection Therapy for Lateral Epicondylosis|The Efficacy of Prolotherapy and Platelet Rich Plasma Injections for Lateral Epicondylosis: a Pilot Study|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|University of Wisconsin, Madison||4|||f||||t||||||||||2017-10-11 03:35:31.333243|2017-10-11 03:35:31.333243
NCT01476592|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-05-01|||December 2011||2011-12-01|May 2017|2017-05-01|January 22, 2018|Anticipated|2018-01-22|October 2013|Actual|2013-10-01||Interventional|||A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors|A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors|Active, not recruiting||N/A|7|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 03:35:31.455808|2017-10-11 03:35:31.455808
NCT01476579|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-06-16|||January 2012||2012-01-01|June 2016|2016-06-01|January 2022|Anticipated|2022-01-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Low-radiation Dose CT Angiography With Invasive Coronary Angiography in Stable Coronary Disease|Diagnostic Accuracy of New Generation Low-dose CT Coronary Angiography|Active, not recruiting||Phase 4|769|Actual|University Hospital of North Norway||1|||f||||f||||||||||2017-10-11 03:35:31.556476|2017-10-11 03:35:31.556476
NCT01476566|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-11-17|||January 2013||2013-01-01|November 2011|2011-11-01|January 2016|Anticipated|2016-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Can Diagnostics and Pharmacological Prescriptions in Patients With Heart Failure be Improved in General Practice?|Can Diagnostics and Pharmacological Prescriptions in Patients With Heart Failure be Improved? A Cluster Randomised Educational Intervention in General Practice. A Study Protocol.|Unknown status|Not yet recruiting|Phase 1/Phase 2|1940|Anticipated|University of Oslo||2|||f||||f||||||||||2017-10-11 03:35:31.652788|2017-10-11 03:35:31.652788
NCT01476553|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2017-05-01|||February 2011||2011-02-01|May 2017|2017-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EIPL||Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer|"Elimination of Peritoneal Tumor Cells With Extensive Intraperitoneal Lavage (EIPL) During Surgical Treatment of Gastric Adenocarcinoma"|Terminated||N/A|30|Actual|Universitätsmedizin Mannheim||1||Prematurely halted after interim data analysis|f||||f||||||||||2017-10-11 03:35:31.841222|2017-10-11 03:35:31.841222
NCT01476540|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-17|||July 2011||2011-07-01|November 2011|2011-11-01||||March 2013|Anticipated|2013-03-01||Interventional|||Deep Brain Stimulation for the Treatment of Refractory Anorexia Nervosa|Deep Brain Stimulation for the Treatment of Refractory Anorexia Nervosa|Unknown status|Recruiting|Phase 1|12|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 03:35:31.974424|2017-10-11 03:35:31.974424
NCT01476527|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-17|||May 2011||2011-05-01|November 2011|2011-11-01||||March 2013|Anticipated|2013-03-01||Interventional|||Deep Brain Stimulation for the Treatment of Refractory Bipolar Disorder||Unknown status|Recruiting|Phase 1|6|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 03:35:32.062557|2017-10-11 03:35:32.062557
NCT01476514|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2014-09-03|||October 2011||2011-10-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Mutations of the Glycine Gene Associated With Hyperekplexia on Central Pain Processing|Effects of Mutations of the Glycine Gene Associated With Hyperekplexia on Central Pain Processing|Terminated||N/A|9|Actual|University Hospital Inselspital, Berne||1||Recruitment problems|f||||f||||||||||2017-10-11 03:35:32.176208|2017-10-11 03:35:32.176208
NCT01476501|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2015-05-26|||October 2011||2011-10-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Vitamin D Supplementation in Diabetic Nephropathy|Vitamin D Supplementation and Bone Health in Adults With Diabetic Nephropathy|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|University of Alberta||2|||f||||t||||||||||2017-10-11 03:35:32.304579|2017-10-11 03:35:32.304579
NCT01476488|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2015-05-24|||July 2011||2011-07-01|May 2015|2015-05-01||||March 2013|Actual|2013-03-01||Interventional|||Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients|Conversion of Twice-a-day Tacrolimus to Once-Daily Tacrolimus Extended-Release Formulation in Stable Pediatric Kidney Transplant Recipients|Completed||Phase 2/Phase 3|||Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 03:35:32.418394|2017-10-11 03:35:32.418394
NCT01476475|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-12-16|2016-12-16|2013-12-19|November 2011||2011-11-01|December 2016|2016-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients|A Randomized, 24-week, Open-label, 2-arm Parallel-group, Multicenter Study Comparing the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine on Top of Metformin in Type 2 Diabetic Patients|Completed||Phase 2|323|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 03:35:32.543812|2017-10-11 03:35:32.543812
NCT01476462|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-05-23|||January 2009||2009-01-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Observational|PdL-SMN1||Second Malignant Neoplasms After Childhood ALL Therapy|Second Malignant Neoplasms After Childhood ALL Therapy; An International Ponte di Legno Study|Completed||N/A|642|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 03:35:33.475855|2017-10-11 03:35:33.475855
NCT01476449|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2016-10-03|||November 2011||2011-11-01|November 2014|2014-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema|Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema|Completed||Phase 2|20|Actual|Retina Vitreous Associates of Florida||2|||f||||t||||||||||2017-10-11 03:35:33.56867|2017-10-11 03:35:33.56867
NCT01476436|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2012-04-10|||November 2011||2011-11-01|April 2012|2012-04-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Low Carbohydrate Diet - Effect on Plasma Lipids and Metabolic Markers|Low Carbohydrate Diet - Effect on Plasma Lipids and Metabolic Markers|Unknown status|Recruiting|N/A|22|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 03:35:33.729881|2017-10-11 03:35:33.729881
NCT01476423|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2014-12-19|||January 2004||2004-01-01|December 2014|2014-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Observational Registry of the Treatment of Glanzmann's Thrombasthenia|Treatment of Glanzmann's Thrombasthenia: A Prospective Observational Registry|Completed||N/A|218|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:35:33.892175|2017-10-11 03:35:33.892175
NCT01476410|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-09-27|||November 2011||2011-11-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma|A Phase II Trial of Sequential SGN-35 Therapy With Adriamycin, Vinblastine, and Dacarbazine (S-AVD) for Older Patients With Untreated Hodgkin Lymphoma|Active, not recruiting||Phase 2|48|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 03:35:34.038236|2017-10-11 03:35:34.038236
NCT01476397|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-11-03|||December 2011||2011-12-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Probiotic Formula and Infant Growth|ASSESSMENT OF GROWTH OF INFANTS FED FORMULA WITH PROBIOTICS|Completed||N/A|||Nestlé||2|||f||||f||||||||||2017-10-11 03:35:34.190002|2017-10-11 03:35:34.190002
NCT01476384|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-04-10|||October 2010||2010-10-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Orthogonal Polarisation Study in Young, Elderly and Type 2 Diabetics|Postprandial Insulin Release and the Impact on Muscle Perfusion|Completed||N/A|45|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:35:34.28878|2017-10-11 03:35:34.28878
NCT01476371|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2014-09-25|||January 2012||2012-01-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|June 2012|Actual|2012-06-01||Interventional|||Study of Mindfulness-based Group Treatment in Patients With Depression and Anxiety|Mindfulness-based Group Treatment of Patients With Depression and Anxiety: Effects on Symptoms and Inflammatory Markers in a Randomized Controlled Multicenter Study in Primary Care|Completed||N/A|215|Actual|Lund University||2|||f||||f||||||||||2017-10-11 03:35:34.406489|2017-10-11 03:35:34.406489
NCT01476358|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-11-12|||November 2011||2011-11-01|November 2012|2012-11-01||||June 2013|Anticipated|2013-06-01||Interventional|NNVAS||Effect of Vitamin A Supplementation on Immune Responses in Human Neonates|A Randomized Controlled Trial in Human Neonates to Determine the Effect of Vitamin A Supplementation on Immune Responses|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 03:35:34.510944|2017-10-11 03:35:34.510944
NCT01476345|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-10-03|2014-10-03||November 2011||2011-11-01|October 2014|2014-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||All randomized participants.|A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Participants|Bioequivalence Study Comparing the Pharmacokinetics and Pharmacodynamics of LY2963016 With Insulin Glargine in Healthy Volunteers|Completed||Phase 1|80|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:35:34.627866|2017-10-11 03:35:34.627866
NCT01476332|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2012-05-15|||November 2011||2011-11-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)|A Single Dose (Part 1) and Multiple Dose (Part 2) Phase I, Double-blind, Placebo-controlled, Safety, Tolerability and Pharmacokinetic Study of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers|Completed||Phase 1|37|Actual|Laurantis Pharma, Ltd.||3|||f||||f||||||||||2017-10-11 03:35:34.935437|2017-10-11 03:35:34.935437
NCT01476319|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2017-04-05|||November 9, 2009|Actual|2009-11-09|April 2017|2017-04-01|September 9, 2014|Actual|2014-09-09|September 9, 2014|Actual|2014-09-09||Interventional|||Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department||Completed||N/A|22|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||||||||||||2017-10-11 03:35:35.050714|2017-10-11 03:35:35.050714
NCT01476306|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-17|||November 2011||2011-11-01|November 2011|2011-11-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|TELEMED-PD||Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing— A Comparative Effectiveness Study|Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing— A Comparative Effectiveness Study|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:35:35.134982|2017-10-11 03:35:35.134982
NCT01476293|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-02-17|||August 2011||2011-08-01|November 2011|2011-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation|Non-invasive Optical Medical Device for Monitoring and Detecting Peripheral Intravenous Infusion Sites for Infiltration and Extravasation in Subjects Receiving Continuous Fluids|Completed||N/A|139|Actual|ivWatch, LLC|||1||f||||t||||||||||2017-10-11 03:35:35.214905|2017-10-11 03:35:35.214905
NCT01476280|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-17|||May 2011||2011-05-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Palonosetron Versus Ramosetron for the Prevention of Postoperative Nausea and Vomiting|A Randomized Double Blind Study to Evaluate Efficacy of Ramosetron and Palonosetron for Prevention of Postoperative Nausea and Vomiting After Gynaecological Laparoscopic Surgery|Completed||N/A|100|Actual|Incheon St.Mary's Hospital||2|||f||||t||||||||||2017-10-11 03:35:35.284728|2017-10-11 03:35:35.284728
NCT01476267|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2016-11-01|||October 2011||2011-10-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers|An Open Label, Single Centre Study to Investigate the Metabolic Profile of Dalcetrapib After a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:35:35.354163|2017-10-11 03:35:35.354163
NCT01476254|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2012-11-19|||November 2011||2011-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Respiratory Complications After Laparoscopic Surgery|Respiratory Complications After Laparoscopic Surgery|Completed||N/A|60|Actual|Herlev Hospital|||2||f||||f||||||||||2017-10-11 03:35:35.423105|2017-10-11 03:35:35.423105
NCT00018564|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 2000||2000-10-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Novel Therapies for Essential Tremor|Novel Therapies for Essential Tremor|Completed||Phase 3|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.96874|2017-10-11 04:33:12.96874
NCT01476241|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-17|||September 2005||2005-09-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Observational|||Percutaneous Endoscopic Gastrostomy Tube Placement by Otorhinolaryngologist|Percutaneous Endoscopic Gastrostomy Tube Placement by Otorhinolaryngologist: a Single Institution Experience|Completed||N/A|292|Actual|Helsinki University|||2||f||||f||||||||||2017-10-11 03:35:35.533241|2017-10-11 03:35:35.533241
NCT01476228|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-11-17|||November 2011||2011-11-01|August 2011|2011-08-01|December 2015|Anticipated|2015-12-01|November 2013|Anticipated|2013-11-01||Interventional|||EEG Objectification in Neuropsychiatry|EEG Objectification in Neuropsychiatry|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 03:35:35.624131|2017-10-11 03:35:35.624131
NCT01476215|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-11-20|||November 2009||2009-11-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions|A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions|Completed||Phase 1|18|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:35:35.720791|2017-10-11 03:35:35.720791
NCT01476202|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2013-07-30|2013-07-30||November 2011||2011-11-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|NRT||Provoked Craving Relief Study by NRT|A Pilot Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Strip, Nicorette ® Nicotine Lozenge and Gum|Completed||Phase 2|120|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:35:35.839046|2017-10-11 03:35:35.839046
NCT01476189|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-11-20|||November 2009||2009-11-01|June 2014|2014-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations|A Repeat Dose PK Study Investigating the Extent of Paracetamol Absorption From Two Sustained Release Paracetamol Formulations|Completed||Phase 1|28|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:35:36.532333|2017-10-11 03:35:36.532333
NCT01476176|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-11-20|||July 2009||2009-07-01|June 2014|2014-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Pharmacokinetic Study of an Experimental Paracetamol Formulation|A Pivotal Pharmacokinetic Study Investigating the Extent of Absorptions of Paracetamol and Caffeine for Two Different Paracetomol Formulations Containing Caffeine|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:35:36.64782|2017-10-11 03:35:36.64782
NCT01476163|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-08-24||||||August 2017|2017-08-01||||||||Expanded Access|||Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease|Physician Initiated Expanded Access Request for Treatment Use of Migalastat Hydrochloride (AT1001), an Investigational Treatment for Individual Patients With Fabry Disease (AT1001-188)|Available||N/A|||Amicus Therapeutics|||||f||||||||||||||2017-10-11 03:35:36.739368|2017-10-11 03:35:36.739368
NCT01476150|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2011-11-22|||January 2012||2012-01-01|November 2011|2011-11-01|March 2014|Anticipated|2014-03-01|January 2014|Anticipated|2014-01-01||Observational|||Prevalence and Predictors of Osteoporosis in the Beijing's Urban Population|Prevalence and Predictors of Osteoporosis in the Beijing's Urban Population|Unknown status|Not yet recruiting|N/A|10000|Anticipated|China-Japan Friendship Hospital|||8||f||||t||||||Samples Without DNA|"     complete blood   "|||2017-10-11 03:35:36.85374|2017-10-11 03:35:36.85374
NCT01476137|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2013-11-07|||October 2011||2011-10-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers|An Open-Label, Two Part, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination With the AKT Inhibitor GSK2110183 in Subjects With Solid Tumors and Multiple Myeloma|Completed||Phase 1|20|Actual|GlaxoSmithKline||10|||f||||t||||||||||2017-10-11 03:35:36.945507|2017-10-11 03:35:36.945507
NCT01476124|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2013-07-15|||August 2011||2011-08-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine|A Double-Blind, 3-Part Crossover Study to Assess the Pharmacokinetics and Tolerability of Single Doses of Gabapentin Enacarbil and Morphine Administered Alone and in Combination in Healthy Subjects|Completed||Phase 1|18|Actual|XenoPort, Inc.||3|||f||||f||||||||||2017-10-11 03:35:37.078003|2017-10-11 03:35:37.078003
NCT01476111|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2015-03-06|||December 2011||2011-12-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer|A Prospective, Exploratory Observational Study Evaluating Specific Biomarkers in Primary Invasive Breast Cancer and Their Modulation by Standard Neoadjuvant Therapy|Terminated||N/A|117|Actual|GlaxoSmithKline|||1|"Study termination due to negative Phase III of another study product from same technology   platform."|f||||||||||Samples With DNA|"     Tissue   "|||2017-10-11 03:35:37.192106|2017-10-11 03:35:37.192106
NCT01476085|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-06-27|||July 2011||2011-07-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL)|An Open-label Study to Evaluate the Utility of the Apoptosis Imaging Biomarker 18F]ML10 to Assess the Response to Chemotherapy in Patients With Non-Hodgkin's Lymphoma(NHL).|Terminated||Phase 1|1|Actual|GlaxoSmithKline||1||"Study terminated as ongoing analysis suggested objectives not practical to achieve with study   as implemented"|f||||f||||||||||2017-10-11 03:35:37.461949|2017-10-11 03:35:37.461949
NCT01476072|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2013-06-27|||April 2010||2010-04-01|June 2013|2013-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||31P MRS Ischaemic Exercise Optimisation and COPD|31P MRS Ischaemic Exercise Optimisation and COPD Myopathy Study|Completed||Phase 1|75|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:35:37.545995|2017-10-11 03:35:37.545995
NCT01476059|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-04|2017-06-26|||May 2004||2004-05-01|June 2017|2017-06-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|ADERE (Ped)||Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT|Prospective, Parallel-group, Randomized Study to Evaluate the Compliance to the Treatment of Children Aged Between 6 and 14 Years Old With Persistent Moderate or Severe Asthma, Receiving the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose Twice a Day. ADERE PROJECT|Completed||Phase 4|472|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:35:37.629497|2017-10-11 03:35:37.629497
NCT01476046|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-15|2017-06-09|||March 8, 2011|Actual|2011-03-08|June 2017|2017-06-01|June 17, 2012|Actual|2012-06-17|June 17, 2012|Actual|2012-06-17||Interventional|||Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.|A Two-part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamicsof Single and Repeat Doses of Intravenously Infused GSK1995057 in Healthy Subjects.|Completed||Phase 1|56|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:35:37.723325|2017-10-11 03:35:37.723325
NCT01476033|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2013-04-09|||October 2011||2011-10-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Strong Women Study|Impact of Encapsulated Fruit, Berry and Vegetable Juice Powder Concentrate on Oxidative Stress, Inflammation and Blood Flow Before and Post Exercise in Overweight, Middle-aged, Women.|Completed||N/A|44|Actual|Green Beat||2|||f||||t||||||||||2017-10-11 03:35:37.83552|2017-10-11 03:35:37.83552
NCT01476020|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-17|||November 2011||2011-11-01|November 2011|2011-11-01|July 2015|Anticipated|2015-07-01|July 2012|Anticipated|2012-07-01||Observational|ITALICplus||Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel|Is There A LIfe for DES After Discontinuation of Clopidogrel:The ITALIC PLUS Trial|Unknown status|Not yet recruiting|Phase 3|1240|Anticipated|Gilard, Martine|||2||f||||t||||||||||2017-10-11 03:35:37.926789|2017-10-11 03:35:37.926789
NCT01475994|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2012-04-04|||November 2011||2011-11-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|Neurop||Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic Dermatitis|Pilot Study to Assess the Effect of Pollen Challenges in an Environmental Challenge Chamber on Dermal Symptoms in Patients With Atopic Dermatitis|Completed||N/A|18|Actual|Fraunhofer-Institute of Toxicology and Experimental Medicine||2|||f||||f||||||||||2017-10-11 03:35:38.118501|2017-10-11 03:35:38.118501
NCT01475981|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2011-11-17|||January 2010||2010-01-01|November 2011|2011-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects|Randomized,Double-blind,Placebo-controlled,Ascending Dose Part Evaluating Safety,Tolerability and Pharmacokinetics (PK) of JTK-853 (Fasted/Fed) and Randomized,Open-label,Crossover Part Evaluating Food Effect on PK in Healthy Male Subjects|Completed||Phase 1|70|Actual|Akros Pharma Inc.||11|||f||||f||||||||||2017-10-11 03:35:38.188222|2017-10-11 03:35:38.188222
NCT01475968|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2013-11-05|||December 2004||2004-12-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|June 2011|Actual|2011-06-01||Interventional|XCON||Physiological Changes in Adults With Metabolic Syndrome Exposed to Ultrafine Air Particles|Physiological Changes in Adults With Metabolic Syndrome Exposed to Concentrated Ultrafine Chapel Hill Air Particles|Completed||N/A|48|Actual|Environmental Protection Agency (EPA)||2|||f||||f||||||||||2017-10-11 03:35:38.286483|2017-10-11 03:35:38.286483
NCT01475955|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-09-23|2013-09-20||December 2011||2011-12-01|September 2016|2016-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)|A Phase II Study of Photodynamic Therapy With LEVULAN® Topical Solution + Blue Light Versus LEVULAN® Topical Solution Vehicle + Blue Light Using Spot and Broad Area Application and Incubation Times of 1, 2 and 3 Hours for the Treatment of Multiple Actinic Keratoses on the Face or Scalp|Completed||Phase 2|235|Actual|DUSA Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-10-11 03:35:38.6505|2017-10-11 03:35:38.6505
NCT01475942|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-01-26|||January 2011||2011-01-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Probiotic Intervention With Elderly Subjects|Randomized Placebo Controlled Study to Assess the Effect of a Probiotic Supplement on the Subclinical Levels of Intestinal C. Difficile Among Elderly|Completed||Phase 2|104|Actual|Danisco||2|||f||||f||||||||No||2017-10-11 03:35:45.865029|2017-10-11 03:35:45.865029
NCT01475929|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-08-11|||June 2011||2011-06-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|IBS2||Effect of Probiotic Supplement on Bowel Function|Effect of Probiotic Supplement on Bowel Function|Terminated||Phase 2|149|Actual|Danisco||3||Protocol violations|f||||f||||||||||2017-10-11 03:35:45.95147|2017-10-11 03:35:45.95147
NCT01475916|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2011-11-17|||December 2011||2011-12-01|November 2011|2011-11-01|October 2012|Anticipated|2012-10-01|April 2012|Anticipated|2012-04-01||Interventional|||Quality of Life in Asthmatic Children at School Age|Quality of Life in Asthmatic Children at School Age : Influence of Therapeutic Education|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||f||||||||||2017-10-11 03:35:46.040178|2017-10-11 03:35:46.040178
NCT01475903|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2011-11-17|||November 2011||2011-11-01|November 2011|2011-11-01|May 2015|Anticipated|2015-05-01|November 2014|Anticipated|2014-11-01||Observational|ERNEST||Assessment of Nutritional Consequences of Sleeve Gastrectomy|Assessment of Nutritional Consequences of Sleeve Gastrectomy|Unknown status|Not yet recruiting|N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 03:35:46.112385|2017-10-11 03:35:46.112385
NCT01475890|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-03-15|||July 2011||2011-07-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|June 2013|Actual|2013-06-01||Interventional|||Vitamin D Supplementation in HIV|Safe and Effective Vitamin D Supplementation in HIV|Completed||Phase 2/Phase 3|58|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 03:35:46.204448|2017-10-11 03:35:46.204448
NCT01475877|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-05-01|||May 2011||2011-05-01|May 2016|2016-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy|Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)|Completed||Phase 4|20|Actual|Virdi Eye Clinic|||1||f||||f||||||||No|In the observational study conducted, there was no significant difference in pain levels or epithelial healing of post-photorefractive keratectomy patients who were treated with bromfenac 0.09% or nepafenac 0.1%|2017-10-11 03:35:46.296969|2017-10-11 03:35:46.296969
NCT01475864|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2013-06-26|||November 2011||2011-11-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone Clearance|Prospective Evaluation of the Clinical Utility of Endoscopically-placed Self Expandable Stents|Withdrawn||N/A|0|Actual|University of Florida|||1|no subjects were found who met criteria|f||||f||||||||||2017-10-11 03:35:46.372789|2017-10-11 03:35:46.372789
NCT01475851|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2015-06-18|2013-08-22||December 2011||2011-12-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|June 2013|Actual|2013-06-01||Interventional|||Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs|A Multi-center, Open-label Study of GSK548470 (Tenofovir Disoproxil Fumarate) in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs|Completed||Phase 3|34|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:35:46.466046|2017-10-11 03:35:46.466046
NCT01475838|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-05-06|2015-01-08|2014-08-25|November 2011||2011-11-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Interventional||Safety Analysis Set: participants were randomized and received at least one dose of study medication.|Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients|A Phase 3b Randomized, Open-Label Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI + RTV) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (EVG/COBI/FTC/TDF) in Virologically-Suppressed, HIV-1 Infected Patients|Completed||Phase 3|438|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||f||||||||||2017-10-11 03:35:47.463397|2017-10-11 03:35:47.463397
NCT01475825|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-08-01|||December 2011||2011-12-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|FOCUS FH||A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol|Completed||Phase 3|310|Actual|Kastle Therapeutics, LLC||6|||f||||t||||||||||2017-10-11 03:35:48.77793|2017-10-11 03:35:48.77793
NCT01475812|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2011-11-18|||March 2007||2007-03-01|November 2011|2011-11-01||||||||Observational|Hyperinflation||Daily Activities Are Sufficient to Induce Dynamic Pulmonary Hyperinflation and Dyspnea in Chronic Obstructive Pulmonary Disease Patients||Completed||N/A|19|Actual|Federal University of São Paulo|||1||f||||f||||||||||2017-10-11 03:35:49.214164|2017-10-11 03:35:49.214164
NCT01475799|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-10-31|||November 2011||2011-11-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|July 2014|Actual|2014-07-01||Interventional|||Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis|Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis|Active, not recruiting||N/A|112|Actual|Direct Flow Medical, Inc.||1|||f||||t||||||||||2017-10-11 03:35:49.287722|2017-10-11 03:35:49.287722
NCT01475786|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-09-20||2015-12-07|August 2012||2012-08-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy|A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy|Completed||Phase 2|104|Actual|ViroMed Co., Ltd. dba VM BioPharma||3|||f||||t||||||||||2017-10-11 03:35:49.385823|2017-10-11 03:35:49.385823
NCT01475773|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-18|||November 2011||2011-11-01|October 2011|2011-10-01||||November 2012|Anticipated|2012-11-01||Observational|||Psychological Assessment of Adults Seeking Orthodontic Treatment|Impact of Personality Characteristics and Self-esteem on the Relationship Between Orthodontic Treatment Need and Oral-health Related Quality of Life in Adults.|Unknown status|Not yet recruiting|N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 03:35:49.5148|2017-10-11 03:35:49.5148
NCT01475760|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2012-08-01|||November 2011||2011-11-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease|A Multi-Center, Open Label Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease|Completed||N/A|167|Actual|Denver Nephrologists, P.C.||3|||f||||f||||||||||2017-10-11 03:35:49.582606|2017-10-11 03:35:49.582606
NCT01475747|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-01-19|||September 2011||2011-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|SPRINTFAST||Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study|Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)|Recruiting||N/A|600|Anticipated|University of Utah|||1||f||||t||||||Samples Without DNA|"     Urine, plasma and serum samples.   "|||2017-10-11 03:35:49.683095|2017-10-11 03:35:49.683095
NCT01475734|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2016-11-20|2014-04-17|2012-11-21|December 2011||2011-12-01|November 2016|2016-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes|A Single-site, Randomized, Double-blind, Placebo-controlled, Parallel-group, Stepped Glucose Clamp Study to Assess the Effects of Albiglutide on Counter-regulatory Hormone Responses and Recovery From Hypoglycemia in Subjects With Type 2 Diabetes Mellitus.|Completed||Phase 2|44|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:35:49.833591|2017-10-11 03:35:49.833591
NCT00005459|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||September 2000||2000-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.059769|2017-10-11 04:27:05.059769
NCT01475721|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-04-24|2015-12-03||November 18, 2011|Actual|2011-11-18|April 2017|2017-04-01|June 23, 2015|Actual|2015-06-23|June 23, 2015|Actual|2015-06-23||Interventional|AUSTRI||SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.|SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma|Completed||Phase 4|11751|Actual|GlaxoSmithKline||6|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:35:51.20265|2017-10-11 03:35:51.20265
NCT01475708|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-03-23|||May 2011||2011-05-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|||Doxycycline in Therapy of Erythema Migrans|Doxycycline in Therapy of Erythema Migrans - do the Accompanying Symptoms Influence the Outcome?|Completed||N/A|400|Actual|University Medical Centre Ljubljana|||3||f||||f||||||Samples Without DNA|"     whole blood, serum, cerebrospinal fluid, skin tissue   "|Undecided||2017-10-11 03:35:55.595979|2017-10-11 03:35:55.595979
NCT01475695|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-06-27|||April 21, 2011|Actual|2011-04-21|June 2017|2017-06-01|May 19, 2011|Actual|2011-05-19|May 19, 2011|Actual|2011-05-19||Interventional|||GSK2251052 Mass Balance in Healthy Adult Subjects|An Open Label, Non-Randomized, Single Dose, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2251052 Administered as a Single Intravenous Dose to Healthy Adult Subjects|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:35:55.879216|2017-10-11 03:35:55.879216
NCT01475682|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2014-07-16|||November 2011||2011-11-01|July 2014|2014-07-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea|Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea - Prospective 9 Years Follow-up Study|Unknown status|Recruiting|N/A|167|Anticipated|The University of Hong Kong|||1||f||||t||||||||||2017-10-11 03:35:56.002375|2017-10-11 03:35:56.002375
NCT01475669|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2014-09-17|||January 2012||2012-01-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|REPLACE||Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery|REPLACE (Randomized Evaluation of Fibrinogen Versus Placebo in Complex Cardiovascular Surgery): a Prospective, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study for the Use of Fibrinogen Concentrate (Human) (FCH) in Complex Cardiovascular Surgery|Completed||Phase 3|152|Actual|CSL Behring||2|||f||||t||||||||||2017-10-11 03:35:56.110427|2017-10-11 03:35:56.110427
NCT01475656|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2013-04-17|||November 2011||2011-11-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Efficacy of Keppra for Neonatal Seizures|Safety, Tolerability, and Efficacy of Levetiracetam for Neonatal Seizures|Terminated||N/A|2|Actual|Children's Hospital Medical Center, Cincinnati|||2|difficulty with recruitment|f||||t||||||||||2017-10-11 03:35:56.289001|2017-10-11 03:35:56.289001
NCT01475643|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2017-04-25|||June 2013|Actual|2013-06-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.|Safety and Efficacy of Topical Loteprednol Etabonate 0.5%, Versus Prednisolone Acetate 1%, for the Treatment of Intraocular Inflammation Following Surgery for Childhood Cataract|Active, not recruiting||Phase 3|170|Anticipated|Bausch & Lomb Incorporated||2|||f||||f||||||||Yes||2017-10-11 03:35:56.361523|2017-10-11 03:35:56.361523
NCT01475630|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2011-11-21|||June 2003||2003-06-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||Physical Therapy for Temporomandibular Joint (TMJ) Closed Lock|Randomised Controlled Trial on Physical Therapy PT) for TMJ Closed Lock|Completed||N/A|49|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-10-11 03:35:56.443541|2017-10-11 03:35:56.443541
NCT01475617|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-01-20|||November 2011||2011-11-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy of a Novel Multivitamin-Mineral Supplement in Preventing Vitamin Deficiency in Postoperative Bariatric Patients|Efficacy of a Novel Multivitamin-Mineral Supplement in Preventing Vitamin Deficiency in Postoperative Bariatric Patients|Completed||Phase 2/Phase 3|61|Actual|Yasoo Health||2|||f||||f||||||||||2017-10-11 03:35:56.545296|2017-10-11 03:35:56.545296
NCT01475604|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-17|2012-07-06|||November 2011||2011-11-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Impact of Noninvasive Targeted Pulsed Electromagnetic Field (tPEMF) on Opioid Use, Pain, and Joint Function Following Total Knee Arthroplasty|Impact of Noninvasive Targeted Pulsed Electromagnetic Field (tPEMF) on Opioid Use, Pain, and Joint Function Following Total Knee Arthroplasty: A Double-Blind, Randomized, Sham-controlled Trial|Terminated||Phase 4|23|Actual|Amp Orthopedics, Inc.||2||Sponsor decision|f||||f||||||||||2017-10-11 03:35:56.726046|2017-10-11 03:35:56.726046
NCT01475591|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-09-22|||October 2011||2011-10-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|||Individually Tailored Web-based Multimodal Pain Rehabilitation in Primary Health Care|Individually Tailored Web-based Multimodal Pain Rehabilitation in Primary Health Care|Completed||N/A|109|Actual|Luleå Tekniska Universitet||1|||f||||f||||||||||2017-10-11 03:35:56.836686|2017-10-11 03:35:56.836686
NCT01475578|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-11-16|||March 2002||2002-03-01|November 2011|2011-11-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)|A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel, Comparative, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)|Completed||Phase 2|240|Actual|Sinphar Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-11 03:35:56.921531|2017-10-11 03:35:56.921531
NCT01475565|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2015-12-10|||May 2013||2013-05-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome|Insulin Resistance Before and During Pregnancy in Women With PCOS|Terminated||N/A|2|Actual|Virginia Commonwealth University|||2|Only 2 participants were enrolled|f||||f||||||Samples With DNA|"     -  blood sample        -  blood sample sample for DNA        -  fasting plasma for insulin, glucose, sex steroids (testosterone, androstenedione,          DHEA-sulfate, estradiol, estrone, progesterone), sex hormone-binding globulin and          estrogen metabolites        -  blood sample for oral glucose tolerance test        -  urine for estrogen metabolites   "|||2017-10-11 03:35:57.046534|2017-10-11 03:35:57.046534
NCT01475552|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-12-12|||September 2010||2010-09-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus|The Effect of Point-of-care Platelet Function Assay Guided Antiplatelet Therapy on the Periprocedural Increase of Cardiac Enzymes.|Completed||Phase 4|130|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 03:35:57.181312|2017-10-11 03:35:57.181312
NCT01475539|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-01-09|||November 2011||2011-11-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine|Immunogenicity and Safety of Different Sequential Schedules of Inactivated Poliomyelitis Vaccine (IMOVAX Polio®) Followed by Oral Poliomyelitis Vaccine in Healthy Infants in China Versus Oral Poliomyelitis Vaccine Alone.|Completed||Phase 4|456|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:35:57.269913|2017-10-11 03:35:57.269913
NCT01475526|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-11-16|||October 2011||2011-10-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||The Value of Our Health|El Valor de Nuestra Salud (The Value of Our Health)|Completed||N/A|370|Actual|San Diego State University||2|||f||||t||||||||||2017-10-11 03:35:57.367466|2017-10-11 03:35:57.367466
NCT01475513|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-03-23|||November 2011||2011-11-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women|Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women|Active, not recruiting||Phase 4|47|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 03:35:57.456074|2017-10-11 03:35:57.456074
NCT01475500|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-03-07|||April 2011||2011-04-01|March 2017|2017-03-01|November 30, 2022|Anticipated|2022-11-30|July 30, 2022|Anticipated|2022-07-30||Observational|||Nashville Early Diagnosis Lung Cancer Project|Nashville Early Diagnosis Lung Cancer Project|Recruiting||N/A|320|Anticipated|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||Samples With DNA|"     Sputum, Blood, Urine, Nasal brushings, Buccal cells, Bronchical washings, Bronchioalveolar     lavage brushings, Endobronchial biopsies   "|||2017-10-11 03:35:57.597782|2017-10-11 03:35:57.597782
NCT01475487|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-06-24|2015-06-24||April 2011||2011-04-01|June 2015|2015-06-01|September 2013|Actual|2013-09-01|September 2011|Actual|2011-09-01||Interventional||Characteristics of participants and human cadavers|Ultrasound Guided Versus Palpation Guided Cricothyrotomy With Poorly Defined Anatomical Landmarks|A Comparison of Ultrasound Versus Digital Palpation Guided Cricothyrotomy in Subjects With Poorly Defined Anatomical Landmarks|Completed||N/A|47|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 03:35:57.738021|2017-10-11 03:35:57.738021
NCT01475474|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2013-09-27|2013-07-02||December 2009||2009-12-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|REST||A Study to Evaluate the Safety, Tolerability and Effectiveness of the Renew Insert in Treating Accidental Bowel Leakage|A Multi-Center, Prospective, Non-Randomized Study of the Renew Insert Efficacy, Safety and Tolerability For the Management of Accidental Bowel Leakage Due to Bowel Incontinence|Completed||N/A|97|Actual|Renew Medical||1|||f||||f||||||||||2017-10-11 03:35:58.188884|2017-10-11 03:35:58.188884
NCT01475461|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-12-06|2016-12-06|2014-04-21|November 2011||2011-11-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Baseline analysis population included all randomized participants who received at least 1 dose of study treatment.|Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes|A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose-ranging, Parallel Group Study To Evaluate Safety And Efficacy Of Pf-04937319 And Sitagliptin On Glycemic Control In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin|Completed||Phase 2|345|Actual|Pfizer||6|||f||||t||||||||||2017-10-11 03:35:58.504584|2017-10-11 03:35:58.504584
NCT01475448|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-05-02|||January 2012||2012-01-01|November 2011|2011-11-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Long Distance Running Training by Older Adults|Effects of Long Distance Running Training on the Posture and Movement Control of Sedentary Older Adults|Completed||N/A|34|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:36:01.69065|2017-10-11 03:36:01.69065
NCT01475435|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-11-16|||August 2011||2011-08-01|August 2011|2011-08-01|August 2013|Anticipated|2013-08-01|December 2011|Anticipated|2011-12-01||Interventional|||Oxidative Stress Markers Evaluation Before and After Periodontal Treatment of Diabetics Type 2 Patients|Oxidative Stress Markers Evaluation Before and After Periodontal Treatment of Diabetics Type 2 Patients With Generalized Chronic Periodontitis and Healthy Periodontium|Unknown status|Recruiting|Early Phase 1|200|Anticipated|University of Sao Paulo||4|||f||||t||||||||||2017-10-11 03:36:01.81067|2017-10-11 03:36:01.81067
NCT01475422|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-11-16|||September 2011||2011-09-01|November 2011|2011-11-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||Effectiveness of the Self Monitoring of Capillary Blood Glucose at Home|Effectiveness of the Self Monitoring of Capillary Blood Glucose at Home in Metabolic Control of People With Diabetes Mellitus|Unknown status|Recruiting|N/A|91|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:36:01.961887|2017-10-11 03:36:01.961887
NCT01475409|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-11-16|||July 2008||2008-07-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study on Changes in IFN-gamma Levels Following Anti-TNF Treatment in Patients Undergoing Serial QuantiFERON-TB Gold In-Tube|Dynamic Changes in IFN-gamma Plasma Levels Following Anti-TNF Treatment in Patients With Inflammatory Rheumatic Diseases Undergoing Serial QuantiFERON-TB Gold In-Tube Testing: a Prospective Study in a Low Tuberculosis Burden Country|Completed||N/A|119|Actual|University of Roma La Sapienza||1|||f||||f||||||||||2017-10-11 03:36:02.095742|2017-10-11 03:36:02.095742
NCT01475396|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2012-06-18|||March 2006||2006-03-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of Physical Activity on the Brain|Clinical Study on the Effect of Physical Activity on Cognition and Memory in the Elderly|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|University Hospital Muenster||3|||f||||f||||||||||2017-10-11 03:36:02.222919|2017-10-11 03:36:02.222919
NCT01475383|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-07-30|||April 2012||2012-04-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome|A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study Of The Safety And Efficacy Of PF-03654746 In Adults With Tourette's Syndrome|Terminated||Phase 2|1|Actual|Pfizer||2||See termination reason in detailed description.|f||||f||||||||||2017-10-11 03:36:02.383674|2017-10-11 03:36:02.383674
NCT01475357|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2014-10-14|||October 2011||2011-10-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Intestinal Function in Neonates With Complex Congenital Heart Disease|Intestinal Function in Neonates With Complex Congenital Heart Disease|Completed||N/A|27|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:36:02.621125|2017-10-11 03:36:02.621125
NCT01475344|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-12-07|||September 2011||2011-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)|A Multicenter Double-blind, Placebo Controlled, Randomized, Pilot Trial to Assess the Efficacy of Pre-hospital Administration of Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)|Completed||Phase 1/Phase 2|67|Actual|Medical University Innsbruck||2|||f||||t||||||||||2017-10-11 03:36:02.741595|2017-10-11 03:36:02.741595
NCT01475331|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-03-09|||November 2011||2011-11-01|March 2017|2017-03-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts||Completed||Phase 2|46|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 03:36:02.858564|2017-10-11 03:36:02.858564
NCT01475318|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2011-11-16|||October 2011||2011-10-01|November 2011|2011-11-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of Pregnancy|A Pilot Study on the Combined Use of Letrozole, Miferpristone and Misoprostol in Termination of First Trimester Pregnancy up to 63 Days Gestation|Unknown status|Recruiting|N/A|50|Anticipated|The University of Hong Kong||1|||f||||||||||||||2017-10-11 03:36:02.944012|2017-10-11 03:36:02.944012
NCT01475305|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2017-07-20|2017-04-05||October 20, 2011|Actual|2011-10-20|July 2017|2017-07-01|December 13, 2012|Actual|2012-12-13|December 3, 2011|Actual|2011-12-03||Interventional||The Intent-to-treat (ITT) population included all participants who were randomized into the study.|Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)|A Phase 1 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of MEDI-557 in Healthy Adults Intranasally Challenged With Respiratory Syncytial Virus (RSV)|Terminated||Phase 1|7|Actual|MedImmune LLC|The study was terminated before an adequate number of subjects were enrolled.|2||"The study was terminated as it was determined to not be feasible to complete enrollment and the   study within the required timeline and budget."|f||||f||||||||||2017-10-11 03:36:03.064951|2017-10-11 03:36:03.064951
NCT01475292|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-05-02|||November 2011||2011-11-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Tolerability of Treatment With Repeat Doses of Inhaled RV568 in Patients With COPD|Completed||Phase 2|30|Actual|Respivert Ltd||3|||f||||f||||||||||2017-10-11 03:36:04.204107|2017-10-11 03:36:04.204107
NCT01475279|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-11-07|||July 2011||2011-07-01|November 2011|2011-11-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin|An Open-Label, Multiple-Dose, Single-Center, Sequential, Inpatient Study to Determine the Effect of T89 on Steady-State Pharmacodynamics of Warfarin in Healthy Subjects|Completed||Phase 1|24|Actual|Tasly Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 03:36:04.302708|2017-10-11 03:36:04.302708
NCT01475266|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-03-27|||November 2011||2011-11-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)|Randomized, Placebo-controlled, Double-blinded Study of Single Immediate Instillation of EO9 After TURBT in Patients With NMIBC|Terminated||Phase 2/Phase 3|51|Actual|Nippon Kayaku Co.,Ltd.||2||Sponsor's decision|f||||t||||||||||2017-10-11 03:36:04.381406|2017-10-11 03:36:04.381406
NCT01475253|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-08-19|2014-08-05||November 2011||2011-11-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis|A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension|Terminated||Phase 2|104|Actual|Allergan|As per protocol, efficacy analyses were not performed for the Sham Cytoscopic Procedure-Randomized Study Arm/Group. Only safety analyses were completed.|3||This study was not enrolled completely and was terminated.|f||||t||||||||||2017-10-11 03:36:04.538357|2017-10-11 03:36:04.538357
NCT01475240|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2014-04-10|||January 2012||2012-01-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|SSAT044||The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function|A Cross-sectional Controlled Study to Evaluate the Impact of Hyperbilirubinemia on Markers of Cardiovascular Disease, Neurocognitive Function and Renal Markers in HIV-1 Infected Subjects on Protease Inhibitors|Completed||N/A|101|Actual|St Stephens Aids Trust|||2||f||||f||||||||||2017-10-11 03:36:05.501519|2017-10-11 03:36:05.501519
NCT01475227|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2012-03-21|||December 2011||2011-12-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|SSAT043||Atazanavir/Ritonavir and Zinc Pharmacokinetic Study|A Randomized Crossover Study of the Effects of Zinc Sulphate Supplementation on Atazanavir/Ritonavir-associated Hyperbilirubinemia|Completed||Phase 4|16|Actual|St Stephens Aids Trust||2|||f||||f||||||||||2017-10-11 03:36:05.610091|2017-10-11 03:36:05.610091
NCT01475214|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2015-09-18|2015-06-10||January 2012||2012-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Musculoskeletal Effects of Bicarbonate|Musculoskeletal Benefits of Bicarbonate in Older Adults - A Dose-Finding Trial|Completed||Phase 2|244|Actual|Tufts University||3|||f||||f||||||||||2017-10-11 03:36:05.760242|2017-10-11 03:36:05.760242
NCT01475201|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-03-21|||February 2012||2012-02-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SMARTER||Step Monitoring to Improve ARTERial Health|Step Monitoring to Improve ARTERial Health|Completed||N/A|347|Actual|McGill University Health Center||2|||f||||f||||||||No||2017-10-11 03:36:06.367684|2017-10-11 03:36:06.367684
NCT01475188|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-18|||March 2007||2007-03-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy|Regulatory Lymphocytes (Treg) in the Modulation of Allergic Inflammation in Patients Treated With Specific Immunotherapy.|Completed||Phase 4|41|Actual|Ministry of Science and Higher Education, Poland||2|||f||||f||||||||||2017-10-11 03:36:06.514316|2017-10-11 03:36:06.514316
NCT01475175|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-09-12|2012-09-12||November 2011||2011-11-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Adaptive Cardiac Resynchronization Therapy Optimization at Rest and During Exercise (AdOPT CRT)|Adaptive Cardiac Resynchronization Therapy Optimization at Rest and During Exercise (AdOPT CRT)|Terminated||N/A|12|Actual|Medtronic Cardiac Rhythm and Heart Failure|A pre-planned interim evaluation of the sample size calculation assumptions was conducted. The variability of the outcome measures was higher than assumed. The study was stopped since the planned sample size would unlikely be sufficient.|1||"Decision was made to stop the study based on a pre-planned interim analysis that the sample   size would unlikely be sufficient to satisfy the primary objective."|f||||||||||||||2017-10-11 03:36:06.629559|2017-10-11 03:36:06.629559
NCT01475162|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-02-17|||August 2011||2011-08-01|February 2016|2016-02-01|August 2021|Anticipated|2021-08-01|December 2020|Anticipated|2020-12-01||Interventional|||Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease|Phase I-II Study Using Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease|Terminated||Phase 1/Phase 2|13|Actual|Medical College of Wisconsin||1||"While the study did not meet the protocol stopping rules, it was the opinion of the DSMB that   the risks of the study now outweighed the potential benefits."|f||||t||||||||||2017-10-11 03:36:06.917054|2017-10-11 03:36:06.917054
NCT01475149|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-03-23|||September 2010||2010-09-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|September 2013|Actual|2013-09-01||Observational|||Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)|Effect of Hydroxychloroquine on the Annexin A5 Resistance Assay in Antiphospholipid Antibody-Positive Patients With and Without Systemic Lupus Erythematosus|Completed||N/A|33|Actual|Hospital for Special Surgery, New York|||6||f||||f||||||Samples Without DNA|"     serum, plasma   "|No||2017-10-11 03:36:07.016593|2017-10-11 03:36:07.016593
NCT01475136|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2013-01-10|||November 2011||2011-11-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study of LY2140023 in Hepatic Impaired Participants|A Single Dose Pharmacokinetic Study of LY2140023 in Subjects With Hepatic Impairment|Completed||Phase 1|60|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:36:07.13567|2017-10-11 03:36:07.13567
NCT01475123|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-03-02|||June 2008||2008-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|June 2011|Actual|2011-06-01||Interventional|||Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil|Effects of Nicorandil on Cardiovascular Events in Patients With Coronary Artery Disease Receiving Hemodialysis|Active, not recruiting||Phase 4|268|Actual|Kumamoto University||2|||f||||t||||||||Undecided||2017-10-11 03:36:07.223457|2017-10-11 03:36:07.223457
NCT01475110|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2017-08-31|||February 2012||2012-02-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CML0609||Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib|Observational Study in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia (CML) Treated With Nilotinib: Follow-up of the Italian Patients. GIMEMA Study CML0609|Recruiting||N/A|100|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||||2017-10-11 03:36:07.324117|2017-10-11 03:36:07.324117
NCT01475097|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-06-03|2014-03-11||October 2011||2011-10-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography|A Phase 4 Randomized, Double-blind Study Comparing Patient Comfort and Safety Between Iodixanol 320 mg I/mL and Iopamidol 370 mg I/mL in Patients Undergoing Peripheral Arteriography|Completed||Phase 4|255|Actual|GE Healthcare||2|||f||||t||||||||||2017-10-11 03:36:07.603828|2017-10-11 03:36:07.603828
NCT01475084|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2015-09-08|||November 2011||2011-11-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study|Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study|Completed||Phase 2/Phase 3|40|Actual|The University Clinic of Pulmonary and Allergic Diseases Golnik||1|||f||||t||||||||||2017-10-11 03:36:07.910767|2017-10-11 03:36:07.910767
NCT01475071|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2016-03-17|2013-08-29||March 2012||2012-03-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|CoMet||Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses|Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses.|Completed||Phase 3|100|Actual|Galderma||2|||f||||f||||||||||2017-10-11 03:36:07.989019|2017-10-11 03:36:07.989019
NCT01475058|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-02-14||2017-01-31|April 2012||2012-04-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant|A Phase I/II Study of Cellular Immunotherapy With Donor Central Memory-derived Virus-specific CD8+ T-cells Engineered to Target CD19 for CD19+ Malignancies After Allogeneic Hematopoietic Stem Cell Transplant|Completed||Phase 1/Phase 2|1|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 03:36:08.424131|2017-10-11 03:36:08.424131
NCT01475045|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-11-18|||January 2011||2011-01-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Observational|ANASA||ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment)|Multicenter, Prospective, Non Interventional Observational Study in Treatments of Asthma and Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|1160|Actual|Elpen Pharmaceutical Co. Inc.|||3||f||||f||||||||||2017-10-11 03:36:08.522651|2017-10-11 03:36:08.522651
NCT01475032|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-03-28|||September 2011||2011-09-01|March 2017|2017-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PAED2/FRESH||"Efficacy Study of the Product CHF 1535 Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children"|A Phase III, 12-week, Multicentre, Multinational, Randomised, Double-blind, Double-dummy, 3 Arm-parallel Group Study to Test the Efficacy of CHF 1535 (Fixed Combination of Beclomethasone Dipropionate (BDP) Plus Formoterol Fumarate (FF)) Versus a Free Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate and Versus a Monotherapy of Beclomethasone Dipropionate in Partly Controlled Asthmatic Children|Completed||Phase 3|638|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||t||||||||||2017-10-11 03:36:08.606929|2017-10-11 03:36:08.606929
NCT01470404|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-06-12|||July 2008||2008-07-01|June 2013|2013-06-01||||May 2014|Anticipated|2014-05-01||Observational|||Pharmacogenomic Study (Adjuvant Chemotherapy)|Pharmacogenomic Study to Predict Toxicity and Response in Gastric Cancer Patients Treated With Adjuvant Chemotherapy|Unknown status|Recruiting|N/A|1000|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:37:50.814888|2017-10-11 03:37:50.814888
NCT01475019|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-11-18|||January 2004||2004-01-01|November 2011|2011-11-01|December 2012|Anticipated|2012-12-01|January 2010|Actual|2010-01-01||Interventional|||The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)|The Effect of Weight Loss With Orlistat or Sibutramine Administration , Hypocaloric Diet and Physical Exercise , on AMH Levels, in Women With Polycystic Ovary Syndrome|Unknown status|Active, not recruiting|Phase 4|200|Anticipated|Aristotle University Of Thessaloniki||4|||f||||t||||||||||2017-10-11 03:36:08.71068|2017-10-11 03:36:08.71068
NCT01475006|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-04-14|||February 2012||2012-02-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||AMG 595 First-in-Human in Recurrent Gliomas|A Phase 1 First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 595 in Subjects With Recurrent Malignant Glioma Expressing Mutant Epidermal Growth Factor Receptor Variant III (EGFRvIII)|Completed||Phase 1|32|Actual|Amgen||2|||f||||f||||||||||2017-10-11 03:36:08.802352|2017-10-11 03:36:08.802352
NCT01474993|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-02-08|2014-11-04||December 2011||2011-12-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Sulforaphane-rich Broccoli Sprout Extract for Autism|Sulforaphane-rich Broccoli Sprout Extract for Autism|Completed||Phase 2|44|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 03:36:08.925149|2017-10-11 03:36:08.925149
NCT01474980|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-17|||January 2010||2010-01-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|January 2011|Actual|2011-01-01||Observational|POCoMS||Pregnancy Outcomes in Congenital Myasthenie Syndrome|Retrospective Study :Describe the Changes of the Disease in Many Cases Likely to Aggravate.|Completed||N/A|25|Actual|Institut de Myologie, France|||1||f||||t||||||||||2017-10-11 03:36:10.339793|2017-10-11 03:36:10.339793
NCT01474967|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2011-11-18|||February 2010||2010-02-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome|Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome|Completed||N/A|50|Actual|Hormozgan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:36:10.42061|2017-10-11 03:36:10.42061
NCT01474954|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2015-05-08|||September 2011||2011-09-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors|A Phase 2b Randomized, Double-Blind, Double-Dummy Trial of 100 or 200 mg Once-Daily Doses of Cenicriviroc (CVC, TBR-652) or Once-Daily EFV, Each With Open-Label FTC/TDF, in HIV-1-Infected, Antiretroviral Treatment-Naïve, Adult Patients With Only CCR5-Tropic Virus|Terminated||N/A|5|Actual|University of California, San Francisco|||1|Low enrollment|f||||t||||||||||2017-10-11 03:36:10.559432|2017-10-11 03:36:10.559432
NCT01474941|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-01-25|||June 2011||2011-06-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects|A Phase 1, Randomized, Double-Blind, Parallel, Placebo-Controlled, Multiple-Dose Escalation Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of A Modified-Release Formulation Of PF-04620110 In Otherwise Healthy Overweight Or Obese Adult Subjects|Completed||Phase 1|27|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:36:10.623854|2017-10-11 03:36:10.623854
NCT01474928|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-05-25|||August 2009||2009-08-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|October 2013|Actual|2013-10-01||Interventional|||Asthma and Health Literacy in Newcomer Communities in the Greater Vancouver Area|Asthma and Health Literacy in Newcomer Communities in the Greater Vancouver Area (GVA): A Population-based Qualitative Study|Completed||N/A|92|Actual|University of British Columbia||4|||f||||t||||||||||2017-10-11 03:36:10.707912|2017-10-11 03:36:10.707912
NCT01474915|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2013-11-08|2013-04-30||June 2007||2007-06-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting|Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting|Completed||Phase 4|122|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 03:36:10.811445|2017-10-11 03:36:10.811445
NCT01474902|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2013-08-25|||August 2011||2011-08-01|August 2013|2013-08-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery|A Randomized Controlled Trial of Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery|Withdrawn||Phase 3|0|Actual|The Hospital for Sick Children||2||Poor enrollment|f||||t||||||||||2017-10-11 03:36:11.159926|2017-10-11 03:36:11.159926
NCT01474889|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-02-24|||October 2011||2011-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Glucose Counterregulation in Long Standing Type 1 Diabetes|Effect of Real-Time Continuous Glucose Monitoring on Glucose Counterregulation in Long Standing Type 1 Diabetes|Recruiting||N/A|36|Anticipated|University of Pennsylvania||1|||f||||t||||||||Undecided||2017-10-11 03:36:11.251673|2017-10-11 03:36:11.251673
NCT01474876|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2015-06-15|2015-05-18||November 2011||2011-11-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||Participants who received adalimumab treatment|Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis|Multicountry Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab in Patients With Ankylosing Spondylitis and Psoriatic Arthritis|Completed||N/A|566|Actual|AbbVie|||2||f||||f||||||||||2017-10-11 03:36:11.408709|2017-10-11 03:36:11.408709
NCT01474863|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2017-06-02|2017-03-22||August 2012||2012-08-01|June 2017|2017-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Citrulline in Severe Sepsis|Prospective, Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Intravenous Citrulline to Prevent or Mitigate Acute Lung Injury in Patients With Severe Sepsis|Completed||Phase 2|72|Actual|Vanderbilt University Medical Center||3|||f||||f||||||||||2017-10-11 03:36:12.397668|2017-10-11 03:36:12.397668
NCT01474850|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-12-05|||November 2011||2011-11-01|December 2014|2014-12-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|||Thoraco-abdominal Volume Variations During Anesthesia Studied by OEP.|Thoraco-abdominal Volume Variation During Recovery From Total Intravenous Anesthesia Studied by Opto-electronic Plethysmography (OEP).|Completed||N/A|18|Actual|Uppsala University Hospital||2|||f||||f||||||||||2017-10-11 03:36:12.755655|2017-10-11 03:36:12.755655
NCT01474837|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-16|2014-01-16|||October 2011||2011-10-01|January 2014|2014-01-01||||November 2013|Actual|2013-11-01||Interventional|HEALTH||Exercise for Depression in Young People|The H.E.A.L.T.H. Project: Help Enabling Active Lifestyles Toward Health in Young People With Depression.|Completed||N/A|86|Actual|University of Nottingham||2|||f||||t||||||||||2017-10-11 03:36:12.826318|2017-10-11 03:36:12.826318
NCT01474824|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2014-12-03|||January 2013||2013-01-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Validation of Nexfin Cardiac Output in Elderly Patients With Hip Fracture|Validation of the Nexfin Non-invasive Cardiac Output Monitor in Patients Undergoing Hip Fracture Repair|Terminated||N/A|6|Actual|University of Nottingham|||1|Unable to recruit sufficient participants|f||||f||||||||||2017-10-11 03:36:12.909221|2017-10-11 03:36:12.909221
NCT01474811|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-05-01|||November 2011||2011-11-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network|HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.|Recruiting||N/A|4500|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     All patients will be invited to participate in the HCV-TARGET Biorepository Specimen Bank     (BSB).      The following will be collected: Blood (Serum and DNA).      All samples will be collected on a voluntary basis and participation in this project will not     affect participation in the main study.      Samples collected will be stored at the University of Florida for up to 15 years after the     end of the study (database closure) at which time they will be destroyed. The implementation     and use of the BSB specimens is governed by the University of Florida Biospecimen Repository     policy to ensure the appropriate use of the deposited samples.   "|||2017-10-11 03:36:12.993146|2017-10-11 03:36:12.993146
NCT01474798|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-06-05||2014-06-05|February 2012||2012-02-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris|A Phase II Open Label Study of the Safety, Pharmacokinetics, and Efficacy of a True Human Anti-Inflammatory Therapeutic Antibody (RA-18C3) in Subjects With Moderate to Severe Acne Vulgaris|Completed||Phase 2|11|Actual|XBiotech, Inc.||1|||f||||f||||||||||2017-10-11 03:36:14.948669|2017-10-11 03:36:14.948669
NCT01474785|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-01-30|||January 2012||2012-01-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||RYGB and the Gastric Adipose Axis|RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis|Completed||Phase 1|49|Actual|Vanderbilt University Medical Center||3|||f||||t||||||||||2017-10-11 03:36:15.091662|2017-10-11 03:36:15.091662
NCT01474772|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-11-17|2014-05-21||October 2011||2011-10-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)|A Phase 3b Multicenter, Double-blind, Randomized, Placebo-controlled Cross-over Efficacy And Safety Study Of Pregabalin In The Treatment Of Patients With Painful Diabetic Peripheral Neuropathy And Pain On Walking|Completed||Phase 3|217|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:36:15.216788|2017-10-11 03:36:15.216788
NCT01474759|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2015-05-14|||July 2012||2012-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Portion Size Strategies for Management of Body Weight||Completed||N/A|186|Actual|Penn State University||3|||f||||t||||||||||2017-10-11 03:36:16.492495|2017-10-11 03:36:16.492495
NCT01474746|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-08-25|2017-03-27||January 2012||2012-01-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Trial of Sertraline to Treat Children With Fragile X Syndrome|A Controlled Trial of Sertraline in Young Children With Fragile X Syndrome|Completed||Phase 2|57|Actual|University of California, Davis|Several secondary analyses. Subject non-compliance with eye tracking led to unreliable/uninterpretable data. Subjects and caregivers were unblinded at the time they completed the study. Limited number of girls in the study (total 9 girls).|2|||f||||t||||||||||2017-10-11 03:36:16.602738|2017-10-11 03:36:16.602738
NCT01474733|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2015-10-14|||November 2011||2011-11-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effects of a Longitudinal Health Literacy Training Program on Family Medicine Residents|Effects of a Longitudinal Health Literacy Training Program on Family Medicine Residents|Completed||N/A|12|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-10-11 03:36:17.492456|2017-10-11 03:36:17.492456
NCT01474720|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2013-09-16|||November 2011||2011-11-01|November 2011|2011-11-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Zostavax in Systemic Lupus Erythematosus|Immunologic Response to Varicella Zoster Vaccination With Zostavax in Patients With Systemic Lupus Erythematosus|Completed||Phase 1|20|Actual|Oklahoma Medical Research Foundation||2|||f||||t||||||||||2017-10-11 03:36:17.667932|2017-10-11 03:36:17.667932
NCT01474707|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2016-05-25|||January 2011||2011-01-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|COPD||Educational Interventions for Chronic Obstructive Pulmonary Disease (COPD) Self-management in Ethno-cultural Communities|Assessing Chronic Obstructive Pulmonary Disease (COPD) Knowledge, Beliefs, and Health Literacy in Chinese Immigrant Adults With a Diagnosis of COPD|Completed||N/A|120|Actual|University of British Columbia||4|||f||||t||||||||||2017-10-11 03:36:17.739895|2017-10-11 03:36:17.739895
NCT01474694|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2015-11-25|||October 2011||2011-10-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|CALS||Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver|Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver: A Prospective, Non Randomized Study|Completed||N/A|14|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-11 03:36:17.835399|2017-10-11 03:36:17.835399
NCT01474681|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-04-03|2017-04-03||January 9, 2012|Actual|2012-01-09|March 2017|2017-03-01|October 3, 2016|Actual|2016-10-03|October 3, 2016|Actual|2016-10-03||Interventional|||Safety and Tolerability of HSC835 in Patients With Hematological Malignancies|A First-in-human, Single-arm, Single-center, Open-label, Proof-of-concept Study to Evaluate the Safety and Tolerability of Infusing HSC835 (LFU835-expanded Umbilical Cord Blood Hematopoietic Stem Cells) in Patients With Hematological Malignancies|Completed||Phase 1/Phase 2|27|Actual|Novartis||1|||f||||t||||||||||2017-10-11 03:36:17.958823|2017-10-11 03:36:17.958823
NCT01474668|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-11-01|||October 2011||2011-10-01|November 2016|2016-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects|A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14c]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects|Completed||Phase 1|5|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:36:19.764257|2017-10-11 03:36:19.764257
NCT01380158|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2011-07-07|||January 2011||2011-01-01|June 2011|2011-06-01||||October 2012|Anticipated|2012-10-01||Interventional|PrePPy||Preventing Preterm Birth With a Pessary|Preventing Preterm Birth With a Pessary|Unknown status|Recruiting|N/A|238|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-11 04:06:01.752925|2017-10-11 04:06:01.752925
NCT01474655|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2011-11-15|||September 2009||2009-09-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Retinal Layers and Visual Rehabilitation After Epiretinal Membrane Removal|Assessment of Retinal Layers and Visual Rehabilitation After Epiretinal Membrane Removal|Completed||N/A|52|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:36:19.851568|2017-10-11 03:36:19.851568
NCT01474642|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2015-12-28|||September 2008||2008-09-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Interventional|||Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma|A Randomized Phase II Trial of Capecitabine Plus Cisplatin (XP) Versus Capecitabine Plus Genexol (XG) as a First-line Treatment for Advanced or Recurrent Esophageal Squamous Cell Carcinoma|Completed||Phase 2|64|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 03:36:19.918362|2017-10-11 03:36:19.918362
NCT01474629|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2013-04-09|||October 2011||2011-10-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||Probiotic Sport Study|Impact of Supplementation With Probiotics on Exercise-induced Oxidative Stress and Endotoxemia in Trained Men|Completed||N/A|24|Actual|Green Beat||2|||f||||t||||||||||2017-10-11 03:36:19.99426|2017-10-11 03:36:19.99426
NCT01474616|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-01-25|||August 2011||2011-08-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|MOVE||Mobility of Vulnerable Elders (MOVE): Translating Knowledge to Health Care Aides in Long-term Care Facilities|Mobility of Vulnerable Elders (MOVE): Translating Knowledge to Health Care Aides in Long-term Care Facilities|Completed||N/A|113|Actual|University of Alberta||1|||f||||f||||||||||2017-10-11 03:36:20.100229|2017-10-11 03:36:20.100229
NCT01474603|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-03-14|||November 2011||2011-11-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|November 2014|Actual|2014-11-01||Observational|IMPEDE-DM2||Impact of n-3 Polyunsaturated Fatty Acids in a Protein-enriched Diet With Low GI in Type 2 Diabetes Patients|IMpact of n-3 Polyunsaturated Fatty Acids With a Protein-Enriched DiEt With Low Glycemic Index on Metabolic and Inflammatory Parameters in Type 2 Diabetic and Obese Patients: an Observational Pilot Study|Completed||N/A|30|Actual|Medical University of Vienna|||1||f||||f||||||Samples Without DNA|"     serum and plasma samples for biochemical analyses   "|||2017-10-11 03:36:20.197842|2017-10-11 03:36:20.197842
NCT01474590|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2017-08-25|2017-01-17||November 2011||2011-11-01|August 2017|2017-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|POWER||Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne|Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Associated With 200 mg Doxycycline Capsules Versus Vehicle Gel Associated With Isotretinoin Capsules in the Treatment of Severe Acne|Completed||Phase 3|266|Actual|Galderma||2|||f||||f||||||||||2017-10-11 03:36:20.317283|2017-10-11 03:36:20.317283
NCT01474577|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-05-18|||November 8, 2011|Actual|2011-11-08|November 2016|2016-11-01|May 18, 2017|Actual|2017-05-18|May 18, 2017|Actual|2017-05-18||Observational|||Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging||Completed||N/A|57|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:36:20.864353|2017-10-11 03:36:20.864353
NCT01474564|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-10-03|||November 2011||2011-11-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma|Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma|Recruiting||N/A|60|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     Blood   "|||2017-10-11 03:36:20.98|2017-10-11 03:36:20.98
NCT01474551|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2015-10-20|2015-04-15||November 2011||2011-11-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation|A Single Center Phase II Trial of Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation|Terminated||Phase 2|2|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-11 03:36:21.115951|2017-10-11 03:36:21.115951
NCT01474538|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-02-04|2014-02-04||December 2011||2011-12-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||All randomized participants who received at least 1 dose of study drug.|Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy|A Randomized, Double-Blind, Crossover Trial Comparing the Safety and Efficacy of Insulin Lispro With the Safety and Efficacy of Insulin Aspart in Subjects With Type 2 Diabetes on CSII Therapy|Completed||Phase 3|122|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:36:21.389078|2017-10-11 03:36:21.389078
NCT01474525|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-11-17|||January 2010||2010-01-01|November 2011|2011-11-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Managing Diabetes During Pregnancy in the Wireless Age|Managing Diabetes During Pregnancy in the Wireless Age: a RCT of Glucose Telemonitoring|Unknown status|Recruiting|N/A|100|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 03:36:22.530682|2017-10-11 03:36:22.530682
NCT01474512|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-04-20|2016-04-20|2014-09-29|November 2011||2011-11-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|June 2014|Actual|2014-06-01||Interventional|UNCOVER-1|All randomized participants who received at least 1 dose of study drug.|A Phase 3 Study in Participants With Moderate to Severe Psoriasis|A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period and a Long- Term Extension Period to Evaluate the Efficacy and Safety of LY2439821 in Patients With Moderate-to-Severe Plaque Psoriasis|Active, not recruiting||Phase 3|1296|Actual|Eli Lilly and Company||4|||f||||t||||||||||2017-10-11 03:36:22.742412|2017-10-11 03:36:22.742412
NCT01474499|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2012-09-24|||September 2011||2011-09-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation|A Multi-center, Randomized, Single-blind Clinical Study of the Comparative Safety and Efficacy of Docusate Sodium and Sorbitol Rectal Solution and Glycerine Enemas in Patients With Constipation|Completed||Phase 3|300|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:36:27.352878|2017-10-11 03:36:27.352878
NCT01474486|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-28|2017-02-21|||April 2010||2010-04-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Feasibility and Effectiveness of Micronutrients as Palliative Care Therapy in Patients With Congestive Heart Failure|Feasibility and Effectiveness of a Multi-Micronutrient Intervention as a Palliative Care Therapy in Patients With Congestive Heart Failure(CHF)|Completed||N/A|20|Actual|Phoenix VA Health Care System||1|||f||||t||||||||No||2017-10-11 03:36:27.44181|2017-10-11 03:36:27.44181
NCT01474473|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2014-04-08|||August 2011||2011-08-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|DIAPLIQ||Efficacy Of CACIPLIQ20 On Diabetic Ulcers In Patients Wearing An Nonremovable, Windowed, Fiberglass Cast Boot|A Pilot Placebo-Controlled, Randomized and Double Blind Monocenter Study Evaluating CACIPLIQ20 Efficacy On Neuropathic Perforating Foot Ulcer Healing In Diabetic Patients Wearing An Irremovable Windowed Resin Cast|Completed||N/A|20|Actual|Organ, Tissue, Regeneration, Repair and Replacement||2|||f||||f||||||||||2017-10-11 03:36:27.518433|2017-10-11 03:36:27.518433
NCT01474460|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-03-07|||September 2011||2011-09-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy|Use of Phytonadione to Reduce INR Variability in Patients on Long-term Warfarin Therapy|Completed||N/A|370|Actual|James A. Haley Veterans Administration Hospital||2|||f||||t||||||||No||2017-10-11 03:36:27.596292|2017-10-11 03:36:27.596292
NCT01474447|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2013-02-28|||December 2011||2011-12-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Effect of Grinberg Method (GM) Intervention on Low-back Pain (LBP) and Improving the Quality of Life|The Research Protocol: The Effect of Grinberg Method (GM) Intervention on Low-back Pain (LBP) and Improving the Quality of Life|Unknown status|Recruiting|N/A|140|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||||2017-10-11 03:36:27.684798|2017-10-11 03:36:27.684798
NCT01474434|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-03-16|2015-06-04||December 2011||2011-12-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||The safety analysis set included all patients who received at least one dose of study drug.|Efficacy of LCQ908 on Cardiovascular Risk|A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy of LCQ908 on Cardiovascular Risk|Terminated||Phase 2|41|Actual|Novartis|The study was terminated based on the interim analysis on Part A, Cohort 1 after patients completed Part A. Part B was not conducted. Not all the planned assessments were completed due to the termination|2||The study was terminated based on interim analysis. See detailed description.|f||||||||||||||2017-10-11 03:36:27.918728|2017-10-11 03:36:27.918728
NCT01474421|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-05-02|||September 15, 2011|Actual|2011-09-15|May 2017|2017-05-01|February 21, 2013|Actual|2013-02-21|February 21, 2013|Actual|2013-02-21||Interventional|||Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease|A Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multiple Oral Dose Study to Assess the Efficacy, Safety and Tolerability of AQW051 in Reducing L-dopa Induced Dyskinesias in Parkinson's Patients With Moderate to Severe L-dopa Induced Dyskinesias|Completed||Phase 2|71|Actual|Novartis||3|||f|||||t|f||||||||2017-10-11 03:36:28.583686|2017-10-11 03:36:28.583686
NCT01474408|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-02-13|||November 2011||2011-11-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Venous Function in Cardiovascular Disease Patients|Venous Function in Cardiovascular Disease Patients; The Neglected Part of Circulatory Regulation|Completed||N/A|10|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 03:36:28.784527|2017-10-11 03:36:28.784527
NCT01474369|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-07-02|||December 2011||2011-12-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux Disease|A Phase 3, Randomized, Double Blind, Placebo Control, Multicenter Study to Evaluate the Efficacy and Safety of TAK- 438 (10 and 20 mg Once-Daily) in Patients With Non-Erosive Gastroesophageal Reflux Disease.|Completed||Phase 3|827|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:36:29.113249|2017-10-11 03:36:29.113249
NCT01474356|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2011-11-15|||November 2006||2006-11-01|November 2011|2011-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Hyperthermia Combined Brachytherapy in CCU|HDR Brachytherapy Combined With Interstitial Hyperthermia 500 kHz in Locally Advanced Cervical Cancer Patients. A Prospective Clinical Trial|Completed||Phase 3|224|Actual|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology||2|||f||||t||||||||||2017-10-11 03:36:29.297792|2017-10-11 03:36:29.297792
NCT01474343|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-05-05|||August 2011||2011-08-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Intracerebral Gene Therapy for Sanfilippo Type A Syndrome|An Open-label, Single Arm, Monocentric, Phase I/II Clinical Study of Intracerebral Administration of Adeno-associated Viral Vector Serotype 10 Carrying the Human SGSH and SUMF1 cDNAs for the Treatment of Sanfilippo Type A Syndrome.|Completed||Phase 1/Phase 2|4|Actual|LYSOGENE||1|||f||||t||||||||||2017-10-11 03:36:29.383275|2017-10-11 03:36:29.383275
NCT01474330|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-03-25|||August 2011||2011-08-01|March 2016|2016-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects|A Phase 1, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) Following Multiple Daily Doses in Healthy Male Subjects|Completed||Phase 1|33|Actual|Celgene Corporation||3|||f||||f||||||||||2017-10-11 03:36:29.472813|2017-10-11 03:36:29.472813
NCT01474317|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-16|2016-01-29|2012-11-30||November 2011||2011-11-01|January 2016|2016-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Study of an Investigational Glucose Meter System|Performance of the G3 Blood Glucose Monitoring System With TATSU Strip|Completed||N/A|226|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 03:36:29.570259|2017-10-11 03:36:29.570259
NCT01474304|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-09-27|||November 2011||2011-11-01|September 2016|2016-09-01||||June 2017|Anticipated|2017-06-01||Interventional|IVAC||Intravenous Acetaminophen for Craniotomy Patients|Intravenous Acetaminophen for Craniotomy Patients: A Single-blinded, Randomized Controlled Trial to Evaluate the Effect of Intravenous Acetaminophen Administered at Induction and Emergence From Craniotomy|Recruiting||Phase 2|80|Anticipated|Swedish Medical Center||2|||f||||f||||||||||2017-10-11 03:36:29.823272|2017-10-11 03:36:29.823272
NCT01474291|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-09-08|2016-09-08||January 2012||2012-01-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|ACT SOLO|Efficacy population, defined as all participants who received at least one infusion of tocilizumab and who met all inclusion and exclusion criteria.|An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice|Evaluation of Factors Influencing Use of RoActemra® as Monotherapy in Rheumatoid Arthritis Patients in a Real Life Setting - ACT SOLO|Completed||N/A|608|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:36:29.972387|2017-10-11 03:36:29.972387
NCT01474278|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-11-01|||December 2011||2011-12-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of RO5028442 in Adult Male High-Functioning Autistic Patients|A Multi-centre, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over, Exploratory Biomarker and Safety and Tolerability Study of a Single Dose of RO5028442 in Adult Male High-functioning Autistic Patients|Completed||Phase 1|19|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:36:32.628239|2017-10-11 03:36:32.628239
NCT01474265|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-08-07|||November 2011||2011-11-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Sympathovagal Balance in Smoking Cessation|Alterations in the Autonomic Nervous System During Smoking Quit Attempts- Possible Effects of Pharmacological Interventions|Completed||Phase 4|85|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||5|||f||||f||||||||||2017-10-11 03:36:32.702667|2017-10-11 03:36:32.702667
NCT01474252|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-06-01|||July 2008||2008-07-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Intubation Duration Between Rapid Sequence Intubation (RSI) Technique and Non-RSI Technique|Comparison of Intubation Duration Between Rapid Sequence Intubation Technique and Non- Rapid Sequence Intubation Technique in Siriraj Hospital by Emergency Medicine Residences|Completed||Phase 4|224|Actual|Siriraj Hospital||2|||f||||t||||||||||2017-10-11 03:36:32.780133|2017-10-11 03:36:32.780133
NCT01474239|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2016-02-16|2015-07-09||November 2011||2011-11-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Safety population included all randomized participants with at least one administration of the study drug and at least one safety assessment.|A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma|Randomized Non Comparative Phase II Trial With Bevacizumab and Fotemustine in the Treatment of Recurrent Glioblastoma|Completed||Phase 2|91|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:36:32.908077|2017-10-11 03:36:32.908077
NCT01474226|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2013-07-26|||January 2011||2011-01-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Metabolic Availability of Lysine From Rice|Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Lysine From Cooked Rice Protein in Adult Men|Completed||Phase 1|5|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 03:36:34.513761|2017-10-11 03:36:34.513761
NCT01474213|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2012-10-22|2012-06-06||November 2011||2011-11-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation|Dexmedetomidine Versus Remifentanil Target Controlled Infusion for Sedation During Awake Fibreoptic Nasotracheal Intubation|Completed||Phase 4|42|Actual|Shanghai 9th People's Hospital|The sample number is relatively small|2|||f||||t||||||||||2017-10-11 03:36:34.656772|2017-10-11 03:36:34.656772
NCT01474200|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2017-04-04|2015-07-23||January 2012||2012-01-01|April 2017|2017-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|AVOID-HF|3 patients in the IV Loop Diuretics (LD) arm were randomized, but withdrawn from the study prior to beginning study treatment. These patients are excluded from the number of baseline participants (analysis population).|Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment|Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure (AVOID-HF)|Terminated||N/A|224|Actual|Baxter Healthcare Corporation|Due to patient recruitment challenges, the study was terminated early. At that time, no interim analyses of the data had been completed; therefore the decision to close the study was not related to any underlying concerns about safety or futility.|2||"Closed due to patient recruitment challenges. No interim analyses were completed; study closure   was not related to any concerns about safety or futility."|f||||t||||||||||2017-10-11 03:36:35.235589|2017-10-11 03:36:35.235589
NCT01474187|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2011-11-15|||November 2011||2011-11-01|November 2011|2011-11-01|December 2012|Anticipated|2012-12-01|November 2011|Actual|2011-11-01||Interventional|||Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer|Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer|Unknown status|Recruiting|Phase 1|60|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-11 03:36:36.626923|2017-10-11 03:36:36.626923
NCT01474174|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-07-28|||September 2011|Actual|2011-09-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors|A Pilot Study of Influenza Vaccine Efficacy in Patients With Central Nervous System Tumors|Completed||N/A|38|Actual|Wake Forest University Health Sciences|||1||f||||f|f|f||||||||2017-10-11 03:36:36.738282|2017-10-11 03:36:36.738282
NCT01474161|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2012-11-23|||November 2011||2011-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505|Comparative Bioavailability Study of a New GFT505 Formulation With the Existing One After 120 mg Single Oral GFT505 Administration and Assessment of the Gender Effect in Young Healthy Male and Female Volunteers Followed by a Single and Multiple Ascending Dose Safety, Tolerability and Pharmacokinetic Study of GFT505 in Overweight or Obese Subjects and in Diabetic Patients|Completed||Phase 1|96|Actual|Genfit||3|||f||||f||||||||||2017-10-11 03:36:36.825687|2017-10-11 03:36:36.825687
NCT01474148|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-06-02|||July 1, 2011|Actual|2011-07-01|June 2017|2017-06-01|January 31, 2019|Anticipated|2019-01-31|January 31, 2019|Anticipated|2019-01-31||Interventional|Trunk Protocol||A Neuroprosthesis for Seated Posture and Balance|A Neuroprosthesis for Seated Posture and Balance|Recruiting||N/A|10|Anticipated|VA Office of Research and Development||1|||f||||f|f|t|f|f|f|||Undecided||2017-10-11 03:36:36.916752|2017-10-11 03:36:36.916752
NCT01443676|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2016-10-31|||October 2011||2011-10-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Interventional|ARTE||Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma|Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma|Completed||Phase 2|75|Actual|University of Zurich||2|||f||||t||||||||||2017-10-11 03:46:46.158285|2017-10-11 03:46:46.158285
NCT01474135|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2016-09-12||2014-02-17|December 2011||2011-12-01|September 2016|2016-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure|A Double-masked, Randomized, Controlled Study Assessing the Safety and Ocular Hypotensive Efficacy of Two AR 12286/Travoprost Fixed-dose Combination Products Compared to Travatan® Z in Patients With Elevated Intraocular Pressure|Completed||Phase 2|93|Actual|Aerie Pharmaceuticals||3|||f||||f||||||||||2017-10-11 03:36:37.015483|2017-10-11 03:36:37.015483
NCT01474122|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-11-22|2015-01-19||December 2011||2011-12-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|DUAL-2|Full analysis set|Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients|Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis|Terminated||Phase 3|265|Actual|Actelion||3||company decision|f||||t||||||||||2017-10-11 03:36:37.13807|2017-10-11 03:36:37.13807
NCT01474109|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-01-02|2014-12-03||December 2011||2011-12-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|DUAL-1|Full analysis set|Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients|Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Ischemic Digital Ulcers Associated With Systemic Sclerosis|Completed||Phase 3|289|Actual|Actelion||3|||f||||t||||||||||2017-10-11 03:36:39.436673|2017-10-11 03:36:39.436673
NCT01474096|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2015-04-08|||January 2010||2010-01-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Implementation Strategy for a Breastfeeding Guideline in Primary Care|Effectiveness of Implementation Strategy for a Breastfeeding Guideline in Primary Care: Cluster Randomised Trial|Completed||N/A|208|Actual|Gerencia de Atención Primaria, Madrid||2|||f||||t||||||||||2017-10-11 03:36:41.224634|2017-10-11 03:36:41.224634
NCT01474083|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2013-09-03||2012-10-03|November 2011||2011-11-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Multiple-Dose Study Assessing the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of GK1-399 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|248|Actual|vTv Therapeutics||4|||f||||t||||||||||2017-10-11 03:36:41.303694|2017-10-11 03:36:41.303694
NCT01474070|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2016-10-17|||November 2011||2011-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|||GAT-DCT-Discordance Due to Corneal Properties|Influence of Discordant Intraocular Eye Pressure Readings Taken by Dynamic Contour Tonometry and Goldmann Applanation Tonometry|Completed||Phase 4|112|Actual|University of Zurich|||1||f||||f||||||||No||2017-10-11 03:36:41.399153|2017-10-11 03:36:41.399153
NCT01474057|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-26|2012-01-11|||May 2008||2008-05-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|DESTRESS-PC||DElivery of Self Training and Education for Stressful Situations-Primary Care Version|"Online Early Resilience Intervention for Combat-Related PTSD in Military Primary Healthcare Settings: A Randomized Trial of DESTRESS-PC"|Completed||Phase 2|133|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||t||||||||||2017-10-11 03:36:41.643731|2017-10-11 03:36:41.643731
NCT01474044|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2013-07-06|||August 2011||2011-08-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG)|A Phase IV Study to Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis|Completed||Phase 4|851|Actual|Xinjiang Biochemical Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:36:41.773349|2017-10-11 03:36:41.773349
NCT01474031|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-14|||October 2011||2011-10-01|August 2011|2011-08-01||||||||Observational|||Prospective Study Deltamotion - DAA THA Study|Prospective Study Deltamotion - DAA THA Study|Unknown status|Recruiting|N/A|40|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-11 03:36:41.887173|2017-10-11 03:36:41.887173
NCT01474018|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2014-05-20|||November 2011||2011-11-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes|QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes|Completed||Phase 4|15|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 03:36:41.993816|2017-10-11 03:36:41.993816
NCT01474005|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-06-28|||October 2011||2011-10-01|June 2012|2012-06-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|LA||Establishment of an Artificial Larynx After Total Laryngectomy|Establishment of an Artificial Larynx After Total Laryngectomy|Unknown status|Recruiting|N/A|5|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 03:36:42.107091|2017-10-11 03:36:42.107091
NCT01473992|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-11-20|2014-05-06||January 2011||2011-01-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Comparative Outcomes Assessment of the C-Leg With a New Knee Prosthesis|Comparative Outcomes Assessment of the C-Leg With a New Knee Prosthesis|Completed||N/A|25|Actual|University of South Florida||3|||f||||t||||||||||2017-10-11 03:36:42.206969|2017-10-11 03:36:42.206969
NCT01473979|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2012-01-24|||January 2012||2012-01-01|January 2012|2012-01-01|July 2014|Anticipated|2014-07-01|January 2014|Anticipated|2014-01-01||Interventional|||Delayed Primary Versus Late Secondary Wound Closure in Sternum Infections|Delayed Primary Versus Late Secondary Wound Closure in the Treatment of Postsurgical Sternum Osteomyelitis|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||||2017-10-11 03:36:42.517193|2017-10-11 03:36:42.517193
NCT01473966|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-11-14|||November 2011||2011-11-01|November 2011|2011-11-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Coffee Against Obstipation in Intensive Care Treatment|Coffee Against Obstipation in Intensive Care Treatment|Unknown status|Enrolling by invitation|N/A|120|Anticipated|University Hospital Heidelberg||3|||f||||f||||||||||2017-10-11 03:36:42.599647|2017-10-11 03:36:42.599647
NCT01473784|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-04-03|||December 3, 2007|Actual|2007-12-03|April 2017|2017-04-01|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck|A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System|Recruiting||N/A|360|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:36:46.428853|2017-10-11 03:36:46.428853
NCT01473953|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-03-22|2013-06-20||October 2011||2011-10-01|March 2017|2017-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects|Investigation on Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects. A Randomised, Double-blind, Placebo-controlled Trial Investigating Subcutaneously Single Dose Escalation of a Sustained Release Formulation of Liraglutide Lysine in Healthy Male Subjects|Completed||Phase 1|31|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-10-11 03:36:42.705636|2017-10-11 03:36:42.705636
NCT01473940|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-04-11|||April 2012||2012-04-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery|Ipilimumab and Gemcitabine for Advanced Pancreas Cancer: A Phase Ib Study|Active, not recruiting||Phase 1|21|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 03:36:43.365891|2017-10-11 03:36:43.365891
NCT01473927|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-03-11|||October 2011||2011-10-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Observational|||Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease|Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease|Completed||N/A|136|Actual|University of Bern|||2||f||||f||||||Samples With DNA|"     Serum Stool   "|||2017-10-11 03:36:43.454829|2017-10-11 03:36:43.454829
NCT01473914|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2016-12-14|||November 2012||2012-11-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Trace Element Replenishment Study in Hemodialysis Patients|Trace Element Replenishment Study in Hemodialysis Patients|Completed||Phase 3|150|Actual|University of Alberta||3|||f||||f||||||||No||2017-10-11 03:36:43.538604|2017-10-11 03:36:43.538604
NCT01473901|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-09-12|||December 30, 2011|Actual|2011-12-30|September 2017|2017-09-01|May 17, 2017|Actual|2017-05-17|May 17, 2017|Actual|2017-05-17||Interventional|||A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma|A Phase I, Two-stage, Multi-center, Open Label, Dose-escalation Study of BKM120 in Combination With Adjuvant Temozolomide and With Concomitant Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma|Completed||Phase 1|38|Actual|Novartis||2|||f||||f|t|f||||||||2017-10-11 03:36:43.640419|2017-10-11 03:36:43.640419
NCT01473888|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2012-11-07|||January 2011||2011-01-01|November 2011|2011-11-01|January 2012|Actual|2012-01-01|July 2011|Actual|2011-07-01||Interventional|||A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes|An Open-label, One-sequence, Two Periods, Crossover Trial Study to Evaluate the Effect of T89 on the Pharmacokinetics of Five CYP450 Substrates Cocktail in Healthy Subjects|Completed||Phase 1|24|Actual|Tasly Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-10-11 03:36:45.16219|2017-10-11 03:36:45.16219
NCT01473875|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-02-17||2017-02-17|November 2011||2011-11-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102|An Open Label Multicenter Extension Study to Evaluate the Long-term Efficacy and Safety of SBC-102 in Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102|Terminated||Phase 2/Phase 3|10|Actual|Alexion Pharmaceuticals||1||Study has been merged with NCT01371825|f||||f||||||||Undecided||2017-10-11 03:36:45.297945|2017-10-11 03:36:45.297945
NCT01473862|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2016-08-11|||January 2012||2012-01-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|December 2013|Actual|2013-12-01||Observational|ALOSS||Adolescent Loss: The Impact of Loss on Adolescent Oncology Patients|Adolescent Loss: The Impact of Loss on Adolescent Oncology Patients|Completed||N/A|153|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 03:36:45.398162|2017-10-11 03:36:45.398162
NCT01473849|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2012-12-19|||May 2010||2010-05-01|December 2012|2012-12-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Observational|VHENUS||Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients|Non-interventional, Prospective Study to Evaluate the Impact of CMV Replication Over Hepatitis C Recurrence in Liver Transplant Recipients|Unknown status|Active, not recruiting|N/A|179|Anticipated|Sociedad Española de Trasplante Hepático|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 03:36:45.459761|2017-10-11 03:36:45.459761
NCT01473836|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-12-18|2013-10-10||November 2011||2011-11-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection|A Phase 3, Multicenter, Unblind, Non-Comparative Study To Confirm Efficacy And Safety Of Intravenous Metronidazole In Patients With Intrabdominal Infection In Combination With Intravenous Ceftriaxone|Completed||Phase 3|38|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:36:45.564237|2017-10-11 03:36:45.564237
NCT01473823|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-03-02|||January 2012||2012-01-01|March 2012|2012-03-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Interventional|Omega-Treat||Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Development of Bronchial Asthma in Childhood|Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Development of Bronchial Asthma in Childhood|Enrolling by invitation||N/A|160|Anticipated|Ostergotland County Council, Sweden||2|||f||||f||||||||||2017-10-11 03:36:45.962968|2017-10-11 03:36:45.962968
NCT01473810|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-06-19|||November 2011||2011-11-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant|Immunotherapy of HIV-infected Patients: A Single-blinded, Randomized, Immunogenicity, Pilot Study of Intranasal Administration of Vacc-4x With Endocine as Adjuvant|Completed||Phase 1/Phase 2|24|Actual|Oslo University Hospital||4|||f||||f||||||||||2017-10-11 03:36:46.179131|2017-10-11 03:36:46.179131
NCT01473797|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-09-28|||November 2011||2011-11-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|ECLA||Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis|Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Patients With Pulmonary Langerhans Cell Histiocytosis and Impairment of Lung Function|Active, not recruiting||Phase 2|10|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 03:36:46.322061|2017-10-11 03:36:46.322061
NCT01473771|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-09-12|||November 2011||2011-11-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Caring Letters for Military Suicide Prevention|Caring Letters for Military Suicide Prevention: A Randomized Controlled Trial|Active, not recruiting||N/A|4730|Anticipated|National Center for Telehealth and Technology||2|||f||||f||||||||||2017-10-11 03:36:46.593217|2017-10-11 03:36:46.593217
NCT01473758|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-12-22|2015-07-23|2015-02-20|February 2012||2012-02-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|TREAT|Full Analysis set consisted of all randomized patients who received at least 1 dose of investigational medicinal product (IMP)|Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Effect of Roflumilast 500 μg Tablets Once Daily at Acute COPD Exacerbations Treated With Standard Therapy of Oral Steroids and Antibiotics. A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial|Terminated||Phase 2|81|Actual|AstraZeneca||2||Company decision: No Safety or Efficacy Concerns|f||||f||||||||||2017-10-11 03:36:46.922709|2017-10-11 03:36:46.922709
NCT01473745|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-10-28|2014-08-06||July 2011||2011-07-01|August 2011|2011-08-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional||Taiwanese Class III patients|The Nasal Changes Affected by Different Alar Base Suture Techniques After Maxillary LeFort I Osteotomy|The Nasal Changes Affected by 2 Different Alar Base Suture Techniques After Maxillary LeFort I Osteotomy--A Randomized Controlled Trial|Completed||Phase 2/Phase 3|48|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 03:36:49.967922|2017-10-11 03:36:49.967922
NCT01473732|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-11-16|||November 2011||2011-11-01|November 2011|2011-11-01||||December 2013|Anticipated|2013-12-01||Interventional|||Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity|Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity|Unknown status|Active, not recruiting|N/A|30|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 03:36:50.915561|2017-10-11 03:36:50.915561
NCT01473719|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-09-15|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|HEAT||Emerging Adults Who Use Alcohol and Marijuana|Reducing STIs in Emerging Adults Who Use Alcohol and Marijuana|Completed||Phase 3|566|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-11 03:36:51.020335|2017-10-11 03:36:51.020335
NCT01473706|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2013-07-16|||August 2011||2011-08-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Observational|||Validation of a Nutrition Screening Tool|Mini Nutritional Assessment: Consumer Validation|Completed||N/A|463|Actual|Nestlé|||2||f||||f||||||||||2017-10-11 03:36:51.121053|2017-10-11 03:36:51.121053
NCT01473693|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-01-14|||November 2011||2011-11-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging|Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging|Terminated||N/A|1|Actual|Memorial Sloan Kettering Cancer Center|||2|Lack of Accrual|f||||||||||||||2017-10-11 03:36:51.19947|2017-10-11 03:36:51.19947
NCT01473680|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2012-09-12|||November 2011||2011-11-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients|Pilot Study of Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients|Terminated||N/A|2|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-10-11 03:36:51.28003|2017-10-11 03:36:51.28003
NCT01473667|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-11-05|||November 2011||2011-11-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|March 2015|Actual|2015-03-01||Interventional|||Superficial Cervical Plexus Block for Pacemaker Insertion|Superficial Cervical Plexus Block for Pacemaker Insertion|Terminated||N/A|30|Actual|Mayo Clinic||2||change in practice occured|f||||f||||||||||2017-10-11 03:36:51.372745|2017-10-11 03:36:51.372745
NCT01473654|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-08-11|||November 2011||2011-11-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|ADAPT||The Avoiding Diabetes Thru Action Plan Targeting Pilot Randomized Control Trial|Avoiding Diabetes Thru Action Plan Targeting (ADAPT): A Pilot Randomized Control Trial of an Electronic Medical Record Embedded Prediabetes Shared Goal Setting Tool in Primary Care|Completed||N/A|60|Actual|Boston University||2|||f||||f||||||||||2017-10-11 03:36:51.464027|2017-10-11 03:36:51.464027
NCT01473641|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-05-17|||November 2011||2011-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|NORA||Nexplanon Observational Risk Assessment Study (NORA)|Nexplanon Observational Risk Assessment Study (NORA)|Active, not recruiting||N/A|7384|Actual|Center for Epidemiology and Health Research, Germany|||1||f||||t||||||||||2017-10-11 03:36:51.540543|2017-10-11 03:36:51.540543
NCT01473628|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-04-18|||May 2013|Actual|2013-05-01|April 2017|2017-04-01|May 2027|Anticipated|2027-05-01|May 2027|Anticipated|2027-05-01||Interventional|||Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II|Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II|Recruiting||Phase 1/Phase 2|130|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 03:36:51.618342|2017-10-11 03:36:51.618342
NCT01473615|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-05-06|||November 2011||2011-11-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression|Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression|Unknown status|Active, not recruiting|N/A|60|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:36:51.708472|2017-10-11 03:36:51.708472
NCT01473602|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-04-10|2014-11-10||January 2012||2012-01-01|April 2015|2015-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Full Analysis Set: All randomized participants who received at least 1 dose of study drug.|Second Study of the Effect of Teriparatide on Hip Fracture Healing|Second Study of the Effect of Teriparatide on Femoral Neck Fracture Healing|Completed||Phase 3|39|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:36:51.819661|2017-10-11 03:36:51.819661
NCT01473589|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-04-10|2014-11-10||February 2012||2012-02-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Full Analysis Set (FAS): All randomized participants who received at least 1 dose of study drug.|Effect of Teriparatide on Hip Fracture Healing|Effect of Teriparatide on Femoral Neck Fracture Healing|Completed||Phase 3|122|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:36:53.048929|2017-10-11 03:36:53.048929
NCT01473576|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2016-04-14|||August 2011||2011-08-01|October 2012|2012-10-01|December 2013|Actual|2013-12-01|July 2012|Actual|2012-07-01||Interventional|PRO-Nitrate||Impact of Nitrate Ingestion on Protein Synthesis|The Impact of Dietary Nitrate Ingestion on Muscle Protein Synthesis in Elderly Type II Diabetics|Completed||N/A|25|Actual|Maastricht University Medical Center||2|||f||||f||||||||No||2017-10-11 03:36:55.114141|2017-10-11 03:36:55.114141
NCT01473563|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2014-10-03|2014-06-12||December 2011||2011-12-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Safety Population: Participants who received at least 1 dose of study drug.|A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)|Home Delivery of Pemetrexed as Maintenance Treatment in Patients Who Have Not Progressed After Induction Therapy for Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Feasibility Study|Completed||Phase 2|52|Actual|Eli Lilly and Company|A thorough literature search revealed that no specific validated questionnaire was available to assess participant and physician satisfaction with home care or resource utilization, therefore specific questions were created by the sponsor for use.|1|||f||||f||||||||||2017-10-11 03:36:55.251412|2017-10-11 03:36:55.251412
NCT01473550|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2016-03-04|||November 2011||2011-11-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|MHEN||Mental Health Engagement Network (MHEN)|Mental Health Engagement Network (MHEN): Connecting Clients With Their Health Team|Completed||N/A|400|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:36:56.501861|2017-10-11 03:36:56.501861
NCT01473537|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-09-21|||October 2011||2011-10-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|Fluor-Ca||Optimised Fluoride Prevention by Double Rinse With Fluoride and Calcium|A Double Blind, Randomized, Cross Over Designed Trial of Fluoride Prevention by Double Rinse With Calcium and Fluoride|Completed||Phase 1|9|Actual|Karolinska Institutet||3|||f||||t||||||||||2017-10-11 03:36:56.610587|2017-10-11 03:36:56.610587
NCT01473524|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-05-10|2016-12-20||January 2012||2012-01-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|December 2013|Actual|2013-12-01||Interventional|POISE|71 subjects were randomized in the OCA 5-10 mg group, however 1 subject never received treatment. Therefore, the Baseline Analysis Population of 70 subjects is the Intent-to-Treat Population|Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis|A Phase 3, Double Blind, Placebo Controlled Trial and Long Term Safety Extension of Obeticholic Acid in Patients With Primary Biliary Cirrhosis|Active, not recruiting||Phase 3|217|Actual|Intercept Pharmaceuticals||3|||f||||t||||||||||2017-10-11 03:36:56.74719|2017-10-11 03:36:56.74719
NCT01473511|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2016-09-01|||February 2010||2010-02-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|SF-ON||Strongest Families Ontario (Formerly the Family Help Program)|Delivering Intervention for Pediatric Behaviour Problems at a Distance: a Randomized Trial of Strongest Families Ontario|Completed||Phase 3|172|Actual|IWK Health Centre||2|||f||||t||||||||No|Aggregate summary data would be made available but not individual data.|2017-10-11 03:36:58.494136|2017-10-11 03:36:58.494136
NCT01473498|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-05-09|||January 2013||2013-01-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|DORESEP||Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock|Personalized Haemodynamic Management of Septic Shock: Influence of Mean Arterial Pressure Level on Renal Function: Randomized Controlled Trial|Completed||N/A|27|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:36:58.589495|2017-10-11 03:36:58.589495
NCT01473485|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-05-17|||April 2011||2011-04-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors|A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors|Recruiting||N/A|10|Anticipated|InSightec||1|||f||||f||||||||||2017-10-11 03:36:58.680818|2017-10-11 03:36:58.680818
NCT01473472|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-05-10|||January 2012||2012-01-01|May 2017|2017-05-01|December 15, 2016|Actual|2016-12-15|June 30, 2016|Actual|2016-06-30||Interventional|IPERGAY||On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men|On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men|Completed||Phase 3|400|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||No||2017-10-11 03:36:58.755761|2017-10-11 03:36:58.755761
NCT01473459|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-04-25|||April 2012||2012-04-01|April 2012|2012-04-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Comparison Between Two Fertility Protocols in Obese Polycystic Ovary Syndrome Patients|Comparison Between Two Fertility Protocols in Obese Polycystic Ovary Syndrome|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 03:36:58.850708|2017-10-11 03:36:58.850708
NCT01473446|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-03-27|||January 2012||2012-01-01|March 2013|2013-03-01||||December 2013|Actual|2013-12-01||Interventional|||Traditional Versus Goal Directed Perioperative Fluid Therapy in High Risk Patients|Traditional Versus Goal Directed Perioperative Fluid Therapy in High Risk Patients. A Randomized, Assessor-blinded Study|Terminated||N/A|30|Actual|Haukeland University Hospital||2||High exclusion rate|f||||f||||||||||2017-10-11 03:36:58.933131|2017-10-11 03:36:58.933131
NCT01473433|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-07-23|||January 2012||2012-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|adiFLAP||Pericardic Adipose Pedicle Transposition Over the Myocardial Infarct (adiFLAP Trial)|Randomized Trial to Evaluate the Safety and Efficacy of a New Surgical Approach to Cardiac Regeneration: Pericardic Adipose Pedicle Transposition Over the Myocardial Infarct (adiFLAP Trial)|Completed||Phase 1/Phase 2|10|Actual|Germans Trias i Pujol Hospital||2|||f||||||||||||||2017-10-11 03:36:59.038052|2017-10-11 03:36:59.038052
NCT01473420|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-05-01||2015-02-23|November 2011||2011-11-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|AiME - 13||A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin|A Therapeutic-Equivalence Study Comparing the Efficacy and Safety of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment|Completed||Phase 3|320|Actual|Hospira, now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-10-11 03:36:59.171574|2017-10-11 03:36:59.171574
NCT01473238|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2013-08-22|||January 2014||2014-01-01|August 2013|2013-08-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|||Desktop Versus Mobile Data Collection in Clinical Trial|Desktop vs. Mobile Data Collection in a Prospective Multicenter Clinical Trial|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of Zurich||2|||f||||t||||||||||2017-10-11 03:37:04.315936|2017-10-11 03:37:04.315936
NCT01473407|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-05-01||2015-02-23|November 2011||2011-11-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|AiME - 01||A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin|A Therapeutic-Equivalence Study Comparing the Efficacy and Safety of Intravenous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment|Completed||Phase 3|612|Actual|Hospira, now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-10-11 03:36:59.410177|2017-10-11 03:36:59.410177
NCT01473394|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-02-21|2014-02-21||December 2011||2011-12-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Safety population: All randomized participants who received at least 1 dose of double-blind investigational product.|Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder|A Double-blind, Placebo-controlled, Fixed-dose Study of Vilazodone in Patients With Major Depressive Disorder|Completed||Phase 4|518|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 03:36:59.876134|2017-10-11 03:36:59.876134
NCT01473381|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-08-06|2014-06-13||December 2011||2011-12-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|VLZ-MD-01|Safety population: All randomized participants who received at least 1 dose of double-blind investigational product (placebo, vilazodone, or citalopram).|Safety and Efficacy of Vilazodone in Major Depressive Disorder|A Double-blind, Placebo- and Active-controlled, Fixed-dose Study of Vilazodone in Patients With Major Depressive Disorder|Completed||Phase 4|1162|Actual|Forest Laboratories||4|||f||||f||||||||||2017-10-11 03:37:00.687334|2017-10-11 03:37:00.687334
NCT01473368|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-03-03|2016-03-30||April 2012||2012-04-01|March 2017|2017-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota|Open Label, Randomized Pilot Study to Examine The Effects of the Probiotic Saccharomyces Boulardii, the Antibiotic Amoxicillin/Clavulanate and the Combination on the Gut Microbiota of Healthy Volunteers|Completed||N/A|53|Actual|Beth Israel Deaconess Medical Center||4|||f||||f||||||||||2017-10-11 03:37:02.476502|2017-10-11 03:37:02.476502
NCT01473355|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2017-08-21|||October 2011||2011-10-01|August 2017|2017-08-01|October 2016|Actual|2016-10-01|September 2014|Actual|2014-09-01||Interventional|||Study on OsseoSpeed™ TX Narrow Implants in the Lower Jaw in a Chinese Population|An Open, Prospective, Multi-center Study to Evaluate OsseoSpeed™ TX Single Implant 3 mm Diameter in the Anterior Mandible. A 3-years Follow-up Study.|Completed||N/A|45|Actual|Dentsply Sirona Implants||1|||f||||||||||||||2017-10-11 03:37:03.239953|2017-10-11 03:37:03.239953
NCT01473342|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-10-23|||April 2011||2011-04-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|September 2013|Actual|2013-09-01||Interventional|||Mila Blooms Intervention Study|Mila Blooms Intervention Study: An App for Promoting Physical Activity and Health Diet Among Adolescent Survivors of Childhood Cancer|Completed||N/A|21|Actual|Duke University||1|||f||||t||||||||||2017-10-11 03:37:03.342505|2017-10-11 03:37:03.342505
NCT01473329|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2011-11-18|||January 2009||2009-01-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Structured Diabetes Self-Management Education in Primary Care and Metabolic Control|Structured Diabetes Self-Management Education in Primary Care and Metabolic Control: a Randomized Clinical Trial.|Completed||N/A|138|Actual|Hospital de Clinicas de Porto Alegre||1|||f||||t||||||||||2017-10-11 03:37:03.437374|2017-10-11 03:37:03.437374
NCT01473316|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-11-01|||November 2011||2011-11-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980|An Open-Label, Fixed-Sequence, 2-Period Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980|Completed||Phase 1|22|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:37:03.534138|2017-10-11 03:37:03.534138
NCT01473303|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-06-27|||August 2012||2012-08-01|June 2016|2016-06-01||||August 2012|Actual|2012-08-01||Interventional|||Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer|Phase IB/Randomized Phase II Study of Folfirinox Plus AMG-479 (Ganitumab) or Placebo in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma|Withdrawn||Phase 1/Phase 2|0|Actual|Alliance for Clinical Trials in Oncology||2||"CALGB 81003 closed about a week after it was activated because of withdrawal of support. No   patients were registered on this study."|f||||||||||||||2017-10-11 03:37:03.648272|2017-10-11 03:37:03.648272
NCT01473290|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2016-07-01||||||July 2016|2016-07-01||||||||Interventional|||Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy|A Phase III, Randomized, Double-Blind Placebo Controlled Study of the Probiotic Preparation VSL#3® Versus Placebo in the Prevention of Acute Enteritis in Patients Receiving Concurrent Chemotherapy and Pelvic Radiation Therapy|Withdrawn||Phase 3|0|Actual|Alliance for Clinical Trials in Oncology||2||The study was not activated.|f||||||||||||||2017-10-11 03:37:03.770605|2017-10-11 03:37:03.770605
NCT01473277|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-14|||January 2012||2012-01-01|November 2011|2011-11-01|January 2013|Anticipated|2013-01-01|June 2012|Anticipated|2012-06-01||Interventional|||Botulinum Toxin Type A (BT-A) in Hemiplegic Shoulder Pain Versus Steroid|Intra-articular Injection of Botulinum Toxin Type A in Hemiplegic Shoulder Pain: a Multicentric, Double Blind Randomised, Versus Steroid Study|Unknown status|Not yet recruiting|Phase 2|52|Anticipated|The Foundation Institute San Raffaele G. Giglio of Cefalù||2|||f||||t||||||||||2017-10-11 03:37:03.908759|2017-10-11 03:37:03.908759
NCT01473264|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-11-16|||January 2000||2000-01-01|November 2011|2011-11-01|December 2003|Actual|2003-12-01|June 2002|Actual|2002-06-01||Interventional|||Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)|Safety and Tolerability of Recombinant Human Clara Cell 10kDa Protein (rhCC10) Delivered Intratracheally to Premature Neonates With Respiratory Distress Syndrome|Completed||Phase 1/Phase 2|22|Actual|Clarassance, Inc.||3|||f||||t||||||||||2017-10-11 03:37:04.028144|2017-10-11 03:37:04.028144
NCT01473251|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-12-16|||November 2011||2011-11-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration|Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration|Completed||N/A|16|Actual|Vitreo-Retinal Associates, Michigan||3|||f||||f||||||||||2017-10-11 03:37:04.204474|2017-10-11 03:37:04.204474
NCT01473225|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2015-05-19|||November 2011||2011-11-01|May 2015|2015-05-01|September 2014||2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Can Calorie Labels Increase Caloric Intake|Can Calorie Labels Increase Caloric Intake? A Test of Possible Perverse Effects of Calorie Labels|Withdrawn||N/A|0|Actual|Carnegie Mellon University||2||Funding was pulled after unsuccessful pilot study|f||||||||||||||2017-10-11 03:37:04.431807|2017-10-11 03:37:04.431807
NCT01473199|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-04-15|||November 2011||2011-11-01|April 2016|2016-04-01||||||||Interventional|||BioPoly RS Knee Registry Study for Cartilage Defect Replacement|Multi-centre, Open Label, Prospective, Consecutive Series Registry Database of BioPoly RS Partial Resurfacing Knee Implant|Completed||N/A|38|Actual|BioPoly LLC||1|||f||||f||||||||||2017-10-11 03:37:04.513431|2017-10-11 03:37:04.513431
NCT01473186|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-05-29|||January 2011||2011-01-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Study of Menstrual Irregularities and Endometrial Pathology in Women Undergoing Bariatric Surgery|Prevalence of Menstrual Irregularities and Endometrial Pathology in Women Who Are Candidates for Bariatric Surgery: Correlation With Perceived Risk, Biomarkers, and Weight Loss|Completed||N/A|100|Anticipated|University of Virginia|||1||f||||t||||||Samples With DNA|"     blood, omentum, endometrium, adipose tissue   "|||2017-10-11 03:37:04.60649|2017-10-11 03:37:04.60649
NCT01473173|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2013-04-09|||November 2011||2011-11-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study, to Investigate the Safety, Tolerability, PK and PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects|Completed||Phase 1|59|Actual|CJ HealthCare Corporation||7|||f||||f||||||||||2017-10-11 03:37:04.710754|2017-10-11 03:37:04.710754
NCT01473160|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2013-04-16|2012-11-19||November 2011||2011-11-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Daily Disposable Contact Lens Tear Film Study|DAILIES TOTAL1 Pre-Lens Tear Film Performance - Pilot Trial|Completed||N/A|9|Actual|Alcon Research|Pilot study. Small number of participants analyzed.|2|||f||||f||||||||||2017-10-11 03:37:04.827286|2017-10-11 03:37:04.827286
NCT01473147|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2013-07-28|||October 2011||2011-10-01|November 2011|2011-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|AGAC2||Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients|Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients|Completed||N/A|51|Actual|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-10-11 03:37:05.320318|2017-10-11 03:37:05.320318
NCT01473134|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-08-31|||December 2011||2011-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:37:05.411057|2017-10-11 03:37:05.411057
NCT01473121|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-09-11|||August 13, 2012|Actual|2012-08-13|September 2017|2017-09-01|October 31, 2017|Anticipated|2017-10-31|June 30, 2017|Actual|2017-06-30||Observational|||Hepatocellular Carcinoma Registry for Turkey (3K Trial)|Profile of the Hepatocellular Carcinoma Patients in Turkey|Active, not recruiting||N/A|600|Actual|Bayer|||1||f||||f|f|f||||||||2017-10-11 03:37:05.45652|2017-10-11 03:37:05.45652
NCT01473108|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-12-01|||March 2010||2010-03-01|December 2015|2015-12-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|||Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862|Study to Investigate the Effectiveness of Different Single Oral Doses of BAY94-8862 on Natriuresis After Administration of 0.5 mg Fludrocortisone (Astonin H®) With 50 mg Eplerenone (Inspra®) as Active Control in Healthy Male Subjects in a Randomized, Single-blind, Placebo-controlled, Combined 3-fold Crossover and Parallel-group Design|Completed||Phase 1|68|Actual|Bayer||5|||f||||f||||||||||2017-10-11 03:37:05.534534|2017-10-11 03:37:05.534534
NCT01473095|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-03-17|||November 2011||2011-11-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma|A Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma|Active, not recruiting||Phase 1|125|Anticipated|ArQule||1|||f||||f||||||||||2017-10-11 03:37:05.655201|2017-10-11 03:37:05.655201
NCT01473082|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-02-12|||February 2012||2012-02-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation|Comparison of Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation for the Treatment of Closed Unstable Trochanteric Fractures - A Randomized-controlled Trial|Completed||Phase 4|251|Actual|AO Clinical Investigation and Documentation||2|||f||||t||||||||||2017-10-11 03:37:05.744274|2017-10-11 03:37:05.744274
NCT01473069|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2011-11-17|||March 2010||2010-03-01|November 2011|2011-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects|A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of JTK-853 Administered for Two Weeks in Healthy Subjects|Terminated||Phase 1|41|Actual|Akros Pharma Inc.||5|||f||||f||||||||||2017-10-11 03:37:05.93255|2017-10-11 03:37:05.93255
NCT01473056|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2011-11-17|||August 2010||2010-08-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|October 2010|Actual|2010-10-01||Interventional|||Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects|Phase I,Randomized,Double-blind,Placebo-controlled,Multiple Dose Study Evaluating Safety,Tolerability,Pharmacokinetics and Antiviral Activity of JTK-853 in HCV Genotype 1 Infected Subjects,Followed by a Genotypic Resistance Monitoring Study|Completed||Phase 1|29|Actual|Akros Pharma Inc.||5|||f||||f||||||||||2017-10-11 03:37:06.025394|2017-10-11 03:37:06.025394
NCT01473043|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-05-28|||March 2012||2012-03-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Expanded Access|||Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment|Clinical Study With Axitinib (AG 013736) In Patients With Metastatic Renal Cell Carcinoma After Failure Of One Prior Systemic First-Line Therapy|No longer available||N/A|||Pfizer|||||||||f||||||||||2017-10-11 03:37:06.11935|2017-10-11 03:37:06.11935
NCT01472848|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-14|2011-11-11|||April 2011||2011-04-01|November 2011|2011-11-01|August 2011|Anticipated|2011-08-01|July 2011|Anticipated|2011-07-01||Interventional|||A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects|A Randomized, Double-Blind, Outpatient, Placebo-Controlled, Dose Titration Study Of Gastrointestinal Tolerability Of Pf 05212389 (Oap-189) In Obese Subjects|Withdrawn||Phase 1|0|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 03:37:09.232527|2017-10-11 03:37:09.232527
NCT01473030|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2015-12-01|||November 2011||2011-11-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue|Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue|Active, not recruiting||N/A|80|Actual|University of Illinois at Chicago|||2||f||||f|||||||"     Biopsy tissue (Year 2 and Year 4) already collected in REDUCE trial   "|||2017-10-11 03:37:06.192799|2017-10-11 03:37:06.192799
NCT01473017|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-11-14|||November 2011||2011-11-01|November 2011|2011-11-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Improving Mental Health in Diabetes: A Guided Self-Help Study|Improving Mental Health in Diabetes: A Guided Self-Help Study|Unknown status|Not yet recruiting|N/A|120|Anticipated|University of Edinburgh||2|||f||||t||||||||||2017-10-11 03:37:06.285581|2017-10-11 03:37:06.285581
NCT01473004|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2017-04-10|||October 31, 2011|Actual|2011-10-31|April 2017|2017-04-01|January 1, 2019|Anticipated|2019-01-01|February 23, 2017|Actual|2017-02-23||Interventional|||SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver|An Open-Label, Single Institution, Phase II Study Using Radioactive Yttrium90 Microsphere (SIR-Sphere®) in Uveal Melanoma Patients With Hepatic Metastasis|Active, not recruiting||Phase 2|48|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 03:37:06.378939|2017-10-11 03:37:06.378939
NCT01472991|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2013-04-22||2013-04-22|November 2011||2011-11-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Fixed Dose Study to Assess Efficacy, Safety, and Tolerability of TC-5619 in Adults With Inattentive-Predominant Attention Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|250|Actual|Targacept Inc.||3|||f||||f||||||||||2017-10-11 03:37:06.472527|2017-10-11 03:37:06.472527
NCT01472978|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-06-11|||December 2011||2011-12-01|June 2012|2012-06-01||||December 2014|Anticipated|2014-12-01||Interventional|c diff||Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy|Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy|Unknown status|Recruiting|N/A|50|Anticipated|State University of New York at Buffalo||2|||f||||f||||||||||2017-10-11 03:37:06.5851|2017-10-11 03:37:06.5851
NCT01472952|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-10-20|||February 2012||2012-02-01|October 2014|2014-10-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Observational|||System-level Monitoring of Immune Activation Concerning Susceptibility to Sepsis in Trauma Patients||Withdrawn||N/A|0|Actual|Universitätsmedizin Mannheim|||1||f||||t||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 03:37:06.846465|2017-10-11 03:37:06.846465
NCT01472939|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2014-04-25|2014-03-04||February 2012||2012-02-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Safety Analysis Set was used which consisted of all randomized subjects who took at least 1 dose of investigational product. Three subjects did not receive investigational product, therefore n=477.|Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)|A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn|Completed||Phase 2|480|Actual|Shire||4|||f||||t||||||||||2017-10-11 03:37:06.972844|2017-10-11 03:37:06.972844
NCT01472926|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-08-09|||December 2011||2011-12-01|August 2012|2012-08-01|January 2014|Anticipated|2014-01-01|September 2013|Anticipated|2013-09-01||Interventional|ATTEST||Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)|Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis - Pilot Phase (ATTEST)|Unknown status|Recruiting|Phase 2|104|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||t||||||||||2017-10-11 03:37:08.078165|2017-10-11 03:37:08.078165
NCT01472913|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-04-20|||August 2010||2010-08-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Fibrin Sealant in Bilateral Simultaneous Total Knee Arthroplasty With Focus on Blood Loss, Pain, Swelling and Strength|Fibrin Sealant in Bilateral Simultaneous Total Knee Arthroplasty. A Prospective Randomised Double-blinded Study Focus in on: Blood Loss, Pain, ROM, Swelling and Strength|Completed||Phase 4|48|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 03:37:08.216169|2017-10-11 03:37:08.216169
NCT01472900|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-12|2012-06-17|||October 2010||2010-10-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne|A Randomized Split-Face Controlled Trial Comparing Efficacy of 2940 Nanometer Er:YAG Laser to 2.5% BP Gel for the Treatment of Inflammatory Acne|Completed||N/A|25|Anticipated|Chulalongkorn University||2|||f||||||||||||||2017-10-11 03:37:08.348329|2017-10-11 03:37:08.348329
NCT01472887|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2016-11-02|||January 2012||2012-01-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|STARLYTE||SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients|An Open Label Non-Randomized Phase 2 Study Evaluating SAR3419, an Anti-CD19 Antibody - Maytansine Conjugate, Administered as Single Agent by Intravenous Infusion to Patients With Relapsed or Refractory CD19+ Diffuse Large B-Cell Lymphoma|Completed||Phase 2|61|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:37:08.462138|2017-10-11 03:37:08.462138
NCT01472874|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2014-05-19|2014-04-21||January 2010||2010-01-01|May 2014|2014-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease|Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease|Completed||N/A|8|Actual|Yale University||1|||f||||f||||||||||2017-10-11 03:37:08.64146|2017-10-11 03:37:08.64146
NCT01472861|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2015-06-10|||October 2009||2009-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|AECCT||Autologous Endometrial Coculture (AECCT)|A Randomized Controlled Trial Evaluating Autologous Endometrial Coculture (AECC) As An Effective Tool For Young Patients With Poor Ovarian Reserve|Terminated||N/A|20|Actual|Weill Medical College of Cornell University||2||poor recruitment|f||||f||||||||||2017-10-11 03:37:09.116987|2017-10-11 03:37:09.116987
NCT01472835|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2016-10-31|2014-03-19||March 2011||2011-03-01|October 2016|2016-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Sedation on Diagnostic Injections|Randomized, Cross-over Study Evaluating the Effect of Sedation on Pain Relief After Diagnostic Injections|Completed||N/A|73|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:37:09.352745|2017-10-11 03:37:09.352745
NCT01472822|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2012-12-27|2012-07-26||March 2011||2011-03-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy of Omija (Schisandra Chinensis) Extract in Subjects With Knee Osteoarthritis|Efficacy and Safety of Omija Extract on Gonarthritis|Completed||Phase 2/Phase 3|60|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 03:37:09.83399|2017-10-11 03:37:09.83399
NCT01472809|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-11-20|||December 2011||2011-12-01|November 2015|2015-11-01||||December 2012|Actual|2012-12-01||Interventional|||A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers|A Randomized, Double Blind Placebo Controlled Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZYGK1, a Novel Glucokinase Activator, Following Oral Administration in Healthy Volunteers|Suspended||Phase 1|96|Anticipated|Cadila Healthcare Limited||2||Not achieved the objective till 4 mg single dose|f||||t||||||||||2017-10-11 03:37:10.779008|2017-10-11 03:37:10.779008
NCT01472796|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2011-11-11|||July 2011||2011-07-01|November 2011|2011-11-01|March 2014|Anticipated|2014-03-01|July 2013|Anticipated|2013-07-01||Interventional|VDATH||Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension|Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension (VDATH)|Unknown status|Recruiting|Phase 4|92|Anticipated|Wayne State University||2|||f||||t||||||||||2017-10-11 03:37:10.884596|2017-10-11 03:37:10.884596
NCT01472783|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2016-11-15|||November 2011||2011-11-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|Veli-BRCA||Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation|Veliparib (ABT888) Monotherapy for Patients With BRCA Germline Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer|Completed||Phase 1/Phase 2|49|Actual|Vejle Hospital||1|||f||||t||||||||||2017-10-11 03:37:11.0159|2017-10-11 03:37:11.0159
NCT01472770|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-12-03|||October 2011||2011-10-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|GemCaP||A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer|A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer|Completed||Phase 2|49|Actual|Vejle Hospital||1|||f||||t||||||||||2017-10-11 03:37:11.131327|2017-10-11 03:37:11.131327
NCT01472757|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2014-05-09||2014-05-09|October 2011||2011-10-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma|A Randomised, Double-blind, Placebo-controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of VR506 Inhaled From a New Inhaler in Adolescent and Adult Subjects With Asthma|Completed||Phase 2/Phase 3|374|Actual|Vectura Limited||4|||f||||||||||||||2017-10-11 03:37:11.230009|2017-10-11 03:37:11.230009
NCT01472744|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-02-21|||August 2011||2011-08-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|FAST||Fit & Active Seniors Trial|Influence of Fitness on Brain and Cognition II|Completed||N/A|247|Actual|University of Illinois at Urbana-Champaign||4|||f||||t||||||||No||2017-10-11 03:37:11.553375|2017-10-11 03:37:11.553375
NCT01472731|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-11-13|||December 2011||2011-12-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Imaging Study of GC1008 in Glioma|Guiding GC1008 Treatment of Primary Brain Tumors by 89Zr-GC1008 PET Imaging.|Completed||Phase 2|12|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-10-11 03:37:11.680266|2017-10-11 03:37:11.680266
NCT01472718|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2012-05-24|||February 2009||2009-02-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|||Thromboaspiration in Patients With High Thrombotic Burden Undergoing Primary Percutaneous Coronary Intervention (PCI)|Efficacy of Thromboaspiration in Patients With High Thrombotic Burden Undergoing Primary Percutaneous Coronary Intervention|Completed||Phase 4|208|Actual|University of Pisa||2|||f||||f||||||||||2017-10-11 03:37:11.811167|2017-10-11 03:37:11.811167
NCT01472705|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-12-01|||November 2010||2010-11-01|December 2015|2015-12-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Observational|EverBio||Everolimus- Versus Biolimus-Eluting Stents in All-Comers|Long-Term Comparison of Everolimus-Eluting and Biolimus-Eluting Stents in All-Comer Patients|Completed||N/A|814|Actual|University of Freiburg|||2||f||||f||||||||||2017-10-11 03:37:11.895834|2017-10-11 03:37:11.895834
NCT01472692|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2014-03-31|||October 2011||2011-10-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure|Treatment of Uric Acid With the Xanthine Oxidase Inhibitor Febuxostat: Effects on Blood Pressure, Metabolic Markers, and Aortic Stiffness in Prehypertensive|Completed||Phase 4|47|Actual|University of California, San Diego||2|||f||||t||||||||||2017-10-11 03:37:11.986447|2017-10-11 03:37:11.986447
NCT01472679|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-05-02|||October 2011||2011-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2013|Actual|2013-05-01||Observational|||Body Composition: a Predictor of Mortality in Subjects Over 65 Years|Body Composition: a Predictor of Mortality in Subjects Over 65 Years|Active, not recruiting||N/A|4500|Anticipated|University Hospital, Geneva|||1||f||||f||||||||No||2017-10-11 03:37:12.07018|2017-10-11 03:37:12.07018
NCT01472666|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-02-29|||October 2011||2011-10-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||"Dairy Lipids, Proteins, and the Metabolic Syndrome - DairyHealth"|"Dairy Lipids, Proteins, and the Metabolic Syndrome - DairyHealth"|Completed||N/A|63|Actual|University of Aarhus||4|||f||||f||||||||No|No plan to share data|2017-10-11 03:37:12.178388|2017-10-11 03:37:12.178388
NCT01472653|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2011-12-11|||December 2011||2011-12-01|December 2011|2011-12-01|December 2016|Anticipated|2016-12-01|March 2014|Anticipated|2014-03-01||Interventional|||Treatment Selection According to Skin Reaction to Cetuximab|Skin Reaction to Cetuximab as Criteria for Treatment Selection in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Phase 2 Study|Unknown status|Recruiting|Phase 2|120|Anticipated|Institute of Oncology Ljubljana||1|||f||||f||||||||||2017-10-11 03:37:12.301731|2017-10-11 03:37:12.301731
NCT01472640|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2015-10-09|||November 2011||2011-11-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|||The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus|A Randomised, Double-blind, Placebo-controlled Study of the Effect of LIraglutide on Left VEntricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes (The LIVE-study)|Completed||N/A|240|Actual|Flyvbjerg, Allan, DMSc||2|||f||||f||||||||||2017-10-11 03:37:12.427768|2017-10-11 03:37:12.427768
NCT01472627|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-06-30|||October 2010||2010-10-01|June 2017|2017-06-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Observational|||Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro|Effect of Bortezomib (Velcade)-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro|Active, not recruiting||N/A|20|Anticipated|Dana-Farber Cancer Institute|||1||f||||t||||||Samples Without DNA|"     Peripheral blood samples, bone marrow   "|||2017-10-11 03:37:12.546271|2017-10-11 03:37:12.546271
NCT01472614|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2013-05-24|||September 2011||2011-09-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus|Effect of Add-on Therapy With DLBS3233 on Glycemic Control, Lipid Profile, and Adiponectin in Patients With Type-2 Diabetes Mellitus|Completed||Phase 3|54|Actual|Dexa Medica Group||1|||f||||t||||||||||2017-10-11 03:37:12.658491|2017-10-11 03:37:12.658491
NCT01472601|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2017-04-25|||May 24, 2011|Actual|2011-05-24|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Observational|||A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile|A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile in Patients Receiving Adjuvant Therapy With FOLFOX-6 After Curative Resection of Colon Cancer|Recruiting||N/A|2660|Anticipated|Samsung Medical Center|||2||f||||f||||||||||2017-10-11 03:37:12.778786|2017-10-11 03:37:12.778786
NCT01472588|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2014-09-30|||September 2007||2007-09-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Translating the Diabetes Prevention Program (DPP) Lifestyle Intervention to Rural African-American Communities (HEALTHY Ways)|Translating the DPP Lifestyle Intervention to Rural African-American Communities|Completed||Phase 2|277|Actual|University of Arkansas||3|||f||||||||||||||2017-10-11 03:37:12.87097|2017-10-11 03:37:12.87097
NCT01472562|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-24|2017-02-23|2017-02-22||June 2011||2011-06-01|February 2017|2017-02-01|October 2020|Anticipated|2020-10-01|April 2014|Actual|2014-04-01||Interventional|||Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma|Phase II Study of Lenalidomide Plus Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma|Active, not recruiting||Phase 2|38|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 03:37:13.129997|2017-10-11 03:37:13.129997
NCT01472549|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-12-04|||September 2011||2011-09-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||The Skin Prep Study|Antiseptic Skin Preparation for Preventing Surgical Site Infection at Cesarean Delivery: a Randomized Comparative Effectiveness Trial|Completed||N/A|1147|Actual|Washington University School of Medicine||2|||f||||t||||||||No||2017-10-11 03:37:13.413198|2017-10-11 03:37:13.413198
NCT01472536|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2016-01-24|||November 2011||2011-11-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|eX-FLU||A Study of Exclusion Criteria in a University Population|A Randomized Study of Exclusion Criteria in a University Population|Completed||N/A|1400|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 03:37:13.505505|2017-10-11 03:37:13.505505
NCT01472523|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-06-23|||April 2007||2007-04-01|June 2017|2017-06-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Observational|IONA||A Safer Pre-Natal Diagnosis Using Free DNA in Maternal Blood|A Safer Pre-Natal Diagnosis Using Free DNA in Maternal Blood|Recruiting||N/A|600|Anticipated|Premaitha Health|||2||f||||t||||||Samples With DNA|"     Maternal peripheral blood samples taken in EDTA with that required for existing analysis.      Approx 1ml of fluid from amniocentesis/chorionic villus sampling is taken additional.     Patients will be followed up for 1 year after sample taken.   "|||2017-10-11 03:37:13.578777|2017-10-11 03:37:13.578777
NCT01472510|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-03-13|||December 2011||2011-12-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|July 2013|Actual|2013-07-01||Interventional|||Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy|Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy|Completed||Phase 2|20|Actual|Vitreo-Retinal Associates, PC||2|||f||||t||||||||||2017-10-11 03:37:13.649889|2017-10-11 03:37:13.649889
NCT01472497|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-06-03|||April 2007||2007-04-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Pioglitazone in Hypertensive Patients|Effects of Pioglitazone and Glimepiride in Hypertensive Patients - Relationship With AGE, Inflammatory Cytokines and Cardiac Markers -|Completed||Phase 4|16|Actual|Tottori University Hospital||1|||f||||f||||||||||2017-10-11 03:37:13.733686|2017-10-11 03:37:13.733686
NCT01472484|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-06-18|||December 2011||2011-12-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Impact of Bean Polyphenols and Phytic Acid on Iron Absorption|A Stable Iron Isotope Study to Investigate the Impact of Phytic Acid and Polyphenols on Iron Absorption From Beans in Humans|Completed||N/A|20|Actual|Swiss Federal Institute of Technology||4|||f||||f||||||||||2017-10-11 03:37:13.833141|2017-10-11 03:37:13.833141
NCT01472471|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2013-06-05|||November 2010||2010-11-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Urinary 8-isoprostane is Elevated in Acute Childhood Asthma|Urinary 8-isoprostane is Elevated in Acute Childhood Asthma|Completed||N/A|52|Actual|Stony Brook University|||2||f||||f||||||Samples Without DNA|"     urine   "|||2017-10-11 03:37:13.931243|2017-10-11 03:37:13.931243
NCT01472458|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-02-03|||November 2011||2011-11-01|February 2017|2017-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PremaTOR||Premature Termination of Resuscitation in Survivors of Cardiac Arrest|Premature Termination of Resuscitation in Survivors of Cardiac Arrest|Completed||N/A|905|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 03:37:14.174333|2017-10-11 03:37:14.174333
NCT01472432|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-08-27|2015-05-19||May 2011||2011-05-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes|Dipeptidyl Peptidase (DPP) IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Patients With Type 2 Diabetes|Completed||Phase 4|106|Actual|"University of Campania Luigi Vanvitelli"||2|||f||||f||||||||Undecided||2017-10-11 03:37:14.353504|2017-10-11 03:37:14.353504
NCT01472419|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2013-04-07|||March 2012||2012-03-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Observational|||Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma|Fluoropyrimidine/Platinum-based First-line Chemotherapy in Metastatic Esophageal Squamous Cell Carcinoma: Prognostic Factor Analysis in 239 Patients|Completed||N/A|239|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:37:14.846365|2017-10-11 03:37:14.846365
NCT01472406|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2013-05-22|||November 2011||2011-11-01|June 2012|2012-06-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)|Artificial Pancreas Device Feasibility Study for Type 1 Diabetes Patients Using Model-predictive Control and Health Monitoring System Algorithms With an Approved Subcutaneous Insulin Delivery Pump and Subcutaneous Continuous Glucose Monitor|Unknown status|Recruiting|Early Phase 1|20|Anticipated|William Sansum Diabetes Center||1|||f||||t||||||||||2017-10-11 03:37:14.929902|2017-10-11 03:37:14.929902
NCT01472393|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2015-01-29|||November 2011||2011-11-01|January 2015|2015-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Creatine on Bone Mass in Postmenopausal Women|A Randomized Controlled Trial: Effects of Creatine Supplementation on Bone Mass and Turnover and Muscle Function in Healthy Postmenopausal Women|Recruiting||N/A|200|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:37:15.073114|2017-10-11 03:37:15.073114
NCT01472380|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2012-07-30|2012-06-15||November 2011||2011-11-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz|An Open-label, Drug Interaction Study to Investigate the Effects of Steady-State Fenofibric Acid on the Single-Dose Pharmacokinetics of Efavirenz in Healthy Subjects|Completed||Phase 1|30|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-10-11 03:37:15.175938|2017-10-11 03:37:15.175938
NCT01472367|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2017-09-28|||December 7, 2011|Actual|2011-12-07|September 2017|2017-09-01|January 23, 2020|Anticipated|2020-01-23|January 23, 2020|Anticipated|2020-01-23||Interventional|||A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170)|A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in Pediatric Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin)|Recruiting||Phase 3|130|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 03:37:15.60996|2017-10-11 03:37:15.60996
NCT01472354|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-05-29|||October 2010||2010-10-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|LEAP-C||Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults|Feasibility of a HCV Decision-Making Intervention Among HIV-infected Adults|Completed||N/A|50|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-11 03:37:15.819481|2017-10-11 03:37:15.819481
NCT01472341|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2017-01-30|2015-02-04||November 2008||2008-11-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|BETADECLINE||Beta-Cell Dysfunction and Insulin Resistance Among Italian Patients With Type 2 Diabetes (MK-0000-113)|Beta-Cell Dysfunction and Insulin Resistance Among Italian Patients With Type 2 Diabetes|Completed||N/A|507|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-10-11 03:37:15.931042|2017-10-11 03:37:15.931042
NCT01472328|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2011-11-20|||March 2012||2012-03-01|November 2011|2011-11-01|August 2015|Anticipated|2015-08-01|March 2015|Anticipated|2015-03-01||Interventional|||Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes|Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes|Unknown status|Not yet recruiting|N/A|30|Anticipated|German Diabetes Center||2|||f||||f||||||||||2017-10-11 03:37:17.684166|2017-10-11 03:37:17.684166
NCT01472315|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2013-03-08|||January 2000||2000-01-01|March 2013|2013-03-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities|Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities|Completed||Phase 2/Phase 3|34|Actual|Turku University Hospital||2|||f||||||||||||||2017-10-11 03:37:17.796349|2017-10-11 03:37:17.796349
NCT01472302|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2014-03-05|||April 2012||2012-04-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Closed Loop Ventilation Strategy in Intensive Care Unit (ICU) Patients|Effect of a Closed Loop Ventilation Strategy on Reducing the Total Duration of Mechanical Ventilation of Intubated Intensive Care Unit Patients: A Randomized Controlled Trial|Completed||Phase 4|229|Actual|Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital||2|||f||||f||||||||||2017-10-11 03:37:17.883911|2017-10-11 03:37:17.883911
NCT01472289|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-10-16|2015-07-17||February 2011||2011-02-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional||A total of 17 subjects who met the eligibility criteria were enrolled in this study.|Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia|To Study and Demonstrate the Safety and Efficacy of RES-Q Prepared Bone Marrow Mononuclear Cells Injected Into Ischemic Tissue of Patients With Non-Reconstructable Critical Limb Ischemia (CLI).|Completed||Phase 1/Phase 2|17|Actual|TotipotentSC Scientific Product Pvt. Ltd.||1|||f||||t||||||||||2017-10-11 03:37:17.965945|2017-10-11 03:37:17.965945
NCT01472276|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-03-11|||April 2011||2011-04-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effect of a Unique Web-based Behaviour Change Program on Weight Loss and Cardiovascular Risk Factors|Effect of a Unique Web-based Behaviour Change Program for Physical Activity and Weight Management on Weight Loss and Cardiovascular Risk Factors in Overweight or Obese Adults at High Risk of Cardiovascular Disease|Completed||Phase 2|65|Actual|Queen's University, Belfast||2|||f||||f||||||||||2017-10-11 03:37:18.338701|2017-10-11 03:37:18.338701
NCT01472263|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2015-03-17|||September 2009||2009-09-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|Pentox||Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases|Effectiveness of Pentoxifylline in Attenuating Neurological Disease Associated With HTLV-1 and Negative Modulator of Pathological Immune Response.|Completed||Phase 3|48|Actual|Hospital Universitário Professor Edgard Santos||2|||f||||t||||||||||2017-10-11 03:37:18.436804|2017-10-11 03:37:18.436804
NCT01472250|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-05-07|||November 2011||2011-11-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China|A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China|Completed||N/A|498|Actual|Peking University|||1||f||||f||||||Samples With DNA|"     the tumor tissue samples were collected to do gene mutation analysis   "|||2017-10-11 03:37:18.638156|2017-10-11 03:37:18.638156
NCT01472237|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2015-09-18|||March 2012||2012-03-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PICNIC||Nutritional Intervention Program in Malnourished Patients Admitted for Heart Failure|Randomized Cotrolled Trial of Nutritional Intervention Program in Malnourished (Mini Nutritional Assessment < 17) Patients Admitted for Heart Failure|Terminated||Phase 3|120|Actual|Hospital San Juan de la Cruz||2||"Randomization was stopped early because a significant beneficial effect of nutritional   intervention was found in the interim analysis"|f||||||||||||||2017-10-11 03:37:18.712807|2017-10-11 03:37:18.712807
NCT01472224|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-13|2013-07-22|||October 2011||2011-10-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Volume Measurement and Progression Surveillance of Intracerebral Haemorrhage Using Transcranial Ultrasound|Volume Measurement and Progression Surveillance of Intracerebral Haemorrhage Using Transcranial Ultrasound|Completed||N/A|30|Anticipated|Bispebjerg Hospital|||1||f||||f||||||||||2017-10-11 03:37:18.795036|2017-10-11 03:37:18.795036
NCT01472211|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-06-17|||September 2011||2011-09-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Water-based Zinc Intervention Trial in Zinc Deficient Children|An Efficacy Trial of a Gravity-fed Household Water Treatment Device as a Delivery System for Zinc in Zinc Deficient Preschool Children and Pregnant Women From Rural Settings With Poor Access to Potable Water in Benin.|Terminated||Early Phase 1|317|Actual|Swiss Federal Institute of Technology||3||"Zn released from vehicle led to fortification levels higher than planned. New filter will be   developed."|f||||t||||||||||2017-10-11 03:37:18.883398|2017-10-11 03:37:18.883398
NCT01472198|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2015-02-19||2014-08-06|November 2011||2011-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|October 2013|Actual|2013-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma|A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine as First Line Treatment for Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|250|Actual|Gilead Sciences||4|||f||||t||||||||||2017-10-11 03:37:18.995519|2017-10-11 03:37:18.995519
NCT01472185|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-11|2014-10-15|2014-10-08|2013-12-12|November 2011||2011-11-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Baseline characteristics are reported for the Safety Analysis Set following randomization. The Safety Analysis Set includes randomized participants who received at least one dose of study treatment, analyzed based on actual treatment received.|Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|465|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 03:37:19.258863|2017-10-11 03:37:19.258863
NCT01472172|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-12-03|||February 2010||2010-02-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Pleural Cryobiopsies During Semirigid Thoracoscopy: A New Technique|Pleural Cryobiopsies During Semirigid Thoracoscopy: A New Technique|Completed||Early Phase 1|15|Actual|The University Clinic of Pulmonary and Allergic Diseases Golnik||1|||f||||t||||||||||2017-10-11 03:37:20.52096|2017-10-11 03:37:20.52096
NCT01472159|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-08-01|||October 2011||2011-10-01|August 2017|2017-08-01|August 2015|Actual|2015-08-01|May 2014|Actual|2014-05-01||Interventional|||Can Glucose Monitoring Improve (CGMi Study)|Optimizing CGM Use and Metabolic Outcomes in Youth With Type 1 Diabetes|Completed||N/A|130|Actual|Joslin Diabetes Center||2|||f||||t||||||||||2017-10-11 03:37:20.605486|2017-10-11 03:37:20.605486
NCT01472146|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-05-04|||October 2011|Actual|2011-10-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|July 2016|Actual|2016-07-01||Interventional|||ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer|Phase II Clinical Trial of Neoadjuvant Treatment With Zolendronic Acid Plus Anthracycline and Taxane in Locally Advanced Breast Cancer|Completed||Phase 2|58|Actual|Instituto Nacional de Cancer, Brazil||1|||f||||t||||||||No|I don`t plan to share IPD|2017-10-11 03:37:20.697815|2017-10-11 03:37:20.697815
NCT01472133|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-02-11|||June 2012||2012-06-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Validation of Respiration Rate Algorithms|Validation of Respiration Rate Algorithms|Completed||N/A|130|Anticipated|Guy's and St Thomas' NHS Foundation Trust|||5||f||||f||||||||||2017-10-11 03:37:20.787792|2017-10-11 03:37:20.787792
NCT01472120|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-11-15|||December 2011||2011-12-01|August 2011|2011-08-01|January 2013|Anticipated|2013-01-01|September 2012|Anticipated|2012-09-01||Observational|||Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)|The Relationship of Adiponectin With Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease|Unknown status|Not yet recruiting|N/A|160|Anticipated|Gulhane School of Medicine|||1||f||||f||||||||||2017-10-11 03:37:20.888958|2017-10-11 03:37:20.888958
NCT01472094|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-08-02|||September 9, 2011|Actual|2011-09-09|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults|Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults|Recruiting||N/A|700|Anticipated|City of Hope Medical Center|||1||f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 03:37:21.317371|2017-10-11 03:37:21.317371
NCT01471548|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-04-20|||September 2008||2008-09-01|April 2016|2016-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Phase I Dose Escalating Study of TKI258|A Phase I Dose Escalating Study to Evaluate TKI258 Administered Orally on a 5 Days on/2days Off Schedule in Japanese Patients With Advanced Solid Tumors|Completed||Phase 1|31|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:37:31.273683|2017-10-11 03:37:31.273683
NCT01472081|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-04-17|||January 2012||2012-01-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|February 2016|Actual|2016-02-01||Interventional|||Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)|A Phase 1 Study of Nivolumab (BMS-936558) Plus Sunitinib, Pazopanib or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma|Active, not recruiting||Phase 1|175|Anticipated|Bristol-Myers Squibb||5|||f||||f||||||||||2017-10-11 03:37:21.477746|2017-10-11 03:37:21.477746
NCT01472068|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-02-02|||December 2011||2011-12-01|February 2016|2016-02-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||A Pilot Study to Evaluate Safety and Performance of Neuromuscular Electrical Stimulation With the Inko RS Device for the Treatment of Stress Urinary Incontinence|A Pilot Study to Evaluate the Safety and Performance of Neuromuscular Electrical Stimulation (NMES) With the Inko RS Device for the Treatment of Stress Urinary Incontinence|Completed||Phase 1|21|Actual|Bio-Medical Research, Ltd.||1|||f||||f||||||||||2017-10-11 03:37:21.604052|2017-10-11 03:37:21.604052
NCT01472055|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-06|2014-08-18|||October 2011||2011-10-01|August 2014|2014-08-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation|Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|46|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 03:37:21.67373|2017-10-11 03:37:21.67373
NCT01472042|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-07-18|||November 2011||2011-11-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|GATOR||A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes|A Prospective Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes|Completed||N/A|265|Actual|Banyan Biomarkers, Inc|||3||f||||f||||||Samples Without DNA|"     Serum Whole Blood and Plasma   "|||2017-10-11 03:37:21.754513|2017-10-11 03:37:21.754513
NCT01472029|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-06-16|||December 2011||2011-12-01|June 2017|2017-06-01|September 12, 2016|Actual|2016-09-12|August 25, 2014|Actual|2014-08-25||Interventional|HerFLOT||Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach|Multicenter, Explorative Phase II Study of Perioperative 5-FU, Leucovorin, Docetaxel, and Oxaliplatin (FLOT) in Combination With Trastuzumab in Patients With HER2-positive, Locally Advanced, Resectable Adenocarcinoma of the Gastroesophageal Junction or Stomach (HerFLOT)|Completed||Phase 2|53|Actual|AIO-Studien-gGmbH||1|||f||||t||||||||||2017-10-11 03:37:21.831732|2017-10-11 03:37:21.831732
NCT01472016|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2017-06-05|||October 6, 2011|Actual|2011-10-06|June 2017|2017-06-01|April 27, 2017|Actual|2017-04-27|April 27, 2017|Actual|2017-04-27||Interventional|||Study of ABT-700 in Subjects With Advanced Solid Tumors|A Multi-Center, Phase 1/1b, Open-Label, Dose Escalation Study of ABT-700, a Monoclonal Antibody in Subjects With Advanced Solid Tumors|Completed||Phase 1|74|Actual|AbbVie||4|||f||||f||||||||||2017-10-11 03:37:21.911354|2017-10-11 03:37:21.911354
NCT01472003|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-01-10|||October 2011||2011-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types|An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types Likely to Express Epidermal Growth Factor Receptor (EGFR)|Completed||Phase 1|18|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 03:37:22.136592|2017-10-11 03:37:22.136592
NCT01471990|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-08-28|||May 2011||2011-05-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance|The Effect of PACAP38 and VIP on Migraine Patients Assessed by a 3-Tesla MR Scanner|Completed||N/A|24|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-11 03:37:22.246959|2017-10-11 03:37:22.246959
NCT01471977|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2011-11-15|||January 2004||2004-01-01|November 2011|2011-11-01|February 2010|Actual|2010-02-01|December 2007|Actual|2007-12-01||Interventional|TBAD||Treatment Adherence of Tuberculosis Medicines|Interventions to Promote Adherence to Tuberculosis Treatment Among Patients Attending Basic Medical Unit of Taluka Gambat, Pakistan|Completed||N/A|1280|Actual|Gambat Institute of Medical Sciences||1|||f||||f||||||||||2017-10-11 03:37:22.344317|2017-10-11 03:37:22.344317
NCT01471964|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-09-08|||October 20, 2011|Actual|2011-10-20|September 2017|2017-09-01|July 31, 2019|Anticipated|2019-07-31|August 27, 2018|Anticipated|2018-08-27||Interventional|||Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer|A Phase I/II Trial to Assess Safety and Tolerability of an Oral Aurora Kinase A Inhibitor, MLN8237, In Combination With Erlotinib In Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer|Suspended||Phase 1/Phase 2|38|Anticipated|Fox Chase Cancer Center||1||Phase I portion completed. Phase II will open pending amendment approval.|f||||t||||||||||2017-10-11 03:37:22.433136|2017-10-11 03:37:22.433136
NCT01471951|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2011-11-15|||November 2011||2011-11-01|November 2011|2011-11-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|SET||Single Human Embryo Transfer in Assisted Reproduction Programs|Single Human Embryo Transfer: Comparison of Morphologic and Morphometric Parameters for Day 2 Embryo Selection Before Transference.|Unknown status|Recruiting|Early Phase 1|154|Anticipated|Fundacion Para La Investigacion Hospital La Fe||1|||f||||t||||||||||2017-10-11 03:37:22.523382|2017-10-11 03:37:22.523382
NCT01471938|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2012-02-08|||July 2011||2011-07-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Application and Adaption of Device Specific Body Composition Formulas to Various Ethnic Groups|Application and Adaption of Device Specific Body Composition Formulas to Various Ethnic Groups|Completed||N/A|130|Actual|Seca GmbH & Co. Kg.|||4||f||||t||||||Samples Without DNA|"     whole blood   "|||2017-10-11 03:37:22.622422|2017-10-11 03:37:22.622422
NCT01471925|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-07-24||||||November 2011|2011-11-01||||||||Interventional|||Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC|A Phase III, Randomized, Open-label, Superiority Study Comparing the Incremental Product Esomeprazole Associated With Sodium Bicarbonate Made by Eurofarma and Nexium® in the Treatment of Gastroesophageal Reflux Disease|Withdrawn||Phase 3|0|Actual|Eurofarma Laboratorios S.A.||2||Change company strategy|f||||f||||||||||2017-10-11 03:37:22.691538|2017-10-11 03:37:22.691538
NCT01471912|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-06|2011-11-16|||September 2009||2009-09-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|April 2011|Actual|2011-04-01||Interventional|||Elongation of Foveal Tissue After Macular Hole Surgery|Asymmetric Elongation of Foveal Tissue After Macular Hole Surgery and Its Impact on Metamorphopsia|Completed||N/A|31|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:37:22.780794|2017-10-11 03:37:22.780794
NCT01471899|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-09-24|||October 2013||2013-10-01|September 2013|2013-09-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Interventional|||Comparison Of Ketorolac Tromethamine Oral Drops Versus Naproxen For Moderate to Severe Back Pain Treatment|Randomized, Double Blind, Double Dummy To Non-Inferiority Comparison Of Ketorolac Tromethamine Oral Drops Versus Naproxen For Moderate to Severe Back Pain Treatment|Unknown status|Not yet recruiting|Phase 3|78|Anticipated|EMS||2|||f||||t||||||||||2017-10-11 03:37:22.848583|2017-10-11 03:37:22.848583
NCT01471886|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-09-23|||June 2013||2013-06-01|September 2013|2013-09-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|||Comparison Of Ketorolac Tromethamine Versus Naproxen For Moderate to Severe Back Pain Treatment|Randomized, Double Blind, Double Dummy To Non-Inferiority Comparison Of Ketorolac Tromethamine Versus Naproxen For Moderate to Severe Back Pain Treatment|Unknown status|Recruiting|Phase 3|78|Anticipated|EMS||2|||f||||t||||||||||2017-10-11 03:37:22.930582|2017-10-11 03:37:22.930582
NCT01471873|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-01-14|||March 2011||2011-03-01|January 2017|2017-01-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Observational|||Variability of Pentacam-derived Back Elevation Measurements in Keratoconus and Cross-linked Corneas|Variability of Pentacam-derived Back Elevation Measurements in Keratoconus and Cross-linked Corneas|Completed||N/A|67|Actual|Democritus University of Thrace|||2||f||||f||||||||||2017-10-11 03:37:23.033278|2017-10-11 03:37:23.033278
NCT01471860|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-08-04|||February 2012||2012-02-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2015|Actual|2015-05-01||Interventional|||Barostim Neo System in the Treatment of Heart Failure|Neo Randomized Heart Failure Study|Active, not recruiting||N/A|94|Actual|CVRx, Inc.||2|||f||||t||||||||||2017-10-11 03:37:23.120417|2017-10-11 03:37:23.120417
NCT01471847|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-11-30|||February 2012||2012-02-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab|A Phase Ib/Randomized Phase II Study of BEZ235 and Trastuzumab Versus Lapatinib and Capecitabine in Patients With HER2-positive Locally Advanced or Metastatic Breast Cancer Who Failed Prior to Trastuzumab|Completed||Phase 1|5|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:37:23.282206|2017-10-11 03:37:23.282206
NCT01471834|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-10-19|||June 2011||2011-06-01|October 2016|2016-10-01|August 2026|Anticipated|2026-08-01|May 2012|Actual|2012-05-01||Interventional|||Barostim Neo System in the Treatment of Resistant Hypertension|Neo Non-Randomized Hypertension Study|Active, not recruiting||N/A|40|Actual|CVRx, Inc.||1|||f||||t||||||||||2017-10-11 03:37:23.40271|2017-10-11 03:37:23.40271
NCT01471821|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-15|2014-07-28|||October 2011||2011-10-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|OLE||Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression|Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy Instead of a Triple Therapy That Includes Lopinavir/Ritonavir and Lamivudine or Emtricitabine in HIV Patients With Viral Suppression: Controlled Clinical Trial, Open Label, Randomized, of 48 Weeks of Follow-up|Completed||Phase 4|250|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 03:37:23.492567|2017-10-11 03:37:23.492567
NCT01471808|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2013-04-08|||October 2011||2011-10-01|April 2013|2013-04-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Effects of Different Early Intensive Therapies on Long-term β-cell Function|Effects of Oral Hypoglycemic Agents Combined With Short-term CSII on Glycemic Control in Newly-diagnosed Type 2 Diabetic Patients|Enrolling by invitation||Phase 4|336|Anticipated|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 03:37:23.580187|2017-10-11 03:37:23.580187
NCT01471795|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-15|||January 2006||2006-01-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||The Epidemiology of Ventricular Assist Device-Related Infections|The Epidemiology of Ventricular Assist Device-Related Infections|Completed||N/A|150|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||||||2017-10-11 03:37:23.659751|2017-10-11 03:37:23.659751
NCT01471782|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-12-16|2016-09-23|2015-07-23|January 2012||2012-01-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|August 2014|Actual|2014-08-01||Interventional|||Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia|A Single-Arm Multicenter Phase II Study Preceded by Dose Evaluation to Investigate the Efficacy, Safety, and Tolerability of the BiTE® Antibody Blinatumomab (MT103) in Pediatric and Adolescent Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1/Phase 2|93|Actual|Amgen Research (Munich) GmbH||1|||f||||t||||||||||2017-10-11 03:37:23.851967|2017-10-11 03:37:23.851967
NCT01471769|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2012-12-17|||June 2011||2011-06-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Video Education Intervention in the Emergency Department|Video Education Intervention in the Emergency Department|Completed||N/A|100|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 03:37:27.454524|2017-10-11 03:37:27.454524
NCT01471756|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-09-05|||October 2011||2011-10-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|||Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia|Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia: A Randomized Prospective Comparison of Snares and Injectate in the Resection of Large Sessile Colonic Polyps|Completed||Phase 4|66|Actual|Mayo Clinic||4|||f||||t||||||||||2017-10-11 03:37:27.544844|2017-10-11 03:37:27.544844
NCT01471743|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-02-22|||November 2011||2011-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||GI Surgery Pre-Operative Nutrition|"The Effect of Pre-Operative Immunonutrition With Impact Advanced Recovery (R) on Patients Undergoing Major GI Cancer Surgery"|Completed||N/A|108|Actual|James A. Haley Veterans Administration Hospital||2|||f||||t||||||||||2017-10-11 03:37:27.640567|2017-10-11 03:37:27.640567
NCT01471730|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-03-29|||November 2011||2011-11-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ZEPLAST||The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery|The ZEroPLASmaTrial (ZEPLAST): a Randomized, Controlled Trial on Transfusion Avoidance in High Transfusion-risk Cardiac Surgery Patients|Completed||Phase 3|119|Actual|IRCCS Policlinico S. Donato||3|||f||||f||||||||||2017-10-11 03:37:27.721595|2017-10-11 03:37:27.721595
NCT01471535|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-03-08|||May 2008||2008-05-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated|HBsAg Loss/Seroconversion in Inactive Chronic Hepatitis B Carriers Treated With Peginterferon Alpha-2a|Completed||N/A|20|Actual|Beijing Ditan Hospital||1|||f||||t||||||||||2017-10-11 03:37:31.353696|2017-10-11 03:37:31.353696
NCT01471717|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-06-21|||October 2011||2011-10-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|INX-189-004||Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects|A Phase Ib, Single-Center, Randomized, Two-Sequence, Placebocontrolled, Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects|Completed||Phase 1/Phase 2|32|Actual|Bristol-Myers Squibb||6|||f||||t||||||||||2017-10-11 03:37:27.82981|2017-10-11 03:37:27.82981
NCT01471704|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-06-21|||October 2011||2011-10-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|INX-189-005||Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers|A Phase 1b, Drug-Drug Interaction Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers|Completed||Phase 1/Phase 2|24|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-10-11 03:37:27.921354|2017-10-11 03:37:27.921354
NCT01471691|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-04-10|2015-03-17||November 2011||2011-11-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|RAVEN||Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab|Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)|Completed||Phase 1/Phase 2|14|Actual|Hanscom, Thomas, M.D.||2|||f||||f||||||||||2017-10-11 03:37:28.011126|2017-10-11 03:37:28.011126
NCT01471678|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-07-13|||June 30, 2011|Actual|2011-06-30|July 2017|2017-07-01|September 7, 2011|Actual|2011-09-07|September 7, 2011|Actual|2011-09-07||Interventional|ARI115707||Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.|An Open-label, Randomized, Single Dose, Four-Period Crossover Study to Compare the Bioavailability of Fixed Dose Combination Capsule Formulations of Dutasteride and Tamsulosin Hydrochloride (0.5 mg/0.2 mg) With 10% and 15% of Enteric Coated Pellets With Harnal-D Tablets and Harnal Capsules Co-administered With Dutasteride (0.5 mg) Soft Gel Capsules in Healthy Male Subjects of North East Asian Ancestry|Completed||Phase 1|27|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:37:28.26368|2017-10-11 03:37:28.26368
NCT01471652|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-04-09|||March 2012||2012-03-01|April 2015|2015-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|CFS:M||Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder|Chronic Fatigue Syndrome: Correction of Mitochondrial Dysfunction by Conditioning Exercise and Nutraceutical Therapy.|Withdrawn||Phase 2|0|Actual|Columbia University||2||PI left the institution|f||||t||||||||||2017-10-11 03:37:28.457705|2017-10-11 03:37:28.457705
NCT01471639|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-08-16|2017-04-17||November 2011||2011-11-01|August 2017|2017-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|Sprix||An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain|A Prospective, Open-label, Nonrandomized Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain|Completed||N/A|37|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-10-11 03:37:28.56389|2017-10-11 03:37:28.56389
NCT01471626|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-09-06|2012-05-29||December 2011||2011-12-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|sleepbox||Real-time Attended Home-polysomnography Through Telematic Data Transmission|Real-time Attended Home-polysomnography Through Telematic Data Transmission|Completed||N/A|21|Actual|Centre Hospitalier Universitaire Saint Pierre|-technical problems with the Skype® connection|1|||f||||f||||||||||2017-10-11 03:37:29.047092|2017-10-11 03:37:29.047092
NCT01471613|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2014-01-27|||September 2011||2011-09-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury|Safety and Effect of Lithium, Umbilical Cord Blood Cells and the Combination in the Treatment of Acute and Sub-acute Spinal Cord Injury : a Randomized, Double-Blinded Placebo-Controlled Clinical Trial|Completed||Phase 1/Phase 2|16|Actual|China Spinal Cord Injury Network||4|||f||||||||||||||2017-10-11 03:37:29.207819|2017-10-11 03:37:29.207819
NCT01471600|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2013-02-26|||May 2008||2008-05-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|ENDOGLUcide||Safety and Efficacy of Carbohydrate Drink Ingested Two Hours Before Upper Endoscopy Under General Anaesthesia|Randomized Control Study : Safety and Efficacy of Carbohydrate Drink Ingested Two Hours Before Upper Endoscopy Under General Anaesthesia|Completed||N/A|119|Actual|University Hospital, Caen||2|||f||||t||||||||||2017-10-11 03:37:29.301276|2017-10-11 03:37:29.301276
NCT01471587|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-12-01|||December 2011||2011-12-01|December 2011|2011-12-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Observational|||Fibre Specific Signalling in the Locomotor Myopathy of Chronic Obstructive Pulmonary Disease|Fibre Specific Signalling in the Locomotor Myopathy of COPD|Unknown status|Recruiting|N/A|80|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     muscle and blood   "|||2017-10-11 03:37:29.385847|2017-10-11 03:37:29.385847
NCT01471574|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2015-12-22|2015-08-18||December 2011||2011-12-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional||All participants who received at least 1 dose of study therapy.|Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus|A Phase 3, Open Label Study of Safety and Efficacy With BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected With Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)|Completed||Phase 3|549|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 03:37:29.498474|2017-10-11 03:37:29.498474
NCT01471561|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-02-02|||October 2011||2011-10-01|February 2016|2016-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Analysis of Cataract Surgery Induced Dry Eye|Retrospective Analysis of Cataract Surgery-induced Dry Eye Using Tear Osmolarity Testing|Completed||N/A|61|Actual|TearLab Corporation|||1||f||||f||||||||No|No data will be shared.|2017-10-11 03:37:31.203115|2017-10-11 03:37:31.203115
NCT01471509|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-11-18|||August 1982||1982-08-01|November 2011|2011-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Protein, Amino Acids & Insulin & Glucagon Secretion in Humans|The Effect of Ingestion of Foods on the Plasma Glucose and Insulin Response in Subjects With Type 2 Diabetes: Protein, Amino Acids & Insulin & Glucagon Secretion in Humans|Recruiting||N/A|300|Anticipated|Minneapolis Veterans Affairs Medical Center||4|||f||||f||||||||||2017-10-11 03:37:33.40261|2017-10-11 03:37:33.40261
NCT01471496|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2011-11-10|||January 2003||2003-01-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers|Prophylactic Injection Therapy Reduces Recurrent Bleeding Rate In Forrest Type IIb Duodenal Ulcer Bleeding|Completed||N/A|80|Actual|Bakirkoy Dr. Sadi Konuk Research and Training Hospital||2|||f||||t||||||||||2017-10-11 03:37:33.580709|2017-10-11 03:37:33.580709
NCT01471483|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-10-03|||November 2011||2011-11-01|October 2017|2017-10-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer|Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer|Active, not recruiting||N/A|50|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 03:37:33.703395|2017-10-11 03:37:33.703395
NCT01471470|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2017-07-13|||July 2010|Actual|2010-07-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer|A Phase II Study of Neoadjuvant Chemotherapy With Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer|Active, not recruiting||Phase 2|31|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:37:33.806267|2017-10-11 03:37:33.806267
NCT01471457|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-05-16|||September 2009||2009-09-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|TBVAP||Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis|The Use of Trimo-San Gel for the Prevention of Pessary-associated Bacterial Vaginosis|Completed||Phase 2/Phase 3|184|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-11 03:37:33.904385|2017-10-11 03:37:33.904385
NCT01471444|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-01-27|||November 2, 2011|Actual|2011-11-02|January 2017|2017-01-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2018|Anticipated|2018-11-01||Interventional|||Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|A Randomized Study of Once Daily Fludarabine-Clofarabine Versus Fludarabine Alone Combined With Intervenous Busulfan Followed by Allogeneic Hemopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Active, not recruiting||Phase 3|250|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 03:37:34.128777|2017-10-11 03:37:34.128777
NCT01471431|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-06-03|||August 2011||2011-08-01|September 2015|2015-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Extubation Readiness Study in Very Low Birthweight Infants|A Randomized Trial of the Spontaneous Breathing Trial to Extubate Very Low Birthweight Infants|Terminated||N/A|81|Actual|University of Pennsylvania||2||Futility analysis by DSMC recommended termination.|f||||t||||||||||2017-10-11 03:37:34.783779|2017-10-11 03:37:34.783779
NCT01471418|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2015-07-06|||December 2011||2011-12-01|July 2015|2015-07-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||The Use of PET/CT to Evaluate Synovitis in the Temporomandibular Joint (TMJ)|Investigation of the Use of Positron Emission Tomography With 18F-FDG PET/CT for the Diagnosis of Synovitis in the Temporomandibular Joint|Withdrawn||Phase 2|0|Actual|University of Pennsylvania||1||29-Apr-14 UPENN IRB granted approval to close study due to lack of funding|f||||f||||||||||2017-10-11 03:37:34.897585|2017-10-11 03:37:34.897585
NCT01471405|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-03-27|||January 2012||2012-01-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Observational|||One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma|Retrospective Non-interventional Study Evaluating Treatment Adaption During a One Year Follow-up After Completion of the 2-79-52030-207 Study in a Group of Acromegalic Patients With Macroadenoma Who Received 12 Injections of Lanreotide Autogel® 120 mg|Completed||N/A|54|Actual|Ipsen|||1||f||||f||||||||||2017-10-11 03:37:35.018473|2017-10-11 03:37:35.018473
NCT01471392|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2013-05-31|||November 2011||2011-11-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Identigene STD Test Collection Kit Validation Study|Identigene STD Test Collection Kit Validation Study|Unknown status|Recruiting|Phase 3|3000|Anticipated|Identigene||1|||f||||f||||||||||2017-10-11 03:37:35.218562|2017-10-11 03:37:35.218562
NCT01471379|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-03-15|2013-07-03||April 2012||2012-04-01|March 2017|2017-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||The study was terminated early resulting in a small number of subjects enrolled leaving the ability to analyze only certain categories.|Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Milnacipran in the Treatment of Irritable Bowel Syndrome|Terminated||Phase 2|2|Actual|University of North Carolina, Chapel Hill||3||Due to recruitment difficulties the study is terminated.|f||||f||||||||||2017-10-11 03:37:35.386416|2017-10-11 03:37:35.386416
NCT01471366|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-07-25|||November 2011||2011-11-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Method of Fish Oil Administration on Patient Compliance|What is the Best Way to Take Fish Oil?|Completed||N/A|60|Actual|University of Mississippi, Oxford||4|||f||||f||||||||||2017-10-11 03:37:35.875266|2017-10-11 03:37:35.875266
NCT01471353|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-08-07|2016-11-15||November 2011||2011-11-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|October 2015|Actual|2015-10-01||Interventional|SorCape|Adults with metastatic colorectal cancer who had previously received two or more lines of systemic therapy.|Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer|Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|43|Actual|University of Florida||1|||f||||t||||||||||2017-10-11 03:37:36.034399|2017-10-11 03:37:36.034399
NCT01471340|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-12-16|||January 2012||2012-01-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|SPIRO||A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)|A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate/Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma (Protocol No. P06241 Also Known as P202)|Completed||Phase 4|11745|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-10-11 03:37:36.558374|2017-10-11 03:37:36.558374
NCT01471327|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-06-19|||August 9, 2011|Actual|2011-08-09|June 2017|2017-06-01|April 27, 2012|Actual|2012-04-27|April 27, 2012|Actual|2012-04-27||Interventional|||Japanese Phase 1 Study of Mepolizumab|A Single Blind, Placebo Controlled, Parallel Group, Single Ascending Intravenous Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SB-240563 (Mepolizumab) in Healthy Japanese Male Subjects.|Completed||Phase 1|35|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:37:36.71413|2017-10-11 03:37:36.71413
NCT01471314|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2012-08-28||||||August 2012|2012-08-01||||||||Observational|||MRA/fMRI Study of Spontaneous Migraine|Functional MRI and MR Angiography Used in Spontaneous Migraine|Unknown status|Recruiting|N/A|||Glostrup University Hospital, Copenhagen|||1||f||||t||||||||||2017-10-11 03:37:37.834046|2017-10-11 03:37:37.834046
NCT01471301|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-11-14|||June 2011||2011-06-01|November 2011|2011-11-01||||November 2011|Anticipated|2011-11-01||Observational|||Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus|Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|120|Anticipated|Federal University of São Paulo|||1||f||||f||||||Samples With DNA|"     serum   "|||2017-10-11 03:37:37.914039|2017-10-11 03:37:37.914039
NCT01471288|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-11-14|||May 2011||2011-05-01|October 2011|2011-10-01||||December 2011|Anticipated|2011-12-01||Interventional|||Effect of Carum Carvi on Thyroid Hormones and TSH Level|Evaluation of the Effect of Carum Carvi on Levels of Plasma Thyroid Hormones and TSH Level in Patients on Thyroid Hormone Therapy and Normal Controls.|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Mashhad University of Medical Sciences||4|||f||||t||||||||||2017-10-11 03:37:38.00073|2017-10-11 03:37:38.00073
NCT01471275|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-14|2011-12-05|||November 2011||2011-11-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia|The Study of TCM in Prevention and Promote of Community-based Diabetes|Unknown status|Recruiting|N/A|450|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 03:37:38.408903|2017-10-11 03:37:38.408903
NCT01471262|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-11-21|||January 2006||2006-01-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Right Hepatectomy in Patients Beyond 70 Years Old|Right and Extended Right Hepatectomy in Patients Beyond 70 Years of Age - Liver Function and Outcome|Unknown status|Enrolling by invitation|N/A|90|Anticipated|Centre Hospitalier Universitaire Vaudois|||2||f||||t||||||||||2017-10-11 03:37:38.56287|2017-10-11 03:37:38.56287
NCT01471249|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-08-31|||June 2011||2011-06-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Observational|||Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer|Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer (CT0023)|Suspended||N/A|100|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-10-11 03:37:38.666573|2017-10-11 03:37:38.666573
NCT01471236|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-02-28|||June 2011||2011-06-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of the Agili-C Biphasic Implant in the Knee Joint|Evaluation of the Agili-C Bi-phasic Implant Performances in the Repair of Cartilage and Osteochondral Defects|Active, not recruiting||N/A|65|Actual|Cartiheal (2009) Ltd||1|||f||||f||||||||||2017-10-11 03:37:38.738757|2017-10-11 03:37:38.738757
NCT01471223|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-09-18|||March 31, 2012|Actual|2012-03-31|September 2017|2017-09-01|August 8, 2017|Actual|2017-08-08|August 8, 2017|Actual|2017-08-08||Observational|CTS||Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study|Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study (CTS)|Completed||N/A|89|Actual|Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 03:37:38.832887|2017-10-11 03:37:38.832887
NCT01471210|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2017-04-17|||February 2012||2012-02-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma|A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL)|Completed||Phase 1|124|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 03:37:38.911513|2017-10-11 03:37:38.911513
NCT01471197|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-04-14|2014-03-06||July 2012||2012-07-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Randomized participants who received at least one dose of either study medication.|Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer|A Randomized, Open-Label, Phase 2 Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Subjects With Recurrent/Stage IV Non-Squamous, Non-Small Cell Lung Cancer Who Have Not Progressed After Four Cycles of a Platinum-Based First Line Chemotherapy|Terminated||Phase 2|9|Actual|Bristol-Myers Squibb|At the time of the early termination of this study, most participants only had only one on-study tumor assessment performed. Therefore, the tumor response-related endpoints were too immature to report.|2||Administrative reasons|f||||f||||||||||2017-10-11 03:37:39.079252|2017-10-11 03:37:39.079252
NCT01471184|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2011-11-18|||September 2009||2009-09-01|November 2011|2011-11-01||||March 2010|Actual|2010-03-01||Interventional|PPL-003||The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo|A Double-Blind, Randomized, Cross-Over Study of The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo, in Patients With Allergic Rhinitis and Allergic Conjunctivitis in an Environmental Exposure Chamber (EEC) Model|Completed||Phase 1|46|Actual|Bitop AG||2|||f||||f||||||||||2017-10-11 03:37:39.705368|2017-10-11 03:37:39.705368
NCT00005460|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||January 1991||1991-01-01|May 2000|2000-05-01|December 1992|Actual|1992-12-01|||||Observational|||Predictors of Cardiovascular Disease in the Elderly||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.118403|2017-10-11 04:27:05.118403
NCT01471171|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-11-16|2013-05-21||November 2011||2011-11-01|October 2016|2016-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Multiple Dose, Randomised, Double-blind, Placebo Controlled, 2 Period Crossover Clinical Trial to Assess the Effect of Aclidinium Bromide 400 μg BID on Exercise Endurance in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|112|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 03:37:39.803005|2017-10-11 03:37:39.803005
NCT01471158|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2016-11-18|||September 2010||2010-09-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma|Patient Preference Comparison of AZARGA Versus COSOPT After Single Doses in Patients With Open-Angled Glaucoma or Ocular Hypertension|Completed||Phase 4|120|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:37:40.09546|2017-10-11 03:37:40.09546
NCT01471145|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-10|2014-10-10|||January 2013||2013-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|XRNT||Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT|Feasibility, Mechanism of Action and Potential Side Effects of Extended Release Depot Naltrexone in Opioid Dependent Patients|Completed||Phase 4|40|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||1|||f||||f||||||||||2017-10-11 03:37:40.196979|2017-10-11 03:37:40.196979
NCT01471132|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-12-06|||September 2011||2011-09-01|December 2012|2012-12-01|September 2015|Anticipated|2015-09-01|September 2013|Anticipated|2013-09-01||Interventional|SHOP-G01||Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis|Phase 2 Study of Sequential Hyperthermic Intraperitoneal Chemotherapy of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis or Positive Free Cancer Cells in Abdomen|Unknown status|Recruiting|Phase 2|20|Anticipated|Peking University||1|||f||||t||||||||||2017-10-11 03:37:40.307801|2017-10-11 03:37:40.307801
NCT01471119|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-08-11|||October 2011||2011-10-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Sublingual Immunotherapy in Patients With Atopic Dermatitis|Usefulness and Safety of Sublingual Dermatophagoides Farinae Drops in Patients With Atopic Dermatitis:A Randomized,Double-blind,Placebo-controlled Study.|Completed||Phase 2|240|Anticipated|Zhejiang University||4|||f||||f||||||||||2017-10-11 03:37:40.405114|2017-10-11 03:37:40.405114
NCT01471106|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-07-06|||January 2014|Actual|2014-01-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer|Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer|Recruiting||Phase 2|66|Anticipated|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-10-11 03:37:40.495908|2017-10-11 03:37:40.495908
NCT01471093|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-02-23|||November 2011||2011-11-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Safety Study of OPC-12759 Ophthalmic Solution|Safety Study of OPC-12759 Ophthalmic Solution in Healthy Subjects|Completed||Phase 1|100|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:37:40.586193|2017-10-11 03:37:40.586193
NCT01471080|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-07-01|||November 2011||2011-11-01|November 2012|2012-11-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver|A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver：RFA Versus Laparoscopic Hepatectomy.|Completed||N/A|140|Anticipated|Southwest Hospital, China||2|||f||||f||||||||||2017-10-11 03:37:40.663283|2017-10-11 03:37:40.663283
NCT01471067|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-04-27|||July 13, 2012|Actual|2012-07-13|April 2017|2017-04-01|April 25, 2017|Actual|2017-04-25|April 25, 2017|Actual|2017-04-25||Interventional|||Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies|Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies|Completed||Phase 1|33|Actual|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 03:37:40.749426|2017-10-11 03:37:40.749426
NCT01471054|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-12-09|||April 2014||2014-04-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma|Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma|Terminated||Phase 2|6|Actual|Wills Eye||2||Could not enroll enough patients.|f||||f||||||||Undecided||2017-10-11 03:37:40.884491|2017-10-11 03:37:40.884491
NCT01471041|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-04-26|2016-04-26||December 2011||2011-12-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|SAVE|ESRD patients treated with HD having a deep, uncanulatable AVF|Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae|Vital Access Venous Window Needle Guide for Salvage of AV FistulaE (SAVE) Trial|Completed||Phase 2/Phase 3|54|Actual|Vital Access Corp.||1|||f||||t||||||||||2017-10-11 03:37:40.994584|2017-10-11 03:37:40.994584
NCT01471028|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-09-22|||February 2013||2013-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|January 2015|Actual|2015-01-01||Interventional|||Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure|A Randomized, Open-Label, Multicenter, Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)|Completed||Phase 3|203|Actual|Vital Therapies, Inc.||2|||f||||t||||||||||2017-10-11 03:37:41.232184|2017-10-11 03:37:41.232184
NCT01471015|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-05-06|2015-05-06||September 2012||2012-09-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|DANCE||Darbe Administration in Newborns Undergoing Cooling for Encephalopathy|Darbe Administration in Newborns Undergoing Cooling for Encephalopathy|Completed||Phase 1/Phase 2|30|Actual|University of Utah|Due to the small number of participants, infrequent adverse events may not have been detected. There is a lack of long-term follow up to assess for long-term safety concerns.|3|||f||||t||||||||||2017-10-11 03:37:41.436581|2017-10-11 03:37:41.436581
NCT01471002|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2016-04-07|||November 2011||2011-11-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|CRYOREIN||Study to Evaluate the Efficacy of Percutaneous Cryoablation for Renal Tumours < 4cm in Patients Who Are Not Candidates for Partial Nephrectomy|Prospective Study to Evaluate the Efficacy of Percutaneous Cryoablation for Renal Tumours < 4cm in Patients Who Are Not Candidates for Partial Nephrectomy|Completed||N/A|100|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 03:37:41.976995|2017-10-11 03:37:41.976995
NCT01470989|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-02-21|||November 2011||2011-11-01|February 2017|2017-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|β-RELIEVED||β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)|An Open-label Extension Study of CACZ885H2356E2 and CACZ885H2357E2 on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/or Colchicine Are Contraindicated, Not Tolerated or Ineffective|Completed||Phase 3|135|Actual|Novartis||1|||f||||t||||||||||2017-10-11 03:37:42.061347|2017-10-11 03:37:42.061347
NCT01470976|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2016-02-03|||November 2011||2011-11-01|February 2016|2016-02-01|July 2014|Actual|2014-07-01|February 2014|Actual|2014-02-01||Interventional|GRICS||Goal-directed Resuscitation in High-risk Patients Undergoing Cardiac Surgery|Randomized Controlled Trial of Goal-directed Resuscitation in High-risk Patients Undergoing Cardiac Surgery|Completed||Phase 3|126|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:37:42.262731|2017-10-11 03:37:42.262731
NCT01470963|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2014-07-10|||September 2011||2011-09-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Practical Health Co-operation - The Impact of a Referral Template on Quality of Health Care|Practical Health Co-operation - a Randomised Controlled Intervention Study. The Impact of a Referral Template on Quality of Care and Health Care Co-operation Between Primary and Secondary Care|Completed||N/A|500|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 03:37:42.346079|2017-10-11 03:37:42.346079
NCT01470950|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-02-04|||May 2010||2010-05-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||Characterization of the Changes in the Signalling Pathways During Spinal Cord Injury-induced Skeletal Muscle Atrophy|Characterization of the Changes in the Signalling Pathways During Spinal Cord Injury-induced Skeletal Muscle Atrophy|Unknown status|Active, not recruiting|N/A|28|Anticipated|Clinique Romande de Readaptation||1|||f||||||||||||||2017-10-11 03:37:42.423082|2017-10-11 03:37:42.423082
NCT01470937|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2011-11-10|||February 1998||1998-02-01|November 2011|2011-11-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|EDIP||Early Diabetes Intervention Program|Early Diabetes Intervention Program|Completed||Phase 4|219|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 03:37:42.494203|2017-10-11 03:37:42.494203
NCT01470924|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-10|||January 2003||2003-01-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|||||Observational|||Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007|High Curability Via Intensive Reinduction Chemotherapy and Stem Cell Transplantation in Young Adults With Relapsed Acute Lymphoblastic Leukemia in Sweden 2003-2007|Completed||N/A|76|Actual|Region Örebro County|||1||f||||||||||||||2017-10-11 03:37:42.637822|2017-10-11 03:37:42.637822
NCT01470911|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2012-11-21|||November 2011||2011-11-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects|Phase-I Study in Healthy Male Subjects to Investigate Safety, Tolerability and Pharmacokinetics of Orally Inhaled Single Doses of SB010, a Human GATA-3-specific DNAzyme Solution for Nebulisation.|Completed||Phase 1|46|Actual|Sterna Biologicals GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 03:37:42.700946|2017-10-11 03:37:42.700946
NCT01470898|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2012-07-09|||February 2011||2011-02-01|November 2011|2011-11-01|February 2013|Anticipated|2013-02-01|July 2011|Actual|2011-07-01||Interventional|||Bispectral Index (BIS) Monitoring in Abdominal Surgery|Effect of Bispectral Index (BIS) Monitoring on Faster Recovery Time and Analgesic Consumption in Abdominal Surgery Patients|Unknown status|Active, not recruiting|Phase 4|40|Anticipated|University Hospital Dubrava||2|||f||||f||||||||||2017-10-11 03:37:42.793741|2017-10-11 03:37:42.793741
NCT01470885|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-05-02|||March 2011||2011-03-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|ROGAAP||Relation of Glucose and Acute Pancreatitis|the Influence of Glucose to the Prognosis of Patients of Acute Pancreatitis|Completed||N/A|350|Actual|Huashan Hospital|||1||f||||t||||||||||2017-10-11 03:37:42.893869|2017-10-11 03:37:42.893869
NCT01470859|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-09-21|2015-06-23||December 2011||2011-12-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease|a Pilot Follow-up Study of Investigating the Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Chinese Patients With Early Parkinson's Disease|Completed||N/A|30|Actual|Huashan Hospital|In the further study, a larger sample size and strict enrollment of early PD patients may enhance the accuracy of clinical trial conclusions.|2|||f||||t||||||||||2017-10-11 03:37:43.007237|2017-10-11 03:37:43.007237
NCT01470846|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-08-13|||November 2011||2011-11-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|PERIDIGE||Postoperative Analgesia in Abdominal Surgery: a Medico-economic Study|Epidural Analgesia vs. Morphine Patient-controlled Analgesia in Abdominal Surgery Under Laparotomy : a Medico-economic Study|Terminated||Phase 4|35|Actual|University Hospital, Limoges||2||Lack of patients eligible for the study|f||||f||||||||||2017-10-11 03:37:43.548305|2017-10-11 03:37:43.548305
NCT01470833|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-08-17|||April 2011||2011-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Non-operative Treatment of Acute Achilles Tendon Rupture Using Dynamic Rehabilitation. Influence of Early Weight-bearing Compared With Non-weight-bearing|Non-operative Treatment of Acute Achilles Tendon Rupture Using Dynamic Rehabilitation. The Influence of Early Weight-bearing Compared With Non-weight-bearing|Completed||N/A|60|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 03:37:43.655846|2017-10-11 03:37:43.655846
NCT01470820|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2011-11-10|||July 2009||2009-07-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||"Dose-response Relationship of Phototherapy for Hyperbilirubinaemia Using Diodes: is There a Saturation Point"|"Dose-response Relationship of Phototherapy for Hyperbilirubinaemia Using Diodes: is There a Saturation Point?"|Completed||N/A|151|Actual|University of Aarhus||4|||f||||f||||||||||2017-10-11 03:37:43.741766|2017-10-11 03:37:43.741766
NCT01470807|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-11-28|||October 2011||2011-10-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing|Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes|Completed||N/A|5|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:37:43.827493|2017-10-11 03:37:43.827493
NCT01470794|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-02-23|||January 2012||2012-01-01|February 2016|2016-02-01|July 2016|Anticipated|2016-07-01|May 2016|Anticipated|2016-05-01||Interventional|||Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor|A P1 Ascending Dose Trial of Safety and Tolerability of Toca 511, a Retroviral Replicating Vector, Administered to Subjects at the Time of Resection for Recurrent High Grade Glioma & Followed by Treatment With Toca FC, Extended-Release 5-FC|Active, not recruiting||Phase 1|58|Actual|Tocagen Inc.||1|||f||||t||||||||||2017-10-11 03:37:43.920513|2017-10-11 03:37:43.920513
NCT01470781|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-03-22|||June 2011||2011-06-01|March 2017|2017-03-01|August 1, 2016|Actual|2016-08-01|August 1, 2016|Actual|2016-08-01||Interventional|TREC-BD||Treatment to Enhance Cognition in Bipolar Disorder|Efficacy of a Cognitive Remediation Treatment Program for Bipolar Disorder|Completed||N/A|84|Actual|Mclean Hospital||2|||f||||f||||||||||2017-10-11 03:37:44.022433|2017-10-11 03:37:44.022433
NCT01470768|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2012-03-20|||January 2012||2012-01-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas|Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based Formulas|Withdrawn||N/A|0|Actual|Mead Johnson Nutrition||2||Sponsor cancelled study|f||||f||||||||||2017-10-11 03:37:44.14715|2017-10-11 03:37:44.14715
NCT01470755|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-05-22|||January 2012||2012-01-01|July 2011|2011-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|DORESI||Study of Dose-response to Bronchodilator and Dose-finding in Child 2.5 to 6 Years - Study Golden|Study on Dose-response to Bronchodilator Then Bronchodilator Dose-finding Using the Flow Interruption Technique in Children Aged 2.5 TO 6 Years|Completed||Phase 2|90|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||||2017-10-11 03:37:44.231366|2017-10-11 03:37:44.231366
NCT01470742|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-04-30|||September 2010||2010-09-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|February 2015|Actual|2015-02-01||Interventional|||Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer|A Randomized, Phase III, Multicenter Clinical Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 03:37:44.327877|2017-10-11 03:37:44.327877
NCT01470729|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-12-15|||November 2011||2011-11-01|June 2014|2014-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|BIOSCA||Biomarkers in Autosomal Dominant Cerebellar Ataxia|Identification of Biomarkers in Patients With Autosomal Dominant Cerebellar Ataxia|Completed||N/A|102|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||Samples With DNA|"     blood   "|||2017-10-11 03:37:44.41417|2017-10-11 03:37:44.41417
NCT01470716|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-08-24|||January 2012||2012-01-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations|A Phase II Study of Neo-adjuvant Erlotinib for Operable Stage IIB or IIIA Non-small Cell Lunc Cancer With Epidermal Growth Factor Receptor Activation Mutations|Recruiting||Phase 2|26|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-10-11 03:37:44.493352|2017-10-11 03:37:44.493352
NCT01470703|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-09-25|||October 2011||2011-10-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|July 2017|Actual|2017-07-01||Interventional|EOLIA||Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome|Extracorporeal Membrane Oxygenation(ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS)|Recruiting||N/A|331|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:37:44.582411|2017-10-11 03:37:44.582411
NCT01470690|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-11-26|||October 2011||2011-10-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|PROMO||Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)|Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)|Completed||Phase 1|24|Actual|Radboud University||3|||f||||f||||||||||2017-10-11 03:37:44.668158|2017-10-11 03:37:44.668158
NCT01470677|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-01-19|||November 2011||2011-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Tachosil for the Prevention of Symptomatic Lymph Cysts|A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles After Pelvic Lymphadenectomy in Women With Gynecologic Malignancies: a Randomized Clinical Trial|Completed||Phase 3|220|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-11 03:37:44.749439|2017-10-11 03:37:44.749439
NCT01470664|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-09-22||2015-09-03|December 2012||2012-12-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||FST-100 in the Treatment of Acute Adenoviral Conjunctivitis|A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis|Completed||Phase 2|176|Actual|Shire||3|||f||||f||||||||||2017-10-11 03:37:44.828727|2017-10-11 03:37:44.828727
NCT01470651|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-12-19|2016-10-25||October 2011||2011-10-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Armodafinil for Patients Starting Hepatitis C Virus Treatment|Armodafinil for Patients Starting Hepatitis C Treatment|Terminated||Phase 4|26|Actual|Research Foundation for Mental Hygiene, Inc.|It is difficult to attribute side effects to Armodafinil or placebo given patients were undergoing Hepatitis C Treatment throughout the trial.|2||European Medicines Agency issued a drug/drug interaction: sofosbuvir/modafinil|f||||t||||||||No||2017-10-11 03:37:44.91851|2017-10-11 03:37:44.91851
NCT01470638|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-07-03|||June 2009||2009-06-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Study of Flt3-Ligand Levels in Sjögrens Syndrome|Analyzes of Cerebrospinal Fluid in Autoimmune Systemic Diseases|Recruiting||N/A|50|Anticipated|Göteborg University|||1||f||||f||||||Samples Without DNA|"     Serum, cerebrospinal fluid   "|||2017-10-11 03:37:45.45071|2017-10-11 03:37:45.45071
NCT01470625|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2013-01-11|||September 2010||2010-09-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Improving Quality of Care for the Dying Patient in Hospice: A Quasi Experimental Trial in Liguria Region||Completed||Phase 2|282|Actual|Regional Palliative Care Network||1|||f||||f||||||||||2017-10-11 03:37:45.520983|2017-10-11 03:37:45.520983
NCT01470586|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2011-11-10|||May 2009||2009-05-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|October 2010|Actual|2010-10-01||Interventional|||Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal Cancer|Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal Cancer|Completed||N/A|60|Actual|G. Hatzikosta General Hospital||2|||f||||t||||||||||2017-10-11 03:37:48.286195|2017-10-11 03:37:48.286195
NCT01470573|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-12-07|||November 2011||2011-11-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|MeRSO09||Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex Vivo|Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Autologous Cells of Sclerocorneal Limbus Amplified ex Vivo|Completed||Phase 2|10|Actual|Fundacion Clinic per a la Recerca Biomédica||1|||f||||f||||||||||2017-10-11 03:37:48.384167|2017-10-11 03:37:48.384167
NCT01470560|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-12-10|||February 2011||2011-02-01|December 2014|2014-12-01|February 2013|Actual|2013-02-01|May 2012|Actual|2012-05-01||Interventional|MBSR-Yoga||Mindfulness-Based Stress Reduction Techniques and Yoga for Treatment of Urinary Urge Incontinence (MBSR-Yoga)|Mindfulness-Based Stress Reduction Techniques and Yoga for Treatment of Urinary Urge Incontinence (MBSR-Yoga)|Completed||N/A|||University of Utah||2|||f||||f||||||||||2017-10-11 03:37:48.487146|2017-10-11 03:37:48.487146
NCT01470547|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-03-27|||April 2012||2012-04-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|April 2017|Anticipated|2017-04-01||Observational|PRO-LIVER||Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry|Portal Vein Thrombosis Relevance On Liver Cirrhosis: Italian Venous Thrombotic Events Registry|Active, not recruiting||N/A|1100|Anticipated|University of Roma La Sapienza|||1||f||||t||||||Samples Without DNA|"     Plasma and serum samples (in ancillary study)   "|No||2017-10-11 03:37:48.567087|2017-10-11 03:37:48.567087
NCT01470534|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-10-04|||November 2011||2011-11-01|October 2012|2012-10-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Mechanisms Underlying Postoperative Insulin Resistance and Inflammation|Investigating Whether the Magnitude of Postoperative Inflammatory and Insulin Resistant Responses is Related to Body Composition and Physiological Function of Skeletal Muscle & Adipose Tissue|Unknown status|Recruiting|Phase 4|32|Anticipated|University of Nottingham||4|||f||||t||||||||||2017-10-11 03:37:48.649019|2017-10-11 03:37:48.649019
NCT01470521|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-01-28|||December 2011||2011-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|WIRMS||Worms for Immune Regulation of Multiple Sclerosis|Worms for Immune Regulation of Multiple Sclerosis (WIRMS)|Completed||Phase 2|72|Actual|University of Nottingham||2|||f||||t||||||||No||2017-10-11 03:37:48.786987|2017-10-11 03:37:48.786987
NCT01470508|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-05-16|||August 2010||2010-08-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PAS||Engaging Latino Families in Eating Disorders Treatment|Engaging Latino Families in Eating Disorders Treatment|Completed||N/A|25|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 03:37:48.893335|2017-10-11 03:37:48.893335
NCT01470495|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-03-27|||January 2015||2015-01-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|REPEAT||Combined Treatment of RFA and Sorafenib on Recurrent HCC|Radiofrequency Ablation Plus Sorafenib Administration in Early Recurrent Hepatocellular Carcinoma: a Prospective Multicenter Cohort Trial (Repeat) Tumors for BCLC B Stage HCC Undergone Curative Hepatectomy|Recruiting||N/A|430|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-10-11 03:37:48.995257|2017-10-11 03:37:48.995257
NCT01470482|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-06-08|||August 2006||2006-08-01|June 2015|2015-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Does Tourniquet Use in Total Knee Replacement Improve Fixation|Does Tourniquet Use in Total Knee Replacement Improve Fixation|Completed||Phase 3|50|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-11 03:37:49.088999|2017-10-11 03:37:49.088999
NCT01470469|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-04-24|2014-04-24||January 2012||2012-01-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)|A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).|Completed||Phase 2|83|Actual|Shire|Efficacy endpoints were exploratory. No statistical testing was performed because the study was not powered.|2|||f||||||||||||||2017-10-11 03:37:49.186931|2017-10-11 03:37:49.186931
NCT01470456|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-11-12|||November 2011||2011-11-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|July 2013|Actual|2013-07-01||Interventional|||Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma|An Open Label, Multicenter Phase II Study of Intravenous SAR3419, an Anti-CD19 Antibody-Maytansine Conjugate, in Combination With Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphomas|Completed||Phase 2|50|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:37:49.658656|2017-10-11 03:37:49.658656
NCT01470443|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-02-15|||December 28, 2011|Actual|2011-12-28|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma|A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of GEMOX(Gemcitabine/Oxaliplatin) vs XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma|Recruiting||Phase 3|240|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 03:37:49.930909|2017-10-11 03:37:49.930909
NCT01470430|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-01-26|||March 2012||2012-03-01|January 2014|2014-01-01||||March 2014|Anticipated|2014-03-01||Observational|||VEGF In Systemic Circulation Of ROP-infants|Study to Measure Systemic VEGF Levels in ROP Infants Following Intravitreal Anti-VEGF Therapy or Retinal Laser Treatment|Withdrawn||N/A|0|Actual|University Hospital Freiburg|||2||f||||f||||||||||2017-10-11 03:37:50.061236|2017-10-11 03:37:50.061236
NCT01470417|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-03-31|2015-01-08||October 2011||2011-10-01|March 2017|2017-03-01|January 2019|Anticipated|2019-01-01|January 2014|Actual|2014-01-01||Interventional|GAIN-1|Adults with pathologically confirmed resectable or borderline resectable pancreatic adenocarcinoma|Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma|GAIN-1 Study: Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|10|Actual|University of Florida||2|||f||||t|t|f||||||||2017-10-11 03:37:50.196521|2017-10-11 03:37:50.196521
NCT01470391|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2012-12-17|||November 2011||2011-11-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Adductor-Canal-Blockade Versus the Femoral Nerve Block Effect on Muscle Strength, Pain and Mobilization After Total Knee Replacement|"A Comparison of the Efficacy of the Adductor-Canal-Blockade Versus the Femoral Nerve Block on Muscle Strength, Pain and Mobilization After Total Knee Arthroplasty: a Randomized Study"|Completed||N/A|54|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 03:37:50.892964|2017-10-11 03:37:50.892964
NCT01470378|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2013-08-07|||January 2011||2011-01-01|August 2013|2013-08-01|November 2013|Anticipated|2013-11-01|November 2012|Actual|2012-11-01||Interventional|Thight_lift||Manual Lymphatic Drainage in Women Undergone to Thigh Lifting|Manual Lymphatic Drainage in Women Undergone to Thigh Lifting After Bariatric Surgery|Unknown status|Recruiting|Phase 1|20|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:37:50.984847|2017-10-11 03:37:50.984847
NCT01470365|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-01-25|||November 3, 2011|Actual|2011-11-03|January 2017|2017-01-01|February 9, 2018|Anticipated|2018-02-09|August 2015|Actual|2015-08-01||Interventional|||3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors|Phase I Study of Pulsed Low Dose Rate Reirradiation Delivered With 3DCRT/IMRT for Palliation of Recurrent Tumors|Active, not recruiting||Phase 1|24|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 03:37:51.111272|2017-10-11 03:37:51.111272
NCT01470352|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-09-26|||December 2011||2011-12-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2017|Actual|2017-09-01||Interventional|||Multiparametric MRI Study of Endogenous Analgesia and Prediction the Efficacy of Migraine Pharmacological Prevention||Recruiting||N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-11 03:37:51.200099|2017-10-11 03:37:51.200099
NCT01470339|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-09-16|||December 2011||2011-12-01|September 2015|2015-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile||Completed||N/A|200|Actual|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-11 03:37:51.292884|2017-10-11 03:37:51.292884
NCT01470313|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2014-01-27|||November 2011||2011-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus|A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)|Terminated||Phase 1|28|Actual|Pfizer||2||See termination reason in detailed description.|f||||f||||||||||2017-10-11 03:37:51.464639|2017-10-11 03:37:51.464639
NCT01470300|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2011-11-10|||September 2010||2010-09-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Reducing Energy Density by Different Methods to Decrease Energy Intake|Reducing Energy Density by Different Methods to Decrease Energy Intake|Completed||N/A|62|Actual|Penn State University||4|||f||||f||||||||||2017-10-11 03:37:51.616796|2017-10-11 03:37:51.616796
NCT01470287|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-05-17|||December 2011||2011-12-01|May 2017|2017-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age|A Phase-III, Single Arm, Multi-Center, Open-Label Study to Assess the Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent Vaccine (DTwP-Hib-HepB Vaccine) When Administered to Indian Infants at 6, 10, and 14 Weeks of Age|Completed||Phase 3|175|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:37:51.700892|2017-10-11 03:37:51.700892
NCT01470274|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-07-28|||November 2011||2011-11-01|July 2016|2016-07-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Observational|||Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients|Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients|Completed||N/A|18|Actual|Norwegian University of Science and Technology|||1||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 03:37:51.779206|2017-10-11 03:37:51.779206
NCT01470261|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2016-09-20|||February 2012||2012-02-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Observational|ADDUCE||Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects|Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects|Completed||N/A|1398|Actual|NHS Tayside|||3||f||||t||||||||||2017-10-11 03:37:51.852792|2017-10-11 03:37:51.852792
NCT01470248|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-03-08|2017-01-18||August 2011||2011-08-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Study of Arsenic Trioxide in Small Cell Lung Cancer|A Single Arm, Two-Stage Phase II Study of Arsenic Trioxide in Previously Treated Small Cell Lung Cancer|Completed||Phase 2|20|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:37:51.949281|2017-10-11 03:37:51.949281
NCT01470235|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-10-31|||September 2011||2011-09-01|October 2013|2013-10-01|August 2015|Anticipated|2015-08-01|September 2014|Anticipated|2014-09-01||Observational|||Hypodontia and Ovarian Cancer|Hypodontia and Ovarian Cancer - the Connection Between Dental Agenesis and Epithelial Cancers, Especially Ovarian Cancer.|Unknown status|Recruiting|N/A|200|Anticipated|University of Aarhus|||3||f||||t||||||Samples With DNA|"     5ml EDTA full blood for DNA analysis.      1 PAX-tube for RNA analysis. Biopsi from removed tumor-tissue for DNA analysis. Both     preserved in Danish Cancer Biobank for later analysis.   "|||2017-10-11 03:37:52.214403|2017-10-11 03:37:52.214403
NCT01470222|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2011-11-10|||September 2010||2010-09-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|March 2011|Actual|2011-03-01||Interventional|HWL||The Healthy Weight for Life Program|The Healthy Weight for Life Program|Completed||N/A|175|Actual|Tufts University||2|||f||||f||||||||||2017-10-11 03:37:52.327962|2017-10-11 03:37:52.327962
NCT01470209|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-03-01|||January 2012||2012-01-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies|A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies|Active, not recruiting||Phase 1|43|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:37:52.412493|2017-10-11 03:37:52.412493
NCT01372241|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-04-20|||December 2005||2005-12-01|June 2011|2011-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|FMM||Faith Moves Mountains: An Appalachian Cervical Cancer Prevention Project|An Appalachian Cervical Cancer Prevention Project|Completed||N/A|345|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-11 04:08:19.19081|2017-10-11 04:08:19.19081
NCT01470196|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-05-01|2017-03-20||October 2011||2011-10-01|May 2017|2017-05-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|CaRD||Carfilzomib, Rituximab and Dexamethasone in Waldenstrom's Macroglobulinemia|Carfilzomib, Rituximab, and Dexamethasone (CaRD) in Waldenstrom's Macroglobulinemia|Completed||Phase 2|31|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||Undecided||2017-10-11 03:37:52.719212|2017-10-11 03:37:52.719212
NCT01470183|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-02-05|||October 2011||2011-10-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients|Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients|Completed||N/A|46|Actual|Columbia University|||2||f||||f||||||||||2017-10-11 03:37:53.062295|2017-10-11 03:37:53.062295
NCT01470170|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-08-07|2015-03-17||October 2010||2010-10-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy|The Optimal Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy：a Prospective Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 4|173|Actual|Chang Gung Memorial Hospital||5|||f||||f||||||||||2017-10-11 03:37:53.181339|2017-10-11 03:37:53.181339
NCT01470157|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2011-11-09|||July 2011||2011-07-01|November 2011|2011-11-01|July 2012|Anticipated|2012-07-01|March 2012|Anticipated|2012-03-01||Interventional|||A Clinical Trial of Oral Midazolam Plus Oral Ketamine for Sedation During Laceration Repair|A Randomized, Clinical Trial of Oral Midazolam Plus Placebo Versus Oral Midazolam Plus Oral Ketamine for Sedation During Laceration Repair|Unknown status|Recruiting|Phase 4|60|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 03:37:54.369408|2017-10-11 03:37:54.369408
NCT01470144|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-06-01|2016-10-18||June 1, 2011|Actual|2011-06-01|June 2017|2017-06-01|July 1, 2015|Actual|2015-07-01|June 1, 2015|Actual|2015-06-01||Interventional|Epitome2ext||Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension|An Open-label Extension of Study AC-066A301 Investigating the Safety and Tolerability of ACT-385781A in Patients With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 3|41|Actual|Actelion||1|||f||||f||||||||||2017-10-11 03:37:54.926999|2017-10-11 03:37:54.926999
NCT01470131|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-12-12|||May 2011||2011-05-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|April 2013|Anticipated|2013-04-01||Interventional|||A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma|A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled, 2-parallel Group, Phase 3 Study to Compare Efficacy and Safety of Masitinib 6 mg/kg/Day in Combination With Bortezomib and Dexamethasone to Placebo in Combination With Bortezomib and Dexamethasone in the Treatment of Patients With Relapsing Multiple Myeloma Who Received One Previous Therapy|Unknown status|Recruiting|Phase 3|300|Anticipated|AB Science||2|||f||||t||||||||||2017-10-11 03:37:55.417013|2017-10-11 03:37:55.417013
NCT01470118|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2013-01-18|2012-12-13||October 2011||2011-10-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis||Completed||Phase 4|127|Actual|Allergan||3|||f||||f||||||||||2017-10-11 03:37:55.561789|2017-10-11 03:37:55.561789
NCT01470105|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-07-05|||November 2011||2011-11-01|July 2017|2017-07-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases|Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases|Recruiting||N/A|230|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"     Blood   "|||2017-10-11 03:37:56.070418|2017-10-11 03:37:56.070418
NCT01470092|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2017-08-07|||July 2012||2012-07-01|August 2017|2017-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression|Double-Blind Randomised Investigation of Tibolone Alone or in Adjunct to Standard Antidepressant Treatment for Depression in Menopausal Women|Recruiting||Phase 4|120|Anticipated|The Alfred||2|||f||||t||||||||||2017-10-11 03:37:56.177344|2017-10-11 03:37:56.177344
NCT01470079|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2011-11-10|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:37:56.278033|2017-10-11 03:37:56.278033
NCT01470066|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-10|||August 2004||2004-08-01|September 2005|2005-09-01|May 2012|Anticipated|2012-05-01|May 2010|Actual|2010-05-01||Observational|||Clinical Usefulness and Prognostic Significance of Interim 18F-FDG PET/CT for the Treatment of Peripheral T Cell Lymphomas||Unknown status|Recruiting|N/A|80|Anticipated|Chonnam National University Hospital|||1||f||||t||||||||||2017-10-11 03:37:56.31859|2017-10-11 03:37:56.31859
NCT01470053|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2013-08-26|||March 2011||2011-03-01|November 2011|2011-11-01|November 2012|Actual|2012-11-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis|A Multicenter, Randomized, Double-blind Phase Ⅲ Study of Mometasone Furoate/Azelastine Hydrochloride Combination Group and Mometasone Furoate and Azelastine Hydrochloride Group 4 Weeks After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Perennial Allergic Rhinitis Patient.|Completed||Phase 3|347|Actual|Hanlim Pharm. Co., Ltd.||3|||f||||f||||||||||2017-10-11 03:37:56.383791|2017-10-11 03:37:56.383791
NCT01470040|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2012-01-17|||February 2012||2012-02-01|January 2012|2012-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma?|Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma?|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 03:37:56.491274|2017-10-11 03:37:56.491274
NCT01470027|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-10-31|||January 2012||2012-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|NAC for PD||N-Acetylcysteine for Neuroprotection in Parkinson's Disease|N-Acetylcysteine for Neuroprotection in Parkinson's Disease|Completed||Phase 1/Phase 2|50|Actual|Weill Medical College of Cornell University||3|||f||||f||||||||||2017-10-11 03:37:56.599671|2017-10-11 03:37:56.599671
NCT01470014|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-12-09|||October 2011||2011-10-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Cardiac Computed Tomography: Characteristics of Isolated Left Ventricular Non-compaction||Completed||N/A|39|Actual|University of Zurich|||2||f||||||||||||||2017-10-11 03:37:56.690427|2017-10-11 03:37:56.690427
NCT01470001|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-07-24|2016-09-28||November 2011||2011-11-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||The Effect of Solifenacin on Post Void Dribbling in Women|The Effect of Solifenacin on Post Void Dribbling in Women: A Randomized Controlled Multicenter Trial|Completed||N/A|118|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 03:37:56.761977|2017-10-11 03:37:56.761977
NCT01469988|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2014-04-25|||November 2012||2012-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|VITA-HF||The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial|The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial|Terminated||Phase 2|318|Anticipated|University of Alberta||2||Feasibility|f||||t||||||||||2017-10-11 03:37:57.425148|2017-10-11 03:37:57.425148
NCT01469975|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-05-16|||December 2011||2011-12-01|May 2017|2017-05-01|June 30, 2015|Actual|2015-06-30|February 3, 2015|Actual|2015-02-03||Interventional|SYNFRIZZ||First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10|First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10 (FZD10) in Patients With Relapsed or Refractory Non Resectable Synovial Sarcomas|Terminated||Phase 1|20|Actual|Centre Leon Berard||3||Too slow accrual.|f||||t||||||||||2017-10-11 03:37:57.532117|2017-10-11 03:37:57.532117
NCT01469962|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2014-06-18|||November 2011||2011-11-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Observational|FIBROTEST||Evaluation of Liver Fibrosis Following Surgical-induced Weight Loss|Evolution of Fibrosis Scores During Weight Loss in a Population of Patients Operated on for Morbid Obesity|Completed||N/A|255|Actual|University Hospital, Rouen|||1||f||||t||||||||||2017-10-11 03:37:57.663253|2017-10-11 03:37:57.663253
NCT01469949|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-09|||May 2011||2011-05-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Observational|MI||Mental Imagery Enhances Proprioception in Patients With Low Back Pain|Effect of Mental Imagery in Improvement of the Repositioning Accuracy and Proprioception in Patients With Low Back Pain|Completed||N/A|55|Actual|Lebanese University|||3||f||||t||||||||||2017-10-11 03:37:57.734521|2017-10-11 03:37:57.734521
NCT01469936|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-09-06|||November 2011||2011-11-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|February 2016|Actual|2016-02-01||Interventional|L2009-03||Effect of PERMEAPROTECT on the Quality of Life of Patients With Fibromyalgia|Study of the Effect of the Food Supplement PERMEAPROTECT on the Quality of Life of Patients With Fibromyalgia (a Pilot, Double-blind, Randomized, Placebo-controlled Study)|Active, not recruiting||N/A|40|Actual|Lescuyer Laboratory||2|||f||||f||||||||||2017-10-11 03:37:57.813547|2017-10-11 03:37:57.813547
NCT01469923|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2012-07-23|||March 2012||2012-03-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses|A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2820 After Administration of Multiple Ascending Doses|Terminated||Phase 1|18|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:37:57.908524|2017-10-11 03:37:57.908524
NCT01469910|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2012-07-09|||September 2011||2011-09-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Subjects|Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Subjects|Completed||Phase 1|63|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:37:58.039102|2017-10-11 03:37:58.039102
NCT01469897|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-09-25|||January 2012||2012-01-01|September 2017|2017-09-01|March 2017|Actual|2017-03-01|December 2014|Actual|2014-12-01||Observational|||Cost of Care for Juvenile Idiopathic Arthritis|Cost of Care for Juvenile Idiopathic Arthritis|Completed||N/A|165|Actual|The Cleveland Clinic|||1||f||||f||||||||||2017-10-11 03:37:58.15249|2017-10-11 03:37:58.15249
NCT01469884|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2015-04-01|||November 2011||2011-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|CONCERVIC||Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients|A Prospective, Single-center, Open-label, Pilot Study to Investigate the Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients.|Completed||Phase 4|30|Actual|Irmandade Santa Casa de Misericórdia de Porto Alegre||2|||f||||f||||||||||2017-10-11 03:37:58.234207|2017-10-11 03:37:58.234207
NCT01469871|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2011-11-09|||February 2009||2009-02-01|November 2011|2011-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Evaluation of Three Types of Dressings After Hip Surgery|Reduction of Tape Blisters After Hip Surgery. A Prospective Evaluation of Three Types of Dressings.|Completed||Phase 4|150|Actual|Hopital de l'Enfant-Jesus||3|||f||||f||||||||||2017-10-11 03:37:58.349307|2017-10-11 03:37:58.349307
NCT01469858|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2011-11-08|||November 2011||2011-11-01|September 2011|2011-09-01|November 2015|Anticipated|2015-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Perception and Multisensory Integration in Neurological Patients Using fMRI|Perception and Multisensory Integration in Neurological Patients Using fMRI|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 03:37:58.450864|2017-10-11 03:37:58.450864
NCT01469845|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-09|2015-03-24|||October 2011||2011-10-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|SABRE||The SABRE Trial of Hypertonic Saline in Acute Bronchiolitis|Hypertonic Saline in Acute Bronchiolitis: Randomised Controlled Trial and Economic Evaluation|Completed||Phase 3|300|Actual|Sheffield Children's NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:37:58.536295|2017-10-11 03:37:58.536295
NCT01469832|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-02-20||2016-09-16|November 2011||2011-11-01|February 2017|2017-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)|A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)|Completed||Phase 1/Phase 2|12|Actual|Astellas Pharma Inc||1|||f||||t||||||||Undecided||2017-10-11 03:37:58.633238|2017-10-11 03:37:58.633238
NCT01442961|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2013-04-09|||January 2009||2009-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Vaginal Hysterectomy, Laparoscopic Hysterectomy, Postoperative Pain|Postoperative Pain After Vaginal or Laparoscopic Hysterectomy: a Prospective Trial|Completed||N/A|188|Actual|Tampere University Hospital||2|||f||||f||||||||||2017-10-11 03:46:59.642005|2017-10-11 03:46:59.642005
NCT01469819|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-05-05|2016-05-09||June 2012||2012-06-01|May 2017|2017-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Lubiprostone Effect on Gastrointestinal Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation|The Effect of Lubiprostone on Transit Times Within the Alimentary Tract, Measured by Novel Smartpill Methodology in Patients With Chronic Constipation|Completed||Phase 2/Phase 3|37|Actual|Texas Tech University Health Sciences Center, El Paso||1|||f||||f||||||||No||2017-10-11 03:37:58.726059|2017-10-11 03:37:58.726059
NCT01469806|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-09-26|||November 2011||2011-11-01|March 2012|2012-03-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Observational|PFJPMCF||Patello-Femoral Joint Post Market Clinical Follow-up Within the Knee Registry|Zimmer(R) Gender Solutions(TM) Patello-Femoral Joint Prothesis Used Within the Knee Registry Protocol|Withdrawn||N/A|0|Actual|Zimmer Biomet|||1|"Suspended pending internal review/direction of the company's focus. No sites ever engaged or   collected data."|f||||f||||||||No||2017-10-11 03:37:59.039589|2017-10-11 03:37:59.039589
NCT01469793|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-01-06|||November 2011||2011-11-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer|A Phase I, Open Label Study of the Safety and Pharmacokinetics of Escalating Doses of DMOT4039A in Patients With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer|Completed||Phase 1|71|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 03:37:59.100889|2017-10-11 03:37:59.100889
NCT01469780|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2012-03-07|||April 1999||1999-04-01|March 2012|2012-03-01|February 2005|Actual|2005-02-01|August 2003|Actual|2003-08-01||Observational|||Assessing Pain as a Mediator of Behavior Change in Post-coronary Angioplasty Patients|Assessing Pain as a Mediator of Behavior Change in Post-coronary Angioplasty Patients|Completed||N/A|660|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-10-11 03:37:59.195518|2017-10-11 03:37:59.195518
NCT01469767|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-04-27|2017-01-27||February 1, 2012|Actual|2012-02-01|April 2017|2017-04-01|August 17, 2013|Actual|2013-08-17|August 17, 2013|Actual|2013-08-17||Interventional|||Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis|Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis|Completed||N/A|10|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||No||2017-10-11 03:37:59.271495|2017-10-11 03:37:59.271495
NCT01469754|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-05-01|||September 2011||2011-09-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Observational|CLEAR Stress||Longitudinal Survey Analysis in Lymphoma Survivors|Coping With Lymphoma to Enhance Adjustment and Reduce Stress in Lymphoma Survivors|Completed||N/A|97|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-10-11 03:37:59.571399|2017-10-11 03:37:59.571399
NCT01469741|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2015-06-01|||June 2011||2011-06-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|REMI-PD||Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study|Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study|Completed||N/A|74|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 03:37:59.645253|2017-10-11 03:37:59.645253
NCT01469728|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2011-11-08|||November 2007||2007-11-01|November 2011|2011-11-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Comparison of Thoracoscopic Talc Pleurodesis by Thoracic Epidural or General Anesthesia|Randomized Study of Thoracoscopic Talc Pleurodesis Performed by Thoracic Epidural or General Anesthesia|Completed||Phase 2|40|Actual|University of Rome Tor Vergata||2|||f||||f||||||||||2017-10-11 03:37:59.71429|2017-10-11 03:37:59.71429
NCT01469715|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-07-03|2015-07-03||November 2011||2011-11-01|July 2015|2015-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|SMA002||A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)|A Clinical Study of the Warm-Up, Accuracy, and Lag Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)|Completed||Phase 2|16|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:37:59.804327|2017-10-11 03:37:59.804327
NCT01469702|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-11-10|||December 2011||2011-12-01|November 2011|2011-11-01||||August 2012|Anticipated|2012-08-01||Interventional|||The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease|Open Label Study of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease|Unknown status|Not yet recruiting|Phase 4|10|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 03:37:59.98283|2017-10-11 03:37:59.98283
NCT01469689|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-05-29|||March 2011||2011-03-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Raising Awareness of Online Therapies for Depression: Pilot Study|Raising Awareness of Online Therapies for Depression: Pilot Study|Completed||Phase 1|8231|Actual|University of Plymouth||4|||f||||f||||||||||2017-10-11 03:38:00.066531|2017-10-11 03:38:00.066531
NCT01469676|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-11-09|||February 2007||2007-02-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|February 2010|Actual|2010-02-01||Interventional|PulmFunction||Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function|Effects of CPB-leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function.|Completed||N/A|22|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:38:00.193996|2017-10-11 03:38:00.193996
NCT01469663|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-26|2011-11-09|||July 2011||2011-07-01|November 2011|2011-11-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Observational|||Event Related Potentials in Borderline Personality Disorder and Major Depression|Event Related Potentials in Borderline Personality Disorder and Major Depression|Unknown status|Recruiting|N/A|40|Anticipated|State University of New York - Upstate Medical University|||4||f||||f||||||||||2017-10-11 03:38:00.303184|2017-10-11 03:38:00.303184
NCT01469650|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-09-13|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||Serum 25(OH)D Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants|Serum 25(OH)D Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants|Completed||N/A|32|Actual|University of Nebraska||2|||f||||f||||||||||2017-10-11 03:38:01.106002|2017-10-11 03:38:01.106002
NCT01469637|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2012-09-26|2012-09-26||November 2011||2011-11-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/Mesalamine|A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Sulfamethoxazole Administered Alone and in Combination With MMX® Mesalazine/Mesalamine in Healthy Adult Subjects|Completed||Phase 1|44|Actual|Shire||2|||f||||||||||||||2017-10-11 03:38:01.337633|2017-10-11 03:38:01.337633
NCT01469624|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2011-11-08|||April 2011||2011-04-01|November 2011|2011-11-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy|Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy|Unknown status|Recruiting|N/A|||Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:38:01.716723|2017-10-11 03:38:01.716723
NCT01469611|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-02-15|||July 2010|Actual|2010-07-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|October 2012|Actual|2012-10-01||Interventional|||A Trial of JX-594 in Refractory Colorectal Carcinoma|A Phase 1b Dose Escalation Study of JX-594 (Thymidine Kinase-Inactivated Vaccinia Virus Plus GM-CSF) Administered by Biweekly (Every Two Weeks) Intravenous Infusion in Patients With Metastatic, Refractory Colorectal Carcinoma|Completed||Phase 1|15|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:38:01.855057|2017-10-11 03:38:01.855057
NCT01469598|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-12-28|||August 2011||2011-08-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional|||Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer|Phase II Study of Docetaxel and Gemcitabine in Previously Treated Metastatic Esophageal Squamous Cell Cancer|Completed||Phase 2|24|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:38:01.946029|2017-10-11 03:38:01.946029
NCT01469585|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-08-18|||November 2011||2011-11-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|June 2012|Actual|2012-06-01||Interventional|||Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial MMPs|Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial MMPs|Unknown status|Active, not recruiting|N/A|14|Anticipated|University of Hawaii||2|||f||||f||||||||||2017-10-11 03:38:02.029169|2017-10-11 03:38:02.029169
NCT01469572|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-11-17|||December 2011||2011-12-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases|Phase IB/II Study of Pasireotide, Everolimus and Selective Internal Radioembolization Therapy (SIRT) for Unresectable Neuroendocrine Hepatic Metastases|Active, not recruiting||Phase 1|13|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:38:02.152902|2017-10-11 03:38:02.152902
NCT01469559|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2012-08-09|||August 2011||2011-08-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|IIDPN||Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral Neuropathy|A Phase IIa Dose Escalation Pilot Study to Investigate the Safety and Tolerability of Intranasal Insulin in Subjects With Diabetic Polyneuropathy.|Completed||Phase 2|12|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 03:38:02.282584|2017-10-11 03:38:02.282584
NCT01469546|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-07-26|2015-11-03||January 2012||2012-01-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|April 2015|Actual|2015-04-01||Interventional||42 patients were enrolled. 12 patients did not complete the first cycle or undergo repeat tumor imaging (due to adverse event, disease progression, non-compliance or physician discretion). Only 30 patients were analyzed.|Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer|Phase II Trial Evaluating Axitinib (AG-013736) In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer|Completed||Phase 2|42|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 03:38:02.421037|2017-10-11 03:38:02.421037
NCT01469533|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-08|||July 2011||2011-07-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Pressure Pain Thresholds and Basal Electromyographic Activities Following Spinal Mechanical Manipulation|Changes in Pressure Pain Thresholds and Basal Electromyographic Activities Following Spinal Mechanical Manipulation in Asymptomatic Subjects|Completed||N/A|30|Actual|RenJi Hospital||2|||f||||t||||||||||2017-10-11 03:38:02.896141|2017-10-11 03:38:02.896141
NCT01469520|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2011-11-08|||October 2010||2010-10-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|November 2011|Anticipated|2011-11-01||Interventional|||Bioequivalence Study of Pediatric Formulations to Treat HIV Infection|Phase I Three-way Crossover Bioequivalence Study of Pediatric Formulations of Lamivudine/Zidovudine/Nevirapine Using Healthy Adult Volunteers|Unknown status|Active, not recruiting|Phase 1|24|Actual|Elim Pediatric Pharmaceuticals Inc.||3|||f||||t||||||||||2017-10-11 03:38:03.007267|2017-10-11 03:38:03.007267
NCT01469507|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2013-02-20||||||February 2013|2013-02-01||||||||Interventional|VESTA||Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis|Comparative Study of Efficacy and Safety of Three Intra Articular Injections of V0220 Versus Hyalgan® in Patients Suffering From Symptomatic Knee Osteoarthritis. A Multinational Multicentric, Randomised, Double-blind, Parallel-group Study|Withdrawn||N/A|0|Actual|Pierre Fabre Medicament||2|||f||||f||||||||||2017-10-11 03:38:03.137166|2017-10-11 03:38:03.137166
NCT01469494|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2015-03-19|||February 2012||2012-02-01|August 2014|2014-08-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Breast and Abdominal Related Morbidity of DIEP and SIEA Flaps|A Randomized Clinical Trial Comparing Breast and Abdominal Related Morbidity of DIEP and SIEA Flaps|Unknown status|Active, not recruiting|N/A|91|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-10-11 03:38:03.228036|2017-10-11 03:38:03.228036
NCT01469481|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2012-01-27|||November 2011||2011-11-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532|An Open Label, Single-Period, Phase 1 Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance And Metabolism Of [14c]-PF-04991532 In Healthy Adult Male Subjects|Completed||Phase 1|6|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:38:03.327928|2017-10-11 03:38:03.327928
NCT01469468|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-29|2011-12-27|||November 2011||2011-11-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects|A Phase 1, Open-Label, Fixed-Sequence Study To Estimate The Effect Of Repeated Dosing Of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects|Completed||Phase 1|14|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:38:03.419004|2017-10-11 03:38:03.419004
NCT01469455|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-06-16|||October 2011||2011-10-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|DRIIM||DNA Repair Inhibitor & Irradiation on Melanoma|An Open Label, Non-randomized, First-in-human, Multi-centre Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Locally Administered DT01 in Combination With Radiotherapy and Concomitant Dose of Chloroquine in Patients With Local Metastatic Melanoma With Relapsed Cutaneous/Subcutaneous Tumors Including Melanoma-in-transit|Completed||Phase 1|27|Actual|DNA Therapeutics||1|||f||||t||||||||||2017-10-11 03:38:03.523238|2017-10-11 03:38:03.523238
NCT01469442|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2017-07-11|||May 2009||2009-05-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Postoperative Biliary Fistula Prevention After Hepatectomy|Postoperative Biliary Fistula Prevention After Hepatectomy by External Biliary Duct Stent:Prospective Multicenter Randomized Trial|Recruiting||N/A|304|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 03:38:03.635594|2017-10-11 03:38:03.635594
NCT01469429|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-10-04|||September 4, 2007|Actual|2007-09-04|October 2017|2017-10-01|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.|Food-Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer|Active, not recruiting||Phase 1/Phase 2|70|Actual|Ohio State University Comprehensive Cancer Center||4|||f||||t||||||||||2017-10-11 03:38:03.784071|2017-10-11 03:38:03.784071
NCT01469416|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2014-07-16|||March 2012||2012-03-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Drug Interaction Study of Clopidogrel and Rosuvastatin|The Effects of Administering Clopidogrel on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers|Completed||Phase 1|10|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:38:03.926825|2017-10-11 03:38:03.926825
NCT01469403|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-03-16|||August 2011||2011-08-01|November 2011|2011-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Weight Loss Intervention Before Total Knee Replacement|Weight Loss Intervention Before Total Knee Replacement, a Randomized Controlled Trial|Completed||N/A|76|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 03:38:04.025362|2017-10-11 03:38:04.025362
NCT01469377|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-02-26|||December 2011||2011-12-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder|A Double-Blind, Placebo-Controlled Study Of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder|Completed||Phase 2|819|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 03:38:04.139176|2017-10-11 03:38:04.139176
NCT01469364|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2015-12-22|2015-10-23||March 2013||2013-03-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|AZLI||Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)|Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation|Completed||Phase 4|30|Actual|Duke University||1|||f||||f||||||||||2017-10-11 03:38:04.424136|2017-10-11 03:38:04.424136
NCT01469351|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2013-04-18|||January 2012||2012-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Identifying Potential Effects of Liraglutide on Degenerative Changes|Neurodegenerative Changes in Alzheimer's Disease: Identifying Potential Effects of Liraglutide on Degenerative Changes|Completed||N/A|34|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:38:04.866985|2017-10-11 03:38:04.866985
NCT01469338|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-11-21|||July 2012||2012-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel|A Phase II Clinical Trial of Cabazitaxel Plus Prednisone With Octreotide in the Treatment of Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel|Terminated||Phase 2|9|Actual|University of Southern California||1||lack of funding|f||||t||||||||||2017-10-11 03:38:04.96445|2017-10-11 03:38:04.96445
NCT01469325|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2011-11-20|||November 2011||2011-11-01|November 2011|2011-11-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Sequential Left Prefrontal Repetitive Transcranial Magnetic Stimulation, With High Frequency, for Treatment-Resistant Depression|Effectiveness of of Sequential Left Prefrontal Repetitive Transcranial Magnetic Stimulation, With High Frequency, for Treatment-Resistant Depression, in TMS Unit, Neurcognitive Lab, Iranian National Center for Addiction Studies (INCAS), in 2011. A Randomized, Controlled Trial.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:38:05.088626|2017-10-11 03:38:05.088626
NCT01469312|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-09|||April 2010||2010-04-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Pasta on Blood Glucose Response in Normal Subjects|Effect of Pasta on Blood Glucose Response in Normal Subjects|Completed||N/A|20|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-11 03:38:05.196992|2017-10-11 03:38:05.196992
NCT01469299|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-01-09|||October 2011||2011-10-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee System|Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee System|Completed||N/A|285|Actual|Orthosensor, Inc.|||1||f||||f||||||||||2017-10-11 03:38:05.295858|2017-10-11 03:38:05.295858
NCT01469286|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-04-27|||March 2010||2010-03-01|April 2017|2017-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|TEA||Transcutaneous Electroacupuncture for Gastroparesis|Transcutaneous Electroacupuncture for Gastroparesis|Completed||Phase 1|26|Actual|Transtimulation Research, Inc||2|||f||||t||||||||||2017-10-11 03:38:05.404203|2017-10-11 03:38:05.404203
NCT01469273|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2011-11-09|||November 2011||2011-11-01|November 2011|2011-11-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Interventional|PIURA||Prophylaxis of Gastrointestinal Infections With EcN|Prophylaxis of Gastrointestinal Infections in Newborn and Infants With a Suspension Containing the Probiotic Escherichia Coli Strain Nissle|Unknown status|Not yet recruiting|Phase 4|198|Anticipated|Hospital San Bartolome||3|||f||||f||||||||||2017-10-11 03:38:05.525785|2017-10-11 03:38:05.525785
NCT01469260|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2011-11-08|||November 2011||2011-11-01|November 2011|2011-11-01|November 2014|Anticipated|2014-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Pedometer Use to Prevent Excessive Pregnancy Weight Gain in Overweight Women|Effective Pedometer Use to Prevent Excessive Gestational Weight Gain in Overweight/Obese Women|Unknown status|Not yet recruiting|N/A|480|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 03:38:05.664735|2017-10-11 03:38:05.664735
NCT01469247|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-07-05|||December 2011|Actual|2011-12-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)|Phase I/II Study of Reirradiation of Recurrent or Progressive Brainstem Glioma|Active, not recruiting||Phase 1/Phase 2|12|Actual|M.D. Anderson Cancer Center||1|||f||||t|f|f||||||||2017-10-11 03:38:06.018796|2017-10-11 03:38:06.018796
NCT01469234|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2015-02-20|2013-02-12||October 2011||2011-10-01|February 2015|2015-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)|A Double-Blind, Parallel, Randomized, Placebo Controlled Trial to Evaluate Onset of Action of Loratadine and Fexofenadine in Subjects With Seasonal Allergic Rhinitis in a Pollen Challenge Chamber|Completed||Phase 4|255|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:38:06.232156|2017-10-11 03:38:06.232156
NCT01469221|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2015-06-02|||July 2011||2011-07-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)|A Phase 3 International, Double-Bind Trial Evaluating Efficacy and Safety of Multiple Instillations of Intravesical Apaziquone vs. Placebo in Patients With Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer (NMIBC)|Unknown status|Active, not recruiting|Phase 3|658|Anticipated|Spectrum Pharmaceuticals, Inc||2|||f||||t||||||||||2017-10-11 03:38:08.304394|2017-10-11 03:38:08.304394
NCT01469208|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2013-07-31|||October 2011||2011-10-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|MAGIC||Music Therapy: An Adjunct To Gastroschisis Infants' Care|The Effect of Music Therapy On Infants Born With Gastroschisis|Unknown status|Recruiting|N/A|30|Anticipated|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||||2017-10-11 03:38:08.481305|2017-10-11 03:38:08.481305
NCT01469195|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2011-11-07|||December 2011||2011-12-01|November 2011|2011-11-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|||A Lead Rectangle to Lower the Operator's Radiation Exposure|A Lead Rectangle to Lower the Radiation Exposure for Operators Who Uses Radial Approach in Coronary Procedures.|Unknown status|Not yet recruiting|N/A|50|Anticipated|Sunnybrook Health Sciences Centre|||2||f||||f||||||||||2017-10-11 03:38:08.576729|2017-10-11 03:38:08.576729
NCT01469182|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-01-18|2014-04-25||November 2011||2011-11-01|January 2017|2017-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)|A 28-Day Study Evaluating the Safety of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet (SCH 39641/MK-3641) Treatment in Ragweed Allergic Adults (Phase 3, Protocol No.P05751)|Completed||Phase 3|914|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-10-11 03:38:08.680041|2017-10-11 03:38:08.680041
NCT01469169|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-03-30|||June 19, 2012|Actual|2012-06-19|March 2017|2017-03-01|December 14, 2016|Actual|2016-12-14|December 26, 2014|Actual|2014-12-26||Interventional|IBUKI||Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study|A Multi-center, Non-randomized, Open Label, Single-arm Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of BAY q 6256 (Iloprost) Inhalation in Patients With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 3|27|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:38:09.36875|2017-10-11 03:38:09.36875
NCT01469156|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-02-19|||September 2011||2011-09-01|February 2014|2014-02-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy|Treatment of Polypoidal Choroidal Vasculopathy With High Dose Ranibizumab (Lucentis): A Phase I Safety Study.|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|Southeast Retina Center, Georgia||2|||f||||f||||||||||2017-10-11 03:38:09.491296|2017-10-11 03:38:09.491296
NCT01469143|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2015-02-20|||November 2011||2011-11-01|February 2015|2015-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes|A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes|Completed||Phase 1|40|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:38:09.591377|2017-10-11 03:38:09.591377
NCT01469130|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-05-26|||November 2011||2011-11-01|May 2017|2017-05-01|December 31, 2017|Anticipated|2017-12-31|April 2014|Actual|2014-04-01||Interventional|||A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors|A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|21|Actual|Array BioPharma||1|||f||||||||||||||2017-10-11 03:38:09.695402|2017-10-11 03:38:09.695402
NCT01469117|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2014-08-06|||November 2011||2011-11-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Feeding Trial in Pediatric Patients|Enteral Formula Tolerance In Pediatric Patients With Developmental Disabilities|Completed||N/A|16|Actual|Nestlé|||1||f||||f||||||||||2017-10-11 03:38:09.780932|2017-10-11 03:38:09.780932
NCT01469104|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2011-11-09|||August 2009||2009-08-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|CHO-free diet||Metabolic Response to 3-day Fast Versus Carbohydrate-free Diet in Type 2 Diabetes|Metabolic Response to 3-day Fast Versus Carbohydrate-free Diet in Type 2 Diabetes|Completed||N/A|7|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-11 03:38:09.889295|2017-10-11 03:38:09.889295
NCT01469091|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-03-12|||February 2011||2011-02-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|September 2012|Actual|2012-09-01||Interventional|ROC||Tobacco's Impact on Postoperative Complications in Acute Surgery|Tobacco's Impact on Postoperative Complications in Acute Vascular Surgery. A Randomized Clinical Trial|Terminated||N/A|160|Anticipated|Rigshospitalet, Denmark||2||Lack of patient inclusion|f||||f||||||||||2017-10-11 03:38:09.965045|2017-10-11 03:38:09.965045
NCT01469078|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-11-07|||October 2011||2011-10-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|April 2012|Actual|2012-04-01||Interventional|||Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)|Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D) (PK-CKD-05)|Completed||Phase 1|18|Actual|Pharmacosmos A/S||3|||f||||t||||||||||2017-10-11 03:38:10.066103|2017-10-11 03:38:10.066103
NCT01469065|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2013-09-26|2013-06-12||December 2011||2011-12-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes|A 2-week, Phase 1, Placebo-Controlled, Parallel Group Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Oral Doses Of PF-04991532 Given As Monotherapy To Adult Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|82|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:38:11.689582|2017-10-11 03:38:11.689582
NCT00005461|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1991||1991-04-01|July 2004|2004-07-01|June 2002|Actual|2002-06-01|||||Observational|||Epidemiology of Symptom Perception in Childhood Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.169573|2017-10-11 04:27:05.169573
NCT01469052|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-02-25|2012-02-25||November 2002||2002-11-01|February 2012|2012-02-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors|Phase I, Open-Label, Multicenter, Dose-Escalation Study Of The Tyrosine Kinase Inhibitor Of VEGFR-2, AG013736, In Patients With Advanced Solid Tumors|Completed||Phase 1|36|Actual|Pfizer||6|||f||||f||||||||||2017-10-11 03:38:13.381472|2017-10-11 03:38:13.381472
NCT01469039|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2016-11-21|2015-11-04|2014-04-14|December 2011||2011-12-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional||Randomized Population|A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia|Completed||Phase 3|623|Actual|Alkermes, Inc.||2|||f||||t||||||||||2017-10-11 03:38:14.223232|2017-10-11 03:38:14.223232
NCT01469026|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2011-11-09|||November 2011||2011-11-01|November 2011|2011-11-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||CUP Project PET/CT|The Value of Early PET/CT in Patients With Metastasising Cancer of Unknown Primary|Unknown status|Not yet recruiting|Phase 4|220|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-10-11 03:38:15.235727|2017-10-11 03:38:15.235727
NCT01469000|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-08-25|2016-03-28||February 2012||2012-02-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|April 2015|Actual|2015-04-01||Interventional||All participants who received at least 1 dose of study drug.|A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)|A Randomised Phase 2 Trial of Pemetrexed and Gefitinib Versus Gefitinib as First Line Treatment for Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations|Active, not recruiting||Phase 2|195|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:38:15.526918|2017-10-11 03:38:15.526918
NCT01468987|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2013-09-27||2013-09-27|December 2011||2011-12-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|IMAGINE 4||A Study in Participants With Type 2 Diabetes Mellitus|The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus Advanced to Multiple Injection Bolus Insulin With Insulin Lispro: a Double-Blind, Randomized, 26-week Study - The IMAGINE 4 Study|Completed||Phase 3|1325|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:38:17.509947|2017-10-11 03:38:17.509947
NCT01468974|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2016-01-28|||November 2011||2011-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System|A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System for the Treatment of Subjects With Symptomatic Claudication From Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries.|Completed||N/A|35|Actual|Abbott Vascular||1|||f||||t||||||||||2017-10-11 03:38:17.991726|2017-10-11 03:38:17.991726
NCT01468961|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-08-17|||November 2011||2011-11-01|August 2017|2017-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Pilot Study of Internet-based Cognitive Behavior Therapy for Fibromyalgia|Pilot Study of Internet-based Cognitive Behavior Therapy for Fibromyalgia|Completed||N/A|41|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 03:38:18.155065|2017-10-11 03:38:18.155065
NCT01468948|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-06-30|||October 28, 2011||2011-10-28|July 18, 2012|2012-07-18|July 18, 2012|Actual|2012-07-18|July 18, 2012|Actual|2012-07-18||Interventional|||Octanoic Acid for Essential Tremor|Dose Escalation Study of Oral Octanoic Acid in Patients With Essential Tremor|Completed||Phase 1|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:38:18.230525|2017-10-11 03:38:18.230525
NCT01468935|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-09-22|||October 31, 2011||2011-10-31|September 21, 2017|2017-09-21|September 21, 2017||2017-09-21|||||Observational|||Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning|Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning|Completed||N/A|79|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:38:18.294536|2017-10-11 03:38:18.294536
NCT01468922|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-09-12|||October 24, 2011||2011-10-24|January 17, 2017|2017-01-17|February 11, 2016|Actual|2016-02-11|September 30, 2014|Actual|2014-09-30||Interventional|||Pazopanib and ARQ 197 for Advanced Solid Tumors|Phase Ib Study of the Combination of Pazopanib, an Oral VEGFR Inhibitor, and ARQ 197 (Tivantinib), an Oral MET Inhibitor, in Patients With Refractory Advanced Solid Tumors|Completed||Phase 1|32|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:38:18.363017|2017-10-11 03:38:18.363017
NCT01468909|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-05-10|||December 2011||2011-12-01|May 2017|2017-05-01||||May 2017|Anticipated|2017-05-01||Interventional|||Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer|A Randomized Phase IIB Evaluation of Weekly Paclitaxel (NSC #673089) Plus Pazopanib (NSC #737754) Versus Weekly Paclitaxel Plus Placebo in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Active, not recruiting||Phase 2|110|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 03:38:18.580025|2017-10-11 03:38:18.580025
NCT01468896|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-08|2017-07-31|2017-07-31||November 4, 2011|Actual|2011-11-04|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|July 12, 2013|Actual|2013-07-12||Interventional|||Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery|A Phase I/II Trial of Cetuximab in Combination With Interleukin-12 Administered to Patients With Unresectable Primary or Recurrent Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 1/Phase 2|23|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:38:19.027185|2017-10-11 03:38:19.027185
NCT01468506|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-09-23|||September 2011||2011-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|UPSAC||Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)|Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)|Withdrawn||N/A|0|Actual|Baptist Health South Florida|||1||f||||f||||||||||2017-10-11 03:38:25.059541|2017-10-11 03:38:25.059541
NCT01468883|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-01|2017-10-05|||September 13, 1979||1979-09-13|November 18, 2016|2016-11-18|November 17, 2016|Actual|2016-11-17|November 17, 2016|Actual|2016-11-17||Interventional|||The Treatment of Stage I and II Breast Cancer With Mastectomy and Axillary Dissection vs. Excisional Biopsy, Axillary Dissection, and Radiotherapy|The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection vs. Excisional Biopsy, Axillary Dissection, and Definitive Irradiation|Completed||Phase 3|256|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:38:19.781045|2017-10-11 03:38:19.781045
NCT01468857|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-09-29|||September 26, 2011||2011-09-26|September 28, 2017|2017-09-28|September 28, 2017||2017-09-28|||||Observational|||Physical and Emotional Health of Caregivers for People Who Have Had Stem Cell Transplants|A Pilot Study to Examine Physiological and Clinical Markers of Chronic Stress in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients|Completed||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:38:19.875189|2017-10-11 03:38:19.875189
NCT01468844|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-08|2017-09-21|||September 26, 2011||2011-09-26|September 15, 2017|2017-09-15|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Minocycline to Treat Central Retinal Vein Occlusion|A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Central Retinal Vein Occlusions|Recruiting||Phase 1/Phase 2|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:38:19.949785|2017-10-11 03:38:19.949785
NCT01468831|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-08|2017-09-21|||September 19, 2011||2011-09-19|September 15, 2017|2017-09-15|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Minocycline to Treat Branch Retinal Vein Occlusion|A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Branch Retinal Vein Occlusions|Recruiting||Phase 1/Phase 2|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:38:20.062756|2017-10-11 03:38:20.062756
NCT01468818|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-05-19|2016-05-19||September 2011||2011-09-01|May 2016|2016-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma|A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanoma|Terminated||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)|Study was closed prematurely due to slow and insufficient accrual.|1||Study was closed prematurely due to slow and insufficient accrual.|f||||f||||||||No||2017-10-11 03:38:20.179028|2017-10-11 03:38:20.179028
NCT01468805|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2017-06-30|||September 4, 2011||2011-09-04|November 15, 2013|2013-11-15|November 15, 2013|Actual|2013-11-15|November 15, 2013|Actual|2013-11-15||Interventional|||Childhood Asthma Reduction Study|Childhood Asthma Reduction Study|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:38:20.551863|2017-10-11 03:38:20.551863
NCT01468792|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-02-18|||September 2011||2011-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Hemodynamic Changes in Connective Tissue Disease|Hemodynamic Changes in Connective Tissue Disease|Completed||N/A|85|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-11 03:38:20.61379|2017-10-11 03:38:20.61379
NCT01468779|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-03-01|||February 2010||2010-02-01|March 2017|2017-03-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Probiotics in Patients Undergoing Surgery for Periampullary Neoplasms|Effect of the Probiotics Use in Patients Undergoing Surgery for Periampullary Neoplasia - A Randomized Clinical Trial|Completed||Phase 3|58|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 03:38:20.677196|2017-10-11 03:38:20.677196
NCT01468766|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-04-18|||February 2011||2011-02-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|BEST||Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy|Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy - A Randomised Controlled Intervention Trial|Completed||N/A|160|Actual|German Cancer Research Center||2|||f||||||||||||||2017-10-11 03:38:20.7504|2017-10-11 03:38:20.7504
NCT01468753|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-05-13|||March 2012||2012-03-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pilot Study: Acceptability, Feasibility and Efficacy of Vaginal Insemination in HIV Discordant Couples (Female Positive, Male Negative) Desiring Conception in Kisumu, Kenya|Pilot Study: Acceptability, Feasibility and Efficacy of Vaginal Insemination in HIV Discordant Couples (Female Positive, Male Negative) Desiring Conception in Kisumu, Kenya|Completed||N/A|40|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 03:38:20.844607|2017-10-11 03:38:20.844607
NCT01468740|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2011-11-07|||March 2004||2004-03-01|November 2011|2011-11-01|July 2012|Anticipated|2012-07-01|February 2012|Anticipated|2012-02-01||Interventional|||Prospective Study on HIV-related Hodgkin Lymphoma|A Prospective Multicenter Study on HIV-associated Hodgkin Lymphoma|Unknown status|Recruiting|Phase 2|130|Anticipated|Harlachinger Krebshilfe e.V.||1|||f||||||||||||||2017-10-11 03:38:20.926369|2017-10-11 03:38:20.926369
NCT01468727|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-14|||January 2007||2007-01-01|November 2011|2011-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|WIPE||Study on Use of Xylitol-wipes to Prevent Dental Caries|Effectiveness of Xylitol Wipes on Infants in Reducing Bacterial Transmission and Colonization From Mother to Child|Completed||N/A|88|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:38:21.046634|2017-10-11 03:38:21.046634
NCT01468714|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-11-11|||October 2011||2011-10-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects|A Phase I, Open-Label, Fixed Sequence Study To Estimate The Steady-State Effect Of Ketoconazole On The Single-Dose Pharmacokinetics Of PF-04937319 In Healthy Adult Subjects|Completed||Phase 1|10|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:38:21.118448|2017-10-11 03:38:21.118448
NCT01468701|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-08-25|||November 7, 2011|Actual|2011-11-07|August 2017|2017-08-01|January 14, 2020|Anticipated|2020-01-14|January 14, 2020|Anticipated|2020-01-14||Observational|||GLORIA-AF Registry Program - Second and Third Phases|GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)|Active, not recruiting||N/A|19000|Anticipated|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 03:38:21.285174|2017-10-11 03:38:21.285174
NCT01467583|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-06-18|2015-03-17||November 2011||2011-11-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Fondaparinux in Critically Ill Patients With Renal Failure|Use of Fondaparinux in Critically Ill Patients With Renal Failure|Completed||Phase 4|32|Actual|Wayne State University||3|||f||||f||||||||||2017-10-11 03:38:46.956921|2017-10-11 03:38:46.956921
NCT01468688|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-06|2017-07-05|||April 20, 2012|Actual|2012-04-20|July 2017|2017-07-01|July 29, 2016|Actual|2016-07-29|July 29, 2016|Actual|2016-07-29||Interventional|||A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients|A Multi-arm Dose-finding Phase Ib Multicenter Study of Imatinib in Combination With the Oral Phosphatidyl-inositol 3-kinase (PI3-K) Inhibitor BKM120 in Patients With Gastrointestinal Stromal Tumor (GIST) Who Failed Prior Therapy With Imatinib and Sunitinib|Completed||Phase 1|60|Actual|Novartis||3|||f||||f|t|f||||||||2017-10-11 03:38:23.207093|2017-10-11 03:38:23.207093
NCT01468675|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-03-20|2016-12-21||February 2013||2013-02-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care|Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care|Completed||N/A|6075|Actual|Brigham and Women's Hospital||2|||f||||f||||||||No||2017-10-11 03:38:23.31821|2017-10-11 03:38:23.31821
NCT01468662|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-10-27|||November 2011||2011-11-01|October 2014|2014-10-01||||April 2013|Actual|2013-04-01||Observational|||CMR Repeatability in STEMI|Cardiovascular Magnetic Resonance Scan Repeatability in ST Segment Elevation Myocardial Infarction|Completed||N/A|40|Actual|University of Bristol|||1||f||||f||||||||||2017-10-11 03:38:23.565925|2017-10-11 03:38:23.565925
NCT01468649|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-03-03|||June 2011||2011-06-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|||Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer|Phase II Real-Time NIR-Guided Sentinel Lymph Node Mapping in Breast Cancer|Completed||Early Phase 1|50|Actual|Beth Israel Deaconess Medical Center||1|||f||||f|f|f||||||||2017-10-11 03:38:23.617047|2017-10-11 03:38:23.617047
NCT01468636|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-10-31|||November 2011||2011-11-01|October 2016|2016-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts|A Randomized Controlled Trial to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts|Terminated||Phase 4|50|Actual|University of British Columbia||2||There was no clear benefit but numerous side effects.|f||||f||||||||||2017-10-11 03:38:23.695063|2017-10-11 03:38:23.695063
NCT01468623|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2013-01-29|||September 2011||2011-09-01|January 2013|2013-01-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|PROFUSE||Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6|A Prospective, Randomized, Open-label Trial Comparing OnDose® AUC Optimized 5-FU Based Administration Versus Standard Body Surface Area (BSA) Dosing in Metastatic Colorectal Cancer Patients (mCRC) Treated With mFOLFOX6|Terminated||Phase 4|51|Actual|Myriad Genetic Laboratories, Inc.||2||Study terminated due to slow enrollment.|f||||t||||||||||2017-10-11 03:38:23.781112|2017-10-11 03:38:23.781112
NCT01468610|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-04-08|||January 2012||2012-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Neurocognition and Work Productivity in Major Depressive Disorder (MDD)|Neurocognition and Work Productivity in Major Depressive Disorder|Completed||N/A|47|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 03:38:24.078316|2017-10-11 03:38:24.078316
NCT01468597|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-01-26|||January 2011||2011-01-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Platelet Inhibition and Bleeding in Patients Undergoing Emergent Cardiac Surgery|Does Platelet Inhibition Predict Surgery Related Bleeding in Patients Undergoing Emergent Cardiac Surgery During Dual Antiplatelet Therapy - a Pilot Study|Completed||N/A|161|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-11 03:38:24.151091|2017-10-11 03:38:24.151091
NCT01468584|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2014-10-29|2014-10-29||November 2011||2011-11-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients|A Phase 3 Study of MP-424 in Combination With Peginterferon Alfa-2b and Ribavirin, in Subjects With Genotype 2 Hepatitis C, Who Did Not Respond to Previous Treatment|Completed||Phase 3|10|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 03:38:24.217432|2017-10-11 03:38:24.217432
NCT01468571|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-05-06|||July 2011||2011-07-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension|Effects of Spironolactone on Collagen Metabolism in Pulmonary Arterial Hypertension|Unknown status|Recruiting|Phase 4|50|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 03:38:24.405183|2017-10-11 03:38:24.405183
NCT01468558|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2013-12-09|2013-08-19||July 2010||2010-07-01|December 2013|2013-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole|A Phase I Evaluation of the Effect of Ketoconazole on the Pharmacokinetics and Safety of Dihydroergotamine Mesylate (DHE) Delivered by Oral Inhalation (MAP0004) in Healthy Volunteers Compared to DHE Delivered Intravenously (DHE 45®)|Completed||Phase 1|24|Actual|Allergan||1|||f||||f||||||||||2017-10-11 03:38:24.501834|2017-10-11 03:38:24.501834
NCT01468545|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-08-28|||October 2011||2011-10-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|January 2013|Actual|2013-01-01||Observational|Inventa||Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System|Prospective, Non-interventional, Multi-centre Study. The Observation Period for Each Subject Covers 1 Year of Treatment. One Initial Visit and 4 Follow-up Visits Every 3 Months and One Extra Educational Reinforcement at Baseline and at 6 Months Will be Given to a Group of Patients.|Completed||N/A|38|Actual|Bayer|||2||f||||f||||||||||2017-10-11 03:38:24.702431|2017-10-11 03:38:24.702431
NCT01468532|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-12-02|||October 2011||2011-10-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer|Phase I/II Trial to Establish the Safety and Preliminary Efficacy of the Combination of Docetaxel, Prednisone, and SOM 230 (Pasireotide) in Metastatic Castrate Resistant Prostate Cancer (CRPC).|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-10-11 03:38:24.848219|2017-10-11 03:38:24.848219
NCT01468519|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-02|2014-12-10|||January 2012||2012-01-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|ECSIITED||Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients|Effects of Continuous Subcutaneous Insulin Infusion (CSII) on Erectile Dysfunction in T2DM Patients: A Prospective, Exploratory, Controlled Trial|Completed||Phase 4|20|Actual|Jothydev's Diabetes and Research Centre||2|||f||||t||||||||||2017-10-11 03:38:24.953475|2017-10-11 03:38:24.953475
NCT01468493|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-29|2017-04-20|||January 2011||2011-01-01|April 2017|2017-04-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|SuparSDRF||A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients|A Prospective Controlled Follow-up of Serum Soluble Urokinase Receptor in the Cyclosporine A-treated Patients With Steroid-dependent and Steroid-resistant Focal Segmental Glomerulosclerosis|Recruiting||N/A|90|Anticipated|Guangdong General Hospital|||3||f||||t||||||||||2017-10-11 03:38:25.137295|2017-10-11 03:38:25.137295
NCT01468480|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2011-11-08|||June 2010||2010-06-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Human Pulpal Response After Pulp Capping With Four Different Agents|Comparison of Human Pulpal Response After Pulpal Exposure to Common Treatments and Single-visit MTA|Completed||Phase 2/Phase 3|32|Actual|Islamic Azad University, Tehran||4|||f||||t||||||||||2017-10-11 03:38:25.227343|2017-10-11 03:38:25.227343
NCT01468467|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-11-30|||April 2012||2012-04-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)|A Phase 1 Study of AC220 (ASP2689) as Maintenance Therapy in Subjects With Acute Myeloid Leukemia Who Have Been Treated With an Allogeneic Hematopoietic Stem Cell Transplant|Completed||Phase 1|13|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-11 03:38:25.342296|2017-10-11 03:38:25.342296
NCT01468454|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-01-31||2013-08-07|January 2009||2009-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2014|Actual|2014-06-01||Interventional|F-DOPA PET||Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia|A Phase II Safety and Efficacy Study of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Children With Hyperinsulinemic Hypoglycemia|Active, not recruiting||Phase 2|128|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-11 03:38:25.444109|2017-10-11 03:38:25.444109
NCT01468441|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2012-07-12|||September 2011||2011-09-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|Gonapeptyl||Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days|Effect of Ovarian Stimulation Using Recombinant FSH and GHRH Antagonist in Alternate Days on ICSI Outcomes|Completed||N/A|96|Actual|Fertility - Assisted Fertilization Center||2|||f||||f||||||||||2017-10-11 03:38:25.537331|2017-10-11 03:38:25.537331
NCT01468428|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-10|||October 2010||2010-10-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Small Intestinal Function in Patients With Cystic Fibrosis|Small Intestinal Function in Patients With Cystic Fibrosis|Unknown status|Enrolling by invitation|N/A|15|Actual|University of Aarhus|||1||f||||t||||||||||2017-10-11 03:38:25.62352|2017-10-11 03:38:25.62352
NCT01468415|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-06|2011-11-08|||June 2011||2011-06-01|May 2011|2011-05-01||||June 2013|Anticipated|2013-06-01||Interventional|||Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs|Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs|Unknown status|Recruiting|Phase 1|60|Anticipated|Assaf-Harofeh Medical Center||1|||f||||t||||||||||2017-10-11 03:38:25.688729|2017-10-11 03:38:25.688729
NCT01468389|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2011-11-08|||November 2011||2011-11-01|November 2011|2011-11-01|June 2013|Anticipated|2013-06-01|January 2013|Anticipated|2013-01-01||Interventional|||Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction|A Randomized Multicenter Phase III Study:Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone vs.Taxanes or Platinum Combined With Capecitabine in Advanced Adenocarcinoma of the Stomach or Esophagogastric Junction.|Unknown status|Recruiting|Phase 3|300|Anticipated|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||2|||f||||t||||||||||2017-10-11 03:38:25.848047|2017-10-11 03:38:25.848047
NCT01468376|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2012-01-26|||February 2011||2011-02-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||GLU-xx Formulations in Individuals With Impaired Glucose Tolerance|An Open-label, Dose-finding Pilot Study of Various Formulations of Glucose-lowering Products in Otherwise Healthy Individuals With Impaired Glucose Tolerance|Terminated||Phase 1|17|Actual|Afexa Life Sciences Inc||6||Sponsor company was acquired and new owner chose not to proceed with clinical study|f||||f||||||||||2017-10-11 03:38:25.955228|2017-10-11 03:38:25.955228
NCT01468363|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2011-11-09|||November 2011||2011-11-01|November 2011|2011-11-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Hypervolemia in ESRD Patients in Zonguldak (Prospective Study)|Hypervolemia and Treatment Guided by Bioimpedance in End Stage Renal Disease Patients in Zonguldak (Prospective Study)|Unknown status|Recruiting|Phase 4|550|Anticipated|Zonguldak Karaelmas University||2|||f||||f||||||||||2017-10-11 03:38:26.046939|2017-10-11 03:38:26.046939
NCT01468350|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-05-22|2014-03-24||December 2011||2011-12-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional||Safety Population (Took at least one dose)|Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy|A Double-Blind, Placebo-Controlled, Crossover Study in Subjects With Cerebral Palsy to Evaluate the Safety and Tolerability and the Effect on Sensorimotor Function of Dalfampridine-ER|Completed||Phase 1|35|Actual|Acorda Therapeutics||4|||f||||f||||||||||2017-10-11 03:38:26.214293|2017-10-11 03:38:26.214293
NCT01468337|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2014-11-12|2014-11-12||October 2011||2011-10-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Topical Interferon Gamma-1b for Central Serous Chorioretinopathy|Pilot Phase I/II Study of the Treatment of Classic Central Serous Chorioretinopathy With Topical Interferon Gamma-1b|Completed||Phase 1/Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)|After study completion, a participant presented with a cataract on 4/12/13 (last study dose:10/3/12 and TOTAL study dosage received: 2758 µg). Although age (58) was consistent with the possibility of cataract, relatedness to drug cannot be ruled out.|1|||f||||f||||||||||2017-10-11 03:38:26.829997|2017-10-11 03:38:26.829997
NCT00005462|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-11|||September 1991||1991-09-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Genetics of Atherosclerosis in Mexican Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.236856|2017-10-11 04:27:05.236856
NCT01468324|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2017-06-30|||October 5, 2011||2011-10-05|April 22, 2014|2014-04-22|April 23, 2014|Actual|2014-04-23|April 23, 2014|Actual|2014-04-23||Interventional|||AZD7451 for Recurrent Gliomas|Phase I Trial of AZD7451, A Topomysin-Receptor Kinase (TRK) Inhibitor, For Adults With Recurrent Glioblastoma Multiforme (GBM)|Completed||Phase 1|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:38:27.202205|2017-10-11 03:38:27.202205
NCT01468311|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2017-04-17|2017-04-17||October 11, 2011|Actual|2011-10-11|April 2017|2017-04-01|September 1, 2021|Anticipated|2021-09-01|November 16, 2014|Actual|2014-11-16||Interventional|||Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin s Lymphoma|Phase I/II Trial of Yttrium-90-labeled Daclizumab (Anti-CD25) Radioimmunotherapy With High-dose BEAM Chemotherapy and Autologous Hematopoietic Stem Cell Rescue in Recurrent and Refractory Hodgkin s Lymphoma|Active, not recruiting||Phase 1/Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f|t|f||||||No||2017-10-11 03:38:27.297678|2017-10-11 03:38:27.297678
NCT01468298|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2011-11-07|||August 2010||2010-08-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Global Posture Reeducation (GPR) Compared To Isostretching in Chronic Low Back Pain Patients|Comparing the Global Posture Reeducation With Isostretching in Chronic Low Back Pain Patients|Unknown status|Active, not recruiting|Early Phase 1|40|Anticipated|Centro Universitario de Maringa||2|||f||||f||||||||||2017-10-11 03:38:27.844031|2017-10-11 03:38:27.844031
NCT01468285|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2013-05-29|||February 2012||2012-02-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|CBF||The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow|A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Effect of Betahistine on Cerebral Blood Flow and Gait in Subjects at Risk of Falling|Completed||Phase 4|27|Actual|Abbott||2|||f||||f||||||||||2017-10-11 03:38:27.928398|2017-10-11 03:38:27.928398
NCT01468272|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-03-28|||November 2011||2011-11-01|March 2017|2017-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PAED4||Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old|A Single-dose,Open-label,Randomized,2-way Cross-over,Clinical Pharmacology Study of CHF1535 50/6 NEXT DPI® Fixed Combination of Beclomethasone Dipropionate 50µg Plus Formoterol Fumarate 6µg)Versus the Free Combination of Licensed Beclomethasone DPI and Formoterol DPI in Asthmatic Children|Completed||Phase 2|26|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 03:38:28.002988|2017-10-11 03:38:28.002988
NCT01468259|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2013-03-27|||October 2012||2012-10-01|March 2013|2013-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||A Multi-Center, Open-Label Study|A Phase I, Multi-Center, Open-Label Study to Examine the Pharmacokinetics of a Single Dose of Droxidopa in Subjects With Renal Impairment Compared to Healthy Volunteers|Withdrawn||Phase 1|0|Actual|Chelsea Therapeutics||5|||f||||f||||||||||2017-10-11 03:38:28.081575|2017-10-11 03:38:28.081575
NCT01468246|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2017-07-25|||November 2006||2006-11-01|July 2017|2017-07-01|January 2026|Anticipated|2026-01-01|November 2025|Anticipated|2025-11-01||Observational|HOHO||The Young Women's Breast Cancer Study|Helping Ourselves, Helping Others: The Young Women's Breast Cancer Study|Active, not recruiting||N/A|1302|Actual|Dana-Farber Cancer Institute|||1||f||||f||||||Samples With DNA|"     The investigators are collecting blood and tumor specimens.   "|||2017-10-11 03:38:28.173546|2017-10-11 03:38:28.173546
NCT01468233|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-10-15|2015-09-16|2015-04-28|November 2011||2011-11-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|PIONEER II||Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa|A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER II|Completed||Phase 3|326|Actual|AbbVie||6|||f||||t||||||||||2017-10-11 03:38:28.392139|2017-10-11 03:38:28.392139
NCT01468220|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-08-16|||January 2012||2012-01-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|July 2017|Actual|2017-07-01||Interventional|||Normobaric Hypoxic Training and Metabolic Syndrome|Normobaric Hypoxic Training Compared to Ambient Training on the Course of the Metabolic Syndrome|Active, not recruiting||N/A|40|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 03:38:29.45127|2017-10-11 03:38:29.45127
NCT01468207|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-10-15|2015-09-16|2015-01-22|November 2011||2011-11-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|PIONEER I||Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa|A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER I|Completed||Phase 3|307|Actual|AbbVie||6|||f||||t||||||||||2017-10-11 03:38:29.566001|2017-10-11 03:38:29.566001
NCT01468194|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2011-11-08|||July 2011||2011-07-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Change in Peripheral Oxygen Saturation by Using Different Breathing Procedures in High Altitude||Completed||N/A|30|Anticipated|University of Giessen||3|||f||||f||||||||||2017-10-11 03:38:31.096495|2017-10-11 03:38:31.096495
NCT01468181|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-01-16|2014-12-08|2014-04-14|November 2011||2011-11-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All enrolled participants|A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus|A 52-Week, Open-Label, Long-Term Safety Study of LY2189265 in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|394|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 03:38:31.258727|2017-10-11 03:38:31.258727
NCT01468155|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2012-10-16|||November 2011||2011-11-01|October 2012|2012-10-01|July 2014|Anticipated|2014-07-01|January 2014|Anticipated|2014-01-01||Interventional|DAPPARAF||DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation|Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation|Unknown status|Recruiting|Phase 4|200|Anticipated|Lawson Health Research Institute||1|||f||||t||||||||||2017-10-11 03:38:34.584925|2017-10-11 03:38:34.584925
NCT01356810|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-20|||September 2009||2009-09-01|August 2009|2009-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|MAPDI||Prophylactic Environmental Management of Delirium|Manejo Ambiental Profilactico Del Delirium Intrahospitalario|Completed||N/A|287|Actual|Universidad de Valparaiso||2|||f||||f||||||||||2017-10-11 04:13:53.210315|2017-10-11 04:13:53.210315
NCT01468142|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-12-19|||February 2012||2012-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure|Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure|Completed||N/A|6|Actual|Karolinska University Hospital|||1||f||||f||||||||||2017-10-11 03:38:34.670846|2017-10-11 03:38:34.670846
NCT01468129|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-08|||November 2011||2011-11-01|November 2011|2011-11-01|December 2012||2012-12-01|December 2012||2012-12-01||Interventional|||Cell Saver Use in Bilateral Total Hip Arthroplasty (THA)|A Prospective, Randomized Controlled Trial to Evaluate the Efficacy of Cell Saver to Redue Blood Loss in One-stage Bilateral Total Hip Arthroplasty (THA)|Unknown status|Recruiting|N/A|||Rothman Institute Orthopaedics||2|||f||||f||||||||||2017-10-11 03:38:34.734209|2017-10-11 03:38:34.734209
NCT01468116|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-07|||March 2011||2011-03-01|November 2011|2011-11-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Observational|||The Effect of Roux-en-Y Gastric Bypass on Mitochondrial Function in Type 2 Diabetes||Unknown status|Recruiting|N/A|30|Anticipated|Hvidovre University Hospital|||3||f||||f||||||Samples Without DNA|"     serum, plasma   "|||2017-10-11 03:38:34.810123|2017-10-11 03:38:34.810123
NCT01468103|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-06|2011-11-08|||August 2009||2009-08-01|November 2011|2011-11-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Laser Iridotomy Versus Surgical Iridectomy in Early Angle Closure|Laser Peripheral Iridotomy Versus Surgical Peripheral Iridectomy in Early Angle Closure:a Randomized Clinical Trial|Unknown status|Recruiting|N/A|120|Anticipated|Sun Yat-sen University||2|||f||||f||||||||||2017-10-11 03:38:34.913672|2017-10-11 03:38:34.913672
NCT01468090|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-09-15|||October 2011||2011-10-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Disease Course in an IBD Cohort in the Era of Biological Treatment|Risk of Surgery Among Patients Wih Ulcerative Colitis and Croh'ns Disease After Seven Years of Follow-up in the Era of Biological Treatment.|Completed||N/A|192|Actual|Hvidovre University Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood and faeces will be retained for biobank   "|||2017-10-11 03:38:35.023897|2017-10-11 03:38:35.023897
NCT01468077|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2015-07-20|2015-06-23||November 2011||2011-11-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Intent-to-treat (ITT) Population: All participants enrolled in the study who had been randomly assigned to one of the two study treatments.|A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment|Multicenter, Randomized, Parallel Group Study to Compare the Incidence of Tocilizumab Related Infusion Reactions in Patients With Moderate to Severe Active RA, When Infusion is Given Over 31 Minutes Compared to 1 Hour|Completed||Phase 2|47|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:38:35.129602|2017-10-11 03:38:35.129602
NCT01468064|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-11-12|||November 2011||2011-11-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|AMETIS||Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke|Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Patients With Ischemic Stroke: a Randomized Controlled Trial|Recruiting||Phase 1/Phase 2|20|Anticipated|Southern Medical University, China||3|||f||||f||||||||||2017-10-11 03:38:36.097413|2017-10-11 03:38:36.097413
NCT01468038|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2011-11-08|||April 2008||2008-04-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||A Double-blind Placebo Controlled Trial of Sentra PM, a Medical Food|Sentra PM (a Medical Food) and Trazadone in the Management of Sleep Disorders|Completed||Phase 3|111|Actual|Targeted Medical Pharma||4|||f||||t||||||||||2017-10-11 03:38:36.284815|2017-10-11 03:38:36.284815
NCT01468025|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2011-11-05|||February 2009||2009-02-01|November 2011|2011-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effectiveness of Theramine on Chronic Back Pain|A Randomized Double-blind Placebo Study to Determine the Effectiveness of Theramine and a Low Dose Naproxen on the Management of Chronic Back Pain|Completed||Phase 3|127|Actual|Targeted Medical Pharma||3|||f||||f||||||||||2017-10-11 03:38:36.561117|2017-10-11 03:38:36.561117
NCT01468012|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-10-25|2016-10-25||July 2014||2014-07-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|July 2014|Actual|2014-07-01||Interventional|COST||Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence|Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence|Completed||Phase 2/Phase 3|23|Actual|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-11 03:38:36.642147|2017-10-11 03:38:36.642147
NCT01467999|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-04-03|||February 2012||2012-02-01|March 2017|2017-03-01|October 2016|Actual|2016-10-01|April 2016|Actual|2016-04-01||Interventional|GUAN||Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence|Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence|Completed||Phase 1|22|Actual|New York State Psychiatric Institute||1|||f||||t|t|f||||||No||2017-10-11 03:38:36.998943|2017-10-11 03:38:36.998943
NCT01467986|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2016-12-29|||August 2013||2013-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|RIST-rNB-2011||Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma|Prospective, Open Label, Randomized Phase II Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-risk Neuroblastoma|Recruiting||Phase 2|114|Anticipated|University of Regensburg||2|||f||||t||||||||||2017-10-11 03:38:37.076357|2017-10-11 03:38:37.076357
NCT01467973|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-04-20|||February 2012||2012-02-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2012|Actual|2012-11-01||Observational|GulfCARE||Gulf Acute Heart Failure Registry|Gulf aCute heArt failuRe rEgistry (Gulf CARE)|Completed||N/A|5005|Actual|Gulf Heart Association|||1||f||||t||||||||||2017-10-11 03:38:37.182912|2017-10-11 03:38:37.182912
NCT01467960|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2013-09-23|2013-06-11||November 2011||2011-11-01|September 2013|2013-09-01|November 2013|Anticipated|2013-11-01|June 2013|Actual|2013-06-01||Observational|ApoD||Apolipoprotein D (ApoD) In Human Serum As Marker Of Parkinson's Disease|Detection of Apolipoprotein D (ApoD) in Human Serum as Marker of Parkinson's Disease|Unknown status|Enrolling by invitation|N/A|180|Actual|Privatklinik Villa Melitta|||6||f||||f||||||Samples With DNA|"     Serum   "|||2017-10-11 03:38:37.255035|2017-10-11 03:38:37.255035
NCT01467947|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2016-12-12|2015-10-16||November 2011||2011-11-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert|Prospective Open-label Uncontrolled Multi-center Post-marketing Study to Assess Inhibitory Antibody Formation in Subjects With Congenital C1-INH Deficiency and Acute Hereditary Angioedema (HAE) Attacks Treated With Berinert® , a C1-esterase Inhibitor|Completed||Phase 4|46|Actual|CSL Behring||1|||f||||||||||||||2017-10-11 03:38:37.680565|2017-10-11 03:38:37.680565
NCT01467934|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2014-07-19|2014-06-22||November 2011||2011-11-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Observational|||FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging|FeverText: Assessing Fever Rates After Influenza and Pneumococcal Vaccination During the 2011-12 Influenza Season Using Text Messaging|Completed||N/A|530|Actual|Columbia University|||3||f||||f||||||||||2017-10-11 03:38:37.99302|2017-10-11 03:38:37.99302
NCT01467921|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-06|2011-11-14|||December 2010||2010-12-01|November 2011|2011-11-01||||February 2012|Anticipated|2012-02-01||Interventional|||Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma|A Randomized Phase II Study of Leucovorin, 5-fluorouracil With or Without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma.|Unknown status|Recruiting|Phase 2|68|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 03:38:38.291175|2017-10-11 03:38:38.291175
NCT01467908|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2013-02-12|||June 2011||2011-06-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|February 2012|Actual|2012-02-01||Interventional|C-fMRI-NBS||Navigated Brain Stimulation in Diagnosis of Minimally Conscious State|Navigated Brain Stimulation in Diagnosis of Minimally Conscious State|Completed||N/A|6|Actual|Clinical Institute of the Brain, Russia||1|||f||||t||||||||||2017-10-11 03:38:38.373947|2017-10-11 03:38:38.373947
NCT01467882|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2017-07-27|2015-06-25|2014-08-19|April 2012||2012-04-01|July 2017|2017-07-01|July 2014|Actual|2014-07-01|August 2013|Actual|2013-08-01||Interventional||Intention to treat, defined as all participants enrolled|Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty|An Open-label, Non-comparative, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Triptorelin Pamoate (Embonate) 22.5 mg 6-month Formulation in Patients Suffering From Central (Gonadotropin-dependent) Precocious Puberty|Completed||Phase 3|44|Actual|Debiopharm International SA||1|||f||||f||||||||||2017-10-11 03:38:38.488555|2017-10-11 03:38:38.488555
NCT01467869|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-12-12|||January 1991||1991-01-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|MFP||Male Fertility Program|The Miami Project Male Fertility Program|Recruiting||N/A|100|Anticipated|University of Miami|||1||f||||t||||||||||2017-10-11 03:38:39.559558|2017-10-11 03:38:39.559558
NCT01467856|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-02-15|||October 2010||2010-10-01|February 2017|2017-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|SDB||Sleep Disordered Breathing|Sleep Disordered Breathing (SDB) in Persons With Chronic Tetraplegia: Characterization and Treatment|Completed||N/A|304|Actual|University of Miami|||1||f||||t||||||Samples Without DNA|"     Insulin Sensitivity (SI) and Lipid/Inflammation panels: (30 minutes, Taken at Baseline, 1     month, and 3 month time points) SI will be calculated using the Quantitative Insulin     Sensitivity Check Index (QUICKI) method177 that requires single fasting blood glucose and     insulin values. The same blood sample will be used to assay for a lipid panel containing     total cholesterol, LDL, HDL, and triglycerides and an inflammatory panel testing hs-CRP and     IL-6.   "|||2017-10-11 03:38:39.623321|2017-10-11 03:38:39.623321
NCT01467830|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2014-07-03|||December 2011||2011-12-01|December 2011|2011-12-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|||Open Inguinal Hernia Repair With Mesh,the Use of Absorbable Versus Non Absorbable Fixation Sutures|Open Inguinal Hernia Repair With Mesh,the Use of Absorbable Versus Non Absorbable Fixation Sutures|Withdrawn||N/A|0|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 03:38:39.775784|2017-10-11 03:38:39.775784
NCT01467817|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-11-29|||September 2010||2010-09-01|February 2016|2016-02-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI)|Obesity/Overweight in Persons With Early and Chronic SCI: A Randomized Multi-Center Controlled Lifestyle Intervention|Completed||N/A|29|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 03:38:39.840196|2017-10-11 03:38:39.840196
NCT01467804|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-07|2011-11-09|||November 2011||2011-11-01|January 2010|2010-01-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||"Randomized Double Blinding Controlled Study on Jia Wei Xiao Yao Jiaonang Treating Mild to Moderate Major Depressive Disorder"|"Randomized Double Blinding Controlled Study on Jia Wei Xiao Yao Jiaonang Treating Mild to Moderate Major Depressive Disorder"|Unknown status|Not yet recruiting|N/A|180|Anticipated|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-10-11 03:38:39.936068|2017-10-11 03:38:39.936068
NCT01467791|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2015-12-04|||November 2011||2011-11-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|RESAPH||Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)|Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)|Recruiting||N/A|300|Anticipated|University of Cincinnati|||1||f||||f||||||Samples Without DNA|"     Serum samples   "|||2017-10-11 03:38:40.026906|2017-10-11 03:38:40.026906
NCT01467778|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-22|2011-11-07|||December 2010||2010-12-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||Safety Study of Three Formulations of the Dermal Implant ELAPR|A Phase I Study to Assess the Safety of Three Formulations of the Dermal Implant ELAPR in Healthy Subjects|Completed||Phase 1|14|Actual|Elastagen Pty Ltd||4|||f||||f||||||||||2017-10-11 03:38:40.107995|2017-10-11 03:38:40.107995
NCT01467765|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-05|2012-08-07|||November 2011||2011-11-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|Elental||The Effect of Elemental Diet on Gastric Emptying|The Comparative Study of Elemental Diet and Regular Liquid Diet on Gastric Emptying in Patients With Percutaneous Endoscopic Gastrostomy|Completed||N/A|20|Anticipated|Showa Inan General Hospital||2|||f||||f||||||||||2017-10-11 03:38:40.208068|2017-10-11 03:38:40.208068
NCT01467752|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2011-11-08|||January 2005||2005-01-01|November 2011|2011-11-01|December 2009|Actual|2009-12-01|January 2005|Actual|2005-01-01||Interventional|MJRUVCBG||Metacarpophalangeal Joint Reconstruction Using a Vascularized Cartilage and Bone Graft|Phase 1 Study for Reconstruction of Metacarpophalangeal Joint Using a Vascularized Cartilage and Bone Graft From the Third Metacarpal|Completed||Phase 1|15|Actual|The Second Hospital of Qinhuangdao||1|||f||||t||||||||||2017-10-11 03:38:40.276215|2017-10-11 03:38:40.276215
NCT01467726|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2014-12-01|||November 2011||2011-11-01|December 2014|2014-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects|A Phase 1, Randomized, Placebo−Controlled, Double−Blind, Study of Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects|Completed||Phase 1|40|Actual|Theravance Biopharma R & D, Inc.||3|||f||||f||||||||||2017-10-11 03:38:40.510338|2017-10-11 03:38:40.510338
NCT01467713|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-04-08|2016-04-08||December 2011||2011-12-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||All randomized participants.|Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar I Disorder in Adult Patients|Terminated||Phase 3|642|Actual|Takeda||4||Business Decision; No Safety Concerns.|f||||f||||||||||2017-10-11 03:38:40.660349|2017-10-11 03:38:40.660349
NCT01467700|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-04-08|2016-04-08||December 2011||2011-12-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||All randomized participants.|Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) in the Treatment of Acute Depressive Episodes Associated With Bipolar I Disorder in Adult Patients Who Are on Lithium and/or Valproate|Terminated||Phase 3|490|Actual|Takeda||4||Business Decision; No Safety Concerns|f||||f||||||||||2017-10-11 03:38:43.065432|2017-10-11 03:38:43.065432
NCT01467687|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2011-11-08|||July 2007||2007-07-01|November 2011|2011-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Synerx Pharma and Verelan PM 300 mg Verapamil HCl Extended Release Capsules Controlled-Onset in Healthy Aduly Volunteers Under Fed Conditions|Completed||Phase 1|58|Actual|Synerx Pharma, LLC||2|||f||||t||||||||||2017-10-11 03:38:44.653713|2017-10-11 03:38:44.653713
NCT01467674|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2011-11-08|||January 2008||2008-01-01|November 2011|2011-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||The Effect Of Glycemic Control On Malondialdehyde, Glutathione Peroxidase, Glutathione And Paraoxonase|Malondialdehyde And Antioxidant Levels In Chronic Periodontitis Patients With Type 2 Diabetes Mellitus Under Different Stages Of Metabolic Control|Completed||N/A|84|Actual|Suleyman Demirel University|||4||f||||f||||||||||2017-10-11 03:38:44.737603|2017-10-11 03:38:44.737603
NCT01467661|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-06-22|2016-05-02||November 2011||2011-11-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional||Safety analysis set included all enrolled participants who had taken at least 1 dose of SPD422 since enrolment into Study SPD422-308 (NCT01214915).|Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia|A Phase 3, Multi-centre, Open-label, Extension Study to Investigate the Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia|Completed||Phase 3|41|Actual|Shire||1|||f||||f||||||||||2017-10-11 03:38:44.904048|2017-10-11 03:38:44.904048
NCT01467648|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2011-11-08|||October 2010||2010-10-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia|The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia|Completed||Phase 4|12|Actual|Prince of Songkla University||2|||f||||f||||||||||2017-10-11 03:38:46.359355|2017-10-11 03:38:46.359355
NCT01467635|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-07-12|||May 2014||2014-05-01|July 2016|2016-07-01|July 2016|Anticipated|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||EBUS-TBNA Versus EBUS-TBNB|Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) Versus Endobronchial Ultrasound Transbronchial Needle Biopsy (EBUS-TBNB) in the Assessment of Mediastinal and Hilar Lymphadenopathy: a Randomised Trial|Withdrawn||N/A|0|Actual|Royal Brompton & Harefield NHS Foundation Trust||2||Manufacturer did not develop and deliver the necessary biopsy forceps needles in time|f||||f||||||||||2017-10-11 03:38:46.621226|2017-10-11 03:38:46.621226
NCT01467622|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2013-05-06|||April 2009||2009-04-01|May 2013|2013-05-01|October 2011|Actual|2011-10-01|August 2009|Actual|2009-08-01||Observational|||Effects of Local Protocols on Duration of Chest Tube Therapy Following Thoracic Surgery|Prospective, Non Randomized Investigator Initiated Multi-centre Trial on the Effects of Local Treatment Protocols on the Duration of Chest Tube Therapy Following Thoracic Surgery in Germany|Completed||N/A|80|Actual|Schillerhoehe Hospital|||1||f||||f||||||||||2017-10-11 03:38:46.71945|2017-10-11 03:38:46.71945
NCT01467596|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2012-11-14|||November 2011||2011-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|US-SCB||Ultrasound-guided Supraclavicular Brachial Plexus Block in Elderly|Effects of Age on Minimum Effective Volume of Local Anesthetic for Ultrasound-guided Supraclavicular Brachial Plexus Block (US-SCB)|Completed||N/A|44|Actual|Šarić, Jadranka Pavičić, M.D.||2|||f||||f||||||||||2017-10-11 03:38:46.866398|2017-10-11 03:38:46.866398
NCT01467570|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2014-02-14|2013-11-20||June 2009||2009-06-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis|Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis: Randomized, Double-Blind Controlled Trial|Completed||Phase 4|147|Actual|Medical University of Warsaw|Potential limitations included lack of perfect blinding. Because of technological reasons, it was not feasible to produce study products that were identical in colour, smell and taste.|2|||f||||t||||||||||2017-10-11 03:38:47.258979|2017-10-11 03:38:47.258979
NCT01467557|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2015-10-22|2015-07-01||October 2011||2011-10-01|October 2015|2015-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|TEMPO||Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY|1•DAY ACUVUE® TruEye™ Brand Contact Lenses & 1•DAY ACUVUE® MOIST® Brand Contact Lenses With LACREON® TECHNOLOGY Daily Disposable Performance Overview Registry -TEMPO Study|Completed||N/A|1171|Actual|Johnson & Johnson Vision Care, Inc.|||2||f||||f||||||||||2017-10-11 03:38:47.892428|2017-10-11 03:38:47.892428
NCT01467544|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2013-05-17|||June 2011||2011-06-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Reduce Cardiovascular Risk in Women Through Tai Chi Intervention|Exploring the Effects of Tai Chi on Cardiometabolic Risk in Women|Completed||N/A|96|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 03:38:48.375507|2017-10-11 03:38:48.375507
NCT01467531|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-10-11|||November 2011||2011-11-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects|A Phase 1, Open-Label, Crossover Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects|Completed||Phase 1|28|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 03:38:48.479845|2017-10-11 03:38:48.479845
NCT01467518|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-04-05|||December 2011||2011-12-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.|A Phase 1, Open-Label, 2-Period Drug Interaction Study to Assess Steady State Plasma Methadone Enantiomer Pharmacokinetics Following Co-Administration of Methadone QD With Dolutegravir (GSK1349572) 50 mg Twice Daily in Opiate-Dependent, HIV Seronegative Adult Subjects.|Completed||Phase 1|11|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 03:38:48.59477|2017-10-11 03:38:48.59477
NCT01467505|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-06-01|2015-05-02||February 2012||2012-02-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Full analysis set included all participants who received at least 1 dose of study drug.|An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients|A 2-Part, Open Label Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Chronically Infected With Genotype 1 Hepatitis C Virus Following Liver Transplantation|Terminated||Phase 2|61|Actual|Vertex Pharmaceuticals Incorporated|It was decided by Sponsor on 13 January 2014 to terminate the study early at the primary efficacy endpoint (SVR12) as part of a decision to modify the drug development plan. Eligible participants completed virologic follow-up after termination.|2||"The study was terminated early by the sponsor on 13 January 2014 due to a decision to modify   the drug development plan."|f||||f||||||||||2017-10-11 03:38:48.734199|2017-10-11 03:38:48.734199
NCT01467492|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-07-13|2015-06-01||January 2012||2012-01-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Full Analysis (FA) Set included all enrolled participants who received at least 1 dose of any study drug.|Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C|An Open-Label, Phase 4 Study of Telaprevir, Peginterferon Alfa-2a (Pegasys®), and Ribavirin (Copegus®) in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C Who Have Not Achieved a Sustained Viral Response With a Prior Course of Interferon-Based Therapy|Terminated||Phase 4|121|Actual|Vertex Pharmaceuticals Incorporated|It was decided by Sponsor on 13 January 2014 to terminate the study early as part of a decision to modify the drug development plan. Eligible participants completed virologic follow-up after termination.|2||"It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy   endpoint as part of a decision to modify drug development plan."|f||||f||||||||||2017-10-11 03:38:49.966885|2017-10-11 03:38:49.966885
NCT01467479|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-03-03|2015-03-03||December 2011||2011-12-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||The Full Analysis Set (FAS), included all randomized participants who received at least 1 dose of study drug.|A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)|An Open Label,Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1)|Terminated||Phase 3|185|Actual|Vertex Pharmaceuticals Incorporated|It was decided by Sponsor on 13 January 2014 to terminate the study early at the primary efficacy endpoint (SVR12) as part of a decision to modify the drug development plan. Eligible participants completed virologic follow-up after termination.|3||"It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy   endpoint as part of a decision to modify drug development plan."|f||||t||||||||||2017-10-11 03:38:51.871208|2017-10-11 03:38:51.871208
NCT01467466|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-10-03|||February 7, 2013|Actual|2013-02-07|October 2017|2017-10-01|September 29, 2017|Actual|2017-09-29|September 29, 2017|Actual|2017-09-29||Interventional|PRESERVE||Prevention of Serious Adverse Events Following Angiography|CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)|Completed||Phase 3|5183|Actual|VA Office of Research and Development||4|||f||||t|t|f|||f|||||2017-10-11 03:38:55.906098|2017-10-11 03:38:55.906098
NCT01467453|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-14|||November 2011||2011-11-01|November 2011|2011-11-01|December 2012||2012-12-01|||||Observational|||Clinical Application of Sensimed Triggerfish Sensor (TS) With Wireless Signal Transmission for Continuous Intraocular Pressure Measurement||Unknown status|Enrolling by invitation|Phase 4|30|Anticipated|University of Zurich|||1||f||||||||||||||2017-10-11 03:38:56.177367|2017-10-11 03:38:56.177367
NCT01467440|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-01-05|||November 2011||2011-11-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines||Unknown status|Enrolling by invitation|Phase 4|200|Anticipated|University of Zurich|||2||f||||||||||||||2017-10-11 03:38:56.268139|2017-10-11 03:38:56.268139
NCT01467414|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2013-11-26|||October 2011||2011-10-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes|A Trial Investigating the Pharmacodynamic Properties of NN1250 in Japanese Subjects With Type 2 Diabetes|Terminated||Phase 1|1|Actual|Novo Nordisk A/S||1||This trial was terminated due to low recruitment|f||||f||||||||||2017-10-11 03:38:56.617751|2017-10-11 03:38:56.617751
NCT01467401|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-02-22|||August 19, 2002|Actual|2002-08-19|February 2017|2017-02-01|May 15, 2003|Actual|2003-05-15|May 15, 2003|Actual|2003-05-15||Interventional|||Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes|A Multi-National, Multi-Centre, Randomised, Open-Labelled, Parallel Trial Comparing Efficacy and Safety of NovoMix® 30 FlexPen® and Mixtard® 30 Twice Daily Injections in Subjects With Type 2 Diabetes|Completed||Phase 4|292|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:38:56.710013|2017-10-11 03:38:56.710013
NCT01467388|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-01-05|||November 2011||2011-11-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients||Unknown status|Enrolling by invitation|N/A|200|Anticipated|University of Zurich|||2||f||||||||||||||2017-10-11 03:38:56.934904|2017-10-11 03:38:56.934904
NCT01467375|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-02-22|||January 8, 2001|Actual|2001-01-08|February 2017|2017-02-01|October 22, 2004|Actual|2004-10-22|October 22, 2004|Actual|2004-10-22||Interventional|||Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes|An Open Label, Non Comparative, Multicentre Extension Trial to Assess the Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Who Have Completed BIAsp-1234|Completed||Phase 3|89|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:38:57.525214|2017-10-11 03:38:57.525214
NCT01467362|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-02-20|||November 2011||2011-11-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy Emollient on Xerosis in Children With Atopic Dermatitis|Efficacy of the V0034CR01B Emollient on Xerosis in Children With Atopic Dermatitis. Randomised, Vehicle-controlled, Parallel-groups, Double-blind Study With an Open Label Extension.|Completed||Phase 3|251|Actual|Pierre Fabre Medicament||2|||f||||f||||||||||2017-10-11 03:38:57.679418|2017-10-11 03:38:57.679418
NCT01467349|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2013-02-08|||December 2011||2011-12-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Observational|Real-Life||Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan|Efficacy of Raltegravir in a Large Urban HIV Clinic Population in Milan (Efficacy of Raltegravir in a Large Urban HIV Clinic Setting)|Completed||N/A|400|Actual|Università Vita-Salute San Raffaele|||1||f||||f||||||||||2017-10-11 03:38:58.016327|2017-10-11 03:38:58.016327
NCT01467336|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-02-08|||December 2011||2011-12-01|February 2012|2012-02-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Supra-spinatus Rehabilitation Program Comparison|Prospective Randomized Study Comparing 3 Post-operative Rehabilitation Programs After Arthroscopic Supra-spinatus Tendon Repair|Unknown status|Recruiting|N/A|294|Anticipated|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-10-11 03:38:58.09431|2017-10-11 03:38:58.09431
NCT01467323|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-01-03|||April 1998||1998-04-01|January 2017|2017-01-01|September 1998|Actual|1998-09-01|September 1998|Actual|1998-09-01||Interventional|||Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes|An Open-labelled, Randomised, Parallel Group, Multicentre, Multinational Efficacy and Safety Comparison of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30/70 as Meal Related Insulin in a Twice Daily Regimen in Type 1 and Type 2 Diabetic Subjects|Completed||Phase 3|303|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:38:58.217188|2017-10-11 03:38:58.217188
NCT01467310|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-03-09|||January 2012||2012-01-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212|Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212|Completed||Early Phase 1|15|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t|t|f||||||||2017-10-11 03:38:58.413035|2017-10-11 03:38:58.413035
NCT01467284|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2014-07-17|||July 2009||2009-07-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||School Worksite Weight Gain Prevention Intervention Study|School Worksite Weight Gain Prevention Intervention Study|Completed||Phase 2/Phase 3|844|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 03:38:58.634666|2017-10-11 03:38:58.634666
NCT01467271|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-02-01|||April 2011||2011-04-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|NSsaFe||Observational Study on the Incidence of NSF in Renal Impaired Patients Following DOTAREM Administration|Observational Study on the Incidence of NSF in Renal Impaired Patients Following DOTAREM Administration|Active, not recruiting||N/A|540|Actual|Guerbet|||1||f||||f||||||||||2017-10-11 03:38:58.773548|2017-10-11 03:38:58.773548
NCT01467258|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2013-07-26|||November 2011||2011-11-01|July 2013|2013-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Urinary Excretion of Acetylamantadine by Normal Healthy Volunteers|Urinary Excretion of Acetylamantadine by Normal Healthy Volunteers|Completed||N/A|20|Actual|University of Manitoba||1|||f||||f||||||||||2017-10-11 03:38:58.896025|2017-10-11 03:38:58.896025
NCT01467063|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2013-05-02|||October 2011||2011-10-01|May 2013|2013-05-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Glutamine and Insulin Sensitivity in Type I Diabetes|Dietary Amino Acids and Insulin Sensitivity in Children With Type 1 Diabetes|Unknown status|Active, not recruiting|N/A|20|Anticipated|Nemours Children's Clinic||2|||f||||f||||||||||2017-10-11 03:39:00.928629|2017-10-11 03:39:00.928629
NCT01467245|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2012-06-08|||August 2009||2009-08-01|June 2012|2012-06-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|The CO2||Open or Keyhole Surgery Through the Chest for Newborn Babies: Effect on Blood Gases|Hypercapnia During Thoracoscopy or Open Surgery for Repair of Oesophageal Atresia With Tracheo-oesophageal Fistula or Congenital Diaphragmatic Hernia in Neonates: Pilot Randomised Controlled Trial|Unknown status|Recruiting|N/A|30|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||2|||f||||||||||||||2017-10-11 03:38:58.970266|2017-10-11 03:38:58.970266
NCT01467232|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2015-11-30|||September 2011||2011-09-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|November 2014|Actual|2014-11-01||Interventional|IMPACT-CABG||IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting|Implantation of Autologous CD133+ Stem Cells in Patients Undergoing CABG|Completed||Phase 2|20|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 03:38:59.089503|2017-10-11 03:38:59.089503
NCT01467219|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-06-19|||January 2012||2012-01-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer|Intra-operative Lymph Node Evaluation Using a Hand Held PET Gamma Probe in Endometrial Cancer Surgery - A Pilot Study|Completed||N/A|12|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 03:38:59.184582|2017-10-11 03:38:59.184582
NCT01467206|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-09-18|||November 2011|Actual|2011-11-01|September 2017|2017-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|LAST||Life After STroke - the LAST Study|Life After STroke - the LAST Study. A Norwegian Multi Centre Randomized Controlled Trial|Completed||N/A|380|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 03:38:59.281358|2017-10-11 03:38:59.281358
NCT01467193|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-09-08|||August 2011||2011-08-01|September 2014|2014-09-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Observational|||The Effect of Dietary Fat Load and Physical Exercise on the Flexibility and Partitioning of Ectopic Lipids.|The Effect of Dietary Fat Load and Physical Exercise on the Flexibility and Partitioning of Ectopic Lipids.|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital Inselspital, Berne|||3||f||||f||||||||||2017-10-11 03:38:59.415575|2017-10-11 03:38:59.415575
NCT01467180|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-04-04|||November 2011||2011-11-01|April 2017|2017-04-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|HicoRhabdo||Myoglobin Removal by High Cut-off CVVHD|Myoglobin Reduction by High Cut-off (HCO) Continuous Veno- Venous Hemodialysis (CVVHD) in Patients With Rhabdomyolysis and an Increased Risk for Acute Kidney Injury|Completed||N/A|16|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-10-11 03:38:59.516772|2017-10-11 03:38:59.516772
NCT01467167|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-10-24|||October 2011||2011-10-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Observational|||Utility of the Smart Pilot View in Clinical Practice: A Two Center Prospective Observational Study|Utility of the Smart Pilot View in Clinical Practice: A Two Center Prospective Observational Study|Recruiting||N/A|400|Anticipated|University Medical Center Groningen|||2||f||||f||||||||||2017-10-11 03:38:59.599543|2017-10-11 03:38:59.599543
NCT01467154|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-08|||May 2008||2008-05-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Observational|||Evaluation of Intravenous N-acetylcysteine to Prevent Contrast Media Induced Nephrotoxicity in an Emergency Center|Does Ultra-High Dose i.v. N-acetylcysteine Prevent Contrast Nephropathy in Patients With Chronic Kidney Disease Undergoing Emergency Contrast Tomography.|Completed||N/A|124|Actual|University Hospital, Geneva|||2||f||||f||||||||||2017-10-11 03:38:59.686564|2017-10-11 03:38:59.686564
NCT01467141|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-02-22|||June 19, 2002|Actual|2002-06-19|February 2017|2017-02-01|October 15, 2003|Actual|2003-10-15|October 15, 2003|Actual|2003-10-15||Interventional|||Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes|Meal-related Insulin Aspart Therapy Versus Meal-related Human Insulin Therapy in Children 2-6 Years of Age With Type 1 Diabetes Mellitus: A Multi-centre Randomised, Open-labelled, Cross-over, Safety and Efficacy Trial|Completed||Phase 4|26|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:38:59.748744|2017-10-11 03:38:59.748744
NCT01467128|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2012-06-05|||June 2011||2011-06-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Adverse Drug Event Prevention Using Structured Pharmacist Review|Title of Study: Adverse Drug Event (ADE) Incidence in Older Patients Following Hospital Admission and Pharmacist Review to Older Persons' Prescriptions and Its' Effect on ADE Reduction in Hospital: a Randomised Controlled Trial|Completed||Phase 4|720|Actual|University College Cork||2|||f||||f||||||||||2017-10-11 03:38:59.852638|2017-10-11 03:38:59.852638
NCT01467102|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2014-07-16|||July 2011||2011-07-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|PAIN-OUT||euCPSP: European Observational Study on Chronic Post Surgical Pain,PAIN-OUT Study|euCPSP: European Observational Study on Chronic Post Surgical Pain,PAIN-OUT|Completed||N/A|3618|Actual|European Society of Anaesthesiology|||1||f||||f||||||||||2017-10-11 03:39:00.110669|2017-10-11 03:39:00.110669
NCT01467089|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-09-19|||November 2011||2011-11-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||The Assessment of Movement Disorders Utilizing Live Two-Way Video|The Assessment of Movement Disorders Utilizing Live Two-Way Video|Completed||N/A|37|Actual|Northwell Health|||1||f||||f||||||||||2017-10-11 03:39:00.230176|2017-10-11 03:39:00.230176
NCT01467076|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2016-11-03|2016-11-03||November 2011||2011-11-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional||"Infants randomized to the Control group were given the placebo dose.
Infants randomized to the Low Dose IPGE1 were given the lower dose.
Infants randomized to the High Dose IPGE1 were given the higher dose."|Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)|Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide|Terminated||Phase 2|7|Actual|NICHD Neonatal Research Network||3||"The study was halted due to futility concerns based on the unmet benchmarks as specified in the   pilot study protocol."|f||||t||||||||||2017-10-11 03:39:00.324926|2017-10-11 03:39:00.324926
NCT01467037|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-03-17|2015-11-16||February 2012||2012-02-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational||Among all active surveillance eligible patients, patients were included if parent/legal guardian had provided informed consent, and if an adequate stool specimen was provided within 7 days of hospital presentation. Patients needed to be aged <15 months at RV1 program implementation (November 1, 2011), AND aged ≥16 weeks at symptom onset.|Vaccine Effectiveness of RV1 in a Naïve Population|Vaccine Effectiveness of RV1 in a Naïve Population|Completed||N/A|374|Actual|McGill University Health Center|||2||f||||f||||||Samples Without DNA|"     stool sample   "|||2017-10-11 03:39:01.13872|2017-10-11 03:39:01.13872
NCT01467011|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-11-01|||December 2010||2010-12-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation|An Open-label Study of the Pharmacokinetics of Mycophenolic Acid as Myfortic (Enteric-coated Mycophenolate Sodium) When Used in Combination With Prograf (Tacrolimus) and Corticosteroids in Patients Undergoing de Novo Liver Transplantation|Completed||Phase 4|25|Actual|The Methodist Hospital System|||1||f||||f||||||Samples Without DNA|"     Serum will be retained and frozen for MPA levels   "|Undecided|Plan to share data to be determined.|2017-10-11 03:39:01.697414|2017-10-11 03:39:01.697414
NCT01466998|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-05-05|||January 2012||2012-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|MaTURE||Menopausal Treatment Using Relaxation Exercises (MaTURE)|Menopausal Treatment Using Relaxation Exercises (MaTURE)|Completed||N/A|123|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:39:01.818551|2017-10-11 03:39:01.818551
NCT01466985|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2015-10-01|||October 2011||2011-10-01|October 2015|2015-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005)|A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiretroviral Activity of MK-1439 in HIV-1 Infected Patients|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 03:39:01.906805|2017-10-11 03:39:01.906805
NCT01466972|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-09-14|||April 2012||2012-04-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|February 2016|Actual|2016-02-01||Interventional|||Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib|Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib|Active, not recruiting||Phase 2|30|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:39:02.011372|2017-10-11 03:39:02.011372
NCT01466959|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-03-23|||November 2011||2011-11-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Effect of Citrasate Dialysate on Heparin Dose in Hemodialysis|The Effect of Citrasate Dialysate on Heparin Dose: A Randomized Cross Over Trial in Hemodialysis Patients.|Completed||N/A|20|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 03:39:02.158021|2017-10-11 03:39:02.158021
NCT01466946|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-02-10|||November 2011||2011-11-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients|Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients|Completed||N/A|25|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:39:02.271596|2017-10-11 03:39:02.271596
NCT01466933|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2013-07-16|||January 2011||2011-01-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Responsive Parenting Program for Infants in Rural Bangladesh|Design, Implementation and Evaluation of a Parent Support/Counselling Program With a Focus on Responsive Stimulation for Infants and Young Children in Rural Bangladesh|Completed||N/A|474|Actual|McGill University||3|||f||||f||||||||||2017-10-11 03:39:02.364722|2017-10-11 03:39:02.364722
NCT01466920|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-04-07|||November 2011||2011-11-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|August 2013|Actual|2013-08-01||Observational|||Why Are so Many Patients Dissatisfied With Knee Replacement Surgery? Exploring Variations of the Patient Experience|Why Are so Many Patients Dissatisfied With Knee Replacement Surgery? Exploring Variations of the Patient Experience|Unknown status|Active, not recruiting|N/A|515|Actual|University of British Columbia|||1||f||||||||||||||2017-10-11 03:39:02.488652|2017-10-11 03:39:02.488652
NCT01466907|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2014-01-22|||February 2008||2008-02-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|||Secondary Prevention and Health Promotion After Stroke|Secondary Prevention and Health Promotion After Stroke A Nurse-led Randomized Controlled Open Trial|Completed||N/A|597|Actual|Skane University Hospital||2|||f||||f||||||||||2017-10-11 03:39:02.586024|2017-10-11 03:39:02.586024
NCT01466894|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-12-04|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis|A Randomized, Double-Blind, Placebo-Controlled Dosing, Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis|Withdrawn||Phase 2|0|Actual|Immuron Ltd.||3||Sponsor administrative decision|f||||f||||||||||2017-10-11 03:39:02.679691|2017-10-11 03:39:02.679691
NCT01466881|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2016-02-09|2016-02-09||October 2011||2011-10-01|January 2015|2015-01-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional||Only eligible patients were included in the analysis.|Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma|Phase II Trial of the Aurora Kinase A Inhibitor MLN8237, in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 03:39:02.810808|2017-10-11 03:39:02.810808
NCT01442948|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-09-28|||May 2007||2007-05-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|August 2009|Actual|2009-08-01||Observational|PHAMOS||CD16+ Monocytes in Coronary Heart Disease (CHD)|CD16+ Monocytes in Patients With Coronary Heart Disease|Completed||N/A|1000|Actual|Martin-Luther-Universität Halle-Wittenberg|||2||f||||f||||||||||2017-10-11 03:46:59.720885|2017-10-11 03:46:59.720885
NCT01466868|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2014-07-09|||November 2011||2011-11-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|AKTIL||Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma|A Phase II Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma|Terminated||Phase 2|22|Actual|Centre Leon Berard||1||Regarding the comments of the iDSMB, the sponsor decided to stop the inclusions|f||||t||||||||||2017-10-11 03:39:03.680818|2017-10-11 03:39:03.680818
NCT01466855|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-02-28|||October 2011||2011-10-01|February 2017|2017-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|IARB1||A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma|A Pilot Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma|Terminated||N/A|36|Actual|Children's Hospital Medical Center, Cincinnati||1||Competing studies|f||||t||||||||||2017-10-11 03:39:03.928961|2017-10-11 03:39:03.928961
NCT01466842|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-07|||January 2012||2012-01-01|November 2011|2011-11-01|January 2016|Anticipated|2016-01-01|January 2013|Anticipated|2013-01-01||Interventional|AFLIT-PAF||Ablation as First Line Treatment in Paroxysmal Atrial Fibrillation|Ablation as First Line Treatment in Paroxysmal Atrial Fibrillation|Unknown status|Not yet recruiting|N/A|160|Anticipated|Maastricht University Medical Center||2|||f||||||||||||||2017-10-11 03:39:04.005699|2017-10-11 03:39:04.005699
NCT01466829|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-05-30|||October 2012||2012-10-01|August 2013|2013-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|PAATH||Treatment With PTH After Sternotomy in Cardiac Surgery Patients|Clinical Effects of Parathyroid Hormone as Adjuvant Therapy for Bone Healing After Sternotomy.|Completed||Phase 3|20|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:39:04.089748|2017-10-11 03:39:04.089748
NCT01466816|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-11-03|||October 2008||2008-10-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Lipids and Insulin Sensitivity|Skeletal Muscle Lipid Metabolism and Insulin Sensitivity: Can Dietary Fatty Acid Composition Modulate Muscle Lipid Storage?|Completed||N/A|10|Actual|Maastricht University Medical Center||3|||f||||||||||||||2017-10-11 03:39:04.180598|2017-10-11 03:39:04.180598
NCT01466803|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2013-04-27|||October 2011||2011-10-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects|Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects|Completed||Phase 1|12|Actual|Turku University Hospital||2|||f||||||||||||||2017-10-11 03:39:04.259126|2017-10-11 03:39:04.259126
NCT01466790|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-01-26|2014-10-17||January 2012||2012-01-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|COSMOS||A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients|An Exploratory Phase IIa, Randomized, Open-Label Trial to Investigate the Efficacy and Safety of 12 Weeks or 24 Weeks of TMC435 in Combination With PSI-7977 (GS7977) With Or Without Ribavirin in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Subjects|Completed||Phase 2|168|Actual|Janssen R&D Ireland||4|||f||||t||||||||||2017-10-11 03:39:04.362231|2017-10-11 03:39:04.362231
NCT01466777|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2016-03-23|||November 2010||2010-11-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy|Robotic-assisted vs. Traditional Laparoscopic Surgery in Treatment of Endometrial Cancer Patients|Unknown status|Active, not recruiting|N/A|100|Anticipated|Tampere University Hospital||2|||f||||f||||||||||2017-10-11 03:39:05.510575|2017-10-11 03:39:05.510575
NCT01466764|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-07-10|2017-06-06||October 2011||2011-10-01|July 2017|2017-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain|Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain|Terminated||N/A|13|Actual|Stanford University|The trial terminated early. We did not expect to see an effect in such a small number of subjects.|2||Due to inability to demonstrate benefit in this patient population.|f||||t||||||||||2017-10-11 03:39:05.613687|2017-10-11 03:39:05.613687
NCT01466738|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2012-02-20|||September 2011||2011-09-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of Human Rhinovirus Type 16 (HRV-16) Following Administration in the Nose of Healthy Adult Volunteers|Clinical Characterization of a Human Rhinovirus Type 16 Challenge Pool Following Intranasal Administration to Healthy Adult Subjects|Completed||Phase 1|52|Actual|Centocor Ortho Biotech Services, L.L.C.||2|||f||||||||||||||2017-10-11 03:39:06.065211|2017-10-11 03:39:06.065211
NCT01466725|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2016-05-02||2013-08-16|November 2011||2011-11-01|May 2016|2016-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus|A Phase 2, Pilot, Multicenter, Randomized, Placebo-Controlled Sequential, Ascending Dose Study to Characterize the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Activity of CC-930 in Subjects With Recalcitrant Discoid Lupus Erythematosus (DLE)|Terminated||Phase 2|5|Actual|Celgene Corporation||4||The benefit/risk profile does not support continuation of this study.|f||||t||||||||||2017-10-11 03:39:06.144805|2017-10-11 03:39:06.144805
NCT01466712|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2013-07-29|||November 2011||2011-11-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways Function|Randomized Double-blind Placebo-controlled Crossover Study to Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways Function in COPD Patients.|Unknown status|Enrolling by invitation|Phase 4|20|Anticipated|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 03:39:06.26208|2017-10-11 03:39:06.26208
NCT01466699|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2011-11-07|||January 2012||2012-01-01|November 2011|2011-11-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Observational|||The Study of Blood Pressure Variability to Impact Arterial Stiffness and Carotid Atherosclerosis|The Relationship of Blood Pressure Variability, Arterial Stiffness and Carotid Atherosclerosis in Beijing Residents|Unknown status|Enrolling by invitation|N/A|1235|Anticipated|Capital Medical University|||1||f||||t||||||||||2017-10-11 03:39:06.351808|2017-10-11 03:39:06.351808
NCT01466686|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-10-05|||September 2012||2012-09-01|October 2017|2017-10-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Low Dose Radiation Therapy for Glioblastoma Multiforme|A Phase II Trial of Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Salvage Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma Multiforme|Recruiting||Phase 2|49|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:39:06.401688|2017-10-11 03:39:06.401688
NCT01466673|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-06-14|2013-02-22||December 2008||2008-12-01|June 2013|2013-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment|Comparative Study of the Effect on Acne With Norgestimate Containing Triphasic Oral Contraceptive and Biphasic Preparation Containing Desogestrel|Completed||Phase 4|201|Actual|Janssen-Cilag Ltd.,Thailand||2|||f||||f||||||||||2017-10-11 03:39:06.534419|2017-10-11 03:39:06.534419
NCT01466660|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-04|2017-07-07|2017-04-04||December 13, 2011|Actual|2011-12-13|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|April 8, 2016|Actual|2016-04-08||Interventional||Randomised set which included all patients randomised to receive treatment, whether treated or not.|LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung|LUX-Lung 7: A Randomised, Open-label Phase IIb Trial of Afatinib Versus Gefitinib as First-line Treatment of Patients With EGFR Mutation Positive Advanced Adenocarcinoma of the Lung|Active, not recruiting||Phase 2|319|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:39:07.238089|2017-10-11 03:39:07.238089
NCT01466647|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2012-11-09|||January 2011||2011-01-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)|A Phase I Pilot Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Squamous Non-small-cell Lung Cancer|Completed||Phase 1|12|Actual|Axelar AB||1|||f||||t||||||||||2017-10-11 03:39:08.731495|2017-10-11 03:39:08.731495
NCT01466634|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-11-04|||August 2011||2011-08-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Observational|||Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis|Bioabsorbable Versus Permanent Polymer Bare Metal Stents in Saphenous Vein Graft Disease: Insights From a Meta-analysis of 6221 Patients|Completed||N/A|6221|Actual|Azienda Ospedaliero Universitaria Maggiore della Carita|||2||f||||f||||||||||2017-10-11 03:39:08.813133|2017-10-11 03:39:08.813133
NCT01466621|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2016-02-23|||October 2011||2011-10-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients|Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients|Completed||N/A|743|Actual|Allina Health System|||2||f||||f||||||||||2017-10-11 03:39:08.907053|2017-10-11 03:39:08.907053
NCT01466608|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2014-05-15|||November 2011||2011-11-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Interventional|||Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients|Lipid Lowering Effect, and Lipidomic Profiles by Genotype of OATP1B1 and BCRP After Administration of Rosuvastatin in Patients With Hyperlipidemia|Completed||Phase 4|21|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 03:39:08.98328|2017-10-11 03:39:08.98328
NCT01466595|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-11-08|2013-09-03||September 2011||2011-09-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Rifaximin as a Modulator of Microbial Translocation and Immune Activation|A Pilot Study of Rifaximin as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Individuals With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy|Completed||Phase 2|73|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 03:39:09.115516|2017-10-11 03:39:09.115516
NCT01466582|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-01-04|||October 2010||2010-10-01|January 2016|2016-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|agehIV||Comorbidity and Aging With HIV|Comorbidity and Aging With HIV, the agehIV Cohort Study|Completed||N/A|1148|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||2||f||||f||||||Samples With DNA|"     whole blood, serum (EDTA/heparin/citrate), PBMCs, urine   "|||2017-10-11 03:39:10.357506|2017-10-11 03:39:10.357506
NCT01466569|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-06-22|||November 2011||2011-11-01|June 2015|2015-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors|A Phase 1 A/B Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AbGn-7 Therapy Alone and in Combination With the FOLFOX7 Treatment Regimen in Patients With Advanced Solid Tumors|Completed||Phase 1|13|Actual|AbGenomics B.V Taiwan Branch||5|||f||||f||||||||||2017-10-11 03:39:10.440039|2017-10-11 03:39:10.440039
NCT01466556|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-07|||November 2011||2011-11-01|November 2011|2011-11-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||The Incidence of Metabolic Syndrome Among Obese Children in Our Region||Unknown status|Recruiting|N/A|70|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 03:39:10.534516|2017-10-11 03:39:10.534516
NCT01466543|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2011-11-07|||November 2011||2011-11-01|November 2011|2011-11-01|November 2012|Anticipated|2012-11-01|March 2012|Anticipated|2012-03-01||Interventional|SMCZN01||Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity|Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity in Normal and Subcortical Vascular Cognitive Impairment Subjects|Unknown status|Not yet recruiting|Phase 2|80|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 03:39:10.616958|2017-10-11 03:39:10.616958
NCT01466530|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2011-11-06|||January 2006||2006-01-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Sublingual Misoprostol & Isoflurane During Caesarean Section|Effects of Preoperative Sublingual Misoprostol on Uterine Tone During Isoflurane Anaesthesia for Caesarean Section|Completed||Phase 2|366|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 03:39:10.741427|2017-10-11 03:39:10.741427
NCT01466517|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-02-07|||November 2011||2011-11-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|B4371005||A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.|A Phase IV, Open Label, Randomized, Two-Way Crossover, Single Dose Study To Determine The Relative Bioavailability Of Ibupirac 40 mg/ml (Laboratorios Pfizer LTDA) Oral Suspension Form Versus Alivium® 50mg/ml (Mantecorp Industria Quimicae Farmaceutica LTDA.) Oral Suspension Form, Under Fasted Conditions In Healthy Volunteers.|Completed||Phase 4|70|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:39:10.843828|2017-10-11 03:39:10.843828
NCT01466504|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2013-04-11|||May 2011||2011-05-01|March 2013|2013-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin|A Study of the Effect of Sorafenib or Regorafenib on p63 Expression and Keratinocyte Differentiation in Human Skin|Terminated||N/A|4|Actual|Dartmouth-Hitchcock Medical Center|||1|"Accrual did not meet expectations. Over nearly 2 years just 4 subjects were treated on study.   The goal of 30 subjects was not attainable."|f||||t||||||Samples Without DNA|"     skin biopsies will be performed using a 4mm biopsy punch. Participants will undero 2 skin     biopsies - one prior to starting sorafenib or regorafenib, the other once rash develops. If a     rash does not develop within 84 days a biopsy of normal skin will be done.   "|||2017-10-11 03:39:10.928255|2017-10-11 03:39:10.928255
NCT01466491|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-06-26|2017-06-26||October 2011||2011-10-01|June 2017|2017-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion|Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion|Completed||Phase 4|282|Actual|Oregon Health and Science University||4|||f||||f||||||||||2017-10-11 03:39:11.009428|2017-10-11 03:39:11.009428
NCT01466478|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-10-24|||November 2011||2011-11-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris|A Phase I Exploratory Study Evaluating 3 Formulations of LEO 29102 Plus Calcipotriol, Ointment, LEO 29102 Ointment, Calcipotriol Ointment, Daivonex® Ointment and Diprosone® Ointment in the Treatment of Psoriasis|Completed||Phase 1|24|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-11 03:39:11.410967|2017-10-11 03:39:11.410967
NCT01466465|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2015-06-24|||October 2011||2011-10-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Vitamin D and Grass Pollen Specific Immunotherapy||Completed||Phase 2|35|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:39:11.493898|2017-10-11 03:39:11.493898
NCT01466452|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2011-11-07|||September 2011||2011-09-01|November 2011|2011-11-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|ASABYVALV||Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery||Unknown status|Recruiting|Phase 2|99|Anticipated|Centro Cardiologico Monzino||3|||f||||f||||||||||2017-10-11 03:39:11.657473|2017-10-11 03:39:11.657473
NCT01466439|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2013-06-07|||May 2011||2011-05-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Interventional|rTMS-P50||Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component|Evaluation of Effect of Low and High-frequencies of Repetitive Transcranial Magnetic Stimulation (rTMS) by the Suppression of P50 Evoked Potential Component (rTMS-P50)|Completed||Phase 2|30|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-10-11 03:39:11.832332|2017-10-11 03:39:11.832332
NCT01466426|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-10-26|||November 2011||2011-11-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|PETVET||The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study)|The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders|Completed||N/A|40|Actual|Odense University Hospital|||4||f||||f||||||||||2017-10-11 03:39:11.922908|2017-10-11 03:39:11.922908
NCT01466413|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2012-10-11|||September 2011||2011-09-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Two Formulations of ELAPR Compared to Restylane® Vital Light Following Repeat Implants in the Upper Arm Dermis|A Phase 1B Study to Assess the Safety and Efficacy of Two Formulations of ELAPR Compared to Restylane® Vital Light Following Repeat Implants in the Upper Arm Dermis|Completed||Phase 1|16|Actual|Elastagen Pty Ltd||1|||f||||f||||||||||2017-10-11 03:39:12.027123|2017-10-11 03:39:12.027123
NCT01466400|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-07-21|||November 2011||2011-11-01|July 2015|2015-07-01|August 2013|Actual|2013-08-01|November 2012|Actual|2012-11-01||Observational|||Fermentation Rate of Infant Formula||Completed||N/A|13|Actual|Boys Town National Research Hospital|||1||f||||f||||||||||2017-10-11 03:39:12.12986|2017-10-11 03:39:12.12986
NCT01466374|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2015-09-23||2015-09-23|December 2011||2011-12-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease|A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease|Completed||Phase 2|121|Actual|Bristol-Myers Squibb||7|||f||||t||||||||||2017-10-11 03:39:13.401209|2017-10-11 03:39:13.401209
NCT01466361|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2012-11-08|2012-08-23||September 2010||2010-09-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving|Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving|Completed||Phase 2|187|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:39:13.723916|2017-10-11 03:39:13.723916
NCT01466348|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2013-09-25|2013-06-27||February 2011||2011-02-01|September 2013|2013-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Effects of a Common Cold Treatment on Cognitive Function|Effects of a Common Cold Treatment on Cognitive Function|Completed||Phase 4|72|Actual|GlaxoSmithKline|Apparent carryover effect from the paracetamol/ caffeine treatment taken in Period 1 into the baseline assessment of Period 2 was observed, hence the statistical analysis was amended after unblinding the statistician.|2|||f||||f||||||||||2017-10-11 03:39:14.244302|2017-10-11 03:39:14.244302
NCT01466335|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-06-19|||October 27, 2011|Actual|2011-10-27|June 2017|2017-06-01|March 5, 2012|Actual|2012-03-05|March 5, 2012|Actual|2012-03-05||Interventional|||An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers|A Randomized, Double Blind, Parallel Group, Single Center, Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret; a Calcium Sensing Receptor Antagonist) for Durations Not to Exceed 28 Days, Versusplacebo in Healthy Human Volunteers.|Completed||Phase 1|39|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-10-11 03:39:14.672295|2017-10-11 03:39:14.672295
NCT01466322|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2017-07-05|||December 22, 2010|Actual|2010-12-22|July 2017|2017-07-01|February 15, 2011|Actual|2011-02-15|February 15, 2011|Actual|2011-02-15||Interventional|P1A114919||A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.|An Open-label, Randomised, Crossover Study to Assess the Relative Bioavailability of Different 2mg Formulations of GSK2018682(S1P1 Agonist) in Healthy Volunteers|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:39:14.770024|2017-10-11 03:39:14.770024
NCT01466309|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2011-11-06|||July 2011||2011-07-01|November 2011|2011-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|ThaiSomnoguard||Efficacy of Adjustable Thermoplastic Oral Appliances in Patient With OSA|The Efficacy of Adjustable Thermoplastic Oral Appliances in Thai Patient With OSA|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Mahidol University||1|||f||||f||||||||||2017-10-11 03:39:14.883388|2017-10-11 03:39:14.883388
NCT01466296|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2011-11-03|||October 2010||2010-10-01|November 2011|2011-11-01|April 2012|Anticipated|2012-04-01|April 2011|Actual|2011-04-01||Interventional|MESF||"The Middle East Stepping Forward Project (MESF)"|Improving Treatment of People With Movement Disorders in the Middle East|Unknown status|Recruiting|Phase 2|120|Anticipated|Assaf-Harofeh Medical Center||3|||f||||t||||||||||2017-10-11 03:39:15.003416|2017-10-11 03:39:15.003416
NCT01466283|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2016-05-17|||October 2011||2011-10-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Biomarkers in Patients With Rhabdomyosarcoma|Integrative Epigenomic Approach to Gene Discovery in Rhabdomyosarcoma (RMS)|Completed||N/A|20|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:39:15.226896|2017-10-11 03:39:15.226896
NCT01466270|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-07-28|2014-12-31||April 2012||2012-04-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||All randomized patients.|Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction|A Feasibility Study of Donepezil in Female Breast Cancer Survivors With Self-Reported Cognitive Dysfunction Following Chemotherapy|Completed||Phase 2|62|Actual|Wake Forest University Health Sciences||2|||f||||t|t|f|||f|||||2017-10-11 03:39:15.308316|2017-10-11 03:39:15.308316
NCT01466257|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-05-17|||November 21, 2011|Actual|2011-11-21|May 2017|2017-05-01|January 1, 2012|Actual|2012-01-01|January 1, 2012|Actual|2012-01-01||Observational|||Biomarkers in Patients With Head and Neck Cancer|Detection of DNA Mutations in Head and Neck Squamous Cell Carcinoma|Completed||N/A|70|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 03:39:15.755353|2017-10-11 03:39:15.755353
NCT01466244|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-05-16|||November 11, 2011|Actual|2011-11-11|May 2017|2017-05-01|January 11, 2012|Actual|2012-01-11|January 11, 2012|Actual|2012-01-11||Observational|||Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397|PTEN Determination in Squamous Cell Cancer of The Head and Neck Treated on E5397, A Randomized Phase III Trial of Cisplatin Plus Placebo Versus Cisplatin Plus C225 (Cetuximab) in Metastatic/Recurrent Head and Neck Cancer|Completed||N/A|42|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 03:39:15.855318|2017-10-11 03:39:15.855318
NCT01466231|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-01-11|||November 2011||2011-11-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Everolimus in Refractory Testicular Germ Cell Cancer|Phase II Study of Everolimus in Refractory Testicular Germ Cell Cancer.|Completed||Phase 2|15|Actual|National Cancer Institute, Slovakia||1|||f||||t||||||||||2017-10-11 03:39:15.946028|2017-10-11 03:39:15.946028
NCT01466218|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2014-06-27|||November 2011||2011-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||World Trade Center (WTC) CHEST|Pulmonary Abnormalities, Diastolic Dysfunction, and World Trade Center Exposure: Implications for Diagnosis and Treatment|Completed||N/A|1012|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||||||2017-10-11 03:39:16.046936|2017-10-11 03:39:16.046936
NCT01466205|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-07-19|||January 2011||2011-01-01|July 2012|2012-07-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|SPD||Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder|Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder|Unknown status|Recruiting|Phase 2|20|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 03:39:16.143723|2017-10-11 03:39:16.143723
NCT01466192|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2014-10-29|2014-10-29||May 2012||2012-05-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients|A Phase 3 Study of MP-424 in Combination With Peginterferon Alfa-2b and Ribavirin in Subjects With Genotype 2 Hepatitis C, Who Relapsed After Previous Treatment|Completed||Phase 3|108|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-10-11 03:39:16.260352|2017-10-11 03:39:16.260352
NCT01466179|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-07-18|2014-12-21||December 2011||2011-12-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|October 2013|Actual|2013-10-01||Interventional||Primary Analysis Set|Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)|An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE® Antibody Blinatumomab in Adult Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2|225|Actual|Amgen Research (Munich) GmbH||1|||f||||t||||||||||2017-10-11 03:39:18.092913|2017-10-11 03:39:18.092913
NCT01466166|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-07-17|||November 15, 2011|Actual|2011-11-15|July 2017|2017-07-01|June 30, 2017|Actual|2017-06-30|June 30, 2017|Actual|2017-06-30||Observational|EyesOnGOUT||Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout|Observational Study of the Use of KRYSTEXXA® (Pegloticase)in Adult Hyperuricemic Patients With Gout Refractory to Conventional Therapy|Completed||N/A|187|Actual|Horizon Pharma Rheumatology LLC|||1||f||||f||||||Samples Without DNA|"     Serum samples   "|||2017-10-11 03:39:19.327132|2017-10-11 03:39:19.327132
NCT01466153|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-04-20|2017-04-20||February 7, 2012||2012-02-07|April 2017|2017-04-01|January 8, 2016|Actual|2016-01-08|January 8, 2016|Actual|2016-01-08||Interventional||Intent-to-treat (ITT) Population includes all participants who were randomized into the study.|A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)|A Phase 2 Open-label Study of MEDI-551 and Bendamustine vs Rituximab and Bendamustine in Adults With Relapsed or Refractory CLL|Completed||Phase 2|183|Actual|MedImmune LLC||3|||f||||t||||||||||2017-10-11 03:39:19.584629|2017-10-11 03:39:19.584629
NCT01466140|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2011-11-04|||January 2011||2011-01-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||Effects of Writing Down the Request for Help on Patient Satisfaction in General Practices|Effects of Writing Down the Request for Help With Regard to Patient Satisfaction in General Practices|Completed||N/A|209|Actual|Medical Research Foundation, The Netherlands||2|||f||||f||||||||||2017-10-11 03:39:21.358234|2017-10-11 03:39:21.358234
NCT01466127|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-03-03|2016-11-04||October 2011||2011-10-01|March 2017|2017-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Although 60 participants were enrolled, only 30 participants had usable physiological data from recording electrodes, and therefore, the only data analyzed were from these 30 participants (16 placebo and 14 oxytocin).|The Effect of Oxytocin on Fear Memory Consolidation Novel Intervention to Prevent Posttraumatic Stress Disorder (PTSD)|The Effect of Oxytocin on Fear Memory Consolidation: A Novel Intervention to Prevent PTSD|Completed||N/A|60|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:39:21.428539|2017-10-11 03:39:21.428539
NCT01466114|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-04-19|||October 2011||2011-10-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|November 2018|Anticipated|2018-11-01||Interventional|||Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition|A Double-Blind, Placebo Controlled Trial of Estriol Treatment in Women With Multiple Sclerosis: Effect on Cognition.|Recruiting||Phase 2|64|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 03:39:21.659027|2017-10-11 03:39:21.659027
NCT01466101|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-20|2012-02-17|||January 2011||2011-01-01|February 2012|2012-02-01||||||||Interventional|||Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy|Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy|Withdrawn||N/A|0|Actual|Northwestern University||2||PI left the institution. No subjects screened or enrolled.|f||||f||||||||||2017-10-11 03:39:21.769992|2017-10-11 03:39:21.769992
NCT01466088|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-05-11||2015-05-11|October 2011||2011-10-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)|Double-Blind, Positive Comparator, Randomized, Parallel Study of Efficacy, Safety, and Tolerability of AZD3480 (TC-1734-226) as Monotherapy in Patients With Mild to Moderate Dementia of the Alzheimer's Type|Completed||Phase 2|386|Actual|Targacept Inc.||2|||f||||f||||||||||2017-10-11 03:39:21.846333|2017-10-11 03:39:21.846333
NCT01466075|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-01-29|2012-12-21||November 2011||2011-11-01|January 2016|2016-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study of an Investigational Glucose Meter System|Clinical Study of the Apollo Evolution BGMS With Tatsu Blood Glucose Test Strips|Completed||N/A|207|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 03:39:22.16052|2017-10-11 03:39:22.16052
NCT01466062|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2013-06-13|2013-04-25||August 2011||2011-08-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions|Multi-center, Open-label, Uncontrolled Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions|Completed||Phase 3|28|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 03:39:22.381785|2017-10-11 03:39:22.381785
NCT01466049|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-03|2014-08-04|||December 2011||2011-12-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||New Biomarkers Evaluating Ovarian Cancer|Evaluation of New Biomarker Assays in Ovarian Cancer Patients Presenting to a Generalist With an Adnexal Mass|Completed||N/A|280|Actual|Fujirebio Diagnostics, Inc.|||1||f||||t||||||||||2017-10-11 03:39:23.008293|2017-10-11 03:39:23.008293
NCT01466036|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-04-14|||July 2012||2012-07-01|April 2017|2017-04-01|April 2022|Anticipated|2022-04-01|October 2018|Anticipated|2018-10-01||Interventional|||Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors|An Open-Label, Phase II Study of Cabozantinib (XL184) in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors|Active, not recruiting||Phase 2|62|Actual|Massachusetts General Hospital||2|||f||||t||||||||No||2017-10-11 03:39:23.069761|2017-10-11 03:39:23.069761
NCT01466023|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-05-02|||October 2011|Actual|2011-10-01|July 2011|2011-07-01|April 2016|Actual|2016-04-01|April 2014|Actual|2014-04-01||Observational|||The Reduced Thyroid Function of the Premature Newborn: Relation With Molecular Changes in the Placenta and Maternal Thyroid Hormone Status and Neurodevelopmental Implications|The Reduced Thyroid Function of the Premature Newborn: Relation With Molecular Changes in the Placenta and Maternal Thyroid Hormone Status and Neurodevelopmental Implications|Completed||N/A|319|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples With DNA|"     Placenta and blood samples   "|||2017-10-11 03:39:23.17494|2017-10-11 03:39:23.17494
NCT01466010|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2011-11-04|||January 1998||1998-01-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|||||Observational|||Treatment Outcome After Surgical Treatment of Osteoid Osteoma|Treatment Outcome After Surgical Treatment of Osteoid Osteoma, a Retrospective Study|Completed||N/A|150|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||||||2017-10-11 03:39:23.236035|2017-10-11 03:39:23.236035
NCT01465984|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-12-06|||November 2011||2011-11-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy of Intravenous (IV) Paracetamol for Treatment of Acute Pain|Comparison of IV Paracetamol With Intravenous Morphine Sulfate in Treatment of Acute Pain Due to Limb Trauma|Completed||Phase 4|60|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:39:24.460478|2017-10-11 03:39:24.460478
NCT01465971|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2012-04-04|||May 2011||2011-05-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|PerOxySleep||Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude|Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During the Sleep in High Altitude|Completed||N/A|6|Actual|Goethe University|||2||f||||f||||||||||2017-10-11 03:39:24.552797|2017-10-11 03:39:24.552797
NCT01465789|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2013-08-05|||July 2011||2011-07-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Observational|||Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children|Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children|Terminated||N/A|33|Actual|West Virginia School of Osteopathic Medicine|||1|Loss of participants to follow-up|f||||f||||||Samples Without DNA|"     saliva   "|||2017-10-11 03:39:29.816583|2017-10-11 03:39:29.816583
NCT01465958|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-02-23|2015-01-19||November 2011||2011-11-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|KIDS|All 12 enrolled subjects who were infused with any amount of study drug (GAMUNEX-C) were included in the safety population. The demographic data of the safety population are provided.|Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency|An Open-label, Single-sequence, Crossover Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Subcutaneous GAMUNEX®-C in Pediatric Subjects With Primary Immunodeficiency|Completed||Phase 4|12|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 03:39:24.667231|2017-10-11 03:39:24.667231
NCT01465945|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2014-07-19|||March 2012||2012-03-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study of Unsutured Versus Sutured Closure of Rectal Defects After Rectal Lesion Excisions Using Transanal Endoscopic Microsurgery|A Randomized Clinical Trial of Open Versus Suture Closure in Patients With Rectal Lesions Excised Using Transanal Endoscopic Microsurgery|Completed||N/A|50|Actual|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 03:39:25.065146|2017-10-11 03:39:25.065146
NCT01465932|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2011-11-04|||July 2010||2010-07-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Effectiveness of Physical Therapy Program to Treat Rotator Cuff Disorders Among Nursing Professionals|Evaluation of the Effectiveness of Physical Therapy Program to Treat Rotator Cuff Disorders Among Nursing Professionals According to Indicators of Quality of Life and Job Satisfaction|Completed||N/A|16|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:39:25.16187|2017-10-11 03:39:25.16187
NCT01465919|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-04-27|||August 2011||2011-08-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C|Phase 4 Open-labeled Study to Compare the Anti-depressive Efficacy Between Mirtazapine and Psychotherapy for Patients With Interferon-related Depression During Antiviral Therapy for Hepatitis C|Terminated||Phase 4|5|Actual|Seoul National University Boramae Hospital||2||Due to the recent change in standard of care for hepatitis C.|f||||f||||||||Undecided||2017-10-11 03:39:25.249124|2017-10-11 03:39:25.249124
NCT01465906|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2011-11-08|||November 2010||2010-11-01|November 2011|2011-11-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|||Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease||Unknown status|Active, not recruiting|Phase 4|160|Anticipated|Shanghai Zhongshan Hospital||2|||f||||t||||||||||2017-10-11 03:39:25.354221|2017-10-11 03:39:25.354221
NCT01465893|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2011-11-21|||July 2011||2011-07-01|November 2011|2011-11-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|||Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography|The Investigation Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography|Unknown status|Recruiting|Phase 2|60|Anticipated|Isfahan University of Medical Sciences||2|||f||||||||||||||2017-10-11 03:39:25.455921|2017-10-11 03:39:25.455921
NCT01465880|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2011-12-20|||July 2011||2011-07-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Smoking Research Study|A Single-centre, Dose Titration Study in Healthy Volunteers (Smokers and Non-smokers) to Evaluate the Capacity of 2-cyanoethylmercapturic Acid (CEMA) to Detect Low Level of Cigarette Smoking Exposure|Completed||N/A|88|Actual|Philip Morris Products S.A.||2|||f||||f||||||||||2017-10-11 03:39:25.548929|2017-10-11 03:39:25.548929
NCT01465867|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2014-10-25|||April 2012||2012-04-01|October 2014|2014-10-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|Serena||Selenium Supplementation in Pregnancy|Selenium Supplementation Treatment in Euthyroid Pregnant Women With Autoimmune Thyroid Disease: Effects on Obstetrical Complications|Unknown status|Recruiting|Phase 4|150|Anticipated|University of Roma La Sapienza||4|||f||||t||||||||||2017-10-11 03:39:25.628086|2017-10-11 03:39:25.628086
NCT01465854|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-09-28|||November 2011||2011-11-01|September 2017|2017-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|BioCAST||French Biological Observatory on Lung Cancer in Never Smokers|French Biological Observatory on Lung Cancer in Never Smokers|Completed||N/A|422|Actual|Intergroupe Francophone de Cancerologie Thoracique|||1||f||||f||||||Samples With DNA|"     whole blood, serum, plama, white cells   "|||2017-10-11 03:39:25.793263|2017-10-11 03:39:25.793263
NCT01465841|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-09-26|||November 2011||2011-11-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|ACE||Study of the Penumbra Coil 400 System to Treat Aneurysm|ACE: An Aneurysm Coiling Efficiency Study of the Penumbra Coil 400 System|Active, not recruiting||Phase 4|2000|Anticipated|Penumbra Inc.||1|||f||||f||||||||||2017-10-11 03:39:26.002016|2017-10-11 03:39:26.002016
NCT01465815|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2014-11-17|||December 2011||2011-12-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)|Phase I/II Study of Postoperative Adjuvant Chemoradiation for cSCCHN|Withdrawn||Phase 1/Phase 2|0|Actual|OHSU Knight Cancer Institute||3||"Drug manufacturer, Astellas Pharma, informed us that safety and efficacy of Erlotinib and   OSI-906 in other oncology studies was determined to be unfavorable."|f||||t||||||||||2017-10-11 03:39:26.169374|2017-10-11 03:39:26.169374
NCT01465802|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2016-07-07|2016-04-15|2015-12-14|December 2011||2011-12-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ARCHER 1042|As Treated Population - included all participants who received at least 1 dose of study treatment assigned at enrollment.|Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO|Archer 1042: A Phase 2 Study Of Dacomitinib In Advanced Non-Small Cell Lung Cancer (Post-Chemotherapy Or Select First Line Patients) To Evaluate Prophylactic Intervention On Dermatologic And Gastrointestinal Adverse Events And Patient Reported Outcomes|Completed||Phase 2|236|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:39:26.482556|2017-10-11 03:39:26.482556
NCT01465776|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-10-04|||January 10, 2005|Actual|2005-01-10|October 2017|2017-10-01|December 31, 2017|Anticipated|2017-12-31|February 16, 2010|Actual|2010-02-16||Interventional|||Freeze-Dried Black Raspberries in Treating Patients With Oral Squamous Cell Cancer Undergoing Surgery|A Phase 1b Pilot Study Evaluating Oral Administration of Freeze-Dried Black Raspberries in Pre-Surgical Patients With Oral Squamous Cell Carcinoma|Active, not recruiting||N/A|38|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:39:29.899253|2017-10-11 03:39:29.899253
NCT01465763|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-05-01|2016-05-01||April 2012||2012-04-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|OCTAVE|The safety analysis set consists of all randomized participants who received at least 1 dose of study medication.|A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis|A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis|Completed||Phase 3|614|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 03:39:30.053406|2017-10-11 03:39:30.053406
NCT01465750|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2011-11-02|||April 2011||2011-04-01|April 2011|2011-04-01|April 2014|Anticipated|2014-04-01|April 2012|Anticipated|2012-04-01||Observational|||Epidemiology of Ovarian Cancer in Taiwan|Epidemiology of Ovarian Cancer in Taiwan|Unknown status|Recruiting|N/A|10000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 03:39:31.433504|2017-10-11 03:39:31.433504
NCT01465737|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2011-11-02|||April 2011||2011-04-01|November 2011|2011-11-01|April 2013|Anticipated|2013-04-01|April 2012|Anticipated|2012-04-01||Observational|||Epidemiology of Uterine Cancer in Taiwan|Importance of Cohort and Histologic Type for Secular Trends in Rising Incidence and Different Survival of Uterine Cancer -a Taiwan Population-based Registry From 1979 to 2008|Unknown status|Recruiting|N/A|10000|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 03:39:31.509724|2017-10-11 03:39:31.509724
NCT01465724|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2014-12-28|||November 2011||2011-11-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|DREAMS||Denervation of the REnal Artery in Metabolic Syndrome|Sympathetic Denervation of the Renal Artery for the Treatment of Obesity-related Hypertension and Insulin Resistance|Completed||Phase 3|29|Actual|UMC Utrecht||1|||f||||f||||||||||2017-10-11 03:39:31.589121|2017-10-11 03:39:31.589121
NCT01465711|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2014-12-02|||July 2007||2007-07-01|November 2011|2011-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||The Value of PSP in Predicting Outcome in ICU Surgical Peritonitis Patients|Diagnostic Accuracy of Pancreatic Stone Protein in Predicting Severe Outcome in Patients With Peritonitis at the Intensive Care Unit|Completed||N/A|137|Actual|University of Magdeburg|||2||f||||t||||||Samples Without DNA|"     Whole blood, serum, plasma   "|||2017-10-11 03:39:31.695298|2017-10-11 03:39:31.695298
NCT01465698|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-01-21|||November 2011||2011-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|NURSE-RCT||Prevention of Chronic Low Back Pain in Female Nurses|Effectiveness and Financial Feasibility of Neuromuscular Exercise and Counselling Interventions on Pain, Movement Dysfunction, and Fear-avoidance Behaviour in Female Nurses With Non-specific Low Back Pain|Completed||N/A|219|Actual|UKK Institute||4|||f||||f||||||||No||2017-10-11 03:39:31.797529|2017-10-11 03:39:31.797529
NCT01465685|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-01-20|||December 2011||2011-12-01|January 2016|2016-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Emotional Effects of Methylphenidate and MDMA in Healthy Subjects|Emotional Effects of Methylphenidate and MDMA in Healthy Subjects|Completed||Phase 1|16|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 03:39:31.922676|2017-10-11 03:39:31.922676
NCT01465672|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2014-05-19|||October 2011||2011-10-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis|Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis|Completed||N/A|125|Actual|University Hospital, Basel, Switzerland|||1||f||||t||||||||||2017-10-11 03:39:32.037658|2017-10-11 03:39:32.037658
NCT01465659|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-10-10|||November 2011||2011-11-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery|A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET)|Recruiting||Phase 1/Phase 2|39|Anticipated|Northwestern University||5|||f||||t||||||||||2017-10-11 03:39:32.148358|2017-10-11 03:39:32.148358
NCT01465646|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2011-11-04|||June 2003||2003-06-01|November 2011|2011-11-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 100 μg/ 75 μg Tablets||Completed||Phase 1|24|Actual|Heidelberg University||2|||f||||f||||||||||2017-10-11 03:39:32.337748|2017-10-11 03:39:32.337748
NCT01465633|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2011-11-04|||August 2003||2003-08-01|November 2011|2011-11-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets|Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets|Completed||Phase 1|24|Actual|Heidelberg University||2|||f||||f||||||||||2017-10-11 03:39:32.414746|2017-10-11 03:39:32.414746
NCT01465620|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-02-18|||November 2011||2011-11-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study|Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study|Recruiting||N/A|40|Anticipated|Henri Mondor University Hospital||2|||f||||f||||||||||2017-10-11 03:39:32.505013|2017-10-11 03:39:32.505013
NCT01465607|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-05-26|||November 2011||2011-11-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Implementation of an Efficacious Intervention for High Risk Women in Mexico|Implementation of an Efficacious Intervention for High Risk Women in Mexico|Completed||N/A|1228|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 03:39:32.624518|2017-10-11 03:39:32.624518
NCT01465594|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-05-19|||November 2011||2011-11-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study Comparing Urinary Diversion (Transurethral/Suprapubic) After Radical Prostatectomy|Randomized Study Comparing Urinary Diversion by Suprapubic Catheter With Transurethral Catheter in Patients After Radical Prostatectomy|Completed||N/A|106|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 03:39:32.73972|2017-10-11 03:39:32.73972
NCT01465581|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2015-04-16|||July 2011||2011-07-01|November 2011|2011-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|NICNOC||Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale|A Prospective Trial of Division of the Filum Terminale for Neurogenic Bladder Dysfunction With a Normal Conus|Terminated||N/A|5|Actual|Nemours Children's Clinic|||1|Insufficient patient accrual.|f||||f||||||||||2017-10-11 03:39:32.834159|2017-10-11 03:39:32.834159
NCT01465568|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2015-05-11|||December 2011||2011-12-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis|Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis: a Randomized Controlled Trial|Completed||Phase 4|40|Actual|Tuen Mun Hospital||2|||f||||t||||||||||2017-10-11 03:39:32.908809|2017-10-11 03:39:32.908809
NCT01465555|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-04-15|||January 2010||2010-01-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Evaluation of Web-Based Recovery Monitoring With Clinical Alerts|Evaluation of Web-Based Recovery Monitoring With Clinical Alerts|Completed||Phase 1/Phase 2|389|Actual|Treatment Research Institute||2|||f||||t||||||||||2017-10-11 03:39:33.003245|2017-10-11 03:39:33.003245
NCT01465542|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-09-07|||June 2011||2011-06-01|September 2017|2017-09-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Observational|||Treatment of APAP Toxicity With IV and Oral NAC 2008-2011|Treatment of Acetaminophen Toxicity With Intravenous vs. Oral N-acetylcysteine: A Retrospective Review|Completed||N/A|47|Actual|Akron Children's Hospital|||2||f||||f||||||||||2017-10-11 03:39:33.343017|2017-10-11 03:39:33.343017
NCT01465529|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-01-13|||May 2011||2011-05-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|OligoG||A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis|A Double-blind, Randomized, Placebo-controlled, Cross-over Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Alginate Oligosaccharide (OligoG) Administered for 28 Days in Subjects With Cystic Fibrosis Chronically Colonised With Pseudomonas Aeruginosa|Completed||Phase 1/Phase 2|26|Actual|AlgiPharma AS||2|||f||||t||||||||||2017-10-11 03:39:33.420735|2017-10-11 03:39:33.420735
NCT01465503|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-04-06|||January 2008||2008-01-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|NAPLESIII||Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients|Bivalirudin in Patient at High Risk of Bleeding Undergoing Percutaneous Coronary Interventions.|Completed||Phase 3|837|Actual|Clinica Mediterranea||2|||f||||t||||||||||2017-10-11 03:39:33.568766|2017-10-11 03:39:33.568766
NCT01465490|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2011-11-01|||September 2007||2007-09-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Monitoring and Feedback in Substance Abuse Treatment|Monitoring and Feedback in Substance Abuse Treatment|Completed||Phase 1/Phase 2|327|Actual|Treatment Research Institute||2|||f||||t||||||||||2017-10-11 03:39:33.659467|2017-10-11 03:39:33.659467
NCT01465477|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-11-01|||November 2011||2011-11-01|October 2011|2011-10-01|November 2012|Anticipated|2012-11-01|June 2012|Anticipated|2012-06-01||Interventional|||Influenza Vaccination in Fibromyalgia Patients|Influenza Vaccination in Patients Suffering From Fibromyalgia|Unknown status|Not yet recruiting|N/A|80|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 03:39:33.753443|2017-10-11 03:39:33.753443
NCT01465464|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-02-03|||December 2010||2010-12-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|ORIENTAL||Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma|A Randomized, Double-Blind, Placebo-Controlled Phase III Trial Of TSU-68 In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma|Terminated||Phase 3|888|Actual|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 03:39:33.842743|2017-10-11 03:39:33.842743
NCT01465451|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-08-10|||March 2011||2011-03-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|IOCCRC||Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety|A Prospective,Single-center,Randomized,Controlled Phase III Clinical Study Comparing Efficacy and Safety of Intraoperative Chemotherapy With 5-Fluorouracil Plus Curative Resection Versus Surgery Alone for Patients With Colorectal Cancer|Active, not recruiting||Phase 3|695|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:39:33.940904|2017-10-11 03:39:33.940904
NCT01465438|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-11-03|||November 2006||2006-11-01|February 2011|2011-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|HUPSA||HUmira in Psoriatic Arthritis|Can New Imaging- and Biomarkers Improve the Assessment of Disease Activity and Progression and Predict Therapeutic Outcome in Psoriatic Arthritis Patients Receiving Adalimumab?|Completed||Phase 4|42|Actual|Glostrup University Hospital, Copenhagen||1|||f||||t||||||||||2017-10-11 03:39:34.034345|2017-10-11 03:39:34.034345
NCT01465425|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-03-16|||September 2011||2011-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|ACRIN7151||Extracolonic Findings on Computed Tomography (CT) Colonography|"Incidence and Significance of Extracolonic Findings on CT Colonography: Retrospective Analysis of National CT Colonography Trial Data"|Enrolling by invitation||N/A|520|Anticipated|American College of Radiology Imaging Network|||3||f||||t||||||||No||2017-10-11 03:39:34.16813|2017-10-11 03:39:34.16813
NCT01463839|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2011-11-01|||September 2010||2010-09-01|October 2011|2011-10-01|June 2011|Actual|2011-06-01|October 2010|Actual|2010-10-01||Observational|SOHab||Sleep Disorder and Oral Habits in Children|Association Between Quality of Sleep and Harmful Oral Habits Among Children|Completed||N/A|50|Actual|University of Nove de Julho|||1||f||||f||||||||||2017-10-11 03:40:02.634174|2017-10-11 03:40:02.634174
NCT01465412|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-03-08|2016-03-08||November 2011||2011-11-01|March 2016|2016-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Randomized participants|A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)|An Open-label, Single Dose, Oral Administration, Sequential Two Parts Study to Compare the Pharmacokinetics of SCH 420814 / MK-3814 in Subjects With Mild and Moderate Chronic Hepatic Impairment With Their Respectively Matching Healthy Volunteers|Completed||Phase 1|42|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 03:39:34.287984|2017-10-11 03:39:34.287984
NCT01465399|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-12-24|||June 2011||2011-06-01|December 2012|2012-12-01||||||||Interventional|||Plasma Rich in Growth Factors (PRGF-Endoret) in the Regeneration of Post-Extraction Sockets|Randomized Clinical Trial, Controlled With Conventional Treatment, of Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) in the Regeneration of Post-extraction Sockets in Simple Extractions of Molars in the Mandible|Completed||N/A|||Fundación Eduardo Anitua||2|||f||||||||||||||2017-10-11 03:39:34.932122|2017-10-11 03:39:34.932122
NCT01465386|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-02-17|2017-02-17||November 2011||2011-11-01|February 2017|2017-02-01|March 2, 2015|Actual|2015-03-02|January 28, 2014|Actual|2014-01-28||Interventional|||Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission|A Phase II Study of Subcutaneous Bortezomib as Maintenance Therapy for Patients With High-risk Acute Myeloid Leukemia in Remission|Terminated||Phase 2|6|Actual|Fred Hutchinson Cancer Research Center|Difficulty finding patients willing or available to come in to clinic for weekly injections for the duration of the study. Study was ultimately closed because of slow enrollment.|1||Closed early due to slow enrollment|f||||f||||||||||2017-10-11 03:39:35.078325|2017-10-11 03:39:35.078325
NCT01465373|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-05|2011-11-02|||February 2010||2010-02-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs|Comparison of the Effectiveness of Micronized Vaginal Progesterone (Endometrin, Ferring) Vs. Progesterone in Oil for Luteal Phase Support in Donor Egg Recipient IVF Cycles Utilizing Previously Vitrified Donor Oocytes|Completed||Phase 4|10|Actual|Fertility Centers of Illinois||2|||f||||f||||||||||2017-10-11 03:39:35.303154|2017-10-11 03:39:35.303154
NCT01465360|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2012-07-04|||November 2011||2011-11-01|July 2012|2012-07-01||||||||Observational|||Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center|Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study|Completed||N/A|160|Actual|Exonhit|||1||f||||f||||||Samples With DNA|"     Whole blood samples collected in PAXgene® blood RNA tubes   "|||2017-10-11 03:39:35.405577|2017-10-11 03:39:35.405577
NCT01465347|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-06-16|2016-10-04||February 2012||2012-02-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional||The baseline analysis population was the 56 patients in phase 2 given the comparison to historical control (Stupp 2005) wherein patients were treated for 6 weeks.|Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma|Open-label Phase 1/2 (Safety Lead-in) Study of Trans Sodium Crocetinate (TSC) With Concomitant Treatment of Fractionated Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Patients to Evaluate Safety and Efficacy|Completed||Phase 1/Phase 2|59|Actual|Diffusion Pharmaceuticals LLC||1|||f||||t||||||||No||2017-10-11 03:39:35.515346|2017-10-11 03:39:35.515346
NCT01465334|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-05-25|||November 2011||2011-11-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL|A Phase II Study of Ofatumumab-High Dose Methylprednisolone Followed by Ofatumumab-Alemtuzumab in 17p Deletion CLL|Active, not recruiting||Phase 2|30|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 03:39:36.073392|2017-10-11 03:39:36.073392
NCT01465308|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2014-10-07|||August 2011||2011-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|AC-H||The Effect of Honey on Xerostomia and Oral Mucositis|A Randomized Control Trial for the Effect of Honey on Radiotherapy Induced Xerostomia and Oral Mucositis in Patients With Head and Neck Cancers|Completed||Phase 2|72|Actual|Cyprus University of Technology||2|||f||||f||||||||||2017-10-11 03:39:36.192195|2017-10-11 03:39:36.192195
NCT01465295|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2015-11-25|||August 2011||2011-08-01|November 2015|2015-11-01|January 2021|Anticipated|2021-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluate Initial Safety of the HemiBridge™ System in Guided Spinal Growth Treatment of Progressive Idiopathic Scoliosis|Prospective Trial to Evaluate Initial Safety of the HemiBridge™ System in Guided Spinal Growth Treatment of Progressive Idiopathic Scoliosis|Active, not recruiting||N/A|6|Actual|SpineForm LLC||1|||f||||t||||||||||2017-10-11 03:39:36.283318|2017-10-11 03:39:36.283318
NCT01465282|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2013-03-07|||December 2011||2011-12-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris|A Randomized, Placebo-controlled, Phase IIb Study to Evaluate the Efficacy, Safety and Tolerability of 0.05%, 0.1% and 0.5% w/w Topical CT327 When Applied Twice Daily in Subjects With Psoriasis Vulgaris|Completed||Phase 2|160|Actual|Creabilis SA||4|||f||||f||||||||||2017-10-11 03:39:36.390171|2017-10-11 03:39:36.390171
NCT01465269|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2015-07-27|||July 2012||2012-07-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Treatment of Social Competence After Traumatic Brain Injury|Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury|Completed||N/A|231|Actual|Craig Hospital||2|||f||||f||||||||||2017-10-11 03:39:36.505114|2017-10-11 03:39:36.505114
NCT01465256|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-03-25|||April 2012||2012-04-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Postpolypectomy Bleeding in Patients With Antiplatelet Therapy|Postpolypectomy Bleeding in Patients Undergoing Colonoscopy on Antiplatelet Therapy. - Multicenter, Prospective Observational Study -|Unknown status|Recruiting|N/A|500|Anticipated|Soonchunhyang University Hospital||2|||f||||t||||||||||2017-10-11 03:39:36.592141|2017-10-11 03:39:36.592141
NCT01465243|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-02-13|||September 2011||2011-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional|||Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose|An Open , Single-Center, Single Arm Trial to Evaluate the Efficacy and Safety of Dose Escalation of Icotinib in Advanced NSCLC Patients After Routine Icotinib Therapy|Completed||Phase 4|32|Actual|Betta Pharmaceuticals Co.,Ltd.||1|||f||||t||||||||||2017-10-11 03:39:36.664634|2017-10-11 03:39:36.664634
NCT01465230|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2014-10-22|2014-08-26||March 2012||2012-03-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia|Maintenance Therapy With Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia|Terminated||Phase 2|2|Actual|Yale University||1||"This study was unsuccessful in enrolling the target number of subjects during the funding   period."|f||||t||||||||||2017-10-11 03:39:36.742897|2017-10-11 03:39:36.742897
NCT01465217|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2014-12-15|||March 2011||2011-03-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Text Messaging to Improve Hypertension Medication Adherence in African Americans|Text Messaging to Improve Hypertension Medication Adherence in African Americans|Completed||N/A|58|Actual|Wayne State University||2|||f||||f||||||||||2017-10-11 03:39:36.898467|2017-10-11 03:39:36.898467
NCT01465204|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2011-11-03|||November 2007||2007-11-01|November 2011|2011-11-01|July 2012|Anticipated|2012-07-01|December 2010|Actual|2010-12-01||Interventional|||Impact Evaluation of Large-Scale Sanitation and Hygiene Interventions|Impact Evaluation of Large-Scale Sanitation and Hygiene Interventions in Peru, Tanzania, Senegal, Vietnam, Indonesia, and India|Unknown status|Active, not recruiting|N/A|21878|Actual|Water and Sanitation Program, World Bank||4|||f||||||||||||||2017-10-11 03:39:36.967763|2017-10-11 03:39:36.967763
NCT01465191|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2015-01-15|||November 2011||2011-11-01|January 2015|2015-01-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section|Effect of OPRM1 Genotype on the Dose Response to Spinal Morphine for Post-Cesarean Analgesia|Unknown status|Recruiting|Phase 4|300|Anticipated|Columbia University||3|||f||||f||||||||||2017-10-11 03:39:37.041407|2017-10-11 03:39:37.041407
NCT01465178|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2016-10-04|2016-08-03||December 2011||2011-12-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Postmenopausal women with 25(OH)D 10 - 29 ng/ml.|Improving the Understanding of the Response to Vitamin D Supplementation|Improving the Understanding of the Response to Vitamin D Supplementation|Completed||Phase 3|62|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 03:39:37.132423|2017-10-11 03:39:37.132423
NCT01465165|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-05-18|||May 15, 2011|Actual|2011-05-15|May 2017|2017-05-01|June 24, 2012|Actual|2012-06-24|June 24, 2012|Actual|2012-06-24||Observational|||Use of Multiple Brain Imaging Modalities (PET and MRS) to Identify Metabolic Abnormalities in Major Depression|Comparison of Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Magnetic Resonance Spectroscopy (MRS) as Bioenergetic Imaging Modalities in Healthy Human Brain and Major Depressive Disorder|Terminated||N/A|12|Actual|University of Utah|||3|Study procedures were not feasible.|f||||f|f|f|||f|||Yes|De-identified scanning images may be individually examined after the study is completed if new analysis methods become available to collaborators.|2017-10-11 03:39:37.63348|2017-10-11 03:39:37.63348
NCT01465152|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-02-17|||March 6, 2002|Actual|2002-03-06|February 2017|2017-02-01|October 21, 2004|Actual|2004-10-21|October 21, 2004|Actual|2004-10-21||Interventional|||Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes|Multicentre, Randomised, Comparative, Open, Three Armed Parallel Group Study on the Use of Metformin, Repaglinide or the Combination of Both in Type 2 Diabetic Patients After Failure of Dietary Measures|Completed||Phase 4|182|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:39:37.714705|2017-10-11 03:39:37.714705
NCT01465139|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-06-26|||October 2011||2011-10-01|June 2017|2017-06-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers|A Phase 1 Safety, Pharmacokinetic, and Immunologic Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers|Completed||Phase 1|30|Actual|Celldex Therapeutics||1|||f||||f||||||||||2017-10-11 03:39:37.837376|2017-10-11 03:39:37.837376
NCT01465126|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2011-11-01|||January 2011||2011-01-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Enalapril in Collagen Type 4 Nephropathy|Collagen Type 4-related Nephropathies: From Alport to Thin Membrane Nephropathy. A Series of Cases Treated With Angiotensin Converting Enzyme Inhibitor|Completed||N/A|19|Actual|University of Sao Paulo|||1||f||||f||||||||||2017-10-11 03:39:37.906679|2017-10-11 03:39:37.906679
NCT01465113|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-03-09|||May 2010||2010-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus|Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus|Completed||Early Phase 1|26|Actual|Case Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 03:39:37.961793|2017-10-11 03:39:37.961793
NCT01465100|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-06-06|||December 2011||2011-12-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|October 2018|Anticipated|2018-10-01||Interventional|||Liver Cell Transplant for Phenylketonuria|Hepatocyte Transplantation for Phenylketonuria|Suspended||Phase 1/Phase 2|10|Anticipated|University of Pittsburgh||1||seeking additional funding|f||||t||||||||Undecided||2017-10-11 03:39:38.072097|2017-10-11 03:39:38.072097
NCT01465087|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-06-26|||December 2011||2011-12-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional|||Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples|Applications of Nanotechnology and Chemical Sensors for the Detection and Identification of Multiple Sclerosis, In Comparison to Other Autoimmune and Neurological Diseases by Exhalation Samples|Completed||N/A|314|Actual|Carmel Medical Center||1|||f||||t||||||||||2017-10-11 03:39:38.17649|2017-10-11 03:39:38.17649
NCT01465074|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2013-08-09|||November 2011||2011-11-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|NIC-PAS||Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia|Effects of Acute Nicotine on Long-term Potentiation in the Dorsolateral Prefrontal Cortex of Patients With Schizophrenia and Healthy Controls|Terminated||N/A|20|Actual|Centre for Addiction and Mental Health||2||Limited staff and operating resources|f||||f||||||||||2017-10-11 03:39:38.255868|2017-10-11 03:39:38.255868
NCT01465061|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2011-11-01|||February 2011||2011-02-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Observational|||A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis|A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis|Completed||N/A|124|Actual|University of the Philippines|||1||f||||f||||||||||2017-10-11 03:39:38.442771|2017-10-11 03:39:38.442771
NCT01465048|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2013-06-18|2013-04-08||October 2011||2011-10-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2012|Actual|2012-02-01||Interventional|||Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe|A Pilot Study to Optimise Controlled Human Malaria Infections Using Plasmodium Falciparum Sporozoites Administered by Needle and Syringe|Completed||N/A|18|Actual|University of Oxford||3|||f||||t||||||||||2017-10-11 03:39:38.5258|2017-10-11 03:39:38.5258
NCT01465035|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2012-11-28|||October 2011||2011-10-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine|A Phase I Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine|Completed||Phase 1|24|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 03:39:38.887011|2017-10-11 03:39:38.887011
NCT01465022|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-04-14|2015-05-29||January 2005||2005-01-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial|Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial|Completed||N/A|197|Actual|University of New Mexico||2|||f||||f||||||||||2017-10-11 03:39:38.978745|2017-10-11 03:39:38.978745
NCT01465009|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2014-12-10|||November 2003||2003-11-01|November 2011|2011-11-01|March 2005|Actual|2005-03-01|||||Interventional|||Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold|Double-blind, Randomized, Placebo-controlled, Single Dose, Parallel Group Study Evaluating Efficacy and Safety of 1000 mg Acetylsalicylic Acid and 1000 mg Paracetamol in Adult Patients With Sore Throat Associated With a Common Cold|Completed||Phase 4|508|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:39:39.464204|2017-10-11 03:39:39.464204
NCT01464996|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-07-24|2015-06-19||December 2011||2011-12-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|XTR|There were 24 participants in the study. The 24 participants received 83 restorations. As per protocol, participants received restorations from both arms, hence total number of study participants should not be the sum of the number of participants for each arm.|Clinical Evaluation Of A New Two-Component Self-Etch Universal Adhesive|Clinical Evaluation Of A New Two-Component Self-Etch Universal Adhesive (OptiBond XTR)|Completed||N/A|24|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 03:39:39.605755|2017-10-11 03:39:39.605755
NCT01464983|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2014-12-23|||January 2004||2004-01-01|December 2014|2014-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type Headache|A Multicentre Randomised Parallel-groups Double-blind Double-dummy Single-dose Study to Compare Acetylsalicylic Acid 500 mg and 1,000 mg With Ibuprofen 200 mg and 400 mg and Placebo for Tolerability and Efficacy in the Treatment of Episodic Tension-type Headache|Completed||Phase 4|1115|Actual|Bayer||5|||f||||f||||||||||2017-10-11 03:39:39.961316|2017-10-11 03:39:39.961316
NCT01464970|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2012-05-11|||December 2011||2011-12-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Influence of the Superficial Inferior Epigastric System in Deep Inferior Epigastric Perforator (DIEP) Flaps|The Potential Role of the Superficial Inferior Epigastric Vascular System in the Perfusion of Zone IV of Deep Inferior Epigastric Perforator (DIEP) Flaps|Unknown status|Enrolling by invitation|N/A|12|Anticipated|NHS Greater Glasgow and Clyde||4|||f||||f||||||||||2017-10-11 03:39:40.091882|2017-10-11 03:39:40.091882
NCT01464957|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-14|2013-01-23|||November 2003||2003-11-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Interventional|||Skin Cancer Prevention in a Pediatric Population|Skin Cancer Prevention in a Pediatric Population|Completed||Phase 2|867|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 03:39:40.206268|2017-10-11 03:39:40.206268
NCT01464944|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-11-07|||November 2003||2003-11-01|November 2011|2011-11-01|April 2004|Actual|2004-04-01|||||Interventional|||Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin|A Randomized, Double-blind, Double-dummy, Single-dose, Parallel Group, Multicenter Study to Compare the Antipyretic Efficacy of Acetylsalicy-lic Acid 500 mg and 1,000 mg (2 x 500 mg) and Paracetamol 500 mg and 1,000 mg (2 x 500 mg) With Placebo in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin.|Completed||Phase 4|392|Actual|Bayer||5|||f||||f||||||||||2017-10-11 03:39:40.294328|2017-10-11 03:39:40.294328
NCT01464931|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2016-01-22|2015-12-14||November 2011||2011-11-01|January 2016|2016-01-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis|An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis|Completed||Phase 1|32|Actual|Amgen||1|||f||||f||||||||||2017-10-11 03:39:40.43417|2017-10-11 03:39:40.43417
NCT01464905|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2013-09-20|||October 2011||2011-10-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)|A Phase 3, Multicenter, Double-blind,Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of NU100 in Patients With Relapsing Forms of Multiple Sclerosis|Unknown status|Active, not recruiting|Phase 3|500|Anticipated|Nuron Biotech Inc.||3|||f||||f||||||||||2017-10-11 03:39:41.770727|2017-10-11 03:39:41.770727
NCT01464892|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-12-18|||October 2011||2011-10-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|||Imagery Rescripting in the Treatment of Post Traumatic Stress Disorder (PTSD) Following Early Chronic Interpersonal Trauma|Rescripting With vs. Without Prior Stabilization in PTSD Following Early Chronic Interpersonal Trauma|Active, not recruiting||Phase 2|61|Actual|VU University of Amsterdam||3|||f||||t||||||||||2017-10-11 03:39:41.893012|2017-10-11 03:39:41.893012
NCT01464879|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-08-15|2017-06-29|2013-05-13|December 2011||2011-12-01|August 2017|2017-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||The data are presented for Intent-to-treat (ITT) population, which comprised of all subjects who received at least one dose of the Investigational Medicinal Product (IMP).|A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator|A Phase 2, Open-Label, Sequential Dose Escalation Study in Adult Hypogonadal Males to Evaluate the Pharmacokinetics of Three Volumes of FE 999303 (Testosterone Gel), Applied to the Shoulder/Upper Arm, Using an Applicator Compared With Hand Application|Completed||Phase 2|20|Actual|Ferring Pharmaceuticals||4|||f||||f||||||||||2017-10-11 03:39:42.045414|2017-10-11 03:39:42.045414
NCT01464866|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-09-04|||February 2010||2010-02-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Nutritional Supplementation on Pediatric Burn Patients|Effect of Nutritional Supplementation on Pediatric Burn Patients|Completed||Phase 3|116|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-10-11 03:39:42.536607|2017-10-11 03:39:42.536607
NCT01464853|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2011-11-02|||April 2010||2010-04-01|March 2011|2011-03-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Effect of Enteral Nutrition Support for Critically Ill Patients|Effect of Enteral Nutrition Support for Critically Ill Patients|Terminated||Phase 3|84|Actual|Abbott Nutrition||2||"Interim analysis indicated significant additional subjects needed to demonsate statistical   difference in primary outcome."|f||||f||||||||||2017-10-11 03:39:42.628495|2017-10-11 03:39:42.628495
NCT01464840|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-04-04|2013-11-02||November 2011||2011-11-01|April 2017|2017-04-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Observational|PKAZ||The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery|The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery|Completed||N/A|30|Actual|University of Alabama at Birmingham|||3||f||||f||||||Samples Without DNA|"     Maternal blood, maternal adipose tissue, maternal myometrium, maternal breast milk, amniotic     fluid, and fetal cord blood.   "|||2017-10-11 03:39:42.717571|2017-10-11 03:39:42.717571
NCT01464827|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-04-02|2014-12-23|2014-03-25|October 2011||2011-10-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional||Safety population (participants who received at least 1 dose of direct-acting antiviral agent)|ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients|A Randomized, Open-Label, Multicenter Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics, of ABT-450 With Ritonavir (ABT-450/r) in Combination With ABT-267 and/or ABT-333 With and Without Ribavirin (RBV) for 8, 12 or 24 Weeks in Treatment-Naïve and Null Responder Subjects With Genotype 1 Chronic Hepatitis C Virus Infection|Completed||Phase 2|580|Actual|AbbVie||14|||f||||t||||||||||2017-10-11 03:39:44.485402|2017-10-11 03:39:44.485402
NCT01464814|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-11-11|||October 2011||2011-10-01|November 2011|2011-11-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|Probiomega||Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules|A Double Blind Placebo Controlled Crossover Clinical Trial Evaluating The Viability Of KE-99 With Fish Oil In Healthy Adults|Unknown status|Recruiting|N/A|15|Anticipated|Nutrition 21, Inc.||2|||f||||f||||||||||2017-10-11 03:39:46.64469|2017-10-11 03:39:46.64469
NCT01464801|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-06-12|||September 2011||2011-09-01|August 2013|2013-08-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|LIRMOI3||Resveratrol in Patients With Non-alcoholic Fatty Liver Disease|Long-term Investigation of Resveratrol on Management of Metabolic Syndrome, Osteoporosis and Inflammation, and Identification of Plant Derived Anti-inflammatory Compounds, Study 3|Completed||N/A|28|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:39:46.751171|2017-10-11 03:39:46.751171
NCT01464788|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-03-31|2017-01-26||October 2011||2011-10-01|March 2017|2017-03-01|June 11, 2015|Actual|2015-06-11|June 11, 2015|Actual|2015-06-11||Interventional|ARTSS-2||Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke|ARTSS-2: A Pilot, Phase 2b, Randomized, Multi-center Trial of Argatroban in Combination With Recombinant Tissue Plasminogen Activator for Acute Stroke|Terminated||Phase 2|90|Actual|The University of Texas Health Science Center, Houston|Study limitations include the open-label design that was necessary due to prohibitive costs of placebo manufacture and sham aPTT tests. Given that vessel imaging was not mandatory, a meaningful analysis of early recanalization rates was not possible.|3||"The study was halted prematurely at 90 of 105 planned patients due to the beneficial results of   embolectomy clinical trials."|f||||t||||||||||2017-10-11 03:39:46.838933|2017-10-11 03:39:46.838933
NCT01464762|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-01-30||||||January 2017|2017-01-01||||||||Expanded Access|||Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis|Early Access of TMC207 in Combination With Other Anti-Tuberculosis (TB) Drugs in Subjects With Extensively Drug Resistant (XDR) or Pre-XDR Pulmonary Tuberculosis|Approved for marketing||N/A|||Janssen Infectious Diseases BVBA|||||f||||||||||||||2017-10-11 03:39:47.452591|2017-10-11 03:39:47.452591
NCT01464749|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2014-04-09|||May 2011||2011-05-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|May 2012|Actual|2012-05-01||Interventional|||Task-oriented Circuit Class Training in Multiple Sclerosis Subjects||Completed||N/A|24|Actual|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-11 03:39:47.665374|2017-10-11 03:39:47.665374
NCT01464736|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2011-10-31|||January 2006||2006-01-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|kmarrara||Noninvasive Ventilation on Chronic Obstructive Pulmonary Disease (COPD) Patient Functionality|Impact of Aerobic Physical Training Associated With Noninvasive Ventilation on COPD Patient Functionality - A Controlled Randomized Study|Completed||N/A|23|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-10-11 03:39:47.757128|2017-10-11 03:39:47.757128
NCT01464723|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2013-01-22|||May 2008||2008-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2011|Actual|2011-12-01||Interventional|SEAGUL2||Study EvAluating Genotypes While Using Lucentis 2|VEGF and HTRA1 DNA Polymorphisms in Neovascular AMD Pathogenesis and Response to Lucentis|Completed||Phase 4|66|Actual|University of California, San Diego||1|||f||||t||||||||||2017-10-11 03:39:47.867473|2017-10-11 03:39:47.867473
NCT00005463|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1991||1991-08-01|September 2002|2002-09-01|May 1993|Actual|1993-05-01|||||Observational|||Population-Based Modeling of Cholesterol Lowering in the United States||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.344741|2017-10-11 04:27:05.344741
NCT01464710|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-02-18|||April 2008||2008-04-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|GALLEY2||Genetic Assessment of Early to Late Macular Degeneration Study|Genetic Assessment of Early to Late macuLar dEgeneration studY 2|Completed||N/A|170|Actual|University of California, San Diego|||1||f||||t||||||Samples With DNA|"     Specimen collected for genotype analysis.   "|No|Data not available.|2017-10-11 03:39:47.94883|2017-10-11 03:39:47.94883
NCT01464697|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-05-08|||October 2011||2011-10-01|May 2017|2017-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Oral Micronized Progesterone for Perimenopausal Vasomotor Symptoms|Oral Micronized Progesterone for Perimenopausal Vasomotor Symptoms|Active, not recruiting||Phase 3|249|Actual|University of British Columbia||2|||f||||t||||||||No||2017-10-11 03:39:48.027386|2017-10-11 03:39:48.027386
NCT01464684|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-04-18|||October 2011||2011-10-01|April 2017|2017-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Body Composition of Infants: Follow-up to Placenta and Cord Blood Analyses|Body Composition of Infants: Follow-up to Placenta and Cord Blood Analyses|Withdrawn||N/A|0|Actual|University of Arkansas|||1|"determined not enough participants would be able to be enrolled and not enough data collected   for good analyses"|f||||||||||Samples With DNA|"     Blood, urine, and a cheek swab may be collected from study participants   "|||2017-10-11 03:39:48.124714|2017-10-11 03:39:48.124714
NCT01464671|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2014-11-19|||July 2009||2009-07-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|STATUS PCI||Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention|STATUS-PCI: Stable Angina Therapy With Angiomax® or Unfractionated Heparin for patientS Undergoing Percutaneous Coronary Intervention|Terminated||Phase 4|260|Actual|Stony Brook University||2||DSMB halted the study early due to futility. There were no safety concerns.|f||||t||||||||||2017-10-11 03:39:48.191034|2017-10-11 03:39:48.191034
NCT01464658|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-09|2011-11-02|||March 2009||2009-03-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Prospective Study of Functional and Quality of Life Outcomes in Panniculectomy Patients|Prospective Study of Functional and Quality of Life Outcomes in Panniculectomy Patients|Terminated||N/A|2|Actual|Wake Forest University Health Sciences||1||Due to complexity and cost of study (no outside funding)|f||||f||||||||||2017-10-11 03:39:48.287157|2017-10-11 03:39:48.287157
NCT01464645|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2017-02-06|||January 2012||2012-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MRHS||Post-Market Study of the Modular Revision Hip System|Prospective Multicenter Open Label Study Examining the Short-term Safety and Efficacy of the Modular Revision Hip System (MRHS)|Terminated||N/A|16|Actual|Encore Medical, L.P.|||1||f||||f||||||||||2017-10-11 03:39:48.380918|2017-10-11 03:39:48.380918
NCT01464632|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-02|2012-05-14|||November 2011||2011-11-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|EPIK||Post-Market Study of the EPIK Knee System|Prospective, Open Label Study of the Short-and Midterm Safety and Efficacy of the EPIK Uni-Compartmental Knee System in Community Practice|Withdrawn||N/A|0|Actual|Encore Medical, L.P.|||1|Unable to enroll any study participants.|f||||f||||||||||2017-10-11 03:39:48.480444|2017-10-11 03:39:48.480444
NCT01464619|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-03-11|2015-02-03||July 2011||2011-07-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|June 2012|Actual|2012-06-01||Interventional|EPDC||Enhancing Parenting for Depressed Caregivers|Enhancing Parenting for Depressed Caregivers|Completed||N/A|61|Actual|Children's Hospital of Philadelphia|Outcomes are assessed by maternal report measures only. Incentives were given for completing the adapted IY group. There was poor attendance at IY sessions. The study was conducted in only one geographic area .|2|||f||||f||||||||||2017-10-11 03:39:48.571443|2017-10-11 03:39:48.571443
NCT01464606|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-02-01|||September 2011||2011-09-01|February 2016|2016-02-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Interventional|||International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry|International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry Protocol|Recruiting||N/A|125|Anticipated|Children's Hospitals and Clinics of Minnesota||2|||f||||f||||||||||2017-10-11 03:39:49.019698|2017-10-11 03:39:49.019698
NCT01464580|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2016-10-11|||||||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:39:49.23594|2017-10-11 03:39:49.23594
NCT01464567|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-11-23|||January 2012||2012-01-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Spontaneous Breathing Trials Using Pressure-Support or T-Tube in Chronic Obstructive Pulmonary Disease Patients Weaning Mechanical Ventilation|"Comparison Between Spontaneous Breathing Trials Through Pressure-Support Ventilation or T Tube in the Weaning of Mechanical Ventilation in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial"|Completed||Phase 4|190|Actual|Hospital Nossa Senhora da Conceicao||2|||f||||t||||||||||2017-10-11 03:39:49.452863|2017-10-11 03:39:49.452863
NCT01464554|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-05-06|||January 2009||2009-01-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|November 2011|Actual|2011-11-01||Interventional|||Brief Substance Use Intervention for Youth in Teen Court|Brief Substance Use Intervention for Youth in Teen Court|Completed||Phase 1/Phase 2|193|Actual|RAND||2|||f||||f||||||||||2017-10-11 03:39:49.54442|2017-10-11 03:39:49.54442
NCT01464541|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-09-07|||December 2011||2011-12-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Orbital Fractures Measurement: Intraoperative Versus Computed Tomography (CT) Scan||Recruiting||N/A|20|Anticipated|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-10-11 03:39:49.638749|2017-10-11 03:39:49.638749
NCT01464528|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-11-02|||November 2011||2011-11-01|July 2011|2011-07-01|May 2012|Anticipated|2012-05-01|March 2012|Anticipated|2012-03-01||Interventional|||Safety Study of Use of Hyaluronic Acid Gel To Prevent Intrauterine Adhesions In Hysteroscopic Surgery|Use Of Hyaluronic Acid Gel To Prevent Intrauterine Adhesions In Hysteroscopic Surgery|Unknown status|Not yet recruiting|Early Phase 1|10|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 03:39:49.732716|2017-10-11 03:39:49.732716
NCT01464515|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-01-26|||November 2011||2011-11-01|November 2011|2011-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment|Feasibility Study in Order to Test the Efficiency of Deep TMS on Patient With MCI|Unknown status|Recruiting|Phase 1|30|Anticipated|Brainsway||2|||f||||f||||||||||2017-10-11 03:39:49.845334|2017-10-11 03:39:49.845334
NCT01464502|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-04-03|||September 2012||2012-09-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Pressure Wire Guided Cardiac Resynchronisation Therapy|A Prospective Randomised Controlled Trial of Cardiac Resynchronisation Therapy Guided by Invasive dP/dT: Radi-CRT Study|Recruiting||Phase 2/Phase 3|282|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:39:49.944482|2017-10-11 03:39:49.944482
NCT01464489|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-11-01|||May 2011||2011-05-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Intubation Time With Low Dose Rocuronium|Study of Intubation Time Required for Excellent Tracheal Intubation With Low Dose Rocuronium During Propofol Anaesthesia in Children With and Without Atropine|Completed||N/A|44|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 03:39:50.085678|2017-10-11 03:39:50.085678
NCT01464476|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2013-05-02|||November 2011||2011-11-01|May 2013|2013-05-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Interventional|SHIELD-2||Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)|Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator|Terminated||Phase 3|240|Actual|Forest Laboratories||2|||f||||t||||||||||2017-10-11 03:39:50.297583|2017-10-11 03:39:50.297583
NCT01464463|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-06-09|||August 2011||2011-08-01|June 2016|2016-06-01||||April 2016|Actual|2016-04-01||Interventional|||The Impact of Psychological Interventions on Psychometric and Immunological Measures in Patients With Major Depression|The Impact of Psychological Interventions (With and Without Exercise) on Psychometric and Immunological Measures in Patients With Major Depression|Completed||Phase 3|200|Anticipated|Philipps University Marburg Medical Center||4|||f||||f||||||||||2017-10-11 03:39:50.846853|2017-10-11 03:39:50.846853
NCT01464450|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-01-23|||October 2011||2011-10-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants|PK Study of Oral Rivaroxaban in Healthy Subjects|Completed||Phase 1|55|Actual|Janssen Scientific Affairs, LLC||6|||f||||f||||||||||2017-10-11 03:39:50.972649|2017-10-11 03:39:50.972649
NCT01464437|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2014-04-24||2013-11-06|September 2011||2011-09-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||AMG 151 Amgen Protocol Number 20100761|A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|236|Actual|Amgen||7|||f||||t||||||||||2017-10-11 03:39:51.103511|2017-10-11 03:39:51.103511
NCT01464424|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2013-09-05|2013-06-26||October 2011||2011-10-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||This reporting group includes all enrolled subjects.|Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)|Assessment of Late Day IOP Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)|Completed||Phase 4|84|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:39:51.387831|2017-10-11 03:39:51.387831
NCT01464411|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2011-11-02|||July 2011||2011-07-01|November 2011|2011-11-01||||||||Observational|D-First||Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan|Phase II Clinical Trial of Dasatinib First Line Therapy for Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase|Unknown status|Recruiting|N/A|40|Anticipated|Kanto CML Study Group|||1||f||||t||||||Samples With DNA|"     Copy numbers of bcr-abl mRNA in patients with dasatinib treatment will be measured by     real-time RT-PCR to evaluate the efficiency of dasatinib.      For patients resistant to dasatinib therapy, DNA mutation analysis of the bcr-abl gene     associated with drug-resistancy will be performed.   "|||2017-10-11 03:39:51.620796|2017-10-11 03:39:51.620796
NCT01464398|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-05-13|||November 2011||2011-11-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Stress Reduction for Overweight or Obese Women Either With Polycystic Ovary Syndrome (PCOS) or Without PCOS (Non-PCOS)|Stress Reduction for PCOS and Non-PCOS Women|Completed||N/A|86|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 03:39:51.707338|2017-10-11 03:39:51.707338
NCT01464385|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-04-30|||October 2011||2011-10-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Nutrition Beverage Tolerance Study|Nutrition Beverage Tolerance Study|Completed||Phase 2|121|Actual|Abbott Nutrition||3|||f||||t||||||||||2017-10-11 03:39:51.812129|2017-10-11 03:39:51.812129
NCT01464372|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2013-01-30|||October 2011||2011-10-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|ELEC STIM||Electromagnetic Stimulation for the Treatment of Urge Urinary Incontinence and Overactive Bladder|Electrical Field Stimulation for the Treatment of Urge Urinary Incontinence and Overactive Bladder - Version: 3.0 Dated 16 APR 2012.|Terminated||Phase 3|130|Actual|EMKinetics, Inc||2|||f||||f||||||||||2017-10-11 03:39:51.901542|2017-10-11 03:39:51.901542
NCT01464359|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-04-06|2015-04-29||October 2011||2011-10-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||T-Cell Depleted Double UCB for Refractory AML|T-Cell Depleted Double UCB With Post Transplant IL-2 for Refractory Myeloid Leukemia|Terminated||Phase 2|3|Actual|Masonic Cancer Center, University of Minnesota||1||Slow accrual|f||||f||||||||||2017-10-11 03:39:51.985267|2017-10-11 03:39:51.985267
NCT00005464|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||February 1991||1991-02-01|May 2000|2000-05-01|January 1993|Actual|1993-01-01|||||Observational|||DISH Data Analysis Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.401643|2017-10-11 04:27:05.401643
NCT01464333|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-09-06|||December 16, 2011||2011-12-16|September 2017|2017-09-01|October 31, 2018|Anticipated|2018-10-31|October 31, 2018|Anticipated|2018-10-31||Observational|||Special Investigation on Long-term Treatment in Patients With Crohn's Disease|Special Investigation (Long-term Investigation) in Patients With Crohn's Disease|Active, not recruiting||N/A|500|Anticipated|AbbVie|||1||f||||||||||||||2017-10-11 03:39:52.68199|2017-10-11 03:39:52.68199
NCT01464320|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2012-08-21|||November 2011||2011-11-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.|A Phase 1b, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Single-Dose of ABT-614 and the Effect of ABT-614 on Glomerular Filtration Rate in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Albuminuria|Completed||Phase 1|16|Actual|Abbott||2|||f||||f||||||||||2017-10-11 03:39:53.118007|2017-10-11 03:39:53.118007
NCT01464307|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2016-11-04|2016-07-26|2015-07-31|December 2011||2011-12-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|August 2014|Actual|2014-08-01||Interventional|PLUS|The Safety Evaluation Set (SES) is the subset of all subjects who were exposed to Investigational product (IP) in the main period at least once.|Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke|Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Lower Limb|Completed||Phase 3|290|Actual|Merz Pharmaceuticals GmbH||2|||f||||t||||||||||2017-10-11 03:39:53.237891|2017-10-11 03:39:53.237891
NCT01464294|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-01-26|||October 2011||2011-10-01|December 2013|2013-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Clinical Evaluation of Chairside CAD/CAM Nano-ceramic Restorations|Clinical Evaluation of Chairside CAD/CAM Nano-ceramic Restorations|Terminated||N/A|120|Actual|3M|||2|not a required sutudy to be posted|f||||f||||||||||2017-10-11 03:39:54.130057|2017-10-11 03:39:54.130057
NCT01464281|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-11-01|||October 2011||2011-10-01|November 2011|2011-11-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|New Switch||A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml|A Randomized, Multicenter Study Evaluating HBsAg Clearance in CHB Patients Achieving HBeAg Loss and HBV DNA <200copies/ml on Treatment With Nucleotide Analogues and Switched to Peginterferon Alfa-2a|Unknown status|Active, not recruiting|N/A|300|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||f||||||||||2017-10-11 03:39:54.206866|2017-10-11 03:39:54.206866
NCT01464268|ClinicalTrials.gov processed this data on October 10, 2017|2011-11-01|2017-01-18|||November 2011||2011-11-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia|Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia|Active, not recruiting||Phase 3|160|Anticipated|Cornea and Laser Eye Institute||2|||f||||f||||||||||2017-10-11 03:39:54.281427|2017-10-11 03:39:54.281427
NCT01464255|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2014-08-15|2014-04-03||August 2011||2011-08-01|August 2014|2014-08-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional||1 subject being disqualified after 1 week of wear|Comparative Study of Two Marketed 1-day Soft Contact Lenses|Clinical Performance of Ocufilcon D With a Wetting Agent to Ocufilcon B|Completed||N/A|71|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-10-11 03:39:54.398311|2017-10-11 03:39:54.398311
NCT01464242|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-08-22|||November 2011||2011-11-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|GT||Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis|Therapeutic Gain of Adding the Immunomodulator Pentoxifylline to the Treatment of Cutaneous Leishmaniasis|Completed||Phase 2/Phase 3|75|Actual|Centro Internacional de Entrenamiento e Investigaciones Médicas||2|||f||||t||||||||||2017-10-11 03:39:54.885385|2017-10-11 03:39:54.885385
NCT01464229|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-02-28|2016-10-25||April 2012||2012-04-01|February 2017|2017-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability|A Placebo-Controlled Crossover Study of Iloperidone Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder|Completed||Phase 4|20|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:39:54.9898|2017-10-11 03:39:54.9898
NCT01464216|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-12-08|||October 2011||2011-10-01|December 2016|2016-12-01|December 2030|Anticipated|2030-12-01|December 2016|Anticipated|2016-12-01||Observational|FuncProst||MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness|MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness|Recruiting||N/A|180|Anticipated|Oslo University Hospital|||1||f||||f||||||Samples With DNA|"     Blood, bone marrow, lymph nodes, prostate tissue, urine   "|||2017-10-11 03:39:55.212156|2017-10-11 03:39:55.212156
NCT01464203|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-15|2011-10-31|||February 2009||2009-02-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|RADICAL||Role of Cardiac CT in Rapid Access Chest Pain Clinics (RADICAL)|Randomized Controlled Trial to Evaluate the Cost and Clinical Effectiveness of CT Coronary Angiography in Patients With Stable Angina Pectoris (RADICAL Trial)|Unknown status|Recruiting|N/A|600|Anticipated|Wellington Hospital||2|||f||||t||||||||||2017-10-11 03:39:55.290502|2017-10-11 03:39:55.290502
NCT01464190|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2014-03-03|2013-12-20|2013-08-08|September 2011||2011-09-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional||For baseline characteristics, data from All Randomised patients was used.|A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients|An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre Phase 3 Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21 Compared With Sevelamer Carbonate in Dialysis Patients With Hyperphosphataemia. Extension Study for Protocol PA-CL-05A (NCT01324128)|Completed||Phase 3|659|Actual|Vifor Inc.||2|||f||||t||||||||||2017-10-11 03:39:55.441937|2017-10-11 03:39:55.441937
NCT01464177|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-05-10|||October 2011||2011-10-01|May 2016|2016-05-01|October 2021|Anticipated|2021-10-01|October 2020|Anticipated|2020-10-01||Interventional|GBM Hypo RT||Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme|Prospective Randomized Phase II Trial of Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme|Recruiting||Phase 2|40|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:39:57.308227|2017-10-11 03:39:57.308227
NCT01442740|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2013-08-28|||October 2011||2011-10-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|RTP||15-Degree Tilt, Head Up, Feet Down Body Position for Sinus Surgery Patients|15-Degree Reverse Trendelenburg Position for FESS|Completed||N/A|64|Actual|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 03:47:01.638896|2017-10-11 03:47:01.638896
NCT01464164|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-12-20|||January 2012||2012-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ACE-011-DBA||Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia|Phase I/II, Open-Label Study to Determine Safety and Efficacy of Sotatercept (ACE-011) in Adults With Red Blood Cell Transfusion- Dependent Diamond Blackfan Anemia|Recruiting||Phase 1/Phase 2|20|Anticipated|Northwell Health||2|||f||||t||||||||No||2017-10-11 03:39:57.406043|2017-10-11 03:39:57.406043
NCT01464151|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-10-25|||July 2011||2011-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study|Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study|Recruiting||N/A|700|Anticipated|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     biopsies, blood, stool   "|||2017-10-11 03:39:57.536341|2017-10-11 03:39:57.536341
NCT01464138|ClinicalTrials.gov processed this data on October 10, 2017|2009-10-26|2011-11-02|||September 2010||2010-09-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children|Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children|Completed||Phase 2|52|Actual|Jomaa Pharma GmbH||1|||f||||t||||||||||2017-10-11 03:39:57.644025|2017-10-11 03:39:57.644025
NCT01464125|ClinicalTrials.gov processed this data on October 10, 2017|2009-10-26|2011-10-31|||November 2008||2008-11-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|October 2009|Actual|2009-10-01||Interventional|JP011||Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults|Evaluation of Fosmidomycin and Azithromycin When Administered Concurrently to Adult Subjects With Acute Uncomplicated Plasmodium Falciparum Malaria|Unknown status|Active, not recruiting|Phase 2|43|Actual|Jomaa Pharma GmbH||1|||f||||f||||||||||2017-10-11 03:39:57.750456|2017-10-11 03:39:57.750456
NCT01464112|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-12-30|||September 2011||2011-09-01|December 2016|2016-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma|A Phase 1b Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ-26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Subjects With Relapsed Multiple Myeloma|Completed||Phase 1|18|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 03:39:57.836713|2017-10-11 03:39:57.836713
NCT01464099|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-10-26|||June 2008||2008-06-01|October 2016|2016-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes|A Single Center, Randomized, Double-blind, Balanced Two-period Cross-over Trial to Test for Bioequivalence Between a Marketed NovoLog® Formulation Containing 100 U/mL Versus a New NovoLog® Formulation Containing 200 U/mL in a Combined Regimen of a Continuous Subcutaneous Infusion and a Meal-time Bolus in Subjects With Type 1 Diabetes|Completed||Phase 1|24|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:39:57.956033|2017-10-11 03:39:57.956033
NCT01464086|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2016-02-09|||September 2011||2011-09-01|February 2016|2016-02-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|LIFSCREEN||LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)||Recruiting||Phase 3|110|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 03:39:58.051558|2017-10-11 03:39:58.051558
NCT01464073|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-07-28|||November 2011||2011-11-01|July 2015|2015-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|LIPOXmax-RUN||Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet on the Evolution of Body Fat|Evaluation of the Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet Rich in Fruits and Vegetables, on the Evolution of Body Fat in Overweight or Obese Women, as Part of Type 2 Diabetes Prevention in Reunion Island.|Completed||N/A|137|Actual|Centre Hospitalier Universitaire de la Réunion||3|||f||||t||||||||||2017-10-11 03:39:58.147899|2017-10-11 03:39:58.147899
NCT01464047|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-04-25|||October 2011||2011-10-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Korean Post-marketing Surveillance for Sprycel®|Korean Post-marketing Surveillance for Sprycel®|Completed||N/A|670|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 03:39:58.442409|2017-10-11 03:39:58.442409
NCT01464034|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-09-18|||November 2011||2011-11-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|A Multi-Center Phase I/II, Open-Label, Dose-Finding Pilot Study of the Combination of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|117|Anticipated|Academic Myeloma Consortium||1|||f||||f||||||||||2017-10-11 03:39:58.529809|2017-10-11 03:39:58.529809
NCT01464021|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2014-02-03|2013-12-11||December 2011||2011-12-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China|A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China|Terminated||N/A|26|Actual|AbbVie|The study was terminated early due to low enrollment and high drop-out rate. Only serious adverse events and events leading to discontinuation were collected.||1|This study was prematurely terminated due to low enrollment|f||||f||||||Samples Without DNA|"     Whole blood, serum   "|||2017-10-11 03:39:58.711833|2017-10-11 03:39:58.711833
NCT01463826|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2011-11-01|||May 2010||2010-05-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|July 2010|Actual|2010-07-01||Observational|RPCB||Respiratory Problems and Caries in Children With Bruxism|Association Between Respiratory Problem and Dental Caries in Children With Bruxism|Completed||N/A|90|Actual|University of Nove de Julho|||2||f||||f||||||||||2017-10-11 03:40:02.733265|2017-10-11 03:40:02.733265
NCT01464008|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-09-24|||January 2004||2004-01-01|September 2016|2016-09-01|September 2011|Actual|2011-09-01|May 2011|Actual|2011-05-01||Observational|||The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C|The Predictive Values of Rapid Virus Response and Complete Early Virus Response for Sustained Virus Response in Chronic Hepatitis C Treated With Individual Therapeutic Programme|Completed||N/A|297|Actual|Beijing Ditan Hospital|||1||f||||t||||||||||2017-10-11 03:39:59.232491|2017-10-11 03:39:59.232491
NCT01463995|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2017-06-29|||June 2012||2012-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|proNICU||Prognosis in Neurological Intensive Care Unit Patients (proNICU Cohort)|Prognosis in Neurological Intensive Care Unit Patients (proNICU Cohort)|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"     Blood samples (serum, plasma), cerebrovascular fluid   "|||2017-10-11 03:39:59.362982|2017-10-11 03:39:59.362982
NCT01463982|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-04-08|2015-04-08||December 2010||2010-12-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|April 2012|Actual|2012-04-01||Interventional|||Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies|A Phase I Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Cancer|Completed||Phase 1|21|Actual|Hanmi Pharmaceutical Company Limited||1|||f||||f||||||||||2017-10-11 03:39:59.506719|2017-10-11 03:39:59.506719
NCT01463969|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2011-11-01|||May 2010||2010-05-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|||||Observational|||High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome (PCOS)|High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome|Completed||N/A|80|Actual|Gulhane School of Medicine|||2||f||||f||||||||||2017-10-11 03:40:00.237053|2017-10-11 03:40:00.237053
NCT01463956|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2017-01-23|||January 6, 2012||2012-01-06|January 2017|2017-01-01|January 22, 2015|Actual|2015-01-22|June 2014|Actual|2014-06-01||Interventional|||Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation|Pilot Study on the Efficacy of Pegylated Interferon-Ribavirin-Boceprevir Triple Therapy in Patients Infected With Genotype 1 HCV With Cirrhosis and Awaiting Liver Transplantation (ANRS HC 29 BOCEPRETRANSPLANT)|Completed||Phase 2|58|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 03:40:00.32544|2017-10-11 03:40:00.32544
NCT01463943|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-07-24|||February 2012||2012-02-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|ACROSS||Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea|"An Open-Label, Non-Inferiority, Phase III Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® (S. Boulardii - Merck) in the Prevention of Antibiotic-Associated Diarrhea."|Withdrawn||Phase 3|0|Actual|Eurofarma Laboratorios S.A.||3||Change company strategy|f||||||||||||||2017-10-11 03:40:00.509941|2017-10-11 03:40:00.509941
NCT01463930|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2016-02-18|||January 2009||2009-01-01|February 2016|2016-02-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||Audiovisual Videodisc Education and Modification of Expectations With Total Knee Replacement (TKR)|Effects of an Educational Audiovisual Videodisc on Patients' Pre-operative Expectations With Total Knee Replacement: a Randomized Study|Completed||N/A|92|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 03:40:00.659603|2017-10-11 03:40:00.659603
NCT01463917|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-31|||September 2011||2011-09-01|October 2011|2011-10-01|April 2012|Anticipated|2012-04-01|March 2012|Anticipated|2012-03-01||Interventional|||Hypertonic Solution in Off Pump Coronary Artery Bypass Graft Surgery|Use of Hypertonic Versus Isotonic Solutions in Off Pump Coronary Artery Bypass Graft Surgery Targeting the Left Marginal Branch|Unknown status|Recruiting|Phase 4|20|Anticipated|Hospital Pitangueiras||2|||f||||t||||||||||2017-10-11 03:40:00.759772|2017-10-11 03:40:00.759772
NCT01463904|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2011-11-01|||April 2007||2007-04-01|October 2011|2011-10-01|April 2015|Anticipated|2015-04-01|July 2009|Actual|2009-07-01||Observational|SADI-S 250||Single-Anastomosis Duodeno-Ileal Bypass With Sleeve Gastrectomy (SADI-S) for the Treatment of Morbid Obesity and Its Metabolic Complications|Single-Anastomosis Duodeno-Ileal Bypass With Sleeve Gastrectomy (SADI-S) for the Treatment of Morbid Obesity and Its Metabolic Complications|Unknown status|Recruiting|N/A|250|Anticipated|Hospital San Carlos, Madrid|||1||f||||f||||||Samples With DNA|"     Samples of subcutaneous and visceral fat, and samples of liver tissue.   "|||2017-10-11 03:40:00.899804|2017-10-11 03:40:00.899804
NCT01463891|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-12-30|||July 2011||2011-07-01|December 2016|2016-12-01|November 2013|Actual|2013-11-01|December 2012|Actual|2012-12-01||Observational|||Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer (Study HAL01S)|Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer|Completed||N/A|963|Actual|Eisai Inc.|||1||f||||||||||||||2017-10-11 03:40:01.016899|2017-10-11 03:40:01.016899
NCT01463878|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-10-03|2012-06-22||November 2011||2011-11-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|ANUS1014||Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study|Enteral Nutrition and Glycemic Variability NICU Study|Terminated||Phase 4|14|Actual|Eastern Virginia Medical School||2||Unlikely to show statistical significance and slow recruitment.|f||||f||||||||||2017-10-11 03:40:02.037059|2017-10-11 03:40:02.037059
NCT01463865|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-03-19|||November 2011||2011-11-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Selective Block of the Axillary Nerve in Postoperative Pain Management|Selective Block of the Axillary Nerve in Postoperative Pain Management, a Randomised, Blinded, Placebo-controlled Trial|Completed||N/A|60|Actual|Hillerod Hospital, Denmark||2|||f||||f||||||||||2017-10-11 03:40:02.403136|2017-10-11 03:40:02.403136
NCT01463852|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2015-05-08|||October 2012||2012-10-01|February 2014|2014-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)|A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation Status in Patients With Chronic Lymphocytic Leukemia (CLL)|Terminated||Early Phase 1|11|Actual|Dartmouth-Hitchcock Medical Center||1||Enrollment underperformance.|f||||t||||||||||2017-10-11 03:40:02.529506|2017-10-11 03:40:02.529506
NCT00005465|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||August 1991||1991-08-01|May 2001|2001-05-01|July 1996||1996-07-01|||||Observational|||Genetic Mapping of Atherogenic Lipoprotein Phenotypes||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:27:05.450086|2017-10-11 04:27:05.450086
NCT01463800|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-09-28|||May 2011||2011-05-01|September 2017|2017-09-01|January 1, 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Interventional|CARE-GUCH||Rehabilitation in Patients With Congenital Heart Disease|Cardiac Rehabilitation in Patients With Complex Congenital Heart Disease: Improvement of Exercise Intolerance|Terminated||N/A|28|Actual|University Hospital, Basel, Switzerland||2||low inclusion rate|f||||f||||||||||2017-10-11 03:40:02.945228|2017-10-11 03:40:02.945228
NCT01463787|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-04-08|||January 2009||2009-01-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Comparison of Outcomes of Two Approaches in Microsurgical Varicocelectomy in Chinese Infertile Males: A Prospective Randomized, Controlled Trial||Completed||Phase 4|120|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-10-11 03:40:03.062063|2017-10-11 03:40:03.062063
NCT01463774|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2012-11-20|||September 2011||2011-09-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers|Pivotal BE CANA/MET IR FDC - Low Strength|Completed||Phase 1|74|Actual|Janssen Research & Development, LLC||2|||f||||||||||||||2017-10-11 03:40:03.139028|2017-10-11 03:40:03.139028
NCT01463761|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2013-03-05|||July 2010||2010-07-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Autonomic Nervous System, Fatigue and Intolerance to Physical Training, and Overtraining in High-Level Athletes|Autonomic Nervous System, Fatigue and Intolerance to Physical Training, and Overtraining in High-Level Athletes. A Multicentre Study|Completed||N/A|131|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-10-11 03:40:03.243632|2017-10-11 03:40:03.243632
NCT01463748|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-31|2013-07-02|||July 2011||2011-07-01|July 2013|2013-07-01||||April 2013|Actual|2013-04-01||Interventional|||Effects of Graptopetalum Paraguayense E. Walther on the Oxidative Stress, Antioxidant Enzyme Activity and Inflammation in Subjects With Metabolic Syndrome||Completed||Phase 2/Phase 3|54|Actual|Chung Shan Medical University||2|||f||||t||||||||||2017-10-11 03:40:03.350673|2017-10-11 03:40:03.350673
NCT01463735|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-03-17|||November 2011||2011-11-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Vitamin E Supplement in Patients With Cirrhosis and Acanthocytosis||Completed||Phase 2|27|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-10-11 03:40:03.467524|2017-10-11 03:40:03.467524
NCT01463722|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2011-11-01|||March 2010||2010-03-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Accuracy of Amniotic Fluid Lamellar Body Counting for Evaluating of Fetal Lung Maturity|Study of Accuracy of Amniotic Fluid Lamellar Body Counting for Evaluating of Fetal Lung Maturity|Completed||Phase 2|128|Actual|Isfahan University of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:40:03.534435|2017-10-11 03:40:03.534435
NCT01463709|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-02-19|||October 2011||2011-10-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|NPEF||Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer|Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer|Completed||Phase 1|4|Actual|Children's Hospital & Research Center Oakland||1|||f||||f||||||||||2017-10-11 03:40:03.603769|2017-10-11 03:40:03.603769
NCT01463696|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-05-24|2016-03-23||December 21, 2011|Actual|2011-12-21|May 2017|2017-05-01|October 15, 2015|Actual|2015-10-15|September 15, 2014|Actual|2014-09-15||Interventional|||Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)|A Phase I Study to Evaluate the Safety and Tolerability and Pharmacokinetic/Pharmacodynamics of MK-8242 in Patients With Advanced Solid Tumors|Terminated||Phase 1|48|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-10-11 03:40:03.716745|2017-10-11 03:40:03.716745
NCT01463683|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-03-16|2013-10-09||November 2011||2011-11-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)|A Study in Healthy Japanese Young Adults to Assess the Safety, Tolerability, and Immunogenicity of HEPTAVAX-II Manufactured Using a Modified Process|Completed||Phase 3|722|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:40:06.16758|2017-10-11 03:40:06.16758
NCT01463670|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2017-04-25|||October 2011|Actual|2011-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance|A Phase II Clinical Trial of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance|Active, not recruiting||Phase 2|11|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:40:06.592945|2017-10-11 03:40:06.592945
NCT01463657|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2013-01-22|||November 2011||2011-11-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Split-face Comparison Study to Assess ELAPR Compared to Juvéderm® for the Treatment of Nasolabial Folds|A Phase 2 Bilateral (Split-face) Comparison Study to Assess Two Formulations of ELAPR Compared to Juvéderm® Ultra Plus for the Treatment of Moderate to Severe Nasolabial Folds|Completed||Phase 1/Phase 2|30|Anticipated|Elastagen Pty Ltd||2|||f||||f||||||||||2017-10-11 03:40:06.702718|2017-10-11 03:40:06.702718
NCT01463618|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-07-10|||October 2011||2011-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:40:06.935036|2017-10-11 03:40:06.935036
NCT00005466|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1991||1991-08-01|May 2000|2000-05-01|July 1995|Actual|1995-07-01|||||Observational|||Stroke and MI in Users of Estrogen/Progestogen||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.505517|2017-10-11 04:27:05.505517
NCT01463605|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2011-11-01|||October 2011||2011-10-01|October 2011|2011-10-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial|Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Phase II Clinical Trial|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:40:06.974476|2017-10-11 03:40:06.974476
NCT01463592|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2011-11-21|||June 2010||2010-06-01|October 2011|2011-10-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||To Study the Efficacy and Safety of Renessans in Chronic HCV Patients|An Open Labelled, Active Controlled, Three Arm, Parallel- Group Study of the Safety and Efficacy of Renessans Administered Alone and in Combination With Standard Interferon Therapy in Patients Chronic HCV Hepatitis|Unknown status|Active, not recruiting|Phase 3|90|Actual|MTI Medical Private Limited, Pakistan||3|||f||||t||||||||||2017-10-11 03:40:07.051198|2017-10-11 03:40:07.051198
NCT01463579|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-12-11|||December 2011||2011-12-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|REVIVE||Exercise After Intensive Care Unit: a Randomised Controlled Trial|Effectiveness of a Programme of Exercise on Physical Function in Survivors of Critical Illness Following Discharge From the Intensive Care Unit (ICU): a Randomised Controlled Trial|Completed||Phase 2|60|Actual|University of Ulster||2|||f||||t||||||||||2017-10-11 03:40:07.156199|2017-10-11 03:40:07.156199
NCT01463566|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-10-03|||January 2012||2012-01-01|October 2017|2017-10-01|January 2025|Anticipated|2025-01-01|July 2024|Anticipated|2024-07-01||Observational|||Gender Solutions Natural Knee Post-Market Study|Prospective Multicenter Post-market Study of the Zimmer Gender Solutions Natural Knee Flex System|Suspended||N/A|300|Anticipated|Zimmer Biomet|||1|Suspended pending internal review/direction of the company's focus.|f||||f||||||||||2017-10-11 03:40:09.012937|2017-10-11 03:40:09.012937
NCT01463553|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2013-11-10|||July 2011||2011-07-01|November 2013|2013-11-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Improving Primary Spontaneous Pneumothorax (PSP) Treatment Techniques in VATS||Unknown status|Recruiting|Phase 4|320|Anticipated|Beijing Haidian Hospital||2|||f||||t||||||||||2017-10-11 03:40:09.147891|2017-10-11 03:40:09.147891
NCT01463540|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-30|2015-08-17|||September 2010||2010-09-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional|||Gastrostomy Tube Placed After Gastropexy Versus Gastrostomy Tube Placed Using the Traditional Push/Pull Techniques|A Multicentric, Randomised Clinical Trial Comparing Short and Long Time Outcome of Gastrostomy Tube Placed After Gastropexy, Versus Gastrostomy Tube Placed Using the Traditional Push/Pull Techniques|Completed||Phase 4|206|Actual|Arcispedale Santa Maria Nuova-IRCCS||2|||f||||f||||||||||2017-10-11 03:40:09.220241|2017-10-11 03:40:09.220241
NCT01463514|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2015-11-13|||September 2011||2011-09-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension|Noninvasive Determination Of Cerebral Tissue Oxygenation And Cerebral Blood Flow With Near-Infrared Spectroscopy In Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization|Completed||N/A|20|Anticipated|University of Zurich||4|||f||||f||||||||||2017-10-11 03:40:09.690075|2017-10-11 03:40:09.690075
NCT01463501|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-05-11|||October 2011||2011-10-01|September 2011|2011-09-01|December 2016|Anticipated|2016-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer|Prospective Randomized Phase Ⅱ Trial Comparing Preoperative Chemoradiotherapy (Paclitaxel and Carboplatin) Followed by Surgery to Surgery Followed by Postoperative Chemoradiotherapy (Paclitaxel and Carboplatin) for Esophageal Cancer|Unknown status|Recruiting|Phase 2|60|Anticipated|Zhejiang Cancer Hospital||2|||f||||t||||||||||2017-10-11 03:40:09.788314|2017-10-11 03:40:09.788314
NCT01463488|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-29|2012-08-22|||November 2011||2011-11-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I|A Two Part Protocol to Assess, Using Double Blind Placebo Control, the Safety, Tolerability, and Pharmacokinetics of Ascending Single Doses of a New Intra-articular Administration Formulation of SAR113945 (IKK Inhibitor) Followed by Assessment of Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose in Patients With Knee Osteoarthritis|Completed||Phase 1|24|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 03:40:09.889527|2017-10-11 03:40:09.889527
NCT01463475|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-12-02|||September 2011||2011-09-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol|University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol|Completed||N/A|3|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 03:40:09.976125|2017-10-11 03:40:09.976125
NCT01463462|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-05-26|||February 2011||2011-02-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Electronic Catheter Stethoscope|Use of the Electronic Catheter Stethoscope for the Detection of Urinary Tract Injury During Gynecologic Surgery|Completed||N/A|75|Actual|University of South Florida|||1||f||||t||||||||||2017-10-11 03:40:10.135453|2017-10-11 03:40:10.135453
NCT01463449|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2014-08-12|||November 2011||2011-11-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Observational|sCD163||"Can Soluble-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals?"|"Influence of Obesity, Weight Loss, and Diet on Low Grade Inflammation With Particular Focus on the Macrophage Marker, Soluble-CD163 - a New Predictor of Diabetes.Can s-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals?"|Completed||N/A|31|Actual|University of Aarhus|||1||f||||t||||||Samples With DNA|"     Blood, adipose tissue   "|||2017-10-11 03:40:10.282871|2017-10-11 03:40:10.282871
NCT00000197|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||January 1987||1987-01-01|October 2016|2016-10-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Propranolol for Treatment of Cocaine Addiction - 2|Propranolol for Treatment of Cocaine Addiction|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||f||||||||||2017-10-11 04:17:38.323543|2017-10-11 04:17:38.323543
NCT01463436|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2011-11-01|||January 2010||2010-01-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|March 2010|Actual|2010-03-01||Interventional|||The Effect of Soy Isoflavone Supplementation on Endothelial Function|Study of Soy Isoflavone 100 mg/Day in Postmenopausal Women to Elaborate the Effect of Soy Isoflavone in Endothelial Function and to Reduce Oxidative Stress|Completed||Phase 3|200|Actual|Trisakti University||2|||f||||f||||||||||2017-10-11 03:40:10.402574|2017-10-11 03:40:10.402574
NCT01463423|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-10-03|||October 2011||2011-10-01|October 2017|2017-10-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Phase II Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)|Phase II Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)|Recruiting||Phase 2|250|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 03:40:10.530957|2017-10-11 03:40:10.530957
NCT01463410|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2013-05-27|||October 2011||2011-10-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Observational|||Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler|Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler|Terminated||N/A|264|Actual|Skyline Diagnostics BV|||1|"The required number of banked samples could not be met due to limited availability. There is no   realistic possibility to complete the study succesfully."|f||||f||||||Samples With DNA|"     RNA from bone marrow samples will be retained.   "|||2017-10-11 03:40:10.6688|2017-10-11 03:40:10.6688
NCT01463397|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-01-28||2016-01-28|March 2012||2012-03-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Alchemilla||Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain|Multinational, Multicenter, Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain|Completed||Phase 2|191|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:40:10.773259|2017-10-11 03:40:10.773259
NCT01463384|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2014-09-23|2012-10-25||September 2011||2011-09-01|September 2014|2014-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Minocycline in Patients With Alzheimer's Disease|MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy|Completed||Phase 2|13|Actual|Huntington Medical Research Institutes||1|||f||||f||||||||||2017-10-11 03:40:11.005243|2017-10-11 03:40:11.005243
NCT01463371|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2011-10-31|||October 2006||2006-10-01|October 2011|2011-10-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis|Effects of Long-Term Azithromycin Treatment on Airway Oxidative Stress Markers in Patients With Stable Non-Cystic Fibrosis Bronchiectasis|Completed||N/A|30|Actual|Instituto de Investigacion Sanitaria La Fe||2|||f||||t||||||||||2017-10-11 03:40:11.27965|2017-10-11 03:40:11.27965
NCT01463358|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-01-05|||March 2005||2005-03-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|PRESS||Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block|Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block|Completed||N/A|101|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-11 03:40:11.381432|2017-10-11 03:40:11.381432
NCT01463345|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2014-02-02|||November 2011||2011-11-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Blood Conservation in Cardiac Surgery|Blood Conservation in Cardiac Surgery|Terminated||N/A|900|Anticipated|Hackensack University Medical Center||2||PI left and closed study at Hackensack went to RUTGERS - Robert Wood Johnson Medical Center|f||||t||||||||||2017-10-11 03:40:11.495627|2017-10-11 03:40:11.495627
NCT01463332|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2011-10-31|||August 2011||2011-08-01|October 2011|2011-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Effect of Dexmedetomidine on Pain Due to Propofol Injection|Effect of Dexmedetomidine on Pain Due to Propofol Injection:A Randomised, Double-blind, Controlled Clinical Trial|Unknown status|Active, not recruiting|N/A|150|Anticipated|KVG Medical College and Hospital||3|||f||||t||||||||||2017-10-11 03:40:11.574464|2017-10-11 03:40:11.574464
NCT01463319|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2013-02-07|||November 2011||2011-11-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|WW||Warm Water and Unsedated Colonoscopy|Warm Water Colonoscopy: a Novel Method for Unsedated Colonoscopy|Completed||Early Phase 1|818|Actual|Presidio Ospedaliero Santa Barbara||2|||f||||f||||||||||2017-10-11 03:40:11.655771|2017-10-11 03:40:11.655771
NCT01463293|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2014-06-26|2014-06-26||March 2012||2012-03-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|CTT||B. Lactis HN019 for Functional Constipation|Effects of 4-week Bifidobacterium Lactis HN019 Supplementation on Whole Gut Transit Time and Gastrointestinal Symptoms in Adults With Constipation: A Double-blind, Randomized, Placebo-controlled Dose-ranging Trial|Completed||Phase 3|224|Actual|Fonterra Research Centre|A substantial number of protocol violations occurred for the primary end-point. Only 39 out of 224 subjects consumed sufficent radio-opaque markers for baseline and post-intervention transit time.Therefore, the study failed to yield evaluable data.|3|||f||||f||||||||||2017-10-11 03:40:12.667132|2017-10-11 03:40:12.667132
NCT01463280|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-02-23|||January 2011||2011-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Tumescent Lidocaine on Platelet Function|Tumescent Lidocaine Effects on Platelet Function Following Liposuction Surgical Trauma: a Prospective Controlled Dosage-response Phase I Clinical Trial|Completed||Phase 1|129|Actual|Klein, Jeffrey A., M.D.||1|||f||||f||||||||||2017-10-11 03:40:13.223387|2017-10-11 03:40:13.223387
NCT01463267|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2011-10-28|||November 2010||2010-11-01|October 2011|2011-10-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|Heart iRx||Study of Reminding to Improve Medication Adherence in Heart Failure|Heart iRx This Short Non-descriptive Title is the Real Title|Unknown status|Recruiting|N/A|60|Anticipated|Kent State University||4|||f||||f||||||||||2017-10-11 03:40:13.313897|2017-10-11 03:40:13.313897
NCT01463254|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2013-07-11|||October 2011||2011-10-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan|A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan|Completed||N/A|724|Actual|FHI 360|||2||f||||f||||||||||2017-10-11 03:40:13.427664|2017-10-11 03:40:13.427664
NCT01463241|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2015-04-15|||November 2011||2011-11-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|BASIC||Behavioral and Affective Skills in Coping (BASIC) Open Trial|Behavioral and Affective Skills in Coping: Practice-Adapted Child Psychotherapy|Completed||N/A|24|Actual|Judge Baker Children's Center||1|||f||||f||||||||||2017-10-11 03:40:13.54522|2017-10-11 03:40:13.54522
NCT01463228|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2012-08-21|||September 2011||2011-09-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess the Bioequivalence of FDC Tablets of Canagliflozin and Metformin IR (2x150 mg/1000 mg) With Respect to the Individual Components of Canagliflozin (1x300 mg) and Metformin IR (2x1000 mg) Tablets in Healthy Fed Subjects|Completed||Phase 1|83|Actual|Janssen Research & Development, LLC||2|||f||||||||||||||2017-10-11 03:40:13.667432|2017-10-11 03:40:13.667432
NCT01463215|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2013-02-12|||December 2012||2012-12-01|February 2012|2012-02-01|August 2015|Anticipated|2015-08-01|December 2014|Anticipated|2014-12-01||Interventional|||Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease|An Open-Label, Dose Escalation With 2 Dose Levels, Proof-of-Concept Clinical Trial of Ambroxol for the Treatment of Type I Gaucher Disease|Suspended||Phase 1/Phase 2|20|Anticipated|Exsar Corporation||1|||f||||f||||||||||2017-10-11 03:40:13.788513|2017-10-11 03:40:13.788513
NCT01463202|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-02-16|||November 2011||2011-11-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Interventional|DEPO-ABCD||Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression|Effect of Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding Continuation, Contraceptive Continuation, and Postpartum Depression: a Randomized Trial|Active, not recruiting||Phase 4|184|Anticipated|University of Pittsburgh||2|||f||||f||||||||Undecided||2017-10-11 03:40:13.913843|2017-10-11 03:40:13.913843
NCT01463189|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-12-07|||September 2011||2011-09-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Web-based Support to Manage Arthritis Pain|Web-based Support to Manage Arthritis Pain|Completed||Phase 2|228|Actual|Inflexxion, Inc.||2|||f||||t||||||||||2017-10-11 03:40:14.047966|2017-10-11 03:40:14.047966
NCT01463176|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2015-08-10|||October 2011||2011-10-01|August 2015|2015-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Music Therapy as Procedural Support for Young Children Undergoing Immunizations|Music Therapy as Procedural Support for Young Children Undergoing Immunizations: A Randomized Controlled Study|Completed||N/A|150|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 03:40:14.270871|2017-10-11 03:40:14.270871
NCT01463163|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-04-09|||October 2011||2011-10-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)|Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)|Completed||Phase 4|50|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 03:40:14.47992|2017-10-11 03:40:14.47992
NCT01463150|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-07-10|||October 2011||2011-10-01|April 2012|2012-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)|Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)|Completed||Phase 4|27|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 03:40:14.597768|2017-10-11 03:40:14.597768
NCT01463137|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2016-10-29|||October 2011||2011-10-01|October 2016|2016-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|SOFIE-11||Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder|Computerized Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder|Completed||N/A|129|Actual|Umeå University||6|||f||||f||||||||||2017-10-11 03:40:14.706392|2017-10-11 03:40:14.706392
NCT01463124|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-03-12|||September 2012||2012-09-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||School Nurse Intervention and After School Exercise Program for Overweight Teens|School Nurse Intervention and After School Exercise Program for Overweight Teens|Completed||Phase 2|126|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 03:40:14.843987|2017-10-11 03:40:14.843987
NCT01463111|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-05-02|2017-03-21||May 2011||2011-05-01|May 2017|2017-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Decision-Making in Bipolar Disorder|Decision-Making in Bipolar Disorder|Completed||N/A|37|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:40:14.955445|2017-10-11 03:40:14.955445
NCT01463098|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-05-20|||October 2011||2011-10-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006|A 2-Part, Randomized, Double-blind, Placebo- and Active- Controlled, Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Subjects and Otherwise Healthy Subjects With Primary Insomnia|Completed||Phase 1|122|Actual|Eisai Inc.||11|||f||||||||||||||2017-10-11 03:40:15.328977|2017-10-11 03:40:15.328977
NCT01463085|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-05-23|||August 2011||2011-08-01|May 2012|2012-05-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Clinical Trial to Assess the Effects of Low-fat Dairy on Systolic Blood Pressure|A Randomized, Controlled, Trial to Assess the Effects of Low-fat Dairy Intake on Endothelial Function and Blood Pressure in Subjects With Pre-hypertension or Stage 1 Hypertension|Unknown status|Active, not recruiting|N/A|65|Anticipated|Dairy Research Institute||2|||f||||f||||||||||2017-10-11 03:40:15.449153|2017-10-11 03:40:15.449153
NCT00000198|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-10-05|||October 1996||1996-10-01|December 2013|2013-12-01|October 1997|Actual|1997-10-01|October 1997|Actual|1997-10-01||Interventional|||Piracetam for Treatment of Cocaine Addiction - 3|Piracetam for Treatment of Cocaine Addiction|Completed||Phase 1|0||University of Pennsylvania|||||||||||||||||||2017-10-11 04:17:38.396726|2017-10-11 04:17:38.396726
NCT01463072|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-08-18|||June 2012||2012-06-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer|Efficacy and Tolerability of Nanoparticle Albumin Bound Paclitaxel (Abraxane) in Patients 65 and Older With Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 2|40|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 03:40:15.523365|2017-10-11 03:40:15.523365
NCT01463059|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2013-03-19||2013-03-19|October 2011||2011-10-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy|A Randomized, Double-blind, Placebo Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of CDP6038 Administered Subcutaneously for 12 Weeks to Asian Subjects With Active Rheumatoid Arthritis Having Previously Failed TNF Blocker Therapy|Completed||Phase 2|119|Actual|UCB Pharma||6|||f||||f||||||||||2017-10-11 03:40:15.634997|2017-10-11 03:40:15.634997
NCT01463046|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-06-09|||January 2012||2012-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome|A Phase I Dose Finding and Proof-of-concept Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Combination With Standard Dose Cytarabine and Daunorubicin for Older Patients With Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome|Active, not recruiting||Phase 1|28|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:40:15.802382|2017-10-11 03:40:15.802382
NCT01463033|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-12-11|2014-11-11||April 2005||2005-04-01|December 2015|2015-12-01|February 2010|Actual|2010-02-01|June 2008|Actual|2008-06-01||Interventional|||Levetiracetam to Prevent Post-Traumatic Epilepsy|Pilot: Levetiracetam to Prevent Post-Traumatic Epilepsy|Completed||Phase 2|126|Actual|Children's Research Institute||2|||f||||t||||||||||2017-10-11 03:40:15.949223|2017-10-11 03:40:15.949223
NCT01463020|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2013-06-18|||February 2012||2012-02-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Behavioural Activation-Based Treatment Administered Through Smartphone|Behavioural Activation-Based Guided Self-Help Treatment Administered Through a Smartphone Application|Completed||N/A|81|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-11 03:40:16.318398|2017-10-11 03:40:16.318398
NCT01463007|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-05-11|2015-06-24||August 2011||2011-08-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|September 2013|Actual|2013-09-01||Interventional|||Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer|ACCELERATED PARTIAL BREAST IRRADIATION USING NON-INVASIVE IMAGE-GUIDED BREAST BRACHYTHERAPY (ACCUBOOST) FOR EARLY STAGE BREAST CANCERS: A TOXICITY ASSESSMENT|Active, not recruiting||N/A|40|Actual|Brown University||2|||f||||t||||||||||2017-10-11 03:40:16.413487|2017-10-11 03:40:16.413487
NCT01462994|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-03-16|||November 2011||2011-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)|Prospective, Explorative Trial for the Detection of Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)Harboring Activating Mutations of CKIT or PDGFRA Pre/Post Surgery or Pre/Under Treatment With a Tyrosine Kinase Inhibitor or Progressive Disease Irrespective of Current or Planned Treatment. An Open-label, Non-randomized, Multicenter Phase IIIb Clinical Trial|Completed||Phase 3|25|Actual|Technische Universität München||1|||f||||f||||||||||2017-10-11 03:40:16.685992|2017-10-11 03:40:16.685992
NCT01462981|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2011-11-01|||September 2011||2011-09-01|November 2011|2011-11-01|July 2012|Anticipated|2012-07-01|||||Observational|COBRA||Cohort of Hepatitis B Research of Amsterdam|Cohort of Hepatitis B Research of Amsterdam|Unknown status|Recruiting|N/A|172|Anticipated|Public Health Service of Amsterdam|||1||f||||f||||||Samples With DNA|"     Serum, White cells   "|||2017-10-11 03:40:16.762867|2017-10-11 03:40:16.762867
NCT01462968|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-06-25|||November 2011||2011-11-01|October 2011|2011-10-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery|Interruptions in the Coagulationsystem in Relation With Cardiac Surgery -A Randomized Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery|Withdrawn||N/A|0|Actual|Aalborg Universitetshospital||2||The study never started due to problems with Laboratory facilities in collaborating center|f||||f||||||||||2017-10-11 03:40:16.835799|2017-10-11 03:40:16.835799
NCT01462955|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-11-05|||October 2011||2011-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:40:16.9306|2017-10-11 03:40:16.9306
NCT01462942|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2016-12-22|2016-09-14||October 2011||2011-10-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination|Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-dose Combinations Compared With Individual Components and Placebo When Administered to Patients With Stable Chronic Obstructive Pulmonary Disease.|Completed||Phase 3|2443|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 03:40:17.034335|2017-10-11 03:40:17.034335
NCT01462929|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2016-11-16|2013-03-27||November 2011||2011-11-01|November 2016|2016-11-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Multiple Dose, Double-blind, Double-dummy, Placebo Controlled, Parallel Clinical Trial to Assess the Efficacy and Safety of Twice Daily Inhaled Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|414|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 03:40:19.175054|2017-10-11 03:40:19.175054
NCT01462916|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-07-11|||October 2014||2014-10-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Observational|||Honey in Chronic Immune Thrombocytopenia|Effect of Honey Bee Honey Intake on Children With Chronic Immune Thrombocytopenia|Suspended||Phase 2|30|Anticipated|Ain Shams University|||1|problem with the candidate (investigator)|f||||t||||||||||2017-10-11 03:40:19.706408|2017-10-11 03:40:19.706408
NCT01441076|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-04-03|2016-04-05||September 2011||2011-09-01|April 2017|2017-04-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Anakinra for Behcet s Disease|A Pilot Study of Anakinra in Behcet's Disease (BD)|Completed||Phase 1/Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||No||2017-10-11 03:47:38.690197|2017-10-11 03:47:38.690197
NCT01462903|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-11-21|||September 2011||2011-09-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors|A Phase I Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors|Unknown status|Recruiting|Phase 1|20|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 03:40:19.804496|2017-10-11 03:40:19.804496
NCT01462890|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-07-14|||November 2011||2011-11-01|July 2017|2017-07-01|November 2021|Anticipated|2021-11-01|November 2018|Anticipated|2018-11-01||Interventional|BOOST||Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer|A Prospective Randomised Phase III Trial to Evaluate Optimal Treatment Duration of First-line Bevacizumab in Combination With Carboplatin and Paclitaxel in Patients With Primary Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer|Active, not recruiting||Phase 3|800|Anticipated|AGO Study Group||2|||f||||t||||||||||2017-10-11 03:40:19.935066|2017-10-11 03:40:19.935066
NCT01462877|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-28|2015-02-25|2015-02-06||October 2011||2011-10-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional||Full Analysis Set|A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic|An Open-label, Multi-center Study to Evaluate the Efficacy and Safety of Statin-fenofibrate Combination Therapy in Dyslipidemic Chinese Patients|Completed||Phase 4|506|Actual|Abbott||1|||f||||f||||||||||2017-10-11 03:40:20.430761|2017-10-11 03:40:20.430761
NCT01462864|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-05-25|||September 2011||2011-09-01|October 2011|2011-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SUCCESS||Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome|StructUred eduCation Programme to Improve Cardiovascular Risk in womEn With polycyStic Ovary Syndrome; SUCCESS Study|Completed||N/A|162|Actual|University of Leicester||2|||f||||f|f|f||||||No||2017-10-11 03:40:20.869587|2017-10-11 03:40:20.869587
NCT01462851|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2012-03-12|||September 2011||2011-09-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults|A Phase 1, Randomized Investigator-And-Subject-Blind, Sponsor Open, Placebo Controlled Two-Part Study To Characterize The Pharmacokinetics And Pharmacodynamics Of Single Doses Of Pf-05297909 In Healthy Adult Subjects|Completed||Phase 1|51|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:40:20.98447|2017-10-11 03:40:20.98447
NCT01462838|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-06-22|||August 2011||2011-08-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Immune Therapy of HPV-induced Cancers|Phase I/IIa Study of Immunization With a p16INK4a Peptide Combined With MONTANIDE ISA-51 VG in Patients With Advanced HPV-associated Cancers|Completed||Phase 1/Phase 2|26|Actual|Oryx GmbH & Co. KG||1|||f||||t||||||||||2017-10-11 03:40:21.117723|2017-10-11 03:40:21.117723
NCT01462825|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2012-12-17|||November 2011||2011-11-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||The Effect of Tomato Ketchup on Inflammation|The Protective Effect of Tomato Ketchup Consumption on Inflammation Induced Ex-vivo in Human Blood|Completed||N/A|6|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:40:21.243792|2017-10-11 03:40:21.243792
NCT01462812|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-04-20|2015-04-20||January 2011||2011-01-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of a Single 20 mg Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine With or Without Aura|Completed||Phase 3|223|Actual|Optinose US Inc.||2|||f||||f||||||||||2017-10-11 03:40:21.368923|2017-10-11 03:40:21.368923
NCT01462799|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-27|||September 2011||2011-09-01|October 2011|2011-10-01|March 2019|Anticipated|2019-03-01|March 2015|Anticipated|2015-03-01||Interventional|CORPRIM||COR-PRIM: Problem-based Learning (PBL) After Coronary Heart Disease (CHD) - Long-term Evaluation in Primary Care of Self-care|COR-PRIM: Problem-based Learning in Patient Education After an Event of Coronary Heart Disease. A Randomised Study in Primary Care of Long-term Effects on Self-care|Recruiting||N/A|150|Anticipated|Linkoeping University||2|||f||||f||||||||||2017-10-11 03:40:21.761064|2017-10-11 03:40:21.761064
NCT01462786|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2016-05-05|||October 2011||2011-10-01|May 2016|2016-05-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101|Phase 1, Open-Label, Crossover, Safety and Pharmacokinetic Study of ATX-101 (Sodium Deoxycholate Injection) Following Subcutaneous Injections in the Submental and Abdominal Areas|Completed||Phase 1|5|Actual|Kythera Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 03:40:21.883494|2017-10-11 03:40:21.883494
NCT01462773|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-12-30|2014-12-10||January 2006||2006-01-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|October 2010|Actual|2010-10-01||Interventional|||Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma|A Phase I Study of PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma.|Completed||Phase 1|16|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:40:21.965252|2017-10-11 03:40:21.965252
NCT01462760|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-10-27|||October 2011||2011-10-01|October 2011|2011-10-01|August 2012|Anticipated|2012-08-01|May 2012|Anticipated|2012-05-01||Interventional|BIOVAL||Contribution of Actigraphy for the Evaluation of Elbow Range of Motion in the Joint Assessment in Gerontology|Contribution of Actigraphy for the Evaluation of Elbow Range of Motion in the Joint Assessment in Gerontology|Unknown status|Recruiting|N/A|85|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 03:40:22.162805|2017-10-11 03:40:22.162805
NCT01462747|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2013-02-12|||December 2011||2011-12-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|||Efficacy and Safety Study of a Medical Device (KULIST)to Treat Perianal Fistulas|An Open Prospective Study Evaluating the Efficacy and Safety of a Medical Device,KULIST, for the Treatment of Chronic, Non-complicated Perianal Fistulas|Completed||Phase 2|28|Actual|Nordic Drugs AB||1|||f||||f||||||||||2017-10-11 03:40:22.259249|2017-10-11 03:40:22.259249
NCT01462734|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2015-03-31|||October 2011||2011-10-01|March 2015|2015-03-01||||December 2014|Actual|2014-12-01||Observational|||MicroRNA Expression in Human Blood Serum and Vitreous Body|MicroRNA Expression in Human Blood Serum and Vitreous Body|Completed||N/A|8|Actual|Kyorin University|||1||f||||f||||||Samples With DNA|"     3ml of blood serum and 1ml of vitreous   "|||2017-10-11 03:40:22.351804|2017-10-11 03:40:22.351804
NCT01462721|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2014-02-27|||October 2011||2011-10-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||The eSVS® Mesh Randomized Post-Market Study|Post-market Study to Evaluate Post-implant Patency Rates of the External Saphenous Vein Support (eSVS®) Mesh in the Treatment of Saphenous Vein Grafts (SVGs) During Coronary Artery Bypass Grafting (CABG) Versus SVGs Without the eSVS Mesh.|Terminated||N/A|12|Actual|Kips Bay Medical, Inc.||1|||f||||t||||||||||2017-10-11 03:40:22.421844|2017-10-11 03:40:22.421844
NCT01462708|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-11-08|||May 2011||2011-05-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MK9470||Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects|Evaluation of [18F] MK-9470 and PET as a Marker of Cannabinoid-1 Receptor Activity in Subjects With Parkinson Disease Compared With Healthy Controls|Completed||Phase 1|16|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-10-11 03:40:22.508175|2017-10-11 03:40:22.508175
NCT01462695|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-08-18|2015-02-05||January 2012||2012-01-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma|A Phase II Study of Sunitinib (NSC# 736511) in Recurrent, Refractory or Progressive High Grade Glioma and Ependymoma Tumors in Pediatric and Young Adult Patients|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:40:22.895434|2017-10-11 03:40:22.895434
NCT01462682|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-06-20|||July 2011||2011-07-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Perception of Fatigue Among Surgeons During Night Shifts|Perception of Fatigue Among Surgeons During Night Shifts, a Focus Group Study.|Completed||N/A|13|Actual|Herlev Hospital|||1||f||||f||||||||||2017-10-11 03:40:23.560415|2017-10-11 03:40:23.560415
NCT01462669|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-06-09|||April 10, 2012|Actual|2012-04-10|June 2017|2017-06-01|June 27, 2012|Actual|2012-06-27|June 27, 2012|Actual|2012-06-27||Interventional|||Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects|An Open-label, Randomized, Single Centre, 4-way Crossover Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ezogabine/Retigabine in Healthy Adult Taiwanese Subjects|Completed||Phase 1|1|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:40:23.690496|2017-10-11 03:40:23.690496
NCT01462656|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-11-23|||February 2011||2011-02-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Risk of Urinary Retention With Retigabine|A Post Marketing Surveillance Study to Monitor the Risk of Urinary Retention in Retigabine Users|Terminated||N/A|1|Anticipated|GlaxoSmithKline|||1|"This study was halted as the preliminary analysis revealed that the numbers were too low to   warrant continuing the project"|f||||f||||||||||2017-10-11 03:40:23.811989|2017-10-11 03:40:23.811989
NCT01462643|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-28|||August 2011||2011-08-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|PPT4||Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test|A 22 Day Controlled, Randomized Clinical Study (PPT) Investigating the Anti-psoriatic Efficacy and the Tolerability of an Ointment Containing a Retinoid and a Steroid in Different Concentrations|Completed||Phase 2|22|Actual|Almirall, S.A.||7|||f||||f||||||||||2017-10-11 03:40:23.910464|2017-10-11 03:40:23.910464
NCT01462630|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-01-24|||November 3, 2011|Actual|2011-11-03|January 2017|2017-01-01|December 15, 2020|Anticipated|2020-12-15|December 15, 2018|Anticipated|2018-12-15||Interventional|||Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma|Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma|Recruiting||Phase 2|30|Anticipated|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 03:40:24.014886|2017-10-11 03:40:24.014886
NCT01462617|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-07-24|||July 24, 2011|Actual|2011-07-24|July 2017|2017-07-01|March 26, 2012|Actual|2012-03-26|March 26, 2012|Actual|2012-03-26||Interventional|||Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557|A Single-centre. Double-blind, Placebo Controlled Three Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Repeat Doses of Nebulised GSK2269557 in Healthy Male Subjects|Completed||Phase 1|61|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:40:24.14901|2017-10-11 03:40:24.14901
NCT01462604|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2013-07-30|||November 2011||2011-11-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer|PROACTYVE Pilot:Pilot Study of Patient's Adherence to TYKERB™/TYVERB™+Capecitabine in Metastatic Breast Cancer-Observation of Patient Adherence and Evaluation of Predictive Factors for Patient Adherence After Providing Educational Programme|Completed||N/A|27|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:40:24.259406|2017-10-11 03:40:24.259406
NCT01462591|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2014-08-04|||May 2011||2011-05-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||L-citrulline Supplementation & Cold Exposure|The Effects L-citrulline Supplementation on Arterial Stiffness, Wave Reflection, and Cardiac Autonomic Responses to Cold Exposure With Isometric Exercise|Completed||Phase 1/Phase 2|16|Actual|Florida State University||2|||f||||f||||||||||2017-10-11 03:40:24.345817|2017-10-11 03:40:24.345817
NCT01462578|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-09-13|||September 2011||2011-09-01|September 2017|2017-09-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|RELAZA2||Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)|Treatment of Patients With MDS or AML With an Impending Hematological Relapse With Azacitidine (Vidaza)|Recruiting||Phase 2|93|Anticipated|Technische Universität Dresden||1|||f||||f||||||||||2017-10-11 03:40:24.445785|2017-10-11 03:40:24.445785
NCT01462552|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-04-14|||December 2010||2010-12-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Physician Liver Function Test (LFT) Monitoring for Tykerb Pts|Assessment of Physician Compliance to Recommended Liver Function Test Monitoring for Tykerb Patients|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 03:40:24.754022|2017-10-11 03:40:24.754022
NCT01462539|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-11-29|||October 2011||2011-10-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Observational|||Adenotonsillectomy and Obstructive Sleep Apnea Study|Factors That Increase Length of Stay After Outpatient Surgery of 3-6 Year Olds With OSAS Symptoms Versus Without OSAS Symptoms After Adenotonsillectomy|Completed||N/A|200|Actual|Nationwide Children's Hospital|||2||f||||f||||||||||2017-10-11 03:40:24.839253|2017-10-11 03:40:24.839253
NCT01462513|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-07-13|||August 2011||2011-08-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LICC||L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases|LICC: L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases - a Randomized, Placebo-controlled, Multicenter, Multinational, Double Blinded Phase II Trial|Active, not recruiting||Phase 2|122|Actual|Johannes Gutenberg University Mainz||2|||f||||t||||||||||2017-10-11 03:40:24.991474|2017-10-11 03:40:24.991474
NCT01462500|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-08-18|||October 2011||2011-10-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|May 2014|Actual|2014-05-01||Interventional|PK||Pharmacokinetics of Miltefosine in Children and Adults|Pharmacokinetics of Miltefosine in Children and Adults: Implications for the Treatment of Cutaneous Leishmaniasis in Colombia.|Completed||Phase 4|60|Actual|Centro Internacional de Entrenamiento e Investigaciones Médicas||1|||f||||f||||||||||2017-10-11 03:40:25.1604|2017-10-11 03:40:25.1604
NCT01462487|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-04-17|||July 2011||2011-07-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Safety of Inhaled Zanamivir in Pregnancy|Assessing the Safety of Inhaled Zanamivir Exposure in Pregnant Women|Completed||N/A|1|Actual|GlaxoSmithKline|||3||f||||f||||||||||2017-10-11 03:40:25.261969|2017-10-11 03:40:25.261969
NCT01462474|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2011-11-14|||October 2011||2011-10-01|November 2011|2011-11-01||||July 2012|Anticipated|2012-07-01||Interventional|FMTN-I-LNPC||Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma|Phase I Study of Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 1|21|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||||2017-10-11 03:40:25.350636|2017-10-11 03:40:25.350636
NCT01462461|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-10-14|||October 2011||2011-10-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|VIE||Virtual Integrated Environment in Decreasing Phantom Limb Pain|Pilot Study of the Efficacy of a Virtual Integrated Environment in Decreasing Phantom Limb Pain|Completed||N/A|14|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine|||1||f||||f||||||||||2017-10-11 03:40:25.447959|2017-10-11 03:40:25.447959
NCT01462448|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-10-05|||March 2012||2012-03-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|April 2014|Actual|2014-04-01||Observational|||Study to Identify the Genetic Variations Associated With Phantom Limb Pain|Study to Identify the Genetic Variations Associated With Phantom Limb Pain|Active, not recruiting||N/A|41|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine|||2||f||||f|f|f||||Samples With DNA|"     Whole blood, serum   "|||2017-10-11 03:40:25.5407|2017-10-11 03:40:25.5407
NCT01462435|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2014-01-02|2013-02-20||October 2011||2011-10-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Study of Diclofenac Capsules to Treat Pain Following Bunionectomy|A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Diclofenac [Test] Capsules for the Treatment of Acute Postoperative Pain After Bunionectomy|Completed||Phase 3|428|Actual|Iroko Pharmaceuticals, LLC||4|||f||||f||||||||||2017-10-11 03:40:25.683281|2017-10-11 03:40:25.683281
NCT01462422|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2014-06-13|||December 2011||2011-12-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India|Two Community Strategies Comparing Use of Misoprostol for Secondary Prevention to Primary Prevention for Postpartum Hemorrhage: A Randomized Cluster Non-Inferiority Study in Bijapur District, Karnataka, India|Completed||N/A|3032|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 03:40:26.419906|2017-10-11 03:40:26.419906
NCT01462409|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-09-17|||March 2011||2011-03-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Humidity Under Continuous Positive Airway Pressure|Luftfeuchtigkeit Unter CPAP Mit Temperatur- Und Feuchtigkeitskontrolle|Completed||N/A|19|Actual|Institut für Pneumologie Hagen Ambrock eV||3|||f||||f||||||||||2017-10-11 03:40:26.563438|2017-10-11 03:40:26.563438
NCT01462396|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-02-04|||October 2011||2011-10-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|STALLO||Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors|Phase I Study of Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using Major Histocompatibility Complex (MHC) Mismatched Related Donors and Sub-Myeloablative Regimen|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-10-11 03:40:26.683848|2017-10-11 03:40:26.683848
NCT01462383|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2011-12-09|||January 2011||2011-01-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||The Role of the EKG in Anticancer Drug Development|The Role of the EKG in Anticancer Phase I Drug Development|Completed||N/A|525|Actual|M.D. Anderson Cancer Center|||1||f||||t||||||||||2017-10-11 03:40:26.990045|2017-10-11 03:40:26.990045
NCT01462370|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2015-10-08|2013-05-21||November 2011||2011-11-01|October 2015|2015-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)|A Phase III, Randomized, Active-Comparator-Controlled, 2-period, Crossover, Double-Blind Study in China to Assess the Safety and Efficacy of Etoricoxib 120 mg Versus Ibuprofen up to 2400 mg (600 mg Q6h) in the Treatment of Patients With Primary Dysmenorrhea|Completed||Phase 3|139|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 03:40:27.074558|2017-10-11 03:40:27.074558
NCT01462188|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-28|||October 2011||2011-10-01|October 2011|2011-10-01|October 2015|Anticipated|2015-10-01|October 2012|Anticipated|2012-10-01||Interventional|OPTIMASTRATEGY||Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study|Immediate Versus Delayed Stenting in Patients With ST-Elevation Myocardial Infarction Undergoing Mechanical Intervention|Unknown status|Recruiting|Phase 4|100|Anticipated|Università degli Studi di Ferrara||2|||f||||t||||||||||2017-10-11 03:40:37.15326|2017-10-11 03:40:37.15326
NCT01462357|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-03-02|2014-08-11||November 2011||2011-11-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil® Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females|Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 Vaccine and Merck's Gardasil® Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females|Completed||Phase 3|1079|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:40:27.714712|2017-10-11 03:40:27.714712
NCT01462344|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-03-21|2016-05-02||November 2011||2011-11-01|March 2017|2017-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|VESTRI||6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old|A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma|Completed||Phase 4|6250|Actual|GlaxoSmithKline||4|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:40:30.837638|2017-10-11 03:40:30.837638
NCT01462331|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-07-24|||November 2010||2010-11-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||the Dietary Effects of VitaSugar/VitaFiber-IMO in Healthy Adults|Double-blind, Randomized, Placebo Controlled Study to Investigate the Dietary Effects of VitaSugar/VitaFiber-IMO in Healthy Adults|Completed||Phase 1|60|Actual|BioNeutra Inc.||3|||f||||f||||||||||2017-10-11 03:40:34.293487|2017-10-11 03:40:34.293487
NCT01462318|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-01-23|2017-01-23|2014-10-13|November 2011||2011-11-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|OBSERVE||An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis|A Multicenter, Single-Arm, Open-Label Study to Evaluate the Immunogenicity and Pharmacokinetics of BIIB019, Daclizumab High Yield Process (DAC HYP), Prefilled Syringe Administered by Subcutaneous Injection in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|133|Actual|Biogen||1|||f||||t||||||||||2017-10-11 03:40:34.428189|2017-10-11 03:40:34.428189
NCT01462305|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2012-08-06|||December 2011||2011-12-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|SAD||30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder|30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder|Terminated||N/A|36|Actual|Philips Respironics||2||enrollment targets having been met|f||||f||||||||||2017-10-11 03:40:35.33345|2017-10-11 03:40:35.33345
NCT01462279|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-03-03|2016-10-07||September 2011||2011-09-01|March 2017|2017-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|VO2||Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness|The Effect of Thiamine on VO2 Levels in Critically Ill Patients|Completed||N/A|20|Actual|Beth Israel Deaconess Medical Center||1|||f||||t||||||||||2017-10-11 03:40:35.570526|2017-10-11 03:40:35.570526
NCT01462266|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2017-03-24|2014-01-08||January 13, 2012|Actual|2012-01-13|March 2017|2017-03-01|June 7, 2013|Actual|2013-06-07|June 6, 2013|Actual|2013-06-06||Interventional||One participant in both the Sitagliptin group and Placebo group was randomized in error and did not receive study medication.|Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin|Completed||Phase 3|660|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:40:35.787527|2017-10-11 03:40:35.787527
NCT01462240|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-08-31|||May 20, 2008|Actual|2008-05-20|August 2017|2017-08-01|December 2024|Anticipated|2024-12-01|June 2024|Anticipated|2024-06-01||Observational|||LPS Flex Porous Femoral Components|Prospective Multicenter Post-market Study of the Zimmer NexGen LPS-Flex Porous Femoral Components|Active, not recruiting||N/A|150|Anticipated|Zimmer Biomet|||1||f||||f||||||||||2017-10-11 03:40:36.405595|2017-10-11 03:40:36.405595
NCT01462227|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2016-02-17|2016-01-20||August 2011||2011-08-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Baseline population includes subjects that completed study|Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia|The Effect of Opiate Blockade With Naltrexone on Counterregulatory Mechanisms in Hypoglycemia|Completed||N/A|17|Actual|Yale University||2|||f||||f||||||||||2017-10-11 03:40:36.480273|2017-10-11 03:40:36.480273
NCT01462214|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-05-09|||October 2011||2011-10-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer|Phase 1-2 Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer.|Completed||Phase 1/Phase 2|96|Anticipated|VU University Medical Center||1|||f||||f||||||||||2017-10-11 03:40:36.950071|2017-10-11 03:40:36.950071
NCT01462201|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2013-11-10|||July 2012||2012-07-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||A Multicenter,2-Arm,Randomized,Controlled Study Evaluate the Effectiveness of the UltraShape® Contour I VER 3.1 System for Non-Invasive Reduction in Abdominal Circumference|A Multicenter,Two-Arm,Randomized,Controlled Study for the Evaluation of the Treatment of Adipose Tissue Using a Focused Ultrasound Device|Completed||N/A|156|Actual|UltraShape||2|||f||||t||||||||||2017-10-11 03:40:37.068995|2017-10-11 03:40:37.068995
NCT01462175|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2016-11-01|||November 2011||2011-11-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia|A Multi-center, Open Label, First in Human Phase I Dose Escalation Study of Single Agent RO5503781, a Small Molecule MDM2 Antagonist, Administered Orally in Patients With Advanced Malignancies, Except Leukemia|Completed||Phase 1|99|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:40:37.256076|2017-10-11 03:40:37.256076
NCT01462162|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2016-09-08|2015-12-01||September 2011||2011-09-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational||All participants who satisfied inclusion and exclusion criteria of the study were included in the analysis.|A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis|A Prospective Observational Study to Evaluate and Correlate the Impact of Treatment With Tocilizumab (RoActemra®) on Fatigue and Different Factors Influencing Fatigue in Participants With Rheumatoid Arthritis in Routine Clinical Practice|Completed||N/A|122|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:40:37.433209|2017-10-11 03:40:37.433209
NCT01462149|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-05-27|||October 2011||2011-10-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer|Phase II Trial of Docetaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer|Completed||Phase 2|43|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:40:38.508657|2017-10-11 03:40:38.508657
NCT01462136|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2012-08-21|||September 2011||2011-09-01|August 2012|2012-08-01||||||||Interventional|||PK Study of ACHN-490 Injection in Renally Impaired Subjects|A Phase 1 Study To Assess The Pharmacokinetics, Safety, And Tolerability of Intravenous ACHN-490 Injection in Volunteers With Varying Degrees of Renal Dysfunction Compared to Healthy Volunteers|Completed||Phase 1|24|Actual|Achaogen, Inc.||1|||f||||f||||||||||2017-10-11 03:40:38.584309|2017-10-11 03:40:38.584309
NCT01462123|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-27|2011-10-28|||February 2011||2011-02-01|October 2011|2011-10-01||||||||Observational|||Resect and Discard Strategy in Clinical Practice||Completed||N/A|286|Actual|Valduce Hospital|||1||f||||||||||||||2017-10-11 03:40:38.6565|2017-10-11 03:40:38.6565
NCT01462110|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2011-12-20|||November 2011||2011-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:40:38.723741|2017-10-11 03:40:38.723741
NCT01462097|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-08-04|||March 2012||2012-03-01|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|October 31, 2017|Anticipated|2017-10-31||Interventional|AWARD||Exercise Trial in Chronic Kidney Disease|Randomized Trial of Aerobic Exercise Training on Cognitive and Physical Function in Chronic Kidney Disease|Active, not recruiting||N/A|99|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 03:40:38.759298|2017-10-11 03:40:38.759298
NCT01462084|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-04-13|2016-10-19||September 2011||2011-09-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional||A total of 60 patients were screened, 21 met the inclusion criteria, 1 dropped out, 2 patients were not titrated according to protocol and were excluded, leaving data from 18 patients available for inclusion in the analysis.|Effectiveness of Adaptive Servoventilation (ASV) in Patients With Central Sleep Apnea Due to Chronic Opioid Use|Effectiveness of Adaptive Servoventilation (ASV) in Patients With Central Sleep Apnea Due to Chronic Opioid Use|Completed||N/A|21|Actual|ResMed||2|||f||||f|f|t|f||f|||No|There is no plan to share IPD with other researchers|2017-10-11 03:40:38.839429|2017-10-11 03:40:38.839429
NCT01462071|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2016-02-22|||May 2008||2008-05-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|RBC||Red Blood Cell Lifespan|Red Blood Cell Lifespan and Inflammation in Dialysis Patients|Terminated||N/A|58|Actual|Renal Research Institute|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 03:40:39.02313|2017-10-11 03:40:39.02313
NCT01462058|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2012-03-28|||October 2011||2011-10-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|D3-vit-SAD||The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff||Completed||Phase 4|50|Actual|Region Syddanmark||2|||f||||t||||||||||2017-10-11 03:40:39.198769|2017-10-11 03:40:39.198769
NCT01462045|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2014-12-15|2013-06-05||October 2011||2011-10-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy Study of Mindfulness-Based Exercise for Posttraumatic Stress Disorder (PTSD)|The Efficacy of Mindfulness-Based Stretching and Breathing Exercise as a Complementary Therapy for Posttraumatic Stress Disorder: A Prospective Randomized Study|Completed||N/A|29|Actual|University of New Mexico||3|||f||||f||||||||||2017-10-11 03:40:39.313109|2017-10-11 03:40:39.313109
NCT01462032|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-06-03|||April 2011||2011-04-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|NIPA||Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD)|Training Executive, Attention, and Motor Skills (TEAMS): Preliminary Studies|Completed||Phase 2|52|Actual|Queens College, The City University of New York||2|||f||||f||||||||||2017-10-11 03:40:39.684815|2017-10-11 03:40:39.684815
NCT01462019|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2011-10-26|||February 2006||2006-02-01|October 2011|2011-10-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional|||Photobiomodulation as a New Approach for the Treatment of Nipple Traumas||Completed||Phase 1/Phase 2|||Pontifícia Universidade Católica de Minas Gerais||2|||f||||||||||||||2017-10-11 03:40:39.767287|2017-10-11 03:40:39.767287
NCT01462006|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-05-09|||October 2015|Actual|2015-10-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)|Double-blind Placebo-controlled Pilot Study of Sirolimus in IPF|Active, not recruiting||N/A|32|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 03:40:39.854637|2017-10-11 03:40:39.854637
NCT01461993|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2014-11-21|2014-11-21|2014-07-25|September 2011||2011-09-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17|A Phase 2, Randomized, Active-controlled, Observer-blinded Trial, To Assess The Safety, Tolerability, And Immunogenicity Of Gardasil (Registered) (Hpv) Vaccine And Bivalent Rlp2086 Vaccine When Administered Concomitantly In Healthy Subjects Aged >=11 To <18 Years|Completed||Phase 2|2499|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 03:40:39.991256|2017-10-11 03:40:39.991256
NCT00000199|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-03-28||||||March 2017|2017-03-01||||||||Interventional|||Piracetam for Treatment of Cocaine Addiction, Phase II - 4|Piracetam for Treatment of Cocaine Addiction, Phase II|Withdrawn||Phase 1|0|Actual|University of Pennsylvania|||||f||||||||||||||2017-10-11 04:17:38.467662|2017-10-11 04:17:38.467662
NCT01461980|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-07|2015-05-07||September 2011||2011-09-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Intent-to-treat (ITT) population included all participants who were randomized.|A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age|A Phase 2, Randomized, Active-controlled, Observer-blinded Trial, To Assess The Safety, Tolerability, And Immunogenicity Of Mcv4, Tdap Vaccine And Bivalent Rlp2086 Vaccine When Administered Concomitantly In Healthy Subjects Aged > = 10 To <13 Years|Completed||Phase 2|2648|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 03:40:41.45969|2017-10-11 03:40:41.45969
NCT01461967|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-11-01|||September 2011||2011-09-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers|A Single-Center, Randomized, Double-Blind, Single and Multiple Ascending-Dose, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics (Including the Effect of Food) and Pharmacodynamics of RO5508887 Following Oral Administration in Healthy Subjects.|Completed||Phase 1|49|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:40:43.041224|2017-10-11 03:40:43.041224
NCT01461954|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-09-14||2015-03-25|May 2013||2013-05-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||FST-100 in the Treatment of Acute Viral Conjunctivitis|A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis|Completed||Phase 2|132|Actual|Shire||2|||f||||f||||||||||2017-10-11 03:40:43.121959|2017-10-11 03:40:43.121959
NCT01461941|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2014-01-31|||December 2011||2011-12-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||A Phase 2 Study of E6005 in Patients With Atopic Dermatitis|A Phase 2 Study of E6005 in Patients With Atopic Dermatitis|Completed||Phase 2|78|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 03:40:43.208059|2017-10-11 03:40:43.208059
NCT01461928|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-09-08|||December 31, 2011|Actual|2011-12-31|September 2017|2017-09-01|August 31, 2018|Anticipated|2018-08-31|August 31, 2018|Anticipated|2018-08-31||Interventional|MabCute||A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab|A Randomized Study Comparing Maintenance Therapy With Subcutaneous Rituximab Continued Until Progression With Observation Only in Patients With Relapsed or Refractory, Indolent Non-Hodgkin's Lymphoma Who Completed and Responded to Rituximab-based Immunochemotherapy Induction and Initial 2-year Rituximab Maintenance Therapy Administered Subcutaneously|Active, not recruiting||Phase 3|694|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:40:43.327995|2017-10-11 03:40:43.327995
NCT01461915|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-08-25||2016-08-24|November 2011||2011-11-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|December 2012|Actual|2012-12-01||Interventional|PGPC1||Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane|A Randomized Phase II Open Label Study to Assess the Efficacy & Safety of Gemcitabine + Abraxane® With or Without ODSH (2-0, 3-0 Desulfated Heparin) as First Line Treatment of Metastatic Pancreatic Cancer|Completed||Phase 2|61|Actual|Cantex Pharmaceuticals||3|||f||||||||||||||2017-10-11 03:40:43.824601|2017-10-11 03:40:43.824601
NCT01461902|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2015-01-30|||September 2011||2011-09-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|PTBI||Vasospasm in Pediatric Traumatic Brain Injury|Measuring Vasospasm, Biomarkers, and Neurocognitive Outcomes in Pediatric Traumatic Brain Injury|Completed||N/A|6|Actual|Duke University|||1||f||||t||||||||||2017-10-11 03:40:44.096935|2017-10-11 03:40:44.096935
NCT01461889|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-03-23|||July 2011||2011-07-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|I-TRIGER||INR-Triggered Transfusion In GI Bleeders From ER|Transfusion-related Acute Lung Injury in Patients With Liver Disease|Terminated||Phase 3|50|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 03:40:44.168047|2017-10-11 03:40:44.168047
NCT01461876|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2015-10-11|||November 2009||2009-11-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Obesity in HIV After Antiretroviral Therapy|Changes in Overweight/Obesity Status, hsCRP, and D-dimer in HIV-infected Patients After 12 Months of Initial Antiretroviral Treatment|Completed||N/A|200|Actual|Duke University|||2||f||||f||||||Samples Without DNA|"     These samples represent residual plasma retained after clinical testing (HIV RNA PCR) has     been completed. Since the samples were obtained as part of routine clinical care, they are     part of the HIV samples repository at Duke University Medical Center.   "|||2017-10-11 03:40:44.255531|2017-10-11 03:40:44.255531
NCT01461863|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-09-26|||October 2011||2011-10-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|DarDar2B||DarDar Nutrition Study in HIV Breastfeeding Women|Effects of Protein-calorie Supplementation on HIV Disease in Breastfeeding Women|Completed||Phase 2/Phase 3|96|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-11 03:40:44.334726|2017-10-11 03:40:44.334726
NCT01461850|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-03-25|||September 2011||2011-09-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|May 2016|Anticipated|2016-05-01||Interventional|SCORPION||Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm|Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm|Recruiting||Phase 3|166|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 03:40:44.409867|2017-10-11 03:40:44.409867
NCT01461837|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-05-05|||January 2012||2012-01-01|May 2017|2017-05-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|HaploSCD||Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease|Familial Haploidentical T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (IND 14359)|Recruiting||Phase 2|20|Anticipated|New York Medical College||1|||f||||t||||||||||2017-10-11 03:40:44.50405|2017-10-11 03:40:44.50405
NCT01461811|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-08-09|2013-08-09||December 2011||2011-12-01|August 2013|2013-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||This reporting group includes all enrolled and dispensed participants.|Prospective Study of an Investigational Toric Soft Contact Lens|ARES Registration Trial|Completed||N/A|154|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:40:44.793104|2017-10-11 03:40:44.793104
NCT01461798|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2011-10-26|||October 2011||2011-10-01|October 2011|2011-10-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|Ben2011||Assessment of the Efficacy of Plant Stanol Esters in Reducing Cholesterol, Medellin 2011|Assessment of the Efficacy of Plant Stanol Esters in Reducing Cholesterol, Medellin 2011|Unknown status|Not yet recruiting|N/A|40|Anticipated|CES University||2|||f||||t||||||||||2017-10-11 03:40:45.567992|2017-10-11 03:40:45.567992
NCT01461785|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-22|2012-07-14|||April 2012||2012-04-01|July 2012|2012-07-01|November 2013|Anticipated|2013-11-01|June 2013|Anticipated|2013-06-01||Interventional|||The Use of Activated Platelet Rich Plasma (PRP) in Human Autologous Fat Transfer|The Use of Activated Platelet Rich Plasma (PRP) in Human Autologous Fat Transfer|Unknown status|Recruiting|Phase 2/Phase 3|32|Anticipated|Bergman Clinics||2|||f||||f||||||||||2017-10-11 03:40:45.693368|2017-10-11 03:40:45.693368
NCT01461772|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-05-27|||December 2009||2009-12-01|May 2017|2017-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer|Comparison of Concurrent Chemoradiation Therapy With Weekly Cisplatin and Concurrent Chemoradiation Therapy With Weekly Carboplatin in Locally Advanced Cervical Cancer: Phase III Multicenter Prospective Randomized Controlled Trial|Terminated||Phase 3|21|Actual|Asan Medical Center||2||Because of very slow rate of enrollement|f||||f||||||||||2017-10-11 03:40:45.848895|2017-10-11 03:40:45.848895
NCT01461759|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-05-27|||October 2011||2011-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer|A Phase II Trial of Docetaxel / Cisplatin in Patients With Recurrent or Stage IVb Endometrial Cancer|Recruiting||Phase 2|59|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:40:45.941348|2017-10-11 03:40:45.941348
NCT01461746|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-05-27|||October 2011||2011-10-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer|A Phase II Trial of Docetaxel/Cisplatin Chemotherapy Followed by Pelvic Radiation Therapy in Patients, With High-risk Endometrial Carcinoma After Staging Surgery|Recruiting||Phase 2|67|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:40:46.028315|2017-10-11 03:40:46.028315
NCT01461733|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-19|2014-09-09|2014-09-09||July 2007||2007-07-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|AFIB||Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit|Atrial Fibrillation WITHOUT Hemodynamic Stability|Completed||Phase 4|25|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 03:40:46.11932|2017-10-11 03:40:46.11932
NCT01461720|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-03-30|||March 2012||2012-03-01|March 2015|2015-03-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct|An Open Lable, Phase II Exploratory Study Assessing the Efficacy of Intravenous Autologous Mesenchymal Stem Cells in Patients With Middle Cerebral Artery Infarct|Unknown status|Recruiting|Phase 2|50|Anticipated|National University of Malaysia||2|||f||||f||||||||||2017-10-11 03:40:46.348426|2017-10-11 03:40:46.348426
NCT01461707|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-03-24|2017-03-24||October 2012||2012-10-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||The MOTHER (Mobile Technologies to Help Enhancing Regular Physical Activity) Trial for Pregnant Women|A Pilot Study of a Mobile Phone-Based Physical Activity Program in Pregnant Women|Completed||N/A|30|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:40:46.466277|2017-10-11 03:40:46.466277
NCT01461694|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-05-11|||November 2011||2011-11-01|May 2012|2012-05-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser|Comparison of Intense Pulsed Light System 650 Advance Hand-Piece and Alexandrite Laser for Female Facial Hair Reduction|Unknown status|Enrolling by invitation|Phase 2/Phase 3|35|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 03:40:46.847895|2017-10-11 03:40:46.847895
NCT01461681|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2014-05-13|||March 2012||2012-03-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Improving Care of Patients With Heart Failure|A Randomized Controlled Trial for Patients With Heart Failure|Completed||N/A|30|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:40:46.959478|2017-10-11 03:40:46.959478
NCT01461668|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2016-10-25|||July 2012||2012-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Retapamulin for Reducing MRSA Nasal Carriage|Retapamulin for Reducing MRSA Nasal Carriage|Active, not recruiting||Phase 4|150|Anticipated|University of California, Irvine||2|||f||||t||||||||||2017-10-11 03:40:47.050767|2017-10-11 03:40:47.050767
NCT01461655|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-12-30|2013-04-17||November 2011||2011-11-01|December 2016|2016-12-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris|Exploratory Study Evaluating the Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris, Using a Split-Face Model|Completed||Phase 2|40|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 03:40:47.146973|2017-10-11 03:40:47.146973
NCT01461642|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2011-10-27|||October 2011||2011-10-01|October 2011|2011-10-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|E-ASTHMA||E-support for Healthcare Processes - ASTHMA|E-support for Healthcare Processes - ASTHMA|Unknown status|Recruiting|N/A|120|Anticipated|The University Clinic of Pulmonary and Allergic Diseases Golnik||2|||f||||f||||||||||2017-10-11 03:40:47.479308|2017-10-11 03:40:47.479308
NCT01461629|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2016-04-06|||June 2010||2010-06-01|April 2016|2016-04-01||||April 2015|Actual|2015-04-01||Observational|Heart ABC||Self-management and Cognitive Function in Adults With Heart Failure|Cognitive Impairment and Self-management in Adults With Heart Failure|Completed||N/A|372|Actual|Kent State University|||1||f||||||||||Samples Without DNA|"     Urinary sodium   "|||2017-10-11 03:40:47.587022|2017-10-11 03:40:47.587022
NCT01461616|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-12-03|||February 2012||2012-02-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis|Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on IGFBP-1 Production and Serum IGF-I in Subjects With Type 1 Diabetes Mellitus: An Open-label, Randomised, Triple Cross-over Trial|Completed||Phase 3|19|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 03:40:47.678451|2017-10-11 03:40:47.678451
NCT00005467|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||January 1990||1990-01-01|May 2000|2000-05-01|December 1992|Actual|1992-12-01|||||Observational|||Indices of Severity and Prognosis for Sickle Cell Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.562064|2017-10-11 04:27:05.562064
NCT01461603|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-03-02|||September 2011||2011-09-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|February 2013|Actual|2013-02-01||Interventional|||Local Effects of Amino Acids and 3-hydroxybutyrate in the Bilaterally Perfused Human Leg|Local Effects of Amino Acids and 3-hydroxybutyrate in the Bilaterally Perfused Human Leg|Active, not recruiting||N/A|10|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:40:47.821666|2017-10-11 03:40:47.821666
NCT01461590|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2015-03-31|||October 2011||2011-10-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|Tx30||Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia|Phase II Trial of Transfusion Volumes in Children With Acute Severe Anaemia|Completed||Phase 2|160|Actual|KEMRI-Wellcome Trust Collaborative Research Program||2|||f||||f||||||||||2017-10-11 03:40:47.90352|2017-10-11 03:40:47.90352
NCT01461577|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2013-01-29|||November 2011||2011-11-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|GAUDI||Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure|A Multicenter, Open-label, Single-arm, 24 Week Phase IV Study Evaluating the Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure|Completed||Phase 4|89|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:40:47.981759|2017-10-11 03:40:47.981759
NCT01461564|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2014-06-15|||January 2010||2010-01-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Carbon Dioxide During Screening Unsedated Colonoscopy|Randomized Clinical Trial to Compare Air Versus Carbon Dioxide in Screening Unsedated Colonoscopy.|Completed||Phase 4|200|Actual|Jagiellonian University||2|||f||||f||||||||||2017-10-11 03:40:48.059581|2017-10-11 03:40:48.059581
NCT01461551|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-05-06|2014-11-05||October 2011||2011-10-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|February 2012|Actual|2012-02-01||Interventional|OPCAB||Anesthesia and Lymphocytes Apoptosis|Different Effects of Sevoflurane, Propofol and Combine of Sevoflurane and Propofol Maintained Anesthesia on Peripheral Blood Lymphocytes During Off-pump Coronary Artery Bypass Graft Surgery|Completed||N/A|105|Actual|Ruijin Hospital||3|||f||||t||||||||||2017-10-11 03:40:48.143003|2017-10-11 03:40:48.143003
NCT01461538|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-02-05|2015-12-18||October 2011||2011-10-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All participants who received treatment. One additional patient enrolled, but withdrew prior to treatment group assignment.|Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies|A Phase 2, Open-label Study of Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies|Completed||Phase 2|84|Actual|Seattle Genetics, Inc.||3|||f||||f||||||||||2017-10-11 03:40:48.675236|2017-10-11 03:40:48.675236
NCT01461525|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2016-10-04|||October 2011||2011-10-01|September 2016|2016-09-01|September 2021|Anticipated|2021-09-01|September 2019|Anticipated|2019-09-01||Interventional|ASPIRE||Comparison of Sphincter Preservation Surgery and Abdominoperineal Resection (APR): Prospective Clinical Trial|Comparison of Sphincter Preservation Surgery Versus Abdominoperineal Resection for Low Rectal Cancer: Prospective Clinical Trial|Active, not recruiting||N/A|342|Actual|Seoul National University Hospital||2|||f||||t||||||||Undecided||2017-10-11 03:40:50.564317|2017-10-11 03:40:50.564317
NCT01461512|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2011-10-26|||January 2009||2009-01-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Heme Arginate in Functional Magnetic Resonance Imaging (fMRI)|The Effects of Intravenous Heme Arginate on Functional Magnetic Resonance Imaging During Ischemia|Unknown status|Active, not recruiting|Phase 2|16|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 03:40:50.700005|2017-10-11 03:40:50.700005
NCT01461486|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2013-01-23|||October 2011||2011-10-01|January 2013|2013-01-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|OSAS||Continuous Positive Airway Pressure and Oral Appliances Treatments in Mild Obstructive Sleep Apnea|Effectiveness of Continuous Positive Airway Pressure and Oral Appliances in Mild Obstructive Sleep Apnea: a Randomized, Parallel, Single Blind and Controlled Study|Unknown status|Recruiting|N/A|90|Anticipated|Associação Fundo de Incentivo à Pesquisa||3|||f||||t||||||||||2017-10-11 03:40:50.920482|2017-10-11 03:40:50.920482
NCT01461473|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-04-14|2016-12-08||December 2011||2011-12-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|COMET||Comparative Outcomes Management With Electronic Data Technology (COMET) Study|R01: Comparative Outcomes Management With Electronic Data Technology (COMET) Study|Completed||N/A|131|Actual|Stanford University||2|||f||||t||||||||No||2017-10-11 03:40:51.087114|2017-10-11 03:40:51.087114
NCT01461460|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2016-05-02|||November 2011||2011-11-01|May 2016|2016-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects|A Phase 1 Blinded, Placebo-controlled Crossover Study to Evaluate the Effects of Oral TR 701 Free Acid on the Electrocardiogram|Completed||Phase 1|48|Actual|Trius Therapeutics LLC||4|||f||||f||||||||||2017-10-11 03:40:51.739597|2017-10-11 03:40:51.739597
NCT01461447|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-05-23|||March 2012||2012-03-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|HIVIS06||Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines|Safety and Immunogenicity Following Further Boosting With HIV-1 MVA-CMDR Vaccine to HIVIS03 Volunteers Who Were Primed With HIV-1 DNA Low Dose Intradermally or 'Standard' Dose Intramuscularly and Boosted With MVA-CMDR Vaccine|Completed||Phase 1/Phase 2|20|Actual|Muhimbili University of Health and Allied Sciences||1|||f||||t||||||||||2017-10-11 03:40:51.82066|2017-10-11 03:40:51.82066
NCT01461434|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2015-12-20|||November 2011||2011-11-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|May 2015|Actual|2015-05-01||Interventional|GRAF||Graz Study on the Risk of Atrial Fibrillation|Randomized Controlled Trial to Evaluate Implanted Event Recorders for the First Diagnosis of Atrial Fibrillation in High-risk Patients|Active, not recruiting||Phase 4|82|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 03:40:51.893673|2017-10-11 03:40:51.893673
NCT01461421|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-04-06|||July 2011||2011-07-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Acceptance Based Behavioral Intervention for Weight Loss: A Randomized Trial|Acceptance Based Behavioral Intervention for Weight Loss: A Randomized Trial|Completed||N/A|160|Actual|The Miriam Hospital||2|||f||||t||||||||||2017-10-11 03:40:51.985961|2017-10-11 03:40:51.985961
NCT01461408|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2013-10-09|||May 2013||2013-05-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Promoting Human Papillomavirus (HPV) Vaccination Through African American Beauty Salons|Promoting HPV Vaccination Through African American Beauty Salons: a Pilot Test of a Culturally-Competent Education and Empowerment Strategy|Completed||N/A|240|Actual|MEE Productions, Inc.||16|||f||||t||||||||||2017-10-11 03:40:52.095142|2017-10-11 03:40:52.095142
NCT01461395|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-02|2012-08-23|||October 2008||2008-10-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm|A Non-invasive Method to Assess DNA Damage in Individual Sperm|Completed||N/A|84|Actual|University of South Florida|||1||f||||t||||||Samples With DNA|"     sperm   "|||2017-10-11 03:40:52.210597|2017-10-11 03:40:52.210597
NCT01461382|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-27|||May 2008||2008-05-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Workplace Intervention: Activity Monitoring as a Tool for Corporate Wellness and Weight Loss|Workplace Intervention: Activity Monitoring as a Tool for Corporate Wellness and Weight Loss|Completed||N/A|36|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:40:52.267399|2017-10-11 03:40:52.267399
NCT01461369|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2014-04-29|2014-03-12||October 2011||2011-10-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Interventional|||Study of Diclofenac Capsules to Treat Osteoarthritis Pain|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy and Safety Study of Diclofenac [Test] Capsules in Subjects With Osteoarthritis of the Knee or Hip|Completed||Phase 3|305|Actual|Iroko Pharmaceuticals, LLC||3|||f||||f||||||||||2017-10-11 03:40:52.365236|2017-10-11 03:40:52.365236
NCT01461356|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2011-10-27|||March 2007||2007-03-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Minimally Invasive Surgical Approaches In Total Knee Arthroplasty|Prospective, Randomized, Controlled, Blinded Functional Outcomes Of Two Contemporary Surgical Approaches In Total Knee Arthroplasty|Completed||N/A|40|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:40:53.386749|2017-10-11 03:40:53.386749
NCT01461343|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-03-22|||February 2013||2013-02-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Hypertension Using Positron Emission Tomography Imaging|Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Arterial Hypertension Using Functional Positron Emission Tomography Imaging|Recruiting||N/A|15|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:40:53.515803|2017-10-11 03:40:53.515803
NCT01461330|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-01-25|||February 2011|Actual|2011-02-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Lifestyle Changes in Patients With Type 2 Diabetes Mellitus and Hypertension|Lifestyle Changes in Patients With Type 2 DM and Hypertension: DASH Diet and Exercise Effects|Terminated||N/A|40|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 03:40:53.630364|2017-10-11 03:40:53.630364
NCT01461317|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-03-14|||November 30, 2011|Actual|2011-11-30|March 2017|2017-03-01|August 8, 2016|Actual|2016-08-08|August 8, 2016|Actual|2016-08-08||Interventional|||Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis|A Phase II Open-Label Extension Study to Evaluate the Long-Term Safety of Etrolizumab in Patients With Moderate to Severe Ulcerative Colitis|Completed||Phase 2|121|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:40:53.718502|2017-10-11 03:40:53.718502
NCT01461304|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-10-04||||||October 2017|2017-10-01||||||||Expanded Access|||Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism|Dietary Therapy for Inherited Disorders of Energy Metabolism|Available||N/A|||University of Pittsburgh|||||||||||||||||||2017-10-11 03:40:53.85024|2017-10-11 03:40:53.85024
NCT01461291|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-10-23|||October 2011||2011-10-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery|A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery|Unknown status|Active, not recruiting|Phase 3|1200|Anticipated|Glaukos Corporation||2|||f||||t||||||||||2017-10-11 03:40:53.929143|2017-10-11 03:40:53.929143
NCT01461278|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-03-23|||October 2011||2011-10-01|March 2016|2016-03-01|April 2019|Anticipated|2019-04-01|January 2019|Anticipated|2019-01-01||Interventional|||Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery|A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery|Recruiting||Phase 3|1200|Anticipated|Glaukos Corporation||2|||f||||t||||||||||2017-10-11 03:40:54.072954|2017-10-11 03:40:54.072954
NCT01461265|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-07-13|||November 2011||2011-11-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases|Cryoablation for the Palliation of Painful Bone Metastases|Completed||Phase 1|29|Actual|Galil Medical||1|||f||||f||||||||||2017-10-11 03:40:56.109831|2017-10-11 03:40:56.109831
NCT01461252|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2014-03-31|||April 2013||2013-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases|Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases|Withdrawn||Phase 1|0|Actual|Galil Medical||1||No patients were treated due to enrollment challenges.|f||||f||||||||||2017-10-11 03:40:56.266445|2017-10-11 03:40:56.266445
NCT01461239|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2017-04-05|||July 2009||2009-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Interventional|||Clinical Comparison of Endodontically Treated Teeth Restored With Fiber Posts or Cast Metal Posts|Randomized Clinical Comparison of Endodontically Treated Teeth Restored With Fiber Posts or Cast Metal Posts|Recruiting||Phase 3|200|Anticipated|Federal University of Pelotas||3|||f||||f||||||||||2017-10-11 03:40:56.411224|2017-10-11 03:40:56.411224
NCT01461226|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-28|||June 2011||2011-06-01|October 2011|2011-10-01|September 2013|Anticipated|2013-09-01|July 2013|Anticipated|2013-07-01||Interventional|EDOC||Endothelial Dysfunction in Obese Children|Adolescent Obesity: What Determines Vascular Endothelial Dysfunction And Is The Process Reversible?|Unknown status|Recruiting|Phase 3|60|Anticipated|University Hospital, Antwerp||2|||f||||f||||||||||2017-10-11 03:40:56.553317|2017-10-11 03:40:56.553317
NCT01461213|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-03-16|||October 2011||2011-10-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|February 2017|Anticipated|2017-02-01||Interventional|||Gene Therapy for Blindness Caused by Choroideremia|An Open Label Dose Escalation Phase 1 Clinical Trial of Retinal Gene Therapy for Choroideraemia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1)|Active, not recruiting||Phase 1/Phase 2|14|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 03:40:56.688172|2017-10-11 03:40:56.688172
NCT01461200|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-03-26|||March 2011||2011-03-01|March 2014|2014-03-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Observational|||Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome|A Parallel Group Observational Study of the Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome|Completed||N/A|40|Actual|University of Chicago|||2||f||||f||||||||||2017-10-11 03:40:56.836099|2017-10-11 03:40:56.836099
NCT01461187|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-26|||April 2008||2008-04-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Effects in Type of Birth of Physical Exercise During Pregnancy|Effects in Type of Birth of Physical Exercise During Pregnancy|Completed||N/A|66|Actual|Hospital do Servidor Publico Estadual||2|||f||||t||||||||||2017-10-11 03:40:56.980048|2017-10-11 03:40:56.980048
NCT01461174|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-02-03|||November 2011||2011-11-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers|Effects of 15-day Donepezil and Memantine on Cognitive Functions After a 24 Hours Sleep Deprivation Challenge in Healthy Volunteers: a Double-blind, Placebo-controlled, Randomised, Cross-over Study, With Modafinil as Positive Control|Completed||Phase 1|36|Actual|Qualissima||3|||f||||t||||||||||2017-10-11 03:40:57.208012|2017-10-11 03:40:57.208012
NCT01461161|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-03-30|||October 2011||2011-10-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl|A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl|Completed||Phase 1|32|Actual|Reata Pharmaceuticals, Inc.||3|||f||||||||||||||2017-10-11 03:40:57.338637|2017-10-11 03:40:57.338637
NCT01461148|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-06-22|||August 2011||2011-08-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Vaccination Against MSI Colorectal Cancer|Phase I/IIa Study of Immunization With Frameshift Peptides Administered With Montanide® ISA-51 VG in Patients With Advanced MSI-H Colorectal Cancer|Completed||Phase 1/Phase 2|22|Actual|Oryx GmbH & Co. KG||1|||f||||t||||||||||2017-10-11 03:40:57.425961|2017-10-11 03:40:57.425961
NCT01461109|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-06-02|||August 2011||2011-08-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|September 2012|Actual|2012-09-01||Interventional|||Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls|Evaluation of [18F] CFPyPB PET as a Marker of Glycine Transporter-1 (GlyT1) Receptor in Subjects With Parkinson Disease, Alzheimer Disease and Healthy Subjects|Completed||Phase 1|4|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-10-11 03:40:57.531608|2017-10-11 03:40:57.531608
NCT01461096|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-02-10|2016-12-14||March 2012||2012-03-01|December 2016|2016-12-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional||All participants randomized who had results for the respective baseline measure available. The numbers of participants for each measure are shown below.|Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women|A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men and Women|Completed||Phase 3|575|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 03:40:57.660453|2017-10-11 03:40:57.660453
NCT01461083|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-06-02|||September 2011||2011-09-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|November 2012|Actual|2012-11-01||Interventional|MPPF||Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a|Phase I Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a in Subjects With Parkinson Disease and Healthy Subjects|Completed||Phase 1|19|Actual|Institute for Neurodegenerative Disorders||1|||f||||t||||||||||2017-10-11 03:40:58.689526|2017-10-11 03:40:58.689526
NCT01461070|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-07-18|||August 7, 2011||2011-08-07|July 12, 2017|2017-07-12||||||||Observational|||Intestine Bacteria and Breast Cancer Risk|BRANCH:Fecal Microbiota Among Participants in a Pre-paid Health Plan|Completed||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:40:58.769309|2017-10-11 03:40:58.769309
NCT01461057|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-26|2017-08-18|2016-05-19||December 6, 2011||2011-12-06|August 2017|2017-08-01|September 30, 2017|Anticipated|2017-09-30|March 1, 2015|Actual|2015-03-01||Interventional|||A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer|An Open-Label, Randomized, Multicenter Phase IIa Study Evaluating Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer|Active, not recruiting||Phase 2|30|Actual|Hoffmann-La Roche||2|||f||||f||||||||||2017-10-11 03:40:58.866805|2017-10-11 03:40:58.866805
NCT01461044|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-12-18|2015-10-22||September 2011||2011-09-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational||Efficacy population included all participants who did not violate any inclusion or exclusion.|An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer|An Ambispective, Non Interventional Study of 2 Cohorts (Triple Negative or HR+) of Patients With HER2- Metastatic or Locally Advanced Breast Cancer Treated With Avastin® (Bevacizumab) 1st Line for at Least 12 Months and Without Progression for at Least 12 Months.|Completed||N/A|228|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:41:00.057345|2017-10-11 03:41:00.057345
NCT01461031|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2012-07-04|||October 2011||2011-10-01|July 2012|2012-07-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Effect of Nefopam on Acute Postoperative Pain in Patients Undergoing Orthognathic Surgery|Effect of Nefopam on Acute Postoperative Pain in Patients Undergoing Orthognathic Surgery|Unknown status|Recruiting|N/A|40|Anticipated|The Catholic University of Korea||1|||f||||t||||||||||2017-10-11 03:41:01.274764|2017-10-11 03:41:01.274764
NCT01461018|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-11-25|||October 2011||2011-10-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)|A Multicenter Study of Long-Term Clinical Outcomes of Immune Globulin Subcutaneous (Human) (SCIG) IgPro20 in Subjects With Primary Immunodeficiency|Completed||Phase 3|22|Actual|CSL Behring||1|||f||||||||||||||2017-10-11 03:41:01.396704|2017-10-11 03:41:01.396704
NCT01461005|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-10-06|||September 2011||2011-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|DSS||A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS)|A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System(DSS)|Completed||N/A|1|Actual|Paradigm Spine||1|||f||||f||||||||||2017-10-11 03:41:01.57411|2017-10-11 03:41:01.57411
NCT01460992|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-11-27|||March 2012||2012-03-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Observational|ProMRIAFFIRM||ProMRI AFFIRM Study of the EVIA/ENTOVIS Pacemaker With Safio S Pacemaker Leads|Master Study for the MRI Compatibility of the EVIA/ENTOVIS Pacemaker in Combination With Safio S Pacemaker Lead|Completed||N/A|121|Actual|Biotronik SE & Co. KG|||1||f||||t||||||||||2017-10-11 03:41:01.658029|2017-10-11 03:41:01.658029
NCT01460979|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-02-26|||October 2011||2011-10-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|||Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma|Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma|Completed||Phase 2|47|Actual|AGO Study Group||1|||f||||f||||||||||2017-10-11 03:41:01.762318|2017-10-11 03:41:01.762318
NCT01460966|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2017-04-19|||July 2012||2012-07-01|April 2017|2017-04-01|January 31, 2017|Actual|2017-01-31|December 23, 2015|Actual|2015-12-23||Interventional|VAMPIRE3||Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)|Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)|Completed||N/A|200|Actual|Yokohama City University Medical Center||2|||f||||t||||||||||2017-10-11 03:41:01.923383|2017-10-11 03:41:01.923383
NCT01460953|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-10-14|||October 2011||2011-10-01|October 2015|2015-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Use of a Training Video to Teach Medical Students About Health Literacy|Use of a Training Video to Teach Medical Students About Health Literacy|Completed||N/A|110|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-10-11 03:41:02.013795|2017-10-11 03:41:02.013795
NCT01460940|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2017-01-24|2017-01-24||October 13, 2011||2011-10-13|January 2017|2017-01-01|November 16, 2016|Actual|2016-11-16|November 16, 2016|Actual|2016-11-16||Interventional|||A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma|Completed||Phase 2|24|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:41:02.092291|2017-10-11 03:41:02.092291
NCT01460927|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-06-04|2013-09-06||October 2011||2011-10-01|June 2014|2014-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||TriActive+ Radiofrequency (RF) for Non-invasive Treatment of Wrinkles & Rhytides|Clinical Study to Evaluate the Performance of TriActive+ RF for the Non-invasive Treatment of Wrinkles & Rhytides|Completed||N/A|25|Actual|Deka Medical, Inc.||1|||f||||t||||||||||2017-10-11 03:41:02.363859|2017-10-11 03:41:02.363859
NCT01460914|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-05-04|||October 2011||2011-10-01|May 2016|2016-05-01|October 2050|Anticipated|2050-10-01|September 2050|Anticipated|2050-09-01||Observational|||Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment|Outcomes of Cutaneous T-Cell Lymphoma and Chronic Graft-Versus-Host Disease in Patients Treated With Extracorporeal Photopheresis|Active, not recruiting||N/A|100|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||||2017-10-11 03:41:02.575497|2017-10-11 03:41:02.575497
NCT01460901|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-02-04|||October 2011||2011-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|STALLONe||Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma|Phase I Study of Donor Derived,Gene Modified, Multi-virus-specific, Cytotoxic T-Lymphocytes Redirected to the Tumor Marker GD2 for Relapsed/Refractory Neuroblastoma Post-allogeneic Stem Cell Transplantation With a Submyeloblative Conditioning Regimen|Completed||Phase 1|5|Actual|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-10-11 03:41:02.652656|2017-10-11 03:41:02.652656
NCT01460888|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2013-08-16|||July 2013||2013-07-01|December 2011|2011-12-01|August 2018|Anticipated|2018-08-01|July 2015|Anticipated|2015-07-01||Interventional|ROCOCO||Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus|Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus. A Phase I Trial.|Recruiting||Phase 1|36|Anticipated|The Christie NHS Foundation Trust||5|||f||||t||||||||||2017-10-11 03:41:02.737697|2017-10-11 03:41:02.737697
NCT01460875|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-05-17|||April 2008||2008-04-01|May 2016|2016-05-01||||January 2014|Actual|2014-01-01||Interventional|||Recombinant Interferon Alfa-2b in Treating Patients With Melanoma|Pilot Study of IFN-alpha-2b Dose Reduction With Dose Optimization|Active, not recruiting||N/A|35|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:41:02.878174|2017-10-11 03:41:02.878174
NCT01460862|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-03-25|||May 2011||2011-05-01|March 2016|2016-03-01||||||||Observational|||Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations|Analyze the Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations Among Patients With Uncontrolled Asthma Receiving High Dose Inhaled Corticosteroids|Active, not recruiting||N/A|||Novartis|||1||f||||||||||||||2017-10-11 03:41:02.98286|2017-10-11 03:41:02.98286
NCT01460849|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-03-25|||March 2011||2011-03-01|March 2016|2016-03-01||||||||Observational|||Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers|Assess the Increased Mortality Risk With Each Year of Delayed TIS Initiation, and the Effect of TIS on Mortality Across Study Centers|Active, not recruiting||N/A|||Novartis|||1||f||||||||||||||2017-10-11 03:41:03.053518|2017-10-11 03:41:03.053518
NCT01460836|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2011-10-26|||April 2010||2010-04-01|October 2011|2011-10-01||||October 2010|Actual|2010-10-01||Observational|||Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis|Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis|Completed||N/A|||Novartis|||2||f||||||||||||||2017-10-11 03:41:03.113016|2017-10-11 03:41:03.113016
NCT01460823|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-12-15|||October 2011||2011-10-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|October 2012|Actual|2012-10-01||Interventional|PCI-I||Percutaneous Cochlear Implantation: Implementation of Technique|Percutaneous Cochlear Implantation: Implementation of Technique|Terminated||N/A|5|Actual|Vanderbilt University||1||Currently in the process of submitting IDE to the FDA|f||||t||||||||||2017-10-11 03:41:03.183773|2017-10-11 03:41:03.183773
NCT01460810|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-08-29|||July 2011||2011-07-01|August 2017|2017-08-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma|A Prospective Pilot Study of Surgical Radiation Shielding With Vitrectomy & Silicone Oil Tamponade for the Protection of Radiation-induced Ocular Injury in the Treatment of Choroidal Melanoma With Radioactive Iodine-125 Plaque Brachytherapy|Recruiting||N/A|20|Anticipated|University of Colorado, Denver||1|||f||||f||||||||||2017-10-11 03:41:03.277825|2017-10-11 03:41:03.277825
NCT01460797|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2011-10-25|||October 2004||2004-10-01|October 2011|2011-10-01|October 2006|Actual|2006-10-01|June 2005|Actual|2005-06-01||Interventional|||Metabolic Effects of a Caloric Restriction High/Low Glycemic Index Diet Plus Metformin in Overweight/Obese Subjects|Effects of a Caloric Restriction High/Low-glycemic Index Diets and in Combination With Metformin on Glucose Metabolism, Lipid Profile and Body Composition in Overweight/Obese Subjects|Completed||N/A|41|Actual|University of Brasilia||3|||f||||t||||||||||2017-10-11 03:41:03.409323|2017-10-11 03:41:03.409323
NCT01460784|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-12-01|||June 2010||2010-06-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Observational|STAGES||STAGES Trial: Study of Adiposity, Growth and Endocrine Stages|Changes in Adipokines and Adiposity During Puberty and Young Adulthood|Completed||N/A|575|Actual|University of Utah|||3||f||||t||||||Samples With DNA|"     Buffy coat in -80F long-term storage   "|||2017-10-11 03:41:03.51864|2017-10-11 03:41:03.51864
NCT01460758|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2014-04-25|||April 2011||2011-04-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|ACDC||Effectiveness of rTMS With Double-Cone-Coil in Patients With Major Depression|Effectiveness of Medial Frontal Repetitive Transcranial Magnetic Stimulation With Double-Cone-Coil in Patients With Major Depression|Completed||N/A|45|Actual|University of Regensburg||3|||f||||f||||||||||2017-10-11 03:41:03.695251|2017-10-11 03:41:03.695251
NCT01460745|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2014-02-03|||November 2011||2011-11-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|RESECT||A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice|A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice|Completed||N/A|60|Actual|Merck KGaA|||1||f||||||||||||||2017-10-11 03:41:03.795513|2017-10-11 03:41:03.795513
NCT01460732|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-07-08|2012-02-05||November 2010||2010-11-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-Dippers|Home Versus Ambulatory Monitoring in the Assessment of the Diurnal Blood Pressure Profile and the Detection of Non-Dippers|Completed||N/A|81|Actual|University of Athens||1|||f||||f||||||||||2017-10-11 03:41:03.882733|2017-10-11 03:41:03.882733
NCT01460719|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-04-17|||January 24, 2012|Actual|2012-01-24|April 2017|2017-04-01|September 25, 2012|Actual|2012-09-25|September 25, 2012|Actual|2012-09-25||Interventional|||A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With HM Receiving Treatment With Anti-CD20 Monoclonal Antibodies (V212-013)|A Phase I, Open-Label, Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of V212/Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies Receiving Treatment With Anti-CD20 Monoclonal Antibodies|Completed||Phase 1|80|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 03:41:04.16818|2017-10-11 03:41:04.16818
NCT01460706|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2013-12-11|||October 2011||2011-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|DOTAGLI||Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT|PET/CT Imaging of Malignant Glioma With Somatostatin Analog 68Ga-DOTATOC|Completed||Phase 2/Phase 3|30|Actual|Turku University Hospital||1|||f||||t||||||||||2017-10-11 03:41:04.25492|2017-10-11 03:41:04.25492
NCT01460693|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-01|2011-10-26|||August 2008||2008-08-01|October 2011|2011-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|SPIRIT2||Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia|A Phase III, Prospective Randomised Comparison of Imatinib (STI571, Glivec/Gleevec) 400mg Daily Versus Dasatinib 100mg in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia|Unknown status|Recruiting|Phase 3|810|Anticipated|Newcastle University||2|||f||||t||||||||||2017-10-11 03:41:04.341476|2017-10-11 03:41:04.341476
NCT01460680|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-25|||November 2011||2011-11-01|October 2011|2011-10-01|June 2013|Anticipated|2013-06-01|October 2012|Anticipated|2012-10-01||Observational|||Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE)|Association of Membrane Polyunsaturated Fatty Acid Content and Intracellular Magnesium Concentration With Mental and Physical Symptoms in Fibromyalgia and SLE: a Case-control Study|Unknown status|Not yet recruiting|N/A|300|Anticipated|Tel-Aviv Sourasky Medical Center|||3||f||||f||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 03:41:04.461555|2017-10-11 03:41:04.461555
NCT01460654|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2016-11-30|||October 2011||2011-10-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Testosterone and Alendronate in Hypogonadal Men|Testosterone and Alendronate in Hypogonadal Men|Suspended||Phase 2|100|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 03:41:04.805871|2017-10-11 03:41:04.805871
NCT01459536|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-03-16|||September 2011||2011-09-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|ARC||Assessment of Muscle Function and Size in Older Adults With Rotator Cuff Tear|Rotator Cuff Function and Muscle Morphology in Older Adults With Rotator Cuff Tear|Completed||N/A|25|Actual|Wake Forest University Health Sciences|||3||f||||||||||||||2017-10-11 03:41:28.570918|2017-10-11 03:41:28.570918
NCT01460641|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-09-21|||November 2011||2011-11-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2016|Actual|2016-07-01||Observational|||Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer|Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer|Active, not recruiting||N/A|21|Actual|Stanford University|||1||f||||t||||||Samples With DNA|"     If the patient undergoes surgery to remove the lesion in the rectum, the surgical specimen     will be examined by the pathologist, who will perform a variety of tests to detect evidence     of new blood vessel growth. The sample will be stored per routine protocol of the Stanford     Department of Pathology.   "|||2017-10-11 03:41:04.907108|2017-10-11 03:41:04.907108
NCT01460628|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-01-25|2016-07-12||October 2011||2011-10-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Nuvigil on Fatigue|The Effect of Armodafinil (Nuvigil) on Fatigue and Quality of Life in Peri- and Postmenopausal Women|Completed||Phase 4|25|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 03:41:05.030403|2017-10-11 03:41:05.030403
NCT01460615|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-07-01|||February 2011||2011-02-01|October 2011|2011-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy (Whipple Operation)||Completed||Phase 2|||Tampere University Hospital|||||f||||||||||||||2017-10-11 03:41:05.495676|2017-10-11 03:41:05.495676
NCT01460602|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-10|2011-10-25|||May 2010||2010-05-01|October 2011|2011-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Velcade, Nipent, Rituxan (VNR) in Subjects With Relapsed Follicular, Marginal Zone, and Mantle Cell Lymphoma|Phase 1/2 Study of VELCADE (Bortezomib), Nipent (Pentostatin), and Rituxan (Rituximab) (VNR) in Subjects With Relapsed Follicular, Marginal Zone, and Mantle Cell Lymphoma|Terminated||Phase 1/Phase 2|30|Anticipated|Louisiana State University Health Sciences Center Shreveport||2||Investigator has relocated to MD Anderson|f||||f||||||||||2017-10-11 03:41:05.590136|2017-10-11 03:41:05.590136
NCT01460589|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-09-11|||November 2011||2011-11-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Interventional|ECTX||Early Commencement of Adjuvant Chemotherapy for Colon Cancer|Early Commencement of Adjuvant Chemotherapy for Stage III Colon Cancer: a Multicenter Randomized Trial|Recruiting||Phase 2/Phase 3|198|Anticipated|Kyungpook National University||2|||f||||t||||||||||2017-10-11 03:41:05.705277|2017-10-11 03:41:05.705277
NCT01460576|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-05-02|||September 2011||2011-09-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|IMPROV||Improving Prematurity-Related Respiratory Outcomes at Vanderbilt|Improving Prematurity-Related Respiratory Outcomes at Vanderbilt: The Prematurity and Respiratory Outcomes Program (PROP)|Completed||N/A|253|Actual|Vanderbilt University Medical Center|||1||f||||t||||||Samples With DNA|"     saliva for DNA, plasma, red blood cells, urine and tracheal aspirates   "|Undecided||2017-10-11 03:41:05.837091|2017-10-11 03:41:05.837091
NCT01460563|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-12-26|||October 2011||2011-10-01|December 2011|2011-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia|Effects of Valproic Acid and Magnesium Sulphate on Rocuronium Requirement and Postoperative Analgesia in Patients Undergoing Craniotomy for Cerebrovascular Surgery|Unknown status|Recruiting|N/A|60|Anticipated|Seoul National University Bundang Hospital||3|||f||||f||||||||||2017-10-11 03:41:05.920842|2017-10-11 03:41:05.920842
NCT01460550|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-03-31|||November 2011||2011-11-01|March 2015|2015-03-01|March 2017|Anticipated|2017-03-01|October 2016|Anticipated|2016-10-01||Interventional|||A Prospective Randomized Controlled Multicenter Trial of Delayed Gastric Emptying (DGE) After Pancreaticoduodenectomy Evaluating by Gastrointestinal Reconstruction|Comparison Between Antecolic and Retrocolic Gastrointestinal Reconstruction in Delayed Gastric Emptying After Pancreaticoduodenectomy: A Prospective Randomized Controlled Multicenter Trial|Unknown status|Recruiting|Phase 3|240|Anticipated|Kobe University||1|||f||||t||||||||||2017-10-11 03:41:06.026259|2017-10-11 03:41:06.026259
NCT01460537|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-10-02|||November 18, 2011|Actual|2011-11-18|October 2017|2017-10-01|December 18, 2015|Actual|2015-12-18|July 20, 2015|Actual|2015-07-20||Interventional|||Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer|A Phase 1 Study of Copanlisib(Phosphatidylinositol-3 Kinase Inhibitor) in Combination With Gemcitabine (Treatment A) or Cisplatin Plus Gemcitabine (Treatment B) in Subjects With Advanced Solid Malignancy|Completed||Phase 1|50|Actual|Bayer||2|||f||||f||||||||||2017-10-11 03:41:06.126669|2017-10-11 03:41:06.126669
NCT01460524|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2015-06-23|||November 2011||2011-11-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Nebulized Hypertonic Saline for Bronchiolitis|Observational Study on the Use of Hypertonic Saline for the Treatment of Bronchiolitis|Completed||N/A|2580|Actual|Hôpital Armand Trousseau|||1||f||||f||||||||||2017-10-11 03:41:06.237876|2017-10-11 03:41:06.237876
NCT01460511|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-07-11|||October 2011||2011-10-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||Evaluation of Efficacy and Safety of E004 in Children With Asthma|Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma|Completed||Phase 3|70|Actual|Amphastar Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:41:06.320924|2017-10-11 03:41:06.320924
NCT01460498|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-03-08|||August 2012|Actual|2012-08-01|March 2017|2017-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)|Phase I-II Study of Low-Dose Azacitidine (Vidaza) in Patients With Chronic Myeloid Leukemia Who Have Minimal Residual Disease While Receiving Therapy With Tyrosine Kinase Inhibitors (VZ-CML-PI-0236)|Active, not recruiting||Phase 1/Phase 2|48|Anticipated|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 03:41:06.432327|2017-10-11 03:41:06.432327
NCT01460472|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2016-07-28|||September 2010||2010-09-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Immunotherapy With Racotumomab in Advanced Lung Cancer|A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific Immunotherapy With Racotumomab Plus Best Support Treatment Versus Best Support Treatment in Patients With Advanced Non-small Cell Lung Camcer.|Active, not recruiting||Phase 3|1082|Anticipated|Recombio SL||2|||f||||t||||||||||2017-10-11 03:41:06.563929|2017-10-11 03:41:06.563929
NCT01459172|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2016-04-19|||October 2007||2007-10-01|October 2011|2011-10-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Human Breast Tissue Bioavailability of Topically Applied Limonene|Human Breast Tissue Bioavailability of Topically Applied Limonene|Completed||Phase 1|103|Actual|University of Arizona||1|||f||||f||||||||||2017-10-11 03:41:33.540099|2017-10-11 03:41:33.540099
NCT01460459|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-24|||May 2011||2011-05-01|October 2011|2011-10-01|July 2012|Anticipated|2012-07-01|December 2011|Anticipated|2011-12-01||Interventional|||Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 Diabetes|Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 Diabetes: a 9-month Randomised Controlled Trial|Unknown status|Recruiting|N/A|150|Anticipated|Medical Research Foundation, The Netherlands||3|||f||||f||||||||||2017-10-11 03:41:06.784927|2017-10-11 03:41:06.784927
NCT01460446|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-01-07|2013-11-14||October 2011||2011-10-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|ABACUS|Intent-to-treat population: All randomized participants.|ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?|A Prospective, Multi-centre Study With Diabetic Patients Randomized to 24 Weeks Treatment Supported by Either Accu-Chek® Aviva Expert Blood Glucose Meter With an Integrated Bolus Advisor or MDI Standard Therapy With Accu-Chek® Aviva Nano Meter (Without Bolus Advisor)|Completed||N/A|218|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:41:06.957538|2017-10-11 03:41:06.957538
NCT01460433|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-09-04|||September 2008||2008-09-01|September 2014|2014-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Problems With Immune Recovery in the Gut Tissue|A Compartmental Analysis of HIV Reservoirs and Immune Reconstitution (C)|Completed||N/A|21|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples Without DNA|"     Blood, lymphatic tissues and anogenital swabs.   "|||2017-10-11 03:41:07.680569|2017-10-11 03:41:07.680569
NCT01460420|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-07-05|||November 2011||2011-11-01|July 2017|2017-07-01|June 29, 2017|Actual|2017-06-29|June 2017|Actual|2017-06-01||Interventional|EMN-alloRIC||Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation|European Myeloma Network Sequential Phase I / Phase II Trial on RIC Allogeneic Transplantation: an Optimized Program for High Risk Relapsed Patients|Completed||Phase 1/Phase 2|49|Actual|European Myeloma Network||1|||f||||t||||||||||2017-10-11 03:41:07.79034|2017-10-11 03:41:07.79034
NCT01460407|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-04-24|||October 2011||2011-10-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Evaluate the Effect of Clarithromycin on LY2216684|Effect of Clarithromycin on the Pharmacokinetics of LY2216684 in Healthy Subjects|Completed||Phase 1|16|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:41:07.931451|2017-10-11 03:41:07.931451
NCT01460394|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2016-03-31|||October 2011||2011-10-01|March 2016|2016-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Normative Data of Brain Network Activation in Adolescents and Young Adults|Establishment of Normative Data of Brain Network Activation (BNA) Using Evoked Response Potentials in Adolescents and Young Adults|Completed||N/A|71|Actual|ElMindA Ltd|||1||f||||f||||||||Yes||2017-10-11 03:41:08.048892|2017-10-11 03:41:08.048892
NCT01460381|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-11-01|||October 2011||2011-10-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Evaluate the Effect of Genotype on LY2216684|A Study to Investigate the Effect of CYP2C19 Phenotype on the Pharmacokinetics of LY2216684 in Healthy Subjects|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:41:08.141174|2017-10-11 03:41:08.141174
NCT01460368|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2012-03-09|||October 2011||2011-10-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart|A Placebo- and Positive-Controlled Study of the Electrophysiological Effects of a Supratherapeutic Dose of LY2409021 in Healthy Subjects|Completed||Phase 1|68|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 03:41:08.229739|2017-10-11 03:41:08.229739
NCT01460355|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2011-10-25|||September 2006||2006-09-01|October 2011|2011-10-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone|Surgery Associated to Intraoperative Botulinum Toxin A for Large Angle Horizontal Strabismus: a Pilot Study|Completed||Phase 4|23|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 03:41:08.307401|2017-10-11 03:41:08.307401
NCT01460342|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-07-23|2013-07-23||December 2011||2011-12-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||All randomized participants.|Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Study to Evaluate the Efficacy and Safety of Tadalafil Once-a-day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|610|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:41:08.433972|2017-10-11 03:41:08.433972
NCT01460329|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-05-03|||October 2011||2011-10-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Comparing Cardiac Output Measurements in Critically Ill Children Using USCOM and Transthoracic ECHO|Comparing Cardiac Output Measurements in Critically Ill Children Using Ultrasonic Cardiac Output Monitor and Transthoracic Echocardiography.|Completed||N/A|22|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 03:41:09.807375|2017-10-11 03:41:09.807375
NCT01460316|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-01-26|||October 2011||2011-10-01|January 2016|2016-01-01||||May 2015|Actual|2015-05-01||Observational|CCOMET||Conotruncal Cardiac Defects and Nutrigenetic Etiopathogeny|Conotruncal Cardiac Defects and Metabolism, Nutrigenetic Factors of Etiopathogeny of Conotruncal Cardiac Defects|Completed||N/A|400|Actual|Central Hospital, Nancy, France|||2||f||||t||||||||||2017-10-11 03:41:09.894747|2017-10-11 03:41:09.894747
NCT01460303|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-08-02|2017-05-01||January 2011||2011-01-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter|Clinical Trial of Patient Operated Valved Catheter Compared With Standard Indwelling Transurethral Catheter for Postoperative Bladder Management|Completed||N/A|49|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-11 03:41:09.980012|2017-10-11 03:41:09.980012
NCT01460290|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-12-08|2014-03-12||October 2011||2011-10-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Asenapine in the Treatment of Older Adults With Bipolar Disorder|Asenapine in the Treatment of Older Adults With Bipolar Disorder|Completed||Phase 4|15|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-10-11 03:41:10.345005|2017-10-11 03:41:10.345005
NCT01460277|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-22|2016-10-24|||August 2011||2011-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|hydro||Τhe Effectiveness of Hydrotherapy Exercises on the Rehabilitation of Hemiplegic Patients||Completed||Phase 4|60|Actual|University of Ioannina||2|||f||||||||||||||2017-10-11 03:41:10.830438|2017-10-11 03:41:10.830438
NCT01460264|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-04-19|||October 16, 2013|Actual|2013-10-16|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|BIG3||An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study|BIG3 - An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study|Enrolling by invitation||N/A|10000|Anticipated|Region Skane|||2||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 03:41:10.928877|2017-10-11 03:41:10.928877
NCT01460251|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2015-03-18|||January 2012||2012-01-01|July 2014|2014-07-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277|OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277 in Patients Who Have Completed Study 901 and Study 910 (Extension to 901 Phase III Study|Terminated||Phase 3|11|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 03:41:11.006587|2017-10-11 03:41:11.006587
NCT01460238|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-05-04|||October 2011||2011-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia|Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia|Active, not recruiting||N/A|30|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||Samples With DNA|"     10 cc of peripheral blood and Archived lymph node tissue or bone marrow samples   "|||2017-10-11 03:41:11.086598|2017-10-11 03:41:11.086598
NCT01460225|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-19|2012-02-24|||September 2007||2007-09-01|February 2012|2012-02-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation|Effects of Lubiprostone on Gastric Sensory and Motor Function in Patients With Chronic Idiopathic Constipation|Completed||Phase 4|19|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 03:41:11.157969|2017-10-11 03:41:11.157969
NCT01460212|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-09-24|||December 2011||2011-12-01|September 2014|2014-09-01|October 2015|Anticipated|2015-10-01|December 2014|Anticipated|2014-12-01||Interventional|||Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder|Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder|Unknown status|Recruiting|Phase 4|80|Anticipated|Nanjing Medical University||2|||f||||t||||||||||2017-10-11 03:41:11.24428|2017-10-11 03:41:11.24428
NCT01460199|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2013-05-23|||August 2011||2011-08-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease|A Multi Center, Double-Blind, Two-Arm,Placebo Controlled, Randomized Safety and Tolerability Study of CTP-499 in Non-Dialysis Patients With Stage 3 Chronic Kidney Disease|Completed||Phase 1|33|Actual|Concert Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:41:11.384284|2017-10-11 03:41:11.384284
NCT01460186|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-03-30|||December 2011||2011-12-01|March 2016|2016-03-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|StoRM||Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer|Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer : a Multicenter Non-randomized Prospective Cohort Study|Active, not recruiting||N/A|1000|Anticipated|Centre Leon Berard||1|||f||||f||||||||||2017-10-11 03:41:11.479771|2017-10-11 03:41:11.479771
NCT01460173|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-09-24|||February 2011||2011-02-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|DASS||Divided Attention Steering Simulator Alertness Test|Aufmerksamkeitstest Mittels Fahrsimulation Bei Normalpersonen Und Patienten Mit Obstruktivem Schlafapnoesyndrom|Completed||N/A|200|Actual|Institut für Pneumologie Hagen Ambrock eV||2|||f||||f||||||||||2017-10-11 03:41:11.59636|2017-10-11 03:41:11.59636
NCT01460160|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-09-14|||January 30, 2012|Actual|2012-01-30|September 2017|2017-09-01|May 28, 2021|Anticipated|2021-05-28|May 28, 2017|Actual|2017-05-28||Interventional|||Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia|A Phase 2 Multi-Center, Historically Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 2|109|Actual|Bristol-Myers Squibb||1|||f||||t||||||||||2017-10-11 03:41:11.708018|2017-10-11 03:41:11.708018
NCT01460147|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2015-06-26|||October 2011||2011-10-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Osteoporosis and MRI Study in Hemophilia|Bone and Joint Health in an Adult Hemophilia Population|Terminated||N/A|3|Actual|Baxalta US Inc.||1|||f||||f||||||||||2017-10-11 03:41:12.081452|2017-10-11 03:41:12.081452
NCT01460134|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-08-11|||October 2011||2011-10-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers|A Phase 1, Open-label, Dose-escalation, Safety and Pharmacokinetic Study of CDX-1127 in Patients With Selected Refractory or Relapsed Hematologic Malignancies or Solid Tumors|Active, not recruiting||Phase 1|90|Actual|Celldex Therapeutics||4|||f||||f||||||||||2017-10-11 03:41:12.170244|2017-10-11 03:41:12.170244
NCT01460121|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2016-04-05|||February 2012||2012-02-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|October 2015|Actual|2015-10-01||Interventional|||Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness|A Randomized, Double Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness|Active, not recruiting||N/A|40|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 03:41:12.288838|2017-10-11 03:41:12.288838
NCT01460108|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2011-10-26|||April 2011||2011-04-01|October 2011|2011-10-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|CV+||AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation|Utility of the AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation Assessed by the Chartis System|Unknown status|Recruiting|Phase 4|10|Anticipated|LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology||1|||f||||f||||||||||2017-10-11 03:41:12.364114|2017-10-11 03:41:12.364114
NCT01460095|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2016-04-16|||March 2009||2009-03-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|IA3||Improving Access to HbA1c in Sub Saharan Africa|Improving Access to HbA1c Measurement in Sub-Saharan Africa|Completed||N/A|1349|Actual|Yaounde Central Hospital||1|||f||||t||||||||||2017-10-11 03:41:12.461251|2017-10-11 03:41:12.461251
NCT01459744|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-10-05|||September 2011||2011-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|WISDOM||An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations|An Intervention to Improve ICD Deactivation Conversations (WISDOM - Working to Improve discuSsions About DefibrillatOr Management)|Completed||N/A|562|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 03:41:21.077919|2017-10-11 03:41:21.077919
NCT01460082|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2014-03-10|||August 2008||2008-08-01|March 2014|2014-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|EDAECOPD||Endothelial Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)|Endothelial Dysfunction and Systemic Inflammation in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Completed||N/A|29|Actual|LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology|||1||f||||f||||||Samples Without DNA|"     Serum, Plasma   "|||2017-10-11 03:41:14.017642|2017-10-11 03:41:14.017642
NCT01460069|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2013-06-19|||October 2011||2011-10-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis|The Effect of GLP-1 in Psoriasis|Completed||N/A|20|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-11 03:41:14.090701|2017-10-11 03:41:14.090701
NCT01460056|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-01-31|||December 2011||2011-12-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|e-STEPS||e-STEPS: Endotoxin-Associated Sterile Peritonitis Observational Study|e-STEPS: Endotoxin-Associated Sterile Peritonitis Observational Study|Completed||N/A|127|Actual|Baxter Healthcare Corporation|||1||f||||t||||||||||2017-10-11 03:41:14.183533|2017-10-11 03:41:14.183533
NCT01460043|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-11-09|||June 2008||2008-06-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||Trial of Homeopathy on Management of Menorrhagia|Pilot Study of Homeopathy in Dysfunctional Uterine Bleeding Presenting as Menorrhagia|Completed||N/A|25|Actual|NMP Medical Research Institute||2|||f||||t||||||||||2017-10-11 03:41:14.276654|2017-10-11 03:41:14.276654
NCT01460030|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2017-02-28|||November 2011||2011-11-01|February 2017|2017-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism|An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism|Completed||Phase 3|||Kyowa Hakko Kirin Co., Ltd||1|||f||||||||||||||2017-10-11 03:41:14.35386|2017-10-11 03:41:14.35386
NCT01460004|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2015-07-16|||January 2012||2012-01-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of Infrapatellar Strap Treatment on Pain Extent and Athletic Measures in Young Athletes|The Effect of Infra Patellar Strap Treatment on the Extent of Pain and Performance in Young Athletes With Patellar Tendinopathy|Completed||N/A|16|Actual|Wingate Institute||1|||f||||f||||||||||2017-10-11 03:41:14.541666|2017-10-11 03:41:14.541666
NCT01459991|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-26|||October 2008||2008-10-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Interventional|||The Mediterranean Diet and Lactation Study: A Diet Study in Lactating Women|The Mediterranean Diet and Lactation Study: A Diet Study in Lactating Women|Completed||N/A|138|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 03:41:14.615392|2017-10-11 03:41:14.615392
NCT01459978|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-10-07|||September 2012||2012-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|MATICUS||Impact of Monitoring Quality Indicators in Maternity Departments on Mother and Infant Health|Impact of Using Cumulative SUM (CUSUM) Control Chart in Maternity Department on Mother and Infant Health: a Cluster Randomized Trial|Recruiting||N/A|60000|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-10-11 03:41:14.69515|2017-10-11 03:41:14.69515
NCT01459965|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2011-10-25|||July 1993||1993-07-01|October 2011|2011-10-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Stenting Malignant Jaundice for Quality of Life|Endoscopic Palliation of Malignant Biliary Tract Obstruction: Emphasis on Improvement in Quality of Life|Completed||N/A|164|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 03:41:14.782464|2017-10-11 03:41:14.782464
NCT01459952|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-25|2012-06-05|||November 2011||2011-11-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold|A Double-blind, Randomised, Parallel Group, Phase III Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold|Completed||Phase 3|120|Actual|Hyben Vital ApS||2|||f||||f||||||||||2017-10-11 03:41:14.99815|2017-10-11 03:41:14.99815
NCT01459939|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2012-06-05|||October 2011||2011-10-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||A Double-blind, Randomized, Parallel Group, Fase III Comparative Study With Rose Hip Powder Powder and Placebo Given to Patients With Mild to Moderate Osteoarthritis in the Knee or/and Hip|A Double-blind, Randomized, Parallel Group, Fase III Comparative Study With Rose Hip Powder Powder and Placebo Given to Patients With Mild to Moderate Osteoarthritis in the Knee or/and Hip|Completed||Phase 3|120|Actual|Hyben Vital ApS||2|||f||||f||||||||||2017-10-11 03:41:15.084021|2017-10-11 03:41:15.084021
NCT01459926|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-06-04||2013-06-05|November 2011||2011-11-01|June 2015|2015-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation|Completed||Phase 2|217|Actual|Theravance Biopharma R & D, Inc.||4|||f||||f||||||||||2017-10-11 03:41:15.178972|2017-10-11 03:41:15.178972
NCT01459731|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2012-05-01|||September 2011||2011-09-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Optical Coherence Tomography (OCT) Data Collection Study|Optical Coherence Tomography Data Collection Study|Completed||N/A|400|Anticipated|Optovue|||6||f||||f||||||||||2017-10-11 03:41:21.263327|2017-10-11 03:41:21.263327
NCT01459549|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-01-25|||October 2011||2011-10-01|January 2017|2017-01-01|November 2020|Anticipated|2020-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Randomized Controlled Trial of Treating Hepatolithiasis (Accompanied With SOL) With Choledochojejunostomy|Randomized Controlled Trial of Treating Hepatolithiasis(Accompanied With Sphincter of Oddi Laxity) With Roux-en-Y Choledochojejunostomy|Recruiting||N/A|100|Anticipated|Zhejiang University||2|||f||||||||||||||2017-10-11 03:41:28.476955|2017-10-11 03:41:28.476955
NCT01459913|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-05-14|2015-01-26||November 2011||2011-11-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CONCISE|Full Analysis (FA) Set included all subjects who received at least 1 dose of study drug and fulfilled all relevant inclusion criteria. One subject from “Telaprevir 12 Wk +Peg-IFN-alfa-2a,RBV 48 Wk (Non Randomized)” was excluded from the FA Set due to having HCV Genotype 6.|Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype|A Phase 3b Study of 2 Treatment Durations of Telaprevir, Peg-IFN (Pegasys®), and Ribavirin (Copegus®) in Treatment-Naive and Prior Relapser Subjects With Genotype 1 Chronic Hepatitis C and IL28B CC Genotype|Terminated||Phase 3|239|Actual|Vertex Pharmaceuticals Incorporated|The study was terminated early at the primary efficacy endpoint (SVR12), by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.|4||"The study was terminated early by the sponsor on 13 January 2014 due to a decision to modify   the drug development plan."|f||||f||||||||||2017-10-11 03:41:15.353368|2017-10-11 03:41:15.353368
NCT01459900|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-09-19|||September 2011||2011-09-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|ReSET||Renal Sympathectomy in Treatment Resistant Essential Hypertension, a Sham Controlled Randomized Trial|Renal Sympathectomy in Treatment Resistant Essential Hypertension, a Sham Controlled Randomized Trial|Completed||N/A|69|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 03:41:18.216329|2017-10-11 03:41:18.216329
NCT01459887|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-25|||September 2006||2006-09-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma|An Open-labeled, Multi-center, Randomized, Prospective Phase III Study Comparing CMAB304 in Combination With CHOP to CHOP Alone With CMAB304 Maintenance in Patients With DLBCL|Completed||Phase 3|278|Actual|Shanghai CP Guojian Pharmaceutical Co.,Ltd.||2|||f||||t||||||||||2017-10-11 03:41:18.344846|2017-10-11 03:41:18.344846
NCT01459874|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-03-26|||March 2008||2008-03-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Evaluation of an Organizational Model for Remote Monitoring of Pacemaker and Implantable Cardioverter Defibrillator Recipients|Prospective Registry for the Evaluation of an Organizational Model for Remote Monitoring of Pacemaker and Implantable Cardioverter Defibrillator (ICD) Recipients in the Clinical Practice|Completed||N/A|1650|Actual|San Filippo Neri General Hospital|||1||f||||t||||||||||2017-10-11 03:41:18.476469|2017-10-11 03:41:18.476469
NCT01459861|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-03-04|||October 2011||2011-10-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty|Assessment of Early Ambulation in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection vs. Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement|Terminated||N/A|11|Actual|Saint Francis Care||2||Administratively closed early|f||||f||||||||||2017-10-11 03:41:18.748475|2017-10-11 03:41:18.748475
NCT01459848|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-03-24|||January 2011||2011-01-01|March 2014|2014-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Baby Dvd Effects on Cortisol|A Randomized Controlled Trial of Block Play vs Dvd Viewing|Completed||N/A|50|Anticipated|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-11 03:41:18.850258|2017-10-11 03:41:18.850258
NCT01459835|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2014-03-24|||June 2010||2010-06-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Media Impact on Preschool Behavior||Completed||N/A|600|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 03:41:18.959793|2017-10-11 03:41:18.959793
NCT01459822|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-25|||August 2011||2011-08-01|August 2011|2011-08-01|September 2013|Anticipated|2013-09-01|July 2013|Anticipated|2013-07-01||Observational|METPSDS||MiRNAs Evaluate the Prognosis of Sepsis by Dynamic Study|MiRNAhs in the Evaluation of the Value of Sepsis Prognosis Dynamics Observational Research|Unknown status|Recruiting|N/A|70|Anticipated|Chinese PLA General Hospital|||2||f||||t||||||Samples Without DNA|"     human serum   "|||2017-10-11 03:41:19.068975|2017-10-11 03:41:19.068975
NCT01459809|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-01-19|||February 2012||2012-02-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|RECOMMEND||Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients|A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes|Completed||Phase 3|538|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 03:41:19.326539|2017-10-11 03:41:19.326539
NCT01459796|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-06-19|2017-04-23|2013-09-27|November 2011||2011-11-01|June 2017|2017-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|UPSURGE|Baseline population included full analysis set (FAS) comprising of all randomized participants who received any study medication and was based on treatment allocated by Interactive web response system (IWRS) at randomization (as randomized).|Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares|Terminated||Phase 3|220|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-11 03:41:19.572251|2017-10-11 03:41:19.572251
NCT01459783|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-18|2015-05-06|2015-02-25||March 2011||2011-03-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Comparative Effectiveness of Dementia Care Strategies in Underserved Communities|Comparative Effectiveness of Dementia Care Strategies in Underserved Communities|Completed||N/A|144|Actual|RAND||2|||f||||t||||||||||2017-10-11 03:41:20.396883|2017-10-11 03:41:20.396883
NCT01459770|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-04-04|||November 2011||2011-11-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|CKD/ESRD-MIT||Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD|Medication Intervention in Transitional Care to Optimize Outcomes & Costs in CKD & ESRD|Completed||N/A|120|Actual|Providence Medical Research Center||2|||f||||t||||||||No||2017-10-11 03:41:20.833323|2017-10-11 03:41:20.833323
NCT01459757|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-06-17|||October 2011||2011-10-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib|A Non-Interventional Retrospective Correlation Of Tumor Mutation Status To Clinical Benefit From The SU011248, A6181036 Treatment Protocol Titled: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate|Completed||N/A|322|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:41:20.918972|2017-10-11 03:41:20.918972
NCT01459705|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2015-11-09|2015-10-09||October 2011||2011-10-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|VRPE Extension|All participants randomized to a treatment arm included in baseline data analysis|Comparing Virtual Reality Exposure Therapy to Prolonged Exposure|Comparing Virtual Reality Exposure Therapy to Prolonged Exposure in the Treatment of Soldiers With Post Traumatic Stress Disorder (PTSD)|Completed||N/A|162|Actual|National Center for Telehealth and Technology||3|||f||||t||||||||||2017-10-11 03:41:21.51848|2017-10-11 03:41:21.51848
NCT01459692|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-25|||February 2005||2005-02-01|October 2011|2011-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps|Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps|Completed||N/A|40|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 03:41:22.415284|2017-10-11 03:41:22.415284
NCT01459679|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-06-20|||July 2012||2012-07-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|January 2016|Actual|2016-01-01||Interventional|||A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery|A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery|Terminated||Phase 3|1719|Actual|American-European Congress of Ophthalmic Surgery||3|||f||||f||||||||||2017-10-11 03:41:22.50692|2017-10-11 03:41:22.50692
NCT01459666|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-01-17|||September 2011||2011-09-01|January 2012|2012-01-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer|A Prospective, Dual-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy of abobotulinumtoxinA (BTX-A) in Improving Forehead Wounds After Mohs Micrographic Surgery and Reconstruction for Skin Cancer|Unknown status|Recruiting|Phase 4|50|Anticipated|AboutSkin Dermatology and DermSurgery, PC||2|||f||||t||||||||||2017-10-11 03:41:22.947387|2017-10-11 03:41:22.947387
NCT01459653|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-12-09|2015-03-26||March 2010||2010-03-01|December 2015|2015-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|Monitor-GCSF|Baseline characteristics are based on the evaluable sample, e.g. all patients who received at least one dose of the study medication, had no major protocol violation and have a minimum of enrollment cycle and either one follow-up cycle or study end data with valid outcome data (i.e., ANC or completed CIN/FN data).|Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor|International, Prospective, Open-label, Multicenter, Pharmacoepidemiological Study to Determine Predictors of Clinical Outcomes in Chemotherapy-treated Cancer Patients at Risk for Febrile Neutropenia and Treated Prophylactically With Filgrastim Biosimilar.|Completed||N/A|1496|Actual|Sandoz|||1||f||||f||||||||||2017-10-11 03:41:23.224714|2017-10-11 03:41:23.224714
NCT01459640|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-24|||March 2011||2011-03-01|October 2011|2011-10-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Intra-Articular Autologous Bone Marrow Mesenchymal Stem Cells Transplantation to Treat Mild to Moderate Osteoarthritis|Phase 2 Study Assessing the Efficacy of Intra-Articular Autologous Mesenchymal Stem Cells in Patients With Mild to Moderate Osteoarthritis|Unknown status|Recruiting|Phase 2|50|Anticipated|National University of Malaysia||2|||f||||f||||||||||2017-10-11 03:41:27.134853|2017-10-11 03:41:27.134853
NCT01459627|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-09-06|||December 2011||2011-12-01|September 2017|2017-09-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|DAPT-STEMI||Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI|Prospective, Randomized, Open Label Trial of 6 Months vs. 12 Months Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation In ST-elevation Myocardial Infarction|Completed||Phase 4|1100|Anticipated|Maasstad Hospital||2|||f||||t||||||||||2017-10-11 03:41:27.274472|2017-10-11 03:41:27.274472
NCT01459614|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-05-02|||November 2011||2011-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2015|Actual|2015-11-01||Interventional|||Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer|Phase II Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin in Subjects With Metastatic Pancreatic Cancer|Active, not recruiting||Phase 2|43|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 03:41:27.477247|2017-10-11 03:41:27.477247
NCT01459601|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-24|||January 2012||2012-01-01|October 2011|2011-10-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Cabergoline Effect on Blood Sugar in Type 2 Diabetics|Cabergoline Effects on Blood Sugar Control in Type 2 Diabetics|Unknown status|Not yet recruiting|N/A|10|Anticipated|Mashhad University of Medical Sciences||1|||f||||f||||||||||2017-10-11 03:41:27.58375|2017-10-11 03:41:27.58375
NCT01459588|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-02-11|2013-02-11||October 2011||2011-10-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease||Completed||Phase 3|315|Actual|Allergan||4|||f||||f||||||||||2017-10-11 03:41:27.671736|2017-10-11 03:41:27.671736
NCT01459575|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-24|||July 2005||2005-07-01|October 2011|2011-10-01|December 2006|Actual|2006-12-01|December 2005|Actual|2005-12-01||Observational|||Unboosted Atazanavir as Initial ART Therapy in China||Completed||N/A|||National Center for AIDS/STD Control and Prevention, China CDC|||1||f||||f||||||||||2017-10-11 03:41:28.338401|2017-10-11 03:41:28.338401
NCT01459562|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2014-02-17|||September 2011||2011-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy Volunteers|A Randomized Double-blinded Placebo Controlled Single Center Phase I Study of Escalating Single Intravenous Doses of NI-0501 in Healthy Volunteers|Completed||Phase 1|||NovImmune SA||2|||f||||f||||||||||2017-10-11 03:41:28.393635|2017-10-11 03:41:28.393635
NCT01459523|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-11-02|||October 2011||2011-10-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Optimizing Catheter Insertion Technique for Ultrasound-guided Continuous Peripheral Nerve Blocks|Optimizing Catheter Insertion Technique for Ultrasound-guided Continuous Peripheral Nerve Blocks|Active, not recruiting||N/A|200|Anticipated|VA Palo Alto Health Care System||2|||f||||f||||||||||2017-10-11 03:41:28.647352|2017-10-11 03:41:28.647352
NCT01459510|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-10-21|||June 2010||2010-06-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Brief Multimedia Program Affects Parents' Attitudes Toward Physical Punishment|A Brief Multimedia Program Affects Parents' Attitudes Toward Physical Punishment|Completed||Phase 1|260|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 03:41:28.761377|2017-10-11 03:41:28.761377
NCT01459497|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-04-11|||October 2012||2012-10-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer|Phase III Randomized Study of Standard Versus Accelerated Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer and Poor Performance Status|Recruiting||Phase 3|226|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 03:41:28.849707|2017-10-11 03:41:28.849707
NCT01459484|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-03-17|||July 2011||2011-07-01|March 2017|2017-03-01|February 2020|Anticipated|2020-02-01|January 2020|Anticipated|2020-01-01||Interventional|ISG/OS-2||ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma|ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma - Prospective Study (ISG/OS-2)|Recruiting||Phase 2/Phase 3|225|Anticipated|Italian Sarcoma Group||2|||f||||t||||||||||2017-10-11 03:41:28.938047|2017-10-11 03:41:28.938047
NCT01459471|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-21|||April 2010||2010-04-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Staple-line Reinforcement During Laparoscopic Sleeve Gastrectomy Using Three Different Techniques: a Randomized Trial|Staple-line Reinforcement During Laparoscopic Sleeve Gastrectomy Using Three Different Techniques: a Randomized Trial|Completed||N/A|120|Actual|University of Rome Tor Vergata||1|||f||||t||||||||||2017-10-11 03:41:29.096173|2017-10-11 03:41:29.096173
NCT01459458|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2015-11-30|||October 2011||2011-10-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|February 2014|Actual|2014-02-01||Interventional|||Family Planning-based Partner Abuse Intervention to Reduce Unintended Pregnancy|Family Planning-based Partner Abuse Intervention to Reduce Unintended Pregnancy|Completed||Phase 3|3687|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:41:29.41119|2017-10-11 03:41:29.41119
NCT01459445|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-23|||February 2011||2011-02-01|October 2011|2011-10-01|January 2012|Anticipated|2012-01-01|June 2011|Actual|2011-06-01||Interventional|||Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome|Metformin Plus EE30µg-drospirenone and Weight Loss- Impact on Endothelial Function and hsCRP Levels in PCOS|Unknown status|Active, not recruiting|N/A|26|Anticipated|Iuliu Hatieganu University of Medicine and Pharmacy||1|||f||||t||||||||||2017-10-11 03:41:29.487032|2017-10-11 03:41:29.487032
NCT01459432|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-11-06|||November 2011||2011-11-01|November 2015|2015-11-01||||April 2012|Actual|2012-04-01||Observational|||Understanding Immunity Persistence After Adolescent MenC Vaccination|A Study to Evaluate the Persistence of Antibody Seven Years After a Booster Dose of Either a Glycoconjugate or a Polysaccharide Vaccine Against Serogroup C Neisseria Meningitidis Given to Adolescents|Completed||N/A|134|Actual|University of Oxford|||1||f||||||||||||||2017-10-11 03:41:29.586964|2017-10-11 03:41:29.586964
NCT01459419|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2011-10-23|||November 2011||2011-11-01|October 2011|2011-10-01|October 2013|Anticipated|2013-10-01|May 2013|Anticipated|2013-05-01||Interventional|||Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects|A Phase IIa Safety Study of Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects, a Single-blind, Randomized, Controlled Multi-center Study.|Unknown status|Not yet recruiting|Phase 2|36|Anticipated|Inspira Medical AB||2|||f||||f||||||||||2017-10-11 03:41:29.653103|2017-10-11 03:41:29.653103
NCT01459406|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2012-12-18|||October 2011||2011-10-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|FODMAPs||Effects of FODMAPs on Small Bowel Water Content: an MRI Study|Effects of FODMAPs (Fermentable Oligo-, Di-, and Mono-saccharides, And Polyols) on Small Bowel Water Content: an MRI Study|Completed||N/A|17|Actual|University of Nottingham||4|||f||||f||||||||||2017-10-11 03:41:29.742916|2017-10-11 03:41:29.742916
NCT01459393|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-06-27|||November 2010||2010-11-01|February 2014|2014-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment|Evaluation of the Formulation of 5-aminolevulinic Acid With Dimethylsulfoxide in Photodynamic Therapy for Treatment of Actinic Keratosis|Completed||Phase 3|137|Actual|Barretos Cancer Hospital||2|||f||||t||||||||||2017-10-11 03:41:29.852871|2017-10-11 03:41:29.852871
NCT01459380|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-07-24|||October 11, 2011|Actual|2011-10-11|July 2017|2017-07-01|February 11, 2017|Actual|2017-02-11|June 8, 2016|Actual|2016-06-08||Interventional|||Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|A Phase I Trial of Pegylated Liposomal Doxorubicin (PLD), Carboplatin and NCI Supplied Veliparib (ABT-888), and NCI Supplied Bevacizumab in Recurrent Platinum Sensitive Ovarian, Primary Peritoneal and Fallopian Tube Cancer|Completed||Phase 1|41|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 03:41:29.964718|2017-10-11 03:41:29.964718
NCT01459367|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-08-22|||October 2011||2011-10-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis|A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of TAK-438 (10 mg or 20 mg Once-Daily) Compared to AG-1749 (15 mg Once-Daily) in a 24-week Maintenance Treatment in Patients With Healed Erosive Esophagitis (EE).|Completed||Phase 3|607|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:41:30.156631|2017-10-11 03:41:30.156631
NCT01459354|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2011-10-24|||August 2011||2011-08-01|October 2011|2011-10-01||||||||Observational|||The Effects of Bimanual Laryngoscopy on Post-Operative Sore Throat in Adults||Unknown status|Recruiting|N/A|490|Anticipated|China Medical University Hospital|||1||f||||||||||||||2017-10-11 03:41:30.314523|2017-10-11 03:41:30.314523
NCT01459341|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-12-05|||July 2011||2011-07-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Observational|NIRS||Near Infrared Spectroscopy and Transcutaneous Oxygen Pressure in Critical Limb Ischemia Before and After Treatment|Comparison of Near Infrared Spectroscopy (NIRS) and Transcutaneous Oxygen Pressure (TCPO2) Measurements in Critical Limb Ischemia (CLI) Patients After Invasive Treatment (Endovascular or Surgery)|Completed||N/A|15|Actual|Carmel Medical Center|||1||f||||t||||||||||2017-10-11 03:41:30.39417|2017-10-11 03:41:30.39417
NCT01459328|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-24|||September 2009||2009-09-01|October 2011|2011-10-01||||September 2013|Anticipated|2013-09-01||Interventional|||Resource-Sparing Curative Treatment for Rectal Cancer|Resource-Sparing Curative Treatment for Rectal Cancer|Unknown status|Recruiting|Phase 3|350|Anticipated|International Atomic Energy Agency||2|||f||||t||||||||||2017-10-11 03:41:30.476404|2017-10-11 03:41:30.476404
NCT01459315|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2013-07-03|||November 2011||2011-11-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects|Phase I, Open-Label Study in Healthy Male Subjects Describing GSK1349572 Exposure in Blood Plasma, Seminal Fluid and Rectal Mucosal Tissue Following Single and Multiple Dosing|Completed||Phase 1|14|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 03:41:30.635579|2017-10-11 03:41:30.635579
NCT01459302|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-08-30|||January 2009||2009-01-01|August 2017|2017-08-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders|Family Studies in Neuromuscular Disorders|Recruiting||N/A|6000|Anticipated|University of Massachusetts, Worcester|||1||f||||f||||||Samples With DNA|"     DNA(plus Serum, frozen cells when available) will be obtained from the initial blood or     saliva sample for genetic study. RNA, skin cells or lymphoblast cells may be obtained and     stored.   "|||2017-10-11 03:41:30.745749|2017-10-11 03:41:30.745749
NCT01459289|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2011-10-21|||October 2011||2011-10-01|October 2011|2011-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Psychosocial Effect of HPV Positivity|The Psychosocial Effect of Testing Positive for HPV on Hong Kong Chinese Women With Normal Cervical Cytology|Unknown status|Recruiting|N/A|200|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:41:30.840597|2017-10-11 03:41:30.840597
NCT01459276|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2012-05-18|||October 2011||2011-10-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects|A Randomized, Active Controlled, Double-blind, Multi-Centre Study to Evaluate Safety and Immunogenicity of One Dose of FLUVAL AB-like (Trivalent, Whole Virus, Aluminium Phosphate Gel Adjuvanted) Influenza Vaccine Containing 6μgHA of Seasonal A/H1N1, A/H3N2 and B Influenza Antigens in Non-elderly Adult and Elderly Subjects|Completed||N/A|1206|Actual|Fluart Innovative Vaccine Ltd, Hungary||2|||f||||f||||||||||2017-10-11 03:41:32.646584|2017-10-11 03:41:32.646584
NCT01459250|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2011-10-21|||March 2011||2011-03-01|October 2011|2011-10-01||||August 2011|Actual|2011-08-01||Interventional|||Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects|An Open Label, Non-randomised, Parallel Group Study to Characterise and Compare the Pharmacokinetics, Safety and Tolerability of a Single Dose of AGO178C in Subjects With Mild, Moderate, Severe Renal Impairment and End-stage Renal Disease With That in Healthy Matched Control Subjects|Completed||Phase 1|32|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:41:32.869924|2017-10-11 03:41:32.869924
NCT01459237|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-06-30|||October 7, 2011||2011-10-07|April 11, 2017|2017-04-11|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Effects of Hormone Stimulation on Brain Scans for Cushing s Disease|Prospective Evaluation of the Effect of Corticotropin-Releasing Hormone Stimulation on 18F-Fludeoxyglucose High-Resolution Positron-Emission Tomography in Cushing's Disease|Recruiting||Early Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:41:32.966175|2017-10-11 03:41:32.966175
NCT01459224|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-12-01|||September 2011||2011-09-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|September 2014|Actual|2014-09-01||Observational|MELT||MELT - MRI Evaluation of Lymphoma Treatment|Whole Body Functional and Anatomical MRI: Accuracy in Staging and Treatment Response Monitoring in Adolescent Hodgkin's Lymphoma Compared to Conventional Multimodality Imaging|Completed||N/A|58|Actual|University College, London|||1||f||||t||||||||||2017-10-11 03:41:33.058785|2017-10-11 03:41:33.058785
NCT01459211|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-11-07|||May 2012||2012-05-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|LenD||Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)|A Pilot Study to Establish the Safety & Efficacy of a Combination of Dexamethasone & Lenalidomide in Patients With Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL)|Completed||Phase 2|12|Actual|University College, London||1|||f||||t||||||||Undecided||2017-10-11 03:41:33.137435|2017-10-11 03:41:33.137435
NCT01459198|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-12-14|||August 2011||2011-08-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children|A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, RSV MEDI ΔM2-2 Lot RSV#002A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, RSV-Seropositive Children 12 to 59 Months of Age, and RSV-Seronegative Infants and Children 6 to 24 Months of Age|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||t||||||||||2017-10-11 03:41:33.268199|2017-10-11 03:41:33.268199
NCT01459185|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2014-09-23|||June 2005||2005-06-01|September 2014|2014-09-01|March 2012|Actual|2012-03-01|May 2008|Actual|2008-05-01||Interventional|||A Feasibility Study of Oral Adjuvant Chemotherapy With S-1|A Feasibility Study of Adjuvant Chemotherapy With Oral Fluoropyrimidine S-1 for Non-small Cell Lung Cancer|Completed||Phase 2|55|Anticipated|Nagasaki University||1|||f||||f||||||||||2017-10-11 03:41:33.400816|2017-10-11 03:41:33.400816
NCT01459159|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-11-20|||October 2011||2011-10-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome|Phase 2b Study of Oral Ezatiostat Hydrochloride (Telintra®) in Patients With Low to Intermediate-1 Risk, Non-Deletion 5q Myelodysplastic Syndrome|Terminated||Phase 2|162|Anticipated|Telik||1||Study TLK199.2108 was terminated for business reasons.|f||||f||||||||||2017-10-11 03:41:33.634372|2017-10-11 03:41:33.634372
NCT01459146|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2011-10-22|||December 2010||2010-12-01|October 2011|2011-10-01|November 2012|Anticipated|2012-11-01|October 2011|Anticipated|2011-10-01||Interventional|ACTIPT||Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana|The Impact of Intermittent Preventive Malaria Treatment With Artemisinin Combination Therapy (ACT) on Hemoglobin, Malaria, Schistosomiasis, and School Attention Among Primary Schoolchildren in the Kassena-Nankana Districts, Ghana|Unknown status|Recruiting|Phase 4|345|Anticipated|Navrongo Health Research Centre, Ghana||3|||f||||t||||||||||2017-10-11 03:41:33.909224|2017-10-11 03:41:33.909224
NCT01459133|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-03-10|||May 2013||2013-05-01|March 2015|2015-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere Inhalation System|Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere|Withdrawn||N/A|0|Actual|South Orange County Endocrinology||1||"Unable to register Treatment IND with the US Food And Drug Administration's new process of   establishing TLS encryption for email correspondence."|f||||f||||||||||2017-10-11 03:41:34.045711|2017-10-11 03:41:34.045711
NCT01459120|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-02-08|||October 2011||2011-10-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|DoDoPi||Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho|Comparing Door-to-door Versus Community Gathering in Providing HIV Counseling and Testing Within an Integrated Primary Health Care Package: a Cluster Randomized Trial in Rural Lesotho|Completed||N/A|1800|Anticipated|SolidarMed||3|||f||||f||||||||||2017-10-11 03:41:34.137735|2017-10-11 03:41:34.137735
NCT01459107|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-10-04|||July 2011|Actual|2011-07-01|October 2017|2017-10-01|June 2026|Anticipated|2026-06-01|June 2026|Anticipated|2026-06-01||Interventional|||Human Upper Extremity Allotransplantation|Human Upper Extremity Allotransplantation|Recruiting||Phase 2|30|Anticipated|Johns Hopkins University||1|||f||||t||f||||||||2017-10-11 03:41:34.261604|2017-10-11 03:41:34.261604
NCT01459094|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2013-02-18|||October 2011||2011-10-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Food on a Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release in Healthy Volunteers|Single-Dose, Open-Label, Randomized, 2-Period Crossover Study to Assess the Effect of Food Coadministration on the Pharmacokinetics of a Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release in Healthy Subjects|Completed||Phase 1|24|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 03:41:34.380133|2017-10-11 03:41:34.380133
NCT01459081|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2013-01-15|||October 2011||2011-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China|Randomised, Double-blind, Placebo-controlled Trial of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China|Completed||Phase 3|298|Actual|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:41:34.481827|2017-10-11 03:41:34.481827
NCT01459068|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2014-05-19|2014-04-16||August 2011||2011-08-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|MHAP|We estimated 150 participants in each arm using the test for paired means, based on a moderate effect size (0.50), 80% power, two-tailed 5% significance level, design effect of 1.5, and up to a 50% expected drop-out rate (due to frequent cross-border movement).|Mental Health Assessment Project on the Thailand-Burma Border|Study of Effectiveness of Mental Health Interventions Among Torture Survivors on the Thailand-Burma Border|Completed||N/A|347|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 03:41:34.612009|2017-10-11 03:41:34.612009
NCT01459055|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-05-02|||May 2016||2016-05-01|May 2016|2016-05-01|August 2020|Anticipated|2020-08-01|January 2017|Anticipated|2017-01-01||Observational|||Long-term Follow-up in Patients Affected With Acrofacial Vitiligo|Long-term Ten Years Follow-up in Patients Affected With Acrofacial Vitiligo|Not yet recruiting||N/A|100|Anticipated|Irmandade da Santa Casa de Misericordia de Curitiba|||1||f||||f||||||||||2017-10-11 03:41:34.981429|2017-10-11 03:41:34.981429
NCT01459042|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2011-10-24|||January 2010||2010-01-01|October 2011|2011-10-01||||October 2011|Actual|2011-10-01||Observational|||Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China|Prevalence of Primary Aldosteronism and Status of Renin-Angiotensin System in Resistant Hypertension:An Observational Study in China|Completed||N/A|2000|Anticipated|Shanghai Jiao Tong University School of Medicine|||2||f||||t||||||Samples With DNA|"     blood samples,including serum, plasma and whole blood.   "|||2017-10-11 03:41:35.056554|2017-10-11 03:41:35.056554
NCT01459029|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2011-10-24|||November 2011||2011-11-01|October 2011|2011-10-01|October 2014|Anticipated|2014-10-01|October 2013|Anticipated|2013-10-01||Interventional|SATROS||High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia|High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia : A Randomized, Double-Blind, Placebo-Controlled Study|Unknown status|Not yet recruiting|Phase 2|54|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 03:41:35.121359|2017-10-11 03:41:35.121359
NCT01459016|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2016-12-21|2016-12-21||December 2011||2011-12-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All participants who enrolled in the study.|A Non-drug Methods Study in Participants With Alzheimer's Disease|An Exploratory Study of Brain Imaging Biomarkers in Patients With Alzheimer's Pathology Receiving Standard of Care|Completed||Phase 1|56|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:41:35.248213|2017-10-11 03:41:35.248213
NCT01459003|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2014-05-05|||October 2011||2011-10-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|BEAUTY||Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer|Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer|Completed||Phase 3|400|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||||||||||||2017-10-11 03:41:35.881283|2017-10-11 03:41:35.881283
NCT01458990|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-12-16|||October 2011||2011-10-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Proton Pump Inhibitors and Dysbiosis in Cirrhosis||Completed||N/A|50|Anticipated|Hunter Holmes Mcguire Veteran Affairs Medical Center||1|||f||||f||||||||||2017-10-11 03:41:35.96785|2017-10-11 03:41:35.96785
NCT01458977|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2014-06-18|||January 2012||2012-01-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors|Prospective, Randomised, Crossover, Double-Blind, Placebo-Controlled Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors|Completed||Phase 4|48|Actual|Fundacio Lluita Contra la SIDA||2|||f||||f||||||||||2017-10-11 03:41:36.048087|2017-10-11 03:41:36.048087
NCT01458964|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2014-07-08|||January 2008||2008-01-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Quetiapine Compared With Placebo in the Management of Fibromyalgia|Quetiapine Compared With Placebo in the Management of Fibromyalgia|Completed||Phase 4|42|Actual|East Tennessee State University||2|||f||||f||||||||||2017-10-11 03:41:36.152688|2017-10-11 03:41:36.152688
NCT01458951|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-04-26|2016-04-26||June 2012||2012-06-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|OCTAVE|The safety analysis set consists of all randomized participants who received at least 1 dose of study medication.|A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis|A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis.|Completed||Phase 3|547|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 03:41:36.285396|2017-10-11 03:41:36.285396
NCT01458938|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-01-30|||July 2009||2009-07-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|Substance P||This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.|Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study|Terminated||N/A|53|Actual|Carolina Neurosurgery & Spine Associates|||4|Study will need to be redesigned for improved efficacy.|f||||t||||||Samples Without DNA|"     Blood, saliva and cerebrospinal fluid   "|||2017-10-11 03:41:37.359596|2017-10-11 03:41:37.359596
NCT01458925|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-05-04|||November 2011||2011-11-01|May 2016|2016-05-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Feasibility of Check-Cap's P1 Capsule System Screening|Feasibility, Multi-center Prospective Study of Check-Cap's P1 Capsule System in Patients Eligible for ColoRectal Cancer [CRC] Screening|Enrolling by invitation||N/A|100|Anticipated|Ceck Cap Ltd.||1|||f||||t||||||||No||2017-10-11 03:41:37.433733|2017-10-11 03:41:37.433733
NCT01458912|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-11-21|||November 2011||2011-11-01|November 2011|2011-11-01||||May 2013|Anticipated|2013-05-01||Interventional|||Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids|A Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess and Compare Efficacy and Safety of a 12-week Treatment With BI 54903 at Doses of 181.8 Mcg b.i.d. and 363.6 Mcg q.d. (p.m. Dosing) Administered Via Respimat® Inhaler in Patients With Asthma Inadequately Controlled on Low Dose ICS Therapy|Withdrawn||Phase 2|0|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:41:37.507358|2017-10-11 03:41:37.507358
NCT01458899|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2012-01-10|||November 2011||2011-11-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|TC-5214||Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214|Phase I, Open-label, Randomized, Single-dose, Two Treatment (Fed Versus Fasted) Crossover Study to Assess the Effects of Food on the Pharmacokinetics of TC-5214 (S-Mecamylamine) in Healthy Subjects|Completed||Phase 1|18|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:41:37.718674|2017-10-11 03:41:37.718674
NCT01458886|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2013-10-30|||November 2011||2011-11-01|October 2013|2013-10-01||||May 2013|Anticipated|2013-05-01||Interventional|||Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study Assessing Efficacy and Safety of a 12 Week Treatment With BI 54903 Administered at 90.9 Mcg b.i.d. and 181.8 Mcg q.d. (p.m.Dosing) Via Respimat® Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone|Withdrawn||Phase 2|0|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:41:37.831195|2017-10-11 03:41:37.831195
NCT01458873|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2011-10-30|||October 2011||2011-10-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers|Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers|Unknown status|Recruiting|Phase 2/Phase 3|20|Anticipated|Sheba Medical Center||3|||f||||f||||||||||2017-10-11 03:41:37.930407|2017-10-11 03:41:37.930407
NCT01458860|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2011-10-31|||February 2012||2012-02-01|October 2011|2011-10-01|February 2014|Anticipated|2014-02-01|February 2012|Anticipated|2012-02-01||Observational|||Aortic Calcification - is it a Marker for Carotid Artery Stenosis?|Aortic Calcification - is it a Marker for Carotid Artery Stenosis?|Unknown status|Not yet recruiting|N/A|200|Anticipated|Ziv Hospital|||2||f||||f||||||||||2017-10-11 03:41:38.038354|2017-10-11 03:41:38.038354
NCT01458847|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2012-11-09|||October 2009||2009-10-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer|A Single Dose, Dose-escalating, Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of Intravesical Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer|Completed||Phase 1|12|Actual|BioCis Pharma Ltd||3|||f||||t||||||||||2017-10-11 03:41:38.110895|2017-10-11 03:41:38.110895
NCT01458834|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-22|2011-10-22|||September 2011||2011-09-01|October 2011|2011-10-01||||July 2012|Anticipated|2012-07-01||Interventional|||Attentional Training for Smoking Cessation Via Handheld Device or Personal Computer|Attentional Training for Smoking Cessation Via Handheld Device or Personal Computer|Unknown status|Recruiting|N/A|60|Anticipated|Boston University||2|||f||||f||||||||||2017-10-11 03:41:38.229713|2017-10-11 03:41:38.229713
NCT01458821|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2014-05-07|||March 2012||2012-03-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|FEMAICT||Cognitive Training for Firefighters With Tinnitus|Investigating the Impact of Cognitive Training for Firefighters With Tinnitus|Completed||Phase 3|60|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 03:41:38.332412|2017-10-11 03:41:38.332412
NCT01458808|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-10-24|||April 2007||2007-04-01|October 2011|2011-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis Patients|Effects of Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis Patients. A Prospective Randomized Controlled Study|Completed||Phase 4|59|Actual|UPECLIN HC FM Botucatu Unesp||3|||f||||t||||||||||2017-10-11 03:41:38.416649|2017-10-11 03:41:38.416649
NCT01458795|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2011-11-02||||||November 2011|2011-11-01||||||||Interventional|||The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins|The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins|Completed||Phase 4|60|Anticipated|Baskent University||1|||f||||t||||||||||2017-10-11 03:41:38.520872|2017-10-11 03:41:38.520872
NCT01458782|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2016-10-27|||October 2011||2011-10-01|October 2016|2016-10-01|October 2024|Anticipated|2024-10-01|October 2014|Actual|2014-10-01||Interventional|||ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee|A Randomized Trial Comparing Autologous Chondrocyte Implantation Using Collagen Membrane (ACI-C) Versus (Autologous Matrix Induced Chondrogenesis) AMIC for Repair of Cartilage Defects in the Knee|Active, not recruiting||Phase 2/Phase 3|80|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-10-11 03:41:38.589896|2017-10-11 03:41:38.589896
NCT01458769|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-05-23|||December 2010||2010-12-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to Reyataz|Open-labeled, Randomized, Crossover, Single-dose Study in Healthy Male Subjects to Evaluate the Pharmacokinetics, Safety & Tolerability of Stable Isotopologs of Atazanavir (ATV), Administered as Single Agents or as Combinations of Two Isotopologs, With a Pharmacokinetic Comparison to Reyataz®.|Completed||Phase 1|47|Actual|Concert Pharmaceuticals||7|||f||||t||||||||||2017-10-11 03:41:38.688645|2017-10-11 03:41:38.688645
NCT01458756|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2016-10-24|||December 2006||2006-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|GHEPA||Study of Psychological Defense Mechanisms Used by Liver Transplant Patients|Evaluation of Psychological Defense Mechanisms Used by Liver Transplant Patients on Their Somatic Psychological and Social Outcome. Research for Protective or Vulnerability Factors.|Completed||N/A|81|Actual|University Hospital, Lille|||1||f||||f||||||||||2017-10-11 03:41:38.794652|2017-10-11 03:41:38.794652
NCT01458743|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-09-01|||October 2011||2011-10-01|September 2017|2017-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|CeftarolineChi||Ceftaroline China Pharmacokinetics Study|A Phase I, Single Center, Open Label, Two Groups Study to Assess the Safety and Pharmacokinetics of Ceftaroline in Healthy Chinese Volunteers Following Single and Multiple Administration of 600 mg Ceftaroline Fosamil as 60-minute Intravenous Infusion Every 12 Hours and as 120-minute Intravenous Infusion Every 8 Hours|Completed||Phase 1|24|Actual|Pfizer||2|||f||||||||||||||2017-10-11 03:41:38.899529|2017-10-11 03:41:38.899529
NCT01458730|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2012-11-15|||May 2007||2007-05-01|November 2012|2012-11-01|October 2020|Anticipated|2020-10-01|October 2010|Actual|2010-10-01||Interventional|||Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma|Immunochemotherapy in Primary Central Nervous System Lymphoma With Rituximab, HD-MTX, HD-Ara C, Cyclophosphamide, Ifosfamide, Vincristine, Vindesine, Temozolomide and DepoCyte Induction Followed by Maintenance Treatment in Elderly Patients With Temozolomide.|Active, not recruiting||Phase 2|66|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 03:41:39.033185|2017-10-11 03:41:39.033185
NCT01458717|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-06-05|||November 2011||2011-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer|Multicenter Prospective Randomized Phase II/III Study of Neoadjuvant Chemoradiation With Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer|Active, not recruiting||Phase 2/Phase 3|116|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:41:39.136033|2017-10-11 03:41:39.136033
NCT01458704|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-23|2011-10-24|||August 2011||2011-08-01|October 2011|2011-10-01||||April 2013|Anticipated|2013-04-01||Observational|||Cancer Genome Analysis|Cancer Genome Analysis|Unknown status|Recruiting|N/A|100|Anticipated|Seoul National University Hospital|||1||f||||||||||Samples With DNA|"     fresh frozen tumor tissue   "|||2017-10-11 03:41:39.25076|2017-10-11 03:41:39.25076
NCT01458691|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-05-21|||September 2013||2013-09-01|May 2015|2015-05-01||||March 2015|Actual|2015-03-01||Interventional|||Intra-articular Injection of Allogeneic Platelet Rich Plasma (PRP) for Adhesive Capsulitis|Intra-articular Injection of Allogeneic PRP for Adhesive Capsulitis|Completed||N/A|58|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:41:39.326949|2017-10-11 03:41:39.326949
NCT01458678|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2015-09-16|||November 2011||2011-11-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Non Invasive Methods to Guide Volume Optimization|Evaluation of Non Invasive Methods for Goal Directed Fluid Therapy During Abdominal Surgery|Completed||N/A|150|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-11 03:41:39.417441|2017-10-11 03:41:39.417441
NCT01458665|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2014-06-16|||October 2011||2011-10-01|June 2014|2014-06-01||||December 2013|Actual|2013-12-01||Interventional|||Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma (PRP) in Medium to Large Rotator Cuff Tears|Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma (PRP) in Medium to Large Rotator Cuff Tears: A Randomized Controlled Trial|Completed||N/A|74|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:41:39.520827|2017-10-11 03:41:39.520827
NCT01458652|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2014-05-08|||January 2011||2011-01-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammation|Effect of Replacement Volume and AST-120 (Kremezin) on Protein-bound Toxins, Oxidative Stress and MicroInflammation in Patients Receiving Online Hemodiafiltration|Completed||Phase 4|30|Actual|Tungs’ Taichung Metroharbour Hospital||1|||f||||t||||||||||2017-10-11 03:41:39.595831|2017-10-11 03:41:39.595831
NCT01458639|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-10-13|2015-07-20||August 2012||2012-08-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||All subjects enrolled in the trial.|Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism|A Comparison of Technegas® Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging in Subjects Being Evaluated for Pulmonary Embolism|Terminated||Phase 3|18|Actual|Cyclomedica Australia PTY Limited|PE adjudication by Independent Committee for final clinical diagnosis and blinded readings of Xe-133 and Technegas Ventilation and Tc-99m MAA Perfusion images were not performed due to early trial termination. No efficacy data available.|2||Decision to change trial design.|f||||t||||||||||2017-10-11 03:41:39.689177|2017-10-11 03:41:39.689177
NCT01458626|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-08-30|||November 14, 2012|Actual|2012-11-14|August 2017|2017-08-01|August 24, 2016|Actual|2016-08-24|August 24, 2016|Actual|2016-08-24||Interventional|||Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement|A Double-blind, Active-controlled, Randomized Study Comparing Mirtazapine Combined With Paroxetine or Paroxetine Monotherapy in Patients With Major Depressive Patients Without Early Improvement in the First 2 Weeks|Completed||Phase 4|525|Actual|Capital Medical University||3|||f||||t||||||||||2017-10-11 03:41:39.984237|2017-10-11 03:41:39.984237
NCT01458613|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-24|2017-04-25|||October 2011||2011-10-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|BioMaroteaux||Biomarker for Maroteaux-Lamy Disease|Biomarker for Maroteaux-Lamy Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|80|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of mass-spectometry 7,5 ml EDTA     blood, a dry blood spot filter card and a sputum tube are taken. To proof the correct     Maroteaux-Lamy diagnosis in those patients where up to the enrollment in the study no genetic     testing has been done, sequencing of Maroteaux-Lamy will be done as routine diagnostic.      The analyses are done in the      Albrecht-Kossel-Institute for Neuroregeneration Centre for Mental Health University of     Rostock Gehlsheimerstrasse 20 D-18147 Rostock Germany   "|Undecided||2017-10-11 03:41:40.108737|2017-10-11 03:41:40.108737
NCT01458600|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-02-23|||September 2006||2006-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|aGO||Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)|Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)|Completed||Phase 4|65|Actual|Region Skane||2|||f||||t||||||||||2017-10-11 03:41:40.22088|2017-10-11 03:41:40.22088
NCT01458587|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2013-03-12|2012-12-21||November 2011||2011-11-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)|A Phase II Study of Photodynamic Therapy (PDT)With LEVULAN® Topical Solution + Blue Light Versus LEVULAN® Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities|Completed||Phase 2|70|Actual|DUSA Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:41:40.417793|2017-10-11 03:41:40.417793
NCT01458574|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-04-07|2017-04-07||July 20, 2012|Actual|2012-07-20|April 2017|2017-04-01|May 27, 2016|Actual|2016-05-27|May 27, 2016|Actual|2016-05-27||Interventional|OCTAVE|Full analysis set (FAS) included all randomized participants.|A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis|A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis|Completed||Phase 3|593|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 03:41:43.271797|2017-10-11 03:41:43.271797
NCT01458561|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-04-29|2013-07-05||October 2010||2010-10-01|April 2015|2015-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|BARRIER||Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery|An Investigational Plan Evaluating the Operative Management of Parenchymal Bleeding By Means of an Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery|Terminated||Phase 3|1|Actual|CryoLife, Inc.|Early termination leading to small number of subjects evaluated (n=1).|2||Sponsor terminated due to signif. difficulty with pilot investigation enrollment|f||||t||||||||||2017-10-11 03:41:45.661062|2017-10-11 03:41:45.661062
NCT01458548|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-24|||December 2002||2002-12-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|May 2008|Actual|2008-05-01||Interventional|||Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)|Treatment of Patients With Posttransplant Lymphoproliferative Disorder (PTLD) With a Sequential Treatment Consisting of Anti-CD20 Antibody Rituximab and CHOP+GCSF Chemotherapy (Including 1st+2nd Amendment)|Terminated||Phase 2|70|Actual|Charite University, Berlin, Germany||1||"This study had an major amendment in 12/2006 introducing risk stratified sequential treatment   (RSST). The modified protocol is registered with NCT00590447."|f||||f||||||||||2017-10-11 03:41:46.392164|2017-10-11 03:41:46.392164
NCT01458535|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2016-05-31|2016-05-31|2014-05-30|September 2011||2011-09-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Navigator|All participants who received at least 1 dose of study drug.|A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)|An Open-Label, Sequential Arm, Multicenter Study to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-267 With and Without Ribavirin (RBV) in Treatment-Naïve Subjects With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV) Infection|Completed||Phase 2|61|Actual|AbbVie||6|||f||||f||||||||||2017-10-11 03:41:46.567409|2017-10-11 03:41:46.567409
NCT01458509|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-09-07|||October 2011||2011-10-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys|A Comparison of the Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys|Active, not recruiting||N/A|328|Anticipated|Memorial Sloan Kettering Cancer Center|||4||f||||||||||||||2017-10-11 03:41:49.223796|2017-10-11 03:41:49.223796
NCT01458496|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-03-14|||October 2011||2011-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HC||Health Coaching to Effect Lifestyle Behaviour Change|Health Coaching to Effect Lifestyle Behaviour Change: A Randomized Trial of Individuals With Pre-disease|Completed||N/A|219|Actual|Memorial University of Newfoundland||2|||f||||t||||||||||2017-10-11 03:41:49.320279|2017-10-11 03:41:49.320279
NCT01458483|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2012-10-29|||October 2011||2011-10-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|ACES II||Acute Carotid Sinus Endovascular Stimulation II Study|Acute Carotid Sinus Endovascular Stimulation II Study|Completed||Phase 1|9|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-10-11 03:41:49.410103|2017-10-11 03:41:49.410103
NCT00005468|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1990||1990-07-01|June 2000|2000-06-01|December 1992|Actual|1992-12-01|||||Observational|||Lipid Variability--Influence of Stress||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.609596|2017-10-11 04:27:05.609596
NCT01458470|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-03-17|||September 2011||2011-09-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|MITIGATE-HD||A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease|A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease; a Phase IIb Study|Completed||Phase 2|19|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 03:41:49.487457|2017-10-11 03:41:49.487457
NCT01458457|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-02-13|||May 2011||2011-05-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|BBK||Life Quality and Mental State in Patients With Breast Cancer|Life Quality and Mental State in Patients With Breast Cancer - a Randomized Study|Completed||Phase 4|275|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:41:49.58986|2017-10-11 03:41:49.58986
NCT01458444|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2015-08-30|||May 2011||2011-05-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|OPTIFLOW||BIPAP Vision Versus OPTIFLOW System Comparison in Acute Respiratory Failure After Cardio Thoracic Surgery|Acute Respiratory Failure After Cardio Thoracic Surgery: Non Invasive Ventilation (VNI) by BIPAP Vision Versus OPTIFLOW System, Comparison.|Completed||N/A|830|Actual|Centre Chirurgical Marie Lannelongue||2|||f||||t||||||||||2017-10-11 03:41:49.695932|2017-10-11 03:41:49.695932
NCT01458431|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2014-12-20|||October 2011||2011-10-01|October 2011|2011-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Levobupivacaine to the Surgical Wound Following Cesarean|Efficacy of Continuous Infusion of Levobupivacaine to the Surgical Wound Following Cesarean|Completed||Phase 3|70|Actual|Complexo Hospitalario Universitario de A Coruña||2|||f||||t||||||||||2017-10-11 03:41:49.791252|2017-10-11 03:41:49.791252
NCT01458418|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2015-02-17|||December 2011||2011-12-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children|A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children|Terminated||N/A|4|Actual|Children's Mercy Hospital Kansas City||3||Inability to complete enrollment due to difficulty in finding subjects|f||||f||||||||||2017-10-11 03:41:49.888828|2017-10-11 03:41:49.888828
NCT01458405|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-02-01|||October 2012||2012-10-01|February 2017|2017-02-01|September 2021|Anticipated|2021-09-01|September 2017|Anticipated|2017-09-01||Interventional|ALLSTAR||Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration|Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction|Active, not recruiting||Phase 1/Phase 2|134|Anticipated|Capricor Inc.||2|||f||||t||||||||||2017-10-11 03:41:49.995415|2017-10-11 03:41:49.995415
NCT01458392|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-05-23|2017-04-11||October 2011||2011-10-01|May 2017|2017-05-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck|An Open-label Phase 2 Study of Dalantercept in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|46|Actual|Acceleron Pharma, Inc.||1|||f||||t||||||||||2017-10-11 03:41:50.17383|2017-10-11 03:41:50.17383
NCT01458353|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-21|||November 2011||2011-11-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Microbiological Spectrum of the Intraperitoneal Surface After Elective Right-sided Colon Cancer|Microbiological Spectrum of the Intraperitoneal Surface After Elective Right-sided Colon Cancer: Are There Differences in the Peritoneal Contamination After Performing a Stapled or a Handsewn Anastomosis?|Unknown status|Not yet recruiting|Phase 3|80|Anticipated|Hospital General Universitario Elche||2|||f||||t||||||||||2017-10-11 03:41:51.287291|2017-10-11 03:41:51.287291
NCT01458340|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2015-03-04|||December 2011||2011-12-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Phase 2 Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Proof-of-Concept Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|285|Actual|Theravance Biopharma R & D, Inc.||3|||f||||f||||||||||2017-10-11 03:41:51.383723|2017-10-11 03:41:51.383723
NCT01458327|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-02-13||2016-08-18|November 2011||2011-11-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|May 2015|Actual|2015-05-01||Interventional|||Additional MDMA-assisted Psychotherapy for People Who Relapsed After MDMA-assisted Psychotherapy Trial|An Open-Label Proof-of-Principle Study Testing the Use of an Additional MDMA-Assisted Psychotherapy Session in People Who Relapsed After Participating in a Phase 2 Clinical Trial of MDMA-Assisted Psychotherapy to Treat Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)|Completed||Phase 2|3|Actual|Multidisciplinary Association for Psychedelic Studies||1|||f||||f||||||||||2017-10-11 03:41:51.507869|2017-10-11 03:41:51.507869
NCT01458314|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-11-12|||March 2011||2011-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Non Invasive Mechanical Ventilation in Chronic Respiratory Insufficiency Patients During Rehabilitation|Evaluation of the Additional Effect of Non Invasive Mechanical Ventilation During a Rehabilitative Program With Cycloergometer in Patients With Chronic Respiratory Insufficiency Using Nocturnal Home Ventilation|Completed||N/A|35|Actual|Fondazione Salvatore Maugeri||2|||f||||t||||||||||2017-10-11 03:41:51.620041|2017-10-11 03:41:51.620041
NCT01458301|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-02-24|||October 2011||2011-10-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Efficacy and Safety of TAK-385 in the Treatment of Endometriosis|A Phase II, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of TAK-385 10, 20, and 40 mg (p.o.) in the Treatment of Endometriosis|Completed||Phase 2|487|Actual|Takeda||5|||f||||f||||||||||2017-10-11 03:41:51.728979|2017-10-11 03:41:51.728979
NCT01458288|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-12-25|2014-12-16||October 2012||2012-10-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease||Completed||Phase 2|12|Actual|TaiGen Biotechnology Co., Ltd.||1|||f||||||||||||||2017-10-11 03:41:51.950801|2017-10-11 03:41:51.950801
NCT01458275|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-04-16|2014-03-10||November 2011||2011-11-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)|A 2-Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6 to 11 Years With Seasonal Allergic Rhinitis|Completed||Phase 3|847|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 03:41:52.153772|2017-10-11 03:41:52.153772
NCT01458262|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-01-27|||September 2011||2011-09-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Observational|||Observational Study on the Clinical Impact of Desaturation During Liver Surgery|Observational Study on the Clinical Impact of Systemic and Cerebral Desaturation During Liver Transplantation and Hepatectomy|Completed||N/A|100|Actual|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-10-11 03:41:53.594526|2017-10-11 03:41:53.594526
NCT01458249|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2016-03-09|2016-02-07||November 2011||2011-11-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|November 2014|Actual|2014-11-01||Interventional||Full analysis set included all participants who received at least one dose of study drug. Arm 1 included all participants with ADI or LMS. Arm 2 included all participants with OTH.|An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217)|An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma|Completed||Phase 2|52|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 03:41:53.724486|2017-10-11 03:41:53.724486
NCT01458236|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2012-05-10|||November 2011||2011-11-01|May 2012|2012-05-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor|A Multinational, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase III Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor|Withdrawn||Phase 3|0|Actual|Lung Biotechnology PBC||2|||f||||t||||||||||2017-10-11 03:41:54.275832|2017-10-11 03:41:54.275832
NCT01458223|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-03-07|||October 2011||2011-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PARISS||The Effect of Prolonged Postoperative Antibiotics Administration on Rate of Infection in Patients Undergoing Posterior Spine Surgery Requiring a Hemovac Drain|The Effect of Prolonged Postoperative Antibiotics Administration on Rate of Infection in Patients Undergoing Posterior Spine Surgery Requiring a Hemovac Drain|Recruiting||Phase 4|1066|Anticipated|The London Spine Centre||2|||f||||f||||||||||2017-10-11 03:41:54.473451|2017-10-11 03:41:54.473451
NCT01458210|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-10-03|2014-10-03||October 2011||2011-10-01|October 2014|2014-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Participants who received at least 1 dose of study drug.|A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants|Effect of Dulaglutide (LY2189265) on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects|Completed||Phase 1|22|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:41:54.5748|2017-10-11 03:41:54.5748
NCT01458197|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-03-11|||September 2011||2011-09-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.|A Prospective, Multi-center, Placebo-controlled, Randomized, Double-blind, Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering From Overactive Bladder.|Completed||Phase 2|235|Actual|Kwang Dong Pharmaceutical co., ltd.||3|||f||||f||||||||||2017-10-11 03:41:55.029704|2017-10-11 03:41:55.029704
NCT01458184|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2013-04-05|||September 2008||2008-09-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ComplexPt||Study of PhoneCare System to Treat Patients With Chronic Diseases|A Randomized Trial of the PhoneCare System to Improve Ambulatory Care for Patients With Chronic Diseases|Completed||N/A|264|Actual|Boston Medical Center||2|||f||||f||||||||||2017-10-11 03:41:55.130896|2017-10-11 03:41:55.130896
NCT01458171|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-02-27|2013-02-27||April 2011||2011-04-01|February 2013|2013-02-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Interventional|||Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)|A Multicenter Follow-up Study of Long-term Safety, Tolerability, and Efficacy of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency|Completed||Phase 3|23|Actual|CSL Behring||1|||f||||||||||||||2017-10-11 03:41:55.244999|2017-10-11 03:41:55.244999
NCT01458158|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2015-02-20|||October 2011||2011-10-01|February 2015|2015-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|MMACKD||Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease|The Role of Matrix Metalloproteinases -2 and -9 in Atherosclerosis of Patients With Chronic Kidney Disease|Unknown status|Recruiting|N/A|300|Anticipated|Aristotle University Of Thessaloniki|||3||f||||f||||||Samples Without DNA|"     serum and vessels   "|||2017-10-11 03:41:55.87054|2017-10-11 03:41:55.87054
NCT01458145|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-02-27|||September 2009|Actual|2009-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||Minding the Baby Home Visiting: Program Evaluation|Minding the Baby Home Visiting: Program Evaluation|Completed||N/A|151|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:41:56.434913|2017-10-11 03:41:56.434913
NCT01458119|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-05-23||2017-05-23|October 2011||2011-10-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|AT1001-041||Open-Label Phase 3 Long-Term Safety Study of Migalastat|An Open-Label Extension Study to Evaluate the LongTerm Safety and Efficacy of Migalastat Hydrochloride Monotherapy in Subjects With Fabry Disease|Completed||Phase 3|85|Actual|Amicus Therapeutics||1|||f||||t||||||||||2017-10-11 03:41:56.640854|2017-10-11 03:41:56.640854
NCT01458106|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-02-27|2014-12-04||November 2012||2012-11-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Kids ALONG||Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A|An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB031, in the Prevention and Treatment of Bleeding Episodes in Pediatric Subjects With Hemophilia A|Completed||Phase 3|71|Actual|Bioverativ Therapeutics Inc.||1|||f||||t||||||||||2017-10-11 03:41:56.853468|2017-10-11 03:41:56.853468
NCT01458093|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-20|||July 2010||2010-07-01|October 2011|2011-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Large Overuse of Post-polypectomy Surveillance Colonoscopy|Large Overuse of Post-polypectomy Surveillance Colonoscopy: a Prospective Nation-wide Study|Completed||N/A|7081|Actual|Valduce Hospital|||1||f||||f||||||||||2017-10-11 03:41:59.822822|2017-10-11 03:41:59.822822
NCT01458080|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2013-12-05|||May 2011||2011-05-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||WEUSKOP5410: Observational Study in ENABLE Clinical Trials|WEUSKOP5410: A Retrospective Observational Non-Interventional Nested Case Control Study to Evaluate the Risk for Thromboembolic Events Associated With Surgery and Eltrombopag Exposure in the ENABLE Studies|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:41:59.926548|2017-10-11 03:41:59.926548
NCT01458067|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-04-27|||November 10, 2011|Actual|2011-11-10|April 2017|2017-04-01|February 25, 2016|Actual|2016-02-25|November 12, 2015|Actual|2015-11-12||Interventional|||A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency|A Phase I/IIa, First Time in Human, Open-label Dose-escalation Study of GSK2636771 in Subjects With Advanced Solid Tumors With PTEN Deficiency|Completed||Phase 1|30|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:42:00.071121|2017-10-11 03:42:00.071121
NCT01458054|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-07-18|||September 27, 2011|Actual|2011-09-27|July 2017|2017-07-01|November 28, 2011|Actual|2011-11-28|November 28, 2011|Actual|2011-11-28||Interventional|||Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults|Phase 1, Open Label Study to Evaluate the Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults|Completed||Phase 1|28|Actual|GlaxoSmithKline||7|||f||||f||||||||||2017-10-11 03:42:00.185139|2017-10-11 03:42:00.185139
NCT01458041|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2015-02-27|||August 2011||2011-08-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|||Iloprost Therapy in Patients With Critical Limb Ischemia|Iloprost Therapy in Patients With Critical Limb Ischemia: Evaluation of Efficacy and Safety|Completed||N/A|126|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:42:00.306183|2017-10-11 03:42:00.306183
NCT01458028|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-05-05|||September 2011||2011-09-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Age and Gender Effects on the Pharmacokinetics of BAY85-3934|A Parallel Group, Double-Blind Study to Evaluate the Effects of Age and Gender on the Single-Dose Pharmacokinetics of BAY85-3934, Tablet Formulation|Completed||Phase 1|48|Actual|Bayer||2|||f||||f||||||||||2017-10-11 03:42:00.42843|2017-10-11 03:42:00.42843
NCT01458015|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2014-03-25|||October 2011||2011-10-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain|Phase 4 Study of Tapentadol vs Oxycodone in Neuropathic Pain|Terminated||Phase 4|5|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-10-11 03:42:00.667032|2017-10-11 03:42:00.667032
NCT01458002|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-05-10|||April 2009||2009-04-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Project RAISE||Online Tailored Interventions & Relational Agents for Exercise and Sun Protection|Online Tailored Interventions & Relational Agents for Exercise and Sun Protection|Completed||N/A|1364|Actual|University of Rhode Island||3|||f||||f||||||||No||2017-10-11 03:42:00.7882|2017-10-11 03:42:00.7882
NCT01457989|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-10-25|||August 2011||2011-08-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304|Meta-Analysis of VRX-RET-E22-303 and VRX-RET-E22-304: Two Multicenter, Open-Label, Long-Term, Safety, Tolerability and Efficacy Studies of Retigabine in Adult Epilepsy Patients With Partial-onset Seizures (Extensions of Studies VRX-RET-E22-301 and VRX-RET-E22-302)|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:42:00.890849|2017-10-11 03:42:00.890849
NCT01457976|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-08-17|||September 2011||2011-09-01|August 2016|2016-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||A Survey on Attitudes on Financial Incentives|A Survey on Attitudes on Personal Responsibility and the Use of Financial Incentives for Health Promotion|Withdrawn||N/A|0|Actual|University of Pennsylvania|||3|protocol never approved by local IRB|f||||f||||||||||2017-10-11 03:42:00.988452|2017-10-11 03:42:00.988452
NCT01457963|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2011-10-21|||December 2009||2009-12-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|PEICU||Prevalence of Pulmonary Embolism in ICU|Pulmonary Embolism in Mechanically Ventilated Patients Requiring Computed Tomography: Prevalence, Risk Factors and Outcome|Completed||N/A|176|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-10-11 03:42:01.083404|2017-10-11 03:42:01.083404
NCT01457950|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-04-17|2013-08-22||November 2011||2011-11-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab|A Six Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study With a Six Month Open-Label Extension to Evaluate the Efficacy and Safety of Denosumab in Korean Postmenopausal Women With Osteoporosis|Completed||Phase 3|135|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:42:01.22182|2017-10-11 03:42:01.22182
NCT01457937|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-08|2012-09-29|||November 2011||2011-11-01|September 2012|2012-09-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|MEN_BOC||Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)|Boceprevir/Peginterferon Alfa (PegIFN α)-2b/Ribavirin (Riba) in Difficult-to-Treat Menopausal Women With Chronic Hepatitis C Genotype 1 (Gt 1), Either Deemed Nonresponders to Peginterferon/Ribavirin or Treatment-naives (MEN_BOC)|Unknown status|Recruiting|Phase 3|240|Anticipated|University of Modena and Reggio Emilia||2|||f||||t||||||||||2017-10-11 03:42:03.226994|2017-10-11 03:42:03.226994
NCT00000200|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||January 1997||1997-01-01|October 2016|2016-10-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Cocaine Effects in Humans: Physiology and Behavior - 1|Cocaine Effects in Humans: Physiology and Behavior|Completed||Phase 2|19|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-10-11 04:17:38.562577|2017-10-11 04:17:38.562577
NCT01457911|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-05-07|||October 2011||2011-10-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin|A Multicenter, Randomized, Open-label, 2-arm Parallel Group, 20-week Study Comparing the Efficacy and Safety of Fixed-dose Combination of 1 mg Glimepiride and 250 mg Metformin (AMARYL M 1/250 mg) Versus Glimepiride (AMARYL®) in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin.|Completed||Phase 3|244|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:42:03.690861|2017-10-11 03:42:03.690861
NCT01457898|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-21|||April 2008||2008-04-01|October 2011|2011-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Non-invasive Mechanical Ventilation After Cardiac Surgery|Effects of Non-invasive Mechanical Ventilation on Hemodynamics and Gas Exchanges Parameters After Cardiac Surgery in Patients With Relative Hypoxemia|Completed||N/A|42|Actual|Irmandade Santa Casa de Misericórdia de Porto Alegre||1|||f||||f||||||||||2017-10-11 03:42:03.814351|2017-10-11 03:42:03.814351
NCT01457885|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-05-03|2016-06-14||November 2011||2011-11-01|May 2017|2017-05-01|June 14, 2016|Actual|2016-06-14|November 2014|Actual|2014-11-01||Interventional|CloBu4|75 patients were enrolled. Only 74 patients were treated. Of the treated patients, 3 were pediatric and were left off of the analysis. 71 adult patients were analyzed.|Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen|Multi-center Single Arm Phase II Study of Myeloablative Allogeneic Stem Cell Transplantation for Non-remission Acute Myeloblastic Leukemia (AML) Using Clofarabine and Busulfan x 4 (CloBu4) Regimen|Completed||Phase 2|75|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 03:42:03.918665|2017-10-11 03:42:03.918665
NCT01457872|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2014-11-24|||October 2011||2011-10-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|MATRIS||Malmö Treatment Referral and Intervention Study|Malmö Treatment Referral and Intervention Study|Completed||N/A|79|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 03:42:04.388911|2017-10-11 03:42:04.388911
NCT01457859|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2011-10-21|||October 2011||2011-10-01|October 2011|2011-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Effectiveness of Triclosan Coated Sutures in Preventing Leg Wound Infection After Coronary Artery Bypass Surgery|Effectiveness of Triclosan Coated VICRYL\MONOCRYL Sutures in Preventing Leg Wound Infection Compared to POLYSORB\ BIOSYN Sutures in Patients After Coronary Bypass Surgery- a Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 4|410|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 03:42:04.476431|2017-10-11 03:42:04.476431
NCT01457846|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-01-16|2016-02-11||November 2011||2011-11-01|January 2017|2017-01-01|February 2015|Actual|2015-02-01|August 2013|Actual|2013-08-01||Interventional|SHINE||Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer|A Randomised Open-Label Phase II Study to Assess the Efficacy & Safety of AZD4547 Monotherapy Versus Paclitaxel in Patients With Advanced Gastric Adenocarcinoma (Inc. Adenocarcinoma of the Lower Third of the Oesophagus or the Gastro-Oesophageal Junction)With FGFR2 Polysomy or Gene Amplification.|Terminated||Phase 2|960|Actual|AstraZeneca|Prompted by slow recruitment, AZ and the SRC instigated unscheduled analysis of the efficacy and tolerability. It was concluded that the study was unlikely to meet its primary objective. Enrolment ceased and the study closed.|2|||f||||||||||||||2017-10-11 03:42:04.587454|2017-10-11 03:42:04.587454
NCT01457833|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-21|||August 2011||2011-08-01|October 2011|2011-10-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Implantation of Endobronchial Valves Versus Intrabronchial Valves in Patients With Severe Heterogeneous Emphysema|Endoscopic Lung Volume Reduction by Implantation of Endobronchial Valves (EBV) vs. Intrabronchial Valves (IBV) in Patients With Severe Heterogeneous Emphysema|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Heidelberg University||2|||f||||||||||||||2017-10-11 03:42:05.235549|2017-10-11 03:42:05.235549
NCT01457820|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-05-26|||April 2012||2012-04-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|ALLACS||Allopurinol in Acute Coronary Syndrome|Allopurinol as a Possible New Therapy for Acute Coronary Syndromes:The Next Steps|Terminated||Phase 4|26|Actual|University of Dundee||3||slow recruitment: stopped early|f||||f||||||||||2017-10-11 03:42:05.315166|2017-10-11 03:42:05.315166
NCT01457807|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-08-16|||November 2011||2011-11-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers|A Phase I, Single-centre, Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Different Extended Release Formulations of Tablets of AZD3241 (300 mg) After Administration of Multiple Doses in Healthy Male and Female Volunteers|Completed||Phase 1|24|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 03:42:05.403379|2017-10-11 03:42:05.403379
NCT01457794|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-03-03|||May 2011||2011-05-01|March 2017|2017-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||OPUS School Meal Study|OPUS(Optimal Well-being, Development and Health for Danish Children Through a Healthy New Nordic Diet) School Meal Study|Completed||N/A|834|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 03:42:05.627825|2017-10-11 03:42:05.627825
NCT01457781|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2016-08-02||2015-01-30|April 2012||2012-04-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|October 2014|Actual|2014-10-01||Interventional|PAH||Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)|A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 2|80|Actual|Bellerophon||3|||f||||t||||||||||2017-10-11 03:42:05.778512|2017-10-11 03:42:05.778512
NCT01457586|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-21|||September 2011||2011-09-01|October 2011|2011-10-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery|Observational Study of Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery|Unknown status|Recruiting|Phase 4|200|Anticipated|Hospital Pitangueiras||2|||f||||t||||||||||2017-10-11 03:42:09.795206|2017-10-11 03:42:09.795206
NCT01457768|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-05-13|||December 19, 2011|Actual|2011-12-19|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response|A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection|Active, not recruiting||N/A|570|Actual|Gilead Sciences|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 03:42:06.102689|2017-10-11 03:42:06.102689
NCT01457755|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-05-13|||April 13, 2012|Actual|2012-04-13|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Gilead Sustained Virologic Response (SVR) Registry|A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection|Active, not recruiting||N/A|6580|Actual|Gilead Sciences|||1||f||||f||||||Samples Without DNA|"     Plasma   "|||2017-10-11 03:42:07.040727|2017-10-11 03:42:07.040727
NCT01457742|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2012-07-06|||October 2011||2011-10-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effectiveness Study of the Ivivi SofPulse for Pain Amelioration in Adults With Mild to Moderate Knee Osteoarthritis|Non-thermal Pulsed Radio Frequency for Pain Amelioration in Adults With Knee Osteoarthritis: A Double-blind, Randomized, Sham-controlled Trial|Terminated||Phase 4|45|Actual|Amp Orthopedics, Inc.||2||Sponsor decision|f||||f||||||||||2017-10-11 03:42:07.940845|2017-10-11 03:42:07.940845
NCT01457729|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-09-17|||February 2011||2011-02-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Ergometer Training in Patients With OSA|Telemedizinisches Trainings-Monitoring Von Patienten Mit Obstruktivem Schlafapnoesyndrom|Completed||N/A|24|Actual|Institut für Pneumologie Hagen Ambrock eV||2|||f||||f||||||||||2017-10-11 03:42:08.055042|2017-10-11 03:42:08.055042
NCT01457716|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2012-02-02|||October 2011||2011-10-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Pharmacokinetic Pilot Study on Budesonide/Formoterol|Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler: A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||N/A|17|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-10-11 03:42:08.146414|2017-10-11 03:42:08.146414
NCT01457703|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-11-15|2014-06-19||June 2010||2010-06-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Reproductive Hormonal Alterations in Obesity|Reproductive Hormonal Alterations in Obesity, AIMS #1 & #2|Completed||N/A|62|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 03:42:08.256547|2017-10-11 03:42:08.256547
NCT01457690|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2015-11-12|||October 2011||2011-10-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|VEDROP||Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention|Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention|Completed||Phase 3|14|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-10-11 03:42:08.670531|2017-10-11 03:42:08.670531
NCT01457677|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2016-11-01||2016-07-08|December 2011||2011-12-01|November 2016|2016-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment|A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)|Completed||Phase 2|357|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 03:42:08.78471|2017-10-11 03:42:08.78471
NCT01457664|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of RO4995819 in Healthy Elderly Volunteers|A Randomized, Double-Blind, Multiple Dose, Placebo-Controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of RO4995819 Following Oral Administration in Healthy Elderly Subjects.|Completed||Phase 1|30|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:42:09.186744|2017-10-11 03:42:09.186744
NCT01457651|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2013-06-24|||March 2010||2010-03-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|RECR-CABG||Comparison of Four Different Recruitment Maneuvers in Patients After Coronary Surgery|Comparison of Different Types of Postoperative Pulmonary Recruitment and Predicting Its Efficacy Following Off-pump Coronary Artery Bypass Grafting|Completed||N/A|76|Actual|Northern State Medical University||4|||f||||f||||||||||2017-10-11 03:42:09.291339|2017-10-11 03:42:09.291339
NCT01457638|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2011-10-20|||January 2011||2011-01-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|||Inferior Turbinate Surgery in Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Outcomes|Inferior Turbinate Surgery in Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life and Acoustic Rhinometry Outcomes|Unknown status|Recruiting|N/A|50|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-10-11 03:42:09.415191|2017-10-11 03:42:09.415191
NCT01457625|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2011-10-20|||January 2011||2011-01-01|October 2011|2011-10-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Clinical Study of Serum Fetuin A Level, Insulin Resistance and Hepatic Fat Content in Dialysis Patients|The Association of Serum Fetuin A Level, Insulin Resistance and Hepatic Fat Content and Their Associations With Overall Survival in Maintenance Hemodialysis and Peritoneal Dialysis Patients|Unknown status|Recruiting|N/A|300|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-10-11 03:42:09.536751|2017-10-11 03:42:09.536751
NCT01457612|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-02-06|||October 2011||2011-10-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of 6-week Strawberry Supplementation on Insulin Action (STR2)|Effect of 6 Weeks Strawberry Supplementation on Insulin Action and Associated Risk Factors in Insulin Resistant (IR) Subjects (STR2)|Active, not recruiting||N/A|45|Actual|Institute for Food Safety and Health, United States||3|||f||||f||||||||||2017-10-11 03:42:09.631663|2017-10-11 03:42:09.631663
NCT01457599|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-08-15|||July 2011||2011-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Computertomography-guided Wire Marking of the Liver|Computertomography-guided Wire Marking of Colorectal Hepatic Metastases After Complete Response to Neoadjuvant Chemotherapy. A Pilot Study|Completed||N/A|20|Actual|Medical University of Graz|||1||f||||f||||||||Undecided||2017-10-11 03:42:09.727416|2017-10-11 03:42:09.727416
NCT01457560|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2016-08-04|||February 2000||2000-02-01|August 2016|2016-08-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine|Study to Assess the Immunogenicity and Reactogenicity of DTPa-HBV-IPV Mixed With Hib Vaccine in Healthy Infants, Followed by a Dose of the Same Vaccine Administered Simultaneously With One Dose of Oral Polio Vaccine (OPV)|Completed||Phase 3|80|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:42:09.967572|2017-10-11 03:42:09.967572
NCT01457547|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-08-04|||October 2003||2003-10-01|August 2016|2016-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course|Study to Assess and Compare the Immunogenicity and Reactogenicity of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (INFANRIX™ HEXA) and Aventis Pasteur MSD's DTPa-HBV-IPV-Hib Vaccine (HEXAVAC™) Given at 3, 5 and 11-12 Months of Age|Completed||Phase 4|494|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:42:10.085757|2017-10-11 03:42:10.085757
NCT01457534|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2013-02-26|||January 2011||2011-01-01|February 2013|2013-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||The Predictors for Continuous Renal Replacement Therapy in Liver Transplant Patient||Completed||N/A|148|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 03:42:10.281738|2017-10-11 03:42:10.281738
NCT01457521|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2015-12-10|2015-08-11||October 2011||2011-10-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Inclusive of participants who provided follow-up data only|Pain Control In First Trimester Medical Abortion: A Randomized Trial|PAIN CONTROL IN FIRST TRIMESTER MEDICAL ABORTION: A Randomized Trial|Completed||Phase 4|250|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-11 03:42:10.379504|2017-10-11 03:42:10.379504
NCT01457508|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2017-06-15|||January 1999||1999-01-01|June 2017|2017-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately|Study to Assess the Immunogenicity and Reactogenicity of DTPa-HBV-IPV Vaccine Mixed With Hib Vaccine to Healthy Infants at 3, 5 and 11 Months of Age, Compared to Each Vaccine Administered Separately|Completed||Phase 3|440|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 03:42:10.674181|2017-10-11 03:42:10.674181
NCT01457495|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-06-15|||September 1998||1998-09-01|June 2017|2017-06-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly|Study to Assess Immunogenicity and Reactogenicity of SB Biologicals' DTPa-HBV-IPV/Hib Vaccine Given as Three-dose Primary Vaccination Course Compared to DTPa-IPV/Hib and HBV Administered Concomitantly at Separate Sites|Completed||Phase 2|312|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 03:42:10.774429|2017-10-11 03:42:10.774429
NCT01457482|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2012-02-13|||May 2011||2011-05-01|February 2012|2012-02-01||||December 2012|Anticipated|2012-12-01||Interventional|||Art Therapy as Treatment for Fear of Childbirth|Art Therapy as Treatment for Fear of Childbirth:a Randomized Controlled Study|Unknown status|Recruiting|N/A|124|Anticipated|Helsingborgs Hospital||2|||f||||f||||||||||2017-10-11 03:42:10.859639|2017-10-11 03:42:10.859639
NCT01457469|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-05-25|||January 2011||2011-01-01|February 2017|2017-02-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|||Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer|Adapting Smoking Cessation Interventions for the Outpatient Oncology Setting|Completed||Phase 1|6|Actual|Wake Forest University Health Sciences||2|||f||||f|t|f||||||||2017-10-11 03:42:10.95161|2017-10-11 03:42:10.95161
NCT01457456|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-04-25|||October 2011||2011-10-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|BioMorquio||Biomarker for Morquio Disease|Biomarker for Morquio Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|250|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry 7,5 ml EDTA     blood,sputum tube and a dry blood spot filter card are taken. To proof the correct Morquio     diagnosis in those patients where up to the enrollment in the study no genetic testing has     been done, sequencing of Morquio will be done. The analyses are done in the     Albrecht-Kossel-Institute for Neuroregeneration (AKos), POB 100 888, Gehlsheimer Str. 20,     18055 Rostock (Germany)   "|||2017-10-11 03:42:11.068003|2017-10-11 03:42:11.068003
NCT01457443|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-21|2017-05-03|||October 2011||2011-10-01|May 2017|2017-05-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|BioPompe||Biomarker for Pompe Disease|Biomarker for Pompe Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|80|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry 7,5 ml EDTA     blood,sputum tube and a dry blood spot filter card are taken. To proof the correct Pompe     diagnosis in those patients where up to the enrollment in the study no genetic testing has     been done, sequencing of Pompe will be done. The analyses are done in the     Albrecht-Kossel-Institute for Neuroregeneration (AKos), POB 100 888, Gehlsheimer Str. 20,     18055 Rostock (Germany)   "|Undecided||2017-10-11 03:42:11.185911|2017-10-11 03:42:11.185911
NCT01457430|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-10-17|2016-08-11||December 2011||2011-12-01|October 2016|2016-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|IHA||Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE|Open Label, Multicenter Study to Evaluate Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema (IHA)|Completed||Phase 4|19|Actual|Massachusetts General Hospital|All adverse events were recorded and assessed out of total attacks, not total participants. There were 78 HAE attacks; 4 adverse events were identified.|1|||f||||t||||||||Undecided|The data is under review for publication but individual data will likely not be available|2017-10-11 03:42:11.323955|2017-10-11 03:42:11.323955
NCT01457417|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-09-26|2015-01-13||January 2012||2012-01-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors|A Two Part Phase 1 Multicenter Open-label Study of DKN-01 Given Intravenously. Part A: Dose-Escalation in Patients With Multiple Myeloma or Advanced Solid Tumors. Part B: Expansion Cohort in Patients With Relapsed / Refractory Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|32|Actual|Leap Therapeutics, Inc.||5|||f||||f||||||||||2017-10-11 03:42:11.597355|2017-10-11 03:42:11.597355
NCT01457404|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-10-23|||February 2011||2011-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders|Integrated Cognitive Behavioral Therapy for Co-Occurring PTSD and Substance Use Disorders|Completed||Phase 3|56|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 03:42:12.678276|2017-10-11 03:42:12.678276
NCT01457391|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-02-12|||December 2010||2010-12-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment|A Stage II Efficacy Study of Cognitive Behavioral Therapy for PTSD in Community Addiction Treatment|Completed||Phase 3|443|Actual|Dartmouth-Hitchcock Medical Center||3|||f||||t||||||||||2017-10-11 03:42:12.763653|2017-10-11 03:42:12.763653
NCT01457378|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-09-19|||September 2011||2011-09-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Observational|||Gastrointestinal Symptoms in Healthy Subjects and Patients With Irritable Bowel Syndrome|Assessment of Gastrointestinal Symptoms and Health-related Quality of Life in Healthy People and Patients With Irritable Bowel Syndrome|Completed||N/A|200|Actual|Danone Research|||2||f||||f||||||||||2017-10-11 03:42:12.86213|2017-10-11 03:42:12.86213
NCT01457365|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2011-10-20|||December 2011||2011-12-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|February 2012|Anticipated|2012-02-01||Observational|||Vitamin D Deficiency Epidemiological Research in Sichuan, China|Vitamin D Status and Its Correlation to Bone Density, Bone Turnover Markers and Muscle Function in Community-dwelling People in Sichuan Province , P.R. China|Unknown status|Not yet recruiting|N/A|1500|Anticipated|West China Hospital|||1||f||||||||||||||2017-10-11 03:42:12.921322|2017-10-11 03:42:12.921322
NCT01457352|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2017-05-24|||September 2012||2012-09-01|May 2017|2017-05-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Efficacy and Safety of SPARC0921 in Subjects With Spasticity||Active, not recruiting||Phase 3|300|Anticipated|Sun Pharma Advanced Research Company Limited||2|||f||||f||||||||||2017-10-11 03:42:12.992546|2017-10-11 03:42:12.992546
NCT01457339|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-03-03|2012-12-13||October 2011||2011-10-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia|A Phase 1, Randomized, Double-blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending, Multiple Oral Doses of SPD489 (Lisdexamfetamine Dimesylate) in Clinically Stable Adults With Schizophrenia|Completed||Phase 1|31|Actual|Shire||2|||f||||f||||||||||2017-10-11 03:42:13.452156|2017-10-11 03:42:13.452156
NCT01457326|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-07-13|||June 2009||2009-06-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Early Standardized Weight Bearing Utilizing Immersion Therapy Following Periarticular Lower Extremity Fractures|Early Standardized Weight Bearing Utilizing Immersion Therapy Following Periarticular Lower Extremity Fractures: Clinical and Radiographic Outcomes|Terminated||N/A|122|Actual|University of Utah|||2|"Loss to follow-up rate too high for publication and data on completed patients does not allow   for a powered analysis."|f||||f||||||||||2017-10-11 03:42:15.70632|2017-10-11 03:42:15.70632
NCT01457313|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2013-02-04|||October 2011||2011-10-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Observational|||Pain Compared Between the First and the Second Surgery in Staged BTKA|Comparison of Postoperative Pain in the First and Second Knee in Staged Bilateral Total Knee Arthroplasty: Clinical Evidence That Central Sensitization Increases Systemic Pain Sensitivity|Unknown status|Recruiting|N/A|34|Anticipated|Seoul National University Bundang Hospital|||1||f||||f||||||||||2017-10-11 03:42:15.783766|2017-10-11 03:42:15.783766
NCT01457300|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-10-24|||June 2006||2006-06-01|October 2011|2011-10-01|October 2010|Actual|2010-10-01|April 2009|Actual|2009-04-01||Observational|||Outcome of Rehabilitation of Older People in Primary Health Care|Outcome of Multi-Disciplinary, Structured Rehabilitation of Older People in an Inpatient District Rehabilitation Centre Versus Standard Primary Health Care Rehabilitation - An Open Comparative Observational Stdy|Completed||N/A|302|Actual|University of Oslo|||2||f||||t||||||||||2017-10-11 03:42:15.863352|2017-10-11 03:42:15.863352
NCT01457287|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-20|||October 2003||2003-10-01|October 2011|2011-10-01||||||||Observational|||A Longitudinal Investigation of Cognitive Function in Colorectal Cancer Patients|Cognitive Function and Fatigue in Cancer Patients After Chemotherapy: A Longitudinal Controlled Study in Patients With Colorectal Cancer|Completed||N/A|300|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 03:42:16.002214|2017-10-11 03:42:16.002214
NCT01457274|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-04-23|||September 2011||2011-09-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||"Light Versus Deep Bispectral Index (BIS) Guided Sedation for Colonoscopy"|"A Randomised Controlled Trial of Light Versus Deep Sedation for Elective Outpatient Colonoscopy: Recall, Procedural Conditions and Recovery"|Completed||N/A|200|Actual|Melbourne Health||2|||f||||f||||||||||2017-10-11 03:42:16.067643|2017-10-11 03:42:16.067643
NCT01457261|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-11-04|||April 2012||2012-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|TOPICAL-IPF||IPF Drug Deposition Study|A Study of the Pharmacokinetics and Deposition of Inhaled Salbutamol in Patients With Idiopathic Pulmonary Fibrosis (TOPICAL-IPF)|Completed||Phase 1|10|Actual|Royal Brompton & Harefield NHS Foundation Trust||4|||f||||f||||||||||2017-10-11 03:42:16.179489|2017-10-11 03:42:16.179489
NCT01457248|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2014-07-02|||October 2011||2011-10-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|TETRIS||Taper-shaped Cuff Endotracheal Tube Against Respiratory Infections|Effect of Endotracheal Tube With Taper-shaped Cuff on Incidence of Postoperative Pneumonia After Aortic Surgery|Completed||N/A|162|Actual|Groupe Hospitalier Pitie-Salpetriere||2|||f||||t||||||||||2017-10-11 03:42:16.278644|2017-10-11 03:42:16.278644
NCT01456832|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-25|||January 2010||2010-01-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Observational|||Post Operative Hyponatremia in the Renal Transplant Population|Post Operative Hyponatremia in the Renal Transplant Population|Completed||N/A|225|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:42:26.288099|2017-10-11 03:42:26.288099
NCT01457235|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2014-01-29|||August 2011||2011-08-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|REMEDI||The Effects of Cognitive Remediation on Cognitive Function in Remitted Bipolar Disorder - a Proof of Concept Study|The Effects of Cognitive Remediation on Cognitive Function in Remitted Bipolar Disorder - a Proof of Concept Study (REMEDI)|Completed||N/A|46|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 03:42:16.359358|2017-10-11 03:42:16.359358
NCT01457222|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-02-13|||October 2011||2011-10-01|February 2012|2012-02-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|CHAMPS||Cognition and Health in Adolescents, Mindfulness as Prevention of Stress.|Mindfulness as a Method of Improving Mental Health and Cognitive Results and Decreasing Stress in Secondary School Students; a Prospective Randomised Controlled Single-blinded Pilot Study|Unknown status|Active, not recruiting|N/A|150|Anticipated|Region Skane||3|||f||||f||||||||||2017-10-11 03:42:16.43839|2017-10-11 03:42:16.43839
NCT01457209|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2014-01-20|||October 2011||2011-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PCOS-AcupIR||Acupuncture to Treat Insulin Resistance in Women With and Without Polycystic Ovary Syndrome|Effect of Acupuncture on Insulin Sensitivity in Women With and Without Polycystic Ovary Syndrome|Completed||Phase 1|42|Actual|Göteborg University||1|||f||||f||||||||||2017-10-11 03:42:16.524007|2017-10-11 03:42:16.524007
NCT01457196|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-09-26|||September 2011||2011-09-01|September 2017|2017-09-01|September 2019|Anticipated|2019-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions|Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions|Active, not recruiting||N/A|5000|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:42:16.592401|2017-10-11 03:42:16.592401
NCT01457183|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-12-26|||October 2011||2011-10-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Clinical Evaluation of Bedside Pulse Lavage Irrigation Device|Bedside Pulse Lavage Irrigation Project|Completed||N/A|5|Actual|Northwestern University||1|||f||||f||||||||||2017-10-11 03:42:16.660247|2017-10-11 03:42:16.660247
NCT01457170|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2013-07-12|||January 2012||2012-01-01|July 2013|2013-07-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Effects of Apelin on the Lung Circulation in Pulmonary Hypertension|Investigating the Acute Pulmonary Vascular Haemodynamic Effects of Apelin in Pulmonary Hypertension|Unknown status|Recruiting|N/A|63|Anticipated|Golden Jubilee National Hospital||2|||f||||t||||||||||2017-10-11 03:42:16.763034|2017-10-11 03:42:16.763034
NCT01457144|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2016-03-15|||October 2011||2011-10-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|September 2014|Actual|2014-09-01||Interventional|RIBVD||Study of Mantle Cell Lymphoma Treatment by RiBVD|First Line Mantle Cell Lymphoma (MCL) Treatment by RiBVD Schema in Patients Older Than 65 Years or 18 to 65 Years Old Who Cannot or Refuse Receive Conditioning Regimen Followed by Autograft|Completed||Phase 2|76|Actual|French Innovative Leukemia Organisation||1|||f||||t||||||||No||2017-10-11 03:42:16.902975|2017-10-11 03:42:16.902975
NCT01457131|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-06-30|||October 6, 2011||2011-10-06|August 2, 2013|2013-08-02|August 7, 2013|Actual|2013-08-07|August 7, 2013|Actual|2013-08-07||Interventional|||Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer|Phase I/II Study of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Gene Engineered Lymphocytes Cotransduced With Genes Encoding IL-12 and Anti-NY ESO-1 TCR|Terminated||Phase 1|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:42:17.03175|2017-10-11 03:42:17.03175
NCT01457118|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-10-05|||October 2011|Actual|2011-10-01|October 2017|2017-10-01|December 2017|Anticipated|2017-12-01|August 2017|Actual|2017-08-01||Interventional|||An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies|An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies|Active, not recruiting||Phase 2|27|Actual|Nektar Therapeutics||1|||f||||f||||||||||2017-10-11 03:42:17.120043|2017-10-11 03:42:17.120043
NCT01457105|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-20|||November 2006||2006-11-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Covered Self-expandable Metal Stents for Palliation of Malignant Biliary Strictures: Evaluation of a New Type of Stent|"PARTIALLY COVERED NITINOL ComVi STENT FOR PALLIATION OF MALIGNANT NON HILAR BILIARY OBSTRUCTION"|Completed||N/A|70|Actual|Catholic University of the Sacred Heart||1|||f||||f||||||||||2017-10-11 03:42:17.216222|2017-10-11 03:42:17.216222
NCT01457092|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-11-06|||January 2007||2007-01-01|November 2015|2015-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Self-expandable, Fully Covered Metal Stents in Biliary Strictures Due to Chronic Pancreatitis|Self-expandable, Fully Covered Metal Stents in Biliary Strictures Due to Chronic Pancreatitis Not Responding to Plastic Stenting: a Prospective Study With Two Years Follow-up.|Completed||N/A|17|Actual|Catholic University of the Sacred Heart||1|||f||||f||||||||||2017-10-11 03:42:17.283731|2017-10-11 03:42:17.283731
NCT01457079|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-10-17|||December 2011||2011-12-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|||Keloid Radiation Registry|Keloid Radiation Registry|Active, not recruiting||N/A|1000|Anticipated|Tirgan, Michael H., M.D.|||1||f||||f||||||||||2017-10-11 03:42:17.348549|2017-10-11 03:42:17.348549
NCT01457066|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-05-26|||December 2012||2012-12-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|PODER||Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM|Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM|Completed||Phase 1/Phase 2|118|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:42:17.412054|2017-10-11 03:42:17.412054
NCT01457053|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2016-10-24|2014-12-19||November 2011||2011-11-01|October 2016|2016-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics|A Randomized Controlled Pilot Study for Assessment of Coronary Flow Reserve With Cardiac PET Imaging in Acute Decompensated Heart Failure Patients Treated With Diuretics Versus Ultrafiltration|Terminated||N/A|4|Actual|University of Cincinnati||2||Population not available for enrollment|f||||t||||||||No||2017-10-11 03:42:17.474909|2017-10-11 03:42:17.474909
NCT01457027|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2013-02-19|||October 2011||2011-10-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season|A Phase IV, Open Label Study to Evaluate the Short and Long Term Immune Response and CROSS-protection After Vaccination With viroSOME Adjuvanted Inflexal V in Elderly Subjects|Completed||Phase 4|52|Actual|Crucell Holland BV||1|||f||||f||||||||||2017-10-11 03:42:17.89944|2017-10-11 03:42:17.89944
NCT01457014|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-01-22|2015-10-29||September 2011||2011-09-01|January 2016|2016-01-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional||Number of participants that completed the baseline PSG and were randomized for the study.|Sleep Disordered Breathing and Chronic Pain|BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)|Completed||N/A|88|Actual|Philips Respironics||3|||f||||f||||||||||2017-10-11 03:42:17.999917|2017-10-11 03:42:17.999917
NCT01457001|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-11-30|||November 2012||2012-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|NUTRIVITA-D001||Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients|Controlled Randomised Interventional Trial on the Use of 25-OH D Vitamin in Haemodialysis Patients.|Terminated||Phase 3|284|Actual|Italian Society of Nephrology||2|||f||||t||||||||||2017-10-11 03:42:18.556163|2017-10-11 03:42:18.556163
NCT01456975|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-09-21|||January 2007||2007-01-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|December 2012|Actual|2012-12-01||Interventional|EPSTAAA||Extravalvular Procedure for Surgical Treatment of Ascending Aorta Aneurism|Reimplantation Procedure for Surgical Treatment of Ascending Aorta Aneurism With Concomitant Aortic Valve Insufficiency|Unknown status|Active, not recruiting|N/A|60|Anticipated|Meshalkin Research Institute of Pathology of Circulation||1|||f||||f||||||||||2017-10-11 03:42:18.708209|2017-10-11 03:42:18.708209
NCT01456962|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-05-08|2015-05-18||October 2011|Actual|2011-10-01|May 2017|2017-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract|Influence of Raltegravir-Containing Antiretroviral Therapy (ART) on Immune Reconstitution and Activation in the Female Genital Tract|Completed||N/A|36|Actual|University of Colorado, Denver|||2||f||||f||||||Samples Without DNA|"     Blood, vaginal fluid samples, cervical biopsies   "|||2017-10-11 03:42:18.907755|2017-10-11 03:42:18.907755
NCT01456949|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2017-08-28|||May 2012||2012-05-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|STOP AF PAS||Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)|Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)|Active, not recruiting||Phase 4|402|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||t||||||||||2017-10-11 03:42:19.206358|2017-10-11 03:42:19.206358
NCT01456936|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-05-09|2016-01-12||November 2011||2011-11-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|EAGLES|The safety analysis population contained all treated participants i.e. who received at least one partial dose of study medication.|Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders|A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders|Completed||Phase 4|8144|Actual|Pfizer|After database lock and unblinding, one additional participant in the NRT arm of psychiatric cohort was found who had a primary endpoint event (moderate suicidal ideation) which required hospitalization; this event is not included in any analyses.|4|||f||||t||||||||||2017-10-11 03:42:19.520286|2017-10-11 03:42:19.520286
NCT01456923|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-20||||||September 2008|2008-09-01||||||||Interventional|||Chemotherapy With DNA Damaging Agents In Colorectal Cancer|Phase 1 Study Of The Efficacy Of Chemotherapy With DNA Damaging Agents Versus Surgery In Colorectal Cancer|Completed||Phase 1|||Centro Hospitalar Nordeste||2|||f||||||||||||||2017-10-11 03:42:24.047384|2017-10-11 03:42:24.047384
NCT01456910|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2011-10-24|||June 2009||2009-06-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Resistance Training Program, Labor Inclusion, Intellectual Disability|Evaluation and Effects of a Resistance Training Program and Its Relationship With the Labor Inclusion of the Disabled Intellectual|Completed||N/A|40|Actual|University of Brasilia||2|||f||||f||||||||||2017-10-11 03:42:24.102966|2017-10-11 03:42:24.102966
NCT01456897|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-10-05|||October 2011||2011-10-01|October 2016|2016-10-01||||May 2015|Actual|2015-05-01||Interventional|||A Long-term Trial of OPC-34712 in Patients With Schizophrenia||Completed||Phase 3|306|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 03:42:25.834559|2017-10-11 03:42:25.834559
NCT01456884|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-09-06|||January 2012||2012-01-01|September 2017|2017-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Music Therapy for Pain Modification in Pediatric Palliative Care|Music Therapy as a Pain Modifying Intervention in Children With Life-limiting Neurological Impairments and Metabolic Conditions|Completed||N/A|13|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:42:25.900017|2017-10-11 03:42:25.900017
NCT01456871|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2013-05-08|||August 2011||2011-08-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Finger Muscle Reaction After Electrical Stimuli to the Human Finger Pulley System; a Pilot Study|Finger Muscle Reaction After Electrical Stimuli to the Human Finger Pulley System; a Pilot Study|Completed||N/A|6|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:42:26.002046|2017-10-11 03:42:26.002046
NCT01456858|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-20|||December 2003||2003-12-01|November 2003|2003-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Insecticide Treated Polyethylene Sheeting for Prevention of Malaria in Emergencies|Insecticide Treated Polyethylene Sheeting for Prevention of Malaria in Emergencies: an Observational Cohort Study in a Refugee Setting in Sierra Leone|Completed||Phase 3|222|Actual|The Mentor Initiative||4|||f||||t||||||||||2017-10-11 03:42:26.083796|2017-10-11 03:42:26.083796
NCT01456845|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2012-08-30|||August 2010||2010-08-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity|Estimation of Plasma Free and Total Drug Levels of Rifampicin, Isoniazid and Pyrazinamide in Patients on Antituberculosis Therapy and Its Correlation With Development of Drug Induced Hepatotoxicity|Completed||N/A|110|Actual|All India Institute of Medical Sciences, New Delhi|||1||f||||f||||||||||2017-10-11 03:42:26.204561|2017-10-11 03:42:26.204561
NCT01456819|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-04-09|||March 2011||2011-03-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia|Phase II Efficacy Study of Intramuscular Autologous Bone Marrow Mononuclear Cells Plus Mesenchymal Stem Cell Implantation Versus Autologous Bone Marrow Mononuclear Cells Implantation Only in Patients With Chronic Critical Limb Ischemia|Unknown status|Recruiting|Phase 2|50|Anticipated|National University of Malaysia||2|||f||||f||||||||||2017-10-11 03:42:26.370766|2017-10-11 03:42:26.370766
NCT01456806|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2011-10-20|||December 2006||2006-12-01|October 2011|2011-10-01|July 2010|Actual|2010-07-01|March 2007|Actual|2007-03-01||Interventional|PRODIACOR||Educative Intervention to Improve Type 2 Diabetes Mellitus Control in Corrientes|Programme of Diabetes Education in the City of Corrientes (PRODIACOR): Clinical, Metabolic and Economic Outcomes of a Prospective-randomized Trial Based on Different Patient-centered Educational Strategies for People With Type 2 Diabetes|Completed||N/A|468|Actual|Centro de Endocrinologia Experimental y Aplicada||4|||f||||t||||||||||2017-10-11 03:42:26.474473|2017-10-11 03:42:26.474473
NCT01456793|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2017-03-06|||October 2011||2011-10-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Evaluation of the Effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) Program|Evaluation of the Effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) Program|Completed||N/A|598|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-11 03:42:26.589939|2017-10-11 03:42:26.589939
NCT01456780|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-07-06|2017-04-06||August 2011|Actual|2011-08-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|March 2013|Actual|2013-03-01||Interventional|ZvL||Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis|Relative Efficacy of Loteprednol (Lotemax®) vs. Loteprednol/Tobramycin (Zylet®) in Treatment of Chronic Ocular Surface Inflammation Associated With Meibomian Gland Dysfunction (MGD)/Posterior Blepharitis|Completed||Phase 4|60|Actual|Massachusetts Eye and Ear Infirmary||3|||f||||f|t|f|||t|||||2017-10-11 03:42:26.702937|2017-10-11 03:42:26.702937
NCT01456767|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-07-18|||October 2011||2011-10-01|July 2012|2012-07-01||||April 2012|Actual|2012-04-01||Interventional|||Effects of Administration of L.Plantarum WCFS1, L.Plantarum CIP104448, L.Plantarum CIP104450 on Small Intestinal Mucosa|The Effects of Oral Administration of Lactobacillus Plantarum WCFS1, Lactobacillus Plantarum CIP104448, and Lactobacillus Plantarum CIP104450 on Small Intestinal Mucosa and Barrier Function|Completed||N/A|10|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-11 03:42:27.395735|2017-10-11 03:42:27.395735
NCT01456754|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-12-14|||December 2010||2010-12-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning in Impaired Glucose Tolerant (IGT) Men|Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning in Impaired Glucose Tolerant (IGT) Men|Completed||N/A|11|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:42:27.482636|2017-10-11 03:42:27.482636
NCT01456741|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2014-05-19|||August 2011||2011-08-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Role of Endobronchial Needle Aspiration With Rapid On-site Evaluation in the Diagnosis of Central Malignant Lesions|Endobronchial Needle Aspiration With Rapid On-Site Evaluation in the Diagnosis of Central Malignant Lesions, a Randomized Controlled Trial|Completed||N/A|134|Actual|University of Milan||2|||f||||f||||||||||2017-10-11 03:42:27.575752|2017-10-11 03:42:27.575752
NCT01456728|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2013-09-07|||January 2011||2011-01-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|July 2012|Actual|2012-07-01||Interventional|||Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects on Proton Pump Inhibitors|Efficacy of Dietary Supplementation With Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects Treated Only With Proton Pump Inhibitors|Completed||Phase 3|56|Actual|St Marina University Hospital, Varna, Bulgaria||2|||f||||t||||||||||2017-10-11 03:42:27.663869|2017-10-11 03:42:27.663869
NCT01456715|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2015-09-30|||September 2008||2008-09-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.|Immunogenicity and Safety of Gardasil and Twinrix Vaccines Co-administered or Administered a Month Apart, According to the 0, 6 Months Schedule and the Effect of a Third Dose of Gardasil or Cervarix Administered 42 Months Later.|Enrolling by invitation||Phase 3|416|Anticipated|Laval University||2|||f||||f||||||||||2017-10-11 03:42:27.750085|2017-10-11 03:42:27.750085
NCT01456702|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2013-12-30|||October 2014||2014-10-01|December 2013|2013-12-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|||Risk Stratification and Goal-directed Volume Therapy|Influence of Pre-operative Risk Stratefiction and Intraoperaitve Monitoring on Perioperative Volume Therapy and Postoperative Outcome|Unknown status|Not yet recruiting|N/A|300|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:42:27.83673|2017-10-11 03:42:27.83673
NCT01456689|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-09-25|||April 25, 2012|Actual|2012-04-25|September 2017|2017-09-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma|A Multi-Center, Open-Label, Dose Escalation, Phase 1 Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma|Active, not recruiting||Phase 1|79|Actual|Novartis||2|||f|||||t|f||||||||2017-10-11 03:42:27.9366|2017-10-11 03:42:27.9366
NCT01456676|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-09-01|||January 2012||2012-01-01|September 2016|2016-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy|A Single-arm Dose-finding Phase Ib Multicenter Study of the Oral Smoothened Antagonist LDE225 in Combination With Nilotinib in Chronic or Accelerated Phase of Chronic Myeloid Leukemia Patients Who Have Failed Prior Therapy With Other BCR-ABL Tyrosine-kinase Inhibitors|Completed||Phase 1|11|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:42:28.05673|2017-10-11 03:42:28.05673
NCT01456663|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2013-02-04|||May 2011||2011-05-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study to Evaluate the Pharmacokinetics of AFQ056 in Subjects With Hepatic Impairment Compared to Healthy Subjects|A Single-dose, Open-label, Parallel Study to Assess the Pharmacokinetics of AFQ056 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Control Subjects|Completed||Phase 1|118|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:42:28.154995|2017-10-11 03:42:28.154995
NCT01456650|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-01-14|||March 2011||2011-03-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||R230C and C230C Variants of ABCA1 and Glyburide Response|Effect of the R230C Variant of the ATP-binding Cassette Transporter A1 (ABCA1) Gene on the Response to Treatment With Glibenclamide in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|85|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||1|||f||||f||||||||||2017-10-11 03:42:28.235329|2017-10-11 03:42:28.235329
NCT01456637|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-20|2013-01-07|||October 2011||2011-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Online Self-Help Intervention for Insomnia: With or Without Feedback|Online Self-Help Intervention for Insomnia: With or Without Feedback|Completed||Phase 3|262|Actual|Utrecht University||2|||f||||t||||||||||2017-10-11 03:42:28.314388|2017-10-11 03:42:28.314388
NCT01456624|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-06-23|||September 2011||2011-09-01|June 2014|2014-06-01||||June 2012|Actual|2012-06-01||Interventional|||Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fasting and Fed Condition|A Randomized, Open Label, Single Dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of DW-ES(B) and Megace® Under Fasting and Fed Conditions in Healthy Male Volunteers|Completed||Phase 1|56|Actual|Asan Medical Center||4|||f||||f||||||||||2017-10-11 03:42:28.407537|2017-10-11 03:42:28.407537
NCT01456611|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-07-10|||September 2011||2011-09-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%|A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Evaluate the Clinical Equivalence of Diclofenac Sodium 1% Gel (Anchen Pharmaceuticals, Inc.) With Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis) in Patients With Osteoarthritis of the Knee|Completed||Phase 3|749|Actual|Anchen Pharmaceuticals, Inc||3|||f||||f||||||||||2017-10-11 03:42:28.523453|2017-10-11 03:42:28.523453
NCT01456598|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-06-23|||October 2011||2011-10-01|June 2015|2015-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|KLASS-02-RCT||Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer|Prospective Multicenter Randomized Controlled Clinical Trial for Comparison Between Laparoscopic and Open Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer|Active, not recruiting||Phase 3|1050|Anticipated|Ajou University School of Medicine||2|||f||||t||||||||||2017-10-11 03:42:28.710658|2017-10-11 03:42:28.710658
NCT01456585|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-10-10|||April 2012||2012-04-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma|Phase 1 Study of Preoperative Gemcitabine Plus CP-870,893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patient With Newly Diagnosed Resectable Pancreatic Carcinoma|Completed||Phase 1|10|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:42:28.910165|2017-10-11 03:42:28.910165
NCT01456572|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2011-10-18|||January 2007||2007-01-01|October 2011|2011-10-01|July 2011|Actual|2011-07-01|February 2011|Actual|2011-02-01||Interventional|||Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People|Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People|Completed||Phase 1|65|Actual|University Hospital, Basel, Switzerland||6|||f||||f||||||||||2017-10-11 03:42:28.987489|2017-10-11 03:42:28.987489
NCT01456559|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2013-01-16|||October 2011||2011-10-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Detection of Hypovolemia Using Pleth Variability Index (PVI)|Non-invasive Detection of Mild Hypovolemia Using Pleth Variability Index (PVI) During Spontaneous Breathing|Completed||N/A|14|Actual|University Hospital, Linkoeping|||1||f||||f||||||||||2017-10-11 03:42:29.151457|2017-10-11 03:42:29.151457
NCT01456546|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-07-02|||October 2011||2011-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel|Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel|Completed||Phase 1|31|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 03:42:29.230334|2017-10-11 03:42:29.230334
NCT01456533|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2015-11-30|||October 2011||2011-10-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|COMED||Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients|Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients|Completed||N/A|300|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 03:42:29.30281|2017-10-11 03:42:29.30281
NCT01456520|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2012-02-07|||October 2011||2011-10-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Pharmacokinetics and Bioequivalence of Vycavert (10 mg Hydrocodone Bitartrate/325 mg Acetaminophen) Compared to the Reference Drug Norco|An Open Label, Single Dose, Randomized, Two-Period, Two-Way Crossover Study to Evaluate the Pharmacokinetics and Bioequivalence of Vycavert Tablets Compared to Norco® Tablets in Healthy Subjects|Completed||Phase 1|47|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:42:29.385412|2017-10-11 03:42:29.385412
NCT01456507|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-01-12|||October 2011||2011-10-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone|An Open-Label, Single-Dose, Randomized, Three-Way Crossover Study in Healthy Volunteers to Estimate the Effects of Food and of Sprinkling ALO-02 Pellets on Applesauce on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Pellets-in-Capsule Formulation of Oxycodone 40 Mg With Sequestered Naltrexone 4.8 Mg|Completed||Phase 1|24|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:42:29.4708|2017-10-11 03:42:29.4708
NCT01456494|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2013-09-04|||July 2009||2009-07-01|September 2013|2013-09-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|TURI||Teaching Use of Respiratory Inhalers (TURI)|Teaching Use of Respiratory Inhalers (TURI)|Completed||Phase 2|50|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 03:42:29.57559|2017-10-11 03:42:29.57559
NCT01456481|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-08-29|||November 2011||2011-11-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|May 2017|Anticipated|2017-05-01||Interventional|POST 4||Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV|Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV (Post 4)|Recruiting||Phase 4|108|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-11 03:42:29.671737|2017-10-11 03:42:29.671737
NCT01456468|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-07-12|||October 2011||2011-10-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|June 2014|Actual|2014-06-01||Interventional|||Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis|Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis - A Human Pilot Study|Completed||Phase 1|19|Actual|Yale University||1|||f||||f||||||||||2017-10-11 03:42:29.869859|2017-10-11 03:42:29.869859
NCT01456455|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-10-24|||August 2011||2011-08-01|October 2016|2016-10-01|August 2020|Anticipated|2020-08-01|March 2020|Anticipated|2020-03-01|2 Years|Observational [Patient Registry]|||Gastric Cancer Metastasized to the Central Nervous System (CNS)|Registry of Gastric Cancer and Brain Metastases|Active, not recruiting||N/A|150|Actual|University of Zurich|||1||f||||f||||||||No||2017-10-11 03:42:29.968275|2017-10-11 03:42:29.968275
NCT01456442|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-11-13|||January 2011||2011-01-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Short Protocol Barostat for Assessment of Anorectal Function Versus Standard Protocol Barostat in Healthy Volunteers|Short Protocol Barostat for Assessment of Anorectal Function Versus Standard Protocol Barostat in Healthy Volunteers|Completed||Phase 4|26|Actual|University of Zurich||1|||f||||t||||||||||2017-10-11 03:42:30.174223|2017-10-11 03:42:30.174223
NCT01456429|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2013-10-08|||January 2010||2010-01-01|January 2010|2010-01-01|April 2014|Anticipated|2014-04-01|October 2013|Actual|2013-10-01||Interventional|ASTER2||Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.|Assessment of Surgical Mediastinal sTaging Added to Endoscopic Ultrasound in cN1 Lung canceR.|Unknown status|Active, not recruiting|N/A|100|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 03:42:30.255363|2017-10-11 03:42:30.255363
NCT01456416|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2013-04-02|||September 2011||2011-09-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities|Pilot Study for Evaluation of Glatiramer Acetate in RRMS Patients With Comorbid Autoimmune Conditions|Completed||Phase 4|10|Actual|University of Southern California|||1||f||||t||||||||||2017-10-11 03:42:30.352472|2017-10-11 03:42:30.352472
NCT01456403|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-09-06|||January 2011||2011-01-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Histological Validation Of Carotid Plaque Composition In Preoperative Imaging|Histological Validation Of Carotid Plaque Composition In Preoperative Imaging Of Patients Scheduled For Carotid Endarterectomy|Completed||N/A|95|Actual|Lawson Health Research Institute|||1||f||||t||||||Samples Without DNA|"     Histological sections   "|No||2017-10-11 03:42:30.466169|2017-10-11 03:42:30.466169
NCT01456390|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-18|||September 2011||2011-09-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents|A Prospective Evaluation of Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin|Unknown status|Active, not recruiting|N/A|80|Anticipated|Glaukos Corporation||1|||f||||f||||||||||2017-10-11 03:42:30.571831|2017-10-11 03:42:30.571831
NCT01456377|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-10-19|||July 2011||2011-07-01|October 2011|2011-10-01|June 2012|Anticipated|2012-06-01|February 2012|Anticipated|2012-02-01||Interventional|||The Effectiveness of Oral Corticosteroids in the Treatment of Lumbar Stenosis|A Prospective Controlled Study Randomized Double Blind Study, Evaluate the Effectiveness of Oral Corticosteroids in the Treatment of Stenosis of Lumbar Canal In Symptomatic Patients|Unknown status|Recruiting|N/A|60|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:42:30.683678|2017-10-11 03:42:30.683678
NCT01456364|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2013-10-31|||September 2011||2011-09-01|October 2013|2013-10-01|May 2014|Anticipated|2014-05-01|April 2014|Anticipated|2014-04-01||Interventional|ISAR ADAPT PF||Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing|Prospective, Randomized Study of the Platelet Inhibitory Efficacy of Ticagrelor Versus Prasugrel in Clopidogrel Low Responders After Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 4|70|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 03:42:30.805541|2017-10-11 03:42:30.805541
NCT01456351|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-02-11|||September 2003||2003-09-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab|Prospective Randomised Multicenter Study for Therapy Optimization of Recurrent, Progressive Low Grade Non-Hodgkin Lymphomas and Mantle Cell Lymphomas|Completed||Phase 3|230|Actual|University of Giessen||2|||f||||f||||||||||2017-10-11 03:42:30.928734|2017-10-11 03:42:30.928734
NCT01456338|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-18|||June 2007||2007-06-01|October 2011|2011-10-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Interventional|||Cognitive Behavioral Therapy for Post Traumatic Stress Disorder in Addiction Treatment|Cognitive Behavioral Therapy for PTSD in Addiction Treatment: A Randomized Pilot Trial|Completed||Phase 2|78|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-10-11 03:42:31.013144|2017-10-11 03:42:31.013144
NCT01456325|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-11-01|||January 2012||2012-01-01|November 2016|2016-11-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)|A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Onartuzumab (Metmab) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Standard Chemotherapy for Advanced/Metastatic Disease|Completed||Phase 3|494|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:42:31.135898|2017-10-11 03:42:31.135898
NCT01456312|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-15|2012-10-29|||September 2012||2012-09-01|October 2012|2012-10-01|August 2016|Anticipated|2016-08-01|February 2016|Anticipated|2016-02-01||Interventional|S-RGT||HBsAg Related Response Guided Therapy|A Multi Center, Phase IIIb Study to Evaluate the Efficacy of Response Guided Therapy Using Quantitative HBsAg Measurement in Patient With HBeAg Positive Chronic Hepatitis B:|Unknown status|Recruiting|Phase 4|200|Anticipated|Gangnam Severance Hospital||3|||f||||f||||||||||2017-10-11 03:42:31.834229|2017-10-11 03:42:31.834229
NCT01456299|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2014-04-17|2014-02-23||April 2011||2011-04-01|April 2014|2014-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||no differences in patient characteristics|Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil|Target-controlled Infusion of Remifentanil for Laryngeal Mask Airway Insertion During Sevoflurane Induction in Adults|Completed||N/A|102|Actual|Gachon University Gil Medical Center||3|||f||||t||||||||||2017-10-11 03:42:31.962298|2017-10-11 03:42:31.962298
NCT01456286|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2013-10-01|||October 2011||2011-10-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension|Randomized Trial, Masked, and Placebo Controlled to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension|Completed||Phase 2/Phase 3|42|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||t||||||||||2017-10-11 03:42:32.395089|2017-10-11 03:42:32.395089
NCT01456273|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-10-19|||March 2009||2009-03-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||From the Biomedical to the Biopsychosocial Model, From Theory to Practice|Evaluation of the Efficacy of the Integral Approach (Therapeutic Encounter) Versus the Conventional Medical Approach (Medical Consultation) in Patients With Functional Dyspepsia|Unknown status|Recruiting|N/A|200|Anticipated|Faculdade de Medicina do ABC||4|||f||||f||||||||||2017-10-11 03:42:32.493243|2017-10-11 03:42:32.493243
NCT01456260|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-05-07|||September 2011||2011-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|||||Interventional|||Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)|A Phase 3, Multicenter, Single-blind, AG-1749-controlled, Parallel-group, Long-term Extension Study to Evaluate the Safety and Efficacy of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)|Completed||Phase 3|406|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:42:32.659956|2017-10-11 03:42:32.659956
NCT01456247|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-05-07|||March 2012||2012-03-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin|A Phase 3, Multicenter, Single-blind, AG-1749-controlled, Parallel-group, Long-term Extension Study to Evaluate the Safety and Efficacy of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Low-dose Aspirin|Completed||Phase 3|439|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:42:33.005456|2017-10-11 03:42:33.005456
NCT01456234|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2013-08-07|||November 2011||2011-11-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Access||Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)|Comparison of Time From Symptom Onset to Oseltamivir Access When Oseltamivir is Prescribed by Pharmacists vs. Physicians and the Impact on Symptoms, Oseltamivir Resistance, and Patient Safety|Terminated||Phase 4|48|Actual|Trial Management Group Inc.||2||Insufficient recruitment|f||||f||||||||||2017-10-11 03:42:33.329979|2017-10-11 03:42:33.329979
NCT01456221|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-01-30|||July 2012|Actual|2012-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2015|Actual|2015-12-01||Interventional|O3WLIRADOL||Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents|The Impact of Using omega3 Long-chain Polyunsaturated Fatty Acids in Weight Loss and Insulin Resistance in Obese Adolescents|Completed||N/A|366|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||t||||||||No||2017-10-11 03:42:33.489159|2017-10-11 03:42:33.489159
NCT01456208|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-05-17|||October 1999||1999-10-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|January 2017|Actual|2017-01-01||Interventional|||Genetic Mechanisms in Human Hypertension|Vascular Disease and Hbp: Pai-1, Insulin and Genes (Crc): Hypertension Phenotype|Active, not recruiting||N/A|1000|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-11 03:42:33.607996|2017-10-11 03:42:33.607996
NCT01456195|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-03-04|2015-04-08||November 2011||2011-11-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 mg and 50 mg Compared With Placebo in Subjects With Type 2 Diabetes|Completed||Phase 3|421|Actual|Takeda||3|||f||||t||||||||||2017-10-11 03:42:33.757449|2017-10-11 03:42:33.757449
NCT01456182|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-01-23|||December 2011||2011-12-01|January 2012|2012-01-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|||Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia|Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia|Withdrawn||Phase 1|0|Actual|Afexa Life Sciences Inc||5|||f||||f||||||||||2017-10-11 03:42:35.053778|2017-10-11 03:42:35.053778
NCT01456169|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2014-03-21|2013-12-26||October 2011||2011-10-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional||Participants who were randomized into the double-blind treatment period. Baseline was defined as the last observed value while on monotherapy study drug and before the first dose of double-blind study drug.|A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone|A Phase-3 Randomized, Double-Blind, Efficacy and Safety Study Evaluating the Fixed Dose Combinations of TAK-491 Plus Chlorthalidone (40/12.5 mg and 40/25 mg) in Subjects With Grades 2 or 3 Essential Hypertension, Who Do Not Achieve Target Blood Pressure Following Treatment With TAK-491 40 mg Monotherapy|Completed||Phase 3|507|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:42:36.04383|2017-10-11 03:42:36.04383
NCT01456156|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-07-02|||January 2008|Actual|2008-01-01|July 2017|2017-07-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma|Phase 2 Study of Postoperative Three-dimensional Conformal Radiation Therapy/Intensive Modulated Radiation Therapy in Hepatocellular Carcinoma: a Single Center Prospective Study|Completed||N/A|76|Actual|Chinese Academy of Medical Sciences||1|||f||||f||||||||||2017-10-11 03:42:38.462552|2017-10-11 03:42:38.462552
NCT01456143|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-05-06|2016-02-29||December 2011||2011-12-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Optical Imaging of Head and Neck Cancer|In Vivo Multimodal Imaging of Upper Aerodigestive Epithelia|Terminated||N/A|33|Actual|Anandasabapathy, Sharmila, M.D.||1||PI left, study to be re-open with new PI, no planned data analysis|f||||f||||||||Yes||2017-10-11 03:42:38.546521|2017-10-11 03:42:38.546521
NCT01456130|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-03-17|2014-03-17||November 2011||2011-11-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes|A Long-Term, Open-Label Study to Investigate the Long-Term Safety of SYR-322 When Used in Combination With Rapid-Acting Insulin Secretagogues in Subjects With Type 2 Diabetes in Japan|Completed||Phase 3|67|Actual|Takeda||1|||f||||||||||||||2017-10-11 03:42:38.777867|2017-10-11 03:42:38.777867
NCT01456117|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-08-06|||November 2011||2011-11-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants|A Phase 1, Multiple-Dose, Single-Blind Parallel Design, Single-Center, Dose-Ranging Study to Assess the Effects of Daily Administration of Pioglitazone for 14 Days on the Brain Hemodynamics of Healthy Elderly Subjects|Completed||Phase 1|61|Actual|Takeda||4|||f||||f||||||||||2017-10-11 03:42:39.159808|2017-10-11 03:42:39.159808
NCT01456104|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-01-09|||October 2011||2011-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma|Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma|Active, not recruiting||Phase 1|9|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:42:39.252691|2017-10-11 03:42:39.252691
NCT01456091|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-03-21|||October 2011||2011-10-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Evaluation of the Efficacy of the AIM (Adult Identity Mentoring) 4 Teen Moms Program|Evaluation of the Efficacy of the AIM (Adult Identity Mentoring) 4 Teen Moms Program|Completed||N/A|954|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-10-11 03:42:39.328393|2017-10-11 03:42:39.328393
NCT01456078|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2017-03-06|||October 2011||2011-10-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|ILUMINET||A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors|A Multicenter Phase II-Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors|Recruiting||Phase 2|60|Anticipated|Lund University Hospital||1|||f||||f||||||||||2017-10-11 03:42:39.415402|2017-10-11 03:42:39.415402
NCT01456065|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-02-28|||September 2010||2010-09-01|February 2013|2013-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Safety of Active Immunotherapy in Subjects With Ovarian Cancer|A Phase I, Open, Randomized, Study to Investigate the Safety of Active Immunotherapy With Fully Mature, TERT-mRNA and Survivin - Peptide Double Loaded Dendritic Cells (DCs) in Subjects With Advanced Epithelial Ovarian Cancer, Enrolled in the Study Within Twelve Weeks After Completing Primary Therapy|Unknown status|Active, not recruiting|Phase 1|15|Actual|Life Research Technologies GmbH||2|||f||||t||||||||||2017-10-11 03:42:39.505277|2017-10-11 03:42:39.505277
NCT01456052|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2017-07-12|2014-10-15||January 30, 2012|Actual|2012-01-30|July 2017|2017-07-01|September 3, 2013|Actual|2013-09-03|September 3, 2013|Actual|2013-09-03||Interventional||The baseline analysis population is the safety population. One subject was excluded from the safety population as they did not receive any doses of study drug.|A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis|Phase 2 Assessment of the Relationship Between Serotonin and Efficacy in Ulcerative Colitis: A Multi-Center Randomized, Double Blind, Placebo-Controlled, Pilot Study to Evaluate Safety and Preliminary Efficacy of Orally Administered LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis|Completed||Phase 2|59|Actual|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-10-11 03:42:39.612753|2017-10-11 03:42:39.612753
NCT01456039|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-02-01|2016-07-11||December 2011||2011-12-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|July 2015|Actual|2015-07-01||Interventional||Intent to Treat (ITT) includes all participants who received at least one dose of romidepsin.|A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)|A Japanese Phase 1/2, Multicenter, Open-label Study to Assess the Efficacy, Tolerability, Safety and Pharmacokinetics of Romidepsin in Subjects With the Progressive or Relapsed Peripheral T-cell Lymphoma|Active, not recruiting||Phase 1/Phase 2|51|Actual|Celgene||1|||f||||f||||||||||2017-10-11 03:42:40.331122|2017-10-11 03:42:40.331122
NCT01456026|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2011-10-18|||June 2009||2009-06-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes|Acute Effects of Food Advanced Glycation Endproducts on Macrovascular Function in Subjects With Type 2 Diabetes Mellitus|Completed||N/A|19|Actual|Profil Institut für Stoffwechselforschung GmbH||2|||f||||f||||||||||2017-10-11 03:42:42.353081|2017-10-11 03:42:42.353081
NCT01456000|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2016-07-25|2016-04-18|2015-05-27|January 2012||2012-01-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|December 2014|Actual|2014-12-01||Interventional|HeartLight|Average Age|HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)|Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation|Completed||Phase 3|405|Actual|CardioFocus||2|||f||||t||||||||No||2017-10-11 03:42:42.654087|2017-10-11 03:42:42.654087
NCT01455987|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-04|2011-10-19|||June 2010||2010-06-01|October 2011|2011-10-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Observational|KYSOCD||Osteochondritis Dissecans of the Knee|Outcome of the Knee Osteochonditis Dissecans Patiets in Kuopio University Hospital (1990-2009): A Retropective Analysis|Unknown status|Enrolling by invitation|N/A|265|Anticipated|Kuopio University Hospital|||1||f||||||||||||||2017-10-11 03:42:42.977696|2017-10-11 03:42:42.977696
NCT01455974|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-10-19|||October 2010||2010-10-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|February 2011|Actual|2011-02-01||Interventional|||The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients||Completed||N/A|16|Actual|Capital Medical University||1|||f||||||||||||||2017-10-11 03:42:43.071244|2017-10-11 03:42:43.071244
NCT01455961|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2014-08-20|||November 2011||2011-11-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|REED||An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder|An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder Treated With Quetiapine XR and/or Quetiapine IR|Completed||N/A|16000|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:42:43.17444|2017-10-11 03:42:43.17444
NCT01455948|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-09-01|||February 2012||2012-02-01|September 2015|2015-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|CHEC||Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis|Canadian Health Economics, Health Outcome, and Effectiveness Comparison of Treatment of the Frontal Sinus Ostium and Recess and Other Sinuses With Functional Endoscopic Sinus Surgery (FESS) or Balloon Sinuplasty in Patients With Chronic Sinusitis (CRS)|Terminated||Phase 4|25|Actual|Johnson & Johnson Medical Companies||2|||f||||f||||||||||2017-10-11 03:42:43.251592|2017-10-11 03:42:43.251592
NCT01455935|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2012-03-29|||November 2011||2011-11-01|March 2012|2012-03-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|WASSABI||Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention|Wake up Symptomatic Stroke in Acute Brain Ischemia (WASSABI) Trial|Unknown status|Recruiting|Phase 2|90|Anticipated|Jacobs Neurological Institute||3|||f||||t||||||||||2017-10-11 03:42:43.351261|2017-10-11 03:42:43.351261
NCT01455922|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-12-21|||February 2013||2013-02-01|December 2012|2012-12-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes|A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Glimepiride as Add-on Therapy to Metformin in Patients With Type 2 Diabetes|Withdrawn||Phase 3|0|Actual|Intarcia Therapeutics||2|||f||||||||||||||2017-10-11 03:42:43.471862|2017-10-11 03:42:43.471862
NCT01455909|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-12-21|||February 2013||2013-02-01|December 2012|2012-12-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes|A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes|Withdrawn||Phase 3|0|Actual|Intarcia Therapeutics||2|||f||||||||||||||2017-10-11 03:42:43.575714|2017-10-11 03:42:43.575714
NCT01455896|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-01-26||2016-06-03|March 2013|Actual|2013-03-01|January 2017|2017-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650|A Randomized, Multi-Center Study to Evaluate Cardiovascular Outcomes With ITCA 650 in Patients Treated With Standard of Care for Type 2 Diabetes|Completed||Phase 3|4156|Actual|Intarcia Therapeutics||2|||f||||t||||||||||2017-10-11 03:42:43.694634|2017-10-11 03:42:43.694634
NCT01455883|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2012-12-21|||February 2013||2013-02-01|December 2012|2012-12-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes|A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Glimepiride as Add-on Therapy to Metformin in Patients With Type 2 Diabetes|Withdrawn||Phase 3|0|Actual|Intarcia Therapeutics||2|||f||||||||||||||2017-10-11 03:42:43.862805|2017-10-11 03:42:43.862805
NCT01455870|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-05-13||2016-05-13|May 2013||2013-05-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes|A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|535|Actual|Intarcia Therapeutics||2|||f||||t||||||||||2017-10-11 03:42:43.936815|2017-10-11 03:42:43.936815
NCT01455857|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2015-07-28||2015-07-28|March 2013||2013-03-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes|Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes|Completed||Phase 3|460|Actual|Intarcia Therapeutics||3|||f||||t||||||||||2017-10-11 03:42:44.320033|2017-10-11 03:42:44.320033
NCT01455844|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2014-08-21|||September 2011||2011-09-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|TRIFECTA||TRIal For Efficacy of Capre on hyperTriglyceridemiA|A Randomized, Placebo-controlled, Double-blind, Dose-ranging, Multi-centered Trial to Evaluate the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia|Completed||Phase 2|387|Actual|Acasti Pharma Inc.||3|||f||||f||||||||||2017-10-11 03:42:44.6783|2017-10-11 03:42:44.6783
NCT01455831|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-11-17|||September 2011||2011-09-01|November 2016|2016-11-01|December 2024|Anticipated|2024-12-01|December 2022|Anticipated|2022-12-01||Interventional|PERIOP-01||Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer|A Multicentre Randomized Controlled Trial of the Use of Extended Peri-Operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colorectal Cancer|Recruiting||Phase 3|1075|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 03:42:44.864686|2017-10-11 03:42:44.864686
NCT01455818|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-09-13|||March 2011||2011-03-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SSPE||A Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound|A Multicenter Prospective Cohort Management Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound|Recruiting||N/A|300|Anticipated|Ottawa Hospital Research Institute|||1||f||||t||||||||||2017-10-11 03:42:45.047016|2017-10-11 03:42:45.047016
NCT01455805|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-04-13|||June 2012||2012-06-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Minuteman Spinal Fusion Implant Versus Surgical Decompression for Lumbar Spinal Stenosis|Efficacy and Quality of Life Following Treatment of Lumbar Spinal Stenosis, Spondylolisthesis or Degenerative Disc Disease With the Minuteman Interspinous Interlaminar Fusion Implant Versus Surgical Decompression|Recruiting||Phase 4|50|Anticipated|Spinal Simplicity LLC||2|||f||||t||||||||||2017-10-11 03:42:45.162544|2017-10-11 03:42:45.162544
NCT01455792|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-12-27|||September 2011||2011-09-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies.|MRI and Ultrasound Soft Image Fusion Guided Biopsies Compared to Gold Standard Prostate Biopsies|Completed||N/A|200|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 03:42:45.269352|2017-10-11 03:42:45.269352
NCT01455766|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2012-09-04|||June 2005||2005-06-01|September 2012|2012-09-01|November 2011|Actual|2011-11-01|February 2008|Actual|2008-02-01||Observational|EVLW-PNEUMO||Volumetric Monitoring in Major Lung Surgery|Pulmonary Edema Following Major Thoracic Resections: a Value of Perioperative Volumetric Monitoring|Completed||N/A|50|Anticipated|Northern State Medical University|||1||f||||f||||||Samples Without DNA|"     Blood plasma for non-specified additional retrospective tests.   "|||2017-10-11 03:42:45.44514|2017-10-11 03:42:45.44514
NCT01455753|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2012-05-16|||October 2011||2011-10-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Proximity on Flu-Shot Participation|The Effect of Proximity on Flu-Shot Participation|Completed||N/A|1912|Actual|National Bureau of Economic Research, Inc.||1|||f||||f||||||||||2017-10-11 03:42:45.513539|2017-10-11 03:42:45.513539
NCT01455740|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-10-22|||October 2011||2011-10-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|June 2013|Actual|2013-06-01||Interventional|||A Commitment Device for Medication Adherence Among HIV Patients|A Commitment Device for Medication Adherence Among HIV Patients|Completed||N/A|39|Actual|National Bureau of Economic Research, Inc.||2|||f||||f||||||||||2017-10-11 03:42:45.993689|2017-10-11 03:42:45.993689
NCT01455727|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2012-09-13|||August 2011||2011-08-01|September 2012|2012-09-01||||August 2012|Actual|2012-08-01||Interventional|||Pharmaceutical Care of Ambulatory Elderly Diabetes Patients||Completed||N/A|100|Actual|Nantou Hospital||2|||f||||||||||||||2017-10-11 03:42:46.08915|2017-10-11 03:42:46.08915
NCT01455714|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-10-19|||September 2012||2012-09-01|October 2011|2011-10-01|September 2014|Anticipated|2014-09-01|December 2013|Anticipated|2013-12-01||Observational|dysh||Finding Early Predictors of Myocardial Dysfunction in Patients With Hypertension|Finding Early Predictors of Myocardial Dysfunction in Patients With Hypertension|Unknown status|Not yet recruiting|N/A|120|Anticipated|Medical Universtity of Lodz|||1||f||||t||||||Samples Without DNA|"     blood samples   "|||2017-10-11 03:42:46.170698|2017-10-11 03:42:46.170698
NCT01455701|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-08-18|||October 26, 2012|Actual|2012-10-26|August 2017|2017-08-01|July 13, 2017|Actual|2017-07-13|July 28, 2016|Actual|2016-07-28||Interventional|||A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)|A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)|Completed||Phase 1|11|Actual|Hoffmann-La Roche||1|||f|||||t|f||||||||2017-10-11 03:42:46.259355|2017-10-11 03:42:46.259355
NCT01455688|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2013-09-18|||January 2012||2012-01-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Early Antiviral Therapy for Critically Ill HIV Infected Patients|Early Antiretroviral Therapy for Critically Ill HIV Infected Patients|Unknown status|Recruiting|Phase 4|344|Anticipated|Hospital Nossa Senhora da Conceicao||2|||f||||f||||||||||2017-10-11 03:42:46.383164|2017-10-11 03:42:46.383164
NCT01455675|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-07-03|||October 2011||2011-10-01|July 2017|2017-07-01|June 27, 2017|Actual|2017-06-27|June 27, 2017|Actual|2017-06-27||Interventional|PsAer-IgY||Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients|Phase III Study to Evaluate Clinical Efficacy and Safety of Avian Polyclonal Anti-Pseudomonas Antibodies (IgY) in Prevention of Recurrence of Pseudomonas Aeruginosa Infection in Cystic Fibrosis Patients|Completed||Phase 3|164|Actual|Mukoviszidose Institut gGmbH||2|||f||||t||||||||||2017-10-11 03:42:46.479782|2017-10-11 03:42:46.479782
NCT01455662|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-11-02|||January 2010||2010-01-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Relationship Between Tissue Markes in Patients With Post Cardio Respiratory Syndrome|Relationship Between Lactate and Venous Oxygen Saturation Gradient of Carbon Dioxide in Patients With Post Cardio Respiratory Syndrome|Unknown status|Recruiting|N/A|100|Anticipated|Hospital Nossa Senhora da Conceicao|||1||f||||t||||||||||2017-10-11 03:42:46.722578|2017-10-11 03:42:46.722578
NCT01455649|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-19|||November 2011||2011-11-01|October 2011|2011-10-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults|A Prospective, Open-label, Controlled, Randomized Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After 90 to 150 Days After Kidney Transplantation in Adults, Maintaining Corticosteroid and Mycophenolate Sodium Compared to Patients Who Will Maintain the Use of Calcineurin Inhibitor|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Hospital Federal de Bonsucesso||2|||f||||f||||||||||2017-10-11 03:42:46.817936|2017-10-11 03:42:46.817936
NCT01455636|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2015-06-30|||June 2010||2010-06-01|June 2015|2015-06-01|April 2012|Actual|2012-04-01|April 2011|Actual|2011-04-01||Interventional|||Preventing Linear Growth Faltering Among Low Birth Weight Infants in Bangladesh|Preventing Linear Growth Faltering and Reversal of Stunting Among Low Birth Weight Infants in Bangladesh: a Community-based Cluster Randomized Control Trial|Completed||Phase 3|467|Actual|The Hospital for Sick Children||4|||f||||f||||||||||2017-10-11 03:42:46.927357|2017-10-11 03:42:46.927357
NCT01455623|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2014-03-25|||June 2011||2011-06-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|6604||Development and Validation of a Disability Severity Index for CMT|Development and Validation of a Disability Severity Index for Charcot Marie Tooth Disease|Completed||N/A|291|Actual|University of Iowa|||2||f||||f||||||||||2017-10-11 03:42:47.083924|2017-10-11 03:42:47.083924
NCT01455610|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-19|||October 2011||2011-10-01|October 2011|2011-10-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Observational|||Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study|Preoperative Evaluation of Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study|Unknown status|Not yet recruiting|N/A|140|Anticipated|Shanghai Zhongshan Hospital|||1||f||||t||||||||||2017-10-11 03:42:47.164026|2017-10-11 03:42:47.164026
NCT01455597|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-02-24||2014-02-14|October 2011||2011-10-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluate Long-Term Safety and Efficacy WC3011|A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of WC3011 in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women|Completed||Phase 3|309|Actual|Warner Chilcott||1|||f||||f||||||||||2017-10-11 03:42:47.29184|2017-10-11 03:42:47.29184
NCT01455558|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2011-10-18|||February 2009||2009-02-01|October 2011|2011-10-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Pharmacokinetic Comparison of Cilostazol SR and IR Formulations in Healthy Korean Volunteers||Completed||Phase 1|92|Actual|Severance Hospital||1|||f||||||||||||||2017-10-11 03:42:47.734944|2017-10-11 03:42:47.734944
NCT01455545|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2013-06-04|2012-08-17||January 2011||2011-01-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Observational|||Impact of Adherence to Treatment in Asthma Control|Impact of Adherence to Treatment in Asthma Control Using ASK-20 Questionnaire and Prescription Account.|Completed||N/A|100|Actual|Sociedad Española de Neumología y Cirugía Torácica|This is an observational (cross-sectional )study, with the limitations and biases associated. Patients have not been randomized.||1||f||||t||||||||||2017-10-11 03:42:47.830138|2017-10-11 03:42:47.830138
NCT01455532|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2014-10-21|||November 2011||2011-11-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Interventional|||A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors|A Phase 1/1b Dose Escalation Study Evaluating Iniparib (BSI201/SAR240550) as a Single Agent and in Combination With Chemotherapeutic Regimens in Patients With Solid Tumors|Completed||Phase 1|59|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 03:42:48.334089|2017-10-11 03:42:48.334089
NCT01455519|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-07-09|2015-05-26||October 2011||2011-10-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Covidien||True Functional Restoration and Analgesia in Non-Radicular Low Back Pain|True Functional Restoration and Analgesia in Non-Radicular Low Back Pain: a Prospective Double Blind, Placebo-controlled Study of Hydromorphone ER|Completed||Phase 4|51|Actual|Shirley Ryan AbilityLab||2|||f||||t||||||||||2017-10-11 03:42:48.46147|2017-10-11 03:42:48.46147
NCT01455506|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-02-01|||May 2009||2009-05-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||PRO#0118: Decitabine Plus Mini Flu-Bu|PRO#0118: A Phase I Study of Decitabin in Combination With Fludarabin and Busulfan as a Reduced Intensity Conditioning Regimen for the Treatment of Myeloid Malignancies|Completed||Phase 1|20|Actual|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-11 03:42:48.997151|2017-10-11 03:42:48.997151
NCT01455493|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2016-08-09||2016-08-09|December 2011||2011-12-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|March 2013|Actual|2013-03-01||Interventional|||A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma|A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|56|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:42:49.293433|2017-10-11 03:42:49.293433
NCT01455480|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2016-12-05|||December 2011||2011-12-01|December 2016|2016-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn|Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn|Withdrawn||Phase 1/Phase 2|0|Actual|Regenera Pharma Ltd||1|||f||||f||||||||||2017-10-11 03:42:49.42082|2017-10-11 03:42:49.42082
NCT01455467|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-18|||September 2011||2011-09-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery|A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Glaukos Corporation||2|||f||||f||||||||||2017-10-11 03:42:49.489715|2017-10-11 03:42:49.489715
NCT01455454|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-19|||September 2010||2010-09-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Heparin's Influence on ROTEM® Analysis|Evaluation of the Feasibility of Rotational Thromboelastrometry During Cardiopulmonary Bypass Using a Heparinase Modified ROTEM® Assay|Completed||N/A|20|Actual|University of Lausanne Hospitals|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 03:42:49.563737|2017-10-11 03:42:49.563737
NCT01455441|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-19|2015-05-28|||October 2011||2011-10-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes|Does the GLP-1 Receptor Agonist (Victoza®) Improve the Metabolic Response to Physical Training in Patients With Type 2 Diabetes?|Completed||Phase 4|40|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-10-11 03:42:49.638685|2017-10-11 03:42:49.638685
NCT01455428|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-05-20|2015-01-08||December 2011||2011-12-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||All randomized and treated participants were included in the baseline characteristics summarization.|Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)|An 8-week Randomized, Double Blind, Multi-center, Placebo-controlled Study To Evaluate The Efficacy, Safety And Tolerability Of Pregabalin ( 300mg/Day ) Using A Fixed Dosing Schedule In The Treatment Of Subjects With Postherpetic Neuralgia ( Phn )|Completed||Phase 4|223|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:42:49.770924|2017-10-11 03:42:49.770924
NCT01455415|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-04-22|2014-10-30||December 2011||2011-12-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional||Intent-to-Treat Population (ITT) included all randomized participants with at least one dose of study drug. The ITT population was analyzed according to what the randomization schedule intended for the participants to take in each period.|Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain|A Study Of Pregabalin In The Treatment Of Subjects With Painful Diabetic Peripheral Neuropathy With Background Treatment Of Nsaid For Other Pain Conditions|Completed||Phase 3|306|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:42:51.119321|2017-10-11 03:42:51.119321
NCT01455402|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2014-07-08|||July 2010||2010-07-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|CD-1089||An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF|An Observational Study to Assess Respiratory Syncytial Virus (RSV)-Associated Illness in Adults With Chronic Obstructive Pulmonary Disease (COPD) and/or Congestive Heart Failure (CHF)|Completed||N/A|476|Actual|MedImmune LLC|||1||f||||f||||||Samples Without DNA|"     serum, whole blood, plasma, nasal swab, sputum   "|||2017-10-11 03:42:52.340892|2017-10-11 03:42:52.340892
NCT01455389|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2017-03-14|||February 2014||2014-02-01|March 2017|2017-03-01||||March 2018|Anticipated|2018-03-01||Interventional|||FUS1-nanoparticles and Erlotinib in Stage IV Lung Cancer|Phase I/II Clinical Trial Combining FUS1-nanoparticles and Erlotinib in Stage IV Lung Cancer|Recruiting||Phase 1/Phase 2|57|Anticipated|Genprex, Inc.||1|||f||||f||||||||||2017-10-11 03:42:52.527953|2017-10-11 03:42:52.527953
NCT01455376|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2011-10-20|||March 2010||2010-03-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Exogenous Lactate on Neurocognitive in Brain Trauma|Effect of Exogenous Lactate Infusion on Neurocognitive Function of Patients With Mild Traumatic Brain Injury|Completed||N/A|60|Actual|Universitas Padjadjaran||2|||f||||t||||||||||2017-10-11 03:42:52.647487|2017-10-11 03:42:52.647487
NCT01455363|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-04-03|||June 2011||2011-06-01|September 2011|2011-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|HPOB||Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma|Etude peropératoire de la Perfusion Sanguine Des Carcinomes Basocellulaires Par Imageur Laser Doppler, au Cours de la Manipulation de l'Influx artériel Tumoral - Recherche d'un phénomène d'hyperémie Tumorale Post-occlusive|Completed||N/A|12|Actual|Institut Curie||1|||f||||f||||||||||2017-10-11 03:42:52.732348|2017-10-11 03:42:52.732348
NCT01455350|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-11-03|||October 2011||2011-10-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Efficacy of a Physiotherapy Treatment in Women Suffering From Provoked Vestibulodynia|Efficacy of Treatments for Provoked Vestivulodynia : a Randomised Clinical Trial Comparing Multimodal Physiotherapy Treatments to Topical Lidocaine|Completed||N/A|212|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 03:42:52.986476|2017-10-11 03:42:52.986476
NCT01455324|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2012-03-01|||September 2011||2011-09-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Evaluation of the Development of an Advanced, Conformable Prosthetic Socket, Study II||Completed||N/A|1|Actual|Infoscitex Corporation|||1||f||||f||||||||||2017-10-11 03:42:53.152859|2017-10-11 03:42:53.152859
NCT01455311|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2013-02-12|||September 2010||2010-09-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors|Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in the Diagnosis of Cystic Pancreatic Tumors|Terminated||N/A|21|Actual|H. Lee Moffitt Cancer Center and Research Institute|||1|funding unavailable|f||||f||||||Samples With DNA|"     Cataloguing the proteins that are expressed in pancreatic cyst fluid will provide preliminary     data that will be used for identification of candidate biomarkers to predict malignant     transformation.   "|||2017-10-11 03:42:53.217535|2017-10-11 03:42:53.217535
NCT01455298|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2012-10-30|||May 2011||2011-05-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|LIDIA-A1AT||Liver Disease in Adults With Alpha-1 AT Deficiency|Research of Infra Clinical Liver Injuries in Adult Patients Presented With Alpha-1 AT Deficiency|Completed||N/A|33|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-10-11 03:42:53.304854|2017-10-11 03:42:53.304854
NCT01455285|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-18||||||May 2011|2011-05-01||||||||Interventional|||Effectiveness of the Transcutaneous Electrical Nerve Stimulation in Dysmenorrhea|Investigation of the Effectiveness of Different Modulations of Pulse Frequency Transcutaneous Electrical Nerve Stimulation in Dysmenorrhea|Completed||N/A|||Universidade Federal do Piauí|||||f||||t||||||||||2017-10-11 03:42:53.379933|2017-10-11 03:42:53.379933
NCT01455272|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-04-05|||July 2009||2009-07-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||New Therapy for Advanced Stage Leukemia After Stem Cell Transplantation|Clinical Study of Granulocyte Colony-stimulating Factor (G-CSF)-Primed, Peripheral-blood Progenitor Cells for the Prevention of Relapse Advanced Stage Leukemia|Completed||N/A|100|Anticipated|Peking University People's Hospital||1|||f||||t||||||||||2017-10-11 03:42:53.461638|2017-10-11 03:42:53.461638
NCT01455259|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-02-16|||September 2011||2011-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors|Phase I/IIa AdCD40L Immunogene Therapy for Patients With Advanced Malignant Disease.|Completed||Phase 1/Phase 2|30|Actual|Uppsala University||1|||f||||f||||||||||2017-10-11 03:42:53.565985|2017-10-11 03:42:53.565985
NCT01455246|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-10-11|||October 2010||2010-10-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis|Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis: an Open, Randomized, Controlled Clinical Trial|Terminated||Phase 2/Phase 3|32|Actual|University of Padova||2||"Decision of independent monitoring committee after interim analysis: Risk of failure   significantly higher in ceftazidime group."|f||||f||||||||||2017-10-11 03:42:53.685807|2017-10-11 03:42:53.685807
NCT01455220|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-02-14|2016-05-10||January 2011||2011-01-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Tysex||The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis|The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis|Completed||N/A|45|Actual|University of South Florida||1|||f||||f||||||||No||2017-10-11 03:42:54.024685|2017-10-11 03:42:54.024685
NCT01455207|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2014-04-08|||January 2012||2012-01-01|April 2014|2014-04-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|ALCOBRAIN||From Uncomplicated Alcoholism to Korsakoff's Syndrome|From Uncomplicated Alcoholism to Korsakoff's Syndrome: Clinical, Genetic, Neuropsychological and Brain Examinations|Unknown status|Recruiting|N/A|220|Anticipated|University Hospital, Caen||3|||f||||t||||||||||2017-10-11 03:42:54.297858|2017-10-11 03:42:54.297858
NCT01455194|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2016-12-21|2016-04-24||November 2011||2011-11-01|December 2016|2016-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CONTRAST|The full analysis set (FAS) was defined as all randomized participants who took at least 1 dose of double-blind study medication.Baseline data was summarized only for those participants who entered treatment period which was the core period of the trial.|Effect of High Dose Ciclesonide on Asthma Control|Control of Moderate or Severe Asthma With 160, 320 and 640 mcg Ciclesonide/Day. A One-year Randomised, Double-blind, Multicenter Trial.|Completed||Phase 3|520|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 03:42:54.473157|2017-10-11 03:42:54.473157
NCT01455181|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2015-11-10|2015-02-20||August 2011||2011-08-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|REPEAT||A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary|A 6-Month Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study|Completed||Phase 3|24|Actual|Shire||1|||f||||f||||||||||2017-10-11 03:42:57.021529|2017-10-11 03:42:57.021529
NCT01455168|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2011-10-19|||September 2004||2004-09-01|October 2011|2011-10-01|October 2013|Anticipated|2013-10-01|May 2006|Actual|2006-05-01||Observational|Effect of CTR||Efficacy of a Capsular Tension Ring in Preventing Anterior Capsule Shrinkage After Cataract Surgery in Exfoliation Syndrome|Prospective Study to Examine the Efficacy of a Capsular Tension Ring (CTR) in Preventing Anterior Capsule Shrinkage After Cataract Surgery in Exfoliation Syndrome (XFS) With no Zonular Weakness|Unknown status|Active, not recruiting|Phase 3|30|Anticipated|University of Occupational and Environmental Health|||3||f||||f||||||||||2017-10-11 03:42:57.388993|2017-10-11 03:42:57.388993
NCT01455142|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-02-19|||October 2011||2011-10-01|February 2015|2015-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes|A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes|Completed||Phase 1|32|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:42:57.851247|2017-10-11 03:42:57.851247
NCT01455129|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-08-10|||November 2011||2011-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|Tie-COPD||Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China|Early Intervention With Tiotropium （Spiriva） in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized, Double-blind, Placebo-controlled, Parallel, Multicentre Trial|Completed||Phase 4|841|Actual|The First Affiliated Hospital of Guangzhou Medical University||2|||f||||f||||||||||2017-10-11 03:42:57.978272|2017-10-11 03:42:57.978272
NCT01455116|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-15|2016-11-21|||November 2011||2011-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|CASS||The Cooling And Surviving Septic Shock Study (CASS)|Randomized Trial to Determine Whether Mild Induced Hypothermia Can Reduce Mortality in Adult Patients With Septic Shock|Terminated||Phase 2/Phase 3|433|Actual|Danish Procalcitonin Study Group||2||Futility|f||||t||||||||Undecided|The Steering Committee will share data after reviewing study propositions - this to assure quality|2017-10-11 03:42:58.148678|2017-10-11 03:42:58.148678
NCT01455103|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-12-12|||November 2011||2011-11-01|October 2011|2011-10-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|PD-L1||Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma|A Phase I Study of the Biologic Effects of BMS-936559 Treatment in Subjects With Unresectable Stage III or IV Melanoma|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 03:42:58.269231|2017-10-11 03:42:58.269231
NCT01455090|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2017-04-26||2015-09-23|November 30, 2011|Actual|2011-11-30|April 2017|2017-04-01|July 31, 2015|Actual|2015-07-31|March 31, 2014|Actual|2014-03-31||Interventional|||Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications|Open-Label, Multiple-Dose, Dose Escalation Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Coadministration of BMS-650032, BMS-790052, and BMS-791325 When Administered for 24 or 12 Weeks in Treatment-Naïve Subjects Infected With Hepatitis C Virus Genotype 1|Completed||Phase 2|320|Actual|Bristol-Myers Squibb||13|||f||||f||||||||||2017-10-11 03:42:58.364448|2017-10-11 03:42:58.364448
NCT01455077|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-15|2011-10-18|||January 2011||2011-01-01|October 2011|2011-10-01|January 2012|Anticipated|2012-01-01|July 2011|Actual|2011-07-01||Observational|||Portable Monitoring Device for the Diagnosis of Sleep Apnea in Obese Patients|Validation of a Portable Monitoring System for the Diagnosis of Obstructive Sleep Apnea Syndrome in Patients With Level II and III Obesity|Unknown status|Recruiting|N/A|40|Anticipated|Associacao Fundo de Incentivo a Psicofarmcologia|||1||f||||f||||||||||2017-10-11 03:42:58.591608|2017-10-11 03:42:58.591608
NCT01455064|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-15|2013-05-13|2013-02-07||October 2011||2011-10-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|||Navigator II Continuous Glucose Monitor Home Use Study|FreeStyle Navigator II Continuous Glucose Monitor Home Use Evaluation (FSNv2)|Completed||N/A|31|Actual|Abbott Diabetes Care|||1||f||||f||||||||||2017-10-11 03:42:58.691258|2017-10-11 03:42:58.691258
NCT01455051|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2012-01-10|||October 2011||2011-10-01|January 2012|2012-01-01|October 2017|Anticipated|2017-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation|Ofatumumab as Part of the Reduced Intensity Conditioning Regimen for Patients With High Risk Chronic Lymphocytic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: a Pilot Study by GETH and GELLC|Unknown status|Recruiting|Phase 2|25|Anticipated|Grupo Espanol de trasplantes hematopoyeticos y terapia celular||1|||f||||f||||||||||2017-10-11 03:42:58.88878|2017-10-11 03:42:58.88878
NCT01455038|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-18|||January 2010||2010-01-01|October 2011|2011-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Heart Rate Variability of Patients With Bipolar Disorder in Subsyndromal Depressive Phase|Heart Rate Variability of Patients With Bipolar Disorder in Subsyndromal Depressive Phase|Completed||N/A|92|Actual|Asan Medical Center|||2||f||||||||||||||2017-10-11 03:42:59.038456|2017-10-11 03:42:59.038456
NCT01455025|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2016-03-15|||January 2012||2012-01-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|March 2015|Actual|2015-03-01||Interventional|PRIMAL||Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia|A Phase 1, Dose Escalation Study of Plerixafor in Combination With Induction and Consolidation Chemotherapy in Patients With Relapsed Acute Myeloid Leukemia|Terminated||Phase 1|11|Actual|French Innovative Leukemia Organisation||1||no recruitment on time|f||||t||||||||||2017-10-11 03:42:59.103001|2017-10-11 03:42:59.103001
NCT01455012|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2013-07-19|2013-05-14||September 2011||2011-09-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|ENCORE|Baseline Characteristics refer to the Full Analysis Set (FAS). FAS includes all randomized subjects having both a Baseline and a post-Baseline measurement for the primary efficacy variable.|Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome|Multicenter, Double-Blind, Placebo-Controlled, Two-Arm, Randomized, Parallel, Treatment Intervention, Sleep Lab Phase 4 Study to Assess the Effect of Rotigotine on Nocturnal Blood Pressure in Patients With Idiopathic Restless Legs Syndrome|Completed||Phase 4|81|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:42:59.227663|2017-10-11 03:42:59.227663
NCT01454999|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-03-15|||September 2009||2009-09-01|March 2016|2016-03-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|TXT||Cell Phone-Based Expert Systems for Smoking Cessation|Cell Phone-Based Expert Systems for Smoking Cessation|Completed||Phase 1|446|Actual|VA Pacific Islands Health Care System||2|||f||||f||||||||No||2017-10-11 03:43:01.651251|2017-10-11 03:43:01.651251
NCT01454986|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2017-02-02|||November 2011||2011-11-01|February 2017|2017-02-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects|A Phase 1, Randomized, Blinded, Placebo-Controlled, Single-Administration, Sequential-Cohort Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of ALXN1007 in Healthy Subjects|Completed||Phase 1|64|Actual|Alexion Pharmaceuticals||7|||f||||t||||||||||2017-10-11 03:43:01.762768|2017-10-11 03:43:01.762768
NCT01454973|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2012-08-09|||October 2011||2011-10-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects|Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects|Completed||N/A|25|Actual|Foundation for the National Institutes of Health|||1||f||||f||||||||||2017-10-11 03:43:01.885468|2017-10-11 03:43:01.885468
NCT01454960|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-03-31|||July 2011||2011-07-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|February 2013|Actual|2013-02-01||Interventional|BEARI||Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Pilot Study)|Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Pilot Study)|Completed||N/A|28|Actual|University of Southern California||8|||f||||t||||||||||2017-10-11 03:43:01.963692|2017-10-11 03:43:01.963692
NCT01454947|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-03-30|2015-07-20||August 2011||2011-08-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|April 2014|Actual|2014-04-01||Interventional|BEARI|Enrolled Clinicians|Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study)|Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study)|Completed||N/A|248|Actual|University of Southern California||8|||f||||t||||||||||2017-10-11 03:43:02.086441|2017-10-11 03:43:02.086441
NCT01454934|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-08-03|2017-01-11||September 2011||2011-09-01|August 2017|2017-08-01|May 2, 2016|Actual|2016-05-02|July 2015|Actual|2015-07-01||Interventional||Full analysis set included all randomized participants.|A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer||Completed||Phase 3|540|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 03:43:02.806345|2017-10-11 03:43:02.806345
NCT01454921|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-31|2017-02-27|||February 2010||2010-02-01|March 2016|2016-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Development of an Empowerment Intervention for Young Women Living With HIV|A Secondary Prevention Empowerment Intervention for Young Women Living With HIV|Completed||Phase 2|43|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 03:43:04.244914|2017-10-11 03:43:04.244914
NCT01454895|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2015-10-01|||November 2011||2011-11-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Test of a Web-based Intervention to Promote Hearing Protector Use|Test of a Web-based Intervention to Promote Hearing Protector Use|Completed||N/A|498|Actual|University of Michigan||6|||f||||f||||||||||2017-10-11 03:43:04.393134|2017-10-11 03:43:04.393134
NCT01454882|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-01-07|||January 2012||2012-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|November 2015|Actual|2015-11-01||Observational|||Measuring Free-living Energy Expenditure Using Direct Calorimetry|Measuring Free-living Energy Expenditure Using Direct Calorimetry|Completed||N/A|39|Actual|University of Colorado, Denver|||3||f||||t||||||||||2017-10-11 03:43:04.612584|2017-10-11 03:43:04.612584
NCT01454869|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2012-12-14|||February 2012||2012-02-01|December 2012|2012-12-01|June 2014|Anticipated|2014-06-01|June 2012|Anticipated|2012-06-01||Interventional|||The Effect of Heparin on Inhalation Injury|Efficacy of Heparin Nebulization on Lung Injury Score in Inhalation Burn Injury|Withdrawn||Phase 3|0|Actual|Tehran University of Medical Sciences||2||Due to insufficient funds|f||||t||||||||||2017-10-11 03:43:04.713002|2017-10-11 03:43:04.713002
NCT01454856|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-03-23|||October 2011||2011-10-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Perioperative Evaluation of Immuno-inflammatory Parameters|Perioperative Evaluation of Immuno-inflammatory Parameters|Terminated||N/A|20|Actual|Université Catholique de Louvain|||4||f||||t||||||Samples Without DNA|"     Plasma and cells (PBMCs) frozen in cryotubes   "|||2017-10-11 03:43:04.808847|2017-10-11 03:43:04.808847
NCT01454843|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-04-12|||June 2011||2011-06-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LASIK||LASIK Using the Alcon Allegretto Wavefront-Guided Excimer Laser vs AMO Visx Wavefront-Guided Excimer Laser|A Prospective Eye to Eye Comparison of LASIK Using the Alcon Allegretto Wavefront-Guided Excimer Laser Versus AMO Visx Wavefront-Guided Excimer Laser|Active, not recruiting||Phase 4|60|Anticipated|Stanford University||2|||f||||f||||||||||2017-10-11 03:43:04.87572|2017-10-11 03:43:04.87572
NCT01454830|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2016-09-30|2016-08-05||November 2011||2011-11-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|SCIP-PA||Tailored Intervention to Promote Positive Airway Pressure Adherence|Phase I Double-blind Randomized Controlled Trial: Sociocultural and Cognitive Perception Intervention to Promote Positive Airway Pressure Adherence|Completed||Phase 1|118|Actual|Milton S. Hershey Medical Center|Sampling bias with convenience sampling leading to relatively few PAP users meeting definition of non-adherence (threshold definition </= 4hrs/night PAP use); Modest intervention fidelity (i.e., delivery) for telephone-delivered exposure period|2|||f||||f||||||||||2017-10-11 03:43:04.982345|2017-10-11 03:43:04.982345
NCT01454817|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-10-07|||June 2012||2012-06-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||A Study of Symptoms and Quality of Life in Patients With Implantable Cardiac Defibrillators (ICDs) and Their Caregivers|A Study of Symptoms and Quality of Life in Patients With ICDs and Their Caregivers|Completed||N/A|562|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 03:43:05.669556|2017-10-11 03:43:05.669556
NCT01454804|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2016-04-11|||October 2011||2011-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors|Phase I Study of Pazopanib in Combination With Lapatinib or Trastuzumab in Subjects With Solid Tumors|Completed||Phase 1|43|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 03:43:05.766666|2017-10-11 03:43:05.766666
NCT01454791|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-02-12|2014-07-22||January 2011||2011-01-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate|Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients With Multiple Sclerosis Taking Glatiramer Acetate: A Randomized Controlled Double- Blind Crossover Trial|Completed||Phase 4|40|Actual|Brown, Theodore R., M.D., MPH||2|||f||||f||||||||||2017-10-11 03:43:05.904376|2017-10-11 03:43:05.904376
NCT01454778|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-04|2016-04-15|2015-08-12||April 2011||2011-04-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|Pac1||Effects of Paclitaxel on Intimal Hyperplasia|Effects of Paclitaxel on Intimal Hyperplasia Status Post Lower Extremity Revascularization|Completed||N/A|50|Actual|Sanford Health||1|||f||||t||||||||||2017-10-11 03:43:06.283492|2017-10-11 03:43:06.283492
NCT01454765|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-16|2013-12-10|||December 2011||2011-12-01|December 2013|2013-12-01|August 2015|Anticipated|2015-08-01|December 2014|Anticipated|2014-12-01||Observational|||Generation of Haploid Stem Cells From Human Germ Cells|Generation of Haploid Stem Cells From Human Germ Cells|Unknown status|Recruiting|N/A|10|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples With DNA|"     Germ cells and Stem cells   "|||2017-10-11 03:43:06.598837|2017-10-11 03:43:06.598837
NCT01454752|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2012-04-18|||November 2011||2011-11-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and Cognition|Intermittent Parasite Clearance (IPC) in Schools: a Randomised Double-blind Placebo-controlled Trial of the Impact of IPC on Malaria, Anaemia and Cognition Amongst School Children in Kedougou, Senegal|Completed||N/A|860|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 03:43:06.703638|2017-10-11 03:43:06.703638
NCT01454726|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2012-11-23|2012-01-03||January 2011||2011-01-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|TCDMD||Clinical Trial of Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease|A Random Controlled Clinical Trial:l Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease|Completed||Phase 3|27|Actual|Beijing Administration of Traditional Chinese Medicine Bureau|Our study focused only on the effect of Diaoshi Jifa on Meniere's disease after one-time treatment. There still possibilities that after several days' treatment, both experimental and control groups have similar improvement in their DHI scores.|2|||f||||t||||||||||2017-10-11 03:43:07.069285|2017-10-11 03:43:07.069285
NCT01454713|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2017-04-04|||October 2010||2010-10-01|April 2017|2017-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|RAVE||Retrospective Analysis of Veritas in Breast Reconstruction|Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)|Completed||N/A|54|Actual|Baxter Healthcare Corporation|||1||f||||f||||||||||2017-10-11 03:43:07.584106|2017-10-11 03:43:07.584106
NCT01454700|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2015-01-13|||December 2011||2011-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of CSII and CGM on Progression of Late Diabetic Complications|The Effect of Sensor-Augmented Continuous Subcutaneous Insulin Infusion Compared to Multiple Daily Insulin Injections in Prevention of Increasing Urinary Albumin Excretion Rate in Type 1 Diabetes Mellitus|Completed||Phase 4|60|Actual|Steno Diabetes Center||2|||f||||f||||||||||2017-10-11 03:43:07.682871|2017-10-11 03:43:07.682871
NCT01454687|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-04-10|||October 2011||2011-10-01|April 2014|2014-04-01||||April 2014|Actual|2014-04-01||Interventional|||Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes|Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes|Withdrawn||N/A|0|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 03:43:07.801539|2017-10-11 03:43:07.801539
NCT01454674|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-10-18|||October 2007||2007-10-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|June 2010|Actual|2010-06-01||Interventional|||The Vegetable Dose Response Study: Effects of Consumption on Inflammation and Oxidative Stress|The Vegetable Dose Response Study: Effects of Consumption on Inflammation and Oxidative Stress|Completed||N/A|75|Actual|University of Arizona||1|||f||||f||||||||||2017-10-11 03:43:07.880961|2017-10-11 03:43:07.880961
NCT01454661|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2014-04-29|||April 2014||2014-04-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|ProPre||Probiotics and Early Microbial Contact in Preterm Neonates|Probiotic Modulation of Early Microbial Contact in Premature Infants|Unknown status|Recruiting|N/A|100|Anticipated|Turku University Hospital||5|||f||||f||||||||||2017-10-11 03:43:07.97678|2017-10-11 03:43:07.97678
NCT01454648|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-01-15|||January 2005||2005-01-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Prehospital Traumatic Brain Injury|Severe Traumatic Brain Injury - Comparison of Outcome in Paramedic Versus Physician Staffed Emergency Medical Services|Completed||N/A|458|Actual|Tampere University Hospital|||2||f||||f||||||||||2017-10-11 03:43:08.11867|2017-10-11 03:43:08.11867
NCT01454622|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2013-05-03|||September 2011||2011-09-01|May 2013|2013-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers|A Single-Dose, Open-Label, Randomized, 2-Way Crossover Pivotal Study to Assess the Bioequivalence of 2 FDC Tablets of Canagliflozin and Metformin IR (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Fed Subjects|Completed||Phase 1|64|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-10-11 03:43:08.29428|2017-10-11 03:43:08.29428
NCT01454609|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-08|2011-10-18|||January 2009||2009-01-01|October 2011|2011-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy of Bilateral Superficial Cervical Plexus Block in Thyroidectomy|Safety and Efficacy of Bilateral Superficial Cervical Plexus Block in Thyroidectomy - a Double Blind Randomized Controlled Trial|Completed||Phase 2|60|Actual|Jawaharlal Institute of Postgraduate Medical Education & Research||3|||f||||t||||||||||2017-10-11 03:43:08.37829|2017-10-11 03:43:08.37829
NCT01454596|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-10-03|||September 26, 2011||2011-09-26|September 27, 2017|2017-09-27|December 28, 2029|Anticipated|2029-12-28|December 29, 2028|Anticipated|2028-12-29||Interventional|||CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII|A Phase I/II Study of the Safety and Feasibility of Administering T Cells Expressing Anti-EGFRvIII Chimeric Antigen Receptor to Patients With Malignant Gliomas Expressing EGFRvIII|Recruiting||Phase 1/Phase 2|107|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:43:08.470878|2017-10-11 03:43:08.470878
NCT01454583|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-06-20|2013-08-15||October 2008||2008-10-01|June 2016|2016-06-01|July 2012|Actual|2012-07-01|October 2009|Actual|2009-10-01||Observational|3A||Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany|3A-Register Zur Ambulanten Therapie Mit RAS-Inhibitoren in Patienten Mit Arterieller Hypertonie in Deutschland|Completed||N/A|15337|Actual|Stiftung Institut fuer Herzinfarktforschung|||3||f||||f||||||||No||2017-10-11 03:43:08.696381|2017-10-11 03:43:08.696381
NCT01454570|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-04-08|||February 2011||2011-02-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|April 2015|Anticipated|2015-04-01||Observational|VA_ReWalk||The ReWalk Exoskeletal Walking System for Persons With Paraplegia|The ReWalk Exoskeletal Walking System for Persons With Paraplegia|Unknown status|Recruiting|Phase 1|40|Anticipated|James J. Peters Veterans Affairs Medical Center|||1||f||||f||||||||||2017-10-11 03:43:13.619489|2017-10-11 03:43:13.619489
NCT01454557|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-31|||November 2011||2011-11-01|October 2011|2011-10-01||||November 2012|Anticipated|2012-11-01||Interventional|||The Effect of Auditory Stimuli on Heart Rate Variability (HRV) Among Patients With Acquired Brain Injury (ABI)|The Effect of Auditory Stimuli on Heart Rate Variability (HRV) During Resting and During Physical Activity Among Patients With Acquired Brain Injury (ABI)|Unknown status|Not yet recruiting|N/A|80|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 03:43:13.701651|2017-10-11 03:43:13.701651
NCT01454544|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-01-27|||October 2011||2011-10-01|January 2017|2017-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|MT-06||A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet||Completed||Phase 3|992|Actual|ALK-Abelló A/S||3|||f||||f||||||||||2017-10-11 03:43:13.802443|2017-10-11 03:43:13.802443
NCT01454531|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-02-23|2014-12-03||June 2011||2011-06-01|February 2015|2015-02-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional||Subjects treated|An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy|An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy|Completed||Phase 2/Phase 3|199|Actual|ALK-Abelló A/S||1|||f||||f||||||||||2017-10-11 03:43:13.91908|2017-10-11 03:43:13.91908
NCT01454518|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-03-08|||October 2011||2011-10-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||Local Infiltration Analgesia for Hip Arthroscopy|Effectiveness of Ultrasound Guided Hip Infiltration With Local Anesthetic Solution for Pain Control After Hip Arthroscopy|Completed||N/A|36|Actual|Saint Francis Care||2|||f||||f||||||||||2017-10-11 03:43:14.202587|2017-10-11 03:43:14.202587
NCT01454505|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2013-03-29|2013-03-29||October 2011||2011-10-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Efficacy of AL-53817 Nasal Spray Solution|Safety and Efficacy of AL-53817 Nasal Spray Solution in Ragweed Sensitive Subjects in an Environmental Exposure Chamber (EEC)|Completed||Phase 1|110|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:43:14.287565|2017-10-11 03:43:14.287565
NCT01454492|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-18|||September 2011||2011-09-01|October 2011|2011-10-01|September 2012|Anticipated|2012-09-01|March 2012|Anticipated|2012-03-01||Observational|AR-GT||The Relationship Between Allergic Rhinitis and Geographic Tongue||Unknown status|Recruiting|N/A|300|Anticipated|China Medical University Hospital|||2||f||||t||||||||||2017-10-11 03:43:14.720963|2017-10-11 03:43:14.720963
NCT01454479|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-10-18|||March 2011||2011-03-01|October 2011|2011-10-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|||A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma|A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma|Unknown status|Enrolling by invitation|Phase 1|24|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-10-11 03:43:14.818272|2017-10-11 03:43:14.818272
NCT01454466|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2011-10-18|||November 2009||2009-11-01|October 2011|2011-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Partial Posterior Hyaloidectomy in Macular Surgery|Partial Posterior Hyaloidectomy in Macular Surgery : A Modified Procedure of Vitrectomy to Prevent Retinal Break Related to Induction of a Posterior Vitreous Detachment|Completed||Phase 1|50|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 03:43:14.884939|2017-10-11 03:43:14.884939
NCT01454453|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2017-04-18|||May 2012||2012-05-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Optimisation of Antipsychotic Drug Use in Older People|Rationalisation of Antipsychotic Drug Use in Older People, Using [18F]-Fallypride PET|Terminated||Phase 4|64|Actual|Institute of Psychiatry, London||1||Failure to recruit people with very late onset schizophrenia like psychosis|f||||f||||||||No|Not available|2017-10-11 03:43:14.945243|2017-10-11 03:43:14.945243
NCT01454440|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-18|||October 2007||2007-10-01|October 2011|2011-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|INSTANT||The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)|A RANDOMIZED TRIAL COMPARING EPTIFIBATIDE AND PLACEBO IN PATIENTS WITH DIFFUSE CORONARY DISEASE UNDERGOING DRUG-ELUTING STENTING|Terminated||Phase 4|91|Actual|University of Turin, Italy||2||The study was stopped prematurely due to slow enrolment without code breaking.|f||||t||||||||||2017-10-11 03:43:15.102043|2017-10-11 03:43:15.102043
NCT01454427|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-18|2011-10-18|||October 2010||2010-10-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Influence of Anesthesia Drugs on Impedance Aggregometry|The Influence of Drugs Routinely Used in Cardiac Anesthesia on Impedance Aggregometry.|Completed||N/A|20|Actual|University of Lausanne Hospitals|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 03:43:15.303421|2017-10-11 03:43:15.303421
NCT01454414|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2014-05-29|2014-04-25||October 2010||2010-10-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|TICS||Tick-borne Illness and Clothing Study|Preventing Exposure to Ticks and Tick-borne Illness in Outdoor Workers|Completed||N/A|159|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 03:43:15.37409|2017-10-11 03:43:15.37409
NCT01454401|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-08-15|2016-05-17||October 2010||2010-10-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||LeucoPatch™ Study A Multicenter Study on the Effect of LeucoPatch™ in Diabetic Foot Ulcers|LeucoPatch™ Study. A Multicenter Study on the Effect of LeucoPatch™ in Diabetic Foot Ulcers|Completed||Phase 4|60|Actual|Reapplix||1|||f||||t||||||||No||2017-10-11 03:43:16.013475|2017-10-11 03:43:16.013475
NCT01454388|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-12-16|||January 2010||2010-01-01|December 2015|2015-12-01||||May 2012|Actual|2012-05-01||Interventional|||A Trial Comparing Breakfast Versus no Breakfast Prior to Colonoscopy|A Randomized Controlled Trial Comparing Breakfast Versus no Breakfast|Completed||Phase 4|496|Actual|Queen's University||4|||f||||t||||||||||2017-10-11 03:43:16.39284|2017-10-11 03:43:16.39284
NCT01454375|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-15|2014-10-02|||November 2011||2011-11-01|October 2014|2014-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Emergency Department Smoking Cessation Study|Emergency Department Tobacco Cessation Counseling: Implementation and Evaluation of a Community-Based Program|Completed||N/A|1301|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:43:16.483904|2017-10-11 03:43:16.483904
NCT01454349|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2013-08-19|||September 2011||2011-09-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01||Interventional|||Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)|A Randomized Dose-Escalation, Multicenter Safety and Efficacy Study of a Single Transrectal Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)|Completed||Phase 1/Phase 2|40|Actual|Sophiris Bio Corp||2|||f||||t||||||||||2017-10-11 03:43:16.686945|2017-10-11 03:43:16.686945
NCT01454336|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-15|2014-05-10|||June 2010||2010-06-01|February 2010|2010-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone|Phase 1 Trial of Combined Pioglitazone Plus Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients With Compensated Cirrhosis|Completed||Phase 1|3|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 03:43:16.799005|2017-10-11 03:43:16.799005
NCT01454323|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-06-29|||December 2010||2010-12-01|November 2014|2014-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction.|Phase II Clinical Trial on the Effect of Intracoronary Infusion of Bone Marrow Mononuclear Cells on Functional Recovery in Patients With Myocardial Chronic Back and Severely Depressed Left Ventricular Function.|Completed||Phase 2|20|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||1|||f||||t||||||||||2017-10-11 03:43:16.900956|2017-10-11 03:43:16.900956
NCT01454310|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-15|2011-10-18|||November 2010||2010-11-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns|A Prospective Noninferiority Trial to Compare an Acellular Epithelial Skin Substitute With Autologous Split-thickness Skin Grafts in Deep Partial-thickness Burns|Completed||Phase 4|18|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 03:43:17.011956|2017-10-11 03:43:17.011956
NCT01454297|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-09-26|||July 2011||2011-07-01|August 2016|2016-08-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Observational|CoMMpass||Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile|A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship Between Patient Outcomes, Treatment Regimens and Molecular Profiles|Active, not recruiting||N/A|1154|Actual|Multiple Myeloma Research Foundation|||1||f||||f||||||Samples With DNA|"     Bone marrow, Peripheral Blood   "|Yes|Interim Analysis data will be released every 6 months|2017-10-11 03:43:17.115027|2017-10-11 03:43:17.115027
NCT01453920|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-08-27|||November 2011||2011-11-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing|Choroidal Neovascular Membrane Recurrence Rate in Wet AMD Patients Stable on Three Month Ranibizumab Dosing|Completed||Phase 4|44|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 03:43:23.134377|2017-10-11 03:43:23.134377
NCT01454284|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2014-04-14||2014-04-14|January 2012||2012-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|IMAGINE 3||A Study in Patients With Type I Diabetes Mellitus|The Impact of LY2605541 Versus Insulin Glargine for Patients With Type 1 Diabetes Mellitus Treated With Preprandial Insulin Lispro: a Double-Blind, Randomized, 52-week Study|Completed||Phase 3|1113|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:43:17.701867|2017-10-11 03:43:17.701867
NCT01454271|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-09-13|||January 2017||2017-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Follow up Study of Patients Undergoing Total Hip Arthroplasty CERAFIT® Grafted With Poly Sodium Styrene Sulfonate|Follow up Study of Patients Undergoing Total Hip Arthroplasty CERAFIT® Grafted With Poly Sodium Styrene Sulfonate|Not yet recruiting||Phase 1/Phase 2|50|Anticipated|Laboratoire Ceraver-Osteal||1|||f||||f||||||||||2017-10-11 03:43:18.147968|2017-10-11 03:43:18.147968
NCT01454258|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2017-08-15|2015-04-02||October 2011||2011-10-01|August 2017|2017-08-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Observational|INDIZ_IV_I||Indication for Intraoperative Volume Therapy|Indication for Intraoperative Volume Therapy|Completed||N/A|10100|Actual|Johann Wolfgang Goethe University Hospital|||1||f||||||||||||||2017-10-11 03:43:18.227892|2017-10-11 03:43:18.227892
NCT01454245|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-01-30|||July 2011||2011-07-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Evaluate the Bioavailability and Food Effect of JNJ-39439335 in Healthy Adult Male Volunteers|An Open-Label, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of JNJ-39439335 Capsule Formulations Administered as a Single Oral Dose in Healthy Male Adult Subjects|Completed||Phase 1|43|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 03:43:18.381448|2017-10-11 03:43:18.381448
NCT01454232|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2017-09-21|||June 7, 2011|Actual|2011-06-07|September 2017|2017-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|microbaria||Adaptation of Human Gut Microbiota to Energetic Restriction|Modification of Human Gut Microbiota in Massive Obesity After Bariatric Surgery: the Role of Energetic Restriction|Active, not recruiting||N/A|140|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:43:18.475743|2017-10-11 03:43:18.475743
NCT01454219|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2012-02-14|||August 2011||2011-08-01|November 2011|2011-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|GIFA||Measurement of Glycaemic Responses of Bakery and Confectionery Products|Measurement of Glycaemic Responses of Bakery and Confectionery Products|Completed||N/A|14|Actual|Clinical Life Sciences Ltd.||1|||f||||||||||||||2017-10-11 03:43:18.577497|2017-10-11 03:43:18.577497
NCT01454206|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-10-06|||July 2012||2012-07-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Interventional|||Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network|Integration of Internet-facilitated Screening, Brief Intervention, Referral to Treatment (iSBIRT) for Teen Drug Use Into a Pediatric Network|Withdrawn||Phase 2/Phase 3|0|Actual|Boston Children’s Hospital||2||The project was not funded|f||||t||||||||||2017-10-11 03:43:18.654311|2017-10-11 03:43:18.654311
NCT01454193|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2011-10-18|||January 2001||2001-01-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Are we Loading Our Patients With Sodium During Hemodialysis Treatments?||Completed||N/A|10000|Actual|Renal Research Institute|||1||f||||f||||||||||2017-10-11 03:43:18.734111|2017-10-11 03:43:18.734111
NCT01454180|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-10-08|||October 2011||2011-10-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|October 2011|Actual|2011-10-01||Interventional|||Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets|Ensayo Fase II de selección Individualizada Del Tratamiento de Quimioterapia en Pacientes Con Carcinoma de páncreas Avanzado en función de la determinación de Dianas terapéuticas en el Tejido Tumoral|Completed||Phase 2|31|Actual|Centro Nacional de Investigaciones Oncologicas CARLOS III||2|||f||||t||||||||||2017-10-11 03:43:18.800887|2017-10-11 03:43:18.800887
NCT01454167|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2015-05-25|||May 2014||2014-05-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Acid Base and Electrolytes Patterns in Drains Operational Wounds and Its Relation to Complications|Acid Base and Electrolytes Patterns in Drains of Different Operational Wounds and Its Relation to Specific Infections and Seroma Formation|Unknown status|Recruiting|N/A|200|Anticipated|Carmel Medical Center|||1||f||||t||||||||||2017-10-11 03:43:18.896126|2017-10-11 03:43:18.896126
NCT01454154|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-05-05|||November 2011||2011-11-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||Glyburide (RP-1127) for Traumatic Brain Injury (TBI)|A Randomized Clinical Trial of Glyburide (RP-1127) for TBI|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Remedy Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 03:43:18.98312|2017-10-11 03:43:18.98312
NCT01454141|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2011-10-14|||July 2010||2010-07-01|October 2011|2011-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Cognitive Control Training for Depression||Completed||N/A|56|Actual|Boston University||2|||f||||f||||||||||2017-10-11 03:43:19.088726|2017-10-11 03:43:19.088726
NCT01454128|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2011-10-17|||April 2011||2011-04-01|September 2010|2010-09-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||The Role of Exercise-Periodic-Breathing (EPB) in Impaired Ventilation Regulation Dysfunction in Heart Failure Patients|The Role of Exercise-Periodic-Breathing in Impaired Ventilation Regulation Dysfunction in Patients With Heart Failure|Unknown status|Recruiting|N/A|60|Anticipated|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 03:43:19.17349|2017-10-11 03:43:19.17349
NCT01454115|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2011-11-18|||June 2007||2007-06-01|November 2011|2011-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163|Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-708163 in Healthy Male Subjects and a Comparison to Elderly Male and Female Subjects|Completed||Phase 1|116|Actual|Bristol-Myers Squibb||14|||f||||f||||||||||2017-10-11 03:43:19.270957|2017-10-11 03:43:19.270957
NCT01453907|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2013-05-22|||October 2011||2011-10-01|October 2011|2011-10-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Placebo-Controlled, Sequential Group, Single Dose, Dose-Escalation Study to Evaluate the Safety and PK of ETI-204|A Randomized, Double-Blind, Placebo-Controlled, Single Dose, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of ETI-204 in Healthy Subjects|Completed||Phase 1|108|Actual|Elusys Therapeutics||2|||f||||t||||||||||2017-10-11 03:43:23.254424|2017-10-11 03:43:23.254424
NCT01454102|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-09-01|||December 9, 2011|Actual|2011-12-09|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|July 20, 2016|Actual|2016-07-20||Interventional|||Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)|A Multi-arm Phase I Safety Study of Nivolumab in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1|472|Actual|Bristol-Myers Squibb||19|||f||||f|t|f||||||||2017-10-11 03:43:19.438306|2017-10-11 03:43:19.438306
NCT01454089|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-10-06||2015-10-22|October 2011||2011-10-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer|A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma|Completed||Phase 2|183|Actual|Achieve Life Sciences||3|||f||||f||||||||||2017-10-11 03:43:19.629458|2017-10-11 03:43:19.629458
NCT01454063|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-08-05|2014-07-02|2013-07-10|September 2011||2011-09-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|OMS302-ILR-003||Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification|A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study of the Effect of OMS302 on Intraoperative Pupil Diameter and Early Postoperative Pain in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification|Completed||Phase 3|405|Actual|Omeros Corporation||2|||f||||f||||||||||2017-10-11 03:43:19.971062|2017-10-11 03:43:19.971062
NCT01454050|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2012-11-27|||November 2011||2011-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|Lumax 740||Lumax 740 Master Study|PME/Master Study of the Lumax 740 ICD Family|Completed||N/A|189|Actual|Biotronik SE & Co. KG|||1||f||||f||||||||||2017-10-11 03:43:20.587067|2017-10-11 03:43:20.587067
NCT01454037|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-11-12|||October 2011||2011-10-01|March 2012|2012-03-01|October 2015|Anticipated|2015-10-01|October 2013|Anticipated|2013-10-01||Observational|||Immune Profiles and Circulating Tumor Cell Status Following Prostate Cryotherapy|Immune Profiles and Circulating Tumor Cell Status Following Prostate Cryotherapy|Unknown status|Recruiting|N/A|160|Anticipated|National Taiwan University Hospital|||3||f||||||||||||||2017-10-11 03:43:20.642737|2017-10-11 03:43:20.642737
NCT01454024|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-06-11|||November 2011||2011-11-01|June 2015|2015-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice|A Study Evaluating the Safety of NovoPen®3 and FlexPen® in Subjects With Type 1 and Type 2 Diabetes. A 24-week, Prospective, Multi-centre, Open-labelled, Non-interventional Study|Completed||N/A|1031|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:43:20.726693|2017-10-11 03:43:20.726693
NCT01454011|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-10-14|||September 2008||2008-09-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups|Phase 4 Study That Compares the High Density Lipoprotein Cholesterol (HDL) Cholesterol Subgroups of the Patients With Congenital Hypogonadotrophic Hypogonadism With That of the Healthy Control Subjects, and Investigates the Effect of Testosterone Treatment on HDL Subgroups.|Completed||Phase 4|140|Actual|Gulhane School of Medicine||2|||f||||f||||||||||2017-10-11 03:43:20.800312|2017-10-11 03:43:20.800312
NCT01453998|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2014-07-24|2014-05-01|2012-11-16|October 2011||2011-10-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)|Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)|Completed||Phase 2|657|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 03:43:20.919343|2017-10-11 03:43:20.919343
NCT01453985|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-10-14||||||October 2011|2011-10-01||||||||Interventional|||Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD||Unknown status|Recruiting|N/A|||General Public Hospital Zell am See||1|||f||||||||||||||2017-10-11 03:43:22.3265|2017-10-11 03:43:22.3265
NCT01453972|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-08-01|||October 2011||2011-10-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|February 2012|Actual|2012-02-01||Interventional|TRENO||Effects of Exercise-intensity on Physiological Adaptations in Overweight and Obese|Effects of Exercise-intensity on Physiological Adaptations in Overweight and Obese|Completed||N/A|30|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 03:43:22.41169|2017-10-11 03:43:22.41169
NCT01453946|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-11-16|2015-02-11||December 2011||2011-12-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety and Maintenance Study of Entocort for Children With Crohn's Disease|A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC as a Maintenance Treatment for Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive|Completed||Phase 3|55|Actual|Perrigo Company||1|||f||||||||||||||2017-10-11 03:43:22.620349|2017-10-11 03:43:22.620349
NCT01453933|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2013-12-17|||January 2012||2012-01-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|RASSTER||RAltegravir Switch STudy: Effects on Endothelial Recovery|Phase IV, Randomized, Open Label, Crossover, Intervention Trial to Investigate the Effect of the Switch of Lopinavir/Ritonavir to Raltegravir on Endothelial Function, Chronic Inflammation, Immune Activation and HIV Replication <50 Copies/ml|Unknown status|Recruiting|Phase 4|24|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-11 03:43:23.017361|2017-10-11 03:43:23.017361
NCT01453894|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-07-24|2014-07-24||March 2012||2012-03-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Improving Rates of Repeat Colorectal Cancer Screening|Center for Advancing Equity in Clinical Preventive Services Project 1: Improving Rates of Repeat Colorectal Cancer Screening|Completed||N/A|450|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 03:43:23.359088|2017-10-11 03:43:23.359088
NCT01453881|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-03-29|||April 2011||2011-04-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|EFFECT-EV||Fine Particle pMDI Formoterol/Beclomethasone in Asthmatics With and Without Spacer: Comparative Efficacy Evaluation|Randomized Clinical Trials to Compare Asthma Control Efficacy of the Fine-particle Combination Formoterol/Beclomethasone by pMDI Administered With and Without Spacer.|Completed||Phase 3|45|Actual|Universidade Federal de Pernambuco||2|||f||||f||||||||||2017-10-11 03:43:23.604903|2017-10-11 03:43:23.604903
NCT01453868|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2011-10-17|||October 2011||2011-10-01|October 2011|2011-10-01|June 2012|Anticipated|2012-06-01|March 2012|Anticipated|2012-03-01||Interventional|NIA||The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis|The Effects of Neuromuscular Training on Balance in Patients With Multiple Sclerosis|Unknown status|Recruiting|Early Phase 1|60|Anticipated|Nelson Mandela Metropolitan University||2|||f||||t||||||||||2017-10-11 03:43:23.688723|2017-10-11 03:43:23.688723
NCT01453855|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2013-08-13|2013-08-13||November 2011||2011-11-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||This reporting group includes subjects exposed to the study medication. Note: One subject in the TRAVATAN arm was randomized but discontinued prior to exposure to study medication and is not included in this reporting group.|Travoprost 3-Month Safety and Efficacy Study|A Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost Ophthalmic Solution, 0.003% Compared to TRAVATAN in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|1099|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:43:23.795855|2017-10-11 03:43:23.795855
NCT01453842|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-12-01|||March 2011||2011-03-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Diet Oil Induced Stimulation of GLP-1|Diet Oil Induced Stimulation of GLP-1|Completed||Early Phase 1|12|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 03:43:24.124215|2017-10-11 03:43:24.124215
NCT01453829|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-07-19|||October 2014||2014-10-01|July 2017|2017-07-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into the Internal Carotid Artery and Intravenously in Patients After Stroke|Withdrawn||Phase 1/Phase 2|0|Actual|Ageless Regenerative Institute||1||no enrolled participants|f||||f||||||||||2017-10-11 03:43:24.210754|2017-10-11 03:43:24.210754
NCT01453816|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-07-19|||May 2011||2011-05-01|July 2017|2017-07-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Renal Failure|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into the Renal Artery and Intravenously in Patients With Renal Failure|Withdrawn||N/A|0|Actual|Ageless Regenerative Institute||1||No participants and no longer working with off shore center|f||||f||||||||||2017-10-11 03:43:24.30355|2017-10-11 03:43:24.30355
NCT01453803|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2016-09-19|||May 2014||2014-05-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study to Assess the Safety and Effects of Autologous Adipose-Derived SVF Cells in Patients With Parkinson's Disease|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously and Intranasally in Patients With Parkinson's Disease|Recruiting||Phase 1/Phase 2|10|Anticipated|Ageless Regenerative Institute||1|||f||||f||||||||Undecided||2017-10-11 03:43:24.575603|2017-10-11 03:43:24.575603
NCT01453790|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-05-24|||April 2011||2011-04-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Parent Specific Depression Education and Motivation|Effectiveness of Parent Specific Depression Education and Motivation on Intent to Seek Follow-Up Care for Potential Depression Symptoms|Completed||N/A|104|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 03:43:24.692818|2017-10-11 03:43:24.692818
NCT01453777|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-07-19|||May 2011||2011-05-01|March 2017|2017-03-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Diffuse Lesions in the Brain|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Via Catheter Into the Internal Carotid Artery and Intravenously in Patients With Diffuse Lesions in the Brain|Withdrawn||N/A|0|Actual|Ageless Regenerative Institute||1||No participants enrolled|f||||f||||||||||2017-10-11 03:43:24.790088|2017-10-11 03:43:24.790088
NCT01453764|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-08-31|||April 2016||2016-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|December 2018|Anticipated|2018-12-01||Interventional|||Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously Into Patients With Multiple Sclerosis|Withdrawn||N/A|0|Actual|Ageless Regenerative Institute||1||company dissolved|f||||f||||||||||2017-10-11 03:43:24.873525|2017-10-11 03:43:24.873525
NCT01453751|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2016-09-19|||March 2014||2014-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes|An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously in Patients With Type II Diabetes|Recruiting||Phase 1/Phase 2|100|Anticipated|Ageless Regenerative Institute||1|||f||||f||||||||Undecided||2017-10-11 03:43:24.94589|2017-10-11 03:43:24.94589
NCT01453738|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-05-11|||November 2011||2011-11-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Allogeneic Mesenchymal Stem Cells in Osteoarthritis|A Randomized, Double Blind, Multicentric, Placebo Controlled, Phase -II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients With Osteoarthritis of Knee|Completed||Phase 2|60|Actual|Stempeutics Research Pvt Ltd||2|||f||||t||||||||||2017-10-11 03:43:25.041242|2017-10-11 03:43:25.041242
NCT01453725|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-03-10|2014-12-10||February 2012||2012-02-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|March 2014|Actual|2014-03-01||Interventional|GO-AHEAD|The Baseline Analysis Population consisted of all randomized participants.|Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects With Active Axial Spondyloarthritis (Protocol No. P07642, Also Known as MK-8259-006-02).|Completed||Phase 3|198|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:43:25.158757|2017-10-11 03:43:25.158757
NCT01453712|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2011-10-17|||October 2011||2011-10-01|October 2011|2011-10-01||||December 2012|Anticipated|2012-12-01||Interventional|PROTECTION-V||Prospective Randomized Trial On Radiation Dose Estimates Of CT Angiography In Patients Applying Iterative Image Reconstruction Techniques - The PROTECTION V Study -|Prospective Randomized Trial On Radiation Dose Estimates Of CT Angiography In Patients Applying Iterative Image Reconstruction Techniques - The PROTECTION V Study -|Unknown status|Recruiting|Phase 4|400|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 03:43:25.796331|2017-10-11 03:43:25.796331
NCT01453699|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-08-11|||September 2009||2009-09-01|August 2014|2014-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Long-term Consequences of Bereavement in Children, Adolescents and Young Adults|Bereavement in Children, Adolescents and Young Adults. - A Study of Health and Psychosocial Well-being in Adults Who Have Experienced Early Parental Death|Completed||N/A|1225660|Actual|Danish Cancer Society|||1||f||||f||||||||||2017-10-11 03:43:25.892461|2017-10-11 03:43:25.892461
NCT01453686|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2013-12-06|||August 2002||2002-08-01|December 2013|2013-12-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata|A Randomized Controlled Trial of Clobetasol Propionate 0.05% Cream Versus Hydrocortisone 1% Cream in Children With Alopecia Areata|Completed||Phase 3|41|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 03:43:26.004852|2017-10-11 03:43:26.004852
NCT01453673|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2011-10-13|||May 2011||2011-05-01|October 2011|2011-10-01|May 2013|Anticipated|2013-05-01|||||Observational|||Results of Knee Arthroscopic Surgery for Treatment of Cruciate Ligament and Meniscus|Results of Knee Arthroscopic Surgery for Treatment of Cruciate Ligament and Meniscus|Unknown status|Active, not recruiting|N/A|210|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 03:43:26.092231|2017-10-11 03:43:26.092231
NCT01453660|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-05-01|||October 2011|Actual|2011-10-01|May 2017|2017-05-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls|A Pilot Study Measuring Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls|Active, not recruiting||N/A|44|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples Without DNA|"     Blood, urine   "|||2017-10-11 03:43:26.151061|2017-10-11 03:43:26.151061
NCT01453647|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-10-13|||January 2010||2010-01-01|October 2011|2011-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study to Explore the Relationships Among Immunity and Stress and the Symptoms of Fatigue, Pain, and Mood Following Guided Imagery in Women With Fibromyalgia|Self-Efficacy, Stress, Immunity and Symptoms of Fibromyalgia|Completed||N/A|72|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 03:43:26.247574|2017-10-11 03:43:26.247574
NCT01453634|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-09-19|||January 2013||2013-01-01|September 2014|2014-09-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|2007||Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)|A Randomized, Open Label, Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis|Withdrawn||Phase 2|0|Actual|OPKO Health, Inc.||2||The company is no longer pursuing this study.|f||||f||||||||||2017-10-11 03:43:26.360306|2017-10-11 03:43:26.360306
NCT01453621|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-04-15|||November 2011||2011-11-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TBI-KT||Traumatic Brain Injury - Knowledge Translation|Implementation of the Pediatric Emergency Care Applied Research Network (PECARN) Traumatic Brain Injury Prediction Rules Using Computerized Clinical Decision Support: An Interrupted Time Series Trial|Completed||Phase 3|28669|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 03:43:26.453536|2017-10-11 03:43:26.453536
NCT01453608|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-03-17|||October 2011||2011-10-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional|CONFIRM-HF||A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency|A Randomised, Double-blind Controlled Phase 4 Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency|Completed||Phase 4|304|Actual|Vifor Inc.||2|||f||||t||||||||||2017-10-11 03:43:26.556071|2017-10-11 03:43:26.556071
NCT01453595|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2016-02-01|2015-12-14||October 2011||2011-10-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)|A Phase 1b/2 Study of BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)|Terminated||Phase 1/Phase 2|10|Actual|Memorial Sloan Kettering Cancer Center|Given the number of toxicities seen and the difficulty with patient retention in the dose escalation portion, the sponsor decided to close the trial.|1||"Given the number of toxicities seen and the difficulty with patient retention in the dose   escalation portion, the sponsor decided to close the trial."|f||||t||||||||||2017-10-11 03:43:26.660406|2017-10-11 03:43:26.660406
NCT01453582|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-05-27|||December 2011||2011-12-01|May 2012|2012-05-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|||Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris|Phase III Study of Total Flavonoids of Propolis Dropping Pill in Angina Pectoris: A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Clinical Trial on Efficacy and Safety.|Unknown status|Not yet recruiting|Phase 3|480|Anticipated|Shanghai Greenvalley Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:43:27.053552|2017-10-11 03:43:27.053552
NCT01453400|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-07-07|||September 2011||2011-09-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|Tarot||Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain|Onset of Action of a Fast Release Aspirin Tablet and Acetaminophen Caplet in Sore Throat Pain|Completed||Phase 3|177|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:43:29.254915|2017-10-11 03:43:29.254915
NCT01453569|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2015-01-25|2014-11-13||October 2011||2011-10-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||All the treated subjects were evaluated for safety. 2, 8 and 3 subjects were excluded from FAS in placebo, 600 mg and 900 mg group respectively. So the case No. were 83, 76, 83 for placebo, 600 mg and 900 mg group respectively.|Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease|Phase II Study of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer Disease|Completed||Phase 2|255|Actual|Shanghai Greenvalley Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 03:43:27.226277|2017-10-11 03:43:27.226277
NCT01453556|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2011-10-20|||October 2011||2011-10-01|October 2011|2011-10-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Intracorporeal Versus Extracorporeal Mechanical Anastomosis in Laparoscopic Right Colectomy|Intracorporeal Versus Extracorporeal Mechanical Anastomosis in Laparoscopic Right Colectomy. A Prospective Randomized Controlled Clinical Trial|Unknown status|Recruiting|N/A|158|Anticipated|Scientific Institute San Raffaele||2|||f||||t||||||||||2017-10-11 03:43:27.711298|2017-10-11 03:43:27.711298
NCT01453543|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-11-07|||November 2010||2010-11-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|Friction||The Effect of Deep Friction Massage on the Achilles Tendon Blood Flow|The Effect of Deep Friction Massage on the Achilles Tendon Blood Flow|Completed||N/A|62|Actual|University Ghent||1|||f||||f||||||||||2017-10-11 03:43:27.789284|2017-10-11 03:43:27.789284
NCT01453517|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2011-10-13|||September 2010||2010-09-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Psychological and Behavioral Intervention for Post-Bariatric Patients|Dialectical Behavior Therapy (DBT) for Post-Bariatric Patients Experiencing Weight Regain|Completed||N/A|26|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 03:43:27.935761|2017-10-11 03:43:27.935761
NCT01453504|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-17|2017-05-10|||August 2012||2012-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|HD-R3i||Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma|A Prospective, Randomized, Placebo-controlled, Multicenter, International Phase I/II Trial of RAD001 (Everolimus) in Combination With DHAP as Induction Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL)|Recruiting||Phase 1/Phase 2|125|Anticipated|University of Cologne||2|||f||||||||||||||2017-10-11 03:43:28.008513|2017-10-11 03:43:28.008513
NCT01453491|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-05-31|||February 13, 2012|Actual|2012-02-13|May 2017|2017-05-01|March 18, 2013|Actual|2013-03-18|March 18, 2013|Actual|2013-03-18||Interventional|||A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis|A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis|Completed||Phase 1|17|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:43:28.1128|2017-10-11 03:43:28.1128
NCT01453478|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-06-09|||October 12, 2011|Actual|2011-10-12|June 2017|2017-06-01|December 19, 2011|Actual|2011-12-19|December 19, 2011|Actual|2011-12-19||Interventional|||A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced|A Single Centre, 5-Period, Randomized Study To Evaluate The Relative Bioavailability Of An Immediate Release Tablet Formulation And Prototype Bioenhanced Formulations Of GSK1325756 In Healthy Elderly Subjects During Suppression Of Gastric Acid Secretion|Completed||Phase 1|20|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:43:28.257742|2017-10-11 03:43:28.257742
NCT01453465|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-01|2016-02-19|||September 2011||2011-09-01|February 2016|2016-02-01||||January 2100|Anticipated|2100-01-01||Observational|||Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor|Gene Expression (GE) and MicroRNA (MIRNA) Expression Profiles of Malignant Rhabdoid Tumors (MRT) of the Kidney (RTK) and Atypical Teratoid Rhabdoid Tumor (ATRT|Withdrawn||N/A|0|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:43:28.539962|2017-10-11 03:43:28.539962
NCT01453452|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-14|2016-11-04|||March 2012||2012-03-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|August 2015|Actual|2015-08-01||Interventional|||S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors|S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II|Active, not recruiting||Phase 2|50|Anticipated|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 03:43:28.641094|2017-10-11 03:43:28.641094
NCT01453439|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-03-15|||August 2011||2011-08-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder|CBT Versus Supportive Psychotherapy for Body Dysmorphic Disorder|Recruiting||N/A|120|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:43:28.863712|2017-10-11 03:43:28.863712
NCT01453426|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2013-09-12|||January 2012||2012-01-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|109HV108||Phase 1 Study to Evaluate the PK, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Healthy Volunteers|An Open-Label, Parallel-Group, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Adult Healthy Volunteers|Completed||Phase 1|71|Actual|Biogen||6|||f||||f||||||||||2017-10-11 03:43:28.982982|2017-10-11 03:43:28.982982
NCT01453413|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-02-21|2012-11-12||October 2011||2011-10-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Blood Glucose Testing and You|Blood Glucose Testing and You|Completed||N/A|297|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 03:43:29.079526|2017-10-11 03:43:29.079526
NCT00000201|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11||||||October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||Pharmacological Modulation of Cocaine Effects - 1|Pharmacological Modulation of Cocaine Effects|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:38.643938|2017-10-11 04:17:38.643938
NCT01453387|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-03-27|2016-04-08||September 2011||2011-09-01|March 2017|2017-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Safety analysis set included all subjects who received at least one administration of the trial medication.|MSC2015103B in Solid Tumors|A Phase I Dose-Escalation First-In-Human Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral MEK Inhibitor MSC2015103B Administered With Two Different Treatment Schedules in Subjects With Advanced Solid Tumors|Terminated||Phase 1|28|Actual|EMD Serono|The study was terminated early during Part 1 of the trial due to administrative reason. Pharmacodynamics evaluations were not performed due to early termination.|2||Due to an administrative reason|f||||f||||||||||2017-10-11 03:43:29.376489|2017-10-11 03:43:29.376489
NCT01453374|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-06-19|2015-05-21||January 2011||2011-01-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||All subjects who received at least 1 injection of VIVITROL|A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration|A Phase 4, Pilot, Open-label Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration|Completed||Phase 4|27|Actual|Alkermes, Inc.|The outcome measure of opioid dependence was not analyzed.|1|||f||||f||||||||||2017-10-11 03:43:32.292194|2017-10-11 03:43:32.292194
NCT01453361|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-07-28|||October 2011||2011-10-01|July 2017|2017-07-01|March 22, 2016|Actual|2016-03-22|March 22, 2016|Actual|2016-03-22||Interventional|||Phase II FANG™ in Advanced Melanoma|Phase II Trial of FANG™ Autologous Tumor Cell Vaccine in Advanced Melanoma|Terminated||Phase 2|18|Actual|Gradalis, Inc.||1||Business Decision to pursue other indications|f||||t||||||||||2017-10-11 03:43:32.720565|2017-10-11 03:43:32.720565
NCT01453335|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-12-21|||June 2011||2011-06-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Observational|||Percentage Venous Options in Pediatrics & Adults|Utilizing a Near Infrared Vein Visualization Device To Increase Peripheral Intravenous Access Targets in Pediatric & Adult Patients (% Venous Options)|Completed||N/A|300|Actual|Christie Medical Holdings, Inc.|||1||f||||f||||||||||2017-10-11 03:43:33.445333|2017-10-11 03:43:33.445333
NCT01453322|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-10-17|||September 2011||2011-09-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Video Documentation of Localized Complications|Video Documentation of Localized Complications in IV Cannulation Using Near-Infrared Technology|Completed||N/A|10|Actual|Christie Medical Holdings, Inc.|||1||f||||f||||||||||2017-10-11 03:43:33.524181|2017-10-11 03:43:33.524181
NCT01453309|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-14|||October 2011||2011-10-01|October 2011|2011-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Cost Effectiveness and Clinical Utility of Cell Saver Use for Two to Three Level Lumbar Fusions|Cost Effectiveness and Clinical Utility of Cell Saver Use for Two to Three Level Lumbar Fusions|Unknown status|Not yet recruiting|N/A|240|Anticipated|Norton Leatherman Spine Center||2|||f||||f||||||||||2017-10-11 03:43:33.59619|2017-10-11 03:43:33.59619
NCT01453296|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-11-29|2013-06-06|2012-07-26|August 2010||2010-08-01|November 2016|2016-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects|A Randomized, Double-blind, Placebo-controlled, Two-way Crossover 7-day Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Repeat Dose Inhaled GW642444 25 μg (Micrograms) in Children Aged 5-11 Years With Persistent Asthma.|Completed||Phase 2|28|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:43:33.806504|2017-10-11 03:43:33.806504
NCT01453283|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-01|2017-06-30|||December 20, 2006||2006-12-20|April 4, 2012|2012-04-04|October 11, 2011|Actual|2011-10-11|October 11, 2011|Actual|2011-10-11||Interventional|||Tabectedin to Treat Children and Adolescents With Cancer|A Phase I Trial and Pharmacokinetic Study of Trabectedin (YONDELIS [R], ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors|Completed||Phase 1|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:43:35.29927|2017-10-11 03:43:35.29927
NCT01453270|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2014-09-23|||November 2011||2011-11-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|AGONIST||Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial|Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial|Completed||N/A|122|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 03:43:35.380116|2017-10-11 03:43:35.380116
NCT01453257|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2011-10-18|||October 2009||2009-10-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|TT||Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients|A Phase 2 Study of Target-Guided Personalized Chemotherapy in Metastatic Colorectal Cancer Patients|Completed||Phase 2|72|Actual|Grupo Hospital de Madrid||1|||f||||f||||||||||2017-10-11 03:43:35.473927|2017-10-11 03:43:35.473927
NCT01453244|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2013-05-30|||July 2011||2011-07-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Pharmacogenomic Research in Korean Patients With Hepatitis C|Pharmacogenomic Research for Prediction of Drug Response in Korean Patients With Hepatitis C|Completed||N/A|373|Actual|Inje University|||2||f||||f||||||Samples With DNA|"     DNA extracted from blood   "|||2017-10-11 03:43:35.567053|2017-10-11 03:43:35.567053
NCT01453231|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2013-05-27|||March 2009||2009-03-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Quality of Life and Body Image in Women Underwent Thighplasty|Quality of Life and Body Image in Women Underwent Thighplasty|Completed||Phase 1|30|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:43:35.63818|2017-10-11 03:43:35.63818
NCT01453218|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-03-28|||October 2011||2011-10-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|ATG_HVH||Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction|Single Centre, Prospective, Open, Non Controlled, Pilot Study for Efficacy and Security Evaluation of Low Nephrotoxicity Immunosuppression, Based on the Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction|Recruiting||Phase 3|30|Anticipated|Hospital Vall d'Hebron||2|||f||||f||||||||||2017-10-11 03:43:35.714162|2017-10-11 03:43:35.714162
NCT01453205|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-06-29||2017-06-29|February 27, 2012|Actual|2012-02-27|June 2017|2017-06-01|July 11, 2016|Actual|2016-07-11|July 11, 2016|Actual|2016-07-11||Interventional|||A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|A Phase 2 Randomized Open-label Study of MEDI-551 in Adults With Relapsed or Refractory DLBCL|Completed||Phase 2|187|Actual|MedImmune LLC||3|||f||||t|t|f||||||||2017-10-11 03:43:35.842534|2017-10-11 03:43:35.842534
NCT01453192|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2016-07-11|||December 2011||2011-12-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|ANRS153TREVE||Renal Transplantation and Raltegravir in HIV-Infected Patients|National, Multicenter, Phase III Prospective Trial About Clinical and Immunological Follow-up After Renal Transplantation in HIV-1 Infected Patients With End Stage Chronic Renal Insufficiency|Completed||Phase 3|27|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 03:43:36.168386|2017-10-11 03:43:36.168386
NCT01453179|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-04-13|||October 2011||2011-10-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|LEIDA 2||Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)|Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp With Respect to the Risk of Progression to In-situ and Invasive Squamous Cell Carcinoma|Completed||Phase 4|221|Actual|MEDA Pharma GmbH & Co. KG||2|||f||||f||||||||||2017-10-11 03:43:36.335347|2017-10-11 03:43:36.335347
NCT01453166|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2012-07-16|2012-03-15||September 2011||2011-09-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Brazilian Heart-Prevent Meal - A Pilot Randomized Clinical Trial|The Effect of Brazilian Heart Prevent Meal Program Accessible for the Population to Prevent New Cardiovascular Events: A Pilot Randomized Clinical Trial|Completed||N/A|122|Actual|Hospital do Coracao|Small numbers of subjects analyzed, We did not evaluate the patient’s adherence to food intake, The high purchasing power of patients, Randomization with opaque envelope technique, Low statistical power.|3|||f||||t||||||||||2017-10-11 03:43:36.532222|2017-10-11 03:43:36.532222
NCT01453153|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-10-12|||September 2011||2011-09-01|September 2013|2013-09-01|May 2015|Actual|2015-05-01|February 2014|Actual|2014-02-01||Interventional|||Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer|A Phase 1b/2 Multicenter, International, Randomized, Double Blind, Placebo-Controlled, Study of Gemcitabine Combined With PEGPH20 Compared to Gemcitabine Combined With Placebo in Patients With Stage IV Previously Untreated Pancreatic Cancer|Completed||Phase 1/Phase 2|28|Actual|Halozyme Therapeutics||2|||f||||f||||||||||2017-10-11 03:43:37.033255|2017-10-11 03:43:37.033255
NCT01453127|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-03-21|||October 2011||2011-10-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||DaTSCAN Imaging in Aging and Neurodegenerative Disease|DaTSCAN Imaging in Aging and Neurodegenerative Disease|Enrolling by invitation||Phase 4|130|Anticipated|Mayo Clinic||8|||f||||f||||||||||2017-10-11 03:43:37.236198|2017-10-11 03:43:37.236198
NCT01453114|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-04-06|||November 2008||2008-11-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Cognitive-Behavioral Therapy (CBT) in Women Discontinuing Antidepressant for Pregnancy|Cognitive-Behavioral Therapy in Women Discontinuing Antidepressant for Pregnancy|Completed||N/A|15|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:43:37.325695|2017-10-11 03:43:37.325695
NCT01453101|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2017-06-14|||June 9, 2010|Actual|2010-06-09|June 2017|2017-06-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|Flu-Mel-Vel||Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma|A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Using a Conditioning Regimen of Fludarabine, Melphalan, and Bortezomib|Active, not recruiting||Phase 2|55|Actual|Hackensack University Medical Center||1|||f||||t||||||||||2017-10-11 03:43:37.398899|2017-10-11 03:43:37.398899
NCT01453088|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-08-08|||June 24, 2010|Actual|2010-06-24|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older|(PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older|Recruiting||Phase 2|208|Anticipated|Hackensack University Medical Center||2|||f||||t||||||||||2017-10-11 03:43:37.481905|2017-10-11 03:43:37.481905
NCT01453075|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-09-30|2016-06-13||November 2011||2011-11-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)|Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and Herpes Simplex Virus 2 (HSV-2) Infection (Phase I)|Completed||Phase 1|31|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 03:43:37.626051|2017-10-11 03:43:37.626051
NCT01453062|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2014-07-03|||September 2011||2011-09-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Phase IV Observational Study in Chronic Lymphocytic Leukemia|Phase IV Observational Study in Chronic Lymphocytic Leukemia Patients Receiving Ofatumumab in the European Union|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:43:37.950304|2017-10-11 03:43:37.950304
NCT01453049|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-03-22|2011-10-27||April 2010||2010-04-01|December 2011|2011-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients|A Multi-center, Randomized, Double-blind, Parallel-group Study to Compare the Efficacy and Safety of Fixed-dose Rosiglitazone/Glimepiride Combination Therapy With Glimepiride Monotherapy for 24 Weeks in Drug Naive Subjects With Type 2 Diabetes|Terminated||Phase 3|86|Actual|GlaxoSmithKline||2||US FDA/EMA/SFDA decisions to rosiglitazone-containing medicines, ethic|f||||f||||||||||2017-10-11 03:43:38.086809|2017-10-11 03:43:38.086809
NCT01453036|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2013-07-31|2012-06-07||August 2011||2011-08-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Clarithromycin Resistant Tailored Therapy|Eradication of Helicobacter Pylori According to 23S rRNA Point Mutations Associated With Clarithromycin Resistance|Completed||Phase 4|924|Actual|The Catholic University of Korea||3|||f||||t||||||||||2017-10-11 03:43:39.298971|2017-10-11 03:43:39.298971
NCT01453023|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-11-20|2013-06-06||October 2011||2011-10-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study|A Randomized, Double-blind, Repeat Dose, Two Period Crossover Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Inhaled Fluticasone Furoate/Vilanterol 100/25 Micrograms in Children Aged 5 to 11 Years With Persistent Asthma|Completed||Phase 2|26|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:43:39.771091|2017-10-11 03:43:39.771091
NCT01452997|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-03-30|||November 2012||2012-11-01|March 2013|2013-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Evaluation of Anti-inflammatories in the Reduction of Bite Reactions|Evaluation of Topical Ibuprofen and Steroid in the Reduction of Local Reactions and Symptoms From an Aedes Aegypti Mosquito Bite|Completed||Phase 4|40|Actual|London School of Hygiene and Tropical Medicine||4|||f||||f||||||||||2017-10-11 03:43:41.680582|2017-10-11 03:43:41.680582
NCT01452984|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-03-18|||July 2011||2011-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project|Experience of Patients With Non-Melanoma Skin Cancer of the Head and Neck Undergoing Mohs Surgery|Completed||N/A|16|Actual|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-11 03:43:41.785459|2017-10-11 03:43:41.785459
NCT01452971|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2011-10-14|||October 2011||2011-10-01|October 2011|2011-10-01||||||||Observational|||A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer|A Study of the Interaction Between Tumor Susceptibility Gene GNMT and Lung Cancer|Unknown status|Not yet recruiting|N/A|200|Anticipated|China Medical University Hospital|||1||f||||t||||||||||2017-10-11 03:43:41.869384|2017-10-11 03:43:41.869384
NCT01452958|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2013-01-29|||June 2010||2010-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Endotoxin & Cytokines. Do Protein Loss and Metabolic Effects Depend on Central Nervous System (CNS) Activation of Stress Hormones or on Local Mechanisms in Muscle and Fat?|Endotoxin & Cytokines. Do Protein Loss and Metabolic Effects Depend on CNS Activation of Stress Hormones or on Local Mechanisms in Muscle and Fat?|Completed||N/A|24|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-10-11 03:43:41.923773|2017-10-11 03:43:41.923773
NCT01452945|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2015-05-19|||October 2012||2012-10-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department (ED) With Wheezing|Prospective Observational Study Evaluating the Use of Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department With Wheezing|Completed||N/A|30|Actual|Children's Research Institute|||1||f||||f||||||||||2017-10-11 03:43:42.026381|2017-10-11 03:43:42.026381
NCT01452932|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-13|2012-06-22|||June 2010||2010-06-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Muscle Training Effectiveness in the Degree of Dyspnea and Aerobic Capacity in COPD|Muscle Training Effectiveness in the Degree of Dyspnea and Aerobic Capacity in COPD in an Institution Health Service Provider in the Department of Antioquia|Unknown status|Active, not recruiting|Phase 1/Phase 2|44|Actual|CES University||2|||f||||f||||||||||2017-10-11 03:43:42.28885|2017-10-11 03:43:42.28885
NCT01452919|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-01-11||2013-01-11|November 2011||2011-11-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Physical Dependence Study in Schizophrenia|A Phase 3, Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of LY2140023 Monohydrate in Patients With DSM-IV-TR Schizophrenia|Completed||Phase 3|150|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:43:42.412098|2017-10-11 03:43:42.412098
NCT01452906|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-12-08|||September 2011||2011-09-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Drug-Drug Interaction Study of Omeprazole and PA21|A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Omeprazole in Healthy Male and Female Adults|Completed||Phase 1|45|Actual|Vifor Inc.||3|||f||||f||||||||||2017-10-11 03:43:42.556957|2017-10-11 03:43:42.556957
NCT01452893|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-01-03|||March 2011||2011-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|May 2012|Actual|2012-05-01||Observational|CANDI||Counterregulatory Hormone Production in Adrenal Insufficiency and Diabetes Type I|Counterregulatory Hormone Production and Cognitive Function in Patients With Adrenal Insufficiency and Diabetes Mellitus Type I|Completed||N/A|40|Actual|University of Wuerzburg|||4||f||||f||||||Samples Without DNA|"     blood samples for hormonal analysis   "|||2017-10-11 03:43:42.656817|2017-10-11 03:43:42.656817
NCT01452880|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-12|||January 2010||2010-01-01|October 2011|2011-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|ESWL||Remifentanil in Extracorporeal Shock Wave Lithotripsy|Total Intravenous Anaesthesia Using Remifentanil In Extracorporeal Shock Wave Lithotripsy (ESWL). Comparison of Two Dosages.|Completed||Phase 4|228|Actual|University of Roma La Sapienza||1|||f||||t||||||||||2017-10-11 03:43:42.778025|2017-10-11 03:43:42.778025
NCT01452867|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-10-14|||April 2011||2011-04-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Comparison of Ventilation With Bag-Valve-Mask, Laryngeal Tube S-D and Laryngeal Mask Airway Supreme|Comparison of Ventilation With Bag-Valve-Mask, Laryngeal Tube S-D and Laryngeal Mask Airway Supreme|Completed||N/A|150|Anticipated|Krankenhaus Bruneck||3|||f||||t||||||||||2017-10-11 03:43:42.875011|2017-10-11 03:43:42.875011
NCT01452503|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-05-23|||May 2007||2007-05-01|May 2016|2016-05-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6|Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6|Completed||N/A|170|Actual|FHI 360||3|||f||||f||||||||No||2017-10-11 03:43:48.092841|2017-10-11 03:43:48.092841
NCT01452854|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2014-08-13|2014-06-10||October 2011||2011-10-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|OVA-LGG|Low recruitment necessitated the closing of the study. No results available.|Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide|Ovarian Aging in Women Newly Diagnosed With Low Grade Glioma Treated With Temozolomide (Temodar®)|Terminated||N/A|2|Actual|University of California, San Francisco|||1|Low recruitment, sponsor withdrew funding.|f||||t||||||||||2017-10-11 03:43:42.977548|2017-10-11 03:43:42.977548
NCT01452841|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-10-14|||August 2009||2009-08-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Grapefruit Feeding Trial in Healthy, Overweight Adults|Efficiency of Daily Grapefruit Exposure in Reducing Body Weight and Inflammatory Markers|Completed||N/A|85|Actual|University of Arizona||2|||f||||t||||||||||2017-10-11 03:43:43.161772|2017-10-11 03:43:43.161772
NCT01452828|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-05-02|||October 2011||2011-10-01|May 2016|2016-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Pharmacokinetics and Safety Study in Subjects With Renal Impairment|A Phase I Open-Label Study With 200 mg Intravenous TR-701 Free Acid to Assess Safety and Pharmacokinetics in Advanced Renal Impairment Subjects|Completed||Phase 1|24|Actual|Trius Therapeutics LLC||3|||f||||f||||||||||2017-10-11 03:43:43.251967|2017-10-11 03:43:43.251967
NCT01452815|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-04-24|||September 2011||2011-09-01|August 2012|2012-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of Once-Daily Administrations of TZP-102 for the Treatment of Symptoms Associated With Diabetic Gastroparesis|Completed||Phase 2|201|Actual|Tranzyme, Inc.||3|||f||||f||||||||||2017-10-11 03:43:43.372314|2017-10-11 03:43:43.372314
NCT01452802|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2016-06-10|||October 2011||2011-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|March 2016|Actual|2016-03-01||Observational|ROADMAP||Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management|Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients|Completed||N/A|200|Actual|St. Jude Medical|||2||f||||f||||||||||2017-10-11 03:43:43.583483|2017-10-11 03:43:43.583483
NCT01452789|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-02-03|||November 2011||2011-11-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome|A Randomized, Active-Control, Double-Blind, Double-Dummy Clinical Trial Comparing Sublingual Buprenorphine And Morphine Solution For The Treatment Of Neonatal Opioid Abstinence Syndrome|Completed||Phase 3|62|Actual|Thomas Jefferson University||2|||f||||t||||||||Yes||2017-10-11 03:43:43.790801|2017-10-11 03:43:43.790801
NCT01452776|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2013-11-02|||September 2011||2011-09-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis|A Phase 3, Randomized, Single-Blind, Multicenter Study to Evaluate the Safety of TAK-438 (10 and 20 mg Once-daily) in a 52-week Maintenance Treatment in Patients With Healed Erosive Esophagitis (EE)|Completed||Phase 3|305|Actual|Takeda||2|||f||||f||||||||||2017-10-11 03:43:43.887953|2017-10-11 03:43:43.887953
NCT01452763|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-01-17|||October 2011||2011-10-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin|A Phase 3, Multicenter, Randomized, Double-blind, AG-1749-controlled, Parallel-group, Comparison Study to Evaluate the Efficacy and Safety of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Low-dose Aspirin|Completed||Phase 3|621|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:43:44.046833|2017-10-11 03:43:44.046833
NCT01452750|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-02-04|||October 2011||2011-10-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)|A Phase 3, Multicenter, Randomized, Double-blind, AG-1749-controlled, Parallel-group, Comparison Study to Evaluate the Efficacy and Safety of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Non-steroidal Anti-inflammatory Drug (NSAID).|Completed||Phase 3|642|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:43:44.527007|2017-10-11 03:43:44.527007
NCT01452737|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-09-17|||November 2011||2011-11-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Comparing 4L Golytely to 2L Golytely With 15mg Bisacodyl Regimens for Inpatient Colonic Preparation|2L Golytely and Oral Bisacodyl 15 mg Versus 4L Golytely Regimen for Inpatient Colonoscopy Bowel Preparation: A Randomized, Non-Inferiority Open Trial|Withdrawn||N/A|0|Actual|University of British Columbia||2|||f||||||||||||||2017-10-11 03:43:44.778159|2017-10-11 03:43:44.778159
NCT01452724|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2013-08-19|||October 2011||2011-10-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer|A Phase 3, Randomized, Double Blind, Double-Dummy, Multicenter, Parallel Group Comparison Study to on Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Comparing With AG-1749 in Patients With Duodenal Ulcer|Completed||Phase 3|372|Actual|Takeda||2|||f||||f||||||||||2017-10-11 03:43:44.926302|2017-10-11 03:43:44.926302
NCT01452711|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2013-06-19|||November 2011||2011-11-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer|A Phase 3, Randomized, Double Blind, Double-Dummy, Multicenter, Parallel Group Comparison Study to on Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Comparing With AG-1749 in Patients With Gastric Ulcer.|Completed||Phase 3|482|Actual|Takeda||2|||f||||f||||||||||2017-10-11 03:43:45.157522|2017-10-11 03:43:45.157522
NCT01452698|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2012-11-07||||||November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis|A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of TAK-438 (20 mg Once-Daily) Compared to AG-1749 (30mg Once-Daily) in Patients With Erosive Esophagitis|Completed||Phase 3|409|Actual|Takeda||2|||f||||f||||||||||2017-10-11 03:43:45.38521|2017-10-11 03:43:45.38521
NCT00000202|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2013-07-24|||August 1988||1988-08-01|December 2002|2002-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Buprenorphine Maintenance for Opioid Addicts - 1|Buprenorphine Maintenance for Opioid Addicts|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-10-11 04:17:38.711925|2017-10-11 04:17:38.711925
NCT01452685|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-05-07|||March 2012||2012-03-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis|A Phase II, Multicenter, Long-term Extension Study to Compare the Safety and Efficacy of TAK-385 (10, 20, and 40 mg) Following Oral Administration for 12 Weeks or More in the Treatment of Endometriosis|Completed||Phase 2|397|Actual|Takeda||5|||f||||f||||||||||2017-10-11 03:43:45.541367|2017-10-11 03:43:45.541367
NCT01452672|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-14|||March 2007||2007-03-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer|Resource-sparing Radiotherapy for Breast Cancer|Unknown status|Recruiting|Phase 3|600|Anticipated|International Atomic Energy Agency||2|||f||||t||||||||||2017-10-11 03:43:45.785299|2017-10-11 03:43:45.785299
NCT01452659|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2013-01-17|||October 2011||2011-10-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids|A Phase II, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of TAK-385 10, 20, and 40 mg (p.o.) in the Treatment of Uterine Fibroids|Completed||Phase 2|216|Actual|Takeda||4|||f||||f||||||||||2017-10-11 03:43:45.939299|2017-10-11 03:43:45.939299
NCT01452633|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-06-06|||November 2011||2011-11-01|June 2013|2013-06-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Study to Compare Reduction in Pain After Surgery With and Without Local Anesthesia During Laparoscopy|Effect of Preincisional Local Analgesia on Post-Operative Pain in 10-12mm Lateral Port Sites|Unknown status|Recruiting|N/A|100|Anticipated|Stony Brook University||4|||f||||f||||||||||2017-10-11 03:43:46.358034|2017-10-11 03:43:46.358034
NCT01452620|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2011-10-14|||January 2011||2011-01-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|EVAR||Endovascular Abdominal Aortic Aneurysm Repair by Interventional Cardiologists||Completed||N/A|170|Actual|St. Joseph Mercy Oakland Hospital|||1||f||||||||||||||2017-10-11 03:43:46.463274|2017-10-11 03:43:46.463274
NCT01452607|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-06-27|||May 2006||2006-05-01|June 2016|2016-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study to Evaluate the Safety and Pharmacokinetics of SPI-1005|A Phase 1, Double-blind, Placebo-controled, Randomized Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SPI-1005 (Ebselen)in Healthy Adult Subjects|Completed||Phase 1|32|Actual|Sound Pharmaceuticals, Incorporated||5|||f||||t||||||||Undecided||2017-10-11 03:43:46.533099|2017-10-11 03:43:46.533099
NCT01452594|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-09-04|||October 2011||2011-10-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Analysis of Diphenylcyclopropenone (DPCP) in Normals|Analysis of Immune Reactions Occurring in Normal Volunteers Upon Administration of the Topical Immunomodulator Diphenylcyclopropenone|Completed||N/A|30|Anticipated|Rockefeller University|||1||f||||f||||||Samples With DNA|"     Skin Biopsy   "|||2017-10-11 03:43:46.618489|2017-10-11 03:43:46.618489
NCT01452581|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2015-03-05|||October 2011||2011-10-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty|Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty|Terminated||N/A|5|Actual|Rigshospitalet, Denmark||2||Lack of enrollment|f||||f||||||||||2017-10-11 03:43:46.702175|2017-10-11 03:43:46.702175
NCT01452568|ClinicalTrials.gov processed this data on October 10, 2017|2009-09-22|2014-08-04|||June 2005||2005-06-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin|Early Anticoagulation Therapy After Bioprosthetic Aortic Valve Implantation: Comparing Warfarin Versus Aspirin|Completed||Phase 4|370|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 03:43:46.787844|2017-10-11 03:43:46.787844
NCT01452555|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-12|||August 2011||2011-08-01|August 2011|2011-08-01||||||||Interventional|||Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos|Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos|Unknown status|Recruiting|Phase 3|200|Anticipated|Rhode Island Hospital||2|||f||||||||||||||2017-10-11 03:43:46.877765|2017-10-11 03:43:46.877765
NCT01452542|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-03-19|||October 2011||2011-10-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects|A Pilot, Phase 1, Single-site, Single-dose, Randomized, Open-label, Two-treatment, Two-sequence, Four-period Replicated Crossover Study Evaluating the Within-subject Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects.|Completed||Phase 1|22|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:43:46.97278|2017-10-11 03:43:46.97278
NCT01452529|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2015-08-27|2014-12-01||October 2011||2011-10-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain|A Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open-label Run-in to Assess the Efficacy and Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects With Moderate to Severe Chronic Low Back Pain|Completed||Phase 3|905|Actual|Purdue Pharma LP||2|||f||||t||||||||||2017-10-11 03:43:47.088238|2017-10-11 03:43:47.088238
NCT01452490|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-03-25|||October 2011||2011-10-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Diode Laser Treatment of Onychomycosis|Study of the V-Raser Diode Laser System in the Treatment of Onychomycosis|Completed||N/A|50|Actual|Cynosure, Inc.||1|||f||||f||||||||||2017-10-11 03:43:48.218047|2017-10-11 03:43:48.218047
NCT01452477|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-09-03|||October 2011||2011-10-01|September 2013|2013-09-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Interventional|||Tanshinone in Polycystic Ovary Syndrome|Effect of Tanshinone on Hormonal and Metabolic Features in Women With Polycystic Ovary Syndrome (PCOS)|Unknown status|Recruiting|N/A|100|Anticipated|Heilongjiang University of Chinese Medicine||2|||f||||t||||||||||2017-10-11 03:43:48.335656|2017-10-11 03:43:48.335656
NCT01452464|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-02-25|||September 2011||2011-09-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Safety of MenACWY-CRM Vaccination in Adolescents|A Phase IV Study to Assess the Safety of Menveo Vaccine Being Used by HMO Subjects Aged 11-21 Years of Age|Completed||N/A|55397|Actual|Novartis|||1||f||||||||||||||2017-10-11 03:43:48.467777|2017-10-11 03:43:48.467777
NCT01452451|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-08-08||2016-08-08|December 2011||2011-12-01|August 2016|2016-08-01||||June 2013|Actual|2013-06-01||Interventional|||Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus|A Double-Masked, Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 2 Study to Determine the Tolerability, Pharmacokinetics, and Pharmacodynamics of the GLP 1 Agonist HM11260C in Adult Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy|Completed||Phase 2|72|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||t||||||||||2017-10-11 03:43:48.59615|2017-10-11 03:43:48.59615
NCT01452438|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-08-05|||September 2011||2011-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Safety Surveillance of MenACWY-CRM Vaccine in Children|Post-licensure Observational Safety Surveillance Study of Quadrivalent Meningococcal ACWY Conjugate Vaccine MenACWY-CRM (Menveo) Vaccination in Children 2 Through 10 Years of Age|Completed||N/A|393|Actual|Novartis|||1||f||||||||||||||2017-10-11 03:43:48.717893|2017-10-11 03:43:48.717893
NCT01452425|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-12-15|2014-12-01||October 2011||2011-10-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome|In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome.|Completed||Phase 1|10|Actual|Université Catholique de Louvain||1|||f||||t||||||||||2017-10-11 03:43:48.825956|2017-10-11 03:43:48.825956
NCT01452412|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2016-04-28|||October 2011||2011-10-01|April 2016|2016-04-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Alkali Therapy in Chronic Kidney Disease|Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease|Recruiting||Phase 2/Phase 3|150|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 03:43:49.066214|2017-10-11 03:43:49.066214
NCT01452399|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-09-01|||October 2011||2011-10-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|August 2014|Actual|2014-08-01||Interventional|||A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients|A Randomized Controlled Trial of Routine Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients|Active, not recruiting||N/A|251|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:43:49.199237|2017-10-11 03:43:49.199237
NCT01452386|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-11-06|||June 2011||2011-06-01|November 2016|2016-11-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Modified Functional Magnetic Stimulation Treatment for Constipation Improvement|Modified Functional Magnetic Stimulation Treatment for Constipation Improvement|Withdrawn||N/A|0|Actual|Taipei Medical University WanFang Hospital|||2|no sufficient subjects|f||||f||||||||||2017-10-11 03:43:49.305891|2017-10-11 03:43:49.305891
NCT01452373|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2013-12-10|||October 2011||2011-10-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women|DHEA + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women (Placebo Controlled, Double Blind and Randomized Phase III Study to Evaluate the Effects of 12-Week Treatment With DHEA (Prasterone) and Acolbifene on Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women)|Completed||Phase 3|238|Actual|EndoCeutics Inc.||2|||f||||f||||||||||2017-10-11 03:43:49.396017|2017-10-11 03:43:49.396017
NCT01452360|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-11|||May 2011||2011-05-01|October 2011|2011-10-01|May 2014|Anticipated|2014-05-01|||||Observational|||A Research Proposal to Set up an Integrated National Data Bank and Monitoring System and to Establish the Indicators and Risk Factors for Chronic Kidney Disease|A Research Proposal to Set up an Integrated National Data Bank and Monitoring System and to Establish the Indicators and Risk Factors for Chronic Kidney Disease|Unknown status|Active, not recruiting|N/A|700|Anticipated|Taipei Medical University WanFang Hospital|||3||f||||f||||||||||2017-10-11 03:43:49.536865|2017-10-11 03:43:49.536865
NCT01452347|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-07-11|2014-05-23||October 2011||2011-10-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|RE-ALIGN|Treated Set (TRT): The set of patients who received at least 1 dose of study medication|Dabigatran Etexilate in Patients With Mechanical Heart Valves|A Randomised, Phase II Study to Evaluate the sAfety and Pharmacokinetics of oraL dabIGatran Etexilate in Patients After Heart Valve replacemeNt|Terminated||Phase 2|328|Actual|Boehringer Ingelheim|This study was terminated prematurely due to safety concerns arising during conduct of the trial.|2|||f||||||||||||||2017-10-11 03:43:49.640512|2017-10-11 03:43:49.640512
NCT01452334|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2012-02-22|||November 2011||2011-11-01|February 2012|2012-02-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy|A Phase I Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Immunoregulatory Activity, and Preliminary Antitumor Activity of Anti-Programmed-Death-Ligand 1 (PD-L1) Antibody (BMS-936559) in Subjects With Relapsed or Refractory Hematologic Malignancy|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 03:43:50.23185|2017-10-11 03:43:50.23185
NCT01452321|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-22|2011-10-10|||August 2007||2007-08-01|October 2011|2011-10-01|September 2009|Actual|2009-09-01|July 2008|Actual|2008-07-01||Interventional|rTMSPPD||Repetitive Transcranial Magnetic Stimulation in Postpartum Depression|Repetitive Transcranial Magnetic Stimulation Effects on Clinical, Cognitive and Social Performance in Postpartum Depression|Completed||Phase 2|14|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 03:43:50.312098|2017-10-11 03:43:50.312098
NCT01452308|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-01-02||2013-11-27|November 2011||2011-11-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Interventional|||Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis|A Phase 2a, Pilot, Open-Label Trial Evaluating the Safety, Tolerability and Pharmacodynamic Effects of GS-6624 in Subjects With Fibrosis of the Liver|Completed||Phase 2|20|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 03:43:50.395847|2017-10-11 03:43:50.395847
NCT01452295|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-12-03|||June 2010||2010-06-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion|Registry Protocol for Tracking the Incidence of Transplant, the Incidence and Type of Cancer, and Survival Rate of Subjects Participating in Protocol VTI-206 (NCT00973817)|Withdrawn||Phase 2/Phase 3|0|Actual|Vital Therapies, Inc.||2||"Subjects from lead-in study VTI-206 - NCT00973817 lost to follow-up before enrollment in   VTI-207 (NCT1452295)"|f||||f||||||||||2017-10-11 03:43:50.590995|2017-10-11 03:43:50.590995
NCT01452282|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-08|2013-11-09|||October 2011||2011-10-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|ABRACOS||Ankle-Brachial Index Estimating Cardiac Complications After Surgery|Ankle-Brachial Index Estimating Cardiac Complications After Non-Cardiac Surgery|Completed||N/A|196|Actual|University of Sao Paulo|||1||f||||f||||||Samples Without DNA|"     Whole blood samples will be retained for future exams.   "|||2017-10-11 03:43:50.676042|2017-10-11 03:43:50.676042
NCT01452269|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-06-16|2015-06-16||October 2011||2011-10-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|DWW||Study of a Healthy Lifestyle Intervention for Deaf Adults Who Are Overweight or Obese|Deaf Weight Wise: A Healthy Lifestyle Intervention for Deaf Adults|Completed||N/A|104|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 03:43:50.74838|2017-10-11 03:43:50.74838
NCT01452256|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2016-02-16|||December 2011||2011-12-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Desflurane and Its Effect on Postoperative Morbidity and Mortality in Patients Undergoing Thoracic Surgery|Desflurane and Its Effect on Postoperative Morbidity and Mortality in Patients Undergoing Thoracic Surgery|Completed||Phase 4|460|Actual|University of Zurich||2|||f||||||||||||||2017-10-11 03:43:51.115483|2017-10-11 03:43:51.115483
NCT01452243|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2011-10-11|||November 2008||2008-11-01|October 2011|2011-10-01|April 2012|Anticipated|2012-04-01|November 2011|Anticipated|2011-11-01||Interventional|ANVITAD||Prevention of Falls and Fractures in Old People by Administration of Calcium and Vitamin D. Randomized Clinical Trial|Prevention of Falls and Fractures in Old People by Administration of Calcium and Vitamin D. Randomized Clinical Trial (ANVITAD)|Unknown status|Active, not recruiting|Phase 3|704|Anticipated|Gerencia de Atención Primaria, Albacete||1|||f||||f||||||||||2017-10-11 03:43:51.191441|2017-10-11 03:43:51.191441
NCT01452230|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-11-02|||October 2011||2011-10-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2015|Actual|2015-06-01||Interventional|||Prebariatric Surgery Physical Activity Program|Effectiveness and Efficacity of Presurgery Supervised Physical Activity Training on Health of Obese Individuals Waiting for Bariatric Surgery|Active, not recruiting||N/A|50|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 03:43:51.293098|2017-10-11 03:43:51.293098
NCT01452217|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-13|||September 2010||2010-09-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers|The Use of Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers|Completed||Phase 1|12|Actual|University of Nottingham||1|||f||||f||||||||||2017-10-11 03:43:51.364555|2017-10-11 03:43:51.364555
NCT01452204|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-03-25|||July 2009|Actual|2009-07-01|October 2011|2011-10-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|PEMF||Pulsed Electromagnetic Field (PEMF) in Impingement Shoulder|Pulsed Electromagnetic Field in Patients With Impingement Shoulder: A Randomized, Placebo-Controlled Clinical Trial|Completed||N/A|60|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||f||||||||||2017-10-11 03:43:51.445082|2017-10-11 03:43:51.445082
NCT01452191|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-10-04|||June 2011||2011-06-01|October 2012|2012-10-01||||March 2013|Anticipated|2013-03-01||Interventional|||Helping Children's Centres to Enhance Home Safety|Keeping Children Safe at Home: Cluster Randomised Controlled Trial of the Implementation of an Injury Prevention Briefing in Children's Centres for the Prevention of Fire-related Injuries|Unknown status|Recruiting|N/A|1080|Anticipated|University of Nottingham||3|||f||||t||||||||||2017-10-11 03:43:51.532912|2017-10-11 03:43:51.532912
NCT01452178|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-11|||November 2005||2005-11-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|VaMIS||Vastmanland Myocardial Infarction Study (VaMIS)|Observational Study on Peripheral Vascular Disease, Glucometabolic Status, and Type D Personality in Patients With Acute Myocardial Infarction.|Completed||N/A|1008|Actual|Uppsala University|||1||f||||t||||||Samples With DNA|"     Whole blood and serum.   "|||2017-10-11 03:43:51.635594|2017-10-11 03:43:51.635594
NCT01452165|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-11|||May 2006||2006-05-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|PADVa||Peripheral Artery Disease in Vastmanland|Observational Study on Cardiac Morphology and Function in Patients With Peripheral Artery Disease in Vastmanland County, Sweden(PADVa).|Completed||N/A|457|Actual|Uppsala University|||1||f||||t||||||Samples With DNA|"     Whole blood and serum.   "|||2017-10-11 03:43:51.705628|2017-10-11 03:43:51.705628
NCT01452152|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-05-19|2016-02-18||February 2012||2012-02-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|PAPI-2||Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study|Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study: A Prospective, Multicenter, Randomized Trial of Genotype-directed (G-D)Versus Standard of Care (SOC)Anti-platelet Therapy|Terminated||Phase 4|9|Actual|University of Maryland|The study was terminated early by the sponsor due to low enrollment.|3||Terminated by study sponsor.|f||||t||||||||||2017-10-11 03:43:51.779213|2017-10-11 03:43:51.779213
NCT01452139|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2013-04-23|||September 2011||2011-09-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|RAPID STEMI||Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)|ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy in Patients With ST-segment Elevation Myocardial Infarction|Completed||Phase 2/Phase 3|102|Actual|Ottawa Heart Institute Research Corporation||3|||f||||t||||||||||2017-10-11 03:43:52.190283|2017-10-11 03:43:52.190283
NCT01451931|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-12-02|2014-10-30||September 2011||2011-09-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|STONE||Study of Tomography of Nephrolithiasis Evaluation|Randomized Controlled Trial of Ultrasound Versus CT (Computed Tomography) for Patients in the Emergency Department With Suspected Renal Colic|Completed||Phase 4|2776|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 03:43:55.978981|2017-10-11 03:43:55.978981
NCT01452126|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-10-25|2016-10-25||June 2011||2011-06-01|October 2016|2016-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|MEAC||Minimum Effective Concentration of Ropivacaine for Brachial Plexus Block Via the Supraclavicular and Infraclavicular Approach, Femoral Nerve Block, Sciatic Nerve Block Via the Popliteal and Parasacral Approach|Minimum Effective Anesthetic Concentration of Supraclavicular Block, Infraclavicular Block, Femoral Nerve Block and Sciatic Nerve Block Via the Popliteal and Parasacral Approach|Terminated||Phase 2|49|Actual|University of New Mexico|Early termination leading to small numbers of subjects analyzed. Confidence intervals for primary outcome are not reliable and therefore not reported.|1||Departure of principal investigator|f||||t||||||||||2017-10-11 03:43:52.29553|2017-10-11 03:43:52.29553
NCT01452113|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-09|2014-03-11|||October 2010||2010-10-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|DPPNAC||Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy|Effect of a DPP-IV Inhibitor Treatment on the Secretion of Glucagon in Patients Presenting With Type 1 Diabetes Mellitus With or Without Autonomic Neuropathy|Completed||Phase 2|21|Actual|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-11 03:43:52.509004|2017-10-11 03:43:52.509004
NCT01452100|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-05-06|||June 2011||2011-06-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|MECCORT||Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism)|Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism)|Terminated||Phase 2|39|Actual|University Hospital, Toulouse||2||Inclusion default|f||||t||||||||No||2017-10-11 03:43:54.123917|2017-10-11 03:43:54.123917
NCT01452087|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-11-20|||May 2009||2009-05-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|||Health Benefits of Chronic vs. Acute Exercise in Overweight Adults||Completed||N/A|43|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 03:43:54.213831|2017-10-11 03:43:54.213831
NCT01452074|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-04-28|||July 2011||2011-07-01|April 2017|2017-04-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Progressive Metabolic Adaptations to Low Intensity Exercise Training and Weight Loss||Active, not recruiting||N/A|16|Anticipated|University of Michigan||1|||f||||f||||||||||2017-10-11 03:43:54.295833|2017-10-11 03:43:54.295833
NCT01452061|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-01-27|||January 2012||2012-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder|Understanding Genetic Differences Associated With Autism Spectrum and Attention Deficit/Hyperactivity Disorder|Completed||N/A|456|Actual|The Cleveland Clinic|||4||f||||f||||||Samples With DNA|"     Genetic material via a cheek swab will be collected.   "|||2017-10-11 03:43:54.410985|2017-10-11 03:43:54.410985
NCT01452048|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-06-21|||September 2011||2011-09-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Relationship Between Systemic Fatty Acid Availability and Insulin Sensitivity||Recruiting||N/A|30|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"     frozen tissue, plasma   "|||2017-10-11 03:43:54.512999|2017-10-11 03:43:54.512999
NCT01452035|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-11-07|||January 2009||2009-01-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Exercise Dose Response for Improving Insulin Sensitivity|Comparing the Effects Exercise Intensity and Energy Expended During a Single Exercise Session on Insulin Sensitivity and Fatty Acid Partitioning Within Skeletal Muscle the Next Day in Obese Adults.|Completed||N/A|13|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:43:54.615943|2017-10-11 03:43:54.615943
NCT01452022|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-04-04|||October 2011||2011-10-01|April 2017|2017-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|APOLLO||Performance of Inductigraft in Spinal Fusion|A Prospective Open-label Non-randomdised Multi-centre Clinical Study to Evaluate the Performance of Inductigraft in Posterolateral Fusion|Completed||N/A|125|Actual|Baxter Healthcare Corporation||1|||f||||f||||||||||2017-10-11 03:43:54.730451|2017-10-11 03:43:54.730451
NCT01452009|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-12|2012-02-09|||November 2011||2011-11-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%|Three Month Safety and Efficacy Study of TRAVATAN® vs Travoprost Ophthalmic Solution, 0.004%|Withdrawn||Phase 3|0|Actual|Alcon Research||2||Management Decision|f||||f||||||||||2017-10-11 03:43:54.878112|2017-10-11 03:43:54.878112
NCT01451996|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2013-12-09|||October 2011||2011-10-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||The Efficacy of Claritin in Healthy Subjects|The Efficacy of Claritin in Healthy Subjects|Completed||Phase 4|490|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 03:43:54.975246|2017-10-11 03:43:54.975246
NCT01451983|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-01-07|2014-12-12||May 2010||2010-05-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Genetics, Brain Structure and Thinking Skills in Autism|Genetic, Biochemical, Behavioral and Neuroimaging Phenotypes of Autism Spectrum Disorders (ASDs)|Completed||N/A|138|Actual|The Cleveland Clinic|Modest PTEN-ASD sample size and difficulty in closely matching each PTEN patient to one or more patients from each comparison group; Lack of comprehensively characterized PHTS patients without ASD is also a limitation.||4||f||||t||||||Samples With DNA|"     About 6 tubes of blood or up to 50 ml (3-4 tablespoons) and 30 mL of urine will be collected.   "|||2017-10-11 03:43:55.092401|2017-10-11 03:43:55.092401
NCT01451970|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-02-27|||August 2007||2007-08-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|February 2012|Actual|2012-02-01||Interventional|||Dietary Fatty Acid Composition and Obesity-related Metabolic Abnormalities|Assessing the Effects of Two Diets Enriched in Either Saturated or Unsaturated Fatty Acids to Determine the Cellular and Molecular Mechanisms in Insulin Sensitivity|Active, not recruiting||N/A|40|Anticipated|University of Michigan||2|||f||||f||||||||||2017-10-11 03:43:55.617661|2017-10-11 03:43:55.617661
NCT01451957|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-11-22|||August 2003||2003-08-01|November 2016|2016-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity|Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity|Completed||N/A|7|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:43:55.74421|2017-10-11 03:43:55.74421
NCT01451944|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-12-01|||October 2011||2011-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Home Health Case Management on Asthma Morbidity|Effect of Home Health Nurse Case Management on Asthma Morbidity|Withdrawn||N/A|0|Actual|University of Louisville||1||no one enrolled|f||||f||||||||||2017-10-11 03:43:55.86841|2017-10-11 03:43:55.86841
NCT01451918|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-05-05|||October 2011||2011-10-01|May 2012|2012-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol|Regulation of Intestinal (and Hepatic) Lipoprotein Secretion by Resveratrol|Completed||Phase 2|8|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:43:57.734275|2017-10-11 03:43:57.734275
NCT01451905|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2012-06-20|||August 2011||2011-08-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis||Unknown status|Recruiting|N/A|12|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||||||||||||2017-10-11 03:43:57.833467|2017-10-11 03:43:57.833467
NCT01451892|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-12-12|||July 2010||2010-07-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Dance Therapy and Obesity|The Effect of Dance Therapy on the Functional Capacity of Patients With Advanced Obesity|Completed||N/A|60|Actual|University Hospital, Geneva||2|||f||||t||||||||||2017-10-11 03:43:57.929815|2017-10-11 03:43:57.929815
NCT01451879|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-12-05|||October 2008||2008-10-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Observational Study for Subjects With Pompe Disease Undergoing Immune Modulation Therapies|Effects of Immunomodulation Therapy on Anti-rhGAA Immune Response in Subjects With Pompe Disease Receiving rhGAA Enzyme Replacement Therapy|Recruiting||N/A|25|Anticipated|University of Florida|||1||f||||f||||||Samples With DNA|"     Residual blood specimens from GAA Ab testing   "|||2017-10-11 03:43:58.040005|2017-10-11 03:43:58.040005
NCT01451866|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-11-24|||September 2011||2011-09-01|November 2014|2014-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|dlp||Comparison Between Classic Leg-press Training and Complex Leg-press Training on a Dynamic Leg-press|Comparison of a Classic Leg-press Training Compared to a Complex Training on a Dynamic Leg-press With Visual Feed-back. Pilot-study|Completed||Phase 2/Phase 3|34|Actual|University of Applied Sciences of Western Switzerland||2|||f||||f||||||||||2017-10-11 03:43:58.15738|2017-10-11 03:43:58.15738
NCT01451853|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2017-09-21|||January 15, 2018|Anticipated|2018-01-15|September 2017|2017-09-01|September 23, 2019|Anticipated|2019-09-23|June 26, 2019|Anticipated|2019-06-26||Interventional|||SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss|Safety and Efficacy Study of SPI-1005 for Prevention of Chemotherapy Induced Hearing Loss|Not yet recruiting||Phase 2|80|Anticipated|Sound Pharmaceuticals, Incorporated||4|||||||t|t|f||||||||2017-10-11 03:43:58.245655|2017-10-11 03:43:58.245655
NCT01451840|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2012-10-25|||January 2012||2012-01-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy of Alkalinized Lidocaine Compared to Remifentanil on the Incidence of Coughing During Emergence of Anesthesia|Efficacy of Alkalinized Lidocaine in the Endotracheal Tube Cuff Compared to a Bolus Dose of Intravenous Remifentanil on the Incidence of Coughing During Emergence of Anesthesia|Completed||N/A|85|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 03:43:58.353358|2017-10-11 03:43:58.353358
NCT01451827|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-06-12||2014-06-12|October 2011||2011-10-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|NOCTURNE||8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)|A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind, Placebo-masked, Parallel-group Pilot Trial to Compare the Efficacy, Tolerability, and Safety of Tolvaptan Modified-release and Immediate-release Formulations in Subjects With Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 2|178|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||f||||||||||2017-10-11 03:43:58.567722|2017-10-11 03:43:58.567722
NCT01451814|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-03-06|2015-02-23||October 2011||2011-10-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Participants fully eligible and attending the first session of counseling|Development of Positive Psychotherapy for Smoking Cessation|Development of Positive Psychotherapy for Smoking Cessation|Completed||Phase 2|66|Actual|Brown University||2|||f||||f||||||||||2017-10-11 03:43:58.745956|2017-10-11 03:43:58.745956
NCT01451801|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-10-25|||October 2011||2011-10-01|October 2012|2012-10-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders|Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders|Unknown status|Active, not recruiting|Phase 4|400|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-10-11 03:43:59.229313|2017-10-11 03:43:59.229313
NCT01451788|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-11-14|||November 2011||2011-11-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effect of Human Thrombin With Gelatin Matrix on Perioperative Blood Loss in Scoliosis Surgery|Effectiveness Of Gelatin Matrix With Human Derived Thrombin On Blood Loss, Surgical Time, Hospital Stay And Complications In Adolescents Undergoing Spine Surgery For Adolescent Idiopathic Scoliosis: A Randomized Clinical Trial.|Unknown status|Recruiting|Phase 4|60|Anticipated|Turku University Hospital||2|||f||||f||||||||||2017-10-11 03:43:59.324172|2017-10-11 03:43:59.324172
NCT01451775|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-06-26|2014-05-16||October 2011||2011-10-01|June 2014|2014-06-01||||November 2011|Actual|2011-11-01||Interventional|||Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.|Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet and Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets in an Open, Randomised, Single Dose, Three-period Cross-over Study in Healthy Male and Female Subjects|Completed||Phase 1|18|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:43:59.47506|2017-10-11 03:43:59.47506
NCT01451762|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-02-14|2013-10-28||September 2011||2011-09-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery|A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery|Completed||N/A|90|Actual|Northwestern University|We did not obtain preoperative quality of recovery scores of patients therefore we could not examine whether the effect of diphenhydramine was dependent upon patient's baseline characteristics.|3|||f||||f||||||||||2017-10-11 03:43:59.856558|2017-10-11 03:43:59.856558
NCT01451567|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-15|||June 2005||2005-06-01|May 2005|2005-05-01|March 2006|Actual|2006-03-01|October 2005|Actual|2005-10-01||Interventional|||The Effect of a Structured Personalised Ergonomic Intervention for Hospital Nurses With Musculoskeletal Complains|Study That Examined the Effect of a Structured Personalised Ergonomic Intervention Program for Hospital Nurses With Musculoskeletal Complains.|Completed||N/A|31|Actual|Tel Aviv University||1|||f||||t||||||||||2017-10-11 03:44:04.449891|2017-10-11 03:44:04.449891
NCT01451749|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-10-09|2013-11-24||September 2008||2008-09-01|October 2014|2014-10-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional||216 in Shenwu capusle, and 108 in the Donepezil group was enrolled at baseline, 1 subjects in both group did not meet the inclusion criteria ,and 215 in Shenwu Capsule, and 107 in Donepezil were used to baseline analysis|Efficacy and Safety Study of Shenwu Capsule|Phase III Study of Shenwu Capsule in Treating Amnestic Mild Cognitive Impairment|Completed||Phase 3|324|Actual|North China Pharmaceutical Group Corporation|First, there was no placebo group. As all subjects knew that they were being treated with one of two drugs, and all of the individuals who assessed the patients knew this as well, the results may have been influenced by a positive response bias.|2|||f||||t||||||||||2017-10-11 03:44:00.51214|2017-10-11 03:44:00.51214
NCT01451736|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-06-28|||October 2011||2011-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia|Clinical and Cognitive Effects of Paliperidone Palmitate vs. Oral Risperidone in First-Episode Schizophrenia|Recruiting||Phase 4|170|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 03:44:01.108514|2017-10-11 03:44:01.108514
NCT01451723|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-01-30|2013-12-10||July 2011||2011-07-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|POEMS||Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II|Phase 2 Randomized Placebo Controlled Trial of Polyphenon E in MS|Terminated||Phase 2|11|Actual|Louisiana State University Health Sciences Center in New Orleans|The study was halted prematurely because of the high incidence of liver function abnormalities|2||Unusual high frequency of elevated liver function tests.|f||||t||||||||||2017-10-11 03:44:01.254648|2017-10-11 03:44:01.254648
NCT01451710|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2012-07-09|||March 2011||2011-03-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy|The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy|Completed||N/A|30|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-10-11 03:44:01.696449|2017-10-11 03:44:01.696449
NCT01451697|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-11|||July 2011||2011-07-01|October 2011|2011-10-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Interventional|||Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding|Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding|Unknown status|Recruiting|Early Phase 1|20|Anticipated|Hartford Hospital||2|||f||||f||||||||||2017-10-11 03:44:01.815568|2017-10-11 03:44:01.815568
NCT01451684|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-07-14|||June 2011||2011-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Development of a Non-invasive Prenatal Test|Development of a Non-invasive Prenatal Test|Recruiting||N/A|10000|Anticipated|Roche Sequencing Solutions|||1||f||||f||||||||||2017-10-11 03:44:01.995479|2017-10-11 03:44:01.995479
NCT01451671|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-07-14|||November 2010||2010-11-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Development of a Prenatal Test for Fetal Aneuploidy Detection|Prenatal Test for Fetal Aneuploidy Detection|Recruiting||N/A|1500|Anticipated|Roche Sequencing Solutions|||1||f||||f||||||||||2017-10-11 03:44:02.091219|2017-10-11 03:44:02.091219
NCT01451658|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-13|||December 2009||2009-12-01|October 2011|2011-10-01|October 2012|Anticipated|2012-10-01|December 2009|Actual|2009-12-01||Interventional|||Endoscopic Treatment Alone Versus Combined Propranolol and Endoscopic Treatment of Acute Variceal Hemorrhage in Patients With Hepatocellular Carcinoma||Unknown status|Recruiting|Phase 4|100|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 03:44:02.297282|2017-10-11 03:44:02.297282
NCT01451645|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2014-04-07|2013-09-24||October 2011||2011-10-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional||The study population consisted of adults who met the criteria of the ARA for acute arthritis of primary gout or had monosodium urate monohydrate microcrystals identified in joint fluid, had tophi present in joints or a history of polyarticular gout attacks, a history of ≥2 gout flares in the past year, and were initiating therapy with allopurinol.|Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol||Completed||Phase 4|82|Actual|Regeneron Pharmaceuticals|This clinical trial was not directly related to the development of an investigational/medicinal product.|2|||f||||f||||||||||2017-10-11 03:44:02.403509|2017-10-11 03:44:02.403509
NCT01451632|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-09-06|2016-07-12||October 2011||2011-10-01|September 2016|2016-09-01|June 2014|Actual|2014-06-01|November 2013|Actual|2013-11-01||Interventional|||A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers|A Phase 1 Study of MM-121 in Combination With Cetuximab and Irinotecan in Patients With Advanced Cancers|Completed||Phase 1|48|Actual|Merrimack Pharmaceuticals||2|||f||||f||||||||No||2017-10-11 03:44:02.825498|2017-10-11 03:44:02.825498
NCT01451619|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-03-24|||November 2011||2011-11-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155)|A Randomized, Double-blind, Placebo-controlled, Multi-center, Parallel Group Study to Assess the Pharmacodynamics of MK-0524 in Subjects With Moderate to Severe Erythematotelangiectatic Rosacea. (Protocol No. 155)|Completed||Phase 1|60|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 03:44:04.057899|2017-10-11 03:44:04.057899
NCT01451606|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-04-08|||June 9, 2011|Actual|2011-06-09|April 2017|2017-04-01|November 4, 2015|Actual|2015-11-04|November 4, 2015|Actual|2015-11-04||Interventional|||Duloxetine for the Treatment of Chronic Pelvic Pain|Evaluating Duloxetine's Analgesic Effectiveness in Chronic Pelvic Pain|Terminated||Phase 4|34|Actual|University of Maryland||2||Adequate recruitment was not achieved in the time frame allowed.|f||||t||||||||No||2017-10-11 03:44:04.143044|2017-10-11 03:44:04.143044
NCT01451593|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2015-09-08|||November 2011||2011-11-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Neuroprotection With Phenytoin in Optic Neuritis|A Phase II Double Blind, Randomized, Placebo Controlled Trial of Neuroprotection With Phenytoin in Acute Optic Neuritis|Completed||Phase 2|92|Actual|University College, London||2|||f||||t||||||||||2017-10-11 03:44:04.240861|2017-10-11 03:44:04.240861
NCT01451580|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-12|||September 2005||2005-09-01|October 2011|2011-10-01||||||||Interventional|||Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer|A Phase II Study of Pegylated Liposomal Doxorubicin (Lipo-Dox) Combined With Cyclophosphamide /5-Fluorouracil as Second Line Chemotherapy in the Treatment of Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|47|Anticipated|TTY Biopharm|||||f||||||||||||||2017-10-11 03:44:04.35891|2017-10-11 03:44:04.35891
NCT01451554|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-19|2011-10-19||January 2009||2009-01-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Portion Control Treatment for Obesity|Portion Control for the Treatment of Obesity in the Primary Care Setting|Completed||Phase 2/Phase 3|65|Actual|Mayo Clinic|small sample size and inability to blind staff/study subject to the intervenion|2|||f||||f||||||||||2017-10-11 03:44:04.530824|2017-10-11 03:44:04.530824
NCT01451541|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-04-04|2013-12-19||October 2011||2011-10-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).|A 12-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis|Completed||Phase 3|848|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 03:44:04.839429|2017-10-11 03:44:04.839429
NCT01451528|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-04-02|||July 2014||2014-07-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Allogeneic Umbilical Cord Blood Therapy for Chronic TBI|The Efficacy and Safety of Allogeneic Umbilical Cord Blood Therapy for Chronic Traumatic Brain Injury Patients|Withdrawn||N/A|0|Actual|Bundang CHA Hospital||1||The research fund, which is yet to be raised and expected to take for a while|f||||f||||||||||2017-10-11 03:44:06.177964|2017-10-11 03:44:06.177964
NCT01451515|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-04-11|||May 25, 2012|Actual|2012-05-25|April 2017|2017-04-01|June 30, 2021|Anticipated|2021-06-30|June 30, 2021|Anticipated|2021-06-30||Interventional|||NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma|NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma|Terminated||Phase 2|23|Actual|St. Jude Children's Research Hospital||1||This protocol has been replaced by a protocol with newly developed therapy options.|f||||f|t|f||||||||2017-10-11 03:44:06.269135|2017-10-11 03:44:06.269135
NCT01451502|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-10-04|||October 20, 2011|Actual|2011-10-20|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units|Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units|Recruiting||N/A|250|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-10-11 03:44:06.45225|2017-10-11 03:44:06.45225
NCT01451489|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-03-22|||October 13, 2011|Actual|2011-10-13|March 2017|2017-03-01|October 29, 2016|Actual|2016-10-29|March 23, 2016|Actual|2016-03-23||Interventional|FSGS||The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis|A Randomized,Multicentre,Prospective Study on the Tacrolimus(FK506)for Focal Segmental Glomerulosclerosis|Terminated||N/A|70|Actual|Nanjing University School of Medicine||2||The recruitment of subject is very difficult|f||||t||||||||||2017-10-11 03:44:06.554142|2017-10-11 03:44:06.554142
NCT01451476|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-04-18|||May 2010||2010-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Observational|GEP||Human Skin Aging: Clinical Parameters and Gene Expression Profiling|Human Skin Aging: Clinical Parameters and Gene Expression Profiling|Completed||N/A|122|Actual|Stanford University|||1||f||||f||||||Samples With DNA|"     Blood and skin samples   "|||2017-10-11 03:44:06.663267|2017-10-11 03:44:06.663267
NCT01451450|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2012-07-20||||||July 2012|2012-07-01||||||||Interventional|||Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy|A Phase II, Randomized, Double Blind, Placebo-controlled, Parallel Design, Dose Ranging, Multi-center Trial of Four Levels of Exposure of QGE031 s.c. for 16 Weeks in Subjects Aged 18-50 Years of Age With Peanut Allergy|Withdrawn||Phase 2|0|Actual|Novartis||8|||f||||||||||||||2017-10-11 03:44:06.811511|2017-10-11 03:44:06.811511
NCT01451437|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2017-05-18|2016-02-05||November 18, 2011|Actual|2011-11-18|May 2017|2017-05-01|September 5, 2014|Actual|2014-09-05|September 5, 2014|Actual|2014-09-05||Interventional|||Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649)|A Phase I Study to Evaluate the Safety and Tolerability and Pharmacokinetic/Pharmacodynamics of MK-8242 Administered Alone and in Combination With Chemotherapy in Subjects With Refractory or Recurrent Acute Myelogenous Leukemia (Protocol No. P07649 (005))|Terminated||Phase 1|26|Actual|Merck Sharp & Dohme Corp.||9||The study was terminated early due to business reasons.|f||||f||||||||||2017-10-11 03:44:06.968899|2017-10-11 03:44:06.968899
NCT01451424|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2014-08-08|2014-06-25||February 2012||2012-02-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional||Safety population|Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids|A Phase 2, 3 Arm, Randomized, Double-Blind Study to Evaluate the Safety, PK and Efficacy of Proellex® Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids|Completed||Phase 2|40|Actual|Repros Therapeutics Inc.||5|||f||||f||||||||||2017-10-11 03:44:10.438691|2017-10-11 03:44:10.438691
NCT01451411|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-02-01|2015-12-18||February 2012||2012-02-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose-Titration Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia|Terminated||Phase 3|4|Actual|Cumberland Pharmaceuticals||2||Enrollment goals were not met.|f||||t||||||||||2017-10-11 03:44:10.993428|2017-10-11 03:44:10.993428
NCT01451398|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2014-10-09|2014-07-22|2013-08-19|November 2011||2011-11-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional||Safety population|Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus|A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized, Clinical Trial Evaluating the Efficacy and Safety of Prandial Technosphere® Insulin Inhalation Powder Versus Technosphere Inhalation Powder in Insulin Naïve Subjects With Type 2 Diabetes Mellitus Poorly Controlled With Oral Antidiabetic Agents Over a 24 Week Treatment Period|Completed||Phase 3|353|Actual|Mannkind Corporation||2|||f||||t||||||||||2017-10-11 03:44:11.68446|2017-10-11 03:44:11.68446
NCT00000203|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2013-07-24|||August 1988||1988-08-01|August 2005|2005-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Buprenorphine Maintenance for Opioid Addicts - 2|Buprenorphine Maintenance for Opioid Addicts|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-10-11 04:17:38.77659|2017-10-11 04:17:38.77659
NCT01451385|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-05-18||2017-05-18|September 2011||2011-09-01|May 2017|2017-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain|An Open Label Safety Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain|Completed||Phase 3|376|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-11 03:44:12.86084|2017-10-11 03:44:12.86084
NCT01451372|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2012-11-06|||June 2011||2011-06-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Observational|||Routine Use of Sensor-Augmented Pump Therapy - a Follow up Study|Routine Use of Sensor-Augmented Pump Therapy - a Follow up Study|Completed||N/A|69|Actual|Medtronic|||1||f||||t||||||||||2017-10-11 03:44:13.093911|2017-10-11 03:44:13.093911
NCT01451359|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2013-10-08|||October 2011||2011-10-01|October 2011|2011-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Endobronchial Valves in Persistent Air Leak|Efficacy of Endobronchial Valves in Persistent Air Leak After Anatomical Pulmonary Resection for Cancer.|Completed||N/A|10|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 03:44:13.179141|2017-10-11 03:44:13.179141
NCT01451346|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-12|||January 2008||2008-01-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|April 2008|Actual|2008-04-01||Interventional|AH-PSR-01||Study in Patients With Mild to Moderate Psoriasis|B.Infantis 35624 in Patients With Mild to Moderate Chronic Plaque Psoriasis -a Pilot Study|Completed||Phase 1/Phase 2|47|Actual|Alimentary Health Ltd||2|||f||||t||||||||||2017-10-11 03:44:13.269899|2017-10-11 03:44:13.269899
NCT01451333|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-05|2013-05-10|||September 2011||2011-09-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|ENCORE1-CNS||The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1|The EFV Central Nervous System Exposure Sub-study of Encore1: A Randomised, Double-blind, Placebo-controlled, Clinical Trial to Compare the Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals Over 96 Weeks|Completed||Phase 3|32|Actual|Kirby Institute||2|||f||||t||||||||||2017-10-11 03:44:13.373997|2017-10-11 03:44:13.373997
NCT01451320|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2011-10-11|||January 1993||1993-01-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|TROIA||Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis|Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis|Completed||N/A|182|Actual|Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital||5|||f||||f||||||||||2017-10-11 03:44:13.860464|2017-10-11 03:44:13.860464
NCT01451307|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2013-09-04|||September 2011||2011-09-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Observational|FraMal||Follow-up of Children With Gastrointestinal Malformations and Postnatal Surgery|Follow-up Study of Children Aged 2 Years With Gastrointestinal Malformations and Postnatal Surgery|Completed||N/A|80|Actual|Goethe University|||2||f||||t||||||||||2017-10-11 03:44:13.981588|2017-10-11 03:44:13.981588
NCT01451294|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-10-12|||November 2011||2011-11-01|October 2011|2011-10-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Effect of Blood Pressure on rSO2 in Carotid Endarterectomy (CEA)|The Effect of Phenylephrine Versus Ephedrine on Cerebral Perfusion During Carotid Endarterectomy|Unknown status|Not yet recruiting|N/A|40|Anticipated|UMC Utrecht||2|||f||||||||||||||2017-10-11 03:44:14.066831|2017-10-11 03:44:14.066831
NCT01451281|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-08|2017-06-30|||September 14, 2011||2011-09-14|April 21, 2017|2017-04-21||||||||Observational|||Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy|Evaluation of Skeletal Muscle, Cardiac, and Diaphragm Imaging Biomarkers for GSK2402968 Effects in Ambulatory Boys With Duchenne Muscular Dystrophy|Completed||N/A|35|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:44:14.172151|2017-10-11 03:44:14.172151
NCT01451268|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-09-01|||January 2011||2011-01-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|PANOBEST||Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)|Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk MDS or AML (PANOBEST)|Active, not recruiting||Phase 1/Phase 2|62|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 03:44:14.278641|2017-10-11 03:44:14.278641
NCT01451255|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-08|2016-03-15|||August 2011||2011-08-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging|Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging|Completed||N/A|90|Actual|Mayo Clinic|||1||f||||||||||||||2017-10-11 03:44:14.418607|2017-10-11 03:44:14.418607
NCT01451242|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-12|||October 2011||2011-10-01|October 2011|2011-10-01||||||||Observational|||The Reliability of Heart Rate Variability Among Patients With Brain Injury as Measured by POLAR RC810XE Compared to HOLTER|The Reliability of Heart Rate Variability Measurements Among Patients With Acquired Brain Injury as Measured During Physical Activity by POLAR RC810XE Compared to HOLTER EKG|Unknown status|Not yet recruiting|N/A|30|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 03:44:14.48453|2017-10-11 03:44:14.48453
NCT01451229|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2011-10-12|||June 2009||2009-06-01|October 2011|2011-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Higenamine in Chinese Healthy Subjects|An Open-Label, Single-dose Administration Study of the Pharmacokinetics and Pharmacodynamics of Higenamine, Administered Intravenously Injection to Healthy Chinese Subjects|Completed||Phase 1|10|Actual|Peking Union Medical College Hospital||1|||f||||t||||||||||2017-10-11 03:44:14.566027|2017-10-11 03:44:14.566027
NCT01451216|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2011-10-17|||November 2011||2011-11-01|October 2011|2011-10-01||||||||Observational|||The Evaluation of Balance Control by Quantification of Temporospatial Measures While Forward and Side Reaching|The Evaluation of Balance Control by Quantification of the Temporospatial Measures of Functional Reach Test|Unknown status|Not yet recruiting|N/A|40|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 03:44:14.64165|2017-10-11 03:44:14.64165
NCT01451047|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2012-02-28|||July 2009||2009-07-01|February 2012|2012-02-01||||April 2011|Actual|2011-04-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)|A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Balding Scalp of Subjects With Hair Loss|Completed||Phase 2|31|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:16.590081|2017-10-11 03:44:16.590081
NCT01451203|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2017-06-28|2015-10-18||October 11, 2011|Actual|2011-10-11|June 2017|2017-06-01|October 20, 2014|Actual|2014-10-20|August 28, 2013|Actual|2013-08-28||Interventional||The Full Analysis Set (FAS), which consisted of all participants who had received at least 1 study drug administration and provided efficacy data after the administration of the study drug.|Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of CDP870 in Patients With Early-stage Rheumatoid Arthritis Who Are Naïve to Methotrexate and Have Poor Prognostic Factors|Completed||Phase 3|319|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||f||||||||Yes|Details of the IPD sharing plan for this study can be found at www.clinicalstudydatarequest.com.|2017-10-11 03:44:14.766989|2017-10-11 03:44:14.766989
NCT01451190|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-07-09|||July 2011||2011-07-01|July 2013|2013-07-01||||March 2013|Actual|2013-03-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)|A Multi-center, Phase 2 Study of Ji Gami(TM) CN That Evaluates the Efficacy and Safety of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells Into the Hair Loss Area of the Scalp of Subjects|Completed||Phase 2|88|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:15.523542|2017-10-11 03:44:15.523542
NCT01451177|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-07-09|||May 2010||2010-05-01|July 2013|2013-07-01||||January 2012|Actual|2012-01-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)|A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Cultured Occipital Autologous Dermal and Epidermal Cells vs Dermal Cells, Where Cells Are Expanded ex Vivo From Plucked Scalp, Into the Hair Loss Area of the Scalp of Subjects.|Completed||Phase 2|43|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:15.62812|2017-10-11 03:44:15.62812
NCT01451164|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2016-10-05|||October 2011||2011-10-01|October 2016|2016-10-01||||June 2015|Actual|2015-06-01||Interventional|||A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia|A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia|Completed||Phase 2/Phase 3|458|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-11 03:44:15.720343|2017-10-11 03:44:15.720343
NCT01451151|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-07-09|||December 2010||2010-12-01|July 2013|2013-07-01||||June 2012|Actual|2012-06-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)|A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells Into the Hair Loss Area of the Scalp of Subjects|Completed||Phase 2|33|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:15.822468|2017-10-11 03:44:15.822468
NCT01451138|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-07-09|||November 2010||2010-11-01|July 2013|2013-07-01||||October 2012|Actual|2012-10-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)|A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs Dermal Cells Into the Hair Loss Area of the Scalp of Subjects|Completed||Phase 2|40|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:15.923243|2017-10-11 03:44:15.923243
NCT01451125|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-07-09|||May 2010||2010-05-01|July 2013|2013-07-01||||March 2012|Actual|2012-03-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)|A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Hair Loss Area of the Scalp of Subjects and Synergy With Application of Topical Minoxidil|Completed||Phase 2|43|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:16.023071|2017-10-11 03:44:16.023071
NCT01451112|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-07-09|||August 2009||2009-08-01|July 2013|2013-07-01||||August 2012|Actual|2012-08-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)|A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Hair Loss Area of the Scalp of Subjects|Completed||Phase 2|30|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:16.131194|2017-10-11 03:44:16.131194
NCT01451099|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2012-02-28|||June 2009||2009-06-01|February 2012|2012-02-01||||September 2010|Actual|2010-09-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss|A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss|Completed||Phase 2|21|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:16.218267|2017-10-11 03:44:16.218267
NCT01451086|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2013-03-14|||October 2011||2011-10-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China|Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China|Completed||Phase 3|1200|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 03:44:16.3002|2017-10-11 03:44:16.3002
NCT01451073|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-11|2012-02-28|||January 2009||2009-01-01|February 2012|2012-02-01||||August 2010|Actual|2010-08-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)|A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of a 1 Time Injection vs. Repeat Injections of ex Vivo Expanded Cultured Autologous Occipital Dermal and Epidermal Cells (Same Day as Cell Culture Harvest) Into the Balding Scalp of Subjects With Hair Loss|Completed||Phase 2|33|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:16.406565|2017-10-11 03:44:16.406565
NCT01451060|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-09-06|||June 2011||2011-06-01|October 2011|2011-10-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|Vasopressors||Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for Cesarean|Maternal and Neonatal Outcomes After the Use of Vasopressors to Correct Hypotension During Cesarean Section Under Spinal Anesthesia in Pregnant Women With Severe Preeclampsia: Randomized Clinical Trial|Withdrawn||Phase 3|0|Actual|Instituto Materno Infantil Prof. Fernando Figueira||1||We didn't have enough financial support|f||||t||||||||Yes|We don't have data to share|2017-10-11 03:44:16.498287|2017-10-11 03:44:16.498287
NCT01451034|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-10-12|||January 2009||2009-01-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Clinical Outcomes of Endoscopic Resection for Treating WHYX Lesion|Clinical Outcomes of Endoscopic Resection for Treating Extremely Well Differentiated Intestinal-type Adenocarcinoma (WHYX Lesion)|Completed||Phase 4|872|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 03:44:16.676574|2017-10-11 03:44:16.676574
NCT01451021|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2012-02-28|||October 2008||2008-10-01|February 2012|2012-02-01||||June 2010|Actual|2010-06-01||Interventional|||A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss|A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of a 1 Time Injection vs. Repeat Injections of ex Vivo Expanded Cultured Autologous Occipital Dermal and Epidermal Cells (Day After Cell Culture Harvest) Into the Balding Scalp of Subjects With Hair Loss|Completed||Phase 2|21|Actual|Aderans Research Institute||1|||f||||f||||||||||2017-10-11 03:44:16.772588|2017-10-11 03:44:16.772588
NCT01451008|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2013-07-05|||June 2009||2009-06-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Compression Anastomosis Using the Compression Anastomotic Ring-locking Procedure (CARP)|Safety Study of Compression Anastomotic Ring-locking Procedure (CARP) in Patients Undergoing Colonic Resection|Completed||Phase 1|25|Actual|Region Skane||1|||f||||t||||||||||2017-10-11 03:44:16.85734|2017-10-11 03:44:16.85734
NCT01450995|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-10-10|||December 2009||2009-12-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex|Open-label, 6 Month Crossover Study Evaluating Migraine Patient Satisfaction Comparing Treximet to 2 Aleve and 100mg Imitrex Taken Concomitantly|Completed||Phase 4|50|Actual|Wesley Headache Clinic||2|||f||||t||||||||||2017-10-11 03:44:16.934149|2017-10-11 03:44:16.934149
NCT01450982|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2013-05-03|||June 2011||2011-06-01|May 2013|2013-05-01|October 2011|Actual|2011-10-01|||||Interventional|||A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants|A Study to Investigate the Effects of JNJ-38518168 on Methotrexate Pharmacokinetics in Rheumatoid Arthritis Participants on a Stable Methotrexate Dose|Completed||Phase 1|20|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 03:44:17.051802|2017-10-11 03:44:17.051802
NCT01450969|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2014-09-23|||September 2011||2011-09-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Observational|PREFER||New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)|Prospective Randomized Evaluation of a New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)|Completed||N/A|60|Actual|Baptist Health South Florida|||1||f||||f||||||||||2017-10-11 03:44:17.160139|2017-10-11 03:44:17.160139
NCT01450943|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-06-08|||October 2011||2011-10-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|April 2017|Anticipated|2017-04-01||Interventional|DOLCE||VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic Foot Ulcers|A Comparative Efficacy Study: Treatment of Non-Healing Diabetic Foot|Recruiting||N/A|171|Anticipated|VA Northern California Health Care System||3|||f||||f||||||||||2017-10-11 03:44:17.332908|2017-10-11 03:44:17.332908
NCT01450930|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2012-07-31|||November 2011||2011-11-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|PHYSCA||Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency|Pharmacokinetics of Hydrocortisone After Subcutaneous Administration Compared With Intramuscular Injection in Chronic Adrenal Insufficiency|Completed||Phase 2|12|Actual|University of Wuerzburg||2|||f||||t||||||||||2017-10-11 03:44:17.453122|2017-10-11 03:44:17.453122
NCT01450917|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2011-10-10|||September 2009||2009-09-01|October 2011|2011-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Diaphragmatic Height Index: the New Diagnostic Test for Phrenic Nerve Dysfunction|Diaphragmatic Height Index: the New Diagnostic Test for Phrenic Nerve Dysfunction|Completed||N/A|245|Actual|Mahidol University|||3||f||||f||||||||||2017-10-11 03:44:17.54427|2017-10-11 03:44:17.54427
NCT01450904|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-10|||April 2011||2011-04-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Recovery Time of Quadriceps Strength After Total Knee Arthroplasty (TKA): The Effect of Quadriceps Incision Length|The Recovery Time of Quadriceps Strength After Total Knee Arthroplasty: The Effect of Quadriceps Incision Length|Completed||N/A|60|Actual|Mahidol University||3|||f||||f||||||||||2017-10-11 03:44:17.604901|2017-10-11 03:44:17.604901
NCT01450891|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-05-27|||September 2009||2009-09-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease|Novel Diagnostic Approaches for the Diagnosis of Alzheimer's Disease: Technology Assessment and Clinical Effectiveness|Completed||N/A|304|Actual|Maastricht University Medical Center|||1||f||||f||||||Samples Without DNA|"     Cerebrospinal fluid   "|||2017-10-11 03:44:17.686172|2017-10-11 03:44:17.686172
NCT01450878|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-09-02|||December 2011||2011-12-01|September 2016|2016-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|FRETEP||Renal Graft Function After Treatment With Erythropoietin (EPO)|Interest of a High Dose of Erythropoietin Administered During Graft Processing for Early Graft Outcome in Kidney Transplant Recipients.|Terminated||Phase 3|6|Actual|University Hospital, Limoges||2||Lack of patients eligible for the study.|f||||f||||||||||2017-10-11 03:44:17.785867|2017-10-11 03:44:17.785867
NCT01450865|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2015-01-12|||October 2009||2009-10-01|January 2015|2015-01-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo|Evaluation of the Effect of the K+-Channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo: a Randomised Controlled Trial|Completed||Phase 1|20|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 03:44:18.062963|2017-10-11 03:44:18.062963
NCT01450852|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-10|||January 2010||2010-01-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Strength Training Induced Alterations in Markers of Immune Function|Strength Training Induced Alterations in Markers of Immune Function|Completed||N/A|42|Actual|Louisiana State University Health Sciences Center in New Orleans||2|||f||||f||||||||||2017-10-11 03:44:18.171694|2017-10-11 03:44:18.171694
NCT01450826|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-05-24|||June 24, 2014|Actual|2014-06-24|May 2017|2017-05-01|April 21, 2017|Actual|2017-04-21|April 13, 2017|Actual|2017-04-13||Interventional|||Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide|A Randomized Open Label Phase II Trial of Aprepitant (Emend) in Combination With Ondansetron Compared to Standard 5HT3 Serotonin Antagonist (Ondansetron) in the Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Glioma Patients Receiving a Temozolomide Based Regimen|Completed||Phase 2|136|Actual|Duke University||2|||f||||f||||||||No||2017-10-11 03:44:18.423288|2017-10-11 03:44:18.423288
NCT01450813|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-04-04|2016-03-10||June 2009||2009-06-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy|The Effect of Rocuronium on the Response of Composite Variability Index (CVI) to Laryngoscopy|Completed||N/A|80|Actual|Medtronic - MITG|Sample size for this study calculation was based upon the assumption that that the expected mean of CVI would be 60 with a variance of 30 and that the variance of 30 would be equal for each group.|4|||f||||t||||||||No|Data collected was for device algorithm development|2017-10-11 03:44:18.574998|2017-10-11 03:44:18.574998
NCT01450800|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-12-23|2013-09-30||August 2011||2011-08-01|December 2016|2016-12-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional|STOPP UTI|163 participants were randomized, 82 to nitrofurantoin and 81 to placebo. Four randomized participants were excluded from the final analysis. One in the placebo group was excluded, as she had previously been included in the study during a prior surgery. Three participants in the nitrofurantoin group were excluded due to protocol deviations.|Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)|Antibiotic Prophylaxis for Urinary Tract Infection in Patients Requiring Catheterization After Urogynecologic Surgery|Completed||Phase 4|163|Actual|Duke University|Limitations of our study include recall bias and selection bias. Our findings have limited applicability to elderly patients undergoing pelvic reconstructive surgery.|2|||f||||t||||||||||2017-10-11 03:44:19.062383|2017-10-11 03:44:19.062383
NCT01450787|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2013-08-08|2013-03-09||January 2012||2012-01-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics|Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics|Terminated||N/A|63|Actual|COA Research Foundation, INC|||2|Principle investigator changed practice location and discontinued study|f||||f||||||||||2017-10-11 03:44:19.700287|2017-10-11 03:44:19.700287
NCT01450774|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-03-28|||September 2011||2011-09-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children|A Single Centre, Randomised, Double-blind, Double-dummy, 2-way Cross Over Study to Compare Safety Assessed by Knemometry and Urinary Cortisol Measurements of CHF1535 50/6 Pmdi (Fixed Combination of Beclomethasone Dipropionate and Formoterol Fumarate) and the Free Combination of Licensed Beclomethasone Dipropionate and Formoterol Fumarate in Asthmatic Children Already Treated With Inhaled Corticosteroids|Completed||Phase 3|72|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 03:44:20.10174|2017-10-11 03:44:20.10174
NCT01450761|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-06-14|2016-03-07||December 2011|Actual|2011-12-01|June 2016|2016-06-01|May 17, 2017|Actual|2017-05-17|March 2015|Actual|2015-03-01||Interventional||All randomized participants who received at least one dose of blinded study therapy|Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone|Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab Plus Etoposide/Platinum Versus Etoposide/Platinum in Subjects With Newly Diagnosed Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)|Completed||Phase 3|1414|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-10-11 03:44:20.279972|2017-10-11 03:44:20.279972
NCT01450748|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2015-06-03|||October 2011||2011-10-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux|A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Alginos Oral Suspension (Sodium Alginate 50 mg/ml) for the Treatment of Patients With Laryngopharyngeal Reflux (LPR)|Completed||Phase 3|80|Actual|TTY Biopharm||2|||f||||t||||||||||2017-10-11 03:44:22.612355|2017-10-11 03:44:22.612355
NCT01450735|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-01-13|||October 2011||2011-10-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of the MANOS Carpal Tunnel Release System in Patients With Carpal Tunnel Syndrome||Terminated||N/A|100|Anticipated|Thayer Intellectual Property, Inc.||1||"Enrollment did not reach our intended sample size due to availability of CTR with MANOS outside   of the study."|f||||t||||||||||2017-10-11 03:44:22.723256|2017-10-11 03:44:22.723256
NCT01450722|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2017-05-18|||October 2011||2011-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|finnptx||Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery|Paclitaxel Eluting Stent in Long Superficial Femoral Artery Obstruction: a Prospective, Randomized Comparison With Bypass Surgery Using PTFE Graft in a Finnish Multicenter Study|Recruiting||Phase 3|400|Anticipated|Kuopio University Hospital||2|||f||||t||||||||||2017-10-11 03:44:22.806712|2017-10-11 03:44:22.806712
NCT01450709|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-05-02|||April 2011||2011-04-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Observational|||Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis|Observational Clinical Trials of Kibow Biotics® (a Patented and Proprietary Probiotic Formulation) in Dialysis Patients, in Conjunction With Standardized Care of Treatment|Unknown status|Recruiting|N/A|30|Anticipated|Kibow Biotech Inc.|||1||f||||t||||||Samples With DNA|"     Blood serum, plasma and lymphocytes.   "|||2017-10-11 03:44:22.929947|2017-10-11 03:44:22.929947
NCT01450514|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2014-11-18|||March 2012||2012-03-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia|POC Study of Pipamperone 15mg Added to Stable Risperidone or Paliperidone Treatment in Chronic Schizophrenic and Schizoaffective Patients With Residual Symptoms: a Phase I/IIa, Randomized, Double-blind, Placebo-controlled Trial of 7 Weeks|Completed||Phase 2|7|Actual|PharmaNeuroBoost N.V.||2|||f||||f||||||||||2017-10-11 03:44:28.088997|2017-10-11 03:44:28.088997
NCT00000204|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2013-07-24|||August 1988||1988-08-01|August 2005|2005-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Buprenorphine Maintenance for Opioid Addicts - 3|Buprenorphine Maintenance for Opioid Addicts|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-10-11 04:17:38.850259|2017-10-11 04:17:38.850259
NCT01450696|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-10-05|2016-10-05||December 2011||2011-12-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|HELOISE|The Full Analysis Set (FAS) population included all participants who were randomized in this study.|A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer|A Randomized, Open Label, Multicenter Phase IIIb Study Comparing Two Trastuzumab Dosing Regimens, Each in Combination With Cisplatin/Capecitabine Chemotherapy, as First-Line Therapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Adenocarcinoma Who Have Not Received Prior Treatment for Metastatic Disease|Terminated||Phase 3|296|Actual|Hoffmann-La Roche|Trial was stopped for futility based on pre-planned interim analysis results.|2||futility following planned interim analysis|f||||||||||||||2017-10-11 03:44:23.102429|2017-10-11 03:44:23.102429
NCT01450683|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-03-13|2014-08-29||September 2010||2010-09-01|March 2017|2017-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional||Castrate-resistant Prostate Cancer Patients|Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy|A Phase 2 Study of Itraconazole in Castrate-resistant Prostate Cancer Post-chemotherapy|Terminated||Phase 2|4|Actual|Stanford University||1||Low accrual|f||||t||||||||||2017-10-11 03:44:25.997736|2017-10-11 03:44:25.997736
NCT01450670|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-05-02|||May 2011||2011-05-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|June 2012|Anticipated|2012-06-01||Observational|||Observational Study of Kibow Biotics in Dialysis Patients|Observational Clinical Trials of Kibow Biotics (a Patented and Proprietary Probiotic Dietary Supplement) in Dialysis Patients, in Conjunction With Standardized Care of Treatment|Unknown status|Recruiting|N/A|30|Anticipated|Kibow Biotech Inc.|||1||f||||t||||||Samples With DNA|"     Blood serum and plasma.   "|||2017-10-11 03:44:26.250025|2017-10-11 03:44:26.250025
NCT01450657|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-08-15|||July 2011||2011-07-01|August 2017|2017-08-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|||Observational Study of Kibow Biotics in Chronic Kidney Failure Patients|Observational Clinical Trials of Kibow Biotics (a Patented and Proprietary Probiotic Dietary Supplement) in Chronic Kidney Failure Patients, in Conjunction With Standardized Care of Treatment|Completed||N/A|31|Actual|Kibow Biotech Inc.|||1||f||||t||||||Samples With DNA|"     Blood plasma and serum   "|||2017-10-11 03:44:26.360247|2017-10-11 03:44:26.360247
NCT01450644|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2011-12-07|||October 2011||2011-10-01|December 2011|2011-12-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|H2H-ILD||Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease|A Fast-track Randomised Controlled Trial to Evaluate a Hospital2Home Palliative Care Service for Patients With Advanced Progressive Idiopathic Fibrotic Interstitial Lung Disease|Unknown status|Recruiting|Phase 2|52|Anticipated|Royal Marsden NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:44:26.479961|2017-10-11 03:44:26.479961
NCT01450631|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-06-15|2014-07-03||February 2012||2012-02-01|June 2017|2017-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions|A Prospective, Randomized, Evaluation of the Prevena™ Incision Management System on Closed Incisions in Obese Subjects Undergoing Cesarean Section Surgery|Completed||N/A|92|Actual|KCI USA, Inc.||2|||f||||f||||||||||2017-10-11 03:44:26.601479|2017-10-11 03:44:26.601479
NCT01450618|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-12-04|||March 2011||2011-03-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|November 2011|Actual|2011-11-01||Observational|||Comparative Tolerability of Protease Inhibitors|Comparative Tolerability of Protease Inhibitors and the Associated Impact on Persistence, Healthcare Utilization, and Healthcare Costs|Completed||N/A|26000|Actual|Bristol-Myers Squibb|||4||f||||f||||||||||2017-10-11 03:44:27.26399|2017-10-11 03:44:27.26399
NCT01450605|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-04-20|||December 2011||2011-12-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Korean Post-marketing Surveillance for Reyataz®|Korean Post-marketing Surveillance for Reyataz®|Completed||N/A|601|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 03:44:27.379925|2017-10-11 03:44:27.379925
NCT01450592|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2013-12-26|||May 2012||2012-05-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|STARCH||Study To Assess the Dietary Carbohydrate Content of Indian Diabetic Population|Epidemiological Study to Evaluate the Dietary Composition of Indian Type-2 Diabetic Patients Compared to Non-diabetic Population|Completed||N/A|796|Actual|Bayer|||2||f||||f||||||||||2017-10-11 03:44:27.463879|2017-10-11 03:44:27.463879
NCT01450579|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-09-27|||July 2011||2011-07-01|September 2017|2017-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers|Phase II Study of ASP7373 Evaluation of Immunogenicity and Safety of ASP7373 in Healthy Adults|Completed||Phase 2|180|Actual|UMN Pharma Inc.||4|||f||||f||||||||||2017-10-11 03:44:27.577715|2017-10-11 03:44:27.577715
NCT01450566|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-11-05|||September 2011||2011-09-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Intraureteral Lidocaine for Post-Ureteroscopy Pain|Intraureteral of Alkalinized Lidocaine as Novel Approach to Post-Ureteroscopy Pain: Double-blind Prospective Randomized Controlled Trial|Unknown status|Recruiting|N/A|48|Anticipated|Queen's University||2|||f||||f||||||||||2017-10-11 03:44:27.682976|2017-10-11 03:44:27.682976
NCT01450553|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2012-01-09|||October 2011||2011-10-01|January 2012|2012-01-01||||||||Observational|||Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease|Research and Development Study: Tissue Collection From Patients Who Are Undergoing Surgery for Non-Small Cell Lung Cancer|Unknown status|Recruiting|N/A|450|Anticipated|Precision Therapeutics|||1||f||||f||||||Samples With DNA|"     Human tumor tissues will be collected and preserved in three different tissue formats:        -  Fresh Frozen        -  FFPE        -  RNAlater   "|||2017-10-11 03:44:27.8143|2017-10-11 03:44:27.8143
NCT01450540|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2012-07-31|||September 2011||2011-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:44:27.932302|2017-10-11 03:44:27.932302
NCT01450527|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2013-01-12|||July 2010||2010-07-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Etiology and Outcomes of Tropical Acute Respiratory Distress Syndrome|Etiology and Outcomes of Acute Respiratory Distress Syndrome in Medical ICU in AIIMS|Completed||N/A|64|Actual|All India Institute of Medical Sciences, New Delhi|||1||f||||f||||||||||2017-10-11 03:44:27.986966|2017-10-11 03:44:27.986966
NCT01450501|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-07-22|||March 2011||2011-03-01|July 2013|2013-07-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|QAAD||Chronic Q-fever in Patients With an Abdominal Aortic Disease (QAAD-study)|Chronic Q-fever in Patients With an Abdominal Aortic Disease (QAAD-study)|Unknown status|Active, not recruiting|N/A|999|Anticipated|Jeroen Bosch Ziekenhuis|||1||f||||f||||||Samples With DNA|"     Blood and tissue will be investigated using Polymerase Chain Reaction. Serology for     C.burnetii will be investigated in blood using Immunofluorecense assay (focus diagnostics).   "|||2017-10-11 03:44:28.203343|2017-10-11 03:44:28.203343
NCT01450488|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-10|||June 2005||2005-06-01|October 2011|2011-10-01|January 2010|Actual|2010-01-01|July 2007|Actual|2007-07-01||Interventional|||Masitinib in Patients With Primary Progressive Multiple Sclerosis (PPMS) or Relapse-free Secondary Progressive Multiple Sclerosis (SPMS)|A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Activity of Oral AB1010 Administered at 2 Dose Levels to Patients With Primary Progressive or Relapse-free Secondary Progressive Multiple Sclerosis|Completed||Phase 2|35|Actual|AB Science||2|||f||||f||||||||||2017-10-11 03:44:28.291751|2017-10-11 03:44:28.291751
NCT01450475|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2013-07-22|||August 2011||2011-08-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Study of Remote Ischemic Postconditioning|A Randomized Control Trial of Effect of Remote Ischemic Postconditioning on Children Undergoing Cardiac Surgery|Completed||Phase 1|65|Actual|Xijing Hospital||2|||f||||t||||||||||2017-10-11 03:44:28.368673|2017-10-11 03:44:28.368673
NCT01450462|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2013-12-03|||September 2011||2011-09-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|DASH||Vitamin D and Sexual Health|Vitamin D and Sexual Health (the DASH Study)|Completed||N/A|118|Actual|Ohio State University||2|||f||||t||||||||||2017-10-11 03:44:28.462355|2017-10-11 03:44:28.462355
NCT01450449|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2015-03-23|||February 2009||2009-02-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|December 2013|Actual|2013-12-01||Interventional|||Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme|A Randomized Phase III Study of Short Course (One-week) Radiation Therapy Versus Standard Course (Three-week) Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 3|115|Actual|International Atomic Energy Agency||2|||f||||t||||||||||2017-10-11 03:44:28.548125|2017-10-11 03:44:28.548125
NCT01450436|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2012-11-16|||September 2011||2011-09-01|November 2012|2012-11-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Observational|EPIPOD||Impact of Preterm Body Composition at Discharge on 2 Years Neurological Development (ASQ Evaluation)|Impact of Preterm Body Composition at Discharge on 2 Years Neurological Development (ASQ Evaluation)|Unknown status|Recruiting|N/A|189|Anticipated|Nantes University Hospital|||1||f||||f||||||||||2017-10-11 03:44:28.674404|2017-10-11 03:44:28.674404
NCT01450423|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2011-10-09|||September 2011||2011-09-01|October 2011|2011-10-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|EFA||Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy|Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy Aged 15-50: A Randomized Controlled Trial|Unknown status|Recruiting|Phase 2|40|Anticipated|University of Southern Denmark||2|||f||||||||||||||2017-10-11 03:44:28.758744|2017-10-11 03:44:28.758744
NCT01450410|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2013-01-28|||July 2012||2012-07-01|November 2011|2011-11-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|11MSP011||Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL|Efecto Del ácido nicotínico Sobre la composición de Las lipoproteínas de Alta Densidad (HDL) y la función Del Endotelio Arterial en Los Pacientes Con cardiopatía isquémica Prematura y Concentraciones Elevadas de Colesterol-HDL|Terminated||Phase 4|12|Actual|Hospital Universitari de Bellvitge||2||Study terminated (halted prematurely) as recomended by the drug supplier and medical agencies|f||||t||||||||||2017-10-11 03:44:28.866883|2017-10-11 03:44:28.866883
NCT01450397|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2017-03-20|2013-10-29||March 2011||2011-03-01|March 2017|2017-03-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex|MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex|Completed||Phase 4|5|Actual|Hospital for Special Surgery, New York||1|||f||||f||||||||||2017-10-11 03:44:28.95944|2017-10-11 03:44:28.95944
NCT01450384|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-02-19|||October 2011||2011-10-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors|Phase I Study of Pemetrexed and Sorafenib in Advanced Malignancy|Completed||Phase 1|37|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 03:44:29.132069|2017-10-11 03:44:29.132069
NCT01450371|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2013-01-23|||July 2011||2011-07-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|InterM||Interferential Electrical Stimulation and Vasodilatation in Healthy Individuals|Interferential Electrical Stimulation Improves Peripheral Vasodilatation in Healthy Individuals: A Randomized Crossover Study|Completed||N/A|11|Actual|Hospital de Clinicas de Porto Alegre|||2||f||||f||||||||||2017-10-11 03:44:29.391037|2017-10-11 03:44:29.391037
NCT01450358|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-10|2016-06-07|||January 2012||2012-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.|Evaluation of Antimicrobial Use and Time of Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction (PCR) in Real Time Multiplex to the Conventional Blood Culture for Etiologic Agents Identification. Randomized Clinical Trial.|Completed||Phase 4|200|Actual|Instituto do Coracao||2|||f||||f||||||||||2017-10-11 03:44:29.511667|2017-10-11 03:44:29.511667
NCT01450345|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2011-10-11|||September 2009||2009-09-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Efficacy of Pre-operative Oral Pregabalin in Ambulatory Inguinal Hernia Repair for Post Operative Pain|Efficacy of Pre-operative Oral Pregabalin in Ambulatory Inguinal Hernia Repair for Post Operative Pain|Unknown status|Recruiting|Phase 3|72|Anticipated|University of Malaya||1|||f||||f||||||||||2017-10-11 03:44:29.61332|2017-10-11 03:44:29.61332
NCT01450332|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2011-10-11|||March 2011||2011-03-01|October 2011|2011-10-01|January 2013|Anticipated|2013-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Safety and Efficacy of the Knee-T-nol Anterior Cruciate Ligament (ACL) Prosthesis|A Single Arm, Prospective, Single Center, Study To Evaluate The Safety And Efficacy Of Tavor ACL Prosthesis In Patient With ACL Rupture|Unknown status|Recruiting|N/A|20|Anticipated|Tavor Ltd.||1|||f||||t||||||||||2017-10-11 03:44:29.714359|2017-10-11 03:44:29.714359
NCT01450319|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-10-07|2016-05-10||December 2011||2011-12-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MUTEX|MITT analysis set included all the subjects who received study drug treatment.|Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) Genotype|Phase II Clinical Study of Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favourable FcγR IIa (CD32) Genotype|Completed||Phase 2|73|Actual|Merck KGaA||1|||f||||f||||||||||2017-10-11 03:44:29.816461|2017-10-11 03:44:29.816461
NCT01450306|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-03-25|2012-05-24||July 2010||2010-07-01|March 2016|2016-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics|Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics|Completed||N/A|20|Actual|Hartford Hospital||2|||f||||t||||||||Yes|De-identified data will be made available upon request|2017-10-11 03:44:30.238475|2017-10-11 03:44:30.238475
NCT01450293|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2013-12-11|||October 2011||2011-10-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Children in a Malaria Endemic Area|Safety and Immunogenicity of Heterologous Prime-boost Vaccination With the Candidate Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP in Healthy Infants in a Malaria- Endemic Area|Completed||Phase 1|72|Actual|University of Oxford||6|||f||||t||||||||||2017-10-11 03:44:30.568432|2017-10-11 03:44:30.568432
NCT01450280|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-11-28|||December 2011||2011-12-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS|A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and With MVA CS|Completed||Phase 1|24|Actual|University of Oxford||4|||f||||t||||||||||2017-10-11 03:44:30.67271|2017-10-11 03:44:30.67271
NCT01450254|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2015-07-06|||August 2012||2012-08-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Foot Center of Pressure Manipulation on Hip Osteoarthritis Patients During Gait|Effects of Foot Center of Pressure Manipulation on Hip Biomechanics, Muscle Activation Patterns, and Energy Consumption During Gait in Hip Osteoarthritis Patients|Completed||N/A|14|Actual|HaEmek Medical Center, Israel||2|||f||||||||||||||2017-10-11 03:44:30.918258|2017-10-11 03:44:30.918258
NCT01450241|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-17|2013-06-06|||January 2012||2012-01-01|June 2013|2013-06-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia|Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia: Randomized-controlled Trial|Withdrawn||N/A|0|Actual|Rabin Medical Center||2||slow recruitment, no funding|f||||t||||||||||2017-10-11 03:44:31.03081|2017-10-11 03:44:31.03081
NCT01450228|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2012-04-23|||March 2011||2011-03-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients|A Double-blind, Parallel Group, Randomised, Placebo Controlled, Multicenter, Bridging Phase III Study of Efficacy and Safety of KI1001 in the Improvement of Sleep Quality in ≥ 55 Years Old Insomnia Patients|Completed||Phase 3|170|Actual|Kuhnil Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:44:31.151596|2017-10-11 03:44:31.151596
NCT01450215|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-03-24|||March 2011||2011-03-01|March 2016|2016-03-01||||January 2016|Actual|2016-01-01||Interventional|||Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple Myeloma||Completed||Phase 2|62|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 03:44:31.287887|2017-10-11 03:44:31.287887
NCT01450202|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2012-06-24|||November 2011||2011-11-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|COCE||Safety and Efficacy of Carbon Dioxide Insufflation During Colonoscopy With Consecutive Esophagogastroduodenoscopy in Reduction of Abdominal Pain in Sedated Outpatients|Carbon Dioxide Insufflation During Colonoscopy With Consecutive EGD is Safe and Decreases Abdominal Pain in Sedated Outpatients: a Randomized, Double-blind, Controlled Trial|Completed||Phase 3|100|Actual|Inje University||2|||f||||f||||||||||2017-10-11 03:44:31.370954|2017-10-11 03:44:31.370954
NCT01450189|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2016-11-04|2016-01-13||October 2011||2011-10-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|MP3||A Key Link for Transmission Prevention|Acute HIV Infection - A Key Link for Transmission Prevention: A Randomized Pilot Study|Completed||N/A|46|Actual|University of North Carolina, Chapel Hill|Please note that this trial was a pilot study.|3|||f||||t||||||||||2017-10-11 03:44:31.499872|2017-10-11 03:44:31.499872
NCT01450176|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2014-01-08|||September 2011||2011-09-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Comparing Patient Satisfaction With Pataday or Bepreve|Comparing Patient Satisfaction Throughout the Day With PATADAY (OLOPATADINE HYDROCHLORIDE) 0.2% QD or BEPREVE (BEPOTASTINE BESILATE OPHTHALMIC SOLUTION) 1.5% BID|Completed||N/A|30|Actual|McCabe Vision Center||2|||f||||f||||||||||2017-10-11 03:44:32.822312|2017-10-11 03:44:32.822312
NCT01450163|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-26|2017-05-08|||August 2011|Actual|2011-08-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|PreOx||Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy|PHASE III, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Pregabalin in Prevention and Reduction of Oxaliplatin-induced Painful Neuropathy|Completed||Phase 3|200|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:44:32.923031|2017-10-11 03:44:32.923031
NCT01450150|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-09|2016-01-19|||January 2016||2016-01-01|January 2016|2016-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Transcranial Direct Current Stimulation as an Augmenting Intervention for Major Depression|Transcranial Direct Current Stimulation (tDCS) as an Augmenting Intervention for Treatment-Resistant Major Depression: A Randomized, Double-Blind and Sham-Controlled Trial|Not yet recruiting||Phase 2/Phase 3|30|Anticipated|Douglas Mental Health University Institute||2|||f||||f||||||||||2017-10-11 03:44:33.028817|2017-10-11 03:44:33.028817
NCT01450124|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2015-03-16|||September 2011||2011-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SABA||Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)|Safety, Tolerability And Mechanism Of Action Of Boswellic Acids In Multiple Sclerosis and Clinically Isolated Syndrome: A MRI-Controlled, Multicenter, Baseline-To-Treatment, 32-Weeks, Open-Label, Phase IIa Trial|Completed||Phase 2|29|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||t||||||||||2017-10-11 03:44:33.240734|2017-10-11 03:44:33.240734
NCT01450111|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2011-10-13|||November 2008||2008-11-01|October 2011|2011-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects|Single-site, Randomized, Double-blind, Placebo-controlled, Parallel-group, Single/Repeated Dose Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects|Completed||Phase 1|51|Actual|UCB Pharma||6|||f||||f||||||||||2017-10-11 03:44:33.336911|2017-10-11 03:44:33.336911
NCT01450098|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2012-01-12|||October 2011||2011-10-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of LY2484595 in Healthy Subjects|Single Dose LY2484595 Tablet Formulations to Determine the Impact of Dose Level, Food, and Ethnicity on the Pharmacokinetics in Healthy Subjects|Completed||Phase 1|45|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:44:33.443235|2017-10-11 03:44:33.443235
NCT01450085|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2017-08-15|||September 2012||2012-09-01|August 2017|2017-08-01|December 30, 2016|Actual|2016-12-30|December 2016|Actual|2016-12-01||Interventional|||Chepetsa TB - Reducing TB Among HIV-Infected Malawians|Impact of a New Molecular Tuberculosis (TB) Test on TB/HIV Outcomes Among HIV-|Completed||N/A|1200|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 03:44:33.520429|2017-10-11 03:44:33.520429
NCT01450072|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-05-10|||June 2010||2010-06-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|PREMiSE||Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE|Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE|Completed||Phase 2|20|Actual|University at Buffalo Neurosurgery||2|||f||||t||||||||||2017-10-11 03:44:33.624658|2017-10-11 03:44:33.624658
NCT01450059|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-02-19|||August 2011||2011-08-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|April 2014|Actual|2014-04-01||Observational|||Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section|Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section|Completed||N/A|54|Actual|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples With DNA|"     Umbilical Cord blood Blood from peripheral vene   "|||2017-10-11 03:44:33.711504|2017-10-11 03:44:33.711504
NCT01450046|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-07-05|||October 2011||2011-10-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|March 2013|Actual|2013-03-01||Interventional|||Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects|A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Vitamin E δ-Tocotrienol Following Multiple Dose Administration in Healthy Subjects|Completed||Phase 1|18|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 03:44:33.829663|2017-10-11 03:44:33.829663
NCT01450033|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-08-31|||September 2011||2011-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2017|Actual|2017-01-01||Interventional|Peers4PATH||Peers for Promoting Adolescent Transplant Health|A Peer Mentoring Intervention to Improve Adherence and Quality of Life in Adolescents With Solid Organ Transplants|Active, not recruiting||N/A|74|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 03:44:33.944088|2017-10-11 03:44:33.944088
NCT01450020|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-09-06|||June 1, 2012|Actual|2012-06-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors|Sister Survivor: Improving the Survivorship Care of African-American Women With Breast Cancer|Active, not recruiting||N/A|145|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 03:44:34.065961|2017-10-11 03:44:34.065961
NCT01450007|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-05-16|2016-04-11||May 2012||2012-05-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|||Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery|Perineural Versus Systemic Dexamethasone as an Analgesic Adjunct to Ultrasound-Guided Ropivacaine Interscalene Blockade in Arthroscopic Rotator Cuff Repair|Completed||Phase 4|130|Actual|Mayo Clinic|Although it was designed to have 80% power at 120 patients, double this number would be required to detect very small differences (<10%) in the systemic and perineural groups.|3|||f||||f||||||||No||2017-10-11 03:44:34.21646|2017-10-11 03:44:34.21646
NCT01449994|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2012-02-07|||July 2010||2010-07-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy of Instrumental Chiropractic Treatment Using Activator Methods for Pain and Dysfunction in Juvenile Athletes|Efficacy of Instrumental Chiropractic Treatment Using Activator Methods for Pain and Dysfunction.A Randomized Placebo-controlled Clinical Study on Juvenile Athletes With Leg Pain|Completed||N/A|26|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-11 03:44:34.803327|2017-10-11 03:44:34.803327
NCT01449981|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-09-12|||October 2011||2011-10-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|March 2015|Actual|2015-03-01||Interventional|||Development and Testing of Adolescent Twelve-Step Facilitation|Development and Testing of Adolescent Twelve-Step Facilitation|Completed||N/A|59|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:44:34.890522|2017-10-11 03:44:34.890522
NCT01449968|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-04-25|||June 2011||2011-06-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Observational|UMG||Provision of a Mobile Geriatric Team Extra-Community Hospital|Provision of a Mobile Geriatric Team Extra-Community Hospital in Assessing and Regulating the Hospitalization of Frail Elderly Patients With Complex Medical and Social Situation|Completed||N/A|334|Actual|University Hospital, Grenoble|||2||f||||f||||||||||2017-10-11 03:44:34.983665|2017-10-11 03:44:34.983665
NCT01446081|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-05-23|||June 2011||2011-06-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy|A Phase II Exercise RCT for AML Patients Undergoing Induction Chemotherapy|Completed||Phase 2|83|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:46:02.926442|2017-10-11 03:46:02.926442
NCT01449955|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-03-01|2013-06-18||August 2008||2008-08-01|March 2014|2014-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional||Male Veterans with PTSD|Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory|mTOR Kinase as a Therapeutic Target in Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory|Completed||N/A|54|Actual|University of Texas Southwestern Medical Center|Timing of medication administration may not have been optimal and relatively small sample size|2|||f||||t||||||||||2017-10-11 03:44:35.10518|2017-10-11 03:44:35.10518
NCT01449942|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-06|||May 2009||2009-05-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|NPC-DZ||Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma|Phase I/II Study of EBV-LMP1 Targeted DNAzyme in Nasopharyngeal Carcinoma|Completed||Phase 1/Phase 2|40|Actual|Xiangya Hospital of Central South University||2|||f||||t||||||||||2017-10-11 03:44:35.411817|2017-10-11 03:44:35.411817
NCT01449929|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-05-26|2013-12-12||October 31, 2011|Actual|2011-10-31|May 2017|2017-05-01|December 26, 2016|Actual|2016-12-26|April 22, 2013|Actual|2013-04-22||Interventional|FLAMINGO||Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects|A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of GSK1349572 (Dolutegravir, DTG) 50 mg Once Daily Compared to Darunavir/Ritonavir (DRV/r) 800 mg/100 mg Once Daily Each Administered With Fixed-dose Dual Nucleoside Reverse Transcriptase Inhibitor Therapy Over 96 Weeks in HIV-1 Infected Antiretroviral naïve Adult Subjects|Completed||Phase 3|488|Actual|ViiV Healthcare||2|||f||||f|t|||||||||2017-10-11 03:44:35.549359|2017-10-11 03:44:35.549359
NCT01449903|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2015-05-27|||January 2012||2012-01-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Survival of Different Core Build-up Materials|Core Build-up Materials: a Randomized Clinical Study|Unknown status|Recruiting|N/A|300|Anticipated|Heidelberg University|||3||f||||f||||||||||2017-10-11 03:44:37.164904|2017-10-11 03:44:37.164904
NCT01449890|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2015-06-03|||September 2012||2012-09-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Randomized Trial of Depression Follow-up Care by Email|Randomized Trial of E-mail Follow-up Care After Cognitive Behavioural Treatment for Depression|Completed||N/A|92|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 03:44:37.259704|2017-10-11 03:44:37.259704
NCT01449877|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-07-10|||October 2011||2011-10-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ISROT||Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis|Influence of Trimethoprim-sulfamethoxazole for the Recurrence of Retinochoroiditis Toxoplasma Gondii|Completed||Phase 3|141|Actual|University of Campinas, Brazil||2|||f||||t||||||||Undecided||2017-10-11 03:44:37.364309|2017-10-11 03:44:37.364309
NCT01449864|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2016-09-23|||August 2011||2011-08-01|September 2016|2016-09-01||||June 2013|Actual|2013-06-01||Interventional|||Proton Radiotherapy for Upper Gastrointestinal Malignancies|A Feasibility and Registration Study of Proton Radiotherapy for Upper Gastrointestinal Malignancies|Active, not recruiting||N/A|22|Actual|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:44:37.481528|2017-10-11 03:44:37.481528
NCT01449838|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-07-18|||October 23, 2010|Actual|2010-10-23|July 2017|2017-07-01|December 9, 2010|Actual|2010-12-09|December 9, 2010|Actual|2010-12-09||Interventional|||Phase I Study of Colistin Methanesulfonate Sodium|Phase I Study of Colistin Methanesulfonate Sodium (CMS-Na) -A Randomized, Double Blind, Placebo Controlled, Single and Repeat Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CMS-Na in Healthy Japanese Male Subjects -|Completed||Phase 1|22|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:44:37.560671|2017-10-11 03:44:37.560671
NCT01449825|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2014-04-17|||December 2010||2010-12-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Hepatic Monitoring for Pazopanib|Postmarketing Hepatic Monitoring for Pazopanib Using Observational Databases|Completed||N/A|1|Actual|GlaxoSmithKline|||4||f||||f||||||||||2017-10-11 03:44:37.660067|2017-10-11 03:44:37.660067
NCT01449812|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-04-13|2017-02-28|2012-07-24|October 1, 2011||2011-10-01|April 2017|2017-04-01|January 16, 2012|Actual|2012-01-16|January 16, 2012|Actual|2012-01-16||Interventional|||Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine|Immunogenicity and Safety of a Booster Dose of GlaxoSmithKline Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) in Healthy Chinese Toddlers|Completed||Phase 3|831|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 03:44:37.814751|2017-10-11 03:44:37.814751
NCT01449799|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-07-26|||July 13, 2011|Actual|2011-07-13|July 2017|2017-07-01|September 21, 2011|Actual|2011-09-21|September 21, 2011|Actual|2011-09-21||Interventional|||An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers|A Randomised, Double-blind, Double-dummy, Single Dose, Four Way Cross-over Study to Compare the Pharmacokinetics and Pharmacodynamics of GSK961081 and Fluticasone Propionate When Administered Alone, Concurrently and as a Combination Blend in Healthy Subjects|Completed||Phase 1|24|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:44:39.306383|2017-10-11 03:44:39.306383
NCT01449786|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-04-12|||March 14, 2012|Actual|2012-03-14|April 2017|2017-04-01|December 20, 2016|Actual|2016-12-20|February 28, 2014|Actual|2014-02-28||Interventional|||Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy|Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy|Completed||Phase 2|60|Actual|Medical University of Vienna||3|||f||||t|f|f||||||No||2017-10-11 03:44:39.434502|2017-10-11 03:44:39.434502
NCT01449773|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-02-28|||April 2008||2008-04-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|October 2009|Actual|2009-10-01||Interventional|DBB48||Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes|Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes|Completed||N/A|12|Actual|Laval University||2|||f||||f||||||||||2017-10-11 03:44:39.547399|2017-10-11 03:44:39.547399
NCT01449760|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-12-08|||March 2010||2010-03-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|March 2015|Anticipated|2015-03-01||Interventional|||Ankle Sprain Rehabilitation With the Wii Balance Board||Unknown status|Active, not recruiting|N/A|90|Actual|University Hospital, Geneva||3|||f||||t||||||||||2017-10-11 03:44:39.648322|2017-10-11 03:44:39.648322
NCT01449747|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-11-10|2015-08-23||December 2011||2011-12-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|August 2014|Actual|2014-08-01||Interventional|||Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus|Mechanism of Reduced Response to DPP-4 Inhibitor in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|24|Actual|The Catholic University of Korea||2|||f||||f||||||||||2017-10-11 03:44:39.754158|2017-10-11 03:44:39.754158
NCT01449734|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-09-04|2013-02-26||April 2011||2011-04-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|February 2012|Actual|2012-02-01||Observational||Visiting family members|Family Satisfaction (FS) in the Intensive Care Unit|Observational Study of Family Satisfaction in the Intensive Care Unit Using the German-language FS-ICU|Completed||N/A|217|Actual|Center for Sepsis Control and Care, Germany|||1||f||||f||||||||||2017-10-11 03:44:40.498366|2017-10-11 03:44:40.498366
NCT01449721|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-10-02|2016-11-30||September 2011||2011-09-01|October 2017|2017-10-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01||Interventional|||Preemptive Resuscitation for Eradication of Septic Shock|Preemptive Empiric Resuscitation Protocol for the Prevention of Disease Progression in the Treatment of Sepsis|Completed||N/A|142|Actual|Christiana Care Health Services||2|||f||||f||||||||||2017-10-11 03:44:40.703581|2017-10-11 03:44:40.703581
NCT01449708|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-02-19|2015-02-27||November 2011||2011-11-01|February 2016|2016-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting in Bariatric Surgery|Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting (PONV) in Bariatric Surgery|Completed||Phase 4|124|Actual|Coastal Anesthesiology Consultants||2|||f||||t||||||||No||2017-10-11 03:44:41.044423|2017-10-11 03:44:41.044423
NCT01449695|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-04-04|||November 2011||2011-11-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Intervention to Improve Medication Adherence in Cardiovascular Patients|Nurse- and Web Based Intervention to Improve Medication Adherence in High Risk Cardiovascular Patients.|Completed||N/A|420|Actual|Radboud University||3|||f||||f||||||||||2017-10-11 03:44:41.529512|2017-10-11 03:44:41.529512
NCT01449682|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-04-26|2017-04-26||October 2011||2011-10-01|April 2017|2017-04-01|February 2013|Actual|2013-02-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.|Efficacy of an Intravitreal Dexamethasone Implant on Macular Function in Retinal Vein Occlusion Following Treatment With Intravitreal Anti-VEGF Injections.|Completed||Phase 3|10|Actual|Retina Macula Institute||2|||f||||f||||||||||2017-10-11 03:44:41.640428|2017-10-11 03:44:41.640428
NCT01449669|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-02-07|||September 2011||2011-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|April 2013|Actual|2013-04-01||Observational|SSI||Surgical Site Infection Study|Skeletal Muscle and Plasma Concentrations of Cefazolin During Pediatric Cardiac Surgery Utilizing Cardiopulmonary Bypass, Deep Hypothermic Cardiac Arrest, and Modified Ultrafiltration|Completed||N/A|14|Actual|Children's Hospital of Philadelphia|||1||f||||t||||||||||2017-10-11 03:44:42.032881|2017-10-11 03:44:42.032881
NCT01449656|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-12-09|||October 2011||2011-10-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||A Comparison of the Laryngeal Mask Airway (LMA) Proseal and LMA Supreme in Children|A Randomized Trial Comparing the Laryngeal Mask Airway-SupremeTM With the Laryngeal Mask Airway-ProsealTM in Children|Completed||N/A|60|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||||2017-10-11 03:44:42.10757|2017-10-11 03:44:42.10757
NCT01449630|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2012-04-13|||October 2011||2011-10-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study of LY3031207 in Healthy Subjects|A Single-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3031207 in Healthy Subjects|Completed||Phase 1|42|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:44:42.275786|2017-10-11 03:44:42.275786
NCT01449617|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-07-16|||August 2010||2010-08-01|July 2014|2014-07-01|March 2016|Anticipated|2016-03-01|January 2016|Anticipated|2016-01-01||Observational|ARS||Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting|Observational Study on Predictive Value for Vascular Events of Residual Platelet Aggregation in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting|Unknown status|Recruiting|N/A|272|Anticipated|Azienda Ospedaliera di Perugia|||1||f||||f||||||Samples Without DNA|"     Whole blood samples, plasma samples, serum samples, urines.   "|||2017-10-11 03:44:42.372139|2017-10-11 03:44:42.372139
NCT01449604|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-02|2011-10-06|||October 2011||2011-10-01|October 2011|2011-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Stereotactic Radiation in Vestibular Schwannoma|Randomized Comparison of Steretotactic Radiosurgery and Hypofractionated Steretotactic Radiotherapy in the Treatment of Vestibular Schwannoma|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|Ramathibodi Hospital||2|||f||||f||||||||||2017-10-11 03:44:42.472841|2017-10-11 03:44:42.472841
NCT01449591|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-03-24|||September 2011||2011-09-01|March 2017|2017-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients|A Proof of Concept (PoC) Study to Evaluate the Safety, Tolerability, and Efficacy of 12 Week Administration of BFH772 Ointment in Rosacea Patients|Completed||Phase 2|36|Actual|Novartis||3|||f||||||||||||||2017-10-11 03:44:42.556972|2017-10-11 03:44:42.556972
NCT01449578|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-11-24|||November 2011||2011-11-01|November 2014|2014-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Dexpramipexole SAD/MAD Study|A Randomized, Blinded, Placebo-Controlled Ascending Dose Study of the Safety and Pharmacokinetics of Dexpramipexole in Healthy Volunteers|Completed||Phase 1|63|Actual|Knopp Biosciences||10|||f||||f||||||||||2017-10-11 03:44:42.652926|2017-10-11 03:44:42.652926
NCT01449565|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-04-11|||September 2012||2012-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|TREX||Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)|Extended-Release Naltrexone (XR-NTX, VIVITROL) for the Treatment of Actively-Using Methamphetamine-Dependent Men Who Have Sex With Men|Completed||Phase 2|100|Actual|San Francisco Department of Public Health||2|||f||||t||||||||||2017-10-11 03:44:42.75618|2017-10-11 03:44:42.75618
NCT01449552|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2011-11-04|||June 2008||2008-06-01|November 2011|2011-11-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|||Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT|Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.|Completed||N/A|240|Actual|Mahidol University||4|||f||||f||||||||||2017-10-11 03:44:42.871135|2017-10-11 03:44:42.871135
NCT01449539|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2015-02-20|2014-11-21||February 2012||2012-02-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization|Pilot Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization|Terminated||N/A|8|Actual|University of Arkansas|Study was terminated early because the site that administered the hyperbaric oxygen treatment closed and an alternative site could not be identified. Only four subjects completed the trial.|1||"Study was terminated early because the site that administered the hyperbaric oxygen treatment   closed and an alternative site could not be identified."|f||||t||||||||||2017-10-11 03:44:42.962896|2017-10-11 03:44:42.962896
NCT01449526|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2015-02-13|2014-03-28||August 2011||2011-08-01|February 2015|2015-02-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional||All Eligible, Dispensed Subjects|A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design|A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design|Completed||N/A|166|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 03:44:43.193424|2017-10-11 03:44:43.193424
NCT01449513|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-04-04|2013-10-08||September 2011||2011-09-01|April 2016|2016-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy|A Phase 1, Two-stage, Single-centre, Open Label, Within- and Between-subject Comparison Trial to Explore the Biological Effects of PEP005 (Ingenol Mebutate) Gel, 0.05%, Applied Once Daily for 2 Consecutive Days in Subjects With Actinic Keratosis on the Upper Extrem-ity. A Single-arm First Stage Followed by a Two-arm, Parallel Group, Randomized, Placebo (Vehicle) -Controlled Second Stage|Completed||Phase 1|24|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 03:44:43.522091|2017-10-11 03:44:43.522091
NCT01449500|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-07|||October 2011||2011-10-01|October 2011|2011-10-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Supplementation With L. Reuteri in H. Pylori Infected Adults|Effect of Dietary Supplementation With L. Reuteri ProGastria in H. Pylori-infected Adult Subjects Treated Only With Proton Pump Inhibitors|Unknown status|Not yet recruiting|N/A|56|Anticipated|Lama Medical Care s.r.o.||2|||f||||f||||||||||2017-10-11 03:44:44.238464|2017-10-11 03:44:44.238464
NCT01449487|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-05-20|||January 2012||2012-01-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid|A Randomized, Double-blind, Cross-over Trial in Patients With Irritable Bowel Syndrome Investigating the Efficacy and Safety of PPC-5650 on Sensation and Pain During Standardized Stimulation of the Rectosigmoid|Completed||Phase 1|25|Actual|Aros Pharma ApS||2|||f||||t||||||||||2017-10-11 03:44:44.338377|2017-10-11 03:44:44.338377
NCT01449474|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-02-21|||April 2011||2011-04-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Accuracy of MRI-based Patients Matched Instruments vs Jig-based Instruments in Total Knee Arthroplasty (TKA)|Accuracy of MRI-based Patients Matched Instruments and Jig-based Instruments in Total Knee Arthroplasty|Completed||N/A|80|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 03:44:44.427172|2017-10-11 03:44:44.427172
NCT01449461|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-09-05|2017-05-26||September 20, 2011|Actual|2011-09-20|September 2017|2017-09-01|July 8, 2019|Anticipated|2019-07-08|November 16, 2015|Actual|2015-11-16||Interventional||Safety population included all enrolled participants who received at least one dose of study drug.|A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113)|A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral ALK/EGFR Inhibitor AP26113|Active, not recruiting||Phase 1/Phase 2|137|Actual|Ariad Pharmaceuticals||6|||f||||f|t|f||||||||2017-10-11 03:44:44.581653|2017-10-11 03:44:44.581653
NCT01449448|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-11-02|||September 2000||2000-09-01|November 2016|2016-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|NSAID||Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement Syndrome|A Double-blind Randomized Controlled Trial Comparing the Effects of Subacromial Injection With Corticosteroid Versus NSAID in Patients With Shoulder Impingement Syndrome|Withdrawn||N/A|0|Actual|Madigan Army Medical Center||2||PI didn't have time to finish approval process|f||||t||||||||||2017-10-11 03:44:50.155989|2017-10-11 03:44:50.155989
NCT01449435|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2013-04-24|||August 2011||2011-08-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Predictors of Asthma Exacerbations in Children|Asthma Exacerbations in Young Children With Moderate Asthma - Prospective Evaluation of Predictors|Completed||N/A|75|Actual|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-10-11 03:44:50.284785|2017-10-11 03:44:50.284785
NCT01449422|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2013-03-28|||May 2011||2011-05-01|March 2013|2013-03-01||||January 2013|Actual|2013-01-01||Interventional|||Clinical Trial to Evaluate the Efficacy, Tolerance and Acceptability of URGO Dressing vs a Hydrofibre in the Local Management of Venous or Predominantly Venous Mixed Leg Ulcers.|Evaluation Of The Efficacy, Tolerance And Acceptability Of URGO Dressing 310 3082 Versus A Hydrofibre Dressing In The Local Management Of Venous Or Predominantly Venous Mixed Leg Ulcers|Completed||Phase 4|159|Actual|Laboratoires URGO||2|||f||||f||||||||||2017-10-11 03:44:50.369199|2017-10-11 03:44:50.369199
NCT01449409|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-01-04|||February 2011||2011-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|RIDUNA||Reduce IDentified UNcontrolled Asthma|Reduce IDentified UNcontrolled Asthma: A Real-time Randomized Administrative Outreach Study to Promote Asthma Guideline Implementation (RIDUNA)|Active, not recruiting||Phase 4|3000|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 03:44:50.457734|2017-10-11 03:44:50.457734
NCT01449396|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-07-21|||October 2011||2011-10-01|July 2015|2015-07-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Acupuncture, Chinese Traditional Medicine, in Embryo Transfer|Chinese Traditional Medicine Contribution to Improve In-vitro Fertilization (IVF) Results: Acupuncture in Embryo Transfer|Unknown status|Recruiting|N/A|252|Anticipated|Instituto de Investigacion Sanitaria La Fe||3|||f||||t||||||||||2017-10-11 03:44:50.56409|2017-10-11 03:44:50.56409
NCT01449383|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2012-08-13|||November 2010||2010-11-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|TORNADO||Effect of Diet on Intestinal Microbiota and Obesity Markers in Adults|Molecular Targets Open for Regulation by the Gut Flora - New Avenues for Improved Diet to Optimize European Health (TORANDO): WP2 Individual Intervention Studies- Effect of Diet on Intestinal Microbiota and Obesity Markers in Adults|Completed||N/A|20|Actual|German Institute of Human Nutrition||2|||f||||f||||||||||2017-10-11 03:44:50.699803|2017-10-11 03:44:50.699803
NCT01449370|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-01-13|2017-01-13||October 2011||2011-10-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional||The all subjects as treated (ASaT) population included all enrolled participants who received at least 1 dose of TAK-117.|Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer|A Phase I, Dose Escalation Study of MLN1117 in Subjects With Advanced Solid Malignancies Followed by Expansion in Subjects With Measurable Disease|Completed||Phase 1|125|Actual|Takeda||3|||f||||f||||||||||2017-10-11 03:44:51.248568|2017-10-11 03:44:51.248568
NCT01449357|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2011-10-07||||||October 2011|2011-10-01||||||||Interventional|||Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors|A Single-arm Phase II Trial Investigating the Efficacy and Safety of Zalutumumab in Patients With Non-Small Cell Lung Cancer Who Have Progressive Disease After Treatment With Tyrosine Kinase Inhibitors|Withdrawn||Phase 2|0|Actual|Genmab||1||Trial never initiated|f||||f||||||||||2017-10-11 03:45:10.717103|2017-10-11 03:45:10.717103
NCT01449344|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-03-06|||May 9, 2009|Actual|2009-05-09|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|(R-HAD)||Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL|Efficacy and Safety of Rituximab, High-dose Ara-C and Dexamethasone (R-HAD) Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma|Active, not recruiting||Phase 3|128|Actual|European Mantle Cell Lymphoma Network||2|||f||||f||||||||||2017-10-11 03:45:10.89|2017-10-11 03:45:10.89
NCT01449331|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-04-15|||November 2010||2010-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|OVNI||The Use of Palliative Non Invasive Ventilation in Acute Respiratory Failure. OVNI Study.|Qualitative Outcomes After Palliative Noninvasive Mechanical Ventilation : OVNI Study|Completed||N/A|1450|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 03:45:11.1202|2017-10-11 03:45:11.1202
NCT01449318|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2014-05-15|||July 2012||2012-07-01|September 2013|2013-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Predictors of Postoperative Pain|Predictors of Postoperative Pain Following Abdominal Hysterectomy|Completed||N/A|60|Actual|American University of Beirut Medical Center||1|||f||||f||||||||||2017-10-11 03:45:11.203909|2017-10-11 03:45:11.203909
NCT01449305|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-02-01|2012-12-28||October 2011||2011-10-01|August 2011|2011-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea|Research on Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea|Completed||N/A|44|Actual|Chen Yi Enterprise, Co., Ltd.||1|||f||||||||||||||2017-10-11 03:45:11.343853|2017-10-11 03:45:11.343853
NCT01449292|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-11-13|||June 2012||2012-06-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ASPIRE||Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)|Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)|Terminated||Phase 3|300|Anticipated|Aeris Therapeutics||2|||f||||t||||||||||2017-10-11 03:45:11.587991|2017-10-11 03:45:11.587991
NCT01449279|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-03-30|2017-01-20||October 2011|Actual|2011-10-01|March 2017|2017-03-01|December 1, 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|||Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy|A Pilot Study of Ipilimumab in Subjects With Stage IV Melanoma Receiving Palliative Radiation Therapy|Active, not recruiting||Phase 2|22|Actual|Stanford University|This study was intended to be exploratory and had a limited sample size. Our results are based on a small sample size and further research should be done to really draw firm conclusions.|1|||f||||t|t|f||||||No||2017-10-11 03:45:12.124788|2017-10-11 03:45:12.124788
NCT01449266|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2015-06-09|2015-02-19||November 2011||2011-11-01|June 2015|2015-06-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional||No statistical calculation of sample size was done. According to the literature, a sample of 10 patients was judged sufficient to evaluate the dialysability of Dotarem®.|Safety and Dialysability of Dotarem® in Dialysed Patients|Safety and Dialysability of Dotarem® in Dialysed Patients - Phase 1 Clinical Study|Completed||Phase 1|10|Actual|Guerbet||1|||f||||t||||||||||2017-10-11 03:45:12.437259|2017-10-11 03:45:12.437259
NCT01449253|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-07|2013-01-28|||August 2011||2011-08-01|January 2013|2013-01-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia|Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia|Unknown status|Recruiting|Phase 4|60|Anticipated|All India Institute of Medical Sciences, New Delhi||3|||f||||f||||||||||2017-10-11 03:45:12.796034|2017-10-11 03:45:12.796034
NCT01449240|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2015-10-06|2014-12-01||March 2011||2011-03-01|March 2014|2014-03-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Observational||Safety Population: All patients who had undergone a procedure for CSF sample collection. This included a patient who underwent unsuccessful CSF sample collection. It did not include a patient who provided a retrospective CSF sample.|Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome|A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome|Completed||N/A|10|Actual|Shire|||1||f||||f||||||Samples Without DNA|"     CSF and urine samples will be retained and analyzed for glycosaminoglycans (GAGs), including     sulfated DS/HS oligosaccharides, GAG-degradation products, and other biomarkers of CNS or     lysosomal function.   "|||2017-10-11 03:45:12.938264|2017-10-11 03:45:12.938264
NCT01449227|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-10|||September 2011||2011-09-01|October 2011|2011-10-01||||||||Observational|||Natural Course of Adhesive Capsulitis of Hip|Natural Course of Adhesive Capsulitis of Hip|Unknown status|Recruiting|N/A|50|Anticipated|Seoul National University Hospital|||1||f||||||||||||||2017-10-11 03:45:13.257334|2017-10-11 03:45:13.257334
NCT01449214|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-04-29|||October 2011||2011-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Ultrasound-Guided Technique for Thoracic Epidural Insertion|Ultrasound-Guided Technique for Thoracic Epidural Insertion: A Randomized Controlled Trial|Completed||N/A|60|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-10-11 03:45:13.358139|2017-10-11 03:45:13.358139
NCT01449201|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-09-28|||October 2011||2011-10-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|||PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma|Phase II Trial of PF-00299804 in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of Platinum-containing Therapy|Completed||Phase 2|49|Actual|Yonsei University||1|||f||||f||||||||||2017-10-11 03:45:13.47445|2017-10-11 03:45:13.47445
NCT01449188|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-05-15|||August 2011||2011-08-01|May 2017|2017-05-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects|A Randomized, Double-blind, Four-period Crossover Study to Investigate the Effect of Intravenous Ondansetron, a 5-HT3 Antagonist, on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects.|Completed||Phase 1|58|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:45:13.573873|2017-10-11 03:45:13.573873
NCT01449175|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-19|2013-11-13|||January 2011||2011-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema|A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema|Terminated||N/A|54|Anticipated|Aeris Therapeutics|||1||f||||f||||||||||2017-10-11 03:45:13.679115|2017-10-11 03:45:13.679115
NCT01449162|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2012-09-25|||June 2011||2011-06-01|September 2012|2012-09-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids|A Prospective, Multicenter, Randomised, Double-blind, Placebo-controlled, 2-parallel Groups, Phase 3 Study to Compare the Efficacy and the Safety of Masitinib at 6 mg/kg/Day Versus Placebo in the Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids|Unknown status|Recruiting|Phase 3|300|Anticipated|AB Science||2|||f||||t||||||||||2017-10-11 03:45:13.768262|2017-10-11 03:45:13.768262
NCT01449149|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-12-07|||March 2010||2010-03-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Proton Radiation for Chordomas and Chondrosarcomas|Proton Radiation For Chordomas and Chondrosarcomas|Recruiting||Phase 1/Phase 2|50|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:45:13.869552|2017-10-11 03:45:13.869552
NCT01449136|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2011-10-05|||January 2008||2008-01-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|AC||Use of Antibacterial Cement in Infected Dentin|Phase 1 Study of Clinical and Radiographic Success of Antibacterial Cement in Infected Dentin of Deciduous Teeth|Completed||N/A|45|Actual|University of Pernambuco||1|||f||||t||||||||||2017-10-11 03:45:13.976085|2017-10-11 03:45:13.976085
NCT01449123|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2012-08-08|||September 2011||2011-09-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose Combinations|An Open-label Single Site Single Dose Pilot Study Using Mannitol Challenge Test With the Purpose to Explore Treatment With Fixed Dose Combinations in Adult Subjects With Asthma in Primary Care in Sweden|Completed||Phase 4|97|Actual|Mundipharma AB||1|||f||||f||||||||||2017-10-11 03:45:14.078564|2017-10-11 03:45:14.078564
NCT01449110|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-11-15|||April 2009||2009-04-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|FUNGRAPE||Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease|A Randomized, 12 Months Follow-up, Dose-response, Placebo-Controlled, Double-Blind, 6-Arms Parallel Trial to Evaluate the Safety and Efficacy of a Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Patients of Cardiovascular Disease|Completed||Phase 2|150|Actual|National Research Council, Spain||6|||f||||f||||||||||2017-10-11 03:45:14.166577|2017-10-11 03:45:14.166577
NCT01449097|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-12-21|||October 2011||2011-10-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Adductor-Canal-Blockade Versus the Femoral Nerve Block Effect on Muscle Strength and Mobilization in Healthy Volunteers|Comparison of the Efficacy of the Adductor-Canal-Blockade Versus the Femoral Nerve Block on Muscle Strength and Mobilization in Healthy Volunteers: a Randomized Study|Completed||Phase 4|12|Actual|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-10-11 03:45:14.317978|2017-10-11 03:45:14.317978
NCT01449084|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-10|||December 2009||2009-12-01|October 2011|2011-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Early Pancreatic Duct Stent Removal in Preventing Post-endoscopic Pancreatitis|Immediate Pancreatic Duct Stent Removal Does Not Prevent Pancreatitis After Accidental Pancreatic Duct Cannulation - A Prospective Randomized Trial|Completed||N/A|40|Actual|Nuovo Ospedale Civile S.Agostino Estense||2|||f||||f||||||||||2017-10-11 03:45:14.418178|2017-10-11 03:45:14.418178
NCT01449071|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2014-01-16||2014-01-16|October 2011||2011-10-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)|A Phase1/2, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Pharmacokinetics of One 12 Week Treatment Cycle of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects With Moderate to Severe Disease|Completed||Phase 1/Phase 2|20|Actual|UCB Pharma||5|||f||||f||||||||||2017-10-11 03:45:14.510652|2017-10-11 03:45:14.510652
NCT01449058|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2017-09-29|||March 2012||2012-03-01|September 2017|2017-09-01|August 15, 2017|Actual|2017-08-15|August 31, 2016|Actual|2016-08-31||Interventional|||A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors|A Phase Ib Open-label, Multi-center, Dose Escalation and Expansion Study of Orally Administered MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors|Completed||Phase 1|139|Actual|Array BioPharma||1|||f||||||||||||||2017-10-11 03:45:14.625468|2017-10-11 03:45:14.625468
NCT01449045|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-11|2012-04-25|||July 2011||2011-07-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Trial of Malaria Seasonal IPTc Combined With Community Case Management|Cluster Randomized Trial of Malaria Seasonal IPTc Combined With Community Case Management in Saraya District, SE Senegal|Completed||Phase 3|4554|Actual|Cheikh Anta Diop University, Senegal||2|||f||||t||||||||||2017-10-11 03:45:14.764271|2017-10-11 03:45:14.764271
NCT01449032|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2014-06-07|||April 2010||2010-04-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|MyStromalCell||MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)|MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)|Completed||Phase 2|60|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 03:45:14.858977|2017-10-11 03:45:14.858977
NCT01449019|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-02|2011-10-05|||December 2006||2006-12-01|October 2011|2011-10-01|July 2010|Actual|2010-07-01|August 2007|Actual|2007-08-01||Interventional|DFG_5||The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)|The Contribution of Glucagon-like Peptide 1 (GLP-1) to the Entero-insulinar Axis in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 1|24|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 03:45:14.948443|2017-10-11 03:45:14.948443
NCT01449006|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-04-13|2016-02-09||October 2011||2011-10-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|HANDmac|Data presented reflect baseline demographic and clinical characteristics for participants included in the primary analysis.|A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)|A Randomised Controlled Clinical Trial of the Efficacy of HAART Intensification With Maraviroc in HIV Virally Suppressed Patients With Cognitive Impairment|Completed||Phase 4|19|Actual|St Vincent's Hospital, Sydney|"Small pilot sample size (N=17).
Unrepresentative of international HAND populations.
Open-label design may have contributed to loss to follow-up in controls.
Modified intention-to-treat design potentially introduced bias into analyses."|2|||f||||t||||||||||2017-10-11 03:45:15.260034|2017-10-11 03:45:15.260034
NCT01448993|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2015-04-21|||August 2012||2012-08-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Azithromycin on Oesophageal Hypomotility|Effect Of Azithromycin On Oesophageal Function In Patients With Dysphagia Or Gastro-Oesophageal Reflux Associated With Frequent Oesophageal Hypomotility|Completed||Phase 2|26|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-10-11 03:45:15.815478|2017-10-11 03:45:15.815478
NCT01448980|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-06-05|||May 2012||2012-05-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of Massage in Stroke Spasticity|The Efficacy of Thai Traditional Massage in Decreasing Spasticity for Elderly With Stroke|Completed||Phase 3|396|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 03:45:15.886998|2017-10-11 03:45:15.886998
NCT01448954|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-02-17|||September 2011||2011-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma|A Randomised, Placebo-Controlled, Double-Blind, Parallel Group Phase II Study to Assess the Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma|Completed||Phase 2|36|Anticipated|Pulmagen Therapeutics||2|||f||||f||||||||||2017-10-11 03:45:15.966677|2017-10-11 03:45:15.966677
NCT01448941|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2015-09-09|||October 2011||2011-10-01|October 2014|2014-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Arthrodesis Versus Extra-articular Plate Fixation in Lisfranc Injury|Arthrodesis Versus Extra-articular Bridge Plating of the First Tarsometatarsal Joint After Acute Lisfranc Injury|Unknown status|Active, not recruiting|N/A|48|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 03:45:16.042713|2017-10-11 03:45:16.042713
NCT01448928|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2015-10-30|||September 2008||2008-09-01|October 2015|2015-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|ZEVALIN-DUI||Zevalin Post-marketing Surveillance in Japan|Drug Use Investigation of Zevalin|Recruiting||N/A|400|Anticipated|Spectrum Pharmaceuticals, Inc|||1||f||||f||||||||||2017-10-11 03:45:16.121257|2017-10-11 03:45:16.121257
NCT01448915|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-08-16|||September 2009||2009-09-01|August 2017|2017-08-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)|Management of Hepatitis C in HIV Infected IDUs|Active, not recruiting||N/A|1000|Anticipated|Johns Hopkins University|||1||f||||f|f|f||||Samples Without DNA|"     Serum and plasma specimens are collected at regular intervals   "|||2017-10-11 03:45:16.302263|2017-10-11 03:45:16.302263
NCT01448902|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2011-10-06|||March 2007||2007-03-01|October 2011|2011-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis|A Study Of The Effects Of OC000459 On Responses To Allergen Challenge In The Vienna Chamber In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis|Completed||Phase 2|36|Actual|Oxagen Ltd||2|||f||||f||||||||||2017-10-11 03:45:16.447782|2017-10-11 03:45:16.447782
NCT01448889|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2011-10-06|||September 2009||2009-09-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy|Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy.|Unknown status|Recruiting|N/A|180|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 03:45:16.565035|2017-10-11 03:45:16.565035
NCT01448876|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-02-15|||June 2009||2009-06-01|October 2011|2011-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|Incure||Incubation Time and Test of Cure of Chlamydia Trachomatis|Time to Cure Chlamydia Trachomatis: Prospective Cohort Study on Detection of Chlamydial RNA and DNA in Anorectal and Cervicovaginal Infections During 8 Weeks After Directly Observed Treatment With Azithromycin|Completed||N/A|52|Actual|Maastricht University Medical Center|||1||f||||f|||||||"     self-taken cervicovaginal and snorectal swabs   "|||2017-10-11 03:45:16.69615|2017-10-11 03:45:16.69615
NCT01448863|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2015-03-09|||October 2011||2011-10-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Metabolomic Embryo Profiles of Obese in Vitro Fertilization (IVF) Patients and Their Relationship With Polycystic Ovary Syndrome (PCO)||Completed||N/A|28|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA|||3||f||||f||||||||||2017-10-11 03:45:16.793533|2017-10-11 03:45:16.793533
NCT01448850|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-11-30|2016-06-28||November 2011||2011-11-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|SPRING|Modified intent-to-treat (mITT) population included all participants who were randomized into the study and received any investigational product.|A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease|A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease|Completed||Phase 2|464|Actual|MedImmune LLC||2|||f||||t||||||||||2017-10-11 03:45:16.93327|2017-10-11 03:45:16.93327
NCT01448837|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-05-09|||April 2010||2010-04-01|May 2014|2014-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice|24-Hour Intraocular Pressure Control Obtained With the Bimatoprost/Timolol Fixed Combination Compared With Latanoprost as First Choice Therapy in Subjects With Exfoliation Syndrome, or Exfoliative Glaucoma|Completed||Phase 4|37|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-10-11 03:45:17.91151|2017-10-11 03:45:17.91151
NCT01448824|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2012-02-20|||October 2011||2011-10-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of LY2484595 on Pharmacokinetics in Healthy Subjects|A Phase 1 Study to Evaluate the Safety and Tolerability of LY2484595 SDSD-PG Tablets and the Effect of CYP3A Inhibition by Ketoconazole on the Pharmacokinetics of LY2484595 in Healthy Subjects|Completed||Phase 1|60|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 03:45:18.008559|2017-10-11 03:45:18.008559
NCT01448811|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-07|||March 2007||2007-03-01|October 2011|2011-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Auditory Evoked Potential Monitoring on Bronchoscopy|Impact of Auditory Evoked Potential Index Monitoring on Bronchoscopic Examination in the Mechanical Ventilated Patients - A Prospective, Randomized, Controlled Study|Completed||N/A|37|Actual|Kaohsiung Veterans General Hospital.||2|||f||||||||||||||2017-10-11 03:45:18.094772|2017-10-11 03:45:18.094772
NCT01448798|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2011-10-06|||October 2011||2011-10-01|October 2011|2011-10-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Interventional|AnPro||Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.|Prospective Randomized Investigation of Athermal Nerve-sparing During Robotic-assisted Laparoscopic Prostatectomy Using a Hemostatic Gelatin-thrombin Matrix|Unknown status|Recruiting|N/A|50|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||t||||||||||2017-10-11 03:45:18.178851|2017-10-11 03:45:18.178851
NCT01448785|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-27|||April 2011||2011-04-01|October 2011|2011-10-01|January 2015|Anticipated|2015-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Abiliti™ Treatment in Obese Subjects|Abiliti™ Treatment in Obese Subjects: A Randomized Post-Market Surveillance Multicenter Study|Unknown status|Recruiting|N/A|165|Anticipated|IntraPace, Inc||2|||f||||f||||||||||2017-10-11 03:45:18.276863|2017-10-11 03:45:18.276863
NCT01448772|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2012-03-23|||October 2011||2011-10-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions|A Single-Dose, Replicate Crossover Design Comparative Bioavailability Study of Dronabinol Oral Solution 5 mg Versus Marinol Capsules 5 mg Under Fasted Conditions|Completed||Phase 1|88|Actual|INSYS Therapeutics Inc||2|||f||||f||||||||||2017-10-11 03:45:18.435978|2017-10-11 03:45:18.435978
NCT01448759|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2015-04-23|||October 2011||2011-10-01|April 2015|2015-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|ALCOOTAX||Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel|Prospective Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel Infusion|Completed||N/A|30|Actual|Institut Curie||1|||f||||f||||||||||2017-10-11 03:45:18.5074|2017-10-11 03:45:18.5074
NCT01448746|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-02-03|||October 2011||2011-10-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|January 2016|Actual|2016-01-01||Interventional|||Optimal Prophylactic Method of Venous Thromboembolism (VTE)|Optimal Prophylactic Method of Venous Thromboembolism for Gastrectomy in Korean Patients|Active, not recruiting||Phase 3|682|Actual|The Catholic University of Korea||1|||f||||t||||||||||2017-10-11 03:45:18.575411|2017-10-11 03:45:18.575411
NCT01448733|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2011-10-06|||July 2011||2011-07-01|October 2011|2011-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris|A Pilot Study to Evaluate the Safety and Tolerability of CeraVe® Lotion Followed by Fixed Dose Clindamycin Phosphate 1.2% / Benzoyl Peroxide 2.5% Gel in the Morning in Combination With CeraVe® Lotion Followed by Tretinoin 0.05% Gel in the Evening for the Treatment of Facial Acne Vulgaris.|Unknown status|Active, not recruiting|Phase 4|20|Actual|Zeichner, Joshua, M.D.||1|||f||||t||||||||||2017-10-11 03:45:18.656132|2017-10-11 03:45:18.656132
NCT01448720|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-09-17|||September 2011||2011-09-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate|Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate - A Pilot Study|Completed||Phase 3|142|Actual|Janssen-Cilag Farmaceutica Ltda.||1|||f||||f||||||||||2017-10-11 03:45:18.752744|2017-10-11 03:45:18.752744
NCT01448707|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-02-01|2015-10-30||March 2012||2012-03-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Interventional|PROTEA|Baseline characteristics were analyzed for all participants who were treated.|A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment|PROTEAse Inhibitor (DRV/Rtv) in Mono- or Triple Therapy in Suppressed HIV-1 Infected Subjects|Completed||Phase 3|274|Actual|Janssen-Cilag International NV||2|||f||||t||||||||||2017-10-11 03:45:19.0364|2017-10-11 03:45:19.0364
NCT01448694|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-12-01|||November 2011||2011-11-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|October 2013|Actual|2013-10-01||Observational|||Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss|Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss.|Completed||Phase 2|320|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 03:45:19.946174|2017-10-11 03:45:19.946174
NCT01448681|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-12-01|||August 2011||2011-08-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|July 2017|Anticipated|2017-07-01||Observational|||A Continuous, Non-Invasive, Real-time Method for Estimating and Predicting Intracranial Hypertension|A Continuous, Non-Invasive, Real-time Method for Estimating and Predicting Intracranial Hypertension|Active, not recruiting||N/A|32|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 03:45:20.082925|2017-10-11 03:45:20.082925
NCT01448668|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-30|2013-07-01|||September 2010||2010-09-01|July 2013|2013-07-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|||Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)|Prospective Epidemiological Study to Expand Knowledge on Efficacy and Safety of a Routine Post-operative Supportive Therapy With the Mistletoe Extract Iscador® Qu Within Oncological Treatment of Pancreatic Cancer Stages UICC II-IV|Unknown status|Active, not recruiting|N/A|220|Actual|IFAG AG|||2||f||||f||||||||||2017-10-11 03:45:20.194992|2017-10-11 03:45:20.194992
NCT01448655|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-29|2013-07-01|||September 2010||2010-09-01|July 2013|2013-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)|Prospective Epidemiological Study to Expand Knowledge on Efficacy and Safety of a Routine Post-operative Supportive Therapy With the Mistletoe Extract Iscador® Qu Within Oncological Treatment of Colorectal Cancer Stages UICC II-IV|Unknown status|Recruiting|N/A|300|Anticipated|IFAG AG|||2||f||||f||||||||||2017-10-11 03:45:20.341455|2017-10-11 03:45:20.341455
NCT01448642|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2016-01-19|||April 2012||2012-04-01|January 2016|2016-01-01|November 2019|Anticipated|2019-11-01|September 2018|Anticipated|2018-09-01||Interventional|SECURE-PCI||Statins Evaluation in Coronary Procedures and Revascularization Trial|A Randomized, Multicenter Clinical Trial to Assess the Effect of Atorvastatin in Patients With Acute Coronary Syndrome and Intended Percutaneous Coronary Intervention|Recruiting||Phase 4|4192|Anticipated|Hospital do Coracao||2|||f||||t||||||||||2017-10-11 03:45:20.49952|2017-10-11 03:45:20.49952
NCT01448629|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-02-06|||May 2011||2011-05-01|February 2012|2012-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety and Performance of a New 1-piece Ostomy Product Compared to Standard Care Ostomy Products in Subjects Ileostomy|An Open-labelled, Randomised, Controlled, Comparative, Explorative, Cross-over Study Investigating Safety and Performance of a New 1-piece Ostomy Product Compared Standard Care Ostomy Products in Subjects With Ileostomy|Withdrawn||N/A|0|Actual|Coloplast A/S||2||The study was withdrawn because of problems found with the baseplate|f||||f||||||||||2017-10-11 03:45:20.649946|2017-10-11 03:45:20.649946
NCT01448616|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-12-02|2015-08-05||February 2012||2012-02-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Participants were randomized 2:2:1 to one of the 3 treatment arms after completing the lead-in phase|Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding|Effect of Tenofovir on Genital HSV Shedding: a Randomized, Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 4|73|Actual|University of Washington|The study was not powered to detect differences in lesion rate; the study was appropriately powered to detect a 50% decrease in viral shedding only, and therefore may have been underpowered to detect significant findings for secondary outcomes.|4|||f||||t||||||||||2017-10-11 03:45:20.771152|2017-10-11 03:45:20.771152
NCT01448603|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2012-05-16|||October 2011||2011-10-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||ToleroMune Ragweed Follow up Study|An Optional One Year Follow-up Study to Evaluate the Continued Efficacy of ToleroMune Ragweed in Ragweed Allergic Subjects Following Challenge With Ragweed Allergen in an Environmental Exposure Chamber.|Completed||N/A|109|Actual|Circassia Limited|||5||f||||f||||||||||2017-10-11 03:45:21.412876|2017-10-11 03:45:21.412876
NCT01448590|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-10-12|||June 2011||2011-06-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Post Dural Puncture Headache After Accidental Dural Puncture|Systematic Review: Post Dural Puncture Headache After Accidental Dural Puncture: Does Insertion of Spinal Catheter Decrease Incidence of Headaches?|Withdrawn||N/A|0|Actual|Sunnybrook Health Sciences Centre|||2||f||||f||||||||||2017-10-11 03:45:21.514081|2017-10-11 03:45:21.514081
NCT01448577|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-06|||November 2010||2010-11-01|October 2011|2011-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||"Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal Pancreatitis Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies"|"A Clinical Records Review Study of the Frequency and Severity of Acute Abdominal Pancreatitis Episodes Reported From LPLD Subjects Previously Recruited to Clinical Studies PREPARATION-02, CT-AMT-011-01 and CT-AMT-011-02"|Unknown status|Enrolling by invitation|N/A|22|Actual|Amsterdam Molecular Therapeutics|||2||f||||f||||||||||2017-10-11 03:45:21.583198|2017-10-11 03:45:21.583198
NCT01448551|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-12-20|||October 2011||2011-10-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||MPOWERed Messages: Tailored Mobile Messages to Enhance Weight Loss for Teens|Novel Individually Tailored Mobile Messages to Enhance Weight Loss for Teens|Completed||N/A|50|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:45:21.766138|2017-10-11 03:45:21.766138
NCT01448538|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-09-11|||August 2011||2011-08-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Observational|||Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany|Non-Persistence/Non-Adherence of German wAMD Patients Related to Their Anti-VEGF Injections: Extent, Explanations and Patients' Preferences|Completed||N/A|480|Actual|Bayer|||1||f||||t||||||||||2017-10-11 03:45:21.888988|2017-10-11 03:45:21.888988
NCT01448525|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-06|2013-04-05|2013-04-05||October 2011||2011-10-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence||Completed||Phase 4|88|Actual|Allergan||2|||f||||f||||||||||2017-10-11 03:45:22.002511|2017-10-11 03:45:22.002511
NCT01448512|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-01-20|||September 2010||2010-09-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection|University of Miami Developmental Center for AIDs Research Promoting Male Involvement to Improve PMTCT Uptake and Reduce Antenatal Infection|Completed||N/A|478|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 03:45:22.241324|2017-10-11 03:45:22.241324
NCT01448499|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-02|2015-12-08|||October 2011||2011-10-01|December 2015|2015-12-01||||October 2013|Anticipated|2013-10-01||Interventional|ClozAmi||Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients|Clozapine Versus Amisulpride Versus Their Combination in the Treatment of Drug-resistant Schizophrenia Patients|Withdrawn||N/A|0|Actual|Geha Mental Health Center||3|||f||||f||||||||||2017-10-11 03:45:22.338706|2017-10-11 03:45:22.338706
NCT01448486|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-05-19|2013-11-13||October 2011||2011-10-01|May 2016|2016-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|HANDral||A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV|A Randomised Controlled Clinical Trial of the Efficacy of HAART Intensification With Raltegravir in HIV Virally Suppressed Patients With Cognitive Impairment|Terminated||Phase 4|6|Actual|St Vincent's Hospital, Sydney|Early termination leading to incomplete dataset with sample size too small to produce any meaningful statistical analysis.|2||Funding withdrawn based on unacceptably slow recruitment rate.|f||||t||||||||||2017-10-11 03:45:22.44885|2017-10-11 03:45:22.44885
NCT01446068|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2013-06-19|||March 2011||2011-03-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|||Comparison of Postprandial Inflammation in Lean and Obese Subjects||Completed||Early Phase 1|36|Actual|Agroscope Liebefeld-Posieux Research Station ALP||2|||f||||t||||||||||2017-10-11 03:46:03.012865|2017-10-11 03:46:03.012865
NCT01448473|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2013-03-18|||October 2011||2011-10-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|4vs2||Is a Two-Film Skull X-ray Series as Sensitive as a Four-Film Series in the Diagnosis of Skull Fractures in Paediatric Patients|Is a Two-Film Skull X-ray Series as Sensitive as a Four-Film Series in the Diagnosis of Skull Fractures in Paediatric Patients With Minor Head Trauma?|Completed||N/A|14|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 03:45:22.751034|2017-10-11 03:45:22.751034
NCT01448460|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2013-01-23|||September 2009||2009-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Oocyte Vitrification for In Vitro Fertilization (IVF) Patients and Women With Fertility Threatening Conditions|Oocyte Vitrification for IVF Patients and Women With Fertility Threatening Conditions|Completed||N/A|8|Actual|University of Louisville|||1||f||||t|||||||"     oocytes   "|||2017-10-11 03:45:22.834644|2017-10-11 03:45:22.834644
NCT01448447|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-04-14|||December 2009||2009-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|Mammosite ML||Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®|Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml® Radiation Therapy Delivery System as the Sole Method of Radiation Therapy or as a Boost for Early Stage Breast Cancer and Ductal Carcinoma In Situ of the Breast|Completed||Phase 4|200|Actual|St. John's Mercy Research Institute, St. Louis||2|||f||||f||||||||||2017-10-11 03:45:22.877519|2017-10-11 03:45:22.877519
NCT01448434|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-05-11|||September 2011||2011-09-01|May 2016|2016-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Allogeneic Mesenchymal Stem Cells for Osteoarthritis|A Randomized, Double Blind, Multicentric, Placebo Controlled, Phase -II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients With Osteoarthritis of Knee|Completed||Phase 2|72|Actual|Stempeutics Research Pvt Ltd||2|||f||||t||||||||||2017-10-11 03:45:22.964736|2017-10-11 03:45:22.964736
NCT01448421|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-10-06|||January 2012||2012-01-01|September 2011|2011-09-01|July 2012|Anticipated|2012-07-01|June 2012|Anticipated|2012-06-01||Interventional|||SMT Embolic Deflection CE Mark Trial DEFLECT I|A Prospective, Single Arm Feasibility Study to Evaluate the Safety and Performance of the SMT Embolic Deflection Device in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR)|Unknown status|Not yet recruiting|N/A|36|Anticipated|Keystone Heart||1|||f||||f||||||||||2017-10-11 03:45:23.072135|2017-10-11 03:45:23.072135
NCT01448408|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2011-10-05|||May 2007||2007-05-01|October 2011|2011-10-01|July 2011|Actual|2011-07-01|||||Observational|||Corneal Biomechanical Properties and Anterior Segment Parameters, in Forme Fruste Keratoconus|Evaluation of the Sensitivity, Specificity, and Test Accuracy of Corneal Biomechanical Metrics, Anterior Segment Data and a Combination Model, in Differentiating Forme Fruste Keratoconus (FFK) From Healthy Corneas.|Completed||N/A|||Democritus University of Thrace|||2||f||||f||||||||||2017-10-11 03:45:23.174826|2017-10-11 03:45:23.174826
NCT01448395|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-08-31|||October 2011||2011-10-01|August 2017|2017-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]NXL104|An Open Label Single-Dose Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]NXL104|Completed||Phase 1|6|Actual|Pfizer||1|||f||||||||||||||2017-10-11 03:45:23.26481|2017-10-11 03:45:23.26481
NCT01448382|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-12-28|||October 2011||2011-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study|Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study|Terminated||Phase 1|39|Actual|Given Imaging Ltd.||2|||f||||f||||||||||2017-10-11 03:45:23.370768|2017-10-11 03:45:23.370768
NCT01448369|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-06-09|||December 2011||2011-12-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Eyelid Warming Technology for Meibomian Gland Dysfunction|Eyelid Warming Technology for Relief of Meibomian Gland Dysfunction in an Asian Population|Completed||N/A|75|Actual|Singapore National Eye Centre||3|||f||||f||||||||||2017-10-11 03:45:23.463605|2017-10-11 03:45:23.463605
NCT01448356|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2012-11-14|2012-07-17||January 2012||2012-01-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Controlled Adverse Environment: A Pilot Study to Evaluate Tear Film Stability and Tear Evaporation|Controlled Adverse Environment: A Pilot Study to Evaluate Tear Film Stability and Tear Evaporation|Completed||N/A|10|Actual|Singapore Eye Research Institute||1|||f||||f||||||||||2017-10-11 03:45:23.576751|2017-10-11 03:45:23.576751
NCT01448343|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2013-04-15|||October 2011||2011-10-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|FMS||Effect of Rapid Transfusion With Fluid Management System 2000® (FMS)|Effect of Rapid Transfusion With FMS(Fluid Management System 2000®) on the Plasma Potassium Concentration in Adult Liver Transplantation Recipients)|Completed||N/A|10|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 03:45:23.945269|2017-10-11 03:45:23.945269
NCT01448330|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2011-12-28|||July 2011||2011-07-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin|A Sequence-randomized, Open-label, Single Dose, Crossover Study to Evaluate Pharmacokinetics and Safety After Oral Administration of Clopidogrel and Aspirin in Free Combination and Fixed-dose Combination as HCP0911 in Healthy Male Volunteers|Completed||Phase 1|64|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 03:45:24.007474|2017-10-11 03:45:24.007474
NCT01448317|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-09-27|||May 2011||2011-05-01|September 2016|2016-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered SAR236553 in Japanese Healthy Male Subjects|Completed||Phase 1|32|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 03:45:24.078289|2017-10-11 03:45:24.078289
NCT01448304|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2013-06-27|||June 2011||2011-06-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Alirocumab SAR236553 (REGN727)||Completed||Phase 1|24|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:45:24.159874|2017-10-11 03:45:24.159874
NCT01445704|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-04-08|||June 2010||2010-06-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|Probiotics||Use of Probiotics to Aid in Weight Loss|Use of Probiotics to Aid in Weight Loss|Completed||N/A|151|Actual|Greenville Health System||2|||f||||f||||||||||2017-10-11 03:46:10.841283|2017-10-11 03:46:10.841283
NCT01448291|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2012-04-23|||October 2011||2011-10-01|April 2012|2012-04-01|March 2013|Anticipated|2013-03-01|October 2012|Anticipated|2012-10-01||Interventional|||Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers|The Effects of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring (NuvaRing®) on Vaginal Innate and Inflammatory Biomarkers|Unknown status|Recruiting|Phase 4|30|Anticipated|Eastern Virginia Medical School||1|||f||||f||||||||||2017-10-11 03:45:24.230556|2017-10-11 03:45:24.230556
NCT01448278|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-02-06|||November 2010||2010-11-01|February 2015|2015-02-01|April 2012|Actual|2012-04-01|November 2011|Actual|2011-11-01||Interventional|||Pain Evaluation After Anterior Cruciate Ligament (ACL) Ligamentoplasty|"Pain Evaluation After ACL Ligamentoplasty: All-inside Versus Classical Technique. A Prospective Randomised Comparative Study"|Completed||Phase 4|46|Actual|Hospital Ambroise Paré Paris||2|||f||||f||||||||||2017-10-11 03:45:24.31125|2017-10-11 03:45:24.31125
NCT01448265|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-07-24|||September 2011||2011-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|CRYO-MAP||Real-Time Assessment of Cryoballoon Pulmonary Vein Isolation Using a Novel Circular Mapping Catheter|Real-Time Assessment of Cryoballoon Pulmonary Vein Isolation Using a Novel Circular Mapping Catheter|Completed||Phase 4|40|Actual|Heidelberg University||1|||f||||f||||||||||2017-10-11 03:45:24.378319|2017-10-11 03:45:24.378319
NCT01448252|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2011-10-06|||May 2002||2002-05-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|||T Cell Vaccination in Patients With Progressive Multiple Sclerosis|Autologous T Cell Vaccination With Line Specific for 9 Myelin Peptides in Patients With Progressive / Relapsing Multiple Sclerosis|Completed||Phase 1/Phase 2|30|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 03:45:24.452307|2017-10-11 03:45:24.452307
NCT01448239|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2013-06-27|||February 2011||2011-02-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Injection Site Tolerability, Safety, Pharmacokinetics and Pharmacodynamics Study After a Single Dose Subcutaneous Treatment of Alirocumab SAR236553 (REGN727)||Completed||Phase 1|24|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:45:24.549258|2017-10-11 03:45:24.549258
NCT01448226|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2011-10-06|||January 2000||2000-01-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Observational|||Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction (PCR) Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy|Diagnosing Invasive Aspergillosis by PCR Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy|Completed||N/A|221|Actual|Heidelberg University|||2||f||||f||||||Samples With DNA|"     Aliquots of BAL Samples including fungal DNA   "|||2017-10-11 03:45:24.710828|2017-10-11 03:45:24.710828
NCT01448213|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-08-22|2014-08-04||October 2011||2011-10-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||"Baseline characteristics data are reported in units of eyes as this presentation is most relevant to the assessments presented in the Outcome Measures module."|Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)|Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty|Completed||Phase 2|264|Actual|Price Vision Group||2|||f||||t||||||||||2017-10-11 03:45:24.844183|2017-10-11 03:45:24.844183
NCT01448200|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2012-11-14|||October 2011||2011-10-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1|A Phase 1 Dose-Ranging Study to Assess the Safety, Pharmacokinetics and Antiviral Efficacy of PPI-668 in Healthy Volunteers and Patients With HCV Genotype-1 Infection|Completed||Phase 1|82|Actual|Presidio Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-11 03:45:25.136174|2017-10-11 03:45:25.136174
NCT01448187|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-07-01|||January 2012||2012-01-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|EPIDAURE||Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa|Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa|Completed||N/A|361|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:45:25.243797|2017-10-11 03:45:25.243797
NCT01448174|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-10-05|||October 2011||2011-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients|Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients|Completed||Phase 4|310|Actual|Poznan University of Medical Sciences||3|||f||||f||||||||||2017-10-11 03:45:25.389787|2017-10-11 03:45:25.389787
NCT01448161|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-12-01|||December 2011||2011-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Machine Learning Approach to Continuous Vital Sign Data Analysis|A Machine Learning Approach to Continuous Vital Sign Data Analysis|Enrolling by invitation||N/A|250|Anticipated|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 03:45:25.489282|2017-10-11 03:45:25.489282
NCT01448148|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2016-01-26|||November 2011||2011-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Measuring the Impact of Cognitive and Psychosocial Interventions in Persons With Mild Cognitive Impairment|Measuring the Impact of Cognitive and Psychosocial Interventions in Persons With Mild Cognitive Impairment|Completed||N/A|145|Actual|Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal||3|||f||||t||||||||||2017-10-11 03:45:25.556569|2017-10-11 03:45:25.556569
NCT01448135|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2015-06-22|||October 2011||2011-10-01|January 2014|2014-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings|Pilot Study Evaluating the Efficacy, Tolerance and Safety of VITAL AF (Semi Elemental, High Protein, High Omega 3 Fat Enteral Formula) Versus Osmolite 1.2 (High Protein Enteral Formula) in Multiple ICU Settings (Medical, Surgical, Cardiothoracic)|Completed||N/A|50|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-11 03:45:25.641794|2017-10-11 03:45:25.641794
NCT01448122|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2013-02-26|||October 2011||2011-10-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Avene Compact Honey for Prevention of Pigmentation From Visible Light|A Randomized, Single-blind Study of the Ability of Avène Compact Honey to Prevent Pigmentation Induced by Visible Light in Subjects With Skin Phototype III or IV|Completed||N/A|21|Actual|Pierre Fabre Dermo Cosmetique||2|||f||||f||||||||||2017-10-11 03:45:25.722734|2017-10-11 03:45:25.722734
NCT00045877|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-12|2006-02-02||||||February 2006|2006-02-01||||||||Interventional|||Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments||Completed||Phase 2/Phase 3|||Chiron Corporation|||||||||||||||||||2017-10-11 04:40:21.038267|2017-10-11 04:40:21.038267
NCT01448109|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-09-05|||June 13, 2012|Actual|2012-06-13|September 2017|2017-09-01|December 30, 2017|Anticipated|2017-12-30|October 22, 2017|Anticipated|2017-10-22||Interventional|ADRENAL||ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock|A Randomised Blinded Placebo Controlled Trial of Hydrocortisone in Critically Ill Patients With Septic Shock|Active, not recruiting||Phase 4|3800|Actual|The George Institute||2|||f||||t||||||||||2017-10-11 03:45:25.820309|2017-10-11 03:45:25.820309
NCT01448096|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-08-27|||August 2011||2011-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma|Multi-center Phase II Study of the Combination of R-CHOP (RItuximab Plus Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) and Prophylactic Intrathecal Chemotherapy With Methotrexate in Patients With CD20+ Primary Breast Diffuse Large B-cell Lymphoma|Active, not recruiting||Phase 2|33|Actual|Chonbuk National University Hospital||1|||f||||f||||||||||2017-10-11 03:45:26.052944|2017-10-11 03:45:26.052944
NCT01448083|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-09-16|||October 2011||2011-10-01|September 2012|2012-09-01||||||||Observational|||Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours||Unknown status|Recruiting|N/A|40|Anticipated|Nuclear Medicine Consultants, Inc.|||1||f||||f||||||||||2017-10-11 03:45:26.154488|2017-10-11 03:45:26.154488
NCT01448070|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-02-23|||October 15, 2002|Actual|2002-10-15|February 2017|2017-02-01|December 20, 2002|Actual|2002-12-20|December 20, 2002|Actual|2002-12-20||Interventional|||Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers|A Single Centre, Randomized, Balanced Double Blind, Cross-over Trial Investigating the Bioequivalence of Actrapid® Produced by the Current Process and Human Insulin With the Same Formulation as Actrapid®, Produced by the NN729 Process|Completed||Phase 1|28|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:45:26.255081|2017-10-11 03:45:26.255081
NCT01448057|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2017-01-18|2016-08-16||July 2013||2013-07-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu|A Prospective, Randomized, Investigator-Blind Study to Compare Three Days of Treatment With Paracetamol (500 mg) / Dimethindene Maleate (1 mg) / Phenylephrine Hydrochloride (10 mg) Tablets Versus Paracetamol 500 mg Alone in the Treatment of Nasal Congestion and Other Symptoms Due to Cold and Flu|Completed||Phase 3|341|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:45:26.367908|2017-10-11 03:45:26.367908
NCT01448044|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2015-09-11|2015-08-07||December 2011||2011-12-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C|A Phase 3 Evaluation of BMS-790052 in Combination With Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects With Chronic Hepatitis C Genotype 4|Completed||Phase 3|152|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 03:45:26.677997|2017-10-11 03:45:26.677997
NCT01448031|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2012-05-09|||November 2011||2011-11-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Healthy Female and Male Volunteers Aspirin Study|A Phase I, Open-label, Randomized, Two Way Crossover Pharmacokinetic Study Comparing the Bioavailability of Acetylsalicylic Acid (ASA) After 5 Days Repeated Once Daily Administration of a Fixed Dose Combination Capsule of ASA 81 mg/Esomeprazole 20 mg and ASA 80 mg (European Aspirin Reference Product)|Completed||Phase 1|54|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:45:27.280137|2017-10-11 03:45:27.280137
NCT01448018|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-08-12|||January 2010||2010-01-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|CHIC-3||Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion|Pilot Study on Efficacy and Tolerance of Intravitreous Injection of Ranibizumab (Lucentis®) in Early-onset Central Retinal Vein Occlusion in Comparison to Hemodilution Using Erythrocytapheresis|Completed||Phase 4|45|Actual|Centre Hospitalier Intercommunal Creteil||3|||f||||t||||||||||2017-10-11 03:45:27.351248|2017-10-11 03:45:27.351248
NCT01448005|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-11-11|||February 2011||2011-02-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Observational|||LifeVest Post-CABG Registry|Post-market Release Registry of Wearable Defibrillator Use in Patients With Ventricular Dysfunction Following CABG Surgery|Terminated||N/A|69|Actual|Zoll Medical Corporation|||1|Enrollment|f||||f||||||||||2017-10-11 03:45:27.572106|2017-10-11 03:45:27.572106
NCT01447992|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-06-17|||September 2011||2011-09-01|June 2014|2014-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|HomeCTR1_2||Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Padova|Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing|Completed||Early Phase 1|5|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:45:27.672772|2017-10-11 03:45:27.672772
NCT01447979|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2012-11-28|||March 2012||2012-03-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|HomeCTR1_1||Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Montpellier|Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing|Completed||Early Phase 1|5|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:45:27.751036|2017-10-11 03:45:27.751036
NCT01447966|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-03-24|||May 2011||2011-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|June 2013|Actual|2013-06-01||Interventional|||Family Based Cognitive-Behavioral Treatment for Preschoolers With Obsessive Compulsive Disorder|Family Based Cognitive-Behavioral Treatment for Preschoolers With Obsessive Compulsive Disorder|Completed||N/A|31|Actual|University of South Florida||2|||f||||t||||||||||2017-10-11 03:45:27.822974|2017-10-11 03:45:27.822974
NCT01447953|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-12-14|||October 2011||2011-10-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|June 2013|Actual|2013-06-01||Interventional|||Activity and Life-role Targeted Pain Rehabilitation in Primary Health Care|Activity and Life-role Targeted Pain Rehabilitation in Primary Health Care: a Randomized Controlled Trial|Terminated||N/A|65|Actual|Uppsala University||2||"Organizational changes in health care made further recruitment to the treatment options   unpossible."|f||||f||||||||||2017-10-11 03:45:27.895912|2017-10-11 03:45:27.895912
NCT01447940|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2014-12-08|||January 2012||2012-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2014|Actual|2014-07-01||Interventional|TELEDIAB-3||Prospective Assessment of Meos Telemedicine E-portal on Ambulatory Care of Type 1 Diabetic Patients|Prospective Assessment of Meos Telemedicine E-portal on Ambulatory Care of Type 1 Diabetic Patients|Unknown status|Active, not recruiting|Phase 3|720|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 03:45:27.973376|2017-10-11 03:45:27.973376
NCT01447927|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-06-19|2014-04-02||June 2012||2012-06-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|||Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus|Randomized Double Blind Placebo Controlled Trial of Barrett's Esophagus Chemoprevention With Metformin|Completed||Phase 2|93|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 03:45:28.098349|2017-10-11 03:45:28.098349
NCT01447914|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-03-12|2015-01-26||November 2011||2011-11-01|March 2014|2014-03-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma|A Phase II Study of the c-Met Inhibitor ARQ 197 in Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma|Completed||Phase 2|16|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:45:28.57431|2017-10-11 03:45:28.57431
NCT01447901|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-03-27|||September 2011||2011-09-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies|Prospective, Non-interventional, Non-randomised, Open-label, Adult Study to Assess the Long Term Biological Therapeutic Response to Alipogene Tiparvovec in Lipoprotein Lipase Deficiency (LPLD) and Comparing Postprandial Chylomicron Metabolism Following a Radiolabeled Meal in LPLD Subjects Previously Treated With Alipogene Tiparvovec (Studies CT-AMT-011-01 or -02) to Untreated LPLD Subjects (Study PREPARATION-02) and to Healthy Volunteers|Terminated||N/A|19|Anticipated|Amsterdam Molecular Therapeutics|||3|Business reason|f||||f||||||Samples With DNA|"     whole blood, serum, urine, faeces   "|||2017-10-11 03:45:28.905409|2017-10-11 03:45:28.905409
NCT01447888|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-10-26|||September 2011||2011-09-01|October 2011|2011-10-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Interventional|||Perioperative Pain Management In Spine Surgery Patients: Part I|Perioperative Pain Management In Spine Surgery Patients: Part I|Unknown status|Recruiting|N/A|200|Anticipated|Abbott Northwestern Hospital||2|||f||||f||||||||||2017-10-11 03:45:29.0157|2017-10-11 03:45:29.0157
NCT01447875|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2014-01-28|||May 2011||2011-05-01|May 2012|2012-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of Sedative on the Fluid Responsiveness in Critically Ill Patients|The Effects of Propofol and Dexmedetomidine Infusion on the Fluid Responsiveness in Critically Ill Patients|Completed||Phase 1|100|Actual|Southeast University, China||1|||f||||t||||||||||2017-10-11 03:45:29.109288|2017-10-11 03:45:29.109288
NCT01447862|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2015-05-12|||October 2011||2011-10-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation|Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation|Completed||Phase 4|101|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 03:45:29.171421|2017-10-11 03:45:29.171421
NCT01447849|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-05-05|2012-11-09||August 2011||2011-08-01|November 2015|2015-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Lubiprostone and Mucus Secretion in Patients With Chronic Constipation|The Impact of Lubiprostone on Mucus Secretion in Asymptomatic Volunteers and Patients With Chronic Constipation|Completed||Phase 2/Phase 3|40|Actual|Texas Tech University Health Sciences Center, El Paso||2|||f||||f||||||||No||2017-10-11 03:45:30.718011|2017-10-11 03:45:30.718011
NCT01447836|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-05|||July 2011||2011-07-01|October 2011|2011-10-01|November 2012|Anticipated|2012-11-01|August 2012|Anticipated|2012-08-01||Observational|||Indocyanine Clearance Rate and Septic Liver Injury|Prognostic Value of Indocyanine Clearance Rate for Sepsis Patients in ICU|Unknown status|Recruiting|N/A|100|Anticipated|Sun Yat-sen University|||2||f||||t||||||Samples With DNA|"     Blood for transaminase, hemoglobin, prothrombin time, lactate and oxygen pressure test.   "|||2017-10-11 03:45:31.068649|2017-10-11 03:45:31.068649
NCT01447823|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2011-10-07|||August 2011||2011-08-01|October 2011|2011-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Observational Field Study of Acute Esophageal Food Bolus Impaction by Mean Esophageal Manometry and 24h-pH-monitoring|Observational Field Study of Acute Esophageal Food Bolus Impaction by Mean Esophageal Manometry and 24h-pH-monitoring|Unknown status|Recruiting|Phase 1|40|Anticipated|University of Zurich|||1||f||||t||||||||||2017-10-11 03:45:31.15485|2017-10-11 03:45:31.15485
NCT01447810|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2015-01-12|||October 2011||2011-10-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SJCIT||Constraint-Induced Movement Therapy in a Pediatric Oncology Population|Constraint Induced Movement Therapy in a Pediatric Oncology Population (SJCIT): A Pilot Study|Completed||N/A|10|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 03:45:31.215355|2017-10-11 03:45:31.215355
NCT01447797|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2012-04-01|||September 2011||2011-09-01|September 2011|2011-09-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin|Single Dose Open-label Comparative Pharmacokinetic Study to Assess the Pharmacokinetic Characteristics of Irbesartan and Atorvastatin Between Irbesartan/Atorvastatin Combination Tablet and Coadministration of Irbesartan and Atorvastatin Tablets in Healthy Male Subjects|Completed||Phase 1|52|Actual|Hanmi Pharmaceutical Company Limited||2|||f||||f||||||||||2017-10-11 03:45:31.294771|2017-10-11 03:45:31.294771
NCT01447784|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2013-07-16|||September 2011||2011-09-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||ToleroMune House Dust Mites (HDM) Exposure Chamber Study|A Double-blind, Randomised, Placebo-controlled Study to Evaluate Three Doses of ToleroMune HDM in House Dust Mite Allergic Subjects Following Challenge With House Dust Mite Allergen in an Environmental Exposure Chamber.|Completed||Phase 2|172|Actual|Circassia Limited||4|||f||||f||||||||||2017-10-11 03:45:31.361775|2017-10-11 03:45:31.361775
NCT01447771|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-04-08|||September 2011||2011-09-01|April 2014|2014-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Decision Support for Women With Breast Cancer|Decision Support for Women With Breast Cancer|Terminated||N/A|14|Actual|Sidney Kimmel Comprehensive Cancer Center||1||Lack of funds to continue and volunteer recruitment member left position|f||||t||||||||||2017-10-11 03:45:31.455989|2017-10-11 03:45:31.455989
NCT01447758|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2013-04-30|||September 2011||2011-09-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.|Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. A Multicentre, Prospective, Randomised Phase Ib Study in Subjects Investigating Safety,Tolerability and Pharmacokinetics of LEO 29102 Cream (2.5 mg/g) When Treating Atopic Dermatitis Lesions Twice Daily for 7 Days (Cohorts I, II and III) and 6 Weeks (Cohort IV)|Terminated||Phase 1|58|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 03:45:31.590277|2017-10-11 03:45:31.590277
NCT01447745|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-11-26|||March 2013||2013-03-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Abdominal Fat and Imaging Measurements of Heart Disease|Visceral Obesity/Ectopic Fat and Non-invasive Markers of Atherosclerosis: A Cardiometabolic-cardiovascular Imaging Study|Recruiting||N/A|500|Anticipated|Laval University|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, white cells   "|||2017-10-11 03:45:32.674807|2017-10-11 03:45:32.674807
NCT01447732|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2015-03-17|||October 2011||2011-10-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors|Two-Part, Open-Label, Multi-Center Phase 1 Study of Monoclonal Antibody CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors|Completed||Phase 1|71|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||2|||f||||f||||||||||2017-10-11 03:45:32.755809|2017-10-11 03:45:32.755809
NCT01447719|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-05-17|2012-04-06|2011-11-21|March 2010||2010-03-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Interventional|||Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07|Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07|Completed||Phase 3|110|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:45:32.837024|2017-10-11 03:45:32.837024
NCT01447706|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2016-04-11|2016-02-17||October 2011||2011-10-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|September 2013|Actual|2013-09-01||Interventional|||A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers|A Phase II Randomized Open Label Study of MM-121 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Platinum Resistant/ Refractory Advanced Ovarian Cancers|Completed||Phase 2|223|Actual|Merrimack Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:45:33.196724|2017-10-11 03:45:33.196724
NCT01447693|ClinicalTrials.gov processed this data on October 10, 2017|2007-12-31|2011-10-05||||||October 2011|2011-10-01||||||||Interventional|||Treatment of Uremic Pruritus by Olive-omega 3 Ointment||Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-10-11 03:45:34.151825|2017-10-11 03:45:34.151825
NCT01447680|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-09-04|||August 2011||2011-08-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing|Clinical Trial Comparing Two Types of Blood Samples (Plasma and SMARTplasma) for HIV and HCV Antibody Testing|Completed||N/A|1600|Anticipated|G & W Laboratories Inc.|||3||f||||f||||||Samples Without DNA|"     Plasma and SMARTplasma (SMARTplasma is plasma sample from whole blood treated with SMARTstim)   "|||2017-10-11 03:45:34.200674|2017-10-11 03:45:34.200674
NCT01447654|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-07-08|||November 2011||2011-11-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|INHERIT||Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy|INHibition of the Renin Angiotensin System in Hypertrophic Cardiomyopathy and the Effect on Ventricular Hypertrophy - a Randomized Intervention Trial With Losartan.|Completed||Phase 2|130|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 03:45:34.361597|2017-10-11 03:45:34.361597
NCT01447641|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-04-12|||August 2011||2011-08-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Sleep, Circadian Rhythms and Cluster Headache|Characterisation of Sleep and Circadian Physiology in Individuals With Cluster Headache|Completed||N/A|8|Actual|University of Surrey|||1||f||||f||||||Samples With DNA|"     Blood hormonal and circulating lymphocyte mRNA assays   "|||2017-10-11 03:45:34.453263|2017-10-11 03:45:34.453263
NCT01447628|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-03-08|||October 2011||2011-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients|What is the Effect of Intravenous Iron Supplementation on Cardiopulmonary Haemodynamics, Exercise Capacity and Quality of Life in Patients With IPAH and Iron Deficiency?|Recruiting||Phase 2|60|Anticipated|Imperial College London||2|||f||||f||||||||||2017-10-11 03:45:34.538704|2017-10-11 03:45:34.538704
NCT01447615|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-07-19|||February 2012||2012-02-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 31, 2016|Actual|2016-07-31||Interventional|||Bridges to the Future: Economic Empowerment for AIDS-Orphaned Children in Uganda|Bridges to the Future: Economic Empowerment for AIDS-Orphaned Children in Uganda|Active, not recruiting||N/A|1440|Anticipated|Columbia University||3|||f||||f||||||||||2017-10-11 03:45:34.690065|2017-10-11 03:45:34.690065
NCT01447602|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2014-09-02|||September 2011||2011-09-01|April 2013|2013-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|IPT-A-CSP||A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior|An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior|Completed||Phase 3|10|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 03:45:34.798197|2017-10-11 03:45:34.798197
NCT01447589|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-06-22|||February 2012||2012-02-01|June 2016|2016-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|NelfLung||Radical Lung Radiotherapy Plus Nelfinavir|A Phase I Dose Escalation Study of the HIV Protease Inhibitor, Nelfinavir, Given Concomitantly With Radical Radiotherapy (RT) for the Treatment of Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 1/Phase 2|0|Actual|Oxford University Hospitals NHS Trust||1||failed to recruit, no suitable patients|f||||f||||||||||2017-10-11 03:45:34.903382|2017-10-11 03:45:34.903382
NCT01447576|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-10-06|2015-08-04|2014-01-03|September 2009||2009-09-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder|A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder|Completed||Phase 2|1036|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t||||||||||2017-10-11 03:45:35.154788|2017-10-11 03:45:35.154788
NCT00000205|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-07-07|||October 1990||1990-10-01|July 2016|2016-07-01|September 1993|Actual|1993-09-01|March 1993|Actual|1993-03-01||Interventional|||Buprenorphine Maintenance Protocol - 1|Buprenorphine Maintenance Protocol|Completed||Phase 3|0||University of California, Los Angeles|||||f||||||||||||||2017-10-11 04:17:38.926004|2017-10-11 04:17:38.926004
NCT01447563|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-05|||May 2008||2008-05-01|October 2011|2011-10-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Comparative Bioavailability Study of Two Oral Formulations of Clopidogrel|Bioavailability of Two Oral Formulations of Clopidogrel: A Randomized, Open Label, Single Dose, Two-Period, Crossover Comparison in Healthy Mexican Volunteers|Terminated||Phase 1|32|Actual|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||t||||||||||2017-10-11 03:45:35.58441|2017-10-11 03:45:35.58441
NCT01447550|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-05|2016-08-15|||January 2009||2009-01-01|August 2016|2016-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan|Treatment of Thromboangiitis Obliterans (Buerger's Disease) With Bosentan|Completed||N/A|12|Actual|Hospital Universitario Getafe|||1||f||||t||||||||||2017-10-11 03:45:35.677795|2017-10-11 03:45:35.677795
NCT01447537|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-12-11|||September 2011||2011-09-01|December 2015|2015-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis||Completed||N/A|30|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-11 03:45:35.757206|2017-10-11 03:45:35.757206
NCT01447524|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2011-10-05|||January 2010||2010-01-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Caloric Restriction and Insulin Secretion|Very Low Calorie Diet: a Quick Therapeutic Tool to Improve Beta Cell Function in Morbidly Obese Patients With Type 2 Diabetes Mellitus|Completed||N/A|14|Actual|University of Rome Tor Vergata||1|||f||||t||||||||||2017-10-11 03:45:35.861455|2017-10-11 03:45:35.861455
NCT01447511|ClinicalTrials.gov processed this data on October 10, 2017|2010-01-29|2016-06-22|2014-07-30||May 2009||2009-05-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Pharmacogenetics of Warfarin Induction and Inhibition|Pharmacogenetics of Warfarin Induction and Inhibition|Completed||N/A|39|Actual|University of Minnesota - Clinical and Translational Science Institute||5|||f||||f||||||||||2017-10-11 03:45:35.967253|2017-10-11 03:45:35.967253
NCT01447498|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2015-11-09|||April 2011||2011-04-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment|Effect of a Systematic Screening for Risk-factors for Ulcer Bleeding Before Post-PCI Anti-thrombotic Treatment|Completed||N/A|2024|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 03:45:36.823391|2017-10-11 03:45:36.823391
NCT01447485|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2012-05-06|||August 2011||2011-08-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients|A Multicenter, Open-label, Single-dose Study to Evaluate the Pharmacokinetics of Valsartan in Japanese Pediatric Patients 6 to 14 Years of Age|Completed||Phase 1|12|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:45:36.923913|2017-10-11 03:45:36.923913
NCT01447472|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2011-10-05|||May 2003||2003-05-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2009|Actual|2009-05-01||Interventional|||-Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms|Human Study of the Metabolic Changes Induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in the Metabolism of Dextromethorphan and Caffeine|Completed||Phase 1|27|Actual|Parc de Salut Mar||1|||f||||f||||||||||2017-10-11 03:45:37.027018|2017-10-11 03:45:37.027018
NCT01447459|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2016-12-06|||February 2011||2011-02-01|July 2012|2012-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|IHOP||Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma|Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma|Completed||N/A|144|Actual|University of Louisville||2|||f||||f||||||||||2017-10-11 03:45:37.115026|2017-10-11 03:45:37.115026
NCT01447446|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-02-10|2016-09-27||September 2011||2011-09-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational||Core population: treatment-naive/experienced participants who were without contraindication to Peg-IFN and RBV, end stage renal disease, major organ transplantation, co-infection with hepatitis B or HIV, acute hepatitis and with positive HCV RNA at baseline, known genotype, 1 of 6 treatment (excluding non-G1 participants receiving triple therapy).|An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C|Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C|Completed||N/A|4442|Actual|Hoffmann-La Roche|||6||f||||||||||||||2017-10-11 03:45:37.518856|2017-10-11 03:45:37.518856
NCT01447433|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2012-07-26|2012-01-03||April 2011||2011-04-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Calcium + Vitamin D Supplementation on Weight Management in Very-low Calcium Consumers|A Randomized, Open-label, Parallel Groups-controlled Clinical Trial to Evaluate the Effect of Calcium Plus Vitamin D Supplementation on Weight Management in Overweight and Obese Very-low Calcium Consumers|Completed||Phase 4|53|Actual|Changhai Hospital|The study sample was mostly women.|2|||f||||f||||||||||2017-10-11 03:45:43.44258|2017-10-11 03:45:43.44258
NCT01447420|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-06-24|2016-05-18||February 2011||2011-02-01|June 2016|2016-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||Safety population included all enrolled participants who received at least one dose of any study medication.|A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)|A Clinical Trial Comparing the Sustained Virological Response in Terms of Expression Profile of IL- 28B in Genotype 1 HCV-Infected Treatment-Naïve Subjects With Chronic Hepatitis C on Pegasys® (Peginterferon Alfa-2A) Plus Copegus® (Ribavirin)|Completed||Phase 4|129|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:45:44.06227|2017-10-11 03:45:44.06227
NCT01447407|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2013-05-28|||September 2011||2011-09-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Study to Assess the Effect of Adjuvant and Route of Administration on the Safety, Tolerability, and Immunogenicity of NDV-3 Vaccine Against S.Aureus and Candida|Phase 1b Partially-blind,Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of NDV-3, A Recombinant Alum Adjuvanted Vaccine for S. Aureus and Candida Infections, Administered Either Intramuscular (IM) or Intradermally (ID) to Healthy Adults|Completed||Phase 1|160|Actual|NovaDigm Therapeutics, Inc.||4|||f||||f||||||||||2017-10-11 03:45:44.587345|2017-10-11 03:45:44.587345
NCT01445444|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-03-09|||September 2011||2011-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|December 2015|Actual|2015-12-01||Interventional|||Habit Reversal Training for Children and Adolescents With Trichotillomania|Habit Reversal Training for Children and Adolescents With Trichotillomania: A Controlled Trial|Completed||N/A|50|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-11 03:46:14.730242|2017-10-11 03:46:14.730242
NCT01447394|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2012-02-02|||March 2012||2012-03-01|February 2012|2012-02-01|August 2014|Anticipated|2014-08-01|March 2014|Anticipated|2014-03-01||Interventional|||Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C|A Double-Blinded Randomized Control Study Evaluating the Efficacy and Safety of Pegylated Lambda Interferon Compared to Pegylated Alfa-2a Interferon, Each in Combination With Ribavirin, in the Treatment of Naive Genotype 1 or 4 Chronic Hepatitis C Subjects|Withdrawn||Phase 3|0|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 03:45:44.68188|2017-10-11 03:45:44.68188
NCT01447381|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2012-11-01|||October 2011||2011-10-01|November 2012|2012-11-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|||Systemic Therapies for Pediatric Atopic Dermatitis|Systemic Therapies for Pediatric Atopic Dermatitis|Recruiting||N/A|250|Anticipated|Rady Children's Hospital, San Diego|||4||f||||t||||||||||2017-10-11 03:45:45.106556|2017-10-11 03:45:45.106556
NCT01447368|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-01-14|||May 2010||2010-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients|Comparison of Medical (Oral Cinacalcet) Therapy Versus Surgical Therapy (Total Parathyroidectomy) on Vascular/Valvular Calcification in Chronic Peritoneal Dialysis Patients With Secondary Hyperparathyroidism - A Pilot Study|Recruiting||N/A|70|Anticipated|The University of Hong Kong||2|||f||||f||||||||No||2017-10-11 03:45:45.211431|2017-10-11 03:45:45.211431
NCT01447355|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-10-07|||August 2012||2012-08-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|October 2012|Actual|2012-10-01||Interventional|||Vitamin D Levels in the Skin of Healthy Subjects After Oral Supplementation|Pilot Study on the Bioactivity of Vitamin D in the Skin After Oral Supplementation|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:45:45.323099|2017-10-11 03:45:45.323099
NCT01447342|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-03-23|||September 2011||2011-09-01|March 2015|2015-03-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines||Completed||Phase 2/Phase 3|54|Actual|MyoScience, Inc||1|||f||||f||||||||||2017-10-11 03:45:45.436647|2017-10-11 03:45:45.436647
NCT01447329|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-08-09|||December 2011|Actual|2011-12-01|August 2017|2017-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|BFAKnee||Ear Acupuncture for Pain Associated With Ambulatory Arthroscopic Knee Surgery|Ear Acupuncture for Post-operative Pain Associated With Ambulatory Arthroscopic Knee Surgery - A Randomized Controlled Trial|Completed||N/A|60|Actual|Mike O'Callaghan Federal Hospital||2|||f||||f||||||||||2017-10-11 03:45:45.52087|2017-10-11 03:45:45.52087
NCT01447316|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2013-01-16|||August 2009||2009-08-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Bariatric Surgery on Short Term Weight Loss- Related Changes in Gait|Impact of Bariatric Surgery on Short Term Weight Loss- Related Changes in Gait and Quality of Life|Completed||N/A|36|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 03:45:45.633123|2017-10-11 03:45:45.633123
NCT01447303|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-01-24|||August 2009||2009-08-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Functional and Quality of Life Outcomes Following Viscosupplementation for Knee Osteoarthritis|Functional and Quality of Life Outcomes Following Hyaluronic Acid (HA) Viscosupplementation for Knee Osteoarthritis|Terminated||N/A|43|Actual|University of Florida|||1|Inability to recruit subjects|f||||f||||||||||2017-10-11 03:45:45.73292|2017-10-11 03:45:45.73292
NCT01447290|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-10-10|||May 2012||2012-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|P:C Ratio||Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia|Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia|Completed||N/A|100|Actual|Mike O'Callaghan Federal Hospital|||1||f||||f||||||||||2017-10-11 03:45:45.842265|2017-10-11 03:45:45.842265
NCT01447264|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-05|||February 2009||2009-02-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||Effectiveness of Water Exercises on Isokinetic Muscle Strength|Comparison of the Effectiveness Between Land and Water Exercises on Isokinetic Muscle Strength of Lower Limbs in Women With Rheumatoid Arthritis: a Randomized Controlled Trial|Completed||Phase 3|100|Actual|Federal University of São Paulo||3|||f||||f||||||||||2017-10-11 03:45:46.038754|2017-10-11 03:45:46.038754
NCT01447251|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-10-10|||September 2011||2011-09-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|OSA & DM||Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea|Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea|Completed||N/A|70|Actual|Mike O'Callaghan Federal Hospital||4|||f||||f||||||||||2017-10-11 03:45:46.53399|2017-10-11 03:45:46.53399
NCT01447238|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-10-04|||September 2010||2010-09-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Diagnosis of Pancreatic Cysts: Endoscopic Ultrasound With Fine Needle Aspiration (EUS/FNA), Direct Visualization, and Confocal Laser-induced Endomicroscopy—A Pilot Study|Diagnosis of Pancreatic Cysts: Endoscopic Ultrasound With Fine Needle Aspiration (EUS/FNA), Direct Visualization, and Confocal Laser-induced Endomicroscopy—A Pilot Study|Unknown status|Recruiting|N/A|30|Anticipated|University of California, Irvine|||1||f||||t||||||||||2017-10-11 03:45:46.654295|2017-10-11 03:45:46.654295
NCT01447225|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2016-09-13|2016-07-12||October 2011||2011-10-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors|A Phase 1, Pharmacologic and Pharmacodynamic Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors|Completed||Phase 1|43|Actual|Merrimack Pharmaceuticals||4|||f||||f||||||||||2017-10-11 03:45:46.844853|2017-10-11 03:45:46.844853
NCT00000206|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-11-03|||April 1991||1991-04-01|November 2016|2016-11-01||||August 2005|Actual|2005-08-01||Interventional|||Clinical Rescue Protocol - 2|Clinical Rescue Protocol|Completed||Phase 2|0||University of California, Los Angeles|||||f||||||||||||||2017-10-11 04:17:39.017906|2017-10-11 04:17:39.017906
NCT01447212|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-06-05|||December 2011||2011-12-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|June 2014|Actual|2014-06-01||Interventional|SALOME||Study to Assess Longer-term Opioid Medication Effectiveness (SALOME)|SALOME: Multi-Centre, Double Blind Randomized Controlled Trial Comparing The Effectiveness Of Diacetylmorphine Vs. Hydromorphone For The Treatment Of Long-Term Injection Opioid Users Who Do Not Benefit From Available Therapies|Completed||Phase 3|202|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 03:45:49.26802|2017-10-11 03:45:49.26802
NCT01447199|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-10-31|||September 1994||1994-09-01|October 2016|2016-10-01||||September 2018|Anticipated|2018-09-01||Observational|||The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)|The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)|Recruiting||N/A|2000|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||Samples With DNA|"     Participants will have a single sample (8-10 teaspoons) of blood collected at M. D. Anderson,     depending upon current health status. In the case of individuals not coming to the clinic, a     blood drawing kit will be sent to the participant's home, which will include instructions and     a postage-paid return express mail envelope. If participant unable or unwilling to give a     blood sample, saliva samples can be collected instead.   "|||2017-10-11 03:45:49.405878|2017-10-11 03:45:49.405878
NCT01447186|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-02-16|||September 2012|Actual|2012-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men|Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men|Active, not recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 03:45:49.519714|2017-10-11 03:45:49.519714
NCT01447173|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-10-22|||December 2010||2010-12-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Vitamin and Asthma Study||Completed||Phase 4|10|Actual|Augusta University||2|||f||||||||||||||2017-10-11 03:45:49.620826|2017-10-11 03:45:49.620826
NCT01447160|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-10-05|||October 2011||2011-10-01|July 2011|2011-07-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Effectiveness of Facet Joint Infiltration in Low Back Pain|Effectiveness of Facet Joint Infiltration in Low Back Pain|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 03:45:49.718549|2017-10-11 03:45:49.718549
NCT01447147|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2014-12-12|||October 2011||2011-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX140-B in Diabetic Nephropathy|Completed||Phase 2|332|Actual|ChemoCentryx||3|||f||||t||||||||||2017-10-11 03:45:49.853819|2017-10-11 03:45:49.853819
NCT01447134|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-05|||June 2011||2011-06-01|October 2011|2011-10-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Observational|||RGD-K5 in Head and Neck Cancer Patients|Phase II Study of [18F]RGD-K5 in Head and Neck Cancer Patients|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Chang Gung Memorial Hospital|||3||f||||t||||||||||2017-10-11 03:45:50.258379|2017-10-11 03:45:50.258379
NCT01447121|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-01-29|2012-09-20||September 2011||2011-09-01|January 2016|2016-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||User Study of an Investigational Blood Glucose Monitoring System|Tatsu/Tradewind System User Performance Evaluation|Completed||N/A|118|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 03:45:50.305731|2017-10-11 03:45:50.305731
NCT01447108|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2012-12-26|||November 2011||2011-11-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain|Examining the Efficacy of Low Intensity Low Frequency Surface Acoustic Wave Ultrasound(LILF/SAWU) in Trigeminal Neuralgia Pain|Completed||Phase 4|16|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 03:45:50.474542|2017-10-11 03:45:50.474542
NCT01447095|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-02|2014-07-18|||October 2011||2011-10-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage|Effect of Prostacyclin Infusion on Cerebral Vessels, Cerebral Bloodflow and Cerebral Metabolism in Patients With Subarachnoid Haemorrhage|Completed||Phase 2|90|Actual|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-10-11 03:45:50.574415|2017-10-11 03:45:50.574415
NCT01447082|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-02-06|||October 2008||2008-10-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|GPRD SeroquelS||General Practice Research Database Seroquel XR Safety Study|Epidemiology Study to Assess the Safety of a New Slow-release Form of Seroquel (Quetiapine) in the Post-marketing Phase in the UK|Completed||N/A|37372|Actual|AstraZeneca|||2||f||||||||||||||2017-10-11 03:45:50.769271|2017-10-11 03:45:50.769271
NCT01447069|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2011-10-02|||October 2011||2011-10-01|August 2011|2011-08-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Use of Beta-agonists in Stable Severe Congestive Heart Failure||Unknown status|Not yet recruiting|N/A|30|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 03:45:50.853269|2017-10-11 03:45:50.853269
NCT01447056|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-02-03|||February 2012||2012-02-01|February 2017|2017-02-01|February 2020|Anticipated|2020-02-01|March 2015|Actual|2015-03-01||Interventional|MALTED||Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases|Most Closely HLA-Matched Allogeneic LMP1/2-Specific Cytotoxic T Lymphocytes for Treatment of Patients With Relapsed EBV-Associated Diseases|Active, not recruiting||Phase 1|18|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 03:45:50.936883|2017-10-11 03:45:50.936883
NCT01447043|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-01-24|||January 2009||2009-01-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|August 2011|Actual|2011-08-01||Observational|AURA||Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)|AURA Study: A Retrospective Non-interventional Study (NIS) to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration (wAMD)|Completed||N/A|2609|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:45:51.02634|2017-10-11 03:45:51.02634
NCT01447030|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-02|2014-10-19|||October 2011||2011-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Long Time Follow up After HJ Following Iatrogenic Bile Duct Injuries|Langtidsopfølgning Efter Kirurgisk Behandling af Iatrogene galdevejslæsioner opstået i Forbindelse Med Cholecystektomi|Completed||N/A|139|Actual|Odense University Hospital|||1||f||||f||||||||||2017-10-11 03:45:51.14149|2017-10-11 03:45:51.14149
NCT01447017|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2013-10-18|2013-10-18||November 2011||2011-11-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis|A Randomised, Parallel-group, Double-blind, Placebo-controlled Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis|Completed||Phase 2|69|Actual|DermaGen AB||2|||f||||||||||||||2017-10-11 03:45:51.221428|2017-10-11 03:45:51.221428
NCT01447004|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-04|||March 2010||2010-03-01|February 2010|2010-02-01||||||||Observational|||a Case-control Study of the Association Between Heavy Mental and Children With Attention Deficit Hyperactivity Disorder in Korea|a Case-control Study of the Association Between Heavy Mental and Children With Attention Deficit Hyperactivity Disorder in Korea|Unknown status|Recruiting|N/A|100|Anticipated|Hallym University Medical Center|||1||f||||f||||||||||2017-10-11 03:45:51.512108|2017-10-11 03:45:51.512108
NCT01446991|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2017-08-04|||April 2012||2012-04-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|February 2017|Actual|2017-02-01||Interventional|||Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy|Phase II Trial Assessing the Feasibility and Toxicity of Degarelix in Achieving Prostate Downsizing Prior to Treatment With Permanent Seed Prostate Brachytherapy|Active, not recruiting||Phase 2|50|Actual|British Columbia Cancer Agency||2|||f||||f||||||||||2017-10-11 03:45:51.592461|2017-10-11 03:45:51.592461
NCT01446978|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2015-11-17|||September 2011||2011-09-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs|Hepatitis A Vaccination in Patients With Rheumatoid Arthritis Treated With TNF-inhibitors and/or Methotrexate|Active, not recruiting||Phase 2|150|Anticipated|Sormland County Council, Sweden||2|||f||||t||||||||||2017-10-11 03:45:51.688331|2017-10-11 03:45:51.688331
NCT01446965|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-04-14|||July 2008||2008-07-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|VEST||Vest Prevention of Early Sudden Death Trial and VEST Registry|Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator|Active, not recruiting||Phase 3|2300|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:45:51.813154|2017-10-11 03:45:51.813154
NCT01446952|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2016-04-08|||September 2011||2011-09-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|September 2012|Actual|2012-09-01||Interventional|||Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects|A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Vitamin E δ-Tocotrienol Following Single Dose Administration in Healthy Subjects|Completed||Phase 1|18|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 03:45:52.331986|2017-10-11 03:45:52.331986
NCT01446939|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2012-10-26|||October 2012||2012-10-01|October 2012|2012-10-01|July 2014|Anticipated|2014-07-01|February 2014|Anticipated|2014-02-01||Observational|||Imaging in the Diagnosis of Parkinson's Disease and Essential Tremor|Role of Diffusion Tensor Imaging and Transcranial Sonography in the Parkinson's Disease and Essential Tremor|Unknown status|Recruiting|N/A|150|Anticipated|Hospital Israelita Albert Einstein|||3||f||||t||||||||||2017-10-11 03:45:52.415512|2017-10-11 03:45:52.415512
NCT01446926|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2014-04-01|||September 2011||2011-09-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants||Completed||Phase 1|280|Actual|Sanofi||11|||f||||t||||||||||2017-10-11 03:45:52.498512|2017-10-11 03:45:52.498512
NCT01446900|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-09-28|||January 2011||2011-01-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Interventional|||R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma|Rituximab-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma|Terminated||Phase 2|57|Anticipated|European Institute of Oncology||1||low rate in patient accrual|f||||f||||||||||2017-10-11 03:45:52.706443|2017-10-11 03:45:52.706443
NCT01446887|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-10-08|||January 2007||2007-01-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty|Phase II Study of Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty|Completed||Phase 2/Phase 3|||The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School||2|||f||||t||||||||||2017-10-11 03:45:52.801752|2017-10-11 03:45:52.801752
NCT01446874|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-10-31|||September 2011||2011-09-01|October 2016|2016-10-01||||June 2017|Anticipated|2017-06-01||Interventional|POPP||Prevention of Post-operative Pneumonia (POPP)|Prevention of Postoperative Pneumonia (POPP Study: A Study to Evaluate the Use of a Prophylactic Clinical Strategy to Prevent Postoperative Pneumonia in Patients Undergoing Thoracic Surgery|Active, not recruiting||Phase 2/Phase 3|330|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:45:52.870337|2017-10-11 03:45:52.870337
NCT01446861|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2016-08-23|||January 2011||2011-01-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Exocrine Pancreatic Function Testing in Cystic Fibrosis|Pancreatic Failure in Patients With Cystic Fibrosis A Multimodal Study of Exocrine Pancreatic Failure in Cystic Fibrosis|Active, not recruiting||N/A|60|Anticipated|Haukeland University Hospital|||2||f||||f||||||Samples With DNA|"     Duodenal juice Serum, full Blood Saliva   "|Yes|Data will be published in peer rewieved journals|2017-10-11 03:45:52.939588|2017-10-11 03:45:52.939588
NCT01446848|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2014-08-11|||January 2012||2012-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Oral Iron Supplementation in Pulmonary Hypertension|Oral Iron Supplementation in Pulmonary Hypertension|Completed||N/A|6|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-10-11 03:45:53.008833|2017-10-11 03:45:53.008833
NCT01446835|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-06-26|||October 2011||2011-10-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Asian Clinical Evaluation of an Investigational Contact Lens for Cosmetic Effect||Completed||N/A|151|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:45:53.222949|2017-10-11 03:45:53.222949
NCT00046592|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2016-02-17|||August 2002||2002-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Mechanisms of Disability in Peripheral Arterial Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:40:44.040021|2017-10-11 04:40:44.040021
NCT01446822|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-06-27|||October 2011||2011-10-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors|Transurethral Resection of Bladder Tumors Without Obturator Nerve Block or Relaxation: Extent of Adductor Muscle Contraction With Monopolar Versus Bipolar Resection Technique|Completed||N/A|44|Actual|Cantonal Hospital of St. Gallen||2|||f||||t||||||||||2017-10-11 03:45:53.342577|2017-10-11 03:45:53.342577
NCT01446796|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-02-19|2013-06-21||September 2011||2011-09-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional||Study terminated early|Right Ventricular (RV) Pacing in Early Post-operative Continuous Flow Left Ventricular Assist Device (LVAD)|Hemodynamic and Clinical Effects of Continuous Right Ventricular Pacing in the Early Post-operative Period After Left Ventricular Assist Device Implantation|Terminated||Phase 4|3|Actual|Duke University||2||Recruitment futility|f||||t||||||||||2017-10-11 03:45:53.658229|2017-10-11 03:45:53.658229
NCT01446783|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-11-19|||September 2011||2011-09-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients|IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients|Completed||N/A|15|Actual|Bispebjerg Hospital||4|||f||||f||||||||||2017-10-11 03:45:53.90119|2017-10-11 03:45:53.90119
NCT01446770|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-02|2012-03-12|||November 2010||2010-11-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181|A Prospective, Randomized, Comparative Feasibility Study Evaluating the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181 Adjunctive to Surgical Scar Revision|Completed||Phase 2|19|Actual|Halscion, Inc.||1|||f||||f||||||||||2017-10-11 03:45:54.023402|2017-10-11 03:45:54.023402
NCT01446757|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-03-29|||March 2011||2011-03-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|AGE-FIT||Ambulatory Geriatric Evaluation - Frailty Intervention Trial|Effectiveness of a Comprehensive CGA on Frailty in Community-dwelling Elderly People - A Randomised, Controlled Trial|Completed||N/A|383|Actual|Linkoeping University||2|||f||||f||||||||||2017-10-11 03:45:54.117697|2017-10-11 03:45:54.117697
NCT01446744|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-09-06|||November 2011||2011-11-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|SABR-COMET||Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET)|Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trial|Active, not recruiting||Phase 2|99|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 03:45:54.240274|2017-10-11 03:45:54.240274
NCT01446731|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-02|2016-08-15|||October 2011||2011-10-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer|Dendritic Cell Vaccination in Combination With Docetaxel for Patients With Cancer Prostate - a Randomized Phase II Study|Completed||Phase 2|43|Actual|Herlev Hospital||2|||f||||t||||||||No||2017-10-11 03:45:54.376564|2017-10-11 03:45:54.376564
NCT01446718|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-09-05|||December 2014||2014-12-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|November 2018|Anticipated|2018-11-01||Observational|||A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years|A Longitudinal Observational Cohort Study to Assess Sustained Immunogenicity up to 48 Months to Quadrivalent Human Papillomavirus Vaccine Among HIV-infected Girls and Boys Age 9-14 Years in Kenya|Active, not recruiting||Phase 4|179|Actual|Kenyatta National Hospital|||1||f||||f||||||None Retained|"     Plasma for HPV antibody testing there will be no long term sample storage   "|||2017-10-11 03:45:54.502246|2017-10-11 03:45:54.502246
NCT01446705|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2016-07-14|2015-07-31||December 2012||2012-12-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|June 2015|Actual|2015-06-01||Observational|VLER-IHIE|Baseline cohort consists of Veterans who had 2 outpatient, or 1 inpatient visit to the Indianapolis VAMC in the year prior to the index date of 3/1/12.|Evaluation of VLER-Indiana Health Information Exchange Demonstration Project|Evaluation of VLER_Indiana Health Information Exchange Demonstration Project|Completed||N/A|57073|Actual|VA Office of Research and Development|||2||f||||f||||||||No||2017-10-11 03:45:54.612872|2017-10-11 03:45:54.612872
NCT01446692|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2012-01-11|||November 2011||2011-11-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|||||Observational|||Badalona Major Depressive Disorder Database Study|Therapeutic Strategies for the Management of Patients With Major Depressive Disorder (MDD) and Suboptimal Response to Antidepressant Drugs in Primary Care: the Badalona Database Study|Completed||N/A|2260|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 03:45:54.950546|2017-10-11 03:45:54.950546
NCT01446679|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2013-02-20|||September 2010||2010-09-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|ALWAYS||Special Drug Use-Results Survey of Lipitor Tablets|Special Drug Use-Results Survey of Lipitor Tablets|Completed||N/A|24050|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 03:45:55.057854|2017-10-11 03:45:55.057854
NCT01446653|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-02|2016-10-24|||February 2007||2007-02-01|October 2016|2016-10-01|September 2011|Actual|2011-09-01|July 2010|Actual|2010-07-01||Interventional|EARLY RCT||Reducing Alcohol Exposed Pregnancy Risk: EARLY Randomized Controlled Trial|Reducing Alcohol Exposed Pregnancy Risk|Completed||N/A|232|Actual|University of Virginia||3|||f||||f||||||||||2017-10-11 03:45:55.223301|2017-10-11 03:45:55.223301
NCT00000207|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-07-07|||May 1992||1992-05-01|July 2016|2016-07-01||||April 1997|Actual|1997-04-01||Interventional|||Multicenter Clinical Trial of Buprenorphine - 3|Multicenter Clinical Trial of Buprenorphine|Completed||Phase 3|0||University of California, Los Angeles|||||f||||||||||||||2017-10-11 04:17:39.112036|2017-10-11 04:17:39.112036
NCT01446640|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-04|||October 2011||2011-10-01|October 2011|2011-10-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|MSC||Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury|PhaseⅠ/ⅡTrial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Spinal Cord Injury.|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||1|||f||||t||||||||||2017-10-11 03:45:55.335228|2017-10-11 03:45:55.335228
NCT01446627|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-05-02|||January 2010||2010-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Observational|||Use of Insorb Absorbable Vicryl Staples in Skin Closure for Cesarean Section|Comparison of Vicryl Absorbable Sutures and Metal Staples Used in Skin Closure Following Cesarean Section|Completed||N/A|300|Actual|The University of Texas Health Science Center, Houston|||2||f||||f||||||||||2017-10-11 03:45:55.455831|2017-10-11 03:45:55.455831
NCT01446614|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-04|2011-10-04|||October 2011||2011-10-01|October 2011|2011-10-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease|PhaseⅠ/ⅡTrial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Parkinson's Disease.|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Guangzhou General Hospital of Guangzhou Military Command||1|||f||||t||||||||||2017-10-11 03:45:55.532534|2017-10-11 03:45:55.532534
NCT01446601|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-04-14|||August 2011||2011-08-01|December 2011|2011-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea|Pivotal Study of the Apnex Medical™ Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea|Terminated||Phase 3|132|Anticipated|Apnex Medical, Inc.||2|||f||||t||||||||||2017-10-11 03:45:55.630819|2017-10-11 03:45:55.630819
NCT01446588|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-05-23|||June 2012||2012-06-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|OHAYS||Ocular Hypertension And Yoga Study|Ocular Hypertension And Yoga Study|Withdrawn||N/A|0|Actual|Johns Hopkins University||1||No Funding was acquired.|f||||f||||||||||2017-10-11 03:45:55.914286|2017-10-11 03:45:55.914286
NCT01446562|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-06-15|||May 2007||2007-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|ZEVISS||Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma|Phase II Trial of Y90 Ibritumomab Tiuxetan Post Rituximab-Cyclophosphamide, Doxobrubicn, Vincristine and Prednisone (R-CHOP) Chemotherapy for Newly Diagnosed Patients With Advanced Stage Follicular Lymphoma|Completed||Phase 2|34|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 03:45:55.998523|2017-10-11 03:45:55.998523
NCT01446549|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2013-09-22|||July 2010||2010-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Motor Performance in Parkinson's Disease After High Intensive Exercise or Deep Brain Stimulation|Quantitative Modeling of Motor Performance in Parkinson's Disease After High Intensive Antigravity Locomotor Exercise or Deep Brain Stimulation|Completed||N/A|40|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 03:45:56.079349|2017-10-11 03:45:56.079349
NCT01446536|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2012-03-18|||August 2008||2008-08-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Quality Improvement Tools in Congestive Heart Failure (CHF)|Decreased Readmissions and Improved Quality of Care With Use of Inexpensive Checklist in Heart Failure|Completed||N/A|96|Actual|St. Joseph Mercy Oakland Hospital||2|||f||||||||||||||2017-10-11 03:45:56.151423|2017-10-11 03:45:56.151423
NCT01446523|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-11|2012-04-09|||October 2011||2011-10-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|endtxninHE||S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE|Serum Endotoxins, Inflammatory Mediators and MR Spectroscopy Before and After Treatment in Minimal Hepatic Encephalopathy|Completed||N/A|60|Actual|Govind Ballabh Pant Hospital||2|||f||||t||||||||||2017-10-11 03:45:56.229196|2017-10-11 03:45:56.229196
NCT01446510|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-04-17|||September 2011||2011-09-01|September 2011|2011-09-01|April 2013|Anticipated|2013-04-01|October 2012|Anticipated|2012-10-01||Observational|||Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients|Systematic Review and Meta-Analysis of Venous Thromboembolism Risk Assessment Models in Hospitalized Medical Patients|Withdrawn||N/A|0|Actual|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-10-11 03:45:56.314586|2017-10-11 03:45:56.314586
NCT01446497|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2011-10-03|||October 2010||2010-10-01|October 2011|2011-10-01|August 2012|Anticipated|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma|Randomized, Multicenter, Open-label, Parallel Group Study to Evaluate Efficacy and Safety of Combigan(Brimonidine/Timolol) and 0.5% Timoptic(Timolol) Ophthalmic Solutions in Normal Tension Glaucoma Patients|Unknown status|Recruiting|Phase 4|22|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:45:56.391212|2017-10-11 03:45:56.391212
NCT01446484|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-11-17|||October 2011||2011-10-01|November 2011|2011-11-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection|Phase 1 Pilot Study Using Autologous CD4+CD25+FoxP3+ T Regulatory Cells and Campath-1H to Induce Renal Transplant Tolerance|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Pirogov Russian National Research Medical University||2|||f||||f||||||||||2017-10-11 03:45:56.48313|2017-10-11 03:45:56.48313
NCT01446471|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-11-30|||January 2010||2010-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2014|Actual|2014-11-01||Observational|||REASON 1 Trial: Sonography in Cardiac Arrest|REASON 1 Trial: Sonography in Cardiac Arrest|Completed||N/A|793|Actual|University of Massachusetts, Worcester|||1||f||||f||||||||||2017-10-11 03:45:56.644113|2017-10-11 03:45:56.644113
NCT01446458|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-03-21|||November 2011||2011-11-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer|Phase I Study of Stereotactic Body Radiation Therapy and 5-Fluorouracil, Oxaliplatin and Irinotecan (FOLFIRINOX) in the Neoadjuvant Therapy of Pancreatic Cancer|Completed||Phase 1|13|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:45:56.867829|2017-10-11 03:45:56.867829
NCT01446445|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2015-03-25|||December 2011||2011-12-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.|Individualization of Ganciclovir and Valganciclovir Doses in Renal Transplant Patients for Prophylaxis or Treatment of Cytomegalovirus(CMV)Infection Using Bayesian Prediction.|Completed||Phase 4|60|Actual|Hospital Universitari de Bellvitge||4|||f||||f||||||||||2017-10-11 03:45:57.43232|2017-10-11 03:45:57.43232
NCT01446432|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2015-04-01|||February 2011||2011-02-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Validation of Two New Questionnaires for Dupuytren's Disease|A Prospective Study to Validate Two New Patient Reported Outcome Measures for Dupuytren's Disease in Patients Treated With XIAFLEX|Unknown status|Active, not recruiting|N/A|80|Anticipated|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-11 03:45:57.541887|2017-10-11 03:45:57.541887
NCT01446419|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2016-10-24|2016-07-12||October 2011||2011-10-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Interventional|SMART|Intent to Treat Population|SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain|A Prospective Randomized, Double-blind, Controlled Investigation Evaluating the Intracept Intraosseous Nerve Ablation System for the Reduction of Pain in Patients With Chronic Axial Low Back Pain|Completed||N/A|225|Actual|Relievant Medsystems, Inc.||2|||f||||t||||||||||2017-10-11 03:45:57.634301|2017-10-11 03:45:57.634301
NCT01446406|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-03-29|||October 2011||2011-10-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|MONARCA||The MONARCA Project (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes)|Electronic Daily Self-monitoring of Subjective and Objective Symptoms in Bipolar Disorder - The MONARCA Project (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes)|Completed||N/A|78|Actual|Psychiatric Centre Rigshospitalet||2|||f||||t||||||||||2017-10-11 03:45:58.219435|2017-10-11 03:45:58.219435
NCT01446393|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-11-14|||May 2010||2010-05-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Observational|Ca-Art-PXE||Functional and Structural Characterization of Arteriopathy in Pseudoxanthoma Elasticum (PXE)|Functional and Structural Characterization of the Peripheral Arteriopathy in Pseudoxanthoma Elasticum (PXE)|Completed||N/A|71|Actual|University Hospital, Angers|||1||f||||f||||||Samples With DNA|"     Blood samples for genetic and serum analysis   "|||2017-10-11 03:45:58.305875|2017-10-11 03:45:58.305875
NCT01446380|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-03|2011-10-03|||June 2008||2008-06-01|October 2009|2009-10-01|January 2021|Anticipated|2021-01-01|January 2020|Anticipated|2020-01-01||Observational|||Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort|Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort|Recruiting||N/A|350|Anticipated|University Hospital, Angers|||1||f||||f||||||Samples With DNA|"     Sera,Plasma,DNA,skin biopsy   "|||2017-10-11 03:45:58.393064|2017-10-11 03:45:58.393064
NCT01446367|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-04|||February 2010||2010-02-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Corneal Changes After Retinal Surgery|Corneal Topographic Changes After 20-gauge Pars Plana Vitrectomy Associated With Scleral Buckling for the Treatment of Rhegmatogenous Retinal Detachment|Completed||N/A|25|Actual|Universidade Federal do Paraná|||1||f||||f||||||||||2017-10-11 03:45:58.481658|2017-10-11 03:45:58.481658
NCT01446354|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2012-10-23|||January 2011||2011-01-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Observational|||Goal-orientated Coagulation Management in Hypothermic Cardiac Arrest Surgery|Does the Intraoperative Thromboelastometry-guided Coagulation Management Reduce the Administration of Allogeneic Blood Products in Cardiac Surgery With the Help of Hypothermic Cardiac Arrest? A Retrospective Data Analysis|Completed||N/A|200|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 03:45:58.540283|2017-10-11 03:45:58.540283
NCT01446341|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-10-04|||November 2011||2011-11-01|October 2011|2011-10-01||||May 2012|Anticipated|2012-05-01||Interventional|||Cast Immobilization Versus Functional Therapy for Acute, Severe Lateral Ankle Sprains|A Pilot Study Towards a Randomized Clinical Trial of Cast Immobilization Versus Functional Therapy for Acute, Severe Lateral Ankle Sprains|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:45:58.610243|2017-10-11 03:45:58.610243
NCT01446328|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2016-08-16|||October 2011||2011-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BP2||Bergen Psychosis Project 2 - The Best Intro Study|Bergen Psychosis Project 2 - The Bergen-Stavanger-Innsbruck-Trondheim Study|Recruiting||Phase 4|300|Anticipated|Haukeland University Hospital||3|||f||||t||||||||||2017-10-11 03:45:58.710826|2017-10-11 03:45:58.710826
NCT01446315|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2011-10-04|||October 2011||2011-10-01|October 2011|2011-10-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|Asthma APGAR||Assessing Decision Maker Tools for Asthma: the Asthma APGAR||Unknown status|Enrolling by invitation|Phase 4|1500|Anticipated|Olmsted Medical Center||2|||f||||f||||||||||2017-10-11 03:45:58.857547|2017-10-11 03:45:58.857547
NCT01446302|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2012-08-13|||October 2011||2011-10-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Metabolic and Inflammatory Responses to Hemodialysis and the Effect of a Meal|Metabolic and Inflammatory Responses to Hemodialysis and the Effect of a Meal|Completed||N/A|24|Actual|University of Aarhus||4|||f||||f||||||||||2017-10-11 03:45:58.955425|2017-10-11 03:45:58.955425
NCT01446289|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-09-05|2014-06-20||September 2011||2011-09-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional||All enrolled population|Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings|A Phase II Randomized, Observer-Blind, Multi-Center, Controlled Study of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women|Completed||Phase 2|86|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:45:59.088117|2017-10-11 03:45:59.088117
NCT01446276|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2014-04-25|||November 2011||2011-11-01|October 2013|2013-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease|Long-term Investigation of Resveratrol on Lipid Turnover in Obese Men With Nonalcoholic Fatty Liver Disease. Effects on Liver Fat Content and Basal and Insulin Stimulated FFA and VLDL-triglyceride Metabolism|Completed||N/A|26|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 03:46:00.297984|2017-10-11 03:46:00.297984
NCT01446263|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2013-10-27|||October 2011||2011-10-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|RADIAL-CABG||RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial|A Randomized Comparison of RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial|Completed||Phase 3|128|Actual|North Texas Veterans Healthcare System||2|||f||||t||||||||||2017-10-11 03:46:00.376754|2017-10-11 03:46:00.376754
NCT01445028|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-03-31|2017-03-31||September 2011||2011-09-01|March 2017|2017-03-01|August 2015|Actual|2015-08-01|August 2013|Actual|2013-08-01||Interventional|DELIVER||Isotretinoin for Proliferative Vitreoretinopathy|Determining the Effect of Low-dose Isotretinoin on Proliferative Vitreoretinopathy|Completed||Phase 4|109|Actual|Wills Eye||2|||f||||f|t|||||||No||2017-10-11 03:46:17.868136|2017-10-11 03:46:17.868136
NCT01446250|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-11-18|2016-06-10||December 2011||2011-12-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||All enrolled participants.|Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1|A Randomized, Open Label Trial of the Safety and Efficacy of DEB025/Alisporivir in Combination With Pegylated Interferon-α2a and Ribavirin (Peg-INFα2a/RBV) and Boceprevir in Combination With Peg-INFα2a/RBV in African American Treatment-naïve Patients With Chronic Hepatitis C Genotype 1|Terminated||Phase 3|8|Actual|Debiopharm International SA|Due to the early termination of study enrollment and discontinuation of alisporivir treatment, Amendment 1 changed the number of study arms to 2, combining Arms A and B, and none of the planned outcome measures could be evaluated.|2|||f||||||||||||||2017-10-11 03:46:00.45909|2017-10-11 03:46:00.45909
NCT01446237|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-04-21|2017-03-06||June 1, 2011||2011-06-01|March 2017|2017-03-01|December 15, 2011|Actual|2011-12-15|December 1, 2011|Actual|2011-12-01||Interventional|||U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne|An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne|Completed||N/A|125|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:46:01.103429|2017-10-11 03:46:01.103429
NCT01446224|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2015-03-26|||December 2010||2010-12-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Cardiovascular and Torsades de Pointes Monitoring for Pazopanib|Postmarketing Cardiovascular Ischemia and Torsades de Pointes Monitoring for Pazopanib Using Observational Databases|Completed||N/A|1|Actual|GlaxoSmithKline|||4||f||||f||||||||||2017-10-11 03:46:01.542974|2017-10-11 03:46:01.542974
NCT01446211|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-05-28|||November 2011||2011-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|November 2012|Actual|2012-11-01||Interventional|SPARROW||Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis|Randomised, Evaluator-Blinded, Multicentre, International, Parallel-Group, Active-Controlled Clinical Trial of Gusperimus Versus Conventional Therapy in Relapse of Granulomatosis With Polyangiitis (Wegener's Granulomatosis) SPARROW Study - SPAnidin in Relapsing GRanulomatosis With POlyangiitis Wegener's Granulomatosis)|Terminated||Phase 3|4|Actual|Nordic Pharma SAS||2||Change of design consideration|f||||t||||||||||2017-10-11 03:46:01.639811|2017-10-11 03:46:01.639811
NCT01446198|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-06-29|||March 2012||2012-03-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System|Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System|Completed||N/A|11816|Actual|Gen-Probe, Incorporated|||1||f||||f||||||Samples With DNA|"     Cervical specimens collected in ThinPrep Pap Test vials containing PreservCyt Solution     (Hologic, In., Marlborough, MA) with commercially available collection device or     cytobrush/spatula combination may be tested with the HPV Assay either pre- or post-Pap     processing.   "|||2017-10-11 03:46:01.738655|2017-10-11 03:46:01.738655
NCT01446185|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-01|2013-04-17|||January 2011||2011-01-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|SWITCH||Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients|Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients|Completed||N/A|100|Actual|Genomic Health®, Inc.||1|||f||||f||||||||||2017-10-11 03:46:01.87567|2017-10-11 03:46:01.87567
NCT01446172|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2012-04-20|||November 2009||2009-11-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Agoraphobia|Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Panic Disroder and Agoraphobia|Completed||N/A|132|Anticipated|Modum Bad|||1||f||||t||||||||||2017-10-11 03:46:01.989861|2017-10-11 03:46:01.989861
NCT01446159|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2017-05-23|||June 13, 2011|Actual|2011-06-13|April 2017|2017-04-01|October 27, 2017|Anticipated|2017-10-27|October 27, 2017|Anticipated|2017-10-27||Interventional|||Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer|A Phase 1b/2 Randomized Study of MEDI-573 in Combination With an Aromatase Inhibitor (AI) Versus AI Alone in Women With Metastatic Breast Cancer (MBC)|Active, not recruiting||Phase 2|230|Actual|MedImmune LLC||5|||f||||t||||||||||2017-10-11 03:46:02.119946|2017-10-11 03:46:02.119946
NCT01446146|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2013-07-22|||October 2011||2011-10-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice||Completed||N/A|27|Actual|Michael Debakey Veterans Affairs Medical Center||2|||f||||||||||||||2017-10-11 03:46:02.381782|2017-10-11 03:46:02.381782
NCT01446133|ClinicalTrials.gov processed this data on October 10, 2017|2011-10-03|2017-01-20|||December 12, 2011||2011-12-12|January 2017|2017-01-01||||December 1, 2018|Anticipated|2018-12-01||Interventional|||Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)|Combination of Lenalidomide and Rituximab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) as Initial Treatment or Subsequent Therapy|Active, not recruiting||Phase 2|120|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 03:46:02.470277|2017-10-11 03:46:02.470277
NCT01446120|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2011-10-04||||||October 2011|2011-10-01||||||||Interventional|||Insulin Loaded Orally Dissolved Films (Insulin-ODF)||Unknown status|Not yet recruiting|Phase 1|7|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 03:46:02.578479|2017-10-11 03:46:02.578479
NCT01446107|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2011-10-04|||December 2007||2007-12-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effectiveness of Fissure Sealant and Topical Fluoride Application in Preventing Dental Caries|A Randomized Controlled Trial on the Effectiveness of Fissure Sealant and Topical Fluoride Application in Preventing Dental Caries|Completed||Phase 2/Phase 3|502|Actual|The University of Hong Kong||4|||f||||f||||||||||2017-10-11 03:46:02.673046|2017-10-11 03:46:02.673046
NCT01446094|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-09-29|||August 2011||2011-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease|Diagnostic Value of a Rapid Protocol Regadenoson Stress Cardiovascular Magnetic Resonance Scan for Detection of Coronary Artery Disease|Recruiting||Phase 4|50|Anticipated|The Methodist Hospital System||1|||f||||f|t|f|||f|||||2017-10-11 03:46:02.807597|2017-10-11 03:46:02.807597
NCT00000208|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16|||February 1992||1992-02-01|September 1993|1993-09-01||||||||Interventional|||Methadone/Buprenorphine Cross-Over Study - 4|Methadone/Buprenorphine Cross-Over Study|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:39.205064|2017-10-11 04:17:39.205064
NCT01446055|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2011-10-08|||October 2011||2011-10-01|October 2011|2011-10-01|April 2013|Anticipated|2013-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia|Transplantation of Autologous BM-MNC Processed by ResQ Separator and Conventional Manual Method for Patients With Chronic Limb Ischemia: a Multi-center Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 1/Phase 2|50|Anticipated|Xuanwu Hospital, Beijing||2|||f||||t||||||||||2017-10-11 03:46:03.09959|2017-10-11 03:46:03.09959
NCT01446042|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2012-06-13|||September 2011||2011-09-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism|A 90-Day, Randomized, Dose-Ranging Study, Including Potential Dose Titration, Evaluating the Efficacy and Safety of Intranasal TBS-1 in the Treatment of Male Hypogonadism With Sequential Safety Extension Periods of 90 and 180 Days|Unknown status|Active, not recruiting|Phase 3|280|Anticipated|Trimel Biopharma SRL||2|||f||||t||||||||||2017-10-11 03:46:03.197951|2017-10-11 03:46:03.197951
NCT01446029|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2014-08-01|||March 2012||2012-03-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)|Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease|Completed||Phase 3|601|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||t||||||||||2017-10-11 03:46:03.384802|2017-10-11 03:46:03.384802
NCT01446016|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-09-12|||September 2011||2011-09-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|CAT||Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer Patients Who Have Failed an Anthracycline (CAT)|Phase II Study of The Efficacy And Safety of Chloroquine (C) in CombinAtion With Taxane or Taxane-like (T) Chemo Agents in The Treatment of Patients With Advanced or Metastatic Breast Cancer Who Have Failed Anthracycline Chemo Base Therapy.|Recruiting||Phase 2|47|Anticipated|The Methodist Hospital System||2|||f||||f||||||||Undecided|to be determined|2017-10-11 03:46:03.477207|2017-10-11 03:46:03.477207
NCT01446003|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-06-01|2017-03-20||October 25, 2011|Actual|2011-10-25|May 2017|2017-05-01|March 3, 2012|Actual|2012-03-03|February 18, 2012|Actual|2012-02-18||Interventional||All participants that received treatment with either MK-8457 or Placebo in the study.|A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)|A Multiple-Dose Clinical Trial to Study the Effect of MK-8457 on Ambulatory Blood Pressure in Hypertensive Patients|Completed||Phase 1|31|Actual|Merck Sharp & Dohme Corp.||2|||f||||f|t|f||||||||2017-10-11 03:46:03.602436|2017-10-11 03:46:03.602436
NCT01445990|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2011-10-05|||January 2010||2010-01-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Efficacy Study of Free Flap Monitoring Using Capillary Lactate and Glucose Measurements|Evaluation of Free Tissue Flaps Viability With Capillary Glucose and Lactate Measurements Compared With Clinical Examination|Completed||N/A|31|Actual|Centre Hospitalier Universitaire Dijon||1|||f||||t||||||||||2017-10-11 03:46:03.969588|2017-10-11 03:46:03.969588
NCT01445977|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2013-08-01|||September 2011||2011-09-01|August 2013|2013-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||SoundBite Hearing System Long Term Multi Site Patient Use Study|SoundBite Hearing System Long Term Multi Site Patient Use Study|Unknown status|Active, not recruiting|N/A|150|Anticipated|Sonitus Medical Inc|||1||f||||||||||||||2017-10-11 03:46:04.044699|2017-10-11 03:46:04.044699
NCT01445964|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2012-01-20|||May 2011||2011-05-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Effect of SLCO2B1 Genotype and Apple Juice on Pharmacokinetics of Atenolol After Oral Administration in Healthy Male Korean|An Open-label, Single-dose, Three-treatment, Three-period Study to Investigate the Effect of SLCO2B1 Genotype and Apple Juice on Pharmacokinetics of Atenolol After Oral Administration in Healthy Male Korean|Completed||Phase 4|12|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:46:04.268925|2017-10-11 03:46:04.268925
NCT01445951|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-10-20|2014-07-22|2013-08-19|September 2011||2011-09-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional||Full analysis set|Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period|A Phase 3, Multicenter, Open-label, Randomized, Forced-titration Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Insulin Inhalation Powder in Combination With a Basal Insulin Versus Insulin Aspart in Combination With a Basal Insulin in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period|Completed||Phase 3|518|Actual|Mannkind Corporation||3|||f||||t||||||||||2017-10-11 03:46:04.376412|2017-10-11 03:46:04.376412
NCT01445938|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-12-12|||October 2011||2011-10-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria|An Open-label, Randomized Multicenter Study to Investigate the Anti-parasitic Activity, Pharmacokinetic and Safety of IM SAR97276A With Oral ACTs as Positive Control in Children Presenting With Symptomatic Plasmodium Falciparum Uncomplicated Malaria|Terminated||Phase 2|20|Actual|Sanofi||6||Data Monitoring Committee recommendation|f||||t||||||||||2017-10-11 03:46:05.447735|2017-10-11 03:46:05.447735
NCT01445899|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2015-02-03||2015-01-16|February 2012||2012-02-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|MATISSE||PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)|An Open-Label Dose Escalation Study of PF-04523655 (Stratum I) Combined With a Prospective, Randomized, Double-Masked, Multi-Center, Controlled Study (Stratum II) Evaluating the Efficacy and Safety of PF-04523655 Alone and in Combination With Ranibizumab Versus Ranibizumab Alone in Diabetic Macular Edema (MATISSE STUDY)|Completed||Phase 2|258|Actual|Quark Pharmaceuticals||4|||f||||t||||||||||2017-10-11 03:46:05.608274|2017-10-11 03:46:05.608274
NCT01445873|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2012-05-09|2012-02-14||December 2009||2009-12-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)|Non-Interventional (NI) Drug Study Protocol: Three-Country Pilot Study For Retrospective Chart Review Of Effectiveness Of Thelin® (Sitaxsentan) In Patients With Pulmonary Arterial Hypertension (PAH)|Completed||N/A|36|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:46:07.530301|2017-10-11 03:46:07.530301
NCT01445860|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-09-30|||August 2011||2011-08-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics|A Phase 1, Open-Label, Fixed-Sequence Study To Estimate The Effect Of Repeated Dosing Of PF-03882845 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects|Completed||Phase 1|14|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:46:07.974734|2017-10-11 03:46:07.974734
NCT01445847|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-04-09|2012-06-11||January 2012||2012-01-01|April 2017|2017-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Effect of Intravenous Lidocaine on Post-extubation Laryngospasm|Effect of Intravenous Lidocaine on the Incidence of Post-extubation Laryngospasm: A Randomised Controlled Trial|Terminated||N/A|134|Actual|King Saud University|"Early termination of the trial led to small numbers of subjects that received allocated intervention, (i.e., 99 total participants).
Additionally, protocol violation led to reduce the analyze subjects to 36 for each group."|2||Patient Safety Concerns|f||||t||||||||||2017-10-11 03:46:09.16448|2017-10-11 03:46:09.16448
NCT01445834|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2015-12-01|||June 2011||2011-06-01|December 2015|2015-12-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Observational|||Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence|Retrospective Study About the Age-stratified Outcome of Pelvic Floor Muscle Exercise for Stress (SUI), Mixed (MUI) and Urgency Urinary Incontinence (UUI) 2003-2008|Completed||N/A|150|Actual|University of Zurich|||1||f||||f||||||||||2017-10-11 03:46:09.443125|2017-10-11 03:46:09.443125
NCT01445821|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-07-17|||September 2011||2011-09-01|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|DIScl2011||Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial|Randomized Study of Different Non-myeloablative Conditioning Regimens With Hematopoietic Stem Cell Support in Patients With Scleroderma (Autologous Systemic Sclerosis Immune Suppression Trial - II ASSIST-IIb)|Recruiting||Phase 3|160|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-11 03:46:09.499445|2017-10-11 03:46:09.499445
NCT01445808|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-02-25|||October 2011||2011-10-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|PMT||Psychodynamic Motivation and Training Program|Psychodynamic Motivation and Training Program (PMT) as Secondary Prevention in Patients With Stable Coronary Heart Disease|Completed||N/A|90|Actual|Johannes Gutenberg University Mainz||3|||f||||f||||||||||2017-10-11 03:46:09.611265|2017-10-11 03:46:09.611265
NCT01445795|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2016-06-23||2015-09-23|September 2011||2011-09-01|June 2016|2016-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|INH-189-006||Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects|A Multi-center, Placebo-controlled, Multiple Dose, Study of the Safety and Pharmacokinetics and Pharmacodynamics of INX-08189 Dosed Either QD, BID or Adjunctively With Ribavirin, and a Study of the Food Effect, in Chronically-infected Genotype 1 HCV, Treatment-naïve Subjects|Completed||Phase 1/Phase 2|50|Actual|Bristol-Myers Squibb||8|||f||||||||||||||2017-10-11 03:46:09.728074|2017-10-11 03:46:09.728074
NCT01445782|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-10-05|||October 2011||2011-10-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||AZD2115 Multiple Ascending Dose Study|A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Inhaled Doses of AZD2115 in Healthy Male Subjects|Completed||Phase 1|32|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:46:09.857214|2017-10-11 03:46:09.857214
NCT01445769|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2014-09-16|2014-03-31||September 2011||2011-09-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional||Intent-to-treat population: All enrolled participants. Note that this was a pilot study which was not sufficiently powered.|Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis|An Open-label Assessment of an Alternative Dosing Strategy of Ruxolitinib in Patients With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, and Post-essential Thrombocythemia Myelofibrosis|Completed||Phase 2|45|Actual|Incyte Corporation|This was a single arm pilot study. The patient population differed from Phase III studies of ruxolitinib in myelofibrosis and therefore comparisons to standard dosing cannot be made from this study.|1|||f||||f||||||||||2017-10-11 03:46:09.968543|2017-10-11 03:46:09.968543
NCT01445756|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2014-08-25|||July 2010||2010-07-01|August 2014|2014-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Topical Lidocaine for Pain Control With Intrauterine Device (IUD) Insertion|Topical Lidocaine for Pain Control With IUD Insertion: A Randomized Controlled Trial|Completed||Early Phase 1|40|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 03:46:10.52779|2017-10-11 03:46:10.52779
NCT01445743|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2014-02-12|||September 2011||2011-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|August 2012|Actual|2012-08-01||Interventional|||Immunogenicity and Safety of an Acellular DPT Vaccine During Pregnancy|Immunogenicity and Safety of an Acellular DPT Vaccine in Pregnant Women in Nuevo Leon, Mexico|Completed||Phase 2|204|Actual|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||t||||||||||2017-10-11 03:46:10.604674|2017-10-11 03:46:10.604674
NCT01445730|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-08-08|||August 2011||2011-08-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Fructose Consumption and Metabolic Dysregulation|Fructose Consumption Aggravates Dysregulation of Postprandial Lipid Metabolism in Obese Hypertriglyceridemic Men With High Cardiometabolic Risk Profile and Associates With Liver Fat Deposition|Completed||N/A|82|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 03:46:10.678107|2017-10-11 03:46:10.678107
NCT01445717|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-05-02|||November 2010||2010-11-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|GBS||Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy|Use of a New Rapid Method, BioNanoPore, for Growth and Detection of Group B Streptococcus in Pregnant Patients|Completed||N/A|358|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples Without DNA|"     Specimens are to be retained for one month, frozen in LIM broth, and will be held for use if     reprocessing specimens is required.   "|||2017-10-11 03:46:10.774483|2017-10-11 03:46:10.774483
NCT01445691|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-05-13|||November 2015||2015-11-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery|A Multicenter Phase II Study of 5-Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Newly Diagnosed or Recurrent Malignant Gliomas|Withdrawn||Phase 2|0|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 03:46:10.919457|2017-10-11 03:46:10.919457
NCT01445678|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-03-28|2015-01-09||December 1, 2011|Actual|2011-12-01|March 2017|2017-03-01|October 1, 2013|Actual|2013-10-01|October 1, 2013|Actual|2013-10-01||Interventional|||Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections|A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Efficacy and Safety of Intravenous CXA-201 With That of Meropenem in Complicated Intraabdominal Infections|Completed||Phase 3|494|Actual|Cubist Pharmaceuticals LLC|Two identical P3 protocols were initiated (NCT01445678 and NCT01445665) subsequently, Cubist and FDA agreed that integrated data from the 2 protocols could be analyzed and reported in a single Clinical Study Report. These analyses are presented here.|2|||f||||f||||||||||2017-10-11 03:46:11.035871|2017-10-11 03:46:11.035871
NCT01445652|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-09-11|2013-06-28||September 2011||2011-09-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||This reporting group includes all enrolled and randomized participants.|A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young Patients|A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young Patients|Completed||N/A|113|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:46:11.957576|2017-10-11 03:46:11.957576
NCT01445639|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-01-25|||October 2011||2011-10-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Dexmedetomidine in Patients After Intracranial Surgery|Use of Dexmedetomidine for Prophylactic Analgesia and Sedation in Patients After Intracranial Surgery (Prophylactic Analgesia and Sedation Trial, PASTrial)|Completed||Phase 4|192|Actual|Capital Medical University||2|||f||||t||||||||||2017-10-11 03:46:12.226405|2017-10-11 03:46:12.226405
NCT01445626|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-01-14|2013-01-14||October 2011||2011-10-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)||Completed||N/A|87|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:46:12.317505|2017-10-11 03:46:12.317505
NCT01445613|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2016-07-13|2015-12-03||October 2011||2011-10-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|December 2014|Actual|2014-12-01||Interventional|CANOPY||Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy|CANOPY: Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy|Completed||N/A|1203|Actual|Abbott Vascular||1|||f||||f||||||||No||2017-10-11 03:46:12.609344|2017-10-11 03:46:12.609344
NCT01445600|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-09-21|||November 2012||2012-11-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|ALTARGOPMS||ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)|An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Efficacy of ALTARGO(Retapamulin) Administered in Korean Patients According to the Prescribing Information|Completed||N/A|3612|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:46:13.513221|2017-10-11 03:46:13.513221
NCT01445587|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2012-03-22|||November 2011||2011-11-01|March 2012|2012-03-01|November 2011|Anticipated|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma|An Open-Label, Single Arm, Phase Ib/II Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||2||"Based on the clinical activity, not safety data, of the AKT inhibitor, GSK has decided at this   time to suspend further development of GSK2110183 as monotherapy."|f||||f||||||||||2017-10-11 03:46:13.597461|2017-10-11 03:46:13.597461
NCT01445561|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-06-30|||September 26, 2011||2011-09-26|May 9, 2017|2017-05-09|July 15, 2013|Actual|2013-07-15|July 15, 2013|Actual|2013-07-15||Interventional|||Ultra Low Dose Interleukin-2 in Healthy Volunteers|The Safety and the Tolerability of Ultra Low Dose Interleukin-2 in Healthy Volunteers|Completed||Phase 1|22|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:46:13.680126|2017-10-11 03:46:13.680126
NCT01445548|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2014-05-15|2014-04-07||September 2011||2011-09-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|April 2013|Actual|2013-04-01||Interventional|SIRGA2||Sirolimus for Advanced Age-Related Macular Degeneration|Pilot Study of the Evaluation of Intravitreal Sirolimus in the Treatment of Bilateral Geographic Atrophy Associated With Age-Related Macular Degeneration|Completed||Phase 1/Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 03:46:13.790034|2017-10-11 03:46:13.790034
NCT01445535|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||January 12, 2009||2009-01-12|April 6, 2017|2017-04-06|October 1, 2018|Anticipated|2018-10-01|April 1, 2011|Actual|2011-04-01||Interventional|||Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas|Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in T and NK-Cell Lymphomas|Active, not recruiting||Phase 1|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:14.35571|2017-10-11 03:46:14.35571
NCT01445522|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||December 3, 2008||2008-12-03|June 29, 2012|2012-06-29|July 3, 2012|Actual|2012-07-03|July 3, 2012|Actual|2012-07-03||Interventional|||ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer|A Phase I Study of ABT-888 in Combination With Metronomic Cyclophosphamide in Adults With Refractory Solid Tumors and Lymphomas|Completed||Phase 1|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:14.473634|2017-10-11 03:46:14.473634
NCT01445483|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||September 11, 2008||2008-09-11|August 29, 2017|2017-08-29||||||||Observational|||Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases|A Pilot Study to Evaluate Neuropsychological Outcome Measures and Their Relationship With Prognosis in Patients Receiving Radiation Therapy for Brain Metastases|Recruiting||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:14.644157|2017-10-11 03:46:14.644157
NCT01445431|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-09-29|||April 2011||2011-04-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Trial on the Efficacy and Safety of Virgin Coconut Oil Compared to Mineral Oil in the Treatment of Uremic Xerosis|A Randomized Controlled Trial on the Efficacy and Safety of Virgin Coconut Oil Compared to Mineral Oil in the Treatment of Uremic Xerosis|Completed||Phase 3|45|Actual|University of the Philippines||2|||f||||t||||||||||2017-10-11 03:46:14.811958|2017-10-11 03:46:14.811958
NCT01445418|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||March 11, 2008||2008-03-11|January 5, 2017|2017-01-05|December 1, 2017|Anticipated|2017-12-01|September 2, 2014|Actual|2014-09-02||Interventional|||AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer|A Phase I Study With an Expansion Cohort of the PARP Inhibitor AZD2281 (KU-0059436) Combined With Carboplatin in Breast and Ovarian Cancer in BRCA1/2 Mutation Carriers (Familial Breast and Ovarian Cancer) and Sporadic Triple Negative Breast Cancer and Ovarian Cancer|Active, not recruiting||Phase 1|103|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:46:14.902609|2017-10-11 03:46:14.902609
NCT01445405|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||February 5, 2008||2008-02-05|February 8, 2013|2013-02-08|August 27, 2010|Actual|2010-08-27|August 27, 2010|Actual|2010-08-27||Interventional|||Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer|Phase I Study of Bortezomib and Cetuximab Without or With Cisplatin in Combination With Radiation Therapy for Advanced Head and Neck Cancer|Completed||Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:15.010496|2017-10-11 03:46:15.010496
NCT01445392|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||November 13, 2007||2007-11-13|October 27, 2016|2016-10-27|October 3, 2016|Actual|2016-10-03|January 31, 2014|Actual|2014-01-31||Interventional|||SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma|A Phase 1, Single Center, Dose-Escalation Study of SS1(dsFv)PE38 Administered Concurrently With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Epithelial Pleural Mesothelioma|Completed||Phase 1|24|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:46:15.110524|2017-10-11 03:46:15.110524
NCT01445379|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||October 1, 2007||2007-10-01|November 13, 2015|2015-11-13|November 13, 2015|Actual|2015-11-13|April 18, 2014|Actual|2014-04-18||Interventional|||Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer|A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Adults With Treatment Refractory Cancer|Completed||Phase 1|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:15.209214|2017-10-11 03:46:15.209214
NCT01445366|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-12-04|||April 2012||2012-04-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Solute Removal With High Volume Hemodiafiltration Versus Long High Flux Hemodialysis|Solute Removal With High Volume Hemodiafiltration Versus Long High Flux Hemodialysis|Unknown status|Recruiting|N/A|10|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:46:15.301361|2017-10-11 03:46:15.301361
NCT01445340|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||April 21, 2007||2007-04-21|June 29, 2012|2012-06-29|June 29, 2012|Actual|2012-06-29|||||Interventional|||Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma|Phase I Study of Topical Romidepsin (Depsipeptide) in Early Stage Cutaneous T-Cell Lymphoma|Terminated||Phase 1|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:15.395811|2017-10-11 03:46:15.395811
NCT01445327|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||February 20, 2007||2007-02-20|January 20, 2015|2015-01-20|January 20, 2015||2015-01-20|||||Observational|||Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers|A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies|Terminated||N/A|9|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:15.486661|2017-10-11 03:46:15.486661
NCT01445314|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||February 19, 2007||2007-02-19|May 4, 2017|2017-05-04||||||||Observational|||Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments|Analysis of Stored Data Collected From Individuals Administered Neurobehavioral Assessments on IRB-Approved Protocols|Enrolling by invitation||N/A|462|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:15.570481|2017-10-11 03:46:15.570481
NCT01445288|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||July 28, 2006||2006-07-28|August 2, 2017|2017-08-02||||||||Observational|||Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors|An Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:15.886846|2017-10-11 03:46:15.886846
NCT01445275|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2015-05-27|||January 2100||2100-01-01|May 2015|2015-05-01||||January 2100|Anticipated|2100-01-01||Observational|||Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199|A Comparative Effectiveness Study of Cancer Risk Management for Women at Elevated Genetic Risk of Ovarian Cancer|Not yet recruiting||N/A|2605|Anticipated|Gynecologic Oncology Group|||1||f||||||||||||||2017-10-11 03:46:16.007443|2017-10-11 03:46:16.007443
NCT01445262|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-08-10|||February 2011||2011-02-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Drug Use Investigation for XYZAL®|Drug Use Investigation for XYZAL|Completed||N/A|10728|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:46:16.120379|2017-10-11 03:46:16.120379
NCT01445249|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2011-09-30|||March 2007||2007-03-01|September 2011|2011-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Medial Forefoot Block for Analgesia After Foot Surgery|A Randomised, Blinded Comparison of a Nerve Stimulator Guided Ankle Block Compared to a Landmark Guided Ankle Block for Pain Relief After Forefoot Surgery.|Completed||N/A|72|Actual|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 03:46:16.203296|2017-10-11 03:46:16.203296
NCT01444443|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2012-11-19|||November 2011||2011-11-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|DiaCon2||DiaCon Overnight Closed-Loop Glucose Control Study|DiaCon Closed-Loop Study|Completed||N/A|12|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 03:46:27.836228|2017-10-11 03:46:27.836228
NCT01445236|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2013-12-19|||September 2011||2011-09-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance|Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance|Terminated||N/A|25|Anticipated|Hospital Clinic of Barcelona||1||Insufficient recruitment|f||||t||||||||||2017-10-11 03:46:16.293973|2017-10-11 03:46:16.293973
NCT01445223|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-10-02|||April 2004||2004-04-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)|A Study on ART Naïve Patients On Different Regimens to Treat Hiv (a Phase 4 Study)|Completed||Phase 4|242|Actual|Göteborg University||3|||f||||t||||||||||2017-10-11 03:46:16.393504|2017-10-11 03:46:16.393504
NCT01445210|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2012-10-18|||September 2011||2011-09-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Saphenous Nerve Block: Single Shot Versus Continuous Infusion to Supplement a Continuous Sciatic Nerve Block After Major Ankle Surgery|A Randomized Comparison of Single Injection vs. Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block in Postoperative Pain Treatment After Major Ankle Surgery: Clinical Outcome and Cost Analysis|Completed||N/A|50|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 03:46:16.522011|2017-10-11 03:46:16.522011
NCT01445197|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-02|||December 2012||2012-12-01|October 2017|2017-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development|A Multicentre, Interventional, Non-randomized, Open-label, Single-group Phase III Study to Evaluate Plasma-Derived Antihaemophilic Factor/Von Willebrand Factor Concentrate (Biostate®) for Immune Tolerance Induction in Male Paediatric Subjects With Haemophilia A (≤ 2%) Who Have Developed High-titre Antibodies to Factor VIII (Factor VIII Inhibitors)|Terminated||Phase 3|1|Actual|CSL Behring||1|||f||||||||||||||2017-10-11 03:46:16.656901|2017-10-11 03:46:16.656901
NCT01445171|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-07-13|||January 2010||2010-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|TRITON||Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve|Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve|Active, not recruiting||N/A|295|Anticipated|Edwards Lifesciences||1|||f||||t||||||||||2017-10-11 03:46:16.77809|2017-10-11 03:46:16.77809
NCT01445158|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||January 26, 2007||2007-01-26|September 21, 2017|2017-09-21||||||||Observational|||Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures|Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures|Completed||N/A|17|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:16.895424|2017-10-11 03:46:16.895424
NCT01445145|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||January 26, 2007||2007-01-26|September 25, 2014|2014-09-25|September 25, 2014||2014-09-25|||||Observational|||An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection|An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection|Completed||N/A|63|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:16.971068|2017-10-11 03:46:16.971068
NCT01445132|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||January 11, 2007||2007-01-11|April 24, 2013|2013-04-24|April 24, 2013|Actual|2013-04-24|April 24, 2013|Actual|2013-04-24||Interventional|||Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation|Adoptive Cell Therapy for B-Cell Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation With Costimulated, Tumor-Derived Lymphocytes|Completed||Phase 1|11|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:17.034888|2017-10-11 03:46:17.034888
NCT01445119|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-08-27|||January 2007||2007-01-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas|A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas|Completed||Phase 1|58|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-10-11 03:46:17.123317|2017-10-11 03:46:17.123317
NCT01445106|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||December 11, 2006||2006-12-11|December 2, 2014|2014-12-02|May 9, 2011|Actual|2011-05-09|May 9, 2011|Actual|2011-05-09||Interventional|||A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors|A Phase I Trial of Nelfinavir (Viracept) in Adults With Solid Tumors|Completed||Phase 1|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:17.373228|2017-10-11 03:46:17.373228
NCT01445080|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-08-04|||August 23, 2006||2006-08-23|July 28, 2017|2017-07-28|June 14, 2012|Actual|2012-06-14|June 14, 2012|Actual|2012-06-14||Interventional|||Sorafenib (BAY 43-9006) to Treat Children With Solid Tumors or Leukemias|A Phase I/II Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children With Refractory Solid Tumors or Refractory Leukemias|Completed||Phase 1/Phase 2|2|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 03:46:17.452038|2017-10-11 03:46:17.452038
NCT01445067|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2013-06-07|||November 2011||2011-11-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition|Phase I, Open-Label, Randomized, Single Sequence Study With Two Dose Groups to Compare the Pharmacokinetics of BMS-927711 in Migraine Subjects During an Acute Migraine Attack and During Non-Migraine Period|Completed||Phase 1|48|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 03:46:17.551545|2017-10-11 03:46:17.551545
NCT01445054|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-30|2017-10-05|||February 24, 2007||2007-02-24|May 11, 2017|2017-05-11|August 20, 2014|Actual|2014-08-20|August 20, 2014|Actual|2014-08-20||Interventional|||111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer|A Phase 0 Trial of (111)Indium CHX-A DTPA Trastuzumab Imaging in Cancer|Completed||Early Phase 1|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:17.660032|2017-10-11 03:46:17.660032
NCT01445041|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-03-20|||September 2011||2011-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome|Autologous Cord Blood Cells for Patients With HLHS: Phase I Study of Feasibility and Safety|Suspended||Phase 1|20|Anticipated|Duke University||2||Pending Additional Funding|f||||f||||||||||2017-10-11 03:46:17.763764|2017-10-11 03:46:17.763764
NCT01445015|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2011-09-30|||July 2011||2011-07-01|September 2011|2011-09-01|June 2012|Anticipated|2012-06-01|February 2012|Anticipated|2012-02-01||Interventional|SIPIICAA||Stress Management Intervention in Inner City Adolescents With Asthma|Pilot Study: Stress Management Intervention as a Tool for Managing Persistent Asthma in Inner City Adolescent Patients.|Unknown status|Recruiting|Phase 2|50|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 03:46:18.105057|2017-10-11 03:46:18.105057
NCT01445002|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2013-01-10|||October 2011||2011-10-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy|Safety and Dose Finding Study Based on the Effects of Three Subcutaneous Injections of BM32, a Recombinant Hypoallergenic Grass Pollen Vaccine, on Responses to Allergen Challenge by Skin Testing and in the Vienna Challenge Chamber (VCC) as Well as Immunological Response in Subjects Know to Suffer From Grass-pollen Induced Allergic Rhinitis|Completed||Phase 2|79|Actual|Biomay AG||4|||f||||f||||||||||2017-10-11 03:46:18.192265|2017-10-11 03:46:18.192265
NCT01444989|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-01-24|||September 2011||2011-09-01|January 2017|2017-01-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|AKRQ||Development and Validation of a Quality of Life Instrument for Actinic Keratosis|Development and Validation of a Quality of Life Instrument for Actinic Keratosis|Completed||N/A|150|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 03:46:18.283916|2017-10-11 03:46:18.283916
NCT01444976|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-09-30|||December 2010||2010-12-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||The Effect of Sedation During Transesophageal Echocardiography on Heart Rate Variability|The Effect of Sedation During Transesophageal Echocardiography on Heart Rate Variability:A Comparison of Hypnotic Sedation With Medical Sedation|Completed||N/A|76|Actual|Bakirkoy Dr. Sadi Konuk Research and Training Hospital||3|||f||||f||||||||||2017-10-11 03:46:18.369114|2017-10-11 03:46:18.369114
NCT01444924|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2016-07-18|2014-06-06||September 2011||2011-09-01|July 2016|2016-07-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional||The treatment group, who received TAP block placement, was younger than the saline injection group, on average (55.2 versus 62.1, P = 0.028).|Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery|Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery: A Prospective Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 2|75|Actual|University of Wisconsin, Madison|Unilateral placement of block may decrease overall effectiveness. Sample size was small, from single institution, and encompassed a variety of diagnoses and procedures. Analysis also included intraoperative medications.|2|||f||||t||||||||||2017-10-11 03:46:18.509697|2017-10-11 03:46:18.509697
NCT01444911|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-07-26|2017-01-24||August 2011||2011-08-01|July 2017|2017-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Evaluation of The Vaginal Renewal™ Program in Gynecologic Cancer Patients Experiencing Sexual Dysfunction|Evaluation of a Multifaceted Vaginal Renewal™ Program Utilizing Vibrating Wands in Gynecologic Cancer Patients Experiencing Sexual Dysfunction: A Randomized Controlled Trial|Terminated||Phase 2|29|Actual|University of Wisconsin, Madison|The study was closed before completion due to a slowing accrual rate.|2||Slow accrual|f||||t||||||||||2017-10-11 03:46:18.92776|2017-10-11 03:46:18.92776
NCT01444898|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2016-09-27|2016-06-14||March 2012||2012-03-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome|Effects of Exenatide on Obesity and Appetite in Overweight Patients With Prader-Willi Syndrome|Completed||N/A|10|Actual|Children's Hospital Los Angeles|"small sample size
referral bias due to small recruitment area
confounding factors during the study, including variations in eating schedule, psychotropic medications, caretaker supervision and activity"|1|||f||||f||||||||Undecided||2017-10-11 03:46:19.371458|2017-10-11 03:46:19.371458
NCT01444885|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-07-13|||October 2011||2011-10-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|STELLA||Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of PletaalÒ(Cilostazol) in Subjects With Vasospastic Angina (STELLA)|Completed||Phase 2|50|Actual|Korea Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 03:46:19.832031|2017-10-11 03:46:19.832031
NCT01444872|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-08-24|||August 2011||2011-08-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction|A Randomized, Single-Blind, Placebo-Controlled, Adaptive, Ascending Dose Study to Evaluate the Effects of TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Mild to Moderate Renal Dysfunction|Completed||Phase 1|17|Actual|Trevena Inc.||2|||f||||||||||||||2017-10-11 03:46:19.931784|2017-10-11 03:46:19.931784
NCT01444859|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2012-10-23|||February 2012||2012-02-01|December 2011|2011-12-01|November 2012|Anticipated|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Trenev Trio®/Healthy Trinity® for Recurrent Gastrointestinal Symptoms|Effect of Trenev Trio®/Healthy Trinity® in Otherwise Healthy Adults With Recurrent Gastrointestinal Symptoms: a Double-blind, Randomized, Placebo-controlled, Parallel Group Study|Unknown status|Active, not recruiting|Phase 2/Phase 3|120|Anticipated|Sprim Advanced Life Sciences||2|||f||||f||||||||||2017-10-11 03:46:20.026672|2017-10-11 03:46:20.026672
NCT01444833|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2011-09-29|||October 2008||2008-10-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|March 2009|Actual|2009-03-01||Interventional|ADIRAS||Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker|Molecular - Genetic Alterations in Adipose Tissue After Change in Therapy From ACE Inhibitors to AT1 Receptor Blockers in Patients With Essential Hypertension|Unknown status|Recruiting|N/A|35|Anticipated|Slovak Academy of Sciences||1|||f||||f||||||||||2017-10-11 03:46:20.235054|2017-10-11 03:46:20.235054
NCT01444053|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-06-16|||June 1, 2011|Actual|2011-06-01|June 2017|2017-06-01|December 1, 2011|Actual|2011-12-01|December 1, 2011|Actual|2011-12-01||Observational|||Retrospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses||Completed||N/A|41|Actual|Johnson & Johnson Vision Care, Inc.|||2||f||||f|f|t|f|f|t|||||2017-10-11 03:46:37.92334|2017-10-11 03:46:37.92334
NCT01444820|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-02-01|||January 2012||2012-01-01|February 2017|2017-02-01|January 2023|Anticipated|2023-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate|Phase III Study of Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate, Using 3D-CRT or Intensity-Modulated Radiotherapy|Active, not recruiting||Phase 3|329|Actual|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||t||||||||||2017-10-11 03:46:20.368796|2017-10-11 03:46:20.368796
NCT01444807|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-03-20|||December 2011||2011-12-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|March 2017|Actual|2017-03-01||Interventional|||Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases|A Randomized, Open Label, Multicenter Phase 2 Study, to Evaluate the Efficacy of Sorafenib in Patients With Advanced Renal Cell Carcinoma (RCC) After a Radical Resection of the Metastases|Recruiting||Phase 2|132|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||Yes||2017-10-11 03:46:20.47379|2017-10-11 03:46:20.47379
NCT01444794|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2013-06-19|||September 2011||2011-09-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Observational|VALGAS||Adult Subjects Suffering From Lower Limb Spasticity Following Stroke|A National, Prospective Cohort to Document the Effectiveness of One BoNT-A Injection Cycle Based on Attainment of Individual Person-centred Goals in Adult Subjects Suffering From Lower Limb Spasticity Following Stroke|Completed||N/A|100|Actual|Ipsen|||1||f||||||||||||||2017-10-11 03:46:20.596203|2017-10-11 03:46:20.596203
NCT01444781|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-07-14|2014-06-12||September 2011||2011-09-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional|||Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants|Evaluation of Antibody Persistence Following a Primary Series at 2, 4, and 6 Months on Trial A3L24 and Booster Effect of the DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ Concomitantly Administered With Prevenar™ at 12 to 24 Months of Age in Healthy Latin American Infants|Completed||Phase 3|1106|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 03:46:20.751756|2017-10-11 03:46:20.751756
NCT01444768|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-04-04|||March 2012||2012-03-01|April 2017|2017-04-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Observational|CPOE||Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department|Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-11 03:46:22.440747|2017-10-11 03:46:22.440747
NCT01444755|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2011-09-29|||January 2009||2009-01-01|September 2011|2011-09-01|April 2012|Anticipated|2012-04-01|December 2011|Anticipated|2011-12-01||Observational|||The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric Cancer|Neoadjuvant Chemotherapy Versus Surgery Alone in Locally Advanced Gastric Cancer: A Randomized Controlled Study|Unknown status|Active, not recruiting|N/A|80|Anticipated|Haydarpasa Numune Training and Research Hospital|||2||f||||f||||||None Retained|"     Resected stomach specimen of the patients.   "|||2017-10-11 03:46:22.542716|2017-10-11 03:46:22.542716
NCT01444742|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-01-31|||November 16, 2011|Actual|2011-11-16|January 2017|2017-01-01|January 29, 2017|Actual|2017-01-29|January 29, 2017|Actual|2017-01-29||Interventional|||Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)|Clofarabine Plus Low-Dose Cytarabine for the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome (MDS) Who Have Been Relapsing After, or Are Refractory to, Hypomethylator Therapy|Completed||Phase 2|81|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:46:22.622771|2017-10-11 03:46:22.622771
NCT01444729|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-06-17|||March 2012||2012-03-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Post Approval Commitment Study|A Non-Interventional Post Approval Commitment Study To Evaluate The Outcomes Of The Various Treatment Options For Dupuytren's Contracture|Completed||Phase 4|250|Anticipated|Endo Pharmaceuticals|||2||f||||f||||||||||2017-10-11 03:46:22.722347|2017-10-11 03:46:22.722347
NCT01444716|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2016-12-14|||December 2011||2011-12-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)|Phase II Study of Ofatumumab as Front-line Treatment in Elderly, Unfit Patients With Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 2|34|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:46:22.818882|2017-10-11 03:46:22.818882
NCT01444703|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2016-07-19|||October 2010||2010-10-01|July 2016|2016-07-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Comparison of Licorice Versus Sugar-water Gargle for Prevention of Postoperative Sore Throat and Postextubation Coughing|Randomized, Double-blind Comparison of Licorice Versus Sugar-water Gargle for Prevention of Postoperative Sore Throat and Postextubation Coughing|Completed||N/A|236|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-11 03:46:22.903422|2017-10-11 03:46:22.903422
NCT01444690|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2011-09-30|||January 2012||2012-01-01|September 2011|2011-09-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|DIPANAP||Dimiracetam in Painful Neuropathies Affecting AIDS Patients|Dimiracetam in Painful Neuropathies Affecting AIDS Patients. A Double-blind, Placebo-controlled, Parallel-group, Randomised, Multi-centre Study|Unknown status|Not yet recruiting|Phase 2|244|Anticipated|Neurotune AG||2|||f||||f||||||||||2017-10-11 03:46:22.989448|2017-10-11 03:46:22.989448
NCT01444677|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-07-16|||April 2011||2011-04-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers|A Dose Block-randomized, Double-blind, Placebo-controlled, Single or Multiple Dosing, Dose-escalation Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of MB12066 in Healthy Male Subjects|Completed||Phase 1|40|Anticipated|KT&G Life Sciences Corp||5|||f||||t||||||||||2017-10-11 03:46:23.098156|2017-10-11 03:46:23.098156
NCT01444664|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-03-23|||June 2010||2010-06-01|April 2015|2015-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Aneurysm Wall Histology Registry|Aneurysm Wall Histology and Correlation With Cerebrospinal Fluid and Blood Plasma Registry|Completed||Phase 4|24|Actual|Medical University of South Carolina||1|||f||||f||||||||||2017-10-11 03:46:23.250375|2017-10-11 03:46:23.250375
NCT01444651|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2016-12-04|2016-07-11||August 2011||2011-08-01|December 2016|2016-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Trial of Tadalafil and Glycemic Traits|Phase 3 Randomized Trial of Tadalafil and Glycemic Traits|Completed||Phase 3|73|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:46:23.447819|2017-10-11 03:46:23.447819
NCT01444638|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-01-12|||January 2011||2011-01-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of Ultrasound (US) Assistance for Anesthesia Trainees for Caesarean Section Spinal Placement|Evaluation of US Assistance for Anesthesia Trainees for Spinal Placement in Parturients Having Caesarean Section: A Randomized Control Trial|Completed||N/A|80|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:46:24.036684|2017-10-11 03:46:24.036684
NCT01444625|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2013-05-28|||June 2011||2011-06-01|May 2012|2012-05-01|May 2013|Actual|2013-05-01|September 2012|Actual|2012-09-01||Interventional|CHOCOPO||Flavanols and Skin Photo Protection: a Clinical Trial|Flavanols and Skin Photo Protection: a Double Blind Clinical Trial|Completed||Phase 2|78|Actual|Laval University||2|||f||||f||||||||||2017-10-11 03:46:24.143049|2017-10-11 03:46:24.143049
NCT01444612|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-05-15|||February 2010||2010-02-01|May 2017|2017-05-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Observational|||Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery|Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery|Completed||N/A|4068|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:46:24.249791|2017-10-11 03:46:24.249791
NCT01444599|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2015-03-23|||March 2010||2010-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Observational|||VH-IVUS Plaque Composition Analysis By Fractional Flow Reserve|Virtual Histology (VH)-Intravascular Ultrasound (IVUS) Tissue Characteristics Analysis of the Intermediate Coronary Artery Stenosis Lesion Predicting Physiologic Myocardial Ischemia by Myocardial Fraction Flow Reserve (FFR)|Completed||N/A|100|Actual|Inje University|||2||f||||t||||||||||2017-10-11 03:46:24.374503|2017-10-11 03:46:24.374503
NCT01444586|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-01-19|||October 2011||2011-10-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|August 2013|Actual|2013-08-01||Observational|SOPRANO||Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)|Prospective Multicentre Non-interventional Study on Compliance and Patient/Doctor Behavior of VTE Prevention in Major Orthopedic Surgery|Completed||N/A|2293|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:46:24.459761|2017-10-11 03:46:24.459761
NCT01444573|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-09-21|||September 2011||2011-09-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|December 2012|Actual|2012-12-01||Interventional|REVEAL||Rate Ventricular Control Therapy in Patients With Permanent Atrial Fibrillation|Rate Ventricular Control Therapy by Implantable Continuous Monitor in Patients With Permanent Atrial Fibrillation|Unknown status|Recruiting|Phase 3|90|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 03:46:24.588087|2017-10-11 03:46:24.588087
NCT01444560|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2012-10-15|||December 2008||2008-12-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi|The miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi|Completed||N/A|21|Actual|Ruhr University of Bochum|||3||f||||t||||||Samples With DNA|"     human skin   "|||2017-10-11 03:46:24.715742|2017-10-11 03:46:24.715742
NCT01444547|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2014-05-02|||January 2007||2007-01-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin|A Phase Ⅱ Study on Low-expression and High-expression of ERCC1 in Recurrent or Metastastic Esophageal Cancer Patients Treated With Biweekly Paclitaxel and Cisplatin|Unknown status|Recruiting|Phase 2|92|Anticipated|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:46:24.813971|2017-10-11 03:46:24.813971
NCT01444534|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-10-23|||September 2011||2011-09-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Mobile Phone Applications and Quality of Life|Influence of a Mobile Phone Application on Quality of Life of Patients With Type 1 Diabetes Mellitus: a Randomized Controlled Trial|Completed||N/A|65|Actual|Medical Research Foundation, The Netherlands||2|||f||||f||||||||||2017-10-11 03:46:24.93855|2017-10-11 03:46:24.93855
NCT01444521|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2014-05-02|||April 2011||2011-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer|Genotype-drive Phase II Study of Novel Irinotecan-Cisplatin Combination as First-line Therapy for Advanced Gastric Cancer|Completed||Phase 2|50|Actual|Chinese Academy of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:46:25.0833|2017-10-11 03:46:25.0833
NCT01444495|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-06-15|||January 1999||1999-01-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|June 2008|Actual|2008-06-01||Interventional|||Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer|Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer|Completed||Phase 3|154|Actual|Jagiellonian University||2|||f||||f||||||||||2017-10-11 03:46:25.323773|2017-10-11 03:46:25.323773
NCT01444482|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-09-29|||May 2011||2011-05-01|September 2011|2011-09-01||||November 2011|Anticipated|2011-11-01||Interventional|||Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers|A Phase I Single Blinded Randomised Exploratory Trial in Elderly Volunteers to Assess and Compare Safety and Immunogenicity of Adjuvanted Seasonal Influenza Vaccine (Investigational Vaccine) to Standard Seasonal Influenza Vaccine.|Unknown status|Active, not recruiting|Phase 1|110|Actual|Isconova AB||2|||f||||f||||||||||2017-10-11 03:46:25.460851|2017-10-11 03:46:25.460851
NCT01444469|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-07-22|||September 2011||2011-09-01|November 2013|2013-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|AZALEA||AZithromycin Against pLacebo in Exacerbations of Asthma|A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Oral Azithromycin (500 Mg OD) as a Supplement to Standard Care for Adult Patients With Acute Exacerbations of Asthma|Completed||Phase 4|199|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 03:46:25.564191|2017-10-11 03:46:25.564191
NCT01444456|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-02-07|2014-07-24||October 2011||2011-10-01|February 2017|2017-02-01||||August 2013|Actual|2013-08-01||Observational||Full analysis set, defined as enrolled participants who received at least 1 dose of darbepoetin alfa or any other erythropoiesis-stimulating agent (ESA) before the end of study.|Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia|Electronic Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia: An International Prospective Observational Study (eAQUA)|Completed||N/A|1262|Actual|Amgen|||2||f||||f||||||||||2017-10-11 03:46:25.746848|2017-10-11 03:46:25.746848
NCT01444430|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2016-11-29|2016-04-08||December 2011||2011-12-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents|A 26 Week, Randomized, Double-blind, Parallel-group, Active Controlled, Multicenter, Multinational Safety Study Evaluating the Risk of Serious Asthma-related Events During Treatment With Symbicort®, a Fixed Combination of Inhaled Corticosteroid (ICS) (Budesonide) and a Long Acting β2-agonist (LABA) (Formoterol) as Compared to Treatment With ICS (Budesonide) Alone in Adult and Adolescent (≥12 Years of Age) Patients With Asthma|Completed||Phase 3|12460|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:46:27.976821|2017-10-11 03:46:27.976821
NCT01444417|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-02-07|2016-11-17|2016-01-13|January 2012||2012-01-01|February 2017|2017-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients|A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)|Completed||Phase 3|62|Actual|Amgen||2|||f||||t||||||||||2017-10-11 03:46:30.46109|2017-10-11 03:46:30.46109
NCT01444404|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-01-31|||March 2008||2008-03-01|January 2017|2017-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study of AMG 820 in Subjects With Advanced Solid Tumors|A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics of AMG 820 in Adult Subjects With Advanced Solid Tumors|Completed||Phase 1|25|Actual|Amgen||2|||f||||||||||||||2017-10-11 03:46:31.616402|2017-10-11 03:46:31.616402
NCT01444391|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2014-09-20|2014-06-26||October 2011||2011-10-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|inVENT-visIOn|All enrolled subjects including the lead-in subjects and the study cohort|inVENT-visIOn Study|A Clinical Study of the Acclarent Tympanostomy Tube Delivery and Iontophoresis Systems In-Office|Completed||N/A|42|Actual|Acclarent||1|||f||||f||||||||||2017-10-11 03:46:31.762693|2017-10-11 03:46:31.762693
NCT01444378|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-04-25|2016-09-26||October 2011||2011-10-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|MOMENTUM|Intent-to-Treat Population|Absolute Pro® MOMENTUM™|Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems in the Treatment of Subjects With Atherosclerotic De Novo or Restenotic Lesions in the Native Superficial Femoral Artery and/or Native Proximal Popliteal Artery.|Completed||N/A|141|Actual|Abbott Vascular||1|||f||||t||||||||||2017-10-11 03:46:32.193566|2017-10-11 03:46:32.193566
NCT01444365|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2013-05-07||2013-04-18|October 2011||2011-10-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee|A Phase 2, Randomized Withdrawal Study of the Analgesic Efficacy and Safety of ABT-652 as an Add On Therapy in Subjects With Osteoarthritis of the Knee Experiencing Partial Benefit of a Nonsteroidal Anti-Inflammatory Drug|Completed||Phase 2|202|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 03:46:34.456275|2017-10-11 03:46:34.456275
NCT01444352|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-03-17|||June 2010||2010-06-01|March 2015|2015-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults||Completed||Phase 1|100|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 03:46:34.608398|2017-10-11 03:46:34.608398
NCT01444339|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-09-29|||February 2010||2010-02-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of Two Investigational Pneumococcal Vaccines in Healthy Adults||Completed||Phase 1|131|Actual|Sanofi||6|||f||||f||||||||||2017-10-11 03:46:34.742174|2017-10-11 03:46:34.742174
NCT01444326|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2014-04-01|||March 2010||2010-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|February 2012|Actual|2012-02-01||Interventional|PLI||Impact of Dairy Consumption on Inflammation: a Clinical Study (PLI)|Impact of Dairy Consumption on Inflammation: a Clinical Study|Completed||N/A|140|Anticipated|Laval University||2|||f||||f||||||||||2017-10-11 03:46:34.895165|2017-10-11 03:46:34.895165
NCT01444313|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-10-28|||January 2011||2011-01-01|October 2014|2014-10-01||||March 2013|Actual|2013-03-01||Interventional|||Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses|Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses|Completed||N/A|40|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||||||||||||2017-10-11 03:46:35.040842|2017-10-11 03:46:35.040842
NCT01444300|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-05-16|2014-01-13||September 2011||2011-09-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Dalfampridine for Imbalance in Multiple Sclerosis|Dalfampridine to Improve Imbalance in Multiple Sclerosis: A Pilot Study|Completed||Phase 2|24|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 03:46:35.1546|2017-10-11 03:46:35.1546
NCT01444287|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-05-05|2014-03-27||January 2010||2010-01-01|May 2015|2015-05-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Daytime Corneal Swelling During Wear of Narafilcon B Lenses||Completed||N/A|22|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||f||||||||||2017-10-11 03:46:35.619998|2017-10-11 03:46:35.619998
NCT01444274|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-09-28|||July 2011||2011-07-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Pilot Study to Evaluate A Novel Gastric Space Occupying Device|A Single-Center 60-day Observational, Non-randomized Study to Evaluate Safety and Preliminary Efficacy of a Novel Gastric Space Occupying Device as an Aid for Weight Loss|Completed||N/A|10|Actual|Obalon Therapeutics, Inc.|||1||f||||f||||||||||2017-10-11 03:46:35.97671|2017-10-11 03:46:35.97671
NCT01444261|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-03-29|||December 2010||2010-12-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Prevention of Iron Deficiency in Breastfed Infants|Prevention of Iron Deficiency in Breastfed Infants|Completed||Phase 4|219|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-10-11 03:46:36.038194|2017-10-11 03:46:36.038194
NCT01444248|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-08-21|||August 2010||2010-08-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy|A Multi-center, Open, Randomized, Parallel-group Study to Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy|Completed||Phase 4|168|Actual|Handok Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:46:36.115566|2017-10-11 03:46:36.115566
NCT00000209|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16|||November 1992||1992-11-01|September 1994|1994-09-01||||||||Interventional|||Buprenorphine Dosing Interval - 5|Buprenorphine Dosing Interval|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:39.293369|2017-10-11 04:17:39.293369
NCT01444235|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2013-05-16|||March 2011||2011-03-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery|A Prospective Randomized Double Blind Multicenter Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery Custodiol-N Versus Custodiol|Completed||Phase 2|102|Actual|Dr. F. Köhler Chemie GmbH||2|||f||||t||||||||||2017-10-11 03:46:36.189103|2017-10-11 03:46:36.189103
NCT01444222|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2011-09-30|||October 2011||2011-10-01|September 2011|2011-09-01|August 2012|Anticipated|2012-08-01|||||Observational|||Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart|Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart|Unknown status|Not yet recruiting|N/A|120|Anticipated|Universitaire Ziekenhuizen Leuven|||8||f||||f||||||||||2017-10-11 03:46:36.271969|2017-10-11 03:46:36.271969
NCT01444209|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-01-06|||October 2011||2011-10-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas|Interstitial Radioactive Iodine Implants for the Treatment of Pan-invasive Pituitary Macroadenomas|Recruiting||Phase 2|24|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 03:46:36.444584|2017-10-11 03:46:36.444584
NCT01444196|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2011-09-30|||August 2009||2009-08-01|September 2011|2011-09-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|AECUDATT||Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria|Multi-center, Double Blind, Dose Escalating Study to Compare the Effects of 5 mg, 10mg and 20mg of Desloratadine in Patients With Acquired Cold Urticaria (ACU)|Completed||Phase 4|30|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 03:46:36.525631|2017-10-11 03:46:36.525631
NCT01444183|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2015-04-07|||January 2012||2012-01-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SMILE||Stress Management Intervention for Living With Epilepsy (SMILE)|Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy|Completed||Phase 2|95|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 03:46:36.623217|2017-10-11 03:46:36.623217
NCT01444170|ClinicalTrials.gov processed this data on October 10, 2017|2008-01-30|2011-09-29|||July 2006||2006-07-01|September 2011|2011-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Nutritional Supplement, Eccentric Exercise and Recovery|A Single Site Double Blind Placebo Controlled Study of the Effects of a Dietary Supplement on Muscle Recovery Following Exercise-Induced Muscle Damage|Completed||Phase 1/Phase 2|42|Actual|University of Florida||2|||f||||||||||||||2017-10-11 03:46:36.717317|2017-10-11 03:46:36.717317
NCT01444157|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-07-17|||October 2011||2011-10-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|FamCope||Family and Coping Oriented Palliative Homecare Nursing Aimed at Advanced Cancer Patients|Family and Coping Oriented Palliative Homecare Nursing as a Supplement to Standard Homecare Nursing Aimed at Advanced Cancer Patients - a Randomized Intervention Trial|Completed||Phase 3|700|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 03:46:36.809515|2017-10-11 03:46:36.809515
NCT01444144|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-09-29|||March 2011|Actual|2011-03-01|September 2017|2017-09-01|April 3, 2011|Actual|2011-04-03|April 3, 2011|Actual|2011-04-03||Observational|||Ankle Fracture Treatment in the Elderly|Ankle Fracture Treatment in the Elderly, at Risk Population|Completed||N/A|118|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 03:46:36.913477|2017-10-11 03:46:36.913477
NCT01444131|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-03-25|||April 2011||2011-04-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation|A 26-Week Phase II, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation|Completed||Phase 2|446|Actual|University of Stellenbosch||2|||f||||t||||||||||2017-10-11 03:46:36.998335|2017-10-11 03:46:36.998335
NCT01444118|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-07-20|||November 2011||2011-11-01|July 2015|2015-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NSCLC||A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients|Phase III, Open-label, Multicentre, Randomised Trial to Establish Safety and Efficacy of an EGF Cancer Vaccine in Inoperable, Late Stage (IIIb/IV) NSCLC Patients Eligible to Receive Standard Treatment and Supportive Care.|Terminated||Phase 3|||Bioven Sdn. Bhd.||2||"The early termination is not related to safety/toxicity but to initiate new Phase III with   biomarker to enrich population & to further strengthen OS benefit"|f||||t||||||||||2017-10-11 03:46:37.103251|2017-10-11 03:46:37.103251
NCT01444105|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-18|||September 2011||2011-09-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty|A Prospective, Randomized, Controlled, Parallel Groups Evaluation of Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Glaukos Corporation||2|||f||||f||||||||||2017-10-11 03:46:37.17355|2017-10-11 03:46:37.17355
NCT01444092|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2016-11-16|2015-05-19||November 2011||2011-11-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety Study of Entocort for Children With Crohn's Disease|A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive|Completed||Phase 3|123|Actual|Perrigo Company||1|||f||||||||||||||2017-10-11 03:46:37.281313|2017-10-11 03:46:37.281313
NCT01444079|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2015-01-26|||April 2011||2011-04-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation|Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation|Completed||N/A|48|Actual|Yonsei University|||1||f||||t||||||None Retained|"     Whole blood (serum)   "|||2017-10-11 03:46:37.766732|2017-10-11 03:46:37.766732
NCT01444066|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-11-07|||September 2011||2011-09-01|November 2011|2011-11-01|December 2015|Anticipated|2015-12-01|November 2014|Anticipated|2014-11-01||Interventional|||The Role Of Empiric Dilation In Patients With Dysphagia With Normal Endoscopy|The Role Of Empiric Dilation In Patients With Dysphagia With Normal Endoscopy|Unknown status|Enrolling by invitation|N/A|96|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:46:37.840379|2017-10-11 03:46:37.840379
NCT01444040|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-18|||September 2011||2011-09-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost|A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004%|Unknown status|Recruiting|Phase 4|200|Anticipated|Glaukos Corporation||2|||f||||f||||||||||2017-10-11 03:46:37.997266|2017-10-11 03:46:37.997266
NCT01444027|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2016-10-24|||October 2011||2011-10-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Hospice Problem Solving Intervention|A Problem Solving Intervention for Hospice Caregivers|Completed||Phase 2/Phase 3|514|Actual|University of Washington||3|||f||||f||||||||||2017-10-11 03:46:38.129219|2017-10-11 03:46:38.129219
NCT01444014|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-14|||June 2011||2011-06-01|May 2015|2015-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||YF476 and Type I Gastric Carcinoids (Norway)|A Single Centre, Pilot Trial of YF476 in Patients With Chronic Atrophic Gastritis, Hypergastrinaemia and Type I Gastric Carcinoids|Terminated||Phase 2|8|Actual|Trio Medicines Ltd.||1||Difficulties with recruitment|f||||f||||||||||2017-10-11 03:46:38.225066|2017-10-11 03:46:38.225066
NCT01444001|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-09-29|||February 2007||2007-02-01|September 2011|2011-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers||Completed||Phase 1|63|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 03:46:38.341829|2017-10-11 03:46:38.341829
NCT01443988|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-18|||September 2011||2011-09-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost|A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent) or Travoprost Ophthalmic Solution 0.004%|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|Glaukos Corporation||2|||f||||f||||||||||2017-10-11 03:46:38.441553|2017-10-11 03:46:38.441553
NCT01443975|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-03-28|||September 2011||2011-09-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|X-Pander||Clinical Evaluation on the Use of the X-pander Device|Clinical Evaluation on the Use of the X-pander Device|Completed||N/A|100|Anticipated|Northern Orthopaedic Division, Denmark|||1||f||||f||||||||||2017-10-11 03:46:38.520758|2017-10-11 03:46:38.520758
NCT01443962|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2013-02-02|||November 2011||2011-11-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|lapaPEEP||The Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy|The Effect of PEEP on Regional Cerebral Oxygen Saturation During Laparoscopic Cholecystectomy|Completed||N/A|60|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 03:46:38.602229|2017-10-11 03:46:38.602229
NCT01443949|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-06-30|||September 11, 2011||2011-09-11|April 4, 2013|2013-04-04|April 4, 2013||2013-04-04|||||Observational|||Teenagers, Drug Addiction, and Reward and Impulse Control|Individual Differences in Reward and Impulse Control Circuitry as Risk Factors for Addiction|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:38.687565|2017-10-11 03:46:38.687565
NCT01443936|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2017-07-13|||September 12, 2011||2011-09-12|July 12, 2017|2017-07-12|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Experimental AD4-H5-VTN Vaccine in Healthy Volunteers|Phase 1 Study of Safety and Immunogenicity of Ad4-H5-VTN in Ad4 Seronegative and Seropositive Volunteers|Recruiting||Phase 1|148|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:46:38.755587|2017-10-11 03:46:38.755587
NCT01443923|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2015-07-09|2015-02-25||September 2011||2011-09-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV|An Open Label, On-Treatment Trial to Assess the Effect of HIV-1 Coinfection on Therapeutic Responses Using Boceprevir, Peg-Interferon-alfa-2b and Ribavirin in HCV Genotype 1, IFN Treatment-Naive Subjects With or Without HIV-1|Terminated||Phase 4|4|Actual|National Institutes of Health Clinical Center (CC)||2||Unable to complete enrollment due to newly approved treatment options.|f||||||||||||||2017-10-11 03:46:38.859019|2017-10-11 03:46:38.859019
NCT01443910|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2017-06-30|||August 24, 2011||2011-08-24|April 5, 2017|2017-04-05||||||||Observational|||Weight Management Interactions in a Virtual Clinical Environment|Weight Management Interactions in a Virtual Clinical Environment|Completed||N/A|318|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:39.25721|2017-10-11 03:46:39.25721
NCT01443897|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-09-28|||May 2010||2010-05-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|November 2010|Actual|2010-11-01||Interventional|||Effect of Consumption of Post-harvest UV-B Treated Mushrooms on Vitamin D Status of Healthy Adults|Effect of Consumption of Post-harvest UV-B Treated Mushrooms on Vitamin D Status of Healthy Adults|Completed||N/A|48|Actual|USDA, Western Human Nutrition Research Center||4|||f||||f||||||||||2017-10-11 03:46:39.328151|2017-10-11 03:46:39.328151
NCT01443884|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-12-08|||October 2009||2009-10-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Anti-Inflammatory Activities of Grapes in Humans at Risk for Cardiovascular Disease|Anti-Inflammatory Activities of Grapes in Humans at Risk for Cardiovascular Disease|Completed||N/A|24|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 03:46:39.428402|2017-10-11 03:46:39.428402
NCT01443871|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2015-05-26|||September 2011||2011-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Essential Oils in Aromatherapy on Emotional Relaxation|Effect of Essential Oils in Aromatherapy on Emotional Relaxation|Completed||N/A|48|Actual|University of Phayao||2|||f||||t||||||||||2017-10-11 03:46:39.537202|2017-10-11 03:46:39.537202
NCT01443858|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-29|2014-07-29|2014-04-07||August 2011||2011-08-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Meclizine as a Potential Smoking Cessation Treatment|Meclizine as a Potential Smoking Cessation Treatment|Completed||Phase 2|146|Actual|Duke University||3|||f||||t||||||||||2017-10-11 03:46:39.64881|2017-10-11 03:46:39.64881
NCT00000232|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-05-05|||March 1992||1992-03-01|April 1994|1994-04-01||||||||Interventional|||Alternate Day Buprenorphine Administration, Phase IX - 14|Alternate Day Buprenorphine Administration, Phase IX|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-10-11 04:17:41.0165|2017-10-11 04:17:41.0165
NCT01443845|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-03-16|2016-11-30||September 30, 2011|Actual|2011-09-30|March 2017|2017-03-01|January 31, 2016|Actual|2016-01-31|November 30, 2015|Actual|2015-11-30||Interventional||The demographic information provided here is for the safety population. The safety population (numbering 2352 patients) of the trial does not include 2 patients from the enrolled population (numbering 2354 patients), due to a protocol deviation for one patient and an adverse event for a second patient, both in the placebo arm|Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)|Study to Evaluate the Effect of Roflumilast 500 μg on Exacerbation Rate in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Treated With a Fixed-Dose Combination of Long-Acting Beta Agonist and Inhaled Corticosteroid (LABA/ICS)|Completed||Phase 4|2354|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 03:46:40.554635|2017-10-11 03:46:40.554635
NCT01443832|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-10-29|||September 2010||2010-09-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Observational|||Iron Absorption From Iron-fortified Fonio Porridge: a Stable Isotope Study|Effect of Dephytinisation of Fonio With Intrinsic Wheat Phytase on Iron Absorption in Beninese Women|Completed||Early Phase 1|16|Actual|Wageningen University|||1||f||||f||||||Samples Without DNA|"     2 samples of 8 ml venous blood per subject   "|||2017-10-11 03:46:43.559084|2017-10-11 03:46:43.559084
NCT01443819|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2015-12-14|||May 2011||2011-05-01|December 2015|2015-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Lumbar Transforaminal Epidural Corticosteroid Injection(s) Versus Defined Physical Therapy|Randomized, Prospective Study of Lumbar Transforaminal Epidural Corticosteroid Injection(s) Versus Defined Physical Therapy for the Treatment of Subacute Lumbar Radicular Pain Due to Disc Protrusion|Terminated||Phase 3|5|Actual|Stanford University||3||recruitment problem|f||||f||||||||||2017-10-11 03:46:43.66384|2017-10-11 03:46:43.66384
NCT01443806|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-06-28|||July 2011||2011-07-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand|Characterisation of the Human Carboxylesterase 1 (CES1) Mutation(s) Which May be Responsible for Markedly Reduced Conversion of Oseltamivir Phosphate to Oseltamivir Carboxylate|Unknown status|Recruiting|Phase 4|15|Anticipated|University of Oxford||1|||f||||f||||||||||2017-10-11 03:46:43.778544|2017-10-11 03:46:43.778544
NCT01443793|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-10-02|||September 2011||2011-09-01|October 2011|2011-10-01||||||||Observational|||Longitudinal Pattern of Streptococcus Pneumoniae Nasopharyngeal Carriage and Antimicrobial Susceptibility in Healthy Children Aged Less Then 5 Years, in the Area of Milan and Surroundings, Lombardy, Italy.|Longitudinal Pattern of Streptococcus Pneumoniae Nasopharyngeal Carriage and Antimicrobial Susceptibility in Healthy Children Aged Less Then 5 Years, in the Area of Milan and Surroundings, Lombardy, Italy.|Unknown status|Recruiting|N/A|1300|Anticipated|University of Milan|||1||f||||f||||||||||2017-10-11 03:46:43.86723|2017-10-11 03:46:43.86723
NCT01443780|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-09-30|||January 2003||2003-01-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|KiSel-10||Intervention With Selenium and Q10 on Cardiovascular Mortality and Cardiac Function in the Elderly Population in Sweden|Kisel-10- a Prospective Randomized Double-blind Placebo Controlled Study of the Results of Intervention With Selenium and Coenzyme Q10 Combined, Regarding Effect With Emphasis on Cardiovascular Mortality and Morbidity.|Completed||N/A|443|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-10-11 03:46:43.948744|2017-10-11 03:46:43.948744
NCT01443767|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-02-12|||July 2011||2011-07-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Correlation of Estimated Continuous Cardias Output (esCCO) and Picco in Partial Liver Resection|Pilot Study to Examine the Correlation of 'Estimated Continuous Cardias Output' (esCCO) With Pulse Contour Analysis of the Arterial Waveform (Picco) in Partial Liver Resection|Completed||N/A|27|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-11 03:46:44.042842|2017-10-11 03:46:44.042842
NCT01443754|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-09-30|||September 2011||2011-09-01|February 2015|2015-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|HYBRID||Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease|Hybrid Revascularisation by Combined CABG and PCI in Multivessel Coronary Disease. An Observational Study.|Terminated||N/A|50|Actual|Ettore Sansavini Health Science Foundation|||1|Lack of recruitment|f||||f||||||||No||2017-10-11 03:46:45.528441|2017-10-11 03:46:45.528441
NCT01443741|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2011-09-28|||January 2012||2012-01-01|September 2011|2011-09-01|July 2015|Anticipated|2015-07-01|January 2015|Anticipated|2015-01-01||Interventional|DIABFIT||Evaluation of Interests of FIT Therapy on Diabetics Children Insulin-dependent|Evaluation of Interests of the Functional Insulin Therapy (FIT Therapy) on Metabolic Control, Hypoglycemia Prevention and Life Quality of Diabetics Children Insulin-dependent Treated With Insulin Pump.|Unknown status|Not yet recruiting|Phase 2|88|Anticipated|University Hospital, Angers||2|||f||||f||||||||||2017-10-11 03:46:45.616206|2017-10-11 03:46:45.616206
NCT01443728|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-06-21||2016-10-10|December 2011||2011-12-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|September 2015|Actual|2015-09-01||Interventional|||Vitamin D for Sickle-cell Respiratory Complications|Vitamin D for Sickle-cell Respiratory Complications|Active, not recruiting||Phase 2|130|Anticipated|Columbia University||2|||f||||t||||||||||2017-10-11 03:46:45.75487|2017-10-11 03:46:45.75487
NCT01443715|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2014-09-02|||September 2011||2011-09-01|April 2013|2013-04-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|SCIPT-A||A Stepped Care Model of Adolescent Depression Treatment in Primary Care|A Stepped Care Model of Adolescent Depression Treatment in Primary Care|Completed||Phase 2/Phase 3|48|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 03:46:45.85654|2017-10-11 03:46:45.85654
NCT01443702|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2013-11-29|||January 2011||2011-01-01|November 2013|2013-11-01||||December 2011|Actual|2011-12-01||Interventional|||Use of Lapis Judaicus to Dissolve Kidney Stones||Completed||Phase 1/Phase 2|60|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:46:45.955603|2017-10-11 03:46:45.955603
NCT01443689|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-11-26|||July 2011||2011-07-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Interventional|||Allogenic Stem Cell Therapy in Patients With Acute Burn|A Phase Ι/Π Study of Human Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Acute Burn|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Shenzhen Beike Bio-Technology Co., Ltd.||3|||f||||t||||||||||2017-10-11 03:46:46.052281|2017-10-11 03:46:46.052281
NCT01443663|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2016-02-05|||October 2011||2011-10-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine|Immunogenicity and Safety Study of a 45 Micrograms Dose of Inactivated, Unadjuvanted H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H5N1 and H7N3 Influenza Vaccines and in H5 and Live Attenuated Vaccine Naïve Individuals|Completed||Phase 1|69|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-10-11 03:46:46.247096|2017-10-11 03:46:46.247096
NCT01443650|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2013-06-27|||July 2011||2011-07-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy Subjects|A Randomized Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics After Different Single-Dose Subcutaneous Treatments of SAR236553/REGN727 in Healthy Subjects|Completed||Phase 1|36|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:46:46.329216|2017-10-11 03:46:46.329216
NCT01443637|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2016-04-28|||June 2003||2003-06-01|April 2016|2016-04-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01||Observational|CONFIRM||COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM)|COronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter Registry|Enrolling by invitation||N/A|50000|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||Undecided||2017-10-11 03:46:46.49084|2017-10-11 03:46:46.49084
NCT01443624|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2013-08-13|||October 2011||2011-10-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Interventional|SOFI||Evaluation of Oxidative Stress Induced by Iron Injection in Healthy Volunteers and Critical Care Patients|Evaluation of Oxidative Stress Induced by Iron Injection in Healthy Volunteers Versus Critical Care Patients|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 03:46:46.6777|2017-10-11 03:46:46.6777
NCT01443611|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-08-30|||June 2011||2011-06-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||The Relevance of Performing Lumbar Puncture in Infants Aged 3 to 12 Months With First Episode of Febrile Convulsion||Completed||N/A|122|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-11 03:46:46.805705|2017-10-11 03:46:46.805705
NCT01443598|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2016-06-06|||July 2010||2010-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|December 2011|Actual|2011-12-01||Observational|HYPID||Pulmonary Hypertension in Interstitial Lung Disease|Observational Study of Patients With Pre Capillary Pulmonary Hypertension|Completed||N/A|224|Actual|Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires|||1||f||||f||||||Samples With DNA|"     whole blood, serum and plasma   "|Undecided||2017-10-11 03:46:46.887766|2017-10-11 03:46:46.887766
NCT01443585|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-03-14|||September 2012||2012-09-01|September 2011|2011-09-01||||November 2013|Anticipated|2013-11-01||Interventional|||Clinical Evaluation of a Progressive Addition Lens (PAL)|Clinical Performance Evaluation of a Progressive Addition Lens Among Presbyopic Patients|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Ziv Hospital||1|||f||||t||||||||||2017-10-11 03:46:46.991041|2017-10-11 03:46:46.991041
NCT01443572|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-07-20|||September 2011||2011-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Comparison of Desflurane and Sevoflurane on Postoperative Recovery and Hepatic Function of Biliary Atresia Patients During Kasai Operation||Completed||N/A|40|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 03:46:47.086748|2017-10-11 03:46:47.086748
NCT01443559|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2015-07-16|||September 2011||2011-09-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|XKFPC||Xenogenic Keratoplasty From Porcine Cornea|Phase I Study of Xenogenic Keratoplasty From Porcine Cornea in the Treatment of Infectious Corneal Ulcer|Suspended||Phase 1|20|Anticipated|Xiamen University||2||there was not enough patients recruited in this study|f||||t||||||||||2017-10-11 03:46:47.202773|2017-10-11 03:46:47.202773
NCT01443546|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-06-10|||January 2013||2013-01-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|DUALTRIGGER||Study of Dual Trigger Ovulation in Oocyte Donors|A Randomized Prospective Trial of Dual Trigger Ovulation in Oocyte Donors|Unknown status|Recruiting|Phase 4|180|Anticipated|Weill Medical College of Cornell University||3|||f||||t||||||||||2017-10-11 03:46:47.315012|2017-10-11 03:46:47.315012
NCT01443533|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-06-26|||May 2011||2011-05-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study of Birth Control Use After Childbirth|A Randomized Controlled Trial of a Brief Educational Script on Postpartum Contraceptive Uptake|Completed||N/A|800|Actual|WakeMed Health and Hospitals||2|||f||||f||||||||||2017-10-11 03:46:47.426924|2017-10-11 03:46:47.426924
NCT01443520|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2012-05-21|||October 2011||2011-10-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Duloxetine and Venlafaxine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol: A Three-phase Randomized Balanced Cross-over Study in Healthy Volunteers||Completed||Phase 4|12|Actual|Turku University Hospital||3|||f||||||||||||||2017-10-11 03:46:47.517113|2017-10-11 03:46:47.517113
NCT01443507|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-12-09|||October 2011||2011-10-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Exercise With Low Intensity and Longer Duration Versus High Intensity Interval Training|Does Endurance Exercise With Low Intensity and Longer Duration Improve Aerobic Capacity to the Same Extent as High Intensity Interval Training?|Completed||Phase 2|22|Actual|Volda University College||2|||f||||f||||||||||2017-10-11 03:46:47.61757|2017-10-11 03:46:47.61757
NCT01443494|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-06-13|2014-02-27||June 2011||2011-06-01|June 2017|2017-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Detailed enquiry about the target MAP to their next kin was performed in all of the patients.|High MAP in Septic Shock With Hypertension|High Mean Arterial Pressure Target Improves Microcirculation in Septic Shock Patients With Previous Hypertension|Completed||N/A|19|Actual|Southeast University, China|"Firstly, cardiac output was monitored by NICOM system to minimize the invasive operation.
Secondly, the number of patients enrolled in the study was relatively small. Next, immediate changes of the increase in MAP were investigated."|1|||f||||f||||||||||2017-10-11 03:46:47.701827|2017-10-11 03:46:47.701827
NCT01441674|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-28|2014-02-13|||January 2011||2011-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|AAT||Animal Assisted Therapy in a Pediatric Setting|The Effectiveness of Animal Assisted Therapy for Children Hospitalized in a Pediatric Setting|Completed||Phase 1/Phase 2|30|Actual|Children's Hospitals and Clinics of Minnesota||2|||f||||f||||||||||2017-10-11 03:47:24.920387|2017-10-11 03:47:24.920387
NCT01443481|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-17|2017-06-06|||November 2011||2011-11-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function|A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function|Completed||Phase 1|38|Actual|Novartis||4|||f||||f||||||||||2017-10-11 03:46:47.900895|2017-10-11 03:46:47.900895
NCT01443468|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-28|2017-08-17|||September 6, 2011||2011-09-06|August 16, 2017|2017-08-16||||||||Observational|||Clinical and Genetic Studies of Li-Fraumeni Syndrome|Clinical, Epidemiologic, and Genetic Studies of Li-Fraumeni Syndrome|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:46:48.022507|2017-10-11 03:46:48.022507
NCT01443455|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-09-27|||January 2010|Actual|2010-01-01|September 2017|2017-09-01|September 30, 2012|Actual|2012-09-30|July 31, 2012|Actual|2012-07-31||Interventional|||Adherence and Health Effects of Video Dance in Postmenopausal Women|Phase 2 Trial of Video Dance Versus Walking in Postmenopausal Sedentary Overweight Women|Completed||N/A|168|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 03:46:48.114671|2017-10-11 03:46:48.114671
NCT01443429|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2014-03-03|||August 2011||2011-08-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment|A Pharmacokinetic Study of TRK-100STP -A Single Oral Administration Study in Japanese Patients With Renal Impairment as Compared to Subjects With Normal Renal Function|Completed||Phase 1|24|Actual|Toray Industries, Inc||4|||f||||f||||||||||2017-10-11 03:46:48.274366|2017-10-11 03:46:48.274366
NCT01443416|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-11-06|||April 2012||2012-04-01|November 2015|2015-11-01||||August 2013|Actual|2013-08-01||Interventional|||An Alternative Booster Vaccine Against Meningitis and Ear Infections|An Alternative Booster Vaccine Against Meningitis and Ear Infections.|Completed||Phase 3|178|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 03:46:48.352662|2017-10-11 03:46:48.352662
NCT01443403|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-05-31|2017-04-19||August 17, 2011|Actual|2011-08-17|May 2017|2017-05-01|August 22, 2012|Actual|2012-08-22|August 22, 2012|Actual|2012-08-22||Interventional||The modified intention-to-treat (mITT) population included all randomized participants who received study drug and had at least 1 postdose primary efficacy assessment completed. One participant who randomized twice was excluded from the naldemedine 0.4 mg arm for the mITT population.|A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy|Completed||Phase 2|244|Actual|Shionogi Inc.||4|||f||||f||||||||||2017-10-11 03:46:48.598376|2017-10-11 03:46:48.598376
NCT01443390|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-05-12|||September 2011||2011-09-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer|An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advanced Refractory Cancer|Completed||N/A|11|Actual|Scottsdale Healthcare|||1||f||||f||||||Samples With DNA|"     Biopsy of an accessible lesion   "|||2017-10-11 03:46:51.201472|2017-10-11 03:46:51.201472
NCT01443377|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-05-06|||July 2011||2011-07-01|April 2012|2012-04-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|NEOREC-1||Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer|Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer|Completed||Phase 2|48|Anticipated|National Center for Tumor Diseases, Heidelberg||1|||f||||t||||||||||2017-10-11 03:46:51.422253|2017-10-11 03:46:51.422253
NCT01443364|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-07-06|2016-01-04||December 2011||2011-12-01|July 2017|2017-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|SPEED|The Baseline Characteristics refer to the Safety Set (SS) which consists of all subjects who received at least one dose of study medication.|Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis|Multicenter, Open Label Study to Evaluate the Predictability of Early Response to Certolizumab Pegol (in Combination With Methotrexate) as Confirmed at Week 52 in Subjects With Moderate-severe Rheumatoid Arthritis (RA)|Completed||Phase 4|132|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 03:46:51.597144|2017-10-11 03:46:51.597144
NCT01443351|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-02-04|||March 2012||2012-03-01|February 2015|2015-02-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)|Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Primary Immune Thrombocytopenia (ITP)|Recruiting||N/A|50|Anticipated|Zealand University Hospital|||1||f||||f||||||Samples With DNA|"     Whole blood samples will be collected, seru, plasma and mononuclear cells will be stored in a     biobank for further research use   "|||2017-10-11 03:46:53.407464|2017-10-11 03:46:53.407464
NCT01443338|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-09-28|||September 2011||2011-09-01|September 2011|2011-09-01||||December 2012|Anticipated|2012-12-01||Interventional|||Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2|A Phase4,Multicenter, Randomized,Double-blind,Double Dummy, Parallel Controlled Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Treatment of Chinese Patients With Moderate to Severe Psoriasis Vulgaris|Unknown status|Recruiting|Phase 4|720|Anticipated|Ministry of Health, China||2|||f||||t||||||||||2017-10-11 03:46:53.493389|2017-10-11 03:46:53.493389
NCT01443325|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-06-21|||September 2011||2011-09-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain||Completed||Phase 3|21|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 03:46:53.607924|2017-10-11 03:46:53.607924
NCT01439087|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-04-14|||July 2009||2009-07-01|April 2016|2016-04-01|August 2010|Actual|2010-08-01|October 2009|Actual|2009-10-01||Interventional|||Optical Frequency Domain Imaging for Assessing Colonic Polyps|Pilot Study to Evaluate Optical Frequency Domain Imaging as a Tool for Assessing Colonic Polyps|Completed||Phase 1|15|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:48:25.681429|2017-10-11 03:48:25.681429
NCT01443312|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-08-30|||October 2011||2011-10-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia||Completed||N/A|28|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||Samples With DNA|"     DNA samples will be obtained to analyze the beta and alfa globin genes and the xmn1     polymorphism.   "|||2017-10-11 03:46:53.700166|2017-10-11 03:46:53.700166
NCT01443299|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-12-08|||November 2011||2011-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:46:53.934209|2017-10-11 03:46:53.934209
NCT01443286|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-04-18|||||||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:46:53.98373|2017-10-11 03:46:53.98373
NCT01443273|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-08-08|||October 2011||2011-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010|Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010|Recruiting||N/A|50|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-10-11 03:46:54.036037|2017-10-11 03:46:54.036037
NCT01443260|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-03-09|||February 2012||2012-02-01|March 2014|2014-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis|Phase I/II Study of Intraperitoneal Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Peritoneal Carcinomatosis|Completed||Phase 1/Phase 2|9|Actual|Genelux Corporation||1|||f||||t||||||||||2017-10-11 03:46:54.152219|2017-10-11 03:46:54.152219
NCT01443247|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2011-09-28|||September 2010||2010-09-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Role of Andi-d in Dengue Fever: a Pilot Study|Role of Andi-d in Dengue Fever: a Pilot Study|Completed||N/A|30|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 03:46:54.21466|2017-10-11 03:46:54.21466
NCT01443234|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-01-08|||February 2012||2012-02-01|June 2013|2013-06-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional|OxIGen||OxIGen: Oxford Imagery Generation: Investigating the Effects of an Internet Based Computer Program in Depression|OxIGen: Oxford Imagery Generation: Investigating the Effects of an Internet Based Computer Program in Depression|Completed||Phase 2|150|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 03:46:54.34547|2017-10-11 03:46:54.34547
NCT01443221|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2011-09-28|||December 2010||2010-12-01|October 2010|2010-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.|Open-label, Randomized, Single-dose, 2-way Crossover Study to Investigate Safety and Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.|Completed||Phase 1|24|Actual|JW Pharmaceutical||2|||f||||t||||||||||2017-10-11 03:46:54.4709|2017-10-11 03:46:54.4709
NCT01443208|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2011-12-29|||November 2011||2011-11-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet|A Phase 1, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, Parallel-Group, Single and Multiple-Dose Study of Desvenlafaxine in Korean Healthy Subjects|Completed||Phase 1|36|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:46:54.569842|2017-10-11 03:46:54.569842
NCT01443195|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-08-08|||October 2011||2011-10-01|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Iron Metabolism in Small Pre Term Newborns|Iron Metabolism in Small Pre Term Newborns|Recruiting||N/A|50|Anticipated|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-10-11 03:46:54.70147|2017-10-11 03:46:54.70147
NCT01443182|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2013-10-31|||September 2011||2011-09-01|October 2013|2013-10-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Treatment of Posttraumatic Stress Disorder (PTSD) in Adult Survivors of Early Chronic Interpersonal Trauma|Treatment of PTSD in Adult Survivors of Early Chronic Interpersonal Trauma|Unknown status|Recruiting|Phase 2|90|Anticipated|VU University of Amsterdam||2|||f||||f||||||||||2017-10-11 03:46:54.826658|2017-10-11 03:46:54.826658
NCT01443169|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-04-17|||March 2012||2012-03-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted|A Phase 1, Randomized, Open Label, Single Dose, 5-treatment, 5- Period Crossover Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release Pregabalin Tablet Formulations Administered Following an Evening Meal and the Immediate Release Formulation Administered Fasted|Completed||Phase 1|16|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 03:46:54.973659|2017-10-11 03:46:54.973659
NCT01443156|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-02-14|||January 2012||2012-01-01|February 2013|2013-02-01||||February 2013|Actual|2013-02-01||Observational|||The Effects of Work Schedule and Sleep Patterns on Caregivers' Health||Completed||N/A|211|Actual|Oregon Health and Science University|||1||f||||||||||Samples With DNA|"     Mouthwash swish containing buccal cells.   "|||2017-10-11 03:46:55.160843|2017-10-11 03:46:55.160843
NCT01443143|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-09-27|||December 2010||2010-12-01|September 2011|2011-09-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Blood Glucose Stability and Variability on Two Diets|A Comparison of Glycemic Stability and Variability During Consumption of Usual Diet or a Commercially Available Portion-controlled Diet Among Patients With Type 2 Diabetes|Unknown status|Recruiting|N/A|15|Anticipated|Nutrisystem, Inc.||2|||f||||f||||||||||2017-10-11 03:46:55.313129|2017-10-11 03:46:55.313129
NCT01442974|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2013-03-12|||January 2011||2011-01-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer|Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer|Completed||N/A|15|Actual|Grupo Hospital de Madrid||1|||f||||t||||||||||2017-10-11 03:46:59.553772|2017-10-11 03:46:59.553772
NCT00000233|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16|||May 1993||1993-05-01|September 1995|1995-09-01||||||||Interventional|||Alternate Day Buprenorphine Administration, Phase X - 15|Alternate Day Buprenorphine Administration, Phase X|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:41.081423|2017-10-11 04:17:41.081423
NCT01443130|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-11-03|2015-10-01||February 2012||2012-02-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional||All participants enrolled in the study are included in the baseline analysis population, with the exception of the age continuous for all groups, which is limited to the maternal participants.|Chloroquine for Malaria in Pregnancy|A Randomized, Controlled Clinical Trial of Chloroquine as Chemoprophylaxis Versus Intermittent Preventive Therapy to Prevent Malaria in Pregnancy in Malawi|Completed||Phase 3|900|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The observed placental malaria rate was lower than expected causing the study to be under powered. After review of a futility analysis, the Sponsor and DSMB recommended allowing the study to conclude as planned and not to increase the sample size.|3|||f||||||||||||||2017-10-11 03:46:55.59674|2017-10-11 03:46:55.59674
NCT01443117|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-05-05||||||May 2014|2014-05-01||||August 2014|Anticipated|2014-08-01||Interventional|||Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women|Administration of Polysaccharide or Conjugated Pneumococcal Vaccines to HIV-Infected Pregnant Women: Safety and Magnitude, Persistence, and Transplacental Transfer of Vaccine-Serotype Pneumococcal Anti-Capsular Antibodies|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-10-11 03:46:57.807751|2017-10-11 03:46:57.807751
NCT01443104|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-02-08|||February 2012|Actual|2012-02-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|June 2014|Actual|2014-06-01||Interventional|||Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents|A Randomized Comparison of a Sirolimus-eluting Stent With Biodegradable Polymer Versus an Everolimus-eluting Stent With a Durable Polymer for Percutaneous Coronary Revascularization|Active, not recruiting||N/A|2119|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-10-11 03:46:57.91694|2017-10-11 03:46:57.91694
NCT01443091|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-05-25|||January 2011||2011-01-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Oropharyngeal Colostrum for Immune Stimulation in Very Low Birth Weight Infants|Oropharyngeal Colostrum for Immune Stimulation in Very Low Birth Weight Infants|Completed||N/A|43|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 03:46:58.05439|2017-10-11 03:46:58.05439
NCT01443078|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-09-07|2016-06-29||October 2011||2011-10-01|September 2017|2017-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)|Phase II Trial of Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)|Completed||Phase 2|42|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:46:58.163446|2017-10-11 03:46:58.163446
NCT01443065|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-01-24|||January 2011||2011-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|March 2014|Actual|2014-03-01||Interventional|MEGA||MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma|MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma FNCLCC-FFCD-AGEO PRODIGE 17-ACCORD 20 Randomized Phase II Trial|Active, not recruiting||Phase 2|162|Actual|UNICANCER||3|||f||||t||||||||||2017-10-11 03:46:58.512115|2017-10-11 03:46:58.512115
NCT01443052|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2014-04-11|||November 2010||2010-11-01|April 2014|2014-04-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|GAITRITE||Gait Parameters Analysis in Post-stroke Patients and in Elderly Fallers|"Study of the Temporospatial Gait Parameters With the Electronic Carpet GAITRite in Patients With Walking Impairment After Stroke and in Old Faller Subjects"|Unknown status|Recruiting|N/A|90|Anticipated|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||||||2017-10-11 03:46:58.636224|2017-10-11 03:46:58.636224
NCT01443039|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-01-03|||September 2011||2011-09-01|December 2016|2016-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|SODA||Phenotypical Approach of the Drug Metabolizing Hormones Activity Before and After Roux-en Y-Gastric Bypass|Phenotypical Approach of the Drug Metabolizing Hormones Activity (CYP1A2, CYP2D6, CYP2C9, CYP2C19, CYP3A4 and P-gp) Before and After Roux-en Y-Gastric Bypass. The SODA Protocol: Surgery for Obesity and Drug Availability|Completed||Phase 1|11|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 03:46:58.719228|2017-10-11 03:46:58.719228
NCT01443026|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-12-01|2014-04-17||February 2006||2006-02-01|December 2015|2015-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||The Effects of Lycopene on High Risk Prostatic Tissue|R01 CA90759: The Effects of Lycopene on High Risk Prostatic Tissue|Completed||Phase 2|66|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 03:46:58.877965|2017-10-11 03:46:58.877965
NCT01443013|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-10-18|||September 2010||2010-09-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|TUFEV||Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient|Predictive Value Analysis of Messenger Ribonucleic Acid (mRNA) Urinary Expression of Foxp3 and Vimentin on Graft Outcome in Renal Transplant Recipient: National Prospective Study|Completed||N/A|266|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples Without DNA|"     Urine for mRNA extraction and congelation   "|||2017-10-11 03:46:59.265025|2017-10-11 03:46:59.265025
NCT01443000|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2016-11-03|||March 2012||2012-03-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SIOI||Survey of Patients With Idiopathic Orbital Inflammation Syndrome|Survey of Patients With Idiopathic Orbital Inflammation Syndrome (IOIS): Clinical, Morphological and Pathological Features and Treatment Outcomes|Active, not recruiting||N/A|87|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Blood samples will be frozen to form a serum storage and a DNAthèque. These samples will     achieve further analysis based on the evolution of knowledge on mechanisms contributing to     the orbital inflammation.   "|||2017-10-11 03:46:59.345792|2017-10-11 03:46:59.345792
NCT01442987|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2013-08-12|||May 2011||2011-05-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia|Efficacy and Safety of Coadministered Irbesartan and Atorvastatin in Patients With Hypertension and Hyperlipidemia|Completed||Phase 3|230|Actual|Hanmi Pharmaceutical Company Limited||6|||f||||f||||||||||2017-10-11 03:46:59.443012|2017-10-11 03:46:59.443012
NCT01442935|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-06-17|||February 2011||2011-02-01|June 2016|2016-06-01|February 2019|Anticipated|2019-02-01|November 2016|Anticipated|2016-11-01||Interventional|||Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases|Phase II Multicentric Randomized Trial, Evaluating the Best Protocol of Chemotherapy, Associated With Targeted Therapy According to the Tumor KRAS Status, in Metastatic Colorectal Cancer (CCRM) Patients With Initially Non-resectable Hepatic Metastases|Active, not recruiting||Phase 2|256|Anticipated|UNICANCER||3|||f||||t||||||||||2017-10-11 03:46:59.81135|2017-10-11 03:46:59.81135
NCT01442922|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2013-01-16|||March 2011||2011-03-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Intervertebral Disc Augmentation With Minimally Invasive Surgical Procedure|Intervertebral Disc Nucleus Augmentation With Allograft Meniscus With Minimally Invasive Surgical Procedure|Completed||N/A|1|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 03:46:59.937357|2017-10-11 03:46:59.937357
NCT01442909|ClinicalTrials.gov processed this data on October 10, 2017|2008-05-25|2011-09-27|||March 2008||2008-03-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Pemetrexed Followed by Docetaxel or in Reverse Sequence|Phase IV Randomized Trial of Pemetrexed Followed by Docetaxel or in Reverse Sequence in Non-small-cell Lung Cancer Patients Failed Previous Chemotherapy|Completed||Phase 4|44|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-10-11 03:47:00.028448|2017-10-11 03:47:00.028448
NCT01442896|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-09-28|||September 2011||2011-09-01|September 2011|2011-09-01|September 2015|Anticipated|2015-09-01|October 2013|Anticipated|2013-10-01||Observational|STARFISH||STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk (STARFISH)|STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk (STARFISH)|Unknown status|Recruiting|N/A|130|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-10-11 03:47:00.134756|2017-10-11 03:47:00.134756
NCT01442883|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-03-27|||November 2010||2010-11-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Renal Nerve Ablation in Chronic Kidney Disease Patients|Understanding the Mechanisms of Progressive Decrease in Blood Pressure After Renal Nerve Ablation|Recruiting||N/A|100|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-10-11 03:47:00.220536|2017-10-11 03:47:00.220536
NCT01442870|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-05-05|||September 2011||2011-09-01|May 2017|2017-05-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy|Prospective Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy|Completed||Phase 1|105|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-10-11 03:47:00.320114|2017-10-11 03:47:00.320114
NCT01442857|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2014-08-04|||June 2008||2008-06-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||The Axillary Region in a High Resolution MRI|The Axillary Region in a High Resolution MRI. Imaging Before and After Brachial Plexus Block|Completed||Phase 2|18|Actual|Diakonhjemmet Hospital||1|||f||||f||||||||||2017-10-11 03:47:00.399694|2017-10-11 03:47:00.399694
NCT01442844|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2014-06-18|2014-06-18||September 2011||2011-09-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MomelanMohs||Secondary Intention Wound Healing Versus Micrografting in Patients Undergoing Mohs Surgery|Secondary Intention Wound Healing Versus Micrografting in Patients Undergoing Mohs Surgery|Terminated||N/A|3|Actual|Massachusetts General Hospital||2||The study sponsor was acquired by a company that focuses on chronic wounds|f||||f||||||||||2017-10-11 03:47:00.488214|2017-10-11 03:47:00.488214
NCT01442831|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-04-27|||September 2010||2010-09-01|April 2016|2016-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects|An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of Orally Administered [14C]-TR-701 in Healthy Adult Male Subjects|Completed||Phase 1|6|Actual|Trius Therapeutics LLC||1|||f||||f||||||||||2017-10-11 03:47:00.748063|2017-10-11 03:47:00.748063
NCT01442805|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-03-13|||October 2008||2008-10-01|March 2017|2017-03-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|||Use of Virtual Reality in the Treatment of Flying Phobia|Etude contrôlée Des Effets de la réalité Virtuelle Sur Les symptômes et Les paramètres Physiologiques de Certaines Phobies spécifiques|Completed||N/A|36|Actual|Luxembourg Institute of Health||2|||f||||t||||||||No||2017-10-11 03:47:00.916636|2017-10-11 03:47:00.916636
NCT01442792|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-01-19|||October 2011||2011-10-01|January 2017|2017-01-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|X-PLORER||Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention|Prospective, Multi-center, Randomized, Heparin-controlled Dose-finding Trial to Evaluate the Efficacy and Safety of Rivaroxaban, a Direct Factor Xa Inhibitor, on the Background of Standard Dual Antiplatelet Therapy to Support Elective Percutaneous Coronary Intervention|Completed||Phase 2|108|Actual|Bayer||4|||f||||t||||||||||2017-10-11 03:47:01.006951|2017-10-11 03:47:01.006951
NCT01442779|ClinicalTrials.gov processed this data on October 10, 2017|2009-09-23|2012-04-18|2009-09-23||September 2000||2000-09-01|April 2012|2012-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis|Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis|Completed||Phase 2|18|Actual|Texas Tech University Health Sciences Center||1|||f||||f||||||||||2017-10-11 03:47:01.125339|2017-10-11 03:47:01.125339
NCT01442766|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-09-29|||November 2011||2011-11-01|September 2011|2011-09-01|May 2014|Anticipated|2014-05-01|November 2013|Anticipated|2013-11-01||Interventional|||Donepezil Trial for Motor Recovery in Acute Stroke|A Randomised-controlled Trial of Donepezil for Motor Recovery in Acute Stroke|Unknown status|Not yet recruiting|Phase 1/Phase 2|100|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 03:47:01.348671|2017-10-11 03:47:01.348671
NCT01442753|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2015-06-02|||September 2011||2011-09-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth|Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth: A CBPR RCT|Completed||N/A|800|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 03:47:01.493378|2017-10-11 03:47:01.493378
NCT01442727|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-10-06|||December 2006||2006-12-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|SETAC||Selenium in the Treatment of Arsenic Toxicity and Cancers|Selenite in the Detoxification of Arsenic and the Prevention of Arsenical Melanosis and Cancers Amongst Bangladeshi Arsenicosis Patients: A 48-week, Randomized, Double-blinded, Placebo-controlled Phase III Trial|Completed||Phase 3|819|Actual|Texas Tech University||2|||f||||t||||||||||2017-10-11 03:47:01.736146|2017-10-11 03:47:01.736146
NCT01442701|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-10-13|||March 2010||2010-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|STORK||Stanford's Outcomes Research in Kids|Stanford's Outcomes Research in Kids (STORK)|Active, not recruiting||N/A|200|Anticipated|Stanford University|||1||f||||f||||||Samples With DNA|"     Blood, saliva, skin swabs, stool, urine.   "|||2017-10-11 03:47:01.970518|2017-10-11 03:47:01.970518
NCT01442688|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-08-16|2012-08-16||October 2011||2011-10-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Amoxicillin Drug Interaction Study With MMX® Mesalazine/Mesalamine|A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Amoxicillin Administered Alone and in Combination With MMX® Mesalazine/Mesalamine in Healthy Adult Subjects|Completed||Phase 1|62|Actual|Shire||2|||f||||||||||||||2017-10-11 03:47:02.262219|2017-10-11 03:47:02.262219
NCT01442675|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-11-17|2014-11-11|2012-12-03|September 2011||2011-09-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine|Safety and Immunogenicity of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine|Completed||Phase 2|834|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:47:02.668195|2017-10-11 03:47:02.668195
NCT01442662|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-03-19|||September 2011||2011-09-01|March 2015|2015-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|LMS03||Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas|Phase II Multicenter Study to Determine the Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas|Unknown status|Recruiting|Phase 2|94|Anticipated|UNICANCER||1|||f||||t||||||||||2017-10-11 03:47:03.254433|2017-10-11 03:47:03.254433
NCT01442649|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2016-06-17|||December 2010||2010-12-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab|Phase II, Multicentric Randomized Trial, Evaluating the Efficacy of Fluoropyrimidine-based Standard Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab|Active, not recruiting||Phase 2|132|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-11 03:47:03.480018|2017-10-11 03:47:03.480018
NCT01442636|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-03-06|||July 2011||2011-07-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|DESTINY 2||Drug Eluting Stents In The Critically Ischemic Lower Leg 2|a Prospective, Multicenter, Controlled Trial Evaluating the Implant of a Drug Eluting Stent (XIENCE PRIME, Abbott Vascular) in the Critically Ischemic Lower Leg|Completed||Phase 2/Phase 3|60|Actual|Flanders Medical Research Program||1|||f||||t||||||||||2017-10-11 03:47:03.612938|2017-10-11 03:47:03.612938
NCT01442610|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2016-01-20|||October 2011||2011-10-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|RaSPar||Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease|Effects of Rasagiline on Sleep Disturbances in PD: A Single Center, Randomized, Double-blind, Placebo run-in, Polysomnographic Clinical Phase IV Trial|Completed||Phase 4|30|Actual|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 03:47:03.833322|2017-10-11 03:47:03.833322
NCT01442597|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-01-26|||January 2012||2012-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|Man VS Machine||Computer Based Training in Cognitive Behavioral Therapy Web-based|Computer Based Training in Cognitive Behavioral Therapy Web-based|Active, not recruiting||Phase 1|180|Anticipated|Yale University||3|||f||||t||||||||||2017-10-11 03:47:03.944158|2017-10-11 03:47:03.944158
NCT01442584|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-09-27|||July 2011||2011-07-01|July 2011|2011-07-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|ovatrspl||Transplantation of Ovarian Cortex to Restore Fertility|Transplantation of Ovarian Cortex to Restore Fertility|Unknown status|Recruiting|N/A|5|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 03:47:04.058319|2017-10-11 03:47:04.058319
NCT01442571|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2011-09-27||||||August 2011|2011-08-01||||||||Interventional|||Hyaluronic Acid Injection Post Arthroscopy - Does it Improve Immediate Function? Double Blind Controlled Prospective Study||Unknown status|Not yet recruiting|Phase 1/Phase 2|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 03:47:04.167338|2017-10-11 03:47:04.167338
NCT01442558|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-01-20|||December 2011||2011-12-01|September 2011|2011-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Comparison of Quality of Supraclavicular, Infraclavicular and Axillary Approach of Ultrasound-guided Brachial Plexus Block||Completed||N/A|101|Actual|Hillel Yaffe Medical Center||3|||f||||t||||||||||2017-10-11 03:47:04.250604|2017-10-11 03:47:04.250604
NCT01441661|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2013-03-15|||November 2007||2007-11-01|September 2007|2007-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma|Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma: a Multicenter, Non-interventional, Retrospective Survey|Completed||N/A|400|Actual|Cancer Foundation, China|||1||f||||t||||||||||2017-10-11 03:47:24.997094|2017-10-11 03:47:24.997094
NCT01442545|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2013-03-12|||August 2011||2011-08-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|||||Interventional|||A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants|A Study to Investigate the Effect of Multiple Doses of JNJ 39758979 on Methotrexate Pharmacokinetics in Rheumatoid Arthritis Patients on a Stable Methotrexate Dose|Completed||Phase 1|21|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 03:47:04.325639|2017-10-11 03:47:04.325639
NCT01442532|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2013-03-01|||September 2011||2011-09-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam|A Double-Blind, Randomized, Single- and Multiple-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Healthy Adult Male Subjects and an Open-Label Drug-Drug Interaction Study to Evaluate the Effect of JNJ-38518168 on the Pharmacokinetics of Midazolam, a CYP3A4 Substrate|Completed||Phase 1|94|Actual|Janssen Research & Development, LLC||5|||||||f||||||||||2017-10-11 03:47:04.419226|2017-10-11 03:47:04.419226
NCT01442519|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-09-27|||January 1994||1994-01-01|September 2011|2011-09-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|BCG/EMDA-MMC||Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer|Sequential Bacillus Calmette-Guérin and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin Alone for High Risk Superficial Bladder Cancer: a Prospective Randomised Study|Completed||Phase 3|212|Actual|University of Rome Tor Vergata||2|||f||||t||||||||||2017-10-11 03:47:04.521125|2017-10-11 03:47:04.521125
NCT01442506|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-09-27|||April 2009||2009-04-01|September 2011|2011-09-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Acetic Acid Guided Biopsies Compared With High Definition Endoscopy in the Detection of Barrett`s Esophagus|Acetic Acid Guided Biopsies Compared With High Definition Endoscopy|Unknown status|Recruiting|N/A|100|Anticipated|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-11 03:47:04.620437|2017-10-11 03:47:04.620437
NCT01442493|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2017-06-29|2017-02-01||September 2011||2011-09-01|June 2017|2017-06-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Interventional|||Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment|Reengineering Methadone Treatment: A Randomized Clinical Trial|Completed||N/A|300|Actual|Friends Research Institute, Inc.||2|||f||||t||||||||No||2017-10-11 03:47:04.719795|2017-10-11 03:47:04.719795
NCT01442480|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-09-27|||June 2009||2009-06-01|September 2011|2011-09-01||||August 2010|Actual|2010-08-01||Interventional|||Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles||Completed||N/A|29|Actual|Environmental Protection Agency (EPA)||2|||f||||||||||||||2017-10-11 03:47:05.39769|2017-10-11 03:47:05.39769
NCT01442467|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-03-28|||June 2011||2011-06-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Study of Echocardiogram Accuracy in Patients With Mitral Valve Calcification|Correlation Between Echocardiographic Indices of Diastolic Function (E/E`) and Left Ventricular End Diastolic Pressure (LVEDP) in Patients With Mitral Annular Calcification|Terminated||N/A|4|Actual|Creighton University|||2|Subject accrual too difficult|f||||f||||||||||2017-10-11 03:47:05.473125|2017-10-11 03:47:05.473125
NCT01442454|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-02-29|||October 2010||2010-10-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis|Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis: A Prospective Correlation With Intraoperative Findings and Surgical Pathology|Terminated||N/A|100|Actual|Indiana University|||1|"The PI left and then the PI who would be taking over has left. No other investigator wanted to   take the study since not sponsored"|f||||f||||||||||2017-10-11 03:47:05.548813|2017-10-11 03:47:05.548813
NCT01442441|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-09-03|||February 2009||2009-02-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Correlation of Chronic Pancreatitis Pathology Features With Endoscopic Ultrasound (EUS) Criteria|How Pathologic Features of Chronic Pancreatitis Corelate With Endoscopic Ultrasound (EUS) Criteria for Diagnosing Chronic Pancreatitis|Completed||N/A|400|Anticipated|Indiana University|||1||f||||f||||||||||2017-10-11 03:47:05.615966|2017-10-11 03:47:05.615966
NCT01442428|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-11-20|||January 2014||2014-01-01|November 2013|2013-11-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial|Randomized Controlled Trial for Corticosteroids Versus NSAIDs With or Without Adjunctive Atorvastatin for the Treatment for Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome|Withdrawn||Phase 2/Phase 3|0|Actual|University of Minnesota - Clinical and Translational Science Institute||4||"2011 Thailand flooding led to loss of GMP pharmacy, project delays, and further regulatory   challenges."|f||||t||||||||||2017-10-11 03:47:05.683749|2017-10-11 03:47:05.683749
NCT01442415|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2012-10-22|||October 2011||2011-10-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Vikings Fitness Playbook: A Family Based Lifestyle Modification Program for Overweight and Obese Youth|Vikings Fitness Playbook: A Family Based Lifestyle Modification Program for Overweight and Obese Youth|Terminated||N/A|10|Actual|University of Minnesota - Clinical and Translational Science Institute||1||Unable to achieve enrollment goal.|f||||t||||||||||2017-10-11 03:47:05.81541|2017-10-11 03:47:05.81541
NCT01442402|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2013-02-14|||June 2011||2011-06-01|February 2013|2013-02-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||APOL1 Gene Variants in African American Kidney Transplant Recipients|Impact of APOL1 Gene Variants in African American Kidney Transplant Recipients: A Study of Clinical Outcomes and Molecular Mechanisms|Unknown status|Recruiting|N/A|190|Anticipated|Brigham and Women's Hospital|||2||f||||f||||||Samples With DNA|"     Aims 1 and 2:      Subjects will collect a saliva specimen in an Oragene®•DNA sample collection kit for     genotyping. We will also collected any discarded (no longer utilized for clinical purposes)     tissue from biopsies.      Aim 3:      Prior to transplant, subjects will collect saliva in an Oragene®•DNA sample collection kit     for genotyping and 10cc of blood will be drawn into a Na heparin collection tube for APOL1     protein analysis. When applicable, plasmapheresis effluent will be collected. We will also     collected any discarded (no longer utilized for clinical purposes)tissue from biopsies.   "|||2017-10-11 03:47:05.910753|2017-10-11 03:47:05.910753
NCT01442389|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2012-08-24|||October 2011||2011-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:47:05.996634|2017-10-11 03:47:05.996634
NCT01442376|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-08-04|2014-06-27|2013-04-05|September 2011||2011-09-01|August 2014|2014-08-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional||Full Analysis Set (FAS) population which included all randomized patients receiving the active study drug and HEC or MEC. Following the intent-to-treat principle, patients were assigned to the study treatment group according to the randomized treatment.|Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients|A Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Different Doses of Palonosetron Compared to Ondansetron in the Prevention of CINV in Pediatric Patients Undergoing Single and Repeated Cycles of MEC or HEC|Completed||Phase 3|502|Actual|Helsinn Healthcare SA||3|||f||||t||||||||||2017-10-11 03:47:06.072221|2017-10-11 03:47:06.072221
NCT01442363|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2015-01-26|||November 2011||2011-11-01|January 2015|2015-01-01||||October 2012|Actual|2012-10-01||Interventional|||A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease||Terminated||Phase 2|8|Actual|Braintree Laboratories||3|||f||||f||||||||||2017-10-11 03:47:07.549691|2017-10-11 03:47:07.549691
NCT01442350|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-09-27|||October 2011||2011-10-01|September 2011|2011-09-01|April 2013|Anticipated|2013-04-01|February 2013|Anticipated|2013-02-01||Observational|FAMY||Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers|Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers|Unknown status|Not yet recruiting|N/A|120|Anticipated|Hospital Universitario Virgen de la Arrixaca|||1||f||||t||||||Samples With DNA|"     Genotyping of relatives of mutation-known Fabry probands: in order to know which are the     relatives carrying mutations. (The investigators have already started this task).   "|||2017-10-11 03:47:07.685209|2017-10-11 03:47:07.685209
NCT01442337|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-06-17||2014-06-17|December 2011||2011-12-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients|A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients|Terminated||Phase 2/Phase 3|21|Actual|Astellas Pharma Inc||4||Study was terminated by sponsor decision|f||||t||||||||||2017-10-11 03:47:07.75236|2017-10-11 03:47:07.75236
NCT01442324|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2012-07-17|||February 2011||2011-02-01|July 2012|2012-07-01||||September 2012|Anticipated|2012-09-01||Interventional|||Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma|Studio Clinico Pilota Con Uso di Elettroporazione Irreversibile (IRE) Nel Trattamento di Lesioni Neoplastiche Epatiche Con Localizzazione ad accessibilità Limitata o ad Alto Rischio|Unknown status|Recruiting|N/A|5|Anticipated|Azienda Ospedaliera di Padova||1|||f||||t||||||||||2017-10-11 03:47:07.878217|2017-10-11 03:47:07.878217
NCT01442311|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2015-06-25|||October 2007||2007-10-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Directly Observed Hepatitis C Treatment in Methadone Clinics|Directly Observed Hepatitis C Treatment in Methadone Clinics|Completed||N/A|80|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 03:47:07.976574|2017-10-11 03:47:07.976574
NCT01442298|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-27|||October 2008||2008-10-01|September 2011|2011-09-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|||A Comparison Between an Individual Low Tourniquet Pressure Versus a Standard Pressure During Total Knee Arthroplasty|A Comparison Between an Individual Low Tourniquet Pressure Versus a Standard Pressure During Total Knee Arthroplasty. A Randomized Controlled Study|Completed||N/A|164|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 03:47:08.170517|2017-10-11 03:47:08.170517
NCT01442285|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-16|2015-04-08|||April 2011||2011-04-01|April 2014|2014-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|MHADRO||The Mental Health and Dynamic Referral for Oncology Protocol (MHADRO)|The Mental Health and Dynamic Referral for Oncology Protocol (MHADRO)|Completed||N/A|1000|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-10-11 03:47:08.261009|2017-10-11 03:47:08.261009
NCT01442272|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-05-18|||January 2012||2012-01-01|September 2011|2011-09-01|October 2013|Anticipated|2013-10-01|October 2012|Anticipated|2012-10-01||Interventional|NEFROVID2010||Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D|Clinical Trial, Open, Parallel Groups , Value the Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D|Unknown status|Recruiting|Phase 4|174|Anticipated|Hospital Universitario de Canarias||3|||f||||t||||||||||2017-10-11 03:47:08.361836|2017-10-11 03:47:08.361836
NCT01442259|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-02-28|||January 2011||2011-01-01|February 2017|2017-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects|An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Mild, Moderate or Severe Renal Impairment Compared to Age, Sex, and Body Weight-matched Healthy Subjects|Completed||Phase 1|48|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:47:08.486696|2017-10-11 03:47:08.486696
NCT01442246|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2016-06-20|||July 2011||2011-07-01|June 2016|2016-06-01|January 2023|Anticipated|2023-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.|Phase III Randomised Trial to Evaluate the Benefit of Adjuvant Hormonal Treatment With Leuprorelin Acetate (Eligard® 45 mg) for 24 Months After Radical Prostatectomy in Patients With High Risk of Recurrence.|Recruiting||Phase 3|700|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-11 03:47:08.602703|2017-10-11 03:47:08.602703
NCT01442233|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-04-05|||March 2012|Actual|2012-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PLASMASEP||Plasma Exchanges in Multiple Sclerosis (MS) Relapses|Randomized Clinical Trial of Plasma Exchanges Versus Sham Plasma Exchanges in Disabling Multiple Sclerosis Acute Relapses Refractory to Steroid Treatment|Recruiting||Phase 3|80|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 03:47:08.86414|2017-10-11 03:47:08.86414
NCT01442220|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-09-27|||September 2011||2011-09-01|September 2011|2011-09-01|July 2014|Anticipated|2014-07-01|June 2013|Anticipated|2013-06-01||Observational|||Genome-wide Association Study of Pituitary Tumors|Genome-wide Association Study of Pituitary Tumors|Unknown status|Recruiting|N/A|12500|Anticipated|Huashan Hospital|||1||f||||t||||||Samples With DNA|"     DNA samples   "|||2017-10-11 03:47:09.018917|2017-10-11 03:47:09.018917
NCT01442207|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-12-17|||March 2012||2012-03-01|December 2014|2014-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Cerclage for Prevention on Preterm Birth in Women With Placenta Previa|Cerclage Placement for the Prevention of Preterm Birth in Women With Placenta Previa - A Multicenter Randomized Controlled Trial|Withdrawn||Phase 3|0|Actual|Mednax Center for Research, Education and Quality||2||Lack of randomized participants|f||||t||||||||||2017-10-11 03:47:09.102581|2017-10-11 03:47:09.102581
NCT01442194|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2017-03-03|||August 1, 2011|Actual|2011-08-01|March 2017|2017-03-01|November 28, 2022|Anticipated|2022-11-28|November 28, 2022|Anticipated|2022-11-28||Observational|PASSAGE||Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies|Long-term, Prospective,Multinational, Parallel-cohort Study Monitoring Safety in Patients With MS Newly Started With Fingolimod Once Daily or Treated With Another Approved Disease-modifying Therapy|Recruiting||N/A|3600|Anticipated|Novartis|||2||f||||||||||||||2017-10-11 03:47:09.241925|2017-10-11 03:47:09.241925
NCT01442181|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-05|2015-07-17|2015-02-24||March 2010||2010-03-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|||Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation|Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation|Completed||N/A|25|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 03:47:09.882297|2017-10-11 03:47:09.882297
NCT01442168|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2014-08-18|||September 2011||2011-09-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|||Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria|A Phase I/II, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study of Sevuparin/DF02, as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria|Terminated||Phase 1/Phase 2|53|Actual|Modus Therapeutics AB||2|||f||||t||||||||||2017-10-11 03:47:10.459831|2017-10-11 03:47:10.459831
NCT01442155|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-05-26|2016-05-26||October 2011||2011-10-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer|An Open Label Study of the Effect of Adjuvant Treatment With Capecitabine in Combination With Oxaliplatin on Disease-Free Survival in Patients With Stage III Colon Cancer|Completed||N/A|74|Actual|Hoffmann-La Roche|||1||f||||t||||||||||2017-10-11 03:47:10.544411|2017-10-11 03:47:10.544411
NCT01442142|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-09-05|||May 2008||2008-05-01|September 2017|2017-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|ROC||A Study to Determine the Effectiveness of a Self-regulation Program to Treat Pediatric Obesity|Self-Regulation Treatment for Pediatric Obesity|Completed||N/A|236|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||||2017-10-11 03:47:10.741796|2017-10-11 03:47:10.741796
NCT01442129|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2015-04-10|2014-10-07||April 2012||2012-04-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01||Interventional||Patients with end-stage heart failure, either ischemic or non-ischemic etiology, who are being evaluated for LVAD implantation as a bridge-to-transplant (BTT) or destination therapy (DT)|The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation|LVAD Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function|Completed||Phase 2|30|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 03:47:10.832057|2017-10-11 03:47:10.832057
NCT01442116|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2011-09-28|||June 2009||2009-06-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension|Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension|Completed||N/A|60|Actual|Mustafa Kemal University||1|||f||||||||||||||2017-10-11 03:47:11.59927|2017-10-11 03:47:11.59927
NCT01442103|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2016-03-15|2013-07-01||September 2011||2011-09-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Clinical Utility of a New Silver Gel for Use on Chronic Wounds|Open, Non Comparative, Single Center Investigation Exploring the Clinical Utility of a New Silver Gel for Use on Chronic Wounds|Completed||N/A|10|Actual|Molnlycke Health Care AB|Small study population, 2 patients lost to follow-up.|1|||f||||f||||||||||2017-10-11 03:47:11.675398|2017-10-11 03:47:11.675398
NCT01442090|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-08-08||2016-08-08|October 2011||2011-10-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|May 2013|Actual|2013-05-01||Interventional|||Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy|A Phase II, Open-Label, Randomized Study of GDC-0980 Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following VEGF-Targeted Therapy|Completed||Phase 2|85|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:47:11.891243|2017-10-11 03:47:11.891243
NCT01442077|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-01-17|||November 2011||2011-11-01|January 2012|2012-01-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||Low Intensity Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction- 4 Arms|Low Intensity Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction- 4 Arms|Unknown status|Recruiting|Phase 3|200|Anticipated|Rambam Health Care Campus||4|||f||||f||||||||||2017-10-11 03:47:12.037637|2017-10-11 03:47:12.037637
NCT01442064|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-12-05|2011-12-05||July 2008||2008-07-01|December 2011|2011-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)|An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) or Macular Edema Secondary to Retinal Vein Occlusion (RVO) Who Have Completed a Genentech-Sponsored Ranibizumab Study|Completed||N/A|608|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:47:12.20043|2017-10-11 03:47:12.20043
NCT01442051|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2016-12-20|||September 2011||2011-09-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer|A Pilot Study of Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer|Recruiting||N/A|56|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:47:15.391629|2017-10-11 03:47:15.391629
NCT00000234|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-05-05||||||December 2002|2002-12-01||||||||Interventional|||Alternate Day Buprenorphine Administration, Phase XI - 16|Alternate Day Buprenorphine Administration, Phase XI|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-10-11 04:17:41.150761|2017-10-11 04:17:41.150761
NCT01442038|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2016-06-06|2016-02-09||October 2011||2011-10-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|RIVER-PCI|Safety Analysis Set: participant who were randomized and received at least one dose of study drug|Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization|Completed||Phase 3|2651|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 03:47:15.583552|2017-10-11 03:47:15.583552
NCT01442025|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-08-10|||June 2012||2012-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|TAILORIX||Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease|A Randomized Controlled Trial Investigating Tailored Treatment With Infliximab for Active Luminal Crohn's Disease|Completed||Phase 4|121|Actual|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||3|||f||||t||||||||||2017-10-11 03:47:20.172376|2017-10-11 03:47:20.172376
NCT01442012|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-10-02|||September 2011||2011-09-01|October 2012|2012-10-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|PUCTURE-NVPO||Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery|Randomized Clinical Trial to Evaluate the Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting (PONV) in Ambulatory Surgery|Unknown status|Recruiting|N/A|270|Anticipated|Group G-6||2|||f||||f||||||||||2017-10-11 03:47:20.302594|2017-10-11 03:47:20.302594
NCT01441999|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-08-09|||October 2011||2011-10-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|December 2016|Anticipated|2016-12-01||Interventional|PJK||Proximal Junctional Kyphosis Following Long Instrumented Spinal Fusion: The Effect of Implant Selection|Proximal Junctional Kyphosis Following Long Instrumented Spinal Fusion: The Effect of Implant Selection|Recruiting||Phase 4|24|Anticipated|Globus Medical Inc||2|||f||||f||||||||||2017-10-11 03:47:20.404888|2017-10-11 03:47:20.404888
NCT01441986|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2012-07-11|||September 2011||2011-09-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|DXM/AMT||Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects|A Phase IIa, Double-blind, Placebo-controlled, Randomised, Fourfold Crossover Study to Investigate the Glucose Lowering Effects of Dextromethorphan and Amantadine in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test|Completed||Phase 2|20|Actual|Profil Institut für Stoffwechselforschung GmbH||1|||f||||t||||||||||2017-10-11 03:47:20.530682|2017-10-11 03:47:20.530682
NCT01441973|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-27|2017-07-05|2015-12-22|2015-09-23|December 28, 2011|Actual|2011-12-28|July 2017|2017-07-01|January 17, 2017|Actual|2017-01-17|May 30, 2014|Actual|2014-05-30||Interventional||All participants who received at least 1 dose of study medication|Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma|A Phase 2 Biomarker Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) Monotherapy to Assess the Association Between NK Cell Status and Efficacy in High Risk Smoldering Myeloma|Completed||Phase 2|41|Actual|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-11 03:47:20.650204|2017-10-11 03:47:20.650204
NCT01441960|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-06-01|2015-04-09||May 2011||2011-05-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|July 2013|Actual|2013-07-01||Interventional|||Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)|Optimal Control of Muscle Strength for Electroconvulsive Therapy: A Comparison of Succinylcholine Versus Rocuronium-induced Neuromuscular Blockade|Completed||N/A|45|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:47:21.48796|2017-10-11 03:47:21.48796
NCT01441947|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-07-25|||October 2011||2011-10-01|July 2017|2017-07-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Interventional|||Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer|A Phase II Trial of Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer With Involvement of Bone|Active, not recruiting||Phase 2|68|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:47:21.793904|2017-10-11 03:47:21.793904
NCT01441934|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2013-02-01|||October 2010||2010-10-01|February 2013|2013-02-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|SPHERIC-1||SPHERIC-1. Sildenafil and Pulmonary HypERtension In COPD|A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of Sildenafil in the Treatment of Patients With Pulmonary Hypertension Associated to Chronic Obstructive Lung Disease|Unknown status|Recruiting|Phase 3|32|Anticipated|Italian Association of Hospital Pneumologists||2|||f||||t||||||||||2017-10-11 03:47:22.065869|2017-10-11 03:47:22.065869
NCT01441921|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-26|||September 2011||2011-09-01|September 2011|2011-09-01|September 2013|Anticipated|2013-09-01|March 2013|Anticipated|2013-03-01||Interventional|EPIRDEM||Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes Mellitus|Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes Mellitus|Unknown status|Recruiting|N/A|50|Anticipated|Institut Investigacio Sanitaria Pere Virgili||2|||f||||f||||||||||2017-10-11 03:47:22.195789|2017-10-11 03:47:22.195789
NCT01441908|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-04-13|||June 2011||2011-06-01|April 2012|2012-04-01|April 2012|Anticipated|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Longitudinal Study of Multi-Analyte Profile for Dyslipidemia|Determining Cardiovascular Health Using a Multi-Analyte Profile in a Longitudinal Study of a Statin Intervention for Dyslipidemia|Unknown status|Active, not recruiting|N/A|40|Anticipated|MaiHealth Inc||2|||f||||f||||||||||2017-10-11 03:47:22.293007|2017-10-11 03:47:22.293007
NCT01441895|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-04-22|||September 2011||2011-09-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Corneal Sensation and Incidence of Dry Eye Post Refractive Cataract Extraction With FemtoSecond Laser|A Post Market Pilot Study To Evaluate Corneal Sensation And The Incidence Of Dry Eye In Subjects Undergoing Refractive Cataract Extraction With The Femtosecond Laser For Arcuate Relaxing Incisions|Recruiting||N/A|40|Anticipated|Ophthalmic Consultants of Long Island|||1||f||||f||||||||||2017-10-11 03:47:22.379276|2017-10-11 03:47:22.379276
NCT01441648|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2014-01-17|||December 2011||2011-12-01|December 2011|2011-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Influence of Cosmetic Color Tinted Contact Lenses on the Ocular Surface|Influence of Cosmetic Color Tinted Contact Lenses on the Ocular Surface|Completed||N/A|14|Actual|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|||1||f||||f||||||||||2017-10-11 03:47:25.102798|2017-10-11 03:47:25.102798
NCT01441869|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2012-02-07|||October 2011||2011-10-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc|Bioequivalence Study of the Fixed-dose Combination of Saxagliptin/Metformin XR Tablets Relative to Saxagliptin (Onglyza� ) Tablets and Australia-sourced Diabex XR Tablets Coadministered to Healthy Subjects in the Fed State During Steady-state Administration|Completed||Phase 1|28|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 03:47:22.568713|2017-10-11 03:47:22.568713
NCT01441856|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2017-03-21|||October 2013|Actual|2013-10-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||The ORANGE II PLUS - Trial: Open Versus Laparoscopic Hemihepatectomy|The ORANGE II PLUS - Trial: an International Multicenter Randomized Controlled Trial of Open Versus Laparoscopic Hemihepatectomies.|Recruiting||N/A|250|Anticipated|Maastricht University Medical Center||3|||f||||t||||||||No||2017-10-11 03:47:22.68724|2017-10-11 03:47:22.68724
NCT01441843|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2016-03-01|2013-08-29||October 2010||2010-10-01|March 2016|2016-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||In retrospect, two patients in the lorazepam group should not have been included due to an administrative error. Data for these two patients were, therefore, excluded from analysis.|Resistance Under the Microscope|Resistance Under the Microscope; a Randomized Placebo Controlled Parallel Group Design|Completed||Phase 4|400|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-10-11 03:47:22.89693|2017-10-11 03:47:22.89693
NCT01441830|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-12-17|||September 2011||2011-09-01|December 2014|2014-12-01||||May 2015|Anticipated|2015-05-01||Interventional|||Radial Extracorporeal Shock Wave Therapy (rESWT) Treatment of Subacromial Shoulder Pain|Treatment of Subacromial Shoulder Pain|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 03:47:23.225027|2017-10-11 03:47:23.225027
NCT01441817|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2011-09-27|||May 2002||2002-05-01|September 2011|2011-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Non--operative Treatment of the Medial Malleolus in bi- and Trimalleolar Ankle Fractures|Non--operative Treatment of the Medial Malleolus in bi- and Trimalleolar Ankle Fractures. A Randomized Controlled Trial|Completed||N/A|100|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 03:47:23.363246|2017-10-11 03:47:23.363246
NCT01441804|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2013-09-28|||May 2011||2011-05-01|September 2013|2013-09-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01||Interventional|||A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism||Unknown status|Recruiting|Phase 3|200|Anticipated|Third Affiliated Hospital, Sun Yat-Sen University||2|||f||||f||||||||||2017-10-11 03:47:23.473475|2017-10-11 03:47:23.473475
NCT01441791|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2014-12-07|||February 2011||2011-02-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|PROVHILO||PROVHILO:Protective Ventilation During General Anesthesia for Open Abdominal Surgery|Protective Ventilation During General Anesthesia for Open Abdominal Surgery - a Randomized Controlled Trial|Completed||N/A|900|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 03:47:23.609369|2017-10-11 03:47:23.609369
NCT01441778|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-09-27|||June 2010||2010-06-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy of Buffered Hypertonic Saline(BHS)Nasal Irrigation in Allergic Rhinitis (AR) Children|Efficacy of Buffered Hypertonic Saline Nasal Irrigation in Children With Symptomatic Allergic Rhinitis : A Randomized Double-blind Study.|Completed||Phase 2|81|Actual|Thammasat University||2|||f||||f||||||||||2017-10-11 03:47:23.810288|2017-10-11 03:47:23.810288
NCT01441765|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2016-12-15|2016-07-28||November 2011||2011-11-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine|Phase II Study of PD-1 Blockade Alone or In Conjunction With the Dendritic Cell (DC)/Renal Cell Carcinoma (RCC) Fusion Cell Vaccination|Terminated||Phase 2|11|Actual|Dana-Farber Cancer Institute|Due to lack of funding, the study was terminated early without completing enrollment.|2||Funding|f||||t||||||||||2017-10-11 03:47:23.942783|2017-10-11 03:47:23.942783
NCT01441752|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-06-23|||November 2011||2011-11-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients|State Administration of Traditional Chinese Medicine of Shanghai|Completed||Phase 3|349|Actual|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 03:47:24.471542|2017-10-11 03:47:24.471542
NCT01441739|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2013-12-17|||September 2004||2004-09-01|December 2013|2013-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Intestinal Failure in Necrotising Enterocolitis|Intestinal Failure in Necrotising Enterocolitis|Unknown status|Recruiting|N/A|300|Anticipated|Maastricht University Medical Center|||3||f||||||||||||||2017-10-11 03:47:24.560649|2017-10-11 03:47:24.560649
NCT01441726|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-03-30|||September 2012||2012-09-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Palliative and End-of-life Care in Advanced Dementia: Evaluation of a Program of Organization of Care in Long-term Care|Palliative and End-of-life Care in Advanced Dementia: Evaluation of a Program of Organization of Care in Long-term Care Settings|Completed||N/A|175|Actual|Laval University|||2||f||||f||||||||||2017-10-11 03:47:24.627995|2017-10-11 03:47:24.627995
NCT01441713|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2012-12-04|||September 2011||2011-09-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|||Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer|Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer|Completed||N/A|178|Actual|Copenhagen University Hospital at Herlev|||2||f||||f||||||||||2017-10-11 03:47:24.68775|2017-10-11 03:47:24.68775
NCT01441687|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-06-22|||December 4, 2009|Actual|2009-12-04|June 2017|2017-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome|Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome|Active, not recruiting||N/A|260|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 03:47:24.830414|2017-10-11 03:47:24.830414
NCT01441635|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-11-25||2014-11-25|September 2011||2011-09-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids|Phase 2a Proof Of Concept Study to Evaluate the Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids|Completed||Phase 2|271|Actual|AbbVie||11|||f||||f||||||||||2017-10-11 03:47:25.312954|2017-10-11 03:47:25.312954
NCT01441622|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-06-27|||June 2011||2011-06-01|June 2014|2014-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|AL539||Evaluation of a New Medical Device AL539 in Patients With Obstructive Apneas Sleep Syndrome|In-hospital Assessment of the New Medical Device AL539 Developed for the Home Monitoring of Continuous Positive Airway Pressure (CPAP) Treatment in Patients With Obstructive Sleep Apnea Syndrome by Comparison With Respiratory Polygraphy|Completed||N/A|20|Actual|Air Liquide Santé International||1|||f||||f||||||||||2017-10-11 03:47:25.607427|2017-10-11 03:47:25.607427
NCT01441609|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2011-09-27|||August 2011||2011-08-01|September 2011|2011-09-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Observational|||Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination|Effect of the Expression Level of Th9 Cells and IL-9 In Poor/Non-responsiveness to Hepatitis B Vaccination|Unknown status|Recruiting|N/A|94|Anticipated|Beijing Municipal Science & Technology Commission|||4||f||||t||||||||||2017-10-11 03:47:25.69911|2017-10-11 03:47:25.69911
NCT01441596|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2015-08-25|2015-02-10||October 2011||2011-10-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional||Randomised Set (RS): includes all randomised patients, whether treated or not.|Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases|Lux-Breast 3; Randomised Phase II Study of Afatinib Alone or in Combination With Vinorelbine Versus Investigator's Choice of Treatment in Patients With HER2 Positive Breast Cancer With Progressive Brain Metastases After Trastuzumab and/or Lapatinib Based Therapy|Completed||Phase 2|121|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:47:25.811448|2017-10-11 03:47:25.811448
NCT01441583|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2013-07-16|||October 2011||2011-10-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|June 2012|Actual|2012-06-01||Interventional|IVORY||Ingenio Device Algorithm Study|Ingenio Device Algorithm Study|Completed||N/A|139|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-10-11 03:47:26.98646|2017-10-11 03:47:26.98646
NCT01441570|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2017-03-09|2016-10-31||February 2012||2012-02-01|March 2017|2017-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Impact of Nebivolol Versus Metoprolol on Quality of Life|The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients|Terminated||N/A|11|Actual|Brigham and Women's Hospital||2||due to slow enrollment|f||||f||||||||||2017-10-11 03:47:27.123458|2017-10-11 03:47:27.123458
NCT01441557|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-04-27|||September 2011||2011-09-01|April 2016|2016-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism|Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism|Completed||Phase 2/Phase 3|3|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||||||||||||2017-10-11 03:47:27.459333|2017-10-11 03:47:27.459333
NCT01441544|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2017-07-14|||September 2011|Actual|2011-09-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Effect of Variety on Physical Activity|The Effect of Variety on Physical Activity|Completed||N/A|32|Actual|University of Tennessee||2|||f||||f||||||||||2017-10-11 03:47:27.522171|2017-10-11 03:47:27.522171
NCT01441531|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-03-13|||January 2012||2012-01-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension|Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension During Orif of Tibia Fracture Under General Anesthesia|Withdrawn||Early Phase 1|0|Actual|Baylor College of Medicine||2||Unable to recruit patient due to surgical case type. Not worth continuing study.|f||||f||||||||||2017-10-11 03:47:27.604316|2017-10-11 03:47:27.604316
NCT01441518|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2015-07-07|||May 2010||2010-05-01|September 2011|2011-09-01|November 2013|Actual|2013-11-01|January 2013|Actual|2013-01-01||Interventional|||Home Versus Hospital Care in Glucose Monitoring of Gestational Diabetes and Mild Gestational Hyperglycemia|A Prospective Randomized Trial of Home Versus Hospital Care in Glucose Monitoring of Gestational Diabetes and Mild Gestational Hyperglycemia|Completed||Phase 2|80|Actual|UPECLIN HC FM Botucatu Unesp||2|||f||||||||||||||2017-10-11 03:47:27.687081|2017-10-11 03:47:27.687081
NCT01441505|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2013-02-20|||September 2011||2011-09-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Study of Ketamine as an Antidepressant|A Study of Ketamine as an Antidepressant|Unknown status|Recruiting|Phase 2|42|Anticipated|The University of New South Wales||1|||f||||f||||||||||2017-10-11 03:47:27.91796|2017-10-11 03:47:27.91796
NCT01441492|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-08-21|||September 2011||2011-09-01|August 2017|2017-08-01|July 25, 2017|Actual|2017-07-25|September 2016|Actual|2016-09-01||Interventional|||Pancreas Resection With and Without Drains|A Randomized Prospective Multicenter Trial of Pancreas Resection With and Without Routine Intraperitoneal Drainage|Completed||N/A|398|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 03:47:28.000376|2017-10-11 03:47:28.000376
NCT01441479|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2013-02-05|||June 2011||2011-06-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Strep A Fluorescent Immunoassay and Analyzer Field Study|Strep A Fluorescent Immunoassay and Analyzer Field Study|Completed||N/A|1282|Actual|Quidel Corporation|||1||f||||f||||||||||2017-10-11 03:47:28.142413|2017-10-11 03:47:28.142413
NCT01441466|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-01-02|2013-10-22||November 2011||2011-11-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Observational|||Cohort Isolation and Cross-infection in Bronchiolitis|Cross-infection in Children Hospitalized for Bronchiolitis: Incidence, Symptoms en Effect of Cohort Isolation|Completed||N/A|48|Actual|Princess Amalia Children's Clinic|||2||f||||f||||||Samples Without DNA|"     sputum   "|Undecided||2017-10-11 03:47:28.23883|2017-10-11 03:47:28.23883
NCT01441453|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2011-09-26||||||September 2011|2011-09-01||||||||Interventional|||Transient Elastography in Hepatectomy for Hepatocellular Carcinoma|Value of Transient Elastography in Predicting Postoperative Liver Failure in Patients Undergoing Liver Resection for Hepatocellular Carcinoma.|Unknown status|Not yet recruiting|N/A|120|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||f||||||||||2017-10-11 03:47:28.639185|2017-10-11 03:47:28.639185
NCT01441440|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2015-03-02|2015-03-02||November 2011||2011-11-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)|A Randomized, Double-blind, Placebo Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Venlafaxine Er In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|538|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:47:28.787423|2017-10-11 03:47:28.787423
NCT01441427|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2011-09-26|||January 2010||2010-01-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|April 2011|Actual|2011-04-01||Interventional|||Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial||Completed||Phase 1/Phase 2|93|Actual|Ain Shams University||4|||f||||||||||||||2017-10-11 03:47:29.719842|2017-10-11 03:47:29.719842
NCT01441414|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-12-11|2015-03-27|2014-04-30|November 2011||2011-11-01|December 2015|2015-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||The full analysis (FA) set was the primary population for evaluating all safety and efficacy endpoints per the treatment randomization as well as participant characteristics.|PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma|A Phase II Trial Of PF-04856884 (CVX-060), A Selective Angiopoietin-2 (ANG-2) Inhibitor In Combination With AG-013736 (Axitinib) In Patients With Previously Treated Metastatic Renal Cell Carcinoma|Terminated||Phase 2|18|Actual|Pfizer|On 06 Nov 2012, based on Part I safety findings and due to strategic considerations, Pfizer decided not to open enrolment onto Part II of the study and terminated the study. For primary OM, AEs reported in ≥2 participants overall are presented.|2||See termination reason in detailed description.|f||||f||||||||||2017-10-11 03:47:29.887189|2017-10-11 03:47:29.887189
NCT01441401|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2016-08-15|2016-08-15||December 2011||2011-12-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|||Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)|Special Investigation Of Gabapen For Pediatric (Regulatory Post Marketing Commitment Plan)|Completed||N/A|82|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:47:31.698744|2017-10-11 03:47:31.698744
NCT01441388|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2011-12-19|||December 2011||2011-12-01|December 2011|2011-12-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.|A Phase 1B, Open-Label, Dose Escalation Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of Crizotinib (PF-02341066) Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.|Withdrawn||Phase 1|0|Actual|Pfizer||5||Business/Operational issues|f||||f||||||||||2017-10-11 03:47:32.230979|2017-10-11 03:47:32.230979
NCT01441375|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-10-17|||July 2011||2011-07-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Sickle Cell Disease: A Retrospective Chart Review|Complications in Patients With Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review|Completed||N/A|261|Actual|Novartis|||3||f||||||||||||||2017-10-11 03:47:32.329359|2017-10-11 03:47:32.329359
NCT01441362|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2012-02-16|||September 2011||2011-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Double-lumen Tube Intubation Technique to Reduce Laryngeal Injuries|A Comparison of Two Methods for Intubation With Double-lumen Endobronchial Tube to Reduce Laryngeal Injuries|Completed||N/A|154|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:47:32.406264|2017-10-11 03:47:32.406264
NCT01441349|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-08-24|||August 2011|Actual|2011-08-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer|A Randomized Phase II Study of Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer|Recruiting||Phase 2|192|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-10-11 03:47:32.487837|2017-10-11 03:47:32.487837
NCT01441336|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2017-01-06|||November 2008||2008-11-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2012|Actual|2012-07-01||Interventional|||Laparoscopic Gastrectomy for Advanced Gastric Cancer|Laparoscopic Gastrectomy for Advanced Gastric Cancer|Completed||Phase 2|204|Actual|Seoul National University Bundang Hospital||1|||f||||t||||||||No||2017-10-11 03:47:32.736914|2017-10-11 03:47:32.736914
NCT01441323|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-03-29|||June 2007||2007-06-01|March 2017|2017-03-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|STAND||Strength Training and Nutrition Development for African American Youth|USC Center for Transdisciplinary Research on Energetics and Cancer or Obesity-Related Metabolic Disease Risk: Response to Exercise in Minority Youth|Completed||N/A|62|Actual|University of Southern California||3|||f||||t||||||||No||2017-10-11 03:47:32.830586|2017-10-11 03:47:32.830586
NCT01441310|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2017-01-06|||July 2010||2010-07-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2013|Actual|2013-08-01||Interventional|SNNS||Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer|Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer|Completed||Phase 2|101|Actual|Seoul National University Bundang Hospital||1|||f||||t||||||||No||2017-10-11 03:47:32.945082|2017-10-11 03:47:32.945082
NCT01441297|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-08-24|||December 2011|Actual|2011-12-01|August 2017|2017-08-01|March 31, 2016|Actual|2016-03-31|October 31, 2015|Actual|2015-10-31||Interventional|||BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer|A Phase II Study Of BIBF 1120 as Second-line Treatment for Patients With Small Cell Lung Cancer|Completed||Phase 2|24|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-10-11 03:47:33.021776|2017-10-11 03:47:33.021776
NCT01441284|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-05-04|||December 2017|Anticipated|2017-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor|Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor: a Double-blind, Cross-over, Placebo-controlled Multicenter Study|Withdrawn||Phase 3|0|Actual|University of Pecs||2||Lack of financial support|f||||f|f|f||||||||2017-10-11 03:47:33.10814|2017-10-11 03:47:33.10814
NCT01441271|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-17|2015-04-29|||September 2012||2012-09-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|October 2012|Actual|2012-10-01||Interventional|||Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis|Diverting Loop Ileostomy and Colonic Lavage: An Alternative To Total Abdominal Colectomy For The Treatment Of Fulminant Clostridium Difficile Colitis. A Randomized Controlled Trial.|Terminated||N/A|1|Actual|Massachusetts General Hospital||2||Numer of eligible patients markedly decreased since the initiation of the study.|f||||t||||||||||2017-10-11 03:47:33.214199|2017-10-11 03:47:33.214199
NCT01441258|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-04-07|||October 2011||2011-10-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Adaptation of Dialectical Behavior Therapy Skills-Groups for Individuals With Suicidal Ideation and Depression|Adaptation of Dialectical Behavior Therapy Skills-Groups for Individuals With Suicidal Ideation and Depression|Completed||N/A|26|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:47:33.311576|2017-10-11 03:47:33.311576
NCT01441245|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-06-03|2015-01-26||April 2010|Actual|2010-04-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|June 2016|Actual|2016-06-01||Interventional|diurHF||Loop Diuretics Administration and Acute Heart Failure|Continuous Versus Intermittent Loop Diuretics Infusion Dosing in Acute Heart Failure: Effects on Renal Function, Outcome and BNP Levels|Active, not recruiting||Phase 4|57|Actual|University of Siena|Our study didn't explain the reasons of renal dysfunction during treatment. Concurrent evaluation of BUN could further clarify the primary defect.The multivariate analysis could be inadequate for small sample; we intend to continue enrollment.|2|||f||||t||||||||No||2017-10-11 03:47:33.434993|2017-10-11 03:47:33.434993
NCT01441232|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2012-01-26|||October 2011||2011-10-01|January 2012|2012-01-01||||November 2011|Actual|2011-11-01||Interventional|||A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics|A Phase 1, Open-label, 3-period, 3-treatment, Single Dose Crossover Study to Evaluate the Pharmacodynamic Effects of LX4211 When Administered Concurrently With JANUVIA® (Sitagliptin) in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|18|Actual|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-10-11 03:47:34.054953|2017-10-11 03:47:34.054953
NCT01441219|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-03-04|||January 2011||2011-01-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Evaluation the Performance of Given Diagnostic System in Detection of Bleeding Events in the Small Bowel|Evaluation the Performance of Given Diagnostic System in Detection of Bleeding Events in the Small Bowel: a Single-arm Prospective Cohort Study.|Terminated||Phase 2/Phase 3|6|Actual|Chinese University of Hong Kong||1||Results were obtained in another project.|f||||f||||||||||2017-10-11 03:47:34.163788|2017-10-11 03:47:34.163788
NCT01441206|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-09-13|||September 2011||2011-09-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants|Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants|Terminated||Phase 1|2|Actual|University of North Carolina, Chapel Hill||2||Study to be redesigned.|f||||t||||||||||2017-10-11 03:47:34.285399|2017-10-11 03:47:34.285399
NCT01441193|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-26|2016-03-03|||September 2011||2011-09-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)|A Phase I, Open Label, Safety and Immunogenicity Vaccine Trial Based on the Association of Recombinant HIV-1 Biologically Active Tat and V2-deleted Env Proteins in HIV Uninfected Healthy Adult Volunteers.|Terminated||Phase 1|11|Actual|Istituto Superiore di Sanità||4||"Enrollments were suspended due to delta-V2 Env unavailability, following the   EMA/CHMP/BWP/534898/2008 guideline, not allowing the use of a retest date"|f||||t||||||||||2017-10-11 03:47:34.41012|2017-10-11 03:47:34.41012
NCT01441180|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2014-09-25|2014-04-23||September 2011||2011-09-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|March 2013|Actual|2013-03-01||Interventional|||GS-7977 With Ribavirin for Hepatitis C (SPARE)|A Randomized Controlled Study To Assess Safety, Tolerability And Efficacy Of GS-7977 In Combination With Full or Low Dose RBV In HCV Genotype 1, Monoinfected Treatment Naive Participants|Completed||Phase 1/Phase 2|60|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-10-11 03:47:35.816021|2017-10-11 03:47:35.816021
NCT01441167|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-06-30|||September 14, 2011||2011-09-14|June 5, 2013|2013-06-05|June 5, 2013|Actual|2013-06-05|June 5, 2013|Actual|2013-06-05||Interventional|||Experimental PfSPZ Vaccine in Adults Without Malaria|VRC 312: A Phase 1, Open-Label, Dose-Escalation Clinical Trial With Experimental Challenge to Evaluate Intravenous Administration of the PfSPZ Vaccine in Malaria-Naive Adults|Completed||Phase 1|64|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:47:37.406207|2017-10-11 03:47:37.406207
NCT01441154|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-06-30|||September 1, 2011||2011-09-01|December 1, 2016|2016-12-01||||||||Observational|||Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment|Pharmacokinetic and Pharmacodynamic Studies of Liothyronine. A Study on the Metabolic Effects of Thyroid Hormone|Completed||N/A|16|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:47:37.525775|2017-10-11 03:47:37.525775
NCT01441141|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-06-30|||September 6, 2011||2011-09-06|March 31, 2017|2017-03-31||||||||Observational|||Genetics and Pain Severity in Sickle Cell Disease|Exploratory Studies of Psychophysical Pain Phenotyping and Genetic Variability in Sickle Cell Disease|Completed||N/A|67|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:47:37.627175|2017-10-11 03:47:37.627175
NCT01441128|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-07-06|||September 1, 2011||2011-09-01|February 26, 2015|2015-02-26|February 26, 2015|Actual|2015-02-26|February 28, 2014|Actual|2014-02-28||Interventional|||-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer|A Phase 1, Open-Label, Dose Escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Combined Oral C-Met/ALK Inhibitor (PF-02341066) and Pan-Her Inhibitor (PF-0299804) in Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1|20|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:47:37.74271|2017-10-11 03:47:37.74271
NCT01441115|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-06-30|||September 6, 2011||2011-09-06|April 24, 2013|2013-04-24|April 24, 2013|Actual|2013-04-24|April 24, 2013|Actual|2013-04-24||Interventional|||ECI301 and Radiation for Advanced or Metastatic Cancer|Phase I Trial of ECI301 in Combination With Radiation in Patients With Advanced or Metastatic Cancer|Terminated||Phase 1|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:47:37.869968|2017-10-11 03:47:37.869968
NCT01441102|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-01-18|2015-05-26||August 2011||2011-08-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|June 2014|Actual|2014-06-01||Interventional|MiDME2||Dextromethorphan for Diabetic Macular Edema|A Pilot Phase I/II Study for the Evaluation of Dextromethorphan as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (MiDME2)|Completed||Phase 1/Phase 2|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||No||2017-10-11 03:47:37.99374|2017-10-11 03:47:37.99374
NCT01441089|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-09-12|||August 24, 2011||2011-08-24|August 29, 2017|2017-08-29||||||||Observational|||Collection of Blood From Cancer Patients for Genetic Analysis|Collection of Blood From Patients With Cancer for Analysis of Genetic Differences in Drug Disposition|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:47:38.572456|2017-10-11 03:47:38.572456
NCT01441063|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-06-30|||August 6, 2011||2011-08-06|January 6, 2017|2017-01-06|July 1, 2020|Anticipated|2020-07-01|July 1, 2020|Anticipated|2020-07-01||Interventional|||Tocilizumab for KSHV-Associated Multicentric Castleman Disease|Pilot Study of Tocilizumab in Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV) - Associated Multicentric Castleman Disease|Recruiting||Phase 2|17|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:47:39.129055|2017-10-11 03:47:39.129055
NCT01441037|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-06-30|||July 15, 2011||2011-07-15|December 7, 2016|2016-12-07|November 14, 2016|Actual|2016-11-14|November 14, 2016|Actual|2016-11-14||Interventional|||Danazol for Genetic Bone Marrow and Lung Disorders|Male Hormones for Telomere Related Diseases|Completed||Phase 1/Phase 2|27|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:47:39.228516|2017-10-11 03:47:39.228516
NCT01441024|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-07-06|||July 14, 2011||2011-07-14|February 27, 2014|2014-02-27|June 30, 2014|Actual|2014-06-30|February 27, 2014|Actual|2014-02-27||Interventional|||DAS181 in Patients With Parainfluenza|A Randomized, Double-Blind, Placebo-Controlled Phase II Study of DAS181 in Patients With Parainfluenza Infection|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:47:39.304327|2017-10-11 03:47:39.304327
NCT01441011|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2016-11-22|||August 2011||2011-08-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Rural Women Connecting for Better Health|Group Phone-Based Weight Control for Rural Breast Cancer Survivors|Completed||N/A|210|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 03:47:39.398004|2017-10-11 03:47:39.398004
NCT01440998|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-24|2017-09-04|||September 20, 2011|Actual|2011-09-20|June 2017|2017-06-01||||July 31, 2015|Actual|2015-07-31||Interventional|||Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer|Pilot and Translational Study of Dasatinib (NSC#732517) Paclitaxel and Carboplatin in Women With Advanced Stage and Recurrent Endometrial Cancer|Active, not recruiting||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 03:47:39.484872|2017-10-11 03:47:39.484872
NCT01440985|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2012-07-06|||July 2005||2005-07-01|July 2012|2012-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study on the Effects of Two Nicotine Replacement Products on Tooth Staining|An Evaluator-Blinded, Randomized, Parallel Controlled Study of Nicorette® Freshmint Gum Versus Nicorette® Microtab in Healthy Smokers Motivated to Quit Smoking With Visible Staining of Teeth|Completed||N/A|200|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 03:47:39.618865|2017-10-11 03:47:39.618865
NCT01440972|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-10-24|2015-06-10||September 2011||2011-09-01|October 2016|2016-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|PBFR2||Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis|Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis|Completed||N/A|45|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 03:47:39.980102|2017-10-11 03:47:39.980102
NCT01440959|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2014-01-13|2013-11-12||September 2011||2011-09-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST)|A Phase II Trial of TKI258 in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib(CTKI258AKR01T)|Completed||Phase 2|30|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:47:40.292218|2017-10-11 03:47:40.292218
NCT01440946|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-02-27|2015-06-01||June 2012||2012-06-01|February 2017|2017-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Kids B-LONG||Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B|An Open-label, Multicenter Evaluation of Safety, Pharmacokinetics and Efficacy of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in the Prevention and Treatment of Bleeding Episodes in Pediatric Subjects With Hemophilia B|Completed||Phase 3|30|Actual|Bioverativ Therapeutics Inc.||1|||f||||t||||||||||2017-10-11 03:47:40.584381|2017-10-11 03:47:40.584381
NCT01440933|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2012-07-06|||September 2011||2011-09-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|MagSug||Efficacy of Sugammadex in Magnesium Pretreated Patients|Efficacy of Sugammadex for the Reversal of Moderate and Deep Rocuronium Induced Neuromuscular Block in Patients Pretreated With Magnesium Sulphate|Completed||Phase 2|32|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 03:47:41.40331|2017-10-11 03:47:41.40331
NCT01440920|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-11-10|||September 2011||2011-09-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients|A Phase I Study of OCV-501 in the Treatment of Patients With Acute Myeloid Leukemia|Completed||Phase 1|9|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 03:47:41.482793|2017-10-11 03:47:41.482793
NCT01440907|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-01-20|||May 2011||2011-05-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|June 2012|Actual|2012-06-01||Interventional|||Study of the Impact of a Hospital Discharge Care Coordination Program in an Elderly Population|The Effect of an HIE-Supported Care Coordination Package on Hospital Re-Admission Rates in an Elderly Population|Completed||N/A|201|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||Yes|A fully deidentified data set listing outcomes for the included patients is available by contacting the study PI (Jessica Ancker, jsa7002@med.cornell.edu)|2017-10-11 03:47:41.566472|2017-10-11 03:47:41.566472
NCT01440894|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-25|2011-09-25|||February 2011||2011-02-01|September 2011|2011-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|GBFA||Clinical Trail of Transtek Glass Body Fat Analyzer|Verify the Functions and Efficiency of Transtek Glass Body Fat Analyzer, GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, GBF-950-D.|Completed||N/A|50|Actual|BTS International|||1||f||||f||||||||||2017-10-11 03:47:41.665844|2017-10-11 03:47:41.665844
NCT01440881|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-10|2014-05-16|2014-01-22||April 2010||2010-04-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Does Nesiritide Provide Renal Protection|Does Nesiritide Provide Renal Protection By Attenuating the Inflammatory Response|Completed||Phase 2|37|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 03:47:43.262778|2017-10-11 03:47:43.262778
NCT01440868|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2011-09-26|||October 2011||2011-10-01|September 2011|2011-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|SLIS||Sustained Lung Inflation in the Delivery Room in Preterm Infants at High Risk of Respiratory Distress Syndrome|SLI STUDY: Sustained Lung Inflation in the Delivery Room in Preterm Infants at High Risk of Respiratory Distress Syndrome. A RCT Study|Unknown status|Not yet recruiting|N/A|276|Anticipated|University of Florence||2|||f||||t||||||||||2017-10-11 03:47:45.75431|2017-10-11 03:47:45.75431
NCT01440855|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-09-30|||February 2005||2005-02-01|September 2011|2011-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting|Efficacy and Feasibility of a Psychosocial Intervention Within CCOP Context: Evaluation of the Facing Forward Guide to Facilitate Life After Active Cancer Treatment (CCOP:Community Clinical Oncology Program)|Completed||N/A|340|Actual|Fox Chase Cancer Center||2|||f||||t||||||||||2017-10-11 03:47:45.873142|2017-10-11 03:47:45.873142
NCT01440842|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2012-12-31|||May 2012||2012-05-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|CLASSIC||Closed Loop Glucose Control in Intensive Care Unit|An Open-label, Single-centre, Randomised Controlled Trial to Assess the Safety and Efficacy of Automated Closed-loop Blood Glucose Control in Comparison With Standard Care in Adults in Intensive Care Unit|Completed||Phase 2|24|Actual|University of Cambridge||2|||f||||f||||||||||2017-10-11 03:47:45.980085|2017-10-11 03:47:45.980085
NCT01440829|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-12-18|||December 2011||2011-12-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS|The Effectiveness of L-ornithine-L-aspartate on Plasma Ammonia in Cirrhotic Patients After TIPS Procedure: a Prospective, Randomized, Controlled, Open-label Clinical Trial|Completed||Phase 2/Phase 3|40|Actual|Fourth Military Medical University||2|||f||||t||||||||||2017-10-11 03:47:46.071731|2017-10-11 03:47:46.071731
NCT01440816|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-02-24|||November 2011||2011-11-01|December 2016|2016-12-01|February 2017|Actual|2017-02-01|December 2016|Actual|2016-12-01||Interventional|MCC||IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer|A Phase II Study of Intratumoral Injection of Interleukin-12 Plasmid and in Vivo Electroporation in Patients With Merkel Cell Carcinoma|Completed||Phase 2|15|Actual|OncoSec Medical Incorporated||1|||f||||t||||||||Undecided||2017-10-11 03:47:46.165405|2017-10-11 03:47:46.165405
NCT01440803|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-08-07|||August 2, 2012|Actual|2012-08-02|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women|Randomized Controlled Trial of Teriparatide for the Treatment of Idiopathic Osteoporosis in Premenopausal Women|Active, not recruiting||Phase 2|41|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 03:47:46.255695|2017-10-11 03:47:46.255695
NCT01440790|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-03-11|||August 2010||2010-08-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|AOGI||The Effect of Continuous Sipping of a Glucose Solution on Markers of Oxidation in Men and Women|The Effect of Continuous Sipping of a Glucose Solution on Markers of Oxidation in Men and Women|Completed||N/A|18|Actual|University of Toronto||4|||f||||f||||||||||2017-10-11 03:47:46.343401|2017-10-11 03:47:46.343401
NCT01440777|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2014-09-10|||October 2011||2011-10-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Effectiveness and Adherence to an Online Sleep Program|Effectiveness and Adherence to an Online Sleep Program - A Pilot Study|Completed||N/A|101|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 03:47:46.565111|2017-10-11 03:47:46.565111
NCT01440764|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-05-18|2017-04-11||September 2011||2011-09-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2016|Actual|2016-04-01||Interventional|||Aerosol Inhalation Treatment for Dyspnea|Aerosol Inhalation Treatment for Dyspnea|Completed||Phase 1/Phase 2|24|Actual|Beth Israel Deaconess Medical Center||6|||f||||f||||||||||2017-10-11 03:47:46.670309|2017-10-11 03:47:46.670309
NCT01440751|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-08-15|||February 2010||2010-02-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|MCToCM||Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery|Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery|Completed||Phase 4|94|Actual|Aeon Astron Europe B.V.||2|||f||||t||||||||No||2017-10-11 03:47:47.204768|2017-10-11 03:47:47.204768
NCT01440738|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-21|2011-09-23|||September 2011||2011-09-01|September 2011|2011-09-01|September 2012|Anticipated|2012-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Effectiveness of a Group Intervention to Promote Health Through a Clinical Trial|Effectiveness of a Group Intervention to Promote Health Through a Clinical Trial|Unknown status|Recruiting|N/A|376|Anticipated|Jordi Gol i Gurina Foundation||1|||f||||t||||||||||2017-10-11 03:47:47.338013|2017-10-11 03:47:47.338013
NCT01440725|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2013-01-08|||October 2009||2009-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PRP-RICE||Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma|Multicenter Double Blind, With Evaluator Blinding, Parallel, Randomized Clinical Trial, to Assess the Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma|Completed||Phase 3|71|Actual|Institut de Terapia Regenerativa Tissular||2|||f||||f||||||||||2017-10-11 03:47:47.435767|2017-10-11 03:47:47.435767
NCT01440712|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-07-12|||December 2011||2011-12-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Study of the Effect of Water Soluble Oral Contrast (Gastrografin) on Postoperative Ileus After Colorectal Surgery|Prospective Randomized Double Blind Study of the Effect of Gastrografin on Postoperative Ileus After Colorectal Surgery|Completed||Phase 4|58|Anticipated|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-10-11 03:47:47.554587|2017-10-11 03:47:47.554587
NCT01440699|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2011-09-23|||September 2011||2011-09-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|ALLO-ASC||Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula|Phase I Study of Dose Escalation of Human Allogenic Adipose-derived Stem Cells (ALLO-ASC) to Evaluate Safety and Efficacy in Patients With Crohn's Fistula|Unknown status|Recruiting|Phase 1|6|Anticipated|Anterogen Co., Ltd.||1|||f||||t||||||||||2017-10-11 03:47:47.674412|2017-10-11 03:47:47.674412
NCT01440686|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2012-10-15|||September 2011||2011-09-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|HL-032||Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers|A Dose Block-randomized, Double-blinded, Placebo-controlled, Single-dose, Dose-escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of HL-032 in Healthy Male Volunteers|Completed||Phase 1|40|Anticipated|HanAll BioPharma Co., Ltd.||3|||f||||t||||||||||2017-10-11 03:47:47.788437|2017-10-11 03:47:47.788437
NCT01440673|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-23|||March 2010||2010-03-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Aprepitant for Postoperative Nausea and Vomiting in Laparoscopic Hysterectomy||Completed||N/A|150|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 03:47:47.896505|2017-10-11 03:47:47.896505
NCT01440660|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-10-07|||January 2012||2012-01-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER)|Phenotypes of Nonproliferative Diabetic Retinopathy in Diabetes Type 2 Patients Identified by Optical Coherence Tomography, Colour Fundus Photography, Fluorescein Leakage and Multifocal Electrophysiology (DIAMARKER Project: Genetic Susceptibility for Multi-systemic Complications in Diabetes Type-2: New Biomarkers for Diagnostic and Therapeutic Monitoring).|Completed||N/A|20|Actual|Association for Innovation and Biomedical Research on Light and Image|||2||f||||f||||||||||2017-10-11 03:47:47.981777|2017-10-11 03:47:47.981777
NCT01440647|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2013-02-07|2012-12-26||November 2007||2007-11-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|July 2009|Actual|2009-07-01||Interventional|||Study of Nasal Ventilation In Preterm Infants To Decrease Time on The Respirator|Nasal Intermittent Positive Pressure Ventilation Allows Early Extubation In Infants Less Than 28 Weeks Gestation: A Pilot Study|Completed||N/A|34|Actual|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||||2017-10-11 03:47:48.058809|2017-10-11 03:47:48.058809
NCT01440634|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-11-30|2013-03-08||February 2008||2008-02-01|November 2015|2015-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Community-Based Detection and Treatment of Peripheral Arterial Disease in Hispanics.|Community-Based Detection and Treatment of Peripheral Arterial Disease in Hispanics.|Completed||N/A|347|Actual|University of Texas Southwestern Medical Center|This study was limited by the lack of patients compliance to follow the schedule for the exercise sessions. Patients did not assisted regularly to the walking sessions, and the schedule was completed in 70 % of the plan.|2|||f||||f||||||||||2017-10-11 03:47:48.353566|2017-10-11 03:47:48.353566
NCT01440621|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2012-03-21|||August 2010||2010-08-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|ModCRF||Modafinil in Cancer Related Fatigue|Randomized Controlled Study to Evaluate the Effects of Modafinil in Cancer Related Fatigue in Patients Undergoing Radiation Therapy|Completed||Phase 3|217|Actual|Indira Gandhi Medical College||2|||f||||||||||||||2017-10-11 03:47:48.629016|2017-10-11 03:47:48.629016
NCT01440608|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2012-03-02|||October 2011||2011-10-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental Enteropathy|Randomized, Double-blind, Placebo-controlled Trial Evaluating the Impact of High-dose Zinc Therapy and Albendazole in the Treatment of Sub-clinical Environmental Enteropathy in Rural Malawian Children|Completed||N/A|225|Actual|Washington University School of Medicine||3|||f||||||||||||||2017-10-11 03:47:48.873215|2017-10-11 03:47:48.873215
NCT01440595|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-03-01|2016-02-03||November 2011||2011-11-01|March 2017|2017-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Five participants were randomized as indicated in the Participant Flow Module, but only 3 participants were treated. Baseline Characteristics are presented only for treated participants.|Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)|A Randomized, Partially Double-Blind, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly With Pegylated-Interferon and Ribavirin in Treatment-Naive Patients With Chronic Genotype 2 or 3 Hepatitis C Virus Infection|Terminated||Phase 2|5|Actual|Merck Sharp & Dohme Corp.||4||"Preliminary results of MK-5172 PN003 (NCT01353911) suggested a possible dose relationship to   elevated transaminase levels in treatment with grazoprevir."|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:47:48.980201|2017-10-11 03:47:48.980201
NCT01440582|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-03-24|||February 18, 2013|Actual|2013-02-18|March 2017|2017-03-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Interventional|||Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients|Phase I/Ib Trial of the Efficacy and Safety of Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible Patients With Newly Diagnosed Multiple Myeloma (MM)|Active, not recruiting||Phase 1|77|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:47:49.393393|2017-10-11 03:47:49.393393
NCT01440569|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2016-10-26|2014-10-23|2013-11-17|September 2011||2011-09-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|August 2012|Actual|2012-08-01||Interventional||Full Analysis Set: participants who were enrolled into the study and received at least one dose of study drug.|Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults|A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations|Completed||Phase 3|314|Actual|Gilead Sciences||1|||f||||f||||||||||2017-10-11 03:47:49.584591|2017-10-11 03:47:49.584591
NCT01440556|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2013-07-10|||October 2011||2011-10-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|MM2011||Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma|Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: a Study From the Italian Bone Marrow Transplantation Donor Registry|Completed||N/A|196|Actual|Azienda Ospedaliera San Giovanni Battista|||1||f||||f||||||||||2017-10-11 03:47:51.067273|2017-10-11 03:47:51.067273
NCT01440543|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-12-20|2012-12-19||January 2011||2011-01-01|December 2012|2012-12-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|Water/CO2||Combination of Water Immersion and Carbon Dioxide Insufflation for Minimal Sedation Colonoscopy|Combination of Water Immersion and Carbon Dioxide Insufflation for Minimal Sedation Colonoscopy - a Prospective, Randomized, Single-center Trial|Completed||N/A|420|Actual|Vitkovice Hospital|There were no procedure- or sedation-related complications recorded in the study.|4|||f||||f||||||||||2017-10-11 03:47:51.141291|2017-10-11 03:47:51.141291
NCT01440530|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-23|||February 2010||2010-02-01|September 2011|2011-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|TIDES||Technology Intervention for Diabetes Engagement & Self-Care (TIDES)|Technology Intervention for Diabetes Engagement & Self-Care (TIDES):Comparative Effectiveness Randomized Clinical Trial in Primary Care for Type 2 Diabetes to Improve Engagement, Knowledge, and Self-Care|Completed||N/A|170|Actual|Geisinger Clinic||2|||f||||f||||||||||2017-10-11 03:47:51.521068|2017-10-11 03:47:51.521068
NCT00000235|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16||||||December 2002|2002-12-01||||||||Interventional|||Alternate Day Buprenorphine Administration, Phase XII - 17|Alternate Day Buprenorphine Administration, Phase XII|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:41.21917|2017-10-11 04:17:41.21917
NCT01440517|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-01-02|2013-08-30||August 2011||2011-08-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction|An Open-Label, Multicenter, Proof of Concept, Phase 2 Study Evaluating the Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus (DM) and Heart Failure With Preserved Left Ventricular Ejection Fraction (HFPEF)|Terminated||Phase 2|4|Actual|GE Healthcare||1||Lack of Subject Recruitment|f||||f||||||||||2017-10-11 03:47:51.621972|2017-10-11 03:47:51.621972
NCT01440504|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-02-06|||April 2010||2010-04-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|ABT737 exvivo||Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors|Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors|Completed||Phase 2|36|Actual|Centre Francois Baclesse|||1||f||||t||||||||||2017-10-11 03:47:51.829499|2017-10-11 03:47:51.829499
NCT01440491|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-23|||May 2008||2008-05-01|January 2008|2008-01-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|||Orientation Booklet for Low Back Pain|Effect of Orientation Through a Booklet of Exercise in Patients With Low Back Pain|Completed||N/A|44|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-10-11 03:47:51.927982|2017-10-11 03:47:51.927982
NCT01440478|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2011-10-07|||September 2011||2011-09-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects|Impact of Variations in Urinary pH on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects|Completed||Phase 1|30|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 03:47:52.008988|2017-10-11 03:47:52.008988
NCT01440465|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-02-07|||July 2011||2011-07-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Observational|NAVI||Management of Nausea and Vomiting Chemotherapy-induced in Normandy|Management of Nausea and Vomiting Chemotherapy-induced in Normandy|Completed||N/A|300|Actual|Centre Francois Baclesse|||1||f||||t||||||||||2017-10-11 03:47:52.093828|2017-10-11 03:47:52.093828
NCT01440452|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2016-08-29|||November 2010||2010-11-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|FIRST-STIM||CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies|CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies|Active, not recruiting||Phase 2/Phase 3|35|Actual|Johns Hopkins University||4|||f||||f||||||||||2017-10-11 03:47:52.299387|2017-10-11 03:47:52.299387
NCT01440439|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-11-07|||November 2011||2011-11-01|November 2011|2011-11-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Comparing Long-acting Insulins During Exercise in Type 1 Diabetes|Impact of Insulin Detemir Versus Insulin Glargine on Glycaemic Control and Metabolism During Exercise in Type 1 Diabetes|Unknown status|Recruiting|Phase 4|30|Anticipated|Buckinghamshire Healthcare NHS Trust||2|||f||||f||||||||||2017-10-11 03:47:52.432241|2017-10-11 03:47:52.432241
NCT01440426|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-09-23|||September 2011||2011-09-01|September 2011|2011-09-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects|Connective Tissue Graft vs Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects Randomized Controlled Clinical Trial Assessing Superiority in Health Related Quality of Life and Non-Inferiority in Root Coverage|Unknown status|Recruiting|Phase 4|280|Anticipated|The European Research Group on Periodontology (ERGOPerio)||2|||f||||f||||||||||2017-10-11 03:47:52.548498|2017-10-11 03:47:52.548498
NCT01440413|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-01-31|||December 2011|Actual|2011-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|BREAST IMMUN||Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer|Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer|Active, not recruiting||N/A|40|Anticipated|Centre Leon Berard||1|||f||||f||||||||||2017-10-11 03:47:52.697915|2017-10-11 03:47:52.697915
NCT01440400|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2013-03-11|||October 2011||2011-10-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Ultrasound Guided Spinal Anesthesia in Non Obese Obstetric Patients|The Use of Ultrasound to Guide Spinal Anesthesia in Obstetrics. Is There an Advantage Over Landmark Technique in Non-obese Patients?|Completed||N/A|150|Actual|Corniche Hospital||2|||f||||t||||||||||2017-10-11 03:47:52.795218|2017-10-11 03:47:52.795218
NCT01440387|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-09-22|2013-09-05|2012-07-26|September 2011||2011-09-01|September 2016|2016-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older|A Phase IIIA Study of Immunogenicity and Safety of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older|Completed||Phase 3|112|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:47:52.920197|2017-10-11 03:47:52.920197
NCT01440374|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-05-02|2016-03-10||September 2011||2011-09-01|May 2017|2017-05-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|ASPIRE|Part 3, 59 subjects from Part 2 entered Part 3 (23 of 47 subjects in the placebo group in Part 2 and 36 of 98 subjects in the eltrombopag group in Part 2). All subjects who entered Part 3 received treatment with eltrombopag. SOC was allowed as needed throughout the study. Subjects could receive disease-modifying therapy as needed.|A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia|A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia (Part 1: Open-label, Part 2: Randomized, Double-blind, Part 3: Extension)|Completed||Phase 2|162|Actual|Novartis||4|||f||||t||||||||||2017-10-11 03:47:53.665708|2017-10-11 03:47:53.665708
NCT01440361|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-07-24|||March 2013||2013-03-01|July 2014|2014-07-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.|A Clinical and Mechanistic Proof of Efficacy Study With Belimumab in Chronic Immune Thrombocytopenia (ITP) Patients.|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||2||This study was Cancelled Before Active|f||||f||||||||||2017-10-11 03:47:56.715631|2017-10-11 03:47:56.715631
NCT01440348|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-09-23|||May 2011||2011-05-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Simultaneous Multiple Cruciate Ligament Reconstructions Using a Single Achilles Allograft|Simultaneous Multiple Cruciate Ligament Reconstructions Using a Single Achilles Allograft|Completed||Phase 4|51|Actual|National Police Hospital||1|||f||||t||||||||||2017-10-11 03:47:56.81399|2017-10-11 03:47:56.81399
NCT01440335|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-23|2017-06-30|||July 10, 2011||2011-07-10|January 7, 2015|2015-01-07|April 15, 2014|Actual|2014-04-15|April 15, 2014|Actual|2014-04-15||Interventional|||Initial Study of Fenoterol as a Treatment for Heart Failure|A Study of (R, R') and (S,S': R,R')- Fenoterol: Initial Clinical Evaluation for Pharmacokinetics, Pharmacodynamics, and Safety|Completed||Phase 1|250|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:47:56.890774|2017-10-11 03:47:56.890774
NCT01440322|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-04-24|2014-02-18||September 2011||2011-09-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||The analysis population includes all enrolled participants.|AIR OPTIX® COLORS Registration Trial||Completed||N/A|150|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:47:57.008904|2017-10-11 03:47:57.008904
NCT01440309|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2012-08-01|||November 2011||2011-11-01|September 2011|2011-09-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|MSCsTreatPBC||Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis|Phase I Clinical Trial, Randomized, Controlled, to Evaluate the Efficacy and Safety of Therapy With Allogenic Mesenchymal Stem Cells From Bone Marrow for Patients With Refractory Primary Biliary Cirrhosis|Unknown status|Recruiting|Phase 1|20|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:47:58.215655|2017-10-11 03:47:58.215655
NCT01440296|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-09-23|||March 2010||2010-03-01|September 2011|2011-09-01||||||||Observational|||Magnetic Resonance Imaging (MRI) Characterization of Carotid Plaque and Prediction of End-organ and Clinical Outcomes|Magnetic Resonance Imaging (MRI) Characterization of Carotid Plaque and Prediction of End-organ and Clinical Outcomes|Unknown status|Recruiting|N/A|500|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||||||||||||2017-10-11 03:47:58.382032|2017-10-11 03:47:58.382032
NCT01440283|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-02-03|2015-11-09||September 2011||2011-09-01|November 2015|2015-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma|A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma|Terminated||Phase 2|14|Actual|St. Jude Children's Research Hospital|The study was closed to accrual in January 2014 due to the principal investigator leaving St. Jude. It was expected to re-open to accrual, however, in September 2015, the decision was made to permanently close the trial to participant enrollment.|1|||f||||f||||||||||2017-10-11 03:47:58.469941|2017-10-11 03:47:58.469941
NCT01440270|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2014-05-12|||July 2011||2011-07-01|May 2014|2014-05-01|October 2019|Anticipated|2019-10-01|April 2015|Anticipated|2015-04-01||Interventional|||Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer|Neo-adjuvant Erbitux-based Chemotherapy Followed by Surgery and Radiotherapy for Locally Advanced Oral/Oropharyngeal Cancer|Active, not recruiting||Phase 2|145|Actual|Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||||2017-10-11 03:47:58.810888|2017-10-11 03:47:58.810888
NCT01440257|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-01-08|||September 2011||2011-09-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|February 2013|Actual|2013-02-01||Interventional|||A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria|A Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Effect of CCX140-B on Albuminuria in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|20|Actual|ChemoCentryx||2|||f||||f||||||||||2017-10-11 03:47:58.950578|2017-10-11 03:47:58.950578
NCT01440244|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-08-31|||September 2011||2011-09-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|CT0030||Cervical Video Assisted Thoracoscopic Surgery (C-VATS)|Cervical Video Assisted Thoracoscopic Surgery (C-VATS)Using a Flexible Endoscope for Thoracoscopy|Recruiting||N/A|10|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||f||||||||||2017-10-11 03:47:59.046148|2017-10-11 03:47:59.046148
NCT01440231|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2013-08-20|||February 2012||2012-02-01|August 2013|2013-08-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|ADDRESS||Atacicept Demonstrating Dose RESponSe|A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Dose-Response Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)|Withdrawn||Phase 2|0|Actual|EMD Serono||5|||f||||t||||||||||2017-10-11 03:47:59.141502|2017-10-11 03:47:59.141502
NCT01440218|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2016-11-21|||September 2011||2011-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|IDIOM||Idiopathic Diseases of Man|Idiopathic Diseases of Man (IDIOM)|Enrolling by invitation||N/A|10|Anticipated|Scripps Translational Science Institute|||1||f||||t||||||Samples With DNA|"     Blood, saliva, or tissue will be obtained after informed consent is completed.   "|||2017-10-11 03:47:59.242634|2017-10-11 03:47:59.242634
NCT01440205|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2016-09-13|||September 2011||2011-09-01|September 2016|2016-09-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Interventional|||Licensing Flu Shot Study||Completed||N/A|6098|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-11 03:47:59.3083|2017-10-11 03:47:59.3083
NCT01440192|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-07-14|||September 2011||2011-09-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis|A Phase 1B, Multi-Center, Open-Label, Single Dose Study to Evaluate the Safety of Intravenous Infusion of Human Placental-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis.Sarcoidosis|Terminated||Phase 1|4|Actual|Celgene||2||Study Terminated by Sponsor|f||||t||||||||||2017-10-11 03:47:59.39606|2017-10-11 03:47:59.39606
NCT01440179|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-08-26|||October 2011||2011-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|MYRALL||SAR3419 in Acute Lymphoblastic Leukemia|Phase II Two Stage Finding Run-in Study of SAR3419, An Anti-CD19 Antibody-Maytansine Conjugate, Administered as a Single Agent by Intravenous Infusion in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|Terminated||Phase 2|100|Actual|Sanofi||1||The study is stopped due to very modest activity compared to competitors|f||||||||||||||2017-10-11 03:47:59.491304|2017-10-11 03:47:59.491304
NCT00000236|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16||||||December 2002|2002-12-01||||||||Interventional|||Buprenorphine Pharmacology Related to Addiction Treatment - 18|Buprenorphine Pharmacology Related to Addiction Treatment|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:41.282553|2017-10-11 04:17:41.282553
NCT01440166|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2012-02-02|||September 2011||2011-09-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers|A Single Center, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers|Completed||Phase 1|52|Actual|Catabasis Pharmaceuticals||9|||f||||f||||||||||2017-10-11 03:47:59.595511|2017-10-11 03:47:59.595511
NCT01440153|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-09-23|||September 2009||2009-09-01|September 2011|2011-09-01|November 2011|Anticipated|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Additional Exercise Program in Professional Dancers|Influence of an Additional Intervention Targeting Physical Fitness, Endurance and Motor Control, on Physical Condition and Musculoskeletal Injuries in Contemporary Dancers|Unknown status|Active, not recruiting|N/A|44|Anticipated|University College of Antwerp||2|||f||||f||||||||||2017-10-11 03:47:59.700455|2017-10-11 03:47:59.700455
NCT01440140|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-01-28|||December 2012||2012-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Closing the Loop in Adults With Type 1 Diabetes in the Home Setting|An Open-label, Three-centre, Randomised, Two-period, Crossover Study to Assess the Efficacy, Safety and Utility of Real-time Continuous Subcutaneous Glucose Monitoring Combined With Overnight Closed-loop Glucose Control in the Home Setting in Comparison With Real-time Continuous Subcutaneous Glucose Monitoring Alone in Adults With Type 1 Diabetes on Subcutaneous Insulin Infusion Pump Therapy|Completed||Phase 2|24|Actual|University of Cambridge||2|||f||||t||||||||||2017-10-11 03:47:59.793973|2017-10-11 03:47:59.793973
NCT01440127|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-03-25|||August 2011||2011-08-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers|Randomized Clinical Trial Evaluating the Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers|Terminated||Phase 1|9|Actual|Tufts Medical Center||2||"Unable to accrue all planned subjects in a timely fashion, but data collected will still be   analyzed."|f||||t||||||||||2017-10-11 03:47:59.895433|2017-10-11 03:47:59.895433
NCT01440114|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-09-22|||March 2010||2010-03-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Effect of Intravenous Fentanyl Prior the End of Surgery on Emergence Agitation in Paediatric Patients After General Anesthesia|The Effect of Intravenous Fentanyl Prior the End of Surgery on Emergence Agitation in Paediatric Patients After General Anesthesia|Completed||N/A|144|Actual|Prince of Songkla University||2|||f||||f||||||||||2017-10-11 03:47:59.993873|2017-10-11 03:47:59.993873
NCT01440101|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2014-10-20|2014-09-15||November 2010||2010-11-01|October 2014|2014-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|Tysabri Japan|This was a 2-part, multicenter study, each part (open-label, double-blind) comprising discrete cohorts of BG00002-naïve participants.|Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)|Multicenter Study of BG00002 in Japanese Subjects With RRMS, Consisting of a Multiple-Dose, Open-Label Evaluation of Its Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (Part A) and a Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Evaluation of Safety and Efficacy (Part B)|Completed||Phase 2/Phase 3|106|Actual|Biogen||3|||f||||t||||||||||2017-10-11 03:48:00.154361|2017-10-11 03:48:00.154361
NCT01440075|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-08-18|||October 10, 2011|Actual|2011-10-10|August 2017|2017-08-01|April 13, 2015|Actual|2015-04-13|April 13, 2015|Actual|2015-04-13||Interventional|Kawasaki||Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease|Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease|Completed||N/A|43|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:48:02.394236|2017-10-11 03:48:02.394236
NCT01440062|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-08-01|||December 2011||2011-12-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS)|Phase II Study of Efficacy of Vitamin D Supplementation in Multiple Sclerosis|Terminated||Phase 2|80|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:48:02.507573|2017-10-11 03:48:02.507573
NCT01440049|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-12-21|2012-12-21||September 2008||2008-09-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|PERGAME||Patient's Management Receiving Eplerenone Therapy|Assessment Of Follow-Up Methods For Patients Treated In The Long-Term With A Specific Aldosterone Receptor Antagonist|Completed||N/A|160|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:48:02.65766|2017-10-11 03:48:02.65766
NCT01440036|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-12-15|||October 2011||2011-10-01|December 2011|2011-12-01|October 2014|Anticipated|2014-10-01|October 2012|Anticipated|2012-10-01||Observational|||The Correlation Between the Enzyme Paraoxigenase 1 (PON1) to Carotid Artery Atheromatous Plaque|The Correlation Between the Enzyme Paraoxigenase 1 (PON1) to Carotid Artery Atheromatous Plaque|Unknown status|Recruiting|N/A|100|Anticipated|Ziv Hospital|||1||f||||f||||||Samples Without DNA|"     Atherosclerotic plaque from carotid arteries Blood sample (5cc)   "|||2017-10-11 03:48:03.688509|2017-10-11 03:48:03.688509
NCT01440023|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-01-13|||August 2011||2011-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Developing Cognitive Training for Tourette Syndrome|Developing Effective Response Inhibition Training for Symptom Relief in Tourette Syndrome|Completed||Phase 1|20|Actual|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-10-11 03:48:03.770323|2017-10-11 03:48:03.770323
NCT01440010|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-05-31|||September 2011||2011-09-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|August 2017|Anticipated|2017-08-01||Observational|TARGIT_BQR||TARGeted Intraoperative radioTherapy With INTRABEAM as a Boost for Breast Cancer - A Quality Control Registry|TARGeted Intraoperative radioTherapy With the INTRABEAM-System as an Advanced Boost in Patients With Breast Cancer - A Quality Control Registry in Germany (TARGIT BQR)|Recruiting||N/A|1000|Anticipated|Universitätsmedizin Mannheim|||1||f||||f||||||||||2017-10-11 03:48:03.88834|2017-10-11 03:48:03.88834
NCT01439997|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-12-04|||February 2013||2013-02-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Interventional|||Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study|Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study|Unknown status|Recruiting|Phase 4|50|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:48:04.032598|2017-10-11 03:48:04.032598
NCT01439984|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2012-10-01|||September 2011||2011-09-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Trial of PED-1 in Male Patients With Premature Ejaculation|A Randomized, Double-blind, Placebo-controlled, Fixed Dose, Parallel Grouped, Multi-center Clinical Study to Evaluate the Safety and Efficacy of PED-1 in Male Patients With Premature Ejaculation|Completed||Phase 3|159|Actual|Symyoo||2|||f||||f||||||||||2017-10-11 03:48:04.131715|2017-10-11 03:48:04.131715
NCT01439971|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-04-07|2016-10-20||December 2011||2011-12-01|April 2017|2017-04-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||The baseline analysis population included all enrolled participants who received the study drug.|Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia|An Ascending Single Dose Study To Evaluate The Safety, Tolerability And Pharmacokinetics/Pharmacodynamics Of Pf-05280602, A Recombinant Factor Viia Variant (813d), In Adult Hemophilia A And B Subjects With Or Without Inhibitors|Completed||Phase 1|29|Actual|Catalyst Biosciences|The protocol was amended to a starting dose of 4.5 mcg/kg. The positive anti-PF-05280602 antibody was cross-reactive with NovoSeven and native Factor VII and the weak positive immune response at Day 60 may represent a false-positive test result.|5|||f||||t||||||||No||2017-10-11 03:48:04.356314|2017-10-11 03:48:04.356314
NCT01439958|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2015-04-13|||February 2012||2012-02-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|||Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS)|A Long-term Safety Follow-up Study of L-CsA Therapy for Patients Who Participated in Study 12011.201 and Volunteered to Continue or to Cross-over to L-CsA Inhalation Therapy|Terminated||Phase 3|14|Actual|Pari Pharma GmbH||1||Core study 12011.201 was terminated.|f||||f||||||||||2017-10-11 03:48:06.720853|2017-10-11 03:48:06.720853
NCT01439945|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-02-17|2016-12-08||September 2011||2011-09-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes|Completed||Phase 2|289|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-10-11 03:48:06.866508|2017-10-11 03:48:06.866508
NCT01439932|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-02-17|||October 2011||2011-10-01|September 2011|2011-09-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Effectiveness of Manual Therapy Combined With Standard Treatment in the Management of Plantar Fasciitis|Effectiveness of Manual Therapy Combined With Standard Treatment in the Management of Plantar Fasciitis, a Randomized Control Trial|Completed||N/A|50|Actual|Meir Medical Center||1|||f||||f||||||||||2017-10-11 03:48:08.645342|2017-10-11 03:48:08.645342
NCT01439919|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-03-14||2013-03-14|January 2012||2012-01-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|ACT11705||A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain|A Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain|Terminated||Phase 2|5|Actual|Sanofi||2||due to strategic reasons|f||||t||||||||||2017-10-11 03:48:08.772567|2017-10-11 03:48:08.772567
NCT01439906|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-04-27|||January 2010||2010-01-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Observational|||Surgical Treatment for Degenerative Scoliosis|Evaluation of Pain Relief and Functional Improvement After the Surgical Treatment for Low Back Pain Due to Degenerative Kyphoscoliosis - Pilot Study|Completed||N/A|31|Actual|Istituto Ortopedico Rizzoli|||1||f||||f||||||||||2017-10-11 03:48:08.877865|2017-10-11 03:48:08.877865
NCT01439893|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-08-01|||June 2011||2011-06-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients|A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Efficacy/Safety of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure|Terminated||Phase 3|14|Actual|Zensun Sci. & Tech. Co., Ltd.||2||Sponsor has designed another study with different endpoint to replace the current study|f||||t||||||||||2017-10-11 03:48:08.960687|2017-10-11 03:48:08.960687
NCT01439880|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-06-13|||October 7, 2011|Actual|2011-10-07|June 2017|2017-06-01|June 27, 2018|Anticipated|2018-06-27|June 27, 2018|Anticipated|2018-06-27||Interventional|OSLER||Open Label Study of Long Term Evaluation Against LDL-C Trial|A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 (Evolocumab)|Active, not recruiting||Phase 2|1324|Actual|Amgen||2|||f||||f||||||||||2017-10-11 03:48:09.119086|2017-10-11 03:48:09.119086
NCT01439867|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2017-07-13|2017-07-13|2017-04-25|June 22, 2012|Actual|2012-06-22|July 2017|2017-07-01|June 3, 2016|Actual|2016-06-03|June 3, 2016|Actual|2016-06-03||Interventional|||Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism|An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis|Terminated||Phase 2|18|Actual|Amgen||1||Sponsor decision|f||||f||||||||||2017-10-11 03:48:09.954255|2017-10-11 03:48:09.954255
NCT01439854|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-09-28|||March 2011||2011-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DAPA MITO||Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action|Regulation of Hepatic and Peripheral Glucose Metabolism: Protocol IVA. Effect of Plasma Glucose Reduction by Selective SLGT2 Inhibition on Mitochondrial Dysfunction and Impaired Insulin Signaling/Sensitivity in T2DM|Recruiting||N/A|30|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 03:48:11.247125|2017-10-11 03:48:11.247125
NCT01439841|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-09-26|||October 2011||2011-10-01|September 2017|2017-09-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|ProGut||The Effect of Probiotics in HIV-1 Infection|The Effect of Probiotics on Microbial Translocation and Immune Activation in HIV-1 Infection. A Randomised Placebo-controlled Trial|Completed||N/A|32|Actual|Oslo University Hospital||3|||f||||f||||||||||2017-10-11 03:48:11.362449|2017-10-11 03:48:11.362449
NCT01439828|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-01-18|||February 2012||2012-02-01|January 2012|2012-01-01|February 2015|Anticipated|2015-02-01|February 2012|Anticipated|2012-02-01||Interventional|MUCOCRAV||Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal|Randomized and Double-blind Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal|Unknown status|Not yet recruiting|Phase 2|150|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:48:11.46304|2017-10-11 03:48:11.46304
NCT01439815|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-01-25|||September 2011||2011-09-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo|A Single-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy of Flonase (Fluticasone Propionate Nasal Spray) Compared to Placebo Nasal Spray in the Allergen BioCube (ABC) Model|Completed||Phase 4|21|Actual|ORA, Inc.||2|||f||||t||||||||||2017-10-11 03:48:11.600511|2017-10-11 03:48:11.600511
NCT01439802|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-09-22|||August 2008||2008-08-01|September 2011|2011-09-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional|||Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery|Transcesarean IUD Insertion: A Prospective Cohort Study|Completed||Phase 4|90|Actual|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 03:48:11.723756|2017-10-11 03:48:11.723756
NCT01439789|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-08-01|||June 2011||2011-06-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients|A Phase III, Multi-center,Randomized, Double-blind, Based on Standard Therapy, Placebo-controlled Study of the Efficacy/Safety of Recombinant Human Neuregulin-1β in Patients With Chronic Systolic Heart Failure|Terminated||Phase 3|146|Actual|Zensun Sci. & Tech. Co., Ltd.||2||Sponsor has designed another study with different endpoint to replace the current study|f||||t||||||||||2017-10-11 03:48:11.816837|2017-10-11 03:48:11.816837
NCT01439776|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2011-09-22|||September 2011||2011-09-01|September 2011|2011-09-01|August 2013|Anticipated|2013-08-01|February 2013|Anticipated|2013-02-01||Interventional|Addwin||Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients|A Randomized, Multi-center, Phase IV Open-label Study Evaluating the Antiviral Efficacy of Addition of Vitamin D in Patients With Treatment Naïve Chronic Hepatitis C Receiving Peginterferon Alfa-2a Plus Ribavirin|Unknown status|Not yet recruiting|Phase 4|222|Anticipated|Hanyang University||2|||f||||f||||||||||2017-10-11 03:48:11.945158|2017-10-11 03:48:11.945158
NCT01439763|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-09-14|||September 2011||2011-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|ABC||Assessment of Bullying in Children|Assessment of Bullying in Children With Psychiatric Symptoms: An Emergency Department Based Evaluation|Recruiting||N/A|80|Anticipated|New York City Health and Hospitals Corporation|||1||f||||f||||||||||2017-10-11 03:48:12.153718|2017-10-11 03:48:12.153718
NCT01439750|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-08-04|||May 2012|Actual|2012-05-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)|Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma: A Phase I/II Study (PSHCI 10-011)|Active, not recruiting||Phase 1|13|Actual|Milton S. Hershey Medical Center||2|||f||||t|t|f|||t|||||2017-10-11 03:48:12.256342|2017-10-11 03:48:12.256342
NCT01439737|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-09-22|||September 2011||2011-09-01|September 2011|2011-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Metabolomic Analysis of Exhaled Breath Condensate in Asthmatics|Metabolomic Analysis of Exhaled Breath Condensate, Plasma and Urine Specimens in Adult Asthmatics|Unknown status|Not yet recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     Exhaled breath condensates, serum, urine   "|||2017-10-11 03:48:12.385642|2017-10-11 03:48:12.385642
NCT01439724|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-03-07|2014-03-07||June 2007||2007-06-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|June 2008|Actual|2008-06-01||Interventional||The primary end point of the study was the incidence of grade 3–4 OM according to the WHO scale. Assuming an α = 0.05 and a β = 0.20, with the estimates of proportion being 0.40 for placebo (P0) and 0.15 for LLLT (P1) a total of 94 patients were evaluated.|Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients|Phase III Trial of Low-level Laser Therapy to Prevent Induced Oral Mucositis in Head and Neck Cancer Patients Submitted to Concurrent Chemoradiation|Completed||Phase 3|94|Actual|Instituto Nacional de Cancer, Brazil||2|||f||||t||||||||||2017-10-11 03:48:12.476022|2017-10-11 03:48:12.476022
NCT01439711|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-07-11|||February 2012||2012-02-01|July 2017|2017-07-01||||August 2016|Actual|2016-08-01||Interventional|||Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ|Phase II Study of Neoadjuvant Letrozole for Postmenopausal Women With Estrogen Receptor Positive Ductal Carcinoma In SITU (DCIS)|Active, not recruiting||Phase 2|108|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 03:48:12.786687|2017-10-11 03:48:12.786687
NCT01439698|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-02-16|||September 2011||2011-09-01|February 2017|2017-02-01|December 30, 2018|Anticipated|2018-12-30|December 1, 2018|Anticipated|2018-12-01|1 Year|Observational [Patient Registry]|RFA-Registry||Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry|Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry|Recruiting||N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|No IPD Sharing|2017-10-11 03:48:12.939226|2017-10-11 03:48:12.939226
NCT01439685|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-06-01|||July 2011||2011-07-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|PDT||Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCP|Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy During Endoscopic Retrograde Cholangiopancreatography (ERCP): A Retrospective and Prospective Analysis|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University|||2|A single cohort, alternative trial was started.|f||||f||||||||||2017-10-11 03:48:13.046763|2017-10-11 03:48:13.046763
NCT01439672|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-10-24|2015-03-30||August 2010||2010-08-01|October 2016|2016-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|BPK005||Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability|Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability|Completed||N/A|35|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:48:13.116845|2017-10-11 03:48:13.116845
NCT01439659|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-03-17|||February 2003|Actual|2003-02-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer|A Randomized Phase II Study of the Nutritional Supplements Juice Plus + and Juice Plus + Complete in Ovarian Cancer Patients|Active, not recruiting||Phase 2|75|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 03:48:13.276839|2017-10-11 03:48:13.276839
NCT01439646|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-08-11|||August 2011||2011-08-01|August 2015|2015-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy|Observational, Retrospective Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy|Completed||N/A|100|Actual|Fortis Hospital, India|||1||f||||f||||||||||2017-10-11 03:48:13.374965|2017-10-11 03:48:13.374965
NCT01439633|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-04-14|||October 2010||2010-10-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus|Pilot Study to Evaluate OFDI Surveillance and Image Guided Biopsy of the Esophagus|Completed||Phase 1|22|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:48:13.620771|2017-10-11 03:48:13.620771
NCT01439620|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-10-27|||February 2009||2009-02-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Optical Frequency Domain Imaging (OFDI) for Biliary Stricture Imaging|Pilot Study to Evaluate Optical Frequency Domain Imaging (OFDI) for Biliary Stricture Imaging|Completed||Phase 1|20|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-11 03:48:13.739411|2017-10-11 03:48:13.739411
NCT01439607|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2014-05-22|||December 2009||2009-12-01|April 2014|2014-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|MGMC||Cellular and Molecular Mechanisms Governing Bone Marrow Stem Cells in Gaucher Disease|Cellular and Molecular Mechanisms Governing Bone Marrow Stem Cells, Macrophages and Plasma Cell Biology in Gaucher Disease.|Completed||N/A|30|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 03:48:13.845489|2017-10-11 03:48:13.845489
NCT01439594|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-10-27|||October 2008||2008-10-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|OFDI||Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation|Pilot Study to Evaluate Optical Frequency Domain Imaging as a Tool for Assessing the Tissue Response to Radiofrequency Ablation|Completed||Phase 1|17|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-11 03:48:13.945035|2017-10-11 03:48:13.945035
NCT01439568|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-01-03||2014-04-25|September 2011||2011-09-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|January 2014|Actual|2014-01-01||Interventional|||A Study of LY2510924 in Patients With Extensive-Stage Small Cell Lung Carcinoma|A Randomized Phase 2 Study of LY2510924 and Carboplatin/Etoposide Versus Carboplatin/Etoposide in Extensive-Stage Small Cell Lung Carcinoma|Completed||Phase 2|92|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:48:14.114765|2017-10-11 03:48:14.114765
NCT01439555|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-01-06|||November 2011||2011-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Endothelial Facilitation in Alzheimer's Disease|Endothelial Facilitation in Alzheimer's Disease. An Open Label Pilot Study of the Sequential and Cumulative Effects of Simvastatin, L-Arginine, and Sapropterin (Kuvan) on Cerebral Blood Flow and Cognitive Function in Patients With Alzheimer's Disease.|Active, not recruiting||Phase 2|10|Actual|University of Massachusetts, Worcester||1|||f||||f||||||||||2017-10-11 03:48:14.241432|2017-10-11 03:48:14.241432
NCT01439542|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-07-22|||September 2011||2011-09-01|July 2014|2014-07-01||||December 2021|Anticipated|2021-12-01||Interventional|FASTR||FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer|FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer|Terminated||Phase 2|19|Actual|Lawson Health Research Institute||1||Higher then expected Gr3 GU/GI toxicity|f||||t||||||||||2017-10-11 03:48:14.319807|2017-10-11 03:48:14.319807
NCT01439529|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-08-09|||April 2009||2009-04-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2016|Actual|2016-09-01||Interventional|BEST||ECG Optimization of CRT: Evaluation of Mid-term Response|Optimization of Response to Cardiac Resynchronization Therapy by Electrocardiogram: an Assessment of Medium-term Response|Active, not recruiting||Phase 3|180|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-10-11 03:48:14.399898|2017-10-11 03:48:14.399898
NCT01439516|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-04-15|||August 2012||2012-08-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|PREPARED||Providing Resources to Enhance African American Patients' Readiness to Make Decisions About Kidney Disease (PREPARED) Study|Information and Financial Interventions for Kidney Donation in African Americans|Completed||N/A|92|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 03:48:14.478116|2017-10-11 03:48:14.478116
NCT01439503|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-12-02|||September 2012||2012-09-01|December 2014|2014-12-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Safer Sex Program for Young African-American Men|A Brief, Clinic-Based, Safer Sex Program for Young African-American Men|Recruiting||Phase 2|620|Anticipated|University of Kentucky||2|||f||||f||||||||||2017-10-11 03:48:14.627127|2017-10-11 03:48:14.627127
NCT01439490|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-04-17|||August 2011||2011-08-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||FES-PET to Determine ER-expression in Epithelial Ovarian Cancer|Feasibility Study: FES-PET to Determine ER-expression in Epithelial Ovarian Cancer|Completed||Phase 2|15|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-11 03:48:14.740291|2017-10-11 03:48:14.740291
NCT01439477|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-11-17|||December 2013||2013-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||StrongWomen- Healthy Hearts: A Community Based Program for Midlife and Older Women|StrongWomen- Healthy Hearts: A Community Based Program for Midlife and Older Women|Completed||N/A|763|Actual|Tufts University|||1||f||||t||||||||||2017-10-11 03:48:14.840241|2017-10-11 03:48:14.840241
NCT01439464|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-22|2011-09-22|||October 2010||2010-10-01|September 2011|2011-09-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Interventional|||Study of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion|Clinical Efficacy and Safety of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion and, Titanium Cage Controlled, 1-year, Single-Blind, Non-Inferiority Trial|Unknown status|Recruiting|N/A|86|Anticipated|BioAlpha Inc.||2|||f||||f||||||||||2017-10-11 03:48:14.917178|2017-10-11 03:48:14.917178
NCT01439451|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-11|2015-08-05|||August 2011||2011-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2013|Actual|2013-08-01||Interventional|BaMPer||Effect of Perturbation Training on Balance Control in Elderly Persons|Effect of Balance Perturbation to Improve Gait and Balance Control and Prevent Falls in Elderly Persons -A Randomized Control Trial|Completed||N/A|48|Actual|Barzilai Medical Center||2|||f||||t||||||||||2017-10-11 03:48:15.050188|2017-10-11 03:48:15.050188
NCT01439438|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-06-27|||July 22, 2011|Actual|2011-07-22|June 2017|2017-06-01|September 11, 2011|Actual|2011-09-11|September 11, 2011|Actual|2011-09-11||Interventional|||Topiramate Bioequivalence Study Brazil - Fast|A Relative Bioavailability Study of Two Formulations of Topiramate 100 mg Coated Tablet in Healthy Male Volunteers, the Test Formulation Produced by Dr. Reddy's Laboratories Ltd. and the Reference Formulation (Topamax®) Marked by Janssen-Cilag Farmacêutica Ltda.|Completed||Phase 1|26|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:48:15.157303|2017-10-11 03:48:15.157303
NCT01439425|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2011-09-21|||November 2011||2011-11-01|September 2011|2011-09-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis|Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis: a Randomized, Investigator-blinded Study|Unknown status|Not yet recruiting|Phase 4|42|Anticipated|Universita di Verona||1|||f||||f||||||||||2017-10-11 03:48:15.263887|2017-10-11 03:48:15.263887
NCT01439412|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-03-23|||March 17, 2014|Actual|2014-03-17|March 2017|2017-03-01|March 17, 2018|Anticipated|2018-03-17|March 17, 2018|Anticipated|2018-03-17||Interventional|Acuback||Acupuncture in Acute Nonspecific Low Back Pain|Acupuncture in Acute Nonspecific Low Back Pain; a Randomized Controlled Multicenter Study in General Practice|Active, not recruiting||N/A|185|Actual|University of Oslo||2|||f||||f|f|f||||||Undecided||2017-10-11 03:48:15.370349|2017-10-11 03:48:15.370349
NCT01439399|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-21|||December 2005||2005-12-01|September 2011|2011-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Analgesic Efficacy of Intravenous Lidocaine and/or Ketamine|Analgesic Efficacy of Intravenous Perfusion of Lidocaine, Ketamine or a Combination After Laparotomy in a Placebo-controlled, Randomized, Double-blind Prospective Study|Completed||N/A|52|Actual|University of Lausanne Hospitals||4|||f||||f||||||||||2017-10-11 03:48:15.489033|2017-10-11 03:48:15.489033
NCT01439386|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-04-25|||September 2011||2011-09-01|July 2014|2014-07-01|July 2016|Actual|2016-07-01|July 2013|Actual|2013-07-01||Interventional|APPROVAL||Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter|Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter|Completed||Phase 3|86|Anticipated|Texas Cardiac Arrhythmia Research Foundation||2|||f||||f||||||||||2017-10-11 03:48:15.635542|2017-10-11 03:48:15.635542
NCT01439347|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-07-20|||March 2012||2012-03-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL|Phase 3 Study of Study to Evaluate Marqibo® in the Combination Chemotherapy in the Treatment of Subjects >or=60 Years Old With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)|Terminated||Phase 3|26|Actual|Spectrum Pharmaceuticals, Inc||2||Sponsor decision|f||||f||||||||||2017-10-11 03:48:18.315353|2017-10-11 03:48:18.315353
NCT01439334|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-22|2011-09-21|||December 2009||2009-12-01|September 2011|2011-09-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Interventional|SBIRT||Multiple Behavior Screening, Brief Intervention and Referral to Treatment (SBIRT) Model of Drug Abuse in Primary Care|Multiple Behavior SBIRT Model of Drug Abuse in Primary Care|Withdrawn||N/A|0|Actual|University of Florida||3||PI left UF|f||||t||||||||||2017-10-11 03:48:18.426788|2017-10-11 03:48:18.426788
NCT01439321|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2012-06-21|||November 2010||2010-11-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim|Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim|Completed||N/A|280|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:48:18.515067|2017-10-11 03:48:18.515067
NCT01439295|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2015-11-17|||August 2010||2010-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia|Urinary Ascorbyl Peroxide as an Early Biological Marker of Bronchopulmonary Dysplasia in Preterm Infants Less Than 33 Weeks of Gestation|Completed||N/A|51|Actual|St. Justine's Hospital|||1||f||||f||||||Samples With DNA|"     Urine sample (650 µl) Blood sample (500 µl)   "|||2017-10-11 03:48:18.709106|2017-10-11 03:48:18.709106
NCT01439282|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2016-05-11|2016-05-11||August 2011||2011-08-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|November 2012|Actual|2012-11-01||Interventional||Full Analysis Set (FAS) included all participants who received at least one dose of eribulin mesylate plus capecitabine.|Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer|A Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer|Completed||Phase 2|77|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 03:48:18.845884|2017-10-11 03:48:18.845884
NCT01438723|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-07-28|||November 2011||2011-11-01|November 2011|2011-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|MetCAB||The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial|The Metformin in CABG (MetCAB) Trial|Completed||Phase 4|100|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 03:48:30.617831|2017-10-11 03:48:30.617831
NCT01439269|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-01-30|||June 2008||2008-06-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|July 3, 2012|Actual|2012-07-03||Interventional|||Family Nurture Intervention (FNI) in Neonatal Intensive Care Unit (NICU)|Enhancement of Co-regulation Between Mother and Infant Via Family Nurture Intervention (FNI) in the NICU: Short and Long Term Effects on Development|Active, not recruiting||N/A|150|Anticipated|Columbia University||2|||f||||f||||||||Undecided||2017-10-11 03:48:21.333577|2017-10-11 03:48:21.333577
NCT01439256|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-02-14|||September 2011||2011-09-01|February 2017|2017-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|HTNMedTrack||Telehealth & Remote Measurement Technologies to Improve Medication Adherence in Hypertension|Telehealth & Remote Measurement Technologies to Improve Medication Adherence in Hypertension|Completed||N/A|207|Actual|Boston Medical Center||2|||f||||f|f|f||||||No||2017-10-11 03:48:21.457418|2017-10-11 03:48:21.457418
NCT01439243|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-20|||June 2007||2007-06-01|September 2011|2011-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Donepezil 10 mg Tablets Under Fed Conditions|Randomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Donepezil (Test) 10 mg Tablet and Aricept® (Reference) Following a 10 mg Dose in Healthy Subjects Under Fed Conditions|Completed||Phase 1|26|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-10-11 03:48:21.539765|2017-10-11 03:48:21.539765
NCT01439230|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-20|||June 2007||2007-06-01|September 2011|2011-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Donepezil 10 mg Tablets Under Fasting Conditions|Randomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Donepezil 10 mg Tablet and Aricept® (Reference) Following a 10 mg Dose in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|36|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-10-11 03:48:21.621318|2017-10-11 03:48:21.621318
NCT01439217|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2013-04-15|||June 2011||2011-06-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Endothelial Function, Arterial Stiffness and Components|Endothelial Function, Arterial Stiffness and Components of Metabolic Syndrome in Acute Lymphoblastic Leukemia (ALL) Survivors|Completed||N/A|32|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||||||2017-10-11 03:48:21.709158|2017-10-11 03:48:21.709158
NCT01439204|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-02-21|2013-11-04||October 2011||2011-10-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb|A Randomized, Open-label, Parallel-Group, Single-dose, Biocomparability Study of the Pharmacokinetics of Abatacept (BMS-188667) Drug Products Using Active Pharmaceutical Ingredient Manufactured at Devens, MA Site Relative to Active Pharmaceutical Ingredient Manufactured at Lonza, New Hampshire (NH) in Healthy Subjects|Completed||Phase 1|223|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 03:48:21.801947|2017-10-11 03:48:21.801947
NCT01439191|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-09-21|||July 2005||2005-07-01|June 2005|2005-06-01|May 2007|Actual|2007-05-01|February 2007|Actual|2007-02-01||Interventional|||Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer|An Open-Label Randomized Phase II Study of Cipterbin® or Cipterbin® in Combination With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer (MBC)|Completed||Phase 2|109|Actual|Shanghai CP Guojian Pharmaceutical Co.,Ltd.||2|||f||||t||||||||||2017-10-11 03:48:23.664157|2017-10-11 03:48:23.664157
NCT01439178|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-09-21|||August 2011||2011-08-01|September 2011|2011-09-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|||Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab|Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab|Unknown status|Recruiting|N/A|28|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-11 03:48:23.775483|2017-10-11 03:48:23.775483
NCT01439152|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-08-15|||September 7, 2011|Actual|2011-09-07|August 2017|2017-08-01|December 31, 2017|Anticipated|2017-12-31|September 30, 2017|Anticipated|2017-09-30||Interventional|||Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.|An Open Label Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Maximum Tolerated Dose of the Anti-mesothelin Antibody Drug Conjugate BAY94-9343 in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|147|Actual|Bayer||4|||f||||f|t|f||||||||2017-10-11 03:48:24.683225|2017-10-11 03:48:24.683225
NCT01439139|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-03-27|||September 2011||2011-09-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Bone UltraSonic Scanner (BUSS): Validation Study|Portable Bone Ultrasonometer for Osteoporosis Assessment|Completed||N/A|130|Actual|Artann Laboratories|||1||f||||f||||||||||2017-10-11 03:48:24.802609|2017-10-11 03:48:24.802609
NCT01439126|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-10-15|2013-06-18||August 2011||2011-08-01|October 2014|2014-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder|A 40-Week, Phase 4, Double-Blind, Placebo-Controlled, Multicenter, Randomized-Withdrawal Study to Evaluate the Long-Term Efficacy and Safety of KAPVAY™ (Clonidine Hydrochloride) Extended-Release in Children and Adolescents With ADHD|Completed||Phase 4|135|Actual|Concordia Pharmaceuticals Inc., Barbados||2|||f||||f||||||||||2017-10-11 03:48:24.894238|2017-10-11 03:48:24.894238
NCT01439113|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2011-09-21|||June 2010||2010-06-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Single-operator Ultrasound-guided IV Placement by Emergency Nurses|A Randomized Trial of Single-Operator Ultrasound-Guided vs. Standard-of-Care IV Placement by Emergency Nurses|Completed||N/A|50|Actual|Tufts Medical Center||2|||f||||f||||||||||2017-10-11 03:48:25.468273|2017-10-11 03:48:25.468273
NCT01439100|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-02-05|||October 2011||2011-10-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain||Completed||Phase 3|172|Anticipated|Mundipharma Research GmbH & Co KG||2|||f||||||||||||||2017-10-11 03:48:25.545889|2017-10-11 03:48:25.545889
NCT01436708|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2016-09-04|||June 2011||2011-06-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||The Association of Pelvic Organ Prolapse Severity and Urinary Symptoms/Sexual Function||Recruiting||N/A|500|Anticipated|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-10-11 03:49:14.4593|2017-10-11 03:49:14.4593
NCT01439074|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-09-26|2014-09-26||September 2011||2011-09-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||An Open, Randomized, Multi-centre Investigation With Mepilex Ag Versus Silver Sulfadiazine in the Treatment of Deep Partial Thickness Burn Injuries.|An Open, Randomized, Comparative, Multi-centre Investigation Evaluating the Efficacy and Tolerance of Mepilex Ag Versus Silver Sulfadiazine in the Treatment of Deep Partial Thickness Burn Injuries.|Completed||Phase 4|162|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-11 03:48:25.755746|2017-10-11 03:48:25.755746
NCT01439061|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-04-20|||March 2012||2012-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS ITA||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy|"Easypod Connect: A National, Multicentre, Observational Registry to Evaluate Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Italy"|Completed||N/A|220|Actual|Merck KGaA|||1||f||||||||||||||2017-10-11 03:48:26.068834|2017-10-11 03:48:26.068834
NCT01439048|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-08-27|||June 2009||2009-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Placental and Cord Blood Markers Associated With Premature Birth and Disorders of Premature Birth in Newborn Infants|Study of Environmental Toxicants and Inflammatory Markers in Prematurity and Diseases of Prematurity|Completed||N/A|82|Actual|Medical College of Wisconsin|||2||f||||f||||||Samples With DNA|"     whole blood, placenta   "|||2017-10-11 03:48:26.202954|2017-10-11 03:48:26.202954
NCT01439035|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-10-27|||August 2009||2009-08-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults|Pilot Study to Evaluate Use of Optical Frequency Domain Imaging (OFDI) for Duodenal Imaging in Celiac Disease in Children, Adolescents and Young Adults|Completed||Phase 1|6|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-10-11 03:48:26.353203|2017-10-11 03:48:26.353203
NCT01439022|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-10-20|||September 2011||2011-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Exercise Interventions in Parkinson's Disease|Longer-term Exercise Interventions in People With Parkinson's Disease|Completed||Phase 2|105|Actual|Oxford Brookes University||2|||f||||f||||||||||2017-10-11 03:48:26.432862|2017-10-11 03:48:26.432862
NCT01438996|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-02-04|2013-12-16||October 2011||2011-10-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults|A Phase 2, Open-label, Single-center, Extension Study to Evaluate the Booster Response Induced by Vi-CRM197 After Priming With Either Vi-CRM197 or Typherix Administered in Adult Subjects in H01_04TP Study (NCT01193907)|Completed||Phase 2|51|Actual|Novartis||3|||f||||f||||||||||2017-10-11 03:48:26.699437|2017-10-11 03:48:26.699437
NCT01438983|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2011-09-21|||July 2009||2009-07-01|September 2011|2011-09-01|June 2010|Actual|2010-06-01|||||Observational|||Oral Candida in Infants and Dietary Type|Evaluation the Effect of Dietary Type on Oral Candida Carriage in Infants|Completed||N/A|90|Actual|Shahid Sadoughi University of Medical Sciences and Health Services|||2||f||||t||||||Samples With DNA|"     infants with unremarkable health histories, normal weight, free of sign or symptom of oral     candidiasis or other mucosal disease.their mothers were also healthy and without sign or     symptom of vagina or mammary candidiasis.   "|||2017-10-11 03:48:27.399656|2017-10-11 03:48:27.399656
NCT01438970|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-08-10|||September 2011||2011-09-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function|Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function in Patients With Cirrhosis and Recurrent or Refractory Ascites|Active, not recruiting||Phase 2|12|Anticipated|Sequana Medical AG||1|||f||||f||||||||||2017-10-11 03:48:27.486102|2017-10-11 03:48:27.486102
NCT01438957|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-03-20|||June 2011||2011-06-01|November 2015|2015-11-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery With Epidural Anesthesia or Spinal Anesthesia Without Intubation|Phase III Randomized Placebo-controlled Double Blind Comparative Study to Investigate the Efficacy and Safety of DA-9501 in Sedation During the Surgery With Epidural Anesthesia or Spinal Anesthesia Without Intubation Under Monitored Sedation Care|Completed||Phase 3|120|Actual|Hospira, now a wholly owned subsidiary of Pfizer||5|||f||||f||||||||||2017-10-11 03:48:27.592667|2017-10-11 03:48:27.592667
NCT01438944|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-04-07|||July 2011|Actual|2011-07-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction|Evaluation of Nicotine Receptor Up-regulation Activity Through Metabolic Induction and Changes in Responsiveness Using Surrogate Evaluation Methods|Completed||Phase 1|52|Actual|The Queen Elizabeth Hospital||1|||f||||t||||||||Yes|Available upon request|2017-10-11 03:48:27.731521|2017-10-11 03:48:27.731521
NCT01438931|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-07-23|||July 2011||2011-07-01|July 2015|2015-07-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation|Phase III Randomized Placebo-controlled Double Blind Comparative Study to Investigate the Efficacy and Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation Under Monitored Sedation Care|Completed||Phase 3|162|Actual|Hospira, now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-10-11 03:48:27.851864|2017-10-11 03:48:27.851864
NCT01438918|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2012-01-24|||March 2012||2012-03-01|January 2012|2012-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee|A Long-term, Confirmatory, Phase 3, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study To Investigate The Safety And Efficacy Of Orally Administered Sd-6010 In Subjects With Symptomatic Osteoarthritis Of The Knee|Withdrawn||Phase 3|0|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 03:48:27.997054|2017-10-11 03:48:27.997054
NCT01438905|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-03-03|||September 2011||2011-09-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Joint Mobilization in the Treatment of Chronic Ankle Instability|Effect of Joint Mobilization on Muscle Activation and Function in Individuals With Chronic Ankle Instability|Completed||N/A|30|Anticipated|Creighton University||3|||f||||f||||||||||2017-10-11 03:48:28.109175|2017-10-11 03:48:28.109175
NCT01438892|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-04-04|||February 2012||2012-02-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Impact Of RA Therapy Compliance On Patient-Reported Outcomes|Impact Of RA Therapy Compliance On Patient-Reported Outcomes|Completed||N/A|396|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 03:48:28.217476|2017-10-11 03:48:28.217476
NCT01438879|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-21|||October 2011||2011-10-01|September 2011|2011-09-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||Lymphocytic Herpesviruses and Cerebrospinal Fluid Polymerase Chain Reaction (PCR)|Molecular Methods in the Etiological Diagnostics of Acute Central Nervous System Infections: Lymphocytic Herpesviruses and PCR|Unknown status|Not yet recruiting|N/A|60|Anticipated|PaijatHame Central Hospital|||2||f||||f||||||Samples With DNA|"     CSF white cells + CSF supernatant, Blood white cells and serum   "|||2017-10-11 03:48:28.352908|2017-10-11 03:48:28.352908
NCT01438853|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-21|||December 2004||2004-12-01|September 2011|2011-09-01|February 2008|Actual|2008-02-01|July 2006|Actual|2006-07-01||Interventional|||Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome|The Safety, Pharmacokinetics, and Pharmacodynamic Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome|Completed||Phase 1|18|Actual|Altor BioScience||2|||f||||t||||||||||2017-10-11 03:48:28.607632|2017-10-11 03:48:28.607632
NCT01438840|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2016-12-12||2015-06-29|February 2012||2012-02-01|December 2016|2016-12-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenia Purpura)|Completed||Phase 3|49|Actual|Eisai Inc.||3|||f||||t||||||||||2017-10-11 03:48:28.739963|2017-10-11 03:48:28.739963
NCT01438827|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-01-20|||September 2011||2011-09-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Avanz Phleum Pratense Maintenance Dose|Avanz Phleum Pratense Maintenance Dose|Completed||Phase 2/Phase 3|450|Actual|ALK-Abelló A/S||3|||f||||||||||||||2017-10-11 03:48:28.892293|2017-10-11 03:48:28.892293
NCT01438814|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2014-11-13|2014-02-28||November 2011||2011-11-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Treated set (TS): all patients treated with at least 1 dose of randomised study medication|Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control|A Randomised, Double-blind, Double-dummy, Active-comparator Controlled Study Investigating the Efficacy and Safety of Linagliptin Co-administered With Metformin QD at Evening Time Versus Metformin BID Over 14 Weeks in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control|Completed||Phase 4|689|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:48:29.008785|2017-10-11 03:48:29.008785
NCT01438801|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2013-12-19|||May 2013||2013-05-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)|Predictive Value of Baseline and Stimulated Serum IGF-1 and IGFBP-3 During a Dose-escalation IGF-1 Generation Test for the 1 Year Growth Response to Growth Hormone (GH) Therapy in Short Children With Low IGF-1 and a Normal GH Peak in a Provocation Test|Withdrawn||Phase 4|0|Actual|Ipsen||1||Participant enrollment was not feasible|f||||t||||||||||2017-10-11 03:48:29.972918|2017-10-11 03:48:29.972918
NCT01438788|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-10-28|||October 2011||2011-10-01|October 2016|2016-10-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|LPD||Low Protein Diet in Patients With Collagen VI Related Myopathies|Low Protein Diet to Correct Defective Autophagy in Patients With Collagen VI Related Myopathies|Completed||Phase 2|8|Actual|Istituto Ortopedico Rizzoli||1|||f||||f||||||||||2017-10-11 03:48:30.076547|2017-10-11 03:48:30.076547
NCT01438775|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-04-01||2014-04-01|September 2011||2011-09-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)|Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart|Completed||Phase 3|192|Actual|Nymox Corporation||1|||f||||f||||||||||2017-10-11 03:48:30.157216|2017-10-11 03:48:30.157216
NCT01438762|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-03-23|||June 2011||2011-06-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Early Intervention for Adolescents With Patellofemoral Pain Syndrome|Early Intervention for Adolescents With Patellofemoral Pain Syndrome - a Cluster Randomized Trial|Completed||N/A|102|Actual|Northern Orthopaedic Division, Denmark||3|||f||||f||||||||||2017-10-11 03:48:30.304467|2017-10-11 03:48:30.304467
NCT01438749|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2016-11-01|||October 2011||2011-10-01|November 2016|2016-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users|Human Abuse Liability Study in Recreational Drug Users to Investigate the Abuse Liability Potential of RO4917838|Completed||Phase 1|177|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:48:30.424702|2017-10-11 03:48:30.424702
NCT01438736|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-21|||September 2011||2011-09-01|September 2011|2011-09-01||||November 2012|Anticipated|2012-11-01||Interventional|||Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?|A Randomized Study to Evaluate the Predictive Impact of Using Cerazette Progestin Only Pill Before Nexplanon Insertion Regarding Bleeding Pattern|Unknown status|Not yet recruiting|Phase 4|90|Anticipated|VL-Medi Oy||2|||f||||||||||||||2017-10-11 03:48:30.52813|2017-10-11 03:48:30.52813
NCT00000237|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16|||May 1997||1997-05-01|May 1997|1997-05-01||||||||Interventional|||Buprenorphine Detoxification - BBDVI - 19|Buprenorphine Detoxification - BBDVI|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:41.348252|2017-10-11 04:17:41.348252
NCT01438710|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-09-15|2015-03-23||December 2011||2011-12-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|August 2012|Actual|2012-08-01||Interventional|STRATO|44 patients started on the initial one-week treatment on Prograf and 41 were switched to the one-week LCP-Tacro treatment. 40 patients completed the one-week treatment on LCP-Tacro and continued into the 24-months extended use period.|Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)|Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)|Completed||Phase 3|44|Actual|Veloxis Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:48:30.73679|2017-10-11 03:48:30.73679
NCT01438697|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-01-11|||October 2011||2011-10-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|SHUTi||An Interactive Internet Intervention for Adults With Insomnia|An Internet Intervention for Insomnia: Efficacy and Dissemination|Completed||Phase 3|303|Actual|University of Virginia||2|||f||||t||||||||No||2017-10-11 03:48:31.079885|2017-10-11 03:48:31.079885
NCT01438684|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2015-08-30|||September 2012||2012-09-01|August 2015|2015-08-01|October 2018|Anticipated|2018-10-01|January 2017|Anticipated|2017-01-01||Interventional|RPh-in-CVS||The Impact of RPh201 on Chronic Vegetative State (CVS): fMRI Study|Phase 1 Study of RPh201 in Patients With Chronic Vegetative or Minimal Conscious State|Recruiting||Phase 1|10|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 03:48:31.18391|2017-10-11 03:48:31.18391
NCT01438671|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-09-29|||September 2011||2011-09-01|September 2016|2016-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Wii Fit Balance Training Compared to Traditional Balance Training in Patients With SCI/TBI/CVA|Does Wii Fit Balance Training Significantly Improve Standing Balance Compared to Traditional Balance Training and Is Wii Fit Balance Training Preferred Over Traditional Balance Training by Patients With SCI/TBI/CVA?|Withdrawn||N/A|0|Actual|University of Missouri-Columbia||1||Facility where study was taking place closed.|f||||f||||||||No||2017-10-11 03:48:31.269892|2017-10-11 03:48:31.269892
NCT01438658|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2011-09-27|||September 2011||2011-09-01|September 2011|2011-09-01|December 2040|Anticipated|2040-12-01|December 2040|Anticipated|2040-12-01||Observational|UM||Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma|Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma|Recruiting||N/A|250|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples Without DNA|"     sera from patients   "|||2017-10-11 03:48:31.351795|2017-10-11 03:48:31.351795
NCT01438645|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-01-16|||September 2011||2011-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy|ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy for Improved Endoscopic Performance and Enhanced Patient Experience|Completed||N/A|250|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 03:48:31.43605|2017-10-11 03:48:31.43605
NCT01438632|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2013-03-11|||September 2011||2011-09-01|August 2011|2011-08-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Pharmacology of Insulin Injected With Jet-injection in Diabetes|Pharmacology of Rapid-acting Insulin Injected by Needle-free Jet-injection in Patients With Diabetes|Completed||Phase 4|24|Actual|Radboud University||2|||f||||t||||||||||2017-10-11 03:48:31.544368|2017-10-11 03:48:31.544368
NCT01438619|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2013-01-21|||April 2011||2011-04-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Research for the Improvement in Measurement Methods and the Effect of Sodium Intake on Cardiovascular Health|Sodium Intake: Research for the Improvement in Measurement Methods and the Effect of Sodium Intake on Cardiovascular Health|Completed||N/A|620|Actual|DongGuk University|||1||f||||f||||||||||2017-10-11 03:48:31.678176|2017-10-11 03:48:31.678176
NCT01438606|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2016-06-13|||October 2011||2011-10-01|June 2016|2016-06-01||||January 2013|Actual|2013-01-01||Interventional|||Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of VSV-Indiana HIV Gag Vaccine Given Intramuscularly in Healthy, HIV-1-Uninfected Adult Participants|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||10|||f||||t||||||||||2017-10-11 03:48:31.763573|2017-10-11 03:48:31.763573
NCT01438593|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-07-31|||January 2013||2013-01-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke|An Exploratory Clinical Trial to Assess Treatment of Chronic Ischemic Stroke With Brain Transplants of Purified CD34+ Umbilical Cord Blood Stem Cells|Unknown status|Not yet recruiting|Phase 1|6|Anticipated|China Medical University Hospital||1|||f||||t||||||||||2017-10-11 03:48:31.886487|2017-10-11 03:48:31.886487
NCT01438580|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-05-18|||January 2010||2010-01-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Interventional|||The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation||Completed||Phase 4|260|Actual|Nanjing Medical University||3|||f||||t||||||||||2017-10-11 03:48:31.992848|2017-10-11 03:48:31.992848
NCT01438567|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2014-10-13|||September 2011||2011-09-01|January 2014|2014-01-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy|A Randomised, Double-blind, Double-dummy, Parallel-group Multicenter Study to Demonstrate Improvement in Symptoms of Constipation and Non-inferiority in Analgesic Efficacy in Subjects With Non-malignant or Malignant Pain That Require Around-the-clock Opioid Therapy Taking 50/25 - 80/40 mg Twice Daily as Oxycodone/Naloxone Prolonged Release (OXN PR) Tablets Compared to Subjects Taking 50 - 80 mg Twice Daily Oxycodone Prolonged Release (OxyPR) Tablets Alone|Completed||Phase 3|270|Actual|Mundipharma Research GmbH & Co KG||2|||f||||||||||||||2017-10-11 03:48:32.081759|2017-10-11 03:48:32.081759
NCT01438554|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2017-04-26|||October 2011|Actual|2011-10-01|April 2017|2017-04-01||||April 2016|Actual|2016-04-01||Interventional|||Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma|Phase I Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib, a VEGFR/PDGFR/Raf Inhibitor, and GSK1120212, a MEK Inhibitor, in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer, Soft Tissue Sarcoma, and Cholangiocarcinoma|Active, not recruiting||Phase 1|111|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 03:48:32.166881|2017-10-11 03:48:32.166881
NCT01436695|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-17|2011-09-19|||November 2011||2011-11-01|September 2011|2011-09-01||||June 2012|Anticipated|2012-06-01||Observational|||Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers|Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers|Unknown status|Not yet recruiting|N/A|30|Anticipated|Epicall LTD|||1||f||||f||||||||||2017-10-11 03:49:14.526943|2017-10-11 03:49:14.526943
NCT01438541|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2016-08-22|2016-05-13||September 2011||2011-09-01|August 2016|2016-08-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Interventional|||A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration|A Multi-centre, Post CE-mark, Open Study to Evaluate the Performance of Thin Self-adherent Dressing Coated With a Soft Silicone Layer on Subjects With High Risk of Category 2 or Above Pressure Ulceration|Completed||Phase 4|29|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 03:48:32.261485|2017-10-11 03:48:32.261485
NCT01438528|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-04-20|||December 2011||2011-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS CHN||Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment|"Easypod Connect: A National, Multicentre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using easypodTM Electromechanical Device for Growth Hormone Treatment in China"|Completed||N/A|75|Actual|Merck KGaA|||1||f||||||||||||||2017-10-11 03:48:32.467079|2017-10-11 03:48:32.467079
NCT01438515|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-21|2017-08-17|||August 2008||2008-08-01|August 2017|2017-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization|Randomized Controlled Trial of Chlorhexidine Gluconate, Intranasal Mupirocin, Rifampin and Doxycycline Versus Chlorhexidine Gluconate and Intranasal Mupirocin Alone for the Eradication of Methicillin-resistant Staphylococcus Aureus Among an Ambulatory Patient Population|Active, not recruiting||N/A|100|Actual|Horizon Health Network||2|||f||||f||||||||||2017-10-11 03:48:32.663448|2017-10-11 03:48:32.663448
NCT01438502|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2013-11-23||||||November 2013|2013-11-01||||||||Observational|||"The Effect of Reduced Fluid Load After Cardiac Surgery"|"The Impact of Hypertonic Saline/ Colloids Infusion During Cardio-pulmonary-bypass in Patients Expected Long CPB-time"|Withdrawn||Early Phase 1|0|Actual|Haukeland University Hospital|||1|Changes in staff resulted in logistic difficulties to perform the study|f||||t||||||||||2017-10-11 03:48:32.774184|2017-10-11 03:48:32.774184
NCT01438489|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-08-29|2016-07-05||January 2012||2012-01-01|August 2016|2016-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Intent-to-treat (ITT) population included all participants who were randomized into the study.|A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus|A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus|Completed||Phase 2|626|Actual|MedImmune LLC||3|||f||||t||||||||||2017-10-11 03:48:32.89039|2017-10-11 03:48:32.89039
NCT01438476|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-09-26|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas|Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient Controlled Analgesia (3:1) in Patients Undergoing Liver and/or Pancreatic Resection|Active, not recruiting||Phase 3|178|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 03:48:34.77032|2017-10-11 03:48:34.77032
NCT01438463|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-05-28|||September 2011||2011-09-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis|A Multi-centre, Randomized, Double-blind, Placebo-controlled, Dose Range Finding Study to Identify the Optimal Dose of PURETHAL® Mites SCIT in Patients With House Dust Mites-induced Persistent Allergic Rhinitis/Rhinoconjunctivitis|Completed||Phase 2|290|Actual|HAL Allergy||5|||f||||t||||||||||2017-10-11 03:48:34.882896|2017-10-11 03:48:34.882896
NCT01438450|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-07-12|||October 2007||2007-10-01|July 2012|2012-07-01|September 2014|Anticipated|2014-09-01|August 2013|Anticipated|2013-08-01||Interventional|OTCHCC||Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma|RCT Of Oral Thalidomide And Capecitabine Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma (BCLC D)|Unknown status|Recruiting|Phase 2/Phase 3|74|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-10-11 03:48:35.101281|2017-10-11 03:48:35.101281
NCT01438437|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-07-12|||March 2001||2001-03-01|July 2012|2012-07-01|September 2015|Anticipated|2015-09-01|August 2014|Anticipated|2014-08-01||Interventional|||Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis||Unknown status|Recruiting|Phase 4|54|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-10-11 03:48:35.237667|2017-10-11 03:48:35.237667
NCT01438424|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2012-07-19|2012-06-12||January 2001||2001-01-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials|A Preliminary Assessment of Safety and Antiviral Activity of Open-label Entecavir in Subjects With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials|Completed||Phase 2|1053|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 03:48:35.513331|2017-10-11 03:48:35.513331
NCT01438411|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-08-15|||January 2010||2010-01-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis|An Open Label, Single Center, Nonrandomized Continuation Study of Cholic Acid Capsules to Treat Subjects With Inborn Errors of Bile Acid Synthesis|Completed||Phase 3|53|Actual|Retrophin, Inc.||1|||f||||f||||||||||2017-10-11 03:48:40.474381|2017-10-11 03:48:40.474381
NCT01438398|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2017-05-09|||April 8, 2011|Actual|2011-04-08|May 2017|2017-05-01|October 22, 2015|Actual|2015-10-22|January 6, 2015|Actual|2015-01-06||Interventional|||Efficacy & Safety of Submucosal Endoscopic Myotomy With Mucosal Flap (SEMF) in the Treatment of Patients With Achalasia|A Prospective, Single Center, Proof of Concept Pilot Study of the Efficacy and Safety of Submucosal Endoscopic Myotomy With Mucosal Flap (SEMF) Technique in the Treatment of Patients With Achalasia|Completed||N/A|120|Actual|Winthrop University Hospital||1|||f||||t||||||||||2017-10-11 03:48:40.571055|2017-10-11 03:48:40.571055
NCT01438385|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-02-16|||July 2011||2011-07-01|February 2017|2017-02-01|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Observational|||Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders|Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders|Recruiting||N/A|12000|Anticipated|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|No IPD Sharing|2017-10-11 03:48:40.659258|2017-10-11 03:48:40.659258
NCT01436682|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2013-10-24|||September 2011||2011-09-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Assisted Nerve Blocks||Completed||N/A|13|Actual|McGill University Health Center|||1||f||||f||||||||||2017-10-11 03:49:14.61691|2017-10-11 03:49:14.61691
NCT01438372|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-01-04|||November 2011||2011-11-01|September 2011|2011-09-01|March 2012|Anticipated|2012-03-01|February 2012|Anticipated|2012-02-01||Interventional|||IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD|Intravenous Iron Sucrose Versus Oral Ferrous Sulfate in Treating Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease|Withdrawn||Phase 2|0|Actual|Wayne State University||2||"The study was terminated prior to enrolling patients as we were unable to secure enough funding   to complete the study."|f||||t||||||||||2017-10-11 03:48:40.759563|2017-10-11 03:48:40.759563
NCT01438359|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2011-09-29|||July 2011||2011-07-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Drug-Drug Interaction Study of Furosemide and PA21|A Single-centre, Open-label, Three-period Study of the Pharmacokinetic Effect of PA21 on Furosemide in Healthy Male and Female Adults|Completed||Phase 1|42|Anticipated|Vifor Inc.||3|||f||||f||||||||||2017-10-11 03:48:40.855002|2017-10-11 03:48:40.855002
NCT01438346|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2016-12-01|||August 2011||2011-08-01|December 2016|2016-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Behavioral Treatment for Substance Abuse|A Pilot Study of Two Group-based Intervention Programs for Patients With Substance Abuse Problems|Completed||N/A|38|Actual|University of Utah||2|||f||||f||||||||No||2017-10-11 03:48:40.930945|2017-10-11 03:48:40.930945
NCT01438333|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-06-16|||September 2011||2011-09-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection|Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection: a Randomized, Double Masked, Placebo Controlled Clinical Trial|Completed||N/A|15|Actual|University of L'Aquila||2|||f||||t||||||||||2017-10-11 03:48:41.060923|2017-10-11 03:48:41.060923
NCT01438320|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-03-18|||July 2011||2011-07-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|Q||Q-Trial in Patients With Hepatitis C|A Phase 1 Study of Quercetin in Patients With Hepatitis C|Completed||Phase 1|34|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-10-11 03:48:41.232303|2017-10-11 03:48:41.232303
NCT01438307|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-04-24|2017-03-03||September 2011||2011-09-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer|Phase II Study of a Novel Taxane (Cabazitaxel-XRP6258) in Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients|Completed||Phase 2|28|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 03:48:41.322478|2017-10-11 03:48:41.322478
NCT01438294|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2014-10-05|2014-07-05||November 2011||2011-11-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||Exercise Training in Asthma Children|Effects of Exercise Training on Markers of Lung Inflammation and Clinical Crontrol in Asthma Children|Completed||N/A|36|Actual|Hospital Sirio-Libanes||2|||f||||f||||||||||2017-10-11 03:48:41.664091|2017-10-11 03:48:41.664091
NCT01438281|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-07-16|||July 2011||2011-07-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|November 2011|Actual|2011-11-01||Interventional|||Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers|Phase I Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers|Completed||Phase 1|30|Actual|Sylentis, S.A.||1|||f||||f||||||||||2017-10-11 03:48:42.062105|2017-10-11 03:48:42.062105
NCT01438268|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-11-15|||July 2011||2011-07-01|November 2013|2013-11-01|January 2014|Anticipated|2014-01-01|August 2013|Actual|2013-08-01||Observational|TRAM||TRAM Procedure in Ambulatory Surgical Facility: Quality of Recovery Outcomes|Expedited Discharge of Patients Undergoing Pedicled TRAM Flap Breast Reconstruction Procedure in Ambulatory Surgical Facility: Quality of Recovery Outcomes|Unknown status|Active, not recruiting|N/A|60|Anticipated|Women's College Hospital|||1||f||||f||||||||||2017-10-11 03:48:42.16808|2017-10-11 03:48:42.16808
NCT01438255|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2012-08-21|||July 2010||2010-07-01|August 2012|2012-08-01||||July 2012|Actual|2012-07-01||Observational|||Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real Practice||Completed||N/A|274|Actual|Handok Pharmaceuticals Co., Ltd.|||1||f||||f||||||||||2017-10-11 03:48:42.261318|2017-10-11 03:48:42.261318
NCT01438242|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-03-20|||January 2015||2015-01-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression|An Open Label Study of the Genecept™ Assay to Evaluate Efficacy of Using Assay Guided Treatment in Outpatient Adults With Treatment Resistant Depression|Withdrawn||N/A|0|Actual|Genomind, LLC||2|||f||||f||||||||||2017-10-11 03:48:42.344055|2017-10-11 03:48:42.344055
NCT01438229|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2015-05-24|2015-04-17||October 2011||2011-10-01|February 2014|2014-02-01|July 2014|Actual|2014-07-01|September 2012|Actual|2012-09-01||Interventional|EnligHTN-I|Subjects completing renal artery ablation procedure|Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients|Ablation-induced Renal Sympathetic Denervation Trial|Completed||N/A|47|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 03:48:42.492405|2017-10-11 03:48:42.492405
NCT01438216|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2011-09-19|||September 2011||2011-09-01|September 2011|2011-09-01|March 2012|Anticipated|2012-03-01|February 2012|Anticipated|2012-02-01||Observational|ANICK||Anidulafungin Pharmacokinetics in Intensive Care Unit Patients|Anidulafungin Population Kinetics in the Intensive Care Population|Unknown status|Recruiting|N/A|20|Anticipated|VU University Medical Center|||2||f||||f||||||Samples Without DNA|"     whole blood   "|||2017-10-11 03:48:43.606316|2017-10-11 03:48:43.606316
NCT01438203|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-08-31|||February 2011||2011-02-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Thrust Manipulation Versus Non-Thrust Manipulation|Early Use of Thrust Manipulation Versus Non-Thrust Manipulation: A Randomized Clinical Trial|Completed||Phase 2|149|Actual|Walsh University||2|||f||||f||||||||||2017-10-11 03:48:43.740862|2017-10-11 03:48:43.740862
NCT01438190|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2013-07-11|||June 2013||2013-06-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Metformin in Step-down Regimen Versus Conventional Low Dose Step-up Protocol in Patients With PCOS Undergoing IVF|A Comparison Study of a Novel Stimulation Protocol With Metformin in Step-down Regimen and the Conventional Low Dose Step-up Protocol in Patients With Polycystic Ovary Syndrome Undergoing in Vitro Fertilization|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|University of Modena and Reggio Emilia||2|||f||||f||||||||||2017-10-11 03:48:43.825668|2017-10-11 03:48:43.825668
NCT01438177|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-06-16|2015-05-14||October 2011||2011-10-01|June 2016|2016-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma|A Phase II, Trial of Chloroquine in Combination With VELCADE and Cyclophosphamide in Patients With Relapsed and Refractory Myeloma|Completed||Phase 2|11|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 03:48:43.924408|2017-10-11 03:48:43.924408
NCT01438164|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-09-20|||June 2005||2005-06-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|June 2010|Actual|2010-06-01||Observational|||Cost-effectiveness of FDG-PET|Estudo de Custo-efetividade Para o Sistema único de Saúde - SUS Sobre o Exame de Metabolismo de Glicose Marcada Com Flúor-18 Pela Tomografia de emissão de pósitron-PET|Completed||N/A|500|Actual|University of Sao Paulo|||1||f||||f||||||||||2017-10-11 03:48:44.440789|2017-10-11 03:48:44.440789
NCT01438151|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-03-04|2014-01-06||December 2011||2011-12-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease|Association of Serum Infliximab and Antibodies Toward Infliximab (ATI) to Clinical Outcomes in Crohn's Disease|Terminated||N/A|11|Actual|Icahn School of Medicine at Mount Sinai|Study was terminated without completion due to poor enrollment.|1||terminated due to poor enrollment|f||||f||||||||||2017-10-11 03:48:44.508731|2017-10-11 03:48:44.508731
NCT01438138|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-17|2016-05-16|||September 2011||2011-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia|Validation of a Classifier for the Prediction of Risk of Relapse Using Single Cell Network Profiling (SCNP) Assays for Childhood AML|Completed||N/A|98|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     bone marrow   "|||2017-10-11 03:48:44.706045|2017-10-11 03:48:44.706045
NCT01438125|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-03-28|||February 2009||2009-02-01|March 2013|2013-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||MF-4181 for the Reduction of Scars Secondary to Abdominoplasty or Laparoscopy/Laparotomy Gynecologic Procedures|A Pilot Study to Evaluate the Safety and Preliminary Efficacy of MF-4181 for the Reduction of Scars Secondary to Abdominoplasty or Laparoscopy/Laparotomy Gynecologic Procedures|Completed||Phase 2|100|Actual|Halscion, Inc.||2|||f||||f||||||||||2017-10-11 03:48:44.811883|2017-10-11 03:48:44.811883
NCT01438112|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2016-07-27|||March 2014||2014-03-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|November 2018|Anticipated|2018-11-01||Interventional|BOND||Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer|An Integrated Phase II/III, Open Label, Randomized and Controlled Study of the Safety and Efficacy of CG0070 Adenovirus Vector Expressing GM-CSF in Patients With Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ Disease Who Have Failed BCG|Terminated||Phase 2/Phase 3|22|Actual|Cold Genesys, Inc.||2||Change in study design|f||||t||||||||||2017-10-11 03:48:44.929333|2017-10-11 03:48:44.929333
NCT01438099|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-08-23|||October 2011||2011-10-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Reliability of Ultrasound Assisted Epidural Analgesia in Obese and Normal Weight Parturients|Reliability of Ultrasound Assisted Epidural Analgesia in Obese and Normal Weight Parturients|Completed||N/A|300|Actual|Università degli Studi dell'Insubria|||2||f||||t||||||||||2017-10-11 03:48:45.090486|2017-10-11 03:48:45.090486
NCT01438073|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2017-06-16|||September 2011|Actual|2011-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling|Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling|Recruiting||Phase 1|156|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:48:45.302466|2017-10-11 03:48:45.302466
NCT01438060|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2013-11-07|2012-02-01||August 2000||2000-08-01|November 2013|2013-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type|A Multicenter, Randomized, Double-Blind, Placebo Controlled Flexible Dose Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type|Completed||Phase 3|232|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|Limitations of the study, such as early termination leading to small numbers of subjects analyzed and technical problems with measurement leading to unreliable or uninterpretable data|2|||f||||f||||||||||2017-10-11 03:48:45.588386|2017-10-11 03:48:45.588386
NCT01438047|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-04-03|||September 2010||2010-09-01|April 2014|2014-04-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|||Optical Frequency Domain Imaging (OFDI) in Dermatology|OFDI in Dermatology|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||1|"The study was closed due to a shift in research priorities and a lack of resources available   for the project."|f||||f||||||||||2017-10-11 03:48:49.064138|2017-10-11 03:48:49.064138
NCT01438034|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2017-06-16|||November 2011||2011-11-01|June 2017|2017-06-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Interventional|||Kisspeptin in the Evaluation of Delayed Puberty|Kisspeptin in the Evaluation of Delayed Puberty|Recruiting||Phase 1|100|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:48:49.136704|2017-10-11 03:48:49.136704
NCT01438021|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-11-08|||September 2012||2012-09-01|November 2012|2012-11-01||||November 2013|Anticipated|2013-11-01||Interventional|||Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease|Characterization of the Pharmacokinetics and Efficacy of Intraventricular Methotrexate Continuously Delivered Via a Mini Pump for Treatment of Leptomeningeal Disease|Withdrawn||N/A|0|Actual|City of Hope Medical Center||1||Lack of funding|f||||t||||||||||2017-10-11 03:48:49.252693|2017-10-11 03:48:49.252693
NCT01438008|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-08-04|||May 2012|Actual|2012-05-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Pilot Study of Sucrose to Reduce Pain in Sick Babies|Be Sweet to Sick Babies: Analgesic Effects of Oral Sucrose and Concomitant Opioid Analgesics; a Pilot Randomized Controlled Trial|Terminated||Phase 4|9|Actual|Children's Hospital of Eastern Ontario||2||Feasibility of study at single site; changes in clinical practice in opioid use|f||||t||||||||||2017-10-11 03:48:49.365117|2017-10-11 03:48:49.365117
NCT01437995|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2017-03-14|2016-10-07||March 2012||2012-03-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|LASST||Long-acting Beta Agonist Step Down Study|Long-acting Beta Agonist Step Down Study|Completed||Phase 4|459|Actual|Johns Hopkins University|At the time of this release, this data has not undergone peer-review.|3|||f||||t||||||||||2017-10-11 03:48:49.516124|2017-10-11 03:48:49.516124
NCT01437982|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-02-08|||February 2013|Actual|2013-02-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%|A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%|Active, not recruiting||Phase 4|140|Anticipated|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 03:48:51.062965|2017-10-11 03:48:51.062965
NCT01437969|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2012-04-14|||September 2011||2011-09-01|April 2012|2012-04-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|||Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.|Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Chronic Infection naïve to Antiviral Treatment.|Unknown status|Recruiting|N/A|500|Anticipated|Casa Sollievo della Sofferenza IRCCS|||1||f||||||||||Samples With DNA|"     DNA from blood sample   "|||2017-10-11 03:48:51.173207|2017-10-11 03:48:51.173207
NCT01437956|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2011-09-20|||October 2011||2011-10-01|September 2011|2011-09-01|October 2016|Anticipated|2016-10-01|May 2016|Anticipated|2016-05-01||Observational|||KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis|Acute Bronchiolitis in Infants: Analysis of a Biomarker of Epithelial Lung Injury - Clinical and Virological Correlation|Unknown status|Not yet recruiting|N/A|200|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 03:48:51.260719|2017-10-11 03:48:51.260719
NCT01437943|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2017-03-21|2017-01-15||April 2010||2010-04-01|March 2017|2017-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients|P-MR Spectroscopy Evaluation of the Effect of Short-Term Treatment With Aliskiren on Kidney β-ATP/Pi Level in Kidney Transplant Patients|Terminated||Phase 4|10|Actual|Brigham and Women's Hospital|In December 2011, all studies involving Aliskiren were terminated by Novartis after interim analysis of the ALTITUDE trial.|2||"Novartis has have decided to terminate all clinical investigator-initiated research projects   involving aliskiren"|f||||f||||||||||2017-10-11 03:48:51.328889|2017-10-11 03:48:51.328889
NCT01437930|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-07-28|||September 2011||2011-09-01|March 2012|2012-03-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Interventional|||Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemic Patients|Influence of Intervention With n-3 PUFA-supplemented Products in Moderate Hypertriglyceridemic Patients on Cardiovascular Risk Factors|Completed||N/A|60|Actual|University of Jena||1|||f||||t||||||||||2017-10-11 03:48:51.667515|2017-10-11 03:48:51.667515
NCT01437917|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2012-05-15|||September 2011||2011-09-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|NOMAC||NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.|NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.|Completed||N/A|10|Actual|Rennes University Hospital||3|||f||||f||||||||||2017-10-11 03:48:51.782713|2017-10-11 03:48:51.782713
NCT01437904|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-11-05|||March 2011||2011-03-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||A Pilot Study Assessing The Feasibility Of Outpatient Tubeless Percutaneous Nephrolithotomy (PCNL)|A Pilot Study Assessing The Feasibility Of Outpatient Tubeless Percutaneous Nephrolithotomy (PCNL)|Completed||N/A|10|Actual|Queen's University||2|||f||||f||||||||||2017-10-11 03:48:51.954303|2017-10-11 03:48:51.954303
NCT01437891|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2012-02-02|||September 2011||2011-09-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|GWF001||Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF)|An Open-label Clinical Outcomes Study to Determine the Safety and Efficacy of Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder and Gulf War Fibromyalgia|Completed||N/A|30|Actual|Targeted Medical Pharma|||1||f||||f||||||||||2017-10-11 03:48:52.045414|2017-10-11 03:48:52.045414
NCT01437878|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2015-10-16|2014-12-12||March 2012||2012-03-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)|A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease|Terminated||Phase 2|2|Actual|Actelion||2||low recruitment|f||||f||||||||||2017-10-11 03:48:52.13659|2017-10-11 03:48:52.13659
NCT01437865|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2012-04-05|||September 2011||2011-09-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Gadofosveset for Axillary Staging in Breast Cancer Patients|Non-invasive Nodal Staging in Breast Cancer With MRI Lymphography Using Gadofosveset; a Pilot-study|Completed||N/A|10|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 03:48:52.666059|2017-10-11 03:48:52.666059
NCT01437839|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2011-10-21|||September 2011||2011-09-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Food Effect Study For Apixaban Commercial Image Tablets|An Open Label, Randomized, 2-period Crossover Study Evaluating Single Dose Food Effect On Apixaban Commercial Image Tablets In Healthy Subjects|Completed||Phase 1|22|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:48:52.862681|2017-10-11 03:48:52.862681
NCT01437826|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2011-09-19|||March 1988||1988-03-01|September 2011|2011-09-01|June 1996|Actual|1996-06-01|June 1996|Actual|1996-06-01||Interventional|||Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial|Evaluation of the Efficacy of a Combination of Micronutrients (Vitamin A, C, E, Selenium and Zinc) in Reducing the Incidence of Colorectal Metachronous Adenomas. A Double Blind, Phase III, Randomized, Placebo-controlled Trial|Terminated||Phase 3|411|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||2||50% of eligible patients refused to enter the study|f||||f||||||||||2017-10-11 03:48:52.973469|2017-10-11 03:48:52.973469
NCT01436669|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2012-10-17|||June 2011||2011-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:49:14.677104|2017-10-11 03:49:14.677104
NCT01437813|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2011-09-20|||January 2011||2011-01-01|January 2011|2011-01-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|GLMT13||BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study|Bioavailability of Glimepiride/Extended Release Metformin (4/850 mg) After a High Fat Diet, in Healthy Mexican Volunteers|Completed||Phase 1|24|Actual|Laboratorios Silanes S.A. de C.V.||1|||f||||t||||||||||2017-10-11 03:48:53.062446|2017-10-11 03:48:53.062446
NCT01437800|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2011-09-20|||January 2011||2011-01-01|January 2011|2011-01-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|GLMT12-SIL||BIOAVAILABILITY OF GLI/METXR (4/850 mg)|Bioavailability of Glimepiride/Extended Release Metformin (4/850 mg) in Healthy Mexican Volunteers|Completed||Phase 1|24|Actual|Laboratorios Silanes S.A. de C.V.||1|||f||||t||||||||||2017-10-11 03:48:53.140901|2017-10-11 03:48:53.140901
NCT01437787|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2015-12-08||2015-12-08|December 2011||2011-12-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|JAKARTA||Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study of SAR302503 in Patients With Intermediate-2 or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly|Completed||Phase 3|289|Actual|Sanofi||3|||f||||||||||||||2017-10-11 03:48:53.245569|2017-10-11 03:48:53.245569
NCT01437774|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-09-04|||October 2011||2011-10-01|September 2012|2012-09-01|October 2013|Anticipated|2013-10-01|September 2013|Anticipated|2013-09-01||Interventional|||ReStore Thrombectomy Trial for Flow Restoration in Acute Ischemic Stroke Patients|Prospective Mult-center Randomized Study of the Reverse Medial ReStore Device for Flow Restoration in Arteries of Patients Experiencing Acute Ischemic Stroke|Suspended||N/A|210|Anticipated|Reverse Medical Corporation||2||DSMB recommendation to suspend trial due to control device|f||||t||||||||||2017-10-11 03:48:53.827266|2017-10-11 03:48:53.827266
NCT01437761|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-04-10|||August 2011||2011-08-01|April 2017|2017-04-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Observational|Sorb2||Sorbent Treatment Prescriptions Pilot Study|Hemodialysis With the 2008 Sorbent System: A Pilot Evaluation of Different Treatment Prescriptions|Terminated||N/A|12|Actual|Renal Research Institute|||1|Change of Institutional Affliation & Funding Changes|f||||t|f|||||||No||2017-10-11 03:48:53.920777|2017-10-11 03:48:53.920777
NCT01437748|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2014-10-28|||August 2011||2011-08-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Closing Volume Interpretation and Bronchodilators Effect|Small Airways Evaluation and Peripherical Effect of Two Bronchodilators in Healthy Subjects and Stable COPD Patients|Completed||Phase 4|40|Actual|University of Milan||2|||f||||t||||||||||2017-10-11 03:48:54.02656|2017-10-11 03:48:54.02656
NCT01437735|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-03-03||2016-03-03|August 2011||2011-08-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Dose Finding Study for QAW039 in Asthma|A Randomized, Placebo-controlled, Dose-ranging, Multi-centre Trial of QAW039 (1-450 mg p.o.), to Investigate the Effect on FEV1 and ACQ in Patients With Moderate-to-severe, Persistent, Allergic Asthma, Inadequately Controlled With ICS Therapy.|Completed||Phase 2|1043|Actual|Novartis||15|||f||||f||||||||||2017-10-11 03:48:54.152332|2017-10-11 03:48:54.152332
NCT01437722|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2013-10-27||2012-10-17|August 2011||2011-08-01|October 2013|2013-10-01||||December 2012|Actual|2012-12-01||Interventional|||Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)|A Double-blind, Multicenter, Randomized, Placebo-controlled, Dose-ranging Study to Determine the Efficacy and Safety of SPL7013 Gel (VivaGel®) Administered Vaginally to Prevent the Recurrence of Bacterial Vaginosis|Completed||Phase 2|205|Actual|Starpharma Pty Ltd||3|||f||||||||||||||2017-10-11 03:48:54.758591|2017-10-11 03:48:54.758591
NCT01437709|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-01-11|||September 2011||2011-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant|Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant|Active, not recruiting||Phase 2|30|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 03:48:54.852671|2017-10-11 03:48:54.852671
NCT01437696|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-09-04|||October 2011||2011-10-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months?|How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months? - An Investigation in Veterans Living at Ste-Anne's Hospital|Completed||Phase 4|77|Actual|McGill University||3|||f||||f||||||||||2017-10-11 03:48:54.955434|2017-10-11 03:48:54.955434
NCT01437683|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-10-12|||February 2010||2010-02-01|November 2010|2010-11-01|June 2012|Actual|2012-06-01|October 2011|Actual|2011-10-01||Observational|PariS-TBI||PariS-TBI Study : Paris Severe Traumatic Brain Injury Study|Four Year Outcome After Severe Traumatic Brain Injury in the Parisian Area|Completed||N/A|252|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-10-11 03:48:55.061466|2017-10-11 03:48:55.061466
NCT01437670|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2014-05-28|||September 2011||2011-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Observational|OAB||Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin|A Prospective, Multicenter, Observation Study to Estimate the Dry Mouth in OAB Patients With Solifenacin|Completed||N/A|262|Actual|Asan Medical Center|||1||f||||t||||||||||2017-10-11 03:48:55.142592|2017-10-11 03:48:55.142592
NCT01437657|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-11-01||2016-07-06|October 2011||2011-10-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy|A Randomized, Double-blind, Parallel-group Study of the Safety and Efficacy of RO4917523 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder With Inadequate Response to Ongoing Antidepressant Treatment|Completed||Phase 2|319|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 03:48:55.248542|2017-10-11 03:48:55.248542
NCT01437644|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2015-04-30|||October 2011||2011-10-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|POPPIES||The Post-Operative Pain in Cerebral Palsy (POPPIES) Trial|Post-operative Pain in Children With Cerebral Palsy Following Major Hip Surgery: a Double Blind Randomised Placebo Controlled Trial of Pre-operative Botulinum Toxin Type A|Completed||Phase 3|54|Actual|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:48:55.467215|2017-10-11 03:48:55.467215
NCT00083863|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2013-08-08|||June 2004||2004-06-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Framingham: Inflammation, Genes & Cardiovascular Disease||Completed||N/A|7374|Actual|Boston University|||2||f||||||||||||||2017-10-11 04:50:59.051754|2017-10-11 04:50:59.051754
NCT01437631|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2016-07-11|||September 2011||2011-09-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||EFficacy of Prophylactic Clip Application in Decrease of Immediate Postpolypectomy Bleeding and Delayed Postpolypectomy Bleeding After Colonoscopic Removal for a Large Pedunculated Polyps|Does a Prophylactic Clip Application Decrease IPPB(Immediate Postpolypectomy Bleeding) and DPPB(Delayed Postpolypectomy Bleeding) After Colonoscopic Removal for a Large Pedunculated Polyps (>1cm)?|Recruiting||N/A|384|Anticipated|Asan Medical Center||2|||f||||f||||||||||2017-10-11 03:48:55.540557|2017-10-11 03:48:55.540557
NCT01437618|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-09-20|||June 2009||2009-06-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|||||Observational|||First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer|FOLFOXIRI Plus Bevacizumab as First-line Treatment for BRAF V600E Mutant Metastatic Colorectal Cancer: a Prospective Evaluation|Completed||N/A|15|Actual|Azienda Ospedaliero, Universitaria Pisana|||1||f||||||||||||||2017-10-11 03:48:55.624432|2017-10-11 03:48:55.624432
NCT01437605|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-07-25|||October 11, 2011|Actual|2011-10-11|July 2017|2017-07-01|September 30, 2019|Anticipated|2019-09-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC|A Randomized Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC in Patients With Resected MAGE-A3 Positive, Stage IV Melanoma|Active, not recruiting||Phase 2|14|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-10-11 03:48:55.707953|2017-10-11 03:48:55.707953
NCT01437592|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-09-24|||September 2011||2011-09-01|September 2015|2015-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects|A Trial Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects|Completed||Phase 1|24|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 03:48:55.816101|2017-10-11 03:48:55.816101
NCT01437579|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2011-09-20|||June 2011||2011-06-01|September 2011|2011-09-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Interventional|||Efficacy of Botulinum Toxin Type A in Patients With Bladder Pain Syndrome/Intersticial Cystitis and Hunners' Lesions|Randomized Controlled Trial for Efficacy of Botulinum Toxin Type A in Treatment of Patients Suffering Bladder Pain Syndrome/Interstitial Cystitis With Hunners' Lesions|Unknown status|Recruiting|Phase 2|60|Anticipated|Moscow State University of Medicine and Dentistry||2|||f||||f||||||||||2017-10-11 03:48:56.081947|2017-10-11 03:48:56.081947
NCT01437566|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-11-01|||October 2011||2011-10-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy|A Phase II, Double-Blind, Placebo Controlled, Randomized Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor Therapy|Completed||Phase 2|318|Actual|Genentech, Inc.||5|||f||||||||||||||2017-10-11 03:48:56.181651|2017-10-11 03:48:56.181651
NCT01437553|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2016-06-29|||August 2011||2011-08-01|June 2016|2016-06-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|iWONDER||Imaging Whole Coronary Artery With Intravascular Ultrasound (Ivus) And Imap For Plaque Tissue Composition In Patients With Acute Myocardial Infarction|Registry Using IVUS and iMAP to Evaluate Atherosclerotic Coronary Plaque in Acute Coronary Syndromes|Completed||N/A|100|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 03:48:56.63441|2017-10-11 03:48:56.63441
NCT01437540|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-04-03|2016-12-19|2013-04-05|September 19, 2011|Actual|2011-09-19|March 2017|2017-03-01|April 30, 2013|Actual|2013-04-30|March 31, 2013|Actual|2013-03-31||Interventional|||Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Long-Term, Randomized, Study of the Safety and Tolerability of a Fixed-Dose Combination of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|590|Actual|AstraZeneca|The objective of the study is to assess the long-term safety and tolerability of inhaled aclidinium bromide/formoterol fixed-dose combination (FDC) Therefore there were were no primary and secondary efficacy assessments|2|||f||||t||||||||||2017-10-11 03:48:56.804672|2017-10-11 03:48:56.804672
NCT01437527|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-20|2016-02-11|||December 2011||2011-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PIPA||Body Image Therapy in Anorexia Nervosa|Body Image Therapy in Anorexia Nervosa|Completed||N/A|100|Actual|Centre Hospitalier St Anne||2|||f||||f||||||||||2017-10-11 03:48:58.997219|2017-10-11 03:48:58.997219
NCT01437514|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-10-08|||August 2011||2011-08-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|December 2015|Actual|2015-12-01||Interventional|||Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer|the Effect of the Preoperative Short-course Radiotherapy for the cT3/cN+ Mid-lower Rectal Cancer: a Prospective Randomized Study|Terminated||Phase 2/Phase 3|410|Actual|West China Hospital||4|||f||||t||||||||||2017-10-11 03:48:59.096|2017-10-11 03:48:59.096
NCT01437501|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-09-19|2013-05-02||October 2011||2011-10-01|September 2013|2013-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Broccoli Sprout Intervention in Qidong, P.R. China|Broccoli Sprout Intervention in Qidong, P.R. China|Completed||Phase 2|291|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 03:48:59.227817|2017-10-11 03:48:59.227817
NCT01437488|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-07-11|2017-06-05||February 16, 2012|Actual|2012-02-16|July 2017|2017-07-01|March 30, 2017|Actual|2017-03-30|August 4, 2014|Actual|2014-08-04||Interventional|||Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy|A Phase II Study of Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy|Completed||Phase 2|14|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 03:48:59.560145|2017-10-11 03:48:59.560145
NCT01437475|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2011-10-05|||November 2011||2011-11-01|October 2011|2011-10-01|November 2013|Anticipated|2013-11-01|March 2013|Anticipated|2013-03-01||Interventional|||Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients|Efficiency of the Novel Hepatitis B Vaccine Sci-B-Vac in HIV Positive Patients, a Prospective Cohort Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-10-11 03:48:59.912174|2017-10-11 03:48:59.912174
NCT01437462|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2013-04-09|||October 2008||2008-10-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Sevoflurane, Propofol, Postoperative Pain|Postoperative Pain After Propofol Sevoflurane Anaesthesia: a Prospective, Randomized, Single-blinded Trial|Completed||Phase 4|168|Actual|Tampere University Hospital||1|||f||||f||||||||||2017-10-11 03:48:59.990537|2017-10-11 03:48:59.990537
NCT01437449|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2016-10-18|||October 2011||2011-10-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|December 2018|Anticipated|2018-12-01||Interventional|||Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With SCCHN|Active, not recruiting||Phase 2|27|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 03:49:00.072073|2017-10-11 03:49:00.072073
NCT01437436|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2011-09-21|||October 2010||2010-10-01|September 2011|2011-09-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Observational|||The Effect of Obesity on Ventilation Tube Insertion|The Effect of Obesity on Ventilation Tube Insertion|Unknown status|Enrolling by invitation|N/A|120|Anticipated|Soonchunhyang University Hospital|||2||f||||f||||||||||2017-10-11 03:49:00.158906|2017-10-11 03:49:00.158906
NCT01437423|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2016-11-06|2016-11-06||June 2011||2011-06-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Regulatory Post-Marketing Surveillance Study for TETRAXIM™|Regulatory Post-Marketing Surveillance (PMS) Study for TETRAXIM™(Combined Vaccine of Adsorbed Diphtheria, Tetanus, Acellular Pertussis and Enhanced Inactivated Poliomyelitis)|Completed||Phase 4|600|Actual|Sanofi||1|||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at www.clinicalstudydatarequest.com. While making information available we continue to protect the privacy of the participants in our clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: Clinicalstudydatarequest.com/Sanofi.|2017-10-11 03:49:00.243344|2017-10-11 03:49:00.243344
NCT01437410|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2011-09-19|||January 2009||2009-01-01|September 2011|2011-09-01||||July 2010|Actual|2010-07-01||Observational|||Endoscopic Ultrasound-guided Fine Needle Aspiration of Solid Masses: Histological and Immunohistochemical Evaluation|Endoscopic Ultrasound-guided Fine Needle Aspiration of Solid Masses: Histological and Immunohistochemical Evaluation|Completed||Phase 4|116|Actual|Samsung Medical Center|||1||f||||||||||Samples Without DNA|"     cytopathologic result acquired by endoscopic ultrasound-guided fine needle aspiration     (EUS-FNA).   "|||2017-10-11 03:49:00.759789|2017-10-11 03:49:00.759789
NCT01437397|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-02-02|2016-11-16|2013-04-05|September 2011||2011-09-01|January 2017|2017-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Safety population comprising all patients randomized to a treatment group who received at least 1 dose of double-blind investigational treatment.|Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Phase III, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo for 24- Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|1692|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 03:49:00.877715|2017-10-11 03:49:00.877715
NCT01437384|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-05-18|||September 2011||2011-09-01|May 2012|2012-05-01||||March 2012|Actual|2012-03-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.|An Open-label, Single-sequence, Four-treatment Period Study to Evaluate Pharmacokinetic and Pharmacodynamic Interactions Between E5501 and Verapamil, and E5501 and Cyclosporine, Known P-glycoprotein Inhibitors in Healthy Subjects|Completed||Phase 1|36|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 03:49:02.870714|2017-10-11 03:49:02.870714
NCT01437371|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-09-30|||August 2011||2011-08-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|HF 80||Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?|Is There a Benefit to Optimize HF (Heart Failure) Treatment in Aged Over 80 Year's Old Patients?|Completed||Phase 3|35|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-10-11 03:49:02.943347|2017-10-11 03:49:02.943347
NCT01437358|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2012-02-27|||August 2011||2011-08-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|||Epidural Analgesia in Intensive Care Unit (APD-REA: Analgesie PeriDurale en REAnimation)|Epidural Analgesia in Intensive Care Unit Patients: an Observational Prospective Multicenter Feasibility and Safety Study|Completed||N/A|80|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-10-11 03:49:03.04107|2017-10-11 03:49:03.04107
NCT01437332|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2011-09-19|||September 2011||2011-09-01|September 2011|2011-09-01||||September 2016|Anticipated|2016-09-01||Observational|||Molecular Mediators of Nerve Injury Signaling|Molecular Mediators of Nerve Injury Signaling|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Rambam Health Care Campus|||3||f||||t||||||||||2017-10-11 03:49:03.210391|2017-10-11 03:49:03.210391
NCT01437319|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2016-01-28|2015-11-16||September 2011||2011-09-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||The analysis population consists of all subjects that entered Phase 1.|Mucin Balls and Corneal Inflammation Events||Completed||Phase 1/Phase 2|289|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||||||||||||2017-10-11 03:49:03.31176|2017-10-11 03:49:03.31176
NCT01437306|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-05-01|||September 2011||2011-09-01|May 2017|2017-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Lofexidine Food Effect Study in Healthy Volunteers|A Single-Dose, Open-Label, Randomized, Two-Way Crossover Food Effect Study of Lofexidine 400 μg (2 x 200 μg) Tablets|Completed||Phase 1|13|Actual|US WorldMeds LLC||2|||f||||f||||||||||2017-10-11 03:49:03.740856|2017-10-11 03:49:03.740856
NCT01437293|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-18|2012-10-25|||August 2010||2010-08-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|COST||Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)|Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)|Completed||Phase 1|15|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-10-11 03:49:03.828513|2017-10-11 03:49:03.828513
NCT01437280|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-08-12||||||August 2013|2013-08-01||||||||Interventional|GOAT||GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers|GOAT; Phase I Single-Center Open Label Dose Escalation Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Therapy of Advanced Cancers|Withdrawn||Phase 1|0|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 03:49:03.934542|2017-10-11 03:49:03.934542
NCT01437267|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-03-05|2014-03-05||October 2011||2011-10-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Analysis was done on all enrolled subjects.|Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants|A Phase 2, Randomized, Controlled, Observer Blind, Single Center Study of the Safety, Reactogenicity and Immunogenicity of the NVGH Glycoconjugate Vaccine Against S. Typhi in Children, Older Infants and Infants|Completed||Phase 2|120|Actual|Novartis||6|||f||||t||||||||||2017-10-11 03:49:04.043153|2017-10-11 03:49:04.043153
NCT01437254|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-09-29|||October 2011||2011-10-01|September 2014|2014-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||A Prospective Phase I Study of Cyclotron-produced Tc-99m Pertechnetate (CPERT) in Patients With Thyroid Cancer|To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-10-11 03:49:05.103713|2017-10-11 03:49:05.103713
NCT01437241|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-17|2011-10-30|||January 2009||2009-01-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Observational|||Etravirine Plus 2 Analogs in HIV-infected Patients|Virological Efficacy and Safety of Etravirine Plus 2 Active Nucleos(t)Ide Reverse-transcriptase Inhibitors (NRTIs) in HIV-1-infected Patients|Completed||N/A|175|Actual|Hospitales Universitarios Virgen del Rocío|||1||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 03:49:05.192101|2017-10-11 03:49:05.192101
NCT01437228|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2011-11-16|||October 2010||2010-10-01|November 2011|2011-11-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Does Preoperative Vaginal Preparation With Povidone-iodine Before Cesarean Delivery Reduce the Risk of Endometritis?||Completed||Phase 4|668|Actual|Erzincan Military Hospital||2|||f||||||||||||||2017-10-11 03:49:05.301917|2017-10-11 03:49:05.301917
NCT01437215|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-17|2013-06-05|||November 2010||2010-11-01|June 2013|2013-06-01|August 2016|Anticipated|2016-08-01|September 2011|Actual|2011-09-01||Interventional|||Pilot Study of the Endologix Fenestrated Stent Graft System|Prospective, Multicenter, Single Arm Feasibility and Initial Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms|Unknown status|Active, not recruiting|Phase 1|15|Actual|Endologix||1|||f||||f||||||||||2017-10-11 03:49:05.387072|2017-10-11 03:49:05.387072
NCT01437202|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-07-08|||September 2011||2011-09-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|VATIC||Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia|Retrospective Study to Validate Pharmacogenetics Model for Imatinib Metabolism in Patients With Chronic Myeloid Leukemia|Completed||N/A|100|Actual|Asan Medical Center|||3||f||||f||||||Samples With DNA|"     whole blood 4cc   "|||2017-10-11 03:49:05.456866|2017-10-11 03:49:05.456866
NCT01437189|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2011-09-19|||August 2011||2011-08-01|August 2011|2011-08-01|March 2013|Anticipated|2013-03-01|November 2012|Anticipated|2012-11-01||Interventional|PD; PDD||The Effects of Sertraline on Depression in Parkinson's Disease|Clinical Protocol of Self-Controlled Study on the Effects of Sertraline on Depression in Parkinson's Disease|Unknown status|Recruiting|N/A|35|Anticipated|Zhejiang University||1|||f||||f||||||||||2017-10-11 03:49:05.542558|2017-10-11 03:49:05.542558
NCT01437176|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2015-02-04|||September 2011||2011-09-01|February 2015|2015-02-01|August 2015|Anticipated|2015-08-01|July 2015|Anticipated|2015-07-01||Interventional|||Treatment of Intertrochanteric Fracture With New Type of Intramedullary Nail|Treatment of Intertrochanteric Fracture With New Type of Intramedullary Nail|Unknown status|Recruiting|Phase 4|36|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-11 03:49:05.648876|2017-10-11 03:49:05.648876
NCT01437163|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-18|2016-07-11|||September 2011||2011-09-01|July 2016|2016-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|LLLT||Treatment of Androgenetic Alopecia in Males and Females|The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.|Completed||N/A|88|Actual|Apira Science, Inc.||2|||f||||f||||||||||2017-10-11 03:49:05.763656|2017-10-11 03:49:05.763656
NCT01437150|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2015-02-04|||August 2011||2011-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Interventional|||Treatment of Acetabular Posterior Wall Fracture With Anatomical Locking Plate|Treatment of Acetabular Posterior Wall Fracture With Anatomical Locking Plate|Completed||Phase 4|25|Actual|Chinese PLA General Hospital||2|||f||||f||||||||||2017-10-11 03:49:05.855344|2017-10-11 03:49:05.855344
NCT01437137|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-06-01|||September 2011||2011-09-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Clinical Efficacy of Recently Developed Supraglottic Airway Device, I-gel™, in Neonates and Infants: Comparison With Classic-laryngeal Mask Airway (c-LMA)||Completed||N/A|54|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 03:49:07.544732|2017-10-11 03:49:07.544732
NCT01437124|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2016-04-27|2016-04-27||October 2011||2011-10-01|April 2016|2016-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01|5 Years|Observational [Patient Registry]|COM||Metal Ions in Ceramic on Metal Total Hip Arthroplasty|Measurement of Metal Ion Levels and Chromosome Abnormalities in Ceramic on Metal Total Hip Arthroplasty in Vivo|Completed||N/A|83|Actual|Wirral University Teaching Hospital NHS Trust|||1||f||||t||||||||||2017-10-11 03:49:07.695319|2017-10-11 03:49:07.695319
NCT01437111|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-04-05|2013-12-03||October 26, 2011|Actual|2011-10-26|April 2017|2017-04-01|December 5, 2012|Actual|2012-12-05|December 5, 2012|Actual|2012-12-05||Interventional||Baseline Analysis was performed on the All Patients as Treated (APaT) population, which included all participants who received treatment. Of 200 participants enrolled in the study, baseline data were not provided for two participants who did not receive treatment.|Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)|A Phase III (Phase IV Program) Open-Label, Multicenter Clinical Trial in Thailand to Study the Effect of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (Fosamax Plus 70/5600) for 6 Months on 25-Hydroxyvitamin D Levels in the Treatment of Osteoporosis in Postmenopausal Women and Men|Completed||Phase 3|200|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:49:07.898143|2017-10-11 03:49:07.898143
NCT01437098|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-05-19|2015-10-02||October 2011||2011-10-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|April 2013|Actual|2013-04-01||Interventional||As Treated Subjects|Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis|Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis|Active, not recruiting||N/A|55|Actual|Medtronic Cardiovascular||1|||f||||t||||||||||2017-10-11 03:49:08.216873|2017-10-11 03:49:08.216873
NCT01437085|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-01-23|||October 2011||2011-10-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant|Quantifying Needle Deflection and Tissue Deformation in Transperineal Interstitial Permanent Prostate Brachytherapy: A Basis for Development of Next-Generation Implant Technique|Active, not recruiting||N/A|25|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 03:49:10.690734|2017-10-11 03:49:10.690734
NCT01437072|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-01-18|||November 2010||2010-11-01|January 2017|2017-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Changing Diabetes® World Tour|Changing Diabetes® World Tour a Study on the Association of Risk Factors and the Presence of Undiagnosed Diabetes in the Middle East, Northern Africa and Europe|Completed||N/A|8304|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:49:10.769384|2017-10-11 03:49:10.769384
NCT01437059|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2012-10-11|||September 2011||2011-09-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)|A Phase 1, Randomized, Single-blind, Placebo-Controlled, Single Ascending Dose, Safety, Tolerability and Pharmacokinetics Study of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)|Completed||Phase 1|32|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:49:10.875455|2017-10-11 03:49:10.875455
NCT01437033|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-06-30|||August 29, 2011||2011-08-29|September 23, 2016|2016-09-23|September 23, 2016||2016-09-23|||||Observational|||Breath Test for Chemicals (Volatile Organic Compounds)|A Pilot Study of a Breath Test for Assessment of Volatile Organic Compounds|Completed||N/A|5|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:49:11.223384|2017-10-11 03:49:11.223384
NCT01437020|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2013-08-26||||||August 2013|2013-08-01||||||||Interventional|||SCH708980 With and Without AmBisome for Visceral Leishmaniasis|A Phase I/II Clinical Trial To Assess the Safety and Biologic Activity of the Anti-IL-10 Monoclonal Antibody, SCH708980, in Combination With AmBisome(Registered Trademark), Versus That of Placebo in Combination With Ambisome(Registered Trademark), in Subjects With Visceral Leishmaniasis (VL)|Withdrawn||Phase 1/Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Drug Product no longer available.|f||||t||||||||||2017-10-11 03:49:11.32005|2017-10-11 03:49:11.32005
NCT01437007|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2017-06-30|||August 26, 2011||2011-08-26|October 9, 2012|2012-10-09|June 21, 2012|Actual|2012-06-21|June 21, 2012|Actual|2012-06-21||Interventional|||TKM 080301 for Primary or Secondary Liver Cancer|A Phase 1 Dose Escalation Study of Hepatic Intra-Arterial Administration of TKM 080301 (Lipid Nanoparticles Containing siRNA Against the PLK1 Gene Product) in Patients With Colorectal, Pancreas, Gastric, Breast, Ovarian and Esophageal Cancers With Hepatic|Completed||Phase 1|1|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:49:11.443988|2017-10-11 03:49:11.443988
NCT01436994|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2016-09-20|||July 2004||2004-07-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Interventional|||Antithyroid Drug Treatment of Thyrotoxicosis in Young People|A Randomised Study of Two Anti-thyroid Drug Treatment Regimens in Young People|Completed||Phase 3|81|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-10-11 03:49:11.58366|2017-10-11 03:49:11.58366
NCT01436981|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-06-03|||October 2012||2012-10-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Pharmacokinetics of Pavaverine After Intraluminal Administration|Observational Study on Papaverine During Cardiac Surgical Procedures|Completed||N/A|12|Actual|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-10-11 03:49:11.747599|2017-10-11 03:49:11.747599
NCT01436968|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2017-10-04|||September 2011||2011-09-01|October 2017|2017-10-01||||December 2020|Anticipated|2020-12-01||Interventional|PrTK03||Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer|A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer|Recruiting||Phase 3|711|Anticipated|Advantagene, Inc.||2|||f||||t||||||||||2017-10-11 03:49:11.843217|2017-10-11 03:49:11.843217
NCT01436955|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-03-02|||November 2011||2011-11-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Study of RG1662 in Individuals With Down Syndrome|A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome|Completed||Phase 1|35|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:49:12.08996|2017-10-11 03:49:12.08996
NCT01436942|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-02-02|||September 2011||2011-09-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Exercise on Disease Activity and Cardiovascular Risk Factors in Patients With Ankylosing Spondylitis|Effect of Exercise on Disease Activity and Cardiovascular Risk Factors in Patients With AS: A Single Blind Randomized Controlled Trail|Completed||N/A|34|Actual|Diakonhjemmet Hospital||2|||f||||t||||||||||2017-10-11 03:49:12.20581|2017-10-11 03:49:12.20581
NCT01436929|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2012-12-13|||September 2011||2011-09-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|PESOHHERZ||Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs|Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs|Unknown status|Recruiting|N/A|600|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:49:12.308669|2017-10-11 03:49:12.308669
NCT01436916|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-10-23|||September 2011||2011-09-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Oral Cholecalciferol in Prevention of Type 2 Diabetes Mellitus|Oral Cholecalciferol in Prevention of Type 2 DM in Prediabetic Population With Vitamin D Insufficiency|Completed||Phase 4|50|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 03:49:12.425968|2017-10-11 03:49:12.425968
NCT01436903|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2013-03-07|||September 2010||2010-09-01|March 2013|2013-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length|Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length, a Questionnaire Investigation on 290 Patients|Completed||Phase 4|290|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 03:49:12.546296|2017-10-11 03:49:12.546296
NCT01436890|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-06-20|||October 2011||2011-10-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma|A Phase II, 12-week Randomized, Double-blind, Triple Dummy, Parallel Group, Placebo-controlled, Dose Range Finding Study to Evaluate Safety, Tolerability and Efficacy of Revamilast in Patients With Chronic Persistent Asthma|Completed||Phase 2|273|Actual|Glenmark Pharmaceuticals Ltd. India||4|||f||||f||||||||||2017-10-11 03:49:12.667366|2017-10-11 03:49:12.667366
NCT01436877|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-09-18|||September 2011||2011-09-01|September 2015|2015-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia|One-arm Feasibility and Prospective Pivotal Study to Assess the Safety and Efficacy of MediTate Temporary Implantable Nitinol Device (TIND) in Subjects Presenting Bladder Outlet Obstruction Secondary to BPH|Completed||Phase 1/Phase 2|6|Actual|Medi-Tate Ltd.||1|||f||||f||||||||||2017-10-11 03:49:12.893702|2017-10-11 03:49:12.893702
NCT01436864|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2014-03-21|||August 2011||2011-08-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|December 2012|Actual|2012-12-01||Interventional|PHOENIX||A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD|A Phase 3 Clinical Trial of Intravitreal Injections of Human Recombinant Vascular Endothelial Growth Factor Receptor-Fc Fusion Protein in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration|Completed||Phase 3|125|Actual|Chengdu Kanghong Biotech Co.,Ltd.||2|||f||||||||||||||2017-10-11 03:49:12.977551|2017-10-11 03:49:12.977551
NCT01436851|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-08-14|||November 24, 2010|Actual|2010-11-24|August 2017|2017-08-01|December 2014|Actual|2014-12-01|September 1, 2011|Actual|2011-09-01||Interventional|NPT||Nasal Provocation Testing in Occupational Rhinitis|Nasal Provocation Testing With Nasal Lavage in Allergic and Non-allergic Occupational Rhinitis|Completed||N/A|17|Actual|Haukeland University Hospital||1|||f||||f||||||||||2017-10-11 03:49:13.211731|2017-10-11 03:49:13.211731
NCT01436838|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-19|2016-09-02|||March 2012||2012-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Observational|||China Betaferon Adherence, Coping and Nurse Support Study|Prospective Study of Betaferon in Adherence, Coping and Nurse Support in Patients of Chinese Origin With Multiple Sclerosis|Completed||N/A|110|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:49:13.296802|2017-10-11 03:49:13.296802
NCT01436825|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-08-07|||October 2011||2011-10-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|June 2014|Actual|2014-06-01||Observational|OPTIMS||Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients|A Validation Study of the OPTIMS Pharmacokinetic Calculator for Clinician Use in Prophylactic Treatment of Patients With Haemophilia A.|Completed||N/A|69|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:49:13.375844|2017-10-11 03:49:13.375844
NCT01436812|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-08-08|||September 2011||2011-09-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Positive End Expiratory Pressure (PEEP) on Cerebral Oxymetry During Laparoscopy|International Reveiw Board of Gachon Univerity Gil Hospital|Completed||N/A|30|Actual|Gachon University Gil Medical Center||2|||f||||t||||||||||2017-10-11 03:49:13.459723|2017-10-11 03:49:13.459723
NCT01436799|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-08-25|2013-02-05||March 2011||2011-03-01|August 2013|2013-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Desflurane Versus Propofol in the Sitting Position|International Review Board of Gachon University Gil Hospital|Completed||N/A|40|Actual|Gachon University Gil Medical Center|limitations of this study is that the ventilation was adjusted according to ETCO2 value instead of the arterial carbon dioxide tensions (PaCO2).|2|||f||||t||||||||||2017-10-11 03:49:13.542478|2017-10-11 03:49:13.542478
NCT01436786|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-05-14|||June 2010||2010-06-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effectiveness of Guided Imagery Intervention on Factors Associated With Maternal Stress and Preterm Birth|Guided Imagery Effects on Pregnancy Symptoms and Outcomes|Completed||N/A|73|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 03:49:13.899213|2017-10-11 03:49:13.899213
NCT01436773|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-07-20|||May 2009||2009-05-01|July 2017|2017-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events|Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events|Completed||N/A|66|Actual|University of Pittsburgh|||3||f||||t||||||||||2017-10-11 03:49:14.008857|2017-10-11 03:49:14.008857
NCT01436760|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2012-03-23|||May 2011||2011-05-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Genetic Contribution of Pain and Inflammation in IBS|Genetic Contribution of Pain and Inflammation in Irritable Bowel Syndrome.|Completed||N/A|72|Actual|University of Florida|||1||f||||f||||||Samples With DNA|"     The delinked blood/DNA is stored in the genetics laboratory and they will be analyzed for     possible polymorphisms   "|||2017-10-11 03:49:14.078183|2017-10-11 03:49:14.078183
NCT01436747|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-04-05|||July 2012||2012-07-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients|Efficacy and Safety of Selective Vitamin D Receptor Activation With Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients: a Randomized Controlled Trial|Completed||Phase 3|168|Actual|University Medical Centre Ljubljana||2|||f||||t||||||||||2017-10-11 03:49:14.158883|2017-10-11 03:49:14.158883
NCT01436734|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-07-10|||July 2011||2011-07-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125||Completed||N/A|5|Actual|University Hospital, Gentofte, Copenhagen||1|||f||||t||||||||||2017-10-11 03:49:14.273572|2017-10-11 03:49:14.273572
NCT01436721|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-19|||August 2011||2011-08-01|September 2011|2011-09-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Use of an Oxidized Regenerated Cellulose After Hepatic Surgery|The Randomized Clinical Trial of Surgicel® Absorbable Haemostat Covering the Raw Cut Surface During the Hepatectomy|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Fudan University||1|||f||||t||||||||||2017-10-11 03:49:14.346429|2017-10-11 03:49:14.346429
NCT01436656|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2017-08-21|||September 2011||2011-09-01|August 2017|2017-08-01|July 31, 2018|Anticipated|2018-07-31|October 2012|Actual|2012-10-01||Interventional|||A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma|A Phase I, Multicenter, Open-label, Dose-escalation Study of Oral LGX818 in Adult Patients With Locally Advanced or Metastatic BRAF Mutant Melanoma|Active, not recruiting||Phase 1|107|Actual|Array BioPharma||2|||f||||f||||||||||2017-10-11 03:49:14.72052|2017-10-11 03:49:14.72052
NCT01436643|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-09-24|2014-09-01||November 2011||2011-11-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|REGAIN|The safety set was used for analysis, which consists of 54 patients, of whom 2 patients did not start treatment with any antidepressant|Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression|A 21-week, Multicenter, Open Label Study to Evaluate the Safety and Tolerability Profile of the Combination of a SSRI or SNRI Antidepressive Therapy With Oral Fingolimod in the Treatment of RRMS Patients With Mild to Moderate Depression|Terminated||Phase 4|54|Actual|Novartis||3||Due to slow enrollment the study was terminated early|f||||||||||||||2017-10-11 03:49:14.855656|2017-10-11 03:49:14.855656
NCT01436630|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2011-09-19|||February 2010||2010-02-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Observational|||Step Test and Six Minute Walk Test in Stroke|Comparação Entre o Teste de Caminhada de Seis Minutos e o Teste do Degrau de Seis Minutos em Pacientes Com Acidente Vascular Encefálico|Completed||N/A|12|Actual|Faculdades Metropolitanas Unidas|||1||f||||f||||||||||2017-10-11 03:49:15.633899|2017-10-11 03:49:15.633899
NCT01436617|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-03-07|||January 2010||2010-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|IgES||Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab|Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab|Completed||Phase 2|303|Actual|Centre Francois Baclesse|||1||f||||t||||||||||2017-10-11 03:49:15.73881|2017-10-11 03:49:15.73881
NCT01436604|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-07-27|||February 2012||2012-02-01|July 2017|2017-07-01|May 2017|Actual|2017-05-01|August 2015|Actual|2015-08-01||Interventional|MRTOX||Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging|Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging|Terminated||Phase 2|19|Actual|Centre Francois Baclesse||2||lack of recruitment|f||||t||||||||||2017-10-11 03:49:15.820908|2017-10-11 03:49:15.820908
NCT01436591|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2012-09-07|||March 2009||2009-03-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|TEP-Sein||Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors|Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors|Terminated||N/A|63|Actual|Centre Francois Baclesse|||1||f||||t||||||||||2017-10-11 03:49:15.91284|2017-10-11 03:49:15.91284
NCT01436578|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2015-07-06|||February 2012||2012-02-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)|Post Marketing Surveillance for General Drug Use to Assess the Safety and Efficacy Profile of NOXAFIL Oral Suspension in Usual Practice|Completed||N/A|273|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-10-11 03:49:15.979432|2017-10-11 03:49:15.979432
NCT01436565|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2014-06-12|||November 2011||2011-11-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers|A Phase 1b Dose-escalation Study of the Safety and Pharmacokinetics of SAR245408 Administered in Combination With SAR256212 in Patients With Solid Tumor Cancers|Completed||Phase 1|26|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 03:49:16.053787|2017-10-11 03:49:16.053787
NCT01436552|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2011-09-16|||February 2010||2010-02-01|February 2010|2010-02-01|February 2014|Anticipated|2014-02-01|February 2012|Anticipated|2012-02-01||Observational|FPRMCI||Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia|Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia|Unknown status|Recruiting|N/A|392|Anticipated|Centre Hospitalier Esquirol|||1||f||||t||||||||||2017-10-11 03:49:16.138502|2017-10-11 03:49:16.138502
NCT01436539|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-16|||September 2011||2011-09-01|September 2011|2011-09-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Interventional|||Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients|A Multi-center, Open Label, Randomized Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Capsule Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients|Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Capital Medical University||2|||f||||t||||||||||2017-10-11 03:49:16.211025|2017-10-11 03:49:16.211025
NCT01436526|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2015-04-02|2011-11-18||August 2009||2009-08-01|April 2015|2015-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban|Single-dose, Open-label, Randomized, 2-way Crossover Pivotal Bioequivalence Study of 2x5 mg Tablets Rivaroxaban Versus 1x10 mg Tablet Rivaroxaban Under Fasted Condition in Healthy Subjects|Completed||Phase 1|28|Actual|Bayer||2|||f||||f||||||||||2017-10-11 03:49:16.412471|2017-10-11 03:49:16.412471
NCT01436513|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2012-03-14|||October 2011||2011-10-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.|Phase 1, Open-Label, Randomized, Single-Dose, Crossover Bioequivalence And Food Effect Study For A New Formulation Of Premarin Compared With A Reference Tablet In Japanese Healthy Postmenopausal Women|Completed||Phase 1|72|Actual|Pfizer||4|||f||||||||||||||2017-10-11 03:49:16.818953|2017-10-11 03:49:16.818953
NCT01435798|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-02-15|2014-06-26||April 2003||2003-04-01|February 2017|2017-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial|Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial|Completed||Phase 2|26|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 03:49:38.867751|2017-10-11 03:49:38.867751
NCT01436500|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-02-27|2016-12-22||October 2011||2011-10-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|||Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients|A Multi-Center, Double-Blind, Randomized, Controlled Study to Determine the Safety and Pharmacokinetics of Ifetroban Injection in Hepatorenal Syndrome|Completed||Phase 2|55|Actual|Cumberland Pharmaceuticals||9|||f||||t||||||||No||2017-10-11 03:49:17.056743|2017-10-11 03:49:17.056743
NCT01436487|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-07-29||2016-07-29|October 2011||2011-10-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Study to Examine the Effects of MultiStem in Ischemic Stroke|Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke|Completed||Phase 2|134|Actual|Athersys, Inc||3|||f||||t||||||||No||2017-10-11 03:49:18.046925|2017-10-11 03:49:18.046925
NCT01436474|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2013-01-22|||June 2011||2011-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Pilot Study of Varenicline to Treat Opioid Dependence|The Role of Varenicline in Treating Opioid Dependence: A Pilot Study|Completed||Phase 1|21|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 03:49:18.215677|2017-10-11 03:49:18.215677
NCT01436461|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-05-28|||December 2012||2012-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:49:18.314738|2017-10-11 03:49:18.314738
NCT01436448|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-19|||October 2011||2011-10-01|September 2011|2011-09-01|May 2013|Anticipated|2013-05-01|November 2012|Anticipated|2012-11-01||Interventional|GRIP||Probiotics (Lactobacillus Rhamnosus) in Reducing Glucose Intolerance During and After Pregnancy|Effects of Probiotics (Lactobacillus Rhamnosus) In Reducing Glucose Intolerance During and After Pregnancy: A Double Blind Randomized Controlled Trial in Antenatal Clinic of Karachi-Pakistan (GRIP)|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Aga Khan University||2|||f||||f||||||||||2017-10-11 03:49:18.375447|2017-10-11 03:49:18.375447
NCT01436435|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-09-03|2016-07-16||September 2011||2011-09-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|JET||The Jetstream (JET) Post-market Registry|Jetstream NAVITUS™ System Endovascular Therapy Post-market Registry (JET)|Completed||Phase 4|241|Actual|Boston Scientific Corporation||1|||f||||f||||||||No||2017-10-11 03:49:18.497679|2017-10-11 03:49:18.497679
NCT01436422|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2015-08-19|||August 2011||2011-08-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine|A Phase 1 Evaluation of the Safety and Immunogenicity of the Recombinant Live Attenuated Tetravalent Dengue Virus Vaccine Admixtures TV003 and TV005 in Healthy Flavivirus-Naïve Adult Subjects|Completed||Phase 1|112|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 03:49:18.796567|2017-10-11 03:49:18.796567
NCT01436409|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-11-25|||December 2005||2005-12-01|July 2011|2011-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|PINKFINGER||Rates of Fetal Extractions Between Only Vaginal Touch Usually Realized and Vaginal Touch + Echography|Comparison of the Rates of Fetal Extractions Between a Systematic Practice of an Echography of Presentation and the Only Vaginal Touch Usually Realized During the Labor|Completed||N/A|1900|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:49:18.911576|2017-10-11 03:49:18.911576
NCT01436396|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2014-04-01|||September 2011||2011-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|||Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers|Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril®) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru|Completed||Phase 3|792|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 03:49:19.004483|2017-10-11 03:49:19.004483
NCT01436383|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2011-09-20|||March 2005||2005-03-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|December 2005|Actual|2005-12-01||Interventional|||Oxidative Stress in Hypobaric Hypoxia|Oxidative Stress in Hypobaric Hypoxia and Influence on Vessel-tone Modifying Mediators|Completed||N/A|36|Actual|University Hospital Inselspital, Berne||1|||f||||t||||||||||2017-10-11 03:49:19.150492|2017-10-11 03:49:19.150492
NCT01436370|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-12-04|2014-04-17||October 2011||2011-10-01|February 2013|2013-02-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional||The baseline analysis population includes all participants who were enrolled and vaccinated.|TIV and High Dose TIV in Subjects With Rheumatoid Arthritis|A Phase II Study in Adults With Rheumatoid Arthritis Receiving TNF-alpha-inhibitor Therapy to Assess the Immunogenicity and Safety of Trivalent Inactivated Vaccine (TIV) and High Dose Trivalent Inactivated Vaccine (High-Dose TIV) Administered at Two Dosage Levels|Completed||Phase 2|102|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 03:49:19.293134|2017-10-11 03:49:19.293134
NCT01436357|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-09-14|||March 6, 2012|Actual|2012-03-06|April 5, 2017|2017-04-05|July 28, 2018|Anticipated|2018-07-28|July 28, 2018|Anticipated|2018-07-28||Interventional|||Staged Phase I/II Hepatitis C Prophylactic Vaccine|A Staged Phase I/II Study, to Assess Safety, Efficacy and Immunogenicity of a New Hepatitis C Prophylactic Vaccine Based on Sequential Use of AdCh3NSmut1 and MVA-NSmut|Active, not recruiting||Phase 1/Phase 2|548|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f|||||t|f|||f|||||2017-10-11 03:49:21.976532|2017-10-11 03:49:21.976532
NCT01436344|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2015-07-22|||September 2011||2011-09-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Observational|||Markers of Paroxysmal Atrial Fibrillation in Esophageal Holter Electrocardiography|Markers of Paroxysmal Atrial Fibrillation in Esophageal Holter Electrocardiography|Completed||N/A|50|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-10-11 03:49:22.100179|2017-10-11 03:49:22.100179
NCT01436331|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-01-07|||April 2010||2010-04-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|GETUP-PIANO||A Large Pragmatic Cluster Randomized Controlled Trial of a Multi-element Psychosocial Intervention for Early Psychosis|A Pragmatic Cluster Randomized Controlled Trial of a Multi-element Psychosocial Intervention for Early Psychosis in a 10 Million Inhabitant Catchment Area Aimed to Measure the Treatment's Feasibility and Effectiveness: GET UP-PIANO Trial|Completed||N/A|626|Actual|Universita di Verona||2|||f||||f||||||||||2017-10-11 03:49:22.211812|2017-10-11 03:49:22.211812
NCT01436318|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2014-09-22|||April 2011||2011-04-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|||Respiratory Muscle Strength and Function in Healthy Kids|Respiratory Muscle Strength and Function in Healthy Children|Completed||N/A|7|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 03:49:22.345678|2017-10-11 03:49:22.345678
NCT01436305|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-08-29|2016-11-10||September 2011||2011-09-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Randomized participants|Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation|Optimization of NULOJIX® (Belatacept) Usage as a Means of Avoiding CNI and Steroids in Renal Transplantation (CTOT-10)|Terminated||Phase 2|19|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Enrollment of 210 participants was planned, but study was stopped after 19 participants enrolled due to safety concerns and change in alemtuzumab availability. Enrolled participants continued follow-up after enrollment ended.|3||Secondary to safety concerns plus change in Campath® (alemtuzumab) availability.|f||||t||||||||||2017-10-11 03:49:22.500581|2017-10-11 03:49:22.500581
NCT01436292|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-09-16|||September 2011||2011-09-01|September 2011|2011-09-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|Halburns||Hypoalbuminemia in Burn Patients|Hypoalbuminemia in Burn Patients: Should we Care? - A Randomized Controlled Clinical Pilot Trial|Unknown status|Not yet recruiting|Phase 4|128|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t||||||||||2017-10-11 03:49:24.712023|2017-10-11 03:49:24.712023
NCT01436279|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-05-16|2017-04-11||July 2011||2011-07-01|May 2017|2017-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|SaMi2||Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks|Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks|Completed||Phase 3|50|Actual|Boston University||2|||f||||t|t|f|||f|||No||2017-10-11 03:49:24.84122|2017-10-11 03:49:24.84122
NCT01436266|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-04-18|2017-04-18||July 2011|Actual|2011-07-01|April 2017|2017-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PreopMiso||Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion|Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester|Terminated||Phase 3|3|Actual|Boston University|1 of the 3 consented subjects became ineligible due to spontaneous rupture of amniotic membranes prior to the abortion. Early study termination, the PI left the institution, and study records could not be located for secondary data outcomes.|2||Slow enrollment|f||||f|t|f||||||No||2017-10-11 03:49:25.366776|2017-10-11 03:49:25.366776
NCT01436253|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2015-03-27|2013-12-03||December 2008||2008-12-01|March 2015|2015-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)|Non-Interventional Study In Hyperlipidemic Patients Who Do Not Reach Satisfactory Lipid Values With Existing Hypolipemic Therapy|Completed||N/A|2196|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-10-11 03:49:25.619208|2017-10-11 03:49:25.619208
NCT01436240|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-05-22|||September 2011|Actual|2011-09-01|May 2017|2017-05-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)|Linguistic Validation of the Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)|Completed||N/A|112|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:49:25.785195|2017-10-11 03:49:25.785195
NCT01436227|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-09-18|||January 2012|Actual|2012-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Pazopanib in Von Hippel-Lindau (VHL) Syndrome|A Phase II Trial of Pazopanib in Von Hippel-Lindau Syndrome|Active, not recruiting||Phase 2|32|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:49:25.866118|2017-10-11 03:49:25.866118
NCT01436214|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2015-07-15|||August 2011||2011-08-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer|Phase 1/2a, Open-Label, Dose-Escalation and Safety Study of APC-100 [Pentamethylchromanol, 2,2,5,7,8-Pentamethyl-6] in Men With Advanced Prostate Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|Adamis Pharmaceuticals Corporation||1|||f||||t||||||||||2017-10-11 03:49:25.946172|2017-10-11 03:49:25.946172
NCT01436201|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-10-03|2014-10-03||September 2011||2011-09-01|October 2014|2014-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants|Effect of Dulaglutide (LY2189265) on the Pharmacokinetics of Digoxin in Healthy Subjects|Completed||Phase 1|24|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:49:26.03475|2017-10-11 03:49:26.03475
NCT01436188|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-03-15|||September 2011||2011-09-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|||||Interventional|||A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease|A Biomarker Study to Measure CSF Proteins Upon Application of an Indwelling Lumbar Catheter for 36 Hours in Elderly Healthy Subjects and Subjects With Mild Cognitive Impairment or Alzheimer's Disease|Completed||Early Phase 1|5|Actual|Janssen Research & Development, LLC||5|||f||||||||||||||2017-10-11 03:49:26.566937|2017-10-11 03:49:26.566937
NCT01436175|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2015-02-05|2015-02-05||February 2012||2012-02-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Safety analysis set included all participants who took at least 1 dose of investigational product and had at least 1 post-Visit 0 (Week 0) safety assessment in this study.|SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study|A Phase 3, Open-label, Multicenter, 12-month Extension Safety and Tolerability Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Residual Symptoms or Inadequate Response Following Treatment With an Antidepressant|Terminated||Phase 3|1570|Actual|Shire|The study was terminated on 11 Feb 2014. SPD489 failed to demonstrate a benefit as adjunctive treatment to antidepressants. Termination was not related to any new safety findings.|1||"SPD489 failed to demonstrate a benefit as adjunctive treatment to antidepressants. Termination   was not related to any new safety findings."|f||||||||||||||2017-10-11 03:49:26.72432|2017-10-11 03:49:26.72432
NCT01436162|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-11-06|2014-10-31|2014-08-20|October 2011||2011-10-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Safety Analysis Set: All subjects who took at least 1 dose of randomized investigational product and who had at least 1 safety assessment.|Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder|The SPD489-323 Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible Dose Titration, Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Inadequate Response to Prospective Treatment With an Antidepressant|Completed||Phase 3|1105|Actual|Shire||2|||f||||||||||||||2017-10-11 03:49:28.300696|2017-10-11 03:49:28.300696
NCT01436149|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2015-04-13|2014-11-10|2014-08-20|October 2011||2011-10-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Safety Analysis Set: All subjects who took at least 1 dose of randomized investigational product and who had at least 1 safety assessment (e.g., coming back for any visit, reporting of an adverse event [AE], or reporting the absence of AEs) after the Augmentation Baseline Visit (Visit 8).|Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder|The SPD489-322 Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible Dose Titration, Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Inadequate Response to Prospective Treatment With an Antidepressant|Completed||Phase 3|1262|Actual|Shire||2|||f||||||||||||||2017-10-11 03:49:29.292911|2017-10-11 03:49:29.292911
NCT01436136|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-05-10|||October 2011||2011-10-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|CVD||Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months|Effectiveness of Team Intervention Over 12 Months in Reducing Modifiable CVD Risk Factors on Framingham 10yr Risk Scores Outcomes in HIV-1 Subjects on Antiretroviral Therapy|Completed||N/A|92|Actual|Holdsworth House Medical Practice||2|||f||||f||||||||||2017-10-11 03:49:30.113518|2017-10-11 03:49:30.113518
NCT01436123|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-05-17|||December 2010||2010-12-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|NANOM PCI||Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis Versus Stenting|Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis With The Use of Gold Nanoparticles With Iron Oxide-Silica Shells Versus Stenting|Terminated||Phase 1|62|Actual|Ural Medical University||2||"The study was terminated under the political pressure of the Federal Security Service of the   Russian Federation (FSB) and the Russian Society of Cardiology"|f||||t||||||||||2017-10-11 03:49:30.310666|2017-10-11 03:49:30.310666
NCT01436110|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-11-18|2014-08-21|2013-03-14|September 2011||2011-09-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma|A Randomised, Double-blind, Double-dummy, Placebo Controlled Multi-centre Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Inhalation Powder and Fluticasone Propionate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents Not Currently Treated With Inhaled Corticosteroids|Completed||Phase 3|351|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:49:30.455519|2017-10-11 03:49:30.455519
NCT01436097|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-01-14|||October 2011||2011-10-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|WTE||Randomized Trial of Healthy Eating Interventions|Financial Incentives for Healthy Eating: A Randomized Pilot Study|Completed||N/A|42|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 03:49:31.145537|2017-10-11 03:49:31.145537
NCT01436084|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-06-14|2016-05-10||December 2011||2011-12-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||SB1518 for Patients With Myelodysplastic Syndrome (MDS)|Phase II Study of SB1518 for Patients With Myelodysplastic Syndrome (MDS)|Terminated||Phase 2|8|Actual|M.D. Anderson Cancer Center||1||Colloborating sponsor decision.|f||||f||||||||||2017-10-11 03:49:31.257505|2017-10-11 03:49:31.257505
NCT01436071|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-11-20|2014-08-21|2013-02-28|September 2011||2011-09-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma|A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Multi-centre Study to Evaluate the Efficacy and Safety of Inhaled Fluticasone Furoate in the Treatment of Persistent Asthma in Adults and Adolescents Not Currently Receiving Inhaled Corticosteroids|Completed||Phase 3|248|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:49:31.457312|2017-10-11 03:49:31.457312
NCT01436058|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2011-09-16|||September 2010||2010-09-01|May 2010|2010-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Ankle Joint Osteoartritis|Phase 1 Study of Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Patients With Ankle Joint Osteoarteritis|Completed||Phase 1|6|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 03:49:33.746407|2017-10-11 03:49:33.746407
NCT01436045|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2015-09-25|2015-04-09||September 2011||2011-09-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.|A Double-Blind, Placebo-Controlled Single Dose Study of the Safety and Efficacy of Glulisine on Cognitive Function and Memory in Individuals Diagnosed With Probable Mild to Moderate Alzheimer's Disease/Intranasal Insulin Study.|Completed||Phase 2|12|Actual|HealthPartners Institute||2|||f||||t||||||||||2017-10-11 03:49:33.856166|2017-10-11 03:49:33.856166
NCT01436032|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2012-03-12||2012-03-12|October 2011||2011-10-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery|A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of Intravenous N1539 in Subjects After Abdominal Laparoscopic Surgery|Terminated||Phase 3|50|Actual|Alkermes, Inc.||5|||f||||f||||||||||2017-10-11 03:49:34.179978|2017-10-11 03:49:34.179978
NCT01436019|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-16|||October 2011||2011-10-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Observational|||Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis|Analysis of Anti-infliximab, Anti-adalimumab and Anti-etanercept Antibodies in Children and Young Adolescents With Juvenile Idiopathic Arthritis|Unknown status|Not yet recruiting|N/A|100|Anticipated|Blood Transfusion Centre of Slovenia|||1||f||||t||||||Samples Without DNA|"     Serum samples   "|||2017-10-11 03:49:34.273349|2017-10-11 03:49:34.273349
NCT01436006|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-09-03|2014-05-26||February 2011||2011-02-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|October 2011|Actual|2011-10-01||Observational|MDCTDOSE||Adult and Paediatric Patient Radiation Doses From Multidetector Row Computed Tomography Scans: a National Survey|Adult and Paediatric Patient Radiation Doses From Multidetector CT Scans: a National Survey|Completed||N/A|6700|Actual|University of Palermo|||1||f||||t||||||||||2017-10-11 03:49:34.373463|2017-10-11 03:49:34.373463
NCT01435993|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-06-19|||September 8, 2011|Actual|2011-09-08|June 2017|2017-06-01|January 23, 2012|Actual|2012-01-23|January 23, 2012|Actual|2012-01-23||Interventional|||Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis|A Randomized, Single Blind, Placebo-controlled, Single Ascending Dose/Repeat Dose Cohort Study to Assess Safety, Tolerability, Pharmacokinetics and Immunogenicity of GSK1223249 in Patients With Relapsing Forms of Multiple Sclerosis.|Terminated||Phase 1|3|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:49:35.764501|2017-10-11 03:49:35.764501
NCT01435980|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-03-25|||February 2008||2008-02-01|March 2015|2015-03-01|February 2016|Anticipated|2016-02-01|January 2016|Anticipated|2016-01-01||Interventional|||Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes|Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes|Unknown status|Recruiting|Phase 4|60|Anticipated|Third Military Medical University||3|||f||||t||||||||||2017-10-11 03:49:35.875188|2017-10-11 03:49:35.875188
NCT01435967|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-03-06|||September 2011||2011-09-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™|Observational, Ecological, Database Study on Epidemiology of Hospitalisations With Rotavirus Gastroenteritis Confirmed in Children Aged ≤5 Years, and Any Impact in the Change From Lyophilised to Liquid Formulation of Rotarix™, in Belgium|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:49:36.016284|2017-10-11 03:49:36.016284
NCT01435954|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-05-15|||August 2010||2010-08-01|May 2017|2017-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy|Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy|Completed||N/A|13551|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:49:36.154902|2017-10-11 03:49:36.154902
NCT01435941|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-05-15|||September 2009||2009-09-01|May 2017|2017-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine|Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine|Completed||N/A|11249|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:49:36.266579|2017-10-11 03:49:36.266579
NCT01435928|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2016-03-10|2014-07-25||September 2011||2011-09-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||PEARL Schizophrenia Maintenance|A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia|Completed||Phase 3|676|Actual|Sunovion||2|||f||||t||||||||||2017-10-11 03:49:36.391046|2017-10-11 03:49:36.391046
NCT01435915|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-07-05|||June 28, 2010|Actual|2010-06-28|July 2017|2017-07-01|August 5, 2010|Actual|2010-08-05|August 5, 2010|Actual|2010-08-05||Interventional|||Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects|A Single Dose and Repeat Dose Study to Investigate the Pharmacokinetics of Ropinirole After Single and Multiple Doses of a PR-formulation in Chinese Healthy Male and Female Subjects|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 03:49:37.906638|2017-10-11 03:49:37.906638
NCT01435902|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-06-19|||January 2012||2012-01-01|June 2014|2014-06-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise|A Randomized, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Asthmatic Adolescent and Adult Subjects With Exercise-Induced Bronchoconstriction|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||2||Study was cancelled prior to enrolling any subjects|f||||f||||||||||2017-10-11 03:49:38.016039|2017-10-11 03:49:38.016039
NCT01435889|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-16|2015-12-01|||June 2006||2006-06-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Long Term (1 Year) Respiratory Sequelae in Children Surviving an Acute Respiratory Distress Syndrome|Long Term (1 Year) Respiratory Sequelae in Children Surviving Acute Respiratory Distress Syndrome|Completed||N/A|38|Actual|University Hospital, Lille|||1||f||||f||||||||||2017-10-11 03:49:38.124501|2017-10-11 03:49:38.124501
NCT01435876|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-15|||May 2006||2006-05-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||Surgery and Convergence Insufficiency Intermittent Exotropia|Treatment for Convergence Insufficiency Intermittent Exotropia; A Randomized Trial|Completed||N/A|76|Actual|Sudhalkar Eye Hospital||4|||f||||t||||||||||2017-10-11 03:49:38.22369|2017-10-11 03:49:38.22369
NCT01435863|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-08-11|||September 2011||2011-09-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|April 2015|Actual|2015-04-01||Interventional|||A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)|A Phase 1 Study of SP-02L (Darinaparsin for Injection) in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)|Completed||Phase 1|17|Actual|Solasia Pharma K.K.||1|||f||||f||||||||||2017-10-11 03:49:38.323479|2017-10-11 03:49:38.323479
NCT01435850|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-04-01|||April 2009||2009-04-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|October 2012|Actual|2012-10-01||Interventional|SL-PLUS||Safety and Efficacy of the SL PLUS and the SL PLUS MIA Hip Stem|"Enfoncement de la Tige SL-PLUS et de la Tige SL-PLUS MIA:Etude Comparative"|Completed||Phase 4|80|Actual|Smith & Nephew, Inc.||2|||f||||t||||||||||2017-10-11 03:49:38.402834|2017-10-11 03:49:38.402834
NCT01435837|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-24|2013-06-10|||October 2010||2010-10-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Interaction of Caffeine and Hydration on Voice|Effects of the Interaction of Caffeine and Hydration on Voice Performance|Completed||Early Phase 1|80|Actual|Southern Illinois University Carbondale||2|||f||||f||||||||||2017-10-11 03:49:38.479273|2017-10-11 03:49:38.479273
NCT01435824|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-05-12|||June 2011||2011-06-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Bioavailability of Amoxicillin Dissolved in Human Milk|Bioavailability of Amoxicillin Dissolved in Human Milk: An Adult Volunteer Study as a First Step Towards Defining Drug Doses for Infants|Completed||Phase 1|16|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 03:49:38.56674|2017-10-11 03:49:38.56674
NCT01435811|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-05-06|||August 2011||2011-08-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|April 2012|Actual|2012-04-01||Interventional|CIN-002||Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)|Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)|Completed||Phase 1|60|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 03:49:38.643856|2017-10-11 03:49:38.643856
NCT01435785|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-03-27|||April 2011|Actual|2011-04-01|March 2017|2017-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|TCIGeriatric||Performance Evaluation of Four Pharmacokinetic-Pharmacodynamic(PKPD) Models of Propofol in Elderly Patients|Derivation and Prospective Validation of Four Pharmacokinetic-Pharmacodynamic Models of Propofol in Elderly Patients|Completed||N/A|14|Actual|Universidad del Desarrollo|||1||f||||t|f|f||||Samples With DNA|"     whole blood will be centrifugated, the plasma will be frozen and all the samples where     analysed wiht HPLC technique   "|Yes|Open TCI proyect|2017-10-11 03:49:39.217788|2017-10-11 03:49:39.217788
NCT01435759|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2015-02-03|2015-02-03||October 2011||2011-10-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Safety Analysis Set: All subjects who took at least 1 dose of randomized investigational product and who had at least 1 post-augmentation baseline safety assessment (e.g. coming back for any visit, reporting of an adverse event [AE] or reporting the absence of AEs). Subjects who received only single-blind placebo were not included in this group.|SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder|A Phase 2, Multicenter, Double- Blind, Parallel-group, Randomized, Placebo-controlled, Forced-dose Titration, Dose-ranging Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Inadequate Response to Prospective Treatment With an Antidepressant|Completed||Phase 2|1197|Actual|Shire||5|||f||||||||||||||2017-10-11 03:49:39.459949|2017-10-11 03:49:39.459949
NCT01435746|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2011-09-16|||November 2011||2011-11-01|September 2011|2011-09-01|November 2013|Anticipated|2013-11-01|November 2012|Anticipated|2012-11-01||Interventional|TROLL||Transfusion Requirements After Orthotopic Liver Transplantation|A Randomized, Controlled Pilot Trial of Transfusion Requirements After Orthotopic Liver|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|University Medical Center Goettingen||2|||f||||f||||||||||2017-10-11 03:49:40.665601|2017-10-11 03:49:40.665601
NCT01435733|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2017-08-09|||September 2011||2011-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Parenting a Child With Autism Spectrum Disorder and Marital Status|Parenting a Child With Autism Spectrum Disorder and Marital Status|Recruiting||N/A|200|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 03:49:40.757251|2017-10-11 03:49:40.757251
NCT01435720|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-09-09|||September 2011||2011-09-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)|Phase 1/2 Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients With Relapsed or Refractory B Cell Malignancies|Unknown status|Active, not recruiting|Phase 1/Phase 2|15|Anticipated|Senesco Technologies, Inc.||4|||f||||t||||||||||2017-10-11 03:49:40.865759|2017-10-11 03:49:40.865759
NCT01435707|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-12-24|||September 2011||2011-09-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids|The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids|Completed||N/A|125|Actual|Samsung Medical Center||4|||f||||f||||||||||2017-10-11 03:49:40.968833|2017-10-11 03:49:40.968833
NCT01435694|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-01-15|||April 2011||2011-04-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Robot-assisted Gait Training in Multiple Sclerosis Subjects|The Effects of Robot-assisted Gait Training on Locomotor Function and Motor Unit Firing in Multiple Sclerosis Subjects With Severe Gait Impairments. A Randomized Control Trial|Completed||N/A|60|Actual|University Hospital of Ferrara||2|||f||||t||||||||||2017-10-11 03:49:41.084401|2017-10-11 03:49:41.084401
NCT01435681|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-09-07|||May 2012||2012-05-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|October 2014|Actual|2014-10-01||Observational|||Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments?|Can Short Latency Afferent Inhibition Give us Clues to Better Dystonia Treatments?|Completed||N/A|5|Actual|University of Florida|||2||f||||t||||||||Yes||2017-10-11 03:49:41.192169|2017-10-11 03:49:41.192169
NCT01435668|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2014-01-03|||September 2011||2011-09-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|AURAIA||AURAIA Study : Impact Evaluation at 3 Months Follow-up of a Brief Motivational Intervention in Reducing Alcohol Consumption Among Adolescents Aged 16-24 in Pontchaillou Hospital Emergency Department in Rennes, France|Impact Evaluation at 3 Months Follow-up of a Brief Motivational Intervention in Reducing Alcohol Consumption Versus Simple Written Advice Only Among Adolescents Aged 16-24 in Pontchaillou Hospital Emergency Department in Rennes, France|Completed||N/A|258|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 03:49:41.268329|2017-10-11 03:49:41.268329
NCT01435655|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-08-10|2015-02-24||November 2011||2011-11-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin|The Effect On Transthyretin Stabilization, Safety, Tolerablity, Efficacy And Pharmacokinetics Of Orally Administered Tafamidis In Transthyretin Amyloid Polyneuropathy Patients With V30m Or Non-v30m Transthyretin: A Phase Iii, Open-label Study|Completed||Phase 3|10|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 03:49:41.390517|2017-10-11 03:49:41.390517
NCT01435642|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-01-19|||September 2011||2011-09-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Observational|Diabcare||A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 Diabetes|Diabcare Paediatric - A Survey-study on Diabetes Management, Complications and Psychosocial Aspects of Type 1 Childhood Diabetics|Completed||N/A|349|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:49:42.047801|2017-10-11 03:49:42.047801
NCT01435447|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-05-09|||April 2011||2011-04-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult ALL|Fludarabine/Busulfan and Post-infusion Cyclophosphamide as Conditioning for Adult Patients With ALL Undergoing Allogeienc Stem Cell Transplantation|Recruiting||Phase 2|40|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||No||2017-10-11 03:49:45.152244|2017-10-11 03:49:45.152244
NCT01435629|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-05-04|||November 22, 2012|Actual|2012-11-22|May 2017|2017-05-01|December 4, 2015|Actual|2015-12-04|December 4, 2015|Actual|2015-12-04||Observational|||A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin|Open-label, Multicenter, Observational, Non-intervention Study to Retrospectively Evaluate the Efficacy of Norditropin® (Adult Height) in Patients With Achondroplasia/Hypochondroplasia Enrolled in the GH-1941 Study [Follow-up Survey]|Completed||N/A|81|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:49:42.137012|2017-10-11 03:49:42.137012
NCT01435616|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2014-04-14||2014-04-14|October 2011||2011-10-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|IMAGINE 2||A Study in Patients With Type 2 Diabetes Mellitus|A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study|Completed||Phase 3|1516|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:49:42.236834|2017-10-11 03:49:42.236834
NCT01435603|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2016-10-06|||August 2011||2011-08-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|I-D-HEALTH||Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study|Community Translation of a Lifestyle Intervention to Improve Health in Diabetes|Completed||N/A|331|Actual|Northwestern University||2|||f||||t||||||||No||2017-10-11 03:49:42.677908|2017-10-11 03:49:42.677908
NCT01435590|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-05-27|||September 2011||2011-09-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Endocervical Evaluation With the Curette Versus Cytobrush for the Diagnosis of Dysplasia of the Uterine Cervix||Completed||N/A|180|Anticipated|University Hospital, Geneva|||||f||||f||||||||||2017-10-11 03:49:42.796629|2017-10-11 03:49:42.796629
NCT01435577|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2013-06-24|2013-03-05||September 2011||2011-09-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||The summary statistics provided for baseline was based on safety population that included 64 subjects in the tapentadol group and 65 in the placebo group. The safety population includes randomized participants that received at least one dose of study drug.|Intravenous Tapentadol in Post-Bunionectomy Pain|A Randomized, Double-blind, Placebo-controlled Parallel Group, Multicenter Trial to Evaluate the Efficacy and Safety of Multiple Dose Administration of an Intravenous Formulation of Tapentadol in the Treatment of Acute Pain Following Bunionectomy.|Completed||Phase 2|177|Actual|Grünenthal GmbH||2|||f||||f||||||||||2017-10-11 03:49:42.902143|2017-10-11 03:49:42.902143
NCT01435564|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-06-18|||June 2011||2011-06-01|June 2014|2014-06-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Interventional|||Pilot Study: Mobile Phone Based Physical Activity in Sedentary Men and Women|Innovations in Mobile Phone Based Physical Activity- A Pilot of Clinical Trial in Sedentary Men and Women|Withdrawn||N/A|0|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 03:49:43.978814|2017-10-11 03:49:43.978814
NCT01435551|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-02-02||||||February 2016|2016-02-01||||||||Expanded Access|||Using Hypnotherapy For Dementia & Alzheimer's|Phase 1 a One Year Study of Using Hypnotherapy to Control Beta-amyloid Buildup That Causes Alzheimer's & Dementia CANCELLED|No longer available||N/A|||Families To The Rescue|||||f||||||||||||||2017-10-11 03:49:44.079327|2017-10-11 03:49:44.079327
NCT01435525|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-04-14|||September 2011||2011-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation|Nexium Capsules Specific Clinical Experience Investigation Concerning Helicobacter Pylori Eradication|Completed||N/A|369|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 03:49:44.228497|2017-10-11 03:49:44.228497
NCT01435499|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-05-23|||September 2011||2011-09-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|January 2013|Actual|2013-01-01||Interventional|||Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma|A Feasibility and Toxicity Study of a Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Secreting Allogeneic Melanoma Vaccine Administered Alone or in Combination With Cyclophosphamide in Subjects With Surgically Resected At-Risk Melanoma|Completed||Phase 1|21|Actual|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 03:49:44.554929|2017-10-11 03:49:44.554929
NCT01435486|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-03-31|||November 2011||2011-11-01|May 2014|2014-05-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants|Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants: A Randomized, Double Blind, Controlled Trial (RCT)|Completed||N/A|90|Actual|Hamad Medical Corporation||2|||f||||t||||||||||2017-10-11 03:49:44.638237|2017-10-11 03:49:44.638237
NCT01435473|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-01-29|||July 2011||2011-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Observational|CATCH||Clinical Assessment of Thrombosis in Children After Heart Surgery|Clinical Assessment of Thrombosis in Children After Heart Surgery: The CATCH Study|Completed||N/A|400|Actual|The Hospital for Sick Children|||1||f||||t||||||||||2017-10-11 03:49:44.732804|2017-10-11 03:49:44.732804
NCT01435460|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-02-17|2012-02-17||August 2010||2010-08-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)|A Clinical Safety and Efficacy Evaluation of Alrex® (Loteprednol Etabonate Ophthalmic Suspension, 0.2%) Versus Patanol (Olopatadine Hydrochloride Ophthalmic Solution, 0.1%) in the Treatment of Seasonal Allergic Conjunctivitis (SAC)|Completed||Phase 3|300|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 03:49:44.82061|2017-10-11 03:49:44.82061
NCT01435421|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2011-09-15|||October 2011||2011-10-01|September 2011|2011-09-01||||December 2012|Anticipated|2012-12-01||Observational|||Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or Recovery|Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or Recovery|Unknown status|Not yet recruiting|N/A|112|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-10-11 03:49:45.37855|2017-10-11 03:49:45.37855
NCT01435408|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-10-17|||April 2011||2011-04-01|October 2016|2016-10-01|February 2021|Anticipated|2021-02-01|February 2016|Actual|2016-02-01||Interventional|DANAMI-3||DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction|A Randomised Comparison of the Clinical Outcome After Postconditioning or Deferred Stent Implantation Versus Conventional Treatment|Active, not recruiting||N/A|2000|Anticipated|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-10-11 03:49:45.435991|2017-10-11 03:49:45.435991
NCT01435395|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-04-25|||December 2011||2011-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme|Phase I Trial of Temozolomide, Bevacizumab Plus Bortezomib for Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 1|12|Actual|Emory University||1|||f||||t||||||||||2017-10-11 03:49:45.565036|2017-10-11 03:49:45.565036
NCT01435356|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2017-06-15|||August 2011|Actual|2011-08-01|June 2017|2017-06-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|MAGNOLIA||Safety and Efficacy Study of Cancer Immunotherapeutic MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy|A Randomized, Double Blind, Placebo Controlled Phase II Trial to Evaluate the Safety and Efficacy of recMAGE-A3 + AS15 ASCI in Patients With MAGE-A3 Positive Muscle Invasive Bladder Cancer After Cystectomy|Terminated||Phase 2|83|Actual|European Association of Urology Research Foundation||2|||f||||t||||||||||2017-10-11 03:49:45.920452|2017-10-11 03:49:45.920452
NCT01435343|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-04-23|||July 2012||2012-07-01|September 2016|2016-09-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia|Multicenter, Prospective, Open-label, Single-arm, Phase I-II Clinical Trial to Analyze Induction Therapy With a Combination of Fludarabine, Idarubicin, Cytarabine, G-CSF and Plerixafor for the Treatment of Young Patients With Relapsed or Refractory AML|Completed||Phase 1/Phase 2|55|Actual|PETHEMA Foundation||1|||f||||t||||||||||2017-10-11 03:49:46.14379|2017-10-11 03:49:46.14379
NCT01435330|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-04-23|||March 2011||2011-03-01|April 2015|2015-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Tolerability of BVS857 in Subjects With Insulin Resistance|A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Parenterally Administered BVS857 in Healthy Subjects Without and With Insulin Resistance|Completed||Phase 1|43|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:49:46.2475|2017-10-11 03:49:46.2475
NCT01435317|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-07-10|||November 2011||2011-11-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2013|Actual|2013-06-01||Interventional|RRL||"Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus (RESET Real Life)"|"Prospective Clinical Study for Confirmation of Efficacy and Safety of Acoustic CR®-Neuromodulation by CE Marked ANM T30 CR®-System in a Real Life Patient Population With Chronic Tonal Tinnitus"|Completed||Phase 4|200|Actual|ANM Adaptive Neuromodulation GmbH||1|||f||||t||||||||||2017-10-11 03:49:46.34945|2017-10-11 03:49:46.34945
NCT01435304|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-03-23|||September 2011||2011-09-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass|The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass|Completed||Phase 4|100|Actual|Maine Medical Center||2|||f||||t||||||||||2017-10-11 03:49:46.479692|2017-10-11 03:49:46.479692
NCT01435291|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-15|2014-07-28|||October 2011||2011-10-01|August 2011|2011-08-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|AADAPT||AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation|Prospective Pharmacokinetic and Pharmacogenetic Analysis of Advagraf After Transplantation|Completed||Phase 4|45|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-10-11 03:49:46.55555|2017-10-11 03:49:46.55555
NCT01435278|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2012-07-25|||September 2011||2011-09-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy and Safety of Glucosanol in Maintaining Body Weight|Open-label Clinical Investigation to Evaluate the Safety and Efficacy of Glucosanol in Maintaining Body Weight Loss in Overweight and Obese Subjects|Completed||Phase 4|51|Actual|InQpharm Group||1|||f||||f||||||||||2017-10-11 03:49:46.644501|2017-10-11 03:49:46.644501
NCT01435265|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-01-24|2012-12-19||January 2010||2010-01-01|January 2017|2017-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab|The Effectiveness of Nurse Education and Its Impact on Treatment Adherence in Subjects With Moderate to Severe Psoriasis Undergoing Treatment With Adalimumab|Completed||N/A|7|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-11 03:49:46.740705|2017-10-11 03:49:46.740705
NCT01435252|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-05-10|||September 2011||2011-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab|A Phase II, Randomized, Open-Label, Single Center Study In Patients With Advanced Head And Neck Cancer To Investigate Efficacy And Safety Of Standard Chemoradiation And Add-On Concurrent Cetuximab ± Consolidation Cetuximab|Active, not recruiting||Phase 2|68|Actual|University of Zurich||2|||f||||t||||||||||2017-10-11 03:49:47.224715|2017-10-11 03:49:47.224715
NCT01435239|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-03-04|||September 2011||2011-09-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Comparison of Two Different Methods of Partial Inflation of Cuff for Facile Insertion of Laryngeal Mask Airway in Pediatric Patients||Completed||N/A|78|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 03:49:47.321229|2017-10-11 03:49:47.321229
NCT01435226|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2013-11-22||2013-11-22|September 2011||2011-09-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) Compared With GS-5885, GS-9451 With Tegobuvir or RBV in Treatment-Experienced Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection|Completed||Phase 2|170|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 03:49:47.400227|2017-10-11 03:49:47.400227
NCT01435213|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2013-02-15|||September 2011||2011-09-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|AIMI||Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline|Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline - a PET Study in Healthy Human Subjects|Completed||Phase 1|10|Actual|University of Turku||6|||f||||f||||||||||2017-10-11 03:49:47.599108|2017-10-11 03:49:47.599108
NCT01435200|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-01-31|||June 2011||2011-06-01|January 2017|2017-01-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy|Prevention of Blood Transfusion With Intravenous Iron in Gynecologic Cancer Patients Receiving Platinum Based Chemotherapy|Completed||Phase 3|64|Actual|Chulalongkorn University||2|||f||||f||||||||No||2017-10-11 03:49:47.821634|2017-10-11 03:49:47.821634
NCT01435187|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-11-04|||August 2011||2011-08-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|April 2015|Actual|2015-04-01||Observational|PROP||Prematurity and Respiratory Outcomes Program (PROP)|Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol|Completed||N/A|835|Actual|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"     Saliva for DNA, Urine and Tracheal Aspirate   "|Undecided||2017-10-11 03:49:47.921713|2017-10-11 03:49:47.921713
NCT01435161|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-11-15|||May 2007||2007-05-01|November 2012|2012-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF|The Effect of Nifedipine Versus Telmisartan on Prevention of Atrial Fibrillation Recurrence in Hypertensive Patients With Paroxysmal Atrial Fibrillation by Intensive Lower Blood Pressure|Completed||Phase 4|160|Actual|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||||2017-10-11 03:49:48.269276|2017-10-11 03:49:48.269276
NCT01435148|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-14|||December 2006||2006-12-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Deep Brain Stimulation in Treatment Resistant Depression|A Double Blind Randomised Pilot Study of Deep Brain Stimulation in Patients With Treatment Resistant Unipolar Major Depressive Disorder.|Unknown status|Active, not recruiting|N/A|8|Actual|North Bristol NHS Trust||2|||f||||t||||||||||2017-10-11 03:49:48.39587|2017-10-11 03:49:48.39587
NCT01435122|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-08-30|2017-03-22||October 25, 2011|Actual|2011-10-25|August 2017|2017-08-01|June 30, 2018|Anticipated|2018-06-30|January 4, 2017|Actual|2017-01-04||Interventional||All participants.|A Study of Axitinib in Advanced Carcinoid Tumors|A Phase II Study of Axitinib in Advanced Carcinoid Tumors|Active, not recruiting||Phase 2|30|Actual|H. Lee Moffitt Cancer Center and Research Institute|Results are limited by a relatively high rate of participant withdrawal before progression due to toxicity. Post analysis, 2 participants are still on study at UCSF.|1|||f||||t|t|f||||||||2017-10-11 03:49:48.650307|2017-10-11 03:49:48.650307
NCT01435109|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-06-06|||July 2011||2011-07-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PRIMO||Patient and Provider Interventions for Managing Osteoarthritis in Primary Care|Patient and Provider Interventions for Managing Osteoarthritis in Primary Care|Completed||N/A|537|Actual|Duke University||4|||f||||f||||||||||2017-10-11 03:49:49.351107|2017-10-11 03:49:49.351107
NCT01435096|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-09-13|||November 2004||2004-11-01|September 2011|2011-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||BN80927 in Patients With Advanced Malignant Solid Tumors|A Phase I Dose Finding Study of BN80927 Administered as an Intravenous Infusion Once Every 3 Weeks in Patients With Advanced Malignant Solid Tumors|Completed||Phase 1|56|Actual|Ipsen||1|||f||||||||||||||2017-10-11 03:49:49.522191|2017-10-11 03:49:49.522191
NCT01435083|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-12-04|||November 2011||2011-11-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study|Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study|Completed||Phase 4|50|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:49:49.601502|2017-10-11 03:49:49.601502
NCT01435070|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2011-09-14|||January 2011||2011-01-01|September 2011|2011-09-01|October 2013|Anticipated|2013-10-01|July 2013|Anticipated|2013-07-01||Observational|||Functional Outcome Following Fracture of the Distal Radius|A Correlation of Functional Outcome Measures of Fractures of the Distal Radius Following Operative Management|Unknown status|Recruiting|N/A|50|Anticipated|University of Warwick|||1||f||||f||||||||||2017-10-11 03:49:49.685122|2017-10-11 03:49:49.685122
NCT01435057|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-05-27|||April 2011||2011-04-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||Effects of Different Exercise Training Regimens on Visceral Fat Dynamic and Resting Energy Expenditure in Obese Patients|Monocentric, Randomized, Controlled Study for Reduction on Visceral Fat Dynamic and Resting Energy Expenditure in Obese Patients Via Strength Versus Endurance Training (STEN Study - STrength Versus ENdurance Training)|Unknown status|Recruiting|N/A|200|Anticipated|University of Leipzig||2|||f||||f||||||||||2017-10-11 03:49:49.775004|2017-10-11 03:49:49.775004
NCT01435044|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2014-01-07||2013-11-20|September 2011||2011-09-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|QUANTUM||Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection|QUANTUM: An International, Multi-center, Blinded, Randomized Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Administration of Regimens Containing PSI-352938, PSI-7977, and Ribavirin in Patients With Chronic Hepatitis C Virus (HCV) Infection|Completed||Phase 2|239|Actual|Gilead Sciences||7|||f||||f||||||||||2017-10-11 03:49:49.869444|2017-10-11 03:49:49.869444
NCT01435031|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-02-17|2014-11-14||September 2011||2011-09-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2014|Actual|2014-02-01||Interventional|EXPERT CTO|ITT subjects (n=222) include all subjects who met the study entry criteria, signed the written informed consent, were enrolled in the trial and whose target lesion was successfully crossed and predilated.|EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions|Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions|Active, not recruiting||N/A|250|Actual|Abbott Vascular||1|||f||||f||||||||||2017-10-11 03:49:50.165084|2017-10-11 03:49:50.165084
NCT01435018|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2016-09-20|||August 2013||2013-08-01|September 2016|2016-09-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS|A Randomized Comparison of Three Regimens of Chemotherapy With Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings|Recruiting||Phase 3|706|Anticipated|AIDS Clinical Trials Group||3|||f||||t||||||||||2017-10-11 03:49:53.482146|2017-10-11 03:49:53.482146
NCT01435005|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-01-04|||March 2010||2010-03-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|April 2013|Actual|2013-04-01||Interventional|BETA||Breast Cancer and Exercise Trial in Alberta|Breast Cancer and Exercise Trial in Alberta: The BETA Trial|Completed||Phase 3|400|Actual|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-10-11 03:49:53.653038|2017-10-11 03:49:53.653038
NCT01434992|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-04-19|||August 2011||2011-08-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Detection of Helicobacter Pylori Infection by High Resolution Endoscopy|Detection of Helicobacter Pylori Infection by Non-magnifying High Resolution Endoscopy is Possible Within the Gastric Corpus|Completed||N/A|585|Actual|Kyunghee University Medical Center|||1||f||||t||||||Samples Without DNA|"     Gastric mucosa for detecting Helicobacter pylori   "|||2017-10-11 03:49:53.754453|2017-10-11 03:49:53.754453
NCT01434966|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2015-12-10|||September 2011||2011-09-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain|Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain|Completed||N/A|47|Actual|Creighton University||3|||f||||f||||||||||2017-10-11 03:49:53.928293|2017-10-11 03:49:53.928293
NCT01434953|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-07-13|||July 13, 2009|Actual|2009-07-13|July 2017|2017-07-01|July 9, 2012|Actual|2012-07-09|July 9, 2012|Actual|2012-07-09||Interventional|Tanya K23||Prehypertension Labeling|Diagnostic Labeling: Effect on White Coat Hypertension|Terminated||N/A|100|Actual|Columbia University||2||PI left institution|f||||f||||||||||2017-10-11 03:49:54.046794|2017-10-11 03:49:54.046794
NCT01434940|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-07-27|||April 2010||2010-04-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|January 2018|Anticipated|2018-01-01||Interventional|MOMAD||Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression|Early Oculomotor Markers in Alzheimer's Disease: Test of Predictive Value in the Differential Diagnosis Depression/Alzheimer|Recruiting||N/A|288|Anticipated|Centre Hospitalier Universitaire de Besancon||3|||f||||t||||||||||2017-10-11 03:49:54.130227|2017-10-11 03:49:54.130227
NCT01434927|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-09-13|||October 2009||2009-10-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||The Clinical Acceptability of Unsedated Colonoscopy|Unsedated Colonoscopy: An Option For Some But Not For All|Completed||N/A|964|Actual|Valduce Hospital|||1||f||||f||||||||||2017-10-11 03:49:54.216787|2017-10-11 03:49:54.216787
NCT01434914|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-05-12|||October 2011||2011-10-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds|Randomized, Double-blind, Single-center, Placebo-controlled Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds|Terminated||Phase 4|9|Actual|Schülke & Mayr GmbH||2||early termination due to poor recruitment|f||||f||||||||||2017-10-11 03:49:54.287309|2017-10-11 03:49:54.287309
NCT01434901|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-05-17|||August 15, 2011|Actual|2011-08-15|May 2017|2017-05-01|July 7, 2014|Actual|2014-07-07|July 7, 2014|Actual|2014-07-07||Interventional|||The Effects of Bethanechol on Glucose Homeostasis|The Effects of Bethanechol, a Muscarinic Agonist, on Plasma Insulin, Glucagon, and Glucose Levels in Humans With and Without Type 2 Diabetes Mellitus|Completed||Phase 1|40|Anticipated|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 03:49:54.383655|2017-10-11 03:49:54.383655
NCT01434888|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2012-06-07|||September 2011||2011-09-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pharmacokinetics, Safety and Tolerability of the Preservative-free Fixed Dose Combination of Tafluprost 0.0015% and Timolol 0.5% Eye Drops|A Phase I, Randomized, Double-masked, 3-period Cross-over Clinical Study to Compare the Pharmacokinetics, Safety and Tolerability of the Preservative-free Fixed Dose Combination of Tafluprost 0.0015% and Timolol 0.5% Eye Drops to Those of Preservative-free Tafluprost 0.0015% and Timolol 0.5% Eye Drops in Healthy Volunteers|Completed||Phase 1|15|Actual|Santen Oy||3|||f||||f||||||||||2017-10-11 03:49:54.500818|2017-10-11 03:49:54.500818
NCT01434862|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2014-04-30|||February 2011||2011-02-01|April 2014|2014-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|ALM002||Pramlintide Combined With Model Predictive Control Algorithm|Pramlintide Combined With Model Predictive Control Algorithm|Terminated||N/A|2|Actual|University of Virginia||3||Modified study; created new study as a result of these modifications|f||||f||||||||||2017-10-11 03:49:54.592122|2017-10-11 03:49:54.592122
NCT01434849|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-11-14|||July 2012||2012-07-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|TiPPIH||Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)|Phase 1 Study of Topical Beta Blocker to Prevent the Proliferative Stage of Infantile Hemangioma|Terminated||Phase 1|26|Actual|The University of Texas Health Science Center at San Antonio||2||Difficulty with enrolled patients to complete trial.|f||||t||||||||No|Many participants did not complete trial so there is not enough data to share.|2017-10-11 03:49:54.687326|2017-10-11 03:49:54.687326
NCT01434836|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2013-05-30|||September 2011||2011-09-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Neuro-modulation of the Depressed Brain Using Working Memory Training and Transcranial Direct Current Stimulation (tDCS)|Neuro-modulation of the Depressed Brain Using Working Memory Training and tDCS|Completed||Phase 2|40|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:49:54.788825|2017-10-11 03:49:54.788825
NCT01434823|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-11-30|2013-03-01||September 2011||2011-09-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||824 patients were randomized to the intervention group, 4 of which have been excluded from analyses to due incomplete data (n=820), 785 were randomized to the control group, 7 of which have been excluded from analyses due to incomplete data (n=778).|24 Hour Intensivist Coverage in the Medical Intensive Care Unit|The Effects of 24-hour Intensivist Coverage in the Medical ICU|Completed||N/A|1609|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 03:49:55.0708|2017-10-11 03:49:55.0708
NCT01434797|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-11-13|||September 2011||2011-09-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection|Prospective Study on the Usefulness and Diagnostic Value of F-18-FDG PET/CT in the Diagnosis of Permanent Central Venous Catheters Infection|Recruiting||N/A|40|Anticipated|University of Lausanne Hospitals|||3||f||||f||||||||No||2017-10-11 03:49:55.607684|2017-10-11 03:49:55.607684
NCT01434784|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2017-06-08|||September 2011||2011-09-01|June 2017|2017-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Update of the EORTC QLQ-LC13 Quality of Life Questionnaire|Update of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Lung Cancer 13 (EORTC QLQ-LC13) Phases I - III|Completed||N/A|200|Actual|University Hospital Regensburg|||9||f||||f||||||||No||2017-10-11 03:49:55.699871|2017-10-11 03:49:55.699871
NCT01434771|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2013-10-15|||December 2012||2012-12-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Monitoring Blood Flow and Breathing Using a New Device (RFII) Compared to the Gold Standard Device in Post Operative Cardiac Patients|Simultaneous Hemodynamic and Ventilatory Monitoring Using Radio Frequency Impedance Interrogation (RFII), Thoracic Impedance Cardiography and Invasive Hemodynamic Monitoring Methods in Post Operative Cardiac Patients|Withdrawn||N/A|0|Actual|University of Florida|||1|Sponsor never funded study.|f||||f||||||||||2017-10-11 03:49:55.784394|2017-10-11 03:49:55.784394
NCT01434758|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2016-11-13|||April 2011||2011-04-01|November 2013|2013-11-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Observational|||Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture|Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture|Completed||N/A|560|Actual|Oxford University Clinical Research Unit, Vietnam|||1||f||||f||||||Samples With DNA|"     -  sputum        -  gastric aspirate        -  blood        -  urine        -  cerebrospinal fluid   "|||2017-10-11 03:49:55.847459|2017-10-11 03:49:55.847459
NCT01434745|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-03-21|||September 2011||2011-09-01|March 2012|2012-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation|Smith-Lemli Opitz Syndrome: A Clinical Investigation of the Effect of Simvastatin in Patients Receiving Cholesterol Supplementation|Unknown status|Recruiting|N/A|16|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 03:49:55.940064|2017-10-11 03:49:55.940064
NCT01434719|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2016-11-13|||November 2010||2010-11-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|||Human Suis and Pig Diseases in Northern Vietnam|Spatial and Temporal Associations Between Human Streptococcus Suis Infections and Pig Diseases in Northern Vietnam, 2010|Completed||N/A|273|Actual|Oxford University Clinical Research Unit, Vietnam|||2||f||||f||||||||||2017-10-11 03:49:56.13257|2017-10-11 03:49:56.13257
NCT01434706|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-12-02|||December 2006||2006-12-01|December 2014|2014-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection|NAT: The Early Test Program: Implementation of NAT Screening to Identify Acute and Early HIV Infection at San Diego Public HIV Counseling and Testing Sites|Unknown status|Recruiting|Phase 3|12000|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-10-11 03:49:56.224865|2017-10-11 03:49:56.224865
NCT01434693|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2013-05-17|2013-02-26||November 2011||2011-11-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease|A Sequential Dose-Escalation, Double-Blind, Placebo-Controlled, Phase I Study to Evaluate the Safety and Tolerability of Single Doses of 3 Different Doses of Oral CNDO 201 Trichuris Suis Ova Suspension (Tso) in Patients With Crohn's Disease|Completed||Phase 1|36|Actual|Coronado Biosciences, Inc.||4|||f||||f||||||||||2017-10-11 03:49:56.365494|2017-10-11 03:49:56.365494
NCT01434680|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2017-03-13|2013-07-18||September 2011||2011-09-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers|A Phase 2, Randomized, Comparative, Multicenter Observer-Blind Study Evaluating the Safety and Immunogenicity of the New Liquid Formulation of Novartis Meningococcal C Conjugate Vaccine and of the Novartis Lyophilized Meningococcal C Conjugate Vaccine Manufactured at Two Different Sites, in Healthy Toddlers|Completed||Phase 2|992|Actual|Novartis||3|||f||||||||||||||2017-10-11 03:49:56.948229|2017-10-11 03:49:56.948229
NCT01434667|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-07-30|||January 2010||2010-01-01|July 2013|2013-07-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV|Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV|Unknown status|Active, not recruiting|N/A|360|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:49:57.474329|2017-10-11 03:49:57.474329
NCT01434654|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2016-07-06|2016-02-09||September 2011||2011-09-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|HANDobs|Data presented reflect baseline demographic and clinical characteristics for participants included in the primary analysis.|Efficacy of Neuro-HAART in Patients With HIV|The Efficacy of Neuro-HAART in HIV Infected Individuals|Terminated||N/A|19|Actual|St Vincent's Hospital, Sydney|Lower than expected participant recruitment rate and early termination led to a small sample size and underpowered statistical analyses||2|Slower than expected recruitment|f||||f||||||Samples Without DNA|"     Cerbrospinal fluid and bloods   "|||2017-10-11 03:49:57.614892|2017-10-11 03:49:57.614892
NCT01434641|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2016-03-10|2012-10-01||July 2011||2011-07-01|March 2016|2016-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Rapid Stress/Rest Single-Day Tc-99m Sestamibi Myocardial Single Photon Emission Computed Tomography|Rapid Stress/Rest Single-Day Tc-99m Sestamibi Myocardial SPECT|Completed||N/A|102|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||f||||||||||2017-10-11 03:49:58.833199|2017-10-11 03:49:58.833199
NCT01434628|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2014-05-22|||July 2011||2011-07-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses|One Arm, Open Label, Prospective, Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses in Resource Limited Settings for HIV Prevention|Completed||N/A|590|Actual|Ministry of Health, Rwanda||1|||f||||f||||||||||2017-10-11 03:49:59.176473|2017-10-11 03:49:59.176473
NCT01434615|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2012-11-08|||October 2008||2008-10-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|SASHFR||Medtronic South Asian Systolic Heart Failure Registry|SASHFR (South Asian Systolic Heart Failure Registry) : A Multi-center, Nonrandomized, Prospective Study to Collect Data Pertaining to the Demographic and Cardiovascular Profiles, Management Strategies and Clinical Outcomes of HF Patients.|Unknown status|Active, not recruiting|Phase 4|502|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f||||||||||2017-10-11 03:49:59.308448|2017-10-11 03:49:59.308448
NCT01434602|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-09-26|||October 21, 2015||2015-10-21|September 20, 2017|2017-09-20|July 1, 2020|Anticipated|2020-07-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas|A Phase I-II Trial of Everolimus and Sorafenib in Patients With Recurrent High-Grade Gliomas|Recruiting||Phase 1/Phase 2|118|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 03:49:59.426281|2017-10-11 03:49:59.426281
NCT01434576|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-08-01|||December 2011||2011-12-01|August 2013|2013-08-01||||December 2012|Anticipated|2012-12-01||Interventional|||Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacodynamics and Safety of HGS1025, a Human Monoclonal Anti-CCR5 Antibody, in Subjects With Ulcerative Colitis|Withdrawn||Phase 1|0|Actual|Human Genome Sciences Inc.||3||Sponsor withdrew study for business reasons|f||||f||||||||||2017-10-11 03:49:59.724846|2017-10-11 03:49:59.724846
NCT01434563|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2012-10-22|||October 2011||2011-10-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|CNS HAND||The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort -|The CNS HAND Study: The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort|Completed||N/A|326|Actual|Holdsworth House Medical Practice|||2||f||||f||||||||||2017-10-11 03:49:59.818162|2017-10-11 03:49:59.818162
NCT01434550|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-02-21|||March 2012||2012-03-01|February 2017|2017-02-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer|Phase II Study of First-line Stereotactic Body Radiation Therapy (SBRT) in Patients With Non-Metastatic Unresectable Pancreatic Cancer|Withdrawn||N/A|0|Actual|H. Lee Moffitt Cancer Center and Research Institute||2||research cancelled|f||||t||||||||||2017-10-11 03:49:59.894173|2017-10-11 03:49:59.894173
NCT01434537|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-09-14|||January 2011||2011-01-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Observational|VENSCAN||Evaluation of a Touchless Vein Scanner for Venepuncture and Cannulation in Pediatric Patients|Venepuncture and Vein Cannulation With Support of the AccuVein AV300 Vein Scanner in Paediatric Patients in a Pre-operation Setting|Completed||N/A|238|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 03:49:59.998224|2017-10-11 03:49:59.998224
NCT00000238|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2008-11-19|||August 1997||1997-08-01|November 2008|2008-11-01||||||||Interventional|||Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20|Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:41.41604|2017-10-11 04:17:41.41604
NCT01434511|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-06-26|2014-12-11||August 2011||2011-08-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||This study was terminated early and only enrolled one participant. Due to concerns that the participant would be at risk of being re-identified, study results are not posted. The decision to terminate this study was not related to any safety and/or efficacy concern of OBI-1 in the indication described within this study (Congenital Hemophilia A).|Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A|Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Patients With Congenital Hemophilia A With Factor VIII Inhibitors|Terminated||Phase 3|1|Actual|Baxalta US Inc.||1|||f||||t||||||||||2017-10-11 03:50:00.177137|2017-10-11 03:50:00.177137
NCT01434498|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2013-11-26||2013-11-26|September 2011||2011-09-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of GS-5885, GS-9451, Tegobuvir and Ribavirin; GS-5885, GS-9451 and Tegobuvir; GS-5885, GS-9451 and Ribavirin in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b HCV Infection (Protocol No. GS US 248 0132)|Completed||Phase 2|163|Actual|Gilead Sciences||3|||f||||t||||||||||2017-10-11 03:50:00.462464|2017-10-11 03:50:00.462464
NCT01434485|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-14|2014-04-14|||September 2011||2011-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Nexium Capsules Clinical Experience Investigation|Nexium Capsules Clinical Experience Investigation|Completed||N/A|3691|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 03:50:00.684842|2017-10-11 03:50:00.684842
NCT01434472|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-05-26|||November 16, 2011|Actual|2011-11-16|May 2017|2017-05-01||||November 2017|Anticipated|2017-11-01||Interventional|||High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma|A Phase II Trial of High-Dose 90Y-Ibritumomab Tiuxetan (Anti-CD20) Followed by Fludarabine and Low-Dose Total Body Irradiation and HLA-Matched Allogeneic Hematopoietic Transplantation for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma|Recruiting||Phase 2|24|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 03:50:00.85818|2017-10-11 03:50:00.85818
NCT01434459|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2015-05-01|||September 2011||2011-09-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|January 2014|Actual|2014-01-01||Interventional|||Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin|Phase I Trial of Gemcitabine With TheraSphere® (Yttrium-90) in Patients With Hepatic Tumors of Pancreatobiliary Origin|Terminated||Phase 1|9|Actual|Emory University||1||PI moved to different institution|f||||t||||||||||2017-10-11 03:50:01.02181|2017-10-11 03:50:01.02181
NCT01434446|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2012-04-02|||September 2011||2011-09-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Interventional|||The Effect of Sound Stimulation on Hearing Ability|The Effect of Sound Stimulation on Hearing Ability|Completed||N/A|21|Actual|Earlogic Korea, Inc.||1|||f||||||||||||||2017-10-11 03:50:01.111757|2017-10-11 03:50:01.111757
NCT01434433|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-01-12|||July 2011||2011-07-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|ABC||Alere Triage fs B-type Natriuretic Peptide (BNP) Method Comparison Evaluation|Alere Triage fs BNP Method Comparison Evaluation|Completed||N/A|360|Actual|Alere San Diego|||1||f||||f||||||||||2017-10-11 03:50:01.204569|2017-10-11 03:50:01.204569
NCT01434420|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-12-30|||March 2011||2011-03-01|December 2014|2014-12-01|March 2020|Anticipated|2020-03-01|August 2014|Actual|2014-08-01||Interventional|||Triple Negative Breast Cancer: Study of Molecular and Genetic Factors|Triple Negative Breast Cancer: Study of Molecular and Genetic Factors|Active, not recruiting||N/A|200|Anticipated|Institut Paoli-Calmettes||1|||f||||f||||||||||2017-10-11 03:50:01.259854|2017-10-11 03:50:01.259854
NCT01434407|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2012-09-03|||August 2011||2011-08-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|AGE-1||Effects of Advanced Glycation Endproducts on Satiety and Inflammation|Crossover Meal Study Investigating Effects of Advanced Glycation Endproducts on Satiety and Inflammation|Completed||N/A|19|Actual|University of Copenhagen||2|||f||||t||||||||||2017-10-11 03:50:01.380402|2017-10-11 03:50:01.380402
NCT01434394|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2017-08-16|||August 2011||2011-08-01|May 2014|2014-05-01|February 2017|Actual|2017-02-01|October 2014|Actual|2014-10-01||Interventional|EAGLE||Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer|Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer|Completed||Phase 2/Phase 3|243|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 03:50:01.495412|2017-10-11 03:50:01.495412
NCT01434381|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2014-02-10|||August 2011||2011-08-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)|Open Label Phase 1 Study in Malaria Naive Adults of the Safety and Immunogenicity of Pfs25-EPA/Alhydrogel, a Transmission Blocking Vaccine Against Plasmodium Falciparum|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-11 03:50:01.592461|2017-10-11 03:50:01.592461
NCT01434368|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-07-26|||September 6, 2011||2011-09-06|July 20, 2017|2017-07-20||||||||Observational|||A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty|A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty|Recruiting||N/A|344|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:50:01.704057|2017-10-11 03:50:01.704057
NCT01434342|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-05-08|2017-05-08||October 2011||2011-10-01|May 2017|2017-05-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional||All randomized participants|Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients|Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Lung Cancer Patients Receiving Outpatient Treatment: A Pilot Study|Completed||N/A|146|Actual|Wake Forest University Health Sciences||2|||f||||t|t|f||||||No||2017-10-11 03:50:02.071895|2017-10-11 03:50:02.071895
NCT00000239|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16||||||December 2002|2002-12-01||||||||Interventional|||Buprenorphine Pharmacology Related to Addiction Treatment - 21|Buprenorphine Pharmacology Related to Addiction Treatment|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:41.477165|2017-10-11 04:17:41.477165
NCT01434329|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2016-04-14|||October 2011||2011-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia|S8600-S9031-S9333-A, Identification of Differentially Methylated Genomic Regions That Are Prognostically Significant in AML|Completed||N/A|200|Actual|Southwest Oncology Group|||1||f||||f||||||||||2017-10-11 03:50:02.760004|2017-10-11 03:50:02.760004
NCT01434316|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-06-30|||November 1, 2011|Actual|2011-11-01|May 2017|2017-05-01||||June 30, 2017|Anticipated|2017-06-30||Interventional|||Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors|Phase 1 Trial of ABT-888 and SCH727965 in Patients With Advanced Solid Tumors|Recruiting||Phase 1|130|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 03:50:02.835018|2017-10-11 03:50:02.835018
NCT01434303|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-09-04|||January 10, 2012|Actual|2012-01-10|July 2017|2017-07-01||||March 1, 2012|Actual|2012-03-01||Interventional|||Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only|Phase I and Phase I Trastuzumab Cohort Study of Entinostat, Lapatinib and Trastuzumab in Patients With HER2-Positive Metastatic Breast Cancer in Whom Trastuzumab Has Failed|Active, not recruiting||Phase 1|37|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 03:50:02.962812|2017-10-11 03:50:02.962812
NCT01434277|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-13|||April 2011||2011-04-01|September 2011|2011-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Safety Evaluation of a New Preservative in a Lubricating Eye Drop|A Single-Center Study Evaluating the Safety of a New Preservative in an OTC Lubricant Eye Drop Used QID in Healthy Adults and in Subjects Diagnosed With Dry Eye|Completed||N/A|44|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 03:50:03.351192|2017-10-11 03:50:03.351192
NCT01434264|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-03-07|||September 2011||2011-09-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluating Personalized Effect of an Individualized Intervention|Cross-disciplinary Evaluation of Efficacy and Effectiveness of Individualized Complementary Therapies: Evaluating Personalized Effect of Energy Healing as an Individualized Intervention|Completed||N/A|247|Actual|University of Southern Denmark||4|||f||||t||||||||||2017-10-11 03:50:03.495343|2017-10-11 03:50:03.495343
NCT01434251|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-05-26|||September 2011||2011-09-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|TOHOP||Treatment of Hypotension of Prematurity (TOHOP)|Treatment of Hypotension of Prematurity: a Randomized, Non-blinded Cohort Clinical Trial|Unknown status|Recruiting|N/A|150|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-10-11 03:50:03.601649|2017-10-11 03:50:03.601649
NCT01434238|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2011-09-14|||June 2008||2008-06-01|September 2011|2011-09-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||Evaluation of an Infant Feeding Intervention for HIV-exposed Haitian Infants|Evaluation of an Infant Feeding Support Strategy for HIV-exposed Infants 6-12 Months Old in Urban Haiti|Completed||N/A|82|Actual|Cornell University||1|||f||||f||||||||||2017-10-11 03:50:03.713766|2017-10-11 03:50:03.713766
NCT01434225|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-09-11|||August 2011||2011-08-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|NEMO1||NEMO1:NEonatal Seizure Using Medication Off-patent|NEMO1: An Open Label Exploratory Dose Finding and Pharmacokinetic Clinical Trial of Bumetanide for the Treatment of Neonatal Seizure Using Medication Off-patent|Completed||Phase 1/Phase 2|14|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 03:50:03.801252|2017-10-11 03:50:03.801252
NCT01434212|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2011-10-27|||May 2010||2010-05-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|sIFN-pred1||Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy|Study of Parameters of Early Hepatitis C Virus Dynamics for Predicting the Outcome of Standard Interferon Therapy With Chinese Cohort|Unknown status|Active, not recruiting|N/A|40|Anticipated|First Hospital of Jilin University|||1||f||||t||||||Samples With DNA|"     Blood serum,Peripheral blood mononuclear cells (PBMC)   "|||2017-10-11 03:50:03.909177|2017-10-11 03:50:03.909177
NCT01434199|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-09-13|||July 2011||2011-07-01|September 2011|2011-09-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|UPD-3||Does Endoscope Position Detecting Unit Facilitate a Complete Colonoscopy Examination|Does Endoscope Position Detecting Unit Facilitate Caecal Intubation? A Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|870|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 03:50:04.036215|2017-10-11 03:50:04.036215
NCT01434186|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-03-07|2017-03-07||May 2012||2012-05-01|March 2017|2017-03-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone|Completed||Phase 3|32|Actual|AstraZeneca||2|||f||||t||||||||||2017-10-11 03:50:04.158706|2017-10-11 03:50:04.158706
NCT01434173|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2014-07-07|||July 2001||2001-07-01|July 2014|2014-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Risk of Acute Liver Injury in Users of Antimicrobials|Risk of Acute Liver Injury in Users of Antimicrobials in the HealthCore Integrated Research Database Population|Completed||N/A|1299056|Actual|Bayer|||2||f||||f||||||||||2017-10-11 03:50:04.523571|2017-10-11 03:50:04.523571
NCT01434160|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-07-24|||September 2011||2011-09-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|June 2013|Actual|2013-06-01||Interventional|||LCS12 Adolescent Study|Multi-center, Single-arm Study to Assess the Safety, Efficacy, Discontinuation Rate and Pharmacokinetics of the Low-dose Levonorgestrel Intrauterine Contraceptive System (LCS12) in Post-menarcheal Female Adolescents Under 18 Years of Age for 1 Year, and an Optional 2-year Extension Phase|Completed||Phase 3|304|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:50:04.635805|2017-10-11 03:50:04.635805
NCT01434147|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-03-06|||October 2011||2011-10-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy|Preoperative Induction Chemotherapy in Combination With Bevacizumab Followed by Combined Chemoradiotherapy in Locally Advanced Rectal Cancer With High Risk of Recurrence- Phase II Pilot Study With Preoperative Administration of Capecitabine (Xeloda), Oxaliplatin and Bevacizumab (Avastin) Followed by Capecitabine (Xeloda) Plus Radiotherapy (RTx)|Completed||Phase 2|25|Actual|Austrian Breast & Colorectal Cancer Study Group||1|||f||||t||||||||||2017-10-11 03:50:04.79954|2017-10-11 03:50:04.79954
NCT01434134|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2014-10-21|||September 2011||2011-09-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|PRADA||Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy|Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: A Randomized, Placebo-controlled, 2x2 Factorial, Double Blind Trial of Candesartan and Metoprolol|Completed||Phase 2|130|Actual|University Hospital, Akershus||4|||f||||t||||||||||2017-10-11 03:50:04.933091|2017-10-11 03:50:04.933091
NCT01434121|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-05-30|2014-03-04||May 2010||2010-05-01|May 2014|2014-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Ascorbic Acid (Vitamin C) Infusion in Human Sepsis|Ascorbic Acid (Vitamin C) Infusion in Human Sepsis|Completed||Phase 1/Phase 2|24|Actual|Virginia Commonwealth University||3|||f||||t||||||||||2017-10-11 03:50:05.07227|2017-10-11 03:50:05.07227
NCT01434108|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2015-03-19|||October 2011||2011-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding|Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding|Completed||Phase 2/Phase 3|48|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-11 03:50:05.606677|2017-10-11 03:50:05.606677
NCT01434095|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-14|||October 2008||2008-10-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy||Completed||N/A|16|Actual|Surugadai Nihon University Hospital||1|||f||||f||||||||||2017-10-11 03:50:05.731209|2017-10-11 03:50:05.731209
NCT01434082|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2011-09-12|||September 2011||2011-09-01|September 2011|2011-09-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Observational|JIA||Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis|Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis|Unknown status|Recruiting|N/A|150|Anticipated|University of Washington|||1||f||||t||||||Samples With DNA|"     Morning urine and saliva   "|||2017-10-11 03:50:05.811828|2017-10-11 03:50:05.811828
NCT01434069|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2015-12-22|||September 2011||2011-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Phase I Trial of Combination of FOLFIRI and SOM 230|Phase I Trial of Combination of FOLFIRI and SOM 230 in Advanced Gastrointestinal Malignancies|Completed||Phase 1|16|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 03:50:05.889344|2017-10-11 03:50:05.889344
NCT01434056|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-13|||November 2011||2011-11-01|September 2011|2011-09-01|February 2015|Anticipated|2015-02-01|November 2014|Anticipated|2014-11-01||Observational|||Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging|Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging|Unknown status|Not yet recruiting|N/A|400|Anticipated|Hospital Israelita Albert Einstein|||1||f||||t||||||||||2017-10-11 03:50:05.970529|2017-10-11 03:50:05.970529
NCT01434043|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-05-15|||September 2011||2011-09-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|||Diagnostic Accuracy of Cardiac CT Perfusion Compared to PET Imaging|Diagnostic Accuracy of Cardiac CT Perfusion Compared to PET Imaging|Recruiting||N/A|30|Anticipated|University of Washington|||1||f||||f||||||||||2017-10-11 03:50:06.073422|2017-10-11 03:50:06.073422
NCT01434030|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2014-08-25|2014-08-08||April 2010||2010-04-01|August 2014|2014-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Phase1||Development of a Behavioral Observer for Type 1 Diabetes Mellitus|Development of a Behavioral Observer for Type 1 Diabetes Mellitus|Completed||N/A|57|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:50:06.151165|2017-10-11 03:50:06.151165
NCT01434017|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2014-02-26|||November 2008||2008-11-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Comparison of Three Different Prophylactic Treatments of Postoperative Nausea and Vomiting (PONV) in Children|Comparison of Three Different Prophylactic Treatments of PONV in Children|Completed||Phase 4|300|Actual|Centre Hospitalier Universitaire Vaudois||3|||f||||f||||||||||2017-10-11 03:50:06.499968|2017-10-11 03:50:06.499968
NCT01434004|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-04-08|||January 2003||2003-01-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|EASE||Eating, Activity, and Stress Education|A Diet, Physical Activity, and Meditation Intervention in Men With Rising Prostate-specific Antigen|Completed||N/A|58|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-11 03:50:06.622442|2017-10-11 03:50:06.622442
NCT01433991|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-08-11||2016-04-11|October 2011||2011-10-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|March 2015|Actual|2015-03-01||Interventional|||E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)|An Open-Label, Multicenter Phase 1b/2 Study of E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)|Active, not recruiting||Phase 1/Phase 2|30|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 03:50:06.719805|2017-10-11 03:50:06.719805
NCT01433978|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2016-03-10||2015-06-29|April 2012||2012-04-01|February 2016|2016-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)|A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)|Terminated||Phase 3|23|Actual|Eisai Inc.||3||Data not entered|f||||t||||||||||2017-10-11 03:50:06.85216|2017-10-11 03:50:06.85216
NCT01433965|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2016-11-08|||August 2012||2012-08-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome|Phase I Trial of Maintenance Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome Post Allogeneic Bone Marrow Transplantation|Recruiting||Phase 1|24|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-10-11 03:50:06.973735|2017-10-11 03:50:06.973735
NCT01433952|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-13|||June 2009||2009-06-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Pharmacokinetics of Oral Thiamine|Pharmacokinetics of High Dose Oral Thiamine|Completed||Phase 1|14|Actual|Baystate Medical Center||4|||f||||f||||||||||2017-10-11 03:50:07.108997|2017-10-11 03:50:07.108997
NCT01433939|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2014-03-12|||September 2011||2011-09-01|March 2014|2014-03-01|September 2014|Anticipated|2014-09-01|May 2012|Actual|2012-05-01||Observational|||Position Changes During Colonoscope Insertion Increases Patient Comfort|Position Changes During Colonoscope Insertion Increases Patient Comfort: a Prospective Trial|Unknown status|Active, not recruiting|N/A|200|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 03:50:07.225607|2017-10-11 03:50:07.225607
NCT01433926|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2011-09-13|||September 2009||2009-09-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Observational|LongHer||Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years|Observational, Cross-sectional Study to Analyze the Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete Remission, Partial Remission or Stabilization of Disease During More Than 3 Years|Completed||N/A|114|Actual|Asociación para el Progreso de la Oncología en Málaga|||1||f||||t||||||Samples With DNA|"     primary tumor, preserved in paraffin   "|||2017-10-11 03:50:07.318861|2017-10-11 03:50:07.318861
NCT01433913|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-04-29|2015-04-29||November 2011||2011-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery|Phase II Study of Metformin in a Pre-prostatectomy Prostate Cancer Cohort|Completed||Phase 2|20|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 03:50:07.510919|2017-10-11 03:50:07.510919
NCT01433900|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-05-15|||May 2012||2012-05-01|September 2011|2011-09-01|June 2014|Anticipated|2014-06-01|May 2013|Actual|2013-05-01||Interventional|||Switching From Preserved to Preserved-free Treatments for Glaucoma.|The Advantage of Switching From Preserved to Preserved-free Treatments in Glaucoma. A Clinical and Confocal Study.|Unknown status|Recruiting|Phase 3|40|Anticipated|University of Milan||2|||f||||f||||||||||2017-10-11 03:50:07.964578|2017-10-11 03:50:07.964578
NCT01433887|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-11|2014-11-14|||November 2011||2011-11-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6|Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic|Completed||Phase 3|535|Actual|Third Affiliated Hospital, Sun Yat-Sen University||3|||f||||f||||||||||2017-10-11 03:50:08.174549|2017-10-11 03:50:08.174549
NCT01433874|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-09-13|||February 2011||2011-02-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Decreasing Upper and Shoulder Pain After Laparoscopic Surgery|Maneuvers to Decrease Upper and Shoulder Pain After Gynecologic Laparoscopic Surgery|Unknown status|Recruiting|Phase 3|200|Anticipated|Taipei Veterans General Hospital, Taiwan||4|||f||||t||||||||||2017-10-11 03:50:08.297141|2017-10-11 03:50:08.297141
NCT01433861|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2017-01-06|||July 2012||2012-07-01|January 2017|2017-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|PRAPT||Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy|Phase III Prospective Randomized Clinical Trial of Laparoscopy-assisted Proximal Gastrectomy (LAPG) and Laparoscopy-assisted Total Gastrectomy (LATG) for Upper Gastric Cancer. (Multicenter Study)|Terminated||Phase 3|7|Actual|Seoul National University Bundang Hospital||2||We planed to study later|f||||t||||||||No||2017-10-11 03:50:08.425194|2017-10-11 03:50:08.425194
NCT01433848|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-09-13|||June 2011||2011-06-01|September 2011|2011-09-01||||||||Observational|||Prospective Analysis Of Cardiac Function In Cirrhotic Patients By Echocardiography And Its Correlation With Events|Prospective Analysis Of Cardiac Function In Cirrhotic Patients By Echocardiography And Its Correlation With Adverse Events|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Rio de Janeiro State University|||3||f||||f||||||||||2017-10-11 03:50:08.528684|2017-10-11 03:50:08.528684
NCT01433835|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-11|2013-08-01|||September 2011||2011-09-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers|Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers|Completed||Phase 1|48|Actual|Microbiotix, Inc.||2|||f||||f||||||||||2017-10-11 03:50:08.603239|2017-10-11 03:50:08.603239
NCT01433809|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2014-01-20|||June 2011||2011-06-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm|Biomarkers in Thyroid Cancer|Completed||N/A|1|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Blood, RNA/DNA from fine needle aspirate biopsies of thyroid nodules, fresh frozen surgical     tissue, formalin fixed paraffin embedded tissue.   "|||2017-10-11 03:50:08.694078|2017-10-11 03:50:08.694078
NCT01433796|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-11|2016-03-06|||October 2011||2011-10-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|May 2013|Actual|2013-05-01||Observational|||Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment|Tuberculosis in HIV-infected Patients Managed in Health Centres in Ethiopia - Identification of a Screening Algorithm for Active Tuberculosis and Determination of Outcome of Combined Antituberculosis and Antiretroviral Treatment|Completed||N/A|812|Actual|Lund University|||1||f||||f||||||Samples Without DNA|"     Aliquoted plasma samples from consenting participants are stored at -80 C for analysis of     biomarkers of tuberculosis and for prognostic markers. Stool and urine samples are stored at     -20 C for analysis of alternative biomarkers of active tuberculosis.   "|||2017-10-11 03:50:08.758588|2017-10-11 03:50:08.758588
NCT01433770|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2012-02-17|||October 2011||2011-10-01|February 2012|2012-02-01|October 2014|Anticipated|2014-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Alefacept in Kidney Transplant Recipients|Effects of Alefacept on Donor-Specific Memory in Kidney Transplant Recipients|Withdrawn||N/A|0|Actual|University Hospitals Cleveland Medical Center||1||The drug will no longer be available in the United States.|f||||f||||||||||2017-10-11 03:50:08.854976|2017-10-11 03:50:08.854976
NCT01433757|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-07-03|||September 2011||2011-09-01|July 2017|2017-07-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Ampicillin for DYT-1 Dystonia Motor Symptoms|A Pilot, Randomized, Double-Blind, Placebo-Controlled Phase I Study to Determine the Safety and Efficacy of Ampicillin in Treating Primary Dystonia Symptoms|Completed||Phase 1|2|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 03:50:08.9238|2017-10-11 03:50:08.9238
NCT01433744|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2011-09-13|||January 2010||2010-01-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Short-term Changes on C-Reactive Protein (CRP) Levels After Non-surgical Periodontal Treatment|Short-term Changes on C-Reactive Protein (CRP) Levels After Non-surgical Periodontal Treatment|Completed||N/A|44|Actual|State University of Maringá||2|||f||||t||||||||||2017-10-11 03:50:09.009977|2017-10-11 03:50:09.009977
NCT01433731|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-02-23|2015-12-15||November 2011||2011-11-01|January 2016|2016-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)|A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase 1b Study to Assess the Safety, Pharmacodynamics and Pharmacokinetics of SHP 141, A Histone Deacetylase Inhibitor, Administered Topically Up to 28 Days to Patients With Stage IA, IB or IIA Cutaneous T-Cell Lymphoma|Completed||Phase 1|18|Actual|TetraLogic Pharmaceuticals||4|||f||||t||||||||||2017-10-11 03:50:09.091035|2017-10-11 03:50:09.091035
NCT01433718|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-04-19|||September 2011||2011-09-01|April 2017|2017-04-01|June 2012|Anticipated|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Decreasing Knee Injury Risk Factors With Neuromuscular Training|The Effectiveness of Neuromuscular Training on Modifiable Anterior Cruciate Ligament Injury Risk Factors|Withdrawn||N/A|0|Actual|Ohio University||1|||f||||f||||||||||2017-10-11 03:50:09.640545|2017-10-11 03:50:09.640545
NCT01433705|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-13|2017-04-14|||November 2011||2011-11-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers|Evaluation of the Normal Distribution of Rubidium-82(Rb-82), Nitrogen-13 (N-13)Ammonia, and Fluorine-18 Fluorodeoxyglucose (F-18FDG) in Normal Volunteers|Recruiting||Phase 1|145|Anticipated|University of Michigan||3|||f||||f|t|f|||f|||No||2017-10-11 03:50:09.713331|2017-10-11 03:50:09.713331
NCT01433692|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2013-01-11|||March 2012||2012-03-01|January 2013|2013-01-01|July 2014|Anticipated|2014-07-01|March 2014|Anticipated|2014-03-01||Interventional|CANABIC||CANABIC : CANnabis and Adolescents, a Brief Intervention (BI) to Reduce Their Consumption|Does a BI Conducted by General Practitioners Reduce Consumption of Canabis in 15 to 25 Years Old ?|Unknown status|Recruiting|N/A|750|Anticipated|University Hospital, Clermont-Ferrand||2|||f||||f||||||||||2017-10-11 03:50:09.798806|2017-10-11 03:50:09.798806
NCT01433679|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2012-07-12|||September 2011||2011-09-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Effect of a Web-Based Behavioral Intervention on Physical Activity Levels in Adolescents|The Effect of a Web-Based Behavioral Intervention on Physical Activity Levels in Adolescents|Completed||N/A|448|Actual|HopeLab Foundation||2|||f||||f||||||||||2017-10-11 03:50:09.88952|2017-10-11 03:50:09.88952
NCT01433666|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-09-03|||September 2011||2011-09-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|July 2012|Actual|2012-07-01||Interventional|EEGrofl||Roflumilast and Cognition|Effects of Roflumilast on Cognition in Healthy Adults: a Behaviour-EEG Study|Completed||Phase 2|22|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-11 03:50:09.973234|2017-10-11 03:50:09.973234
NCT01433653|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-06-08|||May 2005||2005-05-01|June 2015|2015-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|CG-CBT||Cognitive Behavioral Therapy for Complicated Grief|Randomized Controlled Clinical Trial of Cognitive Behavioral Therapy for Complicated Grief|Completed||N/A|51|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 03:50:10.064538|2017-10-11 03:50:10.064538
NCT01433640|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-03-17|||July 2011||2011-07-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Observational|||Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study|Evaluation of Contrast-enhanced Mammography and Contrast-enhanced Breast Tomosynthesis: Comparison to Contrast-enhanced Breast MRI- A Pilot Study|Completed||N/A|30|Actual|Hologic, Inc.|||3||f||||f||||||||||2017-10-11 03:50:10.132603|2017-10-11 03:50:10.132603
NCT01433627|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2015-01-28|||October 2011||2011-10-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|November 2014|Actual|2014-11-01||Interventional|MATRIX||Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX|Phase IIIb Study Minimizing Adverse Haemmhorragic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)|Unknown status|Active, not recruiting|Phase 3|7200|Anticipated|Italian Society of Invasive Cardiology||6|||f||||t||||||||||2017-10-11 03:50:10.217567|2017-10-11 03:50:10.217567
NCT01433601|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2011-09-13|||August 2007||2007-08-01|September 2011|2011-09-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|DotArv||Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure|A Randomised Controlled Trial to Assess Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure|Unknown status|Active, not recruiting|N/A|640|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 03:50:12.090973|2017-10-11 03:50:12.090973
NCT01433588|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-02-22|||October 2014||2014-10-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||The Calmer Project|Calmer: A Novel Approach for Treating Infant Pain|Recruiting||N/A|60|Anticipated|Children's & Women's Health Centre of British Columbia||2|||f||||f||||||||||2017-10-11 03:50:12.172757|2017-10-11 03:50:12.172757
NCT01433575|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-11-01|||September 2011||2011-09-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers|A Single-center, Open-label, Single Dose, Randomized, Two-way Cross-over Study to Investigate the Pharmacokinetics, Safety, and Tolerability of RO4917838 in Healthy Chinese Volunteers|Completed||Phase 1|16|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:50:12.252284|2017-10-11 03:50:12.252284
NCT01433562|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2013-05-10|||August 2011||2011-08-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients|Combination of DLBS1425 With Anthracyclin-based Regimen as a Neoadjuvant Therapy in Subjects With Stage II or III Breast Cancer|Completed||Phase 2/Phase 3|40|Actual|Dexa Medica Group||2|||f||||t||||||||||2017-10-11 03:50:12.316657|2017-10-11 03:50:12.316657
NCT01433549|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2013-04-30|2013-03-20||August 2011||2011-08-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|INVERMERE|This reporting group includes all participants enrolled and dispensed product.|Lens Wear Schedules and End-of-Day Comfort|Effect of Recovery Periods on Ocular Comfort During Daily Lens Wear|Completed||N/A|44|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:50:12.406192|2017-10-11 03:50:12.406192
NCT01433536|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2016-01-26|||December 2010||2010-12-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|BMP-9||Evaluation of Circulating Osteogenic Factors in Trauma Patients|Evaluation of Circulating Osteogenic Factors in Trauma Patients (BMP-9)|Active, not recruiting||N/A|60|Anticipated|Centre de recherche du Centre hospitalier universitaire de Sherbrooke|||6||f||||t||||||Samples Without DNA|"     blood samples   "|Undecided||2017-10-11 03:50:12.758|2017-10-11 03:50:12.758
NCT01433523|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-01-27|||August 2011||2011-08-01|January 2017|2017-01-01|February 2014|Actual|2014-02-01|April 2013|Actual|2013-04-01||Interventional|MITRA||House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma|Efficacy of ALK House Dust Mite Allergy Immunotherapy Tablet in Subjects With House Dust Mite Induced Asthma. The MITRA Trial|Completed||Phase 3|834|Actual|ALK-Abelló A/S||3|||f||||f||||||||||2017-10-11 03:50:12.828094|2017-10-11 03:50:12.828094
NCT01433510|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2011-09-13|||November 2007||2007-11-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|GRAAL||Tolerability of Grazax in Patients With Hayfever in Real Life Settings|Observational National Clinical Trial of Safety and Tolerance in Patients Suffering of an Allergic Grass Pollen Rhinitis and Treated by Grazax in Real Life Settings|Completed||Phase 4|628|Actual|ALK-Abelló A/S||1|||f||||f||||||||||2017-10-11 03:50:12.923432|2017-10-11 03:50:12.923432
NCT01433497|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2017-04-20|||August 2011||2011-08-01|April 2017|2017-04-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|||A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Primary Progressive or Relapse-free Secondary Progressive Multiple Sclerosis|A 96 Week, Prospective, Multicentre, Randomized, Double-blind, Placebo-controlled, 2 Parallel-groups, Phase 3 Study to Compare Efficacy and Safety of Masitinib 4.5 mg/kg/Day Versus Placebo in the Treatment of Patients With Primary Progressive or Relapse-free Secondary Progressive Multiple Sclerosis|Recruiting||Phase 2/Phase 3|450|Anticipated|AB Science||2|||f||||t||||||||||2017-10-11 03:50:13.000961|2017-10-11 03:50:13.000961
NCT01433484|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-08-27|||September 2011||2011-09-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Heart-Healthy Lenoir Lifestyle Study|Community-Based Lifestyle Intervention to Reduce CVD Risk & Disparities in Risk|Completed||Phase 3|339|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 03:50:13.08807|2017-10-11 03:50:13.08807
NCT01433471|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-06-01|2016-04-26||August 2012||2012-08-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MUCUS||Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova|Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova|Completed||N/A|4|Actual|New York University School of Medicine|Because of the small sample size of this study, investigators decided it was not possible to draw meaningful conclusions from the outcome measures and outcome measures were not collected or analyzed as originally planned.|2|||f||||t||||||||||2017-10-11 03:50:13.186448|2017-10-11 03:50:13.186448
NCT01433458|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-01-20|||July 2011||2011-07-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Subjects|A Single-dose, Open-label Parallel Study to Assess the Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Control Subjects|Completed||Phase 1|55|Actual|Novartis||4|||f||||||||||||||2017-10-11 03:50:13.524667|2017-10-11 03:50:13.524667
NCT01433432|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2013-03-05|||October 2011||2011-10-01|March 2013|2013-03-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|OLE||Open Label Extension Study to Protocol C2/13/DR-6MP-02|Clinical Efficacy and Safety of Delayed Release 6-Mercaptopurine (DR-6MP) for Targeted Ileal Delivery in Patients With Moderately Active Crohn's Disease - Open Label Extension Study|Withdrawn||Phase 2|0|Actual|Teva GTC||2||Sponsor withdrew support for study due to reorganization and project prioritization|f||||f||||||||||2017-10-11 03:50:13.740006|2017-10-11 03:50:13.740006
NCT01433419|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2013-03-21|||January 2012||2012-01-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Open-label Study of TAK-875||Completed||Phase 3|333|Actual|Takeda||2|||f||||||||||||||2017-10-11 03:50:13.840312|2017-10-11 03:50:13.840312
NCT01433406|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2014-01-24|||October 2011||2011-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Long-term Study of TAK-875||Completed||Phase 3|1222|Actual|Takeda||2|||f||||f||||||||||2017-10-11 03:50:13.992952|2017-10-11 03:50:13.992952
NCT01433393|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2012-11-07||||||November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Double-blind Comparative Study of TAK-875||Completed||Phase 3|192|Actual|Takeda||3|||f||||||||||||||2017-10-11 03:50:14.303591|2017-10-11 03:50:14.303591
NCT01433380|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2012-05-16|||July 2011||2011-07-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study To Evaluate PF-05175157 In Healthy Volunteers|Phase 1 Study To Evaluate The Effect Of Single Doses Of Pf-05175157 On Pharmacodynamic And Metabolic Parameters In Healthy Volunteers|Completed||Phase 1|22|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:50:14.430375|2017-10-11 03:50:14.430375
NCT01433367|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2015-04-17|||May 2010||2010-05-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|CerPass||A Clinical Trial Evaluating a Total Disc Replacement in Patients With Cervical Disc Disease|A Prospective Observational Study Evaluating the Performance of the CerPass® Total Disc Replacement in Patients With Single-Level Cervical Disc Disease|Terminated||N/A|2|Actual|NuVasive|||1|Marketing of CE marked device has been discontinued.|f||||f||||||||||2017-10-11 03:50:14.512547|2017-10-11 03:50:14.512547
NCT01433354|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-02-24|2015-09-14||November 2011||2011-11-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||All enrolled participants who received at least one dose of the study drug (AFQ056) during the study.|Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)|An Open-label Study to Evaluate the Long-term Safety and Tolerability of AFQ056 in Adolescent Patients With Fragile X Syndrome|Terminated||Phase 2/Phase 3|119|Actual|Novartis|The sponsor decided to terminate this study prematurely, as the study treatment failed to demonstrate efficacy in target population in two other clinical studies: CAFQ056B2214 (NCT01357239) and CAFQ056A2212 (NCT01253629).|1||"The study treatment failed to demonstrate efficacy in target population in two other clinical   studies (CAFQ056B2214 and CAFQ056A2212)."|f||||t||||||||||2017-10-11 03:50:14.619011|2017-10-11 03:50:14.619011
NCT01433341|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2013-11-10|||March 2012||2012-03-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Evaluation of Postural Control After Exercise in Athletes Using Tetra Axial Posturography (tetrax1)||Completed||N/A|30|Actual|Meir Medical Center|||1||f||||t||||||||||2017-10-11 03:50:15.2097|2017-10-11 03:50:15.2097
NCT01433328|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2012-04-04|||January 2012||2012-01-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain|Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain|Terminated||Phase 4|4|Actual|Jewish General Hospital||2||Safety considerations|f||||f||||||||||2017-10-11 03:50:15.293251|2017-10-11 03:50:15.293251
NCT01433315|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-08-26|||October 2011||2011-10-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Physiologic Effects of Sleep Restriction|Physiologic Effects of Sleep Restriction|Recruiting||N/A|36|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:50:15.387693|2017-10-11 03:50:15.387693
NCT01433302|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-05-05|||March 2012||2012-03-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass|Determination of the Effect of Lymphatico-venous Bypass Surgery on Inflammatory Responses and Tissue Fibrosis|Completed||N/A|21|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 03:50:15.483851|2017-10-11 03:50:15.483851
NCT01433289|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-02-02|||December 2010||2010-12-01|February 2015|2015-02-01|July 2015|Anticipated|2015-07-01|August 2014|Actual|2014-08-01||Interventional|||Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals|Placebo-Controlled, Dose-Blinded, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Polyphenon E (EGCG) as Monotherapy for 14 Days in Antiretroviral Naïve and Experienced, HIV-1-Infected Subjects|Unknown status|Recruiting|Phase 1|24|Anticipated|Baylor College of Medicine||3|||f||||t||||||||||2017-10-11 03:50:15.563152|2017-10-11 03:50:15.563152
NCT01433276|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-09-12|||July 2009||2009-07-01|August 2011|2011-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock|The Clinical Efficacy and Safety of a Proprietary Solution Containing Hypertonic Sodium Lactate (Totilac®) Infusion for Resuscitation of Patients With Hemorrhagic Shock Due to Multiple Injuries|Completed||Phase 3|71|Actual|Innogene Kalbiotech Pte. Ltd||2|||f||||f||||||||||2017-10-11 03:50:15.679475|2017-10-11 03:50:15.679475
NCT01433263|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2016-02-02|2015-04-24||August 2011||2011-08-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas|A Randomized, Double-blind, Placebo-controlled Multi-center Study of BYM338 for Treatment of Cachexia in Patients With Stage IV Non-small Cell Lung Cancer or Stage III/IV Adenocarcinoma of the Pancreas|Completed||Phase 2|57|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:50:15.793891|2017-10-11 03:50:15.793891
NCT01433250|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2016-02-16|2015-05-28||February 2012||2012-02-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis|An Open Label Extension Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis|Completed||Phase 2|39|Actual|Novartis|Further development of secukinumab in MS is not being pursued and the extension study , CAIN457B2201E1, further enrollment stopped . Not completing enrollment of this study was not related to the safety or tolerability concerns observed in the study.|2|||f||||f||||||||||2017-10-11 03:50:17.396963|2017-10-11 03:50:17.396963
NCT01433237|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-05-17|||September 2011||2011-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma|A Retrospective Study on the Diagnostic Value of Serum miR-206 in Rhabdomyosarcoma|Completed||N/A|40|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:50:18.087268|2017-10-11 03:50:18.087268
NCT01433224|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-05-17|||October 2011||2011-10-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression|Genomic Signatures of Malignant Germ Cell Tumor Progression: A Retrospective Study of Banked Specimens|Completed||N/A|90|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:50:18.158817|2017-10-11 03:50:18.158817
NCT01433211|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-11|||August 2009||2009-08-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Nutrition and Frailty in Older Persons|Relation Between Nutrition and Frailty in Community-dwelling Older Persons|Completed||N/A|206|Actual|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-10-11 03:50:18.236749|2017-10-11 03:50:18.236749
NCT01433198|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-09-12|||September 2011||2011-09-01|September 2011|2011-09-01||||December 2013|Anticipated|2013-12-01||Interventional|||Aquatic Training in Patients With Severe Scarring|Aquatic Training in Patients With Severe Scarring|Unknown status|Not yet recruiting|N/A|10|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 03:50:18.315517|2017-10-11 03:50:18.315517
NCT01433185|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2015-01-19|||April 2012||2012-04-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|SMS4PMTCT||Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV|Improving Uptake of Early Infant Diagnosis of HIV for PMTCT: a Randomized Trial of a Text Messaging Intervention|Completed||N/A|388|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 03:50:18.392888|2017-10-11 03:50:18.392888
NCT01433172|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2017-07-25|2016-11-01||October 2012||2012-10-01|July 2017|2017-07-01|February 28, 2018|Anticipated|2018-02-28|January 2016|Actual|2016-01-01||Interventional||All participants.|Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer|A Randomized Phase I/II Trial Using a GM-CSF-Producing and CD40L-Expressing Bystander Cell Line (GM.CD40L) Vaccine in Combination With CCL21 for Patients With Stage IV Adenocarcinoma of the Lung|Active, not recruiting||Phase 1/Phase 2|73|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||t||||||||||2017-10-11 03:50:18.5312|2017-10-11 03:50:18.5312
NCT01433159|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2014-01-10|2013-10-09||September 2011||2011-09-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury|Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury|Terminated||Phase 2|19|Actual|Healthpoint||2||Business decision|f||||f||||||||||2017-10-11 03:50:19.59912|2017-10-11 03:50:19.59912
NCT01433146|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2012-06-04|||September 2011||2011-09-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Observational|||Effect of Temperament, Anxiety and Depression on Immuninity in Colorectal Cancer Patients. Effetti Del Temperamento, Dell'Ansia e Della Depressione Sulla Sopravvivenza Globale e Sulla Risposta Immunitaria Del Paziente Affetto da Adenocarcinoma Colo-Rettale.|Effect of Temperament, Anxiety and Depression on Immuninity in Colorectal Cancer Patients.|Completed||N/A|120|Anticipated|University of Roma La Sapienza|||1||f||||t||||||Samples Without DNA|"     Blood samples for cell-mediated immunity evaluaion   "|||2017-10-11 03:50:20.110548|2017-10-11 03:50:20.110548
NCT01433133|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2016-09-12|||October 2012||2012-10-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|October 2013|Actual|2013-10-01||Interventional|||Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients|Phase I-II, Open Label, Uncontrolled, Dose Escalation Study of the Safety, Tolerability and Biologic Activity of the INFRADURE Biopump Secreting Sustained Interferon Alpha-2b (IFNα), in Combination With Oral Ribavirin for Genotype 3 Newly Diagnosed Hepatitis C Patients|Terminated||Phase 1/Phase 2|3|Actual|Medgenics Medical Israel Ltd.||1||Company strategic decision|f||||f||||||||No||2017-10-11 03:50:20.191413|2017-10-11 03:50:20.191413
NCT01433120|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2014-06-10|||September 2011||2011-09-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|June 2012|Actual|2012-06-01||Interventional|||Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.|Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.|Completed||N/A|58|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 03:50:20.263295|2017-10-11 03:50:20.263295
NCT01433107|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2013-12-03|2013-04-08||August 2011||2011-08-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis|A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of Terbinafine Film Forming Solution, 1% (as Hydrochloride), in Patients With Tinea Pedis|Completed||Phase 3|290|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:50:20.361732|2017-10-11 03:50:20.361732
NCT01433094|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-20|2017-09-06|||September 2012|Actual|2012-09-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|SPERA-S||Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia|Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia|Completed||N/A|112|Actual|University of Cagliari||2|||f||||t|f|f||||||||2017-10-11 03:50:20.625216|2017-10-11 03:50:20.625216
NCT01433081|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2014-02-19|2013-11-13||February 2011||2011-02-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Magnesium Sulfate Infusion on the Quality of Recovery of Ambulatory Patients|The Effect of Magnesium Sulfate Infusion on the Quality of Recovery of Ambulatory Patients|Completed||N/A|50|Actual|Northwestern University|We only examined subjects with normal kidney function that were at low risk for magnesium toxicity. It is possible that the current intervention regimen could have led to toxic levels in higher risk patients.|2|||f||||f||||||||||2017-10-11 03:50:20.736308|2017-10-11 03:50:20.736308
NCT01433068|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-02-19|||October 2011||2011-10-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|May 2014|Actual|2014-05-01||Interventional|||NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity|An Open-Label, Single Arm, Feasibility And Safety Phase I Study With Nbtxr3 Intratumor Implantation (By Injection) And Activated By External Beam Radiation Therapy In Patients With Soft Tissue Sarcoma Of The Extremity And Trunk Wall|Completed||Phase 1|22|Actual|Nanobiotix||1|||f||||t||||||||||2017-10-11 03:50:21.005806|2017-10-11 03:50:21.005806
NCT01433055|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-06-07|2016-05-16||July 2011||2011-07-01|June 2017|2017-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients|Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients|Completed||N/A|52|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 03:50:21.11468|2017-10-11 03:50:21.11468
NCT01433042|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-12-15|2013-02-12||August 2011||2011-08-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||18 years and older patients with history suggestive and /or symptoms suggestive of small bowel disease and whom are eligible and indicated for SB capsule endoscopy and agreed to sign ICF|PillCam SB3 Capsule- Feasibility Study|Assessment the Performance of PillCam SB3 Capsule in Detecting Small Bowel Lesions in Patients|Completed||N/A|225|Actual|Given Imaging Ltd.||1|||f||||f||||||||||2017-10-11 03:50:21.552608|2017-10-11 03:50:21.552608
NCT01433029|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-01-27|||September 1, 2011|Actual|2011-09-01|January 2017|2017-01-01|January 22, 2017|Actual|2017-01-22|January 22, 2017|Actual|2017-01-22||Observational|||Objective Assessment of Technical Skills in Cardiothoracic Surgery|Objective Assessment of Technical Skills in Cardiothoracic Surgery|Completed||N/A|8|Actual|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-10-11 03:50:21.77136|2017-10-11 03:50:21.77136
NCT01431365|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2014-12-12|||August 2011||2011-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of an Acute Bout of Exercise on Smoking Topography|Does an Acute Bout of Exercise Affect Smoking Topography?|Completed||N/A|110|Actual|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 03:50:52.576662|2017-10-11 03:50:52.576662
NCT01433016|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-11|2014-04-08|2014-02-11||November 2011||2011-11-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|OBT for HCC|Cirrhotic patients with suspected HCC|Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI|Evaluation of the Capability of the ¹³C-Octanoate Breath Test (OBT) Measurement in Patients With Chronic Liver Disease to Differentiate Between Presence and Absence of HCC Determined by MRI|Terminated||Phase 2|20|Actual|Exalenz Bioscience LTD.|Early termination leading to small numbers of subjects analyzed.|1||Due to budgetary issues, the company has decided to focus on other applications at this stage.|f||||f||||||||||2017-10-11 03:50:21.866669|2017-10-11 03:50:21.866669
NCT01433003|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2013-04-16|||April 2012||2012-04-01|April 2013|2013-04-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|PLEX-RCT||The Plasma Large-Volume Exchange RCT|The Plasma Large-Volume Exchange Randomized Controlled Trial (PLEX-RCT)|Withdrawn||Phase 3|0|Actual|London Health Sciences Centre||2||Funding not obtained|f||||t||||||||||2017-10-11 03:50:22.035751|2017-10-11 03:50:22.035751
NCT01432990|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2012-07-15|||January 2013||2013-01-01|July 2012|2012-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Robotic Gait Training VS.Conventional Rehabilitation in SCI|Robotic Gait Training VS. Conventional Physical Therapy in Spinal Cord Injury Patients.|Unknown status|Not yet recruiting|Phase 3|16|Anticipated|Prasat Neurological Institute||2|||f||||t||||||||||2017-10-11 03:50:22.115159|2017-10-11 03:50:22.115159
NCT01432977|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2012-10-30|||September 2011||2011-09-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|PARATRON||Drug Interactions Between Paracetamol and Setrons in Pain Management|Paracetamol and Setrons : Drug Interactions in the Management of Pain After Tonsillectomy in Children|Completed||Phase 3|72|Actual|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 03:50:22.222193|2017-10-11 03:50:22.222193
NCT01432964|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2011-09-12|||December 2008||2008-12-01|September 2011|2011-09-01|October 2010|Actual|2010-10-01|||||Observational|||Use of a Low Profile Titanium Mesh in Orbital Reconstruction|Low Profile Titanium Mesh in the Use of Orbital Reconstruction|Completed||N/A|27|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-10-11 03:50:22.318012|2017-10-11 03:50:22.318012
NCT01432951|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-02-14|||November 2011||2011-11-01|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|January 2013|Actual|2013-01-01||Interventional|||A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma|Pharmacokinetics of Enzastaurin HCl in Native Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma|Active, not recruiting||Phase 1|40|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:50:22.435036|2017-10-11 03:50:22.435036
NCT01432938|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2014-10-03|2014-10-03||September 2011||2011-09-01|October 2014|2014-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Participants who received at least 1 dose of study drug (dulaglutide or warfarin).|A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants|The Effect of Dulaglutide (LY2189265) on the Pharmacokinetics and Pharmacodynamics of Single Dose Warfarin in Healthy Subjects|Completed||Phase 1|28|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:50:22.553416|2017-10-11 03:50:22.553416
NCT01432925|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-05-23|||September 2011||2011-09-01|May 2016|2016-05-01||||January 2017|Anticipated|2017-01-01||Interventional|Burulitime||Timing of Surgical Intervention in Buruli Ulcer Patients Treated With Antibiotics|Timing of the Decision on Surgical Intervention for Buruli Ulcer Patients Treated With Rifampicin/Streptomycin|Active, not recruiting||N/A|260|Anticipated|University Medical Center Groningen||2|||f||||t||||||||||2017-10-11 03:50:23.026249|2017-10-11 03:50:23.026249
NCT01432912|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-11|2013-06-18|||September 2011||2011-09-01|September 2011|2011-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study Evaluating the Effect of Physician Education on Smoking Cessation Counselling|Pilot Study Evaluating the Influence of Physician Education Regarding the 5A's Smoking Cessation Counselling Strategy, as Evaluated by Patient Interpretation of the Strategy Principles|Completed||N/A|98|Actual|Assuta Hospital Systems||1|||f||||f||||||||||2017-10-11 03:50:23.15139|2017-10-11 03:50:23.15139
NCT01432899|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2017-06-30|||August 26, 2011||2011-08-26|March 9, 2017|2017-03-09||||||||Observational|||Studying Childhood-Onset Hemidystonia|Characteristics and Mechanism of Childhood-Onset Hemidystonia|Completed||N/A|21|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:50:23.229281|2017-10-11 03:50:23.229281
NCT01432886|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2016-08-29|2015-03-19||October 2011||2011-10-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer|A Phase 1 Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer|Completed||Phase 1|12|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 03:50:23.43247|2017-10-11 03:50:23.43247
NCT01432873|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2012-05-31|||June 2011||2011-06-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Oral Selenium Therapy for the Prevention of Mucositis|A Randomized Double Blinded Placebo Controlled Oral Selenium Therapy for the Prevention of Mucositis in Patients Undergoing High Dose Chemotherapy With Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 1/Phase 2|76|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:50:23.854865|2017-10-11 03:50:23.854865
NCT01432860|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-07-10|||September 2011||2011-09-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination|A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination|Completed||N/A|1000|Actual|Northwestern University||4|||f||||t||||||||Yes|publication of results with listing in My NCBI|2017-10-11 03:50:24.009906|2017-10-11 03:50:24.009906
NCT01432847|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2017-06-30|||August 26, 2011||2011-08-26|May 15, 2017|2017-05-15||||||||Observational|||Cell Collection to Study Eye Diseases|Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls|Recruiting||N/A|930|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:50:24.105252|2017-10-11 03:50:24.105252
NCT01432834|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2017-01-14|||April 2010||2010-04-01|January 2017|2017-01-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||Efficacy of the Wavefront Optimized (WFO) Profile in Non-anterior Astigmatisms|Evaluation of the Efficacy of the Allegretto Wave and the Wavefront Optimized Ablation Profile in Non-anterior Astigmatisms|Completed||N/A|74|Actual|Democritus University of Thrace||2|||f||||f||||||||||2017-10-11 03:50:24.186602|2017-10-11 03:50:24.186602
NCT01432821|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-11-04|||September 2011||2011-09-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Interventional|BYE BYE DOPA||Blinking and Yawning in Epilepsy: The Role of Dopamine|"Dopaminergic Reactivity In Idiopathic Generalized Epilepsy: A Proof Of Concept Clinical, Pharmacological And Neurophysiological Study"|Completed||N/A|31|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-10-11 03:50:24.273646|2017-10-11 03:50:24.273646
NCT01432795|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2013-06-21|||November 2010||2010-11-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Practicability of Gliding Aids for Medical Compression Stockings|Gliding Aids for Medical Compression Stockings - Practicability in Elderly Patients With Chronic Venous Insufficiency|Completed||Phase 4|40|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 03:50:24.377169|2017-10-11 03:50:24.377169
NCT01432782|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2011-09-09|||February 2010||2010-02-01|September 2011|2011-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|Botox||Botulinum Toxin Injection to Treat Diffuse Esophageal Spasm|Prospective Randomised Double-blind Sham Study on the Use of Botox for the Treatment of Diffuse Esophageal Spasm|Unknown status|Recruiting|N/A|30|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 03:50:24.46612|2017-10-11 03:50:24.46612
NCT01432769|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-09|||January 2011||2011-01-01|September 2011|2011-09-01|March 2012|Anticipated|2012-03-01|February 2012|Anticipated|2012-02-01||Interventional|||Enteral Nutrition After Cardiovascular Surgery|Effect of Enteral Nutrition in the Outcome of Patients With Cardiovascular Surgery|Unknown status|Recruiting|Phase 4|38|Anticipated|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-11 03:50:24.561602|2017-10-11 03:50:24.561602
NCT01432756|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-08-07|2015-07-10||September 2011||2011-09-01|August 2015|2015-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A South African Pilot Worksite Parenting Program to Prevent HIV Among Adolescents|A South African Pilot Worksite Parenting Program to Prevent HIV Among Adolescents|Completed||N/A|132|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 03:50:24.663466|2017-10-11 03:50:24.663466
NCT01432743|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-21|2011-09-12|||September 2007||2007-09-01|September 2011|2011-09-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|CAVERN||Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation|Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation|Completed||Phase 2|101|Actual|Barts & The London NHS Trust||2|||f||||f||||||||||2017-10-11 03:50:25.062732|2017-10-11 03:50:25.062732
NCT01432730|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-04-14|||August 31, 2011|Actual|2011-08-31|April 2017|2017-04-01|February 28, 2013|Actual|2013-02-28|February 28, 2013|Actual|2013-02-28||Interventional|||A Study to Assess the Efficacy of Gefapixant (AF-219/MK-7264), a P2X3 Receptor Antagonist, in Subjects With Chronic Cough|A Study to Assess the Efficacy of AF-219, a P2X3 Receptor Antagonist, in Subjects With Chronic Cough|Completed||Phase 2|22|Actual|Afferent Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:50:25.154373|2017-10-11 03:50:25.154373
NCT01432717|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2012-11-05|||September 2011||2011-09-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Study of ACE-536 in Healthy Postmenopausal Women|A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of ACE-536 in Healthy Postmenopausal Women|Completed||Phase 1|40|Actual|Acceleron Pharma, Inc.||2|||f||||f||||||||||2017-10-11 03:50:25.230937|2017-10-11 03:50:25.230937
NCT01432704|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-09-12|||March 2008||2008-03-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|100207MS-H||Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)|Phase IV Study of Colecalciferol as an Add-on Treatment to Subcutaneously Administered Interferon-beta-1b for Treatment of MS|Completed||Phase 2/Phase 3|70|Actual|University of Turku||2|||f||||||||||||||2017-10-11 03:50:25.325819|2017-10-11 03:50:25.325819
NCT01432691|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-04-17|||June 2010||2010-06-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2011|Actual|2011-06-01||Interventional|THA||Hemi Artificial Hipjoint Versus Total Artificial Hipjoint|Clinical and RSA Comparison of Hemi Versus Total Hip Arthroplasty After Displaced Femoral Neck Fracture. A Randomized Double-Blind Study|Completed||Phase 4|70|Actual|Hvidovre University Hospital||1|||f||||t||||||||||2017-10-11 03:50:25.456439|2017-10-11 03:50:25.456439
NCT01432678|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-10|2014-09-08|||April 2011||2011-04-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Vitamin D Status in Pediatric Asthma|Vitamin D Status in Pediatric Asthma|Completed||N/A|120|Anticipated|Mahidol University|||1||f||||t||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 03:50:25.563468|2017-10-11 03:50:25.563468
NCT01432665|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2013-07-26|||September 2011||2011-09-01|July 2013|2013-07-01||||May 2013|Actual|2013-05-01||Interventional|||Lybrido for Female Sexual Dysfunction||Completed||Phase 2|196|Actual|Emotional Brain NY Inc.||7|||f||||f||||||||||2017-10-11 03:50:25.662172|2017-10-11 03:50:25.662172
NCT01432652|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-12|2015-07-27|||September 2011||2011-09-01|September 2011|2011-09-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Observational|||The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery|Efficacité du Traitement antiagrégant Par Acide acétylsalicylique en Chirurgie Vasculaire mesurée Par agrégométrie Par impédance|Completed||N/A|45|Actual|University of Lausanne Hospitals|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:50:25.819818|2017-10-11 03:50:25.819818
NCT01432639|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-06-05|||May 2011||2011-05-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in CAD|Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in Coronary Artery Disease Patients|Completed||N/A|96|Actual|Universidade do Porto||2|||f||||f||||||||||2017-10-11 03:50:25.90635|2017-10-11 03:50:25.90635
NCT01432626|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-03-21|2016-03-21||September 2011||2011-09-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|||Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG|The Evaluation of the Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG Imaging|Completed||N/A|10|Actual|University of Pittsburgh||1|||f||||t||||||||No||2017-10-11 03:50:26.047106|2017-10-11 03:50:26.047106
NCT01432613|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-06-27|||September 2010||2010-09-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2016|Actual|2016-06-01||Interventional|DARWIM||Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies|Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies|Active, not recruiting||N/A|139|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-11 03:50:26.233802|2017-10-11 03:50:26.233802
NCT01432600|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-04-18|2017-03-06||November 2011||2011-11-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional||All participants. Arm D (a part of Arm B) started in July 2012 when, per protocol guidelines, 17 participants from Arm B elected to crossover to Arm D. Some measures may include arm D, making the total of participants evaluated higher.|Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide|Evaluation of Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide in Patients With Relapsed and Refractory Myeloma|Completed||Phase 1/Phase 2|80|Actual|H. Lee Moffitt Cancer Center and Research Institute|Phase 2 nature of design may have limited power to detect statistically significant differences in some efficacy outcomes and toxicity measures.|4|||f||||t||||||||||2017-10-11 03:50:26.377158|2017-10-11 03:50:26.377158
NCT01432587|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-08-21|||August 2011||2011-08-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|DFNS01||The Effect of Diflunisal on Familial Transthyretin Amyloidosis|"The Effect of Diflunisal on Familial Transthyretin Amyloidosis: An Open Label Extension Study of the Diflunisal Trial (IND 68092), and an Open Label Observational Study on Previously Untreated Patients With Familial Transthyretin Amyloidosis."|Completed||N/A|55|Actual|Umeå University|||1||f||||f||||||Samples Without DNA|"     Serum Whole blood Urine   "|||2017-10-11 03:50:28.270452|2017-10-11 03:50:28.270452
NCT01432574|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-06-30|2015-04-23||December 7, 2012|Actual|2012-12-07|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|May 23, 2014|Actual|2014-05-23||Interventional||All participants|Study of Gardasil in Mid-Adult Males (MAM)|A Phase II Study of Gardasil in Human Papillomavirus Research The Mid-Adult Male Vaccine Study - The MAM STUDY|Active, not recruiting||Phase 2|150|Actual|H. Lee Moffitt Cancer Center and Research Institute|Participants were followed for just 7 months post-dose one of the vaccine; therefore, investigators were unable to assess the durability of the vaccine response in men vaccinated at an older age.|1|||f||||t|t|f||||||||2017-10-11 03:50:28.359924|2017-10-11 03:50:28.359924
NCT01432561|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2013-09-23|2013-07-03||September 2011||2011-09-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™|Food-Effect on Bioavailability of Cystagon™ in Normal, Healthy Adults|Completed||N/A|8|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 03:50:28.636602|2017-10-11 03:50:28.636602
NCT01432548|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-09-12|||July 2011||2011-07-01|September 2011|2011-09-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Interventional|IP||Ischemic Preconditioning. Prospective Comparison|Ischemic Preconditioning Versus Intermittent Portal Triad Clamping in Liver Resection. Prospective Randomized Comparison|Unknown status|Recruiting|N/A|60|Anticipated|Hospital General de Agudos “Dr. Cosme Argerich”||1|||f||||t||||||||||2017-10-11 03:50:29.030924|2017-10-11 03:50:29.030924
NCT01432535|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-03-09|2013-07-23||November 2011||2011-11-01|March 2017|2017-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655)|A Single Dose Study to Assess Pharmacokinetics of SCH 54031 in Patients With Renal Impairment (P05655)|Completed||Phase 1|25|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:50:29.123586|2017-10-11 03:50:29.123586
NCT01432522|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-19|2011-09-12|||July 2010||2010-07-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|Epinephrine||A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine|Comparison of Absorption of Epinephrine Into the Circulation After Epinephrine Intranasal Spray Administration and After Intramuscular Injection|Completed||N/A|12|Anticipated|Siriraj Hospital||1|||f||||f||||||||||2017-10-11 03:50:29.83991|2017-10-11 03:50:29.83991
NCT01432509|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-06-23|||September 2011||2011-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|DiabeNord||Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord)|DiabeNord: A 5-year Prospective Follow-up Cohort Study in Pre-diabetic Subjects for the Identification of New Biomarkers|Active, not recruiting||N/A|207|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 03:50:29.953154|2017-10-11 03:50:29.953154
NCT01432496|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2013-02-22|||September 2011||2011-09-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy|A Multicentric, Randomized, Controlled, Double Blinded, Phase III Clinical Trial; Comparing Peritoneal Nebulization of Ropivacaine 150 mg With Peritoneal Nebulization of Saline|Terminated||Phase 3|130|Anticipated|San Gerardo Hospital||2||There was insuficient recruitment in two centers|f||||f||||||||||2017-10-11 03:50:30.068696|2017-10-11 03:50:30.068696
NCT01432483|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-01-22||||||January 2015|2015-01-01||||||||Expanded Access|||Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)|Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)|No longer available||N/A|||Eisai Inc.|||||||||||||||||||2017-10-11 03:50:30.216833|2017-10-11 03:50:30.216833
NCT01432470|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-16|2011-09-12|||August 2010||2010-08-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women|A Double-blind, Placebo Controlled Multi-centre Study to Evaluate the Effects of Topical Oxytocin on Vaginal Atrophy in Postmenopausal Women|Completed||Phase 2|74|Anticipated|PepTonic Medical AB||2|||f||||f||||||||||2017-10-11 03:50:30.312404|2017-10-11 03:50:30.312404
NCT01432457|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2013-12-17|2013-06-27||October 2011||2011-10-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional||The numbers are correct. Participants flow starts with all randomized subjects while baseline is summarized for safety population defined as randomized AND took at least one dose. Started- (Other Did not take study drug) is the number for baseline summary.|Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)|A Phase IV, Multicenter, Randomized, 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy of 2 Fixed Doses (50 and 100 mg/Day) of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder|Completed||Phase 4|924|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 03:50:30.491257|2017-10-11 03:50:30.491257
NCT00000290|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||May 1997||1997-05-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Stress Hormones and Human Cocaine Use - 7|Stress Hormones and Human Cocaine Use|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.092261|2017-10-11 04:17:43.092261
NCT01432444|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-04-20|2014-12-19||September 2011||2011-09-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ARRIVE US||Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole|Open-label Study to Assess Hospitalization Rates in Adult Schizophrenic Patients Treated With Oral Antipsychotics for 6 Months and IM Depot Aripiprazole for 6 Months, Respectively, in a Naturalistic Community Setting|Completed||Phase 3|493|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 03:50:31.46263|2017-10-11 03:50:31.46263
NCT01432431|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2013-09-04|||October 2011||2011-10-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital Staff|Archstone Spiritual Care Demonstration Project: Outcomes for Patients, Families, and Staff|Completed||N/A|100|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 03:50:32.311135|2017-10-11 03:50:32.311135
NCT01432418|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-05-06|||June 2012||2012-06-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effectiveness of a Wheelchair Skills Training Program for Power Mobility Users: A Randomized Controlled Trial|Effectiveness of a Wheelchair Skills Training Program for Power Mobility Users: A Randomized Controlled Trial|Completed||N/A|116|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 03:50:32.413645|2017-10-11 03:50:32.413645
NCT01432405|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-03-14|2016-02-17||June 2007||2007-06-01|March 2016|2016-03-01|June 2009|Actual|2009-06-01|July 2008|Actual|2008-07-01||Interventional|||Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes|Effect of Exenatide Treatment on Hepatic Fat Content and Plasma Adipocytokine Levels in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|24|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 03:50:32.50376|2017-10-11 03:50:32.50376
NCT01432392|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2012-05-09|||September 2011||2011-09-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease|A Prospective, Observational Study to Describe Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease (GERD)|Completed||N/A|1000|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:50:32.900728|2017-10-11 03:50:32.900728
NCT01432379|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2016-10-19|2016-07-26||September 2011||2011-09-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational||The Treated Population includes all patients who received at least 1 dose of botulinum toxin Type A and is used for baseline characteristics.|BOTOX® Prophylaxis in Patients With Chronic Migraine||Completed||N/A|1168|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:50:32.975487|2017-10-11 03:50:32.975487
NCT01432366|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-12-14|2015-12-14||October 2010||2010-10-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|December 2013|Actual|2013-12-01||Observational|CONTENT|Baseline analysis set (BAS) included all participants who were enrolled in the study and seen at baseline.|Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA)|Subcutaneous Anti-tnf-αlpha In Rheumatoid Arthritis: Analyze The Correlation Between Objective Measures Of Disease Activity And Safety And A Subjective Measure Such As Patient Beliefs About A Medicine|Completed||N/A|460|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:50:33.342852|2017-10-11 03:50:33.342852
NCT01432353|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-11-01|||September 2011||2011-09-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma|An Open-label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|39|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 03:50:35.82759|2017-10-11 03:50:35.82759
NCT01432340|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-09|||June 2010||2010-06-01|September 2011|2011-09-01|March 2013|Anticipated|2013-03-01|||||Observational|||Seasonal Influenza Vaccine Effectiveness Study in Kenya|Seasonal Influenza Vaccine Effectiveness Study in the Kenyan Communities of Kibera and Lwak|Unknown status|Recruiting|N/A|10000|Anticipated|Centers for Disease Control and Prevention|||2||f||||f||||||Samples With DNA|"     Nasopharyngeal and oropharyngeal swabs.Potentially has DNA and RNA retained.   "|||2017-10-11 03:50:35.919019|2017-10-11 03:50:35.919019
NCT01432327|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2015-02-23|2012-02-15||August 2010||2010-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Impact of Real-time Feedback on Physical Activity Patterns in Flemish Employees|The Impact of Real-time Feedback on Physical Activity Patterns in Flemish Employees: an Intervention Study|Completed||N/A|227|Actual|Katholieke Universiteit Leuven|Malfunction of the SenseWear Armband: 4 out of the 320 baseline measurements|4|||f||||f||||||||||2017-10-11 03:50:36.036333|2017-10-11 03:50:36.036333
NCT01432314|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2014-06-24|||October 2011||2011-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|RTANDTACE||Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)|A Phase II Trial of Radiation Therapy, Followed by Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Invading 1st or 2nd Order Branch of Portal Vein|Withdrawn||Phase 2|0|Actual|Asan Medical Center||1||Another phase 2 randomized study has been started by other investigators.|f||||t||||||||||2017-10-11 03:50:36.470258|2017-10-11 03:50:36.470258
NCT01432301|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-03-03||||||March 2016|2016-03-01||||||||Expanded Access|||Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination|An Open-Label Protocol for the Use of Uridine Triacetate as an Antidote to Treat Patients at Excess Risk of 5-Fluorouracil Toxicity Due to Overdosage or Impaired Elimination|Approved for marketing||N/A|||Wellstat Therapeutics|||||||||||||||||||2017-10-11 03:50:36.552563|2017-10-11 03:50:36.552563
NCT01432288|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-08-08|||August 2011||2011-08-01|August 2017|2017-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Touch and Attention MRI Study|Effects of Touch and Attention on Central Nervous System Resting State Network (RSN) Activity|Completed||N/A|10|Actual|Wake Forest University Health Sciences|||1||f||||t|f|f||||||||2017-10-11 03:50:36.611767|2017-10-11 03:50:36.611767
NCT01432275|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-09|2017-04-27|2013-07-10||September 2011||2011-09-01|April 2017|2017-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|IHUT||Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study|Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study|Completed||N/A|179|Actual|Abbott Diabetes Care||2|||f||||f||||||||||2017-10-11 03:50:37.979941|2017-10-11 03:50:37.979941
NCT00000291|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||October 1997||1997-10-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Effects of Labetalol on Human Cocaine Use - 8|Effects of Labetalol on Human Cocaine Use|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.160814|2017-10-11 04:17:43.160814
NCT01432262|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-01-18|2012-12-04||July 2011||2011-07-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico|A Phase 3, Open Label, Single Arm, Multicenter, Trial to Assess The Safety, Tolerability And Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine In Healthy Adults Aged => 50 Years of Age Who Are Naive To 23-Valent Pneumococcal Polysaccharide Vaccine in Mexico.|Completed||Phase 3|324|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:50:38.328466|2017-10-11 03:50:38.328466
NCT01432249|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-11-14|||March 2013||2013-03-01|November 2013|2013-11-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis|Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis|Withdrawn||Phase 4|0|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:50:39.338536|2017-10-11 03:50:39.338536
NCT01432236|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2014-10-21|2014-05-12||October 2011||2011-10-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression|A Phase 3b Multicenter, Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study Of Pregabalin In The Treatment Of Fibromyalgia With Concurrent Antidepressant Therapy For Comorbid Depression (Protocol A0081275)|Completed||Phase 3|197|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:50:39.486199|2017-10-11 03:50:39.486199
NCT01432223|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-04-21|||September 2011||2011-09-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional|||Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab|Phase II Study of Primary Chemotherapy With Anthracycline-based Regimen Followed by Nab-paclitaxel and Trastuzumab in Patients With HER2 Positive Breast Cancer|Completed||Phase 2|46|Actual|Osaka Medical College||1|||f||||t||||||||||2017-10-11 03:50:41.256401|2017-10-11 03:50:41.256401
NCT01432210|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2016-09-28|||September 2011||2011-09-01|September 2016|2016-09-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Provitamin A Absorption and Conversion With Avocados|Enhancing Human Intestinal Absorption of Carotenoids and Bioconversion of Carotene to Vitamin A in the Presence of Hass Avocados|Completed||N/A|24|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 03:50:41.360009|2017-10-11 03:50:41.360009
NCT01432197|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2011-09-09|||March 2010||2010-03-01|September 2011|2011-09-01||||June 2011|Actual|2011-06-01||Interventional|||Occupational Therapy for Cancer Patients: a Randomised, Controlled Study|Occupational Therapy for Cancer Patients: A Randomised Controlled Study|Completed||Early Phase 1|116|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 03:50:41.454579|2017-10-11 03:50:41.454579
NCT01432184|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-10-16|||July 2010||2010-07-01|October 2015|2015-10-01|October 2013|Actual|2013-10-01|July 2011|Actual|2011-07-01||Interventional|Tête-à-coeur||Feasibility Trial to Maintain Normal Cerebral Oxygen Saturation in High-Risk Cardiac Surgery|Perioperative Interventions to Optimize Cerebral Oxygen Saturation (rSO2) in High-risk Patients Undergoing Cardiac Surgery Should Have a Beneficial Systemic Effect for Enhancing Global Tissue Perfusion and Improve Outcomes.|Completed||N/A|200|Actual|Montreal Heart Institute||2|||f||||t||||||||||2017-10-11 03:50:41.536848|2017-10-11 03:50:41.536848
NCT01432171|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-05-24|||July 2012||2012-07-01|May 2016|2016-05-01||||July 2018|Anticipated|2018-07-01||Interventional|||Lacosamide for Seizure Prophylaxis in High-Grade Gliomas|Randomized, Double-Blind, Placebo-Controlled Trial of Lacosamide for Seizure Prophylaxis in Patients With High-Grade Gliomas|Active, not recruiting||N/A|302|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 03:50:41.643993|2017-10-11 03:50:41.643993
NCT01432158|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-11-06|||January 2012||2012-01-01|November 2015|2015-11-01||||August 2012|Actual|2012-08-01||Interventional|||Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines|A Detailed Kinetics Study to Assess the Antibody and the B Cell Response to Either a 13-valent Conjugate Vaccine or a 23-valent Plain Pneumococcal Polysaccharide Vaccine Administered to Healthy Adults Without Prior Pneumococcal Vaccination|Completed||Phase 3|4|Actual|University of Oxford||2|||f||||f||||||||||2017-10-11 03:50:41.784069|2017-10-11 03:50:41.784069
NCT01432145|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-05-27|||May 2011||2011-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|6MP||A Clinical Trial in Patients With BRCA Defective Tumours|Phase II Clinical Trial Of 6-Mercaptopurine (6MP) and Low-Dose Methotrexate In Patients With Known BRCA Defective Tumours|Completed||Phase 2|74|Actual|University of Oxford||1|||f||||f||||||||||2017-10-11 03:50:41.873828|2017-10-11 03:50:41.873828
NCT01432132|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-08-03|||August 24, 2011|Actual|2011-08-24|August 2017|2017-08-01|July 25, 2017|Actual|2017-07-25|July 25, 2017|Actual|2017-07-25||Observational|||Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer|Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer|Completed||N/A|25|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-10-11 03:50:41.964176|2017-10-11 03:50:41.964176
NCT01432119|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2013-04-08|||December 2012||2012-12-01|April 2013|2013-04-01||||December 2019|Anticipated|2019-12-01||Interventional|||Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib|Phase I Trial of Cetuximab and Erlotinib (EGFR Inhibitors) and SIR-Spheres (Yttrium Microspheres) in Patients With Advanced Malignancies and Liver Metastases|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 03:50:42.081246|2017-10-11 03:50:42.081246
NCT01432106|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2013-11-14|||February 2011||2011-02-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SAAVE||The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome|A Randomized, Double Blind, Active Comparator, Parallel-group Study to Determine Whether the Combination of Valsartan and Aliskiren Provides Cardioprotection in African American Patients With Hypertension and Elements of the Metabolic Syndrome|Withdrawn||Phase 1|0|Actual|University of Michigan||2||"Novartis terminated all projects involving aliskiren. Findings of the DMC overseeing the   ALTITUDE clinical trial found a higher incidence of adverse events."|f||||f||||||||||2017-10-11 03:50:42.194384|2017-10-11 03:50:42.194384
NCT01432093|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-11-11|||October 2011||2011-10-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Intensive Glycemic Management and Outcomes Following Liver Transplantation|Intensive Glycemic Management and Outcomes Following Liver Transplantation: A Randomized Controlled Trial|Completed||N/A|270|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 03:50:42.292495|2017-10-11 03:50:42.292495
NCT01432080|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-08-28|||September 2011||2011-09-01|August 2017|2017-08-01|December 30, 2013|Actual|2013-12-30|December 2012|Actual|2012-12-01||Interventional|||Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant|Does Increasing Immunosuppression Prevent Transplant-associated Lung-disease Triggered by Viral Respiratory Tract Infection Following Allogeneic Stem Cell Transplant? A Pilot Study|Terminated||Phase 2|12|Actual|Maisonneuve-Rosemont Hospital||2||Not meeting recruitment targets|f||||f||||||||||2017-10-11 03:50:42.392596|2017-10-11 03:50:42.392596
NCT01432067|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2014-09-29|||October 2011||2011-10-01|September 2014|2014-09-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|CAPADOGE||Physical Activity Advices to Prevent Loss of Autonomy in Cancer Treated Elderly Patients. An Intervention Randomized Study||Unknown status|Active, not recruiting|N/A|400|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 03:50:42.550214|2017-10-11 03:50:42.550214
NCT01432054|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-06-24||||||September 2011|2011-09-01||||||||Observational|||Human Tissue Repository for Wound Care|Human Tissue Repository for Wound Care|Withdrawn||N/A|0|Actual|KCI USA, Inc.|||1|business decision|f||||f||||||Samples With DNA|"     wound biopsy   "|||2017-10-11 03:50:42.673349|2017-10-11 03:50:42.673349
NCT01432041|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2011-09-09|||September 2004||2004-09-01|September 2011|2011-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Brief Child Safety Interventions in Emergency Departments (Safety in Seconds)|Brief Child Safety Interventions in Emergency Departments (Safety in Seconds)|Completed||N/A|901|Actual|Johns Hopkins Bloomberg School of Public Health|||||f||||f||||||||||2017-10-11 03:50:42.740411|2017-10-11 03:50:42.740411
NCT01432028|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-19|2014-01-23|||March 2007||2007-03-01|January 2014|2014-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women|Polymorphisms in Genes Encoding the Estrogen Metabolism Enzymes and Effects of Hormone Therapy for Oral Low Dose or Not Oral on Variables Related Endothelial Function, Inflammation and Metabolic Profile in Patients in Recent Menopause Study Pharmacogenetic|Completed||N/A|90|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 03:50:42.818366|2017-10-11 03:50:42.818366
NCT01432015|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2017-02-24|2015-04-29||September 2011||2011-09-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting|A Phase IV Study Comparing the Efficacy of Fosaprepitant to Aprepitant for Chemotherapy Induced Nausea and Vomiting in Patients Treated for Gynecological Cancer|Completed||Phase 4|20|Actual|Gynecologic Oncology Associates||2|||f||||f||||||||No||2017-10-11 03:50:42.942555|2017-10-11 03:50:42.942555
NCT01432002|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2017-05-12|||November 2007||2007-11-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2013|Actual|2013-05-01||Observational|||FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer|Application of 18F-[FDG] PET/CT to Simulation and Planning of Radiotherapy (RT) for Breast Cancer. Definition of Target Volume for 3-D RT and for Partial Breast Irradiation (PBI) by IMRT Technique|Active, not recruiting||N/A|60|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-10-11 03:50:43.38838|2017-10-11 03:50:43.38838
NCT01431989|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-07-18|2012-01-05||May 27, 2011|Actual|2011-05-27|July 2017|2017-07-01|June 11, 2011|Actual|2011-06-11|June 11, 2011|Actual|2011-06-11||Interventional|||Amoxicillin Bioequivalence Study Brazil - Fast|Evaluation of Pharmaceutical Bioequivalence of Amoxicillin Trihydrate - Clamoxyl 500mg/5mL (Glaxo Wellcome Production.) in the Form Powder for Oral Suspension Versus Amoxil ® 500mg/5mL (GlaxoSmithKline Mexico SA) in the Form of Powder for Oral Suspension in Healthy Volunteers and Fasting, Using Techniques of Liquid Chromatography|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:50:43.554886|2017-10-11 03:50:43.554886
NCT01431976|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-01-25|2014-08-14||September 2011||2011-09-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|February 2014|Actual|2014-02-01||Interventional|||Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents|A Multi-center, Uncontrolled, Open-label, Evaluation of Lamotrigine Monotherapy on Newly Diagnosed Typical Absence Seizures in Children and Adolescents|Completed||Phase 3|20|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:50:43.956103|2017-10-11 03:50:43.956103
NCT01431963|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-09-23|2013-09-26||September 2011||2011-09-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|March 2013|Actual|2013-03-01||Interventional||Baseline data were collected in members of the Safety Population, comprised of all participants who had taken at least one dose of investigational product.|Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy|A Multi-center, Uncontrolled, Open-label, Evaluation of Lamotrigine Monotherapy in Newly Diagnosed Epilepsy or Recurrent Epilepsy (Currently Untreated)|Completed||Phase 3|70|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:50:44.464749|2017-10-11 03:50:44.464749
NCT01431950|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2016-11-18|2014-08-21|2013-03-14|September 2011||2011-09-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents|A Randomised, Double-blind, Multi-centre Study to Evaluate the Efficacy and Safety of Inhaled Fluticasone Furoate in the Treatment of Persistent Asthma in Adults and Adolescents Currently Receiving Mid to High Strength Inhaled Corticosteroids.|Completed||Phase 3|238|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:50:44.880031|2017-10-11 03:50:44.880031
NCT01431937|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-07-05|||October 10, 2010|Actual|2010-10-10|July 2017|2017-07-01|March 29, 2011|Actual|2011-03-29|March 29, 2011|Actual|2011-03-29||Interventional|P1A114347||Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers|A Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Ascending Doses of GSK2018682 (S1P1 Agonist) in Healthy Volunteers|Completed||Phase 1|40|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:50:45.499646|2017-10-11 03:50:45.499646
NCT01431924|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2013-02-21|||October 2010||2010-10-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients|Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients|Completed||N/A|7779|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:50:45.610312|2017-10-11 03:50:45.610312
NCT01431911|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-05-15|||October 2010||2010-10-01|May 2017|2017-05-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Observational|||Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation|Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation|Completed||N/A|3806|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:50:45.693299|2017-10-11 03:50:45.693299
NCT01431898|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2012-07-23|||September 2011||2011-09-01|March 2012|2012-03-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection|A Phase 1b, Randomized, Single-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 1|82|Actual|Gilead Sciences||1|||f||||||||||||||2017-10-11 03:50:45.782105|2017-10-11 03:50:45.782105
NCT01431885|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-04-14|||August 2011||2011-08-01|April 2014|2014-04-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Two Methods of Diagnosing Preterm Labor|Randomized Controlled Trial of Two Methods of Diagnosing Preterm Labor|Unknown status|Recruiting|Phase 3|136|Anticipated|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:50:45.943117|2017-10-11 03:50:45.943117
NCT01431872|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-11-03|||April 2011||2011-04-01|November 2015|2015-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors|Systemic DKK1 During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors|Completed||N/A|17|Actual|University of Arkansas|||1||f||||f||||||||||2017-10-11 03:50:46.035525|2017-10-11 03:50:46.035525
NCT01431859|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2016-04-05|||July 2012||2012-07-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Can we Help People With the Oral Allergy Syndrome Eat Fresh Fruit?|A Double Blind Placebo Controlled Randomised Trial to Study the Effects of Birch Pollen Specific Immunotherapy (BP-SIT) on the Symptoms of the Oral Allergy Syndrome in Adult Patients|Active, not recruiting||Phase 4|40|Anticipated|Royal Sussex County Hospital||2|||f||||f||||||||||2017-10-11 03:50:46.101984|2017-10-11 03:50:46.101984
NCT01431846|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-04-06|2014-11-19||August 2011||2011-08-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Transition From Hospital to Home Post Cardiac Condition|Pilot Intervention to Improve the Transition From Hospital to Home|Completed||N/A|19|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 03:50:46.176972|2017-10-11 03:50:46.176972
NCT01431833|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2016-05-19|||August 2011||2011-08-01|May 2016|2016-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A PK and Safety Study in Subjects With Hepatic Impairment|A Phase 1 Open-Label Study With Oral TR-701 FA to Assess Pharmacokinetics and Safety in Subjects With Moderate or Severe Hepatic Impairment|Completed||Phase 1|32|Actual|Trius Therapeutics LLC||3|||f||||f||||||||||2017-10-11 03:50:46.468061|2017-10-11 03:50:46.468061
NCT01431820|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-11-02||2015-11-02|May 2012||2012-05-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|SOLUTION||Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis|Safety and Efficacy of Luliconazole Solution, 10% With Two Dosing Regimens in Distal Subungual Onychomycosis of the Toenails: A Randomized, Double-Blind, Vehicle-Controlled, Phase 2B/3 Study|Completed||Phase 2/Phase 3|334|Actual|Topica Pharmaceuticals||4|||f||||f||||||||||2017-10-11 03:50:46.569464|2017-10-11 03:50:46.569464
NCT01431807|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2016-06-10|||September 2011||2011-09-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Long-term Study of SYR-472|An Open-label, Multicenter, Long-term Phase 3 Study to Evaluate the Safety and Efficacy of Long-term Treatment With SYR-472 in the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control Despite Diet and/or Exercise Therapies or Treatment With an Existing Oral Anti-diabetic Drug Added to Diet and/or Exercise Therapies|Completed||Phase 3|680|Actual|Takeda||1|||f||||f||||||||||2017-10-11 03:50:46.86527|2017-10-11 03:50:46.86527
NCT01431794|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-10-05|||September 2011||2011-09-01|October 2017|2017-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma|Phase 1/2 Safety and Feasibility of Gemcitabine and Nab-Paclitaxel in Combination With LDE-225 as Neoadjuvant Therapy in Patients With Borderline Resectable Pancreatic Adenocarcinoma.|Active, not recruiting||Phase 1/Phase 2|52|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 03:50:47.037307|2017-10-11 03:50:47.037307
NCT01431781|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-25|||August 2011||2011-08-01|September 2011|2011-09-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||The Prophylactic Effect of Stilamin on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis|A Prospective, Multi-center, Investigator Sponsored, Randomized Controlled Trial-- The Prophylactic Effect of Stilamin on Post-ERCP Pancreatitis|Unknown status|Recruiting|N/A|908|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-10-11 03:50:47.167396|2017-10-11 03:50:47.167396
NCT01431768|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2014-04-28|||July 2011||2011-07-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B|Clinical Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B in the Primary Health Setting|Completed||N/A|250|Anticipated|Respirio Pty Ltd||1|||f||||f||||||||||2017-10-11 03:50:47.309266|2017-10-11 03:50:47.309266
NCT01431755|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-04-23|2013-10-16||September 2011||2011-09-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of Treatment Preference During Cheek Contouring Comparing Restylane® SubQ With and Without the Addition of Lidocaine Hydrochloride|A Randomised, Subject-blinded Study of Treatment Preference During Cheek Contouring Comparing Restylane® SubQ With and Without the Addition of Lidocaine Hydrochloride 0.3%|Completed||N/A|54|Actual|Q-Med AB||2|||f||||||||||||||2017-10-11 03:50:47.395494|2017-10-11 03:50:47.395494
NCT01431742|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2012-04-16|||July 2012||2012-07-01|April 2012|2012-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain|An Open Label, Longterm Treatment Evaluation of the Safety and Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Low Back Pain|Withdrawn||Phase 3|0|Actual|BioDelivery Sciences International||1|||f||||f||||||||||2017-10-11 03:50:47.78266|2017-10-11 03:50:47.78266
NCT01431729|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2011-09-19|||June 2010||2010-06-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Observational|||Honey and a Mixture of Honey, Beeswax and Olive Oil-propolis Extract in Treatment of Chemotherapy-induced Oral Mucositis|Honey and a Mixture of Honey, Beeswax and Olive Oil-propolis Extract in Treatment of Chemotherapy-induced Oral Mucositis: a Randomized Controlled Pilot Study|Completed||Phase 2|90|Actual|Ain Shams University|||1||f||||t||||||||||2017-10-11 03:50:47.879835|2017-10-11 03:50:47.879835
NCT01431716|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-01-02|2015-01-02||March 2011||2011-03-01|January 2015|2015-01-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|EPITOME-2|All-treated set (One patient enrolled in the study but withdrew consent prior completing baseline assessment and receiving study drug).|Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension|A Multicenter, Single-arm, Open-label, Phase 3b Study to Assess the Effects of Switching From Flolan® to EFI/ACT-385781A in Patients With Pulmonary Arterial Hypertension|Completed||Phase 3|42|Actual|Actelion||1|||f||||f||||||||||2017-10-11 03:50:47.980066|2017-10-11 03:50:47.980066
NCT01431703|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-01-08|2016-04-26||May 2010||2010-05-01|January 2017|2017-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||The Learning Curve of NBI With Magnification in the Diagnosis of Colorectal Lesions|The Learning Curve of NBI With Magnification in the Diagnosis of Colorectal Lesions|Completed||N/A|326|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||t||||||Samples Without DNA|"     if the lesion is neoplastic or sm deeper cancer, we just take biopsy.If the lesion is     adenomatous or sm1-2 cancer,we do polypectomy, EMR or ESD to get the specimen.   "|No||2017-10-11 03:50:48.437015|2017-10-11 03:50:48.437015
NCT01431690|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-04-23|||August 2011||2011-08-01|April 2015|2015-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals|An Open-label, 2-cohort Study to Evaluate the Effect of Multiple Doses of Epanova® on the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin and to Compare the Systemic Exposure of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Following Multiple-dose Administrations of Epanova® Compared to Lovaza® in Healthy Normal Subjects|Completed||Phase 1|52|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 03:50:48.592326|2017-10-11 03:50:48.592326
NCT01431677|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-10-05|||May 17, 2010||2010-05-17|July 29, 2014|2014-07-29|July 29, 2014|Actual|2014-07-29|June 16, 2014|Actual|2014-06-16||Interventional|||Muscle Biopsies in Healthy Volunteers|Muscle Biopsies in Healthy Volunteers: a Pilot Study|Terminated||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:50:48.681539|2017-10-11 03:50:48.681539
NCT01431664|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2014-12-01|||September 2011||2011-09-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia|A Cancer Research UK Phase I/IIa Trial of AT9283 (A Selective Inhibitor of Aurora Kinases) Given Over 72 Hours Every 21 Days Via Intravenous Infusion in Children and Adolescents Aged 6 Months to 18 Years With Relapsed and Refractory Acute Leukemia|Completed||Phase 1|7|Actual|Cancer Research UK||1|||f||||||||||||||2017-10-11 03:50:48.759484|2017-10-11 03:50:48.759484
NCT01431651|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2012-05-05|||October 2011||2011-10-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|||Probiotics Improve Gastrointestinal Symptoms After Roux-en-Y Gastric Bypass: A Prospective Randomized Trial|Asian Pacific Weight Loss and Metabolic Surgery Center|Unknown status|Recruiting|N/A|60|Anticipated|Min-Sheng General Hospital||1|||f||||t||||||||||2017-10-11 03:50:48.855524|2017-10-11 03:50:48.855524
NCT01431638|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-03-20|||August 2011||2011-08-01|March 2017|2017-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients|A 36-week Open-label Extension Study of CACZ885H2361 on the Safety and Tolerability of Canakinumab 150 mg s.c. Pre-filled Syringe (PFS) in Treating Acute Gouty Arthritis Flares in Frequently Flaring Patients|Completed||Phase 3|233|Actual|Novartis||1|||f||||t||||||||||2017-10-11 03:50:48.951766|2017-10-11 03:50:48.951766
NCT01431625|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2011-09-08|||January 2011||2011-01-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype|Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Chronic Obstructive Pulmonary Disease Phenotype|Unknown status|Recruiting|Phase 4|30|Anticipated|Hospitales Universitarios Virgen del Rocío||2|||f||||t||||||||||2017-10-11 03:50:49.181557|2017-10-11 03:50:49.181557
NCT01431612|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2011-09-07|||November 2008||2008-11-01|September 2011|2011-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Effects of Adrenergic Drugs on the Fluid Balance During Surgery|The Effects of ß1-receptor Blockade and α1-adrenergic Agonist on the Kinetics of Lactated Ringer's Solution During Surgery|Completed||Phase 1/Phase 2|60|Actual|Sodertalje Hospital||3|||f||||f||||||||||2017-10-11 03:50:49.293797|2017-10-11 03:50:49.293797
NCT01431586|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2012-05-09||||||May 2012|2012-05-01||||||||Interventional|||First in Humans Study of JDTic|A Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic in Healthy Male Subjects|Terminated||Phase 1|24|Actual|RTI International||1||No further subjects will be enrolled due to adverse events.|f||||t||||||||||2017-10-11 03:50:49.478779|2017-10-11 03:50:49.478779
NCT01431573|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-08-14|||July 2011|Actual|2011-07-01|August 2017|2017-08-01|August 2020|Anticipated|2020-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Wake Therapy in the Treatment of Depression|Combined Wake Therapy, Light Therapy, and Lithium for Bipolar and Refractory Depression|Recruiting||N/A|25|Anticipated|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 03:50:49.568923|2017-10-11 03:50:49.568923
NCT01431560|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-08|||June 2008||2008-06-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|January 2010|Actual|2010-01-01||Interventional|||Outcomes of Operative Treatment of Unstable Ankle Fracture - Comparison Between Metallic and Biodegradable Implants|Outcomes of Operative Treatment of Unstable Ankle Fracture - Comparison Between Metallic and Biodegradable Implants|Completed||Phase 4|109|Actual|National Police Hospital||2|||f||||t||||||||||2017-10-11 03:50:49.708476|2017-10-11 03:50:49.708476
NCT01431547|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-06-16|||February 2012||2012-02-01|June 2016|2016-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)|A Phase I Study of Monotherapy Dalotuzumab and Ridaforolimus-Dalotuzumab Combination Treatment in Pediatric Patients With Advanced Solid Tumors|Completed||Phase 1|21|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 03:50:49.786083|2017-10-11 03:50:49.786083
NCT01431521|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2017-07-27|2016-02-24||October 26, 2011|Actual|2011-10-26|June 2017|2017-06-01|October 1, 2012|Actual|2012-10-01|September 18, 2012|Actual|2012-09-18||Interventional|||Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)|An Exploratory Study to Evaluate Changes in Hepatic Fat Following Multiple-Dose Administration of MK-4074 and Pioglitazone Hydrochloride|Completed||Phase 1|31|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 03:50:49.937335|2017-10-11 03:50:49.937335
NCT01431508|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2017-03-31|2011-10-13||August 1, 2007|Actual|2007-08-01|March 2017|2017-03-01|June 1, 2009|Actual|2009-06-01|June 1, 2009|Actual|2009-06-01||Interventional|||A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)|An Open-label, Single Arm, Prospective Study to Evaluate the Safety and Anti-hypertensive Efficacy of Losartan 50 mg / Hydrochlorothiazide (HCTZ) 12.5 mg Combination in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 4|15|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:50:50.661861|2017-10-11 03:50:50.661861
NCT01431495|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-09-08|||April 2010||2010-04-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|(CAPP)||Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)|Clinical Assessment of Pidogrel® Versus Plavix®|Completed||Phase 4|219|Actual|Les Laboratoires des Médicaments Stériles||2|||f||||t||||||||||2017-10-11 03:50:50.899686|2017-10-11 03:50:50.899686
NCT01431482|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-05-01|||August 2010||2010-08-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Evaluation of the Composition of Human Milk and Health Outcomes in Children|Evaluation of the Composition of Human Milk and Health Outcomes in Children|Completed||N/A|245|Actual|Mead Johnson Nutrition|||1||f||||f||||||Samples Without DNA|"     Human milk samples   "|||2017-10-11 03:50:51.00448|2017-10-11 03:50:51.00448
NCT01431469|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2012-12-05|||September 2011||2011-09-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, Brazil||Completed||N/A|250|Anticipated|Mead Johnson Nutrition||2|||f||||||||||||||2017-10-11 03:50:51.084721|2017-10-11 03:50:51.084721
NCT01431456|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-08|||October 2011||2011-10-01|September 2011|2011-09-01||||October 2014|Anticipated|2014-10-01||Interventional|DARINA||Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery|A Randomized Pilot Study Comparing the Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|Martini Hospital Groningen||3|||f||||t||||||||||2017-10-11 03:50:51.208864|2017-10-11 03:50:51.208864
NCT01431443|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2015-04-08|||May 2011||2011-05-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|CHOCENTA||Consumption of Chocolate in Pregnant Women.|Consumption of Chocolate in Pregnant Women at High Risk for Preeclampsia.|Completed||Phase 2|160|Actual|Laval University||2|||f||||t||||||||||2017-10-11 03:50:51.322336|2017-10-11 03:50:51.322336
NCT01431430|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-08-25|||January 2012||2012-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|VITALE||VITamine D Supplementation in RenAL Transplant Recipients - VITALE|Prospective Double Blind Multicentre Randomized Trial of Vitamine D Estimating the Profit of a Treatment by Vitamin D3 at the Dose of 100000 UI by Comparison With a Treatment in the Dose of 12 000 UI at Renal Transplanted Patients|Active, not recruiting||Phase 4|538|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:50:51.422195|2017-10-11 03:50:51.422195
NCT01431417|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2015-06-02|||August 2011||2011-08-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Observational|||Validation of a Kinematic Functional Shoulder Score Including Only Essential Movements|Validation of a Kinematic Functional Shoulder Score Including Only Essential Movements|Completed||N/A|108|Actual|Haute Ecole Cantonale Vaudoise de Santé|||5||f||||f||||||||||2017-10-11 03:50:51.530288|2017-10-11 03:50:51.530288
NCT01431404|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2013-07-03|||August 2011||2011-08-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects|Randomized,Double-blind,Single-dosing,Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 With Active Comparator|Completed||Phase 1|44|Actual|Hanwha Chemical||2|||f||||f||||||||||2017-10-11 03:50:51.623776|2017-10-11 03:50:51.623776
NCT01431391|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-04-24|2017-01-05||September 2011||2011-09-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer|A Randomized, Open-Label, Phase 2 Trial Examining the Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men With Non-metastatic Prostate Cancer and a Rising Serum Prostate Specific Antigen After Primary Therapy|Completed||Phase 2|68|Actual|Dendreon||2|||f||||f||||||||Undecided||2017-10-11 03:50:51.73043|2017-10-11 03:50:51.73043
NCT01431378|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-12-10|||September 2011||2011-09-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|May 2012|Actual|2012-05-01||Observational|MBIR||Pilot Study of Model Based Iterative Reconstruction Using 64-Slice|Pilot Study of Model Based Iterative Reconstruction Using 64-Slice Multidetector-Row CT Datasets Obtained From the Central Nervous System, Thorax, and Abdomen|Terminated||N/A|92|Actual|GE Healthcare|||4|Feasibility study, sufficient amount of data collected.|f||||f||||||||||2017-10-11 03:50:52.5006|2017-10-11 03:50:52.5006
NCT00000292|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||April 1996||1996-04-01|April 1996|1996-04-01|December 2001||2001-12-01|||||Interventional|||Acute Withdrawal From Smoked Cocaine - 9|Acute Withdrawal From Smoked Cocaine|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.229569|2017-10-11 04:17:43.229569
NCT01431352|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2013-11-04|||September 2009||2009-09-01|November 2013|2013-11-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)|The Effects of Chinese Herbal Medicine and Letrozole on Live Birth in Infertile Women With Polycystic Ovary Syndrome:A Double-blind Randomized Controlled Trial|Unknown status|Recruiting|N/A|420|Anticipated|Heilongjiang University of Chinese Medicine||2|||f||||f||||||||||2017-10-11 03:50:52.667686|2017-10-11 03:50:52.667686
NCT01431339|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2013-12-27|2013-12-27||July 2011||2011-07-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections|A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Dalbavancin to a Comparator Regimen (Vancomycin and Linezolid) for the Treatment of Acute Bacterial Skin and Skin Structure Infections|Completed||Phase 3|739|Actual|Durata Therapeutics Inc., an affiliate of Allergan plc||2|||f||||f||||||||||2017-10-11 03:50:52.839798|2017-10-11 03:50:52.839798
NCT01431326|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-03-21|||November 2011||2011-11-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|PTN_POPS||Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care|Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care|Recruiting||N/A|10000|Anticipated|Duke University|||1||f||||t|t|f||||Samples With DNA|"     whole blood   "|No|Completed study datasets (limited PHI) may be requested from https://pediatrictrials.org/data-sharing-opportunities|2017-10-11 03:50:53.536093|2017-10-11 03:50:53.536093
NCT01431313|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-09-29|||April 2012||2012-04-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Inhaled Nitrite in Subjects With Pulmonary Hypertension|A Dose Escalation Study to Evaluate the Effect of Inhaled Nitrite on Cardiopulmonary Hemodynamics in Subjects With Pulmonary Hypertension|Recruiting||Phase 2|50|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 03:50:55.296715|2017-10-11 03:50:55.296715
NCT01431300|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-10-20|2013-08-01||August 2011||2011-08-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants|Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants|Completed||N/A|30|Actual|Duke University||3|||f||||f||||||||||2017-10-11 03:50:55.401662|2017-10-11 03:50:55.401662
NCT01431287|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-06-19|2015-06-19|2014-03-28|September 2011||2011-09-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Treated set (TS): This patient set included all patients in the randomised set who were dispensed study medication and were documented to have taken any dose of study medication.|Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Parallel Group Study to Assess the Efficacy and Safety of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (2.5 µg / 5 µg; 5 µg / 5 µg) (Delivered by the Respimat® Inhaler) Compared With the Individual Components (2.5 µg and 5 µg Tiotropium, 5 µg Olodaterol) (Delivered by the Respimat® Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [TOnado TM 2]|Completed||Phase 3|2539|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 03:50:56.266859|2017-10-11 03:50:56.266859
NCT01431274|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2015-06-19|2015-06-19|2014-03-28|September 2011||2011-09-01|June 2015|2015-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Treated set (TS): This patient set included all patients in the randomised set who were dispensed study medication and were documented to have taken any dose of study medication.|Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Parallel Group Study to Assess the Efficacy and Safety of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (2.5 µg / 5 µg; 5 µg / 5 µg) (Delivered by the Respimat® Inhaler) Compared With the Individual Components (2.5 µg and 5 µg Tiotropium, 5 µg Olodaterol) (Delivered by the Respimat® Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD). [TOnado TM 1]|Completed||Phase 3|2624|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 03:51:05.629743|2017-10-11 03:51:05.629743
NCT01431261|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-10-06|||January 2012||2012-01-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|WADNECXT||Neck Exercises, Training and Pain Management as a Treatment for Whiplash Patients With Chronic Neck Pain|Neck Exercises, Physical and Cognitive Behavioural Graded Activity as a Treatment for Adult Whiplash Patients With Chronic Neck Pain|Completed||N/A|200|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 03:51:12.917886|2017-10-11 03:51:12.917886
NCT01431248|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-01-15|||September 2011||2011-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|PEACE||PPROM Erythromycin Versus Azithromycin|Preterm Premature Rupture of Membranes: Erythromycin Versus Azithromycin. A Randomized Trial Comparing Their Efficacy to Prolong Latency|Completed||N/A|7|Actual|University of Oklahoma|||2||f||||f||||||||||2017-10-11 03:51:13.109363|2017-10-11 03:51:13.109363
NCT01431235|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-08|2017-01-13|||August 2011||2011-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders|Investigating the Efficacy of Cognitive Behavioral Therapy in Patients With Substance Use Disorder and Comorbid ADHD. A Randomized Controlled Trial With Cognitive Behavioral Therapy|Completed||N/A|184|Actual|Arkin||2|||f||||f||||||||||2017-10-11 03:51:13.21283|2017-10-11 03:51:13.21283
NCT01431222|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-08|||September 2011||2011-09-01|September 2011|2011-09-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Interventional|ISAR-CLIP||Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery|Interventional Strategy to Abrogate Mitral Regurgitation Using the MitraClip System in High-Risk Patients Considered Unsuitable for Surgery (ISAR-CLIP)|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 03:51:13.313947|2017-10-11 03:51:13.313947
NCT01431209|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2017-05-01|||August 2011||2011-08-01|May 2017|2017-05-01|August 2019|Anticipated|2019-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Ruxolitinib Phosphate in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Donor Stem Cell Transplant|A Phase 2 Multicenter, Investigator Initiated Study of Oral Ruxolitinib Phosphate for the Treatment of Relapsed or Refractory Diffuse Large B-Cell and Peripheral T-Cell Non-Hodgkin Lymphoma|Recruiting||Phase 2|90|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-11 03:51:13.432373|2017-10-11 03:51:13.432373
NCT01431196|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2016-05-18|||February 2011||2011-02-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|June 2012|Actual|2012-06-01||Interventional|||Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer|Phase II Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer|Completed||Phase 2|29|Actual|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||Yes|By 2017 scientific data should be communicated|2017-10-11 03:51:13.575705|2017-10-11 03:51:13.575705
NCT01431183|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2011-09-07|||October 2008||2008-10-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|February 2009|Actual|2009-02-01||Interventional|||Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions|Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions|Completed||N/A|3618|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:51:13.707439|2017-10-11 03:51:13.707439
NCT01431170|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-06-15|2015-12-23||September 2011||2011-09-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children|A Prospective, Double-Blinded, Parallel-Group, Randomized Study to Assess the Safety and Efficacy of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children|Completed||Phase 1|24|Actual|Rutgers, The State University of New Jersey|Limitations include the small sample size which was reduced by participant drop out.We enrolled 24 subjects, completed and collected primary outcome measure data on 20.The recurrence rate was low at 10% (2 subjects), limiting secondary data analysis.|2|||f||||t||||||||||2017-10-11 03:51:13.801016|2017-10-11 03:51:13.801016
NCT01431157|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-12-09|||November 2011||2011-11-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure|Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure|Terminated||N/A|20|Anticipated|University of Maryland||2||Poor enrollment|f||||f||||||||||2017-10-11 03:51:14.173451|2017-10-11 03:51:14.173451
NCT01431144|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-12-06|2013-07-07||September 2011||2011-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Implant Placement With Simultaneous Gum Grafting|The Effect of Implant Placement and Simultaneous Soft Tissue Augmentation in the Esthetic Zone Using Either Connective Tissue Autograft or Acellular Dermal Matrix Allograft on Peri-implant Hard and Soft Tissue Healing|Completed||N/A|27|Actual|University of Louisville|There were no adverse events. There were 2 cases of implant mobility and these was treated as a potential expected complication and handled with routine clinical practice guidelines.|2|||f||||f||||||||||2017-10-11 03:51:14.279219|2017-10-11 03:51:14.279219
NCT01431131|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-12-06|2013-07-07||September 2011||2011-09-01|December 2016|2016-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Ridge Preservation Comparing an Intrasocket Graft Alone to an Intrasocket Graft Plus a Facial Overlay Graft|Ridge Preservation Comparing a Socket Allograft Alone to a Socket Allograft Plus a Facial Overlay Xenograft: A Clinical and Histologic Study In Humans|Completed||N/A|24|Actual|University of Louisville|"There were no adverse events.
1 patient in the Intrasocket plus facial overlay graft group was excluded as an outlier. There was a large amount of bone gain and this skewed the data."|2|||f||||f||||||||||2017-10-11 03:51:14.612043|2017-10-11 03:51:14.612043
NCT01431118|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2012-07-21|||April 2011||2011-04-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Iron Metabolism in Dragon Boat Athletes|Iron Metabolism in Dragon Boat Athletes - An Analysis of Changes in Blood Count Parameters Under Sport-specific Stress|Completed||N/A|40|Anticipated|University of Giessen||2|||f||||f||||||||||2017-10-11 03:51:14.888287|2017-10-11 03:51:14.888287
NCT01431105|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-10-25|||July 2012||2012-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities|Phase I/IIa Study of Pharmacokinetics and Safety of Atorvastatin in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease|Recruiting||Phase 1/Phase 2|32|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 03:51:14.973704|2017-10-11 03:51:14.973704
NCT01431092|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-06-05|||October 2011||2011-10-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|SMART||Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia|Prolonged-release Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia: a Randomized Clinical Trial|Completed||Phase 4|86|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 03:51:15.130384|2017-10-11 03:51:15.130384
NCT01431079|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-03|2013-01-30|2012-09-30||September 2011||2011-09-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men|Designing and Evaluating a Health Belief Model Based Intervention to Increase Intent of HPV Vaccination Among College Men: Use of Qualitative and Quantitative Methodologies|Completed||Phase 4|90|Actual|University of Cincinnati|"Overall limitation of the trial were due to attrition at the one month follow up.
This was due to the end of school year.This meant that students were busy preparing for finals, starting co-ops/internships, moving back home, or lack of interest."|2|||f||||f||||||||||2017-10-11 03:51:15.254426|2017-10-11 03:51:15.254426
NCT01431066|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2014-02-27|||December 2011||2011-12-01|September 2011|2011-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||ActiPatch Plantar Fasciitis Clinical Trial|Continuous Low Energy Pulsed Radio Frequency Electromagnetic Field Therapy for the Treatment of Plantar Fasciopathy|Completed||Phase 3|28|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:51:15.858059|2017-10-11 03:51:15.858059
NCT01431053|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-03-12|||July 2011||2011-07-01|March 2013|2013-03-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer|Phase 2 Study of Aspirin Plus Exemestane Comparing With Exemestane Alone in the Adjuvant Treatment of Postmenopausal Breast Cancer|Unknown status|Recruiting|Phase 2|160|Anticipated|Chinese Academy of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:51:15.939539|2017-10-11 03:51:15.939539
NCT01431040|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-06-13|||January 2011||2011-01-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2012|Actual|2012-08-01||Interventional|||Patient Experience and Bowel Preparation for Transvaginal Surgical Management of Vaginal Prolapse|Patient Experience and Bowel Preparation for Transvaginal Surgical Management of Vaginal Prolapse|Completed||N/A|150|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 03:51:16.044539|2017-10-11 03:51:16.044539
NCT01431027|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-08-15|||August 2011||2011-08-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function|Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function|Completed||N/A|45|Actual|University of Alabama at Birmingham|||1||f||||t||||||||||2017-10-11 03:51:16.392964|2017-10-11 03:51:16.392964
NCT01431014|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2014-02-06|2014-02-06||August 2011||2011-08-01|September 2011|2011-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Steroid for the Postoperative Swelling After Orthognathic Surgery|The Effect of Steroid on Reducing Facial Swelling After Orthognathic Surgery|Completed||Phase 4|56|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 03:51:16.473941|2017-10-11 03:51:16.473941
NCT01431001|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-05-15|||October 2011||2011-10-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression|Determining Effectiveness of Multi-Coil rTMS for Patients With Major Depressive Disorder: A Pilot Study|Completed||N/A|40|Actual|Cervel Neurotech, Inc.||2|||f||||f||||||||||2017-10-11 03:51:16.743535|2017-10-11 03:51:16.743535
NCT01430988|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-05-02|||September 2011||2011-09-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Observational Study of the BrainScope® Ahead™ M-100 in UK Emergency Department Patients With Head Injury|An Observational Clinical Study of the BrainScope® Ahead™ M-100 Hand Held Electroencephalogram in Emergency Department Patients With Head Injury (B-AHEAD UK Trial)|Terminated||N/A|318|Actual|BrainScope Company, Inc.|||3|"The trial was terminated prematurely following a suspected data processing concern in the study   device. The concern did not pose a patient safety issue."|f||||f||||||||||2017-10-11 03:51:16.827271|2017-10-11 03:51:16.827271
NCT01430975|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-04-24|||September 2011||2011-09-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites|A Prospective Study to Estimate Inadvertent Radiation Exposure From Strontium Isotopes in Patients Who Have Undergone CardioGen-82® PET MPI Scanning at Two Clinical Sites|Completed||N/A|72|Actual|Bracco Diagnostics, Inc|||1||f||||f||||||||||2017-10-11 03:51:16.920888|2017-10-11 03:51:16.920888
NCT01430962|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-07-22|||November 2011||2011-11-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Observational|EBUS-GA-MS||Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Performed Under General Anesthesia Versus Moderate Sedation|Randomized Controlled Trial Comparing Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) Performed Under General Anesthesia Versus Conscious Sedation|Completed||N/A|149|Actual|Baylor College of Medicine|||2||f||||f||||||||||2017-10-11 03:51:16.987164|2017-10-11 03:51:16.987164
NCT01430949|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-09-27|||November 2011||2011-11-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|GENESIS||GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation|A Single-Arm Multi-Center Trial of Radiofrequency Ablation for the Treatment of Paroxysmal Atrial Fibrillation Using the Bard Over-the-Wire Ablation System|Completed||Phase 2|42|Actual|C. R. Bard||1|||f||||t||||||||||2017-10-11 03:51:17.072508|2017-10-11 03:51:17.072508
NCT01430936|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-07-09|||January 2011||2011-01-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|REMOTE-HF-1||Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices|Remote Monitoring of Heart Failure Patients (REMOTE-HF-1) Study - to Assess Utility of a Mobile Device for Improved Management of At-risk Patients|Completed||N/A|51|Actual|Aventyn, Inc.|||1||f||||f||||||||||2017-10-11 03:51:17.163458|2017-10-11 03:51:17.163458
NCT01430923|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-07-11|||September 2011||2011-09-01|July 2012|2012-07-01|August 2012|Anticipated|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost|Randomized,Active Comparator-Controlled,Three Months,Open Label Clinical Trial to Compare Efficacy and Safety of Refrigeration-Free Latanoprost (0.005%) and Latanoprost (0.005%) Stored at Refrigeration Temperature in Patients With OAG or OHT|Unknown status|Active, not recruiting|N/A|30|Anticipated|Aurolab||2|||f||||f||||||||||2017-10-11 03:51:17.332111|2017-10-11 03:51:17.332111
NCT01430910|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2017-08-31|||September 2011||2011-09-01|August 2017|2017-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and Separately|A Phase I, 2-Part, Open-Label, Pharmacokinetic and Drug-Drug Interaction Study of CAZ104 (Avibactam and Ceftazidime in Healthy Subjects)|Completed||Phase 1|43|Actual|Pfizer||3|||f||||||||||||||2017-10-11 03:51:17.428593|2017-10-11 03:51:17.428593
NCT01430897|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2011-09-07|||April 2007||2007-04-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Observational|||Right Ventricular Hypertrophy After Atrial Switch and Cardiovascular Magnetic Resonance (CMR) Findings|Right Ventricular Hypertrophy After Atrial Switch Operation and Its Role in a Systemic RV: Normal Adaptation Process or Risk Factor? A Cardiovascular Magnetic Resonance Study|Completed||N/A|37|Actual|University of Leipzig|||1||f||||t||||||||||2017-10-11 03:51:17.596355|2017-10-11 03:51:17.596355
NCT01430884|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-12-02|||April 2004||2004-04-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|March 2015|Anticipated|2015-03-01||Observational|AHCA||Analysis of Human Coronary Aspirate|Human Coronary Aspirate: Characterization of Particular and Soluble Substances and the Impact on Microvascular Obstruction|Unknown status|Recruiting|N/A|500|Anticipated|Universität Duisburg-Essen|||1||f||||f||||||Samples With DNA|"     -  coronary arterial blood distal to the lesion before stent implantation        -  coronary aspirate blood during stent implantation   "|||2017-10-11 03:51:17.662138|2017-10-11 03:51:17.662138
NCT01430871|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2012-06-14|||January 2011||2011-01-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Effects of Serotonin Excess on Bone in Carcinoid Syndrome|Effects of Serotonin Excess on Bone in Carcinoid Syndrome|Completed||N/A|52|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||2||f||||f||||||Samples Without DNA|"     24 hour urine collections serum samples whole blood samples blood spot on cards   "|||2017-10-11 03:51:17.77631|2017-10-11 03:51:17.77631
NCT01430858|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-12-14|||March 2011||2011-03-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Does Vibration Therapy Induce Higher Than Normal Bone Strains and Strain Rates Than Those Experienced During Habitual Daily Activities|Measurement of Induced Strains in the Human Tibia During Vibration Therapy and Habitual Activities|Unknown status|Recruiting|N/A|5|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 03:51:17.854723|2017-10-11 03:51:17.854723
NCT01430845|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-02-22|||September 2011||2011-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay|Predicting Developmental Disability Type and Mental Retardation Level in Children Who Were Diagnosed in General Developmental Delay|Completed||N/A|150|Actual|Sheba Medical Center|||1||f||||f||||||||Undecided||2017-10-11 03:51:17.959918|2017-10-11 03:51:17.959918
NCT01430832|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-02-22|||September 2011||2011-09-01|February 2016|2016-02-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Observational|||Developmental Outcomes of Extreme Prematurity, 5-15 Years Postpartum|The Long-Term Developmental Outcomes of Extreme Prematurity: Correlations With Maternal Post-Traumatic Symptoms, Parental Stress and Post-Traumatic Growth, 5-15 Years Postpartum|Terminated||N/A|95|Actual|Sheba Medical Center|||2||f||||f||||||||Undecided||2017-10-11 03:51:18.053725|2017-10-11 03:51:18.053725
NCT01430819|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-05-16|2013-03-18||September 2011||2011-09-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults|Safety and Immunogenicity Among Adults of Fluzone®, Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route)|Completed||Phase 4|300|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:51:18.133752|2017-10-11 03:51:18.133752
NCT01430806|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2011-09-07|||October 2011||2011-10-01|September 2011|2011-09-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks|Dronedarone for Patients With Recurrent ICD Shocks Due to Ventricular Arrhythmia Resistant to Their Antiarrhythmic Drug Therapy or Ablation|Unknown status|Not yet recruiting|N/A|20|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 03:51:18.5769|2017-10-11 03:51:18.5769
NCT01430793|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-04-07|||November 2011||2011-11-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EVIREST-D||Determination of Effective Vitamin D Replacement and Monitoring Strategies in Vitamin D Deficiency State|Vitamin D Dosing and Monitoring Study|Completed||N/A|99|Actual|Aga Khan University||4|||f||||f||||||||||2017-10-11 03:51:18.656773|2017-10-11 03:51:18.656773
NCT01430780|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-03-21|||August 2009||2009-08-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||A Prospective Study to Evaluate the Effect of Chronic Nitrate Therapy on Vasodilation Function in Coronary Heart Disease|A Prospective Study to Evaluate the Influence of Oxygen Free Radical Injury Induced by Long-term Nitrates Therapy on Vasodilation Function of Patients With Coronary Heart Disease|Unknown status|Recruiting|N/A|68|Anticipated|Zhejiang University|||2||f||||t||||||||||2017-10-11 03:51:18.756342|2017-10-11 03:51:18.756342
NCT01430767|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-04-18|||September 2011||2011-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder|Measuring Adherence to Standard-of-Care Medication for Depression and ADHD in a College Student Population|Completed||N/A|33|Actual|Wake Forest University Health Sciences|||2||f||||f|f|f||||||||2017-10-11 03:51:18.870297|2017-10-11 03:51:18.870297
NCT01430754|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-10-08|2014-08-08|2013-05-21|September 2011||2011-09-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Run-In - Not Randomized includes the demographics for patients who participated in the run-in phase but who were not randomized.|Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder|A Randomized Withdrawal Study to Demonstrate the Maintenance of Effect of 20 mg Tasimelteon in the Treatment of N24HSWD|Completed||Phase 3|20|Actual|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:51:18.964296|2017-10-11 03:51:18.964296
NCT01430741|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-05-22|2016-10-20||October 2012||2012-10-01|May 2017|2017-05-01|June 2016|Actual|2016-06-01|September 2015|Actual|2015-09-01||Interventional||Limited baseline characteristics were collected for the Veteran population who received case management. Only age was collected for Veterans. No baseline characteristics were collected on the staff population.|MISSION-Vet HUD-VASH Implementation Study|MISSION-Vet HUD-VASH Implementation Study|Completed||N/A|227|Actual|VA Office of Research and Development|First peer specialists were not readily available to teams in the IU condition in two of the three sites. Second, HOMES data on case managers reports. Third, we believe the services documented underrepresented the actual amount of services delivered.|4|||f||||f||||||||No||2017-10-11 03:51:19.531552|2017-10-11 03:51:19.531552
NCT01430728|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-04-05|||April 2011||2011-04-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Cerebral Tissue Oxygenation in Very Low Birthweight Infants in the First 3 Days of Life|Cerebral Tissue Oxygen Saturation in Preterm Neonates Below 1500g Birth Weight During the First 72 Hours|Recruiting||N/A|200|Anticipated|University of Ulm|||1||f||||f||||||||||2017-10-11 03:51:20.069106|2017-10-11 03:51:20.069106
NCT01430715|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-04-19|||July 2011||2011-07-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Estimating Energy Expenditure in Active Video Gaming Compared to Unstructured, Outdoor Play in Children|Active Video Gaming Compared to Unstructured, Outdoor Play in Children: Measurements of Estimated Energy Expenditure and Measured Percent Time in Moderate-to-Vigorous Physical Activity|Completed||N/A|16|Actual|University of Tennessee||1|||f||||t||||||||||2017-10-11 03:51:20.1498|2017-10-11 03:51:20.1498
NCT01430702|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-01-14|||September 2011||2011-09-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|EMMA||Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults|Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults That Require Medication Assistance During Transition Form Hospital to Home|Withdrawn||N/A|0|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 03:51:20.222804|2017-10-11 03:51:20.222804
NCT01430689|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-04-13|||September 2011|Actual|2011-09-01|April 2017|2017-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Maternal Flu Vaccine Trial in Bamako, Mali|Prospective, Randomized, Controlled, Observer-Blind Trial to Measure the Efficacy, Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine and the Safety and Immunogenicity of Quadrivalent Meningococcal Polysaccharide Diphtheria Conjugate Vaccine in Pregnant Malian Women and Their Infants up to 6 Months of Age|Completed||Phase 4|4193|Actual|University of Maryland||2|||f||||t||||||||No||2017-10-11 03:51:20.294052|2017-10-11 03:51:20.294052
NCT01430676|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2011-11-30|||January 2007||2007-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|January 2011|Actual|2011-01-01||Observational|||Risk Factors for Morbidity After Incisional Hernia Repairs|Risk Factors for Morbidity After Incisional Hernia Repairs|Completed||N/A|3460|Actual|University Hospital Koge|||1||f||||f||||||||||2017-10-11 03:51:20.394339|2017-10-11 03:51:20.394339
NCT01430663|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-05-23|||April 2007||2007-04-01|May 2016|2016-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples|Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples|Completed||N/A|87|Actual|Heidelberg University|||2||f||||f||||||||||2017-10-11 03:51:20.477129|2017-10-11 03:51:20.477129
NCT01430650|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-09-19|||July 2010||2010-07-01|September 2017|2017-09-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|||Endometrial Priming for Embryo Transfer|A Randomised Control Trial to Evaluate Efficacy and Safety of Two Different Protocols of Endometrial Priming for Embryo Transfer.|Completed||Phase 4|140|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 03:51:20.56377|2017-10-11 03:51:20.56377
NCT01430637|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-05-17|||September 2011||2011-09-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1|Comprehensive Genome Sequencing of Desmoplastic Small Round Cell Tumors|Completed||N/A|20|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:51:20.632837|2017-10-11 03:51:20.632837
NCT01430624|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-03-14|2015-11-02||May 2009||2009-05-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Prevention of Post Sexual Assault Stress|Prevention of Postrape Drug Abuse: Replication Study|Completed||Phase 1/Phase 2|245|Actual|Medical University of South Carolina||3|||f||||f||||||||||2017-10-11 03:51:20.72626|2017-10-11 03:51:20.72626
NCT01430611|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-04-09|2014-02-28||August 2011||2011-08-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children|Safety and Immunogenicity of Sanofi Pasteur Meningococcal (Groups A and C) Polysaccharide Vaccine Versus Lanzhou Institute for Biological Products Meningococcal (Groups A and C) Polysaccharide Vaccine in Children 2-6 Years of Age in China|Completed||Phase 4|666|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 03:51:21.567084|2017-10-11 03:51:21.567084
NCT01430598|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-09-07|||August 2011||2011-08-01|September 2011|2011-09-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Study Comparing Patient Function and Satisfaction With Arthroscopic Subacromial Decompression Before and After Repair of Complete Rotator Cuff Tears|Randomized Single Blinded Study Comparing Patient Function and Satisfaction With Arthroscopic Subacromial Decompression Before and After Repair of Complete Rotator Cuff Tears|Unknown status|Recruiting|N/A|100|Anticipated|Genesys Regional Medical Center||2|||f||||f||||||||||2017-10-11 03:51:22.157815|2017-10-11 03:51:22.157815
NCT01430585|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2014-07-18|2014-07-18||March 2012||2012-03-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer|An Open-Label, Randomised Phase 1b/2 Study Of PF-04691502 In Combination With Letrozole Compared With Letrozole Alone In Patients With Estrogen Receptor Positive, Her-2 Negative Early Breast Cancer|Terminated||Phase 2|14|Actual|Pfizer|Study was prematurely terminated due to PF-04691502 tolerability findings that prompted Sponsor to re-evaluate strategic goals of program. Unexpected frequency of severe skin toxicity was observed and no participant was enrolled in phase 2 of study.|3||See termination reason in detailed description.|f||||f||||||||||2017-10-11 03:51:22.286347|2017-10-11 03:51:22.286347
NCT01430572|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-02-08|||October 2011|Actual|2011-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients|Phase I Combination of Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients With Advanced Solid Tumors Refractory to Standard Therapy|Active, not recruiting||Phase 1|62|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:51:22.940973|2017-10-11 03:51:22.940973
NCT01430559|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2013-06-24|||October 2011||2011-10-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee|A Double-Blind Placebo-Controlled Multicentre Parallel Group Study Of The Effect Of Meloxicam In Mainland Chinese Patients With Osteoarthritis Of The Knee|Completed||N/A|353|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:51:23.051963|2017-10-11 03:51:23.051963
NCT01430546|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2016-03-24|||November 2010||2010-11-01|March 2016|2016-03-01||||January 2016|Actual|2016-01-01||Observational|||Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line|Phase IV Study on QoL in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide|Completed||N/A|133|Actual|Karolinska University Hospital|||1||f||||t||||||||||2017-10-11 03:51:23.210508|2017-10-11 03:51:23.210508
NCT01430533|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-02-27|||September 2011||2011-09-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation|A Randomized, Double-blind, Vehicle Controlled Phase 1 Dermal Safety Study to Evaluate the Sensitizing Potential of Topically Applied Azelaic Acid Pre-foam Formulation in Healthy Subjects Using a Human Repeated Insult Patch Test Design|Completed||Phase 1|240|Actual|Bayer||3|||f||||||||||||||2017-10-11 03:51:23.272756|2017-10-11 03:51:23.272756
NCT01430520|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2013-06-04|||September 2011||2011-09-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA)|Analgesic Effect of Perioperative Escitalopram for Patients With High Preoperative Level of Pain Catastrophising in Total Knee Arthroplasty|Completed||Phase 4|120|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 03:51:23.368646|2017-10-11 03:51:23.368646
NCT01430507|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2012-12-27|||September 2011||2011-09-01|August 2012|2012-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|TERRA||A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis|A Phase IIb, 12 Week Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate Efficacy, Safety and Tolerability of Revamilast in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate|Completed||Phase 2|406|Actual|Glenmark Pharmaceuticals Ltd. India||4|||f||||f||||||||||2017-10-11 03:51:23.508748|2017-10-11 03:51:23.508748
NCT01429571|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-09-06|||August 2009||2009-08-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Observational|||The Role of Antibiotics After Surgical Treatment of Simple Hand Infections: A Prospective Study||Completed||N/A|90|Actual|BG Trauma Center Tuebingen|||3||f||||||||||||||2017-10-11 03:51:39.099987|2017-10-11 03:51:39.099987
NCT01430494|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2015-04-22|||June 2011||2011-06-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|OVERTURE||Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease|A Multi-center, Longitudinal, Observational Study of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) to Establish the Rate, Characteristics, and Determinants of Disease Progression|Completed||N/A|3409|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|||1||f||||f||||||||||2017-10-11 03:51:23.754891|2017-10-11 03:51:23.754891
NCT01430481|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2016-08-09|||August 2011||2011-08-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Rosehip Powder for Knee Osteoarthritis|Comparing Different Preparations and Dosages of Rosehip Powder in Patients With Painful Osteoarthritis of the Knee: An Exploratory Randomised Controlled Trial|Completed||Phase 2|150|Actual|Frederiksberg University Hospital||3|||f||||f||||||||||2017-10-11 03:51:24.455261|2017-10-11 03:51:24.455261
NCT01430468|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-01-18|2017-01-18||September 2010||2010-09-01|January 2017|2017-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|TIOSO - GPS||Patient Specific Instruments Versus Standard Surgical Instruments|Comparison of Glenoid Component Position Using Patient Specific Instruments Versus Standard Surgical Instruments: A Randomized Prospective Clinical Trial|Completed||N/A|34|Actual|The Cleveland Clinic||2|||f||||f||||||||No|There is no plan to share IPD with other researchers.|2017-10-11 03:51:24.549279|2017-10-11 03:51:24.549279
NCT01430442|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-07|2015-09-23||2015-09-23|October 2011||2011-10-01|September 2015|2015-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Dose Ranging Study of a Drug for the Treatment of Acute Migraine|Phase IIb: Double-Blind, Randomized, Placebo Controlled, Dose-ranging Trial of BMS-927711 for the Acute Treatment of Migraine|Completed||Phase 2|885|Actual|Bristol-Myers Squibb||8|||f||||f||||||||||2017-10-11 03:51:24.879205|2017-10-11 03:51:24.879205
NCT01430429|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2014-04-03||||||June 2012|2012-06-01||||||||Interventional|PIANO||Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody|An Open Label Single Arm Study to Investigate the Safety and Efficacy of Multiple Administrations of NI-0801, a Fully Human Anti-CXCL10 Monoclonal Antibody in PBC Patients With an Incomplete Response to Ursodeoxycholic Acid|Terminated||Phase 2|||NovImmune SA||1|||f||||f||||||||||2017-10-11 03:51:25.062681|2017-10-11 03:51:25.062681
NCT01430416|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-05-09|||December 20, 2011|Actual|2011-12-20|May 2017|2017-05-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Interventional|||Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients|A Phase 1 Study of AEB071, an Oral Protein Kinase C Inhibitor, in Patients With Metastatic Uveal Melanoma|Active, not recruiting||Phase 1|153|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:51:25.134294|2017-10-11 03:51:25.134294
NCT01430403|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-05-25|2015-08-14||September 2011||2011-09-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|PROSE|Intent-to-treat|Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations|Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)|Completed||Phase 4|478|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 03:51:25.244528|2017-10-11 03:51:25.244528
NCT01430390|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-10-03|||September 2011||2011-09-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies|A Phase I Dose Escalation Trial Using In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies|Recruiting||Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:51:27.961601|2017-10-11 03:51:27.961601
NCT01430377|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-03|2011-09-07|||August 2011||2011-08-01|September 2011|2011-09-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Interventional|SBPS||Side Branch Predilatation Strategy in Coronary Bifurcation Lesion Stenting (SBPS)|Side Branch Predilatation Strategy in Coronary Bifurcation Lesion Stenting (SBPS)|Unknown status|Recruiting|Phase 4|120|Anticipated|Medica Cor Heart Hospital||1|||f||||t||||||||||2017-10-11 03:51:28.061805|2017-10-11 03:51:28.061805
NCT01430364|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-03|2013-12-24|||September 2011||2011-09-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|BIOSS LIM||BIfurcation Optimal Treatment Strategy With LYMus Eluting Dedicated Bifurcation Versus Convention Stent Randomized Study|BIfurcation Optimal Treatment Strategy With LIMus Eluting Dedicated Bifurcation Versus Convention Stent Randomized Study|Unknown status|Recruiting|Phase 4|60|Anticipated|Medica Cor Heart Hospital||1|||f||||t||||||||||2017-10-11 03:51:28.152545|2017-10-11 03:51:28.152545
NCT01430351|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-12-19|||September 2011||2011-09-01|December 2016|2016-12-01||||September 2018|Anticipated|2018-09-01||Interventional|||Phase I Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin for Post-Radiation Therapy (RT) Glioblastoma Multiforme (GBM)|A Phase I lead-in to a 2x2x2 Factorial Trial of Dose Dense Temozolomide, Memantine, Mefloquine, and Metformin As Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme|Active, not recruiting||Phase 1|144|Anticipated|M.D. Anderson Cancer Center||7|||f||||f||||||||||2017-10-11 03:51:28.255041|2017-10-11 03:51:28.255041
NCT01430338|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2015-03-16|||December 2010||2010-12-01|September 2011|2011-09-01||||December 2011|Actual|2011-12-01||Observational|||Different Metabolic Characteristics in the Presence of Brown Adipose Tissue in Humans|Different Metabolic Characteristics in the Presence of Brown Adipose Tissue in Humans|Completed||N/A|90|Actual|Korea University|||1||f||||t||||||Samples Without DNA|"     plasma and serum   "|||2017-10-11 03:51:28.424665|2017-10-11 03:51:28.424665
NCT01430325|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2013-02-12|2013-01-03||July 2011||2011-07-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|TOP-DIVER||Test of Chamber Pressure to Divers and Chamber Attendants|"Test of Chamber Pressure to Divers and Chamber Attendants: A Blinded Trial to Investigate if Pressure-familiar Individuals Can Determine Pressure"|Completed||N/A|42|Actual|Intermountain Health Care, Inc.|Smaller sample size; enrollment was stopped at 42 participants when investigators had exhausted the planned recruitment methods. Very few inside attendants enrolled. Pressures in this study were relatively close.|4|||f||||f||||||||||2017-10-11 03:51:28.514658|2017-10-11 03:51:28.514658
NCT01430312|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-02-27|||September 2011||2011-09-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation|A Randomized, Double-blind, Vehicle-controlled Phase 1 Dermal Safety Study Using a 21 Day Cumulative Irritant Patch Test Design to Evaluate the Local Tolerability of Azelaic Acid Pre-Foam Formulation in Healthy Volunteers|Completed||Phase 1|40|Actual|Bayer||4|||f||||||||||||||2017-10-11 03:51:30.356374|2017-10-11 03:51:30.356374
NCT01430299|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-04-24|||June 2011||2011-06-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|March 2016|Actual|2016-03-01||Interventional|||Efficacy and Safety of Accell Evo3 DBM in Instrumented Posterolateral Lumbar Spine Fusion|Efficacy and Safety of Integra Accell Evo3 Demineralized Bone Matrix Instrumented Posterolateral Lumbar Spine Fusion|Completed||N/A|55|Actual|SeaSpine, Inc.||1|||f||||f||||||||||2017-10-11 03:51:30.458332|2017-10-11 03:51:30.458332
NCT01430286|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2014-07-25|||October 2011||2011-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|DIAPASON||Web-based Psycho-Educational Program to Support Carers of Alzheimer's Patients|Evaluation of a Web-based Psycho-Educational Program for Informal Caregivers of Patients With Alzheimer's Disease (AD).|Completed||N/A|49|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:51:30.534297|2017-10-11 03:51:30.534297
NCT01430273|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2015-04-02|||June 2013||2013-06-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|June 2015|Anticipated|2015-06-01||Observational|BLOOD||Assessment of Blood Loss With a Point Of Care Device|Assessment of Blood Loss With a Point Of Care Device During Hip/Knee Surgery Performed On Dual/Single Antiplatelet Therapy|Unknown status|Recruiting|N/A|200|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"     salivary kit (Oragnèe-DNA approved by FDA) or blood (2 tubes 2.5ml)   "|||2017-10-11 03:51:30.648136|2017-10-11 03:51:30.648136
NCT01430260|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2012-09-05|||January 2011||2011-01-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Omnaris Versus Levocetirizine Phase 4 Study|A Multi-center, Open, Randomized, Three-arm, Parallel-group, Phase IV Study to Compare the Efficacy of Ciclesonide Nasal Spray and Levocetirizine, Alone and in Combination for the Patient With Allergic Rhinitis|Completed||Phase 4|349|Actual|Handok Pharmaceuticals Co., Ltd.||3|||f||||t||||||||||2017-10-11 03:51:30.73896|2017-10-11 03:51:30.73896
NCT01430247|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2011-09-06|||September 2011||2011-09-01|September 2011|2011-09-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Vision Screening for the Detection of Amblyopia|Vision Screening of the Four Year Old Children for the Detection of Amblyopia in The Town of Zagreb|Unknown status|Enrolling by invitation|N/A|7000|Anticipated|General Hospital Sveti Duh||1|||f||||f||||||||||2017-10-11 03:51:30.836418|2017-10-11 03:51:30.836418
NCT01430234|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2015-03-10|||October 2011||2011-10-01|March 2015|2015-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|SAPES||Enzyme Suppletion in Exocrine Pancreatic Dysfunction|Enzyme Substitution in Exocrine Pancreatic Insufficiency; Self Administration Against a Fixed Dose Regimen|Completed||Phase 4|10|Actual|Foundation for Liver Research||1|||f||||f||||||||||2017-10-11 03:51:30.948764|2017-10-11 03:51:30.948764
NCT01430221|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2017-02-23|||May 2011||2011-05-01|February 2017|2017-02-01|February 15, 2017|Actual|2017-02-15|February 15, 2017|Actual|2017-02-15||Interventional|AWARENESS||Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes|Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes|Completed||N/A|140|Anticipated|Duke University||2|||f||||t||||||||||2017-10-11 03:51:31.045597|2017-10-11 03:51:31.045597
NCT01430208|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-07|||January 2010||2010-01-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||A New Alternative to Traditional Hysteroscopy|New Mini-resectoscope as Alternative to Traditional Hysteroscopy in the Treatment of Uterine Lesions|Completed||N/A|401|Actual|Catholic University of the Sacred Heart||3|||f||||f||||||||||2017-10-11 03:51:31.145447|2017-10-11 03:51:31.145447
NCT01430195|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2013-03-21|||June 2011||2011-06-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|CUV102||Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)|Proof of Concept Study to Compare Efficacy and Safety of Subcutaneous, Bioresorbable Afamelanotide Implants and Narrow-Band Ultraviolet B (NB-UVB) Light Versus NB-UVB Light Alone in the Treatment of Nonsegmental Vitiligo|Completed||Phase 1|56|Actual|Clinuvel Pharmaceuticals Limited||2|||f||||f||||||||||2017-10-11 03:51:31.368163|2017-10-11 03:51:31.368163
NCT01430182|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-03-03|2016-03-03||September 2011||2011-09-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Intraoperative Methadone vs Morphine for Postoperative Pain Control in Patients Undergoing Surgery of the Tibia|Intraoperative Methadone Versus Morphine for Postoperative Pain Control in Patients Undergoing Intramedullary Nailing or Open Reduction and Internal Fixation of the Tibia|Terminated||N/A|17|Actual|Baylor College of Medicine|Early termination leading to small numbers of subjects analyzed. Shortages of IV methadone prompted closure of trial.|2||Shortages of study drug, difficulty enrolling patients|f||||f||||||||No||2017-10-11 03:51:31.496996|2017-10-11 03:51:31.496996
NCT01430169|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-09-07|2015-02-04||September 2011||2011-09-01|September 2017|2017-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease|A Phase 2, Open-Label Study to Assess the Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease|Completed||Phase 2|20|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-10-11 03:51:31.900754|2017-10-11 03:51:31.900754
NCT01430156|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-05-26|||January 2012||2012-01-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|HOT||Induction of HO-1; a Therapeutic Approach to Reduce Ischaemia Reperfusion Injury (IRI) Following Deceased Donor Renal Transplantation|A Randomised Placebo-Controlled Trial to Investigate the Effect of Pre-treatment With Haem Arginate (Normosang) on Heme-Oxygenase 1 (HO-1) Upregulation in Recipients of Deceased Donor Kidneys|Completed||Phase 3|40|Actual|University of Edinburgh||2|||f||||t||||||||||2017-10-11 03:51:32.329681|2017-10-11 03:51:32.329681
NCT01430143|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-09-06|||September 2009||2009-09-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|June 2011|Actual|2011-06-01||Interventional|FINE||Physical Activity for a Long and Healthy Life|Physical Activity for a Long and Healthy Life - Project FINE|Unknown status|Active, not recruiting|N/A|64|Actual|University of Copenhagen||3|||f||||f||||||||||2017-10-11 03:51:32.438978|2017-10-11 03:51:32.438978
NCT00005469|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1990||1990-09-01|May 2000|2000-05-01|November 1996|Actual|1996-11-01|||||Observational|||Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.785293|2017-10-11 04:27:05.785293
NCT01430130|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-11-21|2014-11-10||September 2011||2011-09-01|November 2014|2014-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|IMPROVE|After meeting all eligibility criteria, 12 patients were enrolled.|Investigation of a Novel Silicone Dressing to Maximize the Outcomes of Scar Revision Procedures (IMPROVE)|Investigation of a Novel Mechanomodulating Polymer to Maximize the Outcomes of Scar Revision Procedures|Completed||N/A|12|Actual|Neodyne Biosciences, Inc.|"The Neodyne Dressing is referred to as the embrace device."|1|||f||||f||||||||||2017-10-11 03:51:32.564858|2017-10-11 03:51:32.564858
NCT01430117|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2012-08-20|||October 2011||2011-10-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Biological Standardization of Poa Pratensis Allergen Extract|Biological Standardization of Poa Pratensis Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units|Completed||Phase 2|31|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 03:51:32.798042|2017-10-11 03:51:32.798042
NCT01430104|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2013-01-07|2012-11-27||August 2011||2011-08-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of Teriparatide in Japanese Osteoporosis Patients|A Study to Assess the Effects on Serum Calcium When Teriparatide is Used With Active Vitamin D in Osteoporosis Patients|Completed||Phase 4|30|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 03:51:32.905958|2017-10-11 03:51:32.905958
NCT01430091|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2012-10-05|2012-10-05||September 2011||2011-09-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet|Relative Bioavailability of a Prasugrel Paediatric Orally Disintegrating Tablet Formulation Compared to the Tablet in Healthy Adult Subjects|Completed||Phase 1|18|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 03:51:33.545676|2017-10-11 03:51:33.545676
NCT01430078|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-09-06|||September 2010||2010-09-01|September 2011|2011-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Study to Assess the Bioavailability of ASP015K|A Phase 1, Open-Label, 4-Way Crossover Regional Drug Absorption Study to Assess the Bioavailability of ASP015K in Healthy Subjects|Completed||Phase 1|12|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 03:51:33.935297|2017-10-11 03:51:33.935297
NCT01430065|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-09-06|||June 2009||2009-06-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers|A Phase 1, Open Label, Single Sequence, Drug Interaction Study of the Pharmacokinetics of ASP015K and Tacrolimus After Separate and Concomitant Administration to Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:51:34.023209|2017-10-11 03:51:34.023209
NCT01430052|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2015-04-20|||April 2009||2009-04-01|April 2015|2015-04-01|September 2015|Anticipated|2015-09-01|December 2012|Actual|2012-12-01||Interventional|||Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer|Randomized Phase II Study Comparing Gemcitabine/S-1 Combination Chemoradiotherapy With Gemcitabine/S-1 Combination Chemotherapy for Unresectable Locally Advanced Pancreatic Cancer.|Unknown status|Active, not recruiting|Phase 2|110|Actual|Osaka Medical Center for Cancer and Cardiovascular Diseases||2|||f||||t||||||||||2017-10-11 03:51:34.132119|2017-10-11 03:51:34.132119
NCT01430039|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2015-04-07|||October 2011||2011-10-01|March 2012|2012-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|syndecan1||Syndecan-1 a Surrogate Marker for IBD|Syndecan-1 as a Surrogate Marker for Inflammatory Bowel Disease|Completed||N/A|42|Actual|Meir Medical Center|||2||f||||f||||||None Retained|"     Venous blood sample for syndecan-1 levels, blood count, CRP levels,serum albumin and total     protein   "|||2017-10-11 03:51:34.24004|2017-10-11 03:51:34.24004
NCT01430026|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2015-09-17|||March 2011||2011-03-01|September 2015|2015-09-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Observational|||Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis|Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis|Completed||N/A|40|Actual|Mahidol University|||1||f||||f||||||||||2017-10-11 03:51:34.34557|2017-10-11 03:51:34.34557
NCT01430013|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-11-02|||June 2011||2011-06-01|September 2011|2011-09-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Trial of Endostar Combined With CHOPT for T Cell Lymphoma|Phase II Trial of Endostar Combined With CHOPT for T Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Tianjin Medical University Cancer Institute and Hospital||1|||f||||t||||||||||2017-10-11 03:51:34.44337|2017-10-11 03:51:34.44337
NCT01430000|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2014-04-16||||||April 2014|2014-04-01||||||||Interventional|||Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump|Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump|Withdrawn||Phase 1/Phase 2|0|Actual|Medgenics Medical Israel Ltd.||1|||f||||t||||||||||2017-10-11 03:51:34.533599|2017-10-11 03:51:34.533599
NCT01429987|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2016-04-26||2016-04-26|October 2011||2011-10-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Plecanatide Chronic Idiopathic Constipation (CIC) Study|Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation|Completed||Phase 2/Phase 3|951|Actual|Synergy Pharmaceuticals Inc.||4|||f||||f||||||||||2017-10-11 03:51:34.629063|2017-10-11 03:51:34.629063
NCT01429974|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-05-24|||September 2011||2011-09-01|May 2017|2017-05-01|July 7, 2015|Actual|2015-07-07|July 7, 2015|Actual|2015-07-07||Observational|||Detection of Meconium in Amniotic Fluid in Post Term Pregnancies|Detection of Meconium in Amniotic Fluid in Post Term Pregnancies|Terminated||N/A|27|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 03:51:34.995662|2017-10-11 03:51:34.995662
NCT01429961|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2011-09-06|||May 2011||2011-05-01|September 2011|2011-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma|Phase II Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|38|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 03:51:35.107171|2017-10-11 03:51:35.107171
NCT01429948|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2011-09-06|||April 2008||2008-04-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Observational|ICONS||Identification the Cause of Silent Cerebral infarctiON in Healthy Subjects (ICONS)|Novel Biomarkers for Personalized Therapy in Korean Patients With Ischemic Stroke|Completed||N/A|581|Actual|Samsung Medical Center|||3||f||||t||||||||||2017-10-11 03:51:35.200234|2017-10-11 03:51:35.200234
NCT01429909|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-06-16|||February 2011||2011-02-01|June 2016|2016-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|2010-A01115-34||Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's Disease|Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's Disease: T2* Measurement in the Cortex and the Basal Ganglia|Completed||N/A|19|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 03:51:35.397492|2017-10-11 03:51:35.397492
NCT01429896|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2015-01-13|||October 2012||2012-10-01|January 2015|2015-01-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Interventional|Ex-Factor||The Effect of Extrinsic Factors on Food Allergy|The Effect of Extrinsic Factors on Food Allergy|Unknown status|Recruiting|Phase 2|100|Anticipated|Cambridge University Hospitals NHS Foundation Trust||6|||f||||t||||||||||2017-10-11 03:51:35.476026|2017-10-11 03:51:35.476026
NCT01429883|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2015-06-02|||July 2011||2011-07-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?|Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?|Completed||Phase 4|36|Actual|University of Zurich|||1||f||||t||||||||||2017-10-11 03:51:35.589627|2017-10-11 03:51:35.589627
NCT01429870|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-12-09|||August 2011||2011-08-01|December 2015|2015-12-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|DIPSO||Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis|A Phase IV, Randomized, Double Blind, Placebo Controlled, Single-center Study of the Impact of Topical Steroids on Narrow Band UVB (Ultraviolet B) and Dithranol Combination Treatment of Psoriasis (DIPSO)|Suspended||Phase 4|88|Anticipated|University of Zurich||2||Lack of recruitment|f||||f||||||||||2017-10-11 03:51:35.64826|2017-10-11 03:51:35.64826
NCT01429857|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-01|2013-06-13|||June 2010||2010-06-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure|Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure|Completed||N/A|304|Actual|University Hospital, Saarland|||1||f||||f||||||||||2017-10-11 03:51:35.723679|2017-10-11 03:51:35.723679
NCT01429844|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2011-09-06|||January 2001||2001-01-01|September 2011|2011-09-01|August 2010|Actual|2010-08-01|October 2007|Actual|2007-10-01||Interventional|EAILTX||Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation|Randomized, Open-label, Multi-Center Study Comparing Tacrolimus With Cyclosporin, Both Arms in Combination With Mycophenolate Mofetil and Corticosteroids for Prevention of Bronchiolitis Obliterans Syndrome in Lung Transplant Patients|Completed||Phase 3|274|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 03:51:35.795464|2017-10-11 03:51:35.795464
NCT01429831|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2014-05-19|||September 2011||2011-09-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Aripiprazole for the Augmentation of Antidepressant Therapy|Aripiprazole for the Augmentation of Antidepressant Therapy: An Observational, Outpatients Study in Inadequate Responders Diagnosed With Major Depressive Disorder|Completed||Phase 4|300|Actual|Taiwan Otsuka Pharm. Co., Ltd||1|||f||||||||||||||2017-10-11 03:51:36.063498|2017-10-11 03:51:36.063498
NCT01429818|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2011-09-06|||July 2007||2007-07-01|September 2011|2011-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients|Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients. Positron Emission Tomography Assessment(PET)|Completed||Phase 4|16|Actual|Laboratorios Silanes S.A. de C.V.||2|||f||||f||||||||||2017-10-11 03:51:36.141768|2017-10-11 03:51:36.141768
NCT01429805|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2012-06-19|||September 2011||2011-09-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|BAHA-I||Balloon Assisted Hip Arthroscopy - Clinical Evaluation of a New Tool for Hip Arthroscopy|Balloon Assisted Hip Arthroscopy - Clinical Evaluation of a New Tool for Hip Arthroscopy|Completed||N/A|30|Actual|Pivot Medical Inc.||1|||f||||f||||||||||2017-10-11 03:51:36.231601|2017-10-11 03:51:36.231601
NCT01429779|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2014-04-10|||July 2012||2012-07-01|April 2014|2014-04-01||||October 2014|Anticipated|2014-10-01||Interventional|||The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme|The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme, a Randomised Controlled Trial|Unknown status|Recruiting|Phase 4|80|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 03:51:36.491995|2017-10-11 03:51:36.491995
NCT01429753|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2011-09-06|||October 2011||2011-10-01|September 2011|2011-09-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||PRISM Cardiac Resynchronisation Therapy (CRT) Randomised Controlled Trial|A Prospective Randomised Study of Advanced Imaging Guided Cardiac Resynchronisation Therapy (CRT) vs Conventional CRT Implantation in Patients With Chronic Heart Failure|Unknown status|Not yet recruiting|Phase 2/Phase 3|270|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:51:36.67603|2017-10-11 03:51:36.67603
NCT01429740|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2012-04-10|||August 2011||2011-08-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults|A Phase 1, Placebo-Controlled, Randomized, Subject- And Investigator-Blind, Sponsor-Open, Crossover Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-05180999 After First-Time Administration Of Single Ascending Doses To Healthy Adult Subjects|Completed||Phase 1|29|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:51:36.769307|2017-10-11 03:51:36.769307
NCT01429727|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-03-21|||July 2011||2011-07-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Observational|SCAD||"The Virtual Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry"|"The Virtual Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry"|Recruiting||N/A|900|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:51:36.85396|2017-10-11 03:51:36.85396
NCT01429714|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2015-09-28|||March 2011||2011-03-01|July 2015|2015-07-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|IDEAL||The Ideal Deep Venous Thrombosis (DVT) Study|Individually Tailored Elastic Compression Therapy After Deep Venous Thrombosis in Relation to the Incidence of Post Thrombotic Syndrome, a Randomized Multicenter Trial|Unknown status|Active, not recruiting|N/A|847|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 03:51:36.983206|2017-10-11 03:51:36.983206
NCT01429701|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-05|2013-03-01|||May 2012||2012-05-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous|Unicentric Comparing Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol to Betamethasone + Gentamicin + Tolnaftate + Clioquinol in Acute and Sub-acute Dermatitis Eczematous|Completed||Phase 3|76|Actual|EMS||2|||f||||t||||||||||2017-10-11 03:51:37.141431|2017-10-11 03:51:37.141431
NCT01429688|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-09-06|||July 2011||2011-07-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Pharmacokinetic / Pharmacodynamic (PK/PD) Study of Multiple Doses of DP-R202 in Healthy Volunteers|A Randomized, Single-dose, 2-sequence, 2-period Crossover Study to Investigate the Food-effect Pharmacokinetics of Sarpogrelate HCl Controlled Release Tablet in Healthy Male Subjects|Completed||Phase 1|36|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-11 03:51:37.243903|2017-10-11 03:51:37.243903
NCT01429675|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-10-31|||August 2011||2011-08-01|September 2011|2011-09-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers|Randomized, Open-label Crossover Study to Evaluate Comparative Pharmacokinetics of Ibandronate Between DP-R206(150mg Ibandronate / 24,000 IU Vitamin D3 Complex Tablet) and a 150mg Ibandronate Tablet in Healthy Adult Volunteers|Completed||Phase 1|105|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-11 03:51:37.342564|2017-10-11 03:51:37.342564
NCT01429662|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-03|2012-05-27|||August 2011||2011-08-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Modified Relaxation (MR) Technique for Treating Hypertension in Postmenopausal Women|Phase 3 Study of Modified Relaxation (MR) Technique for Treating Hypertension in Postmenopausal Women|Completed||Phase 3|429|Actual|Chiang Mai University||2|||f||||t||||||||||2017-10-11 03:51:37.434408|2017-10-11 03:51:37.434408
NCT01429649|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-03|2011-09-06|||September 2011||2011-09-01|September 2011|2011-09-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|pGGO||Study of Ablation for the Pulmonary Focal Pure Ground Glass Opacity (pGGO)|A Prospective Study of Ablation of Pulmonary Focal Pure Ground Glass Opacity|Unknown status|Recruiting|Phase 3|100|Anticipated|Dongfang Hospital Affiliated to Beijing University of Chinese Medicine||2|||f||||t||||||||||2017-10-11 03:51:37.537439|2017-10-11 03:51:37.537439
NCT01429636|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-12-28|||August 2011||2011-08-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Applied Relaxation (AR) Technique Versus Its Modified Version for Treating Menopausal Symptoms|Phase 3 Study of Applied Relaxation (AR) Technique That Treating Menopausal Symptoms|Completed||Phase 3|60|Actual|Chiang Mai University||2|||f||||t||||||||||2017-10-11 03:51:37.622226|2017-10-11 03:51:37.622226
NCT01429623|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-03|2017-06-14|2017-01-31||February 2012||2012-02-01|June 2017|2017-06-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional||103 were randomized to ladostigil, however 1 subject withdrew consent before first dose.|A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment|A 36-month, Multi-centre, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment (MCI)|Completed||Phase 2|210|Actual|Avraham Pharmaceuticals Ltd||2|||f||||t||||||||||2017-10-11 03:51:37.765087|2017-10-11 03:51:37.765087
NCT01429610|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-07-18|||November 2011||2011-11-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|RADICAL||Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic Leukemia|Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 2|78|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:51:38.598634|2017-10-11 03:51:38.598634
NCT01429597|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-06|2017-06-12|||August 2011||2011-08-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Observational|FaCard||Fabry and Cardiomyopathy (FaCard) Epidemiological Study for the Analysis of Biomarkers and the Clinical Course of Patients With Fabry Disease and the N215S-mutation|Fabry and Cardiomyopathy (FaCard) Epidemiological Study for the Analysis of Biomarkers and the Clinical Course of Patients With Fabry Disease and the N215S-mutation AN INTERNATIONAL,MULTICENTER, EPIDEMIOLOGICAL STUDY|Recruiting||N/A|40|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     The laboratory examinations of the blood samples for measuring the lyso-Gb3-level will be     done at the Laboratory of the Albrecht-Kossel-Institute, University of Rostock in     collaboration with associated diagnostic laboratory partners. This laboratory offers an     existing infrastructure, a highly standardized quality of the workflow, a short examination     time of the samples and a long period of experiences in the assessment of the biological     impact of mutations and polymorphism, as evidenced recently in the sifap1-study.   "|Undecided||2017-10-11 03:51:38.745674|2017-10-11 03:51:38.745674
NCT01429584|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-27|2013-12-09|2012-06-16||May 2008||2008-05-01|December 2013|2013-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function|Investigation Into the Effect of 0.25% Bupivacaine for Interscalene Peripheral Nerve Block vs 0.125% Bupivacaine on Pulmonary Function|Completed||N/A|30|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 03:51:38.839233|2017-10-11 03:51:38.839233
NCT01429558|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2013-04-23|||August 2011||2011-08-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Observational|||Electrophysiological Recording for Patients Receiving Deep Brain Stimulation Electrode for Treatment-resistant Obsessive-compulsive Disorder||Completed||N/A|2|Actual|University of Arizona|||1||f||||f||||||||||2017-10-11 03:51:39.177503|2017-10-11 03:51:39.177503
NCT01429545|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-09-06|||April 2007||2007-04-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||Single Versus Combination Therapy in Acute Tocolysis|Phase 2 Study of Clinical Utility of Combination Tocolysis in Preterm Labor|Completed||Phase 2|110|Actual|Tawam Hospital||2|||f||||t||||||||||2017-10-11 03:51:39.243311|2017-10-11 03:51:39.243311
NCT01429532|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2014-06-06|2012-12-25||July 2010||2010-07-01|June 2014|2014-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Outcomes of 3 Incision-size-dependent Phacoemulsification Systems|Clinical Evaluation of Three Incision-size-dependent Phacoemulsification Systems|Completed||N/A|120|Actual|Sun Yat-sen University|||3||f||||t||||||||||2017-10-11 03:51:39.49448|2017-10-11 03:51:39.49448
NCT01429519|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2016-12-05|||December 2011||2011-12-01|October 2012|2012-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds|A PRELIMINARY OPEN CLINICAL STUDY, TO ASSESS THE SAFETY AND EFFICACY OF RPh201 APPLIED TOPICALLY FOR THE TREATMENT OF HARD TO HEAL CHRONIC ULCERATED WOUNDS|Terminated||Phase 1/Phase 2|15|Anticipated|Regenera Pharma Ltd||1||Due to slow recruitment|f||||f||||||||||2017-10-11 03:51:39.943699|2017-10-11 03:51:39.943699
NCT01429506|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2015-10-23|||January 2011||2011-01-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes|Effect of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes|Completed||N/A|30|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||t||||||||||2017-10-11 03:51:40.07173|2017-10-11 03:51:40.07173
NCT01429493|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-06-02|||February 2013||2013-02-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases|Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases: a Randomized Phase II/III Trial|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-10-11 03:51:40.209951|2017-10-11 03:51:40.209951
NCT01429480|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2011-09-06|||August 2011||2011-08-01|September 2011|2011-09-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|TAP||Comparison of TAP (Transversus Abdominis Plane) and Ilioinguinal/Iliohypogastric Nerve Block for Analgesia of Open Inguinal Herniorrhaphy|Comparison Between Two Ultrasound-guided Blocks (Transversus Abdominis Plane and Ilioinguinal/Iliohypogastric Nerve Blocks) for Pain Relief After Open Inguinal Herniorrhaphy|Unknown status|Recruiting|N/A|90|Anticipated|Hillel Yaffe Medical Center||3|||f||||t||||||||||2017-10-11 03:51:40.345528|2017-10-11 03:51:40.345528
NCT01429467|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-05-27|||August 2012||2012-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|February 2014|Actual|2014-02-01||Interventional|INDIGO 2||Glucose Variability in Type 1 Diabetes and Its Effect on Factors That Influence New Vessel Formation|Improving Glucose Variability in Type 1 Diabetes and Its Effect on the Underlying Homeostatic Metabolic Pathways of Angiogenesis|Completed||N/A|35|Actual|University of Dundee||1|||f||||t||||||||||2017-10-11 03:51:40.473108|2017-10-11 03:51:40.473108
NCT01429454|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2015-11-30|||August 2011||2011-08-01|November 2015|2015-11-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||NAPLS Omega-3 Fatty Acid Versus Placebo Study|Randomized Double-Blind Trial of Omega 3 Fatty Acid Versus Placebo in Individuals at Risk for Psychosis|Active, not recruiting||Phase 1|128|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-10-11 03:51:40.571871|2017-10-11 03:51:40.571871
NCT01429441|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-02-18|2015-10-29||October 2011||2011-10-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|OASIS|Safety Set: The Safety Set consists of all subjects who received treatment.|Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole|A Randomized, Sham-controlled, Double-masked, Multicenter Study Evaluating Ocriplasmin Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole|Completed||Phase 3|220|Actual|ThromboGenics||2|||f||||t||||||||||2017-10-11 03:51:40.735908|2017-10-11 03:51:40.735908
NCT01429428|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2011-09-04|||July 2011||2011-07-01|September 2011|2011-09-01|March 2012|Anticipated|2012-03-01|November 2011|Anticipated|2011-11-01||Interventional|||Far-IR Emitted by Compression Stockings for Cellulitis Treatment|Randomized and Controlled Study About Efficacy and Safety of Far-Infra Red Radiation Emitted by Compression Stockings for Cellulitis Treatment|Unknown status|Active, not recruiting|N/A|30|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 03:51:41.546509|2017-10-11 03:51:41.546509
NCT01429415|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-11-19|||September 2011||2011-09-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MAGNUMPA||Magnesium Nebulization Utilization in Management of Pediatric Asthma|Magnesium Nebulization Utilization in Management of Pediatric Asthma|Recruiting||Phase 2|816|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 03:51:41.64717|2017-10-11 03:51:41.64717
NCT01429402|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-04|2011-09-06|||July 2000||2000-07-01|August 2011|2011-08-01|August 2013|Anticipated|2013-08-01|August 2010|Actual|2010-08-01||Interventional|||Botulinum Toxin to Improve Results in Cleft Lip Repair|Botulinum Toxin to Improve Results in Cleft Lip Repair|Unknown status|Recruiting|Phase 3|120|Anticipated|Chang Gung Memorial Hospital||4|||f||||t||||||||||2017-10-11 03:51:41.805579|2017-10-11 03:51:41.805579
NCT01429389|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-10-27|||May 2011||2011-05-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Observational|||Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy|Collection of Whole Blood Specimens From Pregnant Women at Increased Risk of Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma|Recruiting||N/A|2000|Anticipated|Sequenom, Inc.|||1||f||||f||||||Samples With DNA|"     Whole blood specimens will be collected and processed to plasma. DNA will be extracted from     the plasma.   "|No|Samples are used for research and development of a noninvasive prenatal test. However, samples used for publications will have data shared as defined by journal.|2017-10-11 03:51:41.95091|2017-10-11 03:51:41.95091
NCT01428648|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-03-03|||August 2012||2012-08-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|||Impact of Dance Therapy on Parkinson's Disease|Impact of Dance Therapy on Parkinson's Disease|Withdrawn||N/A|0|Actual|University of Arkansas||2||Recruitment slow|f||||f||||||||||2017-10-11 03:51:54.111094|2017-10-11 03:51:54.111094
NCT01429376|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-06|||October 2009||2009-10-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||Pulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPD|1) Pulmonary Function in CHF; 2) COPD Prevalence, Underdiagnosis and Overdiagnosis in CHF Patients and Its Independent Predictors; 3) Are There Signs of Systemic Inflammation in CHF With or Without COPD?|Completed||N/A|234|Actual|Rijnstate Hospital||1|||f||||f||||||||||2017-10-11 03:51:42.100083|2017-10-11 03:51:42.100083
NCT01429363|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-12-29|||August 2011||2011-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|TDD||Targeted Disc Decompression (TDD) for Contained Herniated Lumbar Discs|Targeted Disc Decompression (TDD) for Contained Herniated Lumbar Discs. A Prospective Clinical Series|Terminated||N/A|9|Actual|Rijnstate Hospital||1|||f||||f||||||||||2017-10-11 03:51:42.18669|2017-10-11 03:51:42.18669
NCT01429350|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-11-08|||May 2012||2012-05-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|October 2016|Actual|2016-10-01||Interventional|THERAPY||Assess the Penumbra System in the Treatment of Acute Stroke|The THERAPY Trial: The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke|Active, not recruiting||Phase 4|692|Anticipated|Penumbra Inc.||2|||f||||t||||||||||2017-10-11 03:51:42.296481|2017-10-11 03:51:42.296481
NCT01429337|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-09-11|||March 7, 2011|Actual|2011-03-07|September 2017|2017-09-01|May 30, 2018|Anticipated|2018-05-30|May 30, 2018|Anticipated|2018-05-30||Interventional|||Pharmacokinetics and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function|An Open-label, Multiple Dose, Parallel Group, Phase I Study to Assess the Pharmacokinetics and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function|Recruiting||Phase 1|42|Anticipated|Novartis||4|||f||||f|t|f||||||||2017-10-11 03:51:42.415937|2017-10-11 03:51:42.415937
NCT01429324|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2012-05-18|||July 2011||2011-07-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Near Infrared Spectroscopy (NIRS)|Validation of Near Infrared Spectroscopy (NIRS) Neuro-monitoring During Deep Hypothermic Circulatory Arrest for Aortic Arch Surgery|Completed||N/A|20|Actual|Nonin Medical, Inc|||1||f||||f||||||||||2017-10-11 03:51:42.534935|2017-10-11 03:51:42.534935
NCT01429311|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-04-26|||April 2011||2011-04-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|ADRN-01||Interferon Responses in Eczema Herpeticum|Investigation of Reduced Interferon Responses in Peripheral Blood Mononuclear Cells of Participants With Atopic Dermatitis and a History of Eczema Herpeticum (ADRN-01)|Completed||N/A|84|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||f||||||Samples With DNA|"     Blood samples, RNA, serum, protein and cells will be retained.   "|||2017-10-11 03:51:42.603538|2017-10-11 03:51:42.603538
NCT01429298|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-06|||March 2010||2010-03-01|September 2011|2011-09-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Comparing Intravenous Hydromorphone to Usual Care|Randomized Clinical Trial Comparing IV Hydromorphone to Usual Care|Unknown status|Active, not recruiting|Phase 4|350|Actual|Montefiore Medical Center||2|||f||||f||||||||||2017-10-11 03:51:42.703857|2017-10-11 03:51:42.703857
NCT01429285|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-06|||July 2009||2009-07-01|September 2011|2011-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Safety and Efficacy of Intravenous Hydromorphone in Elderly Emergency Department Patients With Acute Severe Pain|Safety and Efficacy of Intravenous Hydromorphone Using Incremental Doses of 0.5 mg in Elderly ED Patients With Acute Severe Pain|Unknown status|Recruiting|Phase 4|350|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-10-11 03:51:42.78177|2017-10-11 03:51:42.78177
NCT01429259|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-03-26|2015-03-17||February 2012||2012-02-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Enrolled participants receiving at least 3 doses of meropenem as a 3 hour prolonged infusion.|Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children|An Open Label Study to Assess the Population Pharmacokinetics, Safety, and Practicality of Administering Meropenem as a Prolonged Infusion to Cystic Fibrosis Children Admitted With an Acute Pulmonary Exacerbation|Completed||Phase 4|30|Actual|Hartford Hospital||1|||f||||f||||||||||2017-10-11 03:51:42.970869|2017-10-11 03:51:42.970869
NCT01429246|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-07-27|||February 2009||2009-02-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|CSSS-Tibet||China Salt Substitute Study in Tibet|China Salt Substitute Study in Tibet: Efficacy of Salt Substitute in Reducing Blood Pressure in Hypertensive Adults|Completed||N/A|282|Actual|The George Institute for Global Health, China||2|||f||||f||||||||||2017-10-11 03:51:43.216309|2017-10-11 03:51:43.216309
NCT01429233|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-09-06|||August 2011||2011-08-01|September 2011|2011-09-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Observational|XPRES||Real Life Experience of the Use of Isomers as ALENCAL (Levamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients|Real Life Experience of the Use of Isomers as ALENCAL(Levoamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients|Unknown status|Recruiting|N/A|2000|Anticipated|Closter Pharma|||1||f||||f||||||||||2017-10-11 03:51:43.311041|2017-10-11 03:51:43.311041
NCT01429220|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2014-09-12|||August 2011||2011-08-01|September 2014|2014-09-01||||April 2014|Actual|2014-04-01||Observational|||Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming||Completed||N/A|9|Actual|Great Lakes NeuroTechnologies Inc.|||1||f||||||||||||||2017-10-11 03:51:43.374551|2017-10-11 03:51:43.374551
NCT01429207|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2012-06-28|||August 2011||2011-08-01|June 2012|2012-06-01||||||||Observational|||Capturing Parkinson's Disease Medication Side Effects During Daily Activities|Phase I Study: Monitoring Levodopa-Induced Dyskinesia Using Accelerometer & Gyroscope-based Motion Detection System|Completed||N/A|15|Actual|Great Lakes NeuroTechnologies Inc.|||1||f||||||||||||||2017-10-11 03:51:43.444003|2017-10-11 03:51:43.444003
NCT01427335|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-07-08|||October 2011||2011-10-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|OHSS||Calcium for Prevention of Ovarian Hyperstimulation Syndrome|Does Intravenous Calcium Infusion Effectively Prevent OHSS : a Randomised Controlled Trial|Completed||Phase 3|200|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 03:52:16.524688|2017-10-11 03:52:16.524688
NCT01429194|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-06-15|||April 2012||2012-04-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The ACE Follow-up Study|"Continuation of Follow-up for Patients Who Were Previously Enrolled in the Clinical Study: Open Prospective Study to Evaluate the Safety and Preliminary Effectiveness of the BaroSense ACE Stapler for the Treatment of Obesity - (Protocol 11-03)."|Completed||N/A|69|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 03:51:43.509521|2017-10-11 03:51:43.509521
NCT01429181|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-03-28|||January 2012|Actual|2012-01-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain|Pilot Study to Evaluate Efficacy, Tolerability and Safety Nonracemic Methadone HCl in Patients With Chronic Peripheral Neuropathic Pain: Double-Blind, Placebo-Controlled, Crossover Study Followed by Open-Label, Single-Arm Extension|Completed||Phase 2|37|Actual|MetaPharm, Inc.||2|||f||||f||||||||||2017-10-11 03:51:43.74698|2017-10-11 03:51:43.74698
NCT01429168|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-04-08|||October 2011||2011-10-01|April 2015|2015-04-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|RESPOND-EUROPE||A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)|The Randomized Etoricoxib Study in Patients With Osteoarthritis Not Responding to Analgesic Drugs - THE RESPOND-EUROPE STUDY|Withdrawn||Phase 4|0|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 03:51:43.828596|2017-10-11 03:51:43.828596
NCT01429155|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2014-09-16|||August 2011||2011-08-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Observational|||Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B|Post Transplant Course of Hepatitis C Patients After Living Donor Liver Transplant in Association With Interleukin 28 B|Completed||N/A|36|Actual|Henry Ford Health System|||2||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 03:51:43.936124|2017-10-11 03:51:43.936124
NCT01429142|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2016-11-12|||September 2011||2011-09-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|June 2014|Actual|2014-06-01||Interventional|AIMS||AIMS Study: Improving HIV Treatment Adherence|AIMS Study: Cost-effectiveness of a Nurse-based Intervention to Support HIV-treatment Adherence|Completed||N/A|226|Actual|Wageningen University||2|||f||||f||||||||Yes|Upon request|2017-10-11 03:51:44.061506|2017-10-11 03:51:44.061506
NCT01429129|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-10-14|||May 2012||2012-05-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Randomized Controlled Trial of Mailed Nicotine Replacement Therapy to Canadian Smokers|Randomized Controlled Trial of Mailed Nicotine Replacement Therapy to Canadian Smokers|Completed||Phase 4|1000|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 03:51:44.227057|2017-10-11 03:51:44.227057
NCT01429116|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-04-20|||October 2011||2011-10-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception|An Extension Open-Label Safety Study of a 24-month 20 mg Dose Regimen of Tasimelteon for the Treatment of Non-24-Hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception Who Have Enrolled in Other Tasimelteon Clinical Trials|Completed||Phase 3|200|Anticipated|Vanda Pharmaceuticals||1|||f||||f||||||||||2017-10-11 03:51:44.370438|2017-10-11 03:51:44.370438
NCT01429103|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-02-27|||May 2011||2011-05-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Hormones and Cognition in the Menopausal Transition|Hormones and Cognition in the Menopausal Transition|Completed||N/A|117|Actual|University of Rochester|||2||f||||f||||||Samples Without DNA|"     Subjects will have 20 mL of blood drawn by venipuncture by a trained nurse   "|||2017-10-11 03:51:44.549501|2017-10-11 03:51:44.549501
NCT01429090|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-09-02|||October 1999||1999-10-01|September 2011|2011-09-01|January 2000|Actual|2000-01-01|November 1999|Actual|1999-11-01||Interventional|||Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution||Completed||Phase 1|12|Actual|University Medicine Greifswald||2|||f||||||||||||||2017-10-11 03:51:44.635745|2017-10-11 03:51:44.635745
NCT01429077|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-11-27|2013-06-05||October 2007||2007-10-01|November 2013|2013-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Augmenting Language Therapy for Aphasia: Levodopa|Augmenting Language Therapy for Aphasia: A Randomized Double-Blind Placebo-Controlled Trial of Levodopa in Combination With Speech-Language Therapy|Completed||Phase 2/Phase 3|36|Actual|Shirley Ryan AbilityLab|"Dosage and timing of the L-dopa in relation to the behavioral treatment may not have been optimum.
Efficacy of the behavioral treatment in both arms may have overridden the enhancing effect of the l-dopa in one arm"|2|||f||||f||||||||||2017-10-11 03:51:44.756555|2017-10-11 03:51:44.756555
NCT01429064|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-01-03|2016-10-28||June 2011||2011-06-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||Safety|Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001|Safety and Tolerability of ODM-201 in Patients With Castrate Resistant Prostate Cancer: Open, Non-randomised, Uncontrolled, Multicentre, Extension Study to Study 3104001|Completed||Phase 2|76|Actual|Orion Corporation, Orion Pharma||1|||f||||t||||||||||2017-10-11 03:51:45.170917|2017-10-11 03:51:45.170917
NCT01429051|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2014-02-20|2014-01-01||August 2011||2011-08-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|NOSE-400|The safety analysis set included all participants who received at least 1 dose of INFS (including the initial test dose).|A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain|A Dose Titrated Clinical Trial With a Placebo-controlled, Double-blind, Randomised, Cross-over Phase to Demonstrate the Efficacy of 400 μg Intranasal Fentanyl (INFS) Dose Strength, and to Evaluate 12 Weeks Safety and Nasal Tolerability of All Dose Strengths Between 50 μg and 400 μg, in Cancer Patients With Breakthrough Pain.|Completed||Phase 3|46|Actual|Takeda||1|||f||||f||||||||||2017-10-11 03:51:47.095314|2017-10-11 03:51:47.095314
NCT01429038|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-01-17|||February 2012||2012-02-01|January 2013|2013-01-01|February 2017|Anticipated|2017-02-01|February 2016|Anticipated|2016-02-01||Interventional|||Mesenchymal Stem Cells After Renal or Liver Transplantation|Infusion of Third-party Mesenchymal Stem Cells After Renal or Liver Transplantation. A Phase I-II, Open-label, Clinical Study|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|University Hospital of Liege||2|||f||||f||||||||||2017-10-11 03:51:48.08151|2017-10-11 03:51:48.08151
NCT01429025|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2017-08-07|||May 2012|Actual|2012-05-01|August 2017|2017-08-01||||November 2014|Actual|2014-11-01||Interventional|||Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma|A Pilot/Feasibility Phase I Study of Bendamustine, Rituximab and Lenalidomide in Patients With Refractory/Relapsed Indolent NHL|Active, not recruiting||Phase 1|26|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 03:51:48.188218|2017-10-11 03:51:48.188218
NCT01429012|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-01-17|||October 2013||2013-10-01|January 2013|2013-01-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting|Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting. A Randomized, Double-blind, Controlled Study|Not yet recruiting||Phase 2|40|Anticipated|University Hospital of Liege||2|||f||||f||||||||||2017-10-11 03:51:49.819229|2017-10-11 03:51:49.819229
NCT01428999|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-02|||September 2011||2011-09-01|June 2011|2011-06-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora|Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora|Unknown status|Not yet recruiting|N/A|48|Anticipated|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-10-11 03:51:49.919805|2017-10-11 03:51:49.919805
NCT01428986|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2014-09-24|||November 2009||2009-11-01|September 2014|2014-09-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Observational|MVC-Bone||Safety Study of Maraviroc's Effect on Human Osteoclasts|Safety Study of Maraviroc's Effect on Human Osteoclasts|Completed||N/A|16|Actual|National Center for Global Health and Medicine, Japan|||2||f||||t||||||Samples Without DNA|"     Blood serum, blood plasma, urine   "|||2017-10-11 03:51:50.005206|2017-10-11 03:51:50.005206
NCT01428973|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-11-08|||September 2011||2011-09-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens|Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donors After Reduced-intensity Conditioning: a Phase II Randomized Study Comparing 2 GVHD Prophylaxis Regimens|Recruiting||Phase 2|200|Anticipated|University Hospital of Liege||2|||f||||f||||||||||2017-10-11 03:51:50.085569|2017-10-11 03:51:50.085569
NCT01428960|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2013-10-30|||June 2011||2011-06-01|October 2012|2012-10-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Study of Acute Effects of Sn-1 and Sn-3 Palmitic Acid-rich or Stearic Acid-rich Fats on Metabolic Markers|Acute Effects of Sn-1 and Sn-3 Palmitic Acid-rich or Stearic Acid-rich Fats on Postprandial Lipemia, Haemostatic and Inflammatory Markers, Gut Hormone Concentrations, Satiety, and Insulinemic Response in Human Volunteers|Completed||N/A|36|Actual|Malaysia Palm Oil Board||3|||f||||f||||||||||2017-10-11 03:51:50.219909|2017-10-11 03:51:50.219909
NCT01428947|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2016-02-23|||September 2011||2011-09-01|February 2016|2016-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Does Coronary Angiography Cause Cognitive Dysfunction?|Study of Cognitive Function Before and After Coronary Angiography|Completed||N/A|80|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-10-11 03:51:50.306969|2017-10-11 03:51:50.306969
NCT01428934|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-09-08|||July 2011||2011-07-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Observational|MARK||Improving Intermediate Risk Management. MARK Study|Improving Intermediate Risk Management. MARK Study|Active, not recruiting||N/A|2495|Actual|Jordi Gol i Gurina Foundation|||1||f||||t||||||Samples Without DNA|"     Blood sample: Cholesterol and triglycerides concentration, HDL cholesterol, LDL cholesterol,     Glucose concentration, glycated hemoglobin and creatinine Urine sample:urine albumin, to     calculate the albumin/creatinine index. Postprandial glucose (mg / dl) will be self-measured     by patients at home 2 hours after meals (breakfast, lunch and dinner) for one day using an     Accu-chek ® glucometer.   "|No||2017-10-11 03:51:50.386112|2017-10-11 03:51:50.386112
NCT01428921|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-10-18|||August 2011||2011-08-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Long Term Efficacy of Education Programme on Continuous Positive Airway Pressure Treatment|Long-term Efficacy of Extended Education Programme on Improving Treatment Adherence to Continuous Positive Airway Pressure in Obstructive Sleep Apnea|Completed||N/A|100|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 03:51:50.524364|2017-10-11 03:51:50.524364
NCT01428908|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2012-04-17|||September 2011||2011-09-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children|A Phase III Clinical Trial the Immunogenicity and Safety Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children.|Completed||Phase 3|2394|Actual|Jiangsu Province Centers for Disease Control and Prevention||4|||f||||f||||||||||2017-10-11 03:51:50.669886|2017-10-11 03:51:50.669886
NCT01428895|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-12-28|||March 2009||2009-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Femoral Bone Metastases|A Prospective Cohort Study of the Role of Surgery and/or Radiotherapy for Bone Metastases of the Femur at High Risk of Pathological Fracture|Recruiting||N/A|180|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:51:50.86321|2017-10-11 03:51:50.86321
NCT01428882|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-04-16|2016-03-17||June 2011||2011-06-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|MIDAPROP|Patients were similar at baseline without differences regarding age, gender, body mass index, ASA class or indication for colonoscopy.|Propofol vs. Midazolam-based Balanced Propofol for Nonanesthesiologist Moderate Sedation in Colonoscopy|Phase 4, Prospective, Randomized, Double-blinded, Placebo-controlled Study Comparing Propofol vs. Midazolam Plus Propofol for Nonanesthesiologist Targeted Moderate Sedation in Outpatient Colonoscopy|Completed||Phase 4|135|Actual|Infante, Javier Molina, M.D.|Single center study. Small sample size. Fixed and relatively high-dose midazolam (2 mg). Lack of distinction between complications related to either pain stimuli or oversedation.|2|||f||||t||||||||Yes||2017-10-11 03:51:50.970299|2017-10-11 03:51:50.970299
NCT01428869|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2011-09-08|||August 2011||2011-08-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|||||Observational|||Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer|The Effect of Combination Statin, Acetylsalicylic Acid and Dutasteride Use on Prostate Cancer - a Sub Analysis of the REDUCE Trial|Completed||N/A|8231|Actual|University Health Network, Toronto|||4||f||||f||||||Samples Without DNA|"     Specimens were retained as part of the REDUCE protocol, but no biospecimens are required for     the current protocol.   "|||2017-10-11 03:51:51.430832|2017-10-11 03:51:51.430832
NCT01428843|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-06-21|||January 2011||2011-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|FER||Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy|A Controlled, Randomised, Double-blind, Multicenter Study, Comparing Ferrisat Versus Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy|Terminated||Phase 3|60|Actual|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||2||Lack of enrollment|f||||f||||||||||2017-10-11 03:51:51.52007|2017-10-11 03:51:51.52007
NCT01428830|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2015-01-15|||January 2012||2012-01-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery|Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery|Completed||N/A|524|Actual|EngenderHealth||2|||f||||t||||||||||2017-10-11 03:51:51.674936|2017-10-11 03:51:51.674936
NCT01428817|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2012-03-23|||June 2011||2011-06-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Carbetocin at Elective Cesarean Delivery Part 2|Carbetocin at Elective Cesarean Delivery: A Dose Finding Study (Part 2)|Completed||N/A|120|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||5|||f||||f||||||||||2017-10-11 03:51:51.819315|2017-10-11 03:51:51.819315
NCT01428804|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-08-22|||June 2011||2011-06-01|August 2016|2016-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|DEPRESCO||Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression|Pilot Study of Feasibility of the Effect of Treatment With tDCS in Patients Suffering From Resistant Depression|Completed||Phase 2|24|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||No||2017-10-11 03:51:51.915359|2017-10-11 03:51:51.915359
NCT01428791|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2015-05-12|||March 2011||2011-03-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|January 2015|Actual|2015-01-01||Interventional|BRIGHTEN-Heart||Reducing Disparities in Late Life Depression and Metabolic Syndrome|BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome|Unknown status|Active, not recruiting|N/A|250|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 03:51:52.025966|2017-10-11 03:51:52.025966
NCT01428778|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-11-07|||September 2011||2011-09-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Berlin Beat of Running Study|Berlin Beat of Running Study - Frequency of Cardiac Arrhythmias & Cerebral Lesions in Marathon Runners|Completed||N/A|110|Actual|Charite University, Berlin, Germany|||1||f||||f||||||Samples Without DNA|"     Whole blood samples   "|||2017-10-11 03:51:52.128291|2017-10-11 03:51:52.128291
NCT01428765|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2014-01-21|2014-01-21||May 2011||2011-05-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||GLORIA-AF Registry Program (Phase I)|GLORIA-AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase I)|Completed||N/A|1096|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 03:51:52.231277|2017-10-11 03:51:52.231277
NCT01428752|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2011-09-08|||September 2011||2011-09-01|September 2011|2011-09-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal Cancer|Prevalence of Colorectal Adenoma in 30- to 49-year-old Asymptomatic Subjects With a First Relative History of Colorectal Cancer|Unknown status|Recruiting|N/A|1000|Anticipated|Asan Medical Center|||1||f||||t||||||Samples Without DNA|"     whole blood and serum Colorectal polyp/cancer tissue   "|||2017-10-11 03:51:52.757715|2017-10-11 03:51:52.757715
NCT01428739|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-21|2017-01-23|||December 2007||2007-12-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer|Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer|Completed||N/A|8|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 03:51:52.831241|2017-10-11 03:51:52.831241
NCT01428726|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-03-15|||June 2011||2011-06-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Phase IIa Study of NT-KO-003 for Multiple Sclerosis|A Phase IIa Multicenter Double Blind Study to Evaluate the Efficacy and Safety of Low Doses of Oral NT-KO-003 for the Treatment of Multiple Sclerosis|Completed||Phase 2|99|Anticipated|Neurotec Pharma||3|||f||||f||||||||||2017-10-11 03:51:52.899|2017-10-11 03:51:52.899
NCT01428713|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-08-08|2014-06-09||August 2011||2011-08-01|August 2016|2016-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||17 post-menarchal girls with menorrhagia or menometrorrhagia without underlying bleeding disorders, pelvic pathology, pelvic infection, thyroid abnormalities or pregnancy.|Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study|Prospective Crossover Trial of Oral Tranexamic Acid and Combined Oral Contraceptive in Adolescents With Menorrhagia - A Pilot Study|Completed||N/A|17|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 03:51:53.039326|2017-10-11 03:51:53.039326
NCT01428700|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2015-12-02|||August 2011||2011-08-01|December 2015|2015-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C|Development of Gene Expression Signatures for the Diagnosis of Liver Allograft Rejection and Recurrent Hepatitis C Disease (CTOT-07)|Completed||N/A|275|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||f||||||Samples With DNA|"     Liver tissue, whole blood, and serum specimens   "|||2017-10-11 03:51:53.334685|2017-10-11 03:51:53.334685
NCT01428687|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-08-29|||August 2011||2011-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Short Term Effects of Increasing Sleep Duration|Increasing Sleep Duration: A Novel Approach to Weight Control|Completed||Phase 2|60|Actual|The Miriam Hospital||3|||f||||f||||||||||2017-10-11 03:51:53.404399|2017-10-11 03:51:53.404399
NCT01428674|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-03-16|||February 2011||2011-02-01|March 2017|2017-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Time, Touch, Attention and the Autonomic Nervous System|The Impact of Interpersonal Mindful Compassion on Autonomic Nervous System Function|Completed||N/A|20|Actual|Wake Forest University Health Sciences||4|||f||||t||||||||||2017-10-11 03:51:53.506566|2017-10-11 03:51:53.506566
NCT01428661|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2015-06-01|2015-01-06|2013-06-12|September 2011||2011-09-01|June 2015|2015-06-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|MAGELLAN||Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder|MAGELLAN: A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Study to Investigate the Safety and Efficacy of 20 Mg Tasimelteon Versus Placebo in Adult Subjects With Major Depressive Disorder Followed by a 52-Week Open-Label Extension|Completed||Phase 2/Phase 3|507|Actual|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:51:53.59773|2017-10-11 03:51:53.59773
NCT01428635|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-06-13|||January 13, 2012|Actual|2012-01-13|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Eltrombopag for the Management of Thrombocytopenia Associated With Tyrosine Kinase Therapy in Patients With Chronic Myeloid Leukemia (CML) and Myelofibrosis (MF)|Eltrombopag for the Management of Thrombocytopenia Associated With Tyrosine Kinase Therapy in Patients With Chronic Myeloid Leukemia (CML) and Myelofibrosis (MF)|Active, not recruiting||Phase 2|23|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:51:54.193642|2017-10-11 03:51:54.193642
NCT01428622|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-11-21|||October 2011||2011-10-01|November 2011|2011-11-01||||||||Interventional|||Olodaterol Bridging Study in Asthma|Single Dose Comparison of 3 Doses of Olodaterol in Double Fixed Dose Combination With BI54903 vs. 3 Doses of Olodaterol Mono in Free Combination|Withdrawn||Phase 2|0|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-10-11 03:51:54.293144|2017-10-11 03:51:54.293144
NCT01428609|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2012-03-21|||September 2009||2009-09-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Blood Mercury Levels Following Retrograde Amalgam Surgeries|Blood Mercury Levels Following Retrograde Amalgam Surgeries|Completed||Phase 4|14|Actual|Isfahan University of Medical Sciences||1|||f||||t||||||||||2017-10-11 03:51:54.444503|2017-10-11 03:51:54.444503
NCT01428596|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-04-21|||September 2010||2010-09-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|GCHT01||Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects|A Phase I Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Replication-defective HIV-1 Vaccine (HIVAX™) in HIV-1 Infected Subjects Receiving Highly Active Antiretroviral Therapy|Recruiting||Phase 1|30|Anticipated|GeneCure Biotechnologies||3|||f||||t||||||||No||2017-10-11 03:51:54.536893|2017-10-11 03:51:54.536893
NCT01428583|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-02|2016-09-28|2016-09-28|2013-07-08|December 2010||2010-12-01|June 2016|2016-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Safety analysis set included all enrolled participants who had at least 1 dose of oxycodone HCl and naltrexone HCl extended-release capsules.|Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain|A Multicenter, 12-month, Open-label, Single-arm, Safety Study Of Oxycodone Hydrochloride And Naltrexone Hydrochloride Extended-release Capsules In Subjects With Moderate To Severe Chronic Noncancer Pain|Completed||Phase 3|395|Actual|Pfizer|Outcome measure reporting of Participants With Response to Urine Drug Test were based on qualitative point of contact results only.|1|||f||||f||||||||||2017-10-11 03:51:54.693814|2017-10-11 03:51:54.693814
NCT01428570|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2011-09-02|||August 2011||2011-08-01|September 2011|2011-09-01|October 2011|Anticipated|2011-10-01|September 2011|Anticipated|2011-09-01||Interventional|||Comparison of the Pentax AWS® With the Macintosh Laryngoscopic Intubation in Obstructive Sleep Apnea Syndrome Patients|Comparison of the Pentax AWS® With the Macintosh Laryngoscope for Tracheal Intubation in Patients With Obstructive Sleep Apnea Syndrome: a Randomized Comparative Study|Unknown status|Recruiting|Phase 4|50|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-11 03:51:55.677093|2017-10-11 03:51:55.677093
NCT01428557|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2014-03-05|||March 2011||2011-03-01|March 2014|2014-03-01|July 2014|Anticipated|2014-07-01|January 2014|Actual|2014-01-01||Observational|BREATHE||BREATHE Registry - I Brazilian Registry of Heart Failure|BREATHE Registry - I Brazilian Registry of Heart Failure|Unknown status|Active, not recruiting|N/A|1200|Anticipated|Hospital do Coracao|||1||f||||t||||||||||2017-10-11 03:51:55.771567|2017-10-11 03:51:55.771567
NCT01428544|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2015-07-13|||March 2012||2012-03-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)|Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)|Completed||N/A|5|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:51:55.84928|2017-10-11 03:51:55.84928
NCT01428531|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2015-07-13|||January 2012||2012-01-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment|Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment|Completed||N/A|200|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:51:55.9436|2017-10-11 03:51:55.9436
NCT01428518|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-04-21|||November 2011||2011-11-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Special Drug Use Investigation for LAMICTAL Bipolar|Special Drug Use Investigation for LAMICTAL Bipolar|Completed||N/A|1036|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:51:56.027416|2017-10-11 03:51:56.027416
NCT01428505|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-02-04|||July 2011||2011-07-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||[18F]PBR111 and Microglial Activation in Multiple Sclerosis|A Study to Characterize the Novel TSPO PET Radioligand [18F]PBR111 as an in Vivo Marker of Microglial Activation in Multiple Sclerosis|Terminated||Phase 2|50|Actual|GlaxoSmithKline||1||The Study was terminated because there was insufficient data to complete the study objectives|f||||f||||||||||2017-10-11 03:51:56.104227|2017-10-11 03:51:56.104227
NCT01428492|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-03-08|||December 2011||2011-12-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|PKB115125||Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma|A Phase Ib Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the Oral AKT Inhibitor GSK2110183 Administered in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma|Completed||Phase 1|90|Actual|Novartis||3|||f||||f||||||||||2017-10-11 03:51:56.212491|2017-10-11 03:51:56.212491
NCT01428479|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-07-18|||January 7, 2011|Actual|2011-01-07|July 2017|2017-07-01|April 4, 2011|Actual|2011-04-04|April 4, 2011|Actual|2011-04-04||Interventional|||Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males|Phase1 Study of GR121167- A Double Blind, Placebo Controlled, Randomized, Dose Ascending, Single and Multiple Dose Study to Investigate the Safety and Pharmacokinetics Following Intravenous Administration of GR121167 in Healthy Japanese Males-|Completed||Phase 1|18|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 03:51:56.373918|2017-10-11 03:51:56.373918
NCT01428466|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-08-02|||November 18, 2010|Actual|2010-11-18|August 2017|2017-08-01|February 15, 2011|Actual|2011-02-15|February 15, 2011|Actual|2011-02-15||Interventional|JPN P1||Japanese Phase 1 Study of GSK2585823|Dermal Safety Study of GSK2585823 (Clindamycin 1%-Benzoyl Peroxide 3% Gel) With Healthy Japanese Male and Female Subjects|Completed||Phase 1|20|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:51:56.468144|2017-10-11 03:51:56.468144
NCT01428427|ClinicalTrials.gov processed this data on October 10, 2017|2009-12-10|2012-09-27|||August 2009||2009-08-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors|A Phase IB Combination Study of MEK Inhibitor GSK1120212 With Gemcitabine in Subjects With Solid Tumors|Completed||Phase 1|32|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:51:56.895186|2017-10-11 03:51:56.895186
NCT01428414|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2012-08-21|||August 2011||2011-08-01|August 2012|2012-08-01|February 2015|Anticipated|2015-02-01|August 2014|Anticipated|2014-08-01||Interventional|||Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer|Multicenter, Randomized, Open-label Phase II Study to Compare the Efficacy and Safety of Trastuzumab and Paclitaxel Based Regimen Plus Carboplatin or Epirubicin as Neoadjuvant Therapy in HER2-positive Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 03:51:56.984233|2017-10-11 03:51:56.984233
NCT01428401|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-09-02|||January 2008||2008-01-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke||Completed||Phase 2|80|Actual|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 03:51:57.09684|2017-10-11 03:51:57.09684
NCT01428388|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2014-04-10|||September 2011||2011-09-01|April 2014|2014-04-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|CRAVE||Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion|Comparison of Anti-vascular Endothelial Growth Factors Agents in the Treatment of Macular Edema Following Retinal Vein Occlusion|Unknown status|Active, not recruiting|N/A|150|Anticipated|Barnes Retina Institute||2|||f||||t||||||||||2017-10-11 03:51:57.178751|2017-10-11 03:51:57.178751
NCT01428375|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2013-02-04|||August 2011||2011-08-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Intravenous Infusion of Paracetamol for Intrapartum Analgesia of Labor|Evaluation of Intravenous Infusion of Paracetamol as Intrapartum Analgesic in the First Stage of Labor: a Double-blind Randomized Trial|Completed||Phase 3|120|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 03:51:57.274444|2017-10-11 03:51:57.274444
NCT01428362|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2013-11-15||2013-10-23|August 2011||2011-08-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|AD-201||VI-1121 for the Treatment Alzheimer's Disease|A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Safety, Tolerability and Efficacy of VI-1121 in Subjects With Alzheimer's Disease|Completed||Phase 2|61|Actual|VIVUS, Inc.||2|||f||||f||||||||||2017-10-11 03:51:57.372481|2017-10-11 03:51:57.372481
NCT01428349|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2015-05-29|||May 2011||2011-05-01|November 2011|2011-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates|Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates|Completed||N/A|180|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 03:51:57.479695|2017-10-11 03:51:57.479695
NCT01428336|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2017-06-22|2016-11-30||September 2011||2011-09-01|June 2017|2017-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|25CST|Every participant underwent three ACTH stimulation test using a dose of 1 ug cotrosyn, 25 ug cortrosyn, 250ug cortrosyn and one Insulin tolerance test|Value of 25 mcg Cortrosyn Stimulation Test|The Value of 25 mcg Cortrosyn Stimulation Test to Assess Adult HPA Axis|Completed||N/A|22|Actual|The Cleveland Clinic|Small number of participants Cortisol Binding globulin was not measured|2|||f||||t||||||||No||2017-10-11 03:51:57.57691|2017-10-11 03:51:57.57691
NCT01428323|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-09-01|||January 2011||2011-01-01|September 2011|2011-09-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Study of the Aerosol Deposition With Vented and Unvented Jet Nebulizer in Healthy Subjets||Unknown status|Recruiting|N/A|7|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-10-11 03:51:57.969578|2017-10-11 03:51:57.969578
NCT01428310|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2015-10-29|||September 2011||2011-09-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke|A Single Center, Single-Blind, Randomized, Crossover Pilot Study to Evaluate the Safety and Effects of Anatabloc™, a Dietary Supplement, in Reducing the Urge to Smoke in Daily Smokers Followed by an Open-Label Extension|Completed||Phase 1|109|Actual|Rock Creek Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 03:51:58.034952|2017-10-11 03:51:58.034952
NCT01428297|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2015-02-02|||May 2011||2011-05-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|3||A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome|A First-In-human Study to Evaluate Safety and Tolerability of Topical BPR277 in Healthy Volunteers, and Proof of Concept (PoC) Studies to Evaluate the Safety, Tolerability, and Efficacy of Topical BPR277 in Patients With Atopic Dermatitis and Netherton Syndrome|Completed||Phase 1|12|Actual|Novartis||4|||f||||||||||||||2017-10-11 03:51:58.121852|2017-10-11 03:51:58.121852
NCT01428284|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2012-02-16|||August 2011||2011-08-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study to Assess the Effects of Multiple-Dose Probenecid on the Multiple-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers|An Open-Label, Fixed-Sequence Study to Assess the Effects of Multiple-Dose Probenecid on the Multiple-Dose Pharmacokinetics of Canagliflozin in Healthy Subjects|Completed||Phase 1|14|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 03:51:58.358739|2017-10-11 03:51:58.358739
NCT01428271|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-06-01|||August 2011||2011-08-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Comparison Between the Expected Site of Sacral Hiatus by Conventional Method and the Real Site by Ultrasonography for Caudal Block in Children||Completed||N/A|80|Actual|Yonsei University|||1||f||||f||||||||||2017-10-11 03:51:58.463085|2017-10-11 03:51:58.463085
NCT01427166|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2016-03-14|||August 2011||2011-08-01|March 2016|2016-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Non-Invasive Imaging for Cording in Breast Cancer Patients|Evaluation of Non Invasive Imaging for Assessing the Pathophysiology of Cording in Patients Treated for Breast Cancer|Completed||N/A|5|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:52:26.282553|2017-10-11 03:52:26.282553
NCT01428258|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-02-28|2016-10-11||September 2011||2011-09-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|November 2015|Actual|2015-11-01||Interventional|PKU||Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria|Phase 2 Study of Glycomacropeptide vs. Amino Acid Diet for the Management of PKU|Completed||N/A|32|Actual|University of Wisconsin, Madison|The trial was completed as planned with an adequate number of subjects and there were no limitations.|2|||f||||t||||||||No||2017-10-11 03:51:58.562989|2017-10-11 03:51:58.562989
NCT01428245|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-05-26|||January 27, 2009|Actual|2009-01-27|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 9, 2018|Anticipated|2018-01-09||Interventional|JCM026||Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition|Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Early Pubertal Girls (JCM026)|Active, not recruiting||N/A|10|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-11 03:51:59.496608|2017-10-11 03:51:59.496608
NCT01428232|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2017-04-21|||May 2012||2012-05-01|January 2017|2017-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||"Effectiveness of Well-child Clinics as the Community Basis of Step 10 of the Baby Friendly Hospital Initiative"|Comparison of Two Clinic-based Interventions to Promote Early Initiation and Exclusive Breastfeeding Through 6 Months After Birth in Kinshasa, Democratic Republic of Congo|Completed||N/A|992|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 03:51:59.60546|2017-10-11 03:51:59.60546
NCT01428219|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-08-03|2016-03-29||February 2012||2012-02-01|August 2017|2017-08-01|September 2015|Actual|2015-09-01|October 2014|Actual|2014-10-01||Interventional|||Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone|A Phase II Trial of Cabozantinib (XL184) in Patients With Castrate-Resistant Prostate Cancer Metastatic to Bone|Terminated||Phase 2|25|Actual|University of Michigan Cancer Center||1||Closed due to slowing enrollment and negative results of a phase III trial using cabozantinib.|f||||t||||||||||2017-10-11 03:51:59.758175|2017-10-11 03:51:59.758175
NCT01428206|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2013-06-13|||June 2009||2009-06-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Liverpool Care Pathway for the Dying at Residential Care Homes|Liverpool Care Pathway for the Dying at Residential Care Homes|Completed||N/A|260|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 03:52:00.212069|2017-10-11 03:52:00.212069
NCT01428180|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-04-05|||April 2011||2011-04-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|October 2012|Actual|2012-10-01||Observational|||Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants|Changes of Cerebral Tissue Oxygen Saturation During Treatment of Patent Ductus Arteriosus in Neonates|Completed||Phase 4|35|Actual|University of Ulm|||3||f||||f||||||||||2017-10-11 03:52:00.432678|2017-10-11 03:52:00.432678
NCT01428167|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-06-05|||June 2011||2011-06-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|Thyroid Cancer||Hashimotos Thyroiditis and Thyroid Cancer|Is There Any Association Between Thyroid Cancer and Hashimotos Thyroiditis?|Completed||N/A|26|Actual|The University of Texas Medical Branch, Galveston|||1||f||||f||||||Samples Without DNA|"     Plasma samples with be stored to measure anti inflammatory factors.   "|||2017-10-11 03:52:00.527314|2017-10-11 03:52:00.527314
NCT01428154|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-06-16|||April 2016||2016-04-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease|An Open-label, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Darbepoetin Alfa in Paediatric Subjects From Birth to Less Than 1 Year of Age With Anemia Due to Chronic Kidney Disease|Withdrawn||Phase 1|0|Actual|Amgen||1||"Difficulty in recruitment. PDCO in the Day 30 summary report agrred to remove the PK study in   children <1 year of age."|f||||f||||||||||2017-10-11 03:52:00.631159|2017-10-11 03:52:00.631159
NCT01428141|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2014-02-13|||September 2011||2011-09-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||A Phase I Study of E7050 in Subjects With Solid Tumors|A Phase I Study of E7050 in Subjects With Solid Tumors|Completed||Phase 1|18|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 03:52:00.744717|2017-10-11 03:52:00.744717
NCT01428128|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-09-06|2014-06-18||April 2011||2011-04-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||"Excluded: screen failures, withdrawals for any cause prior to completion of 2 chemotherapy cycles, or received Neulasta for only one cycle.
Note: The 2 patients who received Neulasta for only one cycle and were not evaluable, were included in the adverse event numbers since they received study drug. Participant number will be 35 for AE module."|Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector|A Phase II Study of Low Dose Arsenic Trioxide in Patients With Malignancies as a Potential Chemotherapy Protector|Completed||Phase 2|50|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 03:52:00.853868|2017-10-11 03:52:00.853868
NCT01428115|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2014-10-31|2014-10-02||December 2011||2011-12-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|RELAX||Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving Adalimumab|Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving Adalimumab|Completed||N/A|83|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 03:52:01.290447|2017-10-11 03:52:01.290447
NCT01428102|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-09-13|||July 2011||2011-07-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|R-TEG MA||RapidTEG MA Validation|Validation of the RapidTEG™ MA Compared to Kaolin in Trauma and Cardiac Patients.|Terminated||N/A|17|Actual|Haemonetics Corporation|||2|Terminiated for trial redesign|f||||f||||||||||2017-10-11 03:52:01.82024|2017-10-11 03:52:01.82024
NCT01428089|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-02-23|||May 2008||2008-05-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone|Suppression of Daytime and Nighttime LH Frequency by Progesterone in Early Pubertal Girls With and Without Hyperandrogenemia (JCM024)|Recruiting||Phase 1|40|Anticipated|University of Virginia||2|||f||||t|t|f||||||Undecided|We do not have current plans to share IPD|2017-10-11 03:52:01.94306|2017-10-11 03:52:01.94306
NCT01428076|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-02-19|2014-01-15||August 2011||2011-08-01|February 2015|2015-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||Safety population|Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)|An Open-Label Single-Center Study in Patients With Great Saphenous Vein Incompetence to Investigate the Pharmacokinetic Properties of Polidocanol Endovenous Microfoam (PEM)|Completed||Phase 1|21|Actual|BTG International Inc.||2|||f||||f||||||||||2017-10-11 03:52:02.07881|2017-10-11 03:52:02.07881
NCT01428063|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-04-21|2015-08-19||September 2011||2011-09-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional||All participants who received at least 1 dose of study drug|Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials|An Open-Label Re-Treatment Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C|Completed||Phase 2|276|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 03:52:02.478665|2017-10-11 03:52:02.478665
NCT01428050|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2015-03-17|||May 2011||2011-05-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||The Use of a Restrictive Fluid Regimen With Hypertonic Saline for Patients Undergoing Pancreaticoduodenectomy|Prospective Randomized Controlled Trial on the Use of a Restrictive Fluid Regimen With Hypertonic Saline for Patients Undergoing Pancreaticoduodenectomy|Unknown status|Recruiting|Phase 2|264|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 03:52:04.482315|2017-10-11 03:52:04.482315
NCT01428037|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2013-11-21|||March 2012||2012-03-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor|A Randomized,Double-blind,Placebo-controlled, Multicenter Study of the Efficacy and Safety of Vaginal Misoprostol for Cervical Ripening and Induction of Labor|Completed||Phase 3|225|Actual|Regenex Pharmaceutical, China||2|||f||||f||||||||||2017-10-11 03:52:04.595332|2017-10-11 03:52:04.595332
NCT01427998|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-09-01|||August 1999||1999-08-01|September 2011|2011-09-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Effect of Olive Leaves as Hypoglycemic Agents in Diabetic Subjects|A Phase Three Clinical Intervention Trial of Olive Leaves and Their Extracts in Human Diabetic Subjects|Completed||Phase 3|79|Actual|Wolfson Medical Center||2|||f||||t||||||||||2017-10-11 03:52:04.909977|2017-10-11 03:52:04.909977
NCT01427985|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-04-05|||June 2011||2011-06-01|April 2016|2016-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Influence of Premedication Protocols for Neonatal Endotracheal Intubation on Cerebral Oxygenation|The Influence of Two Different Premedication Protocols for Endotracheal Intubation in Neonates on Cerebral Oxygenation|Completed||Phase 4|24|Actual|University of Ulm||2|||f||||f||||||||||2017-10-11 03:52:04.99754|2017-10-11 03:52:04.99754
NCT01427959|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-10-18|||November 2015||2015-11-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|TheBrainS||Tampere Traumatic Head and Brain Injury Study|Tampere Traumatic Head and Brain Injury Study|Recruiting||N/A|100|Anticipated|Tampere University Hospital|||1||f||||f||||||Samples With DNA|"     1. 10ml whole blood        2. 10ml EDTA-blood x2   "|||2017-10-11 03:52:05.19938|2017-10-11 03:52:05.19938
NCT01427946|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-11-12|||July 2011||2011-07-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|June 2014|Actual|2014-06-01||Interventional|||Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer|A Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in Patients With KRAS Mutant NSCLC|Completed||Phase 1/Phase 2|47|Actual|Infinity Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:52:05.274677|2017-10-11 03:52:05.274677
NCT01427933|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-12-09|2014-07-29|2014-04-25|November 2011||2011-11-01|December 2016|2016-12-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional||All randomized participants|A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer|An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination With Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy|Completed||Phase 2|141|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:52:05.412595|2017-10-11 03:52:05.412595
NCT01427920|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-01-10|2013-07-03||September 2011||2011-09-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|SimpleMix™||Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes|A 20 Week Randomised, Multinational, Open Labelled, 2 Armed, Parallel Group Comparison of Twice Daily Subject Driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Versus Twice Daily Investigator-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Both in Combination With Metformin in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin Analogues|Completed||Phase 4|348|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:52:06.472541|2017-10-11 03:52:06.472541
NCT01427712|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-11-28|||December 2011||2011-12-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|Recruiting||N/A|30|Anticipated|Mylan Inc.|||1||f||||f||||||||||2017-10-11 03:52:12.552363|2017-10-11 03:52:12.552363
NCT01427907|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2015-12-11|2015-03-11||September 2011||2011-09-01|December 2015|2015-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|COS-002||Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients|Randomized,Multi-center,Phase IV, 2-arm,Open-Label,Cross-over Study to Demonstrate the Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients|Completed||Phase 4|38|Actual|Fresenius Medical Care North America|The Last Patient Last Visit (LPLV) was on 06-July-2012 and last site close out visit was 31 May 2013. Due to inadvertent study deviations, no reliable conclusions can be drawn from the study.|2|||f||||f||||||||||2017-10-11 03:52:07.015494|2017-10-11 03:52:07.015494
NCT01427894|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2016-03-15|||November 2011||2011-11-01|September 2011|2011-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Maternal Singing During Kangaroo Care in Preterm Infants|The Combined Effects of Maternal Singing During Skin to Skin Contact (Kangaroo Care) in Preterm Infants in the Neonatal Intensive Care Unit Environment.|Completed||N/A|30|Actual|Meir Medical Center||2|||f||||f||||||||||2017-10-11 03:52:07.310744|2017-10-11 03:52:07.310744
NCT01427881|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-05-17|2017-04-11||September 2011||2011-09-01|May 2017|2017-05-01|July 2015|Actual|2015-07-01|June 2014|Actual|2014-06-01||Interventional|||Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies|A Phase II Study to Evaluate the Efficacy of Posttransplant Cyclophosphamide for Prevention of Chronic Graft-versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|43|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 03:52:07.402431|2017-10-11 03:52:07.402431
NCT01427868|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-09-01|||September 2010||2010-09-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Bioequivalence of LB80380 Free Base and Maleate Salt Tablets|An Open-label, Phase I Study in Healthy Male Subjects to Compare the Pharmacokinetics of LB80331 and LB80317, Metabolites of LB80380, After a Single Oral Administration of LB80380 Free Base 150 mg (60 mg + 90 mg) Tablet or LB80380 Maleate Tablet 183 mg (150 mg as a Free Base)|Completed||Phase 1|32|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 03:52:09.172881|2017-10-11 03:52:09.172881
NCT01427855|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-02-14|||January 2012|Actual|2012-01-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|November 2016|Actual|2016-11-01||Interventional|||Dietary Protein Sources and Atherogenic Dyslipidemia|Saturated Fat and Protein Effects on Atherogenic Dyslipidemia|Active, not recruiting||N/A|113|Anticipated|Children's Hospital & Research Center Oakland||6|||f||||t||||||||||2017-10-11 03:52:09.335649|2017-10-11 03:52:09.335649
NCT01427842|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2011-09-01|||August 2011||2011-08-01|August 2011|2011-08-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|DEVINE||Dose Enhancement of Vancomycin IN Everyday Patients|A Single-centred Randomised Trial of a New Vancomycin Dosing Method Compared to Standard Care in Everyday Patients Receiving Vancomycin|Unknown status|Recruiting|Phase 2|100|Anticipated|The Canberra Hospital||1|||f||||f||||||||||2017-10-11 03:52:09.446315|2017-10-11 03:52:09.446315
NCT01427829|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-09-01|||July 2010||2010-07-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|CaPRA||Computer-assisted Psychosocial Risk Assessment (CaPRA) for Refugee Health and Settlement|Computer-assisted Psychosocial Risk Assessment (CaPRA) for Refugee Health and Settlement - Evaluation Phase|Completed||N/A|50|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 03:52:09.53498|2017-10-11 03:52:09.53498
NCT01427816|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2013-10-29||||||October 2013|2013-10-01||||||||Interventional|||A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome|A Randomized, Double Blind, Placebo Controlled, Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome|Completed||Phase 2|180||Kissei Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-10-11 03:52:09.600238|2017-10-11 03:52:09.600238
NCT01427803|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2015-09-24|2013-02-05||September 2011||2011-09-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|Kiefer AUT||Actual Use Trial of Naproxen Sodium|An Actual Use Trial In A Simulated OTC Environment of an Extended-Release Over-the-Counter NSAID|Completed||Phase 3|778|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:52:09.697555|2017-10-11 03:52:09.697555
NCT01427777|ClinicalTrials.gov processed this data on October 10, 2017|2011-09-01|2011-09-01|||September 2011||2011-09-01|September 2011|2011-09-01|June 2012|Anticipated|2012-06-01|||||Observational|||3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China|The Thirty-six-Month Immunogenicity Evaluation of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Chinese Female Subjects Aged 9 to 45 Years and Male Subjects Aged 9 to 15 Years|Unknown status|Not yet recruiting|N/A|300|Anticipated|Guangxi Center for Disease Control and Prevention|||1||f||||f||||||||||2017-10-11 03:52:10.273885|2017-10-11 03:52:10.273885
NCT01427764|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-31|||February 2009||2009-02-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Dentin Hypersensitivity Following Non-surgical Periodontal Therapy With Hand or Ultrasonic Instruments|Dentin Hypersensitivity Following Non-surgical Periodontal Therapy With Hand or Ultrasonic Instruments|Completed||N/A|14|Actual|Escola Bahiana de Medicina e Saude Publica||1|||f||||||||||||||2017-10-11 03:52:10.349735|2017-10-11 03:52:10.349735
NCT01427751|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-01-19|2015-11-03||October 2011||2011-10-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion||Completed||Phase 4|307|Actual|Allergan||2|||f||||f||||||||||2017-10-11 03:52:10.42925|2017-10-11 03:52:10.42925
NCT01427738|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-03|2015-02-12|2015-01-06||June 2011||2011-06-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|September 2012|Actual|2012-09-01||Interventional||All participants who enrolled.|Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis|A Phase III, Open-Label, Randomized, Assessment-Blinded Clinical Trial to Compare the Safety and Efficacy of Gentian Violet Oral Solution to That of Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-1 Infected Participants in Non-U.S. Settings|Completed||Phase 3|221|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 03:52:11.039782|2017-10-11 03:52:11.039782
NCT01427725|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2015-06-09|||October 2011||2011-10-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency|Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis, Pancreatectomy and Other Conditions Except Cystic Fibrosis|Completed||N/A|562|Actual|Mylan Inc.|||1||f||||||||||||||2017-10-11 03:52:11.911133|2017-10-11 03:52:11.911133
NCT01427699|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2012-10-29|||June 2011||2011-06-01|October 2012|2012-10-01||||October 2012|Actual|2012-10-01||Interventional|||A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes|A Phase II Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes|Completed||Phase 2|7|Actual|XBiotech, Inc.||1|||f||||f||||||||||2017-10-11 03:52:12.707373|2017-10-11 03:52:12.707373
NCT01427686|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-04-05|||June 2011||2011-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|February 2015|Actual|2015-02-01||Interventional|||Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates|Effect of Dobutamine as Compared to Dopamine on Cerebral Oxygenation, Mean Arterial Pressure and Cerebral Hemodynamics in Term and Preterm Neonates With Arterial Hypotension|Active, not recruiting||Phase 4|20|Anticipated|University of Ulm||2|||f||||f||||||||||2017-10-11 03:52:12.789071|2017-10-11 03:52:12.789071
NCT01427673|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-08-31|||December 2011||2011-12-01|August 2011|2011-08-01|February 2014|Anticipated|2014-02-01|December 2013|Anticipated|2013-12-01||Interventional|OS||Continuous Positive Airway Pressure Versus Noninvasive Ventilation in Patients With Overlap Syndrome|Phase III Single-blind Randomized Controlled Trial of Bipap Versus CPAP in Overlap Syndrome|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|United States Air Force||2|||f||||f||||||||||2017-10-11 03:52:12.878156|2017-10-11 03:52:12.878156
NCT01427660|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-09-08|||September 2011||2011-09-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|iDecide||iDecide.Decido: Diabetes Medication Decision Support Study|Technologically Enhanced Community Health Worker (CHW) Delivery of Personalized Diabetes Information|Completed||N/A|190|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 03:52:12.993276|2017-10-11 03:52:12.993276
NCT01427647|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2016-07-21|||June 2007||2007-06-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|May 2009|Actual|2009-05-01||Interventional|CRC||Inflammatory Response After Colorectal Cancer Surgery|Inflammatory Response Following Colorectal Cancer Surgery Depends on the Type of Anesthesia and Surgery|Completed||N/A|63|Actual|Universidad Complutense de Madrid||3|||f||||t||||||||||2017-10-11 03:52:13.091909|2017-10-11 03:52:13.091909
NCT01427634|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2013-09-05|||July 2011||2011-07-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families|Randomized Controlled Trial of Proactive Palliative Care for Patients With Ventricular Assist Devices and Their Families|Completed||N/A|18|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 03:52:13.189528|2017-10-11 03:52:13.189528
NCT01427621|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2011-08-31|||March 2010||2010-03-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|||Effect of Combined Remote Ischemic Preconditioning and Postconditioning on Acute Pulmonary Injury in Patients Undergoing Valvular Heart Surgery|Effect of Combined Remote Ischemic Preconditioning and Postconditioning on Acute Pulmonary Injury in Patients Undergoing Valvular Heart Surgery|Completed||Phase 4|54|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 03:52:13.288425|2017-10-11 03:52:13.288425
NCT01427608|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-06-08|||October 2011||2011-10-01|June 2017|2017-06-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|STOP-PD||Sustaining Remission of Psychotic Depression|Sustaining Remission of Psychotic Depression|Active, not recruiting||Phase 4|269|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-11 03:52:13.373097|2017-10-11 03:52:13.373097
NCT01427595|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-12-16|||July 2008||2008-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone|Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone in Hyperandrogenemic Adolescent Girls (JCM025)|Active, not recruiting||N/A|11|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:52:13.482885|2017-10-11 03:52:13.482885
NCT01427582|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2011-08-30||||||August 2011|2011-08-01||||||||Expanded Access|||YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access|YONDELIS(Trabectedin) Single Patient Compassionate Use / Expanded Access in Soft Tissue Sarcoma|No longer available||N/A|||University of Texas Southwestern Medical Center|||||||||||||||||||2017-10-11 03:52:13.57102|2017-10-11 03:52:13.57102
NCT01427569|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2015-12-23|||March 2012||2012-03-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers|A Randomized, Placebo-controlled, Double-blind Phase II Study to Evaluate the Efficacy of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers|Completed||Phase 2|82|Actual|Izun Pharma Ltd||2|||f||||f||||||||||2017-10-11 03:52:13.669043|2017-10-11 03:52:13.669043
NCT01427556|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-08-15|||August 2009||2009-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Observational|FL-74||The Hormonal and Behavioral Impact of Eating Breakfast|CCRC: The Hormonal and Behavioral Impact of Eating Breakfast|Completed||N/A|120|Anticipated|USDA, Western Human Nutrition Research Center|||2||f||||f||||||Samples With DNA|"     Serum and saliva samples will be retained.   "|||2017-10-11 03:52:13.752311|2017-10-11 03:52:13.752311
NCT01427543|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-05-15|||July 2011||2011-07-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The HJ MILE HIV Prevention Intervention for Post-incarcerated Men|The HJ MILE HIV Prevention Intervention for Post-incarcerated Bisexual African American Men|Completed||Phase 3|212|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 03:52:13.835979|2017-10-11 03:52:13.835979
NCT01427530|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-10-29|||August 2010||2010-08-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes|Local Field Potentials Recorded From Deep Brain Stimulating Electrodes Implanted for the Treatment of Parkinson's Disease|Completed||N/A|10|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||||2017-10-11 03:52:13.930661|2017-10-11 03:52:13.930661
NCT01427517|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-08-02|2013-05-22||July 2011||2011-07-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease|Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease|Completed||Phase 1|9|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-11 03:52:14.004343|2017-10-11 03:52:14.004343
NCT00000293|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||January 1999||1999-01-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10|Effect of Nefazodone on Relapse in Females With Cocaine Abuse|Completed||Phase 3|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.285641|2017-10-11 04:17:43.285641
NCT01427504|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2013-06-04|2012-11-16||August 2011||2011-08-01|June 2013|2013-06-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers|A Bioequivalence Study to Evaluate the Potential for Drug-drug Interactions Between Boceprevir 800mg Thrice Daily and the HIV Non-nucleoside Reverse Transcriptase Inhibitor Etravirine 200mg Twice Daily in HIV/(Hepatitis C Virus) (HCV) Negative Volunteers|Completed||N/A|26|Actual|University of Colorado, Denver|"Healthy volunteer study does not take into account other medications being prescribed to treat the co-infected population.
An interaction at the level of enzyme induction is difficult to rule out since we sampled etravirine over 12 hours."|6|||f||||f||||||||||2017-10-11 03:52:14.463515|2017-10-11 03:52:14.463515
NCT01427491|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2013-07-29|||August 2011||2011-08-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers|A Prospective, Multi-center, Randomized, Comparative Clinical Study to Compare Aquacel® Ag vs. Mepilex® Border Ag to Manage Bioburden in Leg Ulcers.|Completed||Phase 3|18|Actual|ConvaTec Inc.||2|||f||||f||||||||||2017-10-11 03:52:15.147729|2017-10-11 03:52:15.147729
NCT01427478|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2017-02-22|||September 2011||2011-09-01|February 2017|2017-02-01|September 2021|Anticipated|2021-09-01|September 2018|Anticipated|2018-09-01||Interventional|BIBW2992ORL||Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck|A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02|Recruiting||Phase 3|315|Anticipated|Centre Leon Berard||2|||f||||t||||||||||2017-10-11 03:52:15.25493|2017-10-11 03:52:15.25493
NCT01427465|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-22|2011-11-21|||September 2007||2007-09-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|Brief||Brief Integrative Alcohol Interventions for Adolescents|Brief Integrative Alcohol Interventions for Adolescents|Withdrawn||N/A|0|Actual|University of Florida||4||PI left University of Florida|f||||t||||||||||2017-10-11 03:52:15.607461|2017-10-11 03:52:15.607461
NCT01427452|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-03-14|||August 2011||2011-08-01|March 2016|2016-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|KDOC||Kidney Donor Outcomes Cohort (KDOC) Study|Kidney Donor Outcomes Cohort (KDOC) Study|Active, not recruiting||N/A|720|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-10-11 03:52:15.733942|2017-10-11 03:52:15.733942
NCT01427439|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-07-07|||February 2011||2011-02-01|July 2015|2015-07-01||||February 2015|Actual|2015-02-01||Observational|PERFORM||A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder|A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder|Completed||N/A|1455|Actual|H. Lundbeck A/S|||1||f||||f||||||||||2017-10-11 03:52:15.846267|2017-10-11 03:52:15.846267
NCT01427426|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2014-03-14|||January 2012||2012-01-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Does a Nutritional Supplement Increase Vitality, Energy and Perceived Well Being?|Does a Nutritional Supplement Increase Vitality, Energy and Perceived Well Being?|Completed||Phase 4|120|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:52:15.92139|2017-10-11 03:52:15.92139
NCT01427413|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2017-07-20|||September 2011||2011-09-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Observational|||Identification and Standardization of a Method That Would Allow the Study of the Metabolic Profile of Blastocoele Lays the Foundation to Assess Blastocyst Metabolomic Profile and Its Relation With Embryo Morphology and Embryo Implantation|Identification and Standardization of a Method That Would Allow the Study of the Metabolic Profile of Blastocoele Lays the Foundation to Assess Blastocyst Metabolomic Profile and Its Relation With Embryo Morphology and Embryo Implantation|Recruiting||N/A|100|Anticipated|Cervesi Hospital, Cattolica, Italy|||1||f||||t||||||Samples With DNA|"     blastocoele fluid   "|||2017-10-11 03:52:16.015755|2017-10-11 03:52:16.015755
NCT01427400|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2016-07-28|||October 2011||2011-10-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|Botox||The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction|The Use of Botulinum Toxin-A in Two-stage Tissue Expander/Implant Breast Reconstruction: A Prospective, Randomized, Double-Blind Placebo Controlled Trial|Recruiting||Phase 4|128|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:52:16.1043|2017-10-11 03:52:16.1043
NCT01427387|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2011-09-22|||June 2011||2011-06-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects|Phase I Study of ASP0456 - A Double-blind, Placebo-controlled, Multiple Ascending Dose Study / Investigational Study for Dose Timing Selection in Non Elderly Healthy Subjects-|Completed||Phase 1|44|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 03:52:16.222683|2017-10-11 03:52:16.222683
NCT01427374|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-05-04|||May 2011||2011-05-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients|Clinical, Biochemical and Genetic Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients (CKDCS/LUCID)|Active, not recruiting||N/A|7000|Anticipated|University of Alberta|||1||f||||f||||||Samples With DNA|"     Blood and urine will be obtained at baseline, 6 months and annually thereafter. Blood samples     will be immediately divided into multiple aliquots, from which plasma, DNA, RNA and/or cells     will be extracted and separately stored. Urine specimens will also be aliquoted to allow     future measurement of genetic and cellular material. Specimens will be labeled using unique     study identifiers to maintain confidentiality.   "|||2017-10-11 03:52:16.308852|2017-10-11 03:52:16.308852
NCT01427361|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-06|2012-09-17|||October 2009||2009-10-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|BHR||Clinical Outcome of Birmingham Hip Resurfacing (BHR) Using VISIONAIRE Femoral Alignment Guide|Prospective, Multi- Site, Clinical Study of Clinical Outcomes Following Hip Resurfacing Using VISIONAIRE Femoral Alignment Guide|Completed||N/A|25|Actual|Smith & Nephew, Inc.|||1||f||||f||||||||||2017-10-11 03:52:16.396263|2017-10-11 03:52:16.396263
NCT01427348|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2012-05-28|||September 2011||2011-09-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|||Maintaining the Head Extension by an Assistant Decreases Dental Contact|Maintaining the Head Extension by an Assistant Decreases Dental Contact Between Laryngoscope Blade and Maxillary Incisors During Direct Laryngoscopy|Completed||N/A|68|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:52:16.458666|2017-10-11 03:52:16.458666
NCT01427322|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-07-06|||September 2011||2011-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease|A Randomized Study of Lapatinib With Radiation Versus Radiation Alone in Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease|Terminated||Early Phase 1|6|Actual|Virginia Commonwealth University||2||Slow accrual|f||||t||||||||||2017-10-11 03:52:16.604273|2017-10-11 03:52:16.604273
NCT01427309|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-03-30|2014-07-08||September 2011||2011-09-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional||The Full Analysis Set (FAS) as randomized, groups the participants according to the vaccine they were randomized to receive in the study.|A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults|Efficacy Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults|Completed||Phase 4|31989|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 03:52:16.861216|2017-10-11 03:52:16.861216
NCT01427296|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-05-30|||August 2011||2011-08-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing|A Phase 4, Randomized, Active Comparator, Open-Label, Multicenter Study to Assess the Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing|Unknown status|Active, not recruiting|Phase 4|2000|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||t||||||||||2017-10-11 03:52:23.766162|2017-10-11 03:52:23.766162
NCT01427283|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2015-02-11|||August 2011||2011-08-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain|A Randomized, Double-blind, Double-dummy, Placebo-controlled, Active-controlled, Parallel-group, Multicenter Trial of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess the Analgesic Efficacy (Compared to Placebo) and the Management of Opioid-induced Constipation (Compared to Oxycodone Controlled-release Tablets (OXY)) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain and a History of Opioid-induced Constipation Who Require Around-the-clock Opioid Therapy|Completed||Phase 3|450|Actual|Purdue Pharma LP||3|||f||||f||||||||||2017-10-11 03:52:23.889906|2017-10-11 03:52:23.889906
NCT01427270|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-11-06|||August 2011||2011-08-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain|A Randomized, Double-blind, Double-dummy, Placebo-controlled, Active-controlled, Parallel-group, Multicenter Trial of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess the Analgesic Efficacy (Compared to Placebo) and the Management of Opioid-induced Constipation (Compared to Oxycodone Controlled-release Tablets (OXY)) in Opioid-experienced Subjects With Uncontrolled Moderate to Severe Chronic Low Back Pain and a History of Opioid-induced Constipation Who Require Around-the-clock Opioid Therapy|Completed||Phase 3|455|Actual|Purdue Pharma LP||3|||f||||f||||||||||2017-10-11 03:52:24.531157|2017-10-11 03:52:24.531157
NCT01427257|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2012-09-28|||February 2012||2012-02-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus|Phase 1 Open-Label Two-Way Cross Over Study to Assess the Pharmacokinetic Profile of Two Formulations of PB1023 Injection Following a Single Dose Administered By Subcutaneous Injection in Adult Subjects With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 1|10|Actual|PhaseBio Pharmaceuticals Inc.||3|||f||||t||||||||||2017-10-11 03:52:25.591389|2017-10-11 03:52:25.591389
NCT01427244|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2014-06-12|||August 2011||2011-08-01|June 2014|2014-06-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Evaluation of Trastuzumab In Patients With HER2 Positive Persistent Or Recurrent Vulvar Paget's Disease|A Phase II Evaluation of Trastuzumab In Patients With HER2 Positive Persistent Or Recurrent Vulvar Paget's Disease|Withdrawn||Phase 2|0|Actual|Yale University||1|||f||||t||||||||||2017-10-11 03:52:25.668322|2017-10-11 03:52:25.668322
NCT01427231|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2012-03-20|||August 2011||2011-08-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Short-term Effect of Glucose and Sacharose Ingestion on Cognitive Performance and Mood in Elderly|The Short-term Effect of Glucose and Sacharose Ingestion on Cognitive Performance and Mood in Elderly Subjects|Completed||N/A|43|Actual|Wageningen University||3|||f||||||||||||||2017-10-11 03:52:25.747635|2017-10-11 03:52:25.747635
NCT01427218|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-14|2011-08-31|||November 2010||2010-11-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|MUMPS||Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease|A Prospective Evaluation of a Medication Therapy Management Clinic Versus Usual Medical Care in Patients Post Acute Coronary Syndrome: The MUMPS Study|Unknown status|Recruiting|N/A|170|Anticipated|Middle Tennessee Research Institute||2|||f||||f||||||||||2017-10-11 03:52:25.83114|2017-10-11 03:52:25.83114
NCT01427205|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-04-04|||June 2013||2013-06-01|April 2013|2013-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)|Phase II Study of Cetuximab With or Without OSI-906, a Dual Insulin-like Growth Factor-1 Receptor and an Insulin Receptor Inhibitor, in Platinum-Refractory, Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 03:52:25.928313|2017-10-11 03:52:25.928313
NCT01427192|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-14|2012-12-11|||November 2010||2010-11-01|August 2011|2011-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CSRPH||Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension|Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension (CSRPH)|Completed||Phase 2|23|Actual|University of Zurich||5|||f||||t||||||||||2017-10-11 03:52:26.017967|2017-10-11 03:52:26.017967
NCT01427179|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-08-02|||May 2011||2011-05-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Observational|||Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)|Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)|Recruiting||N/A|1000|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     A 30 ml sample of blood from a vein or an existing catheter will be drawn at Mayo Clinic or     another medical center and returned through the mail in a kit. Alternatively, a saliva sample     will be collected and returned through the mail in a kit. An additional 10 ml (2 teaspoons)     of blood, buccal smear, and/or available tissue samples may also be collected.   "|||2017-10-11 03:52:26.130255|2017-10-11 03:52:26.130255
NCT01427153|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-07-31|||August 2012|Actual|2012-08-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|SMART||A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis|Orthopaedic Manual Physical Therapy Versus Corticosteroid Injections for Osteoarthritis of the Knee|Active, not recruiting||N/A|156|Actual|Madigan Army Medical Center||2|||f||||f||||||||||2017-10-11 03:52:26.39515|2017-10-11 03:52:26.39515
NCT01427140|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-12-08|||September 2011||2011-09-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|LIPOGAIN||Metabolic Consequences of Moderate Weight Gain - Role of Dietary Fat Composition (LIPOGAIN)|Metabolic Consequences of Moderate Weight Gain - Role of Dietary Fat Composition (LIPOGAIN): a Randomized Double-Blind Controlled Study|Completed||N/A|41|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 03:52:26.518448|2017-10-11 03:52:26.518448
NCT01427127|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-30|||December 2010||2010-12-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Effect of Ramosetron on Bowel Motility After Colorectal Resection|Effect of Ramosetron on Bowel Motility and PONV After Laparoscopic Stomach and Colorectal Resection|Unknown status|Recruiting|Phase 4|64|Anticipated|Kyunghee University Medical Center||2|||f||||t||||||||||2017-10-11 03:52:26.626754|2017-10-11 03:52:26.626754
NCT01427114|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-08-15|||July 1, 2011|Actual|2011-07-01|August 2017|2017-08-01|August 1, 2018|Anticipated|2018-08-01|August 1, 2014|Actual|2014-08-01||Interventional|||R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML)|Open-labeled, Multicenter Phase II Study of Rituximab, Cyclophosphamide, Vincristine, and Prednisolone (R-CVP) Chemotherapy in Patients With Non-conjunctival Ocular Adnexal MALT Lymphoma|Active, not recruiting||Phase 2|33|Anticipated|Konkuk University Medical Center||1|||f||||f||||||||||2017-10-11 03:52:26.75288|2017-10-11 03:52:26.75288
NCT01427101|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2011-08-31|||September 1993||1993-09-01|August 2011|2011-08-01||||||||Observational|||Results of CRS and Debulking in PMP Patients|Comparison Between Cyotreductive Surgery and Debulking Surgery in Patients With Pseudomyxoma Peritonei|Unknown status|Active, not recruiting|N/A|||Uppsala University|||1||f||||f|||||||"     Patients treated from 1993 are included and during these years treatment strategy has     changed. The different strategies are compared but its juts one cohort of patients. No     completion date are set due to that reports from other centres show that there are longtime     survivers in both treatment groups.   "|||2017-10-11 03:52:26.864197|2017-10-11 03:52:26.864197
NCT01427088|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2015-02-15|||August 2011||2011-08-01|February 2015|2015-02-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia|Short-Term Response of Serum Brain-Derived Neurotrophic Factor to Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Schizophrenia|Completed||N/A|21|Actual|Jeonbuk Provincial Maeumsarang Hospital||1|||f||||f||||||||||2017-10-11 03:52:26.943283|2017-10-11 03:52:26.943283
NCT01427075|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2012-04-07|||March 2011||2011-03-01|April 2012|2012-04-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Evaluation Of The Pharynx in Patients Undergoing Lateral Pharyngoplasty|Evaluation of the Pharynx Through MRI in Patients Undergoing Lateral Pharyngoplasty for Treatment of Obstructive Sleep Apnea|Unknown status|Active, not recruiting|N/A|15|Anticipated|Hospital do Servidor Publico Estadual||1|||f||||f||||||||||2017-10-11 03:52:27.039821|2017-10-11 03:52:27.039821
NCT01427049|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-01-31|||August 2011||2011-08-01|January 2017|2017-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||The Effect of Renal Denervation on Biological Variables|The Evaluation of Renal Denervation on Several Biological Variables in Patients With Uncontrolled Hypertension. An Observational Feasibility Study.|Completed||N/A|54|Actual|UMC Utrecht|||1||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 03:52:27.241285|2017-10-11 03:52:27.241285
NCT01427036|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-05-25|||June 2010||2010-06-01|May 2016|2016-05-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Interventional|MISSvsPHS||On the Impact of Bleeding on Two Strategies Osteosynthesis of Trochanteric Fractures|Impact Sur le Saignement Per et Post opératoire de 2 stratégies d'ostéosynthèse Des Fractures du Massif trochantérien du Sujet > 65 Ans : Essai randomisé Comparant le système MISS et le système PHS|Completed||Phase 4|108|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 03:52:27.343028|2017-10-11 03:52:27.343028
NCT01427023|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2014-02-05|||August 2012||2012-08-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Observational|||Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing|Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay|Completed||N/A|532|Actual|Gen-Probe, Incorporated|||1||f||||f||||||Samples With DNA|"     urine specimen, vaginal swab specimen, endocervical swab specimen and PreservCyt specimen   "|||2017-10-11 03:52:27.433034|2017-10-11 03:52:27.433034
NCT01427010|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2015-11-30|||January 2012||2012-01-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.|A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.|Active, not recruiting||N/A|20|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:52:27.519731|2017-10-11 03:52:27.519731
NCT01426997|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-06-20|||July 2010||2010-07-01|April 2016|2016-04-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Phenotype Depression Study|Phenotyping Major Depression With Increased Inflammation|Completed||N/A|279|Actual|Emory University|||3||f||||t||||||Samples With DNA|"     Diurnal plasma samples are collected hourly from 9 am to 9 pm once; Cerebrospinal fluid once;     mRNA from peripheral blood leuckocytes collected 5 times; DNA for analysis of genetic     polymorphisms is collected once.   "|No||2017-10-11 03:52:27.614524|2017-10-11 03:52:27.614524
NCT01426633|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2014-12-15|||November 2011||2011-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas|Phase I Dose Escalating Trial Evaluating the Combination of Gemcitabine and Trabectedin in Patients With Advanced and/or Metastatic Leiomyosarcoma or Liposarcoma|Completed||Phase 1|5|Actual|Heidelberg University||1|||f||||f||||||||||2017-10-11 03:52:32.656512|2017-10-11 03:52:32.656512
NCT01426984|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2012-08-22|||May 2012||2012-05-01|August 2012|2012-08-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||A Double Blind Crossover Study on the Effect of MPH on Decision-making Ability of Adults With BPD Compared to Adults With ADHD and Healthy Adults|A Double Blind Crossover Study on the Effect of Methylphenidate on Decision-making Ability of Adults With Borderline Personality Disorder (BPD) Compared to Adults With Attention Deficit Hyperactivity Disorder (ADHD) and Healthy Adults|Unknown status|Recruiting|N/A|20|Anticipated|Shalvata Mental Health Center||1|||f||||t||||||||||2017-10-11 03:52:27.698919|2017-10-11 03:52:27.698919
NCT01426971|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2012-11-23|||December 2012||2012-12-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine.|National, Controlled, Randomized, Double-blind, Parallel Study to Investigate the Efficacy of 2 Capsules of Ibuprofen 400mg in Association With Caffeine 100mg in Fixed Dose Combination Compared to Two Capsules of Ibuprofen 400mg in the Treatment of Migraine|Withdrawn||Phase 3|0|Actual|Sanofi||2|||f||||||||||||||2017-10-11 03:52:27.78214|2017-10-11 03:52:27.78214
NCT01426958|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-06-03|2013-08-08||August 2011||2011-08-01|October 2013|2013-10-01||||December 2011|Actual|2011-12-01||Interventional|||Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects|Relative Bioavailability of a Single Oral Dose of 40 mg Afatinib Given Alone Compared to Concomitant and Timed Administration of Multiple Oral Doses of Ritonavir - an Open-label, Randomised, Three-way Crossover Trial in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 03:52:27.860301|2017-10-11 03:52:27.860301
NCT01426945|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2016-05-17|||November 2011||2011-11-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Protein Expression in Samples From Young Patients With Rhabdomyosarcoma|Evaluating Candidate Protein Expression in Human Rhabdomyosarcoma (RMS)|Completed||N/A|77|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Tumor tissue   "|||2017-10-11 03:52:28.357158|2017-10-11 03:52:28.357158
NCT01426932|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-27|2013-06-27|||October 2011||2011-10-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||The Head Impulse Test in the Screening of Vestibular Function|The Head Impulse Test in the Screening of Vestibular Function|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 03:52:28.424842|2017-10-11 03:52:28.424842
NCT01426919|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-08-07|||December 2012||2012-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01||Observational|ALERT-TBI||Evaluation of Biomarkers of Traumatic Brain Injury|A Prospective Clinical Evaluation of Biomarkers of Traumatic Brain Injury|Completed||N/A|2011|Actual|Banyan Biomarkers, Inc|||1||f||||f||||||||||2017-10-11 03:52:28.497509|2017-10-11 03:52:28.497509
NCT01426906|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-31|2011-08-31|||January 2011||2011-01-01|August 2011|2011-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Pharmacokinetic Drug Interaction Study in Healthy Male Subjects|A Randomized, Open-Label, Drug-Drug Interaction Study To Evaluate The Effect Of Ketoconazole Or Rifampicin On The Pharmacokinetic Characteristics And Safety Of Lc15-0444 In Healthy Male Volunteers|Completed||Phase 1|24|Actual|LG Life Sciences||2|||f||||f||||||||||2017-10-11 03:52:28.63164|2017-10-11 03:52:28.63164
NCT01426893|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2012-03-28|||October 2011||2011-10-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct|Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct|Completed||N/A|310|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:52:28.709332|2017-10-11 03:52:28.709332
NCT01426880|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-02-12|||August 2011||2011-08-01|February 2016|2016-02-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|GeparSixto||Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer|A Randomized Phase II Trial Investigating the Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer|Completed||Phase 2/Phase 3|595|Actual|German Breast Group||2|||f||||t||||||||||2017-10-11 03:52:28.799003|2017-10-11 03:52:28.799003
NCT01426867|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2013-05-17|2013-05-17|2012-07-17|September 2011||2011-09-01|May 2013|2013-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||This reporting group includes all randomized subjects.|A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%|A Descriptive Comfort Study of Brinzolamide 1% / Brimonidine Tartrate 0.2% Fixed Combination Ophthalmic Suspension, Brinzolamide 1% Ophthalmic Suspension and Brimonidine Tartrate 0.2% Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|103|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 03:52:28.930869|2017-10-11 03:52:28.930869
NCT01426854|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-05-10|2013-03-27||July 2011||2011-07-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||Demographics are presented for the 248 participants who received at least one dose of study drug or discontinued before surgery and failed to return the test article bottle or returned the bottle with a broken seal.|Nepafenac Compared to Placebo for Ocular Pain and Inflammation|Clinical Evaluation of Safety and Efficacy of Nepafenac Ophthalmic Suspension, 0.1% Compared to Placebo for the Prevention and Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery in Adult Chinese Subjects|Completed||Phase 3|260|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:52:29.351863|2017-10-11 03:52:29.351863
NCT01426841|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2014-10-01|||August 2011||2011-08-01|October 2014|2014-10-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer|Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 1|10|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 03:52:29.756519|2017-10-11 03:52:29.756519
NCT01426828|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-05-01|||August 2011||2011-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2016|Actual|2016-06-01||Interventional|||Id-KLH Vaccine + T Cells|Randomized Phase II Trial of CD3/CD28 Activated Id-KLH Primed Autologous Lymphocytes in Subjects With Myeloma Undergoing Autologous Transplant|Active, not recruiting||Phase 2|43|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 03:52:29.864783|2017-10-11 03:52:29.864783
NCT01426620|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-27|2014-02-18|||June 2011||2011-06-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|BIT-2||Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer|Salvage Therapy With Docetaxel and Blueberry Powder in Non-Small Cell Lung Cancer|Terminated||Phase 2|4|Actual|James Graham Brown Cancer Center||1||slow accrual|f||||t||||||||||2017-10-11 03:52:32.758666|2017-10-11 03:52:32.758666
NCT01426815|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-12-04|||March 2012||2012-03-01|December 2014|2014-12-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|CRESPA||Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria|Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria|Unknown status|Recruiting|Phase 3|60|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 03:52:30.019252|2017-10-11 03:52:30.019252
NCT01426802|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2017-02-23|||October 2010||2010-10-01|February 2017|2017-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin|A 12 Week Multi Center, Open Label, Single Arm Study to Assess the Safety and Efficacy of Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin|Completed||Phase 4|150|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:52:30.141357|2017-10-11 03:52:30.141357
NCT01426789|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2015-08-06|2015-02-12||August 2011||2011-08-01|August 2015|2015-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients|A Multicenter, 12 Week, Randomized, Double-blind, Placebo-controlled Biomarker Study of Secukinumab (AIN457) in Rheumatoid Arthritis Patients Followed by an Open Label Extension|Completed||Phase 2|100|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:52:30.255487|2017-10-11 03:52:30.255487
NCT01426776|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2012-07-24|||September 2010||2010-09-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|CSR||Effect of Heart Valve Replacement on Cheyne-Stokes Respiration|Effect of Heart Valve Replacement on Cheyne-Stokes Respiration in Patients With Rheumatic Heart Disease|Completed||N/A|26|Actual|Nanjing Medical University||1|||f||||f||||||||||2017-10-11 03:52:31.220086|2017-10-11 03:52:31.220086
NCT01426763|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2014-03-19|2012-11-30||September 2011||2011-09-01|March 2014|2014-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase|An Open-label Multiple-dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Administration of CINRYZE® (C1 Esterase Inhibitor [Human]) With Recombinant Human Hyaluronidase (rHuPH20) in Subjects With Hereditary Angioedema|Completed||Phase 2|12|Actual|Shire||2|||f||||f||||||||||2017-10-11 03:52:31.334246|2017-10-11 03:52:31.334246
NCT01426750|ClinicalTrials.gov processed this data on October 10, 2017|2008-03-28|2011-08-29|||June 2002||2002-06-01|August 2011|2011-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Enteral Nutrition Support in Children and Adolescents With Cancer|Enteral Nutrition Support in Children and Adolescents With Cancer: a Non-randomized Controlled Clinical Trial|Completed||Phase 4|||Grupo de Apoio ao Adolescente e a Crianca com Cancer||1|||f||||t||||||||||2017-10-11 03:52:31.588534|2017-10-11 03:52:31.588534
NCT01426737|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2011-08-29|||April 2011||2011-04-01|August 2011|2011-08-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||The Swiss Glucose Variability Study|The Swiss Glucose Variability Study|Unknown status|Recruiting|Phase 4|50|Anticipated|University of Zurich||1|||f||||t||||||||||2017-10-11 03:52:31.652842|2017-10-11 03:52:31.652842
NCT01426724|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2014-05-20|||September 2011||2011-09-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease|Effects of Active Form of Vitamin D on Renal Blood Flow, Glomerular Filtration Rate, Proteinuria and Inflammation in Patients With Chronic Kidney Disease and Hyperparathyroidism|Withdrawn||N/A|0|Actual|University of Virginia||1||Difficult to enroll eligible subjects.|f||||f||||||||||2017-10-11 03:52:31.722998|2017-10-11 03:52:31.722998
NCT01426711|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2011-08-30|||September 2009||2009-09-01|July 2011|2011-07-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Observational|CREST||Critical Care Excellence in Sepsis and Trauma|Critical Care Excellence in Sepsis and Trauma|Unknown status|Enrolling by invitation|N/A|2600|Anticipated|Medical University of South Carolina|||1||f||||t||||||||||2017-10-11 03:52:31.803713|2017-10-11 03:52:31.803713
NCT01426698|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-12-03|||August 2011||2011-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|18mo||18 Month Follow Up of Preterm Infants Enrolled in the Cord Clamping Study|18 Month Follow Up of Preterm Infants Enrolled in the Cord Clamping Study|Completed||Phase 2|208|Actual|University of Rhode Island||2|||f||||t||||||||||2017-10-11 03:52:31.908278|2017-10-11 03:52:31.908278
NCT01426685|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2015-12-09|||August 2007||2007-08-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|ARTEMIS||Prognosis of Type 2 Diabetic Patients|Prediction of Cardiovascular Events in Type 2 Diabetic Patients With Coronary Artery Disease- Application of Novel Risk Markers and Technology|Active, not recruiting||N/A|1880|Actual|University of Oulu|||1||f||||f||||||Samples With DNA|"     Blood samples are stored for analysis of various biomarkers and for extracting DNAs.   "|||2017-10-11 03:52:32.049895|2017-10-11 03:52:32.049895
NCT01426672|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-30|||January 2009||2009-01-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Monovision for the Treatment of Diplopia|Monovision for Treatment of Diplopia|Completed||Phase 1|20|Actual|Mount Sinai Hospital, Canada||1|||f||||f||||||||||2017-10-11 03:52:32.317733|2017-10-11 03:52:32.317733
NCT01426659|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2015-06-02|||September 2011||2011-09-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|LAMOPRESCO||Language and Motor Skills of Preterm Infants in Pre-school Age: Diagnosis and Early Intervention|Evaluation of Language and Sensorimotor Constraints of Very Premature Babies at the Age of 3 Years 1 / 2 Without Cerebral Palsy. Randomised Study of Stimulation Training Implicit in Children Vulnerable|Completed||N/A|139|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 03:52:32.419359|2017-10-11 03:52:32.419359
NCT01426646|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-18|2012-01-03|||September 2011||2011-09-01|January 2012|2012-01-01|September 2016|Anticipated|2016-09-01|September 2014|Anticipated|2014-09-01||Interventional|||S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer|Randomized Multicenter Phase II Trial of S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy After Curative Resection of Stage II-IV(M0) Gastric Cancer|Unknown status|Recruiting|Phase 2|218|Anticipated|Kyungpook National University||2|||f||||t||||||||||2017-10-11 03:52:32.53804|2017-10-11 03:52:32.53804
NCT01426607|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-12-12|||March 2011||2011-03-01|August 2011|2011-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|VASO-AM||VASO-AM :Impact of Oral Appliance Therapy on Endothelial Function in Obstructive Sleep Apnea|VASO-AM :Impact of Oral Appliance Therapy on Endothelial Function in Obstructive Sleep Apnea|Completed||N/A|150|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 03:52:32.859124|2017-10-11 03:52:32.859124
NCT01426594|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-08-30|||August 2011||2011-08-01|August 2011|2011-08-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Observational|XPERT||Real-life Experience of the Use of Isomers as METPURE XL (S (-) Metoprolol Succinate) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients||Unknown status|Recruiting|N/A|2000|Anticipated|Closter Pharma|||1||f||||||||||||||2017-10-11 03:52:32.936321|2017-10-11 03:52:32.936321
NCT01426581|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2013-09-04|||August 2011||2011-08-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|E-TRaIN||Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN)|Effectiveness of Interventions to Teach Respiratory Inhaler techNique (E-TRaIN)|Completed||Phase 2|100|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 03:52:33.024369|2017-10-11 03:52:33.024369
NCT01426568|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2013-08-27|||January 2011||2011-01-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Trial of Multi-convergent Therapy for Functional Symptoms and Stress in Patients With Inflammatory Bowel Disease|A Randomised Controlled Trial of Multi-convergent Therapy for Inflammatory Bowel Disease Patients With Functional Abdominal Symptoms and High Perceived Stress|Completed||Phase 1/Phase 2|66|Actual|Cardiff and Vale University Health Board||2|||f||||t||||||||||2017-10-11 03:52:33.125584|2017-10-11 03:52:33.125584
NCT01426555|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-03-11|2016-01-14||February 2011||2011-02-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI)|FES-Rowing Versus Zoledronic Acid to Improve Bone Health in SCI: A Comparative Clinical Trial|Terminated||Phase 2/Phase 3|70|Actual|Boston VA Research Institute, Inc.|No Data Safety Monitor Board established for this project. Incomplete data set and analysis.|2||Incomplete data set & analysis|f||||f||||||||No|The study has been closed by the VABHS IRB.|2017-10-11 03:52:33.217604|2017-10-11 03:52:33.217604
NCT01426542|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-06-26|||March 2011||2011-03-01|June 2017|2017-06-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Preventing Brain Injury in Infants With Congenital Heart Disease|Pilot Study of Topiramate Prophylaxis in Infants Undergoing Surgery for Congenital Heart Disease|Active, not recruiting||Phase 1|24|Actual|University of California, Davis||2|||f||||f||||||||||2017-10-11 03:52:33.648877|2017-10-11 03:52:33.648877
NCT01426529|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2017-03-21|||October 1, 2010|Actual|2010-10-01|March 2017|2017-03-01|October 15, 2017|Anticipated|2017-10-15|October 15, 2017|Anticipated|2017-10-15||Interventional|||Caveolin-1 and Vascular Dysfunction|Caveolin-1 and Vascular Dysfunction|Active, not recruiting||Phase 1|120|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-11 03:52:33.758327|2017-10-11 03:52:33.758327
NCT01426516|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2015-10-28|2015-08-25||September 2011||2011-09-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PAGE-1_AG1||Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)|A Six-month Study of the Genecept Assay vs. Treatment as Usual to Evaluate Efficacy of Using Assay Guided Treatment in Outpatient Adults With Treatment Resistant Depression|Terminated||N/A|29|Actual|Genomind, LLC||2||Invalid data collection|f||||t||||||||||2017-10-11 03:52:33.86446|2017-10-11 03:52:33.86446
NCT01426490|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2014-02-17|||August 2011||2011-08-01|August 2011|2011-08-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer||Unknown status|Recruiting|Phase 2/Phase 3|300|Anticipated|Taichung Veterans General Hospital||4|||f||||t||||||||||2017-10-11 03:52:34.910778|2017-10-11 03:52:34.910778
NCT01426477|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2017-04-04|||August 2011||2011-08-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|VIBE||Veritas in Non-Bridging Ventral Hernia Repair|Veritas in Non-Bridging Ventral Hernia Repair|Terminated||N/A|20|Actual|Baxter Healthcare Corporation|||1||f||||f||||||||||2017-10-11 03:52:35.088041|2017-10-11 03:52:35.088041
NCT01426464|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-27|2011-08-29|||September 2011||2011-09-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|November 2011|Anticipated|2011-11-01||Interventional|||Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy|Phase 2 Study of Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy|Unknown status|Not yet recruiting|Phase 2|22|Anticipated|Nanduri, Padma, M.D., FACS||1|||f||||f||||||||||2017-10-11 03:52:35.203065|2017-10-11 03:52:35.203065
NCT01426451|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2014-03-26|||November 2011||2011-11-01|March 2014|2014-03-01||||December 2012|Actual|2012-12-01||Interventional|||Assessment of a Drama Workshop Program for Immigrant and Refugee Adolescents|Assessment of a Drama Workshop Program for Immigrant and Refugee Adolescents|Completed||N/A|464|Actual|McGill University Health Center||3|||f||||||||||||||2017-10-11 03:52:35.310797|2017-10-11 03:52:35.310797
NCT01426438|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2016-01-04|2014-10-15||November 2011||2011-11-01|January 2016|2016-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate|Effect of HDL-Raising Therapies on Endothelial Function, Lipoproteins, and Inflammation in HIV-infected Subjects With Low HDL Cholesterol: A Phase II Randomized Trial of Extended Release Niacin vs. Fenofibrate|Completed||Phase 2|99|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 03:52:35.462102|2017-10-11 03:52:35.462102
NCT01426425|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2017-02-14|2016-09-22|2016-08-02|May 2012||2012-05-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional||The modified intent-to-treat (mITT) set consists of subjects who signed the ICY-AVNRT consent form and met all Pre-EP and Post-EP study inclusion and no exclusion criteria who had a Freezor Xtra Cardiac Cryoablation Catheter inserted into the vasculature for the purpose of the ICY-AVNRT study.|Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia|ICY-AVNRT (Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia)|Completed||Phase 3|572|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||t||||||||||2017-10-11 03:52:37.904542|2017-10-11 03:52:37.904542
NCT01426412|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2013-08-15|||September 2011||2011-09-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol|A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3015014 in Subjects With Elevated LDL-C|Completed||Phase 1|68|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 03:52:38.693717|2017-10-11 03:52:38.693717
NCT01425684|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2017-08-03|||January 2011||2011-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Brain Circuits in Schizophrenia and Smoking|Brain Circuits in Schizophrenia and Smoking|Recruiting||N/A|800|Anticipated|University of Maryland|||2||f||||f||||||Samples With DNA|"     -  Whole Blood        -  Saliva   "|||2017-10-11 03:52:52.847486|2017-10-11 03:52:52.847486
NCT01426399|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-12-27|||August 2011||2011-08-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects|A Randomized, Open-label, Multiple Dosing, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects|Completed||Phase 1|30|Actual|LG Life Sciences||3|||f||||||||||||||2017-10-11 03:52:38.778218|2017-10-11 03:52:38.778218
NCT01426386|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2013-06-17||2013-04-12|September 2011||2011-09-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|April 2012|Actual|2012-04-01||Interventional|||A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment|A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme|Completed||Phase 2|265|Actual|Ferring Pharmaceuticals||6|||f||||t||||||||||2017-10-11 03:52:38.873972|2017-10-11 03:52:38.873972
NCT01426373|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-12-08|2015-12-08|2014-05-30|August 2011||2011-08-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area|Multicenter, Open-label Study of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area|Completed||Phase 3|165|Actual|Kythera Biopharmaceuticals||1|||f||||f||||||||||2017-10-11 03:52:39.243991|2017-10-11 03:52:39.243991
NCT01426360|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-11-14|2011-10-01||September 2011||2011-09-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Instant and Lasting Relief Effects of Strontium Chloride/Potassium Nitrate Dentifrice on Dentin Hypersensitivity|A Randomized, Double-blind Clinical Trial to Assess the Instant and Lasting Relief Effects of a Dentifrice Containing 2% Strontium Chloride and 5% Potassium Nitrate on Dentin Hypersensitivity|Completed||N/A|79|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:52:40.095658|2017-10-11 03:52:40.095658
NCT01426347|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2017-01-27|2016-09-14||January 2009||2009-01-01|January 2017|2017-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis|Vitamin Therapy in Rheumatoid Arthritis|Completed||N/A|139|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:52:40.652898|2017-10-11 03:52:40.652898
NCT01426334|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2014-04-01|||September 2011||2011-09-01|June 2013|2013-06-01||||June 2012|Actual|2012-06-01||Interventional|||Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate|Exploiting Synergy in Chronic Myelogenous Leukemia: A Phase Ib Evaluation of Dasatinib Plus Cyclosporine in Patients With Ph+ Leukemia (ESCAPE1b)|Terminated||Phase 1|4|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:52:41.033816|2017-10-11 03:52:41.033816
NCT01426321|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-08-14|||August 2011||2011-08-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CRT clinic||Combining Myocardial Strain and Cardiac CT to Optimize Left Ventricular Lead Placement in CRT Treatment|Individually Tailored Cardiac Resynchronization Therapy - Combing Myocardial Strain and Cardiac CT to Optimize Left Ventricular Lead Placement in Cardiac Resynchronization Therapy|Active, not recruiting||N/A|100|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 03:52:41.155591|2017-10-11 03:52:41.155591
NCT01426308|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2016-04-26|||August 2011||2011-08-01|September 2011|2011-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test|Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test|Completed||N/A|900|Actual|Illumina, Inc.|||2||f||||f||||||||No||2017-10-11 03:52:41.247085|2017-10-11 03:52:41.247085
NCT01426295|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2016-05-02|||April 2011||2011-04-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|Caphosol||Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital|Pharmaco-economic Cost-effective Prospective Randomized Trial Evaluating the Open Interest Caphosol ® Mouthwashes in the Prevention and Treatment of Severe Oral Mucositis in Patients Receiving High-dose Chemotherapy in Hematology|Completed||Phase 2|92|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-10-11 03:52:41.317597|2017-10-11 03:52:41.317597
NCT01426282|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-29|||February 2009||2009-02-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||The Effects of Health Education in Cardiovascular Diseases Prevention and Treatment|The Effects of Health Education Given by Nurse on Out-patient Compliance in Cardiovascular Diseases Prevention and Treatment in China|Completed||N/A|5|Actual|Harbin Medical University||2|||f||||f||||||||||2017-10-11 03:52:41.424414|2017-10-11 03:52:41.424414
NCT01426269|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2014-07-08|2013-12-17||September 2011||2011-09-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||The safety population included 235 enrolled subjects. However, Baseline demographics were based on the ITT population which included 230 subjects; 5 subjects were excluded from this population due to consent issues.|Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo|Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea® and MetroGel® 1% in Adults With Rosacea|Completed||Phase 4|235|Actual|Galderma Laboratories, L.P.||3|||f||||f||||||||||2017-10-11 03:52:41.539682|2017-10-11 03:52:41.539682
NCT01426256|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2017-07-11|||October 2011||2011-10-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|April 2017|Actual|2017-04-01||Interventional|DISC||Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)|Vitamin D for Enhancing the Immune System in Cystic Fibrosis|Completed||Phase 3|91|Actual|Emory University||2|||f||||t||||||||||2017-10-11 03:52:42.44407|2017-10-11 03:52:42.44407
NCT01426243|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-10|2017-07-27|||July 2011||2011-07-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|EP46 NOVAA||The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.|The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient|Active, not recruiting||Phase 3|71|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||f||||||||||2017-10-11 03:52:42.562394|2017-10-11 03:52:42.562394
NCT00000294|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||September 1998||1998-09-01|March 1999|1999-03-01|December 2001||2001-12-01|||||Interventional|||Effects of Carvedilol on Cocaine Use in Humans - 11|Effects of Carvedilol on Cocaine Use in Humans|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.346768|2017-10-11 04:17:43.346768
NCT01426230|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2013-03-18|2013-01-11||September 2011||2011-09-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Observational|||Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia|A Phase 4, Open Label, Study of Safety and Effectiveness of GRALISE™(Gabapentin) Tablets in the Treatment of Patients With Postherpetic Neuralgia in Clinical Practice|Completed||N/A|201|Actual|Depomed|||2||f||||f||||||||||2017-10-11 03:52:42.66285|2017-10-11 03:52:42.66285
NCT01426217|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-12-13|||August 2011||2011-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:52:42.969065|2017-10-11 03:52:42.969065
NCT01426204|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-08-30|||September 2011||2011-09-01|August 2011|2011-08-01|August 2013|Anticipated|2013-08-01|June 2012|Anticipated|2012-06-01||Observational|OBSERVER||Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)||Unknown status|Not yet recruiting|N/A|40|Anticipated|Closter Pharma|||1||f||||f||||||||||2017-10-11 03:52:43.012576|2017-10-11 03:52:43.012576
NCT01426191|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2012-09-10|||August 2011||2011-08-01|September 2012|2012-09-01|November 2013|Anticipated|2013-11-01|August 2013|Anticipated|2013-08-01||Observational|SWSB||Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection|A Open Multi-center Clinical Study on Cefotaxime Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary Tract Infection|Unknown status|Enrolling by invitation|Phase 4|2000|Anticipated|Xiangbei Welman Pharmaceutical Co., Ltd|||1||f||||t||||||||||2017-10-11 03:52:43.072211|2017-10-11 03:52:43.072211
NCT01426178|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-07-04|||July 2011||2011-07-01|July 2014|2014-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Neurally Adjusted Ventilatory Assist (NAVA) in NonInvasive Ventilation (NIV)|Neurally Adjusted Ventilatory Assist (NAVA) in NonInvasive Ventilation (NIV)|Completed||Phase 1|17|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 03:52:43.161699|2017-10-11 03:52:43.161699
NCT01426165|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-01-31|||April 2011||2011-04-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients|Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients|Terminated||N/A|5|Actual|CAMC Health System||2||Issues with recruitment. PI decided to terminate study|f||||f||||||||||2017-10-11 03:52:43.439398|2017-10-11 03:52:43.439398
NCT01426152|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2011-08-29|||January 2006||2006-01-01|August 2011|2011-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|ProgBBN||Progesterone on the Day of Ovulation Induction is Associated With Pregnancy Outcome|Association Between Progesterone Levels on the Day of Ovulation Induction and IVF Outcome: Retrospective Study With 2500 Controlled Ovarian Stimulations Cycles|Completed||N/A|2555|Actual|Bollmann Bruckner Noss|||3||f||||t||||||||||2017-10-11 03:52:43.52966|2017-10-11 03:52:43.52966
NCT01426139|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-04-03|||August 2011||2011-08-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions|BIOTRONIK-Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in the Treatment of Patients With Single de Novo Coronary Artery Lesions in an Indian Population|Completed||N/A|120|Actual|Biotronik AG||1|||f||||t||||||||||2017-10-11 03:52:43.598795|2017-10-11 03:52:43.598795
NCT01426126|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-12-06|||December 2007||2007-12-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|July 2010|Actual|2010-07-01||Interventional|||Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum|Phase II Study of Genexol-PM, a Cremophor-free, Polymeric Micelle Formulation of Paclitaxel for Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum|Completed||Phase 2|37|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 03:52:43.702738|2017-10-11 03:52:43.702738
NCT01426113|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2015-09-02|2015-06-29||September 2011||2011-09-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma||Terminated||Phase 3|6|Actual|Allergan||2||Study terminated due to corporate decision.|f||||t||||||||||2017-10-11 03:52:43.808861|2017-10-11 03:52:43.808861
NCT01426100|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-30|2012-09-11|||August 2011||2011-08-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||CKD-828 Telmisartan Non-Responder Trial|A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Telmisartan and S-Amlodipine(CKD-828) Versus Telmisartan Monotherapy in Hypertensive Patients Inadequately Controlled by Telmisartan Monotherapy|Completed||Phase 3|183|Actual|Chong Kun Dang Pharmaceutical||3|||f||||||||||||||2017-10-11 03:52:44.091837|2017-10-11 03:52:44.091837
NCT01426087|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2011-08-31|||July 2011||2011-07-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices|Investigator Sponsored Study of Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices|Unknown status|Recruiting|N/A|126|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 03:52:44.21651|2017-10-11 03:52:44.21651
NCT01426074|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2016-09-23|||August 2011||2011-08-01|September 2016|2016-09-01||||August 2014|Actual|2014-08-01||Interventional|||DCE-MRI PET Bevacizumab Study in Rectal Cancer|A Phase II/Pharmacodynamic Study of Preoperative or Definitive FOLFOX Plus Bevacizumab, With the Additional Pharmacodynamic Goal of Assessing Tumor Blood Flow as Measured by Dynamic Contrast-enhanced MRI, and the Induction of Hypoxia and Apoptosis as Measured by PET in Patients With Rectal Cancer|Active, not recruiting||Phase 2|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 03:52:44.332662|2017-10-11 03:52:44.332662
NCT01426061|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-29|||May 2006||2006-05-01|August 2011|2011-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Clinical Effect of Reflexology and Homeopathy Added to Conventional Asthma Management|Effect of Reflexology, Homeopathy and Conventional Medical Treatment in Asthma: A Randomised Controlled, Parallel Group Trial.|Completed||N/A|98|Actual|University of Aarhus||3|||f||||t||||||||||2017-10-11 03:52:44.415355|2017-10-11 03:52:44.415355
NCT01426048|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-01-21|||November 2008||2008-11-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|||||Observational|||Long-term Outcome of the TVT Procedure Without Preoperative Urodynamic Examination|Long-term Outcome of the TVT Procedure Without Preoperative Urodynamic Examination|Completed||Early Phase 1|138|Actual|Turku University Hospital|||1||f||||||||||||||2017-10-11 03:52:44.526298|2017-10-11 03:52:44.526298
NCT01426035|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-03-01|||September 2014||2014-09-01|March 2013|2013-03-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate Cream In The Superficial Varicose Veins Treatment|Phase III of Safety and Efficacy Study of Topic Mucopolysaccharide Polysulfate Cream 5mg/g in the Superficial Varicose Veins Treatment|Suspended||Phase 3|76|Anticipated|EMS||2||Study suspended by decision strategically.|f||||t||||||||||2017-10-11 03:52:44.593448|2017-10-11 03:52:44.593448
NCT01426022|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2012-10-17|||October 2011||2011-10-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Moderate Alcohol Consumption on Postprandial Mood|The Effect of Moderate Alcohol Consumption With a Meal in Different Ambiances on Postprandial Mood, Evaluated by Subjective and Physiological Responses|Completed||N/A|28|Actual|TNO||2|||f||||f||||||||||2017-10-11 03:52:44.664137|2017-10-11 03:52:44.664137
NCT01426009|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2016-06-07||2013-12-18|August 2011||2011-08-01|June 2016|2016-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Seven Arm, Four-Period Cross-over, Incomplete Block Design, 7-Day Dosing Study to Assess the Dose-Response, Safety, and Efficacy of EP-101 (SUN101) in Subjects With Moderate to Severe COPD|Completed||Phase 2|275|Actual|Sunovion Respiratory Development Inc.||4|||f||||f||||||||||2017-10-11 03:52:44.769897|2017-10-11 03:52:44.769897
NCT01425996|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2013-04-16|||July 2011||2011-07-01|April 2013|2013-04-01|October 2015|Anticipated|2015-10-01|April 2015|Anticipated|2015-04-01||Interventional|||A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma|A Phase I/II, Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Taiwan Liposome Company||1|||f||||t||||||||||2017-10-11 03:52:44.884081|2017-10-11 03:52:44.884081
NCT01425983|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-09-04|||March 2011||2011-03-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|asn01||Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01)|Dietary Intervention of Stress-Induced Neurovegetative Disorders in Men and Women With a Specific Amino Acid Composition With Micronutrients|Completed||Phase 3|80|Actual|Kyberg Vital GmbH||2|||f||||f||||||||||2017-10-11 03:52:44.993403|2017-10-11 03:52:44.993403
NCT01425970|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-10-12||2015-09-23|May 2012||2012-05-01|October 2015|2015-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin|A Phase II, Randomized, Multi-center, Two Part Study of the Safety and Efficacy of Double-blind, Placebo-controlled INX-08189 in Adjunctive Treatment With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Study Part A, and Open-label INX-08189 in Adjunctive (Interferon Free) Treatment With Daclatasvir and/or Ribavirin (Copegus®) in Study Part B, in Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects|Terminated||Phase 2|210|Actual|Bristol-Myers Squibb||9||Termination of study was due to safety reasons|f||||t||||||||||2017-10-11 03:52:45.116099|2017-10-11 03:52:45.116099
NCT01425957|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-10-30|||December 2011||2011-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment|Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Two-part Clinical Study. PartA: Multisite MRI Acquisition, Protocol Harmonization. PartB: Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Clinical Study|Completed||N/A|229|Actual|Qualissima||1|||f||||f||||||||||2017-10-11 03:52:46.832023|2017-10-11 03:52:46.832023
NCT01425944|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2017-09-11|||September 2010||2010-09-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome|The Brain Vascular Malformations Clinical Research Network: Predictors of Clinical Course, Project 2: Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome|Recruiting||N/A|600|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|||1||f||||f||||||Samples With DNA|"     Aim 1 retains data and samples without DNA. Aim 2 retains data without DNA. Aim 3 retains     anonymous data with DNA.   "|||2017-10-11 03:52:46.975108|2017-10-11 03:52:46.975108
NCT01425931|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2014-08-05|||June 2014||2014-06-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Gastrointestinal Microcirculation During Cardiopulmonary Bypass||Completed||N/A|50|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-10-11 03:52:47.092222|2017-10-11 03:52:47.092222
NCT01425918|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2016-12-29|||January 2012||2012-01-01|December 2016|2016-12-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Social Cognitive Development in Young Children With Autism|Effects of Self-Generated Experiences on Social Cognitive Development in Young Children With Autism|Completed||N/A|61|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||||2017-10-11 03:52:47.166869|2017-10-11 03:52:47.166869
NCT01425905|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-27|2017-06-30|||August 23, 2011||2011-08-23|January 27, 2016|2016-01-27|August 10, 2015|Actual|2015-08-10|August 10, 2015|Actual|2015-08-10||Interventional|||Mood and Insulin Resistance in Adolescents At-Risk for Diabetes|Mood and Insulin Resistance in Adolescents At-Risk for Diabetes|Completed||Phase 2|174|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 03:52:47.253918|2017-10-11 03:52:47.253918
NCT01425892|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-27|2017-06-30|||July 29, 2011||2011-07-29|April 19, 2017|2017-04-19||||||||Observational|||The Pathogenesis and Natural History of Sjogren s Syndrome|The Pathogenesis and Natural History of Sjogren s Syndrome|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:52:47.34891|2017-10-11 03:52:47.34891
NCT01425879|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-27|2016-05-16|2016-03-15||April 2011||2011-04-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery|A Multi-Institutional Phase II Study of the Akt Inhibitor MK-2206 in Refractory Biliary Cancers|Completed||Phase 2|8|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:52:47.461812|2017-10-11 03:52:47.461812
NCT01425320|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2012-11-16|||January 2013||2013-01-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne||Withdrawn||Phase 1|0|Actual|Allergan||4||"Study was never initiated due to company decision. No study subjects were ever enrolled or   dosed."|f||||f||||||||||2017-10-11 03:52:57.919155|2017-10-11 03:52:57.919155
NCT01425866|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-09-04|||October 2011|Actual|2011-10-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|ERMIES||Two Years Maintenance of Structured Group Self-management Education in Type 2 Diabetes : a Randomized Controlled Trial|Multicenter Randomized Trial of Structured Educational Intervention at the Community Level in Insufficiently Controlled Patients With Type 2 Diabetes in Reunion Island|Completed||N/A|132|Actual|Centre Hospitalier Universitaire de la Réunion||2|||f||||f||||||||||2017-10-11 03:52:47.954413|2017-10-11 03:52:47.954413
NCT01425853|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2016-01-29|2015-07-20||September 2011||2011-09-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|MOVES|PP population was defined as all randomized patients who met the inclusion criteria, received study medication, had a baseline efficacy measurement and at least one corresponding post-baseline efficacy measurement (for the main efficacy variable) and did not present major violations of the protocol (n=522).|Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis|Non-Inferiority Clinical Trial On The Efficacy And Safety Of Chondroitin Sulfate And Glucosamine Hydrochloride In Combination Versus Celecoxib In Patients With Knee Osteoarthritis|Completed||Phase 4|606|Actual|Bioiberica||2|||f||||t||||||||Undecided||2017-10-11 03:52:48.115643|2017-10-11 03:52:48.115643
NCT01425840|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-27|||March 2008||2008-03-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||Liposomal Lidocaine Gel for Oral Topical Anesthesia|Efficacy of Liposome Lidocaine Gel for Topical Anesthesia in the Palatal Mucosa|Completed||Phase 1|40|Actual|University of Campinas, Brazil||1|||f||||t||||||||||2017-10-11 03:52:48.9262|2017-10-11 03:52:48.9262
NCT01425827|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-08-27|||November 2010||2010-11-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Duloxetine for Pain in Older Adults With Knee Osteoarthritis (OA)||Completed||N/A|288|Actual|Faculty of Medicine, University of Alexandria||1|||f||||t||||||||||2017-10-11 03:52:49.003431|2017-10-11 03:52:49.003431
NCT01425814|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2017-02-27|2017-01-03||August 2011||2011-08-01|February 2017|2017-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population|A Phase IIa, Randomised, Single Dose, Double-blind, Double-dummy, 6 Way Complete Cross-over, Placebo Controlled Clinical Trial to Assess the Efficacy, Safety and Tolerability of 4 Strengths of LAS100977 QD Compared to Placebo and an Active Comparator in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|87|Actual|AstraZeneca||6|||f||||f||||||||||2017-10-11 03:52:49.137424|2017-10-11 03:52:49.137424
NCT01425788|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-06-25|||August 2011||2011-08-01|June 2015|2015-06-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|Osiris||Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense|Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense|Completed||Phase 2|236|Actual|ALK-Abelló A/S||3|||f||||f||||||||||2017-10-11 03:52:51.281205|2017-10-11 03:52:51.281205
NCT01425775|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-27|||April 2010||2010-04-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|||The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)||Completed||N/A|248|Actual|Faculty of Medicine, University of Alexandria||2|||f||||t||||||||||2017-10-11 03:52:51.368258|2017-10-11 03:52:51.368258
NCT01425762|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-11-10|||August 2011||2011-08-01|November 2015|2015-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.|Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.|Completed||N/A|120|Anticipated|Stanford University||2|||f||||t||||||||||2017-10-11 03:52:51.453685|2017-10-11 03:52:51.453685
NCT01425749|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-03-02|2015-12-13||June 2011||2011-06-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|July 2013|Actual|2013-07-01||Interventional|Mel55||Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI|T Cell Activation and Immune Cell Function in Melanoma Patients Treated With recMAGE-A3 + AS15 Immunological Adjuvant System|Completed||Early Phase 1|25|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 03:52:51.560101|2017-10-11 03:52:51.560101
NCT01425736|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-06-01|||January 2009||2009-01-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|January 2011|Actual|2011-01-01||Interventional|||Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma|Phase 2 Study of Nimotuzumab in Combination With TPF for Head and Neck Squamous Cell Carcinoma|Completed||Phase 2|91|Actual|Shanghai 9th People's Hospital||2|||f||||t||||||||||2017-10-11 03:52:52.213584|2017-10-11 03:52:52.213584
NCT01425710|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-02-12|||August 2011||2011-08-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma|Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma|Completed||N/A|15|Actual|Medical University of Vienna|||2||f||||f||||||Samples Without DNA|"     whole blood, serum   "|||2017-10-11 03:52:52.646739|2017-10-11 03:52:52.646739
NCT01425697|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2013-06-28|||November 2008||2008-11-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|ERASE||Eliminate Risk of Cardiac Surgical Site Events|Randomized,Prospective Evaluation of 2% Chlorhexidine Gluconate Cloths to Reduce Surgical Site Infections in Cardiothoracic Surgery Patients|Completed||N/A|739|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 03:52:52.739336|2017-10-11 03:52:52.739336
NCT01425671|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2017-03-16|||January 2011||2011-01-01|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States|Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States|Recruiting||N/A|800|Anticipated|University of Maryland|||2||f||||f||||||Samples With DNA|"     Blood sample   "|No||2017-10-11 03:52:52.955137|2017-10-11 03:52:52.955137
NCT01425658|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2012-05-16|||August 2011||2011-08-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Comparison of Postoperative Analgesic Effect of Intrathecal Clonidine and Fentanyl Added to Bupivacaine in Patients Undergoing Cesarean Section||Completed||Phase 1/Phase 2|90|Actual|Qazvin University Of Medical Sciences||3|||f||||||||||||||2017-10-11 03:52:53.063134|2017-10-11 03:52:53.063134
NCT01425645|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-27|2017-09-11|||January 2012||2012-01-01|September 2017|2017-09-01|March 1, 2017|Actual|2017-03-01|March 1, 2017|Actual|2017-03-01||Interventional|FDD||Families Defeating Diabetes|Families Defeating Diabetes: Canadian Intervention for Family-Centered Diabetes Prevention Following Gestational Diabetes (GDM)|Completed||N/A|180|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-10-11 03:52:53.157991|2017-10-11 03:52:53.157991
NCT01425632|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2015-11-10|2015-09-17||August 2011||2011-08-01|September 2015|2015-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis|A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis (A Randomized, Double-blind, Placebo-controlled Study)|Completed||Phase 3|490|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-10-11 03:52:53.247539|2017-10-11 03:52:53.247539
NCT01425619|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2015-10-07|||October 2011||2011-10-01|September 2012|2012-09-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests||Completed||N/A|160|Anticipated|Meir Medical Center||4|||f||||f||||||||||2017-10-11 03:52:53.57355|2017-10-11 03:52:53.57355
NCT01425606|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-08-28|||September 2011||2011-09-01|August 2011|2011-08-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Observational|||Pseudohyponatremia of Multiple Myeloma is True Hyponatremia|a Study to Evaluate the Electrolyte Changes in Particular Sodium,in Multiple Myeloma and the Effect of the m- Proteins on the Strong Ion Difference|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 03:52:53.665447|2017-10-11 03:52:53.665447
NCT01425593|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2012-11-04|||March 2009||2009-03-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|March 2010|Actual|2010-03-01||Observational|||T Cell Function in Chronic Idiopathic Urticaria|T Cell Function in Chronic Idiopathic Urticaria|Unknown status|Recruiting|N/A|40|Anticipated|Meir Medical Center|||1||f||||t||||||Samples Without DNA|"     venous blood sample   "|||2017-10-11 03:52:53.733262|2017-10-11 03:52:53.733262
NCT01425580|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2016-08-31|||January 2012||2012-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Liraglutide and Heart Failure in Type 2 Diabetes|Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment Versus Glimepiride Both in Combination With Metformin|Completed||Phase 2|62|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:52:53.799185|2017-10-11 03:52:53.799185
NCT01425567|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-01-09|||August 2011||2011-08-01|December 2016|2016-12-01||||August 2020|Anticipated|2020-08-01||Interventional|Omegaven||Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury|Compassionate Use of an Intravenous Lipid Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Children|Recruiting||N/A|50|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 03:52:53.912494|2017-10-11 03:52:53.912494
NCT01425554|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-28|2015-02-09|||August 2011||2011-08-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Doppler Sonography, MR Venography, Plethysmography for the Diagnosis of CCSVI|Doppler Sonography, Magnetic Resonance Venography, Air-plethysmography in the Non-invasive Diagnostics of Chronic Cerebrospinal Venous Insufficiency (CCSVI)|Completed||N/A|126|Actual|Euromedic Specialist Clinics, Poland||1|||f||||t||||||||||2017-10-11 03:52:54.009871|2017-10-11 03:52:54.009871
NCT01425541|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-09-03|||April 2000||2000-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition|Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition in Normal and Hyperandrogenemic Adolescent Girls (JCM010)|Completed||N/A|60|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 03:52:54.097438|2017-10-11 03:52:54.097438
NCT01425528|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2014-03-03|2014-01-08||August 2011||2011-08-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study of Kuvan Treatment in Adults With GTPCH Deficiency|Pilot Study to Assess Impact of Kuvan® Supplementation as an Adjunct Treatment in Subjects With Dominantly-inherited GTPCH Deficiency on Mood, Behavioral and Motor Phenotypes|Completed||Phase 1/Phase 2|12|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 03:52:54.196158|2017-10-11 03:52:54.196158
NCT01425515|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2014-11-17|||September 2011||2011-09-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Improving Care for Patients With High Blood Pressure|Heart Healthy Lenoir: Improving Care for Patients With High Blood Pressure|Completed||N/A|535|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 03:52:54.647066|2017-10-11 03:52:54.647066
NCT01425502|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2016-01-31|||September 2012||2012-09-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|DQIP||Data-driven Quality Improvement in Primary Care - Trial|Data-driven Quality Improvement in Primary Care: Cluster Randomised Controlled Trial to Test the Effectiveness of a Multifaceted Intervention in Reducing High Risk Prescribing of Non-steroidal Anti-inflammatory Drugs and Antiplatelet Agents|Completed||N/A|33|Actual|University of Dundee||1|||f||||t||||||||Undecided|Follow up data is routinely collected clinical data. The trial team are data processors not data controllers, so cannot make the decision to share, although an application to share can be made to the National Health Service data controllers.|2017-10-11 03:52:54.739144|2017-10-11 03:52:54.739144
NCT01425333|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-26|||April 2011||2011-04-01|August 2011|2011-08-01|February 2013|Anticipated|2013-02-01|August 2012|Anticipated|2012-08-01||Interventional|||The Impact of Surgical Treatment of Endometriomas on Ovarian Reserve|The Impact of Surgical Treatment of Ovarian Endometriomas on Ovarian Reserve: a Randomised Controlled Trial of Laparoscopic Ovarian Cystectomy Versus Cyst Ablation - a Pilot Study|Unknown status|Recruiting|N/A|20|Anticipated|Derby Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:52:57.797026|2017-10-11 03:52:57.797026
NCT01425489|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-29|2016-11-23|||August 2011||2011-08-01|November 2016|2016-11-01|November 2018|Anticipated|2018-11-01|October 2018|Anticipated|2018-10-01||Observational|BioKrabbe||Biomarker for Krabbe Disease|Biomarker for Krabbe Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL|Recruiting||N/A|250|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"     For the development of the new biomarkers using the technique of Mass-spectometry 7,5 ml EDTA     blood and a dry blood spot filter card are taken. To proof the correct Krabbe diagnosis in     those patients where up to the enrollment in the study no genetic testing has been done,     sequencing of Krabbe will be done. The analyses are done in the Albrecht-Kossel-Institute for     Neuroregeneration (AKos), POB 100 888, Gehlsheimer Str. 20, 18055 Rostock (Germany)   "|Undecided||2017-10-11 03:52:54.859955|2017-10-11 03:52:54.859955
NCT01425476|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2017-08-08|||July 2008||2008-07-01|August 2017|2017-08-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors|Breast Cancer Prevention Using Synergistic Prostaglandin Inhibitors (The Vitamin D/Celecoxib Study)|Completed||Phase 1/Phase 2|45|Actual|Hartford Hospital||3|||f||||f||||||||||2017-10-11 03:52:54.970874|2017-10-11 03:52:54.970874
NCT01425463|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-05-08|2014-10-30||March 2011||2011-03-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional||Baseline Characteristics refer to the Full Analysis Set (FAS). FAS consists of all enrolled subjects who took at least one dose of study medicine and have at least one post-baseline effectiveness measurement (Hemoglobin-value). It also includes subjects with protocol deviance and incomplete data due to withdrawal.|A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects|A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy|Completed||Phase 3|256|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:52:55.208461|2017-10-11 03:52:55.208461
NCT01425450|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2011-10-28|||July 2011||2011-07-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers|A Randomised, Double-blind Placebo-controlled Study to Assess the Safety of Four Single Ascending Doses of HF1020 in Healthy Male Subjects|Completed||Phase 1|32|Actual|Trident Pharmaceuticals Inc||2|||f||||f||||||||||2017-10-11 03:52:55.710465|2017-10-11 03:52:55.710465
NCT01425437|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2014-11-14|||June 2012||2012-06-01|November 2014|2014-11-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Observational|||Keloid Tissue Bank|Keloid Tissue Bank - Longitudinal Clinical Data Repository; A Genomic and Molecular Research to Identifying Molecular Markers and Signal Transduction Pathways in Keloid; and Correlations With the Natural History of the Disease.|Terminated||N/A|78|Actual|Tirgan, Michael H., M.D.|||1|Poor Enrollment|f||||f||||||Samples With DNA|"     Sample of keloid tissue and small amount of normal appearing skin from an area that is     adjacent to the keloid will be collected from each participant. Each patient may undergo one     or more biopsies during the span of this study. Tissue biopsy may be repeated from the same     or a different keloid in the same patient. Patients may be re-contacted for additional blood     or other tissue samples.   "|||2017-10-11 03:52:55.861801|2017-10-11 03:52:55.861801
NCT01425424|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-12-17|||April 2012||2012-04-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study|Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study|Terminated||N/A|18|Actual|Pennington Biomedical Research Center||3||The PI was leaving Pennington|f||||f||||||||||2017-10-11 03:52:55.955498|2017-10-11 03:52:55.955498
NCT01425411|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-29|||November 2006||2006-11-01|August 2011|2011-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy|Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy|Completed||Phase 4|38|Actual|Mustafa Kemal University||1|||f||||||||||||||2017-10-11 03:52:56.071201|2017-10-11 03:52:56.071201
NCT01425398|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2011-08-29|||November 2011||2011-11-01|August 2011|2011-08-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||A Trial to Evaluate the Effect of Rosuvastatin on Inflammation in Patients Undergoing Isolated Cardiac Valve Surgery|A Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Effect of Rosuvastatin on Inflammation in Patients Undergoing Isolated Cardiac Valve Surgery|Unknown status|Not yet recruiting|Phase 3|170|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 03:52:56.173383|2017-10-11 03:52:56.173383
NCT01425385|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-08-17|||September 2011||2011-09-01|August 2017|2017-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Autoregulation Assessment During Liver Transplantation|Non-Invasive Assessment of Cerebral Blood Flow Autoregulation in Patients Undergoing Liver Transplantation|Completed||N/A|10|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 03:52:56.274304|2017-10-11 03:52:56.274304
NCT01425372|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-07-22|||November 2010||2010-11-01|July 2015|2015-07-01|June 2013|Actual|2013-06-01|May 2012|Actual|2012-05-01||Observational|P13UK||Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months|A Prospective Study to Evaluate the Immune Response of UK Infants Receiving the 13-valent Pneumococcal Conjugate Vaccine as Part of Their Routine Primary Immunisation Schedule at 2 and 4 Months|Completed||N/A|93|Actual|Public Health England|||1||f||||t||||||||||2017-10-11 03:52:56.355291|2017-10-11 03:52:56.355291
NCT01425359|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-10-30|2014-10-20|2013-10-08|September 2011||2011-09-01|October 2014|2014-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|TERISA|Safety Analysis Set: randomized participants who received at least one dose of study treatment.|Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina|A Phase 4, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of Ranolazine in Subjects With Chronic Stable Angina and Coronary Artery Disease With a History of Type 2 Diabetes Mellitus|Completed||Phase 4|949|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 03:52:56.465686|2017-10-11 03:52:56.465686
NCT01425346|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-26|||June 2011||2011-06-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||ClearPath DS-120 Clinical Study Protocol|Freedom Meditech ClearPath DS-120 Clinical Study Protocol FM2-002-CTP|Completed||N/A|128|Actual|Freedom Meditech|||1||f||||f||||||||||2017-10-11 03:52:57.701782|2017-10-11 03:52:57.701782
NCT01425307|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-05-02|2016-04-13||August 2011||2011-08-01|May 2017|2017-05-01|November 2015|Actual|2015-11-01|March 2015|Actual|2015-03-01||Interventional|TWiTCH||Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea|TCD With Transfusions Changing to Hydroxyurea (TWiTCH): A Phase III Randomized Trial to Compare Standard Therapy (Erythrocyte Transfusions) With Alternative Therapy (Hydroxyurea) for the Maintenance of Lowered TCD Velocities in Pediatric Subjects With Sickle Cell Anemia and Abnormal Pre-treatment TCD Velocities|Terminated||Phase 3|159|Actual|Children's Hospital Medical Center, Cincinnati|Further analysis is required to verify that the Adverse Events are accurately represented.|2||The study was stopped early due to successfully meeting the primary endpoint|f||||t||||||||No||2017-10-11 03:52:58.043236|2017-10-11 03:52:58.043236
NCT01425294|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-02-17|||August 2011||2011-08-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment|A Multicenter, Non-interventional, Prospective Study to Collect Efficacy and Safety Data in Chinese Patients Who Have Received Faslodex 250mg Treatment Under the Condition of Actual Usage in Clinical Practice|Terminated||N/A|231|Actual|AstraZeneca|||1|"The study has been decided to be early terminated for the FAS 500 mg has launched in 2015. The   use mothod of 250mg per month in clinical practice is off-label."|f||||t||||||||||2017-10-11 03:52:59.221502|2017-10-11 03:52:59.221502
NCT01425268|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-05-23|2017-02-26||October 2011||2011-10-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|XPAND||Patient Controlled Tissue Expansion for Breast Reconstruction|AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction|Completed||N/A|158|Actual|AirXpanders, Inc.|"Device improvements occurred during the study with later subjects completing the study with a revised version of the device.
Results include all subjects treated in the study, regardless of device version."|2|||f||||t||t|f|||||No||2017-10-11 03:52:59.67545|2017-10-11 03:52:59.67545
NCT01425255|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2016-06-18|||August 2011||2011-08-01|August 2011|2011-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||The Impact of Continuous Glucose Monitoring Use on Sleep in Parents of Children With Type 1 Diabetes Mellitus|Prospective Exploratory Study Evaluating Sleep Quality and Sleep-Wake Patterns in Parents of Children With Type 1 Diabetes Before and Several Weeks After Initiating Using RT-CGM of Their Children.|Withdrawn||N/A|0|Actual|Wolfson Medical Center|||1|Enrollment finished and a paper was published.|f||||f||||||||||2017-10-11 03:53:00.237239|2017-10-11 03:53:00.237239
NCT01425242|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2014-12-08|||September 2011||2011-09-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PISA||Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension|An Open-label PET-observer-blinded Pilot Study of the Effect of Aliskiren- Versus Amlodipine-based Antihypertensive Treatment in Patients With Small Abdominal Aortic Aneurysm and Mild to Moderate Hypertension on Aneurysmal FDG-uptake|Terminated||N/A|3|Actual|VU University Medical Center||2||Insufficient number of participants|f||||f||||||||||2017-10-11 03:53:01.138429|2017-10-11 03:53:01.138429
NCT01425229|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-05-03|2014-07-08||June 2011||2011-06-01|May 2017|2017-05-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Observational|||Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin|Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Steady State Bosentan Before and During CYP3A4-inhibition by Clarithromycin|Completed||N/A|16|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-11 03:53:01.282469|2017-10-11 03:53:01.282469
NCT01425216|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-10-17|||March 2013||2013-03-01|October 2016|2016-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Sorafenib for Patients With Extensive Keloids|Phase II Trial of Sorafenib in Patients With Extensive Keloids|Terminated||Phase 2|60|Anticipated|Tirgan, Michael H., M.D.||1||IND application was not approved by the US FDA - Project was never started|f||||f||||||||||2017-10-11 03:53:01.645761|2017-10-11 03:53:01.645761
NCT01425203|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-03-09|2014-07-29||November 2011||2011-11-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Baseline Characteristics were reported only for the Full Analysis Set (FAS), which consisted of all randomized participants who received at least 1 dose of any trial medication (PEG, RBV, or BOC) in the Treatment Phase. The Crossover Arm is not included as these participants originally started the study in the PBO + PR Control Arm at Baseline.|The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160)|Safety and Efficacy of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for Treatment of Chronic Hepatitis C Genotype 1 in Russia: Previously Untreated Patients and Patients Who Failed Prior Treatment With Pegylated-Interferon Plus Ribavirin|Completed||Phase 3|238|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:53:01.766441|2017-10-11 03:53:01.766441
NCT01425190|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-03-09|2014-10-03||January 2012||2012-01-01|March 2017|2017-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||The Baseline Population includes all participants in Cohort 1 that received boceprevir. The trial was terminated prior to enrolling participants in either Cohorts 2 or 3.|Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)|Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (Phase 1b); Protocol No. P07614|Terminated||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||3||"The US FDA and the EU CHMP provided guidance indicating preference for intereferon-free   regimens in pediatric studies of HCV infection."|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:53:02.415411|2017-10-11 03:53:02.415411
NCT01424969|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2014-02-12|||August 2008||2008-08-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||The Effects of Platelet Rich Plasma on the Integrity of Rotator Cuff Repair|Effects of Platelet-Rich Fibrin Matrix on Repair Integrity of At-Risk Rotator Cuff Tears|Completed||N/A|37|Actual|University of Utah|||2||f||||f||||||||||2017-10-11 03:53:04.27399|2017-10-11 03:53:04.27399
NCT01425177|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2011-08-26|||August 2011||2011-08-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|SIDEROD||Effect of Saline Irrigation to DEcrease Rate Of Residual Common Bile Duct Stones|Effect of Saline Irrigation to Decrease Rate of Residual Common Bile Duct Stones|Unknown status|Recruiting|Phase 3|160|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 03:53:02.749013|2017-10-11 03:53:02.749013
NCT01425164|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-06-27|||January 2011||2011-01-01|June 2012|2012-06-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol|Ischemia In Hemodialysed Patients And Outcome: Ivabradine Versus Carvedilol. A Randomized, Double Blind Study|Unknown status|Recruiting|Phase 4|220|Anticipated|"University of Campania Luigi Vanvitelli"||2|||f||||f||||||||||2017-10-11 03:53:02.857645|2017-10-11 03:53:02.857645
NCT01425151|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2011-09-20|||January 2010||2010-01-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||The i-GelTM. A Randomized, Crossover Study With the Laryngeal Mask Airway ProSealTM in Anesthetized Pediatric Patients||Completed||N/A|60|Anticipated|Schulthess Klinik||2|||f||||f||||||||||2017-10-11 03:53:02.951326|2017-10-11 03:53:02.951326
NCT01425138|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2011-09-28|||June 2009||2009-06-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Systematic Review And Meta-Analysis Of Psoriasis Treatments.|Biologic And Non-biologic Systemic Treatments For Moderate To Severe Plaque Psoriasis: A Systematic Review & Meta-Analysis|Completed||N/A|0|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-11 03:53:03.035176|2017-10-11 03:53:03.035176
NCT01425125|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-12-09|||November 2011||2011-11-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Fractional Urate Excretion in Nonedematous Hyponatremia|Study of Nonedematous Hyponatremia and the Utility of Fractional Urate Excretion in Hyponatremia and Suspected Renal Salt Wasting Without Hyponatremia-|Withdrawn||N/A|0|Actual|Winthrop University Hospital||1|||f||||f||||||||||2017-10-11 03:53:03.109869|2017-10-11 03:53:03.109869
NCT01425112|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-26|||December 2007||2007-12-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy|Clinical Trial Comparing Subconjunctival and Topical Bevacizumab as Adjuncts to Trabeculectomy in Improving Outcomes for Primary Open Angle Glaucoma|Completed||N/A|180|Actual|Sudhalkar Eye Hospital||1|||f||||t||||||||||2017-10-11 03:53:03.200294|2017-10-11 03:53:03.200294
NCT01425099|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-11-03|||September 2011||2011-09-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Drug Interaction Study Between Dolutegravir and Prednisone|An Adaptive, Two Part, Two Period, Single Sequence, Drug Interaction Study Between Dolutegravir 50 mg and Prednisone in Adult Healthy Volunteers|Completed||Phase 1|12|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 03:53:03.283589|2017-10-11 03:53:03.283589
NCT01425073|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2014-04-09|||February 2012||2012-02-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya|Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya: a Randomized Trial|Completed||N/A|500|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 03:53:03.469977|2017-10-11 03:53:03.469977
NCT01425060|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-03-13|||October 2011||2011-10-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Improving Effective Contraceptive Use Among Opioid-maintained Women|Improving Effective Contraceptive Use Among Opioid-maintained Women|Completed||Phase 1|31|Actual|University of Vermont||2|||f||||t||||||||||2017-10-11 03:53:03.582694|2017-10-11 03:53:03.582694
NCT01425047|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2011-08-31|||November 2010||2010-11-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Observational|||Bioavailability of Xanthones From Mangosteen|Bioavailability and Anti-inflammatory Activities of Mangostins: a Pilot Study|Completed||N/A|10|Actual|Ohio State University|||2||f||||t||||||Samples Without DNA|"     Sera and urine   "|||2017-10-11 03:53:03.691703|2017-10-11 03:53:03.691703
NCT01425034|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2017-08-11|||September 2011||2011-09-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|LRTI||Postoperative Rehabilitation Following Trapeziectomy and Ligament Reconstruction Tendon Interposition|Postoperative Rehabilitation Following Trapeziectomy and Ligament Reconstruction Tendon Interposition: a Prospective, Randomized Multi-center Study|Active, not recruiting||N/A|229|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 03:53:03.759074|2017-10-11 03:53:03.759074
NCT01425021|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-08-17|||August 2010||2010-08-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Retrieval and Analysis of Orthopedic Implants at Revision Arthroplasty Surgery|Retrieval and Analysis of Orthopedic Implants at Revision Arthroplasty Surgery|Completed||N/A|199|Actual|University of Utah|||1||f||||t||||||||||2017-10-11 03:53:03.844395|2017-10-11 03:53:03.844395
NCT01425008|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-06-26|||September 15, 2011|Actual|2011-09-15|June 2017|2017-06-01|March 1, 2018|Anticipated|2018-03-01|April 11, 2017|Actual|2017-04-11||Interventional|||Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma|An Open-Label, Phase 1, Dose Escalation Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Melanoma|Active, not recruiting||Phase 1|149|Actual|Takeda||1|||f||||f|t|f||||||||2017-10-11 03:53:03.907696|2017-10-11 03:53:03.907696
NCT01424995|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-08-11|||December 2010||2010-12-01|August 2017|2017-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||The Natural History of Congenital Trigger Thumbs|The Natural History of Congenital Trigger Thumbs|Active, not recruiting||N/A|100|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 03:53:04.022966|2017-10-11 03:53:04.022966
NCT01424982|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2017-09-11|||October 2011|Actual|2011-10-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Hyper-CVAD and Ponatinib in Ph-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)|Phase II Study of Combination of Hyper-CVAD and Ponatinib in Patients With Philadelphia (PH) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||3|||f||||f|t|f||||||||2017-10-11 03:53:04.101787|2017-10-11 03:53:04.101787
NCT01424956|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2013-04-16|||July 2011||2011-07-01|April 2013|2013-04-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Observational|||CRRS-4 Pivotal Somo•v™ ABUS ROC Reader Observer Study|To Determine the Impact on Reader Performance, as Defined by the Area Under the Receiver Operating Characteristic Curve, When Automated Breast Ultrasound and a Screening Mammogram Are Combined, Compared to a Screening Mammogram Alone in Asymptomatic Women With >50% Parenchymal Density and a Screening Mammogram Assigned a BI-RADS Assessment Category 1 (Negative) or 2 (Normal With Benign Findings).|Completed||N/A|17|Actual|U-Systems, Inc.|||1||f||||f||||||||||2017-10-11 03:53:04.34973|2017-10-11 03:53:04.34973
NCT01424943|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-12-09|2014-07-22||December 2010||2010-12-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Parents of children with disabilities eligible for IDEA Part C Services and their identified child|Family Networks Project Study One: An Efficacy Study of Stepping Stones Triple P for Children Under Age Two|The Family Networks Project Study One: Supporting Family Confidence, Competence, and Community Connections|Completed||N/A|49|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-11 03:53:04.439506|2017-10-11 03:53:04.439506
NCT01424930|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2014-07-14|2014-03-28||October 2011||2011-10-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer|An Open-Label Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Subjects With Metastatic Castration-Resistant Prostate Cancer|Completed||Phase 2|25|Actual|Janssen-Ortho Inc., Canada||2|||f||||t||||||||||2017-10-11 03:53:04.825962|2017-10-11 03:53:04.825962
NCT01424917|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-22|2017-01-23|||March 2008||2008-03-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|CAV||Noninvasive Predictors of Transplant Vasculopathy|Noninvasive Predictors of Transplant Vasculopathy|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute|||1|Investigator Left university|f||||f||||||||||2017-10-11 03:53:05.62956|2017-10-11 03:53:05.62956
NCT01424904|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2013-10-17|||February 2012||2012-02-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||DGB-01 Effects on Endurance Exercise|DGB-01 Effects on Endurance Exercise|Completed||N/A|29|Actual|University of Kentucky||1|||f||||f||||||||||2017-10-11 03:53:05.809037|2017-10-11 03:53:05.809037
NCT01424891|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-08-25|||April 2004||2004-04-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|July 2006|Actual|2006-07-01||Interventional|||Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe|Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe|Completed||N/A|31|Actual|Heidelberg University||3|||f||||f||||||||||2017-10-11 03:53:05.902035|2017-10-11 03:53:05.902035
NCT01424878|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2017-10-05|||July 5, 2010||2010-07-05|February 12, 2014|2014-02-12|February 12, 2014||2014-02-12|||||Observational|||Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients|Study of Molecular Pathways in Medullary Thyroid Carcinoma (MTC) and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients|Completed||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:53:05.99467|2017-10-11 03:53:05.99467
NCT01424865|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-05-06|||November 2011||2011-11-01|May 2015|2015-05-01||||December 2015|Anticipated|2015-12-01||Observational|||Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial|Evaluation of the Co-Expression of the Cancer Stem Cell Marker ALDH1 and of HER2 as a Predictor of Adjuvant Trastuzumab Response in Breast Cancers of Women in NSABP B31|Unknown status|Active, not recruiting|N/A|1874|Anticipated|NSABP Foundation Inc|||1||f||||f||||||||||2017-10-11 03:53:06.062734|2017-10-11 03:53:06.062734
NCT01424852|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2012-02-21|||January 2012||2012-01-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Does Administration of Probiotics During Infancy Increase the Caries Risk of a Child|Early Administration of Bifidobacterium Lactis BB-12 and the Caries Occurence of Children a 4 Years of Age|Withdrawn||N/A|0|Actual|University of Turku||2||Too few of the invited subjects wanted to participate|f||||t||||||||||2017-10-11 03:53:06.161715|2017-10-11 03:53:06.161715
NCT01424839|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-06-03|||October 2011||2011-10-01|June 2015|2015-06-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|SIOPCNSGCTII||Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors|SIOP CNS GCT II: Prospective Trial for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Intracranial Germ Cell Tumors|Recruiting||Phase 4|400|Anticipated|University Hospital Muenster||7|||f||||t||||||||||2017-10-11 03:53:06.258682|2017-10-11 03:53:06.258682
NCT01424826|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2013-10-30|||January 2012||2012-01-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|RIFRAL||The Effect of Intermittent Rifampicin on Raltegravir|A Single Arm, 3 Phase Study to Determine the Effect of Intermittent Dosing of Rifampicin on the Pharmacokinetics of Raltegravir in Healthy Volunteers|Completed||Phase 1|18|Actual|University of Liverpool||1|||f||||t||||||||||2017-10-11 03:53:06.398594|2017-10-11 03:53:06.398594
NCT01424813|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-05-28|2015-05-01|2014-05-08|December 2012||2012-12-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional||Randomized participants|A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma|A 12-week Comparison of the Efficacy and Safety of Albuterol Spiromax® Versus Placebo in Subjects 12 Years and Older With Persistent Asthma|Completed||Phase 3|158|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 03:53:06.50343|2017-10-11 03:53:06.50343
NCT01424800|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-03-05|||July 2011||2011-07-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Influence of Variations in Systemic Blood Flow and Blood Pressure on Cerebral Oxygenation Measured by Cerebral Oximetry|Influence of Variations in Systemic Blood Flow and Blood Pressure on Cerebral Oxygenation Measured by Cerebral Oximetry|Completed||N/A|34|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:53:07.430597|2017-10-11 03:53:07.430597
NCT01424787|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-26|2015-03-05|||October 2011||2011-10-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|Steering||Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)|Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)|Completed||N/A|324|Actual|Fresenius Medical Care Deutschland GmbH|||1||f||||f||||||||||2017-10-11 03:53:07.508742|2017-10-11 03:53:07.508742
NCT01424774|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2012-08-13|||September 2011||2011-09-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning|A Prospective Study to Estimate Inadvertent Radiation Exposure From Strontium Isotopes in Patients Who Have Undergone CardioGen-82® PET MPI Scanning|Completed||N/A|155|Actual|Bracco Diagnostics, Inc|||1||f||||f||||||||||2017-10-11 03:53:07.630222|2017-10-11 03:53:07.630222
NCT01424761|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2013-06-10|||August 2011||2011-08-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Coenzyme Q10 in Relation to the Antioxidative Vitamins, Oxidative Stress and Inflammation in Coronary Artery Disease Patients During Statin Therapy||Completed||Phase 2/Phase 3|51|Actual|Taichung Veterans General Hospital||2|||f||||t||||||||||2017-10-11 03:53:07.706688|2017-10-11 03:53:07.706688
NCT01424748|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-23|2011-08-26|||April 2003||2003-04-01|August 2011|2011-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Clinical Trial of Tahitian Noni Juice Safety|A Single Centre, Double-blind, Three Dose Level, Parallel Group, Placebo Controlled Safety Study With Tahitian Noni Juice in Healthy Subjects|Completed||Phase 1|96|Actual|Tahitian Noni International, Inc.||4|||f||||t||||||||||2017-10-11 03:53:07.783583|2017-10-11 03:53:07.783583
NCT01424735|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-26|||July 2006||2006-07-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||TLR-9 Antagonism in Steroid Resistant Optic Neuritis|Outcomes of TLR-9 Antagonism in Steroid Resistant Optic Neuritis; A Pilot Study|Completed||N/A|8|Actual|Sudhalkar Eye Hospital||1|||f||||t||||||||||2017-10-11 03:53:07.848426|2017-10-11 03:53:07.848426
NCT01424722|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2017-08-03|||August 2011|Actual|2011-08-01|August 2017|2017-08-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|AnalyzeST||ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients|ST Monitoring to Detect ACS Events in ICD Patients|Terminated||N/A|2258|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 03:53:07.946317|2017-10-11 03:53:07.946317
NCT01424709|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2014-09-23|||December 2010||2010-12-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|May 2014|Actual|2014-05-01||Interventional|BRAVO||Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)|Individualized 1st Line Chemotherapy Based on BRCA1 and RRM1 mRNA Expression Levels for Advanced Non-small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|Tongji University||2|||f||||t||||||||||2017-10-11 03:53:08.213726|2017-10-11 03:53:08.213726
NCT01424696|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-09-25|||December 2011||2011-12-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|BONUS||Baby Observational and Nutritional Study|Baby Observational and Nutritional Study (BONUS)|Completed||Phase 2|231|Actual|Seattle Children's Hospital|||1||f||||t||||||Samples With DNA|"     -  serum and/or plasma        -  urine        -  stool        -  oropharyngeal swab (OP swab)        -  saliva        -  sweat        -  buccal brushings   "|||2017-10-11 03:53:08.311401|2017-10-11 03:53:08.311401
NCT01424683|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2013-06-04|||August 2011||2011-08-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Development of a Method for Converting Visual Analogue Scale (VAS) Scores for Pain and Mobility to EQ-5D Answers|Development of a Method for Converting VAS Scores for Pain and Mobility to EQ-5D Answers|Completed||N/A|217|Actual|Aalborg Universitetshospital|||2||f||||t||||||||||2017-10-11 03:53:08.440089|2017-10-11 03:53:08.440089
NCT01424657|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-08-26|||October 1997||1997-10-01|August 2011|2011-08-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary Obstruction||Terminated||Phase 3|378|Actual|McGill University Health Center||2||The study was terminated before reaching the estimated sample size because of trial fatigue.|f||||f||||||||||2017-10-11 03:53:08.749251|2017-10-11 03:53:08.749251
NCT01424644|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2014-01-21|2013-11-20||September 2011||2011-09-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents|A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of a Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine (Tdap, Boostrix®) and Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine (Gardasil®) in Healthy Adolescents When Administered With MenACWY Conjugate Vaccine|Completed||Phase 4|801|Actual|Novartis||2|||f||||f||||||||||2017-10-11 03:53:08.868524|2017-10-11 03:53:08.868524
NCT01423669|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-25|||August 2010||2010-08-01|August 2011|2011-08-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Observational|||Epidemiology Study of Psychosis|The Hong Kong Morbidity Survey 2010 Part 3: Epidemiology Study of Psychosis Disorder and Sub-clinical Psychotic Experiences|Unknown status|Recruiting|N/A|5000|Anticipated|The University of Hong Kong|||1||f||||f||||||||||2017-10-11 03:53:09.435395|2017-10-11 03:53:09.435395
NCT01423656|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-01-25|||August 2011||2011-08-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102||Completed||Phase 1|102|Actual|LEO Pharma||2|||f||||f||||||||||2017-10-11 03:53:09.529288|2017-10-11 03:53:09.529288
NCT01423643|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-02-22|||March 2001||2001-03-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||HCV/HIV Coinfection: Antiviral Therapy and Fibrosis|HCV/HIV Coinfection: Antiviral Therapy and Fibrosis|Completed||N/A|1250|Actual|Johns Hopkins University|||2||f||||f||||||Samples Without DNA|"     Frozen serum and plasma samples. Liver biopsy fixed slides.   "|||2017-10-11 03:53:09.600938|2017-10-11 03:53:09.600938
NCT01423630|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2017-08-22|||August 2011|Actual|2011-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver|Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver|Active, not recruiting||N/A|40|Anticipated|Region Skane||1|||f||||f||||||||||2017-10-11 03:53:09.693485|2017-10-11 03:53:09.693485
NCT01423617|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2015-04-05|2015-03-25||July 2011||2011-07-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy and Safety of Zenoctil in Reducing Body Weight|Double-blind, Randomized, Placebo-controlled, Bicentric Study to Evaluate the Safety and Efficacy of Zenoctil in Reducing Body Weight of Overweight Subjects|Completed||Phase 3|92|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-11 03:53:09.801775|2017-10-11 03:53:09.801775
NCT01424631|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-26||||||August 2011|2011-08-01||||||||Interventional|||Single Incision Versus Conventional Laparoscopic Appendectomy||Completed||N/A|2|Actual|Mansoura University||2|||f||||||||||||||2017-10-11 03:53:12.051139|2017-10-11 03:53:12.051139
NCT01424618|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-25|||January 2006||2006-01-01|August 2011|2011-08-01||||September 2012|Anticipated|2012-09-01||Interventional|||A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs|A Novel Approach to Endometrial Preparation in Recipients of Donor Cycles|Unknown status|Recruiting|N/A|20|Anticipated|Kelly, Maureen, M.D.||2|||f||||t||||||||||2017-10-11 03:53:12.130884|2017-10-11 03:53:12.130884
NCT01424605|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-08-26|||January 2010||2010-01-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Glidescope||The Comparison of Glidescope® and the Direct Laryngoscopy in the Insertion of the Double Lumen Endotracheal Tube|The Comparison of Glidescope® and the Direct Laryngoscopy in the Insertion of the Double Lumen Endotracheal Tube|Completed||N/A|60|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||t||||||||||2017-10-11 03:53:12.234416|2017-10-11 03:53:12.234416
NCT01424592|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-08-31|||April 2011||2011-04-01|August 2015|2015-08-01|March 2016|Anticipated|2016-03-01|February 2015|Actual|2015-02-01||Observational|||In-Hospital Portable Sleep Monitoring for the Evaluation of Obstructive Sleep Apnea (OSA)|Inpatient Portable Sleep Apnea Testing of Hospitalized Medical Patients for the Evaluation of Obstructive Sleep Apnea Prospectively Compared to Outpatient Laboratory-based Polysomnography|Unknown status|Active, not recruiting|N/A|140|Anticipated|John H. Stroger Hospital|||1||f||||f||||||||||2017-10-11 03:53:12.308936|2017-10-11 03:53:12.308936
NCT01424579|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2013-04-03|||February 2008||2008-02-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Diacutaneous Fibrolysis and Subacromial Syndrome|Effectiveness of Diacutaneous Fibrolysis for the Treatment of Subacromial Impingement Syndrome: a Randomised Controlled Trial|Completed||N/A|120|Actual|Jordi Gol i Gurina Foundation||3|||f||||f||||||||||2017-10-11 03:53:12.392308|2017-10-11 03:53:12.392308
NCT01424566|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2016-07-04||2016-06-24|January 2012||2012-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer|A Two-part, Placebo-controlled, Study of the Safety and Efficacy of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Have Inadequate Analgesia Even With Optimized Chronic Opioid Therapy.|Completed||Phase 3|406|Actual|GW Pharmaceuticals Ltd.||2|||f||||t||||||||||2017-10-11 03:53:12.519135|2017-10-11 03:53:12.519135
NCT01424553|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2015-04-20|||October 2011||2011-10-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|EPIPAGEADO||Respiratory Outcome at Adolescence of Very Low Birthweight Infants|Respiratory Outcome at Adolescence of Very Low Birthweight Infants : the EPIPAGE Cohort|Completed||N/A|355|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 03:53:14.026213|2017-10-11 03:53:14.026213
NCT01424540|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-07-18|||September 1, 2011|Actual|2011-09-01|July 2017|2017-07-01|October 3, 2011|Actual|2011-10-03|October 3, 2011|Actual|2011-10-03||Interventional|||Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805|A Randomized, Double Blind, Single Dose, Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805 in Healthy Adult Volunteers|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:53:14.100566|2017-10-11 03:53:14.100566
NCT01424527|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-05-15|||December 2010||2010-12-01|May 2017|2017-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|CAT||Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study|Validation of the New COPD Assessment Test Translated Into Korean in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|100|Actual|GlaxoSmithKline|||1||f||||f||||||None Retained|"     none retained   "|||2017-10-11 03:53:14.185654|2017-10-11 03:53:14.185654
NCT01424501|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2016-11-29|2016-11-29|2014-05-29|November 2011||2011-11-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease|Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 When Administered to Adults With TB Disease|Terminated||Phase 2|142|Actual|GlaxoSmithKline|Due to a safety signal found at a planned interim safety review, further conduct of this safety study is not recommended hence the study was terminated.|6||"Due to a safety signal found at a planned interim safety review, further conduct of this safety   study is not recommended hence the study was terminated."|f||||||||||||||2017-10-11 03:53:14.604283|2017-10-11 03:53:14.604283
NCT01424488|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-08-26|||September 2011||2011-09-01|August 2011|2011-08-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Sugammadex Efficacy and Safety for Reversal of Pipecuronium-induced Neuromuscular Blockade|Randomized, Parallel-group, Placebo-controlled, Safety-assessor Blinded Trial in Adult Subjects Evaluating the Efficacy and Safety of Sugammadex for Reversal of Pipecuronium-induced Neuromuscular Blockade in Subjects Undergoing Abdominal Surgery Under General Anesthesia|Unknown status|Not yet recruiting|Phase 4|42|Anticipated|Central Clinical Hospital #1 of LLC Russian Railways||2|||f||||f||||||||||2017-10-11 03:53:19.052487|2017-10-11 03:53:19.052487
NCT01424306|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2017-07-06|2017-04-19||October 2011||2011-10-01|July 2017|2017-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|DASI|Only results of 24 subjects who completed study 'per protocol' are reported here|Diet and Systemic Inflammation|Diet and Systemic Inflammation|Completed||N/A|25|Actual|Fred Hutchinson Cancer Research Center||3|||f||||f||||||||||2017-10-11 03:53:20.623654|2017-10-11 03:53:20.623654
NCT01424475|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-05-10|||August 11, 2011|Actual|2011-08-11|May 2017|2017-05-01|January 12, 2015|Actual|2015-01-12|January 12, 2015|Actual|2015-01-12||Interventional|||LRRK2 Mutation and Parkinson's Disease|LRRK2 Mutation and Parkinson's Disease: A Functional Neuroimaging and Behavioural Study Characterising the Neurocognitive Phenotype|Terminated||Phase 1|5|Actual|GlaxoSmithKline||2||"Following extensive efforts to increase recruitment, it will not be possible to complete the   study protocol within a reasonable time"|f||||f||||||||||2017-10-11 03:53:19.142227|2017-10-11 03:53:19.142227
NCT01424462|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2017-06-19|||April 19, 2010|Actual|2010-04-19|June 2017|2017-06-01|July 6, 2010|Actual|2010-07-06|July 6, 2010|Actual|2010-07-06||Interventional|||Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.|An Open Label, Randomised Healthy Volunteer Study to Assess the Single Dose Safety and Pharmacokinetics of Three Modified Release Dosage Forms of Firategrast|Completed||Phase 1|20|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 03:53:19.220744|2017-10-11 03:53:19.220744
NCT01424449|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-12-13|||January 2010||2010-01-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A PET Study in Healthy Volunteers|A Positron Emission Tomography Study in Healthy Male Subjects to Examine the Test-retest Reliability of the D2/3 Agonist Radiotracer [11C]PHNO|Completed||Phase 1|7|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:53:19.314734|2017-10-11 03:53:19.314734
NCT01424436|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-06-13|||May 19, 2010|Actual|2010-05-19|June 2017|2017-06-01|December 8, 2011|Actual|2011-12-08|December 8, 2011|Actual|2011-12-08||Interventional|||Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient|Modulation of Beta-amyloid Levels in CSF and Plasma by GSK933776 in Patients With Mild Alzheimer's Disease or Mild Cognitive Impairment|Completed||Phase 1|19|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:53:19.395511|2017-10-11 03:53:19.395511
NCT01424423|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-09-19|||February 11, 2010|Actual|2010-02-11|September 2017|2017-09-01|August 26, 2010|Actual|2010-08-26|August 26, 2010|Actual|2010-08-26||Interventional|||NOGO-A in Multiple Sclerosis FTIH|A Randomized, Single-blind (Investigator and Subject), Placebo-controlled, Single Ascending Dose Study Exploring the Preliminary Safety, Tolerability, and Pharmacokinetics of GSK1223249 Administered by Intravenous (IV) Infusion to Subjects With Relapsing Forms of Multiple Sclerosis, Not on Disease Modifying Therapy|Terminated||Phase 1|3|Actual|GlaxoSmithKline||10|||f||||f||||||||||2017-10-11 03:53:19.502075|2017-10-11 03:53:19.502075
NCT01424410|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-12|||February 2012||2012-02-01|June 2017|2017-06-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Observational|||Health Benefits of Repeated Treatment in Pediatric Schistosomiasis|Health Benefits of Repeated Treatment in Pediatric Schistosomiasis|Completed||N/A|360|Actual|University of Edinburgh|||1||f||||f||||||||||2017-10-11 03:53:19.700773|2017-10-11 03:53:19.700773
NCT01424384|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-12|2017-07-05|||September 19, 2008|Actual|2008-09-19|July 2017|2017-07-01|April 30, 2009|Actual|2009-04-30|April 30, 2009|Actual|2009-04-30||Interventional|||Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic|Emotional Processing in Healthy Male Volunteers Treated With GSK424887. A Single Centre, Randomised, Double-blind, Placebo-controlled Parallel Group Study|Completed||Phase 1|54|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 03:53:19.906873|2017-10-11 03:53:19.906873
NCT01424371|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2012-09-28|||November 2011||2011-11-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|April 2013|Anticipated|2013-04-01||Observational|||Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)|A Case-Control Study to Evaluate the Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine in the Elderly Aged ≥65 Years.|Unknown status|Recruiting|N/A|1000|Anticipated|Fraser Health|||3||f||||f||||||||||2017-10-11 03:53:20.01251|2017-10-11 03:53:20.01251
NCT01424358|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2015-03-23|||July 2011||2011-07-01|December 2012|2012-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Web-based Education on Oral Cancer for Primary Care Physicians in Ohio|Web-based Education on Oral Cancer for Primary Care Physicians in Ohio|Completed||N/A|10|Actual|Creighton University||1|||f||||f||||||||||2017-10-11 03:53:20.103205|2017-10-11 03:53:20.103205
NCT01424345|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2012-10-04|||December 2011||2011-12-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient|A Randomized, Controlled Trial Evaluating the Role of ImmuKnow® in the Management of Immunosuppressants Regarding Opportunistic Infections and Acute Rejection in the Renal Transplant Patient|Terminated||Phase 4|40|Anticipated|CAMC Health System||2||The PI is relocating to another State/ another hospital|f||||f||||||||||2017-10-11 03:53:20.196043|2017-10-11 03:53:20.196043
NCT01424332|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2011-08-25|||December 2007||2007-12-01|August 2011|2011-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects|A Randomized, Open Label, Three-way Crossover Study to Evaluate the Pharmacodynamic Interactions Between Darexaban (YM150)/Darexaban Glucuronide (YM-222714) and Acetyl Salicylic Acid (ASA) in Healthy Male Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-10-11 03:53:20.307529|2017-10-11 03:53:20.307529
NCT01424319|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-08-25|||August 2011||2011-08-01|August 2017|2017-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan|Reducing Residual Albuminuria in Subjects With Diabetes & Nephropathy With Atrasentan - A Phase 2b, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety & Efficacy in Japanese Subjects|Completed||Phase 2|58|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 03:53:20.43177|2017-10-11 03:53:20.43177
NCT01423097|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2012-10-09|||September 2011||2011-09-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|MOVES||Magnitude of Osteoarthritis disadVantage on pEoples liveS|Magnitude of Osteoarthritis disadVantage on pEoples liveS|Completed||N/A|1015|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 03:53:38.678027|2017-10-11 03:53:38.678027
NCT01424293|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-29|2015-08-06|||May 2010||2010-05-01|August 2015|2015-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Fluorescent Evaluation of Colorectal Anastamoses|The Use of Fluorescent Imaging to Evaluate Bowel Anastomotic Perfusion|Unknown status|Active, not recruiting|N/A|120|Anticipated|Maimonides Medical Center||1|||f||||f||||||||||2017-10-11 03:53:21.432907|2017-10-11 03:53:21.432907
NCT01424280|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2011-12-01|||August 2011||2011-08-01|December 2011|2011-12-01||||November 2011|Actual|2011-11-01||Interventional|||Single Dose Study of GSK1440115 in Patients With Asthma|A Phase 1, Randomized, Placebo Controlled, Crossover Study to Evaluate the Efficacy of GSK1440115 After a Single Oral Dose in Patients With Asthma|Completed||Phase 1|12|Actual|Accenture||2|||f||||f||||||||||2017-10-11 03:53:21.539109|2017-10-11 03:53:21.539109
NCT01424267|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2012-10-10|||July 2010||2010-07-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Zenith® LP Abdominal Aortic Aneurysm (AAA) Post-Market Registry|Zenith® LP AAA Endovascular Graft Post-Market Registry|Terminated||N/A|76|Actual|Cook Group Incorporated|||1|The registry was discontinued due to significant resources required.|f||||||||||||||2017-10-11 03:53:21.621514|2017-10-11 03:53:21.621514
NCT01424254|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-25|||October 2003||2003-10-01|August 2011|2011-08-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||The Effectiveness of Video-capsule Endoscopy in Gastrointestinal Bleeding of Obscure Origin||Completed||Phase 3|79|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 03:53:21.906746|2017-10-11 03:53:21.906746
NCT01424228|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2014-08-13|2013-11-11||June 2011||2011-06-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SPD555-401|The Safety Population was used for demographics. The Safety Population includes all subjects randomized into the study who took at least 1 dose of investigational product. Three subjects did not receive investigational product and therefore were not included in the Safety Population (n = 361).|Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 Years|A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Quality of Life, Safety and Tolerability of Long-term Treatment (24 Weeks) With Prucalopride in Subjects Aged ≥18 Years With Chronic Constipation|Completed||Phase 4|364|Actual|Shire||2|||f||||f||||||||||2017-10-11 03:53:22.0927|2017-10-11 03:53:22.0927
NCT01424215|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-08-12|||January 2011||2011-01-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy|The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy|Completed||N/A|100|Actual|Maimonides Medical Center||2|||f||||t||||||||||2017-10-11 03:53:23.241468|2017-10-11 03:53:23.241468
NCT01424202|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-25|||September 2008||2008-09-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|MIEICU||Effects of Mechanical Insufflation-Exsufflation in Preventing Respiratory Failure After Extubation|Effects of Mechanical Insufflation-Exsufflation in Preventing Respiratory Failure After Extubation|Completed||N/A|92|Actual|Hospital Sao Joao||2|||f||||f||||||||||2017-10-11 03:53:23.33427|2017-10-11 03:53:23.33427
NCT01424189|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-03-06|2017-01-13||July 2011||2011-07-01|March 2017|2017-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||This analysis population includes all participants with successful IOL implantation in at least 1 eye.|Clinical Investigation of AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL)|Clinical Investigation of AcrySof® IQ ReSTOR® Multifocal Toric Intraocular Lens Models SND1T3/ SND1T4/ SND1T5/ SND1T6|Completed||N/A|677|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 03:53:23.439747|2017-10-11 03:53:23.439747
NCT01424176|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-11-24|||July 2011||2011-07-01|November 2014|2014-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Dexpramipexole Renal PK Study|A Multicenter, Open-Label, Single-dose, Pharmacokinetic and Safety Study of Dexpramipexole (BIIB050) in Healthy Subjects and Subjects With Renal Impairment|Completed||Phase 1|36|Actual|Knopp Biosciences||2|||f||||f||||||||||2017-10-11 03:53:24.173711|2017-10-11 03:53:24.173711
NCT01424163|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-11-24|||August 2011||2011-08-01|November 2014|2014-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Dexpramipexole Japanese PK Study|A Single and Multiple Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Dexpramipexole (BIIB050) in Healthy Japanese and Caucasian Subjects|Completed||Phase 1|56|Actual|Knopp Biosciences||4|||f||||f||||||||||2017-10-11 03:53:24.266893|2017-10-11 03:53:24.266893
NCT01424150|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2017-08-28|||July 2013||2013-07-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|RELIEF||REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study|Restrictive Versus Liberal Fluid Therapy in Major Abdominal Surgery|Active, not recruiting||Phase 4|3000|Actual|Bayside Health||2|||f||||t||||||||||2017-10-11 03:53:24.348447|2017-10-11 03:53:24.348447
NCT01424137|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2012-02-02|||September 2011||2011-09-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|SALIF||Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)|Inspiratory Flow Parameters With Placebo Dry Powder Inhalers, Easyhaler and Diskus; an Open, Randomised, Multicentre Study in Patients With Asthma or COPD|Completed||N/A|227|Actual|Orion Corporation, Orion Pharma||3|||f||||f||||||||||2017-10-11 03:53:24.437361|2017-10-11 03:53:24.437361
NCT01424124|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-07-08|||November 2011||2011-11-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Efficacy of YHD001 in Asthma|Randomized, Double-blind, Placebo/Active-controlled, Multi-center Clinical Trial to Investigate the Safety/Tolerability and Efficacy of YHD001 Following 8 Weeks Oral Administration of YHD001 in Patients With Partially Controlled Asthma|Completed||Phase 2|56|Actual|Yuhan Corporation||4|||f||||f||||||||||2017-10-11 03:53:24.526985|2017-10-11 03:53:24.526985
NCT01424111|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-05-08|||August 2011||2011-08-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Exploring Biomarkers for Depression|Exploring Biomarkers for Depression|Active, not recruiting||N/A|40|Anticipated|Wyss Institute at Harvard University|||2||f||||f||||||||||2017-10-11 03:53:24.6171|2017-10-11 03:53:24.6171
NCT01424098|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-08-24|||August 2011||2011-08-01|August 2011|2011-08-01||||September 2012|Anticipated|2012-09-01||Interventional|||Balance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized Controlled Trial of Balance Training in Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|46|Anticipated|West Park Healthcare Centre||2|||f||||f||||||||||2017-10-11 03:53:24.708959|2017-10-11 03:53:24.708959
NCT01424085|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2016-07-07|||May 2012||2012-05-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|January 2016|Actual|2016-01-01||Observational|||Antibiotic Prophylaxis Before Percutaneous Gastrostomy|Antibiotic Prophylaxis Before Percutaneous Gastrostomy: A Randomized, Controlled Clinical Trial|Completed||N/A|124|Actual|University of Washington|||2||f||||t||||||||No||2017-10-11 03:53:24.785743|2017-10-11 03:53:24.785743
NCT01424072|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2013-04-22|2013-01-28||January 2010||2010-01-01|April 2013|2013-04-01|September 2011|Actual|2011-09-01|July 2010|Actual|2010-07-01||Interventional|||Auriculotherapy as a Coping Strategy in Professional Nursing|Applicability of Auriculotherapy as a Strategy for Stress and Coping in Nursing Professionals|Completed||Phase 1/Phase 2|75|Actual|University of Sao Paulo|Number of the participants(reduced sample)|3|||f||||f||||||||||2017-10-11 03:53:24.859553|2017-10-11 03:53:24.859553
NCT01424059|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-24|||January 2011||2011-01-01|August 2011|2011-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Induction of Women With Fear of Labor|Planned Induction of Women With Fear of Labor and Evaluation of the Experience of Delivery|Unknown status|Recruiting|N/A|250|Anticipated|Uppsala University Hospital|||1||f||||f||||||||||2017-10-11 03:53:25.435942|2017-10-11 03:53:25.435942
NCT01424046|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-12-04|||May 2011||2011-05-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Interventional|||Health Care for Type 1 Diabetes in Developing World|Evaluation of Differing Type 1 Diabetes Regimens in Youth in the Developing World|Completed||N/A|50|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:53:25.507234|2017-10-11 03:53:25.507234
NCT01424033|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2017-02-22|2016-01-14||December 2011||2011-12-01|February 2017|2017-02-01||||February 2013|Actual|2013-02-01||Interventional|||A Clinical Trial for CTD-ILD Treatment|Clinical Trial of Oral Medication for CTD-ILD Treatment|Terminated||Phase 2/Phase 3|5|Actual|University of Michigan|Five subjects were consented. Study was terminated prior to conclusion due to departure of PI.|1||Departure of study team|f||||t||||||||||2017-10-11 03:53:25.635459|2017-10-11 03:53:25.635459
NCT01424020|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-12-15|||September 2011||2011-09-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|WELCH-2||Walking Estimated Limitation Calculated by History - Study 2|Estimation de la capacité Fonctionnelle à la Marche Par Questionnaire Clinique Chez Les Patients adressés Pour Bilan artériel Des Membres inférieurs|Recruiting||Phase 4|800|Anticipated|University Hospital, Angers||1|||f||||f||||||||||2017-10-11 03:53:25.884049|2017-10-11 03:53:25.884049
NCT01424007|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2016-10-25|||December 2011||2011-12-01|April 2016|2016-04-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|MENU||Metabolism, Exercise and Nutrition at UCSD (MENU Study)|Diet Composition and Genetics: Effects on Weight, Inflammation and Biomarkers|Completed||N/A|245|Actual|University of California, San Diego||3|||f||||t||||||||||2017-10-11 03:53:26.101214|2017-10-11 03:53:26.101214
NCT01423994|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-08-29|||August 2011||2011-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|Spritely||Syncope: Pacing or Recording in the Later Years|Syncope: Pacing or Recording in the Later Years (SPRITELY)|Active, not recruiting||Phase 4|120|Anticipated|University of Calgary||2|||f||||t||||||||||2017-10-11 03:53:26.217309|2017-10-11 03:53:26.217309
NCT01423981|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-10-03|||November 2011||2011-11-01|October 2016|2016-10-01|June 2031|Anticipated|2031-06-01|December 2030|Anticipated|2030-12-01||Observational|||Web Based Investigation of Natural History of Keloid Disorder, an Online Survey|Web Based Investigation of Natural History of Keloid Disorder, an Online Survey|Recruiting||N/A|10000|Anticipated|Tirgan, Michael H., M.D.|||1||f||||f||||||||Yes|All data will be shared and published|2017-10-11 03:53:26.48786|2017-10-11 03:53:26.48786
NCT01423968|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-09-02|||July 2011||2011-07-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|LPS||Effect of Lipopolysaccharide on Skeletal Muscle Functions|Impact & Time-Course of Effect of Intravenous Lipopolysaccharide Infusion on Skeletal Muscle Protein Turnover and Insulin Sensitivity in Healthy Human Volunteers|Completed||N/A|6|Actual|University of Nottingham||2|||f||||f||||||||||2017-10-11 03:53:26.595426|2017-10-11 03:53:26.595426
NCT01423955|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2013-10-24|||October 2011||2011-10-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|EPRICS||Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery|EPO to Protect Renal Function After Cardiac Surgery. A Phase II Double Blind Randomized Controlled Study.|Completed||Phase 2|75|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 03:53:26.689641|2017-10-11 03:53:26.689641
NCT01423942|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-05-07|||October 2011||2011-10-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Maturation of the Autonomic Nervous System in Prematures|Maturation of the Autonomic Nervous System in Prematures|Completed||N/A|300|Actual|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 03:53:26.773886|2017-10-11 03:53:26.773886
NCT01423929|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2016-08-30|||January 2012||2012-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|SOCCER||Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion|Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion|Completed||Phase 4|100|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 03:53:26.840693|2017-10-11 03:53:26.840693
NCT01423916|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-09-29|2015-08-04||July 2011||2011-07-01|September 2015|2015-09-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder|A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|218|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||f||||||||||2017-10-11 03:53:26.981863|2017-10-11 03:53:26.981863
NCT01423903|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-01-14|||February 2010||2010-02-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer|Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once-Daily OPB-51602 in Subjects With Advanced Cancer|Completed||Phase 1|45|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 03:53:27.992167|2017-10-11 03:53:27.992167
NCT01423890|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-03-26|||January 2012||2012-01-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ONCOTYPEDX||A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer|A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer|Completed||N/A|1011|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||f||||||||||2017-10-11 03:53:28.104307|2017-10-11 03:53:28.104307
NCT01423877|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-03-31|||August 2011||2011-08-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Comparative Effectiveness of Bariatric Surgery Versus Medical Management to Induce Diabetes Remission in Diabetic Patients With BMI 30-35||Completed||N/A|55|Anticipated|New York University School of Medicine|||1||f||||t||||||||||2017-10-11 03:53:28.287644|2017-10-11 03:53:28.287644
NCT01423864|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-25|||June 2005||2005-06-01|August 2011|2011-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|IP steroid||Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome|Retrospective Study of Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome|Completed||Phase 2|29|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 03:53:28.386851|2017-10-11 03:53:28.386851
NCT01423851|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-09-26|||June 2011||2011-06-01|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF|A Phase 1/2, Open-label, Dose-Escalation Multi-center Study to Assess the Safety, Tolerability, PK and PD of Orally Administered NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF|Active, not recruiting||Phase 1/Phase 2|77|Actual|NS Pharma, Inc.||1|||f||||t||||||||||2017-10-11 03:53:28.524738|2017-10-11 03:53:28.524738
NCT01423838|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-25|||September 2011||2011-09-01|August 2011|2011-08-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder|Comparison of Oxybutynin and Solifenacin in the Treatment of Overactive Bladder: a Randomized Controlled Multicenter Trial|Unknown status|Not yet recruiting|Phase 4|500|Anticipated|Adana Numune Training and Research Hospital||2|||f||||t||||||||||2017-10-11 03:53:28.648205|2017-10-11 03:53:28.648205
NCT01423825|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2016-06-01|||August 2011||2011-08-01|June 2016|2016-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)|A Phase 1 Placebo-Controlled Study Extension to HVTN 073 / SAAVI 102, to Evaluate the Safety and Immunogenicity of Novartis Sub C gp140 Vaccine With MF59 Adjuvant, as a Boost Following SAAVI DNA-C2 Vaccine and SAAVI MVA-C Vaccine, in HIV Uninfected Healthy Adult Participants in South Africa and the United States|Completed||Phase 1|27|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 03:53:28.771737|2017-10-11 03:53:28.771737
NCT01423799|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2015-11-11|||July 2012||2012-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Neoimmune||Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment|Immunonutrition to Improve Quality of Life of Upper Gastrointestinal Cancer Patients Undergoing Oncological Treatment|Completed||Phase 3|300|Actual|Nestlé||2|||f||||f||||||||||2017-10-11 03:53:28.966445|2017-10-11 03:53:28.966445
NCT01423786|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-25|||August 2011||2011-08-01|August 2011|2011-08-01||||March 2013|Anticipated|2013-03-01||Interventional|||Early Oral Nutrition in Mild Acute Pediatric Pancreatitis|Early Oral Nutrition in Mild Acute Pediatric Pancreatitis|Unknown status|Recruiting|N/A|35|Anticipated|Nationwide Children's Hospital||1|||f||||||||||||||2017-10-11 03:53:29.052521|2017-10-11 03:53:29.052521
NCT01423773|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2013-06-20|2012-11-21||August 2011||2011-08-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression|Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression|Completed||N/A|20|Actual|Alcon Research|The sample size may be small for establishing relationship between ocular comfort and other measurable variables.|2|||f||||f||||||||||2017-10-11 03:53:29.128761|2017-10-11 03:53:29.128761
NCT01423760|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-08-10|2016-06-02||January 2012||2012-01-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional||Screening analysis set included all the subjects included in the trial.|Common Safety Follow-up Trial of Tecemotide (L-BLP25)|An Open-label Trial to Collect Long-term Data on Subjects Following Participation in Previous EMD 531444 (L-BLP25 or BLP25 Liposome Vaccine) Clinical Trials|Terminated||N/A|27|Actual|Merck KGaA|The study was terminated prematurely as the sponsor decided to discontinue program with Tecemotide in non-small cell lung cancer (NSCLC).|2||"The study is terminated prematurely as the sponsor decided to discontinue program with   Tecemotide in NSCLC."|f||||f||||||||||2017-10-11 03:53:29.310897|2017-10-11 03:53:29.310897
NCT01423747|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2015-06-25|||July 2003||2003-07-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|September 2011|Actual|2011-09-01||Interventional|||Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia|Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|St. Anna Kinderkrebsforschung||3|||f||||t||||||||||2017-10-11 03:53:30.164883|2017-10-11 03:53:30.164883
NCT01423734|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2017-05-04|||August 2011||2011-08-01|May 2017|2017-05-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases|Pilot Study To Assess The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases|Active, not recruiting||N/A|20|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:53:30.322034|2017-10-11 03:53:30.322034
NCT01423721|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2013-10-31|||August 2011||2011-08-01|October 2013|2013-10-01||||October 2011|Actual|2011-10-01||Interventional|||Relative Bioavailability of Bromhexine Given as Granules and Syrup in Healthy Volunteers (Clinical Phase I Study)|Relative Bioavailability of Bromhexine for Oral Administration of 16 mg of Bromhexine Hydrochloride Granules Compared to 16 mg of Bromhexine Hydrochloride Syrup in Healthy Male and Female Volunteers (an Open-label, Randomised, Single-dose, Replicate Design Phase I Study With Two Treatments in Four Crossover Periods)|Completed||Phase 1|39|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 03:53:30.414469|2017-10-11 03:53:30.414469
NCT01423708|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2012-07-17|||February 2010||2010-02-01|July 2012|2012-07-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|EPOCAL||Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study|Terapia Con Everolimus Nel Trapianto de Novo di Fegato: Uno Studio Multicentrico Randomizzato|Unknown status|Recruiting|Phase 2|117|Anticipated|Azienda Ospedaliera di Padova||2|||f||||t||||||||||2017-10-11 03:53:30.489653|2017-10-11 03:53:30.489653
NCT01423695|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-25|2011-08-25|||February 2001||2001-02-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer|Weekly Application of Trastuzumab and Paclitaxel in the Treatment of HER2-overexpressing Metastatic Breast Cancer|Completed||Phase 2|121|Actual|WiSP Wissenschaftlicher Service Pharma GmbH||1|||f||||f||||||||||2017-10-11 03:53:30.644685|2017-10-11 03:53:30.644685
NCT01423682|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2014-12-04|||April 2012||2012-04-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||The Influence of Eccentric Training on the Volume and Vascularisation of the Rotator Cuff in Patients With Rotator Cuff Tendinopathy and Healthy Subjects|The Influence of Eccentric Training on the Volume and Vascularisation of the Rotator Cuff in Patients With Rotator Cuff Tendinopathy and Healthy Subjects|Unknown status|Recruiting|N/A|60|Anticipated|University Ghent||2|||f||||f||||||||||2017-10-11 03:53:30.719452|2017-10-11 03:53:30.719452
NCT01423604|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2017-01-27|2016-04-01|2014-04-04|July 2011||2011-07-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|June 2013|Actual|2013-06-01||Interventional|RECAP||Study of Ruxolitinib in Pancreatic Cancer Patients|A Randomized Phase 2 Study of Ruxolitinib Efficacy and Safety in Combination With Capecitabine for Subjects With Recurrent or Treatment Refractory Metastatic Pancreatic Cancer (The RECAP Trial)|Completed||Phase 2|136|Actual|Incyte Corporation||2|||f||||t||||||||||2017-10-11 03:53:30.833789|2017-10-11 03:53:30.833789
NCT01423591|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-08-25|||June 2007||2007-06-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica|Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica: a Double Blind Placebo Controlled Trial|Unknown status|Active, not recruiting|Phase 3|23|Actual|Hospital Universitario Marqués de Valdecilla||2|||f||||t||||||||||2017-10-11 03:53:32.739926|2017-10-11 03:53:32.739926
NCT01423578|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2017-06-23|||August 21, 2007|Actual|2007-08-21|June 2017|2017-06-01|June 20, 2017|Actual|2017-06-20|May 2, 2011|Actual|2011-05-02||Interventional|||Effects of Yoga and Cardiovascular Exercise on Smoking Motivation|Effects of Yoga and Cardiovascular Exercise on Smoking Motivation|Completed||N/A|79|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f|f|f||||||||2017-10-11 03:53:32.852417|2017-10-11 03:53:32.852417
NCT01423565|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-03-17|||September 2011||2011-09-01|March 2015|2015-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Comparison of Constant Current to Constant Voltage Stimulation in Subthalamic Deep Brain Stimulation for Parkinson's Disease|Comparison of Constant Current to Constant Voltage Stimulation in Subthalamic DBS for Parkinson's Disease|Completed||N/A|8|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 03:53:32.959141|2017-10-11 03:53:32.959141
NCT01423552|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-08-25|||November 2011||2011-11-01|August 2011|2011-08-01||||||||Observational|||Pharmacology of Immunosuppressants Following Heart Transplantation|Correlation of Immunosuppressant Pharmacokinetics, Pharmacodynamics, Pharmacogenomics and Outcomes Following Heart Transplantation|Unknown status|Not yet recruiting|N/A|100|Anticipated|University Hospital Birmingham|||1||f||||f||||||Samples With DNA|"     Myocardial biopsy, whole blood, peripheral lymphocytes   "|||2017-10-11 03:53:33.057103|2017-10-11 03:53:33.057103
NCT01423539|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2016-11-01|||October 2011||2011-10-01|November 2016|2016-11-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||A Study of Navitoclax in Addition to Bendamustine and Rituximab in Patients With Relapsed Diffuse Large B-Cell Lymphoma (NAVIGATE)|A Phase II, Multicenter, Randomized, Controlled, Open-Label Study of Bendamustine + Rituximab With or Without Navitoclax in Patients With Relapsed Diffuse Large B-Cell Lymphoma|Withdrawn||Phase 2|0|Actual|Genentech, Inc.||2||The NAVIGATE study has been terminated due to non-safety related reasons.|f||||||||||||||2017-10-11 03:53:33.171897|2017-10-11 03:53:33.171897
NCT01423526|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-02-23|||August 2011||2011-08-01|August 2011|2011-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Single Dose Study of DWP10292 in Healthy Male Subjects|A Dose Block-randomized, Double-blind, Placebo Controlled, Single-dosing, Dose-escalation Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of DWP10292 After Oral Administration in Healthy Male Subjects|Completed||Phase 1|52|Actual|Daewoong Pharmaceutical Co. LTD.||2|||f||||t||||||||||2017-10-11 03:53:33.303508|2017-10-11 03:53:33.303508
NCT01423513|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-03-03|||March 2011||2011-03-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effects of Ankle Support on Muscle Activation and Function|Effects of Ankle Support on Muscle Activation and Function|Completed||N/A|26|Actual|Creighton University||2|||f||||f||||||||||2017-10-11 03:53:33.399849|2017-10-11 03:53:33.399849
NCT01423500|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-06-25|||January 2007||2007-01-01|June 2015|2015-06-01|September 2016|Anticipated|2016-09-01|September 2011|Actual|2011-09-01||Interventional|ALL-SCT-BFMi||ALL-SCT BFM International- HSCT in Children and Adolescents With ALL|Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia|Unknown status|Active, not recruiting|Phase 3|405|Anticipated|St. Anna Kinderkrebsforschung||3|||f||||t||||||||||2017-10-11 03:53:33.505252|2017-10-11 03:53:33.505252
NCT01423487|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-07-31|||August 2011||2011-08-01|July 2012|2012-07-01|August 2013|Anticipated|2013-08-01|February 2013|Anticipated|2013-02-01||Interventional|||Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea|Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea:a 24-week, Randomized, Placebo-controlled, Double-blind, Fixed-dose Study|Withdrawn||N/A|0|Actual|Central South University||2||Difficult to obtain informed consent|f||||t||||||||||2017-10-11 03:53:33.853771|2017-10-11 03:53:33.853771
NCT01423474|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2017-02-02|||January 2012||2012-01-01|February 2017|2017-02-01||||October 2020|Anticipated|2020-10-01||Interventional|PATRIOT||Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time|Randomized Phase II Study of 2 Hypofractionated Radiotherapy Schedules for Low- and Intermediate-Risk Prostate Cancer|Active, not recruiting||Phase 2|152|Actual|CancerCare Manitoba||2|||f||||t||||||||Undecided||2017-10-11 03:53:33.949841|2017-10-11 03:53:33.949841
NCT01423461|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-25|||July 2005||2005-07-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|PACT||Personalized Asthma Care Team|Individualized Health Care for Children With Common Chronic Diseases|Completed||N/A|201|Actual|Brigham and Women's Hospital|||1||f||||||||||||||2017-10-11 03:53:34.049157|2017-10-11 03:53:34.049157
NCT01423448|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-01-13||||||January 2015|2015-01-01||||||||Interventional|ShareIT||Effectiveness of an Online Bulletin Board for Depression: a Longitudinal Randomized Controlled Trial|A Randomized Controlled Trial of an Online Bulletin Board for Depression|Withdrawn||Early Phase 1|0|Actual|Australian National University||2||Recruitment of participants did not commence due to lack of available staff to run the trial.|f||||f||||||||||2017-10-11 03:53:34.13182|2017-10-11 03:53:34.13182
NCT01423435|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-10-02|||August 2011||2011-08-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males|A Pharmacokinetic Study of TRK-100STP -A Single Oral Administration Study in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males -|Completed||Phase 1|36|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 03:53:34.220827|2017-10-11 03:53:34.220827
NCT01423422|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-25|||November 2011||2011-11-01|August 2011|2011-08-01|October 2012|Anticipated|2012-10-01|May 2012|Anticipated|2012-05-01||Observational|||Effects of Low Frequency Magnetic Field on Exercise Induced Angina|Effects of Low Frequency Electromagnetic Field on Patients With Exercise Induced Angina|Unknown status|Not yet recruiting|N/A|40|Anticipated|Aerotel Ltd|||1||f||||f||||||||||2017-10-11 03:53:34.301748|2017-10-11 03:53:34.301748
NCT01423409|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2013-07-22|||June 2011||2011-06-01|April 2013|2013-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|EVA_SOURD||Multicenter Trial Assessing an Innovative VAS of Pain Among Deaf People|Assessment of an Innovative Visual Analogue Scale of Pain (Pictorial VAS) Versus the Usual VAS (VAS) Among Deaf People|Completed||Phase 2/Phase 3|289|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-10-11 03:53:34.39613|2017-10-11 03:53:34.39613
NCT01423396|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2017-05-17|||March 15, 2010|Actual|2010-03-15|May 2017|2017-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|COVARAD||Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease|Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease|Recruiting||N/A|406|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||No||2017-10-11 03:53:34.506499|2017-10-11 03:53:34.506499
NCT01423383|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-10-17|||September 2011||2011-09-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|June 2020|Anticipated|2020-06-01||Observational|||Epidemiology Study of Keloid|Epidemiology Study of Keloid|Recruiting||N/A|100000|Anticipated|Tirgan, Michael H., M.D.|||1||f||||f||||||||||2017-10-11 03:53:34.606291|2017-10-11 03:53:34.606291
NCT01423370|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2014-07-30|||November 2011||2011-11-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Efficacy of YHD1023 in Erectile Dysfunction|Multi-center, Randomized, Double-blind, Placebo/Active-controlled, Phase II Clinical Trial to Assess the Safety and Efficacy of YHD1023 in Patients With Erectile Dysfunction|Completed||Phase 2|104|Anticipated|Yuhan Corporation||5|||f||||t||||||||||2017-10-11 03:53:34.694297|2017-10-11 03:53:34.694297
NCT01423357|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-08-24|||February 2009||2009-02-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|PLACE||Targeting Interventions at Venues Where Risk of HIV Transmission is High|Targeting Interventions at Venues Where Risk of HIV Transmission is High|Completed||Phase 1|537|Actual|University of Zambia||2|||f||||f||||||||||2017-10-11 03:53:34.793809|2017-10-11 03:53:34.793809
NCT01423344|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-24|||February 2011||2011-02-01|August 2011|2011-08-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Observational|||Clinical Evaluation of the Serum Free Light Chain Analysis|Assessment of the Value of the Free Kappa and Free Lambda Light Chain Assay in Clinical Evaluation of Response to Treatment|Unknown status|Recruiting|N/A|30|Anticipated|University of Southern Denmark|||1||f||||t||||||Samples Without DNA|"     serum and urine   "|||2017-10-11 03:53:34.876242|2017-10-11 03:53:34.876242
NCT01423331|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-24|||August 2011||2011-08-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||An Evaluation and Factor Analysis for Maternal Mental Health|An Evaluation and Factor Analysis for Maternal Mental Health - The Analytic Study of the Shin Kong Wu Ho-Su Memorial Hospital|Unknown status|Not yet recruiting|N/A|200|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital|||1||f||||t||||||||||2017-10-11 03:53:34.949752|2017-10-11 03:53:34.949752
NCT01423318|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Doses of Lebrikizumab in Healthy Japanese and Caucasian Volunteers|Completed||Phase 1|60|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:53:35.004557|2017-10-11 03:53:35.004557
NCT01423305|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-10-20|||August 2011||2011-08-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|BF-BLOCK||Phase I Pharmacokinetic Study (BF-BLOCK)|Effect of Charcoal on Gastrointestinal Absorption of Budesonide and Formoterol|Completed||Phase 1|20|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-11 03:53:35.090028|2017-10-11 03:53:35.090028
NCT01423292|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-08-02|||August 2011||2011-08-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Ultrasound Guided Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection||Completed||Phase 3|56|Actual|National Cancer Center, Korea||2|||f||||||||||||||2017-10-11 03:53:35.159674|2017-10-11 03:53:35.159674
NCT01423279|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2016-03-15|||February 2013||2013-02-01|March 2016|2016-03-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Effect of a Diabetic- and a Kidney-like Environment on Gene and Protein Expression in Cultured EC and SMC|The Effect of a Diabetic- and a Kidney-like Environment on Gene and Protein Expression in Mono- and Co-cultured Endothelial and Smooth Muscle Cells|Recruiting||N/A|20|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 03:53:35.236528|2017-10-11 03:53:35.236528
NCT01423266|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-05-19|||December 2009||2009-12-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of a High Protein Diet on Clinical Outcomes in Heart Failure|Examining the Effects of a High Protein Diet on Adiposity and Cardiac Structure in Patients With Heart Failure, Obesity, and Diabetes Mellitus|Completed||N/A|78|Actual|University of California, Irvine||2|||f||||t||||||||Yes|Data management and analysis is in progress.|2017-10-11 03:53:35.299978|2017-10-11 03:53:35.299978
NCT01423240|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2012-12-11|||January 2012||2012-01-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|RESOLVE2||Major Depressive Disorder With Mixed Features|A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features|Withdrawn||Phase 3|0|Actual|Sunovion||3|||f||||t||||||||||2017-10-11 03:53:37.15782|2017-10-11 03:53:37.15782
NCT01423227|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2012-07-24|||October 2011||2011-10-01|July 2012|2012-07-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|HomeBase||Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease|Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|Phase 3|144|Anticipated|La Trobe University||2|||f||||t||||||||||2017-10-11 03:53:37.303851|2017-10-11 03:53:37.303851
NCT01423214|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-03-09|||June 2013||2013-06-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|COLRAR||A Trial to Assess Robot-assisted Surgery and Laparoscopy-assisted Surgery in Patients With Mid or Low Rectal Cancer||Recruiting||Phase 3|540|Anticipated|Kyungpook National University||2|||f||||t||||||||||2017-10-11 03:53:37.430407|2017-10-11 03:53:37.430407
NCT01423201|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-04-26|||September 2010||2010-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 31, 2017|Anticipated|2017-12-31||Observational|||Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk|TIA Triage Trial and Evaluation of Vascular-Specific Inflammatory BiomarkerLp-PLA2 as a Stratification Tool for TIA Triage and Stroke Risk|Active, not recruiting||N/A|262|Actual|Stanford University|||1||f||||f||||||Samples Without DNA|"     First 100 cases:      2 tiger top or gold top tubes 2 lavender top tubes        -  Blood specimens should be inverted 10 times before processing.        -  Centrifuge and separate within four hours of venipuncture.        -  Transfer 1.0 ml into 2 transfer tubes      Freeze at -70 C      Additional 80 cases:      3 PAXgene tubes (total 16cc) - containing 7.5 cc preservative to stabilize RNA immediately.      Invert 20 times then sit at room temperature overnight Place into a -70C freezer until     processed      2 tiger top or gold top tubes 2 lavender top tubes        -  Blood specimens should be inverted 10 times before processing.        -  Centrifuge and separate within four hours of venipuncture.        -  Transfer 1.0 ml into 2 transfer tubes      Freeze at -70 C   "|||2017-10-11 03:53:37.526086|2017-10-11 03:53:37.526086
NCT01423188|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-09-19|||August 2011||2011-08-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|SUSTAIN||The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation|Phase IIb Multi-center, Double-blind, Randomized, Parallel Group, Placebo Controlled Clinical Trial for the Assessment of Lipid Trends and Safety of RVX000222 in Statin Treated Subjects With Low Baseline HDL-C Concentrations|Completed||Phase 2|176|Actual|Resverlogix Corp||2|||f||||t||||||||||2017-10-11 03:53:37.617845|2017-10-11 03:53:37.617845
NCT01423175|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-24|2011-08-26|||July 2011||2011-07-01|August 2011|2011-08-01||||January 2015|Anticipated|2015-01-01||Interventional|ClAraC-SCT||ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS|Randomized, Multi-centre, Phase II Trial to Compare the Event-Free Survival of Clofarabine / Ara-C (ClAraC) or of FLAMSA Treatment in Patients With High Risk AML or Advanced MDS Scheduled for Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|60|Anticipated|Hannover Medical School||2|||f||||f||||||||||2017-10-11 03:53:37.916956|2017-10-11 03:53:37.916956
NCT01423162|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2012-08-22|2012-08-22||August 2011||2011-08-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Iron Bioavailability of Fortified Oat Drink|Iron Bioavailability Study Of Fortified Oat Drink|Completed||Phase 4|21|Actual|PepsiCo Global R&D|One of the isotopes was not detected in blood sample of 1 participant, therefore data from this participant was excluded from final per protocol analysis|2|||f||||f||||||||||2017-10-11 03:53:38.037588|2017-10-11 03:53:38.037588
NCT01423149|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-10-28||2011-10-28|March 2005||2005-03-01|October 2011|2011-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia|A Phase II, Dose Ranging, Multi-Center Study to Evaluate the Safety and Efficacy of Combretastatin A4 Phosphate for Treating Subfoveal Choroidal Neovascularization in Subjects With Pathologic Myopia|Completed||Phase 2|23|Actual|Mateon Therapeutics||3|||f||||t||||||||||2017-10-11 03:53:38.288208|2017-10-11 03:53:38.288208
NCT01423136|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2014-05-30|||October 2010||2010-10-01|May 2014|2014-05-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Observational|PROSE 3||Remote Electrocardiographic (ECG) ST-Monitoring (PROSE 3)in Post-op Patients|Postop Remote ECG ST-Monitoring (PROSE 3)|Completed||N/A|89|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||||||2017-10-11 03:53:38.37319|2017-10-11 03:53:38.37319
NCT01423123|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-07-07|||May 2011||2011-05-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|August 2012|Actual|2012-08-01||Interventional|||Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer|A Phase I Dose-Escalation Study Evaluating the Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer|Completed||Phase 1|21|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-10-11 03:53:38.469924|2017-10-11 03:53:38.469924
NCT01423110|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-02-21|||August 2011||2011-08-01|February 2017|2017-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis|A Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of BYM338 in Patients With Sporadic Inclusion Body Myositis|Completed||Phase 2|14|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:53:38.580934|2017-10-11 03:53:38.580934
NCT01423084|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-02-03|2015-02-03||August 2011||2011-08-01|February 2015|2015-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||adolescents aged 11-17 years|Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years|A Phase 3, Randomized, Comparative, Multicenter Observer-Blind Study Evaluating the Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years|Completed||Phase 3|344|Actual|Novartis|None reported|2|||f||||f||||||||||2017-10-11 03:53:38.774942|2017-10-11 03:53:38.774942
NCT01423071|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-06-17|||August 2011||2011-08-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life|Chronisch Obstruktive Lungenerkrankung Und Pulmonale Hypertonie: Prävalenz Und Lebensqualität|Completed||N/A|220|Actual|Wissenschaftliches Institut Bethanien e.V|||3||f||||f||||||||||2017-10-11 03:53:39.393176|2017-10-11 03:53:39.393176
NCT01423058|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-01-16||2015-01-16|August 2011||2011-08-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis|A Phase I/II, Open-Label Study Evaluating Twice-Daily Administration of CYT387 in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis|Completed||Phase 1/Phase 2|61|Actual|Gilead Sciences||1|||f||||t||||||||||2017-10-11 03:53:39.609008|2017-10-11 03:53:39.609008
NCT01423045|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-08-24|||October 2011||2011-10-01|August 2011|2011-08-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Observational|||Association Between Urine Concentration Ability and the Progression of Chronic Kidney Disease|Association Between Urine Concentration Ability and the Progression of Chronic Kidney Disease|Unknown status|Not yet recruiting|N/A|200|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 03:53:39.722718|2017-10-11 03:53:39.722718
NCT01423032|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-08-24|||September 2001||2001-09-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)|Bendamustine Versus Fludarabine as 2nd-line Treatment in Chronic Lymphocytic Leukemia, Stage BINET B+C / RAI II-IV|Completed||Phase 2/Phase 3|96|Actual|WiSP Wissenschaftlicher Service Pharma GmbH||2|||f||||f||||||||||2017-10-11 03:53:39.818972|2017-10-11 03:53:39.818972
NCT01423019|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-01-20|||October 2011||2011-10-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Comparative Effectiveness Study Evaluating the Effects of Thermogenic Supplements on Body Composition|A Comparative Effectiveness Study Evaluating the Effects of Two Thermogenic Supplements on Body Composition Using a Double-Blinded Placebo-Controlled Protocol|Completed||N/A|75|Anticipated|Integrative Health Technologies, Inc.||3|||f||||f||||||||||2017-10-11 03:53:39.910783|2017-10-11 03:53:39.910783
NCT01423006|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2013-11-13|||August 2011||2011-08-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Pilot Study on Focal Prostate Radio-Frequency Ablation|Pilot Study on Focal Prostate Radio-Frequency Ablation for the Treatment of Very-Low Risk Prostate Cancer|Completed||N/A|5|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 03:53:40.092656|2017-10-11 03:53:40.092656
NCT01422993|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-12-28|||July 2011||2011-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|||Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy|A Pilot Study of a Strength and Balance Training Program for Persons With Oxaliplatin Induced Peripheral Neuropathy|Completed||N/A|4|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 03:53:40.21946|2017-10-11 03:53:40.21946
NCT01422980|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2016-10-07|||November 2010||2010-11-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|||Effect of Consumption of Dairy Product on Upper Gastric Discomfort|Effect of Consumption of Dairy Product on Upper Gastric Discomfort|Completed||N/A|236|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 03:53:40.333715|2017-10-11 03:53:40.333715
NCT01422967|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-08-24|||June 2010||2010-06-01|August 2011|2011-08-01|December 2013|Anticipated|2013-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Changes Of Sleep on the Sensoriomotor and Cytokine In Patients With Osteoarthritis|Changes of Sleep on the Sensorimotor and Cytokine in Patients With Knee Osteoarthritis|Unknown status|Recruiting|N/A|60|Anticipated|Universidade Federal de Sao Carlos||2|||f||||t||||||||||2017-10-11 03:53:40.438898|2017-10-11 03:53:40.438898
NCT01422954|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2013-04-26|||January 2012||2012-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis|Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis|Completed||N/A|20|Actual|Radboud University||3|||f||||t||||||||||2017-10-11 03:53:40.576192|2017-10-11 03:53:40.576192
NCT01422941|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-07-27|||October 2010||2010-10-01|August 2011|2011-08-01||||June 2011|Actual|2011-06-01||Interventional|||Safety and Performance of the CAVU Medical, Inc. Attune Tubing Study|A PROSPECTIVE, MULTI-CENTER CLINICAL EVALUATION TO ASSESS SAFETY AND PERFORMANCE OF CAVU MEDICAL, INC.'S ATTUNE TUBING WHEN USED WITH NEWLY-IMPLANTED LAPAROSCOPIC ADJUSTABLE GASTRIC BANDS (LAGBs)|Completed||Phase 1|40|Actual|Cavu Medical, Inc.||1|||f||||t||||||||||2017-10-11 03:53:40.693851|2017-10-11 03:53:40.693851
NCT01422928|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-05-22|||December 2010||2010-12-01|May 2015|2015-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Acupuncture for the Immune System in Radiation Cancer Patients|Does Radiation Therapy Adversely Affect the Immune System, and Can Acupuncture Ameliorate the Effect? A Pilot Study|Withdrawn||Phase 3|0|Actual|British Columbia Cancer Agency||2||Study was not approved by research ethics board.|f||||f||||||||||2017-10-11 03:53:40.767781|2017-10-11 03:53:40.767781
NCT01422915|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2017-03-14|2013-08-20||May 2011||2011-05-01|March 2017|2017-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|EPP||Sorbent Therapy of the Cutaneous Porphyrias|Sorbent Therapy of the Cutaneous Porphyrias|Completed||Phase 2/Phase 3|4|Actual|Brigham and Women's Hospital|1 subject was removed during Period 1 because of abnormal liver chemistries.|1|||f||||f||||||||||2017-10-11 03:53:40.869568|2017-10-11 03:53:40.869568
NCT01422902|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-02-04|||April 2012||2012-04-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|e-CAeSAR||Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults|Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach|Completed||Phase 2|150|Actual|Posit Science Corporation||2|||f||||f||||||||||2017-10-11 03:53:41.107497|2017-10-11 03:53:41.107497
NCT01422889|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-01-06|2014-04-23||September 2011||2011-09-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|June 2013|Actual|2013-06-01||Observational||Subjects that recevied at least one study stent|ION US Post-Approval Study|A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System|Completed||N/A|1120|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 03:53:41.241363|2017-10-11 03:53:41.241363
NCT01422876|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2015-04-01|2015-01-15|2014-05-15|August 2011||2011-08-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||FAS|Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients|A Phase III Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Once Daily Oral Administration of BI 10773 25 mg/Linagliptin 5 mg and BI 10773 10 mg/Linagliptin 5 mg Fixed Dose Combination Tablets Compared With the Individual Components (BI 10773 25 mg, BI 10773 10 mg, and Linagliptin 5 mg) for 52 Weeks in Treatment naïve and Metformin Treated Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control|Completed||Phase 3|1405|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 03:53:42.122804|2017-10-11 03:53:42.122804
NCT01422863|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2017-08-15|||October 2010||2010-10-01|August 2017|2017-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Lifestyle Interventions for Seniors With Apnea|Effects of Weight Loss Through Diet and Exercise on Sleep Apnea Severity and Cardiovascular Risk in Older Adults|Completed||N/A|18|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 03:53:44.618184|2017-10-11 03:53:44.618184
NCT01422850|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2014-03-26|2013-08-05||August 2011||2011-08-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|ALECSAT||Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy|A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of Administering Repeated Doses of ALECSAT to Prostate Cancer Patients.|Completed||Phase 1|21|Actual|CytoVac A/S||1|||f||||f||||||||||2017-10-11 03:53:44.71014|2017-10-11 03:53:44.71014
NCT01422837|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2014-08-06|||August 2011||2011-08-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|VICTORY||ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry|VIvitrol's Cost and Treatment Outcomes RegistrY|Completed||N/A|403|Actual|Alkermes, Inc.|||1||f||||f||||||||||2017-10-11 03:53:44.951881|2017-10-11 03:53:44.951881
NCT01422824|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-02-26|2016-02-26||June 2010||2010-06-01|February 2016|2016-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational||Safety population included all treated participants.|An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis|An Observational. Non-interventional Study to Observe the Safety and Efficacy of MIRCERA in the Treatment of Chronic Renal Anemia in Maintenance ESA Treated Patients on Haemodialysis (STABILE)|Completed||N/A|185|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 03:53:45.265769|2017-10-11 03:53:45.265769
NCT01422811|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-08-23|||February 2008||2008-02-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|||Unnecessary, Avoidable Lengths of Stay: a Strategy for Clinician Empowerment and Effectiveness Evaluation|Unnecessary, Avoidable Lengths of Stay: a Strategy for Clinician Empowerment and Effectiveness Evaluation|Completed||Phase 3|3862|Actual|Azienda Ospedaliero-Universitaria di Parma||2|||f||||f||||||||||2017-10-11 03:53:45.512554|2017-10-11 03:53:45.512554
NCT01422798|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-02-29|||April 2012||2012-04-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda|An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda|Completed||N/A|396|Actual|Epicentre|||1||f||||f||||||||No||2017-10-11 03:53:45.608452|2017-10-11 03:53:45.608452
NCT01422785|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-08-22|||July 2011||2011-07-01|August 2011|2011-08-01||||December 2011|Anticipated|2011-12-01||Interventional|||A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne|A Pilot Study to Evaluate the Efficacy of Fixed Dose Combination Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel Alone Versus Fixed Dose Combination Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel Plus Benzoyl Peroxide 6% Foaming Cloths in the Treatment of Facial Acne Vulgaris|Unknown status|Recruiting|Phase 4|40|Anticipated|Zeichner, Joshua, M.D.||2|||f||||t||||||||||2017-10-11 03:53:45.683322|2017-10-11 03:53:45.683322
NCT01422772|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2015-01-25|||January 2007||2007-01-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|February 2010|Actual|2010-02-01||Interventional|||Safety Study of Gene Therapy for Ischemic Heart Disease in Korea|Open-label, Dose-escalation, Phase 1 Trial to Evaluate the Safety of VM202RY Gene Medicine Injected Into Myocardial Territory With Incomplete Revascularization During Coronary Artery Bypass Graft in Patients With Ischemic Heart Disease|Completed||Phase 1|9|Actual|ViroMed Co., Ltd. dba VM BioPharma||3|||f||||f||||||||||2017-10-11 03:53:45.78272|2017-10-11 03:53:45.78272
NCT01422759|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-12-16|||November 2016||2016-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess|Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess (CBS006)|Recruiting||N/A|20|Anticipated|University of Virginia||1|||f||||f||||||||No||2017-10-11 03:53:45.877096|2017-10-11 03:53:45.877096
NCT01422746|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-12-16|||December 2016||2016-12-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess|Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess (CBS005)|Recruiting||N/A|20|Anticipated|University of Virginia||1|||f||||t||||||||No||2017-10-11 03:53:45.990303|2017-10-11 03:53:45.990303
NCT01422733|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-12-16|||April 2017||2017-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction|Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction in Overweight Early Pubertal Girls With Androgen Excess (CBS0004)|Not yet recruiting||N/A|20|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-11 03:53:46.102908|2017-10-11 03:53:46.102908
NCT01422720|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-06-29|2014-05-09||April 2010||2010-04-01|June 2017|2017-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients|Safety and Efficacy of Eslicarbazepine Acetate (ESL) as Adjunctive Therapy for Partial Seizures in Elderly Patients|Completed||Phase 3|72|Actual|Bial - Portela C S.A.||1|||f||||f||||||||||2017-10-11 03:53:46.234693|2017-10-11 03:53:46.234693
NCT01422707|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-12-16|||April 2017||2017-04-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess|Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS003)|Not yet recruiting||N/A|20|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-11 03:53:46.708809|2017-10-11 03:53:46.708809
NCT01422694|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2017-09-12|||August 4, 2011||2011-08-04|August 23, 2017|2017-08-23||||||||Observational|||Natural History and Development of Spondyloarthritis|Studies on the Natural History and Pathogenesis of Spondyloarthritis|Recruiting||N/A|999999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:53:46.836035|2017-10-11 03:53:46.836035
NCT01422681|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2014-01-20|||May 2011||2011-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|DECOPD||Extracorporeal CO2 Removal in COPD Exacerbation|Extracorporeal Carbon Dioxide Removal in Patients With Severe COPD Exacerbation Failing Noninvasive Ventilation|Completed||Phase 2|30|Actual|University of Turin, Italy||1|||f||||f||||||||||2017-10-11 03:53:46.92341|2017-10-11 03:53:46.92341
NCT01422655|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-01-22|||August 2011||2011-08-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Transcutaneous Bilirubinometry in Neonates|Accuracy of Transcutaneous Bilirubin Determinations in Neonates: The Effect of Gestational Age, Time and Site of Measurement|Completed||N/A|255|Actual|University of Patras|||1||f||||f||||||||||2017-10-11 03:53:47.098926|2017-10-11 03:53:47.098926
NCT01422642|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-08-29|||January 2001||2001-01-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|April 2001|Actual|2001-04-01||Interventional|||Do We Need High-Flexing Total Knee Arthroplasty to Improve the Survivorship and to Decrease the Incidence of Osteolysis?|Do We Need High-Flexing Total Knee Arthroplasty to Improve the Survivorship and to Decrease the Incidence of Osteolysis? A Minimum of Ten Years of Follow-up|Completed||Phase 4|111|Actual|Ewha Womans University||2|||f||||f||||||||||2017-10-11 03:53:47.183365|2017-10-11 03:53:47.183365
NCT01422629|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2014-04-08|||October 2011||2011-10-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||High Intensity Focused Ultrasound (HIFU) to Treat Breast Fibroadenoma|High Intensity Focused Ultrasound (HIFU) to Treat Breast Fibroadenoma: a Feasibility Study. A Multicentric, Open, Uncontrolled Study|Completed||N/A|24|Actual|Theraclion||1|||f||||t||||||||||2017-10-11 03:53:47.298493|2017-10-11 03:53:47.298493
NCT01422616|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2016-12-12|||March 2012||2012-03-01|October 2016|2016-10-01|February 2019|Anticipated|2019-02-01|December 2018|Anticipated|2018-12-01||Interventional|ENCHANTED||Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)|An International Randomised Controlled Trial to Establish the Effects of Low-dose rtPA and the Effects of Early Intensive Blood Pressure Lowering in Patients With Acute Ischaemic Stroke|Recruiting||Phase 3|4700|Anticipated|The George Institute||4|||f||||t||||||||||2017-10-11 03:53:47.418748|2017-10-11 03:53:47.418748
NCT01422603|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-10-12|||February 2011||2011-02-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2014|Actual|2014-05-01||Interventional|||Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)|A Pilot Study of Clofarabine Pre-conditioning Prior to Full or Reduced Intensity Allogeneic Transplantation in the Treatment of High Risk Acute Myeloid Leukaemia and Myelodysplasia.|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|University Hospital Southampton NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 03:53:47.57616|2017-10-11 03:53:47.57616
NCT01422590|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-09-06|||May 2010||2010-05-01|September 2011|2011-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin|Pharmacodynamics After Concomitant Administration With Mitiglinide and Sitagliptin Compared to Mitiglinide, Sitagliptin Single Administration in Patients With Type 2 Diabetes|Completed||Phase 1|26|Actual|Samsung Medical Center||3|||f||||f||||||||||2017-10-11 03:53:47.69224|2017-10-11 03:53:47.69224
NCT01422577|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-08-10|||October 2010||2010-10-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|September 2012|Actual|2012-09-01||Interventional|||Diagnosis of Colonic Adenomas by Bright Narrow Band Imaging (B-NBI)|A Randomized Comparison Between White Light Endoscopy (WLE) and Bright Narrow Band Imaging (B-NBI) in the Diagnosis of Colonic Adenomas in Asymptomatic Subjects Undergoing Screening Colonoscopy|Completed||N/A|1006|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:53:47.792994|2017-10-11 03:53:47.792994
NCT01422564|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2015-05-14|||January 2007||2007-01-01|March 2014|2014-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|MOM||Metal on Metal Versus Metal on Highly Crossed Linked Polyethylene Sytem|A Randomized Multicentre Clinical Trial Comparing The Metal on Metal Hip System Versus The Metal on Highly Crossed Linked Polyethylene System|Terminated||Phase 4|41|Actual|Nova Scotia Health Authority||2||Components were recalled by Depuy|f||||f||||||||||2017-10-11 03:53:47.8778|2017-10-11 03:53:47.8778
NCT01422551|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2011-08-22|||September 1999||1999-09-01|August 2011|2011-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Facilitating Positive Adaptation to Breast Cancer|Facilitating Positive Adaptation to Breast Cancer|Completed||Phase 2|240|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 03:53:48.106331|2017-10-11 03:53:48.106331
NCT01422538|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2013-06-19|2013-06-19||May 2011||2011-05-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Ultherapy™ Treatment Following Sculptra® Treatment|Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck Following Sculptra® Treatment|Completed||N/A|30|Actual|Ulthera, Inc|"Entrance criteria possibly restricted to a population with too little skin laxity to assess a difference.
Group C time from Sculptra to Ultherapy may be too long to discern any added benefit of both treatments."|3|||f||||f||||||||||2017-10-11 03:53:48.214061|2017-10-11 03:53:48.214061
NCT01422525|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2014-12-01|||November 2011||2011-11-01|December 2014|2014-12-01||||February 2012|Actual|2012-02-01||Observational|||Changes of the Peripapillary Retinal Nerve Fiber Layer After Filtration Surgery in Glaucoma Patients|Effect of Trabeculectomy on Peripapillary Retinal Nerve Fiber Layer Thickness Using Spectral Domain Optical Coherence Tomography|Terminated||N/A|12|Actual|University Eye Hospital, Würzburg|||1|short of study staff|f||||f||||||||||2017-10-11 03:53:48.778032|2017-10-11 03:53:48.778032
NCT01422512|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2011-10-10|||September 2011||2011-09-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects|A Phase III Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture, Formulation 2011/2012, When Administered to Adult and Elderly Subjects|Completed||Phase 3|126|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:53:48.849345|2017-10-11 03:53:48.849345
NCT01422499|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2016-10-14|||March 2012||2012-03-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Vorinostat in Children|Phase I/II Intra-patient Dose Escalation Study of Vorinostat in Children With Relapsed Solid Tumor, Lymphoma or Leukemia|Active, not recruiting||Phase 1/Phase 2|50|Actual|National Center for Tumor Diseases, Heidelberg||1|||f||||t||||||||||2017-10-11 03:53:48.930818|2017-10-11 03:53:48.930818
NCT01422486|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2013-11-20|||October 2011||2011-10-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome|Phase 2 Study of Oral Ezatiostat Hydrochloride (Telintra®) in Patients With Lenalidomide (Revlimid®) Refractory or Resistant, Low to Intermediate-1 Risk, Deletion 5q Myelodysplastic Syndrome|Terminated||Phase 2|2|Actual|Telik||1||Study TLK199.2107 was terminated for business reasons.|f||||f||||||||||2017-10-11 03:53:49.023166|2017-10-11 03:53:49.023166
NCT01422473|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2013-06-04|||August 2011||2011-08-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques|Hemorrhoidectomy Using the Enseal Device: A Comparison to Open Hemorrhoidectomy Techniques|Terminated||N/A|9|Actual|Swedish Medical Center||1||Terminated due to poor accrual.|f||||f||||||||||2017-10-11 03:53:49.209767|2017-10-11 03:53:49.209767
NCT01422460|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-14|2011-08-23|||August 2011||2011-08-01|August 2011|2011-08-01|June 2013|Anticipated|2013-06-01|June 2012|Anticipated|2012-06-01||Interventional|||The Efficacy of Platelets Rich Plasma Injection With PRGF Method in the Treatment for Osteoarthritis of the Subtalar Joint||Unknown status|Not yet recruiting|N/A|30|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 03:53:49.29652|2017-10-11 03:53:49.29652
NCT01422447|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-11-24|||October 2010||2010-10-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|RPIMHP||Research of Prevention and Intervention of Mental Health Problems|Prevention and Mental Health Education for Mental Health Problems in Community: A Model of Common Mental Health Problems in Seven Metropolis of China|Completed||N/A|42016|Actual|Shanghai Mental Health Center||2|||f||||f||||||||||2017-10-11 03:53:49.400725|2017-10-11 03:53:49.400725
NCT01422434|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-03-25|2013-09-24||July 2011||2011-07-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||LEO 90105 Ointment in Japanese Subjects With Psoriasis|Efficacy and Safety of LEO 90105 Ointment (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis Vulgaris|Completed||Phase 3|676|Actual|LEO Pharma||3|||f||||f||||||||||2017-10-11 03:53:49.505657|2017-10-11 03:53:49.505657
NCT01422421|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-23|2017-03-14|||August 2011||2011-08-01|March 2017|2017-03-01|December 2022|Anticipated|2022-12-01|March 2021|Anticipated|2021-03-01||Interventional|||Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease|Intensive Blood Pressure and LDL Lowering for Better Survival and Cardiovascular Outcome in Diabetic Patients With Coronary Artery Disease: Randomized Controlled Trial|Recruiting||Phase 4|1000|Anticipated|Kyoto University, Graduate School of Medicine||2|||f||||t||||||||||2017-10-11 03:53:49.939947|2017-10-11 03:53:49.939947
NCT01422395|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2014-06-03|||August 2011||2011-08-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Oocyte Vitrification on Fertilization Rate, Embryo Quality and Development|A Study to Compare Vitrified/Warmed Oocytes vs. Fresh Sibling Oocytes Collected Following Controlled Ovarian Stimulation Using Follistim AQ and Ganirelix Acetate on Fertilization Rates, Zygote Quality, Embryo Quality and Embryo Development|Completed||Early Phase 1|40|Actual|Main Line Fertility Center||2|||f||||f||||||||||2017-10-11 03:53:51.021662|2017-10-11 03:53:51.021662
NCT01422382|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-07-05|2012-01-03||May 2011||2011-05-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin|Drug-Drug Interaction Study to Assess the Effects of Steady-State Cardizem LA (Diltiazem Hydrochloride) and Steady-State Pitavastatin on Their Respective Pharmacokinetics in Healthy Adult Volunteers|Completed||Phase 4|28|Actual|Kowa Research Institute, Inc.||1|||f||||f||||||||||2017-10-11 03:53:51.106532|2017-10-11 03:53:51.106532
NCT01422369|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-07-05|2012-01-03||April 2011||2011-04-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin|Drug-Drug Interaction Study to Assess the Effects of Steady-State Darunavir/Ritonavir on Steady-State Pitavastatin in Healthy Adult Volunteers|Completed||Phase 4|28|Actual|Kowa Research Institute, Inc.||1|||f||||f||||||||||2017-10-11 03:53:51.32405|2017-10-11 03:53:51.32405
NCT01422356|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-12-19|2013-10-27||September 2010||2010-09-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|HYPER||Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men|Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men|Completed||N/A|200|Actual|The Alfred|The findings from this study may or may not extend to other populations of teenage MSM.||1||f||||f||||||Samples With DNA|"     Genital samples (genital swabs from anus, penis), oral rinse, and serum.   "|||2017-10-11 03:53:51.557514|2017-10-11 03:53:51.557514
NCT01422343|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2014-09-08|||May 2009||2009-05-01|September 2014|2014-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Microparticles and the Risk of Re-stenosis Following Balloon Angioplasty in Patients With Peripheral Arterial Disease|Correlation of Microparticles With Risk of Early Re-stenosis After Percutaneous Transluminal Angioplasty in Patients With Peripheral Arterial Disease|Withdrawn||N/A|0|Actual|University Hospital Inselspital, Berne|||1|Shortage of personnel / main study initiator no longer available|f||||f||||||||||2017-10-11 03:53:51.700063|2017-10-11 03:53:51.700063
NCT01422330|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-10-10|||September 2011||2011-09-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients|An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Etravirine (ETR) in Combination With Other Antiretrovirals (ARVs) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects|Completed||Phase 4|211|Actual|Janssen R&D Ireland||1|||f||||f||||||||||2017-10-11 03:53:51.780702|2017-10-11 03:53:51.780702
NCT01422317|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-02-18|||September 1995||1995-09-01|February 2012|2012-02-01|December 2002|Actual|2002-12-01|December 1997|Actual|1997-12-01||Interventional|OFAMI||Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction|Effects of a High-dose Concentrate of n-3 Fatty Acids or Corn Oil Introduced Early After an Acute Myocardial Infarction on Serum Triacylglycerol and High-density Lipoprotein (HDL)- Cholesterol|Completed||Phase 3|300|Actual|Helse Stavanger HF||2|||f||||t||||||||||2017-10-11 03:53:51.938782|2017-10-11 03:53:51.938782
NCT01422304|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2017-04-12|2013-08-19||October 12, 2011|Actual|2011-10-12|April 2017|2017-04-01|September 26, 2012|Actual|2012-09-26|September 26, 2012|Actual|2012-09-26||Interventional|||Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)|A Randomized, Controlled, Parallel-group, Double-blind Trial of Sugammadex or Usual Care (Neostigmine or Spontaneous Recovery) for Reversal of Rocuronium- or Vecuronium-induced Neuromuscular Blockade in Patients Receiving Thromboprophylaxis and Undergoing Hip Fracture Surgery or Joint (Hip/Knee) Replacement (Protocol No. P07038)|Completed||Phase 3|1198|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 03:53:52.059132|2017-10-11 03:53:52.059132
NCT01422291|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-08-22|||January 2011||2011-01-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||IV Paracetamol, Dexketoprofen or Morphine for the Treatment of Low Back Pain|Pamukkale University Medical School,Dept. of Emergency Medicine|Completed||Phase 4|120|Actual|Pamukkale University||2|||f||||f||||||||||2017-10-11 03:53:53.012776|2017-10-11 03:53:53.012776
NCT01422278|ClinicalTrials.gov processed this data on October 10, 2017|2006-01-16|2011-08-22|||September 2007||2007-09-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Rehabilitation of Conversion Gait Disorder|Patients With Conversion Gait Disorder - Effect on Treatment and Common Gait Patterns. Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 03:53:53.102128|2017-10-11 03:53:53.102128
NCT01422265|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-11-01|||June 2011||2011-06-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Patient Reported Symptoms in Ovarian Cancer (PRECISION)|Patient Reported Symptoms in Ovarian Cancer|Completed||N/A|56|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 03:53:53.174776|2017-10-11 03:53:53.174776
NCT01422252|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2015-04-20|||October 2011||2011-10-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|December 2013|Actual|2013-12-01||Interventional|VIGI91||Evaluation of a Fall Detection Device in Isolated Elderly|Evaluation of Falls Occurring at Home in People Over 75 Equipped or Non-equipped With a Precocious Detection Device. Prospective Interventional Study.|Terminated||N/A|33|Actual|Assistance Publique - Hôpitaux de Paris||2||no more inclusions|f||||f||||||||||2017-10-11 03:53:53.405106|2017-10-11 03:53:53.405106
NCT01422239|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2013-06-06|2013-03-19||January 2011||2011-01-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Smoking Cessation Treatment for Adult Women|A Smoking Cessation Treatment for Adult Women|Completed||Phase 1|28|Actual|Yale University|Small sample size, half to two-thirds of participants dropped out of the active study phase, half to one quarter did not complete the one month follow up. Female participants only results can not be generalized to men.|2|||f||||f||||||||||2017-10-11 03:53:53.521073|2017-10-11 03:53:53.521073
NCT01422226|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-12-08|2015-02-11||July 2011||2011-07-01|December 2016|2016-12-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Intra Uterine Device Insertion in Nulliparous Women|IUD Insertion in Nulliparous Women: A Randomized, Placebo-Controlled Trial of Misoprostol for Cervical Priming|Terminated||N/A|3|Actual|University of Colorado, Denver||2||Unable to recruit participants|f||||f||||||||||2017-10-11 03:53:53.891383|2017-10-11 03:53:53.891383
NCT01422213|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2014-07-08|2014-05-14||December 2011||2011-12-01|July 2014|2014-07-01||||May 2013|Actual|2013-05-01||Interventional|FOCUS|"Age + Gender: all-patients-treated set (APTS) – all patients in the APRS who took at least one dose of IMP.
Study-specific Measures: full-analysis set (FAS) – all patients in the APTS who had a valid baseline assessment and at least one valid post-baseline assessment of the DSST, RAVLT (learning [acquisition]), and RAVLT (memory [delayed recall])."|Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder|Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed Dose Study on the Efficacy of [Vortioxetine] Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder (MDD)|Completed||Phase 3|598|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-10-11 03:53:54.232754|2017-10-11 03:53:54.232754
NCT01422200|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-08-22|||August 2011||2011-08-01|August 2011|2011-08-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||Flu Vaccine Study in Neuromuscular Patients 2011|Comparison of the Immunogenicity of Intramuscular Versus Subcutaneous Administration of Trivalent Inactivated Influenza Vaccine in Individuals With Neuromuscular Diseases|Unknown status|Recruiting|N/A|30|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 03:53:55.516698|2017-10-11 03:53:55.516698
NCT01422187|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-04-18|2015-11-06||August 2011||2011-08-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease|A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease|Completed||Phase 3|19|Actual|Protalix||2|||t||||f||||||||||2017-10-11 03:53:55.644885|2017-10-11 03:53:55.644885
NCT00000295|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||April 1999||1999-04-01|April 1999|1999-04-01|December 2001||2001-12-01|||||Interventional|||Progesterone Treatment in Female Smokers - 12|Progesterone Treatment in Female Smokers|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.420015|2017-10-11 04:17:43.420015
NCT01422174|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-03-02|||March 2012||2012-03-01|March 2015|2015-03-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|ESCAPE-ICD||Clinical Registry on Sudden Death Primary Prevention at Latin America|Clinical Registry on Sudden Death Primary Prevention at Latin America (rEgiStro Clinico en America Latina de Prevencion Primaria en muErte Subita)|Withdrawn||N/A|0|Actual|Biotronik SE & Co. KG|||2|Study stopped due to lost of interest.|f||||f||||||||||2017-10-11 03:53:56.532861|2017-10-11 03:53:56.532861
NCT01422148|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-07-11|||October 2011||2011-10-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|MINA||Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery|Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery (MINA)|Recruiting||N/A|40|Anticipated|Baystate Medical Center||2|||f||||t||||||||||2017-10-11 03:53:56.764642|2017-10-11 03:53:56.764642
NCT01422122|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2017-04-19|||June 2010||2010-06-01|April 2017|2017-04-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|VitaminD||Study of Vitamin D Supplementation on Improvement of Gums Health|The Effect of Vitamin D Supplementation on the Periodontal Health and Associated Outcomes in Pregnant Women|Completed||N/A|115|Actual|Aga Khan University||2|||f||||t||||||||No||2017-10-11 03:53:56.960474|2017-10-11 03:53:56.960474
NCT01422109|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-01-05|||July 2011||2011-07-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|YH14659||Comparative Pharmacokinetics of YH14659|Comparative Pharmacokinetics After Single Oral Administration of YH14659, a Fixed Dose Combination Versus Coadministration of Separate Constituents in Healthy Male Volunteers|Completed||Phase 1|44|Actual|Yuhan Corporation||2|||f||||t||||||||||2017-10-11 03:53:57.513976|2017-10-11 03:53:57.513976
NCT01422096|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-12-16|||June 2017||2017-06-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess|Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS007)|Not yet recruiting||N/A|20|Anticipated|University of Virginia||1|||f||||f||||||||No||2017-10-11 03:53:57.61996|2017-10-11 03:53:57.61996
NCT01422083|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2014-12-04|||September 2010||2010-09-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|GIRD||Glenohumeral Internal Rotation Deficit (GIRD)|Correlation Between Loss of Internal Rotation Range of Motion and Size of the Subacromial Space and the Influence of a Home Stretching Program.|Unknown status|Recruiting|N/A|60|Anticipated|University Ghent||2|||f||||f||||||||||2017-10-11 03:53:57.725184|2017-10-11 03:53:57.725184
NCT01422070|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2015-07-31|2015-02-12||November 2011||2011-11-01|July 2015|2015-07-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|ELOISE|337 readmissions, 83 admissions with inconsistencies in dates and 147 patients with unknown vital status at hospital discharge (82 still in hospital at 90 days and 65 with missing vital status) were excluded from the analysis.|European Mortality & Length Of Intensive Care Unit (ICU) Stay Evaluation (ELOISE)|A Multi-centre European Observational Study to Assess Whether Patients Admitted to the ICUs With Availability of Intermediate Care Unit (IMCU) Have Lower Hospital Mortality Than Those Admitted to the ICUs Without Availability of IMCU|Completed||N/A|6433|Actual|Università degli Studi di Ferrara|||1||f||||f||||||||||2017-10-11 03:53:57.814769|2017-10-11 03:53:57.814769
NCT01422057|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-02-05|||January 2010||2010-01-01|February 2014|2014-02-01|January 2016|Anticipated|2016-01-01|January 2014|Actual|2014-01-01||Observational|||Risk Prediction in Type II Diabetics With Ischemic Heart Disease|Risk Prediction in Type II Diabetics With Ischemic Heart Disease by Cardiac Autonomic Function|Unknown status|Recruiting|N/A|500|Anticipated|Thebiosignals.com|||1||f||||f||||||||||2017-10-11 03:53:58.094442|2017-10-11 03:53:58.094442
NCT01422044|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-02-05|||September 2009||2009-09-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|PREDICT-AS||Risk Prediction in Aortic Stenosis|Risk Prediction in Aortic Stenosis by Cardiac Autonomic Function|Completed||N/A|423|Actual|Thebiosignals.com|||1||f||||f||||||||||2017-10-11 03:53:58.176252|2017-10-11 03:53:58.176252
NCT01422031|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-01-23|||September 2007||2007-09-01|January 2015|2015-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Study on Primary Care Health Service Utilization in Hong Kong|Utilization Pattern of Primary Health Care Services in Hong Kong - Does Having a Family Doctor Make Any Difference?|Completed||N/A|3148|Actual|The University of Hong Kong|||3||f||||f||||||||||2017-10-11 03:53:58.239766|2017-10-11 03:53:58.239766
NCT01422018|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-09-22|||August 2011||2011-08-01|September 2011|2011-09-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy||Unknown status|Recruiting|N/A|10|Anticipated|Seoul St. Mary's Hospital||1|||f||||t||||||||||2017-10-11 03:53:58.314813|2017-10-11 03:53:58.314813
NCT01421992|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-08-22|||June 2008||2008-06-01|June 2011|2011-06-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Methylphenidate in Myotonic Dystrophy Type 1|Phase 2/3 Study of Efficacy and Tolerability of Methylphenidate in the Treatment of Excessive Daytime Sleepiness in Myotonic Dystrophy Type 1|Completed||Phase 2/Phase 3|28|Actual|Laval University||2|||f||||f||||||||||2017-10-11 03:53:58.499995|2017-10-11 03:53:58.499995
NCT01421979|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2015-02-04|||April 2011||2011-04-01|February 2015|2015-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans||Completed||N/A|38|Actual|University of Hohenheim||2|||f||||||||||||||2017-10-11 03:53:58.580361|2017-10-11 03:53:58.580361
NCT01421966|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2015-12-03|||August 2011||2011-08-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes|A Phase III Multicenter, Randomized, Double-Blind, Parallel-Group, Sham-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Wound Care in Lower Extremity Chronic Ulcers in Adults With Diabetes Mellitus|Completed||Phase 3|285|Actual|Macrocure Ltd.||2|||f||||t||||||||||2017-10-11 03:53:58.653976|2017-10-11 03:53:58.653976
NCT01421953|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-10-22|||August 2011||2011-08-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|PULMOTEP||Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers|Assessment of Four-dimensional (4D) 18F-fluoro-deoxy-glucose (FDG) Positron Emission Tomography and Computed Tomography System (PET-CT) in Radiotherapy for Non Small Cell Lung Cancers (NSCLC)|Completed||N/A|7|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-10-11 03:54:00.662497|2017-10-11 03:54:00.662497
NCT01421940|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-03-09|||October 2009||2009-10-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|December 2011|Actual|2011-12-01||Interventional|||The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer||Completed||Phase 4|80|Actual|Kyungpook National University||2|||f||||t||||||||||2017-10-11 03:54:00.745416|2017-10-11 03:54:00.745416
NCT01421927|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2015-07-22|||August 2011||2011-08-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|REVALLO||Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma|Safety of a Maintenance Therapy With Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Chemosensitive Relapsed Multiple Myeloma|Completed||Phase 1|13|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-10-11 03:54:00.835173|2017-10-11 03:54:00.835173
NCT01421914|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2012-11-16|||December 2010||2010-12-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|November 2011|Actual|2011-11-01||Interventional|||Determining the Minimum Effective Volume of Local Anesthetic for Ultrasound-guided Axillary Brachial Plexus Block|Determining the Minimum Effective Volume of Local Anesthetic for Ultrasound-guided Axillary Brachial Plexus Block|Completed||N/A|19|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 03:54:00.911798|2017-10-11 03:54:00.911798
NCT01421901|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-06-16|||August 2011||2011-08-01|June 2014|2014-06-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|ASAA||Antibiotics Versus Surgery in Acute Appendicitis|Antibiotics vs.Surgery in Acute Appendicitis;an Intention to Treat Prospective Randomised Study. The ASAA-study|Unknown status|Recruiting|Phase 4|218|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||t||||||||||2017-10-11 03:54:00.9955|2017-10-11 03:54:00.9955
NCT01421888|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-20|2017-06-30|||August 8, 2011||2011-08-08|April 17, 2013|2013-04-17|April 17, 2013||2013-04-17|||||Observational|||The NIH UNI Study: Urea Cycle Disorders, Nutrition and Immunity|The NIH UNI Study: Urea Cycle Disorders, Nutrition and Immunity|Terminated||N/A|4|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:54:01.081982|2017-10-11 03:54:01.081982
NCT01421875|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-20|2017-05-16|||August 17, 2011|Actual|2011-08-17|May 2017|2017-05-01|October 17, 2011|Actual|2011-10-17|October 17, 2011|Actual|2011-10-17||Observational|||Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia|Genetic and Epigenetic Determinants of Chemotherapy Resistance and Adverse Outcome in Elderly Patients With AML|Completed||N/A|257|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 03:54:01.157951|2017-10-11 03:54:01.157951
NCT01421862|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-20|2013-07-09|||September 2011||2011-09-01|August 2011|2011-08-01||||October 2011|Anticipated|2011-10-01||Observational|||Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment|"The Genetics of Non-Response in Adult AML"|Unknown status|Not yet recruiting|N/A|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 03:54:01.241046|2017-10-11 03:54:01.241046
NCT01421849|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2014-12-04|||August 2011||2011-08-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Mandibular Single Implant Overdenture: a Prospective Clinical Trial|Patient Satisfaction and Clinical Outcomes Following Mandibular Single-implant-retained Overdenture Treatment in Residents of Nursing Homes: a Prospective Clinical Trial|Unknown status|Active, not recruiting|N/A|50|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:54:01.443885|2017-10-11 03:54:01.443885
NCT01421836|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-04-27|||May 2011||2011-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|||Prospective Study Comparing EUS vs ERCP Stent Insertion for Malignant Biliary Obstruction|Prospective Study Comparing EUS Guided Biliary Drainage and ERCP With Stent Placement for Malignant Biliary Obstruction|Completed||Phase 2/Phase 3|30|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 03:54:01.561694|2017-10-11 03:54:01.561694
NCT01421823|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-21|2013-12-11|||August 2011||2011-08-01|December 2013|2013-12-01||||April 2012|Anticipated|2012-04-01||Interventional|||A Double Blinded Study to Examine the Effect of Alpha Agonist Ointment on Fecal Incontinence in Patients With Idiopathic Fecal Incontinence||Withdrawn||Phase 1/Phase 2|0|Actual|RDD Pharma Ltd||2|||f||||f||||||||||2017-10-11 03:54:01.687395|2017-10-11 03:54:01.687395
NCT01421810|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-12-16|||December 2010||2010-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CBS001||Ovarian Contribution to Androgen Production in Adolescent Girls|Ovarian Contribution to Androgen Production in Adolescent Girls|Recruiting||N/A|80|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-11 03:54:01.788869|2017-10-11 03:54:01.788869
NCT01421797|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2015-12-07|||October 2006||2006-10-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation|Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation (JCM022)|Recruiting||N/A|84|Anticipated|University of Virginia||1|||f||||f||||||||||2017-10-11 03:54:01.903387|2017-10-11 03:54:01.903387
NCT01421784|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-03-19|||September 2011||2011-09-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Using Rapid Cine-MRI for Monitoring Moving and Deforming Tumors|Investigating the Feasibility of Using Rapid Cine-MRI for Monitoring Moving and Deforming Tumors|Unknown status|Recruiting|N/A|40|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 03:54:02.078761|2017-10-11 03:54:02.078761
NCT01421758|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-04-15|||December 2010||2010-12-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|INSHAPE||Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity|Using Facebook to Increase Social Support for Physical Activity: The INSHAPE Study|Completed||N/A|134|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 03:54:02.485539|2017-10-11 03:54:02.485539
NCT01421745|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2012-05-14|||May 2011||2011-05-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Construct Validity, Responsiveness, and Demographic Predictors of the IAPCC-SV|Construct Validity, Responsiveness, and Demographic Predictors of the Inventory for Assessing the Process of Cultural Competence Among Healthcare Professionals - Student Version (IAPCC-SV)|Completed||N/A|40|Actual|Texas Woman's University||1|||f||||f||||||||||2017-10-11 03:54:02.604406|2017-10-11 03:54:02.604406
NCT01421732|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-09-29|||October 2010||2010-10-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Laboratory Diagnosis and Prognosis of Severe Dengue|Laboratory Diagnosis and Prognosis of Severe Dengue|Completed||N/A|8100|Actual|Oxford University Clinical Research Unit, Vietnam|||1||f||||f||||||||||2017-10-11 03:54:02.705501|2017-10-11 03:54:02.705501
NCT01421719|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-01-20|2011-08-31||February 2009||2009-02-01|January 2017|2017-01-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease|Onabotulinum Toxin Type A (BTX-A) For Treatment of Neurogenic Overactive Bladder Due to Parkinson's Disease: Safety and Efficacy|Completed||Phase 4|20|Actual|Stanford University|The limitations of this trial involved the primary disease disorder of Parkinson's Disease and difficulty of communication with subjects; Four patients withdrew from the study prior to the 6-month endpoint because of loss of efficacy.|1|||f||||f||||||||No||2017-10-11 03:54:02.810158|2017-10-11 03:54:02.810158
NCT01421706|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2012-09-16|||July 2008||2008-07-01|September 2012|2012-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|sibu||Effects of Clopidogrel and Clarithromycin on the Oral Disposition of Sibutramine in Healthy Subjects|Effects of Clopidogrel and Clarithromycin on the Disposition of Sibutramine and Its Active Metabolites M1 and M2 in Relation to CYP2B6*6 Polymorphism|Completed||Phase 1|20|Actual|Inje University||2|||f||||f||||||||||2017-10-11 03:54:03.023522|2017-10-11 03:54:03.023522
NCT01421693|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2016-10-02|||September 2011||2011-09-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|July 2014|Actual|2014-07-01||Interventional|||Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever|Randomized, Open-label, Superiority Trial of the Effectiveness of Gatifloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Enteric Fever.|Completed||Phase 4|300|Actual|Oxford University Clinical Research Unit, Vietnam||2|||f||||t||||||||||2017-10-11 03:54:03.13047|2017-10-11 03:54:03.13047
NCT01421680|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2014-03-12|||August 2011||2011-08-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients|A Prospective Randomized Controlled Trial Evaluating the Effects of Preoperative and Postoperative Oral Nutritional Supplements (ONS) in Malnourished Post-gastrectomy Patients|Completed||N/A|144|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:54:03.221687|2017-10-11 03:54:03.221687
NCT01421667|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-10-14|2016-06-21||August 2011||2011-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||All participants who received treatment.|A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma|A Phase 2 Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)|Completed||Phase 2|176|Actual|Seattle Genetics, Inc.||2|||f||||f||||||||||2017-10-11 03:54:03.369361|2017-10-11 03:54:03.369361
NCT01421654|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2013-03-10|2013-01-31||September 2011||2011-09-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy|Evaluation of Positive Airway Pressure (PAP) Feature to Improve Patient Adherence to Therapy|Completed||N/A|20|Actual|ResMed||2|||f||||f||||||||||2017-10-11 03:54:05.982156|2017-10-11 03:54:05.982156
NCT01421641|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-03-18|2013-11-13||September 2011||2011-09-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Tenaculum Pain Control Study|The Effect of Intracervical Lidocaine Injection Versus Topical Lidocaine Gel on the Pain Experienced by Patients Undergoing Tenaculum Application to the Cervix at the Time of an Office Gynecologic Procedure|Completed||Phase 4|74|Actual|Oregon Health and Science University|There are several limitations to this study, including potential selection bias, difficulty with blinding the intervention, timing of the intervention for maximal effect, and the limitations inherent in measuring pain.|2|||f||||f||||||||||2017-10-11 03:54:06.243348|2017-10-11 03:54:06.243348
NCT01421628|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-08-22|||September 2010||2010-09-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|NLC2010||Enhancement of Physical Fitness in Older Adults|The Effectiveness of a Trainings Program on ADL Performance, Physical Fitness, Wellbeing, and Nocturnal Cramp in Elderly People|Completed||N/A|180|Actual|Hanze University||1|||f||||f||||||||||2017-10-11 03:54:06.687436|2017-10-11 03:54:06.687436
NCT01421615|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-22|||January 2011||2011-01-01|August 2011|2011-08-01|May 2012|Anticipated|2012-05-01|December 2011|Anticipated|2011-12-01||Interventional|BV||Effect of Different Courses of Lactobacilli Treatment on Bacterial Vaginosis and Pregnancy Outcomes|Effect of Different Courses of Lactobacilli Treatment on Bacterial Vaginosis and Related Pregnancy Outcomes|Unknown status|Recruiting|Phase 1|5000|Anticipated|The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine||3|||f||||t||||||||||2017-10-11 03:54:06.768797|2017-10-11 03:54:06.768797
NCT01421602|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-22|2011-09-21|||September 2011||2011-09-01|September 2011|2011-09-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Observational|||A Prospective Observational Study on the Use of a Self Fixating Lightweight Polyester Mesh in Open Inguinal Hernia|A Prospective Observational Study on the Use of a Self Fixating Lightweight Polyester Mesh in Open Inguinal Hernia|Unknown status|Recruiting|N/A|100|Anticipated|De La Salle University Medical Center|||1||f||||f||||||||||2017-10-11 03:54:06.877164|2017-10-11 03:54:06.877164
NCT01421589|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-05-29|2014-03-31||September 2011||2011-09-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Obese male subjects with reduced growth hormone secretion|Growth Hormone Treatment on Phosphocreatine Recovery in Obesity|The Effects of Short Term Growth Hormone Treatment on Skeletal Muscle Phosphocreatine Recovery in Obesity|Completed||N/A|15|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:54:06.967439|2017-10-11 03:54:06.967439
NCT01421576|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-22|||July 2011||2011-07-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions|A Randomized, Single-dose, 2-sequence, 2-period Crossover Study to Investigate the Food-effect Pharmacokinetics of Sarpogrelate HCl Controlled Release Tablet in Healthy Male Subjects|Completed||Phase 1|24|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-11 03:54:07.332147|2017-10-11 03:54:07.332147
NCT01421563|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2011-08-22|||February 2011||2011-02-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers|A Randomized, Open-label, Two-Sequence, Two-Period Crossover Study to Assess the Pharmacokinetic Characteristics of Sarpogrelate HCl Controlled Release Tablet Compared With Sarpogrelate HCl Immediate Release Tablet in Healthy Male Subjects|Completed||Phase 1|36|Actual|Alvogen Korea||2|||f||||f||||||||||2017-10-11 03:54:07.410394|2017-10-11 03:54:07.410394
NCT01421550|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-08-22|||January 2011||2011-01-01|August 2011|2011-08-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|CRUCIAL||Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver Cirrhosis|Conservative Treatment Versus Elective Repair of the Umbilical Hernia in Patients With Ascites and Liver Cirrhosis, a Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|100|Anticipated|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 03:54:07.503921|2017-10-11 03:54:07.503921
NCT01421537|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-08-22|||January 2011||2011-01-01|August 2011|2011-08-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Evaluation Of Enoxaparin Pharmacokinetic For Thromboprophylaxis In Burn Care Patients|Evaluation Of Enoxaparin Pharmacokinetic For Thromboprophylaxis In Burn Care Patients|Unknown status|Recruiting|N/A|180|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-10-11 03:54:07.614736|2017-10-11 03:54:07.614736
NCT01421524|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-06-28|||September 19, 2011|Actual|2011-09-19|June 2017|2017-06-01|October 29, 2018|Anticipated|2018-10-29|October 29, 2018|Anticipated|2018-10-29||Interventional|||Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma|A Phase 1a/1b, Multi-center, Open-label, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Pleiotropic Pathway Modifier CC-122 Administered Orally to Subjects With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma.|Recruiting||Phase 1|296|Anticipated|Celgene||4|||f||||t||||||||||2017-10-11 03:54:07.720302|2017-10-11 03:54:07.720302
NCT01421511|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-03-28|2014-07-15|2014-04-02|September 15, 2011|Actual|2011-09-15|March 2017|2017-03-01|January 10, 2013|Actual|2013-01-10|January 10, 2013|Actual|2013-01-10||Interventional||All randomized participants|TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections|A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of IV to Oral 6-Day TR-701 Free Acid and IV to Oral 10-Day Linezolid for the Treatment of ABSSSI|Completed||Phase 3|666|Actual|Trius Therapeutics LLC|Analyses for this study were conducted using 2 statistical plans, 1 for the US FDA and 1 for the EMA, to address differing guidance on the development of antibacterials. These differences are reflected in the EudraCT and clinicaltrials.gov records.|2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:54:07.986152|2017-10-11 03:54:07.986152
NCT01421498|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-01-05|2015-11-09|2013-07-02|August 2011||2011-08-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|OPUS-1|Safety population included all randomized participants who received at least 1 dose of investigational product.|Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE)|A Phase 3, Multicenter, Randomized, Double- Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of SAR 1118 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (OPUS-1)|Completed||Phase 3|588|Actual|Shire||2|||f||||f||||||||||2017-10-11 03:54:09.008377|2017-10-11 03:54:09.008377
NCT01421485|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-10-03|||August 2011||2011-08-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|April 2015|Actual|2015-04-01||Interventional|ITP||Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth|Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth|Completed||N/A|170|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-10-11 03:54:09.430319|2017-10-11 03:54:09.430319
NCT01421472|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-03-30|2016-02-14||August 2011||2011-08-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer|A Randomized, Phase 2 Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer|Completed||Phase 2|196|Actual|Merrimack Pharmaceuticals||2|||f||||t||||||||||2017-10-11 03:54:09.558249|2017-10-11 03:54:09.558249
NCT01421459|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-12-02|2014-10-03|2013-01-11|September 2011||2011-09-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|ELEMENT 2|All randomized participants who received at least 1 dose of study drug.|A Study in Adults With Type 2 Diabetes|A Prospective, Randomized, Double-Blind Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus in Adult Patients With Type 2 Diabetes Mellitus: The ELEMENT 2 Study|Completed||Phase 3|759|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:54:11.292474|2017-10-11 03:54:11.292474
NCT01421446|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2015-03-30|||September 2011||2011-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational|||Study to Validate a Computerized Neuropsychological Test Battery|Reliability and Validity of Umea Computerized Neuropsychological Battery|Terminated||N/A|1|Actual|LifeBridge Health|||1|Insufficient subject recruitment|f||||f||||||||||2017-10-11 03:54:13.693394|2017-10-11 03:54:13.693394
NCT01421433|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-03-07|||May 2012||2012-05-01|March 2012|2012-03-01|January 2013|Anticipated|2013-01-01|August 2012|Anticipated|2012-08-01||Interventional|||A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol|Non Inferiority,Phase III,Multicentric,Double Blind,Randomized,Parallel Study,Comparing Dolamin Flex (Lysine Clonixinate+Cyclobenzaprine) and Tandrilax(Caffeine +Carisoprodol+Diclofenac+Paracetamol)in Pain Reduction in Patients With Lumbago|Unknown status|Not yet recruiting|Phase 3|160|Anticipated|Farmoquimica S.A.||2|||f||||f||||||||||2017-10-11 03:54:13.764564|2017-10-11 03:54:13.764564
NCT01421420|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-06-10|||July 2001||2001-07-01|January 2015|2015-01-01|July 2025|Anticipated|2025-07-01|December 2024|Anticipated|2024-12-01||Observational|ADCC||Alzheimer's Disease Core Center|Arizona Alzheimer's Disease Core Center|Recruiting||N/A|900|Anticipated|University of Arizona|||4||f||||f||||||Samples With DNA|"     blood, saliva, brain tissue   "|||2017-10-11 03:54:13.870708|2017-10-11 03:54:13.870708
NCT01421407|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-05-05|||August 2011||2011-08-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism|Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Uncontrolled Secondary Hyperparathyroidism in Chronic Haemodialysis Patients|Withdrawn||N/A|0|Actual|Theraclion||2|||f||||f||||||||||2017-10-11 03:54:13.966923|2017-10-11 03:54:13.966923
NCT01421394|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2014-11-18|||November 2010||2010-11-01|July 2011|2011-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|scissors||Spinal Cord Injury Series of Tampere - Retrospective Study|Spinal Cord Injury Series of Tampere - Retrospective Study|Unknown status|Recruiting|N/A|50|Anticipated|Tampere University Hospital|||1||f||||f||||||||||2017-10-11 03:54:14.060673|2017-10-11 03:54:14.060673
NCT01421381|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2013-05-24|||September 2011||2011-09-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Observational|RHODOS-OFU||RHODOS Follow-up Single-visit Study|A Single Visit, Observational, Follow-up Study of Patients With Leber's Hereditary Optic Neuropathy Following Participation in SNT-II-003 Trial|Completed||N/A|60|Actual|Santhera Pharmaceuticals|||1||f||||||||||||||2017-10-11 03:54:14.129247|2017-10-11 03:54:14.129247
NCT01421368|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-04-09|||March 2012||2012-03-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use|Assessing the Effect of Contraception and the Menstrual Cycle on Pharmacokinetics, Pharmacodynamics, and Vaginal Safety in Tenofovir Vaginal Gel Users|Completed||Phase 1|72|Actual|CONRAD||2|||f||||f||||||||||2017-10-11 03:54:14.200994|2017-10-11 03:54:14.200994
NCT01421355|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-06-23|2014-06-23||May 2012||2012-05-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus|A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus|Completed||Phase 1|15|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-11 03:54:14.295834|2017-10-11 03:54:14.295834
NCT01421342|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2016-04-19|||December 2012||2012-12-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|August 2015|Actual|2015-08-01||Interventional|VAST-D||VA Augmentation and Switching Treatments for Improving Depression Outcomes|CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)|Active, not recruiting||Phase 3|1518|Anticipated|VA Office of Research and Development||3|||f||||t||||||||||2017-10-11 03:54:14.444495|2017-10-11 03:54:14.444495
NCT01421316|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2015-06-03|||January 2013||2013-01-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|September 2013|Actual|2013-09-01||Interventional|||Hair-sparing Whole Brain Radiotherapy|Reducing Hair Loss With Volumetric Arc Therapy in Patients Treated With Whole Brain Radiotherapy: a Phase II Trial|Terminated||Phase 2|29|Anticipated|University Hospital, Ghent||1||No reduction in hair loss 1 month after treatment|f||||f||||||||||2017-10-11 03:54:14.709322|2017-10-11 03:54:14.709322
NCT01421303|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-12-05|2014-12-05||October 2009||2009-10-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|AS@WORK|Baseline analysis set (BAS) consisted of all participants enrolled in the study, who were seen at baseline and started the treatment with etanercept (Enbrel).|Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.|Work Productivity In A Cohort Of Employed Ankylosing Spondylitis Patients Treated With Etanercept|Completed||Phase 4|80|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 03:54:14.848205|2017-10-11 03:54:14.848205
NCT01421290|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2015-06-02|||January 2013||2013-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Treatment of Cartilage Lesions in Flanders Today|Clinical Outcome After Treating Cartilage Defects in the Knee by Surgical or Conservative Means|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 03:54:15.731759|2017-10-11 03:54:15.731759
NCT01421277|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-05-26|2014-09-08||May 19, 2011|Actual|2011-05-19|May 2017|2017-05-01|March 23, 2012|Actual|2012-03-23|March 23, 2012|Actual|2012-03-23||Observational|MASTER|All eligible particpants. 2 participants did not specify gender in the online questionnaire.|Study of Treatment Used for Migraine Headaches (MK-0974-076)|Migraine Attack Study of Treatment, Efficacy and Resource Use (MASTER) - McKesson Substudy (MK-0974-076)|Terminated||N/A|216|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-10-11 03:54:15.840108|2017-10-11 03:54:15.840108
NCT01421264|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-06-21|||August 2011||2011-08-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Gabapentin's Effects on Insomnia in Patients With Recent Concussion||Completed||Phase 1|21|Actual|University at Buffalo||1|||f||||f||||||||||2017-10-11 03:54:16.085901|2017-10-11 03:54:16.085901
NCT01421251|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2012-09-11|||June 2011||2011-06-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||H1N1 Vaccine Safety in Manitoba, Canada|The Safety of GSK Biological's H1N1 Pandemic Vaccine in Manitoba, Canada|Unknown status|Active, not recruiting|N/A|800000|Anticipated|International Centre for Infectious Diseases, Canada|||1||f||||f||||||None Retained|"     None collected   "|||2017-10-11 03:54:16.253004|2017-10-11 03:54:16.253004
NCT01421238|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2012-11-20|||May 2006||2006-05-01|November 2012|2012-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Framing and Decision Making in Neonatology|Framing and Perinatal Decision Making at Extremes of Prematurity|Completed||N/A|350|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 03:54:16.341529|2017-10-11 03:54:16.341529
NCT01421212|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-19|||November 1999||1999-11-01|August 2011|2011-08-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation|Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine|Completed||Phase 1/Phase 2|30|Actual|Biotest Pharmaceuticals Corporation|||||f||||f||||||||||2017-10-11 03:54:16.581293|2017-10-11 03:54:16.581293
NCT01421199|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-19|||September 2011||2011-09-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Device Study to Evaluate the Detection and Characterization of Middle Ear Fluid in Children|A Prospective, Multi Center, Non-randomized Clinical Trial to Evaluate the Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children|Unknown status|Not yet recruiting|N/A|125|Anticipated|OtoSonics Inc.||1|||f||||f||||||||||2017-10-11 03:54:16.710572|2017-10-11 03:54:16.710572
NCT01421186|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-09-12|||July 2011||2011-07-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|||A Phase I/IIa Study of Human Anti-CD38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma|A Phase I/IIa, Open-Label, Multicentre, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of the Human Anti-CD38 Antibody MOR03087 as Monotherapy and in Combination With Standard Therapy in Subjects With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|121|Actual|MorphoSys AG||2|||f||||t||||||||||2017-10-11 03:54:16.793048|2017-10-11 03:54:16.793048
NCT01421173|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-11-17|||August 2011||2011-08-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies|Vorinostat (SAHA) Combined With High-Dose Gemcitabine, Busulfan, and Melphalan With Autologous Hematopoietic Cell Support for Patients With Relapsed or Refractory Lymphoid Malignancies|Completed||Phase 1|78|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:54:16.913883|2017-10-11 03:54:16.913883
NCT01421160|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-05-13|||July 2011||2011-07-01|May 2017|2017-05-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Regulating Urine pH Levels to Alleviate Chronic Joint Pain|A Pilot Study to Assess the Effects of Regulating Urine pH Levels for Alleviating Chronic Joint Pain|Withdrawn||Phase 1|0|Actual|Texas Tech University Health Sciences Center, El Paso||1||PI left the institution prior to any data being collected|f||||f||||||||||2017-10-11 03:54:17.049867|2017-10-11 03:54:17.049867
NCT01421147|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2014-10-03|2014-10-03|2012-09-18|August 2011||2011-08-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|August 2012|Actual|2012-08-01||Interventional|ELEMENT 1|All randomized participants who received at least 1 dose of study drug.|A Study in Adults With Type 1 Diabetes|A Prospective, Randomized, Open-label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus in Combination With Mealtime Insulin Lispro in Adult Patients With Type 1 Diabetes Mellitus|Completed||Phase 3|536|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 03:54:17.235008|2017-10-11 03:54:17.235008
NCT01421134|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-07-13|2015-09-10||September 2011||2011-09-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|RESOLVE 1|Two subjects were randomized in error and were not treated.|Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose|A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features|Completed||Phase 3|211|Actual|Sunovion||2|||f||||t||||||||||2017-10-11 03:54:19.928021|2017-10-11 03:54:19.928021
NCT01421121|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2012-11-26|||June 2011||2011-06-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants||Completed||Phase 2|540|Actual|Sinovac Biotech Co., Ltd||5|||f||||t||||||||||2017-10-11 03:54:20.65946|2017-10-11 03:54:20.65946
NCT01421108|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-03-04|||July 2011||2011-07-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||The Effectiveness of Gain- Versus Loss-framed Health Messages to Improve Oral Health Among Iranian Adolescents|The Effectiveness of Gain- Versus Loss-framed Health Messages to Improve Oral Health Among Iranian Adolescents:A Randomized Controlled Trial|Completed||Phase 2|372|Actual|Qazvin University Of Medical Sciences||2|||f||||f||||||||||2017-10-11 03:54:20.771862|2017-10-11 03:54:20.771862
NCT01421095|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-05-02|||January 2011||2011-01-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Ovarian Reserve Testing in Female Young Adult Cancer Survivors|Ovarian Reserve Testing in Female Young Adult Cancer Survivors|Recruiting||N/A|34|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-10-11 03:54:20.857023|2017-10-11 03:54:20.857023
NCT01421082|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2014-03-11|||February 2012||2012-02-01|December 2012|2012-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema|Evaluation of Physiologic Parameters to Study the Mechanism of Action of the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) in Subjects With Homogeneous Emphysema|Completed||Phase 2/Phase 3|10|Actual|PneumRx, Inc.||1|||f||||f||||||||||2017-10-11 03:54:21.041519|2017-10-11 03:54:21.041519
NCT01421069|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-08-14|||October 2011|Actual|2011-10-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|CLIPPER2||Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis|An Open-label Extension Study To Assess The Long-term Safety And Clinical Benefit Of Etanercept In Children And Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-related Arthritis, Or Psoriatic Arthritis Who Were Previously Enrolled In Protocol 0881a1-3338-ww(b1801014)|Active, not recruiting||Phase 3|109|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 03:54:21.147777|2017-10-11 03:54:21.147777
NCT01421043|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2016-10-21|||September 2011||2011-09-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study to Determine Whether an Oral Drops Formulation of Triazolam is Bioequivalent to a Tablet Formulation in Healthy Subjects|An Open Label, Randomized, Single Dose, Crossover Pivotal Bioequivalence Study of Triazolam Liquid Oral Drops at a Dose of 0.25 Mg Versus Triazolam 0.25 Mg Tablet in Healthy Subjects|Completed||Phase 1|34|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:54:21.487884|2017-10-11 03:54:21.487884
NCT01421030|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-09-24|||September 2011||2011-09-01|September 2012|2012-09-01|September 2014|Anticipated|2014-09-01|September 2012|Anticipated|2012-09-01||Interventional|MEQC||Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical Techniques|Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical Techniques.|Unknown status|Recruiting|Early Phase 1|40|Anticipated|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 03:54:21.59474|2017-10-11 03:54:21.59474
NCT01421017|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-02-16|||August 2011|Actual|2011-08-01|February 2017|2017-02-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases|Phase I/II Study of TLR7 Agonist Imiquimod, Cyclophosphamide, and Radiotherapy in Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases|Active, not recruiting||Phase 1/Phase 2|55|Anticipated|New York University School of Medicine||3|||f||||t||||||||||2017-10-11 03:54:21.698084|2017-10-11 03:54:21.698084
NCT01421004|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-01-22|||December 2011||2011-12-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors|A Phase I, Open-label, Multi-center, Randomized, Crossover Study to Assess the Bioequivalence of 2 Formulations of TKI258, FMI Capsule and FMI Tablet, in Patients With Advanced Solid Tumors|Completed||Phase 1|166|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:54:21.8235|2017-10-11 03:54:21.8235
NCT01420991|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-12-31|||August 2011||2011-08-01|December 2015|2015-12-01|December 2024|Anticipated|2024-12-01|February 2014|Actual|2014-02-01||Observational|BAAS||Brain and Abdominal Aneurysm Study|Brain and Abdominal Aneurysm Study (BAAS)|Active, not recruiting||N/A|81|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:54:21.953111|2017-10-11 03:54:21.953111
NCT01420978|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2013-05-12|||August 2011||2011-08-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Cerebrospinal Fluid (CSF) Drainage Study|High Volume Cerebrospinal Fluid Diversion in the Management of Aneurysmal Subarachnoid Hemorrhage: A Pilot Study|Completed||N/A|20|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:54:22.030538|2017-10-11 03:54:22.030538
NCT01420965|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-09-15|||September 2012||2012-09-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer|A Pilot Study to Test the Feasibility and Immunologic Impact of Sipuleucel-T (Provenge) Administered With or Without Anti-PD-1 mAb (CT-011) and Low Dose Cyclophosphamide in Men With Advanced Castrate-Resistant Prostate Cancer|Terminated||Phase 2|7|Actual|Augusta University||3||Drug supply issues|f||||t|t|f||||||||2017-10-11 03:54:22.128567|2017-10-11 03:54:22.128567
NCT01420952|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-06-30|||July 29, 2011||2011-07-29|November 27, 2012|2012-11-27|November 27, 2012|Actual|2012-11-27|November 27, 2012|Actual|2012-11-27||Interventional|||Imaging of Brain Receptors Using (11C)mGlu1|PET Imaging of Brain mGlu1 Receptors Using [11]LY2428703|Terminated||Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:54:22.238568|2017-10-11 03:54:22.238568
NCT01420939|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-06-30|||July 21, 2011||2011-07-21|May 21, 2013|2013-05-21|May 21, 2013||2013-05-21|||||Observational|||Developing Therapies for Traumatic Brain Injury|Biomarkers-Driven Development of Experimental Therapeutics for Traumatic Brain Injury|Terminated||N/A|19|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:54:22.310452|2017-10-11 03:54:22.310452
NCT01420926|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2017-04-10|2016-08-30||November 2011||2011-11-01|April 2017|2017-04-01||||June 2015|Actual|2015-06-01||Interventional||Two (2) participants never received any protocol treatment; per study design these patients were excluded from all analyses.|Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia|A Randomized Phase II Trial of Decitabine-Based Induction Strategies for Patients ≥ 60 Years Old With Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 2|165|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 03:54:22.453144|2017-10-11 03:54:22.453144
NCT01420913|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2011-08-19|||August 2011||2011-08-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects|Randomized,Open-label,Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects|Completed||Phase 1|28|Actual|Yuhan Corporation||4|||f||||f||||||||||2017-10-11 03:54:24.898048|2017-10-11 03:54:24.898048
NCT01420900|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2016-11-01|||September 2011||2011-09-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Ceramic-on-Ceramic Total Hip Arthroplasty and Squeaking: Influence of Component Design|Ceramic-on-Ceramic Total Hip Arthroplasty and Squeaking: A Prospective, Blinded, Randomized Clinical Trial of Influence of Component Design|Active, not recruiting||N/A|204|Actual|Vejle Hospital||2|||f||||f||||||||||2017-10-11 03:54:24.972943|2017-10-11 03:54:24.972943
NCT01420887|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-06-15|||December 2016||2016-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|CPM||Preservation of Joint Function Using Postoperative Continuous Passive Motion (CPM) A Pilot Study|Preservation of Joint Function Using Postoperative Continuous Passive Motion (CPM) A Pilot Study|Recruiting||Phase 3|50|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:54:25.04861|2017-10-11 03:54:25.04861
NCT01420874|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-05-26|||August 2011||2011-08-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)|Treatment of Advanced Colorectal or Pancreatic Cancer With Anti-CD3 x Anti-EGFR-Armed Activated T-Cells (Phase Ib)|Active, not recruiting||Phase 1|30|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 03:54:25.151447|2017-10-11 03:54:25.151447
NCT01420861|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2014-04-23|||September 2011||2011-09-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer|Open Label Study of the Effect of GTx-758 on Serum PSA and Free Testosterone Levels in Men With Castration Resistant Prostate Cancer and Maintained on Androgen Deprivation Therapy|Terminated||Phase 2|8|Actual|GTx||1||FDA Clinical Hold|f||||f||||||||||2017-10-11 03:54:25.235313|2017-10-11 03:54:25.235313
NCT01419873|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-08-25|||August 2008||2008-08-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of a Model-based Approach to Blood Glucose Control in Very-low-birthweight Neonates|Pilot Study of a Model-based Approach to Blood Glucose Control in Very-low-birthweight Neonates|Completed||Phase 4|30|Actual|Christchurch Women's Hospital||1|||f||||f||||||||||2017-10-11 03:54:44.206949|2017-10-11 03:54:44.206949
NCT01420848|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2013-06-09|2013-01-30||January 2011||2011-01-01|June 2013|2013-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Auriculotherapy Effectiveness on Stress and Anxiety in Nursing Student|The Effectiveness of the Auriculotherapy on Reducing Stress and Anxiety in Nursing Student: Randomized Clinical Trial|Completed||Phase 2|71|Actual|University of Sao Paulo|The limitation of the trial was the reduced number of the sample.|3|||f||||f||||||||||2017-10-11 03:54:25.338201|2017-10-11 03:54:25.338201
NCT01420835|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2013-01-17|||September 2011||2011-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2011|Actual|2011-11-01||Interventional|||Chinese Auriculotherapy on Stress and Quality of Life in Nursing Professionals: Randomized Clinical Trial|Randomized Clinical Trial: Chinese Auriculotherapy With and Without Protocol on Stress and Quality of Life in Nursing Professionals|Completed||Phase 2|175|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-10-11 03:54:25.68087|2017-10-11 03:54:25.68087
NCT01420822|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2015-03-26|||December 2010||2010-12-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Special Drug Use Investigation for ALLERMIST (Long Term)|Special Drug Use Investigation for ALLERMIST (Long Term)|Completed||N/A|500|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:54:25.773191|2017-10-11 03:54:25.773191
NCT01420809|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-05-15|||September 2007||2007-09-01|May 2017|2017-05-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Observational|||Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection|Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection|Completed||N/A|1280|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:54:25.838983|2017-10-11 03:54:25.838983
NCT01420796|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-04-25|||November 2013|Actual|2013-11-01|April 2017|2017-04-01|December 15, 2016|Actual|2016-12-15|December 15, 2016|Actual|2016-12-15||Interventional|||Swallowing and Breathing Exercises for Dysphagia in Parkinson Disease|Effect of Oral Motor Exercises and Breathing Exercises for Dysphagia in Parkinson Disease: Randomized Clinical Trial|Completed||N/A|38|Actual|Federal University of Bahia||3|||f||||t||||||||||2017-10-11 03:54:25.902129|2017-10-11 03:54:25.902129
NCT01420783|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-02-17||2016-02-17|October 2011||2011-10-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|November 2012|Actual|2012-11-01||Interventional|||Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia|A Randomized Phase II, Open-Label Study of the Efficacy and Safety of Orally Administered SAR302503 in Patients With Polycythemia Vera (PV) or Essential Thrombocythemia (ET) Who Are Resistant or Intolerant to Hydroxyurea|Completed||Phase 2|81|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 03:54:26.009009|2017-10-11 03:54:26.009009
NCT01420770|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-02-17||2016-02-17|August 2011||2011-08-01|February 2016|2016-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Phase 2 Study of SAR302503 in Patients With Myelofibrosis|A Phase 2 Randomized, Open-Label, Dose-Ranging Study of the Efficacy and Safety of Orally Administered SAR302503 in Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly|Completed||Phase 2|30|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:54:27.656109|2017-10-11 03:54:27.656109
NCT01420757|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-19|||May 1999||1999-05-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|December 2006|Actual|2006-12-01||Interventional|COLIBRI||Laparoscopic Versus Open Incisional Hernia Repair|Laparoscopic Versus Open Incisional Hernia Repair : A Randomized Clinical Trial|Completed||Phase 3|206|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 03:54:27.760027|2017-10-11 03:54:27.760027
NCT01420744|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2015-07-28|||August 2011||2011-08-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|CIGMA||Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP|A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group, Adaptive Group-sequential Phase II Study, to Determine the Efficacy and Safety of BT086 as an Adjunctive Treatment in Severe Community Acquired Pneumonia (sCAP)|Completed||Phase 2|160|Actual|Biotest||2|||f||||t||||||||||2017-10-11 03:54:27.841776|2017-10-11 03:54:27.841776
NCT01420731|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2011-08-19|||September 2011||2011-09-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Back Pain and Male Sexual Disfunction|Phase 4 Study Back Pain and Male Sexual Disfunction|Unknown status|Not yet recruiting|N/A|54|Anticipated|Bezmialem Vakif University|||1||f||||f||||||||||2017-10-11 03:54:27.99577|2017-10-11 03:54:27.99577
NCT01420718|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-19|2012-03-25|||June 2011||2011-06-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Partial Pulpotomy on Caries Free Human Teeth|Partial Pulpotomy on Caries Free Human Teeth Using iRootBP and White ProRoot MTA: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|24|Actual|Islamic Azad University, Tehran||2|||f||||f||||||||||2017-10-11 03:54:28.087756|2017-10-11 03:54:28.087756
NCT01420705|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-12-27|||October 2011||2011-10-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Bacille Calmette-Guérin (BCG) Vaccine and Atopy|The Effect of Giving BCG Vaccine at Birth to Low Birth-weight Infants on Development of Allergy and Asthma in Childhood - Follow up of a Randomised Trial in Guinea-Bissau|Completed||N/A|487|Anticipated|Bandim Health Project|||1||f||||f||||||Samples Without DNA|"     Faecal samples are collected for analyses of parasites and microbes   "|||2017-10-11 03:54:28.21979|2017-10-11 03:54:28.21979
NCT01420692|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-28|2012-08-13|||June 2010||2010-06-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes|The Effects of Insulin Detemir and Gliclazide-MR Treatments in Addition to Life-style Modification and Metformin Therapy on Endothelial Functions in Patients With Type 2 Diabetes : An Open-labelled Randomized Prospective Study|Completed||N/A|64|Actual|Ankara University||2|||f||||t||||||||||2017-10-11 03:54:29.879632|2017-10-11 03:54:29.879632
NCT01420679|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2014-08-11|||August 2011||2011-08-01|August 2014|2014-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients|A Multi-center, Randomized, Phase 3 Study of Sequential Pralatrexate Versus Observation in Patients With Previously Undiagnosed Peripheral T-cell Lymphoma Who Have Achieved an Objective Response Following Initial Treatment With CHOP-based Chemotherapy|Terminated||Phase 3|18|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||t||||||||||2017-10-11 03:54:30.008041|2017-10-11 03:54:30.008041
NCT01420666|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2016-01-04||||||January 2016|2016-01-01||||||||Interventional|||Maxi-Analgesic Osteoarthritis (OA) Study|Maxi-Analgesic OA Study: Multicentre, Double-blind, Placebo-controlled, Randomized, Parallel Group Comparison of the Effects of Maxigesic 325 With Acetaminophen or Ibuprofen on Patients With Pain From Osteoarthritis|Withdrawn||Phase 3|0|Actual|AFT Pharmaceuticals, Ltd.||4||The study was withdrawn for administrative reason|f||||f||||||||||2017-10-11 03:54:30.24831|2017-10-11 03:54:30.24831
NCT01420653|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2016-04-07||2016-02-15|April 2013||2013-04-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Maxigesic 325 Acute Dental Pain Study|Maxigesic 325 Acute Dental Pain Study: A Double-blind, Placebo-controlled, Randomized, Parallel Group Comparison of the Effects of Maxigesic 325 Versus Acetaminophen, Ibuprofen and Placebo in Participants With Acute Dental Pain|Completed||Phase 3|408|Actual|AFT Pharmaceuticals, Ltd.||4|||f||||f||||||||||2017-10-11 03:54:30.336135|2017-10-11 03:54:30.336135
NCT01420640|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2016-02-09|||January 2012||2012-01-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|FMEx||Tai Chi and Aerobic Exercise for Fibromyalgia (FMEx)|Tai Chi and Aerobic Exercise for Fibromyalgia|Completed||N/A|224|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-10-11 03:54:30.435899|2017-10-11 03:54:30.435899
NCT01420627|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-05-09|||December 2013||2013-12-01|May 2017|2017-05-01|March 2019|Anticipated|2019-03-01|September 2017|Anticipated|2017-09-01||Interventional|||EZN-2279 in Patients With ADA-SCID|A Study of EZN-2279 (Polyethylene Glycol Recombinant Adenosine Deaminase [PEG-rADA]) Administered as a Weekly Intramuscular Injection in Patients With Adenosine Deaminase (ADA)-Deficient Combined Immunodeficiency|Recruiting||Phase 3|6|Anticipated|Leadiant Biosciences, Inc.||2|||f||||t||||||||||2017-10-11 03:54:30.54716|2017-10-11 03:54:30.54716
NCT01420601|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-04-02|||September 2011|Actual|2011-09-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Temsirolimus (Torisel) Special Investigation (Regulatory Post Marketing Commitment Plan)|Torisel 25mg For Intravenous Drip Infusion Special Investigation - Survey On Long-term Use -|Active, not recruiting||N/A|120|Anticipated|Pfizer|||1||f||||f||||||||||2017-10-11 03:54:30.884417|2017-10-11 03:54:30.884417
NCT01420588|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-01-26|||August 1, 2011|Actual|2011-08-01|January 2017|2017-01-01|December 30, 2017|Anticipated|2017-12-30|December 2015|Actual|2015-12-01||Observational|||Diagnosis of Gastric Lesions With Na-nose|Study of the Exhaled Breath of Patients With Malignant and Benign Lesions With Na-Nose|Recruiting||N/A|960|Anticipated|Anhui Medical University|||4||f||||t||||||None Retained|"     exhaled breath of volunteers   "|||2017-10-11 03:54:30.994875|2017-10-11 03:54:30.994875
NCT01420575|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-09-17|||October 2010||2010-10-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia|Using a Visual Decision Aid (DA) to Facilitate Shared Decision Making (SDM) During Antipsychotic Treatment in Schizophrenia.|Terminated||N/A|8|Actual|VA Nebraska Western Iowa Health Care System||2||Low enrollment rate.|f||||f||||||||||2017-10-11 03:54:31.12244|2017-10-11 03:54:31.12244
NCT01420562|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2015-01-13|||September 2011||2011-09-01|February 2013|2013-02-01||||March 2015|Anticipated|2015-03-01||Observational|||Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis|Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis|Unknown status|Recruiting|N/A|55|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-11 03:54:31.249245|2017-10-11 03:54:31.249245
NCT01420549|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2016-10-25|||March 2013||2013-03-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|LANCE||Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia|Phase III, Multicenter, Randomized, Open-label, Comparative, Parallel Group Study of the Efficacy and Safety of Rosuvastatin + Ezetimibe Versus Simvastatin + Ezetimibe in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia|Completed||Phase 3|129|Actual|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f||||||||||2017-10-11 03:54:31.368948|2017-10-11 03:54:31.368948
NCT01420523|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-07-23|||December 2011||2011-12-01|July 2015|2015-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ROCnRAL||Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy|Phase II Pilot Study Evaluating the Efficacy of Dual Therapy With Raltegravir Plus Maraviroc in Patients Receiving Suppressive Antiretroviral Therapy and Presenting With Lipohypertrophy (ANRS 157 ROCnRAL).|Terminated||Phase 2|48|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-10-11 03:54:31.615679|2017-10-11 03:54:31.615679
NCT01420510|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-06-20|||September 2011||2011-09-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis|Saginil in Vaginal Cannulas vs. Placebo for the Prevention of Vaginitis in Gynecologic Oncologic Patients Receiving Chemotherapy: a Randomized Controlled Trial.|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Università degli Studi dell'Insubria||2|||f||||t||||||||||2017-10-11 03:54:31.727996|2017-10-11 03:54:31.727996
NCT01420497|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-18|||August 2008||2008-08-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|September 2008|Actual|2008-09-01||Interventional|||Systemic Effects of Epidural Methylprednisolone Injection on Glucose Tolerance in Diabetic Patients||Completed||N/A|25|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||t||||||||||2017-10-11 03:54:31.805322|2017-10-11 03:54:31.805322
NCT01420484|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2013-12-18|||January 2010||2010-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Observational|||CNAP in Heart Surgery|Noninvasive Blood Pressure Measuring|Completed||N/A|50|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-11 03:54:31.877546|2017-10-11 03:54:31.877546
NCT01420471|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-10-26|||September 2011||2011-09-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|FISHNET||Medicated Punctured-Glove-Finger Spacer Study|Medicated Punctured-Glove-Finger Spacer Study|Completed||Phase 4|50|Actual|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 03:54:31.955506|2017-10-11 03:54:31.955506
NCT00005470|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1996||1996-09-01|August 2004|2004-08-01|August 2002|Actual|2002-08-01|||||Observational|||Divergence of Blood Pressure By Race in Adolescent Girls||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.855472|2017-10-11 04:27:05.855472
NCT01420458|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-11-03|||August 2011||2011-08-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Study in Healthy Volunteers to Establish the BioEquivalence of Two Formulations of BG00012|A Randomized, Two-Period Crossover Study in Healthy Volunteers to Establish the Bioequivalence of Two Formulations of BG00012.|Completed||Phase 1|80|Actual|Biogen||1|||f||||f||||||||||2017-10-11 03:54:32.05777|2017-10-11 03:54:32.05777
NCT01420445|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2013-09-25|||September 2011||2011-09-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis|Randomized, Double-blind, Placebo/Active-controlled, Multi-center, Phase 3 Clinical Trial to Investigate the Safety/Tolerability and Efficacy of YHD001 After Oral Administration in Patients With Acute or Chronic Bronchitis|Completed||Phase 2|118|Actual|Yuhan Corporation||4|||f||||f||||||||||2017-10-11 03:54:32.142662|2017-10-11 03:54:32.142662
NCT01420432|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-18|||January 2011||2011-01-01|April 2011|2011-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)|Phase II Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat AS|Unknown status|Recruiting|Phase 1|10|Anticipated|Shandong University||2|||f||||t||||||||||2017-10-11 03:54:32.24576|2017-10-11 03:54:32.24576
NCT01420419|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-29|2013-01-14|||May 2011||2011-05-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|LanP||Evaluating Lanolin for the Treatment of Nipple Pain Among Breastfeeding Women|A Randomized Controlled Trial Evaluating Lanolin for the Treatment of Nipple Pain Among Breastfeeding Women|Completed||Phase 4|186|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 03:54:32.342721|2017-10-11 03:54:32.342721
NCT01420406|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2012-09-11|||June 2010||2010-06-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|May 2011|Actual|2011-05-01||Interventional|||Vitamin A Bioavailability in Lactating Women With Marginal Vitamin A Status|Impact of Daily Feeding of Food Sources of Cryptoxanthin (CX) and Beta-carotene (BC) on Plasma and Breast Milk Concentrations of CX, BC, and Retinol (VA) in Lactating Women With Marginal Vitamin A Status|Completed||N/A|140|Actual|USDA, Western Human Nutrition Research Center||4|||f||||f||||||||||2017-10-11 03:54:32.434039|2017-10-11 03:54:32.434039
NCT01420393|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-06-19|||September 2011||2011-09-01|June 2017|2017-06-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|RAFT-AF||Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation|A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation|Recruiting||N/A|600|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 03:54:32.614531|2017-10-11 03:54:32.614531
NCT01420367|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-18|||November 2011||2011-11-01|August 2011|2011-08-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Are Post-operative Antibiotics Indicated in Simple Appendicitis?|Are Post-operative Antibiotics Indicated in Simple Appendicitis? A Prospective Randomized Trial|Unknown status|Not yet recruiting|N/A|300|Anticipated|Monash University||2|||f||||f||||||||||2017-10-11 03:54:32.906462|2017-10-11 03:54:32.906462
NCT01420354|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-18|2017-03-01|||August 2009||2009-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Can a Spot Urine Replace or Improve 24 Hour Urine Collections in Kidney Stone Patients|Can a Spot Urine Replace or Improve 24 Hour Urine Collections in Kidney Stone Patients|Terminated||N/A|21|Actual|University of British Columbia|||1|The study was combined with our Urine and Stool Study (NCT01637506).|f||||f||||||Samples Without DNA|"     Urine collected over 24 hour period   "|No||2017-10-11 03:54:33.025869|2017-10-11 03:54:33.025869
NCT01420341|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2017-03-02|||August 2011||2011-08-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Co-trimoxazole as Maintenance Therapy for Meliodosis|A Comparison Between 12 vs. 20 Weeks of Co-trimoxazole as Maintenance Therapy for Melioidosis|Recruiting||Phase 4|800|Anticipated|Khon Kaen University||2|||f||||f|f|f||||||No||2017-10-11 03:54:33.099996|2017-10-11 03:54:33.099996
NCT01420328|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2012-12-17|||May 2011||2011-05-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects|To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects|Unknown status|Active, not recruiting|Phase 3|20|Anticipated|Kaleida Health||2|||f||||f||||||||||2017-10-11 03:54:33.198229|2017-10-11 03:54:33.198229
NCT01420315|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2013-02-15|||August 2011||2011-08-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|DEVIT-ALZ||The Prevalence of Vitamin D Deficiency in Patients With Alzheimer's Disease|The Prevalence of Vitamin D Deficiency in Patients With Alzheimer's Disease: a Crosssectional Multicenter Study in Turkey|Completed||N/A|502|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi|||1||f||||t||||||||||2017-10-11 03:54:33.304643|2017-10-11 03:54:33.304643
NCT01420289|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2012-01-06|2011-08-22||January 2009||2009-01-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD|A Randomized, Controlled Trial to Evaluate High Pressure Rapid Sequence, Intermittent Pneumatic Compression (HPIPC) for the Treatment of Intermittent Claudication, Pain and Ulcer Healing in Subjects With PAD|Completed||N/A|44|Actual|Calvary Hospital, Bronx, NY||2|||f||||f||||||||||2017-10-11 03:54:33.565219|2017-10-11 03:54:33.565219
NCT01420276|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-18|||September 2011||2011-09-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Observational|||Female Sexual Function and Back Pain||Unknown status|Not yet recruiting|Phase 4|54|Anticipated|Bezmialem Vakif University|||1||f||||||||||||||2017-10-11 03:54:34.003811|2017-10-11 03:54:34.003811
NCT01420263|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2013-02-07|||August 2011||2011-08-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Re-feeding Gastric Residuals in Preterm Infants|Re-feeding Residuals Versus Feeding Fresh Formula/Milk for Feeding Intolerance in Premature Infants|Completed||N/A|72|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 03:54:34.068469|2017-10-11 03:54:34.068469
NCT01420250|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-10-19|||September 2011||2011-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|July 2015|Actual|2015-07-01||Interventional|||Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer|Phase I Trial of Weekly Cabazitaxel With Concurrent Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy for the Treatment of Locally Advanced High Risk Adenocarcinoma of the Prostate|Active, not recruiting||Phase 1|20|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 03:54:34.179644|2017-10-11 03:54:34.179644
NCT01420237|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-18|2017-06-19|||June 2011||2011-06-01|June 2017|2017-06-01|June 2026|Anticipated|2026-06-01|June 2026|Anticipated|2026-06-01||Interventional|||Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study|Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study With Long Term Data Collection for the Accolade® II Hip Stem|Active, not recruiting||N/A|352|Actual|Stryker Orthopaedics||1|||f||||f||||||||||2017-10-11 03:54:34.296804|2017-10-11 03:54:34.296804
NCT01420224|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2011-08-18|||May 2011||2011-05-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Study of the Effects of Commercial Air Travel on the Lungs|Study of the Effects of Commercial Air Travel on Pulmonary Artery Pressure in Healthy Passengers and in a Patient With Chuvash Polycythaemia|Completed||N/A|9|Actual|University of Oxford|||2||f||||f||||||||||2017-10-11 03:54:34.411262|2017-10-11 03:54:34.411262
NCT01420211|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-08-18|||October 2006||2006-10-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®|Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® in Healthy Volunteers and in Patients With Liver Disease|Completed||Phase 1/Phase 2|45|Actual|University Medicine Greifswald||1|||f||||f||||||||||2017-10-11 03:54:34.500703|2017-10-11 03:54:34.500703
NCT01420198|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-11-09|||January 2015||2015-01-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|MEDIM||Efficiency and Cost-effectiveness of a Culturally Adopted Lifestyle Intervention Program - the MEDIM Study.|A Middle Eastern Immigrant Population At-risk for Diabetes; Contributing Risk Factors and the Efficiency and Cost-effectiveness of a Culturally Adopted Lifestyle Intervention Program - the MEDIM Study.|Completed||N/A|96|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 03:54:34.602396|2017-10-11 03:54:34.602396
NCT01420185|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-18|2015-05-06|||October 2011||2011-10-01|May 2015|2015-05-01||||December 2015|Anticipated|2015-12-01||Observational|||Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28|Molecular Predictors of Loco-Regional Recurrence in Node Positive Breast Cancer|Unknown status|Active, not recruiting|N/A|1300|Anticipated|NSABP Foundation Inc|||1||f||||f||||||||||2017-10-11 03:54:34.698086|2017-10-11 03:54:34.698086
NCT01420172|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-02-24|||August 2011||2011-08-01|October 2015|2015-10-01|July 8, 2016|Actual|2016-07-08|July 8, 2016|Actual|2016-07-08||Observational|||Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation|Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.|Completed||N/A|200|Actual|Ohio State University|||1||f||||f||||||||||2017-10-11 03:54:34.766164|2017-10-11 03:54:34.766164
NCT01420159|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2012-10-30|||August 2011||2011-08-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|STOP!||Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Minor Trauma|A Randomised, Double Blind, Multi-centre, Placebo Controlled Study to Evaluate the Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Patients Presenting to an Emergency Department With Minor Trauma|Completed||Phase 3|300|Actual|Medical Developments International Limited||2|||f||||t||||||||||2017-10-11 03:54:34.846385|2017-10-11 03:54:34.846385
NCT01420146|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-03-07|2017-03-07||August 2011||2011-08-01|January 2015|2015-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|IJBMNZrT003||Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients|Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients : Correlation With FDG-PET/CT and Anatomopathological Results|Completed||Phase 1|20|Actual|Jules Bordet Institute||1|||f||||f||||||||Undecided||2017-10-11 03:54:34.981111|2017-10-11 03:54:34.981111
NCT01420133|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-12-21|||November 2011||2011-11-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Cortisel||Is a Diet Necessary When Corticosteroid Treatment is Prescribed?|Is a Low Salt Diet and Low Sugar Content Necessary When Corticosteroid Treatment is Prescribed?|Completed||N/A|50|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:54:35.221561|2017-10-11 03:54:35.221561
NCT01420120|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2015-07-15|||January 2011||2011-01-01|July 2015|2015-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Remedy, Biodegradable Peripheral Stent Registry|A Prospective Multicenter Registry to Evaluate Safety and Performance of REMEDY, Biodegradable Peripheral Stent for the Treatment of Occluded or Stenotic Superficial Femoral Arteries.|Completed||N/A|100|Anticipated|be Medical|||1||f||||f||||||||||2017-10-11 03:54:35.331212|2017-10-11 03:54:35.331212
NCT01420107|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-16|2011-08-18|||August 2010||2010-08-01|August 2011|2011-08-01|April 2012|Anticipated|2012-04-01|December 2011|Anticipated|2011-12-01||Observational|||Video Recording in the Delivery Room in Very Preterm Infants (Video Apgar Trial)|Video Recording in the Delivery Room in Very Preterm Infants (Video Apgar Trial)|Unknown status|Recruiting|N/A|200|Anticipated|University Medicine Greifswald|||1||f||||t||||||||||2017-10-11 03:54:35.43804|2017-10-11 03:54:35.43804
NCT01420094|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2016-01-14|||June 2011||2011-06-01|January 2016|2016-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|TAROT compare||Evaluate Onset of Action of a Fast Release Aspirin|Comparative Onset of Action of a Fast Release Aspirin Tablet in a Dental Impaction Pain Model|Completed||Phase 3|510|Actual|Bayer||3|||f||||f||||||||||2017-10-11 03:54:35.569258|2017-10-11 03:54:35.569258
NCT01420081|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-05-23|2015-04-30||January 19, 2012|Actual|2012-01-19|May 2017|2017-05-01|December 25, 2015|Actual|2015-12-25|April 30, 2014|Actual|2014-04-30||Interventional|||A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer|A Randomized Phase 2 Non-comparative Study Of The Efficacy Of Pf-04691502 And Pf-05212384 In Patients With Recurrent Endometrial Cancer|Terminated||Phase 2|67|Actual|Pfizer||3||See termination reason in detailed description.|f||||f||||||||No||2017-10-11 03:54:36.027467|2017-10-11 03:54:36.027467
NCT01419860|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-10-31|||January 2010||2010-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of Microcirculation in Colon Wall and Bowel Anastomosis by Laser Induced Fluorescence Video Angiography|Evaluation of Microcirculation in Colon Wall and Bowel Anastomosis by Laser Induced Fluorescence Video Angiography of Indocyanine Green|Active, not recruiting||Early Phase 1|4|Anticipated|Ostfold Hospital Trust||1|||f||||t||||||||||2017-10-11 03:54:44.302871|2017-10-11 03:54:44.302871
NCT01420068|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-10-04|||August 2011||2011-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||52-104 Week Off-therapy Second Extension to Study CSPP100A2365|A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1|Active, not recruiting||N/A|106|Actual|Novartis|||1||f||||||||||||||2017-10-11 03:54:41.667058|2017-10-11 03:54:41.667058
NCT01420055|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-11-16|||August 2011||2011-08-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|GRACE||Fingolimod -Response According to Coping - Evaluation|A 4-month, Prospective, Open-label, Multi-center Phase IV Study to Assess Response to Fingolimod Initiation According to Coping Profile in Adult Patients With Highly Active Relapsing Remitting Multiple Sclerosis in France|Completed||Phase 4|189|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:54:41.933911|2017-10-11 03:54:41.933911
NCT01420042|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2012-11-20|||February 2012||2012-02-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration|A Phase I, Double-Blind, Randomized, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of NNZ-2566 in Healthy Subjects, Following Oral Administration|Completed||Phase 1|24|Actual|Neuren Pharmaceuticals Limited||2|||f||||t||||||||||2017-10-11 03:54:42.148097|2017-10-11 03:54:42.148097
NCT01420029|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2013-09-19|||August 2011||2011-08-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Hospital-Based Phthalate Exposure in Very Low Birth Weight Neonates|Hospital-Based Phthalate Exposure in Very Low Birth Weight Neonates|Completed||N/A|81|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||Samples With DNA|"     Urine, whole blood   "|||2017-10-11 03:54:42.259516|2017-10-11 03:54:42.259516
NCT01420003|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2015-03-19|||November 2011||2011-11-01|March 2015|2015-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics|Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics|Completed||N/A|12|Actual|Hamilton Health Sciences Corporation||1|||f||||f||||||||||2017-10-11 03:54:42.483376|2017-10-11 03:54:42.483376
NCT01419990|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2012-08-14|||August 2011||2011-08-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of GLPG0634 in Healthy Subjects|Double-blind Placebo Controlled Dose-ranging Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Dosing of GLPG0634 in Healthy Subjects|Completed||Phase 1|16|Actual|Galapagos NV||2|||f||||f||||||||||2017-10-11 03:54:42.617181|2017-10-11 03:54:42.617181
NCT01419977|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2015-01-30|2015-01-30||May 2011||2011-05-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|||Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo|Randomized Double Blind Placebo Controlled Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose LMWH Versus Placebo|Completed||Phase 2|34|Actual|Duke University|Limitations to our pilot study include the small study sample size, which leads to difficulty in determining significant differences in the outcome measurements.|2|||f||||t||||||||||2017-10-11 03:54:42.719379|2017-10-11 03:54:42.719379
NCT01419964|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-03-15|||January 2012||2012-01-01|March 2016|2016-03-01||||December 2013|Anticipated|2013-12-01||Interventional|||Efficacy and Safety of ACH24 in the Treatment of Vitiligo|Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Group Study of the Efficacy and Safety of ACH24 in the Treatment of Vitiligo|Withdrawn||Phase 3|0|Actual|Ache Laboratorios Farmaceuticos S.A.||2||"The Brazilian regulatory agency - ANVISA has requested the cancellation of the phase 3 study   for conducting a phase 1 study first."|f||||f||||||||||2017-10-11 03:54:43.131424|2017-10-11 03:54:43.131424
NCT01419951|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2014-10-20|||May 2009||2009-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2011|Actual|2011-10-01||Interventional|||Launch II: A Pilot Randomized Control Trial of a Clinic and Clinic Plus Home Intervention for Preschool Obesity|LAUNCH II: Learning About Activity and Understanding Nutrition for Better Child Health|Completed||Phase 1|60|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||f||||||||||2017-10-11 03:54:43.234502|2017-10-11 03:54:43.234502
NCT01419938|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-04-24|||August 2011||2011-08-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Does Cognitive Behaviour Therapy (CBT) Improve the Effect of Light Therapy|Does CBT Improve the Effect of Light Therapy in Delayed Sleep Phase Syndrome Compared to Only Light Therapy - Short and Long Term Follow up|Completed||N/A|57|Actual|Uppsala University||2|||f||||f||||||||||2017-10-11 03:54:43.356485|2017-10-11 03:54:43.356485
NCT01419912|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2011-08-29||||||January 2011|2011-01-01||||||||Interventional|||Comparison of Soy-milk and Cow Milk Consumption on Inflammatory Factors, Cardiovascular Factors ,Renal Factors, Fibrinolytic Indice and Oxidative Stress Among Type-2 Diabetic Patients With Nephropathy Stage 1 and 2||Completed||Phase 3|||Isfahan University of Medical Sciences||2|||f||||||||||||||2017-10-11 03:54:43.865609|2017-10-11 03:54:43.865609
NCT01419899|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2013-08-05|||January 2011||2011-01-01|August 2013|2013-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|InVITED||Increasing Viral Testing in the Emergency Department|Phase 2/3 Clinical Trial of the Effect of a Brief Intervention on Uptake of Rapid Testing for HIV and Hepatitis C Among Emergency Department Patients|Completed||Phase 2/Phase 3|398|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-10-11 03:54:43.997478|2017-10-11 03:54:43.997478
NCT01419847|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2011-08-17|||March 2002||2002-03-01|May 2006|2006-05-01|May 2006|Actual|2006-05-01|December 2005|Actual|2005-12-01||Interventional|||Topical Penlac Nail Lacquer for Onychomycosis in Children|A Prospective, Double-blind, Placebo-controlled Trial of Topical Penlac Nail Lacquer for Therapy of Onychomycosis in Children|Completed||Phase 4|40|Actual|Rady Children's Hospital, San Diego||2|||f||||f||||||||||2017-10-11 03:54:44.461544|2017-10-11 03:54:44.461544
NCT01419834|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-09-05|||August 2011||2011-08-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors|Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors|Recruiting||Phase 1|74|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-10-11 03:54:44.558697|2017-10-11 03:54:44.558697
NCT01419821|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2013-02-21|||September 2013||2013-09-01|August 2011|2011-08-01|September 2016|Anticipated|2016-09-01|September 2014|Anticipated|2014-09-01||Interventional|VitD||Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5|Supplemental Vitamin D Administered to One Year Old Vitamin D Deficient Infants Until Age 3 and Its Affect on Growth Rates and Bone Mineral Density Until Age 5|Unknown status|Not yet recruiting|N/A|200|Anticipated|Meir Medical Center||3|||f||||f||||||||||2017-10-11 03:54:44.80903|2017-10-11 03:54:44.80903
NCT01419808|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-17|||September 2007||2007-09-01|August 2011|2011-08-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Vascularized Versus Non-Vascularized Bone Grafts in Treating Proximal Pole Scaphoid Non Unions|Vascularized vs. Non-vascularized Bone Grafting in the Treatment of Proximal Pole Scaphoid Non Unions: A Prospective Randomized Trial|Unknown status|Recruiting|N/A|40|Anticipated|Hand and Upper Limb Clinic, Canada||2|||f||||f||||||||||2017-10-11 03:54:44.959761|2017-10-11 03:54:44.959761
NCT01419795|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-07-24|2017-01-31||May 2012||2012-05-01|July 2017|2017-07-01||||September 2013|Actual|2013-09-01||Interventional|||Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant|A Phase II Study Investigating Treatment of Post-Allogeneic Transplant Progression or Relapse of CLL/SLL/PLL or NHL With Lenalidomide Alone or With Rituximab|Terminated||Phase 2|3|Actual|Fred Hutchinson Cancer Research Center||2||Low accrual|f||||t||||||||||2017-10-11 03:54:45.090663|2017-10-11 03:54:45.090663
NCT01419782|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2013-05-06|||March 2011||2011-03-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|WBV-BM||Effects of Unilateral WBV on Muscleactivity of Contralateral Hip Adductor|The Effects Of Femur On The Resting Myoelectrical Activity Of Contralateral Adductor Muscle During Unilateral Lower Extremity Vibration: Bone Myoregulation Reflex|Completed||N/A|20|Actual|Bagcilar Training and Research Hospital||1|||f||||f||||||||||2017-10-11 03:54:45.543795|2017-10-11 03:54:45.543795
NCT01419769|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-09-02|2014-11-12||August 2011||2011-08-01|September 2015|2015-09-01|April 2013|Actual|2013-04-01|June 2012|Actual|2012-06-01||Interventional||Patients between 18 and 75 years of age, suitable for transluminal drainage of symptomatic pancreatic pseudocysts that are greater than or equal to 6 cm in diameter and adherent to the bowel wall are candidates for study treatment.|AXIOS Stent & Delivery System Study|A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System|Completed||N/A|30|Actual|Xlumena, Inc.||1|||f||||t||||||||||2017-10-11 03:54:45.643421|2017-10-11 03:54:45.643421
NCT01419756|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2014-10-03|||August 2011||2011-08-01|July 2013|2013-07-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Observational|VMS TOF||Assessment of Right Ventricular Volume in Tetralogy of Fallott (TOF) Patients|Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Tetralogy of Fallott Following Repair; A Comparison Study to cMRI|Completed||N/A|109|Actual|VentriPoint Diagnostics Ltd.|||1||f||||f||||||||||2017-10-11 03:54:46.125683|2017-10-11 03:54:46.125683
NCT01419743|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2014-02-16|||August 2011||2011-08-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Effect of Vitamin D Supplementation on In-vitro Fertilization (IVF) Outcomes|Randomized Controlled Trial: The Effects of Vitamin D Supplementation on In-vitro Fertilization Outcomes|Terminated||Phase 2|102|Anticipated|Northwestern University|||6|Low recruitment numbers|f||||f||||||||||2017-10-11 03:54:46.238476|2017-10-11 03:54:46.238476
NCT01419730|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-10-05|||August 2011|Actual|2011-08-01|October 2017|2017-10-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Vitamin D and Physical Activity on Bone Health|The Effect of High-Dose Vitamin D and Physical Activity on Bone Health in Breast Cancer Patients Receiving Hormonal Therapy|Recruiting||Phase 2|105|Anticipated|University of Rochester||3|||f||||t||||||||||2017-10-11 03:54:46.351918|2017-10-11 03:54:46.351918
NCT01419717|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-05-26|||November 22, 2011|Actual|2011-11-22|May 2017|2017-05-01|December 27, 2017|Anticipated|2017-12-27|December 27, 2017|Anticipated|2017-12-27||Interventional|||Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer|Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer|Active, not recruiting||Phase 3|129|Actual|Amgen||1|||f||||f||||||||||2017-10-11 03:54:46.457605|2017-10-11 03:54:46.457605
NCT01419704|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-09-05|||May 2011||2011-05-01|September 2017|2017-09-01|May 2030|Anticipated|2030-05-01|May 2025|Anticipated|2025-05-01||Interventional|||Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies|Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies|Suspended||Phase 1/Phase 2|30|Anticipated|University of Louisville||1||Study completed at site, no active participants. IDE open for future enrollment|f||||t|t|f||||||||2017-10-11 03:54:46.761291|2017-10-11 03:54:46.761291
NCT01419691|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2016-01-15|||September 2011||2011-09-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)|A Phase I Phase II Two-Step Study of the Oral Gold Compound Auranofin in Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL)/ Prolymphocytic Lymphoma (PLL)|Completed||Phase 2|15|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-11 03:54:46.845194|2017-10-11 03:54:46.845194
NCT01419678|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2014-12-05|||October 2011||2011-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients|Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients|Completed||N/A|20|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 03:54:46.929554|2017-10-11 03:54:46.929554
NCT00000296|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||November 1997||1997-11-01|February 1999|1999-02-01|December 2001||2001-12-01|||||Interventional|||Role of Metabolites in Nicotine Dependence (4) - 13|Role of Metabolites in Nicotine Dependence (4)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.483988|2017-10-11 04:17:43.483988
NCT01419665|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-05-12|||December 2011||2011-12-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|ASSIST_FL||GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma|A Randomized, Controlled, Double-Blind Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of GP2013 vs. MabThera® in Patients With Previously Untreated, Advanced Stage Follicular Lymphoma|Active, not recruiting||Phase 3|629|Actual|Sandoz||2|||f||||t||||||||Undecided||2017-10-11 03:54:47.059536|2017-10-11 03:54:47.059536
NCT01419652|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-06-08|||July 2009||2009-07-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography|Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography With or Without Percutaneous Coronary Intervention|Completed||Phase 4|351|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 03:54:47.629982|2017-10-11 03:54:47.629982
NCT01419639|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-06-20|2015-07-08||October 2011||2011-10-01|June 2017|2017-06-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2|Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2|Completed||Phase 2|10|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 03:54:47.731218|2017-10-11 03:54:47.731218
NCT01419626|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2011-09-15|||July 2011||2011-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:54:48.034314|2017-10-11 03:54:48.034314
NCT01419613|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2015-06-22|||August 2010||2010-08-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Promoting a Healthier Lifestyle Among Breast Cancer Survivors|Motivational Interviewing to Promote Physical Activity in Breast Cancer Survivors|Completed||N/A|68|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-10-11 03:54:48.083461|2017-10-11 03:54:48.083461
NCT01419600|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2012-07-02|||October 2011||2011-10-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Inhaled AZD8683|A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD8683 After Single Ascending Doses Administered Via Turbuhaler in Healthy Subjects|Completed||Phase 1|38|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:54:48.180301|2017-10-11 03:54:48.180301
NCT01419587|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-02-09|||July 2011||2011-07-01|February 2017|2017-02-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)|A Phase I Trial of a Ketogenic Diet With Concurrent Chemoradiation for Non-small Cell Lung Cancer|Terminated||N/A|11|Actual|University of Iowa||1||Poor accrual and compliance|f||||t||||||||||2017-10-11 03:54:48.301256|2017-10-11 03:54:48.301256
NCT01419574|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-06-30|||July 29, 2011||2011-07-29|April 27, 2016|2016-04-27|April 27, 2016||2016-04-27|||||Observational|||Ultrasound and Other Images of Artery Blockages|Contrast-Enhanced Ultrasound Imaging of Carotid Plaque Neovascularization|Terminated||N/A|12|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:54:48.48486|2017-10-11 03:54:48.48486
NCT01419548|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-06-30|||July 29, 2011||2011-07-29|November 18, 2011|2011-11-18|November 18, 2011|Actual|2011-11-18|November 18, 2011|Actual|2011-11-18||Interventional|||ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems|An Early Phase 1 Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Patients With Hepatic or Renal Dysfunction and Solid Tumors|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:54:48.683787|2017-10-11 03:54:48.683787
NCT01419535|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-06-30|||July 29, 2011||2011-07-29|December 16, 2016|2016-12-16|December 1, 2017|Anticipated|2017-12-01|December 1, 2017|Anticipated|2017-12-01||Interventional|||Mifepristone for Metabolic Syndrome|Effects of the Glucocorticoid Antagonist, Mifepristone, on Glucose Intolerance in Obese and Overweight Individuals|Recruiting||Phase 1/Phase 2|80|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:54:48.775663|2017-10-11 03:54:48.775663
NCT01419522|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-06-30|||July 29, 2011||2011-07-29|January 6, 2014|2014-01-06|January 6, 2014|Actual|2014-01-06|January 6, 2014|Actual|2014-01-06||Interventional|||Treadmill Training at Constant or Different Speeds for People With Traumatic Brain Injury|Effect of Time Varying Walking Velocity in Body-Weight Supported Treadmill Training|Terminated||Phase 3|1|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:54:48.892121|2017-10-11 03:54:48.892121
NCT01419509|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-05-13|||August 2011||2011-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma|DNA Methylation-based Assays for Detecting Disease Spread in Rhabdomyosarcoma|Completed||N/A|170|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Tumor, Blood, and Bone Marrow Samples   "|||2017-10-11 03:54:48.997598|2017-10-11 03:54:48.997598
NCT01419496|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2016-05-17|||September 2011||2011-09-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia|Identifying Stat3-Dependent Chemotherapy Resistance Pathways in Relapsed AML|Completed||N/A|40|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:54:49.106717|2017-10-11 03:54:49.106717
NCT01419483|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-02-09|||July 2011||2011-07-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2017|Anticipated|2017-07-01||Interventional|KETOPAN||Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer|A Phase I Trial of a Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer.|Terminated||N/A|5|Actual|University of Iowa||1||poor accrual|f||||t||||||||||2017-10-11 03:54:49.231468|2017-10-11 03:54:49.231468
NCT01419470|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-07-31|||February 2011||2011-02-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044|Phase Ⅰ/Ⅱ Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 After Oral Administration in Premature Ejaculation Patients|Completed||Phase 1/Phase 2|24|Actual|Yuhan Corporation||3|||f||||f||||||||||2017-10-11 03:54:49.388344|2017-10-11 03:54:49.388344
NCT01419457|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-10-20|||August 2011||2011-08-01|October 2015|2015-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment|A Phase I, Open-Label, Parallel-Group, Multiple-Dose Study to Determine the Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment and in Healthy Control Volunteers|Completed||Phase 1|36|Actual|MDVI, LLC||4|||f||||t||||||||||2017-10-11 03:54:49.520114|2017-10-11 03:54:49.520114
NCT01419444|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-12-17|||August 2011||2011-08-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Telemedicine Versus Traditional Treatment of Muscle Tension Dysphonia|Telemedicine Versus Traditional Treatment of Muscle Tension Dysphonia|Completed||Phase 1/Phase 2|14|Actual|University of Arkansas||2|||f||||t||||||||||2017-10-11 03:54:49.663975|2017-10-11 03:54:49.663975
NCT01419431|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-12-15|||January 2007||2007-01-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Observational|||Attenuated Inflammatory Response in Laparoscopic Colon Surgery|Increased SOCS 3 mRNA in Monocytes From Patients Subjected to Laparoscopic Colon Surgery|Completed||N/A|20|Anticipated|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 03:54:49.785063|2017-10-11 03:54:49.785063
NCT01419418|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-11|2017-05-22|||January 2011||2011-01-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes|A Study of Patients' Perspectives of Factors That Support the Management of Cardiac Care for Improved Outcomes in a Peripheral Arterial Disease Population|Completed||N/A|10|Actual|VA Eastern Colorado Health Care System|||1||f||||f||||||||||2017-10-11 03:54:49.881989|2017-10-11 03:54:49.881989
NCT01419405|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2014-09-11|||December 2011||2011-12-01|September 2014|2014-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Pregabalin and Remifentanil - Analgesia and Ventilation|Pregabalin Has Additive Analgesic and Ventilatory Depressive Effects in Combination With Remifentanil|Completed||Phase 4|12|Actual|Oslo University Hospital||4|||f||||f||||||||||2017-10-11 03:54:50.004817|2017-10-11 03:54:50.004817
NCT01419392|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2012-04-14|||September 2011||2011-09-01|April 2012|2012-04-01|June 2012|Anticipated|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages|Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages: a Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Ain Shams University||2|||f||||t||||||||||2017-10-11 03:54:50.125763|2017-10-11 03:54:50.125763
NCT01419379|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2013-04-16|||July 2011||2011-07-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|EPOCH||This is a Multicenter, Prospective and Retrospective and Descriptive Epidemiology Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Korea|Epidemiologic Review and Prospective Observation of COPD and Health in Korea|Completed||N/A|1118|Actual|Takeda|||1||f||||f||||||||||2017-10-11 03:54:50.236781|2017-10-11 03:54:50.236781
NCT01419366|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-08-21||||||August 2013|2013-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fed Conditions|An Open Label, Randomized, 2-Period, 2-Treatment, Crossover, Single-Dose Bioequivalence Study of Donepezil Hydrochloride Tablets 10mg [Test Formulation, Torrent Pharmaceutical Limited., India] Versus Aricept® (Donepezil Hydrochloride) Tablets 10mg [Reference Formulation, Eisai Inc.), in Healthy Human Volunteers Under Fed Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:54:50.359312|2017-10-11 03:54:50.359312
NCT01419353|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-12-23|||August 2011||2011-08-01|August 2011|2011-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol|Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol|Completed||Phase 4|63|Actual|Meir Medical Center||2|||f||||f||||||||||2017-10-11 03:54:50.468817|2017-10-11 03:54:50.468817
NCT01419340|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-08-17||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fasting Conditions|An Open Label, Randomized, 2-Period, 2-Treatment, Crossover, Single-Dose Bioequivalence Study of Donepezil Hydrochloride Tablets 10mg [Test Formulation, Torrent Pharmaceutical Limited., India] Versus Aricept® (Donepezil Hydrochloride) Tablets 10mg [Reference Formulation, Eisai Inc.), in Healthy Human Volunteers Under Fasting Conditions.|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:54:50.576563|2017-10-11 03:54:50.576563
NCT01419327|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-17|2017-08-30|||March 23, 2009|Actual|2009-03-23|August 2017|2017-08-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|FOSRENOL-HD||Fosrenol Post-marketing Surveillance for Hemodialysis in Japan|Special Drug Use Investigation of Fosrenol (Long-term Investigation for Patients With Hemodialysis)|Active, not recruiting||N/A|3267|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:54:50.667258|2017-10-11 03:54:50.667258
NCT01419314|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-12-05|2012-09-13||August 2011||2011-08-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy|Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy|Completed||N/A|46|Actual|Texas Woman's University|The contrast between the splinting group and liner group was statistically underpowered. The data was collected and analyzed by the primary investigator. The clinical diagnosis of peripheral neuropathy was not confirmed with EMG or punch skin biopsy.|2|||f||||f||||||||||2017-10-11 03:54:50.76675|2017-10-11 03:54:50.76675
NCT01419301|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-05|2014-11-19|||May 2011||2011-05-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|April 2013|Actual|2013-04-01||Interventional|||Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)|Mindfulness Based Stress Reduction in MS|Completed||N/A|31|Actual|Stony Brook University||1|||f||||f||||||||||2017-10-11 03:54:51.665926|2017-10-11 03:54:51.665926
NCT01419288|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-01-08|||June 2009||2009-06-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Treadmill Training With Lower Extremity Amputees||Completed||Phase 1|8|Actual|Stony Brook University||2|||f||||f||||||||||2017-10-11 03:54:51.773888|2017-10-11 03:54:51.773888
NCT01419275|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-07-29|2016-12-21||April 2009||2009-04-01|July 2017|2017-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients|Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients|Completed||N/A|126|Actual|Stanford University||4|||f||||||||||||||2017-10-11 03:54:51.873765|2017-10-11 03:54:51.873765
NCT01419262|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2015-11-16|||September 2011||2011-09-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|DO IT||DO IT Trial: Vitamin D Outcomes and Interventions In Toddlers|DO IT Trial: Vitamin D Outcomes and Interventions In Toddlers|Completed||Phase 3|703|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 03:54:52.111385|2017-10-11 03:54:52.111385
NCT01419249|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-11-26|2013-11-26||September 2011||2011-09-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Full Analysis Set (FAS) population included all the participants who had provided informed consent and had non-missing height at start (defined as within one month prior to treatment start date) and at 1 year (+/- 120 days) of r-hGH treatment and had pharmacogenomics data available.|First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study|First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study|Completed||Phase 4|458|Actual|Merck KGaA|No genetic markers were identified, therefore data for the secondary outcome measures was not analyzed.|1|||f||||f||||||||||2017-10-11 03:54:52.290992|2017-10-11 03:54:52.290992
NCT01419236|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2014-12-12|2014-12-12||August 2011||2011-08-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All randomized participants.|A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels|A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency|Completed||Phase 2|76|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:54:52.804505|2017-10-11 03:54:52.804505
NCT01419223|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-10-25|||July 2011||2011-07-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Patient Participation Beliefs and Post-Traumatic Stress Disorder (PTSD)|Patient Beliefs and Attitudes That Influence Participation in PTSD-TBI Clinical Trials|Completed||N/A|30|Actual|INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium|||2||f||||t||||||||||2017-10-11 03:54:53.680206|2017-10-11 03:54:53.680206
NCT01419210|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2015-09-23|||January 2010||2010-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|April 2014|Actual|2014-04-01||Interventional|||Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer|A Pilot Program to Personalize Care by Integrating Traditional and Complementary Medicine for Women With Ovarian Cancer|Completed||N/A|28|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 03:54:53.753444|2017-10-11 03:54:53.753444
NCT01419197|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2016-08-17|2014-02-07||September 2011||2011-09-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|February 2013|Actual|2013-02-01||Interventional|TH3RESA|Randomized population: All participants who were randomized to the study.|A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy|A Phase III Randomized, Multicenter, Two Arm, Open-label Trial to Evaluate the Efficacy of Trastuzumab Emtansine Compared With Treatment of Physician's Choice in Patients With HER2-positive Metastatic Breast Cancer Who Have Received at Least Two Prior Regimens of HER2 Directed Therapy|Completed||Phase 3|602|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:54:55.43825|2017-10-11 03:54:55.43825
NCT01419184|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2016-01-05|2015-04-23||August 2011||2011-08-01|January 2016|2016-01-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|DAPHEOR1006|Baseline analysis population is drawn from the subset of the entire sample of participants that received at least 1 dose of study drug and that had complete data for calculating the primary outcome, infection-related length of stay (IRLOS).|Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA|A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA)|Completed||Phase 4|250|Actual|Cubist Pharmaceuticals LLC||2|||f||||f||||||||||2017-10-11 03:54:57.852027|2017-10-11 03:54:57.852027
NCT01419171|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2014-09-12|2014-07-24||October 2011||2011-10-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||The OMEGA Clinical Trial|OMEGA: A Prospective, Multicenter Single-Arm Trial to Assess the OMEGA™ Coronary Stent System for the Treatment of a Single De Novo Coronary Artery Lesion|Completed||N/A|328|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 03:54:58.470722|2017-10-11 03:54:58.470722
NCT01419158|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-01-18|||January 2008||2008-01-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|PFT||Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)|Targeted Detection of Alpha-1 Antitrypsin Deficiency in Patients Referred for Pulmonary Function Testing|Completed||N/A|3457|Actual|Alpha-1 Foundation|||1||f||||f||||||||||2017-10-11 03:54:59.80877|2017-10-11 03:54:59.80877
NCT01419145|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-06-15|||October 2011||2011-10-01|June 2017|2017-06-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study|A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study|Completed||N/A|46|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 03:54:59.914143|2017-10-11 03:54:59.914143
NCT01419132|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-10-29|||August 2011||2011-08-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|Tra-HSS-Fur||Troponin I Release After High Diuretic Doses|Effects of High Furosemide Doses Alone or With Hypertonic Saline on Troponin I Myocardial Release in Acute Decompensated Heart Failure: a Double Blind Study.|Completed||Phase 4|60|Anticipated|University of Palermo||2|||f||||f||||||||||2017-10-11 03:55:00.039411|2017-10-11 03:55:00.039411
NCT01419119|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-12-10|||September 2011||2011-09-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|VIDI2||Vitamin Deficiency in Immigrants, a Treatment Study|A Study, Four Parallel Arms, Included Two Arms Open Randomisation to Different Doses of Vitamin D, for Assessment of Efficacy of Treatment With Vitamin D at Vitamin D Deficiency, Vitamin D Insufficiency and Suboptimal Levels of Vitamin D|Completed||Phase 4|160|Actual|Umeå University||4|||f||||f||||||||||2017-10-11 03:55:00.331783|2017-10-11 03:55:00.331783
NCT00000297|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||October 1998||1998-10-01|October 1998|1998-10-01|December 2001||2001-12-01|||||Interventional|||Effects of Labetalol on Nicotine Administration in Humans - 14|Effects of Labetalol on Nicotine Administration in Humans|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.544565|2017-10-11 04:17:43.544565
NCT01419106|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-06-18|||August 2011||2011-08-01|June 2015|2015-06-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|SHoC-ED 1||Sonography in Hypotension and Cardiac Arrest in the Emergency Department.|SHoC-ED 1: Sonography in Hypotension and Cardiac Arrest in the Emergency Department.|Unknown status|Recruiting|N/A|400|Anticipated|Horizon Health Network||2|||f||||t||||||||||2017-10-11 03:55:00.484033|2017-10-11 03:55:00.484033
NCT01419093|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-09-16|||September 2008||2008-09-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Communication Intervention Physical Activity|A Communication Intervention for Physical Activity in Underserved Communities|Completed||N/A|325|Actual|University of Rochester||1|||f||||f||||||||||2017-10-11 03:55:00.623505|2017-10-11 03:55:00.623505
NCT01419067|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-09-28|||August 22, 2011|Actual|2011-08-22|September 2017|2017-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|||A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection|A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection|Active, not recruiting||Phase 2|112|Actual|St. Jude Children's Research Hospital||1|||f||||f|t|t|f|f||||||2017-10-11 03:55:00.826569|2017-10-11 03:55:00.826569
NCT01419054|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2013-11-21|||August 2011||2011-08-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|HHFG||Understanding Hand Hygiene Behavior at Unidad Nacional Oncologia Pediatrica|Understanding Hand Hygiene Behavior at Unidad Nacional Oncologia Pediatrica: A Focus Group Approach|Completed||N/A|55|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 03:55:00.947663|2017-10-11 03:55:00.947663
NCT01419041|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-09-28|||November 2011||2011-11-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function|A Phase I, Single Dose, Parallel-Group Study To Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function|Completed||Phase 1|16|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:55:01.041508|2017-10-11 03:55:01.041508
NCT01419028|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2014-07-17|2014-06-11||August 2012||2012-08-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|June 2013|Actual|2013-06-01||Observational||Thirteen participants were alive at the time of data abstraction and were censored in the analysis|A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)|A Retrospective, Non-interventional Epidemiologic Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)|Completed||N/A|48|Actual|Alexion Pharma GmbH|This was an observational study and, as such, serious and/or other [non-serious] adverse events were not collected/assessed.||1||f||||f||||||||||2017-10-11 03:55:01.195467|2017-10-11 03:55:01.195467
NCT01419015|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-08-24|||June 2011|Actual|2011-06-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|PREVAIL-20J||PREVAIL-20J - Transfemoral Placement of 20mm Aortic Balloon Expandable Transcatheter Valve Trial|A Clinical Trial of a 20mm Transcatheter Bioprosthetic Valve for Patients With Aortic Stenosis|Active, not recruiting||N/A|15|Anticipated|Edwards Lifesciences||1|||f||||t|f|t|f|f|t|||||2017-10-11 03:55:01.555726|2017-10-11 03:55:01.555726
NCT01419002|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-13|2015-07-27|||October 2011||2011-10-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Net-Pac||Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer|Neoadjuvant Radiotherapy in Patients With Primary Resectable Adenocarcinoma of the Pancreatic Head Plus Adjuvant Chemotherapy: a Randomized Controlled Phase III Trial|Terminated||Phase 3|5|Actual|CHIR-Net||2||lack of recruitment|f||||f||||||||||2017-10-11 03:55:01.723699|2017-10-11 03:55:01.723699
NCT01418989|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of Administration of RoActemra/Actemra (Tocilizumab) by Auto-injector Vs. Pre-filled Syringe in Healthy Volunteers|An Open-label, Multi-center Study to Compare the Relative Bioavailability of Tocilizumab in Healthy Subjects Following Single Dose Subcutaneous (SC) Administration Via Disposable Auto-Injector (DAI) Device vs Pre-filled Glass Syringe (PFS)|Completed||Phase 1|239|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:55:01.853508|2017-10-11 03:55:01.853508
NCT01418976|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-04-25|||July 2011||2011-07-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Walking and Balance Post-TBI|IMPROVING WALKING AND BALANCE IN VETERANS WITH TRAUMATIC BRAIN INJURY: A PILOT STUDY EXAMINING FEASIBILITY AND DOSAGE|Completed||N/A|11|Actual|INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium||1|||f||||t||||||||||2017-10-11 03:55:01.967405|2017-10-11 03:55:01.967405
NCT01418963|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study of RO5285119 in Healthy Volunteers|A Single- and Multiple Ascending-Dose, Randomized, Double-Blind, Placebo-Controlled Study in Two Single-Center Study Parts to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5285119 Following Oral Administration in Healthy Subjects|Completed||Phase 1|77|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:55:02.071369|2017-10-11 03:55:02.071369
NCT01418950|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-26|2013-12-16|||April 2009||2009-04-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Improving Parental Knowledge: Supplementation of Prematurity Counseling With Written Information|Improving Parental Knowledge: Randomized Trial of Supplementation of Prematurity Counseling With Written Information|Completed||N/A|60|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-10-11 03:55:02.160997|2017-10-11 03:55:02.160997
NCT01418937|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2015-11-19|2015-07-27||May 2012||2012-05-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study|Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK-580299) in Healthy Female Control Subjects From the GSK HPV-023 Study|Completed||Phase 3|164|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 03:55:02.2453|2017-10-11 03:55:02.2453
NCT01418924|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-10-19|||August 2011||2011-08-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Observational|SHSCL||Sex Hormones & Serum Sclerostin Level|Effects Of Sex Hormones On Serum Sclerostin Level During Menstrual Cycle|Completed||N/A|45|Actual|Bagcilar Training and Research Hospital|||1||f||||f||||||||||2017-10-11 03:55:02.493497|2017-10-11 03:55:02.493497
NCT01418911|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-04-30|||August 2011||2011-08-01|July 2011|2011-07-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Observational|||Attachment Style of Type 2 Diabetics, and Cognitive, Social and Emotional Variables as Explanatory Factors of Adherence to Self-care Behavior and Diabetes Control|Attachment Style of Type 2 Diabetics, and Cognitive, Social and Emotional Variables as Explanatory Factors of Adherence to Self-care Behavior and Diabetes Control|Unknown status|Not yet recruiting|N/A|300|Anticipated|Assuta Hospital Systems|||1||f||||t||||||||||2017-10-11 03:55:02.569842|2017-10-11 03:55:02.569842
NCT01418898|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-16|||August 2011||2011-08-01|August 2011|2011-08-01|April 2012|Anticipated|2012-04-01|December 2011|Anticipated|2011-12-01||Interventional|||Nutrient Fortified Oat Drink|The Effect of a Nutrient Fortified Oat Drink on Iron, Zinc, Vitamin A, and Vitamin C Status Among Filipino Children|Unknown status|Recruiting|Phase 4|80|Anticipated|PepsiCo Global R&D||2|||f||||f||||||||||2017-10-11 03:55:02.668372|2017-10-11 03:55:02.668372
NCT01418885|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-08-16|||September 2010||2010-09-01|August 2010|2010-08-01|December 2011|Anticipated|2011-12-01|September 2011|Anticipated|2011-09-01||Observational|||Cognitive Impairment , Neuroimaging and Inflammatory Markers in Patients With Subcortical Ischemic Vascular Disease|Correlation Exploration Between Cognitive Impairment and Neuroimaging and Inflammatory Markers in Patients With Subcortical Ischemic Vascular Disease|Unknown status|Active, not recruiting|N/A|100|Anticipated|Hebei General Hospital|||3||f||||t||||||None Retained|"     serum   "|||2017-10-11 03:55:02.781563|2017-10-11 03:55:02.781563
NCT01418872|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2015-01-13|||January 2012||2012-01-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SAVINHEARTS||A Clinical Trial Of Two Educational Strategies In Cardiovascular Health In Child Population|A Cluster-Randomized Clinical Trial Of Two Educational Strategies In Cardiovascular Health (CVH) In Child Population. The Savinghearts Project|Completed||Phase 4|1730|Actual|Agencia Lain Entralgo||2|||f||||f||||||||||2017-10-11 03:55:02.877562|2017-10-11 03:55:02.877562
NCT01418859|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-03-19|||August 2011||2011-08-01|March 2012|2012-03-01|December 2015|Anticipated|2015-12-01|December 2012|Anticipated|2012-12-01||Observational|||Clinical Study in Post-operation Treatment of Cervical Cancer|Status and the Application of Topotecan at Post-operation Treatment of Cervical Cancer|Unknown status|Recruiting|N/A|183|Anticipated|Health Science Center of Xi’an Jiaotong University|||3||f||||t||||||||||2017-10-11 03:55:02.976743|2017-10-11 03:55:02.976743
NCT01418846|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2015-01-12|||October 2012||2012-10-01|February 2013|2013-02-01|November 2014|Actual|2014-11-01|June 2014|Actual|2014-06-01||Observational|||Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients|Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients.|Completed||N/A|11|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||||||2017-10-11 03:55:03.07269|2017-10-11 03:55:03.07269
NCT01418833|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2015-02-06|||October 2010||2010-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Preliminary Experience of Routine Voriconazole Therapeutic Drug Monitoring (TDM) in a Tertiary Care Centre|Preliminary Experience of Routine Voriconazole Therapeutic Drug Monitoring (TDM) in a Tertiary Care Centre.|Completed||N/A|160|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-10-11 03:55:03.167398|2017-10-11 03:55:03.167398
NCT01418820|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-11-29|||March 2011||2011-03-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions|Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions|Unknown status|Active, not recruiting|Phase 2/Phase 3|32|Actual|University of Magdeburg||2|||f||||f||||||||||2017-10-11 03:55:03.249844|2017-10-11 03:55:03.249844
NCT01418807|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2012-02-23|||July 2011||2011-07-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Transumbilical Versus Transvaginal Specimen Retrieval at Minilaparoscopy||Completed||Phase 2/Phase 3|56|Actual|Università degli Studi dell'Insubria||2|||f||||||||||||||2017-10-11 03:55:03.345211|2017-10-11 03:55:03.345211
NCT01418794|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-08-16|||October 2010||2010-10-01|October 2010|2010-10-01||||November 2011|Anticipated|2011-11-01||Interventional|||Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease||Unknown status|Recruiting|Phase 4|606|Anticipated|Shenyang Northern Hospital||2|||f||||t||||||||||2017-10-11 03:55:03.436074|2017-10-11 03:55:03.436074
NCT01418781|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-03-14|||January 2008||2008-01-01|March 2016|2016-03-01|March 2010||2010-03-01|March 2010|Actual|2010-03-01||Observational|||CLinical Prediction Rule Score in Veterans|Development of CLinical Prediction Rule Score in Veterans: A Study of Impact of Gout on Health Care Utilization and Costs|Withdrawn||N/A|0|Actual|Minneapolis Veterans Affairs Medical Center|||4|Funding withdrawn by the funding agency; study could not be performed.|f||||f||||||||||2017-10-11 03:55:03.553954|2017-10-11 03:55:03.553954
NCT01418768|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-02-01|||August 2011||2011-08-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Effects of an Inpatient Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease (COPD) III/IV||Completed||N/A|50|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||1|||f||||f||||||||||2017-10-11 03:55:03.64777|2017-10-11 03:55:03.64777
NCT01418755|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-09-14|||January 2009||2009-01-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|November 2009|Actual|2009-11-01||Interventional|||Study of Platelet-rich Plasma in Treating Patients With Tibiofemoral Cartilage Degeneration|Platelet-rich Plasma in Patients With Tibiofemoral Cartilage Degeneration|Completed||N/A|50|Actual|Hospital Znojmo||1|||f||||t||||||||||2017-10-11 03:55:03.745731|2017-10-11 03:55:03.745731
NCT01418742|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-07-11|||August 2011||2011-08-01|March 2013|2013-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment|SKIP - A Double-blind Placebo-controlled Randomized Multicenter Phase II Trial of Skin Toxicity Treatment in Subjects With Advanced or Metastatic Colorectal Carcinoma Receiving Panitumumab|Terminated||Phase 2|11|Actual|Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH||2||"Recruitement did not meet expectations. Prev. differentiation of RAS-wild-type and mutated RAS   are not in accordance with the scientific rank anymore."|f||||f||||||||||2017-10-11 03:55:04.01487|2017-10-11 03:55:04.01487
NCT01418729|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-09-19|||September 2011||2011-09-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|December 2015|Actual|2015-12-01||Interventional|ESTAHEP-2010||Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced Hepatocarcinoma|Phase-II, Multicenter, Randomized, Double-Blind, Parallel-Group Trial to Compare the Efficacy and Safety of Sorafenib Plus Pravastatin Against Sorafenib Plus Placebo in Patients With Advanced Hepatocarcinoma|Completed||Phase 2|216|Actual|Hospital Donostia||2|||f||||t||||||||||2017-10-11 03:55:04.171236|2017-10-11 03:55:04.171236
NCT01418716|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-02-15|||April 2011||2011-04-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2013|Actual|2013-10-01||Interventional|TRANSIT||TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care|A Program to TRANSform InTerprofessional Clinical Practices to Improve Cardiovascular Prevention in Primary Care|Completed||N/A|759|Actual|Fonds de la Recherche en Santé du Québec||2|||f||||f||||||||No||2017-10-11 03:55:04.277538|2017-10-11 03:55:04.277538
NCT01418703|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2014-11-09|2014-06-24||October 2009||2009-10-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|MDB003||Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus|Feasibility Study of a Modular Control to Range System in T1DM|Completed||N/A|38|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 03:55:04.404095|2017-10-11 03:55:04.404095
NCT01418690|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2016-11-28|||September 2011||2011-09-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Observational|||Changes in Tissue Oxygenation Following Regional Anesthesia|Changes in Tissue Oxygenation Following Regional Anesthesia|Completed||N/A|29|Actual|Nationwide Children's Hospital|||1||f||||||||||||||2017-10-11 03:55:04.780471|2017-10-11 03:55:04.780471
NCT01418677|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-05-13|||October 2011||2011-10-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|July 2014|Actual|2014-07-01||Interventional|||An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function|An Open-Label Phase 1 Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function|Completed||Phase 1|19|Actual|Eisai Inc.||3|||f||||f||||||||||2017-10-11 03:55:04.850589|2017-10-11 03:55:04.850589
NCT01418664|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-04-21|||September 2010||2010-09-01|April 2016|2016-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Prevention of Adverse Pregnancy Outcome With Vitamin D Supplementation During Pregnancy|Prevention of Adverse Pregnancy Outcome With Vitamin D Supplementation During Pregnancy|Completed||N/A|172|Actual|Dow University of Health Sciences||2|||f||||t||||||||Yes|Data has been published|2017-10-11 03:55:04.953344|2017-10-11 03:55:04.953344
NCT01418651|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2011-08-16|||March 2011||2011-03-01|January 2011|2011-01-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population|Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population: an Open-label Study|Terminated||Phase 3|20|Anticipated|Banner Health||1||Lack of subjects|f||||f||||||||||2017-10-11 03:55:05.083943|2017-10-11 03:55:05.083943
NCT01418638|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-02-19|||May 2012||2012-05-01|February 2013|2013-02-01||||October 2013|Anticipated|2013-10-01||Observational|||The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder|The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder|Unknown status|Recruiting|N/A|30|Anticipated|Ziv Hospital|||1||f||||f||||||||||2017-10-11 03:55:05.162359|2017-10-11 03:55:05.162359
NCT01418625|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-16||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions|An Open Label, Randomised, Two Period, Two Treatment, Two Sequence, Crossover, Single-Dose Bioequivalence Study of Venlafaxine Hydrochloride Extended-Release Capsules 150mg (Test Formulation, Torrent Pharmaceutical Limited., India) Versus Effexor XR® 150mg Capsule (Reference Formulation, Wyeth Pharmaceuticals Inc., USA) Administered as the Contents of Capsule Sprinkled Over Apple Sauce in Healthy Volunteers Under Fed Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:55:05.271079|2017-10-11 03:55:05.271079
NCT01418612|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-16||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions|An Open Label, Randomised, Two Period, Two Treatment, Two Sequence, Crossover, Single-Dose Bioequivalence Study of Venlafaxine Hydrochloride Extended-Release Capsules 150mg (Test Formulation, Torrent Pharmaceutical Limited., India) Versus Effexor XR® 150mg Capsule (Reference Formulation, Wyeth Pharmaceuticals Inc., USA) in Healthy Volunteers Under Fed Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:55:05.325856|2017-10-11 03:55:05.325856
NCT01418599|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-26||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets Under Fed Conditions|An Open Label, Randomised, Two Period, Two Treatment, Two Sequence, Crossover, Single-Dose Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets vs. Sanofi's Uroxatral ER Tablets in Healthy Human Subjects Under Fed Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:55:05.395352|2017-10-11 03:55:05.395352
NCT01418586|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-16||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets Under Fasted Conditions|An Open Label, Randomised, Two Period, Two Treatment, Two Sequence, Crossover, Single-Dose Bioequivalence Study of Torrent Pharmaceuticals Ltd's Alfuzosin ER Tablets vs. Sanofi's Uroxatral ER Tablets in Healthy Human Subjects Under Fasted Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:55:05.471131|2017-10-11 03:55:05.471131
NCT01418573|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2013-08-12|||August 2011||2011-08-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Glycemic Response After Palaeolithic-type Meals|Glycemic Response After Two Palaeolithic-type Meals Compared to a Modern-type Meal Composed According to WHO Guidelines|Completed||N/A|24|Actual|Unilever R&D||3|||f||||f||||||||||2017-10-11 03:55:05.525705|2017-10-11 03:55:05.525705
NCT01418560|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-07-14|||August 2011|Actual|2011-08-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Renal Sympathetic Modification in Patients With Chronic Renal Failure|Renal Sympathetic Modification in Patients With Chronic Renal Failure|Recruiting||N/A|200|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||||2017-10-11 03:55:05.616078|2017-10-11 03:55:05.616078
NCT01418196|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-03-25|||September 2011||2011-09-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|April 2012|Actual|2012-04-01||Observational|||Relation of Diet to Heart Disease Risk Factors in Children|Relation of Diet to Heart Disease Risk Factors in Children|Completed||N/A|92|Actual|Children's Hospital & Research Center Oakland|||1||f||||t||||||||||2017-10-11 03:55:10.444738|2017-10-11 03:55:10.444738
NCT01418547|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-16||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Limited's Isosorbide Mononitrate 120 mg ER Tablets Under Fed Conditions|An Open Label, Randomized, Two Treatment, Two Sequence, Two Period, Cross-over, Single-dose Comparative Oral Bioavailability Study of Isosorbide Mononitrate 120 mg ER Tablets (Test) of Torrent Pharmaceuticals Ltd., India and Isosorbide Mononitrate 120 mg ER Tablets (Reference) of Kremers Urban, USA in Healthy, Adult, Male, Human Subjects Under Fed Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:55:05.716386|2017-10-11 03:55:05.716386
NCT01418534|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-16||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Limited's ISMN 120 mg ER Tablets Under Fasting Condition|An Open Label, Randomized, Two Treatment, Two Sequence, Two Period, Cross-over, Single-dose Comparative Oral Bioavailability Study of Isosorbide Mononitrate 120 mg ER Tablets (Test) of Torrent Pharmaceuticals Ltd., India and Isosorbide Mononitrate 120 mg ER Tablets (Reference) of Kremers Urban, USA in Healthy, Adult, Male, Human Subjects Under Fasting Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:55:05.775831|2017-10-11 03:55:05.775831
NCT01418521|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-16|||August 2011||2011-08-01|August 2011|2011-08-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|||Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) After Cardiac Surgery|Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) Versus Albumin Solution for Volume Replacement in Patients After Cardiac Surgery|Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 03:55:05.849701|2017-10-11 03:55:05.849701
NCT01418508|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-16|||August 2011||2011-08-01|August 2011|2011-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|ELPD-CKD||Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease (CKD)- ELPD Study|Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease(CKD)- ELPD Study|Unknown status|Recruiting|N/A|120|Anticipated|Peking Union Medical College Hospital||3|||f||||t||||||||||2017-10-11 03:55:05.950628|2017-10-11 03:55:05.950628
NCT01418495|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2017-08-03|||May 26, 2011|Actual|2011-05-26|August 2017|2017-08-01|November 2, 2012|Actual|2012-11-02|November 2, 2012|Actual|2012-11-02||Observational|||Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma|Pharmacokinetics of the Chimeric Anti-GD2 Antibody, ch14.18, in Children With High-Risk Neuroblastoma|Completed||N/A|12|Actual|National Cancer Institute (NCI)|||1||f||||||||||||||2017-10-11 03:55:06.042064|2017-10-11 03:55:06.042064
NCT01418482|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-27|2017-05-03|2016-04-07||January 2011||2011-01-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||small partial thickness burns|Evaluation of Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns|An Open Non-controlled Post-marketing Investigation Evaluating the Experience of Using a Self- Adherent Antimicrobial Soft Silicone, Silver Containing, Foam Dressing, Mepilex Border Ag, in Second Degree Burns|Completed||N/A|15|Actual|Molnlycke Health Care AB||1|||f||||f||||||||||2017-10-11 03:55:06.141453|2017-10-11 03:55:06.141453
NCT01418469|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-16|||December 2002||2002-12-01|August 2011|2011-08-01|December 2004|Actual|2004-12-01|December 2003|Actual|2003-12-01||Interventional|||Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD|The Effects of Exercise on the Metabolic Fate of Branched Chain Amino Acids in Relation to Aging and Chronic Disease.|Completed||N/A|24|Actual|Maastricht University Medical Center||4|||f||||f||||||||||2017-10-11 03:55:06.369118|2017-10-11 03:55:06.369118
NCT01418456|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-08-16|||August 2011||2011-08-01|January 2011|2011-01-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|KADFUT||Outcomes of Non-infected Diabetic Foot Ulcers With/Without Antibiotics|A Prospective Single Blind Randomised Controlled Study to Compare the Outcomes of Patients With Diabetes and Clinically Non-infected Neuro-ischaemic and Neuropathic Foot Ulcers Treated With and Without Oral Antibiotics.|Unknown status|Not yet recruiting|Phase 4|166|Anticipated|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-10-11 03:55:06.47879|2017-10-11 03:55:06.47879
NCT01418443|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-16||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fed Conditions|A Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets of Torrent Pharmaceutical Limited., India and Protonix® (Pantoprazole Sodium) 40 mg Delayed Release Tablets of Wyeth Pharmaceuticals Inc, in Healthy Human Adult Subjects, Under Fed Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:55:06.560268|2017-10-11 03:55:06.560268
NCT01418430|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-08-19||||||July 2011|2011-07-01||||||||Interventional|||Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)|HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)|Completed||Phase 4|||King's College Hospital NHS Trust||1|||f||||t||||||||||2017-10-11 03:55:06.619461|2017-10-11 03:55:06.619461
NCT01418417|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-15||||||August 2011|2011-08-01||||||||Interventional|||Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fasting Conditions|A Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets of Torrent Pharmaceutical Limited., India and Protonix® (Pantoprazole Sodium) 40 mg Delayed Release Tablets of Wyeth Pharmaceuticals Inc, in Healthy Human Adult Subjects, Under Fasting Conditions|Completed||Phase 1|||Torrent Pharmaceuticals Limited|||||f||||||||||||||2017-10-11 03:55:06.692463|2017-10-11 03:55:06.692463
NCT01418404|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-26|2015-04-06|||January 2010||2010-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||The Application of Thermal Stimulation on Functional Recovery of Stroke Patients|The Application of Thermal Stimulation on Functional Recovery of Stroke Patients|Completed||N/A|220|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||6|||f||||f||||||||||2017-10-11 03:55:06.777295|2017-10-11 03:55:06.777295
NCT01418391|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-16|2011-08-16|||June 2011||2011-06-01|May 2011|2011-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||the Effect of the Transversus Abdominis Plane (TAP) Block on the Minimal Laparotomy : a Randomized Controlled Trial|the Effect of the Transversus Abdominis Plane (TAP) Block on the Minimal Laparotomy : a Randomized Controlled Trial|Unknown status|Recruiting|N/A|60|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||t||||||||||2017-10-11 03:55:06.88936|2017-10-11 03:55:06.88936
NCT01418378|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-07-24|||July 1, 2011|Actual|2011-07-01|July 2017|2017-07-01|February 17, 2016|Actual|2016-02-17|February 17, 2016|Actual|2016-02-17||Interventional|||Sigma CR150 Versus Sigma CR Knee RCT|A Double-blinded Randomised Controlled Trial Comparing the Performance of the Sigma® CR150 and Sigma® CR Knee Systems, When Used in Fixed Bearing Primary Cruciate Retaining Total Knee Arthroplasty for the Treatment of Osteoarthritis|Completed||Phase 4|200|Actual|DePuy International||2|||f||||f||||||||||2017-10-11 03:55:06.97243|2017-10-11 03:55:06.97243
NCT01418365|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2013-08-21|2012-07-16||August 2011||2011-08-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine|A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Metronidazole Administered Alone and in Combination With MMX® Mesalazine/Mesalamine in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Shire||2|||f||||||||||||||2017-10-11 03:55:07.092348|2017-10-11 03:55:07.092348
NCT01418352|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-05-06||2015-03-25|July 2011||2011-07-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|Completed||Phase 3|83|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||t||||||||||2017-10-11 03:55:07.368357|2017-10-11 03:55:07.368357
NCT01418339|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-11-04||2014-10-29|July 2011||2011-07-01|November 2014|2014-11-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Flexible-Dose Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|Completed||Phase 3|135|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-10-11 03:55:07.511956|2017-10-11 03:55:07.511956
NCT01418326|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-05-28|||November 2010||2010-11-01|May 2015|2015-05-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Observational|||Cancer Mortality Affected by the Choice of Anesthetic Drugs?|Cancer Mortality Affected by the Choice of Anesthetic Drugs?|Completed||N/A|3284|Actual|Uppsala University|||2||f||||f||||||||||2017-10-11 03:55:07.668847|2017-10-11 03:55:07.668847
NCT01418313|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-01-17|||September 2011||2011-09-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Non-Invasive Imaging of Atherosclerosis|In Vivo Molecular Imaging (MRI) of Atherothrombotic Lesions|Recruiting||N/A|159|Anticipated|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||Samples With DNA|"     Whole Blood, Endarterectomy Specimens   "|||2017-10-11 03:55:07.904362|2017-10-11 03:55:07.904362
NCT01418300|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-13|2015-04-26|||August 2010||2010-08-01|August 2011|2011-08-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial||Completed||Phase 4|159|Actual|Jeil Pharmacy Co.||2|||f||||||||||||||2017-10-11 03:55:08.112061|2017-10-11 03:55:08.112061
NCT01418287|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-09-10|||April 2010||2010-04-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Characterization of Influenza-like Illness in Mexico|An Observational Study to Characterize Children and Adults With Influenza Like Illness (ILI) in Mexico|Completed||N/A|5819|Actual|Mexican Emerging Infectious Diseases Clinical Research Network|||2||f||||f||||||Samples With DNA|"     Plasma, PBMC and Nasopharingeal aspirates   "|||2017-10-11 03:55:08.199146|2017-10-11 03:55:08.199146
NCT01418274|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers|A Study to Investigate the Effect of Multiple Doses of Danoprevir/Ritonavir (DNV/RTV) on the Pharmacokinetics (PK) of Escitalopram (ESC) and S-Demethylcitalopram (S-DCT) in Healthy Subjects|Completed||Phase 1|20|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 03:55:08.342523|2017-10-11 03:55:08.342523
NCT01418261|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-04-24||2014-10-03|September 2011||2011-09-01|April 2017|2017-04-01|February 17, 2017|Actual|2017-02-17|December 2013|Actual|2013-12-01||Interventional|||SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension|Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)|Completed||N/A|535|Actual|Medtronic Vascular||2|||f||||t||||||||No||2017-10-11 03:55:08.453635|2017-10-11 03:55:08.453635
NCT01418248|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-01-08|||August 2011||2011-08-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|EXEC||Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease|Evaluation of Exercise Intolerance and Right Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease|Completed||N/A|108|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Serum, plasma   "|||2017-10-11 03:55:08.738354|2017-10-11 03:55:08.738354
NCT01418235|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2014-10-14|||June 2011||2011-06-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|October 2013|Actual|2013-10-01||Interventional|||Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults|A Phase 1 Placebo-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of SAAVI DNA-C2, SAAVI MVA-C and Novartis Subtype C gp140 With MF59 Adjuvant in Various Vaccination Schedules in HIV-uninfected Healthy Vaccinia-naïve Adult Participants in South Africa|Unknown status|Active, not recruiting|Phase 1|184|Anticipated|HIV Vaccine Trials Network||4|||f||||t||||||||||2017-10-11 03:55:08.821027|2017-10-11 03:55:08.821027
NCT01418222|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-05-25||2016-08-09|September 14, 2011|Actual|2011-09-14|May 2017|2017-05-01|March 18, 2013|Actual|2013-03-18|March 18, 2013|Actual|2013-03-18||Interventional|||FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer|Randomized, Double-Blind, Phase II Study of FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment for Patients With Metastatic Colorectal Cancer|Completed||Phase 2|194|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:55:08.937608|2017-10-11 03:55:08.937608
NCT01418209|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-08-20|2014-06-18||November 2011||2011-11-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Randomized participants per trial arm|MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms|MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and the SNRI Venlafaxine XR for Treatment of Menopausal Symptoms|Completed||N/A|339|Actual|Fred Hutchinson Cancer Research Center|Findings may be specific to the particular dose of each agent used, treatment period, as well as the preparation and oral administration of estrogen therapy.|3|||f||||t||||||||||2017-10-11 03:55:09.121823|2017-10-11 03:55:09.121823
NCT01418183|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-09-04|||July 2011||2011-07-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|PCOGS||Pain Control After Orthognathic Surgery|Intra-operative Trigeminal Nerve Block For Post-operative Pain Control After Orthognathic Surgery|Unknown status|Recruiting|N/A|40|Anticipated|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-11 03:55:10.510801|2017-10-11 03:55:10.510801
NCT01418170|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-17|||September 2011||2011-09-01|August 2011|2011-08-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Dose Response Effects of Cervical Spinal Manipulative Therapy (SMT) on Pressure Sensitivity of Myofascial Trigger Points|Dose Response Effects of Cervical SMT on Pressure Sensitivity of Myofascial Trigger Points|Unknown status|Not yet recruiting|Phase 2|26|Anticipated|Canadian Memorial Chiropractic College||2|||f||||f||||||||||2017-10-11 03:55:10.610908|2017-10-11 03:55:10.610908
NCT01418157|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-06-21|||August 2011||2011-08-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent|Double Blind, Placebo Controlled Randomised Trial of Acetazolamide Versus Placebo in the Prevention of Acute Mountain Sickness During Rapid Ascent|Completed||Phase 4|380|Actual|Oxford University Clinical Research Unit, Vietnam||2|||f||||t||||||||||2017-10-11 03:55:10.724471|2017-10-11 03:55:10.724471
NCT01418144|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-08-21|||August 2010||2010-08-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Interventional|||Effect of Transversus Abdominis Plane (TAP) Block After Laparoscopic Colon Surgery|Effect of Transversus Abdominis Plane (TAP) Block as Postoperative Pain Management After Laparoscopic Colon Surgery|Completed||Phase 4|80|Actual|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 03:55:10.812226|2017-10-11 03:55:10.812226
NCT01418131|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-12-14|||October 2012||2012-10-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|September 2016|Actual|2016-09-01||Interventional|||Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis|A Multi-centre Double Blind Randomised Placebo-controlled Study of the Use of Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis|Completed||Phase 4|21|Actual|The University of Western Australia||2|||f||||t||||||||||2017-10-11 03:55:10.88606|2017-10-11 03:55:10.88606
NCT01418118|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-15|||October 2008||2008-10-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|Free4Flow||Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery|An Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery: A Randomised Study|Completed||Phase 4|25|Actual|Oxford University Hospitals NHS Trust||1|||f||||t||||||||||2017-10-11 03:55:11.069372|2017-10-11 03:55:11.069372
NCT01418105|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2016-10-24|||January 2011||2011-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|DysphagCerv||Dysphagia and Cervical Spine Disorders in Patients With Brain Lesions|Dysphagia and Cervical Spine Disorders in Patients With Neurologic Deficits Due to Brain Lesions|Completed||Phase 1|70|Actual|University of Ioannina||3|||f||||t||||||||||2017-10-11 03:55:11.180063|2017-10-11 03:55:11.180063
NCT01418092|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2012-07-31||2012-07-31|September 2011||2011-09-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)|A Phase 2b Randomized, Double-blind, Placebo-controlled, 12-week Study to Evaluate the Safety and Efficacy of ALKS 37 in Subjects With Opioid-induced Constipation|Completed||Phase 2|91|Actual|Alkermes, Inc.||2|||f||||t||||||||||2017-10-11 03:55:11.289651|2017-10-11 03:55:11.289651
NCT01418079|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-05-21|||August 2011||2011-08-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Accuracy of the O2 MedTech PMS-3000 Monitor|Accuracy of the O2 MedTech PMS-3000 Monitor for the Non-invasive Measurement of Cerebral and Tissue Oxygenation Using Phase-modulated Infrared Spectroscopy|Completed||Phase 2|42|Actual|O2 MedTech, Inc.||1|||f||||f||||||||||2017-10-11 03:55:11.42598|2017-10-11 03:55:11.42598
NCT01418066|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2012-12-05|||August 2011||2011-08-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|AHIB||Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome|Feasibility and Safety of Ayurvedic Herbs in Diarrhoea-predominant Irritable Bowel Syndrome|Completed||N/A|32|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-11 03:55:11.531072|2017-10-11 03:55:11.531072
NCT01418053|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2013-10-29|||August 2011||2011-08-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|CarO||The Effect of Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome|Randomised Controlled Study on the Effect of a Kneipp Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome|Completed||N/A|48|Actual|Universität Duisburg-Essen||3|||f||||f||||||||||2017-10-11 03:55:11.646211|2017-10-11 03:55:11.646211
NCT01418040|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-02-22|||July 2011||2011-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|PROCITT||PROstate Cancer Imaging, Treatment and Toxicity (PROCITT)|A Phase 2 Clinical Trial Exploring 3-Dimensional Imaging of Androgen Deprivation Induced Osteoporosis, Radiotherapy Hypofractionation and the Prognostic Significance of Micrometastatic Disease in Men With Prostate Cancer|Active, not recruiting||N/A|28|Actual|Calvary Mater Newcastle, Australia|||1||f||||t||||||||No|It is not intended that results relating to a specific participant be reported to anyone other than the participant.|2017-10-11 03:55:11.743908|2017-10-11 03:55:11.743908
NCT01418027|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-08-28|||August 2011||2011-08-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)|Combined Intensive and Conventional Exercise Intervention of Nonalcoholic Fatty Liver Disease|Completed||Phase 3|220|Actual|Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||||2017-10-11 03:55:11.819695|2017-10-11 03:55:11.819695
NCT01418014|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2017-08-22|||March 2007||2007-03-01|August 2017|2017-08-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|AMP||Adolescent Master Protocol|Adolescent Master Protocol|Active, not recruiting||N/A|678|Actual|Harvard School of Public Health|||2||f||||f||||||Samples With DNA|"     Serum, cell pellets, plasma, saliva, and urine   "|||2017-10-11 03:55:11.90856|2017-10-11 03:55:11.90856
NCT01418001|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-01-19|2016-01-19||August 2011||2011-08-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)|A Phase IB/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)|Terminated||Phase 1/Phase 2|5|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-11 03:55:13.795393|2017-10-11 03:55:13.795393
NCT01417988|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-02-14|||August 2011||2011-08-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PrOMPT||Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment|Prevention of Early Mortality by Presumptive TB Treatment in HIV-infected Patients Initiating Antiretroviral Therapy|Terminated||Phase 4|44|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2||Study was terminated prematurely due to insufficient enrolment.|f||||t||||||||||2017-10-11 03:55:14.06738|2017-10-11 03:55:14.06738
NCT01417975|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-12-15|||August 2011||2011-08-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effect of an Acute Bout of Exercise on Smoking Satisfaction|Does an Acute Bout of Exercise Affect Smoking Satisfaction?|Completed||N/A|43|Actual|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 03:55:14.181581|2017-10-11 03:55:14.181581
NCT01417962|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-13|2013-04-19|||March 2007||2007-03-01|April 2013|2013-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|MARIAS||Magnetic Resonance Imaging Autopsy Study|Post Mortem Magnetic Resonance Imaging in the Fetus, Infant and Child: A Comparative Study With Conventional Autopsy|Completed||N/A|400|Anticipated|Thayyil, Sudhin|||2||f||||f||||||||||2017-10-11 03:55:14.295283|2017-10-11 03:55:14.295283
NCT01417949|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-11-25|||August 2011||2011-08-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|IDEAL||Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events|Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (IDEAL-Study)|Completed||Phase 4|61|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||No||2017-10-11 03:55:14.395082|2017-10-11 03:55:14.395082
NCT01417936|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2016-09-28|2015-12-29||July 2011||2011-07-01|September 2016|2016-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Full analysis set (FAS) comprised all subjects who had been exposed to trial drug irrespective of their compliance to the planned course of treatment.|Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy|An Open-label, Single Arm, Phase II Trial to Investigate the Safety and Efficacy of Sym004 in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) Who Have Failed Anti-EGFR Monoclonal Antibody-based Therapy|Completed||Phase 2|26|Actual|Symphogen A/S||1|||f||||t||||||||Undecided||2017-10-11 03:55:14.671065|2017-10-11 03:55:14.671065
NCT01417923|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-11-04|||September 2011||2011-09-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain|The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain|Unknown status|Recruiting|Phase 4|80|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 03:55:15.380051|2017-10-11 03:55:15.380051
NCT01417910|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-01-26|||September 2011||2011-09-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients|Prognostic Markers of Outcome in Patients Undergoing Infra-inguinal Revascularisation. A Prospective Observational Study.|Completed||N/A|100|Actual|York Teaching Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 03:55:15.483084|2017-10-11 03:55:15.483084
NCT01417897|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2012-03-02|||September 2011||2011-09-01|March 2012|2012-03-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|HERMES||Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study|Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study|Unknown status|Active, not recruiting|Phase 4|12|Anticipated|ikfe-CRO GmbH||3|||f||||f||||||||||2017-10-11 03:55:15.552772|2017-10-11 03:55:15.552772
NCT01417884|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-01-13|||January 2012||2012-01-01|August 2011|2011-08-01||||December 2014|Anticipated|2014-12-01||Observational|TuePIC||Monocentric Registry to Investigate the Role of Platelet Function, Platelet Pharmacogenomics, Proteomics and Metabonomics in Ischemic and Non-ischemic Heart Disease|Development of a Prospective Cardiovascular Patient Cohort and Biobank and Provision of Genomic Analyses With Focus on Platelet Function and Platelet Mediated Inflammatory Processes|Unknown status|Recruiting|N/A|3000|Anticipated|University Hospital Tuebingen|||2||f||||t||||||Samples With DNA|"     Blood, salivatory   "|||2017-10-11 03:55:15.639639|2017-10-11 03:55:15.639639
NCT01417871|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-15|||February 2010||2010-02-01|February 2010|2010-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||ABC Program in Patients With Metabolic Syndrome||Completed||N/A|140|Actual|University of Magdeburg|||2||f||||f||||||Samples Without DNA|"     blood samples for parameter of lipid metabolism   "|||2017-10-11 03:55:15.732748|2017-10-11 03:55:15.732748
NCT01417858|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-15|||November 2010||2010-11-01|June 2011|2011-06-01|July 2012|Anticipated|2012-07-01|December 2011|Anticipated|2011-12-01||Interventional|||Intraocular Pressure Control After Anterior Segment Laser - Comparison Between 2 Drugs|Short-term Intraocular Pressure Control After YAG Iridotomy - Comparison Between Brimonidine 0.1% vs. 0.2%|Unknown status|Recruiting|N/A|50|Anticipated|Universidade Federal do Paraná||2|||f||||t||||||||||2017-10-11 03:55:15.798097|2017-10-11 03:55:15.798097
NCT01417845|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-01-31|||September 2011||2011-09-01|January 2014|2014-01-01||||August 2012|Actual|2012-08-01||Interventional|||The Effect of Exercise Training Intensity in Patients With Type 2 Diabetes|The Effect of Moderate Versus High Intensity Exercise Training on Physical Fitness and Physical Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial|Completed||N/A|21|Actual|University of Central Arkansas||2|||f||||f||||||||||2017-10-11 03:55:15.958163|2017-10-11 03:55:15.958163
NCT01417819|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-08-27|||December 2010||2010-12-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Mobile Communication on Childhood Cataract Follow-up Adherence|Effect of a Mobile Phone Short Message Service (SMS) on Childhood Cataract Follow-up Adherence in China|Completed||N/A|258|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-10-11 03:55:16.144505|2017-10-11 03:55:16.144505
NCT01417611|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-27|2011-08-15|||September 2010||2010-09-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||The Usefulness of I-scan in Screening Colonoscopy|The Usefulness of I-scan in Screening Colonoscopy: A Randomized Controlled Trial|Completed||N/A|389|Actual|Konkuk University Hospital||2|||f||||t||||||||||2017-10-11 03:55:18.0899|2017-10-11 03:55:18.0899
NCT01417806|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-15|||July 2011||2011-07-01|July 2011|2011-07-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer|A Phase II Trial of SOM230(PasireotideLAR) and Topotecan in Patients With Relapsed or Refractory Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|28|Anticipated|South Florida Veterans Affairs Foundation for Research and Education||1|||f||||t||||||||||2017-10-11 03:55:16.24631|2017-10-11 03:55:16.24631
NCT01417793|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-14|2011-08-15|||August 2011||2011-08-01|August 2011|2011-08-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|||Effects of a Smoking Cessation Program for Prison Inmates|Effects of a Smoking Cessation Program for Prison Inmates-A Case Study of a Prison in Central Taiwan|Unknown status|Recruiting|N/A|500|Anticipated|China Medical University Hospital||1|||f||||f||||||||||2017-10-11 03:55:16.521383|2017-10-11 03:55:16.521383
NCT01417780|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-08-14|||December 2011||2011-12-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Evaluation of Safety, PK and Immunomodulatory Effects of AB103 in Necrotizing Soft Tissue Infections Patients|Evaluation of Safety, Pharmacokinetics and Immunomodulatory Effects of AB103, a CD28 Co-stimulatory Receptor Antagonist, in Patients Diagnosed With Necrotizing Soft Tissue Infections|Completed||Phase 2|43|Actual|Atox Bio Ltd||3|||f||||t||||||||||2017-10-11 03:55:16.604346|2017-10-11 03:55:16.604346
NCT01417767|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-09-08|||September 2011||2011-09-01|September 2011|2011-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Efficacy Study of CHG Regimen vs Decitabine to Treat Higher-risk MDS|Phase 2/3 Study of Efficacy Study of CHG Regimen vs Decitabine to Treat Higher-risk MDS|Unknown status|Not yet recruiting|Phase 2/Phase 3|50|Anticipated|Shanghai 6th People's Hospital||2|||f||||f||||||||||2017-10-11 03:55:16.732111|2017-10-11 03:55:16.732111
NCT01417754|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-08-22|||September 2010||2010-09-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|November 2010|Actual|2010-11-01||Interventional|||Changes in Breast 3D Ultrasound Measurements Using Toremifene|Volume and Circulation Changes of The Breast in 3D Ultrasound During Toremifene Versus Nonmedicated Menstrual Cycle|Completed||Phase 3|20|Actual|Satakunta Central Hospital||1|||f||||f||||||||||2017-10-11 03:55:16.881344|2017-10-11 03:55:16.881344
NCT01417741|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-04-09|||August 2011||2011-08-01|April 2014|2014-04-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Acupuncture and Nausea/Vomiting in Pediatric Patients|Is Intra-operative Acupuncture at P6 Plus IV Antiemetics More Effective Than IV Antiemetic Therapy Alone in Preventing Postoperative Vomiting in Pediatric Patients Following Tonsillectomy With or Without Adenoidectomy?|Unknown status|Recruiting|N/A|200|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 03:55:16.972058|2017-10-11 03:55:16.972058
NCT01417728|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2012-11-29|||May 2011||2011-05-01|November 2012|2012-11-01|August 2013|Anticipated|2013-08-01|April 2013|Anticipated|2013-04-01||Observational|EARLY||Endomicroscopy in IBD Patients|Endomicroscopy for Assessment of Structural and Functional Changes in IBD Patients Treated With Anti-TNFalpha - Insights in the Process in Mucosal Healing|Unknown status|Recruiting|N/A|50|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-10-11 03:55:17.057482|2017-10-11 03:55:17.057482
NCT01417715|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-01-23|||August 2011||2011-08-01|January 2013|2013-01-01|August 2014|Anticipated|2014-08-01|May 2014|Anticipated|2014-05-01||Observational|||Endomicroscopy for Assessment of Mucosal Healing|Advanced Endoscopic Imaging Using Endomicroscopy for Assessment of Mucosal Healing in IBD|Unknown status|Recruiting|N/A|84|Anticipated|University of Erlangen-Nürnberg Medical School|||4||f||||t||||||||||2017-10-11 03:55:17.175571|2017-10-11 03:55:17.175571
NCT01417702|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-01-23|||August 2011||2011-08-01|January 2013|2013-01-01|November 2014|Anticipated|2014-11-01|May 2014|Anticipated|2014-05-01||Observational|||Endoscopy for Assessment of Mucosal Healing in IBD|Advanced Endoscopic Imaging Using HD+ Endoscopy and i-Scan for Assessment of Mucosal Healing in IBD|Unknown status|Recruiting|N/A|232|Anticipated|University of Erlangen-Nürnberg Medical School|||4||f||||t||||||||||2017-10-11 03:55:17.302386|2017-10-11 03:55:17.302386
NCT01417689|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-15|||August 2011||2011-08-01|August 2011|2011-08-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||Eyedrop Instillation Technique|Eyedrop Instillation Technique: A Randomizaed Controlled Trial|Unknown status|Recruiting|N/A|230|Anticipated|Oftalmologia Hospital Sotero del Rio||2|||f||||f||||||||||2017-10-11 03:55:17.418456|2017-10-11 03:55:17.418456
NCT01417676|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-01-11|||April 2011||2011-04-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|Propel||DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study|Pelvic Lymph Node Irradiation With Simultaneous Integrated Boost to Prostate for High Risk Prostate Cancer Patients: A Phase I/II Study|Active, not recruiting||Phase 1/Phase 2|80|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-10-11 03:55:17.511277|2017-10-11 03:55:17.511277
NCT01417650|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-15|||January 2011||2011-01-01|June 2010|2010-06-01|January 2012|Anticipated|2012-01-01|October 2011|Anticipated|2011-10-01||Interventional|||The Effect of Low Level Laser Therapy on Improvement of Temporomandibular Joint Osteoarthritis|A Randomized Clinical Trial of the Effect of Low Level Laser Therapy on Improvement of Temporomandibular Joint Osteoarthritis|Unknown status|Active, not recruiting|N/A|20|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:55:17.752802|2017-10-11 03:55:17.752802
NCT01417637|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-15|||August 2010||2010-08-01|June 2010|2010-06-01|November 2011|Anticipated|2011-11-01|September 2011|Anticipated|2011-09-01||Interventional|||The Effect of Low Level Laser Therapy (LLLT) in Myofacial Pain Syndrome|A Randomized Clinical Trial of the Effect of Low Level Laser Therapy in Myofacial Pain Syndrome|Unknown status|Active, not recruiting|N/A|20|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:55:17.853711|2017-10-11 03:55:17.853711
NCT01417624|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-15|||August 2011||2011-08-01|August 2011|2011-08-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Cardiac Magnetic Resonance Imaging Guided Left Ventricular Lead Placement|The Assessment of Cardiac Magnetic Resonance Imaging Guided Left Ventricular Lead Placement During the Implantation of Cardiac Resynchronisation Therapy on Clinical Outcomes in Patients With Chronic Heart Failure|Unknown status|Recruiting|Phase 3|70|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 03:55:17.978016|2017-10-11 03:55:17.978016
NCT01417598|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-09-07|||January 2010||2010-01-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|BETA||BETA Study: Improving Balance Function in Elderly by Progressive and Specific Training and Physical Activity|Improving Balance Function in Elderly by Progressive and Specific Training and Physical Activity- a Randomized Controlled Study.|Unknown status|Active, not recruiting|N/A|200|Actual|Karolinska Institutet||3|||f||||f||||||||||2017-10-11 03:55:18.18408|2017-10-11 03:55:18.18408
NCT01417585|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2013-04-14|||September 2009||2009-09-01|January 2012|2012-01-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|LAS-2||A Trial of a Client-centered Intervention Aiming to Improve Functioning in Daily Life After Stroke|A Randomized Controlled Trial of a Client-centered Intervention Aiming to Improve Functioning in Daily Life After Stroke|Completed||N/A|280|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 03:55:18.272496|2017-10-11 03:55:18.272496
NCT01417572|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-15|||January 2010||2010-01-01|January 2010|2010-01-01|September 2011|Anticipated|2011-09-01|August 2010|Actual|2010-08-01||Interventional|||Adjunctive Local Application of Lidocaine During Scleral Buckling Under General Anesthesia||Unknown status|Recruiting|Phase 4|30|Anticipated|Isfahan University of Medical Sciences||1|||f||||||||||||||2017-10-11 03:55:18.373378|2017-10-11 03:55:18.373378
NCT01417546|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-13|2017-07-26|||July 29, 2011||2011-07-29|April 7, 2017|2017-04-07|January 1, 2020|Anticipated|2020-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||NHS-IL12 for Solid Tumors|First In-Human Phase I Trial of NHS-IL12 in Patients With Metastatic Solid Tumors|Recruiting||Phase 1|78|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:55:18.470228|2017-10-11 03:55:18.470228
NCT01417533|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-13|2017-06-30|||July 29, 2011||2011-07-29|April 17, 2017|2017-04-17||||||||Observational|||A Natural History Study of Patients With GNE Myopathy|A Natural History Study of Patients With GNE Myopathy|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:55:18.567959|2017-10-11 03:55:18.567959
NCT01417507|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-13|2015-03-17|||October 2011||2011-10-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery|Natural History of Postoperative Cognitive Function, Quality of Life, and Seizure Control in Patients With Supratentorial Low-Risk Grade II Glioma|Completed||N/A|82|Actual|Radiation Therapy Oncology Group|||1||f||||||||||Samples With DNA|"     Tissue will be submitted to the RTOG Biospecimen Resource for the purpose of central review     of pathology (mandatory fo eligibility), tissue banking, and translational research (highly     recommended). For central review, H&E slide and tumor block must be submitted. For tissue     banking and translational research, remaining tissue from the central review will be used and     plasma, whole blood and urine will be collected.   "|||2017-10-11 03:55:18.756918|2017-10-11 03:55:18.756918
NCT01417494|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-13|2016-05-27|||July 2011||2011-07-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|September 2014|Actual|2014-09-01||Interventional|||1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer|Evaluation of Bevacizumab Combined With First Line Chemotherapy in Patients Aged 75 and Over Suffering From Metastatic Colorectal Adenocarcinoma. Phase II Randomized - Intergroup Trial: FFCD, FNCLCC, GERICO|Completed||Phase 2|102|Actual|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||||2017-10-11 03:55:18.971577|2017-10-11 03:55:18.971577
NCT01417481|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-10-30|2014-09-09||March 2012||2012-03-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||The total number of patiens was fewer than planned mainly because other protocols were running concurrently. The protocolo had to be concluded because some of the researchers finished their participation.|Effect of Glycine in Cystic Fibrosis|Evaluation of the Capability of a Glycine Oral Supplement for Diminishing Bronchial Inflammation in Children With Cystic Fibrosis|Terminated||Phase 2|13|Actual|Instituto Nacional de Enfermedades Respiratorias||2||Some of the researchers finished their participation in the study.|f||||t||||||||||2017-10-11 03:55:19.094203|2017-10-11 03:55:19.094203
NCT01417468|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-13|2012-12-15|||May 2011||2011-05-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|February 2013|Anticipated|2013-02-01||Interventional|CVD||How Well do Patients With Traumatic Brain Injury Learn New Material Using Learning Styles in Online Science Classrooms?|Instructional Design Strategies to Support Adult Patients/Students (Civilian & Military) With Traumatic Brain Injury (TBI).|Unknown status|Active, not recruiting|N/A|30|Anticipated|Center for Vision Development, New Market, Maryland||2|||f||||t||||||||||2017-10-11 03:55:19.969601|2017-10-11 03:55:19.969601
NCT01417455|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2016-02-29|2016-01-03||January 2012||2012-01-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Observational|||Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis|Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis|Completed||N/A|101|Actual|Instituto de Medicina Molecular|||3||f||||f||||||Samples With DNA|"     Blood and bone samples   "|Undecided||2017-10-11 03:55:20.098587|2017-10-11 03:55:20.098587
NCT01417442|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-08-13|||July 2011||2011-07-01|August 2011|2011-08-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||BRAF V600E Mutations In Papillary Thyroid Carcinoma|Association Of Prognosis And BRAF V600E Mutations In Papillary Thyroid Carcinoma|Unknown status|Recruiting|Early Phase 1|150|Anticipated|Bezmialem Vakif University||1|||f||||f||||||||||2017-10-11 03:55:20.838861|2017-10-11 03:55:20.838861
NCT01417429|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-05|2015-07-07|||March 2010||2010-03-01|July 2015|2015-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Galantamine Effects on Nicotine Responses in Smokers|Galantamine Effects on Nicotine Responses in Smokers|Completed||Phase 1|12|Actual|Yale University||2|||f||||t||||||||||2017-10-11 03:55:20.926456|2017-10-11 03:55:20.926456
NCT01417416|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2011-08-15||||||February 2009|2009-02-01||||||||Observational|||Changes in the Permeability of the Blood Brain Barrier and Intestinal Barrier in Humans During Conditions of Stress and Immune Activation: in Vivo Studies||Completed||N/A|||National University Hospital, Singapore|||2||f||||||||||||||2017-10-11 03:55:21.028749|2017-10-11 03:55:21.028749
NCT00000298|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16|||August 1995||1995-08-01|January 1996|1996-01-01||||||||Interventional|||Buprenorphine Combination Tablet Feasibility - 1|Buprenorphine Combination Tablet Feasibility|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.628737|2017-10-11 04:17:43.628737
NCT01417403|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-02-01|||August 2011||2011-08-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases|A Phase 1 Study of Hydroxychloroquine in Patients With Solid Tumors Receiving Radiotherapy for Bone Metastases|Terminated||Phase 1|10|Actual|Virginia Commonwealth University||1||"Recently published data that has shown HCQ to be safe when combined with chemo and or radiation   at even higher doses than what is used in this study."|f||||t||||||||||2017-10-11 03:55:21.081348|2017-10-11 03:55:21.081348
NCT01417390|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2014-03-06|||November 2011||2011-11-01|March 2014|2014-03-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma|Randomized Phase Ⅱ Trial of Induction Chemotherapy Using Gemcitabine and Cisplatin in Concurrence With Intensity-modulated Radiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2|80|Anticipated|First People's Hospital of Foshan||2|||f||||t||||||||||2017-10-11 03:55:21.18092|2017-10-11 03:55:21.18092
NCT01417377|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-06-15|2015-09-24||May 31, 2010|Actual|2010-05-31|May 2017|2017-05-01|March 31, 2012|Actual|2012-03-31|March 31, 2012|Actual|2012-03-31||Observational||Intent-to-treat (ITT) analysis set included all participants who were enrolled in the study. Age (continuous) data were reported only for treated participants.|An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Anemic Patients With Chronic Kidney Disease (NORM)|Non-Interventional Study to Document the Efficacy in Routine Clinical Practice of Mircera in Pakistan (NORM)|Completed||N/A|22|Actual|Hoffmann-La Roche|As none of the enrolled participants in the study achieved the endpoint of maintaining Hb level between 11-12 g/dL during the final 2 months of study, therefore efficacy parameters were not analyzed.||1||f||||||||||||||2017-10-11 03:55:21.310942|2017-10-11 03:55:21.310942
NCT01417364|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2015-09-30|||January 2016||2016-01-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||The Effects of Long Term Cyclic Testosterone Administration on Muscle Function and Bone in Older Men|The Effects of Long Term Cyclic Testosterone Administration on Muscle Function and Bone in Older Men|Withdrawn||Phase 4|0|Actual|The University of Texas Medical Branch, Galveston||3||Unable to identify any qualifying subjects willing to enroll into this study.|f||||t||||||||||2017-10-11 03:55:21.542627|2017-10-11 03:55:21.542627
NCT01417351|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2013-07-22|||August 2010||2010-08-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effects of Vitamin D Supplementation During Pregnancy on Clinical Outcomes and Immune Function|Assessment of Inflammatory Markers and Pregnancy Outcomes in Vitamin D-Supplemented Women at Risk of Vitamin D Deficiency: A Double-Blind, Randomized Controlled Trial|Completed||N/A|60|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 03:55:21.648492|2017-10-11 03:55:21.648492
NCT01417338|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-06-07|||August 2009||2009-08-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Registry for Pulmonary Hypertension in China|National, Prospective, Multicenter,Observational Registry Study on Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension in China|Recruiting||N/A|3079|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t||||||||||2017-10-11 03:55:21.742592|2017-10-11 03:55:21.742592
NCT01417325|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-07-27|||January 2010||2010-01-01|July 2015|2015-07-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|BJPCI Registry||Beijing Percutaneous Coronary Intervention Registry|A Registry Study of Percutaneous Coronary Intervention Treatment in Beijing Area of P.R. China|Recruiting||N/A|700000|Anticipated|Chinese Academy of Medical Sciences, Fuwai Hospital|||1||f||||t||||||||||2017-10-11 03:55:21.846169|2017-10-11 03:55:21.846169
NCT01417312|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-08-01|||July 2011||2011-07-01|August 2017|2017-08-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients||Completed||N/A|20|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:55:21.90709|2017-10-11 03:55:21.90709
NCT01417299|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2015-09-20|||October 2011||2011-10-01|August 2011|2011-08-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|CVS||The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements||Withdrawn||Phase 1/Phase 2|0|Actual|Hadassah Medical Organization||2||This record is an additional copy of the study listed above|f||||f||||||||||2017-10-11 03:55:21.982101|2017-10-11 03:55:21.982101
NCT01417286|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-09-21|||December 2010||2010-12-01|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer|Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial|Active, not recruiting||Phase 2|69|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-11 03:55:22.050544|2017-10-11 03:55:22.050544
NCT01417273|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-17|2011-08-12|||February 2010||2010-02-01|August 2011|2011-08-01|August 2013|Anticipated|2013-08-01|February 2013|Anticipated|2013-02-01||Interventional|MS||Impact of Vitamin A on Multiple Sclerosis (MS)|Impact of Vitamin A Supplementation on Disease Activity and Progression in Multiple Sclerotic (MS) Patients|Unknown status|Enrolling by invitation|Phase 4|100|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:55:22.134036|2017-10-11 03:55:22.134036
NCT01417260|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-04-10|||August 2011||2011-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Effects of Breast Feeding on Post-Cesarean and Post-Vaginal Delivery Pain|Effects of Breast Feeding on Post-Cesarean and Post-Vaginal Delivery Pain|Completed||N/A|130|Anticipated|Stanford University|||3||f||||||||||||||2017-10-11 03:55:22.224379|2017-10-11 03:55:22.224379
NCT01417247|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-07-14|||August 2011|Actual|2011-08-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Renal Sympathetic Modification in Patients With Metabolic Syndrome|Renal Sympathetic Modification in Patients With Metabolic Syndrome.|Recruiting||N/A|200|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||||2017-10-11 03:55:22.298568|2017-10-11 03:55:22.298568
NCT01417234|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-12-11|||June 2011||2011-06-01|December 2012|2012-12-01||||February 2013|Anticipated|2013-02-01||Observational|||Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds|Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds|Unknown status|Active, not recruiting|N/A|30|Anticipated|Spiracur, Inc.|||1||f||||f||||||||||2017-10-11 03:55:22.381594|2017-10-11 03:55:22.381594
NCT01417221|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-07-13|||August 2011|Actual|2011-08-01|July 2017|2017-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Renal Sympathetic Modification in Patients With Essential Hypertension|Renal Sympathetic Modification in Patients With Essential Hypertension|Recruiting||N/A|200|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||||2017-10-11 03:55:22.452235|2017-10-11 03:55:22.452235
NCT01417208|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-12-11|||June 2011||2011-06-01|December 2012|2012-12-01||||December 2012|Anticipated|2012-12-01||Observational|||Clinical Evaluation of the SNaP Wound Care System in Promoting Healing in Chronic Wounds|Clinical Evaluation of the SNaP Wound Care System in Promoting Healing in Chronic Wounds|Unknown status|Active, not recruiting|N/A|45|Anticipated|Spiracur, Inc.|||1||f||||f||||||||||2017-10-11 03:55:22.54141|2017-10-11 03:55:22.54141
NCT01417195|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-05-06|2014-03-20|2013-01-08|July 2011||2011-07-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|COMBINE||Menopur Mixed Protocol|A Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Combination of Menopur® and Bravelle® With Menopur® Alone in Subjects Undergoing Assisted Reproductive Technology (ART)|Completed||Phase 4|122|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:55:22.620953|2017-10-11 03:55:22.620953
NCT01417182|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-08|2014-06-16|||September 2010||2010-09-01|June 2014|2014-06-01||||September 2014|Anticipated|2014-09-01||Interventional|||Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer|Phase 1 Biodistribution and Pharmacokinetic Study of 18F-DCFBC PSMA Based PET in Patients With Advanced Prostate Cancer|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:55:23.509316|2017-10-11 03:55:23.509316
NCT01417169|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-07-11|||August 2011||2011-08-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation|Efficacy and Safety in Micafungin Sodium for Prophylaxis Against Invasive Fungal Disease During Neutropenia in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|112|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 03:55:23.605423|2017-10-11 03:55:23.605423
NCT01417156|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-15|2017-01-13|2016-10-25||September 2011||2011-09-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||Treated set (TS): This analysis set included all patients who were given study medication and were documented to have taken at least one dose of the trial medication.|Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)|A Phase II Open Label, Follow up Study to Investigate the Long Term Tolerability and Safety of Oral BIBF 1120 on Top of Pirfenidone in Japanese Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 2|20|Actual|Boehringer Ingelheim|Annual ROD in FVC results to be interpreted with caution & along with descriptive statistics as inferences used might not be valid as suggested by skewed distribution of data thus Absolute Change from baseline in FVC over time has been defined.|1|||f||||||||||||||2017-10-11 03:55:23.706167|2017-10-11 03:55:23.706167
NCT01417143|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-11-11|||September 2011||2011-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|December 2013|Actual|2013-12-01||Interventional|||Dovitinib in Adenoid Cystic Carcinoma|Phase II Study of TKI258 (Dovitinib) Monotherapy in Patients With Unresectable Adenoid Cystic Carcinoma|Completed||Phase 2|33|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 03:55:24.035854|2017-10-11 03:55:24.035854
NCT01417117|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-04-24|||September 2011||2011-09-01|April 2017|2017-04-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|||Effect of Ischemic Strokes on Recovery From Intracerebral Hemorrhages|The Effect of Diffusion Weighted Imaging Abnormalities on Outcomes in Patients With Spontaneous Intracerebral Hemorrhage|Recruiting||N/A|130|Anticipated|Rush University Medical Center|||1||f||||f||||||||No||2017-10-11 03:55:24.214574|2017-10-11 03:55:24.214574
NCT01417104|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-05-09|2012-10-29||October 2009||2009-10-01|May 2017|2017-05-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|ALPINE||Aliskiren Effect on Aortic Plaque Progression|Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double Blind Placebo Controlled Trial|Terminated||Phase 2/Phase 3|71|Actual|Ohio State University||2||Safety concerns with approved medication identified in an unrelated trial|f||||f||||||||||2017-10-11 03:55:24.305945|2017-10-11 03:55:24.305945
NCT01417091|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2015-01-02|||June 2011||2011-06-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta|A Randomized, Open Label Intra-patient Dose Escalation Study With an Untreated Reference Group to Evaluate Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Infusions of BPS804 in Adults With Moderate Osteogenesis Imperfecta|Completed||Phase 2|10|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:55:24.636776|2017-10-11 03:55:24.636776
NCT01417078|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-02-28|2016-12-16|2014-01-27|September 2011||2011-09-01|February 2017|2017-02-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional||Safety Population Number (N)=31 Pharmacokinetic Population N=30|A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode|An Open-Label Study to Determine the Pharmacokinetics of a Single Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode for Which Acute Treatment With a Benzodiazepine is Clinically Indicated|Completed||Phase 2|31|Actual|Acorda Therapeutics||1|||f||||f||||||||||2017-10-11 03:55:24.773489|2017-10-11 03:55:24.773489
NCT01417065|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2014-06-20|||August 2010||2010-08-01|June 2014|2014-06-01||||June 2014|Actual|2014-06-01||Interventional|||Temsirolimus In Phase 0|Phase 0 Trial Evaluating the Effect of Temsirolimus on Known Pharmacodynamic Targets|Completed||Early Phase 1|15|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:55:25.146147|2017-10-11 03:55:25.146147
NCT01417052|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-08-01|||September 2011||2011-09-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis|A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Determine the Safety and Efficacy of Daily Orally Administered LX3305 in Subjects With Active Rheumatoid Arthritis (RA)|Completed||Phase 1|10|Actual|Lexicon Pharmaceuticals||10|||f||||f||||||||||2017-10-11 03:55:25.257549|2017-10-11 03:55:25.257549
NCT01417026|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-02-10|2016-09-02||September 2011||2011-09-01|February 2017|2017-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Intranasal Oxytocin and Learning in Autism|Promoting Social Perceptual Learning With Oxytocin in Autism|Completed||Phase 2|36|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 03:55:25.38243|2017-10-11 03:55:25.38243
NCT01417013|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-02-06|||July 2011||2011-07-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time|A Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time|Withdrawn||N/A|0|Actual|Alcon Research||2||Management Decision|f||||f||||||||||2017-10-11 03:55:25.787368|2017-10-11 03:55:25.787368
NCT01417000|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-04-27|||September 2011||2011-09-01|April 2017|2017-04-01|October 2016|Actual|2016-10-01|September 2012|Actual|2012-09-01||Interventional|||Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer|A Phase 2, Randomized, Multicenter, Open-Label Study of the Efficacy and Immune Response of the Sequential Administration of GVAX Pancreas Vaccine Alone or Followed by CRS-207 in Adults With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|93|Actual|Aduro Biotech, Inc.||2|||f||||t||||||||||2017-10-11 03:55:25.887394|2017-10-11 03:55:25.887394
NCT01416987|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-03-03|||August 2011||2011-08-01|March 2017|2017-03-01|February 18, 2017|Actual|2017-02-18|February 18, 2017|Actual|2017-02-18||Observational|||A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)|A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)|Completed||N/A|542|Actual|Merck KGaA|||1||f||||||||||||||2017-10-11 03:55:26.02059|2017-10-11 03:55:26.02059
NCT01416974|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-09-05|||November 2011||2011-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab|A Phase I Trial of Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab|Active, not recruiting||Phase 1|18|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:55:26.153462|2017-10-11 03:55:26.153462
NCT01416961|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-08-20|||August 2011||2011-08-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)|Phase I Study of High Linear Energy Transfer (Neutron) Therapy Followed by Concurrent Chemotherapy and Standard Photon Thoracic RT (TRT) in Stage III NSCLC (Non-Small Cell Lung Cancer) Patients|Withdrawn||Phase 1|0|Actual|Barbara Ann Karmanos Cancer Institute||1||Neutron therapy has become unavailable|f||||t||||||||||2017-10-11 03:55:26.260074|2017-10-11 03:55:26.260074
NCT01416948|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2013-04-24|||August 2011||2011-08-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CREATE||Cognitive REmediation After Trauma Exposure Trial = CREATE Trial|Randomized Controlled Trial of Galantamine, Methylphenidate, and Placebo for the Treatment of Cognitive Symptoms in Patients With Traumatic Brain Injury (TBI) and/or Posttraumatic Stress Disorder (PTSD)|Terminated||Phase 2|32|Actual|INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium||3||"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the   end of the grant."|f||||t||||||||||2017-10-11 03:55:26.358937|2017-10-11 03:55:26.358937
NCT01416935|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-21|2016-05-24|||January 2011||2011-01-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|January 2015|Actual|2015-01-01||Interventional|||Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation|Anti-Arrhythmic Medication (Amiodarone) Post Surgical Ablation for Atrial Fibrillation - Is it Necessary?|Active, not recruiting||N/A|186|Anticipated|Inova Health Care Services||2|||f||||f||||||||||2017-10-11 03:55:26.480316|2017-10-11 03:55:26.480316
NCT01416922|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-08-12|||June 2009||2009-06-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|||||Observational|||oncoFISH Cervical Test for Detection of 3q26 Region Gain|The oncoFISH Cervical Test for Detection of 3q26 Region Gain|Unknown status|Enrolling by invitation|N/A|1100|Anticipated|Ikonisys, Inc.|||1||f||||t||||||||||2017-10-11 03:55:26.552843|2017-10-11 03:55:26.552843
NCT01416909|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-02-21|||November 2008||2008-11-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional|||Managing Medication-induced Constipation in Cancer: A Clinical Trial|Managing Medication-induced Constipation in Cancer: A Clinical Trial|Completed||N/A|601|Actual|H. Lee Moffitt Cancer Center and Research Institute||5|||f||||f||||||||||2017-10-11 03:55:26.647751|2017-10-11 03:55:26.647751
NCT01416896|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-12|||August 2011||2011-08-01|August 2011|2011-08-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|BME-1||New Needle for Two-Needle Hemodialysis|New Needle for Two-Needle Hemodialysis|Unknown status|Recruiting|Phase 2/Phase 3|70|Anticipated|Biomedical Enterprises Inc||2|||f||||t||||||||||2017-10-11 03:55:26.753011|2017-10-11 03:55:26.753011
NCT01416883|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-08-12|||July 2010||2010-07-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Oral Mucosal Absorption Study of Bicalutamide New Formulation|Oral Mucosal Absorption Study of ICI176,334-1 (Bicalutamide New Formulation) in Japanese Healthy Male Subjects|Terminated||Phase 1|8|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 03:55:26.876851|2017-10-11 03:55:26.876851
NCT01416870|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-01-10|||July 2010||2010-07-01|January 2012|2012-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Bioequivalence of Bicalutamide New Formulation in Japan|Bioequivalence Study of ICI176,334-1 (Bicalutamide New Formulation) in Japanese Healthy Male Subjects - Evaluation of Bioequivalence of ICI176,334-1 and Casodex Tablet (80mg)|Terminated||Phase 1|102|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 03:55:27.061599|2017-10-11 03:55:27.061599
NCT01416857|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-07-08|||August 2011||2011-08-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Emergency Department (ED) Disability Diagnostic Tool|ED Disability Diagnostic Tool: a Health Information Technology Feasibility Study|Completed||N/A|635|Actual|Yale University||2|||f||||f||||||||||2017-10-11 03:55:27.139563|2017-10-11 03:55:27.139563
NCT01416844|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2013-03-06|||September 2012||2012-09-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study of Immune Responses in Patients With Metastatic Melanoma|Phase II Exploratory Study of Immune Responses in Patients With Metastatic Melanoma Treated With Mouse Monoclonal Anti-OX40|Withdrawn||Phase 2|0|Actual|Providence Health & Services||1||Change in the development plan for the anti-OX40 antibody.|f||||f||||||||||2017-10-11 03:55:27.237941|2017-10-11 03:55:27.237941
NCT01416831|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-09-18|||July 2011||2011-07-01|September 2017|2017-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|SBRT/IL-2||Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.|Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Melanoma|Active, not recruiting||Phase 2|43|Actual|Providence Health & Services||2|||f||||f||||||||||2017-10-11 03:55:27.30646|2017-10-11 03:55:27.30646
NCT01416805|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-05-10|||August 2011||2011-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers|Utilizing Health Information Technology to Improve Health Care Quality: Implementation of a Computerized Cognitive Behavioral Therapy Protocol for Childhood Anxiety|Completed||Phase 3|188|Anticipated|University of South Florida||2|||f||||f||||||||||2017-10-11 03:55:27.514015|2017-10-11 03:55:27.514015
NCT01416792|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-03-29|||March 2011||2011-03-01|September 2011|2011-09-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Centrifugation vs. Multiple-pass Hemofiltration of the Residual Cardiopulmonary Bypass Volume|Outcomes & Biochemical Parameters Following Cardiac Surgery: Effects of Transfusion of Residual Blood Using Centrifugation and Multiple-Pass Hemofiltration|Completed||N/A|61|Actual|University of Saskatchewan||1|||f||||f||||||||||2017-10-11 03:55:27.625132|2017-10-11 03:55:27.625132
NCT01416779|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-07|2012-07-15|||February 2011||2011-02-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Finding Balance Writing Intervention for Older Bereaved Caregivers|Finding Balance: The Experience of Hope for Bereaved Caregivers of Palliative Cancer Patients|Completed||N/A|23|Actual|University of Saskatchewan||2|||f||||t||||||||||2017-10-11 03:55:27.720157|2017-10-11 03:55:27.720157
NCT01416766|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-09-15|||August 2011||2011-08-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|October 2014|Actual|2014-10-01||Interventional|CONDUIT-HID||CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes|CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes|Completed||N/A|196|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 03:55:27.818311|2017-10-11 03:55:27.818311
NCT01416753|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-08-30|||September 2011||2011-09-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|BVM-Reg||Response Options to Blood Volume Monitoring in Fluid Overloaded Hemodialysis Patients|A Randomized Controlled Clinical Trial Comparing, in Fluid-Overloaded Hemodialysis Patients, Three Strategies of Fluid Removal: Regulation of Ultrafiltration and Dialysate Conductivity, Regulation of Ultrafiltration and Temperature, and Standard Hemodialysis|Completed||N/A|64|Actual|Medical University of Vienna||3|||f||||f||||||||||2017-10-11 03:55:27.950158|2017-10-11 03:55:27.950158
NCT01416740|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-03-24|||December 2009||2009-12-01|August 2011|2011-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation|A Prospective Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center||1||difficulty with recruitment, PI left the institution|f||||f||||||||||2017-10-11 03:55:28.055159|2017-10-11 03:55:28.055159
NCT01416727|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-09-06|||August 2011||2011-08-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|September 2011|Anticipated|2011-09-01||Interventional|EPIC-OSkER||Simulation Training vs Workplace-Based Supervision in Psychiatry|A Randomised Trial of Simulation Training vs Workplace-Based Supervision for Junior Doctors in Psychiatry|Unknown status|Active, not recruiting|N/A|48|Anticipated|King's College London||2|||f||||f||||||||||2017-10-11 03:55:28.172449|2017-10-11 03:55:28.172449
NCT01416714|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-20|2017-07-24|||July 2, 2008|Actual|2008-07-02|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy|Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy|Recruiting||N/A|1000|Anticipated|University of Chicago|||10||f||||t||||||Samples With DNA|"     blood, tissue, DNA   "|||2017-10-11 03:55:28.264409|2017-10-11 03:55:28.264409
NCT01416701|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2013-04-08|||September 2011||2011-09-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Vitamin D and Chronic Obstructive Lung Disease|Vitamin D and COPD. A Randomised, Double-blind, Placebo-controlled Trial of the Effect of Vitamin D on Withdrawal From Pulmonary Rehabilitation and Exercise Endurance|Withdrawn||Phase 4|0|Actual|Hvidovre University Hospital||2||"It was not possible to enroll the planned amount of subjects. Many patients with chronic   obstructive pulmonary disease already took large doses of vitamin D."|f||||t||||||||||2017-10-11 03:55:28.373642|2017-10-11 03:55:28.373642
NCT01416688|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-02-16|||November 2011||2011-11-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride|S1013: A Prospective Study of Epidermal Growth Factor Receptor (HER-1/EGFR) Inhibitor-Induced Dermatologic Toxicity: Validation of the Functional Assessment of Cancer Therapy-EGFRI 18(FACT-EGFRI 18) Questionnaire for EGFRI-Induced Skin Toxicities|Active, not recruiting||N/A|140|Anticipated|Southwest Oncology Group|||1||f||||t||||||||||2017-10-11 03:55:28.521557|2017-10-11 03:55:28.521557
NCT01416675|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2014-06-05|||June 2011||2011-06-01|June 2014|2014-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|DIPI-ICU||Delirium Assessment in the Pediatric Intensive Care Unit|Delirium Assessment in the Pediatric Intensive Care Unit|Completed||N/A|73|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 03:55:28.905749|2017-10-11 03:55:28.905749
NCT01416662|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2016-05-27|||June 2011||2011-06-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|January 2015|Actual|2015-01-01||Interventional|||Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery|Pharmacogenetics of Gemcitabine: Study of the Impact of Genetic Polymorphism of Cytidine Deaminase (CDA) on Toxicity in Resected Pancreatic Adenocarcinomas|Completed||Phase 2|120|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||f||||||||||2017-10-11 03:55:28.983258|2017-10-11 03:55:28.983258
NCT01416649|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-09-01|||February 2011||2011-02-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Impact of Exenatide on Sleep Duration|Impact of Exenatide on Sleep Duration and Quality in Type 2 Diabetes|Recruiting||N/A|12|Anticipated|University of Chicago|||1||f||||f||||||||||2017-10-11 03:55:29.085973|2017-10-11 03:55:29.085973
NCT01416636|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-10-03|||March 2009||2009-03-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CTREPH||Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)|A Double Blind Controlled Clinical Study to Investigate the Efficacy and Tolerability of Subcutaneous Treprostinil Sodium in Patients With Severe Non-operable Chronic Thromboembolic Pulmonary Hypertension (CTREPH)|Active, not recruiting||Phase 3|100|Anticipated|SciPharm SàRL||2|||f||||f||||||||||2017-10-11 03:55:29.191784|2017-10-11 03:55:29.191784
NCT01416623|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-12-20|||September 2010||2010-09-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies|A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies|Terminated||Phase 1|44|Actual|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||||2017-10-11 03:55:29.290783|2017-10-11 03:55:29.290783
NCT01416610|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-03-10|2015-11-04||April 2010||2010-04-01|March 2017|2017-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|PEGHOPE||An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy|A Prospective, Observational, Multicenter Non-interventional Trial Examining Efficacy of Combination Therapy With PEGASYS® (Peginterferon Alfa-2a 40KD) Plus COPEGUS® (Ribavirin) in Patients With Chronic Hepatitis C, Genotype 2, 3, 1 or 4, Undergoing an Opioid Maintenance-Therapy With Special Focus on Patient Compliance and Quality of Life|Completed||N/A|88|Actual|Hoffmann-La Roche|||1||f||||f||||||||||2017-10-11 03:55:29.394716|2017-10-11 03:55:29.394716
NCT01416597|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2012-12-13|||August 2011||2011-08-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains|Effect of Influenza Vaccine Against Mismatched Strains: Systematic Review|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:55:29.847127|2017-10-11 03:55:29.847127
NCT01416584|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2017-08-11|2016-09-02||October 2008||2008-10-01|August 2017|2017-08-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Interventional|||A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment|A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment|Completed||N/A|98|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-10-11 03:55:29.938767|2017-10-11 03:55:29.938767
NCT01416571|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2016-09-22|2013-12-19|2012-07-26|August 2011||2011-08-01|September 2016|2016-09-01|September 2012|Actual|2012-09-01|November 2011|Actual|2011-11-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults|Immunogenicity and Safety Study of GSK Biologicals' Monovalent Pandemic H5N1 Vaccine 1557484A in Adults Aged 18 - 64 Years|Completed||Phase 2|78|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:55:30.725743|2017-10-11 03:55:30.725743
NCT01416558|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-05-21|||July 2011||2011-07-01|May 2013|2013-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany)|A Multicenter Non-randomized Phase II Study to Evaluate Nab-paclitaxel in Metastatic Brest Cancer Patients Failing a Solvent Based Taxane as (Neo-)Adjuvant Treatment (Tiffany)|Terminated||Phase 2|66|Anticipated|German Breast Group||1||Study was terminated because of extrem low recruitment|f||||t||||||||||2017-10-11 03:55:31.950879|2017-10-11 03:55:31.950879
NCT01416545|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-12|||January 2010||2010-01-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|CETICARP||Children Education and Cardiovascular Risk Reduction in Their Parents|Children Education as Therapeutic Instrument for Cardiovascular Risk Reduction in Their Parents|Completed||N/A|520|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-10-11 03:55:32.059894|2017-10-11 03:55:32.059894
NCT01416532|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-08-17|||January 2006||2006-01-01|July 2011|2011-07-01|December 2015|Anticipated|2015-12-01|December 2007|Actual|2007-12-01||Observational|ESCORT||Evaluation of Subclinical COronary Atherosclerosis for Risk Stratification Using Coronary Computed Tomography (CT) Angiography|Prognostic Value of Coronary CT Angiography in Relation to Evaluation of Subclinical Coronary Atherosclerosis for Risk Stratification in Asymptomatic Individuals From ESCORT Study|Unknown status|Recruiting|N/A|5000|Anticipated|Seoul National University Bundang Hospital|||1||f||||t||||||||||2017-10-11 03:55:32.181961|2017-10-11 03:55:32.181961
NCT01416519|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2014-11-17|||September 2011||2011-09-01|November 2014|2014-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation|Incentive Spirometry Decreases Respiratory Complications After Myocardial Revascularization|Completed||N/A|200|Actual|Santa Casa de Votuporanga||2|||f||||t||||||||||2017-10-11 03:55:32.271694|2017-10-11 03:55:32.271694
NCT01416506|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2013-11-04|||September 2010||2010-09-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Observational|||Community-Acquired Pneumonia (CAP) Surveillance|Community-Acquired Pneumonia (CAP) Mycoplasma Surveillance|Completed||N/A|560|Actual|Bayer|||1||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 03:55:32.39626|2017-10-11 03:55:32.39626
NCT00000319|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16|||June 1996||1996-06-01|June 1996|1996-06-01||||||||Interventional|||Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2|Buprenorphine Maintenance Dose Schedule and Treatment Setting|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:45.622338|2017-10-11 04:17:45.622338
NCT01416493|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-03-09|||May 2011||2011-05-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ALS-003-2008||Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis|An OPEN LABEL Phase II Safety Study of Bovine Intestinal Alkaline Phosphatase (bIAP), an Inflammation Modulating Moiety, in RA Patients|Completed||Phase 1/Phase 2|6|Actual|Alloksys Life Sciences B.V.||1|||f||||t||||||||||2017-10-11 03:55:32.515418|2017-10-11 03:55:32.515418
NCT01416480|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-12|2011-08-12|||May 2010||2010-05-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|||"Clinical Trial to Evaluate the Safety and Efficacy of Theobromine Capsule as an Antitussive in Acute Cougher"|"Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of Theobromine Capsule 300mg as an Antitussive Agent in Acute Cough Patients."|Completed||Phase 3|332|Actual|Ahn-Gook Pharmaceuticals Co.,Ltd||2|||f||||t||||||||||2017-10-11 03:55:32.651933|2017-10-11 03:55:32.651933
NCT01416467|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-09-18|||February 8, 2012|Actual|2012-02-08|September 2017|2017-09-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|CPPGAL||Characterization of the Patient Population With Galactosialidosis|Characterization of the Patient Population With Galactosialidosis|Active, not recruiting||N/A|3|Actual|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     Blood for PPCA gene mutation and AAV2 and AAV8 antibody titer   "|||2017-10-11 03:55:32.795547|2017-10-11 03:55:32.795547
NCT01416454|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-03-20|||October 2010||2010-10-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|April 2012|Actual|2012-04-01||Observational|||Thromboelastography to Assess Age-Related Coagulation Differences in Patients Undergoing Cesarean Delivery|Thromboelastography to Assess Age-Related Coagulation Differences in Patients Undergoing Elective Cesarean Delivery.|Completed||N/A|46|Actual|Stanford University|||2||f||||f||||||||||2017-10-11 03:55:32.880938|2017-10-11 03:55:32.880938
NCT01416441|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-03-25||2015-03-25|August 2011||2011-08-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Safety & Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder|Completed||Phase 3|170|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 03:55:32.989677|2017-10-11 03:55:32.989677
NCT01416428|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-07-14|||September 2011||2011-09-01|July 2017|2017-07-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies|Phase 1b/2, Multicenter, Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies|Active, not recruiting||Phase 1/Phase 2|364|Anticipated|Amgen||2|||f||||t||||||||||2017-10-11 03:55:33.27081|2017-10-11 03:55:33.27081
NCT01416415|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-09-26|||August 2011||2011-08-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Glaucoma Eye Drop Instillation: Impact of Education|Glaucoma Eye Drop Instillation: Impact of Education|Active, not recruiting||N/A|100|Anticipated|Northwestern University||2|||f||||f||||||||||2017-10-11 03:55:33.405101|2017-10-11 03:55:33.405101
NCT01416402|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-03-09||2015-02-19|August 2011||2011-08-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients|A Phase 2, Open-label Study to Evaluate the Safety and Efficacy of Arhalofenate (MBX-102) in Combination With Febuxostat for the Treatment of Hyperuricemia in Patients With Gout|Completed||Phase 2|27|Actual|CymaBay Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 03:55:33.51656|2017-10-11 03:55:33.51656
NCT01416376|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-06-13|||August 30, 2011|Actual|2011-08-30|June 2017|2017-06-01|December 12, 2011|Actual|2011-12-12|December 12, 2011|Actual|2011-12-12||Interventional|||Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation|A Double Blind, Placebo Controlled, Phase I Dose-ranging Study to Evaluate the Activity of SRT2379 on Endotoxin Induced Inflammatory Response in Healthy Male Subjects|Completed||Phase 1|39|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:55:33.781702|2017-10-11 03:55:33.781702
NCT01416363|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-07-05|||May 20, 2011|Actual|2011-05-20|July 2017|2017-07-01|September 17, 2011|Actual|2011-09-17|September 17, 2011|Actual|2011-09-17||Interventional|||Healthy Volunteer Study Using 3 Different Formulations of Firategrast|A Single/Repeat Dose Study With Three Oral Formulations of Firategrast (Immediate Release Tablet, Modified Release Tablet, and Naso-gastric Infusion) in Healthy Male Volunteers|Completed||Phase 1|38|Actual|GlaxoSmithKline||9|||f||||f||||||||||2017-10-11 03:55:33.884074|2017-10-11 03:55:33.884074
NCT01416350|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-07-18|||March 30, 2011|Actual|2011-03-30|July 2017|2017-07-01|May 12, 2011|Actual|2011-05-12|May 12, 2011|Actual|2011-05-12||Interventional|||A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin|A Single and Repeat Dose Pharmacokinetics/ Pharmacodynamics (PK/PD) Study to Characterise theBiomarker Response in Healthy Subjects Treated With the AntiinflammatoryMacrolide Azithromycin|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:55:33.998161|2017-10-11 03:55:33.998161
NCT01416337|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2012-04-12|||June 2011||2011-06-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Absolute Bioavialability of GSK1120212|Determination of the Absolute Bioavailability of GSK1120212 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microdose of GSK1120212 in Subjects With Solid Tumors|Completed||Phase 1|4|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:55:34.074479|2017-10-11 03:55:34.074479
NCT01416324|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-19|||June 15, 2011|Actual|2011-06-15|June 2017|2017-06-01|September 9, 2011|Actual|2011-09-09|September 9, 2011|Actual|2011-09-09||Interventional|||First Time in Human Study Using GSK2330672|A First Time in Human, Single Blind, Randomized, Placebo-controlled,Dose Escalating Crossover Study to Evaluate the Safety,Tolerability, Pharmacokinetic and Pharmacodynamic Parameters of Single Doses of GSK2330672 in Healthy Volunteers|Completed||Phase 1|17|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:55:34.159669|2017-10-11 03:55:34.159669
NCT01416311|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-03-28|||December 2010||2010-12-01|March 2017|2017-03-01|December 27, 2018|Anticipated|2018-12-27|December 27, 2018|Anticipated|2018-12-27||Observational|||Drug Use Investigation for REVOLADE (ITP)|Drug Use Investigation for REVOLADE (Chronic Idiopathic Thrombocytopenic Purpura)|Active, not recruiting||N/A|1000|Anticipated|Novartis|||1||f||||f||||||||||2017-10-11 03:55:34.282726|2017-10-11 03:55:34.282726
NCT01416298|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2012-08-01|||August 2011||2011-08-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Use of Biomarkers to Optimize Fluid Dosing,CRRT Initiation and Discontinuation in Pediatric ICU Patients With AKI|Use of Neutrophil Gelatinase-Associated Lipocalin (NGAL) to Optimize Fluid Dosing, Continuous Renal Replacement Therapy (CRRT) Initiation and Discontinuation in Critically Ill Children With Acute Kidney Injury (AKI)|Unknown status|Recruiting|N/A|100|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-10-11 03:55:34.362478|2017-10-11 03:55:34.362478
NCT01416285|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-07-26|||June 2009||2009-06-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Impact of Heart Failure Center Program on Cardiac Outcomes in Patients With Heart Failure|The Impact of Heart Failure Center Program on The Progression of Biomarkers, Changes in Life Quality, Left Ventricular Ejection Fraction, and Cardiac Outcomes in Patients With Congestive Heart Failure|Recruiting||N/A|300|Anticipated|Chang Gung Memorial Hospital|||2||f||||t||||||Samples Without DNA|"     At baseline and every 6-month visits, 3 ml of venous blood will be collected. At baseline and     each 6-month visit, urinary albumin amount will be measured in the core lab in the hospital.   "|No||2017-10-11 03:55:34.466908|2017-10-11 03:55:34.466908
NCT01416272|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-11-18|2014-11-18||April 2011||2011-04-01|November 2014|2014-11-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses|Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses|Terminated||N/A|12|Actual|Bausch & Lomb Incorporated||1||Study was terminated due to a business decision to cancel the entire project.|f||||f||||||||||2017-10-11 03:55:34.5583|2017-10-11 03:55:34.5583
NCT01416259|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-08-03|||July 2011||2011-07-01|August 2015|2015-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin|A Randomized, Placebo-Controlled, Four-Period Crossover Definitive QT Study Of The Effects of APF530 Exposure, High-Dose IV Granisetron and Moxifloxacin on QTc Prolongation|Completed||Phase 1|56|Actual|Heron Therapeutics|||1||f||||f||||||||||2017-10-11 03:55:34.756828|2017-10-11 03:55:34.756828
NCT01416246|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-04-28|||August 2011||2011-08-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant|Pilot Trial of Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant|Completed||N/A|26|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:55:34.848461|2017-10-11 03:55:34.848461
NCT01416233|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2017-03-08|||September 2010||2010-09-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Autologous Fat Augmentation of Orbital Volume Using a Closed Cannula Technique|Autologous Fat Augmentation of Orbital Volume Using a Closed Cannula Technique|Recruiting||N/A|10|Anticipated|Fox, Donald Munro, M.D., P.C.||1|||f||||t||||||||||2017-10-11 03:55:35.058814|2017-10-11 03:55:35.058814
NCT01416220|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-02-12|||September 2011||2011-09-01|February 2015|2015-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Lithium Versus Paroxetine in Major Depression|A Randomized, Open-label, Trial of Lithium Versus Paroxetine in Subjects With Major Depression Who Have a Family History of Bipolar Disorder or Completed Suicide|Completed||Phase 4|2|Actual|Nova Scotia Health Authority||2|||f||||t||||||||||2017-10-11 03:55:35.144065|2017-10-11 03:55:35.144065
NCT01416207|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-11-03|||August 2011||2011-08-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex® in Chinese Healthy Volunteer Subjects|A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex® in Chinese Healthy Volunteer Subjects|Completed||Phase 1|24|Actual|Biogen||1|||f||||f||||||||||2017-10-11 03:55:35.230556|2017-10-11 03:55:35.230556
NCT01416194|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-09-11|||July 25, 2011|Actual|2011-07-25|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|||Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)|Cohort Study Of Venous Thromboembolism And Other Clinical Endpoints Among Osteoporotic Women Prescribed Bazedoxifene, Bisphosphonates Or Raloxifene In Europe|Active, not recruiting||N/A|10750|Actual|Pfizer|||3||f||||f||||||||||2017-10-11 03:55:35.326376|2017-10-11 03:55:35.326376
NCT01416181|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-08-10|2017-04-13|2016-07-15|September 13, 2011|Actual|2011-09-13|August 2017|2017-08-01|April 13, 2016|Actual|2016-04-13|July 28, 2015|Actual|2015-07-28||Interventional|ASCEND in SPMS|Safety population: all participants who were randomized and received at least 1 infusion of study treatment in Part 1.|A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis, With Optional Open-Label Extension|Terminated||Phase 3|889|Actual|Biogen||2||"The ASCEND Study did not achieve statistical significance on the primary or secondary   endpoints."|f||||t||||||||||2017-10-11 03:55:35.494054|2017-10-11 03:55:35.494054
NCT01416168|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-11-26|||December 2008||2008-12-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|||Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery|Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery|Completed||N/A|15|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-11 03:55:39.781129|2017-10-11 03:55:39.781129
NCT01416155|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-24|2015-12-10|2015-12-10||October 2010||2010-10-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis|A Long-Term, Open-Label, Multicenter, Extension Study to Evaluate Safety and Efficacy of BG00002 in Japanese Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|97|Actual|Biogen||1|||f||||t||||||||||2017-10-11 03:55:39.883558|2017-10-11 03:55:39.883558
NCT01415206|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-05-05|||August 2011||2011-08-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|April 2013|Actual|2013-04-01||Interventional|||The Total Health Study|Extended Care Treatment of Multiple Risk Behaviors in Complex Patients|Unknown status|Active, not recruiting|N/A|250|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:55:58.017827|2017-10-11 03:55:58.017827
NCT01416142|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2013-11-07|2013-02-13||July 2011||2011-07-01|November 2013|2013-11-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional||All Eligible Baseline Participants|A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens|A Study to Evaluate the Product Performance of the PureVision®2 HD Contact Lens|Completed||N/A|63|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 03:55:40.340653|2017-10-11 03:55:40.340653
NCT01416129|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-05-06|2012-10-19||October 2010||2010-10-01|May 2014|2014-05-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Southern Bone & Joint Study - Brimless Sockets|Biomechanical Superiority of Brimless Versus Ischial Ramus Containment (IRC) Sub Atmospheric Transfemoral Interfaces|Completed||Phase 3|10|Actual|University of South Florida||2|||f||||f||||||||||2017-10-11 03:55:40.58402|2017-10-11 03:55:40.58402
NCT01416116|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-01-07|||July 2011||2011-07-01|January 2016|2016-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|LIFT||Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch|Tolerability of QUTENZATM When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study|Completed||Phase 4|122|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-10-11 03:55:40.874598|2017-10-11 03:55:40.874598
NCT01416103|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-02-18|||October 2011||2011-10-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Alcohol and Employment|Alcohol and Employment - a Randomized Controlled Trial|Completed||N/A|113|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 03:55:41.025376|2017-10-11 03:55:41.025376
NCT01416090|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-08-11|||July 2004||2004-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Syndactyly Repair: Comparison of Skin Graft and No Skin Graft Techniques|Syndactyly Repair: Comparison of Skin Graft and No Skin Graft Techniques|Active, not recruiting||N/A|30|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 03:55:41.107354|2017-10-11 03:55:41.107354
NCT01416077|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-12-01|||October 2011||2011-10-01|June 2015|2015-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection|Perioperative Goal Directed Fluid Therapy During Esophageal Resection A Prospective Randomized Controlled Open Multi-centre Trial to Study the Effect on Postoperative Complications|Completed||Phase 4|64|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-11 03:55:41.184998|2017-10-11 03:55:41.184998
NCT01416064|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-04-28||2013-05-22|September 2011||2011-09-01|April 2017|2017-04-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Open-Label, Extension Study to 810P202|Open-Label Extension Study to Evaluate the Safety of Molindone Hydrochloride Extended-Release Tablets as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|78|Actual|Supernus Pharmaceuticals, Inc.||1|||f||||f|t|f||||||||2017-10-11 03:55:41.272712|2017-10-11 03:55:41.272712
NCT01416051|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2015-12-17|||January 2005||2005-01-01|December 2015|2015-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy of Olibra: A 12 Week Controlled Trial|Efficacy of Olibra: A 12 Week Randomized Controlled Trial, and Review of Prior Studies|Completed||Phase 1/Phase 2|82|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 03:55:41.508835|2017-10-11 03:55:41.508835
NCT01416038|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-04-20|||December 2011|Actual|2011-12-01|April 2017|2017-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer|Phase 1-2 Study of an Immunotherapeutic Vaccine, DPX-Survivac With Low Dose Cyclophosphamide in Patients With Surgically Operable or Advanced Stage Ovarian, Fallopian Tube or Peritoneal Cancer|Completed||Phase 1|19|Actual|ImmunoVaccine Technologies, Inc.||3|||f||||t||||||||No||2017-10-11 03:55:41.599657|2017-10-11 03:55:41.599657
NCT01416025|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2016-07-18|2016-04-15||January 2012||2012-01-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|VoriTDM||A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing|A Prospective, Randomized Trial Comparing the Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing|Completed||Phase 4|29|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 03:55:41.720873|2017-10-11 03:55:41.720873
NCT01416012|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2013-04-23|||October 2011||2011-10-01|June 2011|2011-06-01|September 2013|Anticipated|2013-09-01|October 2011|Actual|2011-10-01||Interventional|||Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations|Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations|Unknown status|Recruiting|N/A|180|Anticipated|Centre Hospitalier Universitaire de Nice||4|||f||||f||||||||||2017-10-11 03:55:41.967076|2017-10-11 03:55:41.967076
NCT01415999|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-02-22|||August 2011||2011-08-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|||Cardiovascular Function in Adult Survivors of Childhood Malignancies|Novel Imaging and Circulation Biomarkers for Comprehensive Evaluation of Cardiovascular Function in Adult Survivors of Childhood Malignancies|Unknown status|Recruiting|N/A|150|Anticipated|The University of Hong Kong|||2||f||||f||||||Samples With DNA|"     plasma, serum   "|||2017-10-11 03:55:42.07638|2017-10-11 03:55:42.07638
NCT01415986|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-11-15|2012-05-11||November 2010||2010-11-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|August 2011|Actual|2011-08-01||Interventional|||Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers|Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers - PHASE II PILOT STUDY|Terminated||Phase 2|1|Actual|University of Arkansas|Early termination leading to small numbers of subjects analyzed.|1||"The patient was lost to follow-up and the PI left the institution."|f||||f||||||||||2017-10-11 03:55:42.173465|2017-10-11 03:55:42.173465
NCT01415973|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-01-17|||July 2011||2011-07-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||Nutrient Synergy in Beef and Stimulation of Protein Synthesis in Elderly|Nutrient Synergy in Beef and Stimulation of Protein Synthesis in Elderly|Completed||N/A|20|Actual|University of Arkansas||2|||f||||f||||||||||2017-10-11 03:55:42.37904|2017-10-11 03:55:42.37904
NCT01415960|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-01-19|2015-07-23||September 2011||2011-09-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer|Efficacy and Safety of a New Leuprolide Acetate 22.5 mg Depot Formulation in the Treatment of Prostate Cancer|Completed||Phase 3|163|Actual|GP-Pharm||1|||f||||f||||||||||2017-10-11 03:55:42.470426|2017-10-11 03:55:42.470426
NCT01415947|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2014-12-22|||November 2010||2010-11-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|May 2012|Actual|2012-05-01||Interventional|||V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse|V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse|Terminated||Phase 2|5|Actual|Valtech Cardio Ltd||1||Company business decision|f||||||||||||||2017-10-11 03:55:42.886204|2017-10-11 03:55:42.886204
NCT01415934|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2014-11-19|||May 2011||2011-05-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Statin Discontinuation in Advanced Illness|Multisite Randomized Controlled Trial of Continuing vs. Discontinuing Statins|Completed||N/A|380|Actual|Palliative Care Research Cooperative Group||2|||f||||t||||||||||2017-10-11 03:55:42.972655|2017-10-11 03:55:42.972655
NCT01415921|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-07-27|2016-05-20||October 2011||2011-10-01|July 2017|2017-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|APP-HF||Safety Study of Pyridostigmine in Heart Failure|Augmentation of Parasympathetic Signaling With Pyridostigmine in Heart Failure|Completed||Phase 2|33|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 03:55:43.091147|2017-10-11 03:55:43.091147
NCT01415908|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-01-20|2015-09-25||July 2011||2011-07-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|TLIF||INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine|A Prospective, Multi-center, Pivotal Trial for INFUSE® Bone Graft With CAPSTONE® Spinal System and Posterior Supplemental Fixation to Treat 1- or 2-level Advanced Degenerative Disease of the Lumbosacral Spine For a TLIF Approach|Terminated||Phase 3|15|Actual|Medtronic Spinal and Biologics|A total of 534 ± 10 subjects were planned for enrollment. However, this study was terminated early with only 15 enrolled patients, leading to small numbers of subjects analyzed.|2||"Due to study design challenges including DMC enrollment suspension as required by the protocol   stopping rules and recommended changes to the surgical technique"|f||||t||||||||||2017-10-11 03:55:43.674968|2017-10-11 03:55:43.674968
NCT01415895|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2014-06-24|||July 2011||2011-07-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy of ATNC05 in Reducing Back Pain Compared With Placebo|ATNC05, A Composition to Reduce Back Pain, A Proof-of-Concept, Randomized, Double-Blind - Placebo Controlled Study|Completed||Phase 2|78|Actual|Allodynic Therapeutics, LLC||2|||f||||t||||||||||2017-10-11 03:55:44.275133|2017-10-11 03:55:44.275133
NCT01415882|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-09-05|||January 2012||2012-01-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Ixazomib in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib|Phase 2 Trial of MLN9708 (Ixazomib) in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib|Recruiting||Phase 2|144|Anticipated|Mayo Clinic||4|||f||||t||||||||||2017-10-11 03:55:44.394515|2017-10-11 03:55:44.394515
NCT01415869|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-04-16|||July 2011||2011-07-01|April 2014|2014-04-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients|Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients|Unknown status|Recruiting|N/A|195|Anticipated|Mayo Clinic|||2||f||||f||||||||||2017-10-11 03:55:44.567924|2017-10-11 03:55:44.567924
NCT01415856|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-11|||October 2010||2010-10-01|August 2011|2011-08-01||||May 2012|Anticipated|2012-05-01||Interventional|||Use of Pulsed Electromagnetic Fields for Postoperative Knee Pain|A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Non-Invasive Pulsed Electromagnetic Fields (PEMF) on Postoperative Pain Following Total Knee Arthroplasty|Unknown status|Recruiting|Phase 2|40|Anticipated|Center for Joint Surgery and Sports Medicine, Maryland||2|||f||||t||||||||||2017-10-11 03:55:44.805707|2017-10-11 03:55:44.805707
NCT01415843|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-11|||January 2010||2010-01-01|July 2009|2009-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Observation of Physiotherapy Treatment Sessions - Exploring What Happens in Physiotherapy for Patients After Stroke.|Do Implicit and Explicit Learning Strategies Applied During Gait Re-education Influence Concurrent Expression of Associated Reactions in Individuals With Hemiplegia? Phase 1a|Completed||N/A|8|Actual|University of Southampton|||1||f||||f||||||||||2017-10-11 03:55:44.901138|2017-10-11 03:55:44.901138
NCT01415830|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-02-05|||August 2011||2011-08-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Compare Two Anti-Scorpion Venom Serum In Children|Randomized Controlled Trial To Evaluate Efficacy And Safety Of The Polyvalent Anti-scorpion Venom Serum Of Birmex Versus Other Commercial Venom Serum In Children Population|Completed||Phase 3|120|Actual|Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.||2|||f||||t||||||||||2017-10-11 03:55:44.972327|2017-10-11 03:55:44.972327
NCT01415817|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-11|||August 2010||2010-08-01|August 2011|2011-08-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|EQUIP||Endoscopic Quality Improvement Program|"The Effect of an Intensive Endoscopic Quality Improvement Program (EQUIP) on Improved Detection and Classification of Non-polypoid (Flat and Depressed) and Polypoid Colorectal Adenomas. (EQUIP Study)"|Completed||N/A|15|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 03:55:45.111868|2017-10-11 03:55:45.111868
NCT01415804|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-11|||February 2002||2002-02-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|INSTEAD||Investigation of Stent-grafts in Aortic Dissection (INSTEAD)|A Randomized Comparison of Strategies for Type B Aortic Dissection - the INvestigation of STEnt-grafts in Aortic Dissection (INSTEAD) Trial|Completed||Phase 2/Phase 3|140|Actual|University of Rostock||2|||f||||t||||||||||2017-10-11 03:55:45.191392|2017-10-11 03:55:45.191392
NCT01415791|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2012-05-29|||August 2011||2011-08-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Oral Mucosal Absorption of ICI176,334-1|Oral Mucosal Absorption of ICI176,334-1 in Japanese Healthy Male Subjects|Completed||Phase 1|8|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 03:55:45.270083|2017-10-11 03:55:45.270083
NCT01415778|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2012-05-29|||August 2011||2011-08-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects|Bioequivalence Study of ICI176,334-1 in Japanese Healthy Male Subjects - Evaluation of Bioequivalence of ICI176,334-1 and Casodex 80 mg Tablet -|Completed||Phase 1|48|Actual|AstraZeneca||4|||f||||||||||||||2017-10-11 03:55:45.345019|2017-10-11 03:55:45.345019
NCT01415193|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-03-17|||March 2009||2009-03-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|March 2009|Actual|2009-03-01||Interventional|||Tibial Nerve Versus Sciatic Nerve Block|Selective Tibial Nerve Block vs Popliteal Sciatic Nerve Block in Patients Having Total Knee Arthroplasty|Completed||N/A|80|Actual|Saint Francis Care||2|||f||||f||||||||||2017-10-11 03:55:58.109879|2017-10-11 03:55:58.109879
NCT01415765|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-10-05|||July 15, 2011||2011-07-15|January 7, 2014|2014-01-07|January 7, 2014|Actual|2014-01-07|January 7, 2014|Actual|2014-01-07||Interventional|||MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma|Phase I/II Study of MLN4924 Alone Followed by Dose-Adjusted EPOCH-Rituximab + MLN4924 With Gene Expression Profiling and Mutational Analysis in Relapsed/Refractory de Novo Diffuse Large B-Cell Lymphoma|Withdrawn||Phase 1/Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:55:45.43281|2017-10-11 03:55:45.43281
NCT01415752|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-03-17|||May 2012||2012-05-01|March 2017|2017-03-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma|Intergroup Randomized Phase 2 Four Arm Study In Patients ≥ 60 With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB → R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV→ R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB → LR) or Arm D = Rituximab + Bendamustine + Bortezomib Followed By Lenalidomide + Rituximab Consolidation (RBV → LR)|Recruiting||Phase 2|332|Anticipated|Eastern Cooperative Oncology Group||8|||f||||t||||||||||2017-10-11 03:55:45.655667|2017-10-11 03:55:45.655667
NCT01415739|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2017-08-07|||October 2011||2011-10-01|August 2017|2017-08-01||||January 2100|Anticipated|2100-01-01||Observational|||Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer|Evaluation of a Novel Molecular NSCLC Classification System|Active, not recruiting||N/A|261|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 03:55:47.91635|2017-10-11 03:55:47.91635
NCT01415726|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-02-16|||July 2011||2011-07-01|July 2011|2011-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Stem Cell Educator Therapy in Type 2 Diabetes||Completed||Phase 1/Phase 2|25|Actual|University of Illinois at Chicago||2|||f||||||||||||||2017-10-11 03:55:48.014063|2017-10-11 03:55:48.014063
NCT01415713|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-05-03|||March 2012||2012-03-01|June 2011|2011-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||The Study of Metastatic Pancreatic Adenocarcinoma|Phase I/II Trial of Biweekly S-1, Leucovorin, Oxaliplatin and Gemcitabine (SLOG) in Metastatic Pancreatic Adenocarcinoma|Completed||Phase 1/Phase 2|73|Actual|National Health Research Institutes, Taiwan||1|||f||||t||||||||Undecided||2017-10-11 03:55:48.097984|2017-10-11 03:55:48.097984
NCT01415700|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2014-07-25|||October 2010||2010-10-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|STEPSTIM||Comparison Between Implanted Functional Electrical Stimulation and Foot Orthosis|Implanted Functional Electrical Stimulation of the Levators of the Ankle Versus Orthosis in the Treatment of Chronic Foot Neurological STEPPAGE-gait by Central Attack|Completed||N/A|27|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:55:48.196736|2017-10-11 03:55:48.196736
NCT01415687|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-05-30|||May 2011||2011-05-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|BP||Split Dose Pico-Salax + Bisacodyl vs. PEG Split Dose|A Randomized Prospective Trial Comparing Pico-Salax (Magnesium Citrate) Plus Bisacodyl Versus Split Dose Polyethylene Glycol-Based Lavage In Preparation Of Patients For Colonoscopy|Completed||Phase 3|171|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 03:55:48.296325|2017-10-11 03:55:48.296325
NCT01415674|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-08-31|||January 2012||2012-01-01|August 2015|2015-08-01|February 2016|Anticipated|2016-02-01|July 2015|Actual|2015-07-01||Interventional|PREDICTOR||Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients|Multi-centric Randomized Phase II Study of Pre-operative Afatinib (BIBW2992) Aiming at Identifying Predictive and Pharmacodynamic Biomarkers of Biological Activity and Efficacy in Untreated Non-metastatic Head and Neck Squamous Cell Carcinoma Patients|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|UNICANCER||2|||f||||f||||||||||2017-10-11 03:55:48.391253|2017-10-11 03:55:48.391253
NCT01415661|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2012-04-07|||January 2011||2011-01-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|CP||Efficacy of Cricoid Pressure in Occluding the Esophageal Entrance: A Glidescope ® Study|Efficacy of Cricoid Pressure in Occluding the Esophageal Entrance: A Glidescope ® Study|Completed||N/A|89|Actual|Procare Riaya Hospital||2|||f||||f||||||||||2017-10-11 03:55:48.495339|2017-10-11 03:55:48.495339
NCT01415648|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-08-26|||April 2011||2011-04-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|EMOCAR||Medico-economic Evaluation of Preoperative Cerebral Oximetry Monitoring During Carotid Endarterectomy|Medico-economic Evaluation of Preoperative Cerebral Oximetry Monitoring During Carotid Endarterectomy.|Terminated||Phase 3|879|Actual|Nantes University Hospital||2||Recruitment time expired.|f||||f||||||||||2017-10-11 03:55:48.572484|2017-10-11 03:55:48.572484
NCT01415635|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-12-12|||October 2011||2011-10-01|December 2012|2012-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|DHH||Fortified Hospital Food as Nutritional Support|Positive Effect of Fortified Hospital Food on Nutritional Intake in Patients at Nutritional Risk. A Randomized Controlled Trial.|Completed||N/A|84|Actual|Copenhagen University Hospital at Herlev||1|||f||||t||||||||||2017-10-11 03:55:48.683347|2017-10-11 03:55:48.683347
NCT01415622|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2012-11-16|||April 2011||2011-04-01|August 2011|2011-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Feasibility, Efficacy, and Safety of Venous Ulcer Treatment Using a Hand Plasma Generator (PlasmaDerm) Chronisch venöser Ulzerationen (PlasmaDerm)||Completed||N/A|30|Actual|Cinogy GmbH||2|||f||||t||||||||||2017-10-11 03:55:48.771349|2017-10-11 03:55:48.771349
NCT01415609|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-11-07|||August 2010||2010-08-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|ESD Registry||Endoscopic Submucosal Dissection Registry|Establishment of Registry for Endoscopic Submucosal Dissection for Superficial Gastrointestinal Neoplasia|Completed||N/A|17|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 03:55:48.850843|2017-10-11 03:55:48.850843
NCT01415596|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-11|2011-08-11|||August 2011||2011-08-01|March 2011|2011-03-01|August 2013|Anticipated|2013-08-01|August 2012|Anticipated|2012-08-01||Interventional|||The Effect of High Dose Salbutamol on Muscle Performance|The Effect of High Dose Salbutamol on Dynamic and Isometric Muscle Power and Recovery in Well-trained Males|Unknown status|Active, not recruiting|N/A|20|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 03:55:48.911836|2017-10-11 03:55:48.911836
NCT01415583|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-27|2017-06-12|2016-12-14||July 2010|Actual|2010-07-01|June 2017|2017-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy|Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy|Completed||N/A|314|Actual|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||No||2017-10-11 03:55:48.985748|2017-10-11 03:55:48.985748
NCT01415570|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-05-20|||August 2011||2011-08-01|May 2015|2015-05-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Observational|MADRAD||Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD)|Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD) - A Prospective Data Collection Study|Unknown status|Recruiting|N/A|1050|Anticipated|Los Angeles Biomedical Research Institute|||2||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 03:55:49.304596|2017-10-11 03:55:49.304596
NCT01415557|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2013-11-05|||August 2011||2011-08-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Regular Consumption of Micronutrient Fortified Beverage on the Micronutrient Status of Indian Schoolchildren|The Effects of Regular Consumption of a Multiple Micronutrient Fortified Beverage on the Micronutrient Status of Indian Schoolchildren and on Their Mental and Physical Performance|Completed||N/A|227|Actual|Mondelēz International, Inc.||2|||f||||f||||||||||2017-10-11 03:55:49.38733|2017-10-11 03:55:49.38733
NCT01415544|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2012-02-23|||June 2011||2011-06-01|February 2012|2012-02-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Observational|||Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References|An Evaluation and Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References|Unknown status|Active, not recruiting|N/A|100|Anticipated|InLight Solutions|||4||f||||f||||||None Retained|"     capillary glucose measurements   "|||2017-10-11 03:55:49.474083|2017-10-11 03:55:49.474083
NCT01415531|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-03-18|2013-03-18||August 2011||2011-08-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years) Who Have Stage 1 or 2 Essential Hypertension|Completed||Phase 4|641|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 03:55:49.573283|2017-10-11 03:55:49.573283
NCT01415518|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2014-08-11|2013-11-25||September 2011||2011-09-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SECURE2|Two patients in 'Symbicort Turbuhaler + ipratropium + theophylline' group did not receive study treatment and were excluded from the analysis popolation. Thus the number of patients in that group is 290 (= 290 - 2).|Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients|Efficacy and Tolerability Study of Symbicort Turbuhaler(160/4.5µg/Inhalation,2inhalations Twice Daily) Added to Atrovent (20µg/Inhalation, 2 Inhalations 4 Times Daily)+Theophylline SR(0.1g/Tablet,1 Tablet p.o. Twice Daily) Compared With Atrovent+Theophylline SR in Severe COPD Patients.|Completed||Phase 4|581|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 03:55:50.27415|2017-10-11 03:55:50.27415
NCT01415505|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-05-31|||August 2011||2011-08-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension|A Multicenter, Open-Label, Single-Arm, Free Tablet Combination, Long-Term Study to Evaluate the Safety of Nebivolol in Combination With Valsartan in Patients With Stage 1 or Stage 2 Essential Hypertension|Completed||Phase 3|812|Actual|Forest Laboratories||1|||f||||f||||||||||2017-10-11 03:55:51.37456|2017-10-11 03:55:51.37456
NCT01415492|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2014-12-30|||March 2009||2009-03-01|December 2014|2014-12-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|HD2||Multiple Risk Behavior Intervention in Health Care Settings|Multiple Risk Behavior Intervention in Health Care Settings|Completed||N/A|2440|Actual|Dana-Farber Cancer Institute||3|||f||||f||||||||||2017-10-11 03:55:51.980448|2017-10-11 03:55:51.980448
NCT01415479|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-04-29|||August 2011||2011-08-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|August 2012|Actual|2012-08-01||Interventional|||Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening|Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening|Completed||N/A|212|Anticipated|Indiana University||4|||f||||f||||||||||2017-10-11 03:55:52.089217|2017-10-11 03:55:52.089217
NCT01415466|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2012-04-02|||August 2011||2011-08-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers|A Randomized, Open Label, Multiple-Dose, Cross-over Clinical Study to Investigate Pharmacokinetics and Drug-Drug Interaction Between Rosuvastatin and CS-866 in Healthy Male Volunteers|Completed||Phase 1|36|Actual|Daewoong Pharmaceutical Co. LTD.||3|||f||||f||||||||||2017-10-11 03:55:52.17916|2017-10-11 03:55:52.17916
NCT01415453|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-03-01|2012-06-21||July 2011||2011-07-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Evoked Retinal Response|Evoked Visual Response Using Pulsed Ultrasound|Terminated||N/A|1|Actual|Columbia University|Difficulty in recruiting appropriate volunteers. Study terminated due to poor enrollment.|1||Poor enrollment.|f||||f||||||||||2017-10-11 03:55:52.293647|2017-10-11 03:55:52.293647
NCT01415440|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-06-26|||August 2011||2011-08-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD|Examining the Effects of Stimulant Medication on Emotional Lability in Patients With Attention Deficit Hyperactivity Disorder (ADHD)|Recruiting||N/A|100|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-11 03:55:52.477818|2017-10-11 03:55:52.477818
NCT01415427|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-04-13|2017-04-13||July 2011||2011-07-01|April 2017|2017-04-01|June 16, 2016|Actual|2016-06-16|June 16, 2016|Actual|2016-06-16||Interventional|||Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)|A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)|Completed||Phase 3|173|Actual|BioMarin Pharmaceutical||2|||f||||t||||||||||2017-10-11 03:55:52.743853|2017-10-11 03:55:52.743853
NCT01415414|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-01-19|||September 2011||2011-09-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|July 2012|Actual|2012-07-01||Observational|INDEX||Observational Study of Ultravist in Patients Requiring CECT|The Image Quality and Radiation Dose of CECT With Ultravist® in Patients With Abdominal Pelvic Disease - INDEX|Completed||N/A|11660|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:55:56.211038|2017-10-11 03:55:56.211038
NCT01415180|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-05-24|||June 2013||2013-06-01|May 2013|2013-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|LAPSE||Life After Pediatric Sepsis Evaluation|Life After Pediatric Sepsis Evaluation|Withdrawn||N/A|0|Actual|Seattle Children's Hospital|||2|No funding|f||||f||||||||||2017-10-11 03:55:58.1843|2017-10-11 03:55:58.1843
NCT01415401|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2014-05-30|2014-05-30||September 2011||2011-09-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||This analysis population includes all participants who received study medication.|Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada|Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Canada|Completed||Phase 4|57|Actual|Alcon Research||1|||f||||f||||||||||2017-10-11 03:55:56.291383|2017-10-11 03:55:56.291383
NCT01415388|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-02-20|||August 2011||2011-08-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study to Investigate the Effects of Krill Oil on Fasting Serum Triglycerides|A Double-blind, Randomized, Multi-centre, Placebo-controlled Study to Investigate the Effects of Superba(TM) Krill Oil on Fasting Serum Triglycerides|Completed||N/A|300|Actual|Aker Biomarine Antarctic AS||1|||f||||t||||||||||2017-10-11 03:55:56.476478|2017-10-11 03:55:56.476478
NCT01415375|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-04-16|||September 2004||2004-09-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|July 2007|Actual|2007-07-01||Interventional|||Prostate Cancer Education in African American Men|Prostate Cancer Education in African American Men|Completed||Phase 2/Phase 3|490|Actual|Temple University||2|||f||||t||||||||||2017-10-11 03:55:56.539843|2017-10-11 03:55:56.539843
NCT01415362|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-03-17|||July 2011||2011-07-01|March 2017|2017-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Closed-loop System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy|Development of a Closed-loop Detect-and-treat System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy|Completed||N/A|6|Actual|Spaulding Rehabilitation Hospital||2|||f||||f|f|f||||||||2017-10-11 03:55:56.618729|2017-10-11 03:55:56.618729
NCT01415349|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2014-06-06|2012-06-01||August 2011||2011-08-01|April 2014|2014-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||SSP-002358 Drug Interaction Study With Omeprazole|A Phase 1, Open-label, Randomized, 2-period Crossover Drug Interaction Study in Healthy Adult Subjects to Evaluate the Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of SSP-002358|Completed||Phase 1|42|Actual|Shire||2|||f||||||||||||||2017-10-11 03:55:56.71344|2017-10-11 03:55:56.71344
NCT01415336|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-10|||March 2010||2010-03-01|August 2011|2011-08-01||||March 2013|Anticipated|2013-03-01||Interventional|||AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer|AX (Doxorubicin, Capecitabine) Versus AC (Doxorubicin, Cyclophosphamide) as Adjuvant Treatment for Node-Negative Breast Cancer|Unknown status|Recruiting|Phase 2/Phase 3|300|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 03:55:56.934828|2017-10-11 03:55:56.934828
NCT01415323|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-11-21|||September 2011||2011-09-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Agitation in the Acute Psychiatric Department|Agitation in the Acute Psychiatric Department|Completed||N/A|384|Actual|Norwegian University of Science and Technology|||1||f||||t||||||Samples With DNA|"     Blood samples are collected for storage and analyses both at admittance and discharge from     the psychiatric acute department.   "|||2017-10-11 03:55:57.112426|2017-10-11 03:55:57.112426
NCT01415310|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-10-03|||April 2011||2011-04-01|October 2016|2016-10-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Observational|KVALAP||Quality Register for Geriatric Psychiatry|Quality Register for Geriatric Psychiatry in Viken Research Network for Geriatric Psychiatry|Active, not recruiting||N/A|19000|Anticipated|Norwegian Centre for Ageing and Health|||1||f||||f||||||||||2017-10-11 03:55:57.240886|2017-10-11 03:55:57.240886
NCT01415297|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-05-18|||October 2009|Actual|2009-10-01|May 2017|2017-05-01|January 2016|Actual|2016-01-01|May 2012|Actual|2012-05-01||Interventional|||Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors|A Phase I Dose Escalation Study of NKP-1339 Administered on Days 1, 8 and 15 of Each 28-Day Cycle in Patients With Advanced Solid Tumors Refractory to Treatment|Completed||Phase 1|46|Actual|Intezyne Technologies, Inc.||1|||f||||f||||||||Undecided||2017-10-11 03:55:57.318697|2017-10-11 03:55:57.318697
NCT01415284|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-02-12|||October 2011||2011-10-01|February 2013|2013-02-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia|ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia|Unknown status|Recruiting|Phase 4|30|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||f||||||||||2017-10-11 03:55:57.399451|2017-10-11 03:55:57.399451
NCT01415271|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-08-10|||October 2011||2011-10-01|August 2015|2015-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||3-Month Trial Observation of A1c Change|Assessment of an Internet Blood Glucose Management Program in a Chronic Care Hospital|Terminated||N/A|10|Actual|Endocrine Research Society||1||Preliminary exploration of research concept did not prove to be viable.|f||||f||||||||||2017-10-11 03:55:57.516468|2017-10-11 03:55:57.516468
NCT01415258|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-05-15|||March 2011||2011-03-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|August 2011|Actual|2011-08-01||Observational|||Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre|Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre|Completed||N/A|209|Actual|Centre Oscar Lambret|||1||f||||f||||||||||2017-10-11 03:55:57.604872|2017-10-11 03:55:57.604872
NCT01415245|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2014-05-18|||October 2011||2011-10-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|VEST||Vein External Support Trial|Vein External Support Trial|Completed||N/A|30|Actual|Vascular Graft Solutions Ltd.||2|||f||||t||||||||||2017-10-11 03:55:57.669079|2017-10-11 03:55:57.669079
NCT01415232|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-05-20|2013-02-01||August 2010||2010-08-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Novel Way to Estimate Epidural Depth in Morbidly Obese Parturient|The Use of Ultrasound With the Epidural Depth Equation (EQ-US) to Estimate Epidural Depth (Est-D) in Morbidly Obese Parturients (BMI>40Kg/m2) Will Have a High Correlation With Actual Epidural Needle Depth (ND)|Completed||N/A|160|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 03:55:57.738303|2017-10-11 03:55:57.738303
NCT01415219|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-08|2014-12-17|||March 2008||2008-03-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis|Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis|Completed||Phase 2|80|Actual|University Hospital, Lille||2|||f||||t||||||||||2017-10-11 03:55:57.928006|2017-10-11 03:55:57.928006
NCT00000339|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-10|||June 1996||1996-06-01|June 1996|1996-06-01||||||||Interventional|||Infusion Laboratory: Protocol 3 (Risperidone) - 4|Infusion Laboratory: Protocol 3 (Risperidone)|Unknown status|Active, not recruiting|Phase 1|13||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.157111|2017-10-11 04:17:47.157111
NCT01415167|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-02-10|||August 2011||2011-08-01|February 2017|2017-02-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy|Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy|Recruiting||N/A|2500|Anticipated|Prometheus Laboratories|||1||f||||f||||||||||2017-10-11 03:55:58.2968|2017-10-11 03:55:58.2968
NCT01415154|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-11-11|||August 2011||2011-08-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|September 2013|Actual|2013-09-01||Interventional|||Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder|A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder|Completed||N/A|67|Actual|Neuronetics||2|||f||||f||||||||||2017-10-11 03:55:58.554483|2017-10-11 03:55:58.554483
NCT01415141|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2017-05-05|||July 2011|Actual|2011-07-01|May 2017|2017-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism|A Randomized Trial of Telaprevir, Peginterferon, and Ribavirin Versus Peginterferon and Ribavirin for Treatment of Genotype 1 Hepatitis C Virus With Host Interleukin 28B CC Polymorphism|Withdrawn||Phase 4|0|Actual|University of Vermont||2||Lack of funding|f||||f||||||||||2017-10-11 03:55:59.0188|2017-10-11 03:55:59.0188
NCT01415128|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-28|2011-08-10|||April 2010||2010-04-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects|A PHASE I, SINGLE-CENTER, OPEN-LABEL, CROSSOVER STUDY OF THE EFFECT OF AVANAFIL ON THE PHARMACOKINETICS OF OMEPRAZOLE, DESIPRAMINE AND ROSIGLITAZONE IN HEALTHY MALE SUBJECTS|Completed||Phase 1|60|Actual|VIVUS, Inc.||3|||f||||f||||||||||2017-10-11 03:55:59.125759|2017-10-11 03:55:59.125759
NCT01415115|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-10|||March 2007||2007-03-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|MARC||Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications|A Cross-Sectional Study to Test the Feasibility of Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications|Completed||N/A|250|Actual|VeraLight, Inc.|||2||f||||f||||||None Retained|"     Blood samples will be drawn for laboratory-based quantification of HbA1c and lipids. Urine     samples will be collected to determine urine creatinine and microalbumin   "|||2017-10-11 03:55:59.222758|2017-10-11 03:55:59.222758
NCT01415102|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-29|2011-08-12|||September 2010||2010-09-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372.|A Double Blind (3rd Party Open), Randomised, Placebo-Controlled, Dose Escalation Study To Investigate The Safety, Toleration, And Pharmacokinetics Of Single Inhaled Doses Of Pf-05212372 In Healthy Subjects|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:55:59.310804|2017-10-11 03:55:59.310804
NCT01415089|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-06-15|||May 2009||2009-05-01|October 2013|2013-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|FOCUS-WEB||Tailored Web-Based Intervention for Cancer Patients and Family Caregivers|Tailored Web-Based Intervention for Cancer Patients and Family Caregivers|Completed||N/A|63|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 03:55:59.432283|2017-10-11 03:55:59.432283
NCT01415076|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-09-03|||September 2010||2010-09-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Optimal Timing of Carbon Dioxide Insufflation During Colonoscopy in Unsedated Patients|The Optimal Timing of Carbon Dioxide Insufflation During Colonoscopy in Unsedated Patients|Completed||N/A|200|Actual|Tri-Service General Hospital||2|||f||||t||||||||||2017-10-11 03:56:00.246591|2017-10-11 03:56:00.246591
NCT01415063|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-10|||February 2011||2011-02-01|February 2011|2011-02-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma|Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|120|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 03:56:00.356331|2017-10-11 03:56:00.356331
NCT01415050|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2011-08-10|||January 2009||2009-01-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|||Safety and Efficacy of Whole-body Vibration as add-on Treatment of Osteoporosis in Post-menopausal Women|Multicentered, Randomized Study of Safety and Efficacy of Whole-body Vibration as add-on to Standard Pharmacological Treatment of Osteoporosis in Post-menopausal Women|Completed||Phase 2|80|Anticipated|X-pert Med GmbH||2|||f||||t||||||||||2017-10-11 03:56:00.477224|2017-10-11 03:56:00.477224
NCT01415037|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-05-17|||October 2011||2011-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Annular Array Ultrasound in Ophthalmology|High-frequency-ultrasound Annular Arrays for Ophthalmic Imaging|Enrolling by invitation||N/A|30|Anticipated|Columbia University|||1||f||||f||||||||||2017-10-11 03:56:00.616154|2017-10-11 03:56:00.616154
NCT01415024|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-08-10|||May 2011||2011-05-01|August 2011|2011-08-01||||May 2012|Anticipated|2012-05-01||Interventional|CRTICD Dual LV||Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication|Resynchronization in Paced Heart Failure Patients With ICD Indication|Unknown status|Recruiting|Phase 4|30|Anticipated|Schuechtermann-Klinik||1|||f||||f||||||||||2017-10-11 03:56:00.827562|2017-10-11 03:56:00.827562
NCT01415011|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-10-26|||December 2012||2012-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2015|Actual|2015-08-01||Interventional|TIMELY||Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients|Trial of Afatinib (BIBW 2992) in Suspected or Confirmed Mutant EGFR Lung Cancer Patients Unfit for Chemotherapy|Active, not recruiting||Phase 2|37|Anticipated|University College, London||1|||f||||t||||||||||2017-10-11 03:56:00.952655|2017-10-11 03:56:00.952655
NCT01414998|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2013-03-19|||May 2012||2012-05-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|SenRep||Sensorimotor Replacement With Electronic and De-nicotinised Cigarettes|The Effect of Non-nicotine Sensorimotor Replacement on Withdrawal and Craving: Studies With Electronic and De-nicotinised Cigarettes|Completed||N/A|120|Anticipated|Queen Mary University of London||4|||f||||f||||||||||2017-10-11 03:56:01.095268|2017-10-11 03:56:01.095268
NCT01414803|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-10|||March 2009||2009-03-01|August 2011|2011-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia||Completed||Phase 4|180|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 03:56:03.788589|2017-10-11 03:56:03.788589
NCT01414985|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-13|2017-05-23|||December 2010||2010-12-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|||AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis|Direct CNS Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Serotype rh.10 Expressing the Human CLN2 cDNA to Children With LINCL With Uncommon Genotypes and/or Moderate to Severe Impairment|Recruiting||Phase 1/Phase 2|8|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||Undecided||2017-10-11 03:56:01.205011|2017-10-11 03:56:01.205011
NCT01414972|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-14|2011-08-10|||May 2010||2010-05-01|August 2011|2011-08-01|November 2011|Anticipated|2011-11-01|January 2011|Actual|2011-01-01||Interventional|||The Effect of Vitamin A on Atherosclerosis|The Effect of Vitamin A Supplementation on Gene Expression of Cytokine Secreted by T CD4+ Lymphocyte in Atherosclerotic Patients|Unknown status|Enrolling by invitation|Phase 4|45|Actual|Tehran University of Medical Sciences||3|||f||||t||||||||||2017-10-11 03:56:01.342451|2017-10-11 03:56:01.342451
NCT01414959|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-08-28|||August 2011||2011-08-01|August 2017|2017-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients|Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients|Completed||N/A|16|Actual|Medical University of Vienna|||1||f||||f||||||Samples Without DNA|"     plasma broncheoalvoeolar lavage microdialysates   "|||2017-10-11 03:56:01.469428|2017-10-11 03:56:01.469428
NCT01414946|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-10|||November 2009||2009-11-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||The Effect of Intravenous Nutrition in Patients Undergoing Abdominal Surgery|THE PROTEIN SPARING EFFECT OF PERIOPERATIVE NUTRITION: How Important is the Patient's Catabolic State Before Surgery and do we Need Glucose?|Completed||N/A|40|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 03:56:01.544079|2017-10-11 03:56:01.544079
NCT01414933|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-05-03|||May 2011||2011-05-01|May 2017|2017-05-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Observational|SAFIR-01||High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents|High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents|Completed||N/A|423|Actual|UNICANCER|||1||f||||t||||||Samples With DNA|"     Metastasis biopsy and DNA from biopsy   "|||2017-10-11 03:56:01.645648|2017-10-11 03:56:01.645648
NCT01414920|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-03-04||2016-03-04|August 2011||2011-08-01|March 2016|2016-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus|A Phase 2, Randomized, Placebo-Controlled, Factorial, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of 25 mg and 50 mg of TAK-875 in Combination With Sitagliptin 100 mg in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|368|Actual|Takeda||6|||f||||f||||||||||2017-10-11 03:56:01.872809|2017-10-11 03:56:01.872809
NCT01414907|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-06-04|||October 2010|Actual|2010-10-01|June 2017|2017-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|VIP||Study of Effectiveness of Adding the Health Promotion and Rehabilitation for Treatment for Alcohol and Drug Abusers|VIP (Very Important Patient) Project on Alcohol and Drug Abusers - RCT of Efficacy of the Adding the Health Promotion and Rehabilitation for Treatment of Alcohol and Drug Abusers|Completed||N/A|214|Actual|Skane University Hospital||2|||f||||f||||||||||2017-10-11 03:56:02.237899|2017-10-11 03:56:02.237899
NCT01414894|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-05|2013-06-18|||April 2010||2010-04-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|IMPROVES||Intensive Management of Pressure and Volume Expansion in Patients With Subarachnoid Hemorrhage|Intensive Management of Pressure and Volume Expansion in Patients With Subarachnoid Hemorrhage|Completed||Phase 1|20|Actual|University of Washington||4|||f||||f||||||||||2017-10-11 03:56:02.376481|2017-10-11 03:56:02.376481
NCT01414881|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-08-01|||September 2011||2011-09-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|||Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects|A Phase 1 Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects|Completed||Phase 1|20|Actual|Kastle Therapeutics, LLC||2|||f||||f||||||||||2017-10-11 03:56:02.484713|2017-10-11 03:56:02.484713
NCT01414868|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-17|||March 2010||2010-03-01|December 2009|2009-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)|Could Leukotriene D4 Bronchial Provocation Test be a Clear Indicator for Predicting Therapeutic Outcomes of Leukotriene Receptor Antagonist A Pilot Study|Completed||N/A|32|Actual|Guangzhou Institute of Respiratory Disease||1|||f||||f||||||||||2017-10-11 03:56:02.572459|2017-10-11 03:56:02.572459
NCT01414855|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-04-13|2015-02-05||August 31, 2011|Actual|2011-08-31|April 2017|2017-04-01|December 23, 2016|Actual|2016-12-23|December 31, 2013|Actual|2013-12-31||Interventional|||A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)|A Phase II, Open-Label, Multicenter Study of Efficacy, Safety, and Biomarkers in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma Treated With GA101 (RO5072759) in Combination With CHOP Chemotherapy|Completed||Phase 2|100|Actual|Genentech, Inc.||1|||f||||t||||||||||2017-10-11 03:56:02.694316|2017-10-11 03:56:02.694316
NCT01414842|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-26|||April 2007||2007-04-01|January 2007|2007-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|AIMS||HFR A-equilibrium on Cardiovascular Stability|Randomized Controlled Study on the Effect of the Hemodiafiltration Plasma Sodium Biofeedback System on Cardiovascular Stability in Hemodialysis Patients|Completed||Phase 4|50|Actual|Azienda Ospedaliera di Lecco||2|||f||||f||||||||||2017-10-11 03:56:03.532925|2017-10-11 03:56:03.532925
NCT01414829|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-12-02|||August 2011||2011-08-01|December 2012|2012-12-01|January 2012||2012-01-01|January 2012|Anticipated|2012-01-01||Observational|||Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment|Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment and Comparing of Different Methods for Helicobacter Pylori Disclosure|Withdrawn||N/A|0|Actual|The Baruch Padeh Medical Center, Poriya|||1|difficulty in recruiting parients|f||||f||||||Samples Without DNA|"     gastric biopsies   "|||2017-10-11 03:56:03.638491|2017-10-11 03:56:03.638491
NCT01414816|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-08-20|||April 2008||2008-04-01|August 2014|2014-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Betaferon® Regulatory Post-Marketing Surveillance|Betaferon® Regulatory Post-Marketing Surveillance|Completed||N/A|355|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:56:03.700455|2017-10-11 03:56:03.700455
NCT01414790|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-10|||January 2004||2004-01-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome|The Use of Human Acellular Dermal Matrix in the Prevention of Infraauricular Depressed Deformities and Frey's Syndrome Following Total Parotidectomy|Completed||Phase 3|70|Actual|West China Hospital||2|||f||||t||||||||||2017-10-11 03:56:03.894963|2017-10-11 03:56:03.894963
NCT01414777|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-16|2011-08-10|||November 2009||2009-11-01|August 2011|2011-08-01||||||||Interventional|||Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy Parturients|IRB-HSR# 14583: Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy Parturients|Unknown status|Enrolling by invitation|Phase 2/Phase 3|68|Anticipated|University of Virginia||2|||f||||f||||||||||2017-10-11 03:56:03.997028|2017-10-11 03:56:03.997028
NCT01414764|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-12-07|||May 2011||2011-05-01|December 2014|2014-12-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Interventional|||Does Autologous Conditioned Plasma Enhance Rotator Cuff Tendon Healing After Surgery?|Does Autologous Conditioned Plasma Enhance Rotator Cuff Tendon Healing After Surgery? A Radomized Control Trial.|Unknown status|Enrolling by invitation|Phase 3|60|Anticipated|The University of Western Australia||2|||f||||t||||||||||2017-10-11 03:56:04.157045|2017-10-11 03:56:04.157045
NCT01414751|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-01-09|||November 2009||2009-11-01|January 2013|2013-01-01|August 2013|Anticipated|2013-08-01|June 2011|Actual|2011-06-01||Interventional|IMPACT||Influence of Intervention Methodologies on Patient Choice of Therapy|Interventions for Chronic Diseases: Effect of Patient Values and Effectiveness Information on Patients' Choice of Therapy, Adherence to Therapy and Satisfaction With Therapy|Unknown status|Active, not recruiting|N/A|248|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 03:56:04.281933|2017-10-11 03:56:04.281933
NCT01414738|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-12-28|||October 2011||2011-10-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases|Phase II Trial of Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases|Active, not recruiting||Phase 2|50|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 03:56:04.419646|2017-10-11 03:56:04.419646
NCT01414712|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2013-03-04|||July 2011||2011-07-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Circulating Tumor Cells in Prostate Cancer Patients|Circulating Tumor Cells in Patients Undergoing Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer|Terminated||N/A|2|Actual|University of Texas Southwestern Medical Center|||1||f||||t||||||Samples Without DNA|"     blood   "|||2017-10-11 03:56:04.853294|2017-10-11 03:56:04.853294
NCT01414699|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-01-26|||August 2011||2011-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2011|Actual|2011-12-01||Interventional|||The Influence of Dietary Variety and Course Sequence on Fruit Intake in Preschool-Aged Children|The Influence of Dietary Variety and Course Sequence on Fruit Intake in Preschool-Aged Children|Completed||N/A|16|Actual|University of Tennessee||4|||f||||f||||||||||2017-10-11 03:56:04.970802|2017-10-11 03:56:04.970802
NCT01414686|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-10|||May 2008||2008-05-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|VEHAB||Virtual Environment Rehabilitation for Chronic Stroke|Commercially-Available Interactive Video Games for Individuals With Chronic Mobility and Balance Deficits Post-Stroke|Completed||Phase 2|30|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-11 03:56:05.105835|2017-10-11 03:56:05.105835
NCT01414673|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-10|||April 2009||2009-04-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||HCG Versus Spontaneous LH in Intrauterine Insemination (IUI ) Cycles|Spontaneous Triggering of Ovulation vs. Administration of Human Chorionic Gonadotropin in Patients Undergoing Intrauterine Insemination: a Prospective Randomized Study.|Completed||Early Phase 1|300|Actual|Universitair Ziekenhuis Brussel||2|||f||||t||||||||||2017-10-11 03:56:05.269392|2017-10-11 03:56:05.269392
NCT01414660|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-02-01|||June 2010||2010-06-01|February 2017|2017-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|IL-7tran||Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation|Adipocytes, Insulin Resistance and Immunity: Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation|Completed||N/A|49|Actual|University Hospital, Lille|||3||f||||f||||||Samples With DNA|"     wholeblood and tissue bank   "|No||2017-10-11 03:56:05.371941|2017-10-11 03:56:05.371941
NCT01414647|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2012-04-16|||January 2006||2006-01-01|April 2012|2012-04-01|March 2010|Actual|2010-03-01|December 2006|Actual|2006-12-01||Interventional|Berry||The Health Effect of Diet Rich in Nordic Berries|The Effect of Diet Rich in Nordic Berries on Gut Microbiota, Glucose and Lipid Metabolism and Metabolism on Fenolic Compounds|Completed||N/A|56|Actual|University of Eastern Finland||3|||f||||t||||||||||2017-10-11 03:56:05.516728|2017-10-11 03:56:05.516728
NCT01414634|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-04-08|2014-01-24||February 2010||2010-02-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|ETIMS||Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear Cells|Establish Tolerance in Multiple Sclerosis With Peptide-coupled, Peripheral Blood Mononuclear Cells - A MRI-controlled, Single Center, Phase I Trial in Relapsing-remitting MS Patients|Completed||Phase 1/Phase 2|9|Actual|Universitätsklinikum Hamburg-Eppendorf||8|||f||||t||||||||||2017-10-11 03:56:05.650457|2017-10-11 03:56:05.650457
NCT01414621|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-17|2016-03-07|||August 2009||2009-08-01|March 2016|2016-03-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Observational|||Expression of Angiogenic Factors in Myocardial Tissue|IRB #14547: Expression of Angiogenic Factors in Myocardial Tissue in Diabetic and Non-diabetic Patients Undergoing Coronary Bypass Surgery|Completed||N/A|60|Actual|University of Virginia|||1||f||||f||||||Samples With DNA|"     During the cannulation process before the initiation of CPB(cardiopulmonary bypass) a small     piece of right atrial tissue is cut in order to insert venous drainage cannula to the right     atrium. This small piece of tissue is discarded and is not sent for pathology.   "|No||2017-10-11 03:56:06.0969|2017-10-11 03:56:06.0969
NCT01414608|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-08-23|||January 9, 2012|Actual|2012-01-09|August 2017|2017-08-01||||July 9, 2018|Anticipated|2018-07-09||Interventional|||Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer|A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial|Active, not recruiting||Phase 3|900|Anticipated|Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 03:56:06.269914|2017-10-11 03:56:06.269914
NCT01414595|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-06-26|||March 2012||2012-03-01|June 2017|2017-06-01||||February 2017|Actual|2017-02-01||Observational|||Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer|Molecular Characterization of Lung Cancer: A Collaboration With the Cancer Genome Atlas Project (TGCA)|Completed||N/A|248|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Tumor and blood samples   "|||2017-10-11 03:56:07.202951|2017-10-11 03:56:07.202951
NCT01414582|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2012-06-19|||January 2011||2011-01-01|June 2012|2012-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|tDCS||Transcranial Stimulation and Motor Training in Stroke Rehabilitation|Transcranial Direct Current Stimulation (tDCS) as a Potential Adjunct Intervention in Stroke Rehabilitation|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|University of Oxford||2|||f||||f||||||||||2017-10-11 03:56:07.327454|2017-10-11 03:56:07.327454
NCT01414569|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-06-03|||November 2011||2011-11-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Dexamethasone for Pain After Shoulder Surgery|High Dose Dexamethasone as Pain Treatment After Arthroscopic Shoulder Surgery: A Randomised, Blinded Clinical Trial|Completed||Phase 4|97|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 03:56:07.434222|2017-10-11 03:56:07.434222
NCT01414556|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-03-31|||May 2011||2011-05-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|GIP-HYPO-T2DM||GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes|Effects of Glucose-dependent Insulinotropic Polypeptide at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes|Completed||Early Phase 1|12|Actual|University Hospital, Gentofte, Copenhagen||3|||f||||f||||||||||2017-10-11 03:56:07.523729|2017-10-11 03:56:07.523729
NCT01414543|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2016-05-10|||October 2009||2009-10-01|August 2009|2009-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Psychologists' Lived Experience of Client Violence|Counselling and Clinical Psychologists Lived Experience of Client Violence|Completed||N/A|10|Anticipated|University of East London||4|||f||||t||||||||||2017-10-11 03:56:07.607714|2017-10-11 03:56:07.607714
NCT01414530|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-09-09|||April 2010||2010-04-01|September 2013|2013-09-01||||June 2014|Anticipated|2014-06-01||Interventional|||Oral Contraceptive During Menopausal Transition|Effects of Oral Contraceptive on Muscle or Joint Ache in Women During Menopausal Transition|Unknown status|Recruiting|N/A|52|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 03:56:07.690597|2017-10-11 03:56:07.690597
NCT01414517|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-10|||August 2010||2010-08-01|August 2010|2010-08-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|||Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.|A Double-blind Placebo-controlled Trial of Dietary Supplementation With 15g/Day FOS for Five Weeks in Patients With Endometrial/Cervical Carcinoma or 7.5 Weeks in Patients With Prostate Carcinoma Undergoing Pelvic Radiotherapy.|Unknown status|Recruiting|Phase 3|220|Anticipated|University College London Hospitals||2|||f||||t||||||||||2017-10-11 03:56:07.782313|2017-10-11 03:56:07.782313
NCT01414491|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2016-10-27|||January 2006||2006-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:56:09.6899|2017-10-11 03:56:09.6899
NCT01414478|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-02-01|||August 2010||2010-08-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||High Protein Intake to Decrease Emesis and Promote Patient Satisfaction in Labor|A Prospective, Randomized Trial to Evaluate the Efficacy of High Protein Intake on the Incidence of Emesis and Promotion of Patient Satisfaction After Epidural Analgesia for Labor|Completed||N/A|150|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:56:09.738101|2017-10-11 03:56:09.738101
NCT01414465|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-10|||October 2009||2009-10-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional|||Orlistat Induced Modulation on the Fatty Acid Composition in Obese Females|Orlistat Induced Modulation on the Fatty Acid Composition of the Red Blood Cell Membrane and Plasma Phospholipids, Triglyceride and Cholesteryl Esters in Obese Females|Completed||N/A|17|Actual|University of Campinas, Brazil||3|||f||||f||||||||||2017-10-11 03:56:09.82586|2017-10-11 03:56:09.82586
NCT01414452|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-07-19|||April 2011||2011-04-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|R²ACE||Role of Adiponectin and Endothelial Progenitor Cells in Reperfusion Injury in Patients With Acute Myocardial Infarction|Reperfusion Injury and Cardiac Remodelling After Myocardial Infarction in Relation to Adiponectin Level, Circulating Endothelial Progenitor Cells and Endothelial Microparticles|Completed||N/A|250|Actual|Universiteit Antwerpen|||1||f||||f||||||Samples Without DNA|"     blood samples   "|||2017-10-11 03:56:09.913967|2017-10-11 03:56:09.913967
NCT01414439|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2011-08-27|||August 2011||2011-08-01|August 2011|2011-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Group Psychotherapy Among Congestive Heart Failure Patients|Group Psychotherapy Among Congestive Heart Failure Patients as a Way to Reduce Psychological Distress and Increase Psycho-social Adjustment|Unknown status|Not yet recruiting|N/A|40|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 03:56:09.97967|2017-10-11 03:56:09.97967
NCT01414426|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-05-10|||January 2012||2012-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions|Randomized Placebo- Controlled Pilot Study of ZD6474 as a Chemopreventive Agent for Premalignant Lesions of the Head and Neck|Recruiting||Phase 2|54|Anticipated|University of Chicago||2|||f||||f||||||||||2017-10-11 03:56:10.113135|2017-10-11 03:56:10.113135
NCT01414413|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2014-02-19|2014-02-19||January 2012||2012-01-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|CONDA-YAPA|The 14 clusters included in the study had a combined adult population of 16660, with 8194 adults resident in 3213 households in the OHC arm and 8466 adults resident in 3397 households in the FCO arm. Socio-demographic characteristics assessed in the baseline enumeration were well balanced between intervention groups.|Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi|Home Assessment and Initiation of ART: a Cluster-randomised Trial in Blantyre, Malawi|Completed||N/A|16660|Actual|Liverpool School of Tropical Medicine||2|||f||||f||||||||||2017-10-11 03:56:10.234982|2017-10-11 03:56:10.234982
NCT01414400|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-11|||August 2011||2011-08-01|August 2011|2011-08-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde Cholangiopancreatography).|Prospective Study of Bacteremia and Infection Rates Following Cholangioscopy With the Spyglass Cholangioscope|Unknown status|Recruiting|N/A|50|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 03:56:10.496252|2017-10-11 03:56:10.496252
NCT01414387|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-07-31|||October 2011|Actual|2011-10-01|July 2017|2017-07-01|February 12, 2016|Actual|2016-02-12|February 12, 2016|Actual|2016-02-12||Interventional|||Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting|Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting|Terminated||N/A|33|Actual|Dallas VA Medical Center||2||"Therapy for carotid disease has recently changed. Carotid stenting is now restricted to high   risk patients that are not eligible for the study."|f||||f||||||||||2017-10-11 03:56:10.645231|2017-10-11 03:56:10.645231
NCT01414374|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-02-12|||January 2012||2012-01-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency|Prevalence of Genetic Polymorphisms of DMT1 and Ferroportin Enzymes in Adults With Anemia by Iron Deficiency, and Its Influence on the Efficacy of Conventional and Herbal Treatments|Completed||Phase 3|50|Actual|Casa Espirita Terra de Ismael||2|||f||||f||||||||||2017-10-11 03:56:10.805734|2017-10-11 03:56:10.805734
NCT01414361|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-10|||March 2009||2009-03-01|August 2011|2011-08-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Observational|||Fractional Flow Reserve and Intravascular Ultrasound in Evaluating Intermediate Coronary Lesions|Comparison of Fractional Flow Reserve (FFR) and Minimal Luminal Area (MLA) by Intravascular Ultrasound (IVUS) in Evaluating Intermediate Coronary Artery Stenosis: International Multi-center Study|Unknown status|Recruiting|Phase 4|1000|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 03:56:10.893532|2017-10-11 03:56:10.893532
NCT01414348|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2015-01-26|||March 2012||2012-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Managing Dysexecutive Syndrome (DS): CIHR 2011-2014|Managing the Dysexecutive Syndrome Following Traumatic Brain Injury: An Ecologically Valid Rehabilitation Approach|Completed||N/A|95|Actual|Baycrest||2|||f||||t||||||||||2017-10-11 03:56:11.031413|2017-10-11 03:56:11.031413
NCT01414335|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-10|||October 2009||2009-10-01|August 2011|2011-08-01|September 2010|Actual|2010-09-01|February 2010|Actual|2010-02-01||Interventional|||Amino Acid Composition Reduces Frequency of Common Cold. Results of a Controlled Completely Masked Trial|Amino Acid Composition Reduces Frequency of Common Cold. Results of a Controlled Randomized Completely Masked Trial|Completed||N/A|145|Actual|Kyberg Vital GmbH||2|||f||||f||||||||||2017-10-11 03:56:11.128429|2017-10-11 03:56:11.128429
NCT01414322|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-10|||September 2011||2011-09-01|August 2011|2011-08-01|September 2012|Anticipated|2012-09-01|March 2012|Anticipated|2012-03-01||Observational|||Documentation of Continuous Wheeze and Cough Dynamics in Pediatric ER SOB Patients||Unknown status|Not yet recruiting|N/A|45|Anticipated|KarmelSonix Ltd.|||3||f||||f||||||||||2017-10-11 03:56:11.220545|2017-10-11 03:56:11.220545
NCT01414309|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-01-05|||August 2011||2011-08-01|January 2015|2015-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea|Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea|Terminated||N/A|5|Actual|Respicardia, Inc.|||1|Change in company priorities|f||||f||||||||||2017-10-11 03:56:11.295645|2017-10-11 03:56:11.295645
NCT01414296|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-11-12|||January 2009||2009-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|||Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer|Extended 39-Week Study of PSMA ADC Following the Initial 12-Week Dose-escalation Study in Subjects With Progressive, Castration-resistant, Metastatic Prostate Cancer|Completed||Phase 1|10|Actual|Progenics Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:56:11.382337|2017-10-11 03:56:11.382337
NCT01414283|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-10-31|||October 2008||2008-10-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional|||Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer|A Phase 1 Dose-escalation Study of PSMA ADC in Subjects With Progressive, Castration-resistant, Metastatic Prostate Cancer|Completed||Phase 1|52|Actual|Progenics Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 03:56:11.459912|2017-10-11 03:56:11.459912
NCT01413113|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-11-04|||December 2011||2011-12-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|November 2013|Actual|2013-11-01||Interventional|||Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery|A Phase I Clinical Trial of Pazopanib in Combination With Escalating Doses of Radioactive 131I in Patients With Well-Differentiated Thyroid Carcinoma Refractory to Radioiodine, Despite Having Some Uptake|Completed||Phase 1|6|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 03:56:11.528569|2017-10-11 03:56:11.528569
NCT01413100|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-01-18|||September 15, 2011|Actual|2011-09-15|January 2017|2017-01-01||||September 1, 2019|Anticipated|2019-09-01||Interventional|STAT||Scleroderma Treatment With Autologous Transplant (STAT) Study|A Phase II Multi-center Study of High-Dose Cyclophosphamide and Antithymocyte Globulin Followed by Autologous Hematopoietic Cell Transplantation With Post Transplant Maintenance for the Treatment of Systemic Sclerosis|Recruiting||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 03:56:11.628447|2017-10-11 03:56:11.628447
NCT00000340|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||June 1996||1996-06-01|August 2008|2008-08-01||||||||Interventional|||Pemoline in the Treatment of Stimulant Dependence - 5|Pemoline in the Treatment of Stimulant Dependence|Withdrawn||Phase 2|0|Actual|National Institute on Drug Abuse (NIDA)||||Study was never funded.|f||||||||||||||2017-10-11 04:17:47.241162|2017-10-11 04:17:47.241162
NCT01413087|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2012-08-09|||September 2011||2011-09-01|May 2012|2012-05-01|September 2015|Anticipated|2015-09-01|September 2013|Anticipated|2013-09-01||Interventional|LAPC-BC-819||Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma|A Multi-Center, Open-Label, Randomized, Phase 2b Study to Evaluate the Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma|Unknown status|Active, not recruiting|Phase 2|70|Anticipated|BioCancell Ltd.||1|||f||||f||||||||||2017-10-11 03:56:11.883076|2017-10-11 03:56:11.883076
NCT01413074|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2016-05-17|||June 2011||2011-06-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China|A Prospective, Randomized, Multicenter, Open-Label, Interventional Study Comparing Survival in Subjects Receiving Peritoneal Dialysis vs Hemodialysis in China|Terminated||Phase 4|416|Actual|Baxter Healthcare Corporation||2|||f||||t||||||||||2017-10-11 03:56:11.990961|2017-10-11 03:56:11.990961
NCT01413061|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-06-27|||June 2010||2010-06-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|February 2017|Actual|2017-02-01||Interventional|||Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft|Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft|Active, not recruiting||N/A|140|Actual|AlloSource||2|||f||||f||||||||||2017-10-11 03:56:12.091277|2017-10-11 03:56:12.091277
NCT01413048|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-07|2011-08-08|||January 2011||2011-01-01|August 2011|2011-08-01|September 2012|Anticipated|2012-09-01|March 2012|Anticipated|2012-03-01||Interventional|||Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension|Phase III Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 Versus Carvedilol in Patient With Stage 1 to 2 Essential Hypertension|Unknown status|Recruiting|Phase 3|260|Anticipated|Ahn-Gook Pharmaceuticals Co.,Ltd||2|||f||||t||||||||||2017-10-11 03:56:12.186237|2017-10-11 03:56:12.186237
NCT01413035|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-08|||July 2011||2011-07-01|July 2011|2011-07-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes|Safety/Efficacy Assessed Study on Transplantation Therapy Using Human Umbilical Cord/Placenta-derived Mesenchymal Stem Cells for Type 2 Diabetes Mellitus|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Shandong University||3|||f||||t||||||||||2017-10-11 03:56:12.281706|2017-10-11 03:56:12.281706
NCT01413022|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2016-09-15|||April 2012||2012-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|October 2013|Actual|2013-10-01||Interventional|||FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma|Phase IB Study of FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma|Completed||Phase 1|44|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:56:12.36832|2017-10-11 03:56:12.36832
NCT01413009|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-01-03|||November 2010||2010-11-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|April 2012|Actual|2012-04-01||Observational|ABCDE||Awakening-Breathing Coordination, Delirium Monitoring/Management & Early Mobility (ABCDE) Protocol|Awakening-Breathing Coordination, Delirium Monitoring/Management & Early Mobility (ABCDE) Protocol|Unknown status|Active, not recruiting|N/A|200|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 03:56:12.541851|2017-10-11 03:56:12.541851
NCT01412996|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2012-02-24|||November 2009||2009-11-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Quality of Life Measures After Single Access Vs Conventional Laparoscopic Cholecystectomy: Prospective Randomized Study.|Single Access Laparoscopic Cholecystectomy|Completed||N/A|250|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 03:56:12.730727|2017-10-11 03:56:12.730727
NCT01412983|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2014-03-27|2014-03-27||August 2011||2011-08-01|March 2014|2014-03-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional||All participants enrolled in the study|A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens|A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens|Completed||N/A|100|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 03:56:12.834568|2017-10-11 03:56:12.834568
NCT01412970|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-08-11|||July 2016||2016-07-01|August 2015|2015-08-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Non-invasive Measurement of Central Hemodynamics by Electrical Impedance Tomography|Non-invasive Measurement of Central Hemodynamics and Heart-lung Interactions by Electrical Impedance Tomography|Unknown status|Not yet recruiting|N/A|30|Anticipated|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-10-11 03:56:13.077877|2017-10-11 03:56:13.077877
NCT01414244|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-08-07|2017-04-10||November 2010||2010-11-01|August 2017|2017-08-01|December 30, 2015|Actual|2015-12-30|December 30, 2015|Actual|2015-12-30||Interventional|AT005291||Glutamine for the Treatment of Patients With Irritable Bowel Syndrome|Randomized, Placebo-Controlled Trial of Glutamine for the Treatment of Patients With Irritable Bowel Syndrome|Completed||Phase 2|106|Actual|Tulane University||2|||f||||t||||||||||2017-10-11 03:56:13.326092|2017-10-11 03:56:13.326092
NCT01414231|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-10|||April 2002||2002-04-01|April 2008|2008-04-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Interventional|OSHO#061||Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a|Randomised Comparison of OSHO Induction vs. the German AML Intergroup Standard, Randomised Comparison of AraC/Mtx vs. Flu/AraC/Mtx in Pts Without CR After One Induction Cycle and Randomized Comparison of One vs. Two Consolidation Therapies.|Unknown status|Recruiting|Phase 3|850|Anticipated|University of Leipzig||2|||f||||t||||||||||2017-10-11 03:56:13.61281|2017-10-11 03:56:13.61281
NCT01414218|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2011-08-10|||January 2011||2011-01-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Impact of a Humor Seminar on General Well Being, Quality of Life and Psychological Distress Among Community Dwelling Elders|Influence of Humor as a Way of Life on Well Being, Quality of Life and Immune Function|Completed||N/A|92|Actual|Happy Nation Society||1|||f||||f||||||||||2017-10-11 03:56:13.698422|2017-10-11 03:56:13.698422
NCT01414205|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2017-03-20|2014-03-21||October 31, 2011|Actual|2011-10-31|March 2017|2017-03-01|March 31, 2016|Actual|2016-03-31|March 31, 2013|Actual|2013-03-31||Interventional|||A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)|An Open-label, Multicenter, Randomized Phase II Trial Comparing the Efficacy, Safety, and Pharmacokinetics of GA101 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia|Completed||Phase 2|80|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 03:56:13.803597|2017-10-11 03:56:13.803597
NCT01414192|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-06-05|2015-09-14||November 15, 2008|Actual|2008-11-15|June 2017|2017-06-01|September 15, 2014|Actual|2014-09-15|September 15, 2014|Actual|2014-09-15||Observational|MOBS||A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)|Model-Observation Bridging Study (MOBS) for Ezetrol® and Inegy®|Completed||N/A|3215|Actual|Merck Sharp & Dohme Corp.|||4||f||||f||||||||||2017-10-11 03:56:14.722181|2017-10-11 03:56:14.722181
NCT01414179|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2011-08-10|||October 2010||2010-10-01|August 2010|2010-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|NESCAV||NESCAV Nutrition Environment and Cardiovascular Health|Nutrition Environnement et Santé Cardio Vasculaire NESCAV|Unknown status|Recruiting|N/A|800|Anticipated|Central Hospital, Nancy, France|||1||f||||f||||||Samples Without DNA|"     Blood and urinary biological taking away: glycemia, HbA1C, insulin (specific study analyzes),     total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, apolipoproteines A1 and     B, numeration of blood picture, creatinin, uric acid, gamma WP, GOT, GPT, CRP; and a urinary     collection (a micturition) in order to proportion the microalbuminurie. A plasmathèque will     be made up, in order to measure later on biomarqueurs of the cardiovascular risk (biological     collection stored with the CIC). A measurement of pollutants and poisons will be carried out     starting from taking away of hair.   "|||2017-10-11 03:56:15.179419|2017-10-11 03:56:15.179419
NCT01414166|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-04-27|2013-11-21||September 2011||2011-09-01|April 2015|2015-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)|A 16-Week, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Extended Release Niacin/Laropiprant in South and Southeast Asians Not on a Lipid Modulating Agent, With Decreased High-Density Lipoprotein Cholesterol and Low- Density Lipoprotein Cholesterol at or Below NCEP ATP III Goal|Terminated||Phase 3|244|Actual|Merck Sharp & Dohme Corp.|Due to the small number of participants completing the study (n=70), the resulting underpowered nature of any analyses that might be conducted, and the fact that data are not going to be used, no efficacy analyses were performed.|2||"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a   significant increase in incidence of some types of non-fatal SAEs"|f||||f||||||||||2017-10-11 03:56:15.269721|2017-10-11 03:56:15.269721
NCT01414153|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-08-22|2016-06-27||August 2012||2012-08-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|May 2015|Actual|2015-05-01||Interventional|Nexus||Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD|Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)|Completed||Phase 2|158|Actual|Lpath, Inc.||4|||f||||t||||||||No||2017-10-11 03:56:15.735548|2017-10-11 03:56:15.735548
NCT01414140|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-10|2014-01-08|||May 2007||2007-05-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Mirena Post-marketing Surveillance in Japan|Drug Use Investigation of Mirena|Completed||N/A|567|Actual|Bayer|||1||f||||||||||||||2017-10-11 03:56:17.09037|2017-10-11 03:56:17.09037
NCT01414114|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-02-27|2017-02-27|2015-07-08|December 5, 2011||2011-12-05|February 2017|2017-02-01|May 21, 2012|Actual|2012-05-21|May 21, 2012|Actual|2012-05-21||Interventional|||Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder|A Single-arm, Open-label, Multicenter, Dose Titration Study of KAI-4169 to Treat Secondary Hyperparathyroidism in Hemodialysis Subjects With Chronic Kidney Disease-Mineral and Bone Disorder|Completed||Phase 2|37|Actual|KAI Pharmaceuticals||1|||f||||f|t|f||||||||2017-10-11 03:56:17.179958|2017-10-11 03:56:17.179958
NCT01414101|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-05-16|||August 2011||2011-08-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ISIS 329993 in Subjects With Rheumatoid Arthritis|Completed||Phase 2|51|Actual|Ionis Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 03:56:17.505019|2017-10-11 03:56:17.505019
NCT01414088|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2013-05-17|||April 2011||2011-04-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|NARA||The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects|The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers for the Measurement of Sodium and Water Channel Activity in the Nephron in Healthy Young Subjects|Completed||N/A|23|Actual|Regional Hospital Holstebro||3|||f||||t||||||||||2017-10-11 03:56:17.608251|2017-10-11 03:56:17.608251
NCT01414075|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-04-18|||July 2011||2011-07-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study of FG-4592 to Correct Anemia in New Dialysis Patients||Completed||Phase 2|55|Actual|FibroGen||1|||f||||t||||||||||2017-10-11 03:56:17.695181|2017-10-11 03:56:17.695181
NCT01414062|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2016-05-19|||January 2011||2011-01-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Cocinar Para su Salud! (Cook for Your Life!)|Cocinar Para su Salud! (Cook for Your Life!): Implementing Dietary Change Among Hispanic Breast Cancer Survivors|Active, not recruiting||N/A|82|Actual|Columbia University||2|||f||||t||||||||Undecided||2017-10-11 03:56:17.791972|2017-10-11 03:56:17.791972
NCT01414049|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-03-25|||August 2011||2011-08-01|March 2014|2014-03-01|September 2015|Anticipated|2015-09-01|January 2015|Anticipated|2015-01-01||Interventional|PATENCY||Patency-Coronary Trial|PATency assessmENt of Grafts by Computerized tomographY in CORONARY Patients: the PATENCY-CORONARY Trial|Unknown status|Recruiting|N/A|1200|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 03:56:17.878415|2017-10-11 03:56:17.878415
NCT01413425|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-06-30|||June 29, 2011||2011-06-29|October 20, 2014|2014-10-20|October 20, 2014||2014-10-20|||||Observational|||A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome|Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:56:25.750523|2017-10-11 03:56:25.750523
NCT01414036|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-02-22|2016-01-26||October 2011||2011-10-01|February 2016|2016-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pilot Study of Patient Navigation to Promote Smoking Cessation|Primary Care-based Patient Navigation to Promote Smoking Cessation Treatment: a Pilot Randomized Controlled Trial|Completed||N/A|47|Actual|Boston University||2|||f||||f||||||||Yes|"J Ethn Subst Abuse. 2013 ; 12(4): . doi:10.1080/15332640.2013.819311.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827692/"|2017-10-11 03:56:18.001072|2017-10-11 03:56:18.001072
NCT01414023|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-07-20|||July 2011||2011-07-01|July 2015|2015-07-01||||July 2012|Actual|2012-07-01||Interventional|CCT-OC||Assessing the Effects of a Neurobehavioral Intervention on Symptoms of Obsessive Compulsive Disorder||Completed||N/A|48|Actual|Boston University||2|||f||||f||||||||||2017-10-11 03:56:18.239873|2017-10-11 03:56:18.239873
NCT01414010|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-06-25|2015-12-29||August 2011||2011-08-01|June 2017|2017-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota|Effects of Mushroom Extract, S Boulardii and Amoxicillin on the Human Microbiome|Completed||N/A|32|Actual|Beth Israel Deaconess Medical Center||4|||f||||f||||||||||2017-10-11 03:56:18.32957|2017-10-11 03:56:18.32957
NCT01413997|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-09|||April 2011||2011-04-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|CTMM1||Connective Tissue Motion Measure|Feasibility Study of Connective Tissue Motion Measure - a Biomarker for Perimuscular Connective Tissue Pathology.|Completed||N/A|39|Actual|Stromatec, Inc.|||2||f||||t||||||||||2017-10-11 03:56:18.919684|2017-10-11 03:56:18.919684
NCT01413984|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-03-17|||November 2010||2010-11-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Substance Abuse and Trauma in Incarcerated Women|Substance Abuse and Trauma in Incarcerated Women: An Effectiveness Study|Completed||N/A|95|Actual|University of Tulsa||2|||f||||t||||||||||2017-10-11 03:56:18.976434|2017-10-11 03:56:18.976434
NCT01413958|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-02-20|2012-10-08||August 2011||2011-08-01|February 2015|2015-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)|A Randomized, Placebo-Controlled Trial to Evaluate the Effects of Phenylephrine HCl 30 mg Extended-Release Tablets on Nasal Congestion in Subjects With Allergic Rhinitis|Completed||Phase 3|575|Actual|Bayer||2|||f||||f||||||||||2017-10-11 03:56:19.19784|2017-10-11 03:56:19.19784
NCT01413945|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-12-28|||October 2010||2010-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Ileocecal Sphincter Reflex by Cecal Distension During Colonoscopy|Evaluation of the Ileocecal Valve in Patients With and Without Irritable Bowel Syndrome.(IBS)|Recruiting||N/A|50|Anticipated|Northwell Health|||2||f||||f||||||||No||2017-10-11 03:56:19.860485|2017-10-11 03:56:19.860485
NCT01413932|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2015-11-17||2015-11-17|July 2011||2011-07-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder|A Two-part Study: Part 1 is a Multiple-dose (7-day), Open-label Evaluation of the Safety, Tolerability, and Pharmacokinetics of HT-2157 in Healthy Subjects. Part 2 is a Randomized, Double-blind, Placebo-controlled, Multiple (21-day) Ascending-dose Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HT-2157 in Patients With Major Depressive Disorder|Completed||Phase 1/Phase 2|26|Actual|Dart NeuroScience, LLC||2|||f||||f||||||||||2017-10-11 03:56:19.95444|2017-10-11 03:56:19.95444
NCT01413906|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2013-05-31|||November 2011||2011-11-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors|Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors|Completed||Phase 1|12|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 03:56:20.034937|2017-10-11 03:56:20.034937
NCT01413893|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-08-01|||June 2011||2011-06-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors|An Extension Study of Linifanib in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|35|Actual|Abbott||1|||f||||f||||||||||2017-10-11 03:56:20.119853|2017-10-11 03:56:20.119853
NCT01413867|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-12-10|||March 2011||2011-03-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EEA/PPH2011||Safety and Short Term Effectiveness of EEA Versus PPH Stapler for III Degree Hemorrhoids|Safety and Short Term Effectiveness of EEA Stapler vs PPH Stapler in the Treatment of III Degree Haemorrhoids. Prospective Randomized Controlled Trial|Completed||Phase 3|120|Actual|Societa Italiana di Chirurgia ColoRettale||2|||f||||f||||||||||2017-10-11 03:56:20.202775|2017-10-11 03:56:20.202775
NCT01413854|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-10|||August 2011||2011-08-01|August 2011|2011-08-01||||April 2015|Anticipated|2015-04-01||Interventional|||Diclofenac add-on to Treatment as Usual for Suicidal Patients|"Antiinflammatoriska läkemedels Effekt för Att Minska Suicidalitet Hos Deprimerade Patienter Som Nyligen Har Gjort självmordsförsök"|Unknown status|Not yet recruiting|Phase 1/Phase 2|100|Anticipated|Region Skane||2|||f||||t||||||||||2017-10-11 03:56:20.279565|2017-10-11 03:56:20.279565
NCT01413841|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2012-08-09|||July 2011||2011-07-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|OXYPAIN||Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief|Phase II Randomised Study of Nasal Oxygen Treatment for Pain Relief During Percutaneous Coronary Interventions|Completed||Phase 2|300|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 03:56:20.367041|2017-10-11 03:56:20.367041
NCT01413828|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-08-16|||May 2011||2011-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer|Safety and Efficacy Evaluation of Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer|Completed||Phase 2/Phase 3|201|Actual|Peking Union Medical College Hospital||2|||f||||t||||||||Undecided||2017-10-11 03:56:20.437064|2017-10-11 03:56:20.437064
NCT01413815|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-01-13|||October 2010||2010-10-01|January 2016|2016-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected Patients|Effect of Oral Supplementation With the Amino Acid L-arginine on Peri- Operative Cardio-vascular Risk in Non-selected Patients - Role of Pre-operative Determination of Plasma ADMA Levels for Therapeutic Stratification.|Completed||N/A|269|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-10-11 03:56:20.533287|2017-10-11 03:56:20.533287
NCT01413802|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-06-02|||September 2011||2011-09-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|CoNeMoTS||Intra Operative Continuous Laryngeal Nerve Monitoring During Thyroid Surgery and Interpretation of the Post-operative Voice Quality in Relation to the Electromyography Data Obtained During Surgery|Intra Operative Continuous Laryngeal Nerve Monitoring During Thyroid Surgery and Interpretation of the Post-operative Voice Quality in Relation to the Electromyography Data Obtained During Surgery|Unknown status|Enrolling by invitation|N/A|100|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:56:20.636748|2017-10-11 03:56:20.636748
NCT01413789|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-04-15|||June 2011||2011-06-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Measurement and Comparison of the Occlusive and Hydrating Capacity of Three Silicone Gels and One Gel Cream|Measurement and Comparison of the Occlusive and Hydrating Capacity of Three Silicone Gels: BAP Scar Gel, Dermatix, Kelocote and One Gel- Cream: Alhydran|Completed||N/A|55|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 03:56:20.708577|2017-10-11 03:56:20.708577
NCT01413776|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-03-14|||August 2011||2011-08-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effects of a Fortified Dietary Supplement for Pregnant Women on Maternal and Newborn Outcomes in Kampong Chhnang Province, Cambodia|Effects of a Fortified Dietary Supplement for Pregnant Women on Maternal and Newborn Outcomes in Kampong Chhnang Province, Cambodia|Completed||N/A|547|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:56:20.793326|2017-10-11 03:56:20.793326
NCT01413763|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2012-10-24|||July 2011||2011-07-01|October 2012|2012-10-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis|A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Medicis Global Service Corporation||2|||f||||f||||||||||2017-10-11 03:56:20.871205|2017-10-11 03:56:20.871205
NCT01413750|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2015-07-22|2015-06-05||November 2010||2010-11-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase II Randomized Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced Non-small Cell Lung Cancer|Terminated||Phase 1/Phase 2|23|Actual|National Cancer Institute (NCI)|Study was terminated early by NCI due to slow accrual.|2||Slow Accrual|f||||||||||||||2017-10-11 03:56:20.987392|2017-10-11 03:56:20.987392
NCT01413737|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2017-03-07|||January 2002|Actual|2002-01-01|March 2017|2017-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days|Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days|Completed||N/A|148|Actual|Norwegian University of Science and Technology|||1||f||||||||||||||2017-10-11 03:56:21.982724|2017-10-11 03:56:21.982724
NCT01413724|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-22|2016-08-02|||June 2010||2010-06-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Survey of Postoperative Pain and Pain Management in Norwegian Hospitals|Survey of Postoperative Pain and Pain Management in Norwegian Hospitals|Completed||N/A|300|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 03:56:22.058472|2017-10-11 03:56:22.058472
NCT01413711|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2012-09-12|||June 2012||2012-06-01|September 2012|2012-09-01||||September 2013|Anticipated|2013-09-01||Interventional|||An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms|An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms|Withdrawn||Phase 4|0|Actual|Lundbeck LLC||1|||f||||f||||||||||2017-10-11 03:56:22.147099|2017-10-11 03:56:22.147099
NCT01413698|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-09|||September 2011||2011-09-01|August 2011|2011-08-01|September 2012|Anticipated|2012-09-01|January 2012|Anticipated|2012-01-01||Observational|||Cough Count Validation||Unknown status|Not yet recruiting|N/A|20|Anticipated|KarmelSonix Ltd.|||1||f||||||||||||||2017-10-11 03:56:22.230655|2017-10-11 03:56:22.230655
NCT01413685|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2014-11-13|||January 2009||2009-01-01|November 2014|2014-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Calcineurin Activity in Renal Recipients|Interest of Calcineurin Activity for the Therapeutic Tacrolimus Monitoring in Renal Recipients|Terminated||Phase 4|23|Actual|Assistance Publique - Hôpitaux de Paris||1||no patient corresponding to criteria|f||||t||||||||||2017-10-11 03:56:22.300598|2017-10-11 03:56:22.300598
NCT01413672|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-06|2011-12-09|||August 2011||2011-08-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Preliminary Evaluation of CASTLE Barrier North American Prototype|Peristomal Skin Irritation: A Preliminary Evaluation of CASTLE Barrier North American Prototype|Completed||N/A|30|Actual|Hollister Incorporated|||1||f||||f||||||||||2017-10-11 03:56:22.399233|2017-10-11 03:56:22.399233
NCT01413659|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-24|||September 2011||2011-09-01|July 2011|2011-07-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|||Evaluation of the Effect of Preoperative Symbiotic Bowel Conditioning on Surgical Site Infection After Elective Colorectal Surgery||Unknown status|Not yet recruiting|Early Phase 1|150|Anticipated|Mashhad University of Medical Sciences||1|||f||||||||||||||2017-10-11 03:56:22.48851|2017-10-11 03:56:22.48851
NCT01413646|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-08-09|||February 2010||2010-02-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|Walnut2||Effects of Walnuts on Endothelial Function in Overweight Adults With at Least One Factor of Metabolic Syndrome|Effects of Walnuts on Endothelial Function in Overweight Adults With at Least One Factor of Metabolic Syndrome: A Randomized, Controlled, Cross-Over Trial|Completed||N/A|40|Actual|Griffin Hospital||2|||f||||f||||||||||2017-10-11 03:56:22.558891|2017-10-11 03:56:22.558891
NCT01413633|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-04-07|||January 2012||2012-01-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Novel Technique For Gall Bladder Fundus Retraction In Single Incision Laparoscopic Cholecystectomy|A Novel Technique For Gall Bladder Fundus Retraction In Single Incision Laparoscopic Cholecystectomy|Completed||N/A|34|Actual|Mansoura University||1|||f||||t||||||||||2017-10-11 03:56:22.65515|2017-10-11 03:56:22.65515
NCT01413620|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-08-17|||August 2011||2011-08-01|August 2016|2016-08-01|August 2021|Anticipated|2021-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Vitamin E Supplementation in Burn Patients|Vitamin E Supplementation in Burn Patients|Recruiting||Phase 1|300|Anticipated|Shriners Hospitals for Children||2|||f||||t||||||||No||2017-10-11 03:56:22.752013|2017-10-11 03:56:22.752013
NCT01413607|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-09|||September 2011||2011-09-01|August 2011|2011-08-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy|The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy|Unknown status|Not yet recruiting|Phase 4|250|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 03:56:22.88631|2017-10-11 03:56:22.88631
NCT01413594|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-09-08|||July 2011||2011-07-01|September 2011|2011-09-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|HABIT||Bimanual Training in Children With Hemiplegia|Randomized Clinical Trial of Hand Arm Bimanual Intensive Therapy (HABIT)|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-11 03:56:23.004463|2017-10-11 03:56:23.004463
NCT01413581|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-07-29|||May 2011||2011-05-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|LAIF||Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants|A Prospective, Randomized, Double-Blind, Phase 3 Study Comparing rhBSSL and Placebo Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants Born Before Week 32 of Gestational Age|Terminated||Phase 3|415|Actual|Swedish Orphan Biovitrum||2||Primary endpoint showed no stat significant difference. FU > M12 terminated.|f||||t||||||||||2017-10-11 03:56:23.126474|2017-10-11 03:56:23.126474
NCT01413568|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2016-02-25|||April 2012||2012-04-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies|A Phase I/II Study Evaluating the Safety and Efficacy of Intravenous POL6326 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies|Completed||Phase 1/Phase 2|38|Actual|Polyphor Ltd.||2|||f||||t||||||||||2017-10-11 03:56:23.546172|2017-10-11 03:56:23.546172
NCT01413555|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-06-02|||August 2011||2011-08-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Multicenter Blood Culture Quality Improvement|Multicenter Implementation of a Quality Improvement Program to Reduce Blood Culture Contamination in the Emergency Department|Completed||N/A|14889|Actual|Vanderbilt University||1|||f||||f||||||||||2017-10-11 03:56:23.670392|2017-10-11 03:56:23.670392
NCT01413542|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-10-05|2014-11-07||November 2011||2011-11-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional||This population represents the 29 participants (12 in Group 1; 17 in Group 2) who passed screening and completed at least one study arm. 1 subject did not complete the 2nd arm in Group 1. 4 subjects did not complete the second arm in Group 2. Results and baseline characteristics are presented inclusive of these patients.|Pharmacogenetics of Ace Inhibitor-Associated Angioedema|Pharmacogenetics of Ace Inhibitor-Associated Angioedema:Aim 1|Completed||N/A|44|Actual|Vanderbilt University||4|||f||||t||||||||||2017-10-11 03:56:23.844477|2017-10-11 03:56:23.844477
NCT01413529|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-08-21|||September 2011|Actual|2011-09-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users|HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users|Completed||Phase 2|35|Actual|University of Maryland||2|||f||||f||||||||||2017-10-11 03:56:24.679858|2017-10-11 03:56:24.679858
NCT01413516|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-06-01|2016-02-25||August 2011||2011-08-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|VIP||Varenicline In-Patient Study|A Two-Part Pilot Study of Dosing, Safety and Efficacy of Varenicline Initiated During an Acute Smoke-free Hospitalization and Continued Post-Hospitalization|Completed||Phase 2|17|Actual|Stanford University||2|||f||||t||||||||Undecided||2017-10-11 03:56:24.801444|2017-10-11 03:56:24.801444
NCT01413503|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-01-09|||May 1991||1991-05-01|January 2015|2015-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors|A Phase II Study of 131I-labeled Metaiodobenzylguanidine (MIBG) for Treatment of Patients With Metastatic or Unresectable Pheochromocytoma and Related Tumors|Completed||Phase 2|50|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 03:56:25.15615|2017-10-11 03:56:25.15615
NCT01413490|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-03-30|||May 2012||2012-05-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|HepRiACT||Hepatitis C Rimantadine and Antiviral Combination Therapy|A Clinical Study to Evaluate the Biological Effects of Administering Rimantadine in Patients With Hepatitis C Virus (HCV) Infection Alongside Standard Combination Therapy With Pegylated Interferon and Ribavirin|Completed||Phase 2|10|Actual|The Leeds Teaching Hospitals NHS Trust|||1||f||||t||||||Samples Without DNA|"     blood samples of patients undegoing standard combination therpay for hepatits c virus     infection   "|||2017-10-11 03:56:25.269501|2017-10-11 03:56:25.269501
NCT01413477|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2011-08-08|||August 2011||2011-08-01|August 2011|2011-08-01|June 2012|Anticipated|2012-06-01|February 2012|Anticipated|2012-02-01||Interventional|||Nickel Desensitization Using Topical Therapy|Nickel Desensitization Using Topical Therapy|Unknown status|Not yet recruiting|N/A|24|Anticipated|University of British Columbia||4|||f||||f||||||||||2017-10-11 03:56:25.347189|2017-10-11 03:56:25.347189
NCT01413464|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-07-18|||March 2011||2011-03-01|July 2013|2013-07-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|REPORT||The Risk of Venous Clotting in Patients After Renal Transplant|The Risk of Thromboembolism in Patients Post Renal Transplantation (REPORT) Study|Unknown status|Active, not recruiting|N/A|120|Actual|St. Joseph's Healthcare Hamilton|||1||f||||t||||||Samples With DNA|"     Plasma samples from participants are being banked at various timepoints.   "|||2017-10-11 03:56:25.468701|2017-10-11 03:56:25.468701
NCT01413451|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-06-30|||July 12, 2011||2011-07-12|November 15, 2013|2013-11-15|November 15, 2013|Actual|2013-11-15|November 15, 2013|Actual|2013-11-15||Interventional|||Amatuximab for High Mesothelin Cancers|A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers|Terminated||Early Phase 1|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:56:25.542207|2017-10-11 03:56:25.542207
NCT01413438|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-06-30|||July 15, 2011||2011-07-15|September 26, 2013|2013-09-26|September 26, 2013|Actual|2013-09-26|September 26, 2013|Actual|2013-09-26||Interventional|||Bevacizumab With or Without Surgery for Adult Glioblastomas|Prospective, Randomized Controlled Trial of Surgical Resection Prior to Bevacizumab Therapy for Recurrent Glioblastoma Multiforme|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:56:25.636473|2017-10-11 03:56:25.636473
NCT01413412|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-09-28|||December 2009||2009-12-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Full-thickness Skin vs. Synthetic Mesh in the Repair of Large Incisional Hernia|Full-thickness Skin vs. Synthetic Mesh in the Repair of Large Incisional Hernia - a Prospective Randomized Controlled Study|Unknown status|Active, not recruiting|N/A|50|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 03:56:25.839399|2017-10-11 03:56:25.839399
NCT01413399|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2012-08-03|||August 2011||2011-08-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Pilot Study of Intra-arrest Therapeutic Hypothermia in Patients Suffering Non-Traumatic Out of Hospital Cardiac Arrest|A Pilot Study of Intra-arrest Therapeutic Hypothermia in Patients Suffering Non-Traumatic Out of Hospital Cardiac Arrest|Completed||N/A|363|Actual|Carolinas Medical Center||2|||f||||t||||||||||2017-10-11 03:56:25.964032|2017-10-11 03:56:25.964032
NCT01413386|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-07-23|||September 2011||2011-09-01|July 2017|2017-07-01|April 23, 2013|Actual|2013-04-23|April 18, 2013|Actual|2013-04-18||Interventional|MIRAII||Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent|A Randomized Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent (Niti-S Mira-Cover II Biliary Stent) to the Common Covered Metallic Biliary Stent.|Terminated||Phase 3|74|Actual|Taewoong Medical Co., Ltd.||2||Delayed subject enrollment|f||||f||||||||||2017-10-11 03:56:26.120182|2017-10-11 03:56:26.120182
NCT01413373|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2012-10-15|||August 2008||2008-08-01|October 2012|2012-10-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|ACRO3D||3D Craniofacial Cephalometric Analysis|Clinical Validation of the Three-dimensional Computer Tomography Based Craniofacial Cephalometric Analysis|Unknown status|Recruiting|N/A|15|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-10-11 03:56:26.259192|2017-10-11 03:56:26.259192
NCT01413360|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-06-06|2015-05-20||August 2011||2011-08-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients|Phase 4 Study of High Dose Vitamin C in Chronic Hepatitis Patients|Completed||Phase 4|10|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 03:56:26.391879|2017-10-11 03:56:26.391879
NCT01413347|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-12-07|||August 2011||2011-08-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Method to Reduce Displacement of Double-lumen Tube|The Method to Reduce Displacement of Double-lumen Tube During Patient Positioning|Completed||N/A|100|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:56:26.612179|2017-10-11 03:56:26.612179
NCT01413334|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-09|||May 2011||2011-05-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|August 2011|Anticipated|2011-08-01||Observational|||Transluminal Attenuation Gradient Versus CT Fractional Flow Reserve|Noninvasive Diagnosis of Ischemia Causing Coronary Stenosis Using Coronary CT Angiograms (CCTA) : Comparison of Transluminal Attenuation Gradient (TAG) and Fractional Flow Reserve Computed From CCTA (FFR CT)|Unknown status|Recruiting|N/A|80|Anticipated|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 03:56:26.69271|2017-10-11 03:56:26.69271
NCT01413321|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-10-04|||December 2011|Actual|2011-12-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Observational|||Assessing Special Features of Impaired Gait After Acquired Brain Injury With an Instrumented Treadmill|The Reproducibility and Special Features of Hemiparetic Gait in People With Acquired Brain Injury (ABI) Assessed With an Instrumented Treadmill (Zebris)|Completed||N/A|35|Actual|Sheba Medical Center|||2||f||||f||||||||||2017-10-11 03:56:26.781558|2017-10-11 03:56:26.781558
NCT01413308|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-09|||September 2011||2011-09-01|August 2011|2011-08-01|September 2012|Anticipated|2012-09-01|March 2012|Anticipated|2012-03-01||Observational|||Pulmonary Functions Test in Patients After Fontan Operation|Long-term Effects on Pulmonary Function in Post- Fontan Operation|Unknown status|Enrolling by invitation|N/A|15|Actual|Rambam Health Care Campus|||1||f||||t||||||||||2017-10-11 03:56:26.872579|2017-10-11 03:56:26.872579
NCT01413295|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2014-11-03|||August 2011||2011-08-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer|Randomized Phase II Trial in Patients With Progressive Stage IV Colorectal Cancer to Two Lines of Chemotherapy, in Order to Compare the Best Supportive Treatment Versus Treatment With Dendritic Cells Plus the Best Supportive Treatment|Completed||Phase 2|52|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||t||||||||||2017-10-11 03:56:26.924506|2017-10-11 03:56:26.924506
NCT01413282|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2016-08-03|||July 2011||2011-07-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2014|Actual|2014-02-01||Interventional|BEACON||Better Evaluation of Acute Chest Pain With Computed Tomography Angiography|Better Evaluation of Acute Chest Pain With Computed Tomography Angiography - A Randomized Controlled Trial|Completed||N/A|500|Actual|Erasmus Medical Center||2|||f||||t||||||||No||2017-10-11 03:56:27.017965|2017-10-11 03:56:27.017965
NCT01413269|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2017-07-20|||June 2010||2010-06-01|July 2017|2017-07-01|September 2020|Anticipated|2020-09-01|September 2015|Actual|2015-09-01||Interventional|||Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery|Phase 3 Open-labeled Randomized Clinical Study of Comparing Hypofractionated and Conventional Radiotherapy for Breast Cancer Patients After Breast Conservative Surgery|Active, not recruiting||Phase 3|720|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:56:27.10384|2017-10-11 03:56:27.10384
NCT01413256|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2011-08-09|||October 2011||2011-10-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Allergenic Effect of Ambrosia in Israel||Unknown status|Not yet recruiting|N/A|200|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 03:56:27.189037|2017-10-11 03:56:27.189037
NCT01413243|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-05-05|||September 2012||2012-09-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|TRIOMS||Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome|Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome - A Monocentric, Prospective, Randomized, Double-blind and Placebo-controlled Phase 2 Trial|Terminated||Phase 2|50|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 03:56:27.236835|2017-10-11 03:56:27.236835
NCT01413230|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-11-23|||January 2010||2010-01-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|VITALUP||Vitamin D Supplementation in Systemic Lupus Erythematosus|Evaluation of Immunologic Response After Vitamin D Supplementation in Patients With Systemic Lupus Erythematosus|Completed||N/A|20|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"     blood with RNA   "|||2017-10-11 03:56:27.33401|2017-10-11 03:56:27.33401
NCT01413204|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-05-27|2014-03-26||July 2011||2011-07-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of TA-7284 as Monotherapy in the Treatment of Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|272|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-10-11 03:56:27.575185|2017-10-11 03:56:27.575185
NCT01413191|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-09|2015-06-25|2015-06-25||August 2011||2011-08-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|March 2013|Actual|2013-03-01||Interventional|||Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye|Phase II Study of IMC-A12 in Metastatic Uveal Melanoma|Completed||Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 03:56:28.40632|2017-10-11 03:56:28.40632
NCT01413178|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-03-29|||September 30, 2011|Actual|2011-09-30|March 2017|2017-03-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma|A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma|Active, not recruiting||Phase 3|205|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 03:56:30.363267|2017-10-11 03:56:30.363267
NCT01413152|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-12-26|||July 2011||2011-07-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|EP 49 EVARIST||Residual Risk Assessment Of HIV Transmission|EVALUATION DU RISQUE RESIDUEL DE TRANSMISSION DU VIH CHEZ DES HSH TRAITES AYANT UNE CHARGE VIRALE PLASMATIQUE INDETECTABLE|Completed||N/A|167|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-10-11 03:56:30.465683|2017-10-11 03:56:30.465683
NCT01413139|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-01|2013-09-30|||July 2010||2010-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|May 2011|Actual|2011-05-01||Interventional|4-EVER||4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease|4-EVER Study - Physician-Initiated Trial Investigating the Safety of the Full 4F Endovascular Treatment Approach of Infra-Inguinal Arterial Stenotic Disease|Completed||Phase 4|120|Actual|Flanders Medical Research Program||1|||f||||f||||||||||2017-10-11 03:56:30.54966|2017-10-11 03:56:30.54966
NCT01413126|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-08|||October 2009||2009-10-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|September 2010|Actual|2010-09-01||Interventional|||Peanuts Second Meal Glycemic Response|Acute and Second Meal Effects of Peanuts on Glycemic Response and Appetite in Obese Women With High Type 2 Diabetes Risk: a Randomized Crossover Trial|Completed||N/A|15|Actual|Federal University of Vicosa||3|||f||||f||||||||||2017-10-11 03:56:30.648032|2017-10-11 03:56:30.648032
NCT01412957|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-31|2017-02-07|2016-03-02|2015-07-21|November 2011||2011-11-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|June 2014|Actual|2014-06-01||Interventional|||Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer|A Phase 3, Multicenter, Randomized, Open-label Trial to Evaluate the Survival Benefit of Panitumumab and Best Supportive Care, Compared to Best Supportive Care Alone, in Subjects With Chemorefractory Wild-type KRAS Metastatic Colorectal Cancer|Completed||Phase 3|377|Actual|Amgen||2|||f||||t||||||||||2017-10-11 03:56:30.786883|2017-10-11 03:56:30.786883
NCT01412944|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2015-03-17|2015-01-28||December 2011||2011-12-01|March 2015|2015-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|STATURE||Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis|A Randomized, Double-blind, Double Dummy, Multicenter Study to Assess the Safety, Tolerability and Long-term Efficacy of Intravenous (10mg/kg) and Subcutaneous (300mg) Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Who Are Partial Responders to Secukinumab|Completed||Phase 3|43|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:56:32.223938|2017-10-11 03:56:32.223938
NCT01412931|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-04-22|||September 2011||2011-09-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Protein and Ultrasound Indicators of Preterm Birth|Protein and Ultrasound Indicators of Preterm Birth|Completed||N/A|3|Actual|University of Colorado, Denver|||3||f||||t||||||Samples With DNA|"     Cervicovaginal fluid and placental membranes will be retained for study.   "|||2017-10-11 03:56:34.988265|2017-10-11 03:56:34.988265
NCT01412918|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-01-29|2014-06-23||September 2011||2011-09-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional||The baseline participants with tinnitus demonstrating the Inhibitor™ Tinnitus Masking Device.|Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression|Clinical Evaluation of the Inhibitor Tinnitus Treatment Masking Device & SCN9 Gene Expression|Terminated||N/A|21|Actual|Medical College of Wisconsin||2||Lack of support to continue|f||||f||||||||No||2017-10-11 03:56:35.07029|2017-10-11 03:56:35.07029
NCT01412905|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-08|||February 2007||2007-02-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Observational|||Telemedicine Retinal Screening Utilizing a Mobile Medical Unit|Telemedicine Retinal Screening Utilizing a Mobile Medical Unit With a Trained Technician Accurately Detects Disease in High Risk Ethnically Diverse Populations: Results of a Project Dulce™ Retinal Screening Study|Completed||N/A|1229|Actual|Scripps Whittier Diabetes Institute|||1||f||||||||||||||2017-10-11 03:56:35.33018|2017-10-11 03:56:35.33018
NCT01412892|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2014-11-13|||April 2011||2011-04-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|NFitor||Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas|A Single Arm, Multicenter Phase II a Trial of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas That Cannot be Removed by Surgery|Completed||Phase 2|30|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 03:56:35.40984|2017-10-11 03:56:35.40984
NCT01412879|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-06|2017-05-04|2017-02-15||November 2011||2011-11-01|May 2017|2017-05-01|August 2021|Anticipated|2021-08-01|February 2016|Actual|2016-02-01||Interventional||All eligible patients who started treatment were included in the analysis|S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma|A Randomized Phase II Trial of R-HCVAD/MTX/ARA-C Induction Followed by Consolidation With an Autologous Stem Cell Transplant Vs. R-Bendamustine Induction Followed by Consolidation With an Autologous Stem Cell Transplant for Patients ≤ 65 Years of Age With Previously Untreated Mantle Cell Lymphoma|Terminated||Phase 2|53|Actual|Southwest Oncology Group||2||toxicity in one arm|f||||f||||||||||2017-10-11 03:56:35.586857|2017-10-11 03:56:35.586857
NCT01412853|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-06-20|||February 2008|Actual|2008-02-01|June 2016|2016-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|ERIS||Spectro-IRM and Evaluation Response to Prostatic Radiotherapy|Evaluation of the Response to Irradiation With MR-Spectroscopy for Localised Prostate Cancer Patients (The ERIS Trial)|Completed||N/A|90|Actual|Centre Georges Francois Leclerc||1|||f||||||||||||||2017-10-11 03:56:37.505999|2017-10-11 03:56:37.505999
NCT01412840|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-24|2017-01-22|||August 2015||2015-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Sterile Water Injections for Relieving Ureterolithiasis Pain|Sterile Water Injections as a Complementary Method for Relieving Ureterolithiasis Pain- a Randomized Controlled Trial|Active, not recruiting||N/A|90|Anticipated|University of Skövde||3|||f||||f||||||||||2017-10-11 03:56:37.571193|2017-10-11 03:56:37.571193
NCT01412827|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-07|2016-02-23|||April 2010||2010-04-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|March 2013|Actual|2013-03-01||Interventional|SPECT-Light||Accuracy of Half of the Usual Radiotracer Dose in SPECT|Diagnostic and Prognostic Accuracy of Stress SPECT Myocardial Perfusion Imaging With Half the Usual Radiotracer Dose|Completed||N/A|18|Actual|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-10-11 03:56:37.648307|2017-10-11 03:56:37.648307
NCT01412814|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-12-21|||July 2011||2011-07-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Biomechanics of Gait Pattern Adaptation in Patients After Total Knee Arthroplasty|Biomechanics of Gait Pattern Adaptation in Patients After Total Knee Arthroplasty|Completed||N/A|50|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 03:56:37.731607|2017-10-11 03:56:37.731607
NCT01412801|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2014-09-05|2014-06-20||September 2011||2011-09-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings|A Phase II Open-Label, Multi-Center Study of a Group B Streptococcus Vaccine in HIV Positive and HIV Negative Pregnant Women|Completed||Phase 2|270|Actual|Novartis||3|||f||||||||||||||2017-10-11 03:56:37.90376|2017-10-11 03:56:37.90376
NCT01412788|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-07|2011-08-08|||January 2007||2007-01-01|August 2011|2011-08-01||||January 2013|Anticipated|2013-01-01||Interventional|||Safety and Aesthetic Outcomes of Breast Conserving Surgery With Peri-areolar Incision Approach|Randomized Controlled Trial of Safety and Aesthetic Outcomes of Breast-conserving Surgery With the Peri-areolar Incision Approach|Unknown status|Recruiting|Phase 3|100|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 03:56:40.462769|2017-10-11 03:56:40.462769
NCT01412775|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2011-08-29|||August 2011||2011-08-01|August 2011|2011-08-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Psychological Group Intervention to Reduce Stress and Burnout Among Cardiac Intensive Care Nurses|The Contribution of a Short-term Psychological Group Intervention to Reduce Stress and Burnout Among Cardiac Intensive Care Nurses: A Pilot Study|Unknown status|Not yet recruiting|N/A|24|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 03:56:40.578814|2017-10-11 03:56:40.578814
NCT01412762|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-09-06|||July 2011||2011-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Measuring Patient Expectations for Thyroid Surgery|Measuring Patient Expectations for Thyroid Surgery: Development of a Patient-Reported Outcomes Instrument|Recruiting||N/A|70|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-10-11 03:56:40.65914|2017-10-11 03:56:40.65914
NCT01412749|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-06-27|||April 2011||2011-04-01|June 2013|2013-06-01||||June 2013|Actual|2013-06-01||Observational|TEST||TEST: Registry for Endoscopic Head and Neck Surgery|Transoral Endoscopic Surgery Trial (TEST): A Registry for Endoscopic Head and Neck Surgery (eHNS)|Terminated||N/A|2|Actual|M.D. Anderson Cancer Center|||1|Low Accrual|f||||f||||||||||2017-10-11 03:56:40.752357|2017-10-11 03:56:40.752357
NCT01412736|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-07|2014-12-21|||August 2011||2011-08-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|4563-003||A Phase IIa Study of KHK4563|A Phase IIa , Double-blind, Placebo-controlled Dose-ranging Study to Evaluate the Efficacy and Safety of KHK4563 in Adults With Uncontrolled, Suspected Eosinophilic Asthma|Completed||Phase 2|106|Actual|Kyowa Hakko Kirin Co., Ltd||4|||f||||f||||||||||2017-10-11 03:56:40.82159|2017-10-11 03:56:40.82159
NCT01412723|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-04-10|||October 2011||2011-10-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Ferrous Sulfate Versus Iron Amino Acid Chelate|EFICACIA DEL HIERRO AMINOQUELADO COMPARADO CON EL SULFATO FERROSO COMO COMPLEMENTO ALIMENTARIO EN PREESCOLARES CON DEFICIENCIA DE HIERRO.|Completed||Phase 3|64|Actual|CES University||2|||f||||f||||||||||2017-10-11 03:56:41.170633|2017-10-11 03:56:41.170633
NCT01412697|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2016-02-26|||September 2008||2008-09-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|June 2009|Actual|2009-06-01||Interventional|||An Intervention Targeting Fruit and Vegetable Intake Among Rural Youth|Fruit and Vegetable Intake Among Rural Youth Following a School-based Randomized Controlled Trial|Completed||N/A|1119|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 03:56:41.32793|2017-10-11 03:56:41.32793
NCT01412684|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-08-04|||September 2011||2011-09-01|May 2016|2016-05-01|September 2011|Actual|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|||Distal Pancreatectomy With Partial Splenectomy for Pancreatic Tumors|Pilot Study of Distal Pancreatectomy With Partial Splenectomy for Pancreatic Tumors Arising in the Body and Tail of the Pancreas|Withdrawn||N/A|0|Actual|University of Missouri-Columbia|||1|Never activated|f||||f||||||||||2017-10-11 03:56:41.400089|2017-10-11 03:56:41.400089
NCT01412671|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-07|2012-04-10|||February 2008||2008-02-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program|Special Drug Use Investigation of Nexavar (Unresectable or Advanced Renal Cell Carcinoma: Early Access Program)|Completed||N/A|117|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:56:41.46739|2017-10-11 03:56:41.46739
NCT01412658|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-07|2011-08-08|||November 2006||2006-11-01|August 2011|2011-08-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Clinical Safety of a Novel Milk Protein Peptide|Safety Study of Milk Peptide Supplementation in Healthy Volunteers: a Randomized Placebo Controlled Clinical Trial|Completed||Phase 1|73|Actual|Ambryx Biotechnology||2|||f||||t||||||||||2017-10-11 03:56:41.544533|2017-10-11 03:56:41.544533
NCT01412645|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2013-12-12|||August 2011||2011-08-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|LIRMOI||Long-term Investigation of Resveratrol in Obesity|Long-term Investigation of Resveratrol on Management of Metabolic Syndrome, Osteoporosis and Inflammation, and Identification of Plant Derived Anti-inflammatory Compounds|Completed||N/A|76|Actual|University of Aarhus||3|||f||||f||||||||||2017-10-11 03:56:41.632882|2017-10-11 03:56:41.632882
NCT01412619|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-12-24|||December 2008||2008-12-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|CSINVOS||Non-invasive Measurement of Regional Intracerebral Tissue Oxygenation in Elective Cardiac Surgeries|CSINVOS: Non-invasive Measurement of Regional Intracerebral Tissue Oxygenation in Elective Cardiac Surgeries|Completed||N/A|50|Anticipated|RWTH Aachen University|||1||f||||f||||||Samples Without DNA|"     Cytokine IL-6 Cytokine IL-10 Procalcitonin (PCT) S-100-Protein   "|||2017-10-11 03:56:41.870476|2017-10-11 03:56:41.870476
NCT01412606|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2012-08-28|||July 2009||2009-07-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|ESUS||Endometrial Scratching in Couples With Unexplained Subfertility|Endometrial Scratching in Couples With Unexplained Subfertility|Completed||Phase 2/Phase 3|105|Actual|Mansoura University||2|||f||||f||||||||||2017-10-11 03:56:41.956205|2017-10-11 03:56:41.956205
NCT01412593|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-08|||September 2011||2011-09-01|May 2011|2011-05-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis||Unknown status|Not yet recruiting|Phase 1/Phase 2|50|Anticipated|King Saud University||2|||f||||f||||||||||2017-10-11 03:56:42.037057|2017-10-11 03:56:42.037057
NCT01412580|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-03-23|||April 2002||2002-04-01|March 2017|2017-03-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Observational|CDS||In Utero Capacity Formation and Socio-economic Outcomes|The Contribution of Health in Utero to Capacity Formation, Education and Economic Outcomes: Experimental Evidence From Tanzania|Completed||N/A|4000|Actual|Harvard University|||1||f||||f||||||||No||2017-10-11 03:56:42.116669|2017-10-11 03:56:42.116669
NCT01412567|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-08-08|||October 2005||2005-10-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers|Comparison of Recombinant Hepatitis B Vaccine Plus Hepatitis B Immune Globulin (HBIG) Versus Vaccine Plus Placebo for Prophylaxis of Hepatitis B Infection in Newborns of Hepatitis B Surface Antigen (HBsAg) Positive Mothers|Completed||N/A|259|Actual|Govind Ballabh Pant Hospital||2|||f||||f||||||||||2017-10-11 03:56:42.195186|2017-10-11 03:56:42.195186
NCT01412541|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-03-30|2015-07-14||July 2011||2011-07-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|November 2013|Actual|2013-11-01||Interventional|LEVANT 2||Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries|A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal Arteries|Active, not recruiting||N/A|476|Actual|C. R. Bard||2|||f||||t||||||||||2017-10-11 03:56:42.416262|2017-10-11 03:56:42.416262
NCT01412528|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-28|2011-08-08|||August 2009||2009-08-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Phase II Study to Standardize Allergen Extracts: Determination of Biological Activity in HEP Units||Terminated||Phase 2|160|Anticipated|University of Zurich||1||Recruitment problems|f||||||||||||||2017-10-11 03:56:44.327262|2017-10-11 03:56:44.327262
NCT01412515|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2011-12-29|||June 2008||2008-06-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma|A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma|Terminated||Phase 2|11|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1||results from interim analysis conducted to study interruption|f||||f||||||||||2017-10-11 03:56:44.408758|2017-10-11 03:56:44.408758
NCT01412502|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-11-04|||June 2012||2012-06-01|October 2015|2015-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Post Traumatic Stress Among Relatives of Brain-dead, Withdrawal of Life Support, and Sudden Death Patients|Evaluation of Post Traumatic Stress Among the Nearest Relatives of Brain-dead, Withdrawal of Life Support, and Sudden Death Patients|Unknown status|Recruiting|N/A|294|Anticipated|Centre Hospitalier Universitaire de Nīmes|||3||f||||f||||||||||2017-10-11 03:56:44.554152|2017-10-11 03:56:44.554152
NCT01412489|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-03-24|||August 2011|Actual|2011-08-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|HYGEM||Intrauterine Adhesion Rate After Hysteroscopic Myomectomy and Application of HYALOBARRIER Gel|Prevention of Postsurgical Uterine Synechia With HyalobarrierR Gel Endo in Hysteroscopic Myomectomy : a Prospective Multicenter Study|Completed||N/A|189|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 03:56:44.667491|2017-10-11 03:56:44.667491
NCT01412476|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2012-03-23|||August 2010||2010-08-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|||||Observational|||Coenzyme Q10 and Vitamin A, C, E in Relation to the Oxidative Stress, Antioxidant Enzyme Activity and Inflammation in Subjects With Metabolic Syndrome||Completed||N/A|72|Actual|Chung Shan Medical University|||2||f||||t||||||Samples Without DNA|"     Blood samples   "|||2017-10-11 03:56:44.765376|2017-10-11 03:56:44.765376
NCT01412073|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2014-10-04|||September 2011||2011-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Control of Blood Loss During Caesarean Section|A Randomized Trial to Determine the Best Strategy for the Control of Blood Loss at Elective Caesarean Section|Completed||Phase 3|600|Actual|Cairo University||3|||f||||t||||||||||2017-10-11 03:56:51.923037|2017-10-11 03:56:51.923037
NCT01412463|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-09-30|||May 2011||2011-05-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|DURABILITY+||DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions|DURABILITY+ : a Prospective, Multi-center, Controlled Study Measuring the Durability in Lesions of the Superficial Femoral Artery of the Protégé Everflex+ Stent|Completed||Phase 4|60|Actual|Flanders Medical Research Program||1|||f||||t||||||||||2017-10-11 03:56:44.840824|2017-10-11 03:56:44.840824
NCT01412450|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-02|2013-09-30|||July 2010||2010-07-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|DUR-POP||Efficacity Study With the Protégé EverFlex Stent in Popliteal Lesions|DURABILITY-POP Study - Physician Initiated Trial Investigating the Efficacy of the Implant of Protégé EverFlex Nitinol Stents in Popliteal Lesions|Completed||Phase 4|60|Actual|Flanders Medical Research Program||1|||f||||t||||||||||2017-10-11 03:56:44.925193|2017-10-11 03:56:44.925193
NCT01412437|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-12-16|||April 2011||2011-04-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|PKU||Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria|Multimodal Neuroimaging and Neurocognitive Assessment of Biomarkers and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria|Withdrawn||N/A|0|Actual|Children's Research Institute||2||poor recruitment|f||||t||||||||||2017-10-11 03:56:45.033224|2017-10-11 03:56:45.033224
NCT01412424|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-07-14|2015-10-28||March 2012||2012-03-01|July 2017|2017-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Safety population: All participants enrolled in the study who received any amount of the study drug.|Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly|Efficacy and Safety of Oral Octreolin™ in Patients With Acromegaly Who Are Currently Receiving Parenteral Somatostatin Analogs|Completed||Phase 3|155|Actual|Chiasma, Inc.||1|||f||||t||||||||||2017-10-11 03:56:45.202033|2017-10-11 03:56:45.202033
NCT01412411|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-08|||October 2005||2005-10-01|March 2008|2008-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|CFS||Appropriate Complmentary Feeding Strategies in Infants|Appropriate Complementary Feeding Strategies in Infants: An Evaluation of Various Strategies to Assess the Growth and Health of the Infants.|Completed||N/A|470|Actual|Aga Khan University||3|||f||||t||||||||||2017-10-11 03:56:46.117717|2017-10-11 03:56:46.117717
NCT01412398|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-12-06|||April 2009||2009-04-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|April 2014|Actual|2014-04-01||Observational|FOSRENOL-CAPD||Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan|Special Drug Use Investigation of Fosrenol (Investigation for Patients With Continuous Cyclic Peritoneal Dialysis)|Completed||Phase 4|446|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:56:46.210117|2017-10-11 03:56:46.210117
NCT01412385|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2015-06-26|||August 2011||2011-08-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Immune Globulin Subcutaenous (Human), 20%|A Clinical Study of Immune Globulin Subcutaneous (Human) (IGSC), 20% for the Evaluation of Efficacy, Safety, and Pharmacokinetics in Subjects With Primary Immunodeficiency Diseases|Completed||Phase 2/Phase 3|55|Actual|Baxalta US Inc.||2|||f||||f||||||||||2017-10-11 03:56:46.305405|2017-10-11 03:56:46.305405
NCT01412372|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2017-03-20|||June 2010||2010-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|Mesalamine||The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study|The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study|Recruiting||Phase 3|68|Anticipated|University of Utah||2|||f||||t||||||||||2017-10-11 03:56:46.411513|2017-10-11 03:56:46.411513
NCT01412359|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-03-18|||June 2009||2009-06-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury|Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury|Enrolling by invitation||Phase 2|60|Anticipated|University of Pittsburgh||1|||f||||f||||||||No||2017-10-11 03:56:46.514233|2017-10-11 03:56:46.514233
NCT01412346|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-10-13|||January 2011||2011-01-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|June 2012|Actual|2012-06-01||Interventional|||Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish|Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish|Completed||N/A|111|Actual|National Institute for Health and Welfare, Finland||2|||f||||f||||||||||2017-10-11 03:56:46.601596|2017-10-11 03:56:46.601596
NCT01412333|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2017-07-17|2017-03-30|2016-10-21|September 20, 2011|Actual|2011-09-20|July 2017|2017-07-01|January 16, 2020|Anticipated|2020-01-16|May 12, 2015|Actual|2015-05-12||Interventional||Intent-to-treat (ITT) population included all randomized participants in the study.|A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis|A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate the Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis|Active, not recruiting||Phase 3|835|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 03:56:46.740544|2017-10-11 03:56:46.740544
NCT01412320|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-11-12|||August 2011||2011-08-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Cocoa Flavanols in Renal Disease|The Impact of Dietary Flavanols on Cardiovascular Dysfunction in End-stage Renal Disease|Completed||Phase 1/Phase 2|22|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-10-11 03:56:48.741484|2017-10-11 03:56:48.741484
NCT01412307|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-08-08|||July 2011||2011-07-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2015|Actual|2015-07-01||Interventional|LEBEN||A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma|A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine (LEBEN) in Relapsed and Primary Refractory Hodgkin Lymphoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|36|Anticipated|Fondazione Giovanni Pascale||1|||f||||t||||||||||2017-10-11 03:56:48.841848|2017-10-11 03:56:48.841848
NCT01412294|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-30|2017-07-26|||July 2011||2011-07-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer|Phase II Study to Evaluate Efficacy and Safety of Capecitabine/Cisplatin Combination Therapy in Gastric Cancer Patients Who Relapsed After S-1 Adjuvant Chemotherapy (XParTS)|Active, not recruiting||Phase 2|40|Anticipated|Epidemiological and Clinical Research Information Network||1|||f||||t||||||||||2017-10-11 03:56:48.945077|2017-10-11 03:56:48.945077
NCT00000341|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||August 1996||1996-08-01|August 2008|2008-08-01|August 2000|Actual|2000-08-01|||||Interventional|||Evaluation of Liquid vs. Tablet Buprenorphine - 6|Pharmacokinetics and Bioavailability of Liquid vs Tablet Buprenorphine|Completed||Phase 2|1||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.311697|2017-10-11 04:17:47.311697
NCT01412281|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2013-08-29|2012-10-23||October 2011||2011-10-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers|Randomized, Parallel-group, Double-blind, Single-center Phase III Study to Assess the Immunogenicity and Safety of the 2011/2012-season Influenza Vaccine Formulated With HA Antigen From Two Suppliers, in Elderly and Young Adult Subjects Using the Current EMA Regulations as Guideline|Completed||Phase 3|440|Actual|Crucell Holland BV||4|||f||||f||||||||||2017-10-11 03:56:49.034044|2017-10-11 03:56:49.034044
NCT01412268|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-08|2016-07-23|||August 2011||2011-08-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Observational|||Does Bariatric Surgery Changes Eating Habits and Addiction in Morbid Obesity?|Study of Eating Habits and Addiction Changes in Short and Long Time Follow-up in Morbidly Obese Patients Who Undergo Bariatric Surgery.|Completed||N/A|35|Actual|Bezmialem Vakif University|||1||f||||||||||||||2017-10-11 03:56:49.660077|2017-10-11 03:56:49.660077
NCT01412242|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2015-01-22|||March 2011||2011-03-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|PALLADIO||Simplification of the Diagnosis of Deep Vein Thrombosis|Identification of the Optimal Approach to the Ultrasound Diagnosis of Deep Vein Thrombosis of the Lower Extremities in Symptomatic Patients|Completed||Phase 3|1100|Actual|University of Padova||1|||f||||t||||||||||2017-10-11 03:56:49.72993|2017-10-11 03:56:49.72993
NCT01412229|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-07-05|2017-03-29||February 2012||2012-02-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|June 2015|Actual|2015-06-01||Interventional|||Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|A Phase II Study of Carboplatin, Nab-paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 2|40|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 03:56:49.850505|2017-10-11 03:56:49.850505
NCT01412216|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-11-06|||September 2011||2011-09-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|Bedrest||The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance|The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance|Terminated||Phase 2|5|Actual|University of California, San Francisco||2||Funding Depleted.|f||||||||||||||2017-10-11 03:56:50.349594|2017-10-11 03:56:50.349594
NCT01412203|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-10-10|||April 2005||2005-04-01|October 2013|2013-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|AS!BC||Evaluating the Effectiveness of the Dissemination of Action Schools! BC|Evaluating the Effectiveness of the Dissemination of Action Schools! BC: A Socio-ecological Intervention to Increase Physical Activity and Healthy Eating in School Children|Completed||N/A|1529|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 03:56:50.458189|2017-10-11 03:56:50.458189
NCT01412190|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2012-11-22|||April 2009||2009-04-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Study to Evaluate Restylane Vital Light Using an Injector Device|An Open, Randomized, Single-centre, Intra-individual Controlled, Explorative, Safety and Efficacy Study Comparing Restylane Vital White With no Treatment in the Face, Back of the Hands and décolletage, Using an Injector Device|Completed||N/A|30|Actual|Q-Med AB||2|||f||||f||||||||||2017-10-11 03:56:50.570491|2017-10-11 03:56:50.570491
NCT01412177|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-31|2015-08-18||2015-08-18|November 2013||2013-11-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||OTO-104 for the Treatment of Meniere's Disease|A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 2b Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease|Completed||Phase 2|154|Actual|Otonomy, Inc.||2|||f||||t||||||||||2017-10-11 03:56:50.87487|2017-10-11 03:56:50.87487
NCT01412164|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2016-02-19|2016-02-19||August 2011||2011-08-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2013|Actual|2013-02-01||Interventional|||Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)|A Prospective Multicenter Single-Arm Observational Registry Study Assessing the Safety and Efficacy of FIREHAWK Biodegradable Polymer Target-release Rapamycin-eluting Stent for the Treatment of Coronary Artery Disease: TARGET II|Active, not recruiting||N/A|730|Actual|Shanghai MicroPort Medical (Group) Co., Ltd.||1|||f||||t||||||||||2017-10-11 03:56:50.986538|2017-10-11 03:56:50.986538
NCT01412151|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-07-09|2012-11-28||April 2005||2005-04-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|CREST-X||Creatine Safety & Tolerability in Huntington's Disease|Creatine Safety & Tolerability in Huntington's Disease (CREST-X): A Single-Center, Open-Label, Long-Term Safety & Tolerability Extension Study of Creatine in Subjects With HD|Completed||Phase 2|10|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:56:51.166973|2017-10-11 03:56:51.166973
NCT01412138|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-04-21|||March 2011||2011-03-01|April 2015|2015-04-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Observational|||Somatic Stem Cells in Endometriosis|"Identification, Characterization and Isolation of Somatic Stem Cells in Human Endometrium of Women With Endometriosis"|Unknown status|Active, not recruiting|N/A|30|Anticipated|Igenomix|||1||f||||f||||||Samples With DNA|"     endometrial biopsy   "|||2017-10-11 03:56:51.356307|2017-10-11 03:56:51.356307
NCT01412125|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-10-08|||September 2003||2003-09-01|October 2014|2014-10-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Observational|BIOHD||Study of Biomarkers That Predict the Evolution of Huntington's Disease|Study of Biomarkers That Predict the Evolution of Huntington's Disease|Recruiting||N/A|1800|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||Samples With DNA|"     -  Blood (for DNA analysis) and plasma sample at inclusion visit        -  Plasma sample every year   "|||2017-10-11 03:56:51.428915|2017-10-11 03:56:51.428915
NCT01412112|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-02-08|||June 2010||2010-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:56:51.55033|2017-10-11 03:56:51.55033
NCT01412099|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-02-02|||March 2011||2011-03-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Nutrition and Physical Activity Counseling for Nontraditional College Students|Feasibility of a Health Promotion Program for Nontraditional College Students|Completed||N/A|60|Actual|Boston Medical Center||2|||f||||f||||||||||2017-10-11 03:56:51.58943|2017-10-11 03:56:51.58943
NCT01412086|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-09-27|2012-09-27||August 2011||2011-08-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Inter-rater and Intra-rater Reliability of the Global Eyebrow Assessment Scale||Completed||N/A|112|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:56:51.741556|2017-10-11 03:56:51.741556
NCT01412060|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2015-09-25||2015-09-25|August 2011||2011-08-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Cariprazine Relative to Placebo in the Prevention of Relapse of Symptoms in Patients With Schizophrenia|A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study of Cariprazine(RGH-188) in the Prevention of Relapse in Patients With Schizophrenia|Completed||Phase 3|766|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 03:56:52.031694|2017-10-11 03:56:52.031694
NCT01412047|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-08-23|||March 2012||2012-03-01|August 2017|2017-08-01|June 30, 2013|Actual|2013-06-30|June 2013|Actual|2013-06-01||Observational|||Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study|A Post Marketing, Multi-Center, Trial to Measure Human Anti-Human Antibodies (HAHA) to Soliris (Eculizumab) in Patients With Paroxysmal Nocturnal Hemoglobinuria|Completed||N/A|75|Actual|Alexion Pharmaceuticals|||1||f||||f|f|f||||||||2017-10-11 03:56:52.311674|2017-10-11 03:56:52.311674
NCT01412034|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2015-07-28||2015-07-28|November 2011||2011-11-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|October 2013|Actual|2013-10-01||Interventional|MODE||Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects|Modifying Orphan Disease Evaluation (MODE) Study: A Multicenter, Open-label Study of the Effects of CER-001 on Plaque Volume in Subjects With Homozygous Familial Hypercholesterolemia (HoFH)|Completed||Phase 2|23|Actual|Cerenis Therapeutics, SA||1|||f||||f||||||||||2017-10-11 03:56:52.431026|2017-10-11 03:56:52.431026
NCT01412021|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-07-28|||August 1, 2011||2011-08-01|July 2017|2017-07-01|June 30, 2018|Anticipated|2018-06-30|June 30, 2018|Anticipated|2018-06-30||Observational|||Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis|Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis|Active, not recruiting||N/A|100|Anticipated|AbbVie|||1||f||||||||||||||2017-10-11 03:56:52.577184|2017-10-11 03:56:52.577184
NCT01412008|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2013-09-27|||March 2010||2010-03-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle|Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion|Completed||N/A|5|Actual|New York Presbyterian Hospital||1|||f||||f||||||||||2017-10-11 03:56:53.022254|2017-10-11 03:56:53.022254
NCT01411982|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2015-01-08|||September 2011||2011-09-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Role of PACAP in Nehprotic Syndrome|Role of PACAP in Increased Platelet Count and Aggregability in Childhood Nephrotic Syndrome|Completed||N/A|29|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"     Blood and urine   "|||2017-10-11 03:56:53.180499|2017-10-11 03:56:53.180499
NCT01411969|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-08-05|||June 2010||2010-06-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Observational|ARENDS||Impact of External Nasal Dilator on the Rhinogram|Acoustic Rhinometry: Impact of External Nasal Dilator on the Two First Notches of the Rhinogram|Completed||N/A|16|Actual|University of Sao Paulo General Hospital|||1||f||||f||||||||||2017-10-11 03:56:53.237595|2017-10-11 03:56:53.237595
NCT01411956|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2011-08-05|||October 2009||2009-10-01|August 2011|2011-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||The Effect of a Targeted Video Intervention on Beliefs Regarding Hypertension|The Effect of a Targeted Video Intervention on Beliefs Regarding Hypertension|Completed||N/A|43|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 03:56:53.305501|2017-10-11 03:56:53.305501
NCT01411943|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-12-07|||January 2011||2011-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Observational|||Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer|Epigenetic Factors Associated With Symptoms and Complications of Chronic Disorders|Completed||N/A|75|Actual|Virginia Commonwealth University|||1||f||||f||||||Samples With DNA|"     This study will be examining cytokine and c-reactive protein levels, DNA methylation, DNA     repair proteins, telomere length and chromosomal instability.   "|||2017-10-11 03:56:53.382606|2017-10-11 03:56:53.382606
NCT01411930|ClinicalTrials.gov processed this data on October 10, 2017|2009-09-15|2012-12-19|||March 2009||2009-03-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|March 2010|Actual|2010-03-01||Interventional|||Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics|Acute Impact of IM Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics|Completed||Phase 4|15|Actual|Veterans Medical Research Foundation||2|||f||||f||||||||||2017-10-11 03:56:53.445388|2017-10-11 03:56:53.445388
NCT01411917|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-03-10|||August 2011||2011-08-01|March 2017|2017-03-01|November 30, 2015|Actual|2015-11-30|November 30, 2015|Actual|2015-11-30||Interventional|||Transversus Abdominis Plane Blocks for Ileostomy Takedown: A Prospective Study|Transversus Abdominis Plane Blocks for Ileostomy Takedown: A Prospective Study|Terminated||N/A|69|Actual|University of Wisconsin, Madison||2||Recruitment Difficulties due to some factors|f||||f||||||||||2017-10-11 03:56:53.544378|2017-10-11 03:56:53.544378
NCT01411904|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2015-12-10|||August 2010||2010-08-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia|A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia|Withdrawn||N/A|0|Actual|University of New Mexico||1||"The NPs that we have been buying from a vendor show lot to lot variation. We are making our own   NPs, need to characterize them before we enroll new patients."|f||||f||||||||||2017-10-11 03:56:53.632552|2017-10-11 03:56:53.632552
NCT01411891|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2015-10-01|2012-04-20||August 2011||2011-08-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Post-Operative Colonization Rates of Femoral Nerve Catheters Treated With Chlorhexidine-Impregnated Patch|Prospective Randomized Control Trial of Post-Operative Colonization Rates of Femoral Nerve Catheters With the Use of Chlorhexidine-Impregnated Patch|Completed||Phase 4|100|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 03:56:53.862896|2017-10-11 03:56:53.862896
NCT01411878|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-04-20|||September 2011||2011-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|March 2014|Actual|2014-03-01||Interventional|CHAMPS||Louisville Teen Pregnancy Prevention Project|Creating Healthy Adolescents Through Meaningful Prevention Services|Completed||N/A|1450|Actual|University of Louisville||2|||f||||t||||||||||2017-10-11 03:56:54.124991|2017-10-11 03:56:54.124991
NCT00005471|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1996||1996-09-01|March 2005|2005-03-01|January 2001|Actual|2001-01-01|||||Observational|||Anxiety and Cardiovascular Autonomic Control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.925702|2017-10-11 04:27:05.925702
NCT01411865|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-11-21|||August 2011||2011-08-01|November 2014|2014-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Evaluation of a Toolkit to Improve Cardiovascular Disease Screening and Treatment for People With Diabetes|Evaluation of a Toolkit to Improve Cardiovascular Disease Screening and Treatment for People With Diabetes|Completed||N/A|933789|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 03:56:54.243002|2017-10-11 03:56:54.243002
NCT01411839|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-08-23|||July 2008||2008-07-01|August 2011|2011-08-01|September 2011|Anticipated|2011-09-01|August 2011|Anticipated|2011-08-01||Interventional|||Depression and ART Adherence in HIV+ Latinos|Addressing Depression and ART Adherence in HIV+ Latinos on the U.S.-Mexico Border|Unknown status|Active, not recruiting|N/A|40|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 03:56:55.374585|2017-10-11 03:56:55.374585
NCT01411826|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2012-11-07|||July 2011||2011-07-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Online Programs to Promote Colon Cancer Screening|Online Programs to Promote Colon Cancer Screening|Completed||N/A|306|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 03:56:55.473135|2017-10-11 03:56:55.473135
NCT01411813|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2012-11-01|||November 2010||2010-11-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Alprazolam and Eating Behavior in Anorexia Nervosa|Alprazolam and Eating Behavior in Anorexia Nervosa|Completed||N/A|19|Actual|New York State Psychiatric Institute|||1||f||||t||||||||||2017-10-11 03:56:55.553794|2017-10-11 03:56:55.553794
NCT01411800|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-07-19|||August 2011||2011-08-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Interventional|||An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects|A Phase 1, Randomized, Open-Label, Two-Way Crossover Study of Two Oral Formulations of LX1033 in Healthy Human Subjects|Completed||Phase 1|28|Actual|Lexicon Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:56:55.618594|2017-10-11 03:56:55.618594
NCT01411787|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-05-31|||March 2009||2009-03-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|Bootcamp||Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer|"Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer Can we Kick Down Ki-67, Punch Out Insulin Resistance, and Increase Survival?"|Active, not recruiting||N/A|10|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 03:56:55.686918|2017-10-11 03:56:55.686918
NCT01411774|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2016-11-28|||June 2011||2011-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|||D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)|1/2 D-cycloserine Augmentation of CBT for Pediatric OCD|Active, not recruiting||Phase 3|150|Anticipated|University of South Florida||2|||f||||t||||||||||2017-10-11 03:56:57.246128|2017-10-11 03:56:57.246128
NCT01411761|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-05|||May 2011||2011-05-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Effect of Saccharomyces Boulardii on Indirect Hyperbilirubinemia and Phototherapy Duration in Very Low Birth Weight Infants|Phase 4 Study of Saccharomyces Boulardii on Indirect Hyperbilirubinemia|Unknown status|Recruiting|Phase 4|80|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||t||||||||||2017-10-11 03:56:57.403375|2017-10-11 03:56:57.403375
NCT01411748|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-05|||July 2011||2011-07-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants||Unknown status|Recruiting|Phase 4|140|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||t||||||||||2017-10-11 03:56:57.492198|2017-10-11 03:56:57.492198
NCT01411735|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-05|||July 2003||2003-07-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|June 2004|Actual|2004-06-01||Interventional|PIE-I||Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure|Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure|Completed||Phase 3|71|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 03:56:57.586132|2017-10-11 03:56:57.586132
NCT01411722|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-07-31|||September 2008||2008-09-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Electrical Activity of the Diaphragm During the Weaning Period|Electrical Activity of the Diaphragm in Mechanically Ventilated Patients During the Weaning Period|Completed||Phase 2|50|Actual|University of Turin, Italy||1|||f||||f||||||||||2017-10-11 03:56:57.695834|2017-10-11 03:56:57.695834
NCT01411709|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-03-27|||January 2011||2011-01-01|March 2015|2015-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study On The Effect Of Vitano® On Physiological And Psychological Responses To Psychological Stress|A Pilot Study On The Effect Of Vitano® On Physiological And Psychological Responses To Psychological Stress Assessed Under Laboratory Conditions And In Everyday Life|Completed||Phase 4|80|Actual|University of Surrey||2|||f||||f||||||||||2017-10-11 03:56:57.77261|2017-10-11 03:56:57.77261
NCT01411696|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2013-03-04|2013-03-04||July 2011||2011-07-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)||Completed||N/A|289|Actual|Allergan|||1||f||||f||||||||||2017-10-11 03:56:57.864297|2017-10-11 03:56:57.864297
NCT01411683|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-04-13|||September 2011||2011-09-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|December 2014|Actual|2014-12-01||Interventional|||Mandibular Overdentures Retained by Conventional or Mini Implants|Mandibular Overdentures Retained by Conventional or Mini Implants: a Randomized Clinical Trial|Completed||N/A|120|Actual|University of Sao Paulo||3|||f||||f||||||||No||2017-10-11 03:56:58.14746|2017-10-11 03:56:58.14746
NCT01411475|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-05|||August 2011||2011-08-01|August 2011|2011-08-01|August 2012|Anticipated|2012-08-01|August 2011|Anticipated|2011-08-01||Observational|LATINA||Prognostic Assessment of Different Pattern of Bifurcation Restenosis|Classification of Bifurcation Restenosis: a Prognostic Assessment|Unknown status|Recruiting|N/A|100|Anticipated|Ospedale Santa Maria Goretti|||1||f||||f||||||||||2017-10-11 03:57:02.722033|2017-10-11 03:57:02.722033
NCT01411670|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2015-12-01|||January 2011||2011-01-01|December 2015|2015-12-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|||Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.|Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock: Effects on Microcirculation and Organ Function.|Completed||Phase 2|60|Actual|University of Roma La Sapienza||3|||f||||f||||||||||2017-10-11 03:56:58.265317|2017-10-11 03:56:58.265317
NCT01411657|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2016-08-01|||April 2011||2011-04-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|||NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement||Completed||Phase 1|11|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 03:56:59.580393|2017-10-11 03:56:59.580393
NCT01411644|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-05-15|||January 2005||2005-01-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Pheno- & Genotyping POF (WHO III)|Phenotyping and Genotyping of Women Presenting With Ovarian Dysfunction Associated With a Hypergonadotropic Hypo-estrogenic Hormonal Status (WHO III) and Their First and Second Degree Relatives|Recruiting||N/A|650|Anticipated|UMC Utrecht|||1||f||||f||||||Samples With DNA|"     whole blood, serum and litium heparine   "|||2017-10-11 03:56:59.640873|2017-10-11 03:56:59.640873
NCT01411631|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-05-21|||March 2011||2011-03-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study to Investigate the Effect of Concord Grape Juice on Cognitive Function in Mums of Preteen Children|A Study to Investigate the Effect of Concord Grape Juice on Cognitive Function in Mums of Preteen Children|Completed||N/A|25|Actual|University of Leeds||2|||f||||f||||||||||2017-10-11 03:56:59.717194|2017-10-11 03:56:59.717194
NCT01411618|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2011-08-05|||June 2010||2010-06-01|February 2010|2010-02-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy of Essential Oil Mouthwash With and Without Alcohol: a 3-Day Plaque Accumulation Model|Efficacy of Essential Oil Mouthwash With and Without Alcohol: a 3-Day Plaque Accumulation Model|Completed||N/A|30|Actual|University of L'Aquila||2|||f||||t||||||||||2017-10-11 03:56:59.79963|2017-10-11 03:56:59.79963
NCT01411605|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2012-06-26|||September 2007||2007-09-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|VENTILOBE||Influence of Cardio-ventilatory Factors on Exercise Intolerance in Obese Adolescents: Effects of Exercise Training|Influence of Cardio-ventilatory Factors on Exercise Intolerance in Obese Adolescents: Effects of Exercise Training|Completed||N/A|40|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-10-11 03:56:59.869929|2017-10-11 03:56:59.869929
NCT01411592|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-09-04|2014-09-04||October 2006||2006-10-01|September 2014|2014-09-01|April 2018|Anticipated|2018-04-01|April 2008|Actual|2008-04-01||Interventional|||Single Retainer All-Ceramic Resin-bonded Fixed Dental Protheses|Randomized Clinical Trial on Single Retainer All-Ceramic Resin-bonded Fixed Dental Protheses: Impact of the Bonding System|Active, not recruiting||N/A|30|Actual|University of Kiel||2|||f||||t||||||||||2017-10-11 03:56:59.964374|2017-10-11 03:56:59.964374
NCT01411579|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2014-12-09|||February 2011||2011-02-01|December 2014|2014-12-01|February 2013|Actual|2013-02-01|February 2012|Actual|2012-02-01||Observational|||Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma|Assessment of Diffusion-weighted Magnetic Resonance (MR) Imaging to Predict Chemotherapy Outcome in Liver Metastases and Hepatocellular Carcinoma (HCC)|Completed||N/A|57|Actual|University of Florence|||2||f||||t||||||||||2017-10-11 03:57:00.785704|2017-10-11 03:57:00.785704
NCT01411566|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-02|2011-08-05|||January 2011||2011-01-01|February 2011|2011-02-01|December 2011|Anticipated|2011-12-01|November 2011|Anticipated|2011-11-01||Interventional|KLIPS||Clinical Intervention Psychosis and Addiction|Evaluation of an Integrative Therapeutic Concept for Schizophrenic Patients With Comorbid Substance Use Disorder|Unknown status|Recruiting|Early Phase 1|122|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-11 03:57:00.887552|2017-10-11 03:57:00.887552
NCT01411553|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2016-02-21|||September 2011||2011-09-01|February 2016|2016-02-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|ECG-LW||ECG Leadwires: Disposable Versus Cleaned, Reusable|ECG Leadwires: Do Disposable Leadwires Reduce the Incidence of Bacterial Infections in ICU Patients and Provide Adequate Signaling in Stepdown/Telemetry Environment Compared to Cleaned Reusable ECG Leadwires?|Completed||N/A|4056|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 03:57:00.999907|2017-10-11 03:57:00.999907
NCT01411540|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2017-01-06|||June 2010||2010-06-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of a Wholegrain Diet on Body Composition and Energy Balance|Effects of Diet on Body Composition|Completed||N/A|35|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-10-11 03:57:01.234856|2017-10-11 03:57:01.234856
NCT01411514|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2015-12-17|||August 2011||2011-08-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis|Phase IV Study of Oral Prednisone Taper vs. Placebo Following Intravenous Steroids for the Treatment of Acute Relapses in Multiple Sclerosis Within the Ticino Cohort|Terminated||Phase 4|27|Actual|Ospedale Civico, Lugano||2||Difficulties to recruit patients|f||||f||||||||||2017-10-11 03:57:01.449839|2017-10-11 03:57:01.449839
NCT01411501|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-11-08|2015-09-25||September 2011||2011-09-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety of Acupuncture for Functional Constipation|Efficacy and Safety of Acupuncture for Functional Constipation: a Multi-center Randomized Controlled Trial|Completed||Phase 3|684|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Unblinding of participants in the acupuncture and mosapride groups;an insufficient duration to assess the long term effect or risks;a missing assessment of electrocardiograms for possible cardiovascular harm of mosapride|4|||f||||t||||||||||2017-10-11 03:57:01.60596|2017-10-11 03:57:01.60596
NCT01411488|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2017-08-16|2017-04-18||January 2011||2011-01-01|April 2017|2017-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Comparative Study Between Two Fecal Management Systems||Completed||N/A|79|Actual|The Cleveland Clinic|Single center Small sample size restricted to medical intensive care and other adults requiring rectal tube placement|2|||f||||f||||||||||2017-10-11 03:57:02.493733|2017-10-11 03:57:02.493733
NCT01411436|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2015-03-03|||May 2009||2009-05-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|March 2014|Actual|2014-03-01||Observational|||Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan|Special Drug Use Investigation of Nexavar (Unresectable Hepatocellular Carcinoma)|Completed||N/A|1637|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:57:03.005321|2017-10-11 03:57:03.005321
NCT01411423|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2014-06-20|||April 2008||2008-04-01|June 2014|2014-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan|Special Drug Use Investigation of Nexavar (Unresectable or Advanced Renal Cell Carcinoma)|Completed||N/A|3305|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:57:03.099138|2017-10-11 03:57:03.099138
NCT01411397|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2011-08-05|||June 2005||2005-06-01|June 2005|2005-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Mesh Hernioplasty Of Strangulated Hernias With Intestinal Resection|Mesh Hernioplasty Of Strangulated Hernias With Intestinal Resection|Completed||N/A|163|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 03:57:03.480359|2017-10-11 03:57:03.480359
NCT01411384|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-02-21|||April 2008||2008-04-01|July 2011|2011-07-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||Evaluation of Corneal Hysteresis and Corneal Resistance Factor After Corneal Cross-linking for Keratoconus|Evaluation of Corneal Hysteresis and Corneal Resistance Factor After Corneal Cross-linking for Keratoconus|Completed||N/A|80|Actual|Democritus University of Thrace||1|||f||||f||||||||||2017-10-11 03:57:03.581009|2017-10-11 03:57:03.581009
NCT01411358|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-05|2012-07-10|||August 2011||2011-08-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Immunogenicity and Safety of AdimFlu-S 2011-2012 in Non-Elderly Adult and Elderly Subjects|Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2011-2012, in Non-Elderly Adult and Elderly Subjects|Completed||N/A|128|Actual|Adimmune Corporation||1|||f||||f||||||||||2017-10-11 03:57:03.781985|2017-10-11 03:57:03.781985
NCT01411345|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-08-31|||July 12, 2012||2012-07-12|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|MAPS||A Phase III Randomized Trial of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial|A Phase III Randomized Trial of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial|Recruiting||N/A|80|Anticipated|University of Miami||2|||f||||t|f|t|f|||||||2017-10-11 03:57:03.927263|2017-10-11 03:57:03.927263
NCT01411332|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-06-13|||October 31, 2011|Actual|2011-10-31|June 2017|2017-06-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Interventional|HEIGHT||Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial|A Phase III Trial of Hypofractionated External Beam Image-Guided Highly Targeted Radiotherapy: The HEIGHT Trial|Recruiting||N/A|72|Anticipated|University of Miami||2|||f||||t||||||||Yes|Some data after completion of the trial and publication of the primary endpoint. Additional data after publication of the secondary endpoints.|2017-10-11 03:57:04.075918|2017-10-11 03:57:04.075918
NCT01411319|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-04-10|||December 27, 2011|Actual|2011-12-27|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|LEAD||MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer|A Phase I Trial of MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer|Active, not recruiting||N/A|25|Anticipated|University of Miami||1|||f||||t||||||||||2017-10-11 03:57:04.193653|2017-10-11 03:57:04.193653
NCT01411306|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-10-27|||May 2011||2011-05-01|October 2016|2016-10-01||||November 2015|Actual|2015-11-01||Observational|||Screening for Swallowing Problems in Patients Following Prolonged Intubation: Validation of the Toronto Bedside Swallowing Screening Test (TOR-BSST©)||Completed||N/A|100|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 03:57:04.316738|2017-10-11 03:57:04.316738
NCT01411293|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-01-03|||August 2011||2011-08-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|August 2012|Actual|2012-08-01||Interventional|||Vasoprotective Activities of Low-Fat Milk in Individuals With Metabolic Syndrome|Vasoprotective Activities of Low-Fat Milk in Individuals With Metabolic Syndrome|Completed||N/A|21|Actual|University of Connecticut||2|||f||||f||||||||||2017-10-11 03:57:04.396265|2017-10-11 03:57:04.396265
NCT01411280|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-20|2015-04-29|||June 2006||2006-06-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD)|Ameliorating Attention Problems in Children With SCD|Completed||Phase 3|34|Actual|Temple University||2|||f||||||||||||||2017-10-11 03:57:04.491045|2017-10-11 03:57:04.491045
NCT01411267|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-05-17|||August 2011||2011-08-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia|A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML|Completed||Phase 1|24|Actual|Therapeutic Advances in Childhood Leukemia Consortium||1|||f||||t||||||||||2017-10-11 03:57:04.632634|2017-10-11 03:57:04.632634
NCT01411254|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-07-17||||||July 2014|2014-07-01||||||||Interventional|||Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)|A Randomized, Multicenter, Sham Controlled, Double-Masked, Phase 2/3 Study Assessing Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema|Completed||Phase 2/Phase 3|||Santen Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 03:57:04.846399|2017-10-11 03:57:04.846399
NCT01411241|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-01-09|||July 2011||2011-07-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers|Immunogenicity and Safety of a Booster Injection of DTaP-IPV//Hib (Pentaxim™) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers Aged 15 to 18 Months in Mexico|Completed||Phase 3|720|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 03:57:04.975437|2017-10-11 03:57:04.975437
NCT01411228|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-06-20|2015-11-06||September 2011||2011-09-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease|A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease|Completed||Phase 3|15|Actual|Protalix||2|||t||||t||||||||||2017-10-11 03:57:05.158608|2017-10-11 03:57:05.158608
NCT01411215|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-01-23|2014-01-23||January 2011||2011-01-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|ENBREL NIS CN|Baseline participants were all enrolled participants who received at least 1 dose of etanercept.|A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department|A Non-Interventional Study of the Treatment With Etanercept in Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) Subjects in Rheumatology Department|Terminated||N/A|160|Actual|Pfizer|||1|See termination reason in detailed description.|f||||f||||||||||2017-10-11 03:57:05.976883|2017-10-11 03:57:05.976883
NCT01411202|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-04-26|||June 2011||2011-06-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|OPUS||Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population|Outpatient Pleurodesis Using Sclerosants(OPUS):Comparing Doxycycline Pleurodesis to Continued Drainage With the Pleurx Catheter System in the Treatment of Malignant Pleural Effusions in the Outpatient Setting|Recruiting||Phase 2|40|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||Undecided||2017-10-11 03:57:07.361637|2017-10-11 03:57:07.361637
NCT01411189|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2012-06-27|||September 2011||2011-09-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy|Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy|Completed||Phase 3|33|Actual|Nihon Pharmaceutical Co., Ltd||1|||f||||f||||||||||2017-10-11 03:57:07.4856|2017-10-11 03:57:07.4856
NCT01411176|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2012-06-27|||September 2011||2011-09-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy|Phase III Placebo-controlled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy (Randomized, Double-blind, Parallel-assignment, Placebo-controlled Study)|Completed||Phase 3|85|Actual|Nihon Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-11 03:57:07.598165|2017-10-11 03:57:07.598165
NCT01411163|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-01-10||2014-01-10|April 2010||2010-04-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Pre-CREST-2X||Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability|Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability|Completed||Phase 2|24|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:57:07.681522|2017-10-11 03:57:07.681522
NCT01411150|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-01-10||2014-01-10|May 2009||2009-05-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|Pre-CREST-X||Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study|Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study|Completed||Phase 2|38|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:57:07.773419|2017-10-11 03:57:07.773419
NCT01411137|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-04-18|2016-03-03|2013-09-27|August 2011||2011-08-01|April 2017|2017-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study|An Open Label Conversion Study of Carbidopa-Levodopa (CD-LD) Extended-Release Taken Alone or in Combination With CD-LD Immediate Release to IPX066 Followed by an Open-Label Extension Safety Study of IPX066 in Advanced PD|Completed||Phase 3|43|Actual|IMPAX Laboratories, Inc.||1|||f||||f||||||||No||2017-10-11 03:57:07.871932|2017-10-11 03:57:07.871932
NCT01411124|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2013-07-15|||June 2011||2011-06-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects|A Randomized, Double-Blind, Active- and Placebo-Controlled, Crossover Study Assessing the Effect of 600 mg Gabapentin Enacarbil on Simulated Driving in Healthy Subjects|Completed||Phase 1|36|Actual|XenoPort, Inc.||3|||f||||f||||||||||2017-10-11 03:57:08.315194|2017-10-11 03:57:08.315194
NCT01411111|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2017-07-24|||January 6, 2011|Actual|2011-01-06|July 2017|2017-07-01|February 23, 2011|Actual|2011-02-23|February 23, 2011|Actual|2011-02-23||Interventional|||A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin|An Open Label, Sequential, Single Cohort, Repeat Dose Study to Investigate the Potential Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin in Healthy Adult Subjects.|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:57:08.425506|2017-10-11 03:57:08.425506
NCT01411098|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2015-11-03|||October 2011||2011-10-01|November 2015|2015-11-01||||March 2015|Actual|2015-03-01||Interventional|||Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery|A Phase I Dose-Intensification Study Using Radiation Therapy and Concurrent Cisplatin and Etoposide for Patients With Inoperable Non-small Cell Lung Cancer|Terminated||Phase 1|6|Actual|University of Washington||1||Low accrual|f||||f||||||||||2017-10-11 03:57:08.536586|2017-10-11 03:57:08.536586
NCT01411072|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-10-02|||September 2011||2011-09-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer|Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer|Unknown status|Recruiting|N/A|20|Anticipated|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-10-11 03:57:08.772647|2017-10-11 03:57:08.772647
NCT01411059|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-11-14|||July 2009||2009-07-01|November 2016|2016-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|YESS||Yoga Empowers Seniors Study|Safe and Effective Yoga Prescription of Seniors: Biomechanical Considerations|Completed||N/A|27|Actual|University of Southern California||1|||f||||t||||||||||2017-10-11 03:57:08.91255|2017-10-11 03:57:08.91255
NCT01410682|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2011-08-04|||June 2005||2005-06-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Oral Care and Gram-negative Pathogen in Children|Oral Care and Oropharyngeal and Tracheal Colonization by Gram-negative Pathogens in Children|Completed||N/A|74|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 03:57:11.925341|2017-10-11 03:57:11.925341
NCT01411046|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-04-26|||April 2011||2011-04-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor Gene|Observational Cohort Study on Difference in Glucocorticoid-induced Adrenal Insufficiency in Patients With Rheumatoid Arthritis Related to Different Sensitivity Polymorphisms in the Glucocorticoid Receptor Gene|Recruiting||N/A|106|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||Samples With DNA|"     blood samples and DNA from gene analyses   "|Undecided||2017-10-11 03:57:09.025222|2017-10-11 03:57:09.025222
NCT01411033|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-09-10|||January 1994||1994-01-01|September 2014|2014-09-01||||||||Observational|PoProStu||Poznan Prospective Study of Type 1 Diabetic Patients|Poznan Prospective Study of Type 1 Diabetic Patients Treated With Intensive Insulin Therapy From the Onset of the Disease.|Unknown status|Active, not recruiting|N/A|100|Anticipated|Poznan University of Medical Sciences|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 03:57:09.13985|2017-10-11 03:57:09.13985
NCT01411020|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-05-14|||October 2009||2009-10-01|August 2009|2009-08-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Target-controlled Infusion of Propofol for Induction of Pediatric Anesthesia|Target-controlled Infusion (TCI) of Propofol for Induction in Children 3 to 11 Years|Completed||Phase 4|60|Actual|Pontificia Universidad Catolica de Chile||10|||f||||||||||||||2017-10-11 03:57:09.231868|2017-10-11 03:57:09.231868
NCT01411007|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-07-14|||March 2010||2010-03-01|July 2011|2011-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|RTSmoking||The Impact of Real-time Functional Magnetic Resonance Imaging (fMRI) Feedback on Response to Nicotine Cues|The Impact of Real-time fMRI Feedback on Response to Nicotine Cues|Terminated||N/A|44|Anticipated|Medical University of South Carolina|||2||f||||t||||||||||2017-10-11 03:57:09.324026|2017-10-11 03:57:09.324026
NCT01410994|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2015-08-26|||April 2011||2011-04-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Bariatric Surgery and the Kidney|Study of Renal Parameters After Bariatric Surgical Weight Loss|Completed||N/A|200|Actual|Indiana University|||1||f||||f||||||Samples Without DNA|"     serum, urine   "|||2017-10-11 03:57:09.419342|2017-10-11 03:57:09.419342
NCT01410981|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2013-04-24|||July 2011||2011-07-01|April 2013|2013-04-01||||July 2014|Anticipated|2014-07-01||Observational|||Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma|Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma|Unknown status|Recruiting|N/A|130|Anticipated|Medical University of South Carolina|||1||f||||t||||||Samples With DNA|"     The patients will not have bone marrow biopsy or aspirate solely for this study. When the     patients undergo routine bone marrow aspirate and biopsy for the purpose of initial     diagnosis, followup or restaging, they will be asked and consented for participation in the     study. The patient will then be treated with standard chemotherapy including     Bortezomib-based, Revlimid-based, Thalidomide-based chemoregimen. The bone marrow aspirate     from patients who consent to be in the study will be stained for CXCR4, CD47, pS6, in     addition to standard study flow cytometry panel for multiple myeloma. The staining and flow     cytometry analysis will be performed at the Clinical Flow Cytometry Facility (Director: Dr.     Sally Self) according to the standard flow cytometry procedure. Sphingolipid gene expression     levels will be measured. A small aliquot may be sent to collaborators in Genentech Corp for     measurement of pS6 and Pim kinase expression. The sample information will be de-identified.   "|||2017-10-11 03:57:09.508034|2017-10-11 03:57:09.508034
NCT01410968|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-12-08|||August 2011||2011-08-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|November 2013|Actual|2013-11-01||Interventional|||A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma|A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma|Completed||Phase 1|12|Actual|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 03:57:09.605356|2017-10-11 03:57:09.605356
NCT01410955|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2014-01-22|||December 2011||2011-12-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Prevention of Irinotecan Induced Diarrhea by Probiotics|Prevention of Irinotecan Induced Diarrhea by Probiotics. A Phase III Study|Completed||Phase 3|46|Actual|Monsea Ltd.||2|||f||||f||||||||||2017-10-11 03:57:09.688338|2017-10-11 03:57:09.688338
NCT01410942|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-01-30|||February 2012||2012-02-01|January 2017|2017-01-01||||February 2019|Anticipated|2019-02-01||Interventional|||Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy|Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy|Active, not recruiting||Phase 2|175|Anticipated|M.D. Anderson Cancer Center||8|||f||||t||||||||||2017-10-11 03:57:09.776978|2017-10-11 03:57:09.776978
NCT01410929|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-01-18|||May 2011||2011-05-01|January 2017|2017-01-01||||||||Interventional|MM||Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma|Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma|Withdrawn||Phase 4|0|Actual|Merit Medical Systems, Inc.||1|||f||||f||||||||||2017-10-11 03:57:09.89138|2017-10-11 03:57:09.89138
NCT01410916|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-04-04|||July 2011||2011-07-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|STEC-HUS||Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)|An Open-Label, Multi-Center Trial of Eculizumab in Patients With Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)|Completed||Phase 2/Phase 3|198|Actual|Alexion Pharmaceuticals||1|||f||||f||||||||||2017-10-11 03:57:09.96187|2017-10-11 03:57:09.96187
NCT01410903|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2015-08-18|||April 2011||2011-04-01|August 2015|2015-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Immunoadsorption in Patients With Severe Systemic Sclerosis|Immunoadsorption in Addition to the Established Therapy in Patients With Systemic Sclerosis|Terminated||N/A|1|Actual|GWT-TUD GmbH||1||inadequately recruitment rate, funding is not secured|f||||f||||||||||2017-10-11 03:57:10.232349|2017-10-11 03:57:10.232349
NCT01410890|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-09-13|||November 2014||2014-11-01|September 2017|2017-09-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|PAPAYA||Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease|A Phase 3/4 Prospective Study to Characterize the Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease|Recruiting||Phase 4|20|Anticipated|Sanofi||1|||f||||t||||||||||2017-10-11 03:57:10.332307|2017-10-11 03:57:10.332307
NCT01410877|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-06-04|||August 2011||2011-08-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Assessment of Inspiratory Profiles Through Airflow Resistances Designed to Mimic Inhalers|Assessment of Inspiratory Profiles Through Airflow Resistances Designed to Mimic Inhalers|Completed||N/A|20|Actual|Virginia Commonwealth University|||1||f||||t||||||||||2017-10-11 03:57:10.452582|2017-10-11 03:57:10.452582
NCT01410864|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-02-28|||August 2011||2011-08-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|DuraSeal PAS||DuraSeal Exact Spine Sealant System Post-Approval Study|DuraSeal Exact Spine Sealant System Post-Approval Study|Completed||N/A|924|Actual|Integra LifeSciences Corporation|||2||f||||f||||||||||2017-10-11 03:57:10.532325|2017-10-11 03:57:10.532325
NCT01410851|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2011-08-03|||September 2009||2009-09-01|July 2011|2011-07-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||Pulses, Satiation, Food Intake and Blood Glucose|The Acute Effects of Pulse Consumption on Glycaemic Responses and Measures of Satiety and Satiation|Completed||N/A|24|Actual|University of Toronto||5|||f||||f||||||||||2017-10-11 03:57:10.680159|2017-10-11 03:57:10.680159
NCT01410838|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-05-19|||August 2011||2011-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Monosodium Glutamate on Energy Balance and Eating Behavior|Effects of Ingesting Monosodium Glutamate (MSG) on Energy Balance and Eating Behavior Following Moderate Energy Restriction and Weight Loss in Overweight Women|Completed||N/A|44|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 03:57:10.766582|2017-10-11 03:57:10.766582
NCT01410825|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-01-31|||July 2011||2011-07-01|January 2017|2017-01-01|July 2031|Anticipated|2031-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome|Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome|Active, not recruiting||Phase 1/Phase 2|5|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 03:57:10.858572|2017-10-11 03:57:10.858572
NCT01410799|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-03-13|||May 2011||2011-05-01|March 2017|2017-03-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly|Three Month Treatment of GHRH (Growth Hormone Releasing Hormone) in the Elderly|Terminated||Phase 2|13|Actual|University of Pennsylvania||1||Funding ended|f||||t||||||||||2017-10-11 03:57:11.028333|2017-10-11 03:57:11.028333
NCT01410786|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-08-01|||June 2013||2013-06-01|August 2017|2017-08-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Oxford Partial Knee Comparative Instrument Pilot Study|A Comparison of Signature Guides and Conventional Instrumentation With the Oxford Partial Knee System Pilot Study|Completed||N/A|35|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-10-11 03:57:11.127501|2017-10-11 03:57:11.127501
NCT01410773|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2016-01-29|2012-07-31||July 2011||2011-07-01|January 2016|2016-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||User Performance Evaluation of an Investigational Blood Glucose Monitoring System|Ninja 2 User Performance Evaluation|Completed||N/A|110|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-10-11 03:57:11.224741|2017-10-11 03:57:11.224741
NCT01410760|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2012-06-19|||April 2011||2011-04-01|June 2012|2012-06-01||||April 2013|Anticipated|2013-04-01||Interventional|PERFORM||PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases|Perfusion Computed Tomography Pilot Study in the NCRN FOXFIRE Clinical Trial to Determine Blood Flow to Liver Metastases|Unknown status|Recruiting|Early Phase 1|40|Anticipated|University of Oxford||1|||f||||f||||||||||2017-10-11 03:57:11.436206|2017-10-11 03:57:11.436206
NCT01410747|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2017-05-08|||January 1, 2007|Actual|2007-01-01|May 2017|2017-05-01|January 31, 2020|Anticipated|2020-01-31|January 31, 2020|Anticipated|2020-01-31||Observational|TRUST||A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations|Post Marketing Surveillance For Long Term Treatment With Tacrolimus in Steroid Resistant Lupus Nephritis|Active, not recruiting||N/A|1484|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-10-11 03:57:11.517374|2017-10-11 03:57:11.517374
NCT01410734|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2012-12-19|||July 2011||2011-07-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Fluorescence Imaging on the da Vinci Surgical System for Intra-operative Near Infrared Imaging of the Biliary Tree (up to 2-weeks Post-operatively)|A Prospective Investigation of the Use of the Fluorescence Imaging on the da Vinci Surgical System for Intra-operative Near Infrared Imaging of the Biliary Tree|Completed||N/A|72|Actual|Intuitive Surgical||1|||f||||t||||||||||2017-10-11 03:57:11.620419|2017-10-11 03:57:11.620419
NCT01410721|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-05-17|||January 2012||2012-01-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Neural Markers and Rehabilitation of Executive Functioning in Veterans With Traumatic Brain Injury and Posttraumatic Stress Disorder|Neural Markers and Rehabilitation of Executive Functioning in Veterans With TBI and PTSD|Completed||N/A|241|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 03:57:11.69717|2017-10-11 03:57:11.69717
NCT01410708|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-02-12||||||August 2011|2011-08-01||||||||Interventional|||TORI 104 Pre-Surgical Dasatinib|A Pre-Surgical Study to Evaluate Molecular Changes That Occur in Human Breast Cancer Tissue After Short Term Exposure to Dasatinib and To Correlate These Alterations With Pharmacokinetics Parameters|Withdrawn||Phase 2|0|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 03:57:11.771428|2017-10-11 03:57:11.771428
NCT01410695|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2013-08-13|||July 2011||2011-07-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Phase 2b/3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Methotrexate in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate or to Any Disease-Modifying Antirheumatic Drug|A 24-week With Possible Extension, Prospective, Multicenter, Randomised, Double-blind, Controlled, 3-parallel Groups, Phase 2b/3 Study to Compare Efficacy and Safety of Masitinib at 3 and 6 mg/kg/Day to Methotrexate, With a Randomisation 1:1:1, in Treatment of Patients With Active Rheumatoid Arthritis With Inadequate Response to 1. Methotrexate or to 2. Any DMARD Including at Least One Biologic Drug if Patients Previously Failed Methotrexate or to 3. Methotrexate in Combination With Any DMARD Including Biologic Drugs|Unknown status|Recruiting|Phase 2/Phase 3|450|Anticipated|AB Science||3|||f||||t||||||||||2017-10-11 03:57:11.83497|2017-10-11 03:57:11.83497
NCT01410669|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2011-08-03|||December 2007||2007-12-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|ISIS||Motivational Interviewing Intervention for Intimate Partner Violence|Is Motivational Interviewing an Effective Intervention for Women Coping With Intimate Partner Violence|Completed||N/A|305|Actual|University of Iowa||1|||f||||t||||||||||2017-10-11 03:57:12.00423|2017-10-11 03:57:12.00423
NCT01410656|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-08-04|||May 2011||2011-05-01|August 2011|2011-08-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|PROMOTE||Prostate Cancer Survivors Moving Toward Exercise (PROMOTE) Trial|Prostate Cancer Survivors MOving Toward Exercise (PROMOTE) Trial|Unknown status|Active, not recruiting|Phase 3|423|Actual|University of Alberta||3|||f||||f||||||||||2017-10-11 03:57:12.080438|2017-10-11 03:57:12.080438
NCT01410643|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-30|2015-06-16|||March 2011||2011-03-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PRIMO||Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)|Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)|Completed||N/A|92|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 03:57:12.236834|2017-10-11 03:57:12.236834
NCT01410617|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-03-25|||August 2011||2011-08-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|||The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass||Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|Imam Khomeini Hospital||2|||f||||||||||||||2017-10-11 03:57:12.520915|2017-10-11 03:57:12.520915
NCT01410604|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2012-04-23|2012-03-29||January 2007||2007-01-01|April 2012|2012-04-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Adipokines in Obese Adolescents With Insulin Resistance|Inflammatory Mediators in Obese Adolescents With Insulin Resistance Following Metformin Treatment: Controlled Randomized Clinical Trial|Completed||Phase 4|31|Actual|Hospital Regional de Alta Especialidad del Bajio|During the recruitment phase, 83 children who were diagnosed with obesity and acanthosis nigricans were evaluated. Of these, 45 did not have the insulin concentration values (>15 µU/mL) required to biochemically define Insulin Resistance.|2|||f||||f||||||||||2017-10-11 03:57:12.665748|2017-10-11 03:57:12.665748
NCT01410591|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-01-23|||July 2012||2012-07-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|T8/10SVB||TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding|The Effect of TIPS With 8- or 10-mm Covered Stent for Preventing Variceal Rebleeding in Cirrhotic Patients.|Completed||N/A|127|Actual|Fourth Military Medical University||2|||f||||||||||||||2017-10-11 03:57:13.242383|2017-10-11 03:57:13.242383
NCT01410578|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-04|||September 2009||2009-09-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUO|The Value of Soluble TREM-1, Procalcitonin, and C-reactive Protein Serum Levels as Markers for the Detection of Sepsis and Bacteremia Among Patients With a Fever of Unknown Origin in Intensive Care Units|Completed||N/A|144|Actual|Chinese PLA General Hospital|||3||f||||t||||||||||2017-10-11 03:57:13.339596|2017-10-11 03:57:13.339596
NCT01410565|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-12-12|2016-10-10||July 2011||2011-07-01|December 2016|2016-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Safety Analysis Population included all randomized patients in the double blind phase.|Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer|A Phase 3 International, Multicenter, Double-Blind, Placebo-Controlled, Randomized Trial Evaluating the Efficacy and Safety of Multiple Instillations of Intravesical Apaziquone vs. Placebo in Patients With Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer (NMIBC)|Terminated||Phase 3|66|Actual|Spectrum Pharmaceuticals, Inc||2||Business reason|f||||f||||||||||2017-10-11 03:57:13.433892|2017-10-11 03:57:13.433892
NCT01410552|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2016-11-29|||October 2011||2011-10-01|November 2016|2016-11-01|February 2016|Actual|2016-02-01|August 2015|Actual|2015-08-01||Interventional|ISIS-ICD||Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination|Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination|Completed||Phase 4|1013|Actual|LivaNova||1|||f||||||||||||||2017-10-11 03:57:14.00391|2017-10-11 03:57:14.00391
NCT01410539|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2014-09-24|||January 2010||2010-01-01|September 2014|2014-09-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|Most||Mechanism Of Stent Thrombosis (MOST) Study|Mechanism Of Stent Thrombosis (MOST) Study, a Prospective Multicentre Non-randomized Registry|Completed||Phase 4|20|Actual|Careggi Hospital||2|||f||||t||||||||||2017-10-11 03:57:14.364765|2017-10-11 03:57:14.364765
NCT01410526|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-08-04|||May 2011||2011-05-01|May 2011|2011-05-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Observational|||Assessment of Peritoneal Immune Response in Patients With Severe Intra-abdominal Sepsis Managed With Laparostomy and Vacuum Assisted Closure (VAC)|Assessment of Peritoneal Immune Response in Patients With Severe Intra-abdominal Sepsis Managed With Laparostomy and Vacuum Assisted Closure (VAC)|Unknown status|Recruiting|N/A|60|Anticipated|Aristotle University Of Thessaloniki|||2||f||||t||||||||||2017-10-11 03:57:14.464323|2017-10-11 03:57:14.464323
NCT01410513|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-03-31|||December 2011||2011-12-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia|A Phase 1b, Multicenter, Open-Label, Dose Escalation Study of SAR245409 to Evaluate the Safety, Tolerability and Clinical Activity of SAR245409 in Combination With Rituximab or Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia|Completed||Phase 1|37|Actual|Sanofi||3|||f||||||||||||||2017-10-11 03:57:14.584908|2017-10-11 03:57:14.584908
NCT01410500|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-04-28||||||April 2017|2017-04-01||||||||Expanded Access|||Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease|Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease|Approved for marketing||N/A|||Amgen|||||||||||||||||||2017-10-11 03:57:14.719845|2017-10-11 03:57:14.719845
NCT01410487|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-12-01|||September 2011||2011-09-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational|||Effects of Weight Loss on Cardio-respiratory Function|Effects of Weight Loss on Cardio-respiratory Function and Patient-centered Outcomes in an Underserved, Minority Population With Clinically Severe Obesity|Completed||N/A|150|Actual|New York University School of Medicine|||1||f||||f||||||||||2017-10-11 03:57:14.8007|2017-10-11 03:57:14.8007
NCT01410474|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-09-16|2013-03-12||August 2011||2011-08-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||Analysis was done on all the enrolled subjects.|Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan|A Phase 3, Multicenter, Open-label Study to Evaluate Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) in Healthy Subjects From 2 to 18 Years in Taiwan|Completed||Phase 3|341|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:57:14.900212|2017-10-11 03:57:14.900212
NCT01410461|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2011-08-04|||September 2011||2011-09-01|August 2011|2011-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|PBS||Identifying Predictors of Treatment Success in Painful Bladder Syndrome|Prospective Observational Study That Evaluates Predictor Tests for the Success of Myofascial Pelvic Floor Muscles for the Treatment of PBS|Unknown status|Not yet recruiting|N/A|35|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 03:57:15.613509|2017-10-11 03:57:15.613509
NCT01410448|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-04-03|2016-11-21||November 2011||2011-11-01|March 2017|2017-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|NEVERWOUND||Everolimus in de Novo Kidney Transplant Recipients|A 3-month, Multicenter, Randomized, Open Label Study to Evaluate the Impact of Early Versus Delayed Introduction of Everolimus on Wound Healing in de Novo Kidney Transplant Recipients With a Follow-up Evaluation at 12 Month After Transplant (NEVERWOUND Study)|Completed||Phase 3|383|Actual|Novartis||2|||f||||||||||||||2017-10-11 03:57:15.782082|2017-10-11 03:57:15.782082
NCT01410435|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2013-11-25|||June 2011||2011-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease|An Open-label, Multi-Centre, Non-Randomised Extension Study to Assess the Ability to Maintain a Stable Haemoglobin and to Assess Safety of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease|Completed||Phase 3|39|Actual|Pharmacosmos A/S||1|||f||||t||||||||||2017-10-11 03:57:17.113995|2017-10-11 03:57:17.113995
NCT01410422|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2011-08-04|||May 2011||2011-05-01|May 2011|2011-05-01|April 2014|Anticipated|2014-04-01|||||Observational|||Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis|Exhaled Breath Analysis in Patients With COPD and Bronchiectasis|Unknown status|Recruiting|N/A|250|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples Without DNA|"     Breath condensate, blood, urine   "|||2017-10-11 03:57:17.216349|2017-10-11 03:57:17.216349
NCT01410396|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-08-14|||April 2010||2010-04-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Observational|||Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism|Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism|Completed||N/A|49|Actual|Northwestern University|||1||f||||f||||||||||2017-10-11 03:57:18.054751|2017-10-11 03:57:18.054751
NCT01410383|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-08-31|||October 2011||2011-10-01|August 2012|2012-08-01|October 2014|Anticipated|2014-10-01|October 2013|Anticipated|2013-10-01||Interventional|AKKA||Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care|A Placebo-controlled, Double-blind, Randomised, Parallel-group, Long Term Phase III Trial Assessing the Safety and Efficacy of Eprotirome in Patients With Heterozygous Familial Hypercholesterolaemia Who Are on Optimal Standard of Care|Terminated||Phase 3|236|Actual|Karo Bio AB||3|||f||||t||||||||||2017-10-11 03:57:18.128253|2017-10-11 03:57:18.128253
NCT01410370|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2013-04-22|||June 2011||2011-06-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases|Phase II Study of Continuous Endostar Infusion Combined With Radiotherapy for the Treatment of Patients With Brain Metastases|Unknown status|Recruiting|Phase 2|80|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 03:57:18.205194|2017-10-11 03:57:18.205194
NCT01410357|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-10-03|2017-04-18||July 2011||2011-07-01|October 2017|2017-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|TTIM||Improving Outcomes for Individuals With Serious Mental Illness and Diabetes|Improving Outcomes for Individuals With Serious Mental Illness and Diabetes|Completed||N/A|200|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-10-11 03:57:18.318922|2017-10-11 03:57:18.318922
NCT01410344|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-08-29|||September 2011|Actual|2011-09-01|August 2017|2017-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Allogeneic Transplant in HIV Patients (BMT CTN 0903)|Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)|Active, not recruiting||Phase 2|18|Actual|Medical College of Wisconsin||1|||f||||t||||||||||2017-10-11 03:57:21.052415|2017-10-11 03:57:21.052415
NCT01410331|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2014-10-22|||March 2012||2012-03-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia|A Phase II, Randomized, Double-Blind, Placebo Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Direct Intramuscular Injection to Cohorts of Adults With Critical Limb Ischemia|Completed||Phase 2|48|Anticipated|Juventas Therapeutics, Inc.||4|||f||||t||||||||||2017-10-11 03:57:21.196967|2017-10-11 03:57:21.196967
NCT01410149|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2012-08-13|||April 2007||2007-04-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Sleep Quality in Mechanically Ventilated Patients|The Influence of Mode and Patient-ventilator Interaction on Sleep Quality in the ICU|Completed||N/A|13|Actual|Lawson Health Research Institute||3|||f||||f||||||||||2017-10-11 03:57:29.086894|2017-10-11 03:57:29.086894
NCT01410318|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-02-03|||June 2010||2010-06-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|PESA||Progression of Early Subclinical Atherosclerosis|Early Detection and Progression of Subclinical Atherosclerosis and Its Relationship to Coronary Risk Factors|Active, not recruiting||N/A|4184|Actual|Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III|||1||f||||t||||||Samples With DNA|"     -  Orine (4 x 5 mL)        -  Blood (8 x 0.6 mL)        -  Serum (8 x 0.6 mL)        -  EDTA plasma (8 x 0.6 mL)        -  Buffy Coat (2 x 0.6 mL)        -  Non insultated RNA (2 x 5 mL PAXgene)        -  Insulated DNA (2 x 0.3 mL, 150 ng/microL + 1 x 0.3 mL, 75 ng/microL)   "|Undecided||2017-10-11 03:57:21.46088|2017-10-11 03:57:21.46088
NCT01410305|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-06-24|||September 2011||2011-09-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults|Vitamin D Metabolism Inflammation, and Cardiovascular Risk in HIV-infected Children and Young Adults|Completed||N/A|290|Actual|University Hospitals Cleveland Medical Center|||2||f||||f||||||Samples With DNA|"     plasma, serum, PBMCs, urine   "|||2017-10-11 03:57:21.553867|2017-10-11 03:57:21.553867
NCT01410292|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-04|||March 2011||2011-03-01|August 2011|2011-08-01|January 2012|Anticipated|2012-01-01|September 2011|Anticipated|2011-09-01||Interventional|||Glycemic and Satiety Response to Fiber and Glycemic Index of Meals in Diabetes|Glycemic and Satiety Response to Meals With Different Fiber Content and Glycemic Index in Type 2 Diabetic Patients|Unknown status|Recruiting|N/A|20|Anticipated|Hospital de Clinicas de Porto Alegre||4|||f||||t||||||||||2017-10-11 03:57:21.656699|2017-10-11 03:57:21.656699
NCT01410279|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2011-08-04|||December 2009||2009-12-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|September 2011|Anticipated|2011-09-01||Interventional|||Inspiratory Muscle Training in Pulmonary Hypertension|Inspiratory Muscle Training Effect on the Functional Capacity and the Quality of Life in Chronic Pulmonary Hypertension|Unknown status|Recruiting|N/A|34|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||f||||||||||2017-10-11 03:57:21.780458|2017-10-11 03:57:21.780458
NCT01410266|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2012-11-30|||September 2010||2010-09-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and Uzbekistan|The Acceptability and Feasibility of Reducing the Need for In-Clinic Follow-Up for First Trimester Medical Abortion in Moldova and Uzbekistan|Completed||Phase 4|2400|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-11 03:57:21.894768|2017-10-11 03:57:21.894768
NCT01410253|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2016-03-21|||January 2011||2011-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Cardiac Rehabilitation on Postoperatory of Coronary Artery Bypass Graft.|Evaluation of the Effects of Different Physical Therapy on Cardiac Rehabilitation in Post Operatory Period of Coronary Artery Bypass Graft: Randomized Clinical Trial.|Completed||Phase 3|40|Actual|Hospital de Clinicas de Porto Alegre||4|||f||||t||||||||||2017-10-11 03:57:21.993259|2017-10-11 03:57:21.993259
NCT01410240|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-05-15|2014-02-28||September 2011||2011-09-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty|A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)|Completed||Phase 4|137|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-10-11 03:57:22.336993|2017-10-11 03:57:22.336993
NCT01410227|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-04|2016-03-21|2016-03-21|2015-02-01|November 2011||2011-11-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Baseline consists of all participants in study [N=37] so is a total of the four arms described in Participant Flow (Arm 1: PK50 + Treatment [N=8]; Arm 2: PK50 Only [N=8]; Arm 3: PK80 + Treatment [N=15]; Arm 4: Treatment Only [N=6]).|Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)|A Phase 3 Clinical Study to Determine the Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor : Recombinant Factor VIII (rVWF:rFVIII) and rVWF in the Treatment of Bleeding Episodes in Subjects Diagnosed With Von Willebrand Disease|Completed||Phase 3|49|Actual|Baxalta US Inc.||4|||f||||t||||||||||2017-10-11 03:57:26.863478|2017-10-11 03:57:26.863478
NCT01410214|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2011-12-21|||May 2011||2011-05-01|December 2011|2011-12-01|July 2017|Anticipated|2017-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations|A Phase II Trial of Erlotinib Versus Combination of Vinorelbine Plus Cisplatin as Adjuvant Treatment in Stage IIIA Non-small-cell Lung Cancer After Complete Resection With Sensitizing EGFR Mutation in Exon 19 or 21 and Wild-type K-ras|Unknown status|Recruiting|Phase 2|80|Anticipated|Chinese Lung Cancer Surgical Group||2|||f||||f||||||||||2017-10-11 03:57:28.507821|2017-10-11 03:57:28.507821
NCT01410201|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-07-26|||August 2011||2011-08-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|OZURDEX2||Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane|Dexamethasone Intravitreal Implant After Vitrectomy for Idiopathic Epiretinal Membrane|Terminated||N/A|6|Actual|Barnes Retina Institute||2||recruitment not met|f||||f||||||||||2017-10-11 03:57:28.673691|2017-10-11 03:57:28.673691
NCT01410188|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-02-07||2014-02-07|September 2011||2011-09-01|February 2014|2014-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension|An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 1/Phase 2|160|Actual|Acucela Inc.||6|||f||||t||||||||||2017-10-11 03:57:28.806579|2017-10-11 03:57:28.806579
NCT01410175|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-05-22|||July 2010||2010-07-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Interventional|SCL01||Comparison of the Impact of Electric Scalpels Versus Cold Scalpels|"Impact on the Incidence of Surgical Site Infection in Abdominal Gynecological Surgery by Comparing the Skin and Subcutaneous Tissue Incision With Cold Scalpel and Electrocautery in a Period of Two Years."|Completed||Phase 3|163|Actual|Barretos Cancer Hospital||2|||f||||f||||||||||2017-10-11 03:57:28.92571|2017-10-11 03:57:28.92571
NCT01410162|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-08-31|||December 2010||2010-12-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|SG#153||Advagraf/Prograf Conversion Trial|A Randomized, Open Label, Cross Over Study to Examine the Impact of Prograf and Advagraf on Tacrolimus Exposure, Mycophenolic Acid Pharmacokinetics, Renal Allograft Function or Adverse Effects.|Completed||Phase 4|53|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 03:57:29.008698|2017-10-11 03:57:29.008698
NCT01410136|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-08-07|||April 2011||2011-04-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Chondrofix Osteochondral Allograft Prospective Study|A Post Market Study to Evaluate the Chondrofix® Osteochondral Allograft Utilized for Treatment of Subjects With Cartilage Lesions in the Knee|Terminated||N/A|29|Actual|Zimmer Orthobiologics, Inc.||1||Inadequate enrollment and decreased need for clinical data to support product|f||||f||||||||||2017-10-11 03:57:29.181922|2017-10-11 03:57:29.181922
NCT01410123|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-07-18|||January 2013||2013-01-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Integrated Stepped Care for Unhealthy Alcohol Use in HIV|Integrated Stepped Care for Unhealthy Alcohol Use in HIV|Recruiting||N/A|642|Anticipated|Yale University||2|||f||||t||||||||||2017-10-11 03:57:29.566857|2017-10-11 03:57:29.566857
NCT01410110|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-01-14|2014-12-15||December 2010||2010-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment|Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment|Completed||Phase 2|48|Actual|Yale University|Use of WT limited recruitment to only those willing to participate in a work program for 13 weeks, reducing generalizability. WT may have powerful effects on sobriety that obscured benefits of CRT. As a pilot, this study was not adequately powered.|2|||f||||f||||||||||2017-10-11 03:57:29.708747|2017-10-11 03:57:29.708747
NCT01410084|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-11-14|||October 2010||2010-10-01|November 2013|2013-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|MOW VitD||Improving Vitamin D Status in Home-bound Elders|Improving Vitamin D Status in Home-bound Elders: a Pilot Study|Completed||N/A|68|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 03:57:30.50824|2017-10-11 03:57:30.50824
NCT01410071|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-03|||September 2005||2005-09-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Observational|||Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction|Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction: Evaluation of the Differences Between Those Undergoing Endoscopic Therapy vs.Conservative Care|Terminated||N/A|153|Actual|Wisconsin Center for Advanced Research|||1|Analysis of designed comparison groups not viable|f||||f||||||||||2017-10-11 03:57:30.597842|2017-10-11 03:57:30.597842
NCT01410045|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-07-05|||January 2011||2011-01-01|July 2016|2016-07-01|February 2031|Anticipated|2031-02-01|July 2016|Actual|2016-07-01||Interventional|CRYO-X0||Cryopreservation of Ovarian Cortex in Girls With Turner Syndrome|Cryopreservation of Ovarian Cortex in Girls With Turner Syndrome : Karyotypic, Clinical and Hormonal Criteria to Screen Patients|Active, not recruiting||N/A|47|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||No||2017-10-11 03:57:30.901446|2017-10-11 03:57:30.901446
NCT01410032|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2014-04-25|||July 2010||2010-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Reconstruction Plate Compared With Flexible Intramedullary Nailing for Midshaft Clavicular Fractures|Reconstruction Plate Compared With Flexible Intramedullary Nailing for Midshaft Clavicular Fractures: a Prospective, Randomized Clinical Trial|Completed||Phase 2|59|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 03:57:31.001588|2017-10-11 03:57:31.001588
NCT01410019|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-08-25|||December 2010||2010-12-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|July 2015|Actual|2015-07-01||Interventional|SCID2||Gene Therapy for X-linked Severe Combined Immunodeficiency|Protocol No. 2 of Gene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1) Using a Self Retroviral Vector - SCID2|Active, not recruiting||Phase 1/Phase 2|5|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 03:57:31.103981|2017-10-11 03:57:31.103981
NCT01410006|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-07-21|||May 2011||2011-05-01|July 2017|2017-07-01|July 2017|Actual|2017-07-01|July 2017|Actual|2017-07-01|50 Years|Observational [Patient Registry]|NPRI||Neurofibromatosis Type 1 Patient Registry|Neurofibromatosis Type 1 Patient Registry|Completed||N/A|2391|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-10-11 03:57:31.198025|2017-10-11 03:57:31.198025
NCT01409993|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-03-03|2016-12-07||August 2011||2011-08-01|March 2017|2017-03-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis||Terminated||Phase 4|78|Actual|Vanderbilt University Medical Center||4||Aim 1 was stopped by DSMB. Aim 2 was stopped due to ending of funding.|f||||t||||||||||2017-10-11 03:57:31.279722|2017-10-11 03:57:31.279722
NCT01409980|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-06-22|||July 2011||2011-07-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Triphalangeal Thumbs in the Pediatric Population: Long Term Outcomes Following Surgical Intervention|Triphalangeal Thumbs in the Pediatric Population: Long Term Outcomes Following Surgical Intervention|Completed||N/A|3|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 03:57:31.797327|2017-10-11 03:57:31.797327
NCT01409967|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-08-23|||May 2011||2011-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Observational|BÉA/T||The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias|The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias|Completed||N/A|40|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 03:57:31.869945|2017-10-11 03:57:31.869945
NCT01409590|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-03|||May 2005||2005-05-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|September 2006|Actual|2006-09-01||Interventional|||Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications|Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications|Completed||N/A|100|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 03:57:37.18733|2017-10-11 03:57:37.18733
NCT01409954|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-07-21|||October 2011||2011-10-01|July 2017|2017-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Collecting Bone Graft During Spinal Decompression and Posterolateral Lumbar Fusion to Better Define Bone Making Cells|Defining the Osteogenic Potential of Mesenchymal Stem Cells and Their Progenitors During Spinal Decompression and Posterolateral Lumbar Fusion|Enrolling by invitation||N/A|60|Anticipated|University of Utah|||1||f||||f||||||Samples Without DNA|"     Aliquots of bone marrow aspirates and bone fragments   "|||2017-10-11 03:57:31.949428|2017-10-11 03:57:31.949428
NCT01409941|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-12-22|||January 2009||2009-01-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Observational|||The Relation Between Preoperative ScO2 and the Postoperative Course of Humoral Organ Dysfunction Markers.|The Prognostic Relevance of N-terminal Pro B-type Natriuretic Peptide(NTproBNP), Cerebral Oxygen Saturation (ScO2), and Preoperative Creatinine Clearance in Cardiac Surgery Patients - Amendment 2: the Role of NTproBNP and ScO2 in Predicting Mortality and Postoperative Organ Dysfunction.|Completed||N/A|765|Actual|University of Luebeck|||1||f||||f||||||Samples Without DNA|"     Plasma and urinary samples.   "|||2017-10-11 03:57:32.017105|2017-10-11 03:57:32.017105
NCT01409928|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-03-22|||March 2012||2012-03-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study of the Laparoscopically-placed Adjustable Gastric Band for the Management of Obesity in Adolescent Patients|A Study of the Laparoscopically-placed Adjustable Gastric Band for the Management of Obesity in Adolescent Patients|Terminated||Phase 2|16|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 03:57:32.080199|2017-10-11 03:57:32.080199
NCT01409915|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-05-22|||March 2011||2011-03-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease|Pilot Phase 2 Trial of the Safety & Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor (Leukine®) in the Treatment of Alzheimer's Disease|Active, not recruiting||Phase 2|40|Anticipated|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 03:57:32.152314|2017-10-11 03:57:32.152314
NCT01409902|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-04-22|||June 2008||2008-06-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue|Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue|Completed||N/A|38|Actual|University of South Florida|||1||f||||t||||||||||2017-10-11 03:57:32.249935|2017-10-11 03:57:32.249935
NCT01409889|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-01-15|||May 2011||2011-05-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparing Diabetes Prevention Programs|Comparative Effectiveness of Practice-Based Diabetes Prevention Programs - A Pilot Study|Completed||N/A|92|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 03:57:32.31868|2017-10-11 03:57:32.31868
NCT01409876|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-03|||September 2011||2011-09-01|March 2011|2011-03-01|September 2016|Anticipated|2016-09-01|September 2014|Anticipated|2014-09-01||Interventional|||HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy|HistoScanning- Based Dose-painting Image-guided Interstitial PDR-brachytherapy in Prostate Cancer - a Phase II Trial|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|University Hospital Erlangen||1|||f||||||||||||||2017-10-11 03:57:32.404426|2017-10-11 03:57:32.404426
NCT01409863|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-01-21|||March 2010||2010-03-01|January 2015|2015-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Fractional Laser Therapy and Dermabrasion for Scar Revision|A Comparison Evaluation of Fractional Laser Therapy an Dermabrasion for Scar Revision|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||1||PI has left University of Minnesota.|f||||f||||||||||2017-10-11 03:57:32.506867|2017-10-11 03:57:32.506867
NCT01409850|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-12-02|||July 2010||2010-07-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparison Study of Two Splints Used for Treatment of Acute Temporomandibular Pain.|Pilot Clinical Trial on the Treatment Effectiveness of Two Splints for Acute Temporomandibular Pain.|Terminated||N/A|36|Actual|Heidelberg University||3||Very slow enrollment of participants|f||||f||||||||||2017-10-11 03:57:32.572645|2017-10-11 03:57:32.572645
NCT01409837|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-09-21|2013-06-22||March 1998||1998-03-01|September 2013|2013-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||The Effect and Safety of Lisinopril in Non-hypertensive Men With Infertility From Low Sperm Count|A 5-year Prospective, Placebo-controlled, Crossover Evaluation of the Efficacy and Tolerability of Low-dose Lisinopril in Normotensives With Idiopathic Oligospermic Infertility|Completed||Phase 2|33|Actual|University Of Nigeria Teaching Hospital|The sample size of the study is small thereby limiting the reliability of generalizing the findings. In addition, three subjects who started the study terminated prematurely and it is difficult to assess how this fact has affected the study results.|2|||f||||t||||||||||2017-10-11 03:57:32.866402|2017-10-11 03:57:32.866402
NCT01409824|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-03|||May 2009||2009-05-01|February 2010|2010-02-01|April 2014|Anticipated|2014-04-01|September 2010|Actual|2010-09-01||Interventional|QUALMAT||Health Care Intervention Research- Improving Pre-natal and Maternal Care|Health Care Intervention Research-Quality of Prenatal and Maternal Care: Bridging the Know-do Gap (QUALMAT)|Unknown status|Recruiting|N/A|36|Anticipated|Heidelberg University||2|||f||||t||||||||||2017-10-11 03:57:33.417594|2017-10-11 03:57:33.417594
NCT01409811|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2017-06-07|||September 14, 2012|Actual|2012-09-14|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid|A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer|Active, not recruiting||N/A|40|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 03:57:33.510803|2017-10-11 03:57:33.510803
NCT01409798|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-05-11|||June 2010||2010-06-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Observational|||The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry|The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry|Completed||N/A|175|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 03:57:33.637247|2017-10-11 03:57:33.637247
NCT01409785|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-10-04|||August 2011||2011-08-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||A Comparison of the LMA Unique and LMA Supreme in Children|A Prospective, Randomized Comparison of the LMA Unique and LMA Supreme in Children|Completed||N/A|50|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||||2017-10-11 03:57:33.726081|2017-10-11 03:57:33.726081
NCT01409772|ClinicalTrials.gov processed this data on October 10, 2017|2009-05-22|2012-06-15|||December 2009||2009-12-01|June 2012|2012-06-01|December 2011|Anticipated|2011-12-01|June 2011|Anticipated|2011-06-01||Observational|||Evaluation of the Clinical Practice of Using of a 70% Ethanol Lock Solution for the Prevention of Catheter Related Blood Stream Infections in Pediatric Patients Undergoing Intestinal Rehabilitation|Evaluation of the Clinical Practice of Using of a 70 % Ethanol Lock Solution for the Prevention of Catheter Related Blood Stream Infections in Pediatric Patients Undergoing Intestinal Rehabilitation|Withdrawn||N/A|0|Actual|University of Nebraska|||1|PI decided to withdraw study|f||||f||||||||||2017-10-11 03:57:33.819599|2017-10-11 03:57:33.819599
NCT01409759|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-06-25|||July 2011||2011-07-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||Perforator Based Interposition Plasty|Perforator Based Interposition Flaps for Sustainable Release of Burn Scar Contracture: a Reliable, Simple and Versatile Technique. A Randomised Controlled Trial.|Completed||Phase 2|50|Actual|Association of Dutch Burn Centres||2|||f||||t||||||||||2017-10-11 03:57:34.027774|2017-10-11 03:57:34.027774
NCT01409746|ClinicalTrials.gov processed this data on October 10, 2017|2009-04-06|2017-04-17|||April 2004||2004-04-01|April 2017|2017-04-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Early Brain Development in Twins|Early Brain Development in Twins|Active, not recruiting||N/A|600|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     buccal swabs; MRIs, ultrasounds   "|||2017-10-11 03:57:34.164834|2017-10-11 03:57:34.164834
NCT01409733|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-03|||June 2010||2010-06-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients|TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Heidelberg University||1|||f||||f||||||||||2017-10-11 03:57:35.110938|2017-10-11 03:57:35.110938
NCT01409720|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-03-19|||September 2011||2011-09-01|August 2011|2011-08-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|DISPO||Isometric Muscle Training in Patients With Spinal Bony Metastases Under Radiation Therapy|Isometric Muscle Training of the Spine Musculature in Patients With Spinal Bony Metastases Under Radiation Therapy|Completed||Phase 2|60|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-11 03:57:35.242433|2017-10-11 03:57:35.242433
NCT01409707|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-01-28|2013-10-29||July 2008||2008-07-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|January 2012|Actual|2012-01-01||Interventional|||Mechanisms of Change, Motivation, and Treatment Outcome in Alcohol Dependence - Posttraumatic Stress Disorder|Mechanisms of Change, Motivation, and Treatment Outcome in AD-PTSD|Completed||N/A|126|Actual|University of Mississippi Medical Center|Unclear whether results will generalize to outpatient sample.|3|||f||||f||||||||||2017-10-11 03:57:35.362912|2017-10-11 03:57:35.362912
NCT01409694|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-09-21|||September 2011||2011-09-01|March 2011|2011-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|AD-IDEA||Alzheimer's Disease - Input of Vitamin D With mEmantine Assay|Evaluation d'Une stratégie thérapeutique d'Association médicamenteuse Pour la Prise en Charge de la Maladie d'Alzheimer et Des Maladies apparentées au Stade modéré|Completed||Phase 3|90|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 03:57:35.827197|2017-10-11 03:57:35.827197
NCT01409681|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2014-03-28|||May 2011||2011-05-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|EBUS||A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer|A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer|Terminated||N/A|41|Actual|University of Michigan Cancer Center|||1|PI decided to terminate the study|f||||t||||||Samples With DNA|"     Bronchial brush samples Bronchoscopy samples for RNA extraction and RT-PCR expression Blood     samples        -  7 mL for measurement of Serum total Vit-D levels and 1,25 (OH)2 D3 levels;        -  5 ml collected in EDTA tube for CYP24A1 genotype analysis (common metabolizing agent for          calcitriol) and CYP24 polymorphisms analysis   "|||2017-10-11 03:57:35.944934|2017-10-11 03:57:35.944934
NCT01409668|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-08-03|||September 2007||2007-09-01|May 2007|2007-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|MPH||Efficacy of Two Yogurt Formulations in Healthy Humans|Efficacy of Two Yogurt Formulations as Health Promoting Agents in Healthy Humans|Completed||Phase 1|30|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-11 03:57:36.038219|2017-10-11 03:57:36.038219
NCT01409655|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-02-23|||August 2011||2011-08-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|CARE||Centralized Off-Site Adherence Enhancement Program|Centralized Off-Site Adherence Enhancement Program|Completed||N/A|42|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 03:57:36.128115|2017-10-11 03:57:36.128115
NCT01409642|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-12|2016-05-11|||January 2008||2008-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PFIT||Family Focused Treatment of Pediatric Obsessive Compulsive Disorder|Pilot Feasibility Trial of Positive Family Interaction Therapy|Recruiting||N/A|40|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 03:57:36.248081|2017-10-11 03:57:36.248081
NCT01409629|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-09-28|||February 2011||2011-02-01|September 2011|2011-09-01|March 2012|Anticipated|2012-03-01|May 2011|Actual|2011-05-01||Observational|||Influence of a Computer Game on Youth's Choices of Activities|Influence of a Computer Game on Youth's Choices of Activities|Terminated||N/A|80|Anticipated|University at Buffalo|||1||f||||f||||||||||2017-10-11 03:57:36.880222|2017-10-11 03:57:36.880222
NCT01409616|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-03-19|||April 2009||2009-04-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects|A Randomized, Open-label, Two-period Crossover Study in Healthy Male Subjects to Evaluate the Pharmacodynamic Effect of Darexaban (YM150) on Acetyl Salicylic Acid (ASA) and of Darexaban on the Combination of ASA and Clopidogrel at Steady State|Completed||Phase 1|100|Actual|Astellas Pharma Inc||8|||f||||f||||||||||2017-10-11 03:57:36.945421|2017-10-11 03:57:36.945421
NCT01409603|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-04-09|||January 2010||2010-01-01|April 2013|2013-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their Effects|A Phase I, Open-Label, Randomized 3-Period Crossover Study in Healthy Male Subjects to Evaluate the Pharmacodynamic Interactions Between YM150 on Naproxen at Steady-State|Completed||Phase 1|26|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-10-11 03:57:37.065192|2017-10-11 03:57:37.065192
NCT00005472|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1996||1996-09-01|August 2004|2004-08-01|August 1998|Actual|1998-08-01|||||Observational|||Job Strain, Ambulatory Blood Pressure and Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:05.996194|2017-10-11 04:27:05.996194
NCT01409577|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-11-19|||March 2011||2011-03-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Outcome of FFR-guided Intervention Strategy|Clinical Outcome of Fractional Flow Reserve-guided Coronary Intervention Strategy in Koreans|Unknown status|Recruiting|N/A|1500|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-10-11 03:57:37.292269|2017-10-11 03:57:37.292269
NCT01409564|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-04-14|2013-08-19||May 2010||2010-05-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|June 2012|Actual|2012-06-01||Interventional||18 subjects for each group were enrolled in the final list.|Cilostazol Augmentation Study in Dementia|Cilostazol Augmentation Study In Dementia (CASID): A Randomized, Placebo-controlled Pilot Study to Compare the Efficacy Between Donepezil Monotherapy and Cilostazol Augmentation Therapy in Alzheimer's Disease Patients With Subcortical White Matter Hyperintensities|Completed||Phase 4|46|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 03:57:37.407927|2017-10-11 03:57:37.407927
NCT01409551|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-11-14|||August 2011||2011-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Video-assisted Hyperthermic Pleural Chemoperfusion vs Talc Pleurodesis for Refractory Malignant Pleural Effusions.|Video-assisted Hyperthermic Pleural Chemoperfusion Versus Bed-side Talc Slurry Pleurodesis for Refractory Malignant Pleural Effusions.|Completed||N/A|60|Actual|Theagenio Cancer Hospital||2|||f||||f||||||||||2017-10-11 03:57:37.94219|2017-10-11 03:57:37.94219
NCT01409538|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-03-19|||January 2010||2010-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Brain Imaging and Pain: Analysis of Placebo Analgesia|Brain Imaging and Pain: Analysis of Placebo Analgesia|Completed||Phase 1|140|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 03:57:38.035778|2017-10-11 03:57:38.035778
NCT01409525|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-08-03|||August 2011||2011-08-01|August 2011|2011-08-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Observational|||Rate of Microbial Colonization Over Native Calcified Cardiac Valves|Observational, Prospective, Exploratory Study to Evaluate the Rate of Microbial Colonization Over Native Calcified Cardiac Valves|Unknown status|Not yet recruiting|N/A|200|Anticipated|Rambam Health Care Campus|||1||f||||f||||||Samples Without DNA|"     cardiac valve tissue   "|||2017-10-11 03:57:38.136078|2017-10-11 03:57:38.136078
NCT01409512|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-03|||September 2011||2011-09-01|August 2011|2011-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder|Observational Study on the Effect of Anticholinergic on the Autonomic System in Women With OAB|Unknown status|Not yet recruiting|N/A|30|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 03:57:38.214978|2017-10-11 03:57:38.214978
NCT01409499|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-04-13|||January 2011||2011-01-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|2011PTAHCC||Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)|A Prospective Multicenter Non-randomized Controlled Study of Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma|Recruiting||Phase 4|200|Anticipated|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 03:57:38.326788|2017-10-11 03:57:38.326788
NCT01409486|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-08-03|||September 2011||2011-09-01|August 2011|2011-08-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|LC-MS-MS||Screening for Early Detection and Prevention of Pompe Disease in Israel Using Tandem Mass Spectrometry|Screening for Early Detection and Prevention of Pompe Disease in Israel Using Tandem Mass Spectrometry|Unknown status|Not yet recruiting|N/A|10000|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 03:57:38.451139|2017-10-11 03:57:38.451139
NCT01409473|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2014-02-10|||August 2011||2011-08-01|February 2014|2014-02-01|August 2022|Anticipated|2022-08-01|August 2018|Anticipated|2018-08-01||Interventional|Prostate SBRT||Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer|A Prospective Protocol of Stereotactic Body Irradiation With Concurrent Intraprostatic Lesion Boost Utilizing Intensity Modulated Radiotherapy for Patients With Low- and Intermediate-Risk Prostate Cancer|Withdrawn||Phase 2|0|Actual|Rocky Mountain Cancer Centers||1|||f||||f||||||||||2017-10-11 03:57:38.541578|2017-10-11 03:57:38.541578
NCT01409460|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-03|||October 2008||2008-10-01|October 2008|2008-10-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Obturator Nerve Block With Femoral and Sciatic Block|Is an Obturator Nerve Block Required for Every Patient Having Total Knee Arthroplasty With Femoral and Sciatic Nerve Block?|Completed||N/A|16|Actual|Saint Francis Care||2|||f||||f||||||||||2017-10-11 03:57:38.873587|2017-10-11 03:57:38.873587
NCT01409447|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2011-08-19|||March 2009||2009-03-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Repair of Articular Osteochondral Defect|Repair of Articular Osteochondral Defect|Unknown status|Recruiting|N/A|10|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 03:57:38.95916|2017-10-11 03:57:38.95916
NCT01409434|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-10-10|2014-07-16||June 2010||2010-06-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Patients previously enrolled in the PEAR 1 or 2 study|Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up Study|Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up Study|Completed||Phase 4|44|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 03:57:39.066108|2017-10-11 03:57:39.066108
NCT01409421|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-09-30|||April 2011||2011-04-01|September 2015|2015-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence|An Assessment of the Impact of Motivational Interviewing Via Glaucoma Educator on Glaucoma Treatment Adherence and Persistence|Completed||N/A|201|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-10-11 03:57:39.306897|2017-10-11 03:57:39.306897
NCT01409408|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-03-05|||April 2011||2011-04-01|April 2011|2011-04-01|December 2013|Anticipated|2013-12-01|April 2013|Anticipated|2013-04-01||Interventional|||Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan|Comparison Between Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan: Effects on Endothelial Function and Renin Concentration and Activity|Withdrawn||Phase 4|0|Actual|Hospital Universitario Pedro Ernesto||2||Due to preliminary results of Altitude Trial.|f||||f||||||||||2017-10-11 03:57:39.39543|2017-10-11 03:57:39.39543
NCT01409395|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2014-04-09|||September 2011||2011-09-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Drug-Drug Interaction Study With Metformin and Nizatidine|The Pharmacokinetic Interaction Between Metformin and Nizatidine in Healthy Volunteers|Completed||Phase 1|10|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:57:39.507166|2017-10-11 03:57:39.507166
NCT01409382|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-08-19|2013-04-26||March 2011||2011-03-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|April 2013|Actual|2013-04-01||Interventional||Women with recurrent fetal losses in the first trimester|Maternal Lifestyle and Neonatal Hypoglycemia|Repercussion of Maternal Lifestyle on Obstetric and Neonatal Outcomes|Completed||N/A|480|Actual|Hospital dos Servidores do Estado do Rio de Janeiro||2|||f||||t||||||||Yes||2017-10-11 03:57:39.621667|2017-10-11 03:57:39.621667
NCT01409369|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study on The Effect of Multiple Doses of Activated Charcoal on The Pharmacokinetics of a Single Dose of RO4995819|A Single-Center, Open-Label, Two-Period Crossover Study to Investigate the Effect of Multiple Doses of Activated Charcoal on the Pharmacokinetics of a Single Oral Dose of RO4995819 in Healthy Subjects.|Completed||Phase 1|26|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 03:57:40.732822|2017-10-11 03:57:40.732822
NCT01409356|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2015-03-17|||October 2011||2011-10-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|SPORTDIET||Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis|Effects of Weight Loss on Portal Pressure in Patients With Compensated Cirrhosis and Overweight/Obesity|Completed||Phase 2|60|Actual|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-10-11 03:57:40.84485|2017-10-11 03:57:40.84485
NCT01409343|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2013-12-19|||July 2011||2011-07-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||TrasGEX™: Dose Escalation Study|A Phase I Dose-Escalation and Pharmacokinetic Study of TrasGEX™ in Patients With Locally Advanced or Metastatic HER-2-positive Cancer|Completed||Phase 1|45|Anticipated|Glycotope GmbH|||||f||||t||||||||||2017-10-11 03:57:40.972252|2017-10-11 03:57:40.972252
NCT01409330|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2012-08-21|||February 2011||2011-02-01|August 2012|2012-08-01|December 2013|Anticipated|2013-12-01|September 2013|Anticipated|2013-09-01||Interventional|DDIET||German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET)|Short Term Diet Intervention in Newly Diagnosed Type 2 Diabetes. a Randomised, Multicentric, Controlled, Clinical Trial|Unknown status|Recruiting|Phase 4|40|Anticipated|German Diabetes Center||2|||f||||f||||||||||2017-10-11 03:57:41.06472|2017-10-11 03:57:41.06472
NCT01409317|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-05-26|||April 2013||2013-04-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Neural Predictors and Longitudinal Neural Correlates of Deep Transcranial Magnetic Stimulation for Treating Major Depression|Neural Predictors and Longitudinal Neural Correlates of Clinical Improvement After Standard or Deep Transcranial Magnetic Stimulation in Major Depression: A Randomized Study|Completed||Phase 2/Phase 3|10|Actual|Douglas Mental Health University Institute||2|||f||||t||||||||||2017-10-11 03:57:41.221594|2017-10-11 03:57:41.221594
NCT01409304|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-01-16|||October 2011||2011-10-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness of Deep Transcranial Magnetic Stimulation in Depression|Effectiveness of Deep Transcranial Magnetic Stimulation for Treating Major Depression: a Pilot Study|Completed||Phase 2/Phase 3|18|Actual|Douglas Mental Health University Institute||1|||f||||f||||||||||2017-10-11 03:57:41.389289|2017-10-11 03:57:41.389289
NCT01409291|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2014-08-11|2014-08-11||September 2011||2011-09-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Impact of a Financial Success Education Program in Women and Children|Impact of a Financial Success Education Program on Perceived Financial Well-being, Hopefulness, Financial Competency, Financial Goal Achievement, Quality of Life, and Quantitative Health Outcomes in Women and Children: A Pilot Study|Completed||N/A|64|Actual|Creighton University|||1||f||||f||||||||||2017-10-11 03:57:41.545471|2017-10-11 03:57:41.545471
NCT01409278|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-03|||August 2009||2009-08-01|August 2009|2009-08-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|||Local Anesthetic Infiltration and Infusion for Pain Control After Hip Replacement|The Evaluation of the Efficacy of Local Infiltration Analgesia and Infusion for Total Hip Arthroplasty|Completed||N/A|105|Actual|Saint Francis Care||3|||f||||f||||||||||2017-10-11 03:57:41.837215|2017-10-11 03:57:41.837215
NCT01409265|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-17|2015-02-10|||December 2010||2010-12-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||The Impact of Perceptual Impairment on Social Participation in Stroke Patients|The Impact of Perceptual Impairment on Social Participation in Stroke Patients|Completed||N/A|90|Actual|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-11 03:57:41.933531|2017-10-11 03:57:41.933531
NCT01409252|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-03|2013-01-10|||June 2011||2011-06-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Long Term Outcome After Hemorrhagic Stroke Surgery|Long Term Neurological and Cognitive Outcome After Neurosurgical Operation for Hemorrhagic Stroke (Intracerebral Hemorrhage)|Completed||N/A|191|Actual|Chinese University of Hong Kong|||1||f||||f||||||||||2017-10-11 03:57:42.039606|2017-10-11 03:57:42.039606
NCT01409239|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-11-11|2013-07-02||July 2011||2011-07-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes||Completed||Phase 4|42|Actual|Ohio State University|Since this was a pilot study no formal power analysis was possible. It was hypothesized that IV insulin would be associated with lower LF/HF HRV.|2|||f||||f||||||||||2017-10-11 03:57:42.13379|2017-10-11 03:57:42.13379
NCT01409226|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2012-04-03|||August 2009||2009-08-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women|A Study to Evaluate 3.0 Tesla Magnetic Resonance Imaging of the Breasts in High Risk Women|Withdrawn||N/A|0|Actual|New York University School of Medicine||1||Due to slow accrual|f||||||||||||||2017-10-11 03:57:42.408472|2017-10-11 03:57:42.408472
NCT01409213|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-08-26|2011-12-15||August 2009||2009-08-01|August 2015|2015-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|SIRTA||A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)|Standardized Non-interventional Register Investigating the Daily Clinical Practice for the Treatment of Patients With Diabetes Mellitus Type 2 (SIRTA)|Completed||N/A|1523|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-10-11 03:57:42.495823|2017-10-11 03:57:42.495823
NCT01409200|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-06-27|||March 2012|Actual|2012-03-01|June 2017|2017-06-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Neoadjuvant Axitinib in Prostate Cancer|Pre-surgical Androgen Deprivation Therapy With or Without Axitinib in Previously Untreated Prostate Cancer Patients With Known or Suspected Lymph Node Metastasis|Recruiting||Phase 2|72|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 03:57:42.653163|2017-10-11 03:57:42.653163
NCT01409187|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2012-01-25|||October 2011||2011-10-01|January 2012|2012-01-01||||October 2016|Anticipated|2016-10-01||Interventional|||IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma|IPI-Biotherapy for Patients With Metastatic Melanoma Previously Treated With Cytotoxic Drugs|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:57:42.764217|2017-10-11 03:57:42.764217
NCT01409174|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-05-26|||February 2013||2013-02-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma|IPI-Biochemotherapy for Chemonaive Patients With Metastatic Melanoma|Terminated||Phase 1|19|Actual|M.D. Anderson Cancer Center||1||Slow accrual, closed in Phase I.|f||||f||||||||||2017-10-11 03:57:42.863552|2017-10-11 03:57:42.863552
NCT01409161|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-08-24|||October 2011|Actual|2011-10-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin|Phase II Study of Treatment of Acute Promyelocytic Leukemia (APL) With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin (GO)|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 03:57:42.973312|2017-10-11 03:57:42.973312
NCT01409148|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2012-10-10|||November 2008||2008-11-01|August 2011|2011-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Radioimmunoimaging of AL Amyloidosis|Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody Mu 11-1F4|Completed||Phase 1|38|Actual|University of Tennessee||1|||f||||f||||||||||2017-10-11 03:57:43.100527|2017-10-11 03:57:43.100527
NCT01409135|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2015-10-06|||June 2011||2011-06-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4|A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS-22M6E or ASG-22CE Given as Monotherapy Followed by Expansion Cohorts in Subjects With Malignant Solid Tumors That Express Nectin-4|Completed||Phase 1|34|Actual|Astellas Pharma Inc||9|||f||||f||||||||||2017-10-11 03:57:43.220967|2017-10-11 03:57:43.220967
NCT01409122|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-11-08|||July 2011||2011-07-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects|A Phase 1, Placebo Controlled, Blinded, Multiple Dose Escalation Study of AIR001 (Sodium Nitrite Inhalation Solution) in Healthy Subjects, an Assessment of the Tolerability in Combination With Oral Sildenafil, and an Open-Label Study of Multiple Dose AIR001 in Patients With Pulmonary Arterial Hypertension|Completed||Phase 1|42|Actual|Aires Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 03:57:43.365429|2017-10-11 03:57:43.365429
NCT01409109|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-05-20|||March 2010||2010-03-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|Imaging||Database Registry to Examine Brain Connections and Brain Function in Mental Disorders and Neural Network Biomarkers for Relational Memory and Psychosis in Schizophrenia|Database Registry to Examine Brain Connections and Brain Function in Mental Disorders and Neural Network Biomarkers for Relational Memory and Psychosis in Schizophrenia|Recruiting||N/A|1000|Anticipated|University of Texas Southwestern Medical Center|||2||f||||t||||||||||2017-10-11 03:57:43.469361|2017-10-11 03:57:43.469361
NCT01409083|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2012-12-11|||July 2011||2011-07-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Children|Evaluating the Use of Intravenous Bicarbonate as a Tool to Verify the Intravascular Position of an IV Catheter in Children|Completed||Phase 1/Phase 2|18|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 03:57:44.167161|2017-10-11 03:57:44.167161
NCT01409070|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2012-10-13|||January 2011||2011-01-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|H-1012-015-342||Head to Head Comparison of Azacitidine and Decitabine in Myelodysplastic Syndrome|Head to Head Comparison of Azacitidine and Decitabine in Myelodysplastic Syndrome: Retrospective, Multicenter Study|Completed||Phase 3|300|Actual|Seoul National University Hospital|||2||f||||||||||||||2017-10-11 03:57:44.25435|2017-10-11 03:57:44.25435
NCT01409057|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2012-12-11|||June 2010||2010-06-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Observational|SEOPCAB||Effect of Heart-lung-machine on Selenium Status of Cardiac Surgical Patients Undergoing Coronary Bypass Surgery|SEOPCAB: Effect of Heart-lung-machine on Selenium Status of Cardiac Surgical Patients Undergoing Coronary Bypass Surgery|Completed||N/A|46|Actual|RWTH Aachen University|||2||f||||f||||||||||2017-10-11 03:57:44.331016|2017-10-11 03:57:44.331016
NCT01409044|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-08-09|||June 17, 2011||2011-06-17|August 8, 2017|2017-08-08|August 8, 2017|Actual|2017-08-08|May 9, 2013|Actual|2013-05-09||Interventional|||Effect of Music on Pain and Anxiety After Surgery|The Effect of Music Listening on the Amount of Opioids Used in Surgical Intensive Care Patients|Terminated||Phase 3|62|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 03:57:44.404058|2017-10-11 03:57:44.404058
NCT01409031|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2016-03-22|||July 2011||2011-07-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension|Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension|Terminated||Phase 2|4|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 03:57:44.479546|2017-10-11 03:57:44.479546
NCT01409018|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-11-17|||June 2009||2009-06-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Pharmacokinetics of Itraconazole in Pediatric Cancer Patients|Pharmacokinetics of Itraconazole in Pediatric Cancer Patients|Completed||Phase 1|6|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 03:57:44.763225|2017-10-11 03:57:44.763225
NCT01409005|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2014-02-10|||June 2011||2011-06-01|January 2014|2014-01-01||||February 2013|Actual|2013-02-01||Interventional|||Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer|A Phase II Trial of Gemcitabine Plus UFTE Combination Chemotherapy as Salvage Treatment in Oxaliplatin, Irinotecan and Fluoropyrimidine-Refractory Metastatic Colorectal Cancer|Completed||Phase 2|41|Actual|Seoul National University Bundang Hospital||1|||f||||f||||||||||2017-10-11 03:57:44.846923|2017-10-11 03:57:44.846923
NCT01408992|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-04-17|2011-12-29||July 2011||2011-07-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|Thai_FMHT||Thai-version Five Minute Hearing Test|The Evaluation of Thai-version Five Minute Hearing Test to Screen Hearing in Community|Completed||N/A|558|Actual|Khon Kaen University||1|||f||||f||||||||||2017-10-11 03:57:44.948004|2017-10-11 03:57:44.948004
NCT01408979|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2012-08-20|||August 2011||2011-08-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|MgSO4||Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia|Postpartum Prophylaxis With Short Course Magnesium Sulfate in Severe Preeclampsia: a Randomized Clinical Trial|Completed||Phase 4|120|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||t||||||||||2017-10-11 03:57:45.239354|2017-10-11 03:57:45.239354
NCT01408966|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-02|||August 2008||2008-08-01|August 2011|2011-08-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Interventional|||Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in Cirrhosis|Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in Cirrhosis|Completed||Phase 2|22|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 03:57:45.326362|2017-10-11 03:57:45.326362
NCT01408953|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2016-10-17|||February 2012||2012-02-01|October 2016|2016-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue|A Therapeutic Trial of Intralesional Bevacizumab in Patients With Non-pedunculated Keloids|Terminated||Phase 2|2|Actual|Tirgan, Michael H., M.D.||1||Very low accrual rate.|f||||f||||||||Yes|Only two patients were treated on this study, neither responded. The study was closed due to difficulties in accruing patients.|2017-10-11 03:57:45.443152|2017-10-11 03:57:45.443152
NCT01408927|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-08-08|||October 2008||2008-10-01|August 2014|2014-08-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|VASP||Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft Population|Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary PCI and CABG Population|Unknown status|Recruiting|N/A|1000|Anticipated|Medstar Health Research Institute|||1||f||||f||||||||||2017-10-11 03:57:45.540517|2017-10-11 03:57:45.540517
NCT01408914|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-06-15|2017-05-03||September 2013||2013-09-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|HIRIF||Trial of High-Dose Rifampin in Patients With TB|Randomized Trial of High-Dose Rifampin in Patients With New, Smear-Positive TB|Completed||Phase 2|180|Actual|Harvard University Faculty of Medicine||3|||f||||t||||||||||2017-10-11 03:57:45.64919|2017-10-11 03:57:45.64919
NCT01408901|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2017-02-13|||September 2011||2011-09-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|August 2017|Anticipated|2017-08-01||Interventional|PROPEL||Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)|PROgenitor Cell Release Plus Exercise to Improve functionaL Performance in PAD: The PROPEL Study|Active, not recruiting||N/A|210|Actual|Northwestern University||4|||f||||t||||||||Undecided||2017-10-11 03:57:46.451909|2017-10-11 03:57:46.451909
NCT01408888|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-10-03|2014-10-03||August 2011||2011-08-01|October 2014|2014-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||Participants who received at least one dose of study drug (LY2189265 or Sitagliptin).|A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes|Study to Evaluate the Effect of LY2189265 on Sitagliptin Pharmacokinetics in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|29|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 03:57:46.623382|2017-10-11 03:57:46.623382
NCT01408875|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-03-06|||October 2011||2011-10-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|CREMS-HF||Cardiac Rehabilitation and Low Frequency Electrical MyoStimulation in Chronic Heart Failure|Cardiac Rehabilitation and Low Frequency Electrical MyoStimulation in Chronic Heart Failure|Completed||N/A|94|Actual|French Cardiology Society||2|||f||||t||||||||||2017-10-11 03:57:47.379552|2017-10-11 03:57:47.379552
NCT01408862|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-09-19|2014-09-08||December 2012||2012-12-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational||Platelets from healthy human subjects who were not taken any medication in the previous 10 days were studied. They were subjects with no characteristics of the Metabolic Syndrome components.|Effects of Incretins on Human Platelet Function|Effects of Incretins on Human Platelet Function|Completed||N/A|20|Actual|National Council of Scientific and Technical Research, Argentina|Albeit at high concentrations presumably well above of the physiological range, the use of native and rapidly degradable forms of these peptides may impose a limitation of this study||1||f||||f||||||||||2017-10-11 03:57:47.570815|2017-10-11 03:57:47.570815
NCT01408849|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2016-07-25|||February 2015||2015-02-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Use of Maytenus Ilicifolia in the Treatment of Dyspepsia|Use of Maytenus Ilicifolia Mart. ex Reiss in the Treatment of Dyspepsia|Terminated||Phase 2|4|Actual|Casa Espirita Terra de Ismael||2||Lack of adherence and huge loss of follow up.|f||||f||||||||||2017-10-11 03:57:47.849484|2017-10-11 03:57:47.849484
NCT01408836|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-02|||March 1995||1995-03-01|July 2011|2011-07-01|December 2003|Actual|2003-12-01|June 2003|Actual|2003-06-01||Interventional|MEPEX||Plasma Exchange for Renal Vasculitis|Randomised Trial of Plasma Exchange or High Dose Methyl Prednisolone as Adjunctive Therapy for Severe Renal Vasculitis|Terminated||Phase 2/Phase 3|150|Actual|Cambridge University Hospitals NHS Foundation Trust||2||Completed|f||||f||||||||||2017-10-11 03:57:47.965909|2017-10-11 03:57:47.965909
NCT01408823|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2013-08-07|||July 2011||2011-07-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery|Pharmacokinetics of Epsilon-Aminocaproic Acid in Children and Adolescents With Scoliosis Undergoing Posterior Spinal Fusion|Completed||N/A|20|Actual|Children's Hospital of Philadelphia|||2||f||||f||||||||||2017-10-11 03:57:48.078472|2017-10-11 03:57:48.078472
NCT01408810|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2012-12-17|||February 2011||2011-02-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|HERICA||Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis|Histological and Endoscopic Evaluation of Remission Induced by Infliximab in Moderately to Severely Active Ulcerative Colitis Patients|Completed||Phase 4|21|Actual|Grupo de Estudo da Doença Inflamatória Intestinal||1|||f||||f||||||||||2017-10-11 03:57:48.153859|2017-10-11 03:57:48.153859
NCT01408797|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-19|||March 2011||2011-03-01|February 2011|2011-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|DAWN||Clonal Deletion on Living-Relative Donor Kidney Transplantation|A Prospective, Open-Label, Pilot Study of Clonal Deletion on Living-Relative Donor Kidney Transplantation|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Fuzhou General Hospital||3|||f||||t||||||||||2017-10-11 03:57:48.242363|2017-10-11 03:57:48.242363
NCT01408784|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2012-04-30|||July 2011||2011-07-01|July 2011|2011-07-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|||A New Method for Self-assessment of Daily Calorie Intake|"Evaluating the Validity of the Categories Method: a New Method for Self-report Assessment of Daily Calorie Intake"|Unknown status|Recruiting|N/A|135|Anticipated|Assuta Hospital Systems|||1||f||||t||||||||||2017-10-11 03:57:48.334829|2017-10-11 03:57:48.334829
NCT01408771|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-07|||April 2011||2011-04-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||"Swallow my Urine Back : Inhibition of Detrusor Overactivity by Swallowing Maneuver"|"Swallow my Urine Back : Inhibition of Detrusor Overactivity by Swallowing Maneuver"|Completed||N/A|20|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-10-11 03:57:48.416687|2017-10-11 03:57:48.416687
NCT01408758|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-17|2017-02-24|||January 2011||2011-01-01|February 2017|2017-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|VCRT||Virtual Clinician Research Tool|Creating a Virtual Clinician Research Tool|Completed||N/A|79|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 03:57:48.472235|2017-10-11 03:57:48.472235
NCT01408745|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-04-13|||June 2008||2008-06-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|STEPHIX||Sternal Closure With STERNUMFIX in Patients With High Risk|Multicenter Controlled Study on the Safety and Efficacy of Sternal Closure With STERNUMFIX in Patients With High Risk|Terminated||Phase 4|166|Actual|Aesculap AG||2||terminatedd due to insufficient recruitment|f||||f||||||||||2017-10-11 03:57:48.558848|2017-10-11 03:57:48.558848
NCT01408719|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-10-07|2013-08-12||November 2010||2010-11-01|October 2015|2015-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||It is a cross over trial so the total number of participants is same throughout the study.|Effect of Beta-Glucan on Cholesterol Lowering|Effect of Beta-Glucan Molecular Weight and Viscosity on the Mechanism of Cholesterol Lowering in Humans|Completed||N/A|45|Actual|University of Manitoba||4|||f||||f||||||||||2017-10-11 03:57:48.973162|2017-10-11 03:57:48.973162
NCT01408706|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-06-13|2016-10-24||August 2011||2011-08-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||The Prostate Immobilization Device Study|The Prostate Immobilization Device Study|Completed||N/A|60|Actual|Wheaton Franciscan Healthcare||2|||f||||f||||||||No||2017-10-11 03:57:49.941643|2017-10-11 03:57:49.941643
NCT01408693|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2017-08-21|||August 2011||2011-08-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|April 2015|Actual|2015-04-01||Interventional|MIS-CLAS||Minimal Invasive Anterior Approach Versus Trans-gluteal Approach for Hemi-arthroplasty in Femoral Neck Fractures|Minimal Invasive Anterior Approach Versus Trans-gluteal Approach for Hemi-arthroplasty in Femoral Neck Fractures - A Prospective Randomized Trial|Active, not recruiting||Phase 4|190|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-10-11 03:57:50.267728|2017-10-11 03:57:50.267728
NCT01408680|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-12-02|||November 2011||2011-11-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||CoQ10 Biomarker Trial|Assessing the Effect of the Dietary Supplement Coenzyme Q10 on Biomarkers of Oxidative Stress, Systemic Inflammation, and Endothelial Function in Hemodialysis Patients|Completed||N/A|66|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 03:57:50.378175|2017-10-11 03:57:50.378175
NCT01408667|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2012-07-06|||November 2011||2011-11-01|July 2012|2012-07-01||||March 2012|Actual|2012-03-01||Interventional|||Hyperinsulinemic Euglycemic Clamp Protocol|A Phase 2A, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Efficacy of TRC150094 in Increasing Insulin Sensitivity in Male Patients With Increased Cardiometabolic Risk|Completed||Phase 1/Phase 2|40|Actual|Torrent Pharmaceuticals Limited||2|||f||||f||||||||||2017-10-11 03:57:50.504653|2017-10-11 03:57:50.504653
NCT01408654|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-04-20|||September 2011||2011-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|TSC||Social Connections and Healthy Aging (The Senior Connection)|Social Connections and Healthy Aging (The Senior Connection)|Completed||Phase 2|368|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 03:57:50.597055|2017-10-11 03:57:50.597055
NCT01408641|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-09-10|||September 2012||2012-09-01|September 2012|2012-09-01|August 2013|Anticipated|2013-08-01|July 2013|Anticipated|2013-07-01||Interventional|||Topiramate for Alcohol Use in Posttraumatic Stress Disorder|A 14-week Randomized, Placebo-controlled Study of Topiramate for Alcohol Use Disorders in Veterans With Posttraumatic Stress Disorder|Unknown status|Recruiting|N/A|30|Anticipated|University of Maryland||2|||f||||t||||||||||2017-10-11 03:57:50.685791|2017-10-11 03:57:50.685791
NCT01408628|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-07-01|2015-04-28||August 2011||2011-08-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|I-KAN||The I-KAN Study: Internet Insulin Education for Kansans|The I-KAN Study: Internet Initiation of Insulin for Type 2 Diabetes in Kansas|Completed||N/A|51|Actual|University of Kansas Medical Center|This was a pilot study designed to compare rates of hypoglycemia among Internet managed type 2 patients to those from large clinical trials. It was not a placebo controlled trial.|1|||f||||t||||||||||2017-10-11 03:57:50.769044|2017-10-11 03:57:50.769044
NCT01408615|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-05-08|||September 20, 2011|Actual|2011-09-20|May 2017|2017-05-01|November 18, 2016|Actual|2016-11-18|November 18, 2016|Actual|2016-11-18||Observational|||A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)|Post Marketing Surveillance for General Drug Use to Assess the Safety and Efficacy Profile of ELONVA in Usual Practice|Completed||N/A|472|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-10-11 03:57:50.946745|2017-10-11 03:57:50.946745
NCT01408602|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-05-09|||November 2011||2011-11-01|May 2014|2014-05-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients|A 24-week, Phase 2, Double-blind, Placebo-controlled, Randomized Study to Assess the Safety and Efficacy of 2 Doses of MRC375 in Patients With Moderate to Severe Rheumatoid Arthritis|Unknown status|Active, not recruiting|Phase 2|300|Anticipated|Molecular Research Center, Inc.||3|||f||||f||||||||||2017-10-11 03:57:51.01098|2017-10-11 03:57:51.01098
NCT01408030|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-11-05|||August 2011||2011-08-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|NOSE||North American Study of Epistaxis in HHT|North American Study of Epistaxis in HHT (NOSE)|Completed||Phase 2|121|Actual|Augusta University||4|||f||||t||||||||||2017-10-11 03:58:00.035373|2017-10-11 03:58:00.035373
NCT01408589|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-08-02|||June 2005||2005-06-01|August 2011|2011-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ATX_COMT||A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol|A Pharmacotherapy Study: A Dose Response Effect of Atomoxetine on Alcohol-elicited Craving and Sensitivity to the Acute Effects of Alcohol|Terminated||Phase 1|86|Actual|University of Colorado, Boulder||4|||f||||t||||||||||2017-10-11 03:57:51.114524|2017-10-11 03:57:51.114524
NCT01408576|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-03-14|||July 2011||2011-07-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|EMBODY4||Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus|A Phase 3, Multicenter, Open-label, Extension Study to Assess the Safety and Tolerability of Epratuzumab Treatment in Systemic Lupus Erythematosus Subjects|Completed||Phase 3|1253|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 03:57:51.204522|2017-10-11 03:57:51.204522
NCT01408563|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-09-28|||December 2011||2011-12-01|September 2017|2017-09-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Interventional|||Reduced Intensity Double Umbilical Cord Blood Transplantation|A Phase II Study of Reduced Intensity Double Umbilical Cord Blood Transplantation Using Fludarabine, Melphalan, and Low Dose Total Body Radiation|Completed||Phase 2|32|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:57:53.700345|2017-10-11 03:57:53.700345
NCT01408550|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2013-10-15|||August 2011||2011-08-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids|NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Bullous Pemphigoid Unresponsive to Corticosteroids: Randomized, Double-Blind, Placebo Control,Parallel Assignment Study(Phase III)|Completed||Phase 3|56|Anticipated|Nihon Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-11 03:57:53.806831|2017-10-11 03:57:53.806831
NCT01408537|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-11-14|2013-04-23||May 2010||2010-05-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|JE0153||Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children|Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children|Completed||Phase 3|152|Actual|Mahidol University||1|||f||||f||||||||||2017-10-11 03:57:53.907051|2017-10-11 03:57:53.907051
NCT01408524|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2014-03-31|||February 2010||2010-02-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|November 2012|Actual|2012-11-01||Interventional|||Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem|A Comparative Study in the Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol (Avexa) and Diltiazem|Completed||Phase 1/Phase 2|184|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 03:57:54.197342|2017-10-11 03:57:54.197342
NCT01408511|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-03-19|||July 2011||2011-07-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||HPA Axis Study in Adults|A Multicenter, Open Label Study to Evaluate the Adrenal Suppression Potential of Mapracorat 0.1% Ointment in Adults With Atopic Dermatitis|Completed||Phase 2|23|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:57:54.274408|2017-10-11 03:57:54.274408
NCT01408485|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2017-04-21|2014-01-22||November 2011||2011-11-01|May 2014|2014-05-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|FLEXION-AFL||Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter|Clinical Evaluation of Therapy™ Cool Flex™ Irrigated Ablation System for the Treatment of Typical Atrial Flutter|Completed||N/A|200|Actual|St. Jude Medical||1|||f||||t||||||||No||2017-10-11 03:57:54.447776|2017-10-11 03:57:54.447776
NCT01408472|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2016-08-01|||April 2011||2011-04-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|||NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement|CNTF Cell Implants For Glaucoma: A Phase I Study|Completed||Phase 1|11|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 03:57:54.839096|2017-10-11 03:57:54.839096
NCT01408446|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-10-27|||August 2012||2012-08-01|October 2013|2013-10-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Interventional|ESMAB||Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients|A Randomized, Double-Blind, Placebo Control Trial Comparing Effects and Safety of DANSHU Capsule(Menthol) and Placebo on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Third Military Medical University||2|||f||||t||||||||||2017-10-11 03:57:54.984057|2017-10-11 03:57:54.984057
NCT01408433|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-03-25|||August 2011||2011-08-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional|||Single Embryo Transfer of a Euploid Embryo Versus Double Embryo Transfer|Single Embryo Transfer of a Euploid Embryo Versus Double Embryo Transfer: A Randomized Controlled Trial|Completed||N/A|175|Actual|Reproductive Medicine Associates of New Jersey||2|||f||||f||||||||||2017-10-11 03:57:55.075241|2017-10-11 03:57:55.075241
NCT01408420|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-03-26|||April 2011||2011-04-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|PPC||Perfusion - Pressure - Creatinine Trial|Impact of Perfusion Pressure During Extracorporeal Circulation on Postoperative Kidney Function|Completed||N/A|100|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 03:57:55.176413|2017-10-11 03:57:55.176413
NCT01408407|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2015-05-22|||December 2011||2011-12-01|May 2015|2015-05-01||||May 2014|Actual|2014-05-01||Interventional|||Alkagin Paste in the Prevention of Radiation Dermatitis|A Phase II Study Designed to Evaluate the Value of Alkagin Paste in the Prevention of Radiation Dermatitis for Patients Undergoing External Radiation Therapy|Terminated||Phase 2|2|Actual|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||f||||||||||2017-10-11 03:57:55.273358|2017-10-11 03:57:55.273358
NCT01408017|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-01-09|||September 2011||2011-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 03:58:00.213987|2017-10-11 03:58:00.213987
NCT01408394|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-08-01|||August 2011||2011-08-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam|A Phase 1, Single Center, Randomized (2-Sequence), Single Blind, 3-Period Study Comparing the Safety, Tolerability, and Pharmacokinetics of Ecopipam Controlled Release Capsules With Ecopipam HCl Immediate Release Tablets in Male Adult Volunteers|Completed||Phase 1|16|Actual|Psyadon Pharma||3|||f||||f||||||||||2017-10-11 03:57:55.363312|2017-10-11 03:57:55.363312
NCT01408381|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-03-15|||January 2011||2011-01-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Limb Ischemia (CLI).|Multicenter Phase II, Randomized Open Clinical Trial on the Therapeutic Use of Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Chronic Ischemia of Lower Limbs (CLI).|Completed||Phase 2|38|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||4|||f||||t||||||||||2017-10-11 03:57:55.46155|2017-10-11 03:57:55.46155
NCT01408368|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2011-08-02|||January 2000||2000-01-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Subtotal Versus Total Thyroidectomy for Graves' Disease|Five-year Follow up of a Randomized Clinical Trial of Bilateral Subtotal Thyroidectomy Versus Total Thyroidectomy for Graves' Disease.|Completed||N/A|200|Actual|Jagiellonian University||2|||f||||t||||||||||2017-10-11 03:57:55.574062|2017-10-11 03:57:55.574062
NCT01408355|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-09-08|||July 2011||2011-07-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.|An Exploratory, Open Label, Fixed Sequence Study To Investigate The Pharmacokinetics Of Single Intravenous And Oral Micro Doses Of PF-06273588 In Healthy Male Subjects|Completed||Phase 1|5|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 03:57:55.679579|2017-10-11 03:57:55.679579
NCT01408342|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2014-01-03|||July 2011||2011-07-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|||Alemtuzumab and Rituximab in Aplastic Anemia|Low-doses Alemtuzumab and Rituximab Combination as First Line Treatment in Aplastic Anemia|Withdrawn||N/A|0|Actual|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||t||||||||||2017-10-11 03:57:55.765696|2017-10-11 03:57:55.765696
NCT01408329|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-08-19|2013-05-17||January 2007||2007-01-01|August 2015|2015-08-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|CVAC||Effects of Cyclic Variations in Altitude Conditioning (CVAC) on Wellness and Activity Measures|Effects of Cyclic Variations in Altitude Conditioning (CVAC) on Wellness and Activity Measures|Completed||N/A|28|Actual|Palo Alto Veterans Institute for Research|Small Sample size|2|||f||||f||||||||||2017-10-11 03:57:55.862791|2017-10-11 03:57:55.862791
NCT01408316|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2012-03-15|||July 2011||2011-07-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Study of the Pharmacokinetics and Pharmacodynamics of Crystalline PX-866 Tablets and Amorphous PX-866 Capsules in Healthy Volunteers|A Phase 1 Two-way Cross-over Study of the Pharmacokinetics and Pharmacodynamics of Crystalline PX-866 Tablets and Amorphous PX-866 Capsules Administered in the Fasting State, and of Crystalline PX-866 Tablets Administered Fed and Fasting, in Healthy Subjects|Completed||Phase 1|39|Actual|Cascadian Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 03:57:56.117877|2017-10-11 03:57:56.117877
NCT01408303|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-11-27|2013-06-21||August 2011||2011-08-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|ESPRIT|The Baseline Analysis Population comprised the Safety Population defined as subjects who received at least 1 dose of investigational product.|[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL|A 6-Week, Randomized, Double-Blind, Placebo(Olive Oil)-Controlled Study to Assess the Efficacy and Safety of Add-On Epanova® to Statin Therapy in Subjects With Persistent Hypertriglyceridemia and High Risk for Cardiovascular Disease|Completed||Phase 3|646|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 03:57:56.227344|2017-10-11 03:57:56.227344
NCT01408290|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-05-18|||September 2011||2011-09-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People|A Randomized, Double Blind, Multicentre Study to Evaluate Safety and Immunogenicity of Four Fluval AB-Like Influenza Vaccines With 3.5 μgHA, 6 μgHA, 9 μgHA Or 15 μgHA Of A/H1N1, A/H3N2 and B Influenza Antigens in Adult and Elderly Subjects|Completed||N/A|256|Actual|Fluart Innovative Vaccine Ltd, Hungary||4|||f||||f||||||||||2017-10-11 03:57:57.065233|2017-10-11 03:57:57.065233
NCT01408277|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2014-06-30|2014-04-02||August 2011||2011-08-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional||20 subjects from each group was a priori considered to be a number sufficient to detect an effect size (Cohen’s d) of 0.80, regarded as a large effect, with α = 0.05 and 1-β = 80%.|Using Santyl on Diabetic Foot Ulcers|A Comparison of Collagenase Santyl® Ointment Used Adjunctively to Sharp Surgical Debridement and Sharp Surgical Debridement in the Care of Diabetic Foot Wounds|Completed||Phase 4|55|Actual|Healthpoint||2|||f||||f||||||||||2017-10-11 03:57:57.225907|2017-10-11 03:57:57.225907
NCT01408264|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2013-07-29|||August 2010||2010-08-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||A Trial of 0.025 Wire Guided Cannulation Versus Current Practice 0.035 Wire Guided Cannulation|A Prospective Randomised Trial of 0.025 Wire Guided Cannulation Versus Current Practice 0.035 Wire Guided Cannulation|Completed||Phase 4|184|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 03:57:57.716083|2017-10-11 03:57:57.716083
NCT01408251|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2011-08-01|||January 2008||2008-01-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate Measurements in the Intensive Care Unit|Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit|Completed||N/A|40|Actual|Olive View-UCLA Education & Research Institute|||1||f||||t||||||||||2017-10-11 03:57:57.822199|2017-10-11 03:57:57.822199
NCT01408238|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-08-08|||October 2011||2011-10-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Biological Standardization of Secale Cereale Allergen Extract|Biological Standardization of Secale Cereale Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units|Completed||Phase 2|35|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 03:57:57.879788|2017-10-11 03:57:57.879788
NCT00005473|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1996||1996-07-01|September 2002|2002-09-01|June 2001|Actual|2001-06-01|||||Observational|||Cardiovascular Disease Trends 1980-91--A Gender Specific Perspective||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:06.057932|2017-10-11 04:27:06.057932
NCT01408225|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2017-04-03|||March 2011||2011-03-01|April 2017|2017-04-01||||March 2021|Anticipated|2021-03-01|10 Years|Observational [Patient Registry]|B-SCR-MM||Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource|Buckeye Surveillance, Contact, and Research for Multiple Myeloma and Amyloidosis|Recruiting||N/A|5000|Anticipated|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 03:57:57.967375|2017-10-11 03:57:57.967375
NCT01408212|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-09-01|||July 2011||2011-07-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients||Terminated||N/A|11|Actual|Korean Medicine Hospital of Pusan National University||1||low recruiting|f||||||||||||||2017-10-11 03:57:58.084559|2017-10-11 03:57:58.084559
NCT01408199|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-08-02|||January 2010||2010-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|ORDI-02||Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus|Phase II Study To Evaluate The Safety And Efficacy Of Lenalidomide For The Treatment Of Refractory Cutaneous Lupus|Completed||Phase 4|15|Actual|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||t||||||||||2017-10-11 03:57:58.165888|2017-10-11 03:57:58.165888
NCT01408186|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-02|2017-04-20|||January 2011||2011-01-01|April 2017|2017-04-01|November 2016|Actual|2016-11-01|November 2015|Actual|2015-11-01||Interventional|||ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA|Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention of Recurrent Upper Gastrointestinal Bleeding (UGI) in High-risk Users of Low-dose Aspirin (ASA)|Completed||Phase 3|264|Actual|Chinese University of Hong Kong||2|||f||||t||||||||No||2017-10-11 03:57:58.27416|2017-10-11 03:57:58.27416
NCT01408173|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2013-10-29|||August 2011||2011-08-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Clinical Study of Caffeine for Apnea of Prematurity|A Phase III Clinical Study of NPC-11 in the Treatment of Apnea of Prematurity. - Investigation of Safety, Efficacy and Pharmacokinetics of Caffeine Citrate -|Completed||Phase 3|24|Actual|Nobelpharma||1|||f||||f||||||||||2017-10-11 03:57:58.417601|2017-10-11 03:57:58.417601
NCT01408160|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-01-14|||April 2013||2013-04-01|January 2016|2016-01-01||||June 2016|Anticipated|2016-06-01||Interventional|||Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia|A Phase 1 Study of the Deglycosylated Ricin A Chain-containing Combined Anti-CD19 and Anti-CD22 Immunotoxin Combotox in Combination With High-Dose Cytarabine in Adult Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia|Recruiting||Phase 1|18|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 03:57:58.51929|2017-10-11 03:57:58.51929
NCT01408147|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-05-26|||July 2011||2011-07-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|||Prevention of Postpartum Weight Retention in Low Income WIC Women|Prevention of Postpartum Weight Retention in Low Income WIC Women|Completed||N/A|371|Actual|California Polytechnic State University-San Luis Obispo||2|||f||||t||||||||||2017-10-11 03:57:58.692786|2017-10-11 03:57:58.692786
NCT01408134|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2013-03-28|||June 2011||2011-06-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2012|Actual|2012-02-01||Interventional|VIVA 1||Viability Imaging in Volumetric Angiography (VIVA 1)|Viability Imaging in Volumetric Angiography (VIVA 1): A Single Center Trial of the Detection of Delayed Hyperenhancement on CT Angiography|Terminated||N/A|10|Actual|Medstar Health Research Institute||1||PI/Project director no longer at facility|f||||f||||||||||2017-10-11 03:57:58.801018|2017-10-11 03:57:58.801018
NCT01408121|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2014-08-08|||November 2011||2011-11-01|August 2014|2014-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|AA Genetic||African-American Pharmacogenetics|African-American Pharmacogenetics|Unknown status|Active, not recruiting|N/A|200|Anticipated|Medstar Health Research Institute|||4||f||||f||||||||||2017-10-11 03:57:58.87832|2017-10-11 03:57:58.87832
NCT01408095|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2011-08-23|||September 2011||2011-09-01|August 2011|2011-08-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||A Study in Patients With Type 2 Diabetes|A 12-Week, Phase 2, Randomized, Double-Blind, Active-Controlled Study of LY2608204 Given as Monotherapy or in Combination With Metformin in Patients With Type 2 Diabetes Mellitus|Withdrawn||Phase 2|240|Anticipated|Eli Lilly and Company||2||Trial terminated no patients were screened or enrolled|f||||f||||||||||2017-10-11 03:57:59.114452|2017-10-11 03:57:59.114452
NCT01408082|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-04-16||2014-06-19|October 2011||2011-10-01|April 2015|2015-04-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|DOUBle||Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis|A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-502 Compared to AzaSite Alone, Dexamethasone Alone, and Vehicle in the Treatment of Subjects With Non-Bacterial Blepharitis|Completed||Phase 3|917|Actual|InSite Vision||4|||f||||||||||||||2017-10-11 03:57:59.299663|2017-10-11 03:57:59.299663
NCT01408069|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-03-25|||March 2014||2014-03-01|March 2013|2013-03-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Non-Inferiority Comparison of Migrane® Versus Parcel ® For Treatment of Tensional Cephaleia|Multicentric, Randomizade, Double Blind, Double Dummy To Non-Inferiority Comparison Of Migrane® Versus Parcel ® For Treatment Of Tensional Cephaleia|Suspended||Phase 3|108|Anticipated|EMS||2||Study suspended by decision strategically.|f||||t||||||||||2017-10-11 03:57:59.639453|2017-10-11 03:57:59.639453
NCT01408056|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-10|2014-01-16|||February 2011||2011-02-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|TOUCH||Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)|The Efficacy of Timolol 0.5% Gel Forming Solution for the Treatment of Ulcerated Hemangiomas|Withdrawn||Phase 2|0|Actual|Children's Hospital of Philadelphia||2||Difficulty with recruitment|f||||f||||||||||2017-10-11 03:57:59.727993|2017-10-11 03:57:59.727993
NCT01408043|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-12-06|||October 2011||2011-10-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma|A Study of Hematopoietic Stem Cell Supermobilization in Patients With Non-Hodgkin Lymphoma|Terminated||N/A|25|Actual|Case Comprehensive Cancer Center||1||Slow Accrual|f||||t||||||||||2017-10-11 03:57:59.872331|2017-10-11 03:57:59.872331
NCT01408004|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-07|2014-07-15|||November 2011||2011-11-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|ROPETAR||Rotating Pazopanib and Everolimus to Avoid Resistance|A Randomized Phase II Study to Explore the Efficacy and Feasibility of Upfront Bi-monthly Rotations Between Everolimus and Pazopanib in Patients With Advanced or Metastatic Clear Cell Renal Cancer|Completed||Phase 2|101|Actual|Netherlands Working Group on Immunotherapy of Oncology||2|||f||||t||||||||||2017-10-11 03:58:00.302039|2017-10-11 03:58:00.302039
NCT01407991|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-11-09|||July 2011||2011-07-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Nasogastric/Oral Gastric Tube Placement in Infants: Comparing 2 Measurement Methods|Placement of NG or OG Tube in Infants by Length Versus Traditional Measuring Methods|Terminated||Phase 2|9|Actual|Children's Hospital of Philadelphia||2||"Study terminated due to change in clinical practice affecting recruitment. For majority of   patients, NJ tubes are now used instead of NG tubes."|f||||f||||||||||2017-10-11 03:58:01.663928|2017-10-11 03:58:01.663928
NCT01407978|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-30|2012-05-18|||August 2009||2009-08-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents|Tolerability and Immunogenicity Study of FLUVAL P H1N1 Monovalent Influenza Vaccine of Omninvest in Children and Adolescents|Completed||N/A|58|Actual|Fluart Innovative Vaccine Ltd, Hungary||3|||f||||t||||||||||2017-10-11 03:58:01.771219|2017-10-11 03:58:01.771219
NCT01407965|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-10-14|||April 2012||2012-04-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Pharmacokinetics of Carbapenem Antibiotics in Obese Patients.|Offene, Monozentrische, Nicht Kontrollierte Und Nicht Randomisierte Phase IV-Studie Zur Bestimmung Der Pharmakokinetik Von Carbapenemen in adipösen Patienten.|Completed||Phase 4|13|Actual|University of Ulm||2|||f||||t||||||||||2017-10-11 03:58:01.923829|2017-10-11 03:58:01.923829
NCT01407952|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-05-17|||April 2012||2012-04-01|May 2016|2016-05-01|October 2018|Anticipated|2018-10-01|October 2016|Anticipated|2016-10-01||Interventional|HEAT||Hydrogel Endovascular Aneurysm Treatment Trial|New Generation Hydrogel Endovascular Aneurysm Treatment Trial|Active, not recruiting||N/A|600|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 03:58:02.070273|2017-10-11 03:58:02.070273
NCT01407939|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-03-14|||April 2011||2011-04-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|BL||Efficacy of Bitter Blockers on Taste Perception in Children and Adults|Efficacy of Bitter Taste Blockers on Flavor Acceptance in Pediatric Populations|Completed||N/A|215|Actual|Monell Chemical Senses Center|||1||f||||f||||||Samples With DNA|"     Saliva   "|||2017-10-11 03:58:02.262267|2017-10-11 03:58:02.262267
NCT01407913|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2015-05-26|||October 2010||2010-10-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|FIA1||Caudal Epidural Steroid Injections for Low Back Pain/Sciatic Lumbar Pain|Efficacy Study of Caudal Epidural Steroid Injections in Patients With Low Back Pain/Radiculopathy|Completed||Phase 4|42|Actual|University of Ioannina||1|||f||||f||||||||||2017-10-11 03:58:02.455009|2017-10-11 03:58:02.455009
NCT01407900|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-06-16|||January 2014||2014-01-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction|A Human Physiologic Study to Evaluate the Renal and Neurohumoral Effects of Dual NPR-A and NPR-B Activation With a Novel Chimeric Natriuretic Peptide (CD-NP)in Subjects With Stable Chronic Heart Failure and Moderate Renal Dysfunction|Withdrawn||Phase 1|0|Actual|Mayo Clinic||2||New technique for administration of drug, this is the old technique of administration.|f||||f||||||||||2017-10-11 03:58:02.539107|2017-10-11 03:58:02.539107
NCT01407887|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-12-04|||August 2011||2011-08-01|June 2011|2011-06-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children|Efficacy and Safety of Artesunate-amodiaquine Combined With Methylene Blue for Falciparum Malaria Treatment in African Children|Completed||Phase 2|180|Actual|Heidelberg University||2|||f||||t||||||||||2017-10-11 03:58:02.634583|2017-10-11 03:58:02.634583
NCT01407874|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-10-28||2013-10-04|September 2011||2011-09-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency|A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency|Completed||Phase 2|20|Actual|BioCryst Pharmaceuticals||3|||f||||t||||||||||2017-10-11 03:58:02.721481|2017-10-11 03:58:02.721481
NCT01407861|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2014-12-02|||July 2011||2011-07-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|ARMIG||Aerobic Endurance Training vs. Relaxation Training in Patients With Migraine|Aerobic Endurance Training Versus Relaxation Training in Migraine Prophylaxis|Completed||N/A|56|Actual|Universität Duisburg-Essen||2|||f||||f||||||||||2017-10-11 03:58:02.885583|2017-10-11 03:58:02.885583
NCT01407848|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-09-22|||January 2012||2012-01-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea|Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea|Completed||Phase 2|20|Actual|University of Cologne||2|||f||||t||||||||||2017-10-11 03:58:02.980712|2017-10-11 03:58:02.980712
NCT01407835|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2012-08-08|||October 2011||2011-10-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Biological Standardization of Dactylis Glomerata Allergen Extract|Biological Standardization of Dactylis Glomerata Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units|Completed||Phase 2|31|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 03:58:03.078377|2017-10-11 03:58:03.078377
NCT01407627|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2016-05-10|||July 2011||2011-07-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of Fructose Ingestion and the Renin Angiotensin System in Healthy Humans|Evaluation of Fructose Ingestion and the Renin Angiotensin System in Healthy Humans|Recruiting||N/A|30|Anticipated|University of Calgary||2|||f||||f||||||||Undecided||2017-10-11 03:58:04.589525|2017-10-11 03:58:04.589525
NCT01407822|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-02-28|||December 5, 2011|Actual|2011-12-05|February 2017|2017-02-01|March 2018|Anticipated|2018-03-01|June 2017|Anticipated|2017-06-01||Interventional|EMERGING||Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer|A National, Multi Center, Randomized, Open-label, Phase II Trial of Erlotinib Versus Combination of GC as (Neo)Adjuvant Treatment in Stage IIIA-N2 NSCLC With Sensitizing EGFR Mutation in Exon 19 or 21(EMERGING)|Recruiting||Phase 2/Phase 3|90|Anticipated|Guangdong Association of Clinical Trials||2|||f||||t||||||||Undecided||2017-10-11 03:58:03.163881|2017-10-11 03:58:03.163881
NCT01407809|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-01-02|||January 2012||2012-01-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|June 2017|Anticipated|2017-06-01||Interventional|VSSIIH||Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy|Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy|Recruiting||Phase 1|20|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-10-11 03:58:03.303807|2017-10-11 03:58:03.303807
NCT01407796|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-04-17|||December 2010||2010-12-01|April 2014|2014-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||PET Imaging of Endotoxin-induced iNOS Activation|PET Imaging of Endotoxin-induced iNOS Activation in Healthy Volunteers|Completed||Phase 1|19|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 03:58:03.39217|2017-10-11 03:58:03.39217
NCT01407783|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-07-29|||August 2008||2008-08-01|July 2011|2011-07-01|June 2012|Anticipated|2012-06-01|April 2012|Anticipated|2012-04-01||Interventional|NUMOMS||Systems of Care for New Moms: Integrating Depression Treatment|Systems of Care for New Moms: Integrating Depression Treatment|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 03:58:03.481281|2017-10-11 03:58:03.481281
NCT01407770|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-30|2017-05-25|||September 2011||2011-09-01|December 2013|2013-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer|Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity|Completed||N/A|1000|Actual|Wake Forest University Health Sciences|||1||f||||t|f|f||||Samples With DNA|"     blood and urine samples   "|||2017-10-11 03:58:03.568174|2017-10-11 03:58:03.568174
NCT01407757|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-30|2016-05-17|||July 2011||2011-07-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531|Pharmacogenetics of Gemtuzumab Ozogamicin (GO) Therapy in Acute Myeloid Leukemia|Completed||N/A|1000|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:58:03.678|2017-10-11 03:58:03.678
NCT01407744|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-30|2016-05-16|||March 2012||2012-03-01|May 2016|2016-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial|Examination of the Multiple Genetic and Molecular Targets as Therapeutic Options for Patients With Ependymoma Treated by the Phase II Children's Oncology Group Study ACNS0121|Completed||N/A|80|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Archived tumor tissue   "|||2017-10-11 03:58:03.751556|2017-10-11 03:58:03.751556
NCT01407731|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-30|2016-05-13|||July 2011||2011-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Protein Expression in Human Neuroblastoma Tumor Samples|Analysis of Intersectin Expression in Primary Human Neuroblastomas|Completed||N/A|20|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 03:58:03.817996|2017-10-11 03:58:03.817996
NCT01407718|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2017-02-24|||June 2010||2010-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||The Parapatellar Approach to Intramedullary Tibial Nailing|The Parapatellar Approach to Intramedullary Tibial Nailing: Is There a Difference in Anterior Knee Pain When Compared to a Traditional Flexed Approach?|Active, not recruiting||N/A|60|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 03:58:03.891059|2017-10-11 03:58:03.891059
NCT01407705|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2014-05-19|||May 2007||2007-05-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||High-Resolution Diffusion Tensor Imaging (DTI) of the Cervical Spinal Cord in the Setting of Spinal Cord Injury (SCI)|High-Resolution Diffusion Tensor Imaging (DTI) of the Cervical Spinal Cord in the Setting of Spinal Cord Injury (SCI)|Completed||N/A|31|Actual|University of Utah|||2||f||||f||||||||||2017-10-11 03:58:03.962519|2017-10-11 03:58:03.962519
NCT01407692|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-02-07|||March 2011||2011-03-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|FL-84||Menstrual Cycle Hormones and Eating Behavior|Effect of Menstrual Cycle Hormone Changes on Eating Behavior and Nutrient Metabolism|Completed||N/A|24|Actual|USDA, Western Human Nutrition Research Center|||1||f||||f||||||Samples Without DNA|"     Serum, plasma and urine samples may be retained for future testing.   "|||2017-10-11 03:58:04.038576|2017-10-11 03:58:04.038576
NCT01407679|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2016-05-30|||August 2011||2011-08-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|AliCLE||Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus|Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus: A Multicentre, Open-Label, Prospective Pilot Study|Terminated||Phase 2|7|Actual|University Hospital Muenster||1|||f||||f||||||||||2017-10-11 03:58:04.100009|2017-10-11 03:58:04.100009
NCT01407666|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-17|2014-12-02|||August 2010||2010-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|August 2014|Actual|2014-08-01||Interventional|||Comparison Between Epidural and Bilateral Paravertebral Blocks in Liver Resection|Prospective Randomized Comparative Study Between Epidural and Bilateral Paravertebral Blocks for Perioperative Pain Management in Patients Undergoing Open Liver Resection|Completed||N/A|100|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:58:04.207186|2017-10-11 03:58:04.207186
NCT01407653|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2016-09-28|||June 2011||2011-06-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|REVLOC||Analgesic Effect of a Prototype Device of Virtual Reality in a Population of Patients With Chronic Low Back Pain|Evaluation of the Analgesic Effect of a Prototype Device of Virtual Reality in a Population of Patients With Chronic Low Back Pain. A Randomized Controlled Trial Using a Modified ZELEN Method|Completed||N/A|122|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:58:04.293|2017-10-11 03:58:04.293
NCT01407640|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-07-05|||February 2012||2012-02-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|Allerdiab||Diagnosis and Physiopathology of Insulin Allergy|Diagnosis and Physiopathology of Insulin Allergy (IA)|Active, not recruiting||N/A|55|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 03:58:04.373881|2017-10-11 03:58:04.373881
NCT01407614|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-10|2011-08-01|||December 2007||2007-12-01|August 2011|2011-08-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||The Tilburg Vasospasm Study|Prevention of Secondary Ischemia After Aneurysmal Subarachnoid Hemorrhage With Cerebrospinal Fluid Drainage. A Randomized Controlled Trial|Terminated||Phase 2/Phase 3|20|Actual|Elisabeth-TweeSteden Ziekenhuis||2||patient enrollment too slow|f||||t||||||||||2017-10-11 03:58:04.694381|2017-10-11 03:58:04.694381
NCT01407601|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-08-01|||January 2008||2008-01-01|August 2011|2011-08-01|July 2009|Actual|2009-07-01|May 2008|Actual|2008-05-01||Interventional|||Vitamin K2 Supplementation to Activate Matrix Gla Protein (MGP) as Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients|Food Supplementation With Vitamin K2 to Activate MGP as an Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients|Completed||Phase 3|53|Actual|RWTH Aachen University||3|||f||||f||||||||||2017-10-11 03:58:04.818792|2017-10-11 03:58:04.818792
NCT01407588|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-03-15|||August 2011|Actual|2011-08-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Manual Compared to Magnetic Navigation in Ablation for Atrial Fibrillation|Manual Compared to Magnetic Navigation in Ablation for Atrial Fibrillation|Completed||N/A|51|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||No||2017-10-11 03:58:04.929387|2017-10-11 03:58:04.929387
NCT01407575|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-03-10|2016-01-05||September 2011||2011-09-01|March 2017|2017-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|BUP-TRD||Buprenorphine for Treatment Resistant Depression|Buprenorphine For Treatment Resistant Depression|Completed||Phase 3|13|Actual|University of Pittsburgh||2|||f||||f||||||||No||2017-10-11 03:58:05.050272|2017-10-11 03:58:05.050272
NCT01407562|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-09-21|||August 2011||2011-08-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors|Phase I Study of Pazopanib in Combination With Weekly Paclitaxel and Carboplatin to Assess the Safety and Tolerability in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|34|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-11 03:58:05.485287|2017-10-11 03:58:05.485287
NCT01407549|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2015-06-28|||November 2012||2012-11-01|June 2012|2012-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Influence of Mindfulness Based Intervention on Pain Perception in Chronic Pain Patients|The Influence of Mindfulness Based Intervention on Pain Perception in Chronic Pain Patients Evaluating Personal Characteristics and Possible Mechanism|Completed||N/A|67|Actual|Meir Medical Center||2|||f||||f||||||||||2017-10-11 03:58:05.575443|2017-10-11 03:58:05.575443
NCT01407536|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-26|2011-08-01|||August 2009||2009-08-01|June 2011|2011-06-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Thermal Stimulation on Cortical Excitability and Motor Function in Chronic Stroke Patients||Completed||Phase 1/Phase 2|20|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||||2017-10-11 03:58:05.670535|2017-10-11 03:58:05.670535
NCT01407523|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2013-01-30|2013-01-30||July 2011||2011-07-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures|An Open-label, Multicenter Study to Evaluate the Safety of Adjunctive Treatment With Intravenous Levetiracetam (L059 IV) in Epilepsy Patients Aged ≥ 16 Years With Partial Onset Seizures|Completed||Phase 2|16|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 03:58:05.764048|2017-10-11 03:58:05.764048
NCT01407510|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-02-15|||May 2011||2011-05-01|February 2015|2015-02-01|April 2012|Actual|2012-04-01|September 2011|Actual|2011-09-01||Interventional|||HPA Axis Study in Japanese Adults|A Multicenter, Open-label Study to Evaluate the Adrenal Suppression Potential of Mapracorat 0.1% Ointment in Japanese Adults With Atopic Dermatitis|Completed||Phase 2|12|Actual|Bayer||1|||f||||f||||||||||2017-10-11 03:58:06.080284|2017-10-11 03:58:06.080284
NCT01407497|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2013-12-03|||August 2011||2011-08-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine|A Phase I Trial to Assess Safety and Immunogenicity of i.d. DNA Priming and i.m. MVA Boosting in Healthy Volunteers in Mozambique and to Develop Further HIV Vaccine Trial Capacity Building in Mozambique|Completed||Phase 1|25|Actual|Instituto Nacional de Saúde, Mozambique||4|||f||||t||||||||||2017-10-11 03:58:06.167997|2017-10-11 03:58:06.167997
NCT01407484|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-07-05|||March 2011||2011-03-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Interventional|SIGMA||Male Infertility Related With Post Infection Inflammatory Syndrome|Diagnosis and Treatment of Male Infertility Related to Inflammatory Syndrome: Therapeutic Trial|Completed||N/A|200|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 03:58:06.275393|2017-10-11 03:58:06.275393
NCT01407471|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-07-02|||September 2011||2011-09-01|February 2015|2015-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|SPIREPI||Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy|Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy|Completed||Phase 2|26|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||||2017-10-11 03:58:06.373899|2017-10-11 03:58:06.373899
NCT01407458|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-08-01|||October 2011||2011-10-01|August 2011|2011-08-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||The Impact of a Structured Physical Activity Program on Bone Strength and Psycho-Motor Learning of Young Children||Unknown status|Not yet recruiting|N/A|300|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 03:58:06.497109|2017-10-11 03:58:06.497109
NCT01407445|ClinicalTrials.gov processed this data on October 10, 2017|2011-08-01|2015-11-09|||January 2009||2009-01-01|November 2015|2015-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effects of Tribulus Terrestris on Sexual Function in Post-menopausal Women|Study of the Effects of Tribulus Terrestris on Sexuality in Postmenopausal Women|Completed||Phase 4|60|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo||2|||f||||f||||||||||2017-10-11 03:58:06.574141|2017-10-11 03:58:06.574141
NCT01407432|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-06-08|||November 2011||2011-11-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|FOLFIV||Impact of Folates in the Care of the Male Infertility|Impact of Folates in the Care of the Male Infertility|Completed||Phase 3|162|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 03:58:06.654753|2017-10-11 03:58:06.654753
NCT01407419|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2015-06-08|||July 2011||2011-07-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population|Treating to Target (T2T) for Patients With Rheumatoid Arthritis in a US Population: Outcomes and Feasibility|Completed||N/A|538|Actual|Corrona, LLC.||2|||f||||f||||||||||2017-10-11 03:58:06.776501|2017-10-11 03:58:06.776501
NCT01407406|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-09-12|||September 2011||2011-09-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Phase 1 Study to Evaluate the PK, Safety, Tolerability of BIIB023 in Chinese, Japanese, and Caucasian Healthy Volunteers|A Single-Dose, Randomized, Double-Blind, Parallel-Group, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BIIB023 in Chinese, Japanese, and Caucasian Adult Healthy Volunteers|Completed||Phase 1|48|Actual|Biogen||6|||f||||f||||||||||2017-10-11 03:58:06.857685|2017-10-11 03:58:06.857685
NCT01407393|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2013-10-07|||May 2011||2011-05-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects|Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects|Completed||Phase 4|124|Actual|InQpharm Group||2|||f||||f||||||||||2017-10-11 03:58:06.93968|2017-10-11 03:58:06.93968
NCT01407380|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-10-23|||June 2011||2011-06-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Study of PWT33597 Mesylate in Subjects With Advanced Malignancies|A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of Orally Administered PWT33597 Mesylate in Subjects With Advanced Malignancies|Completed||Phase 1|22|Actual|Pathway Therapeutics, Inc.||1|||f||||f||||||||||2017-10-11 03:58:07.038043|2017-10-11 03:58:07.038043
NCT01407367|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2017-05-01|||April 2011||2011-04-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Safe Kidney Care Cohort Study|Does Under-recognition of Kidney Disease Affect Patient Safety?|Active, not recruiting||N/A|350|Anticipated|University of Maryland|||1||f||||f||||||Samples Without DNA|"     At each yearly research clinic visit (up to 4), 30 cc (6 teaspoons) of blood will be     processed and stored for future assays related to kidney function.      At first research clinic visit, 9 cc urine will be processed and stored for future assays     related to kidney function.      At each yearly research clinic visit, 1 swab of both nares, 1 pharyngeal swab and 1 skin swab     will be obtained, processed and stored with future testing for multiple antibiotic resistant     (MAR) organisms.   "|||2017-10-11 03:58:07.128663|2017-10-11 03:58:07.128663
NCT01407354|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-04-06|2016-04-06||April 2011||2011-04-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|||Comparison of Lokomat and Aquatic Exercise for Individuals With Chronic Incomplete Spinal Cord Injury|Lokomat and Aquatic Therapy in Chronic Motor Incomplete Spinal Cord Injury|Completed||N/A|37|Actual|University of Maryland||2|||f||||t||||||||No||2017-10-11 03:58:07.206513|2017-10-11 03:58:07.206513
NCT01407341|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2014-02-05|||June 2011||2011-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer|ChronOS Stability Study: For Metastatic Cancer|Terminated||Phase 1|1|Actual|University of Southern California||1||Lack of funding|f||||t||||||||||2017-10-11 03:58:07.479362|2017-10-11 03:58:07.479362
NCT01407328|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2013-04-28|||June 2011||2011-06-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||The Effect of the Shoulder Arthroscopic Surgery on Respiratory Mechanics|The Effect of the Shoulder Arthroscopic Surgery on Respiratory Mechanics|Completed||N/A|60|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:58:07.568941|2017-10-11 03:58:07.568941
NCT01407315|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-04-19|||November 2010||2010-11-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor|Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor|Completed||Phase 1|20|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-11 03:58:07.646114|2017-10-11 03:58:07.646114
NCT01407302|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-12-24|||July 2011||2011-07-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Optimal Head Rotation and External Landmark for Internal Jugular Vein Cannulation After Placement of Proseal Laryngeal Mask Airway|Optimal Head Rotation and External Landmark for Internal Jugular Vein Cannulation After Placement of Proseal Laryngeal Mask Airway|Completed||N/A|100|Actual|Samsung Medical Center|||2||f||||f||||||||||2017-10-11 03:58:07.729337|2017-10-11 03:58:07.729337
NCT01407289|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-02-04|||June 2011||2011-06-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia|An Open, Single-centre, Controlled Trial to Investigate the Efficacy and Usability of Published Best Practice to Control Glycaemia in Hospitalised Patients With Type 2 Diabetes|Completed||Phase 4|74|Actual|Medical University of Graz||2|||f||||||||||||||2017-10-11 03:58:07.802814|2017-10-11 03:58:07.802814
NCT01407276|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-06-05|2015-09-29||August 8, 2011|Actual|2011-08-08|June 2017|2017-06-01|March 23, 2012|Actual|2012-03-23|March 23, 2012|Actual|2012-03-23||Interventional|||A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)|An Open-Label, Two-Part, Single-Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of MK-3102 in Patients With Impaired Renal Function|Completed||Phase 1|49|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-10-11 03:58:07.919966|2017-10-11 03:58:07.919966
NCT01407263|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-03-08|||July 2011||2011-07-01|March 2017|2017-03-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Trial of Modifications to Radical Prostatectomy|A Randomized Trial of Modifications to Radical Prostatectomy|Recruiting||Phase 3|2300|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-11 03:58:09.48897|2017-10-11 03:58:09.48897
NCT01407250|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-24|2011-07-31|||August 2011||2011-08-01|July 2011|2011-07-01|March 2012|Anticipated|2012-03-01|November 2011|Anticipated|2011-11-01||Observational|CommwellPG||PhysioGlove Versus Clinic Electrocardiogram Comparison|Reliability of Outpatient Electrocardiogram Recordings in Patients Refered for a Cardiology Consultation|Unknown status|Not yet recruiting|N/A|100|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 03:58:09.61133|2017-10-11 03:58:09.61133
NCT01407237|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2016-08-03|||January 2012||2012-01-01|August 2016|2016-08-01||||March 2015|Actual|2015-03-01||Observational|||Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV|Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV|Completed||N/A|30|Actual|Massachusetts General Hospital|||2||f||||||||||||||2017-10-11 03:58:09.68478|2017-10-11 03:58:09.68478
NCT00000342|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-13|||July 1996||1996-07-01|June 1997|1997-06-01|September 1997|Actual|1997-09-01|August 1997|Actual|1997-08-01||Interventional|||Risperidone for the Treatment of Cocaine Dependence - 7|Risperidone for the Treatment of Cocaine Dependence|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.394239|2017-10-11 04:17:47.394239
NCT01407224|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-31|||May 2010||2010-05-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|iycfch||Assessing Cost and Effectiveness of Training and Supervision of Front Line Workers on Early Breastfeeding Practices|Assessing the Cost and Effectiveness of Training and Supervision of Front Line Workers on Early Breastfeeding Practices (Bangladesh)|Completed||Phase 1|1200|Actual|Eminence||3|||f||||t||||||||||2017-10-11 03:58:09.78371|2017-10-11 03:58:09.78371
NCT01407211|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-14|2012-07-17|||April 2011||2011-04-01|July 2012|2012-07-01|September 2013|Anticipated|2013-09-01|April 2013|Anticipated|2013-04-01||Interventional|MS||Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient|The Impact of Vitamin A Supplementation on Gene Expression of Cytokine Secreted by CD4+ T Lymphocyte in Multiple Sclerosis Patients|Unknown status|Enrolling by invitation|Phase 4|30|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:58:09.892449|2017-10-11 03:58:09.892449
NCT01407198|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-07-24|||August 2011||2011-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|February 2016|Actual|2016-02-01||Interventional|||Nilotinib With Radiation for High Risk Chordoma|Phase I Study of Nilotinib Given With Radiation For Patients With High Risk Chordoma|Active, not recruiting||Phase 1|29|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:58:09.995073|2017-10-11 03:58:09.995073
NCT01407185|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2012-12-31|||June 2011||2011-06-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy of a Home-Based Exercise Program for Heart Failure|Efficacy of a Home-Based Exercise Program in the Management of Heart Failure: An Evidenced-Based Multi-Disciplinary Approach|Terminated||N/A|9|Actual|Catholic Home Care||1||Lack of enrollment. Difficult to obtain Physician approval.|f||||t||||||||||2017-10-11 03:58:10.098239|2017-10-11 03:58:10.098239
NCT01407172|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2013-04-26|||August 2011||2011-08-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Hydrogen Sulfide and Peripheral Arterial Disease|Hydrogen Sulfide and Peripheral Arterial Disease|Completed||N/A|252|Actual|Louisiana State University Health Sciences Center Shreveport|||3||f||||f||||||Samples Without DNA|"     Plasma for additional biomarker evaluation will be stored.   "|||2017-10-11 03:58:10.198083|2017-10-11 03:58:10.198083
NCT01407159|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2014-04-25|||November 2011||2011-11-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|ASSIST||A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting|ASSIST - A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting|Completed||N/A|40|Actual|JOTEC GmbH|||2||f||||||||||||||2017-10-11 03:58:10.290259|2017-10-11 03:58:10.290259
NCT01407146|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2016-07-11|||July 2011||2011-07-01|July 2016|2016-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study|Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study|Completed||N/A|2381|Actual|Yale University|||1||f||||f||||||||Undecided||2017-10-11 03:58:10.395978|2017-10-11 03:58:10.395978
NCT01407133|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2012-08-09|||May 2005||2005-05-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|MagTIN||Conventional Repetitive Transcranial Magnetic Stimulation for Tinnitus Treatment|Assessment of Conventional Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Tinnitus|Completed||Phase 1/Phase 2|64|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 03:58:10.489363|2017-10-11 03:58:10.489363
NCT01407120|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-08-01|||July 2006||2006-07-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|NBF15||15 Year Follow-up of New Beginnings Program for Divorced Families|Effects of NBP for Children of Divorce 15 Years Later|Completed||Phase 2/Phase 3|240|Actual|Arizona State University||3|||f||||f||||||||||2017-10-11 03:58:10.601653|2017-10-11 03:58:10.601653
NCT01407107|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2016-05-31|||January 2011||2011-01-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer|Phase I Dose Escalation Trial of Nitroglycerin in Addition to 5-flourouracil and Radiation Therapy for Neo-adjuvant Treatment of Operable Rectal Cancer|Active, not recruiting||Phase 1|24|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-10-11 03:58:10.710051|2017-10-11 03:58:10.710051
NCT01407094|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-10-14|||September 2010||2010-09-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|EMBARC||Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression|Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression|Active, not recruiting||Phase 4|400|Anticipated|University of Texas Southwestern Medical Center||3|||f||||t||||||||Yes||2017-10-11 03:58:10.798868|2017-10-11 03:58:10.798868
NCT01407081|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-07-31|||August 2011||2011-08-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|SMARTease||SMARTease Trial: Evaluating Stroke Help Distance Interventions to Improve Cognitive Performance Post-Stroke|SMARTease Trial - Turning SMART Goals Into Smart Actions: Evaluating Stroke Help Distance Interventions to Improve Cognitive Performance Post-Stroke|Terminated||Phase 3|10|Anticipated|Nova Scotia Health Authority||1||Poor recruitment|f||||f||||||||||2017-10-11 03:58:10.915266|2017-10-11 03:58:10.915266
NCT01407068|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-09-07|2015-02-04||September 2011||2011-09-01|September 2017|2017-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Administration of Two Injections for Multiple Dupuytren's Contractures|An Open-label Study to Assess the Safety and Efficacy of Concurrent Administration of Two Injections of AA4500 0.58 mg Into the Same Hand of Subjects With Multiple Dupuytren's Contractures|Completed||Phase 3|60|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-10-11 03:58:11.018515|2017-10-11 03:58:11.018515
NCT01407055|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-02-02|||July 2011||2011-07-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Optimizing Expectations in Cardiac Surgery Patients|Clinical Applications of Placebo Research: Optimizing Expectation Effects in Cardiac Surgery Patients|Completed||Phase 2|124|Actual|Philipps University Marburg Medical Center||3|||f||||f||||||||||2017-10-11 03:58:11.347388|2017-10-11 03:58:11.347388
NCT01407042|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-07-16|||September 2011||2011-09-01|July 2016|2016-07-01||||December 2014|Actual|2014-12-01||Observational|||Patellofemoral Pain After Unicondylar Knee Arthroplasty||Completed||N/A|24|Actual|Medical University Innsbruck|||1||f||||||||||||||2017-10-11 03:58:11.470336|2017-10-11 03:58:11.470336
NCT01407029|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-06|2017-04-24|||October 2009|Actual|2009-10-01|April 2017|2017-04-01|March 14, 2017|Actual|2017-03-14|March 14, 2017|Actual|2017-03-14||Observational|||R3® Acetabular System in Patients With Degenerative Hip Disease|A Prospective, Multicenter, Non-randomized, Clinical Outcomes Study of the R3® Acetabular System in Patients With Degenerative Hip Disease|Completed||N/A|158|Actual|Smith & Nephew, Inc.|||1||f||||f||||||||No||2017-10-11 03:58:11.548721|2017-10-11 03:58:11.548721
NCT01407016|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-09-27|||August 2011||2011-08-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects|A Phase 1, Open Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Following Single And Multiple Intravenous Infusion In Healthy Japanese Adult Subjects|Completed||Phase 1|6|Actual|Pfizer||1|||f||||||||||||||2017-10-11 03:58:11.64439|2017-10-11 03:58:11.64439
NCT01407003|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-04-24||2014-03-27|June 2011||2011-06-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)|A Randomized, Double-blind, Placebo-controlled, 4-part, Interwoven Single- and Multiple-ascending Dose Study to Assess Safety, Tolerability, PK and PD of LIK066 in Healthy Subjects and in Patients With T2DM|Completed||Phase 1/Phase 2|138|Actual|Novartis||4|||f||||||||||||||2017-10-11 03:58:11.733064|2017-10-11 03:58:11.733064
NCT01406990|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-08-28|2012-08-28||June 2011||2011-06-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Aspirin Responsiveness in Women With Coronary Artery Disease|Aspirin Responsiveness in Women With Coronary Artery Disease|Completed||N/A|15|Actual|Creighton University|||1||f||||f||||||||||2017-10-11 03:58:11.819251|2017-10-11 03:58:11.819251
NCT01406977|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2013-03-18|||July 2011||2011-07-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)|An Open-label, Intra-patient Dose-escalation Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP).|Completed||Phase 2|9|Actual|Novartis||1|||f||||f||||||||||2017-10-11 03:58:11.991266|2017-10-11 03:58:11.991266
NCT01406964|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2012-03-30|||July 2011||2011-07-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Chlamidia Antibodies Test for Tubal Factor Screening|Chlamidia Antibodies Test for Tubal Factor Screening|Completed||N/A|60|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-10-11 03:58:12.063636|2017-10-11 03:58:12.063636
NCT01406951|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-07-29|||September 2009||2009-09-01|September 2009|2009-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis Patients||Completed||N/A|92|Actual|Chinese PLA General Hospital|||3||f||||t||||||||||2017-10-11 03:58:12.13164|2017-10-11 03:58:12.13164
NCT01406938|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-04-30|2015-02-13||August 2011||2011-08-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SCULPTURE|The Full analysis set (FAS) was comprised of all patients to whom study treatment had been assigned.|Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens|A Randomized, Double-blind, Multicenter Study of Subcutaneous Secukinumab, Assessing Psoriasis Area and Severity Index (PASI) Response and Maintenance of Response in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis on Either a Fixed Dose Regimen or on a Retreatment at Start of Relapse Regimen|Completed||Phase 3|967|Actual|Novartis|A limitation of this study is the lack of a placebo group; however, because the placebo response is very low in psoriasis, it is inappropriate to maintain patients on placebo for 52 weeks. .|6|||f||||t||||||||||2017-10-11 03:58:12.464792|2017-10-11 03:58:12.464792
NCT01406925|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-07-29|||April 2007||2007-04-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers|A Randomised, Placebo-controlled, Double-blind, Cross-over Study in Healthy Men and Women to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Intra-anal Doses of NRL001 for Three Doses Using a Cream Formulation Relative to a Matched Placebo Formulation for Reference|Completed||Phase 1|12|Actual|Norgine||4|||f||||f||||||||||2017-10-11 03:58:21.98148|2017-10-11 03:58:21.98148
NCT01406912|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-11-11|||July 2011||2011-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy of Virtual Reality Exercises in STroke Rehabilitation: A Multicentre Study (EVREST Multicentre)|Efficacy of Virtual Reality Exercises Using Wii Gaming Technology in STroke Rehabilitation: A Multicentre Randomized Clinical Trial (EVREST Multicentre)|Completed||N/A|141|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-10-11 03:58:22.058098|2017-10-11 03:58:22.058098
NCT01406899|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-12-22|||January 2010||2010-01-01|March 2012|2012-03-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT)|Computer-Assisted Cognitive Behavior Therapy for Veterans With Substance Use Disorder|Completed||Phase 1|80|Actual|VA Connecticut Healthcare System||2|||f||||t||||||||||2017-10-11 03:58:22.167027|2017-10-11 03:58:22.167027
NCT01406886|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2017-04-16|||December 2009||2009-12-01|April 2017|2017-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Combined Effects of Energy Density and Eating Rate on Appetite|Combined Effects of Energy Density and Eating Rate on Energy Intake and Biomarkers of Satiety|Completed||N/A|20|Actual|United States Army Research Institute of Environmental Medicine||1|||f||||f||||||||||2017-10-11 03:58:22.23873|2017-10-11 03:58:22.23873
NCT01406873|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-08-16|||June 2011||2011-06-01|August 2017|2017-08-01|March 2017|Actual|2017-03-01|February 2017|Actual|2017-02-01||Interventional|||Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1|A Randomized, Placebo Controlled, Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type-1 (DM1)|Completed||Phase 2|42|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 03:58:22.317195|2017-10-11 03:58:22.317195
NCT01406847|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-09-06|||August 2012||2012-08-01|September 2017|2017-09-01|May 1, 2017|Actual|2017-05-01|May 1, 2017|Actual|2017-05-01||Interventional|||Central Mechanisms of Intervention for Low Back Pain|Central Mechanisms of Body Based Intervention for Musculoskeletal Low Back Pain|Completed||N/A|159|Actual|University of Florida||3|||f||||t||||||||||2017-10-11 03:58:22.517955|2017-10-11 03:58:22.517955
NCT01406834|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-08-14|||October 2011||2011-10-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Treatment for the Mental Health Impact of Killing in War|Treatment for the Mental Health Impact of Killing in War: Augmentation of Existing Evidence-Based Mental Health Interventions|Completed||N/A|8|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 03:58:22.61315|2017-10-11 03:58:22.61315
NCT01406821|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2016-10-12|||August 2009||2009-08-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma|Randomized, Double-blind Clinical Trial of Platelet Rich Plasma for Treatment of Acute and Chronic Patellar Tendinosis|Recruiting||N/A|100|Anticipated|Stanford University||2|||f||||||||||||No||2017-10-11 03:58:22.683164|2017-10-11 03:58:22.683164
NCT01406808|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-10-03|||August 2011||2011-08-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|October 2016|Actual|2016-10-01||Interventional|||Personal Genomics for Preventive Cardiology|A Pilot Randomized Trial of Personal Genomics for Preventive Cardiology|Completed||N/A|100|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 03:58:22.783317|2017-10-11 03:58:22.783317
NCT01406795|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2017-01-06|2016-11-24||December 2010||2010-12-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses|Evaluation of GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface for the Treatment of Venous Occlusions and Stenoses|Terminated||N/A|1|Actual|Stanford University|The study was underpowered, enrolling only a single patient (goal enrollment was 15 patients).|1||Poor enrollment and advances in venoplasty only techniques of the femoral vein|f||||||||||||||2017-10-11 03:58:22.888099|2017-10-11 03:58:22.888099
NCT01406782|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-05-16|||December 13, 2011|Actual|2011-12-13|May 2017|2017-05-01|January 13, 2012|Actual|2012-01-13|January 13, 2012|Actual|2012-01-13||Observational|||DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402|The Influence of KIR and HLA Genotype on the Response to Rituximab Immunotherapy in Patients With Follicular Lymphoma|Completed||N/A|200|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 03:58:23.312749|2017-10-11 03:58:23.312749
NCT01406769|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2017-05-03|||July 2012||2012-07-01|May 2017|2017-05-01||||July 2017|Anticipated|2017-07-01||Interventional|||Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy|A Limited Access Phase II Trial Utilizing Bioimpedance to Measure Lower Extremity Lymphedema Associated With the Surgical Management of a Vulvar Cancer|Active, not recruiting||Phase 2|120|Anticipated|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 03:58:23.392141|2017-10-11 03:58:23.392141
NCT01406743|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-01-13|||May 2011||2011-05-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|EOS-SPINE||Spine Reference Parameters on EOS Imaging|PARAMETRES GLOBAUX DE REFERENCE DU RACHIS CALCULES SUR DES PATIENTS ASYMPTOMATIQUES PAR IMAGERIE EOS™|Completed||N/A|161|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-11 03:58:23.50269|2017-10-11 03:58:23.50269
NCT01406730|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-08-11|||July 2011||2011-07-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Running Effect on Cardiovascular and Muscular Parameters|Effect of 16 Weeks of Running Exercise on Parameters Related to the Cardiovascular System, Blood and Muscle in Untrained Males 30-50 Years Old. A Randomized Controlled Study|Completed||Phase 3|80|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 03:58:23.590928|2017-10-11 03:58:23.590928
NCT01406717|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-02-04|||January 2013||2013-01-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus|Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|360|Actual|Sun Pharmaceutical Industries Limited||2|||f||||f||||||||||2017-10-11 03:58:23.705305|2017-10-11 03:58:23.705305
NCT01406704|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2011-08-18|||January 2004||2004-01-01|January 2004|2004-01-01|December 2013|Anticipated|2013-12-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH|Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH (Non-alcoholic Steato-hepatitis)|Terminated||Phase 4|26|Actual|Seoul St. Mary's Hospital||4||because of withdrawal of Avandia sale due to its risks outweigh its benefits|f||||t||||||||||2017-10-11 03:58:23.868172|2017-10-11 03:58:23.868172
NCT01406691|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2016-11-01|||December 2013||2013-12-01|November 2016|2016-11-01|September 2016|Actual|2016-09-01|June 2016|Actual|2016-06-01||Interventional|||Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)|Treating Sleep Disruption in Teens With Millisecond Light Exposure During Sleep|Completed||Phase 4|104|Actual|VA Palo Alto Health Care System||2|||f||||f||||||||||2017-10-11 03:58:24.166669|2017-10-11 03:58:24.166669
NCT01406678|ClinicalTrials.gov processed this data on October 10, 2017|2009-12-01|2016-05-11|||July 2008||2008-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|October 2012|Actual|2012-10-01||Interventional|||Remote Ischemic Preconditioning in Coronary Artery Bypass Grafting With Cold Crystalloid Cardioplegic Arrest|Effect of Remote Ischemic Preconditioning in Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery With Crystalloid Cardioplegic Arrest|Recruiting||Phase 2/Phase 3|500|Anticipated|University Hospital, Essen||2|||f||||t||||||||||2017-10-11 03:58:24.247502|2017-10-11 03:58:24.247502
NCT01406665|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-07-29|||October 2010||2010-10-01|July 2011|2011-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Skin Autofluorescence (AF) Decision Tree in Detecting Impaired Glucose Tolerance (IGT) or Diabetes Mellitus (DM)|Assessment of Value of Skin Autofluorescence in Detecting Diabetes Mellitus or Impaired Glucose Tolerance. Comparison With Fasting Plasma Glucose and Glycated Hb|Completed||N/A|218|Actual|University Medical Center Groningen|||1||f||||f||||||None Retained|"     none retained   "|||2017-10-11 03:58:24.343947|2017-10-11 03:58:24.343947
NCT01406639|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2013-04-26|||July 2011||2011-07-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)|Ranibizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)|Withdrawn||Phase 1|0|Actual|University of California, San Diego||1||Study withdrawn due to lack of study population.|f||||f||||||||||2017-10-11 03:58:24.49722|2017-10-11 03:58:24.49722
NCT01406626|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2016-01-15|||December 2012||2012-12-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|January 2016|Actual|2016-01-01||Interventional|LINK LA||Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care|Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care|Active, not recruiting||N/A|360|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 03:58:24.571069|2017-10-11 03:58:24.571069
NCT01406613|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2012-06-14|||March 2010||2010-03-01|June 2012|2012-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis|A 2-year Observational Study of Bone Density and Bone Turnover After Prior Treatment With Alendronate, Ibandronate and Risedronate for Postmenopausal Osteoporosis in Secondary Care|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     A venous blood sample will be collected from each participant at each visit to analyse     biochemical bone markers, and basic biochemistry analysis for eligibility screening.      Two urine samples will be collected from each participant at each study visit, one collected     on the morning prior to the study visit and a second sample on the morning of the study     visit.   "|||2017-10-11 03:58:24.641867|2017-10-11 03:58:24.641867
NCT01406600|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-23|2013-04-11|||September 2011||2011-09-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Optimal rhCG(Ovidrel®) Dose in Poor Responder During IVF and ICSI Cycles|Optimal rhCG(Ovidrel®) Dose for Final Oocyte Maturation Triggering in Poor Responder During IVF and ICSI Cycles|Unknown status|Recruiting|N/A|70|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 03:58:24.710711|2017-10-11 03:58:24.710711
NCT01406587|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-10-18|||July 2011||2011-07-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of 50 mg, 100 mg and 200 mg PP4001 Twice Daily for the Treatment of Burning During Urination, Pain, and Urination Frequency Associated With Uncomplicated Urinary Tract Infection|Completed||Phase 2|261|Actual|Pinnacle Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 03:58:24.788082|2017-10-11 03:58:24.788082
NCT01406574|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-05-21|2015-04-14||July 2011||2011-07-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma|A Multicenter, Open-label, Non-randomized, Dose-escalation, Therapeutic Exploratory Trial to Evaluate the Safety and Efficacy of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|23|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 03:58:25.011967|2017-10-11 03:58:25.011967
NCT01406561|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2013-01-03|||August 2011||2011-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy|A Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy|Completed||Phase 3|344|Actual|Omeros Corporation||2|||f||||f||||||||||2017-10-11 03:58:25.473998|2017-10-11 03:58:25.473998
NCT01406548|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-02-18|||July 2011||2011-07-01|February 2015|2015-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density|A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Assess the Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density|Completed||Phase 2|44|Actual|Novartis||6|||f||||||||||||||2017-10-11 03:58:25.609022|2017-10-11 03:58:25.609022
NCT01406535|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-07-29||||||January 2011|2011-01-01||||||||Expanded Access|SYDNEY||Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease|Sustained Improvement of MYocardial Blood Flow by Intermittent PhosphoDiesterase 5 INhibition in REfractory Coronary ArterY Disease Suggests Enhanced Angiogenesis (SYDNEY)|Temporarily not available||N/A|||Medical University of Vienna|||||f||||||||||||||2017-10-11 03:58:25.72187|2017-10-11 03:58:25.72187
NCT01406522|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2013-12-17|||October 2012||2012-10-01|December 2013|2013-12-01|November 2013|Anticipated|2013-11-01|September 2013|Anticipated|2013-09-01||Interventional|||Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics|Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics|Withdrawn||Phase 2|0|Actual|Midwest Biomedical Research Foundation||2||One of the study medications, tacrine, is no longer clinically available|f||||t||||||||||2017-10-11 03:58:25.802109|2017-10-11 03:58:25.802109
NCT01406509|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2012-04-17|||August 2011||2011-08-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children|A Phase I Clinical Trial for Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children|Completed||Phase 1|40|Actual|Jiangsu Province Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 03:58:25.887426|2017-10-11 03:58:25.887426
NCT01406496|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-02-21|||August 2011||2011-08-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Best Timing of Insulin Bolus Before Meals of Different Contents|The Effect of Food Content and Optimal Timing of Pre-meal Insulin Bolus on the Postprandial Glycemic Control in Children With Type 1 Diabetes|Unknown status|Recruiting|N/A|24|Anticipated|Kaplan Medical Center||1|||f||||t||||||||||2017-10-11 03:58:25.967108|2017-10-11 03:58:25.967108
NCT01406483|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2014-08-08|||September 2010||2010-09-01|April 2013|2013-04-01|July 2016|Anticipated|2016-07-01|February 2016|Anticipated|2016-02-01||Interventional|Serial CABG||Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting|Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting|Unknown status|Active, not recruiting|N/A|100|Anticipated|Medstar Health Research Institute||1|||f||||f||||||||||2017-10-11 03:58:26.065147|2017-10-11 03:58:26.065147
NCT01406470|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-01-09|||September 2011||2011-09-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency|An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) IVIG-SN™ in Subjects With Primary Immunodeficiency|Completed||Phase 3|45|Actual|Green Cross Corporation||1|||f||||t||||||||||2017-10-11 03:58:26.139652|2017-10-11 03:58:26.139652
NCT01406457|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-10-20|||June 2010||2010-06-01|October 2015|2015-10-01|March 2014|Actual|2014-03-01|December 2012|Actual|2012-12-01||Observational|MODISH||Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage|Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage|Completed||N/A|7|Actual|University of Cincinnati|||1||f||||f|||||||"     No specimens are to be retained.   "|||2017-10-11 03:58:26.246884|2017-10-11 03:58:26.246884
NCT01406444|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-07-11|||October 2011||2011-10-01|July 2017|2017-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||IGF-1 and Bone Loss in Women With Anorexia Nervosa|IGF-1 and Bone Loss in Women With Anorexia Nervosa|Recruiting||N/A|200|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 03:58:26.300671|2017-10-11 03:58:26.300671
NCT01406431|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-01-01|||August 2011||2011-08-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|August 2011|Actual|2011-08-01||Interventional|||Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects|A Single Dose, Sequence-randomized, Open-label, 2x2 Crossover Study to Compare Pharmacokinetics Between Pitavastatin and Valsartan Co-administration and Livalo® Fixed Combination Drug in Healthy Male Subjects|Completed||Phase 1|48|Actual|JW Pharmaceutical||2|||f||||f||||||||||2017-10-11 03:58:26.392903|2017-10-11 03:58:26.392903
NCT01406418|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2013-12-18|||February 2013||2013-02-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus|A Phase I, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CR6261, a Monoclonal Antibody Against Influenza A Viruses, Following Single-Dose Intravenous Administration|Completed||Phase 1|64|Actual|Crucell Holland BV||12|||f||||t||||||||||2017-10-11 03:58:26.463744|2017-10-11 03:58:26.463744
NCT01406405|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2016-08-29|||July 2011||2011-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|PEEK||PEEK and Allograft Spacers Evaluation in Spinal Fusion Surgeries|Prospective Randomized Clinical Trial Comparing PEEK and Allograft Spacers in Patients Undergoing Spinal Intervertebral Fusion Surgeries|Recruiting||N/A|240|Anticipated|Justin Parker Neurological Institute|||2||f||||f||||||||||2017-10-11 03:58:26.563716|2017-10-11 03:58:26.563716
NCT01406392|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-07-29|||March 2011||2011-03-01|March 2011|2011-03-01|December 2011|Anticipated|2011-12-01|July 2011|Actual|2011-07-01||Interventional|SUBMISO||Sublingual Misoprostol for Induction of Labor|Sublingual Misoprostol 12,5 Mcg Versus Vaginal Misoprostol 25 Mcg for Induction of Labour of Alive and Term Fetus : Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|150|Anticipated|Professor Fernando Figueira Integral Medicine Institute||2|||f||||t||||||||||2017-10-11 03:58:26.635663|2017-10-11 03:58:26.635663
NCT01406379|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2013-08-18|||July 2010||2010-07-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Comparison of Prophylactic Clip and Detachable Snare|Comparison of Clip and Detachable Snare in Preventing Postpolypectomy Bleeding for Pedunculated Colonic Polyps: a Prospective, Randomized Study|Completed||N/A|203|Actual|The Catholic University of Korea||2|||f||||t||||||||||2017-10-11 03:58:26.898047|2017-10-11 03:58:26.898047
NCT01406366|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-29|2011-07-29|||September 2005||2005-09-01|August 2010|2010-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|BFOH||Evaluation of a Bright Futures Oral Health Intervention|Evaluation of a Bright Futures Oral Health Intervention for Pediatric Residents|Completed||N/A|27|Actual|Continuity Research Network|||2||f||||f||||||||||2017-10-11 03:58:26.976441|2017-10-11 03:58:26.976441
NCT01406353|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2016-07-20|||July 2011||2011-07-01|July 2016|2016-07-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|MITIGATE||Early Percutaneous Mitral Intervention in Asymptomatic Moderate Mitral Stenosis|Early Percutaneous Mitral Intervention Versus Conventional Management in Asymptomatic Moderate Mitral Stenosis|Active, not recruiting||Phase 4|166|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 03:58:27.060477|2017-10-11 03:58:27.060477
NCT01406340|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-06-06|||August 30, 2011|Actual|2011-08-30|June 2017|2017-06-01|August 31, 2013|Actual|2013-08-31|August 31, 2013|Actual|2013-08-31||Interventional|||Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment|A Repeat-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Impaired Renal Function|Terminated||Phase 1|22|Actual|GlaxoSmithKline||2||Difficulty enrolling last cohort of subjects|f||||f||||||||||2017-10-11 03:58:27.155068|2017-10-11 03:58:27.155068
NCT01406327|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-08-28|||December 14, 2010|Actual|2010-12-14|August 2017|2017-08-01|August 31, 2020|Anticipated|2020-08-31|August 31, 2020|Anticipated|2020-08-31||Observational|||Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)|Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)|Active, not recruiting||N/A|900|Anticipated|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:58:27.246189|2017-10-11 03:58:27.246189
NCT01406314|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-06-07|||October 13, 2011|Actual|2011-10-13|June 2017|2017-06-01|November 14, 2012|Actual|2012-11-14|November 14, 2012|Actual|2012-11-14||Interventional|||SAP Depleter Dose Assessment Study in Patients|A Phase 1, Open Label, Dose Characteristic Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Intravenous and Subcutaneous Doses of GSK2315698A in Patients With Systemic Amyloidosis|Completed||Phase 1|17|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 03:58:27.319704|2017-10-11 03:58:27.319704
NCT01406301|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-04-23|||March 2008||2008-03-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Fondaparinux EU-RMP (Adherence)|Evaluate (Post Approval) the Adherence to the Prescribing Information for ARIXTRA® (Fondaparinux) in ACS Patients- Commitment of the Fondaparinux EU-RMP|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 03:58:27.402316|2017-10-11 03:58:27.402316
NCT01406288|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2012-11-19|||July 2011||2011-07-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|SHU O104 CUB||Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4|Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 in Bordeaux Urban Area, June 2011: Evaluation of Diagnostic, Prognostic and Pathophysiological Data|Completed||N/A|9|Actual|University Hospital, Bordeaux|||1||f||||f||||||||||2017-10-11 03:58:27.473704|2017-10-11 03:58:27.473704
NCT01406275|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-05-15|||January 2008||2008-01-01|May 2017|2017-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)|Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)|Completed||N/A|363|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 03:58:27.539171|2017-10-11 03:58:27.539171
NCT01406262|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-06-07|||July 6, 2011|Actual|2011-07-06|June 2017|2017-06-01|December 29, 2011|Actual|2011-12-29|December 29, 2011|Actual|2011-12-29||Interventional|||Albiglutide Thorough ECG Study in Healthy Volunteers|A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin)|Completed||Phase 1|94|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:58:27.604552|2017-10-11 03:58:27.604552
NCT01406249|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-07-26|||August 2011||2011-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer|A Randomized Phase II Trial Comparing Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer (XParTS II)|Active, not recruiting||Phase 2|100|Anticipated|Epidemiological and Clinical Research Information Network||2|||f||||t||||||||||2017-10-11 03:58:27.693039|2017-10-11 03:58:27.693039
NCT01406236|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-01-16|||August 2011||2011-08-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|SAFE-PCI||SAFE-PCI for Women|Study of Access Site for Enhancement of PCI for Women (SAFE-PCI for Women)|Terminated||N/A|1787|Actual|Duke University||2||"Study stopped for Statistical Futility. Low rate of bleeding events made it unlikely there   would be statistical power to show a difference in the 2 arms."|f||||t||||||||||2017-10-11 03:58:27.857481|2017-10-11 03:58:27.857481
NCT01406210|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2014-09-10|||September 2011||2011-09-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Observational|RESULT||RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol|Prospective and Retrospective Study to Develop a Multi-center Randomized Study, to Determine if Prevention of GERD Related Aspiration by Surgical Fundoplication Improves Lung Allograft Function|Completed||N/A|647|Actual|Duke University|||2||f||||f||||||Samples Without DNA|"     The bronchiolar lavage fluid (BALF) will be drawn during the bronchoscopy site and     approximately up to 10 ml of the bronchiolar lavage (BAL) fluid will be placed in 7 storage     vials (approximately 1.5 ml per vial), frozen using liquid nitrogen as the freezing agent,     and shipped on dry ice to Duke University Medical Center and/or University of Toronto. Frozen     samples will be stored at -80 °C to -85 °C until shipping, and the time between collection     and freezing will be recorded.      The tests used to assess the bronchiolar lavage fluid (BALF) may include, but are not limited     to the following: Gastrin, Pepsinogen I, Pepsinogen II, Lipopolysaccharide (LPS), Bile acids     (colorimetric and enzymatic approaches), and proteome assessment by mass spectrometry.   "|||2017-10-11 03:58:28.681125|2017-10-11 03:58:28.681125
NCT01406197|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-31|2017-08-09|||July 2011|Actual|2011-07-01|August 2017|2017-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Uterine Electrical Activity Before and After Progesterone Treatment for Preterm Labor|Uterine Abdominal Electromyography Measurements Before and After Progesterone Treatments for Preterm Labor|Withdrawn||N/A|0|Actual|St. Joseph's Hospital and Medical Center, Phoenix||3||Investigator left organization prior to study initiation|f||||f||||||||||2017-10-11 03:58:28.797978|2017-10-11 03:58:28.797978
NCT01406184|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-04-06|||July 2009||2009-07-01|April 2017|2017-04-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Durham Connects RCT Evaluation|RCT Evaluation of the Durham Connects Universal Newborn Nurse Home Visiting Program|Active, not recruiting||N/A|2329|Actual|Duke University||2|||f||||t||||||||No||2017-10-11 03:58:28.904007|2017-10-11 03:58:28.904007
NCT01406171|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-28|||May 2011||2011-05-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Drug Interaction Study of Isavuconazole and Midazolam|A Phase 1, Open-Label, Drug Interaction Study of the Pharmacokinetics of Isavuconazole and Midazolam After Separate and Concomitant Administration to Healthy Adult Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:58:29.00072|2017-10-11 03:58:29.00072
NCT01406158|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-08-23|||May 2011||2011-05-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation|A Phase 1, Open-Label, Randomized, Single Dose, 3-Way Crossover Study to Assess the Relative Bioavailability of Solifenacin Liquid Suspension 10 mg (Formulation B) Versus Solifenacin Liquid Suspension 10 mg (Formulation A) and to Assess the Relative Bioavailability of Solifenacin Liquid Suspension 10 mg (Formulation A and B) Versus the VESIcare (Solifenacin Succinate) 10 mg Tablet in Healthy Volunteers|Completed||Phase 1|24|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 03:58:29.094835|2017-10-11 03:58:29.094835
NCT01406145|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-11-17|||June 2011||2011-06-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil|A Phase 1b, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Sequential Dose Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease on Donepezil|Completed||Phase 1|60|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-10-11 03:58:29.177871|2017-10-11 03:58:29.177871
NCT01406132|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-28|||December 2009||2009-12-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects|A Phase 1, Open-Label, Mass Balance Study to Evaluate the Pharmacokinetics of ASP015K After a Single Oral Dose of 14C-Labeled ASP015K in Healthy Male Subjects|Completed||Phase 1|6|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:58:29.261016|2017-10-11 03:58:29.261016
NCT01406119|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-01-26|||October 2011||2011-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors|An Extension Study of ABT-806 for Subjects With Advanced Solid Tumors|Completed||Phase 1|14|Actual|AbbVie||1|||f||||f||||||||||2017-10-11 03:58:29.338847|2017-10-11 03:58:29.338847
NCT01406106|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-07-28|||January 2010||2010-01-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Effect of Plant Sterols on the Lipid Profile of Patients With Hypercholesterolaemia|EFFECT OF PLANT STEROLS ON THE LIPID PROFILE OF PATIENTS WITH HYPERCHOLESTEROLAEMIA. RANDOMISED, EXPERIMENTAL STUDY|Unknown status|Active, not recruiting|N/A|182|Actual|Gerencia de Atención Primaria, Albacete||2|||f||||f||||||||||2017-10-11 03:58:29.416803|2017-10-11 03:58:29.416803
NCT01406093|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-12-02|||May 2011||2011-05-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Observational|||Early- and Late-onset Candidemia|Early- and Late-onset Candidemia: A Retrospective Study|Completed||N/A|400|Actual|University of Turin, Italy|||1||f||||f||||||||||2017-10-11 03:58:29.528992|2017-10-11 03:58:29.528992
NCT01406080|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-04-05|||January 2013||2013-01-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|FOTEN||A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging|Single-blinded, Multicenter, Randomized, Comparative Study of Efficacy and Safety of Adapalene Gel 0.3% Versus Tretinoin Emollient Cream 0.05% in the Treatment of Cutaneous Photoaging.|Completed||Phase 3|128|Actual|Galderma Brasil Ltda.||2|||f||||t||||||||||2017-10-11 03:58:29.588769|2017-10-11 03:58:29.588769
NCT01406067|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-04-14|||January 2011||2011-01-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Treatment of Children With Peer Related Aggressive Behavior|Treatment of Children With Peer Related Aggressive Behavior With the Treatment Programme THAV - a Randomized Controlled Trial|Completed||Phase 3|100|Anticipated|University of Cologne||2|||f||||f||||||||||2017-10-11 03:58:29.680933|2017-10-11 03:58:29.680933
NCT01406054|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2016-01-26|||July 2011||2011-07-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|June 2014|Actual|2014-06-01||Interventional|KIPP at CPS||Role of Neuromuscular Training in Reducing Sports Injuries and Improving Fitness Among Chicago Public Elementary and Middle School Students|Role of Neuromuscular Training in Reducing Sports Injuries and Improving Fitness Among Chicago Public Elementary and Middle School Students|Active, not recruiting||N/A|905|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-11 03:58:29.7579|2017-10-11 03:58:29.7579
NCT01406041|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-07-28|||February 2011||2011-02-01|April 2011|2011-04-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Observational|||Disturbance of Water and Sodium Metabolism After Surgery of Sellar Lesions, and Correspond Clinical Strategy||Unknown status|Recruiting|N/A|350|Anticipated|Southern Medical University, China|||1||f||||t||||||||||2017-10-11 03:58:29.834859|2017-10-11 03:58:29.834859
NCT01406028|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2011-07-28|||September 2009||2009-09-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Does Emotional Support Decrease In Vitro Fertilization Stress?|Does Emotional Support During the Luteal Phase Decrease the Stress of IVF?|Completed||N/A|131|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:58:29.920608|2017-10-11 03:58:29.920608
NCT01406015|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-03-20|2017-01-29||February 2009||2009-02-01|March 2017|2017-03-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional||Baseline characteristics are based on the total number of participants who completed the study.|Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications|Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications|Completed||N/A|38|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:58:29.994031|2017-10-11 03:58:29.994031
NCT01406002|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2013-04-09|||January 2010||2010-01-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)|An Open-label, One-sequence Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Pharmacokinetics of YM150 (Darexaban) and Metabolites in Young Healthy Male Subjects|Completed||Phase 1|26|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 03:58:30.442064|2017-10-11 03:58:30.442064
NCT01405989|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-03-03|||January 2010||2010-01-01|July 2011|2011-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban)|An Open-label, Randomized, Two-period Crossover Study to Evaluate the Effect of Multiple Doses of Ketoconazole on the Pharmacokinetics of Darexaban and Metabolites in Young Healthy Male Subjects|Completed||Phase 1|26|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 03:58:30.542839|2017-10-11 03:58:30.542839
NCT01405976|ClinicalTrials.gov processed this data on October 10, 2017|2008-07-03|2017-09-22|||May 2009|Actual|2009-05-01|January 2017|2017-01-01|July 2017|Actual|2017-07-01|May 2013|Actual|2013-05-01||Interventional|||Alternative of Treatment in Obesity Hypoventilation Syndrome|Mid-and Long-term Efficacy of Ventilation Non-invasive and Continuos Positive Airway Pressure in Obesity Hypoventilation Syndrome|Completed||N/A|440|Actual|Sociedad Española de Neumología y Cirugía Torácica||5|||f||||t||||||||||2017-10-11 03:58:30.630299|2017-10-11 03:58:30.630299
NCT01405963|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-09-16|||September 2011||2011-09-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma|A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 157 in Subjects With Mild Atopic Asthma|Completed||Phase 1|31|Actual|Amgen||2|||f||||f||||||||||2017-10-11 03:58:30.717277|2017-10-11 03:58:30.717277
NCT01405950|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-06-10|2013-03-27||May 2011||2011-05-01|June 2013|2013-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy|Single-Dose, Phase 1b Study to Assess Pharmacokinetics, Safety and Tolerability, and Pharmacodynamics of Tizanidine at 4 Different Oral Dose Levels in Pediatric Subjects With Mild to Moderate Spasticity Due to Cerebral Palsy|Terminated||Phase 1|10|Actual|Acorda Therapeutics||4||"Please see 'Further study details as provided by Acorda Therapeutics' for explanation of why   study stopped."|f||||t||||||||||2017-10-11 03:58:30.812996|2017-10-11 03:58:30.812996
NCT01405937|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-03-03|2014-10-03||August 2011||2011-08-01|March 2017|2017-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)|A Phase III Study to Evaluate the Safety, Tolerability, and Efficacy of MK-7009 When Concomitantly Administered With Peginterferon Alfa-2b and Ribavirin in Japanese Patients With Chronic Hepatitis C Infection Who Relapsed After Previous Treatment|Completed||Phase 3|51|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 03:58:31.163429|2017-10-11 03:58:31.163429
NCT00000343|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||April 1996||1996-04-01|April 1996|1996-04-01||||||||Interventional|||Brain Changes in Stimulant Dependent Subjects - 8|Brain Changes in Stimulant Dependent Subjects|Completed||Phase 4|90||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.470439|2017-10-11 04:17:47.470439
NCT01405924|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-02-14|2014-10-24||October 2011||2011-10-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EVADE||Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030)|EMEND® IV In Salvage Treatment of Chemotherapy-Induced Vomiting|Terminated||Phase 2|111|Actual|Merck Sharp & Dohme Corp.||1||Low enrollment|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:58:31.890875|2017-10-11 03:58:31.890875
NCT01405911|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-04-10|||August 8, 2011|Actual|2011-08-08|April 2017|2017-04-01|April 9, 2012|Actual|2012-04-09|April 9, 2012|Actual|2012-04-09||Interventional|||Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)|A Phase II, Randomized, Placebo-Controlled, Parallel-group, Double-Blind, Dose Response Finding Clinical Trial to Study the Efficacy and Safety of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance Who Have Inadequate Glycemic Control on Diet/Exercise Therapy|Completed||Phase 2|251|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 03:58:32.208632|2017-10-11 03:58:32.208632
NCT01405898|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-12-08|2015-11-03||January 2010||2010-01-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|April 2013|Actual|2013-04-01||Interventional|||The Chronic Effects of Beetroot Juice in Hypertensive Subjects|The Chronic Effects of Beetroot Juice on Circulating Plasma Nitrate and Nitrite Levels and Blood Pressure in Hypertensive Subjects|Completed||N/A|68|Actual|Queen Mary University of London||2|||f||||f||||||||||2017-10-11 03:58:32.299822|2017-10-11 03:58:32.299822
NCT01405885|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-02-28|||May 2011||2011-05-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus|Phase I, Open Label Study to Evaluate Safety, Tolerability and Immunogenicity of Multiple Combinations of H1 and H5 Influenza Hemagglutinin Plasmids Administered ID Followed by in Vivo Electroporation With CELLECTRA®-3P in Healthy Adults|Completed||Phase 1|116|Actual|Inovio Pharmaceuticals||10|||f||||f||||||||||2017-10-11 03:58:32.645835|2017-10-11 03:58:32.645835
NCT01405872|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-09-05|||September 2011||2011-09-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|PERSIST||Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.|An Observational Study to Assess Persistence, Adherence, Quality of Life, and Treatment Satisfaction in Patients Beginning Therapy With the Avonex® PEN™.|Completed||N/A|270|Actual|Biogen|||1||f||||f||||||||||2017-10-11 03:58:32.801777|2017-10-11 03:58:32.801777
NCT01405859|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-05-10|||January 2010||2010-01-01|May 2016|2016-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||MRI Study of Tic Remission in Tourette Syndrome|Neuroimaging to Elucidate the Mechanism of Tic Resolution in Tourette Syndrome|Completed||N/A|21|Actual|University of Utah|||3||f||||f||||||||||2017-10-11 03:58:33.015092|2017-10-11 03:58:33.015092
NCT01405846|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2016-08-18|||December 2011||2011-12-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|April 2016|Actual|2016-04-01||Interventional|TIDAL1||Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib|Tyrosine Kinase Inhibitors in DyplAsia of Lung Epithelium|Terminated||Phase 2|32|Actual|Papworth Hospital NHS Foundation Trust||1||Futility|f||||t||||||||||2017-10-11 03:58:33.101798|2017-10-11 03:58:33.101798
NCT01405833|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-09-05|||July 2011||2011-07-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study of the Safety, Tolerability, Pharmacokinetics and Safety of BG00010 (Neublastin) in Subjects With Sciatica.|Phase 1: A Multi-Centered, Randomized, Blinded, Placebo-Controlled, Serial-Cohort, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of BG00010 (Neublastin) in Subjects With Sciatica|Completed||Phase 1|56|Actual|Biogen||2|||f||||t||||||||||2017-10-11 03:58:33.193953|2017-10-11 03:58:33.193953
NCT01405820|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-08-03|2015-06-29||August 2011||2011-08-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|REFINE||Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)|A Randomized, Blinded, Parallel-Group, Phase 2 Study Exploring the Safety, Tolerability, and Efficacy of Multiple Regimens of Natalizumab in Adult Subjects With Relapsing Multiple Sclerosis|Completed||Phase 2|290|Actual|Biogen||6|||f||||t||||||||||2017-10-11 03:58:33.296413|2017-10-11 03:58:33.296413
NCT01405807|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2011-07-28|||February 2011||2011-02-01|July 2011|2011-07-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|ALEVIATE||Alemtuzumab for ANCA Associated Refractory Vasculitis|Alemtuzumab for ANCA Associated Refractory Vasculitis - a Study of Safety and Efficacy|Unknown status|Recruiting|Phase 4|24|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 03:58:35.724363|2017-10-11 03:58:35.724363
NCT01405794|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-05-25|2013-07-12||July 2011||2011-07-01|September 2015|2015-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm||Completed||Phase 1/Phase 2|12|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 03:58:35.892885|2017-10-11 03:58:35.892885
NCT01405781|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2017-08-23|||May 2011||2011-05-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Functional and Radiographic Outcomes After Shoulder Surgery|Functional and Radiographic Outcomes After Shoulder Surgery|Enrolling by invitation||N/A|550|Anticipated|University of Utah|||1||f||||f||||||||||2017-10-11 03:58:36.961822|2017-10-11 03:58:36.961822
NCT01405768|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-06-26|2014-05-19||July 2011||2011-07-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional||4 women from the lidocaine arm who did not complete the questionnaire correctly were excluded from analysis|Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)|A Randomized Trial of Buffered vs Nonbuffered Lidocaine With Epinephrine for Cervical Loop Excision|Completed||Phase 2|56|Actual|Washington University School of Medicine|"Small sample - may have missed a significant difference when one really exists
Procedures performed by 2nd year residents vs. procedure performed by more skilled surgeon (less pain)
Used needle extenders/27-gauge needles vs. Potocki needles"|2|||f||||f||||||||||2017-10-11 03:58:37.097396|2017-10-11 03:58:37.097396
NCT01405755|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2013-04-01|||September 2010||2010-09-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|August 2011|Actual|2011-08-01||Interventional|||Partnering With Media and Vaccination Program to Improve Infant and Young Child Feeding|Partnering With Media and Vaccination Program to Improve Infant and Young Child Feeding|Completed||N/A|420|Actual|University of South Carolina||2|||f||||f||||||||||2017-10-11 03:58:38.186753|2017-10-11 03:58:38.186753
NCT01405742|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-09-16|2016-06-08||July 2012||2012-07-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A|R34 Pilot Feasibility Randomized, Noninferiority, Cross-Over Trial of Once-Weekly vs. Thrice-Weekly Prophylaxis With Recombinant Factor VIII in Adults With Severe Hemophilia A|Terminated||Phase 3|4|Actual|University of Pittsburgh||2||study was non-feasible per DSMB|f||||t||||||||Yes|The data from this trial will be available, pending NIH approval, through BioLINCC https://biolincc.nhlbi.nih.gov.|2017-10-11 03:58:38.280356|2017-10-11 03:58:38.280356
NCT01405729|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-02-12|||May 2010||2010-05-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|MPFL||Medial Patellofemoral Ligament Reconstruction: A Review of Technique, Accuracy, and Outcome|Medial Patellofemoral Ligament Reconstruction: A Review of Technique, Accuracy, and Outcome|Completed||N/A|13|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 03:58:38.566033|2017-10-11 03:58:38.566033
NCT01405716|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-09-30|||February 2011||2011-02-01|September 2017|2017-09-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|||Aging Successfully With Pain|Effectiveness of a Mind-Body Program for Older Adults With Chronic Low Back Pain|Completed||N/A|282|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 03:58:38.634068|2017-10-11 03:58:38.634068
NCT01405703|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-07-08|||July 2011||2011-07-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Percutaneous Versus Open Plate Fixation of Diaphyseal Clavicle Fractures|Percutaneous Versus Open Plate Fixation of Diaphyseal Clavicle Fractures|Completed||N/A|35|Actual|University of Utah|||2||f||||f||||||||||2017-10-11 03:58:38.728069|2017-10-11 03:58:38.728069
NCT01405690|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2016-12-02|||September 2008||2008-09-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|June 2014|Actual|2014-06-01||Observational|||The Role Of Noninvasive 320-Row Multidetector Computer Tomography|A Pilot Study: The Role Of Noninvasive 320-Row Multidetector Computer Tomography Coronary Angiogram In Predicting Perioperative Cardiac Complications In Patients Referred For Noncardiac Surgery|Completed||N/A|100|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 03:58:38.838522|2017-10-11 03:58:38.838522
NCT01405677|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-07-28|||June 2004||2004-06-01|December 2013|2013-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine|A Phase II Open, Randomised, Controlled Study to Evaluate the Safety and Immunogenicity of a Paediatric Dose (0.25 mL) and the Standard Dose (0.5 mL) of Epaxal® With Reference to Havrix Junior® Healthy in Healthy Children and Adolescents (>=12 Months - 16 Years of Age) Using a 0/6 Month Schedule|Completed||Phase 2|308|Actual|Crucell Holland BV||3|||f||||t||||||||||2017-10-11 03:58:38.923994|2017-10-11 03:58:38.923994
NCT01405664|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2011-08-11|||September 2011||2011-09-01|July 2011|2011-07-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Study of the Effect of Weight Bearing Status on Patient Outcomes After Surgery for Osteochondral Defects of the Ankle|A Randomized, Controlled Clinical Trial to Evaluate the Effect on Patient Outcomes of Weight Bearing Status After Forage of Osteochondral Defects of the Ankle|Unknown status|Not yet recruiting|N/A|68|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-10-11 03:58:39.020395|2017-10-11 03:58:39.020395
NCT01405651|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2012-06-12|||July 2011||2011-07-01|June 2012|2012-06-01||||October 2011|Actual|2011-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects|A Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 03:58:39.113364|2017-10-11 03:58:39.113364
NCT01405638|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-11-11|||March 2011||2011-03-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|FAITH-CRC||Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention|Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention|Completed||N/A|451|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-10-11 03:58:39.189922|2017-10-11 03:58:39.189922
NCT01405625|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-01-11|||July 2011||2011-07-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Parent Understanding of Instructions About Asthma Care|Improving Parent Understanding of Instructions About Asthma Care|Active, not recruiting||Phase 2|500|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 03:58:39.284812|2017-10-11 03:58:39.284812
NCT01405612|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2012-10-15|||June 2011||2011-06-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers|An Open-label, Single Centre, Randomised, Cross-over Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam After Repeat Dose Administration of Ulimorelin in Healthy Volunteers|Completed||Phase 1|14|Actual|Norgine||2|||f||||t||||||||||2017-10-11 03:58:39.364704|2017-10-11 03:58:39.364704
NCT01405599|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2012-10-15|||June 2011||2011-06-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects|Evaluation of the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ulimorelin in Subjects With Mild, Moderate and Severe Hepatic Impairment, in Comparison With Healthy Subjects|Completed||Phase 1|32|Actual|Norgine||4|||f||||t||||||||||2017-10-11 03:58:39.472932|2017-10-11 03:58:39.472932
NCT01405586|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-26|2017-10-05|||March 2011||2011-03-01|October 2017|2017-10-01|September 2018|Anticipated|2018-09-01|November 2016|Actual|2016-11-01||Interventional|MILES-3||MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer|Randomized Phase III Study of the Addition of Cisplatin in Combination With Gemcitabine as First-line Therapy for Elderly Patients With Advanced Non Small Cell Lung Cancer.|Active, not recruiting||Phase 3|299|Actual|National Cancer Institute, Naples||2|||f||||f||||||||||2017-10-11 03:58:39.584209|2017-10-11 03:58:39.584209
NCT01405573|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-26|2017-03-27|||July 2011||2011-07-01|March 2017|2017-03-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|BOOST||Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma|Sorafenib in the First Line Treatment of Advanced Hepatocellular Carcinoma With Child-Pugh Liver Function Class B: Multicentre Phase 3 Randomized Trial|Terminated||Phase 3|35|Actual|National Cancer Institute, Naples||2||lack of enrolment|f||||t||||||||||2017-10-11 03:58:39.815308|2017-10-11 03:58:39.815308
NCT00000344|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11||||||August 2008|2008-08-01|August 2000|Actual|2000-08-01|||||Interventional|||Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9|Trial of Buprenorphine/Naloxone for Treatment of Opiate Dependence|Completed||Phase 2|40||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.535572|2017-10-11 04:17:47.535572
NCT01405560|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-03-03|2014-10-06||September 2011||2011-09-01|March 2017|2017-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)|A Phase III Study to Evaluate the Safety, Tolerability, and Efficacy of MK-7009 When Administered Concomitantly With Peginterferon Alfa-2b and Ribavirin in Japanese Patients With Chronic Hepatitis C Infection Who Were Non-responders to Previous Treatment|Completed||Phase 3|42|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-10-11 03:58:39.953861|2017-10-11 03:58:39.953861
NCT01405547|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-12-19|||March 2009||2009-03-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Gestational Metabolic Abnormalities and Maternal and Infant Nutrition and Health|Impact of Maternal Metabolic Abnormalities in Pregnancy on Human Milk and Subsequent Infant Metabolic Development|Completed||N/A|271|Actual|University of Toronto|||1||f||||||||||||||2017-10-11 03:58:40.465339|2017-10-11 03:58:40.465339
NCT01405534|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-09-11|||November 2011||2011-11-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|VVC||Evaluation of the Occurrence of Acute Complications Caused by a Central Venous Catheter Placement|Evaluation of the Occurrence of Acute Complications Caused by a Central Venous Catheter Placement: Observational, Prospective, Monocentric Study|Completed||N/A|1780|Actual|Centre Leon Berard|||1||f||||f||||||||||2017-10-11 03:58:40.559968|2017-10-11 03:58:40.559968
NCT01405521|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2017-03-30|||December 2011||2011-12-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|||Understanding Typhoid Disease After Vaccination|Understanding Typhoid Disease After Vaccination: a Single Centre, Randomised, Doubleblind, Placebo Controlled Study to Evaluate M01ZH09 in a Healthy Adult Challenge Model, Using Ty21a Vaccine as a Positive Control.|Active, not recruiting||Phase 2|99|Actual|University of Oxford||3|||f||||t||||||||||2017-10-11 03:58:40.635148|2017-10-11 03:58:40.635148
NCT01405508|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2016-07-04|2016-03-14|2013-06-03|August 2011||2011-08-01|July 2016|2016-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Baseline Characetristics refer to the Safety Population consisting of all subjects who took at least 1 dose of study drug.|Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy|A Multi-center, Open-label, Four-arm, Randomized Trial Evaluating the Safety and Tolerability of Brivaracetam Intravenous Infusion and Bolus, Administered in BID Regimen as an Adjunctive Antiepileptic Treatment in Subjects From 16 to 70 Years Suffering From Epilepsy|Completed||Phase 3|105|Actual|UCB Pharma||4|||f||||f||||||||||2017-10-11 03:58:40.737113|2017-10-11 03:58:40.737113
NCT01405495|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-05-03|||February 2012||2012-02-01|May 2017|2017-05-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Observational|COPTSD||PTSD Among Victims of Sexual Abuse and Changes in Structural and Functional Brain Connectivity|Posttraumatic Stress Disorder (PTSD) Among Victims of Sexual Abuse and Changes in Structural and Functional Brain Connectivity: A Cognitive and Neuroanatomical Markers Study Using fMRI,(DTI) and(ASL)|Completed||N/A|60|Actual|University Hospital, Tours|||3||f||||t||||||Samples Without DNA|"     Salivary cortisol   "|||2017-10-11 03:58:41.207313|2017-10-11 03:58:41.207313
NCT01405482|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-07-28|||August 2011||2011-08-01|July 2011|2011-07-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Botulinum Toxin Injections for Thoracic Outlet Syndrome|Botulin Toxin Type A Injections for Thoracic Outlet Syndrome: A Double-Blind, Randomized Control Trial|Unknown status|Not yet recruiting|Phase 1|60|Anticipated|University of British Columbia||2|||f||||t||||||||||2017-10-11 03:58:41.305343|2017-10-11 03:58:41.305343
NCT01405469|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-05-05|2014-09-04||November 2010||2010-11-01|May 2017|2017-05-01|November 2016|Actual|2016-11-01|June 2011|Actual|2011-06-01||Interventional|POEM||Endoscopic Peroral Myotomy for Treatment of Achalasia|Endoscopic Peroral Myotomy for Treatment of Achalasia: Pilot Study|Completed||N/A|16|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||t||||||||Undecided||2017-10-11 03:58:41.40427|2017-10-11 03:58:41.40427
NCT01405456|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2017-05-16|||January 2012||2012-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 3, 2017|Actual|2017-05-03||Interventional|||Eplerenone in HIV Associated Abdominal Fat Accumulation|Randomized Placebo-controlled Trial to Investigate the Effects of Eplerenone in Patients With HIV-associated Abdominal Fat Accumulation|Active, not recruiting||N/A|46|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:58:41.655348|2017-10-11 03:58:41.655348
NCT01405443|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2014-04-15|||January 2011||2011-01-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Simulator Training for Gastrointestinal Endoscopy|Simulator Training for Gastrointestinal Endoscopy - How Much Simulator Training is Required to Acquire Proficiency in Gastrointestinal Endoscopy?|Terminated||N/A|20|Actual|Universitätsklinikum Hamburg-Eppendorf|||3|invalid data|f||||t||||||||||2017-10-11 03:58:41.73706|2017-10-11 03:58:41.73706
NCT01405430|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2015-06-26|||May 2010||2010-05-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|AVECC||Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab|Exploration of New Biologic Factors' Predictive Value , Especially Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab|Completed||N/A|63|Actual|Centre Leon Berard||1|||f||||f||||||||||2017-10-11 03:58:41.805224|2017-10-11 03:58:41.805224
NCT01405417|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-05-03|||April 2011|Actual|2011-04-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|July 2012|Actual|2012-07-01||Interventional|||Endoscopic Peroral Myotomy for Treatment of Achalasia|Endoscopic Peroral Myotomy for Treatment of Achalasia: Multicenter Study|Active, not recruiting||N/A|70|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||t||||||||||2017-10-11 03:58:41.899455|2017-10-11 03:58:41.899455
NCT01405404|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-05-06|||January 2007||2007-01-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Engaging Low-Income Families in Prevention Programs|Engaging Low-Income Families in Prevention Programs|Completed||Phase 2|323|Actual|Rush University Medical Center||3|||f||||t||||||||||2017-10-11 03:58:41.9808|2017-10-11 03:58:41.9808
NCT01405391|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-01-14|||November 2011||2011-11-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks|Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM01183 on Days 1 and 8 Every Three Weeks (q3wk) in Non-Colorectal Cancer (Non-CRC) Patients|Completed||Phase 1|42|Actual|PharmaMar||1|||f||||f||||||||||2017-10-11 03:58:43.621927|2017-10-11 03:58:43.621927
NCT00005498|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||May 1998||1998-05-01|August 2004|2004-08-01|October 2001|Actual|2001-10-01|||||Observational|||Do Hostility and Stress Predict Cardiovascular Mortality in MRFIT?||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.7244|2017-10-11 04:27:07.7244
NCT01405378|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-06-22|||October 2011||2011-10-01|June 2016|2016-06-01|February 2014|Actual|2014-02-01|January 2014|Actual|2014-01-01||Interventional|||Non-invasive Brain Stimulation for People With Stroke|Combining Transcranial Direct Current Stimulation (tDCS) With Robot Therapy for the Impaired Upper Limb in Stroke Rehabilitation.|Completed||Early Phase 1|23|Actual|University of Southampton||2|||f||||t||||||||||2017-10-11 03:58:43.694131|2017-10-11 03:58:43.694131
NCT01405365|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-23|2011-07-28|||August 2009||2009-08-01|August 2010|2010-08-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||The Impact of Obesity on Nonsurgical Periodontal Therapy|The Impact of Obesity on Nonsurgical Periodontal Treatment of Destructive Periodontal Diseases|Unknown status|Recruiting|N/A|96|Anticipated|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-10-11 03:58:43.760155|2017-10-11 03:58:43.760155
NCT01405352|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-14|2011-07-28|||February 2010||2010-02-01|July 2011|2011-07-01|August 2013|Anticipated|2013-08-01|February 2013|Anticipated|2013-02-01||Interventional|||The Effect of Vitamin A Supplementation on Cytokine Profile in Obesity|The Effect of Vitamin A Supplementation on CD4+ T-cell Secretion in Obese Individuals|Unknown status|Enrolling by invitation|Phase 4|84|Actual|Tehran University of Medical Sciences||3|||f||||t||||||||||2017-10-11 03:58:43.886837|2017-10-11 03:58:43.886837
NCT01405339|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-03-07|||August 2011||2011-08-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|May 2013|Actual|2013-05-01||Interventional|||Budesonide Application Via Mucosal Atomization Device as a Treatment for Chronic Rhinosinusitis When Utilized as a Topical Nasal Steroid Spray|The Effect of Budesonide Spray Via Mucosal Atomization Device on the Hypothalamic-Pituitary Axis|Completed||Phase 1/Phase 2|20|Actual|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 03:58:44.003969|2017-10-11 03:58:44.003969
NCT01405326|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-28|||May 2011||2011-05-01|July 2011|2011-07-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|REWARD||REstore Working Ability in RheumatoiD Arthritis|The Effect of Six Months Adalimumab Treatment on Sick Leaves and Retirement in Patients With Rheumatoid Arthritis Who Are at a Risk of Losing Their Ability to Work|Unknown status|Recruiting|Phase 4|160|Anticipated|The Rheumatological Center of Helsinki||2|||f||||f||||||||||2017-10-11 03:58:44.089446|2017-10-11 03:58:44.089446
NCT01405313|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-01-30|2012-09-20||July 2011||2011-07-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||All 21 patients completed the cross over study design|Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV|Comparison of Modified Adaptive Servoventilation Therapy With Conventional Adaptive Servoventilation Therapy in Patients With Periodic Breathing|Completed||N/A|21|Actual|ResMed|None to report|2|||f||||f||||||||No||2017-10-11 03:58:44.209548|2017-10-11 03:58:44.209548
NCT01405300|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-06-23|||August 2011||2011-08-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function|The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function|Completed||Phase 1|20|Anticipated|Penn State University||2|||f||||f||||||||||2017-10-11 03:58:44.441759|2017-10-11 03:58:44.441759
NCT01405287|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-03-21|||October 2011||2011-10-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|August 2012|Actual|2012-08-01||Interventional|REMEDEE-OCT||Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT|A Prospective Randomized Study to Compare Vascular Healing After Deployment of the Abluminal Sirolimus Coated Bio-Engineered (Combo) Stent Versus the Everolimus Eluting Stent in Patients With Acute Coronary Syndrome by Means of OCT|Completed||Phase 2|60|Actual|OrbusNeich||2|||f||||t||||||||||2017-10-11 03:58:45.666971|2017-10-11 03:58:45.666971
NCT01405274|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-12-11|||July 2011||2011-07-01|December 2015|2015-12-01||||March 2016|Anticipated|2016-03-01||Interventional|||Impact of Physiotherapy Intervention for Children With Ankle Sprains|Exploring the Impact of a Physiotherapy Intervention on the Risk of Re-injury and Recovery in Children and Adolescents With Acute Ankle Sprains: a Randomized Controlled Trial|Recruiting||N/A|120|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-10-11 03:58:45.793301|2017-10-11 03:58:45.793301
NCT01405261|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2013-11-27|||August 2011||2011-08-01|November 2013|2013-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects|Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects|Completed||Phase 1|101|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 03:58:45.866193|2017-10-11 03:58:45.866193
NCT01405248|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-10-22|||July 2011||2011-07-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|BPRIAS||Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting|Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting|Completed||Phase 3|100|Actual|Jinling Hospital, China||2|||f||||t||||||||||2017-10-11 03:58:45.957461|2017-10-11 03:58:45.957461
NCT01405235|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2012-04-11|||September 2006||2006-09-01|September 2006|2006-09-01|January 2015|Anticipated|2015-01-01|June 2012|Anticipated|2012-06-01||Interventional|AGO-Zervix-1||Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma|A Prospective, Randomized Phase III Study to Compare the Effects of Paclitaxel and Topotecan to Those of Cisplatin and Topotecan for Treatment of Patients With Recurrent and Persistent Cervical Cancer|Unknown status|Active, not recruiting|Phase 3|312|Anticipated|Institut fuer Frauengesundheit||2|||f||||t||||||||||2017-10-11 03:58:46.048093|2017-10-11 03:58:46.048093
NCT01405222|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2013-12-16|||January 2012||2012-01-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Cough Frequency in Chronic Obstructive Pulmonary Disease|Objective Measure of COPD Exacerbation Using the Hull Automated Cough Recorder. Verifying Use of Automated Recording Systems in Measuring Symptoms Associated With a COPD Exacerbation|Completed||N/A|24|Actual|Hull and East Yorkshire Hospitals NHS Trust|||1||f||||f||||||||||2017-10-11 03:58:46.143826|2017-10-11 03:58:46.143826
NCT01405209|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2015-03-19|||July 2011||2011-07-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|EKG||Electrocardiogram Variations in the Prediction of Development of Atrial Fibrillation|Variaciones En El Elctrocardiograma Como Prediccion Del Desarrollo De Fibrilacion AURIC|Completed||N/A|100|Actual|Hospital Italiano de Buenos Aires|||2||f||||f||||||||||2017-10-11 03:58:46.226388|2017-10-11 03:58:46.226388
NCT01405014|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2012-03-06|||January 2012||2012-01-01|September 2011|2011-09-01|July 2012|Anticipated|2012-07-01|April 2012|Anticipated|2012-04-01||Interventional|||Outcome Study of Hold Me Tight Program With Acquired Brian Injury (ABI) Populations|Pilot Study of the Hold Me Tight Relationship Enhancement Program With Couples Where One Partner Has an Acquired Brian Injury|Withdrawn||Phase 3|0|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 03:58:49.129291|2017-10-11 03:58:49.129291
NCT01405183|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-09-16|||January 2011||2011-01-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Observational|||Association Between Hepatitis C Infection and Renal Cell Carcinoma|Association Between Hepatitis C Infection and Renal Cell Carcinoma, a Case Control Study|Completed||N/A|240|Actual|Henry Ford Health System|||2||f||||t||||||Samples Without DNA|"     Hepatits C antibody Hepatitis C RNA quantitative Hepatitis C Genotype   "|||2017-10-11 03:58:46.817924|2017-10-11 03:58:46.817924
NCT01405170|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-10-25|||October 2011||2011-10-01|October 2011|2011-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions|Phase 1, Open-Label, Randomized, Single-Dose, 2-Treatment, Crossover Bioequivalence Study Comparing Constituted Methylprednisolone Powder For Oral Suspension 4 mg/mL To Methylprednisolone 32 mg Tablet Under Fed Conditions|Withdrawn||Phase 1|16|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 03:58:46.901978|2017-10-11 03:58:46.901978
NCT01405157|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-10-17|||January 2012||2012-01-01|October 2011|2011-10-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions|Phase 1, Open-Label, Randomized, Single-Dose, 2-Treatment, Crossover Bioequivalence Study Comparing Constituted Methylprednisolone Powder For Oral Suspension 4 mg/mL To Methylprednisolone 16 Mg Tablet Under Fasting Conditions|Withdrawn||Phase 1|16|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 03:58:46.981989|2017-10-11 03:58:46.981989
NCT01405131|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-10-24|||January 2012||2012-01-01|October 2011|2011-10-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets|Phase 1, Open-Label, Randomized, Single-Dose, 2-Treatment, 2-Period Crossover Bioequivalence Study Comparing Constituted Methylprednisolone Powder for Oral Suspension 4 mg/mL to Methylprednisolone 32 mg Tablet Under Fasted Conditions|Withdrawn||Phase 1|16|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 03:58:47.17545|2017-10-11 03:58:47.17545
NCT01405118|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-08-17|||June 2011||2011-06-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers|A Phase 1, Open Labeled, Fixed Sequence Study To Estimate The Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers|Completed||Phase 1|24|Anticipated|Pfizer||1|||f||||f||||||||||2017-10-11 03:58:47.252082|2017-10-11 03:58:47.252082
NCT01405105|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2014-02-13|||August 2009||2009-08-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Exacerbating Factors in Inflammatory Bowel Disease|Exacerbating Factors in Inflammatory Bowel Disease|Completed||N/A|134|Actual|Dallas VA Medical Center|||2||f||||t||||||||||2017-10-11 03:58:47.334378|2017-10-11 03:58:47.334378
NCT01405092|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-28|2012-08-07|||April 2010||2010-04-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy)||Completed||N/A|28|Actual|Dallas VA Medical Center||2|||f||||f||||||||||2017-10-11 03:58:47.408837|2017-10-11 03:58:47.408837
NCT01405079|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-06-05|||July 2011||2011-07-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|March 2017|Actual|2017-03-01||Interventional|ADJUVANT||Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation|A Randomized, Open-label Trial of Gefitinib Versus Combination of Vinorelbine Plus Platinum as Adjuvant Treatment in Pathological Stage II-IIIA(N1-N2) Non-small Cell Lung Cancer With EGFR Mutation|Active, not recruiting||Phase 3|222|Actual|Guangdong Association of Clinical Trials||2|||f||||f||||||||Undecided||2017-10-11 03:58:47.482146|2017-10-11 03:58:47.482146
NCT01405066|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-08-25|||November 2010||2010-11-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Radiation Dose Audit Reports to Reduce Radiation Exposure From CT Exams|CT Technologists Dose Audit Reports and Educational Seminar to Reduce Patient Radiation Exposure From Medical Imaging|Completed||N/A|19|Actual|Kaiser Permanente||1|||f||||f||||||||||2017-10-11 03:58:47.606722|2017-10-11 03:58:47.606722
NCT01405053|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2016-03-21|||June 2011||2011-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs|A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive Development Effects and Safety, and Pharmacokinetics of Adjunctive Rufinamide Treatment in Pediatric Subjects 1 to Less Than 4 Years of Age With Inadequately Controlled Lennox-Gastaut Syndrome|Completed||Phase 3|37|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 03:58:47.695755|2017-10-11 03:58:47.695755
NCT01405040|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2013-04-01|||January 2010||2010-01-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Clinical Evaluation of a New Transpulmonary Thermodilution Method to Assess Thermodilution Cardiac Output, Global End Diastolic Volume and Extravascular Lung Water|Clinical Evaluation of a New Transpulmonary Thermodilution Method to Assess TPTD, GEDV and EVLW|Completed||N/A|97|Actual|Edwards Lifesciences|||1||f||||f||||||||||2017-10-11 03:58:47.825604|2017-10-11 03:58:47.825604
NCT01405027|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-12-22|2014-11-17||December 2011||2011-12-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|OPTIMAL||Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy|Boceprevir in Community Practice: Assessing Safety, Efficacy, Compliance and Quality of Life, Impact of an Education Program|Completed||Phase 4|197|Actual|Chronic Liver Disease Foundation|Smaller sample size than expected due to changing treatment landscape for HCV during course of study.|2|||f||||t||||||||||2017-10-11 03:58:48.051357|2017-10-11 03:58:48.051357
NCT01405001|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2017-05-12|||December 2004||2004-12-01|May 2017|2017-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|REACH||Registry of Emergency Airways Arriving at Combat Hospitals|Registry of Emergency Airways Arriving at Combat Hospitals (REACH)|Completed||N/A|292|Actual|William Beaumont Army Medical Center|||1||f||||f||||||||Undecided||2017-10-11 03:58:49.210874|2017-10-11 03:58:49.210874
NCT01404988|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-05-06|2015-02-23||November 2011||2011-11-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|VIP||Veterans Intensive Personalized Treatment in Heart Failure|VIP (Veterans Intensive Personalized) Treatment in Heart Failure|Completed||N/A|99|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 03:58:49.318422|2017-10-11 03:58:49.318422
NCT01404975|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-12-02|||June 2011||2011-06-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|August 2016|Actual|2016-08-01||Interventional|TAVI PVB||TAVI Protocol - Paravertebral Block Study|Reducing Delirium After Trans-Apical Aortic Valve Replacement (TAVI): A Multifaceted Approach of Perioperative Care|Recruiting||Phase 4|116|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 03:58:50.225379|2017-10-11 03:58:50.225379
NCT01404962|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-11-30|||August 2011||2011-08-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children|A Post Marketing Surveillance Study to Monitor the Reactogenicity and Safety of Vaxem™Hib When Administered According to the Prescribing Information in Korea|Completed||Phase 4|764|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:58:50.323673|2017-10-11 03:58:50.323673
NCT01404949|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2017-08-25|||July 2011||2011-07-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy|Phase II Study of Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy|Active, not recruiting||Phase 2|39|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 03:58:50.422683|2017-10-11 03:58:50.422683
NCT01404936|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-01-30|2012-12-21||July 1996||1996-07-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease|A Phase II Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) for Patients With Hodgkin's Disease|Completed||Phase 2|35|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 03:58:50.563459|2017-10-11 03:58:50.563459
NCT01404923|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-11-03|2014-10-14||December 2009||2009-12-01|November 2014|2014-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)|Assessment of On-demand MeteoSpasmyl® Use Effectiveness in Irritable Bowel Syndrome|Completed||Phase 4|436|Actual|Laboratoires Mayoly Spindler||2|||f||||f||||||||||2017-10-11 03:58:50.786839|2017-10-11 03:58:50.786839
NCT01404910|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-03-14|||May 2013||2013-05-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|RAAPID-II||Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery|Phase 1b Proof-of-Concept Study of Apheresis to Reduce Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) in Pregnant Women With Preeclampsia Using a Dextran Sulfate Adsorption (DSA) Column (LIPOSORBER® LA-15 System)|Completed||N/A|11|Actual|Massachusetts General Hospital||1|||f||||t|f|f||||||No||2017-10-11 03:58:51.246987|2017-10-11 03:58:51.246987
NCT01404897|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2015-03-25|||July 2011||2011-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals|Effects of a Modified Lower Carbohydrate, Higher Fat DASH Diet Plan on Plasma Lipids, Lipoprotein Particle Size, and Blood Pressure in Healthy Adults|Completed||N/A|36|Actual|Children's Hospital & Research Center Oakland||3|||f||||f||||||||||2017-10-11 03:58:51.353397|2017-10-11 03:58:51.353397
NCT01404884|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-05-19|||June 2011||2011-06-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|December 2015|Anticipated|2015-12-01||Interventional|SUPRACOR||SUPRACOR for Myopia and Myopic Astigmatism|A Prospective Study To Evaluate The Safety And Effectiveness Of The SUPRACOR Presbyopic Treatment Algorithm For Myopia And Myopic Astigmatism Using LASIK|Unknown status|Active, not recruiting|Phase 3|60|Anticipated|Technolas Perfect Vision GmbH||1|||f||||f||||||||||2017-10-11 03:58:51.482545|2017-10-11 03:58:51.482545
NCT01404871|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-06|2013-01-30|||April 2009||2009-04-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Predicting Medication Response in Obsessive Compulsive Disorder|Predicting Medication Response in Obsessive Compulsive Disorder|Completed||N/A|26|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 03:58:51.590302|2017-10-11 03:58:51.590302
NCT01404858|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2016-02-03|||September 2011||2011-09-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Observational|||The Impact of Lifestyle Behavior on in Vitro Fertilization (IVF) Outcome|The Impact of Lifestyle Behavior on in Vitro Fertilization (IVF) Outcome|Completed||N/A|12800|Actual|Boston IVF|||1||f||||f||||||||No||2017-10-11 03:58:51.694139|2017-10-11 03:58:51.694139
NCT01404845|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2015-06-23|||September 2011||2011-09-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation|Assessment of the Evolution of Macular Pigment Density in Two Distinct Populations, Before and After Supplementation With Nutrof Total Versus Dietary Supplement Without Lutein and Zeaxanthin, Using the Macular Pigment Module of Visucam 200 or Visucam 500 (Zeiss).|Completed||N/A|200|Actual|Affordance||2|||f||||f||||||||||2017-10-11 03:58:51.78889|2017-10-11 03:58:51.78889
NCT01404832|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2013-02-26|2013-02-26||October 2007||2007-10-01|February 2013|2013-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors|The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors|Terminated||Phase 4|102|Actual|Dallas VA Medical Center||1||Inadequate recruitment|f||||f||||||||||2017-10-11 03:58:51.896279|2017-10-11 03:58:51.896279
NCT01404819|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-03-26|||April 2012||2012-04-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Evaluation of Brain Damage Resulting From Carotid Endarterectomy With Xenon Anesthesia|Evaluation of Brain Damage Resulting From Carotid Endarterectomy With Xenon Anesthesia|Completed||N/A|86|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||||2017-10-11 03:58:52.081568|2017-10-11 03:58:52.081568
NCT01404806|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-07-03|||August 2011||2011-08-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||GSK1349572 Exposure in Blood, Cervicovaginal Fluid, and Cervical and Vaginal Tissue in Healthy Female Subjects|A Phase 1, Open Label, Study in Healthy Female Subjects to Describe GSK1349572 Exposure in Blood, Cervicovaginal Fluid, and Cervical and Vaginal Tissue Following Single and Multiple Dosing of GSK1349572|Completed||Phase 1|10|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 03:58:52.168138|2017-10-11 03:58:52.168138
NCT01404793|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2015-04-23|||September 2011||2011-09-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Observational|||SPME For Metabolomics And Concomitant Measurements Of Rocuronium Bromide Levels In Liver Transplantation|The Use Of Solid Phase Micro Extraction For Metabolomic Profiling And Concomitant Measurements Of Rocuronium Bromide Levels In Recipients Of Orthotopic Liver Transplantations|Completed||N/A|28|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 03:58:52.252059|2017-10-11 03:58:52.252059
NCT01404780|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-02-20|||June 2011||2011-06-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of the Glidescope and Macintosh Laryngoscope for Double Lumen Endotracheal Tube Intubation|Comparison of the Glidescope and Macintosh Laryngoscope for Double Lumen Endotracheal Tube Intubation|Completed||N/A|70|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 03:58:52.349806|2017-10-11 03:58:52.349806
NCT01404767|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2015-04-17|||April 2011||2011-04-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|April 2011|Actual|2011-04-01||Interventional|||Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol|Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol: A Study Comparing the Post Op Continuation of the Preoperative Oral Dose Beta Blockers to Intravenous Esmolol Titrated to a Target Heart Rate (HR)|Terminated||Phase 4|20|Actual|University Health Network, Toronto||2||"Enrollment slow over 2 years a change in the population less on metoprolol than initially   anticipated"|f||||t||||||||||2017-10-11 03:58:52.437907|2017-10-11 03:58:52.437907
NCT01404754|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-10-05|||October 2011||2011-10-01|March 2016|2016-03-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|MT-1||Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers|A Phase 1 Placebo-Controlled, Double-Blind Crossover Study to Assess Psychological Effects of MDMA When Administered to Healthy Volunteers|Enrolling by invitation||Phase 1|100|Anticipated|Multidisciplinary Association for Psychedelic Studies||2|||f||||f||||||||||2017-10-11 03:58:52.543196|2017-10-11 03:58:52.543196
NCT01404741|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-05-26|||July 2011|Actual|2011-07-01|May 2017|2017-05-01|May 2021|Anticipated|2021-05-01|May 2020|Anticipated|2020-05-01||Interventional|||5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)|Comparison Between 5-azacytidine Treatment and 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability|Active, not recruiting||Phase 2|191|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||Undecided||2017-10-11 03:58:52.646417|2017-10-11 03:58:52.646417
NCT01404728|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-04-27|||January 8, 2013|Actual|2013-01-08|April 2017|2017-04-01|March 1, 2017|Actual|2017-03-01|January 22, 2013|Actual|2013-01-22||Observational|||Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy|Prospective Longitudinal Evaluation of Vaginal Stenosis and Sexual Function in Women With Pelvic Malignancies Treated With and Without Pelvic Radiation Therapy|Completed||N/A|8|Actual|University of Colorado, Denver|||1||f||||t||||||||No||2017-10-11 03:58:52.773884|2017-10-11 03:58:52.773884
NCT01404715|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-04-09|||October 2011||2011-10-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Drug-drug Interaction Study With Metformin and Imatinib|Pharmacokinetic Interaction Between Metformin and Imatinib in Healthy Volunteers.|Completed||Phase 1|11|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:58:52.844729|2017-10-11 03:58:52.844729
NCT01404702|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-12-01|||August 2011||2011-08-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma|Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma: Assessment of Tolerability and In Vivo Expansion γδ T-Cells|Terminated||Phase 1|4|Actual|University of Alabama at Birmingham||1||Accrual slower than anticipated|f||||t||||||||||2017-10-11 03:58:52.946265|2017-10-11 03:58:52.946265
NCT01404689|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-24|2013-07-13|||August 2011||2011-08-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|DEMMER||Study to Determine if the Midazolam-Meperidine-Dexmedetomidine is Superior to the Midazolam-Meperidine for Sedation During ERCP|Midazolam With Meperidine and Dexmedetomidine vs Midazolam With Meperidine for Sedation During ERCP|Completed||Phase 4|110|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:58:53.061325|2017-10-11 03:58:53.061325
NCT01404676|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-22|2011-07-27|||June 2010||2010-06-01|July 2011|2011-07-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes|The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes|Unknown status|Recruiting|N/A|46|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 03:58:53.170266|2017-10-11 03:58:53.170266
NCT01404663|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-03-13|||October 2011||2011-10-01|August 2010|2010-08-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Side Effects of Bone Marrow Derived CD133 Transplantation in Cerebral Palsy|Evaluation the Side Effects of Bone Marrow Derived CD133 Cells Transplantation in Cerebral Palsy Patients|Completed||Phase 1|12|Actual|Royan Institute||1|||f||||t||||||||||2017-10-11 03:58:53.270244|2017-10-11 03:58:53.270244
NCT01404650|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-08-10|2016-05-13||December 2011||2011-12-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor|A Phase II Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor|Completed||Phase 2|25|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 03:58:53.379891|2017-10-11 03:58:53.379891
NCT01404637|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-07-30|||July 2011||2011-07-01|July 2011|2011-07-01|October 2013|Anticipated|2013-10-01|July 2013|Anticipated|2013-07-01||Interventional|||Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)|The Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic BPH|Unknown status|Not yet recruiting|N/A|150|Anticipated|Samsung Medical Center||2|||f||||||||||||||2017-10-11 03:58:53.778685|2017-10-11 03:58:53.778685
NCT01404624|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-07-27|||January 2005||2005-01-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|||||Observational|||Characterization of Transcriptional Regulators of Ghrelin Hormone Which Causes Genetic Obesity|Increased Density of Ghrelin-Expressing Cells in the Gastric Fundus and Body in Prader-Willi Syndrome|Completed||N/A|58|Actual|Samsung Medical Center|||1||f||||t||||||||||2017-10-11 03:58:53.849819|2017-10-11 03:58:53.849819
NCT01404611|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2017-10-03|2015-07-23||June 2011||2011-06-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients|A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Media With Tympanostomy Tubes (AOMT) in Pediatric Patients|Completed||Phase 3|331|Actual|Salvat||3|||f||||f||||||||||2017-10-11 03:58:53.912675|2017-10-11 03:58:53.912675
NCT01404598|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-08-10|||January 2010||2010-01-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male|A Phase 1 Study to Assess the Pharmacokinetics of Nitrates and Gamma-Hydroxybutyric Acid (GHB) After Oral Administration of Therapeutic and Supratherapeutic Doses of Naproxcinod in Healthy Male Subjects|Completed||Phase 1|24|Actual|NicOx||3|||f||||f||||||||||2017-10-11 03:58:54.385949|2017-10-11 03:58:54.385949
NCT01404585|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-09-23||2015-09-23|September 2011||2011-09-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|RA||Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BMS-817399 in Adults With Active, Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate|Completed||Phase 2|123|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-10-11 03:58:54.475516|2017-10-11 03:58:54.475516
NCT01404572|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2013-05-03|2013-03-13||August 2011||2011-08-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects|Randomized, Double Blind, Crossover Taste Assessment Study of Two Atazanavir Powder Formulations As Compared to a Reference Atazanavir Powder Formulation in Healthy Subjects|Completed||Phase 1|12|Actual|Bristol-Myers Squibb|This was a taste assessment only; participants did not swallow any treatment blends.|3|||f||||f||||||||||2017-10-11 03:58:54.655275|2017-10-11 03:58:54.655275
NCT01404559|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-12-04|2014-11-17||July 2012||2012-07-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Measures of Gait Efficiency of Three Multi-Axial, Vertical Shock and Energy Storing-Return Prosthetic Feet During Simple & Complex Mobility Activities|Metabolic and Biomechanical Measures of Gait Efficiency of Three Multi-Axial, Vertical Shock and Energy Storing-Return Prosthetic Feet During Simple & Complex Mobility Activities|Completed||N/A|28|Actual|University of South Florida||4|||f||||t||||||||||2017-10-11 03:58:55.142266|2017-10-11 03:58:55.142266
NCT01404546|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2015-03-10|||August 2008||2008-08-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients|A Randomized Controlled Pilot Study of Standardized Counselling and Cost-free Pharmacotherapy for Smoking Cessation Among Stroke and TIA Patients|Completed||N/A|28|Actual|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-10-11 03:58:55.415676|2017-10-11 03:58:55.415676
NCT01404533|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2016-01-05|||November 2009||2009-11-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|NTBIwomen||Iron Interventions and Non-transferrin-bound Iron (NTBI) in Women|The Influence of Iron Interventions on Formation of Non-transferrin-bound Iron (NTBI) in Women|Completed||N/A|32|Actual|Swiss Federal Institute of Technology||3|||f||||f||||||||||2017-10-11 03:58:55.490673|2017-10-11 03:58:55.490673
NCT01404520|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2015-11-30|||June 2011||2011-06-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|PACE-AL||Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)|Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) Health Promoting Rehabilitation. A Multimodal Exercise-based Intervention in Patients With Acute Leukaemia Undergoing Re-induction or Consolidation Chemotherapy|Completed||N/A|70|Actual|Universitetshospitalernes Center for Sygepleje||2|||f||||t||||||||||2017-10-11 03:58:55.569826|2017-10-11 03:58:55.569826
NCT01404507|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-01-14|||December 2010||2010-12-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|ICAT||Efficacy of Combination of IntraCoronary Bolus Abciximab and Aspiration Thrombectomy in STEMI|Efficacy of Combination of IntraCoronary Bolus Abciximab and Aspiration Thrombectomy in Patients With Acute ST-segment Elevation Myocardial Infarction; ICAT Trial|Completed||Phase 4|40|Actual|Yonsei University||3|||f||||t||||||||||2017-10-11 03:58:55.658961|2017-10-11 03:58:55.658961
NCT01404494|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2017-06-30|||April 5, 2011||2011-04-05|February 6, 2015|2015-02-06|February 6, 2015||2015-02-06|||||Observational|||Testing Devices That Involve the Sense of Touch in Subjects With Traumatic Brain Injury|Testing Subjects With Traumatic Brain Injury Using Haptic Technology|Completed||N/A|19|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 03:58:55.746467|2017-10-11 03:58:55.746467
NCT01404481|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-07-22|||March 2010||2010-03-01|July 2015|2015-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|SURE||Clean Intermittant Self Catheterisation: A Trial Comparing Single Use vs Reuse of Nelaton Catheters|Clean Intermittant Self Catheterisation: A Randomised Control Trial Comparing Single Use vs Reuse of Nelaton Catheters|Completed||N/A|23|Actual|St George Hospital, Australia|||2||f||||f||||||||||2017-10-11 03:58:55.818446|2017-10-11 03:58:55.818446
NCT01404468|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-27|||March 2006||2006-03-01|March 2011|2011-03-01|October 2010|Actual|2010-10-01|September 2008|Actual|2008-09-01||Interventional|||The Phonophoresis of Lidocaine Gel and Its Effect on Sensory Blockage|Effect of Lidocaine Phonophoresis on Sensory Blockade: Pulsed or Continuous Mode of Therapeutic Ultrasound?|Completed||Early Phase 1|93|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-10-11 03:58:55.90233|2017-10-11 03:58:55.90233
NCT01404455|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2012-01-16|||December 2010||2010-12-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Wide Pulse Pressure on the Predictability of Stroke Volume Variation for Fluid Responsiveness in Patients Undergoing Off-pump Coronary Artery Bypass Graft||Completed||N/A|66|Actual|Severance Hospital||2|||f||||||||||||||2017-10-11 03:58:55.996111|2017-10-11 03:58:55.996111
NCT01404442|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-05-16|||May 2011||2011-05-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Evaluation of the Analgesic Effect of Midazolam and Ketamine as an Additive to Intrathecal Bupivacaine in Patients Undergoing Cesarean Section||Completed||Phase 1/Phase 2|90|Actual|Qazvin University Of Medical Sciences||3|||f||||t||||||||||2017-10-11 03:58:56.06728|2017-10-11 03:58:56.06728
NCT01404429|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-09-05|2014-08-09||May 2011||2011-05-01|September 2014|2014-09-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|DMIRA||Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid Arthritis|Randomized Controlled Trial of Two Different Starting Doses of Methotrexate in Rheumatoid Arthritis|Completed||Phase 4|100|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-10-11 03:58:56.171982|2017-10-11 03:58:56.171982
NCT01404416|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2015-06-04|||May 2011||2011-05-01|June 2015|2015-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Effect of Antenatal Iron-contained Multiple Micronutrient Supplementation, Cesarean Delivery, and CDMR on Child Health|Effect of Antenatal Iron-contained Multiple Micronutrient Supplementation, Cesarean Delivery, and CDMR on Child Health- A Post-trial Follow-up Chinese Study|Completed||N/A|17000|Actual|Peking University|||1||f||||t||||||||||2017-10-11 03:58:56.487904|2017-10-11 03:58:56.487904
NCT01404403|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-11-04|||August 2011||2011-08-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety Study of the Rapid System for Acute Ischemic Stroke||Completed||Phase 1|12|Actual|Rapid Medical||1|||f||||||||||||||2017-10-11 03:58:56.559572|2017-10-11 03:58:56.559572
NCT01404390|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2014-07-14|||August 2011||2011-08-01|July 2014|2014-07-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||Japanese BAY80-6946 Monotherapy Phase I Study|An Open Label, Single Centre, Phase I Study of PI3K Inhibitor BAY80-6946 to Evaluate the Safety, Tolerability and Pharmacokinetics in Japanese Patients With Advanced or Refractory Solid Tumours|Completed||Phase 1|10|Actual|Bayer||2|||f||||f||||||||||2017-10-11 03:58:56.628941|2017-10-11 03:58:56.628941
NCT01404377|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-11|2011-07-27|||January 2006||2006-01-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Wound Infiltration and Breast Cancer Surgery|Double Blind Randomized Trial of Wound Infiltration With Ropivacaine After Breast Cancer Surgery|Completed||Phase 4|50|Actual|Tenon Hospital, Paris||2|||f||||f||||||||||2017-10-11 03:58:56.713649|2017-10-11 03:58:56.713649
NCT01404364|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-27|||January 2010||2010-01-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye|Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye|Completed||N/A|36|Actual|Hospital Governador Celso Ramos||2|||f||||f||||||||||2017-10-11 03:58:56.79765|2017-10-11 03:58:56.79765
NCT01404351|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-01-03|||May 2011||2011-05-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Use of the PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction|A Prospective, Randomized, Controlled Superiority Study to Evaluate Use of the PEAK PlasmaBlade® 4.0 in Bilateral Breast Reduction|Withdrawn||N/A|0|Actual|Medtronic Surgical Technologies||2||Study terminated due to the acquisition of PEAK Surgical by Medtronic|f||||f||||||||||2017-10-11 03:58:56.884427|2017-10-11 03:58:56.884427
NCT01404338|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-27|||June 2011||2011-06-01|July 2011|2011-07-01||||||||Interventional|Tachyphylaxis||Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis|An Investigator-Initiated, Double-Blind, Vehicle-Controlled Study: Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis|Completed||Phase 1|10|Actual|Patel, Rita Vikram, M.D.||2|||f||||f||||||||||2017-10-11 03:58:56.958887|2017-10-11 03:58:56.958887
NCT01404325|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-04-20|||February 1, 2012|Actual|2012-02-01|April 2017|2017-04-01|January 5, 2017|Actual|2017-01-05|January 5, 2017|Actual|2017-01-05||Interventional|4EVERLUNG||Efficacy of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients|A 2-arm, Prospective, Randomized, Controlled, Open-label, 12 Month Phase III Trial to Evaluate the Efficacy of Everolimus in Combination With a Centre Specific Standard Immunosuppressive Regimen Consisting of CNI, MPA and Steroids Versus a Standard Triple Immunosuppressive Regimen in Lung Transplant Recipients|Completed||Phase 3|131|Actual|Novartis||2|||f||||t|f|f||||||Undecided|Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations. This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com.|2017-10-11 03:58:57.030177|2017-10-11 03:58:57.030177
NCT01404312|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-12-12|||May 2012||2012-05-01|December 2016|2016-12-01||||November 2017|Anticipated|2017-11-01||Interventional|||Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection|Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection|Active, not recruiting||Phase 3|3000|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 03:58:57.134525|2017-10-11 03:58:57.134525
NCT01404299|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-27|2012-01-10|||August 2011||2011-08-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Effects of a Nutritional Supplementation on the Functional Status of Frail Elders With Low Socioeconomic Status (SES)|Effects of a Protein-Energy Nutritional Supplementation on the Functional Status of Frail Older Adults With Low Socioeconomic Status: A Community-based Randomized Trial|Completed||N/A|87|Actual|Gangbuk-gu Community Health Center||2|||f||||t||||||||||2017-10-11 03:58:57.308148|2017-10-11 03:58:57.308148
NCT01404286|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-07-27|||January 2008||2008-01-01|January 2008|2008-01-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|||Resistance Training and Sleep in the Elderly|The Effects of a Session of Resistance Training on Sleep Patterns in the Elderly|Completed||N/A|40|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 03:58:57.377112|2017-10-11 03:58:57.377112
NCT01404273|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-07-29|||September 2009||2009-09-01|July 2013|2013-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ADHD||Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder|Functional MRI of an Open Trial of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder|Completed||N/A|12|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 03:58:57.455274|2017-10-11 03:58:57.455274
NCT01404260|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-12-04|2016-08-09||June 2011||2011-06-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|March 2015|Actual|2015-03-01||Interventional|ISCAN||Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer|Intercalating and Maintenance Use of Iressa vs. Chemotherapy in Selected Advanced NSCLC: a Randomised Study|Completed||Phase 3|219|Actual|Guangdong Association of Clinical Trials||2|||f||||t||||||||Yes||2017-10-11 03:58:57.521298|2017-10-11 03:58:57.521298
NCT01404247|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-07-10|||January 2011||2011-01-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|OCT||Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates|Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates|Completed||Phase 1|20|Actual|Los Angeles Biomedical Research Institute||1|||f||||t||||||||||2017-10-11 03:58:58.598566|2017-10-11 03:58:58.598566
NCT01404234|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-05-12|2014-03-31||December 2011||2011-12-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|PALS|The safety analysis set included all participants who received at least 1 dose of study drug.|Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways|Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa (PA) in the Lower Airways|Completed||Phase 3|61|Actual|Gilead Sciences||1|||f||||t||||||||||2017-10-11 03:58:58.716117|2017-10-11 03:58:58.716117
NCT01404221|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2015-04-13|||March 2009||2009-03-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications|The Combination of Biochemical Markers and Two and Three Dimensional Ultrasound Using Geometric Morphometrics in the Identification of Congenital Anomalies and Maternal or Fetal Complications|Terminated||N/A|350|Actual|Northwell Health|||1|No safety issues. Need to rewrite protocol|f||||t||||||||||2017-10-11 03:58:59.528668|2017-10-11 03:58:59.528668
NCT01404208|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-02-24|2016-09-30||July 2011||2011-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|September 2015|Actual|2015-09-01||Interventional||206 subjects were initially enrolled at MGH and USF. Of those, 32 were considered screen fails and 32 were not randomized either because they did not meet inclusion or exclusion criteria at randomization or because they withdrew consent or dropped out. Thus, 142 participants were randomized.|2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD|2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD|Completed||N/A|206|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:58:59.623544|2017-10-11 03:58:59.623544
NCT01404195|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2016-02-04|||January 2012||2012-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|HIPERPROT||Hyperprotein Nutritional Intervention in Elderly Patients With Hip Fracture and Sarcopenia|High-protein Nutritional Intervention Based on β-hydroxy-β-methylbutirate, Vitamin D3 and Calcium on Obese and Lean Aged Patients With Hip Fractures and Sarcopenia. The HIPERPROT-GER Study.|Completed||N/A|110|Actual|Hospital Viamed Valvanera, Spain||2|||f||||t||||||||||2017-10-11 03:59:00.171261|2017-10-11 03:59:00.171261
NCT01404182|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2012-05-18|||July 2011||2011-07-01|May 2012|2012-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons|Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine (Trivalent, Seasonal, Active Ingredient Content: 15 μg HA/Strain/0.5 mL) in Adults and Elderly Persons|Completed||Phase 4|121|Actual|Fluart Innovative Vaccine Ltd, Hungary||1|||f||||f||||||||||2017-10-11 03:59:00.27381|2017-10-11 03:59:00.27381
NCT01404169|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-03-07|||September 2011|Actual|2011-09-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease|A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease|Completed||Phase 3|260|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 03:59:00.409899|2017-10-11 03:59:00.409899
NCT01404156|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-04-03|||September 2015||2015-09-01|April 2017|2017-04-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|POWERRANGER||Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma|PreOperative Treatment With chEmotheRapy or chemoRAdiatioN in esophaGeal or gastroEsophageal adenocaRcinoma|Recruiting||Phase 2/Phase 3|60|Anticipated|CancerCare Manitoba||2|||f||||t||||||||||2017-10-11 03:59:00.561736|2017-10-11 03:59:00.561736
NCT01404143|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-09-26|||August 2011||2011-08-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||Comparison of Two Methods of Subscapularis Management in Shoulder Arthroplasty: Tenotomy Versus Peel|Comparison of Two Methods of Subscapularis Management in Shoulder Arthroplasty: Tenotomy Versus Peel: A Multicenter, Randomized Controlled|Completed||N/A|100|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 03:59:00.65897|2017-10-11 03:59:00.65897
NCT01404130|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-26|||September 2008||2008-09-01|July 2011|2011-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory|A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory|Completed||Phase 4|18|Actual|University of Aberdeen||1|||f||||f||||||||||2017-10-11 03:59:00.732493|2017-10-11 03:59:00.732493
NCT01404117|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-08-26|||March 2012||2012-03-01|August 2013|2013-08-01|January 2014|Anticipated|2014-01-01|December 2013|Anticipated|2013-12-01||Interventional|||A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability||Withdrawn||Phase 2|0|Actual|Teva Pharmaceutical Industries||3||Study is being redesigned|f||||||||||||||2017-10-11 03:59:00.83224|2017-10-11 03:59:00.83224
NCT01404104|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-07-26|||September 2008||2008-09-01|July 2016|2016-07-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma|A Pilot Study of Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma Undergoing Definitive Therapy With Radical Nephrectomy, or Cytoreductive Nephrectomy: Analysis if Serum and Tissue Biomarkers|Completed||N/A|11|Actual|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||||2017-10-11 03:59:00.910852|2017-10-11 03:59:00.910852
NCT01402778|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-12|2011-12-19|||January 2011||2011-01-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|TDPAFD||Fixation of Thoracic Epidurals Influencing Catheter-related Infections and Dislocation|Fixation of Thoracic Epidural Catheters Influencing Catheter-related Infections and Dislocation|Completed||N/A|140|Actual|Heinrich-Heine University, Duesseldorf|||2||f||||f||||||||||2017-10-11 03:59:22.08601|2017-10-11 03:59:22.08601
NCT01404091|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-02-01|||July 2011||2011-07-01|February 2017|2017-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects|Assessment of Nociceptin/Orphanin FQ Peptide Receptor Occupancy After Single Oral Doses of LY2940094 as Measured by Positron Emission Tomography With the Radioligand LY2959530 in Healthy Subjects|Completed||Phase 1|12|Actual|BlackThorn Therapeutics, Inc.||4|||f||||f||||||||||2017-10-11 03:59:00.99298|2017-10-11 03:59:00.99298
NCT01404078|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-24|2014-11-26|2014-05-19||April 2010||2010-04-01|November 2014|2014-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|TIPSK||Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium|A RCT With Factorial Design to Compare Safety and Efficacy of 2 Capsules of the Indian Polycap Versus a Single Capsule Along With or Without Oral Potassium Among Patients With Stable Cardiovascular Disease|Completed||N/A|518|Actual|St. John's Research Institute||2|||f||||t||||||||||2017-10-11 03:59:01.068825|2017-10-11 03:59:01.068825
NCT01404065|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-03-17|||December 2010||2010-12-01|March 2017|2017-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Transcranial Direct Current Stimulation (tDCS) and Visual Illusion on Chronic Pain Due to Spinal Cord Injury|Investigation of the Mechanisms of Transcranial Direct Current Stimulation of Motor Cortex Coupled With Visual Illusion for the Treatment of Chronic Pain in Spinal Cord Injury|Terminated||N/A|23|Actual|Spaulding Rehabilitation Hospital||3||Recruitment difficulties and stopped funding|f||||f||f||||||||2017-10-11 03:59:01.838832|2017-10-11 03:59:01.838832
NCT01404052|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-03-17|||January 2011||2011-01-01|March 2017|2017-03-01|July 30, 2014|Actual|2014-07-30|July 30, 2014|Actual|2014-07-30||Interventional|||Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound on Osteoarthritis Pain of the Knee|Effects of Transcranial Direct Current Stimulation and Transcranial Ultrasound on the Perception of Pain Due to Osteoarthritis of the Knee|Completed||N/A|38|Actual|Spaulding Rehabilitation Hospital||2|||f||||f|f|f||||||||2017-10-11 03:59:01.95408|2017-10-11 03:59:01.95408
NCT01404039|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-03-14|2015-04-07||September 2010||2010-09-01|March 2017|2017-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Investigating Motor Cortex Processing for Pain Modulation|Investigating Motor Cortex Processing for Pain Modulation|Terminated||Phase 1|115|Actual|Spaulding Rehabilitation Hospital||13||Study was halted due to lack of funding.|f||||f||||||||||2017-10-11 03:59:02.054081|2017-10-11 03:59:02.054081
NCT01404026|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-03-17|||June 2011||2011-06-01|March 2017|2017-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury|Cortical Modulation With Transcranial Direct Current Stimulation (tDCS) for Neuropathic Symptoms Following Burn Injury.|Completed||N/A|3|Actual|Spaulding Rehabilitation Hospital||2|||f||||f|f|f||||||||2017-10-11 03:59:02.751319|2017-10-11 03:59:02.751319
NCT01403987|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2012-09-30|2012-07-09||January 2011||2011-01-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Improving Performance of Paracentesis in Medical Residency Training|Improving Performance of Paracentesis in Medical Residency Training|Completed||N/A|136|Actual|Boston Medical Center|Large number of participants lost to analysis because they forgot their secret personal ID number. The IRB had required we not have a way to link surveys to particular residents, and so lost power with loss of many residents.|3|||f||||f||||||||||2017-10-11 03:59:03.069842|2017-10-11 03:59:03.069842
NCT01403974|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-01-06|||July 2011||2011-07-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||Phase I Trial of BI 836845 for Various Solid Cancer|A Phase I Dose Escalation Trial of Weekly Intravenous Administrations of BI 836845 in Patients With Advanced Solid Cancers With Repeated Administrations in Patients Showing Clinical Benefit|Completed||Phase 1|61|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 03:59:03.46199|2017-10-11 03:59:03.46199
NCT01403961|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-11-09|||July 2011||2011-07-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|HbA1c||Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2|Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2 (HbA1c)|Recruiting||N/A|1760|Anticipated|Hospital Italiano de Buenos Aires|||2||f||||t||||||||No||2017-10-11 03:59:03.545823|2017-10-11 03:59:03.545823
NCT01403948|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-10-03|||August 1, 2011|Actual|2011-08-01|October 2017|2017-10-01|January 22, 2018|Anticipated|2018-01-22|December 4, 2017|Anticipated|2017-12-04||Interventional|||BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)|A Phase I, Open-Label, Dose-Escalation Trial With BI 836826 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma of B Cell Origin|Recruiting||Phase 1|53|Anticipated|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 03:59:03.633605|2017-10-11 03:59:03.633605
NCT01403935|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2015-03-19|||December 2007||2007-12-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|SIR||Sepsis Institutional Registry in Hospital Italiano de Buenos Aires|Sepsis Institutional Registry in Hospital Italiano de Buenos Aires|Completed||N/A|7472|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 03:59:03.70716|2017-10-11 03:59:03.70716
NCT01403922|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2012-10-01|||August 2011||2011-08-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension|A Phase I Randomised, Placebo-Controlled, Double-Blind Study in Hypertensive Patients of the Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors)|Terminated||Phase 1|80|Actual|AstraZeneca||4||Sponsor's decision to terminate|f||||||||||||||2017-10-11 03:59:03.765318|2017-10-11 03:59:03.765318
NCT01403909|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2015-03-24|||November 2014||2014-11-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|November 2015|Anticipated|2015-11-01||Interventional|||Effect of Pneumatic Intermittent Venous Compression on Fluid Volumes Infused During Major Abdominal Surgery|Effect of Pneumatic Intermittent Venous Compression on Fluid Volumes Infused During Major Abdominal Surgery in Non-obese American Soceity of Anesthesiologists (ASA) 1-3 Patients|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes||2||We need somebody to replace the principal inestigator.|f||||t||||||||||2017-10-11 03:59:03.851993|2017-10-11 03:59:03.851993
NCT01403896|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-07-31|||April 2012|Actual|2012-04-01|July 2017|2017-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor|A Pilot Study To Design a Clinical Trial That Will Compare the Ability of Plerixafor Alone Versus Plerixafor Plus G-CSF To Generate a Bone Marrow Versus Blood Transplant Product In Normal Healthy Adults|Completed||Phase 2|10|Actual|Nova Scotia Health Authority||2|||f||||f|f|f||||||||2017-10-11 03:59:03.922709|2017-10-11 03:59:03.922709
NCT01403883|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-30|2015-01-15|||October 2011||2011-10-01|January 2015|2015-01-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|PROSPER||Psychological and Enterostomal Therapy Care|Impact of Psychological and Enterostomal Therapy Care for Patient Undergoing Rectal Cancer Resection With a Temporary Stoma. Monocentric Randomized Study|Unknown status|Recruiting|N/A|50|Anticipated|Association de Recherche Experimentale et Clinique en Chirurgie Digestive||2|||f||||f||||||||||2017-10-11 03:59:05.573854|2017-10-11 03:59:05.573854
NCT01403870|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-11-17|||April 2011||2011-04-01|November 2011|2011-11-01||||||||Observational|||Post Market Study of the Electrophysiological Course of Low Back Pain Using CERSR Technology|Post Market Study of the Electrophysiological Course of Low Back Pain Using CERSR Technology|Terminated||N/A|6|Actual|Verium Diagnostics, Inc.|||1|Company no longer has funding for the study.|f||||f||||||||||2017-10-11 03:59:05.667873|2017-10-11 03:59:05.667873
NCT01403857|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-04-21|||April 2010||2010-04-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|FL75||Evaluating Liking, Acceptability and Health Benefits of Grain Products|Evaluating Liking, Acceptability and Health Benefits of Grain Products|Completed||N/A|45|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 03:59:05.740855|2017-10-11 03:59:05.740855
NCT01403844|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-09-22|||June 2011|Actual|2011-06-01|September 2017|2017-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Carotenoid Response to the Intake of Vegetables and Fruits|Skin Carotenoid Response to Intake of Vegetables and Fruits Recommended by the Dietary Guidelines|Completed||N/A|29|Actual|USDA Grand Forks Human Nutrition Research Center||1|||f||||t||||||||||2017-10-11 03:59:05.81091|2017-10-11 03:59:05.81091
NCT01403831|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-06-18|||July 2011||2011-07-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|TExT-MED||Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes|Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes|Completed||N/A|200|Anticipated|University of Southern California||2|||f||||t||||||||||2017-10-11 03:59:05.888226|2017-10-11 03:59:05.888226
NCT01403818|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-10-10|||June 2011||2011-06-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration|Pharmacokinetic Study of ASP1941 -A Pharmacokinetic Study to Assess Drug-Drug Interaction Between ASP1941 and Mitiglinide Calcium Hydrate|Completed||Phase 1|60|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 03:59:05.954041|2017-10-11 03:59:05.954041
NCT01403805|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2012-04-29|2011-08-02||November 2009||2009-11-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Effects of the Oral Care With Vaccines for Pneumonia in Elderly; Going Home Together Both Physician and Dentist|The Interventional Study in the Effects of Oral Care With Vaccines at Nursing Home; the Role of the Partnership With Physician, Dentist and Other Co-medical Stuff|Completed||N/A|199|Actual|Yubari Kibounomori|small numbers of subjects analyzed|2|||f||||t||||||||||2017-10-11 03:59:06.055368|2017-10-11 03:59:06.055368
NCT01403792|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-12-21|||June 2011||2011-06-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects|A Double-Blind, Placebo-Controlled, Randomised, Dose-Escalation Phase I Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects|Completed||Phase 1|11|Actual|University of Surrey||4|||f||||f||||||||||2017-10-11 03:59:06.411527|2017-10-11 03:59:06.411527
NCT01403779|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-29|2015-12-29|||July 2010||2010-07-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Interventional|KOSIMA||Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer|Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated Intensity Modulated Radiotherapy (IMRT) in Treatment of Breast Cancer: The KOSIMA Trial|Recruiting||Phase 3|226|Anticipated|Universitätsmedizin Mannheim||2|||f||||f||||||||||2017-10-11 03:59:06.605922|2017-10-11 03:59:06.605922
NCT01403766|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-26|||August 2011||2011-08-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Comparison of Markers of Kidney Function|Comparison of Estimated GFR Using Cystatin C Versus Creatinine in Pediatric Renal Transplant Patients|Unknown status|Not yet recruiting|N/A|70|Anticipated|University of California, Los Angeles|||1||f||||f||||||||||2017-10-11 03:59:06.709607|2017-10-11 03:59:06.709607
NCT01403753|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-08-12|||August 2008||2008-08-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Children's Familiarity With Snack Foods Changes Expectations About Fullness|Children's Familiarity With Snack Foods Changes Expectations About Fullness|Completed||N/A|70|Actual|University of Bristol|||1||f||||f||||||||||2017-10-11 03:59:06.796002|2017-10-11 03:59:06.796002
NCT01403740|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-07-26|||September 2011||2011-09-01|June 2011|2011-06-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|EHEM||Turkish Acquired Haemophilia Registry|Observational Acquired Haemophilia Registry|Unknown status|Not yet recruiting|N/A|250|Anticipated|Turkish Society of Hematology|||1||f||||f||||||Samples Without DNA|"     Blood sample for coagulation factor determination   "|||2017-10-11 03:59:06.873413|2017-10-11 03:59:06.873413
NCT01403727|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2013-05-28|||November 2011||2011-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Observational|||Electromagnetic Tracking of Devices During Biopsy Procedures|Electromagnetic Tracking of Devices During Biopsy Procedures|Completed||N/A|50|Actual|Philips Healthcare|||2||f||||f||||||||||2017-10-11 03:59:06.990378|2017-10-11 03:59:06.990378
NCT01403714|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-03-29|||June 2011||2011-06-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|STRETCH||Study of Percutaneous Renal Artery Intervention for Patient With Heart Failure|A Randomized Trial of Percutaneous Renal Intervention With Stenting for Patients With Heart Failure and Hemodynamically Significant Renal Artery Stenosis|Withdrawn||N/A|0|Actual|University of Pennsylvania||2||Inability to recruit eligible subjects|f||||f||||||||||2017-10-11 03:59:07.078028|2017-10-11 03:59:07.078028
NCT01403701|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-02-17|||July 2009||2009-07-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|PT and QOL||Physical Therapy on Quality of Life and Function Following Vaginal Surgery Reconstructive Surgery|Effects of Physical Therapy on Quality of Life and Function Following Vaginal Reconstructive Surgery; a Randomized Trial|Completed||N/A|49|Actual|TriHealth Inc.||2|||f||||f||||||||||2017-10-11 03:59:07.164201|2017-10-11 03:59:07.164201
NCT01403688|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2014-09-16|||June 2011||2011-06-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin|Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin in Women at High Risk for Breast Cancer|Completed||N/A|9|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-11 03:59:07.249229|2017-10-11 03:59:07.249229
NCT01403675|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2014-12-02|||May 2009||2009-05-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Human Ovarian Autotransplantation|Human Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer|Completed||N/A|1|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-11 03:59:07.330599|2017-10-11 03:59:07.330599
NCT01403662|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-12-15|||July 2011||2011-07-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression|A Pilot, Open-label, 8-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Minocycline for the Treatment of Bipolar Depression|Completed||Phase 3|29|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 03:59:07.40932|2017-10-11 03:59:07.40932
NCT01403649|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-05-29|||August 2009||2009-08-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|CollabFlu||Collaborative Efforts to Increase Flu Vaccination|Strategies to Vaccinate All Children for Influenza in a Practice Setting|Completed||N/A|117175|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 03:59:07.512299|2017-10-11 03:59:07.512299
NCT01403636|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-02-17||2016-02-17|October 2011||2011-10-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia|A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma|Completed||Phase 2|167|Actual|Sanofi||4|||f||||t||||||||||2017-10-11 03:59:07.648038|2017-10-11 03:59:07.648038
NCT01403623|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-08-19|||August 2011||2011-08-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Evaluate the Use of Plastic Bags in Preventing and Treating Hypothermia in Neonates|A Randomized Trial to Evaluate the Use of Plastic Bags in Preventing and Treating Hypothermia in Neonates in Developing Countries|Completed||Phase 4|106|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 03:59:07.775265|2017-10-11 03:59:07.775265
NCT01403610|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2017-01-24||2017-01-24|June 2011||2011-06-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab|A Phase 2, Investigator Initiated Study to Determine the Safety, Efficacy and CNS Penetration of TH-302 in Recurrent High Grade Astrocytoma Following Bevacizumab|Completed||Phase 2|29|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||f||||||||||2017-10-11 03:59:07.868265|2017-10-11 03:59:07.868265
NCT01403597|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-11-28|||January 2011||2011-01-01|November 2014|2014-11-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Evaluation of Non-ablative and Fractional Combination Treatment for Improvement in Skin's Appearance|Clinical Evaluation of the Impact of Non-ablative and Fractional Ablative Combination Treatment: a Prospective, Open Label, Single Group With Before-after Study Design|Completed||N/A|9|Actual|Syneron Medical||1|||f||||f||||||||||2017-10-11 03:59:07.95388|2017-10-11 03:59:07.95388
NCT01403571|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-10-04|||October 2009||2009-10-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|LOSS||Effectiveness and Safety of Salba on Weight Loss in Overweight Individuals With Type 2 Diabetes|Efficacy and Safety of Whole Grain Salba (Salvia Hispanica L.) on Weight Loss in Overweight and Obese Individuals With Type 2 Diabetes|Completed||Phase 2|77|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 03:59:08.064573|2017-10-11 03:59:08.064573
NCT01403558|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-05-09|||September 2011||2011-09-01|May 2017|2017-05-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|PSYMO||Personality and Eating Behaviors in Morbidly Obese Patients|Personality and Eating Behaviors in Morbidly Obese Patients|Active, not recruiting||N/A|102|Actual|Sykehuset i Vestfold HF||3|||f||||f||||||||||2017-10-11 03:59:08.255729|2017-10-11 03:59:08.255729
NCT01403545|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-05-23|||August 2011||2011-08-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Evaluation of Liposomal Curcumin in Healthy Volunteers|Safety, Tolerability and Pharmacokinetics of Liposomal Curcumin in Healthy Volunteers - A Phase I Dose Escalation Study|Completed||Phase 1|50|Actual|SignPath Pharma, Inc.||2|||f||||t||||||||||2017-10-11 03:59:08.33711|2017-10-11 03:59:08.33711
NCT01403532|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-01|2014-02-10|||September 2009||2009-09-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Sequential Therapy for Hypogonadotropic Hypogonadism|Efficacy and Safety of Human Chorionic Gonadotropin (HCG) and Follicle Stimulating Hormone (FSH) in the Treatment of Hypogonadotropic Hypogonadism|Completed||Phase 4|100|Actual|Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||||2017-10-11 03:59:08.422116|2017-10-11 03:59:08.422116
NCT01402206|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-08-15|||March 2010||2010-03-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Management of Depression in Primary Care|Management of Depression in Primary Health Care: a Controlled Trial on the Effectiveness of Regular, Structured, Patient-centered Visits|Completed||N/A|258|Actual|Göteborg University||2|||f||||f||||||||||2017-10-11 03:59:29.194806|2017-10-11 03:59:29.194806
NCT01403519|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-26|||July 2011||2011-07-01|July 2011|2011-07-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized|Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized|Unknown status|Not yet recruiting|N/A|70|Anticipated|Rambam Health Care Campus|||3||f||||f||||||Samples Without DNA|"     Blood and CSF   "|||2017-10-11 03:59:08.514449|2017-10-11 03:59:08.514449
NCT01403506|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-26|||April 2011||2011-04-01|January 2011|2011-01-01|November 2012|Anticipated|2012-11-01|April 2012|Anticipated|2012-04-01||Interventional|||Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)|Phase 3 Study of N-acetyl Cysteine as an Antioxidant and Glutathione Synthesis Inducer on Biomarkers of Delayed Renal Graft Function Including NGAL and IL-18|Unknown status|Recruiting|Phase 3|60|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-10-11 03:59:08.612129|2017-10-11 03:59:08.612129
NCT01403493|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-08-09|||August 2007||2007-08-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Multidisciplinary Versus a Nurse Based Patient Education For Patients With Irritable Bowel Syndrome|A Comparison of a Short Nurse Based and a Long Multidisciplinary Version of Structured Patient Education in Irritable Bowel Syndrome.|Completed||N/A|80|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-11 03:59:08.721776|2017-10-11 03:59:08.721776
NCT01403480|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2011-07-26|||January 2008||2008-01-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Observational|||Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions|Rates of Positive BCCs in Re-excisions|Completed||N/A|600|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 03:59:08.821493|2017-10-11 03:59:08.821493
NCT01403467|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-26|||April 2009||2009-04-01|December 2010|2010-12-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation|Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation|Completed||Phase 4|86|Actual|Ramathibodi Hospital||1|||f||||t||||||||||2017-10-11 03:59:08.894523|2017-10-11 03:59:08.894523
NCT01403454|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-04-18|||March 2012||2012-03-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|WISHED||Web-based Interactive Health Communication Application (IHCA) for Successful Home Dialysis|Web-based IHCA for Successful Home Dialysis|Recruiting||N/A|152|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||t||||||||||2017-10-11 03:59:09.002872|2017-10-11 03:59:09.002872
NCT01403441|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-08-03|2016-10-10||July 2010||2010-07-01|August 2017|2017-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Treatment Resistant Depression|Radiosurgical Neuromodulation for Refractory Depression|Radiosurgical Neuromodulation for Refractory Depression|Terminated||N/A|3|Actual|Stanford University||1||Potential AE|f||||t||||||||||2017-10-11 03:59:09.121008|2017-10-11 03:59:09.121008
NCT01403428|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-12-11|||June 2011||2011-06-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Non Invasive Positive Pressure Ventilation in Status Asthmaticus|Effect Of Early Initiation Of Noninvasive Positive Pressure Ventilation On ICU Length Of Stay In Children With Status Asthmaticus, A Prospective Randomized Trial|Withdrawn||Phase 2|0|Actual|Southern Illinois University||2||"In a pilot of early noninvasive positive pressure ventilation, the children did so well that   early NPPV is now used in all children who meet criteria."|f||||t||||||||||2017-10-11 03:59:09.345706|2017-10-11 03:59:09.345706
NCT01403415|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-07-09|||September 2011||2011-09-01|March 2015|2015-03-01||||May 2015|Actual|2015-05-01||Interventional|||Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma|A Phase 1 Study of Temsirolimus in Combination With Intensive Re-induction Therapy for Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma|Completed||Phase 1|13|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 03:59:09.438509|2017-10-11 03:59:09.438509
NCT01403402|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2017-05-05|||September 2009||2009-09-01|May 2017|2017-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01|10 Years|Observational [Patient Registry]|CMDPROS||Congenital Muscle Disease Study of Patient and Family Reported Medical Information|Congenital Muscle Disease Patient and Proxy Reported Outcome Study|Recruiting||N/A|1000|Anticipated|Cure CMD|||1||f||||f||||||||||2017-10-11 03:59:09.720869|2017-10-11 03:59:09.720869
NCT01403389|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-01-25|||August 2011||2011-08-01|January 2013|2013-01-01|February 2014|Anticipated|2014-02-01|August 2013|Anticipated|2013-08-01||Interventional|||A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant|Pilot Study of the Clinical Activity of Eculizumab for Prevention of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation|Unknown status|Recruiting|Phase 2|20|Anticipated|Schroppel, Bernd, M.D.||2|||f||||t||||||||||2017-10-11 03:59:09.852591|2017-10-11 03:59:09.852591
NCT01403376|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-01-21|2013-01-22||September 2011||2011-09-01|January 2016|2016-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|TERIVA||Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide|Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide Treatment and Using a Population of Patients With Multiple Sclerosis as a Reference|Completed||Phase 2|128|Actual|Sanofi||3|||f||||f||||||||||2017-10-11 03:59:09.968429|2017-10-11 03:59:09.968429
NCT01403363|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-06-14|||March 2012||2012-03-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Interventional|||Use of Fentanyl Patch in Partial Doses Than the Original|Use of Fentanyl Patch in Partial Doses Than the Original|Unknown status|Active, not recruiting|N/A|95|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 03:59:10.583645|2017-10-11 03:59:10.583645
NCT01403350|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-02-06|||February 2012||2012-02-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan|Effectiveness of Community Level Deployment of Rapid Diagnostic Tests for Malaria in Afghanistan: Cluster Randomised Trial|Completed||Phase 4|2421|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 03:59:10.672892|2017-10-11 03:59:10.672892
NCT01403337|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-03-14|||July 2011||2011-07-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|CRIPES||Cardiac Remote Ischemic Preconditioning Before Elective Major Vascular Surgery|Cardiac Remote Ischemic Preconditioning Before Elective Major Vascular Surgery (CRIPES)|Completed||Phase 1/Phase 2|205|Actual|Minnesota Veterans Medical Research and Education Foundation||2|||f||||t||||||||||2017-10-11 03:59:10.785819|2017-10-11 03:59:10.785819
NCT01403324|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2016-07-12|||September 2011||2011-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|DOSIMETA||Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer|Comparison of Dosimetry Following Preparation With Either rhTSH or After Withdrawal of Thyroid Hormone Suppression Therapy in Patients With Metastatic or Locally Advanced Differentiated Thyroid Cancer|Terminated||N/A|4|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1||Recruitment difficulties|f||||f||||||||||2017-10-11 03:59:10.862838|2017-10-11 03:59:10.862838
NCT01403311|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-03-24|||October 2010||2010-10-01|March 2014|2014-03-01|March 2015|Anticipated|2015-03-01|December 2011|Actual|2011-12-01||Interventional|ALA||A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain|A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain|Unknown status|Active, not recruiting|Phase 2|18|Anticipated|Legacy Health System||1|||f||||||||||||||2017-10-11 03:59:10.941338|2017-10-11 03:59:10.941338
NCT01403298|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2017-07-03|||December 2009||2009-12-01|July 2017|2017-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Project RAP||Project RAP: Family-based HIV Prevention in the Juvenile Drug Court|Project RAP: Family-based HIV Prevention in the Juvenile Drug Court|Completed||N/A|120|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 03:59:11.216509|2017-10-11 03:59:11.216509
NCT01403285|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-05-16|||August 2011||2011-08-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma|A Phase 1 Trial of Peptide-Based Glioma Vaccine IMA950 in Patients With Glioblastoma (GBM)|Terminated||Phase 1|6|Actual|immatics Biotechnologies GmbH||1||"Due to poor accrual. This decision was taken without any safety reasons. Since beginning of the   study (June 2011) only six patients were enrolled."|f||||t||||||||||2017-10-11 03:59:11.306159|2017-10-11 03:59:11.306159
NCT01403272|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-07-26|||September 2010||2010-09-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting|Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting|Completed||N/A|75|Anticipated|Precision Fabrics Group, Inc.||1|||f||||f||||||||||2017-10-11 03:59:11.39876|2017-10-11 03:59:11.39876
NCT01403259|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2014-08-19|||July 2011||2011-07-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||SOX as Salvage Treatment in Nasopharyngeal Carcinoma|Phase II Study of SOX in Patients With Platinum-resistant Nasopharyngeal Carcinoma|Terminated||Phase 2|16|Actual|Fudan University||1||poor accrual of eligible patients|f||||f||||||||||2017-10-11 03:59:11.487343|2017-10-11 03:59:11.487343
NCT01403233|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-06-13|||May 2011||2011-05-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|StevReb-PK||Bioavailability of Two Doses of cogniVida™ With One Dose of Rebaudioside A in Healthy Male Subjects|An Open-label, Sequential Supplementation Study Comparing the Bioavailability of Two Doses of cogniVida™ With One Dose of Rebaudioside A in Healthy Male Subjects|Completed||Phase 1|10|Actual|DSM Nutritional Products, Inc.||3|||f||||f||||||||||2017-10-11 03:59:11.685346|2017-10-11 03:59:11.685346
NCT01403220|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-03-26|||April 2012||2012-04-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||The Efficacity of Hemodiafiltration Versus Hemofiltration for Renal Insufficiency During Intensive Care|The Efficacity of Hemodiafiltration Versus Hemofiltration for Renal Insufficiency During Intensive Care: a Randomized, Open, Cross-over Study|Completed||N/A|163|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 03:59:11.774912|2017-10-11 03:59:11.774912
NCT01403207|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-03-12|||August 2011||2011-08-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|June 2013|Actual|2013-06-01||Observational|||An Analysis of Potential Sex Differences in Knee Osteoarthritis|An Analysis of Potential Sex Differences in Knee Osteoarthritis|Completed||N/A|20|Actual|Mayo Clinic|||1||f||||t||||||||||2017-10-11 03:59:11.859402|2017-10-11 03:59:11.859402
NCT01403194|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2014-04-14|2014-04-14||March 2011||2011-03-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Continuous Positive Airway Pressure and Cardiometabolic Risk|Impact of Treatment of Sleep Disordered Breathing With Continuous Positive Airway Pressure (CPAP) on Cardiometabolic Risk Markers|Terminated||N/A|11|Actual|Mayo Clinic|Analysis was not done because only 1 subject was able to come back for the 3 month follow up visit.|1||"Analysis was not done because only 1 subject was able to come back for the 3 month follow up   visit."|f||||f||||||||||2017-10-11 03:59:11.951404|2017-10-11 03:59:11.951404
NCT01403181|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-26|2013-11-05|||April 2012||2012-04-01|November 2013|2013-11-01||||October 2013|Actual|2013-10-01||Observational|Boce-Par||Effect of Boceprevir on HCV-specific T Cell Responses|Effect of Boceprevir Therapy on HCV-specific T Cell Responses: Perspectives of Immune Monitoring and Immune Therapy|Completed||N/A|30|Actual|Azienda Ospedaliero-Universitaria di Parma|||1||f||||t||||||Samples With DNA|"     Sera and peripheral blood lymphomononuclear cells   "|||2017-10-11 03:59:12.133076|2017-10-11 03:59:12.133076
NCT01403168|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-06-26|||April 2011||2011-04-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|OSTEOPATHIE||Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in Oncology|Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in Oncology|Terminated||N/A|28|Actual|Centre Leon Berard||2||Recruitment difficulties|f||||f||||||||||2017-10-11 03:59:12.225821|2017-10-11 03:59:12.225821
NCT01403155|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-09-11|||May 2011||2011-05-01|September 2017|2017-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001|PHASE I, OPEN-LABEL, SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF AN H5 INFLUENZA PLASMID VACCINE (INO-3401) IN HEALTHY ADULTS PREVIOUSLY VACCINATED WITH VGX-3400X|Completed||Phase 1|22|Actual|Inovio Pharmaceuticals||1|||f||||f||||||||||2017-10-11 03:59:12.324345|2017-10-11 03:59:12.324345
NCT01403142|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-08-30|||August 18, 2011|Actual|2011-08-18|August 2017|2017-08-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|OCTCAV||Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant|Optical Coherence Tomography to Evaluate Cardiac Allograft Vasculopathy in Patients Undergoing Clinically Indicated Angiographies Post Heart Transplant|Completed||N/A|60|Actual|Columbia University|||1||f||||f|f|f||||||||2017-10-11 03:59:12.406823|2017-10-11 03:59:12.406823
NCT01403129|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-05-17|||December 2010||2010-12-01|May 2016|2016-05-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|||Keratoconus Detection by Ultrasound|Early Detection of Keratoconus Using Ultrasound|Enrolling by invitation||N/A|1000|Anticipated|Columbia University|||3||f||||f||||||||||2017-10-11 03:59:12.474493|2017-10-11 03:59:12.474493
NCT01403103|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-01-16|||April 2012||2012-04-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer|Evaluation of the Effect of 25-OH-Vitamin D3 Therapy on 15-Prostaglandin Dehydrogenase Expression in Primary Tumor and Normal Colorectal Mucosa in Patients With Colorectal Cancer|Withdrawn||Early Phase 1|0|Actual|Case Comprehensive Cancer Center||1||Slow Accrual|f||||t||||||||||2017-10-11 03:59:12.750853|2017-10-11 03:59:12.750853
NCT01403090|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-04-10|2012-08-15||December 2011||2011-12-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary Embolism|A Single Treatment, Open Label, Multicenter, Safety Study of the Angel™ Catheter in Hospitalized Human Subjects With a Temporary Risk of Pulmonary Embolism|Completed||Phase 1|8|Actual|BiO2 Medical||1|||f||||t||||||||||2017-10-11 03:59:12.855122|2017-10-11 03:59:12.855122
NCT01403077|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-02-09|||October 2011||2011-10-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|March 2014|Actual|2014-03-01||Interventional|STANCE||480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions|A Safety Assessment of the 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo SFA Lesions|Completed||N/A|46|Actual|480 Biomedical, Inc.||1|||f||||t||||||||||2017-10-11 03:59:13.023709|2017-10-11 03:59:13.023709
NCT01403064|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-06-23||2014-06-23|July 2011||2011-07-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|April 2013|Actual|2013-04-01||Interventional|||Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects|A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy|Completed||Phase 2|81|Actual|Alder Biopharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-11 03:59:13.121164|2017-10-11 03:59:13.121164
NCT01403051|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-12-22|2014-02-05||September 2011||2011-09-01|December 2015|2015-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Includes only subjects who did not have eligibility violations|High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART|A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 2|167|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 03:59:13.307456|2017-10-11 03:59:13.307456
NCT01403038|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-01-04|||June 2011||2011-06-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females|A Phase 1, Open-Label Study of the Effects of Elagolix on Ovarian Activity, Ovulation and Ovarian Reserve in Premenopausal Females|Completed||Phase 1|216|Actual|AbbVie||7|||f||||f||||||||||2017-10-11 03:59:14.151581|2017-10-11 03:59:14.151581
NCT01403025|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-09-20|||July 2011||2011-07-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes|A Multi-centre, Open Label, Observational, Non-interventional Study to Evaluate the Safety and Effectiveness of Victoza® in Subjects With Type 2 Diabetes Mellitus|Completed||N/A|4121|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 03:59:14.405418|2017-10-11 03:59:14.405418
NCT01403012|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-03-16|||August 2011||2011-08-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Observational|Bostrip||BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis|Differential Analysis of Metabolomic Profiles in Patients With Chronic Plaque Psoriasis Undergoing Systemic Treatment|Terminated||N/A|34|Actual|Technische Universität München|||1||f||||f||||||Samples With DNA|"     Psoriasis patients   "|||2017-10-11 03:59:14.490749|2017-10-11 03:59:14.490749
NCT01402999|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2016-04-20|||May 2012||2012-05-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS HUN||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary|Easypod Connect: A National, Multicentre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Hungary|Completed||N/A|83|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 03:59:14.55749|2017-10-11 03:59:14.55749
NCT01402986|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-03-03|2016-05-31||August 2011||2011-08-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|June 2013|Actual|2013-06-01||Interventional||The intention-to-treat (ITT) population included all participants who were randomized into the study.|A Safety and Efficacy Study of Tralokinumab in Adults With Asthma|A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Uncontrolled, Severe Asthma|Completed||Phase 2|689|Actual|MedImmune LLC||4|||f||||f||||||||||2017-10-11 03:59:14.940228|2017-10-11 03:59:14.940228
NCT01402973|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-11-22|||October 2011||2011-10-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Pilot Study of a Dietary Intervention Based Upon Advanced Glycation End Products||Completed||N/A|24|Anticipated|USDA Beltsville Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 03:59:19.41835|2017-10-11 03:59:19.41835
NCT01402960|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-03-17|||April 2011||2011-04-01|March 2017|2017-03-01|February 13, 2013|Actual|2013-02-13|February 2012|Actual|2012-02-01||Interventional|||Exploration of Parameters of Transcranial Direct Current Stimulation (tDCS) in Chronic Pain|Exploration of Parameters of tDCS in Chronic Pain Patients|Completed||N/A|18|Actual|Spaulding Rehabilitation Hospital||3|||f||||f||f||||||||2017-10-11 03:59:19.513387|2017-10-11 03:59:19.513387
NCT01402947|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-06-01|2012-06-01||July 2011||2011-07-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine|A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Ciprofloxacin XR Administered Alone and in Combination With MMX® Mesalazine/Mesalamine in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Shire||2|||f||||||||||||||2017-10-11 03:59:19.602062|2017-10-11 03:59:19.602062
NCT01402934|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-29|2016-04-20|||May 2011||2011-05-01|July 2011|2011-07-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Pulse Pressure Variation in Spontaneously Breathing Patients|The Ability of Pulse Pressure Variation to Predict Fluid Responsiveness in Spontaneously Breathing Patients Undergoing Thoracic Surgery|Completed||N/A|70|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 03:59:19.92948|2017-10-11 03:59:19.92948
NCT01402921|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2016-11-09|||January 2011||2011-01-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy on Volume Reduction and Tolerance of Progressiv' Medical Compressive Therapy (MCT) V0322 BC in Patients With Chronic Venous Oedema|Efficacy on Volume Reduction and Tolerance of Progressiv' Medical Compressive Therapy (MCT) V0322 BC in Patients With Chronic Venous Oedema. International, Multicentric, Randomised, Controlled, Double Blind Study, in Two Parallel Groups v0322 bc Versus Placebo|Completed||Phase 3|92|Actual|Pierre Fabre Medicament||2|||f||||f||||||||||2017-10-11 03:59:20.022357|2017-10-11 03:59:20.022357
NCT01402908|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-03-30|||August 2011||2011-08-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|July 2014|Actual|2014-07-01||Interventional|PATRON||A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection|A Prospective, Randomized, Double-blind, Placebo Controlled, Parallel-group, International Multicenter Phase III Trial of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection|Terminated||Phase 3|520|Actual|Medigen Biotechnology Corporation||2||Due to Interim Analysis and business concerns|f||||t||||||||||2017-10-11 03:59:20.18361|2017-10-11 03:59:20.18361
NCT01402895|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2012-02-07|||May 2011||2011-05-01|July 2011|2011-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Effect Of A Neurodynamic Treatment On Nerve Conduction In Clients With Low Back Pain|The Effect Of A Neurodynamic Treatment On Nerve Conduction In Clients With Low Back Pain|Completed||N/A|9|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 03:59:20.418097|2017-10-11 03:59:20.418097
NCT01402882|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-12-19|||September 2011||2011-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|CRASH-3||Clinical Randomisation of an Antifibrinolytic in Significant Head Injury|Tranexamic Acid for the Treatment of Significant Traumatic Brain Injury: an International Randomised, Double Blind Placebo Controlled Trial|Recruiting||Phase 3|13000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||Yes|After all relevant publications are completed, totally anonymised data will be available at https://ctu-app.lshtm.ac.uk/freebird/|2017-10-11 03:59:20.57439|2017-10-11 03:59:20.57439
NCT01402869|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-03-25|2013-10-15||August 2011||2011-08-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||1 subject was withdrawn from the no local anesthetic group as the subject required 1 or more dental tooth extractions and required local anesthetic|Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local Anesthetics|Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Prilocaine Versus Lidocaine|Completed||N/A|91|Actual|Loma Linda University|Did not compare locals anesthetics with equivalent concentrations of epinephrine; unable to control length of time methemoglobin blood levels were monitored as all subjects varied in extent of restorative dental procedures needed.|3|||f||||f||||||||||2017-10-11 03:59:20.750735|2017-10-11 03:59:20.750735
NCT01402856|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-10-13|||November 2007||2007-11-01|October 2016|2016-10-01|May 2012|Actual|2012-05-01|May 2008|Actual|2008-05-01||Observational|||Teenage Driving Safety Study: An Emergency Medicine-Trauma Collaborative Study|Teenage Driving Safety Study: An Emergency Medicine-Trauma Collaborative Study|Completed||N/A|3750|Actual|Lehigh Valley Hospital|||3||f||||f||||||||No||2017-10-11 03:59:21.333352|2017-10-11 03:59:21.333352
NCT01402843|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2014-05-12|||June 2011||2011-06-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|COCTAIL||Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia|A Randomized, Double Blind, Double Dummy, Placebo Controlled Phase III Trial to Evaluate the Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia(COCTAIL Study)|Completed||Phase 3|150|Anticipated|JW Pharmaceutical||4|||f||||f||||||||||2017-10-11 03:59:21.422691|2017-10-11 03:59:21.422691
NCT01402830|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-02-08|||November 2007||2007-11-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)|DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients|Completed||Phase 4|271|Actual|Janssen-Cilag, S.A.|||1||f||||||||||||||2017-10-11 03:59:21.523118|2017-10-11 03:59:21.523118
NCT01402817|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-01-27|2016-03-30||March 2012||2012-03-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2015|Actual|2015-10-01||Interventional|||Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas|A Pilot Study of Sutent®/Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor in Subjects With NF-1 Plexiform Neurofibromas|Suspended||Phase 2|19|Actual|Indiana University||1||1 patient died of uncertain cause but possibly related to drug. Regulatory currently reviewing|f||||t||||||||||2017-10-11 03:59:21.653289|2017-10-11 03:59:21.653289
NCT01402804|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-11-08|||July 2011||2011-07-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||NSAIDs in Coronary Artery Disease Patients|Non-steroidal Anti-inflammatory Drugs Impair the Platelet Inhibiting Effect of Acetylsalicylic Acid in Coronary Artery Disease Patients|Completed||N/A|85|Actual|Heinrich-Heine University, Duesseldorf|||2||f||||f||||||||||2017-10-11 03:59:21.943294|2017-10-11 03:59:21.943294
NCT01402791|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-03-25|||January 2011||2011-01-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|DYSEXTRIOSE||Endometriosis: Sexual Dysfunction and Adaptation Strategies Among Couples|Endometriosis: Sexual Dysfunction and Adaptation Strategies Among Couples|Completed||N/A|60|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||||||2017-10-11 03:59:22.017117|2017-10-11 03:59:22.017117
NCT01402765|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-03-25|||March 2012||2012-03-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Interface Pressure Measures for Matresses: Nimbus 3 Versus Summit|Interface Pressure Measures for Matresses: a Randomized, Cross-over, Non-inferiority Study Comparing the Nimbus 3 Versus Summit Matresses|Completed||N/A|31|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 03:59:22.146597|2017-10-11 03:59:22.146597
NCT01402752|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-06-16|||November 2013||2013-11-01|June 2017|2017-06-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||System for Measuring Non-invasive Blood Flow in the Tracheobronchial Mucosa: Validation of Reproducibility|System for Measuring Non-invasive Blood Flow in the Tracheobronchial Mucosa: Validation of Reproducibility|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes||1||20131209 Regulatory authorization is currently blocked at the ANSM.|f||||f||||||||||2017-10-11 03:59:22.209687|2017-10-11 03:59:22.209687
NCT01402739|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-06-12|||August 2011||2011-08-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|HEART-PoC||Algorithm-Guided Transfusions in Cardiac Surgery Patients for Reduction of Drainage Blood Losses|Monocentric Pilot Study of Algorithm-Guided Transfusions in Cardiac Surgery Patients for Reduction of Drainage Blood Losses|Terminated||N/A|100|Actual|Charite University, Berlin, Germany||2||Study terminated prematurely due to futility|f||||f||||||||||2017-10-11 03:59:22.271653|2017-10-11 03:59:22.271653
NCT01402726|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-07-13|||July 2011|Actual|2011-07-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Renal Sympathetic Modification in Patients With Heart Failure|Renal Sympathetic Modification in Patients With Heart Failure|Recruiting||N/A|200|Anticipated|The Second Affiliated Hospital of Chongqing Medical University||2|||f||||t||||||||||2017-10-11 03:59:22.364159|2017-10-11 03:59:22.364159
NCT01402713|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-01-23|||August 2011||2011-08-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children|Randomized, Double Blind, Multicenter, Phase II/III Study to Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children|Completed||Phase 2/Phase 3|311|Actual|Green Cross Corporation||3|||f||||f||||||||||2017-10-11 03:59:22.473096|2017-10-11 03:59:22.473096
NCT01402700|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-03-14|2015-08-11||July 2011||2011-07-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|July 2013|Actual|2013-07-01||Interventional|||VISIBILITY™ Iliac Study|Visi-Pro™ Balloon Expandable Iliac Study (VISIBILITY™ Iliac)|Completed||Phase 2/Phase 3|75|Actual|Medtronic Endovascular||1|||f||||||||||||||2017-10-11 03:59:24.150898|2017-10-11 03:59:24.150898
NCT01402687|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-07-15|||October 2010||2010-10-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Observational|||SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)|Single Nucleotide Polymorphism (SNP)-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants|Completed||N/A|181|Actual|Dana-Farber Cancer Institute|||2||f||||t||||||Samples With DNA|"     Saliva sample   "|||2017-10-11 03:59:24.458322|2017-10-11 03:59:24.458322
NCT01402674|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-23|2013-01-25|||August 2011||2011-08-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|PC-II||Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal|Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal|Completed||N/A|269|Actual|Center for Weight Management, California||2|||f||||f||||||||||2017-10-11 03:59:24.523968|2017-10-11 03:59:24.523968
NCT01402661|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-08-10|||February 2002||2002-02-01|August 2016|2016-08-01||||December 2100|Anticipated|2100-12-01||Observational|CORRONA||The Corrona RA Data Collection Program|The Corrona RA Data Collection Program|Enrolling by invitation||N/A|33312|Actual|Corrona, LLC.|||1||f||||f||||||||||2017-10-11 03:59:24.610659|2017-10-11 03:59:24.610659
NCT01402648|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-25|||October 2009||2009-10-01|July 2011|2011-07-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|CRC||Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence|Effects of the Dietary Supplementation With a Blend of ER Beta Agonists on the Expression of ER Beta and Related Biomarkers of Cell Proliferation and Apoptosis, in Sporadic Colon Adenopolyposis|Completed||Phase 1/Phase 2|60|Actual|CM&D Pharma Limited||2|||f||||f||||||||||2017-10-11 03:59:24.686827|2017-10-11 03:59:24.686827
NCT01402635|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-09|2012-07-22|||January 2011||2011-01-01|July 2012|2012-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|POCTED||Can the Point-Of-Care Chemistry Test (POCT) Solve the Emergency Department (ED) Crowding?|A Randomized Controlled Trial Comparing Central Laboratory and Point-of-care Chemistry Test for Solving the Emergency Department Crowding|Completed||N/A|10244|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 03:59:24.760532|2017-10-11 03:59:24.760532
NCT01402622|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-25|||December 2010||2010-12-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||The Effect of Total Intravenous Anesthesia With Propofol on Postoperative Nausea and Vomiting in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy|The Effect of Total Intravenous Anesthesia With Propofol on Postoperative Nausea and Vomiting in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy|Completed||Phase 4|93|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 03:59:24.839483|2017-10-11 03:59:24.839483
NCT01402609|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-07-28|||September 2011||2011-09-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|December 2013|Actual|2013-12-01||Interventional|||Assessing the Efficacy of an Electronic Discharge Communication Tool|A Randomized Controlled Trial Assessing the Efficacy of an Electronic Discharge Communication Tool for Preventing Death or Hospital Readmission|Completed||N/A|1399|Actual|Ward of the 21st Century||2|||f||||f||||||||Yes||2017-10-11 03:59:25.032892|2017-10-11 03:59:25.032892
NCT01402596|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-06-19|||August 2011||2011-08-01|July 2011|2011-07-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam|Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam - a Randomized Controlled Trial|Withdrawn||Phase 2|0|Actual|University of Sao Paulo||2||"Institution decided on starting a new protocol of sedation, with another methods and that´s why   this study has not started."|f||||f||||||||||2017-10-11 03:59:25.133673|2017-10-11 03:59:25.133673
NCT01401829|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-05-11|||July 2011||2011-07-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Psychosocial Benefits of Exercise in Endometrial Cancer Survivors|Psychosocial Benefits of Exercise in Endometrial Cancer Survivors|Terminated||Phase 1|2|Actual|University of Alabama at Birmingham||3||Terminated due to lack of funding required to continue the study.|f||||f||||||||||2017-10-11 03:59:35.592203|2017-10-11 03:59:35.592203
NCT01402583|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-10-20|||July 2011||2011-07-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Observational|MEN_EPID||Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C|Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C - An Epidemiological Study|Completed||N/A|1000|Actual|University of Modena and Reggio Emilia|||1||f||||f||||||||||2017-10-11 03:59:25.21915|2017-10-11 03:59:25.21915
NCT01402570|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-12-22|2016-01-22||August 2011||2011-08-01|December 2016|2016-12-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional||The target population for this study was individuals between the ages of 50 and 65 who self-reported symptoms consistent with post-polio syndrome and able to ambulate 100 feet without assistive devices.|Glutathione and Health With Post-Polio Syndrome|Oral Glutathione and Health Outcomes Among Persons With Post-Polio Syndrome|Completed||N/A|20|Actual|University of Michigan|Sample size of 20 was quite small to make generalizations to the larger population. Dosing and duration of the intervention may not have been sufficient to effect change.|1|||f||||f||||||||||2017-10-11 03:59:25.316159|2017-10-11 03:59:25.316159
NCT01402557|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-12-26|||August 2007||2007-08-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||"Telehealth for Weight Maintenance of African-American Women (Exercise Your Faith)"|Telehealth for Weight Maintenance of African-American Women|Completed||N/A|88|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 03:59:25.6333|2017-10-11 03:59:25.6333
NCT01402544|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2016-07-14|||July 2011||2011-07-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|COMPASS||Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab|Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)|Terminated||Phase 2/Phase 3|20|Actual|University of California, San Diego||1||Per study sponsor decision.|f||||f||||||||No||2017-10-11 03:59:25.72747|2017-10-11 03:59:25.72747
NCT01402531|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-25|||July 2010||2010-07-01|July 2011|2011-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)|Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)|Unknown status|Recruiting|Phase 2|30|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 03:59:25.829271|2017-10-11 03:59:25.829271
NCT01402518|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-10-24|||November 2009||2009-11-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|POEM||Per-Oral Endoscopic Myotomy|Observational Study of the Per-Oral Endoscopic Myotomy (POEM) Procedure|Recruiting||Phase 1|100|Anticipated|University of California, San Diego|||1||f||||f||||||||||2017-10-11 03:59:25.917242|2017-10-11 03:59:25.917242
NCT01402505|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-10-24|||October 2008||2008-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Transvaginal NOTES Sleeve Gastrectomy|Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Trans-Vaginal Sleeve Gastrectomy|Recruiting||Phase 1|50|Anticipated|University of California, San Diego|||1||f||||f||||||||||2017-10-11 03:59:25.992363|2017-10-11 03:59:25.992363
NCT01402479|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-24|2011-08-05|||October 2004||2004-10-01|July 2011|2011-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||An Open-labeled Trial of Ramipril in Patients With Migraine|An Open-labeled Trial of Ramipril in Patients With Migraine|Completed||Phase 2|50|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 03:59:26.18649|2017-10-11 03:59:26.18649
NCT01402466|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-03-25|||August 2011||2011-08-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|||Urban Health Study II|Finding, Testing and Treating High-Risk Probationers and Parolees With HIV|Completed||Phase 2|49|Actual|RTI International||2|||f||||f||||||||||2017-10-11 03:59:26.260062|2017-10-11 03:59:26.260062
NCT01402453|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-03-07|||August 2011||2011-08-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control|Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control Pilot Study|Completed||N/A|207|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 03:59:26.337116|2017-10-11 03:59:26.337116
NCT01402440|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2015-01-06|||November 2011||2011-11-01|January 2015|2015-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma|An Open-Label, Single-arm, Phase I Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma|Terminated||Phase 1|15|Actual|Novartis||1||"Study terminated due to enrolment challenges and availability of other options for DLBCL   patients. The termination is not a consequence of any safety concern."|f||||||||||||||2017-10-11 03:59:26.460106|2017-10-11 03:59:26.460106
NCT01402427|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-04-30|2014-04-17||March 2011||2011-03-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|VITRIOL||Is Verapamil In TransRadial Interventions OmittabLe?|Omission of Prophylactic Verapamil Use in Transradial Coronary Interventions|Completed||N/A|591|Actual|State Health Center, Hungary|The trial was conducted in a single, high-volume institution by experienced operators. The results may not be applicable to lower-volume centers or to operators with less experience.|2|||f||||f||||||||||2017-10-11 03:59:26.589074|2017-10-11 03:59:26.589074
NCT01402414|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-02-20|||April 2011||2011-04-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis|Study Comparing the Effectiveness of Narrow-band UVB vs. Bath-PUVA and Narrow-band UVB + Salt Water Baths in Atopic Dermatitis|Terminated||N/A|10|Actual|Ruhr University of Bochum||3||Difficulties with the Recruitement|f||||f||||||||||2017-10-11 03:59:27.045961|2017-10-11 03:59:27.045961
NCT01402193|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-06-24|||July 2011||2011-07-01|June 2014|2014-06-01|July 2015|Anticipated|2015-07-01|December 2014|Anticipated|2014-12-01||Interventional|||Study of Arimidex and Radiotherapy Sequencing|A Prospective, Randomized, Bi-center Study to Compare the Outcome of Adjuvant Radiotherapy With Concomitant or Sequential Arimidex in Postmenopausal Women With Breast Cancer|Unknown status|Recruiting|Phase 3|220|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 03:59:29.375152|2017-10-11 03:59:29.375152
NCT01402401|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-24|2014-02-20|||November 2011||2011-11-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients|An Open-label, Single-arm, Multi-center Phase II Study to Evaluate the Efficacy and Safety of AUY922 in Combination With Trastuzumab Standard Therapy as Second-line Treatment in Patients With HER2-positive Advanced Gastric Cancer|Terminated||Phase 2|21|Actual|Novartis||1|||f||||||||||||||2017-10-11 03:59:27.147383|2017-10-11 03:59:27.147383
NCT01402388|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-25|||October 2007||2007-10-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Lifestyle Intervention in Patients With New Onset Type 2 Diabetes.|Effect of Intensive Lifestyle Intervention on Hormonal Factors Regulating Food Intake and Blood Glucose Control in Patients With New Onset Type 2 Diabetes.|Completed||N/A|22|Actual|The Royal Bournemouth Hospital||1|||f||||f||||||||||2017-10-11 03:59:27.248088|2017-10-11 03:59:27.248088
NCT01402375|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-24|2017-02-25|||January 2012|Actual|2012-01-01|February 2017|2017-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Comparing the Efficacy of Oral Opioids for Outpatient Acute Pain Management After ED Discharge Discharge|Comparing the Efficacy of Oral Opioids for Outpatient Acute Pain Management After ED Discharge|Completed||Phase 3|480|Actual|Montefiore Medical Center||4|||f||||f||||||||||2017-10-11 03:59:27.318881|2017-10-11 03:59:27.318881
NCT01402362|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-24|2011-07-25|||September 2011||2011-09-01|June 2011|2011-06-01||||||||Observational|||Prevalence of Glucose Intolerance and Risk Factors in Ethiopian Immigrants in Israel; Follow-up Study.||Unknown status|Not yet recruiting|N/A|550|Anticipated|Hillel Yaffe Medical Center|||1||f||||||||||||||2017-10-11 03:59:27.411071|2017-10-11 03:59:27.411071
NCT01402349|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-08-01|||April 2010||2010-04-01|July 2011|2011-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Chronic Rhinosinusitis in a Danish Population: Evaluation of Causes of Disease, Progress and Treatment|Chronic Rhinosinusitis in a Danish Population: Evaluation of Causes of Disease, Progress and Treatment|Completed||N/A|5000|Actual|Odense University Hospital|||1||f||||f||||||Samples With DNA|"     Blodsamples.   "|||2017-10-11 03:59:27.500794|2017-10-11 03:59:27.500794
NCT01402323|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2014-05-19|||July 2011||2011-07-01|July 2011|2011-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Gingival Clefts and Orthodontic Movement|A Prospective Split-mouth Designed Study on the Incidence of Gingival Clefts During Orthodontic Space Closure Into Recent or Healed Extraction Sockets.|Unknown status|Recruiting|N/A|25|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-10-11 03:59:27.668045|2017-10-11 03:59:27.668045
NCT01402310|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-17|2013-12-08|||November 2008||2008-11-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Bishop Score, Cervical Length and Multiple Proteins in Cervicovaginal Fluid at 40 Weeks to Predict Onset of Labor||Completed||N/A|220|Actual|Seoul National University Hospital|||1||f||||f||||||Samples Without DNA|"     cervicovaginal fluid   "|||2017-10-11 03:59:27.745806|2017-10-11 03:59:27.745806
NCT01402297|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-25|||October 2010||2010-10-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Hydrogen Peroxide and Nitrite Reduction in Exhaled Breath Condensate of COPD Patients|Hydrogen Peroxide and Nitrite Reduction in Exhaled Breath Condensate of COPD Patients|Completed||Phase 1|13|Actual|Medical Universtity of Lodz||1|||f||||f||||||||||2017-10-11 03:59:27.821575|2017-10-11 03:59:27.821575
NCT01402284|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-23|2017-04-14|2017-03-01||July 21, 2011|Actual|2011-07-21|April 2017|2017-04-01|September 1, 2026|Anticipated|2026-09-01|July 10, 2016|Actual|2016-07-10||Interventional|||Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients|Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Clinical and Correlative Phase II Study|Active, not recruiting||Phase 2|45|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f|t|f||||||No||2017-10-11 03:59:27.958348|2017-10-11 03:59:27.958348
NCT01402271|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-23|2016-10-11|||July 2012||2012-07-01|October 2016|2016-10-01||||May 2019|Anticipated|2019-05-01||Interventional|||Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer|Phase IB-II, Open Label, Multicenter Feasibility Study of Pazopanib in Combination With Paclitaxel and Carboplatin in Patients With Platinum-Refractory/Resistant Ovarian, Fallopian Tube or Peritoneal Carcinoma|Recruiting||Phase 1/Phase 2|88|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 03:59:28.731537|2017-10-11 03:59:28.731537
NCT01402258|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2013-04-26|||April 2011||2011-04-01|April 2013|2013-04-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|NOVA-IV||Internet-administrated Treatment of Anxiety Symptoms for Young Adults|Tailored Internet-administrated Treatment of Anxiety Symptoms for Young Adults|Unknown status|Recruiting|N/A|30|Anticipated|Linkoeping University||1|||f||||f||||||||||2017-10-11 03:59:28.859878|2017-10-11 03:59:28.859878
NCT01402245|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-25|||January 2005||2005-01-01|January 2007|2007-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PncHR||Targeting of Immune Response After Pneumococcal Vaccination|Comparison of Immune Response in Pneumococcal Pneumonia and After Vaccination|Completed||Phase 4|42|Actual|Helsinki University Central Hospital||3|||f||||t||||||||||2017-10-11 03:59:28.927177|2017-10-11 03:59:28.927177
NCT01402232|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-08-20|||January 2013||2013-01-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Observational|REICIN||Reduction of Risk for Contrast Nephropathy|Reduction of Risk for Contrast-Induced Nephropathy: A Multicentre Observational Study of Contrast-Induced Nephropathy Following Coronary Angiography or Percutaneous Coronary Intervention|Unknown status|Recruiting|N/A|5000|Anticipated|Guangdong General Hospital|||1||f||||t||||||||||2017-10-11 03:59:29.009928|2017-10-11 03:59:29.009928
NCT01402219|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2013-08-27|||November 2008||2008-11-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|NEIHR||Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients|Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients:A Multicentre Randomized Double-Blind Trail of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease|Terminated||Phase 4|204|Actual|Guangdong General Hospital||2||There were few eligible subjects from other centers.|f||||t||||||||||2017-10-11 03:59:29.111236|2017-10-11 03:59:29.111236
NCT01402180|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2011-07-25|||December 2010||2010-12-01|November 2010|2010-11-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|Nimotuzumab||Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy|A Randomized Phase II Trial Evaluating The Addition Of Nimotuzumab To Chemoradiation For Patients With Esophageal Squamous Cell Carcinoma After Radical Esophagectomy Who Suffer With Lymph Nodes Recurrence|Unknown status|Recruiting|Phase 2/Phase 3|128|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 03:59:29.493745|2017-10-11 03:59:29.493745
NCT01402167|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2015-03-24|||September 2014||2014-09-01|March 2015|2015-03-01|August 2016|Anticipated|2016-08-01|May 2016|Anticipated|2016-05-01||Interventional|||Evaluating Vertebroplasty and Kyphoplasty for Reducing Trauma-related Fractures|Evaluating Transcutaneous Vertebroplasty and Kyphoplasty for Reducing Trauma-related Fractures: a Randomized Pilot Study Using Catscan Volumetry|Withdrawn||N/A|0|Actual|Centre Hospitalier Universitaire de Nīmes||2||Patients refuse randomization.|f||||f||||||||||2017-10-11 03:59:29.588562|2017-10-11 03:59:29.588562
NCT01402154|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-25|2017-06-16|||January 2012||2012-01-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients|The Pre-treatment Detection of Circulating, Functional, Prostate Cells Among Adenocarcinoma Patients: an Evaluation of the EPISPOT Technique|Active, not recruiting||N/A|361|Actual|Centre Hospitalier Universitaire de Nīmes|||1||f||||f||||||Samples Without DNA|"     Following the completion of the biological analyses required for this study, leftover tubes     may be placed in the Nîmes University Hospital biological collection for future ancillary     studies, if patients are agreed with this. The samples concerned include EDTA and CellSave     tubes for each patient.   "|||2017-10-11 03:59:29.687011|2017-10-11 03:59:29.687011
NCT01402141|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-11-21|2012-07-11||October 2010||2010-10-01|November 2012|2012-11-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||A Human Trial to Evaluate the Effects of Chungkookjang on Histamine-induced Wheal Size in Healthy Subjects|Efficacy and Safety of Chungkookjang, a Fermented Soy Paste, on Histamine-induced Wheal Size|Completed||Phase 2/Phase 3|60|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 03:59:29.786895|2017-10-11 03:59:29.786895
NCT01402128|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-11-26|2012-07-26||June 2010||2010-06-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects|The Effect of Barley Beta-glucan on Serum Lipids and Body Weight|Completed||Phase 2/Phase 3|80|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 03:59:30.301507|2017-10-11 03:59:30.301507
NCT01402115|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-10-10|2012-07-26||November 2008||2008-11-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||A 12-week Human Trial to Compare the Efficacy and Safety of Polycan on Bone Metabolism|Efficacy and Safety Study of Polycan on Bone Metabolism|Completed||Phase 2/Phase 3|60|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 03:59:31.00923|2017-10-11 03:59:31.00923
NCT01402102|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-10-11|2012-07-26||July 2010||2010-07-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Interventional|||A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia|Efficacy and Safety of Aged Garlic Powder on Lipids|Completed||Phase 2/Phase 3|60|Actual|Chonbuk National University Hospital||2|||f||||t||||||||||2017-10-11 03:59:31.368442|2017-10-11 03:59:31.368442
NCT01402089|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-01-31|||January 2012||2012-01-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|July 2015|Actual|2015-07-01||Interventional|||Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients|Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients|Completed||Phase 4|54|Actual|Cantonal Hospital of St. Gallen||1|||f||||t||||||||||2017-10-11 03:59:31.777112|2017-10-11 03:59:31.777112
NCT01402076|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-02-14|||August 2011||2011-08-01|February 2014|2014-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects|An Open-Label, Single-Sequence Study to Assess the Effect of Multiple Doses of Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes Using Midazolam and Rosiglitazone as Substrates in Healthy Subjects|Completed||Phase 1|24|Actual|Vanda Pharmaceuticals||2|||f||||f||||||||||2017-10-11 03:59:31.892399|2017-10-11 03:59:31.892399
NCT01402063|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2015-07-08|2015-04-30||September 2011||2011-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|April 2014|Actual|2014-04-01||Interventional|||PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation|PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study|Completed||Phase 2|63|Actual|Brown University||2|||f||||t||||||||||2017-10-11 03:59:32.030302|2017-10-11 03:59:32.030302
NCT01402050|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-08|2016-11-21|||June 2010||2010-06-01|November 2016|2016-11-01|February 2015|Actual|2015-02-01|November 2014|Actual|2014-11-01||Interventional|||Foley Catheter Versus Cervidil for Induction of Labor at Term|A Randomized Controlled Trial of Transcervical Foley Balloon Compared to Controlled Release Prostaglandin (Cervidil) for Labor Induction and Cervical Ripening in Term and Near Term Women|Completed||N/A|330|Actual|Mednax Center for Research, Education and Quality||2|||f||||t||||||||No||2017-10-11 03:59:32.837801|2017-10-11 03:59:32.837801
NCT01402037|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2013-12-27|||July 2011||2011-07-01|December 2013|2013-12-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Beta Cell Function in (Pre)Type 1 Diabetes|Relation Between Residual Beta Cell Function and Glycemic Variability in (Pre) Type 1 Diabetes.|Unknown status|Recruiting|N/A|100|Anticipated|AZ-VUB||4|||f||||f||||||||||2017-10-11 03:59:32.91079|2017-10-11 03:59:32.91079
NCT01402024|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-01-16|||August 2011||2011-08-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Aprepitant||Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy|A Study to Evaluate the Anti-emetic Effect of Aprepitant Versus Placebo as an Add-on Therapy in Children and Adolescent Receiving Chemotherapy: A Randomized, Doubly Blinded Controlled Trial|Completed||Phase 3|96|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 03:59:33.013824|2017-10-11 03:59:33.013824
NCT01401998|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2017-09-15|||June 2011||2011-06-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource|Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource (Hepato/Renal Fibrocystic Diseases Core Center (UAB HFRDCC))|Recruiting||N/A|200|Anticipated|Children's Research Institute|||1||f||||t||||||Samples With DNA|"     Blood-derived DNA and lymphocytes for EBV-immortalized cell lines. Remnant tissue samples     affected with Hepato/Renal Fibrocystic Diseases   "|||2017-10-11 03:59:33.195066|2017-10-11 03:59:33.195066
NCT01401985|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-09-03||2013-06-05|October 2011||2011-10-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)|A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects With Opioid-Induced Constipation|Completed||Phase 2|95|Actual|Theravance Biopharma Antibiotics, Inc.||1|||f||||f||||||||||2017-10-11 03:59:33.427868|2017-10-11 03:59:33.427868
NCT01401972|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-01|2017-05-01|||September 2008||2008-09-01|May 2017|2017-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients|Conventional and Contrast-Assisted Frequency Functional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients|Recruiting||N/A|10|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||Samples With DNA|"     Prostate speciments are retained after radical prostatectomy surgery   "|||2017-10-11 03:59:33.503292|2017-10-11 03:59:33.503292
NCT01401959|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-04-11|||September 23, 2011|Actual|2011-09-23|April 2017|2017-04-01|October 1, 2017|Anticipated|2017-10-01|April 3, 2017|Actual|2017-04-03||Interventional|||Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy|Phase II Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy|Active, not recruiting||Phase 2|128|Actual|SCRI Development Innovations, LLC||3|||f||||f|t|f|||f|||||2017-10-11 03:59:33.592594|2017-10-11 03:59:33.592594
NCT01401946|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-08|2011-07-25|||May 2000||2000-05-01|July 2011|2011-07-01|January 2001|Actual|2001-01-01|October 2000|Actual|2000-10-01||Interventional|||Soy Isoflavone Tablets: Effects on Sleep, Quality of Life, Symptoms and Cognitive Function in Menopausal Women|Soy Isoflavone Tablets: Effects on Questionnaire and Actigraphic Measures of Sleep, Symptoms as Measured by the Women's Health Questionnaire and Cognitive Function as Measured by Computerized Cognitive Performance Tests in Menopausal Women|Completed||Phase 4|88|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 03:59:33.731722|2017-10-11 03:59:33.731722
NCT01401933|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2011-10-31|||May 2011||2011-05-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors|A Phase 1 Study To Assess the Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|14|Actual|Abbott||1|||f||||f||||||||||2017-10-11 03:59:33.825964|2017-10-11 03:59:33.825964
NCT01401920|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2013-12-24|||July 2011||2011-07-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||The Influence of Passive Leg Elevation on the Cross-sectional Area of the Internal Jugular Vein in Infants or Young Children Undergoing Open Heart Surgery|The Influence of Passive Leg Elevation on the Cross-sectional Area of the Internal Jugular Vein in Infants or Young Children Undergoing Open Heart Surgery|Completed||N/A|90|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:59:33.916304|2017-10-11 03:59:33.916304
NCT01401907|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-08-28|2017-02-16||May 2011||2011-05-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|April 2016|Actual|2016-04-01||Interventional|||Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies|Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Advanced Lung and Non-colorectal Gastrointestinal Malignancies|Active, not recruiting||N/A|350|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 03:59:34.012419|2017-10-11 03:59:34.012419
NCT01401894|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-01-28|||October 2010||2010-10-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|October 2012|Actual|2012-10-01||Observational|||Perception Prognosis, Goals of Treatment, and Communication|Pilot Study to Investigate Advanced Cancer Patient's Perspective of Their Prognosis, Goals of Treatment, and Quality of Communication With Their Oncologists|Completed||N/A|50|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 03:59:34.578207|2017-10-11 03:59:34.578207
NCT01401881|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-28|2013-04-22|||December 2009||2009-12-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|ITEMMRI||Ischemic Time and Extent of Myocardial Infarction (MI) With Cardiac Magnetic Resonance Imaging (CMRI) in Patients With ST Elevation Myocardial Infarction (STEMI) and Primary Percutaneous Coronary Intervention (PCI) Study|Ischemic Time and Extent of Myocardial Infarction With Cardiac Magnetic Resonance Image in Patients With STEMI and Primary Percutaneous Coronary Intervention Study|Unknown status|Active, not recruiting|N/A|80|Anticipated|Medstar Health Research Institute|||1||f||||f||||||||||2017-10-11 03:59:34.660045|2017-10-11 03:59:34.660045
NCT01401868|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2013-06-20|||September 2011||2011-09-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors|Phase I Open Label Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 as a Single Agent in Patients With Refractory Solid Tumors|Completed||Phase 1|18|Actual|MEI Pharma, Inc.||1|||f||||t||||||||||2017-10-11 03:59:34.750587|2017-10-11 03:59:34.750587
NCT01401855|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2016-06-15|||June 2011||2011-06-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules|Optical Probe In Thyroid Cancer|Completed||Phase 1|300|Actual|Boston Medical Center|||2||f||||f||||||||||2017-10-11 03:59:34.832542|2017-10-11 03:59:34.832542
NCT01401842|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-05-22|2015-05-05||June 2012||2012-06-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|April 2014|Actual|2014-04-01||Interventional||All enrolled participants who were deemed eligible, completed baseline assessments, and were randomized.|Reduction of Risk for Low Back Injury in Theater of Operations|Reduction of Risk for Low Back Injury in Theater of Operations|Completed||N/A|582|Actual|University of South Florida||2|||f||||t||||||||||2017-10-11 03:59:34.935467|2017-10-11 03:59:34.935467
NCT01401595|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2017-03-28|2014-12-01||December 2009||2009-12-01|March 2017|2017-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|NES||Brain Imaging and Treatment Studies of the Night Eating Syndrome|Brain Imaging and Treatment Studies of the Night Eating Syndrome|Completed||Phase 3|87|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 03:59:37.377801|2017-10-11 03:59:37.377801
NCT01401816|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2012-07-06|||July 2011||2011-07-01|June 2011|2011-06-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||Advanced Provision of Emergency Contraception: Utilizing Technology to Increase Prescription Fill Rates|Advanced Provision of Emergency Contraception: Utilizing Technology to Increase Prescription Fill Rates|Completed||N/A|60|Actual|Boston Medical Center||2|||f||||f||||||||||2017-10-11 03:59:35.719983|2017-10-11 03:59:35.719983
NCT01401803|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2013-09-24|||September 2011||2011-09-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Brow Lifting With Dysport|Brow Lifting With Dysport|Completed||Phase 4|24|Actual|Beer, Kenneth R., M.D., PA||1|||f||||f||||||||||2017-10-11 03:59:35.795722|2017-10-11 03:59:35.795722
NCT01401790|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2011-07-22|||February 2008||2008-02-01|July 2011|2011-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Use of a Telehomecare Program for Young Patients With New Onset Type 1 Diabetes|Use of a Telehomecare Program for Young Patients With New Onset Type 1 Diabetes|Completed||N/A|86|Actual|Huot, Celine, M.D.||2|||f||||f||||||||||2017-10-11 03:59:35.893654|2017-10-11 03:59:35.893654
NCT01401777|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-05-28|||December 2014||2014-12-01|May 2013|2013-05-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Observational|||Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study|Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study|Suspended||N/A|40|Anticipated|Philips Healthcare|||2|On hold pending product development|f||||f||||||||||2017-10-11 03:59:36.009254|2017-10-11 03:59:36.009254
NCT01401764|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2013-01-30|||May 2011||2011-05-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy Subjects|Randomized, Double Blind, Crossover, Single Centre Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy Subjects|Completed||Phase 1|30|Actual|Ablynx||1|||f||||f||||||||||2017-10-11 03:59:36.079274|2017-10-11 03:59:36.079274
NCT01401751|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-07-28|||July 1, 2011|Actual|2011-07-01|July 2017|2017-07-01|December 1, 2011|Actual|2011-12-01|November 1, 2011|Actual|2011-11-01||Interventional|||Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting|Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting|Completed||N/A|13|Actual|Animas Corporation||1|||f||||f|f|t|f|||||||2017-10-11 03:59:36.1666|2017-10-11 03:59:36.1666
NCT01401738|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||May 2011||2011-05-01|July 2011|2011-07-01|May 2013|Anticipated|2013-05-01|||||Observational|||Results of Shoulder Arthroscopic Surgery for Rotator Cuff, Biceps Tendon, Labrum and Capsule|Results of Shoulder Arthroscopic Surgery for Rotator Cuff, Biceps Tendon, Labrum and Capsule|Unknown status|Active, not recruiting|N/A|170|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 03:59:36.24453|2017-10-11 03:59:36.24453
NCT01401725|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-10-14|||April 2011||2011-04-01|October 2015|2015-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|E-SENTRY||Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients|Electronic Strategies to Enhance Venous Thromboprophylaxis in Hospitalized Medical Patients|Completed||N/A|600|Actual|McMaster University||3|||f||||f||||||||||2017-10-11 03:59:36.319259|2017-10-11 03:59:36.319259
NCT01401712|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-10-28|||October 2012||2012-10-01|October 2013|2013-10-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Interventional|||Optimal Method of Pain Management in Patients With Multiple Rib Fractures|Thoracic Epidural Analgesia Compared to Thoracic Paravertebral Pump Infusion for Pain Management in Patients With Three or More Rib Fractures|Unknown status|Recruiting|N/A|96|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 03:59:36.409908|2017-10-11 03:59:36.409908
NCT01401699|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-04-14|||September 2006||2006-09-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction|Optical Coherence Tomography Based Screening and Surveillance of Esophagus and Gastroesophageal Junction|Completed||Phase 1|110|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 03:59:36.538151|2017-10-11 03:59:36.538151
NCT01401673|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-22|||October 2009||2009-10-01|July 2011|2011-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase II Open-Label Pilot Study of V3381 in Chronic Cough|Phase II Open-label Pilot Study of V3381, a Novel N-Methyl-D-Aspartate Receptor Antagonist, in Chronic Cough Patients Attending a Specialist Clinic|Terminated||Phase 2|12|Actual|Vernalis (R&D) Ltd||1||Lack of efficacy|f||||f||||||||||2017-10-11 03:59:36.625785|2017-10-11 03:59:36.625785
NCT01401660|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-29|2011-07-29|||May 2011||2011-05-01|July 2011|2011-07-01||||||||Observational|||Study of Low Back Pain Using CERSR® Imaging Technology|Observational Study of the Electrophysiological Course of Low Back Pain Using CERSR® Imaging Technology|Terminated||N/A|290|Anticipated|Verium Diagnostics, Inc.|||3|Principal Investigator withdrew from the study.|f||||f||||||||||2017-10-11 03:59:36.69094|2017-10-11 03:59:36.69094
NCT01401647|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-03-18|2016-12-05||May 2012||2012-05-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|ALPS||Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia|Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)|Completed||Phase 3|3024|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 03:59:36.779567|2017-10-11 03:59:36.779567
NCT01401634|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-22|||January 2011||2011-01-01|July 2011|2011-07-01||||June 2011|Actual|2011-06-01||Interventional|||Oral Hydration for Mild to Moderate Hyperglycemia in the Emergency Department||Completed||Phase 1|80|Anticipated|University of Southern California||2|||f||||||||||||||2017-10-11 03:59:37.157689|2017-10-11 03:59:37.157689
NCT01401621|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-10-08|||July 2014||2014-07-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||The Effect of a Scratch Off Prompt on Health Engagement|The Effect of a Scratch Off Prompt on Health Engagement|Completed||N/A|84953|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-10-11 03:59:37.222118|2017-10-11 03:59:37.222118
NCT01401608|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-05-18|||March 2011||2011-03-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Stereotaxis Idiopathic Ventricular Tachycardia (VT) Study|RF Ablation of Idiopathic VT and PVCs Using Remote Magnetic Navigation|Terminated||N/A|6|Actual|Stereotaxis|||1|Difficult to recruit eligible subjects|f||||f||||||||||2017-10-11 03:59:37.299024|2017-10-11 03:59:37.299024
NCT01401582|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2017-04-03|2016-10-17||January 2012||2012-01-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2016|Actual|2016-03-01||Interventional|DelpHi|published in Thyrian et al. (2016). Journal of Alzheimer´s Disease (52); 69-617.|Intervention Study to Improve Life and Care for People With Dementia and Their Caregivers in Primary Care|Dementia: Life- and Personcentered Help in Germany|Active, not recruiting||N/A|634|Actual|German Center for Neurodegenerative Diseases (DZNE)||2|||f||||t||||||||No||2017-10-11 03:59:37.797829|2017-10-11 03:59:37.797829
NCT01401569|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-05-31|||October 2010||2010-10-01|May 2016|2016-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|STOB-ACTIV||Efficacy of Exercise and Counseling Intervention on Relapse in Smoker With Depressive Disorders|STOB-ACTIV: The Efficacy of Exercise and Counseling for Depressed Patients as an Aid for Smoking Cessation, a Randomized Controlled Trial|Terminated||Phase 3|70|Actual|University Hospital, Montpellier||2||Difficulties for recruiting patients|f||||f||||||||||2017-10-11 03:59:38.208385|2017-10-11 03:59:38.208385
NCT01401556|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-09-16|||September 2012||2012-09-01|September 2016|2016-09-01|January 2017|Anticipated|2017-01-01|July 2016|Actual|2016-07-01||Interventional|C-STOP#||C-STOP Fracture Trial|Comparing Strategies Targeting Osteoporosis to Prevent Recurrent Fractures: C-STOP# Randomized Trial|Active, not recruiting||Phase 3|360|Actual|University of Alberta||2|||f||||f||||||||Undecided||2017-10-11 03:59:38.313104|2017-10-11 03:59:38.313104
NCT01401543|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-09-12|||July 2011||2011-07-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Bioavailability Study of LY2452473 and Tadalafil|LY2452473 Formulation Exploratory Bioavailability Study|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 03:59:38.411239|2017-10-11 03:59:38.411239
NCT01401530|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-02-05|||July 2011||2011-07-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|August 2015|Actual|2015-08-01||Interventional|||E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma|Phase1/1b Clinical Trial of E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma|Completed||Phase 1|13|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 03:59:38.522124|2017-10-11 03:59:38.522124
NCT01401517|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2014-05-29|2014-05-29||July 2011||2011-07-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC|A Randomized, Double-blinded, Placebo-controlled, Phase IIa Dose-ranging Study to Assess the Safety, Pharmacokinetics, and Tolerability of Multiple Doses of Sodium Nitrite in Patients With Peripheral Arterial Disease (PAD) - SONIC|Completed||Phase 2|55|Actual|TheraVasc Inc.||3|||f||||f||||||||||2017-10-11 03:59:38.621727|2017-10-11 03:59:38.621727
NCT01401504|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2014-06-10|||May 2011||2011-05-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors|A Phase I, Non-randomized, Open-label, Repeat Oral Administration Study of ASP3026 in Patients With Solid Tumors|Completed||Phase 1|29|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-10-11 03:59:39.023057|2017-10-11 03:59:39.023057
NCT01401491|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-07-21|||January 2008||2008-01-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine|Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine|Completed||Phase 4|80|Actual|Taipei Medical University Hospital||2|||f||||f||||||||||2017-10-11 03:59:39.099939|2017-10-11 03:59:39.099939
NCT01401478|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2014-02-28|2014-01-14||July 2011||2011-07-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation|Prospective, Open-label, Multicenter Effectiveness and Safety Observational Study of Zemplar in Patients With Stage 5 Chronic Kidney Disease and Hyperparathyroidism on Hemodialysis in the Russian Federation|Completed||N/A|86|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 03:59:39.201104|2017-10-11 03:59:39.201104
NCT01401465|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-04-29|2012-11-09||July 2011||2011-07-01|April 2013|2013-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray|A Randomized Two Period Two-Way Crossover Study To Evaluate Patient Preference, Satisfaction And Efficacy Of A Nasal Aerosol Versus An Aqueous Nasal Spray Used For The Treatment Of Allergic Rhinitis|Completed||Phase 3|327|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 03:59:39.751138|2017-10-11 03:59:39.751138
NCT01401452|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2017-05-12|2017-05-12||August 2011||2011-08-01|May 2017|2017-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|EPIC||Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities|Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities|Completed||N/A|246|Actual|AbbVie|||1||f||||f||||||||No||2017-10-11 03:59:40.676655|2017-10-11 03:59:40.676655
NCT01401439|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2016-08-05|||June 2012||2012-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|GAIA||Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis|Longitudinal Assessment of Fat Free Mass Index and Its Impact on Lung Health and Overall Health Metrics in Pediatric Patients With Cystic Fibrosis|Completed||N/A|24|Actual|University of Arkansas|||1||f||||f||||||Samples Without DNA|"     Blood sample   "|||2017-10-11 03:59:41.101323|2017-10-11 03:59:41.101323
NCT01401426|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-05-18|||July 2010||2010-07-01|May 2016|2016-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Randomized Prospective Trial: Single Port Laparoscopic Vertical Sleeve Gastrectomy Versus Conventional Five Port Laparoscopic Vertical Sleeve Gastrectomy Surgery|Randomized Prospective Trial: Single Port Laparoscopic Vertical Sleeve Gastrectomy Versus Conventional Five Port Laparoscopic Vertical Sleeve Gastrectomy Surgery|Withdrawn||N/A|0|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||||||||||||2017-10-11 03:59:41.188977|2017-10-11 03:59:41.188977
NCT01401413|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2011-07-22|||January 2008||2008-01-01|July 2011|2011-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder|A Prospective Randomized, Placebo-Controlled Double-Blind Study to Determine the Efficacy of Ramelteon in REM Sleep Behavior Disorder|Completed||Phase 4|20|Anticipated|Sleep Medicine Centers of WNY||2|||f||||f||||||||||2017-10-11 03:59:41.259747|2017-10-11 03:59:41.259747
NCT01401205|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-12-24|||July 2011||2011-07-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||The Predictor of Respiratory Discomfort After the Shoulder Arthroscopic Surgery|The Predictor of Respiratory Discomfort After the Shoulder Arthroscopic Surgery as Measured by Upper Airway Ultrasonography|Completed||N/A|100|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:59:44.756416|2017-10-11 03:59:44.756416
NCT01401400|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2015-08-13|||May 2010||2010-05-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|GIANT-B||Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study|Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study|Completed||N/A|1350|Actual|Foundation for Liver Research|||1||f||||f||||||Samples With DNA|"     whole blood samples from which DNA can be isolated   "|||2017-10-11 03:59:41.337277|2017-10-11 03:59:41.337277
NCT01401387|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-02-21|||October 2011||2011-10-01|February 2013|2013-02-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|EPC||Pancreatic Enzyme Suppletion in Pancreatic Cancer|Exocrine Pancreatic Insufficiency in Pancreatic Cancer: Evaluating the Need and Efficacy of Pancreatic Enzyme Replacement Therapy|Withdrawn||Phase 4|0|Actual|Foundation for Liver Research||2||study never started|f||||f||||||||||2017-10-11 03:59:41.399904|2017-10-11 03:59:41.399904
NCT01401374|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-04-07|||March 2011||2011-03-01|April 2017|2017-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo|Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo|Completed||N/A|3258|Actual|St. Luke's-Roosevelt Hospital Center|||2||f||||f||||||||||2017-10-11 03:59:41.4738|2017-10-11 03:59:41.4738
NCT01401361|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-09-14|2013-11-04||October 2011||2011-10-01|September 2016|2016-09-01|September 2012|Actual|2012-09-01|April 2012|Actual|2012-04-01||Interventional|CONTACT_AFL||Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System|Clinical Evaluation of Contact™ Therapy™ Cool Path™ Cardiac Ablation System in Conjunction With EnSite Velocity Contact™ Technology for the Treatment of Typical Atrial Flutter|Completed||Phase 3|150|Actual|St. Jude Medical||1|||f||||t||||||||No||2017-10-11 03:59:41.547087|2017-10-11 03:59:41.547087
NCT01401348|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-07-15|||December 2010||2010-12-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Stanford Universities: The Stanford HIV Aging Cohort|The Stanford HIV Aging Cohort (SHAC)|Unknown status|Active, not recruiting|N/A|300|Anticipated|Stanford University|||1||f||||f||||||Samples Without DNA|"     PBMC's   "|||2017-10-11 03:59:43.191981|2017-10-11 03:59:43.191981
NCT01401335|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-21|||October 2009||2009-10-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth|A PILOT STUDY Integrating HIV Prevention and Care With Treatment of Psychological Trauma in Vulnerable Rwandan Youth: A Community-based Pilot Intervention|Completed||N/A|120|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 03:59:43.285892|2017-10-11 03:59:43.285892
NCT01401322|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-10-17|2014-10-27||January 2011||2011-01-01|October 2016|2016-10-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional||Relapsed or refractory ALL (at least 1 failed prior treatment regimen)|Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia|Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)|Terminated||Phase 2|5|Actual|Stanford University||1||low accrual|f||||t||||||||||2017-10-11 03:59:43.368446|2017-10-11 03:59:43.368446
NCT01401309|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-24|2014-02-20|||January 2011||2011-01-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|November 2011|Actual|2011-11-01||Observational|||PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer|Effects of Respiratory Gating on FDG/PET Detection of Hepatic Metastasis in Patients With Colon Cancer|Completed||N/A|81|Actual|Southwestern Regional Medical Center|||1||f||||t||||||||||2017-10-11 03:59:43.523146|2017-10-11 03:59:43.523146
NCT01401296|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-12-11|||May 2011||2011-05-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of the Effectiveness of a Web-based Treatment Program for Depression for the Reduction of Depressive Symptoms|Evaluation of the Effectiveness of a Web-based Treatment Program for Depression (Deprexis) for the Reduction of Depressive Symptoms. A Randomized Controlled Trial|Completed||N/A|200|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 03:59:43.574937|2017-10-11 03:59:43.574937
NCT01401283|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-01-06|2015-12-01||July 2011||2011-07-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||GDT by Cardiac Index Trending Via a Radial Arterial Line in General Surgery|Multi-center, Prospective, Randomized Outcome Study Comparing Continuous Cardiac Index Trending Via a Radial Arterial Line Versus Standard Care in General Surgical Patients|Completed||N/A|160|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-10-11 03:59:43.650308|2017-10-11 03:59:43.650308
NCT01401270|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2017-06-23|||November 2011||2011-11-01|June 2017|2017-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Prize Contingency Management for Cocaine-Dependent Methadone Patients|Prize Contingency Management for Cocaine-Dependent Methadone Patients|Active, not recruiting||N/A|300|Anticipated|UConn Health||6|||f||||f||||||||||2017-10-11 03:59:43.853016|2017-10-11 03:59:43.853016
NCT01401257|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-12-23|2016-12-23||December 2010||2010-12-01|July 2011|2011-07-01|December 2012|Actual|2012-12-01|October 2011|Actual|2011-10-01||Interventional|||Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A|A Phase II, Randomized, Placebo-controlled Trial of the Safety, Efficacy, Pharmacodynamics and Pharmacokinetics of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A.|Completed||Phase 2|80|Actual|Pharnext SA||4|||f||||t||||||||No||2017-10-11 03:59:43.925956|2017-10-11 03:59:43.925956
NCT01401244|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-02-23|||July 14, 2011|Actual|2011-07-14|February 2017|2017-02-01|September 27, 2011|Actual|2011-09-27|September 27, 2011|Actual|2011-09-27||Interventional|||Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers|A Trial to Examine the Bioequivalence of Norditropin® Versus Genotropin® in Healthy Adult Volunteers|Completed||Phase 1|30|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 03:59:44.488564|2017-10-11 03:59:44.488564
NCT01401218|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-12-24|||July 2011||2011-07-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Thoracic Aortic Surgery|Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Thoracic Aortic Surgery|Completed||N/A|799|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-10-11 03:59:44.672659|2017-10-11 03:59:44.672659
NCT01401192|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-22|||July 2011||2011-07-01|July 2011|2011-07-01||||December 2013|Anticipated|2013-12-01||Interventional|||Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression|A Randomized Phase II Study Comparing Pemetrexed Plus Cisplatin With Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Non-squamous Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|304|Anticipated|Samsung Medical Center||4|||f||||f||||||||||2017-10-11 03:59:44.844993|2017-10-11 03:59:44.844993
NCT01401179|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-08-05|||April 2005||2005-04-01|July 2011|2011-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|PPROM||Antibiotics Study in Preterm Premature Rupture of the Membranes|Randomized Phase III Trial of Cefazolin or Combination of Cefazolin and Erythromycin or Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of the Membranes|Completed||Phase 3|101|Actual|Samsung Medical Center||3|||f||||t||||||||||2017-10-11 03:59:44.957925|2017-10-11 03:59:44.957925
NCT01401166|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2017-01-19|2015-02-09||October 2011||2011-10-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|May 2013|Actual|2013-05-01||Interventional|PrefHER|Safety Population: All participants who received at least one dose of Herceptin.|Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer|A Randomized, Multi-Center Cross-Over Study to Evaluate Patient Preference and Health Care Professional (HCP) Satisfaction With Subcutaneous (SC) Administration of Trastuzumab in HER2-Positive Early Breast Cancer (EBC)|Completed||Phase 2|488|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 03:59:45.094541|2017-10-11 03:59:45.094541
NCT01401153|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-10-09|2012-08-31||May 2011||2011-05-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|CogniDO||Cognition Intervention Study Dortmund|Cross-over Trial Determining the Short-term Effects of Lunch on Children's Cognitive Functioning|Completed||N/A|105|Actual|Research Institute of Child Nutrition, Dortmund|"Open-label study, in which everyone involved knew about group assignment
Only one cognitive assessment per test day"|2|||f||||f||||||||||2017-10-11 03:59:46.715924|2017-10-11 03:59:46.715924
NCT01401140|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2012-03-16|||June 2010||2010-06-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|Cardioplégie||Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis|Coronary Surgery: Comparing the Protective Effects of Two Cardioplegic Solutions: Custodiol Versus St Thomas, on Cardiac Metabolism, as Assessed Using Microdialysis|Completed||Phase 3|29|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-11 03:59:47.29171|2017-10-11 03:59:47.29171
NCT01401127|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-11-07|||January 2011||2011-01-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Managing Insulin Pumps for Exercise - Study 1|A Comparison of Metabolism During Moderate Exercise Between Healthy Volunteers and People With T1DM Treated With CSII Using 70% of Their Usual Insulin Basal Rate|Completed||N/A|16|Anticipated|Buckinghamshire Healthcare NHS Trust|||2||f||||f||||||Samples Without DNA|"     All samples retained will be plasma samples. Any samples remaining after analysis will be     retained until the 3 trials in this research study have been completed, and will then be     destroyed.   "|||2017-10-11 03:59:47.380973|2017-10-11 03:59:47.380973
NCT01401114|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2015-09-25|||March 2009||2009-03-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Observational|WELLNARA||Wellnara Post-marketing Surveillance in Japan|Drug Use Investigation of Wellnara Tablet|Completed||N/A|411|Actual|Bayer|||1||f||||f||||||||||2017-10-11 03:59:47.478171|2017-10-11 03:59:47.478171
NCT01401101|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-26|2016-07-21|2015-06-28||June 2010||2010-06-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|February 2014|Actual|2014-02-01||Interventional|ViStA|We randomized 206 patients to the PCM condition and 198 to the ECE conditions. However, only 355 patients of the 404 patients randomized completed the baseline survey, So, 49 patients have missing data in the evaluation.|Violence and Stress Assessment (ViStA) Project to Improve Post Traumatic Stress Disorder Management in Primary Care|Improving PTSD Management in Primary Care|Completed||Phase 2|404|Actual|RAND||2|||f||||f||||||||No|No data sharing plan was associated with this project at the time it was funded.|2017-10-11 03:59:47.56913|2017-10-11 03:59:47.56913
NCT01401088|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2013-01-02|||July 2011||2011-07-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|AADI||Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma|Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma|Unknown status|Recruiting|Phase 4|30|Anticipated|Aurolab||1|||f||||f||||||||||2017-10-11 03:59:47.974766|2017-10-11 03:59:47.974766
NCT01401075|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-22|2012-11-06|||March 2006||2006-03-01|July 2011|2011-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients|Prospective Controlled Randomized Comparative Study About Quality of Life (QoL), Immunomodulation and Safety of Adjuvant Mistletoe Treatment in Patients With Gastric Carcinoma Receiving Chemotherapy After Operation|Completed||Phase 4|32|Actual|Abnoba Gmbh||2|||f||||f||||||||||2017-10-11 03:59:48.077504|2017-10-11 03:59:48.077504
NCT01401062|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-02-21|2017-02-21||July 2011||2011-07-01|February 2017|2017-02-01|June 2017|Anticipated|2017-06-01|June 2014|Actual|2014-06-01||Interventional|||Fresolimumab and Radiotherapy in Metastatic Breast Cancer|Fresolimumab and Radiotherapy in Metastatic Breast Cancer|Active, not recruiting||Phase 2|23|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-11 03:59:48.210505|2017-10-11 03:59:48.210505
NCT01401049|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-09-07|2014-12-22||August 2010||2010-08-01|September 2017|2017-09-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Interventional||Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|Preventing Propofol Injection Pain: Prospective Randomized Trial Comparing Propofol Versus Fospropofol|Preventing Propofol Injection Pain: Prospective Randomized Trial Comparing Propofol Versus Fospropofol|Completed||Phase 4|116|Actual|New York University School of Medicine||2|||f||||f|t|f|||f|||||2017-10-11 03:59:48.768326|2017-10-11 03:59:48.768326
NCT01401036|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-11-27|||July 2011||2011-07-01|November 2014|2014-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Nobori And Uncoated Stent In Coronary Attack|Clinical Trial of Nobori Versus Uncoated Stents In Acute Myocardial Infarction|Unknown status|Recruiting|N/A|1400|Anticipated|NAUSICA Investigators||2|||f||||t||||||||||2017-10-11 03:59:48.942638|2017-10-11 03:59:48.942638
NCT01401023|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-10-12|2013-07-30||July 2011||2011-07-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)|Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)|Completed||N/A|10|Actual|Michigan State University||1|||f||||t||||||||||2017-10-11 03:59:49.204573|2017-10-11 03:59:49.204573
NCT01401010|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-10-12|2012-03-06||August 2010||2010-08-01|October 2015|2015-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients|Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients With Possible Bacterial Infection|Completed||Phase 4|12|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 03:59:49.428335|2017-10-11 03:59:49.428335
NCT01400997|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-04-20|||September 2011||2011-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS CZ||Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic|Easypod Connect: A National, Multicentre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Czech Republic|Completed||N/A|206|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 03:59:49.866424|2017-10-11 03:59:49.866424
NCT01400984|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-04-20|||December 2011||2011-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS SVK||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia|Easypod Connect: A National, Multicentre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Slovakia|Completed||N/A|92|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 03:59:49.941282|2017-10-11 03:59:49.941282
NCT01400971|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-10-26|||July 2011||2011-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|MOSAIc||An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes|A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study|Completed||N/A|4530|Actual|Eli Lilly and Company|||2||f||||f||||||||||2017-10-11 03:59:50.053497|2017-10-11 03:59:50.053497
NCT01400958|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-10-25|2013-08-06||December 2010||2010-12-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional||All participants|Nuvigil or Placebo in Newly Diagnosed Malignant Glioma|A Randomized, Double Blind, Placebo-Controlled Study Evaluating the Effect of Nuvigil® (Armodafinil) in Newly Diagnosed Malignant Glioma Patients Experiencing Fatigue Secondary to External Beam Radiation Therapy and Concurrent Temozolomide|Terminated||Phase 2|6|Actual|H. Lee Moffitt Cancer Center and Research Institute|Planned accrual of 60 participants for analysis was not met. Recruitment was closed early due to slow accrual and initiating Principal Investigator (PI) leaving Moffitt.|2||Slow Accrual, Initiating Principal Investigator (PI) left Moffitt|f||||t||||||||||2017-10-11 03:59:50.59544|2017-10-11 03:59:50.59544
NCT01400945|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-09-19|||December 2009||2009-12-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|AGSPT||Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease|Double Blinded, Randomized, Active Drug Comparative, Therapeutic Confirmatory Clinical Study to Evaluate the Efficacy and Safety of AGSPT201 in GERD Patients|Completed||Phase 3|154|Actual|Ahn-Gook Pharmaceuticals Co.,Ltd||1|||f||||t||||||||||2017-10-11 03:59:50.924738|2017-10-11 03:59:50.924738
NCT01400932|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-07-10|2014-07-10||July 2011||2011-07-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects|Study STF115288, a Clinical Confirmation Study of GI148512 (Benzoyl Peroxide 3% Gel) in the Treatment of Acne Vulgaris in Japanese Subjects.- A Multicenter, Randomized, Double-blinded, Vehicle-controlled, Parallel-group Study -|Completed||Phase 3|360|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 03:59:51.114664|2017-10-11 03:59:51.114664
NCT01400919|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-03-14|2015-06-08||July 2011||2011-07-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|November 2013|Actual|2013-11-01||Interventional|||DURABILITY™ Iliac Study|Protege® EverFlex™ and GPS™ Self-Expanding Iliac Study (DURABILITY™ Iliac)|Completed||Phase 2/Phase 3|75|Actual|Medtronic Endovascular||1|||f||||||||||||||2017-10-11 03:59:52.117924|2017-10-11 03:59:52.117924
NCT01400906|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-11-18|2013-07-18||July 2011||2011-07-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.|A Randomized, Double Blind, Placebo-controlled Three-way Crossover Study in Mild Asthmatics to Evaluate the Effect of Smoking Status on the Attenuation by Inhaled Corticosteroids of the Allergen-induced Asthmatic Response.|Completed||Phase 2|36|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 03:59:52.347185|2017-10-11 03:59:52.347185
NCT01400893|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-08-29|2017-03-14||August 2011||2011-08-01|May 2017|2017-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury|A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)|Terminated||Phase 2|134|Actual|CytoPherx, Inc||2|||f||||t||||||||||2017-10-11 03:59:53.052361|2017-10-11 03:59:53.052361
NCT01400880|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-02-10|2014-09-09||July 2011||2011-07-01|February 2015|2015-02-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational||The number of participants was determined by the time allowable by the IRB approval for the site study.|Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability|Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability|Completed||N/A|103|Actual|Convergent Engineering, Inc.|||1||f||||f||||||||||2017-10-11 03:59:53.675309|2017-10-11 03:59:53.675309
NCT01400867|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-01-12|||December 2011||2011-12-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections|A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Ceftaroline Versus Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections|Completed||Phase 2/Phase 3|163|Actual|Forest Laboratories||2|||f||||t||||||||||2017-10-11 03:59:53.899341|2017-10-11 03:59:53.899341
NCT01400854|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2012-10-23|||July 2011||2011-07-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|ERKENTNIS||Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability|ERKENTNIS: Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability|Completed||N/A|600|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-10-11 03:59:54.118921|2017-10-11 03:59:54.118921
NCT01400841|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-11-27|2016-09-30||January 2012||2012-01-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|April 2013|Actual|2013-04-01||Interventional|||HAART Model 300 Annuloplasty Ring|A Prospective, Non-randomized, Multi-center Trial to Evaluate the Safety and Effectiveness of the HAART Model 300 Annuloplasty Ring When Used to Surgically Repair a Leaking Aortic Valve Using a 3-D Intra-annular Mounting Frame|Completed||N/A|18|Actual|Biostable Science & Engineering||1|||f||||t||||||||Undecided||2017-10-11 03:59:54.322142|2017-10-11 03:59:54.322142
NCT01400828|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-07-08|||June 2011||2011-06-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|June 2013|Actual|2013-06-01||Interventional|||Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis|Randomized, Double-blind, Placebo/Active-controlled, Multi-center Clinical Trial to Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg After 14-day Oral Administration in Patients With Seasonal Allergic Rhinitis|Completed||Phase 3|239|Actual|Yuhan Corporation||3|||f||||f||||||||||2017-10-11 03:59:55.144829|2017-10-11 03:59:55.144829
NCT01400815|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-10-25|||July 2011||2011-07-01|October 2011|2011-10-01|January 2012|Anticipated|2012-01-01|November 2011|Anticipated|2011-11-01||Interventional|||Randomized Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid|A Prospective, Double-blind, Randomized, Active Controlled, Parallel Group, Multicenter Phase II Clinical Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid|Unknown status|Active, not recruiting|Phase 2|216|Anticipated|22nd Century Limited, LLC||2|||f||||f||||||||||2017-10-11 03:59:55.253167|2017-10-11 03:59:55.253167
NCT01400802|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2013-01-24|||November 2011||2011-11-01|January 2013|2013-01-01|June 2012|Anticipated|2012-06-01|May 2012|Anticipated|2012-05-01||Interventional|||Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects||Withdrawn||Phase 1|0|Actual|Wockhardt||2||Study was not initiated|f||||f||||||||||2017-10-11 03:59:55.341485|2017-10-11 03:59:55.341485
NCT01400789|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2013-01-24||||||January 2013|2013-01-01||||||||Interventional|||Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in Healthy Subjects||Withdrawn||Phase 1|0|Actual|Wockhardt||2||Study was not initiated|f||||f||||||||||2017-10-11 03:59:55.4351|2017-10-11 03:59:55.4351
NCT01400776|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-02-24||2013-02-28|July 2011||2011-07-01|February 2015|2015-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|VENUS||Safety & Efficacy WC3011 in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women|A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of WC3011 in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women|Completed||Phase 3|722|Actual|Warner Chilcott||4|||f||||f||||||||||2017-10-11 03:59:55.560488|2017-10-11 03:59:55.560488
NCT01400763|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-07-21|||May 2011||2011-05-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|METC-11/07||Lutein Bioavailability From Fresh and Dried Beverages|Bioavailability of Lutein From a Lutein-enriched Egg-yolk-beverage and Its Dried Re-suspended Versions.|Completed||N/A|103|Actual|Wageningen University||1|||f||||t||||||||||2017-10-11 03:59:55.834144|2017-10-11 03:59:55.834144
NCT01400750|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-08-03|||August 2001||2001-08-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|August 2010|Actual|2010-08-01||Interventional|CCTOBI||Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis|Prospective Randomized Trial Comparing Oral Ciproxin Plus Inhaled Colistin With Tobramycin for Inhalation for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis.|Completed||Phase 4|61|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-10-11 03:59:55.921866|2017-10-11 03:59:55.921866
NCT01400737|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-21|||July 2011||2011-07-01|July 2011|2011-07-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|OIP||Oral Ibuprofen Prophylaxis for Patent Ductus Arterioses in Very Extremely Low Birth Weight Infants|Oral Ibuprofen Prophylaxis for Patent Ductus Arterioses in Very Extremely Low Birth Weight Infants|Unknown status|Recruiting|N/A|200|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital||1|||f||||f||||||||||2017-10-11 03:59:56.058043|2017-10-11 03:59:56.058043
NCT01400724|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-07-15|||June 2011||2011-06-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Inofolic NRT and the Metabolic Syndrome|Effects of Inofolic NRT on Post-menopausal Women Affected by the Metabolic Syndrome|Completed||N/A|80|Actual|University of Messina||1|||f||||f||||||||||2017-10-11 03:59:56.155964|2017-10-11 03:59:56.155964
NCT01400711|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-07-21|||October 2010||2010-10-01|August 2010|2010-08-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Enhanced Recovery After Surgery in Major Intrabdominal Procedures.|Enhanced Recovery After Surgery (ERAS) Versus Conventional Postoperative Care in Patients Undergoing Major Intra-abdominal Surgery.|Completed||N/A|54|Actual|St. Andrew's General Hospital, Patras, Greece||2|||f||||f||||||||||2017-10-11 03:59:56.258992|2017-10-11 03:59:56.258992
NCT01400698|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-09-09|2012-06-27||November 1998||1998-11-01|September 2013|2013-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Saizen in Intra-uterine Growth Retardation|An Open Study of the Safety and Efficacy of Saizen®, (Recombinant Human Growth Hormone, r-hGH), in Children Born With Serious Intra-uterine Growth Retardation (IUGR) Treated to Final Height|Completed||Phase 3|91|Actual|Merck KGaA||3|||f||||||||||||||2017-10-11 03:59:56.375502|2017-10-11 03:59:56.375502
NCT01400685|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-11|2017-06-19|||December 2012||2012-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL|Lenalidomide in Combination With Bendamustine and Rituximab for Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma(CLL/SLL): a Phase I Study|Active, not recruiting||Phase 1|34|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 03:59:57.186187|2017-10-11 03:59:57.186187
NCT01400672|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-06-08|||July 17, 2012|Actual|2012-07-17|June 2017|2017-06-01|October 10, 2015|Actual|2015-10-10|June 17, 2015|Actual|2015-06-17||Interventional|||Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma|Imiquimod/BTIC Lysate-Based Vaccine Immunotherapy for Diffuse Intrinsic Pontine Glioma in Children and Young Adults|Completed||Phase 1|8|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 03:59:57.297478|2017-10-11 03:59:57.297478
NCT01400659|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-12-17|||March 2009||2009-03-01|December 2015|2015-12-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Pizza-Salami Study in Children and Adolescents With Type 1 Diabetes|The PIZZA-Salami Trial: Monocentric Randomised Cross-over Study of Carb Counting vs. Carb Plus Fat/Protein Counting Based Insulin Bolus Used for Sensor-augmented Continuous Subcutaneous Insulin Infusion (CSII) in Pediatric Patients|Completed||Phase 4|42|Actual|Kinderkrankenhaus auf der Bult||2|||f||||f||||||||||2017-10-11 03:59:57.389852|2017-10-11 03:59:57.389852
NCT01400646|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-01-23|||October 2011||2011-10-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers|An Open-Label, Non-Randomized, Sequential Two-Treatment Period Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin|Completed||Phase 1|46|Actual|Janssen Research & Development, LLC||2|||f||||||||||||||2017-10-11 03:59:57.48879|2017-10-11 03:59:57.48879
NCT01400633|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-05-22|||December 2010||2010-12-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome|A Prospective Multicenter Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome|Completed||Phase 4|156|Actual|Janssen Korea, Ltd., Korea|||1||f||||||||||||||2017-10-11 03:59:57.603844|2017-10-11 03:59:57.603844
NCT01400620|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-11-13|||March 2012||2012-03-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer|Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer|Active, not recruiting||Phase 2|110|Actual|Izun Pharma Ltd||2|||f||||f||||||||||2017-10-11 03:59:57.721524|2017-10-11 03:59:57.721524
NCT01400607|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-08-29|||July 2011||2011-07-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Neocartilage Implant to Treat Cartilage Lesions of the Knee|Randomized Controlled Trial to Evaluate the Efficacy of a Neocartilage Implant in the Management of ICRS Grade 3 to 4 Articular Cartilage Lesions of the Knee|Terminated||Phase 3|14|Actual|ISTO Technologies, Inc.||2||Poor enrollment|f||||t||||||||||2017-10-11 03:59:58.010172|2017-10-11 03:59:58.010172
NCT01400594|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-05-12||2015-03-17|July 2011||2011-07-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail|A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety & Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail|Completed||Phase 2|182|Actual|Hisamitsu Pharmaceutical Co., Inc.||2|||f||||f||||||||||2017-10-11 03:59:58.168134|2017-10-11 03:59:58.168134
NCT01400568|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-03-09|||August 2011||2011-08-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Suitability of a Low Dose Lipopolysaccharide (LPS) Inhalation as a Challenge Model|A Methodological Pilot Study to Assess the Suitability of a Low Dose LPS Inhalation as a Challenge Model in Early Translational Drug Development|Completed||N/A|12|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f||||f||||||||||2017-10-11 03:59:58.471164|2017-10-11 03:59:58.471164
NCT01400555|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-06-07|||September 1, 2011|Actual|2011-09-01|June 2017|2017-06-01|February 28, 2017|Actual|2017-02-28|May 12, 2014|Actual|2014-05-12||Interventional|mCRPC||A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)|A Phase 1b Safety Study of Abiraterone Acetate (JNJ-212082) and Docetaxel in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)|Completed||Phase 1|22|Actual|Cougar Biotechnology, Inc.||4|||f||||t||f||||||||2017-10-11 03:59:58.680433|2017-10-11 03:59:58.680433
NCT01400542|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-08-09|||December 2010||2010-12-01|August 2016|2016-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|AZAP||Sleep Apnea in Early to Mid-Stage Alzheimer's Disease|Sleep Apnea in Early to Mid-Stage Alzheimer's Disease: What Impact of Treatment on the Cognitive Functions of Elderly Patients With Memory Loss?|Terminated||N/A|22|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2|End of the study because of the inclusions were too difficult|f||||f||||||||No||2017-10-11 03:59:58.821491|2017-10-11 03:59:58.821491
NCT01400529|ClinicalTrials.gov processed this data on October 10, 2017|2007-07-05|2011-07-21|||March 2007||2007-03-01|July 2007|2007-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|3000ARTHROSE||Etude 3000 ARTHROSES Symptomatic Knee and Hip Osteoarthritis Prevalence Survey|Etude 3000 ARTHROSES Symptomatic Knee and Hip Osteoarthritis Prevalence Survey. Programme de Recherche du Groupe Qualité de Vie, de la Section Epidémiologie et de la Section Arthrose de la Société Française de Rhumatologie|Completed||N/A|3000|Actual|Central Hospital, Nancy, France|||1||f||||t||||||||||2017-10-11 03:59:58.946692|2017-10-11 03:59:58.946692
NCT01400516|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2017-02-28|2017-02-28||August 2011||2011-08-01|February 2017|2017-02-01|July 28, 2016|Actual|2016-07-28|July 30, 2015|Actual|2015-07-30||Interventional|TERA|Analysis includes 24 participants who were randomized, 2 participants withdrew prematurely and are not included.|Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial|Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial|Completed||Phase 4|26|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 03:59:59.072368|2017-10-11 03:59:59.072368
NCT01400503|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2017-06-23|||April 1, 2011|Actual|2011-04-01|June 2017|2017-06-01|February 2, 2018|Anticipated|2018-02-02|March 1, 2017|Actual|2017-03-01||Interventional|||A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease|An Open-label, Multicenter Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Subjects With Multicentric Castleman's Disease|Active, not recruiting||Phase 2|59|Actual|Janssen Research & Development, LLC||1|||f||||f||f||||||||2017-10-11 03:59:59.554868|2017-10-11 03:59:59.554868
NCT01400490|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||September 2010||2010-09-01|July 2011|2011-07-01|September 2011|Anticipated|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study|Evaluation of the Biologic Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)-Enriched Oils (EPA-DHA Study)|Unknown status|Active, not recruiting|N/A|120|Anticipated|Cardiovascular Research Associates||4|||f||||f||||||||||2017-10-11 03:59:59.773298|2017-10-11 03:59:59.773298
NCT01400464|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-04-08|||July 2009||2009-07-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|PREDICORT||Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis|Study the Link Between Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis|Unknown status|Active, not recruiting|Phase 4|150|Anticipated|University Hospital, Caen||1|||f||||f||||||||||2017-10-11 04:00:00.052509|2017-10-11 04:00:00.052509
NCT01400451|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-12-10|2014-04-21||November 2011||2011-11-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional||All participants who received at least one dose of study drug.|Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)|A Phase I Trial of Vemurafenib and Ipilimumab in Subjects With V600 BRAF Mutation-positive Metastatic Melanoma|Terminated||Phase 1|18|Actual|Bristol-Myers Squibb|In Phase 1 of the study, MTD was not reached because more than 2 of 6 treated participants experienced DLTs with the combination therapy. Enrollments in Phase 1 were terminated and Phase 2 was not started so only overall safety was summarized.|1||More than 2 of 6 patients treated experienced dose limiting toxicities.|f||||f||||||||||2017-10-11 04:00:00.274707|2017-10-11 04:00:00.274707
NCT01400438|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-07-20|||July 2011||2011-07-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|HER-ception||Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer|Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer: Fatigue and Quality of Life During and Waning of Treatment, Psychosocial Aspects (Environment, Work)|Completed||N/A|70|Actual|Centre Francois Baclesse||2|||f||||f||||||||||2017-10-11 04:00:02.364152|2017-10-11 04:00:02.364152
NCT01400425|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-03-22|2012-12-06||July 2011||2011-07-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline|Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline|Completed||Phase 3|239|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-10-11 04:00:02.53049|2017-10-11 04:00:02.53049
NCT01400412|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2016-05-18|2015-06-17||December 2011||2011-12-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Participants who started study treatment|Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen|A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1|Completed||Phase 2|262|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 04:00:03.15046|2017-10-11 04:00:03.15046
NCT01400399|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-12-08|||August 2010||2010-08-01|December 2015|2015-12-01|August 2020|Anticipated|2020-08-01|August 2016|Anticipated|2016-08-01||Observational|||Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer|Phase II Evaluation of Hypofractionated Breast Irradiation in Patients Undergoing Standard Lumpectomy or Oncolytic Mammoplasty With Bilateral Breast Reduction|Recruiting||N/A|84|Anticipated|Coastal Carolina Radiation Oncology|||1||f||||f||||||||||2017-10-11 04:00:04.201337|2017-10-11 04:00:04.201337
NCT01400386|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-05-21|||November 2010||2010-11-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2011|Actual|2011-06-01||Interventional|||Bioavailability of Chlorogenic and Phenolic Acids From Soluble Coffees|Bioavailability of Chlorogenic and Phenolic Acids From Soluble Coffees|Completed||N/A|14|Actual|Nestlé||4|||f||||t||||||||||2017-10-11 04:00:04.319737|2017-10-11 04:00:04.319737
NCT01400373|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-09|2017-03-01|||June 2010||2010-06-01|March 2017|2017-03-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|PRINCESS||Prehospital Resuscitation Intra Nasal Cooling Effectiveness Survival Study|PRINCESS - Prehospital Resuscitation Intra Nasal Cooling Effectiveness Survival Study|Recruiting||Phase 2|900|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 04:00:04.414702|2017-10-11 04:00:04.414702
NCT01400360|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||August 2009||2009-08-01|May 2011|2011-05-01||||August 2011|Anticipated|2011-08-01||Interventional|IMCVS||Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage|Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage|Unknown status|Recruiting|N/A|92|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 04:00:04.527785|2017-10-11 04:00:04.527785
NCT01400347|ClinicalTrials.gov processed this data on October 10, 2017|2009-11-18|2011-07-20|||July 2012||2012-07-01|November 2009|2009-11-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Observational|||Electromyography During Common Exercises Used in Rehabilitation|Influence of Fatigue and Speed on Electromyographic Activity of Lower Extremity Muscles During Selected Weight Bearing Exercises Commonly Used for Fitness and Rehabilitation|Unknown status|Not yet recruiting|N/A|20|Anticipated|State University of New York - Upstate Medical University|||1||f||||t||||||||||2017-10-11 04:00:06.474632|2017-10-11 04:00:06.474632
NCT01400334|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-12-08|||July 2004||2004-07-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|PAREPET||Prediction of ARrhythmic Events With Positron Emission Tomography|Hibernating Myocardium and Sudden Cardiac Death|Completed||N/A|257|Actual|State University of New York at Buffalo|||1||f||||t||||||Samples Without DNA|"     serum and plasma   "|||2017-10-11 04:00:06.5538|2017-10-11 04:00:06.5538
NCT01400321|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2012-11-15|||July 2011||2011-07-01|November 2012|2012-11-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|GAST||PEERS Multicenter Osseospeed TM TX Profile Implant: German Astra Soft Tissue (GAST) Maintenance Study|PEERS Multicenter OsseoSpeedTM TX Profile Implant: German Astra Soft Tissue (GAST) Maintenance Study An Open, Prospective Observational Study to Evaluate Implant Stability, Marginal Bone and Soft Tissue Maintenance of the Astra Tech Dental Implant System: OsseoSpeedTM TX Profile Implant in Patients With Tooth Loss in the Aesthetic Zone or the Posterior Atrophied Mandible|Unknown status|Recruiting|N/A|300|Anticipated|Johannes Gutenberg University Mainz|||2||f||||f||||||||||2017-10-11 04:00:06.666449|2017-10-11 04:00:06.666449
NCT01400295|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-09-14|||December 2010||2010-12-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|PRECOMIN||PREdictive Value of COntrast voluMe to creatinINe Clearance Ratio|Predictive Value of the Contrast Media Volume to Creatinine Clearance Ratio for the Risk of Contrast-Induced Nephropathy After Coronary Angiography|Completed||N/A|3000|Actual|Guangdong General Hospital|||1||f||||t||||||||||2017-10-11 04:00:06.996071|2017-10-11 04:00:06.996071
NCT01400282|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||July 2011||2011-07-01|June 2011|2011-06-01|September 2012|Anticipated|2012-09-01|June 2012|Anticipated|2012-06-01||Interventional|||Analgesic Efficacy of High Frequency Spinal Cord Stimulation|Analgesic Efficacy of High Frequency Spinal Cord Stimulation: a Placebo-controlled Study|Unknown status|Recruiting|Phase 4|30|Anticipated|Ensemble Hospitalier de la Côte||2|||f||||t||||||||||2017-10-11 04:00:07.115243|2017-10-11 04:00:07.115243
NCT01400269|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-08-12|||September 2010||2010-09-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism|An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism|Completed||N/A|48|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 04:00:07.218112|2017-10-11 04:00:07.218112
NCT01400256|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-05-06|||August 2007||2007-08-01|May 2016|2016-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|BLAST||Blood Pressure Lowering in Acute Stroke Trial|The Use of Valsartan for the Management of Blood Pressure in Acute Stroke: Affects on Cerebral Blood Flow|Withdrawn||Phase 4|0|Actual|Stanford University||1||lack of recruitment/patient population|f||||t||||||||||2017-10-11 04:00:07.323154|2017-10-11 04:00:07.323154
NCT01400243|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-21|2015-04-16|2015-02-20||April 2011||2011-04-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|NMW||Nicotine Patch for Marijuana Withdrawal|Nicotine for Marijuana Withdrawal|Completed||Phase 4|127|Actual|Southern Illinois University Carbondale|The modest sample size limited the ability to precisely characterize how the effects of patch type may be modified by tobacco smoker status, gender, personality traits, and individual differences in marijuana use history.|2|||f||||t||||||||||2017-10-11 04:00:07.527452|2017-10-11 04:00:07.527452
NCT01400230|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2015-03-23|||March 2008||2008-03-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|IMAGES-FFR||Diagnostic Performances of Computed TomographIc Coronary Angiography and Intravascular Ultrasound|Diagnostic Performances of the Computed Tomographic Coronary Angiography and IntraVascular UltraSound to Evaluate Ischemia Causing Coronary Artery Stenosis|Completed||N/A|150|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 04:00:08.302951|2017-10-11 04:00:08.302951
NCT01400217|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2012-10-29|||January 1991||1991-01-01|October 2012|2012-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Qvar Versus Clenil, a General Practice Research Database Study|HFA Beclomethasone in Asthma, a General Practice Research Database Study: Real-life Observational Evaluation of Extra-fine With Standard Particle Size Beclometasone Dipropionate Using the Propellant Hydrofluoroalkane 134a for the Management of Asthma in a Representative UK Primary Care Population|Completed||N/A|56985|Actual|Research in Real-Life Ltd|||6||f||||t||||||||||2017-10-11 04:00:08.398874|2017-10-11 04:00:08.398874
NCT01400204|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||December 2010||2010-12-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Naturalistic Study Into the Hangover Effects of MDMA|A Naturalistic Study Comparing the Hangover Effects of MDMA, Other Drugs, and Alcohol in a Sample of Recreational Polydrug Users|Completed||N/A|39|Actual|Utrecht Institute for Pharmaceutical Sciences|||3||f||||f||||||||||2017-10-11 04:00:08.502939|2017-10-11 04:00:08.502939
NCT01400191|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-06-25|||January 2012||2012-01-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1|The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1 (OCT1) in Healthy Volunteers|Completed||Phase 4|37|Actual|University of Southern Denmark||3|||f||||t||||||||||2017-10-11 04:00:08.570161|2017-10-11 04:00:08.570161
NCT01400178|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-10-28|||November 2009||2009-11-01|October 2016|2016-10-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Observational|||Cochlear Implants in Post-lingually Children: Results After 10 Years|Cochlear Implants in Post-lingually Children: Results After 10 Years|Completed||N/A|10|Actual|University of Sao Paulo|||1||f||||t||||||||||2017-10-11 04:00:08.642885|2017-10-11 04:00:08.642885
NCT01400165|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||July 2011||2011-07-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand Preparations|Examination of the Pharmacokinetic Properties of Three Generic Medications and Their Respective Brand Preparations in Healthy Male Volunteers|Unknown status|Recruiting|Phase 1|30|Anticipated|University of Ottawa||3|||f||||f||||||||||2017-10-11 04:00:08.699242|2017-10-11 04:00:08.699242
NCT01400152|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-21|||December 2007||2007-12-01|July 2011|2011-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Active Warming in Prehospital Trauma Care|The Effect of Active Warming in Prehospital Trauma Care During Road and Air Ambulance Transportation - a Clinical Randomized Trial|Completed||N/A|48|Actual|Umeå University||2|||f||||t||||||||||2017-10-11 04:00:08.791885|2017-10-11 04:00:08.791885
NCT01400139|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-09-23|2014-12-01||July 2011||2011-07-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|||Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.|An Open-label, Multicenter Study to Assess the Long -Term Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects With Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain|Completed||Phase 3|922|Actual|Purdue Pharma LP||1|||f||||t||||||||||2017-10-11 04:00:08.884136|2017-10-11 04:00:08.884136
NCT01400126|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||August 2011||2011-08-01|November 2010|2010-11-01|January 2013|Anticipated|2013-01-01|August 2012|Anticipated|2012-08-01||Observational|||Ultrapure Water System for Hemodialysis Therapy|The Effect of Ultrapure Water System on Hemodialysis Therapy- a Single Center Trial|Unknown status|Not yet recruiting|N/A|150|Anticipated|Tel Aviv Medical Center|||1||f||||f||||||||||2017-10-11 04:00:09.929122|2017-10-11 04:00:09.929122
NCT01399918|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-07-21|||July 2011||2011-07-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)|A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)|Active, not recruiting||Phase 2|55|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:00:11.473045|2017-10-11 04:00:11.473045
NCT01400113|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-04-26|2013-12-03||April 2012||2012-04-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Treating Acutely Agitated Patients With Asenapine Sublingual Tablets|Treating Acutely Agitated Patients With Asenapine Sublingual Tablets: A Single-Dose, Randomized, Double-Blind Placebo Controlled Trial|Completed||Phase 4|120|Actual|St. Joseph Hospital Health Center|"The short observation period of 2 hours.
Dependence on spontaneous self reporting of adverse effects.
Specific inquiry was not made regarding adverse events."|2|||f||||t||||||||Yes|All data available upon request.|2017-10-11 04:00:09.990029|2017-10-11 04:00:09.990029
NCT01400100|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2012-03-04|||August 2011||2011-08-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Intraarterial Octreotide on Pancreatic Texture|Changes in Pancreatic Texture After Single-shot Administration of 500 µg Octreotide in the Gastroduodenal Artery During Pancreatoduodenectomy - a Double-Blinded Randomized Controlled Trial|Completed||N/A|26|Actual|St. Josef Hospital Bochum||2|||f||||t||||||||||2017-10-11 04:00:10.278537|2017-10-11 04:00:10.278537
NCT01400087|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||June 2011||2011-06-01|June 2011|2011-06-01||||November 2013|Anticipated|2013-11-01||Interventional|||Cap-attached Colonoscopy Versus Regular Colonoscopy for Trainees||Unknown status|Recruiting|N/A|500|Anticipated|Showa University||2|||f||||f||||||||||2017-10-11 04:00:10.376882|2017-10-11 04:00:10.376882
NCT01400074|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2014-01-10|||January 2009||2009-01-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|RE-NICE||Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib|A Phase III Multi-center, Open-label, Randomized Study of the Efficacy of Nilotinib Versus Imatinib in Adult Patients With Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib|Unknown status|Recruiting|Phase 3|100|Anticipated|Seoul St. Mary's Hospital||2|||f||||t||||||||||2017-10-11 04:00:10.465059|2017-10-11 04:00:10.465059
NCT01400061|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||August 2011||2011-08-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Observational|||Relation of Blood-boron Levels With Body Mass Index|Phase 1 Study of Blood Boron Levels According to Body Mas Index|Unknown status|Not yet recruiting|N/A|80|Anticipated|SB Istanbul Education and Research Hospital|||4||f||||f||||||Samples Without DNA|"     blood serum analyses   "|||2017-10-11 04:00:10.542436|2017-10-11 04:00:10.542436
NCT01400048|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-04-12|||January 2010||2010-01-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Aloe Vera in Irritable Bowel Syndrome|Aloe Vera Versus Placebo for Patients With Irritable Bowel Syndrome|Recruiting||N/A|150|Anticipated|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-11 04:00:10.610128|2017-10-11 04:00:10.610128
NCT01400035|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-08-14|||May 2010||2010-05-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Observational|CAVIN||Chinese Assessment for Vinpocetine In Neurology|The Investigation of Vinpocetine (Cavinton) for Treatment of Acute Cerebral Infarction, an Open, Multicenter, Randomized, Control Study|Completed||N/A|610|Actual|Shanghai Rxmidas Pharmaceuticals Co. Ltd.|||1||f||||t||||||||||2017-10-11 04:00:10.681896|2017-10-11 04:00:10.681896
NCT01400022|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2013-05-29|||August 2010||2010-08-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus|A Randomized Clinical Study Comparing Topical 0.05% Clobetasol Propianate in Vaseline With UVA-1 Phototherapy in the Treatment of Vulvar Lichen Sclerosus|Completed||N/A|30|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-10-11 04:00:10.741397|2017-10-11 04:00:10.741397
NCT01400009|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-04-06|||October 2010||2010-10-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Vitamin D Replacement in Statin-Induced Myopathy|Vitamin D Replacement in Statin-Induced Myopathy|Withdrawn||N/A|0|Actual|McGill University Health Center||2||lack of enrollment|f||||f||||||||||2017-10-11 04:00:10.816918|2017-10-11 04:00:10.816918
NCT01399996|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-12-16|||April 2012||2012-04-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Influence of a Delivery System on the Efficacy of a Probiotic Intervention|Influence of a Delivery System on the Efficacy of a Probiotic Intervention|Completed||Phase 1|36|Actual|Penn State University||4|||f||||f||||||||||2017-10-11 04:00:10.908267|2017-10-11 04:00:10.908267
NCT01399983|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-03-08|||July 2011||2011-07-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Standardization of 6 Minute Walk Test|Assessment of Exercise Capacity and Standardization of Six Minute Walk Test in Patients With Pulmonary Hypertension|Completed||N/A|29|Actual|Medical University of Graz|||1||f||||f||||||||||2017-10-11 04:00:10.996643|2017-10-11 04:00:10.996643
NCT01399970|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2014-01-12|||April 2011||2011-04-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|Teleacne||Use of Mobile Teledermatology in the Care of Acne Patients|Use of Mobile Teledermatology in the Care of Acne Patients - A Randomized Controlled Trial|Completed||N/A|69|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 04:00:11.057102|2017-10-11 04:00:11.057102
NCT01399957|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-11-09|||August 2010||2010-08-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Observational|||Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients|Responsiveness to Dalfampridine Treatment Among Multiple Sclerosis Patients Followed at the Mandell MS Center: Characterizing Clinical Predictors of Response and Identifying Additional Outcomes|Completed||N/A|52|Actual|Mount Sinai Rehabilitation Hospital|||1||f||||f||||||Samples With DNA|"     15 mL of blood will be collected into an EDTA tube from participants at assessment     appointments. Both serum and cells will be frozen and stored in a -80 degree freezer.   "|||2017-10-11 04:00:11.125578|2017-10-11 04:00:11.125578
NCT01399944|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-09-15|||July 2011||2011-07-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||The Molecular Basis for a Broad Range of Phenotypes Related to hTAS2R38|The Molecular Basis for a Broad Range of Phenotypes Related to hTAS2R38|Completed||N/A|70|Actual|Monell Chemical Senses Center|||1||f||||f||||||Samples With DNA|"     Saliva and taste tissue will be collected from individuals enrolled in the study.   "|||2017-10-11 04:00:11.291885|2017-10-11 04:00:11.291885
NCT01399931|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-10-16|||January 2012||2012-01-01|October 2015|2015-10-01|January 2017|Anticipated|2017-01-01|October 2015|Anticipated|2015-10-01||Observational|2P-HD-10||Dual Point PET Scan in Early Stage Hodgkin Lymphoma Patients With Bulky Lesions|Dual Point Acquisition in the Interim Pet Scan Performed During ABVD Treatment, in Early-Stage Hodgkin's Lymphoma Patients With Bulky Lesions|Unknown status|Recruiting|N/A|150|Anticipated|Ospedale Santa Croce-Carle Cuneo|||1||f||||t||||||||||2017-10-11 04:00:11.362543|2017-10-11 04:00:11.362543
NCT01399905|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2011-07-21|||March 2009||2009-03-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||High and Low Dose Carbidopa Treatment of Parkinson's Disease|A Randomized Controlled Trial of Four Week Outpatient Treatment of Parkinson's Disease Comparing High and Low Dose Carbidopa.|Completed||Phase 2|12|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 04:00:11.561995|2017-10-11 04:00:11.561995
NCT01399892|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-07-21|||September 2008||2008-09-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Fiber Supplementation in Children With Type 1 Diabetes|Effects of Fiber Supplementation on Glycemic Excursions and Incidence of Hypoglycemia in Children With Type 1 Diabetes|Completed||N/A|10|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 04:00:11.653423|2017-10-11 04:00:11.653423
NCT01399879|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-25|2011-07-20|||September 2010||2010-09-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Measuring Skin Electrical Potential With the Kelvin Probe: Minimizing Noise|Measuring Skin Electrical Potential With the Kelvin Probe: Minimizing Noise|Completed||N/A|24|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 04:00:11.726536|2017-10-11 04:00:11.726536
NCT01399866|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-03-14|2015-04-15||May 2011||2011-05-01|March 2016|2016-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||After 4 wks of smoking cessation treatment and CBT, participants who had 18 hrs of abstinence, smoking no cigarettes for at least 18 hrs and CO<10ppm were randomized|Cognitive Remediation With D-Cycloserine|Cognitive Remediation With D-cycloserine to Improve Smoking Cessation Outcomes|Completed||Phase 3|150|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:00:11.801391|2017-10-11 04:00:11.801391
NCT01399853|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-05-29|||July 2011||2011-07-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Interventional|||A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants|A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants|Completed||Phase 2|1200|Actual|Jiangsu Province Centers for Disease Control and Prevention||10|||f||||t||||||||||2017-10-11 04:00:12.169287|2017-10-11 04:00:12.169287
NCT01399840|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-09-14|||June 30, 2011|Actual|2011-06-30|September 2017|2017-09-01|May 31, 2014|Actual|2014-05-31|March 31, 2014|Actual|2014-03-31||Interventional|||Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies|Phase 1, Two-arm, Open-label Study Of Once Daily, Oral Bmn 673 In Patients With Advanced Hematological Malignancies|Completed||Phase 1|33|Actual|Pfizer||2|||f||||||||||||||2017-10-11 04:00:12.275947|2017-10-11 04:00:12.275947
NCT01399827|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-08-23|||February 2012||2012-02-01|August 2017|2017-08-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits|Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With DESR Traits: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial|Active, not recruiting||Phase 2|30|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 04:00:12.384406|2017-10-11 04:00:12.384406
NCT01399814|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-21|||May 2009||2009-05-01|May 2009|2009-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer||Completed||Phase 3|179|Actual|Nanjing PLA General Hospital||2|||f||||f||||||||||2017-10-11 04:00:12.47151|2017-10-11 04:00:12.47151
NCT01399801|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-07-17|||December 2010||2010-12-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|CARE/VOLCANO||Optimizing Left Ventricular Lead To Improve Cardiac Output|Optimizing the Left Ventricular Contractility in Cardiac Resynchronization Therapy Using a Doppler Wire|Unknown status|Recruiting|N/A|40|Anticipated|Main Line Health||2|||f||||t||||||||||2017-10-11 04:00:12.546082|2017-10-11 04:00:12.546082
NCT01399788|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-03-07|2012-02-22||July 2011||2011-07-01|March 2017|2017-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults|An Open Label, Single Dose, 2-Way Cross-Over Randomized Bioequivalence Study Comparing a Fixed Dose Combination Formulation, Myrin®-p Forte, (Contains 150 Mg Rifampicin, 75 Mg Isoniazid, 275 Mg Ethambutol and 400 Mg Pyrazinamide Per Tablet) to an Equivalent Dose of Single Drug Reference Preparations of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide Following Oral Administration in Healthy Adults Under Fasting Conditions|Completed||Phase 1|36|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:00:12.658534|2017-10-11 04:00:12.658534
NCT01399775|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-21|2015-04-07|||May 2010||2010-05-01|April 2015|2015-04-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of Ridge Dimensional Changes After Immediate Implantation and Efficacy of This Procedure|Evaluation of Implant Stability and Dimensional Changes in Alveolar Ridge Following Immediate Implantation|Completed||Phase 1/Phase 2|24|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 04:00:13.145984|2017-10-11 04:00:13.145984
NCT01399762|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-21|||January 2011||2011-01-01|July 2011|2011-07-01||||||||Observational|ENDOSTROKE||International Multicenter Registry for Mechanical Recanalization Procedures in Acute Stroke|International Multicenter Registry for Mechanical Recanalization Procedures in Acute Stroke (ENDOSTROKE)|Unknown status|Recruiting|N/A|500|Anticipated|Goethe University|||1||f||||t||||||||||2017-10-11 04:00:13.229735|2017-10-11 04:00:13.229735
NCT01399749|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-07-21|||September 2011||2011-09-01|July 2011|2011-07-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|ASCROD||Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects|A Comparative Clinical Trial for the Repair of Chondral Knee Defects: Transplantation of Autologous Cultured Chondrocytes vs. Autologous Mesenchymal Stem Cells Derived From Adipose Tissue|Unknown status|Not yet recruiting|Phase 1/Phase 2|30|Anticipated|Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz||2|||f||||f||||||||||2017-10-11 04:00:13.329892|2017-10-11 04:00:13.329892
NCT01399736|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-04-26|||July 2011||2011-07-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|October 31, 2016|Actual|2016-10-31||Interventional|CompareAcute||Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.|Fractional Flow Reserve Guided Primary Multivessel Percutaneous Coronary Intervention to Improve Guideline Indexed Actual Standard of Care for Treatment of ST-elevation Myocardial Infarction in Patients With Multivessel Coronary Disease|Active, not recruiting||Phase 4|885|Anticipated|Maasstad Hospital||2|||f||||t||||||||No||2017-10-11 04:00:13.440553|2017-10-11 04:00:13.440553
NCT01399723|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-01-28|2015-01-28||September 2011||2011-09-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia|Amoxicillin Versus Benzyl Penicillin for Severe Childhood Pneumonia Amongst Inpatients: An Open Label Randomised Controlled Non-inferiority Trial|Completed||Phase 3|561|Actual|KEMRI-Wellcome Trust Collaborative Research Program||2|||f||||t||||||||||2017-10-11 04:00:13.609956|2017-10-11 04:00:13.609956
NCT01399710|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2011-07-21|||July 2007||2007-07-01|July 2011|2011-07-01|March 2010|Actual|2010-03-01|May 2009|Actual|2009-05-01||Interventional|CAD-IMPACT||Impact of Computer-Aided Detection (CAD) as Second Reader in CT Colonography|Measure of Performances of CT Colonography With Computer-Aided Detection (CAD) as Second Reader in Detecting Colorectal Lesion|Completed||Phase 3|651|Actual|im3D S.p.A.||1|||f||||t||||||||||2017-10-11 04:00:13.934488|2017-10-11 04:00:13.934488
NCT01399697|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-06-18|2015-06-18||September 2011||2011-09-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||All treated population|A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate|A Multi-center Study of the Safety and Effect on Disease Activity of Tocilizumab (TCZ) in Combination With MTX Versus Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis, With Inadequate Response to MTX (Defined as DAS 28 > 3,2)|Completed||Phase 4|261|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:00:14.028488|2017-10-11 04:00:14.028488
NCT01399684|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-08-24||2016-07-12|November 2011||2011-11-01|August 2016|2016-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer|Completed||Phase 2|127|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 04:00:14.985266|2017-10-11 04:00:14.985266
NCT01399671|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-03-02|||March 2011||2011-03-01|March 2011|2011-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of the Effectiveness of Vestibular Stimulation as a Coadjuvant Treatment in Major Depression|Clinical Randomized Trial to Evaluate the Efficacy of Vestibular Stimulation as Coadjuvant Therapy in Major Depression|Completed||N/A|80|Actual|Fuerza Aérea de Chile||1|||f||||t||||||||||2017-10-11 04:00:15.257587|2017-10-11 04:00:15.257587
NCT01399658|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-08-09|||September 2011||2011-09-01|August 2016|2016-08-01||||February 2017|Anticipated|2017-02-01||Interventional|AMIGO||Image-Guided Gynecologic Brachytherapy|A Clinical Trial to Evaluate Image-Guided Gynecologic Brachytherapy in the Advanced Multimodality Image-Guided Operating Suite (AMIGO)|Active, not recruiting||Phase 2|93|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 04:00:15.385228|2017-10-11 04:00:15.385228
NCT01399645|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2014-08-25|||May 2011||2011-05-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|LIRAINS||Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes|Randomized Trial of Liraglutide and Insulin Therapy on Hepatic Steatosis as Measured by MRI and MRS in Metformin-treated Patients With Type 2 Diabetes: an Open Pilot Study|Completed||Phase 2|35|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-10-11 04:00:15.507046|2017-10-11 04:00:15.507046
NCT01399632|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2016-07-05|||August 2010||2010-08-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Dietary Fat and High-Density Lipoprotein (HDL) Metabolism-Effect of Carbohydrate and Fat Intake|Dietary Fat and High-Density Lipoprotein (HDL) Metabolism-Effect of Carbohydrate and Fat Intake|Completed||N/A|21|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 04:00:15.639869|2017-10-11 04:00:15.639869
NCT01399619|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-07-28|2015-07-03|2014-06-02|September 2011||2011-09-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional||FAS (All patients who were randomized and received at least one dose of assigned therapy)|Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)|Safety and Efficacy of 120mg and 240mg BI 201335 Once Daily in Combination With Pegylated Interferon Alpha and Ribavirin for Treatment of Chronic Hepatitis C (HCV) Genotype 1 Infection in HIV/HCV Co-infected Patients. A Multinational, Randomised, Parallel Group, Open-label Trial.|Completed||Phase 3|310|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 04:00:15.807783|2017-10-11 04:00:15.807783
NCT01399606|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-01-30|||May 2011||2011-05-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|October 2013|Actual|2013-10-01||Interventional|HARMONYIII||Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)|An Open-label Naturalistic Pragmatic Study to Assess the Long Term Safety of BF2.649 (Pitolisant) in the Treatment of Excessive Daytime Sleepiness (EDS) in Narcolepsy (12 Months Follow-up, Followed by a Prolonged Follow up)|Completed||Phase 3|102|Actual|Bioprojet||1|||f||||t||||||||||2017-10-11 04:00:17.410956|2017-10-11 04:00:17.410956
NCT01399593|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-09-04|2017-03-09|2016-11-18|November 2, 2011|Actual|2011-11-02|September 2017|2017-09-01|November 13, 2015|Actual|2015-11-13|May 13, 2014|Actual|2014-05-13||Interventional|||Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization|A Randomized, Open-label, Multicenter Trial to Determine Safety and Efficacy of Eculizumab in the Prevention of Antibody Mediated Rejection (AMR) in Living Donor Kidney Transplant Recipients Requiring Desensitization Therapy|Terminated||Phase 2|102|Actual|Alexion Pharmaceuticals|Data interpretation confounded by open-label study with potential reporting bias, unequal exposure to randomized prevention therapy between groups, some patients in SOC arm received eculizumab for treatment of AMR, all patients immunosuppressed.|2||Did not achieve statistical significance for primary endpoint|f||||t|t|f||||||||2017-10-11 04:00:17.532789|2017-10-11 04:00:17.532789
NCT01399580|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2013-09-25||2013-09-25|August 2011||2011-08-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy|A Phase 2b, Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy|Completed||Phase 2|48|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 04:00:19.287609|2017-10-11 04:00:19.287609
NCT01399554|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-04-04|||April 2011||2011-04-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults|Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults|Completed||Phase 1|38|Actual|St. Louis University||2|||f||||t||||||||||2017-10-11 04:00:19.541271|2017-10-11 04:00:19.541271
NCT01399541|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-01|2011-07-20|||October 2010||2010-10-01|May 2011|2011-05-01|April 2013|Anticipated|2013-04-01|April 2012|Anticipated|2012-04-01||Observational|||Recovery and Rehabilitation After Lung Cancer Surgery|Recovery and Rehabilitation After Lung Cancer Surgery|Unknown status|Recruiting|N/A|300|Anticipated|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 04:00:19.629187|2017-10-11 04:00:19.629187
NCT01399528|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2012-12-05|||September 2011||2011-09-01|December 2012|2012-12-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||A Pharmacogenomic Exploration of Lacosamide Response|A Pharmacogenomic Exploration of Lacosamide Response|Unknown status|Recruiting|N/A|660|Anticipated|Royal College of Surgeons, Ireland|||5||f||||f||||||Samples With DNA|"     Collecting DNA from blood samples   "|||2017-10-11 04:00:19.762949|2017-10-11 04:00:19.762949
NCT01399515|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2016-04-12|||March 2011||2011-03-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|August 2013|Actual|2013-08-01||Interventional|VPA_RP||Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa||Completed||Phase 2|200|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 04:00:19.891035|2017-10-11 04:00:19.891035
NCT01399502|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-12-09|||November 2011||2011-11-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Promotion of Self-help Strategies for Depression||Completed||Phase 1/Phase 2|1736|Actual|Orygen Youth Health Research Centre||2|||f||||f||||||||||2017-10-11 04:00:19.993555|2017-10-11 04:00:19.993555
NCT01399489|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-31|2014-01-22|||September 2009||2009-09-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients|The Effect of Short-term Aerobic Training on Arterial Stiffness and Blood in Chronic Kidney Disease (CKD) Patients|Completed||N/A|51|Actual|Springfield College||2|||f||||f||||||||||2017-10-11 04:00:20.092159|2017-10-11 04:00:20.092159
NCT01399476|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-04-12|||September 2010||2010-09-01|April 2012|2012-04-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Interventional|POEM||Endoscopic Myotomy of the Lower Esophageal Sphincter for Achalasia|Endoscopic Submucosal Tunnel Dissection for Endoluminal Partial Myotomy of the Lower Esophageal Sphincter for Achalasia|Unknown status|Recruiting|Phase 1|20|Anticipated|The Oregon Clinic||1|||f||||f||||||||||2017-10-11 04:00:20.166269|2017-10-11 04:00:20.166269
NCT01399463|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-07-20|||August 2011||2011-08-01|July 2011|2011-07-01||||||||Interventional|||Pressure-wire Guided PTCA: Drug Eluting Stent Versus Drug Eluting Balloon (WinDEB Study)|Pressure Wire-guided Percutaneous Coronary Intervention of Small Vessels or Side Branches: Functional Outcome of Drug-Eluting Stent (DES) Versus Drug-Eluting Balloon (DEB) With Provisional Bare Metal Stent Implantation|Unknown status|Not yet recruiting|N/A|||Medical University of Vienna||2|||f||||||||||||||2017-10-11 04:00:20.252247|2017-10-11 04:00:20.252247
NCT01399450|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-12-07|||August 2011||2011-08-01|December 2015|2015-12-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients|Effectiveness of Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients: A 8-week Open-label Prospective, Non-comparative Study|Recruiting||Phase 4|70|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 04:00:20.353556|2017-10-11 04:00:20.353556
NCT01399437|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-06-30|||July 3, 2011||2011-07-03|December 24, 2014|2014-12-24|December 24, 2014||2014-12-24|||||Observational|||Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia|Default Network Dysfunction Underlying Visuospatial Attention Deficits in Schizophrenia|Completed||N/A|70|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:00:20.456249|2017-10-11 04:00:20.456249
NCT01399424|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-06-30|||July 16, 2011||2011-07-16|April 25, 2012|2012-04-25|April 25, 2012|Actual|2012-04-25|April 25, 2012|Actual|2012-04-25||Interventional|||Shigella Sonnei OSPC-rDT Conjugate Vaccine|Shigella Sonnei OSPC-rDT Conjugate Vaccine|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:00:20.541936|2017-10-11 04:00:20.541936
NCT01399411|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-09-20|||June 29, 2011||2011-06-29|August 17, 2017|2017-08-17||||||||Observational|||Agricultural Health Study Follow-up|Agricultural Health Study: Health Follow-up|Enrolling by invitation||N/A|89656|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:00:20.616489|2017-10-11 04:00:20.616489
NCT01399398|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-06-30|||June 22, 2011||2011-06-22|December 18, 2013|2013-12-18|December 18, 2013|Actual|2013-12-18|December 18, 2013|Actual|2013-12-18||Interventional|||Imaging of CB1 Receptors Using (11C)SD5024|PET Imaging of CB1 Receptors Using [11C]SD5024|Terminated||Phase 1|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:00:20.692576|2017-10-11 04:00:20.692576
NCT01399385|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2017-10-03|||June 9, 2011||2011-06-09|September 21, 2017|2017-09-21||||||||Observational|||New Heart Imaging Techniques to Evaluate Possible Heart Disease|Magnetic Resonance of Body, Arterial Wall and Angiography Imaging for Non-Invasive Assessment of Arterial Distensibility, Endothelial Dysfunction and Atherosclerotic Disease Using 1.5T High Field (3T) MRI: A Technical Development Study of Cardiac and Body|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:00:20.787003|2017-10-11 04:00:20.787003
NCT01399372|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-10-11|||September 2011||2011-09-01|October 2016|2016-10-01||||September 2021|Anticipated|2021-09-01||Interventional|||Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma|Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma|Active, not recruiting||Phase 2|91|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:00:20.890277|2017-10-11 04:00:20.890277
NCT01399359|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2015-03-05|||August 2011||2011-08-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer|A Study to Evaluate Different Decision-Making Approaches Used by Women Known to be at Increased Risk for Breast Cancer|Completed||N/A|1023|Actual|NSABP Foundation Inc|||2||f||||f||||||||||2017-10-11 04:00:21.129906|2017-10-11 04:00:21.129906
NCT01399346|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-04-19|||April 2011||2011-04-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes|A Single-center, Randomized, Controlled, 2-period Cross-over, Open-labelled Trial to Evaluate the Impact of Different Application Volumes on Pharmacokinetic and Pharmacodynamic Properties of Insulin Aspart in Subjects With Type 1 Diabetes|Completed||Phase 1|12|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-11 04:00:21.308322|2017-10-11 04:00:21.308322
NCT01399333|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-22|||January 2010||2010-01-01|July 2011|2011-07-01|January 2012|Anticipated|2012-01-01|August 2011|Anticipated|2011-08-01||Interventional|PDCAAS||Comparison of Meal Replacements Versus Protein Supplements and Utilizing the Protein Digestibility Corrected Amino Acid Score (PDCAAS) Method|Comparison of Meal Replacements Versus Protein Supplements and Utilizing the PDCAAS Method in the Bariatric Patient|Unknown status|Recruiting|Phase 4|60|Anticipated|Southeast Bariatrics, PA||3|||f||||f||||||||||2017-10-11 04:00:21.388026|2017-10-11 04:00:21.388026
NCT01399320|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-20|||August 2008||2008-08-01|August 2008|2008-08-01|June 2010|Actual|2010-06-01|September 2009|Actual|2009-09-01||Interventional|||Ghnnam Excision Technique for Pilonidal Sinus|Ghnnam Excision Technique for Pilonidal Sinus|Completed||Phase 1|40|Actual|Mansoura University||1|||f||||f||||||||||2017-10-11 04:00:21.477169|2017-10-11 04:00:21.477169
NCT01399307|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-16|2012-01-18|||July 2011||2011-07-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Extraction of Stromal Vascular Fraction and Stem Cells From Fat Tissue|A Proof of Concept Study to Demonstrate the Effectiveness of Antria Cell Preparation Process (Ace Process) in Extraction of Stromal Vascular Fraction From Adipose Tissue|Completed||N/A|4|Actual|Antria||1|||f||||f||||||||||2017-10-11 04:00:21.546926|2017-10-11 04:00:21.546926
NCT01399294|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-19|||May 2010||2010-05-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|July 2010|Actual|2010-07-01||Observational|||Cross Sectional Study of Constipation in Advanced Cancer Patients|Traditional Chinese Medicine Syndrome Distribution of Advanced Cancer Patients With Constipation|Completed||N/A|255|Actual|Yan Chai Hospital|||1||f||||t||||||||||2017-10-11 04:00:21.621393|2017-10-11 04:00:21.621393
NCT01399281|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-02-29|||December 2011||2011-12-01|February 2016|2016-02-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|PharmaChild||Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate|Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (Pharmachild) Treated With Biologic Agents and/or Methotrexate. A PRINTO/PRES Registry|Recruiting||N/A|9000|Anticipated|Istituto Giannina Gaslini|||3||f||||t||||||||||2017-10-11 04:00:21.681508|2017-10-11 04:00:21.681508
NCT01399268|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-07-27|2017-03-23||February 2009||2009-02-01|July 2017|2017-07-01|February 2011|Actual|2011-02-01|August 2010|Actual|2010-08-01||Interventional|||Steroids in Bilateral Total Knee Replacement|Effect of Steroids Given Over 24 Hours on Cytokine Release and Urinary Desmosine Levels in Patients Undergoing Bilateral Total Knee Replacement|Completed||Phase 4|30|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-11 04:00:21.795825|2017-10-11 04:00:21.795825
NCT01399255|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-01-24|||November 2011||2011-11-01|January 2013|2013-01-01|June 2012|Anticipated|2012-06-01|May 2012|Anticipated|2012-05-01||Interventional|||Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects||Withdrawn||Phase 1|0|Actual|Wockhardt||2||Study was not initiated|f||||f||||||||||2017-10-11 04:00:22.215187|2017-10-11 04:00:22.215187
NCT01399242|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-07-20|||August 2011||2011-08-01|March 2011|2011-03-01|June 2013|Anticipated|2013-06-01|June 2012|Anticipated|2012-06-01||Interventional|HUSJ1||Efficacy of Certican® in Combination With Myfortic® in Renal|Efficacy and Safety of Certican® in Combination With Myfortic® in Adult Renal Allograft Recipients Following Calcineurin Inhibitor Withdrawal at Week 16 Compared to Patients Who Are Maintained on Tacrolimus and Myfortic®|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Hospital Universitário São José||2|||f||||t||||||||||2017-10-11 04:00:22.299119|2017-10-11 04:00:22.299119
NCT01399229|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-08-28|2012-11-15||January 2007||2007-01-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Comparison of SureCALL® Labor Monitor® and Tocodynamometer Measurement in Preterm and Term Pregnant Women|Comparison of SureCALL® Labor Monitor® and Tocodynamometer Measurement in Preterm and Term Pregnant Women|Completed||N/A|30|Actual|Reproductive Research Technologies, LP|||3||f||||f||||||||||2017-10-11 04:00:22.425966|2017-10-11 04:00:22.425966
NCT01399216|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-12-13|||July 2011||2011-07-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effects of a Supplement Containing Fucoidan on Basal Body Temperature|Effects of a Supplement Containing Fucoidan as a Major Component on Basal Body Temperature: a Placebo Controlled, Cross-over Study|Completed||N/A|19|Actual|Hiroshima University||2|||f||||f||||||||||2017-10-11 04:00:22.626316|2017-10-11 04:00:22.626316
NCT01399203|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-08-02|||January 2010||2010-01-01|January 2010|2010-01-01|January 2012|Anticipated|2012-01-01|October 2011|Anticipated|2011-10-01||Observational|CONVIN||Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention|Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention|Unknown status|Recruiting|N/A|2000|Anticipated|Guangdong General Hospital|||1||f||||t||||||||||2017-10-11 04:00:22.704117|2017-10-11 04:00:22.704117
NCT01399190|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2016-08-04|2016-08-04||July 2011||2011-07-01|August 2016|2016-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational||Includes enrolled participants eligible for inclusion in the final analysis.|An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer|An Open Label Study of the Effect of First Line Treatment With Bevacizumab in Combination With Capecitabine and Oxaliplatin on Progression-free Survival in Patients With Metastatic Cancer of the Colon and Rectum|Completed||N/A|68|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:00:22.80206|2017-10-11 04:00:22.80206
NCT01399177|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-07-14|||June 2011|Actual|2011-06-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Influence of Changes in Food Group Variety on Food Cravings, Energy Intake, and Weight Loss After Bariatric Surgery|Influence of Changes in Food Group Variety on Food Cravings, Energy Intake, and Weight Loss After Bariatric Surgery|Active, not recruiting||N/A|90|Anticipated|University of Tennessee|||1||f||||f||||||||||2017-10-11 04:00:23.047938|2017-10-11 04:00:23.047938
NCT01398384|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2014-05-20|||October 2010||2010-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|NOMI||Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size|The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size|Completed||Phase 2|250|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-10-11 04:00:33.793379|2017-10-11 04:00:33.793379
NCT01399164|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-10-21|||January 2010||2010-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|FL-72||Cobalamin Absorption From Fortified Food|Cobalamin Absorption From Fortified Food in Older Adults With and Without Proton Pump Inhibitor Induced Achlorhydria|Completed||N/A|6|Actual|USDA, Western Human Nutrition Research Center||1|||f||||t||||||||||2017-10-11 04:00:23.120851|2017-10-11 04:00:23.120851
NCT01399151|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2014-04-21|||January 2011||2011-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional|FL-82||Assessment of Vitamin D Supplementation and Immune Function|Assessment of Vitamin D Supplementation and Immune Function|Completed||N/A|23|Actual|USDA, Western Human Nutrition Research Center||3|||f||||t||||||||||2017-10-11 04:00:23.201811|2017-10-11 04:00:23.201811
NCT01399138|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-12-04|||July 2010||2010-07-01|December 2013|2013-12-01|April 2014|Anticipated|2014-04-01|July 2012|Actual|2012-07-01||Interventional|||The Effect of Blueberry Powder Supplementation on Cardiovascular Risk Factors in Subjects With the Metabolic Syndrome||Unknown status|Active, not recruiting|N/A|50|Anticipated|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 04:00:23.375091|2017-10-11 04:00:23.375091
NCT01399125|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-07-10|2014-05-05||July 2011||2011-07-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease|A 24-Week, Randomized, Double-blind, Double-dummy, Parallel-group, Active-controlled Study to Assess the Efficacy, Safety, and Tolerability of the Once-daily Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (Mini-Mental State Examination (MMSE) 10-20)|Completed||Phase 3|501|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:00:23.482985|2017-10-11 04:00:23.482985
NCT01399112|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-27|2012-12-31|||May 2010||2010-05-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|August 2010|Actual|2010-08-01||Interventional|||A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis|A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis|Completed||N/A|11|Actual|Northwell Health||2|||f||||f||||||||||2017-10-11 04:00:24.008207|2017-10-11 04:00:24.008207
NCT01399099|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-12-17|2014-12-17||June 2011||2011-06-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|REFINE|After meeting all eligibility criteria, 67 patients were enrolled.|A Study of a Novel Silicone Dressing to Minimize Scar Formation|Scar Prevention and the Clinical Effectiveness of a Novel Mechanomodulating Polymer|Completed||N/A|67|Actual|Neodyne Biosciences, Inc.|"The Neodyne Dressing is referred to as the embrace device.
Grant/Funding source: Armed Forces Institute of Regenerative Medicine is funded by US Army Medical Research and Materiel Command (our collaborator) http://www.afirm.mil/"|1|||f||||f||||||||||2017-10-11 04:00:24.084365|2017-10-11 04:00:24.084365
NCT01399086|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-03-12|||April 2011||2011-04-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer|A Retrospective Study of Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer in Greece (The 'RESPONSE' Study)|Completed||N/A|140|Actual|Hellenic Oncology Research Group|||1||f||||f||||||||||2017-10-11 04:00:24.397976|2017-10-11 04:00:24.397976
NCT01399073|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-06-12|||May 2011||2011-05-01|June 2017|2017-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|KMS-Neglect||Virtual Reality for Neglect Diagnostics|Virtual Reality for Neglect Diagnostics|Completed||N/A|27|Actual|Charite University, Berlin, Germany|||3||f||||f||||||||||2017-10-11 04:00:24.482906|2017-10-11 04:00:24.482906
NCT01399060|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-10-23|||April 2011||2011-04-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|CAP||Cough Sensitivity and Taste Preferences|Cough and Taste Preferences in Adolescents and Adults|Completed||N/A|80|Actual|Monell Chemical Senses Center|||1||f||||f||||||Samples With DNA|"     Saliva samples will be obtained from the subjects, if consented. These saliva samples will be     genotyped at the Monell Center for genes that may play a role in chemical irritation and     flavor-perception. This testing is exploratory in nature.   "|||2017-10-11 04:00:24.560127|2017-10-11 04:00:24.560127
NCT01399047|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-11-28|2016-11-28||July 2011||2011-07-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|JUMP||Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis|Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis|Completed||Phase 2|19|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 04:00:24.63043|2017-10-11 04:00:24.63043
NCT01399034|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-07-20|||October 2007||2007-10-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|SZU||Epigenetics, DNA Methylation Patterns and Periodontal Disease|Host DNA Methylation Patterns in Association With Periodontal Disease : MiRNA Changes in Obesity|Completed||N/A|98|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"     -  Gingiva biopsy samples (epithelium, connective tissue)        -  Gingival crevicular fluid        -  Saliva        -  Plaque samples   "|||2017-10-11 04:00:25.070554|2017-10-11 04:00:25.070554
NCT01399021|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-20|||July 2011||2011-07-01|July 2011|2011-07-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Timing of Postoperative Drain Removal Following Parotidectomy - a Prospective Randomized Controlled Study|Timing of Postoperative Drain Removal Following Parotidectomy and Its Effects on Hematoma and Infection Rate and Length of Hospital Stay- a Prospective Randomized Controlled Study|Unknown status|Not yet recruiting|N/A|400|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 04:00:25.136231|2017-10-11 04:00:25.136231
NCT01399008|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2015-09-03|2014-03-20||June 2011||2011-06-01|September 2015|2015-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone|Completed||Phase 2|100|Actual|CymaBay Therapeutics, Inc.||3|||f||||f||||||||||2017-10-11 04:00:25.235344|2017-10-11 04:00:25.235344
NCT01398995|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-07-20|||May 2011||2011-05-01|July 2011|2011-07-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Managing Insulin Pumps for Exercise (Study 2)|To Consider the Effect of the Timing of a Reduction in Basal Insulin Infusion Rate to 50% of Normal Prior to Exercise on Glycaemic Control in People With Type 1 Diabetes Treated With CSII|Terminated||N/A|6|Actual|Buckinghamshire Healthcare NHS Trust||4||Recruitment was terminated due to elevated levels of hypoglycaemia|f||||f||||||||||2017-10-11 04:00:25.484545|2017-10-11 04:00:25.484545
NCT01398982|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-03-30|2014-07-07||July 2011||2011-07-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||TAP Block in DIEP or Free MS-TRAM Donor Site: A RCT|The Use of Transversus Abdominis Plane (TAP) Block in Autologous Breast Reconstruction Donor Site: A Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 4|93|Actual|University Health Network, Toronto|The study limitations include the difficulty in capturing data at all points postoperatively. The repeated measure pain scores at rest and with movement were not recorded for all patients (recorded for 75% at rest and 53% with movement).|2|||f||||f||||||||||2017-10-11 04:00:25.568074|2017-10-11 04:00:25.568074
NCT01398969|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-03-11|||July 2012||2012-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Multi-Centre Trial of Fresh vs. Frozen-and-Thawed HBT(Fecal Transplant)for Recurrent CDI|A Prospective Randomized Multi-Centre Trial of Fresh vs. Frozen-and-Thawed Human Biotherapy (Fecal Transplant) for Recurrent Clostridium Difficile Infection|Completed||Phase 2|232|Actual|McMaster University||2|||f||||t||||||||||2017-10-11 04:00:25.826402|2017-10-11 04:00:25.826402
NCT01398956|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-07-06|2016-09-29||June 2011||2011-06-01|July 2017|2017-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||The Baseline Characteristics refer to the Safety Set (SS) which consisted of all subjects who took at least one dose of study medication in this study.|An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures|An Open-label, Multicenter, Long-term, Follow-up Study in Japan to Evaluate the Safety, Tolerability, and Efficacy of Adjunctive Treatment With Oral L059 (Levetiracetam) in Epilepsy Subjects With Generalized Tonic-clonic (GTC) Seizures|Completed||Phase 3|44|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 04:00:27.317371|2017-10-11 04:00:27.317371
NCT01398943|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-08-15|2016-11-17||September 2010||2010-09-01|August 2017|2017-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)|Regulation of Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease: A Mechanistic Approach|Completed||N/A|60|Actual|Augusta University||2|||f||||t||||||||||2017-10-11 04:00:27.797703|2017-10-11 04:00:27.797703
NCT01398930|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-20|2011-07-20|||September 2007||2007-09-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Acupuncture as an Adjunctive Therapy to the Pharmacological Treatment in Patients With Chronic Pain in Osteoarthritis of the Knee: a Three Armed Randomized Placebo Controlled Trial||Completed||N/A|120|Actual|National and Kapodistrian University of Athens||3|||f||||f||||||||||2017-10-11 04:00:28.252002|2017-10-11 04:00:28.252002
NCT01398917|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2012-07-05|||May 2011||2011-05-01|July 2012|2012-07-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis|Multicenter Randomized Trial Comparing Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis|Unknown status|Recruiting|Phase 3|100|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 04:00:28.347958|2017-10-11 04:00:28.347958
NCT01398904|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2014-12-02|||March 2011||2011-03-01|December 2014|2014-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|VAB||Attentional Bias in Body Dysmorphic Disorder|Attentional Bias in Body Dysmorphic Disorder|Completed||N/A|51|Actual|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-11 04:00:28.486525|2017-10-11 04:00:28.486525
NCT01398891|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2013-03-04|||May 2011||2011-05-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|HOPE||Development of a Positive Psychology Intervention to Reduce Suicide Risk|Development of a Positive Psychology Intervention to Reduce Suicide Risk|Completed||N/A|60|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 04:00:28.56758|2017-10-11 04:00:28.56758
NCT01398878|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-22|||July 2011||2011-07-01|July 2011|2011-07-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Assessing the Impact of a Change to the Work Schedule of Resident Physicians: a Mixed Methods Study|Assessing the Impact of a Change to the Work Schedule of Resident Physicians: a Mixed Methods Study|Unknown status|Recruiting|N/A|80|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 04:00:28.65196|2017-10-11 04:00:28.65196
NCT01398865|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2015-03-12|||December 2008||2008-12-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Escitalopram Neuroimaging Supplement|Cerebral Metabolic Correlates of Treatment Response to Escitalopram in Body Dysmorphic Disorder|Completed||N/A|23|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 04:00:28.773165|2017-10-11 04:00:28.773165
NCT01398852|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-01-25|2012-12-13||December 2010||2010-12-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia|Long Term Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Post-Refractive Corneal Ectasia|Terminated||Phase 3|500|Actual|Topcon Medical Systems, Inc.||1|||f||||f||||||||||2017-10-11 04:00:28.863552|2017-10-11 04:00:28.863552
NCT01398839|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-10|2016-12-05|2012-12-13||December 2010||2010-12-01|December 2016|2016-12-01||||July 2012|Actual|2012-07-01||Interventional|||Safety Study of the VEGA UV-A System to Treat Ectasia||Terminated||Phase 3|103|Actual|Topcon Medical Systems, Inc.||2|||f||||f||||||||||2017-10-11 04:00:29.048859|2017-10-11 04:00:29.048859
NCT01398826|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-20|||May 2011||2011-05-01|July 2011|2011-07-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Observational|||Glycemic Response to Road Cycling in Type 1 Diabetes|A Pilot Study Assessing the Glycemic Response and Its Relationship to Performance During Road Cycling in Elite Athletes With Type 1 Diabetes and Non-Diabetic Controls|Unknown status|Active, not recruiting|N/A|30|Anticipated|Team Type 1, Inc.|||1||f||||f||||||||||2017-10-11 04:00:29.291501|2017-10-11 04:00:29.291501
NCT01398813|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-07-07|||July 2011||2011-07-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|X-CORS||X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey|Survey of X-Linked Hypohidrotic Ectodermal Dysplasia Carrier Women's Outlook Towards Reproduction, Potential XLHED Treatments and Genetic Testing|Completed||N/A|500|Anticipated|Edimer Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:00:29.344435|2017-10-11 04:00:29.344435
NCT01398800|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-02-01|||July 2011||2011-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|MBT||Early Clinical Results of Mobile-Bearing Revision Total Knee Arthroplasty|Early Clinical Results of Mobile-Bearing Revision Total Knee Arthroplasty|Active, not recruiting||N/A|320|Anticipated|Colorado Joint Replacement|||1||f||||f||||||||Undecided||2017-10-11 04:00:29.413852|2017-10-11 04:00:29.413852
NCT01398787|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-02-18|2014-02-18||July 2011||2011-07-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||The analysis population includes all enrolled and exposed participants.|Evaluation of the Cosmetic Performance of AIR OPTIX® COLORS|Cosmetic Validation (US): AIR OPTIX® COLORS Among Habitual Wearers of FRESHLOOK®|Completed||N/A|198|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 04:00:29.482768|2017-10-11 04:00:29.482768
NCT01398774|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-05-01|||June 2011||2011-06-01|May 2017|2017-05-01|April 2018|Anticipated|2018-04-01|September 2015|Actual|2015-09-01||Observational|||Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a|Altered Resting Energy Expenditure as a Cause of Obesity in Pseudohypoparathyroidism 1a: A Pilot Study|Active, not recruiting||N/A|519|Actual|Children's Hospital of Philadelphia|||1||f||||t||||||||||2017-10-11 04:00:29.754265|2017-10-11 04:00:29.754265
NCT01398761|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2014-04-24|||January 2011||2011-01-01|April 2014|2014-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Development of a Sign-Out Tool to Improve Handoffs in Care|Development and Pilot Testing of a Web-Based, Multi-Disciplinary Sign-Out Tool to Improve Handoffs in Care|Completed||N/A|295|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 04:00:29.828372|2017-10-11 04:00:29.828372
NCT01398748|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-07-27|||July 2012||2012-07-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Intranasal Glutathione in Parkinson's Disease|A Phase 1 Study of Intranasal Reduced Glutathione in Parkinson's Disease|Completed||Phase 1|34|Actual|Bastyr University||4|||f||||t||||||||||2017-10-11 04:00:29.906427|2017-10-11 04:00:29.906427
NCT01398722|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-19|||August 2011||2011-08-01|July 2011|2011-07-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Effect of Intensive Insulin Therapy on Clinical Prognosis of Infants Undergoing Cardiac Surgery|Study of the Relationship Between Intensive Insulin Therapy and Clinical Prognosis in Infants Undergoing Cardiac Surgery|Unknown status|Not yet recruiting|Phase 2|800|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 04:00:30.133592|2017-10-11 04:00:30.133592
NCT01398709|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-19|||August 2011||2011-08-01|July 2011|2011-07-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Effect of Rewarming Rate During Cardiopulmonary Bypass on Clinical Prognosis of Infants Undergoing Cardiac Surgery|Study of the Relationship Between Rewarming Rate During Cardiopulmonary Bypass and Clinical Prognosis in Infants Undergoing Cardiac Surgery|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-10-11 04:00:30.272155|2017-10-11 04:00:30.272155
NCT01398696|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-19|2011-10-11|||November 2009||2009-11-01|October 2011|2011-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|PIL||Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour|Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour : a Randomised Controlled Trial in Primary Care.|Completed||Phase 4|400|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-10-11 04:00:30.425513|2017-10-11 04:00:30.425513
NCT01398683|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-11-15|||April 2011||2011-04-01|July 2011|2011-07-01|April 2014|Anticipated|2014-04-01|June 2013|Anticipated|2013-06-01||Observational|||Comparison Epidural Anesthesia and General Anesthesia in Laparoscopic Cholecystectomy|Comparison Epidural Anesthesia and General Anesthesia in Laparoscopic Cholecystectomy|Unknown status|Enrolling by invitation|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 04:00:30.584532|2017-10-11 04:00:30.584532
NCT01398670|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-01-24|||February 2012||2012-02-01|January 2013|2013-01-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|||Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics|Comparison of the Immunogenicity of Wockhardt's Insulin Analogue Lispro and Lispro Mix With Eli Lilly's Insulin Analogue Humalog® and Humalog® Mix in Type 1 Diabetic Patients|Withdrawn||Phase 3|0|Actual|Wockhardt||2||Study was not initiated|f||||f||||||||||2017-10-11 04:00:30.637489|2017-10-11 04:00:30.637489
NCT01398657|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2012-11-13|||July 2011||2011-07-01|March 2012|2012-03-01|June 2016|Anticipated|2016-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer|Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy for High-Risk Localized Prostate Cancer — Open-Label Randomized Clinical Study|Unknown status|Recruiting|Phase 3|182|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 04:00:30.72925|2017-10-11 04:00:30.72925
NCT01398631|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-09|2016-02-16|||June 2009||2009-06-01|February 2016|2016-02-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Observational|HEART||A Comparison of the TIMI, GRACE and HEART Scores|A Prospective Comparison of the TIMI, GRACE and HEART Scores for Predicting Cardiovascular Events in Chest Pain Patients in the Emergency Room|Completed||N/A|2440|Actual|R&D Cardiologie|||1||f||||f||||||||||2017-10-11 04:00:30.927016|2017-10-11 04:00:30.927016
NCT01398618|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-19|||May 2011||2011-05-01|June 2011|2011-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)|Comparing the Efficacy of Two Preventive Regimens for Adult Household Contacts With Latent Tuberculosis Infection|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 04:00:31.006967|2017-10-11 04:00:31.006967
NCT01398605|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-08-16|||September 2008||2008-09-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Physical Activity in Postmenopausal Women|Physical Activity and Exercise Dose-response on Cardiovascular Risk Factors in Postmenopausal Women|Completed||N/A|200|Anticipated|National Taiwan University Hospital||3|||f||||t||||||||||2017-10-11 04:00:31.0902|2017-10-11 04:00:31.0902
NCT01398592|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2013-02-11|||June 2011||2011-06-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|FPG-VISIT||Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy|Cross-over Study to Assess the Difference in Fasting Plasma Glucose (FPG) Between Vildagliptin (Galvus®/Eucreas®) and Sitagliptin (Januvia®/Janumet®) After Two Weeks|Completed||Phase 4|187|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:00:31.165893|2017-10-11 04:00:31.165893
NCT01398579|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-26|2012-07-10|||September 2011||2011-09-01|August 2011|2011-08-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|pCLE-GCEP||Comparison Between Probe-based Confocal Laser Endomicroscopy, White-light Endoscopy and Virtual Chromoendoscopy|Prospective Comparison Between Probe-based Confocal Laser Endomicroscopy, White-light Endoscopy and Virtual Chromoendoscopy for the Diagnosis of Gastric Pre-neoplastic and Neoplastic Lesions (pCLE-GCEP)|Unknown status|Recruiting|Phase 1|20|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-10-11 04:00:31.288186|2017-10-11 04:00:31.288186
NCT01398553|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-29|2016-09-05|||March 2011||2011-03-01|September 2016|2016-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Automated Versus Standard Physiotherapy for Upper Limb Rehabilitation in Patients With Acquired Brain Lesions|Armeo® Versus Standard Physiotherapy for Upper Limb Rehabilitation in Patients With Acquired Brain Lesions|Withdrawn||N/A|0|Actual|Krankenhaus Bozen||2||the human resources in the organisation are to limited to do the trial|f||||f||||||||||2017-10-11 04:00:31.461106|2017-10-11 04:00:31.461106
NCT01398540|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2011-07-19|||November 2010||2010-11-01|June 2010|2010-06-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine|Characterisation of Cellular and Humoral Immunity in Elderly People After Immunization With a Purified, Inactivated Japanese Encephalitis Vaccine.|Unknown status|Enrolling by invitation|Phase 4|30|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-10-11 04:00:31.555705|2017-10-11 04:00:31.555705
NCT01398527|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-05-02|||July 2009||2009-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|ViDOS||Vitamin D Osteoporosis Long-Term Care Study|An Interdisciplinary Knowledge Translation Intervention in Long-term Care: The Vitamin D and Osteoporosis Study (ViDOS) Pilot Cluster Randomized Controlled Trial|Completed||N/A|40|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 04:00:31.611499|2017-10-11 04:00:31.611499
NCT01398514|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2014-06-05|2013-07-25||October 2008||2008-10-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Influence of Escitalopram on Fear Conditioning|Pharmacologic Influence of Escitalopram on the Reduction of Fear Acquisition and Triggered Renewal During Fear Conditioning: a Model for the Prevention and Persistence of Learned Fear and Anxiety in Response to Trauma and Stress|Completed||Phase 4|65|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 04:00:31.704399|2017-10-11 04:00:31.704399
NCT01398501|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-03-21|||August 2011||2011-08-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|September 2015|Actual|2015-09-01||Interventional|||Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant|Phase I Trial of Sorafenib Maintenance Therapy for Patients With FLT3-ITD AML After Allogeneic Stem Cell Transplantation|Completed||Phase 1|22|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 04:00:32.033724|2017-10-11 04:00:32.033724
NCT01398488|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2013-06-05|||July 2011||2011-07-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|July 2012|Actual|2012-07-01||Interventional|||Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education|Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education - a Randomized Open Controlled Trial|Completed||Phase 2|64|Actual|Hannover Medical School||2|||f||||f||||||||||2017-10-11 04:00:32.11931|2017-10-11 04:00:32.11931
NCT01398475|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-03-10|2017-03-10||July 2011||2011-07-01|March 2017|2017-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||All randomized participants.|A Relative Bioavailability and Food Effect Study of New Formulations|Relative Bioavailability of the LY3009104 Free Base Test Formulation Compared to the Reference Phosphate Salt Formulation and the Effect of Food on the Bioavailability of the Test Formulation in Healthy Subjects|Completed||Phase 1|15|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 04:00:32.2112|2017-10-11 04:00:32.2112
NCT01398462|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-17|2016-03-07|||July 2011||2011-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients|A Phase I Clinical Study of CWP232291 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia-2, Myelodysplastic Syndrome Having Failed Hypomethylating Treatment, and High-Risk Myelofibrosis|Completed||Phase 1|69|Actual|JW Pharmaceutical||1|||f||||t||||||||||2017-10-11 04:00:32.66323|2017-10-11 04:00:32.66323
NCT01398449|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-07-19|||April 2011||2011-04-01|March 2011|2011-03-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0|Is Elective Nodal Irradiation (ENI) Necessary For Patients With Thoracic Esophageal Squamous Cell Carcinoma Who Undergo Esophagectomy And With Pathological Stage Of T1-2,N+,M0 -- A Randomized Phase Ⅲ Trial|Recruiting||Phase 3|874|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 04:00:32.741038|2017-10-11 04:00:32.741038
NCT01398436|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-04-19|||March 2011||2011-03-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Hemoglobin Saturation in Superior Vena Cava and Right Atrium|Comparison Between Hemoglobin Saturation in the Superior Vena Cava and in the Right Atrium|Completed||N/A|61|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-10-11 04:00:32.86439|2017-10-11 04:00:32.86439
NCT01398423|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-08-05|||June 2011||2011-06-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria|A 12 Week, Phase II Trial of the Safety, Pharmacokinetics, and Efficacy of INV-144 Compared With Losartan Potassium in Patients With Hypertension and Type 2 Diabetes Mellitus With Nephropathy|Completed||Phase 2|88|Actual|InVasc Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 04:00:32.946068|2017-10-11 04:00:32.946068
NCT01398410|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-11-19|2015-10-16||December 2011||2011-12-01|November 2015|2015-11-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)|Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Open-label Trial-|Completed||Phase 2/Phase 3|405|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 04:00:33.08379|2017-10-11 04:00:33.08379
NCT01398371|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-05-30|||August 2011||2011-08-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|February 2015|Actual|2015-02-01||Interventional|||Digoxin Withdrawal in Stable Heart Failure|A Randomised, Blinded, Placebo Controlled Trial to Assess the Effect of Digoxin Withdrawal in Stable Heart Failure Patients Receiving Optimal Background Therapy|Completed||N/A|16|Actual|The Alfred||2|||f||||f||||||||||2017-10-11 04:00:33.910399|2017-10-11 04:00:33.910399
NCT01398345|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2014-07-01|||April 2003||2003-04-01|July 2014|2014-07-01||||December 2006|Actual|2006-12-01||Interventional|||Exercise and Respiratory Training as Supportive Treatments for Patients With Chronic Pulmonary Hypertension|Phase 3 Study of Physical Exercise and Respiratory Training as Supportive Treatments for Patients With Severe Chronic Pulmonary Hypertension|Completed||Phase 3|30|Anticipated|Heidelberg University||1|||f||||||||||||||2017-10-11 04:00:34.068985|2017-10-11 04:00:34.068985
NCT01398332|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2017-09-07|||January 2011||2011-01-01|September 2017|2017-09-01|November 2022|Anticipated|2022-11-01|November 2012|Actual|2012-11-01||Observational|||Evaluation of the GORE® C3 Delivery System Module|Global Registry for Endovascular Aortic Treatment(GREAT)|Active, not recruiting||N/A|400|Actual|W.L.Gore & Associates|||1||f||||t||||||||||2017-10-11 04:00:34.144303|2017-10-11 04:00:34.144303
NCT01398319|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-10-31|||October 2010||2010-10-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|April 2018|Anticipated|2018-04-01||Interventional|AFIV||Prevention of Alcohol Related Incidents in Air Force Technical Training|Predictors of Smokeless Tobacco and Dual Use in the US Military and the Prevention of Alcohol Related Incidents Using a Brief Alcohol Intervention in Air Force Technical Training|Recruiting||N/A|35000|Anticipated|University of Tennessee||1|||f||||t||||||||||2017-10-11 04:00:34.210017|2017-10-11 04:00:34.210017
NCT01398306|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2012-05-07|||July 2011||2011-07-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|BANN||Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.|Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.|Completed||N/A|40|Actual|University Medical Center Groningen|||2||f||||f||||||Samples With DNA|"     2 x 10mL whole blood, stored as platelet rich and platelet poor plasma.   "|||2017-10-11 04:00:34.28835|2017-10-11 04:00:34.28835
NCT01398293|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects|A Single-center, Single-dose, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Four-way Crossover Study to Investigate the Effect of Danoprevir With Low Dose Ritonavir (DNV/r) on the QT/QTc Interval in Healthy Subjects|Completed||Phase 1|52|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 04:00:34.370417|2017-10-11 04:00:34.370417
NCT01398280|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-01-14|||July 2011||2011-07-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ACA||Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation|A Single Site Evaluation of the Effect of Topical Application of Aminocaproic Acid (ACA) to Inhibit Kallikrein 5 Serine Protease Activity and Production of LL-37 Cathelicidin Peptide, Biochemical Markers of Rosacea-specific Inflammation.|Completed||Early Phase 1|15|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 04:00:34.489111|2017-10-11 04:00:34.489111
NCT01398267|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Investigate the Effects of Aleglitazar 150 µg in Type 2 Diabetic Patients Treated With Lisinopril 20 mg on Renal Function, the Renin-angiotensin System and the Pharmacokinetics of Lisinopril|Completed||Phase 1|55|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:00:34.567929|2017-10-11 04:00:34.567929
NCT01398254|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-04-26|||July 2011||2011-07-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|August 2019|Anticipated|2019-08-01||Interventional|SAFARI-STEMI||Femoral Versus Radial Access for Primary PCI|The Safety and Efficacy of Femoral Access Versus Radial for Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction (SAFARI-STEMI Trial)|Recruiting||N/A|4884|Anticipated|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 04:00:34.653389|2017-10-11 04:00:34.653389
NCT01398241|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of RO5267683 in Healthy Subjects|Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5267683 in an Adaptive, Randomized, Investigator-blind and Subject-blind, Multiple-ascending Dose, Placebo-controlled, Study Following Oral Administrations in Healthy Subjects for 28 Days|Completed||Phase 1|38|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:00:34.769701|2017-10-11 04:00:34.769701
NCT01398228|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-08-08|||September 2011||2011-09-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional|CPACS-3||Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3|Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3|Completed||N/A|29934|Actual|The George Institute for Global Health, China||4|||f||||t||||||||||2017-10-11 04:00:34.848474|2017-10-11 04:00:34.848474
NCT01398215|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-10-24|||January 2009||2009-01-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|NOTES||Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Transvaginal Ventral Hernia Repair|Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Transvaginal Ventral Hernia Repair|Recruiting||N/A|50|Anticipated|University of California, San Diego|||1||f||||f||||||||||2017-10-11 04:00:35.098098|2017-10-11 04:00:35.098098
NCT01398202|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-11-30|||January 2011||2011-01-01|November 2015|2015-11-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults|Comparison of the Bioefficacy of Oral 25-hydroxyvitamin D3 and Vitamin D3 Supplements on Vitamin D Status in Older Adults|Completed||N/A|56|Actual|University College Cork||4|||f||||t||||||||||2017-10-11 04:00:35.18166|2017-10-11 04:00:35.18166
NCT00000345|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||April 1996||1996-04-01|September 1997|1997-09-01||||||||Interventional|||Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10|Evaluation of Lofexidine for Treatment of Opiate Withdrawal|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.616315|2017-10-11 04:17:47.616315
NCT01398189|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2013-11-19|||July 2011||2011-07-01|November 2013|2013-11-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|APC||F-18 Altanserin PET Study of Patients Receiving Clozapine|Validation of Molecular Imaging Technologies for Early Clinical Trials|Unknown status|Recruiting|N/A|12|Anticipated|Seoul National University Bundang Hospital||1|||f||||t||||||||||2017-10-11 04:00:35.261428|2017-10-11 04:00:35.261428
NCT01398176|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2013-12-02|2013-09-25||October 2011||2011-10-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Immune Benefits From Mushroom Consumption|Immune Benefits From Mushroom Consumption|Completed||N/A|52|Actual|University of Florida|No specific limitations outside of the normal limitations to human interventions studies.|2|||f||||f||||||||||2017-10-11 04:00:35.45874|2017-10-11 04:00:35.45874
NCT01398163|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2016-11-23|||April 2009||2009-04-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||A f-MRI Study Of Affective Changes Associated With Four Weeks Consumption Of A Fermented Dairy Product In Healthy Women|A f-MRI STUDY OF AFFECTIVE CHANGES ASSOCIATED WITH FOUR WEEKS CONSUMPTION OF A FERMENTED DAIRY PRODUCT IN HEALTHY WOMEN|Completed||N/A|51|Actual|Danone Research||3|||f||||f||||||||||2017-10-11 04:00:35.711212|2017-10-11 04:00:35.711212
NCT01398150|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-09-16|||March 2009||2009-03-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Cranberry Enhances Human Immune Function and Reduces Illness|Cranberry Enhances Human Immune Function and Reduces Illness|Completed||N/A|54|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 04:00:35.792715|2017-10-11 04:00:35.792715
NCT01398137|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-10-26|||July 2011||2011-07-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Ragweed Observational Study|An Observational Multi-Centre Field Study to Assess Symptom Scores and Rescue Medication Usage in Subjects With a History of Ragweed Allergen-Induced Rhinoconjunctivitis|Completed||N/A|90|Actual|Circassia Limited|||1||f||||f||||||||||2017-10-11 04:00:35.884413|2017-10-11 04:00:35.884413
NCT01398124|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2017-08-21|||December 2012||2012-12-01|August 2017|2017-08-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer|A Pilot Study of Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Patients With Resectable Non-Small Cell Lung Cancer|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center||1||We will not be pursuing this study.|f||||t||||||||||2017-10-11 04:00:35.965755|2017-10-11 04:00:35.965755
NCT01398111|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-04-02|||May 2011||2011-05-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|TRIPLE 1||Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers|Open-label, Randomized, Single-dose, Placebo-controlled, 4-way Crossover Study to Investigate the Pharmacokinetic Interaction of Glycopyrrolate and Formoterol in Healthy Subjects.|Completed||Phase 1|44|Actual|Chiesi Farmaceutici S.p.A.||4|||f||||f||||||||||2017-10-11 04:00:36.034211|2017-10-11 04:00:36.034211
NCT01398098|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-11-28|||October 2011||2011-10-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||Measurement of Gastric Emptying During and After COLOKIT® Intake|Gastric Emptying Time Assessment During Bowel Preparation With COLOKIT®|Completed||Phase 2|30|Actual|Laboratoires Mayoly Spindler||1|||f||||f||||||||||2017-10-11 04:00:36.113319|2017-10-11 04:00:36.113319
NCT01398085|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-10-25|||May 2012||2012-05-01|October 2016|2016-10-01|January 2021|Anticipated|2021-01-01|November 2020|Anticipated|2020-11-01||Interventional|IoN||IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients|Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients|Recruiting||Phase 2/Phase 3|570|Anticipated|University College, London||2|||f||||f||||||||||2017-10-11 04:00:36.1825|2017-10-11 04:00:36.1825
NCT01398072|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-05-31|||December 2011||2011-12-01|May 2012|2012-05-01|April 2013|Anticipated|2013-04-01|January 2013|Anticipated|2013-01-01||Interventional|||Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)|A Phase III Single-blind, Randomised Placebo Controlled Trial of Long Term Therapy in Patients With Stable COPD Using Moxifloxacin, Azithromycin and Doxycycline: a Bayesian Decision Analysis, Including Other Criteria, Will be Used to Distinguish the Optimal Antibiotic Treatment|Unknown status|Recruiting|Phase 3|200|Anticipated|University College, London||4|||f||||f||||||||||2017-10-11 04:00:36.391955|2017-10-11 04:00:36.391955
NCT01398059|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-09-24|||July 2011||2011-07-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Metabolic Effects of Breaks in Sedentary Time|The Metabolic Effects of Breaks in Sedentary Time|Completed||N/A|20|Actual|Children's Hospital of Eastern Ontario||3|||f||||f||||||||||2017-10-11 04:00:36.482468|2017-10-11 04:00:36.482468
NCT01398046|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2015-04-24|||August 2011||2011-08-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effects of Gastric pH on the Pharmacokinetics of Dasatinib|Effects of Gastric pH on the Pharmacokinetics of Dasatinib in Healthy Volunteers|Completed||Phase 1|10|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 04:00:36.559213|2017-10-11 04:00:36.559213
NCT01398033|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-08-03|||April 2012||2012-04-01|August 2015|2015-08-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Interventional|BAIR||Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis|Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis|Withdrawn||Phase 3|0|Actual|Herz-Zentrums Bad Krozingen||2||Study stopped due to lack of patient inclusion|f||||t||||||||||2017-10-11 04:00:36.635772|2017-10-11 04:00:36.635772
NCT01398020|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-09-17|||July 2011||2011-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||Comparing 2L Bi-Pegyte to 4L PegLyte Regiments for Outpatient Colonic Preparation|Oral 2L Bi-PegLyte Versus 4L PegLyte Regimen for Outpatient Colonic Preparation: A Randomized, Non-Inferiority Open Trial|Completed||N/A|318|Actual|University of British Columbia||2|||f||||||||||||||2017-10-11 04:00:36.707295|2017-10-11 04:00:36.707295
NCT01398007|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-03-10|||October 2005||2005-10-01|July 2011|2011-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Use of the Camouflage Syringe to Reduce Dental Anxiety and Fear in Children|Evaluation of the Efficacy of Camouflage Syringe in Reducing Dental Anxiety and Fear in Children|Completed||Phase 2|100|Actual|Government Dental College and Hospital, India||2|||f||||t||||||||||2017-10-11 04:00:36.780881|2017-10-11 04:00:36.780881
NCT01390857|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-05-15|2011-08-18||November 2007||2007-11-01|May 2017|2017-05-01|May 2010|Actual|2010-05-01|September 2008|Actual|2008-09-01||Observational|||Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)|Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)|Completed||N/A|379|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:02:57.424123|2017-10-11 04:02:57.424123
NCT01397994|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-12-07|||September 2011||2011-09-01|December 2011|2011-12-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.|A Comparative Study to Assess the Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment naïve Patients of Chronic Stable Angina.|Unknown status|Recruiting|Phase 4|40|Anticipated|Ferozsons Laboratories Ltd.||2|||f||||f||||||||||2017-10-11 04:00:36.861972|2017-10-11 04:00:36.861972
NCT01397981|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2013-03-05|||July 2011||2011-07-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|April 2012|Actual|2012-04-01||Interventional|||Gait Retraining to Reduce Knee Osteoarthritis Pain|Evaluation of Haptic Technologies for Movement Retraining|Completed||Phase 1/Phase 2|25|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 04:00:36.953662|2017-10-11 04:00:36.953662
NCT01397968|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-09-21||2014-11-17|May 2011||2011-05-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures|A Phase 2 Multicenter, Double-blind, Randomized, Adjunctive, Placebo-controlled Trial With an Open-label Extension to Evaluate the Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures|Active, not recruiting||Phase 2|222|Actual|SK Life Science||2|||f||||t||||||||||2017-10-11 04:00:37.031245|2017-10-11 04:00:37.031245
NCT01397955|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-19|2015-04-16|||January 2009||2009-01-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Observational|||Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan|Drug Use Investigation of Julina Tablets 0.5 mg (Postmenopausal Osteoporosis)|Completed||N/A|148|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:00:37.159278|2017-10-11 04:00:37.159278
NCT01397942|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-03-10|||May 2011||2011-05-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|MAXVEG||Maximising the Taste and Health Value of Plant Food Products|Maximising the Taste and Health Value of Plant Food Products - Impact on Vegetable Consumption, Consumer Preferences and Human Health Factors.|Completed||N/A|92|Actual|Aarhus University Hospital||3|||f||||t||||||||||2017-10-11 04:00:37.23301|2017-10-11 04:00:37.23301
NCT01397929|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-04-06|||June 2011||2011-06-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|January 2016|Actual|2016-01-01||Interventional|||An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors|An Open-Label Phase I/IIa Study of Intravenous BAL101553 in Adult Patients With Advanced Solid Tumors|Completed||Phase 1/Phase 2|73|Actual|Basilea Pharmaceutica||2|||f||||f||||||||||2017-10-11 04:00:37.317657|2017-10-11 04:00:37.317657
NCT01397916|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-18|2012-03-29|||February 2010||2010-02-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|KLL3||Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)|The Activity of Indoleamine 2,3-dioxygenase in Patients With Chronic Lymphocytic Leukemia (CLL)|Completed||N/A|73|Actual|Tampere University Hospital|||2||f||||f||||||Samples With DNA|"     Ido expression   "|||2017-10-11 04:00:37.38806|2017-10-11 04:00:37.38806
NCT01397903|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-06-22|||September 2011||2011-09-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|MADDRE||Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response|A Cross-sectional Observational Study to Describe Treatment Management of Patients With Major Depressive Disorder (MDD) and Inadequate Response to Antidepressants in Greece|Completed||N/A|545|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 04:00:37.455376|2017-10-11 04:00:37.455376
NCT01397890|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-03-25|2014-06-18||July 2011||2011-07-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|SECURE 1|Overall Number of Baseline Participants is not different from the Milestones.|Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Parallel-group, Open-label, Multicentre, 3-month Phase IV, Efficacy and Tolerability Study of Budesonide/Formoterol (Symbicort® Turbuhaler® 160/4.5μg/Inhalation, 2 Inhalations Twice Daily) Added to Tiotropium (SpirivaTM 18 μg/Inhalation, 1 Inhalation Once Daily) Compared With Tiotropium (SpirivaTM18 μg/Inhalation, 1 Inhalation Once Daily) Alone in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients|Completed||Phase 4|793|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:00:37.610757|2017-10-11 04:00:37.610757
NCT01397877|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-03-15|||December 2011||2011-12-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|October 2014|Actual|2014-10-01||Interventional|ENDOPIK||GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer|Phase 2 Multicenter Study to Assess the Safety and Efficacy of BKM120 as Monotherapy in Treatment of Initial or Recurrent Metastatic Endometrial Cancer After 1st Line Therapy in Patients Who Cannot Undergo Local Surgery and/or Radiotherapy|Completed||Phase 2|24|Actual|ARCAGY/ GINECO GROUP||1|||f||||t||||||||||2017-10-11 04:00:38.765526|2017-10-11 04:00:38.765526
NCT01397864|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-10-14|||July 2011||2011-07-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks|C1 Inhibitor Treatment Registry to Assess the Safety and Immunological Profile of Ruconest in the Treatment of HAE Attacks|Recruiting||N/A|300|Anticipated|Pharming Technologies B.V.|||1||f||||f||||||||||2017-10-11 04:00:39.032308|2017-10-11 04:00:39.032308
NCT01397851|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2015-01-07|2014-11-20||December 2010||2010-12-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Interventional|Outgrowers||Stimulating Private Sector Malaria Control|Stimulating Private Sector Malaria Control: The Outgrower Opportunity|Completed||N/A|81597|Actual|PATH||2|||f||||f||||||||||2017-10-11 04:00:39.192695|2017-10-11 04:00:39.192695
NCT01397838|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-19|||September 2011||2011-09-01|July 2011|2011-07-01|January 2012|Anticipated|2012-01-01|December 2011|Anticipated|2011-12-01||Interventional|||Safety Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women|Phase 1 Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|OsteoBuild Ltd.||1|||f||||f||||||||||2017-10-11 04:00:39.550314|2017-10-11 04:00:39.550314
NCT01397825|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-17|2016-11-17||2016-11-17|August 2011||2011-08-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|February 2015|Actual|2015-02-01||Interventional|||MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab & Vincristine|A Multicenter, Phase 1-2 Study of MLN8237, an Oral Aurora A Kinase Inhibitor, in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab and Vincristine|Completed||Phase 1/Phase 2|43|Actual|Takeda||1|||f||||f||||||||||2017-10-11 04:00:39.635153|2017-10-11 04:00:39.635153
NCT01397812|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-04-06|||December 2010||2010-12-01|April 2015|2015-04-01|September 2016|Anticipated|2016-09-01|December 2013|Actual|2013-12-01||Observational|Heartsbreath||Heartsbreath Test for Heart Transplant Rejection|Validation of Heartsbreath Test for Heart Transplant Rejection|Unknown status|Active, not recruiting|N/A|1200|Anticipated|Menssana Research, Inc.|||1||f||||f||||||||||2017-10-11 04:00:39.81437|2017-10-11 04:00:39.81437
NCT01397799|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-12-04|||December 2013||2013-12-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)|A Phase 1b Rising Multiple-Dose Study to Evaluate Safety, Tolerability and Activity of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia Who Are Refractory to or Have Declined Standard Induction Therapy|Completed||Phase 1|24|Actual|Kinex Pharmaceuticals Inc||1|||f||||f||||||||||2017-10-11 04:00:39.92243|2017-10-11 04:00:39.92243
NCT01397786|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-04-03|2017-02-03||September 2011||2011-09-01|April 2017|2017-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|ZENITH||Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia|A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia|Completed||Phase 3|1044|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 04:00:40.109277|2017-10-11 04:00:40.109277
NCT01397773|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-19|||April 2010||2010-04-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Pentraxin-3 in Chronic Renal Failure|The Role Pentraxin-3 in the Inflammatory Process in Chronic Renal Failure, and the Association With Other Inflammatory Parameters|Completed||N/A|85|Anticipated|Haseki Training and Research Hospital|||4||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 04:00:41.81549|2017-10-11 04:00:41.81549
NCT01397760|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-07-19|||August 2011||2011-08-01|July 2011|2011-07-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|||Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control Asthma|Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control Asthma|Unknown status|Not yet recruiting|N/A|20|Anticipated|Fiks, Iara Nely, M.D.|||1||f||||f||||||||||2017-10-11 04:00:41.888829|2017-10-11 04:00:41.888829
NCT01397747|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-12-01|2015-12-01||June 2011||2011-06-01|November 2015|2015-11-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Observational|DeeP-C|All evaluable participants except for participants who had multitargeted sDNA or colonoscopy excluded.|Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer|Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer: DeeP-C Study|Completed||N/A|12776|Actual|Exact Sciences Corporation|||1||f||||f||||||Samples With DNA|"     Residual stool samples may be archived for further research. Clinical data and samples will     be kept in a manner that preserves anonymity of the subjects, using the subject ID as the     only tracking information. Specimens will be stored in a commercial biorepository contracted     by Exact Sciences or at Exact Sciences and may be used for future research.   "|||2017-10-11 04:00:41.969112|2017-10-11 04:00:41.969112
NCT01397734|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2017-06-30|||September 2011||2011-09-01|June 2017|2017-06-01||||September 2017|Anticipated|2017-09-01||Interventional|||Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)|Targeting of the Leukemia Stem Cell Population With Arsenic Trioxide and Tyrosine Kinase Inhibitors for CML|Active, not recruiting||Phase 1|7|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-10-11 04:00:43.849678|2017-10-11 04:00:43.849678
NCT01397721|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2015-04-22|||May 2009||2009-05-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|March 2016|Anticipated|2016-03-01||Observational|MESA-COPD||Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary|Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary (MESA-COPD)|Unknown status|Active, not recruiting|N/A|360|Actual|Columbia University|||1||f||||t||||||Samples With DNA|"     Blood will be stored at Columbia and at University of Vermont, identified only by study ID     and following standard procedures. It will be accessible only to study investigators and, if     the participant approves, outside investigators following MESA/NIH protocols and with IRB     approval. Blood will be kept indefinitely.   "|||2017-10-11 04:00:43.929315|2017-10-11 04:00:43.929315
NCT01397708|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-01-23|||August 2011||2011-08-01|March 2014|2014-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma|A Phase I/II, Open Label Study of Ad-RTS-hIL-12, an Adenovirus Vector Engineered to Express hIL-12, in Combination With an Oral Activator Ligand, in Subjects With Unresectable Stage III or IV Melanoma|Completed||Phase 1/Phase 2|26|Actual|Ziopharm||1|||f||||f||||||||||2017-10-11 04:00:44.009306|2017-10-11 04:00:44.009306
NCT01397695|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-18|||June 2009||2009-06-01|July 2011|2011-07-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)|Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)|Unknown status|Recruiting|Phase 2|50|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-10-11 04:00:44.218765|2017-10-11 04:00:44.218765
NCT01397682|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2012-10-16|||September 2011||2011-09-01|October 2012|2012-10-01|September 2017|Anticipated|2017-09-01|September 2016|Anticipated|2016-09-01||Observational|report-AGE||Epidemiological Observatory on the Health Conditions of Inpatients Aged 65 or Older at the INRCA Research Hospitals|Epidemiological Observatory on the Health Conditions of Inpatients Aged 65 or Older at the INRCA Research Hospitals|Unknown status|Enrolling by invitation|N/A|2250|Anticipated|Istituto Nazionale di Ricovero e Cura per Anziani|||1||f||||||||||Samples With DNA|"     plasma, serum, whole blood   "|||2017-10-11 04:00:44.345733|2017-10-11 04:00:44.345733
NCT01397669|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-12-07|||July 2011||2011-07-01|December 2016|2016-12-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Characteristics of Immune Cells in Gut Mucosa of HIV Negative and HIV Positive Thais||Recruiting||N/A|61|Anticipated|South East Asia Research Collaboration with Hawaii||1|||f||||f||||||||||2017-10-11 04:00:44.448435|2017-10-11 04:00:44.448435
NCT01397643|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-10-05|||October 2010||2010-10-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||A Trial of Non-operative Versus Operative Management of Olecranon Fractures in the Elderly|A Prospective Randomised Trial of Non-operative Versus Operative Management of Olecranon Fractures in the Elderly|Terminated||N/A|19|Actual|Royal Infirmary of Edinburgh||2||Complication rate in operative group on interim analysis and safety monitoring.|f||||f||||||||Yes|Peer reviewed publication - undergoing review|2017-10-11 04:00:44.637195|2017-10-11 04:00:44.637195
NCT01397630|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-06-23|||April 2012||2012-04-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|ACTION||Accelerated Titration of Oxytocin for Nulliparous Patients With Labour Dystocia: ACTION Pilot Study|Accelerate Versus Gradual Titration of Oxytocin Dose for Labour Dystocia: A Pilot Study|Terminated||Phase 3|79|Actual|Ottawa Hospital Research Institute||2||"Due to budgetary concerns, the TSC decided it best to adjust sample size as there was   sufficient data to assess feasibility. Recruitment was terminated early."|f||||t||||||||||2017-10-11 04:00:44.727154|2017-10-11 04:00:44.727154
NCT01397617|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2016-03-22|2015-12-08||April 2006||2006-04-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Randomized, Open Investigation Evaluating the Efficacy of Nobel Biocare SFB and CFB Implants|Evaluation of NobelBiocare SFB and CFB Implants|Completed||N/A|177|Actual|Nobel Biocare||3|||f||||f||||||||No||2017-10-11 04:00:44.829041|2017-10-11 04:00:44.829041
NCT01397604|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-09-19|||July 2011||2011-07-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effects of GLA on Human Volunteers|A Randomized, Blinded, Placebo-Controlled Phase 1 Study to Evaluate the Safety and Immunogenicity of GLA in Healthy Volunteers|Completed||Phase 1|32|Anticipated|Rockefeller University||4|||f||||f||||||||||2017-10-11 04:00:45.183305|2017-10-11 04:00:45.183305
NCT01397591|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-07-28|2014-06-18||October 2011||2011-10-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma|Phase II Trial of Ofatumumab and Bortezomib in Subjects With Relapsed Cluster of Differentiation Antigen 20 (CD20)+ Diffuse Large B Cell Lymphoma, Follicular Lymphoma, or Mantle Cell Lymphoma|Terminated||Phase 2|3|Actual|OHSU Knight Cancer Institute||1||Study closed by PI due to lower than expected accrual.|f||||t||||||||||2017-10-11 04:00:45.263799|2017-10-11 04:00:45.263799
NCT01397578|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2017-07-10||2016-08-10|August 31, 2011|Actual|2011-08-31|July 2017|2017-07-01|April 30, 2014|Actual|2014-04-30|April 30, 2014|Actual|2014-04-30||Interventional|||A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter, Phase II Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|91|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 04:00:45.513824|2017-10-11 04:00:45.513824
NCT01397565|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2015-09-26|||February 2012||2012-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Minilaparoscopic Versus Conventional Laparoscopic Cholecystectomy|Minilaparoscopic Versus Conventional Laparoscopic Cholecystectomy: A Randomized Trial|Completed||Phase 4|115|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 04:00:45.802817|2017-10-11 04:00:45.802817
NCT01397552|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2017-04-25|||September 2009||2009-09-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Dexamethasone Versus Depo Medrol in Lumbar Epidurals|A Prospective, Randomized, Double-Blind Study to Compare the Effects of Dexamethasone Versus Depo-Medrol When Used in Lumbar Epidural Injections|Terminated||N/A|8|Actual|State University of New York - Upstate Medical University||2||Low enrollment, too many subjects getting second injection|f||||f||||||||No||2017-10-11 04:00:45.911669|2017-10-11 04:00:45.911669
NCT01397539|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-03-19|||June 2011||2011-06-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease|A Randomized, Blinded, Placebo-Controlled Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB037 in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|53|Actual|Biogen||2|||f||||t||||||||||2017-10-11 04:00:46.005541|2017-10-11 04:00:46.005541
NCT01397526|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2014-06-30|||July 2011||2011-07-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|||Colloid Osmotic Pressure During Heart Surgery in Children|Colloid Osmotic Pressure During Heart Surgery in Children|Completed||N/A|9|Actual|Oslo University Hospital|||1||f||||f||||||Samples Without DNA|"     Interstitial fluid Serum   "|||2017-10-11 04:00:46.142087|2017-10-11 04:00:46.142087
NCT01397513|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-07-18|||March 2006||2006-03-01|March 2006|2006-03-01|February 2011|Actual|2011-02-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes|Effects of Low and High Doses of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes and Possible Influence of the Glycemic Control.|Completed||Phase 4|48|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-10-11 04:00:46.207092|2017-10-11 04:00:46.207092
NCT01397500|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2016-01-08|||November 2011||2011-11-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional|||Hormone Treatment in Growth Hormone and Testosterone Deficient Patients|Growth Hormone and Gonadotropin Deficiency After Brain Injury (Traumatic Brain Injury, Subarachnoidal Hemorrhage, Ischemic Stroke): the Effects of Hormone Replacement on Cognition, Quality of Life and Body Composition|Terminated||Phase 2|54|Actual|Max-Planck-Institute of Psychiatry||3||Recruitment problems due to change of patient population at site.|f||||f||||||||||2017-10-11 04:00:46.312631|2017-10-11 04:00:46.312631
NCT01397487|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-27|||July 2011||2011-07-01|July 2011|2011-07-01|September 2013|Anticipated|2013-09-01|January 2012|Anticipated|2012-01-01||Interventional|BB||Effects of Day 3 Blastomere Biopsy on Human Embryos|Effects of the Blastomere Biopsy of Day 3 Human Embryos on Blastocyst Percentage, Cell Number of Obtained Blastocyst and Implantation Rate|Unknown status|Recruiting|Early Phase 1|22|Anticipated|Fundacion Para La Investigacion Hospital La Fe||1|||f||||t||||||||||2017-10-11 04:00:46.409974|2017-10-11 04:00:46.409974
NCT01397474|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-01-03|||October 2011||2011-10-01|January 2014|2014-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Peripheral Perfusion Targeted Fluid Management|Peripheral Perfusion Targeted Fluid Management in Critically Ill Patients: a Pilot Study|Unknown status|Recruiting|Phase 4|40|Anticipated|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 04:00:46.504584|2017-10-11 04:00:46.504584
NCT01397461|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-06-01|2016-02-25||March 2012||2012-03-01|June 2016|2016-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||"The baseline analysis population was considered the safety populations. The safety population was defined as all patients who had at least one application of study drug.
One patient was randomised to retapamulin but treated with ozenoxacin. One patient was randomised to retapamulin but not treated."|Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo|A Phase III 3 Arms, Multicenter, Randomised, Investigator-blind Study to Assess the Efficacy and Safety of Ozenoxacin 1% Cream Applied Twice Daily for 5 Days Versus Placebo in the Treatment of Patients With Impetigo|Completed||Phase 3|465|Actual|Ferrer Internacional S.A.||3|||f||||t||||||||||2017-10-11 04:00:46.62018|2017-10-11 04:00:46.62018
NCT01397448|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2014-11-25|2014-10-20||July 2011||2011-07-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)|Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Double-blind Comparative Trial-|Completed||Phase 2/Phase 3|472|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-11 04:00:47.080304|2017-10-11 04:00:47.080304
NCT01397435|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2015-02-03|||July 2011||2011-07-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Observational|MRS in Gaucher||MR Spectroscopy and Disease Severity Score for Gaucher in Pediatric Population|Quantification of Bone Marrow Involvement in Gaucher Disease With Proton MR Spectroscopy, Correlation With Bone Marrow Burden Score, Genotype and Disease Severity Score for Pediatric Patients|Completed||N/A|24|Actual|Children's Hospital of Philadelphia|||2||f||||f||||||||||2017-10-11 04:00:47.849373|2017-10-11 04:00:47.849373
NCT01397409|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-06-02|2015-06-02||September 2011||2011-09-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)||Completed||Phase 2|271|Actual|Allergan||10|||f||||f||||||||||2017-10-11 04:00:48.235476|2017-10-11 04:00:48.235476
NCT01397396|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2017-03-12|||February 2012|Actual|2012-02-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|IMTCO||Effects of Inspiratory Muscle Training in COPD|Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease - a Randomized Controlled Trial|Completed||Phase 3|208|Actual|Katholieke Universiteit Leuven||2|||f||||||||||||||2017-10-11 04:00:49.965822|2017-10-11 04:00:49.965822
NCT01397383|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2017-03-16|||March 2010||2010-03-01|March 2017|2017-03-01|February 3, 2014|Actual|2014-02-03|June 2011|Actual|2011-06-01||Observational|||Vitamin D and Functional Outcomes After Total Hip Arthroplasty (THA)|The Effect of Serum Vitamin D Level and the Short Term Functional Outcomes After Total Hip Arthroplasty|Completed||N/A|219|Actual|Hospital for Special Surgery, New York|||2||f||||t||||||||||2017-10-11 04:00:50.057975|2017-10-11 04:00:50.057975
NCT01397370|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-02-17|||July 2011||2011-07-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects|Double Blind, Placebo Controlled Dose Ranging Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of GLPG0492 in Healthy Subjects|Completed||Phase 1|24|Actual|Galapagos NV||2|||f||||f||||||||||2017-10-11 04:00:50.125987|2017-10-11 04:00:50.125987
NCT01397357|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-09-30|||July 2011||2011-07-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|CARDIO-RM||Cardiac Magnetic Resonance Utilities in the Evaluation of Ischemic Heart Disease|CARDIAC MAGNETIC RESONANCE UTILITIES IN THE EVALUATION OF ISCHEMIC HEART DISEASE: Topographical Correlation Between Ischemic Territory Injury and Coronary Angiography|Completed||N/A|146|Actual|Ettore Sansavini Health Science Foundation|||1||f||||t||||||||No||2017-10-11 04:00:50.194157|2017-10-11 04:00:50.194157
NCT01397344|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-09-01|||July 2011||2011-07-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|June 2012|Actual|2012-06-01||Observational|||Patients' Preferences for Traditional Medicine Doctor's Attire|Patients' Preferences for Traditional Medicine Doctor's Attire|Completed||N/A|175|Actual|Korean Medicine Hospital of Pusan National University|||1||f||||f||||||||||2017-10-11 04:00:50.257238|2017-10-11 04:00:50.257238
NCT01397331|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-07-18|||July 2010||2010-07-01|July 2011|2011-07-01|April 2012|Anticipated|2012-04-01|December 2011|Anticipated|2011-12-01||Interventional|||Influence of Anesthesia on Mechanical Efficiency of Left Ventricle in Patients Undergoing Open Heart Surgery|Influence of Anesthesia on Mechanical Efficiency of Left Ventricle in Patients Undergoing Open Heart Surgery|Unknown status|Recruiting|Phase 4|30|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 04:00:50.307434|2017-10-11 04:00:50.307434
NCT01397318|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2011-07-18|||September 2010||2010-09-01|July 2011|2011-07-01|July 2013|Anticipated|2013-07-01|||||Observational|||Effects of Modified TaiChi Exercise on Maternal Stress, Fatigue, Sleep Quality, Biomarkers, and Infant Gestational Age and Birthweight|Effects of Modified TaiChi Exercise on Maternal Stress, Fatigue, Sleep Quality, Biomarkers, and Infant Gestational Age and Birthweight|Unknown status|Active, not recruiting|N/A|300|Anticipated|Taipei Medical University WanFang Hospital|||2||f||||f||||||||||2017-10-11 04:00:50.37655|2017-10-11 04:00:50.37655
NCT01397305|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-04-19|||April 2011||2011-04-01|April 2016|2016-04-01||||November 2014|Actual|2014-11-01||Interventional|||An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer|An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer|Completed||Phase 1/Phase 2|24|Actual|Isofol Medical AB||1|||f||||f||||||||||2017-10-11 04:00:50.436147|2017-10-11 04:00:50.436147
NCT01397292|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2013-03-15|||July 2011||2011-07-01|July 2011|2011-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Registry for Patients Undergoing Pulmonary Procedures|Registry Examining Retrospective and Prospective Data for Patients Undergoing Pulmonary Procedures|Terminated||N/A|220|Actual|Virginia Commonwealth University|||1|funding/ enrollment|f||||f||||||||||2017-10-11 04:00:50.51917|2017-10-11 04:00:50.51917
NCT01397279|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-11-26|||July 2011||2011-07-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|April 2012|Actual|2012-04-01||Interventional|CLAVA||Assessment of Liver Glucose Metabolism in Diabetic Subjects|Assessment of Liver Glucose Metabolism in Diabetic Subjects|Unknown status|Active, not recruiting|N/A|40|Anticipated|German Diabetes Center||2|||f||||t||||||||||2017-10-11 04:00:50.571828|2017-10-11 04:00:50.571828
NCT01397266|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2011-07-18|||March 2010||2010-03-01|August 2010|2010-08-01|July 2013|Anticipated|2013-07-01|January 2012|Anticipated|2012-01-01||Interventional|TMSCOCAINE||Study of the Effect of Magnetic Stimulation Repetitive Transcranial on Impulsivity in Cocaine Dependence|Effect of Magnetic Stimulation Repetitive Transcranial on Impulsivity in Cocaine Dependence.|Unknown status|Recruiting|Phase 2|20|Anticipated|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-10-11 04:00:50.647933|2017-10-11 04:00:50.647933
NCT01397253|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2015-03-27|2015-03-12||August 2010||2010-08-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Hospitalized medical patients with ≥2 comorbidities and ≥5 chronic medications, at a single center|Virtual Continuity and Its Impact on Complex Hospitalized Patients' Care|Virtual Continuity and Its Impact on Complex Hospitalized Patients' Care|Completed||Phase 3|835|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 04:00:50.737192|2017-10-11 04:00:50.737192
NCT01397240|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-01-08|||July 2011||2011-07-01|July 2011|2011-07-01|June 2013|Anticipated|2013-06-01|January 2012|Anticipated|2012-01-01||Interventional|AL-PA||The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients|The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients Taking Low-dose Aspirin, A Pilot Study|Unknown status|Recruiting|Phase 4|80|Anticipated|Daewoong Pharmaceutical Co. LTD.||2|||f||||t||||||||||2017-10-11 04:00:51.160163|2017-10-11 04:00:51.160163
NCT01397227|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-09-03||2012-09-03|June 2011||2011-06-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model|A Phase I/IIa, Double-blind, Randomized, Placebo-controlled, Dose-escalation Clinical Study Evaluating Safety, Tolerability and Immunogenicity of Two Dose Levels of Recombinant Adenoviral Serotype Ad35 and Serotype Ad26 Vectors Expressing the Malaria Plasmodium Falciparum Circumsporozoite Antigen Administered as Heterologous Prime-boost Regimen, and Assessing Protective Efficacy of the Higher Dose in a Malaria Challenge Model in Unblinded Conditions|Completed||Phase 1/Phase 2|36|Actual|Crucell Holland BV||4|||f||||t||||||||||2017-10-11 04:00:51.238315|2017-10-11 04:00:51.238315
NCT01397214|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2012-06-29|||July 2011||2011-07-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|MGF||Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers|A Randomized, Open-label, Single-dose, Cross-over Study to Investigate Safety and Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers|Completed||Phase 1|103|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-10-11 04:00:51.31973|2017-10-11 04:00:51.31973
NCT01397201|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2014-04-30||2014-04-30|July 2011||2011-07-01|April 2014|2014-04-01||||December 2011|Actual|2011-12-01||Interventional|||Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess and Compare Efficacy and Safety of an 8-week Treatment With BI 54903 at Doses of 45.5, 90.9 and 181.8 mcg b.i.d. Administered Via Respimat® Inhaler and Fluticasone Propionate HFA 220 mcg b.i.d. in Patients With Asthma Inadequately Controlled on Low Dose ICS Therapy|Terminated||Phase 2|30|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 04:00:51.395636|2017-10-11 04:00:51.395636
NCT01397188|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-08-20|||August 2011||2011-08-01|August 2013|2013-08-01|August 2014|Anticipated|2014-08-01|June 2014|Anticipated|2014-06-01||Interventional|PiCCO||Effect of Monitoring of Pulse Index Continuous Cardiac Output (PiCCO) on Shock Patients in Intensive Care Unit|Effect of Monitoring of Pulse Index Continuous Cardiac Output on Shock Patients in ICU|Unknown status|Recruiting|N/A|320|Anticipated|Zhejiang University||2|||f||||f||||||||||2017-10-11 04:00:51.574189|2017-10-11 04:00:51.574189
NCT01397175|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-11-14|||January 2013||2013-01-01|November 2016|2016-11-01|June 2019|Anticipated|2019-06-01|December 2015|Actual|2015-12-01||Interventional|CHOICE||BES, EES, and ZES-R in Real World Practice|A Multicenter, Open-labeled, Randomized Controlled Trial Comparing Three 2nd Generation Drug-Eluting Stents in Real-World Practice|Active, not recruiting||Phase 4|1960|Actual|Yonsei University||3|||f||||t||||||||||2017-10-11 04:00:51.657261|2017-10-11 04:00:51.657261
NCT01397162|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2014-04-30||2014-04-30|July 2011||2011-07-01|April 2014|2014-04-01||||December 2011|Actual|2011-12-01||Interventional|||Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess and Compare Efficacy and Safety of an 8-week Treatment With BI 54903 at Doses of 22.7, 45.5 and 90.9 Doses b.i.d. Administered Via Respimat® Inhaler and Fluticasone Propionate HFA MDI 88 mcg b.i.d. in Patients With Asthma Inadequately Controlled on SABA Therapy|Terminated||Phase 2|29|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 04:00:51.782157|2017-10-11 04:00:51.782157
NCT01397149|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-05-27|||October 2011||2011-10-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|||Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)|A Phase I/II, Multi-centre Trial to Assess the Safety, Efficacy, and Pharmacokinetics of Eltrombopag, Administered to Thrombocytopenic Chronic Lymphocytic Leukemia Patients Prior to Alkylating Agents and/or Purine Analogue-based Therapy|Terminated||Phase 1/Phase 2|4|Actual|University of Ulm||2||Insufficient recruitment|f||||t||||||||||2017-10-11 04:00:51.975806|2017-10-11 04:00:51.975806
NCT01396967|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-08-02|||July 2011||2011-07-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Trying a New Device for Performing Capsulorhexis in Cataract Surgery Surgery|The Efficiency of a New Device for Performing Capsulorhexis in Cataract Surgery|Unknown status|Enrolling by invitation|Phase 1|20|Anticipated|Ziv Hospital||1|||f||||t||||||||||2017-10-11 04:00:53.572435|2017-10-11 04:00:53.572435
NCT01396954|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-18|||November 2007||2007-11-01|November 2007|2007-11-01|August 2012|Anticipated|2012-08-01|August 2011|Anticipated|2011-08-01||Observational|CH-DM||Cirrhosis-Diabetes|Prevalence and Clinical Characteristics of the Patients With Liver Cirrhosis and Different Glucose Metabolism Disorders - A Prospective Study.|Unknown status|Active, not recruiting|N/A|130|Actual|Hospital Universitario Dr. Jose E. Gonzalez|||1||f||||f||||||||||2017-10-11 04:00:53.650704|2017-10-11 04:00:53.650704
NCT01397136|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-02-04|||July 2011||2011-07-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Observational|||Cell-free DNA: a Non-invasive Test for Assessing Embryo Quality|Cell-free DNA: a Non-invasive Test for Assessing Embryo Quality|Completed||N/A|600|Actual|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|||1||f||||f||||||Samples With DNA|"     After normally fertilized oocytes will be identified, they will be transferred into Sydney     IVF Cleavage Medium (Cook Medical) for culture from day 1 to day 3 (up to 8 cell stage). For     a subset of embryos we will also perform culture until blastocyst stage. For this purpose,     embryos will be transferred into Sydney IVF Blastocist medium (Cook Medical) from day 3 to     day 5/6. We will focus on embryo development in a single embryo culture medium. Embryos will     be cultured at 37°C, 6.0% CO2, 5.0% O2 into Galaxy 48R incubators (New Brunswick Scientific).     At the moment of transfer of embryos into the uterine cavity, we will collect embryo culture     media into DNase- and RNase-free 1.5 ml tubes (Eppendorf AG). The media will be immediately     frozen and stored at -20° until nucleic acid purification.   "|||2017-10-11 04:00:52.330123|2017-10-11 04:00:52.330123
NCT01397123|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-07-18|||September 2007||2007-09-01|July 2011|2011-07-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||The Impact of an Intervention Taught by Trained Teachers on Childhood BMI z Score||Completed||N/A|464|Actual|University of Minho||1|||f||||t||||||||||2017-10-11 04:00:52.394211|2017-10-11 04:00:52.394211
NCT01397110|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2015-06-19|||January 2012||2012-01-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects|Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life in Patients With Severe Associated Pulmonary Arterial Hypertension (APAH) as Part of a Congenital Heart Defect With / Without Eisenmenger's Syndrome|Unknown status|Recruiting|Phase 2|50|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-11 04:00:52.474562|2017-10-11 04:00:52.474562
NCT01397097|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-07-22|||September 2011||2011-09-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|June 2013|Actual|2013-06-01||Interventional|||LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study|Multicenter, Open-label, Randomized, Controlled Parallel-group Study to Assess Discontinuation Rates, Bleeding Patterns, User Satisfaction and Adverse Event Profile of LCS12 in Comparison to Etonorgestrel Subdermal Implant Over 12 Months of Use in Women 18 to 35 Years of Age|Completed||Phase 3|766|Actual|Bayer||2|||f||||f||||||||||2017-10-11 04:00:52.56008|2017-10-11 04:00:52.56008
NCT01397084|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2013-02-18|2013-01-16||August 2011||2011-08-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole|An 8-week, Open Label, Multicentre Study to Assess the Efficacy of Esomeprazole 20 mg Once Daily in Subjects With Continuing Symptoms of Heartburn Following Treatment With a Previous Rabeprazole|Completed||Phase 4|107|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 04:00:52.702547|2017-10-11 04:00:52.702547
NCT01397071|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-11-23|||August 2011||2011-08-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Avocado When Added to a Meat Patty on Inflammation in Healthy Men|Hass Avocado Flesh Inhibition of Appearance of Lipid Peroxidation Products When Added to a Ground Beef Patty Consumed by Healthy Volunteers|Completed||Phase 3|11|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 04:00:52.96053|2017-10-11 04:00:52.96053
NCT01397045|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2014-03-26|||July 2011||2011-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Fast Track Rehabilitation Following Video-assisted Lung Segmentectomy||Completed||N/A|120|Actual|Theagenio Cancer Hospital||2|||f||||||||||||||2017-10-11 04:00:53.098073|2017-10-11 04:00:53.098073
NCT01397032|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-05-25|||April 2011||2011-04-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Attention Bias Modification Treatment for Children With Social Anxiety|Attention Bias Modification Treatment for Children With Social Anxiety|Completed||Phase 2|67|Actual|Tel Aviv University||2|||f||||f||||||||||2017-10-11 04:00:53.165136|2017-10-11 04:00:53.165136
NCT01397019|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-09-23|||October 2011||2011-10-01|September 2015|2015-09-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours|Chemotherapy for Patients With Locally Advanced Pancreatic Cancer With Additional Chemo-radiotherapy for Patients With Borderline Resectable Tumours|Unknown status|Recruiting|Phase 2|50|Anticipated|Odense University Hospital||1|||f||||t||||||||||2017-10-11 04:00:53.255877|2017-10-11 04:00:53.255877
NCT01397006|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2014-04-11|||September 2011||2011-09-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Fibromyalgia of Less Than One Year Duration. Study of Pregabalin|Fibromyalgia of Less Than One Year Duration in Primary Care: Treatment Response in a Double Blind, Placebo Controlled Study of Pregabalin|Withdrawn||Phase 4|0|Actual|Newton-Wellesley Hospital||2|||f||||f||||||||||2017-10-11 04:00:53.352244|2017-10-11 04:00:53.352244
NCT01396993|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2015-09-22|||July 2011||2011-07-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|July 2015|Actual|2015-07-01||Observational|iTOP||Prospective Non-randomized Evaluation of Oncoplastic Surgery|Prospective Trial Evaluating Cosmetic And Oncologic Outcome Of Immediate Techniques For Oncoplastic Surgery In Breast Cancer|Unknown status|Active, not recruiting|N/A|150|Anticipated|Medical University of Vienna|||2||f||||t||||||||||2017-10-11 04:00:53.444026|2017-10-11 04:00:53.444026
NCT01396980|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-02-20|||September 2011||2011-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Observational|||Microcirculation During Haemodialysis|Sublingual Microcirculatory Flow Measurements During Haemodialysis in Relation to Blood Volume Change|Completed||N/A|8|Actual|Medical Centre Leeuwarden|||1||f||||f||||||||||2017-10-11 04:00:53.510764|2017-10-11 04:00:53.510764
NCT01396941|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2014-10-25|||May 2011||2011-05-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of Sleep Duration and Architecture on Insulin Sensitivity|Effects of Sleep Duration and Architecture on Insulin Sensitivity|Unknown status|Recruiting|N/A|20|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 04:00:53.711348|2017-10-11 04:00:53.711348
NCT01396928|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-10-01|||November 2000||2000-11-01|November 2000|2000-11-01|July 2010|Actual|2010-07-01|December 2005|Actual|2005-12-01||Observational|||Study of Two Techniques of Rectal Reservoir in Low Anterior Resection of Rectum|Prospective Randomized Study of Two Techniques of Rectal Reservoir in Low Anterior Resection of Rectum|Completed||Phase 2/Phase 3|106|Actual|Hospital Universitari de Bellvitge|||2||f||||f||||||||||2017-10-11 04:00:53.795085|2017-10-11 04:00:53.795085
NCT01396915|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-11|2016-02-02|||February 2011||2011-02-01|May 2013|2013-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|S25||Effects of Increased, Egg-Based Protein Intake on Muscle Composition,|Effects of Increased, Egg-Based Protein Intake on Muscle Composition,|Completed||N/A|22|Actual|Purdue University|||1||f||||f||||||Samples With DNA|"     whole blood, serum, and muscle tissue   "|||2017-10-11 04:00:53.865529|2017-10-11 04:00:53.865529
NCT01396902|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-17|2012-03-09|||July 2010||2010-07-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Text Reminders for Immunization Compliance in Kids (TRICKS) Pilot Study|Text Reminders for Immunization Compliance in Kids|Completed||N/A|90|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 04:00:53.943581|2017-10-11 04:00:53.943581
NCT01396889|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-20|||May 2010||2010-05-01|May 2010|2010-05-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years|Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years in Bandarabbas Children' Hospital|Completed||N/A|100|Actual|Hormozgan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 04:00:54.021219|2017-10-11 04:00:54.021219
NCT01396876|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-17|2014-06-18|||July 2011||2011-07-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effects of Medical Clowns in Children Undergoing Blood Tests|Evaluation of the Effect of Hospital Clown's Performance in the Procedure Room of a Pediatric Emergency Department: A Randomized Controlled Trial|Completed||N/A|60|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-10-11 04:00:54.097945|2017-10-11 04:00:54.097945
NCT01396863|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-03-21|||July 2011||2011-07-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|BRASE||Brain Swelling During Dialysis|Acute Brain Volume Changes in Haemodialysis: Comparison of Low Flux Haemodialysis With Pre-dilution Haemodiafiltration|Completed||N/A|12|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 04:00:54.182145|2017-10-11 04:00:54.182145
NCT01396850|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-17|2011-07-18||||||July 2011|2011-07-01||||||||Observational|||Measurments Of BBB Breakdown In The Pathogenesis Of Psychiatric Disorders|THE ROLE OF BBB BREAKDOWN IN THE PATHOGENESIS OF PSYCHIATRIC DISORDERS|Unknown status|Not yet recruiting|N/A|120|Anticipated|Soroka University Medical Center|||4||f||||||||||||||2017-10-11 04:00:54.266516|2017-10-11 04:00:54.266516
NCT01396837|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2017-04-13|||May 2014|Actual|2014-05-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|August 2016|Actual|2016-08-01||Interventional|||Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.|A Multi-Center, Prospective, Open Label Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.|Completed||Phase 2|20|Actual|RedDress Ltd.||1|||f||||f||||||||||2017-10-11 04:00:54.327011|2017-10-11 04:00:54.327011
NCT01396824|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2016-06-01|||June 2011||2011-06-01|June 2016|2016-06-01|September 2014|Actual|2014-09-01|July 2013|Actual|2013-07-01||Observational|PLICA||Nutritional Status and Prognosis in Heart Failure.|Nutrition Status and Body Composition in Ambulatory Patients With Heart Failure and Its Prognostic Significance (PLiegues en Insuficiencia Cardiaca-PLICA).|Completed||N/A|214|Actual|Germans Trias i Pujol Hospital|||1||f||||f||||||||||2017-10-11 04:00:54.41908|2017-10-11 04:00:54.41908
NCT01396811|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2013-08-20||2013-01-22|July 2011||2011-07-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Topical Antifungal Treatment for Tinea Pedis|A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Product 33525 in Subjects With Tinea Pedis|Completed||Phase 3|322|Actual|Medicis Global Service Corporation||2|||f||||f||||||||||2017-10-11 04:00:54.493476|2017-10-11 04:00:54.493476
NCT01396798|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2012-09-13|||February 2011||2011-02-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|ERNIE3||Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&E.|Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in a High Prevalent Setting: the Paediatric A&E.|Completed||N/A|1500|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-10-11 04:00:54.572669|2017-10-11 04:00:54.572669
NCT01396785|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2013-08-20||2013-01-22|July 2011||2011-07-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Topical Antifungal Treatment for Tinea Pedis|A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Product 33525 in Subjects With Tinea Pedis|Completed||Phase 3|321|Actual|Medicis Global Service Corporation||2|||f||||f||||||||||2017-10-11 04:00:54.641354|2017-10-11 04:00:54.641354
NCT01396772|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-18|||May 2011||2011-05-01|July 2011|2011-07-01||||June 2013|Anticipated|2013-06-01||Interventional|PREPARE||"PREPARE: Prediabetes Research and Education Promoting Activity & Responsible Eating"|A Community-based Healthy Lifestyle Patient-centred Education Program for Middle & Older Adults With Prediabetes, Which Strengthens the Delivery of Health Services and Assists Individuals at High-risk for Diabetes in London, Ontario.|Unknown status|Recruiting|N/A|240|Anticipated|Brescia University College||2|||f||||t||||||||||2017-10-11 04:00:54.738115|2017-10-11 04:00:54.738115
NCT01396759|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2015-07-26|||July 2011||2011-07-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Use of Bubble Continuous Positive Airway Pressure Compared to Nasal Prong Oxygen or Humidified High Flow in Children Under Five With Severe Pneumonia and Hypoxaemia|Use of Bubble CPAP Compared to Nasal Prong Oxygen or Humidified High Flow in Children Under Five With Severe Pneumonia and Hypoxaemia: a Randomized Trial|Completed||N/A|975|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||t||||||||||2017-10-11 04:00:54.845677|2017-10-11 04:00:54.845677
NCT01396746|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-07-17|||June 2011||2011-06-01|July 2011|2011-07-01||||||||Observational|||Cardiovascular Function in Sub Maximal Exercise and Performance in Three Daily Activity Tests After Stroke|Cardiovascular Function in Sub Maximal Exercise and Performance in Three Daily Activity Tests in Persons With Post Stroke Conditions|Unknown status|Recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-10-11 04:00:54.933368|2017-10-11 04:00:54.933368
NCT01396733|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2011-07-18|||April 2011||2011-04-01|July 2011|2011-07-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|RALT||Redifferentiation Therapy Using Alpha Lipoic Acid in Thyroid Cancer|Clinical Trial to Evaluate Efficacy of Redifferentiation Therapy Using Alpha-lipoic Acid in Thyroid Cancer Patients With Decreased Radioactive Iodine Uptake|Unknown status|Recruiting|Phase 2|40|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-10-11 04:00:55.205287|2017-10-11 04:00:55.205287
NCT01396720|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-01-26|||September 2011||2011-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Impact of Citalopharm and Fluvoxamine on Platelet Response to Clopidogrel|Impact of Citalopharm and Fluvoxamine on Platelet Response to Clopidogrel, a Randomized, Double-blind, Crossover Trial|Completed||Phase 1|15|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-10-11 04:00:55.278746|2017-10-11 04:00:55.278746
NCT01396707|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-18|2017-07-13|||June 2011||2011-06-01|July 2017|2017-07-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|Her+XELOX||Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC)|A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer|Active, not recruiting||Phase 2|55|Actual|Asan Medical Center||1|||f||||f||||||||||2017-10-11 04:00:55.343|2017-10-11 04:00:55.343
NCT01396694|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-02-16|||June 2009||2009-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2012|Actual|2012-12-01||Observational|||An Evaluation of Psychological Parameters That May Influence the Outcome Following Arthroscopy and Arthroplasty for Temporomandibular Joint Surgery|Phase 4 Study of the Influence of Psychological Factors on the Outcomes Following Arthroscopy and Arthroplasty for Temporomandibular Joint Dysfunction|Completed||N/A|105|Actual|Emory University|||1||f||||f||||||||||2017-10-11 04:00:55.441332|2017-10-11 04:00:55.441332
NCT01396681|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-15|||December 2004||2004-12-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer|Phase Ⅱ Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiation With Gemcitabine in Patients With Resected Pancreatic Cancer|Completed||Phase 2|70|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 04:00:55.498334|2017-10-11 04:00:55.498334
NCT01396668|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-15|||December 2004||2004-12-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer|Phase Ⅱ Trial of Fixed Dose Rate Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiation With Capecitabine in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 2|35|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 04:00:55.569753|2017-10-11 04:00:55.569753
NCT01396655|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-07-15|||July 2006||2006-07-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|September 2008|Actual|2008-09-01||Interventional|DA-PET||PET in Breast Cancer Receiving Neoadjuvant Chemotherapy|Analysis of Clinical Outcome, Predictive and Prognostic Factors of Therapeutic Responses in Patients Who Treated With Doxorubicin & Docetaxel Neoadjuvant Chemotherapy in Clinical Stage II or III Breast Cancer|Completed||Phase 2|78|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 04:00:55.634216|2017-10-11 04:00:55.634216
NCT01396642|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-04-05|||July 2011||2011-07-01|April 2015|2015-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Topical Emollient Therapy|Effect of Topical Emollient Therapy on Clinical Outcomes in Preterm Neonates - A Clinical Trial|Completed||N/A|258|Actual|Aga Khan University||2|||f||||t||||||||||2017-10-11 04:00:55.700637|2017-10-11 04:00:55.700637
NCT01396629|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2012-11-15|||July 2011||2011-07-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Observational|||Clinical Evaluation of a New Cartridge for the Implantation of Foldable Intraocular Lenses|Clinical Evaluation of a New Cartridge for the Implantation of Foldable Intraocular Lenses|Completed||N/A|99|Actual|Aurolab|||1||f||||f||||||||||2017-10-11 04:00:55.784694|2017-10-11 04:00:55.784694
NCT01396603|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2016-03-14|||December 2008||2008-12-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease||Recruiting||N/A|30|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 04:00:56.040069|2017-10-11 04:00:56.040069
NCT01396590|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-05-02|||December 2010||2010-12-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Demonstrate Bioequivalence Between 6 ? 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects|A Randomized, Open-label, Crossover Study to Demonstrate Bioequivalence Between 6 ? 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects|Completed||Phase 1|54|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 04:00:56.122582|2017-10-11 04:00:56.122582
NCT01396577|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-05-02|||December 2010||2010-12-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Demonstrate Bioequivalence Between 3 x 2-mg Tablets of Perampanel and a Single 6-mg Tablet of Perampanel in Healthy Subjects|A Randomized, Open-label, Crossover Study to Demonstrate Bioequivalence Between 3 x 2-mg Tablets of Perampanel and a Single 6-mg Tablet of Perampanel in Healthy Subjects|Completed||Phase 1|54|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 04:00:56.19757|2017-10-11 04:00:56.19757
NCT01396564|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2011-07-18|||October 2005||2005-10-01|January 2005|2005-01-01|July 2011|Actual|2011-07-01|October 2006|Actual|2006-10-01||Interventional|||Pioglitazone and Metformin in Diabetic Children|Comparison of the Effects of Pioglitazone and Metformin on Resistin Plasma Levels in Children With Type 2 Diabetes|Completed||Phase 1/Phase 2|56|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||||2017-10-11 04:00:56.26956|2017-10-11 04:00:56.26956
NCT01396551|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-05-19|||October 2010|Actual|2010-10-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|||Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy|Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy|Completed||N/A|69|Actual|Varian Medical||1|||f||||f|f|t|t|||||No||2017-10-11 04:00:56.373045|2017-10-11 04:00:56.373045
NCT01396538|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2011-10-11|||June 2011||2011-06-01|October 2011|2011-10-01|May 2012|Anticipated|2012-05-01|||||Observational|||Prevalence of Occult HBV Infection Among Anti-HBc Alone Group in Northern Taiwan|Prevalence of Occult HBV Infection Among Anti-HBc Alone Group in Northern Taiwan|Unknown status|Active, not recruiting|N/A|200|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||t||||||||||2017-10-11 04:00:56.496374|2017-10-11 04:00:56.496374
NCT01396525|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-01-08|2012-08-29||March 2009||2009-03-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|September 2011|Actual|2011-09-01||Interventional|MOBILITY OE||Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery|A Prospective, Non-randomized, Two Arm, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System and the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.|Completed||Phase 3|153|Actual|Abbott Vascular||1|||f||||t||||||||||2017-10-11 04:00:56.630861|2017-10-11 04:00:56.630861
NCT01396512|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2014-03-24|2014-03-24||July 2011||2011-07-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|||Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers|Immunogenicity and Safety of a Single Dose of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) in Comparison With a Single Dose of SA14-14-2 Vaccine (CD.JEVAX™, Chengdu Institute of Biological Products, China) Administered in Healthy Toddlers in South-Korea|Completed||Phase 3|274|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 04:00:58.281253|2017-10-11 04:00:58.281253
NCT01396499|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2016-10-31|||July 2012||2012-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias|A Phase I Open-label Study to Assess the Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, in Patients With Advanced Leukemias|Completed||Phase 1|16|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:00:58.931463|2017-10-11 04:00:58.931463
NCT01396486|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2017-06-28|||February 2012||2012-02-01|June 2017|2017-06-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Inositol and Omega-3 Fatty Acids in Pediatric Mania|A Randomized Controlled Trial of Inositol and Omega-3 Fatty Acids in Pediatric Mania|Recruiting||Phase 4|60|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||No||2017-10-11 04:00:59.008465|2017-10-11 04:00:59.008465
NCT01396473|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-27|2011-07-15|||September 2010||2010-09-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|OSNAP||Study on Out of School Nutrition and Physical Activity Environments|Study on Out of School Nutrition and Physical Activity Environments|Completed||N/A|590|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-11 04:00:59.100302|2017-10-11 04:00:59.100302
NCT01396460|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2012-09-07|||May 2011||2011-05-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Observational|RQ||Respiratory Quotient in Post Roux-en-Y Gastric Bypass Patients|Respiratory Quotient in Post Roux-en-Y Gastric Bypass Patients|Completed||N/A|69|Actual|Gastrocirurgia, Brazil|||2||f||||f||||||||||2017-10-11 04:00:59.168549|2017-10-11 04:00:59.168549
NCT01396447|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2015-02-27||2015-02-27|July 2011||2011-07-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|January 2014|Actual|2014-01-01||Interventional|||Safety, Tolerability, and Efficacy of Cariprazine in Patients With Bipolar Depression|A Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar Depression|Completed||Phase 2|584|Actual|Forest Laboratories||4|||f||||f||||||||||2017-10-11 04:00:59.2431|2017-10-11 04:00:59.2431
NCT01396434|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-12-05|2016-12-05||December 2011||2011-12-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||All participants who received at least 1 dose of 13vPnC.|Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos|A Non-interventional Study Of The Safety Of Pneumococcal 13-valent Conjugate Vaccine (Prevenar 13) In The Philippines: A Post Marketing Surveillance Study|Completed||Phase 4|3006|Actual|Pfizer|The use of 13vPnC was based on the investigator's clinical judgment and was assumed to be consistent with the product's approved label.||1||f||||f||||||||||2017-10-11 04:00:59.585384|2017-10-11 04:00:59.585384
NCT01396421|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-09-29|2015-08-04|2015-01-16|July 2011||2011-07-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|VECTOR||Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia|Completed||Phase 3|636|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||||||||||||2017-10-11 04:01:00.375439|2017-10-11 04:01:00.375439
NCT01396408|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-03-27|||July 14, 2011|Actual|2011-07-14|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Interventional|||A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours|A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours|Active, not recruiting||Phase 2|137|Actual|Canadian Cancer Trials Group||2|||f||||f||||||||||2017-10-11 04:01:02.389591|2017-10-11 04:01:02.389591
NCT01396395|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2016-03-15|2015-09-14||September 2011||2011-09-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|SIGMART|Full analysis set (FAS) included all randomized subjects who received at least one dose of study treatment.|Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina|A Prospective, Multi-center, Random, Open-label Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina|Completed||Phase 4|402|Actual|Merck KGaA||2|||f||||||||||||||2017-10-11 04:01:02.558407|2017-10-11 04:01:02.558407
NCT01396213|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-09-15||2017-09-11|November 7, 2011|Actual|2011-11-07|September 2017|2017-09-01|August 20, 2013|Actual|2013-08-20|August 20, 2013|Actual|2013-08-20||Interventional|||A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease|A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease|Completed||Phase 2|342|Actual|Innovate Biopharmaceuticals||4|||f||||f|t|f||||||||2017-10-11 04:01:07.712875|2017-10-11 04:01:07.712875
NCT01396382|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-02-25|2016-01-14||March 2010||2010-03-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|68Ga|patients with known or suspected pulmonary or gastroenteropancreatic (GEP) neuroendocrine tumors (NETS)|68Ga-DOTATATE PET Scan in Neuroendocrine Cancer|Use of 68Ga-DOTATATE PET Scanning for Diagnosis and Treatment of Metastatic Neuroendocrine Tumors|Completed||Phase 2|97|Actual|Vanderbilt-Ingram Cancer Center|Long term follow-up of lab values was limited in some patients who lived outside the local region.|1|||f||||t||||||||No|Data are primarily imaging data and toxicity data submitted for peer-review publication and US FDA review, but not shared with a public data archive.|2017-10-11 04:01:03.252349|2017-10-11 04:01:03.252349
NCT01396369|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-01-06|||June 2011||2011-06-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Flaxseed Lignan (Brevail)|Impact of Flaxseed Lignan (Brevail) on Polycystic Ovarian Syndrome|Completed||Early Phase 1|9|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-10-11 04:01:03.443149|2017-10-11 04:01:03.443149
NCT01396356|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2013-01-08|||August 2010||2010-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||"Atrial Fibrillation Ablation on Gastric Motility The AF Gut Study"|"Impact of Atrial Fibrillation Ablation on Gastric Motility The AF Gut Study"|Completed||N/A|25|Anticipated|University of Kansas Medical Center|||1||f||||f||||||||||2017-10-11 04:01:03.513783|2017-10-11 04:01:03.513783
NCT01396343|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-07-17|||October 2011||2011-10-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis|Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis|Enrolling by invitation||N/A|1920|Anticipated|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     Total 41ml sample: 17ml plasma/DNA, 10ml serum, 9ml lymphocytes and 5ml RNA frozen.   "|||2017-10-11 04:01:03.577729|2017-10-11 04:01:03.577729
NCT01396330|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-02-28|||September 2011||2011-09-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|EMSOD||Effect of Mental Stress on Glucose Control in Patients With Diabetes Mellitus|Effect of Prolonged Mental Stress During Safe Driving Training Courses on Glucose Control in Patients With Diabetes Mellitus Type 2|Completed||N/A|40|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-10-11 04:01:05.197958|2017-10-11 04:01:05.197958
NCT01396304|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-02-12|||October 2011||2011-10-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers|Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers|Terminated||Phase 4|19|Actual|Hollister Wound Care LLC||2||slow accrual|f||||f||||||||||2017-10-11 04:01:05.353985|2017-10-11 04:01:05.353985
NCT01396291|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-12-03|||December 2011||2011-12-01|December 2015|2015-12-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)|A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder (Phase 3B, Protocol P06384)|Completed||Phase 3|561|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 04:01:05.453341|2017-10-11 04:01:05.453341
NCT01396278|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2014-04-30||2014-04-30|July 2011||2011-07-01|April 2014|2014-04-01||||December 2011|Actual|2011-12-01||Interventional|||Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).|A Randomised, Double-blind, Double-dummy, Active-controlled, Parallel-group Study to Assess and Compare Efficacy and Safety of an 8-week Treatment With BI 54903 at Doses of 90.9, 181.8 and 363.6 µg b.i.d. Administered Via Respimat® Inhaler and Fluticasone Propionate HFA MDI 440 µg b.i.d. in Patients With Asthma Inadequately Controlled on Medium Dose ICS Therapy|Terminated||Phase 2|9|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-10-11 04:01:05.789292|2017-10-11 04:01:05.789292
NCT01396265|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2014-06-03|2013-08-08||July 2011||2011-07-01|October 2013|2013-10-01||||August 2011|Actual|2011-08-01||Interventional|||Drug Interaction Study With Rifampicin and Afatinib|Relative Bioavailability of a Single Oral Dose of 40 mg Afatinib Given Alone and After Multiple Doses of Rifampicin - an Open-label, Two-period, Fixed Sequence Clinical Phase I Trial in Healthy Male Volunteers|Completed||Phase 1|22|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 04:01:05.991857|2017-10-11 04:01:05.991857
NCT01396252|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-15|2013-06-07|||September 2011||2011-09-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Japanese Phase 1 Multiple Ascending Dose (MAD) Study|Randomized, Placebo-Controlled, Double-Blind, Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-820836 in Healthy Japanese Subjects and Japanese Patients With Depression|Completed||Phase 1|57|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 04:01:06.437605|2017-10-11 04:01:06.437605
NCT01396239|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2015-10-12|2013-07-02||July 2011||2011-07-01|July 2015|2015-07-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Efficacy, Safety, Tolerability and Pharmacokinetics Study of AVI-4658(Eteplirsen),in the Treatment of Ambulant Subjects With Duchenne Muscular Dystrophy|Completed||Phase 2|12|Actual|Sarepta Therapeutics|"Due to the small number of study participants, a single adverse event (AE) in 1 patient exceeds the reporting threshold of 5%. Refer to the Post-Hoc Outcome Measures #4 and #5 for a summary of frequent and related AEs."|2|||f||||f||||||||||2017-10-11 04:01:06.537218|2017-10-11 04:01:06.537218
NCT01396226|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-11-22|2012-09-24||September 2011||2011-09-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients|A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness of an Intravenous Infusion of AZD2927 in Patients Undergoing an Invasive Electrophysiological Procedure|Completed||Phase 2|20|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:01:07.114742|2017-10-11 04:01:07.114742
NCT01396200|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-02-25|||June 2011||2011-06-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine|A Pilot Study of Infusional Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Early Phase 1|6|Anticipated|Abramson Cancer Center of the University of Pennsylvania||2|||f||||t||||||||||2017-10-11 04:01:07.923461|2017-10-11 04:01:07.923461
NCT01396187|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2014-12-30|2014-12-30||July 2011||2011-07-01|December 2014|2014-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Safety analysis population included all participants who received at least 1 dose of study medication.|Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes|A Phase 1, Placebo-Controlled Randomized Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Ascending Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|50|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:01:08.03556|2017-10-11 04:01:08.03556
NCT01396174|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2015-04-16|||August 2011||2011-08-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors|A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors|Completed||N/A|184|Actual|Temple University||2|||f||||||||||||||2017-10-11 04:01:09.465407|2017-10-11 04:01:09.465407
NCT01396161|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-09-19|2016-04-01||July 2011||2011-07-01|September 2016|2016-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients|A Phase 1 Placebo-controlled Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Ascending Oral Doses Of Pf-05175157 In Healthy Volunteers And In Patients With Type 2 Diabetes Mellitus (t2dm)|Completed||Phase 1|64|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 04:01:09.567852|2017-10-11 04:01:09.567852
NCT01396148|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-10-04|||June 2012|Actual|2012-06-01|October 2017|2017-10-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor|A Phase I/ii Study Of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor|Completed||Phase 2|6|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:01:10.252061|2017-10-11 04:01:10.252061
NCT01396135|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-09-03|||August 2011||2011-08-01|September 2011|2011-09-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||A Phase 1 Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese Subjects|A Phase 1, Randomized, Subject- And Investigator-Blind, Sponsor-Open, Placebo-Controlled, Single- And Multiple-Dose Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese Subjects|Withdrawn||Phase 1|19|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 04:01:10.538146|2017-10-11 04:01:10.538146
NCT01396122|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-12-25|||March 2011||2011-03-01|July 2011|2011-07-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Clinical Performance of GYNECARE PROSIMA* Pelvic Floor Repair System for Symptomatic Pelvic Organ Prolapse|A Prospective, Multicenter Study to Evaluate the Clinical Performance of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Procedure for Symptomatic POP-Q Stage II-III Pelvic Organ Prolapse|Unknown status|Recruiting|N/A|150|Anticipated|Peking Union Medical College Hospital||1|||f||||f||||||||||2017-10-11 04:01:10.626289|2017-10-11 04:01:10.626289
NCT01396109|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-12-25|||March 2011||2011-03-01|March 2011|2011-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||GYNECARE PROSIMA* Procedure Versus Modified Total Pelvic Floor Reconstructive Surgery for Uterine Prolapse Stage III|A Prospective, Multicenter Trial to Compare GYNECARE PROSIMA* Pelvic Floor Repair System Procedure With Modified Total Pelvic Floor Reconstruction Surgery Concomitantly With TVH to Treat Symptomatic POP-Q Stage III Uterine Prolapse|Unknown status|Recruiting|N/A|200|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-10-11 04:01:10.840386|2017-10-11 04:01:10.840386
NCT01396096|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-01-03|||June 2011||2011-06-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|||Comparison of Obesity Alleles Among Diverse Demographic Patients|Comparison of Obesity Alleles Among Diverse Demographic Patient Populations Undergoing Bariatric Surgery|Recruiting||N/A|2500|Anticipated|New York University School of Medicine|||1||f||||f||||||Samples With DNA|"     DNA will be extracted from 0.35ml of EDTA-anticoagulated whole blood using the Qiagen     MagAttract DNA Blood Midi M48 Kit and Qiagen BioRobot M48 Workstation (Qiagen, Valencia,     California) according to the manufacturer's directions.   "|||2017-10-11 04:01:10.995478|2017-10-11 04:01:10.995478
NCT01396083|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-09-21|2015-01-12||August 2011||2011-08-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|COMRADE-C||Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)|A 6-month Multicenter, Randomized, Double-masked Phase IIIb-study Comparing the Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Visual Impairment Due to Macular Edema Following Central Retinal Vein Occlusion (CRVO)|Completed||Phase 3|243|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:01:11.093362|2017-10-11 04:01:11.093362
NCT01396070|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-02-17|2016-12-28||May 2011||2011-05-01|February 2017|2017-02-01|May 2016|Actual|2016-05-01|April 2015|Actual|2015-04-01||Interventional|||Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level|Exploratory Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level|Completed||Phase 2|36|Actual|Stanford University||1|||f||||t||||||||No||2017-10-11 04:01:11.958821|2017-10-11 04:01:11.958821
NCT01396057|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2014-08-04|2014-06-13||July 2011||2011-07-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|COMRADE-B||Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)|A 6-month Multicenter, Randomized, Double-masked Phase IIIb-study Comparing the Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Visual Impairment Due to Macular Edema Following Branch Retinal Vein Occlusion (BRVO)|Completed||Phase 3|244|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:01:12.470351|2017-10-11 04:01:12.470351
NCT01396044|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-11-05|2012-11-05||July 2011||2011-07-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Daily Checklists and Outcome in the Intensive Care Unit|Daily Checklists and Outcome in the Intensive Care Unit|Completed||N/A|451|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 04:01:13.749724|2017-10-11 04:01:13.749724
NCT01396031|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-14|||January 2010||2010-01-01|July 2011|2011-07-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Feasibility Study of Exercises for Myeloablative Allogeneic Blood and Marrow Transplantation (BMT) Patients|Matched-Status Exercise Program in Patients Undergoing Myeloablative Allogeneic Blood and Marrow Transplantation: A Feasibility Study|Unknown status|Active, not recruiting|N/A|16|Anticipated|Stanford University||1|||f||||t||||||||||2017-10-11 04:01:14.333572|2017-10-11 04:01:14.333572
NCT01396005|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-03-09|2012-12-06||September 2011||2011-09-01|March 2017|2017-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)|An Open-Label, One-Period Study in Patients Receiving Methadone or Buprenorphine/Naloxone Maintenance Therapy to Evaluate the Effect of SCH 503034 (Boceprevir) on Either Methadone or Buprenorphine/Naloxone Plasma Concentrations (Protocol No. P08123)|Completed||Phase 1|21|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:01:14.418372|2017-10-11 04:01:14.418372
NCT01395992|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-05-26|||April 2012||2012-04-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)|A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])|Completed||Phase 3|165|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 04:01:14.823778|2017-10-11 04:01:14.823778
NCT01395979|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-02-22|||October 2011||2011-10-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|THRIVE||HIV Prevention and Trauma Treatment for Men Who Have Sex With Men With Childhood Sexual Abuse Histories||Active, not recruiting||N/A|200|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:01:14.903207|2017-10-11 04:01:14.903207
NCT01395966|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2015-09-22|2015-07-22||June 2011||2011-06-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients|Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients|Completed||Phase 3|331|Actual|Salvat||3|||f||||f||||||||||2017-10-11 04:01:14.999881|2017-10-11 04:01:14.999881
NCT01395953|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-04-06|||November 2011||2011-11-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders|Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||2||This study was withdrawn due to competing research interests and slow recruitment.|f||||f||||||||||2017-10-11 04:01:15.48684|2017-10-11 04:01:15.48684
NCT01395940|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-10-29||||||October 2013|2013-10-01||||||||Interventional|||A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)|A Multicenter, Randomized, Open Label Phase II Study of KLH-2109 in Patients With Endometriosis(1)|Completed||Phase 2|20|Anticipated|Kissei Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-10-11 04:01:15.59843|2017-10-11 04:01:15.59843
NCT01395927|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-05-03|||July 2011||2011-07-01|May 2013|2013-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers|An Open-Label, Fixed-Sequence Study to Assess Effects of Steady-State Rifampin on the Single-Dose Pharmacokinetics of Canagliflozin in Healthy Subjects|Completed||Phase 1|14|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 04:01:15.702903|2017-10-11 04:01:15.702903
NCT01395914|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-08-16|2017-03-15|2014-02-12|July 2011||2011-07-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|June 2014|Actual|2014-06-01||Interventional||The intent-to-treat (ITT) Population included all randomized patients.|Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)|Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study|Completed||Phase 3|513|Actual|Helsinn Therapeutics (U.S.), Inc||2|||f||||t||||||||||2017-10-11 04:01:15.83656|2017-10-11 04:01:15.83656
NCT01395901|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2014-07-29|2014-06-27|2013-03-28|June 2011||2011-06-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional||Full Analysis Set Population|Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients|A Multicenter, Double-blind, Double-dummy, Randomized, Parallel Group, Stratified Study to Evaluate the Efficacy and Safety of a Single IV Dose of Palonosetron Compared to a Single IV Dose of Ondansetron to Prevent Postoperative Nausea and Vomiting in Pediatric Patients.|Completed||Phase 3|670|Actual|Helsinn Healthcare SA||2|||f||||t||||||||||2017-10-11 04:01:17.049847|2017-10-11 04:01:17.049847
NCT01395888|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-11-20|2013-06-06|2013-03-07|June 2011||2011-06-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD|A 12 Week Study to Evaluate the Effect of Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) 100/25 mcg Inhalation Powder Delivered Once Daily Via a Novel Dry Powder Inhaler (NDPI) on Arterial Stiffness Compared With Tiotropium Bromide 18 mcg Delivered Once Daily Via a HandiHaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|260|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:01:17.900475|2017-10-11 04:01:17.900475
NCT01395875|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-05-15|||March 2011||2011-03-01|May 2017|2017-05-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Observational|||Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment|Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment|Completed||N/A|2849|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:01:18.486931|2017-10-11 04:01:18.486931
NCT01395862|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-08-20|||November 2007||2007-11-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)|Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)|Completed||N/A|1001|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:01:18.5639|2017-10-11 04:01:18.5639
NCT01395836|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-11-03|||October 2011||2011-10-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|Monitor-AF||Management of New-Onset Postoperative Atrial Fibrillation|Management of New-Onset Postoperative Atrial Fibrillation Utilizing Insertable Cardiac Monitor Technology to Observe Recurrence of AF|Completed||N/A|23|Actual|Emory University|||2||f||||t||||||||||2017-10-11 04:01:18.770669|2017-10-11 04:01:18.770669
NCT01395823|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-02-15|2016-01-08||June 2011||2011-06-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|April 2014|Actual|2014-04-01||Interventional|||Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients|Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients: A Randomized Clinical Trial|Completed||Phase 4|470|Actual|Dialysis Clinic, Inc.||2|||f||||f||||||||||2017-10-11 04:01:18.859856|2017-10-11 04:01:18.859856
NCT01395810|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-02-22||2016-11-09|April 16, 2012|Actual|2012-04-16|February 2017|2017-02-01|March 31, 2014|Actual|2014-03-31|March 31, 2014|Actual|2014-03-31||Interventional|paradigm™ 4||Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773|Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B|Completed||Phase 3|71|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-10-11 04:01:19.296196|2017-10-11 04:01:19.296196
NCT01395797|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-07-11|2015-08-31||March 2011||2011-03-01|July 2017|2017-07-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|||Pioglitazone for Heroin and for Nicotine Dependence|Effects of Pioglitazone, a PPARγ Agonist, on the Abuse Liability of Heroin and of Nicotine|Terminated||Phase 1/Phase 2|82|Actual|New York State Psychiatric Institute||6||The funding period ended.|f||||t||||||||||2017-10-11 04:01:19.52918|2017-10-11 04:01:19.52918
NCT01395784|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2016-01-26|2015-08-31||August 2010||2010-08-01|November 2013|2013-11-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional||Recreational prescription opioid users.|Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone|Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone|Completed||Phase 2|32|Actual|New York State Psychiatric Institute||3|||f||||t||||||||Yes|Data has been presented at conferences and being prepared for a peer-review publication.|2017-10-11 04:01:20.103845|2017-10-11 04:01:20.103845
NCT01395771|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-18|2011-07-15|||May 2011||2011-05-01|July 2011|2011-07-01|October 2011|Anticipated|2011-10-01|September 2011|Anticipated|2011-09-01||Interventional|EPCIPHA||Effects of a Phone Call Intervention to Promote HAART Adherence|Effects of a Phone Call Intervention to Promote HAART Adherence in Baoshan, China|Unknown status|Recruiting|N/A|300|Anticipated|Baoshan Prefecture Center for Disease Control and Prevention||1|||f||||f||||||||||2017-10-11 04:01:20.338662|2017-10-11 04:01:20.338662
NCT01395758|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2017-01-09|||July 2011||2011-07-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase 2 Randomized Open-label Study of Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Previously Treated KRAS Mutation Positive Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|79|Actual|ArQule||2|||f||||f||||||||||2017-10-11 04:01:20.429503|2017-10-11 04:01:20.429503
NCT01395745|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-02-02|||February 2013||2013-02-01|August 2016|2016-08-01|October 2016|Actual|2016-10-01|July 2016|Actual|2016-07-01||Interventional|CHABLIS-SC1||CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects With Systemic Lupus Erythematosus|Completed||Phase 3|442|Actual|Anthera Pharmaceuticals||2|||f||||t||||||||||2017-10-11 04:01:20.539046|2017-10-11 04:01:20.539046
NCT01395732|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2014-01-06|||March 2011||2011-03-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|HOME||Bosentan in Systemic Sclerosis|Effects of Bosentan in a Homogenous Population of Systemic Sclerosis Subjects With a Predefined Restriction of Blood Flow in the Hands|Completed||Phase 4|18|Actual|Actelion||1|||f||||f||||||||||2017-10-11 04:01:20.979589|2017-10-11 04:01:20.979589
NCT01395719|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-08-17|||June 2011||2011-06-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2015|Actual|2015-06-01||Interventional|Context||Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function|Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function|Unknown status|Active, not recruiting|N/A|220|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-10-11 04:01:21.093048|2017-10-11 04:01:21.093048
NCT01395706|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-07-15|||September 2011||2011-09-01|July 2011|2011-07-01|March 2012|Anticipated|2012-03-01|February 2012|Anticipated|2012-02-01||Interventional|||ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes|Determination of the Sensitifity of ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer - a Monocenter Prospective Open-label Clinical Trial|Unknown status|Not yet recruiting|Phase 2|125|Anticipated|Pulsion Medical Systems SE||1|||f||||t||||||||||2017-10-11 04:01:21.216991|2017-10-11 04:01:21.216991
NCT01395693|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-04-19|||June 2011||2011-06-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Performance of the Salt Lake Mask System|Assessment of the Performance of the Salt Lake Mask System as a Patient Interface in the Provision of Positive Airway Pressure (PAP) Therapy|Completed||Phase 2|20|Actual|ResMed||1|||f||||t||||||||||2017-10-11 04:01:21.316516|2017-10-11 04:01:21.316516
NCT01395680|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-07-14|||August 2011||2011-08-01|June 2011|2011-06-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Observational|||Trajectories of Regenerating Family Resilience in Adolescents With Cancer|Trajectories of Regenerating Family Resilience in Adolescents With Cancer|Unknown status|Not yet recruiting|N/A|60|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 04:01:21.415847|2017-10-11 04:01:21.415847
NCT01395667|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-11-08|||June 2011||2011-06-01|November 2016|2016-11-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX|A Phase I Dose Escalation Trial of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy(IMRT)in Combination With Bevacizumab-FOLFOX for Patients With Locally Advanced Rectal Cancer|Completed||Phase 1|15|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:01:21.491059|2017-10-11 04:01:21.491059
NCT00000346|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-10||||||December 2002|2002-12-01||||||||Interventional|||Cognitive Correlates of Substance Abuse - 11|Cognitive Correlates of Substance Abuse, Part 1|Unknown status|Active, not recruiting|Phase 4|80||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.697067|2017-10-11 04:17:47.697067
NCT01395654|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-12-26|||July 2011||2011-07-01|November 2012|2012-11-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment|Different Reintroduction Regimens of Antituberculosis Drugs After Development of Hepatitis During Anti-tuberculosis Treatment|Unknown status|Recruiting|Phase 4|100|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:01:21.567898|2017-10-11 04:01:21.567898
NCT01395641|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2017-05-16|||October 1, 2014|Actual|2014-10-01|May 2017|2017-05-01|December 2, 2016|Actual|2016-12-02|December 2, 2016|Actual|2016-12-02||Interventional|AADC||A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC|A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC|Completed||Phase 1/Phase 2|10|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 04:01:21.659413|2017-10-11 04:01:21.659413
NCT01395628|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-05-17|||July 2011||2011-07-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Cell Samples From Patients With Leukemia|Xenotransplantation of Primary Leukemia Samples Into Zebrafish|Completed||N/A|10|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     cell samples   "|||2017-10-11 04:01:21.734949|2017-10-11 04:01:21.734949
NCT01395615|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-11-01|||October 2008||2008-10-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia|Utility Measurement Study for Patients With Chronic Lymphocytic Leukaemia|Completed||N/A|34|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:01:21.795575|2017-10-11 04:01:21.795575
NCT01395602|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-10-13|||April 2002||2002-04-01|October 2015|2015-10-01|July 2011|Actual|2011-07-01|September 2003|Actual|2003-09-01||Interventional|||Effect of Cabergoline on Weight and Glucose Tolerance|Randomized Controlled Pilot Study of the Effect of Cabergoline on Body Weight and Glucose Tolerance in Healthy Obese Adults|Completed||Phase 1/Phase 2|40|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 04:01:21.860987|2017-10-11 04:01:21.860987
NCT01395589|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-09-27|||February 2011||2011-02-01|September 2017|2017-09-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|||Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations.|Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations|Completed||Phase 1|597|Actual|Hamad Medical Corporation||2|||f||||t||||||||||2017-10-11 04:01:21.945682|2017-10-11 04:01:21.945682
NCT01395576|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2014-05-18|||February 2011||2011-02-01|October 2012|2012-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Evaluation of the Genu Neurexa Orthosis in Post Stroke Patients|Evaluation of the Genu Neurexa Orthosis in Post Stroke Patients|Terminated||Phase 2|60|Anticipated|Hadassah Medical Organization||1||"statistical significance of the results was reached for the 34 subjects who participated in teh   study."|f||||||||||||||2017-10-11 04:01:22.018789|2017-10-11 04:01:22.018789
NCT01395563|ClinicalTrials.gov processed this data on October 10, 2017|2009-12-04|2015-03-12|||January 2009||2009-01-01|March 2015|2015-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|STOPC||Strength Training on Pancreatic Cancer|Strength Training on Pancreatic Cancer|Withdrawn||N/A|0|Actual|German Cancer Research Center||2|||f||||t||||||||||2017-10-11 04:01:22.083714|2017-10-11 04:01:22.083714
NCT01395550|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-08-29|||January 2010||2010-01-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event|Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.|Completed||N/A|88|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:01:22.155231|2017-10-11 04:01:22.155231
NCT01395537|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2014-12-15|||August 2011||2011-08-01|December 2014|2014-12-01||||December 2014|Actual|2014-12-01||Interventional|||Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ)|Phase I/II Pilot Study of Lapatinib in Combination With Carboplatin and Paclitaxel in the Treatment of Recurrent/Metastatic Adenocarcinoma of the Esophagus and Gastroesophageal Junction (GEJ)|Terminated||Phase 1/Phase 2|13|Actual|Case Comprehensive Cancer Center||1||Research Cancelled|f||||t||||||||||2017-10-11 04:01:22.192675|2017-10-11 04:01:22.192675
NCT01395524|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-01-09|2014-10-13||July 2011||2011-07-01|January 2017|2017-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||A total of 6 patients (1 patient in the NKTR-118 25 mg group, 2 patients in the NKTR-118 12.5 mg group, 3 patients in the placebo group) had been previously randomized within the NKTR-118 program at a different study center and were excluded from the ITT and Safety analysis sets. Baseline characteristics are summarized using the ITT analysis set.|A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation|A Randomized, Double-Blind, Placebo-Controlled 12-Week Extension Study to Assess the Safety and Tolerability of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)|Completed||Phase 3|302|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 04:01:23.644845|2017-10-11 04:01:23.644845
NCT01395511|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-07-14|||December 2009||2009-12-01|December 2009|2009-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Acupuncture for Whiplash Associated Disorder|Acupuncture for Whiplash Associated Disorder: a Randomised, Waiting-list Controlled, Open-label, Parallel-group Pilot Trial|Completed||Phase 2|40|Actual|Kyunghee University Medical Center||2|||f||||f||||||||||2017-10-11 04:01:24.802106|2017-10-11 04:01:24.802106
NCT01395498|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-07-27|||July 2011||2011-07-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Observational|PCP-CMV||Prevalence of Pneumocystis Jirovecii and of Cytomegalovirus in Bronchial Wash Fluid of Patients Undergoing Bronchoscopy|Prevalence of Positive DNA of Pneumocystis Jirovecii and of Cytomegalovirus in Bronchial Wash Fluid of Patients Undergoing Fiberoptic Bronchoscopy|Completed||N/A|93|Actual|Carmel Medical Center|||1||f||||f||||||Samples With DNA|"     samples of bronchoalveolar lavage fluid and blood.   "|No||2017-10-11 04:01:24.885413|2017-10-11 04:01:24.885413
NCT01395485|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2013-11-20|||June 2011||2011-06-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescent (12 to <18 Years) and Adult Subjects With Intermittent or Mild to Moderate Persistent Asthma|Withdrawn||Phase 1|0|Actual|Amgen||4||The study had been cancelled and replaced with protocol 20130250.|f||||||||||||||2017-10-11 04:01:24.965486|2017-10-11 04:01:24.965486
NCT00000390|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2015-04-22||||||April 2000|2000-04-01||||||||Interventional|||Antidepressant Treatment of AIDS Related Depression.||Completed||Phase 2|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:17:52.884864|2017-10-11 04:17:52.884864
NCT01395472|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-07-27|||January 2010||2010-01-01|April 2011|2011-04-01|February 2012|Anticipated|2012-02-01|October 2011|Anticipated|2011-10-01||Interventional|||Influence of Physical Exercise on Cognitive Functioning of Traumatic Brain Injury Patients|Influence of Physical Exercise on Cognitive Functioning of Traumatic Brain Injury Patients|Unknown status|Recruiting|N/A|36|Anticipated|Federal University of São Paulo||3|||f||||f||||||||||2017-10-11 04:01:25.042011|2017-10-11 04:01:25.042011
NCT01395459|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-09|2015-04-07|||September 2008||2008-09-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|March 2011|Actual|2011-03-01||Interventional|CATCH||A Sustainable Approach to Increasing Cancer Screening|A Sustainable Approach to Increasing Cancer Screening|Completed||N/A|13675|Actual|Harvard School of Public Health||3|||f||||f||||||||||2017-10-11 04:01:25.131066|2017-10-11 04:01:25.131066
NCT01395446|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-06-23|||January 2010||2010-01-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Observational|AENEAS||Application of an Electronic Nose in the Early Detection of ASpergillosis|The Application of an Electronic Nose in the Early Detection of ASpergillosis|Completed||N/A|52|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||1||f||||f||||||Samples Without DNA|"     BAL   "|||2017-10-11 04:01:25.204906|2017-10-11 04:01:25.204906
NCT01395433|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-12-07|||January 2010||2010-01-01|December 2012|2012-12-01||||March 2010|Actual|2010-03-01||Interventional|||Bioequivalence Study Comparing Two Formulations of Escitalopram|A Single-dose, Open-label, Randomised, Crossover Bioequivalence Study in Healthy Young Men Comparing Two Formulations of Escitalopram|Completed||Phase 1|32|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-10-11 04:01:25.253592|2017-10-11 04:01:25.253592
NCT01395420|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2017-08-31|||August 2011||2011-08-01|August 2017|2017-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma|A Phase I Open-Label, 2-Part, 3-Cohort, Single-Centre Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid (ELF) and Plasma Using at Least Two Different Dosing Regimens in Healthy Volunteers|Completed||Phase 1|45|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:01:25.324114|2017-10-11 04:01:25.324114
NCT01395407|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-12-02|||July 2011||2011-07-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain Metastases|Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Intra-axial Brain Metastases|Completed||Phase 1|9|Actual|Emory University||3|||f||||t||||||||||2017-10-11 04:01:25.406824|2017-10-11 04:01:25.406824
NCT01395394|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-08-27|2014-07-30||June 2011||2011-06-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Phenylketonuria, Oxidative Stress, and BH4|The Ability of Kuvan® (Sapropterin Dihydrochloride) to Prevent Meal-induced Lipid Peroxidation and Endothelial Dysfunction in Patients With Phenylketonuria: a Pilot Study|Terminated||Phase 2|12|Actual|Emory University|Early termination leading to small number of subjects analyzed.|3||Difficulty with recruitment and agreed with Sponsor to report completed data as case reports|f||||t||||||||||2017-10-11 04:01:25.499925|2017-10-11 04:01:25.499925
NCT01395381|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2014-01-24|||January 2013||2013-01-01|January 2014|2014-01-01||||January 2014|Anticipated|2014-01-01||Interventional|||Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition|Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Benefit of Antihelminthic Therapy in the Community-Based Treatment of Severe Acute Malnutrition in Malawian Children|Withdrawn||N/A|0|Actual|Washington University School of Medicine||2||not funded|f||||f||||||||||2017-10-11 04:01:25.947489|2017-10-11 04:01:25.947489
NCT01395368|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-07-18|2012-04-13||June 2011||2011-06-01|July 2012|2012-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|COMeT||Cognitive Speed as an Objective Measure of Tinnitus|Cognitive Speed as an Objective Measure of Tinnitus|Completed||N/A|108|Actual|Washington University School of Medicine|Tinnitus subjects with moderate or greater depression were excluded from the study. This study may not be reflective of the population of bothersome tinnitus patients due to this exclusion||1||f||||f||||||||||2017-10-11 04:01:26.023045|2017-10-11 04:01:26.023045
NCT01395355|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-05-06|||August 2011||2011-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||An Integrative Intervention for Loss of Control Eating Among Adolescent Girls|An Integrative Intervention for Binge Eating Among Adolescent Girls|Completed||N/A|59|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 04:01:26.189274|2017-10-11 04:01:26.189274
NCT01395342|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2012-07-11|||January 2008||2008-01-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Assessment of Physical Exercise Using Stationary Bicycle for Pregnant Women With Risk for Preeclampsia Development|Assessment of Physical Exercise Using Stationary Bicycle for Pregnant Women With Risk for Preeclampsia Development|Completed||Phase 1|116|Actual|University of Campinas, Brazil||1|||f||||t||||||||||2017-10-11 04:01:26.292606|2017-10-11 04:01:26.292606
NCT01395329|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-04-04|||May 2011||2011-05-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|NETS||Nebivolol and the Endothelin (ET)-1 System|Nebivolol and the Endothelin (ET)-1 System|Completed||Phase 4|48|Actual|University of Colorado, Boulder||3|||f||||t||||||||||2017-10-11 04:01:26.382349|2017-10-11 04:01:26.382349
NCT01395316|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-01-12|||June 2011||2011-06-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|October 2015|Actual|2015-10-01||Interventional|||Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis|Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis|Active, not recruiting||Phase 4|8|Actual|University of Chicago||1|||f||||t||||||||||2017-10-11 04:01:26.475879|2017-10-11 04:01:26.475879
NCT01395303|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-11-10|||April 2011||2011-04-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Observational|||Polymorphisms in the Vitamin D System and Health|Polymorphisms in the Vitamin D System and Health|Completed||N/A|9700|Actual|University of Tromso|||8||f||||f||||||Samples With DNA|"     DNA from blood clots   "|||2017-10-11 04:01:26.550544|2017-10-11 04:01:26.550544
NCT01395290|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2012-09-03|||April 2011||2011-04-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Vitamin D and Staphylococcus Aureus in the Diabetes Study|Vitamin D and Staphylococcus Aureus in the Diabetes Study|Completed||Phase 3|280|Actual|University of Tromso||1|||f||||f||||||||||2017-10-11 04:01:26.626497|2017-10-11 04:01:26.626497
NCT00005499|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1998||1998-07-01|August 2004|2004-08-01|June 2001|Actual|2001-06-01|||||Observational|||Congestive Heart Failure Trends in the Elderly 1970-94||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.79308|2017-10-11 04:27:07.79308
NCT01395277|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2015-07-13|2015-03-24||September 2011||2011-09-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||15 young and 15 elderly subjects participated in portion of the protocol|Role of Flavanols In Cardiovascular Function in Healthy Aging|Effects of Dietary Flavanols on Cutaneous, Peripheral, and Cerebral Vascular Function in Young and Old Humans|Completed||N/A|30|Actual|University of Texas at Austin||2|||f||||f||||||||||2017-10-11 04:01:26.716521|2017-10-11 04:01:26.716521
NCT01395264|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2011-07-14|||August 2011||2011-08-01|May 2011|2011-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Saccadometry in Primary Headache Syndromes|Saccadometry in Primary Headache Syndromes|Unknown status|Not yet recruiting|N/A|162|Anticipated|University College London Hospitals|||4||f||||f||||||||||2017-10-11 04:01:26.97883|2017-10-11 04:01:26.97883
NCT01395251|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-05-15|||February 2012||2012-02-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|TryCort||Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis|Phase II/III Study of Oral Prednisolone Test in Patients With Rheumatoid Arthritis|Completed||Phase 2/Phase 3|130|Actual|Rheumazentrum Ruhrgebiet||1|||f||||t||||||||||2017-10-11 04:01:27.044732|2017-10-11 04:01:27.044732
NCT01395238|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2011-07-14|||September 2010||2010-09-01|May 2011|2011-05-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Enhancing Father's Ability to Support Their Preschool Child|Enhancing Father's Ability to Support Their Preschool Child|Unknown status|Recruiting|Phase 1/Phase 2|125|Anticipated|Queens College, The City University of New York||2|||f||||f||||||||||2017-10-11 04:01:27.131189|2017-10-11 04:01:27.131189
NCT01395225|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-03-12|||August 2011||2011-08-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Observational|||Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer|Standardising an Approach for Analysis of Lymph Node Specimens From Radical Cystectomy With Pelvic Lymph Node Dissection Through the Use of an Organic Fat-emulsifying Agent|Completed||N/A|32|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 04:01:27.218401|2017-10-11 04:01:27.218401
NCT01395212|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2013-10-26|||July 2011||2011-07-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Observational|MYSTAR-5-YEAR||MYSTAR-5-YEAR: Long-term Follow-up of Patients With Ischemic Heart Disease Treated With Cell Therapy|Long-term Follow-up of Patients With Ischemic Heart Disease Treated With Combined Delivery of Autologous Bone-marrow Mononuclear Cells: 5-year Clinical Outcome of the MYSTAR Study|Completed||N/A|60|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 04:01:27.287812|2017-10-11 04:01:27.287812
NCT01395199|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-09-04|||August 2012||2012-08-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|AmloThal||Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major|Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major: a Randomized, Controlled Trial|Completed||Phase 3|62|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 04:01:27.370211|2017-10-11 04:01:27.370211
NCT01395186|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-14|||April 2009||2009-04-01|April 2009|2009-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Varicocelectomy To Treat Pain, Predictors Of Success|Varicocelectomy To Treat Pain, Predictors Of Success : A Prospective Study|Completed||N/A|145|Actual|Mansoura University||1|||f||||t||||||||||2017-10-11 04:01:27.453185|2017-10-11 04:01:27.453185
NCT01395173|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-09-29|||July 2011||2011-07-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|July 2012|Actual|2012-07-01||Interventional|||Position Changes During Colonoscope Withdrawal and Polyp Detection|Position Changes During Colonoscope Withdrawal to Increase Polyp Detection: a Prospective Randomized Trial|Completed||N/A|776|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 04:01:27.513464|2017-10-11 04:01:27.513464
NCT01395160|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-08-30|||July 2011||2011-07-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|FEBA||Female Experiences and Brain Activity|Female Experiences and Brain Activity: an EEG Investigation Across Psychiatric Disorders|Completed||N/A|60|Actual|King's College London|||3||f||||f||||||Samples With DNA|"     Buccal swab samples will be collected for DNA extraction.   "|||2017-10-11 04:01:27.578037|2017-10-11 04:01:27.578037
NCT01395147|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-11-02|||July 2011||2011-07-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder|An Open-label, Long-Term Extension Study to Assess the Safety and Efficacy of Lu AA21004 in Patients With Major Depressive Disorder (Extension to Lu AA21004/CCT-003 Study)|Completed||Phase 3|119|Actual|Takeda||1|||f||||f||||||||||2017-10-11 04:01:27.660075|2017-10-11 04:01:27.660075
NCT01395134|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-07-14|||September 2009||2009-09-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Visualization Versus Neuromonitoring of the External Branch of the Superior Laryngeal Nerve During Thyroidectomy.|Randomized Controlled Trial of Visualization Versus Neuromonitoring of the External Branch of the Superior Laryngeal Nerve During Thyroidectomy.|Completed||N/A|210|Actual|Jagiellonian University||2|||f||||t||||||||||2017-10-11 04:01:27.948552|2017-10-11 04:01:27.948552
NCT01395121|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2017-06-07|||December 2009|Actual|2009-12-01|June 2017|2017-06-01|December 12, 2016|Actual|2016-12-12|December 12, 2016|Actual|2016-12-12||Interventional|NICAM||A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread|A Phase II Trial of Nilotinib in the Treatment of Patients With c-KIT Mutated Advanced Acral and Mucosal Melanoma|Completed||Phase 2|29|Actual|Institute of Cancer Research, United Kingdom||1|||f||||t||||||||||2017-10-11 04:01:28.050019|2017-10-11 04:01:28.050019
NCT01395108|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-07-13|||January 2008||2008-01-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Clinical Study on Oral Nemonoxacin Malate Capsules|Phase I Clinical Study on Oral Nemonoxacin Malate Capsules|Completed||Phase 1|76|Actual|TaiGen Biotechnology Co., Ltd.||6|||f||||f||||||||||2017-10-11 04:01:28.148438|2017-10-11 04:01:28.148438
NCT01395095|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2016-03-14|||September 2011||2011-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|OPTICARE||OPTImal CArdiac REhabilitation (OPTICARE) Following Acute Coronary Syndromes|OPTImal CArdiac REhabilitation (OPTICARE)Following Acute Coronary Syndromes: A Randomized, Controlled Trial to Investigate the Benefits of an Expanded Educational and Behavioural Intervention Program.|Completed||N/A|914|Actual|Erasmus Medical Center||3|||f||||f||||||||Yes||2017-10-11 04:01:28.232246|2017-10-11 04:01:28.232246
NCT00000412|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2015-07-02|||September 1997||1997-09-01|July 2015|2015-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Osteoporosis Prevention After Heart Transplant|Prevention of Osteoporosis After Cardiac Transplantation|Completed||Phase 3|149|Actual|Columbia University||2|||f||||||||||||||2017-10-11 04:17:55.205018|2017-10-11 04:17:55.205018
NCT01395082|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-06-28|||April 2011||2011-04-01|June 2017|2017-06-01|April 2024|Anticipated|2024-04-01|April 2024|Anticipated|2024-04-01||Observational|||ACAM2000® Myopericarditis Registry|ACAM2000® Myopericarditis Registry|Active, not recruiting||N/A|200|Anticipated|Sanofi|||1||f||||f||||||||Yes|Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available at Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com|2017-10-11 04:01:28.346674|2017-10-11 04:01:28.346674
NCT01395069|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-01-12|||February 2010||2010-02-01|January 2016|2016-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|PNK||Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery|Randomized Clinical Trial Comparing Prophylactic Nepafenac 0.1% and Ketorolac 0.5% Versus Placebo in Preventing Postoperative Macular Edema After Uncomplicated Phacoemulsification Cataract Extraction (PNK)|Completed||Phase 4|162|Actual|Queen's University||3|||f||||f||||||||||2017-10-11 04:01:28.435675|2017-10-11 04:01:28.435675
NCT01395056|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-14|2015-07-20|||July 2011||2011-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Observational|DCCIK||Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients|Study of Chemotherapy Combined With Adoptive Cellular Therapy With Dendritic and Cytokine-induced Killer Cells in Triple Negative Breast Cancer Patients|Completed||N/A|23|Actual|Beijing Cancer Hospital|||1||f||||t||||||None Retained|"     about 4ml peripheral vein blood，paraffin section on metastatic tissue，   "|||2017-10-11 04:01:28.531665|2017-10-11 04:01:28.531665
NCT01395043|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-01-05|2011-10-06||September 2010||2010-09-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Transversus Abdominis Plane Catheter: a Study of Method|TAP-catheter With Intermittent Bolus Injections of Bupivacain, an Alternative to Epidural Catheter Infusion After Colon Surgery?|Completed||N/A|15|Actual|Aalborg Universitetshospital|Not randomised or blinded. Limited number of patients. Dermatome level of the block and the incidence of postoperative nausea and vomiting was not registered. The study does not compare TAP-catheter and epidural catheter.|1|||f||||f||||||||||2017-10-11 04:01:28.645184|2017-10-11 04:01:28.645184
NCT01395030|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-05-31|||July 2011||2011-07-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|May 31, 2017|Actual|2017-05-31||Interventional|||Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer|Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer|Active, not recruiting||Phase 1/Phase 2|60|Actual|Queen's Medical Centre||1|||f||||t||||||||||2017-10-11 04:01:28.949766|2017-10-11 04:01:28.949766
NCT01395017|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-03-10|2014-10-24||June 2011||2011-06-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|October 2013|Actual|2013-10-01||Interventional|LAPC||Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer|Placebo-controlled Double-blind Trial of Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer|Completed||Phase 2|202|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|5 participants (who had not experienced disease progression at the time of event-driven data cut-off) were told the study results and were instructed to indicate “sponsor discontinued study” if they did not want to continue in the study.|2|||f||||t||||||||||2017-10-11 04:01:29.135553|2017-10-11 04:01:29.135553
NCT01394991|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-10|2012-04-03|2010-09-10||January 2006||2006-01-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia|A Randomized, Open-Label, Multicenter Study Evaluating Thrombovascular Events in Subjects With Cancer Receiving Chemotherapy and Administered Epoetin Alfa Once or Three Times a Week for the Treatment of Anemia|Completed||Phase 4|504|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-10-11 04:01:30.55641|2017-10-11 04:01:30.55641
NCT01394978|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-06-09|2017-04-17||June 2011||2011-06-01|June 2017|2017-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study|AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure|Completed||N/A|444|Actual|C. R. Bard||2|||f||||t||||||||||2017-10-11 04:01:31.679312|2017-10-11 04:01:31.679312
NCT01394965|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2013-10-18|||October 2013||2013-10-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Electrocardiographic Mapping and Imaging|Electrocardiographic Mapping and Imaging|Withdrawn||Early Phase 1|0|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 04:01:32.17528|2017-10-11 04:01:32.17528
NCT01394952|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2016-10-19|||July 2011||2011-07-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|REWIND||Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)|The Effect of Dulaglutide on Major Cardiovascular Events in Patients With Type 2 Diabetes: Researching Cardiovascular Events With a Weekly INcretin in Diabetes (REWIND)|Active, not recruiting||Phase 3|9622|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 04:01:32.335794|2017-10-11 04:01:32.335794
NCT01394939|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2016-01-06|||January 2012||2012-01-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma|A Phase 1/2a Dose-escalation Study of JX 594 (Thymidine Kinase-Deactivated Vaccinia Virus Plus GM-CSF) Administered by Multiple Intravenous (IV) Infusions Alone and in Combination With Irinotecan in Patients With Metastatic, Refractory Colorectal Carcinoma.|Completed||Phase 1/Phase 2|52|Actual|SillaJen, Inc.||2|||f||||f||||||||||2017-10-11 04:01:33.136058|2017-10-11 04:01:33.136058
NCT01394926|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-04-16|2014-03-07||June 2011||2011-06-01|April 2014|2014-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease|A Multi-Center, Open-Label, Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease|Terminated||Phase 2|21|Actual|GE Healthcare||1||Lack of Subject Recruitment|f||||f||||||||||2017-10-11 04:01:33.246061|2017-10-11 04:01:33.246061
NCT01394913|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2013-03-01|||August 2013||2013-08-01|March 2013|2013-03-01|June 2014|Anticipated|2014-06-01|March 2014|Anticipated|2014-03-01||Interventional|||Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis|A Prospective, Double-blind, Randomized Study to Compare Efficacy of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis|Suspended||Phase 3|216|Anticipated|EMS||2||Study suspended by decision strategically.|f||||t||||||||||2017-10-11 04:01:33.411645|2017-10-11 04:01:33.411645
NCT01394900|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-02-03|||July 2012||2012-07-01|February 2017|2017-02-01|April 30, 2017|Anticipated|2017-04-30|December 31, 2016|Actual|2016-12-31||Interventional|CNU||Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM|Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM|Active, not recruiting||N/A|424|Actual|Columbia University||2|||f||||f|f|f||||||Undecided||2017-10-11 04:01:33.488501|2017-10-11 04:01:33.488501
NCT01394887|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-07-15|||July 2002||2002-07-01|July 2002|2002-07-01|July 2011|Actual|2011-07-01|July 2003|Actual|2003-07-01||Interventional|||Metformin & Inflammation in Pre-diabetic Children|Metformin Decreases Plasma Resistin Concentrations in Pediatric Patients With Impaired Glucose Tolerance: A Placebo-controlled Randomized Clinical Trial|Completed||Phase 2/Phase 3|52|Actual|Coordinación de Investigación en Salud, Mexico||2|||f||||f||||||||||2017-10-11 04:01:33.58448|2017-10-11 04:01:33.58448
NCT01394874|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-05-01|||July 2011||2011-07-01|May 2013|2013-05-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|BOOST||Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee OA?|Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee OA?|Unknown status|Recruiting|N/A|100|Anticipated|Boston University||2|||f||||f||||||||||2017-10-11 04:01:33.670013|2017-10-11 04:01:33.670013
NCT01394861|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-03-04|||June 2011||2011-06-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|ESD||Endoscopic Submucosal Dissection (ESD)- Master Slave Robotic System - Human Study||Completed||Early Phase 1|3|Actual|Asian Institute of Gastroenterology, India||1|||f||||t||||||||||2017-10-11 04:01:33.871523|2017-10-11 04:01:33.871523
NCT01394848|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-12-03|||October 2011||2011-10-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|INNOVATION||Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy|EndothelIal progeNitor Cell Capture steNt With 1-mOnth Dual Antiplatelet Therapy Versus eVerolimus-eluting Stent With stAndard 12-month Dual anTIplatelet Therapy in Elderly (≥ 70 Year) With Stable corONary Artery Disease - INNOVATION Trial|Terminated||Phase 4|1|Actual|Yonsei University||4||"Previous other study including EPC capture stent raised the issue of safety (significant high   incidence of instent restenosis)"|f||||t||||||||||2017-10-11 04:01:33.956792|2017-10-11 04:01:33.956792
NCT01394835|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-13|||September 2011||2011-09-01|July 2011|2011-07-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients||Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Rabin Medical Center||1|||f||||||||||||||2017-10-11 04:01:34.088825|2017-10-11 04:01:34.088825
NCT01394822|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-12-08|||September 2011||2011-09-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Neuromuscular Ultrasound for Focal Neuropathies|Neuromuscular Ultrasound for Focal Neuropathies|Completed||N/A|120|Actual|Wake Forest University Health Sciences|||2||f||||f||||||||||2017-10-11 04:01:34.176983|2017-10-11 04:01:34.176983
NCT01394809|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2014-12-02|||August 2010||2010-08-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PROFinD-TP4||Effects of Motor Cognitive Training on Functional Loss After Osteoporotic Wrist Fractures|Effects of Motor Cognitive Training on Functional Loss Through Immobilization After Osteoporotic Distal Radius Fractures: a Randomised Clinical Pilot Study in Elderly Patients|Completed||N/A|27|Actual|University of Stuttgart||3|||f||||f||||||||||2017-10-11 04:01:34.245396|2017-10-11 04:01:34.245396
NCT01394783|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-11-17|||July 2011||2011-07-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Videolaryngoscope vs Classic Laryngoscope in Teaching Neonatal Endotracheal Intubation: a Randomized Controlled Trial.|Videolaryngoscope vs Classic Laryngoscope in Teaching Neonatal Endotracheal Intubation: a Randomized Controlled Trial.|Completed||Phase 4|268|Actual|St. Justine's Hospital||2|||f||||t||||||||||2017-10-11 04:01:34.453305|2017-10-11 04:01:34.453305
NCT01394770|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-07-09|||September 2009||2009-09-01|July 2012|2012-07-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients|Cardiovascular Events in Hypertensive Hemodialysed Patients: Aliskiren Versus Amlodipine. A Randomized, Double-blind Study.|Unknown status|Active, not recruiting|Phase 4|350|Anticipated|"University of Campania Luigi Vanvitelli"||2|||f||||f||||||||||2017-10-11 04:01:34.545204|2017-10-11 04:01:34.545204
NCT01394757|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2013-12-29|||August 2011||2011-08-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Network Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI)|Brain Network Dysfunction as a Model for Schizophrenia: Connectivity Alterations Using Ketamine and Pharmacological Magnetic Resonance Imaging|Completed||N/A|52|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 04:01:34.634144|2017-10-11 04:01:34.634144
NCT01394744|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2017-09-01|||August 2011||2011-08-01|September 2017|2017-09-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Observational|||Determination of Metal Ion Serum Levels and Cytokines in Total Hip Replacement|Determination of Metal Ion Levels in the Serum and Assessment of the Respective Cytokine Production of Peripheral Blood Cells in Patients With a Hard-on-hard Bearing Total Hip Replacement|Active, not recruiting||N/A|30|Actual|Ludwig-Maximilians - University of Munich|||1||f||||f||||||Samples Without DNA|"     Blood serum samples for metal ion and cytokine measurement; blood cells for cytokine-RNA     assessment   "|||2017-10-11 04:01:34.710944|2017-10-11 04:01:34.710944
NCT01394731|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-07-13|||December 2010||2010-12-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Analgesic Effects of Intravenous Paracetamol on Labor Pain|Analgesic Effects of Intravenous Acetaminophen on Labor Pain|Completed||Phase 4|||King Abdulaziz University||3|||f||||||||||||||2017-10-11 04:01:34.827167|2017-10-11 04:01:34.827167
NCT01394718|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2016-03-17|2016-03-17||July 2011||2011-07-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|June 2014|Actual|2014-06-01||Interventional|IV APAP SF|Analysis population includes only those subjects who completed at least 24 hours of post-operative data collection. 3 subjects who were enrolled and received at least 1 dose were removed before reaching the 24 hour post-operative milestone.|Analgesic Efficacy of Repeated Doses of Intravenous (IV) Acetaminophen in Post-operative Pediatric Spine Fusion Patients|Analgesia Efficacy of Repeated Doses of Intravenous Acetaminophen (Paracetamol) in the Pediatric Spinal Fusion Population|Completed||Phase 3|67|Actual|Children's Hospital of Philadelphia|This is a single center study with subjects confined to a single surgical procedure with a small sample size, possibly limiting generalizability of results.|2|||f||||f||||||||||2017-10-11 04:01:34.940792|2017-10-11 04:01:34.940792
NCT01394705|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-12-05|||June 2011||2011-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||FITT Exercise Counseling With Interactive Accelerometry and Physical Activity in Adolescents at Increased Risk of Early Cardiovascular Disease: A Pilot Study|FITT Exercise Counseling With Interactive Accelerometry and Physical Activity in Adolescents at Increased Risk of Early Cardiovascular Disease: A Pilot Study|Active, not recruiting||N/A|40|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 04:01:35.422241|2017-10-11 04:01:35.422241
NCT01394692|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-10-29|2012-09-20||October 2007||2007-10-01|October 2012|2012-10-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01||Interventional|||Comparative Study of Intraoperative MRI-guided vs. Conventional Glioma Surgery|Resection Control of Primary Brain Tumours Using a Low-Field Intraoperative MRI|Completed||N/A|58|Actual|Goethe University||2|||f||||f||||||||||2017-10-11 04:01:35.526884|2017-10-11 04:01:35.526884
NCT01394679|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-09-27|||September 1, 2017|Actual|2017-09-01|September 2017|2017-09-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer|A Multicenter Phase 3 Study Comparing the Diagnostic Accuracy of 99mTc EC DG SPECT/CT Versus 18F FDG PET/CT for Diagnosing and Staging Patients Who Have Clinical and Radiological (CT) Evidence Consistent With a Diagnosis of Lung Cancer|Recruiting||Phase 3|154|Anticipated|Cell>Point LLC||2|||f||||t|t|f||||||||2017-10-11 04:01:35.857226|2017-10-11 04:01:35.857226
NCT01394666|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-07-08|||May 2011||2011-05-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML)|Treatment Patterns and Associated Outcomes in Chronic Phase (CP) Chronic Myelogenous Leukemia (CML) Patients Who Fail Imatinib 400 mg Daily|Completed||N/A|150|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 04:01:35.999369|2017-10-11 04:01:35.999369
NCT01394653|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-10-10|||July 2011||2011-07-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water Intake|Bioequivalence Study of YM060 Orally-disintegrating Tablet and Conventional Tablet - Ingestion With Water -|Completed||Phase 1|36|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 04:01:36.082214|2017-10-11 04:01:36.082214
NCT01394640|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-29|||October 2009||2009-10-01|October 2009|2009-10-01|January 2011|Actual|2011-01-01|May 2010|Actual|2010-05-01||Observational|||Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients|Evaluation of Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Oncologic and Hematologic Patients|Completed||N/A|124|Actual|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|||2||f||||f||||||Samples Without DNA|"     Serum and blood sample   "|||2017-10-11 04:01:36.167248|2017-10-11 04:01:36.167248
NCT01394614|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-05-12|2014-11-28||June 2011||2011-06-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Risk of Narcolepsy Associated With Administration of H1N1 Vaccine|Risk of Narcolepsy Associated With Administration of Inactivated Adjuvanted (AS03) A/H1N1 Pandemic Influenza Vaccine in Quebec|Completed||N/A|24|Actual|Hopital du Sacre-Coeur de Montreal|Small number of subjects; Impossibility to completely exclude a confounding effect of the A/H1N1 virus infection itself.||2||f||||f||||||Samples With DNA|"     HLA typing   "|||2017-10-11 04:01:36.399864|2017-10-11 04:01:36.399864
NCT01394601|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-11-02|||August 2011||2011-08-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|RECONNECT-S||A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia|RECONNECT-S ALPHA: A Non-interventional Study to Observe Real-life Allocation of Antipsychotics in the Acute Inpatient Management of Schizophrenia|Completed||N/A|600|Actual|AstraZeneca|||1||f||||f||||||None Retained|"     Clinical Practice   "|||2017-10-11 04:01:36.785834|2017-10-11 04:01:36.785834
NCT01394588|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2014-05-02|||August 2010||2010-08-01|May 2014|2014-05-01||||||||Observational|||Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery|A Prospective Observational Trial of Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery|Withdrawn||N/A|0|Actual|Yale University|||1|"On further investigation, it was found that the continuous glucose monitors required a   calibration period that precluded reliable data collection."|f||||f||||||||||2017-10-11 04:01:36.894823|2017-10-11 04:01:36.894823
NCT01394575|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2013-03-26|||July 2011||2011-07-01|June 2011|2011-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|IMRT-SIB||Whole Breast Irradiation With Intensity Modulated Radiotherapy and Simultaneously Integrated Boost for Early Stage Breast Cancer Patients|Phase 2 Study of Whole Breast Irradiation With Inversely Intensity Modulated Radiotherapy and Simultaneously Integrated Boost for Early Stage Breast Cancer Patients|Unknown status|Recruiting|Phase 2|190|Anticipated|Fudan University||1|||f||||f||||||||||2017-10-11 04:01:37.005896|2017-10-11 04:01:37.005896
NCT01394562|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-05-16|||July 2011||2011-07-01|December 2015|2015-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|EFFECT-HF||Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure|Multicentre, Prospective, Randomised, 2-arm Study to Assess the Impact of Ferric Carboxymaltose on Exercise Capacity in Chronic Heart Failure Patients With Iron Deficiency|Completed||Phase 3|174|Actual|Vifor Inc.||2|||f||||t||||||||||2017-10-11 04:01:37.330395|2017-10-11 04:01:37.330395
NCT01394549|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-06-20|||June 2011||2011-06-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Observational|CASSANDRE||Causes, Analysis of the Sub-evaluating Coronary Syndromes Acute and Disparities in France in Women|Causes, Analysis of the Sub-evaluating Coronary Syndromes Acute and Disparities in France in Women|Completed||N/A|319|Actual|French Cardiology Society|||1||f||||t||||||||||2017-10-11 04:01:37.410817|2017-10-11 04:01:37.410817
NCT01394536|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-10-16|||June 2011||2011-06-01|October 2012|2012-10-01||||May 2012|Actual|2012-05-01||Interventional|||Overnight Use of Electroacustimulation on Postoperative Nausea and Vomiting in the Outpatient Surgery Population|The Effect of Overnight Use of Electroacustimulation on Postoperative Nausea and Vomiting in the Outpatient Surgery Population|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison||2||"The study was closed prior to enrollment of any subjects. No subjects were enrolled in this   study."|f||||f||||||||||2017-10-11 04:01:37.476398|2017-10-11 04:01:37.476398
NCT01394523|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-03-24|||August 2011||2011-08-01|March 2017|2017-03-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Caudal Versus Rectus Sheath Study|A Prospective, Double-blinded, Randomized Comparison of Caudal Analgesia Versus Ultrasound Guided Rectus Sheath Blocks for Umbilical Herniorrhaphy in the Pediatric Population|Terminated||Phase 2/Phase 3|39|Actual|Nationwide Children's Hospital||3||Interim power analysis was prohibitive to continuing the study|f||||f||||||||||2017-10-11 04:01:37.563692|2017-10-11 04:01:37.563692
NCT01394510|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-05-10|2016-05-10||June 2011||2011-06-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|September 2014|Actual|2014-09-01||Interventional||Patients with type 2 diabetes either on metformin alone or treated with diet and lifestyle only.|Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes|Effect of Anti-oxidants on Beta-cell Function in Humans|Completed||N/A|13|Actual|Utzschneider, Kristina, M.D.||1|||f||||f||||||||No|The study sample size is very small. The data will be made available upon request.|2017-10-11 04:01:37.651314|2017-10-11 04:01:37.651314
NCT01394497|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2013-02-15|||December 2006||2006-12-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Use of N-Acetylcysteine During Liver Procurement|Infusione Sistemica e Loco-regionale di N-Acetilcisteina Nel Prelievo di Fegato: Uno Studio Prospettico Randomizzato Controllato. Fase II.|Completed||Phase 2|140|Actual|Azienda Ospedaliera di Padova||2|||f||||t||||||||||2017-10-11 04:01:37.850747|2017-10-11 04:01:37.850747
NCT01394484|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2013-02-25|||December 2010||2010-12-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|FL-83||Dairy Foods Compared to Dietary Supplements and Bone Health|Milk and Yogurt vs. Calcium and Vitamin D Supplements for Bone Health of Women|Completed||N/A|12|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 04:01:37.961455|2017-10-11 04:01:37.961455
NCT01394471|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-06-09|||July 2011||2011-07-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|OTS-12WK||Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia|Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia|Completed||Phase 1|68|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 04:01:38.070203|2017-10-11 04:01:38.070203
NCT01394458|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2015-12-03|||August 2011||2011-08-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study|Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution to Prevent Hemodialysis Catheter-Related Infections: A Pilot Study|Completed||N/A|40|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-11 04:01:38.17133|2017-10-11 04:01:38.17133
NCT01394445|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-02-20|||June 2011||2011-06-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|PHANOS||Pilot Study of Physostigmine-Enhanced Opioid Analgesia|Influence of Physostigmine on Patient-Controlled Analgesia|Completed||Phase 3|20|Actual|Medical University of Graz||2|||f||||f||||||||||2017-10-11 04:01:38.347886|2017-10-11 04:01:38.347886
NCT01394432|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2015-09-21|||July 2011||2011-07-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2012|Actual|2012-11-01||Interventional|ESTIMATION||"ESTIMATION Study for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction"|Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction|Unknown status|Recruiting|Phase 3|50|Anticipated|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-10-11 04:01:38.443759|2017-10-11 04:01:38.443759
NCT01394419|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2013-03-04|||September 2010||2010-09-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effect of N-acetylcysteine on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass Graft|Effect of N-acetylcysteine on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass Graft|Completed||Phase 4|115|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 04:01:38.577969|2017-10-11 04:01:38.577969
NCT01394406|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-03-04|||January 2010||2010-01-01|March 2014|2014-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Ketamine Added to Intravenous Patient-controlled Analgesia on Postoperative Pain, Nausea and Vomiting in Patients Undergoing Lumbar Spinal Surgery|Effect of Ketamine Added to Intravenous Patient-controlled Analgesia on Postoperative Pain, Nausea and Vomiting in Patients Undergoing Lumbar Spinal Surgery|Completed||Phase 4|50|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 04:01:38.661995|2017-10-11 04:01:38.661995
NCT01394393|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-05-30|||January 2011||2011-01-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|AVATOB||Virtual Environments For Supporting Obesity Treatment|Ambientes Virtuales Como Auxiliares en el Tratamiento de la Obesidad|Unknown status|Recruiting|Phase 1|40|Anticipated|Universidad Nacional Autonoma de Mexico||3|||f||||t||||||||||2017-10-11 04:01:38.772319|2017-10-11 04:01:38.772319
NCT01394380|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2014-06-03|||October 2011||2011-10-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|REDUCS||Reduction of Sweetened Beverages and Intrahepatic Fat|Effects of a Reduction of Sweetened Beverages Consumption in Overweight High Consumers on Cardiometabolic Risk Factors|Completed||N/A|29|Actual|University of Lausanne||2|||f||||f||||||||||2017-10-11 04:01:38.972371|2017-10-11 04:01:38.972371
NCT01394367|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2014-07-01|||June 2010||2010-06-01|July 2014|2014-07-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension|Study of Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension|Unknown status|Recruiting|Phase 3|90|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-11 04:01:39.129264|2017-10-11 04:01:39.129264
NCT01394354|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-04-05|||August 2011||2011-08-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|VBDD||Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM)|Safety of Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma, A Phase I/II Study, Short Title: VBDD|Completed||Phase 1/Phase 2|34|Actual|University Hospital Freiburg||1|||f||||f||||||||||2017-10-11 04:01:39.279383|2017-10-11 04:01:39.279383
NCT01394341|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-10-08|||September 2011||2011-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Liraglutide Treatment to Patients With Severe Renal Insufficiency|Safety and Effect of Liraglutide in Patients With Type 2 Diabetes and Severe Renal Insufficiency|Completed||Phase 4|40|Actual|Rigshospitalet, Denmark||4|||f||||t||||||||||2017-10-11 04:01:39.413051|2017-10-11 04:01:39.413051
NCT01394328|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-13|||April 2006||2006-04-01|July 2011|2011-07-01|November 2008|Actual|2008-11-01|||||Observational|||Delirium in Persons With Dementia|Delirium in Persons With Dementia|Completed||N/A|308|Actual|Penn State University|||1||f||||f||||||||||2017-10-11 04:01:39.542267|2017-10-11 04:01:39.542267
NCT01394315|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2013-05-02|||August 2011||2011-08-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|DOT||Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer|Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer|Terminated||N/A|8|Actual|National Cancer Centre, Singapore|||1||f||||f||||||Samples With DNA|"     Pre-operative biopsy specimens and definitive surgical specimens   "|||2017-10-11 04:01:39.642203|2017-10-11 04:01:39.642203
NCT01394302|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-07-13|||July 2011||2011-07-01|June 2011|2011-06-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|||The Functional Profile of People Suffering From Trigger Finger|Functional Profile of People Suffering From Trigger Finger|Unknown status|Not yet recruiting|N/A|60|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 04:01:39.734659|2017-10-11 04:01:39.734659
NCT01394289|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-08-24|||September 2011||2011-09-01|August 2011|2011-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Biological Standardization of Lolium Perenne Allergen Extract|Biological Standardization of Lolium Perenne Allergen Extract to Determine the Biological Activity in HEP Units|Completed||Phase 2|31|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-10-11 04:01:39.832992|2017-10-11 04:01:39.832992
NCT01394276|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2016-04-30|2016-04-30||May 2011||2011-05-01|April 2016|2016-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational||The total population included all participants who met all inclusion/exclusion criteria described in the study and received at least one dose of study medication.|An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)|Rheumatoid Arthritis Patients Treated With Tocilizumab in Real Clinical Practice: Effectiveness and Safety (TRUST Study)|Completed||N/A|322|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:01:40.011134|2017-10-11 04:01:40.011134
NCT01394263|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2012-09-27|||May 2000||2000-05-01|September 2012|2012-09-01|December 2003|Actual|2003-12-01|December 2001|Actual|2001-12-01||Interventional|||Study of Histrelin Subdermal Implant in Patients With Prostate Cancer|Phase III, Open-Label Randomized, Parallel, Active-Control Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Patients With Metastatic Prostate Cancer|Completed||Phase 3|59|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-10-11 04:01:41.660437|2017-10-11 04:01:41.660437
NCT01394250|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-07-27|2015-03-27||June 2011||2011-06-01|July 2016|2016-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||"Baseline analysis population includes all subjects who were randomized and whose first attempt at IV access was successful (i.e., subjects in the Successful IV Placement & Follow-Up group)"|Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief|Testing the Efficacy of a Vibrating, Cold Device for Pediatric IV Cannulation Pain Relief in the Emergency Department|Completed||Phase 2|240|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 04:01:41.764707|2017-10-11 04:01:41.764707
NCT01394237|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2014-03-11|||June 2011||2011-06-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Observational|||Laparoscopic Sacrocolpopexy: Long Term Follow-up|Laparoscopic Sacrocolpopexy: Long Term Results With Special Focus on Anatomical Results and Quality of Life|Completed||N/A|75|Actual|Kantonsspital Aarau|||1||f||||t||||||||||2017-10-11 04:01:42.104412|2017-10-11 04:01:42.104412
NCT01394224|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-10-05|||June 2011||2011-06-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects|A Single Site, Open-label, Randomized, Single-dose, Two-way Cross-over Study in Healthy Japanese Subjects to Evaluate the Bioequivalence, Safety & Tolerability of Levetiracetam Administered as an Oral Tablet or Intravenous Infusion|Completed||Phase 1|25|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 04:01:42.210385|2017-10-11 04:01:42.210385
NCT01394211|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-03-29|||July 13, 2011|Actual|2011-07-13|March 2017|2017-03-01|April 12, 2012|Actual|2012-04-12|April 12, 2012|Actual|2012-04-12||Interventional|||Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer|Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer|Terminated||Phase 2|2|Actual|University of Arizona||1||Slow accrual|f||||t||||||||||2017-10-11 04:01:42.329529|2017-10-11 04:01:42.329529
NCT01394198|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-01-07|||March 2011||2011-03-01|June 2011|2011-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings|Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings|Completed||N/A|70|Actual|A.T. Still University of Health Sciences|||1||f||||f||||||||||2017-10-11 04:01:42.436171|2017-10-11 04:01:42.436171
NCT01394185|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-08-02|2017-04-18||February 2011||2011-02-01|August 2017|2017-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Dronabinol (Oral THC) on Cannabis Use|Effects of Dronabinol (Oral THC) on Cannabis Use|Completed||Phase 1/Phase 2|25|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 04:01:42.506003|2017-10-11 04:01:42.506003
NCT01394172|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2015-08-11|||June 2011||2011-06-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|May 2014|Actual|2014-05-01||Observational|||A Novel Method of Non-invasive Ventilation in Children|Non-invasive Ventilation Generated by External Chest Pressure in Children|Completed||N/A|100|Anticipated|University of Alberta|||1||f||||f||||||||||2017-10-11 04:01:42.889777|2017-10-11 04:01:42.889777
NCT01394159|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-03-30|2015-03-18||July 2011||2011-07-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||22G FNA Needle vs. 22G ProCore Needle|Randomized Trial Comparing the 22-gauge Aspiration and 22-gauge Biopsy Needles for EUS-guided Sampling of Solid Pancreatic Mass Lesions|Completed||N/A|56|Actual|Florida Hospital||2|||f||||f||||||||||2017-10-11 04:01:42.98361|2017-10-11 04:01:42.98361
NCT01394146|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-09-28|||April 2011||2011-04-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Impact of Food Additives on Phosphorus Metabolism|Impact of Food Additives on Phosphorus Metabolism|Completed||N/A|54|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-11 04:01:43.373132|2017-10-11 04:01:43.373132
NCT01394133|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2013-04-29|||July 2011||2011-07-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women|Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women|Withdrawn||N/A|0|Actual|University of Alabama at Birmingham|||1|Lack of enrollment|f||||t||||||Samples Without DNA|"     5 mL of plasma   "|||2017-10-11 04:01:43.4726|2017-10-11 04:01:43.4726
NCT01394120|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-03-24|||August 2011||2011-08-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer|Phase II Study of Chemotherapy Selection Based on Therapeutic Targets for the Treatment of Advanced Pancreatic Cancer|Unknown status|Recruiting|Phase 2|60|Anticipated|Grupo Hospital de Madrid||2|||f||||t||||||||||2017-10-11 04:01:43.567272|2017-10-11 04:01:43.567272
NCT01394107|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2015-07-27|||January 2011||2011-01-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Evaluation of the LMWH Thromboprophylaxis in Pregnancy|Evaluation of the Impact of the Thromboprophylactic Dose of LMWH on Coagulation in Pregnant Women.|Unknown status|Recruiting|N/A|50|Anticipated|Charles University, Czech Republic|||2||f||||f||||||Samples With DNA|"     whole blood, serum   "|||2017-10-11 04:01:43.699025|2017-10-11 04:01:43.699025
NCT01394094|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-13|2011-07-13|||July 2011||2011-07-01|July 2011|2011-07-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Effects of Gum Chewing on Recovery of Bowel Function Following Benign Gynecologic Surgery|Effects of Gum Chewing on Recovery of Bowel Function Following Benign Gynecologic Surgery: a Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 2/Phase 3|124|Anticipated|ChaingMai University||2|||f||||t||||||||||2017-10-11 04:01:43.800475|2017-10-11 04:01:43.800475
NCT01394068|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-08-17|||January 2011||2011-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|SICS||Prospective, Non-randomized Observational Trial of Selenium in Cardiac Surgery|SICS: A Prospective, Non-randomized Observational Trial of Selenium in Cardiac Surgery|Completed||N/A|100|Anticipated|RWTH Aachen University|||1||f||||f||||||Samples Without DNA|"     Procalcitonin, CRP, IL-6, IL-10, Leukocytes, Thrombocytes, Bilirubin, Creatinine, Lactate,     Albumin, AT-III   "|||2017-10-11 04:01:44.046582|2017-10-11 04:01:44.046582
NCT01394055|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-09-21|||July 2011||2011-07-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis|Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose, 2-Period Crossover Study to Evaluate the Pharmacodynamics of RM-131 Administered to Patients With Diabetic Gastroparesis|Completed||Phase 1|20|Actual|Motus Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 04:01:44.134143|2017-10-11 04:01:44.134143
NCT01394042|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-12|||June 2011||2011-06-01|July 2011|2011-07-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint|Exploratory Evaluation of a Transrectal Scintigraphic Detector (Proxiscan) for Detection of Primary Prostate Cancer Utilizing a Radiotracer Targeting Prostate Specific Membrane Antigen (PMSA)|Unknown status|Enrolling by invitation|Early Phase 1|12|Anticipated|Radiological Associates of Sacramento Medical Group Inc.||1|||f||||t||||||||||2017-10-11 04:01:44.239368|2017-10-11 04:01:44.239368
NCT01394029|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-02-01|||July 2011||2011-07-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox|International Sentinel Site Surveillance of Patients With Transfusional Hemosiderosis Treated With Deferasirox in Actual Practice Setting|Completed||N/A|120|Actual|Novartis|||1||f||||||||||||||2017-10-11 04:01:44.36961|2017-10-11 04:01:44.36961
NCT01394016|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-03-20|||December 7, 2009|Actual|2009-12-07|March 2017|2017-03-01|April 3, 2018|Anticipated|2018-04-03|May 29, 2014|Actual|2014-05-29||Interventional|||A Phase 1 Study of LY2835219 In Participants With Advanced Cancer|A Phase 1 Study of a CDK 4/6 Dual Inhibitor in Participants With Advanced Cancer|Active, not recruiting||Phase 1|220|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:01:44.480584|2017-10-11 04:01:44.480584
NCT01393990|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2014-01-17|||August 2008||2008-08-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|||A Study of LY2228820 in Patients With Advanced Cancer|A Phase 1 Study of an Oral p38 MAPK Inhibitor in Patients With Advanced Cancer|Completed||Phase 1|60|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:01:44.642199|2017-10-11 04:01:44.642199
NCT01393964|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-06-27|2015-12-18||January 6, 2012|Actual|2012-01-06|June 2017|2017-06-01|July 18, 2016|Actual|2016-07-18|March 21, 2014|Actual|2014-03-21||Interventional||All participants who received at least one dose of study drug (Treated Population).|Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function|PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis|Completed||Phase 1|35|Actual|Bristol-Myers Squibb||3|||f||||f|t|f||||||||2017-10-11 04:01:44.890853|2017-10-11 04:01:44.890853
NCT01393951|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-09-27|||May 2011||2011-05-01|September 2017|2017-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers|Study for Immunogenicity and Safety of ASP7374 for Subcutaneous and Intramuscular Vaccination in Healthy Adults|Completed||Phase 1/Phase 2|165|Actual|UMN Pharma Inc.||3|||f||||f||||||||||2017-10-11 04:01:47.508137|2017-10-11 04:01:47.508137
NCT01393938|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2015-01-06|||April 2010||2010-04-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|January 2012|Actual|2012-01-01||Interventional|MDA-3DUS||Comparison of MRI Versus Three Dimensional Ultrasound in the Diagnosis of Mullerian Duct Anomalies|Comparison of MRI Versus Three Dimensional Ultrasound in the Diagnosis of Mullerian Duct Anomalies|Terminated||N/A|16|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 04:01:47.610221|2017-10-11 04:01:47.610221
NCT01393925|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-11-19|||July 2011||2011-07-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Effect of Parecoxib on Postoperative Shoulder Pain After Gynecological Laparoscopy.||Completed||N/A|126|Actual|First Affiliated Hospital, Sun Yat-Sen University||1|||f||||t||||||||||2017-10-11 04:01:47.697454|2017-10-11 04:01:47.697454
NCT01393912|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-04-24|||July 2011||2011-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2014|Actual|2014-09-01||Interventional|||PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma|Platelet Derived Growth Factor Receptor (PDGFR) Inhibitor Crenolanib in Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma Including Diffuse Intrinsic Pontine Glioma|Completed||Phase 1|55|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-10-11 04:01:47.781255|2017-10-11 04:01:47.781255
NCT01393899|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-11-10|2016-08-29||March 2012||2012-03-01|November 2016|2016-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||The safety analysis set consisted of all participants who received at least 1 dose of study medication in this study.|The Safety And Efficacy Of Maintenance Therapy With CP-690,550|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study To Investigate The Safety And Efficacy Of CP-690,550 For Maintenance Therapy In Subjects With Moderate To Severe Crohn's Disease|Completed||Phase 2|180|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 04:01:47.915907|2017-10-11 04:01:47.915907
NCT01393886|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-02-01|||June 2013||2013-06-01|February 2013|2013-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|LGCP||LGCP (Laparoscopic Greater Curvature Plication)|A Prospective, Open-label Study to Evaluate the Safety and Efficacy of Laparoscopic Greater Curvature Plication (LGCP) in the Treatment of Obese Patients|Withdrawn||Phase 2|0|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-10-11 04:01:51.541869|2017-10-11 04:01:51.541869
NCT01393873|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-09-26|||July 2011||2011-07-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)|The Effect of Bariatric Surgery on the Progression of Diabetic Retinopathy|Terminated||N/A|2|Actual|New York University School of Medicine|||1|Investigator has moved to other state.|f||||f||||||||||2017-10-11 04:01:51.639494|2017-10-11 04:01:51.639494
NCT01393860|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-13|||December 2010||2010-12-01|July 2011|2011-07-01||||June 2011|Actual|2011-06-01||Observational|||Real-world Aliskiren Use in Diabetic Patients|Aliskiren Use in Diabetic Patients: Who's Using it, Why, and How is it Working ?|Completed||N/A|200|Anticipated|Novartis|||1||f||||||||||||||2017-10-11 04:01:51.717694|2017-10-11 04:01:51.717694
NCT01393847|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-06-30|||June 17, 2011||2011-06-17|December 5, 2013|2013-12-05|December 5, 2013||2013-12-05|||||Observational|||Nitric Oxide and Sickle Cell Pain|Biochemical and Genetic Mechanisms for Etiology of Sickle Cell Pain|Terminated||N/A|12|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:01:51.79481|2017-10-11 04:01:51.79481
NCT01393834|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-02-20|||December 2011||2011-12-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Delayed Umbilical Cord Clamping Versus Cord Milking in Preterm Neonate|Delayed Umbilical Cord Clamping Versus Cord Milking in Preterm Neonate - a Randomized, Controlled Trial|Terminated||N/A|2|Actual|Medstar Health Research Institute||3||difficulty with enrollment|f||||t||||||||||2017-10-11 04:01:51.868028|2017-10-11 04:01:51.868028
NCT01393821|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-03-21|||January 2012|Actual|2012-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab|A Randomized, Double-Blind Placebo-Controlled Exploration of a Topical Menadione-Containing Lotion to the Face for Prevention and Palliation of Epidermal Growth Factor Receptor Inhibitor-Induced Cutaneous Discomfort and Psychological Distress|Active, not recruiting||N/A|40|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 04:01:51.964931|2017-10-11 04:01:51.964931
NCT01393808|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-03-02|||September 2011||2011-09-01|March 2017|2017-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PROCEED||Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes|A Prospective, Randomized, Cross-over, Double-blind, Placebo-controlled Study to Assess the Antiproteinuric Effect of Selective Vitamin d Receptor Activation by Paricalcitol in Type 2 Diabetes Patients on Low or High Sodium Diet and Stable Ras Inhibitor Therapy|Completed||Phase 2|112|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-11 04:01:52.108179|2017-10-11 04:01:52.108179
NCT01393795|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-02-19|||August 2011||2011-08-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients|A Double-blind, Randomized, Crossover Clinical Study to Assess the Efficacy of Qutenza® for the Reduction of Site Pain Caused by Continuous Subcutaneous Infusion of Remodulin®, in Pulmonary Arterial Hypertension Patients|Completed||Phase 2|11|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 04:01:52.277661|2017-10-11 04:01:52.277661
NCT01393782|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2014-02-18|||July 2011||2011-07-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ATHOS||Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study|Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study|Completed||Phase 1|20|Actual|George Washington University||2|||f||||f||||||||||2017-10-11 04:01:52.377399|2017-10-11 04:01:52.377399
NCT01393769|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-08-01|||November 2009||2009-11-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage|An Open, Single-centre Non-randomized Phase II Clinical Trial on Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage|Terminated||Phase 2|5|Actual|Hospital Sant Joan de Deu||1||Only 5 subjects could be enrolled. Sample of 25 pat. not be achieved (rare disease).|f||||f||||||||||2017-10-11 04:01:52.474096|2017-10-11 04:01:52.474096
NCT01393756|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2016-02-16|||December 2010||2010-12-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|July 2013|Actual|2013-07-01||Interventional|R2-CHOP2||Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma|A Phase Ib/II Study of Escalating Doses of Revlimid in Association With R-CHOP (R2-CHOP) in the Treatment of B-cell Lymphoma|Completed||Phase 2|80|Actual|The Lymphoma Academic Research Organisation||1|||f||||t||||||||||2017-10-11 04:01:52.582115|2017-10-11 04:01:52.582115
NCT01393743|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2017-07-27|2015-05-29||September 2011||2011-09-01|July 2017|2017-07-01|November 2015|Actual|2015-11-01|May 2014|Actual|2014-05-01||Interventional||The Core Study Full Analysis Set (FAS) and Extension Phase FAS included participants who were randomized to study drug, received at least 1 dose of study drug in that phase, had baseline and any postbaseline seizure frequency data during the Randomization Phase, and at least 1 observation of valid seizure diary data during treatment duration.|A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures|Completed||Phase 3|163|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 04:01:52.745554|2017-10-11 04:01:52.745554
NCT01393730|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-06-21|2017-03-17||September 2011||2011-09-01|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|||Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer|Phase II Trial of Abiraterone Acetate Combined With Dutasteride With Correlative Assessment of Tumor Androgen Levels and Androgen Receptor Sequence and Signaling at Baseline and at Progression|Active, not recruiting||Phase 2|40|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No|This will not be done.|2017-10-11 04:01:53.69598|2017-10-11 04:01:53.69598
NCT01393717|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-02-02|||October 20, 2011|Actual|2011-10-20|February 2017|2017-02-01|February 1, 2017|Actual|2017-02-01|February 1, 2017|Actual|2017-02-01||Interventional|||Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma|A Phase II Study of Brentuximab Vedotin as Salvage Therapy for Hodgkin Lymphoma Prior to Autologous Hematopoietic Stem Cell Transplantation|Completed||Phase 2|57|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 04:01:54.193765|2017-10-11 04:01:54.193765
NCT01393704|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-04-07|2016-11-28||July 2011||2011-07-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|||Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial|Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial|Completed||Phase 4|152|Actual|Brigham and Women's Hospital|Due to practice pattern differences among sites, there was some missing data for the change in hematocrit variable, and a smaller amount of data missing for suction canister blood loss calculation.|2|||f||||f||||||||No||2017-10-11 04:01:54.308979|2017-10-11 04:01:54.308979
NCT01393691|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2015-07-08|||June 2011||2011-06-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Clinical Research Studying Interventions for Nighttime Fears in Preschool Children|Interventions for Nighttime Fears in Preschool Children: Assessment of Predictors and Outcomes|Completed||N/A|90|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-10-11 04:01:54.706563|2017-10-11 04:01:54.706563
NCT01393678|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2011-07-12|||November 1997||1997-11-01|July 2011|2011-07-01|May 1998|Actual|1998-05-01|March 1998|Actual|1998-03-01||Interventional|||Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease|A Multicenter, Randomized, Double-blind, 2 Parallel Group, Phase 3 Study of PENNEL Capsule in Chronic Liver Disease|Completed||Phase 3|220|Actual|PharmaKing||2|||f||||t||||||||||2017-10-11 04:01:54.874323|2017-10-11 04:01:54.874323
NCT01393665|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2011-07-12|||December 1996||1996-12-01|July 2011|2011-07-01|October 1997|Actual|1997-10-01|May 1997|Actual|1997-05-01||Interventional|||Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease|Multicenter, Randomized, Placebo-Controlled, Double-blind Phase 2 Study to Evaluate the Short-term Efficacy, Safety and Tolerance and to Find an Optimal Dosage of the PENNEL Capsule for the Patients With Chronic Liver Disease|Completed||Phase 2|88|Actual|PharmaKing||2|||f||||t||||||||||2017-10-11 04:01:54.960168|2017-10-11 04:01:54.960168
NCT01393652|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2011-09-30|||May 2011||2011-05-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|SINGLE DOSE||Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679|A Phase I, Randomized, Placebo-Controlled, Dose Escalating Cross Over Study To Evaluate The Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of PF-05105679 Under Fasted Conditions In Healthy Volunteers|Completed||Phase 1|32|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 04:01:55.037765|2017-10-11 04:01:55.037765
NCT01393639|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2014-08-12|||September 2011||2011-09-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis|A Phase 2, Randomized, Double Blind Assessment Of Efficacy And Safety Of PF-04171327 (1, 5, 10, 15 Mg Dose, Daily) Compared To 5 Mg And 10 Mg Prednisone Daily And Placebo Daily In Subjects With Rheumatoid Arthritis Over An 8 Week Period Followed By A 4 Week Period Of Tapering Of Study Drug|Completed||Phase 2|323|Actual|Pfizer||7|||f||||t||||||||||2017-10-11 04:01:55.138903|2017-10-11 04:01:55.138903
NCT01393626|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-03-17|2016-02-22||October 2011||2011-10-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|February 2015|Actual|2015-02-01||Interventional||Safety analysis set - included all participants who received at least one dose of study medication.|A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study To Investigate The Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease|Completed||Phase 2|280|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 04:01:55.513777|2017-10-11 04:01:55.513777
NCT01393613|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-10-26|2015-08-11|2015-02-27|July 2011||2011-07-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|BEACON||Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia|Completed||Phase 3|674|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||f||||||||||2017-10-11 04:01:57.704845|2017-10-11 04:01:57.704845
NCT01393600|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-07-14|2017-05-11|2013-04-30|August 2011||2011-08-01|July 2017|2017-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Two-Period Cross-Over Study to Evaluate the Efficacy and Safety of NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 2|37|Actual|Neurocrine Biosciences||2|||f||||f||||||||||2017-10-11 04:01:59.405104|2017-10-11 04:01:59.405104
NCT01393587|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2012-07-17||||||July 2011|2011-07-01||||||||Interventional|||A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery|A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery|Unknown status|Not yet recruiting|N/A|||Western Galilee Hospital-Nahariya||1|||f||||||||||||||2017-10-11 04:01:59.875246|2017-10-11 04:01:59.875246
NCT01393574|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-07-12|||June 2011||2011-06-01|July 2011|2011-07-01||||June 2012|Anticipated|2012-06-01||Interventional|||Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties|Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties|Unknown status|Recruiting|Phase 4|46|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-10-11 04:01:59.957542|2017-10-11 04:01:59.957542
NCT01393561|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-27|2016-10-27|||July 2014||2014-07-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis|Multicenter Clinical Trial, Phase III, Randomized, Double-blind, Placebo Controlled, Comparative for Evaluate the Efficacy and Safety of Fixed Dose Combination of Brompheniramine Maleate + Phenylephrine Chlorhydrate for the Treatment of Nasal Congestion and Runny Nose Present in Acute Crisis of Viral Rhinitis (Common Cold) and Allergic Reactions, in Patients Over 12 Years Old|Completed||Phase 3|167|Actual|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f||||||||||2017-10-11 04:02:00.050772|2017-10-11 04:02:00.050772
NCT01393548|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-27|2017-01-12|||August 2014||2014-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2016|Actual|2016-11-01||Interventional|||Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis|Multicenter, Phase III, Randomized, Open, Parallel, Comparative to Evaluate the Efficacy and Safety of the Treatment of Nasal Congestion and Runny Nose Present in Acute Crisis of Viral Rhinitis and Allergic Reactions, in Pediatric Patients|Completed||Phase 3|879|Actual|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f||||||||||2017-10-11 04:02:00.132467|2017-10-11 04:02:00.132467
NCT01393535|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-11|||July 2011||2011-07-01|July 2011|2011-07-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Observational|||Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery|Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery|Unknown status|Not yet recruiting|N/A|800|Anticipated|Xijing Hospital|||1||f||||t||||||||||2017-10-11 04:02:00.237031|2017-10-11 04:02:00.237031
NCT01393509|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-09|2017-06-14|||July 2011|Actual|2011-07-01|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies|The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies|Active, not recruiting||Phase 1|47|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:02:00.425338|2017-10-11 04:02:00.425338
NCT01393496|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-05-10|||July 2011||2011-07-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|ETTNO||Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants|Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants (ETTNO)- a Blinded Randomized Controlled Multicenter Trial|Active, not recruiting||Phase 4|920|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-11 04:02:00.511563|2017-10-11 04:02:00.511563
NCT01393483|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-08-31|||March 2011|Actual|2011-03-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)|A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)|Recruiting||N/A|400|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||Samples Without DNA|"     tissue and serum   "|||2017-10-11 04:02:00.653473|2017-10-11 04:02:00.653473
NCT01393470|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-05-14|||May 2011||2011-05-01|May 2014|2014-05-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Observational|||Evaluation of Long-term HPV Vaccine Efficacy|A Long-term Follow-up Registry-based Cohort Study of HPV Vaccine Efficacy Against Cervical Pre-cancerous Lesions and Cervical Cancers in a Cohort of Females Previously Enrolled From Finland in Study HPV-008, as Compared to a Non-intervention Population -Based Reference Cohort of Females From Finland|Enrolling by invitation||N/A|10000|Anticipated|University of Tampere|||3||f||||f||||||Samples With DNA|"     Cytological cervical (liquid based and/or conventional) samples. Colposcopy directed cervical     biopsy samples fixed in formalin.   "|||2017-10-11 04:02:00.785818|2017-10-11 04:02:00.785818
NCT01393457|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-05-03|||June 2011||2011-06-01|May 2017|2017-05-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Cognitive Remediation for Cocaine Dependence|Cognitive-enhancing DA Medications for Cocaine Dependence|Completed||Phase 2|200|Anticipated|The University of Texas Health Science Center, Houston||4|||f||||t||||||||||2017-10-11 04:02:01.022803|2017-10-11 04:02:01.022803
NCT01393444|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-10-18|2016-08-17||May 2011||2011-05-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All individuals were English speaking, with a disability of at least one hand/arm, but no other health issues which would interfere with or be made worse by study participation.|ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis|Acute Electrocorticography (ECoG) Direct Brain Interface for Individuals With Upper Limb Paralysis|Completed||N/A|6|Actual|University of Pittsburgh||1|||f||||t||||||||Yes|Study sponsors, as well as the FDA, will have access to research data and documents in order to monitor the integrity of the study.|2017-10-11 04:02:01.150942|2017-10-11 04:02:01.150942
NCT01393431|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-08-03|||August 2007||2007-08-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Futility of Exhaled Breath Condensate pH Measurements in Ventilated Patients in Intensive Care Unit (ICU)|Exhaled Breath Condensate pH in Mechanically Ventilated Patients|Terminated||N/A|34|Actual|Universidad Nacional de Rosario|||1|"IRB recommended to stop the trial becasue none of the 4 procedures showed a predictive value   for VAP, duration of MV or mortality."|f||||t||||||||||2017-10-11 04:02:01.382076|2017-10-11 04:02:01.382076
NCT01393418|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-12-14|||November 2010||2010-11-01|December 2016|2016-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|EPO||Evaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery|EPO: A Renal Biomarker After Cardiac Surgery|Completed||N/A|80|Actual|University of Michigan|||1||f||||f||||||Samples Without DNA|"     Blood   "|No||2017-10-11 04:02:01.477443|2017-10-11 04:02:01.477443
NCT01393405|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-04-24|||February 2012|Actual|2012-02-01|April 2017|2017-04-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|Merit-UC||Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis|Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis (MEthotrexate Response In Treatment of UC - MERIT-UC)|Completed||Phase 2|179|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 04:02:01.614973|2017-10-11 04:02:01.614973
NCT01393392|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-05-05|||October 2011||2011-10-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Developing a Smoking Cessation Intervention for Methadone Maintained Smokers|Developing a Smoking Cessation Intervention for Methadone Maintained Smokers|Completed||Phase 1|91|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-11 04:02:01.814425|2017-10-11 04:02:01.814425
NCT01393379|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2015-06-19|||April 2010||2010-04-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Observational|||ELVR in PH Patients With Severe Emphysema|Effect of Endoscopic Lung Volume Reduction (ELVR) on Pulmonary Hypertension (PH) in Patients With Severe Emphysema and Pulmonary Hypertension|Completed||N/A|10|Actual|Heidelberg University|||1||f||||f||||||||||2017-10-11 04:02:01.964413|2017-10-11 04:02:01.964413
NCT01393366|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2017-02-21|||September 2011||2011-09-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|FORTIS||Facing Obstacles to RDI (Relative Dose Intensity) Through Telephone Intervention Strategy|Facing Obstacles to RDI(Relative Dose Intensity)Through Telephone Intervention Strategy|Completed||N/A|60|Actual|University Hospital, Toulouse||2|||f||||f||||||||No||2017-10-11 04:02:02.694477|2017-10-11 04:02:02.694477
NCT01393353|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2014-12-12|||May 2011||2011-05-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Cognitive Training in Parkinson's Disease|A Computerized, Multidimensional and Disease Specific Training of Cognition in Patients With M. Parkinson|Completed||N/A|39|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 04:02:02.825707|2017-10-11 04:02:02.825707
NCT01393340|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-11|||December 2006||2006-12-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma|Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma|Completed||Phase 2|23|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 04:02:02.921887|2017-10-11 04:02:02.921887
NCT01393327|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-06-19|||January 2010||2010-01-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Influence of Respiratory and Exercise Therapy on Oxygen Uptake and Right Heart Function in CTEPH Patients After PEA|Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Heart Function in Chronic Thromboembolic Pulmonary Hypertension After Thromboendarterectomy|Unknown status|Recruiting|Phase 3|90|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-10-11 04:02:03.060073|2017-10-11 04:02:03.060073
NCT01393314|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-12|||November 2007||2007-11-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Trial of Telemonitoring in Adults With Heart Failure|A Randomized Controlled Trial of Telemonitoring in Older Adults With Heart Failure|Completed||N/A|105|Actual|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-10-11 04:02:03.183873|2017-10-11 04:02:03.183873
NCT01393301|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-04-25|||October 2011||2011-10-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Project Quit||Integrated Treatment for Smoking Cessation & Anxiety in People With HIV|Integrated Treatment for Smoking Cessation & Anxiety in People With HIV|Completed||N/A|72|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:02:03.278368|2017-10-11 04:02:03.278368
NCT01393288|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-11-12|||November 2013||2013-11-01|November 2013|2013-11-01|November 2015||2015-11-01|November 2014||2014-11-01||Interventional|PDNVF||Developing Individualized Strategies to Prevent Nausea and Vomiting|Developing Individualized Strategies to Prevent Nausea and Vomiting|Withdrawn||N/A|0|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-10-11 04:02:03.406687|2017-10-11 04:02:03.406687
NCT01393275|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-11-05|||February 2010||2010-02-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|November 2010|Actual|2010-11-01||Interventional|||Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes|Effects of Exercise Intervention in Patients With Type 2 Diabetes - Strength Endurance Exercise Intervention Versus Combination of Strength Endurance Exercise Intervention and Rehabilitation Exercise Intervention|Completed||N/A|68|Actual|University of Giessen||2|||f||||f||||||||||2017-10-11 04:02:03.554819|2017-10-11 04:02:03.554819
NCT01393262|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-12-07|||November 2009||2009-11-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Observational|||Orthopaedic Hand Service Data Repository|Orthopaedic Hand Service Data Repository|Enrolling by invitation||N/A|2000|Anticipated|Massachusetts General Hospital|||2||f||||t||||||||||2017-10-11 04:02:03.707873|2017-10-11 04:02:03.707873
NCT01393249|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-12-08|||July 2011||2011-07-01|December 2016|2016-12-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|AAP2008||PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL|PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL|Completed||N/A|31|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 04:02:03.796897|2017-10-11 04:02:03.796897
NCT01393236|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-12-13|||July 2011||2011-07-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Heart Rate Variability During Sleep After Fast-track Surgery||Completed||N/A|10|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-10-11 04:02:03.879825|2017-10-11 04:02:03.879825
NCT01393223|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-09-11|||April 2015||2015-04-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|April 2018|Anticipated|2018-04-01||Interventional|||Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome|A Single-Center, Double-Blind, Randomized, Dose-Ranging, Placebo Controlled Trial Comparing the Safety, Tolerability and Efficacy of LP-08 With Placebo in Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)|Recruiting||Phase 2|36|Anticipated|Lipella Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-10-11 04:02:03.951179|2017-10-11 04:02:03.951179
NCT01393210|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-03-29|||May 2011||2011-05-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Beta-glucan and Insulin Sensitivity in Obese Humans|The Influence of Beta-glucan 1.3D-1.6D, Added to the Low-calorie Diet, on Insulin Sensitivity and the Expression of Selected Proinflammatory Cytokines in Adipose Tissue and Peripheral Blood Mononuclear Cells in Obese Humans|Completed||N/A|40|Actual|Polish Academy of Sciences||2|||f||||f||||||||No||2017-10-11 04:02:04.066946|2017-10-11 04:02:04.066946
NCT01393197|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-12-17|||March 2011||2011-03-01|November 2010|2010-11-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|TACE-KMG||Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)|Clinical Trial of Transcatheter Arterial Chemoembolization (TACE)With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas|Unknown status|Recruiting|N/A|2480|Anticipated|Tianjin Medical University Cancer Institute and Hospital||4|||f||||f||||||||||2017-10-11 04:02:04.149679|2017-10-11 04:02:04.149679
NCT01393184|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-07-12|||March 2011||2011-03-01|March 2011|2011-03-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Interventional|||Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN|Prospective, Randomized, Controlled, Phase II，Multiple Centered Clinical Trial of Nimotuzumab Combined With Radiotherapy for Senile Locally Advanced SCCHN|Unknown status|Enrolling by invitation|Phase 2|92|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 04:02:04.268593|2017-10-11 04:02:04.268593
NCT01393171|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-03-24|||October 2005||2005-10-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|OARS||Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis|Prospective Randomized Trial of Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis|Active, not recruiting||N/A|100|Anticipated|Kaiser Permanente||3|||f||||f||||||||No||2017-10-11 04:02:04.366742|2017-10-11 04:02:04.366742
NCT01393145|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-09|2017-02-14|||August 2011||2011-08-01|February 2017|2017-02-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD|Multicenter, Phase III, Randomized, Open Label Study to Evaluate the Efficacy and Safety of a Fixed-dose Combination of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD).|Withdrawn||Phase 3|0|Actual|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f||||||||||2017-10-11 04:02:04.545459|2017-10-11 04:02:04.545459
NCT01393132|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-12-21|2015-12-08||March 2011||2011-03-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye|Comparative Study of Thymosin Beta 4 Eye Drops or Vehicle in the Treatment of Patients With Ocular Surface Defects Due to Severe Dry Eye|Completed||Phase 2|9|Actual|Michigan Cornea Consultants, PC||2|||f||||f||||||||||2017-10-11 04:02:04.633385|2017-10-11 04:02:04.633385
NCT01393119|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2014-04-23|||August 2011||2011-08-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Phase II, Dose Finding Study of GTx-758|Phase II, Open-label, Loading and Maintenance Dose Finding Study of GTx-758 in Men With Prostate Cancer|Terminated||Phase 2|43|Actual|GTx||4||FDA Clinical Hold|f||||f||||||||||2017-10-11 04:02:04.966945|2017-10-11 04:02:04.966945
NCT01393106|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-11-20|2015-08-28||September 2011||2011-09-01|November 2015|2015-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Intent-to-treat (ITT) Analysis Set: participants who received at least one dose of study drug.|Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma|A Phase 2 Study to Assess the Efficacy and Safety of GS-1101 (CAL-101) in Patients With Relapsed or Refractory Hodgkin Lymphoma|Completed||Phase 2|25|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|1|||f||||f||||||||||2017-10-11 04:02:05.106213|2017-10-11 04:02:05.106213
NCT01393093|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-06-09|||March 2011||2011-03-01|November 2010|2010-11-01|December 2018|Anticipated|2018-12-01|November 2016|Actual|2016-11-01||Interventional|TACE-KMG||Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas|Clinical Trial of Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas|Recruiting||N/A|2840|Anticipated|Tianjin Medical University Cancer Institute and Hospital||4|||f||||f||||||||||2017-10-11 04:02:05.632584|2017-10-11 04:02:05.632584
NCT01393080|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-02-14|||March 2011||2011-03-01|February 2013|2013-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NSCLC||Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients|The Study of Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for Patient With the Advanced Non-small Cell Lung Cancer( NSCLC)|Unknown status|Recruiting|N/A|160|Anticipated|Tianjin Medical University Cancer Institute and Hospital||2|||f||||t||||||||||2017-10-11 04:02:05.73653|2017-10-11 04:02:05.73653
NCT00094263|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2016-02-17|||September 2004||2004-09-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Long-Term Predictors of Morbidity in Older Age||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:59:46.975729|2017-10-11 04:59:46.975729
NCT01393067|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2016-08-27|||March 2011||2011-03-01|August 2016|2016-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||cSEMS vs. NEPS in Stricture of Biliary Anastomosis After Liver Transplantation|Comparison of Use of Covered, Self-expandable Metal Stents (cSEMS) and Non-expandable Plastic Stents (NEPS) in Temporary Endoscopic Treatment of Stenosis of the Bilio-biliary Anastomosis After Liver Transplantation|Completed||N/A|60|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-10-11 04:02:05.857598|2017-10-11 04:02:05.857598
NCT01393054|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-12|2011-07-12|||July 2011||2011-07-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|||Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension|Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension|Unknown status|Recruiting|Phase 3|76|Anticipated|Indonesia University||1|||f||||t||||||||||2017-10-11 04:02:05.952273|2017-10-11 04:02:05.952273
NCT01393041|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2012-08-10|||June 2011||2011-06-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|||St. Jude Medical Angio-Seal VIP Vascular Closure Device|Clinical Study of the St. Jude Medical Angio-Seal VIP Vascular Closure Device Following Diagnostic and/or Interventional Endovascular Procedures|Completed||N/A|50|Actual|St. Jude Medical||1|||f||||f||||||||||2017-10-11 04:02:06.022835|2017-10-11 04:02:06.022835
NCT01393028|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-11-11|||July 2011||2011-07-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|CRESCENT||Computed Tomography Versus Exercise Testing in Suspected Coronary Artery Disease|Computed Tomography Versus Exercise Testing in Suspected Coronary Artery Disease|Terminated||N/A|350|Actual|Erasmus Medical Center||2||Insufficient funds|f||||t||||||||||2017-10-11 04:02:06.239059|2017-10-11 04:02:06.239059
NCT01393015|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-12|||July 2011||2011-07-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Using a Closed-loop System for Oxygen Delivery (FreeO2) to Optimize Oxygentherapy in Patients With COPD Exacerbation|Using a Closed-loop System for Oxygen Delivery (FreeO2) to Optimize Oxygentherapy in Patients With Exacerbations of Chronic Obstructive Pulmonary Disease.|Unknown status|Recruiting|N/A|50|Anticipated|Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec||2|||f||||f||||||||||2017-10-11 04:02:06.359385|2017-10-11 04:02:06.359385
NCT01393002|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2013-10-17|||July 2011||2011-07-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Observational|IFI_ICU||Perception and Prevalence of Fungal Infections in Berlin - Brandenburg|Web-based Structured Survey of Retrospective Data of Invasive Mycosis in Intensive Care Patients in Berlin - Brandenburg|Completed||N/A|25|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 04:02:06.481126|2017-10-11 04:02:06.481126
NCT01392989|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-12-05|||March 2011||2011-03-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|January 2018|Anticipated|2018-01-01||Interventional|||Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders|Post Transplant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidative Therapy After Non-Myeloablative Allogeneic Transplantation in Patients With Myelodysplasia or Myeloproliferative Disorders|Active, not recruiting||Phase 2|44|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 04:02:06.581009|2017-10-11 04:02:06.581009
NCT01392976|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2014-08-13|||April 2011||2011-04-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors|A Phase I, Open-Label, Two-stage, Randomized, Crossover, Comparative Pharmacokinetic and Safety Study of Two Formulations of CO-1.01 for Injection in Patients With Advanced Solid Tumors|Completed||Phase 1|17|Actual|Clovis Oncology, Inc.||2|||f||||f||||||||||2017-10-11 04:02:06.716054|2017-10-11 04:02:06.716054
NCT01392950|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-27|||September 2010||2010-09-01|July 2011|2011-07-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|||Clinical Study of Clariti Monthly Contact Lens|Clinical Performance of the Clariti Monthly Contact Lens for Daily Wear|Completed||N/A|90|Actual|Sauflon Pharmaceuticals Ltd||2|||f||||f||||||||||2017-10-11 04:02:06.968822|2017-10-11 04:02:06.968822
NCT01392937|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-11|||March 2010||2010-03-01|July 2011|2011-07-01|March 2011|Actual|2011-03-01|April 2010|Actual|2010-04-01||Interventional|||Clinical Performance of All-in-One Light Multi-purpose for Silicone Hydrogel Contact Lenses|The Clinical Performance of the All-in-One Light Multi-purpose Care Regimen for Silicone Hydrogel Contact Lenses|Completed||N/A|257|Actual|Sauflon Pharmaceuticals Ltd||2|||f||||f||||||||||2017-10-11 04:02:07.0749|2017-10-11 04:02:07.0749
NCT01392924|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-12-02|||August 2011||2011-08-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors|An Open Label, Dose Escalation Study Evaluating the Safety and Pharmacokinetics of SAR245408 Administered Orally Daily in Patients With Solid Tumors|Completed||Phase 1|10|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 04:02:07.204422|2017-10-11 04:02:07.204422
NCT01392911|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-06-06|||June 2011||2011-06-01|June 2014|2014-06-01||||September 2014|Anticipated|2014-09-01||Interventional|HR1||Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB|A Phase IIA Dose Ranging Trial to Evaluate the Safety, Tolerability, Extended Early Bactericidal Activity and Pharmacokinetics of Higher Doses of Rifampicin in Adult Subjects With Newly Diagnosed, Uncomplicated, Smear-Positive, Pulmonary Tuberculosis|Unknown status|Active, not recruiting|Phase 2|128|Anticipated|Radboud University||9|||f||||t||||||||||2017-10-11 04:02:07.357587|2017-10-11 04:02:07.357587
NCT01392898|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2013-08-01|||February 2012||2012-02-01|July 2011|2011-07-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|ELEGANT||Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes|The Effect of Liraglutide on Insulin-associated wEight GAiN in Patients With Type 2 Diabetes Mellitus (ELEGANT Trial)|Unknown status|Active, not recruiting|N/A|50|Actual|Radboud University||2|||f||||||||||||||2017-10-11 04:02:07.555028|2017-10-11 04:02:07.555028
NCT01392066|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-04-22|||July 2011||2011-07-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Observational|||Psychosocial Adjustment of Patients and Their Partners Following Breast Cancer Diagnosis|Psychosocial Adjustment of Patients and Their Partners Following Breast Cancer Diagnosis. A Prospective Cohort Study.|Completed||N/A|1584|Actual|University of Southern Denmark|||1||f||||f||||||||||2017-10-11 04:02:35.107922|2017-10-11 04:02:35.107922
NCT01392885|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2015-07-20|||July 2011||2011-07-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|June 2014|Actual|2014-06-01||Observational|PEHP||Brain Health and Exercise in Schizophrenia|Brain Health: Effects of Exercise on Hippocampal Volume and Memory Deficits in Persons With Schizophrenia|Unknown status|Enrolling by invitation|N/A|60|Anticipated|BC Mental Health and Addictions Research Institute|||1||f||||f||||||Samples With DNA|"     No Biospecimens to be retained   "|||2017-10-11 04:02:07.696076|2017-10-11 04:02:07.696076
NCT01392872|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-07-28|||November 2009||2009-11-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CoQualSEP||Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant|Evaluation of Cognitive Disability and Quality of Life of Patients Suffering From Multiple Scleroses and Treat With Immunosuppressant|Completed||N/A|48|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 04:02:07.875753|2017-10-11 04:02:07.875753
NCT01392859|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-12|||June 2011||2011-06-01|July 2011|2011-07-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Characterization of the Role of Histamine in Children With Asthma|Characterization of the Role of Histamine in Children With Asthma|Unknown status|Recruiting|N/A|204|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||t||||||||||2017-10-11 04:02:07.993137|2017-10-11 04:02:07.993137
NCT01392846|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-12-11|||July 2011||2011-07-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||The IRIS-Resolute Integrity (IRIS-Integrity)|Evaluation of Effectiveness and Safety of Resolute Integrity DES in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study (IRIS-Integrity)|Active, not recruiting||N/A|3000|Actual|CardioVascular Research Foundation, Korea|||1||f||||t||||||||||2017-10-11 04:02:08.108177|2017-10-11 04:02:08.108177
NCT01392833|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-12|||December 1999||1999-12-01|March 2011|2011-03-01|January 2008|Actual|2008-01-01|November 2006|Actual|2006-11-01||Interventional|||Steroids and Azathioprine in Advanced IgAN|Steroids and Azathioprine in Early and Advanced IgA Nephropathy: Amendments to a Prospective Randomised Multicenter Trial|Completed||Phase 3|46|Actual|A. Manzoni Hospital||2|||f||||f||||||||||2017-10-11 04:02:08.241367|2017-10-11 04:02:08.241367
NCT01392820|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-11-14|||July 2011||2011-07-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers|A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers|Completed||Phase 1|48|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:02:08.348508|2017-10-11 04:02:08.348508
NCT01392807|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2014-10-13|||July 2011||2011-07-01|October 2014|2014-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function|An Open-label, Single-center Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function and Subjects With Normal Hepatic Function Following Administration of a Single Dose of 25mg NKTR-118|Completed||Phase 1|24|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 04:02:08.446606|2017-10-11 04:02:08.446606
NCT01392794|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-11|||April 2011||2011-04-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional Tablet|Bioequivalence Study of YM060 Orally-disintegrating Tablet and Conventional Tablet - Ingestion Without Water|Completed||Phase 1|36|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 04:02:08.556129|2017-10-11 04:02:08.556129
NCT01392781|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-12|||April 2011||2011-04-01|July 2011|2011-07-01|January 2012|Anticipated|2012-01-01|October 2011|Anticipated|2011-10-01||Observational|||Markers and Calculation of Cardiovascular Risk in the Distinct Phenotypes of Polycystic Ovary Syndrome||Unknown status|Recruiting|N/A|300|Anticipated|Aristotle University Of Thessaloniki|||4||f||||t||||||Samples Without DNA|"     blood serum   "|||2017-10-11 04:02:08.629632|2017-10-11 04:02:08.629632
NCT01392768|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-10-27|||January 2013||2013-01-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|Mozart||Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization|A Double-blind, Phase III, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Levetiracetam as Adjunctive Therapy, in Partial Seizures Control Associated With Refractory Focal Epilepsy|Completed||Phase 3|126|Actual|Ache Laboratorios Farmaceuticos S.A.||2|||f||||f||||||||||2017-10-11 04:02:08.704431|2017-10-11 04:02:08.704431
NCT01392755|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Volunteers|A Study to Evaluate the Effects of Two Different Meal Types, Omeprazole and Ranitidine on Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Subjects|Completed||Phase 1|32|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:02:08.791965|2017-10-11 04:02:08.791965
NCT01392742|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-03-10|2015-11-09||May 31, 2011|Actual|2011-05-31|March 2017|2017-03-01|July 31, 2014|Actual|2014-07-31|July 31, 2014|Actual|2014-07-31||Observational||Intent-to-treat (ITT) population included all screened participants.|An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin|Prospective Observational Study on Predictors of Early On-treatment Response and Sustained Virological Response in HCV-infected Patients Receiving Peginterferon Alfa-2a Plus Ribavirin|Completed||N/A|443|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:02:08.906952|2017-10-11 04:02:08.906952
NCT01392729|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-11-01|||September 2010||2010-09-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)|An Open Label, Prospective, Observational, Local, Non-interventional Study of BeVacizumab (Avastin) and IntErpherone (IFN) Alpha 2a in Patients With Metastatic and Locally Advanced Renal Cell CAncer (VERA Study)|Completed||N/A|40|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:02:09.503074|2017-10-11 04:02:09.503074
NCT01392716|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-11-01|||October 1997||1997-10-01|November 2016|2016-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma|An Open-label Study of MabThera on Objective Overall Tumor Response in Treatment-naïve Patients With Non-bulky Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|48|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:02:09.570479|2017-10-11 04:02:09.570479
NCT01392703|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-01-04|2012-11-05||July 2011||2011-07-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations|Open-label, Randomized, 3-period, 3-treatment Crossover, Bioequivalence Study Comparing Dasatinib (BMS-354825) Liquid Formulation and the Dispersed Tablet Formulation Relative to the Reference Tablet Formulation in Health Subjects|Completed||Phase 1|141|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 04:02:09.732168|2017-10-11 04:02:09.732168
NCT01392690|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-27|||March 2000||2000-03-01|July 2011|2011-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|TrucsDeDom||Evaluation of a Primary Prevention Program for Anxiety Disorders Using Story Books|Evaluation of a Primary Prevention Program for Anxiety Disorders Using Story Books|Completed||N/A|73|Actual|Universite du Quebec en Outaouais||2|||f||||f||||||||||2017-10-11 04:02:11.912483|2017-10-11 04:02:11.912483
NCT01392677|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2014-02-11|2013-11-05||October 2011||2011-10-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Interventional||Full Analysis Set defined as all randomized participants (as randomized) who received at least one dose of study medication during the 24-week short-term double blind treatment period who have a non-missing baseline value and at least one post-baseline value for at least one efficacy variable to be analyzed at week 24.|Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea|A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, International Phase III Study With a 28-week Extension Period to Evaluate the Safety and Efficacy of Dapagliflozin 10mg Once Daily in Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on a Background Combination of Metformin and Sulfonylurea|Completed||Phase 3|311|Actual|AstraZeneca|For participants who did not complete 8 and/or 24 weeks, respectively, last observation carried forward (LOCF) was used for analyses of secondary endpoints. All endpoints were evaluated by excluding data after rescue.|2|||f||||f||||||||||2017-10-11 04:02:12.032013|2017-10-11 04:02:12.032013
NCT01392664|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-06-06|||February 2009||2009-02-01|June 2016|2016-06-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Observational|||TVTO Versus TVTFFM for Urinary Stress Incontinence||Completed||N/A|200|Actual|Western Galilee Hospital-Nahariya|||1||f||||f||||||||||2017-10-11 04:02:12.612583|2017-10-11 04:02:12.612583
NCT01392651|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-07-02|||January 2009||2009-01-01|July 2011|2011-07-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Observational|||Tension-free-vaginal-tape-obturator (TVTO) Versus Tension-free-vaginal-tape-Secur (TVTS) for Treatment of SUI|Outcome of Treatment of Women With Urinary Stress Incontinence Treated by Tension-free-vaginal-tape-obturator (TVTO) Compared to Tension-free-vaginal-tape-Secur (TVTS)|Completed||N/A|200|Actual|Western Galilee Hospital-Nahariya|||1||f||||f||||||||||2017-10-11 04:02:12.680081|2017-10-11 04:02:12.680081
NCT01392638|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-25|2012-10-29|||July 2010||2010-07-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Sildenafil in Resistant Hypertensives and Genetic Polymorphism|Influence of the Nitric Oxide Synthase T-786C Polymorphism on the Response to Acute Inhibition of Phosphodiesterase 5 in Resistant Hypertension|Completed||N/A|120|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-10-11 04:02:12.863719|2017-10-11 04:02:12.863719
NCT01392612|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2011-07-13|||November 2006||2006-11-01|July 2011|2011-07-01|July 2007|Actual|2007-07-01|February 2007|Actual|2007-02-01||Interventional|||Erythropoietin and Platelet Activation Markers|The Effect of Erythropoietin on Platelet Activation Markers: a Prospective Study in Healthy Volunteers|Completed||Phase 4|12|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 04:02:13.10361|2017-10-11 04:02:13.10361
NCT01392599|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-11|||January 2009||2009-01-01|June 2011|2011-06-01|October 2013|Anticipated|2013-10-01|January 2013|Anticipated|2013-01-01||Interventional|||Surgical Treatment Of Complex Regional Pain Syndrome Type II (CRPS II)|Surgical Treatment of Complex Regional Pain Syndrome Type II (CRPS II) by Regional Subcutaneous Venous Sympathectomy|Unknown status|Recruiting|Phase 3|20|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-10-11 04:02:13.186103|2017-10-11 04:02:13.186103
NCT01392586|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-02-02|||February 2012||2012-02-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|SUBMIT||Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer|Systemic Therapy With or Without Up Front Surgery of the Primary Tumor in Breast Cancer Patients With Distant Metastases at Initial presenTation|Terminated||Phase 3|10|Actual|Jeroen Bosch Ziekenhuis||2||due to low accrual rate|f||||t||||||||||2017-10-11 04:02:13.29868|2017-10-11 04:02:13.29868
NCT01392573|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-04-26|2016-11-23|2012-12-19|November 28, 2011|Actual|2011-11-28|April 2017|2017-04-01|October 4, 2012|Actual|2012-10-04|October 1, 2012|Actual|2012-10-01||Interventional|DUAL™ II|Full analysis set (FAS) included all randomised subjects except 15 subjects (8 in IDegLira arm and 7 in IDeg arm) that were excluded due to site closure.|A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes|A 26-week Randomised, Parallel Two-arm, Double-blind, Multi-centre, Multinational, Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide With Insulin Degludec in Subjects With Type 2 Diabetes|Completed||Phase 3|413|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 04:02:13.491456|2017-10-11 04:02:13.491456
NCT01392560|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2014-05-16|2014-05-16||June 2011||2011-06-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Treated Set|Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration|An Open-label 8-week Adjunctive-to-insulin and Renal Mechanistic Pilot Trial of BI 10773 in Type 1 Diabetes Mellitus (the ATIRMA Trial)|Completed||Phase 2|52|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 04:02:14.231525|2017-10-11 04:02:14.231525
NCT01389349|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2012-05-17|||July 2011||2011-07-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Acupuncture for Tonsillectomy Pain|Acupuncture for Tonsillectomy Pain|Completed||N/A|130|Anticipated|Children's ENT of San Diego, Inc.||2|||f||||f||||||||||2017-10-11 04:03:33.674774|2017-10-11 04:03:33.674774
NCT01392547|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-03-29|2013-09-27|2012-09-20|July 2011||2011-07-01|February 2015|2015-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|adept™2||Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors|Efficacy and Safety of NNC 0078-0000-0007 in Treatment of Acute Bleeding Episodes in Patients With Congenital Haemophilia and Inhibitors|Completed||Phase 3|72|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 04:02:14.505139|2017-10-11 04:02:14.505139
NCT01392534|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2012-07-03|||July 2010||2010-07-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|POTASSIUM||Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting|Evaluation of the Real-life Efficacy and Safety of a Fixed-dose Telmisartan/Hydrochlorothiazide, Including Its Effect on Plasma Potassium and on Glucose and Lipid Metabolism Parameters in Patients With Essential Arterial Hypertension|Completed||N/A|1586|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:02:15.042495|2017-10-11 04:02:15.042495
NCT01392521|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-04-16|||July 2011||2011-07-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|||Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced Cancer|Phase Ib Trial of the Combination of PI3K Inhibitor BAY 80-6946 and Allosteric-MEK Inhibitor BAY 86-9766 in Subjects With Advanced Cancer|Completed||Phase 1|64|Actual|Bayer||1|||f||||f||||||||||2017-10-11 04:02:15.139315|2017-10-11 04:02:15.139315
NCT01392508|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-04-13|||March 2011||2011-03-01|April 2017|2017-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|IMPRESSED||IMproved PREdiction of Severe Sepsis in the Emergency Department|Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.|Completed||N/A|759|Actual|Axis Shield Diagnostics Ltd|||1||f||||f||||||Samples With DNA|"     Plasma (LiHep and citrate)   "|||2017-10-11 04:02:15.271499|2017-10-11 04:02:15.271499
NCT01392495|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-07-13|2015-03-24||June 2011||2011-06-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)|An Open-label Extension Study to CQTI571A2102 to Evaluate the Long-term Safety, Tolerability and Efficacy of QTI571 (Imatinib) in the Treatment of Severe Pulmonary Arterial Hypertension|Terminated||Phase 3|17|Actual|Novartis||1||"Novartis discontinued the development of imatinib in PAH due to requirement of regulatory   authorities for additional data to secure marketing approval in PAH."|f||||t||||||||||2017-10-11 04:02:15.384812|2017-10-11 04:02:15.384812
NCT01392482|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-09-14|||July 2011||2011-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|IBIS||IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder|IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder|Completed||N/A|751725|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:02:15.99742|2017-10-11 04:02:15.99742
NCT01392469|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-02-20|||April 20, 2011||2011-04-20|February 2017|2017-02-01|December 24, 2012|Actual|2012-12-24|December 24, 2012|Actual|2012-12-24||Interventional|||Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients|A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients|Terminated||Phase 3|21|Actual|Novartis||1||"Termination due to not achieving the recruitment target because of change in the development   program for QTI571 in PAH."|f|||||f|f||||||||2017-10-11 04:02:16.129187|2017-10-11 04:02:16.129187
NCT01392456|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-02-02|||June 2004||2004-06-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|September 2010|Actual|2010-09-01||Interventional|ROM-OHIP-ED||Validation and Cross-Cultural Adaptation of the Romanian Version of Oral Health Impact Profile in Edentulous Adults|Patient Satisfaction With the Use of Three Different Systems as Retention for Implant Supported Mandibular Overdentures.|Completed||N/A|69|Actual|Concordia Dent Srl||3|||f||||f||||||||||2017-10-11 04:02:16.237177|2017-10-11 04:02:16.237177
NCT01392430|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2012-05-16|||June 2009||2009-06-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients|Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients Who Had CD4+ Cell Count <200 Cells/mm3 But Undetectable Plasma HIV-1 RNA|Completed||N/A|74|Actual|Chiang Mai University||2|||f||||f||||||||||2017-10-11 04:02:16.460273|2017-10-11 04:02:16.460273
NCT01392417|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-07-02|||February 2009||2009-02-01|July 2011|2011-07-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Observational|||Anterior Prolift Versus Posterior Prolift for Pelvic Floor Prolapse||Completed||N/A|140|Actual|Western Galilee Hospital-Nahariya|||1||f||||f||||||||||2017-10-11 04:02:16.576428|2017-10-11 04:02:16.576428
NCT01392391|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-10-28|||July 2011||2011-07-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|JAMMS||Exercise For Sub-acute Stroke Patients in Jamaica|Jamaica and Maryland Mobility in Stroke|Recruiting||Phase 2|150|Anticipated|Baltimore VA Medical Center||2|||f||||t||||||||||2017-10-11 04:02:16.677159|2017-10-11 04:02:16.677159
NCT01392378|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2014-01-10|2014-01-10||August 2011||2011-08-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®|A Phase 4, Randomized, Open-Label Trial To Assess The Impact Of Prophylactic Antipyretic Medication On The Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine Given With Routine Pediatric Vaccinations In Healthy Infants|Completed||Phase 4|908|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 04:02:17.371037|2017-10-11 04:02:17.371037
NCT01386021|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-12-20|||June 2011||2011-06-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Observational|||Saphenous Vein Allografts for Coronary Bypass|Single Center Evaluation of CryoVein Saphenous Vein Allografts for Coronary Artery Bypass Grafting|Completed||N/A|1|Actual|CryoLife, Inc.|||1||f||||f||||||||||2017-10-11 04:04:26.235476|2017-10-11 04:04:26.235476
NCT01392365|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-06-12|||July 2011||2011-07-01|June 2016|2016-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease|Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease|Completed||N/A|117|Actual|Asan Medical Center|||2||f||||f||||||||No||2017-10-11 04:02:24.975809|2017-10-11 04:02:24.975809
NCT01392352|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-01-04|||April 2011||2011-04-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2014|Actual|2014-09-01||Interventional|HYPAZ||HYPAZ: Hypertension Induced by Pazopanib|HYPAZ: An Open-label Investigation Into Hypertension Induced by Pazopanib Therapy|Terminated||Phase 2|31|Actual|Cambridge University Hospitals NHS Foundation Trust||1||Following DMC review, due to slow recruitment of evaluable patients.|f||||t||||||||||2017-10-11 04:02:25.074462|2017-10-11 04:02:25.074462
NCT01392326|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-01-05|2015-10-20||September 2011||2011-09-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|FUTURE 1||Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)|A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Secukinumab to Demonstrate the Efficacy at 24 Weeks and to Assess the Long Term Safety, Tolerability and Efficacy up to 2 Years in Patients With Active Psoriatic Arthritis|Completed||Phase 3|606|Actual|Novartis||3|||f||||t||||||||||2017-10-11 04:02:25.390209|2017-10-11 04:02:25.390209
NCT01392313|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-11|||May 2010||2010-05-01|July 2011|2011-07-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine|Measurement of Glomerular Filtration Rate (GFR) Using Iohexol in Healthy Subjects Taking Creatinine Supplements|Withdrawn||N/A|5|Anticipated|Montefiore Medical Center||1|||f||||f||||||||||2017-10-11 04:02:28.124328|2017-10-11 04:02:28.124328
NCT01392300|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-11-29|2016-01-13|2014-03-19|September 2011||2011-09-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|March 2013|Actual|2013-03-01||Interventional|PURE|Safety evaluation set (The subset of all subjects who were exposed to investigational product in the main period)|Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke|Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Post-stroke Spasticity of the Upper Limb|Completed||Phase 3|317|Actual|Merz Pharmaceuticals GmbH||2|||f||||t||||||||||2017-10-11 04:02:28.248765|2017-10-11 04:02:28.248765
NCT01392287|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-01-30|||May 2010|Actual|2010-05-01|January 2017|2017-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Treatment Resistant Geriatric Depression in Primary Care|Treatment Resistant Geriatric Depression in Primary Care: Is NAAG (N-Acetylaspartylglutamate), Measured by Proton Magnetic Resonance Spectroscopy (1H-MRS) at 3 Tesla, a Predictor of Treatment Response?|Completed||Phase 1|12|Actual|Mclean Hospital||1|||f||||f||||||||No||2017-10-11 04:02:30.466207|2017-10-11 04:02:30.466207
NCT01392274|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-12-02|||April 2012||2012-04-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|FOCUS||pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture|pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture|Completed||N/A|121|Actual|Mauna Kea Technologies|||1||f||||f||||||||||2017-10-11 04:02:30.555979|2017-10-11 04:02:30.555979
NCT01391325|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-05-16|2014-04-01||July 2011||2011-07-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|LASSO|All subjects who received at least one dose of allopurinol.|Allopurinol Outcome Study|Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO)|Completed||Phase 4|1735|Actual|Ardea Biosciences, Inc.||1|||f||||f||||||||||2017-10-11 04:02:30.662427|2017-10-11 04:02:30.662427
NCT01391312|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2012-08-24|2012-08-24||June 2011||2011-06-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines|A Pilot Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Glabellar Lines - Establishing Patient Satisfaction|Completed||Phase 4|40|Actual|Allergan||2|||f||||f||||||||||2017-10-11 04:02:31.576975|2017-10-11 04:02:31.576975
NCT01391299|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2012-10-26|2012-10-26||June 2011||2011-06-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines|A Multi-Centre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Single Treatment Cycle Study of BOTOX® Cosmetic (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects With Forehead and Glabellar Rhytides|Completed||N/A|175|Actual|Allergan||3|||f||||f||||||||||2017-10-11 04:02:31.841388|2017-10-11 04:02:31.841388
NCT01391286|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-05-21|2013-05-21||July 2011||2011-07-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis|A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-daily Application of Bimatoprost Solution 0.03% Compared to Vehicle to Treat Chemotherapy-induced Hypotrichosis of the Eyelashes in Japanese Subjects|Completed||Phase 3|36|Actual|Allergan||2|||f||||f||||||||||2017-10-11 04:02:32.225792|2017-10-11 04:02:32.225792
NCT01391273|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-05-21|2013-05-21||July 2011||2011-07-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis|A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-Daily Application of Bimatoprost Solution 0.03% Compared to Vehicle in Increasing Overall Eyelash Prominence in Japanese Subjects With Hypotrichosis of the Eyelashes|Completed||Phase 3|173|Actual|Allergan||2|||f||||f||||||||||2017-10-11 04:02:32.70637|2017-10-11 04:02:32.70637
NCT01392261|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-07|2011-07-08|||October 2009||2009-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 04:02:33.03256|2017-10-11 04:02:33.03256
NCT01385085|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-06-28|||November 2011||2011-11-01|June 2011|2011-06-01||||||||Observational|||Impact of Work Environment Absent of Natural Light on Vitamin D Levels|Impact of Work Environment Absent of Natural Light on Vitamin D Levels|Unknown status|Not yet recruiting|N/A|300|Anticipated|Medical Corps, Israel Defense Force|||3||f||||f||||||||||2017-10-11 04:04:40.829973|2017-10-11 04:04:40.829973
NCT01392248|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-11-26|||July 2011||2011-07-01|November 2013|2013-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Prediction of Pain After Breast Cancer Surgery With EEG|EEG as a Predictor for Postoperative Pain and the Development of Chronic Postsurgical Pain After Breast Cancer Surgery|Terminated||N/A|4|Actual|Maastricht University Medical Center|||1|funding and recruiting problems|f||||f||||||||||2017-10-11 04:02:33.079648|2017-10-11 04:02:33.079648
NCT01392235|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2012-02-08|||June 2011||2011-06-01|July 2011|2011-07-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)|A Single-arm, Open, Multicenter, Phase II Study of Famitinib as ≥Third Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)|Unknown status|Recruiting|Phase 2|58|Anticipated|Jiangsu HengRui Medicine Co., Ltd.||1|||f||||t||||||||||2017-10-11 04:02:33.148049|2017-10-11 04:02:33.148049
NCT01392222|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-06-20|||June 2011|Actual|2011-06-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others|Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others|Completed||N/A|21|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-10-11 04:02:33.235787|2017-10-11 04:02:33.235787
NCT01392209|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-04-04|||July 2011|Actual|2011-07-01|April 2017|2017-04-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma|A PHASE I DOSE ESCALATION STUDY OF HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY WITH BEVACIZUMAB IN THE TREATMENT OF RECURRENT MALIGNANT GLIOMA|Active, not recruiting||Phase 1|15|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:02:33.356682|2017-10-11 04:02:33.356682
NCT01392196|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-01-30|||October 2011||2011-10-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|SymplicityHF||Renal Denervation in Patients With Chronic Heart Failure & Renal Impairment Clinical Trial|Renal Denervation in Patients With Chronic Heart Failure & Renal Impairment|Terminated||N/A|39|Actual|Medtronic Vascular||1||"No evidence of a physiological response; no significant safety concerns; post 24-month   follow-up; Data Monitoring Committee agreed"|f||||t||||||||||2017-10-11 04:02:33.46514|2017-10-11 04:02:33.46514
NCT01392183|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-09-11|||October 24, 2012|Actual|2012-10-24|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)|A Randomized Phase 2 Trial of Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma|Active, not recruiting||Phase 2|69|Actual|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 04:02:33.534484|2017-10-11 04:02:33.534484
NCT01392170|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2015-04-13|2015-03-31||October 2011||2011-10-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pegasys in Patients With Chronic Myeloid Leukemia (CML)|Phase II Study of Pegylated Ifná-2a (Pegasys) in Patients With Chronic Myeloid Leukemia Who Have Minimal Residual Disease While Receiving Therapy With Tyrosine Kinase Inhibitors|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center|Early termination due to slow accrual, no analysis possible.|1||Slow Accrual|f||||f||||||||||2017-10-11 04:02:33.642885|2017-10-11 04:02:33.642885
NCT01392157|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-11-26|||June 2011||2011-06-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|June 2012|Actual|2012-06-01||Interventional|||Acceptability and Continuation Rate of Implanon in a Brazilian Public Sector|Acceptability and Continuation Rate of Implanon in a Brazilian Public Sector|Completed||Phase 4|300|Actual|University of Campinas, Brazil||3|||f||||f||||||||||2017-10-11 04:02:33.791545|2017-10-11 04:02:33.791545
NCT01392144|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-04-01|||August 2011||2011-08-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Phase II Evaluation of Exhaled Nitric Oxide (NO)|Phase II Evaluation of Exhaled Nitric Oxide as a Predictive Biomarker for Radiation Pneumonitis|Completed||N/A|36|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-10-11 04:02:33.874893|2017-10-11 04:02:33.874893
NCT01392131|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2012-12-11|||July 2011||2011-07-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|December 2012|Anticipated|2012-12-01||Interventional|||Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)|Study to Evaluate Safety and Therapeutic Efficacy of a Nutritional Supplement 'Oncoxin' in Patients With Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|40|Anticipated|Clinical Research Organization, Dhaka, Bangladesh||2|||f||||t||||||||||2017-10-11 04:02:33.966297|2017-10-11 04:02:33.966297
NCT01392118|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-10|2011-07-11|||July 2011||2011-07-01|January 2011|2011-01-01|December 2012|Anticipated|2012-12-01|||||Observational|||Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change|Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change|Unknown status|Not yet recruiting|N/A|400|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||Samples Without DNA|"     ESBL strains of E. coli or K. pneumoniae from blood cultures under normal practice   "|||2017-10-11 04:02:34.650054|2017-10-11 04:02:34.650054
NCT01392105|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-11|||March 2007||2007-03-01|July 2009|2009-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|SEED-MSC||Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction|A Randomized, Open-label, Multicenter Trial for the Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction|Completed||Phase 2/Phase 3|80|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 04:02:34.738585|2017-10-11 04:02:34.738585
NCT01392092|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2017-04-20|||July 2011||2011-07-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|NAC||Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)|Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers|Recruiting||N/A|15|Anticipated|Wayne State University|||1||f||||t||||||||||2017-10-11 04:02:34.850896|2017-10-11 04:02:34.850896
NCT01392079|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-05-27|||February 2008||2008-02-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine|A Prospective, Multi-center Phase II Study of Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Stem-cell Transplantation, in Chronic Lymphocytic Leukemia Which is Associated With 17p Deletion or is Refractory to Fludarabine|Unknown status|Active, not recruiting|Phase 2|135|Actual|University of Ulm||1|||f||||t||||||||||2017-10-11 04:02:34.929034|2017-10-11 04:02:34.929034
NCT01392053|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2015-02-18|2012-05-16||September 2009||2009-09-01|February 2015|2015-02-01|July 2011|Actual|2011-07-01|September 2010|Actual|2010-09-01||Interventional|||Massage for Pain Relief During the Active Phase of Labor|Assessment of the Effects of Massage Pain Relief in Nulliparous Women During the Active Phase of Labor|Completed||Phase 4|46|Actual|University of Sao Paulo|The influence of the pain of other women in labor or under the effect of childbirth analgesia; Accompanying with no physical or emotional preparation; Brazilian culture, which associates pain with suffering.|2|||f||||t||||||||||2017-10-11 04:02:35.25188|2017-10-11 04:02:35.25188
NCT01392040|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-01-16|||November 2010||2010-11-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Observational|||Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy|Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy|Completed||N/A|100|Actual|University Of Perugia|||1||f||||t||||||||||2017-10-11 04:02:35.798182|2017-10-11 04:02:35.798182
NCT01392027|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-11-07|||April 2011||2011-04-01|November 2016|2016-11-01||||September 2021|Anticipated|2021-09-01||Interventional|SPORE-PANC||Biospecimens for Identification of Diseases of the Pancreas.|Biospecimens for the Early Detection, Prevention, Diagnosis and Treatment of Diseases of the Pancreas.|Active, not recruiting||N/A|5000|Anticipated|University of Michigan||1|||f||||t||||||||||2017-10-11 04:02:35.887662|2017-10-11 04:02:35.887662
NCT01392014|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-07-08|||December 2008||2008-12-01|August 2008|2008-08-01|October 2010|Actual|2010-10-01|March 2010|Actual|2010-03-01||Interventional|DHP+PQ||Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases|Effectiveness of Dihydroartemisinin-piperaquine With or Without Primaquine on Gametocytes Plasmodium Falciparum in Mesoendemic Area of Indonesia|Completed||Phase 4|374|Actual|Indonesia University||2|||f||||f||||||||||2017-10-11 04:02:35.97896|2017-10-11 04:02:35.97896
NCT01392001|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-11-01|||March 2011||2011-03-01|November 2016|2016-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab)|Evaluation of Glucocorticoid Sparing Effect in Patients Receiving RoActemra® for Rheumatoid Arthritis in Real Life.|Completed||N/A|322|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:02:36.086913|2017-10-11 04:02:36.086913
NCT01391988|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2014-03-06|||January 2008||2008-01-01|March 2014|2014-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|Harmonic||Trial Comparing Electric and Harmonic Scalpel in Mastectomy|Prospective Trial Comparing the Use of Conventional Electric Scalpel and Harmonic Scalpel in Mastectomy|Completed||Phase 3|97|Actual|Barretos Cancer Hospital||2|||f||||f||||||||||2017-10-11 04:02:36.960216|2017-10-11 04:02:36.960216
NCT01391975|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-11|||May 2012||2012-05-01|July 2011|2011-07-01|October 2014|Anticipated|2014-10-01|May 2014|Anticipated|2014-05-01||Interventional|SPIDA||Surveillance and Proactive Intervention for Dialysis Access|A Multi Centre Randomized Controlled Trial of the Clinical and Cost Effectiveness of Duplex Ultrasound Surveillance With Proactive Intervention Versus no Surveillance and Reactive Intervention for the Management of Stenosis in Arterio-venous Fistulae for Dialysis Vascular Access.|Unknown status|Not yet recruiting|N/A|850|Anticipated|University of Hull||2|||f||||f||||||||||2017-10-11 04:02:37.073035|2017-10-11 04:02:37.073035
NCT01391949|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-05-14|||July 2011||2011-07-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PEDAL||Pedaling Exercises for Disability and Activity Limitations|UCFit Pedaling Exercises to Limit Disability in the Outpatient Setting|Terminated||Phase 1/Phase 2|1|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 04:02:37.308659|2017-10-11 04:02:37.308659
NCT01391936|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2016-10-05|||September 2010||2010-09-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||A Trial of Plate Fixation Versus Tension Band Wire for Olecranon Fractures|A Prospective Randomised Trial of Plate Fixation Versus Tension Band Wire for Olecranon Fractures|Completed||N/A|67|Actual|Royal Infirmary of Edinburgh||2|||f||||f||||||||Yes|Peer reviewed publication - under review|2017-10-11 04:02:37.410302|2017-10-11 04:02:37.410302
NCT01391923|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-06-20|||July 2011||2011-07-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Non-Invasive Reduction of Fat in the Arms With the CoolFlex Applicator|Non-Invasive Reduction of Fat in the Arms With the CoolFlex Applicator|Completed||N/A|20|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 04:02:37.51766|2017-10-11 04:02:37.51766
NCT01391910|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-12-11|||June 2011||2011-06-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Response Shift in Sinus Surgery Outcomes|Response Shift in Sinus Surgery Outcomes|Completed||N/A|32|Actual|University of Washington|||1||f||||f||||||||||2017-10-11 04:02:37.596586|2017-10-11 04:02:37.596586
NCT01391897|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2011-07-11|||January 2011||2011-01-01|June 2011|2011-06-01|September 2012|Anticipated|2012-09-01|January 2012|Anticipated|2012-01-01||Observational|TREPS||Epigenetics of Posttraumatic Stress Disorder and Somatoform Disorders in the Course of Psychotherapy||Unknown status|Recruiting|N/A|300|Anticipated|Hannover Medical School|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 04:02:37.694534|2017-10-11 04:02:37.694534
NCT01391884|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2012-09-18|||June 2011||2011-06-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Elimination of Incretin Hormones in Patients With Severe Kidney Failure|Elimination and Biodegradation of the Incretin Hormones GLP-1 and GIP in Patients With End-stage Renal Disease|Completed||N/A|24|Actual|Rigshospitalet, Denmark|||2||f||||t||||||||||2017-10-11 04:02:37.778133|2017-10-11 04:02:37.778133
NCT01391871|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2013-08-01|||June 2011||2011-06-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Observational|HAT-TRICK-OCT||Vascular Healing of DES at 3 Months|A Randomized Prospective Multicenter Trial to Compare Vascular Healing and Vasodilation at 3 Months After Deployment of PRO-Kinetic Drug-eluting Stent and Endeavor Resolute Zotarolimus-eluting Stent in Patients With Acute Coronary Syndromes by Means of Optical Coherence Tomography and Coronary Flow Reserve|Completed||N/A|46|Actual|University of Turku|||2||f||||f||||||Samples With DNA|"     Serum, plasma   "|||2017-10-11 04:02:37.866736|2017-10-11 04:02:37.866736
NCT01391858|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-08-08|2013-12-31||December 2006||2006-12-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|November 2012|Actual|2012-11-01||Interventional|||Postoperative Pain and Morphine Consumption After Mastectomy - Lyrica|Effects of Oral Pregabalin Versus Placebo on Postoperative Pain and Morphine Consumption After Mastectomy|Completed||Phase 3|80|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 04:02:38.006726|2017-10-11 04:02:38.006726
NCT01391845|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-07-19|||July 2011||2011-07-01|May 2011|2011-05-01|June 2012|Anticipated|2012-06-01|March 2012|Anticipated|2012-03-01||Interventional|||Ulipristal Acetate on Progesterone Levels and Glycodelin-A Endometrial Pattern|Effect of Ulipristal Acetate Administration on Serum Progesterone Levels and Glycodelin-A Endometrial Pattern in Women Undergoing Controlled Ovulation Stimulation.|Unknown status|Not yet recruiting|N/A|16|Anticipated|Programa de Asistencia Reproductiva de Rosario||4|||f||||t||||||||||2017-10-11 04:02:38.462026|2017-10-11 04:02:38.462026
NCT01391832|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2017-05-19|||July 2011||2011-07-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)|Novel Treatment of Emotional Dysfunction in PTSD|Completed||N/A|106|Actual|The University of Texas at Dallas||2|||f||||t||||||||||2017-10-11 04:02:38.596906|2017-10-11 04:02:38.596906
NCT01391819|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-03-16|2017-03-16||September 2011||2011-09-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children|An Epidemiological Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children|Completed||N/A|2117|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 04:02:38.727191|2017-10-11 04:02:38.727191
NCT01391806|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-11|||January 2009||2009-01-01|January 2009|2009-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||The Impact of Preoperative Breast MRI in Patients With Breast Cancer Selected for Breast Conserving Surgery|The Impact of Preoperative Breast MRI in Newly Diagnosed Breast Cancer. A Prospective Study of Treatment Outcome in Patients Selected for Breast Conserving Surgery in a Norwegian Multidisciplinary Breast Cancer Clinic.|Completed||N/A|145|Actual|Nordlandssykehuset HF|||1||f||||f||||||||||2017-10-11 04:02:39.723887|2017-10-11 04:02:39.723887
NCT01391793|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-05-02|||September 2011||2011-09-01|May 2017|2017-05-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|STARRS||Corticosteroids for Children With Febrile Urinary Tract Infections|Corticosteroids for Children With Febrile Urinary Tract Infections|Recruiting||Phase 3|390|Anticipated|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 04:02:39.838488|2017-10-11 04:02:39.838488
NCT01391780|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-12-10|||March 1997||1997-03-01|March 2011|2011-03-01|December 1998|Actual|1998-12-01|||||Observational|||Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence|Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence. A Prospective Trial|Completed||N/A|51|Actual|UPECLIN HC FM Botucatu Unesp|||2||f||||f||||||||||2017-10-11 04:02:39.964762|2017-10-11 04:02:39.964762
NCT01391767|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2013-07-05|||July 2011||2011-07-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Observational|||Histologic Evaluation of Healing Following Tooth Extraction With Ridge Preservation Using NuOss XC and NuOss Particulate|Histologic Evaluation of Healing Following Tooth Extraction With Ridge Preservation Using NuOss XC and NuOss Particulate|Completed||N/A|22|Actual|University of Oklahoma|||2||f||||f||||||Samples Without DNA|"     Hard tissue histological evaluation   "|||2017-10-11 04:02:40.065416|2017-10-11 04:02:40.065416
NCT01391754|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-07-08|||October 2003||2003-10-01|July 2011|2011-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effectiveness Trial for Project SafeCare for Child Neglect|Effectiveness Trial for Project SafeCare for Child Neglect|Completed||N/A|2175|Actual|University of Oklahoma||4|||f||||t||||||||||2017-10-11 04:02:40.181825|2017-10-11 04:02:40.181825
NCT01391741|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-11|||April 2008||2008-04-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD)|The Effect of High-Volume Walking With Visual Cues on Gait in People With Parkinson´s Disease. A Randomized Controlled Trial|Completed||Phase 3|26|Actual|University of Iceland||2|||f||||f||||||||||2017-10-11 04:02:40.301797|2017-10-11 04:02:40.301797
NCT01391728|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2013-02-06|||March 2011||2011-03-01|June 2011|2011-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Active Lifestyle All Your Life-an Intervention Programme for Preventing Fall Injuries||Completed||N/A|138|Actual|Karolinska Institutet||2|||f||||||||||||||2017-10-11 04:02:40.415984|2017-10-11 04:02:40.415984
NCT01391715|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2012-01-16|||August 2011||2011-08-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|DRNERD||Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD|Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD: a Randomized Controlled Trial|Withdrawn||Phase 3|0|Actual|Inje University||2||patients could not be recuited within study duration|f||||f||||||||||2017-10-11 04:02:40.51977|2017-10-11 04:02:40.51977
NCT01391689|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-04-13|||February 2011||2011-02-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|September 2014|Actual|2014-09-01||Interventional|||Diindolylmethane in Treating Patients With Breast Cancer|Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast Cancer The Diindolylmethane Efficacy Study|Active, not recruiting||Phase 2/Phase 3|144|Actual|University of Arizona||2|||f||||t||||||||||2017-10-11 04:02:40.704544|2017-10-11 04:02:40.704544
NCT01391676|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-09-09|||March 2011||2011-03-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|SDOCT-TE||Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography|Imaging of Blebs After Trabeculectomy With Mitomycin C 0,02% Using the Spectral Domain Optical Coherence Tomography|Completed||N/A|30|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 04:02:40.800512|2017-10-11 04:02:40.800512
NCT00000413|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2006-12-28|||July 1998||1998-07-01|February 2003|2003-02-01|June 2002||2002-06-01|||||Interventional|||Osteoporosis Prevention in Preadolescent Girls|Osteoporosis Prevention in Preadolescent Girls|Completed||Phase 2|340||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:17:55.311722|2017-10-11 04:17:55.311722
NCT01391663|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-02-17|2012-10-29||July 2011||2011-07-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple-Dose Study of the Pharmacokinetics and Pharmacodynamics of Alogliptin 12.5 mg, 25 mg and 50 mg in Healthy Korean Subjects|Completed||Phase 1|48|Actual|Takeda||3|||f||||f||||||||||2017-10-11 04:02:40.905872|2017-10-11 04:02:40.905872
NCT01391650|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-05-22|||March 2010||2010-03-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Stability of the Knee Joint After Single and Double Bundle Anterior Cruciate Ligament Reconstruction|Rotational and Anteroposterior Stability of the Knee Joint After Single- and Double- Bundle ACL Reconstruction|Completed||N/A|60|Actual|Hospital Znojmo||1|||f||||f||||||||||2017-10-11 04:02:41.60956|2017-10-11 04:02:41.60956
NCT01391637|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-05-11|||June 2011||2011-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)|Long-Term Follow-Up Safety and Preliminary Efficacy Study of Human Central Nervous System Stem Cell (HuCNS-SC®) Transplantation in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)|Completed||Phase 1|4|Actual|StemCells, Inc.|||1||f||||f||||||||||2017-10-11 04:02:41.699367|2017-10-11 04:02:41.699367
NCT01391624|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-11|||August 2010||2010-08-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|OMEGA3CHOCO||Study on the Possible Effects of Diet Supplementation With Essential Fatty Acids in Chocolate Craving Volunteers|Study on the Possible Effects of Diet Supplementation With Essential Fatty Acids in Chocolate Craving Volunteers|Completed||Phase 2/Phase 3|30|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 04:02:41.79346|2017-10-11 04:02:41.79346
NCT01391611|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2017-02-22|2016-12-19||July 2011||2011-07-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)|A Phase II Study of Pazopanib in Patients With Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)|Terminated||Phase 2|25|Actual|Stanford University||1||Lack of efficacy - Futility endpoint reached|f||||t||||||||||2017-10-11 04:02:41.934907|2017-10-11 04:02:41.934907
NCT01391598|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2011-07-11|||January 2010||2010-01-01|December 2009|2009-12-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|||Lidocaine on Pain Relief and IL and Substance P in Fibromyalgia|Evaluation of the Effect of Intravenous Lidocaine on Pain Relief and Plasma Concentrations of Interleukins (IL-1 and IL-6) and Substance P in Patients With Fibromyalgia|Unknown status|Recruiting|Phase 3|40|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 04:02:44.314219|2017-10-11 04:02:44.314219
NCT01391585|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2014-02-10|||June 2011||2011-06-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management|Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management|Completed||N/A|135|Actual|Denver Health and Hospital Authority||1|||f||||f||||||||||2017-10-11 04:02:44.43817|2017-10-11 04:02:44.43817
NCT01391572|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2011-07-20|||April 2011||2011-04-01|March 2011|2011-03-01||||December 2013|Anticipated|2013-12-01||Interventional|||A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer|A Randomized Phase II Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Locoregionally Advanced Thoracic Esophageal Squamous Cell Carcinoma|Unknown status|Recruiting|Phase 2|300|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 04:02:44.522969|2017-10-11 04:02:44.522969
NCT01391559|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-07-05|2013-04-01||July 2011||2011-07-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease|Efficacy of Inhaling Bronchodilator Medications in Patients With Chronic Obstructive Pulmonary Disease Who Have a Low Peak Inspiratory Flow Rate|Completed||N/A|20|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 04:02:44.646996|2017-10-11 04:02:44.646996
NCT01391546|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-03-13|||June 2011||2011-06-01|March 2017|2017-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Subjects Aged From 50 Years Old|An Open-label, Randomised, Comparative, Multicentre Study of the Immunogenicity and Safety of ZOSTAVAX When Administered by Intramuscular Route or Subcutaneous Route to Subjects of 50 Years of Age and Older|Completed||Phase 3|354|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:02:46.046642|2017-10-11 04:02:46.046642
NCT01391533|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-04-12|||July 2011||2011-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|SARMET||Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors|Dose Escalation, Safety, Pharmacokinetic and Pharmacodynamic, First in Man Study, of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors|Completed||Phase 1|72|Actual|Sanofi||1|||f||||||||||||||2017-10-11 04:02:46.150286|2017-10-11 04:02:46.150286
NCT01391520|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-08|||January 2012||2012-01-01|July 2011|2011-07-01|June 2013|Anticipated|2013-06-01|March 2013|Anticipated|2013-03-01||Interventional|||Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Deferiprone in the Reduction of Morbidity and Mortality in Patients With Chronic Kidney Disease Undergoing Diagnostic or Interventional Cardiac Procedures and Receiving an Iodinated Radiocontrast Agent|Unknown status|Not yet recruiting|Phase 3|800|Anticipated|CorMedix||2|||f||||||||||||||2017-10-11 04:02:46.252355|2017-10-11 04:02:46.252355
NCT01391507|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2014-10-08|2014-08-11||October 2011||2011-10-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Intention-to-treat (ITT) population included all participants who were randomly assigned to treatment.|Pilot Study of COR-1 in Heart Failure|COR-1, an Anti-Beta1 Receptor Antibody Cyclopeptide in Heart Failure: a Phase II, Multicentre, Randomised, Double-Blind and Placebo-Controlled Study With Parallel Groups|Completed||Phase 2|36|Actual|Corimmun GmbH|Due to the decision to amend protocol to a pilot study coupled with the high study agent discontinuation rate, safety or efficacy of JNJ-54452840 could not be concluded due to the insufficient sample size and drug exposure to investigational agent.|4|||f||||t||||||||||2017-10-11 04:02:46.38716|2017-10-11 04:02:46.38716
NCT01391494|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-11|2012-04-26|||February 2011||2011-02-01|January 2011|2011-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants|A Phase I Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Adults, Children and Infants|Completed||Phase 1|288|Actual|Chinese Academy of Medical Sciences||15|||f||||t||||||||||2017-10-11 04:02:48.446056|2017-10-11 04:02:48.446056
NCT01391481|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2012-04-09|||August 2011||2011-08-01|April 2012|2012-04-01|April 2015|Anticipated|2015-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome|The Randomized Controlled Trial (RCT) on the Vaporized Perfluorocarbon (PFC) Inhalation Treatment of Acute Respiratory Distress Syndrome With the Invasive Mechanical Ventilation（IMV）|Unknown status|Recruiting|Phase 2|200|Anticipated|Chinese PLA General Hospital||2|||f||||t||||||||||2017-10-11 04:02:48.578751|2017-10-11 04:02:48.578751
NCT01391468|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2015-10-09|2015-02-02||August 2011||2011-08-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Beneficial Effect of Probiotics on Chronic Kidney Disease|Beneficial Effect of Probiotics on Chronic Kidney Disease|Completed||Phase 4|47|Actual|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 04:02:48.670714|2017-10-11 04:02:48.670714
NCT01391455|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-11|||July 2011||2011-07-01|July 2011|2011-07-01|August 2013|Anticipated|2013-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Isolation of the Spermatic Cord in Mesh Inguinal Hernia Repair|Isolation of the Spermatic Cord Following Mesh Inguinal Hernia Repair|Unknown status|Recruiting|N/A|220|Anticipated|Chatham Kent Health Alliance||2|||f||||t||||||||||2017-10-11 04:02:48.958898|2017-10-11 04:02:48.958898
NCT01391442|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2016-03-07|||July 2011||2011-07-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|STANISLASV4||- 4th Visit at 17 Years of Cohort STANISLAS - Stanislas Ancillary Study ESCIF|Family Heritability, Investigating Gene-gene and Gene-environment Interactions in the Field of Cardiovascular Diseases - 4th VISIT (at 17 Years) of the STANISLAS COHORT|Recruiting||N/A|4006|Anticipated|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-10-11 04:02:49.056652|2017-10-11 04:02:49.056652
NCT01391429|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-02-22|||October 2010||2010-10-01|February 2016|2016-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Testing a Video Decision Support Tool to Supplement Goals-of-Care Discussions|Testing a Video Decision Support Tool to Supplement Goals-of-Care Discussions With Patients and Surrogates Receiving an Inpatient Palliative Care Consult|Completed||N/A|37|Actual|Boston Medical Center||2|||f||||f||||||||||2017-10-11 04:02:49.173392|2017-10-11 04:02:49.173392
NCT01391416|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2011-07-11|||June 2010||2010-06-01|May 2010|2010-05-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Observational|||Prevalence Of Hyperhomocysteinemia In Thai Chronic Kidney Disease (CKD) Patients|Prevalence Of Hyperhomocysteinemia In Thai CKD Patients And Relationship To Cardiovascular Events: Subgroup Analysis From Thai SEEK Study|Completed||N/A|98|Actual|Bangkok Metropolitan Administration Medical College and Vajira Hospital|||2||f||||t||||||Samples Without DNA|"     serum   "|||2017-10-11 04:02:49.407353|2017-10-11 04:02:49.407353
NCT01391403|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-07-10|||September 2008||2008-09-01|July 2016|2016-07-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia|A Double-Blind, Randomized, Placebo-Controlled Trial of Artemisinin as an Add-on Therapy to Risperidone in the Treatment of Drug-Naive First-Episode Patients With Schizophrenia|Completed||Phase 3|88|Actual|Beijing HuiLongGuan Hospital||2|||f||||t||||||||||2017-10-11 04:02:49.484959|2017-10-11 04:02:49.484959
NCT01391390|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-07-10|||September 2008||2008-09-01|July 2016|2016-07-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Melatonin Treatment for Tardive Dyskinesia in Schizophrenia|The Effect of Melatonin Treatment on Tardive Dyskinesia and Oxidative Stress: A Double-Blind Placebo-Controlled Trial|Completed||N/A|120|Actual|Beijing HuiLongGuan Hospital||2|||f||||t||||||||||2017-10-11 04:02:49.578588|2017-10-11 04:02:49.578588
NCT01391377|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-05|2013-02-25|||July 2011||2011-07-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease|The Effects of Chronic High-density Lipoprotein (HDL) Elevation With Extended Release Niacin on Peripheral Arterial Disease|Terminated||N/A|7|Actual|Bayside Health||2||Tredaptive has been suspended worldwide|f||||f||||||||||2017-10-11 04:02:49.68428|2017-10-11 04:02:49.68428
NCT01391364|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-08-10|||April 2011||2011-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 04:02:49.781515|2017-10-11 04:02:49.781515
NCT01391351|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2016-07-20|||June 2011||2011-06-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|November 2015|Actual|2015-11-01||Interventional|miRSa||Search for Predictors of Therapeutic Response in Ovarian Carcinoma|Search for Predictors of Therapeutic Response in Patients With Carcinoma of the Ovary, the Fallopian Tube or Peritoneal Serous-type Advanced|Completed||N/A|107|Actual|Centre Francois Baclesse||2|||f||||f||||||||||2017-10-11 04:02:49.82235|2017-10-11 04:02:49.82235
NCT01391338|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-08|2013-03-19|||June 2011||2011-06-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|AZURE||A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)|A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group, Adaptive, Combined Proof of Concept and Dose-Finding Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP3652 in the Treatment of CP/CPPS|Completed||Phase 2|239|Actual|Astellas Pharma Inc||6|||f||||t||||||||||2017-10-11 04:02:49.932239|2017-10-11 04:02:49.932239
NCT01391260|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-08-01|||July 2011||2011-07-01|August 2011|2011-08-01|July 2017|Anticipated|2017-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)|A Phase II Trial of Radiation Therapy Combined With Iressa in Patients With Locally Advanced Non-small Cell Lung Cancer With Harboring Active EGFR Mutations|Unknown status|Recruiting|Phase 2|30|Anticipated|ZhuGuangYing||1|||f||||f||||||||||2017-10-11 04:02:50.149972|2017-10-11 04:02:50.149972
NCT01391247|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-02-05|||January 2011||2011-01-01|December 2010|2010-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation|Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation|Completed||N/A|59|Actual|Universitaire Ziekenhuizen Leuven|||3||f||||f||||||||||2017-10-11 04:02:50.270459|2017-10-11 04:02:50.270459
NCT01391234|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2017-05-04|||June 2011||2011-06-01|May 2017|2017-05-01|May 2015|Actual|2015-05-01|July 2014|Actual|2014-07-01||Interventional|||Rapid Radiation Therapy for Painful Osseous Metastatic Disease|Phase II Pilot Single Arm Prospective Clinical Trial of Rapid Institution of Helical TomoTherapy-based Radiation Therapy for Patients With Painful Osseous Metastatic Disease|Completed||N/A|28|Actual|University of Virginia||1|||f||||t||||||||No||2017-10-11 04:02:50.348428|2017-10-11 04:02:50.348428
NCT01391221|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2012-07-17|||July 2011||2011-07-01|July 2011|2011-07-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Inflammatory Markers and Cognitive Function in Major Depression|Inflammatory Markers and Cognitive Function in Major Depression:a Pilot Study|Unknown status|Recruiting|Phase 4|20|Anticipated|Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine||1|||f||||f||||||||||2017-10-11 04:02:50.437231|2017-10-11 04:02:50.437231
NCT01391208|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2012-10-10|||February 2011||2011-02-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Esophageal Protocol for Detection of Neoplasia in the Digestive Tract|A Phase I In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract|Completed||Phase 1|25|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 04:02:50.538468|2017-10-11 04:02:50.538468
NCT01391195|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-12|||January 2006||2006-01-01|December 2005|2005-12-01|October 2007|Actual|2007-10-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Low Level Laser Therapy (808nm) on Muscle Performance of Young Women Submitted to Physical Training|Effects of Low Level Laser Therapy (808nm) on Muscle Performance of Young Women Submitted to Physical Training|Completed||Phase 1|45|Actual|Universidade Federal de Sao Carlos||1|||f||||t||||||||||2017-10-11 04:02:50.783598|2017-10-11 04:02:50.783598
NCT01391182|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-02-25|||July 2011||2011-07-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)|Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)|Completed||N/A|60|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 04:02:50.876177|2017-10-11 04:02:50.876177
NCT01391169|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-08|||April 2009||2009-04-01|April 2009|2009-04-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||Pedicled Seromuscular Flap For Enforcement Of High Risk Intestinal Anastomoses|Pedicled Seromuscular Flap For Enforcement Of High Risk Intestinal Anastomoses|Completed||N/A|60|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 04:02:50.955268|2017-10-11 04:02:50.955268
NCT01391156|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-07-19|||March 2011||2011-03-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss|Efficacy of 3% Minoxidil Versus Combined 3% Minoxidil and 0.1% Finasteride for Male Pattern Hair Loss: a Randomized, Double-blinded, Comparative Study|Completed||Phase 3|40|Actual|Mae Fah Luang University Hospital||2|||f||||f||||||||||2017-10-11 04:02:51.025808|2017-10-11 04:02:51.025808
NCT01391143|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-09-07|||July 2011||2011-07-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety Study of MGA271 in Refractory Cancer|A Phase 1 Dose Escalation Study of MGA271 in Refractory Cancer|Recruiting||Phase 1|151|Anticipated|MacroGenics||1|||f||||f||||||||||2017-10-11 04:02:51.10887|2017-10-11 04:02:51.10887
NCT01391130|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-04-21||2015-01-16|August 2011||2011-08-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|September 2014|Actual|2014-09-01||Interventional|||A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma|Randomized, Multicenter, Open-label, Active-Controlled, Phase 2 Study of LY2510924 and Sunitinib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|108|Anticipated|Eli Lilly and Company||2||Study Terminated due to Insufficient Efficacy|f||||f||||||||||2017-10-11 04:02:51.245307|2017-10-11 04:02:51.245307
NCT01391117|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2012-10-25|||June 2011||2011-06-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin|A Phase Ib, Double-Blind, Randomized, Placebo-Controlled Trial in Genotype 1 HCV-Infected Subjects to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Repeated Doses of TMC649128 Given as Monotherapy and Given in Combination With Pegylated Interferon + Ribavirin|Terminated||Phase 1|14|Actual|Tibotec BVBA||10||"Antiviral activity was considered insufficient to warrant further clinical development of   TMC649128."|f||||f||||||||||2017-10-11 04:02:51.354344|2017-10-11 04:02:51.354344
NCT01391104|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2012-10-03|||April 2009||2009-04-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|RESPONS||Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension|Reproducibility and Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension|Completed||N/A|22|Actual|Laval University||2|||f||||t||||||||||2017-10-11 04:02:51.536001|2017-10-11 04:02:51.536001
NCT01391091|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-10-17|||December 2010||2010-12-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|CONFIRM||Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine|Effect of Catheter Ablation on the Prevalence, Clinical Manifestation and MRI Findings of Migraine in AF Patients With or Without a Previous History of Migraine|Completed||Phase 3|173|Actual|Texas Cardiac Arrhythmia Research Foundation||2|||f||||f||||||||||2017-10-11 04:02:51.6261|2017-10-11 04:02:51.6261
NCT01391078|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2012-11-27|||June 2011||2011-06-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Comparison of Sensimed Triggerfish With Goldmann Applanation Tonometry and Perkins Tonometry|Comparison of Sensimed Triggerfish (TF) 24 Hour IOP Monitoring With Goldmann Applanation Tonometry (GAT) and Perkins Tonometry in Glaucoma Patients|Completed||N/A|12|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-10-11 04:02:51.733545|2017-10-11 04:02:51.733545
NCT01391065|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-07|||March 2011||2011-03-01|June 2011|2011-06-01|March 2017|Anticipated|2017-03-01|March 2014|Anticipated|2014-03-01||Interventional|MR-PET Brachy||MR-PET Guided Biologically Optimised Interstitial Brachytherapy|MR-PET Guided Biologically Optimised Interstitial Brachytherapy for Postoperative Recurrent Cervical Cancers|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Tata Memorial Hospital|||||f||||t||||||||||2017-10-11 04:02:51.818201|2017-10-11 04:02:51.818201
NCT01390870|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2017-05-15|2012-02-16||May 2009||2009-05-01|May 2017|2017-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence|Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence|Completed||N/A|400|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:02:57.257725|2017-10-11 04:02:57.257725
NCT01391052|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-07|||January 2011||2011-01-01|January 2011|2011-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|Mirena IUD||Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding|Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding|Unknown status|Recruiting|Phase 4|80|Anticipated|Scott and White Hospital & Clinic||2|||f||||f||||||||||2017-10-11 04:02:51.907906|2017-10-11 04:02:51.907906
NCT01391039|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-11-26|||September 2011||2011-09-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Diagnostic Study of Early Breast Cancer Using Ultrasound|Microbubble Contrast Ultrasound and Transient Elastography Imaging of Early Breast Cancer|Terminated||N/A|12|Actual|Sunnybrook Health Sciences Centre||1||Low recruitment|f||||f||||||||||2017-10-11 04:02:52.017993|2017-10-11 04:02:52.017993
NCT01391026|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-08-31|||June 2011||2011-06-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|CASE||Computer Assisted Symptom Evaluation of Complex Patients|Computer Assisted Quality of Life and Symptom Assessment of Complex Patients|Completed||N/A|200|Actual|John H. Stroger Hospital||2|||f||||f||||||||||2017-10-11 04:02:52.108167|2017-10-11 04:02:52.108167
NCT01391013|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-05-22|2013-02-13||June 2009||2009-06-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|MONARCH||A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients|A Randomised, Controlled, Open-Label Trial to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg O.D. Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Subjects With Undetectable Plasma HIV-1 RNA on Their Current Treatments.|Completed||Phase 2|30|Actual|Janssen-Cilag S.p.A.||2|||f||||f||||||||||2017-10-11 04:02:52.213438|2017-10-11 04:02:52.213438
NCT01391000|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-04-20|2017-02-03||July 2011||2011-07-01|April 2017|2017-04-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|||Laser CO2 Versus TENS After Reconstruction of the Rotator Cuff|Light Amplification by Simulated Emission Radiation Carbon Dioxide (Laser CO2) Versus Transcutaneous Electrical Stimulation (TENS) for the Reduction of Pain in Patients After Reconstruction of the Rotator Cuff. A Randomized Controlled Trial|Completed||N/A|70|Actual|Istituto Ortopedico Rizzoli||2|||f||||f||||||||||2017-10-11 04:02:52.92068|2017-10-11 04:02:52.92068
NCT01390987|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-01-17|||June 2011||2011-06-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|TBsurvey||Access to Care and Adherence Tuberculosis (TB) Survey|Survey Nazionale Sui Determinanti Del Ritardato Accesso Alle Cure e Della Mancata Aderenza al Trattamento Antitubercolare (National Survey on the Determinats of Delayed Access to Care and Non-adherence to Tuberculosis Treatment)|Completed||N/A|137|Actual|Azienda Ospedaliera San Gerardo di Monza|||1||f||||f||||||||||2017-10-11 04:02:53.164405|2017-10-11 04:02:53.164405
NCT01390974|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-02-07|||July 2011||2011-07-01|February 2014|2014-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|GAMMA||Identification of Clopidogrel CYP2C19 Metabolizer and Thienopyridine Treatment After an Acute Coronary Syndrome|Bedside Genetic Approach to Identify Clopidogrel CYP2C19 Metabolizer and Optimize Maintenance Thienopyridine Treatment After an Acute Coronary Syndrome: The GAMMA Study|Completed||Phase 4|270|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 04:02:53.235196|2017-10-11 04:02:53.235196
NCT01390961|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-07|||August 2011||2011-08-01|July 2011|2011-07-01|January 2012|Anticipated|2012-01-01|December 2011|Anticipated|2011-12-01||Interventional|||Comparison of Tolerability Between Two Allergy Drops|Comparison of Tolerability Between Two Allergy Drops|Unknown status|Enrolling by invitation|Phase 4|48|Anticipated|Hom, Milton M., OD, FAAO||1|||f||||f||||||||||2017-10-11 04:02:53.309231|2017-10-11 04:02:53.309231
NCT01390935|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-11-28|||March 2011||2011-03-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|SUGAR||SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World|SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real WorldMulticenter, Retrospective Observation Study in Korea|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:02:55.161246|2017-10-11 04:02:55.161246
NCT01390922|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-03-26|||August 2011||2011-08-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)|Special Drug Use Investigation for Botox® (Botulinum) Spasticity|Completed||N/A|1038|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:02:55.280873|2017-10-11 04:02:55.280873
NCT01390909|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2012-10-04|2011-10-13||May 2010||2010-05-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database|Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database|Completed||N/A|12386|Actual|GlaxoSmithKline|||6||f||||f||||||||||2017-10-11 04:02:55.420374|2017-10-11 04:02:55.420374
NCT01390896|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-07-24|||September 2009||2009-09-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery|Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery|Completed||N/A|329|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:02:57.112268|2017-10-11 04:02:57.112268
NCT01390883|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-03-26|||December 2008||2008-12-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)|Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)|Completed||N/A|475|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 04:02:57.186197|2017-10-11 04:02:57.186197
NCT00000454|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-05-18||||||May 2010|2010-05-01|August 2002||2002-08-01|||||Interventional|||Smoking Cessation in Alcoholism Treatment|Field Study of Smoking Cessation in Alcoholism Treatment|Completed||Phase 4|112||Yale University|||||f||||f||||||||||2017-10-11 04:17:58.334045|2017-10-11 04:17:58.334045
NCT01390844|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-03-10|2016-05-20||October 2011||2011-10-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||All Participants Randomized|Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063)|Safety and Efficacy of Boceprevir in Combination With Peginterferon Plus Ribavirin for Treatment of Asia Pacific Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Pegylated Interferon Plus Ribavirin|Completed||Phase 3|282|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:02:57.815042|2017-10-11 04:02:57.815042
NCT01390831|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-08|||November 2011||2011-11-01|April 2011|2011-04-01|June 2015|Anticipated|2015-06-01|November 2014|Anticipated|2014-11-01||Interventional|||Renal Denervation in Patients With Uncontrolled Hypertension in Chinese|Renal Denervation in Patients With Uncontrolled Hypertension in Chinese|Unknown status|Not yet recruiting|Phase 1/Phase 2|100|Anticipated|The Second People's Hospital of Chengdu||2|||f||||t||||||||||2017-10-11 04:02:58.901438|2017-10-11 04:02:58.901438
NCT01390818|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2017-01-17|2016-05-01||May 2011||2011-05-01|January 2017|2017-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||The Safety analysis set (SAF) included subjects who received at least one (non-zero) administration of the trial IMPs (pimasertib and/or SAR245409).|Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors|An Open-Label, Phase Ib Dose Escalation Trial of Oral Combination Therapy With MSC1936369B and SAR245409 in Subjects With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|146|Actual|EMD Serono||2|||f||||t||||||||||2017-10-11 04:02:59.161353|2017-10-11 04:02:59.161353
NCT01390805|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-05-15|||November 2006||2006-11-01|May 2017|2017-05-01|March 2011|Actual|2011-03-01|April 2009|Actual|2009-04-01||Observational|||Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)|Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)|Completed||N/A|462|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:03:12.605631|2017-10-11 04:03:12.605631
NCT01390792|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-05-15|||January 2007||2007-01-01|May 2017|2017-05-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Observational|||Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)|Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)|Completed||N/A|622|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:03:12.674954|2017-10-11 04:03:12.674954
NCT01390779|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2013-12-03|2013-06-04||July 2011||2011-07-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor|Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor|Completed||N/A|33|Actual|Sensimed AG||1|||f||||f||||||||||2017-10-11 04:03:12.787652|2017-10-11 04:03:12.787652
NCT01390766|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-08-30|||August 2002||2002-08-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)|Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)|Completed||N/A|41|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:03:12.971378|2017-10-11 04:03:12.971378
NCT01390753|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-02-13|||April 2012||2012-04-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Role of Human Milk Bank in the Protection of Severe Respiratory Disease in Very Low Birth Weight Premature Infants|Preventing Respiratory Disease Hospitalizations in Premature Infants Fed Donor Human Milk|Completed||N/A|300|Actual|Fundacion Infant||4|||f||||f||||||||No||2017-10-11 04:03:13.039467|2017-10-11 04:03:13.039467
NCT01390740|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2012-06-13|||May 2011||2011-05-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|E2T3A||Observatory of Screening Aneurysms of the Abdominal Aorta During Echocardiography. National Epidemiological Survey|Observatory of Screening Aneurysms of the Abdominal Aorta During Echocardiography. National Epidemiological Survey|Completed||N/A|1412|Actual|French Cardiology Society|||1||f||||t||||||||||2017-10-11 04:03:14.596337|2017-10-11 04:03:14.596337
NCT01390727|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2016-05-06|||May 2011||2011-05-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effects of Slow Breathing on Blood Pressure and Autonomic Function|Effects of Slow Breathing on Blood Pressure and Autonomic Function in Hypertensive Patients|Completed||Phase 4|32|Actual|Fundação de Amparo à Pesquisa do Estado de São Paulo||2|||f||||f||||||||No||2017-10-11 04:03:14.703567|2017-10-11 04:03:14.703567
NCT01390714|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-03-13|||July 2011||2011-07-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects|An Open-label, Cross-over, Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects|Completed||Phase 1|30|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 04:03:14.815263|2017-10-11 04:03:14.815263
NCT01390701|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-07|||January 2008||2008-01-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|HyperTENSion||Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation|Blood Pressure Lowering Effect of Low-frequency Transcutaneous Electrical Nerve Stimulation and Felodipin|Completed||N/A|41|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-10-11 04:03:14.895206|2017-10-11 04:03:14.895206
NCT01390688|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-07|||June 2009||2009-06-01|June 2009|2009-06-01|March 2012|Anticipated|2012-03-01|December 2010|Actual|2010-12-01||Observational|||Brain-derived Neurotrophic Factor and Cogntive Function|Brain-derived Neurotrophic Factor: A Link to Obesity, Insulin Resistance and Cognitive Dysfunktion?|Unknown status|Active, not recruiting|N/A|200|Actual|Rigshospitalet, Denmark|||3||f||||t||||||Samples With DNA|"     Plasma, Serum, DNA, Muscle tissue and fat tissue   "|||2017-10-11 04:03:14.99066|2017-10-11 04:03:14.99066
NCT01390675|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-07-25|||June 2011||2011-06-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Observational|AVIATOR||Anesthesia for Catheter Aortic Valve ImplantATIOn Registry||Recruiting||N/A|5000|Anticipated|Deutsches Herzzentrum Muenchen|||1||f||||f||||||||||2017-10-11 04:03:15.091405|2017-10-11 04:03:15.091405
NCT01390662|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-03-27|||March 2011||2011-03-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|May 2012|Anticipated|2012-05-01||Interventional|D3-vit-dep||Can Vitamin D3 Supplementation Affect Treatment Outcomes in Patients With Depression|Phase 4 Study of Vitamin D3 Supplementation for Outcomes in Patients With Unipolar Depression|Unknown status|Recruiting|Phase 4|150|Anticipated|Region Syddanmark||2|||f||||t||||||||||2017-10-11 04:03:15.162311|2017-10-11 04:03:15.162311
NCT01390649|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-03-10|2015-09-16||November 2011||2011-11-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Subjects treated with Privigen|A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)|An Open-label, Prospective, Multicenter Study to Investigate the Specificity of in Vivo Antibody Binding to Red Blood Cells in Subjects With Chronic Immune Thrombocytopenic Purpura (ITP) Treated With IgPro10 (Privigen®) Who Have Shown Signs of Hemolysis|Completed||Phase 4|57|Actual|CSL Behring||1|||f||||t||||||||||2017-10-11 04:03:15.280133|2017-10-11 04:03:15.280133
NCT01390636|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-11-25|||July 2011||2011-07-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|July 2011|Actual|2011-07-01||Observational|REACT5||Type 1 Diabetes and Eating Disorder Diurnal Glucose Patterns|Characterizing Diurnal Glucose Patterns of Individuals With Type 1 Diabetes and Eating Disorders|Terminated||N/A|1|Actual|HealthPartners Institute|||1|The study was a collaboration that could not be effectively run.|f||||f||||||||||2017-10-11 04:03:15.490076|2017-10-11 04:03:15.490076
NCT01390623|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2014-07-04|||July 2011||2011-07-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women|Efficacy and Safety Study of Short Term Antibiotic During Seven Days With Ceftriaxone Intravenous the First Day Then Cefixime the Second Day Till the Seventh Day of Acute Uncomplicated Pyelonephritis in Women Between 18 and 65 Years Old|Completed||Phase 4|39|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 04:03:15.580815|2017-10-11 04:03:15.580815
NCT01390610|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-11-25|||June 2011||2011-06-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|REACT4||Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition|Observational Evaluation Using Continuous Glucose Monitoring to Determine Timing and Frequency of Self-Monitored Blood Glucose by Therapy Type in Patients With Type 2 Diabetes (REACT-4 Matrix Definition Study)|Completed||N/A|27|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-10-11 04:03:15.717726|2017-10-11 04:03:15.717726
NCT01390597|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-05-16|||June 28, 2011|Actual|2011-06-28|May 2017|2017-05-01|August 28, 2011|Actual|2011-08-28|August 28, 2011|Actual|2011-08-28||Observational|||Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms|The Molecular Mechanisms of Transformation in Peripheral T-cell and NK Lymphomas|Completed||N/A|32|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 04:03:15.853513|2017-10-11 04:03:15.853513
NCT01390584|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-07-07|||April 2, 2012|Actual|2012-04-02|July 2017|2017-07-01|January 24, 2014|Actual|2014-01-24|January 24, 2014|Actual|2014-01-24||Interventional|ACRIN-6700||Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma|Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and II Classical Hodgkin Lymphoma (HL)|Terminated||Phase 2|6|Actual|American College of Radiology Imaging Network||1||slow accrual|f||||t|f|f||||||||2017-10-11 04:03:15.938007|2017-10-11 04:03:15.938007
NCT01390571|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-04-13|||July 2011||2011-07-01|April 2016|2016-04-01||||May 2017|Anticipated|2017-05-01||Interventional|||Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma|A Cancer Research UK Phase I Trial of Olaparib (AZD2281), an Oral PARP Inhibitor, in Combination With Extended Low-Dose Oral Temozolomide in Patients With Relapsed Glioblastoma|Recruiting||Phase 1|34|Anticipated|Cancer Research UK||1|||f||||||||||||||2017-10-11 04:03:16.052145|2017-10-11 04:03:16.052145
NCT01390558|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-11-06|||June 2011||2011-06-01|June 2011|2011-06-01|June 2020|Anticipated|2020-06-01|June 2015|Anticipated|2015-06-01||Observational|||Gait Parameters of Persons With Down Syndrome With and Without Orthotics Using GaitRite|Gait Parameters of Persons With Down Syndrome With and Without Orthotics Using GaitRite|Recruiting||N/A|300|Anticipated|Oregon Health and Science University|||2||f||||t||||||||||2017-10-11 04:03:16.19344|2017-10-11 04:03:16.19344
NCT01390545|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-03-13||2016-03-13|August 2011||2011-08-01|March 2016|2016-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|VELVET||VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis|VELVET (Veltuzumab Various Doses Exploratory Trial), a Randomized, Double Blind, Placebo Controlled, Multicentre, Multinational Phase II Dose Range Finding Trial in Subjects With Moderate to Severe Rheumatoid Arthritis Insufficiently Controlled With Either Methotrexate Alone or Methotrexate Plus Anti-tumour Necrosis Factor Biological Treatment, Comparing 3 Different Subcutaneous Dosages of Anti-CD20 Monoclonal Antibody Veltuzumab to Placebo as an add-on Therapy to Methotrexate.|Terminated||Phase 2|300|Anticipated|Takeda||4||Trial re-design; no safety issues identified|f||||||||||||||2017-10-11 04:03:16.306219|2017-10-11 04:03:16.306219
NCT01390532|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2011-07-08|||August 2010||2010-08-01|July 2011|2011-07-01|October 2011|Anticipated|2011-10-01|August 2011|Anticipated|2011-08-01||Interventional|||Rest/Stress Quantification Of Left Ventricular Dyssynchrony By 3D Gated Blood Pool D-SPECT|Left Ventricular Dyssynchrony: Rest/Stress 3D Blood-Pool Gated D-SPECT Quantification With a High-Speed Dedicated Cardiac Camera Before CRT|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 04:03:16.559395|2017-10-11 04:03:16.559395
NCT01390519|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-01-12|||June 2011||2011-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|OSAT||A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor|Observational Study Evaluating Efficacy, Tolerability and Treatment Algorithm of Advanced Renal Cell Cancer Patients Under Afinitor Treatment|Completed||N/A|30|Actual|Novartis|||1||f||||||||||None Retained|"     None Retained   "|||2017-10-11 04:03:16.672001|2017-10-11 04:03:16.672001
NCT01390506|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2016-11-29|||January 2017||2017-01-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|SCPR||Selenium to Improve Neurological Outcome After Cardiac Arrest|Effect of High Dose Selenium on Inflammation and Neurological Outcome After Cardiac Arrest: A Randomized, Double Blind Placebo Controlled Phase 2a Study|Not yet recruiting||Phase 2|52|Anticipated|Medical University of Graz||2|||f||||t||||||||||2017-10-11 04:03:16.773903|2017-10-11 04:03:16.773903
NCT01390493|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-03-10|||October 2010||2010-10-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Therapeutic Effects of Neurofeedback in Anorexia Nervosa|Therapeutic Effects of Alpha-neurofeedback in the Treatment of Anorexia Nervosa|Completed||Phase 1/Phase 2|12|Actual|Medical University of Graz||1|||f||||f||||||||||2017-10-11 04:03:16.883529|2017-10-11 04:03:16.883529
NCT01383551|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2013-12-12|||June 2011||2011-06-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||"Becoming Parents: A Hospital-community Partnership"|"Becoming Parents: A Hospital-community Partnership to Enhance Transition to Parenthood"|Completed||N/A|290|Anticipated|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 04:05:01.424838|2017-10-11 04:05:01.424838
NCT01390480|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2015-04-16|||November 2010||2010-11-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes|Placebo Controlled Pilot Study on Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes on Immunological, Endocrine and Metabolic Parameters: Step 2 in the Austrian Diabetes Prevention Programme|Completed||Phase 4|31|Actual|Medical University of Graz||2|||f||||t||||||||||2017-10-11 04:03:16.977074|2017-10-11 04:03:16.977074
NCT01390467|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2012-01-26|||July 2011||2011-07-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|July 2011|Actual|2011-07-01||Interventional|ICP||Cognitive Impact of Paracetamol in Healthy Volunteers|Cognitive Impact of Paracetamol in Healthy Volunteers|Completed||Phase 1|44|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 04:03:17.096864|2017-10-11 04:03:17.096864
NCT01390454|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-03-25|||March 2012||2012-03-01|March 2015|2015-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|EPICORE||Relationships Between Ultrasound Data and the Impact of Lateral Epicondylar Pain|Study of the Relationship Between Functional Ultrasound Data and the Impact of Lateral Epicondylar Pain|Completed||N/A|40|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 04:03:17.161852|2017-10-11 04:03:17.161852
NCT01390441|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-06-08|2016-03-24||July 2011||2011-07-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)|A Two-Part, Phase I Randomized, Double-Blind, Active-Comparator Controlled, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of MK-8808 and to Compare the Pharmacokinetics of MK-8808 With EU-approved MabThera® and US-licensed Rituxan® in Patients With Rheumatoid Arthritis (RA)|Terminated||Phase 1|100|Actual|Merck Sharp & Dohme Corp.||5||The study was terminated early by the Sponsor for business reasons.|f||||f||||||||||2017-10-11 04:03:17.289042|2017-10-11 04:03:17.289042
NCT01390428|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-03-01|2016-02-03||July 2011||2011-07-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172-013)|An Open-label, 3-Part, Multiple Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172)|Completed||Phase 1|50|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:03:19.260091|2017-10-11 04:03:19.260091
NCT01390415|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-10-20|2011-08-09||September 2008||2008-09-01|October 2015|2015-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)|A Retrospective Survey to Evaluate the Renoprotective Effect of Losartan in Type II Diabetic Patients With Microalbuminuria and Hypertension in Real Life|Completed||N/A|136|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-10-11 04:03:20.234168|2017-10-11 04:03:20.234168
NCT01390402|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-01-04|2015-11-25||January 2012||2012-01-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG|Natural Killer (NK) Cells and Nonmyeloablative Stem Cell Transplantation for Chronic Myelogenous Leukemia (CML)|Completed||Phase 2|6|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:03:20.545019|2017-10-11 04:03:20.545019
NCT01390389|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2013-10-30|2013-08-26||July 2011||2011-07-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression|Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression: A 31 Phosphorus MR Spectroscopy Study|Completed||N/A|19|Actual|Mclean Hospital||2|||f||||t||||||||||2017-10-11 04:03:20.825252|2017-10-11 04:03:20.825252
NCT01390376|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-03-29|||September 2010||2010-09-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||DAAOI-1 Treatment for Treatment-resistant Schizophrenia|DAAOI-1 Treatment for Treatment-resistant Schizophrenia|Completed||Phase 2|60|Actual|China Medical University Hospital||3|||f||||f||||||||||2017-10-11 04:03:21.106522|2017-10-11 04:03:21.106522
NCT01390363|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-04-12|||May 1, 2010|Actual|2010-05-01|April 2017|2017-04-01|July 31, 2011|Actual|2011-07-31|July 31, 2011|Actual|2011-07-31||Interventional|||Study of Adolescent Immunization Recall Systems|Adolescent Immunization Recall Systems: A Randomized Controlled Trial|Completed||N/A|420|Actual|Boston Children’s Hospital||3|||f||||f||||||||||2017-10-11 04:03:21.195303|2017-10-11 04:03:21.195303
NCT01390350|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2017-02-06|||July 2011||2011-07-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|January 2018|Anticipated|2018-01-01||Interventional|ILESCH||Ilaris® Effects in Schnitzler Syndrome (ILESCH)|A Multi-center, Double-blind, Placebo-controlled Phase II Study of the Efficacy and Safety of Canakinumab in Subjects With Schnitzler Syndrome|Active, not recruiting||Phase 2|20|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 04:03:21.293934|2017-10-11 04:03:21.293934
NCT01390337|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-10-29|||October 2011||2011-10-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)|A Phase 1 Study of AC220 (ASP2689) in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 1|19|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-11 04:03:21.401526|2017-10-11 04:03:21.401526
NCT01390324|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-10-18|||December 2011||2011-12-01|October 2016|2016-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|Atenéia||Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine|A Multicenter, National, Double-blind, Randomized Study to Evaluate the Efficacy and Safety of a Fixed-dose Combination of Naratriptan 2,5 mg + Naproxen 500 mg Relative to Efficacy and Safety of Each Monotherapy for the Acute Treatment of Migraine|Withdrawn||Phase 3|0|Actual|Ache Laboratorios Farmaceuticos S.A.||3|||f||||f||||||||||2017-10-11 04:03:21.506049|2017-10-11 04:03:21.506049
NCT01390311|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-04-24|||April 2012||2012-04-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|March 2014|Actual|2014-03-01||Interventional|||Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant|A Phase I Study of the Safety and Feasibility of Azacitidine After Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome After Allogeneic Stem Cell Transplantation|Completed||Phase 1|14|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 04:03:21.590295|2017-10-11 04:03:21.590295
NCT01390285|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2011-07-06|||February 2012||2012-02-01|April 2011|2011-04-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Interventional|TENSSENS||Transcutaneous Electrical Nerve Stimulation in Relation to Central Sensitization in Osteoarthritis of the Knee|Effect of Transcutaneous Electrical Nerve Stimulation in Relation to Central Sensitization in Patients With Osteoarthritis of the Knee: a Randomized Controlled Clinical Trial.|Unknown status|Not yet recruiting|N/A|98|Anticipated|Vrije Universiteit Brussel||2|||f||||f||||||||||2017-10-11 04:03:21.767351|2017-10-11 04:03:21.767351
NCT01390272|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-02-28|||July 27, 2012|Actual|2012-07-27|February 2017|2017-02-01|October 31, 2016|Actual|2016-10-31|October 31, 2016|Actual|2016-10-31||Interventional|TDM||Titrated Disease Management for Patients With Hypertension|Randomized Trial of Titrated Disease Management for Patients With Hypertension|Completed||N/A|385|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-10-11 04:03:21.825868|2017-10-11 04:03:21.825868
NCT01390259|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2014-07-24|2014-06-27||January 2010||2010-01-01|July 2014|2014-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|MDB005||Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System|Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System|Completed||N/A|11|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 04:03:21.91627|2017-10-11 04:03:21.91627
NCT01390246|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-07-09|||July 2011||2011-07-01|May 2016|2016-05-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Bupropion for Smoking Cessation During Pregnancy|Bupropion for Smoking Cessation During Pregnancy|Completed||Phase 4|65|Actual|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-10-11 04:03:22.353189|2017-10-11 04:03:22.353189
NCT01390233|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-11|2014-05-01|2014-05-01||July 2010||2010-07-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Comparison of Pre-Induction Cervical Ripening|Comparison of Pre-Induction Cervical Ripening Using Prepidil Gel Administered Through a Urinary Balloon Catheter.|Completed||N/A|102|Actual|University of South Carolina|Limits included: patients enrolled who did not meet inclusion criteria (Bishop score too favorable, but recruited by clinician), patients who were enrolled but catheter could not be placed, patient enrolled who ultimately decided to undergo cesarean.|3|||f||||f||||||||||2017-10-11 04:03:22.457932|2017-10-11 04:03:22.457932
NCT01390220|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-09-19|||June 2011||2011-06-01|April 2017|2017-04-01||||March 2017|Actual|2017-03-01||Interventional|ARTEMIS1||Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters|A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Intranasal Midazolam (USL261) in the Outpatient Treatment of Subjects With Seizure Clusters. ARTEMIS-1: Acute Rescue Therapy in Epilepsy With Midazolam Intranasal Spray-1|Terminated||Phase 3|201|Actual|Proximagen, LLC||2|||f||||t||||||||||2017-10-11 04:03:22.814039|2017-10-11 04:03:22.814039
NCT01390207|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-08-03|||January 2010||2010-01-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|16mm||Earlier Triggering in Rec-FSH/GnRH Antagonist Cycles|Does Earlier Administration Of Human Chorionic Gonadotropin (hCG) Improve The Probability Of Pregnancy In Cycles Stimulated With Rec-FSH AND GnRH Antagonists? A Prospective Randomized Trial|Completed||Phase 2/Phase 3|100|Actual|Universitair Ziekenhuis Brussel||1|||f||||f||||||||||2017-10-11 04:03:23.270001|2017-10-11 04:03:23.270001
NCT01390194|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2015-11-12|||July 2011||2011-07-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||A Rapid 10-minute Liver MRI|A Rapid 10-minute Liver MRI|Completed||N/A|25|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 04:03:23.345417|2017-10-11 04:03:23.345417
NCT01390181|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-03-02|2017-03-02||September 2011||2011-09-01|March 2017|2017-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Losartan in Bicuspid Aortic Valve Patients|The Effect of Losartan Treatment on Matrix Metalloproteinase Levels and Outcomes in Bicuspid Aortic Valve Patients|Terminated||N/A|4|Actual|University of Michigan||1||"Due to low enrollment the decision was made to terminate study prior to final data collection   for any individual."|f||||||||||||||2017-10-11 04:03:23.420856|2017-10-11 04:03:23.420856
NCT01390168|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2013-03-04|||January 2010||2010-01-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|NOVA II||Internet-administrated Treatment of Anxiety Disorders|Tailored Internet-administrated Treatment of Anxiety Disorders - A Randomised Controlled Trial (NOVA II)|Completed||N/A|100|Actual|Umeå University||2|||f||||||||||||||2017-10-11 04:03:23.604741|2017-10-11 04:03:23.604741
NCT01390155|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2013-05-23|||July 2011||2011-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Characterization of Ischemia Related Changes in Esophageal Electrocardiography|Characterization of Ischemia Related Changes in Esophageal Electrocardiography|Completed||N/A|45|Actual|University Hospital Inselspital, Berne|||4||f||||f||||||||||2017-10-11 04:03:23.698731|2017-10-11 04:03:23.698731
NCT01390142|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2013-10-17|||July 2011||2011-07-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|RIRE-1||Remote Ischemic Preconditioning Combined to Local Ischemic Postconditioning in Acute Myocardial Infarction|Remote Ischemic Preconditioning Combined to Local Ischemic Postconditioning in Acute Myocardial Infarction (RIRE-1)|Completed||Phase 3|60|Actual|University Hospital, Angers||3|||f||||||||||||||2017-10-11 04:03:23.798478|2017-10-11 04:03:23.798478
NCT01390129|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2012-10-23|||July 2011||2011-07-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|RIP-Valve||Remote Ischemic Preconditioning in Aortic Valve Surgery|Remote Ischemic Preconditioning in Aortic Valve Surgery (RIP-Valve)|Completed||N/A|100|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-10-11 04:03:23.89305|2017-10-11 04:03:23.89305
NCT01390116|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2013-11-12|||February 2010||2010-02-01|November 2013|2013-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||The Effect of Aged Garlic Extract Supplementation on Immune System|The Effect of Aged Garlic Extract Supplementation on Immune System|Completed||N/A|120|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 04:03:23.977737|2017-10-11 04:03:23.977737
NCT01390103|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2013-04-18|||March 2011||2011-03-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Do Hip Injections Improve Short-Term Biomechanical Outcomes In Patients With Hip Pain|Do Hip Injections Improve Short-Term Biomechanical Outcomes In Patients With Hip Pain|Completed||N/A|29|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 04:03:24.063918|2017-10-11 04:03:24.063918
NCT01390090|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-11-17|||January 2011||2011-01-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Ultrasound Confirmation of Fluoroscopically Guided Piriformis Muscle Injections|Ultrasound Confirmation of Fluoroscopically Guided Piriformis Muscle Injections: Does Accuracy Improve Efficacy?|Withdrawn||N/A|0|Actual|University of Florida|||1|The Principal Investigator left the University|f||||f||||||||||2017-10-11 04:03:24.132464|2017-10-11 04:03:24.132464
NCT01390077|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-05-12|||January 2011||2011-01-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria|Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria|Active, not recruiting||Phase 2/Phase 3|8|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 04:03:24.186839|2017-10-11 04:03:24.186839
NCT01390064|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-08-30|||July 2011||2011-07-01|August 2017|2017-08-01|February 2021|Anticipated|2021-02-01|February 2020|Anticipated|2020-02-01||Interventional|||Vaccination of High Risk Breast Cancer Patients|Phase 1 Safety Study of a Carbohydrate Mimotope Based Vaccine With MONTANIDE ISA 51 VG Adjuvant|Active, not recruiting||Phase 1|24|Anticipated|University of Arkansas||3|||f||||t||||||||||2017-10-11 04:03:24.27282|2017-10-11 04:03:24.27282
NCT01390051|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-08-17|||July 2011||2011-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|IUGR||Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?|Can Treatment With Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?|Completed||Phase 4|50|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 04:03:24.35283|2017-10-11 04:03:24.35283
NCT01390038|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-03-14|2016-02-16||July 2011||2011-07-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Simpliciti IDE Trial; Replacing the Humeral Head in Total Shoulder Arthroplasty|Simpliciti IDE Trial|Completed||Phase 3|157|Actual|Tornier, Inc.||1|||f||||f||||||||||2017-10-11 04:03:24.45702|2017-10-11 04:03:24.45702
NCT01390025|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-03-30|||September 2011||2011-09-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza|Phase 1 Study of TCN-032 (Human Monoclonal Antibody Directed Against the M2 Protein of Influenza A Virus) in Healthy Adult Volunteers|Completed||Phase 1|40|Actual|Theraclone Sciences, Inc.||2|||f||||t||||||||||2017-10-11 04:03:24.691695|2017-10-11 04:03:24.691695
NCT01390012|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2014-01-14|||August 2011||2011-08-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|OVID||Oral Versus Intravenous Dexamethasone|Oral Versus Intravenous Dexamethasone in Community-Acquired Pneumonia|Completed||Phase 3|30|Actual|St. Antonius Hospital||2|||f||||f||||||||||2017-10-11 04:03:24.766875|2017-10-11 04:03:24.766875
NCT01389999|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2015-03-24|||January 2012||2012-01-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|BBQ||Validation of the French Version of the Back Belief Questionnaire|Validation of the French Version of the Back Belief Questionnaire|Terminated||N/A|131|Actual|Centre Hospitalier Universitaire de Nīmes|||1|difficult recruitment curve|f||||f||||||||||2017-10-11 04:03:24.83934|2017-10-11 04:03:24.83934
NCT01389986|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-08-29|||July 2011||2011-07-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer|Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer: a Randomized Controlled Trial|Withdrawn||Phase 2/Phase 3|0|Actual|Chiang Mai University||2|||f||||f||||||||||2017-10-11 04:03:24.914496|2017-10-11 04:03:24.914496
NCT01389973|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-07|2016-06-17|2014-08-19|2013-05-22|September 2011||2011-09-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Efficacy analysis set included all participants who received at least 1 administration of ustekinumab (full or partial).|A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid|A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Efficacy and Safety of Ustekinumab in Subjects With Primary Biliary Cirrhosis Who Had an Inadequate Response to Ursodeoxycholic Acid (UDCA)|Completed||Phase 2|20|Actual|Janssen Research & Development, LLC|Based on the efficacy results of Part 1, Part 2 of the study was not initiated and as per the study design, the study was considered completed after part 1.|5|||f||||||||||||||2017-10-11 04:03:24.998226|2017-10-11 04:03:24.998226
NCT01389947|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2012-02-08|||March 2011||2011-03-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Observational|CITRON4||Microcirculation During Extracorporeal Circulation|Study of Non Major Microcirculation During Extracorporeal Circulation : Relation Between Endothelial Dysfunction and Digestive|Completed||N/A|66|Actual|Centre Hospitalier Universitaire de Besancon|||2||f||||t||||||Samples Without DNA|"     Plasma measurments Tissular oxygen saturation using NIRS probe   "|||2017-10-11 04:03:25.494528|2017-10-11 04:03:25.494528
NCT01389934|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-02-02|||July 2011||2011-07-01|July 2011|2011-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Infusion of a Local Anaesthetic in the Surgical After Modified Radical Mastectomy With Expander|Infusion of a Local Anaesthetic in the Surgical After Modified Radical Mastectomy With Expander|Completed||Phase 4|80|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 04:03:25.563997|2017-10-11 04:03:25.563997
NCT01389921|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-03-22|||February 2011||2011-02-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|September 2011|Actual|2011-09-01||Interventional|||Study of Electroencephalogram (EEG) Measurement During Different Stimulations of the Lower Urinary Tract|Investigation of Lower Urinary Tract Afferent and Cortical Brain Activity During Lower Urinary Tract Stimulation Using Electroencephalogram Measurements|Completed||N/A|83|Actual|University of Zurich||3|||f||||f||||||||||2017-10-11 04:03:25.632243|2017-10-11 04:03:25.632243
NCT01389908|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-07|||June 2011||2011-06-01|June 2011|2011-06-01||||July 2014|Anticipated|2014-07-01||Interventional|||A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder||Unknown status|Recruiting|N/A|2|Anticipated|Shalvata Mental Health Center||1|||f||||t||||||||||2017-10-11 04:03:25.706653|2017-10-11 04:03:25.706653
NCT01389895|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-01-09|||October 2011||2011-10-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus|A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus|Terminated||Phase 1|1|Actual|Amgen||2||slow enrollment|f||||f||||||||||2017-10-11 04:03:25.790192|2017-10-11 04:03:25.790192
NCT01389882|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-01-05|2011-09-18||March 2011||2011-03-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants|Application of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants and Assessment of Its Benefits Compared to Synchronized Intermittent Mandatory Ventilation (SIMV) With Pressure Support (PS)|Completed||Phase 2|26|Actual|Seoul National University Hospital|Two patients were excluded prior to the study and five patients were interrupted the study because of a developed exclusion criterion during the protocol. Because of eliminated participants, the number of subjects analyzed was reduced.|1|||f||||t||||||||||2017-10-11 04:03:25.901562|2017-10-11 04:03:25.901562
NCT01389869|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2013-12-05|||June 2011||2011-06-01|December 2013|2013-12-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Appetite Regulation by Human Chemosignals From Tears and Plasma||Completed||N/A|22|Actual|Seoul National University Hospital||4|||f||||t||||||||||2017-10-11 04:03:26.575808|2017-10-11 04:03:26.575808
NCT01389856|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-04-09|2015-03-09||December 2011||2011-12-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|FUTURE 4|Randomized and treated patients|Persistent Pulmonary Hypertension of the Newborn|Multicenter, Double-blind, Placebo-controlled, Randomized, Prospective Study of Bosentan as Adjunctive Therapy to Inhaled Nitric Oxide in the Management of Persistent Pulmonary Hypertension of the Newborn (PPHN)|Terminated||Phase 3|23|Actual|Actelion||2||"To be compliant with the timelines as agreed with Paediatric Committee (PC) within the   Paediatric Investigational Plan"|f||||t||||||||||2017-10-11 04:03:26.703808|2017-10-11 04:03:26.703808
NCT01389843|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-04-25|||March 2011||2011-03-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|KorAHF||Registry (Prospective Cohort) for Heart Failure in Korea (KorAHF)|Registry (Prospective Cohort) for Heart Failure in Korea (KorAHF)|Active, not recruiting||N/A|5625|Actual|Seoul National University Hospital|||1||f||||t||||||||Yes|Data be shared with participating institution and NNIH|2017-10-11 04:03:27.868359|2017-10-11 04:03:27.868359
NCT01389830|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-08-01|||June 2011|Actual|2011-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer|End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer|Active, not recruiting||N/A|230|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-10-11 04:03:27.931565|2017-10-11 04:03:27.931565
NCT01389817|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2014-09-23|2014-09-23||July 2011||2011-07-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|LHON||Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)|Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)|Terminated||Phase 1/Phase 2|4|Actual|Medical College of Wisconsin||2||"Unable to record n95 pERG peak (primary measure), as LHON subjects are unable to focus on   target."|f||||f||||||||||2017-10-11 04:03:28.037141|2017-10-11 04:03:28.037141
NCT01389804|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-03|2012-04-19|||July 2010||2010-07-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Parents of Pediatric Solid Organ Transplant Recipients: Transition to Home and Chronic Illness Care|Parents of Pediatric Solid Organ Transplant Recipients: Transition to Home and Chronic Illness Care|Completed||N/A|51|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-10-11 04:03:28.323312|2017-10-11 04:03:28.323312
NCT01389791|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2012-01-06|||May 2011||2011-05-01|January 2012|2012-01-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||MgSO4 Combined With Rocuronium Priming|MgSO4 Combined With Rocuronium Priming|Unknown status|Recruiting|N/A|100|Anticipated|Seoul National University Bundang Hospital||4|||f||||t||||||||||2017-10-11 04:03:28.40207|2017-10-11 04:03:28.40207
NCT01389778|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-03-21|||June 2011||2011-06-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Polycystic Ovary Syndrome Genetics and Treatment Response|Polycystic Ovary Syndrome Genetics and Treatment Response|Active, not recruiting||N/A|200|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 04:03:28.490909|2017-10-11 04:03:28.490909
NCT01389765|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-09-12|||July 2011||2011-07-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Evaluate the Effect of Food on LY2216684|Effect of Food on the Pharmacokinetics of LY2216684 in Healthy Subjects|Completed||Phase 1|24|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 04:03:28.568088|2017-10-11 04:03:28.568088
NCT01389752|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-09-23|||July 2011||2011-07-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects|Effect of Activated Charcoal on the Pharmacokinetics of LY2216684 in Healthy Subjects|Completed||Phase 1|22|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 04:03:28.791653|2017-10-11 04:03:28.791653
NCT01389739|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-14|2015-03-31|||June 2009||2009-06-01|May 2013|2013-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Intervention to Improve Continuity of Care in Lung Cancer Patients|Evaluation of a Multi-faceted Intervention to Improve Continuity of Care for Patients With Lung Cancer|Completed||N/A|206|Actual|Laval University||2|||f||||f||||||||||2017-10-11 04:03:28.863267|2017-10-11 04:03:28.863267
NCT01389726|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-06|||January 2012||2012-01-01|July 2011|2011-07-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|COPE||Comparing Interventions To Improve The Well-Being Of Custodial Grandfamilies|Comparing Interventions To Improve The Well-Being Of Custodial Grandfamilies|Unknown status|Not yet recruiting|Phase 2/Phase 3|504|Anticipated|Kent State University||3|||f||||t||||||||||2017-10-11 04:03:28.93721|2017-10-11 04:03:28.93721
NCT01389713|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-11|||September 2008||2008-09-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|clomid||Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve|Patients With Reduced Ovarian Reserve and In Vitro Fertilization (IVF) Cycles. A Randomized Multicentric Comparison of a Protocol With High Doses of Gonadotropins and a Protocol With Clomiphene Citrate Only. Evaluation of Clinical Effectiveness and Economic Issues|Completed||N/A|289|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||||2017-10-11 04:03:29.049265|2017-10-11 04:03:29.049265
NCT01389336|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2013-05-07|||July 2011||2011-07-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|KAFA||Add-on Complex Ayurvedic Treatment in Fibromyalgia-Syndrome Compared to Standard Care Alone|Kontrollierte Klinische Nicht-randomisierte Pilotstudie Zur Komplexen Āyurveda-Therapie Beim Fibromyalgiesyndrom im Vergleich Zur Konventionellen Standardbehandlung|Completed||N/A|31|Actual|Charite University, Berlin, Germany|||2||f||||t||||||||||2017-10-11 04:03:33.747908|2017-10-11 04:03:33.747908
NCT01389700|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2014-11-25||2014-03-17|October 2011||2011-10-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients|A Randomized, Double-blind, Placebo-controlled Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of SAR279356 in Patients Hospitalized in Intensive Care Unit and on Mechanical Ventilation|Terminated||Phase 2|7|Actual|Sanofi||3||Difficulty in patient recruitment in the participating sites|f||||||||||||||2017-10-11 04:03:29.127723|2017-10-11 04:03:29.127723
NCT01389687|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2013-03-28|||July 2011||2011-07-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan|Immunogenicity and Safety of the SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan|Completed||Phase 3|74|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 04:03:29.205981|2017-10-11 04:03:29.205981
NCT01389674|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-03|2014-06-06|||April 2010||2010-04-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Hybrid Intraprocedural Imaging Based on 2 Different Imaging Methods|Hybrid Intraprocedural Imaging From 2D-Strain-echocardiography and X-ray Based Biplane Coronary Angiography for Guiding Interventional Revascularization Therapy|Withdrawn||N/A|0|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-10-11 04:03:29.28824|2017-10-11 04:03:29.28824
NCT01389661|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2017-04-25|||April 2011|Actual|2011-04-01|April 2017|2017-04-01|April 25, 2016|Actual|2016-04-25|April 25, 2016|Actual|2016-04-25||Interventional|BIOMAX||Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)|Regeneration of Maxillary Bone Cystic Cavities by Bio Implant of MSHV-H Cells Associated to a Cross-linked Serum Scaffold|Completed||Phase 1/Phase 2|11|Actual|Red de Terapia Celular||1|||f||||t||||||||||2017-10-11 04:03:29.357607|2017-10-11 04:03:29.357607
NCT01389648|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2013-09-15|||November 2011||2011-11-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Pre-operative Physiotherapy to Prevent Post-operative Complications|The Effect of Pre-operative Chest Physiotherapy on Post-operative Complications After Major Abdominal Surgery.|Completed||N/A|157|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-10-11 04:03:29.44248|2017-10-11 04:03:29.44248
NCT01389635|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-07|||March 2009||2009-03-01|July 2011|2011-07-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Observational|||Abdominoplasty Under Epidural Anesthesia|Abdominoplasty Under Epidural Anesthesia: Safer for the Patient, Easier for the Surgeon.|Completed||N/A|31|Actual|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 04:03:29.512714|2017-10-11 04:03:29.512714
NCT01389622|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-11-17|||July 2011||2011-07-01|March 2014|2014-03-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Effect of Self-administered Auricular Acupressure on Smoking Cessation—a Pilot Study|Effect of Self-administered Auricular Acupressure on Smoking Cessation—a Pilot Study|Unknown status|Recruiting|Phase 2|60|Anticipated|Queen's University||3|||f||||f||||||||||2017-10-11 04:03:29.652599|2017-10-11 04:03:29.652599
NCT01389609|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-10-05|||July 2011||2011-07-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition|Phase 1, Open-Label, Randomized, Single-Dose, 3-Way Crossover Study Assessing Bioequivalence Of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition|Completed||Phase 1|24|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 04:03:29.75392|2017-10-11 04:03:29.75392
NCT01389596|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-03-23|2017-01-31||September 2011||2011-09-01|March 2017|2017-03-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|PERIWINKLE|Safety population included all randomized participants who received at least 1 dose of study drug.|A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years|A Double-blind, Placebo-controlled, Parallel-group, Multicenter Study Of The Efficacy And Safety Of Pregabalin As Adjunctive Therapy In Children 4 -16 Years Of Age With Partial Onset Seizures|Completed||Phase 3|295|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 04:03:29.87199|2017-10-11 04:03:29.87199
NCT01389583|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2015-02-23|||October 2011||2011-10-01|September 2013|2013-09-01|October 2019|Anticipated|2019-10-01|May 2015|Anticipated|2015-05-01||Interventional|||A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients|A Phase II Study of AUY922, a Novel HSP Inhibitor, in Patients With Advanced GIST Failed to or Intolerance of Imatinib and Sunitinib Therapy|Recruiting||Phase 2|25|Anticipated|National Health Research Institutes, Taiwan||1|||f||||t||||||||||2017-10-11 04:03:31.866482|2017-10-11 04:03:31.866482
NCT01389570|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-07-15|||September 2011||2011-09-01|June 2011|2011-06-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Interventional|Acunausea||Postoperative Nausea/Vomiting and Acupressure|Postoperative Nausea/Vomiting and Acupressure Can Acupressure With Wristbands Reduce the Use of Antiemetics for the Treatment of Postoperative Nausea and Vomiting?|Unknown status|Not yet recruiting|Phase 2|2000|Anticipated|National Research Centre of Complementary and Alternative Medicine, Norway||1|||f||||f||||||||||2017-10-11 04:03:32.011145|2017-10-11 04:03:32.011145
NCT01389557|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2012-03-22|||February 2011||2011-02-01|November 2011|2011-11-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatra|Evaluation of Impact Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lempasing Village, Lampung Province, Southern Sumatra|Completed||Phase 4|77|Actual|Indonesia University||1|||f||||f||||||||||2017-10-11 04:03:32.093739|2017-10-11 04:03:32.093739
NCT01389544|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2016-11-01|||June 2011||2011-06-01|November 2016|2016-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study on the Interaction Between Danoprevir/Ritonavir and Methadone|Investigation of the Effect of Multiple Doses of Danoprevir/Ritonavir on Methadone in Subjects on Stable Methadone Maintenance Therapy (MMT)|Completed||Phase 1|18|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:03:32.167882|2017-10-11 04:03:32.167882
NCT01389531|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2014-12-30|||April 2011||2011-04-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Interventional|||Efficacy and Safety Evaluation of HCPA-1 Silicone Stent in the Treatment of Central Airway Obstructions|Evaluation of the Efficacy and Safety of the HCPA-1 Silicone Stent in the Treatment of Central Airway Obstructions|Unknown status|Recruiting|N/A|110|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||t||||||||||2017-10-11 04:03:32.252541|2017-10-11 04:03:32.252541
NCT01389518|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-15|2011-11-24|||May 2009||2009-05-01|November 2011|2011-11-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome|Evaluation of the Efficacy and Safety of Fixed Combination of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Symptomatic Common Cold and Flu Syndrome in Adults|Completed||Phase 3|146|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-10-11 04:03:32.360843|2017-10-11 04:03:32.360843
NCT01389505|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-07|||February 2011||2011-02-01|January 2011|2011-01-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy|Structural and Functional Evaluation of the Macula in Patients With Proliferative Diabetic Retinopathy Treated With Panretinal Photocoagulation and Bevacizumab (Avastin ®)|Unknown status|Recruiting|Phase 2|30|Anticipated|Instituto do Coracao||2|||f||||f||||||||||2017-10-11 04:03:32.436305|2017-10-11 04:03:32.436305
NCT01389492|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2011-07-06|||October 2010||2010-10-01|October 2009|2009-10-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|||The Effect of Meat and Food Drived Polyphenols on Oxidize LDL Level|Nutritional Study:The Effect of Meat and Food Drived Polyphenols on Oxidize LDL Level|Completed||N/A|14|Actual|Hadassah Medical Organization||4|||f||||t||||||||||2017-10-11 04:03:32.524822|2017-10-11 04:03:32.524822
NCT01389479|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2017-06-07|||January 2005||2005-01-01|May 2017|2017-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults|Active-control Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ S/F Influenza Vaccine in Healthy Adults Aged 18-64 Years of Age|Completed||Phase 3|1000|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 04:03:32.596875|2017-10-11 04:03:32.596875
NCT01389466|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-19|2014-11-20|||February 2010||2010-02-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers|Randomized Phase I/II Study to Evaluate the Safety and Immunogenicity of 'MG1109(Egg-based, Pre-pandemic Influenza(H5N1) Vaccine)' Administered Intramuscularly in Healthy Adult Volunteers|Completed||Phase 1/Phase 2|346|Actual|Green Cross Corporation||3|||f||||f||||||||||2017-10-11 04:03:32.662673|2017-10-11 04:03:32.662673
NCT01389453|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2013-02-26|||April 2011||2011-04-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||The Clinical Trial Research of Stem Cell Transplantation Treats Cerebral|Umbilical Cord Mesenchyma Stem Cell Transplantation in Patients With Cerebral Hemorrhage and Cerebral Infarction|Withdrawn||Phase 2|0|Actual|General Hospital of Chinese Armed Police Forces||2||There were not enough number of patients recruited till DEC 31th in 2012.|f||||t||||||||||2017-10-11 04:03:32.746357|2017-10-11 04:03:32.746357
NCT01389440|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2017-08-23|||May 2011||2011-05-01|August 2017|2017-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|GEMCAD1003||Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer|Phase II Study Open, Not Randomized to Evaluate the Efficacy and Safety of Neoadjuvant Treatment With Gemcitabine and Erlotinib Followed by Gemcitabine, Erlotinib and Radiotherapy in Patients With Resectable Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|24|Anticipated|Grupo Espanol Multidisciplinario del Cancer Digestivo||1|||f||||t||||||||||2017-10-11 04:03:32.82023|2017-10-11 04:03:32.82023
NCT01389427|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2017-03-08|||November 2011|Actual|2011-11-01|March 2017|2017-03-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|T³||Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL).|A Multicenter Phase IB Dose Escalation Study to Evaluate the Safety, Feasibility and Efficacy of the Torisel-Rituximab-Cyclophosphamide-Doxorubicin-Vincristine-Prednisone (T-R-CHOP), Torisel-Rituximab-Fludarabine-Cyclophosphamide (T-R-FC) and Torisel-Rituximab-Aracytine High Dose-Dexamethasone (T-R-DHA) for the Treatment of Patients in Relapsed/Refractory Mantle Cell Lymphoma|Completed||Phase 1/Phase 2|41|Actual|The Lymphoma Academic Research Organisation||4|||f||||t||||||||||2017-10-11 04:03:33.096162|2017-10-11 04:03:33.096162
NCT01389414|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2015-05-27|||May 2010||2010-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|September 2013|Actual|2013-09-01||Interventional|Vecti-BIL||Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma|Phase II, Open-label, Randomized Clinical Trial of Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX) Versus GEMOX Alone as First Line Treatment in Advanced Biliary Tract Adenocarcinoma|Completed||Phase 2|89|Actual|Fondazione del Piemonte per l'Oncologia||2|||f||||f||||||||||2017-10-11 04:03:33.231116|2017-10-11 04:03:33.231116
NCT01389401|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2013-03-05|||January 2009||2009-01-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Observational|||Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis|Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis: Final Results|Completed||N/A|36|Actual|Faculdade de Ciências Médicas da Santa Casa de São Paulo|||3||f||||f||||||Samples Without DNA|"     whole saliva   "|||2017-10-11 04:03:33.336578|2017-10-11 04:03:33.336578
NCT01389388|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-16|2015-05-06|||January 2013||2013-01-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|RORAAS||Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease|Cholesterol Plaques in Carotid and Coronary Arteries and the Effect of Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases|Completed||N/A|114|Actual|Diakonhjemmet Hospital||1|||f||||f||||||||||2017-10-11 04:03:33.425746|2017-10-11 04:03:33.425746
NCT01389375|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-06-08|||July 2011||2011-07-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ISAR-CLOSURE||Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial|Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial|Completed||Phase 4|4524|Actual|Deutsches Herzzentrum Muenchen||3|||f||||f||||||||||2017-10-11 04:03:33.507101|2017-10-11 04:03:33.507101
NCT00000455|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-06-17||||||June 2011|2011-06-01|September 2002||2002-09-01|||||Interventional|||Naltrexone for Early Problem Drinkers|Targeted Naltrexone for Early Problem Drinkers|Completed||Phase 4|160||UConn Health|||||f||||f||||||||||2017-10-11 04:17:58.391455|2017-10-11 04:17:58.391455
NCT01389323|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2015-09-19|2015-08-17||September 2011||2011-09-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional||All treated participants.|BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C|Open-Label, Single Arm Evaluation of BMS-790052 (Daclatasvir) in Combination With Peg-Interferon Alfa-2a and Ribavirin in Black-African Americans, Latinos and White-Caucasians With Chronic Hepatitis C Genotype 1 Infection|Completed||Phase 3|448|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 04:03:33.954942|2017-10-11 04:03:33.954942
NCT01389310|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2014-12-22|||July 2011||2011-07-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe|Post-marketing Safety Surveillance Program in HIV-infected Children Exposed to Atazanavir in Europe|Completed||N/A|249|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 04:03:34.784659|2017-10-11 04:03:34.784659
NCT01389297|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-02-24|||September 2011||2011-09-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery|Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery|Completed||N/A|189|Actual|Behavior Therapy Associates, LLP||3|||f||||f||||||||||2017-10-11 04:03:34.902713|2017-10-11 04:03:34.902713
NCT01389284|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2015-08-12|2012-09-14||June 2011||2011-06-01|August 2015|2015-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|VERNE||Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium|A Randomized, Double-Blind, Placebo Controlled Trial to Assess the Analgesic Efficacy and Safety of Extended Release Naproxen Sodium Tablets in Postsurgical Dental Pain|Completed||Phase 3|300|Actual|Bayer||3|||f||||f||||||||||2017-10-11 04:03:35.017991|2017-10-11 04:03:35.017991
NCT01389271|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-08-14|||February 3, 2011|Actual|2011-02-03|August 2017|2017-08-01|September 12, 2017|Anticipated|2017-09-12|September 12, 2017|Anticipated|2017-09-12||Observational|OPTION||Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years|Open-label, Uncontrolled, Prospective Long-term Observation of Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years|Active, not recruiting||N/A|118|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:03:36.0481|2017-10-11 04:03:36.0481
NCT01389258|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-08-21|||June 2011||2011-06-01|August 2017|2017-08-01|August 2016|Actual|2016-08-01|August 2014|Actual|2014-08-01||Interventional|||Study on OsseoSpeed™ TX Narrow Implants in the Upper Jaw in a Chinese Population|An Open, Prospective, Multi-center Study to Evaluate OsseoSpeed™ TX Single Implant 3 mm Diameter in the Anterior Maxilla. A 3-years Follow-up Study.|Completed||N/A|45|Actual|Dentsply Sirona Implants||1|||f||||||||||||||2017-10-11 04:03:36.13348|2017-10-11 04:03:36.13348
NCT01389245|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-08-21|||June 2011||2011-06-01|August 2017|2017-08-01|September 2017|Anticipated|2017-09-01|July 2015|Actual|2015-07-01||Interventional|||Study on OsseoSpeed™ TX Implants in the Upper Jaw in a Chinese Population|An Open, Prospective, Multi-center Study to Evaluate the OsseoSpeed™ TX Implant With an Early Loading Protocol in Patients With Tooth Loss in the Posterior Maxilla. A 3-years Follow-up Study.|Active, not recruiting||N/A|42|Actual|Dentsply Sirona Implants||1|||f||||||||||||||2017-10-11 04:03:36.210006|2017-10-11 04:03:36.210006
NCT01389219|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2011-07-07|||October 2007||2007-10-01|October 2007|2007-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Post Partum Maternal and Neonatal Intervention Package|Post Partum Maternal and Neonatal Intervention Package: A Cluster Randomized Control Trial in District Sukkur, Pakistan|Completed||N/A|1200|Actual|Aga Khan University||2|||f||||f||||||||||2017-10-11 04:03:36.389297|2017-10-11 04:03:36.389297
NCT01389206|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-06|2017-04-21|||June 1, 2011||2011-06-01|April 2017|2017-04-01|March 1, 2018|Anticipated|2018-03-01|January 1, 2018|Anticipated|2018-01-01|3 Years|Observational [Patient Registry]|PAH QuERI Ext||Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program|Pulmonary Arterial Hypertension (PAH) Quality Enhancement Research Initiative (QuERI) Extension Program|Active, not recruiting||N/A|800|Anticipated|Actelion|||1||f||||f||||||||||2017-10-11 04:03:36.483356|2017-10-11 04:03:36.483356
NCT01389193|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-12-28|||June 2013||2013-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|IBU-003||Ibudilast in the Treatment of Patients With Chronic Migraine.|Targeting Glial Inhibition to Attenuate Chronic Migraine: AN INTERNATIONAL DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF IBUDILAST|Completed||Phase 1|33|Actual|Aalborg University||2|||f||||t||||||||||2017-10-11 04:03:36.800823|2017-10-11 04:03:36.800823
NCT01389180|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2016-09-28|||December 2010||2010-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Behavioral Drug and HIV Risk Reduction Counseling With MMT in China|Behavioral Drug and HIV Risk Reduction Counseling With MMT in China|Completed||Phase 3|300|Actual|Yale University||3|||f||||f||||||||||2017-10-11 04:03:36.901149|2017-10-11 04:03:36.901149
NCT01389167|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-12-05|||September 2011||2011-09-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|September 2016|Actual|2016-09-01||Interventional|||Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia|Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia|Active, not recruiting||Phase 3|320|Anticipated|Yale University||4|||f||||t||||||||||2017-10-11 04:03:36.983071|2017-10-11 04:03:36.983071
NCT01389154|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2014-07-16|||June 2011||2011-06-01|July 2014|2014-07-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|ALOSPNDY||Pilot Study to Measure Lung Biopsy Diagnostic Yield Using Always On Electromagnetic Tip Tracked Devices|A Pilot Prospective Study Evaluating the SPiN Drive(TM)Electromagnetic Tip Tracked Devices Used in Diagnostic Bronchoscopy|Withdrawn||Phase 4|0|Actual|Veran Medical Technologies||1||Product Enhancements completed|f||||t||||||||||2017-10-11 04:03:37.069143|2017-10-11 04:03:37.069143
NCT01389141|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-21|2011-08-11|||February 2010||2010-02-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Age-related Changes in Ovarian Follicular Wave Dynamics|Ovarian Follicular Wave Dynamics During The Menstrual Cycle: Relationship To Age, Reproductive Hormones And Musculoskeletal Health|Completed||N/A|70|Actual|University of Saskatchewan|||3||f||||f||||||Samples Without DNA|"     Serum samples are isolated and frozen for retrospective analyses.   "|||2017-10-11 04:03:37.148943|2017-10-11 04:03:37.148943
NCT01389115|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2015-12-10|||July 2001||2001-07-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|May 2016|Anticipated|2016-05-01||Observational|||Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation|Fatty Acids Lipidome and Oxidative Stress Markers as Indicators of Liver Transplant Outcome|Recruiting||N/A|320|Anticipated|University of Roma La Sapienza|||3||f||||t||||||Samples With DNA|"     Blood samples and liver biopsy specimens   "|||2017-10-11 04:03:37.339065|2017-10-11 04:03:37.339065
NCT01389102|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-06-08|2012-02-29||December 2004||2004-12-01|June 2012|2012-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Estradiol Metered-Dose Transdermal Spray (MDTS) in the Treatment of Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 3|454|Actual|Lumara Health, Inc.||6|||f||||f||||||||||2017-10-11 04:03:37.454634|2017-10-11 04:03:37.454634
NCT01389089|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-07-06|||January 2007||2007-01-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Interventional|||Effective Treatment of Posttraumatic and Postoperative Edema|Effective Treatment of Posttraumatic and Postoperative Edema in Patients With Ankle- and Hindfoot Fractures. A Randomized Controlled Trial Comparing Multi-layer Compression Therapy and A-V Impulse Compression to the Standard Treatment With Ice|Completed||Phase 4|64|Actual|Luzerner Kantonsspital||3|||f||||t||||||||||2017-10-11 04:03:38.201009|2017-10-11 04:03:38.201009
NCT01389076|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-12-01|2016-06-02||July 2011||2011-07-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|February 2014|Actual|2014-02-01||Interventional|||Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma|Phase II Trial of Low-Dose Methotrexate and Iodine I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma|Terminated||Phase 2|22|Actual|University of Michigan Cancer Center|This trial was abandoned prematurely due to the withdrawal of Bexxar by the manufacturer and failure to find another supplier.|1||Bexxar isn't being produced by the manufacturer as of Feb. 2014|f||||t||||||||||2017-10-11 04:03:38.322187|2017-10-11 04:03:38.322187
NCT01389063|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2013-12-17|||January 2012||2012-01-01|December 2013|2013-12-01|October 2014|Anticipated|2014-10-01|September 2014|Anticipated|2014-09-01||Interventional|MASTER||Maraviroc Abacavir STudy - Effect on Endothelial Recovery|Maraviroc Abacavir STudy - Effect on Endothelial Recovery|Unknown status|Recruiting|Phase 4|24|Anticipated|UMC Utrecht||2|||f||||f||||||||||2017-10-11 04:03:40.207282|2017-10-11 04:03:40.207282
NCT01389050|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-09-21|||June 2011||2011-06-01|September 2017|2017-09-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|||High Precision RT For Soft-Tissue Sarcoma|Use of High Precision Radiotherapy in the Management of Soft-Tissue Sarcomas|Active, not recruiting||Phase 2|70|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 04:03:40.292561|2017-10-11 04:03:40.292561
NCT01389037|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-06|||October 2011||2011-10-01|May 2011|2011-05-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Understanding Health Care Information for African Americans With High Blood Pressure|Promoting Health Literacy of African Americans With High Blood Pressure|Unknown status|Not yet recruiting|N/A|100|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 04:03:40.408518|2017-10-11 04:03:40.408518
NCT01389024|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-09-03|||October 2011||2011-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|HUPrevent||Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease|Hydroxyurea to Prevent Central Nervous System (CNS) Complications of Sickle Cell Disease in Children|Recruiting||Phase 2|40|Anticipated|Johns Hopkins University||2|||f||||t||||||||No||2017-10-11 04:03:40.510568|2017-10-11 04:03:40.510568
NCT01389011|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-09-06|||September 2010||2010-09-01|July 2011|2011-07-01||||||||Observational|PI-PVI||Perfusion Index (PI) and Pleth Variability Index (PVI) in Patients With Interscalene Blocks in Orthopedic Surgery|An Evaluation of PI and PVI (Masimo) in Patients With Interscalene Blocks in Orthopedic Surgery|Completed||N/A|30|Anticipated|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-11 04:03:40.657369|2017-10-11 04:03:40.657369
NCT01388998|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-04-22|||January 2011||2011-01-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Fluid Management Study to Evaluate Changes in Intravascular Volume After Applying Various Pressure Levels on the Caval Vein|External Pressure Applied on the Caval Vein and Its Effects on Difference in Pulse Pressure (dPP) and Pleth Variability Index (PVI)|Completed||N/A|24|Actual|Johannes Gutenberg University Mainz||1|||f||||f||||||||||2017-10-11 04:03:40.735181|2017-10-11 04:03:40.735181
NCT01388985|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-03-04|||October 2011||2011-10-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Simplifying the Rabies Pre-exposure Vaccination|Simplifying the Rabies Pre-exposure Vaccination|Completed||Phase 3|500|Actual|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||||2017-10-11 04:03:40.826825|2017-10-11 04:03:40.826825
NCT01388972|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2015-03-22|||February 2011||2011-02-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|||Assessment of Food Environment and Physical Activity Opportunities in Three Neighbourhoods of Buenos Aires City|Assessment of Food Environment and Physical Activity Opportunities in Three Neighbourhoods of Buenos Aires City|Completed||N/A|2924|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 04:03:40.939933|2017-10-11 04:03:40.939933
NCT01388959|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-11-01|||November 1998||1998-11-01|November 2016|2016-11-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma|Multicentre, Open Label, Phase II Trial to Evaluate the Efficacy and Safety of Treatment With Rituximab in Patients Suffering From Follicular Non-Hodgkin's Lymphoma (FNHL) With Residual Minimal Disease After Autologous Transplantation of hematopoïetic Stem Cell (Bone Marrow or Peripheral Blood)|Completed||Phase 2|40|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:03:41.166522|2017-10-11 04:03:41.166522
NCT01388946|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-07-05|2015-05-06||May 2010||2010-05-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||To assess differences in patients’ characteristics between the two groups, two-independent samples t-tests for normally distributed variables (age and duration of surgery) and Mann-Whitney tests for abnormally distributed variables (BMI and CO2 total volume consumed) were carried out.|Analgesia in Laparoscopic Cholecystectomy|Perioperative Ropivacaine Wound Infusion in Laparoscopic Cholecystectomy. A Randomized Controlled Double-blind Trial|Completed||N/A|110|Actual|University of Athens||2|||f||||f||||||||No|No plan to share data. The study has been published|2017-10-11 04:03:41.312466|2017-10-11 04:03:41.312466
NCT01388933|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2015-05-18||2015-05-18|September 2011||2011-09-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease|A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease|Terminated||Phase 2|79|Actual|Tsumura USA||2||Study stopped due to low enrollment|f||||f||||||||||2017-10-11 04:03:41.953272|2017-10-11 04:03:41.953272
NCT01388920|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-04-04|2014-04-04||September 2011||2011-09-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Doses of Tesamorelin in Stable Ambulatory COPD Subjects With Muscle Wasting|Terminated||Phase 2|3|Actual|Theratechnologies||3||The study was terminated based on a non-safety related corporate decision.|f||||f||||||||||2017-10-11 04:03:42.160454|2017-10-11 04:03:42.160454
NCT01388907|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-11-16|2013-06-21||May 2006||2006-05-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery|Efficacy and Safety of Prevadh™ in the Prevention of Adhesions in Gynaecological Surgery: a Multicenter, Randomized, French Study|Completed||Phase 4|61|Actual|Medtronic - MITG|the surgeons were not blinded to the patients’ allocation group at second-look laparoscopy.Recruitment was stopped early. 2 data analyses have been performed over the study period for primary endpoint, without any error type I adjustment.|2|||f||||f||||||||||2017-10-11 04:03:42.531442|2017-10-11 04:03:42.531442
NCT01388894|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-05|||December 2010||2010-12-01|May 2011|2011-05-01||||||||Observational|||Functional MRI and MRA in Migraine With Aura|Functional MRI and MRA in Migraine With Aura|Unknown status|Recruiting|N/A|80|Anticipated|Glostrup University Hospital, Copenhagen|||1||f||||f||||||||||2017-10-11 04:03:43.001492|2017-10-11 04:03:43.001492
NCT01388881|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-07-22|||March 2011||2011-03-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Effects of Music Education for Children With Reading Difficulties|Effects of Music Education on Domain of Reading and Cognitive Abilities in Children With Reading Difficulties: a Cluster Randomized Clinical Trial|Unknown status|Active, not recruiting|N/A|270|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 04:03:43.105304|2017-10-11 04:03:43.105304
NCT01388868|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-05-11|||June 2011||2011-06-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Strategy for Maintaining Partial Neuromuscular Blocking Adequate for Motor Evoked Potential During Neurosurgery|Determination of ED50 and ED95 of Vecuronium Infusion Dose for Maintaining Response of Train of Four Less Than 2 During the MEP Monitoring for Neurosurgery|Completed||N/A|90|Actual|Samsung Medical Center||3|||f||||f||||||||||2017-10-11 04:03:43.261597|2017-10-11 04:03:43.261597
NCT01388855|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-06-18|||September 2011||2011-09-01|June 2015|2015-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Pilot Study of Vitamin D Supplementation in Heart Failure|A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin D in Heart Failure: A Pilot Study|Completed||N/A|13|Actual|Fraser Health||2|||f||||f||||||||||2017-10-11 04:03:43.356916|2017-10-11 04:03:43.356916
NCT01388842|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-23|2016-02-29|||September 2011||2011-09-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children|Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide (iNO) as Adjunctive Treatment for Cerebral Malaria in Children: A Randomized Open Label Phase II Clinical Trial|Completed||Phase 2|92|Actual|Epicentre||2|||f||||t||||||||No||2017-10-11 04:03:43.458173|2017-10-11 04:03:43.458173
NCT01388829|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-08-09|||July 2011||2011-07-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532|A Phase 1, Single-Dose, Open-Label, Crossover Study To Assess The Relative Bioavailability Of 2 Different Formulations Of PF-04991532|Completed||Phase 1|10|Anticipated|Pfizer||1|||f||||||||||||||2017-10-11 04:03:43.684698|2017-10-11 04:03:43.684698
NCT01388816|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-03-18|2014-03-18||July 2011||2011-07-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional||All randomized patients|A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of DRL-17822 in Patients With Type II Hyperlipidemia|Completed||Phase 2|176|Actual|Dr. Reddy's Laboratories Limited||4|||f||||f||||||||||2017-10-11 04:03:43.785291|2017-10-11 04:03:43.785291
NCT01388803|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-19|||January 2010||2010-01-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Observational|||The Depth of Right Bronchial Blocker Placement in Taiwanese in Video-assisted Thoracoscopic Surgery(VATS)|Right Side Bronchial Blocker in Video-assisted Thoracoscopic Surgery|Completed||N/A|60|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 04:03:44.517084|2017-10-11 04:03:44.517084
NCT01388790|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-09-09|2013-09-09||June 2011||2011-06-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|August 2012|Actual|2012-08-01||Interventional||Intent-to-treat (ITT) population included all participants who received at least one dose of study treatment.|Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer|Open-label, Single-arm, Multicenter Phase II Trial Investigating Cetuximab in Combination With S-1 and Cisplatin as First-line Treatment for Patients With Advanced Gastric Adenocarcinoma Including Adenocarcinoma of the Gastroesophageal Junction|Completed||Phase 2|40|Actual|Merck KGaA||1|||f||||t||||||||||2017-10-11 04:03:44.591479|2017-10-11 04:03:44.591479
NCT01388777|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2017-06-19|||January 24, 2012|Actual|2012-01-24|June 2017|2017-06-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|||Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy|A Pilot Study to Determine the Efficacy of Cryoablation for the Treatment of Invasive Breast Carcinoma Following Neoadjuvant Therapy|Completed||Phase 2|1|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:03:44.928745|2017-10-11 04:03:44.928745
NCT01388764|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2012-06-30|||January 2012||2012-01-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids|Pilot Study: To Assess the Safety, Tolerability and Effects of L-Arginine on Muscles in Boys With Dystrophinopathy on Corticosteroids|Completed||Phase 1|7|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 04:03:45.04347|2017-10-11 04:03:45.04347
NCT01388738|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-12-22|||January 2011||2011-01-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|3C||Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.|Navigation Brain Stimulation (NBS) for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.|Completed||Phase 3|30|Anticipated|Clinical Institute of the Brain, Russia||3|||f||||t||||||||||2017-10-11 04:03:45.200972|2017-10-11 04:03:45.200972
NCT01388725|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-06|||September 2009||2009-09-01|July 2010|2010-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Comparison the Value of Several Biomarkers of Sepsis|Comparison of the Value of Serum sTREM-1, sCD163, PCT, CRP Concentrations, WBC Count and SOFA Score During Sepsis and Their Clinical Informative Value in Predicting Outcome|Completed||N/A|130|Actual|Chinese PLA General Hospital|||2||f||||t||||||||||2017-10-11 04:03:45.296046|2017-10-11 04:03:45.296046
NCT01388699|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2011-07-06|||October 2010||2010-10-01|June 2011|2011-06-01|September 2011|Anticipated|2011-09-01|August 2011|Anticipated|2011-08-01||Observational|||Migraine and Endothelial Dysfunction|Migraine and Endothelial Dysfunction|Unknown status|Recruiting|N/A|60|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 04:03:45.468192|2017-10-11 04:03:45.468192
NCT01388686|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2016-11-22|||August 2009||2009-08-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|December 2010|Actual|2010-12-01||Observational|||Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg|Retrospective Analysis of Proven Bacteremia, CVC-associated Infections and Sepsis|Terminated||N/A|13|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 04:03:45.551301|2017-10-11 04:03:45.551301
NCT01388673|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-02-07|||October 2011||2011-10-01|February 2012|2012-02-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Safety and Preliminary Effectiveness of the BaroSense Articulating Circular Endoscopic (ACE) Stapler for Plication of Dilated Post-surgical Gastric Anatomy|Open Prospective Study to Evaluate the Safety and Preliminary Effectiveness of the BaroSense ACE Stapler for Plication of Dilated Post-surgical Gastric Anatomy|Withdrawn||N/A|0|Actual|BaroSense Inc.||1|||f||||f||||||||||2017-10-11 04:03:45.627391|2017-10-11 04:03:45.627391
NCT01388660|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2014-03-25|||June 2011||2011-06-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin|A Randomized, Open-label, Single-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a Tablet Containing 75 mg of Clopidogrel and 100 mg of Aspirin and The Simultaneous Administration of The Separate Formulations of The Two Drugs in Healthy Male Volunteers|Unknown status|Recruiting|Phase 1|60|Anticipated|Ajou University School of Medicine||2|||f||||f||||||||||2017-10-11 04:03:45.709308|2017-10-11 04:03:45.709308
NCT01388647|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-05|2015-07-30|2015-05-28||August 2011||2011-08-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer|Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer|Terminated||Phase 1/Phase 2|12|Actual|Vector Oncology|Although MTD of eribulin with carboplatin & trastuzuamb as neoadjuvant therapy was determined by protocol definitions, study closed early due to increased hematologic toxicity & possible reduced efficacy. Phase II of this trial was not initiated.|1||Closed early due to increased hematologic toxicity and possible reduced efficacy|f||||f||||||||||2017-10-11 04:03:45.821639|2017-10-11 04:03:45.821639
NCT01388634|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-11-30|||June 2010||2010-06-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|December 2010|Actual|2010-12-01||Observational|LOSHERNIA||Prolonged Hospital Stay and Readmission After Elective Ventral Hernia Repair|Nationwide Analysis of Prolonged Hospital Stay and Readmission After Elective Ventral Hernia Repair|Completed||N/A|2258|Actual|University Hospital Koge|||2||f||||f||||||||||2017-10-11 04:03:46.587401|2017-10-11 04:03:46.587401
NCT01388621|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-08-19|||October 2011||2011-10-01|August 2013|2013-08-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|PROVE||Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer|PROVE A Randomized Phase II Trial of Standard Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer|Unknown status|Recruiting|Phase 2|140|Anticipated|WiSP Wissenschaftlicher Service Pharma GmbH||2|||f||||t||||||||||2017-10-11 04:03:46.670128|2017-10-11 04:03:46.670128
NCT01388608|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-08-20|||June 2009||2009-06-01|July 2011|2011-07-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Observational|||Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept|Correlation of Standard Disease Activity Parameters in Rheumatoid Arthritis With Activities of Daily Living Measured With the Step Activity Monitor, Based on the Influence of Etanercept Therapy on the Disease Activity|Completed||N/A|28|Actual|University Hospital Muenster|||1||f||||f||||||||||2017-10-11 04:03:46.862031|2017-10-11 04:03:46.862031
NCT01388595|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2014-04-21|||November 2006||2006-11-01|December 2013|2013-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Fluticasone and Salmeterol in Allergic Rhinitis|A Proof of Concept Study to Evaluate Effects of Intranasal Salmeterol and Fluticasone Given Alone and in Combination in Allergic Rhinitis|Completed||Phase 4|23|Actual|University of Dundee||3|||f||||t||||||||||2017-10-11 04:03:46.971247|2017-10-11 04:03:46.971247
NCT01388582|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-05-16|||April 2011||2011-04-01|May 2012|2012-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||The Effect of Hormonal Contraceptives on Breast-milk Production and Infant Growth|The Effect of 30mcg and Levonorgestrel 150 Combined Oral Contraceptive, Etonogestrel-releasing Subdermal Implant and Levonorgestrel-releasing Intrauterine System on Breast-Milk Production and Infant Growth in Fully Breast-Feeding Women|Completed||Phase 4|40|Actual|University of Campinas, Brazil||4|||f||||f||||||||||2017-10-11 04:03:47.067893|2017-10-11 04:03:47.067893
NCT01383174|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-06-12|2015-05-05||February 2011||2011-02-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Nuevo Amanecer: Promoting the Psychosocial Health of Latinas|Nuevo Amanecer: Promoting the Psychosocial Health of Latinas|Completed||N/A|151|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 04:05:11.131736|2017-10-11 04:05:11.131736
NCT01388569|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-02|2017-05-16|||June 28, 2011|Actual|2011-06-28|May 2017|2017-05-01|September 28, 2011|Actual|2011-09-28|September 28, 2011|Actual|2011-09-28||Observational|||Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim|Immune Counter-Regulation in Melanoma Patients Vaccinated With GM-CSF|Completed||N/A|48|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 04:03:47.179822|2017-10-11 04:03:47.179822
NCT01388556|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-12-07|||July 2009||2009-07-01|December 2015|2015-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|PD4PD||PD4PD:Partnered Dance for Parkinson Disease|PD4PD:Partnered Dance for Parkinson Disease|Completed||Phase 2/Phase 3|62|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 04:03:47.250102|2017-10-11 04:03:47.250102
NCT01388543|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-05-01|||September 2006||2006-09-01|May 2017|2017-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Genetics and HIV-1 Protease Inhibitors|Genetic-determinants of Protease Inhibitor Pharmacology|Completed||Phase 4|31|Actual|University of Colorado, Denver||2|||f||||t||||||||No|No plan to share|2017-10-11 04:03:47.356208|2017-10-11 04:03:47.356208
NCT01388530|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2016-03-23|2013-01-26||July 2011||2011-07-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)|An Eight-Week, Open Trial Pilot Investigation of Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Early Phase 1|25|Actual|University of California, Los Angeles|Early terminations were due to ambivalence about participation of social difficulties with compliance. No one left the study for adverse events or safety reasons. There were no clinically meaningful adverse events related to treatment.|1|||f||||f||||||||||2017-10-11 04:03:47.475729|2017-10-11 04:03:47.475729
NCT01388517|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2012-09-25|||January 2008||2008-01-01|September 2012|2012-09-01|January 2011|Actual|2011-01-01|August 2010|Actual|2010-08-01||Interventional|||Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba|A Double Blind Randomized Trial, Placebo-controled of 0.0003% Calcitriol Ointment Versus 0.1% Tacrolimus Ointment in the Treatment of Pityriasis Alba|Completed||Phase 4|39|Actual|Universidad Autonoma de San Luis Potosí||3|||f||||f||||||||||2017-10-11 04:03:47.805916|2017-10-11 04:03:47.805916
NCT01388504|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2016-01-20|||July 2011||2011-07-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|NIAMI||Nitrites in Acute Myocardial Infarction|Does Sodium Nitrite Administration Reduce Ischaemia-reperfusion Injury in Patients Presenting With Acute ST Segment Elevation Myocardial Infarction?|Completed||Phase 2/Phase 3|200|Actual|University of Aberdeen||2|||f||||t||||||||||2017-10-11 04:03:48.012298|2017-10-11 04:03:48.012298
NCT01388491|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2017-03-09|2013-09-23||October 2011||2011-10-01|March 2017|2017-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||Safety Population (all randomized participants who took 1 or more doses of study drug)|A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women|A Multinational, Multicenter, Randomized, Open-label Study to Evaluate the Impact of DR-102 Compared to a 28-day Standard Oral Contraceptive Regimen, on Hemostatic Parameters in Healthy Women|Completed||Phase 2|293|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 04:03:48.163069|2017-10-11 04:03:48.163069
NCT01388478|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-03-22||2016-03-22|July 2011||2011-07-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease|Safety/Tolerability and Effects on Cognitive Impairment, Impaired Cerebral Cortical Metabolism and Oxidative Stress of R(+)Pramipexole Administered to Subjects With Early Alzheimer's Disease|Completed||Phase 2|20|Actual|Virginia Commonwealth University||1|||f||||t||||||||No||2017-10-11 04:03:49.120036|2017-10-11 04:03:49.120036
NCT01388465|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-05-18|||June 2011||2011-06-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ImpACT||Text-message Support to Improve Oral Antibiotic Adherence After ED Discharge|Feasibility of Using Text-Message Support to Improve Antibiotic Adherence After ED Discharge|Completed||N/A|200|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 04:03:49.208996|2017-10-11 04:03:49.208996
NCT01388452|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-05-13|||June 2011||2011-06-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||HIV Diagnosis in Hospitalized Malawian Infants|Presumptive and Definitive Virologic HIV Diagnosis in Hospitalized Malawian Infants|Completed||N/A|300|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 04:03:49.289204|2017-10-11 04:03:49.289204
NCT01388439|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-07-05|||January 2011||2011-01-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Pharmacokinetics of Oseltamivir in Newborns and Infants|Pharmacokinetics of Oseltamivir in Newborns and Infants|Completed||N/A|19|Actual|St. Louis Children's Hospital|||1||f||||f||||||Samples With DNA|"     Two whole blood samples (0.5 mL) were obtained at steady state (day 3 of therapy or later),     collected in K3EDTA mini-collection tubes labeled with a sample identification number. Plasma     specimens were separated by centrifugation of 1500 g for 10 minutes at 4 degrees Celsius     within 60 minutes of sample collection. Plasma supernatant was transferred into a cryovial     labeled with the same sample identification number. Cryovials were immediately stored at -70     degrees Celsius. Sample obtainment and processing was directly supervised by the principle     investigator.      The blood samples are currently being stored at -70 degrees Celsius in a research laboratory     operated by medical faculty of the Washington University School of Medicine Department of     Pediatrics Division of Infectious Diseases in the McDonnell Medical Sciences Building.   "|||2017-10-11 04:03:49.392289|2017-10-11 04:03:49.392289
NCT01388426|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-01-08|||July 2011||2011-07-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Moisture Chamber Glasses for Dry Eye in Asian Population|Moisture Chamber Glasses for Dry Eye in Asian Population|Completed||N/A|11|Actual|Singapore National Eye Centre||1|||f||||t||||||||||2017-10-11 04:03:49.497553|2017-10-11 04:03:49.497553
NCT01388413|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-02-23|||August 2011||2011-08-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|January 2016|Actual|2016-01-01||Interventional|PACHIU||Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder|A Randomized, Multicenter, Parallel Group Study to Evaluate Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder|Completed||Phase 4|45|Actual|University Hospital, Tours||2|||f||||t|f|f||||||No||2017-10-11 04:03:49.616828|2017-10-11 04:03:49.616828
NCT00000478|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-24|||November 1990||1990-11-01|February 2002|2002-02-01|June 1997||1997-06-01|||||Interventional|||Asymptomatic Cardiac Ischemia Pilot (ACIP) Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:00.116467|2017-10-11 04:18:00.116467
NCT01388400|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2011-07-10|||May 2009||2009-05-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Enriched Environments for Upper Limb Stroke Rehabilitation|Enriched Environments for Stroke Rehabilitation; Pilot Study to Determine Appropriate Outcome Measures and Their Sensitivity to Different Training Protocols|Completed||N/A|12|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 04:03:49.724372|2017-10-11 04:03:49.724372
NCT01388387|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2017-04-19|||January 2012||2012-01-01|September 2016|2016-09-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Pharmacogenetic Study of Tacrolimus in Hepatic Transplant (CYPTAC'H)|Impact of Donor and Recipient CYP3A5 Genetic Polymorphism on Tacrolimus Exposure in Patients With Hepatic Transplant|Recruiting||N/A|150|Anticipated|Rennes University Hospital||1|||f||||t||||||||||2017-10-11 04:03:49.821063|2017-10-11 04:03:49.821063
NCT01388374|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2015-04-21|||December 2010||2010-12-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||The (Cost-)Effectiveness of Nurse Practitioners Working at the Primary Out of Hours Emergency Service|A Study on the (Cost-)Effectiveness of Nurse Practitioners Working at the Primary Out of Hours Emergency Service and the Feasibility of Implementing These Nurses|Completed||N/A|12092|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 04:03:49.933299|2017-10-11 04:03:49.933299
NCT01388361|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2017-01-20|2015-10-23|2013-11-28|September 2011||2011-09-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|BEGIN™|The full analysis set (FAS) included all randomised patients except for 7 subjects (2 subjects with IDeg+ liraglutide; 5 subjects with IDeg+IAsp arm) fasting plasma glucose (FPG) values were missing at baseline. Non-randomised set (NAS) included all non-randomised subjects, the FPG values were missing for 10 subjects at baseline.|Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin|A Trial Comparing the Efficacy and Safety of Adding Liraglutide Versus Addition of Insulin Aspart With the Largest Meal to Insulin Degludec, Both in Combination With Metformin, in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification (BEGIN™: VICTOZA® ADD-ON)|Completed||Phase 3|413|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 04:03:50.098169|2017-10-11 04:03:50.098169
NCT01388348|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-15|2011-07-04|||July 2011||2011-07-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||"Diagnosis of Bladder Outlet Obstruction Using Dynamic Urine Vibration Holter in Comparison to Pressure Flow Study"|"Diagnosis of Bladder Outlet Obstruction Using Dynamic Urine Vibration Holter in Comparison to Pressure Flow Study"|Unknown status|Not yet recruiting|N/A|100|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-10-11 04:03:51.191692|2017-10-11 04:03:51.191692
NCT01388335|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2012-12-17|||August 2011||2011-08-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin|The Effect of Enzastaurin on CYP2C9: Enzastaurin - S-Warfarin Drug Interaction Study in Patients With Cancer|Completed||Phase 1|20|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:03:51.281278|2017-10-11 04:03:51.281278
NCT01388322|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-12-20|||March 2012||2012-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2016|Actual|2016-06-01||Interventional|HOPPE||Low Weight Heparin prOphylaxis for Placental‐Mediated Complications of PrEgnancy|Enoxaparin for the Prevention of Placental‐Mediated Complications of Pregnancy in Women With Obstetric History or Abnormal Uterine Artery Doppler at First Trimester Ultrasound and Without Thrombophilia: a Multicenter Randomized Controlled Trial|Completed||Phase 3|361|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-11 04:03:51.414037|2017-10-11 04:03:51.414037
NCT01388309|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs|DAS Evaluation of RA Activity in Patients Treated With Tocilizumab|Completed||N/A|64|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:03:51.519252|2017-10-11 04:03:51.519252
NCT01388296|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2013-12-02|||June 2011||2011-06-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Minimum Alveolar Concentrations of Sevoflurane for Maintaining Bispectral Index Below 50 in Morbidly Obese Patients|Minimum Alveolar Concentrations of Sevoflurane for Maintaining Bispectral Index Below 50 in Morbidly Obese Patients|Unknown status|Recruiting|N/A|30|Anticipated|Procare Riaya Hospital|||3||f||||f||||||None Retained|"     Bisbectral index (BIS)   "|||2017-10-11 04:03:51.614462|2017-10-11 04:03:51.614462
NCT01388283|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-05|||January 1999||1999-01-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|May 2004|Actual|2004-05-01||Observational|||Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia||Completed||N/A|129|Actual|Oslo University Hospital|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 04:03:51.707823|2017-10-11 04:03:51.707823
NCT01388270|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-02-03|||September 2011||2011-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis|The Effect of a Heparin-coated Dialysis Filter (Evodial) on Clotting and Intravascular Coagulation During Hemodialysis (HD) When Compared to a Conventional Polyflux Filter (170H)|Completed||Phase 4|12|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 04:03:51.779318|2017-10-11 04:03:51.779318
NCT01388257|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2012-06-06|||October 2011||2011-10-01|June 2012|2012-06-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|FACC||Anal Crohn Fistula Surgery|"A National, Multicenter, Randomized Open-Label Study of Proctological Surgery Efficacy on Anoperineal Fistulas Healing in Crohn's Disease Patients Treated With Adalimumab. (Official French Title: Étude Nationale, Multicentrique, randomisée et en Ouvert de l'efficacité de la Chirurgie Proctologique Sur la Cicatrisation Des Fistules anopérinéales de la Maladie de Crohn Chez Des Patients traités Par Adalimumab)"|Unknown status|Recruiting|N/A|180|Anticipated|French Society of Coloproctology||2|||f||||f||||||||||2017-10-11 04:03:51.884592|2017-10-11 04:03:51.884592
NCT01388244|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-10-23|||January 2010||2010-01-01|June 2011|2011-06-01|January 2020|Anticipated|2020-01-01|January 2017|Anticipated|2017-01-01||Interventional|ROSE||Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)|Risk-stratified Osteoporosis Strategy Evaluation Study (ROSE)|Active, not recruiting||N/A|35000|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-11 04:03:52.071138|2017-10-11 04:03:52.071138
NCT00000766|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||September 1995|Actual|1995-09-01||Interventional|||CMV Retinitis Retreatment Trial|CMV Retinitis Retreatment Trial|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.903538|2017-10-11 04:18:15.903538
NCT01388231|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-07-07|||September 2010||2010-09-01|July 2011|2011-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice|Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice (SophoPrax)|Unknown status|Recruiting|Phase 2/Phase 3|116|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 04:03:52.175757|2017-10-11 04:03:52.175757
NCT01388218|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2015-07-30|||July 2011||2011-07-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|||Non-interventional Cross-over Study to Reduce Items of PROactive Tools Measuring Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)|Non-interventional Cross-over Study to Reduce Items of the Draft PROactive Tools as a Measure of Physical Activity in Daily Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|236|Actual|Centre for Research in Environmental Epidemiology, Spain|||2||f||||t||||||||||2017-10-11 04:03:52.274924|2017-10-11 04:03:52.274924
NCT01388205|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-10-08|||April 2011||2011-04-01|October 2015|2015-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|FIT||Trial of a Novel Family-Based Intervention to Increase Outdoor Time and Fitness|An Exploratory Randomized Controlled Trial of a Novel Family-Based Intervention to Increase Outdoor Time for the Prevention of Myopia and Increase Physical Activity Among Singapore Youth|Completed||Phase 3|285|Actual|National University, Singapore||2|||f||||t||||||||||2017-10-11 04:03:52.371212|2017-10-11 04:03:52.371212
NCT01388192|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-01-24|||November 2011||2011-11-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Effects of Pancreaticoduodenectomy on Glucose Metabolism|Effects of Pancreaticoduodenectomy on Glucose Metabolism|Recruiting||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 04:03:52.453742|2017-10-11 04:03:52.453742
NCT01388179|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-02-04|||March 2014||2014-03-01|July 2011|2011-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.|Deep rTMS(Repetitive Transcranial Magnetic Stimulation) for Treatment of Autism Symptoms in Children With Low Functioning ASD (Autism Spectrum Disorders)|Unknown status|Recruiting|Phase 2|20|Anticipated|Brainsway||2|||f||||f||||||||||2017-10-11 04:03:52.532385|2017-10-11 04:03:52.532385
NCT01388166|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2014-11-28|2014-11-28||September 2011||2011-09-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational||Patients from the Treated Set: This patient set includes all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment. As it was an inclusion criterion that all patients were treated with Spiriva within the last month, TS consists of all patients involved in the trial.|ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice|ADESPI: Adherence to Spiriva® in Patients With COPD, Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice in Central & Eastern European Region|Completed||N/A|1253|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 04:03:52.640753|2017-10-11 04:03:52.640753
NCT01388153|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-04|2013-08-27|||June 2011||2011-06-01|August 2013|2013-08-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet|Randomized, Non-blinded, 3-fold Crossover Study to Investigate the Bioequivalence Between Glucobay ODT Taken Without and With Water and the Glucobay Standard Tablet Following Single Oral Dosing in Healthy Male Subjects|Completed||Phase 1|33|Actual|Bayer||3|||f||||f||||||||||2017-10-11 04:03:53.224252|2017-10-11 04:03:53.224252
NCT01388140|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-05|||March 2011||2011-03-01|January 2011|2011-01-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||Psychopathology of Dissociative Disorders|A Psychopathological Study of Dissociative Disorders in Psychiatric Inpatients at an Acute Stage|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 04:03:53.336517|2017-10-11 04:03:53.336517
NCT01388127|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2011-07-05|||July 2011||2011-07-01|June 2011|2011-06-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|Minocycline||Minocycline Treatment in Acute Hemorrhagic Stroke|Minocycline Treatment in Acute Hemorrhagic Stroke for Evaluation of Treatment Efficacy and Blood Brain Barrier Permeability|Unknown status|Not yet recruiting|N/A|150|Anticipated|Wolfson Medical Center|||1||f||||f||||||||||2017-10-11 04:03:53.410684|2017-10-11 04:03:53.410684
NCT01388114|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-11-15|||November 2010||2010-11-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Clinical Evaluation of e- Ab Sensor - Based Real-time Diagnosis of Serum Procalcitonin Level|Clinical Evaluation of e- Ab Sensor - Based Real-time Diagnosis of Serum Procalcitonin Level|Completed||N/A|200|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:03:53.492961|2017-10-11 04:03:53.492961
NCT01388101|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-12-20|||September 2010||2010-09-01|December 2012|2012-12-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)|Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:03:53.564399|2017-10-11 04:03:53.564399
NCT01388088|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-19|2012-03-27|||September 2010||2010-09-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|hass||The Effect of Amiloride and Spironolactone in Patients With Hypertension|Effect of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables in Patients With Essential Hypertension in a Doublle-blinded Randomised Placebo-controlled, Cross-over Study.|Completed||Phase 4|23|Actual|Regional Hospital Holstebro||3|||f||||t||||||||||2017-10-11 04:03:53.666334|2017-10-11 04:03:53.666334
NCT01388075|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2011-07-05|||July 2011||2011-07-01|July 2011|2011-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||Genetic Variability in the Response to Warfarin at Baseline and During Induction of CYP2C9||Not yet recruiting||N/A|150|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 04:03:53.766951|2017-10-11 04:03:53.766951
NCT01388062|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-12-26|||August 2010||2010-08-01|November 2012|2012-11-01|October 2013|Anticipated|2013-10-01|July 2013|Anticipated|2013-07-01||Interventional|||e- Ab Sensor - Based Real-time Diagnosis of Influenza Virus|e- Ab Sensor - Based Real-time Diagnosis of Influenza Virus|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:03:53.994362|2017-10-11 04:03:53.994362
NCT01388049|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-12-26|||July 2010||2010-07-01|November 2011|2011-11-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||e- Ab Sensor - Based Real-time Diagnosis of Enterovirus Type 71|e- Ab Sensor - Based Real-time Diagnosis of Enterovirus Type 71|Unknown status|Recruiting|N/A|72|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:03:54.078197|2017-10-11 04:03:54.078197
NCT01388036|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2011-07-05|||July 2011||2011-07-01|July 2011|2011-07-01||||May 2015|Anticipated|2015-05-01||Interventional|||Genetic Determinants of Hemodynamic Response to Esmolol|A Study in Healthy Subjects to Evaluate Genetic Determinants of the Variability in Hemodynamic Response to Esmolol|Unknown status|Recruiting|N/A|100|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 04:03:54.182601|2017-10-11 04:03:54.182601
NCT01388023|ClinicalTrials.gov processed this data on October 10, 2017|2008-01-17|2012-11-19|||January 2008||2008-01-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|SmellX||Day Long Prevention of Oral Malodor With a Palatal Patch (SmellX) Containing A Herbal Formula|Phase 2 Clinical Study of a Day Long Effect of SmellX Palatal Patch Containing A Herbal Formula on Malodor|Completed||Phase 2|60|Actual|Hadassah Medical Organization||4|||f||||f||||||||||2017-10-11 04:03:54.293761|2017-10-11 04:03:54.293761
NCT01388010|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-03|2016-10-26|||September 2009||2009-09-01|October 2016|2016-10-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Study of the Effect of a Fermented Dairy Product on Gastrointestinal Well Being in Adult Women|"Effect of the Consumption of a Fermented Dairy Product on Gastrointestinal Well-being in a Healthy Population of Women With Minor Digestive Symptoms"|Completed||N/A|336|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 04:03:54.407716|2017-10-11 04:03:54.407716
NCT01387997|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-11-19|||June 2010||2010-06-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses|Nano-mechanical and Nano-electrosensing Devices Based Interaction Force and Interaction Kinetics Analysis of Oncogenic Human Papilloma Viruses|Unknown status|Recruiting|N/A|72|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:03:54.490586|2017-10-11 04:03:54.490586
NCT01387984|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-05|||April 2010||2010-04-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||YKL-40 and Complications in Type 2 Diabetes|Association Study of the Plasma Concentration of YKL-40 and Vascular Complications in Patients With Type 2 Diabetes|Completed||N/A|473|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 04:03:54.585299|2017-10-11 04:03:54.585299
NCT01387971|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-05|||September 2009||2009-09-01|April 2011|2011-04-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders|Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 04:03:54.668054|2017-10-11 04:03:54.668054
NCT01387958|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-05-06|||July 2011||2011-07-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients|Double-blind, Randomized, Placebo-controlled, Multi-center Trial, to Determine the Safety and Antiviral Effect of 14 Days of LCQ908 Monotherapy in Hepatitis C Infected Patients|Terminated||Phase 2|32|Actual|Novartis||2||Terminated early due to futility|f||||||||||||||2017-10-11 04:03:54.759509|2017-10-11 04:03:54.759509
NCT01387945|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2016-03-31|||September 2010||2010-09-01|March 2016|2016-03-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|eBPcontrol||Pilot Study of Home Blood Pressure Control Program (eBP Control)|Pilot Study of Home Blood Pressure Control Program (eBP Control)|Completed||N/A|28|Actual|Memorial Hospital of Rhode Island||2|||f||||f||||||||||2017-10-11 04:03:54.867716|2017-10-11 04:03:54.867716
NCT01387932|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-11|2017-06-30|||April 2011||2011-04-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2017|Anticipated|2017-12-01||Interventional|HiQuality||HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer|Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma|Active, not recruiting||Phase 3|520|Anticipated|Merit Medical Systems, Inc.||2|||f||||t||||||||||2017-10-11 04:03:54.98156|2017-10-11 04:03:54.98156
NCT01387919|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-08|||February 2011||2011-02-01|January 2011|2011-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Time Course and Nature of Nutrient Sensing During Fasting in Humans|Time Course and Nature of Nutrient Sensing During Fasting in Humans|Completed||N/A|12|Actual|Leiden University Medical Center||1|||f||||f||||||||||2017-10-11 04:03:55.19525|2017-10-11 04:03:55.19525
NCT01387906|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2012-06-14|||March 2011||2011-03-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo|Latisse(Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo|Completed||Phase 4|20|Actual|Beer, Kenneth R., M.D., PA||1|||f||||t||||||||||2017-10-11 04:03:55.281256|2017-10-11 04:03:55.281256
NCT01387893|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-10-01|||May 2008||2008-05-01|October 2015|2015-10-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|||A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia|Study of a Self-Administered Maneuver to Initiate and Maintain Urine Flow Impeded by Benign Prostatic Hyperplasia|Completed||N/A|48|Actual|Kaiser Permanente||1|||f||||f||||||||||2017-10-11 04:03:55.38057|2017-10-11 04:03:55.38057
NCT01387880|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-03-18|||January 2010||2010-01-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Interventional|ICE||Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer|Phase II Examination of Irinotecan, Cetuximab and Everolimus to Chemotherapy Resistent Patients With Metastatic Colorectal Cancer and KRAS Mutations or After Progression With KRAS Wildtype on Irinotecan and Cetuximab - Effect and Biological Markers|Completed||Phase 2|100|Actual|Herlev Hospital||2|||f||||t||||||||||2017-10-11 04:03:55.473911|2017-10-11 04:03:55.473911
NCT01387867|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-02-05|||October 2009||2009-10-01|July 2013|2013-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Exercise in Patients With Osteoarthritis of the Hip|Effects of Strength Training and Nordic Walking in Patients With Osteoarthritis of the Hip|Completed||N/A|152|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-10-11 04:03:55.575581|2017-10-11 04:03:55.575581
NCT01387854|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-03-31|||June 2011||2011-06-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Observational|||Observational Study of Patients With Mucopolysaccharidosis (MPS) VI Who Previously Participated in ASB-00-02|A Re-Survey Study of Patients With MPS VI (Maroteaux-Lamy Syndrome) Who Previously Participated in ASB-00-02|Completed||N/A|59|Actual|BioMarin Pharmaceutical|||1||f||||f||||||||||2017-10-11 04:03:55.682954|2017-10-11 04:03:55.682954
NCT01387841|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2013-07-23|||May 2010||2010-05-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting|Comparison of Yoga Versus Relaxation on Chemotherapy Induced Nausea and Vomiting (CINV) Outcomes Following Chemotherapy|Completed||Phase 2|120|Actual|Bharath Charitable Cancer Hospital and Institute||3|||f||||t||||||||||2017-10-11 04:03:55.759156|2017-10-11 04:03:55.759156
NCT01387828|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2011-07-06|||January 2001||2001-01-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Comparison Between Open and Laparoscopic Splenic Aneurysms Repair|Prospective Randomized Comparison of Open Versus Laparoscopic Management of Splenic Artery Aneurysms. A Ten-Year Study|Completed||Phase 3|29|Actual|Azienda Ospedaliera Spedali Civili di Brescia||2|||f||||t||||||||||2017-10-11 04:03:55.855295|2017-10-11 04:03:55.855295
NCT01387789|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2014-04-21|2014-03-14||August 2011||2011-08-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|RELIVE||A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia|An Observational Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia|Completed||N/A|71|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 04:03:56.446071|2017-10-11 04:03:56.446071
NCT01387776|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-31|2015-07-24|||June 2012||2012-06-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|PlGF||Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21|Study for the Evaluation of the Benefits of 1 st Trimester Risk Markers in Detecting Early Onset Pre-eclampsia and the Use of the Placental Growth Factor (PlGF) as a Potential Marker for Trisomy 21 and Other Aneuploidies|Terminated||N/A|370|Actual|OVO R & D|||1|The technique has been approved and validated|f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 04:03:56.751895|2017-10-11 04:03:56.751895
NCT01387763|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-04-04|||January 2012||2012-01-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|DALIAH||A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms|Danish Study of Low-dose Interferon Alpha Versus Hydroxyurea in the Treatment of Philadelphia Chromosome Negative (Ph-)Chronic Myeloid Neoplasms.|Active, not recruiting||Phase 3|200|Anticipated|Odense University Hospital||5|||f||||t||||||||||2017-10-11 04:03:56.816848|2017-10-11 04:03:56.816848
NCT01387750|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-05|||May 2007||2007-05-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Mentholated Cream Containing Oxygenated Glycerol Triesters on Acute Pain of the Muscles and Joints|Evaluating the Efficacy, Tolerance and Acceptability of a Mentholated Cream Containing Oxygenated Glycerol Triesters (OGT) on Acute Pain in Subjects Suffering From a Recent Inflammation of the Muscles and/or Joints|Completed||Phase 1/Phase 2|71|Actual|NEMA Research, Inc.||2|||f||||t||||||||||2017-10-11 04:03:56.983881|2017-10-11 04:03:56.983881
NCT01387737|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2014-05-27|2014-03-26||May 2011||2011-05-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus|An Open-Label, Multicenter Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of TA-7284 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|1299|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 04:03:57.075655|2017-10-11 04:03:57.075655
NCT01387724|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2016-05-17|||June 2011||2011-06-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma|Neuropeptide Y and Its Receptors in Neuroblastoma|Completed||N/A|300|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     blood and tissue   "|||2017-10-11 04:03:58.058304|2017-10-11 04:03:58.058304
NCT01387711|ClinicalTrials.gov processed this data on October 10, 2017|2011-07-01|2016-12-01|||August 2011||2011-08-01|December 2016|2016-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology|A Phase I, Single-centre, Open Label, Within-subject Comparison Trial to Explore the Biological Effects of PEP005 (Ingenol Mebutate) Gel, 0.05%, Applied Once Daily for 2 Consecutive Days in Patients With Actinic Keratosis on the Upper Extremity|Completed||Phase 1|27|Actual|LEO Pharma||1|||f||||f||||||||||2017-10-11 04:03:58.125553|2017-10-11 04:03:58.125553
NCT01387698|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-10-28|||June 2011||2011-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|OPTIMUM||Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis|Observatoire Prospectif, Longitudinal Dans la Prise en Charge Thérapeutique de La Rectocolite Hémorragique légère à Modérée|Completed||N/A|812|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:03:58.203194|2017-10-11 04:03:58.203194
NCT01387685|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-06-19|||February 2009||2009-02-01|June 2014|2014-06-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Treatment of Pelvic Organ Prolapse by PIVS Versus Surgeon Cut Mesh||Withdrawn||N/A|0|Actual|Western Galilee Hospital-Nahariya|||1||f||||f||||||||||2017-10-11 04:04:00.038895|2017-10-11 04:04:00.038895
NCT01383161|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-05-03|||March 2012||2012-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|Curcumin||18-Month Study of Curcumin|18-Month Double-Blind, Placebo-Controlled Study of Curcumin|Active, not recruiting||Phase 2|132|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 04:05:11.974174|2017-10-11 04:05:11.974174
NCT01387672|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-05-06|2015-02-17||September 2011||2011-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|NABT;NABT-B||Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study|Nitrates and Bone Turnover (NABT): Trial to Select the Best Nitrate Preparation|Completed||Phase 3|265|Actual|University of Toronto||6|||f||||t||||||||||2017-10-11 04:04:00.216521|2017-10-11 04:04:00.216521
NCT01387659|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-09-30|||March 2011||2011-03-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations|Study to Evaluate Tolerability of Myfortic With Simulect Induction and Tacrolimus Without Steroids in Three Patient Populations; 1: Kidney/Pancreas Transplants,2: Diabetic Kidney Transplants, and 3: Non-diabetic Kidney Transplants|Terminated||Phase 4|2|Actual|The University of Texas Medical Branch, Galveston||1||Study terminated due to slow enrollment|f||||t||||||||||2017-10-11 04:04:00.767237|2017-10-11 04:04:00.767237
NCT01387646|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-01|||October 2004||2004-10-01|June 2011|2011-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Behavioral Intervention for Minority Adolescent Women|Behavioral Intervention for Minority Adolescent Women|Completed||Phase 2|562|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:04:00.846201|2017-10-11 04:04:00.846201
NCT01387620|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-06-30|||June 2009||2009-06-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2%|Intraindividual Randomized Clinical Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2% in Phacoemulsification|Completed||Phase 4|39|Actual|University of Sao Paulo||1|||f||||f||||||||||2017-10-11 04:04:01.019389|2017-10-11 04:04:01.019389
NCT01387594|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-05-04|2016-11-15||May 2012||2012-05-01|April 2017|2017-04-01|November 2015|Actual|2015-11-01|March 2014|Actual|2014-03-01||Interventional|TOSCA||Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs|A Multi-Center, Phase 1, Open-Label Evaluation Of The Effect Of PF-00547659 (Anti Madcam Monoclonal Antibody) On Cerebrospinal Fluid (CSF) Lymphocytes In Volunteers With Crohns Disease Or Ulcerative Colitis Who Are Anti-TNFInadequate Responders (TOSCA)|Completed||Phase 1|49|Actual|Shire||2|||f||||t||||||||||2017-10-11 04:04:01.212457|2017-10-11 04:04:01.212457
NCT01387581|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2014-11-05|2014-04-03||October 2011||2011-10-01|November 2014|2014-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Does the Aid of MelaFind Affect Clinical Management Decisions|To Excise or Not?: Comparing Clinical Management Decisions for Melanoma Between Dermatologists With and Without the Aid of MelaFind|Completed||N/A|227|Actual|MELA Sciences, Inc.|A limitation of this study is the reader study format. Lesions were presented to participating dermatologists as photographs via the online system. This presentation can only approximate an in-person clinical exam.||3||f||||f||||||||||2017-10-11 04:04:01.99277|2017-10-11 04:04:01.99277
NCT01387568|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-04-18|||March 2010||2010-03-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Lidocaine Infusion for Major Abdominal Pediatric Surgery|The Effects of Intravenous Lidocaine Infusion During and After Major Abdominal Pediatric Surgery. A Randomized Double-blinded Study|Completed||Phase 3|80|Actual|Mansoura University||2|||f||||t||||||||||2017-10-11 04:04:02.526355|2017-10-11 04:04:02.526355
NCT01387555|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-03-10|||December 2008||2008-12-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|TRAVERSE||A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib|A Phase 2b Randomized Trial of JX-594 (Vaccinia GM-CSF / TK-deactivated Virus) Plus Best Supportive Care Versus Best Supportive Care in Patients With Advanced Hepatocellular Carcinoma Who Have Failed Sorafenib Treatment|Completed||Phase 2|129|Actual|Jennerex Biotherapeutics||2|||f||||t||||||||||2017-10-11 04:04:03.074236|2017-10-11 04:04:03.074236
NCT01387542|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2013-01-29|2013-01-29||August 2009||2009-08-01|January 2013|2013-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|PRESENT||Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants|An Open-label, PRospective Study to Evaluate Social Function and Overall Improvement of Paliperidone ER Treatment in Thai Schizophrenia PatieNT (PRESENT)|Completed||Phase 4|40|Actual|Janssen-Cilag Ltd.,Thailand|Study had an open-label trial design with lack of a comparator arm; therefore it was difficult to conclude the efficacy and safety results.|1|||f||||f||||||||||2017-10-11 04:04:03.265869|2017-10-11 04:04:03.265869
NCT01387529|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2014-03-06|||June 2011||2011-06-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Observational|||Reference Values for Non-invasive Hydration Status Markers H10-14|Reference Values for Non-invasive Hydration Status Markers|Completed||N/A|62|Actual|U.S. Army Medical Research and Materiel Command|||1||f||||t||||||||||2017-10-11 04:04:03.53725|2017-10-11 04:04:03.53725
NCT01387516|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-06-02|||July 2007|Actual|2007-07-01|June 2017|2017-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Motivation and Skills for Detained Teen Smokers|Motivation and Skills for Detained Teen Smokers|Completed||N/A|314|Actual|University of Rhode Island||4|||f||||t||||||||No||2017-10-11 04:04:03.594164|2017-10-11 04:04:03.594164
NCT01387503|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-01|||January 2011||2011-01-01|June 2011|2011-06-01|January 2014|Anticipated|2014-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging|Controlled Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging Procedures: a Randomized Trial (XXL Trial)|Unknown status|Recruiting|Phase 2/Phase 3|260|Anticipated|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||2|||f||||f||||||||||2017-10-11 04:04:03.710128|2017-10-11 04:04:03.710128
NCT01382043|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-24|||June 2009||2009-06-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Observational|||Angiographic and IVUS Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)||Completed||N/A|48|Actual|Liuhuaqiao Hospital|||2||f||||f||||||||||2017-10-11 04:05:26.830223|2017-10-11 04:05:26.830223
NCT01387490|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-03-02|||June 2011||2011-06-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|October 2014|Actual|2014-10-01||Interventional|CONTACT||CONcussion Treatment After Combat Trauma (CONTACT)|The Effect of Telephone Follow up on Outcome for Service Members With Mild TBI/PTSD|Completed||N/A|366|Actual|INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium||2|||f||||t||||||||||2017-10-11 04:04:03.819356|2017-10-11 04:04:03.819356
NCT01387477|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-01|||June 2011||2011-06-01|June 2011|2011-06-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Lactate and Hypoglycemia|Comparison of Two Strategies of Hypoglycemia Correction in ICU|Unknown status|Recruiting|Phase 4|50|Anticipated|Institut d'Anesthesiologie des Alpes Maritimes||2|||f||||f||||||||||2017-10-11 04:04:03.899253|2017-10-11 04:04:03.899253
NCT01387464|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-06-02|2016-04-26|2012-01-30|July 2011||2011-07-01|June 2016|2016-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||Intent-to-treat Population|Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery|A Double-Masked Clinical Study To Determine The Aqueous Humor Concentration Of Bromfenac Sodium In Subjects Administered Multiple Topical Ocular Doses Of ISV-303 Or Bromday™ Once Daily (QD) Prior To Cataract Surgery|Completed||Phase 2|60|Actual|InSite Vision||2|||f||||f||||||||||2017-10-11 04:04:03.98813|2017-10-11 04:04:03.98813
NCT01387451|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-01|||October 2010||2010-10-01|April 2010|2010-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||The Detection and Factors of Brown Adipose Tissue in Different Locations of Adults|Cross Sectional Study on the Detection and Factors of Brown Adipose Tissue in Different Locations of Adults|Unknown status|Active, not recruiting|N/A|30|Anticipated|Huashan Hospital|||1||f||||t||||||Samples Without DNA|"     Adipose tissue, plasma   "|||2017-10-11 04:04:04.383449|2017-10-11 04:04:04.383449
NCT01387438|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-07-01|||December 2009||2009-12-01|November 2009|2009-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||The Incidence,Factors,and Importance of Brown Adipose Tissue in Chinese Adults|Cross-sectional Study on the Incidence,Factors,and Importance of Brown Adipose Tissue in Adult Chinese|Unknown status|Active, not recruiting|N/A|200|Anticipated|Huashan Hospital|||1||f||||t||||||Samples Without DNA|"     plasma   "|||2017-10-11 04:04:04.444452|2017-10-11 04:04:04.444452
NCT01387425|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2015-12-01|||June 2011||2011-06-01|December 2015|2015-12-01||||December 2015|Actual|2015-12-01||Interventional|DIASMOKE||Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE)|Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: A Double-Blind, Placebo-Controlled, Randomized, Trial|Completed||N/A|300|Actual|Universita degli Studi di Catania||2|||f||||||||||||||2017-10-11 04:04:04.511182|2017-10-11 04:04:04.511182
NCT01387412|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-11-30|||April 2012||2012-04-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|VIVA||The Role of Genital Warts in HIV Acquisition in Peru|"The Role of Genital Warts in HIV Acquisition Among MSM in Peru"|Completed||N/A|600|Actual|University of California, Los Angeles|||1||f||||f||||||Samples With DNA|"     serum, lesion biopsies   "|||2017-10-11 04:04:04.59763|2017-10-11 04:04:04.59763
NCT01387399|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-02-14|||June 2011||2011-06-01|February 2013|2013-02-01|July 2013|Anticipated|2013-07-01|March 2013|Anticipated|2013-03-01||Interventional|HIPEC ROC I||Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer|Phase I Study of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion With Cisplatin in Patients With Recurrent Ovarian Cancer|Unknown status|Active, not recruiting|Phase 1|9|Anticipated|University Hospital, Bonn||1|||f||||t||||||||||2017-10-11 04:04:04.668472|2017-10-11 04:04:04.668472
NCT01387373|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-03-20|||April 2010||2010-04-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer|Intra-hepatic Chemotherapy With Oxaliplatin Every Second Week in Combination With Systemic Capecitabine in Patient With Non-resectable Liver Metastases From Breast Cancer. A Phase II Trial|Unknown status|Recruiting|Phase 2|100|Anticipated|Herlev Hospital||1|||f||||f||||||||||2017-10-11 04:04:04.743982|2017-10-11 04:04:04.743982
NCT01387360|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-05-19|||June 2011||2011-06-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|SUPRACOR||Presbyopic Supracor Treatment for Near Myopic/Hyperopic Pseudophakic Eyes|A Prospective Study to Evaluate the Safety and Effectiveness of the Supracor Presbyopic Treatment Algorithm for Pseudophakic Eyes Using Lasik|Completed||Phase 4|33|Actual|Technolas Perfect Vision GmbH||1|||f||||t||||||||||2017-10-11 04:04:04.844803|2017-10-11 04:04:04.844803
NCT01387347|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-06-10|2012-11-29||August 2011||2011-08-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye|A Double-Masked, Randomized, Single-Center Study Evaluating the Safety and Efficacy of 0.1% Tβ4 Ophthalmic Solution Compared to Vehicle on the Signs and Symptoms of Dry Eye in the Controlled Adverse Environment (CAE) Model|Completed||Phase 2|72|Actual|ReGenTree, LLC|"There were no limitations to trial RGN-DE-202 entitled:Safety and Efficacy of Thymosin beta 4 Ophthalmic Solution in Patients with Dry Eye. All subjects were enrolled."|2|||f||||f||||||||||2017-10-11 04:04:04.942534|2017-10-11 04:04:04.942534
NCT01387334|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-06-30|||February 2007||2007-02-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|February 2009|Actual|2009-02-01||Interventional|RE||The Effectiveness of Resistance Exercise for Glycemic Control in Type 2 Diabetes Mellitus Patients|The Effectiveness of a Home-Based Resistance Exercise Training Program With Rubber Bands for Glycemic Control in Individuals With Type 2 Diabetes Mellitus|Completed||Phase 2|60|Actual|Prince of Songkla University||1|||f||||f||||||||||2017-10-11 04:04:05.292904|2017-10-11 04:04:05.292904
NCT01387321|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-01-26|||September 2011||2011-09-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||A Study of BYL719 in Adult Patients With Advanced Solid Malignancies|A Study of BYL719 in Adult Patients With Advanced Solid Malignancies|Completed||Phase 1|33|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:04:05.392487|2017-10-11 04:04:05.392487
NCT01387308|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-10-27|||August 2011||2011-08-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib Tablets|An Open-label, Partially Randomized, 5-way Crossover Study in Healthy Volunteers to Assess the Relative Bioavailability of 100 and 150 mg Fostamatinib Tablets Compared With 50 mg Fostamatinib Tablets|Completed||Phase 1|24|Anticipated|AstraZeneca||5|||f||||||||||||||2017-10-11 04:04:05.518657|2017-10-11 04:04:05.518657
NCT01387295|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-03-20|||April 2010||2010-04-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease|Intra-hepatic Chemotherapy With Oxaliplatin Every Second Week in Combination With Systemic Capecitabine in Patient With Non-resectable Liver Metastases From Breast Cancer A Phase II Trial in Patients With Limited Extrahepatic Disease|Unknown status|Recruiting|Phase 2|100|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-10-11 04:04:05.628519|2017-10-11 04:04:05.628519
NCT01387282|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-08-16|2017-03-15|2014-02-12|July 2011||2011-07-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|November 2013|Actual|2013-11-01||Interventional|||Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)|Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): A Randomized Double-Blind Placebo-Controlled Multicenter Phase III Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients With NSCLC-C|Completed||Phase 3|495|Actual|Helsinn Therapeutics (U.S.), Inc||2|||f||||t||||||||||2017-10-11 04:04:05.788533|2017-10-11 04:04:05.788533
NCT01387269|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-08-16|2017-03-15|2014-02-12|July 2011||2011-07-01|August 2017|2017-08-01|February 2015|Actual|2015-02-01|January 2014|Actual|2014-01-01||Interventional||The intent-to-treat (ITT) Population included all randomized patients.|Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)|Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): A Randomized Double-Blind Placebo-Controlled Multicenter Phase III Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients With NSCLC-C|Completed||Phase 3|484|Actual|Helsinn Therapeutics (U.S.), Inc||2|||f||||t||||||||||2017-10-11 04:04:06.821221|2017-10-11 04:04:06.821221
NCT01387256|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2011-07-18|||May 2009||2009-05-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Comparing Two Regimens for Medical Abortion: Mifepristone + Misoprostol Versus Misoprostol Alone|Comparing Two Regimens for Medical Abortion: Mifepristone + Misoprostol Versus Misoprostol Alone-3 Hour Intervals|Completed||Phase 4|441|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-10-11 04:04:08.067829|2017-10-11 04:04:08.067829
NCT01387243|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-29|2012-10-25|||January 2010||2010-01-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Survey on the Pharmacy Follow-up of Alli Purchasers|Survey on the Pharmacy Follow up of Alli Purchasers|Completed||N/A|80|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:04:08.182358|2017-10-11 04:04:08.182358
NCT01387230|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-11-21|2013-12-19||July 2011||2011-07-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD|A12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of GSK573719 Delivered Once-Daily Via a Novel Dry Powder Inhaler in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|206|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:04:08.270279|2017-10-11 04:04:08.270279
NCT01387217|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2017-06-07|||May 21, 2010|Actual|2010-05-21|June 2017|2017-06-01|December 20, 2010|Actual|2010-12-20|December 20, 2010|Actual|2010-12-20||Interventional|P1A114070||GSK2018682 FTIH in Healthy Volunteers|A Single-blind, Placebo-controlled, Two Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of GSK2018682 in Healthy Volunteers|Completed||Phase 1|27|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:04:08.947992|2017-10-11 04:04:08.947992
NCT01387204|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-04-03|||February 2011||2011-02-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212|An Open-label Mass Balance Study to Investigate the Absorption, Distribution, Metabolism and Elimination of a Single Oral Dose of MEK Inhibitor [14C]GSK1120212 in Male Subjects With Solid Tumors|Completed||Phase 1|2|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 04:04:09.055179|2017-10-11 04:04:09.055179
NCT01387191|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-05-15|||August 1999||1999-08-01|May 2017|2017-05-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Observational|||Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg|Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg|Completed||N/A|748|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:04:09.174218|2017-10-11 04:04:09.174218
NCT01387178|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-05-15|2011-09-21||July 2008||2008-07-01|May 2017|2017-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease|Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease|Completed||N/A|22223|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 04:04:09.271981|2017-10-11 04:04:09.271981
NCT01387165|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2017-06-07|||October 2004||2004-10-01|May 2017|2017-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|DEAL||Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina|A Multi-center, Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latin America|Completed||N/A|3592|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:04:09.947385|2017-10-11 04:04:09.947385
NCT01387152|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-02-02|||November 2011||2011-11-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|November 2012|Actual|2012-11-01||Observational|||Prognosis of Very Low Dose SPECT|Prognosis of Very Low Dose Stress First Myocardial Perfusion SPECT in Patients With Chest Pain Using an Alcyone Camera|Completed||N/A|100|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 04:04:10.050354|2017-10-11 04:04:10.050354
NCT01387139|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-07-20|2015-12-03||January 2011||2011-01-01|July 2017|2017-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Ketamine Versus Co-administration of Ketamine and Propofol for Procedural Sedation in a Pediatric Emergency Department|Comparison of Ketamine Versus Co-Administration of Ketamine and Propofol for Procedural Sedation in a Pediatric Emergency Department|Completed||Phase 3|183|Actual|University of Colorado, Denver||2|||f||||t|t|f||||||||2017-10-11 04:04:10.138304|2017-10-11 04:04:10.138304
NCT00005500|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2008-01-25|||September 1992||1992-09-01|January 2008|2008-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Observational|||Collaborative Studies on the Genetics of Asthma (CSGA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.864035|2017-10-11 04:27:07.864035
NCT01387126|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-07-18||||||July 2017|2017-07-01||||||||Interventional|||Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program|A Randomized, Controlled Trial Evaluating the Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program, on Body Weight in Overweight and Obese Individuals|Suspended||Phase 3|240|Anticipated|Canadian Center for Functional Medicine||2||No grant funding yet for this trial.|f||||||||||||||2017-10-11 04:04:10.719391|2017-10-11 04:04:10.719391
NCT01387113|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-01-31|||May 2011||2011-05-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|PERFUSE||The PERFusion Use in Stroke Evaluation Study|Expanding the Time Window for IV Thrombolysis With Rt-PA in Acute Ischemic Stroke Patients Using Computed Tomography Perfusion Imaging: The PERFusion Use in Stroke Evaluation (PERFUSE) Study|Recruiting||N/A|100|Anticipated|California Pacific Medical Center Research Institute|||1||f||||f||||||||||2017-10-11 04:04:10.781877|2017-10-11 04:04:10.781877
NCT01387100|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-02-20|||June 2011||2011-06-01|February 2015|2015-02-01|March 2016|Anticipated|2016-03-01|December 2015|Anticipated|2015-12-01||Interventional|Work It||A Modified Rehabilitation Intervention for Working Persons With Arthritis|Efficacy of a Modified Vocational Rehabilitation Intervention for Work Disability|Unknown status|Active, not recruiting|N/A|300|Anticipated|Boston University||2|||f||||f||||||||||2017-10-11 04:04:10.877118|2017-10-11 04:04:10.877118
NCT01387087|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-06-30|||July 2008||2008-07-01|June 2011|2011-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP015K Following Single Oral Doses to Healthy Volunteers|Completed||Phase 1|72|Actual|Astellas Pharma Inc||12|||f||||f||||||||||2017-10-11 04:04:10.954769|2017-10-11 04:04:10.954769
NCT01387074|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2013-12-13|2013-12-13||June 2011||2011-06-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity|A Prospective, Non-interventional, Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity|Completed||N/A|108|Actual|Allergan|||1||f||||f||||||||||2017-10-11 04:04:11.057869|2017-10-11 04:04:11.057869
NCT01387061|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-09-18|||June 2001||2001-06-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Resection for Multiple Hepatocellular Carcinomas (HCC)|Hepatic Resection for Multiple Hepatocellular Carcinoma on Cirrhosis|Completed||N/A|87|Actual|University of Milan||1|||f||||||||||||||2017-10-11 04:04:11.585447|2017-10-11 04:04:11.585447
NCT01387048|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2013-07-05|||August 2011||2011-08-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|SKADI||Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin|Phase IV An Evaluator-Blind Controlled Parallel-Group Study To Assess Efficacy And Safety Of Skinoren® 15% Gel And Differin® 0,1% Gel For The Treatment And Maintenance Treatment Of Facial Acne Vulgaris And Late-Type Acne In Females|Completed||Phase 4|60|Actual|University of Magdeburg||3|||f||||t||||||||||2017-10-11 04:04:11.667083|2017-10-11 04:04:11.667083
NCT01387035|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-07-01|||January 2010||2010-01-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Observational|||Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases|Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases|Unknown status|Recruiting|Phase 3|50|Anticipated|Heidelberg University|||1||f||||f||||||||||2017-10-11 04:04:11.760035|2017-10-11 04:04:11.760035
NCT01387022|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-03-23|2017-01-30||June 2011||2011-06-01|March 2017|2017-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|TOAST|All participants who were randomised and initiated on ART|Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral Suppression|Open Label Randomized Controlled Trial to Assess the Impact of Prophylactic Exposure to Tenofovir Gel on the Efficacy of Subsequent Tenofovir-containing Antiretroviral Therapy on Viral Suppression|Completed||N/A|59|Actual|Centre for the AIDS Programme of Research in South Africa|The main limitation of the study was the small sample size. The eligible pool of participants was dependent on two other tenofovir gel trials, one of which experienced long delay in starting.|2|||f||||t||||||||||2017-10-11 04:04:11.847421|2017-10-11 04:04:11.847421
NCT01387009|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2016-01-26|||June 2011||2011-06-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|February 2016|Anticipated|2016-02-01||Observational|||Acquisition of Normative Data for Musculoskeletal Ultrasound in Children||Enrolling by invitation||N/A|100|Anticipated|Children's Hospital of Eastern Ontario|||1||f||||||||||||||2017-10-11 04:04:12.363421|2017-10-11 04:04:12.363421
NCT01386996|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-12-21|||July 2011||2011-07-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler|Pharmacokinetic Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 320/9 Microg/Inhalation and Symbicort Turbuhaler Forte; a Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects|Completed||Phase 1|74|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-10-11 04:04:12.431093|2017-10-11 04:04:12.431093
NCT01386983|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-28|2017-05-15|2011-02-28||March 2009||2009-03-01|May 2017|2017-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment|Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment|Completed||N/A|332|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 04:04:12.555413|2017-10-11 04:04:12.555413
NCT01386970|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-05-01|||May 2005||2005-05-01|May 2017|2017-05-01|July 2010|Actual|2010-07-01|July 2008|Actual|2008-07-01||Interventional|||Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics|Sex and Disease Dependent Nucleoside Analog Toxicity|Completed||Phase 4|51|Actual|University of Colorado, Denver||2|||f||||t||||||||No|No plan to share.|2017-10-11 04:04:12.825815|2017-10-11 04:04:12.825815
NCT01386957|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2012-03-07|||July 2011||2011-07-01|March 2012|2012-03-01|July 2015|Anticipated|2015-07-01|July 2013|Anticipated|2013-07-01||Observational|||Steroid Treatment of Idiopathic Nephrotic Syndrome|Steroid Treatment of Childhood Idiopathic Nephrotic Syndrome: Epidemiology, Therapeutic Adequacy, Medium and Long Term Outcomes. A Prospective Observational Cohort Study.|Unknown status|Recruiting|N/A|120|Anticipated|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi|||1||f||||f||||||Samples Without DNA|"     Whole Blood and Urine   "|||2017-10-11 04:04:12.929758|2017-10-11 04:04:12.929758
NCT01386944|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-07-24|2014-07-24||July 2011||2011-07-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|AURORA|The Baseline Analysis Population refers to the Full Analysis Set (FAS). The FAS is a subset of the Safety Set and consists of all patients who received treatment with Neupro at least once and had a Visit 1 and at least one post-Visit 1 measurement on the primary variable documented.|Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation|Non Interventional Observational Study to Collect Data for the Effect of Switching to Neupro® on Severity of Restless Leg Syndrome (RLS) Symptoms and Augmentation as Well as the Change in Treatment Regimen Used, in RLS Patients With Previous Augmentation|Completed||N/A|102|Actual|UCB Pharma|||1||f||||f||||||||||2017-10-11 04:04:13.13539|2017-10-11 04:04:13.13539
NCT01386931|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-09-05|||June 2011||2011-06-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||On-site Cytopathology EUS-FNA|The Clinical Impact of Immediate On-site Cytopathology Evaluation During Endoscopic Ultrasound-Guided Fine Needle Aspiration of Pancreatic Mass: A Multicenter, Prospective Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|238|Anticipated|Washington University School of Medicine|||2||f||||t||||||||||2017-10-11 04:04:13.6516|2017-10-11 04:04:13.6516
NCT01386918|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-01-04|||February 2004||2004-02-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in Schizophrenia|A Randomized Double-Blind Sham-Controlled Trial of Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in Schizophrenia|Completed||N/A|144|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-10-11 04:04:13.770075|2017-10-11 04:04:13.770075
NCT01386905|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2014-03-11|||June 2011||2011-06-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||A Study of the TransPyloric Shuttle™ (TPS™) for Weight Reduction in Obese Subjects|A Study of the TransPyloric Shuttle™ (TPS™) for Weight Reduction in Obese Subjects (ENDObesity™ I Study)|Completed||N/A|20|Actual|BaroNova, Inc.||1|||f||||t||||||||||2017-10-11 04:04:13.861193|2017-10-11 04:04:13.861193
NCT01386892|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2014-02-10|||March 2011||2011-03-01|February 2014|2014-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Immunological Characterization of Blood of Normal Individuals|Immunological Characterization of Blood of Normal Individuals|Active, not recruiting||N/A|1500|Anticipated|Ohio State University|||1||f||||f||||||Samples With DNA|"     Blood Saliva Urine   "|||2017-10-11 04:04:13.939207|2017-10-11 04:04:13.939207
NCT01386879|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-05-12|||July 2011||2011-07-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Evaluation of Above the Cuff Suctioning During General Anesthesia|Evaluation of Microaspiration and Efficacy of Above the Cuff Suctioning During General Anesthesia: A Comparison of Two Endotracheal Tubes With Suction Above Cuff With a Standard Endotracheal Tube|Terminated||Phase 4|60|Actual|Thomas Jefferson University||3||The study was terminated because of slower than anticipated enrollment|f||||f||||||||||2017-10-11 04:04:14.031774|2017-10-11 04:04:14.031774
NCT01386866|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2011-07-14|||May 2009||2009-05-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors|An Open-label, Single Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]-Labelled AMG 706 (Motesanib) Followed by Extended Treatment With Motesanib in Patients With Advanced Solid Tumors|Completed||Phase 1|4|Actual|Amgen||1|||f||||||||||||||2017-10-11 04:04:14.15042|2017-10-11 04:04:14.15042
NCT01386853|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-06-30|||July 2011||2011-07-01|June 2011|2011-06-01|July 2012|Anticipated|2012-07-01|March 2012|Anticipated|2012-03-01||Interventional|||Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients|A 12-week, Randomized, Multicenter, Double-blind, Active-controlled, Non-inferiority Study to Compare the Efficacy and Safety of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Tai Tien Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-10-11 04:04:14.245451|2017-10-11 04:04:14.245451
NCT01386840|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-25|2015-05-15|||January 2008||2008-01-01|May 2015|2015-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|ISPOT||IndiaCLEN Multicentre Trial of Home Versus Hospital Oral Amoxicillin for Management of Severe Pneumonia in Children|IndiaCLEN Multicentric Trial of Home Versus Hospital Oral Amoxicillin for Management of Severe Pneumonia in Children|Completed||N/A|1118|Actual|Lata Medical Research Foundation, Nagpur||2|||f||||t||||||||||2017-10-11 04:04:14.397559|2017-10-11 04:04:14.397559
NCT01386827|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-10-27|||January 2008||2008-01-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis|Ability of the New Vero-cell-derived Inactivated Japanese Encephalitis Vaccine (IXIARO) to Elicit a Booster Response in Travellers Previously Vaccinated With Traditional Mouse-brain Derived Vaccine (JE-MB)|Completed||Phase 3|120|Actual|Helsinki University Central Hospital||4|||f||||t||||||||||2017-10-11 04:04:14.493597|2017-10-11 04:04:14.493597
NCT01386814|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-06-30|||July 2011||2011-07-01|May 2009|2009-05-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Observational|Hypoxia||Neuropsychological Sleep Physical Exercise Hypoxia|Aspects of Neuropsychological Assessment, Standard and Sleep Efficiency in People Exposed to Altitude|Unknown status|Not yet recruiting|N/A|60|Anticipated|Federal University of São Paulo|||1||f||||t||||||||||2017-10-11 04:04:14.596346|2017-10-11 04:04:14.596346
NCT01386801|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2013-09-05|||December 2009||2009-12-01|August 2013|2013-08-01|June 2050|Anticipated|2050-06-01|December 2049|Anticipated|2049-12-01||Observational|IHS||Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana|Multicenter Research Study to Build a Repository That Will Allow Researchers to Study Chronic Diseases in the Population of Central Indiana|Active, not recruiting||N/A|1000|Anticipated|Fairbanks Institute|||2||f||||t||||||Samples With DNA|"     DNA = 1 Serum = 2 Plasma = 2 RNA = 2   "|||2017-10-11 04:04:14.661835|2017-10-11 04:04:14.661835
NCT01386788|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-08-05|2013-09-13||April 2009||2009-04-01|August 2016|2016-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|RISK||European Survey: Risk of Cyanide Poisoning in Smoke Inhalation|European Survey: Risk of Cyanide Poisoning in Smoke Inhalation, Symptoms, Key Treatment and Outcome (RISK)|Completed||N/A|102|Actual|Dr. Ernst MW Koch|General limitations of observational study||1||f||||f||||||||||2017-10-11 04:04:14.755771|2017-10-11 04:04:14.755771
NCT01381666|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-10-07||2011-06-24|January 2003||2003-01-01|October 2015|2015-10-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)||Terminated||Phase 2|22|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 04:05:33.079219|2017-10-11 04:05:33.079219
NCT01386775|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-06-26|||June 2011||2011-06-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Observational|||Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation|Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation|Completed||N/A|64|Actual|Edimer Pharmaceuticals|||2||f||||f||||||||||2017-10-11 04:04:14.933022|2017-10-11 04:04:14.933022
NCT01386762|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2011-06-30|||June 2011||2011-06-01|June 2011|2011-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effect of Intense Multi-modal Training on Bone Health and Quality of Life in Persons With Spinal Cord Injury|Effect of Intense Multi-modal Training on Bone Health and Quality of Life in Persons With Spinal Cord Injury|Unknown status|Recruiting|Early Phase 1|30|Anticipated|California State University, San Marcos||1|||f||||f||||||||||2017-10-11 04:04:15.012908|2017-10-11 04:04:15.012908
NCT01386749|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-07-27|||February 2011||2011-02-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Low-Magnitude, High Frequency Vibration Treatment on Femoral Shaft Fracture Healing|The Efficacy of Low-Magnitude, High Frequency Vibration Treatment on Accelerating the Healing of Femoral Shaft Fracture - A Prospective Randomized Controlled Clinical Trial|Completed||Phase 2/Phase 3|50|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 04:04:15.104349|2017-10-11 04:04:15.104349
NCT01386736|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2011-06-30|||April 2011||2011-04-01|June 2011|2011-06-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Vitamin D and Glucose Metabolism in Pediatrics|Vitamin D Concentrations and Their Effect on Glucose Metabolism in Pediatrics|Unknown status|Recruiting|Phase 4|110|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 04:04:15.180239|2017-10-11 04:04:15.180239
NCT01386723|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-01-31|||June 2011||2011-06-01|January 2017|2017-01-01|June 30, 2019|Anticipated|2019-06-30|March 30, 2019|Anticipated|2019-03-30||Observational|||End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia|End of EXTEND: Observing for Sustained Response Despite Discontinuation of Medication in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Treated With Eltrombopag|Recruiting||N/A|20|Anticipated|Weill Medical College of Cornell University|||1||f||||t|t|f|||f|Samples Without DNA|"     Blood specimens   "|Undecided||2017-10-11 04:04:15.275258|2017-10-11 04:04:15.275258
NCT01386710|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-08-22|||September 2011||2011-09-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma|Phase I/II Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory Glioblastoma Multiforme And Anaplastic Astrocytoma|Suspended||Phase 1/Phase 2|60|Anticipated|Northwell Health||2||In the process of transferring IRB to PI's current institution|f||||t||||||||||2017-10-11 04:04:15.372166|2017-10-11 04:04:15.372166
NCT01386697|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2014-10-10|||November 2010||2010-11-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||DIBH Proton Planning|A Prospective Radiation Oncology Planning Study For Lung, Gastrointestinal And Lymphomatous Malignancies Using Proton Radiotherapy As Compared To 3D Conformal And Intensity-Modulated X-Ray Therapy For Dosimetric Evaluation Of Tumoral Coverage And Dose To Organs-At-Risk.|Completed||N/A|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||1||f||||t||||||||||2017-10-11 04:04:15.468327|2017-10-11 04:04:15.468327
NCT01386671|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-02-19|||August 2011||2011-08-01|February 2014|2014-02-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Interventional|COMET||Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes|Safety and Efficacy of Metformin Glycinate vs Metformin Hydrochloride on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Patients|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|Laboratorios Silanes S.A. de C.V.||2|||f||||f||||||||||2017-10-11 04:04:15.667488|2017-10-11 04:04:15.667488
NCT01386658|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-02-06|||November 2011||2011-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema|A Multicenter, Open-Label, Non-Randomized Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Administration of Icatibant in Children and Adolescents With Hereditary Angioedema|Active, not recruiting||Phase 3|30|Anticipated|Shire||1|||f||||f||||||||||2017-10-11 04:04:15.911033|2017-10-11 04:04:15.911033
NCT01386645|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-10-05|||July 2011||2011-07-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|GIdiet||Effect of Dietary Glycemic Index on Beta-cell Function|Effect of Dietary Glycemic Index on Beta-cell Function|Active, not recruiting||N/A|53|Actual|Seattle Institute for Biomedical and Clinical Research||3|||f||||f||||||||||2017-10-11 04:04:16.130827|2017-10-11 04:04:16.130827
NCT01386632|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2017-05-17|2016-01-18||May 2011||2011-05-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|August 2014|Actual|2014-08-01||Interventional|||Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma|Phase II Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Stage III-IV Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 2|50|Actual|Sanford Health||2|||f||||t||||||||No||2017-10-11 04:04:16.273452|2017-10-11 04:04:16.273452
NCT01386619|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-09-14|||January 2004||2004-01-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)|Natural Killer Cell Selected T-cell Depleted Donor Lymphocyte Infusions (NK-DLI) in Patients After HLA-haploidentical Allogeneic Stem Cell Transplantation|Completed||Phase 1/Phase 2|15|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-10-11 04:04:17.127812|2017-10-11 04:04:17.127812
NCT01385059|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2017-06-08|||October 28, 2011|Actual|2011-10-28|June 2017|2017-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer|A Randomized, Phase II Study Assessing Axitinib as Pre-Surgical Therapy in Patients With High Risk Prostate Cancer|Active, not recruiting||Phase 2|60|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 04:04:41.003|2017-10-11 04:04:41.003
NCT01386606|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-08-21|2014-06-13||June 2011||2011-06-01|August 2015|2015-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||The baseline analysis consisted of all subjects enrolled.|The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)|A Randomized, Single Blind, Multi-Center Phase II Study to Evaluate the Effect of Three Different Doses of Androxal and AndroGel on 24-Hour Luteinizing Hormone and Testosterone in Normal Healthy Men|Completed||Phase 2|60|Actual|Repros Therapeutics Inc.||4|||f||||f||||||||||2017-10-11 04:04:17.239926|2017-10-11 04:04:17.239926
NCT01386593|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-04-16|||May 2011||2011-05-01|April 2015|2015-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||"Pharmacokinetic Study to Characterize Phenotyping Metrics of the Basel Cocktail After CYP Induction or Inhibition"|"Single-center, Randomized, Open-label, Two-way Crossover Study to Characterize Phenotyping Metrics of the Basel Cocktail After CYP Induction or Inhibition in Healthy Male Subjects"|Completed||Phase 1|16|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-11 04:04:18.283239|2017-10-11 04:04:18.283239
NCT01386580|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-01-21|||July 2011||2011-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.|An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.|Completed||Phase 1/Phase 2|84|Actual|BBB-Therapeutics B.V.||4|||f||||f||||||||||2017-10-11 04:04:18.375216|2017-10-11 04:04:18.375216
NCT01386567|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2013-05-16|||July 2011||2011-07-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203|A One Year Open Label Study of Androxal in the Treatment of Secondary Hypogonadism in Men Who Have Completed Protocol ZA-203|Completed||Phase 2|48|Actual|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 04:04:18.528886|2017-10-11 04:04:18.528886
NCT01386554|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-08-02|||August 2011||2011-08-01|August 2017|2017-08-01|May 5, 2017|Actual|2017-05-05|November 21, 2016|Actual|2016-11-21||Interventional|CHART||Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients|A Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Study of H.P. Acthar Gel (Acthar) in Treatment-Resistant Subjects With Persistent Proteinuria and Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy (iMN)|Completed||Phase 4|60|Actual|Mallinckrodt||2|||f||||||||||||||2017-10-11 04:04:18.651007|2017-10-11 04:04:18.651007
NCT01386541|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-05-04|||June 2011||2011-06-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers|Investigation of Safety/Tolerability, Pharmacokinetics and Pharmacodynamics After Multiple Ascending Doses of BYK324677 in Healthy Volunteers. A Monocentre, Placebo-controlled, Cross-over, Double-blind, Randomised Trial|Completed||Phase 1|36|Anticipated|Nycomed||2|||f||||||||||||||2017-10-11 04:04:18.781599|2017-10-11 04:04:18.781599
NCT01386528|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-07-24|2017-06-21|2014-01-24|June 7, 2012|Actual|2012-06-07|July 2017|2017-07-01|December 1, 2013|Actual|2013-12-01|December 1, 2013|Actual|2013-12-01||Interventional|paradigm™ 3|The full analysis set consists of all patients exposed to nonacog beta pegol.|Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B|An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B|Completed||Phase 3|13|Actual|Novo Nordisk A/S|This is a single armed study having no comparator.|1|||f||||f||||||||||2017-10-11 04:04:18.885498|2017-10-11 04:04:18.885498
NCT01386515|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-06-30|||June 7, 2011||2011-06-07|January 7, 2016|2016-01-07|January 7, 2016||2016-01-07|||||Observational|||The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (DMD)|The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (DMD)|Terminated||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:04:19.328889|2017-10-11 04:04:19.328889
NCT01386502|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-06-30|||June 15, 2011||2011-06-15|October 31, 2011|2011-10-31|October 31, 2011|Actual|2011-10-31|||||Interventional|||CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors|Phase I Trial of Escalating Doses of Anti-PD1 Monoclonal Antibody (CT-011) in Combination With p53 Vaccine in Adults With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:04:19.415256|2017-10-11 04:04:19.415256
NCT01386489|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-07-06|||June 17, 2011||2011-06-17|March 19, 2014|2014-03-19|March 19, 2014|Actual|2014-03-19|March 9, 2014|Actual|2014-03-09||Interventional|||Immune Responses to Two Experimental HIV Vaccines in Healthy Adults|VRC 016: A Phase 1b Open-Label, Randomized Clinical Trial to Evaluate Early Innate and Adaptive Immune Responses to the Investigational HIV-1 Vaccines: VRC-HIVADV014-00-VP and VRC-HIVDNA016-00-VP in Ad5 Seronegative Healthy Adults|Completed||Phase 1|36|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:04:19.494484|2017-10-11 04:04:19.494484
NCT01386476|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-10-05|||June 15, 2011||2011-06-15|September 1, 2016|2016-09-01|September 1, 2016||2016-09-01|||||Observational|||(18F)FCWAY and the Blood-Brain Barrier|The Serotonin-1A Receptor Radioligand (18F)FCWAY as a Potential Substrate for Efflux Transport at the Blood-Brain Barrier|Completed||N/A|18|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:04:19.572926|2017-10-11 04:04:19.572926
NCT01386437|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-09-07|||June 15, 2011||2011-06-15|August 31, 2017|2017-08-31||||||||Observational|||Natural History of Individuals With Immune System Problems That Lead to Fungal Infections|The Natural History, Immunologic Correlates and Genetic Defects in Patients With Mucocutaneous and Invasive Fungal Infections|Recruiting||N/A|700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:04:19.643105|2017-10-11 04:04:19.643105
NCT01386424|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-07-13|||June 1, 2011||2011-06-01|July 12, 2017|2017-07-12||||||||Observational|||Screening Volunteers for Influenza Challenge Studies|Screening of Volunteers for Influenza Human Challenge and Vaccine Studies|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:04:19.719076|2017-10-11 04:04:19.719076
NCT01386411|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-01-16|||June 2011||2011-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer|Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer|Active, not recruiting||N/A|108|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"     peripheral blood leucocytes and/or mouthwash-collected buccal epithelial cells)   "|||2017-10-11 04:04:21.415191|2017-10-11 04:04:21.415191
NCT01386398|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2015-01-20||||||January 2015|2015-01-01||||||||Interventional|||Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma|Progression Free Survival (PFS) Comparison Between Suberoylanilide Hydroxamic Acid (SAHA, Vorinostat TM) in Combination With Bortezomib (Velcade TM) and SAHA Alone in Refractory or Recurrent Advanced CTCL. A Randomized Study.|Withdrawn||Phase 3|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC||1||Company withdrew interest|f||||||||||||||2017-10-11 04:04:21.514228|2017-10-11 04:04:21.514228
NCT01386385|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-30|2017-10-04|||June 20, 2011|Actual|2011-06-20|June 2017|2017-06-01|January 2, 2021|Anticipated|2021-01-02|January 2, 2021|Anticipated|2021-01-02||Interventional|||Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery|A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy With Carboplatin and Paclitaxel for Unresectable Stage III Non-small Cell Lung Cancer (NSCLC), (NCI Study Number 8811)|Recruiting||Phase 1/Phase 2|162|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 04:04:21.664468|2017-10-11 04:04:21.664468
NCT01386372|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2016-12-14|||June 2011||2011-06-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|INSERT||Tolvaptan for In-hospital Hyponatremia|A Pilot Study To Evaluate The Incidence Of Hyponatremia In A Medical-Surgical Hospital And To Explore The Efficacy And Safety Of Tolvaptan In The Clinical Practice|Terminated||Phase 2|3|Actual|Mario Negri Institute for Pharmacological Research||2||futility|f||||f||||||||||2017-10-11 04:04:23.04565|2017-10-11 04:04:23.04565
NCT01386359|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-09-26|||February 29, 2012|Actual|2012-02-29|September 2017|2017-09-01|April 30, 2019|Anticipated|2019-04-30|April 30, 2019|Anticipated|2019-04-30||Observational|ENLIST||Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant|Evaluating Nulojix Long-Term Safety in Transplant|Active, not recruiting||N/A|1130|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 04:04:23.151304|2017-10-11 04:04:23.151304
NCT01386346|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-01-23|||June 2011|Actual|2011-06-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|August 2014|Actual|2014-08-01||Interventional|VEOX||Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer|Phase I Study of Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy in Patients With Resectable Esophageal Cancer|Active, not recruiting||Phase 1|12|Actual|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-11 04:04:23.503459|2017-10-11 04:04:23.503459
NCT01386333|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2013-11-01|||June 2011||2011-06-01|November 2013|2013-11-01||||October 2013|Actual|2013-10-01||Interventional|FTDOXY10EF||Safety Study of Intranasal Oxytocin in Frontotemporal Dementia|A Phase I Dose Finding Study of Intranasal Oxytocin in Frontotemporal Dementia, Protocol # FTDOXY10EF|Completed||Phase 1|23|Actual|Lawson Health Research Institute||4|||f||||f||||||||||2017-10-11 04:04:23.66158|2017-10-11 04:04:23.66158
NCT01386320|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-04-15|||February 2011||2011-02-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|USGAB||Ultrasound Guided Ankle Block Versus Medial Forefoot Block for Forefoot Surgery|A Randomised, Blinded Comparison of an Ultrasound Guided Ankle Block Compared to a Nerve Stimulator Guided Ankle Block for Pain Relief After Forefoot Surgery.|Completed||N/A|60|Actual|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||f||||||||||2017-10-11 04:04:23.77609|2017-10-11 04:04:23.77609
NCT01386307|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2015-03-19|||March 2011||2011-03-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Observational|Pain||Prevalence of Pain in Inpatient at the Hospital Italiano de Buenos Aires|¿Cuál es la Prevalencia de Dolor en internación en el Hospital Italiano?|Completed||N/A|800|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 04:04:23.870199|2017-10-11 04:04:23.870199
NCT01386294|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-04-16|||October 2011||2011-10-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection|A Phase III, Multi-Centre, Randomized Controlled Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel in the Prevention of Human Immunodeficiency Virus Type 1 Infection in Women, and to Examine Effects of the Microbicide on the Incidence of Herpes Simplex Virus Type 2 Infection|Completed||Phase 3|2059|Actual|CONRAD||2|||f||||t||||||||||2017-10-11 04:04:23.948999|2017-10-11 04:04:23.948999
NCT01386281|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-07-10|||October 2008||2008-10-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|||||Observational|JULINA-CLIMA||Julina Post-marketing Surveillance for Climacteric Symptoms in Japan|Drug Use Investigation of Julina Tablets 0.5 mg (Postmenopausal Osteoporosis)|Completed||N/A|506|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:04:24.062571|2017-10-11 04:04:24.062571
NCT01386268|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-08-20|||June 2011||2011-06-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Observational|KG0910KR||Kogenate FS Regulatory Post-Marketing Surveillance|KOGENATE® FS , Local Post Authorization Safety Study|Completed||N/A|64|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:04:24.147285|2017-10-11 04:04:24.147285
NCT01386255|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-08-26|||April 2009||2009-04-01|August 2017|2017-08-01|April 30, 2012|Actual|2012-04-30|April 2012|Actual|2012-04-01||Interventional|||Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy|Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy|Withdrawn||Phase 4|0|Actual|Boston Children’s Hospital||2||No participants were enrolled|f||||t||||||||||2017-10-11 04:04:24.234545|2017-10-11 04:04:24.234545
NCT01386242|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-01-04|||May 2011||2011-05-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer|Phase II/III Study of Recombinant Anti-tumor and Anti-Virus Protein for Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Second-Line and More Than Second-line Treatment|Completed||Phase 2|108|Actual|The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||4|||f||||t||||||||||2017-10-11 04:04:24.320316|2017-10-11 04:04:24.320316
NCT01386229|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-06-30|||March 2011||2011-03-01|June 2011|2011-06-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery||Unknown status|Recruiting|Phase 4|40|Anticipated|Baskent University||2|||f||||f||||||||||2017-10-11 04:04:24.413023|2017-10-11 04:04:24.413023
NCT01381484|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-30|2011-06-23|||March 2009||2009-03-01|March 2011|2011-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Argireline in Treatment of Periorbital Wrinkles|Efficacy and Safety of Topical Argireline in the Treatment of Periorbital Wrinkles|Completed||Phase 3|70|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 04:05:40.862959|2017-10-11 04:05:40.862959
NCT01386216|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-01-23|||April 2011||2011-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|April 2016|Actual|2016-04-01||Interventional|CLI||Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)|Phase I, Non-Randomized, Feasibility Study for the Use of Bone Marrow Cell Concentrate Prepared Using the Magellan System for the Treatment of Critical Limb Ischemia|Completed||Phase 1|18|Actual|Arteriocyte, Inc.||1|||f||||t||||||||||2017-10-11 04:04:24.491909|2017-10-11 04:04:24.491909
NCT01386203|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2012-02-28|||June 2011||2011-06-01|February 2012|2012-02-01|May 2018|Anticipated|2018-05-01|May 2016|Anticipated|2016-05-01||Observational|||Exhaled Breath Biomarkers in Lung Cancer|Early Detection of Lung Cancer - Exhaled Breath Nano-Analysis|Recruiting||N/A|300|Anticipated|Sheba Medical Center|||3||f||||f||||||Samples Without DNA|"     exhaled breath and CTC and biomarkers   "|||2017-10-11 04:04:24.585488|2017-10-11 04:04:24.585488
NCT01386190|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-07-01|||June 2011||2011-06-01|July 2011|2011-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Impact of Exercise on Body Composition in Premature Infants|Impact of Exercise on Body Composition in Premature Infants: New Approaches|Unknown status|Recruiting|N/A|200|Anticipated|University of California, Irvine||2|||f||||t||||||||||2017-10-11 04:04:24.669156|2017-10-11 04:04:24.669156
NCT01386177|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-01-20|||July 2011||2011-07-01|January 2016|2016-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)|Interactive Effects of Doxazosin and 3,4-Methylenedioxymethamphetamine (MDMA) in Healthy Subjects|Completed||Phase 1|16|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 04:04:24.768913|2017-10-11 04:04:24.768913
NCT01386164|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-08-15|||August 2011||2011-08-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|December 2012|Actual|2012-12-01||Interventional|HIPAVAC||Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults|Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults|Completed||Phase 4|92|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 04:04:24.874925|2017-10-11 04:04:24.874925
NCT01386151|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2016-10-12|||August 2009||2009-08-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients|Safety and Efficacy of Parenteral KGF in Moderate Asthmatic Subjects|Completed||Phase 2|24|Actual|University Hospital Southampton NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 04:04:24.979684|2017-10-11 04:04:24.979684
NCT01386138|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2013-10-16|||July 2011||2011-07-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Treating South African Pregnant Women for Methamphetamine|Treating South African Pregnant Women for Methamphetamine|Completed||N/A|60|Actual|RTI International||2|||f||||t||||||||||2017-10-11 04:04:25.116524|2017-10-11 04:04:25.116524
NCT01386125|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-03-16|2013-10-31||June 2011||2011-06-01|March 2017|2017-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) in the Treatment of Nasal Polyps (Protocol No. P05604)|Completed||Phase 3|748|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:04:25.215093|2017-10-11 04:04:25.215093
NCT01386112|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-10-31|||September 2011||2011-09-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis|A Multicenter, Randomized, Double-blind, Placebo-controlled, Safety and Tolerability Phase 1/2a Study of Two Dosing Regimens of EUR-1100 for Oral Use, in Subjects With Eosinophilic Esophagitis (EoE)|Completed||Phase 1/Phase 2|24|Actual|Forest Laboratories||3|||f||||||||||||||2017-10-11 04:04:25.478347|2017-10-11 04:04:25.478347
NCT01386099|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-08-16|||May 2011||2011-05-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|||A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM)|A Phase IIa Study to Build an Understanding of the Pharmacokinetic-Pharmacodynamic Relationship of PSN821 in Type 2 Diabetes Patients (T2DM).|Completed||Phase 2|66|Actual|Prosidion Ltd.||2|||f||||||||||||||2017-10-11 04:04:25.570336|2017-10-11 04:04:25.570336
NCT01386086|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2016-03-15|||June 2011||2011-06-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Aripiprazole and Resistant Postpartum Depression|Augmentation Therapy of Resistant Postpartum Depression With Aripiprazole|Completed||Phase 3|10|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-10-11 04:04:25.706954|2017-10-11 04:04:25.706954
NCT01386073|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2012-06-13|||July 2011||2011-07-01|June 2012|2012-06-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity|Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity|Unknown status|Recruiting|Phase 4|40|Anticipated|Innovative Medical||2|||f||||f||||||||||2017-10-11 04:04:25.865194|2017-10-11 04:04:25.865194
NCT01386060|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-04-11|||June 2011||2011-06-01|April 2017|2017-04-01|June 2017|Anticipated|2017-06-01|June 2015|Actual|2015-06-01||Interventional|||Mindfulness Meditation in Chronic Stress|Mindfulness Meditation in Chronic Stress: Measures of Adherence, Ability & Stress|Active, not recruiting||N/A|250|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 04:04:25.966512|2017-10-11 04:04:25.966512
NCT01386047|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-10-03|||August 2010||2010-08-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|iCPR and EHR||Evidence Based Decision Making: Integrating Clinical Prediction Rules|Evidence Based Decision Making: Integrating Clinical Prediction Rules Into Electronic Health Records|Completed||N/A|168|Actual|Northwell Health||2|||f||||f||||||||||2017-10-11 04:04:26.054996|2017-10-11 04:04:26.054996
NCT01386034|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2016-05-19|||July 2012||2012-07-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|CITRUGRELE 2||Effects of Oral Citrulline on Protein Metabolism in Patients With Intestinal Failure (Citrugrêle 2)|Effects of Oral Citrulline on Protein Metabolism in Patients With Intestinal Failure : a Prospective, Randomized, Double-blind, Cross-over Study|Completed||Phase 3|11|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 04:04:26.150309|2017-10-11 04:04:26.150309
NCT01381289|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2012-02-08||||||February 2012|2012-02-01||||||||Expanded Access|||VX-770 Expanded Access Program|VX-770 Expanded Access Program (EAP)|Approved for marketing||N/A|||Vertex Pharmaceuticals Incorporated|||||||||||||||||||2017-10-11 04:05:42.83891|2017-10-11 04:05:42.83891
NCT01386008|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-22|2014-02-04|2013-11-01||May 2011||2011-05-01|February 2014|2014-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Evaluation of DW Silicone Hydrogel Lens Compared to DW Silicone Hydrogel Lens||Terminated||N/A|28|Actual|Coopervision, Inc.|Incomplete data sets / Data not analyzed / Not all subjects completed the study measures at each outcome measurement time frame before the study was terminated. 20 participants completed V1 and only 1 participant completed the V2 follow-up.|1||unexpected adverse events|f||||f||||||||||2017-10-11 04:04:26.315384|2017-10-11 04:04:26.315384
NCT01385995|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-02-10|2012-02-21||January 2004||2004-01-01|February 2014|2014-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Treatment of Sleep Apnea on Metabolic Syndrome|A Controlled Trial of Continuous Positive Airway Pressure (CPAP) Therapy on Metabolic Control in Individuals With Impaired Glucose Tolerance and Sleep Apnea|Completed||Phase 2|50|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 04:04:26.583806|2017-10-11 04:04:26.583806
NCT01385982|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-01-15|||July 2011||2011-07-01|January 2016|2016-01-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|OutptATR||Improving Management of Outpatient Actionable Test Results|Improving Management of Outpatient Actionable Test Results|Completed||Phase 3|6000|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-10-11 04:04:27.081113|2017-10-11 04:04:27.081113
NCT01385969|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-11-05|||June 2011||2011-06-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||LMA Cuff Pressure and LMA-induced Complications|Using the Natural Recoil of the Inflating Syringe as a Safety Valve to Limit LMA Cuff Pressure and Decrease LMA-Induced Complications|Completed||N/A|360|Actual|Mayo Clinic|||3||f||||f||||||||||2017-10-11 04:04:27.162558|2017-10-11 04:04:27.162558
NCT01385956|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2014-11-24|||June 2011||2011-06-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||SOM 230 and Gemcitabine in Advanced Pancreatic Cancer|Phase I Study of Combination of SOM 230 Long Acting Release (LAR) + Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 1|20|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 04:04:27.270708|2017-10-11 04:04:27.270708
NCT01385943|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-09-27|||April 2011||2011-04-01|September 2013|2013-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|EUNET||VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine|VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine|Unknown status|Active, not recruiting|N/A|500|Anticipated|Lucid, Inc.|||1||f||||f||||||Samples Without DNA|"     Cutaneous tissue specimens in the form of histopathology slides and tissue blocks, clinical     pictures, dermoscopic pictures and confocal microscopy images   "|||2017-10-11 04:04:27.383715|2017-10-11 04:04:27.383715
NCT01385930|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-07-01|||March 2011||2011-03-01|March 2011|2011-03-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|DAP_K||Dietary Advice on Prescription in Kungsbacka|A New Concept for Lifestyle Change, Dietary Advice on Prescription (DAP) in Combination With Motivational Interviewing (MI), Social Support and Mobile Services|Unknown status|Recruiting|N/A|200|Anticipated|Halmstad University||2|||f||||f||||||||||2017-10-11 04:04:27.475172|2017-10-11 04:04:27.475172
NCT01385917|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2016-04-11|||October 2011||2011-10-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|pre U7-53||Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping|Study of Clinical and Radiological Changes in Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping|Recruiting||N/A|45|Anticipated|Genethon|||1||f||||f||||||None Retained|"     Total blood count with differential leukocyte count Assay of immunoglobulins and the various     sub-classes (IgG, IgM, IgA, IgE) Test for immunisation against all AAV serotypes Serum urea,     creatinine, AST/ALT , GammaGT, bilirubin, CK, alkalin phosphatase   "|||2017-10-11 04:04:27.574599|2017-10-11 04:04:27.574599
NCT01385904|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-06-29|||June 2011||2011-06-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Blood Levels of Ketamine in Patients Using Topical Application of 10% Ketamine Gel for Neuropathic Pain|Plasma Concentrations of Ketamine and Norketamine in Patients Using Topical Application of 10% Ketamine for Neuropathic Pain.|Unknown status|Recruiting|N/A|15|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-11 04:04:27.679575|2017-10-11 04:04:27.679575
NCT01385891|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-07-06|||August 2008||2008-08-01|July 2008|2008-07-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|CLOVE||Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children|Clofarabine, Cyclophosfamide, And Etoposide For The Treatment Of Relapsed Or Resistant Acute Leukemia In Pediatric Patients|Completed||Phase 2/Phase 3|40|Actual|Istituto Giannina Gaslini||1|||f||||t||||||||||2017-10-11 04:04:27.764387|2017-10-11 04:04:27.764387
NCT01385865|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-10-27|||January 2011||2011-01-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Mulberry Leaf Extract on Blood Glucose|Effect of Mulberry Leaf Extract on Blood Glucose in Subjects With Impaired Fasting Glucose|Completed||N/A|40|Anticipated|Ewha Womans University||2|||f||||t||||||||||2017-10-11 04:04:27.954665|2017-10-11 04:04:27.954665
NCT01385852|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-06-05|||May 2010||2010-05-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|February 2011|Actual|2011-02-01||Interventional|||CME With Different Fluidic Parameters|Impact of Different Fluidic Parameters on Development of Cystoid Macular Edema Following Phacoemulsification|Completed||Phase 4|150|Actual|Iladevi Cataract and IOL Research Center||3|||f||||t||||||||||2017-10-11 04:04:28.060189|2017-10-11 04:04:28.060189
NCT01385839|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-12-20|||October 2009||2009-10-01|December 2016|2016-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata|Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata|Terminated||N/A|4|Actual|Icahn School of Medicine at Mount Sinai||1||low enrollment|f||||t||||||||||2017-10-11 04:04:28.153255|2017-10-11 04:04:28.153255
NCT00005501|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1998||1998-09-01|December 2000|2000-12-01|August 2000|Actual|2000-08-01|||||Observational|||Hypertensive Treatment and Epidemiological Analyses||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.939816|2017-10-11 04:27:07.939816
NCT01385826|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2016-12-15|||June 2011||2011-06-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|November 2014|Actual|2014-11-01||Interventional|ADJUVITE||Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis|Evaluation of the Efficacy of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis: Randomized Double-blind Placebo-controlled Trial|Completed||Phase 2/Phase 3|34|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 04:04:28.231704|2017-10-11 04:04:28.231704
NCT01385813|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2011-07-15|||January 1999||1999-01-01|May 2011|2011-05-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Observational|||Inflammatory Markers in Preeclampsia||Completed||N/A|129|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 04:04:28.331098|2017-10-11 04:04:28.331098
NCT01385800|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2013-08-14|||August 2011||2011-08-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||ToleroMune Grass Exposure Unit Study|A Double-blind, Randomised, Placebo-controlled Study to Evaluate Three Doses of ToleroMune Grass in Grass Allergic Subjects Following Challenge With Grass Allergen in an Environmental Exposure Unit|Completed||Phase 2|280|Anticipated|Circassia Limited||4|||f||||f||||||||||2017-10-11 04:04:28.384828|2017-10-11 04:04:28.384828
NCT01385787|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-09-05|||October 2011|Actual|2011-10-01|September 2017|2017-09-01|May 2017|Actual|2017-05-01|May 2017|Actual|2017-05-01||Observational|||MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia|The Role of Minimal Residual Disease Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia|Completed||N/A|150|Actual|Center for International Blood and Marrow Transplant Research|||1||f||||t||||||||||2017-10-11 04:04:28.485919|2017-10-11 04:04:28.485919
NCT01385774|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-07-07|||November 2010||2010-11-01|May 2011|2011-05-01|April 2014|Anticipated|2014-04-01|November 2013|Anticipated|2013-11-01||Interventional|SUPER||SUPER Study; SUPERvised Exercise or Angioplasty for Intermittent Claudication Due to an Iliac Artery Obstruction.|SUPERvised Exercise Therapy (SET) or Immediate Percutaneous Transluminal Angioplasty (PTA) for Intermittent Claudication (IC) in Patients With an Iliac Artery Obstruction: A Randomized Controlled Trial. SUPER Study|Unknown status|Recruiting|N/A|400|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-10-11 04:04:28.621931|2017-10-11 04:04:28.621931
NCT01385761|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-03-09|||June 2011||2011-06-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||LMA Unique TM & the Self Pressurized Air-Q TM Intubating Laryngeal Airway in Children|A Prospective, Randomized Non- Crossover Investigation of the LMA Unique TM and the Self Pressurized Air-Q TM Intubating Laryngeal Airway in Children|Completed||N/A|60|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||||2017-10-11 04:04:28.976256|2017-10-11 04:04:28.976256
NCT01385748|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-07-10|2016-10-27|2015-07-07|April 2010||2010-04-01|July 2017|2017-07-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis|A Phase II, Multi-center, Randomised, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Lauriad® 50 μg and 100 μg Mucoadhesive Buccal Tablet (MBT) Applied Once Daily to Those of Placebo in the Prevention and Treatment of Chemoradiation Therapy Induced Oral Mucositis in Patients With Head and Neck Cancer|Completed||Phase 2|183|Actual|Onxeo||3|||f||||f||||||||||2017-10-11 04:04:29.113774|2017-10-11 04:04:29.113774
NCT01385735|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-06-29|||October 2011||2011-10-01|June 2011|2011-06-01|April 2013|Anticipated|2013-04-01|October 2012|Anticipated|2012-10-01||Interventional|RasQ||Emotion, Mood and Executive Function in Parkinson`s Disease (PD)|Effects of Azilect (Rasagiline) on Processing of Emotions, Mood and Executive Function in Parkinson`s Disease|Unknown status|Not yet recruiting|Phase 4|70|Anticipated|St. Josef Hospital Bochum||2|||f||||t||||||||||2017-10-11 04:04:31.264953|2017-10-11 04:04:31.264953
NCT01385722|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-09-07|||August 2011||2011-08-01|September 2017|2017-09-01|June 2031|Anticipated|2031-06-01|June 2031|Anticipated|2031-06-01||Observational|||Molecular Analysis of Thoracic Malignancies|Molecular Analysis of Thoracic Malignancies|Enrolling by invitation||N/A|1000|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"     The potential tumor tissues to be collected include paraffin-embedded tissue, frozen tissues,     or fresh tissue. These will be stored in conjunction with the Stanford Tissue Bank.   "|||2017-10-11 04:04:31.350118|2017-10-11 04:04:31.350118
NCT01385709|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-02-17|||August 2008||2008-08-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|August 2012|Actual|2012-08-01||Observational|||The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels|The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels|Completed||N/A|29|Actual|Weill Medical College of Cornell University|||2||f||||f||||||Samples Without DNA|"     Whole blood will be drawn.   "|||2017-10-11 04:04:31.425489|2017-10-11 04:04:31.425489
NCT01385696|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2015-05-28|2013-01-14||June 2011||2011-06-01|May 2015|2015-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients|Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in COPD Diagnosed Patients|Completed||Phase 3|130|Actual|Almirall, S.A.||2|||f||||||||||||||2017-10-11 04:04:31.510052|2017-10-11 04:04:31.510052
NCT01385683|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-03-21|||June 2011||2011-06-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|IMAGINE||Investigation Drug-drug Interaction Between Dabigatran and Clarithromycin|Investigation Drug-drug Interaction Between Dabigatran and Clarithromycin|Completed||Phase 1|10|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-11 04:04:31.73229|2017-10-11 04:04:31.73229
NCT01385670|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-06-29|||June 2011||2011-06-01|June 2011|2011-06-01||||June 2012|Anticipated|2012-06-01||Interventional|InterSEPT||InterSEPT: In‐Tunnel SeptRx European PFO Trial|InterSEPT: In‐Tunnel SeptRx European PFO Trial: A Prospective, Multi‐Center Study to Evaluate the Safety and Performance of the SeptRx IPO PFO Closure System|Unknown status|Recruiting|N/A|70|Anticipated|SeptRx, Inc.||1|||f||||t||||||||||2017-10-11 04:04:31.826763|2017-10-11 04:04:31.826763
NCT01385657|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-09-27||2013-09-27|July 2011||2011-07-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Tolerability of REGN668 (SAR231893) in Patients With Moderate to Severe Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Sequential Ascending, Repeated-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous REGN668 in Patients With Moderate-to-Severe Atopic Dermatitis|Completed||Phase 1/Phase 2|37|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-10-11 04:04:31.917597|2017-10-11 04:04:31.917597
NCT00005525|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||August 1998||1998-08-01|March 2005|2005-03-01|July 2002|Actual|2002-07-01|||||Observational|||Sleep Apnea in Elderly Male Twins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.913971|2017-10-11 04:27:09.913971
NCT01385644|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-11-24|2015-10-20||October 2010||2010-10-01|November 2015|2015-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|MSC in IPF|All participants meet all inclusion criteria and none of the exclusion criteria|A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis|A Phase I Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis|Completed||Phase 1|8|Actual|The Prince Charles Hospital||2|||f||||t||||||||||2017-10-11 04:04:32.042966|2017-10-11 04:04:32.042966
NCT01385631|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2014-09-01|||June 2011||2011-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|OCTIVUS||Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.|The Effect Of Ezetimibe In Addition To Optimal Cholesterol-Lowering Statin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction - Assessed By Optical Coherence Tomography And Intravascular Ultrasound.|Completed||Phase 4|87|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-11 04:04:32.577492|2017-10-11 04:04:32.577492
NCT01385618|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2015-03-24|||October 2010||2010-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Gene-polymorphisms Relating to Human Subfertility|Analysis of Gene-polymorphisms Relating to Human Subfertility: Estradiol-receptor-polymorphism and Progesterone-receptor-polymorphism|Completed||N/A|150|Actual|Infertility Treatment Center Dortmund|||3||f||||f||||||Samples With DNA|"     buccal swabs   "|||2017-10-11 04:04:32.701874|2017-10-11 04:04:32.701874
NCT01385605|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-29|2017-01-06|||August 2015||2015-08-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|March 2017|Anticipated|2017-03-01||Observational|||Analysis of Toxins in Follicle Fluid|Analysis of Toxins in Follicle Fluid From Women With Unfulfilled Pregnancy|Recruiting||N/A|250|Anticipated|Infertility Treatment Center Dortmund|||1||f||||f||||||Samples Without DNA|"     follicular fluid   "|No||2017-10-11 04:04:32.794365|2017-10-11 04:04:32.794365
NCT01385592|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-03-22||2016-03-22|November 2011||2011-11-01|March 2016|2016-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias|12-week, Double-blind, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease|Completed||Phase 2|78|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:04:32.886192|2017-10-11 04:04:32.886192
NCT01385579|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-11-18|2013-11-18||January 2010||2010-01-01|November 2013|2013-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse Population|A Randomized Controlled Trial of a Direct-to-Patient Outreach Program to Improve Rates of Colorectal Cancer Screening in a Low Income and Racially Diverse Population|Completed||N/A|202|Actual|Northwestern University|Single site study|2|||f||||f||||||||||2017-10-11 04:04:33.034026|2017-10-11 04:04:33.034026
NCT01385566|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-05-19|2012-12-11||September 2011||2011-09-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)|A Partially Blinded Randomized Clinical Trial to Study the Immunogenicity and Safety of Intradermal Administration of ZOSTAVAX™ (V211)|Completed||Phase 1|223|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 04:04:33.245781|2017-10-11 04:04:33.245781
NCT01385553|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-02-18|||June 2011||2011-06-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Fathers for Change for Men With Co-occurring Domestic Violence and Substance Abuse|Randomized Trial of Fathers for Change: An Intervention for Fathers With Co-Occuring Domestic Violence and Substance Abuse|Completed||Phase 1/Phase 2|20|Actual|Yale University||2|||f||||t||||||||||2017-10-11 04:04:34.073776|2017-10-11 04:04:34.073776
NCT01385540|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-02-29|||July 2011||2011-07-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Exploration of Cortical Neural Network in Patients With Bothersome Tinnitus|Exploration of Cortical Neural Network in Patients With Bothersome Tinnitus|Terminated||N/A|7|Actual|Washington University School of Medicine|||1|Study tasks to difficult for subjects to complete.|f||||f||||||||||2017-10-11 04:04:34.169913|2017-10-11 04:04:34.169913
NCT01385527|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-03-08|||June 2011||2011-06-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Pediatric Atopic Dermatitis (AD) Internet Survey|Using an Internet Survey to Improve Adherence in Pediatric Atopic Dermatitis|Active, not recruiting||N/A|40|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-10-11 04:04:34.247841|2017-10-11 04:04:34.247841
NCT01385514|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2012-03-22|||July 2011||2011-07-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|||||Observational|||Staphylococcus Aureus Skin and Soft Tissue Infections|Evaluating Strategies to Prevent Staphylococcus Aureus Skin and Soft Tissue Infections in Soldiers During Infantry Training|Unknown status|Recruiting|N/A|1050|Anticipated|Medical Corps, Israel Defense Force|||3||f||||f||||||Samples Without DNA|"     nasal swabs to detect Staphylococcus aureus skin infection to detect Staphylococcus aureus   "|||2017-10-11 04:04:34.341265|2017-10-11 04:04:34.341265
NCT01385501|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-02|2015-04-02|||June 2011||2011-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|April 2013|Actual|2013-04-01||Interventional|||Educational Intervention to Improve Vaccine Acceptance||Completed||N/A|155|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 04:04:34.414304|2017-10-11 04:04:34.414304
NCT01385488|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2017-04-07|||May 2011||2011-05-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bioelectrical Impedance for Self-monitoring of Lymphedema|Bioelectrical Impedance for Self-monitoring of Breast Cancer Related Lymphedema|Completed||N/A|72|Actual|Vanderbilt University||2|||f||||f||||||||Undecided||2017-10-11 04:04:34.494049|2017-10-11 04:04:34.494049
NCT01385475|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-28|||June 2009||2009-06-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Resistance Training to Improve Physical Function in the Elderly|Efficacy of Resistance Training Guidelines to Improve Function in Older Adults|Completed||N/A|25|Actual|University of Wisconsin, Milwaukee||1|||f||||f||||||||||2017-10-11 04:04:34.583185|2017-10-11 04:04:34.583185
NCT01385449|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-10-06|||June 2011||2011-06-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|July 2014|Actual|2014-07-01||Interventional|||Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks|Continuous Interscalene Block (CISB) Versus Single Injection Interscalene Block in Those Undergoing Shoulder Surgery in the Ambulatory Setting|Unknown status|Active, not recruiting|N/A|73|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 04:04:34.65642|2017-10-11 04:04:34.65642
NCT01385436|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-06-29|||May 2010||2010-05-01|June 2011|2011-06-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Observational|HPV-cancer||Distribution of Human Papillomavirus (HPV) Genotypes in Patients With Cervical Cancer From Croatia|Pre-vaccination Distribution of Human Papillomavirus (HPV) Genotypes in Patients With High Grade Cervical Squamous Intraepithelial Lesion (HSIL) and Cervical Cancer From Croatia|Unknown status|Recruiting|N/A|400|Anticipated|University Hospital for Infectious Diseases, Croatia|||1||f||||f||||||Samples With DNA|"     DNA isolates from biopsy specimens of cervical lesions.   "|||2017-10-11 04:04:34.738184|2017-10-11 04:04:34.738184
NCT01385423|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-01-21|||September 2011||2011-09-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)|Haploidentical Donor Natural Killer (NK) Cell Infusion With Intravenous Recombinant Human IL-15 (rhIL-15) in Adults With Refractory or Relapsed Acute Myelogenous Leukemia (AML)|Completed||Phase 1|26|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 04:04:34.835305|2017-10-11 04:04:34.835305
NCT01385410|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-10-24|||June 2011||2011-06-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Providing Peer Mother Support Through Cell Phone and Group Meetings to Increase Exclusive Breastfeeding in Kenya|Effectiveness of a Baby-friendly Hospital Based Mothers' Support Group, and a Cell-phone Based Peer Support Program in Supporting Exclusive Breastfeeding in an Urban Kenyan Community.|Completed||N/A|823|Actual|University of Toronto||3|||f||||f||||||||||2017-10-11 04:04:34.945252|2017-10-11 04:04:34.945252
NCT01385397|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-10-13|||September 2006||2006-09-01|October 2011|2011-10-01||||November 2007|Actual|2007-11-01||Interventional|||Integrated Obesity Care Management System|Integrated Obesity Care Management System|Completed||N/A|39|Actual|Université de Sherbrooke||1|||f||||f||||||||||2017-10-11 04:04:35.027723|2017-10-11 04:04:35.027723
NCT01385384|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-03-18|||June 2011||2011-06-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Diaphragmatic Pacemaker in Tetraplegic Patients With Spinal Cord Injuries|Evaluation of the NeuRx RA/4 Diaphragmatic Pacemaker in Tetraplegic Patients With Spinal Cord Injuries in Ventilator Support|Completed||N/A|5|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-10-11 04:04:35.100172|2017-10-11 04:04:35.100172
NCT01385371|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2017-01-18|2013-07-01||June 2011||2011-06-01|January 2017|2017-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Grass (Phleum Pratense) Sublingual Tablet (SCH 697243) in Subjects Between 5 and 65 Years of Age, With a History of Grass Pollen-Induced Rhinoconjunctivitis, With or Without Asthma (Protocol No. P08067)|Completed||Phase 3|1501|Actual|ALK-Abelló A/S||2|||f||||t||||||||||2017-10-11 04:04:35.198642|2017-10-11 04:04:35.198642
NCT01385358|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-06-29|||April 2011||2011-04-01|June 2011|2011-06-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|CASA-AF||Catheter Versus Thoracoscopic Surgical Ablation Strategy in Persistent Atrial Fibrillation|A Study to Assess Catheter Ablation Versus Thoracoscopically Assisted Surgical Ablation in Persistent Atrial Fibrillation|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 04:04:35.894675|2017-10-11 04:04:35.894675
NCT01385345|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2015-06-09|||August 2012||2012-08-01|January 2013|2013-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|VITALITY||Vitamin D Replacement in Insulin Resistant South Asians|Can Vitamin D Replacement Reduce Insulin Resistance In South Asians With Vitamin D Deficiency?|Terminated||N/A|3|Actual|University of Leicester||2||"Recommended by DMEC. Poor recruitment, changes in current clinical management of Vit D   deficiency. Research question no longer relevant"|f||||t||||||||||2017-10-11 04:04:35.998453|2017-10-11 04:04:35.998453
NCT01385332|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-28|2017-09-19|||March 2010||2010-03-01|September 2017|2017-09-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||A Comparative Study of Two Patterns of Controlled Ovarian Hyperstimulation in Mid Follicular Phase or Early Luteal Phase for Egg Donors|A Comparative Study of Two Patterns of Controlled Ovarian Hyperstimulation in Mid Follicular Phase or Early Luteal Phase for Egg Donors|Completed||N/A|10|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 04:04:36.1171|2017-10-11 04:04:36.1171
NCT01385319|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-10-06|||June 2011||2011-06-01|October 2012|2012-10-01|December 2017|Anticipated|2017-12-01|September 2012|Actual|2012-09-01||Interventional|ZEUS||Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study|Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study|Active, not recruiting||Phase 3|1606|Actual|Università degli Studi di Ferrara||2|||f||||t||||||||||2017-10-11 04:04:36.198532|2017-10-11 04:04:36.198532
NCT01385306|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2016-02-17|||June 2011||2011-06-01|February 2016|2016-02-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|BC-SA-01||Noninvasive Neurostimulation of the Vagus Nerve for the Relief of Acute Bronchoconstriction Due to Asthma|Noninvasive Neurostimulation of the Vagus Nerve With the AlphaCore System for the Relief of Acute Bronchoconstriction Due to Asthma|Terminated||Phase 1/Phase 2|6|Actual|ElectroCore LLC||1||Slow enrollment|f||||t||||||||||2017-10-11 04:04:36.320187|2017-10-11 04:04:36.320187
NCT01385293|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-04-14|2017-02-22||August 2011||2011-08-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||BKM120 in Metastatic Castration-resistant Prostate Cancer|Phase II Study of BKM120 in Men With Metastatic Castration-Resistant Prostate Cancer|Terminated||Phase 2|30|Actual|Duke University||1||The trial was stopped at the first stage due to futility|f||||f||||||||||2017-10-11 04:04:36.596382|2017-10-11 04:04:36.596382
NCT01385280|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-12-02|||February 2011||2011-02-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|January 2013|Actual|2013-01-01||Interventional|||Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer|A Pilot Study Of Estradiol Followed By Exemestane For Post-Menopausal Hormone Receptor Positive Metastatic Breast Cancer After Prior Failed Endocrine Therapy: Reversing Endocrine Resistance|Completed||N/A|13|Actual|University of Arizona||1|||f||||t||||||||||2017-10-11 04:04:37.199857|2017-10-11 04:04:37.199857
NCT01385072|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-11-14|||August 2011||2011-08-01|June 2011|2011-06-01|April 2015|Anticipated|2015-04-01|August 2014|Anticipated|2014-08-01||Interventional|||Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies|Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 04:04:40.911642|2017-10-11 04:04:40.911642
NCT01385267|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-09-07|||June 2009||2009-06-01|September 2016|2016-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Fetal Lung Maturation in Twin Gestations|Fetal Lung Maturation in Twin Gestations Based on Birth Order and Weight Discordance|Completed||N/A|50|Actual|TriHealth Inc.|||1||f||||t||||||Samples Without DNA|"     A sample of amniotic fluid will be drawn from the amniotic sac of Twin A and Twin B. Each     amniotic sac will be aspirated by the obstetrician and sent to the laboratory for     determination of fetal lung maturity index and lamellar body count. Fetal lung maturity index     and lamellar body count will be correlated to see if there is an association between Twin A     and Twin B.      Fetal Lung Maturity index and lamellar body count will be calculated and compared based on     fetal weight, sex, zigosity, and birth order. Demographic information, maternal obstetrical     and medical history, newborn/fetal data, indications for cesarean section and twin A and B     outcomes will be obtained through OB Traceview or patient chart.   "|No||2017-10-11 04:04:37.327005|2017-10-11 04:04:37.327005
NCT01385254|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-20|2013-12-10|||January 2010||2010-01-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Observational|||Mother Sibling Interactions Following Very Low Birth Weight (VLBW) Infant Homecoming|Mother Sibling Interactions Following Very Low Birth Weight (VLBW) Infant Homecoming|Completed||N/A|300|Actual|Duke University|||2||f||||t||||||||||2017-10-11 04:04:37.41752|2017-10-11 04:04:37.41752
NCT01385241|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-10-20|||July 2011||2011-07-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women|Feasibility of a Stigma Reduction Intervention for HIV-infected Women|Completed||N/A|99|Actual|Duke University||2|||f||||t||||||||||2017-10-11 04:04:37.501389|2017-10-11 04:04:37.501389
NCT01385228|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2017-04-03|||June 2011||2011-06-01|April 2017|2017-04-01|February 2016|Actual|2016-02-01|July 2015|Actual|2015-07-01||Interventional|||Pazopanib, Docetaxel, Prednisone Prostate|Phase I Study of Docetaxel, Prednisone and Pazopanib in Men With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and Poor-Risk Factors|Completed||Phase 1|36|Actual|Duke University||2|||f||||f||||||||||2017-10-11 04:04:37.59197|2017-10-11 04:04:37.59197
NCT01385215|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2012-12-05|||April 2011||2011-04-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Strategies for Enhancing Mucosal Immunity to Influenza Vaccine|Strategies for Enhancing Mucosal Immunity to Influenza Vaccine|Completed||Early Phase 1|60|Actual|Duke University||4|||f||||f||||||||||2017-10-11 04:04:37.73169|2017-10-11 04:04:37.73169
NCT01385202|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-01-20|2014-12-17||June 2011||2011-06-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional||All enrolled subjects, including all who signed inform consent form.|THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation|THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation|Completed||Phase 3|172|Actual|Biosense Webster, Inc.||1|||f||||||||||||||2017-10-11 04:04:37.832069|2017-10-11 04:04:37.832069
NCT01385189|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-05-30|2017-01-13||May 2012||2012-05-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|January 2015|Actual|2015-01-01||Interventional|||Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant|Phase I Study of the Safety and Immunogenicity of Na-GST-1/Alhydrogel® With Different Doses of the Novel Immunostimulant GLA-AF in Healthy Adults|Completed||Phase 1|40|Actual|Baylor College of Medicine||5|||f||||t||||||||||2017-10-11 04:04:38.364918|2017-10-11 04:04:38.364918
NCT01385163|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-07-15|||October 2010||2010-10-01|June 2011|2011-06-01|July 2013|Anticipated|2013-07-01|August 2012|Anticipated|2012-08-01||Interventional|||Intervention Effectiveness in Improving Psychosocial and Economic Well-being of Sexual Violence Survivors in DRC|Study of Intervention Effectiveness in Improving Psychosocial and Economic Well-being of Sexual Violence Survivors in DRC|Unknown status|Recruiting|N/A|1000|Anticipated|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||||2017-10-11 04:04:39.023593|2017-10-11 04:04:39.023593
NCT01385150|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-05-18|||January 3, 2012|Actual|2012-01-03|May 2017|2017-05-01|February 3, 2012|Actual|2012-02-03|February 3, 2012|Actual|2012-02-03||Observational|||Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia|Analysis of Serum 2-Hydroxyglutarate (2HG) Levels, IDH Mutations and Clinical Outcome in Acute Myeloid Leukemia (AML)|Completed||N/A|220|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 04:04:39.139403|2017-10-11 04:04:39.139403
NCT01385137|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-02-23|2016-11-15||February 2012||2012-02-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy|S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III|Completed||Phase 3|262|Actual|Southwest Oncology Group||2|||f||||t||||||||No||2017-10-11 04:04:39.280344|2017-10-11 04:04:39.280344
NCT01385124|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-06-18|||September 2012||2012-09-01|September 2012|2012-09-01||||December 2015|Anticipated|2015-12-01||Interventional|||Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation|Safety and Efficacy of Oral Cannabidiol for GVHD Prophylaxis in Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-10-11 04:04:40.544973|2017-10-11 04:04:40.544973
NCT01385111|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-10-17|||June 2011||2011-06-01|June 2011|2011-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Combined Application of EBUS and EUS in Lung Cancer|Combined Application of EBUS-TBNA and EUS-B-FNA in Mediastinal Staging of Lung Cancer; EBUS-TBNA Centered Procedure vs. EUS-B-FNA Centered Procedure, a Randomized Study.|Completed||N/A|162|Actual|National Cancer Center, Korea||2|||f||||t||||||||||2017-10-11 04:04:40.644906|2017-10-11 04:04:40.644906
NCT01385046|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-28|||August 2009||2009-08-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|FIT||Project Fit:a School- and Community-based Obesity Intervention|Project Fit:a School- and Community-based Intervention to Address Physical Activity and Healthy Eating Among Low-income Elementary School Children|Completed||N/A|403|Actual|Michigan State University||1|||f||||t||||||||||2017-10-11 04:04:41.209125|2017-10-11 04:04:41.209125
NCT01385033|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-06-01|2014-01-06||August 19, 2011|Actual|2011-08-19|June 2017|2017-06-01|May 15, 2012|Actual|2012-05-15|May 15, 2012|Actual|2012-05-15||Interventional|||[18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)|A Clinical Trial to Characterize the Performance of [18F]MK-3328 in Subjects With Alzheimer's Disease or Mild Cognitive Impairment, and Healthy Young, and Healthy Elderly Subjects|Terminated||Phase 1|20|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 04:04:41.331056|2017-10-11 04:04:41.331056
NCT01385020|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-10-13|||July 2011||2011-07-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Gemfibrozil on the Safety and Pharmacokinetics of Red Yeast Rice in Healthy Subjects|Effect of Gemfibrozil on the Safety and Pharmacokinetics of Red Yeast Rice in Healthy Subjects|Completed||Phase 4|12|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:04:41.624129|2017-10-11 04:04:41.624129
NCT01385007|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-06-28|||August 2011||2011-08-01|June 2011|2011-06-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|PAVED-T||Preventing Aggression In Veterans With Dementia (PAVED) - Telephone Sub-Study With Rural Veterans|Preventing Aggression In Veterans With Dementia (PAVED) - Telephone Sub-Study With Rural Veterans|Unknown status|Not yet recruiting|N/A|40|Anticipated|Michael Debakey Veterans Affairs Medical Center||1|||f||||f||||||||||2017-10-11 04:04:41.709594|2017-10-11 04:04:41.709594
NCT01384994|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2012-07-05|||August 2011||2011-08-01|July 2012|2012-07-01|August 2014|Anticipated|2014-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients||Unknown status|Recruiting|Phase 2|111|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 04:04:41.771094|2017-10-11 04:04:41.771094
NCT01384981|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-09-03|||January 2011||2011-01-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Non-invasive Ventilation on Rehabilitation Outcome in COPD-patients|Effects of Non-invasive Ventilation on Exercise Capacity and Quality of Life in COPD-patients GOLD III/IV|Terminated||N/A|31|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2||major problems in recruiting patients due to very strict inclusion criteria|f||||f||||||||||2017-10-11 04:04:41.888748|2017-10-11 04:04:41.888748
NCT01384968|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-10-16|||July 2011||2011-07-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|||Acute Nitrate Supplementation in Cyclists|Acute Dietary Nitrate Supplementation to Improve Performance in Endurance Trained Athletes|Completed||N/A|20|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 04:04:41.971958|2017-10-11 04:04:41.971958
NCT01384955|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-03-31|||January 2010||2010-01-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Observational|||HRQoL and Function of Adults Treated in Adolescence for Scoliosis With Physical Exercises|THE ASSESSMENT OF QUALITY OF LIFE AND FUNCTION OF ADULTS TREATED IN ADOLESCENCE FOR IDIOPATHIC SCOLIOSIS WITH PHYSICAL EXERCISES|Completed||N/A|143|Actual|Józef Piłsudski University of Physical Education|||2||f||||f||||||||||2017-10-11 04:04:42.070364|2017-10-11 04:04:42.070364
NCT01384942|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-11-07|||June 2010||2010-06-01|August 2013|2013-08-01|October 2013|Actual|2013-10-01|March 2012|Actual|2012-03-01||Interventional|||Meaning-based Group Counselling for Bereavement|The Development and Pilot Testing of Meaning-based Group Counselling Intervention for Bereavement|Completed||Phase 2|26|Actual|Jewish General Hospital||2|||f||||||||||||||2017-10-11 04:04:42.157024|2017-10-11 04:04:42.157024
NCT01384929|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-06-28|||July 2010||2010-07-01|April 2011|2011-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|INDICAPS||Study of Intensive Care Units in India|Indian Intensive Care Case Mix and Practice Patterns Study|Completed||N/A|4236|Actual|Indian Society of Critical Care Medicine|||1||f||||f||||||||||2017-10-11 04:04:42.233977|2017-10-11 04:04:42.233977
NCT01384916|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-04-12|||June 2011||2011-06-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Interventional|HAD||Holistic Approaches to Depression|Holistic Approaches to Depression|Completed||Phase 2|121|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-11 04:04:42.298098|2017-10-11 04:04:42.298098
NCT01384903|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-03-22|||June 2011||2011-06-01|March 2017|2017-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|3357-004||An Open-label Study of KW-3357|An Open-label Study of KW-3357 Compared to Plasma-derived Antithrombin for Disseminated Intravascular Coagulation (DIC) Associated With Infection|Completed||Phase 3|221|Actual|Kyowa Hakko Kirin Co., Ltd||2|||f||||||||||||||2017-10-11 04:04:42.3722|2017-10-11 04:04:42.3722
NCT01384890|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-02-05|||July 2011||2011-07-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Feasibility of VMAT and CBCT for Head and Neck Carcinomas|Feasibility of Volumetric Modulated Arc Therapy and Cone-Beam Computed Tomography for Head and Neck Carinomas: Analysis of Clinical Throughput and Patient Reported Outcomes.|Completed||Phase 1|20|Actual|British Columbia Cancer Agency||2|||f||||f||||||||||2017-10-11 04:04:42.529511|2017-10-11 04:04:42.529511
NCT01384877|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-07-23|||December 2011||2011-12-01|July 2015|2015-07-01||||August 2017|Anticipated|2017-08-01||Interventional|||Subcutaneous Lidocaine For Cancer-Related Pain|A Randomized Double Blind Placebo Controlled Crossover Trial of the Use of Subcutaneous Lidocaine Infusion (SCLI) for Chronic Cancer-related Pain|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|British Columbia Cancer Agency||2|||f||||f||||||||||2017-10-11 04:04:42.609815|2017-10-11 04:04:42.609815
NCT01384864|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-01-07|||August 2011||2011-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia|Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia|Completed||Early Phase 1|30|Actual|Anandasabapathy, Sharmila, M.D.||1|||f||||t||||||||||2017-10-11 04:04:42.710674|2017-10-11 04:04:42.710674
NCT01384851|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-30|||July 2011||2011-07-01|February 2011|2011-02-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|||Efficacy of the Chronic Application of Tear Formulations|Therapeutic Efficacy of the Chronic Application of Tear Formulations for Dry Eye and Normal Subjects Under Conditions of Environmental Stress|Unknown status|Not yet recruiting|N/A|38|Anticipated|Glasgow Caledonian University||3|||f||||t||||||||||2017-10-11 04:04:42.784757|2017-10-11 04:04:42.784757
NCT01384838|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-06-03|||June 2011||2011-06-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Exercise Training in Postmenopausal Patients With Breast Cancer|Randomized Trial of Exercise Training in Postmenopausal Patients With Hormone-receptor Positive Breast Cancer Undergoing Treatment With Aromatase Inhibitors|Completed||N/A|80|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||2|||f||||f||||||||||2017-10-11 04:04:42.883951|2017-10-11 04:04:42.883951
NCT01384825|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-09-14|||December 2010||2010-12-01|September 2012|2012-09-01|October 2012|Anticipated|2012-10-01|September 2012|Actual|2012-09-01||Observational|COSMO||Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases|Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases|Unknown status|Active, not recruiting|N/A|2000|Anticipated|Fondazione Italiana Sclerosi Multipla|||3||f||||t||||||||||2017-10-11 04:04:42.966323|2017-10-11 04:04:42.966323
NCT01384812|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-11-08|||September 2010||2010-09-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Prostaglandin E2 in Migraine Suffers Without Aura.|Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of Prostaglandin E2 in Migraine Suffers Without Aura.|Completed||N/A|12|Anticipated|Danish Headache Center||2|||f||||t||||||||||2017-10-11 04:04:43.104817|2017-10-11 04:04:43.104817
NCT01384786|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-06-28|||October 2004||2004-10-01|June 2011|2011-06-01|July 2005|Actual|2005-07-01|||||Observational|||The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter|The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter|Completed||N/A|4474|Actual|Copenhagen University Hospital at Herlev|||1||f||||t||||||||||2017-10-11 04:04:43.268652|2017-10-11 04:04:43.268652
NCT01384773|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-09-27||||||September 2017|2017-09-01||||||||Expanded Access|||Progressive Keratoconus or Ectasia Treatment Plan|Increasing CrossLinking of Corneal Collagen in Eyes With Progressive Keratoconus or Ectasia|No longer available||N/A|||Columbia University|||||||||||||||||||2017-10-11 04:04:43.334854|2017-10-11 04:04:43.334854
NCT01384760|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2015-02-03|2014-08-04||January 2011||2011-01-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|OSA||Lifestyle Modification Program to Treat Obstructive Sleep Apnea Patients|A Randomized Controlled Study to Examine the Effect of Lifestyle Modification Program in Obstructive Sleep Apnea Patients|Completed||N/A|185|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 04:04:43.409466|2017-10-11 04:04:43.409466
NCT01384747|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2017-02-23|||July 2011||2011-07-01|February 2017|2017-02-01|May 31, 2019|Anticipated|2019-05-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)|A Randomized, Double-blind Study of Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease|Active, not recruiting||Phase 4|186|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||No|This is not a publicly funded trial.|2017-10-11 04:04:45.225805|2017-10-11 04:04:45.225805
NCT01384734|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-09-04|||July 26, 2011|Actual|2011-07-26|September 2017|2017-09-01|May 12, 2017|Actual|2017-05-12|May 12, 2017|Actual|2017-05-12||Interventional|||HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections|A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose|Completed||Phase 2|246|Actual|ViiV Healthcare||5|||f||||t||||||||||2017-10-11 04:04:45.395767|2017-10-11 04:04:45.395767
NCT01384721|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2017-01-23|||September 2010||2010-09-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|PRORECAD||Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease|Computed Tomography Coronary Angiography Prognostic Registry for Coronary Artery Disease - CTCA-PRORECAD|Recruiting||N/A|1000|Anticipated|Azienda Ospedaliero-Universitaria di Parma|||1||f||||f||||||||||2017-10-11 04:04:45.641842|2017-10-11 04:04:45.641842
NCT01384708|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-01-07|||August 2010||2010-08-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer|Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer|Completed||Early Phase 1|70|Actual|Anandasabapathy, Sharmila, M.D.||1|||f||||t||||||||||2017-10-11 04:04:45.786748|2017-10-11 04:04:45.786748
NCT01384695|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-01-08|||June 2009||2009-06-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1|A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia - Project 1|Terminated||Early Phase 1|67|Actual|Anandasabapathy, Sharmila, M.D.||2||Low/no enrollment. No subjects were enrolled over the past year.|f||||f||||||||||2017-10-11 04:04:45.866078|2017-10-11 04:04:45.866078
NCT01384682|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-01-18|||August 2011||2011-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|MARCH||Maraviroc Switch Collaborative Study|Randomised, Openlabel Study Evaluating Efficacy and Safety of Maraviroc as a Switch for Either NRTI or PI/r in HIV-1 Infected Individuals With Stable, Well‐Controlled Plasma HIV‐RNA While Taking Their First N(t)RTI + PI/r Regimen of cART|Completed||Phase 4|399|Actual|Kirby Institute||3|||f||||t||||||||||2017-10-11 04:04:45.962101|2017-10-11 04:04:45.962101
NCT01384669|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-06-01|||June 2011||2011-06-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis|Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis|Unknown status|Recruiting|N/A|80|Anticipated|Yonsei University|||2||f||||f||||||Samples With DNA|"     mRNA extract from Thyroid tissue 2mmx2mmx2mm (nomal thyroid and papillary thyroid     microcarcinoma >5mm)   "|||2017-10-11 04:04:46.305002|2017-10-11 04:04:46.305002
NCT00005526|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1991||1991-08-01|August 2004|2004-08-01|November 2001|Actual|2001-11-01|||||Observational|||Genetic Basis of Abdominal Aortic Aneurysm||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.961673|2017-10-11 04:27:09.961673
NCT01384656|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-03-04|||February 2011||2011-02-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome|Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome|Completed||Phase 4|66|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 04:04:46.410186|2017-10-11 04:04:46.410186
NCT01384643|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-04-10|||May 2011||2011-05-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery|Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery: A Prospective, Randomized Controlled Trial|Completed||Phase 4|112|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 04:04:46.492644|2017-10-11 04:04:46.492644
NCT01384630|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2014-06-05||2014-06-05|September 2011||2011-09-01|June 2014|2014-06-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis|A Phase II Open Label Study of the Safety, Pharmacokinetics, and Efficacy of a True Human Anti-inflammatory Therapeutic Antibody (RA-18C3) in Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 2|8|Actual|XBiotech, Inc.||1|||f||||f||||||||||2017-10-11 04:04:46.571001|2017-10-11 04:04:46.571001
NCT01384617|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-07-20|||June 2011||2011-06-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2014|Actual|2014-06-01||Interventional|||Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy|Roux-en-Y Anastomosis of the Pancreatic Stump Following Distal Pancreatectomy|Completed||N/A|136|Anticipated|Wakayama Medical University||2|||f||||t||||||||||2017-10-11 04:04:46.657883|2017-10-11 04:04:46.657883
NCT01384604|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-06-21|||December 2007||2007-12-01|June 2012|2012-06-01||||August 2012|Anticipated|2012-08-01||Observational|BSNIP||Neurophysiological Studies in Schizophrenia and Psychiatric Disorders|Neurophysiological and Genetic Studies in Schizophrenia and Other Psychiatric Disorders|Unknown status|Recruiting|N/A|1189|Anticipated|University of Texas Southwestern Medical Center|||1||f||||t||||||Samples With DNA|"     Blood, no more than 30cc; urine, small collection cup (about 30cc) to administer drug urine     screen and pregnancy tests for females; buccal swabs (at least 5 swabs from volunteers that     cannot donate blood); and, optional: 4mm punch of skin for dermal biopsy.   "|||2017-10-11 04:04:46.770138|2017-10-11 04:04:46.770138
NCT01384591|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-07-01|||July 2011||2011-07-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly|Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly|Completed||Phase 1/Phase 2|6|Actual|The University of Texas Medical Branch, Galveston||3|||f||||t||||||||||2017-10-11 04:04:46.86805|2017-10-11 04:04:46.86805
NCT01384578|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-10-08|||July 2011||2011-07-01|July 2012|2012-07-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis|A Randomized Controlled Project to Study the Efficacy of Combined Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis|Withdrawn||Phase 3|0|Actual|Institute of Liver and Biliary Sciences, India||2||Lack of funds|f||||f||||||||||2017-10-11 04:04:46.968106|2017-10-11 04:04:46.968106
NCT01384565|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2013-07-30|||July 2011||2011-07-01|July 2012|2012-07-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease|A Prospective Randomized Double Blind Trial to Study the Efficacy of G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease|Completed||Phase 3|55|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 04:04:47.05473|2017-10-11 04:04:47.05473
NCT01384552|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-25|2012-04-19|||June 2011||2011-06-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Do Weight Status and the Level of Dietary Restraint Moderate the Relationship Between Package Unit Size and Food Intake?|Do Weight Status and the Level of Dietary Restraint Moderate the Relationship Between Package Unit Size and Food Intake?|Completed||N/A|64|Actual|University of Tennessee||8|||f||||f||||||||||2017-10-11 04:04:47.128552|2017-10-11 04:04:47.128552
NCT01384539|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-07-14|2017-07-14||July 2011|Actual|2011-07-01|July 2017|2017-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Vitamin D and Arterial Function in Patients With Chronic Kidney Disease|Vitamin D and Arterial Function in Patients With Chronic Kidney Disease|Completed||N/A|128|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 04:04:47.240969|2017-10-11 04:04:47.240969
NCT01384526|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2015-03-06|||June 2011||2011-06-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Investigating the Impact of Tamoxifen Therapy on Ovarian Aging|Investigating the Impact of Tamoxifen Therapy on Ovarian Aging|Completed||N/A|266|Actual|University of California, San Francisco|||2||f||||t||||||Samples With DNA|"     Serum AMH, FSH, estradiol, and Inhibin B will be measured. Blood will be collected and     processed by the UCSF Center for Reproductive Health. Serum samples will be stored at -80oC     in a designated freezer with an alarm system. Biomarker assessments will be performed by     Quest Laboratories under standard quality control.   "|||2017-10-11 04:04:47.496162|2017-10-11 04:04:47.496162
NCT01384513|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-10-18|||August 2011||2011-08-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|January 2018|Anticipated|2018-01-01||Interventional|||A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies|A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies|Recruiting||Phase 2|50|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 04:04:47.579488|2017-10-11 04:04:47.579488
NCT01384500|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-09-27|||July 2011||2011-07-01|September 2016|2016-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|OCTOPUS||The Ornge Comparison of Tracheal Occlusion Pressures to Ensure Safety Trial|The Ornge Comparison of Tracheal Occlusion Pressures to Ensure Safety (OCTOPUS) Trial|Withdrawn||N/A|0|Actual|Ornge Transport Medicine||2||Workforce issues precluding study completion.|f||||t||||||||||2017-10-11 04:04:47.790353|2017-10-11 04:04:47.790353
NCT01384487|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-02-17|||June 2011||2011-06-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Nidek RS3000 Comparative Study|Comparative Study of the Nidek Optical Coherence Tomography RS-3000 and the RTVue OCT Predicate Device for the Measurements of Retinal and RNFL Thickness, Optic Disc Analysis, Pachymetry, Anterior Chamber Imaging and SLO Imaging.|Completed||N/A|89|Actual|Nidek Co. LTD.|||4||f||||f||||||||||2017-10-11 04:04:48.03796|2017-10-11 04:04:48.03796
NCT01384474|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-07-17|||September 2011||2011-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Observational|IDILIC||Impact of Crew Resource Management Training to Improve the Effectiveness of Surgical Safety Checklist (IDILIC)|Impact of Crew Resource Management Training to Improve the Effectiveness of Surgical Safety Checklist|Completed||N/A|23056|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-10-11 04:04:48.134605|2017-10-11 04:04:48.134605
NCT01384461|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2016-11-01|||January 2011||2011-01-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE)|An Open-label, Multicenter Non-interventional Trial to Evaluate Safety, Tolerability and Efficacy of Tocilizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis|Completed||N/A|251|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:04:48.211393|2017-10-11 04:04:48.211393
NCT01384448|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-03-21|||August 2011||2011-08-01|March 2017|2017-03-01|February 2017|Actual|2017-02-01|February 2016|Actual|2016-02-01||Interventional|||Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain|A Randomized Trial Comparing Coronary CT Angiography and Stress Echocardiography for Evaluation of Low-to-Intermediate Risk Emergency Department Chest Pain Patients|Completed||N/A|400|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 04:04:48.319481|2017-10-11 04:04:48.319481
NCT01384435|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-11-29||||||March 2012|2012-03-01||||||||Interventional|||A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)|A Randomized, Double Blind, Placebo-controlled Phase II Study of KPS-0373 in Patients With SCD|Completed||Phase 2|200|Anticipated|Kissei Pharmaceutical Co., Ltd.||5|||f||||f||||||||||2017-10-11 04:04:48.419941|2017-10-11 04:04:48.419941
NCT01384422|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-08-14|||June 2011||2011-06-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients||Completed||Phase 2|36|Actual|Galapagos NV||3|||f||||f||||||||||2017-10-11 04:04:48.508499|2017-10-11 04:04:48.508499
NCT01384409|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-03-22|||February 2012||2012-02-01|March 2017|2017-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|3357-006||A Phase 3 Clinical Study of KW-3357 in Patients With DIC|A Clinical Study of KW-3357 in Patients Diagnosed as Disseminated Intravascular Coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC Criteria|Terminated||Phase 3|5|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||||||||||||2017-10-11 04:04:48.586035|2017-10-11 04:04:48.586035
NCT01384396|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-03-22|||December 2011||2011-12-01|March 2017|2017-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|3357-005||A Clinical Study of KW-3357 in Patients With DIC|A Clinical Study of KW-3357 in Patients Diagnosed as Disseminated Intravascular Coagulation (DIC) by the Diagnostic Criteria for DIC Established by the Japanese Ministry of Health and Welfare|Completed||Phase 3|15|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||||||||||||2017-10-11 04:04:48.654718|2017-10-11 04:04:48.654718
NCT01384383|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2014-01-02||2013-11-26|August 2011||2011-08-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype|A Phase 2 Randomized, Open-Label, Exploratory Trial of GS-5885, GS-9451 With Peginterferon Alfa 2a and Ribavirin (RBV) in Treatment-Naïve Subjects With Chronic Genotype 1 Hepatitis C Virus Infection and IL28B CC Genotype|Terminated||Phase 2|248|Actual|Gilead Sciences||2|||f||||||||||||||2017-10-11 04:04:48.738213|2017-10-11 04:04:48.738213
NCT01384370|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-18|2011-10-04|||June 2011||2011-06-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|AHPV-GT||APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results|Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the TIGRIS® DTS® System in Women With ASC-US Pap Test Results and in Women 30 Years of Age or Older With Negative Pap Test Results Using ThinPrep Pap Test Specimens|Completed||N/A|1260|Anticipated|Gen-Probe, Incorporated|||1||f||||f||||||Samples With DNA|"     Cervical specimens collected in ThinPrep Pap Test vials containing PreservCyt Solution     (Hologic, Inc., Marlborough, Massachusetts) with commercially available collection devices     (broom-type collection device or cytobrush/spatula combination)* may be tested with the     AHPV-GT Assay either pre- or post-Pap processing.   "|||2017-10-11 04:04:48.957461|2017-10-11 04:04:48.957461
NCT01384357|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-27|||July 2007||2007-07-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Ultrasound-Guided Needle Biopsy in the Diagnosis of Malignant Cervical Lymphadenopathies|Real-time Ultrasound-Guided Needle Biopsy in the Diagnosis of Malignant Cervical Lymphadenopathies|Completed||N/A|116|Actual|Far Eastern Memorial Hospital|||1||f||||f||||||||||2017-10-11 04:04:49.058418|2017-10-11 04:04:49.058418
NCT01384344|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-12-17|||June 2011||2011-06-01|May 2011|2011-05-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and Actigraphy|Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Interest on Video Recognition and Actigraphy|Completed||N/A|82|Actual|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-10-11 04:04:49.132477|2017-10-11 04:04:49.132477
NCT01384331|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-28|||July 2011||2011-07-01|June 2011|2011-06-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|||New Treatments for Troublesome Bleeding in Implanon Users|Phase 4 Study Comparison of Two Combined Oral Contraceptive Regimens and an Intravaginal Hormonal Ring Against Placebo for Management of Bleeding Problems in Women Using Implanon, the Sub-dermal Contraceptive Implant|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Family Planning Association New South Wales||4|||f||||f||||||||||2017-10-11 04:04:49.211774|2017-10-11 04:04:49.211774
NCT01384318|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-11-29|||June 2011||2011-06-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Accuracy of Using the CPAP Technique to Eliminate Air Leak and Prevent Excessive Endotracheal Tube Cuff Pressures||Completed||N/A|200|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 04:04:49.31525|2017-10-11 04:04:49.31525
NCT01384305|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2011-06-28|||December 2009||2009-12-01|June 2011|2011-06-01||||||||Observational|||"Establish a Taiwan Rare Disorder Tissue Bank, to Collect and Repost Biological Samples and Disease Information From Patients With Rare Disorders"||Unknown status|Enrolling by invitation|N/A|500|Anticipated|China Medical University Hospital|||1||f||||f||||||||||2017-10-11 04:04:49.386874|2017-10-11 04:04:49.386874
NCT01384292|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-28|2015-05-28|2014-10-13||June 2011||2011-06-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Relieving Opioid-Induced Constipation (OIC) in Patients With Cancer-Related Pain|Terminated||Phase 3|14|Actual|AstraZeneca|Due to recruitment challenges, enrollment was stopped early. 14 patients were randomized (<5% of planned number), thus, there was insufficient data to perform the protocol-specified statistical analyses. Secondary outcome measures are not reported.|3||The study was stopped early due to recruitment challenges|f||||||||||||||2017-10-11 04:04:49.462465|2017-10-11 04:04:49.462465
NCT01384279|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-02-23|||May 2011||2011-05-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity|The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity|Completed||N/A|25|Actual|Beitou Armed Forces Hospital, Taipei, Taiwan||1|||f||||t||||||||||2017-10-11 04:04:50.41879|2017-10-11 04:04:50.41879
NCT01384266|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-13|2017-06-28|||May 2010||2010-05-01|June 2017|2017-06-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Observational|||A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery|A Randomized, Multicenter, Masked Evaluation of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate for the Treatment of Inflammation Following Cataract Surgery|Completed||N/A|90|Actual|Associated Eye Care, Minnesota|||1||f||||f||||||||||2017-10-11 04:04:50.499012|2017-10-11 04:04:50.499012
NCT01384253|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-09-29|||July 2011||2011-07-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|October 2015|Actual|2015-10-01||Interventional|||Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy|Phase I Trial of Intraperitoneal ²¹²Pb-TCMC-Trastuzumab for HER-2 Expressing Malignancy|Completed||Phase 1|18|Actual|Areva Med LLC||1|||f||||t||||||||||2017-10-11 04:04:50.575641|2017-10-11 04:04:50.575641
NCT01384240|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-01-08|||April 2010||2010-04-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|||Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia|Evaluation of Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia|Terminated||Early Phase 1|183|Actual|Anandasabapathy, Sharmila, M.D.||1||Study is closed as the PI transferred to another institution.|f||||t||||||||||2017-10-11 04:04:50.682262|2017-10-11 04:04:50.682262
NCT01384227|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-01-08|||February 2009||2009-02-01|January 2016|2016-01-01||||July 2011|Actual|2011-07-01||Interventional|||Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study|Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study|Completed||Early Phase 1|40|Actual|Anandasabapathy, Sharmila, M.D.||1|||f||||t||||||||||2017-10-11 04:04:50.77605|2017-10-11 04:04:50.77605
NCT01384214|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-28|||October 2008||2008-10-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia|Pilot Study of the Effect of Botulinum Toxin Type A Treatment on Swallowing in Patients With Cervical Dystonia|Completed||Phase 4|28|Actual|Allergan||1|||f||||f||||||||||2017-10-11 04:04:50.850239|2017-10-11 04:04:50.850239
NCT01384201|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-27|||August 2007||2007-08-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|R-CE-GCEP||Confocal Endomicroscopy Detection of Gastric Preneoplasia and Neoplasia|Evaluation of the Use of Confocal Endomicroscopy in Conjunction With Chromoendoscopy in the Detection of Gastric Preneoplastic Neoplasia and Neoplasia in a High-Risk Population (R-CE-GCEP)|Completed||N/A|100|Actual|National University Hospital, Singapore|||2||f||||f||||||None Retained|"     Biopsies from the stomach   "|||2017-10-11 04:04:50.933313|2017-10-11 04:04:50.933313
NCT01384188|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-01-17|||June 2011||2011-06-01|July 2012|2012-07-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women|A Two-part, Crossover Study to Investigate the Effects of Morning Versus Evening Dosing and Food Interaction on the Pharmacodynamics and Pharmacokinetics of Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women|Completed||Phase 1/Phase 2|25|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 04:04:50.99944|2017-10-11 04:04:50.99944
NCT01384175|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-28|||January 2008||2008-01-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Epidural Anesthesia and Postoperative Analgesia With Ropivacaine and Fentanyl|Epidural Anesthesia and Postoperative Analgesia With Ropivacaine and Fentanyl in Off-pump Coronary Artery Bypass Grafting|Completed||N/A|93|Actual|Northern State Medical University||3|||f||||f||||||||||2017-10-11 04:04:51.09335|2017-10-11 04:04:51.09335
NCT01384162|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-01-26|||June 2009||2009-06-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis|An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis, Using an Implanted Catheter and SynchroMed® II Pump|Terminated||Phase 1/Phase 2|15|Actual|Newron Sweden AB||1||"Issues with development and supply of infusion system for delivery of IMP. Lack of favorable   benefit risk ratio in sNN0029-003 study (review of interim data)."|f||||t||||||||||2017-10-11 04:04:51.205724|2017-10-11 04:04:51.205724
NCT01384149|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-08-11|||September 2011||2011-09-01|August 2014|2014-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|ETSG||EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA|A Pioneer Study: External Selective Laser Trabeculoplasty for Treating Uncontrolled Open Angle Glaucoma|Completed||Phase 1|32|Actual|Meir Medical Center||2|||f||||f||||||||||2017-10-11 04:04:51.302236|2017-10-11 04:04:51.302236
NCT01384136|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-27|||June 2011||2011-06-01|June 2011|2011-06-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies|The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies|Unknown status|Active, not recruiting|N/A|100|Anticipated|Meir Medical Center|||2||f||||t||||||||||2017-10-11 04:04:51.427475|2017-10-11 04:04:51.427475
NCT01384123|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-04-08|||August 2011||2011-08-01|October 2013|2013-10-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|||Rehabilitation in Pulmonary Sarcoidosis: a Prospective Study||Unknown status|Recruiting|N/A|50|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 04:04:51.494973|2017-10-11 04:04:51.494973
NCT01384110|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-11-14|||June 2011||2011-06-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy of a Brown Seaweed Extract Rich in Polyphenols on Glycemic Response to Sucrose in Human|Efficacy of a Brown Seaweed Extract Rich in Polyphenols on Glycemic Response to Sucrose in Human|Completed||Phase 1|43|Actual|innoVactiv Inc.||2|||f||||f||||||||||2017-10-11 04:04:51.566312|2017-10-11 04:04:51.566312
NCT01384097|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-09-07|||September 2007||2007-09-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Observational|ERAS_feasi||An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac Surgery|An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac Surgery - a Feasibility Study|Completed||N/A|774|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 04:04:51.651253|2017-10-11 04:04:51.651253
NCT01384084|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-05-19|||June 2011||2011-06-01|May 2011|2011-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Pelvic Organ Prolapse Repair Plus Mini-Sling Versus Pelvic Organ Prolapse Repair Alone|URINARY INCONTINENCE AND URO-GENITAL PROLAPSE: A RANDOMIZED TRIAL OF PELVIC ORGAN PROLAPSE REPAIR PLUS MINI-SLING VERSUS PELVIC ORGAN PROLAPSE REPAIR ALONE|Completed||Phase 3|50|Actual|University Of Perugia||2|||f||||f||||||||||2017-10-11 04:04:51.733669|2017-10-11 04:04:51.733669
NCT01384071|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-02-20|||January 2011||2011-01-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||The Effects of Unstable Shoes on Chronic Low Back Pain||Completed||N/A|40|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-10-11 04:04:51.822991|2017-10-11 04:04:51.822991
NCT01384058|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-06-18|||November 2007||2007-11-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|EZE||Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes|The Effect of Ezetimibe 10 mg, Simvastatin 20 mg and the Combination of Simvastatin 20 mg Plus 10 mg Ezetimibe on Low Density Lipoprotein (LDL)-Subfractions in Patients With Type 2 Diabetes|Completed||Phase 4|41|Actual|University Hospital Freiburg||3|||f||||t||||||||||2017-10-11 04:04:51.918051|2017-10-11 04:04:51.918051
NCT01384045|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-12-17|||February 2009||2009-02-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Outreach for Diabetes Cure|Randomized Trial of Health Promotion Outreach for Diabetes Cure|Completed||N/A|2800|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 04:04:52.035037|2017-10-11 04:04:52.035037
NCT01384032|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-27|||January 2009||2009-01-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|October 2010|Actual|2010-10-01||Interventional|Satgene||Study Into Genetic Influence on Cholesterol Response to Dietary Fat|Apolipoprotein E Genotype as a Determinant of LDL-cholesterol Response to Dietary Fat Manipulation|Completed||N/A|88|Actual|University of Reading||3|||f||||t||||||||||2017-10-11 04:04:52.107717|2017-10-11 04:04:52.107717
NCT01384019|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-02-14|2013-01-14||January 2004||2004-01-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|June 2008|Actual|2008-06-01||Interventional|||Distal Protection Device in ST-elevation Myocardial Infarction (STEMI)|Distal Protection Device Did Not Improve Microvascular Obstruction Evaluated by Cardiac MR After Primary Percutaneous Intervention for ST-elevation Myocardial Infarction|Completed||Phase 4|126|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-10-11 04:04:52.201236|2017-10-11 04:04:52.201236
NCT01384006|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-30|||June 2011||2011-06-01|June 2011|2011-06-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Observational|EXPAND||Extended Pancreas Donor Program - The EXPAND Study|EXTENDED PANCREAS DONOR PROGRAM - THE EXPAND STUDY|Unknown status|Recruiting|N/A|110|Anticipated|University of Regensburg|||2||f||||t||||||||||2017-10-11 04:04:52.431951|2017-10-11 04:04:52.431951
NCT01383993|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-04-08|2014-04-07||September 2011||2011-09-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection|An Open-Label, Non-Controlled, Multicenter, Intravenous To Oral Switch, Phase 2 Study To Evaluate The Pharmacokinetics, Safety And Tolerability Of Voriconazole In Immunocompromised Children Aged 2 To Less Than 15 Years Who Are At High Risk For Systemic Fungal Infection|Completed||Phase 2|21|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:04:52.544111|2017-10-11 04:04:52.544111
NCT01383980|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-27|||July 2011||2011-07-01|June 2011|2011-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Trial of Continuous Versus Interrupted Feeding for Intubated Intensive Care Unit Patients|A Randomized Trial of Continuous Versus Interrupted Enteral Feeding in Critically Ill Surgical Patients Requiring Mechanical Ventilation|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 04:04:53.518117|2017-10-11 04:04:53.518117
NCT01383967|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-06-13|||July 2011||2011-07-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of LY2979165 in Healthy Subjects|Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Multiple-Ascending Doses of LY2979165 in Healthy Subjects|Completed||Phase 1|102|Actual|Eli Lilly and Company||8|||f||||f||||||||||2017-10-11 04:04:53.622695|2017-10-11 04:04:53.622695
NCT01383954|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-07-14|2017-04-05||June 2011|Actual|2011-06-01|July 2017|2017-07-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional||Modified Intent-to-Treat Population, all participants who completed at least 50% of the study (at least 2 weeks of drug treatment).|The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis|The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis|Completed||Phase 4|52|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 04:04:53.722056|2017-10-11 04:04:53.722056
NCT01383941|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-03-14|||August 2011||2011-08-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|APIC||Asthma Phenotypes in the Inner City|Asthma Phenotypes in the Inner City (ICAC-19)|Completed||N/A|717|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     Participants had the option of having blood, RNA, and DNA stored for use in future research     studies.   "|||2017-10-11 04:04:53.914118|2017-10-11 04:04:53.914118
NCT01383746|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-08-06|||October 2011||2011-10-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|CHOLANGIOSIR||Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION|Efficacy and Tolerance of RADIOEMBOLIZATION for Patients With Unresectable Intrahepatic Cholangiocarcinoma With Tumor Progression After First-line Therapy|Terminated||Phase 1/Phase 2|5|Actual|Assistance Publique - Hôpitaux de Paris||1||Not enough inclusion|f||||t||||||||||2017-10-11 04:04:58.47125|2017-10-11 04:04:58.47125
NCT01383915|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-08-24|||September 2009||2009-09-01|August 2017|2017-08-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Clinical Risk State for Bipolar Disorder in Adolescents|Characterizing the Clinical Risk State for Bipolar Disorder in Adolescents|Recruiting||N/A|112|Anticipated|Northwell Health|||1||f||||f||||||||||2017-10-11 04:04:57.140387|2017-10-11 04:04:57.140387
NCT01383902|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-06-27|||May 2009||2009-05-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Chocolate Meal Study|The Effect of Meal Type on the Rate of Gastric Emptying|Completed||N/A|4|Actual|Quadram Institute||1|||f||||t||||||||||2017-10-11 04:04:57.315398|2017-10-11 04:04:57.315398
NCT01383889|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-03-04|||December 2011||2011-12-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|EXPREG||Acute Maternal and Fetal Effects of Exercise in Pregnancy|Acute Effects on the Mother and Fetus in Two Modalities of Exercise in Pregnancy: a Randomized Controlled Trial.|Completed||N/A|120|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||t||||||||||2017-10-11 04:04:57.383144|2017-10-11 04:04:57.383144
NCT01383876|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-10-21|||June 2011||2011-06-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Collar Immobilization Following a Posterior Cervical Laminectomy and Fusion|Collar Immobilization Following a Posterior Cervical Laminectomy and Fusion: A Randomized Controlled Trial|Terminated||N/A|11|Actual|Brigham and Women's Hospital||2||Enrollment too slow|f||||f||||||||||2017-10-11 04:04:57.46528|2017-10-11 04:04:57.46528
NCT01383863|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-07-29|||October 2011||2011-10-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|TRIPTOCARE LT||A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer|A Prospective Observational Study Cohort to Assess the Rate of Castration Resistance, Disease Progression and Overall Survival Over a 3-year Period Post-androgen Deprivation Therapy Induction in Patients With Advanced Prostate Cancer Who Have Previously Participated in the Triptocare Study (Http://Clinicaltrials.Gov/ct2/Show/Study/NCT01020448)|Completed||N/A|180|Actual|Ipsen|||1||f||||f||||||||||2017-10-11 04:04:57.542764|2017-10-11 04:04:57.542764
NCT01383850|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-09|2011-06-27|||February 2008||2008-02-01|June 2011|2011-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS)||Completed||Phase 2|51|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||||2017-10-11 04:04:57.670731|2017-10-11 04:04:57.670731
NCT01383837|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-18|2015-08-27|||August 2010||2010-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|STYLEnS||HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment|HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment|Completed||Phase 1/Phase 2|86|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 04:04:57.743151|2017-10-11 04:04:57.743151
NCT01383824|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-05-25|||January 2011||2011-01-01|August 2014|2014-08-01|July 2015|Actual|2015-07-01|July 2013|Actual|2013-07-01||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the Silent Hip™ in Primary Total Hip Replacement Surgery|A Multi-centre, Prospective, Uncontrolled Post Market Clinical Follow-up Study (PMCFS) to Monitor the Survival and Performance of the Silent™ Hip in Subjects Requiring a Total Hip Replacement|Terminated||N/A|89|Actual|DePuy International||1||Rationalization of the Silent Hip Prosthesis for business reasons only|f||||f||||||||||2017-10-11 04:04:57.824868|2017-10-11 04:04:57.824868
NCT01383811|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-03-05|||June 2011||2011-06-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Exercise in Treatment Resistant Depression (TRD): A Feasibility Study|Clinical and Neuroendocrine/Metabolic Benefits of Exercise in Treatment Resistant Depression (TRD): A Feasibility Study|Completed||N/A|21|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-10-11 04:04:57.969268|2017-10-11 04:04:57.969268
NCT01383798|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-03-13|||August 2008||2008-08-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||How Does Iron Supplementation Affect Training and Performance in Female Collegiate Rowers?|How Does Iron Deficiency Without Anemia (IDNA) Affect Endurance Training In Female Collegiate Endurance Athletes?|Completed||N/A|40|Actual|Cornell University||2|||f||||f||||||||||2017-10-11 04:04:58.062463|2017-10-11 04:04:58.062463
NCT01383785|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2012-02-20|||November 2009||2009-11-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|TOLEDO1||Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab|Phase 4 Study of Primary Angioplasty Combined Distal Injection of Abciximab to Thrombus and Aspiration With Catheter|Unknown status|Recruiting|Phase 4|186|Anticipated|Hospital Virgen de la Salud||3|||f||||t||||||||||2017-10-11 04:04:58.151517|2017-10-11 04:04:58.151517
NCT01383772|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2015-04-30|||June 2012||2012-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility|A Prospective Clinical Study of the Effects of Panretinal Photocoagulation Delivered With a Multi-spot Photocoagulator on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy|Completed||N/A|43|Actual|Moorfields Eye Hospital NHS Foundation Trust||1|||f||||t||||||||||2017-10-11 04:04:58.27964|2017-10-11 04:04:58.27964
NCT01383759|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-05-10|||June 24, 2011|Actual|2011-06-24|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis|Pilot Study of Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis|Active, not recruiting||N/A|20|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:04:58.372192|2017-10-11 04:04:58.372192
NCT01383733|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2016-11-01|||July 2011||2011-07-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of RO5458640 in Patients With Advanced Solid Tumors|A Phase I Multiple Ascending Dose (MAD) Study of RO5458640, a Humanized Monoclonal Antibody Against the TNF-like Weak Inducer of Apoptosis (TWEAK) Ligand, in Patients With Advanced Solid Tumors|Completed||Phase 1|54|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:04:58.554696|2017-10-11 04:04:58.554696
NCT01383720|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-05-23|2013-04-16||April 2012||2012-04-01|May 2017|2017-05-01|May 9, 2017|Actual|2017-05-09|May 2012|Actual|2012-05-01||Interventional|REPRISE I||REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm|REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm|Completed||N/A|11|Actual|Boston Scientific Corporation||1|||f||||f||||||||No|There is no plan to make individual participant data (IPD) available.|2017-10-11 04:04:58.646564|2017-10-11 04:04:58.646564
NCT01383707|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2017-05-17|2016-07-22||August 12, 2011|Actual|2011-08-12|May 2017|2017-05-01|May 18, 2016|Actual|2016-05-18|May 28, 2014|Actual|2014-05-28||Interventional||The intent-to-treat analysis set (ITT), which included all enrolled participants, who received at least one dose of any study medication.|A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer|A Multi-center, Open-label Clinical Trial to Evaluate the Objective Response Rate of Bevacizumab in Combination With Modified FOLFOX-6 Followed by One Year of Maintenance With Bevacizumab Alone in Patients With Initially Not or Borderline Resectable Colorectal Liver Metastases (The CLMO-001 Trial)|Completed||Phase 2|77|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:04:59.4582|2017-10-11 04:04:59.4582
NCT01383694|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-02-27|||June 2011||2011-06-01|February 2015|2015-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|FIS 2009_2||Effect Of Piperine In Patients With Oropharyngeal Dysphagia|Effect of Natural Agonists of TRPV1 in the Treatment of Functional Oropharyngeal Dysphagia in Neurological Diseases and the Elderly: Piperine|Completed||Phase 1/Phase 2|40|Actual|Hospital de Mataró||2|||f||||||||||||||2017-10-11 04:04:59.808489|2017-10-11 04:04:59.808489
NCT01383681|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2013-09-09|2013-09-09||February 2011||2011-02-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Retrospective Study of Patients With Spasticity in the Spanish Population|Observational Study To Establish The Methodology Used In The Evaluation, Treatment And Assessment Of Progression Of Spasticity In The Spanish Population|Completed||N/A|235|Actual|Allergan|Not enough data was collected for analysis of Physician's Assessment of Spasticity outcome measures.||1||f||||f||||||||||2017-10-11 04:04:59.883528|2017-10-11 04:04:59.883528
NCT01383668|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-12-13|||June 2011||2011-06-01|December 2012|2012-12-01||||||||Interventional|||Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer|Combined PKCiota and mTOR Inhibition for Treatment of Advanced Squamous Lung Cancer|Withdrawn||Phase 1|0|Actual|Mayo Clinic||1||lack of access to study drug|f||||t||||||||||2017-10-11 04:05:00.117444|2017-10-11 04:05:00.117444
NCT01383655|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-01-20|||March 2011||2011-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Intravenous Magnesium in Wheezy Bronchitis|The Efficacy of Intravenous Magnesium in Acute Wheezy Bronchitis in Small Children - a Randomized, Controlled Study|Completed||N/A|61|Actual|University of Oulu||2|||f||||f||||||||||2017-10-11 04:05:00.23903|2017-10-11 04:05:00.23903
NCT01383642|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-03-06|||July 2010||2010-07-01|March 2017|2017-03-01||||June 2013|Actual|2013-06-01||Observational|||Physiology of Vestibular Dysfunction and Clinical Implications||Active, not recruiting||N/A|50|Actual|Johns Hopkins University|||1||f||||||||||||||2017-10-11 04:05:00.338876|2017-10-11 04:05:00.338876
NCT01383629|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-27|||January 2010||2010-01-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||The Effect of Preoperative Counseling on Patient Fear From Visual Experience During Vitrectomy Surgery Under Regional Anesthesia|The Effect of Preoperative Counseling on Patient Fear From Visual Experience During Vitrectomy Surgery Under Regional Anesthesia|Completed||N/A|100|Actual|University of Malaya||2|||f||||t||||||||||2017-10-11 04:05:00.409982|2017-10-11 04:05:00.409982
NCT01383616|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-06-03|2017-03-16||July 2006||2006-07-01|June 2017|2017-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||21 patients received bipedicular intervention. 3 lost to follow up at 3 months (n=18) and 6 total lost at 12 months (n=15) 23 patients received unipedicular intervention. 5 lost to 3 month follow up (n=18) and 9 total lost at 12 months (n=14) Pre and post-op vertebral height measures were available in 14 unipedicular and 17 bipedicular patients|Unipedicular vs. Bipedicular Kyphoplasty for the Treatment of Osteoporotic Vertebral Fractures|Unipedicular vs. Bipedicular Kyphoplasty for the Treatment of Osteoporotic Vertebral Fractures|Completed||Phase 4|84|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 04:05:00.513521|2017-10-11 04:05:00.513521
NCT01383603|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-06-10|||October 2011||2011-10-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis|Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis|Completed||Phase 1|10|Actual|Circassia Limited||1|||f||||f||||||||||2017-10-11 04:05:01.025093|2017-10-11 04:05:01.025093
NCT01383590|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-01-21|||October 2011||2011-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis|Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis|Completed||Phase 1|10|Actual|Circassia Limited||1|||f||||f||||||||||2017-10-11 04:05:01.10239|2017-10-11 04:05:01.10239
NCT01383577|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-09-24|||March 2010||2010-03-01|September 2013|2013-09-01|November 2013|Anticipated|2013-11-01|February 2013|Actual|2013-02-01||Interventional|||Comparison Between Single and Triple Rubber Band Ligation for the Treatment of Hemorrhoids|Double-blind Randomized Controlled Study of Single Versus Triple Rubber Band Ligation of Hemorrhoids|Unknown status|Active, not recruiting|N/A|76|Anticipated|Federal University of Amazonas||2|||f||||t||||||||||2017-10-11 04:05:01.186564|2017-10-11 04:05:01.186564
NCT01383564|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2016-07-28|||January 2011||2011-01-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|OSA||Continuous Positive Airway Pressure Use in Asthma With Moderate to Severe Obstructive Sleep Apnea Patients|Effect of Nasal Continuous Positive Airway Pressure in Uncontrolled Nocturnal Asthmatic Patients With Moderate Obstructive Sleep Apnea Syndrome|Completed||N/A|101|Actual|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-11 04:05:01.312197|2017-10-11 04:05:01.312197
NCT01383538|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-08-07|||August 23, 2011|Actual|2011-08-23|August 2017|2017-08-01|May 26, 2015|Actual|2015-05-26|December 13, 2012|Actual|2012-12-13||Interventional|||FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma|A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma|Completed||Phase 1|15|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 04:05:01.532483|2017-10-11 04:05:01.532483
NCT01383525|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-08-09|||July 2011||2011-07-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|March 2018|Anticipated|2018-03-01||Interventional|DSLT||Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma|Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma . Single Site Study|Active, not recruiting||N/A|40|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 04:05:01.634744|2017-10-11 04:05:01.634744
NCT01383512|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-09-15|||June 2011||2011-06-01|September 2015|2015-09-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|REM_AVC||Rehabilitation Robotics After a Stroke|Medical and Economical Evaluation of Upper Limb's Rehabilitation Robotics After a Stroke|Recruiting||Phase 3|240|Anticipated|University Hospital, Brest||3|||f||||t||||||||||2017-10-11 04:05:01.779083|2017-10-11 04:05:01.779083
NCT01383499|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-03-26|2013-09-23||August 2011||2011-08-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||Total number of patients randomised and treated at all in the study.|A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma|A Phase II Randomised, Double-blind, Placebo-controlled Incomplete Crossover Trial With 4-week Treatment Periods to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (Doses of 1.25 µg, 2.5 µg and 5 µg) Delivered Via Respimat® Inhaler Once Daily in the Evening in Children 6 to 11 Yrs Old With Moderate Persistent Asthma|Completed||Phase 2|101|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 04:05:02.066725|2017-10-11 04:05:02.066725
NCT01383486|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-09-24|2012-08-30||July 2011||2011-07-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|KEIFER SST||Self Selection Trial of Naproxen Sodium|A Pilot Self Selection Trial of an Extended-Release Over-the-Counter Analgesic|Completed||Phase 3|253|Actual|Bayer||1|||f||||f||||||||||2017-10-11 04:05:02.73774|2017-10-11 04:05:02.73774
NCT01383473|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-08-26|||August 2011||2011-08-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|||Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients|Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients|Completed||N/A|14|Actual|St. Jude Children's Research Hospital|||2||f||||f||||||||||2017-10-11 04:05:02.968996|2017-10-11 04:05:02.968996
NCT01383460|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-26|2016-12-04|||July 2011||2011-07-01|July 2012|2012-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver Failure|Randomized Placebo-controlled Trial to Assess the Efficacy of Granulocyte Colony-stimulating Factor (G-CSF) and Erythropoetin (EPO) in the Survival of Patients With Acute-on-chronic Liver Failure (ACLF)|Completed||Phase 3|55|Actual|Institute of Liver and Biliary Sciences, India||2|||f||||f||||||||||2017-10-11 04:05:03.040992|2017-10-11 04:05:03.040992
NCT01383447|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-07-07|2017-04-14||October 2010||2010-10-01|July 2017|2017-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia|A Phase 1/2 Study of SNDX-275 in Combination With Imatinib for Relapsed/Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|Terminated||Phase 1/Phase 2|2|Actual|National Cancer Institute (NCI)||1||This study was halted prematurely by the NCI for low accrual.|f||||||||||||||2017-10-11 04:05:03.140463|2017-10-11 04:05:03.140463
NCT01383434|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-10-12|||June 2011||2011-06-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Bone Marrow Transplant Trial for Patients With Refractory Severe Aplastic Anemia|A Phase II Trial of Myeloablative Conditioning and Transplantation of HLA-matched, Partially HLA-mismatched, HLA-haploidentical or Matched Unrelated (MUD) Bone Marrow for Patients With Refractory Severe Aplastic Anemia|Terminated||Phase 2|4|Actual|Sidney Kimmel Comprehensive Cancer Center||1||New revised SAA BMT study opened to take over this study|f||||t||||||||||2017-10-11 04:05:03.954432|2017-10-11 04:05:03.954432
NCT01383421|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-26|2017-04-10|2017-04-10||September 2011||2011-09-01|April 2017|2017-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|PASSION|ITT population: all enrolled participants who received at least 1 dose of study drug.|Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP)|A Post-Marketing Observational Study (PMOS) to Determine the Effectiveness and Patient Satisfaction With Adalimumab Treatment in Patients With Rheumatoid Arthritis (PASSION Study)|Completed||N/A|1036|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 04:05:04.250334|2017-10-11 04:05:04.250334
NCT01383408|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-05-05|||March 2011||2011-03-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection|Distinction Between Lung Cancer and Gynecological Cancers by Exhalation Analysis and Canine Scent Detection|Terminated||Phase 2|752|Actual|Schillerhoehe Hospital||4||Inconsistent training status of sniffer dogs|f||||f||||||||||2017-10-11 04:05:06.846261|2017-10-11 04:05:06.846261
NCT01383395|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2015-05-18|||June 2011||2011-06-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Cilostazol on the Pharmacokinetics of Simvastatin|Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects|Completed||Phase 1|20|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-10-11 04:05:06.947781|2017-10-11 04:05:06.947781
NCT01383382|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2012-09-07|||September 2009||2009-09-01|June 2011|2011-06-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Observational|PRISM||Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool|Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool|Completed||N/A|1399|Actual|Saint Luke's Health System|||1||f||||f||||||||||2017-10-11 04:05:07.030433|2017-10-11 04:05:07.030433
NCT01383369|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-09-27|||February 2011||2011-02-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Postoperative Sleep Disturbances Role in Cognitive Test Results After Fast-track Hip and Knee Arthroplasty|Postoperative Sleep Disturbances Role in Cognitive Test Results After Fast-track Hip and Knee Arthroplasty|Completed||N/A|20|Anticipated|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-10-11 04:05:07.1274|2017-10-11 04:05:07.1274
NCT00005528|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1995||1995-04-01|August 2004|2004-08-01|February 2000|Actual|2000-02-01|||||Observational|||Genetics of CVD Risk Factors in Samoans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:10.079628|2017-10-11 04:27:10.079628
NCT01383356|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2014-02-27|2012-12-18||June 2011||2011-06-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Dosed participants from combined studies|Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet|A Single Dose Comparative Bioavailability Study of Linagliptin/Metformin hydrochloride2.5mg/500mg Combination Tablets Versus Linagliptin 2.5mg Tablets Administered With Glucophage 500mg Tablets Under Fasting Conditions|Completed||Phase 1|58|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 04:05:07.3414|2017-10-11 04:05:07.3414
NCT01383343|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-25|2017-04-18|||August 2011||2011-08-01|April 2017|2017-04-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer|Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies|Completed||Phase 1|17|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:05:07.707885|2017-10-11 04:05:07.707885
NCT01383330|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-27|2011-06-27|||July 2011||2011-07-01|June 2011|2011-06-01||||September 2011|Anticipated|2011-09-01||Interventional|||A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition|Phase 1 Study of Daewon-ES(A) & Daewon-ES(B) in Healthy Male Volunteers Under Fed Condition|Unknown status|Not yet recruiting|Phase 1|15|Anticipated|Asan Medical Center||3|||f||||f||||||||||2017-10-11 04:05:07.86243|2017-10-11 04:05:07.86243
NCT01383317|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-06-02|||June 2011||2011-06-01|June 2017|2017-06-01|April 30, 2017|Actual|2017-04-30|April 30, 2016|Actual|2016-04-30||Interventional|RIPCEPP||Remote Ischemic PreConditioning Effect on Postsurgical Pain|Remote Ischemic Preconditioning (RIPC) and Its Effect on the Postoperative Pain Experience Following Intra-abdominal Surgery|Completed||N/A|54|Actual|Wake Forest University Health Sciences||2|||f||||f|f|t||||||||2017-10-11 04:05:07.941066|2017-10-11 04:05:07.941066
NCT01383304|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-05-11|||November 2007||2007-11-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|January 2011|Actual|2011-01-01||Observational|||Aspirin Response in High Risk Patients With Coronary Artery Disease|Is a Reduced Biochemical Response to Aspirin Associated With Increased Cardiovascular Morbidity and Mortality in High Risk Patients With Coronary Artery Disease?|Unknown status|Active, not recruiting|N/A|906|Actual|University of Aarhus|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, plasma, urine   "|||2017-10-11 04:05:08.043003|2017-10-11 04:05:08.043003
NCT01383291|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-26|2014-06-19|||February 2009||2009-02-01|June 2014|2014-06-01|June 2013|Anticipated|2013-06-01|January 2013|Anticipated|2013-01-01||Observational|||Prolift Versus IVS for Pelvic Floor Prolapse|Postoperative Comparison Between Posterior Prolift Mesh Placement and Posterior IVS Sling Placement|Withdrawn||N/A|0|Actual|Western Galilee Hospital-Nahariya|||1||f||||f||||||||||2017-10-11 04:05:08.126779|2017-10-11 04:05:08.126779
NCT01383278|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2015-12-18|||February 2012||2012-02-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation of a Computer-Delivered 5 A's Intervention for Smoking|Evaluation of a Computer-Delivered 5 A's Intervention for Smoking|Terminated||N/A|8|Actual|Virginia Commonwealth University||2||Insufficient sample size to complete study and merged with parent grant funded study|f||||t||||||||||2017-10-11 04:05:08.197095|2017-10-11 04:05:08.197095
NCT01383265|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-06-13|||March 2010||2010-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Combined Chromoendoscopy and Water Method for Screening Colonoscopy|Randomized Controlled Trial (RCT) to Compare Adenoma Detection Rate of Combined Chromoendoscopy (Indigo Carmine) With Water Infusion in Lieu of Air Insufflation (Water Method) vs. Water Method Alone in Screening Colonoscopy|Completed||N/A|1177|Actual|VA Northern California Health Care System||2|||f||||f||||||||||2017-10-11 04:05:08.275595|2017-10-11 04:05:08.275595
NCT01383252|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-06-13|||February 2010||2010-02-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance|Comparison of Study Method Versus Conventional Method for Performing Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance|Completed||N/A|10|Actual|VA Northern California Health Care System||2|||f||||t||||||||||2017-10-11 04:05:08.399249|2017-10-11 04:05:08.399249
NCT01383239|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2016-11-03|||September 2011||2011-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Impact of Postoperative Management on Outcomes and Healing of Rotator Cuff Repairs|Impact of Postoperative Management on Outcomes and Healing of Rotator Cuff Repairs|Completed||N/A|27|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 04:05:08.519524|2017-10-11 04:05:08.519524
NCT01383226|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-10-08|||June 2011||2011-06-01|June 2011|2011-06-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Interventional|LASSO||Linear Endosonography for the Assessment of Sarcoidosis Stage O|CT Enlarged Mediastinal/Hilar Lymph Nodes Not Visible on Chest X-ray in the Non Cancer Patient : Diagnosis and Clinical Implications Using Endobronchial or Esophageal Ultrasound Controlled Needle Aspiration E(B)US-NA|Unknown status|Active, not recruiting|N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 04:05:08.625923|2017-10-11 04:05:08.625923
NCT01383213|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2013-12-31|2013-12-31||February 2010||2010-02-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Helmet Continuous Positive Airway Pressure (CPAP) Versus Oxygen Venturi in Severe Acute Respiratory Failure in Pneumonia|A Prospective, Randomized, Controlled Trial to Evaluate the Efficacy of CPAP Delivered by Helmet in Comparison With Oxygen Therapy by Venturi Mask in Severe Acute Respiratory Failure Caused by Pneumonia|Completed||N/A|81|Actual|University of Milan||2|||f||||t||||||||||2017-10-11 04:05:08.729748|2017-10-11 04:05:08.729748
NCT01383200|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-07-13|2013-01-14||June 2011||2011-06-01|June 2017|2017-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Tetracaine Versus Lidocaine Gel for Anesthetic Effect and Comfort in Patients Undergoing LASIK|Comparison of 0.5% Tetracaine Drops Versus 2% Lidocaine Gel for Anesthetic Efficacy and Comfort in Patients Undergoing LASIK|Terminated||Phase 4|11|Actual|University of Miami||2||eyes that received gel had slightly thinner than intended flaps|f||||f||||||||||2017-10-11 04:05:09.042534|2017-10-11 04:05:09.042534
NCT01383187|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-03-21|||November 2008||2008-11-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Autologous Platelets Concentrate and Autologous Thrombin for the Treatment of Deep Burn Trauma|An Open-label, Non Randomized, Single-Center Registry Study to Assess the Safety and Effects of Autologous Platelets Concentrate and Autologous Thrombin for the Treatment of Deep Burns Trauma|Completed||Phase 2/Phase 3|30|Actual|University Hospital Ostrava||2|||f||||t||||||||||2017-10-11 04:05:09.288819|2017-10-11 04:05:09.288819
NCT01383148|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-01-04|||April 2012||2012-04-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2015|Actual|2015-07-01||Interventional|TIME||Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer|A Phase IIB/III Randomized, Double-blind, Placebo Controlled Study Comparing First Line Therapy With or Without TG4010 Immunotherapy Product in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2/Phase 3|222|Actual|Transgene||2|||f||||t||||||||||2017-10-11 04:05:12.07556|2017-10-11 04:05:12.07556
NCT01383122|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-03-23|||May 2011||2011-05-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||The Efficacy of Pulsed Electromagnetic Field Therapy for Management of Post-operative Pain Following Cesarean Delivery|The Efficacy of Pulsed Electromagnetic Field Therapy for Management of Post-operative Pain Following Cesarean Delivery: a Randomised, Double-blind, Placebo-controlled Study|Terminated||N/A|125|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2||Planned interim analysis-no statistical significance for the primary outcome.|f||||f||||||||||2017-10-11 04:05:12.480063|2017-10-11 04:05:12.480063
NCT01383109|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2012-01-25|||June 2011||2011-06-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Human Mass Balance Study of Pyronaridine|A Human Mass Balance Study of Pyronaridine Using Accelerator Mass Spectrometry|Completed||Phase 1|6|Actual|Medicines for Malaria Venture||1|||f||||t||||||||||2017-10-11 04:05:12.574289|2017-10-11 04:05:12.574289
NCT01383096|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-01-19|2014-05-12||April 2012||2012-04-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||The Safety population was comprised of all randomized subjects who received any amount of study drug and was based on the actual treatment received at each time point, if this differed from that to which the subject was randomized.|Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers|A Phase I Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers|Completed||Phase 1|52|Actual|Medicines for Malaria Venture||11|||f||||f||||||||||2017-10-11 04:05:12.686434|2017-10-11 04:05:12.686434
NCT01383083|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-29|2011-06-27|||November 2010||2010-11-01|November 2010|2010-11-01|November 2012|Anticipated|2012-11-01|June 2011|Anticipated|2011-06-01||Observational|EIGER||Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease|Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease (Eisenmenger Physiology): Safety, Tolerability, Clinical, and Hemodynamic Effect.|Unknown status|Active, not recruiting|Phase 4|42|Anticipated|Maryknoll Medical Center|||1||f||||t||||||||||2017-10-11 04:05:13.615567|2017-10-11 04:05:13.615567
NCT01383070|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-06-27|||April 2010||2010-04-01|June 2011|2011-06-01|November 2012|Anticipated|2012-11-01|September 2012|Anticipated|2012-09-01||Interventional|BFC||Evaluation of Effectiveness of Cell Phone Technology as Community Based Intervention to Improve Exclusive Breast Feeding|Effectiveness of Cell Phone Counseling to Improve Breast Feeding Indicators|Unknown status|Recruiting|N/A|1036|Anticipated|Lata Medical Research Foundation, Nagpur||2|||f||||f||||||||||2017-10-11 04:05:13.679187|2017-10-11 04:05:13.679187
NCT01383057|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-02-15|||June 2011||2011-06-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery|Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery|Completed||Phase 4|29|Actual|Innovative Medical||1|||f||||f||||||||||2017-10-11 04:05:13.770841|2017-10-11 04:05:13.770841
NCT01383044|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-27|||June 2011||2011-06-01|June 2011|2011-06-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Banding Ligation With Carvedilol Versus Carvedilol for the Prevention of First Bleeding|Banding Ligation With Carvedilol vs. Carvedilol for the Prevention of First Bleeding in Cirrhotics With Moderate Varices|Unknown status|Recruiting|Phase 4|150|Anticipated|E-DA Hospital||2|||f||||t||||||||||2017-10-11 04:05:13.837749|2017-10-11 04:05:13.837749
NCT01383031|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-07-06|||October 2010||2010-10-01|October 2010|2010-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Safety and Efficacy Study of Transumbilical Laparoendoscopic Single Site Cholecystectomy|Randomized Controlled Trial Of Transumbilical Laparoendoscopic Single Site Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy|Unknown status|Recruiting|Phase 2/Phase 3|600|Anticipated|Beijing Friendship Hospital||2|||f||||t||||||||||2017-10-11 04:05:13.929425|2017-10-11 04:05:13.929425
NCT01383005|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2013-04-30|2012-12-28||June 2011||2011-06-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|QD-Kapital||Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)|Treatment Perception of QD Dosed Kaletra (Tablets) Based Treatment in HIV Infected Patients. Observational Cross-Sectional Study (QD-KAPITAL)|Completed||N/A|97|Actual|AbbVie|||2||f||||f||||||||||2017-10-11 04:05:14.283444|2017-10-11 04:05:14.283444
NCT01382992|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-06-24|||June 2010||2010-06-01|June 2011|2011-06-01||||||||Observational|||A Retrospective EGFR Mutation Status Study in Chinese NSCLC Patients Using Paired Plasma and Tissue Samples||Unknown status|Active, not recruiting|N/A|150|Anticipated|Peking Union Medical College Hospital|||2||f||||||||||Samples With DNA|"     Formalin-fixed, paraffin-embedded tissue slices and plasma samples are to be retained.   "|||2017-10-11 04:05:14.919913|2017-10-11 04:05:14.919913
NCT01382979|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-06-24|||July 2007||2007-07-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of AlcoholEdu for College|Evaluation of AlcoholEdu: A Randomized Multi-Campus Trial|Completed||N/A|9571|Actual|Pacific Institute for Research and Evaluation||2|||f||||f||||||||||2017-10-11 04:05:15.034405|2017-10-11 04:05:15.034405
NCT00005529|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|November 2001|2001-11-01|August 2000|Actual|2000-08-01|||||Observational|||Self-Scored Cardiovascular Disease Risk Appraisal||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:10.149685|2017-10-11 04:27:10.149685
NCT01382966|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-06-27|||July 2011||2011-07-01|June 2011|2011-06-01|October 2011|Anticipated|2011-10-01|September 2011|Anticipated|2011-09-01||Observational|||Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients|The Association of Serum Sclerostin Levels,Echocardiographic Parameters, Arteriovenous Fistula Thrombosis and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients|Unknown status|Not yet recruiting|N/A|400|Anticipated|RFM Renal Treatment Services|||1||f||||t||||||||||2017-10-11 04:05:15.108528|2017-10-11 04:05:15.108528
NCT01382953|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-01-07|||August 2011||2011-08-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||The Simple ECG Monitoring Trial (Comparison of a Novel Recording System With a Standard Holter Monitor)|The Simple ECG Monitoring Trial (Comparison of a Simple ECG Recording System With a Standard ECG Recording System for Holter Monitoring)|Completed||N/A|50|Actual|Seattle Institute for Cardiac Research|||1||f||||t||||||||||2017-10-11 04:05:15.20988|2017-10-11 04:05:15.20988
NCT01382940|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2017-07-05|2014-01-06||July 26, 2011|Actual|2011-07-26|July 2017|2017-07-01|January 6, 2013|Actual|2013-01-06|January 6, 2013|Actual|2013-01-06||Interventional|RATE-RA||A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis|A Multicenter, Open-label, Single-arm Study to Evaluate the Safety Administering Rituximab at a More Rapid Infusion Rate in Patients With Rheumatoid Arthritis|Completed||Phase 4|351|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:05:15.319765|2017-10-11 04:05:15.319765
NCT01382927|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-24|||April 2011||2011-04-01|June 2011|2011-06-01||||||||Observational|||Impact of Spontaneous Breathing on Ventilation Distribution in Obese Patients|Impact of Spontaneous Breathing on Ventilation Distribution in Obese Patients|Unknown status|Recruiting|N/A|16|Anticipated|Technische Universität Dresden|||2||f||||f||||||||||2017-10-11 04:05:15.899609|2017-10-11 04:05:15.899609
NCT01382914|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-01-16|||April 2011||2011-04-01|January 2012|2012-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Determination of a Threshold for Mouth Rinse Induced Discoloration of Teeth|Determination of a Threshold for Mouth Rinse Induced Discoloration of Teeth|Completed||N/A|16|Actual|Technische Universität Dresden||1|||f||||f||||||||||2017-10-11 04:05:15.991177|2017-10-11 04:05:15.991177
NCT01382901|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-23|2011-07-08|2011-02-23||March 2006||2006-03-01|July 2011|2011-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)|A Phase 2a Study Evaluating the Efficacy and Safety of a Novel Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)|Completed||Phase 2|45|Actual|Luitpold Pharmaceuticals||2|||f||||||||||||||2017-10-11 04:05:16.112158|2017-10-11 04:05:16.112158
NCT01382888|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2014-05-07|||July 2011||2011-07-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Local Tolerability of Topically Applied Heparin on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis|Efficacy and Local Tolerability of Topically Applied Heparin (Heparin 2,400 IU /ml Cutaneous Spray) on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis. A Multicentre, Randomized, Double-blind and Placebo-controlled Pilot Study|Terminated||Phase 2|30|Actual|Cyathus Exquirere Pharmaforschungsgmbh||2||The Sponsor decided to terminate the study due to the low patient recruitment.|f||||t||||||||||2017-10-11 04:05:16.444401|2017-10-11 04:05:16.444401
NCT01382875|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-07-27|||September 2009||2009-09-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Comparison of Comprehensive Multi-disciplinary Program and Conventional Care Program on Fragility Fracture Elderly|Medico-social Impact of a Comprehensive Multi-disciplinary Program for the Care of Fragility Fracture of the Elderly -Implications for Healthcare Policy in Hong Kong|Completed||Phase 3|160|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 04:05:16.561658|2017-10-11 04:05:16.561658
NCT01382862|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2015-09-14|||May 2011||2011-05-01|February 2013|2013-02-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|PHANTOM-S||PHANTOM-S: The Pre-Hospital Acute Neurological Therapy and Optimization of Medical Care in Stroke Patients - Study|PHANTOM-S: The Pre-Hospital Acute Neurological Therapy and Optimization of Medical Care in Stroke Patients - Study|Completed||Phase 2|614|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 04:05:16.668202|2017-10-11 04:05:16.668202
NCT01382849|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-11-17|||August 2011||2011-08-01|November 2014|2014-11-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)|F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)|Withdrawn||N/A|0|Actual|Sunnybrook Health Sciences Centre|||3||f||||f||||||||||2017-10-11 04:05:16.905329|2017-10-11 04:05:16.905329
NCT01382836|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2015-11-05|||January 2011||2011-01-01|November 2015|2015-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||The Role of Epigenetics in Inner City Asthma|The Role of Epigenetics in Inner City Asthma (ICAC-15)|Completed||N/A|200|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||t||||||Samples With DNA|"     DNA, RNA, serum, and plasma specimens   "|||2017-10-11 04:05:17.01392|2017-10-11 04:05:17.01392
NCT01382823|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-10-05|||September 2010||2010-09-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Laser Cataract Surgery With the Femtosecond Laser Technology|Laser Cataract Surgery With the Femtosecond Laser Technology|Completed||Phase 4|10|Anticipated|Innovative Medical||1|||f||||f||||||||||2017-10-11 04:05:17.140545|2017-10-11 04:05:17.140545
NCT01382810|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-06-13|||March 2011||2011-03-01|June 2012|2012-06-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms|A Randomized Masked Evaluation of Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms|Unknown status|Recruiting|Phase 4|100|Anticipated|Innovative Medical||2|||f||||f||||||||||2017-10-11 04:05:17.253757|2017-10-11 04:05:17.253757
NCT01382797|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-06-12||2012-05-07|August 2011||2011-08-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)|A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose Study to Evaluate the Safety, Tolerability, and Efficacy of ALKS 37 in Subjects With Opioid-induced Constipation|Completed||Phase 2|157|Actual|Alkermes, Inc.||2|||f||||t||||||||||2017-10-11 04:05:17.398964|2017-10-11 04:05:17.398964
NCT00005530|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-10|||May 1994||1994-05-01|May 2016|2016-05-01|April 2000||2000-04-01|||||Observational|||Diet, Insulin Resistance, and Cardiovascular Risk||Completed||N/A|||University of South Carolina|||||f||||||||||||||2017-10-11 04:27:10.200791|2017-10-11 04:27:10.200791
NCT01382784|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-06-24|||May 2011||2011-05-01|May 2011|2011-05-01||||||||Observational|||Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study|Psoriasis and the Risk of Cardiovascular Disease. A Prospective Observational Study to Detect Cardiovascular Risk Factors|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Oslo University Hospital|||1||f||||t||||||Samples With DNA|"     blood, tissue   "|||2017-10-11 04:05:17.564818|2017-10-11 04:05:17.564818
NCT01382771|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-10-10|||October 2010||2010-10-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Intraarticular Lumbar Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected Population|A Randomized, Double-Blind, Placebo Controlled Perspective Study of Intraarticular Lumbar Zygapophysial Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected Population|Completed||Early Phase 1|28|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 04:05:17.652588|2017-10-11 04:05:17.652588
NCT01382758|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2013-01-17|||July 2011||2011-07-01|June 2012|2012-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Near Infrared Spectroscopy for the Detection of Acute Kidney Injury in Children Following Cardiac Surgery|Use of Near Infrared Spectroscopy (NIRS) for the Early Detection of Acute Kidney Injury in Children Post Cardiopulmonary Bypass|Completed||N/A|107|Actual|University of Colorado, Denver|||2||f||||t||||||Samples Without DNA|"     Serum, Urine   "|||2017-10-11 04:05:17.77369|2017-10-11 04:05:17.77369
NCT01382745|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-01-25|||January 2012||2012-01-01|January 2013|2013-01-01|January 2022|Anticipated|2022-01-01|September 2021|Anticipated|2021-09-01||Interventional|||Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers|A Phase II Clinical Study Using Nimotuzumab in Combination With External Beam Radiation Therapy in the Treatment of Patients With Carcinomas of the Anal Canal|Terminated||Phase 2|1|Actual|Sir Mortimer B. Davis - Jewish General Hospital||1||low recruitment|f||||t||||||||||2017-10-11 04:05:17.869199|2017-10-11 04:05:17.869199
NCT01382732|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2015-01-01|||January 2012||2012-01-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia|Carbetocin Versus Oxytocin for Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia: a Double Blind Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|636|Anticipated|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-11 04:05:17.955497|2017-10-11 04:05:17.955497
NCT01382719|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2014-12-02|2013-09-05||June 2011||2011-06-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder|A Placebo-controlled, Randomized, Parallel Group, Dose-finding Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With FSAD (Female Sexual Arousal Disorder) and/or HSDD (Hypoactive Sexual Desire Disorder)|Completed||Phase 2|612|Actual|Palatin Technologies||4|||f||||t||||||||||2017-10-11 04:05:18.100596|2017-10-11 04:05:18.100596
NCT01382706|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-04-08|||June 13, 2011|Actual|2011-06-13|April 2017|2017-04-01|December 15, 2017|Anticipated|2017-12-15|July 15, 2013|Actual|2013-07-15||Interventional|||Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder|Single Arm Phase II Study of Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder as Second Line Treatment|Terminated||Phase 2|15|Actual|University of Southern California||1||Trial not progressing toward scientific goals|f||||t|t|f|||f|||||2017-10-11 04:05:19.561653|2017-10-11 04:05:19.561653
NCT01382693|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-07-03|||June 2011||2011-06-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Effects of Involvement in a Group-based Creative Expression Program on Psychotropic Drug Use in Persons With Dementia|Effects of Involvement in a Group-based Creative Expression Program on Psychotropic Drug Use in Persons With Dementia in Long-term Care: a Cluster-randomized Pilot Study|Completed||N/A|20|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 04:05:19.79977|2017-10-11 04:05:19.79977
NCT01382667|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2012-11-08|||July 2011||2011-07-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|||Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy|Evaluation of Dyspeptic Symptoms in Oncological Frail Patients With Extraintestinal Cancer in Chemotherapy. Assessment of Circulating Levels of Glucagon-like Peptide 2 (GLP-2) in Relation to Mucositis|Completed||N/A|70|Actual|Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis|||1||f||||f||||||Samples Without DNA|"     whole blood serum   "|||2017-10-11 04:05:19.967478|2017-10-11 04:05:19.967478
NCT01382654|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-10-08||2011-06-24|September 2006||2006-09-01|October 2015|2015-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis||Completed||Phase 2|131|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-10-11 04:05:20.086859|2017-10-11 04:05:20.086859
NCT01382641|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2011-10-05|||September 2010||2010-09-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract Surgery|Relevance of Eye Dominance in the Selection of Patients Suitable for Treatment With Monovision After Cataract Surgery|Unknown status|Active, not recruiting|Phase 4|20|Anticipated|Innovative Medical||2|||f||||f||||||||||2017-10-11 04:05:20.172731|2017-10-11 04:05:20.172731
NCT01382628|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-07-07|||May 2011||2011-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon|Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon.|Suspended||N/A|50|Anticipated|Georgetown University|||5|We are currently trying to find someone to assay the collagen|f||||f||||||Samples Without DNA|"     A tissue sample (20mg) of the Achilles tendon will be collected at this time. This tissue     will be preserved in a dry ice container and shipped to Midwestern University for processing     by the sub-investigator (CC). The specimens will be labeled numerically with a predetermined     subject number. No patient identifying information will be on these samples.   "|||2017-10-11 04:05:20.262022|2017-10-11 04:05:20.262022
NCT01382615|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-12|2016-05-23|||August 2010||2010-08-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research|Evaluation of Immune Parameters and Function in Multiple Myeloma Patients and Healthy Individuals' Blood and Marrow Samples|Terminated||N/A|75|Anticipated|Dartmouth-Hitchcock Medical Center|||2|Unable to fill cohort|f||||t||||||Samples With DNA|"     15mL of peripheral blood 10mL of bone marrow aspirate   "|||2017-10-11 04:05:20.337034|2017-10-11 04:05:20.337034
NCT01382602|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2017-02-02||2017-02-02|December 2011||2011-12-01|February 2017|2017-02-01|January 29, 2017|Actual|2017-01-29|January 14, 2016|Actual|2016-01-14||Interventional|||Autologous Muscle-derived Cells Female Stress Urinary Incontinence Clinical Study|A Double-blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Effectiveness of Cook MyoSite Incorporated AMDC in Female Patients With Stress Urinary Incontinence|Completed||Phase 3|150|Actual|Cook Group Incorporated||2|||f|||||f|f||||||||2017-10-11 04:05:20.409297|2017-10-11 04:05:20.409297
NCT01382589|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-03-21|||September 2011||2011-09-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|NSV||Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo|A Phase II Randomised Pilot Study to Compare the Efficacy and Safety of Subcutaneous, Bioresorbable Afamelanotide Implants and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo|Completed||Phase 2|15|Actual|Clinuvel Pharmaceuticals Limited||2|||f||||f||||||||||2017-10-11 04:05:20.588755|2017-10-11 04:05:20.588755
NCT01382576|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2012-03-09|||January 2010||2010-01-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity|Women With Polycystic Ovary Syndrome Have Increased Plasma Chitotriosidase Activity: A Pathophysiological Link Between Inflammation and Impaired Insulin Sensitivity?|Completed||N/A|78|Actual|Gulhane School of Medicine|||2||f||||f||||||None Retained|"     No biospecimens were to be retained   "|||2017-10-11 04:05:20.671543|2017-10-11 04:05:20.671543
NCT01382563|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2017-01-20|||November 2012||2012-11-01|January 2017|2017-01-01|June 2051|Anticipated|2051-06-01|December 2050|Anticipated|2050-12-01||Observational|EoE||Registry for Eosinophilic Gastrointestinal Disorders (REGID)|Registry for Eosinophilic Gastrointestinal Disorders (REGID)|Active, not recruiting||N/A|10000|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 04:05:20.750315|2017-10-11 04:05:20.750315
NCT01382550|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-09-12|||March 1993||1993-03-01|September 2012|2012-09-01||||September 2012|Actual|2012-09-01||Observational|||Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.|Prevention of Recurrent Venous Thromboembolism in Patients With Low Circulating Levels of Antithrombin. Extended Anticoagulation vs 12-Month Oral Anticoagulation|Unknown status|Recruiting|N/A|900|Anticipated|Federico II University|||1||f||||t||||||||||2017-10-11 04:05:20.844591|2017-10-11 04:05:20.844591
NCT01382537|ClinicalTrials.gov processed this data on October 10, 2017|2009-09-21|2014-07-24|||January 2008||2008-01-01|July 2014|2014-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy of the InterX 5000 in the Treatment of Chronic Neck Pain|Evaluation of the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder Pain|Completed||N/A|89|Actual|Canadian Memorial Chiropractic College||2|||f||||f||||||||||2017-10-11 04:05:20.941106|2017-10-11 04:05:20.941106
NCT01382524|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2013-06-12|||June 2011||2011-06-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Observational|PIV Secural||Peripheral Intravenous Catheter Complication Rate Comparison of Two Different Catheter-Stabilization Systems|Peripheral I.V. Catheter Complication Rate Comparison of Two Different Catheter-Stabilization Systems|Completed||N/A|682|Actual|3M|||2||f||||f||||||||||2017-10-11 04:05:21.040849|2017-10-11 04:05:21.040849
NCT01382511|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-23|||July 2011||2011-07-01|October 2009|2009-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||Simvastatin Treatment of Pachyonychia Congenita|Simvastatin Treatment of Pachyonychia Congenita|Unknown status|Not yet recruiting|N/A|10|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||||||||||||2017-10-11 04:05:21.122953|2017-10-11 04:05:21.122953
NCT01382498|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-21|2011-06-24|||November 2009||2009-11-01|April 2011|2011-04-01||||June 2011|Anticipated|2011-06-01||Interventional|||Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic Retinopathy||Unknown status|Enrolling by invitation|Phase 4|90|Actual|Tabriz University||2|||f||||||||||||||2017-10-11 04:05:21.177978|2017-10-11 04:05:21.177978
NCT01382485|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-01-16|||August 2012||2012-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Reamer Irrigator Aspirator (RIA) vs Autogenous Iliac Crest Bone Graft (AICBG) for the Treatment of Non-unions|Reamer Irrigator Aspirator Versus Autogenous Iliac Crest Bone Graft for the Treatment of Non-Unions: A Multi-Centre Randomized Controlled Trial|Recruiting||N/A|104|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 04:05:21.260002|2017-10-11 04:05:21.260002
NCT01382472|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-08-24|||September 2011||2011-09-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|MICROS||Microcirculation In Acute Coronary Syndromes|MICROS-Pilot Study Microcirculation In Acute Coronary Syndromes; Effect of Pre-treatment of High Dose Rosuvastatin on Coronary Microcirculation in Primary PCI|Recruiting||Phase 4|40|Anticipated|Helse Stavanger HF||2|||f||||f||||||||No||2017-10-11 04:05:21.37217|2017-10-11 04:05:21.37217
NCT01382459|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-24|||July 2011||2011-07-01|June 2011|2011-06-01||||||||Observational|||Constructed Intervention by Home and School Diabetes Nurse Visits on Diabetic Control of Children With Type I Diabetes|The Efficacy of Constructed Intervention by Home and School Visits by Diabetes Nurses on Diabetic Control of Children With Type I Diabetes|Unknown status|Not yet recruiting|N/A|100|Anticipated|Soroka University Medical Center|||2||f||||t||||||||||2017-10-11 04:05:21.495467|2017-10-11 04:05:21.495467
NCT01382446|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-12-12|2013-07-24||July 2010||2010-07-01|December 2016|2016-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Chlorhexidine Gluconate Oral Care for Adults Experiencing Trauma|Evaluating Effectiveness of Chlorhexidine Gluconate Oral Care for Adults|Completed||N/A|66|Actual|St. Joseph's Hospital and Medical Center, Phoenix|Enrolling of trauma patients - consenting patients with unknown identification or next of kin status led to small number of subjects analyzed|2|||f||||f||||||||||2017-10-11 04:05:21.574492|2017-10-11 04:05:21.574492
NCT01382433|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-12-29|||July 2011||2011-07-01|December 2011|2011-12-01||||July 2012|Anticipated|2012-07-01||Interventional|||Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia|Clinical Assessment of Negative Symptoms Neurocognitive and Electrophysiological Characteristics in Chronic Cannabis Users|Unknown status|Recruiting|N/A|115|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 04:05:21.88325|2017-10-11 04:05:21.88325
NCT01382420|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2015-11-16|||May 2011||2011-05-01|November 2015|2015-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma|Long-term Effects of Adrenalectomy on Metabolic Syndrome, Glucose Metabolism, Lipid Metabolism, and Bone Metabolism in Subclinical Cushing's Syndrome of Adrenal Incidentaloma|Recruiting||N/A|234|Anticipated|Samsung Medical Center||2|||f||||||||||||||2017-10-11 04:05:21.987901|2017-10-11 04:05:21.987901
NCT01382407|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-04-26|||July 2011||2011-07-01|April 2017|2017-04-01|April 1, 2017|Actual|2017-04-01|April 1, 2017|Actual|2017-04-01||Observational|||Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab|Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab?|Completed||N/A|100|Actual|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 04:05:22.080864|2017-10-11 04:05:22.080864
NCT01382394|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-08-03|||July 2009||2009-07-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Impact of Clinical, Demographic and Laboratory Variables on Brain Natriuretic Peptide Levels|Impact of Clinical, Demographic and Laboratory Variables on Brain Natriuretic Peptide Levels|Withdrawn||N/A|60|Actual|Rambam Health Care Campus|||1|No Patients were recruited during the study period|f||||f||||||||||2017-10-11 04:05:22.156227|2017-10-11 04:05:22.156227
NCT01382381|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-24|||July 2011||2011-07-01|February 2011|2011-02-01|July 2012|Anticipated|2012-07-01|||||Observational|||Intravascular Stents Fracture Effects|Evaluation of Implanted Aortic Arch and Branch Pulmonary Artery Stents Durability and Function|Unknown status|Not yet recruiting|N/A|20|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 04:05:22.21579|2017-10-11 04:05:22.21579
NCT01382368|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2012-11-13|||September 2011||2011-09-01|November 2012|2012-11-01|September 2013|Anticipated|2013-09-01|November 2012|Anticipated|2012-11-01||Interventional|||Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients|Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients|Unknown status|Enrolling by invitation|Phase 4|60|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-10-11 04:05:22.263454|2017-10-11 04:05:22.263454
NCT01382355|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-08-02|||August 2011||2011-08-01|August 2011|2011-08-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||Prospective Donor Specific Antibody (DSA) Monitoring Protocol|Prospective Donor Specific Antibody (DSA) Monitoring Protocol To Detect Patient Characteristics and /or Changes In Immunosuppression on the Development of De Novo Antibodies|Unknown status|Recruiting|N/A|60|Anticipated|Providence Health & Services|||1||f||||f||||||Samples With DNA|"     1 ml aliquots of serum collected at specified time points   "|||2017-10-11 04:05:22.340456|2017-10-11 04:05:22.340456
NCT01382342|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-02-03|||June 2011||2011-06-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||The Effect of Rasagiline on Cognition in Parkinson's Disease||Completed||Phase 4|50|Actual|Brown University||2|||f||||f||||||||||2017-10-11 04:05:22.443089|2017-10-11 04:05:22.443089
NCT01382329|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2015-10-07|||June 2011||2011-06-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|August 2011|Actual|2011-08-01||Interventional|||H5N1 Vaccine Study in Japanese Adults|A Blinded, Randomized Phase 2/3 Study to Assess Immunogenicity and Safety of Two Different Dose Levels of a Vero Cell-Derived Whole Virus H5N1 Influenza Vaccine in a Healthy Japanese Adult Population Aged 18 to 59 Years|Completed||Phase 2/Phase 3|340|Actual|Nanotherapeutics, Inc.||4|||f||||t||||||||||2017-10-11 04:05:22.529603|2017-10-11 04:05:22.529603
NCT01382316|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2011-06-24|||July 2005||2005-07-01|June 2011|2011-06-01|August 2007|Actual|2007-08-01|May 2006|Actual|2006-05-01||Interventional|MAAEZ||Making Alcoholics Anonymous Easier|Making Alcoholics Anonymous Easier: A Group TSF Approach|Completed||Phase 3|508|Actual|Alcohol Research Group||2|||f||||t||||||||||2017-10-11 04:05:22.616083|2017-10-11 04:05:22.616083
NCT01382303|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-03-31|2017-02-13||October 25, 2010|Actual|2010-10-25|March 2017|2017-03-01|December 20, 2013|Actual|2013-12-20|December 20, 2013|Actual|2013-12-20||Interventional|||Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients|Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients : Prospective, Randomized, Double Blinded Active Control, Multicenter Study|Completed||Phase 4|174|Actual|Ajou University School of Medicine||2|||f||||t||||||||No||2017-10-11 04:05:22.703449|2017-10-11 04:05:22.703449
NCT01382290|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-05|||March 2008||2008-03-01|August 2016|2016-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|MRIS||Magnetic Resonance Imaging of the Spine|Magnetic Resonance Imaging of the Spine|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta||||No patients were enrolled, due to logistic difficulties, no funding was acquired.|f||||f||||||||||2017-10-11 04:05:23.033872|2017-10-11 04:05:23.033872
NCT01382277|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-23|||March 2011||2011-03-01|February 2011|2011-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|REDUCT||Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume|Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Evaluated by Multi-slice Spiral CT in Patients With Stable Coronary Heart Disease and Hyperlipidemia|Unknown status|Recruiting|Phase 4|600|Anticipated|Peking University First Hospital||1|||f||||t||||||||||2017-10-11 04:05:23.104305|2017-10-11 04:05:23.104305
NCT01382264|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-24|||July 2011||2011-07-01|June 2011|2011-06-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Interventional|CADS||Use of a Computer-Assisted Decision Support (CADS) System in Management of Patients With Type 2 Diabetes|The Use of a Computer-Assisted Decision Support (CADS) System to Improve Outcomes in Patients With Type 2 Diabetes|Unknown status|Not yet recruiting|N/A|570|Anticipated|Walter Reed Army Medical Center||1|||f||||t||||||||||2017-10-11 04:05:23.197437|2017-10-11 04:05:23.197437
NCT01382251|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-12-17|2013-07-03||July 2010||2010-07-01|December 2013|2013-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|FOCUS|Demographic characteristics shown for those patients and caregivers completing study|Functional Recovery and Caregiver Burden Following Surgery in the Elderly|Functional Recovery and Caregiver Burden Following Surgery in the Elderly|Completed||N/A|123|Actual|Ottawa Hospital Research Institute|Single center, relatively infrequent assessment, assessment of caregiver burden limited to primary caregiver, majority of caregivers were not employed outside the home.||2||f||||f||||||||||2017-10-11 04:05:23.287046|2017-10-11 04:05:23.287046
NCT01382238|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-09-15|||June 2011||2011-06-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir|Relative Bioavailability Study of a Tablet Formulation vs. Pediatric Granule Formulation of Dolutegravir 50 mg and Effect of Different Types of Water Plus Infant Formula on the Pediatric Granule Formulation in Healthy Male and Female Volunteers|Completed||Phase 1|20|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-10-11 04:05:23.58522|2017-10-11 04:05:23.58522
NCT01382225|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-05-20|2013-05-20||July 2011||2011-07-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Of the 1454 subjects randomized, 4 withdrew participation prior to exposure to test article. This reporting group includes the 1450 subjects exposed to test article.|Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome|A Phase 3 Multicenter, Randomized, Controlled, Double-Masked Study of Safety and Efficacy of Sodium Hyaluronate Ophthalmic Solution, 0.18% in Dry Eye Syndrome|Completed||Phase 3|1936|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 04:05:23.77637|2017-10-11 04:05:23.77637
NCT01382212|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-24|2016-11-08|2016-09-16|2016-04-22|October 2011||2011-10-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis|A Phase 3, Open-Label, Multicenter Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis|Completed||Phase 3|13|Actual|AbbVie|The sample size of the study was limited to 13 subjects and there was no comparator group, so the study was not designed to analyze efficacy.|1|||f||||f||||||||||2017-10-11 04:05:24.181913|2017-10-11 04:05:24.181913
NCT01382199|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-06-23|||September 2011||2011-09-01|June 2011|2011-06-01|March 2014|Anticipated|2014-03-01|September 2013|Anticipated|2013-09-01||Interventional|||Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients|A Phase III Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients|Unknown status|Not yet recruiting|Phase 3|340|Anticipated|Ventria Bioscience||1|||f||||t||||||||||2017-10-11 04:05:24.806654|2017-10-11 04:05:24.806654
NCT01382186|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-04-06|2014-10-28||April 2012||2012-04-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational||Participants were Veterans registered for My HealtheVet and opted-in to use Secure Messaging in the Tampa FL and Boston MA areas.|Veterans Experiences Using Secure Messaging|Veterans' Experiences Using Secure Messaging on MyHealtheVet|Completed||N/A|852|Actual|VA Office of Research and Development|||2||f||||f||||||||||2017-10-11 04:05:24.900671|2017-10-11 04:05:24.900671
NCT01382173|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-09-10|||March 2012||2012-03-01|September 2015|2015-09-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Observational|||Monitoring of Acute Knee Injuries to Understand Osteoarthritis Development|The Acute Knee Injury Project|Recruiting||N/A|600|Anticipated|Lund University|||1||f||||f||||||Samples Without DNA|"     Joint fluid, Serum & Plasma   "|||2017-10-11 04:05:25.44234|2017-10-11 04:05:25.44234
NCT01382160|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-02|2013-10-01|||January 2011||2011-01-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|AFORA||Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)|Serum Concentration of Adalimumab (Humira) as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)|Completed||Phase 4|69|Actual|University Hospital, Tours||1|||f||||t||||||||||2017-10-11 04:05:25.578367|2017-10-11 04:05:25.578367
NCT01382147|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-09-06|||July 2009||2009-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|August 2012|Actual|2012-08-01||Interventional|AMLCG 2008||"Evaluation of Dose-dense Therapy by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)"|A Randomized, Risk and Age Adapted Comparison of the Dose-Dense Regimen S-HAM (Sequential High Dose Cytosine Arabinoside and Mitoxantrone) Versus Standard Double Induction for Initial Chemotherapy of Adult Patients With Acute Myeloid Leukemia|Active, not recruiting||Phase 3|400|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 04:05:25.704629|2017-10-11 04:05:25.704629
NCT01382134|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-11-14|||July 2011||2011-07-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction|Effect of Aspirin, in Vitro Hemodilution and Desmopressin on Platelet Dysfunction Associated With Mild Hypothermia in Healthy Volunteers|Completed||N/A|60|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-10-11 04:05:25.848393|2017-10-11 04:05:25.848393
NCT01382121|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2012-06-25|||September 2010||2010-09-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|AFAP||Adolescent Fitness Assessment Program|Increasing Self-efficacy and VO2 Max Scores in Obese Adolescents: a Peer Modeling Intervention|Completed||Early Phase 1|49|Actual|University of Western Ontario, Canada||2|||f||||f||||||||||2017-10-11 04:05:25.936428|2017-10-11 04:05:25.936428
NCT01382108|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-10-31|2013-06-18||June 2011||2011-06-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|KITCHENER||Meibography and Tear Scan Using the Oculus Keratograph 4|Meibography and Tear Scan Using the Oculus Keratograph 4|Completed||N/A|39|Actual|University of Waterloo|||2||f||||f||||||||||2017-10-11 04:05:26.034276|2017-10-11 04:05:26.034276
NCT01382095|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-04-24|||July 2011||2011-07-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|August 2012|Actual|2012-08-01||Interventional|||Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea|A Phase 1 Dose-Escalating Study of dscCfaE, Co-Administered With and Without LTR192G, by Transcutaneous Immunization (TCI) in Healthy Adult U.S. Volunteers|Completed||Phase 1|40|Actual|U.S. Army Medical Research and Materiel Command||4|||f||||f||||||||||2017-10-11 04:05:26.294291|2017-10-11 04:05:26.294291
NCT01382082|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-06-01|||May 17, 2011|Actual|2011-05-17|June 2017|2017-06-01|July 2018|Anticipated|2018-07-01|December 2017|Anticipated|2017-12-01||Observational|CANTAB||Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy|Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment,Post-Treatment and at Six Months Follow Up|Active, not recruiting||N/A|1432|Anticipated|University of Rochester|||3||f||||t||||||Samples Without DNA|"     Blood   "|||2017-10-11 04:05:26.394561|2017-10-11 04:05:26.394561
NCT01382069|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-25|2017-06-29|||March 2012||2012-03-01|July 2016|2016-07-01|May 2017|Actual|2017-05-01|February 2017|Actual|2017-02-01||Interventional|DMAUPhase1||Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men|Single Dose, Dose-Ranging and 28-Day Repeat-Dose Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Dimethandrolone Undecanoate (DMAU) in Healthy Men|Completed||Phase 1|100|Actual|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-10-11 04:05:26.613898|2017-10-11 04:05:26.613898
NCT01382056|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2014-02-11|||March 2012||2012-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PULV-2011||Effects of Pulse Varieties on Blood Vessel Function in Peripheral Artery Disease|Effects of Pulse Varieties on Blood Vessel Function in Individuals With Peripheral Artery Disease (PAD)|Completed||N/A|62|Actual|University of Manitoba||3|||f||||f||||||||||2017-10-11 04:05:26.716901|2017-10-11 04:05:26.716901
NCT01382030|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-23|||June 2005||2005-06-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|NeoWTS||Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma|A Phase II Study Evaluating Neo-/Adjuvant EIA Chemotherapy, Surgical Resection and Radiotherapy in High-risk Soft Tissue Sarcoma|Completed||Phase 2|50|Actual|Heidelberg University||1|||f||||t||||||||||2017-10-11 04:05:26.902992|2017-10-11 04:05:26.902992
NCT01382017|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-08-28|||June 2011||2011-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effects of Lacosamide on Human Motor Cortex Excitability: a Transcranial Magnetic Stimulation Study||Completed||N/A|18|Actual|University of Kiel||4|||f||||t||||||||||2017-10-11 04:05:26.991067|2017-10-11 04:05:26.991067
NCT01382004|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-04-11|||September 2010||2010-09-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Single-dose Azithromycin for the Treatment of Yaws|Single-dose Azithromycin Versus Penicillin G Benzathine for the Treatment of Yaws in Children|Completed||Phase 3|255|Actual|Lihir Medical Centre||2|||f||||f||||||||||2017-10-11 04:05:27.078576|2017-10-11 04:05:27.078576
NCT01381991|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-06-24|||July 2010||2010-07-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|November 2010|Actual|2010-11-01||Interventional|||The Efficacy of i-Scan for Detecting Reflux Esophagitis|A Prospective Randomized Controlled Trial of the Efficacy of i-Scan for Detecting Reflux Esophagitis|Completed||N/A|500|Anticipated|Konkuk University Hospital||1|||f||||f||||||||||2017-10-11 04:05:27.16972|2017-10-11 04:05:27.16972
NCT01381978|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-05-21|||October 2010||2010-10-01|May 2012|2012-05-01||||||||Observational|||Obesity Childhood in Cuenca-Ecuador: Prevalence and Risk Factors|Baseline Study. Obesity Childhood in Cuenca-Ecuador: Prevalence and Risk Factors|Completed||N/A|700|Actual|Universidad de Cuenca|||1||f||||||||||||||2017-10-11 04:05:27.24374|2017-10-11 04:05:27.24374
NCT01381965|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2012-07-31|||March 2008||2008-03-01|July 2012|2012-07-01|February 2011|Actual|2011-02-01|February 2010|Actual|2010-02-01||Interventional|||Foveal Cone Outer Segment Resumption to Predict Visual Recovery After Macular Hole Surgery|Foveal Cone Outer Segment Resumption to Predict Visual Recovery After Macular Hole Surgery|Completed||N/A|72|Actual|Kyorin University||1|||f||||f||||||||||2017-10-11 04:05:27.308993|2017-10-11 04:05:27.308993
NCT01381952|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2014-04-23|2014-01-28||June 2011||2011-06-01|April 2014|2014-04-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Image Quality and Radiation Dose in Angiography|XRES4 Neuro Claim Study|Completed||N/A|20|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-10-11 04:05:27.39494|2017-10-11 04:05:27.39494
NCT01381939|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-24|||January 2000||2000-01-01|March 2010|2010-03-01|April 2010|Actual|2010-04-01|December 2006|Actual|2006-12-01||Observational|ILICP||Induction of Labor in Intrahepatic Cholestasis of Pregnancy|Induction of Labor in Intrahepatic Cholestasis of Pregnancy|Completed||N/A|5000|Anticipated|Karolinska Institutet|||3||f||||f||||||||||2017-10-11 04:05:27.639364|2017-10-11 04:05:27.639364
NCT01381926|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-05-19|2017-01-14||February 2011||2011-02-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|CMBD|This is a crossover study. Not all patients completed both arms of the study. 14 patients were screened. 10 presented for the baseline study and were provided some study medication. 1 participant's specimen was not analyzed and she is not included in analysis for that reason. 5 started Exenatide; 5 started Placebo.|Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist|Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist (UAB Core Center for Basic Skeletal Research)|Terminated||Phase 4|14|Actual|University of Alabama at Birmingham|Study was closed due to unavailability of study drug/matching placebo prior to recruitment of target participants. The original drug company was bought and new company was unwilling to supply medication. Small participant number limits data analysis.|2||unavailability of study drug and matching placebo|f||||f|t|f||||||Undecided||2017-10-11 04:05:27.718657|2017-10-11 04:05:27.718657
NCT01381913|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-23|||October 2005||2005-10-01|October 2005|2005-10-01|May 2011|Actual|2011-05-01|December 2008|Actual|2008-12-01||Observational|||Feasibility Trial of Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer|Feasibility Trial of Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer Combined With Adjacent Tissue Invasion|Completed||N/A|12|Actual|Kagawa University|||1||f||||f||||||Samples Without DNA|"     tissue   "|||2017-10-11 04:05:28.045661|2017-10-11 04:05:28.045661
NCT01381900|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2014-04-23|2013-11-21||August 2011||2011-08-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, 18-Week Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea|Completed||Phase 3|678|Actual|Janssen Research & Development, LLC||3|||f||||t||||||||||2017-10-11 04:05:28.117029|2017-10-11 04:05:28.117029
NCT01381887|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-04-19|||June 2011||2011-06-01|April 2013|2013-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes Mellitus|A Double-Blind, Placebo-Controlled, Randomized, Crossover, Multicenter Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|37|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||f||||||||||2017-10-11 04:05:30.349377|2017-10-11 04:05:30.349377
NCT01381874|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-07-20|||August 24, 2011|Actual|2011-08-24|July 2017|2017-07-01|September 30, 2018|Anticipated|2018-09-30|September 20, 2018|Anticipated|2018-09-20||Interventional|||A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy|Randomized, Open-Label Study of Abiraterone Acetate (JNJ-212082) Plus Prednisone With or Without Exemestane in Postmenopausal Women With ER+ Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy|Active, not recruiting||Phase 2|299|Actual|Janssen Research & Development, LLC||3|||f||||t||f||||||||2017-10-11 04:05:30.496185|2017-10-11 04:05:30.496185
NCT01381861|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-12-03|||July 2011||2011-07-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|August 2012|Actual|2012-08-01||Interventional|||Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|A Phase 2 Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|23|Actual|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||||2017-10-11 04:05:30.94772|2017-10-11 04:05:30.94772
NCT01381848|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2013-01-08|||October 2009||2009-10-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study of Doripenem in Infants Less Than 12 Weeks of Age|An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants (Term and Preterm), Less Than 12 Weeks Chronological Age|Completed||Phase 1|52|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-10-11 04:05:31.078843|2017-10-11 04:05:31.078843
NCT01381835|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-10-11|||July 2011||2011-07-01|October 2013|2013-10-01|January 2012|Actual|2012-01-01|||||Interventional|||TMC435-TiDP16-C126 - Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435|Phase I, Open-label Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435|Completed||Phase 1|16|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||t||||||||||2017-10-11 04:05:31.216513|2017-10-11 04:05:31.216513
NCT01381809|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-03-14|||October 2011||2011-10-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2015|Actual|2015-01-01||Interventional|||An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Epoetin Alfa Versus Placebo in Anemic Patients With IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes|Completed||Phase 3|130|Actual|Janssen-Cilag International NV||2|||f||||t||||||||||2017-10-11 04:05:31.418824|2017-10-11 04:05:31.418824
NCT01381783|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-07|2011-06-24|||January 2006||2006-01-01|March 2011|2011-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Phacoemulsification Under Topical Anesthesia and Its Complications||Completed||Phase 1|111|Anticipated|Instituto de Oftalmologia Ivo Correa-Meyer||1|||f||||t||||||||||2017-10-11 04:05:31.700149|2017-10-11 04:05:31.700149
NCT01381770|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-08-24|||September 2010||2010-09-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Platelet-derived Factors for Treatment of Muscular Lesions|Platelet-derived Factors for Treatment of Muscular Lesions: a Phase II Trial|Completed||Phase 2|25|Actual|IRCCS Policlinico S. Matteo||1|||f||||f||||||||||2017-10-11 04:05:31.763198|2017-10-11 04:05:31.763198
NCT01381757|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-06-30|||May 31, 2011||2011-05-31|March 5, 2013|2013-03-05|March 5, 2013||2013-03-05|||||Observational|||Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali|Uitlity of MODS for the Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali|Terminated||N/A|340|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:05:31.842094|2017-10-11 04:05:31.842094
NCT01381744|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-01-28|||February 2012||2012-02-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers|A Phase I Safety and Immunogenicity Dose Escalation Trial of Plague Vaccine, Flagellin/F1/V, In Healthy Adult Volunteers|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 04:05:31.917395|2017-10-11 04:05:31.917395
NCT01381731|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-10-29||2011-06-24|April 2005||2005-04-01|October 2015|2015-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)||Terminated||Phase 2|14|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 04:05:32.013843|2017-10-11 04:05:32.013843
NCT01381718|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-07-10|||August 2011||2011-08-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor|A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor|Active, not recruiting||Phase 2|123|Actual|University of South Florida||2|||f||||t||||||||||2017-10-11 04:05:32.105594|2017-10-11 04:05:32.105594
NCT01381705|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-05-16|||February 6, 2012|Actual|2012-02-06|May 2017|2017-05-01|July 6, 2012|Actual|2012-07-06|July 6, 2012|Actual|2012-07-06||Observational|||Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma|Validating the Predictive Value (of Response to Rituximab Induction and Maintenance) of the FCGR3A 158V/F Polymorphism Using Complimentary Genotyping Methods|Completed||N/A|259|Actual|Eastern Cooperative Oncology Group|||1||f||||||||||||||2017-10-11 04:05:32.450337|2017-10-11 04:05:32.450337
NCT01381692|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-09-04|||July 20, 2011|Actual|2011-07-20|May 2017|2017-05-01||||June 1, 2020|Anticipated|2020-06-01||Interventional|||Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma|A Randomized Phase I/II Study of Bortezomib, Rituximab, Dexamethasone and Temsirolimus in Patients With Relapsed Waldenstrom Macroglobulinemia and Relapsed/Refractory Mantle Cell, Follicular, Marginal Zone or Small Lymphocytic Lymphomas (Phase I), and Untreated/Relapsed Waldenstrom Macroglobulinemia (Phase II)|Active, not recruiting||Phase 1/Phase 2|144|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:05:32.538482|2017-10-11 04:05:32.538482
NCT01381679|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-10-12|2011-11-23||May 2009||2009-05-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|ACT II||Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1)|Austrian Cholesterol Screening And Treatment II (ACT II)|Completed||N/A|1682|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-10-11 04:05:32.762949|2017-10-11 04:05:32.762949
NCT01381653|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-05-30|||November 2011||2011-11-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||An Innovative HIV Prevention Intervention Using Social Networking Technology|An Innovative HIV Prevention Intervention Using Social Networking Technology|Completed||N/A|60|Actual|Hunter College of City University of New York||1|||f||||t||||||||||2017-10-11 04:05:33.155544|2017-10-11 04:05:33.155544
NCT01381640|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-07-05|||April 2010||2010-04-01|July 2016|2016-07-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||A Study to Compare Two Paracetamol Tablets|A Single Dose Pharmacoscintigraphic Study Investigating the Differences in Gastrointestinal Behavior and Paracetamol Absorption Between Sustained Release Formula and Standard Release Formula|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||2||Study was cancelled prior to enrolling any subjects.|f||||f||||||||||2017-10-11 04:05:33.25298|2017-10-11 04:05:33.25298
NCT01381627|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-02-27|||June 2011||2011-06-01|June 2011|2011-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|EBUSed||Safety Evaluation of Dexmedetomidine for EBUS-TBNA|Safety Evaluation of Dexmedetomidine Monitored Anesthesia Care for Endobronchial Ultrasound-guided Transbronchial Needle Aspiration|Unknown status|Recruiting|Phase 4|60|Anticipated|Maisonneuve-Rosemont Hospital||2|||f||||t||||||||||2017-10-11 04:05:33.3468|2017-10-11 04:05:33.3468
NCT01381614|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-05-09|||March 2011||2011-03-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)|Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:33.458318|2017-10-11 04:05:33.458318
NCT01381601|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-05-09|||March 2011||2011-03-01|May 2013|2013-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)|Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:33.535925|2017-10-11 04:05:33.535925
NCT01381588|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-05-15|||October 2010||2010-10-01|May 2017|2017-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|TOP||The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women|The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women|Completed||N/A|1136|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:33.620404|2017-10-11 04:05:33.620404
NCT01381575|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-03-13|2013-06-28||June 2011||2011-06-01|January 2017|2017-01-01|November 2014|Actual|2014-11-01|June 2012|Actual|2012-06-01||Interventional|||Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls|Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 Vaccine When Administered According to Alternative 2-dose Schedules in 9 - 14 Year Old Females|Completed||Phase 3|1447|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:05:33.911979|2017-10-11 04:05:33.911979
NCT01381549|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-08-09|2017-08-09|2012-11-15|June 28, 2011|Actual|2011-06-28|August 2017|2017-08-01|March 6, 2012|Actual|2012-03-06|March 6, 2012|Actual|2012-03-06||Interventional|||GSK2251052 in Complicated Urinary Tract Infection|A Randomised, Double-blind, Dose-finding, Multicenter Study of the Safety, Tolerability, and Efficacy of GSK2251052 Therapy Compared to Imipenem-cilastatin in the Treatment of Adult Subjects With Febrile Complicated Lower Urinary Tract Infections and Acute Pyelonephritis|Terminated||Phase 2|20|Actual|GlaxoSmithKline||3||"Microbiological findings of resistance on therapy in patients with complicated urinary tract   infection"|f||||t||||||||||2017-10-11 04:05:37.955439|2017-10-11 04:05:37.955439
NCT01381536|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2017-06-09|||July 20, 2010|Actual|2010-07-20|June 2017|2017-06-01|November 27, 2010|Actual|2010-11-27|November 27, 2010|Actual|2010-11-27||Interventional|||Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)|GSK1550188, A Randomised, Single-blind, Placebo Controlled, Dose Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:05:40.491259|2017-10-11 04:05:40.491259
NCT01381523|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-02-21|||November 2010||2010-11-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data|A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data|Completed||N/A|1|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 04:05:40.577713|2017-10-11 04:05:40.577713
NCT01381510|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-08-23|||June 2010||2010-06-01|August 2012|2012-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database|Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database|Completed||N/A|54459|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 04:05:40.681212|2017-10-11 04:05:40.681212
NCT01381497|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-08-23|||March 2010||2010-03-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy|Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:40.770598|2017-10-11 04:05:40.770598
NCT01381471|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-03-15|2012-02-02||August 2009||2009-08-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|11060|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:40.969245|2017-10-11 04:05:40.969245
NCT01381458|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-05-19|||September 2010||2010-09-01|May 2017|2017-05-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Observational|||Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation|Differences in the Risk of Re-hospitalization and Other COPD-related (Chronic Obstructive Pulmonary Disease) Exacerbations and Costs for Patients Receiving Fluticasone Propionate-salmeterol Xinafoate Combination 250/50mcg (FSC) Versus Anticholinergics [i.e. Tiotropium (TIO) and Ipratropium or Combination Ipratropium-albuterol (IPR) Post-hospitalization or ED Visit for the Treatment of COPD.|Completed||N/A|1936|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:41.153534|2017-10-11 04:05:41.153534
NCT01381445|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-07-18|||April 14, 2011|Actual|2011-04-14|July 2017|2017-07-01|July 7, 2011|Actual|2011-07-07|July 7, 2011|Actual|2011-07-07||Interventional|||A Study Assessing GW870086's Potential to Cause Skin Thinning|A Randomised, Double-blind (for GW870086), Placebo-controlled Study of Topical GW870086 Formulation to Explore the Potential for Skin Thinning in Healthy Adult Volunteers|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 04:05:41.232763|2017-10-11 04:05:41.232763
NCT01381432|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-05-09|||December 2004||2004-12-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)|Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)|Completed||N/A|39|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:41.321767|2017-10-11 04:05:41.321767
NCT01381419|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-07-05|||October 20, 2008|Actual|2008-10-20|July 2017|2017-07-01|April 1, 2009|Actual|2009-04-01|April 1, 2009|Actual|2009-04-01||Interventional|||First Time in Human Study (FTIH) With Positron Emission Tomography (PET)|A Single-blind, Randomised, Placebo-controlled, Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1144814 in Healthy Male and Female Subjects and an Open-label Positron Emission Tomography Study in Healthy Male Subjects to Evaluate the Neurokinin-1 (NK1) Receptor Occupancy of GSK1144814 in the Living Human Brain Using 11C GR205171.|Completed||Phase 1|21|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 04:05:41.381993|2017-10-11 04:05:41.381993
NCT01381406|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-05-19|2011-09-15||July 2008||2008-07-01|May 2017|2017-05-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Observational|||Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations|Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations|Completed||N/A|3333|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:41.462763|2017-10-11 04:05:41.462763
NCT01381393|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-11-28|||June 2007||2007-06-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|BONPMS||BONVIVA(Ibandronate) PMS(Post-marketing Surveillance )|An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety of BONVIVA(Ibandronate) Administered in Korean Patients According to the Prescribing Information|Completed||N/A|659|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:05:41.97736|2017-10-11 04:05:41.97736
NCT01381380|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-24|||November 2006||2006-11-01|November 2007|2007-11-01|December 2009|Actual|2009-12-01|November 2007|Actual|2007-11-01||Interventional|||Manual Therapy Treatment for Myofascial Pain|Effect of Manual Therapy After Trigger Point Injection for Myofascial Pain Syndrome|Completed||N/A|30|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 04:05:42.076722|2017-10-11 04:05:42.076722
NCT01381367|ClinicalTrials.gov processed this data on October 10, 2017|2009-02-16|2011-06-24|||February 2009||2009-02-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD)|Phase 4 Study of PPSV23 Pneumococcal Vaccine in COPD Patients Using High Daily Dose of Inhaled Corticosteroid|Completed||Phase 4|38|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-10-11 04:05:42.183277|2017-10-11 04:05:42.183277
NCT01381354|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-11-22|||October 2010||2010-10-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|February 2016|Actual|2016-02-01||Interventional|||Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)|Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)|Completed||Phase 1|38|Actual|University of Iowa||1|||f||||t||||||||||2017-10-11 04:05:42.283998|2017-10-11 04:05:42.283998
NCT01381341|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2012-03-21|||May 2011||2011-05-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.|A Phase 1 Pharmacokinetic Study To Compare the Relative Bioavailability of Two Clinical Formulations of Linifanib in Subjects With Solid Tumors|Completed||Phase 1|13|Actual|Abbott||1|||f||||f||||||||||2017-10-11 04:05:42.468092|2017-10-11 04:05:42.468092
NCT01381328|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-02-08|||December 2011||2011-12-01|February 2013|2013-02-01|September 2013|Anticipated|2013-09-01|March 2013|Anticipated|2013-03-01||Observational|||GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance|GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance|Unknown status|Recruiting|N/A|100|Anticipated|Università Vita-Salute San Raffaele|||1||f||||f||||||Samples Without DNA|"     whole blood   "|||2017-10-11 04:05:42.552408|2017-10-11 04:05:42.552408
NCT01381315|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-01-06|||September 2009||2009-09-01|January 2017|2017-01-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Axillary Reverse Mapping|ARM: Axillary Reverse Mapping|Completed||Phase 2|210|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 04:05:42.670881|2017-10-11 04:05:42.670881
NCT01381302|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-02-08|||August 2011||2011-08-01|February 2016|2016-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Trodat 1 SPECT and Dopamine Polymorphism|Association of Polymorphism in Genes Associated With Control of Dopamine Levels in Parkinson's Disease and Tc-99m-Trodat-1 SPECT Imaging.|Completed||N/A|90|Actual|Wolfson Medical Center|||1||f||||f||||||Samples With DNA|"     Blood samples with DNA   "|||2017-10-11 04:05:42.764586|2017-10-11 04:05:42.764586
NCT01381276|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-12-08|||June 2011||2011-06-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|FL-80||Vitamin A Absorption From Cassava in Women|Vitamin A Equivalence of Carotenoids From Cassava in Women|Completed||Phase 2|10|Actual|USDA, Western Human Nutrition Research Center||3|||f||||t||||||||||2017-10-11 04:05:42.900577|2017-10-11 04:05:42.900577
NCT01381263|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-20|2011-06-23|||January 2011||2011-01-01|June 2011|2011-06-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Behavioral Medicine Treatment for Adolescents in Pain|Development, Evaluation and Cost Effectiveness of a Treatment Program With a Behavioural Medicine Approach for Adolescents With Persistent Pain.|Unknown status|Recruiting|N/A|100|Anticipated|Uppsala University||2|||f||||t||||||||||2017-10-11 04:05:42.995953|2017-10-11 04:05:42.995953
NCT01381250|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-29|||May 2004||2004-05-01|January 2004|2004-01-01|January 2009|Actual|2009-01-01|January 2006|Actual|2006-01-01||Interventional|||Effects of Internet-based Treatment of Pathological Gambling|Prediction and Treatment Outcome of Internet-based Treatment of Pathological Gambling With Three-year Follow-up|Completed||N/A|284|Actual|Umeå University||1|||f||||f||||||||||2017-10-11 04:05:43.104343|2017-10-11 04:05:43.104343
NCT01381237|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-22|||August 2007||2007-08-01|March 2007|2007-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effects of Game-based Balance Exercise for Older Adults With Fall History|Full Title Interactive Computer Game Exercise Regime, Effects on Balance Impairment in Frail Community-Dwelling Older Adults. A Randomized Controlled Trial|Completed||Phase 2|30|Actual|University of Manitoba||1|||f||||t||||||||||2017-10-11 04:05:43.181208|2017-10-11 04:05:43.181208
NCT01381224|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-04-18|||January 2011||2011-01-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Do Lower Spine Injections Improve Outcomes for Lower Back Pain Patients|Do Lumbar Spine Injections Improve Short-Term Biomechanical Outcomes in Patients With Chronic Low Back Pain|Completed||N/A|30|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 04:05:43.261123|2017-10-11 04:05:43.261123
NCT01381211|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2015-06-02|||September 2011||2011-09-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|September 2015|Anticipated|2015-09-01||Interventional|TRACE||Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)|Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of HCC: A Multicenter Randomized Controlled Trial (TRACE Trial)|Unknown status|Recruiting|Phase 2|140|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 04:05:43.352106|2017-10-11 04:05:43.352106
NCT01381198|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-07-08|||June 2007||2007-06-01|January 2011|2011-01-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|RectusTrans||Distal Rectus Femoris Transfer as a Part of Multilevel Surgery in Children With Spastic Diplegia|Distal Rectus Femoris Transfer as a Part of Multilevel Surgery in Children With Spastic Diplegia - a Randomized Clinical Trial|Completed||N/A|36|Actual|Heidelberg University||2|||f||||f||||||||||2017-10-11 04:05:43.442568|2017-10-11 04:05:43.442568
NCT01381185|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-10-26|||May 2011||2011-05-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|REACT-MI||REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction|Phase IV Study of Aspirin and Clopidogrel Therapy Tailored by Functional Thrombocyte Examination (PFA-100, LTA and VerifyNOW) in Acute Myocardial Infarction|Completed||Phase 4|154|Actual|University Hospital Ostrava||2|||f||||t||||||||||2017-10-11 04:05:43.554042|2017-10-11 04:05:43.554042
NCT01381172|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-03-01|||January 2011||2011-01-01|March 2017|2017-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|FIX-HF-5C||Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C|Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C|Active, not recruiting||N/A|160|Actual|Impulse Dynamics||2|||f||||t||||||||||2017-10-11 04:05:43.69035|2017-10-11 04:05:43.69035
NCT01381159|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-07-12|||January 2011||2011-01-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|MI-ACT||Motivational Intervention for Asthma|Motivational Intervention for Asthma Control Trial|Recruiting||Phase 3|182|Anticipated|Hopital du Sacre-Coeur de Montreal||2|||f||||f||||||||||2017-10-11 04:05:43.910202|2017-10-11 04:05:43.910202
NCT01381146|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-04-21|||July 15, 2016|Actual|2016-07-15|April 2017|2017-04-01|July 15, 2016|Actual|2016-07-15|July 15, 2016|Actual|2016-07-15||Interventional|||Victim Impact Modules for Jail Inmates|Phase 1-2 Study of Victim Impact Group Modules for Jail Inmates|Withdrawn||N/A|0|Actual|George Mason University||2||"Results from Phase II Study did not support dismantling"|f||||t||||||||||2017-10-11 04:05:44.076036|2017-10-11 04:05:44.076036
NCT01381133|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-08-13|||September 2002||2002-09-01|August 2013|2013-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|AOCCS||Adolescent Outpatient and Continuing Care Study|Adolescent Outpatient and Continuing Care Study|Completed||Phase 3|320|Actual|Chestnut Health Systems||4|||f||||t||||||||||2017-10-11 04:05:44.247775|2017-10-11 04:05:44.247775
NCT01381120|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-02|2012-08-21|2012-02-09||October 2010||2010-10-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms|Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms (LUTS) Post Ureteroscopy for Stone Management|Completed||Phase 4|84|Actual|Barrie Urology Associates||2|||f||||t||||||||||2017-10-11 04:05:44.411692|2017-10-11 04:05:44.411692
NCT01381107|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-08-18||2011-08-18|May 2011||2011-05-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD|A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Tolerability of ALKS 33-BUP Administration in Subjects With Major Depressive Disorder (MDD)|Completed||Phase 1/Phase 2|32|Anticipated|Alkermes, Inc.||2|||f||||t||||||||||2017-10-11 04:05:45.023535|2017-10-11 04:05:45.023535
NCT01381094|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-03-29||2012-10-03|June 2011||2011-06-01|March 2016|2016-03-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia|Phase 2a Randomized, Double-Blind, Placebo-Controlled, Dose Range Study to Assess the Pharmacodynamic Response, Pharmacokinetics, Safety, and Tolerability of 42-Day Repeat Oral Doses of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), Stages 3 and 4|Completed||Phase 2|93|Actual|Akebia Therapeutics||5|||f||||f||||||||||2017-10-11 04:05:45.131274|2017-10-11 04:05:45.131274
NCT01381081|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-02-23|||July 2011||2011-07-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Platelet-rich Plasma Intra-articular Knee Injections for Knee Osteoarthritis|A Prospective, Randomized, Double-blinded, Clinical Trial, Comparing Platelet-rich Plasma Intra-articular Knee Injections Versus Corticosteroid Intra-articular Knee Injections for Knee Osteoarthritis|Completed||Phase 3|74|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-10-11 04:05:45.280475|2017-10-11 04:05:45.280475
NCT01381068|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-07-08|||October 2009||2009-10-01|June 2011|2011-06-01|September 2011|Anticipated|2011-09-01|May 2011|Actual|2011-05-01||Interventional|||Quantitative End Tidal CO2 Monitoring in the Delivery Room (DR)|Quantitative End Tidal CO2 Monitoring in the Delivery Room: Can we Prevent Hypo/Hypercapnia Upon Admission to the NICU?|Unknown status|Active, not recruiting|N/A|50|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 04:05:45.3788|2017-10-11 04:05:45.3788
NCT01381055|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2017-01-25|||March 2012|Actual|2012-03-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|January 2015|Actual|2015-01-01||Interventional|||Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis|Double-blind Placebo Controlled Trial Using Pentoxifylline Associated With Pentavalent Antimony in Cutaneous Leishmaniasis|Completed||Phase 2/Phase 3|164|Actual|Hospital Universitário Professor Edgard Santos||2|||f||||t||||||||||2017-10-11 04:05:45.474763|2017-10-11 04:05:45.474763
NCT01381042|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-23|||February 2010||2010-02-01|December 2009|2009-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||The Incidence and Factors of Brown Adipose Tissue in Chinese|Retrospective Study on the Incidence and Factors of Brown Adipose Tissue in Adult Chinese|Unknown status|Active, not recruiting|N/A|600|Anticipated|Huashan Hospital|||1||f||||t||||||||||2017-10-11 04:05:45.560273|2017-10-11 04:05:45.560273
NCT01381029|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-02-08|||September 2009||2009-09-01|January 2016|2016-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals|A Study to Examine Immunological Response in HIV-Infected Patients Receiving the Seasonal Influenza Vaccine|Completed||N/A|74|Actual|George Washington University|||1||f||||f||||||||No||2017-10-11 04:05:45.623009|2017-10-11 04:05:45.623009
NCT01381016|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-04-02|2015-02-02||June 2011||2011-06-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Estrogen Sensitivity and Ovulatory Dysfunction in Obesity|Estrogen Sensitivity and Ovulatory Dysfunction in Obesity|Completed||N/A|30|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 04:05:45.710986|2017-10-11 04:05:45.710986
NCT01381003|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-06-01|||November 2011||2011-11-01|June 2012|2012-06-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD)|Phase I/II Gene Therapy Protocol for X-Linked Chronic Granulomatous Disease|Withdrawn||Phase 1/Phase 2|0|Actual|Great Ormond Street Hospital for Children NHS Foundation Trust||1||"Study is withdrawn before recruting participants, new trial will be multi centre, sponsored by   different organisation."|f||||f||||||||||2017-10-11 04:05:46.192135|2017-10-11 04:05:46.192135
NCT01380990|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2015-09-11|||November 2012||2012-11-01|September 2015|2015-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Lentiviral Gene Therapy for Adenosine Deaminase (ADA) Deficiency|Phase I/II, Non-controlled, Open-label, Non-randomised, Single-centre Trial to Assess the Safety and Efficacy of EF1αS-ADA Lentiviral Vector Mediated Gene Modification of Autologous CD34+ Cells From ADA-deficient Individuals|Recruiting||Phase 1/Phase 2|10|Anticipated|Great Ormond Street Hospital for Children NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 04:05:46.313061|2017-10-11 04:05:46.313061
NCT01380977|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-05-03|||August 2002||2002-08-01|May 2013|2013-05-01|July 2016|Anticipated|2016-07-01|August 2013|Anticipated|2013-08-01||Interventional|IOC-1||Trial of Impact of Crime Group Intervention for Jail Inmates||Unknown status|Active, not recruiting|Phase 1/Phase 2|51|Actual|George Mason University||2|||f||||t||||||||||2017-10-11 04:05:46.470682|2017-10-11 04:05:46.470682
NCT01380964|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-08-16|||June 2011||2011-06-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|IBISD||Research of Biomarkers in Duchenne Muscular Dystrophy Patients|Research of Biomarkers for Disease Diagnosis, Disease Monitoring and Therapeutic Treatment Response in Duchenne Muscular Dystrophy Patients|Completed||N/A|220|Actual|Genethon|||2||f||||f||||||Samples With DNA|"     DNA, serum, t lymphocytes, urine   "|||2017-10-11 04:05:46.637628|2017-10-11 04:05:46.637628
NCT01380951|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-23|||May 2011||2011-05-01|June 2011|2011-06-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)|Clinical Study of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B|Unknown status|Recruiting|Phase 4|120|Anticipated|The Fifth People's Hospital of Suzhou||1|||f||||f||||||||||2017-10-11 04:05:46.748812|2017-10-11 04:05:46.748812
NCT01380938|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2012-04-14|||October 2010||2010-10-01|April 2012|2012-04-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|WRITE||Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)|RCT Comparing Different Ribavirin Dosages and Durations of Treatment in Combination With Peginterferon in HCV Genotypes 2 and 3 (WRITE)|Unknown status|Recruiting|Phase 3|1150|Anticipated|Casa Sollievo della Sofferenza IRCCS||3|||f||||f||||||||||2017-10-11 04:05:46.883953|2017-10-11 04:05:46.883953
NCT01380925|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-05-10|||October 2010||2010-10-01|May 2016|2016-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||The Jewels in Our Genes Study - an African American Family Study of Breast Cancer|Search for Novel Breast Cancer Susceptibility Genes in Pedigrees of African Ancestry|Completed||N/A|330|Actual|University at Buffalo|||1||f||||f||||||Samples With DNA|"     Saliva sample   "|No||2017-10-11 04:05:47.228142|2017-10-11 04:05:47.228142
NCT01380912|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2011-06-23|||August 2010||2010-08-01|June 2011|2011-06-01|August 2012|Anticipated|2012-08-01|August 2011|Anticipated|2011-08-01||Observational|||Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast Cancer|Can Injection of Methylprednisoloneacetate 80 mg, in the Cavity After Mastectomy for Primary Breast Cancer, at the Time of Removal of the Drain, Prevent Seroma Formation?|Unknown status|Recruiting|N/A|160|Anticipated|Copenhagen University Hospital at Herlev|||1||f||||t||||||Samples Without DNA|"     seroma will be analysed for concentration of cytokines, and eventual growth of bacteria   "|||2017-10-11 04:05:47.320304|2017-10-11 04:05:47.320304
NCT01379768|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-03-06|2013-01-31||May 2011||2011-05-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|CORNWALL||Study of the Cell Response in the Tear Film After Overnight Contact Lens Wear|Polymorphonuclear Leukocyte Response During Overnight Lens Wear|Completed||N/A|65|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 04:06:17.323419|2017-10-11 04:06:17.323419
NCT01380899|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-05-02|||February 2011||2011-02-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|October 2014|Actual|2014-10-01||Observational|||Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.|Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.|Enrolling by invitation||N/A|23|Anticipated|Universidad Autonoma de San Luis Potosí|||2||f||||t||||||||||2017-10-11 04:05:47.454493|2017-10-11 04:05:47.454493
NCT01380886|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-02-14|||June 2011||2011-06-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Growth and Tolerance of Young Infants Fed Infant Formulas|Growth and Tolerance of Young Infants Fed Infant Formulas|Completed||Phase 3|209|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-10-11 04:05:47.573311|2017-10-11 04:05:47.573311
NCT01380873|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-06-23|||January 2010||2010-01-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy Subject||Completed||Phase 1|30|Actual|CJ HealthCare Corporation||3|||f||||f||||||||||2017-10-11 04:05:47.712422|2017-10-11 04:05:47.712422
NCT01380860|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-10-24|||November 2012||2012-11-01|October 2016|2016-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|GRECCAR 07||Primary Prevention of Peristomial Hernias Via Parietal Prostheses|Primary Prevention of Peristomial Hernias Via Parietal Prostheses: a Randomized, Multicentric Study|Active, not recruiting||N/A|200|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||t||||||||||2017-10-11 04:05:47.82586|2017-10-11 04:05:47.82586
NCT01380847|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-01-29|||June 2011||2011-06-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|June 2016|Anticipated|2016-06-01||Observational|Prefigur||Prediction of Chronic Allograft Nephropathy|Early Prediction of Chronic Allograft Nephropathy by Non Invasive Monitoring of Urinary Cell mRNAs|Active, not recruiting||N/A|300|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"     RNA profiling of urinary cells in kidney transplant recipients   "|||2017-10-11 04:05:48.088365|2017-10-11 04:05:48.088365
NCT01380834|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-05-06|2015-04-16||November 2010||2010-11-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Bilateral Paravertebral Blockade (T7-10) vs. Incisional Local Anesthetic Administration for Pediatric Patients|Bilateral Paravertebral Blockade (T7-10) vs. Incisional Local Anesthetic Administration for Laparoscopic Cholecystectomy: a Prospective, Randomized Clinical Study|Completed||N/A|84|Actual|Children's Hospital of Pittsburgh||2|||f||||t||||||||||2017-10-11 04:05:48.18406|2017-10-11 04:05:48.18406
NCT01380821|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-05-02|||March 2011||2011-03-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|DSB-SPECT||DNA Double-strand Breaks After SPECT|DNA Double-strand Breaks Following Myocardial Scintigraphy|Completed||N/A|40|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-10-11 04:05:48.484199|2017-10-11 04:05:48.484199
NCT01380808|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2013-07-25|||May 2011||2011-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)|A Phase II Study of Capecitabine and Pseudomonas Aeruginosa Combination in the Salvage Treatment of Metastatic Breast Cancer|Completed||Phase 2|100|Actual|Fudan University||1|||f||||t||||||||||2017-10-11 04:05:48.569396|2017-10-11 04:05:48.569396
NCT01380795|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-03-25|||March 2011||2011-03-01|September 2014|2014-09-01||||February 2013|Actual|2013-02-01||Interventional|CTC-Poumon||Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas|Biological Study of Feasibility Concerning the Research for Mutation of the Gene of EGFR and for K-Ras in Circulating Tumoral Cells(CTCs) of the Patients Carriers of Metastatic Non Small Cells Bronchial Carcinomas|Completed||Early Phase 1|30|Anticipated|Centre Georges Francois Leclerc||1|||f||||t||||||||||2017-10-11 04:05:48.842675|2017-10-11 04:05:48.842675
NCT01380782|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-08-15|2014-07-14||May 2012||2012-05-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional||One participant from Arm B (GBM) was removed from analysis, aside from the review of adverse events, due to later determining she did not meet eligibility requirements as a result of prior stereotatic radiosurgery received prior to starting the study.|BIBF 1120 for Recurrent High-Grade Gliomas|Phase II Trial of Triple Receptor Tyrosine Kinase Receptor Inhibitor BIBF 1120 in Recurrent High-Grade Gliomas|Completed||Phase 2|37|Actual|Dana-Farber Cancer Institute|The trial intended to enroll 14 participants onto Arm A GBM, but only 10 enrolled due to futility. In addition, 10 AG participants were to be enrolled onto each Arm as exploratory cohorts, but again due to futility only 4 enrolled onto Arm B.|2|||f||||t||||||||||2017-10-11 04:05:48.973689|2017-10-11 04:05:48.973689
NCT01380769|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-04-18|2015-10-26||June 2011||2011-06-01|April 2017|2017-04-01|October 2014|Actual|2014-10-01|February 2013|Actual|2013-02-01||Interventional||Intention-to-treat (ITT) and Patient Safety Population (PSP), includes all CRLX101 + BSC subjects who received at least 1 dose of study treatment and all randomized BSC alone subjects who attended at least 1 study visit.|A Phase 2 Study of CRLX101 in Patients With Advanced Non-Small Cell Lung Cancer|A Randomized, Phase 2, Study to Assess the Safety and Activity of CRLX101, a Nanoparticle Formulation of Camptothecin, in Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed One or Two Previous Regimens of Chemotherapy|Completed||Phase 2|157|Actual|NewLink Genetics Corporation||2|||f||||f||||||||||2017-10-11 04:05:49.906858|2017-10-11 04:05:49.906858
NCT01380756|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-02-18|||July 2011||2011-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Interventional|||Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia|A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia|Completed||Phase 1|35|Actual|Amgen||2|||f||||f||||||||||2017-10-11 04:05:50.471606|2017-10-11 04:05:50.471606
NCT01380743|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2013-12-05||2013-12-05|October 2011||2011-10-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Drug-drug Interaction Study|An Open-Label, Multi-Center, Study to Investigate Drug-Drug Interactions Between AT2220 (Duvoglustat Hydrochloride) and Alglucosidase Alfa in Patients With Pompe Disease|Completed||Phase 2|25|Actual|Amicus Therapeutics||4|||f||||t||||||||||2017-10-11 04:05:50.590585|2017-10-11 04:05:50.590585
NCT01380548|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-03-26|||June 2011||2011-06-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of 5-Aminolevulinic Acid on Iron Deficiency Anemia|A Double-blind, Placebo Controlled Study to Assess Efficacy of 5-Aminolevulinic Acid in Subjects With Iron Deficiency Anemia|Completed||N/A|135|Anticipated|Hiroshima University||5|||f||||||||||||||2017-10-11 04:05:56.678701|2017-10-11 04:05:56.678701
NCT01380730|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-23|2016-06-09|2015-09-01|2013-03-26|July 2011||2011-07-01|June 2016|2016-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|LAPLACE|Full analysis set (all randomized participants who received at least 1 dose of investigational product).|LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy|LAPLACE TIMI 57 - A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose-ranging Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Combination With HMG-CoA Reductase Inhibitors in Hypercholesterolemic Subjects|Completed||Phase 2|631|Actual|Amgen||8|||f||||t||||||||||2017-10-11 04:05:50.780384|2017-10-11 04:05:50.780384
NCT01380717|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2014-02-26|||February 2011||2011-02-01|September 2012|2012-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|RenVas||Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)|The Role of Renal and Peripheral Vascular Resistance in Chronic Kidney Disease|Completed||Phase 4|83|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 04:05:55.183412|2017-10-11 04:05:55.183412
NCT01380704|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-11-22|||June 2011||2011-06-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled Study of Safety and Pharmacodynamic Effects of ABT-436 in Major Depressive Disorder Subjects|Completed||Phase 1|51|Actual|Abbott||2|||f||||f||||||||||2017-10-11 04:05:55.264825|2017-10-11 04:05:55.264825
NCT01380691|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-09-16|||June 2011||2011-06-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study of LY2216684 in Healthy Subjects|A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction of LY2216684 With Alcohol in Healthy Subjects|Completed||Phase 1|28|Anticipated|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 04:05:55.358202|2017-10-11 04:05:55.358202
NCT01380678|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-14|2011-07-07|||January 2009||2009-01-01|July 2010|2010-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|bevacizumab||Intralesional Bevacizumab Injection on Primary Pterygium|A Randomized Controlled Trial of Intralesional Bevacizumab Injection on Primary Pterygium: Preliminary Results|Unknown status|Recruiting|Phase 3|206|Anticipated|Khon Kaen University||2|||f||||f||||||||||2017-10-11 04:05:55.459278|2017-10-11 04:05:55.459278
NCT01380665|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-08-19|||October 2009||2009-10-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|Prevena2009-45||Prevena™ Incision Management System Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee Arthroplasty|Prospective, Single Arm, Post-Marketing Trial to Examine the Safety and Functionality of the Prevena™ Incision Management System, A Negative Pressure Based Surgical Wound Management System, Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee Arthroplasty|Withdrawn||Phase 4|0|Actual|KCI USA, Inc.||1|||f||||f||||||||||2017-10-11 04:05:55.546582|2017-10-11 04:05:55.546582
NCT01380652|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2015-03-05|||September 2010||2010-09-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|||Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation|Effects of Whole Body Vibration Training on Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) III/IV-Patients During a Three-week Rehabilitation|Completed||N/A|72|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 04:05:55.621558|2017-10-11 04:05:55.621558
NCT01380639|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2013-09-27|2013-09-27||September 2010||2010-09-01|September 2013|2013-09-01||||April 2011|Actual|2011-04-01||Interventional|||Effects of Vibration Training on Exercise Capacity in COPD-patients|Effects of Vibration Training During a Three-week Rehabilitation on Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD) III/IV-Patients|Completed||N/A|72|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-10-11 04:05:55.714642|2017-10-11 04:05:55.714642
NCT01380626|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-12-16|||February 2010||2010-02-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients|Effects of Exercise Training on Quadriceps Gene Expression in COPD-patients in Comparison to Alpha-1-Antitrypsin-deficiency-patients|Completed||N/A|20|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||1|||f||||f||||||||||2017-10-11 04:05:56.028471|2017-10-11 04:05:56.028471
NCT01380613|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-07|2013-09-04|||September 2007||2007-09-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Workshop||Neighborhoods, Networks, Depression, and HIV Risk|The Impact of Neighborhoods, Networks, and Depression on Drug Users' HIV Risk|Completed||Phase 2|965|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 04:05:56.195447|2017-10-11 04:05:56.195447
NCT01380600|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-01-06|||July 2010||2010-07-01|March 2012|2012-03-01|December 2015|Actual|2015-12-01|November 2012|Actual|2012-11-01||Interventional|||Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma|A Phase 1b Dose Escalation Study of JX-594 (Thymidine Kinase-Inactivated Vaccinia Virus Plus GM-CSF) Administered by Biweekly (Every Two Weeks) Intravenous Infusion in Patients With Metastatic, Refractory Colorectal Carcinoma|Completed||Phase 1|15|Actual|SillaJen, Inc.||1|||f||||f||||||||||2017-10-11 04:05:56.304394|2017-10-11 04:05:56.304394
NCT01380587|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2013-08-26|||November 2010||2010-11-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|XCL1||Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia|Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia|Completed||N/A|25|Actual|Hospital Universitario Dr. Jose E. Gonzalez|||1||f||||f||||||Samples With DNA|"     whole blood, serum, white cells, blasts   "|||2017-10-11 04:05:56.399602|2017-10-11 04:05:56.399602
NCT01380574|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-06-26|||June 2011||2011-06-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|FinCV||Safety of Cardioversion of Acute Atrial Fibrillation|Safety of Cardioversion of Acute Atrial Fibrillation|Completed||N/A|7700|Actual|Turku University Hospital|||1||f||||f||||||||||2017-10-11 04:05:56.486661|2017-10-11 04:05:56.486661
NCT01380561|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-10-14|||June 2011||2011-06-01|October 2011|2011-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers|A Metabolite Identification, Mass Balance, and Pharmacokinetic Study of a Single Oral Dose of [14C]-Asimadoline Followed by Twice Daily Oral Dosing of 0.5 mg Asimadoline to Healthy Adult Male Volunteers|Completed||Phase 1|6|Actual|Tioga Pharmaceuticals||1|||f||||f||||||||||2017-10-11 04:05:56.567521|2017-10-11 04:05:56.567521
NCT01380535|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-08-14|||November 2011|Actual|2011-11-01|August 2017|2017-08-01|March 10, 2017|Actual|2017-03-10|March 10, 2017|Actual|2017-03-10||Interventional|||A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease|A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy With UVADEX for the Treatment of Patients With Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD)|Completed||Phase 1|60|Actual|Mallinckrodt||2|||f||||t||||||||||2017-10-11 04:05:56.802086|2017-10-11 04:05:56.802086
NCT01380522|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-22|||August 2002||2002-08-01|June 2011|2011-06-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Bioavailability Study of Metronidazole Capsules Under Fed Conditions|To Compare the Relative Bioavailability of 375 mg Metronidazole Capsules (Kali) With That of Flagyl 375 mg Capsules/( G.D. Searle, Inc) Under Fed Conditions|Completed||Phase 1|18|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-10-11 04:05:56.983364|2017-10-11 04:05:56.983364
NCT01380509|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-22|||August 2002||2002-08-01|June 2011|2011-06-01|October 2002|Actual|2002-10-01|September 2002|Actual|2002-09-01||Interventional|||Bioavailability Study of Metronidazole Capsules Under Fasting Conditions|To Compare the Relative Bioavailability of 375 mg Metronidazole Capsules (Kali) With That of Flagyl 375 mg Capsules( G.D. Searle, Inc) Under Fasting Conditions|Completed||Phase 1|28|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-10-11 04:05:57.078979|2017-10-11 04:05:57.078979
NCT01380496|ClinicalTrials.gov processed this data on October 10, 2017|2008-04-01|2017-09-22|||November 1999||1999-11-01|September 2017|2017-09-01|November 1999|Actual|1999-11-01|November 1999|Actual|1999-11-01||Interventional|||Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions|Randomized, 3-Way Crossover, Comparative Bioequivalence Study of Par Pharmaceutical Inc. (USA) and Oclassen Pharmaceuticals Inc. (USA)(Monodox(R)) Doxycycline Monohydrate Equivalent to 100 mg Doxycycline Administered as a Single Dose of 100 mg In Healthy Adult Males Under Fasting and Fed Conditions|Completed||Phase 1|24|Actual|Par Pharmaceutical, Inc.||3|||f||||f||||||||||2017-10-11 04:05:57.170957|2017-10-11 04:05:57.170957
NCT01380483|ClinicalTrials.gov processed this data on October 10, 2017|2008-04-01|2011-06-22|||January 2000||2000-01-01|June 2011|2011-06-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions|Randomized, 2-way Crossover, Comparative Bioequivalence Study of Par Pharmaceutical Inc. (USA) and Oclassen Pharmaceuticals Inc. (USA) (Monodox(R)) Doxycycline Monohydrate Equivalent to 100 mg Doxycycline Administered as a Single Dose of 100 mg In Healthy Adult Males Under Fasting Conditions|Completed||Phase 1|40|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-10-11 04:05:57.268992|2017-10-11 04:05:57.268992
NCT01380470|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-23|||February 2010||2010-02-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Observational|||Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease Sufferers in the Region of Murcia|Prevalence of Undiagnosed Sufferers in Murcia :Cross-sectional Study|Completed||N/A|2627|Actual|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia|||1||f||||f||||||||||2017-10-11 04:05:57.400107|2017-10-11 04:05:57.400107
NCT01380457|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-22|||January 2006||2006-01-01|June 2011|2011-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions|A Comparative Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions|Completed||Phase 1|69|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-10-11 04:05:57.49468|2017-10-11 04:05:57.49468
NCT01380444|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-04-21|||December 2011|Actual|2011-12-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|INSITE||Intramedullary Nail Versus Sliding Hip Screw Inter-Trochanteric Evaluation|A Multi-Center Randomized Controlled Trial of Intramedullary Nails Versus Sliding Hip Screws in the Management of Intertrochanteric Fractures of the Hip|Completed||N/A|880|Actual|Stryker Trauma GmbH||2|||f||||f|||||f|||No||2017-10-11 04:05:57.62627|2017-10-11 04:05:57.62627
NCT01380431|ClinicalTrials.gov processed this data on October 10, 2017|2008-04-01|2011-06-22|||August 1999||1999-08-01|June 2011|2011-06-01|October 1999|Actual|1999-10-01|October 1999|Actual|1999-10-01||Interventional|||A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study|Randomized, Open-label, Three Treatment Crossover Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study|Completed||Phase 1|18|Actual|Par Pharmaceutical, Inc.||3|||f||||f||||||||||2017-10-11 04:05:57.952397|2017-10-11 04:05:57.952397
NCT01380418|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-09-08|||June 2011||2011-06-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Factors Associated With Chronic Respiratory Failure in Obesity|Factors Associated With Chronic Respiratory Failure in Obesity: A Cross-sectional Study|Completed||N/A|78|Actual|Oxford University Hospitals NHS Trust|||1||f||||f||||||Samples With DNA|"     Blood, fat, muscle   "|||2017-10-11 04:05:58.048411|2017-10-11 04:05:58.048411
NCT01380405|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-23|||May 2011||2011-05-01|June 2011|2011-06-01|June 2012|Anticipated|2012-06-01|February 2012|Anticipated|2012-02-01||Interventional|||Educational Intervention for Managing Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Patients|Effectiveness of an Educational Intervention for Managing Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Patients in Primary Care: A Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|864|Anticipated|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||3|||f||||f||||||||||2017-10-11 04:05:58.138033|2017-10-11 04:05:58.138033
NCT01380392|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-23|||February 2011||2011-02-01|June 2011|2011-06-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Observational|||The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma|The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 04:05:58.286675|2017-10-11 04:05:58.286675
NCT01380379|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-12-07|2016-10-11||April 2011||2011-04-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|August 2013|Actual|2013-08-01||Interventional|||Self-Defense Training in Women With Trauma|A Pilot Study of Self-Defense Training in Women With Trauma|Completed||N/A|9|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 04:05:58.384484|2017-10-11 04:05:58.384484
NCT01380366|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-01-12|2014-02-14||October 2006||2006-10-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2011|Actual|2011-02-01||Interventional|rHGH|Patients Consented to be Given rHGH|rHGH and Intestinal Permeability in Intestinal Failure|Influence of Recombinant Human Growth Hormone on Intestinal Permeability and Liver Injury in Intestinal Failure Patients Receiving Parenteral Nutrition (Serono Project)|Completed||Phase 4|15|Actual|Northwestern University|Number of participants is low. Time period of evaluation may not have been adequate for evaluating the impact on liver injury. Parameters used to evaluate the impact of gut permeability changes on hepatic inflammation and injury were very limited.|1|||f||||f||||||||||2017-10-11 04:05:58.659691|2017-10-11 04:05:58.659691
NCT01380353|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-08-17|||June 2011||2011-06-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine|Pilot Study to Test Uniformity of Transdermal Drug Delivery to the Breast Using Diclofenac Epolamine as a Model|Active, not recruiting||Early Phase 1|25|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-11 04:05:59.04131|2017-10-11 04:05:59.04131
NCT01380340|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-27|||July 2011||2011-07-01|June 2011|2011-06-01|May 2012|Anticipated|2012-05-01|September 2011|Anticipated|2011-09-01||Interventional|||Seniors Driving Cessation Early Intervention Group|Study of the Effects of a New Concept of Early Intervention on the Driving Cessation, Mental Health, and Quality of Life of Senior Drivers|Unknown status|Not yet recruiting|N/A|20|Anticipated|Fraser Health||2|||f||||f||||||||||2017-10-11 04:05:59.148708|2017-10-11 04:05:59.148708
NCT01380327|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2014-06-05|2014-05-02||May 2011||2011-05-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|BioCSI-2||Biomarkers of Cockroach Sublingual Immunotherapy 2|A Biomarker-Based Pilot Study of Cockroach Sublingual Immunotherapy in Cockroach Sensitive Children With Asthma and/or Perennial Allergic Rhinitis|Completed||Phase 1/Phase 2|99|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 04:05:59.262903|2017-10-11 04:05:59.262903
NCT01380314|ClinicalTrials.gov processed this data on October 10, 2017|2008-05-07|2011-06-22|||March 2008||2008-03-01|June 2011|2011-06-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis|Treatment of Bolivian Cutaneous Leishmaniasis With a Combination of Oral Miltefosine Plus Topical Imiquimod 5%|Completed||Phase 2|60|Anticipated|Foundation Fader||2|||f||||f||||||||||2017-10-11 04:06:00.054289|2017-10-11 04:06:00.054289
NCT01380301|ClinicalTrials.gov processed this data on October 10, 2017|2009-01-28|2011-06-22|||March 2007||2007-03-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony|Treatment of Bolivian Cutaneous Leishmaniasis With a Combination of Short Courses of Miltefosine and Antimony|Terminated||Phase 2|19|Actual|Foundation Fader||2||Low efficacy rates|f||||f||||||||||2017-10-11 04:06:00.180156|2017-10-11 04:06:00.180156
NCT01380288|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2012-08-14|||June 2011||2011-06-01|April 2011|2011-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|CAREER||Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine|Changes of Cognitive Function in Patients With Mild to Moderate Alzheimer's Disease Associated With or Without White Matter Changes After Rivastigmine Patch Therapy - Multi-center, Prospective, Open-label Clinical Trial|Unknown status|Active, not recruiting|N/A|300|Anticipated|Dong-A University||2|||f||||t||||||||||2017-10-11 04:06:00.303146|2017-10-11 04:06:00.303146
NCT01380262|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-24|||June 2010||2010-06-01|June 2011|2011-06-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|STLDD-1||Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment|Prospective Phase II Study on Skin Toxicity on Low-Dose Doxycycline in Metastatic Colorectal Cancer Patients During Cetuximab and Panitumumab Treatment|Unknown status|Recruiting|N/A|40|Anticipated|Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology|||1||f||||f||||||||||2017-10-11 04:06:00.529869|2017-10-11 04:06:00.529869
NCT01380249|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2013-01-04|||June 2011||2011-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|||PDM08 Clinical Trial in Advanced Solid Tumors|Phase I Study, Open, Dose Escalation, in Adult Patients With Advanced Solid Tumours, to Evaluate Tolerability, Pharmacokinetics and Pharmacodynamics of PDM08 Administered Twice a Week Cycles of 4 Weeks.|Completed||Phase 1|22|Actual|Prodimed S.A.||1|||f||||t||||||||||2017-10-11 04:06:00.617103|2017-10-11 04:06:00.617103
NCT01380236|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2012-11-29|||November 2011||2011-11-01|November 2012|2012-11-01|May 2013|Anticipated|2013-05-01|June 2012|Anticipated|2012-06-01||Interventional|||A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma|A Phase II, Two-centre, Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Adult Subjects With Moderate to Severe Asthma|Withdrawn||Phase 2|0|Actual|Pharmaxis||1||Protocol not progressed. Study not implemented.|f||||f||||||||||2017-10-11 04:06:00.711342|2017-10-11 04:06:00.711342
NCT01380223|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-10-09|||August 2005||2005-08-01|October 2015|2015-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Pharmacokinetic and Pharmacodynamic Study of Omecamtiv Mecarbil in Healthy Volunteers|A First-in-Man, Phase I, Double-Blind, Randomized, Four-Way Crossover, Placebo-Controlled, Dose-Escalation, Pharmacokinetic and Pharmacodynamic Study of CK-1827452 (Omecamtiv Mecarbil) in Healthy Volunteers|Completed||Phase 1|35|Actual|Cytokinetics||4|||f||||f||||||||||2017-10-11 04:06:00.776187|2017-10-11 04:06:00.776187
NCT01380210|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-07-06|||February 2011||2011-02-01|July 2011|2011-07-01||||||||Observational|||MRI Findings of Encephalopathy Associated With Carbon Dioxide (CO2) Intoxication||Unknown status|Active, not recruiting|N/A|6|Actual|China Medical University Hospital|||1||f||||t||||||||||2017-10-11 04:06:00.892058|2017-10-11 04:06:00.892058
NCT01380197|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-08-05|2015-02-02||May 2010||2010-05-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2014|Actual|2014-01-01||Interventional|COMPARE||Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally|Choosing Opioid Management for Pain and Analyzing ACS Rates Equally|Active, not recruiting||Phase 3|40|Actual|Children's Healthcare of Atlanta||2|||f||||f||||||||||2017-10-11 04:06:00.959348|2017-10-11 04:06:00.959348
NCT01380184|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-02-06|||July 2011||2011-07-01|February 2015|2015-02-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|||Pharmacokinetics of Ridaforolimus in Chinese Participants (MK-8669-059)|A Study to Assess the Pharmacokinetics of Ridaforolimus in Chinese Patients|Completed||Phase 1|15|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 04:06:01.322672|2017-10-11 04:06:01.322672
NCT01380171|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-24|2011-06-24|||February 2007||2007-02-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Observational|||Primary Palatoplasty in Pediatric Patients - A Retrospective Review of Surgical Outcomes|Primary Palatoplasty in Pediatric Patients - A Retrospective Review of Surgical Outcomes|Completed||N/A|1295|Actual|Children's Healthcare of Atlanta|||1||f||||t||||||||||2017-10-11 04:06:01.609716|2017-10-11 04:06:01.609716
NCT01380145|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-10-31|2016-09-07||September 2011||2011-09-01|October 2016|2016-10-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional||Includes all subjects enrolled in the study.|MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation|Pilot Study of recMAGE-A3 + AS15 ASCI as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation|Completed||Phase 1|13|Actual|Ludwig Institute for Cancer Research||1|||f||||f||||||||Yes||2017-10-11 04:06:02.000067|2017-10-11 04:06:02.000067
NCT01380132|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-06-27|||February 2004||2004-02-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence|Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence|Completed||Phase 1/Phase 2|35|Actual|Uppsala University Hospital||1|||f||||f||||||||||2017-10-11 04:06:02.597036|2017-10-11 04:06:02.597036
NCT01380106|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-02-01|||August 2010||2010-08-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma|A Controlled, Parallel-Group, Randomized, Open-Label Study to Evaluate Two Lenalidomide Dose Regimens When Used in Combination With Low Dose Dexamethasone for the Treatment of Subjects With Relapsed Multiple Myeloma|Active, not recruiting||Phase 2|80|Anticipated|Boston VA Research Institute, Inc.||2|||f||||t||||||||No||2017-10-11 04:06:02.920948|2017-10-11 04:06:02.920948
NCT01380093|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2012-04-26|2012-04-26||February 2011||2011-02-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users|A Randomized, Double-Blind, Placebo- and Active-Controlled, 3-Way Crossover Study to Determine the Abuse Potential of Oral Administration of Crushed EMBEDA Relative to Crushed Controlled-Release Morphine Sulfate and Placebo in Non Dependent, Recreational Opioid Users|Completed||Phase 1|80|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 04:06:03.481918|2017-10-11 04:06:03.481918
NCT01380080|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-01-24|2016-01-26||October 2011||2011-10-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|January 2015|Actual|2015-01-01||Interventional|REMEMBER|Intent to treat: All eligible participants were included in the baseline characteristics.|REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment|Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment Regimens (REMEMBER)|Completed||Phase 4|851|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 04:06:09.263761|2017-10-11 04:06:09.263761
NCT01380067|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-22|||January 2000||2000-01-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2005|Actual|2005-12-01||Observational|||a New Way for Laparoscopic Inguinal Hernia Repair in Pediatric|Phase 3 Study of a New Way for Laparoscopic Inguinal Hernia Repair in Pediatric|Completed||N/A|486|Actual|The Second People's Hospital of GuangDong Province|||2||f||||t||||||||||2017-10-11 04:06:10.434581|2017-10-11 04:06:10.434581
NCT01380054|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-04-13|||May 31, 2011|Actual|2011-05-31|April 2017|2017-04-01|May 20, 2016|Actual|2016-05-20|May 20, 2016|Actual|2016-05-20||Observational|HyPsy||Pulmonary Hypertension, Quality of Life and Psychosocial Factors|Pulmonary Hypertension: Impact of the Evolution of a Rare Disease on the Quality of Life and Role of Variables Psychosocial as Predictive of the Current and Later Quality of Life|Completed||N/A|55|Actual|University Hospital, Montpellier|||1||f||||f||||||||||2017-10-11 04:06:10.506859|2017-10-11 04:06:10.506859
NCT01380041|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2015-07-20|||June 2011||2011-06-01|June 2011|2011-06-01|June 2013|Actual|2013-06-01|June 2011|Actual|2011-06-01||Observational|CYTOSEP||Cytokine in Cerebrospinal Fluid (CSF) From Multiple Sclerosis Patients|Identification of Multiple Sclerosis Biomarkers in Human CSF by Means of Cytokine Array|Terminated||N/A|101|Actual|University Hospital, Montpellier|||1|Results obtained are sufficient for a publication.|f||||f||||||Samples With DNA|"     Samples with DNA   "|||2017-10-11 04:06:10.580825|2017-10-11 04:06:10.580825
NCT01380028|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-07-22|||September 2010||2010-09-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|September 2014|Actual|2014-09-01||Interventional|hemacort||Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas|Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas. Prospective Randomized Multicenter Trial|Unknown status|Active, not recruiting|Phase 3|340|Anticipated|University Hospital, Montpellier||2|||f||||f||||||||||2017-10-11 04:06:10.641794|2017-10-11 04:06:10.641794
NCT01380015|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-01-21|||July 2011||2011-07-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Efficacy of Spearmint Tea in Relieving Osteoarthritis of the Knee|Human Clinical Trial to Investigate the Effects of High Rosmarinic Acid Spearmint Tea on Markers of Pain, Physical Function and Disease Activity in Osteoarthritis of the Knee|Completed||Phase 4|49|Actual|University of Guelph||2|||f||||f||||||||||2017-10-11 04:06:10.718886|2017-10-11 04:06:10.718886
NCT01380002|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-22|||December 2010||2010-12-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Observational|||Home-Care Needs in Liver or Renal Transplantation Recipients and Their Spouses|Home-Care Needs in Liver or Renal Transplantation Recipients and Their Spouses|Unknown status|Recruiting|N/A|400|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 04:06:10.792461|2017-10-11 04:06:10.792461
NCT01379989|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-04-06|||June 2011||2011-06-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|INOVATYON||INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer|Phase III International, Randomized Study of Trabectedin Plus Pegylated Liposomal Doxorubicin (PLD) Versus Carboplatin Plus PLD in Patients With Ovarian Cancer Progressing Within 6-12 Months of Last Platinum|Recruiting||Phase 3|588|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||t||||||||||2017-10-11 04:06:10.862163|2017-10-11 04:06:10.862163
NCT01379781|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-07-13|2015-05-12||August 2011||2011-08-01|February 2013|2013-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression|Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression|Completed||N/A|54|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 04:06:16.936366|2017-10-11 04:06:16.936366
NCT01379976|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-04-23|||April 2011||2011-04-01|July 2014|2014-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer|Randomized, Double-blind, Placebo-controlled Phase 3 Trial to Assess the Efficacy and Safety of Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer|Terminated||Phase 3|107|Actual|Mario Negri Institute for Pharmacological Research||2||"Recruitment was prematurely stopped due to difficulty of recruitment encountered by the   experimental centers"|f||||t||||||||||2017-10-11 04:06:12.915738|2017-10-11 04:06:12.915738
NCT01379963|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2017-06-15|2015-11-20||April 30, 2009|Actual|2009-04-30|May 2017|2017-05-01|February 28, 2011|Actual|2011-02-28|February 28, 2011|Actual|2011-02-28||Observational||Baseline population included all enrolled participants.|A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)|Non-interventional Study of Six-month Retrospective Reporting of Hemoglobin Levels in Patients With Renal Anaemia Who Are Treated With MIRCERA® (Methoxy-polyethylene-glycol-epoetin Beta)|Completed||N/A|780|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:06:13.041722|2017-10-11 04:06:13.041722
NCT01379950|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-06-22|||August 2011||2011-08-01|June 2011|2011-06-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||Role of Macrophage in Inflammation Resolution in Periodontal Patients|The Role of Macrophages in the Inflammatory Resolution Phase in Periodontal Patients|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 04:06:13.336839|2017-10-11 04:06:13.336839
NCT01379937|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2016-09-22|2013-08-02|2012-11-16|July 2011||2011-07-01|September 2016|2016-09-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children|Safety and Immunogenicity Study of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine GSK1562902A in Children Aged 3 to 17 Years|Completed||Phase 3|520|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:06:13.500297|2017-10-11 04:06:13.500297
NCT01379924|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-23|||September 2007||2007-09-01|June 2011|2011-06-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|YPP ProCon||Young Parents Program, Project Connect|Young Parents Program, Project Connect|Unknown status|Recruiting|Early Phase 1|250|Anticipated|Boston Children’s Hospital||3|||f||||t||||||||||2017-10-11 04:06:15.873252|2017-10-11 04:06:15.873252
NCT01379911|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2016-01-20|||February 2013||2013-02-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Developing Methods for Completing Future Satiety Studies|Developing and Validating a Method for Satiety Studies|Completed||N/A|20|Actual|University of Guelph||2|||f||||f||||||||||2017-10-11 04:06:15.992638|2017-10-11 04:06:15.992638
NCT01379898|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-05-09|||December 2011||2011-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|PRESCRIPT||Phenoxybenzamine Versus Doxazosin in PCC Patients|Pheochromocytoma Randomised Study Comparing Adrenoreceptor Inhibiting Agents for Preoperative Treatment|Recruiting||Phase 4|134|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 04:06:16.090737|2017-10-11 04:06:16.090737
NCT01379885|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2013-01-30|||June 2011||2011-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|RID||Reducing Immunization Distress (RID)|Childhood Immunization: Reducing Immunization Distress (RID) Using Multi-Modal Distraction|Terminated||N/A|77|Actual|University of California, San Francisco||2||"Estimated sample size not achieved due to decline in number of eligible patients and difficulty   recruiting and retaining research staff."|f||||f||||||||||2017-10-11 04:06:16.26082|2017-10-11 04:06:16.26082
NCT01379872|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-02-12|||June 2011||2011-06-01|June 2011|2011-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|ANROTAT||Assessment of New Radiation Oncology Technologies and Treatments|The Assessment of New Radiation Oncology Technologies and Treatments (ANROTAT) TROG Research Project TRP11.A|Completed||N/A|138|Actual|Trans-Tasman Radiation Oncology Group (TROG)|||4||f||||f||||||||||2017-10-11 04:06:16.366743|2017-10-11 04:06:16.366743
NCT01379846|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-03-04|||June 2011||2011-06-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Study of TAK-816 in Healthy Infants|A Randomized, Double-Blind, Multicenter, Parallel-Group Comparative Phase III Study Evaluating the Efficacy and Safety of TAK-816 Compared With ActHIB in Healthy Infants|Completed||Phase 3|416|Actual|Takeda||2|||f||||f||||||||||2017-10-11 04:06:16.487119|2017-10-11 04:06:16.487119
NCT01379833|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-21|||May 2011||2011-05-01|June 2011|2011-06-01|May 2012|Anticipated|2012-05-01|March 2012|Anticipated|2012-03-01||Observational|||Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy|Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy|Unknown status|Recruiting|N/A|20|Anticipated|State University of New York at Buffalo|||2||f||||f||||||||||2017-10-11 04:06:16.640393|2017-10-11 04:06:16.640393
NCT01379820|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-22|||June 2011||2011-06-01|June 2011|2011-06-01|June 2011|Anticipated|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Use of Orotracheal Continuous Positive Airway Pressure (CPAP) in Newborns With Respiratory Failure|Use of Orotracheal CPAP ( Gregory System) for Treatment of Respiratory Failure in Newborns|Unknown status|Not yet recruiting|Phase 2/Phase 3|100|Anticipated|Hospital Angeles del Pedregal||1|||f||||t||||||||||2017-10-11 04:06:16.726507|2017-10-11 04:06:16.726507
NCT01379807|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2015-03-10|||December 2010||2010-12-01|April 2011|2011-04-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|SPIGA||Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma|A Phase II Trial to Assess the Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma|Unknown status|Active, not recruiting|Phase 2|55|Anticipated|Grupo Gallego de Investigaciones Oncologicas||1|||f||||f||||||||||2017-10-11 04:06:16.790064|2017-10-11 04:06:16.790064
NCT01379794|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-04-12|||January 2009||2009-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 04:06:16.881568|2017-10-11 04:06:16.881568
NCT00005531|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||December 1996||1996-12-01|August 2004|2004-08-01|November 2000|Actual|2000-11-01|||||Observational|||Genetic Epidemiology of Sarcoidosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:10.259945|2017-10-11 04:27:10.259945
NCT01379755|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-07-13|||August 2010||2010-08-01|June 2011|2011-06-01|July 2011|Anticipated|2011-07-01|December 2010|Actual|2010-12-01||Observational|||Comparison of Stability and Outcomes in Single-radius Femoral Component for Total Knee Arthroplasty|Study of Compare Mid-flexion Stability and Clinical Outcomes in Single-radius Femoral Design or Multi-radius Femoral Design.|Unknown status|Active, not recruiting|N/A|213|Anticipated|Chonnam National University Hospital|||1||f||||t||||||||||2017-10-11 04:06:17.713827|2017-10-11 04:06:17.713827
NCT01379742|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2013-02-11|||April 2010||2010-04-01|February 2013|2013-02-01||||February 2013|Actual|2013-02-01||Interventional|||Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy|Comparison of Health Related Quality of Life and Other Clinical Parameters Between ThinSeed™ and OncoSeed™ for Permanent Low Dose Rate Implantation in Localized Prostate Cancer|Unknown status|Recruiting|Phase 4|240|Anticipated|Prostate Cancer Foundation of Chicago||2|||f||||t||||||||||2017-10-11 04:06:17.770242|2017-10-11 04:06:17.770242
NCT01379729|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2013-12-27|||May 2011||2011-05-01|December 2013|2013-12-01|May 2018|Anticipated|2018-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Bet Cell Therapy in Diabetes Type 1|Functional Survival of Beta Cell Allografts After Transplantation in the Peritoneal Cavity of Non-uremic Type 1 Diabetic Patients|Recruiting||Phase 2|10|Anticipated|AZ-VUB||2|||f||||t||||||||||2017-10-11 04:06:17.852321|2017-10-11 04:06:17.852321
NCT01379716|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-22|||January 2011||2011-01-01|December 2010|2010-12-01||||January 2012|Anticipated|2012-01-01||Interventional|STTR||Immunolabeling Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls|Immunolabeling Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia (PHN) and Age and Gender-Matched Normal Controls|Unknown status|Recruiting|Phase 1|10|Anticipated|Albany Medical College||1|||f||||f||||||||||2017-10-11 04:06:18.066187|2017-10-11 04:06:18.066187
NCT01379703|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-10-10|2011-08-09||February 2004||2004-02-01|October 2011|2011-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|KaleEAST||Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use|Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use|Completed||N/A|2288|Actual|Abbott|||1||f||||f||||||||||2017-10-11 04:06:18.208723|2017-10-11 04:06:18.208723
NCT01379690|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2012-02-21|||April 2011||2011-04-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Retrospective Study: Hip Fractures in Diabetic Patients|Association of HBA1C and Hip Fractures in Elderly Type 2 Diabetic Patients|Completed||N/A|1162|Actual|Changi General Hospital|||2||f||||f||||||||||2017-10-11 04:06:19.833878|2017-10-11 04:06:19.833878
NCT01379677|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-05-13|||February 2011||2011-02-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison|Diagnosis of Coronary Artery Disease With Rubidium-82 PET and Technetium-99m-MIBI SPET: A Head to Head Comparison, Versus Coronary CT Angiography|Completed||Phase 3|135|Actual|Advanced Accelerator Applications||1|||f||||t||||||||||2017-10-11 04:06:19.922974|2017-10-11 04:06:19.922974
NCT01379664|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-02-25|2016-11-29||July 2011||2011-07-01|February 2017|2017-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project|Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project|Completed||N/A|1584|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-10-11 04:06:20.018783|2017-10-11 04:06:20.018783
NCT01379651|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-09-19|2011-06-24||January 2008||2008-01-01|September 2011|2011-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|EGGSOTI||Time-limited Specific Oral Tolerance Induction in Children With Severe Egg Allergy|Specific Oral Tolerance Induction in Children With Severe Egg Allergy: A Randomized Controlled Trial Using a 6 Months Protocol|Completed||Phase 1/Phase 2|20|Actual|Ospedale Buon Consiglio Fatebenefratelli||2|||f||||t||||||||||2017-10-11 04:06:20.27674|2017-10-11 04:06:20.27674
NCT01379638|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2011-06-22|||December 2008||2008-12-01|December 2008|2008-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Best Cardiac Output During Cardiopulmonary Bypass|Best Cardiac Output During Cardiopulmonary Bypass|Completed||N/A|20|Actual|Aalborg Universitetshospital|||1||f||||f||||||||||2017-10-11 04:06:20.551306|2017-10-11 04:06:20.551306
NCT01379625|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-03-21|2016-07-12||September 2011||2011-09-01|March 2017|2017-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Triheptanoin|Subjects were 7 years of age or greater with one of 3 fatty acid oxidation disorders: CPT2, VLCAD or LCHAD/TFP.|Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder|Phase 2 Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorders|Completed||Phase 2|32|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 04:06:20.664566|2017-10-11 04:06:20.664566
NCT01379612|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-06-14|||May 2010||2010-05-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|||Ultrasound Elastography in Patients With Rectal Cancer|Ultrasound Elastography of Rectal Cancer Patients Treated With Preoperative Chemoradiation|Completed||N/A|31|Actual|Vejle Hospital|||1||f||||f||||||||||2017-10-11 04:06:21.086521|2017-10-11 04:06:21.086521
NCT01379599|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-22|2016-12-17|||November 2004||2004-11-01|December 2016|2016-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|SAFE||Brief Intervention to Reduce STDs in ER Drug Users|Brief Intervention to Reduce STDs in ER Drug Users|Completed||Phase 3|1030|Actual|Boston Medical Center||2|||f||||t||||||||Yes|de-identified may be shared on request|2017-10-11 04:06:21.151921|2017-10-11 04:06:21.151921
NCT01379586|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2012-06-12|||June 2011||2011-06-01|June 2012|2012-06-01||||July 2011|Actual|2011-07-01||Interventional|||A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers|A Phase 1, Single Centre, Three-part, Randomised, Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Single and Multiple Ascending Doses of Oral ONO-4053 and the Effects of Food on This Profile in Healthy Male and Female Subjects|Terminated||Phase 1|15|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 04:06:21.23187|2017-10-11 04:06:21.23187
NCT01379560|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-03-21|||May 2011||2011-05-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration||Completed||Phase 2|33|Actual|Sucampo Pharma Americas, LLC||2|||f||||||||||||||2017-10-11 04:06:21.527013|2017-10-11 04:06:21.527013
NCT01379547|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2012-11-26|||June 2011||2011-06-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|ProShort||Procalcitonin to Shorten Antibiotics Duration in ICU Patients|Procalcitonin to Shorten Antibiotics Duration in ICU Patients- A China, Hong-Kong, Taiwan Multicenter Trial|Unknown status|Recruiting|Phase 3|1700|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 04:06:21.608021|2017-10-11 04:06:21.608021
NCT01379534|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-05-02|2015-03-18||November 2011||2011-11-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer|A Phase II, Open-label, Single-arm, Non-randomized, Multi-center Study to Evaluate the Efficacy of Oral TKI258 as Second-line Therapy in Patients With Either FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer|Completed||Phase 2|53|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:06:21.806169|2017-10-11 04:06:21.806169
NCT01379521|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-04-13|2016-06-09||June 2011||2011-06-01|April 2017|2017-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|TRACER||Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC|A Phase II Randomized, Double-blinded, Multicenter Asian Study Investigating the Combination of Transcatheter Arterial Chemoembolization (TACE) and Oral Everolimus (RAD001, Afinitor®) in Localised Unresectable Hepatocellular Carcinoma (HCC) - The TRACER Study|Terminated||Phase 2|65|Actual|Novartis||2||"The study was terminated due to low enrollment. This resulted in the study being underpowered   and inconclusive."|f||||t||||||||||2017-10-11 04:06:22.793767|2017-10-11 04:06:22.793767
NCT01379495|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-05-22|||July 2010||2010-07-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||Education Program for Burn Patients|Randomized Controlled Clinical Trial on Telephone Follow-up in Rehabilitation of Burn Patients: Impact on Health Status|Completed||N/A|83|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 04:06:23.577637|2017-10-11 04:06:23.577637
NCT01379482|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-05-05|||January 2005||2005-01-01|May 2011|2011-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer|Phase II Study of Patients With Peritoneal Carcinomatosis From Gastric Cancer Treated With Preoperative Systemic Chemotherapy Followed by Peritonectomy and Intraperitoneal Chemotherapy|Completed||Phase 2|18|Actual|Uppsala University||1|||f||||f||||||||||2017-10-11 04:06:23.660351|2017-10-11 04:06:23.660351
NCT01379469|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-05-10|||January 2012||2012-01-01|May 2017|2017-05-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|CBZ||Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency|A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency|Recruiting||Phase 2|30|Anticipated|Washington University School of Medicine||2|||f||||t||||||||Yes|We will share data and liver tissue with other researchers. They may be doing research in areas similar to this research or in other unrelated areas. These researchers may be at Washington University, at other research centers and institutions, or industry sponsors of research. We may also share research data with large data repositories (a repository is a database of information) for broad sharing with the research community. If individual research data is placed in one of these repositories only qualified researchers, who have received prior approval from individuals that monitor the use of the data, will be able to look at the information.|2017-10-11 04:06:23.751994|2017-10-11 04:06:23.751994
NCT01379456|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-09-21|||February 2011|Actual|2011-02-01|September 2017|2017-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|Eva-Hip||Eva-Hip, Evaluation of Rehabilitation After Hip-fracture|The Effect on Gait and Activity Level of a Physiotherapy Intervention Aimed at Improving Mediolateral Stability 4 Months After a Hip Fracture|Completed||N/A|223|Actual|Norwegian University of Science and Technology||2|||f||||t|f|f||||||||2017-10-11 04:06:23.918193|2017-10-11 04:06:23.918193
NCT01379443|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-22|||April 2007||2007-04-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Rehabilitation of Children With Multiple Disabilities|The Comparative Effect and Expense of More and Less Integration of Services That Provide Treatment and Rehabilitation for Children With Multiple Disabilities: A Randomized Controlled Trial|Completed||Phase 1|445|Actual|Children's Treatment Network||2|||f||||f||||||||||2017-10-11 04:06:23.990739|2017-10-11 04:06:23.990739
NCT01379430|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2012-10-02|||June 2010||2010-06-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas|Safety and Immunogenicity of Heterologous Prime-boost With the Candidate Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP in Healthy Adults in a Malaria Endemic Area|Completed||Phase 1|30|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 04:06:24.081093|2017-10-11 04:06:24.081093
NCT01379417|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-08-26|||November 2007||2007-11-01|August 2011|2011-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Probiotics Supplementation in Premature Infants|Probiotics Supplementation and Nutritional Benefit in Premature Infants|Completed||N/A|199|Actual|Nestlé||4|||f||||f||||||||||2017-10-11 04:06:24.163475|2017-10-11 04:06:24.163475
NCT01379404|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-05-19|||February 2011||2011-02-01|May 2015|2015-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|BIOVISION||Bioimpedance Analysis in Septic Intensive Care Unit (ICU) Patients|Does Bio-impedance Analysis Predict Volume Overload States and Clinically Relevant Outcomes in Septic Intensive Care Unit (ICU) Patients With Acute Kidney Injury? A Prospective Observational Study|Completed||N/A|55|Actual|St. Joseph's Healthcare Hamilton|||1||f||||f||||||Samples Without DNA|"     Blood only for chemistry.   "|||2017-10-11 04:06:24.274367|2017-10-11 04:06:24.274367
NCT01379391|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-10-07|||June 2010||2010-06-01|September 2015|2015-09-01||||September 2015|Actual|2015-09-01||Interventional|TPO||Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT|A Phase IV, Open-label, Prospective, Multicenter Study of the Efficacy and Safety of Recombinant Human Thrombopoietin Injection (rHuTPO, TPIAO)on Platelet Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation in China|Unknown status|Recruiting|Phase 4|80|Anticipated|Nanfang Hospital of Southern Medical University||2|||f||||t||||||||||2017-10-11 04:06:24.36632|2017-10-11 04:06:24.36632
NCT01379378|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-07-20|||October 2011||2011-10-01|July 2016|2016-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Male Stress Urinary Incontinence and Sexual Health|Male Stress Urinary Incontinence and Sexual Health|Withdrawn||N/A|0|Actual|Stanford University|||1||f||||t||||||||||2017-10-11 04:06:24.492764|2017-10-11 04:06:24.492764
NCT01379365|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-03-23|||June 2011||2011-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Cryo-Touch III Refinement Study Investigational Plan||Completed||Phase 2/Phase 3|88|Actual|MyoScience, Inc||1|||f||||f||||||||||2017-10-11 04:06:24.568588|2017-10-11 04:06:24.568588
NCT01379352|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-12-24|||June 2011||2011-06-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane Anesthesia|Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane Anesthesia|Completed||N/A|35|Actual|Samsung Medical Center|||2||f||||f||||||||||2017-10-11 04:06:24.642473|2017-10-11 04:06:24.642473
NCT01379339|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-02-09|||April 2011||2011-04-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Cabazitaxel - PF Induction Chemotherapy|Phase I Study of Cabazitaxel - Platinum Fluorouracil Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|40|Actual|Icahn School of Medicine at Mount Sinai||5|||f||||t||||||||||2017-10-11 04:06:24.739229|2017-10-11 04:06:24.739229
NCT01379326|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-12-04|||December 2011||2011-12-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ConWorm||Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2|The Efficacy of a Single-dose Mebendazole Against Soil-transmitted Helminths in School Children|Completed||Phase 4|250|Actual|University Ghent||1|||f||||f||||||||||2017-10-11 04:06:24.898597|2017-10-11 04:06:24.898597
NCT01379313|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2012-09-27|||June 2011||2011-06-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position|The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position|Completed||N/A|100|Actual|Samsung Medical Center||4|||f||||f||||||||||2017-10-11 04:06:25.028103|2017-10-11 04:06:25.028103
NCT01379300|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-10-01|||May 2011||2011-05-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1)|A Randomized Clinical Trial to Validate Novel Biomarker Approaches After Single Doses of Anticoagulants in Healthy Young Male Subjects and in Healthy Elderly Subjects|Completed||Phase 1|42|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 04:06:25.149798|2017-10-11 04:06:25.149798
NCT01379287|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-07-05|||June 2011|Actual|2011-06-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors|A Phase I, Open-Label, Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|29|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:06:25.223192|2017-10-11 04:06:25.223192
NCT01379274|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2013-11-26|||January 2011||2011-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes|A Phase II Trial of Revlimid® (Lenalidomide) and Low Dose Vidaza® (Azacitidine) in Patients With Low - Intermediate-1 Risk Myelodysplastic Syndromes|Terminated||Phase 2|2|Actual|Rush University Medical Center||1||Loss of funding.|f||||t||||||||||2017-10-11 04:06:25.42268|2017-10-11 04:06:25.42268
NCT01379261|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-11-05|||June 2011||2011-06-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional|CHILL-MI||Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction|Rapid Endovascular Catheter Core Cooling Combined With Cold Saline as an Adjunct to Percutaneous Coronary Intervention For the Treatment of Acute Myocardial Infarction|Completed||Phase 2/Phase 3|120|Actual|Region Skane||2|||f||||t||||||||||2017-10-11 04:06:25.523112|2017-10-11 04:06:25.523112
NCT01379248|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-10-27|||June 2011||2011-06-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset||Completed||Phase 4|152|Actual|University of Leipzig||2|||f||||||||||||||2017-10-11 04:06:25.697055|2017-10-11 04:06:25.697055
NCT01379235|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-15|2014-11-18|||January 2012||2012-01-01|June 2012|2012-06-01|July 2013|Actual|2013-07-01|October 2012|Actual|2012-10-01||Interventional|||Association Between Pilatis Exercise, Balance and Stability Measurements, and Quality of Life Among Elderly Population|Association Between Pilatis Exercise, Balance and Stability Measurements, and Quality of Life Among Elderly Population|Completed||N/A|88|Actual|Meir Medical Center||2|||f||||t||||||||||2017-10-11 04:06:25.775129|2017-10-11 04:06:25.775129
NCT01379222|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-01-11|||August 2011||2011-08-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|August 2017|Anticipated|2017-08-01||Interventional|ENGAGE PAS||Endurant Stent Graft System Post Approval Study|Post Approval Study Evaluating the Long Term Safety and Effectiveness of the Endurant Stent Graft System (ENGAGE PAS)|Active, not recruiting||Phase 4|178|Actual|Medtronic Endovascular||1|||f||||f||||||||No||2017-10-11 04:06:25.854873|2017-10-11 04:06:25.854873
NCT01379209|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2015-10-26|||September 2011||2011-09-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)|A Phase 1/2a, Open-Label, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravenous Administration of RGI-2001 in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)|Unknown status|Active, not recruiting|Phase 1/Phase 2|71|Anticipated|Regimmune Inc.||1|||f||||t||||||||||2017-10-11 04:06:25.955276|2017-10-11 04:06:25.955276
NCT01379196|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-04-25|||May 2011||2011-05-01|April 2017|2017-04-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy|Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy|Withdrawn||Phase 1/Phase 2|0|Actual|Rabin Medical Center||1||Patients were not interested in enrolling|f||||t||||||||Undecided||2017-10-11 04:06:26.079941|2017-10-11 04:06:26.079941
NCT01379183|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2016-02-19|2013-12-11||June 2011||2011-06-01|February 2016|2016-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility|Magnetic Resonance (MR) Evaluation of the Effect of Erythromycin Upon Gastric and Small Bowel Motility|Completed||Phase 2/Phase 3|40|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-10-11 04:06:26.177879|2017-10-11 04:06:26.177879
NCT01379170|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-05-13|||June 2011||2011-06-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Thyroid Study Type 2 Diabetes Mellitus (T2DM)|Effects of Thyroid Hormone Treatment on Mitochondrial Function, Ectopic Fat Accumulation, Insulin Sensitivity and Brown Adipose Tissue in Type 2 Diabetes Mellitus|Unknown status|Recruiting|Phase 4|17|Anticipated|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 04:06:26.650845|2017-10-11 04:06:26.650845
NCT01379157|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-09-19|||November 2011||2011-11-01|December 2011|2011-12-01|July 2014|Actual|2014-07-01|August 2013|Actual|2013-08-01||Interventional|||Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia|The Pharmacodynamics of Imipenem in Critically Ill Patients With Ventilator-associated Pneumonia Following Administration by 4 h or 0.5 h Infusion|Completed||Phase 4|8|Actual|Prince of Songkla University||2|||f||||f||||||||||2017-10-11 04:06:26.807345|2017-10-11 04:06:26.807345
NCT01379144|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-21|||January 2003||2003-01-01|June 2011|2011-06-01|April 2003|Actual|2003-04-01|March 2003|Actual|2003-03-01||Interventional|||A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension|A 4 Week, Dose-Ranging, Multi-Center, Randomized, Double-Masked, Parallel Study Comparing The Efficacy, Safety, And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma Aand Ocular Hypertension|Completed||Phase 2|282|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 04:06:26.929075|2017-10-11 04:06:26.929075
NCT01379131|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2015-10-01|||September 2009||2009-09-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Previous Cardiovascular Disease, Cardiovascular Risk Factors and Chest Pain in First Myocardial Infarction|MI as the First Manifestation of Coronary Heart Disease: Distribution of Previous Cardiovascular Disease, Cardiovascular Risk Factors and Chest Pain in First MI|Completed||N/A|9000|Actual|London School of Hygiene and Tropical Medicine|||1||f||||t||||||||||2017-10-11 04:06:27.087185|2017-10-11 04:06:27.087185
NCT01379118|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-09-14|||July 2012||2012-07-01|September 2016|2016-09-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Observational|TKR||Comparison of Clinical Outcomes and Performance of Total Knee Replacement Patients Before and After Surgery|Comparison of Clinical Scales and Quantitative Knee Motion Data in Assessing the Clinical Outcomes and Performance of Total Knee Replacement Patients Before and After Surgery|Completed||N/A|50|Anticipated|Loma Linda University|||1||f||||t||||||||||2017-10-11 04:06:27.16607|2017-10-11 04:06:27.16607
NCT01379105|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-22|||August 2010||2010-08-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Electromyographic Responses by Static Stretching and Neural Mobilization|Electromyographic Responses of Sedentary Students Submitted to Static Stretching and Neural Mobilization|Completed||N/A|45|Actual|Euro-American Network of Human Kinetics||1|||f||||t||||||||||2017-10-11 04:06:27.256493|2017-10-11 04:06:27.256493
NCT01379092|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-03-15|||June 2011||2011-06-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging|An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging|Unknown status|Recruiting|N/A|100|Anticipated|Levine, Gary M. , M.D.||1|||f||||f||||||||||2017-10-11 04:06:27.368176|2017-10-11 04:06:27.368176
NCT01379079|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-31|2014-05-12|||April 2011||2011-04-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|ASPIRETENSION||Aspirin in Reduction of Tension II Study|Aspirin AM or PM in Reduction of Tension: a Randomized Cross-over Trial|Completed||Phase 4|290|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-10-11 04:06:27.470398|2017-10-11 04:06:27.470398
NCT01379066|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-08-12|||August 2009||2009-08-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|TBVOC||Tuberculosis Volatile Organic Compounds|Detection of Mycobacteria in Lungs and Culture Using an Ultra-fast Gas Chromatograph|Completed||N/A|15|Actual|Landon Pediatric Foundation|||2||f||||f||||||||||2017-10-11 04:06:27.564264|2017-10-11 04:06:27.564264
NCT01379053|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-08-12|||August 2009||2009-08-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|MRSAVOC||Volatile Organic Compounds in Staphylococcus Aureus Patients|Detection of Methicillin Resistant Staphylococcus Aureus Colonization Using the zNose®, an Ultra-fast Gas Chromatograph|Completed||N/A|10|Actual|Landon Pediatric Foundation|||2||f||||f||||||||||2017-10-11 04:06:27.639037|2017-10-11 04:06:27.639037
NCT01379040|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-08-12|||August 2009||2009-08-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|VOCCF||Volatile Organic Compounds in Cystic Fibrosis|Detection of Pulmonary Colonization in Cystic Fibrosis Patients|Completed||N/A|24|Actual|Landon Pediatric Foundation|||2||f||||f||||||||||2017-10-11 04:06:27.713145|2017-10-11 04:06:27.713145
NCT01379027|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2017-02-28|||October 2011||2011-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|||MoodHelper: Internet Cognitive Behavioral Therapy (CBT) for Depression|Internet CBT for Depression: Comparing Pure, Guided, and Stepped Care|Active, not recruiting||N/A|1800|Anticipated|Kaiser Permanente||4|||f||||t||||||||||2017-10-11 04:06:27.784795|2017-10-11 04:06:27.784795
NCT01379014|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-11-01|||July 2011||2011-07-01|November 2011|2011-11-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|CORAL||CORAL Study: Proof of Concept Trial|The CORAL Study of a Decision Aid Tool Regarding Disclosure of Mental Health Status to an Employer: Proof of Concept Randomised Control Trial|Unknown status|Recruiting|N/A|84|Anticipated|Institute of Psychiatry, London||2|||f||||f||||||||||2017-10-11 04:06:27.902776|2017-10-11 04:06:27.902776
NCT00005532|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-06|||May 1996||1996-05-01|January 2016|2016-01-01|August 2005||2005-08-01|||||Observational|||Dietary Fat, Plasma Lipids, and Other CHD Risk Factors||Completed||N/A|||Tufts University|||||f||||||||||||||2017-10-11 04:27:10.320529|2017-10-11 04:27:10.320529
NCT01379001|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-01-03|||July 2008||2008-07-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI|Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI|Completed||N/A|60|Actual|Hebrew Rehabilitation Center, Boston||2|||f||||f||||||||||2017-10-11 04:06:28.014722|2017-10-11 04:06:28.014722
NCT01378988|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-06-29|2015-05-29|2012-09-12|June 2011||2011-06-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||Safety Evaluable Population consisted of all subjects who received any amount of study drug.|Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 Months|A Phase II, Randomized, Open-Label, Single Center, Pharmacokinetic and Pharmacodynamic Study of Dexmedetomidine in Pediatric Subjects Aged 12 Months Through <24 Months|Completed||Phase 2|5|Actual|Hospira, now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-10-11 04:06:28.122415|2017-10-11 04:06:28.122415
NCT01378975|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-06-20|2016-06-20||July 2011||2011-07-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||The intent-to-treat (ITT) population included all participants who were enrolled in the study.|A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases|An Open-label, Single-arm, Phase II, Multicenter Study, to Evaluate the Efficacy of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases|Completed||Phase 2|146|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:06:28.735104|2017-10-11 04:06:28.735104
NCT01378962|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-08-21|2015-09-30||March 31, 2011|Actual|2011-03-31|August 2017|2017-08-01|January 31, 2017|Actual|2017-01-31|June 30, 2013|Actual|2013-06-30||Interventional||Safety population included all participants enrolled in the study who received at least 1 dose of treatment and had at least 1 safety assessment.|A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)|Phase II, Open-label Study of Erlotinib (Tarceva®) Treatment in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer Who Present Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor (EGFR) - (TRIGGER)|Completed||Phase 2|50|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:06:31.399849|2017-10-11 04:06:31.399849
NCT01378949|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-19|2011-06-22|||September 2011||2011-09-01|June 2011|2011-06-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Psoas Compartment Block Versus Fascia Iliaca Block After Total Hip Arthroplasty||Unknown status|Not yet recruiting|N/A|90|Anticipated|Hillel Yaffe Medical Center||3|||f||||t||||||||||2017-10-11 04:06:31.803823|2017-10-11 04:06:31.803823
NCT01378936|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2013-05-03|||August 2009||2009-08-01|May 2013|2013-05-01|June 2016|Anticipated|2016-06-01|December 2013|Anticipated|2013-12-01||Interventional|IOC||Jail-Based Impact of Crime Intervention|Phase 2 RCT of Jail-Based Impact of Crime Intervention to Reduce Recidivism, Substance Abuse and HIV Risk Behavior|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|George Mason University||2|||f||||t||||||||||2017-10-11 04:06:31.88269|2017-10-11 04:06:31.88269
NCT01378910|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2014-07-02|||June 2011||2011-06-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia|Use Of Genotypic HIV-1 Tropism Testing In Proviral DNA To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia|Completed||Phase 4|74|Actual|Fundacio Lluita Contra la SIDA||1|||f||||f||||||||||2017-10-11 04:06:32.206512|2017-10-11 04:06:32.206512
NCT01378897|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-08-10|||June 2011||2011-06-01|August 2016|2016-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Bariatric Surgery Telemedicine Study|A Telehealth Innovation to Support Weight Loss|Withdrawn||Phase 1|0|Actual|Baystate Medical Center||1||PI decided to not initiate this study.|f||||f||||||||||2017-10-11 04:06:32.412403|2017-10-11 04:06:32.412403
NCT01378884|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-03|2013-03-18|||March 2010||2010-03-01|March 2013|2013-03-01|March 2014|Anticipated|2014-03-01|March 2012|Anticipated|2012-03-01||Interventional|||The Use of Domperidone for Gastroparesis|Monitoring Study for the Use of Gastroparesis for Patient Who Have Failed Standard Therapy|Withdrawn||Phase 3|0|Actual|Allegiance Health||1|||f||||t||||||||||2017-10-11 04:06:32.475477|2017-10-11 04:06:32.475477
NCT01378871|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-02-12|||September 2010||2010-09-01|February 2015|2015-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma|Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma|Completed||Phase 2|1|Actual|Albert Einstein College of Medicine, Inc.||1|||f||||f||||||||||2017-10-11 04:06:32.566742|2017-10-11 04:06:32.566742
NCT01378858|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2015-01-14|||July 2011||2011-07-01|January 2015|2015-01-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients|Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients|Unknown status|Active, not recruiting|N/A|100|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 04:06:32.700485|2017-10-11 04:06:32.700485
NCT01378845|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-12-12|||July 2011||2011-07-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Interventional|Anti-Vasospasm||Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands|Monocenter, IIT, Open Controlled and Prospectiv Study to Define the Prognostic Influence of Light Rheography Measurement of Patients With Secundary Raynaud Syndrome With Ulcers at Fingertips Throughout the Medicinal Therapy|Unknown status|Recruiting|N/A|30|Anticipated|University of Freiburg||2|||f||||f||||||||||2017-10-11 04:06:32.79349|2017-10-11 04:06:32.79349
NCT01378832|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-21|||January 2010||2010-01-01|January 2010|2010-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|lavage||Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Postoperative Colorectal Cancer Infection in Elective Surgery|Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Infection in Elective Surgery|Completed||Phase 3|102|Actual|Universidad Miguel Hernandez de Elche||1|||f||||f||||||||||2017-10-11 04:06:32.910627|2017-10-11 04:06:32.910627
NCT01378819|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-21|||February 2010||2010-02-01|February 2010|2010-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||3-midline-ports Cholecystectomy|Three Ports Placed in the Line Alba of the Abdomen (3-midline-ports Technique): an Alternative Approach for Laparoscopic Cholecystectomy|Completed||Phase 3|100|Actual|Universidad Miguel Hernandez de Elche||1|||f||||f||||||||||2017-10-11 04:06:32.983662|2017-10-11 04:06:32.983662
NCT01378806|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-07-12|||April 2007||2007-04-01|July 2012|2012-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|WEIGHT||Family Partners for Health|Children and Parents Partnering Together to Manage Their Weight|Completed||N/A|718|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 04:06:33.04867|2017-10-11 04:06:33.04867
NCT01378793|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-02-02|||June 15, 2011|Actual|2011-06-15|February 2017|2017-02-01|December 15, 2013|Actual|2013-12-15|December 15, 2013|Actual|2013-12-15||Interventional|AcuSnooze||Acupressure for Insomnia|Acupressure for Chronic Insomnia in Adults With Chronic Low Back Pain|Terminated||N/A|5|Actual|University of Michigan||3||Inadequate enrollement|f||||f||||||||||2017-10-11 04:06:33.136337|2017-10-11 04:06:33.136337
NCT01378780|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-04-27|||May 2011||2011-05-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SHARE||Stroke Health and Risk Education (SHARE)|Stroke Health and Risk Education (SHARE)|Completed||N/A|760|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 04:06:33.230695|2017-10-11 04:06:33.230695
NCT01378767|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-20|||September 2010||2010-09-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Health Benefits of a 21-day Daniel Fast|Biochemical, Hemodynamic, and Anthropometric Effects of a 21-day Daniel Fast in Men and Women|Completed||N/A|39|Actual|University of Memphis||2|||f||||f||||||||||2017-10-11 04:06:33.319385|2017-10-11 04:06:33.319385
NCT01378754|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2012-10-02|||June 2011||2011-06-01|October 2012|2012-10-01|June 2014|Anticipated|2014-06-01|May 2014|Anticipated|2014-05-01||Interventional|||Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia|A DOSE RANGING STUDY TO EVALUATE THE EFFECTIVENESS OF FOSPROPOFOL (LUSEDRA®) FOR INDUCTION OF ANESTHESIA FOR OUTPATIENT UROLOGIC HYDRODILATION THERAPY|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||3||Loss of funding before enrollment.|f||||t||||||||||2017-10-11 04:06:33.426297|2017-10-11 04:06:33.426297
NCT01378741|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-04-17|||April 2011||2011-04-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|July 2014|Actual|2014-07-01||Interventional|||Reducing Delirium After Cardiac Surgery: A Multifaceted Approach Of Perioperative Care|Reducing Delirium After Cardiac Surgery: A Multifaceted Approach Of Perioperative Care|Completed||N/A|185|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 04:06:33.505464|2017-10-11 04:06:33.505464
NCT01378728|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-05-18|||February 2009||2009-02-01|May 2017|2017-05-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Observational|||Clinical Validation of a 'Hand-held' Fluorescence Digital Imaging Device for Wound Care Applications|Clinical Validation Study of a 'Hand-held' Point-of-Care Fluorescence Digital Imaging Device for Real-time Detection and Diagnosis of Wound Infections and Longitudinal Monitoring of Wound Healing Status|Completed||N/A|75|Actual|University Health Network, Toronto|||1||f||||t||||||||||2017-10-11 04:06:33.589843|2017-10-11 04:06:33.589843
NCT01378715|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-20|||June 2010||2010-06-01|May 2011|2011-05-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|TIPS-3||Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study|Rosuvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study (TIPS-3)|Unknown status|Recruiting|Phase 3|400|Anticipated|University Hospital, Motol||2|||f||||f||||||||||2017-10-11 04:06:33.668139|2017-10-11 04:06:33.668139
NCT01378702|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2011-06-20|||January 2008||2008-01-01|May 2007|2007-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Immunological Effects of Two Mistletoe Preparations in Healthy Volunteers|Safety and Immunological Effects of Iscucin Populi and Viscum Mali e Planta Tota in Healthy Volunteers|Completed||Phase 1|71|Actual|University Hospital Freiburg||3|||f||||t||||||||||2017-10-11 04:06:33.766119|2017-10-11 04:06:33.766119
NCT01378689|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-01-14|||September 2010||2010-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids|Improving Bone Health Among RA Patients on Chronic Glucocorticoids|Completed||Phase 4|4659|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 04:06:33.847533|2017-10-11 04:06:33.847533
NCT01378663|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2012-03-19|||April 2010||2010-04-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Review of Pain Management After Congenital Cardiac Surgery|Review of Pain Management After Congenital Cardiac Surgery|Completed||N/A|92|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 04:06:34.188638|2017-10-11 04:06:34.188638
NCT01378650|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2014-05-21|||July 2011||2011-07-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|CITI-ESR||A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus|A Randomized, Prospective, Placebo-controlled Double-blind, Pilot Study on the Effect of Cilostazol for 4 Weeks in Patients With Chronic Tinnitus|Completed||N/A|50|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 04:06:34.261233|2017-10-11 04:06:34.261233
NCT01378637|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-18|2016-12-07|||January 2011||2011-01-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|December 2016|Actual|2016-12-01||Interventional|AMES||AMES Treatment of the Impaired Leg in Chronic Stroke Patients|AMES Treatment of the Impaired Leg in Chronic Stroke Patients|Active, not recruiting||Phase 1/Phase 2|22|Actual|AMES Technology||1|||f||||t||||||||No||2017-10-11 04:06:34.364648|2017-10-11 04:06:34.364648
NCT01378624|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2013-10-30|||June 2011||2011-06-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Ex Vivo Effect of Surfactant Protein D on Pulmonary Cells in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging|Ex Vivo Effect of Fragments and Modified Forms of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging|Completed||N/A|15|Actual|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f||||f||||||||||2017-10-11 04:06:34.467519|2017-10-11 04:06:34.467519
NCT01378611|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-28|||March 2006||2006-03-01|June 2011|2011-06-01|March 2013|Anticipated|2013-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Does VNS Interact With the Serotonergic and Immune System in Children With Intractable Epilepsy?|Does VNS Interact With the Serotonergic and Immune System in Children With Intractable Epilepsy? A Randomized Clinical Study.|Unknown status|Active, not recruiting|Phase 2/Phase 3|45|Anticipated|Epilepsiecentrum Kempenhaeghe||2|||f||||t||||||||||2017-10-11 04:06:34.549514|2017-10-11 04:06:34.549514
NCT01378598|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-27|2012-06-22|||September 2010||2010-09-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer|Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer: A Feasibility Pilot Study|Completed||N/A|30|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 04:06:34.64012|2017-10-11 04:06:34.64012
NCT01378585|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2012-08-21|||May 2011||2011-05-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety and Efficacy of DLBS1033 in Healthy Subjects|A Randomized, Double Blind, Placebo Controlled, Cross-over, and Fixed Dose Study to Evaluate the Safety and Efficacy of DLBS1033 in Healthy Subjects|Completed||N/A|20|Actual|Dexa Medica Group||2|||f||||||||||||||2017-10-11 04:06:34.714668|2017-10-11 04:06:34.714668
NCT01378572|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-06-21|||November 2009||2009-11-01|June 2011|2011-06-01||||||||Observational|EMOSIDD||Electrophysiologic and Morphologic Assessment of the Substrate to Guide Implantation of Defibrillators in Dilated Cardiomyopathy||Unknown status|Recruiting|N/A|200|Anticipated|Catholic University of the Sacred Heart|||1||f||||t||||||||||2017-10-11 04:06:34.826664|2017-10-11 04:06:34.826664
NCT01378559|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-02-21|||June 2011||2011-06-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Patient Satisfaction and Complications With the New Titan® One Touch Release (OTR) Penis Prosthesis|Patient Satisfaction and Complications With the New Titan® One Touch Release (OTR) Penis Prosthesis|Completed||N/A|26|Actual|Copenhagen University Hospital at Herlev|||1||f||||f||||||||||2017-10-11 04:06:34.947084|2017-10-11 04:06:34.947084
NCT01378546|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2013-07-17|||May 2005||2005-05-01|July 2013|2013-07-01||||May 2015|Anticipated|2015-05-01||Expanded Access|||Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP|Treatment of Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenic Syndromes With 3, 4-Diaminopyridine|No longer available||N/A|||Columbia University|||||||||f||||||||||2017-10-11 04:06:35.050789|2017-10-11 04:06:35.050789
NCT01378533|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-12-27|||May 2011||2011-05-01|December 2011|2011-12-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Interventional|||The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC|Randomized Phase Ⅲ Trial Comparing Dose-dense Epirubicin and Cyclophosphamide Followed by Paclitaxel With Paclitaxel Plus Carboplatin as Adjuvant Therapy for Triple-negative Breast Cancer.|Unknown status|Recruiting|Phase 3|100|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-10-11 04:06:35.125734|2017-10-11 04:06:35.125734
NCT01378520|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-09-11|2013-09-11||June 2011||2011-06-01|September 2013|2013-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|KetoRLB||Effect of Ketoconazole on Breathlessness|The Effect of Ketoconazole on Breathlessness During Resistive Load Breathing in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|20|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 04:06:35.237973|2017-10-11 04:06:35.237973
NCT01378507|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-21|||January 2009||2009-01-01|May 2011|2011-05-01|April 2013|Anticipated|2013-04-01|June 2011|Anticipated|2011-06-01||Interventional|||Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms|Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms|Unknown status|Recruiting|N/A|500|Anticipated|Chinese PLA General Hospital||1|||f||||t||||||||||2017-10-11 04:06:35.482634|2017-10-11 04:06:35.482634
NCT01378494|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2016-05-31|||June 2011||2011-06-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Bone Mineral Density in HIV+ Patients|Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)|Completed||N/A|200|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||||||2017-10-11 04:06:35.600279|2017-10-11 04:06:35.600279
NCT01378481|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-12-22|||June 2012||2012-06-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma|High-Dose Vorinostat With Radiation Therapy in the Treatment of Recurrent Glioma|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:06:35.682149|2017-10-11 04:06:35.682149
NCT01378468|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2017-01-30|||January 2009||2009-01-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Observational|||Prognostic Impact of an Oral Triglyceride Tolerance Test in Patients After Acute Ischemic Stroke|The Berlin 'Cream&Sugar' Study: the Prognostic Impact of an Oral Triglyceride Tolerance Test in Patients After Acute Ischemic Stroke|Active, not recruiting||N/A|573|Actual|Charite University, Berlin, Germany|||1||f||||t||||||||||2017-10-11 04:06:35.793318|2017-10-11 04:06:35.793318
NCT01378455|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2016-10-03|||March 2010||2010-03-01|May 2011|2011-05-01|February 2015|Actual|2015-02-01|March 2012|Actual|2012-03-01||Interventional|||Effectiveness of Handwriting Training Program on Handwriting Performance in Cerebral Palsy|Effectiveness of Interactive Computerized Handwriting Training Program on Handwriting Performance in Children With Cerebral Palsy|Completed||N/A|20|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-10-11 04:06:35.892255|2017-10-11 04:06:35.892255
NCT01378442|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-06-10|||August 2007||2007-08-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Relationship of Bone Strength and Fitness Training in Children With Cerebral Palsy|The Relationship of Bone Strength and Fitness Training in Children With Cerebral Palsy|Completed||N/A|60|Actual|Chang Gung Memorial Hospital||3|||f||||t||||||||||2017-10-11 04:06:35.993754|2017-10-11 04:06:35.993754
NCT01378429|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2014-04-29|2013-12-19|2012-11-02|July 2011||2011-07-01|April 2014|2014-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis|A 6-Week Randomized, Double-blind, Placebo-controlled, Parallel Group, Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal (HPA) Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|89|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 04:06:36.138057|2017-10-11 04:06:36.138057
NCT00005533|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-07-14|||February 1997||1997-02-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Hostility, Depression, Social Environment and CHD Risk|Hostility, Depression, Social Environment and CHD Risk|Completed||N/A|592|Actual|Duke University|||1||f||||||||||||||2017-10-11 04:27:11.009993|2017-10-11 04:27:11.009993
NCT01378416|ClinicalTrials.gov processed this data on October 10, 2017|2008-09-30|2011-07-02|2008-09-30||April 2005||2005-04-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|January 2006|Actual|2006-01-01||Interventional|||Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|A Phase I Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Completed||Phase 1|16|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 04:06:37.011415|2017-10-11 04:06:37.011415
NCT01378403|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-21|||September 2007||2007-09-01|June 2011|2011-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Evaluation of Dorsal Visual Stream in Patients With Schizophrenia|Evaluation of Dorsal Visual Stream in Patients With Schizophrenia|Completed||N/A|22|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-10-11 04:06:37.572078|2017-10-11 04:06:37.572078
NCT01378390|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2011-06-21|||December 2008||2008-12-01|June 2011|2011-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|FATT||Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease|Randomized, Single-blind, Placebo Controlled Multicenter Phase III Study to Assess the Efficacy and Safety of Expanded Autologous Adipose-derived Stem Cells (ASCs) (CX-401), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease|Terminated||Phase 3|56|Actual|Cellerix||2||"After the investigators and experts in the field imput it became apparent that the protocol was   not reflective of clinical reality. No safety issues reported."|f||||t||||||||||2017-10-11 04:06:37.645809|2017-10-11 04:06:37.645809
NCT01378364|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-10-31|||June 2011||2011-06-01|October 2013|2013-10-01||||November 2011|Actual|2011-11-01||Interventional|||Phase I Study of AbGn-168H in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics Study of Single Rising Doses of AbGn-168H Administered by Intravenous Infusion (125 μg/kg, 500 μg/kg, 1 mg/kg, 2 mg/kg) or Subcutaneous Injection (125 μg/kg, 1 mg/kg) to Healthy Male Volunteers (Randomised, Double-blind, Placebo-controlled Within Dose Groups)|Completed||Phase 1|48|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-10-11 04:06:37.86947|2017-10-11 04:06:37.86947
NCT01378351|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-21|2013-08-22|||June 2011||2011-06-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey|Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Study|Terminated||N/A|2|Actual|Baylor Research Institute|||1|Inadequate recruitment, investigator left institution|f||||f||||||||||2017-10-11 04:06:38.003285|2017-10-11 04:06:38.003285
NCT01378338|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2013-09-30|||June 2012||2012-06-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|Refresh||Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational|Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational Study|Completed||N/A|855|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 04:06:38.081671|2017-10-11 04:06:38.081671
NCT01378325|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2014-08-11|2014-07-02||July 2012||2012-07-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||with β of 0.2 and α of 0.05 and two-sided test for comparing two means (http://www.stat.ubc.ca/~rollin/stats/ssize/n2.html), the calculated number of patients was 37 in each group.|Variable Rate Phenylephrine Infusion for Prevention of Spinal-induced Hypotension for Cesarean Delivery|Crystalloid Coload Combined With Variable Rate Phenylephrine Infusion for Prevention of Hypotension During Spinal Anesthesia for Elective Cesarean Delivery vs Crystalloid Coload Alone|Completed||Phase 4|80|Actual|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-11 04:06:38.190714|2017-10-11 04:06:38.190714
NCT01378312|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-24|2014-03-14|||February 2011||2011-02-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||A Study to Evaluate Safety and Immunogenicity of AERAS-402|A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-402 When Administered to HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection|Completed||Phase 1|12|Actual|Aeras||2|||f||||t||||||||||2017-10-11 04:06:38.435661|2017-10-11 04:06:38.435661
NCT01378299|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-05-31|||October 1, 2011|Actual|2011-10-01|May 2017|2017-05-01|October 31, 2017|Anticipated|2017-10-31|November 7, 2016|Actual|2016-11-07||Interventional|||CYP19A1 Gene and Pharmacogenetics of Response to Testosterone Therapy|CYP19A1 Gene and Pharmacogenetics of Response|Active, not recruiting||Phase 1|105|Anticipated|VA Office of Research and Development||1|||f||||t|t|f|||f|||Yes|"People who ensure quality from the institutions where the research is being done, federal and other regulatory agencies will have access to all of the research data such as Food and Drug Administration (FDA) and Data Monitoring Committee (DMC). The purpose of collecting information covered under 38 U.S.C. 7332 is to conduct scientific research and no personnel involved in this study will identify, directly or indirectly, any individual patient or subject in any report of such research.
The only research data that will leave the MEDVA MC will be emailed to the FDA and Data Monitoring Committee, and will include only data on subjects who developed side effects including heart attacks, strokes, high hematocrit, high PSA, psychiatric problems and other adverse events, and the results of their tests. None of the 18 HIPAA identifiers will be included."|2017-10-11 04:06:38.533135|2017-10-11 04:06:38.533135
NCT01378286|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2013-07-17|||January 2012||2012-01-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria|A Randomised Comparative Study to Assess the Efficacy and Tolerability of Blood Schizonticidal Treatments With Artesunate Amodiaquine Winthrop® / Coarsucam (ASAQ) Versus Chloroquine (CQ) for Uncomplicated Plasmodium Vivax Monoinfection Malaria|Completed||Phase 3|380|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 04:06:38.633987|2017-10-11 04:06:38.633987
NCT01378273|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-09-27|||December 2013||2013-12-01|September 2016|2016-09-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|PENUT||Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)|Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)|Active, not recruiting||Phase 3|941|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 04:06:38.729738|2017-10-11 04:06:38.729738
NCT01378260|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-05-16|||July 2011||2011-07-01|May 2017|2017-05-01|August 2015|Actual|2015-08-01|September 2014|Actual|2014-09-01||Observational|||Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)|Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)|Completed||N/A|323|Actual|University of Washington|||3||f||||f||||||||||2017-10-11 04:06:38.877448|2017-10-11 04:06:38.877448
NCT01378247|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-04-14|||June 2011||2011-06-01|April 2017|2017-04-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Multicenter Study of Family Nursing to Treat Heart Failure|Family Focused Nursing for Outpatients With Heart Failure|Completed||N/A|468|Actual|University of Southern Denmark||2|||f||||f||||||||Yes|Data will be entered into Odense Patient data Explorative Network (OPEN) database|2017-10-11 04:06:38.973229|2017-10-11 04:06:38.973229
NCT01378234|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-21|||June 2009||2009-06-01|June 2011|2011-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|EDPP||Enhanced Discharge Planning Program -- Prospective|The Impact of a Social Work Driven Transitional Care Model on Health Outcomes for At-Risk Older Adults|Completed||N/A|740|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 04:06:39.077748|2017-10-11 04:06:39.077748
NCT01378221|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2013-12-11|2013-12-11||September 2009||2009-09-01|December 2013|2013-12-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Observational|VISE||VItamin D Metabolism in SEnescent Cardiac Surgery Patients|Vitamin D Metabolism in Senescent Cardiac Surgery Patients|Completed||N/A|75|Actual|Heart and Diabetes Center North-Rhine Westfalia|||2||f||||f||||||||||2017-10-11 04:06:39.178303|2017-10-11 04:06:39.178303
NCT01378208|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2013-11-19|||June 2011||2011-06-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||How Often Should We Eat|VEK-H-3-2011-023. Fasting and Meal Frequency Project|Completed||N/A|10|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-10-11 04:06:39.440412|2017-10-11 04:06:39.440412
NCT01378195|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2013-02-22|2012-08-30||May 2011||2011-05-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|iCare||iCare Stress Management e-Training for Dementia Family Caregivers|iCare Stress Management e-Training for Dementia Family Caregivers|Completed||Phase 2|150|Actual|Photozig, Inc.||2|||f||||||||||||||2017-10-11 04:06:39.542826|2017-10-11 04:06:39.542826
NCT01378182|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2014-12-30|||April 2011||2011-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis|Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis|Completed||N/A|10|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi||1|||f||||f||||||||||2017-10-11 04:06:39.857505|2017-10-11 04:06:39.857505
NCT01378169|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-03-06|||January 1, 2011|Actual|2011-01-01|March 2017|2017-03-01|June 1, 2013|Actual|2013-06-01|January 1, 2013|Actual|2013-01-01||Observational|Captain||SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICU|Early Detection and Diagnostic Performance of Bio-markers During Bacterial Sepsis: Multicentre Cohort Study in Intensive Care|Completed||N/A|300|Anticipated|Groupe Hospitalier Paris Saint Joseph|||1||f||||f||||||Samples Without DNA|"     blood, urin, CSF, BAL   "|||2017-10-11 04:06:39.923|2017-10-11 04:06:39.923
NCT01378156|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-30|2015-08-10|||June 2010||2010-06-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of pGA2/JS7 DNA and MVA/HIV62B in HIV-infected Adults With Suppressed Viremia Who Started ART Within 18 Months of a Negative HIV Antibody Test|Completed||Phase 1|9|Actual|GeoVax, Inc.||1|||f||||f||||||||||2017-10-11 04:06:40.019632|2017-10-11 04:06:40.019632
NCT01378143|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2014-10-20|||March 2011||2011-03-01|February 2013|2013-02-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy|A Phase II Clinical Study Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy (mFOLFOX6 or FOLFIRI) as Second-Line Treatment|Completed||Phase 2|53|Actual|Oncozyme Pharma Inc.||1|||f||||t||||||||||2017-10-11 04:06:40.12189|2017-10-11 04:06:40.12189
NCT01378130|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2013-04-25|||April 2011||2011-04-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Central Serous Chorioretinopathy: Etiology, Course and Prognosis|Central Serous Chorioretinopathy: An Observational Study About Etiology, Course and Prognosis|Completed||N/A|50|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-10-11 04:06:40.233951|2017-10-11 04:06:40.233951
NCT01378117|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-07|2014-06-07|2013-07-09||August 2011||2011-08-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||DPP4 Inhibitor in the Hospital|Randomized Controlled Study of DPP4 Inhibitor (Sitagliptin) Therapy in the Inpatient Management of Patients With Type 2 Diabetes|Completed||Phase 4|90|Actual|Emory University||3|||f||||t||||||||||2017-10-11 04:06:40.310403|2017-10-11 04:06:40.310403
NCT01378104|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-02-03|2012-12-14||October 2008||2008-10-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)|The Response of Reducing Dose of Peginterferon Alfa-2a in Koreans With Chronic Hepatitis C Genotype 1; Randomized Controlled Multicenter Study 100% Versus 80%|Completed||Phase 4|178|Actual|The Catholic University of Korea||2|||f||||t||||||||||2017-10-11 04:06:40.642382|2017-10-11 04:06:40.642382
NCT01378091|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-05-06|||August 2005||2005-08-01|May 2016|2016-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer|Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Every Three Week Docetaxel (Taxotere®) In Subjects With Androgen Independent Prostate Cancer|Completed||Phase 1|64|Actual|Columbia University||1|||f||||t||||||||Undecided||2017-10-11 04:06:41.132249|2017-10-11 04:06:41.132249
NCT01378078|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-07-19|||June 2011||2011-06-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia|Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia|Completed||N/A|20|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-10-11 04:06:41.21296|2017-10-11 04:06:41.21296
NCT00005534|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-03-05|||January 1997||1997-01-01|March 2014|2014-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||Prevalence of Asymptomatic Ventricular Dysfunction||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-10-11 04:27:12.61453|2017-10-11 04:27:12.61453
NCT01378065|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-09-29|2015-08-20||June 2011||2011-06-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|(A&P)||Restorelle Direct Fix Anterior and Posterior (A&P) for Female Pelvic Organ Prolapse: A Prospective Post Market Study|Restorelle Direct Fix A&P for Female Pelvic Organ Prolapse: A Prospective Post Market Study|Completed||N/A|31|Actual|Coloplast A/S|The study N was small.||1||f||||f||||||||||2017-10-11 04:06:41.327102|2017-10-11 04:06:41.327102
NCT01378052|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-21|||June 2011||2011-06-01|June 2011|2011-06-01||||June 2012|Anticipated|2012-06-01||Observational|||DNA Methylation and Urothelial Carcinoma|Level of DNA Methylation in People With Urothelial Carcinoma|Unknown status|Recruiting|N/A|200|Anticipated|China Medical University Hospital|||2||f||||t||||||||||2017-10-11 04:06:42.359486|2017-10-11 04:06:42.359486
NCT01378039|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-04-11|||June 2004||2004-06-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|December 2006|Actual|2006-12-01||Interventional|CAPTA||Pathogenetic Mechanisms of Chronic Obstructive Pulmonary Diseases|Evaluation of Pathogenetic Mechanisms of Chronic Obstructive Pulmonary Diseases|Completed||N/A|200|Actual|Lithuanian University of Health Sciences||1|||f||||f||||||||||2017-10-11 04:06:42.435717|2017-10-11 04:06:42.435717
NCT01378026|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-20|||January 2012||2012-01-01|June 2011|2011-06-01||||||||Observational|||Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation||Unknown status|Not yet recruiting|N/A|120|Anticipated|China Medical University Hospital|||1||f||||||||||Samples With DNA|"     whole blood, serum and DNA   "|||2017-10-11 04:06:42.508278|2017-10-11 04:06:42.508278
NCT01378013|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-03-24|||August 2011||2011-08-01|July 2011|2011-07-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Observational|SaMPLE||SurgicAl Metabolic Phenotyping Longitudinal Evaluation Study|Metabolic Phenotyping and Systems Biology in Surgery|Completed||N/A|50|Actual|Imperial College London|||2||f||||t||||||Samples With DNA|"     1. Urine        2. Blood (plasma)        3. Stool / small bowel content        4. Tissue (Colon, small bowel,stomach,eosophagus, breast, lymph nodes)   "|||2017-10-11 04:06:42.56159|2017-10-11 04:06:42.56159
NCT01378000|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-20|||October 2009||2009-10-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|UHPCI||Study on Continuous Intravenous of Unfractionated Heparin (UFH) to Treat Progressive Cerebral Infarction|Study Effects of Ultra-slow Continuous Intravenous Infusion of Unfractionated Heparin on Progressive Cerebral Infarction - a Clinical Study|Completed||N/A|480|Actual|Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine|||4||f||||t||||||Samples With DNA|"     serum   "|||2017-10-11 04:06:42.688499|2017-10-11 04:06:42.688499
NCT01377987|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-01-04|||August 2011||2011-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|HF-ACZ||Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients|Physiological Study to Predict Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients|Completed||N/A|29|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 04:06:42.783759|2017-10-11 04:06:42.783759
NCT01377974|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2015-06-08|||July 2009||2009-07-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis|Randomized Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis at Federal District, Brazil|Completed||Phase 2|40|Actual|Brasilia University Hospital||2|||f||||f||||||||||2017-10-11 04:06:42.878966|2017-10-11 04:06:42.878966
NCT01377961|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-30|2015-06-24|||September 2010||2010-09-01|June 2015|2015-06-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Effect of Lycopene and Isoflavones on Glucose Metabolism|Effect of Lycopene and Isoflavones on Glucose Metabolism|Withdrawn||N/A|0|Actual|The University of Texas Medical Branch, Galveston||2||FDA needs more information from the manufacturing company of the supplements.|f||||t||||||||||2017-10-11 04:06:42.967718|2017-10-11 04:06:42.967718
NCT01377948|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-03-08|||June 2010||2010-06-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Reducing Aggression in Children and Adolescent on an Inpatient Unit|Phase 1 Study of Anger Control Therapy Augmented With RAGE-Control (Regulate and Gain Emotional-Control)Delivered on an Inpatient Psychiatric Unit|Completed||Phase 1|20|Actual|Gonzalez-Heydrich, Joseph, M.D.||1|||f||||f||||||||||2017-10-11 04:06:43.06695|2017-10-11 04:06:43.06695
NCT01377935|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-09-19|||August 2009||2009-08-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Risk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments|Comparison of Risk of Hospitalization for Acute Kidney Injury Between Patients With Type 2 Diabetes Initiating Saxagliptin and Those Initiating Other Oral Antidiabetic Treatments|Completed||N/A|113505|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 04:06:43.157881|2017-10-11 04:06:43.157881
NCT01377909|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2013-08-21|||March 2012||2012-03-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity|An Investigator-initiated Pilot Study Using Statins to Improve the Anti-HCV Response to Peginterferon Alfa 2-b and Ribavirin in Previous Non-responders|Terminated||Phase 1|20|Actual|Bader, Ted, M.D.||1||Principal Investigator retiring|f||||f||||||||||2017-10-11 04:06:43.35342|2017-10-11 04:06:43.35342
NCT01377896|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-27|||July 2010||2010-07-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours|The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours|Completed||N/A|221|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:06:43.436663|2017-10-11 04:06:43.436663
NCT01377883|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-19|2011-06-21|||January 2010||2010-01-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Clown Care for Botulinum Toxin (BTX)||Completed||N/A|25|Actual|Shaare Zedek Medical Center||2|||f||||||||||||||2017-10-11 04:06:43.486402|2017-10-11 04:06:43.486402
NCT00000242|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-04-06|||October 1, 1992|Actual|1992-10-01|July 1996|1996-07-01|January 25, 1997|Actual|1997-01-25|January 25, 1997|Actual|1997-01-25||Interventional|||Carbamazepine Treatment of Cocaine Dependence - 1|Carbamazepine Treatment of Cocaine Dependence|Completed||Phase 2|0||Medical University of South Carolina|||||f||||||||||||||2017-10-11 04:18:25.97546|2017-10-11 04:18:25.97546
NCT01377870|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-19|2014-04-24|||December 2011||2011-12-01|August 2010|2010-08-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis|Effect and Side Effect of Mesenchymal Stem Cell in Multiple Sclerosis|Completed||Phase 1/Phase 2|22|Actual|Royan Institute||2|||f||||t||||||||||2017-10-11 04:06:43.568378|2017-10-11 04:06:43.568378
NCT01377857|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-18|2015-05-13|||May 2011||2011-05-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies|HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies|Completed||N/A|8572|Actual|University of California, San Francisco||10|||f||||f||||||||||2017-10-11 04:06:43.66256|2017-10-11 04:06:43.66256
NCT01377844|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2015-03-04||2014-07-23|December 2011||2011-12-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus|Efficacy and Safety of EGT0001442 Compared With Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Diet and Exercise and up to One Oral Anti-diabetes Agent|Completed||Phase 2|288|Actual|Theracos||2|||f||||t||||||||||2017-10-11 04:06:43.747364|2017-10-11 04:06:43.747364
NCT01377818|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-20|||March 2006||2006-03-01|March 2006|2006-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|COPD||Non Invasive Mechanical Ventilation Versus Respiratory Rehabilitation in Hypercapnic COPD|Prospective Aleatory Study of Non Invasive Mechanical Ventilation Versus Respiratory Rehabilitation in Hypercapnic Stable Severe COPD|Completed||Phase 4|45|Actual|Hospitales Universitarios Virgen del Rocío||3|||f||||f||||||||||2017-10-11 04:06:43.912229|2017-10-11 04:06:43.912229
NCT01377805|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-19|2015-04-02|||June 2011||2011-06-01|April 2015|2015-04-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Observational|||Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life|Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life -- a Retrospective Analysis|Withdrawn||N/A|0|Actual|Genetic Disease Investigators|||1|No participants|f||||t||||||||||2017-10-11 04:06:44.006252|2017-10-11 04:06:44.006252
NCT01377792|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-01-29|||March 2009||2009-03-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|May 2011|Actual|2011-05-01||Interventional|||Study of Long-term Treatment With Hypertonic Saline in Patients With Cystic Fibrosis|Phase 4 Study of the Efficacy of Long-term Treatment With Hypertonic Saline on Pulmonary Exacerbations in Patients With Cystic Fibrosis|Completed||Phase 4|71|Actual|Hospital Universitario Ramon y Cajal||2|||f||||t||||||||||2017-10-11 04:06:44.078209|2017-10-11 04:06:44.078209
NCT01377779|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2011-06-20|||September 2009||2009-09-01|July 2009|2009-07-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||Efficiency of Intercoat (Oxiplex/AP Gel)in Decreasing Intrauterine Adhesions|Intercoat (Oxiplex/AP Gel) for Preventing Intrauterine Adhesions Following Operative Hysteroscopy for Suspected Retained Products of Conception - a Prospective Randomized Pilot Study|Completed||N/A|60|Actual|Assaf-Harofeh Medical Center||2|||f||||t||||||||||2017-10-11 04:06:44.150877|2017-10-11 04:06:44.150877
NCT01377766|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-11-05|||October 2008||2008-10-01|November 2011|2011-11-01|November 2011|Anticipated|2011-11-01|October 2010|Actual|2010-10-01||Observational|||The Relationship Between Psychological Factors and Bell's Palsy|Study of Psychological Factors on the Occurence of Bell's Palsy|Unknown status|Recruiting|N/A|800|Anticipated|Huazhong University of Science and Technology|||1||f||||t||||||||||2017-10-11 04:06:44.230249|2017-10-11 04:06:44.230249
NCT01377753|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-18|2017-08-04|||May 26, 2011||2011-05-26|July 28, 2017|2017-07-28|January 1, 2019|Anticipated|2019-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||MR Image Guided Therapy in Prostate Cancer|MR Image Guided Focal Therapy in Prostate Cancer|Active, not recruiting||Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:06:44.325566|2017-10-11 04:06:44.325566
NCT01377740|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-20|||July 2011||2011-07-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Non-Invasive Reduction of Abdominal Fat Utilizing the CoolFlex and eZ App 6.3 Applicators|Non-Invasive Reduction of Abdominal Fat Utilizing the CoolFlex and eZ App 6.3 Applicators|Completed||N/A|20|Actual|Zeltiq Aesthetics||1|||f||||f||||||||No||2017-10-11 04:06:44.402594|2017-10-11 04:06:44.402594
NCT01377701|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2011-06-20|||June 2011||2011-06-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor|The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor|Unknown status|Recruiting|N/A|150|Anticipated|Huashan Hospital|||1||f||||t||||||||||2017-10-11 04:06:44.495415|2017-10-11 04:06:44.495415
NCT01377688|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2014-06-02|||October 2011||2011-10-01|March 2014|2014-03-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|DKDPilot||Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes|Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes|Completed||N/A|19|Actual|Duke University|||1||f||||f||||||||||2017-10-11 04:06:44.567102|2017-10-11 04:06:44.567102
NCT01377675|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2014-12-01|||April 2011||2011-04-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|WipeCOPD||Web-based, Interactive Professional Education for Chronic Obstructive Pulmonary Disease|Assessment of an Interactive Education Tool to Disseminate Best Practice Recommendations on Chronic Obstructive Pulmonary Disease to Primary Care|Completed||N/A|10|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-10-11 04:06:44.631686|2017-10-11 04:06:44.631686
NCT01377662|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2014-09-27||2014-09-27|August 2011||2011-08-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)|PHASE IIA: Randomized, Double Blind, Placebo Controlled, Single Center Clinical Trial of a Combination of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)|Completed||Phase 2|30|Actual|Duke University||2|||f||||f||||||||||2017-10-11 04:06:44.707091|2017-10-11 04:06:44.707091
NCT01377649|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-09-26|||July 2011||2011-07-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)|Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease|Completed||N/A|18|Actual|Oregon Health and Science University|||2||f||||t||||||||||2017-10-11 04:06:44.80346|2017-10-11 04:06:44.80346
NCT01377636|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-22|2015-02-17|2013-12-02||August 2009||2009-08-01|February 2015|2015-02-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With Isoproterenol|Study to Measure BIS and Awareness in Patients Receiving Isoproterenol During Catheter Ablation for Atrial Fibrillation|Completed||N/A|20|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-10-11 04:06:44.895537|2017-10-11 04:06:44.895537
NCT01377623|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-03|2017-06-09|2016-03-14||September 2010||2010-09-01|June 2017|2017-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||Baseline data is only available for those participants who completed the study|Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar Spinal Fusion|Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar Spinal Fusion|Terminated||N/A|66|Actual|New York University School of Medicine||2|||f||||f||||||||Yes||2017-10-11 04:06:45.494414|2017-10-11 04:06:45.494414
NCT01377610|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-07-13|||June 2011||2011-06-01|July 2017|2017-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Improved Strategies for Outpatient Opioid Detoxification|Long-acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone vs. Buprenorphine|Recruiting||Phase 1|210|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 04:06:45.869003|2017-10-11 04:06:45.869003
NCT01377597|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-11-16|||June 2011||2011-06-01|November 2016|2016-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|RVO in Japan||Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion|A 3-month, Phase III, Open-label, Single Arm, Multicenter Study Assessing the Efficacy and Safety of 0.5 mg Ranibizumab Monthly Intravitreal Injections as Monotherapy in Patients With Visual Impairment Due to Macular Edema Secondary to Branch or Central Retinal Vein Occlusion (RVO)|Completed||Phase 3|47|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:06:45.979831|2017-10-11 04:06:45.979831
NCT01377584|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-09-29|2017-07-12||March 2014||2014-03-01|September 2017|2017-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|COMMENCE||COMMunication and Education for the New CPAP Experience|COMMENCE Study: COMMunication and Education for the New CPAP Experience|Completed||N/A|60|Actual|University of Pittsburgh||6|||f||||f||||||||||2017-10-11 04:06:46.139903|2017-10-11 04:06:46.139903
NCT01377571|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-06-30|||October 2009||2009-10-01|June 2016|2016-06-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants|A Phase II, Randomized, Double-blind, Vaccine-controlled Dose-escalating Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Oral Live Attenuated Human Rotavirus (HRV) Vaccine (Rotavin-M1) in Healthy Infants in Vietnam|Completed||Phase 2|200|Actual|National Institute of Hygiene and Epidemiology, Vietnam||4|||f||||t||||||||||2017-10-11 04:06:47.233147|2017-10-11 04:06:47.233147
NCT01377558|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-22|||April 2011||2011-04-01|April 2011|2011-04-01|June 2012|Anticipated|2012-06-01|November 2011|Anticipated|2011-11-01||Interventional|||Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes|Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes - Aerobic Endurance Training Versus Strength Endurance Training Versus Combined Aerobic Endurance and Strength Endurance Training -|Unknown status|Active, not recruiting|N/A|100|Actual|University of Giessen||4|||f||||t||||||||||2017-10-11 04:06:47.320421|2017-10-11 04:06:47.320421
NCT01377545|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2013-01-16|||January 2013||2013-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Continuous Infraclavicular Nerve Blocks: Needle Versus Catheter Local Anesthetic Bolus|Continuous Infraclavicular Nerve Blocks: Needle Versus Catheter Local Anesthetic Bolus|Withdrawn||Phase 4|0|Actual|University of California, San Diego||2||lack of funding|f||||f||||||||||2017-10-11 04:06:47.419037|2017-10-11 04:06:47.419037
NCT01377532|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2014-12-23|||August 2009||2009-08-01|December 2014|2014-12-01|August 2021|Anticipated|2021-08-01|August 2020|Anticipated|2020-08-01||Expanded Access|||Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma|Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma|Available||N/A|||University of California, San Francisco||||Study has been suspended after the event of an serious adverse event.|||||t||||||||||2017-10-11 04:06:47.513634|2017-10-11 04:06:47.513634
NCT01377519|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2014-01-15|||June 2011||2011-06-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|PROMISe||Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids|Magnetic Resonance-Guided Focused Ultrasound to Treat Uterine Fibroids: A Pilot Randomized, Placebo-Controlled Trial|Completed||N/A|20|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 04:06:47.596135|2017-10-11 04:06:47.596135
NCT01377506|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2012-06-21|||September 2007||2007-09-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|Coaches||Translation of Obesity and Cognitive Program by Lay Health Educators|Translation of Obesity and Cognitive Research in a Rural State Via Senior Centers|Completed||N/A|16|Actual|University of Arkansas||2|||f||||f||||||||||2017-10-11 04:06:47.668889|2017-10-11 04:06:47.668889
NCT01377493|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-20|||December 2009||2009-12-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|February 2010|Actual|2010-02-01||Interventional|||Effects of a Chewing Gum Containing POs-Ca and Fluoride on Enamel|Effects of a Chewing Gum Containing POs-Ca and Fluoride on Remineralization of Enamel Subsurface Lesions in Situ|Completed||Early Phase 1|36|Actual|Tokyo Medical and Dental University||3|||f||||f||||||||||2017-10-11 04:06:47.73175|2017-10-11 04:06:47.73175
NCT01377480|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-04-17|2015-07-13||July 6, 2011|Actual|2011-07-06|April 2017|2017-04-01|January 12, 2015|Actual|2015-01-12|July 22, 2014|Actual|2014-07-22||Interventional|STOP CHAGAS||A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)|Phase 2 Proof-of-Activity Study of Oral Posaconazole in the Treatment of Asymptomatic Chronic Chagas Disease (Phase 2, Protocol No. P05267)|Completed||Phase 2|120|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:06:47.799584|2017-10-11 04:06:47.799584
NCT00005535|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|October 2002|2002-10-01|August 2000|Actual|2000-08-01|||||Observational|||Gene Mapping for Quantitative Traits||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:12.687602|2017-10-11 04:27:12.687602
NCT01377467|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-04-26|2016-01-22||June 2011||2011-06-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|May 2015|Actual|2015-05-01||Interventional|POSTOP|Randomized patients with a functioning graft|Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients|A Phase 3, Investigator-initiated, Randomized, Open-label Single-center Study of the Effect of Denosumab on the Prevention of Bone Mineral Density Loss After Renal Transplantation|Completed||Phase 3|90|Actual|University of Zurich||2|||f||||f||||||||No||2017-10-11 04:06:48.390028|2017-10-11 04:06:48.390028
NCT01377454|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2012-08-07|||June 2011||2011-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Balance and Mild Traumatic Brain Injury (TBI)|Wearable Sensor to Detect Postural Instability in People After Mild Traumatic Brain Injury (mTBI)|Completed||N/A|47|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-10-11 04:06:51.459141|2017-10-11 04:06:51.459141
NCT01377441|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2015-01-26|2014-12-12||September 2011||2011-09-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||All data was lost after Hurricane Sandy.|Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia.|Randomized, Double-blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes|Terminated||Phase 4|6|Actual|New York University School of Medicine||2||Samples lost during Hurricane Sandy. Study now taking place at other medical centers.|f||||t||||||||||2017-10-11 04:06:51.525357|2017-10-11 04:06:51.525357
NCT01377428|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-04-19|||September 2011||2011-09-01|May 2012|2012-05-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Efficacy of Indacaterol 150 µg Versus Formoterol|A 12-week Treatment, Multicenter, Randomized, Double Blind, Double Dummy, Parallel-group Study to Assess the Efficacy of Indacaterol (150 μg o.d.) in Patients With Chronic Obstructive Pulmonary Disease, Using Formoterol (12 μg b.i.d.) as an Active Control|Withdrawn||Phase 4|0|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:06:51.713958|2017-10-11 04:06:51.713958
NCT01377415|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-21|||January 2009||2009-01-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Continuous Subacromial Bupivacaine|The Analgesic Effect of Continuous Subacromial Bupivacaine Infusion After Arthroscopic Shoulder Surgery: a Randomized Controlled Trial|Completed||N/A|90|Anticipated|Turku University Hospital||2|||f||||||||||||||2017-10-11 04:06:51.783264|2017-10-11 04:06:51.783264
NCT01377402|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-03-19|2015-07-28||November 2005||2005-11-01|March 2017|2017-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|ARRA-RACS|Patients with suspected ACS.|ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study|ARgentinean Risk Assessment Registry in Acute Coronary Syndrome; the ARRA-RACS Study.|Completed||N/A|982|Actual|Helse Stavanger HF|||1||f||||t||||||Samples Without DNA|"     Serum, Citrated plasma, EDTA-plasma and packed red blood cells are kept in suitable aliquots     at -80 degrees Celcius.   "|No||2017-10-11 04:06:51.87065|2017-10-11 04:06:51.87065
NCT01377389|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-04-10|||June 17, 2011|Actual|2011-06-17|April 2017|2017-04-01|April 7, 2017|Actual|2017-04-07|April 7, 2017|Actual|2017-04-07||Interventional|||Ipilimumab + Androgen Deprivation Therapy in Prostate Cancer|A Phase II Study of Ipilimumab PLUS Androgen Deprivation Therapy in Castrate Sensitive Prostate Carcinoma|Completed||Phase 2|30|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 04:06:52.251064|2017-10-11 04:06:52.251064
NCT01377376|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2016-12-05|||July 2011||2011-07-01|December 2016|2016-12-01||||November 2015|Actual|2015-11-01||Interventional|ATTENTION||A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib|A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Subjects With Locally Advanced or Metastatic, Non-Squamous, Non-Small-Cell Lung Cancer With Wild-type Epidermal Growth Factor Receptor|Terminated||Phase 3|||Kyowa Hakko Kirin Co., Ltd||2|||f||||||||||||||2017-10-11 04:06:52.403077|2017-10-11 04:06:52.403077
NCT01377363|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-06-20|||December 2009||2009-12-01|June 2011|2011-06-01||||||||Observational|||Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis|Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis|Completed||N/A|236|Actual|Spanish Breast Cancer Research Group|||1||f||||f||||||Samples Without DNA|"     primary tumor sample and metastasis sample   "|||2017-10-11 04:06:52.501982|2017-10-11 04:06:52.501982
NCT01377350|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-06-20|||June 2011||2011-06-01|March 2011|2011-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Non-invasive Heart Failure Monitoring Using Novel Acceleration Sensors System|Non-invasive Heart Failure Monitoring Using Novel Acceleration Sensors System|Unknown status|Not yet recruiting|N/A|50|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-11 04:06:52.599737|2017-10-11 04:06:52.599737
NCT01377337|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-11-06|||December 2011||2011-12-01|November 2011|2011-11-01|March 2014|Anticipated|2014-03-01|December 2013|Anticipated|2013-12-01||Interventional|SB CAT||Sodium Bicarbonate in Cardiopulmonary Resuscitation|Does the Early Use of Sodium Bicarbonate Improve Results of Cardiopulmonary Resuscitation Following Out-of-Hospital Cardiac Arrest - a Prospective, Controlled Clinical Trial|Unknown status|Not yet recruiting|Phase 4|2130|Anticipated|Rambam Health Care Campus||2|||f||||t||||||||||2017-10-11 04:06:52.707824|2017-10-11 04:06:52.707824
NCT01377324|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-10-14|||May 2011||2011-05-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites|In Vivo Imaging of the Effect of Fulvestrant on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Tumor Lesions Using FES-PET|Completed||Phase 2|16|Actual|University Medical Center Groningen||1|||f||||f||||||||||2017-10-11 04:06:52.80219|2017-10-11 04:06:52.80219
NCT01377311|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2011-06-20|||July 2008||2008-07-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||The Application of Cultured Cornea Stem Cells in Patients Suffering From Corneal Stem Cell Insufficiency|Phase 1 Study of Cornea Stem Cells Cultured on Amniotic Membrane Transplanted on Patients Suffering From Corneal Stem Cell Insufficiency|Terminated||Phase 1|0|Actual|National Taiwan University Hospital||1||We didn't use this tech in patient.|f||||t||||||||||2017-10-11 04:06:52.906192|2017-10-11 04:06:52.906192
NCT01377298|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-06-20|||June 2011||2011-06-01|June 2011|2011-06-01|May 2014|Anticipated|2014-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma|A Phase II Study of Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Refractory to Platinum-Based Chemotherapy|Unknown status|Recruiting|Phase 2|45|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 04:06:52.998336|2017-10-11 04:06:52.998336
NCT01377285|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-08|2016-10-13|||June 2010||2010-06-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CKD||Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)|Renoprotection by Combining Pentoxifylline and Angiotensin Blockade in Chronic Kidney Disease|Recruiting||Phase 4|350|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||No|if the subject have serious adverse event and Data Monitoring Committee decide need to make individual participant data,study team will provide data.|2017-10-11 04:06:53.092223|2017-10-11 04:06:53.092223
NCT01377272|ClinicalTrials.gov processed this data on October 10, 2017|2008-10-22|2011-07-01|||October 2008||2008-10-01|May 2011|2011-05-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Observational|||Spatial Epidemiology of HIV Infection|Spatial Epidemiology of HIV Infection|Completed||N/A|1264|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 04:06:53.221528|2017-10-11 04:06:53.221528
NCT01377259|ClinicalTrials.gov processed this data on October 10, 2017|2008-09-14|2011-06-20|||September 2008||2008-09-01|May 2011|2011-05-01|June 2011|Anticipated|2011-06-01|December 2009|Actual|2009-12-01||Observational|||The Changes of Tissue Oxygen Saturation Under Spinal Anesthesia|The Changes of Tissue Oxygen Saturation Under Spinal Anesthesia|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 04:06:53.298562|2017-10-11 04:06:53.298562
NCT01377246|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2017-07-06|||May 2011||2011-05-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ALADIN 2||Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency|A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED CLINICAL TRIAL TO ASSESS THE EFFECTS OF LONG-ACTING SOMATOSTATIN (OCTREOTIDE LAR) THERAPY ON DISEASE PROGRESSION IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND MODERATE TO SEVERE RENAL INSUFFICIENCY|Active, not recruiting||Phase 3|98|Anticipated|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-11 04:06:53.393183|2017-10-11 04:06:53.393183
NCT01377233|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-20|2016-02-22|2016-01-15|2014-05-14|July 2011||2011-07-01|February 2016|2016-02-01||||February 2012|Actual|2012-02-01||Interventional||Baseline characteristics for the 4 patients enrolled in the open-label period but not randomized to the double blinded period, are reported in the first (open-label) study arm. Baseline characteristics for the 42 patients who were subsequently randomized to the double-blind period are reported across the last four (randomized) study arms.|Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia|A Randomised, Double-blind, Parallel-group, Explorative Study of the Safety, Tolerability, and Pharmacokinetics of Daily Dosing Compared to Weekly Dosing of Zicronapine in Patients With Schizophrenia|Completed||Phase 2|46|Actual|H. Lundbeck A/S||5|||f||||t||||||||||2017-10-11 04:06:53.528886|2017-10-11 04:06:53.528886
NCT01377220|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-06-20|||June 2011||2011-06-01|January 2011|2011-01-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|CHOLPET||Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma|Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Commissariat A L'energie Atomique||1|||f||||f||||||||||2017-10-11 04:06:54.681216|2017-10-11 04:06:54.681216
NCT01377207|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-25|2013-04-18|||January 2011||2011-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|OCTAVIA||Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial|Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial|Completed||Phase 4|140|Actual|Italian Society of Invasive Cardiology||2|||f||||t||||||||||2017-10-11 04:06:54.849831|2017-10-11 04:06:54.849831
NCT01377194|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2013-08-22|2013-08-22|2012-04-27|June 2011||2011-06-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||The Baseline Participant population is based on the 562 randomized patients who went on to receive double-blind treatment (Safety Population).|Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder|A Double-blind, Placebo-Controlled, Fixed-Dose Study of Levomilnacipran SR in Patients With Major Depressive Disorder|Completed||Phase 3|568|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 04:06:55.072366|2017-10-11 04:06:55.072366
NCT01377181|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-02|2011-06-21|||January 2000||2000-01-01|January 2000|2000-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Laparoscopic Hernia Repair With Lateral Umbilicus Ligament for Children|Phase 3 Study of Laparoscopic Hernia Repair With Lateral Umbilicus Ligament for Children|Completed||N/A|575|Actual|The Second People's Hospital of GuangDong Province|||2||f||||t||||||||||2017-10-11 04:06:56.045716|2017-10-11 04:06:56.045716
NCT01377168|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-06-14|||May 2014||2014-05-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2016|Actual|2016-06-01||Interventional|||Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder|Oral Naltrexone for Improved Medication Compliance Among HIV-infected Men With Alcohol Use Disorder|Completed||Phase 4|159|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 04:06:56.141438|2017-10-11 04:06:56.141438
NCT01377155|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2013-08-23|||June 2011||2011-06-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Comparison of Two Initial Dosing Formulas|A Comparison of Two Initial Dosing Formulas for Basal Insulin in Type 2 Diabetes Mellitus|Completed||N/A|20|Actual|Diabetes Care Center||1|||f||||f||||||||||2017-10-11 04:06:56.223687|2017-10-11 04:06:56.223687
NCT01377142|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2016-06-13|||June 2011||2011-06-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|VAULT||Vaginal Uphold Hysteropexy and Laparoscopic Sacral Hysteropexy for the Treatment of Uterovaginal Pelvic Organ Prolapse|Vaginal Uphold Hysteropexy and Laparoscopic Sacral Hysteropexy for the Treatment of Uterovaginal Pelvic Organ Prolapse|Completed||N/A|148|Actual|The Cleveland Clinic|||2||f||||t||||||||No||2017-10-11 04:06:56.320265|2017-10-11 04:06:56.320265
NCT01377129|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2015-03-24|||October 2011||2011-10-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|LCA IRM||Anterior Cruciate Ligament Reconstruction: Residual Rotational Laxity for Single Versus Double Bundle Techniques|Reconstruction of the Anterior Cruciate Ligament: a Comparative MRI Study Evaluating Residual Rotational Laxity for Single Versus Double Bundle Surgical Techniques|Terminated||N/A|46|Actual|Centre Hospitalier Universitaire de Nīmes||2||Patient enrolment proved to be more difficult than foreseen and was stopped at 46 inclusions.|f||||f||||||||||2017-10-11 04:06:56.438408|2017-10-11 04:06:56.438408
NCT01377103|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-07-14|||July 2011||2011-07-01|April 2011|2011-04-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Testosterone Therapy in Heart Failure|Cardiovascular and Functional Effects of Testosterone Therapy for Hypogonadal Patients With Heart Failure|Withdrawn||N/A|0|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 04:06:56.512599|2017-10-11 04:06:56.512599
NCT01377090|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2013-07-11|||January 2011||2011-01-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Observational|CAP||Digital Ulceration|A Multicenter, Prospective Cohort Study Using Nailfold VideoCAPillaroscopy(NVC) and Other Factors to Determine the Risk of Developing Digital Ulceration in Patients With Systemic Sclerosis (SSc)|Completed||N/A|630|Actual|Actelion|||2||f||||f||||||||||2017-10-11 04:06:56.596884|2017-10-11 04:06:56.596884
NCT01377077|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-20|||June 2011||2011-06-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|MiniSNIP||Punchgrafting Techniques for Vitiligo|Autologous Punch Grafting in Vitiligo Patients: the Effect of Punchdepth and Punchsize|Unknown status|Recruiting|Phase 4|35|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||4|||f||||f||||||||||2017-10-11 04:06:56.781152|2017-10-11 04:06:56.781152
NCT01377064|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-12-10|||March 2011||2011-03-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk|Home-based Exercise for Management of HIV-associated Cardiovascular Disease|Completed||Phase 1|60|Actual|University of South Carolina||2|||f||||t||||||||||2017-10-11 04:06:56.881535|2017-10-11 04:06:56.881535
NCT01377051|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2014-10-28|||May 2011||2011-05-01|October 2014|2014-10-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea|Acute Effect of Indacaterol Maleate on Static and Dynamic Lung Volume in COPD Subjects.|Completed||Phase 4|60|Actual|University of Milan||2|||f||||t||||||||||2017-10-11 04:06:56.961299|2017-10-11 04:06:56.961299
NCT01377038|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2016-10-24|||September 2011||2011-09-01|October 2016|2016-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|OASIS||OASIS: Osteoarthritis Sensitivity Integration Study|Central Pain Mechanisms in Osteoarthritis: A Longitudinal Cohort|Withdrawn||N/A|0|Actual|University of Michigan||2||Funding|f||||t||||||||||2017-10-11 04:06:57.055945|2017-10-11 04:06:57.055945
NCT01377025|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-12-02|||June 2011||2011-06-01|December 2014|2014-12-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|STREAM||A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma|A Randomized Discontinuation, Blinded, Placebo-Controlled Phase II Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|University Hospital, Essen||3|||f||||f||||||||||2017-10-11 04:06:57.136177|2017-10-11 04:06:57.136177
NCT01377012|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-02-09|2016-05-24||August 30, 2011|Actual|2011-08-30|February 2017|2017-02-01|September 9, 2015|Actual|2015-09-09|September 9, 2015|Actual|2015-09-09||Interventional|REASSURE||Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents|A Randomized, Double-blind, Placebo-controlled Study of Secukinumab to Demonstrate the Efficacy at 24 Weeks and to Assess the Safety, Tolerability and Long Term Efficacy up to 2 Years in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNFα Agents (CAIN457F2302) and a Three Year Extension Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Rheumatoid Arthritis (CAIN457F2302E1)|Completed||Phase 3|637|Actual|Novartis||3|||f||||t||||||||||2017-10-11 04:06:57.296192|2017-10-11 04:06:57.296192
NCT01376999|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-09-19|||April 2010||2010-04-01|September 2017|2017-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Step Up Versus Step Down in Controlled Ovarian Stimulation|Step Up Versus Step Down in Controlled Ovarian Stimulation for Intrauterine Insemination. A Controlled Randomised Trial.|Completed||Phase 4|158|Actual|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 04:06:59.211226|2017-10-11 04:06:59.211226
NCT01376986|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-06-26|||September 2013||2013-09-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|MOPO||Activation of Young Men - Population-Based Randomised Controlled Trial|Activation of Young Men - Population-Based Randomised Controlled Trial|Completed||N/A|507|Actual|University of Oulu||2|||f||||t||||||||||2017-10-11 04:06:59.297983|2017-10-11 04:06:59.297983
NCT01376973|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-17|||March 2008||2008-03-01|June 2011|2011-06-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Observational|||Efficiency of Two Occlusal Splints on TMD Treatment of Police Officers|Efficiency of Two Occlusal Splints on TMD Treatment: Randomised Clinical Trial|Completed||N/A|30|Actual|University of Campinas, Brazil|||2||f||||t||||||||||2017-10-11 04:06:59.41513|2017-10-11 04:06:59.41513
NCT01376960|ClinicalTrials.gov processed this data on October 10, 2017|2009-07-29|2016-08-19|||June 2011||2011-06-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|January 2015|Actual|2015-01-01||Interventional|||Ankle Block Versus Popliteal Fossa Block as Primary Anesthesia for Forefoot Surgical Procedures|Ankle Block Versus Popliteal Fossa Block as Primary Anesthesia for Forefoot Surgical Procedures: A Prospective Comparison|Completed||Phase 4|202|Actual|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-11 04:06:59.507526|2017-10-11 04:06:59.507526
NCT01376947|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-24|2011-06-17|||November 2010||2010-11-01|June 2011|2011-06-01|October 2011|Anticipated|2011-10-01|June 2011|Anticipated|2011-06-01||Observational|||Comparison of the Difficulty on Insertion of IUD Devices Between Nulliparous and Multiparous Women|Comparison of the Difficulty on Insertion of IUD Devices Between Nulliparous and Multiparous and Evaluation of Cause of Failure of Insertion|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Campinas, Brazil|||3||f||||f||||||||||2017-10-11 04:06:59.593916|2017-10-11 04:06:59.593916
NCT01376934|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-17|||March 2011||2011-03-01|June 2011|2011-06-01||||March 2011|Actual|2011-03-01||Interventional|||Clinical Trial of Hysteroscopy in Postmenopausal Women to Compare Techniques|Phase 1 Study of Two Techniques in Hysteroscopy That Compare Carbon Dioxide Versus Saline Solution|Unknown status|Recruiting|N/A|140|Anticipated|University of Campinas, Brazil||1|||f||||f||||||||||2017-10-11 04:06:59.682224|2017-10-11 04:06:59.682224
NCT01376921|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2016-04-22|||September 2012||2012-09-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|ECOS ESP||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain|Easypod Connect: A National, Multicentre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Spain|Completed||N/A|300|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 04:06:59.77993|2017-10-11 04:06:59.77993
NCT01376375|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-06-30|||June 10, 2011||2011-06-10|April 26, 2013|2013-04-26|April 26, 2013|Actual|2013-04-26|April 26, 2013|Actual|2013-04-26||Interventional|||Acupuncture to Reduce Signs of Inflammation in Participants With Chronic Low Back Pain|A Pilot Study to Evaluate the Effect of Acupuncture on Epigenetic Regulation of Inflammatory Mediators in Participants With Chronic Low Back Pain|Completed||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:07:09.527841|2017-10-11 04:07:09.527841
NCT01376908|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-08-17|2015-07-31||June 2011||2011-06-01|August 2017|2017-08-01|February 17, 2017|Actual|2017-02-17|July 2014|Actual|2014-07-01||Interventional|SPARK|Intention-to-treat (ITT) population consisted of all the randomized subjects at the start of the study and were analyzed according to the group allocated.|Kuvan® in Phenylketonuria Patients Less Than 4 Years Old|A Phase IIIb, Multicentre, Open-Label, Randomized, Controlled Study of the Efficacy, Safety, and Population Pharmacokinetics of Sapropterin Dihydrochloride (Kuvan®) in Phenylketonuria (PKU) Patients <4 Years Old.|Completed||Phase 3|56|Actual|BioMarin Pharmaceutical||2|||f||||f||||||||||2017-10-11 04:06:59.899456|2017-10-11 04:06:59.899456
NCT01376895|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-03-07|||July 2011||2011-07-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Power||Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W)|Developing and Testing of an HIV Prevention Intervention Targeting Black Men Who Have Sex With Men and Women (BMSM/W)|Completed||Phase 1/Phase 2|211|Actual|Nova Southeastern University||2|||f||||f||||||||||2017-10-11 04:07:01.045418|2017-10-11 04:07:01.045418
NCT01376882|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-03-28|||March 2011||2011-03-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Cognitive and Cerebral Blood Flow Effects of 2-week Caffeine Abstinence or Maintenance|Behavioural and Cerebral Haemodynamic Effects of Caffeine Withdrawal and Caffeine Administration Following 2-week Maintenance or Abstinence|Completed||N/A|110|Actual|Northumbria University||4|||f||||f||||||||||2017-10-11 04:07:01.146069|2017-10-11 04:07:01.146069
NCT01376869|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-06-22|||June 2011||2011-06-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Investigation of the Acute Cognitive, Mood and Autonomic Effects of Hops in Healthy Participants|Investigation of the Acute Cognitive, Mood and Autonomic Effects of Hops in Healthy Participants|Completed||N/A|150|Anticipated|Northumbria University||5|||f||||f||||||||||2017-10-11 04:07:01.2481|2017-10-11 04:07:01.2481
NCT01376856|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-06-01|||June 2011||2011-06-01|June 2013|2013-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection|Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection|Terminated||N/A|33|Actual|Yonsei University|||1||f||||f||||||Samples Without DNA|"     whole blood for perfoming Quantiferon-TB Gold in tube assay   "|||2017-10-11 04:07:01.358371|2017-10-11 04:07:01.358371
NCT01376843|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-03-04|||June 2011||2011-06-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers|Conversion Rate of TST and Quantiferon-TB Gold In Tube Assay in Health Care Workers|Completed||N/A|53|Actual|Yonsei University|||1||f||||f||||||Samples Without DNA|"     whole blood for perfoming Quantiferon-TB Gold in tube assay   "|||2017-10-11 04:07:01.421447|2017-10-11 04:07:01.421447
NCT01376830|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2015-08-21|||June 2011||2011-06-01|June 2011|2011-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients|Biomarkers and Clinical Characteristics That Identify the Risk of an Exacerbation Following Viral Upper Respiratory Tract Infections in COPD Patients|Completed||N/A|35|Actual|Imperial College London|||1||f||||f||||||Samples Without DNA|"     Sputum,nasal lavage, serum   "|||2017-10-11 04:07:01.508281|2017-10-11 04:07:01.508281
NCT01376817|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-17|||July 2008||2008-07-01|February 2009|2009-02-01|December 2011|Anticipated|2011-12-01|July 2011|Anticipated|2011-07-01||Interventional|||Comparative Study About the Impact of Two Oil Emulsions Administered Intravenously on Severe Acute Pancreatitis|Comparative Study About the Impact of Two Oil Emulsions, One of Them Formulated With MCT, LCT, Olive Oil and Omega 3 Fatty Acids Versus Another One Formulated With MCT and LCT, Administered Intravenously on Severe Acute Pancreatitis Clinical Evolution|Unknown status|Recruiting|Phase 4|60|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||f||||||||||2017-10-11 04:07:01.610245|2017-10-11 04:07:01.610245
NCT01376804|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-06-15|2014-03-27||July 31, 2011|Actual|2011-07-31|June 2017|2017-06-01|May 31, 2013|Actual|2013-05-31|May 31, 2013|Actual|2013-05-31||Interventional||Baseline measures were based on the Intent-to-treat population that included all enrolled patients who had taken at least one dose of study drug.|A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients|Tolerability of up to 200 Days of Valganciclovir Oral Solution or Tablets in Pediatric Kidney Transplant Recipients|Completed||Phase 4|57|Actual|Hoffmann-La Roche||1|||f|||||t|f||||||||2017-10-11 04:07:01.762227|2017-10-11 04:07:01.762227
NCT01376791|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2013-04-19|||December 2010||2010-12-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Assess the Effect of Treating Periodontal Disease on Cardiovascular Function in Young Adults|Oral Flora, Periodontitis, and Vascular Dysfunction in Young Native Americans.|Completed||N/A|92|Actual|San Diego State University|||1||f||||f||||||Samples With DNA|"     Serum, dental scrapings and saliva   "|||2017-10-11 04:07:02.451216|2017-10-11 04:07:02.451216
NCT01376778|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-07-19|||April 2012||2012-04-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|CMV||A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)|A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)|Recruiting||Phase 3|800|Anticipated|The George Washington University Biostatistics Center||2|||f||||t||||||||||2017-10-11 04:07:02.521988|2017-10-11 04:07:02.521988
NCT01376765|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-02-14||||||April 2012|2012-04-01||||||||Interventional|||Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study|Phase I, Double-Blinded, Placebo-Controlled, Dose- Escalation Study of the Safety and Immunogenicity of Recombinant SARS-CoV deltaTM S Protein Vaccine Formulated With and Without Alhydrogel® in Healthy Adults When Administered by the Intramuscular Route|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 04:07:03.020757|2017-10-11 04:07:03.020757
NCT01376752|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2016-06-16|||April 2011||2011-04-01|June 2016|2016-06-01|December 2020|Anticipated|2020-12-01|April 2020|Anticipated|2020-04-01||Interventional|CHIPOR||Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment|A Phase III Randomized Study of Phase III Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian Cancer|Recruiting||Phase 3|444|Anticipated|UNICANCER||2|||f||||t||||||||||2017-10-11 04:07:03.122548|2017-10-11 04:07:03.122548
NCT01376739|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-06-16|||August 2007||2007-08-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Magnevist Post-marketing Surveillance in Japan|Drug Use Investigation of Magnevist|Completed||N/A|2051|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:07:03.368133|2017-10-11 04:07:03.368133
NCT01376726|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-03-30|||July 2011||2011-07-01|March 2017|2017-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials|A Phase I Open-Label Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Subtype C gp140 Vaccine With MF59 Adjuvant in Healthy, HIV-1 Uninfected Adult Participants Previously Primed or Unprimed With HIV-1 Subtype B Envelope Subunit Vaccines With MF59|Completed||Phase 1|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 04:07:03.461247|2017-10-11 04:07:03.461247
NCT01376713|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-10-04|||June 2011||2011-06-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|||Anti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic Melanoma|CD20-Immunotargeting in Metastatic Melanoma Patients- A Prospective, Open Label, Sequential Pilot Study|Completed||Phase 2|10|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 04:07:03.589548|2017-10-11 04:07:03.589548
NCT01376700|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2015-06-26|2014-09-17||August 2011||2011-08-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|EPIC||Early Prophylaxis Immunologic Challenge (EPIC) Study|A Phase 3b Clinical Study to Assess Whether Regular Administration of ADVATE in the Absence of Immunological Danger Signals Reduces the Incidence Rate of Inhibitors in Previously Untreated Patients With Hemophilia A|Terminated||Phase 3|22|Actual|Baxalta US Inc.|"Early termination lead to:
No statistical tests done on risk factors & inhibitor formation.
FVIII consumption by participant not calculated due to large variation in # of EDs.
FVIII-Specific Antibody Isotypes summary statistics not done."|1||"It became unlikely to achieve the study objective of 50% reduction over published inhibitor   rates. The Data Monitoring Committee supported this decision."|f||||t||||||||||2017-10-11 04:07:03.754051|2017-10-11 04:07:03.754051
NCT01376687|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-11-30|||September 2010||2010-09-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Observational|||Osteopathic Manipulative Medicine and Kinetics||Completed||N/A|41|Actual|Michigan State University|||2||f||||f||||||||||2017-10-11 04:07:04.98148|2017-10-11 04:07:04.98148
NCT01376674|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-08-15|||March 2011||2011-03-01|August 2013|2013-08-01||||||||Observational|||T-cell-immunity During Standard Radiotherapy in Localised Prostate Cancer|Changes of T-cell-immune-status During Curative Radiotherapy in Prostate Cancer|Completed||N/A|22|Actual|University Hospital Tuebingen|||1||f||||f||||||Samples With DNA|"     Peripheral blood mononuclear cells and serum are frozen and stored.   "|||2017-10-11 04:07:05.077822|2017-10-11 04:07:05.077822
NCT01376661|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2012-09-12|||May 2009||2009-05-01|September 2012|2012-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study|Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study|Recruiting||N/A|500|Anticipated|St. Joseph Hospital of Orange|||1||f||||f||||||||||2017-10-11 04:07:05.159423|2017-10-11 04:07:05.159423
NCT01376648|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-17|||December 2009||2009-12-01|November 2009|2009-11-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Observational|||Thyroid Hormones Effect on Brown Adipose Tissue|Study on the Relationship Between the Thyroid Hormones and the Activity of Brown Adipose Tissue in Human|Unknown status|Recruiting|N/A|20|Anticipated|Huashan Hospital|||1||f||||t||||||Samples Without DNA|"     TSH, TT3, TT4, fT3, fT4,     γT3,Norepinephrine,Blood-fat,FPG,Insulin,Leptin,Aadiponectin,Retinol-binding protein 4,Fatty     acid binding protein 4,IL-6,TNF-α,CRP,Monocyte chemotactic protein 1   "|||2017-10-11 04:07:05.292263|2017-10-11 04:07:05.292263
NCT01376635|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2011-06-17|||May 2008||2008-05-01|May 2008|2008-05-01|May 2009|Actual|2009-05-01|||||Observational|HRV||Depressed Cardiac Autonomic Modulation in Patients With Chronic Kidney Disease Diagnosed by Spectral Analysis|Depressed Cardiac Autonomic Modulation in Patients With Chronic Kidney Disease Diagnosed by Spectral Analysis of Heart Rate Variability Upon Postural Stress|Completed||N/A|46|Actual|Core Educational Research and Treatment in Nephrology|||1||f||||t||||||||||2017-10-11 04:07:05.395713|2017-10-11 04:07:05.395713
NCT01376622|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-06-17|||November 2008||2008-11-01|July 2010|2010-07-01||||||||Observational|||Changes in Pituitary Iron and Volume With Deferasirox|Changes in Pituitary Iron and Volume With Deferasirox in Transfusional Iron Overload|Completed||N/A|130|Actual|Children's Hospital Los Angeles|||2||f||||f||||||||||2017-10-11 04:07:05.454606|2017-10-11 04:07:05.454606
NCT01376609|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2011-07-29|||August 2011||2011-08-01|June 2011|2011-06-01|August 2013|Anticipated|2013-08-01|March 2012|Anticipated|2012-03-01||Observational|COIG||The Correlation Between Outcome and Infarct Growth in Patients With Acute Ischemic Stroke|A MRI-based Study of Ischaemic Penumbra: the Correlation Between Outcome and Infarct Growth in Patients With Acute Ischemic Stroke|Unknown status|Not yet recruiting|N/A|80|Anticipated|Beijing Hospital of Traditional Chinese Medicine|||1||f||||f||||||||||2017-10-11 04:07:05.528916|2017-10-11 04:07:05.528916
NCT01376596|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-04-09|||August 2011||2011-08-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia|Manualized Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia: An Efficacy Pilot Study.|Completed||Phase 1/Phase 2|49|Actual|McGill University||2|||f||||t||||||||||2017-10-11 04:07:05.610187|2017-10-11 04:07:05.610187
NCT01376583|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-11-28|||March 2011||2011-03-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Exercise Controls Tumor Cell Growth Through AMPK Activation|Running From Cancer|Unknown status|Recruiting|N/A|10|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||Samples Without DNA|"     Bloodsamples wherefrom, serum is isolated and kept at -20 degrees celsius   "|||2017-10-11 04:07:05.709024|2017-10-11 04:07:05.709024
NCT01376570|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-07-31|||June 2012||2012-06-01|July 2017|2017-07-01|August 10, 2017|Anticipated|2017-08-10|August 10, 2017|Anticipated|2017-08-10||Interventional|Project FIRST||Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment|A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load|Active, not recruiting||N/A|242|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 04:07:05.796888|2017-10-11 04:07:05.796888
NCT01376362|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2012-09-06|2012-08-03||June 2011||2011-06-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|JakStat2||Topical Interferon Gamma for Macular Edema Secondary to Uveitis|The Treatment of Macular Edema Secondary to Uveitis Using Topical Interferon Gamma|Completed||Phase 1/Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:07:09.637983|2017-10-11 04:07:09.637983
NCT01376557|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-10-29|2014-10-27||June 2011||2011-06-01|October 2014|2014-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of LX4211 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy|Completed||Phase 2|299|Actual|Lexicon Pharmaceuticals||5|||f||||f||||||||||2017-10-11 04:07:05.941543|2017-10-11 04:07:05.941543
NCT01376544|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-06-17|||August 2008||2008-08-01|June 2011|2011-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Trial of Weaning by Synchronized Ventilation|Randomised Trial Comparing Assist Control Ventilation to Pressure Support Ventilation During Weaning|Completed||N/A|36|Actual|King's College London||2|||f||||f||||||||||2017-10-11 04:07:06.954823|2017-10-11 04:07:06.954823
NCT01376531|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2013-04-12|||January 2011||2011-01-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|dARICUCVVH||Influence Continuous Veno-venous Hemodialysis the Autoregulation|Influence of Continuous Veno-venous Hemodialysis on Cerebrovascular Autoregulation in Patients With Acute Renal Failure|Completed||N/A|20|Actual|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-11 04:07:07.029441|2017-10-11 04:07:07.029441
NCT01376518|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-17|||January 2011||2011-01-01|August 2010|2010-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|dARICUPEEP||Influence Positive End-expiratory Pressure on Autoregulation in Patients With Respiratory Insufficiency|Influence of Positive End-expiratory Pressure on the Cerebrovascular Autoregulation in Patients With Respiratory Failure|Completed||N/A|20|Actual|Johannes Gutenberg University Mainz|||1||f||||f||||||||||2017-10-11 04:07:07.110677|2017-10-11 04:07:07.110677
NCT01376505|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-06-15|||June 2011||2011-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Solid Tumors|Phase I Active Immunotherapy Trial With a Combination of Two Chimeric (Trastuzumab-like and Pertuzumab-like)Human Epidermal Growth Factor Receptor 2 (HER-2) B Cell Peptide Vaccine Emulsified in ISA 720 and Nor-MDP Adjuvant in Patients With Advanced Solid Tumors|Recruiting||Phase 1|36|Anticipated|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||Undecided||2017-10-11 04:07:07.185399|2017-10-11 04:07:07.185399
NCT01376492|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-03-07|||November 2010||2010-11-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain|Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain|Completed||Phase 4|709|Actual|Janssen-Cilag, S.A.|||2||f||||||||||||||2017-10-11 04:07:07.450188|2017-10-11 04:07:07.450188
NCT01376479|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-05-05|||August 2011||2011-08-01|May 2015|2015-05-01|April 2012|Actual|2012-04-01|November 2011|Actual|2011-11-01||Interventional|||Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71|Phase I, Double Blind, Randomized, Placebo-controlled, Dose Escalation Study to Assess the Safety and Immunogenicity of a Prophylactic Vaccine Against Enterovirus Infection in Healthy Adults|Completed||Phase 1|36|Actual|Takeda||2|||f||||f||||||||||2017-10-11 04:07:07.523749|2017-10-11 04:07:07.523749
NCT01376466|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2012-11-08|||February 2009||2009-02-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|February 2011|Actual|2011-02-01||Observational|||Impact of CT on Diagnosis of Acute Appendicitis|The Impact Of Computed Tomography On The Diagnoses Of Acute Appendicitis|Completed||N/A|102|Actual|University of Aarhus|||1||f||||t||||||||||2017-10-11 04:07:07.608656|2017-10-11 04:07:07.608656
NCT01376453|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2016-09-09|||June 2011||2011-06-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|November 2014|Actual|2014-11-01||Interventional|||Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer|Phase I Study of Pre-operative Continuous 5-FU, and Sorafenib With External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma|Completed||Phase 1|18|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 04:07:07.679073|2017-10-11 04:07:07.679073
NCT01376440|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-01-23|||June 2011||2011-06-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Acceptability and Effectiveness of Household Water Treatment in Reducing Diarrhea Among Under Five Children|Acceptability and Effectiveness of Household Water Chlorination in Reducing the Prevalence of Diarrhea Among Under Five Children in Eastern Ethiopia|Completed||Phase 1|845|Actual|Haramaya Unversity||2|||f||||t||||||||||2017-10-11 04:07:07.768306|2017-10-11 04:07:07.768306
NCT01376427|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-04-23|||January 2007||2007-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years|PROTOCOL TREATMENT for Acute Lymphoblastic Leukemia Ph '(BCR / ABL) POSITIVE PATIENTS AGED> 55 YEARS|Recruiting||N/A|100|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-11 04:07:07.845675|2017-10-11 04:07:07.845675
NCT01376414|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2016-08-24|||March 2011||2011-03-01|August 2012|2012-08-01|March 2015|Actual|2015-03-01|August 2014|Actual|2014-08-01||Observational|||H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department|Pilot Study to Estimate the Prevalence of Helicobacter Pylori (H. Pylori) Infection in Patients Presenting With Non-specific Upper Abdominal Pain to the Emergency Department (ED.)|Completed||N/A|212|Actual|George Washington University|||1||f||||f||||||||||2017-10-11 04:07:07.916826|2017-10-11 04:07:07.916826
NCT01376401|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2016-05-16|||July 2011||2011-07-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|June 2014|Actual|2014-06-01||Interventional|||Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma||Completed||Phase 2|60|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-11 04:07:08.007319|2017-10-11 04:07:08.007319
NCT01376388|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2016-11-18|2013-12-19||August 2011||2011-08-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|DB2115362||Long-term Safety Study for GSK573719/GW642444 in Japanese|A 52-week, Multi-centre, Open-label Study to Evaluate the Safety and Tolerability of GSK573719 125 mcg Once-daily in Combination With GW642444 25 mcg Once-daily Via Novel Dry Powder Inhaler (nDPI) in Japanese Subjects With Chronic Obstructive Pulmonary Disease.|Completed||Phase 3|131|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:07:08.150258|2017-10-11 04:07:08.150258
NCT01376349|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2017-07-25|2016-12-08||July 2011||2011-07-01|July 2017|2017-07-01||||August 2013|Actual|2013-08-01||Interventional||All patients that were randomized to treatment were included in baseline characteristics.|Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms|Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial|Active, not recruiting||Phase 3|464|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 04:07:10.155225|2017-10-11 04:07:10.155225
NCT01376336|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-17|||August 2011||2011-08-01|June 2011|2011-06-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Trial of Safe Water Storage Among People Living With HIV|Randomized Controlled Trial of Safe Water Storage Among People Living With HIV|Unknown status|Not yet recruiting|N/A|1600|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 04:07:11.700726|2017-10-11 04:07:11.700726
NCT01376310|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-03|2017-09-26|||March 28, 2011|Actual|2011-03-28|September 2017|2017-09-01|November 30, 2017|Anticipated|2017-11-30|November 30, 2017|Anticipated|2017-11-30||Interventional|||GSK1120212 Rollover Study|MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors and Leukemia|Active, not recruiting||Phase 2|250|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-11 04:07:11.960908|2017-10-11 04:07:11.960908
NCT01376297|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-11-06|2014-11-06|2013-01-16|July 2011||2011-07-01|November 2014|2014-11-01||||September 2012|Actual|2012-09-01||Interventional||Safety Population, i.e. patients receiving study drugs (either netupitant/palonosetron combination or aprepitant/palonosetron regimen, both with dexamethasone)|A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting|A Phase III, Multicenter, Randomized, Double-blind, Unbalanced (3:1) Active Control Study to Assess the Safety and Describe the Efficacy of Netupitant and Palonosetron for the Prevention of Chemotherapy-induced Nausea and Vomiting in Repeated Chemotherapy Cycles.|Completed||Phase 3|413|Actual|Helsinn Healthcare SA||2|||f||||t||||||||||2017-10-11 04:07:13.668145|2017-10-11 04:07:13.668145
NCT01376284|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-07-24|||December 2010||2010-12-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|October 2013|Actual|2013-10-01||Observational|||Drug Use Investigation for AVOLVE(BPH)|Drug Use Investigation for AVOLVE(BPH)|Completed||N/A|1000|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:14.558684|2017-10-11 04:07:14.558684
NCT01376271|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-06-30|||January 2010||2010-01-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)|Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)|Completed||N/A|600|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:14.749763|2017-10-11 04:07:14.749763
NCT01376258|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-05-19|||October 2010||2010-10-01|May 2017|2017-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database|Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database|Completed||N/A|28903|Actual|GlaxoSmithKline|||2||f||||f||||||||||2017-10-11 04:07:14.829934|2017-10-11 04:07:14.829934
NCT01376245|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2016-11-20|2013-12-10||April 2011||2011-04-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD|A 24-week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder Delivered Once Daily Via a Dry Powder Inhaler Compared With Placebo in Subjects of Asian Ancestry With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|646|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:07:14.927752|2017-10-11 04:07:14.927752
NCT01376232|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-07|||November 8, 2010|Actual|2010-11-08|June 2017|2017-06-01|December 20, 2010|Actual|2010-12-20|December 20, 2010|Actual|2010-12-20||Interventional|DDI||Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)|Open Label Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)|Completed||Phase 1|23|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:07:15.791331|2017-10-11 04:07:15.791331
NCT01376219|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-08-11|||January 2010||2010-01-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|EU-COAST||European Cost of Asthma Treatment|EU-COAST STUDY: European Cost of Asthma Treatment Economic Impact of Asthma Control|Completed||N/A|2752|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:15.878744|2017-10-11 04:07:15.878744
NCT01376206|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-05-19|||December 2009||2009-12-01|May 2017|2017-05-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Observational|||Drug Use Investigation for ALLERMIST|Drug Use Investigation for ALLERMIST|Completed||N/A|2000|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:15.953751|2017-10-11 04:07:15.953751
NCT01376193|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-05-16|||April 2009||2009-04-01|May 2013|2013-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet|Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet|Completed||N/A|500|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:16.011485|2017-10-11 04:07:16.011485
NCT01376180|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2016-11-08|||December 2008||2008-12-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Drug Use Investigation for LAMICTAL|Drug Use Investigation for LAMICTAL|Completed||N/A|3000|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:16.083383|2017-10-11 04:07:16.083383
NCT01376167|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-04-25|||September 19, 2011|Actual|2011-09-19|April 2017|2017-04-01|November 18, 2016|Actual|2016-11-18|November 18, 2016|Actual|2016-11-18||Interventional|||Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse|A Multi-centre, Double-blind, Randomised, Parallel-group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tafenoquine (SB-252263, WR238605) in Subjects With Plasmodium Vivax Malaria.|Completed||Phase 2|851|Actual|GlaxoSmithKline||9|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:07:16.159447|2017-10-11 04:07:16.159447
NCT01376154|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-05-19|||June 2006||2006-06-01|May 2017|2017-05-01|February 2011|Actual|2011-02-01|December 2009|Actual|2009-12-01||Observational|||Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)|Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)|Completed||N/A|342|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:16.321024|2017-10-11 04:07:16.321024
NCT01376141|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-03|2017-05-19|||September 2001||2001-09-01|May 2017|2017-05-01|November 2005|Actual|2005-11-01|February 2005|Actual|2005-02-01||Observational|||Drug Use Investigation for IMIGRAN Tablet|Drug Use Investigation for IMIGRAN Tablet|Completed||N/A|3571|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:16.394642|2017-10-11 04:07:16.394642
NCT01376128|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-05-19|||March 2008||2008-03-01|May 2017|2017-05-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Observational|||Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)|Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)|Completed||N/A|96|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:16.467434|2017-10-11 04:07:16.467434
NCT01376115|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-30|||January 18, 2008|Actual|2008-01-18|June 2017|2017-06-01|October 18, 2017|Anticipated|2017-10-18|October 18, 2017|Anticipated|2017-10-18||Observational|||Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg|Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg|Recruiting||N/A|300|Anticipated|Novartis|||1||f||||f|t|f||||||||2017-10-11 04:07:16.631644|2017-10-11 04:07:16.631644
NCT01376102|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-06-12|||November 2007||2007-11-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|BONINJPMS||BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)|An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety of BONVIVA(Ibandronate) Injection Administered in Korean Patients According to the Prescribing Information|Completed||N/A|657|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:07:16.792917|2017-10-11 04:07:16.792917
NCT01376089|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-11-05|2013-05-30||May 2011||2011-05-01|November 2013|2013-11-01|February 2012|Actual|2012-02-01|October 2011|Actual|2011-10-01||Interventional|||Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis|A Phase 4 Randomized, Double-blind Study Comparing Patient Comfort and Safety Between Iodixanol 320 mg I/mL and Iopamidol 370 mg I/mL in Patients Undergoing Contrast-Enhanced Computed Tomographic (CECT) Imaging of the Abdomen/Pelvis|Completed||Phase 4|304|Actual|GE Healthcare||2|||f||||t||||||||||2017-10-11 04:07:16.907097|2017-10-11 04:07:16.907097
NCT01376076|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-02-07|||June 2011||2011-06-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia|Evaluation of the Effects of Sequential Multiple-Dose Regimens of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia|Completed||Phase 1|129|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 04:07:17.328298|2017-10-11 04:07:17.328298
NCT01376063|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-17|||March 2010||2010-03-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects|A Phase 1, Single-Center, One-Sequence, Open-Label Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects|Completed||Phase 1|20|Actual|FibroGen||1|||f||||f||||||||||2017-10-11 04:07:17.418967|2017-10-11 04:07:17.418967
NCT01376050|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-11-07|2015-07-10||June 2011||2011-06-01|November 2015|2015-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy Study of the Application of Low Level Laser Light to Treat Venous Stasis Ulcers|A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia ML Scanner (MLS) on Venous Stasis Ulcers|Terminated||N/A|24|Actual|Erchonia Corporation||2||recruitment difficulties|f||||f||||||||||2017-10-11 04:07:17.482599|2017-10-11 04:07:17.482599
NCT01376037|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2014-05-07|2013-04-11||March 2011||2011-03-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy Study of the Effect of Low Level Laser Light Therapy on Reducing Upper Arm Circumference|An Evaluation of the Effectiveness of the Erchonia ML Scanner (MLS) as a Non-invasive Dermatological Aesthetic Treatment for the Reduction of Circumference of the Upper Arms Clinical Study|Completed||N/A|62|Actual|Erchonia Corporation||2|||f||||f||||||||||2017-10-11 04:07:17.912674|2017-10-11 04:07:17.912674
NCT01376024|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-03-11|||March 2007||2007-03-01|March 2015|2015-03-01|August 2025|Anticipated|2025-08-01|August 2025|Anticipated|2025-08-01||Observational|BJAM||Basal Joint Arthritis Prospective|Multicenter Prospective Study on Basal Joint Arthritis of the Thumb|Recruiting||N/A|500|Anticipated|Columbia University|||1||f||||f||||||||||2017-10-11 04:07:18.188029|2017-10-11 04:07:18.188029
NCT01376011|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-01-26|||June 2009||2009-06-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|June 2012|Actual|2012-06-01||Interventional|Quercetin||Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement|Hypoxia-inducible Transcription Factor 1 (HIF-1) in Vascular Aging|Completed||Early Phase 1|106|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 04:07:18.345132|2017-10-11 04:07:18.345132
NCT01375998|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-08-03|||June 9, 2011|Actual|2011-06-09|August 2017|2017-08-01|July 22, 2018|Anticipated|2018-07-22|August 30, 2017|Anticipated|2017-08-30||Observational|||YAZ Post-marketing Surveillance in Japan|Drug Use Investigation of YAZ|Active, not recruiting||N/A|3273|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:07:18.431492|2017-10-11 04:07:18.431492
NCT01375985|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-06-10|||June 2011||2011-06-01|June 2013|2013-06-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Safety Study of Single Administration Intravenous Treatment for Influenza|A Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects|Terminated||Phase 1|8|Actual|Sarepta Therapeutics||2||The study was halted after enrollment of the first cohort because of lack of funding|f||||t||||||||||2017-10-11 04:07:18.53259|2017-10-11 04:07:18.53259
NCT00005536|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1997||1997-07-01|March 2005|2005-03-01|June 2003|Actual|2003-06-01|||||Observational|||Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:12.743074|2017-10-11 04:27:12.743074
NCT01375972|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2011-12-05|||March 2008||2008-03-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma|Randomized Phase II Trial of SP vs. GP in Advanced Biliary Cancer|Completed||Phase 2|92|Actual|Asan Medical Center||2|||f||||f||||||||||2017-10-11 04:07:18.629299|2017-10-11 04:07:18.629299
NCT01375959|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-06-16|||April 2011||2011-04-01|June 2011|2011-06-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|RSV||Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance|The Effect of Resveratrol in Older Adults With Impaired Glucose Tolerance: a Double-Blind Crossover Study|Unknown status|Recruiting|N/A|30|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 04:07:18.71802|2017-10-11 04:07:18.71802
NCT01375933|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-05-10|||May 2011||2011-05-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers|A Phase 3, Multicenter, Double-Blinded, Randomized, Study to Assess Comparability of a Single Phase 3 Lot and a Single Commercial Lot of 3'-Aminomethylnicotine-P. Aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) in Healthy Adult Smokers|Completed||Phase 3|260|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 04:07:18.868508|2017-10-11 04:07:18.868508
NCT01375920|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-17|2014-07-16|||February 2011||2011-02-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|ADD||Antiglucocorticoid Augmentation of antiDepressants in Depression|Antiglucocorticoid Augmentation of antiDepressants in Depression|Completed||Phase 3|190|Actual|Northumberland, Tyne and Wear NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 04:07:18.965|2017-10-11 04:07:18.965
NCT01375907|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-07-01|||August 2009||2009-08-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults|A Phase 1 Study to Evaluate Safety and Reactogenicity of a Vietnamese Rotavirus Vaccine (Rotavin-M1 at 10e6.3FFU/Dose) Among Healthy Adults in Vietnam|Completed||Phase 1|29|Actual|National Institute of Hygiene and Epidemiology, Vietnam||1|||f||||t||||||||||2017-10-11 04:07:19.092424|2017-10-11 04:07:19.092424
NCT01375894|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-12-29|||March 2012||2012-03-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Body Movement Imitation and Perspective Perception Among Psychiatric Patients||Unknown status|Not yet recruiting|N/A|60|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-10-11 04:07:19.181322|2017-10-11 04:07:19.181322
NCT01375881|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-05-03|||June 2009||2009-06-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice|Post Authorization Non-interventional Study in HIV1-Infected Patients Starting or Already in Treatment With Darunavir|Completed||Phase 4|31|Actual|Janssen-Cilag S.p.A.|||1||f||||||||||||||2017-10-11 04:07:19.267379|2017-10-11 04:07:19.267379
NCT01375868|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2016-09-02|||October 2011||2011-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis|Phase IIIb Study of Recombinant Tetravalent HPV Vaccine in Patients With Recurrent Respiratory Papillomatosis|Active, not recruiting||Phase 3|50|Anticipated|Institute of Hematology and Blood Transfusion, Czech Republic||1|||f||||t||||||||||2017-10-11 04:07:19.342002|2017-10-11 04:07:19.342002
NCT01375855|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-28|2011-06-16|||October 2007||2007-10-01|February 2007|2007-02-01||||||||Interventional|LISAII||Late Incomplete Stent Apposition Evaluation II: Comparison Between Polimer-based and No-polimer Stent System. IVUS Based Study|Late Incomplete Stent Apposition Evaluation II: Vascular Effects Evaluation After Polimer and No-polimer Based Coronary Artery Drug Eluting Stent Ilmplantation. An IVUS Based Study|Unknown status|Recruiting|Phase 4|320|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-10-11 04:07:19.42907|2017-10-11 04:07:19.42907
NCT01375842|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-08-01|||June 21, 2011|Actual|2011-06-21|August 2017|2017-08-01|May 7, 2018|Anticipated|2018-05-07|May 7, 2018|Anticipated|2018-05-07||Interventional|||A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Atezolizumab (MPDL3280A) Administered Intravenously as a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies|Active, not recruiting||Phase 1|661|Actual|Genentech, Inc.||9|||f||||||||||||||2017-10-11 04:07:19.655534|2017-10-11 04:07:19.655534
NCT01375829|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-30|||June 27, 2011|Actual|2011-06-27|May 2017|2017-05-01||||June 30, 2017|Anticipated|2017-06-30||Interventional|||Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery|Phase I Study of Ixabepilone and Temsirolimus in Adult Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:07:19.808844|2017-10-11 04:07:19.808844
NCT01375816|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-06-03|||May 2011||2011-05-01|November 2013|2013-11-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|PEPCOL||Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer|A Randomized Phase II Study of PEP02 or Irinotecan in Combination With Leucovorin and 5-Fluorouracil in Second Line Therapy of Metastatic Colorectal Cancer|Terminated||Phase 2|55|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2||efficacy interim analysis as per protocol|f||||t||||||||||2017-10-11 04:07:19.931996|2017-10-11 04:07:19.931996
NCT01375803|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-16|||June 2009||2009-06-01|June 2011|2011-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity|Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes|Completed||N/A|45|Actual|Cargill||3|||f||||f||||||||||2017-10-11 04:07:20.05139|2017-10-11 04:07:20.05139
NCT01375790|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2012-08-28|||November 2010||2010-11-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|GERIAPLAT||Whole-body Vibration Training in Older People|Neuromuscular Training With Whole Body Vibration in Older People: A Randomized Multicentre Clinical Trial With Blinded to Evaluator|Completed||Phase 3|160|Actual|Asociacion Colaboracion Cochrane Iberoamericana||2|||f||||f||||||||||2017-10-11 04:07:20.156903|2017-10-11 04:07:20.156903
NCT01375777|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-09-03|2015-09-03|2013-03-26|July 2011||2011-07-01|September 2015|2015-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|MENDEL|Full analysis set (all randomized participants who received at least 1 dose of investigational product).|Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels|A Randomized, Placebo- and Ezetimibe-controlled, Dose-ranging Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Hypercholesterolemic Subjects With a 10-year Framingham Risk Score of 10% or Less|Completed||Phase 2|411|Actual|Amgen||9|||f||||t||||||||||2017-10-11 04:07:20.293761|2017-10-11 04:07:20.293761
NCT01375764|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-11-19|2015-09-02|2013-03-26|July 2011||2011-07-01|November 2015|2015-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|GAUSS|Full analysis set (all randomized participants who received at least 1 dose of investigational product).|Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects|A Randomized, Multicenter Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor|Completed||Phase 2|160|Actual|Amgen||5|||f||||t||||||||||2017-10-11 04:07:22.169247|2017-10-11 04:07:22.169247
NCT01375751|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2015-08-28|2015-08-28|2013-04-02|August 2011||2011-08-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|RUTHERFORD|Full analysis set (all randomized participants who received at least 1 dose of investigational product).|Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Subject With Heterozygous Familial Hypercholesterolemia|Completed||Phase 2|168|Actual|Amgen||3|||f||||t||||||||||2017-10-11 04:07:23.798277|2017-10-11 04:07:23.798277
NCT01375738|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-09-12|||July 2011||2011-07-01|September 2012|2012-09-01|May 2014|Anticipated|2014-05-01|June 2013|Anticipated|2013-06-01||Interventional|||Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With Diabetes Mellitus|The Effect and Mechanism of Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With DM Who Receive Surgical Treatment|Unknown status|Recruiting|N/A|40|Anticipated|Yonsei University||2|||f||||f||||||||||2017-10-11 04:07:24.570323|2017-10-11 04:07:24.570323
NCT01375712|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-01-26|||June 2011||2011-06-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy Evaluation of Probiotic Product on Bowel Habits in Healthy Subjects|Evaluation of the Impact of a Fermented Milk Containing Lactobacillus Casei Strain Shirota on Stool Consistency, Stool Frequency, Constipation-related Symptoms and Quality of Life in People Who Frequently Have Hard or Lumpy Stools|Completed||N/A|238|Actual|Yakult Honsha Co., LTD||2|||f||||f||||||||||2017-10-11 04:07:24.733868|2017-10-11 04:07:24.733868
NCT01375699|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-05-03|||August 11, 2011||2011-08-11|May 2017|2017-05-01|September 29, 2017|Anticipated|2017-09-29|September 29, 2017|Anticipated|2017-09-29||Interventional|||Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers|Randomized Open-label Phase 1b Study of Doxorubicin-based Chemotherapy Regimens, With and Without Sildenafil, With Exploratory Analysis of Intermediate Cardiac Markers|Active, not recruiting||Phase 1|26|Actual|Virginia Commonwealth University||2|||f||||t|t|f|||t|||||2017-10-11 04:07:24.827951|2017-10-11 04:07:24.827951
NCT01375686|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-12-03|||June 2011||2011-06-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Observational|NSEEDS||Noninvasive Screening for Early Evidence of Diabetes With SCOUT DS|Noninvasive Screening for Early Evidence of Diabetes With SCOUT DS|Completed||N/A|486|Actual|VeraLight, Inc.|||1||f||||f||||||Samples Without DNA|"     Serum will be stored to later analyze lipids and insulin. This will be useful in     understanding metabolic disorders experienced by the patients measured. These measurements     can be used directly, or combined in a manner similar to the McAuley index to understand the     risk of insulin insensitivity.   "|||2017-10-11 04:07:24.924737|2017-10-11 04:07:24.924737
NCT01375673|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-08|2015-04-06|||November 2011||2011-11-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Effects of Exercise Training on Fluid Instability in Heart Failure Patients|Effects of Exercise Training on Fluid Instability in Heart Failure Patients|Completed||N/A|60|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:07:24.987711|2017-10-11 04:07:24.987711
NCT01375660|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-02-17|2014-11-25||May 2011||2011-05-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|October 2013|Actual|2013-10-01||Interventional|DIVA||D Vitamin Intervention in VA|Vitamin D Deficiency and Treatment in Male Veterans at Risk for Diabetes|Completed||N/A|205|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:07:25.106873|2017-10-11 04:07:25.106873
NCT01375647|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-04-13|||May 2011||2011-05-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|PROVIDE||Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh|Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh|Completed||Phase 3|700|Actual|University of Vermont||4|||f||||f||||||||||2017-10-11 04:07:25.679917|2017-10-11 04:07:25.679917
NCT01375621|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-07-18|||May 29, 2011||2011-05-29|July 10, 2017|2017-07-10||||||||Observational|||Livestock Contact and MRSA in Rural Areas|Epidemiology of Rural MRSA : Is Livestock Contact a Risk Factor?|Completed||N/A|3100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:07:25.87801|2017-10-11 04:07:25.87801
NCT01375608|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-01-10|2017-01-10||June 2011||2011-06-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|December 2015|Actual|2015-12-01||Interventional|||Decitabine for High-Risk Sickle Cell Disease|An Extended Phase 2 Study of Decitabine in Subjects With High Risk Sickle Cell Disease|Completed||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:07:25.955282|2017-10-11 04:07:25.955282
NCT01375595|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-30|||May 26, 2011||2011-05-26|October 30, 2015|2015-10-30|October 30, 2015||2015-10-30|||||Observational|||Brain Areas Involved in Sound and Spoken Word Memory|The Role of the Inferior Frontal Gyrus in Long-Term Auditory Memory a rTMS Study|Terminated||N/A|45|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:07:26.210672|2017-10-11 04:07:26.210672
NCT01375582|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-12-13|||June 2011||2011-06-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Objective Evaluation of Ocular Surface Lubricants in Two Environments|Objective Evaluation of Ocular Surface Lubricants|Completed||Early Phase 1|20|Actual|University of Rochester||1|||f||||t||||||||||2017-10-11 04:07:26.287677|2017-10-11 04:07:26.287677
NCT01375569|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-29|2015-03-04||June 22, 2011|Actual|2011-06-22|June 2017|2017-06-01|December 1, 2015|Actual|2015-12-01|February 1, 2014|Actual|2014-02-01||Interventional|||TRC105 for Liver Cancer That Has Not Responded to Sorafenib|A Phase II Study of TRC105 in Patients With Hepatocellular Carcinoma (HCC) Who Have Progressed on Sorafenib|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f|t|f||||||||2017-10-11 04:07:26.390137|2017-10-11 04:07:26.390137
NCT01375556|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-06-30|||May 26, 2011||2011-05-26|January 20, 2016|2016-01-20|January 20, 2016|Actual|2016-01-20|January 20, 2016|Actual|2016-01-20||Interventional|||Genetics of the Acute Response to Alcohol in Social Drinkers|Genetics of the Acute Response to Alcohol in Humans|Terminated||Phase 1|33|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:07:26.803653|2017-10-11 04:07:26.803653
NCT01375543|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-09-12|||June 9, 2011||2011-06-09|September 6, 2017|2017-09-06||||||||Observational|||Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols|Next Generation Sequencing to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols|Enrolling by invitation||N/A|80|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:07:26.864914|2017-10-11 04:07:26.864914
NCT01375530|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2017-10-05|||May 26, 2011||2011-05-26|August 31, 2017|2017-08-31||||||||Observational|||Screening Volunteers for Clinical Trials|VRC 500:Screening of Volunteers for Clinical Trials of Investigational Products and Licensed Products Evaluated for Research Purposes|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:07:26.931127|2017-10-11 04:07:26.931127
NCT01375504|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2012-04-18|||July 2011||2011-07-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Self Regulation With Mindfulness Training on Body Mass Index and Cardiovascular Risk Markers in Obese Adults|Enhancing Self Regulation With Mindfulness Training and Its Effect on Body Mass Index and Cardiovascular Risk Markers in Obese Adults: A Randomized Pilot Clinical Trial|Completed||N/A|36|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 04:07:27.015537|2017-10-11 04:07:27.015537
NCT01375491|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2013-05-17|||October 2009||2009-10-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|DOXY||Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans|Blockade of Receptor Cleavage in Diabetes Mellitus With an MMP Inhibitor|Completed||Phase 4|50|Actual|University of California, San Diego||2|||f||||f||||||||||2017-10-11 04:07:27.097782|2017-10-11 04:07:27.097782
NCT01375478|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2016-11-01|||April 2011||2011-04-01|November 2016|2016-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis|Multicenter REtrospective Study to Evaluate coMpliance to Therapy and Drug survIval of Tocilizumab (TCZ) in patientS With Moderate to Severe actIve rheumatOid Arthritis in routiNe Daily Clinical Practice (REMISSION Study)|Completed||N/A|197|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:07:27.200571|2017-10-11 04:07:27.200571
NCT01375465|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2013-09-20|||February 2011||2011-02-01|September 2013|2013-09-01||||July 2013|Actual|2013-07-01||Interventional|||The 001-DIOR Multicenter Registry|The 001-DIOR Multicenter Registry (A Novel Percutaneous Coronary Intervention With the New Paclitaxel-eluting Balloon DIOR in Ostial Bifurcated Lesions)|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Eurocor GmbH||1|||f||||f||||||||||2017-10-11 04:07:27.404669|2017-10-11 04:07:27.404669
NCT01375452|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-23|||March 2008||2008-03-01|May 2011|2011-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting Conditions|An Open Label, Balanced, Randomized, Two Treatment, Two Sequence, Two Period, Cross-Over, Single-Dose, Comparative Oral Bioavailability Study Of Letrozole 2.5 mg Tablets (Test) of Dr.Reddy's Laboratories Ltd and Femara 2.5 mg Tablets (Reference)of Novartis Pharmaceuticals Corporation, USA In Healthy, Post Menopausal Women Subjects Under Fasting Conditions|Completed||Phase 1|36|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 04:07:27.491647|2017-10-11 04:07:27.491647
NCT01375439|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-23|2015-06-19|||August 2011||2011-08-01|July 2011|2011-07-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous Pregnancy|Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous Pregnancy and Submitted to Active Search of Genital Infection|Completed||N/A|280|Actual|UPECLIN HC FM Botucatu Unesp||1|||f||||f||||||||||2017-10-11 04:07:27.574685|2017-10-11 04:07:27.574685
NCT01375426|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-16|2011-06-16|||September 2003||2003-09-01|June 2011|2011-06-01|June 2004||2004-06-01|||||Interventional|||Efficacy Study for Standard Versus Double Dose of Amoxicillin in WHO Defined Non-severe Pneumonia|Comparison of Standard Versus Double Dose of Amoxicillin in the Treatment of Non-Severe Pneumonia in Children Aged 2-59 Months: A Multi-centre Randomized Double Blind Controlled Trial in Pakistan|Completed||Phase 1/Phase 2|900||ARI Research Cell|||||f||||||||||||||2017-10-11 04:07:27.652978|2017-10-11 04:07:27.652978
NCT01375413|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-10-30|||June 2011||2011-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|Duality-PD||Dual Task Practice in Parkinson's Disease|Motor Learning in Parkinson's Disease: a Randomized Comparison of Integrated Versus Consecutive Dual Task Training|Completed||Phase 3|121|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 04:07:27.724851|2017-10-11 04:07:27.724851
NCT00000263|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||January 1997||1997-01-01|May 2015|2015-05-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||Effects of Combined Alcohol and Nitrous Oxide Intake - 15|Effects of Combined Alcohol and Nitrous Oxide Intake|Completed||N/A|11|Actual|University of Chicago||3|||f||||||||||||||2017-10-11 04:18:28.172193|2017-10-11 04:18:28.172193
NCT01375387|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-19|2011-08-19|||March 2011||2011-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males|A Phase I, Randomized Double-blind, Placebo-controlled, Single-center, Single-dose, Three-way Cross-over Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Lacosamide Tablets in Healthy Male Chinese and Japanese Subjects|Completed||Phase 1|33|Actual|UCB Pharma||8|||f||||f||||||||||2017-10-11 04:07:27.899192|2017-10-11 04:07:27.899192
NCT01375361|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-20|2013-10-09|||April 2009||2009-04-01|October 2013|2013-10-01||||July 2010|Actual|2010-07-01||Interventional|ACHE||Nebulized Albuterol for Congestive Heart Failure Exacerbation||Withdrawn||Phase 2/Phase 3|0|Actual|University of California, San Francisco||2||Low enrollment.|f||||t||||||||||2017-10-11 04:07:28.366193|2017-10-11 04:07:28.366193
NCT01375348|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-02-13|||June 2011||2011-06-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Relationship Between Cognitive Function and Pain|Cognitive Function in Healthy Volunteers Exposed to Acute Pain Before and After Administration of Remifentanil|Completed||Phase 3|23|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 04:07:28.487545|2017-10-11 04:07:28.487545
NCT01375335|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-08-06|||June 2011||2011-06-01|August 2013|2013-08-01||||August 2013|Actual|2013-08-01||Interventional|||The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve Replacement|The Effects of Dobutamine on Postoperative Systolic Deformation and Diastolic Function in Patients With Hypertrophic Cardiomyopathy Operated for Aortic Valve Stenosis|Suspended||Phase 4|10|Anticipated|University of Aarhus||1||Insufficient patient eligible for recruitment|f||||t||||||||||2017-10-11 04:07:28.589046|2017-10-11 04:07:28.589046
NCT01375322|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2011-06-16|||June 2007||2007-06-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria|Efficacy and Safety of Two Fixed-combination Antihypertensive Regimens, Amtrel® and Co-Diovan® in Type 2 Diabetes Hypertension Patients With Microalbuminuria|Completed||Phase 4|226|Actual|TSH Biopharm Corporation Limited||2|||f||||f||||||||||2017-10-11 04:07:28.693525|2017-10-11 04:07:28.693525
NCT01375309|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2012-03-28|||January 2010||2010-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|Bifido(RCT)||Bifidobacterium Supplementation for Very Low Birth Weight Infants|Effect of Bifidobacterium Bifidum Supplementation on Morbidity of Very Low Birth Weight Infants|Completed||N/A|246|Actual|Tokyo Women's Medical University||2|||f||||t||||||||||2017-10-11 04:07:28.808779|2017-10-11 04:07:28.808779
NCT01375296|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2011-06-16|||May 2009||2009-05-01|April 2009|2009-04-01|November 2011|Anticipated|2011-11-01|October 2011|Anticipated|2011-10-01||Interventional|SESIL||China Made Sirolimus Eluting Stent for Intermediate Lesion|China Made Sirolimus Eluting Stent for Treatment of Coronary Intermediate Lesion|Unknown status|Recruiting|Phase 2/Phase 3|600|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||||||||||||2017-10-11 04:07:28.897127|2017-10-11 04:07:28.897127
NCT01375283|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-01-04|||June 2011||2011-06-01|January 2012|2012-01-01||||August 2012|Anticipated|2012-08-01||Observational|||Sensory Mapping Following Video-assisted Thoracic Surgery|Sensory Mapping Following Video-assisted Thoracic Surgery|Unknown status|Recruiting|N/A|48|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-10-11 04:07:28.987534|2017-10-11 04:07:28.987534
NCT01375270|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-12-02|||April 2011||2011-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|||Glucolipotoxicity and Type 2 Diabetes|The Effects of Experimental Elevation of Plasma Glucose and Lipid on Pancreatic Beta-cell Function in Humans|Completed||N/A|30|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-10-11 04:07:29.096247|2017-10-11 04:07:29.096247
NCT01375257|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-07-20|||June 2011||2011-06-01|July 2017|2017-07-01||||July 2017|Anticipated|2017-07-01||Interventional|POET||Partial Oral Treatment of Endocarditis|Partial Oral Treatment of Endocarditis|Recruiting||Phase 4|400|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 04:07:29.199451|2017-10-11 04:07:29.199451
NCT01375244|ClinicalTrials.gov processed this data on October 10, 2017|2008-04-01|2011-06-16|||June 1999||1999-06-01|April 2008|2008-04-01|October 1999|Actual|1999-10-01|October 1999|Actual|1999-10-01||Interventional|||Comparative Bioavailability Study of Lisinopril Tablets, 10 mg|Randomized, Open-label, Two-treatment Crossover, of a 10 mg Single Oral Dose, Study to Compare the Lisinopril Plasma Levels Produced After Administration of the Test Formulation With Those Produced After Administration of a Marketed Reference Product, Zestril(R), Under Fasting Conditions.|Completed||Phase 1|36|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-10-11 04:07:29.343052|2017-10-11 04:07:29.343052
NCT01375231|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2014-06-26|||June 2011||2011-06-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Anatomic Reconstruction of the Patellofemoral Joint|Anatomic Reconstruction of the Patellofemoral Joint: A Solution for Anterior Knee Pain|Completed||Phase 4|52|Anticipated|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-11 04:07:29.447674|2017-10-11 04:07:29.447674
NCT01375218|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-01-16|||June 2011||2011-06-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Efficacy and Satisfaction Comparing Two Braces in the Treatment of Developmental Dysplasia of the Hip (DDH) in Infants|Efficacy and Satisfaction Comparing Two Braces in the Treatment of DDH in Infants: A Randomized Clinical Trial|Completed||Phase 4|30|Actual|OrthoCarolina Research Institute, Inc.||2|||f||||t||||||||||2017-10-11 04:07:29.551796|2017-10-11 04:07:29.551796
NCT01375205|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2011-06-20|||June 2011||2011-06-01|June 2011|2011-06-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants|A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis|Unknown status|Recruiting|N/A|250|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-10-11 04:07:29.63352|2017-10-11 04:07:29.63352
NCT01375179|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-05-11|||December 2010||2010-12-01|May 2015|2015-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients|A Multi-centre, Double-blind, Placebo Controlled, Parallel Group, Proof of Concept Study to Evaluate the Efficacy, Safety and Tolerability of KRP203 in Subjects With Moderately Active Refractory Ulcerative Colitis|Terminated||Phase 2|27|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:07:29.775701|2017-10-11 04:07:29.775701
NCT01375166|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-11|2016-12-01|||March 2013||2013-03-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Coupling of Neural Activity and Retinal Blood Flow in Diabetes||Recruiting||N/A|48|Anticipated|Medical University of Vienna|||2||f||||t||||||||||2017-10-11 04:07:29.928501|2017-10-11 04:07:29.928501
NCT01375153|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-04-04|||November 2010||2010-11-01|April 2017|2017-04-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|BNP/Appetite||Brain Natriuretic Peptide Effects on Appetite Regulating Hormones and Endothelial Derived Peptides|Effects of Brain Natriuretic Peptide on Appetite-regulating Hormones and Endothelial-derived Peptides|Completed||N/A|10|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 04:07:30.022732|2017-10-11 04:07:30.022732
NCT01375140|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2017-06-26|||September 2011|Actual|2011-09-01|June 2017|2017-06-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Ruxolitinib and Lenalidomide for Patients With Myelofibrosis|Evaluation of Ruxolitinib and Lenalidomide Combination as a Therapy for Patients With Myelofibrosis|Active, not recruiting||Phase 2|49|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 04:07:30.18415|2017-10-11 04:07:30.18415
NCT01375127|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2013-09-25|2013-05-17||August 2011||2011-08-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients|An Observational Study To Collect Follow-up Clinical Data From Kidney Transplant Recipients Who Received Tofacitinib (CP-690,550) In Completed Phase 2 Studies|Completed||N/A|83|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 04:07:30.329038|2017-10-11 04:07:30.329038
NCT01375114|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-07-13|||October 2011|Actual|2011-10-01|July 2017|2017-07-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||The Effects of Ginseng on Cancer-Related Fatigue|The Effects of Ginseng on Cancer-Related Fatigue|Active, not recruiting||Phase 2|158|Anticipated|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-10-11 04:07:31.111745|2017-10-11 04:07:31.111745
NCT01375101|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-07-25|||April 2010||2010-04-01|July 2011|2011-07-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus||Unknown status|Recruiting|Phase 1|30|Anticipated|Mashhad University of Medical Sciences||2|||f||||||||||||||2017-10-11 04:07:31.237393|2017-10-11 04:07:31.237393
NCT01375088|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2012-11-21|||October 2010||2010-10-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers|Phase I Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers|Completed||Phase 2|20|Actual|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-10-11 04:07:31.323096|2017-10-11 04:07:31.323096
NCT01375075|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-05-24||2012-05-24|June 2011||2011-06-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study of LY2484595 in Japanese Subjects|A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects|Completed||Phase 2|150|Anticipated|Eli Lilly and Company||6|||f||||t||||||||||2017-10-11 04:07:31.42788|2017-10-11 04:07:31.42788
NCT01375062|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-10-16|||May 2009||2009-05-01|March 2014|2014-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Obtaining Undifferentiated Cells From Testis Biopsy|Isolation, Culture and Characterization Stem Cells From Testis Biopsy|Completed||N/A|65|Actual|Igenomix||1|||f||||f||||||||||2017-10-11 04:07:31.539546|2017-10-11 04:07:31.539546
NCT01375049|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2014-07-07|2014-05-29||August 2011||2011-08-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|ALPINE|Safety Analysis Set: participants who received at least 1 dose of study drug|Aztreonam Lysine for Pseudomonas Infection Eradication Study|Open-Label Phase 2 Trial to Evaluate the Safety and Efficacy of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Pediatric Patients With Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Culture Positive for Pseudomonas Aeruginosa (PA)|Completed||Phase 2|105|Actual|Gilead Sciences||1|||f||||t||||||||||2017-10-11 04:07:31.629857|2017-10-11 04:07:31.629857
NCT01375036|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-01-09|||August 2011||2011-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|AIR-CF5||Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients|A Prospective, 5-year Registry Study to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa (PA) Isolates From Patients With Cystic Fibrosis in the United States [AIR-CF5]|Completed||N/A|510|Actual|Gilead Sciences|||1||f||||f||||||Samples Without DNA|"     Pseudomonas aeruginosa isolates from sputum or throat swab specimens   "|||2017-10-11 04:07:32.5965|2017-10-11 04:07:32.5965
NCT01375023|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-06-19|||June 2009||2009-06-01|September 2012|2012-09-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||"Allogenic Haematopoietic Cell Transplantation for Patients With Refractory Triple Negative Breast Cancer"|"Allogenic Haematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients With Refractory Triple Negative Breast Cancer"|Terminated||Phase 2|3|Actual|European Institute of Oncology||1||Very low accrual rate|f||||f||||||||||2017-10-11 04:07:32.760551|2017-10-11 04:07:32.760551
NCT00005537|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1997||1997-07-01|August 2004|2004-08-01|June 2002|Actual|2002-06-01|||||Observational|||Genetics of Airway Responsiveness and Lung Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:12.798375|2017-10-11 04:27:12.798375
NCT01374997|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2011-07-07|||June 2011||2011-06-01|March 2011|2011-03-01||||March 2012|Anticipated|2012-03-01||Interventional|||Detection of Fabry Disease in Chronic Renal Failure Patients in Area Provence - Alpes - Côte d'Azur|Screening Project for a Detection of Fabry Disease in Chronic Renal Failure Patients in Area PACA|Unknown status|Active, not recruiting|N/A|380|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||||||||||||2017-10-11 04:07:33.028245|2017-10-11 04:07:33.028245
NCT01374984|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-08-19|||August 2007||2007-08-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|August 2017|Anticipated|2017-08-01||Observational|||VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection|Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection|Enrolling by invitation||Phase 4|100|Anticipated|Cangene Corporation|||1||f||||f||||||Samples With DNA|"     A plasma sample for the determination of anti-vaccinia antibody level collected 5 days after     VIGIV administration and 5 days after VIGIV re-dosing as well (if applicable). Samples     collected Day 5 ±3 days will still provide valuable information for assessing anti-vaccinia     antibody levels in these subjects post-VIGIV administration. While plasma samples are     preferred, serum samples will also be accepted if available. Failure to obtain a Day 5 sample     does not preclude retrospective enrollment into the VA-005 study to provide observational     data only.   "|Undecided||2017-10-11 04:07:33.124246|2017-10-11 04:07:33.124246
NCT01374971|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-02-26|2014-01-10||September 2011||2011-09-01|February 2014|2014-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||All subjects who meet screening criteria were enrolled until target number of 12 subjects was met.|Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)|Open-Label Pre and Post Treatment Arthroscopic Synovial Biopsy Study for the Assessment of Certolizumab Pegol Immunomodulatory Synovial Effects on Select Biomarkers and Gene Expression|Completed||Phase 3|12|Actual|Arthritis Treatment Center, Maryland|Small sample size|1|||f||||f||||||||||2017-10-11 04:07:33.231231|2017-10-11 04:07:33.231231
NCT01373424|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-08-01|||January 2011||2011-01-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|June 2018|Anticipated|2018-06-01||Observational|DCP||The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias|Natural History and Biospecimen Repository for Dystonia; Comprehensive Rating Tools for Cervical Dystonia; Validity & Reliability of Diagnostic Methods & Measures of Spasmodic Dysphonia|Recruiting||N/A|5000|Anticipated|Emory University|||8||f||||f||||||Samples With DNA|"     Whole blood, DNA, white blood cells, cell lines   "|||2017-10-11 04:07:33.49854|2017-10-11 04:07:33.49854
NCT01373411|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2015-03-24|||September 2011||2011-09-01|March 2013|2013-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|TAP-CABG||Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery|Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery (CABG)|Completed||Phase 4|70|Actual|Cardiology Research UBC||2|||f||||t||||||||||2017-10-11 04:07:33.805223|2017-10-11 04:07:33.805223
NCT01373398|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-03-12|||May 2011||2011-05-01|March 2012|2012-03-01||||February 2012|Actual|2012-02-01||Interventional|||Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)|Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetics of Intravesical Instillation of EO9 in Patients With Non-muscle Invasive Bladder Cancer(NMIBC)|Completed||Phase 1|11|Actual|Handok Pharmaceuticals Co., Ltd.||1|||f||||f||||||||||2017-10-11 04:07:33.901803|2017-10-11 04:07:33.901803
NCT01373385|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-14|2017-01-03|||July 2010||2010-07-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Prospective Pediatric Vesicoureteral Reflux Surgery Database|Prospective Pediatric Vesicoureteral Reflux Surgery Database|Completed||N/A|134|Actual|Connecticut Children's Medical Center|||1||f||||f||||||||No||2017-10-11 04:07:33.974307|2017-10-11 04:07:33.974307
NCT01373372|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2014-09-03|||December 2014||2014-12-01|September 2014|2014-09-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia|CRH Responsiveness in Children With Functional Dyspepsia: A Pilot Study|Unknown status|Not yet recruiting|N/A|24|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-10-11 04:07:34.059303|2017-10-11 04:07:34.059303
NCT01374945|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2013-02-26||||||February 2013|2013-02-01||||||||Interventional|||Clearpath Miniprep Colonoscopy Study||Withdrawn||N/A|0|Actual|EasyGlide||2||Withdrawn for business reasons|f||||f||||||||||2017-10-11 04:07:34.757|2017-10-11 04:07:34.757
NCT01374919|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-03-13|2013-03-18||June 2011||2011-06-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia|Total Dose Infusion of Ferumoxytol (1020mg) in 15 Minutes for Iron Defeciency Anemia|Completed||N/A|60|Actual|Auerbach Hematology Oncology Associates P C||1|||f||||f||||||||||2017-10-11 04:07:34.98081|2017-10-11 04:07:34.98081
NCT01374906|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2017-05-25|||November 4, 2011|Actual|2011-11-04|May 2017|2017-05-01|November 22, 2016|Actual|2016-11-22|November 22, 2016|Actual|2016-11-22||Interventional|||Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease|A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Pasireotide LAR in Patients With Cushing's Disease|Completed||Phase 3|150|Actual|Novartis||2|||f||||t|t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 04:07:35.268206|2017-10-11 04:07:35.268206
NCT01374893|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-15|||September 2011||2011-09-01|May 2011|2011-05-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|AGECAR||Physical Training in Hospitalized Elderly|Effects of an Intrahospital Exercise Program in Functional Capacity of Old Inpatients|Unknown status|Not yet recruiting|N/A|150|Anticipated|Hospital General Universitario Gregorio Marañon||2|||f||||f||||||||||2017-10-11 04:07:35.508461|2017-10-11 04:07:35.508461
NCT01374880|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2013-08-13|||June 2009||2009-06-01|June 2013|2013-06-01|January 2014|Anticipated|2014-01-01|September 2013|Anticipated|2013-09-01||Observational|||Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease|Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease|Unknown status|Recruiting|N/A|3000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||6||f||||t||||||Samples Without DNA|"     Biomarkers assessment in plasma at different times according to the study cohort.   "|||2017-10-11 04:07:35.58465|2017-10-11 04:07:35.58465
NCT01374867|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-01-02|||October 2010||2010-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|CardShock||CardShock Study and Registry|Pathophysiology and Prognostic Factors in Cardiogenic Shock - CardShock Study|Completed||N/A|220|Actual|Helsinki University Central Hospital|||1||f||||f||||||Samples Without DNA|"     plasma, urine   "|||2017-10-11 04:07:35.682381|2017-10-11 04:07:35.682381
NCT01374854|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2012-11-18|||January 2009||2009-01-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|December 2010|Actual|2010-12-01||Interventional|||Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus|Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus: A Randomized Controlled Open-label Study|Unknown status|Active, not recruiting|Phase 1/Phase 2|44|Actual|Fuzhou General Hospital||2|||f||||t||||||||||2017-10-11 04:07:35.76269|2017-10-11 04:07:35.76269
NCT01374841|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2016-08-09|||August 2010||2010-08-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Interventional|||Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors|Nonmyeloablative Hematopoietic Stem Cell Transplantation (SCT) for High-Risk Hematologic Malignancies With Related, HLA-Haploidentical Donors: A Phase II Trial of Immunosuppression With Cyclophosphamide Administered Before and After SCT|Recruiting||Phase 2|20|Anticipated|European Institute of Oncology||1|||f||||f||||||||||2017-10-11 04:07:35.927352|2017-10-11 04:07:35.927352
NCT01374828|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2013-01-09|||January 2012||2012-01-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Ketolorac Versus Saline at Laparoscopic Incision Sites|Prospective Randomized Double-blind Study of Incisional Local Anesthesia in Laparoscopic Surgery (Ketorolac Versus Normal Saline)|Withdrawn||Phase 4|0|Actual|The Cleveland Clinic||1||lack of funding|f||||f||||||||||2017-10-11 04:07:36.032048|2017-10-11 04:07:36.032048
NCT01374815|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2014-03-04|||June 2011||2011-06-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Online Advocate: Health Related Social Problems And Diet Quality Pilot Study|The Online Advocate: Health Related Social Problems And Diet Quality Pilot Study|Completed||N/A|350|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-10-11 04:07:36.118104|2017-10-11 04:07:36.118104
NCT01374802|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-07-03|2015-07-03||June 2011||2011-06-01|July 2015|2015-07-01||||July 2011|Actual|2011-07-01||Interventional||The study was performed as an open-label, multiple-dose, single-group, fixed-sequence study in 14 healthy volunteers.|Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers|Effect of Multiple Dosing With 240 mg QD BI 201335 on the Steady-state Pharmacokinetics of 800 mg QD Darunavir Coadministered With 100 mg QD Ritonavir (DRV/r) in Healthy Male and Female Volunteers (an Open-label, Multiple-dose, Single Group, Single Fixed Sequence Phase I Study)|Completed||Phase 1|14|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 04:07:36.209201|2017-10-11 04:07:36.209201
NCT01374789|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-30|2015-06-02|||July 2010||2010-07-01|June 2015|2015-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|PURO||PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer|PURO - An Open-label, Randomised, Multicentre, Phase II Study to Evaluate the Efficacy of Chemotherapy With Gemcitabine and Cisplatin in Combination With the EGF Receptor Antibody Panitumumab (GemCisP) Versus GemCis in the First-line Therapy of Locally Advanced/Metastatic Urothelial Carcinoma in Patients With Wild-type HRAS|Terminated||Phase 2|2|Actual|WiSP Wissenschaftlicher Service Pharma GmbH||2||The study was terminated due to insufficient recruitment.|f||||t||||||||||2017-10-11 04:07:36.540208|2017-10-11 04:07:36.540208
NCT01374776|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2013-12-12|||February 2013||2013-02-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|September 2014|Anticipated|2014-09-01||Interventional|||Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance In Non Anemic Premenopausal Women With Low Ferritin Levels||Unknown status|Recruiting|Phase 4|24|Anticipated|University of Zurich||1|||f||||||||||||||2017-10-11 04:07:37.103103|2017-10-11 04:07:37.103103
NCT01374763|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2012-02-17|||July 2011||2011-07-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery|A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery|Completed||Phase 4|165|Actual|Tampere University Hospital||2|||f||||f||||||||||2017-10-11 04:07:37.178081|2017-10-11 04:07:37.178081
NCT01374750|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2016-05-30|||May 2010||2010-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|Sirolimus||Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)|A Randomized Phase Ⅱ, Trial With Sirolimus-containing Versus mTOR-inhibitor Free Immunosuppression in Patients Undergoing Living Donor Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria|Completed||Phase 2|45|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 04:07:37.260838|2017-10-11 04:07:37.260838
NCT01374737|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-15|||June 2011||2011-06-01|June 2011|2011-06-01|February 2012|Anticipated|2012-02-01|December 2011|Anticipated|2011-12-01||Interventional|||ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children|ED50 of Dexmedetomidine for Reduction of Emergence Agitation Incidence Undergoing Tonsillectomy or Adenoidectomy in Desflurane Anesthesia Following Sevoflurane Induction in Children|Unknown status|Recruiting|Phase 4|25|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 04:07:37.369473|2017-10-11 04:07:37.369473
NCT01374724|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-10-31|||May 2011||2011-05-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|AFV||Preventing Relapse Following Involuntary Smoking Abstinence|Preventing Relapse Following Involuntary Smoking Abstinence|Active, not recruiting||N/A|23000|Anticipated|University of Tennessee||3|||f||||t||||||||||2017-10-11 04:07:37.47572|2017-10-11 04:07:37.47572
NCT01374711|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-06-26|||May 2011||2011-05-01|June 2013|2013-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||The Effects of Immunostimulation With GM-CSF or IFN-y on Immunoparalysis Following Human Endotoxemia|The Effects of Immunostimulation With GM-CSF or IFN-y on Immunoparalysis Following Human Endotoxemia. A Parallel Randomized Double-blind Placebo-controlled Study|Completed||N/A|18|Actual|Radboud University||3|||f||||t||||||||||2017-10-11 04:07:37.597411|2017-10-11 04:07:37.597411
NCT01374698|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2013-05-13|||January 2011||2011-01-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.|Preprocedural Asprin Reload for Native Coronary Disease Treated by Angioplasty: Reperfusion Indexes Evaluation and Improvement of Clinical Outcome -PANTAREI Study|Completed||Phase 4|100|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-10-11 04:07:37.697585|2017-10-11 04:07:37.697585
NCT01374685|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2017-06-30|||June 7, 2011||2011-06-07|January 7, 2016|2016-01-07|January 7, 2016||2016-01-07|||||Observational|||Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans|Family Communication of Hereditary Cancer Risk Among African Americans|Terminated||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:07:37.777188|2017-10-11 04:07:37.777188
NCT01374672|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2015-05-08|||July 2011||2011-07-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma|Observational - Methylation Status as Predictor of Response to Neoadjuvant Chemotherapy in Osteosarcoma|Completed||N/A|20|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:07:39.630479|2017-10-11 04:07:39.630479
NCT01374659|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-15|2011-06-15|||July 2009||2009-07-01|January 2011|2011-01-01|August 2012|Anticipated|2012-08-01|June 2011|Actual|2011-06-01||Observational|||Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma|Effectiveness of [124I]-PET/CT and [18F]-FDG-PET/CT for Localizing Recurrence in Patients With Differentiated Thyroid Carcinoma Who Have Elevated Serum Thyroglobulin Levels But Are Tumor-negative on Conventional Imaging Studies|Unknown status|Recruiting|N/A|50|Anticipated|Korean Association of Endocrine Surgeons|||1||f||||t||||||||||2017-10-11 04:07:39.734479|2017-10-11 04:07:39.734479
NCT01374646|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-07-01|||November 2010||2010-11-01|January 2011|2011-01-01|January 2012|Anticipated|2012-01-01|August 2011|Anticipated|2011-08-01||Interventional|||Community-based Program to Treat Childhood Obesity|Effects of a Community-based Program to Treat Childhood and Adolescent Obesity|Unknown status|Active, not recruiting|N/A|150|Anticipated|UnitedHealth Group||1|||f||||f||||||||||2017-10-11 04:07:39.819943|2017-10-11 04:07:39.819943
NCT01374633|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-03-26|||December 2011||2011-12-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|SEPIA||Sevoflurane Sedation on Intra Cranial Pressure in Traumatic Brain Injury Patients|Effect on Sevoflurane Sedation on Intra Cranial Pressure in Traumatic Brain Injury Patients|Terminated||Phase 2|10|Actual|Assistance Publique - Hôpitaux de Paris||1||Sponsor decision|f||||t||||||||||2017-10-11 04:07:39.895384|2017-10-11 04:07:39.895384
NCT01374620|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-07-28|||June 2011||2011-06-01|July 2016|2016-07-01|April 2013|Actual|2013-04-01|February 2013|Actual|2013-02-01||Interventional|PAL-ANGI2||Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel|Phase I Study : Dose Escalation of Intravenous Weekly Paclitaxel in Association With Metronomic Administration of Cyclophosphamide|Completed||Phase 1|28|Actual|Centre Oscar Lambret||2|||f||||t||||||||No||2017-10-11 04:07:39.988348|2017-10-11 04:07:39.988348
NCT01374607|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-01-24|||July 2011||2011-07-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Observational|||Comparison Between High-sensitivity Cardiac Troponin T and Standard Tnl Assays in Early Cardiac Ischemia Detection|Assessment of Highly Sensible T Troponin (Hs-TnT) Assay Compared to Standard Troponin Assay in the Early Detection of Cardiac Ischemia in Patients With Acute Coronary Syndrome|Completed||N/A|80|Actual|University of Lausanne Hospitals|||1||f||||f||||||||No||2017-10-11 04:07:40.09225|2017-10-11 04:07:40.09225
NCT01374594|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-01-22|||June 2011||2011-06-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Observational|||Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients||Completed||N/A|30|Actual|University Hospital, Gentofte, Copenhagen|||2||f||||f|||||||"     blood samples   "|||2017-10-11 04:07:40.17182|2017-10-11 04:07:40.17182
NCT01374581|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-10-21|||May 2012||2012-05-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|QuinAct||Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria|A Randomized Clinical Trial to Measure the Impact of Retreatment With an Artemisinin-based Combination on Malaria Incidence and Its Potential Selection of Resistant Strains|Completed||Phase 3|2117|Actual|Universiteit Antwerpen||3|||f||||t||||||||||2017-10-11 04:07:40.232008|2017-10-11 04:07:40.232008
NCT01374568|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2017-06-23|2017-01-18||July 2010||2010-07-01|June 2017|2017-06-01|September 2015|Actual|2015-09-01|July 6, 2012|Actual|2012-07-06||Interventional|DRTC|6 patients were screened. 1 patient did not return for baseline visit. 5 patients were provided study medication.|Changes in Bone Turnover With Increased Incretin Hormone Exposure|Changes in Bone Turnover With Increased Incretin Hormone Exposure (UAB Diabetes Research and Training Center Pilot and Feasibility Study)|Terminated||Phase 4|6|Actual|University of Alabama at Birmingham|Study was closed due to end of funding prior to recruitment of target participants. Small participant number limits data analysis. We were unable to obtain additional funding to complete the study.|2||Study closed by sponsor. Funding ended.|f||||f||||||||||2017-10-11 04:07:40.356245|2017-10-11 04:07:40.356245
NCT01374555|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-02-20|||August 2010||2010-08-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease|Validation of the CardioSond Sonospectrographic Digital Electronic Stethoscope in Diagnosing Coronary Artery Disease Versus CT Angiography|Suspended||N/A|200|Anticipated|SonoMedica, Inc.|||1|Phase II cohort recruitment suspended until analysis of Phase I cohort completed|f||||f||||||||||2017-10-11 04:07:41.915515|2017-10-11 04:07:41.915515
NCT01374542|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2017-02-12|||June 2011||2011-06-01|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications|Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications|Recruiting||N/A|4000|Anticipated|Singapore General Hospital|||1||f||||f||||||||||2017-10-11 04:07:42.011118|2017-10-11 04:07:42.011118
NCT01374503|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2012-04-16|||June 2011||2011-06-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4|A Phase I, Single-centre, Randomised, Single-blinded, Placebo-controlled Single Ascending Dose Study, Followed by an Open-label Extension, Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of ALX-0651, Administered Intravenously to Healthy Male Volunteers|Terminated||Phase 1|52|Actual|Ablynx||2||Proof of principle established with completed SAD part|f||||t||||||||||2017-10-11 04:07:42.319282|2017-10-11 04:07:42.319282
NCT01374490|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2013-05-17|||June 2011||2011-06-01|July 2012|2012-07-01||||October 2012|Actual|2012-10-01||Interventional|||Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea|A Phase 3, Multicenter, Open-Label Evaluation of the Safety and Tolerability of Crofelemer in HIV-Positive Subjects With Diarrhea|Completed||Phase 3|251|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 04:07:42.422423|2017-10-11 04:07:42.422423
NCT01374477|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2015-01-01|||June 2012||2012-06-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Observational|||Hypertensive Disorders of Pregnancy in Adolescence and Primipaternity|Hypertensive Disorders of Pregnancy in Adolescence and the Primipaternity Concept. Cases and Control Trial|Unknown status|Recruiting|N/A|110|Anticipated|Saint Thomas Hospital, Panama|||2||f||||f||||||||||2017-10-11 04:07:42.572495|2017-10-11 04:07:42.572495
NCT01374464|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-15|||August 2012||2012-08-01|June 2011|2011-06-01|March 2013|Anticipated|2013-03-01|February 2013|Anticipated|2013-02-01||Interventional|||Reducing Respiratory Side Effects of Interscalene Brachial Plexus Block|A Double Blind Randomised Control Trial Assessing Effects of Local Anaesthetic Concentration (0.5% vs 0.75%) and Volume (5mls vs 15mls) on the Respiratory Consequences of Ultrasound Guided Interscalene Brachial Plexus Nerve Block|Unknown status|Not yet recruiting|Phase 4|92|Anticipated|Royal Surrey County Hospital||4|||f||||f||||||||||2017-10-11 04:07:42.671532|2017-10-11 04:07:42.671532
NCT01374451|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-10-26|2016-02-16||June 2011||2011-06-01|October 2016|2016-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|COOPERATE-2|Full analysis set (FAS) was defined according to the intention to treat principle. The FAS consisted of all randomized patients. Following the intention to treat principle patients were analyzed according to the treatment (and stratum) they were assigned to at randomization.|Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET|A Randomized, Open-label Phase II Multicenter Study Evaluating the Efficacy of Oral Everolimus Alone or in Combination With Pasireotide LAR i.m. in Advanced Progressive Pancreatic Neuroendocrine Tumors (PNET) - The COOPERATE-2 Study|Terminated||Phase 2|160|Actual|Novartis|A planned primary analysis was completed with data cut of 02-Apr-2014. The study did not meet its primary objective, which was based on progression-free survival as per local radiology assessment and was prematurely terminated.|2||The study was stopped for not meeting the primary endpoint for PFS.|f||||t||||||||||2017-10-11 04:07:42.953909|2017-10-11 04:07:42.953909
NCT01374438|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-11-05|2014-09-25||July 2011||2011-07-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional||All randomized subjects completed the full study and are included in the analysis.|3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease|A 3-month Randomized, Double-Blind, Placebo-Controlled, Feasibility Study to Evaluate the Effects of MSDC-0160 on Brain Glucose Utilization, Cognition, Safety and Tolerability in Older Persons With Mild Alzheimer's Disease|Completed||Phase 2|29|Actual|Metabolic Solutions Development Company||2|||f||||f||||||||||2017-10-11 04:07:44.543083|2017-10-11 04:07:44.543083
NCT01374425|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-06-30|2016-06-30||August 2011||2011-08-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|MAVERICC|Intent-to-Treat (ITT) Population: All randomized participants regardless of receiving any study drug.|Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)|MAVERICC (Marker Evaluation for Avastin Research in CRC): A Randomized Phase II Study of Bevacizumab+mFOLFOX6 Vs. Bevacizumab+FOLFIRI With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Cancer|Completed||Phase 2|376|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 04:07:45.38328|2017-10-11 04:07:45.38328
NCT01374412|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-14|2016-12-06|||July 2010||2010-07-01|December 2016|2016-12-01|July 2022|Anticipated|2022-07-01|July 2018|Anticipated|2018-07-01||Observational|||Investigation of Bone Defects and Microcirculation With Computed Tomography and Magnetic Resonance Imaging|Examination of Bone Defects and Microcirculation Using Volume Computed Tomography and Dynamic Contrast-enhanced Magnetic Resonance Imaging|Recruiting||N/A|60|Anticipated|German Cancer Research Center|||1||f||||f||||||||||2017-10-11 04:07:47.868678|2017-10-11 04:07:47.868678
NCT01374399|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2017-07-13|||February 2011||2011-02-01|July 2017|2017-07-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|PETRA||Physical Exercise Therapy vs Relaxation in Allogeneic Stem Cell Transplantation (PETRA)|Effects of an One-year Physical Exercise Intervention on Prognosis, Side-effects and Complications After Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 3|256|Anticipated|German Cancer Research Center||2|||f||||f||||||||||2017-10-11 04:07:48.17907|2017-10-11 04:07:48.17907
NCT01374386|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-15|||October 2010||2010-10-01|June 2011|2011-06-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Impact of Exergaming on Adolescent Youth|RCMI Clinical Research Infrastructure Initiative: Exergaming|Unknown status|Recruiting|N/A|100|Anticipated|Charles Drew University of Medicine and Science||2|||f||||f||||||||||2017-10-11 04:07:48.287385|2017-10-11 04:07:48.287385
NCT01374373|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2016-04-06|||June 2011||2011-06-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia|A Phase 4 Study in the Treatment of Anemia With Weekly Epoetin Alfa Doses in Patients With Solid Tumors or Lymphoma Receiving Chemotherapy|Completed||Phase 4|30|Actual|Bio Sidus SA||1|||f||||f||||||||||2017-10-11 04:07:48.396814|2017-10-11 04:07:48.396814
NCT01374360|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2017-02-17|||January 2007|Actual|2007-01-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry|Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry|Active, not recruiting||N/A|4700|Actual|Alexion Pharmaceuticals|||2||f||||t||||||||No||2017-10-11 04:07:48.532765|2017-10-11 04:07:48.532765
NCT01374347|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-02-08|||May 2011||2011-05-01|February 2016|2016-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|CIALIS||Brain SPECT Following Cialis (Tadalafil ) Administration|Brain SPECT Perfusion Imaging Following Cialis (Tadalafil ) Administration in Patients With Vascular Risk Factors|Completed||N/A|30|Actual|Wolfson Medical Center|||2||f||||f||||||||||2017-10-11 04:07:48.627122|2017-10-11 04:07:48.627122
NCT01374334|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-07-06|||December 2008||2008-12-01|August 2010|2010-08-01|October 2011|Anticipated|2011-10-01|September 2011|Anticipated|2011-09-01||Observational|||Lower Extremities Muscle Strength and Power Thresholds Required for Mobility Independence|Lower Extremities Muscle Strength and Power Thresholds Required for Mobility Independence in Older Adults|Unknown status|Active, not recruiting|N/A|53|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-10-11 04:07:48.701128|2017-10-11 04:07:48.701128
NCT01374321|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-11-21|||October 2011||2011-10-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction|Phase II, Multicenter, Randomized, Double-blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction|Completed||Phase 2|168|Actual|Trophos||2|||f||||t||||||||||2017-10-11 04:07:48.767105|2017-10-11 04:07:48.767105
NCT01374308|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2012-12-11|||June 2011||2011-06-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|NASVAC||NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) Patients|Phase IIII Study of a Therapeutic Vaccine Candidate Containing Hepatitis B Virus (HBV) Core Antigen (HBcAg) and HBV Surface Antigen (HBsAg) for Treatment of Patients With Chronic HBV Infection|Unknown status|Active, not recruiting|Phase 3|160|Anticipated|Clinical Research Organization, Dhaka, Bangladesh||2|||f||||f||||||||||2017-10-11 04:07:48.935988|2017-10-11 04:07:48.935988
NCT01374295|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-03-21|||March 2011||2011-03-01|June 2011|2011-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge|Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge: A Randomized Control Study|Completed||N/A|120|Actual|Albany Medical College||2|||f||||t||||||||||2017-10-11 04:07:49.0675|2017-10-11 04:07:49.0675
NCT01374282|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2015-10-21||||||October 2015|2015-10-01||||||||Expanded Access|||Post Marketing Surveillance Study of Cuprimine|Post Marketing Surveillance Study of Cuprimine (MK-0172-001)|No longer available||N/A|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:07:49.17844|2017-10-11 04:07:49.17844
NCT01374269|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2014-03-18|2013-09-20||June 2009||2009-06-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|DLSEA||Improvement in Pain,Function and HRQoL ( Health Related Quality of Life) in Subacute Low Back Pain: A Controlled Clinical Trial of Exercise vs NSAIDs (Nonsteroidal Antiinflammatory)|Improvement in Pain, Function and Quality of Life With a Protocolized Exercise Program Compared With Non-steroidal Anti-inflammatory Analgesics in Patients With Subacute Low Back Pain in Medellín, Colombia, 2009-2010|Completed||Phase 4|90|Actual|Grupo Rehabilitacion en Salud|The study population was associated with the university’s health service. Female subjects predominated. The 6-month follow-up prevents conclusions about the improvement duration. No subgroup classification was performed. No control group was planned.|2|||f||||t||||||||||2017-10-11 04:07:49.371191|2017-10-11 04:07:49.371191
NCT01374256|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2011-06-14|||July 2011||2011-07-01|June 2011|2011-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia|Effectiveness of Imipenem and Sulbactam in the Treatment of Bacteremic Patients Contracted With Imipenem-resistant Acinetobacter Baumannii|Unknown status|Not yet recruiting|N/A|200|Anticipated|Taipei Veterans General Hospital, Taiwan|||2||f||||f||||||Samples Without DNA|"     Acinetobacter baumannii isolates from the blood samples of patients   "|||2017-10-11 04:07:51.08369|2017-10-11 04:07:51.08369
NCT01374243|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2012-11-05|||April 2011||2011-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 04:07:51.198322|2017-10-11 04:07:51.198322
NCT01374230|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2017-05-02|||September 2011||2011-09-01|May 2017|2017-05-01|September 2021|Anticipated|2021-09-01|September 2021|Anticipated|2021-09-01||Interventional|||Long-Term Multicenter Evaluation of the E1® Tibial Bearing|Long-Term Multicenter Evaluation of the E1® Tibial Bearing|Active, not recruiting||N/A|50|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 04:07:51.260828|2017-10-11 04:07:51.260828
NCT01374217|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2016-10-12|||August 2011||2011-08-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|January 2014|Actual|2014-01-01||Interventional|||Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma|Administration of an Oral PDE5 Inhibitor, Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma|Terminated||Phase 2|14|Actual|Sidney Kimmel Comprehensive Cancer Center||1||early stopping rule|f||||t||||||||||2017-10-11 04:07:51.375715|2017-10-11 04:07:51.375715
NCT01374204|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2015-08-31|||July 2011||2011-07-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|EPISTIGMA||Epilepsy-Associated Stigma|EPILEPSY-ASSOCIATED STIGMA AND ILLNESS EXPERIENCE IN PEOPLE WITH EPILEPSY|Unknown status|Active, not recruiting|N/A|200|Anticipated|University Hospital, Limoges|||1||f||||f||||||||||2017-10-11 04:07:51.48223|2017-10-11 04:07:51.48223
NCT01374191|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2015-08-25|||January 2015||2015-01-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|May 2017|Anticipated|2017-05-01||Interventional|||Botulinum Toxin Type A for Neuroma Pain|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial of Botulinum Toxin Type A for Neuroma Pain|Withdrawn||Phase 2|0|Actual|Southern Illinois University||3|||f||||t||||||||||2017-10-11 04:07:51.558041|2017-10-11 04:07:51.558041
NCT01374178|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2014-10-03|2014-10-03||June 2011||2011-06-01|October 2014|2014-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects|Relative Bioavailability of LY2963016 to LANTUS® After Single Dose Subcutaneous Administration to Healthy Subjects|Completed||Phase 1|16|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 04:07:51.687246|2017-10-11 04:07:51.687246
NCT01374165|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2015-01-05||||||January 2015|2015-01-01||||||||Observational|||Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients|A Phase I Open Label, Unblinded, Single Dose Study for Evaluating the Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients|Suspended||Phase 1|15|Anticipated|Prolong Pharmaceuticals|||2|Study cancelled.|f||||t||||||Samples Without DNA|"     Whole blood and urine   "|||2017-10-11 04:07:52.146917|2017-10-11 04:07:52.146917
NCT00005538|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1987||1987-07-01|August 2004|2004-08-01|June 2000|Actual|2000-06-01|||||Observational|||CHD Risk, Behavioral Stress and Reproductive Hormones||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:12.846395|2017-10-11 04:27:12.846395
NCT01374152|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2012-07-15|||July 2008||2008-07-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Perfetti Method in Upper Extremity of Stroke Patients|A Randomized Controlled Trial of Cognitive Sensory Motor Training Therapy on the Recovery of Upper Extremity Function in Acute Stroke Patients|Completed||Phase 3|40|Actual|Prasat Neurological Institute||2|||f||||f||||||||||2017-10-11 04:07:52.23842|2017-10-11 04:07:52.23842
NCT01374139|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-11-28|||August 2011||2011-08-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects|A Phase 1, Open-Label, Randomized, Single-Dose, 2-Cohort, 2-Way Crossover Bioequivalence Study To Compare The Bosutinib Clinical Tablet And Clinical Capsule And To Investigate Food Effect On Bosutinib Commercial Formulation in Healthy Subjects|Completed||Phase 1|88|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:07:52.503032|2017-10-11 04:07:52.503032
NCT01374126|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2013-08-22|||July 2011||2011-07-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Azithromycin Combination Therapy for the Treatment of Severe Malaria|Azithromycin Combination Therapy for the Treatment of Severe Malaria - A Pilot Safety and Efficacy Study in Uncomplicated Falciparum Malaria in Bangladesh|Completed||Phase 2|75|Actual|Medical University of Vienna||2|||f||||||||||||||2017-10-11 04:07:52.633785|2017-10-11 04:07:52.633785
NCT01374113|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-03-28|||June 2011||2011-06-01|October 2011|2011-10-01||||October 2011|Actual|2011-10-01||Interventional|||Safinamide Renal Impairment Trial|An Open-label, Parallel-group, Single Center, Single Oral Dose Trial to Investigate the Pharmacokinetics (PK) of 50 mg Safinamide in Subjects With Moderate and Severe Renal Impairment Compared to Matched Subjects With Normal Renal Function|Completed||Phase 1|24|Actual|Newron||3|||f||||f||||||||||2017-10-11 04:07:52.744698|2017-10-11 04:07:52.744698
NCT01374100|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2016-09-15|||February 2009||2009-02-01|September 2016|2016-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy|Effect of Qigong Therapy in Patients With Advanced NSCLC and GI Cancer Undergoing Chemotherapy|Terminated||N/A|52|Actual|McGill University||2||Slow accrual, and revised power calculation for primary end-points|f||||t||||||||Yes|Peer-reviewed manuscripts and conference proceedings|2017-10-11 04:07:52.85969|2017-10-11 04:07:52.85969
NCT01374087|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-12-28|2016-12-28||November 2011||2011-11-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ANABRAQ|Safety population: Safety population consisted of all randomised subjects who received at least one dose of study medication. Subjects were allocated to the treatment they actually received.|Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer|Proof-of-concept Multicentre, Prospective, Randomised, Open-label- Parallel-group Clinical Trial to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy Using Triptorelin 22.5 mg 6-month Formulation in Patients With Recurrence of Prostate Cancer Previously Treated With Radiotherapy|Terminated||Phase 2|32|Actual|Ipsen|The study was prematurely stopped due to the slow enrolment of subjects and therefore no efficacy analyses were conducted.|2||Slow enrollment of patients.|f||||f||||||||||2017-10-11 04:07:53.004978|2017-10-11 04:07:53.004978
NCT01374074|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-09-21|||March 2011||2011-03-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Racial Disparity in Barrett's Esophagus|Racial Disparity in Barrett's Esophagus|Completed||N/A|255|Actual|University of North Carolina, Chapel Hill|||4||f||||t||||||Samples With DNA|"     serum, plasma, buffy, esophageal biopsies   "|||2017-10-11 04:07:53.620265|2017-10-11 04:07:53.620265
NCT01374061|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2014-05-07|||June 2011||2011-06-01|May 2014|2014-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|EVE||Pre Hospital Evaluation of Video Laryngoscopy|Pre Hospital Evaluation of Video Laryngoscopy : a Comparative Study of Macintosh and GLIDESCOPE Ranger®|Withdrawn||Phase 4|0|Actual|Assistance Publique - Hôpitaux de Paris||2||Sponsor decision|f||||f||||||||||2017-10-11 04:07:53.711597|2017-10-11 04:07:53.711597
NCT01374048|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-06-13||||||June 2011|2011-06-01||||||||Observational|||Intracranial Pressure Waves Via Lumbar Puncture|Are Intracranial Pressure Waves Measurable Through Lumbar Puncture?|Completed||N/A|10|Actual|Umeå University|||1||f||||f||||||||||2017-10-11 04:07:53.816703|2017-10-11 04:07:53.816703
NCT01374035|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2015-03-17|||August 2010||2010-08-01|April 2011|2011-04-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Western Norway Mental Health Interface Study on Referral Letters|Interface Between Primary Care and Specialist Mental Health Care - the Referral Letters|Active, not recruiting||N/A|100|Anticipated|Helse Fonna||2|||f||||f||||||||||2017-10-11 04:07:53.902759|2017-10-11 04:07:53.902759
NCT01374022|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-05-08|||June 2011|Actual|2011-06-01|May 2017|2017-05-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|ART||ART - Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial|Randomized Controlled Trial of Maximum Alveolar Recruitment Maneuver Plus Titrated PEEP Versus ARDSNet Strategy for ARDS|Active, not recruiting||N/A|1013|Actual|Hospital do Coracao||2|||f||||t||||||||||2017-10-11 04:07:54.038914|2017-10-11 04:07:54.038914
NCT01374009|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2017-01-17|||April 2010||2010-04-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|July 2010|Actual|2010-07-01||Observational|||H1N1 Vaccine in Pregnancy: a Registry for the Fall and Winter of 2009|H1N1 Vaccine in Pregnancy: a Registry for the Fall and Winter of 2009|Terminated||N/A|504|Actual|Dalhousie University|||1|Participants were consented but registry was not developed due to low numbers|f||||f||||||||||2017-10-11 04:07:54.212357|2017-10-11 04:07:54.212357
NCT01373996|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-14|||June 2011||2011-06-01|April 2011|2011-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Clinical Investigation of Wireless Transmission of Invasive Blood Pressure Signal|Feasibility and Accuracy of Wireless Transmission of Invasive Blood Pressure Signal From Patient to Patient's Bedside Monitor|Completed||N/A|12|Actual|University Medical Centre Ljubljana|||2||f||||t||||||||||2017-10-11 04:07:54.317933|2017-10-11 04:07:54.317933
NCT01373983|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2014-12-28|||August 2011||2011-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|ZicBol||Intrathecal Bolus Doses of Ziconotide|Evaluation of a Structured Algorithm for Intrathecal Bolus Doses of Ziconotide (Prialt®)- The Swedish Ziconotide Bolus Study|Completed||Phase 4|26|Actual|University Hospital, Linkoeping||1|||f||||t||||||||||2017-10-11 04:07:54.426826|2017-10-11 04:07:54.426826
NCT01372033|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-10|||June 2007||2007-06-01|June 2009|2009-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Man Tx||Effects of Manualized Treatment in a Seamless System|Effects of Manualized Treatment in a Seamless System of Care: Handling Probation|Completed||Phase 3|251|Actual|George Mason University||1|||f||||t||||||||||2017-10-11 04:08:22.439334|2017-10-11 04:08:22.439334
NCT01373970|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-12-05|||May 2011||2011-05-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|CLARIFY||The Clinical Significance of Acid Rebound in Functional Dyspepsia|The Clinical Significance of Acid Rebound: Symptoms of Reflux After PPI Treatment in Patients With Functional Dyspepsia|Terminated||Phase 4|184|Actual|University Hospital Koge||2|||f||||t||||||||||2017-10-11 04:07:54.531284|2017-10-11 04:07:54.531284
NCT01373957|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2014-07-10|||July 2011||2011-07-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|EPICOR-RUS||Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Russia|Long-tErm Follow-uP of Antithrombotic Management Patterns In Acute CORonary Syndrome Patients in RUSsia|Completed||N/A|600|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:07:54.63296|2017-10-11 04:07:54.63296
NCT01373944|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-12-20|||May 2010||2010-05-01|December 2013|2013-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI|Rapid-Acquisition Low-Dosimetry Tc-99m Stress-Only Myocardial Perfusion SPECT on the Spectrum Dynamics System: Comparison of Efficiency and Outcomes With Stress-Only Anger SPECT|Completed||N/A|500|Actual|Aspire Foundation|||2||f||||f||||||||||2017-10-11 04:07:54.764815|2017-10-11 04:07:54.764815
NCT01373931|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2012-01-24|||June 2011||2011-06-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of LY2216684 in Healthy Females|Effect of LY2216684 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects|Completed||Phase 1|20|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 04:07:54.870844|2017-10-11 04:07:54.870844
NCT01373918|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-05-10|2016-02-22||December 2010||2010-12-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders|Low Dose Parenteral Fat for the Prevention of Parenteral Nutrition Associated Cholestasis in Neonates With Congenital/Acquired Gastrointestinal Disorders|Terminated||Phase 4|41|Actual|University of California, Los Angeles|Early termination leading to small number of subjects analyzed.|2||The study was terminated due to slow enrollment.|f||||t||||||||No||2017-10-11 04:07:54.991358|2017-10-11 04:07:54.991358
NCT01373905|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-06-14|||January 2007||2007-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Stepwise Positive End Expiratory Pressure Elevation For Lung Recruitment in Acute Respiratory Distress Syndrome (ARDS)|Stepwise PEEP Elevation With Determination of the Alveolar Collapsing Pressure Versus Sustained Lung Inflation as a Recruitment Maneuver in Patients With ARDS|Completed||N/A|24|Actual|Faculty of Medicine, University of Alexandria||2|||f||||f||||||||||2017-10-11 04:07:55.44826|2017-10-11 04:07:55.44826
NCT01373892|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-03-05|||January 2011||2011-01-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|December 2013|Actual|2013-12-01||Interventional|Sleevepet2||Prospective, Randomised Study: Metabolic and Functional Effects of Bariatric Surgery Accessed Using PET and MRI.|Prospective, Randomised Study: Metabolic and Functional Effects of Bariatric Surgery Accessed Using PET and MRI|Completed||N/A|50|Actual|Turku University Hospital||2|||f||||f||||||||No||2017-10-11 04:07:55.545672|2017-10-11 04:07:55.545672
NCT01373879|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2013-03-13|||June 2010||2010-06-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area|Safety and Immunogenicity of Heterologous Prime-boost With the Candidate Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP in Healthy Adults and Children in a Malaria Endemic Area|Completed||Phase 1|52|Actual|University of Oxford||8|||f||||t||||||||||2017-10-11 04:07:55.642944|2017-10-11 04:07:55.642944
NCT01373866|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-05-17|||November 15, 2010|Actual|2010-11-15|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|MULTIMODHAL||Multimodal MRI-guided rTMS to Treat Refractory Hallucinations|Multimodal MRI-guided Repetitive Transcranial Magnetic Stimulation to Treat Drug-resistant Hallucinations: a Randomized Control Trial|Recruiting||N/A|70|Anticipated|University Hospital, Lille||2|||f||||t|f|f||||||No||2017-10-11 04:07:55.769233|2017-10-11 04:07:55.769233
NCT01373853|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-05-19|||April 2011||2011-04-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|1103||A Single Centre Study to Compare the Efficacy and Safety of Femtosecond Laser-Assisted Versus Manual Cataract Surgery|A Single Centre Study to Compare the Efficacy and Safety of Femtosecond Laser-Assisted Versus Manual Cataract Surgery|Completed||Phase 3|131|Actual|Technolas Perfect Vision GmbH||2|||f||||t||||||||||2017-10-11 04:07:55.870278|2017-10-11 04:07:55.870278
NCT01373840|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-08-02|||September 2011||2011-09-01|August 2011|2011-08-01||||April 2016|Anticipated|2016-04-01||Observational|||Role of Dopamine Receptors in Primary Focal Dystonias|Role of Dopamine Receptors in Primary Focal Dystonias|Unknown status|Not yet recruiting|N/A|40|Anticipated|Washington University School of Medicine|||2||f||||f||||||||||2017-10-11 04:07:55.992987|2017-10-11 04:07:55.992987
NCT01373827|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2012-03-23|||June 2011||2011-06-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Protocol To Evaluate Patient Measurements After Ultrasonic Treatment|Protocol To Evaluate Patient Measurements After Ultrasonic Treatment.|Completed||N/A|7|Actual|Sound Surgical Technologies, LLC.|||1||f||||f||||||||||2017-10-11 04:07:56.085948|2017-10-11 04:07:56.085948
NCT01373814|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-03-29|||September 2010||2010-09-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Nutritional Therapy for Diabetic Cardiomyopathy|Nutritional Therapy for Diabetic Cardiomyopathy|Enrolling by invitation||N/A|20|Anticipated|Washington University School of Medicine|||1||f||||t||||||Samples With DNA|"     blood samples   "|||2017-10-11 04:07:56.166907|2017-10-11 04:07:56.166907
NCT01373801|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-08-09|||July 2011||2011-07-01|April 2011|2011-04-01||||July 2012|Anticipated|2012-07-01||Interventional|||Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations|THE EFFICACY AND SAFETY OF HEMCON© BANDAGE FOLLOWING SURGICAL REPAIR IN MANAGEMENT OF POSTPARTUM BLEEDING DUE TO THE MULTIPLE VAGINAL LACERATIONS|Unknown status|Recruiting|N/A|85|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-10-11 04:07:56.238578|2017-10-11 04:07:56.238578
NCT01373775|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-14|||April 2009||2009-04-01|June 2011|2011-06-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Observational|||Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department Siriraj Hospital|Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department in Siriraj Hospital: The One Year Period.|Completed||N/A|533|Actual|Mahidol University|||2||f||||f||||||||||2017-10-11 04:07:56.36626|2017-10-11 04:07:56.36626
NCT01373762|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2014-12-11|||January 2011||2011-01-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|FitGAME||The Fitness, Game Bike Adherence, Motivation and Exercise Study|Interactive Videogame Bikes and Their Effect on Exercise Adherence and Health Related Fitness Among Families|Completed||N/A|74|Actual|University of Victoria||2|||f||||t||||||||||2017-10-11 04:07:56.4522|2017-10-11 04:07:56.4522
NCT01373749|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-14|||March 2011||2011-03-01|January 2011|2011-01-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||Nitro Oxide Inhalation Continued With Sildenafil on Neonatal Persistent Pulmonary Hypertension|Compare of Continued Nitro Oxide Inhalation and Nitro Oxide Inhalation Continued With Oral Sildenafil on Treatment of Neonatal Persistent Pulmonary Hypertension|Unknown status|Recruiting|N/A|40|Anticipated|Third Military Medical University||2|||f||||t||||||||||2017-10-11 04:07:56.610206|2017-10-11 04:07:56.610206
NCT01373736|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-06-13||||||June 2011|2011-06-01||||||||Interventional|||123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors||Unknown status|Not yet recruiting|Phase 3|||Vancouver Coastal Health|||||f||||t||||||||||2017-10-11 04:07:56.723895|2017-10-11 04:07:56.723895
NCT01373723|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-14|||September 2010||2010-09-01|June 2011|2011-06-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|CRICERVA||Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer|Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer in the County of Valles Occidental: CRICERVA Clinical Trial.|Unknown status|Recruiting|N/A|20994|Anticipated|Jordi Gol i Gurina Foundation||3|||f||||t||||||||||2017-10-11 04:07:56.805331|2017-10-11 04:07:56.805331
NCT01373710|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-08-25|||May 19, 2011|Actual|2011-05-19|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|September 2017|Anticipated|2017-09-01||Interventional|HIT||Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis|Phase 1-2 Study of Safety and Efficacy of Intrathecal Trastuzumab Administration in Metastatic HER2 Positive Breast Cancer Patients Developing Carcinomatous Meningitis|Active, not recruiting||Phase 1/Phase 2|34|Actual|Institut Curie||1|||f||||t||||||||||2017-10-11 04:07:56.92028|2017-10-11 04:07:56.92028
NCT01373697|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-22|2011-06-14|||June 2011||2011-06-01|June 2011|2011-06-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel|Clinical Multicenter, Phase III, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Ibuprofen 50mg/g Gel in the Treatment of Patients With Muscle Pain, Joint, or Pain Caused by Sprains, Contusions, Tendinitis, or Myofascial Compared to Profenid ® 25mg/g. Gel|Unknown status|Not yet recruiting|Phase 3|144|Anticipated|Laboratório Teuto Brasileiro S/A||2|||f||||t||||||||||2017-10-11 04:07:57.165574|2017-10-11 04:07:57.165574
NCT01373684|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-14|2016-08-09|||March 2012||2012-03-01|August 2016|2016-08-01|October 2018|Anticipated|2018-10-01|June 2018|Anticipated|2018-06-01||Interventional|PAS||PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients|Induction of HBsAg Decline Using an add-on Treatment of Peginterferon Alfa-2a in HBeAg-negative Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogous (PAS)|Recruiting||Phase 4|90|Anticipated|Foundation for Liver Research||2|||f||||f||||||||||2017-10-11 04:07:57.314691|2017-10-11 04:07:57.314691
NCT01373671|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2016-11-18|2016-04-27||May 2011||2011-05-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|DBT||Evaluation of the Efficacy of Digital Breast Tomosynthesis Imaging|Multi-center Case Collection Study to Create a Library of Images From Various Approved Full Field Digital Mammography (FFDM) Systems and 3D Images From Siemens Inspiration Digital Breast Tomosynthesis (DBT) System for Studies in Support of the Inspiration Digital Breast Tomosynthesis Approval|Completed||N/A|764|Actual|Siemens Medical Solutions USA - CSG||1|||f||||f||||||||No||2017-10-11 04:07:57.479419|2017-10-11 04:07:57.479419
NCT01373658|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2011-06-13|||May 2010||2010-05-01|March 2010|2010-03-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|SERY-II||Safety and Efficacy Registry of Yinyi Stent (SERY-II)|Safety and Efficacy Registry of Yinyi Polymer-free Paclitaxel-eluting Stent|Unknown status|Recruiting|Phase 2/Phase 3|200|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||f||||||||||2017-10-11 04:07:57.677097|2017-10-11 04:07:57.677097
NCT01373645|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2015-07-27|||January 2009||2009-01-01|October 2008|2008-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SERY-I||Safety and Efficacy Registry of Yinyi Stent|Safety and Efficacy Registry of Yinyi Polymer-free Paclitaxel-eluting Stent|Completed||Phase 2/Phase 3|1045|Actual|Shanghai Jiao Tong University School of Medicine||1|||f||||||||||||||2017-10-11 04:07:57.779953|2017-10-11 04:07:57.779953
NCT01373632|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-06-14|||June 2011||2011-06-01|June 2011|2011-06-01|September 2013|Anticipated|2013-09-01|June 2012|Anticipated|2012-06-01||Interventional|FESTA||Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease|Multicenter, Randomized, Non-inferiority Study of Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease|Unknown status|Recruiting|Phase 4|570|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-10-11 04:07:57.887836|2017-10-11 04:07:57.887836
NCT01373619|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2012-01-18|||January 2010||2010-01-01|January 2010|2010-01-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine|Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine|Completed||Phase 4|150|Actual|"University of Campania Luigi Vanvitelli"||1|||f||||t||||||||||2017-10-11 04:07:58.043562|2017-10-11 04:07:58.043562
NCT01373606|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2012-02-13|||November 2007||2007-11-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|HRS||A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1|An Exploratory Study of FE999908 in Patients With Hepatorenal Syndrome Type 1|Completed||Phase 1/Phase 2|8|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-11 04:07:58.178933|2017-10-11 04:07:58.178933
NCT01373593|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2012-06-19|||January 2011||2011-01-01|January 2011|2011-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Ultrasound Guided Blocks of the Iliohypogastric and Ilioinguinal Nerves in Persistent Postherniorrhaphy Pain Patients|Ultrasound Guided Blocks of the Iliohypogastric and Ilioinguinal Nerves in Persistent Postherniorrhaphy Pain Patients|Terminated||Phase 4|12|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 04:07:58.318917|2017-10-11 04:07:58.318917
NCT01371526|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-09|2013-02-05|||September 2010||2010-09-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|RoSA||Revival of Stem Cells in Addison's Study|Revival of Autochthonous Adrenocortical Stem Cells in Autoimmune Addison's Disease|Completed||Phase 4|13|Actual|Newcastle University||1|||f||||t||||||||||2017-10-11 04:08:38.168539|2017-10-11 04:08:38.168539
NCT01373567|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-07|2012-11-21|||December 2010||2010-12-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis|An Open Label, Non-comparative, Multicentre, Phase IV Study to Evaluate the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis|Completed||Phase 4|298|Actual|Piramal Enterprises Limited||1|||f||||f||||||||||2017-10-11 04:07:58.5876|2017-10-11 04:07:58.5876
NCT01373554|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2013-12-08|||May 2011||2011-05-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|PMK-N01GI1||Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled, A Multicenter, Randomized, Double-blind, Placebo-controlled, 3 Parallel Groups, Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Oltipraz in Patients With Non-alcoholic Fatty Liver Disease (Except Liver Cirrhosis)|Completed||Phase 2|60|Actual|PharmaKing||2|||f||||t||||||||||2017-10-11 04:07:58.743842|2017-10-11 04:07:58.743842
NCT01373541|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2014-02-11|||May 2011||2011-05-01|January 2012|2012-01-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China|Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China: a Double Blind, Multi-center, Randomized, Controlled Trial|Completed||N/A|171|Actual|Enzymotec||3|||f||||f||||||||||2017-10-11 04:07:58.887357|2017-10-11 04:07:58.887357
NCT01373528|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2012-05-16|||December 2010||2010-12-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Impact of Topical Sinonasal Budesonide Irrigation on Hypothalamic-Pituitary-Adrenal Axis Function|Impact of Topical Sinonasal Budesonide Irrigation on Hypothalamic-Pituitary-Adrenal (HPA) Axis Function|Terminated||N/A|2|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-11 04:07:59.011875|2017-10-11 04:07:59.011875
NCT01373515|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2013-06-03|||April 2011||2011-04-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia|Phase 1 Study of Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|12|Actual|DCPrime BV||4|||f||||t||||||||||2017-10-11 04:07:59.122312|2017-10-11 04:07:59.122312
NCT01373502|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-24|2012-02-20|||October 2009||2009-10-01|February 2012|2012-02-01|September 2015|Anticipated|2015-09-01|April 2011|Actual|2011-04-01||Interventional|NEXT||International Randomized Comparison Between DES Limus Carbostent and Taxus Drug Eluting Stents in the Treatment of De-novo Coronary Lesions||Unknown status|Active, not recruiting|Phase 3|323|Actual|CID - Carbostent & Implantable Devices||2|||f||||f||||||||||2017-10-11 04:07:59.247165|2017-10-11 04:07:59.247165
NCT01373489|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2016-09-29|||July 2011||2011-07-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TACM-DM||Technology-assisted Case Management in Adults With Type 2 Diabetes|Effectiveness of Technology-Assisted Case Management in Low Income Adults With Type 2 Diabetes|Completed||N/A|113|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 04:07:59.420956|2017-10-11 04:07:59.420956
NCT01373476|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2013-05-10|||March 2011||2011-03-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy|Multicentre,Randomized,Double-blind, Multiple-dose, Placebo-controlled, Parallel-Group Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy With Blood Stasis Syndrome and Deficiency of Qi-Yin Syndrome|Completed||Phase 2|240|Actual|Chengdu University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-10-11 04:07:59.543778|2017-10-11 04:07:59.543778
NCT01373463|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2012-07-24|||May 2011||2011-05-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|CisPemXetSrg||Cisplatin and Pemetrexed With Radiation Followed by Lobectomy|A Phase I Trial of Preoperative Carboplatin or Cisplatin and Pemetrexed With Thoracic Radiation Therapy Followed by Lobectomy in Resectable Stage III Patients With Non-Squamous Non Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|48|Actual|Medical University of South Carolina||2||Investigator left site|f||||t||||||||||2017-10-11 04:07:59.689604|2017-10-11 04:07:59.689604
NCT01373450|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2015-09-01|2013-05-20||June 2011||2011-06-01|September 2015|2015-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)|Evaluation of the Glucoregulatory Effects of GLP-1 Receptor Activation in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 04:07:59.802755|2017-10-11 04:07:59.802755
NCT01373437|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-14|||September 2010||2010-09-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Ultrasonography in Confirming Proper Position of Endotracheal Tube|Ultrasonography in Confirming Proper Position of Endotracheal Tube in Emergency Department at Siriraj Hospital: Applicability and Accuracy|Completed||N/A|80|Actual|Mahidol University|||1||f||||f||||||||||2017-10-11 04:08:00.477439|2017-10-11 04:08:00.477439
NCT01373359|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-13|||March 2007||2007-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin|A One Year Double Blind Randomized Controlled Trial of Sublingual Misoprostol (400 µg) Versus Intramuscular Oxytocin (10 IU) in the Prevention of Postpartum Bloodloss at KLE Hospital, Belgaum|Completed||Phase 3|652|Actual|Jawaharlal Nehru Medical College||2|||f||||f||||||||||2017-10-11 04:08:00.551819|2017-10-11 04:08:00.551819
NCT01373346|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2012-08-30|2012-03-11||February 2010||2010-02-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|LoLiRoRe||Safety and Efficacy of Long Limb Roux-en Y Reconstruction|Long Limb Roux-en Y Reconstruction After Gastrectomy As A Potential Cure for Type 2 Diabetes Mellitus in Non-Obese Gastric Cancer Patients - a Pilot Project to Validate a Prospective Randomized Control Trial|Completed||N/A|15|Actual|Gangnam Severance Hospital|One mortality due to early recurrence leading to reduced number of subject analyzed.|1|||f||||t||||||||||2017-10-11 04:08:00.660765|2017-10-11 04:08:00.660765
NCT01373333|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2016-07-18|||September 1997||1997-09-01|July 2016|2016-07-01||||September 2012|Anticipated|2012-09-01||Expanded Access|34-DAP||Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome|Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome|No longer available||N/A|||The Cleveland Clinic|||||||||||||||||||2017-10-11 04:08:01.307126|2017-10-11 04:08:01.307126
NCT01373320|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2013-10-21|||March 2010||2010-03-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Faith Moves Mountains: A Community Based Participatory Research (CBPR) Appalachian Wellness & Cancer Prevention Program|Faith Moves Mountains: A CBPR Appalachian Wellness & Cancer Prevention Program|Completed||N/A|1415|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-11 04:08:01.392062|2017-10-11 04:08:01.392062
NCT01373307|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-07-10|||March 2010||2010-03-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|July 2012|Actual|2012-07-01||Interventional|||An Intergenerational Community Based Participatory Research (CBPR) Intervention to Reduce Appalachian Health Disparities|An Intergenerational CBPR Intervention to Reduce Appalachian Health Disparities|Completed||N/A|1250|Actual|University of Kentucky||2|||f||||f||||||||||2017-10-11 04:08:01.49907|2017-10-11 04:08:01.49907
NCT01373294|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-07-28|2015-12-28||November 30, 2011|Actual|2011-11-30|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|January 9, 2015|Actual|2015-01-09||Interventional||The Primary Outcome Measure addresses Arm A only, whose participants received the experimental drug. Too few participants were enrolled into Arm B to conduct the planned per arm comparison. Demographic details and Adverse Events have been reported for all participants in both arms.|Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer|Immune Modulation by Addition of Oral Lenalidomide to Intravesical BCG (Bacille Calmette-Guerrin) for Therapy of Non-muscle-invasive Transitional Cell Bladder Cancer|Active, not recruiting||Phase 2|17|Actual|H. Lee Moffitt Cancer Center and Research Institute|This study closed to accrual early, due to slow accrual. Too few participants were enrolled into Arm B to conduct the planned per arm comparisons.|2|||f||||f||||||||||2017-10-11 04:08:01.63092|2017-10-11 04:08:01.63092
NCT01373281|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-03-24|2015-09-15||June 2011||2011-06-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|August 2014|Actual|2014-08-01||Interventional|||Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia|Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia|Active, not recruiting||Phase 3|10275|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 04:08:02.167287|2017-10-11 04:08:02.167287
NCT01373255|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2015-06-14|||January 2009||2009-01-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|Accreta||Balloon Catheters in Cases of Abnormal Placentation|Balloon Catheter for Occlusion of the Pelvic Vasculature as an Adjuvant Therapy in Cases of Placenta Accreta|Completed||N/A|24|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-10-11 04:08:06.149826|2017-10-11 04:08:06.149826
NCT01373242|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2017-07-24|||June 2011||2011-06-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|SLIT-TLC||Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance|Peanut Sublingual Immunotherapy and Induction of Clinical Tolerance in Peanut Allergic Children (SLIT Tolerance TLC) {Sublingual Immunotherapy for Peanut Allergy}|Active, not recruiting||Phase 1/Phase 2|49|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 04:08:06.23382|2017-10-11 04:08:06.23382
NCT01373216|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2016-01-31|||June 2011||2011-06-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|May 2014|Actual|2014-05-01||Interventional|Executive||Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass|EXEnatide in Patients Undergoing Coronary Artery Bypass Grafting for Improved glUcose conTrol and hemodynamIc ValuEs|Completed||Phase 3|38|Actual|Charles University, Czech Republic||2|||f||||t||||||||||2017-10-11 04:08:06.423227|2017-10-11 04:08:06.423227
NCT01373203|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-06-13|||January 2011||2011-01-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|||||Observational|||The Role of Fibrocytes in Acute Lung Injury|The Role of Fibrocytes in Acute Lung Injury|Unknown status|Active, not recruiting|N/A|20|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 04:08:06.508227|2017-10-11 04:08:06.508227
NCT01373190|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2013-06-20|||May 2011||2011-05-01|June 2011|2011-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy|Thermographic Examination of Low Back and Abdominal Area Skin Temperatures in Individuals With and Without Focal Onset Epilepsy|Completed||N/A|100|Actual|Atlantic University|||2||f||||f||||||||||2017-10-11 04:08:06.573402|2017-10-11 04:08:06.573402
NCT01373177|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2015-03-17|||January 2011||2011-01-01|August 2014|2014-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years|A Randomized Crossover Study to Evaluate Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years|Completed||N/A|211|Actual|Children's Hospital of Philadelphia|||2||f||||f||||||||||2017-10-11 04:08:06.652169|2017-10-11 04:08:06.652169
NCT01373164|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-01-16||2015-12-23|June 2011||2011-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2015|Actual|2015-11-01||Interventional|||A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer|A Phase 1b/2 Study With Gemcitabine and LY2157299 for Patients With Metastatic Cancer (Phase 1b) and Advanced or Metastatic Unresectable Pancreatic Cancer (Phase 2)|Completed||Phase 1/Phase 2|12|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 04:08:06.738057|2017-10-11 04:08:06.738057
NCT01373151|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-09-13||2015-07-24|June 2011||2011-06-01|September 2017|2017-09-01|June 2015|Actual|2015-06-01|September 2012|Actual|2012-09-01||Interventional|||Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate|A Phase IIB , Randomized, Multi-Center, Double-Blind, Dose-Ranging, Placebo/Active Controlled Study to Evaluate the Efficacy and Safety of BMS-945429 Subcutaneous Injection With or Without Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Methotrexate.|Completed||Phase 2|418|Actual|Vitaeris INC||7|||f||||t||||||||||2017-10-11 04:08:06.901202|2017-10-11 04:08:06.901202
NCT01373138|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-13|||April 2006||2006-04-01|June 2006|2006-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions|Randomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Desloratadine and Pseudoephedrine 5 mg/240 mg Extended-Release Tablet and Clarinex-D® 24-Hour (Reference) Following a 5 mg/240 mg Dose in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|34|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 04:08:07.36822|2017-10-11 04:08:07.36822
NCT01373125|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-09-21|||June 2011||2011-06-01|September 2015|2015-09-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||"Is the Neosquamous Epithelium Normal Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?"|"Is the Neosquamous Epithelium Normal Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?"|Completed||N/A|99|Actual|University of North Carolina, Chapel Hill|||4||f||||f||||||Samples With DNA|"     esophageal biopsies   "|||2017-10-11 04:08:07.461091|2017-10-11 04:08:07.461091
NCT01373112|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-04-10|||December 2011||2011-12-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection|Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection|Recruiting||N/A|140|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 04:08:07.530328|2017-10-11 04:08:07.530328
NCT01373099|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-04-10|||August 2011||2011-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|SPACERHIP||Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement|Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Hip Infection|Recruiting||N/A|80|Anticipated|Rush University Medical Center||2|||f||||t||||||||||2017-10-11 04:08:07.634886|2017-10-11 04:08:07.634886
NCT01373086|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-11-30||2012-11-30|May 2011||2011-05-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension|A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Proof-of-concept Study to Evaluate the Efficacy and Safety of LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension|Terminated||Phase 2|19|Actual|Novartis||4|||f||||f||||||||||2017-10-11 04:08:07.748819|2017-10-11 04:08:07.748819
NCT01373073|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-02-19|||August 2011||2011-08-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of a Novel Human Milk Fortifier in Preterm Infants|Evaluation of a Novel Human Milk Fortifier in Preterm Infants|Completed||Phase 3|147|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-10-11 04:08:07.877259|2017-10-11 04:08:07.877259
NCT01373060|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-10-10|||February 2011||2011-02-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects|A Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of ASP1941 in Healthy Male Taiwanese Subjects|Completed||Phase 1|56|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 04:08:07.982318|2017-10-11 04:08:07.982318
NCT01373047|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-07-29|||June 2011||2011-06-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|HITM||CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells|Phase I Trial Of Intrahepatic Infusion Of 2nd Generation Designer T Cells For Cea-Expressing Liver Metastases|Completed||Phase 1|8|Actual|Roger Williams Medical Center||1|||f||||t||||||||||2017-10-11 04:08:08.066514|2017-10-11 04:08:08.066514
NCT01373034|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-06-13|||July 2011||2011-07-01|June 2011|2011-06-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome|The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome: Double-blind, Randomized, Placebo-controlled, Cross Over Clinical Trial|Unknown status|Not yet recruiting|N/A|36|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 04:08:08.153645|2017-10-11 04:08:08.153645
NCT01373021|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2012-03-06|||June 2011||2011-06-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||The Effect of Dexmedetomidine on Postoperative Analgesia|Assessment of the Effect of Dexmedetomidine in the Management of Postoperative Pain When Combined With Fentanyl in the Patient-controlled Analgesia|Completed||Phase 4|95|Actual|Seoul National University Hospital||2|||f||||||||||||||2017-10-11 04:08:08.253093|2017-10-11 04:08:08.253093
NCT01373008|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2015-08-11|||June 2011||2011-06-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)|Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD); Prospective, Double Blind, Randomized Placebo-control, Multi-center Study|Unknown status|Recruiting|Phase 2|60|Anticipated|Bnai Zion Medical Center||2|||f||||f||||||||||2017-10-11 04:08:08.353779|2017-10-11 04:08:08.353779
NCT01372995|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2016-11-10|2016-07-28||July 2011||2011-07-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|R21 HL-110044|The participant randomized to the 250,000 IU of Vitamin D3 study arm, whose spouse withdrew consent to participate in the study, is not represented in the Baseline Analysis Population.|Vitamin D in Ventilated ICU Patients|High-Dose Vitamin D and Antimicrobial Peptide Expression in Lung Failure|Completed||Phase 2|31|Actual|Emory University|Limitations to generalizability of this pilot study include the small sample size and imbalances in chronic conditions between treatment arms at study entry.|3|||f||||t||||||||||2017-10-11 04:08:08.474566|2017-10-11 04:08:08.474566
NCT01372982|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2011-06-13|||April 2008||2008-04-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions|An Open Label, Balanced, Randomized, Two Treatment, Two Sequence, Two Period, Cross-Over, Single-Dose, Comparative Oral Bioavailability Study Of Letrozole 2.5 mg Tablets (Test) Of Dr.Reddy's Laboratories Ltd And Femara 2.5 mg Tablets (Reference) Of Novartis Pharmaceuticals Corporation, USA In Healthy, Post Menopausal Women Subjects Under Fed Conditions|Completed||Phase 1|36|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 04:08:09.465489|2017-10-11 04:08:09.465489
NCT01372020|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2013-12-21|||February 2011||2011-02-01|December 2013|2013-12-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Neuromuscular Electrical Therapy in Venous Ulcers|The Effect of Neuromuscular Electrical Therapy on Pain in Patients With Venous Ulcers: a Controlled Clinical Trial|Completed||Phase 4|20|Actual|Faculdade Evangelica do Parana||2|||f||||f||||||||||2017-10-11 04:08:22.520664|2017-10-11 04:08:22.520664
NCT01372969|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-30|2011-06-13|||June 2009||2009-06-01|June 2011|2011-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.|Multicenter Phase I/IIa Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.|Completed||Phase 1/Phase 2|24|Actual|Cellerix||1|||f||||f||||||||||2017-10-11 04:08:09.55579|2017-10-11 04:08:09.55579
NCT01372956|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-12-21|||August 2011||2011-08-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|CRESENDO||Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea|Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESCENDO)|Completed||N/A|4950|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:08:09.661069|2017-10-11 04:08:09.661069
NCT01372943|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-10-19|||January 2010||2010-01-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection|"A Study Using Synthetic Stool or Pure Cultures of Probiotic Intestinal Bacteria From Healthy Donor Stool That Can be Used as an Enema to Replace the Use of Stool Transplant, for Treatment of Recurrent and Refractory CDI"|Unknown status|Active, not recruiting|N/A|30|Anticipated|Queen's University||1|||f||||f||||||||||2017-10-11 04:08:09.759913|2017-10-11 04:08:09.759913
NCT01372930|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-11|||April 2010||2010-04-01|March 2010|2010-03-01||||July 2014|Anticipated|2014-07-01||Interventional|||Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction|The Safety and Efficacy of Etanercept in Treating Patient With Acute ST Segment Elevated Myocardial Infarction|Unknown status|Recruiting|Phase 4|200|Anticipated|Xijing Hospital||2|||f||||f||||||||||2017-10-11 04:08:09.987413|2017-10-11 04:08:09.987413
NCT01372917|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2012-06-11|||January 2010||2010-01-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|February 2011|Actual|2011-02-01||Observational|||Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study|Evaluating Sterile Human Acellular Dermal Matrix in Immediate Expander-Based Breast Reconstruction: A Multi-centered Prospective Cohort Study|Completed||N/A|39|Actual|National Center for Plastic Surgery, Virginia|||1||f||||f||||||Samples Without DNA|"     A 1 cm square of AlloMax will be harvested from the first 20 patients for histologic     examination to determine wether or not there is neovascularization and collagen deposition.   "|||2017-10-11 04:08:10.083373|2017-10-11 04:08:10.083373
NCT01372904|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2014-07-16|||June 2011||2011-06-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment|Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment.|Completed||Phase 4|30|Actual|Meir Medical Center||1|||f||||f||||||||||2017-10-11 04:08:10.140312|2017-10-11 04:08:10.140312
NCT01372891|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-11-21|||April 2010||2010-04-01|November 2011|2011-11-01|December 2014|Anticipated|2014-12-01|April 2013|Anticipated|2013-04-01||Observational|||Urine Adiponectin Concentration in Prediction of Contrast Induced Nephropathy|Urine Total Adiponectin and Its Isoforms Concentration in Prediction of Percutaneous Coronary Interventions Contrast Induced Nephropathy|Unknown status|Recruiting|N/A|400|Anticipated|Xijing Hospital|||1||f||||f||||||Samples Without DNA|"     serum,urine   "|||2017-10-11 04:08:10.235257|2017-10-11 04:08:10.235257
NCT01372878|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-05|2014-05-13|2014-04-02||June 2011||2011-06-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||CRC population|Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon|MA-204: Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon|Completed||N/A|884|Actual|Given Imaging Ltd.||1|||f||||f||||||||||2017-10-11 04:08:10.32472|2017-10-11 04:08:10.32472
NCT01372865|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-13|2017-09-15|||June 2012|Actual|2012-06-01|September 2017|2017-09-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)|A Phase III, Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis With Eurofarma Mometasone or Reference Mometasone.|Completed||Phase 3|364|Actual|Eurofarma Laboratorios S.A.||2|||f||||t|f|f||||||||2017-10-11 04:08:10.54294|2017-10-11 04:08:10.54294
NCT01372852|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-11|2011-06-13|||May 2010||2010-05-01|May 2010|2010-05-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Observational|||Plasma Adiponectin Concentration, Activity and Isoforms in Newly Diagnosed and Untreated Type 2 Diabetes Mellitus|Plasma Adiponectin Concentration, Activity and Isoforms in Newly Diagnosed and Untreated T2DM Patients in Chinese Population|Unknown status|Recruiting|N/A|300|Anticipated|Xijing Hospital|||2||f||||f||||||Samples Without DNA|"     blood，abdominal fat tissue   "|||2017-10-11 04:08:10.614601|2017-10-11 04:08:10.614601
NCT01372839|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-11|||July 2010||2010-07-01|July 2010|2010-07-01||||July 2012|Anticipated|2012-07-01||Interventional|PCI||Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome|The Safety and Efficacy of Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome|Unknown status|Recruiting|Phase 4|300|Anticipated|Xijing Hospital||2|||f||||f||||||||||2017-10-11 04:08:10.696436|2017-10-11 04:08:10.696436
NCT01372826|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2014-10-13|||June 2011||2011-06-01|October 2014|2014-10-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function|An Open-Label, Parallel-Group, Phase I Study to Compare the Pharmacokinetics of NKTR-118 Following a Single Oral Dose in Subjects With Renal Impairment and Subjects With Normal Renal Function|Completed||Phase 1|32|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 04:08:10.795312|2017-10-11 04:08:10.795312
NCT01372813|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-11|2015-10-02|2011-12-19||December 2007||2007-12-01|October 2015|2015-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Vandetanib to Treat Advanced Kidney Cancer|A Phase II Study of ZD6474 (Vandetanib) in Subjects With Advanced Clear Cell Renal Carcinoma|Terminated||Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)|Study was designed to accrue up to 37 patients but only 3 were enrolled. Study was terminated due to low accrual.|1||Terminated for insufficient accrual.|f||||f||||||||||2017-10-11 04:08:10.916948|2017-10-11 04:08:10.916948
NCT01371552|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-10-02|2012-10-02||May 2011||2011-05-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|TUNGSTEN||Performance Evaluation of a New Daily Disposable Silicone Hydrogel Lens|Performance Evaluation of a New Daily Disposable Silicone Hydrogel Lens (TUNGSTEN)|Completed||N/A|119|Actual|Alcon Research||3|||f||||f||||||||||2017-10-11 04:08:37.467811|2017-10-11 04:08:37.467811
NCT01372800|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2013-11-19|||May 2011||2011-05-01|November 2011|2011-11-01||||October 2016|Anticipated|2016-10-01||Observational|||Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases|Serum Adiponectin Concentration, Activity and Isoforms in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases|Unknown status|Recruiting|N/A|30000|Anticipated|Xijing Hospital|||1||f||||f||||||None Retained|"     blood   "|||2017-10-11 04:08:11.316525|2017-10-11 04:08:11.316525
NCT01372787|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-11|2017-05-03|||April 2011||2011-04-01|May 2017|2017-05-01||||January 2014|Actual|2014-01-01||Observational|||Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer|Quality of Life and Care Needs in Patients With Persistent or Recurrent Platinum-Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer|Active, not recruiting||N/A|103|Actual|Gynecologic Oncology Group|||1||f||||||||||||||2017-10-11 04:08:11.420319|2017-10-11 04:08:11.420319
NCT01372761|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-12-28|||June 2011||2011-06-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers|Phase 1b Trial of Beloranib, a Novel Methionine Aminopeptidase 2 (MetAP-2) Inhibitor for Treatment of Extreme Obesity: Randomized, Double-Blind, Placebo-Controlled, Escalating Doses in Female Volunteers|Completed||Phase 1|25|Actual|Zafgen, Inc.||2|||f||||f||||||||||2017-10-11 04:08:11.981592|2017-10-11 04:08:11.981592
NCT01372748|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-11-03|2016-08-08||June 2011||2011-06-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|August 2015|Actual|2015-08-01||Interventional|CCC||Continuous Chest Compressions vs AHA Standard CPR of 30:2|Trial Of Continuous Compressions Versus Standard CPR In Patients With Out-Of-Hospital Cardiac Arrest|Completed||Phase 4|23711|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 04:08:12.075981|2017-10-11 04:08:12.075981
NCT01372735|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-10|||August 2011||2011-08-01|June 2011|2011-06-01|August 2017|Anticipated|2017-08-01|August 2013|Anticipated|2013-08-01||Interventional|NEOPANC||Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer|Clinical Phase I/II Trial to Investigate Neoadjuvant Intensity-Modulated Short Term Radiation Therapy (5x5 Gy) and Intraoperative Radiation Therapy (15 Gy) in Patients With Primarily Resectable Pancreatic Cancer - NEOPANC|Unknown status|Not yet recruiting|Phase 1/Phase 2|46|Anticipated|University Hospital Heidelberg||1|||f||||f||||||||||2017-10-11 04:08:12.479137|2017-10-11 04:08:12.479137
NCT01372722|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2013-10-28|||May 2010||2010-05-01|October 2013|2013-10-01|July 2015|Anticipated|2015-07-01|May 2015|Anticipated|2015-05-01||Interventional|DBS-BIPO||Deep Brain Stimulation (DBS) for Treatment Resistant Bipolar Disorder|Phase I Study of Bilateral DBS to the Nucleus Accumbens (NAcc-DBS) for Treatment Resistant Bipolar Disorder|Unknown status|Recruiting|Phase 2/Phase 3|12|Anticipated|University Hospital, Bonn||2|||f||||f||||||||||2017-10-11 04:08:12.603282|2017-10-11 04:08:12.603282
NCT01372709|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2017-05-01|||May 2011||2011-05-01|October 2016|2016-10-01|January 2019|Anticipated|2019-01-01|December 2014|Actual|2014-12-01||Observational|||TriVascular Post-Market Registry|A Post-Market Study to Evaluate the Safety and Performance of the Ovation™ or Ovation Prime™ Abdominal Stent Graft System|Active, not recruiting||N/A|501|Actual|TriVascular, Inc.|||1||f||||t||||||||||2017-10-11 04:08:12.748108|2017-10-11 04:08:12.748108
NCT01372696|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-12-15|||November 2009||2009-11-01|December 2015|2015-12-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|C-LST||Endoscopic Characteristics of Colonic Tumours|A Correlation of the Endoscopic Characteristics of Colonic LSTs With Their Somatic or Germline Mutations. A Prospective, Genome Wide Study|Recruiting||N/A|350|Anticipated|Western Sydney Local Health District||1|||f||||f||||||||||2017-10-11 04:08:12.9308|2017-10-11 04:08:12.9308
NCT01372670|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2016-11-14|||January 2012||2012-01-01|February 2016|2016-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder|Hydroxyzine Effects on Meal-Related Anxiety in Underweight Adolescents and Young Adults Diagnosed With an Eating Disorder - A Pilot Study|Withdrawn||Phase 4|0|Actual|HealthPartners Institute||2||Due to unforseen recruiting difficulties, the study was closed.|f||||t||||||||||2017-10-11 04:08:13.131288|2017-10-11 04:08:13.131288
NCT01372657|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-01-07|||April 2011||2011-04-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Intraocular Lens (IOL) Calculation Improvement|Intraocular Lens (IOL) Formula Calculation Improvement|Terminated||N/A|11|Actual|University Hospital, Basel, Switzerland|||1|slow recruitment|f||||f||||||||||2017-10-11 04:08:13.229584|2017-10-11 04:08:13.229584
NCT01372644|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2016-12-02|||November 2007||2007-11-01|December 2016|2016-12-01|November 2013|Actual|2013-11-01|December 2010|Actual|2010-12-01||Interventional|||Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial|Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial|Completed||Phase 1|15|Actual|New York University School of Medicine||1|||f||||t||||||||Undecided||2017-10-11 04:08:13.316969|2017-10-11 04:08:13.316969
NCT01372631|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2017-06-16|||April 2011||2011-04-01|November 2016|2016-11-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins|A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins|Recruiting||N/A|210|Anticipated|Duke University||3|||f||||||||||||Undecided||2017-10-11 04:08:13.40281|2017-10-11 04:08:13.40281
NCT01372618|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-09-08|||June 2011|Actual|2011-06-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor|Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor|Terminated||Phase 1/Phase 2|7|Actual|New York University School of Medicine||1||PI has passed away. Requested by department to terminate study.|f||||t|t|f||||||||2017-10-11 04:08:13.520607|2017-10-11 04:08:13.520607
NCT01372605|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-12|2016-10-19|2016-04-11||April 2010||2010-04-01|October 2016|2016-10-01|June 2014|Actual|2014-06-01|April 2014|Actual|2014-04-01||Interventional|SLAM DUNC|All randomized participants|Trial of Collaborative Depression Care Management for HIV Patients|SLAM DUNC: Strategies to Link Antidepressant and Antiretroviral Management at Duke University, University of Alabama at Birmingham, Northern Outreach Clinic (Henderson, NC), and University of North Carolina|Completed||N/A|304|Actual|Duke University||2|||f||||t||||||||||2017-10-11 04:08:13.620952|2017-10-11 04:08:13.620952
NCT01372592|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-25|2017-03-22|||March 2011||2011-03-01|March 2017|2017-03-01|December 6, 2016|Actual|2016-12-06|December 6, 2016|Actual|2016-12-06||Observational|||SpineTRACK Registry - Spinal Outcomes Registry|SpineTRACK (Translating Radiographic and Clinical Knowledge) Registry: Outcomes Data Collection in Degenerative, Deformity, and Trauma Patients|Completed||N/A|10000|Anticipated|NuVasive|||3||f||||f||||||||No||2017-10-11 04:08:14.345095|2017-10-11 04:08:14.345095
NCT01372579|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-07-05|||August 2011||2011-08-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients|Phase II Neoadjuvant Trial With Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients|Active, not recruiting||Phase 2|30|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 04:08:14.493056|2017-10-11 04:08:14.493056
NCT01372566|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-12-05|||May 2011||2011-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effect of Platelet Rich Plasma on Photoaged Skin|Effect of Autologous Platelet-rich Plasma on Photoaged Skin: A Prospective Randomized Controlled Trial (Phases A and B)|Active, not recruiting||Phase 1/Phase 2|23|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-11 04:08:14.607071|2017-10-11 04:08:14.607071
NCT01372553|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-04-15|||October 2009||2009-10-01|April 2014|2014-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|GGMI||Guilford Genomic Medicine Initiative (GGMI)|Guilford Genomic Medicine Initiative (GGMI)|Completed||Phase 4|1184|Actual|The Moses H. Cone Memorial Hospital|||1||f||||f||||||Samples With DNA|"     Total number of project participants that completed family health history tool was 1,184..     Out of the 1,184 subjects, 75 DNA saliva samples were collected.   "|||2017-10-11 04:08:14.686192|2017-10-11 04:08:14.686192
NCT01372540|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2016-12-27|||February 2012||2012-02-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||Study of Arry-520 and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma|A Phase I Study of Arry-520 and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1|75|Actual|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-10-11 04:08:14.772562|2017-10-11 04:08:14.772562
NCT01372527|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2014-10-02|||June 2011||2011-06-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|June 2012|Actual|2012-06-01||Interventional|TopCare||Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health IT|Technology for Optimizing Population Care in a Resource-limited Environment|Completed||N/A|103870|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 04:08:14.887163|2017-10-11 04:08:14.887163
NCT01372514|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2015-12-16|||August 2006||2006-08-01|December 2015|2015-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|IRTD||Institutional Registry of Thromboembolic Disease|Institutional Registry of Thromboembolic Disease|Recruiting||N/A|4500|Anticipated|Hospital Italiano de Buenos Aires|||1||f||||t||||||||||2017-10-11 04:08:14.978421|2017-10-11 04:08:14.978421
NCT01372501|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2016-12-29|2016-02-13||September 2010||2010-09-01|December 2016|2016-12-01|September 2012|Actual|2012-09-01|November 2011|Actual|2011-11-01||Interventional|||Study of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner|A Pilot Trial of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner|Completed||Phase 2|19|Actual|GI Dynamics||1|||f||||f||||||||Yes|De-identified individual data is available on site at Sponsor|2017-10-11 04:08:15.129127|2017-10-11 04:08:15.129127
NCT01372488|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-09|2011-06-22|||April 2010||2010-04-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Are Patients Willing and Capable of Removing Their Own Non-absorbable Sutures|Are Patients Willing and Capable of Removing Their Own Non-absorbable Sutures|Completed||N/A|160|Actual|Fraser Health||2|||f||||f||||||||||2017-10-11 04:08:15.358959|2017-10-11 04:08:15.358959
NCT01372475|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2014-03-11||2014-03-11|March 2011||2011-03-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|Hymovis||Hymovis™ Versus Placebo in Knee Osteoarthritis|A Multi-Centre, Double-Blind, Randomized, Placebo Controlled Study To Evaluate The Safety And Effectiveness Of A New Viscoelastic Hydrogel (Hymovis) In The Treatment Of Knee OA With An Open-Label Extension|Completed||Phase 3|800|Actual|Fidia Farmaceutici s.p.a.||2|||f||||f||||||||||2017-10-11 04:08:15.461645|2017-10-11 04:08:15.461645
NCT01372462|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2016-08-18|2015-03-08||July 2011||2011-07-01|August 2016|2016-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||The primary endpoint is difference in endurance between cannula oxygen and NIOV+O2. Assuming 153 sec clinically important difference, 183 sec SD of increase and α=0.05, a sample size of 15 yields 85% power.|Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease|A Pilot Study of the Physiologic Effects of Using the Breathe Technologies Noninvasive Open Ventilation System During Constant Work Rate Exercise in Subjects With Chronic Obstructive Pulmonary Disease|Completed||N/A|15|Actual|Breathe Technologies, Inc.||4|||f||||f||||||||||2017-10-11 04:08:15.659141|2017-10-11 04:08:15.659141
NCT01372449|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-03-17|||December 2011||2011-12-01|March 2017|2017-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)|A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning|Completed||Phase 2|23|Actual|Anagnostou, Evdokia, M.D.||2|||f||||t||||||||No||2017-10-11 04:08:16.015677|2017-10-11 04:08:16.015677
NCT01372436|ClinicalTrials.gov processed this data on October 10, 2017|2008-04-22|2013-01-23|||June 2007||2007-06-01|April 2008|2008-04-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||Caries Risk Assessment in Children and Adolescents in the Alpes Maritimes (France)|Caries Risk Assessment in Children and Adolescents in the Alpes Maritimes (France)|Unknown status|Recruiting|N/A|678|Anticipated|Centre Hospitalier Universitaire de Nice|||2||f||||f||||||||||2017-10-11 04:08:16.100338|2017-10-11 04:08:16.100338
NCT01372254|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-07-12|||January 2011||2011-01-01|July 2011|2011-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|BA-DAS||Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment|Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment|Unknown status|Recruiting|Phase 1/Phase 2|90|Anticipated|University of Maryland||2|||f||||f||||||||||2017-10-11 04:08:19.04772|2017-10-11 04:08:19.04772
NCT01372423|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2012-07-10|||May 2011||2011-05-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Evaluation of Clinical Equivalence Between Two Lubiprostone Products|A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Evaluate the Clinical Equivalence of Lubiprostone 24 Mcg Capsules (Anchen Pharmaceuticals, Inc.) With AMITIZA® (Lubiprostone) 24 Mcg Capsules (Sucampo Pharmaceuticals, Inc.) in the Treatment of Chronic Idiopathic Constipation|Completed||Phase 3|808|Actual|Anchen Pharmaceuticals, Inc||3|||f||||f||||||||||2017-10-11 04:08:16.186431|2017-10-11 04:08:16.186431
NCT01372410|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2016-11-23|2013-12-19|2012-05-17|July 2011||2011-07-01|November 2016|2016-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|AC4115321||A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|163|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:08:16.569589|2017-10-11 04:08:16.569589
NCT01372397|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2017-03-29|||May 2010||2010-05-01|March 2017|2017-03-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Reversal of Obesity Cardiomyopathy|Reversal of Obesity Cardiomyopathy After Gastric Bypass|Active, not recruiting||N/A|50|Anticipated|Washington University School of Medicine|||1||f||||t||||||Samples With DNA|"     Blood Samples   "|||2017-10-11 04:08:17.62586|2017-10-11 04:08:17.62586
NCT01372384|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2016-01-03|2015-10-16||January 2012||2012-01-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations|Phase II, Open-label Study of Erlotinib (Tarceva®) Treatment in Patients With Locally Advanced, Metastatic or Recurrent Non-small Cell Lung Cancer Who Present Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor|Completed||Phase 2|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:08:17.707227|2017-10-11 04:08:17.707227
NCT01372371|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-10|||June 2011||2011-06-01|June 2011|2011-06-01|June 2013|Anticipated|2013-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Efficacy of Local Powder Prophylactics|Effects of Applying Powdered Prophylactics Verses Intravenous Antibiotics Only on Post-operative Infection Rate|Unknown status|Recruiting|N/A|1844|Anticipated|Ganga Hospital||3|||f||||f||||||||||2017-10-11 04:08:18.113342|2017-10-11 04:08:18.113342
NCT01372358|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-26|2011-06-10|||January 2005||2005-01-01|January 2011|2011-01-01|February 2005|Actual|2005-02-01|January 2005|Actual|2005-01-01||Interventional|||Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions|Single Dose, Randomized, Two-period, Two-treatment, Two-sequence Crossover Relative Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets Under Non-Fasting Condition.|Completed||Phase 1|32|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 04:08:18.218491|2017-10-11 04:08:18.218491
NCT01372345|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-27|2011-06-10|||February 2005||2005-02-01|January 2011|2011-01-01|March 2005|Actual|2005-03-01|February 2005|Actual|2005-02-01||Interventional|||Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions|Single Dose, Randomized, Two-period, Two-treatment, Two-sequence Crossover Relative Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets Under Fasting Condition|Completed||Phase 1|43|Actual|Dr. Reddy's Laboratories Limited||2|||f||||f||||||||||2017-10-11 04:08:18.310201|2017-10-11 04:08:18.310201
NCT01372332|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2014-05-27|||June 2011||2011-06-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|Hemi-Drive||Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)|Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)|Completed||N/A|60|Actual|University Hospital Tuebingen|||2||f||||f||||||||||2017-10-11 04:08:18.41274|2017-10-11 04:08:18.41274
NCT01372319|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2014-05-27|||June 2011||2011-06-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Observational|GlaucomaEXPLOR||Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)|Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)|Completed||N/A|60|Actual|University Hospital Tuebingen|||2||f||||f||||||||||2017-10-11 04:08:18.528642|2017-10-11 04:08:18.528642
NCT01372306|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-27|2011-06-29|||October 2004||2004-10-01|October 2004|2004-10-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition|Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Dr.Reddy's Laboratories, Ltd. and Janssen Pharmaceutical Products, l.P. (Reminyl®)4 mg Galantamine HBr Tablets in Healthy Adult Male Volunteers Under Fed Conditions|Completed||Phase 1|24|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 04:08:18.616064|2017-10-11 04:08:18.616064
NCT01372293|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-09-08|||January 2005||2005-01-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|January 2008|Actual|2008-01-01||Interventional|17b-ACO||71A/G HSD17B5 SNP and Effects of Oral Contraceptive Pill in PCOS Women|17-hydroxysteroid Dehydrogenase Type 5 Gene Polymorphism (71A/G HSD17B5 SNP) and Effects of Oral Contraceptive Pill on Hirsutism, Androgens and Metabolic Profile in Non-obese PCOS Women: a Pilot Study|Completed||N/A|49|Actual|Federal University of Rio Grande do Sul||1|||f||||f||||||||||2017-10-11 04:08:18.714244|2017-10-11 04:08:18.714244
NCT01372280|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-25|2011-06-29|||October 2004||2004-10-01|January 2011|2011-01-01|November 2004|Actual|2004-11-01|October 2004|Actual|2004-10-01||Interventional|||Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition|Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Dr. Reddy's Laboratories, Ltd. and Janssen Pharmaceutical Products, l.P. (Reminyl®)4 mg Galantamine HBr Tablets in Healthy Adult Male Volunteers Under Fasting Conditions|Completed||Phase 1|28|Actual|Dr. Reddy's Laboratories Limited||2|||f||||t||||||||||2017-10-11 04:08:18.816442|2017-10-11 04:08:18.816442
NCT01372267|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-07-21|||October 2011||2011-10-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|January 2016|Actual|2016-01-01||Interventional|||Psychosocial Pain Management During Addictions Treatment to Improve Outcomes||Completed||N/A|510|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 04:08:18.933326|2017-10-11 04:08:18.933326
NCT01372228|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2017-06-02|||April 2011||2011-04-01|June 2017|2017-06-01|April 2028|Anticipated|2028-04-01|April 2025|Anticipated|2025-04-01||Interventional|||Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders|Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|University of Louisville||1|||t||||t|t|f||||||Undecided||2017-10-11 04:08:19.316773|2017-10-11 04:08:19.316773
NCT01372215|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2015-05-12|||May 2011||2011-05-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Multi-Compression Spot Mammography|Multi-Compression Spot Mammography|Terminated||N/A|3|Actual|State University of New York - Upstate Medical University|||1|Referral physician no longer available|f||||f||||||||||2017-10-11 04:08:19.449966|2017-10-11 04:08:19.449966
NCT01372202|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-07-28|2017-05-11||June 2011||2011-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2014|Actual|2014-06-01||Interventional|J10130||CHFR Methylation Status Esophageal Cancer Study|A Phase 2 Study of Paclitaxel With Cisplatin Versus Fluoropyrimidine With a Platinum Agent for Neoadjuvant Therapy in Operable Esophageal Cancer Based on CHFR Methylation Status in Diagnostic Biopsies|Active, not recruiting||Phase 2|31|Actual|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 04:08:19.536819|2017-10-11 04:08:19.536819
NCT01372189|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-18|2012-01-30|||January 2011||2011-01-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Molecular Imaging of Epidermal Growth Factor Receptor in Colorectal Neoplasia Using Confocal Laser Endomicroscopy|In Vivo Molecular Imaging of Epidermal Growth Factor Receptor in Patients With Colorectal Neoplasia Using Confocal Laser Endomicroscopy|Completed||N/A|40|Actual|Shandong University|||2||f||||t||||||Samples With DNA|"     Take biospecimen during colonoscopy.   "|||2017-10-11 04:08:20.137401|2017-10-11 04:08:20.137401
NCT01372176|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-01-04|||June 2013||2013-06-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|EAT-ICU||Early Goal-Directed Nutrition in ICU Patients - EAT-ICU Trial|Early Goal-Directed Nutrition in ICU Patients - EAT-ICU Trial|Completed||Phase 4|203|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 04:08:20.24073|2017-10-11 04:08:20.24073
NCT01372163|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2012-05-22|||July 2011||2011-07-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients|A Phase 1 Placebo-Controlled Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Ascending Doses Of PF-05190457 In Healthy And Type 2 Diabetic Adults|Terminated||Phase 1|35|Actual|Pfizer||7||"B3301002 was discontinued on 18 April 2012 for strategic reasons.There were no safety concerns   leading to discontinuation of this study."|f||||f||||||||||2017-10-11 04:08:20.346838|2017-10-11 04:08:20.346838
NCT01372150|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2016-04-29|2015-10-19||November 2011||2011-11-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Safety population - included all randomized participants who received at least 1 dose of study drug.|A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD|A Multicenter, Randomized, Double-blind, Placebo-controlled, Fluoxetine-referenced, Parallel-group Study To Evaluate The Efficacy, Safety And Tolerability Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder|Completed||Phase 3|340|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 04:08:20.475218|2017-10-11 04:08:20.475218
NCT01372137|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-01-22|||July 2011||2011-07-01|June 2014|2014-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94|First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94|Completed||Phase 1|64|Actual|NOXXON Pharma AG||2|||f||||f||||||||||2017-10-11 04:08:21.587388|2017-10-11 04:08:21.587388
NCT01372124|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2012-10-18|||June 2011||2011-06-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase I Clinical Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36|A Phase I, Open Label, Parallel Group, Multi-center Single Dose Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36|Completed||Phase 1|32|Actual|NOXXON Pharma AG||1|||f||||f||||||||||2017-10-11 04:08:21.681642|2017-10-11 04:08:21.681642
NCT01372111|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-12-08|||March 2011||2011-03-01|December 2015|2015-12-01||||March 2016|Anticipated|2016-03-01||Interventional|||Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer|Chemoradiotherapy With Very Low Dose Elective Nodal IMRT for Locally Advanced Head & Neck Cancer: the CCRO11 Multi-Institutional Phase II Trial|Active, not recruiting||Phase 2|76|Anticipated|Coastal Carolina Radiation Oncology||1|||f||||f||||||||||2017-10-11 04:08:21.777226|2017-10-11 04:08:21.777226
NCT01372098|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-06-08|||May 2011||2011-05-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Nurse-family Partnership (NFP) Curriculum Study|Development and Evaluation of an Intervention for Intimate Partner Violence in the Context of Nurse Home Visits|Completed||N/A|492|Actual|McMaster University||2|||f||||t||||||||||2017-10-11 04:08:21.893|2017-10-11 04:08:21.893
NCT01372072|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-10|||June 2011||2011-06-01|March 2011|2011-03-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||A Study to Investigate the Effects of Heated Humidification During Non-Invasive Ventilation|A Pilot Study to Investigate the Physiological and Clinical Effects of Heated Humidification During Non-Invasive Ventilation|Unknown status|Not yet recruiting|N/A|16|Anticipated|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 04:08:22.119265|2017-10-11 04:08:22.119265
NCT01372059|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-08-04|||January 2010||2010-01-01|August 2017|2017-08-01|June 2, 2014|Actual|2014-06-02|May 30, 2014|Actual|2014-05-30||Interventional|||The Effects of a Rhythm and Music-based Therapy Program and Therapeutic Riding in Late Recovery Phase Following Stroke|The Effects of a Rhythm and Music-based Therapy Program and Therapeutic Riding in Late Recovery Phase Following Stroke|Completed||N/A|123|Actual|Göteborg University||3|||f||||t||||||||||2017-10-11 04:08:22.222878|2017-10-11 04:08:22.222878
NCT01372046|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-10|||February 2008||2008-02-01|June 2009|2009-06-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|JAARP||Implementing & Testing Assessment and Referral Technologies in Juvenile Justice||Completed||Phase 3|1000|Anticipated|George Mason University||3|||f||||t||||||||||2017-10-11 04:08:22.350365|2017-10-11 04:08:22.350365
NCT01372007|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-10-06|||July 2011||2011-07-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma|Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma|Completed||Phase 3|24|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 04:08:22.617676|2017-10-11 04:08:22.617676
NCT01371994|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2014-10-06|2014-10-06||August 2011||2011-08-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Safety analysis set, defined as all participants who took at least one dose of study drug.|A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy|A Randomized, Double-Blind, Parallel, Placebo-Controlled, Phase 4, Multicenter Study to Assess Efficacy and Safety of VESIcare® (Solifenacin Succinate) to Improve Urinary Continence of Subjects After Robotic Assisted Radical Prostatectomy|Completed||Phase 4|640|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||f||||||||||2017-10-11 04:08:22.741344|2017-10-11 04:08:22.741344
NCT01371968|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-06-10|||February 2011||2011-02-01|June 2011|2011-06-01|November 2011|Anticipated|2011-11-01|August 2011|Anticipated|2011-08-01||Interventional|||Optimal Dose of Alfentanil for Removal of Supreme Laryngeal Mask Airway During Emergence From Desflurane Anaesthesia|Optimal Dose of Alfentanil for Removal of Supreme Laryngeal Mask Airway During Emergence From Desflurane Anaesthesia|Unknown status|Recruiting|N/A|30|Anticipated|University of Malaya||1|||f||||t||||||||||2017-10-11 04:08:24.507932|2017-10-11 04:08:24.507932
NCT01371955|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2013-11-14|||January 2011||2011-01-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|NEPHRODIANOX||Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy|Impact of c242T Polymorphism of p22phox in the Development of Diabetic Nephropathy,in Caucasian Diabetic Type 1 Patient.|Completed||N/A|162|Actual|University Hospital, Grenoble|||3||f||||t||||||Samples With DNA|"     We will include 60 patients to reach the required number. We take 2 blood samples: one for     genetic analysis and one to determine HBA1c and plasma creatinine. We also take one urinary     sample to determine the urinary albumine / creatinine ratio   "|||2017-10-11 04:08:24.59984|2017-10-11 04:08:24.59984
NCT01371942|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2011-06-10|||May 2010||2010-05-01|June 2011|2011-06-01|May 2013|Anticipated|2013-05-01|||||Observational|||Mutational Profiling in Colorectal Tumors to Determine Its Role in the Diagnosis, Prognostic Significance and Their Impact in Clinical Management|Mutational Profiling in Colorectal Tumors to Determine Its Role in the Diagnosis, Prognostic Significance and Their Impact in Clinical Management|Unknown status|Active, not recruiting|N/A|300|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 04:08:26.251196|2017-10-11 04:08:26.251196
NCT01371929|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-04-12|||February 2013||2013-02-01|April 2017|2017-04-01|August 2019|Anticipated|2019-08-01|June 2019|Anticipated|2019-06-01||Observational|PliNOSa® Test||Plasma Inducible Nitric Oxide Synthase (iNOS) Assay and Sepsis Study|Evaluation of the PliNOSa® Test as an Aid in the Risk Assessment for the Onset of Sepsis|Suspended||N/A|300|Anticipated|Research & Diagnostic Antibodies|||2|NIH funding ended prior to full enrollment in the clinical study|f||||t||||||Samples Without DNA|"     heparinized plasma samples   "|||2017-10-11 04:08:26.321112|2017-10-11 04:08:26.321112
NCT01371916|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2014-08-18|||September 2010||2010-09-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Observational|||Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF|Diagnosis of Tuberculous Meningitis by a Secretory Antigenic Target 6 (ESAT-6) in CSF|Completed||N/A|316|Actual|Xijing Hospital|||2||f||||f||||||||||2017-10-11 04:08:26.387172|2017-10-11 04:08:26.387172
NCT01371903|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-10|2014-03-20|||August 2010||2010-08-01|June 2011|2011-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|Capno||The Effects of Patient Features on Opioid Induced End-Tidal CO2|The Effect of Patient Features on Opioid Induced End-Tidal CO2|Completed||N/A|278|Actual|Albany Medical College|||1||f||||t||||||||||2017-10-11 04:08:26.451877|2017-10-11 04:08:26.451877
NCT01371890|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-01-27|||May 2011||2011-05-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|MATCH-Sodium||Mechanisms and Treatment of Intradialytic Hypertension - Sodium|Mechanisms and Treatment of Intradialytic Hypertension - Sodium|Completed||N/A|18|Actual|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples Without DNA|"     Samples stored for nitric oxide and endothelin-1 measurements   "|||2017-10-11 04:08:26.514387|2017-10-11 04:08:26.514387
NCT01371877|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-08-30|2014-12-01||November 2011|Actual|2011-11-01|August 2017|2017-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment|The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment|Completed||N/A|42|Actual|University of Nebraska||2|||f||||f||||||||||2017-10-11 04:08:26.586419|2017-10-11 04:08:26.586419
NCT01371864|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-04-21|||August 2011||2011-08-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Families and Pediatric Cardiac Surgery Multidisciplinary Teams: How Well Do We Communicate|Families and Pediatric Cardiac Surgery Multidisciplinary Teams: How Well Do We Communicate?|Completed||N/A|23|Actual|University of North Carolina, Chapel Hill|||4||f||||f||||||||||2017-10-11 04:08:26.923831|2017-10-11 04:08:26.923831
NCT01371851|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-07-24|2015-06-22||June 2011||2011-06-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Those eligible participants who received at least one dose of study medication.|Doxazosin for Psychostimulant Dependence|Clinical Efficacy of Doxazosin for Psychostimulant Dependence|Completed||Phase 1/Phase 2|22|Actual|University of Arkansas||2|||f||||t||||||||||2017-10-11 04:08:26.998849|2017-10-11 04:08:26.998849
NCT01371539|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-06-28|2012-06-28||June 2011||2011-06-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Clinical Comparison of Two Multifocal Contact Lenses Made of Silicone Hydrogel Materials|Clinical Comparison of Two Multifocal Contact Lenses Made of Silicone Hydrogel Materials|Completed||N/A|109|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 04:08:37.946243|2017-10-11 04:08:37.946243
NCT01371838|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2017-09-01|2014-05-28||December 2011||2011-12-01|September 2017|2017-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||All randomized subjects who were intended to receive study treatment and were of PORT risk class III and IV. There was one patient with PORT risk class II who was not included in baseline analysis population.|A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia|A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia|Completed||Phase 3|848|Actual|Pfizer||2|||f||||||||||||||2017-10-11 04:08:27.58936|2017-10-11 04:08:27.58936
NCT01371825|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2016-08-04|2016-01-14||May 2011||2011-05-01|August 2016|2016-08-01|April 2018|Anticipated|2018-04-01|August 2014|Actual|2014-08-01||Interventional|VITAL||SurVival of Lysosomal Acid Lipase Deficiency (LAL-D) Infants Treated With SebelipAse aLfa|An Open Label, Multicenter, Dose Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SBC-102 (Sebelipase Alfa) in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency|Active, not recruiting||Phase 2/Phase 3|9|Actual|Alexion Pharmaceuticals||1|||f||||t||||||||Undecided||2017-10-11 04:08:28.802002|2017-10-11 04:08:28.802002
NCT01371812|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-07-18|||March 29, 2011|Actual|2011-03-29|July 2017|2017-07-01|July 1, 2011|Actual|2011-07-01|July 1, 2011|Actual|2011-07-01||Interventional|||GSK2239633 FTIH Study|A Randomised, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses of GSK2239633 in Healthy Male Subjects.|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 04:08:29.581539|2017-10-11 04:08:29.581539
NCT01371799|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2017-06-12|||December 17, 2009|Actual|2009-12-17|June 2017|2017-06-01|June 18, 2010|Actual|2010-06-18|June 18, 2010|Actual|2010-06-18||Interventional|MAA113746||A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers|A Double Blind, Randomized, Placebo Controlled, Cross-over Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers|Completed||Phase 1|9|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:08:29.680164|2017-10-11 04:08:29.680164
NCT01371786|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-09-05|2012-08-03||June 2011||2011-06-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler|A Phase 1, Open Label, Two Period, Randomized, Cross Over Scintigraphy Study Assessing Nasal Deposition of a Single Dose of a Ciclesonide Radiolabeled Solution Following Nasal Inhalation of a Novel Nasal Metered Dose Inhaler (MDI) and of a Mometasone Furoate Monohydrate Radiolabeled Suspension Via an Aqueous (AQ) Nasal Spray|Completed||Phase 1|14|Actual|Sunovion|Both the formulations used in this study were radiolabeled and not the individual corticosteroid molecules. Therefore the distribution of the corticosteroid molecules over 10 minutes post-administration was not quantified.|2|||f||||f||||||||||2017-10-11 04:08:29.79566|2017-10-11 04:08:29.79566
NCT01371773|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-12-07|||June 2011||2011-06-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Repositioning Method for Left-sided Double Lumen Tubes|Repositioning Method for Left-sided Double Lumen Tubes Introduced Into Right Mainstem Bronchus|Completed||N/A|50|Anticipated|Seoul National University Hospital||1|||f||||f||||||||||2017-10-11 04:08:30.195453|2017-10-11 04:08:30.195453
NCT01371760|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-12-16|||August 2012||2012-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|BRAVE-DREAMS||BRAVE-DREAMS (BRAin VEnous DRainage Exploited Against Multiple Sclerosis)|Randomized Multi-centered Study for Evaluating the Efficacy and Safety of Angioplastic Surgery of the Extracranial Veins in the Treatment of Multiple Sclerosis. Studio Randomizzato Multicentrico Per la Valutazione Dell'Efficacia e Sicurezza Dell'Intervento di Disostruzione Delle Vene Extracraniche Nel Trattamento Della Sclerosi Multipla|Completed||N/A|212|Actual|S. Anna Hospital||2|||f||||t||||||||Yes|Data analysis on behalf of the independent Biostatistic Center will be completed within May 2016|2017-10-11 04:08:30.27333|2017-10-11 04:08:30.27333
NCT01371747|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-04-24|2015-11-11|2014-10-30|June 2011||2011-06-01|April 2017|2017-04-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|AMETHYST-DN|306 participants were randomized and stratified by baseline serum potassium (2 randomized participants in Stratum 1 did not receive any study drug: 1 participant withdrew consent and 1 participant was randomized in error and was withdrawn from the study); 304 participants were analyzed for safety.|Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)|A Multicenter, Randomized, Open-Label, Dose Ranging Study to Evaluate the Efficacy and Safety of Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy Receiving Angiotensin-converting Enzyme Inhibitor (ACEI) and/or Angiotensin II Receptor Blocker (ARB) Drugs, With or Without Spironolactone|Completed||Phase 2|324|Actual|Relypsa, Inc.||6|||f||||f||||||||||2017-10-11 04:08:30.442915|2017-10-11 04:08:30.442915
NCT01371734|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-01-30|2016-03-07||August 2011||2011-08-01|January 2017|2017-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||Safety population - included all randomized participants who received at least 1 dose of study drug.|A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Evaluate The Efficacy, Safety And Tolerability Of Desvenlafaxine Succinate Sustained-release (Dvs Sr) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder|Completed||Phase 3|363|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 04:08:32.343914|2017-10-11 04:08:32.343914
NCT01371721|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2016-12-16|2016-04-19||February 2012||2012-02-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||Safety population - included all randomized participants who received at least 1 dose of study drug.|A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD|A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder|Completed||Phase 3|269|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 04:08:33.399055|2017-10-11 04:08:33.399055
NCT01371708|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-06-28|2016-10-14||February 2, 2012|Actual|2012-02-02|June 2017|2017-06-01|April 22, 2016|Actual|2016-04-22|April 22, 2016|Actual|2016-04-22||Interventional||All participants who received at least 1 dose of study drug|A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD|A 6-month, Open-label, Multi-center, Flexible Dose Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder|Completed||Phase 3|283|Actual|Pfizer||1|||f||||t|t|f||||||||2017-10-11 04:08:34.270331|2017-10-11 04:08:34.270331
NCT01371695|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-10|||May 2011||2011-05-01|June 2011|2011-06-01|September 2013|Anticipated|2013-09-01|September 2011|Anticipated|2011-09-01||Observational|||Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer|Phase 1 of Serum IGF II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer|Unknown status|Enrolling by invitation|N/A|60|Actual|Onconix, Inc|||1||f||||f||||||Samples With DNA|"     frozen serum   "|||2017-10-11 04:08:35.188305|2017-10-11 04:08:35.188305
NCT01371682|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-10|2017-06-21|||September 18, 2009|Actual|2009-09-18|June 2017|2017-06-01|December 2, 2009|Actual|2009-12-02|December 2, 2009|Actual|2009-12-02||Interventional|||A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda|An Open Label Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets (Ropinirole XL, Marketed as REQUIP-MODUTAB™, REQUIP XL™ at 2 mg) Manufactured at Crawley and Aranda|Completed||Phase 1|50|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:08:35.25351|2017-10-11 04:08:35.25351
NCT01371669|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-13|2013-03-27|||June 2010||2010-06-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|Sommeil_HTAP||Screening for Sleep Hypoxemia in Pulmonary Arterial Hypertension|Study Searching for Hypoxemic Sleep Breathing Disorders in a Cohort of Patients With Idiopathic Pulmonary Arterial Hypertension (IPAH) and Chronic Post-embolic Pulmonary Hypertension (CPEPH)|Completed||N/A|50|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-10-11 04:08:35.329149|2017-10-11 04:08:35.329149
NCT01371656|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-04|2017-09-05|||June 2011||2011-06-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|June 2017|Actual|2017-06-01||Interventional|||Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation|A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)|Active, not recruiting||Phase 3|740|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:08:35.41938|2017-10-11 04:08:35.41938
NCT01371643|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2016-07-25|2016-02-05||April 2004||2004-04-01|July 2016|2016-07-01|December 2011|Actual|2011-12-01|July 2010|Actual|2010-07-01||Interventional|||Surgical Debulking of Pituitary Adenomas|Does Surgical Debulking Of Pituitary Adenomas Improve Responsiveness To Octreotide LAR In The Treatment Of Acromegaly: An Investigator-Initiated Study|Completed||Phase 4|41|Actual|New York University School of Medicine||2|||f||||||||||||||2017-10-11 04:08:35.847369|2017-10-11 04:08:35.847369
NCT01371630|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-08-16|||August 2011|Actual|2011-08-01|August 2017|2017-08-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Study of the Combination of Inotuzumab Ozogamycin (CMC-544) With Low-intensity Chemotherapy in Patients With Acute Lymphoblastic Leukemia (ALL)|Phase I/II Study of the Combination of Inotuzumab Ozogamycin (CMC-544) With Low-intensity Chemotherapy in Patients With Acute Lymphoblastic Leukemia (ALL)|Recruiting||Phase 1/Phase 2|206|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 04:08:36.293659|2017-10-11 04:08:36.293659
NCT01371617|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-11-14|||October 2011||2011-10-01|November 2012|2012-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Phase 2 Study With IPI-926 in Patients With Myelofibrosis|A Phase 2 Study of IPI-926 in Patients With Myelofibrosis|Completed||Phase 2|14|Actual|Infinity Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 04:08:36.489041|2017-10-11 04:08:36.489041
NCT01371604|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-02-05|||July 2011||2011-07-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)|A Randomized, Double-Blind Study to Evaluate the Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Infection|Completed||Phase 2|68|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 04:08:36.613168|2017-10-11 04:08:36.613168
NCT01371591|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-08-01|||August 1, 2017|Anticipated|2017-08-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|CHEER||Capsule Endoscopy for Hemorrhage in the Emergency Room|Pilot Study to Investigate the Use of Wireless Capsule Endoscopy for Emergency Department Patients With Suspected Acute Upper Gastrointestinal Bleeding|Not yet recruiting||N/A|100|Anticipated|George Washington University||2|||f||||t|f|t|f|f||||||2017-10-11 04:08:36.74166|2017-10-11 04:08:36.74166
NCT01371578|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-01-14||2014-01-14|July 2011||2011-07-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy Using Combinations of Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection (Protocol GS US 256 0124)|Completed||Phase 2|163|Actual|Gilead Sciences||1|||f||||t||||||||||2017-10-11 04:08:36.918409|2017-10-11 04:08:36.918409
NCT01371565|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-02-19|2013-09-19||November 2010||2010-11-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional||Subjects who received one dose of study drug were included in the safety analysis.|Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome|Compassionate Use Protocol for the Administration of CORLUX® (Mifepristone) in the Treatment of the Signs and Symptoms of Endogenous Cushing's Syndrome|Completed||Phase 3|4|Actual|Corcept Therapeutics||1|||f||||f||||||||||2017-10-11 04:08:37.193686|2017-10-11 04:08:37.193686
NCT00005564|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1997||1997-07-01|July 2004|2004-07-01|June 2002|Actual|2002-06-01|||||Observational|||Impact of Adult Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:14.472069|2017-10-11 04:27:14.472069
NCT01371513|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-05-19|||May 2010||2010-05-01|May 2017|2017-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|RESPECT||Korean Practice Patterns for Screening PCA(Prostate Cancer)|Korean's Practice Patterns for Screening PCA(Prostate Cancer) According to PSA(Prostate-specific Antigen) Level|Completed||N/A|1|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:08:38.257012|2017-10-11 04:08:38.257012
NCT01371487|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-04-03|||May 2011||2011-05-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||GSK1120212 Food-effect Study|An Open-Label, Two-Period, Randomized, Crossover Study to Evaluate the Effect of Food on the Single Dose Pharmacokinetics of the MEK Inhibitor, GSK1120212, in Subjects With Solid Tumors|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 04:08:38.345477|2017-10-11 04:08:38.345477
NCT01371474|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-05-19|||April 2006||2006-04-01|May 2017|2017-05-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Observational|||Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)|Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)|Completed||N/A|1483|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:08:38.445047|2017-10-11 04:08:38.445047
NCT01371461|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-06-07|||January 2004||2004-01-01|May 2017|2017-05-01|October 2004|Actual|2004-10-01|July 2004|Actual|2004-07-01||Observational|||Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)|Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)|Completed||N/A|390|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:08:38.532238|2017-10-11 04:08:38.532238
NCT01371448|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-06-07|||May 2001||2001-05-01|May 2017|2017-05-01|September 2005|Actual|2005-09-01|September 2004|Actual|2004-09-01||Observational|||Special Drug Use Investigation for PAXIL Tablet (Long-term)|Special Drug Use Investigation for PAXIL Tablet (Long-term)|Completed||N/A|339|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 04:08:38.616131|2017-10-11 04:08:38.616131
NCT01371435|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-06-07|||April 2001||2001-04-01|May 2017|2017-05-01|December 2005|Actual|2005-12-01|September 2005|Actual|2005-09-01||Observational|||Drug Use Investigation for PAXIL Tablet|Drug Use Investigation for PAXIL Tablet|Completed||N/A|3708|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 04:08:38.690645|2017-10-11 04:08:38.690645
NCT01371422|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-10|2015-03-23|||August 2011||2011-08-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Trial Comparing the Effect of a Paravertebral Block on Pain Post Percutaneous Nephrolithotomy|Randomized Controlled Trial Comparing the Effect of a Paravertebral Block on Pain Post Percutaneous Nephrolithotomy|Terminated||N/A|3|Actual|University of British Columbia||2||There was no resources to complete the study at this time|f||||f||||||||||2017-10-11 04:08:38.780799|2017-10-11 04:08:38.780799
NCT01371409|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-06-27|||April 2011||2011-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|February 2014|Actual|2014-02-01||Interventional|InHIb||Interhemispheric Inhibitory Interactions|Interhemispheric Contributions to Neuroplasticity and Motor Learning After Stroke|Completed||N/A|49|Actual|University of British Columbia||2|||f||||f||||||||Undecided||2017-10-11 04:08:38.897777|2017-10-11 04:08:38.897777
NCT01371396|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2012-04-20|||September 2007||2007-09-01|April 2012|2012-04-01|June 2014|Anticipated|2014-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Effect of Dietary Macronutrient Composition|Effect of Dietary Macronutrient Composition on Liver Substrate Metabolism|Unknown status|Active, not recruiting|N/A|24|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 04:08:38.997702|2017-10-11 04:08:38.997702
NCT01371383|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2012-05-11|||January 2005||2005-01-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Effect of Fish Oil in Major Depressive Disorder|The Effect of Fish Oil in Major Depressive Disorder: a Double-blind Placebo-controlled Monotherapy Trail to Demonstrate the Therapeutic Effects of Depression|Completed||Phase 2/Phase 3|120|Actual|National Science Council, Taiwan||2|||f||||t||||||||||2017-10-11 04:08:39.080959|2017-10-11 04:08:39.080959
NCT01371370|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-08-04|||December 2010||2010-12-01|August 2014|2014-08-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Low-intensity Resistance Exercise and Diet on Arterial Function and Blood Pressure|Effects of Low-intensity Resistance Exercise Training and Diet on Central Hemodynamics and Arterial Stiffness in Obese Middle-aged Women With High Blood Pressure|Completed||N/A|41|Actual|Florida State University||4|||f||||f||||||||||2017-10-11 04:08:39.173458|2017-10-11 04:08:39.173458
NCT01371357|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-12-18|||May 2011||2011-05-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Effects of 8-week Choline, Betaine, and Folic Acid Supplementation on Plasma Homocysteine Concentration During Guanidinoacetic Acid Loading in Young Healthy Volunteers||Completed||Phase 3|40|Actual|Center for Health, Exercise and Sport Sciences, Serbia||4|||f||||t||||||||||2017-10-11 04:08:39.27268|2017-10-11 04:08:39.27268
NCT01371331|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-03-07|||June 2011||2011-06-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|OPTION||A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation|A Multicentre, Open-label, Pharmacokinetic Study of Modigraf® (Tacrolimus Granules) in de Novo Paediatric Allograft Recipients|Completed||Phase 4|52|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 04:08:39.474926|2017-10-11 04:08:39.474926
NCT01371318|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-12-29|||July 2011||2011-07-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|OWEMR||Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics|Wound EMR to Decrease Limb Amputations in Persons With Diabetes|Completed||N/A|1609|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 04:08:39.836786|2017-10-11 04:08:39.836786
NCT01371305|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2017-08-10|||July 16, 2012|Actual|2012-07-16|August 2017|2017-08-01|March 24, 2017|Actual|2017-03-24|March 24, 2017|Actual|2017-03-24||Interventional|||STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose-Escalation Study of STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 2|43|Actual|Biogen||2|||f||||t||||||||||2017-10-11 04:08:39.997037|2017-10-11 04:08:39.997037
NCT01371292|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-09-15|||January 2012||2012-01-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|AIM||A Transformational Teaching Intervention: Adolescents in Motion (AIM) Trial|A Transformational Teaching Intervention: Adolescents in Motion (AIM) Trial|Completed||N/A|2160|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 04:08:40.152955|2017-10-11 04:08:40.152955
NCT01371266|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-08-12|||June 2011||2011-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2014|Actual|2014-12-01||Interventional|||Glycemic Effects of Honey|Glycemic Effects of Honey|Completed||N/A|55|Actual|USDA Grand Forks Human Nutrition Research Center||3|||f||||t||||||||||2017-10-11 04:08:40.405683|2017-10-11 04:08:40.405683
NCT01371253|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2012-01-18|||June 2011||2011-06-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|WIICAN||10 Weeks of NIntendo wIi Fit balanCe Training Improved Postural balANce and Muscle Strength in Elderly Individuals|10 Weeks of NIntendo wIi Fit balanCe Training Improved Postural balANce and Muscle Strength in Elderly Individuals: Double Blinded, Randomised Controlled Trial|Completed||N/A|58|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-10-11 04:08:40.533076|2017-10-11 04:08:40.533076
NCT01371240|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-06-10|||June 2011||2011-06-01|June 2011|2011-06-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Interventional|||Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity|Evaluation of Efficiency of Secretin-Assisted Computed Tomography Scan and Secretin-Assisted Magnetic Resonance Imaging in Improving Pancreatic Enhancement and Tumor Conspicuity: Prospective Study|Unknown status|Recruiting|Early Phase 1|40|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||||||||||||2017-10-11 04:08:40.646054|2017-10-11 04:08:40.646054
NCT01371227|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2013-07-03|||April 2011||2011-04-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma|A Phase 1 of JNS002 (Doxorubicin HCl Liposome Injection) in Combination With Bortezomib for Japanese Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|3|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 04:08:40.742483|2017-10-11 04:08:40.742483
NCT01371214|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-06-02|||June 2011||2011-06-01|June 2015|2015-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PLIÉ-pilot||Preventing Loss of Independence Through Exercise (PLIÉ) - Pilot|Maintaining Independence in Alzheimer's Disease|Completed||Phase 1|12|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 04:08:40.852725|2017-10-11 04:08:40.852725
NCT01371201|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-01-25|||December 2011||2011-12-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Interventional|FIRSTMAPPP||First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma|First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)|Recruiting||Phase 2|74|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t||||||||||2017-10-11 04:08:40.961871|2017-10-11 04:08:40.961871
NCT01371188|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-09|||December 2008||2008-12-01|June 2011|2011-06-01|February 2011|Actual|2011-02-01|October 2010|Actual|2010-10-01||Observational|||Effects of Exposure to Biomass-burning Air Pollution on Lung Function, Heart Rate Variability and Inflammatory Markers in Sugarcane Workers|Effects of Exposure to Outdoor Air Pollution From Biomass Burning on Lung Function, Heart Rate Variability and Systemic Inflammatory Blood Markers in Sugarcane Workers|Completed||N/A|222|Actual|InCor Heart Institute|||2||f||||f||||||Samples With DNA|"     Whole blood.   "|||2017-10-11 04:08:41.114543|2017-10-11 04:08:41.114543
NCT01371175|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-09|||April 2003||2003-04-01|June 2011|2011-06-01||||May 2005|Actual|2005-05-01||Interventional|||A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers|A Randomized, Placebo-Controlled, Dosage-Escalating Phase 2A Study, Double-Blinded With Respect to Assignment to Either Vaccine or Placebo, to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Administered Intramuscularly Followed by an MVA HIV-1 Vaccine Administered at Three Different Dosage Levels and by Three Different Routes to HIV-Uninfected, Healthy, Volunteers.|Completed||Phase 2|115|Actual|International AIDS Vaccine Initiative||9|||f||||t||||||||||2017-10-11 04:08:41.18533|2017-10-11 04:08:41.18533
NCT01371162|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-11-01|||June 2011||2011-06-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C|A Multi-Center, Randomized, Double-Blind, Multiple Ascending Dose, Placebo-Controlled, Parallel Group 2-Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of the HCV Nucleoside Inhibitor RO5428029 in Healthy Subjects and in CHC Genotype 1 Infected Patients|Completed||Phase 1|42|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 04:08:41.302929|2017-10-11 04:08:41.302929
NCT01371149|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-04-02|||January 2011||2011-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Patient -Ventilator Interaction in Chronic Respiratory Failure|A Clinical Trial to Optimise Patient-ventilator Interaction in Patients With Chronic Respiratory Failure|Completed||Phase 2|58|Actual|Guy's and St Thomas' NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 04:08:41.403414|2017-10-11 04:08:41.403414
NCT01371136|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-11-16|||June 2010||2010-06-01|November 2015|2015-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Developing a Curriculum to Teach Laparoscopic Colorectal Surgery||Completed||N/A|25|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 04:08:41.502376|2017-10-11 04:08:41.502376
NCT01371123|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-07-26|||June 2011||2011-06-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Serum Aluminum Concentration of Pediatric Patients Receiving Long-Term Parenteral Nutrition|Serum Aluminum Concentration of Pediatric Patients Receiving Long-Term Parenteral Nutrition: Is There a Problem in Canada?|Completed||N/A|50|Actual|The Hospital for Sick Children|||2||f||||f||||||None Retained|"     serum   "|||2017-10-11 04:08:41.58949|2017-10-11 04:08:41.58949
NCT01371110|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-09-27|2017-04-18||June 2012||2012-06-01|September 2017|2017-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|IVKetamine||Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder|Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder|Terminated||Phase 1/Phase 2|3|Actual|Baylor College of Medicine|Early termination due to limited funding lead to small numbers of subjects analyzed (n=3) compared to what was planned (n=12).|2||no funding|f||||t|t|f||||||||2017-10-11 04:08:41.688252|2017-10-11 04:08:41.688252
NCT01371097|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-03-09|||September 2006||2006-09-01|March 2015|2015-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|B15||Progressive Resistance Strength Training (PRT) in Hospitalised Elderly Patients|The Effect of Progressive Resistance Strength Training in Hospitalised Elderly Patients|Completed||N/A|71|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-10-11 04:08:42.140721|2017-10-11 04:08:42.140721
NCT01371084|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2014-01-16|||June 2011||2011-06-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|Pedal@Work||Pedal@Work: A Worksite Wellness Program|Pilot Study to Test the Efficacy of a Worksite Intervention for Reducing Daily Sedentary Time and Improving Risk Factors for Cardiometabolic Disease Among Sedentary, Overweight, Full-time Working Adults|Completed||N/A|40|Actual|East Carolina University||2|||f||||f||||||||||2017-10-11 04:08:42.242337|2017-10-11 04:08:42.242337
NCT01371071|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-06-09|||January 2011||2011-01-01|June 2011|2011-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|CIS-COHORT||Cohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis|Clinically Isolated Syndrome and Newly Diagnosed Multiple Sclerosis: Diagnostic, Prognostic and Therapy - Response Markers - a Prospective Observational Study (Berlin CIS-COHORT)|Recruiting||N/A|200|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"     blood samples (serum and plasma, with DNA), urine, saliva, CSF (if routine lumbar puncture     was performed, no additional lumbar punctures for the study)   "|||2017-10-11 04:08:42.360036|2017-10-11 04:08:42.360036
NCT01371058|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2015-12-15|||March 2011||2011-03-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|spirit||Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)|Study of Policosanol to Improve High on Clopidogrel Platelet Reactivity After Percutaneous Coronary Stent Implantation(Spirit)|Completed||Phase 4|350|Actual|Shenyang Northern Hospital||3|||f||||t||||||||||2017-10-11 04:08:42.468475|2017-10-11 04:08:42.468475
NCT01371045|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2011-06-09|||June 2011||2011-06-01|June 2011|2011-06-01||||||||Observational|||Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs|Hormonal and Metabolic Responses to Oral Glucose During Somatostatin Analog Use|Unknown status|Recruiting|N/A|36|Anticipated|Cedars-Sinai Medical Center|||3||f||||f||||||Samples With DNA|"     Blood will be drawn (approx. 64cc) to gather baseline hormone and metabolic panels. Blood     will again be collected (approx. 36cc) during the Oral Glucose Tolerance Test.   "|||2017-10-11 04:08:42.565876|2017-10-11 04:08:42.565876
NCT01371032|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2017-04-04|||June 2011||2011-06-01|April 2017|2017-04-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Study: Study to Compare Video Miller Device to Direct Laryngoscopy|A Randomized, Prospective Study to Compare the Video Miller Device to Direct Laryngoscopy Using a Standard Pediatric Miller Blade for Tracheal Intubation of Children < 3 Years of Age Undergoing General Anesthesia|Enrolling by invitation||N/A|120|Anticipated|Cedars-Sinai Medical Center||2|||f||||f|f|f||||||||2017-10-11 04:08:42.664285|2017-10-11 04:08:42.664285
NCT01371019|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-06-09|||April 2011||2011-04-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Observational|PAPR||Proteomic Assessment of Preterm Birth|Proteomic Assessment of Preterm Birth|Completed||N/A|5500|Actual|Sera Prognostics, Inc.|||2||f||||t||||||Samples Without DNA|"     Serum, plasma   "|||2017-10-11 04:08:42.756398|2017-10-11 04:08:42.756398
NCT01371006|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2015-07-03|2015-07-03||June 2011||2011-06-01|July 2015|2015-07-01||||September 2011|Actual|2011-09-01||Interventional|||Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers|Effect of Multiple Dosing With 240mg q 12hrs BI 201335 on the Pharmacokinetics of 50 mg Single Dose Efavirenz and Effect of Multiple Dosing With 600mg QD Efavirenz on Cyp 3A4 and the Pharmacokinetics of BI 201335 in Healthy Volunteers|Completed||Phase 1|29|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 04:08:42.884657|2017-10-11 04:08:42.884657
NCT01370993|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-09|||May 2011||2011-05-01|May 2011|2011-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||The Prediction Model of Hypoxemia for Safe Bronchoscopy|The Prediction Model of Hypoxemia for Safe Bronchoscopy Under MAC Anesthesia|Unknown status|Recruiting|N/A|150|Anticipated|Seoul National University Bundang Hospital|||1||f||||t||||||||||2017-10-11 04:08:43.882183|2017-10-11 04:08:43.882183
NCT01370980|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2012-07-16|||July 2010||2010-07-01|July 2012|2012-07-01|September 2014|Anticipated|2014-09-01|December 2011|Actual|2011-12-01||Observational|||Collaborative Seamless Care in Oncology : Measure and Reinforce Safety and Adherence to Oral Cancer Treatment|Collaborative and Seamless Care in Oncology : a Study in Primary Care to Measure and Reinforce Safety and Adherence to Oral Cancer Treatment|Unknown status|Recruiting|N/A|80|Anticipated|Policlinique Médicale Universitaire|||1||f||||f||||||||||2017-10-11 04:08:43.97163|2017-10-11 04:08:43.97163
NCT01370967|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-12-23|||July 2011||2011-07-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant Formula|Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant Formula: A Prospective, Observational Cohort Study In China|Completed||Phase 4|460|Actual|Nestlé|||3||f||||f||||||||||2017-10-11 04:08:44.081705|2017-10-11 04:08:44.081705
NCT01370954|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-05-07|||May 2011||2011-05-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|||NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)|NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)|Completed||N/A|204|Actual|Pamlab, Inc.|||1||f||||f||||||||||2017-10-11 04:08:44.209325|2017-10-11 04:08:44.209325
NCT01370941|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2012-03-20|||April 2011||2011-04-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|Chymosin||The Effect of Chymosin on the Intestinal Absorption of Calcium|The Effect of Chymosin on the Intestinal Absorption of Calcium: A Randomized Controlled Cross-over Trial|Completed||Phase 1|125|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 04:08:44.302307|2017-10-11 04:08:44.302307
NCT01370928|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-21|2012-04-26|||March 2011||2011-03-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Colonoscopy Screening Using a Novel Slim Colonoscope - a Randomized Controlled Trial|Colonoscopy Screening Using a Novel Slim Colonoscope - a Randomized Controlled Trial|Completed||Phase 3|190|Actual|Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-11 04:08:44.405279|2017-10-11 04:08:44.405279
NCT01370915|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2011-06-09|||September 2010||2010-09-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|November 2011|Anticipated|2011-11-01||Interventional|||Perioperative Administration of Pregabalin for Pain After Septoplasty|Perioperative Administration of Pregabalin for Pain After Septoplasty|Unknown status|Recruiting|N/A|100|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 04:08:46.173837|2017-10-11 04:08:46.173837
NCT01370902|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-12-20|||May 2011||2011-05-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis|A Randomised, Double-blind, Placebo-controlled, Single-dose and Multiple-dose, Dose-escalation Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis|Completed||Phase 1|92|Actual|Innate Pharma||3|||f||||f||||||||||2017-10-11 04:08:46.273533|2017-10-11 04:08:46.273533
NCT01370889|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-10-08|||June 2011||2011-06-01|April 2014|2014-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Resveratrol in Postmenopausal Women With High Body Mass Index|Pilot Study of Resveratrol in Postmenopausal Women With High Body Mass Index|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:08:46.367328|2017-10-11 04:08:46.367328
NCT01370876|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2013-12-09|||September 2010||2010-09-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|August 2011|Actual|2011-08-01||Interventional|||Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Trial Evaluating Efficacy and Safety of Opatin® (Oxaliplatin)/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer|Terminated||Phase 2|46|Anticipated|Nang Kuang Pharmaceutical Co., Ltd.||1||company policy|f||||t||||||||||2017-10-11 04:08:46.450992|2017-10-11 04:08:46.450992
NCT01370863|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-06-25|2013-04-15||December 2010||2010-12-01|April 2014|2014-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||The Safety Population was used defined as all subjects randomized into the study with at least 1 administration of the investigational product. Two subjects never received investigational product (n = 65).|An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients|An Explorative, Randomized, Placebo-controlled, DB, Parallel-group Trial, to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Subjects With GERD & With Persistent Symptoms Despite Taking a Stable Dose of PPIs|Terminated||Phase 2|67|Actual|Shire|Results data should be interpreted with caution since the study’s early termination affects the statistical power to detect true differences between treatment groups.|2||This study was terminated early due to recruitment difficulties. There were no safety concerns.|f||||f||||||||||2017-10-11 04:08:46.542469|2017-10-11 04:08:46.542469
NCT01370850|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2011-06-09|||March 2011||2011-03-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Clinical Validation Study of RTVue Features|Clinical Validation Study of RTVue Features|Completed||N/A|53|Actual|Optovue|||3||f||||f||||||||||2017-10-11 04:08:46.916876|2017-10-11 04:08:46.916876
NCT01370837|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-04-16|2015-03-30||May 2012||2012-05-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Neurogenic Inflammation in Diabetes|Neurogenic Inflammation in Diabetic Polyneuropathy and Charcot Neuro-osteoarthropathy: Response to Intracutaneous Candida Albicans|Completed||N/A|41|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-10-11 04:08:46.990698|2017-10-11 04:08:46.990698
NCT01370824|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-05-16|||June 2011||2011-06-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Clinical Diagnosis of Basal Cell Carcinoma Subtype|Clinical Diagnosis Versus Histological Diagnosis by Punch Biopsy to Determine the Subtype of Basal Cell Carcinoma|Completed||N/A|150|Actual|Maastricht University Medical Center|||1||f||||f||||||Samples Without DNA|"     A punch biopsy and surgical excision of the BCC will be performed. Both biospecimens will be     prepared with either frozen section histology, or paraffin embedded fixed tissue pathology.   "|||2017-10-11 04:08:47.435573|2017-10-11 04:08:47.435573
NCT01370798|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-08-18|||May 2011||2011-05-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|HYPOSPADES||Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications|Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications.|Active, not recruiting||Phase 3|485|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 04:08:47.659681|2017-10-11 04:08:47.659681
NCT01370785|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-06-09|||||||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 04:08:47.778764|2017-10-11 04:08:47.778764
NCT01370772|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2016-03-15|||May 2011||2011-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|September 2014|Actual|2014-09-01||Interventional|||Intensified Rituimab Prephase Before FCR in Untreated B-CLL|Phase II Multicentric, Randomized Trial, Exploring Intensified Rituximab Prephase Monotherapy Before Standard Fludarabine-Cyclophosphamide-Rituximab Regimen in Previously Untreated Symptomatic B-cell Chronic Lymphocytic Leukemia|Completed||Phase 2|140|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||No||2017-10-11 04:08:47.817112|2017-10-11 04:08:47.817112
NCT01370759|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-09|2014-04-09|||September 2011||2011-09-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|RD-400||Feasibility Study to Evaluate the Performance of Flocculation-Adsorption System for Colon Cleansing Enhancement|Flocculation-Adsorption System for Colon Cleansing Enhancement: A Feasibility Study|Terminated||Phase 1|81|Actual|Given Imaging Ltd.||1||Terminated due to sponsor desicioun|f||||f||||||||||2017-10-11 04:08:47.944258|2017-10-11 04:08:47.944258
NCT01370746|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-06-01|||April 2012||2012-04-01|June 2017|2017-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation|Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation (CTOTC-05)|Completed||N/A|502|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||t||||||||||2017-10-11 04:08:48.032777|2017-10-11 04:08:48.032777
NCT01370733|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-10-05|2015-06-02||May 2012||2012-05-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|NEST-MDD||Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder|Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial|Completed||Phase 3|202|Actual|NeoSync, Inc.||2|||f||||f||||||||||2017-10-11 04:08:48.22924|2017-10-11 04:08:48.22924
NCT01370720|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2012-06-16|||February 2010||2010-02-01|June 2012|2012-06-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|CMD-IBS09(2)||Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients|Effect of the Oral Administration in IBS Patients of the Association of 200 mg Micronised Palmitoylethanolamide (PEA) and 20 mg Polydatin, on Parameters of Intestinal Inflammation and Visceral Hyperalgesia.|Unknown status|Recruiting|Phase 2|60|Anticipated|CM&D Pharma Limited||2|||f||||f||||||||||2017-10-11 04:08:48.948241|2017-10-11 04:08:48.948241
NCT01370707|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2013-02-13|||April 2011||2011-04-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients|A Randomized, Double-blind, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Patients With Type 2 Diabetes and Inadequate Glycemic Control ; Phase III Study|Completed||Phase 3|187|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 04:08:49.050726|2017-10-11 04:08:49.050726
NCT01370694|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-06-06|2015-10-23||August 19, 2011|Actual|2011-08-19|June 2017|2017-06-01|December 1, 2014|Actual|2014-12-01|December 1, 2014|Actual|2014-12-01||Interventional|||Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)|An Open-Label, Single Arm Study of MK-8808 in Patients With Advanced CD20-Positive Follicular Lymphoma|Terminated||Phase 1|7|Actual|Merck Sharp & Dohme Corp.|The study was terminated for business reasons. Not all planned analyses were performed|1||The study was terminated for business reasons.|f||||f||||||||||2017-10-11 04:08:49.319667|2017-10-11 04:08:49.319667
NCT01370681|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-06-09|||October 2009||2009-10-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Pharmacokinetic Study of CJ30001 and HKB0701/SLM0807 in Healthy Subject|An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetics After Administration of CJ30001 and Co-administration of HKB0701/SLM0807 in Korean Healthy Subjects|Completed||Phase 1|30|Actual|CJ HealthCare Corporation||2|||f||||f||||||||||2017-10-11 04:08:49.6988|2017-10-11 04:08:49.6988
NCT01370668|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-10|2011-06-09|||January 2009||2009-01-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Functional Remediation for Bipolar Disorder|Comparative Efficacy of Two Psychosocial Strategies of Intervention (Neurocognitive vs Psychoeducative) as add-on Therapy Versus Treatment as Usual in Bipolar Disorder|Completed||N/A|198|Actual|Centro de Investigación Biomédica en Red de Salud Mental||3|||f||||f||||||||||2017-10-11 04:08:49.780825|2017-10-11 04:08:49.780825
NCT01370655|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-04-17|2017-02-17||June 2011||2011-06-01|April 2017|2017-04-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)|A Phase Ib, Randomized, Double-Blind, 4-Treatment, 2-Period Incomplete Block Study to Evaluate the Multiple Dose Effects of MK-7145 and Hydrochlorothiazide Compared to Placebo on Blood Pressure in Male Patients With Hypertension|Completed||Phase 1|46|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 04:08:49.903278|2017-10-11 04:08:49.903278
NCT01370642|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-03-03|2014-09-26||June 2011||2011-06-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)|A Phase III Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of MK-7009 When Administered Concomitantly With Peginterferon Alfa-2b and Ribavirin in Japanese Treatment-Naïve Patients With Chronic Hepatitis C Infection|Completed||Phase 3|294|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 04:08:51.28727|2017-10-11 04:08:51.28727
NCT01370629|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-07-29|||August 2011||2011-08-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)|A Prospective Observational Registry Study to Characterise Normal Conditions of Use, Dosing and Safety Following Administration of Vernakalant IV Sterile Concentrate|Recruiting||N/A|2000|Anticipated|Cardiome Pharma|||1||f||||t||||||||||2017-10-11 04:08:52.39539|2017-10-11 04:08:52.39539
NCT01370616|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-02-17|2014-11-24||September 2011||2011-09-01|February 2017|2017-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All Randomized Participants|Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)|A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium in the Treatment of Diabetic Foot Infections in Chinese Adults|Completed||Phase 3|565|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:08:52.716146|2017-10-11 04:08:52.716146
NCT01370603|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-01-21|2013-05-21||September 2011||2011-09-01|January 2015|2015-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)|A Randomized, Double-Blind, Active-Controlled, Multicenter, Crossover Study to Evaluate the Efficacy of Ezetimibe/Atorvastatin 10 mg/40 mg Fixed-Dose Combination Tablet Compared to Co-Administration of Marketed Ezetimibe 10 mg and Atorvastatin 40 mg in Patients With Primary Hypercholesterolemia|Completed||Phase 3|328|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:08:53.345652|2017-10-11 04:08:53.345652
NCT01370590|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-01-21|2013-05-17||September 2011||2011-09-01|January 2015|2015-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)|A Randomized, Double-Blind, Active-Controlled, Multicenter, Crossover Study to Evaluate the Efficacy and Safety of Ezetimibe/Atorvastatin 10 mg/20 mg Fixed-Dose Combination Tablet Compared to Co-administration of Marketed Ezetimibe 10 mg and Atorvastatin 20 mg in Patients With Primary Hypercholesterolemia|Completed||Phase 3|406|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:08:53.815426|2017-10-11 04:08:53.815426
NCT01370577|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-01-11|||July 2011||2011-07-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|Prelude||The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly|The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly|Completed||N/A|297|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:08:54.289244|2017-10-11 04:08:54.289244
NCT01370564|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-12-02|||June 2011||2011-06-01|December 2011|2011-12-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|IPC||Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures|Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures|Unknown status|Active, not recruiting|Phase 2|21|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-10-11 04:08:54.380511|2017-10-11 04:08:54.380511
NCT01370551|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2012-08-21|||April 2011||2011-04-01|January 2011|2011-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|Gynoflor||Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients|A Clinical Study of Pharmacokinetics, Efficacy and Safety of Vaginal Application of Lyophilised Lactobacilli and 0.03 mg Estriol (Gynoflor®) on Atrophic Vaginitis in Postmenopausal Breast Cancer Patients Treated With Aromatase Inhibitors|Completed||Phase 1|16|Actual|Medinova AG||1|||f||||f||||||||||2017-10-11 04:08:54.474569|2017-10-11 04:08:54.474569
NCT01370538|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-03-01|2012-10-19||August 2011||2011-08-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|NEXT2||Efficacy of Esomeprazole in Patients With Frequent Heartburn|A Phase III Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of 14 Day Treatment With Esomeprazole 20 mg Once Daily in Subjects With Frequent Heartburn|Completed||Phase 3|341|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:08:54.586468|2017-10-11 04:08:54.586468
NCT01370525|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-02-12|2012-10-19||August 2011||2011-08-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|NEXT1||Efficacy of Esomeprazole in Patients With Frequent Heartburn|A Phase III Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of 14 Day Treatment With Esomeprazole 20 mg Once Daily in Subjects With Frequent Heartburn|Completed||Phase 3|340|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:08:55.086911|2017-10-11 04:08:55.086911
NCT01370512|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-07-31|||November 2011||2011-11-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Droxidopa / Pyridostigmine in Orthostatic Hypotension|Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine Hypertension|Recruiting||Phase 2|45|Anticipated|Mayo Clinic||3|||f||||f||||||||||2017-10-11 04:08:55.539164|2017-10-11 04:08:55.539164
NCT01370499|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2014-04-14||2014-04-14|August 2011||2011-08-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of LY2216684 in Patients With Major Depression Disorder|Long-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Adult Patients With Major Depressive Disorder Who Were Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment|Completed||Phase 3|237|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:08:55.635123|2017-10-11 04:08:55.635123
NCT01370486|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-06-09|||August 2011||2011-08-01|June 2011|2011-06-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects|Double Blind, Randomised, Cross-over Study Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects|Unknown status|Not yet recruiting|Phase 4|6|Anticipated|Institution de Lavigny||2|||f||||f||||||||||2017-10-11 04:08:55.740364|2017-10-11 04:08:55.740364
NCT01370473|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2015-03-19|||December 2006||2006-12-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|Hyponatremia||Institutional Registry of Hyponatremia|Institutional Registry of Hyponatremia|Completed||N/A|2000|Actual|Hospital Italiano de Buenos Aires|||1||f||||f||||||||||2017-10-11 04:08:55.832904|2017-10-11 04:08:55.832904
NCT01370460|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2013-07-03|2013-03-27||June 2011||2011-06-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty|Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty|Completed||Phase 2|101|Actual|Henry Ford Health System|Blood loss was calculated taking change in hemoglobin as described (units g/dL) and converting to blood loss (mL) according to the formulas includes in the papers cited in this entry (Good 2003 Br J Anesthesia; Nadler 1962 Surgery).|2|||f||||f||||||||||2017-10-11 04:08:55.909993|2017-10-11 04:08:55.909993
NCT01370447|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2016-03-18|||February 2010||2010-02-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||EPI-743 for Mitochondrial Respiratory Chain Diseases|Emergency Use Protocol for EPI-743 in Acutely Ill Patients With Inherited Mitochondrial Respiratory Chain Disease Within 90 Days of End-of-Life Care|Active, not recruiting||Phase 2|87|Actual|Edison Pharmaceuticals Inc||1|||f||||f||||||||||2017-10-11 04:08:56.284845|2017-10-11 04:08:56.284845
NCT01370434|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-06-09|||July 2006||2006-07-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|PADinMM||Two Cycles of PAD Combination by AHCT in MM|Two Cycles of Pad Combination (Ps-341/Bortezomib, Adriamycin, and Dexamethasone) Followed by Autologous Hematopoietic Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients|Completed||Phase 2|43|Actual|Cooperative Study Group A for Hematology||1|||f||||t||||||||||2017-10-11 04:08:56.38114|2017-10-11 04:08:56.38114
NCT01370421|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-04-02|||April 2011||2011-04-01|April 2014|2014-04-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Observational|POKR||Prediction of Outcomes Following Total Knee Replacement|Prediction of Outcomes Following Total Knee Replacement|Unknown status|Recruiting|N/A|200|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"     saliva and blood   "|||2017-10-11 04:08:56.476143|2017-10-11 04:08:56.476143
NCT01370408|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-03-16|2016-10-06||February 2012||2012-02-01|March 2017|2017-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients|A Unique Schedule of Palonosetron, Ondansetron, and Dexamethasone for the Prevention of Delayed Nausea and Vomiting in Patients Receiving Moderately Emetogenic Myeloablative Chemotherapy|Completed||Phase 2|85|Actual|Northside Hospital, Inc.||1|||f||||f||||||||No||2017-10-11 04:08:56.565736|2017-10-11 04:08:56.565736
NCT01370382|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-04-16|||January 2011||2011-01-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|BOSCH2||Comparison Between the New Highly Sensitive Troponin T and the Conventional Troponin T Test in Elderly Patients|Comparison Between the New Highly Sensitive Troponin T and the Conventional Troponin T Test of the 4th Generation for the Early Identification of Myocardial Necrosis in Elderly Patients With Acute Coronary Syndromes Without ST-segment Elevation|Completed||N/A|180|Actual|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||Samples Without DNA|"     Serum and plasma blood samples   "|||2017-10-11 04:08:57.548198|2017-10-11 04:08:57.548198
NCT01370369|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-08-15|2017-06-29|2012-07-16|May 2011||2011-05-01|August 2017|2017-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||The data are presented for Intent-to-treat (ITT) population, which comprised of all subjects who received at least one dose of the Investigational Medicinal Product (IMP). In this study, the safety, ITT, full analysis set (FAS) and per protocol (PP) populations were identical.|Efficacy, Pharmacokinetics and Safety of Testosterone|A Phase 2 Open-Label, Sequential Dose Escalation Study to Evaluate the Efficacy, Pharmacokinetics and Safety of Three Volumes (1.25, 2.50 and 3.75 mL) of Testosterone Gel 2% (FE 999303) Equivalent to 23, 46 And 70 mg of Testosterone in Hypogonadal Males|Completed||Phase 2|20|Actual|Ferring Pharmaceuticals||6|||f||||f||||||||||2017-10-11 04:08:57.671467|2017-10-11 04:08:57.671467
NCT01370356|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2014-08-29|2014-07-02||July 2011||2011-07-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction|A Phase 4, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction|Completed||Phase 4|1510|Actual|Pfizer|Two cases of fetal exposure during pregnancy occurred but are not included in the SAE section as they did not meet the criteria of serious in the safety database. One of them relates to a non-study participant who was the study participant`s partner.|2|||f||||t||||||||||2017-10-11 04:08:58.387768|2017-10-11 04:08:58.387768
NCT01370343|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-09-03|||July 2011||2011-07-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health Volunteers|A Phase 1, Single-Dose, Open-Label, Crossover Study To Assess The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Healthy Adult Subjects|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:08:59.240527|2017-10-11 04:08:59.240527
NCT01370330|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-06-14|||April 2000||2000-04-01|June 2012|2012-06-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Expanded Access|||131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol|131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol|Available||N/A|||University of California, San Francisco|||||||||f||||||||||2017-10-11 04:08:59.33769|2017-10-11 04:08:59.33769
NCT01370317|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-01-19|||June 2011||2011-06-01|January 2016|2016-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study To Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma|Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-1029 or Placebo in Patients With Mild to Moderate Asthma|Completed||Phase 1|27|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:08:59.459471|2017-10-11 04:08:59.459471
NCT01370304|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2012-02-13|||June 2011||2011-06-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Repetitive Transcranial Magnetic Stimulation Compared or Associated With Venlafaxine for Depressive Disorder|Repetitive Transcranial Magnetic Stimulation (rTMS) Compared or Associated With Venlafaxine for Depressive Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study|Unknown status|Recruiting|Phase 3|60|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 04:08:59.561219|2017-10-11 04:08:59.561219
NCT01370291|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2012-02-13|||June 2011||2011-06-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|rTMSfMRI||Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients|Repetitive Transcranial Magnetic Stimulation (rTMS) for First-episode Schizophrenia Patients:A Double-blinded , Randomized and Functional Magnetic Resonance Imaging (fMRI)Study|Unknown status|Recruiting|Phase 3|60|Anticipated|Xijing Hospital||3|||f||||t||||||||||2017-10-11 04:08:59.667129|2017-10-11 04:08:59.667129
NCT01370278|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-07-21|||June 2011|Actual|2011-06-01|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Clearance Of Mucus In Stents|Clearance Of Mucus In Stents (COMIS)|Recruiting||N/A|40|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 04:08:59.777772|2017-10-11 04:08:59.777772
NCT01370265|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2013-09-03|2012-10-06||February 2011||2011-02-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress|Quantification of Myocardial Blood Flow by Positron Emission Tomography and N-13 Ammonia During Regadenoson vs Adenosine Stress|Completed||N/A|12|Actual|Mayo Clinic|Small sample size; Subjects had no evidence of overt coronary artery disease, occult coronary artery disease affecting stress drug induced hyperemic PET MBF is a possibility; however, hyperemic MBF with both stress drugs would be equally affected.|2|||f||||f||||||||||2017-10-11 04:08:59.899526|2017-10-11 04:08:59.899526
NCT01370252|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-06-08|||June 2011||2011-06-01|June 2011|2011-06-01||||||||Observational|||Arthroscopic Ankle Arthrodesis: Measuring Post-operative Pain to Assess the Potential for Outpatient Surgery.|Arthroscopic Ankle Arthrodesis: Measuring Post-operative Pain to Assess the Potential for Outpatient Surgery.|Unknown status|Recruiting|N/A|40|Anticipated|Hammond, Allan, M.D.|||2||f||||f||||||||||2017-10-11 04:09:00.393967|2017-10-11 04:09:00.393967
NCT01370239|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-03-06|||November 2013||2013-11-01|March 2017|2017-03-01|October 2017|Anticipated|2017-10-01|October 2015|Actual|2015-10-01||Interventional|||HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy|A Multicenter Phase II Study of Treatment With Hu3S193 in Women With Advanced Breast Cancer That Progressed After Hormonal Therapy|Suspended||Phase 2|60|Anticipated|Instituto do Cancer do Estado de São Paulo||1||futility|f||||t||||||||||2017-10-11 04:09:00.477501|2017-10-11 04:09:00.477501
NCT01370226|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-04-06|||January 2012||2012-01-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Health Explorer - Optimizing Alcohol Brief Interventions|Optimizing Alcohol Brief Interventions in the ED: Computer vs. Clinician Delivery|Completed||N/A|750|Actual|University of Michigan||3|||f||||f||||||||No||2017-10-11 04:09:00.571913|2017-10-11 04:09:00.571913
NCT01370213|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-03-24|||September 2011||2011-09-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|January 2017|Anticipated|2017-01-01||Interventional|||NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases|Multi-Center Phase II Trial of NK Cell Based Non-Myeloablative Haploidentical Transplantation for Patients With High-Risk Acute Myeloid Diseases|Active, not recruiting||Phase 2|25|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-10-11 04:09:00.656068|2017-10-11 04:09:00.656068
NCT01370200|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2015-05-26|||April 2011||2011-04-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Regional Citrate Anticoagulation in Plasma Exchange Treatment|Regional Citrate Anticoagulation in Plasma Exchange Treatment|Completed||N/A|140|Actual|University Medical Centre Ljubljana||2|||f||||f||||||||||2017-10-11 04:09:00.780732|2017-10-11 04:09:00.780732
NCT01370187|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-06-13|||July 2010||2010-07-01|June 2010|2010-06-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing|Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing in Infants 3 to 12 Months of Age in Bandar Abbas Children' Hospital|Completed||N/A|146|Actual|Hormozgan University of Medical Sciences||2|||f||||t||||||||||2017-10-11 04:09:01.009024|2017-10-11 04:09:01.009024
NCT01370174|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-08-09|||July 2011||2011-07-01|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|December 9, 2016|Actual|2016-12-09||Interventional|LIFT||Intervention to Enhance Lateral Balance Function and Prevent Falls in Aging|Intervention to Enhance Lateral Balance Function and Prevent Falls in Aging|Active, not recruiting||N/A|100|Anticipated|University of Maryland||4|||f||||t||||||||||2017-10-11 04:09:01.110343|2017-10-11 04:09:01.110343
NCT01370161|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-07-29|||July 2011||2011-07-01|July 2017|2017-07-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for High Risk Acute Variceal Bleeding in Cirrhotic Patients|Early Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene Covered Stents Versus Standard Medical Therapy for High Risk Acute Variceal Bleeding in Cirrhotic Patients|Recruiting||N/A|120|Anticipated|Fourth Military Medical University||2|||f||||||||||||||2017-10-11 04:09:01.23675|2017-10-11 04:09:01.23675
NCT01370148|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2014-04-30|||April 2011||2011-04-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan|A Phase 1, Open-Label Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan|Completed||Phase 1|17|Actual|Cumberland Pharmaceuticals||2|||f||||f||||||||||2017-10-11 04:09:01.398382|2017-10-11 04:09:01.398382
NCT01370135|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2013-01-15|||November 2008||2008-11-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|LucNVG0108||Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma|An Open Label, Prospective, Monocenter, Prove of Concept Study to Evaluate the Short- and Long-term Effects of 0.5mg Intraocular Ranibizumab (Lucentis) Injections as Adjuvant for Patients With Rubeosis and Neovascular Glaucoma|Completed||N/A|20|Actual|University of Luebeck||1|||f||||t||||||||||2017-10-11 04:09:01.544891|2017-10-11 04:09:01.544891
NCT01370122|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-07-18|||May 2011||2011-05-01|July 2016|2016-07-01||||October 2012|Actual|2012-10-01||Observational|||Pelvic Floor Disorders in Survivors of Gynecologic Malignancies|The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors|Active, not recruiting||N/A|225|Actual|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-11 04:09:01.672695|2017-10-11 04:09:01.672695
NCT01370109|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-12-06|||April 2011||2011-04-01|December 2016|2016-12-01||||April 2017|Anticipated|2017-04-01||Observational|||Cardiovascular Effects of Sunitinib Therapy (CREST)|The Cardiovascular Effects of Sunitinib Therapy: Off Target Changes in Cardiac Metabolism and Ventricular Vascular Mechanics (CREST)|Recruiting||N/A|20|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||4||f||||t||||||||||2017-10-11 04:09:01.775714|2017-10-11 04:09:01.775714
NCT01370096|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-10-24|||February 2012||2012-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension|Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension|Terminated||Phase 2|3|Actual|University of Alberta||1||Difficulty with patient recruitment|f||||t||||||||No||2017-10-11 04:09:01.901361|2017-10-11 04:09:01.901361
NCT01370083|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-01-14|2015-11-24||September 2011||2011-09-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|TPPT|Individuals with dysphagia following stroke (within 4-16 weeks post onset) with radiographically confirmed difficulties with thin liquid bolus control.|Tongue Pressure Profile Training for Dysphagia Post Stroke|Tongue Pressure Profile Training for Dysphagia Post Stroke|Completed||Phase 2|14|Actual|Toronto Rehabilitation Institute||2|||f||||f||||||||||2017-10-11 04:09:02.016138|2017-10-11 04:09:02.016138
NCT01370070|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-01-11|||July 2011||2011-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2016|Actual|2016-12-01||Interventional|MC1079||MK-2206 in Recurrent Nasopharyngeal Carcinoma|Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma|Completed||Phase 2|12|Actual|Chinese University of Hong Kong||1|||f||||||||||||||2017-10-11 04:09:02.433457|2017-10-11 04:09:02.433457
NCT01370057|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-07-18|||May 2011||2011-05-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||The Use of Thoraco-lumbo-sacral Orthoses (TLSOs) in the Treatment of Adolescent Idiopathic Scoliosis (AIS)|The Use of TLSOs in the Treatment of Adolescent Idiopathic Scoliosis: A Prospective, Randomized Controlled Study|Terminated||N/A|2|Actual|Chinese University of Hong Kong||2||Failure of Subject Recruitment|f||||f||||||||||2017-10-11 04:09:02.509893|2017-10-11 04:09:02.509893
NCT01370044|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-07-27|||August 2012||2012-08-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|CARDIF||Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures|Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures|Terminated||Phase 2/Phase 3|96|Actual|Charite University, Berlin, Germany||2||results of interim analysis (not safety relevant)|f||||||||||||||2017-10-11 04:09:02.59548|2017-10-11 04:09:02.59548
NCT01370031|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2017-03-28|||April 2011||2011-04-01|March 2017|2017-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices|Pilot, Open-Label, Randomized, Repeated Dose, 4-Way Cross-Over, Clinical Pharmacology Study of Beclomethasone Dipropionate (Clenil® Modulite®) 250 µg HFA pMDI Using the Aerochamber Plus™ Spacer Device Versus the Volumatic™ Spacer Device Without or With Charcoal Block in Asthmatic Adults Patients|Completed||Phase 2|16|Actual|Chiesi Farmaceutici S.p.A.||4|||f||||f||||||||||2017-10-11 04:09:02.68642|2017-10-11 04:09:02.68642
NCT01370005|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2016-01-22|2014-05-16||June 2011||2011-06-01|January 2016|2016-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Full analysis set (FAS) included all randomised and treated patients who had a baseline HbA1c value and a baseline mean 24-h SBP value. Treatment assignment as randomized|12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus|A Phase III Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of BI 10773 (10 mg, 25 mg) Administered Orally, Once Daily Over 12 Weeks in Hypertensive Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|825|Actual|Boehringer Ingelheim||3|||f||||||||||||Yes|Boehringer Ingelheim Policy on Transparency and Publication http://trials.boehringer-ingelheim.com/transparency_policy.html|2017-10-11 04:09:02.937951|2017-10-11 04:09:02.937951
NCT01369992|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2011-06-08|||May 2011||2011-05-01|June 2011|2011-06-01|May 2013|Anticipated|2013-05-01|||||Observational|||Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites|Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites|Unknown status|Active, not recruiting|N/A|20|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 04:09:04.189663|2017-10-11 04:09:04.189663
NCT01369979|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2012-06-25|||May 2011||2011-05-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Hepatic Sugar Metabolism Measured by PET/CT in Patients and Healthy Subjects|Hepatic Glucose Metabolism Measured by FDG PET/CT in Patients With Liver Disease and Healthy Subjects|Completed||N/A|13|Actual|University of Aarhus|||2||f||||f||||||Samples Without DNA|"     Plasma for measuring levels of ICG, insulin, c.peptide, FFA, glucagon,and 3H-glucose.   "|||2017-10-11 04:09:04.266272|2017-10-11 04:09:04.266272
NCT01369966|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-10-05|||May 16, 2011||2011-05-16|December 24, 2014|2014-12-24|December 24, 2014||2014-12-24|||||Observational|||Brain Circuits in Schizophrenia and Smoking|Brain Circuits in Schizophrenia and Smoking|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:09:04.35757|2017-10-11 04:09:04.35757
NCT01369953|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-06-30|||May 29, 2011||2011-05-29|January 31, 2014|2014-01-31|January 31, 2014||2014-01-31|||||Observational|||Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants|Informed Consent for Whole Genome Sequencing: Civic Ideals and Social Norms Referenced by Early Participants|Completed||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:09:04.87693|2017-10-11 04:09:04.87693
NCT01369940|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-09-01|||May 29, 2011||2011-05-29|September 2017|2017-09-01|September 30, 2014|Actual|2014-09-30|August 25, 2013|Actual|2013-08-25||Observational|||The NICHD Fetal Growth Study: Twin Gestations|NICHD Fetal Growth Study: Twin Gestations|Completed||N/A|171|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||||||||||||2017-10-11 04:09:04.950155|2017-10-11 04:09:04.950155
NCT01369927|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-07-06|||May 15, 2011||2011-05-15|April 24, 2013|2013-04-24|April 24, 2013|Actual|2013-04-24|April 24, 2013|Actual|2013-04-24||Interventional|||Shigella Sonnel O-SPC/rBRU Conjugate Vaccine|Shigella Sonnel O-SPC/rBRU Conjugate Vaccine|Completed||Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:09:05.115593|2017-10-11 04:09:05.115593
NCT01369914|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-06-30|||May 20, 2011||2011-05-20|February 5, 2016|2016-02-05|February 5, 2016||2016-02-05|||||Observational|||The Natural History of Graft-Versus-Host Disease in the Eyes|The Natural History of Ocular Graft-Versus Host Disease|Completed||N/A|61|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:09:05.204339|2017-10-11 04:09:05.204339
NCT01369901|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-06-30|||May 20, 2011||2011-05-20|June 13, 2017|2017-06-13|March 13, 2014|Actual|2014-03-13|||||Interventional|||Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy|Effect of Functional Exercise in Patients With Spinal and Bulbar Muscular Atrophy|Completed||Phase 1/Phase 2|61|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:09:05.300084|2017-10-11 04:09:05.300084
NCT01369888|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-01-26|2015-01-15||May 2011||2011-05-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma|A Phase I/II Study of IL-15 Administration Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen and Autologous Lymphocyte Transfer in Metastatic Melanoma|Terminated||Phase 1/Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)||4||Closed this protocol due to autoimmune toxicity.|f||||f||||||||||2017-10-11 04:09:05.461906|2017-10-11 04:09:05.461906
NCT01369875|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2015-10-06|2013-02-14||May 2011||2011-05-01|September 2015|2015-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma|Phase II Study of Lymphocytes Generated With Engineered Cells for Costimulation Enhancement in Patients With Metastatic Melanoma Following Lymphodepletion|Completed||Phase 2|2|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:09:06.099428|2017-10-11 04:09:06.099428
NCT01369862|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-04|2014-01-09|||January 2011||2011-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults|Randomised, Double-blind, Placebo-controlled, Phase I/II Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults|Completed||Phase 1/Phase 2|80|Anticipated|AVIR Green Hills Biotechnology AG||2|||f||||f||||||||||2017-10-11 04:09:08.220206|2017-10-11 04:09:08.220206
NCT01369849|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2017-08-17|2016-05-20||September 2011||2011-09-01|August 2017|2017-08-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||All patients that began protocol treatment were included in the baseline analysis.|Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase I/II Study of the Combination of Bendamustine, Rituximab and MK-2206 in the Treatment of Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Completed||Phase 1/Phase 2|15|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:09:08.321967|2017-10-11 04:09:08.321967
NCT01369836|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-09-12|||July 2011||2011-07-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects|An Investigator And Subject-Blind Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-06291826 (Tafamidis) After Single Oral Administration To Japanese And Western Healthy Subjects|Completed||Phase 1|21|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 04:09:09.170714|2017-10-11 04:09:09.170714
NCT01369823|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-06-08|||June 2009||2009-06-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|||||Observational|DIAMOND-1||Diabetes Multicenter Observational Study (DIAMOND-1-)|Prospective, Multicenter, Non-interventional Post Market Release Study , to Examine Whether Pump Treatment Combined With the Use of Continuous Glucose Monitoring System is a Mean to Normalize Glycaemic Control.|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Medtronic Hellas Medical Devices ΑEE|||1||f||||f||||||||||2017-10-11 04:09:09.283396|2017-10-11 04:09:09.283396
NCT01369810|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-08|2013-11-29|||July 2011||2011-07-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease|Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or COPD in Iceland|Completed||N/A|20000|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:09:09.392031|2017-10-11 04:09:09.392031
NCT01369797|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-02-23|||May 2011||2011-05-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|GEROPASS||Prospective Randomized Study of the Impact on the Autonomy of the Elderly of 75 Years of Age and Older by the UPSAV|Prospective Randomized Study of the Impact on the Autonomy of the Elderly of 75 Years of Age and Older by the Unit for Prevention, Monitoring and Analysis of Aging (UPSAV).|Completed||N/A|440|Actual|University Hospital, Limoges||2|||f||||f||||||||||2017-10-11 04:09:09.472782|2017-10-11 04:09:09.472782
NCT01369784|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-23|2016-03-17|2014-07-21||February 2009||2009-02-01|March 2016|2016-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|PRO-R-IPI|12 patients were not included in the data analysis for not fulfilling selection criteria|Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma|Observational, Post-authorization, Cross-sectional Study to Evaluate the Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma|Completed||N/A|158|Actual|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea|||1||f||||f||||||||||2017-10-11 04:09:09.605097|2017-10-11 04:09:09.605097
NCT01369771|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-05|2014-10-27|||August 2010||2010-08-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma|An Open-label, Phase IV, Pilot Study, to Evaluate Confocal Microscopic Findings of Cornea, Ocular Signs and Symptoms in Patients With OH or OAG Switching From Latanoprost 0.005% to Preservative Free Tafluprost 0.0015% Eye Drops|Completed||Phase 4|30|Actual|FinnMedi Oy||1|||f||||f||||||||||2017-10-11 04:09:10.468589|2017-10-11 04:09:10.468589
NCT01369758|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-11|2017-08-09|2014-10-23||November 2010||2010-11-01|August 2017|2017-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||290 Subjects enrolled. Nine (9) subjects removed from analysis because they did not meet the inclusion criteria. Three (3) subjects removed from analysis because they met the exclusion criteria.|MyoSure Hysteroscopic Tissue Removal System Registry Study|MyoSure Hysteroscopic Tissue Removal System Registry Study|Completed||N/A|290|Actual|Hologic, Inc.||1|||f||||f||||||||||2017-10-11 04:09:10.556833|2017-10-11 04:09:10.556833
NCT01369745|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-04-29|2014-02-10||June 2011||2011-06-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|Synergy|population randomized to double blind phase of study and recieved at least one dose of study drug|A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis|A Phase II, Double-Blind, Placebo-Controlled, Multi-Center, Randomized Withdrawal Design Trial Using Adaptive Randomization Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis|Completed||Phase 2|294|Actual|Zalicus|The study did not progress past the first stage of adaptive randomization. The number of subjects allocated to the dipyridamole 360 mg, prednisolone 2.7 mg, and prednisone 5 mg arms was insufficient to allow analysis of the secondary objectives.|5|||f||||t||||||||||2017-10-11 04:09:10.805163|2017-10-11 04:09:10.805163
NCT01369732|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2013-07-24|2013-07-10||May 2011||2011-05-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest|Prevention of Acute Kidney Injury by Erythropoietin in Patients Undergoing Thoracic Aorta Surgery With Hypothermic Cardiac Arrest|Completed||Phase 4|66|Actual|Yonsei University||2|||f||||f||||||||||2017-10-11 04:09:11.640222|2017-10-11 04:09:11.640222
NCT01369719|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-06-13|||February 2010||2010-02-01|January 2010|2010-01-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload|Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload Patients With β-Thalassemia and Intermediate Thalassemia in Bandarabbas|Completed||N/A|138|Actual|Hormozgan University of Medical Sciences||2|||f||||f||||||||||2017-10-11 04:09:11.997643|2017-10-11 04:09:11.997643
NCT01369706|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-04-10|2015-10-27||September 2009||2009-09-01|April 2017|2017-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety of Screening Procedures With Hand-held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices|Safety of Screening Procedures With Hand-held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices|Completed||N/A|388|Actual|Deutsches Herzzentrum Muenchen|Convenience sample of patients|1|||f||||f||||||||||2017-10-11 04:09:12.110502|2017-10-11 04:09:12.110502
NCT01369186|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-03-23|||May 2011||2011-05-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Drug Drug Interactions of Aspirin and P2Y12-inhibitors|Drug Drug Interactions of Antiplatelet Drugs and Morphine|Completed||Phase 4|95|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 04:09:28.499821|2017-10-11 04:09:28.499821
NCT01369693|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-16|2011-06-08|||May 2004||2004-05-01|June 2011|2011-06-01|April 2005|Actual|2005-04-01|August 2004|Actual|2004-08-01||Interventional|SMWS03||In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus|In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Four Brands of Swedish 'Snus' in Regular Snus Users.|Completed||Phase 1|32|Actual|Contract Research Organization el AB||4|||f||||f||||||||||2017-10-11 04:09:12.280522|2017-10-11 04:09:12.280522
NCT01369680|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2013-02-11|2012-10-24||May 2011||2011-05-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|KETA-2011||Oral Ketamine for Control of Chronic Pain in Children|Oral Ketamine for Control of Chronic Pain in Children|Completed||Phase 1|12|Actual|University of Rochester|Three subjects were lost to follow-up, limiting the data available for neuro-cognitive assessment at the last visit.|4|||f||||f||||||||||2017-10-11 04:09:12.397948|2017-10-11 04:09:12.397948
NCT01369667|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-08-15|||April 2012||2012-04-01|June 2011|2011-06-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|VITD-CD||Vitamin D Supplementation in Adult Crohn's Disease|Vitamin D and Immunomodulation: Effects in Crohn's Disease|Completed||Phase 4|117|Actual|University of Dublin, Trinity College||2|||f||||||||||||||2017-10-11 04:09:12.908717|2017-10-11 04:09:12.908717
NCT01369654|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-06-02|||May 2011||2011-05-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|September 2012|Actual|2012-09-01||Interventional|BSO||Development and Pilot Test of an Elective Bilateral Salpingo-Oophorectomy (BSO) Decision Support Guide|Development and Pilot Test of an Elective Bilateral Salpingo-Oophorectomy (BSO) Decision Support Guide|Completed||N/A|63|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 04:09:12.98755|2017-10-11 04:09:12.98755
NCT01369641|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2016-10-19|2014-01-24||August 2011||2011-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy|A Pilot, Randomized, Self-controlled Study of the Effects of Intratympanic Sodium Thiosulfate on the Degree of Hearing Loss in Patients Receiving Cisplatin Therapy|Terminated||N/A|1|Actual|Thomas Jefferson University|Study terminated due to poor accrual, prior to subjects being analyzed.|2||Poor accrual|f||||t||||||||||2017-10-11 04:09:13.076281|2017-10-11 04:09:13.076281
NCT01369628|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-10-21|||June 2011||2011-06-01|October 2013|2013-10-01||||November 2011|Actual|2011-11-01||Interventional|||Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil|A Phase Ib, Multicenter, Open Label, Dose-Escalating, Repeat-Dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept When Administered to Subjects With Lupus Nephritis on a Stable Regimen of Mycophenolate Mofetil (MMF) With or Without Corticosteroids|Terminated||Phase 1|1|Actual|EMD Serono||1||Please see Purpose Statement below|f||||t||||||||||2017-10-11 04:09:13.314987|2017-10-11 04:09:13.314987
NCT01369615|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-08-26|2015-01-07||October 2011||2011-10-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|December 2013|Actual|2013-12-01||Interventional||The extension safety population was the group of patients who received at least 1 dose of study drug during the Extension Study.|Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001|An Open-label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study|Completed||Phase 3|23|Actual|Purdue Pharma LP|"Enrollment for study OTR3002 was closed by Purdue Pharma L.P. on 01-January-2014 due to administrative reasons not related to safety.
Interpretation is limited by the small number of patients in each age group in this study."|1|||f||||t||||||||||2017-10-11 04:09:13.406309|2017-10-11 04:09:13.406309
NCT01369602|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2012-02-21|||July 2011||2011-07-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532|A Phase 1, Single-Dose, Open-Label Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532|Completed||Phase 1|27|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 04:09:14.014873|2017-10-11 04:09:14.014873
NCT01369589|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-04-02|||November 2010||2010-11-01|July 2014|2014-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness|An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness in Subjects With Xerostomia Related to Sjogren's Syndrome|Completed||Phase 1/Phase 2|24|Actual|Parion Sciences||2|||f||||f||||||||||2017-10-11 04:09:14.118152|2017-10-11 04:09:14.118152
NCT01369576|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-07-16|||May 2011||2011-05-01|July 2015|2015-07-01|November 2014|Actual|2014-11-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep Apnea|A Double-blind, Randomized, Parallel Group Study to Determine the Effect of Initial Prescription of Zopiclone on the Level of Compliance With CPAP in Adult Patients Treated for OSA at 26 Weeks|Completed||Phase 3|264|Actual|OSR Medical Inc.||2|||f||||t||||||||||2017-10-11 04:09:14.203495|2017-10-11 04:09:14.203495
NCT01369563|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2016-12-02|||August 2011||2011-08-01|September 2016|2016-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|SISRIP||Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis|Non-interventional Clinical Trial, to Assess the Efficacy, Safety and Tolerability of Ciclesonide 200 Mcg Once Daily, Applied as a Nasal Spray for Four Weeks, in the Treatment of Intermittent and Persistent Rhinitis|Completed||N/A|1630|Actual|AstraZeneca|||1||f||||t||||||||||2017-10-11 04:09:14.310422|2017-10-11 04:09:14.310422
NCT01369550|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-06-08|||August 2010||2010-08-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy Study of Stearidonic Acid (SDA) Soybean Oil-containing Foods on Red Blood Cell Fatty Acid Content|A Randomized, Controlled Trial to Assess the Effects of Stearidonic Acid-Containing Foods on Eicosapentaenoic Acid Levels of Red Blood Cells and the Omega-3 Index|Completed||N/A|127|Actual|Monsanto Company, LLC||3|||f||||f||||||||||2017-10-11 04:09:14.379578|2017-10-11 04:09:14.379578
NCT01369537|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-09-05|||November 2011||2011-11-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|||Neurological Impact of Vascular Events In Noncardiac Surgery patIents cOhort evaluatioN Pilot Study|Neurological Impact of Vascular Events In Noncardiac Surgery patIents cOhort evaluatioN Pilot Study|Completed||N/A|100|Actual|McMaster University|||1||f||||f||||||||||2017-10-11 04:09:14.48446|2017-10-11 04:09:14.48446
NCT01369524|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-08|||January 2011||2011-01-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Observational|||Effect of Fluid Resuscitation and Microcirculation|Evaluation of Effect of Fluid Resuscitation on Sublingual Microcirculation by SDF Imaging in Intensive Care Patients, a Pilot Study|Completed||N/A|50|Actual|Medical Centre Leeuwarden|||1||f||||f||||||||||2017-10-11 04:09:14.543638|2017-10-11 04:09:14.543638
NCT01369511|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-04-14||2014-04-14|July 2011||2011-07-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement|A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Undergoing Elective Total Hip Arthroplasty|Completed||Phase 2|384|Anticipated|Eli Lilly and Company||4|||f||||t||||||||||2017-10-11 04:09:14.621919|2017-10-11 04:09:14.621919
NCT01369498|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-10-22||2015-10-22|June 2011||2011-06-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis|A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adult Subjects With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis|Completed||Phase 2|54|Actual|Gilead Sciences||4|||f||||f||||||||||2017-10-11 04:09:14.81736|2017-10-11 04:09:14.81736
NCT01369485|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2014-09-04|2014-04-14||June 2011||2011-06-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|Beacon|Intent to treat population|Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder|Multi-center, Prospective, Randomized, Double-blind, Sham-controlled Clinical Study to Evaluate Safety and Effectiveness of a Transcutaneous, High-frequency, Amplitude-modulated, Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Subjects With Overactive Bladder (OAB)|Completed||N/A|163|Actual|Ethicon Endo-Surgery|There was a higher than anticipated rate of patient withdrawals observed in both groups due to skin irritation.|2|||f||||f||||||||||2017-10-11 04:09:14.948911|2017-10-11 04:09:14.948911
NCT01369472|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2012-02-13|||June 2011||2011-06-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule|A Randomized, Open-label, Single Dose, Dose-rising 10-sequence, 3-period Balanced Incomplete Blocked Clinical Trial to Evaluate Dose-proportionality of Dilatrend SR in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Chong Kun Dang Pharmaceutical||5|||f||||f||||||||||2017-10-11 04:09:15.774678|2017-10-11 04:09:15.774678
NCT01369459|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-08-03|||November 2011||2011-11-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|MIP||Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder|Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD|Completed||Phase 1|14|Actual|The National Center on Addiction and Substance Abuse at Columbia University||2|||f||||t||||||||||2017-10-11 04:09:15.861754|2017-10-11 04:09:15.861754
NCT01369446|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2012-07-20|||June 2011||2011-06-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|Eeva||Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst Stage|Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst Stage|Completed||N/A|160|Actual|Progyny, Inc.|||1||f||||f||||||||||2017-10-11 04:09:15.942254|2017-10-11 04:09:15.942254
NCT01369433|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-04|2017-06-20|||June 2010||2010-06-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|June 2015|Actual|2015-06-01||Interventional|||A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols|A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols|Completed||N/A|225|Actual|AVEO Pharmaceuticals, Inc.||6|||f||||f||||||||No||2017-10-11 04:09:16.040746|2017-10-11 04:09:16.040746
NCT01369420|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2016-11-07|||May 2011||2011-05-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer|A Safety Evaluation of the NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer - A Pilot Study|Completed||Phase 2|10|Anticipated|Angiodynamics, Inc.||1|||f||||f||||||||||2017-10-11 04:09:16.289823|2017-10-11 04:09:16.289823
NCT01369407|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-02-08|||July 2015||2015-07-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01|2 Years|Observational [Patient Registry]|REVIVAL||REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE|REVIVE-IT Registry (REVIVAL: Registry Evaluation of Vital Information For VADs in Ambulatory Life)|Active, not recruiting||N/A|400|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"     Biomarker Samples will be collected at the Baseline B assessment. Samples for Genomic     Analysis will be collected at the Baseline B visit for subjects that consented to collection     of this sample type.   "|||2017-10-11 04:09:16.451914|2017-10-11 04:09:16.451914
NCT01369394|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-12-08|||June 2011||2011-06-01|December 2014|2014-12-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Making Decisions About the Measles-Mumps-Rubella Vaccine|Developing a Computer-based Intervention That Provides Individually-tailored Educational Information for MMR Vaccine-hesitant Parents|Completed||N/A|79|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 04:09:16.586274|2017-10-11 04:09:16.586274
NCT01369381|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-08-03|||December 2011||2011-12-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Cervical Spine Biomechanics During Endotracheal Intubation|Intubation Mechanics of the Stable and Unstable Cervical Spine|Completed||N/A|14|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 04:09:16.670379|2017-10-11 04:09:16.670379
NCT01369368|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-06-23|||August 2013||2013-08-01|June 2015|2015-06-01|October 2020|Anticipated|2020-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Treatment of Acute Leukemia Relapse After Allotransplantation|Treatment of Relapsed Acute Leukemia After Allogeneic Stem Cell Transplantation: Disease Stabilization Through Chemotherapy, Immunomodulatory Treatment and Immunotherapy|Recruiting||Phase 1/Phase 2|20|Anticipated|University of Bergen||1|||f||||t||||||||||2017-10-11 04:09:16.755006|2017-10-11 04:09:16.755006
NCT01369355|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-04-05|2016-10-17|2016-04-14|September 13, 2011|Actual|2011-09-13|April 2017|2017-04-01|October 19, 2019|Anticipated|2019-10-19|June 10, 2015|Actual|2015-06-10||Interventional|||A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)|A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects With Moderately to Severely Active Crohn's Disease|Active, not recruiting||Phase 3|1282|Actual|Janssen Research & Development, LLC|The global study was interrupted due to issues with the clinical supply.|6|||f||||t|t|||||||||2017-10-11 04:09:16.911382|2017-10-11 04:09:16.911382
NCT00005565|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||August 1997||1997-08-01|January 2008|2008-01-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Observational|||Mechanisms of Low Levels of Apolipoprotein B||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:14.542874|2017-10-11 04:27:14.542874
NCT01369316|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-12-15|||June 2011||2011-06-01|December 2015|2015-12-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Interventional|CSIEMR||Circumferential Submucosal Incision Endoscopic Mucosal Resection Versus Conventional Endoscopic Mucosal Resection of Colonic Polyps|Circumferential Submucosal Incision Endoscopic Mucosal Resection Versus Conventional Endoscopic Resection for the Removal of Large Laterally Spreading Tumours and Sessile Polyps of the Colon|Recruiting||N/A|160|Anticipated|Western Sydney Local Health District||2|||f||||f||||||||||2017-10-11 04:09:24.656652|2017-10-11 04:09:24.656652
NCT01369303|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-12-11|||January 2012||2012-01-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel|Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel Using the Bat 24 Regimen Versus Daily and Pericoital Dosing|Completed||Phase 1|194|Actual|CONRAD||3|||f||||f||||||||||2017-10-11 04:09:24.770104|2017-10-11 04:09:24.770104
NCT01369290|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-18|2011-11-28|||October 2009||2009-10-01|November 2011|2011-11-01|October 2013|Anticipated|2013-10-01|October 2012|Anticipated|2012-10-01||Observational|EEG-SP||Electroencephalography (EEG) Signal Processing|EEG Signal Processing as a Predictor of Antidepressant Response|Unknown status|Recruiting|N/A|150|Anticipated|St. Joseph's Healthcare Hamilton|||5||f||||f||||||||||2017-10-11 04:09:24.86809|2017-10-11 04:09:24.86809
NCT01369277|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-09-20|||June 2011||2011-06-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532|A Phase 1, Randomized, Double Blind, Placebo-Controlled, Single Dose Escalation Study In Japanese Healthy Subjects, And Open Label, Single Dose Study In Western Healthy Subjects To Investigate The Safety, Tolerability, And Pharmacokinetics of PF-04991532.|Completed||Phase 1|22|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:09:25.040122|2017-10-11 04:09:25.040122
NCT01369264|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-18|2011-06-07|||July 2007||2007-07-01|July 2007|2007-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|ERP||The Effect of Repetitive Transcranial Magnetic Stimulation on Brain Activity in Healthy Human Volunteers|Evaluation of the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Brain Electrical Activity in Healthy Human Volunteers|Completed||N/A|17|Actual|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-11 04:09:25.16153|2017-10-11 04:09:25.16153
NCT01369251|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-06-07|||May 2011||2011-05-01|April 2011|2011-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Simple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord|Simple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord: a Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|400|Anticipated|ASST Fatebenefratelli Sacco||2|||f||||f||||||||||2017-10-11 04:09:25.272554|2017-10-11 04:09:25.272554
NCT01369238|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-06-07|||June 2011||2011-06-01|June 2011|2011-06-01|March 2012|Anticipated|2012-03-01|January 2012|Anticipated|2012-01-01||Interventional|||East-West Collaborative Medicine Using Bee-Venom Acupuncture on Whiplash-Associated Disorders|Clinical Research on the Efficacy of East-West Collaborative Medicine Using Bee-Venom Acupuncture Therapy on Whiplash-Associated Disorders After Traffic Collisions; A Randomized, Controlled, Parallel Trial|Unknown status|Not yet recruiting|N/A|90|Anticipated|Korean Pharmacoacupuncture Institute||3|||f||||t||||||||||2017-10-11 04:09:25.367047|2017-10-11 04:09:25.367047
NCT01369225|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-01-19|2016-06-15||July 2011||2011-07-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||The baseline analysis population included all participants who were enrolled in the study and received at least 1 infusion of study medication.|Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease|A Multicenter, Open-label Extension, Multiple Dose, Parallel Group Study To Investigate The Long-term Safety And Tolerability Of Aab-003 (Pf-05236812) Administered Intravenously In Subjects With Mild To Moderate Alzheimer's Disease Previously Treated With Aab-003 Or Placebo In Protocol B2601001|Completed||Phase 1|52|Actual|Pfizer||5|||f||||f||||||||||2017-10-11 04:09:25.521899|2017-10-11 04:09:25.521899
NCT01369212|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-08-22|||November 2012||2012-11-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|August 2019|Anticipated|2019-08-01||Interventional|HBRN||Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B|Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in HBeAg-positive and HBeAg-negative Chronic Hepatitis B|Active, not recruiting||N/A|201|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 04:09:28.18887|2017-10-11 04:09:28.18887
NCT01369199|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-08-24|||May 2012||2012-05-01|March 2017|2017-03-01|February 14, 2017|Actual|2017-02-14|February 14, 2017|Actual|2017-02-14||Interventional|HBRN||Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B|Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B|Completed||Phase 3|28|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-10-11 04:09:28.34545|2017-10-11 04:09:28.34545
NCT00005566|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-22|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Cognitive Aspects of Adolescent Suicide||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:27:14.59727|2017-10-11 04:27:14.59727
NCT01369173|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-05-04|||October 2011||2011-10-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|COMIDAS||COMIDAS Comparing Original Mexican Diets and Standard US Diets|Metabolic Response to Western vs. Indigenous Diets in Hispanic Women|Completed||N/A|50|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 04:09:28.605641|2017-10-11 04:09:28.605641
NCT01369160|ClinicalTrials.gov processed this data on October 10, 2017|2009-04-22|2014-05-23|||May 2005||2005-05-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|May 2007|Actual|2007-05-01||Observational|SCD_Cross||Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease|Curative vs Disease-Modifying Therapies in Children With Severe Sickle Cell Disease: A Pilot, Cross-Sectional Study|Completed||N/A|33|Actual|Emory University|||4||f||||t||||||||||2017-10-11 04:09:28.682923|2017-10-11 04:09:28.682923
NCT01369147|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-09-20|||July 2011||2011-07-01|September 2017|2017-09-01||||July 2019|Anticipated|2019-07-01||Interventional|||The Energy Dose Study|Comparative Effectiveness of Energy Doses in Critical Illness|Active, not recruiting||Phase 2|60|Anticipated|Emory University||3|||f||||t|t|f||||||||2017-10-11 04:09:28.843034|2017-10-11 04:09:28.843034
NCT01369134|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2014-05-29|||January 2011||2011-01-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Clinical Evaluation of a Self-etch Adhesive Using a Selective Etch Technique|Clinical Evaluation of 3M ESPE Adper Easy Bond Self-Etch Adhesive Using a Selective Etch Technique|Completed||N/A|40|Actual|3M|||1||f||||f||||||||||2017-10-11 04:09:28.949956|2017-10-11 04:09:28.949956
NCT01369121|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-07-29|||June 2010||2010-06-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||Tolerability Study of Xerecept® in Pediatric Patients|A Phase I/II Open Label Individual Dose Titration Trial of the Human Corticotropin- Releasing Factor (hCRF), Corticorelin Acetate Injection (Xerecept®), to Determine the Tolerability of Xerecept® in a Pediatric Population|Terminated||Phase 1/Phase 2|15|Actual|Celtic Pharma Development Services||1||Single subject remained on study - transferred to compassionate use|f||||f||||||||||2017-10-11 04:09:29.036231|2017-10-11 04:09:29.036231
NCT01369095|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-09-23||2015-09-23|July 2011||2011-07-01|September 2015|2015-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression|A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).|Completed||Phase 2|976|Actual|Bristol-Myers Squibb||5|||f||||t||||||||||2017-10-11 04:09:29.416842|2017-10-11 04:09:29.416842
NCT01369082|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-10-14|||May 2011||2011-05-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Extended Follow-Up After Islet Transplantation in T1D|Extended Follow-Up After Islet Transplantation in Type 1 Diabetes (CIT-08)|Enrolling by invitation||Phase 3|75|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     Participants are given the option to provide consent for:        1. the collection and storage of blood samples for future research studies        2. the collection and storage of blood samples for future genetic (i.e., DNA) testing.   "|||2017-10-11 04:09:29.780295|2017-10-11 04:09:29.780295
NCT01369069|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-09-20|||April 2012||2012-04-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|October 2017|Anticipated|2017-10-01||Interventional|SHINE||Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial|Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial|Recruiting||Phase 3|1400|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 04:09:29.947637|2017-10-11 04:09:29.947637
NCT01369056|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-05-24|||July 2010||2010-07-01|May 2016|2016-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence|HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence|Completed||N/A|150|Actual|University of Tartu||2|||f||||f||||||||No||2017-10-11 04:09:30.422055|2017-10-11 04:09:30.422055
NCT01369043|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-03-06|||May 2011||2011-05-01|March 2015|2015-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Effects of Vitamin E and Vitamin C and Exercise|Modulation of Insulin and Exercise Responses by Vitamin E and Vitamin C|Terminated||N/A|1|Actual|USDA Grand Forks Human Nutrition Research Center||2||Lack of successful recruiting, budget cuts, and potential study flaws.|f||||t||||||||||2017-10-11 04:09:30.57503|2017-10-11 04:09:30.57503
NCT01369030|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2014-05-08|2013-04-18||November 2010||2010-11-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational||A total of 594 completed the baseline and follow-up surveys and of those only 554 with a baseline PHQ-9>=5 were included in the analysis. Majority of the participants were female, and the study was approximately equal distribution across the four depression severity groups of interest.|Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)|Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)|Completed||N/A|554|Actual|Pamlab, Inc.|Patients self-enrolled in the program and data presented was based on self-reported close-ended questions; selection bias may be present for those who chose not to enroll or complete the surveys. No clinical evaluations were conducted.||1||f||||f||||||||||2017-10-11 04:09:30.684482|2017-10-11 04:09:30.684482
NCT01369017|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2013-07-11|||October 2011||2011-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Kintox||Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers|A Study of the Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Center Reference Endotoxin in Normal Volunteers|Completed||Phase 1|17|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 04:09:30.933177|2017-10-11 04:09:30.933177
NCT01369004|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-04-21|||February 2011||2011-02-01|September 2012|2012-09-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|WEIGH||The WEIGH Study: Weighing to Improve and Gain Health|The Use of Weight Tracking Technology to Promote Weight Loss Among Overweight Adults|Completed||N/A|91|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 04:09:31.048347|2017-10-11 04:09:31.048347
NCT01368822|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2012-11-08|||June 2010||2010-06-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|R-21||Effect of Obesity on Long-term Clinical Outcomes After Kidney Donation||Completed||N/A|150|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 04:09:33.978523|2017-10-11 04:09:33.978523
NCT01368991|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2011-06-07|||July 2011||2011-07-01|April 2011|2011-04-01|July 2013|Anticipated|2013-07-01|September 2012|Anticipated|2012-09-01||Interventional|Kryptonite||Clinical Trial of Kryptonite for Prevention of Sternal Complications in High Risk Patients Undergoing Cardiac Surgery|Randomized Clinical Trial of Kryptonite for Prevention of Sternal Complications in High Risk Patients Undergoing Cardiac Surgery|Unknown status|Not yet recruiting|Phase 3|48|Anticipated|Cardiology Research UBC||2|||f||||t||||||||||2017-10-11 04:09:31.153178|2017-10-11 04:09:31.153178
NCT01368978|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-21|2014-09-04|||December 2009||2009-12-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pediatric Diabetics Type 1 Using InsuPatch|Evaluation of the Effect of lnsuPatch on the Pharmacokinetic and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs Given as a Bolus by Continuous Subcutaneous Insulin Infusion (CSII)|Completed||Phase 3|27|Actual|Insuline Medical Ltd.||2|||f||||f||||||||||2017-10-11 04:09:31.262278|2017-10-11 04:09:31.262278
NCT01368965|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-02-10|2014-02-10||March 2011||2011-03-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|October 2011|Actual|2011-10-01||Interventional||Fifty-four subjects were consented and enrolled. Two subjects withdrew consent prior to treatment. Data analyses are based on 52 treated subjects.|Lifting and Tightening of the Face in Subjects With Skin of Darker Color|Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Cheek Tissue and Improvement in Jawline Definition and Submental Skin Laxity in Patients With Fitzpatrick Skin Phototypes 3 Through 6|Completed||N/A|54|Actual|Ulthera, Inc|"Study Limitations:
Masked assessment was not completed as photos were not usable, i.e., poor image quality, positioning and timing.
Site staffing changes.
Overburdened site staff.
Poor photography quality
Subject selection"|1|||f||||f||||||||||2017-10-11 04:09:31.363657|2017-10-11 04:09:31.363657
NCT01368952|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-06-07|||March 2011||2011-03-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||The Effect of Pure Prone Positioning Therapy for the Patients With Mild to Moderate Obstructive Sleep Apnea|Efficacy Study of Pure Prone Positioning Therapy in Patients With Mild to Moderate Obstructive Sleep Apnea|Completed||N/A|29|Actual|Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital||2|||f||||f||||||||||2017-10-11 04:09:31.656268|2017-10-11 04:09:31.656268
NCT01368939|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2012-04-20|||March 2012||2012-03-01|April 2012|2012-04-01|June 2013|Anticipated|2013-06-01|September 2012|Anticipated|2012-09-01||Observational|ROSE||Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)|A Pilot, Single Centre, Prospective Clinical Study Investigation of the Acceptability of a Dedicated High Resolution Nuclear Breast Imaging Camera (MBI) in Breast Imaging of Patients Administered Tc-99m Sestamibi (ROSE)|Unknown status|Recruiting|N/A|150|Anticipated|Hamilton Health Sciences Corporation|||1||f||||f||||||||||2017-10-11 04:09:31.764507|2017-10-11 04:09:31.764507
NCT01368926|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-11-01|||June 2011||2011-06-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Pharmacokinetic Study of RO4917523 in Healthy Japanese and Caucasian Subjects|A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics, Safety and Tolerability of RO4917523 Conducted in 2 Phases: a Single-Dose, Cross-Over Administration to Healthy Japanese Subjects and a Multiple-Dose Administration to Healthy Japanese and Caucasian Subjects.|Completed||Phase 1|42|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:09:31.842098|2017-10-11 04:09:31.842098
NCT01368913|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-06-11|||June 2011||2011-06-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Observational|MELT||MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis|MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis With Special Focus on Patient Satisfaction|Completed||N/A|138|Actual|Ferring Pharmaceuticals|||2||f||||f||||||||||2017-10-11 04:09:31.950447|2017-10-11 04:09:31.950447
NCT01368900|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2013-09-16|2013-04-17||March 2011||2011-03-01|September 2013|2013-09-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional||Adults between 30 and 65 years of age who provided informed consent and who met the inclusion/exclusion criteria and required infraorbital, lateral orbit, and brow regions to be treated bilaterally.|Reducing Wrinkles Around the Eyes Using the Ulthera® System|Evaluation of the Ulthera® System for Obtaining a Reduction of Wrinkles Around the Eyes|Completed||N/A|68|Actual|Ulthera, Inc|"FWCS scores assessed globally, not per eye, leading to limited data for analysis.
FWCS protocol amended to 3+ after enrollment of 19 subjects with FWCS of 2.
Unacceptable lighting, focus, exposure making some photos impossible to evaluate."|1|||f||||f||||||||||2017-10-11 04:09:32.354039|2017-10-11 04:09:32.354039
NCT01368887|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-06-07|||April 2013||2013-04-01|June 2011|2011-06-01|April 2014|Anticipated|2014-04-01|November 2013|Anticipated|2013-11-01||Interventional|||Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis|Phase II Study of a Non-Steroidal Novel Treatment for Scalp Psoriasis|Suspended||Phase 2|160|Anticipated|DermiPsor, Ltd.||4||Sponsor seeking additional financial support before starting the study|f||||t||||||||||2017-10-11 04:09:32.690983|2017-10-11 04:09:32.690983
NCT01368874|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-04-17|2013-06-03||March 2011||2011-03-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Lifting and Tightening of the Face and Neck Utilizing the Ulthera® System|Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck|Completed||N/A|71|Actual|Ulthera, Inc||3|||f||||f||||||||||2017-10-11 04:09:32.798069|2017-10-11 04:09:32.798069
NCT01368861|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-07-28|||June 2010||2010-06-01|July 2015|2015-07-01|March 2012|Actual|2012-03-01|September 2010|Actual|2010-09-01||Observational|||Effective Analgesia During Routine Immunizations|Effective Analgesia Using the 5 S's During Routine Immunizations at 2 and 4 Months|Completed||N/A|230|Actual|Children's Hospital of The King's Daughters|||4||f||||f||||||||||2017-10-11 04:09:33.624641|2017-10-11 04:09:33.624641
NCT01368848|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2013-08-29|||April 2010||2010-04-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)|Phase II Study to Investigate the Treatment of Patients With NSCLC Stage IIIB and IV Without the Option of Surgery With a Combination of Cisplatin, Docetaxel and Bevacizumab|Completed||Phase 2|7|Actual|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||||2017-10-11 04:09:33.716886|2017-10-11 04:09:33.716886
NCT01368835|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-01-13|2013-03-25||July 2010||2010-07-01|January 2014|2014-01-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional||N=33 Excluded from analysis: N=22 excluded for inclusion criteria/photo lighting/positional/makeup issues and N=11 lost to follow-up.|Evaluation of the Ulthera™ System for Obtaining Lift and Tightening of the Cheek Tissue|Evaluation of the Ulthera™ System For Obtaining Lift and Tightening of the Cheek Tissue and Improvement in Jawline Definition and Submental Skin Laxity|Completed||N/A|103|Actual|Ulthera, Inc||1|||f||||t||||||||||2017-10-11 04:09:33.79643|2017-10-11 04:09:33.79643
NCT01368809|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2016-03-09|2015-09-10||June 2011||2011-06-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|LMA||Effect of Fentanyl on Coughing and Recovery After Anesthesia With an LMA Laryngeal Mask Airway)for Airway Management|Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effect of Fentanyl on the Incidence of Coughing and Recovery After Propofol-Desflurane Anesthesia With an LMA for Airway Management|Completed||Phase 4|100|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 04:09:34.050981|2017-10-11 04:09:34.050981
NCT01368796|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-04-14|||July 2011||2011-07-01|April 2015|2015-04-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|PCIRNRT09||Comparison of 4 Influenza Vaccines in Seniors|Controlled Comparison in Canadian Seniors of Seasonal Influenza Vaccines for 2011-2012|Completed||Phase 4|953|Actual|University of British Columbia||4|||f||||f||||||||||2017-10-11 04:09:36.270853|2017-10-11 04:09:36.270853
NCT01368783|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-06-07|||June 2011||2011-06-01|May 2011|2011-05-01||||||||Interventional|||Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers|Two Randomized, Open-labeled, Parallel Designed Multiple-dose Clinical Trials to Evaluate Pharmacokinetics of Ritonavir-unboosted and Ritonavir-boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers|Unknown status|Not yet recruiting|Phase 1|32|Anticipated|Asan Medical Center||4|||f||||||||||||||2017-10-11 04:09:36.360604|2017-10-11 04:09:36.360604
NCT01368770|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-04-01|||July 2011||2011-07-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Stress Testing Compared to Coronary Computed Tomographic Angiography in Patients With Suspected Coronary Artery Disease|Stress-rest Single Photon-Emission Computed Tomography(SPECT)Compared to Coronary Computed Tomographic Angiography in the Initial Evaluation of Patients With Suspected Coronary Artery Disease-A Pilot Randomized Controlled Trial|Completed||Phase 3|303|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-10-11 04:09:36.445284|2017-10-11 04:09:36.445284
NCT01368757|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2015-03-06|||June 2010||2010-06-01|March 2015|2015-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Lenalidomide in Patients With Chronic Myelomonocytic Leukemia|A Phase I/II Study of Lenalidomide in Patients With Chronic Myelomonocytic Leukemia|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||||2017-10-11 04:09:36.550538|2017-10-11 04:09:36.550538
NCT01368744|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-06-06|||March 2010||2010-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology|Intraoperative Examination of Sentinel Lymph Nodes: Comparison of the OSNA Breast Cancer System to Extensive Frozen Section Histopathology|Completed||N/A|150|Anticipated|Sysmex America, Inc.|||1||f||||t||||||Samples With DNA|"     Samples of the tissue homogenate will be retained and may be used for for further testing.   "|||2017-10-11 04:09:36.649411|2017-10-11 04:09:36.649411
NCT01368731|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-12-15|||May 2011||2011-05-01|December 2015|2015-12-01|January 2020|Anticipated|2020-01-01|January 2014|Actual|2014-01-01||Interventional|||Prophylactic Coagulation for the Prevention of Bleeding in Endoscopic Mucosal Resection of Large Sessile Colonic Polyps|Prophylactic Endoscopic Coagulation for the Prevention of Bleeding in Endoscopic Mucosal Resection (EMR) of Large Sessile Colonic Polyps: A Multi-centre, Randomised Control Trial|Active, not recruiting||N/A|328|Anticipated|Western Sydney Local Health District||2|||f||||f||||||||||2017-10-11 04:09:36.723878|2017-10-11 04:09:36.723878
NCT01368718|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-06-02|||October 2012||2012-10-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Nasal Continuous Positive Airway Pressure (CPAP) in Chronic Fatigue and Sleep-disordered Breathing|The Effect of Nasal CPAP in Patients With Chronic Fatigue and Sleep-disordered Breathing|Unknown status|Recruiting|Phase 4|55|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 04:09:36.802846|2017-10-11 04:09:36.802846
NCT01368705|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2013-08-16|||August 2009||2009-08-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Nitrogen Balance in Infants After Post Cardiothoracic Surgery|Determination of Protein Needs Using Nitrogen Balance in Infants Immediately Post Cardiothoracic Surgery|Completed||Phase 4|24|Actual|The Hospital for Sick Children||3|||f||||t||||||||||2017-10-11 04:09:36.893272|2017-10-11 04:09:36.893272
NCT01368692|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-22|2013-01-14|||June 2011||2011-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Shoulder Retraction on Success Rate of Subclavian Vein Catheterization||Completed||N/A|362|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-10-11 04:09:38.292156|2017-10-11 04:09:38.292156
NCT01368679|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-11-18||||||November 2014|2014-11-01||||||||Interventional|Stent-Graft||A Clinical Study to Evaluate the Safety and Performance of the Modular AAA Stent-Graft System|Phase III of the Prospective, Non-randomized and Multicenter Clinical Evaluation of the Safety and Performance of the Modular AAA Stent-Graft System When Used in the Treatment of Subjects With Abdominal Aortic Aneurysms (AAA)|Withdrawn||Phase 3|0|Actual|Scitech Produtos Medicos Ltda||1|||f||||t||||||||||2017-10-11 04:09:38.400672|2017-10-11 04:09:38.400672
NCT01368666|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2015-05-21|||February 2010||2010-02-01|May 2015|2015-05-01|September 2018|Anticipated|2018-09-01|October 2014|Actual|2014-10-01||Interventional|CAVALIER||Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark|Perceval S Valve Clinical Trial for Extended CE Mark|Active, not recruiting||Phase 2/Phase 3|658|Actual|LivaNova||1|||f||||t||||||||||2017-10-11 04:09:38.484166|2017-10-11 04:09:38.484166
NCT01368653|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-11-17|2014-11-07||June 2012||2012-06-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional||The total number of participants in the sample was 93. The 40 participants randomly assigned to Very low nicotine cigarettes or Advice and encouragement only were a subset of the 93 participants randomly assigned to initial experimental conditions (Standard treatment or Standard treatment+practice quitting) if still smoking at 4-week follow-up.|Evaluation of Learning-Theory-Based Smoking Cessation Strategies|Evaluation of Learning-Theory-Based Smoking Cessation Strategies|Completed||N/A|93|Actual|Rutgers University||4|||f||||f||||||||||2017-10-11 04:09:38.625497|2017-10-11 04:09:38.625497
NCT01368640|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2012-10-02|||April 2011||2011-04-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|September 2011|Actual|2011-09-01||Observational|||Generation of Prediction Equations to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA)|Generation of Prediction Equations to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA)|Completed||N/A|153|Actual|Seca GmbH & Co. Kg.|||1||f||||t||||||Samples Without DNA|"     whole blood   "|||2017-10-11 04:09:39.084796|2017-10-11 04:09:39.084796
NCT01368627|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2012-08-22|||January 2008||2008-01-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions|"A Prospective, Multinational Investigation of the Supralimus® Sirolimus-Eluting Stent for the Treatment of Unselected Patients With Coronary Lesions in the Real- World Clinical Practice"|Completed||Phase 4|1274|Actual|Sahajanand Medical Technologies Pvt. Ltd.||1|||f||||t||||||||||2017-10-11 04:09:39.178876|2017-10-11 04:09:39.178876
NCT01368614|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2015-09-18|||July 2011||2011-07-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||AVAPS-AE Efficacy Study|Randomized Controlled Trial Evaluating the Feasibility of AVAPS-AE vs. CPAP vs.Bilevel Pressure Support Ventilation in Obesity Hypoventilation Syndrome|Completed||N/A|32|Actual|Philips Respironics||3|||f||||f||||||||||2017-10-11 04:09:39.413817|2017-10-11 04:09:39.413817
NCT01368601|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2016-10-17|||May 2011||2011-05-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|June 2017|Anticipated|2017-06-01||Interventional|||Effects of Intraoperative Continuous Airway Pressure (CPAP) on the Inflammatory Response to One-lung Ventilation|Effects of Intraoperative Continuous Airway Pressure (CPAP) on the Inflammatory Response of the Lung With Cancer Undergoing Lobectomy. A Randomised Placebo-controlled Trial|Recruiting||N/A|60|Anticipated|Parc de Salut Mar||2|||f||||f||||||||||2017-10-11 04:09:39.510467|2017-10-11 04:09:39.510467
NCT01368588|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2017-05-18|||July 2011|Actual|2011-07-01|May 2017|2017-05-01||||July 2027|Anticipated|2027-07-01||Interventional|||Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer|Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial|Recruiting||Phase 3|2580|Anticipated|Radiation Therapy Oncology Group||2|||f||||t||||||||No||2017-10-11 04:09:39.682328|2017-10-11 04:09:39.682328
NCT01368575|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-09-21|||May 2011||2011-05-01|September 2015|2015-09-01|November 2015|Anticipated|2015-11-01|May 2014|Actual|2014-05-01||Interventional|TIME||Surgical Treatment of Ischemic Mitral Regurgitation|The Effect of Different Surgical Methods in the Treatment of Patients With Ischemic Mitral Regurgitation and Assess the Dynamics of Heart Failure and the Effectiveness of Surgical Treatment of Mitral Valve.|Unknown status|Recruiting|Phase 4|420|Anticipated|Meshalkin Research Institute of Pathology of Circulation||5|||f||||t||||||||||2017-10-11 04:09:40.412697|2017-10-11 04:09:40.412697
NCT01368562|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||January 2003||2003-01-01|July 2011|2011-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Compassionate Use Study of Methylnaltrexone|A Compassionate Use Study of Methylnaltrexone in Patients With Opioid-Induced Side Effects|Completed||N/A|26|Actual|Valeant Pharmaceuticals International, Inc.||1|||t||||f||||||||||2017-10-11 04:09:40.516545|2017-10-11 04:09:40.516545
NCT01368536|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2013-03-18|2013-02-14||May 2011||2011-05-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|VALENCIA||Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes|A 12-week, Multi-Center, Randomized Double-Blind, Active Control Parallel Group Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes|Terminated||Phase 4|975|Actual|Novartis||3||"Based on results from an ALTITUDE study interim analysis, testing aliskiren concomitantly with   an ACE inhibitor or ARB, in diabetics with renal impairment"|f||||f||||||||||2017-10-11 04:09:40.867252|2017-10-11 04:09:40.867252
NCT01368523|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-11-15|||December 2008||2008-12-01|November 2016|2016-11-01||||January 2010|Actual|2010-01-01||Interventional|||Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial|An Open-label, Multicenter Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to ENACT (CAMN107A2109) Trial|Completed||Phase 4|19|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:09:41.501222|2017-10-11 04:09:41.501222
NCT01368510|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-12-16|||July 2011||2011-07-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder|Cognitive-Behavioral Therapy and Glutamate in Cingulate Gyrus in OCD|Unknown status|Recruiting|N/A|75|Anticipated|University of California, Los Angeles||3|||f||||f||||||||||2017-10-11 04:09:41.605534|2017-10-11 04:09:41.605534
NCT01368497|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-08-23|||September 2012||2012-09-01|August 2017|2017-08-01|December 23, 2016|Actual|2016-12-23|December 23, 2016|Actual|2016-12-23||Interventional|||Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection|Clinical Trial of Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic HBV Infection (HBRN)|Completed||Phase 3|60|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-10-11 04:09:41.704197|2017-10-11 04:09:41.704197
NCT01368484|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-07|2011-06-07|||December 2009||2009-12-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Effect of Dietary DHA Supplementation on Sperm Quality|Effect of Dietary DHA Supplementation on Sperm Quality.|Completed||N/A|120|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-10-11 04:09:41.821473|2017-10-11 04:09:41.821473
NCT01368471|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-17|2013-05-28|||June 2011||2011-06-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|MASTER||Safety and Efficacy Study of MGuard Stent After a Heart Attack|MASTER: MGUARD for Acute ST Elevation Reperfusion|Completed||Phase 4|433|Actual|InspireMD||2|||f||||t||||||||||2017-10-11 04:09:41.909683|2017-10-11 04:09:41.909683
NCT01368458|ClinicalTrials.gov processed this data on October 10, 2017|2008-07-01|2017-02-07|||December 2007||2007-12-01|February 2017|2017-02-01|July 2008|Actual|2008-07-01|||||Interventional|MOPE||Conversion to Antipsychotic Monotherapy|A Randomized, Rater-Blind, Controlled, Clinical Trial of Conversion to Antipsychotic Monotherapy vs. Continued Polypharmacy for Patients With Schizophrenia or Schizoaffective Disorder|Terminated||N/A|24|Anticipated|Nathan Kline Institute for Psychiatric Research||2|||f||||f||||||||||2017-10-11 04:09:42.009835|2017-10-11 04:09:42.009835
NCT01368445|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-10-05|||August 2006||2006-08-01|October 2011|2011-10-01|April 2008|Actual|2008-04-01|November 2006|Actual|2006-11-01||Interventional|||A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies|Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 in Patients With Seasonal Allergic Rhinitis|Completed||Phase 3|617|Actual|Meda Pharmaceuticals||4|||f||||f||||||||||2017-10-11 04:09:42.104956|2017-10-11 04:09:42.104956
NCT01368432|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-08-31|2016-07-13||April 2010||2010-04-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions|Escitalopram (Lexapro) for the Treatment of TBI Depression and Other Comorbid Psychiatric Conditions|Completed||Phase 2|16|Actual|Johns Hopkins University||2|||f||||t||||||||No||2017-10-11 04:09:42.261957|2017-10-11 04:09:42.261957
NCT01368419|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-04-22|||May 2011||2011-05-01|April 2013|2013-04-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients|Phase II Study of Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients|Unknown status|Recruiting|Phase 2|40|Anticipated|Jiangsu Simcere Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-10-11 04:09:42.875155|2017-10-11 04:09:42.875155
NCT01368406|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-04-12|2012-09-12||August 2007||2007-08-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia|Efficacy of a Non-pharmacological Intervention for Weight Gain Management for Patients With Schizophrenia: Multicentric, Randomized Clinical Trial|Completed||N/A|160|Actual|Federal University of São Paulo|short duration of the intervention (12 weeks) and duration of follow up. This lifestyle intervention was previously conducted in all sites that participated of this study.|2|||f||||f||||||||||2017-10-11 04:09:42.975328|2017-10-11 04:09:42.975328
NCT01368393|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2012-12-14|||October 2011||2011-10-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Electroacupuncture Analgesia for Colonoscopy|Electroacupuncture Analgesia for Colonoscopy: a Prospective, Randomized, Double-blind, Sham-controlled Study|Completed||Phase 3|128|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 04:09:43.281029|2017-10-11 04:09:43.281029
NCT01368380|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2015-02-25|||October 2011||2011-10-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional|HIH||Hand in Hand. Psychological Support and Counseling to Breast Cancer Patients and Their Partners|Hand in Hand. Psychological Intervention for Breast Cancer Patients and Their Partners. A Randomised, Controlled Trial.|Completed||N/A|198|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-10-11 04:09:43.365019|2017-10-11 04:09:43.365019
NCT01368367|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-06-06|||December 2007||2007-12-01|November 2010|2010-11-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Exercise Training Post Burn Injury|Safety and Efficacy of Exercise Training Post Burn Injury: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|36|Anticipated|The University of Queensland||2|||f||||f||||||||||2017-10-11 04:09:43.465863|2017-10-11 04:09:43.465863
NCT01368354|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2015-02-10|||April 2012||2012-04-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SANTOSOIL||Taenia Solium Control Case Study in Zambia|Impact of Community-Led Total Sanitation on the Control of Taenia Solium and Soil Transmitted Helminths in the Eastern Province of Zambia|Completed||N/A|1197|Actual|University of Zambia||2|||f||||f||||||||||2017-10-11 04:09:43.547771|2017-10-11 04:09:43.547771
NCT01368341|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-12-11|||June 2011||2011-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|NorTick_EM||Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice|Tick Borne Diseases in Norwegian General Practice. A Randomized, Controlled Trial for Treatment of Erythema Migrans in Norwegian General Practice. A Comparison of Phenoxymethylpenicillin, Amoxicillin and Doxycycline.|Completed||Phase 4|225|Anticipated|University of Oslo||3|||f||||t||||||||||2017-10-11 04:09:43.628872|2017-10-11 04:09:43.628872
NCT01368328|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-12|2011-06-06|||March 2010||2010-03-01|February 2011|2011-02-01|September 2011|Anticipated|2011-09-01|July 2011|Anticipated|2011-07-01||Interventional|||Effect of the Chromium Nicotinate on Type 2 Diabetes|Effect of Chromium Supplementation on Insulin Sensitivity in Patients With Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 3|57|Anticipated|Universidade Federal de Goias||3|||f||||f||||||||||2017-10-11 04:09:43.744106|2017-10-11 04:09:43.744106
NCT01368315|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-06-06||||||June 2011|2011-06-01||||||||Interventional|CT327 AD01-09||"CT 327 in the Atopy Patch Test Model"|"CT 327 in the Atopy Patch Test Model"|Withdrawn||Phase 1|20|Anticipated|Creabilis SA||4||Strategic decision|f||||f||||||||||2017-10-11 04:09:43.863781|2017-10-11 04:09:43.863781
NCT01368302|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-12-01|||July 2011||2011-07-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD)|Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD)|Completed||Phase 2|52|Actual|Tel Aviv University||2|||f||||f||||||||||2017-10-11 04:09:43.980836|2017-10-11 04:09:43.980836
NCT01368289|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-02-05|||September 2008||2008-09-01|February 2017|2017-02-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Observational|ACEEMR||Australian Multicentre Colonic Endoscopic Mucosal Resection Study|Australian Multicentre Colonic Endoscopic Mucosal Resection (ACE/EMR) Study|Recruiting||N/A|2000|Anticipated|Western Sydney Local Health District|||1||f||||f||||||||||2017-10-11 04:09:44.076194|2017-10-11 04:09:44.076194
NCT01368276|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2015-11-12|2015-09-22||October 2010||2010-10-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma|An Extension Protocol to Evaluate the Efficacy and Safety of Extended Use Treatment With OncoVEX^GM-CSF for Eligible Melanoma Patients Participating in Study 005/05|Completed||Phase 3|31|Actual|BioVex Limited||2|||f||||||||||||||2017-10-11 04:09:44.18098|2017-10-11 04:09:44.18098
NCT01368263|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2015-03-16|2015-01-23||September 2011||2011-09-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer|A Multisite International Collaborative Phase 2 Study of Neoadjuvant Goserelin and a Non-steroidal Aromatase Inhibitor for Premenopausal Women With Estrogen Receptor Positive HER2 Negative Clinical Stage 2 and 3 Breast Cancer|Terminated||Phase 2|8|Actual|Washington University School of Medicine||3||Due to funding source and lack of accrual|f||||t||||||||||2017-10-11 04:09:44.779739|2017-10-11 04:09:44.779739
NCT01368250|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2017-02-15|||February 2011||2011-02-01|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||SWISS TAVI Registry|SWISS TAVI Registry: Prospective, National, Multi-Center Registry of Patients Undergoing Transcatheter Aortic Valve Implantation|Recruiting||N/A|3000|Anticipated|University Hospital Inselspital, Berne|||1||f||||t||||||||||2017-10-11 04:09:45.259598|2017-10-11 04:09:45.259598
NCT01368237|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-10-27|||May 2006||2006-05-01|October 2014|2014-10-01||||June 2014|Actual|2014-06-01||Observational|||Dynamic Myocardial Perfusion Imaging by 320 Multidetector Computed Tomography|Dynamic Myocardial Perfusion Imaging by 320 Multidetector Computed Tomography|Completed||N/A|75|Anticipated|University of Edinburgh|||1||f||||f||||||||||2017-10-11 04:09:45.346329|2017-10-11 04:09:45.346329
NCT01368224|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2011-06-06|||June 2004||2004-06-01|June 2011|2011-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Two Supplemented Against Skin Reactivity|PLACEBO-CONTROLLED STUDY OF THE EFFECT OF TWO FOOD SUPPLEMENTS ON SKIN REACTIVITY|Completed||Phase 3|96|Actual|L'Oreal||3|||f||||t||||||||||2017-10-11 04:09:45.426525|2017-10-11 04:09:45.426525
NCT01368211|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-05-23|2014-02-27||September 2010||2010-09-01|May 2016|2016-05-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|PRESS||Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study)|PRESS Pathogen Reduction Extended Storage Study PRESS (Pathogen Reduction Extended Storage Study) A Pilot Study of Mirasol Platelets Treated in Platelet Additive Solution in Thrombocytopenic Patients|Terminated||Phase 2/Phase 3|16|Actual|Terumo BCTbio|Small numbers of subjects|2||Part 1 completed, part 2 not done due to slow enrollment|f||||t||||||||||2017-10-11 04:09:45.524495|2017-10-11 04:09:45.524495
NCT01368198|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2012-01-31|||March 2011||2011-03-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion|The Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion|Completed||N/A|50|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 04:09:45.7724|2017-10-11 04:09:45.7724
NCT01368185|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-10-09|2011-08-02||November 2008||2008-11-01|October 2015|2015-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)|A Retrospective Survey to Evaluate the Impact of Hyzaar on Uric Acid in the Management of Hypertensive Patients in Normal Practice|Completed||N/A|1705|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-10-11 04:09:46.012387|2017-10-11 04:09:46.012387
NCT01368172|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-04-07|||July 2011||2011-07-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Physical Activity Guidelines for People With Spinal Cord Injury (SCI)|Implementation and Evaluation of the New Physical Activity Guidelines for People With Spinal Cord Injury.|Completed||Phase 1|30|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 04:09:46.227094|2017-10-11 04:09:46.227094
NCT01368159|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2011-09-13|||November 2010||2010-11-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the Great Saphenous Vein|Randomised, Comparative Trial in Parallel Groups and Blinded, to Compare Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the G.S V. Under Echography Control, Between Three Types of Medical Compression Hose|Completed||Phase 4|120|Actual|Le Club Mousse||3|||f||||f||||||||||2017-10-11 04:09:46.314386|2017-10-11 04:09:46.314386
NCT01368146|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-04-15|||March 2011||2011-03-01|April 2015|2015-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Human Repeat Insult Patch Test of Wound Dressings||Completed||Phase 1|216|Actual|Covalon Technologies Inc.||3|||f||||f||||||||||2017-10-11 04:09:46.396592|2017-10-11 04:09:46.396592
NCT01368133|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2013-09-24|||May 2011||2011-05-01|September 2013|2013-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||The Observational Study of Growth Hormone-secreting Pituitary Tumors|The Observational Study of the Structures and Functions of Multiple Organs in Patients With Growth Hormone-secreting Tumors|Unknown status|Recruiting|N/A|60|Anticipated|Huashan Hospital|||1||f||||t||||||Samples With DNA|"     Plasma, DNA and pituitary tumor tissues   "|||2017-10-11 04:09:46.478663|2017-10-11 04:09:46.478663
NCT01368120|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-04-15|||April 2011||2011-04-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Antimicrobial Activity of IV Clear™ Dressing - Prevention of Antimicrobial Regrowth||Completed||Phase 1|37|Actual|Covalon Technologies Inc.||3|||f||||f||||||||||2017-10-11 04:09:46.566|2017-10-11 04:09:46.566
NCT01368107|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2015-02-06|||June 2011||2011-06-01|December 2013|2013-12-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|||Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients|A Randomised, Multicentric, Phase 2a Study Evaluating the Impact of an Immunotherapy by IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients|Completed||Phase 2|24|Actual|Centre Leon Berard||4|||f||||t||||||||||2017-10-11 04:09:46.658422|2017-10-11 04:09:46.658422
NCT01368094|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-05-02|||June 2011||2011-06-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Early (4 Days) Versus Standard Drainage of the Abdominal Cavity After Pancreaticoduodenectomy|Early (4 Days) Versus Standard Drainage Removal of the Abdominal Cavity After Pancreaticoduodenectomy- - A Randomized Multicenter Study|Completed||N/A|141|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-10-11 04:09:46.783788|2017-10-11 04:09:46.783788
NCT01368081|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-05-16|2014-05-16||May 2011||2011-05-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus|A 52-week, Randomised, Multi-centre, Parallel Group Study to Investigate the Safety and Efficacy of BI 10773 (10 mg or 25 mg Administered Orally Once Daily) as add-on Therapy to an Oral Antidiabetic Drug (Sulfonylurea, Biguanide, Thiazolidinedione, Alpha Glucosidase Inhibitor, DPP-IV Inhibitor, or Glinide) in Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control|Completed||Phase 3|1162|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 04:09:46.928315|2017-10-11 04:09:46.928315
NCT01368068|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-03-29|||July 2012||2012-07-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Investigation of Tibolone and Escitalopram in Perimenopausal Depression|Double-Blind Randomised Investigation of Tibolone or Escitalopram in First Onset Perimenopausal Depression|Terminated||Phase 4|2|Actual|The Alfred||3||Difficulty in recruiting|f||||t||||||||||2017-10-11 04:09:50.039216|2017-10-11 04:09:50.039216
NCT00005567|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-22|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||Parental Knowledge and Beliefs About Infant Sleep Position||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:27:14.664308|2017-10-11 04:27:14.664308
NCT01368055|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-08-10|||September 2011||2011-09-01|August 2017|2017-08-01|September 2036|Anticipated|2036-09-01|December 2017|Anticipated|2017-12-01||Interventional|PR07||Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer|An Expanded Phase II Study of Hypofractionated Dose Intense Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate|Active, not recruiting||N/A|360|Anticipated|University of Florida||2|||f||||t|f|f||||||||2017-10-11 04:09:50.157348|2017-10-11 04:09:50.157348
NCT01368042|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2014-07-29|2014-06-26||August 2011||2011-08-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|QUALITIZE|All participants in the enrolled population, regardless of whether or not they completed the study (i.e., the 6-month post-enrollment follow-up). Of the 265 participants enrolled, 11 were considered to have protocol deviations and were excluded from the enrolled population; therefore, 254 participants were included in the study analyses.|Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous|Quality of Life in Greek Hemodialysis Patients Receiving Zemplar i.v (QualitiZe)|Completed||N/A|265|Actual|AbbVie|||1||f||||f||||||||||2017-10-11 04:09:50.299601|2017-10-11 04:09:50.299601
NCT01368029|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-01-10|||September 2011||2011-09-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine|Double Blind Randomized Controlled Trial to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine|Completed||Phase 1|28|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:09:51.209661|2017-10-11 04:09:51.209661
NCT01368016|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2012-07-06|||April 2011||2011-04-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine Gum|Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Product and Nicotine Gum 4 mg. A Study in Healthy Smokers|Completed||N/A|346|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 04:09:51.326231|2017-10-11 04:09:51.326231
NCT01368003|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2015-08-29|||April 2011||2011-04-01|August 2015|2015-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling|A Biomarker Study of STA9090 in Castration-Resistant Prostate Cancer (CRPC) With Assessment of Androgen Receptor Pathway Signaling|Withdrawn||Phase 2|0|Actual|Dana-Farber Cancer Institute||2||Loss of funding.|f||||t||||||||||2017-10-11 04:09:51.474844|2017-10-11 04:09:51.474844
NCT01367990|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-05|2012-03-22|||July 2011||2011-07-01|March 2012|2012-03-01|April 2012|Anticipated|2012-04-01|February 2012|Actual|2012-02-01||Interventional|||Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy|Alopecia Prevention Trial of Topical Vasoconstrictor Therapy in Head and Neck Cancer Patients Treated With Intensity Modulated Radiotherapy (IMRT)|Terminated||Phase 1|3|Actual|ProCertus BioPharm, Inc||1||Study site has terminated the study due to the complexity of the study|f||||f||||||||||2017-10-11 04:09:51.57261|2017-10-11 04:09:51.57261
NCT01367977|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-05|2015-04-02|||May 2011||2011-05-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life|"Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia (POTS -- Postural Orthostatic Tachycardia Syndrome)Later in Life -- a Retrospective Analysis"|Completed||N/A|21|Actual|Genetic Disease Investigators|||1||f||||t||||||||||2017-10-11 04:09:51.690772|2017-10-11 04:09:51.690772
NCT01367964|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-02-03|||July 2011||2011-07-01|February 2015|2015-02-01||||June 2015|Anticipated|2015-06-01||Interventional|PREVENT-WS||Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)|Early Treatment of Infants at High Risk of Developing West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)|Unknown status|Recruiting|N/A|28|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-10-11 04:09:51.795357|2017-10-11 04:09:51.795357
NCT01367951|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-10-24|||July 2011||2011-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Acute, Unstable Chest Wall Injuries|A Multi Centered Randomized Controlled Trial of Operative Versus Non-operative Treatment of Acute, Unstable Chest Wall Injuries|Recruiting||N/A|206|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 04:09:51.966055|2017-10-11 04:09:51.966055
NCT01367938|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-22|2012-12-12|||November 2009||2009-11-01|December 2012|2012-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||Clinical Outcomes With Apex (OK) Knee System|Clinical Outcomes With Omni Apex (OK) Knee System|Unknown status|Recruiting|N/A|56|Anticipated|Spokane Joint Replacement Center|||1||f||||t||||||||||2017-10-11 04:09:52.130696|2017-10-11 04:09:52.130696
NCT01367925|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-22|2012-12-12|||December 2007||2007-12-01|December 2012|2012-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Stryker Cruciate Substituting/Posterior Stabilized Outcomes Study|Triathlon® Cruciate Substituting Versus Posterior Stabilized Outcomes Study|Unknown status|Active, not recruiting|N/A|126|Anticipated|Spokane Joint Replacement Center|||2||f||||t||||||||||2017-10-11 04:09:52.216595|2017-10-11 04:09:52.216595
NCT01367912|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2011-06-06|||February 2008||2008-02-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Timing of Estrogen Support During the Luteal Phase of in Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycle|Timing of Estrogen Support During the Luteal Phase of IVF / Intracytoplasmic Sperm Injection Cycle: a Randomized Controlled Trial|Completed||N/A|301|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||3|||f||||f||||||||||2017-10-11 04:09:52.294283|2017-10-11 04:09:52.294283
NCT01367899|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2014-10-24|||November 2010||2010-11-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||CONSERVE Plus Post-Approval Study (PAS)|Conserve Plus Total Hip Resurfacing System: A Non-Randomized, Multi-center, NewEnrollement Post Approval Study|Terminated||N/A|199|Actual|MicroPort Orthopedics Inc.|||1||f||||f||||||||||2017-10-11 04:09:52.428635|2017-10-11 04:09:52.428635
NCT01367886|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-02-10|2013-07-09||August 2010||2010-08-01|February 2015|2015-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||The overall number of participants is 21. The 21 participants that took Fesoterodine were the basis for analysis.|Comparative Urine Proteomic Studies of Overactive Bladder in Humans|Comparative Urine Proteomic Studies of Overactive Bladder in Humans|Completed||N/A|21|Actual|Washington University School of Medicine|No serious adverse events.|1|||f||||t||||||||||2017-10-11 04:09:52.51002|2017-10-11 04:09:52.51002
NCT01367873|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-01-18|||June 2011||2011-06-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects|A Randomized, Double-blind, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of VIA-3196 in Healthy Subjects|Completed||Phase 1|72|Actual|Madrigal Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 04:09:52.805751|2017-10-11 04:09:52.805751
NCT01367860|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-05-19|2013-04-01||June 2011||2011-06-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|April 2012|Actual|2012-04-01||Interventional|PDOP_TLR||Percutaneous Diskectomy SpineJet x Open Microdiskectomy in Treatment of Lumbar Radiculopathy|Comparison of Percutaneous Diskectomy SpineJet x Open Microdiscectomy for Treatment of Lumbar Radiculopathy in Contained Disc Herniation: Randomized Clinical Trial|Completed||N/A|40|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 04:09:52.928423|2017-10-11 04:09:52.928423
NCT01367847|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2014-06-13|||September 2010||2010-09-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|October 2012|Actual|2012-10-01||Interventional|TE-HNC||Technology-Enhanced Helping the Noncompliant Child|Technology Enhanced Delivery of Treatment for Early Conduct Problems|Completed||Phase 1|22|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 04:09:54.149052|2017-10-11 04:09:54.149052
NCT01367834|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-02-03|2016-12-12||May 2010||2010-05-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome|Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome|Completed||N/A|17|Actual|University of North Carolina, Chapel Hill|Low scan success rate and subject drop out resulted in small sample size (5 GH treated, 1 control).|2|||f||||f||||||||No||2017-10-11 04:09:54.242285|2017-10-11 04:09:54.242285
NCT01367821|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-10-04|||May 2011||2011-05-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Immune Function in Patients With Obstructive Jaundice|Quorum Sensing Signal Molecules (QSSMs) and Immune Dysfunction in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) for Obstructive Jaundice|Unknown status|Recruiting|N/A|50|Anticipated|University of Nottingham|||2||f||||f||||||Samples Without DNA|"     Plasma Bile   "|||2017-10-11 04:09:54.689193|2017-10-11 04:09:54.689193
NCT01367808|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2011-06-06|||February 2011||2011-02-01|December 2010|2010-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|PosaBupre||Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine|Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine: A Three-phase Cross-over Study in Healthy Subjects|Completed||Phase 1|12|Anticipated|Turku University Hospital||3|||f||||f||||||||||2017-10-11 04:09:54.792322|2017-10-11 04:09:54.792322
NCT01367795|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-14|2015-03-26|||July 2010||2010-07-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Surgical Procedures for Advanced Tumor Disease. A Prospective Study Evaluating Quality of Life|Surgical Procedures for Advanced Tumor Disease. A Prospective Study Evaluating Quality of Life|Completed||N/A|26|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 04:09:54.873149|2017-10-11 04:09:54.873149
NCT01367782|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2014-09-10|||May 2011||2011-05-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease|A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease|Unknown status|Recruiting|N/A|51|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 04:09:54.966605|2017-10-11 04:09:54.966605
NCT01367769|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2017-04-21|||March 2011||2011-03-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|December 2015|Actual|2015-12-01||Observational|||Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis|Evaluation of Perivascular Venous Vascularization and Inflammation by Contrast-enhanced Ultrasound (CEUS) in Patients With Acute Deep Vein Thrombosis and Superficial Thrombophlebitis - a Pilot Study|Terminated||N/A|20|Actual|University Hospital, Basel, Switzerland|||1|insufficient recruitment|f||||f||||||Samples Without DNA|"     The investigators will also determine level of inflammatory markers as the cytokines     interleukin-6 (IL-6), interleukin-8 (IL-8), monocyte chemoattractant-1 (MCP-1), Vascular     cellular adhesion molecule-1 (VCAM-1), von Willebrand factor (vWF) and C-reactive protein     (CRP) at each visit (baseline, 2 weeks, and 3 months).   "|||2017-10-11 04:09:55.214777|2017-10-11 04:09:55.214777
NCT01367756|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2016-11-01|||May 2011||2011-05-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study of RO4995819 in Combination With Citalopram in Healthy Volunteers|A Single Center, Randomized, Double-blind, Parallel-design Study to Investigate the Safety and Tolerability of RO4995819 in Combination With Citalopram Following Oral Administration in Healthy Volunteers|Completed||Phase 1|32|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:09:55.344407|2017-10-11 04:09:55.344407
NCT01367743|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-04-21|||September 2011||2011-09-01|April 2017|2017-04-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Interventional|OptimaCC||Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock|Optimizing the Use of Vasopressor After Coronary Reperfusion in Cardiogenic Shock Secondary to Myocardial Infarction. Pathophysiological Study Comparing the Efficacy and Cardio-circulatory Tolerability of Epinephrine and Norepinephrine|Completed||Phase 4|58|Actual|Central Hospital, Nancy, France||2|||f||||t||||||||||2017-10-11 04:09:55.445371|2017-10-11 04:09:55.445371
NCT01367730|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-12-01|||April 2012||2012-04-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Assessment of Bone Micro-Architecture Using HR-pQCT|Non-Invasive Assessment of Bone Micro-architecture and Strength Changes in Men With Osteopenia and Osteoporosis|Completed||N/A|80|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 04:09:55.61019|2017-10-11 04:09:55.61019
NCT01367717|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2012-09-14|||May 2009||2009-05-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|ECSUC||Effect of Creatine on Serum and Urine Creatinine|Effect of Creatine Monohydrate and Creatine Ethyl Ester on Serum and Urinary Creatinine|Completed||N/A|25|Actual|Beth Israel Medical Center||2|||f||||t||||||||||2017-10-11 04:09:55.726582|2017-10-11 04:09:55.726582
NCT00005569|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-22|2008-03-03|||April 2000||2000-04-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Interventional|||Effects of Topical SLPI on Skin Wounds|Effects of Topical Anti-Inflammatory Agents on Cutaneous Wound Healing|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:14.721125|2017-10-11 04:27:14.721125
NCT01367704|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2014-07-16|2014-05-29||October 2009||2009-10-01|July 2014|2014-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|CBIM||"Evaluation Of Coaching Boys Into Men (CBIM) Program"|"A Randomized Controlled Trial of an Adolescent Relationship Abuse Prevention Program Entitled Coaching Boys Into Men"|Completed||N/A|2006|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 04:09:55.852705|2017-10-11 04:09:55.852705
NCT01367691|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2014-01-31|||June 2011||2011-06-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Cardiac MR (CMR) in Cardiac Resynchronization Therapy Non-responders|Cardiac MR (CMR) in Cardiac Resynchronization Therapy (CRT) Non-responders: Therapy Optimization by Means of Tissue Characterization, Hemodynamic Analysis and Analysis of Myocardial Activation|Terminated||N/A|1|Actual|University Hospital, Bonn||1|||f||||f||||||||||2017-10-11 04:09:56.503174|2017-10-11 04:09:56.503174
NCT01367678|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2011-08-23|||May 2011||2011-05-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Mucosal Pressure of the Laryngeal Mask Airway Supreme Versus the i-Gel in Paralyzed Anesthetized Female Patients|Directly Measured Mucosal Pressure for Two Different Extraglottic Airway Devices|Completed||N/A|30|Anticipated|Schulthess Klinik||2|||f||||t||||||||||2017-10-11 04:09:56.599191|2017-10-11 04:09:56.599191
NCT01367665|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2017-08-29|||July 1, 2011|Actual|2011-07-01|August 2017|2017-08-01|June 14, 2017|Actual|2017-06-14|June 14, 2017|Actual|2017-06-14||Interventional|||STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma|A Single Arm, Open-label, Phase II, Multicentre Study, to Assess the Safety of Vismodegib (GDC-0449) in Patient With Locally Advanced or Metastatic Basal Cell Carcinoma (BCC)|Completed||Phase 2|1226|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:09:56.751015|2017-10-11 04:09:56.751015
NCT01367652|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2014-01-17|||March 2008||2008-03-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions|A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fasted Conditions|Completed||Phase 1|28|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 04:09:57.18855|2017-10-11 04:09:57.18855
NCT01367639|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2013-11-22|||March 2011||2011-03-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers|Pilot Randomized Controlled Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers|Completed||Phase 2|67|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 04:09:57.257426|2017-10-11 04:09:57.257426
NCT01367626|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2014-01-17|||March 2008||2008-03-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions|A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fed Conditions|Completed||Phase 1|28|Actual|Roxane Laboratories||2|||f||||f||||||||||2017-10-11 04:09:57.370304|2017-10-11 04:09:57.370304
NCT01367613|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-18|||March 2004||2004-03-01|July 2011|2011-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Open-Label Treatment Extension of Protocol MNTX 302|A Three-Month Open-Label Treatment Extension of Protocol MNTX 302|Completed||Phase 3|89|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||t||||||||||2017-10-11 04:09:57.672947|2017-10-11 04:09:57.672947
NCT01367600|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-18|||February 2003||2003-02-01|July 2011|2011-07-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Open-Label Treatment Extension of Protocol MNTX 301|A Three-Month Open-Label Treatment Extension of Protocol MNTX 301|Completed||Phase 3|27|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||t||||||||||2017-10-11 04:09:57.741042|2017-10-11 04:09:57.741042
NCT01367587|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2011-07-18|||April 2002||2002-04-01|July 2011|2011-07-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone|Safety and Gastrointestinal Effects of Multiple-Dosed Intravenous Methylnaltrexone in Healthy Human Volunteers|Completed||Phase 2|12|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 04:09:57.838934|2017-10-11 04:09:57.838934
NCT01367574|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-18|||April 2002||2002-04-01|July 2011|2011-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction|A Phase II Double-Blind, Randomized, Parallel Group, Dose Ranging Study of Subcutaneous Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction|Completed||Phase 2|39|Actual|Valeant Pharmaceuticals International, Inc.||3|||f||||f||||||||||2017-10-11 04:09:57.921477|2017-10-11 04:09:57.921477
NCT01367561|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-18|||October 2002||2002-10-01|July 2011|2011-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function|A Phase I Urodynamic Study of the Opioid Antagonist, Naloxone and Intravenous Methylnaltrexone Reverse Opioid Effects on Bladder Function in Healthy Volunteers|Completed||Phase 1|15|Actual|Valeant Pharmaceuticals International, Inc.||3|||f||||f||||||||||2017-10-11 04:09:58.027735|2017-10-11 04:09:58.027735
NCT01367548|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-18|||July 2003||2003-07-01|July 2011|2011-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus|A Phase II Double-Blind Randomized Parallel Group Study of Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus|Completed||Phase 2|65|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 04:09:58.102446|2017-10-11 04:09:58.102446
NCT01367535|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||March 2006||2006-03-01|July 2011|2011-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan|A Phase I, Randomized, Open-Label, Active- and Placebo-Controlled Parallel Group Study of the Effect of Subcutaneous and Intravenous Methylnaltrexone on CYP450 2D6 Activity in Healthy Extensive Metabolizers of Dextromethorphan|Completed||Phase 1|54|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-10-11 04:09:58.193436|2017-10-11 04:09:58.193436
NCT01367522|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||March 2004||2004-03-01|July 2011|2011-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function|A Phase 1, Open-Label, Study to Evaluate Single Dose Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Volunteers With Impaired Hepatic Function|Completed||Phase 1|24|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 04:09:58.288248|2017-10-11 04:09:58.288248
NCT00005322|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-09-27|||January 1990||1990-01-01|August 2004|2004-08-01|December 1998|Actual|1998-12-01|||||Observational|||Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:59.341257|2017-10-11 04:27:59.341257
NCT01367509|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||March 2004||2004-03-01|July 2011|2011-07-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|||Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function|A Phase 1, Open-Label Study to Evaluate Single Dose Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function|Completed||Phase 1|32|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 04:09:58.377058|2017-10-11 04:09:58.377058
NCT01367496|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||June 2002||2002-06-01|July 2011|2011-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose|An Open-Label, Phase I Study of the Pharmacokinetics and Bioavailability of Single, Ascending Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose in Normal, Healthy Male Volunteers|Completed||Phase 1|6|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-10-11 04:09:58.487929|2017-10-11 04:09:58.487929
NCT01367483|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||June 2005||2005-06-01|July 2011|2011-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX|An Open-Label, Phase I, Single Dose Study of the Pharmacokinetics, Mass Balance and Disposition of Intravenously Administered 14C-Methylnaltrexone in Normal, Healthy Volunteers|Completed||Phase 1|6|Anticipated|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 04:09:58.634826|2017-10-11 04:09:58.634826
NCT01367470|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2014-01-09|||April 2010||2010-04-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Influence of Probiotic VSL#3 Administration on Metabolic and Immunological Profile of the Milk of Breastfeeding Mothers|Effects on Cytokines, Immunoglobulins, Antibodies, Sphingomyelinase and PAF Hydrolysis Capacity in the Maternal Milk After Probiotic VSL#3 Administration in the Last Four Weeks of Gestation and First Month of Lactation|Completed||Phase 4|67|Actual|Policlinico Hospital||2|||f||||t||||||||||2017-10-11 04:09:58.720871|2017-10-11 04:09:58.720871
NCT01367457|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-03-25|2016-03-25||January 2011||2011-01-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational||Baseline population included all participants with RCC or MCL who received atleast 1 dose of study treatment.|INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus|Inhibitor - Estudio Retrospectivo De Casos Clinicos De Pacientes Con Carcinoma De Celulas Renales Y Con Linforma De Celulas Del Manto Tratados Con Temsirolimus|Completed||N/A|243|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 04:09:58.848019|2017-10-11 04:09:58.848019
NCT01367431|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-15|2015-07-23|||August 2011||2011-08-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Xanthohumol and Metabolic Syndrome|Xanthohumol and Metabolic Syndrome|Completed||N/A|48|Actual|Oregon State University|||3||f||||t||||||||||2017-10-11 04:10:01.987994|2017-10-11 04:10:01.987994
NCT01367418|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2012-03-16|||September 2010||2010-09-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|AIMS||Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy|Comparison Between Epidural and Patient Controlled Analgesia on Immunological and Inflammatory Systems Following Radical Retropubic Prostatectomy|Completed||Phase 3|26|Actual|Örebro University, Sweden||2|||f||||t||||||||||2017-10-11 04:10:02.11647|2017-10-11 04:10:02.11647
NCT01367405|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2016-10-12|||October 2013||2013-10-01|November 2013|2013-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|COSMIC||Comparing Surgical Decompression Versus Conservative Treatment in Incomplete Spinal Cord Injury|COSMIC: Conservative or Early Surgical Management of Incomplete Cervical Cord Syndrome Without Spinal Instability. Randomized Controlled Trial|Terminated||N/A|1|Actual|Radboud University||2||only 1 inclusion in 1.5 years due to strict exclusion criteria|f||||f||||||||||2017-10-11 04:10:02.225107|2017-10-11 04:10:02.225107
NCT01367392|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-06|2012-02-14|||June 2011||2011-06-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System|Confirmation of Clinical Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System|Completed||Phase 4|20|Actual|ActiViews Ltd.||1|||f||||f||||||||||2017-10-11 04:10:02.30305|2017-10-11 04:10:02.30305
NCT01367379|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2012-01-03|||June 2011||2011-06-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||The Effect of the Duty Loading on the Stress Response of Physician|The Effect of the Duty Loading on the Stress Response of Physician|Unknown status|Recruiting|N/A|15|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 04:10:02.371322|2017-10-11 04:10:02.371322
NCT01367366|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-20|2011-06-06|||May 2010||2010-05-01|May 2011|2011-05-01||||April 2012|Anticipated|2012-04-01||Observational|||Dx Mediastinal Malignant LAP:Compare PET and EBUS-TBNA|Dx Mediastinal Malignant LAP:Compare PET and EBUS-TBNA|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 04:10:02.454245|2017-10-11 04:10:02.454245
NCT01367353|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-10|2011-06-06|||January 2010||2010-01-01|May 2011|2011-05-01|December 2013|Anticipated|2013-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Characterization of Ovarian Cancer Stem Cell|Characterization of Ovarian Cancer Stem Cell: Focus on Identification of Biomarker and Drug Resistance|Unknown status|Recruiting|N/A|250|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:10:02.526488|2017-10-11 04:10:02.526488
NCT01367340|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-09|2012-05-16|||August 2010||2010-08-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Effect of Physical Activity Intervention Children With Spastic Diplegia After Resistance Training|Effect of Physical Activity Intervention on Mobility Changes and Participation for School-Age Children With Spastic Diplegia and After Resistance Training|Unknown status|Active, not recruiting|N/A|32|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 04:10:02.629978|2017-10-11 04:10:02.629978
NCT00000558|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||November 1995||1995-11-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.453035|2017-10-11 04:19:04.453035
NCT01367327|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-09|2012-05-16|||January 2009||2009-01-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Therapeutic Music Combined With Loaded Sit-to-Stand Resistance Exercise for Children With Spastic Diplegia|Effects of Therapeutic Music Combined With Loaded Sit-to-Stand Resistance Exercise for Children With Spastic Diplegia|Completed||N/A|36|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 04:10:02.746278|2017-10-11 04:10:02.746278
NCT01367314|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2011-06-06|||August 2009||2009-08-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of Topical NVC-422 Gel in Impetigo|A Phase IIa, Double Blind, Randomized, Sequential Group Study to Evaluate the Safety and Efficacy of Topical NVC-422 Dermal Gel in Impetigo|Completed||Phase 2|129|Actual|NovaBay Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 04:10:02.989971|2017-10-11 04:10:02.989971
NCT01367301|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2015-01-16|||May 2011||2011-05-01|January 2015|2015-01-01||||January 2016|Anticipated|2016-01-01||Interventional|||Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer|"A Pilot Trial of Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With Uterine Carcinosarcoma"|Unknown status|Recruiting|N/A|18|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 04:10:03.088245|2017-10-11 04:10:03.088245
NCT01367288|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-17|2014-05-28|||April 2010||2010-04-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|NEOZOL||Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers|Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers|Completed||Phase 2|53|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 04:10:03.706802|2017-10-11 04:10:03.706802
NCT01367262|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2011-08-09|||June 2011||2011-06-01|June 2011|2011-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Disposition of 14C-LY2886721 Following Oral Administration in Healthy Human Subjects|Disposition of [14C]-LY2886721 Following Oral Administration in Healthy Human Subjects|Completed||Phase 1|8|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:10:04.026669|2017-10-11 04:10:04.026669
NCT01367249|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2014-04-04|2014-04-04|2013-02-04|May 2011||2011-05-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional||Intent to treat population (ITT), all randomized participants|Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery|Efficacy and Safety of Bromfenac Ophthalmic Solution vs. Placebo for the Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery.|Completed||Phase 3|440|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 04:10:04.134987|2017-10-11 04:10:04.134987
NCT01367236|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2017-01-09|||January 2013||2013-01-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|CogUK||Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa|A Randomised, Prospective Study, Assessing Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa.|Completed||Phase 4|60|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 04:10:05.195273|2017-10-11 04:10:05.195273
NCT01367223|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2013-09-05|||April 2010||2010-04-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|July 2012|Actual|2012-07-01||Interventional|||Modulation of Systemic Inflammatory Response in Critically Ill Children After Glutamine Supplementation|Modulation of Systemic Inflammatory Response in Critically Ill Children After Glutamine Supplementation|Completed||Phase 4|101|Actual|Hospital Sant Joan de Deu||2|||f||||f||||||||||2017-10-11 04:10:05.324945|2017-10-11 04:10:05.324945
NCT01367210|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2016-02-05|||June 2011||2011-06-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|GUSTA||Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)|Switch to Darunavir/r + Maraviroc QD in Patients With R5 Tropism by Viral DNA Genotyping With Suppressed Viremia (GUSTA): a Multicenter, Open-label, Randomized Controlled Trial|Terminated||Phase 4|165|Actual|Catholic University of the Sacred Heart||2||Because a higher rate of virological failures in study versus control arm.|f||||f||||||||||2017-10-11 04:10:05.50317|2017-10-11 04:10:05.50317
NCT01367197|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-06-03|||January 2009||2009-01-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Study of the Effect of Exercise Training on Patients in Atrial Fibrillation|Randomised Study of the Effect of Exercise Training on Patients in Atrial Fibrillation|Completed||N/A|49|Actual|Copenhagen University Hospital, Hvidovre||2|||f||||f||||||||||2017-10-11 04:10:05.628589|2017-10-11 04:10:05.628589
NCT01367184|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2013-06-20|||May 2011||2011-05-01|June 2013|2013-06-01|May 2014|Anticipated|2014-05-01|April 2013|Actual|2013-04-01||Observational|||National Inferior Vena Cava (IVC) Filter Registry|IVC Filter Study to Monitor and Measure Patients Outcomes Through Standardized Collection and Analysis of Clinical Information|Terminated||N/A|20000|Actual|American Venous Forum|||1||f||||t||||||||||2017-10-11 04:10:05.727655|2017-10-11 04:10:05.727655
NCT01367171|ClinicalTrials.gov processed this data on October 10, 2017|2010-09-17|2015-10-29|||August 2010||2010-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 04:10:05.898093|2017-10-11 04:10:05.898093
NCT01367158|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-03|2014-11-17|2014-02-11||July 2011||2011-07-01|November 2014|2014-11-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|||Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines|Phase 2, Observer-Blind, Controlled, Randomized, Multi-Center Extension Study to Evaluate Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY in Adolescents Who Previously Received the Same Study Vaccines|Completed||Phase 2|440|Actual|Novartis||11|||f||||f||||||||||2017-10-11 04:10:06.074471|2017-10-11 04:10:06.074471
NCT00005347|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||February 1992||1992-02-01|May 2000|2000-05-01|January 1997|Actual|1997-01-01|||||Observational|||Framingham Cycle V Offspring-Spouse Nutrition Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.504899|2017-10-11 04:28:02.504899
NCT01367145|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2014-08-24|||January 2011||2011-01-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease|OMEGA-3-POLYUNSATURATED FATTY-ACIDS (n3-PUFA) IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: EFFECTS ON ENDOTHELIAL FUNCTION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL|Completed||Phase 3|71|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-10-11 04:10:11.484313|2017-10-11 04:10:11.484313
NCT01367132|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-02-20|||February 2011||2011-02-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Assessment of the Number of Umbilical Cord Vessels at the Time of Nuchal Translucency Screening|Assessment of the Number of Umbilical Cord Vessels at the Time of Nuchal Translucency Screening|Completed||N/A|123|Actual|Medstar Health Research Institute|||1||f||||f||||||||||2017-10-11 04:10:11.569781|2017-10-11 04:10:11.569781
NCT01367119|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-08-05|2013-03-18||May 2011||2011-05-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Ketamine Anesthesia in Electroconvulsive Therapy|A Randomized Comparison of Ketamine and Methohexital Anesthesia for Electroconvulsive Therapy (ECT) in Depression|Completed||N/A|38|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 04:10:11.663536|2017-10-11 04:10:11.663536
NCT01367106|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2016-09-28|||November 2012||2012-11-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2016|Actual|2016-06-01||Interventional|GLUCODEX||"Effects of in UTERO Exposure to Glucocorticoids"|"Study of the Effects in Carbohydrate Metabolism and Renal Function of in UTERO Exposure to Glucocorticoids in Adult Offsprings (GLUCODEX)"|Active, not recruiting||N/A|46|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 04:10:12.026884|2017-10-11 04:10:12.026884
NCT01367093|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-05-02|||July 2011||2011-07-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|FROG-ICU||French and EuRopean Outcome Registry in Intensive Care Unit|French and EuRopean Outcome Registry in Intensive Care Unit|Completed||N/A|2137|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"     Plasma and urine at admission and ICU discharge   "|||2017-10-11 04:10:12.11601|2017-10-11 04:10:12.11601
NCT01367080|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-08-06|2013-02-20||July 2011||2011-07-01|August 2014|2014-08-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|DWETR||A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg|Clinical Trials to Compare the Pharmacokinetics Profile of Etravil®(Amitriptyline Hydrochloride) Tablet 10mg and Etravil®(Amitriptyline Hydrochloride) Tablet 25mg After a Single Oral Administration in Healthy Male Volunteers|Completed||Phase 1|12|Actual|Dong Wha Pharmaceutical Co. Ltd.|"When collecting blood samples, few subjects were drawn blood later than that stated in protocol for about 1 ~ 2 minutes where results may not be effected.
One of the subjects came in late for Post-study visit for about 4~6 days."|2|||f||||t||||||||||2017-10-11 04:10:12.241778|2017-10-11 04:10:12.241778
NCT01367067|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-07-01|||January 2010||2010-01-01|May 2011|2011-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|CLAUSTRO II||Prediction of Claustrophobia During MR Imaging|Prediction of Claustrophobia During MR Imaging: An Observational 18-Months Single Center Study|Completed||N/A|8000|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-10-11 04:10:12.672663|2017-10-11 04:10:12.672663
NCT01367054|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2011-06-03|||June 2008||2008-06-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|July 2011|Anticipated|2011-07-01||Interventional|||Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg|Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg|Unknown status|Active, not recruiting|N/A|26|Anticipated|Biocinese||1|||f||||f||||||||||2017-10-11 04:10:12.77707|2017-10-11 04:10:12.77707
NCT01367041|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2013-01-29|||April 2011||2011-04-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|PMO-WBV-sEMG||Effect of Bone on Vibration-Induced Muscle Electrical Activity|Effect of Hip Bone Mineral Density / Content on Vibration-Induced Hip Adductors Muscle Electrical Activity in Postmenopausal Women|Completed||N/A|80|Actual|Bagcilar Training and Research Hospital||2|||f||||t||||||||||2017-10-11 04:10:12.891937|2017-10-11 04:10:12.891937
NCT01367028|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-05-12|||June 2011||2011-06-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|ABCSG 32||A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer|Multicentre Randomized Phase II Study of Neoadjuvant Trastuzumab Plus Docetaxel With and Without Bevacizumab and Trastuzumab Plus Docetaxel Plus Non-pegylated Liposome-encapsulated Doxorubicin (NPLD) With and Without Bevacizumab in HER2-positive Early Breast Cancer|Completed||Phase 2|100|Actual|Austrian Breast & Colorectal Cancer Study Group||4|||f||||t||||||||||2017-10-11 04:10:13.013936|2017-10-11 04:10:13.013936
NCT01367015|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-06-03|||April 2006||2006-04-01|April 2006|2006-04-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|AREDF||Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF)|A Randomized Clinical Trial on Comparison of Early Versus Late Initiation of Feeding in Preterm Small for Gestation Infants Below 35 Weeks Gestation With Prenatal Absent or Reversal of End Diastolic Flow (AREDF) in Umbilical Artery|Completed||N/A|60|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 04:10:13.25124|2017-10-11 04:10:13.25124
NCT01367002|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-08-21|||June 2011||2011-06-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer|Randomized Phase II Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in HER2/Neu+ Patients With Advance/Recurrent Uterine Serous Papillary Carcinoma|Active, not recruiting||Phase 2|61|Actual|Yale University||2|||f||||f||||||||||2017-10-11 04:10:13.388755|2017-10-11 04:10:13.388755
NCT01366989|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-02-15|||October 2010|Actual|2010-10-01|February 2017|2017-02-01|June 4, 2013|Actual|2013-06-04|June 4, 2013|Actual|2013-06-04||Observational|||INBONE Total Ankle Arthroplasty(TAA)Using Calcaneal Stem Fixation|INBONE Total Ankle Arthroplasty(TAA)Using Calcaneal Stem Fixation|Terminated||N/A|24|Actual|Wright Medical Technology|||1|"The retrospective data review did not provide adequate information to continue the   investigation."|f||||t||||||||||2017-10-11 04:10:13.555512|2017-10-11 04:10:13.555512
NCT01366794|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-03-14|||September 2011||2011-09-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional|||Macronutrients and Gut Hormone Secretion|Effects of Macronutrients on Gut Hormone and Islet Hormone Secretion in Healthy Volunteers and Type 2 Diabetes|Completed||N/A|36|Anticipated|Lund University||2|||f||||t||||||||||2017-10-11 04:10:16.912214|2017-10-11 04:10:16.912214
NCT01366976|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2015-01-14|2015-01-06||July 2011||2011-07-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Patients were eligible for the study if he/she was 18-80 years of age and undergoing elective cardiac surgery requiring cardiopulmonary bypass.|Inhibition of Lipid Peroxidation During Cardiac Surgery|Inhibition of Lipid Peroxidation During Cardiopulmonary Bypass|Completed||N/A|67|Actual|Vanderbilt University|The exploratory analysis of acute kidney injury (AKI) was limited by the low incidence of postoperative AKI in the current study, so we were underpowered to detect small differences in creatinine or NGAL concentrations.|2|||f||||f||||||||||2017-10-11 04:10:13.674629|2017-10-11 04:10:13.674629
NCT01366963|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-17|2016-08-15|||March 2011||2011-03-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Cognitive Dysfunction in Postural Tachycardia Syndrome|Origins of Cognitive Dysfunction in Postural Tachycardia Syndrome (POTS)|Completed||N/A|60|Actual|Vanderbilt University|||2||f||||f||||||||||2017-10-11 04:10:14.198382|2017-10-11 04:10:14.198382
NCT01366950|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-12-28|||June 2011||2011-06-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|HEALTHCHANGE||Work Place Health Promotion: a Change Project|Work Place Health Promotion as a Change Project|Completed||Phase 2|406|Actual|University of Southern Denmark||2|||f||||f||||||||||2017-10-11 04:10:14.304367|2017-10-11 04:10:14.304367
NCT01366937|ClinicalTrials.gov processed this data on October 10, 2017|2009-01-16|2011-08-03|||August 2007||2007-08-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Assessment of Vitamin B12 Bioavailability From Egg|Assessment of Vitamin B12 Bioavailability From Egg|Completed||N/A|10|Anticipated|USDA, Western Human Nutrition Research Center|||1||f||||f||||||Samples With DNA|"     Plasma, serum, buffy coat, urine, stool   "|||2017-10-11 04:10:14.698759|2017-10-11 04:10:14.698759
NCT01366924|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-07-19|||May 2007||2007-05-01|June 2011|2011-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Essential Amino Acids Supplementation and Muscle Protein Synthesis|The Effect of Amino Acid Supplementation on Skeletal Muscle Protein Turnover Following Endurance Exercise|Completed||Phase 1/Phase 2|23|Actual|United States Army Research Institute of Environmental Medicine||4|||f||||f||||||||||2017-10-11 04:10:14.763791|2017-10-11 04:10:14.763791
NCT01366911|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-09-12|||April 2011||2011-04-01|September 2017|2017-09-01|January 10, 2014|Actual|2014-01-10|January 10, 2014|Actual|2014-01-10||Observational|||Stem Cells Predicting Orthopedic Outcomes|Can Stem Cells Predict Orthopaedic Outcomes? The Correlation of Bone Density Findings Post Total Hip Arthoplasty With Stem Cell Assays Obtaned at Time of Surgery|Completed||N/A|203|Actual|University of Nebraska|||1||f||||f||||||||||2017-10-11 04:10:14.87502|2017-10-11 04:10:14.87502
NCT01366898|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-11-10|||May 2010||2010-05-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)|PROTOCOL FOR THE TREATMENT Acute Lymphoblastic Leukemia With Ph 'NEGATIVE IN ELDERLY PATIENTS (> 55 Years)|Recruiting||Phase 4|100|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-11 04:10:14.945064|2017-10-11 04:10:14.945064
NCT01366885|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-05-05|2016-04-02||February 2008||2008-02-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||Mothers of at least one child with autism and pregnant before the third trimester|Vitamin D to Prevent Autism in Newborn Siblings|Study of Vitamin D to Prevent Autism in Newborn Siblings|Completed||Phase 2|20|Actual|Oregon Health and Science University||1|||f||||t||||||||Yes|Please see publication in Medical Hypotheses-88(2016) 74-78-entitled: Autism: Will vitamin D Supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings? G. Stubbs et al.|2017-10-11 04:10:15.034275|2017-10-11 04:10:15.034275
NCT01366872|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-11-20|2012-10-16||December 2010||2010-12-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Observational|||Agility LP Ankle Arthroplasty Outcomes|Agility LP Ankle Arthroplasty: Clinical and Radiographic Outcomes|Completed||N/A|50|Actual|Orthopaedic Associates of Michigan, PC|||1||f||||f||||||||||2017-10-11 04:10:15.22908|2017-10-11 04:10:15.22908
NCT01366859|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-11-02|||May 2011||2011-05-01|March 2016|2016-03-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior|Nutritional Intervention Using Supplementation With Cysteine-Rich Whey Protein Isolate (Immunocal®) in Children With Autism: Effects in Core Areas of Behavior- A Randomized Double-Blind Study|Completed||Phase 2|81|Actual|Nova Southeastern University||2|||f||||f||||||||||2017-10-11 04:10:15.48602|2017-10-11 04:10:15.48602
NCT01366846|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-01-30|2016-11-08||May 2011||2011-05-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|LEAP-On|Intent-to-treat|Persistence of Oral Tolerance to Peanut|The Persistence of Oral Tolerance Induction to Peanut and Its Immunological Basis (ITN049AD)|Completed||Phase 2|556|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|ITN049AD (LEAP-On) is a continuation of the ITN032AD LEAP Study. The plan is to share data in: 1.) ImmPort, a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts; and 2.)TrialShare, a clinical trials research portal developed by the Immune Tolerance Network.|2017-10-11 04:10:15.727416|2017-10-11 04:10:15.727416
NCT01366833|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2011-06-03|||June 2011||2011-06-01|June 2011|2011-06-01|December 2013|Anticipated|2013-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Optimal Management of Malignant Dysphagia|Management of Malignant Dysphagia: Stent vs. Stent Plus Endoluminal Brachytherapy for the Palliation of Dysphagia in Metastatic Esophageal Cancer|Unknown status|Not yet recruiting|Phase 1|72|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-10-11 04:10:16.568238|2017-10-11 04:10:16.568238
NCT01366820|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-29|2016-03-21|||February 2013||2013-02-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|INTREPID2566||Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC|A Randomized, Double-Blind, Placebo-Controlled, Study of NNZ-2566 in Patients With Traumatic Brain Injury (TBI) Conducted Under an Exception From Informed Consent (EFIC)|Completed||Phase 2|261|Actual|Neuren Pharmaceuticals Limited||2|||f||||t||||||||No||2017-10-11 04:10:16.716343|2017-10-11 04:10:16.716343
NCT01366807|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2015-03-23|||January 2011||2011-01-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Screening of Nutritional Status in Cardiac Surgery|Screening of Nutritional Status and Predictors of Adverse Outcome in Cardiac Surgery|Completed||N/A|894|Actual|Meshalkin Research Institute of Pathology of Circulation|||1||f||||t||||||Samples Without DNA|"     Serum, white cells   "|||2017-10-11 04:10:16.822219|2017-10-11 04:10:16.822219
NCT01366781|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-09-29|||May 2011||2011-05-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Gut Hormones After Meal Ingestion in Males Versus Females|Effects of Varying Meal Size on Gut Hormone and Islet Hormone Secretion in Males Versus Females|Completed||N/A|24|Actual|Lund University||2|||f||||t||||||||||2017-10-11 04:10:17.018318|2017-10-11 04:10:17.018318
NCT01366768|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-10-09|||May 2011||2011-05-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Gut Hormones After Oral Versus Intravenous Amino Acids|Release of Gut Hormones After Oral Versus Intravenous Amino Acids|Completed||N/A|12|Actual|Lund University||2|||f||||t||||||||||2017-10-11 04:10:17.115569|2017-10-11 04:10:17.115569
NCT01366742|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-05-13|||December 1987||1987-12-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women|Natural History of Human Papillomavirus From Infection to Neoplasia in Adolescents and Young Women - Effect of Tobacco on Cervical Neoplasia in Young Women|Completed||N/A|900|Actual|University of California, Los Angeles|||1||f||||f||||||Samples With DNA|"     Rbc, WBC vaginal lavages ,cytology,saliva ,anal samples   "|||2017-10-11 04:10:17.228856|2017-10-11 04:10:17.228856
NCT01366729|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2015-07-07|||November 2011||2011-11-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Gait Rehabilitation Post Stroke:the Long Term Effect of Two Walking Aids -Canes and TheraTogs|How to Improve Walking, Balance and Social Participation Following Stroke: a Comparison of Cane Walking to an Orthosis TheraTogs in Early Post-stroke Gait Rehabilitation. A Multi-centred, Single Blind,Randomized Control Trial.|Terminated||N/A|12|Actual|Technical University of Bern||2||Unable to recruite enough subjects to reach statistical power|f||||f||||||||||2017-10-11 04:10:17.305152|2017-10-11 04:10:17.305152
NCT01366716|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-07-26|||April 2008||2008-04-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Contingency Management for Cocaine Dependence: Cash Versus Vouchers|Contingency Management for Cocaine Dependence: Cash Versus Vouchers|Completed||N/A|352|Actual|Treatment Research Institute||3|||f||||t||||||||||2017-10-11 04:10:17.41798|2017-10-11 04:10:17.41798
NCT01366703|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-05-12|||May 2011||2011-05-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|pharao||Optimized Heart Failure Therapy Through Continuous Monitoring|Optimized Heart Failure Therapy Through Continuous Monitoring. The PHARAO Multi-centre Study|Unknown status|Recruiting|N/A|50|Anticipated|Kennemer Gasthuis|||1||f||||t||||||||||2017-10-11 04:10:17.512864|2017-10-11 04:10:17.512864
NCT01366690|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-09-08|||June 2011||2011-06-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|August 2013|Actual|2013-08-01||Interventional|PeerCARE||The PeerCARE Study (Peer Community-based Assistant in REtention)|The PeerCARE Study (Peer Community-based Assistant in REtention): Effect of Peer Health Workers on People Living With HIV Not on Antiretroviral Therapy—A Randomized Trial|Completed||N/A|250|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 04:10:17.629073|2017-10-11 04:10:17.629073
NCT01366677|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-05-23|||August 2010||2010-08-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|RPY||Yoga for Persons With Severe Visual Impairment|Development of a Yoga Intervention for Symptoms Related to Severe Visual Impairment|Completed||N/A|21|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-10-11 04:10:17.733672|2017-10-11 04:10:17.733672
NCT01366664|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-10-03|||April 2011||2011-04-01|October 2014|2014-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin|A Randomized, Double-blind, Placebo-Controlled, Crossover Study Assessing the Pharmacodynamic Effects of Dapoxetine Concomitantly Administered in Subjects Taking Terazosin|Completed||Phase 1|24|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-10-11 04:10:17.838915|2017-10-11 04:10:17.838915
NCT01366651|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2013-12-04|||March 2012||2012-03-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of Age|An Open-Label Study to Evaluate the Penetration of Doripenem in Cerebrospinal Fluid After Doripenem Administration in Pediatric Subjects Less Than 1 Year Chronological Age|Terminated||Phase 1|1|Actual|Janssen Research & Development, LLC||1||Trial terminated early per business decision.|f||||f||||||||||2017-10-11 04:10:17.981928|2017-10-11 04:10:17.981928
NCT01366638|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-04-10|2013-10-17|2013-04-23|May 2011||2011-05-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection|A Phase III, Open-Label Study in Japan to Assess the Efficacy and Safety of TMC435 as Part of a Treatment Regimen Including Peginterferon Alfa-2b and Ribavirin in Hepatitis C, Genotype 1 Infected Subjects|Completed||Phase 3|79|Actual|Janssen Pharmaceutical K.K.|"All outcome measures reported in this study are Exploratory; not Primary as indicated. Primary was chosen for each outcome measure because Exploratory is not available as an outcome measure type on this form."|3|||f||||f||||||||||2017-10-11 04:10:18.098927|2017-10-11 04:10:18.098927
NCT01366625|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-01-25|||July 2011|Actual|2011-07-01|January 2017|2017-01-01|November 28, 2016|Actual|2016-11-28|February 8, 2016|Actual|2016-02-08||Interventional|||Renal Denervation in Patients With Resistant Hypertension and Obstructive Sleep Apnea|Effects of Renal Denervation on Blood Pressure and Clinical Course of Obstructive Sleep Apnea in Patients With Resistant Hypertension|Completed||N/A|60|Actual|Institute of Cardiology, Warsaw, Poland||2|||f||||f||||||||||2017-10-11 04:10:19.260079|2017-10-11 04:10:19.260079
NCT01366612|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-08-08|||June 16, 2010|Actual|2010-06-16|August 2017|2017-08-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Interventional|FLUBUTBI||PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation|PRO#1278: A Phase III Study of Fludarabine and Busulfan Versus Fludarabine, Busulfan and Low Dose Total Body Irradiation in Patients Receiving an Allogeneic Hematopoietic Stem Cell Transplant|Recruiting||Phase 3|54|Anticipated|Hackensack University Medical Center||2|||f||||t||||||||||2017-10-11 04:10:19.342307|2017-10-11 04:10:19.342307
NCT01366599|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-05-23|||May 2009||2009-05-01|May 2017|2017-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||CV Events in Emetogenic Chemotherapy|Cardiovascular Events in Cancer Patients Receiving Highly Emetogenic or Moderately Emetogenic Chemotherapy|Completed||N/A|12058|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:10:19.478205|2017-10-11 04:10:19.478205
NCT01366014|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2013-06-06||2013-06-06|June 2011||2011-06-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee||Completed||Phase 2|157|Actual|Array BioPharma||3|||f||||f||||||||||2017-10-11 04:10:33.410113|2017-10-11 04:10:33.410113
NCT01366586|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2011-12-27|||May 2011||2011-05-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Confocal Laser Endomicroscopy for in Vivo Molecular Imaging of Gastric Cancer by Targeting MG7-Ag|Confocal Laser Endomicroscopy for in Vivo Molecular Imaging of Gastric Cancer by Targeting MG7 Antigen|Completed||N/A|5|Actual|Shandong University|||1||f||||t||||||Samples With DNA|"     Taken biopsies during endoscopy   "|||2017-10-11 04:10:19.561338|2017-10-11 04:10:19.561338
NCT01366573|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-07-18|||May 13, 2011|Actual|2011-05-13|July 2017|2017-07-01|September 16, 2011|Actual|2011-09-16|September 16, 2011|Actual|2011-09-16||Interventional|||GSK1521498 Alcohol Interaction Study|A Randomised, Double-Blind, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics and Pharmacodynamics of GSK1521498 in Healthy Subjects|Completed||Phase 1|1|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 04:10:19.623452|2017-10-11 04:10:19.623452
NCT01366560|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-03|2017-07-14|||August 31, 2010|Actual|2010-08-31|July 2017|2017-07-01|October 22, 2010|Actual|2010-10-22|October 22, 2010|Actual|2010-10-22||Interventional|||Effect of GSK962040 on Oesophageal Function|A Double Blind Randomised Placebo Controlled Two Way Cross Over Study to Determine the Effect of GSK962040 on Oesophageal Function and Gastric Emptying in Healthy Male Volunteers.|Completed||Phase 1|14|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 04:10:19.735914|2017-10-11 04:10:19.735914
NCT01366547|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-08-04|||June 2011||2011-06-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets|A Randomized, Open-Label, Single‑Dose, 3‑Period, Crossover Evaluation of the Relative Bioavailability of Two Experimental Fixed-Dose Combination Tablet Formulations of Dolutegravir 50 mg/Abacavir 600 mg/Lamivudine 300 mg Compared to Co‑Administered Dolutegravir 50 mg and EPZICOM™ (Abacavir 600 mg/Lamivudine 300 mg) Tablets in Healthy Adult Subjects|Completed||Phase 1|18|Actual|ViiV Healthcare||1|||||||f||||||||||2017-10-11 04:10:19.93085|2017-10-11 04:10:19.93085
NCT01366534|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-05-04|2017-05-04|2012-11-16|August 10, 2011|Actual|2011-08-10|May 2017|2017-05-01|July 3, 2012|Actual|2012-07-03|February 27, 2012|Actual|2012-02-27||Interventional|||Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults|Safety, Immunogenicity and Efficacy Against Malaria in the Sporozoite Challenge Model of One Dose of Ad35.CS.01 Malaria Vaccine Followed by Two Doses of Malaria 257049 Vaccine in Healthy Malaria-naïve Adults|Completed||Phase 2|68|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:10:20.165182|2017-10-11 04:10:20.165182
NCT01366521|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2016-11-21|2015-11-05|2013-01-04|February 2011||2011-02-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils|A Multicenter, Open-label, Dose Ranging Study to Determine the Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Intravenously or Subcutaneously to Adult Asthmatic Subjects With Elevated Blood Eosinophil Levels|Completed||Phase 2|70|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:10:21.788583|2017-10-11 04:10:21.788583
NCT01366508|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2014-08-11|||October 2009||2009-10-01|August 2014|2014-08-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food|An Experimental Medicine Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food in Healthy Volunteers|Terminated||Phase 1|5|Actual|GlaxoSmithKline||2||"Results of the study would unfortunately no longer be of any scientific interest to the sponsor   and would not be used to inform future studies."|f||||f||||||||||2017-10-11 04:10:23.867792|2017-10-11 04:10:23.867792
NCT01366495|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-02-14|||April 2011||2011-04-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections|A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care Corrections|Completed||N/A|697|Actual|Friends Research Institute, Inc.||2|||f||||f||||||||||2017-10-11 04:10:23.953208|2017-10-11 04:10:23.953208
NCT01366482|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2015-08-14|||July 2011||2011-07-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|DEFINITIVE AR||Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease|Directional AthErectomy Followed by a PaclItaxel-Coated BallooN to InhibiT RestenosIs and Maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment|Completed||Phase 1/Phase 2|121|Actual|Medtronic Endovascular||3|||f||||t||||||||||2017-10-11 04:10:24.034812|2017-10-11 04:10:24.034812
NCT01366469|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-02-18|||April 2011||2011-04-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|CABG BALF||Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting|Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting|Completed||N/A|10|Actual|Emory University|||1||f||||t||||||Samples With DNA|"     BAL fluid, Serum   "|||2017-10-11 04:10:24.116466|2017-10-11 04:10:24.116466
NCT01366456|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2011-06-08|||June 2011||2011-06-01|April 2010|2010-04-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Clinical Trials for Comparison of Two Kinds of Moxibustion|Clinical Trials for Comparison Between Shingigu and Charcoal Moxa on CV-12|Unknown status|Recruiting|N/A|40|Anticipated|Semyung University||2|||f||||t||||||||||2017-10-11 04:10:24.179257|2017-10-11 04:10:24.179257
NCT01366443|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-07-30|2012-04-26||September 2010||2010-09-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Analysis of ROM Plus to Detect Rupture of Membranes|Analysis of ROM Plus to Detect Rupture of Membranes|Completed||N/A|288|Actual|Clinical Innovations, LLC|||1||f||||t||||||||||2017-10-11 04:10:24.258953|2017-10-11 04:10:24.258953
NCT01366430|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-02|||January 2009||2009-01-01|January 2009|2009-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|HC BPPV||Treatment of Geotropic Horizontal Canal Benign Paroxysmal Positional Vertigo|Treatment of Geotropic Horizontal Canal Benign Paroxysmal Positional Vertigo; Randomized Controlled Trial of Barbeque Rotation and Gufoni Maneuver|Completed||Phase 3|170|Actual|Chonbuk National University||3|||f||||f||||||||||2017-10-11 04:10:24.477736|2017-10-11 04:10:24.477736
NCT01366417|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-08-31|2012-02-16||May 2011||2011-05-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Topical Antimicrobial Effectiveness Testing|Test for Preinjection Skin Preparation|Completed||Phase 4|25|Actual|CareFusion||1|||f||||f||||||||||2017-10-11 04:10:24.657147|2017-10-11 04:10:24.657147
NCT01366404|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-12-13|||June 2011||2011-06-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|IRIS FFR||Study of the Natural History of FFR Guided Percutaneous Coronary Intervention|A Multicenter, Prospective Cohort to Evaluate the Natural History of FFR Guided Percutaneous Coronary Intervention|Recruiting||N/A|10000|Anticipated|CardioVascular Research Foundation, Korea|||1||f||||t||||||||No|This is not publicly funded trial|2017-10-11 04:10:24.934067|2017-10-11 04:10:24.934067
NCT01366391|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2011-06-03|||January 2011||2011-01-01|June 2011|2011-06-01|October 2011|Anticipated|2011-10-01|August 2011|Anticipated|2011-08-01||Interventional|||Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome|Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome|Unknown status|Recruiting|Phase 4|24|Anticipated|Biocinese||1|||f||||f||||||||||2017-10-11 04:10:25.226789|2017-10-11 04:10:25.226789
NCT01366378|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-18|||January 2007||2007-01-01|July 2011|2011-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX|A Phase 1, Open-Label, Study of the Effect of Cimetidine, a Known Inhibitor of Active Renal Secretion, on the Single-Dose Pharmacokinetics of Intravenously-Administered Methylnaltrexone in Healthy Adults|Completed||Phase 1|18|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 04:10:25.342728|2017-10-11 04:10:25.342728
NCT01366365|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||October 2006||2006-10-01|July 2011|2011-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide|A Phase 1 Randomized, Double-Blind, Placebo Controlled Parallel Group Study of the Pharmacokinetics, Safety and Tolerability of Methylnaltrexone Bromide Administered as Single and Multiple Intravenous Doses to Healthy Adults and Elderly Male and Female Subjects|Completed||Phase 1|28|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 04:10:25.435304|2017-10-11 04:10:25.435304
NCT01366352|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||February 2004||2004-02-01|July 2011|2011-07-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets|Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets: A Double-Blind, Single Dose, Crossover, Phase 1 Study in Normal Volunteers|Completed||Phase 1|24|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 04:10:25.517072|2017-10-11 04:10:25.517072
NCT01366339|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||October 2003||2003-10-01|July 2011|2011-07-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Tolerance and Pharmacokinetics Study of MNTX Tablets|A Replicate Design, Double-Blind, Randomized, Placebo-Controlled Tolerance and Pharmacokinetics Study of N-Methylnaltrexone Tablets in Normal, Healthy Volunteers|Completed||Phase 1|37|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-10-11 04:10:25.609335|2017-10-11 04:10:25.609335
NCT01366326|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||July 2010||2010-07-01|July 2011|2011-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects|A Multiple-Dose, Open-Label Study to Evaluate the Pharmacokinetics of MNTX in Healthy Adult Subjects|Completed||Phase 1|20|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 04:10:25.734515|2017-10-11 04:10:25.734515
NCT01366313|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-12-07|||September 2007||2007-09-01|January 2011|2011-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||The Median Effective Dose (ED50) of Paracetamol and Morphine : A Study of Interaction Study|The Median Effective Dose (ED50) of Paracetamol and Morphine for Postoperative Patients: A Study of Interaction.|Completed||N/A|90|Actual|Procare Riaya Hospital||3|||f||||t||||||||||2017-10-11 04:10:25.813028|2017-10-11 04:10:25.813028
NCT01366300|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2011-06-03|||June 2010||2010-06-01|March 2011|2011-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effect of Intravenous Lidocaine on BIS-guided Propofol Requirements During General Anesthesia|Estimation of the Effect of Intravenous Lidocaine on BIS-guided Propofol Requirements During General Anesthesia|Completed||Phase 4|40|Anticipated|Pontificia Universidad Catolica de Chile||2|||f||||f||||||||||2017-10-11 04:10:25.913199|2017-10-11 04:10:25.913199
NCT01366287|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-04|2011-06-02|||January 2011||2011-01-01|June 2011|2011-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption|A Randomized, Open-Label, Single Dose, Crossover Study To Estimate The Relative Oral Bioavailability And Food Effect Of PF-03882845 In Healthy Adult Volunteers|Completed||Phase 1|12|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 04:10:26.01424|2017-10-11 04:10:26.01424
NCT01366274|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-03|||September 2007||2007-09-01|November 2010|2010-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Protective Manual Hyperinflation in Acute Mechanically Ventilated Trauma Patients|Comparison of Protective Manual Hyperinflation With Current Methods in Ventilated Acute Trauma Patients: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|40|Anticipated|The University of Queensland||2|||f||||f||||||||||2017-10-11 04:10:26.110528|2017-10-11 04:10:26.110528
NCT01366261|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-11-09|||January 2008||2008-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Rigid Versus Semirigid Thoracoscopy in Diagnosing Pleural Diseases: a Randomized Study|Rigid Versus Semirigid Thoracoscopy in Diagnosing Pleural Diseases: a Randomized Study|Completed||Phase 3|84|Actual|The University Clinic of Pulmonary and Allergic Diseases Golnik||2|||f||||t||||||||||2017-10-11 04:10:26.189925|2017-10-11 04:10:26.189925
NCT01366248|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-07-27|||August 2010||2010-08-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|IO-OS-BC||Integrative Oncology Outcomes Study in Breast Cancer|Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study|Active, not recruiting||N/A|750|Actual|Bastyr University|||2||f||||t||||||||||2017-10-11 04:10:26.271424|2017-10-11 04:10:26.271424
NCT01366235|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2015-01-23|||May 2011||2011-05-01|May 2011|2011-05-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Clinical Trial for Evaluation of Ethnic Differences in Pharmacokinetics of Chloroquine, an Anti-malarial Drug|Clinical Trial for Evaluation of Ethnic Differences in Pharmacokinetics of Chloroquine, an Anti-malarial Drug|Completed||Phase 1|10|Actual|Asan Medical Center||4|||f||||||||||||||2017-10-11 04:10:26.358194|2017-10-11 04:10:26.358194
NCT01366222|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-06-02|||November 2007||2007-11-01|June 2011|2011-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|FSAC||Food Concentrates Supplementation to Alleviate Asthma in Children|Food Concentrates Supplementation to Alleviate Asthma in Children|Completed||N/A|192|Actual|Academia Sinica, Taiwan||2|||f||||f||||||||||2017-10-11 04:10:26.448438|2017-10-11 04:10:26.448438
NCT01366209|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-03-08|2015-02-27||June 2011||2011-06-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ASCEND||Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)|A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study of the Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (ASCEND Trial)|Completed||Phase 3|555|Actual|Genentech, Inc.||2|||f||||t||||||||||2017-10-11 04:10:26.571476|2017-10-11 04:10:26.571476
NCT01366196|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-05-22|2017-03-23||October 2008||2008-10-01|May 2017|2017-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Pregabalin for the Treatment of Pain After Posterior Spinal Fusions|Pregabalin for the Treatment of Pain After Posterior Spinal Fusions.|Completed||N/A|86|Actual|Hospital for Special Surgery, New York||2|||f||||f||||||||||2017-10-11 04:10:27.424733|2017-10-11 04:10:27.424733
NCT01366183|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-05-03|||August 2011||2011-08-01|May 2017|2017-05-01||||December 2019|Anticipated|2019-12-01||Observational|||Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer|Chemotherapy Toxicity in Elderly Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Active, not recruiting||N/A|290|Anticipated|Gynecologic Oncology Group|||1||f||||f||||||||||2017-10-11 04:10:27.717255|2017-10-11 04:10:27.717255
NCT01366170|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-05-17|||May 2011||2011-05-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma|Expression of T Immunoregulatory Proteins in ALK+ Anaplastic Large Cell Lymphoma (ALCL)|Completed||N/A|7|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:10:28.704205|2017-10-11 04:10:28.704205
NCT01366157|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-05-13|||May 2011||2011-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma|Investigation to Evaluate the Levels of Human Germinal-center-Associated Lymphoma (HGAL) Protein in Pediatric Hodgkin Lymphoma and Correlate With Early Response|Completed||N/A|23|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Tissue   "|||2017-10-11 04:10:30.527269|2017-10-11 04:10:30.527269
NCT01366144|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-07-25|||June 20, 2011|Actual|2011-06-20|July 2017|2017-07-01||||July 31, 2017|Anticipated|2017-07-31||Interventional|||Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction|An Early Phase 1 Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Patients With Hepatic or Renal Dysfunction and Solid Tumors|Recruiting||Phase 1|276|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:10:30.623447|2017-10-11 04:10:30.623447
NCT01366131|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-11-01||2016-08-10|June 2011||2011-06-01|November 2016|2016-11-01||||February 2013|Actual|2013-02-01||Interventional|||Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin , Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease|Completed||Phase 2|104|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 04:10:30.813637|2017-10-11 04:10:30.813637
NCT01366118|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-02|||October 2009||2009-10-01|October 2009|2009-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|TT||Study of Therapeutic Targets Tailored Ch and IMRT as Neoadjuvant Treatment in Rectal Carcinoma Patients|Prospective Pilot Study of Therapeutic Targets (TT) Tailored Chemotherapy (Ch) and Intensity Modulated Radiotherapy (IMRT) as Neoadjuvant Treatment in Patients With Rectal Carcinoma|Completed||N/A|16|Actual|Grupo Hospital de Madrid||1|||f||||f||||||||||2017-10-11 04:10:30.984697|2017-10-11 04:10:30.984697
NCT01366105|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2013-04-01|||August 2008||2008-08-01|April 2013|2013-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||VAC NPWT KCI Dressing Study|Use of Negative Pressure Wound Therapy for At Risk Surgical Closures|Withdrawn||N/A|0|Actual|Georgetown University||2|||f||||f||||||||||2017-10-11 04:10:31.075309|2017-10-11 04:10:31.075309
NCT01366092|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2016-08-01|2014-12-18||July 2011||2011-07-01|August 2016|2016-08-01||||October 2014|Actual|2014-10-01||Interventional|||Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease|A Phase II Trial of Daily Low-Dose Interleukin-2 (IL-2) for Steroid-Refractory Chronic Graft-Versus-Host-Disease|Active, not recruiting||Phase 2|35|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 04:10:31.175828|2017-10-11 04:10:31.175828
NCT01366079|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2015-03-30|||July 2011||2011-07-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Dynamic Position Change in Colonic Adenoma Detection|Dynamic Position Change in Colonic Adenoma Detection: a Prospective, Randomized, Multicenter Study|Completed||N/A|1072|Actual|The Catholic University of Korea||2|||f||||||||||||||2017-10-11 04:10:32.930346|2017-10-11 04:10:32.930346
NCT01366066|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2013-05-23|||May 2011||2011-05-01|May 2013|2013-05-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Interventional|||Transcutaneous Mechanical Nerve Stimulation in the Treatment of Incontinence|Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Treatment of Stress Incontinence and Urge Incontinence|Terminated||Phase 3|4|Actual|Copenhagen University Hospital at Herlev||4||Failure to recruit participants|f||||f||||||||||2017-10-11 04:10:33.006024|2017-10-11 04:10:33.006024
NCT01366053|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2016-12-21|||March 2011||2011-03-01|December 2016|2016-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|DELAY||Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists|Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists: A Prospective, Observational, Phase IV Study (DELAY)|Completed||N/A|125|Actual|CMX Research|||1||f||||f||||||||Undecided||2017-10-11 04:10:33.106795|2017-10-11 04:10:33.106795
NCT01366040|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2013-09-12|||June 2011||2011-06-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|ASPECT||Avonex PEN Satisfaction and Patients Experience Clinical Trial|An Open-Label, Survey-Based, Multicenter Study to Determine Patient Satisfaction With Single-Use Prefilled Avonex® PEN Autoinjector in Multiple Sclerosis Patients|Completed||N/A|89|Actual|Biogen|||1||f||||f||||||||||2017-10-11 04:10:33.226285|2017-10-11 04:10:33.226285
NCT01366027|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2014-04-15|||May 2011||2011-05-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||PRISM Registry: Pseudobulbar Affect Registry Series|PRISM Registry: Pseudobulbar Affect Registry Series|Completed||N/A|5290|Actual|Avanir Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:10:33.30131|2017-10-11 04:10:33.30131
NCT01366001|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2012-03-08|||August 2011||2011-08-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine|A Phase 1, Multiple-dose, Parallel Group Study to Evaluate the Safety and Pharmacodynamic Effects of RDC-0313-buprenorphine (ALKS 33-BUP) Administered Alone and Co-administered With Cocaine to Opioid-experienced Cocaine Abusers|Completed||Phase 1|33|Actual|Alkermes, Inc.||3|||f||||t||||||||||2017-10-11 04:10:33.598099|2017-10-11 04:10:33.598099
NCT01365988|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-06-30|||May 15, 2011||2011-05-15|February 26, 2013|2013-02-26|February 26, 2013||2013-02-26|||||Observational|||Neutral Correlates of Risk-taking in Adolescents Exposed to Drugs Prenatally|Neural Correlates of Risk-Taking in Urban Adolescents|Completed||N/A|70|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:10:33.700781|2017-10-11 04:10:33.700781
NCT01365975|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-06-30|||May 15, 2011||2011-05-15|February 1, 2017|2017-02-01||||||||Observational|||Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study|Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study|Completed||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:10:33.787047|2017-10-11 04:10:33.787047
NCT01365962|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-05-17|||June 2011||2011-06-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma|A Study to Assess and Quantify Surface Insulin-like Growth Factor I Receptor (IGF-IR) in Rhabdomyosarcoma (RMS) Tumor Tissue|Completed||N/A|60|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:10:33.875555|2017-10-11 04:10:33.875555
NCT01365949|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-07-07|||May 2011||2011-05-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Biomarker in Tissue Samples From Patients With Ewing Sarcoma|INI-1 Deletions in Ewing Sarcoma|Completed||N/A|40|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Tissue   "|||2017-10-11 04:10:33.960755|2017-10-11 04:10:33.960755
NCT01365936|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-03-28|||January 2008||2008-01-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF|Influence of Ovarian Stimulation With hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF|Completed||Phase 4|80|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital||2|||f||||f||||||||||2017-10-11 04:10:34.051971|2017-10-11 04:10:34.051971
NCT01365923|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-06-29|||May 2011||2011-05-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Comparison of Dexmedetomidin and Remifentanil for the Effect on Airway Reflex and Hemodynamic Response During Emergence in Patients Undergoing Craniotomy|Comparison of Dexmedetomidin and Remifentanil for the Effect on Airway Reflex and Hemodynamic Response During Emergence in Patients Undergoing Craniotomy|Completed||Phase 4|74|Actual|Yonsei University||2|||f||||t||||||||||2017-10-11 04:10:34.153558|2017-10-11 04:10:34.153558
NCT01365910|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2014-08-24|2014-06-13||June 2011||2011-06-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|May 2012|Actual|2012-05-01||Interventional|||Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer|An Investigator Initiated, Phase II Study of Linifanib in Patients With Advanced, Refractory Colorectal Cancer Expressing Mutated kRas|Terminated||Phase 2|30|Actual|Vanderbilt-Ingram Cancer Center||1||Interim analysis determined the study did not meet criteria to proceed|f||||t||||||||||2017-10-11 04:10:34.245599|2017-10-11 04:10:34.245599
NCT01365897|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-02|||September 2010||2010-09-01|November 2010|2010-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effectiveness of Modafinil in Improving Cognitive Performance of University Students|Effectiveness of Modafinil in Improving Mnesic Performance and Executive Functions of University Students From Careers of High Academic Performance|Completed||Phase 4|128|Actual|Universidad de Valparaiso||2|||f||||f||||||||||2017-10-11 04:10:34.669199|2017-10-11 04:10:34.669199
NCT01365884|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2012-06-13|||June 2011||2011-06-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age|Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age|Unknown status|Recruiting|N/A|40|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-10-11 04:10:34.760924|2017-10-11 04:10:34.760924
NCT01365871|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-01-17|||June 2011||2011-06-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||CREMS Prostate Biopsy Pain Relief Study|Pain Relief With Local Anesthetic at Time of Prostate Biopsy: Comparing Apical and Basal Injection Versus Basal Injection Alone|Completed||N/A|300|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 04:10:34.834|2017-10-11 04:10:34.834
NCT01365858|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2014-11-12|||May 2011||2011-05-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|VAPS REHAB||Virtual Action Planning in Stroke: a Control Rehabilitation Study|Effectiveness of Virtual Reality-based Cognitive Training in Daily Living in Stroke Patients Using Virtual Action Planning Supermarket (VAP-S)|Completed||N/A|29|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 04:10:34.901066|2017-10-11 04:10:34.901066
NCT01365845|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-07-20|2014-09-11||April 2012||2012-04-01|July 2017|2017-07-01|January 2019|Anticipated|2019-01-01|March 2014|Actual|2014-03-01||Interventional|BR01||Proton Therapy for Lymph Nodes in Breast Cancer|Proton Therapy for Peripheral Lymph Nodes in Breast Cancer|Active, not recruiting||N/A|18|Actual|University of Florida||2|||f||||t|f|f||||||||2017-10-11 04:10:34.9879|2017-10-11 04:10:34.9879
NCT01365832|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-06-03|||January 2007||2007-01-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Change in C-reactive Protein (CRP) in Men and Women With Sleep Apnea After Continuous Positive Airway Pressure (CPAP)|CRP Evolution Pattern in CPAP Treated Obstructive Sleep Apnea Patients. Does Gender Play a Role?|Completed||N/A|436|Actual|University of Crete||1|||f||||f||||||||||2017-10-11 04:10:35.373686|2017-10-11 04:10:35.373686
NCT01365819|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-01-05|2017-01-05||February 2012||2012-02-01|January 2017|2017-01-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Varenicline for Methamphetamine Dependence|Varenicline for Methamphetamine Dependence: Phase II Clinical Trial|Completed||Phase 2|52|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 04:10:35.45753|2017-10-11 04:10:35.45753
NCT01365806|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-03-06|||August 2011||2011-08-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Observational|NEW HEART||Home Electrocardiogram (ECG) Monitoring After Heart Transplantation|Home ECG Monitoring to Detect Allograft Rejection Following Heart Transplantation|Completed||N/A|345|Actual|University of California, Los Angeles|||1||f||||t||||||||||2017-10-11 04:10:35.725273|2017-10-11 04:10:35.725273
NCT01365793|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-05-12|||November 2010||2010-11-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|September 2016|Actual|2016-09-01||Interventional|||Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis|Fluid Therapy and Cerebral Injury in Pediatric Diabetic Ketoacidosis|Completed||Phase 3|1405|Actual|University of California, Davis||4|||f||||t|t|||||||No||2017-10-11 04:10:35.799639|2017-10-11 04:10:35.799639
NCT01365780|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2012-11-27|||September 2011||2011-09-01|November 2012|2012-11-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|HBOTRadius||Hyperbaric Oxygen Therapy in Distal Radius Fractures: Can it Shorten Recovery Time and Increase Fracture Healing?|Identification of Microcirculation in Distal Radius Fractures After Surgical Treatment With and Without Hyperbaric Oxygen Therapy (HBOT)|Suspended||N/A|100|Anticipated|RWTH Aachen University||2||"nump    acceptence by patient too low"|f||||f||||||||||2017-10-11 04:10:35.935134|2017-10-11 04:10:35.935134
NCT01365767|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2013-07-15|||May 2011||2011-05-01|July 2013|2013-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|KULT||Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease|Kontrast UltraLydsskanning af Tyndtarmen Hos Patienter Med Crohns Sygdom - et Pilotstudie. (Danish) Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease - a Pilot Study (English)|Completed||N/A|5|Actual|Regionshospitalet Silkeborg|||1||f||||t||||||||||2017-10-11 04:10:36.0323|2017-10-11 04:10:36.0323
NCT01365754|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-09-19|||September 2011||2011-09-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|December 2017|Anticipated|2017-12-01||Interventional|DYNORFUSE||Dynamic Stabilization Versus Fusion|Posterior Dynamic Stabilization Versus Fusion in the Treatment of Lumbar Degenerative Disease|Active, not recruiting||N/A|440|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-10-11 04:10:36.132546|2017-10-11 04:10:36.132546
NCT01365741|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-21|2017-09-28|||February 2011||2011-02-01|September 2017|2017-09-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient|Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient|Completed||N/A|20|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 04:10:36.220997|2017-10-11 04:10:36.220997
NCT01365728|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-04-12|||April 2011||2011-04-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||An Outcomes Study Comparing the Intralase FS 60 to the Intralase iFS When Performing LASIK Surgery for Nearsightedness|A Prospective Randomized Comparison of Fellow Eyes Undergoing LASIK With the Intralase FS 60 Versus the Intralase IFS|Active, not recruiting||N/A|60|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 04:10:36.317838|2017-10-11 04:10:36.317838
NCT01365715|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2014-02-25|||May 2011||2011-05-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Preoperative Embolization in Surgical Treatment of Spinal Metastases.|Preoperative Embolization in Surgical Treatment of Spinal Metastases. A Randomized Controlled Trial.|Completed||N/A|48|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 04:10:36.408112|2017-10-11 04:10:36.408112
NCT01365702|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-06|||June 2011||2011-06-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Tiotropium in Patients With Tuberculosis (TB) Destroyed Lung|Clinical Efficacy of Tiotripium in Patients With Airflow Obstruction Due to TB Destroyed Lung|Unknown status|Recruiting|N/A|70|Anticipated|Seoul National University Bundang Hospital|||1||f||||f||||||||||2017-10-11 04:10:36.518308|2017-10-11 04:10:36.518308
NCT01365689|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2012-02-14|||May 2011||2011-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 04:10:36.608715|2017-10-11 04:10:36.608715
NCT01365676|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-12-05|||March 2012||2012-03-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|657/10UFCSPA||GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms|Phase 3 Study Efficacy and Tolerance: The Use of 2 Phytomedicines in Association GAMALINE® 900mg + HIPERICIN® 300mg for the Treatment of Pre-Menstrual Syndrome (PMS) and Vasomotor Symptoms|Unknown status|Not yet recruiting|Phase 3|240|Anticipated|Phytopharm Consulting Brazil||4|||f||||t||||||||||2017-10-11 04:10:36.674733|2017-10-11 04:10:36.674733
NCT01365663|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2012-01-26|||May 2011||2011-05-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Multiple Ascending Dose Study of SPC4955 in Healthy Subjects|A First-in-Human (FIH), Randomized, Dose-Escalation, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SPC4955 Administered to Healthy Subjects|Completed||Phase 1|18|Actual|Santaris Pharma A/S||6|||f||||f||||||||||2017-10-11 04:10:36.796366|2017-10-11 04:10:36.796366
NCT01365650|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2015-06-24|2012-08-06||December 2007||2007-12-01|June 2015|2015-06-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis|Open Label, Three-Way Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of a Single Dose of Oxymetazoline Hydrochloride and Multiple Doses of Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis|Completed||Phase 1|24|Actual|Luitpold Pharmaceuticals||3|||f||||f||||||||||2017-10-11 04:10:36.906659|2017-10-11 04:10:36.906659
NCT01365637|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-10-04|||June 2011||2011-06-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period.|A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Parallel Group Multiple Dose Escalation Study To Investigate The Safety, Toleration And Pharmacokinetics Of PF-05089771 In Healthy Subjects.|Completed||Phase 1|30|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 04:10:37.276881|2017-10-11 04:10:37.276881
NCT01364506|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-01|||January 2000||2000-01-01|May 2011|2011-05-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||The Effects of Aerobic Water Exercise on Pregnancy|Randomized Clinical Study of the Effects of Aerobic Water Exercise on Maternal Cardiovascular Adaptation to Pregnancy|Completed||N/A|41|Actual|UPECLIN HC FM Botucatu Unesp||2|||f||||f||||||||||2017-10-11 04:11:00.051838|2017-10-11 04:11:00.051838
NCT01365624|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-01-03|2012-08-02||February 2008||2008-02-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects|A Phase 1 Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects|Completed||Phase 1|30|Actual|Luitpold Pharmaceuticals||1|||f||||f||||||||||2017-10-11 04:10:37.375438|2017-10-11 04:10:37.375438
NCT01365611|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-02-06|2012-08-09||February 2007||2007-02-01|February 2017|2017-02-01|March 2008|Actual|2008-03-01|May 2007|Actual|2007-05-01||Interventional|||Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects|Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Multiple Doses of Fluticasone Propionate in Healthy Subjects|Completed||Phase 1|36|Actual|Egalet Ltd||1|||f||||f||||||||||2017-10-11 04:10:37.690638|2017-10-11 04:10:37.690638
NCT01365598|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-06-11|||December 2011||2011-12-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda|Evaluation of the Efficacy and Safety of Primaquine for Clearance of Gametocytes in Uncomplicated Falciparum Malaria in Uganda|Completed||Phase 3|468|Actual|London School of Hygiene and Tropical Medicine||4|||f||||t||||||||||2017-10-11 04:10:37.95542|2017-10-11 04:10:37.95542
NCT01365585|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-03-07|2012-10-05||July 2011||2011-07-01|March 2017|2017-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension|Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension|Completed||N/A|227|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 04:10:38.25008|2017-10-11 04:10:38.25008
NCT01365572|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-02|||January 2010||2010-01-01|March 2011|2011-03-01|March 2012|Anticipated|2012-03-01|September 2011|Anticipated|2011-09-01||Interventional|Restenosis||New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )|Prospective, Single-blinded, Randomized Comparison of the Clinical and Angiographic Results With Intravascular Analysis of EverolimuS-Eluting Versus ZoTarolimus-Eluting steNTs for In-Stent Restenosis(ISR) Lesions: Volumetric Analysis With Intravascular Ultrasound(IVUS) : Phase IV Multicenter Trial ( RESTENT-ISR Trial )|Unknown status|Recruiting|Phase 4|292|Anticipated|Korea University Anam Hospital||2|||f||||t||||||||||2017-10-11 04:10:38.682281|2017-10-11 04:10:38.682281
NCT01365559|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-02-27|||May 2, 2011|Actual|2011-05-02|February 2017|2017-02-01|March 1, 2016|Actual|2016-03-01|June 13, 2014|Actual|2014-06-13||Interventional|||Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments|A Phase I/II Study of Carfilzomib as a Replacement for Multiple Myeloma Patients Failing Bortezomib-containing Regimens|Completed||Phase 1/Phase 2|45|Anticipated|Oncotherapeutics||2|||f||||f||||||||||2017-10-11 04:10:38.809843|2017-10-11 04:10:38.809843
NCT01365546|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2015-03-05|2015-01-06||June 2011||2011-06-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|WONDERS||Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery|Prospective, Open-Label, Multi-Center, Phase III CLinical Study to Investigate the Efficacy and Safety of Human Factor VWF/FVIII Concentrate (Wilate) in Subjects With Inherited Von Willebrand Disease Who Undergo Surgical Procedures|Completed||Phase 3|30|Actual|Octapharma||1|||f||||t||||||||||2017-10-11 04:10:38.933882|2017-10-11 04:10:38.933882
NCT01365533|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2016-10-24|||December 2004||2004-12-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma|A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma|Completed||Phase 2|48|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:10:39.268716|2017-10-11 04:10:39.268716
NCT01365520|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2017-02-09|||June 2011||2011-06-01|February 2017|2017-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A|Multi-Centre, Open-Label, Randomised Trial Investigating the Pharmacokinetics of a Single Dose of NNC 0155-0000-0004 (N8) in Patients With Haemophilia A|Completed||Phase 1|4|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 04:10:39.356755|2017-10-11 04:10:39.356755
NCT01365507|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-02-09|2015-10-19|2012-05-09|June 2011||2011-06-01|February 2017|2017-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|BOOST™||Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens|A Trial Comparing the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily in Insulin-naïve Subjects With Type 2 Diabetes Mellitus When Using Two Different Titration Algorithms (BOOST™: SIMPLE USE)|Completed||Phase 3|276|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 04:10:39.469581|2017-10-11 04:10:39.469581
NCT01365494|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2014-04-03|2014-01-28||July 2011||2011-07-01|April 2014|2014-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules|A Phase IV, Multi-center, Randomized, Open-label Study of PCECV (Rabipur®) Comparing the Immunogenicity and Safety of Two Different Simulated Post Exposure Schedules (Zagreb 2-1-1 Versus Essen Regimen 1-1-1-1-1) in Healthy Indian Subjects|Completed||Phase 4|250|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:10:39.980374|2017-10-11 04:10:39.980374
NCT01365481|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2016-06-13|2016-03-09||August 2011||2011-08-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age|A Multicenter, Open-label, 18 Month Study to Evaluate the Long-term Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age With Hypertension and With or Without Chronic Kidney Disease|Completed||Phase 3|150|Actual|Novartis||1|||f||||f||||||||||2017-10-11 04:10:40.378495|2017-10-11 04:10:40.378495
NCT01365468|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-05-10|2016-03-15||April 2012||2012-04-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)|A Phase II Study of RAD001 in the Treatment of Patients With Plexiform Neurofibromas (PN) Associated With Neurofibromatosis Type 1 (NF1)|Terminated||Phase 2|9|Actual|Novartis|Study got terminated because of poor patient's accrual.|1||Poor patients' accrual|f||||||||||||||2017-10-11 04:10:41.421961|2017-10-11 04:10:41.421961
NCT01365455|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-01-19|2015-02-16||June 2011||2011-06-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|ERASURE||Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year|A Randomized, Double-blind, Placebo Controlled, Multicenter Study of Subcutaneous Secukinumab to Demonstrate Efficacy After Twelve Weeks of Treatment, and to Assess the Safety, Tolerability and Long-term Efficacy up to One Year in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis|Completed||Phase 3|738|Actual|Novartis||5|||f||||||||||||||2017-10-11 04:10:42.024487|2017-10-11 04:10:42.024487
NCT01365442|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-10|2013-05-21|||May 2011||2011-05-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Observational|||Pilot Introduction of Oral Cholera Vaccine in Orissa, India|Pilot Introduction of the Modified Bivalent Killed Whole Cell Oral Cholera Vaccine in Orissa|Completed||N/A|31552|Actual|International Vaccine Institute|||1||f||||f||||||||||2017-10-11 04:10:47.584383|2017-10-11 04:10:47.584383
NCT01365429|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-02|2017-09-20|||May 2011||2011-05-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|February 2018|Anticipated|2018-02-01||Interventional|||Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs|Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs|Recruiting||N/A|126|Anticipated|XVIVO Perfusion||2|||f||||t||||||||||2017-10-11 04:10:47.826567|2017-10-11 04:10:47.826567
NCT01365416|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-11-10|||November 2011||2011-11-01|October 2012|2012-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Personalised Medicine for Morbid Obesity|Genetic Analysis for Personalised Medicine for Morbid Obesity|Completed||N/A|2000|Actual|Imperial College London|||1||f||||f||||||Samples With DNA|"     SALIVA BLOOD URINE AND FAECES TISSUE (Muscle, Liver, Subcutaneous fat, Visceral fat)   "|No||2017-10-11 04:10:48.132643|2017-10-11 04:10:48.132643
NCT01365403|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2016-11-01|||April 2011||2011-04-01|November 2016|2016-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study on The Effect of Multiple Dose Carbamazepine on Single Dose Pharmacokinetics of RO4917838 in Healthy Volunteers|A SINGLE CENTER, OPEN LABEL, FIXED SEQUENCE, TWO-PERIOD STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE CARBAMAZEPINE ON SINGLE DOSE PHARMACOKINETICS OF RO4917838 IN HEALTHY MALE VOLUNTEERS|Completed||Phase 1|16|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:10:48.211372|2017-10-11 04:10:48.211372
NCT01365390|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-07-24|||June 2011||2011-06-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries|To Evaluate Incidence of Acute Otitis Media in Children Aged < 6 Years in Five East European Countries|Completed||N/A|2258|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-10-11 04:10:48.302783|2017-10-11 04:10:48.302783
NCT01365377|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-02|||April 2011||2011-04-01|April 2011|2011-04-01|April 2013|Anticipated|2013-04-01|April 2012|Anticipated|2012-04-01||Interventional|FAMILLE||Impact of Information Strategy Based on Booklet on Anxiety in Family in ICU|Impact of the Deliverance and Use of a Written Detailed Information Brochure on Anxiety Felt by the Family Members of Patients Admitted in Intensive Care Unit|Unknown status|Recruiting|N/A|180|Anticipated|Groupe Hospitalier Pitie-Salpetriere||2|||f||||f||||||||||2017-10-11 04:10:48.443785|2017-10-11 04:10:48.443785
NCT01365364|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-06-02|||March 2009||2009-03-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|DOPATRANSPLM||Dopamine Transporter Density Profiles in Patients With Periodic Limb Movements|Dopamine Transporter Density Profiles Assessed by Tc-TRODAT and SPECT in Patients With Periodic Limb Movements|Completed||N/A|16|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 04:10:48.546192|2017-10-11 04:10:48.546192
NCT01365351|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-06-01|||December 1, 2007|Actual|2007-12-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON|Non-interventional Study With ZOMACTON in Children With Growth Hormone Deficiency|Completed||N/A|1034|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:10:48.640653|2017-10-11 04:10:48.640653
NCT01365338|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2012-12-21|||June 2011||2011-06-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects|Subject And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, Parallel Group Study To Assess Effects Of PF-04958242 On Bold Functional MRI During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects|Completed||Phase 1|112|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 04:10:48.837026|2017-10-11 04:10:48.837026
NCT01365325|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-06-01|||January 2009||2009-01-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Handled Echocardiography and Chronic Heart Failure|Management of Chronic Heart Failure: Role of the Handled Echocardiography in Home Monitoring Care Programs|Completed||N/A|118|Actual|Federico II University||2|||f||||t||||||||||2017-10-11 04:10:48.924747|2017-10-11 04:10:48.924747
NCT01365312|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-10-02|||February 2010||2010-02-01|October 2014|2014-10-01||||June 2011|Actual|2011-06-01||Interventional|||Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates|A Prospective, Randomized, Blinded, Placebo-Controlled Trial of Periodic, Brief Ethanol Locks to Prevent Peripherally-Inserted Central Catheter (PICC) Infections in Preterm Infants in the Neonatal Intensive Care Unit|Terminated||N/A|10|Actual|East Carolina University||2||Primary investigator relocated|f||||t||||||||||2017-10-11 04:10:49.00347|2017-10-11 04:10:49.00347
NCT01365286|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-06-11|||May 2009||2009-05-01|May 2011|2011-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease|Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease|Completed||Phase 4|40|Actual|Medical Universtity of Lodz||2|||f||||t||||||||||2017-10-11 04:10:49.083387|2017-10-11 04:10:49.083387
NCT01365273|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2014-01-17|2012-05-02||February 2011||2011-02-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts|Open, Prospective, Randomised Investigation Evaluating Pain With the Use of Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts|Completed||Phase 4|43|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-10-11 04:10:49.184959|2017-10-11 04:10:49.184959
NCT00005348|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1991||1991-04-01|April 2000|2000-04-01|March 1993|Actual|1993-03-01|||||Observational|||Adipose Distribution and Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.565682|2017-10-11 04:28:02.565682
NCT01365260|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-12-04|||October 2011||2011-10-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Efficacy of an Injectable Medical Device to Treat Knee Osteoarthritis|A Double-Blind, Randomized, Feasibility Controlled Study to Assess the Safety and Efficacy of MM-II, an Injectable Intraarticular Medical Device, Intended to the Treatment of Symptomatic Knee Osteoarthritis|Completed||Phase 1/Phase 2|40|Actual|Moebius Medical Ltd.||2|||f||||f||||||||||2017-10-11 04:10:49.430431|2017-10-11 04:10:49.430431
NCT01365247|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2015-05-13|||September 2008||2008-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD)|A Randomized Trial of Concurrent Treatment for PTSD and Substance Dependence|Completed||N/A|110|Actual|The City College of New York||3|||f||||t||||||||||2017-10-11 04:10:49.526297|2017-10-11 04:10:49.526297
NCT01365234|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-10-10|||July 2011||2011-07-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Model 20066 Left Ventricular (LV) Lead Study|Model 20066 Left Ventricular (LV) Lead Study|Completed||Phase 1|40|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||Undecided||2017-10-11 04:10:49.622949|2017-10-11 04:10:49.622949
NCT01365221|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-10-31|||December 2010||2010-12-01|October 2013|2013-10-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|SWITCH 600/60||The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel|SWITCH 600/60: The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel|Unknown status|Active, not recruiting|Phase 4|260|Anticipated|Medstar Health Research Institute||2|||f||||f||||||||||2017-10-11 04:10:49.727889|2017-10-11 04:10:49.727889
NCT01365208|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-03-22|||July 2011||2011-07-01|March 2017|2017-03-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Observational|||New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer|Prospective Evaluation of Plasma EBV DNA Half-life and PET-CT Scanning as a New Tool in Assessing Early Response to Chemotherapy in Patients With Advanced Nasopharyngeal Carcinoma|Completed||N/A|70|Actual|Chinese University of Hong Kong|||1||f||||f||||||Samples With DNA|"     EBV DNA   "|||2017-10-11 04:10:50.148704|2017-10-11 04:10:50.148704
NCT01365195|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-04-04|||May 2011||2011-05-01|April 2017|2017-04-01|October 2018|Anticipated|2018-10-01|March 2018|Anticipated|2018-03-01||Interventional|||Effect of Ketamine on Postoperative Clinical Outcomes|Intraoperative Ketamine Administration in Colorectal Surgery: Effect on Postoperative Clinical Outcomes|Enrolling by invitation||Phase 4|102|Anticipated|Cedars-Sinai Medical Center||3|||f||||f||||||||||2017-10-11 04:10:50.22521|2017-10-11 04:10:50.22521
NCT01365182|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2015-02-16|||January 2009||2009-01-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Improving Urinary Continence and Quality of Life in Prostate Cancer Patients|Improving Urinary Continence and Quality of Life in Prostate Cancer Patients|Completed||Phase 3|279|Actual|Case Western Reserve University||3|||f||||t||||||||||2017-10-11 04:10:50.334583|2017-10-11 04:10:50.334583
NCT01365156|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-03-21|||August 2011|Actual|2011-08-01|March 2017|2017-03-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix|A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy|Active, not recruiting||Phase 3|600|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:10:50.579914|2017-10-11 04:10:50.579914
NCT01365143|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2014-05-30|||May 2011||2011-05-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy||Terminated||Phase 4|10|Actual|Mayo Clinic||2||Closing due to slow enrollment|f||||||||||||||2017-10-11 04:10:50.669442|2017-10-11 04:10:50.669442
NCT01365130|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2014-06-12|2014-02-20||June 2011||2011-06-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|December 2012|Actual|2012-12-01||Interventional||Patients with metastatic gastroesophageal cancer that have relapsed after at least one line of chemotherapy|Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen|A Phase II Study Of Cabazitaxel For Metastatic Gastroesophageal Adenocarcinomas That Have Relapsed After At Least One Line Of Chemotherapy|Terminated||Phase 2|15|Actual|Brown University||1||As of 12/12/12 study closed to enrollment because study was determined to be ineffective.|f||||t||||||||||2017-10-11 04:10:50.758992|2017-10-11 04:10:50.758992
NCT01365117|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2012-06-12|||January 2011||2011-01-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||Pharmacokinetic Study in Healthy Volunteers|Phase 1, Single-center, Open-label, Randomized, Crossover Design Clinical Trial in Healthy Normal Volunteers to Evaluate Insulin Exposure and Dose-proportionality Following Inhalation of Technosphere® Insulin Inhalation Powder (3 U and 4 U Insulin/mg) Using the Gen2 Inhaler|Completed||Phase 1|50|Actual|Mannkind Corporation||2|||f||||f||||||||||2017-10-11 04:10:51.03082|2017-10-11 04:10:51.03082
NCT01365104|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2015-01-26|||March 2008||2008-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|June 2012|Actual|2012-06-01||Interventional|DFO||Modulation of Cerebral Blood Flow Using Iron Chelators|Hypoxia-Inducible Transcription Factor 1 (HIF-1)in Vascular Aging|Completed||Early Phase 1|97|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 04:10:51.203726|2017-10-11 04:10:51.203726
NCT01365091|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2015-04-21|2013-03-20||June 2011||2011-06-01|April 2015|2015-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil|Bioequivalence Study of Fixed Dose Combinations of Saxagliptin/Metformin Extended Release (XR) Relative to Co-administration of the Individual Components in Healthy Subjects in the Fasted and Fed States|Completed||Phase 1|112|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 04:10:51.338596|2017-10-11 04:10:51.338596
NCT01365078|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2012-03-07|||July 2011||2011-07-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Stearidonic Acid and Lipid Metabolism|Effects of Stearidonic Acid on Serum Triacylglycerol Concentrations in Overweight and Obese Subjects|Completed||N/A|36|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 04:10:52.356973|2017-10-11 04:10:52.356973
NCT01365065|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-04-24|||May 2011|Actual|2011-05-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy|A Pilot Study to Assess the Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy|Active, not recruiting||Phase 2|20|Actual|Bayside Health||1|||f||||t||||||||||2017-10-11 04:10:52.458854|2017-10-11 04:10:52.458854
NCT01365052|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2015-05-13|2014-01-24|2012-05-30|May 2011||2011-05-01|May 2015|2015-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|MUST||Safety Trial of Naproxen Sodium/ Diphenhydramine|A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Safety and Tolerability Trial of Naproxen Sodium/ Diphenhydramine Combination in an OTC Population|Completed||Phase 3|326|Actual|Bayer||2|||f||||f||||||||||2017-10-11 04:10:52.561132|2017-10-11 04:10:52.561132
NCT01365039|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-11-20|2013-11-20||June 2011||2011-06-01|November 2013|2013-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Efficacy of a Contact Lens for Daily Disposable Use|A Study to Evaluate the Safety and Efficacy of a Novel Contact Lens for Daily Disposable Use|Completed||N/A|173|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 04:10:53.212858|2017-10-11 04:10:53.212858
NCT01365026|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2017-01-30|||January 6, 2016|Actual|2016-01-06|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|PVS||PVS: Innovative Programs For Healthy Lifestyle Promotion in Primary Care: 'Prescribe Healthy Life'|Feasibility and Effectiveness of Innovative Programs for Health Promotion in Primary Care: The 'Prescribe Healthy Life' Project (PVS)|Recruiting||N/A|4017|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-11 04:10:53.433432|2017-10-11 04:10:53.433432
NCT01365013|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2016-07-28|||June 2011||2011-06-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|June 2013|Actual|2013-06-01||Interventional|DE-PLAN E||Evaluation of the Translation of the DE-PLAN Program for the Primary Prevention of Type 2 Diabetes in Routine Primary Care|Effectiveness of the Translation of a Type 2 Diabetes Primary Prevention Program in Routine Context of Primary Heath Care|Completed||Phase 4|1113|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 04:10:53.513891|2017-10-11 04:10:53.513891
NCT01365000|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-10-13|||June 2011||2011-06-01|October 2014|2014-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects|A Phase I, Open-label, Randomized, Balanced, Single-dose, Two-Part Study to Assess the Relative Bioavailability of NKTR-118 in Three Formulations Under Fasted (3-Way Crossover) and Fed (2-Way Crossover) Conditions in Male and Non-fertile Female Subjects|Completed||Phase 1|21|Actual|AstraZeneca||5|||f||||f||||||||||2017-10-11 04:10:53.587501|2017-10-11 04:10:53.587501
NCT01364987|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-06-01|||May 2009||2009-05-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy Volunteers|A Phase 1, Open Label, Single Sequence, Drug Interaction Study of the Pharmacokinetics of ASP015K and Mycophenolate Mofetil (MMF) After Separate and Concomitant Administration to Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 04:10:53.684208|2017-10-11 04:10:53.684208
NCT01364974|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-06-01|||January 2009||2009-01-01|May 2011|2011-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Group, Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP015K in Healthy, Non-Elderly Male and Female Adult Volunteers|Completed||Phase 1|48|Actual|Astellas Pharma Inc||5|||f||||f||||||||||2017-10-11 04:10:53.751008|2017-10-11 04:10:53.751008
NCT01364961|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-17|2013-11-12|||January 2011||2011-01-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|December 2012|Actual|2012-12-01||Interventional|||Resveratrol and Serum Apo A-I|The Effects of Resveratrol on Serum Apolipoprotein A-I Concentrations in Men and Women With Low HDL-cholesterol Concentrations|Completed||N/A|50|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 04:10:53.821894|2017-10-11 04:10:53.821894
NCT01364948|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2011-06-01|||January 2006||2006-01-01|December 2005|2005-12-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|TopOilTewl||Effect of Coconut Oil Application in Reducing Water Loss From Skin of Premature Babies in First Week of Life (TEWL)|Effect of Topical Oil Application on Trans-epidermal Water Loss (TEWL) in Preterm Very Low Birth Weight (VLBW) Infants - A Randomized Clinical Trial|Completed||N/A|74|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-10-11 04:10:53.89102|2017-10-11 04:10:53.89102
NCT01364935|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-06-24|||March 2011||2011-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Comparison of DuoFertility, LadyComp/BabyComp and Clearblue Monitors|Pilot Study Comparing Fertility Monitors: DuoFertility Monitor, LadyComp/Babycomp Monitor and Clearblue Ovulation Tests in Support of FDA Application|Completed||N/A|30|Actual|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 04:10:54.142822|2017-10-11 04:10:54.142822
NCT01364922|ClinicalTrials.gov processed this data on October 10, 2017|2011-06-01|2013-12-23|2013-11-01|2012-10-26|June 2011||2011-06-01|December 2013|2013-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Phase 2 Chronic Low Back Pain Study|A Phase 2, Randomized Withdrawal Study of the Analgesic Efficacy and Safety of Hydrocodone/Acetaminophen Extended Release Compared to Placebo in Subjects With Chronic Low Back Pain|Completed||Phase 2|168|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 04:10:54.209895|2017-10-11 04:10:54.209895
NCT01364909|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-06-02|||June 2007||2007-06-01|October 2008|2008-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Exercise in Critically Ill Patients With Sepsis|Early Intervention With Exercise in Critically Ill Patients With Sepsis: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|40|Anticipated|The University of Queensland||2|||f||||f||||||||||2017-10-11 04:10:54.650267|2017-10-11 04:10:54.650267
NCT01364896|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-03-09|2015-12-03||June 2011||2011-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Observational|AnalHPV&IBD||Anal Human Papillomavirus in Inflammatory Bowel Disease Study|Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study|Completed||N/A|46|Actual|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"     Venous blood, anal swabs, vaginal swabs, high resolution anoscopy (HRA), anal biopsy samples   "|No||2017-10-11 04:10:54.744767|2017-10-11 04:10:54.744767
NCT01364883|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2013-07-26|||July 2011||2011-07-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP|A Phase I Study to Assess the Safety and Immunogenicity of Novel Schedules for Vaccination With the Candidate Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP|Completed||Phase 1|39|Actual|University of Oxford||7|||f||||t||||||||||2017-10-11 04:10:55.113083|2017-10-11 04:10:55.113083
NCT01364857|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-02-23|||November 2010|Actual|2010-11-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|CONAPE||French National Cohort of Children With Port Wine Stain|"French National Prospective Cohort of Children With Port Wine Stain on a Limb = Cohorte Nationale d'Enfants Avec Angiome Plan de Membre inférieur"|Active, not recruiting||N/A|150|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-10-11 04:10:55.366158|2017-10-11 04:10:55.366158
NCT01364844|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-02-24|||July 2011||2011-07-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors|A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors|Completed||Phase 1|42|Actual|Daiichi Sankyo, Inc.||1|||f||||f||||||||||2017-10-11 04:10:55.479885|2017-10-11 04:10:55.479885
NCT01364831|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-29|2013-12-31|||June 2011||2011-06-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Connection Between Sleep and Athletic Performance|Connection Between Sleep Quality and Duration and Performance in Young Athletes|Completed||N/A|19|Actual|Wingate Institute||1|||f||||f||||||||||2017-10-11 04:10:55.572509|2017-10-11 04:10:55.572509
NCT01364818|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-04-14|||September 2011||2011-09-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment|Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment|Completed||N/A|25|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||No||2017-10-11 04:10:55.645776|2017-10-11 04:10:55.645776
NCT01364805|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-07-20|||April 2011||2011-04-01|July 2017|2017-07-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||New Treatment Option for Pancreatic Cancer|Translation of in Vitro and in Vivo Ascorbate Research Into a New Treatment Option for Pancreatic Cancer: Phase I/IIa Clinical Trial|Completed||Phase 1|14|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-11 04:10:55.73288|2017-10-11 04:10:55.73288
NCT01364792|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-11-30|||April 2011||2011-04-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||To Rescue Cognition With Valaciclovir|A Double Blind Placebo Controlled Study of Valaciclovir in Treatment of Psychosis in Patients With Schizophrenia|Completed||Phase 2|24|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 04:10:55.831436|2017-10-11 04:10:55.831436
NCT01364779|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2013-05-14|||April 2010||2010-04-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients|Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients|Completed||N/A|15|Actual|Northwell Health|||1||f||||t||||||Samples Without DNA|"     Blood draw   "|||2017-10-11 04:10:55.948416|2017-10-11 04:10:55.948416
NCT01364766|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-04-13|||September 2010||2010-09-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Continuous Glucose Monitor Use in School|The Impact of Continuous Glucose Monitor Use in the Classroom/School Environment|Completed||N/A|40|Actual|Stanford University|||1||f||||f||||||||Undecided||2017-10-11 04:10:56.020491|2017-10-11 04:10:56.020491
NCT01364753|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-12-05|||January 2006||2006-01-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||Age-related Longitudinal Changes in Aviator Performance|Age-related Longitudinal Changes in Aviator Performance|Completed||N/A|139|Actual|Stanford University|||1||f||||f||||||Samples With DNA|"     saliva   "|||2017-10-11 04:10:56.091423|2017-10-11 04:10:56.091423
NCT01364740|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-12-02|2016-10-10||June 2008||2008-06-01|December 2016|2016-12-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|PMP-300E||PMP-300E (Smart Watch): Portable Monitoring Device Study|PMP-300E: Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.|Completed||Phase 3|10|Actual|Stanford University||1|||f||||f||||||||Yes||2017-10-11 04:10:56.168958|2017-10-11 04:10:56.168958
NCT01364727|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-03-17|2017-01-23||June 2011||2011-06-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|July 2014|Actual|2014-07-01||Interventional|||A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies|A Phase II Study of Amrubicin in Relapsed or Refractory Thymic Malignancies|Active, not recruiting||Phase 2|33|Actual|Stanford University||1|||f||||t|t|f||||||No||2017-10-11 04:10:56.459722|2017-10-11 04:10:56.459722
NCT01364714|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-09-27|||January 2010|Actual|2010-01-01|September 2017|2017-09-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Observational|||Biomechanical Properties in Intensive Care Unit (ICU) Survivors 12-month After Discharge|Biomechanical Properties in ICU Survivors 12-month After Discharge|Completed||N/A|32|Actual|Rigshospitalet, Denmark|||2||f||||||||||||||2017-10-11 04:10:56.943896|2017-10-11 04:10:56.943896
NCT01364701|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-06-17|||June 2011||2011-06-01|April 2011|2011-04-01|July 2012|Anticipated|2012-07-01|June 2012|Anticipated|2012-06-01||Interventional|PDE5i||Evaluation of Safety and Effectiveness of 2 Lower Dose Combined PDE5i's Versus Single Maximal Dose PDE5i Treatment|A Prospective, Randomized, 3-arm Parallel Trial to Evaluate the Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Treatment|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Rambam Health Care Campus||3|||f||||f||||||||||2017-10-11 04:10:57.005753|2017-10-11 04:10:57.005753
NCT01364688|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-05-31|||May 2011||2011-05-01|May 2011|2011-05-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease|Randomized Control Trial of Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease|Unknown status|Recruiting|Phase 2|80|Anticipated|Ramathibodi Hospital||2|||f||||f||||||||||2017-10-11 04:10:57.114563|2017-10-11 04:10:57.114563
NCT01364675|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-01|||January 2012||2012-01-01|May 2011|2011-05-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|PPCVD||Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects|Primary Prevention of Cardiovascular Disease in Pre-diabetic & Pre-hypertensive Subjects Using Multiple Risks Reduction Strategy: A Multi-center, Double-blind, Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|8900|Anticipated|Ramathibodi Hospital||2|||f||||t||||||||||2017-10-11 04:10:57.222849|2017-10-11 04:10:57.222849
NCT01364662|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2015-11-16||2013-05-22|June 2011||2011-06-01|November 2015|2015-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|121|Actual|Supernus Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-10-11 04:10:57.344693|2017-10-11 04:10:57.344693
NCT01364649|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-10-06|2014-10-06||June 2011||2011-06-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||All randomized set (N=447): All study participants who were screened and randomized to one of two treatment arms.|Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction|A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction|Completed||Phase 3|447|Actual|Takeda||2|||f||||f||||||||||2017-10-11 04:10:57.50597|2017-10-11 04:10:57.50597
NCT01364636|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-06-06|||February 2011||2011-02-01|April 2011|2011-04-01|September 2012|Anticipated|2012-09-01|May 2012|Anticipated|2012-05-01||Observational|CYNDERELA-HF||Accuracy of Urinary NGAL in Predicting CardioRenal Syndrome in Acute Heart Failure at Emergency - CYNDERELA-HF Study|Accuracy of Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Predicting Cardio-renal Syndrome in Acute Decompensated Heart Failure at Emergency - CYNDERELA-HF Study|Unknown status|Recruiting|N/A|180|Anticipated|Pro-Cardiaco Hospital|||1||f||||t||||||Samples Without DNA|"     Urine plasma serum   "|||2017-10-11 04:10:58.340519|2017-10-11 04:10:58.340519
NCT01364623|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-06-04|||September 2011||2011-09-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women|An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels|Completed||Phase 1|24|Actual|Trimel Biopharma SRL||3|||f||||t||||||||||2017-10-11 04:10:58.446841|2017-10-11 04:10:58.446841
NCT01364610|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2015-06-19|||July 2008||2008-07-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||An Assessment of pH Testing Methods|A Prospective Assessment of pH Testing Methods in Alberta|Completed||N/A|86|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 04:10:58.757315|2017-10-11 04:10:58.757315
NCT01364597|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-08-31|||July 2011||2011-07-01|August 2017|2017-08-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy|Open-label, Single-arm, Multicenter, Long-term Study to Evaluate Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Pediatric Subjects With Epilepsy|Enrolling by invitation||Phase 3|600|Anticipated|UCB Pharma||1|||f||||f||||||||||2017-10-11 04:10:58.838703|2017-10-11 04:10:58.838703
NCT01364571|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-07-25||2014-07-25|August 2011||2011-08-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|April 2012|Actual|2012-04-01||Interventional|||Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years|Phase I/2 Placebo-Controlled, Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 3 Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years|Completed||Phase 1/Phase 2|456|Actual|Pfizer||4|||f||||t||||||||||2017-10-11 04:10:59.094593|2017-10-11 04:10:59.094593
NCT01364558|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2014-05-20|2012-07-20||February 2011||2011-02-01|May 2014|2014-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers|"A Three-Period, Three-Treatment, Six-Sequence Randomized Crossover Study of the Bioavailability and Pharmacokinetics of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers,"|Completed||Phase 1|24|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-11 04:10:59.246058|2017-10-11 04:10:59.246058
NCT01364545|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-06-01|||May 2011||2011-05-01|May 2011|2011-05-01||||May 2012|Anticipated|2012-05-01||Interventional|||Ketogenic Diets for Symptoms of Parkinson's Disease|Ketogenic Diets for Symptoms of Parkinson's Disease|Unknown status|Recruiting|N/A|20|Anticipated|University of Oxford||1|||f||||t||||||||||2017-10-11 04:10:59.63867|2017-10-11 04:10:59.63867
NCT01364532|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-05-31|||April 2011||2011-04-01|April 2011|2011-04-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|AURA||Transradial Versus Transulnar Artery Approach for Coronary Interventions|A Randomized Study of Transradial Versus Transulnar Artery Approach for Coronary Interventions|Unknown status|Recruiting|Phase 3|572|Anticipated|University of Patras||2|||f||||f||||||||||2017-10-11 04:10:59.750014|2017-10-11 04:10:59.750014
NCT01364519|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-02-10|||July 2011||2011-07-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In Volunteers|A Randomized, Double-Blind (3rd Party Open), Placebo-Controlled, 2-Way Crossover Study To Determine The Effects Of A Single Inhaled Dose Of 500 MCG Fluticasone Propionate On Induced Sputum Neutrophils Following Inhaled Lipopolysaccharide (LPS) Challenge In Healthy Volunteers|Completed||Phase 1|17|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:10:59.905404|2017-10-11 04:10:59.905404
NCT01363960|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-05-31|||March 1999||1999-03-01|June 2009|2009-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Retinopathy of Prematurity:Summary of a Decade||Completed||N/A|609|Actual|Saglik Bilimleri Universitesi Gulhane Tip Fakultesi|||1||f||||t||||||||||2017-10-11 04:11:09.473511|2017-10-11 04:11:09.473511
NCT01364493|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-05-07|||May 2011||2011-05-01|May 2017|2017-05-01|February 2014|Actual|2014-02-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer|An Open-label, Single Arm Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) as a First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer|Completed||Phase 2|51|Actual|Peking University||1|||f||||f||||||||||2017-10-11 04:11:00.16679|2017-10-11 04:11:00.16679
NCT01364480|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-08-15|||May 2011||2011-05-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Microelectrode Brain-Machine Interface for Individuals With Tetraplegia|Microelectrode Brain-Machine Interface for Individuals With Tetraplegia|Recruiting||N/A|5|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 04:11:00.29723|2017-10-11 04:11:00.29723
NCT01364467|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-02-03|||May 2011||2011-05-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study|The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study|Recruiting||Phase 2|36|Anticipated|Virginia Commonwealth University||2|||f||||f|t|f||||||||2017-10-11 04:11:00.428447|2017-10-11 04:11:00.428447
NCT01364454|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-08-18|||June 2010||2010-06-01|August 2016|2016-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening|Effect of Eligible Patients Paper-based Reminder for General Practitioners on Colorectal Cancer Screening Participation|Completed||Early Phase 1|8140|Actual|Paris 12 Val de Marne University||2|||f||||f||||||||||2017-10-11 04:11:00.531139|2017-10-11 04:11:00.531139
NCT01364441|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2012-06-12|||May 2011||2011-05-01|June 2012|2012-06-01||||August 2011|Actual|2011-08-01||Interventional|||Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects|A Double-Blind, Placebo-Controlled, Single-Dose Escalation and Food Effect Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects|Completed||Phase 1|48|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||f||||||||||2017-10-11 04:11:00.653584|2017-10-11 04:11:00.653584
NCT01364428|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2017-01-20|2015-10-16|2012-05-09|June 2011||2011-06-01|January 2017|2017-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|BEGIN™||Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus|A Trial Comparing the Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Subjects With Type 2 Diabetes Mellitus (BEGIN™: COMPARE)|Completed||Phase 3|373|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-10-11 04:11:00.761839|2017-10-11 04:11:00.761839
NCT01364415|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-06-27|||August 2011||2011-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)|A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)|Completed||Phase 1|29|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:11:01.360996|2017-10-11 04:11:01.360996
NCT01364402|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-10-09|||August 2011||2011-08-01|September 2011|2011-09-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Prevention of Contrast Induced Nephropathy by Erythropoietin|Prevention of Contrast Induced Nephropathy by Erythropoietin in Patients With Diabetes Mellitus and eGFR<60 ml/Min/1.73m2 Undergoing Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 3|142|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||t||||||||||2017-10-11 04:11:01.450265|2017-10-11 04:11:01.450265
NCT01364389|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-10|2015-03-10|2015-02-17||February 2011||2011-02-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica|A 2-week Single-blind, Randomized, 3-arm Proof of Concept Study of the Effects of AIN457 (Anti-IL17 Antibody), ACZ885 (Canakinumab, Anti-IL1b Antibody), or Corticosteroids in Patients With Polymyalgia Rheumatica, Followed by an Open Label Phase to Assess Safety and Long Term Efficacy|Terminated||Phase 2|16|Actual|Novartis||3||"Data did not show that the two biologic treatments impacted PMR disease activity to the same   degree as steroid treatment within a 2-week treatment period."|f||||||||||||||2017-10-11 04:11:01.575498|2017-10-11 04:11:01.575498
NCT01364376|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-08-20|||June 2011||2011-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|Focus||S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma|S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma: a Multi-center, Open-labeled, Randomized Controlled Trial|Completed||N/A|583|Actual|Zhejiang University||2|||f||||||||||||||2017-10-11 04:11:02.063303|2017-10-11 04:11:02.063303
NCT01364363|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-04|2013-12-05|||March 2005||2005-03-01|December 2013|2013-12-01|January 2023|Anticipated|2023-01-01|January 2021|Anticipated|2021-01-01||Interventional|||Unrelated Donor Stem Cell Transplantation|Allogeneic Hematopoietic Progenitor Cell Transplantation From Unrelated Donors|Recruiting||N/A|50|Anticipated|Scripps Health||7|||f||||f||||||||||2017-10-11 04:11:02.154786|2017-10-11 04:11:02.154786
NCT01364350|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-03-27|||March 2011||2011-03-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|T2P1||TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study|TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study of the TODAY Clinical Trial Cohort|Completed||N/A|550|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||Samples Without DNA|"     Blood and urine are collected on an annual basis and sent to the Central Biospecimen     Laboratory for analysis and storage.      Analyses performed on an annual basis are: HbA1c, insulin sensitivity and secreation (fasting     glucose, insulin, C-peptide, and proinsulin), 2-hour OGTT, pancreatic autoimmunity, serum     creatinine, liver function tests, lipids (LDL, triglycerides, free fatty acids, lipoprotein     subclass levels, average LDL particle density, and total apoB levels), cardiovascular risk     factors (fibrinogen, c-reactive protein, homocysteine vitamin B-12, plasminogran activator     inhibitor-1, interleukin-6), microalbumin.      HbA1c is also analyzed quarterly.   "|||2017-10-11 04:11:02.265005|2017-10-11 04:11:02.265005
NCT01363427|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2011-05-31|||March 2007||2007-03-01|May 2011|2011-05-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Observational|Crohn 2||Retrospective Data Analysis in Crohn's Disease|Retrospective Data Analysis of Newly Diagnosed Crohn's Disease Patients in Gastroenterological Surgeries|Completed||N/A|161|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:11:23.775409|2017-10-11 04:11:23.775409
NCT01364337|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-01|||November 2010||2010-11-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|Taiwan_DASH||Blood Pressure and Glucose Lowering Diet for Taiwanese|Design and Testing Efficacy of Blood Pressure and Glucose Lowering Diet for Taiwanese Pre-/1st Staged Hypertension Patients and/or Pre-diabetes Patients|Unknown status|Active, not recruiting|N/A|50|Anticipated|National Health Research Institutes, Taiwan||2|||f||||f||||||||||2017-10-11 04:11:02.37127|2017-10-11 04:11:02.37127
NCT01364324|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2017-04-12|||September 2010||2010-09-01|April 2017|2017-04-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients|Absorption of Anti-tuberculosis Drugs and Its Effect to Treatment Response in Gastrectomized Patients|Recruiting||N/A|40|Anticipated|National Cancer Center, Korea|||2||f||||t||||||||||2017-10-11 04:11:02.443158|2017-10-11 04:11:02.443158
NCT01364311|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2015-04-14|||July 2011||2011-07-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Treatment of Dry Eye With Supplements|Treatment of Dry Eye With Supplements|Withdrawn||N/A|0|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 04:11:02.524499|2017-10-11 04:11:02.524499
NCT01364298|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2013-12-18|2013-07-30||April 2011||2011-04-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Safety population included all the randomized participants who received at least one dose of study drug.|Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management|Multicenter, Randomized, Open-label, Parallel Group, Phase IV Study to Compare the Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in the Management of Diabetic Peripheral Neuropathic Pain|Completed||Phase 4|353|Actual|Merck KGaA||2|||f||||t||||||||||2017-10-11 04:11:02.612475|2017-10-11 04:11:02.612475
NCT01364285|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-06-01|||May 2009||2009-05-01|May 2011|2011-05-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia|A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia|Unknown status|Recruiting|N/A|200|Anticipated|Stanford University|||1||f||||||||||||||2017-10-11 04:11:03.408013|2017-10-11 04:11:03.408013
NCT01364272|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-06-01|||September 2008||2008-09-01|May 2011|2011-05-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia|Investigation of Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia|Unknown status|Recruiting|N/A|50|Anticipated|Stanford University|||1||f||||t||||||||||2017-10-11 04:11:03.479149|2017-10-11 04:11:03.479149
NCT01364259|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-02-16|2016-12-16||September 2008||2008-09-01|February 2017|2017-02-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|||A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia|A Randomized, Placebo-controlled Trial of Amifostine for Prevention of Facial Numbness in Patients Receiving Stereotactic Radiosurgery for Trigeminal Neuralgia|Terminated||Phase 3|17|Actual|Stanford University||2||Patterns of practice changed and this technique is no longer used.|f||||t||||||||No||2017-10-11 04:11:03.56448|2017-10-11 04:11:03.56448
NCT01364246|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-11-26|||January 2010||2010-01-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|March 2013|Anticipated|2013-03-01||Interventional|||Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica|Phase I/II Study of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Shenzhen Beike Bio-Technology Co., Ltd.||1|||f||||t||||||||||2017-10-11 04:11:03.84938|2017-10-11 04:11:03.84938
NCT01364220|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2014-11-19|||August 2010||2010-08-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|EUREKA||The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke|An Investigator-Sponsored,Double Blind,Placebo-controlled,Randomised,Multi-centre Study to Assess the Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke|Terminated||Phase 3|318|Actual|Severance Hospital||2||Slow enrollment|f||||t||||||||||2017-10-11 04:11:04.032583|2017-10-11 04:11:04.032583
NCT01364207|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-05|2012-10-01|2012-06-08||November 2010||2010-11-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|August 2011|Actual|2011-08-01||Interventional|||The Effects of Caffeinated Coffee on Intraocular Pressure|The Effects of Caffeinated Coffee on Intraocular Pressure|Completed||N/A|112|Actual|Massachusetts Eye and Ear Infirmary|We gave subjects caffeinated coffee on one visit and decaffeinated coffee on the other visit. The changes in outcome parameters we observed (ie IOP changes) could be due to other non-caffeine components in the coffee.|2|||f||||f||||||||||2017-10-11 04:11:04.170451|2017-10-11 04:11:04.170451
NCT01364194|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-01|||March 2010||2010-03-01|May 2011|2011-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Local Infiltration With Bupivacaine to Increase Quality of Post-operative Pain Control in Total Knee Replacement|Periarticular Injection With Bupivacaine For Post-Operative Pain Control In Total Knee Replacement: A Prospective Randomized Double-Blind Controlled Trial|Completed||Phase 4|60|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 04:11:04.368807|2017-10-11 04:11:04.368807
NCT01364181|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-17|||March 2010||2010-03-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients|The Impact of Udenafil on Exercise Capacity in Severe COPD Patients|Completed||Phase 3|23|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-10-11 04:11:04.457805|2017-10-11 04:11:04.457805
NCT01364168|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-09-06|||February 2011||2011-02-01|September 2016|2016-09-01|December 2021|Anticipated|2021-12-01|December 2018|Anticipated|2018-12-01||Observational|PROSCIS||Prospective Cohort With Incident Stroke|Prospective Cohort With Incident Stroke|Recruiting||N/A|850|Anticipated|Ludwig-Maximilians - University of Munich|||1||f||||f||||||Samples With DNA|"     whole blood, serum, RNA   "|||2017-10-11 04:11:04.553958|2017-10-11 04:11:04.553958
NCT01364155|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-05-31|||May 2011||2011-05-01|May 2011|2011-05-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR|A Randomized, Single-Blind, Placebo-Controlled Phase 2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR|Unknown status|Recruiting|Phase 2|50|Anticipated|Limerick BioPharma||2|||f||||f||||||||||2017-10-11 04:11:04.653335|2017-10-11 04:11:04.653335
NCT01364142|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-06-20|||June 2011||2011-06-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Observational|||A Blind Maneuver to Position an Endobronchial Blocker|A Blind Maneuver to Position an Endobronchial|Completed||N/A|56|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 04:11:04.794311|2017-10-11 04:11:04.794311
NCT01364129|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2016-03-07|||August 2006||2006-08-01|March 2016|2016-03-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy|The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy|Completed||N/A|567|Actual|Legacy Health System||2|||f||||f||||||||||2017-10-11 04:11:06.905896|2017-10-11 04:11:06.905896
NCT01364116|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-06-05|||February 2011||2011-02-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|||||Observational|||The Accuracy of Noninvasive and Continuous Hemoglobin Measurement by Pulse CO-Oximetry™ in Children Undergoing Volume Expansion||Completed||N/A|46|Actual|Seoul National University Hospital|||1||f||||f||||||||||2017-10-11 04:11:07.003503|2017-10-11 04:11:07.003503
NCT01364103|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-01-31|||February 2011||2011-02-01|January 2012|2012-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study About Predicting Fluid Responsiveness in Children Undergoing Neurosurgery||Completed||N/A|33|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 04:11:07.075455|2017-10-11 04:11:07.075455
NCT01364077|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2012-06-20|||January 2010||2010-01-01|June 2012|2012-06-01||||January 2011|Actual|2011-01-01||Interventional|||Ivabradine in Hemodialysed Patients With Increased Heart Rate|Efficacy and Safety of Ivabradine in Hemodialysed Patients With Increased Heart Rate|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|"University of Campania Luigi Vanvitelli"||2|||f||||t||||||||||2017-10-11 04:11:07.298042|2017-10-11 04:11:07.298042
NCT01364064|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-02-24|||January 2007||2007-01-01|September 2013|2013-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma|Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma|Completed||Phase 3|1153|Actual|King Faisal Specialist Hospital & Research Center||2|||f||||t||||||||||2017-10-11 04:11:07.381377|2017-10-11 04:11:07.381377
NCT01364051|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-09-04|||May 25, 2011|Actual|2011-05-25|August 2017|2017-08-01||||June 1, 2016|Actual|2016-06-01||Interventional|||Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies|Phase I Study of the Combination of the VEGFR Inhibitor, AZD2171, and MEK Inhibitor, AZD6244, in the Treatment of Solid Malignancies|Active, not recruiting||Phase 1|19|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:11:07.454296|2017-10-11 04:11:07.454296
NCT01364025|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2015-05-19|||August 2011||2011-08-01|May 2015|2015-05-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Prophylactic Uterosacral Ligament Suspension at the Time of Hysterectomy for Prevention of Vaginal Vault Prolapse|Prophylactic Uterosacral Ligament Suspension at the Time of Hysterectomy for Prevention of Vaginal Vault Prolapse (PULS)|Active, not recruiting||N/A|800|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 04:11:07.575508|2017-10-11 04:11:07.575508
NCT01364012|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-07-26|||May 23, 2011|Actual|2011-05-23|July 2017|2017-07-01|August 30, 2017|Anticipated|2017-08-30|August 30, 2017|Anticipated|2017-08-30||Interventional|||A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy|A Randomized, Double-blinded, Placebo-controlled, Multicenter Phase III Study Comparing Bevacizumab Plus Carboplatin/Paclitaxel Versus Placebo Plus Carboplatin/Paclitaxel in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy For Advanced Disease|Active, not recruiting||Phase 3|276|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:11:07.653828|2017-10-11 04:11:07.653828
NCT01363999|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2016-11-01|||June 2011||2011-06-01|November 2016|2016-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers|A Single-center, Randomized, Open-label, Four Treatments, Four Periods, Four Sequence, Four-way Crossover Study to Explore the Pharmacokinetic Performance of Dalcetrapib and Atorvastatin Fixed Dose Combination Prototype Formulations in Healthy Volunteers|Completed||Phase 1|24|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 04:11:09.025272|2017-10-11 04:11:09.025272
NCT01363986|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2014-07-23|2014-05-07||September 2011||2011-09-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Intent to treat (ITT) population included all consented participants who received study treatment.|A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer|A Multicenter, Open Label Study to Assess the Effect of Trastuzumab + Whole Brain Radiotherapy (WBRT) on Brain Metastases From HER-2 Positive Breast Cancer. (bHERt-2)|Terminated||Phase 2|3|Actual|Hoffmann-La Roche||1||"Study was prematurely terminated due to difficulties experienced in recruiting patients in a   reasonable timeframe."|f||||||||||||||2017-10-11 04:11:09.127597|2017-10-11 04:11:09.127597
NCT01363973|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2015-02-27|||January 2012||2012-01-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|EETI-01||Effect of Transcutaneous Electrical Stimulation on Post-stroke Dysphagic Patients|Pilot Study to Evaluate the Efficacy and Safety of Transcutaneous Electrical Stimulation on Swallowing in Patients With Oropharyngeal Dysphagia After Stroke|Completed||N/A|20|Actual|Hospital de Mataró||2|||f||||t||||||||||2017-10-11 04:11:09.390585|2017-10-11 04:11:09.390585
NCT01363947|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-06-05|||June 14, 2011|Actual|2011-06-14|June 2017|2017-06-01|June 3, 2016|Actual|2016-06-03|June 3, 2016|Actual|2016-06-03||Interventional|||Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer|A Phase I, Open-Label Study of the Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Patients With Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer|Completed||Phase 1|87|Actual|Genentech, Inc.||2|||f||||f|t|f||||||||2017-10-11 04:11:09.55481|2017-10-11 04:11:09.55481
NCT01363934|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-07-17|||June 2011||2011-06-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin|A Dose-Block Randomized, Double-blind Placebo Controlled, Open-label Active Controlled, Dose-escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GC1113 After Single Intravenous/Subcutaneous Administration in Healthy Male Subjects|Completed||Phase 1|100|Actual|Green Cross Corporation||10|||f||||t||||||||||2017-10-11 04:11:09.666209|2017-10-11 04:11:09.666209
NCT01363921|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-04-04|||April 2011||2011-04-01|April 2017|2017-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|HicoCARD||Effect of HCO1100 on Cardiovascular Function|Effect of High Cut-off Membranes on Cardiovascular Function in Patients With End-stage Renal Disease (HICOCARD)|Terminated||N/A|10|Actual|Baxter Healthcare Corporation||1||insufficient patient recruiting|f||||f||||||||||2017-10-11 04:11:09.780984|2017-10-11 04:11:09.780984
NCT01363908|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2015-05-27|2015-05-06||August 2011||2011-08-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||The Safety Analysis Set, defined as all participants who had taken at least 1 dose of investigational product.|Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload|A Phase 2, Open Label, Multi-Center, Single-Dose Pharmacokinetics, and Multiple Dose Study of the Safety, Efficacy and Tolerability of SSP-004184 (SPD602) in a Pediatric Population With Transfusional Iron Overload|Terminated||Phase 2|30|Actual|Shire|This study was terminated early because of non-clinical safety results. As such, not all subjects completed the study. The available efficacy data were summarized and analyzed as specified in the SAP; however, no efficacy conclusions could be drawn.|3||"This study was terminated due to treatment stop resulting in an inability to draw conclusions   from the data. Evaluation of nonclinical rat findings is ongoing."|f||||t||||||||||2017-10-11 04:11:10.045242|2017-10-11 04:11:10.045242
NCT01363895|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-25|2017-04-10|||November 2010||2010-11-01|April 2017|2017-04-01|November 2013|Actual|2013-11-01|November 2012|Actual|2012-11-01||Interventional|ISAR-AF||Interventional Strategies in Treatment of Atrial Fibrillation: Percutaneous Closure of the Left Atrial Appendage Versus Catheter Ablation|Interventional Strategies in Treatment of Atrial Fibrillation: Percutaneous Closure of the Left Atrial Appendage Versus Catheter Ablation|Completed||N/A|120|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 04:11:10.959012|2017-10-11 04:11:10.959012
NCT01363882|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-28|2011-05-31|||February 2008||2008-02-01|May 2011|2011-05-01||||January 2011|Actual|2011-01-01||Interventional|||Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)|Progression of Respiratory Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients: A Comparison of Standard of Practice vs Polysomnography-Directed Nocturnal Non-Invasive Positive Pressure Ventilation|Unknown status|Active, not recruiting|N/A|40|Anticipated|Columbia University||2|||f||||f||||||||||2017-10-11 04:11:11.056315|2017-10-11 04:11:11.056315
NCT01363869|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2013-04-23|||June 2011||2011-06-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals|Effects of Green Tea on Level of Serum Uric Acid in Healthy Individuals|Completed||N/A|30|Actual|Chiang Mai University||3|||f||||t||||||||||2017-10-11 04:11:11.158983|2017-10-11 04:11:11.158983
NCT01363856|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-06-01|||February 2010||2010-02-01|May 2011|2011-05-01|June 2015|Anticipated|2015-06-01|June 2013|Anticipated|2013-06-01||Observational|CSB_PROSCIS||Center for Stroke Research Berlin (CSB) Prospective Stroke Cohort|Center for Stroke Research Berlin (CSB) Prospective Stroke Cohort|Unknown status|Recruiting|N/A|750|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"     Samples with DNA whole blood, serum, RNA   "|||2017-10-11 04:11:11.251785|2017-10-11 04:11:11.251785
NCT01363843|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2014-07-25|2014-06-17||May 2010||2010-05-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)|Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)|Completed||Phase 2|39|Actual|Brown University||1|||f||||t||||||||||2017-10-11 04:11:11.384152|2017-10-11 04:11:11.384152
NCT01363830|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2013-10-18|||August 2009||2009-08-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Short Versus Long Post-Operative Restrictions Following Lumbar Discectomy|Short (2-weeks) Versus Long (6-weeks) Post-Operative Restrictions Following Lumbar Discectomy: A Prospective Randomized Control Study|Unknown status|Recruiting|N/A|420|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 04:11:11.791856|2017-10-11 04:11:11.791856
NCT01363817|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2017-09-15|||September 28, 2011|Actual|2011-09-28|September 2017|2017-09-01|October 2, 2017|Anticipated|2017-10-02|October 1, 2017|Anticipated|2017-10-01||Interventional|||Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma|Phase 1 Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BMS-906024 in Subjects With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma|Active, not recruiting||Phase 1|42|Anticipated|Bristol-Myers Squibb||2|||f||||f|t|f||||||||2017-10-11 04:11:12.054742|2017-10-11 04:11:12.054742
NCT01363804|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-06-01|||May 2011||2011-05-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Phase 1 Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Tivozanib in Healthy Subjects|A Phase 1, Open-label, Two-period, Single-sequence Study to Evaluate the Effect of Rifampin on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Tivozanib in Healthy Subjects|Completed||Phase 1|30|Actual|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 04:11:12.166565|2017-10-11 04:11:12.166565
NCT01363791|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2015-05-26|||May 2009||2009-05-01|May 2015|2015-05-01|March 2016|Anticipated|2016-03-01|March 2014|Actual|2014-03-01||Observational|||Meta-analyses of Fructose and Cardiometabolic Risk|Effect of Fructose on Metabolic Control in Humans: A Series of Systematic Reviews and Meta-analyses to Provide Evidence-based Guidance for Nutrition Guidelines Development|Unknown status|Active, not recruiting|N/A|1|Anticipated|University of Toronto|||1||f||||f||||||||||2017-10-11 04:11:12.241736|2017-10-11 04:11:12.241736
NCT01363778|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2012-06-01|||May 2011||2011-05-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Phase 1 Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics of Tivozanib in Healthy Subjects|A Phase 1, Open-label Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Tivozanib in Healthy Subjects|Completed||Phase 1|30|Actual|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 04:11:12.354344|2017-10-11 04:11:12.354344
NCT01363765|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2014-03-11|2013-08-05||February 2012||2012-02-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Those are notified patients with pulmonary TB by the clinics which drain to the 14 participant labs all participants who were notified whether or not they were linked to the lab database. Further analyses do not correspond to all notified patients, it included only those linked in both databases.|Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil|Pilot Roll Out of the Xpert MTB/Rif for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil: a Stepped Wedge Trial|Completed||Phase 4|34758|Actual|Ataulpho de Paiva Foundation|The design has potential for bias, due to delayed treatment effects or to conditions that change over time. Both are unlikely: outcome (notification) was shortly after test and adjustment for time in multilevel mixed model confirmed primary analysis.|2|||f||||f||||||||||2017-10-11 04:11:12.440331|2017-10-11 04:11:12.440331
NCT01363752|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2015-06-12|||March 2011||2011-03-01|June 2015|2015-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ADHERE||A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.|A Multicenter, Two Arm, Randomized, Open Label Clinical Study Investigating Renal Function in an Advagraf® Based Immunosuppressive Regimen With or Without Sirolimus in Kidney Transplant Patients|Completed||Phase 4|853|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 04:11:12.827455|2017-10-11 04:11:12.827455
NCT01363739|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-31|2011-05-31|||April 2009||2009-04-01|May 2011|2011-05-01||||||||Observational|PROVETTA||Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab|Prospective Evaluation of -1498 c/t VEGF Polymorphism in the Prediction of Benefit From First-line Folfiri Plus Bevacizumab in Metastatic Colorectal Cancer Patients|Unknown status|Recruiting|N/A|265|Anticipated|Azienda Ospedaliero, Universitaria Pisana|||1||f||||f||||||||||2017-10-11 04:11:13.045442|2017-10-11 04:11:13.045442
NCT01363726|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2011-05-31|||October 2005||2005-10-01|October 2005|2005-10-01||||||||Observational|||Surveillance of Rotavirus Gastroenteritis in Children <5 Years|Surveillance of Rotavirus Gastroenteritis Among Children <5 Years of Age Visiting the Pediatric Emergency Room in Southern Israel|Unknown status|Recruiting|N/A|30000|Anticipated|Soroka University Medical Center|||1||f||||f||||||||||2017-10-11 04:11:13.110543|2017-10-11 04:11:13.110543
NCT01363713|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2014-09-25|2014-09-16|||||September 2014|2014-09-01||||September 2012|Actual|2012-09-01||Interventional|||A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis|A Long-term Open-label Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis - Phase 3 -|Completed||Phase 3|130|Actual|Santen Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-10-11 04:11:13.188959|2017-10-11 04:11:13.188959
NCT01363700|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2014-11-05|2014-10-22|||||November 2014|2014-11-01||||June 2012|Actual|2012-06-01||Interventional|||Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis|Double-masked, Comparison Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis - Phase 3, Confirmatory Study -|Completed||Phase 3|87|Actual|Santen Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 04:11:13.404788|2017-10-11 04:11:13.404788
NCT01363687|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2013-12-24|||August 2011||2011-08-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Effect of Remote Postconditioning on Graft Function in Patients Undergoing Living-related Kidney Transplantation|The Effect of Remote Postconditioning on Graft Function in Patients Undergoing Living-related Kidney Transplantation|Completed||N/A|60|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-10-11 04:11:13.747852|2017-10-11 04:11:13.747852
NCT01363674|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2016-04-20|||April 2013||2013-04-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|ECOS GRE||To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece|Easypod Connect: A National, Multicentre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using Easypod™ Electromechanical Device for Growth Hormone Treatment in Greece|Completed||N/A|180|Actual|Merck KGaA|||1||f||||f||||||||||2017-10-11 04:11:13.83231|2017-10-11 04:11:13.83231
NCT01363661|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2014-09-25|2014-09-15||June 2011||2011-06-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MEDCOR|This population corresponded to the per protocol cohort: patients who had been randomized to placebo or molsidomine and who had completed the study in accordance with the protocol.|Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris|Double-blind Parallel Placebo-controlled Study to Evaluate the Effect of Molsidomine on the Endothelial Dysfunction in Patients With Stable Angina Pectoris Undergoing a Percutaneous Coronary Intervention|Completed||Phase 4|165|Actual|Therabel Pharma SA/NV|Too limited sample size. Huge variability in all measurements. High drop-out rate. Add-on treatment was a challenge to demonstrate a difference between Coruno and placebo.|2|||f||||t||||||||||2017-10-11 04:11:13.915794|2017-10-11 04:11:13.915794
NCT01363648|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-29|2013-10-11|||November 2010||2010-11-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|GLITTER||The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia|A Randomized, Double-blind, Placebo-controlled Phase IV Trial for an Evaluation of the Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia|Completed||Phase 4|222|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-10-11 04:11:14.393546|2017-10-11 04:11:14.393546
NCT01363635|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-28|2011-06-02|||June 2011||2011-06-01|June 2011|2011-06-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Observational|||Severe Sepsis/Septic Shock on Admission to the General Surgical ICU|Severe Sepsis/Septic Shock on Admission to the General Surgical ICU|Unknown status|Not yet recruiting|N/A|800|Anticipated|Mahidol University|||1||f||||f||||||||||2017-10-11 04:11:14.598753|2017-10-11 04:11:14.598753
NCT01363622|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-06-01|||May 2010||2010-05-01|March 2011|2011-03-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Observational|||Vaspin Levels Compared With Serum Insulin and Blood Glucose Levels in Neonates|Zekai Tahir Burak Maternity Teaching Hospital|Unknown status|Recruiting|N/A|82|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||3||f||||f||||||||||2017-10-11 04:11:14.691586|2017-10-11 04:11:14.691586
NCT01363609|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2015-02-17|||October 2011||2011-10-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|LIBRA||Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes|Central Effects of Endogenous Glucagon Like Peptide-1 (GLP-1) and the GLP-1 Analog Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes|Completed||N/A|50|Actual|VU University Medical Center||3|||f||||f||||||||||2017-10-11 04:11:14.765016|2017-10-11 04:11:14.765016
NCT01363596|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-05-05|||January 2006||2006-01-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Observational|iNEST||International NaProTechnology Evaluation and Surveillance of Treatment for Infertility and Miscarriage (iNEST)|International Natural Procreative Technology Evaluation and Surveillance of Treatment for Infertility and Miscarriage (iNEST)|Active, not recruiting||N/A|798|Actual|University of Utah|||1||f||||f||||||||||2017-10-11 04:11:14.859033|2017-10-11 04:11:14.859033
NCT01363583|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-05-27|||January 2002||2002-01-01|September 2001|2001-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study on the Effect of Prostacyclin Compared to Placebo in Traumatic Brain Injury|Prostacyclin Treatment in Severe Traumatic Brain Injury: a Microdialysis and Outcome Study|Completed||Phase 1|48|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 04:11:14.976376|2017-10-11 04:11:14.976376
NCT01363570|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2016-03-15|||January 2012||2012-01-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes|Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes|Completed||N/A|70|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 04:11:15.100462|2017-10-11 04:11:15.100462
NCT01363557|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2014-05-12|||March 2012||2012-03-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|August 2012|Actual|2012-08-01||Interventional|ARPEGE||Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis|Randomized to Assess the Efficacy of Whole Brain Radiation Therapy (WBRT) With Concomitant Gefitinib Followed by Maintenance Gefitinib, and Gefitinib Alone, in Lung Cancer Patients With Brain Metastasis|Terminated||N/A|1|Actual|Assistance Publique - Hôpitaux de Paris||2||Decision of Sponsor|f||||f||||||||||2017-10-11 04:11:15.209634|2017-10-11 04:11:15.209634
NCT01363544|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-12-08|||June 2010||2010-06-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD)|Train Your Brain? Exercise and Neurofeedback Intervention for ADHD|Completed||Phase 2/Phase 3|112|Actual|VU University of Amsterdam||3|||f||||f||||||||||2017-10-11 04:11:15.312695|2017-10-11 04:11:15.312695
NCT01363531|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-08-26|||December 2009||2009-12-01|March 2015|2015-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PDA||Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies|Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies in the Non-complicated Acute Respiratory Tract Infections in General Practice|Completed||Phase 4|405|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||4|||f||||t||||||||||2017-10-11 04:11:15.441724|2017-10-11 04:11:15.441724
NCT01363518|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-03-23|||May 2010||2010-05-01|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Operative Versus Nonoperative Treatment of Humeral Shaft Fractures: A Prospective Cohort Comparison Study|Operative Versus Nonoperative Treatment of Humeral Shaft Fractures: A Prospective Cohort Comparison Study|Enrolling by invitation||N/A|164|Anticipated|St. Louis University|||2||f||||t||||||||No|Results will be shared|2017-10-11 04:11:15.53374|2017-10-11 04:11:15.53374
NCT01363505|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2014-01-31|||May 2011||2011-05-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters|Is Intravesicular Pressure a Better Tool to Predict Renal Failure in Critically Ill Patients Compared With Routine Hemodynamic Parameters?|Completed||N/A|16|Actual|Northwell Health|||1||f||||t||||||||||2017-10-11 04:11:15.642811|2017-10-11 04:11:15.642811
NCT01363492|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-31|2014-04-17|2014-03-25||May 2011||2011-05-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Safety Study of Replagal® Therapy in Children With Fabry Disease|An Open-Label Clinical Trial of Replagal® Enzyme Replacement Therapy in Children With Fabry Disease Who Are Naive to Enzyme Replacement Therapy|Completed||Phase 2|15|Actual|Shire||1|||f||||f||||||||||2017-10-11 04:11:15.754964|2017-10-11 04:11:15.754964
NCT01363466|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2011-05-30|||May 2003||2003-05-01|May 2011|2011-05-01|November 2006|Actual|2006-11-01|||||Interventional|||Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer|Randomized Phase III Trial Evaluating the Impact of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer|Terminated||Phase 3|61|Actual|UNICANCER||2||low recruitment|f||||f||||||||||2017-10-11 04:11:17.12457|2017-10-11 04:11:17.12457
NCT01363453|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2011-05-31|||October 2007||2007-10-01|May 2011|2011-05-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Observational|CARE||User Surveillance in Ulcerative Colitis|Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine|Completed||N/A|500|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:11:17.286669|2017-10-11 04:11:17.286669
NCT01363440|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-04-25|2014-08-28|2014-02-11|May 2011||2011-05-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|January 2013|Actual|2013-01-01||Interventional|VISTA DME|Baseline population analyzed using the SAF|Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema|A Double-Masked, Randomized, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients With Diabetic Macular Edema|Completed||Phase 3|466|Actual|Regeneron Pharmaceuticals||3|||f||||t||||||||||2017-10-11 04:11:17.764157|2017-10-11 04:11:17.764157
NCT01363414|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-05-31|||January 2007||2007-01-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes|Randomized Controlled Trial of the Effects of Sodium Hyaluronate on Wavefront Aberrations in Dry Eye Patients|Completed||N/A|50|Actual|Ramathibodi Hospital||2|||f||||f||||||||||2017-10-11 04:11:23.886118|2017-10-11 04:11:23.886118
NCT01363401|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2017-02-02|2015-12-08||February 2011||2011-02-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis|An Open-label, Phase I/II Trial for Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis|Completed||Phase 1/Phase 2|72|Actual|Corestem, Inc.||2|||f||||f||||||||No||2017-10-11 04:11:24.008779|2017-10-11 04:11:24.008779
NCT01363388|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-07-25|||August 2011||2011-08-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|October 2015|Actual|2015-10-01||Interventional|||A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis on Background of Cyclophosphamide or Rituximab Treatment|Completed||Phase 2|67|Actual|ChemoCentryx||2|||f||||t||||||||||2017-10-11 04:11:24.528308|2017-10-11 04:11:24.528308
NCT01363375|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-31|||June 2009||2009-06-01|February 2008|2008-02-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Observational|||Effects of Different Foot Structures on Plantar Fasciitis and Therapeutic Footwear Intervention|The Investigation of Biomechanical Mechanism of Different Foot Structures on Plantar Fasciitis and the Evaluation of Efficacy on Therapeutic Footwear|Unknown status|Recruiting|N/A|40|Anticipated|Chang Gung Memorial Hospital|||3||f||||t||||||||||2017-10-11 04:11:24.726105|2017-10-11 04:11:24.726105
NCT01363362|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-12-17|||December 2010||2010-12-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|SLT/OBF||Selective Lasertrabeculoplasty and Ocular Hemodynamics in Glaucoma|Effect of Selective Lasertrabeculoplasty (SLT) on Ocular Hemodynamics in Glaucoma|Completed||N/A|150|Actual|Technische Universität Dresden||1|||f||||f||||||||||2017-10-11 04:11:24.852098|2017-10-11 04:11:24.852098
NCT01363349|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-30|2014-09-17|2014-04-22||May 2011||2011-05-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|CLARITY||Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia|A Randomized, Double-Blind, Active-Controlled,Phase 2/3 Study to Determine the Short-Term (6-Week) and Long-Term (6 Month) Cognitive and Anti-Psychotic Efficacy, Safety and Tolerability of CYP-1020 Compared to Risperidone in Patients With Schizophrenia|Terminated||Phase 2/Phase 3|269|Actual|BioLineRx, Ltd.||2||"pre-planned interim analysis of the Phase II/III CLARITY trial of BL-1020 indicate that the   trial would not meet the pre-specified primary efficacy endpoint."|f||||f||||||||||2017-10-11 04:11:24.945142|2017-10-11 04:11:24.945142
NCT01363336|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2015-04-03|||November 2009||2009-11-01|April 2015|2015-04-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease|Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease|Completed||N/A|1882|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:11:25.53056|2017-10-11 04:11:25.53056
NCT01363323|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-07-17|||November 2004||2004-11-01|July 2011|2011-07-01|February 2005|Actual|2005-02-01|January 2005|Actual|2005-01-01||Interventional|||Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization|A Randomized, Double-Blind, Placebo/Positive Controlled, Evaluation of the Effects of MNTX on ECG Parameters and Cardiac Repolarization in Normal Volunteers|Completed||Phase 1|546|Actual|Valeant Pharmaceuticals International, Inc.||5|||f||||f||||||||||2017-10-11 04:11:25.621661|2017-10-11 04:11:25.621661
NCT01363310|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2014-01-07|||October 2010||2010-10-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||The Quietude Study: Quetiapine Use for Agitated Depression|A Multi-Centre, Double-Blind, Randomised, Parallel Group, Escitalopram Controlled Phase III-B Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR TM) as Monotherapy in the Treatment of Adult Patients With Agitated Major Depressive Disorder|Terminated||Phase 3|250|Anticipated|Physicians Research And Education Network||2||Termination of sponsorship|f||||||||||||||2017-10-11 04:11:25.707049|2017-10-11 04:11:25.707049
NCT01363297|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-03-02|2015-08-25|2015-07-31|August 2011||2011-08-01|March 2017|2017-03-01|January 2016|Actual|2016-01-01|August 2014|Actual|2014-08-01||Interventional||Safety analysis set - included all enrolled participants who received at least 1 dose of study medication.|Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia|An Open-label, Phase 1/2 Study Of Inotuzumab Ozogamicin In Subjects With Relapsed Or Refractory Cd22-positive Acute Lymphocytic Leukemia|Completed||Phase 2|72|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 04:11:25.94174|2017-10-11 04:11:25.94174
NCT01363271|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-05-21|||May 2011||2011-05-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients|Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients|Completed||Phase 4|7260|Actual|Pfizer|||2||f||||f||||||||||2017-10-11 04:11:29.992487|2017-10-11 04:11:29.992487
NCT01363245|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-31|2015-07-01|||July 2011||2011-07-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|December 2014|Actual|2014-12-01||Interventional|||Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients|Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients.|Completed||N/A|1618|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 04:11:30.221064|2017-10-11 04:11:30.221064
NCT00000559|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||March 1995||1995-03-01|May 2005|2005-05-01|August 2001|Actual|2001-08-01|||||Interventional|||Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.513958|2017-10-11 04:19:04.513958
NCT01363232|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-07-17|||August 2011||2011-08-01|July 2017|2017-07-01|December 31, 2017|Anticipated|2017-12-31|March 2014|Actual|2014-03-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients|A Phase Ib, Open-label, Multi-center, Dose-escalation and Expansion Study of an Orally Administered Combination of BKM120 Plus MEK162 in Adult Patients With Selected Advanced Solid Tumors|Active, not recruiting||Phase 1|89|Actual|Array BioPharma||1|||f||||||||||||||2017-10-11 04:11:30.312099|2017-10-11 04:11:30.312099
NCT01363206|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2014-03-06|||May 2011||2011-05-01|March 2014|2014-03-01|May 2015|Anticipated|2015-05-01|May 2014|Anticipated|2014-05-01||Interventional|GIPI||Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma|GM-CSF and Ipilimumab as Therapy in Metastatic Melanoma, a Phase II Study|Unknown status|Active, not recruiting|Phase 2|43|Anticipated|Northern California Melanoma Center||1|||f||||f||||||||||2017-10-11 04:11:30.431165|2017-10-11 04:11:30.431165
NCT01363193|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2013-05-13|||July 2011||2011-07-01|May 2013|2013-05-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients|Assessing Safety and Efficacy of Lean Body Weight-based Intravenous Heparin Dosing in Obese/Morbidly Obese Patients. A Pilot Study|Unknown status|Recruiting|N/A|100|Anticipated|Nazareth Hospital||1|||f||||f||||||||||2017-10-11 04:11:30.554208|2017-10-11 04:11:30.554208
NCT01363180|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-11-15|||June 2011||2011-06-01|May 2011|2011-05-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|ARC5||Stress-induced Drinking in Emerging Adults: the Role of Trauma History|Stress-induced Drinking in Emerging Adults: the Role of Trauma History|Unknown status|Recruiting|N/A|240|Anticipated|Medical University of South Carolina|||3||f||||f||||||||||2017-10-11 04:11:30.650685|2017-10-11 04:11:30.650685
NCT01363167|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2014-11-21|||October 2011||2011-10-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2|Identifying Vit D Deficiency in VLBW Infants Part 2|Completed||N/A|68|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-10-11 04:11:30.737558|2017-10-11 04:11:30.737558
NCT01363154|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2013-06-02|||November 2010||2010-11-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Prevention of Photoparoxysmal Abnormalities by Mozart K448|Prevention of Photoparoxysmal Abnormalities Through Patterned Auditory Stimulation|Terminated||N/A|10|Actual|Medical University of South Carolina||3||terminated|f||||t||||||||||2017-10-11 04:11:30.934453|2017-10-11 04:11:30.934453
NCT01363141|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2015-05-06|||December 2010||2010-12-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of a Low Advanced Glycation End Products (AGE) Diet in the Metabolic Syndrome|Effects of Glycooxidative Stress on Human Aging- Study #3|Completed||N/A|383|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 04:11:31.062515|2017-10-11 04:11:31.062515
NCT01363128|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-10-02|||July 12, 2011|Actual|2011-07-12|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Hyper CVAD Plus Ofatumumab in CD - 20 Positive Acute Lymphoblastic Leukemia (ALL)|Phase II Study of the Hyper - CVAD Regimen in Combination With Ofatumumab as Frontline Therapy for Patients With CD-20 Positive Acute Lymphoblastic Leukemia|Recruiting||Phase 2|80|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 04:11:31.175133|2017-10-11 04:11:31.175133
NCT01363115|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-05-27|||July 2005||2005-07-01|May 2011|2011-05-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|CaSHeW||Calcium Supplementation for a Healthy Weight (CaSHeW)|Calcium Supplementation for a Healthy Weight (CaSHeW)|Completed||N/A|130|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 04:11:31.328352|2017-10-11 04:11:31.328352
NCT01363089|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-02-07|||January 2007||2007-01-01|February 2017|2017-02-01|February 2008|Actual|2008-02-01|March 2007|Actual|2007-03-01||Interventional|||Study to Assess the PK of Ketorolac Tromethamine Intranasal and to Assess the Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac Tromethamine|Open Label, 2-Way Crossover Study to Assess the PK of Intranasal Ketorolac Tromethamine and to Assess the Effects of a Single Dose of Oxymetazoline Hydrochloride on the PK of Intranasal Ketorolac Tromethamine in Healthy Male Subjects|Completed||Phase 1|21|Actual|Egalet Ltd||2|||f||||t||||||||||2017-10-11 04:11:31.582082|2017-10-11 04:11:31.582082
NCT01363076|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-02-07|2012-03-08||June 2007||2007-06-01|February 2017|2017-02-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||The Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years|A Study of the Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years|Completed||Phase 1|20|Actual|Egalet Ltd||2|||f||||||||||||||2017-10-11 04:11:31.705047|2017-10-11 04:11:31.705047
NCT01363063|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-05-27|||December 2006||2006-12-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|||Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers|A Phase 1, Double-Blind, Study of the Tolerability of Formulations of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers|Completed||Phase 1|40|Actual|Luitpold Pharmaceuticals||2|||f||||||||||||||2017-10-11 04:11:32.100983|2017-10-11 04:11:32.100983
NCT01363050|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-02-07|2012-08-29||January 2006||2006-01-01|February 2017|2017-02-01|September 2006|Actual|2006-09-01|February 2006|Actual|2006-02-01||Interventional|||Study to Determine the Tolerability, Safety and Pharmacokinetics of Ketorolac Tromethamine by Intranasal Administration in Healthy Volunteers|A Phase 1, Open Label, Multiple Dose Study to Determine the Tolerability, Safety and Pharmacokinetics of Ketorolac Tromethamine by Intranasal Administration in Healthy Volunteers|Completed||Phase 1|15|Actual|Egalet Ltd||1|||f||||f||||||||||2017-10-11 04:11:32.191249|2017-10-11 04:11:32.191249
NCT01363037|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2015-09-09|||November 2011||2011-11-01|September 2015|2015-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring|Phase 1 Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring|Completed||Phase 1|48|Actual|International Partnership for Microbicides, Inc.||4|||f||||t||||||||||2017-10-11 04:11:32.526197|2017-10-11 04:11:32.526197
NCT01363024|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-11-01|||August 2011||2011-08-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors|An Open-Label, Multicenter, Phase I Dose-Escalation Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors|Completed||Phase 1|24|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 04:11:32.631609|2017-10-11 04:11:32.631609
NCT01363011|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2016-03-29|2014-10-27|2014-01-10|May 2011||2011-05-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|January 2013|Actual|2013-01-01||Interventional||Safety Analysis Set: participants were randomized and received at least one dose of study drug|Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment|A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment|Completed||Phase 3|106|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 04:11:33.141156|2017-10-11 04:11:33.141156
NCT01362998|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-05-31|||March 2011||2011-03-01|May 2011|2011-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Epidural Morphine Versus Epidural Fentanyl Infusion Following Cesarean Section|A Comparison of Single Dose Preservative Free Morphine With Fentanyl Infusion for Post-Cesarean Section Analgesia|Unknown status|Recruiting|N/A|200|Anticipated|Goodman, Evan, M.D.||2|||f||||t||||||||||2017-10-11 04:11:35.005826|2017-10-11 04:11:35.005826
NCT01362985|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2015-08-12|||July 2009||2009-07-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor|Monitoring of Plerixafor Off-Label Use in the European Group for Blood and Bone Marrow Transplantation (EBMT) Registry|Completed||Phase 4|201|Actual|Sanofi|||1||f||||f||||||||||2017-10-11 04:11:35.168778|2017-10-11 04:11:35.168778
NCT01362972|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-08-23|||March 2011||2011-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor|Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor|Completed||N/A|7801|Actual|Sanofi|||4||f||||f||||||||||2017-10-11 04:11:35.259577|2017-10-11 04:11:35.259577
NCT01362959|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-08-26|||June 2012||2012-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|NicGoWell||Nicotine Replacement Therapy in the Intensive Care Unit|Nicotine Replacement Therapy in the Intensive Care Unit: a Randomized, Controlled Pilot Study|Completed||Phase 4|47|Actual|Gelderse Vallei Hospital||2|||f||||t||||||||||2017-10-11 04:11:35.342199|2017-10-11 04:11:35.342199
NCT01362946|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-07|2015-12-10|2015-03-03||January 2012||2012-01-01|December 2015|2015-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits|Designing a Novel Behavioral Treatment Protocol for Children Characterized by Conduct Problems and Callous-unemotional Traits|Completed||N/A|48|Actual|Florida International University||2|||f||||t||||||||||2017-10-11 04:11:35.548699|2017-10-11 04:11:35.548699
NCT01362933|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2015-03-05|||May 2011||2011-05-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Observational|CARMEN||National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients|National Evaluation of the Adherence to Recommendations of VTE Treatment in Cancer Patients|Completed||N/A|502|Actual|Floralis|||1||f||||f||||||||||2017-10-11 04:11:36.514442|2017-10-11 04:11:36.514442
NCT01362920|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-06|2013-02-15|||April 2011||2011-04-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|PCT||Diagnostic and Prognostic Value of Serial Procalcitonin (PCT) Measurements in Critically Ill Patients|Diagnostic and Prognostic Value of Serial PCT Measurements in Critically Ill Patients|Completed||N/A|300|Actual|The Cleveland Clinic|||2||f||||f||||||||||2017-10-11 04:11:36.96127|2017-10-11 04:11:36.96127
NCT01362907|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-06-28|2012-06-28||May 2011||2011-05-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Clinical Comparison of Silicone Hydrogel and HEMA-based Daily Disposable Contact Lenses||Completed||N/A|40|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 04:11:37.068536|2017-10-11 04:11:37.068536
NCT01362894|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-07-03|2012-07-03||May 2011||2011-05-01|July 2012|2012-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Clinical Comparison of Two Daily Disposable Toric Lenses|Clinical Comparison of Two Daily Disposable Toric Lenses|Completed||N/A|240|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 04:11:37.33637|2017-10-11 04:11:37.33637
NCT01362881|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-08-31|||January 2012|Actual|2012-01-01|June 2017|2017-06-01|August 31, 2017|Actual|2017-08-31|February 2016|Actual|2016-02-01||Observational|||Study of the Surgical Treatment of Early Onset Scoliosis Using a Non-invasive Growing Rod|A Prospective Cohort Study of the Surgical Treatment of Early Onset Scoliosis Using a Remotely Expandable Device for Non-invasive Lengthening of a Growing Rod (Magec™) and Its Performance in Prevention of Progression of Scoliosis.|Completed||N/A|14|Actual|Ellipse Technologies, Inc.|||1||f||||f||||||||||2017-10-11 04:11:37.593851|2017-10-11 04:11:37.593851
NCT01362868|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-11-08|||May 2011||2011-05-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Water Drinking Test During Intraocular Pressure Fluctuation (IOP) Monitoring|Water Drinking Test (WDT) During Continuous Recording of Intraocular Pressure Fluctuation|Terminated||N/A|32|Anticipated|Sensimed AG||1||Too low effect on the output and low rate of responders|f||||f||||||||||2017-10-11 04:11:37.778971|2017-10-11 04:11:37.778971
NCT01362855|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-02-09|||September 2011||2011-09-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Observational|ACCEPT||Advance Care Planning Evaluation in Hospitalized Elderly Patients|Advance Care Planning Evaluation in Hospitalized Elderly Patients: A Multicenter, Prospective Study|Unknown status|Recruiting|N/A|900|Anticipated|Clinical Evaluation Research Unit at Kingston General Hospital|||1||f||||f||||||||||2017-10-11 04:11:37.861395|2017-10-11 04:11:37.861395
NCT01362842|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2011-05-27|||January 2011||2011-01-01|December 2010|2010-12-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Observational|||Psychological and Physical Distress and Care Needs in Operable Lung Cancer Patients Receiving Surgery|Psychological and Physical Distress and Care Needs in Operable Lung Cancer Patients Receiving Surgery|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 04:11:37.948587|2017-10-11 04:11:37.948587
NCT00000560|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-12|||June 1994||1994-06-01|April 2005|2005-04-01|September 1999||1999-09-01|||||Interventional|||Beta-Blocker Evaluation in Survival Trial (BEST)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.5733|2017-10-11 04:19:04.5733
NCT01362829|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-06-20|||August 2009||2009-08-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation|Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation|Completed||N/A|90|Actual|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"     For each patient enrolled, 10mL blood is collected in EDTA-coated tube, which will be used     for plasma separation and for peripheral blood mononuclear cell collection.   "|||2017-10-11 04:11:38.048783|2017-10-11 04:11:38.048783
NCT01362816|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2016-08-01|||June 2011||2011-06-01|July 2016|2016-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|EPCCS||The European Palliative Care Cancer Symptom Study (EPCCS)|The European Palliative Care Cancer Symptom Study (EPCCS). A Prospective Data Collection|Completed||N/A|1739|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 04:11:38.14231|2017-10-11 04:11:38.14231
NCT01362803|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2017-08-04|||May 11, 2011||2011-05-11|July 26, 2017|2017-07-26|July 2, 2024|Anticipated|2024-07-02|September 10, 2019|Anticipated|2019-09-10||Interventional|||AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors|A Phase 1/2 Study of the Mitogen Activated Protein Kinase Kinase(MEK) 1 Inhibitor Selumetinib (AZD6244, Hydrogen Sulfate) in Children With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)|Recruiting||Phase 1/Phase 2|104|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:11:38.223561|2017-10-11 04:11:38.223561
NCT01362777|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-09-19|||November 2007||2007-11-01|September 2011|2011-09-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|Rehsolvas||Rehabilitation Program as an Alternative Therapy for Moderate to Severe Obstructive Sleep Apnea Syndrome|Effects of an In-Patient Individualized Rehabilitation Program on Severity and Symptoms of Obstructive Sleep Apnea Syndrome (OSAS):Results of a Randomized Controlled Pilot Study|Completed||Phase 3|26|Actual|5 Santé||2|||f||||f||||||||||2017-10-11 04:11:38.472747|2017-10-11 04:11:38.472747
NCT01362764|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-27|2012-11-26|||May 2011||2011-05-01|November 2012|2012-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers|A Single-Dose, Open-Label, Randomized, Crossover Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation Under Fasted Condition in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Cougar Biotechnology, Inc.||3|||f||||f||||||||||2017-10-11 04:11:38.571548|2017-10-11 04:11:38.571548
NCT01362751|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-07|2012-09-02|||October 2010||2010-10-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Orthostatic Hypotension in Elderly Nursing Home Residents||Completed||N/A|290|Actual|Medical Research Foundation, The Netherlands|||1||f||||f||||||||||2017-10-11 04:11:38.641558|2017-10-11 04:11:38.641558
NCT01362738|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-04-25|||November 2010||2010-11-01|October 2016|2016-10-01|November 2016|Actual|2016-11-01|June 2014|Actual|2014-06-01||Interventional|BELIEF||Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation|Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation|Completed||Phase 3|156|Anticipated|Texas Cardiac Arrhythmia Research Foundation||2|||f||||f||||||||||2017-10-11 04:11:38.712759|2017-10-11 04:11:38.712759
NCT01362725|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-07-19|||April 2011||2011-04-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|August 2014|Actual|2014-08-01||Interventional|SCS HEART||Spinal Cord Stimulation For Heart Failure|Spinal Cord Stimulation For Heart Failure As A Restorative Treatment|Completed||Phase 2/Phase 3|20|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 04:11:38.789741|2017-10-11 04:11:38.789741
NCT01362712|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2012-05-17|||May 2011||2011-05-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Interventional|||Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects|An Exploratory, Phase I, Open Label, Multi-Center, Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects|Terminated||Phase 1|7|Actual|Siemens Molecular Imaging||1||Unable to enroll breast cancer patients with current I/E criteria.|f||||f||||||||||2017-10-11 04:11:38.887008|2017-10-11 04:11:38.887008
NCT01362699|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-04-27|||August 2011||2011-08-01|April 2012|2012-04-01|August 2012|Anticipated|2012-08-01|||||Interventional|||Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults|A Single Center, Randomized, Double Blind, Placebo Controlled, Parallel Group Study of the Efficacy of JNJ 31001074 on Cue Induced Craving for Alcohol in Adult Subjects With Alcohol DependenceH3 Alcoholism|Withdrawn||Phase 2|0|Actual|Janssen Research & Development, LLC||2||Re-prioritization lead to study cancellation.|f||||t||||||||||2017-10-11 04:11:38.964181|2017-10-11 04:11:38.964181
NCT01362686|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-01-08|2016-07-22||April 2011||2011-04-01|January 2017|2017-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|COMET-AD||Comparative Research of Alzheimer's Disease Drugs|Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs|Terminated||N/A|200|Actual|Indiana University|Small sample size limits generalizability and may introduce type II error. The study took place at a time when most third-party payers declared donepezil the preferred AChEI due to cost that may have influenced study’s results.|3||Low study accrual caused the study to be ended early.|f||||t||||||||||2017-10-11 04:11:39.087585|2017-10-11 04:11:39.087585
NCT01362673|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-10-05|||May 2011||2011-05-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions|A Phase 1, Randomized, Subject- And Investigator Blind, Sponsor Open, Placebo Controlled, Single- And Multiple-Dose Escalation Study Of PF-04171327 In Healthy Adult Japanese And Western Subjects In Fasting And Fed Conditions|Completed||Phase 1|27|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:11:39.660445|2017-10-11 04:11:39.660445
NCT00000561|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-22|||June 1995||1995-06-01|May 2005|2005-05-01|May 2002||2002-05-01|||||Interventional|||Mode Selection Trial in Sinus Node Dysfunction (MOST)||Completed||Phase 3|||Mt. Sinai Medical Center, Miami|||||f||||||||||||||2017-10-11 04:19:04.638181|2017-10-11 04:19:04.638181
NCT01362660|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2013-02-05|||June 2011||2011-06-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||A Study to Evaluate Infants With Potential Exposure to Tanezumab Before Birth|A Protocol to Monitor the Neurological Development of Infants With Exposure In-utero From Birth to Aged 15 Months in Tanezumab Clinical Studies at Investigational Sites Overseen by Schulman and Associates Institutional Review Board|Completed||N/A|7|Actual|Pfizer|||1||f||||t||||||||||2017-10-11 04:11:39.76722|2017-10-11 04:11:39.76722
NCT01362647|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-10-04|||May 2011||2011-05-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Postoperative Residual Curarisation at Arrival in the Post-anesthesia Care Unit|A Non-interventional / Observational Study on Postoperative Residual Curarisation at Arrival in the Post-anesthesia Care Unit After Spontaneous Recovery or After Reversal of the Neuromuscular Block|Completed||N/A|625|Actual|Onze Lieve Vrouw Hospital|||1||f||||f||||||||||2017-10-11 04:11:39.863246|2017-10-11 04:11:39.863246
NCT01362634|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-03-27|||August 2011||2011-08-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|December 2015|Actual|2015-12-01||Interventional|||A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV|A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV|Active, not recruiting||N/A|750|Anticipated|Nova Southeastern University||3|||f||||t||||||||||2017-10-11 04:11:39.952593|2017-10-11 04:11:39.952593
NCT01362621|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-06-15|||February 2008||2008-02-01|June 2011|2011-06-01||||February 2010|Actual|2010-02-01||Observational|||Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma|A 2-year Prospective, Multi-center, Observational and Epidemiologic Outcomes Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma|Completed||N/A|474|Actual|Novartis|||1||f||||||||||Samples With DNA|"     A venous blood sample was collected at either screening (Visit 1) or enrollment (Visit 2).     These samples were collected for DNA extraction. The extracted DNA is stored at Novartis     Pharmaceuticals Corporation for pharmacogenetic analysis and storage.   "|||2017-10-11 04:11:40.057526|2017-10-11 04:11:40.057526
NCT01362608|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-06-07|2016-05-19||June 20, 2011|Actual|2011-06-20|June 2017|2017-06-01|May 19, 2015|Actual|2015-05-19|May 19, 2015|Actual|2015-05-19||Interventional|||Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective|A Randomized, Double-blind, Double-dummy, Active Controlled Study of Canakinumab (ACZ885) on the Treatment and Prevention of Gout Flares in Patients With Frequent Flares for Whom NSAIDs and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective|Terminated||Phase 3|136|Actual|Novartis|This study was terminated early. The decision to terminate study was not out of concerns for efficacy or safety of canakinumab|2|||f||||||||||||||2017-10-11 04:11:40.285091|2017-10-11 04:11:40.285091
NCT01362595|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2016-12-20|||June 2013||2013-06-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|LeucineDBA||Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia|The Use of Novel Therapies to Reconstitute Blood Cell Production and Promote Organ Performance Using Bone Marrow Failure as a Model: a Pilot, Phase I/II Study of the Amino Acid Leucine in the Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Northwell Health||1|||f||||t||||||||No||2017-10-11 04:11:41.873667|2017-10-11 04:11:41.873667
NCT01362582|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-25|2014-09-24|||March 2010||2010-03-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional|PANUSCO||Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer|Open-label Randomized Multicentre Phase IIIb Trial Comparing Parenteral Substitution Versus Best Supportive Nutritional Care in Patients With Pancreatic Cancer Receiving 2nd Line Chemotherapy|Terminated||Phase 3|32|Actual|National Center for Tumor Diseases, Heidelberg||2|||f||||t||||||||||2017-10-11 04:11:42.039297|2017-10-11 04:11:42.039297
NCT01362556|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2014-06-02|||March 2011||2011-03-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|BABICA||Blood Gas Analysis and Buffering In Cardiac Arrest|Blood Gas Analysis and Buffering In Cardiac Arrest - A Multicenter, Prospective, Randomised, Double Blind Prehospital Trial to Evaluate the Impact of Early Blood-gas-analysis Targeted Buffer Therapy on ROSC After OOHCA|Completed||N/A|700|Anticipated|Medical University of Graz||2|||f||||t||||||||||2017-10-11 04:11:42.232695|2017-10-11 04:11:42.232695
NCT01362543|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2014-05-13|||June 2011||2011-06-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Traumatized Refugees -Stress Management Versus Cognitive Re-structuring|Treatment With Cognitive Behavioural Therapy in Traumatised Refugees - Stress Management Versus Cognitive Restructuring - a Randomised Clinical Trial|Completed||Phase 3|143|Actual|Mental Health Services in the Capital Region, Denmark||2|||f||||t||||||||||2017-10-11 04:11:42.335103|2017-10-11 04:11:42.335103
NCT01362530|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-04-24|2014-02-24||September 13, 2011|Actual|2011-09-13|April 2017|2017-04-01|August 16, 2013|Actual|2013-08-16|March 14, 2013|Actual|2013-03-14||Interventional||Intent-to-treat (ITT) population: all randomized participants who received study medication.|A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)|A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial, Conducted Under In-House Blinding Conditions, to Examine the Efficacy and Safety of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Patients|Completed||Phase 3|307|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:11:42.448512|2017-10-11 04:11:42.448512
NCT01362517|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2013-08-29|2013-03-27||April 2010||2010-04-01|August 2013|2013-08-01|April 2011|Actual|2011-04-01|July 2010|Actual|2010-07-01||Interventional|||Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B|Assessment of the Immunogenicity and Safety of Quinvaxem Vaccine (DTwP-HepB-Hib) Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by H. Influenzae Among Healthy Vietnamese Children|Completed||Phase 3|131|Actual|Crucell Holland BV||1|||f||||f||||||||||2017-10-11 04:11:43.448164|2017-10-11 04:11:43.448164
NCT01362504|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-10-07|||May 2011||2011-05-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Observational|||Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis|Zekai Tahir Burak Maternity Teaching Hospital Neonatal Intensive Care Unit|Completed||N/A|80|Anticipated|Zekai Tahir Burak Women's Health Research and Education Hospital|||3||f||||f||||||||||2017-10-11 04:11:43.749481|2017-10-11 04:11:43.749481
NCT01362491|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-07-29|2013-03-07||June 2011||2011-06-01|July 2014|2014-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Ibuprofen Sodium Tension Headache Study|Ibuprofen Sodium Tension Headache Study|Completed||Phase 3|226|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 04:11:43.864925|2017-10-11 04:11:43.864925
NCT01362478|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2012-06-27|||August 2011||2011-08-01|June 2012|2012-06-01|July 2014|Anticipated|2014-07-01|||||Observational|||Gene Promoter DNA Methylations and Their Relationships With Endophenotypes in Patients With Schizophrenia|Gene Promoter DNA Methylations and Their Relationships With Endophenotypes in Patients With Schizophrenia|Unknown status|Recruiting|N/A|120|Anticipated|Taipei Medical University WanFang Hospital|||2||f||||f||||||Samples With DNA|"     Gene promoter DNA methylations   "|||2017-10-11 04:11:45.188507|2017-10-11 04:11:45.188507
NCT01362465|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2012-09-18|||June 2011||2011-06-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|ICM||Characterization of Interventricular Conduction Measurements|Characterization of Interventricular Conduction Measurements|Completed||Early Phase 1|25|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-10-11 04:11:45.255262|2017-10-11 04:11:45.255262
NCT01362452|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-08-02|||December 7, 2012|Actual|2012-12-07|August 2017|2017-08-01|July 25, 2017|Actual|2017-07-25|July 25, 2017|Actual|2017-07-25||Interventional|||Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells|Donor-Derived, CD19-Specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies After Umbilical Cord Blood Transplantation|Completed||Phase 1|5|Actual|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 04:11:45.320495|2017-10-11 04:11:45.320495
NCT01362439|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2013-04-29|2013-02-14||January 2009||2009-01-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years|Efficacy and Tolerability of Flexible Doses of Paliperidone ER in Symptomatic Subjects With Schizophrenia With Duration of Illness < 10 Years|Completed||Phase 4|133|Actual|Janssen-Cilag S.p.A.||1|||f||||f||||||||||2017-10-11 04:11:45.417589|2017-10-11 04:11:45.417589
NCT01362426|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-03-09|||March 2011||2011-03-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)|A Quality Use of Medicine Clinical Registry to Assess Clinical Outcomes in Patients With Schizophrenia Treated With Intramuscular Injections of Paliperidone Palmitate|Completed||Phase 4|127|Actual|Janssen-Cilag Pty Ltd|||1||f||||||||||||||2017-10-11 04:11:45.743043|2017-10-11 04:11:45.743043
NCT01362413|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2015-03-27|||January 2011||2011-01-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Observational|Rebone-test||Validation of Laboratory Test for Predicting Bone Tissue Regeneration|Validation of Laboratory Test for Predicting Bone Tissue Regeneration in Patient Affected by Aseptic Pseudarthrosis and Treated With Platelet Gel|Completed||N/A|20|Actual|Istituto Ortopedico Rizzoli|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 04:11:45.827912|2017-10-11 04:11:45.827912
NCT01362400|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2014-05-16|||May 2011||2011-05-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer|A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer|Completed||Phase 2|226|Actual|Infinity Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 04:11:47.607288|2017-10-11 04:11:47.607288
NCT01362387|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2013-02-13|||April 2011||2011-04-01|May 2011|2011-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||R U OK? The Acceptability and Feasibility of New Communication Technologies for Follow-up After Medical Abortion|R U OK? The Acceptability and Feasibility of New Communication Technologies for Follow-up After Medical Abortion|Completed||N/A|999|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 04:11:47.854782|2017-10-11 04:11:47.854782
NCT01362374|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-08-22|||July 11, 2011|Actual|2011-07-11|August 2017|2017-08-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|||Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors|A Phase Ib, Open-label, Dose-escalation Study of the Safety and Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|123|Actual|Genentech, Inc.||4|||f||||||||||||||2017-10-11 04:11:47.945512|2017-10-11 04:11:47.945512
NCT01362361|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2012-04-05|||June 2011||2011-06-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|AIO-KRK-0111||TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)|TRICC-C: A Multicenter, Randomized, Phase II Trial: BIBF 1120 vs. Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)|Unknown status|Recruiting|Phase 2|2|Anticipated|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-10-11 04:11:48.114195|2017-10-11 04:11:48.114195
NCT01362348|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-08-23|2017-07-18|2012-10-04|July 7, 2011|Actual|2011-07-07|August 2017|2017-08-01|April 16, 2012|Actual|2012-04-16|April 16, 2012|Actual|2012-04-16||Interventional|||12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)|An Open-label, Phase 2a Study to Evaluate Pazopanib Eye Drops Administered for 12 Weeks to Patients With Neovascular Age-related Macular Degeneration|Terminated||Phase 2|19|Actual|GlaxoSmithKline||1||Lack of efficacy identified during a preliminary analysis|f||||f||||||||||2017-10-11 04:11:48.39302|2017-10-11 04:11:48.39302
NCT01362335|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2013-01-15|||May 2011||2011-05-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Nexfin®-Monitoring System|Electronic Registration of Noninvasively Acquired Hemodynamic Parameters Using Nexfin®-Monitoring System|Completed||N/A|120|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-10-11 04:11:49.046055|2017-10-11 04:11:49.046055
NCT00000562|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||June 1974||1974-06-01|January 2000|2000-01-01|November 1979|Actual|1979-11-01|||||Interventional|||Extracorporeal Support for Respiratory Insufficiency (ECMO)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.712965|2017-10-11 04:19:04.712965
NCT01362296|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-06-26|2013-06-06||September 2011||2011-09-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer|A Phase II, Open-label, Multicenter, Randomized Study to Assess the Efficacy and Safety of GSK1120212 Compared With Docetaxel in 2nd Line Subjects With Targeted Mutations (KRAS, NRAS, BRAF, MEK1) in Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC Stage IV)|Completed||Phase 2|134|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 04:11:49.386057|2017-10-11 04:11:49.386057
NCT01362283|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-11-30|||August 2010||2010-08-01|November 2016|2016-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|WONDeR||Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients|A Multi-center, Observational, Cross-sectional Study to Evaluate CVD Risk Factors in Korean Hypertensive Patients|Completed||N/A|3109|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 04:11:52.236312|2017-10-11 04:11:52.236312
NCT01362270|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-05-18|||July 2011||2011-07-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2015|Actual|2015-07-01||Interventional|||Acupuncture for Sedation in the Intensive Care Unit (ICU)|Acupuncture for Sedation in the Intensive Care Unit|Active, not recruiting||Phase 4|60|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 04:11:52.310069|2017-10-11 04:11:52.310069
NCT01362257|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-06-26|||April 29, 2011|Actual|2011-04-29|June 2017|2017-06-01|June 22, 2011|Actual|2011-06-22|June 22, 2011|Actual|2011-06-22||Interventional|||A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719|An Open-label, Two Period Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719, Administered as Single Dose of an Oral Solution and an Intravenous Infusion, to Healthy Male Adults|Completed||Phase 1|6|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:11:52.401071|2017-10-11 04:11:52.401071
NCT01362244|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2016-02-25|2015-11-23||May 2009||2009-05-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Mepolizumab in Nasal Polyposis|A Two-Part, Randomised, Double-Blind, Placebo Controlled, Multi-Center Study To Investigate The Use Of Mepolizumab (Sb-240563) In Reducing The Need For Surgery In Subjects With Severe Bilateral Nasal Polyposis|Completed||Phase 2|109|Actual|GlaxoSmithKline|Part B was removed due to the low numbers of participants enrolling into Part B. GSK determined it was no longer feasible to achieve a meaningful number of participants and therefore recruitment into this portion of the study was stopped.|3|||f||||t||||||||||2017-10-11 04:11:52.684292|2017-10-11 04:11:52.684292
NCT01362231|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-12|2015-07-07|||December 2010||2010-12-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis|A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-6624 in Adult Subjects With Idiopathic Pulmonary Fibrosis|Completed||Phase 1|48|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 04:11:55.849019|2017-10-11 04:11:55.849019
NCT01362218|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2013-04-23|||October 2010||2010-10-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol|Cardiovascular Fixed Combination Pill ASR: Pharmacodynamic Clinical Trial of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril (Cardiovascular Polypill); LDL Cholesterol|Terminated||Phase 2|107|Actual|Ferrer Internacional S.A.||2||Per sponsor's decision|f||||||||||||||2017-10-11 04:11:55.944084|2017-10-11 04:11:55.944084
NCT01362205|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-24|2017-06-19|2017-05-16||March 2012||2012-03-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|December 2015|Actual|2015-12-01||Interventional|||Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Dexmedetomidine (Precedex®), With Lorazepam Rescue, for the Management of Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)|Terminated||Phase 4|49|Actual|Denver Health and Hospital Authority|Early termination due to slow enrollment leading to small numbers of subjects analyzed|2||DSMB recommendation for slow enrollment|f||||t||||||||No||2017-10-11 04:11:56.04439|2017-10-11 04:11:56.04439
NCT01362192|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2015-01-26|2013-06-17||May 2011||2011-05-01|January 2015|2015-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Treatment of Lower Extremity Spider Veins With Excel V|A Clinical Evaluation of the Treatment of Lower Extremity Spider Veins Using a Dual Wavelength Laser Emitting 532 nm and 1064 nm Laser Energy|Completed||Phase 4|20|Actual|Cutera Inc.||1|||f||||f||||||||||2017-10-11 04:11:56.789115|2017-10-11 04:11:56.789115
NCT01362179|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-06-13|||October 2010||2010-10-01|October 2016|2016-10-01|September 30, 2020|Anticipated|2020-09-30|September 30, 2020|Anticipated|2020-09-30||Observational|LTDFU||National Marrow Donor Program Long-Term Donor Follow-Up|Incidence of Hematologic and Non-Hematologic Malignancies, Thrombotic Events, and Autoimmune Disorders in Unrelated Normal Donors Undergoing Bone Marrow Harvest Versus Peripheral Blood Stem Cell Mobilization With Recombinant Human Granulocyte Colony-Stimulating Factor (rHuG-CSF)|Active, not recruiting||N/A|21932|Anticipated|Center for International Blood and Marrow Transplant Research|||2||f||||t||||||||||2017-10-11 04:11:57.075653|2017-10-11 04:11:57.075653
NCT01362166|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-05-27|||May 2011||2011-05-01|May 2011|2011-05-01||||||||Observational|YCFR||Frequency Response of the Foot-Yangming Stomach Channel: Zu-San-Li and Xian-Gu|With Different Frequency Electric Signals Study the Frequency Response of the Foot-Yangming Stomach Channel: Zu-San-Li and Xian-Gu|Unknown status|Recruiting|N/A|30|Anticipated|China Medical University Hospital|||1||f||||t||||||||||2017-10-11 04:11:57.224197|2017-10-11 04:11:57.224197
NCT01362153|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-10|2017-09-28|||December 26, 2007|Actual|2007-12-26|September 2017|2017-09-01|February 27, 2009|Actual|2009-02-27|February 27, 2009|Actual|2009-02-27||Interventional|||A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)|An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis|Completed||Phase 1|49|Actual|Centocor, Inc.||2|||f||||f||f||||||||2017-10-11 04:11:57.305766|2017-10-11 04:11:57.305766
NCT01362127|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-02-17|||October 2006||2006-10-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2013|Actual|2013-06-01||Interventional|NeoRes||Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia|Adjuvant Treatment of Cancer of the Esophagus or Cardia Before Resection With Curative Intent. Comparative Study Between Chemotherapy and Radiochemotherapy|Active, not recruiting||Phase 2|180|Anticipated|Karolinska University Hospital||2|||f||||t||||||||||2017-10-11 04:11:58.491808|2017-10-11 04:11:58.491808
NCT01362114|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2012-04-16|||July 2010||2010-07-01|April 2012|2012-04-01|June 2012|Anticipated|2012-06-01|May 2012|Anticipated|2012-05-01||Interventional|||The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung|Phase 4 Study of The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung : A Randomized, Double Blind, Placebo-control Trial|Unknown status|Recruiting|Phase 4|160|Anticipated|Korea Health Industry Development Institute||2|||f||||t||||||||||2017-10-11 04:11:58.585136|2017-10-11 04:11:58.585136
NCT01362101|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2013-07-09|||July 2010||2010-07-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|physio||Effect of Behavioral Training on Physiological Responses to Smoking Cues, Affect and Cortisol|Effect of Behavioral Training on Physiological Responses to Smoking Cues, Affect and Cortisol|Completed||Phase 4|56|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 04:11:58.676951|2017-10-11 04:11:58.676951
NCT01362088|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2012-10-31|||September 2011||2011-09-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Microcirculation in Continuous Venovenous Hemofiltration Patients on the Intensive Care Unit|Evaluation of Sublingual Microcirculation by Means of SDF Imaging by Stepwise Ultrafiltration in CVVH Patients on the ICU|Completed||N/A|14|Actual|Medical Centre Leeuwarden|||1||f||||f||||||||||2017-10-11 04:11:58.762688|2017-10-11 04:11:58.762688
NCT01362075|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2014-08-07|||July 2011||2011-07-01|August 2014|2014-08-01|October 2014|Anticipated|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Pain Management After Shoulder Prosthesis: A Clinical Trial of Nerve Block and Local Infiltration|Pain Management After Shoulder Arthroplasty: A Randomised Clinical Trial of Interscalene Block and Local Infiltration Analgesia|Terminated||N/A|74|Actual|Horsens Hospital||2||After 3 years of recruitment, the study was stopped due to time constraints.|f||||f||||||||||2017-10-11 04:11:58.834533|2017-10-11 04:11:58.834533
NCT01362062|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2017-06-28|2016-03-03||October 26, 2010|Actual|2010-10-26|June 2017|2017-06-01|January 1, 2015|Actual|2015-01-01|January 1, 2015|Actual|2015-01-01||Observational||All enrolled participants who were considered evaluable for analysis.|Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy|A Study to Observe the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-biologic DMARD and/or Anti TNF Therapy.|Completed||N/A|110|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:11:58.963834|2017-10-11 04:11:58.963834
NCT01362049|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-05-01|2016-11-28||March 2010||2010-03-01|May 2017|2017-05-01|December 2013|Actual|2013-12-01|July 2011|Actual|2011-07-01||Interventional|||Mechanisms of Specific Trunk Exercises in Low Back Pain|Mechanisms of Specific Trunk Exercises in Low Back Pain|Completed||N/A|102|Actual|University of Vermont|The sample size was relatively small, providing adequate power for only comparing the matched to unmatched treatments (and not the stabilization vs. Movement System Impairment exercises).|4|||f||||t||||||||No||2017-10-11 04:12:00.105964|2017-10-11 04:12:00.105964
NCT01362036|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-23|2016-08-29|||April 2011||2011-04-01|August 2016|2016-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia|Phase 1 Open-Label Dose-Escalating Study Evaluating the Safety and Preliminary Efficacy of TXA127 in Patients With Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia|Terminated||Phase 1|2|Actual|Tarix Pharmaceuticals||1||Enrollment feasibility issues, new study in design|f||||f||||||||||2017-10-11 04:12:00.804435|2017-10-11 04:12:00.804435
NCT01362023|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2011-06-09|||May 2011||2011-05-01|May 2011|2011-05-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|EDAL2||Efficacy of an Educational School-based Intervention to Reduce Prevalence of Obesity in Childhood-EdAl-2|A Primary-school-based Study to Reduce Prevalence of Childhood Obesity in Terres de l'Ebre (Catalunya (Spain) - EDAL-Educació en Estils Saludables de Vida alimentació-2: Study Protocol for a Randomized Controlled Trial|Unknown status|Enrolling by invitation|N/A|800|Anticipated|University Rovira i Virgili||2|||f||||t||||||||||2017-10-11 04:12:00.894944|2017-10-11 04:12:00.894944
NCT01362010|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2013-08-14|||January 2012||2012-01-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients|Pilot, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study, to Evaluate the Tolerability and Safety of FXFM244 Antibiotic Foam and to Monitor Its Clinical Effect in Acne Vulgaris Patients|Completed||Phase 2|150|Actual|Foamix Ltd.||3|||f||||f||||||||||2017-10-11 04:12:00.988717|2017-10-11 04:12:00.988717
NCT01361997|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2016-08-17|||June 2011||2011-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination|Comparative Study of 70% Isopropyl Alcohol Against 2% Chlorhexidine- 70% Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination|Completed||Phase 3|1102|Actual|Universidad de Guanajuato||2|||f||||f||||||||||2017-10-11 04:12:01.083661|2017-10-11 04:12:01.083661
NCT01361984|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-07-18|||June 2011||2011-06-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography|Inspiratory Capacity and HRCT Comparison of Nebulized Arformoterol (Brovana) vs. Dry-powder Inhaler Salmeterol (Serevent)|Unknown status|Recruiting|Phase 4|20|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 04:12:01.177756|2017-10-11 04:12:01.177756
NCT01361971|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2013-09-17|||April 2011||2011-04-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|HOTAIR||Hyperbaric Oxygen Treatment Ameliorates Insulin Resistance|Hyperbaric Oxygen Treatment Ameliorates Insulin Resistance|Completed||N/A|20|Actual|University of Adelaide||1|||f||||f||||||||||2017-10-11 04:12:01.280332|2017-10-11 04:12:01.280332
NCT01361958|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-05-26|||February 1997||1997-02-01|May 2011|2011-05-01|September 1998|Actual|1998-09-01|November 1997|Actual|1997-11-01||Interventional|||Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol|Double-blind, Comparative, Randomized, Single Center, Between-subject, Dose-finding Clinical Trial to Compare 4 Doses of the Combination 17beta-estradiol/Nomegestrol Acetate Administered From Day 1 to Day 21 of the Menstrual Cycle on the Inhibition of Ovulation|Completed||Phase 2|38|Actual|Theramex||4|||f||||f||||||||||2017-10-11 04:12:01.348597|2017-10-11 04:12:01.348597
NCT01361945|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-05-05|||July 2011|Actual|2011-07-01|December 2015|2015-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer|A Phase I/ II, Multi-center, Open-label Study, to Evaluate the Efficacy of AUY922 in Combination With Lapatinib With Letrozole in Postmenopausal Patients With Locally Advanced or Metastatic ER+ , HER2 + Breast Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|Texas Tech University Health Sciences Center, El Paso||1||Closed due to no enrollment|f||||f||||||||No|the study has not been completed|2017-10-11 04:12:01.407893|2017-10-11 04:12:01.407893
NCT01361932|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2013-03-25|||November 2011||2011-11-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|January 2012|Actual|2012-01-01||Interventional|||Using Online Videos to Supplement Emergency Department Discharge Instructions|Speak Fast, Use Jargon, and Don't Repeat Yourself: Using Online Videos to Supplement Emergency Department Discharge Instructions|Completed||N/A|133|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 04:12:01.486939|2017-10-11 04:12:01.486939
NCT01361906|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2014-05-28|||September 2010||2010-09-01|May 2014|2014-05-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Sensomotoric Training on Neck/Scapular Pain in People With Visual Disability|Effects of Sensomotoric Training on Neck/Scapular Pain in People With Visual Disability|Completed||Phase 4|52|Actual|Centre for Rehabilitation Research, Örebro||2|||f||||f||||||||||2017-10-11 04:12:01.646772|2017-10-11 04:12:01.646772
NCT01361893|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-06-30|||December 2004||2004-12-01|June 2017|2017-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SIDS||Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)|Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)|Completed||N/A|616|Actual|University of Virginia||1|||f||||t||||||||||2017-10-11 04:12:01.834429|2017-10-11 04:12:01.834429
NCT01361880|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-06-30|||June 2011||2011-06-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SIDS||Reduce African-American Infant Mortality|Randomized Messaging Trial to Reduce African-American Infant Mortality|Completed||N/A|1200|Actual|University of Virginia||1|||f||||f||||||||||2017-10-11 04:12:01.922033|2017-10-11 04:12:01.922033
NCT01361867|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-05-23|2017-04-10||November 2009|Actual|2009-11-01|May 2017|2017-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Robotic Assessment of Lower Extremity Motor Learning|Robotic Assessment of Lower Extremity Motor Learning|Completed||N/A|15|Actual|Spaulding Rehabilitation Hospital|The study was based on pilot experiments (N=35) aimed to determine how to use the robot to perturb step length and step height during gait. In the actual study (N=15), the investigators assessed how individuals adapted to the perturbations.|1|||f||||f||t|f|f|f|||No||2017-10-11 04:12:02.007671|2017-10-11 04:12:02.007671
NCT01361854|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2015-05-22|2015-02-20||August 2011||2011-08-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||patients suspected of OSA|Comparison of 2 Different Hook-up Protocols to Perform Home-based Polysomnography|Comparison of 2 Different Hook-up Protocols to Perform Home-based Polysomnography|Completed||N/A|102|Actual|Centre Hospitalier Universitaire Saint Pierre||1|||f||||f||||||||||2017-10-11 04:12:02.219399|2017-10-11 04:12:02.219399
NCT01361841|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-05-26|||January 2009||2009-01-01|December 2010|2010-12-01|January 2013|Anticipated|2013-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma|Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma|Unknown status|Recruiting|N/A|141|Anticipated|Centre de recherche du Centre hospitalier universitaire de Sherbrooke||1|||f||||t||||||||||2017-10-11 04:12:02.502074|2017-10-11 04:12:02.502074
NCT01361828|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-05-26|||January 2010||2010-01-01|January 2010|2010-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Optic Nerve and Retinal Functions With Bevacizumab|Electrophysiological Assessment of Optic Nerve and Retinal Functions Following Intravitreal Injection of Bevacizumab (Avastin).|Completed||N/A|45|Actual|Cairo University|||1||f||||f||||||||||2017-10-11 04:12:02.620752|2017-10-11 04:12:02.620752
NCT01361815|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2015-02-01|||July 2011||2011-07-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)|A Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) for Subjects With MDD Who Complete/ Discontinued the CTP-0001-00 Protocol|Completed||Phase 3|75|Actual|Brainsway||1|||f||||t||||||||||2017-10-11 04:12:02.72312|2017-10-11 04:12:02.72312
NCT01361048|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-02-22|2013-11-18||December 2011||2011-12-01|February 2017|2017-02-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Interventional|||Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis|Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis|Completed||Phase 2|40|Actual|University of Alabama at Birmingham|pilot study|3|||f||||f||||||||||2017-10-11 04:12:18.383961|2017-10-11 04:12:18.383961
NCT01361802|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-04-30||2014-04-30|May 2011||2011-05-01|April 2014|2014-04-01||||August 2011|Actual|2011-08-01||Interventional|||Ambroxol Spray Sore Throat Study|A Multi-centre, Randomised, Double-blind, Placebo Controlled Parallel Group, Dose Finding Study to Assess the Efficacy and Safety of Ambroxol Spray (2.5mg, 5mg or 10mg) Versus Placebo for the Temporary Relief of Sore Throat Pain in Patients With Acute Pharyngitis|Completed||Phase 2|494|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 04:12:02.87104|2017-10-11 04:12:02.87104
NCT01361789|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-26|2011-05-26|||January 2004||2004-01-01|May 2011|2011-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined|COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined|Completed||Phase 4|93|Actual|Asker & Baerum Hospital||3|||f||||f||||||||||2017-10-11 04:12:03.010398|2017-10-11 04:12:03.010398
NCT01361776|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2015-11-17|||September 2011||2011-09-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Humoral Response to Tick-borne Encephalitis Vaccine in Elderly|Humoral Response to TBE Vaccine in Elderly (50+ Year Olds) After Changed Dosage Intervals/Number of Doses?|Completed||Phase 2/Phase 3|200|Actual|Sormland County Council, Sweden||4|||f||||t||||||||||2017-10-11 04:12:03.108894|2017-10-11 04:12:03.108894
NCT01361763|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-02-10|||June 2011||2011-06-01|December 2013|2013-12-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Interventional|SONICA||Safety Study of Dabigatran in CADASIL|Phase II, Randomized, Crossover, Single Blind, Safety Trial of DABIGATRAN Versus ASA for Preventing Ischaemic Brain Lesions in Patients Affected by CADASIL|Unknown status|Recruiting|Phase 2|50|Anticipated|S. Andrea Hospital||2|||f||||t||||||||||2017-10-11 04:12:03.208627|2017-10-11 04:12:03.208627
NCT01361750|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-26|||May 2011||2011-05-01|March 2011|2011-03-01|May 2013|Anticipated|2013-05-01|May 2012|Anticipated|2012-05-01||Interventional|||The Effects of Gastric Tube on the Quality of Life and Nutritional Status After Ivor-Lewis Esophagectomy|The Effects of Gastric Tube on the Quality of Life and Nutritional Status After Ivor-Lewis Esophagectomy: A Randomized Control Trial and Physiological Study|Unknown status|Recruiting|Phase 3|144|Anticipated|Peking University||2|||f||||t||||||||||2017-10-11 04:12:03.338867|2017-10-11 04:12:03.338867
NCT01361737|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-07-03|||January 1999||1999-01-01|May 2011|2011-05-01|May 2004|Actual|2004-05-01|January 1999|Actual|1999-01-01||Observational|||Serum Markers in Preeclamptic Women||Completed||N/A|||Oslo University Hospital|||1||f||||t||||||||||2017-10-11 04:12:03.422995|2017-10-11 04:12:03.422995
NCT01361711|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-09-14|||June 2011||2011-06-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia|A Phase 2 Trial of Alemtuzumab-Ofatumumab Combination in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 2|60|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 04:12:03.57781|2017-10-11 04:12:03.57781
NCT01361698|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-02-07|||February 2011||2011-02-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|IMR||Illness Management and Recovery (IMR) in Danish Community Mental Health Centres|Illness Management and Recovery (IMR) in Danish Community Mental Health Centres: Protocol of a Randomized, Assessor-blinded Multi-centre Clinical Trial of a Recovery-oriented Program for People With Schizophrenia or Bipolar Disorder|Completed||N/A|198|Actual|Mental Health Centre Copenhagen||2|||f||||f||||||||No||2017-10-11 04:12:03.680975|2017-10-11 04:12:03.680975
NCT01361685|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-06-08|||May 2011||2011-05-01|March 2016|2016-03-01|May 2021|Anticipated|2021-05-01|February 2021|Anticipated|2021-02-01||Observational|||Model 4396 Left Ventricular (LV) Lead Chronic Performance Study|Attain Ability® Family Left Ventricular Lead Chronic Performance Study|Active, not recruiting||N/A|367|Actual|Medtronic|||1||f||||f||||||||||2017-10-11 04:12:03.804114|2017-10-11 04:12:03.804114
NCT01361672|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-10-04|||May 2011||2011-05-01|October 2017|2017-10-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Model 4296 Left Ventricular (LV) Lead Chronic Performance Study|Attain Ability® Family Left Ventricular Lead Chronic Performance Study|Active, not recruiting||N/A|1141|Actual|Medtronic|||1||f||||f||||||||||2017-10-11 04:12:04.008729|2017-10-11 04:12:04.008729
NCT01361659|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-12|2011-07-11|||May 2007||2007-05-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|SWAAM||Shockwave Treatment for Advanced Angina in Maastricht|Shockwave Treatment for Advanced Angina in Maastricht (SWAAM-study).|Unknown status|Recruiting|N/A|60|Anticipated|Maastricht University Medical Center||1|||f||||f||||||||||2017-10-11 04:12:04.303967|2017-10-11 04:12:04.303967
NCT01361646|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-06-10|||June 2011||2011-06-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189||Completed||Phase 1|129|Actual|LG Life Sciences||3|||f||||||||||||||2017-10-11 04:12:04.377144|2017-10-11 04:12:04.377144
NCT01361633|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-05-18|2011-06-22||January 2008||2008-01-01|May 2012|2012-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly|The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly|Completed||Phase 2|51|Actual|Hartford Hospital|DCS dosing was 1 hour prior to testing, rather than 4-8; the sample had homogenous cognitive capabilities; repeatedly administering DCS may have enhanced cognitive functioning; the measures may not have adequately tapped hippocampal-based learning.|2|||f||||f||||||||||2017-10-11 04:12:04.446444|2017-10-11 04:12:04.446444
NCT01361620|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2013-10-29|2013-08-19||December 2007||2007-12-01|January 2011|2011-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|ARSENAL||Genotypic and Phenotypic Correlates of Resistance to Aspirin|Genotypic and Phenotypic Correlates of Resistance to Anti-platelet Actions of Aspirin in an At-risk Patient Population and in the General Population|Completed||N/A|190|Actual|George Washington University||1|||f||||f||||||||||2017-10-11 04:12:04.689304|2017-10-11 04:12:04.689304
NCT01361607|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-07-04||2016-06-24|May 2011||2011-05-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|SPRAY III||Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer|A Double Blind, Randomized, Placebo-controlled, Parallel Group Study of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy|Completed||Phase 3|399|Actual|GW Pharmaceuticals Ltd.||2|||f||||t||||||||||2017-10-11 04:12:04.83689|2017-10-11 04:12:04.83689
NCT01361594|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-03|2014-12-18|2014-12-18||June 2011||2011-06-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CABG|Only subjects that completed the study were accounted for in the baseline characteristics.|Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery|Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery|Completed||Phase 3|338|Actual|Emory University||2|||f||||t||||||||||2017-10-11 04:12:05.174367|2017-10-11 04:12:05.174367
NCT01361581|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-05-26|||January 2008||2008-01-01|May 2011|2011-05-01||||||||Observational|Citrate||Metabolic Aspects of Citrate Anticoagulation in Renal Replacement Therapy|Metabolic Aspects of Citrate Anticoagulation in Renal Replacement Therapy|Unknown status|Recruiting|N/A|120|Anticipated|Charles University, Czech Republic|||3||f||||f||||||Samples Without DNA|"     frozen plasma   "|||2017-10-11 04:12:05.483385|2017-10-11 04:12:05.483385
NCT01361568|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2014-05-20|2013-02-18||July 2011||2011-07-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery|A Multi-Center, Double-Randomized, Double Blind, Placebo Controlled Study to Evaluate the Analgesic Efficacy and Safety of Intravenous CR845 Dosed Preoperatively and Postoperatively in Patients Undergoing a Laparoscopic Hysterectomy|Completed||Phase 2|203|Actual|Cara Therapeutics, Inc.||2|||f||||f||||||||||2017-10-11 04:12:05.589959|2017-10-11 04:12:05.589959
NCT01361555|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2015-09-23||2015-09-23|August 2011||2011-08-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression|A Multicenter, Double-Blind, 58 Week Rollover Study to Assess the Safety and Tolerability of BMS-820836 in Patients With Treatment Resistant Major Depression|Terminated||Phase 2|789|Actual|Bristol-Myers Squibb||3||Failure to meet primary endpoint|f||||t||||||||||2017-10-11 04:12:09.254637|2017-10-11 04:12:09.254637
NCT01361542|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-01-25|||February 2011||2011-02-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population|Effect Of Anti TNF Alpha Therapy On Disease Activity And Bone Health, And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population|Completed||N/A|24|Actual|All India Institute of Medical Sciences, New Delhi||1|||f||||f||||||||||2017-10-11 04:12:11.082267|2017-10-11 04:12:11.082267
NCT01361529|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-26|||June 2009||2009-06-01|May 2011|2011-05-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Interventional|||Safety Study of FLP Injection to Treat Tumor Patients|Phase 1 Study of FLP Injection on Tumor Patients|Unknown status|Recruiting|Phase 1|30|Anticipated|Acea Bio (Hangzhou) Co., Ltd.||1|||f||||f||||||||||2017-10-11 04:12:11.168585|2017-10-11 04:12:11.168585
NCT01361516|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-05-25|||July 2011||2011-07-01|April 2011|2011-04-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Interventional|||Comparison of General Anaesthesia and Sedation on the Stone Fragmentation in Lithotripsy|Comparison of General Anaesthesia and Sedation on the Stone Fragmentation Efficacy of the Third Generation Lithotriptor|Unknown status|Not yet recruiting|N/A|180|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 04:12:11.250576|2017-10-11 04:12:11.250576
NCT01361503|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-19|2015-02-03|||April 2010||2010-04-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders|Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders|Completed||N/A|20|Actual|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-11 04:12:11.331744|2017-10-11 04:12:11.331744
NCT01361490|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-07-19|||November 2010||2010-11-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Observational|ARRO||Rehabilitating Overweight People Back to Working Life|Rehabilitating Overweight People Back to Working Life|Completed||N/A|405|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 04:12:11.411874|2017-10-11 04:12:11.411874
NCT01361477|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-05-25|||May 2011||2011-05-01|May 2011|2011-05-01|May 2012|Anticipated|2012-05-01|April 2012|Anticipated|2012-04-01||Observational|||Data Registry of Intensive Care Unit (ICU) Siamitra and Intensive Care Unit (ICU) Salad-Samung|Data Registry of ICU Siamitra and ICU Salad-Samung|Unknown status|Recruiting|N/A|1000|Anticipated|Mahidol University|||1||f||||f||||||||||2017-10-11 04:12:11.478842|2017-10-11 04:12:11.478842
NCT01361464|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-03-19|2013-11-15||May 2011||2011-05-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia|Phase 2 Trial of R115777 in Previously Untreated Older Adults With AML and Baseline Presence of a Specific 2-Gene Expression Signature Ratio|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)|Due to trial not meeting primary endpoint of at least 3 CR/CRi after 2 cycles, accrual was suspended. 1 year survival was not calculated, not relevant in the setting of a median survival of 6.6 months and with study not meeting its primary endpoint.|1|||f||||||||||||||2017-10-11 04:12:11.692827|2017-10-11 04:12:11.692827
NCT01361451|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-10-22|||January 2011||2011-01-01|November 2010|2010-11-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Observational|||Myotrace: An Evaluation of a Novel Critical Illness Monitoring System|Myotrace: A Phase II Evaluation of a Novel Critical Illness Monitoring System|Completed||N/A|120|Actual|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||Samples With DNA|"     It is envisaged that a subset of patients will have venous blood samples taken for future     analysis for inflammatory cytokines   "|||2017-10-11 04:12:12.129603|2017-10-11 04:12:12.129603
NCT01361438|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-08-31|||June 2011|Actual|2011-06-01|August 2017|2017-08-01|October 2017|Anticipated|2017-10-01|October 2014|Actual|2014-10-01||Interventional|LAL1509||De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients|A Multicenter Total Therapy Strategy for De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients. GIMEMA Protocol LAL1509, EudraCT Number 2010-019119-39|Active, not recruiting||Phase 2|60|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-10-11 04:12:12.228005|2017-10-11 04:12:12.228005
NCT01361425|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-27|||May 2011||2011-05-01|April 2011|2011-04-01|February 2013|Anticipated|2013-02-01|May 2012|Anticipated|2012-05-01||Interventional|METILDOPAPE||Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)|Effectiveness Of Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia: Randomized Placebo-Controlled Clinical Trial|Unknown status|Recruiting|Phase 4|200|Anticipated|Professor Fernando Figueira Integral Medicine Institute||2|||f||||t||||||||||2017-10-11 04:12:12.45877|2017-10-11 04:12:12.45877
NCT01361412|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-10-06|||March 2011||2011-03-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy|An Optional Research Study to Identify Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy in Subjects Already Enrolled in Clinical Study TR002|Completed||Phase 2|20|Anticipated|Circassia Limited||5|||f||||||||||||||2017-10-11 04:12:12.559943|2017-10-11 04:12:12.559943
NCT01361399|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2011-05-25|||November 2004||2004-11-01|May 2011|2011-05-01|May 2005|Actual|2005-05-01|||||Interventional|||Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold|A 4-arm, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled, Single Dose, Parallel Group Study Comparing Efficacy and Safety of a Fixed Combination of 500 mg Acetylsalicylic Acid + 4 mg Lidocaine With 500 mg Acetylsalicylic Acid and 4 mg Lidocaine Monotherapy as Well as Placebo in Adult Patients With Sore Throat Associated With a Common Cold.|Completed||Phase 3|1088|Actual|Bayer||4|||f||||f||||||||||2017-10-11 04:12:12.636873|2017-10-11 04:12:12.636873
NCT01361386|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2014-06-13|||June 2011||2011-06-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|EPICOR ASIA||Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia|Long-Term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia|Completed||N/A|13011|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:12:12.766307|2017-10-11 04:12:12.766307
NCT01361373|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-06|2011-05-26|||May 2010||2010-05-01|May 2011|2011-05-01|August 2012|Anticipated|2012-08-01|May 2012|Anticipated|2012-05-01||Interventional|||Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study||Unknown status|Recruiting|Phase 4|50|Anticipated|Shaare Zedek Medical Center||2|||f||||||||||||||2017-10-11 04:12:13.177311|2017-10-11 04:12:13.177311
NCT01361360|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-07-24|||May 2011||2011-05-01|July 2017|2017-07-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Permissive Hypercapnia and Brain Development in Premature Infants||Completed||N/A|10|Actual|Arkansas Children's Hospital Research Institute|||2||f||||||||||||||2017-10-11 04:12:13.276399|2017-10-11 04:12:13.276399
NCT01361347|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-24|2017-01-02|||February 2008||2008-02-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children|Phase 4 Study: Milk Oral Immunotherapy for Cow's Milk Allergy in School-aged Children|Completed||Phase 4|28|Actual|Tampere University Hospital||2|||f||||t||||||||||2017-10-11 04:12:13.343832|2017-10-11 04:12:13.343832
NCT01361334|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-03-14|||June 2011||2011-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PAZOPANIB-AML||Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible|Phase II Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible|Completed||Phase 2|20|Actual|University Hospital Muenster||1|||f||||t||||||||||2017-10-11 04:12:13.430643|2017-10-11 04:12:13.430643
NCT01361321|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2013-09-09|||June 2011||2011-06-01|September 2013|2013-09-01|October 2014|Anticipated|2014-10-01|June 2014|Anticipated|2014-06-01||Observational|||Bone Quality and Quantity Following Guided Bone Regeneration|Examining Bone Quantity and Quality Following Standard Guided Bone Regeneration Procedures|Unknown status|Recruiting|N/A|50|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples Without DNA|"     Reisdual bone tissue formed while preparing alveolar bone for dental implant (by drilling     with a trephine bur)   "|||2017-10-11 04:12:13.53209|2017-10-11 04:12:13.53209
NCT01361308|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-10-14|2013-07-16|2013-04-09|May 2011||2011-05-01|October 2015|2015-10-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|N30-003||Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)|A Phase 3, Twelve-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Mesafem (Paroxetine Mesylate) Capsules in the Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|614|Actual|Noven Therapeutics||2|||f||||t||||||||||2017-10-11 04:12:13.695889|2017-10-11 04:12:13.695889
NCT01361295|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-09-25|||March 2015||2015-03-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|March 2017|Actual|2017-03-01||Interventional|CE-AF||Cerebral Embolism (CE) in Catheter Ablation of Atrial Fibrillation (AF)|The Occurrence of Cerebral Embolism (CE) in Catheter Ablation of Atrial Fibrillation (AF) Using Two Different Ablation Catheters|Enrolling by invitation||N/A|70|Anticipated|Leiden University Medical Center||2|||f||||t||||||||||2017-10-11 04:12:15.251937|2017-10-11 04:12:15.251937
NCT01361282|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-03-08|||November 9, 2010|Actual|2010-11-09|March 2017|2017-03-01|September 9, 2016|Actual|2016-09-09|September 9, 2016|Actual|2016-09-09||Observational|||Using the Optovue OCT to Select IOL Power|Evaluation of Total Corneal Power Calculations for Intraocular Lens Selection Using the Optovue OCT in Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Patients|Terminated||N/A|50|Actual|Legacy Health System|||1|The DSAEK procedure was discontinued as the standard of care for the intended cohort.|f||||f||||||||||2017-10-11 04:12:15.459741|2017-10-11 04:12:15.459741
NCT01361269|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-25|||June 2011||2011-06-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|September 2011|Anticipated|2011-09-01||Interventional|||Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria|Multicentre Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in African Children|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|Zentopharm GmbH||1|||f||||f||||||||||2017-10-11 04:12:15.550368|2017-10-11 04:12:15.550368
NCT01361256|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2016-10-27|||May 2011||2011-05-01|October 2016|2016-10-01|May 2016|Anticipated|2016-05-01|April 2015|Anticipated|2015-04-01||Interventional|||Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration|Pilot Study of WA-NG Telescope Prosthesis in Patients With Central Vision Impairment Associated With End-stage Age-related Macular Degeneration|Withdrawn||Early Phase 1|0|Actual|VisionCare, Inc.||1||No participants enrolled|f||||f||||||||||2017-10-11 04:12:15.642921|2017-10-11 04:12:15.642921
NCT01361243|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-07-13|||April 2011||2011-04-01|July 2017|2017-07-01|February 1, 2018|Anticipated|2018-02-01|February 1, 2018|Anticipated|2018-02-01||Interventional|NOURISH+||NOURISH+: Nourishing Our Understanding of Role Modeling to Improve Support and Health|NOURISHing Families to Promote Healthy Eating and Exercise in Overweight Children|Active, not recruiting||N/A|800|Anticipated|Virginia Commonwealth University||2|||f||||t||||||||||2017-10-11 04:12:15.750061|2017-10-11 04:12:15.750061
NCT01361230|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-19|2011-05-25|||December 2009||2009-12-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|||IMPROVE Critical Care Study (Pilot)|PILOT STUDY: A Randomized Controlled Trial of Intensive Care Management of Sedation Using Patient Responsiveness in Critical Care IMPROVE Critical Care Study Pilot|Completed||N/A|74|Actual|GE Healthcare||2|||f||||f||||||||||2017-10-11 04:12:15.846609|2017-10-11 04:12:15.846609
NCT01361204|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2013-07-14|||May 2011||2011-05-01|July 2013|2013-07-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Anti-stress Effect of Theanine on Students During Long-term Pharmacy Practices|Measurement of Stress Symptom in Students During Long-term Pharmacy Practices and Evaluation of Anti-stress Effect of Theanine Consumption on Students|Completed||N/A|20|Actual|University of Shizuoka||1|||f||||t||||||||||2017-10-11 04:12:16.019694|2017-10-11 04:12:16.019694
NCT01361191|ClinicalTrials.gov processed this data on October 10, 2017|2008-04-14|2013-10-29|||June 2007||2007-06-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|R-MEGACHOP||Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma|Early Treatment Stratification Based on PET Scan Response to R-MEGACHOP Followed by R-MEGACHOP or R-IFE Plus Peripheral Autologous Stem Cell Transplant (PBSCT) in Patients With Poor Prognosis DLBCL|Completed||Phase 2|71|Actual|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||t||||||||||2017-10-11 04:12:16.139582|2017-10-11 04:12:16.139582
NCT01361178|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-02-01|2017-02-01||January 2011||2011-01-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement|Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement - Observational Arm|Completed||N/A|133|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 04:12:16.307955|2017-10-11 04:12:16.307955
NCT01361165|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-24|||September 2006||2006-09-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|||||Observational|||Data Analysis for 04-C-0234 Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of Its Effect on Bone Metabolism|Data Analysis for 04-C-0234 Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of Its Effect on Bone Metabolism|Completed||N/A|10|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:12:16.826727|2017-10-11 04:12:16.826727
NCT01361152|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-10-04|||April 1993||1993-04-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|March 1996|Actual|1996-03-01||Interventional|||Long-Term Comparison of Fixed- and Mobile-Bearing Total Knee Arthroplasties (TKAs) in Patients With OA ≤50 Years Old|Long-Term Comparison of Fixed- and Mobile-Bearing Total Knee Arthroplasties in Patients With Osteoarthritis Younger Than Fifty Years of Age|Completed||Phase 4|216|Actual|Ewha Womans University||2|||f||||f||||||||||2017-10-11 04:12:16.915459|2017-10-11 04:12:16.915459
NCT01361139|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2015-01-14|||August 2011||2011-08-01|June 2012|2012-06-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Observational|||Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)|Detection and Characterization of Cardio-Pulmonary Patho-Physiological States and Diseases by Transthoracic Parametric Doppler (TPD)|Completed||N/A|500|Actual|Echosense Ltd.|||1||f||||f||||||||||2017-10-11 04:12:17.026918|2017-10-11 04:12:17.026918
NCT01361126|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-04-03|2016-04-03|2015-11-05|July 2011||2011-07-01|April 2016|2016-04-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional||Safety Population|A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B|A Phase I/II Open-label, Multicenter, Safety and Efficacy Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Subjects With Hemophilia B|Completed||Phase 1/Phase 2|17|Actual|CSL Behring||2|||f||||t||||||||||2017-10-11 04:12:17.124548|2017-10-11 04:12:17.124548
NCT01361113|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2017-05-19|2017-03-30||June 2011||2011-06-01|May 2017|2017-05-01|January 2017|Actual|2017-01-01|January 2015|Actual|2015-01-01||Interventional|||Neoadjuvant Pazopanib in Renal Cell Carcinoma|Neoadjuvant Pazopanib: A Phase II Study to Evaluate the Effect on Disease Response and Recurrence and to Establish Predictive Biomarkers of Drug Activity in Renal Cell Carcinoma|Completed||Phase 2|21|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:12:17.578849|2017-10-11 04:12:17.578849
NCT01361100|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-08|2012-10-01|||December 2010||2010-12-01|October 2012|2012-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract|Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract|Unknown status|Recruiting|N/A|485|Anticipated|Centre Leon Berard||1|||f||||f||||||||||2017-10-11 04:12:17.938493|2017-10-11 04:12:17.938493
NCT01361087|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2016-02-04|||April 2011||2011-04-01|February 2016|2016-02-01||||December 2014|Actual|2014-12-01||Interventional|||Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome|Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With|Withdrawn||Phase 3|0|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||1||No outside recruitment of subjects from Main Atenolol VS Losartan NIH study|f||||f||||||||Undecided||2017-10-11 04:12:18.086103|2017-10-11 04:12:18.086103
NCT01361074|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2015-12-03|||January 2011||2011-01-01|September 2013|2013-09-01|January 2013|Actual|2013-01-01|May 2011|Actual|2011-05-01||Interventional|VARESAP||In Vivo Versus Augmented Reality Exposure for Small Animal Phobia|In Vivo Versus Augmented Reality Exposure for Small Animal Phobia Treatment: A Randomized Controlled Trial|Completed||N/A|60|Actual|Universitat Jaume I||2|||f||||f||||||||||2017-10-11 04:12:18.155447|2017-10-11 04:12:18.155447
NCT01361061|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-12-14|||June 2010||2010-06-01|December 2011|2011-12-01|September 2014|Anticipated|2014-09-01|December 2013|Anticipated|2013-12-01||Observational|||AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver|AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver- am Multicenter HCC- Surveillance Study|Unknown status|Recruiting|N/A|600|Anticipated|University Hospital Freiburg|||1||f||||f||||||Samples Without DNA|"     measurement of tumor markers AFP, AFP-L3 and DCP in serum samples every 6 months   "|||2017-10-11 04:12:18.264892|2017-10-11 04:12:18.264892
NCT00005349|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-06-18|||April 1991||1991-04-01|June 2013|2013-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|ECAC||Epidemiology of Coronary Artery Calcification||Completed||N/A|1736|Actual|University of Michigan|||1||f||||||||||||||2017-10-11 04:28:02.621961|2017-10-11 04:28:02.621961
NCT01361035|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-03-09|||June 2008||2008-06-01|March 2017|2017-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients|Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients|Completed||N/A|168|Actual|Tulane University||2|||f||||f||||||||||2017-10-11 04:12:18.682982|2017-10-11 04:12:18.682982
NCT01361022|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2013-10-31|||August 2011||2011-08-01|October 2013|2013-10-01||||November 2011|Actual|2011-11-01||Interventional|||To Assess the Bioequivalence of Brotizolam Tablets 250 Mcg vs. Lendormin Tablets 250 Mcg Administered to Healthy Adult Volunteers|A Randomized, Single-dose, Two-way Cross-over Study to Assess the Bioequivalence of Lendormin Tablets 0.25 mg (Delpharm Reims) vs. Lendormin Tablets 0.25 mg (Synmosa Biopharma Co. Ltd.) Administered to Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 04:12:18.775167|2017-10-11 04:12:18.775167
NCT01361009|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2014-05-07|2013-01-31||May 2011||2011-05-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients|Safety of Pramipexole Monotherapy or Combination Therapy in Chinese Patients With Parkinson¿s Disease: a 12 Week Post Marketing Surveillance|Completed||N/A|2017|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 04:12:18.87638|2017-10-11 04:12:18.87638
NCT01360996|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-25|2017-03-30|2016-04-19||August 2011||2011-08-01|March 2017|2017-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|BEYAZ-PCOS|oligomenorrhea and biochemical hyperandrogenism (total T >1.38 nmol/l or free androgen index [FAI] >3.87) and exclusion of other etiologies (non-classic congenital adrenal hyperplasia, androgen-secreting tumors, hyperprolactinemia, Cushing syndrome, thyroid dysfunction and primary ovarian insufficiency|Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism|Positive Clinical and Hormonal Effects of Ethinylestradiol Combined With Drospirenone (EE/DRSP) in Women With Polycystic Ovary Syndrome (PCOS): Impact of Body Weight and Relevance to Hyperandrogenism|Completed||Phase 4|64|Actual|Woman's|Limitations include evaluation after 24 weeks in a limited number of patients, The time may be too short and sample size too small to measure differences between normal and overweight PCOS women and the use of indirect measures of insulin action.|3|||f||||t||||||||No||2017-10-11 04:12:19.4682|2017-10-11 04:12:19.4682
NCT01360970|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-11-17|||September 2009||2009-09-01|November 2015|2015-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Hepatitis A Vaccine in Patients With Immunomodulating Drugs|Hepatitis A Vaccination in Patients With Rheumatoid Arthritis Treated With TNF-inhibitors and/or Methotrexate|Completed||Phase 2|68|Actual|Sormland County Council, Sweden||1|||f||||t||||||||||2017-10-11 04:12:19.921334|2017-10-11 04:12:19.921334
NCT01360957|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-11-17||||||February 2011|2011-02-01|June 2011|Actual|2011-06-01|||||Interventional|||Effect of Consumption of Black Cumin (Nigella Sativa L.) Water Extract on Weight Loss in Overweight Women||Withdrawn||N/A|0|Actual|Shahid Beheshti University of Medical Sciences||2||"Mahnaz Kazemipoor has not handed over human subject review board approval letter to her   colleague."|f||||f||||||||||2017-10-11 04:12:20.029122|2017-10-11 04:12:20.029122
NCT01360944|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-06-04|||May 2011||2011-05-01|June 2015|2015-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test|An Investigator-blind, Controlled Exploratory Study to Assess the Efficacy and Safety of Different Concentrations of Active Ingredients in the Project LAS 41004 Compared to a Bland Ointment and to Active Control in a Psoriasis- Plaque- Test|Completed||Phase 2|22|Actual|Almirall, S.A.||8|||f||||f||||||||||2017-10-11 04:12:20.114175|2017-10-11 04:12:20.114175
NCT01360931|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-05-27|||January 2011||2011-01-01|May 2011|2011-05-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||The Roles of Neutrophil Elastase in Lung Cancer|The Roles of Neutrophil Elastase in Lung Cancer|Unknown status|Recruiting|N/A|60|Anticipated|The University of Hong Kong|||2||f||||f||||||Samples With DNA|"     Small bronchial biopsy alongside with the corresponding Bronchoalveolar lavage and bronchial     aspirate will be collected in the same one bronchoscopy session   "|||2017-10-11 04:12:20.205684|2017-10-11 04:12:20.205684
NCT01360918|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-07-06|||May 2011||2011-05-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|CONTROL-AF||Concomitant Epicardial Pulmonary Vein Isolation in Patients With Atrial Fibrillation Undergoing Elective Cardiac Surgery|Concomitant Epicardial Pulmonary Vein Isolation in Patients With Atrial Fibrillation Undergoing Elective Cardiac Surgery|Terminated||N/A|2|Actual|Medisch Spectrum Twente||2||Inclusion rate insufficiënt|f||||f||||||||||2017-10-11 04:12:20.285832|2017-10-11 04:12:20.285832
NCT01360905|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2014-01-17|||May 2011||2011-05-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|July 2012|Actual|2012-07-01||Observational|||Study to Support Fetal Heart Rate and Uterine Contraction for Preterm Labor in Singleton and Multiple Pregnancies|Study to Determine the Equivalence of the Monica AN24 Monitor to Predicate Devices for (FHR) and (UC) During Pre-term Labor and Multiples|Terminated||N/A|8|Actual|Monica Healthcare Ltd|||1|Difficulty in recruiting|f||||f||||||||||2017-10-11 04:12:20.365135|2017-10-11 04:12:20.365135
NCT01360892|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-21|2011-05-24|||September 2010||2010-09-01|August 2010|2010-08-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Observational|PICTURE||Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography|Prediction of Incidence of Liver Cancer or PorTal Hypertension in Patients With Viral Hepatitis by Use of Real-time Tissue Elastography|Unknown status|Recruiting|N/A|1000|Anticipated|Japan Liver Oncology Group|||1||f||||t||||||||||2017-10-11 04:12:20.43588|2017-10-11 04:12:20.43588
NCT01360879|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-21|2011-05-25|||September 2010||2010-09-01|August 2010|2010-08-01|September 2013|Anticipated|2013-09-01|August 2013|Anticipated|2013-08-01||Observational|FIBROELAST||Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease|Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease|Unknown status|Recruiting|N/A|500|Anticipated|Japan Liver Oncology Group|||1||f||||t||||||Samples Without DNA|"     whole blood, serum, liver tissue   "|||2017-10-11 04:12:20.518456|2017-10-11 04:12:20.518456
NCT01360866|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-01-25|||October 2011||2011-10-01|January 2017|2017-01-01|May 2017|Anticipated|2017-05-01|April 2017|Anticipated|2017-04-01||Interventional|Orion||Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)|A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder, the Orion Trial|Active, not recruiting||Phase 3|3000|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t||||||||No||2017-10-11 04:12:20.614157|2017-10-11 04:12:20.614157
NCT01360853|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2016-08-02||2016-08-01|May 2011||2011-05-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|ONTRAC||Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer|A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer|Completed||Phase 3|160|Actual|Onconova Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 04:12:20.88633|2017-10-11 04:12:20.88633
NCT01360840|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2015-11-09|2015-07-24||April 2011||2011-04-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|April 2013|Actual|2013-04-01||Interventional|PERSEUS|All Subjects (ALL) analysis set included subjects who signed the Informed consent document.|EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer|A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Trial Investigating Two Doses of EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer (mCRPC)|Completed||Phase 2|180|Actual|EMD Serono||3|||f||||t||||||||||2017-10-11 04:12:21.169245|2017-10-11 04:12:21.169245
NCT01360827|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2014-06-16|||August 2010||2010-08-01|June 2014|2014-06-01||||April 2011|Actual|2011-04-01||Interventional|||EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck|Phase Ib Trial of Multiple-ascending Doses of EMD 1201081 in Combination With 5-FU/Cisplatin and Cetuximab in First-line Subjects With Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 1|13|Actual|Merck KGaA||2||Study terminated due to potential safety concerns in combination with platinum-based therapies|f||||f||||||||||2017-10-11 04:12:23.903274|2017-10-11 04:12:23.903274
NCT01360814|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2014-09-03|||January 2005||2005-01-01|September 2014|2014-09-01||||March 2009|Actual|2009-03-01||Interventional|||Structured Multidisciplinary Intervention or Standard Medical Care in Improving Quality of Life in Patients Receiving Active Cancer Treatment|A Structured Multidisciplinary Intervention to Improve Quality of Life of Patients Receiving Active Oncological Treatment: A Randomized Trial|Completed||N/A|160|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-10-11 04:12:24.004195|2017-10-11 04:12:24.004195
NCT01360801|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2014-04-08|||February 2011||2011-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||High Definition White Light Endoscopy and Narrow Band Imaging for the Assessment of Barrett's Disease After Endoscopic Therapy|High Definition White Light Endoscopy and Narrow Band Imaging for the Assessment of Barrett's Disease After Endoscopic Therapy|Terminated||N/A|21|Actual|Mayo Clinic|||1|enrollment moved very slowly which was not anticipated, and, funding issues|f||||f||||||||||2017-10-11 04:12:24.10023|2017-10-11 04:12:24.10023
NCT01360788|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-05-24|||February 2009||2009-02-01|May 2011|2011-05-01|February 2011|Actual|2011-02-01|||||Observational|GOLD||GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)|GOLD Stage I COPD: Is it Really a Disease ? Exercise Tolerance, Muscle Function and Response to Bronchodilation in GOLD Stage I COPD Patients|Completed||N/A|53|Actual|Laval University|||3||f||||t||||||Samples Without DNA|"     Muscle biopsies Venous blood samples   "|||2017-10-11 04:12:24.176387|2017-10-11 04:12:24.176387
NCT01360775|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-25|||January 2010||2010-01-01|October 2009|2009-10-01||||June 2012|Anticipated|2012-06-01||Interventional|atdom_nut||Nutritional Education for Dependant Patients|Intervention of Nutritional Education Addressed to Carers of Dependant Patients|Unknown status|Recruiting|Phase 1|200|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||||||||||||2017-10-11 04:12:24.281115|2017-10-11 04:12:24.281115
NCT01360762|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2016-02-04|||November 2011||2011-11-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study|Secondary Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients Using Pentamidine as a Prophylactic Agent: a Prospective Cohort Study|Completed||Phase 3|72|Actual|Institute of Tropical Medicine, Belgium||1|||f||||t||||||||||2017-10-11 04:12:24.35893|2017-10-11 04:12:24.35893
NCT01360749|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-04-12|||May 2011||2011-05-01|April 2012|2012-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal|Multicentre, Double-Blind Trial to Evaluate the Efficacy and Safety of Lambdalina vs Placebo as an Anesthetic for Laser Hair Removal|Completed||Phase 2|42|Actual|ISDIN||2|||f||||f||||||||||2017-10-11 04:12:24.467583|2017-10-11 04:12:24.467583
NCT01360736|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-06-12|||September 2009||2009-09-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|SAFEMIL||A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)|A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2|Active, not recruiting||N/A|186|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||t||||||||No||2017-10-11 04:12:24.566888|2017-10-11 04:12:24.566888
NCT01360723|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-26|||May 2011||2011-05-01|May 2011|2011-05-01||||May 2014|Anticipated|2014-05-01||Observational|||DNA Methylation and Arsenic-associated Urothelial Carcinoma|Comparison of DNA Methylation Between Urothelial Carcinoma and Healthy Controls|Unknown status|Recruiting|N/A|600|Anticipated|China Medical University Hospital|||2||f||||f||||||||||2017-10-11 04:12:24.681413|2017-10-11 04:12:24.681413
NCT01360710|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-02-01|||January 2012||2012-01-01|February 2012|2012-02-01||||January 2014|Anticipated|2014-01-01||Interventional|||The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension|The Effect of Moxonidine and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension: a Randomised, Double Blind, Active Comparator Clinical Trial|Unknown status|Recruiting|Phase 4|100|Anticipated|Baker IDI Heart and Diabetes Institute||2|||f||||||||||||||2017-10-11 04:12:24.813388|2017-10-11 04:12:24.813388
NCT01360697|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-07-31|||May 2011||2011-05-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|JADE-JA||An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients|A Multi-Centre Demonstration Project to Evaluate the Effectiveness and Acceptability of the Joint Asia Diabetes Evaluation (JADE) in Chinese Type 2 Diabetic Patients in Jiangsu and Anhui (JA), China|Unknown status|Active, not recruiting|N/A|4800|Anticipated|Asia Diabetes Foundation||2|||f||||t||||||||||2017-10-11 04:12:24.903972|2017-10-11 04:12:24.903972
NCT01360294|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2013-06-27|||September 2011||2011-09-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|SADQ||Development of Small Airway Disease Questionnaire|The Development of a Questionnaire to Assess Symptoms of Small Airways Disease in Patients With Asthma|Completed||N/A|65|Actual|University Medical Center Groningen|||2||f||||f||||||||||2017-10-11 04:12:38.426952|2017-10-11 04:12:38.426952
NCT01360684|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-25|||July 2010||2010-07-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Study of Axillary Skin Temperature as a Marker of Ovulation|Pilot Study of Measuring Axillary Skin Temperature, Using DuoFertility, as a Marker of Ovulation in 10 Women of Childbearing Age|Unknown status|Recruiting|N/A|10|Anticipated|Cambridge University Hospitals NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 04:12:25.034305|2017-10-11 04:12:25.034305
NCT01360671|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2012-05-24|||March 2012||2012-03-01|May 2012|2012-05-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn|An Open Label Single Arm, Single Centre Study to Investigate the Safety and Efficacy of IV Sildenafil in Neonates With Persistent Pulmonary Hypertension of the Newborn (PPHN)|Withdrawn||Phase 2|0|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 04:12:25.13449|2017-10-11 04:12:25.13449
NCT01360658|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2013-07-29|||June 2011||2011-06-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|IGUS||Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria|Phase 2 Multicentric Study Evaluating the Efficacy of Polyvalent Intravenous Immunoglobulins in Idiopathic Severe and Refractory Solar Urticaria|Completed||Phase 2|10|Actual|Centre Hospitalier Universitaire de Besancon||1|||f||||t||||||||||2017-10-11 04:12:25.232022|2017-10-11 04:12:25.232022
NCT01360645|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-10-26|2015-08-10|2014-05-01|July 2011||2011-07-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|Pyxis|Randomized sample were used. Randomized sample comprises all who were randomized in Phase B.|Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Pyxis Trial|Completed||Phase 3|826|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-10-11 04:12:25.453882|2017-10-11 04:12:25.453882
NCT01360632|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-11-30|2015-08-11|2014-10-14|June 2011||2011-06-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|Polaris||Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Two Fixed Doses of OPDC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Polaris Trial|Completed||Phase 3|1539|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-10-11 04:12:28.566957|2017-10-11 04:12:28.566957
NCT01360619|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-24|||June 2007||2007-06-01|October 2007|2007-10-01|October 2007||2007-10-01|September 2007|Actual|2007-09-01||Observational|||Clinical Study About Fat Measurement on Multifunction Keito by Comparison Versus Its Predicate K014009||Completed||N/A|177||Aguiflai Iberica, S.L.|||1||f||||f||||||||||2017-10-11 04:12:31.771371|2017-10-11 04:12:31.771371
NCT01360606|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-04-24|||September 2011||2011-09-01|April 2017|2017-04-01|June 2020|Anticipated|2020-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Stereotactic Body Radiation Therapy (SBRT) for Liver Mets|A Phase I Study of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases|Recruiting||Phase 1|18|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 04:12:31.845433|2017-10-11 04:12:31.845433
NCT01360593|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2017-06-23|||July 2011||2011-07-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Interventional|||Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma|Induction Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma A Prospective Evaluation in Patients With Locally Advanced Pancreas Cancer|Active, not recruiting||Phase 2|50|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 04:12:31.988684|2017-10-11 04:12:31.988684
NCT01360580|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2013-01-23|||January 2011||2011-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|February 2012|Actual|2012-02-01||Observational|Deglutube||Swallowing Disorders After Prolonged Mechanical Ventilation|Current Care Study of Incidence and Consequences of Swallowing Disorders After Invasive Mechanical Ventilation|Completed||N/A|138|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-11 04:12:32.106112|2017-10-11 04:12:32.106112
NCT01360567|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-04-27|||May 2011||2011-05-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia|Taipei City Hospital, Taipei, Taiwan|Completed||Phase 3|102|Actual|Taipei City Hospital||2|||f||||t||||||||||2017-10-11 04:12:32.183882|2017-10-11 04:12:32.183882
NCT01360554|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-12|2017-04-24|2016-09-07|2014-10-27|June 16, 2011||2011-06-16|April 2017|2017-04-01|September 14, 2015|Actual|2015-09-14|September 30, 2013|Actual|2013-09-30||Interventional|ARCHER 1009|The baseline analysis population included all treated participants.|ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer|Archer 1009:a Randomized, Double Blind Phase 3 Efficacy And Safety Study Of Pf-00299804 (Dacomitinib) Versus Erlotinib For The Treatment Of Advanced Non-small Cell Lung Cancer Following Progression After, Or Intolerance To, At Least One Prior Chemotherapy|Completed||Phase 3|878|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 04:12:32.372223|2017-10-11 04:12:32.372223
NCT01360541|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2016-07-05|||December 2010||2010-12-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|RF-DBG||Radiofrequency Ablation for Barrett Oesophagus With Low Grade Dysplasia|Endoscopic Radiofrequency Ablation for Barrett Oesophagus With Low Grade Dysplasia: a Randomised Controlled Trial vs Endoscopic Surveillance|Active, not recruiting||Phase 2|125|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 04:12:35.248421|2017-10-11 04:12:35.248421
NCT01360528|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-02-15|||February 2011||2011-02-01|February 2011|2011-02-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Observational|FALIPI||Serum Folic Acid Levels in Preterm Infants|Zekai Tahir Burak Maternity and Teaching Hospital|Completed||N/A|100|Actual|Zekai Tahir Burak Women's Health Research and Education Hospital|||3||f||||f||||||||||2017-10-11 04:12:35.355394|2017-10-11 04:12:35.355394
NCT01360515|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-02-01|||October 2010||2010-10-01|February 2012|2012-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||A Study of Disposable Transnasal Esophagoscope|A Novel Disposable Transnasal Esophagoscope: a Prospective Pilot Trial of Feasibility, Safety and Tolerance|Completed||N/A|50|Actual|Yonsei University|||1||f||||t||||||||||2017-10-11 04:12:35.4253|2017-10-11 04:12:35.4253
NCT01359917|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2011-06-09|||August 2006||2006-08-01|March 2006|2006-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome|Psychological Morbidity and Facial Volume in HIV Lipodystrophy:|Completed||N/A|50|Actual|NHS Lothian|||3||f||||t||||||||||2017-10-11 04:12:44.630502|2017-10-11 04:12:44.630502
NCT01360502|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2011-05-24|||December 2009||2009-12-01|September 2009|2009-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Safety of Capsule Endoscopy in Patients With Implantable Cardiac Devices|Safety of Capsule Endoscopy Using Human Body Communication in Patients With Cardiac Pacemakers and Implantable Cardiac Defibrillators|Completed||N/A|6|Actual|Yonsei University|||1||f||||t||||||||||2017-10-11 04:12:35.500178|2017-10-11 04:12:35.500178
NCT01360476|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-12-08|||August 2011||2011-08-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|AdDReaCH||Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients|Adjunct Vitamin D Therapy as a Means to Reduce the Disparity in Subclinical Target Organ Cardiac Damage Among Vulnerable Hypertensive Patients|Completed||N/A|354|Actual|Wayne State University||2|||f||||t||||||||||2017-10-11 04:12:35.566714|2017-10-11 04:12:35.566714
NCT01360463|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2016-08-15|||May 2009||2009-05-01|May 2011|2011-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|JAKPRO||Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia|Efficacy of Drug-HIV Counseling Among IDU at Methadone Clinics in Jakarta|Completed||Phase 2|276|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 04:12:35.658937|2017-10-11 04:12:35.658937
NCT01360450|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-13|2017-08-15|2017-06-09||July 2011||2011-07-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|July 2011|Actual|2011-07-01||Interventional||The gestational age of the infant and the birth weight were collected as baseline measurements|Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants|Efficacy of Clonidine in Reducing Iatrogenic-induced Opioid Dependence in Infants:|Terminated||Phase 2/Phase 3|12|Actual|Johns Hopkins University||2||The study was treminated because of low accural|f||||t||||||||||2017-10-11 04:12:35.749663|2017-10-11 04:12:35.749663
NCT01360437|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-06-21|||May 2011||2011-05-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention|Ticagrelor in Comparison to Prasugrel for Inhibition of Platelet Reactivity, in Patients With Acute Coronary Syndrome (ACS) Presenting Resistance to the Usual Clopidogrel Dose After PCI|Completed||Phase 3|44|Actual|University of Patras||2|||f||||f||||||||||2017-10-11 04:12:36.352527|2017-10-11 04:12:36.352527
NCT01360424|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2015-09-27|||May 2011||2011-05-01|September 2015|2015-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Teriparatide Treatment in Patients With Inherited Osteoporosis|Efficacy of Teriparatide Treatment in Patients With New Forms of Inherited Low-Turnover Osteoporosis|Completed||Phase 4|6|Actual|Helsinki University Central Hospital||1|||f||||f||||||||||2017-10-11 04:12:37.068739|2017-10-11 04:12:37.068739
NCT01360411|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-26|2012-09-04|||January 2007||2007-01-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|||Tissue Characterisation by Endoscopic GI-elastography|Tissue Characterisation Using Ultrasound Based Strain Imaging(Elastography)Examining Lesions in the Gastrointestinal Wall, Adjacent Lymph Nodes and Pancreatic Lesions|Completed||N/A|137|Actual|Haukeland University Hospital|||3||f||||f||||||Samples With DNA|"     Tissue samples are stored as pathological slides in the diognostic biobank of Dep. of     Pathology, Helse Bergen.   "|||2017-10-11 04:12:37.160509|2017-10-11 04:12:37.160509
NCT01360385|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-28|2012-09-11|||October 2010||2010-10-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|LuRVO||Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab|Objective Measurement of Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With a Vascular Endothelial Growth Factor Inhibitor.|Completed||N/A|24|Actual|Glostrup University Hospital, Copenhagen|||1||f||||f||||||||||2017-10-11 04:12:37.377273|2017-10-11 04:12:37.377273
NCT01360372|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-16|2015-03-10|||October 2010||2010-10-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates|The Effect Of Methylnaltrexone (Relistor™) on Gut Motility and Tolerance to Tube Feeding in Patients Treated With Opiate Therapy|Withdrawn||Phase 3|0|Actual|Drexel University||2||No eligible subjects identified|f||||t||||||||||2017-10-11 04:12:37.47972|2017-10-11 04:12:37.47972
NCT01360359|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2015-03-09|||May 2011||2011-05-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Recurrent Low Back Pain: Linking Mechanism to Outcomes (RCT)|Recurrent Low Back Pain: Linking Mechanism to Outcomes (RCT)|Completed||N/A|17|Actual|Drexel University||2|||f||||f||||||||||2017-10-11 04:12:37.578704|2017-10-11 04:12:37.578704
NCT01360346|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-04-23|||January 2012||2012-01-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients|Multicentric, Single Blind, Randomized Controlled Trial on Enteral Sedation Versus Intravenous Sedation in Critically Ill High-risk ICU Patients|Unknown status|Recruiting|Phase 3|300|Anticipated|University of Milan||2|||f||||t||||||||||2017-10-11 04:12:37.678932|2017-10-11 04:12:37.678932
NCT01360333|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-05-11|||May 2011||2011-05-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|OFVEX||Oral Fluid Volume Expansion|Oral Fluid: Absorption and Expansion of the Blood Volume|Completed||N/A|10|Actual|University Hospital, Linkoeping||1|||f||||f||||||||||2017-10-11 04:12:37.949398|2017-10-11 04:12:37.949398
NCT01360320|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-04-05|||November 2011||2011-11-01|April 2012|2012-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|MIRACLE||Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-|Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-|Recruiting||Phase 2|2941|Anticipated|Martin-Luther-Universität Halle-Wittenberg||2|||f||||t||||||||||2017-10-11 04:12:38.058373|2017-10-11 04:12:38.058373
NCT01360307|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-12-05|||June 2011||2011-06-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|CUDOS||Validation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) Scale|Psychometric Validation of the Spanish Version of the CUDOS Scale (Clinically Useful Depression Outcome Scale) in Major Depressive Disorder|Completed||N/A|330|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:12:38.306821|2017-10-11 04:12:38.306821
NCT01360281|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-05-23|||May 2011||2011-05-01|May 2011|2011-05-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Neuromuscular Electrical Stimulation and Strength Training in Patients With Knee Osteoarthritis|Neuromuscular Electrical Stimulation and Strength Training in Patients With Knee Osteoarthritis|Unknown status|Recruiting|N/A|34|Anticipated|Universidade Gama Filho||3|||f||||f||||||||||2017-10-11 04:12:38.507967|2017-10-11 04:12:38.507967
NCT01360268|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2011-05-24|||January 2011||2011-01-01|February 2011|2011-02-01|December 2013|Anticipated|2013-12-01|||||Observational|||The Metabolic Profile and Adipocytokine Alterations of Patients With HCV Infection Before and After HCV Therapy|"The Metabolic Profile and Adipocytokine Alterations of Patients With HCV Infection Before and After HCV Therapy"|Unknown status|Recruiting|N/A|100|Anticipated|Chang Gung Memorial Hospital|||1||f||||f||||||||||2017-10-11 04:12:38.626209|2017-10-11 04:12:38.626209
NCT01360255|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-12-14|||May 2010||2010-05-01|December 2011|2011-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)|AFP - L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital Freiburg|||1||f||||f||||||Samples Without DNA|"     measurement of tumor markers AFP, AFP-L3 and DCP in serum samples   "|||2017-10-11 04:12:38.717396|2017-10-11 04:12:38.717396
NCT01360216|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-09-25|||May 2011||2011-05-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|LARC||Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training|Cluster, Randomized Trial on Provider LARC Education and Training|Completed||N/A|1500|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 04:12:39.12864|2017-10-11 04:12:39.12864
NCT01360203|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-05-10|||October 2011||2011-10-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|BEAT-HF||Better Effectiveness After Transition - Heart Failure|Variations in Care: Comparing Heart Failure Care Transition Intervention Effects|Completed||N/A|1437|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 04:12:39.269183|2017-10-11 04:12:39.269183
NCT01360190|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2011-05-24|||August 1994||1994-08-01|May 2011|2011-05-01|August 1996|Actual|1996-08-01|August 1996|Actual|1996-08-01||Interventional|Lilly||Neurophysiologic Monitoring of Antidepressant Treatment|Neurophysiologic Monitoring of Antidepressant Treatment|Completed||Phase 4|24|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 04:12:39.394651|2017-10-11 04:12:39.394651
NCT01360177|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2016-07-18|||July 2010||2010-07-01|July 2016|2016-07-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers|Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers|Withdrawn||N/A|0|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 04:12:39.494755|2017-10-11 04:12:39.494755
NCT01360164|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-11-26|||January 2010||2010-01-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia|Phase I/II Study of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Shenzhen Beike Bio-Technology Co., Ltd.||1|||f||||t||||||||||2017-10-11 04:12:39.61591|2017-10-11 04:12:39.61591
NCT01360151|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-12|2011-05-27|||February 2011||2011-02-01|April 2011|2011-04-01|May 2011|Anticipated|2011-05-01|May 2011|Anticipated|2011-05-01||Interventional|||Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy||Unknown status|Recruiting|N/A|16|Anticipated|Seoul St. Mary's Hospital||3|||f||||t||||||||||2017-10-11 04:12:39.754823|2017-10-11 04:12:39.754823
NCT01360138|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-24|||May 2011||2011-05-01|May 2011|2011-05-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||A Clinical Comparison in Cervical Epidural Pressure Changes Between Midline and Paramedian Approaches|Advantages of the Paramedian Approach for Cervical Epidural Steroid Injections: A Clinical Comparison in Cervical Epidural Pressure Changes Between Midline and Paramedian Approaches|Unknown status|Recruiting|N/A|25|Anticipated|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-10-11 04:12:39.896025|2017-10-11 04:12:39.896025
NCT01360125|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-21|2016-04-14|||June 2011||2011-06-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy|S0106A, Proteomic Signatures Associated With Complete Response (CR) and Complete Continuous Response at One Year (CCR1) Following Cytarabine-Based Induction Chemotherapy in Younger Adult Patients (18-60 Years of Age) With a Newly Diagnosed Non-M3 AML|Completed||N/A|310|Actual|Southwest Oncology Group|||1||f||||f||||||||||2017-10-11 04:12:40.041487|2017-10-11 04:12:40.041487
NCT01360112|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-06-30|||April 16, 2011||2011-04-16|November 3, 2016|2016-11-03||||||||Observational|||Preventing the Spread of Malaria in Mali|Malaria Transmission Blocking Assay Development and Gametocyte Carriage in a Vaccine Testing Site in Mali|Completed||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:12:40.149544|2017-10-11 04:12:40.149544
NCT01360099|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-06-30|||May 4, 2011||2011-05-04|January 11, 2017|2017-01-11|January 11, 2017||2017-01-11|||||Observational|||Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study|Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study|Completed||N/A|120|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:12:40.237968|2017-10-11 04:12:40.237968
NCT00000563|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2012-04-26|||June 1976||1976-06-01|April 2012|2012-04-01|August 1983|Actual|1983-08-01|||||Interventional|||Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.765691|2017-10-11 04:19:04.765691
NCT01360086|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2016-05-27|||June 2011||2011-06-01|May 2016|2016-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction|Trial Evaluating the Efficacy and Tolerance of Perioperative Chemotherapy With 5FU-Cisplatin-Cetuximab in Adenocarcinomas of the Stomach and Gastroesophageal Junction. Phase II Single Arm, Multicenter.|Completed||Phase 2|65|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||f||||||||No||2017-10-11 04:12:40.335722|2017-10-11 04:12:40.335722
NCT01360073|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-11-13|||July 2011||2011-07-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death|Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death - Nested Case Control Analyses in a Cohort of Patients With Acute Serious Coronary Heart Disease|Completed||N/A|42542|Actual|AstraZeneca|||2||f||||||||||||||2017-10-11 04:12:40.689755|2017-10-11 04:12:40.689755
NCT01360060|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-05-24|||December 2010||2010-12-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Analgesia After Cesarean Section||Completed||N/A|503|Actual|Seoul National University Bundang Hospital|||2||f||||||||||||||2017-10-11 04:12:40.804841|2017-10-11 04:12:40.804841
NCT01360047|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-24|2012-11-13|||June 2011||2011-06-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death|Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death - Nested Case Control Analyses in a Cohort of First-time Users of Low Dose ASA for Secondary Prevention of Cerebrovascular and Cardiovascular Outcomes.|Completed||N/A|39513|Actual|AstraZeneca|||2||f||||||||||||||2017-10-11 04:12:40.90819|2017-10-11 04:12:40.90819
NCT01360034|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-01-01|||December 2015||2015-12-01|January 2015|2015-01-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Interventional|||Nifedipine Versus Indomethacin in the Treatment of Preterm Labour|Nifedipine vs. Indomethacin in the Treatment of Preterm Labour and Short Cervix. A Randomized, Controlled Trial.|Unknown status|Not yet recruiting|Phase 3|216|Anticipated|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-11 04:12:41.007991|2017-10-11 04:12:41.007991
NCT01360021|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-01-27|2013-07-19||November 2011||2011-11-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|BAI|All Randomized patients|New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day|A 12-week, Double-blind, Randomized, Multi-centre, Parallel-group Study Evaluating the Efficacy Safety, and Patient Use (User Study) of Symbicort® (Budesonide/Formoterol) Breath Actuated Metered Dose Inhaler (BA MDI) 2x160/4.5 μg Twice Daily Compared With Symbicort (Budesonide/Formoterol) AC (Actuation Counter) pMDI® 2x160/4.5 μg Twice Daily and Budesonide AC pMDI 2x160 μg Twice Daily in Adult and Adolescent Asthmatics|Completed||Phase 3|214|Actual|AstraZeneca|No. of participants in the safety analysis set is (71 for all the group) as 1 patients from the Budesonide group has not taken any dose of the IP, so not included in the Safety population.|3|||f||||||||||||||2017-10-11 04:12:41.132443|2017-10-11 04:12:41.132443
NCT01360008|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-06-16|||April 2011||2011-04-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|January 2016|Actual|2016-01-01||Observational|||FREEZE Cohort Study|FREEZE Cohort Study|Active, not recruiting||N/A|4071|Actual|Stiftung Institut fuer Herzinfarktforschung|||2||f||||t||||||||Yes|De-identified patient data will be published after end of follow up period|2017-10-11 04:12:42.291383|2017-10-11 04:12:42.291383
NCT01359995|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-23|||November 2010||2010-11-01|May 2011|2011-05-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Observational|||Topical Ganciclovir in Patients Receiving Penetrating Keratoplasty With Cytomegalovirus Endotheliitis|Topical Ganciclovir in Patients Receiving Penetrating Keratoplasty With Cytomegalovirus Endotheliitis|Unknown status|Recruiting|N/A|7|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 04:12:42.480783|2017-10-11 04:12:42.480783
NCT01359982|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2015-05-19|||September 2011||2011-09-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|DINAMIC||Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects|A Phase I, Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of RRx-001 in Subjects With Advanced Solid Tumors or Lymphomas For Which There Are No Currently Accepted Curative Therapies|Completed||Phase 1|26|Actual|EpicentRx, Inc.||1|||f||||||||||||||2017-10-11 04:12:42.594093|2017-10-11 04:12:42.594093
NCT01359969|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-10-14|||December 2011||2011-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients|Open-label, Phase II, Single Arm Study to Evaluate the Safety, Immunogenicity, Pharmacokinetics and Efficacy of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema, From 2 up to and Including 13 Years of Age|Recruiting||Phase 2|20|Anticipated|Pharming Technologies B.V.||1|||f||||f||||||||||2017-10-11 04:12:42.728863|2017-10-11 04:12:42.728863
NCT01359956|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-04-01|||April 2002||2002-04-01|April 2014|2014-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|SICOG 0109||Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma|Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma: Phase III Study|Completed||Phase 3|269|Actual|National Cancer Institute, Naples||4|||f||||f||||||||||2017-10-11 04:12:42.914996|2017-10-11 04:12:42.914996
NCT01359943|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-02-12|2015-02-12||October 2011||2011-10-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate|A Randomized, Double-blind, Placebo-controlled Study of Efficacy, Safety and Tolerability of Secukinumab at 12 Weeks Administered With an Intravenous (i.v.) or Subcutaneous (s.c.) Loading Regimen Compared to Placebo in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate|Completed||Phase 2|221|Actual|Novartis||3|||f||||f||||||||||2017-10-11 04:12:43.07708|2017-10-11 04:12:43.07708
NCT01359930|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-01-11|||August 2011||2011-08-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study|Phase 1 Study of Interactions Between Oral Naltrexone and Bupropion and Intravenous Methamphetamine in Methamphetamine Experienced Volunteers|Completed||Phase 1|16|Anticipated|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-10-11 04:12:44.496866|2017-10-11 04:12:44.496866
NCT01359904|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2017-02-10|2014-03-25||May 2011||2011-05-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||forty subjects were needed to detect a difference in the mean change in the HbA1c from baseline to at the end of the study of 1% in the two dialysate concentration groups with a two-tailed t-test and variance of 1%, the required sample size will be 20 for each group with a power of 88% and alpha set at 0.05.|Effect of Dialysis Glucose Bath on Glycemic Control in Hemodialysis (HD)|The Effect of Glucose Concentration in the Dialysate Bath on Glycemic Control Among Hemodialysis Patients With Type 2 Diabetes Mellitus|Completed||N/A|33|Actual|McGill University Health Center|The study was only short term.|2|||f||||f||||||||No||2017-10-11 04:12:44.760458|2017-10-11 04:12:44.760458
NCT01359891|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2016-11-12|||November 2010||2010-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Observational|NOBIS||Clinical Evaluation of Novel Biomarkers in Patients With Septicemia|Clinical Evaluation of Novel Biomarkers for Diagnosis, Therapy- Monitoring and Prognosis of Outcome in Patients With Septicemia|Recruiting||N/A|750|Anticipated|Medical University of Graz|||3||f||||t||||||Samples Without DNA|"     Left over EDTA-whole blood samples will be used for both, the Presage™ST2 assay and the     suPARnostic™ assay except for the additional EDTA-whole blood samples taken on day 1 and 2 of     study enrollment being only tested for sST2.   "|||2017-10-11 04:12:45.168469|2017-10-11 04:12:45.168469
NCT01359878|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-09-19|||May 2011||2011-05-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|FIB-PPH||Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial|Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage - A Randomised Clinically Controlled Trial|Completed||Phase 2/Phase 3|249|Actual|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-10-11 04:12:45.269436|2017-10-11 04:12:45.269436
NCT01359865|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2015-09-30|||July 2012||2012-07-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Anesthetic Techniques on Total Hip Arthroplasty|The Influence of Anesthetic Technique on Post-operative Pain Scores and Range of Motion in Primary Total Hip Arthroplasty|Terminated||N/A|70|Anticipated|Milton S. Hershey Medical Center||1||change in clinical practice- both surgeons have left the institution|f||||t||||||||||2017-10-11 04:12:45.384499|2017-10-11 04:12:45.384499
NCT01359852|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-07-21|||December 2010||2010-12-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study of [11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult Volunteers|An Open-Label Study to Investigate the Dosimetry of the Positron Emission Tomography Ligand for the Metabotropic Glutamate Receptor-2 (mGlu2R), [11C]JNJ-42491293, and Displacement by the mGlu2R Positive Allosteric Modulator JNJ-40411813 in Healthy Male Subjects|Completed||Phase 1|20|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||||||||||||2017-10-11 04:12:45.745844|2017-10-11 04:12:45.745844
NCT01359839|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2013-05-08|||August 2010||2010-08-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effectiveness of a Relaxation-Response Based Cognitive Behavioral Therapy Group for Depressed Chinese Patients|Relaxation-Response Based Cognitive Behavioral Therapy Group for Depressed Chinese Patients in the Community|Completed||N/A|40|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 04:12:45.846421|2017-10-11 04:12:45.846421
NCT01359826|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-19|2015-09-17|||October 2011||2011-10-01|September 2015|2015-09-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|||The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients|The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort|Withdrawn||Phase 4|0|Actual|Loma Linda University||2||"PI has let the institution. We are unable to locate any study documents that would indicate   study enrollment"|f||||f||||||||||2017-10-11 04:12:45.927932|2017-10-11 04:12:45.927932
NCT01359813|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2014-05-12|||December 2008||2008-12-01|July 2010|2010-07-01|June 2012|Actual|2012-06-01|September 2011|Actual|2011-09-01||Interventional|ALB-CIRINF||Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial Peritonitis|Effects of Albumin Administration in Septic Cirrhotic Patients With Child > 8 Unrelated to Spontaneous Bacterial Peritonitis on Renal Function and Survival: A Multicenter Randomized Controlled Trial Comparing Use and Non-use of Human Albumin (Vialebex ®)|Terminated||Phase 3|193|Actual|Centre Hospitalier Universitaire de Besancon||2||"decision of independent monitoring committee:Risk of death at 3 months higher in Albumin group   than in control group, without reaching significance level."|f||||t||||||||||2017-10-11 04:12:46.025639|2017-10-11 04:12:46.025639
NCT01359800|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2016-03-03|||October 2010||2010-10-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|February 2013|Actual|2013-02-01||Observational|ISS OBS T-004||Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients|A Multicentre, Observational, Cross-sectional Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients in Selected Areas of Gauteng and Eastern Cape|Completed||N/A|531|Actual|Istituto Superiore di Sanità|||2||f||||f||||||Samples With DNA|"     Whole blood, cervical samples   "|||2017-10-11 04:12:46.20169|2017-10-11 04:12:46.20169
NCT01359787|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2015-01-19|||May 2011||2011-05-01|January 2015|2015-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)|Double-blind, Randomized, Vehicle-controlled, Multicenter, Multinational, Parallel-group Study of the Efficacy and Safety of Mapracorat Ointment in Three Concentrations Over Max. 4 Weeks in Subjects With Atopic Dermatitis (AD)|Completed||Phase 2|197|Actual|Bayer||4|||f||||f||||||||||2017-10-11 04:12:46.317429|2017-10-11 04:12:46.317429
NCT01359774|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-09-20|||April 2011||2011-04-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|PRO-MH||31P-MRS and Huntington Disease|31Phosphorus-Magnetic Resonance Spectroscopy and Huntington Disease|Completed||N/A|30|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||||||||||||2017-10-11 04:12:46.428954|2017-10-11 04:12:46.428954
NCT01359761|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-06-12|||February 2011||2011-02-01|June 2017|2017-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Post Admission Cognitive Therapy (PACT) for the Inpatient Treatment of Military Personnel With Suicidal Behaviors|Post Admission Cognitive Therapy (PACT) for the Inpatient Treatment of Military Personnel With Suicidal Behaviors: A Multi-Site Randomized Controlled Trial|Recruiting||N/A|218|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||t||||||||No||2017-10-11 04:12:46.542012|2017-10-11 04:12:46.542012
NCT01359748|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-07-22|2011-06-02||March 2011||2011-03-01|July 2014|2014-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Clinical Study About Blood Pressure Measurement Efficacy on Multifunction KEITO|Clinical Study About Blood Pressure Measurement Efficacy on Multifunction KEITO|Completed||N/A|89|Actual|Aguiflai Iberica, S.L.||4|||f||||f||||||||||2017-10-11 04:12:46.847228|2017-10-11 04:12:46.847228
NCT01359735|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2017-05-31|2016-09-13|2013-09-12|May 2011||2011-05-01|May 2017|2017-05-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Interventional|||Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients|A Phase II Randomized, Open-label Study Investigating the Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients|Completed||Phase 2|8|Actual|Healthpoint||2|||f||||f||||||||||2017-10-11 04:12:47.329666|2017-10-11 04:12:47.329666
NCT01359709|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-05-11|||June 2011||2011-06-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking|Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking|Completed||Phase 1|60|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 04:12:48.113273|2017-10-11 04:12:48.113273
NCT01359696|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2017-04-11|||July 11, 2011|Actual|2011-07-11|April 2017|2017-04-01|May 29, 2014|Actual|2014-05-29|May 29, 2014|Actual|2014-05-29||Interventional|||A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma|An Open-Label, Phase I, Dose Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma|Completed||Phase 1|40|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 04:12:48.207254|2017-10-11 04:12:48.207254
NCT01359683|ClinicalTrials.gov processed this data on October 10, 2017|2008-04-07|2013-06-12|||September 2007||2007-09-01|April 2008|2008-04-01||||September 2009|Actual|2009-09-01||Interventional|||Heart Rate Variability Changes During Cardiac Surgery And The Incidence Of Post-Operative Cardiac Arrhythmias|Heart Rate Variability Changes During Cardiac Surgery And The Incidence Of Post-Operative Cardiac Arrhythmias|Withdrawn||N/A|0|Actual|Drexel University||1|||f||||f||||||||||2017-10-11 04:12:48.299842|2017-10-11 04:12:48.299842
NCT01359670|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2013-08-19|||May 2011||2011-05-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Tadalafil and Sildenafil for Duchenne Muscular Dystrophy|Functional Muscle Ischemia and PDE5A Inhibition in Duchenne Muscular Dystrophy|Completed||N/A|30|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-10-11 04:12:48.369637|2017-10-11 04:12:48.369637
NCT01359657|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2016-03-15|||September 2011||2011-09-01|July 2015|2015-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma|A Phase 1b, Open-label, Multicenter Study of (BMS-936564) in Combination With Lenalidomide (Revlimid) Plus Low-dose Dexamethasone, or With Bortezomib (Velcade) Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|46|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 04:12:48.486581|2017-10-11 04:12:48.486581
NCT01359644|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2015-09-23|2015-08-21||June 2011||2011-06-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|January 2013|Actual|2013-01-01||Interventional|||Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care|Parallel, Open-Label, Randomized Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of PSI-7977 in Combination With BMS-790052 With or Without Ribavirin in Treatment Naive Subjects Chronically Infected With Hepatitis C Virus Genotypes 1, 2, or 3|Completed||Phase 2|350|Actual|Bristol-Myers Squibb||10|||f||||f||||||||||2017-10-11 04:12:48.636783|2017-10-11 04:12:48.636783
NCT01359631|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-05-13|||June 2011||2011-06-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Cephalic Vascular Recording Upon SPG Stimulation|Cephalic Vascular Recording Upon SPG Stimulation in CH Patients - Amendment to the Pathway CH-1 Trial|Completed||N/A|7|Actual|Autonomic Technologies, Inc.|||1||f||||||||||||||2017-10-11 04:12:50.116466|2017-10-11 04:12:50.116466
NCT01359618|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2012-12-11|||June 2011||2011-06-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart|A Single-centre, Randomised, Double-blind, Placebo Controlled Phase I Study in Two Parts: Part A to Assess a Safe and Tolerable Supratherapeutic Dose of TC-5214 After Single Ascending Oral Doses in Healthy Male Subjects, Followed by Part B: A Four-period Double-dummy Crossover Study to Investigate the Effect of 2 Single Doses (Therapeutic and Supratherapeutic) of TC-5214 on the QT/QTc Interval, Compared to Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Subjects|Terminated||Phase 1|16|Actual|AstraZeneca||6||Sponsor decision to terminate|f||||f||||||||||2017-10-11 04:12:50.17097|2017-10-11 04:12:50.17097
NCT01359605|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-12-16|||June 2011||2011-06-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects|An Open-Label, Single-Dose, Study to Assess the Metabolism and Elimination of Varespladib After Oral Administration of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects|Completed||Phase 1|6|Actual|Anthera Pharmaceuticals||1|||f||||f||||||||||2017-10-11 04:12:50.283974|2017-10-11 04:12:50.283974
NCT01359592|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-21|2017-10-03|||September 2011||2011-09-01|October 2017|2017-10-01|March 2024|Anticipated|2024-03-01|June 2020|Anticipated|2020-06-01||Interventional|||S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma|A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL)|Active, not recruiting||Phase 2|159|Actual|Southwest Oncology Group||2|||f||||f||||||||||2017-10-11 04:12:50.379941|2017-10-11 04:12:50.379941
NCT01359579|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-03-19|||June 2011||2011-06-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|April 2012|Anticipated|2012-04-01||Interventional|||A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function|A Phase 1, Open-label, Pharmacokinetic, Safety, and Tolerability Study of a Single Oral Dose of Varespladib Methyl in Subjects With Normal Renal Function, and Subjects With Mild, Moderate, or Severe Renal Impairment|Terminated||Phase 1|28|Actual|Anthera Pharmaceuticals||4||Lack of efficacy|f||||f||||||||||2017-10-11 04:12:51.125675|2017-10-11 04:12:51.125675
NCT01359566|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-22|2017-04-24||2015-12-28|May 2011||2011-05-01|April 2017|2017-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis|A Randomized, Double Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis|Completed||Phase 3|228|Actual|Indivior Inc.||4|||f||||f||||||||No||2017-10-11 04:12:51.209342|2017-10-11 04:12:51.209342
NCT01359553|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-22|2016-10-24|||May 2011||2011-05-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Observational|||Clinical Study of Novel Diagnostic Techniques for Knee Osteoarthritis|Comparison Between Intra-articular Ultrasound Imaging, Non-invasive Ultrasound Imaging, Quantitative MRI Imaging, Contrast-enhanced CT Imaging and Arthroscopy for Diagnostics of Knee Osteoarthritis|Completed||N/A|12|Actual|University of Oulu|||1||f||||f||||||||||2017-10-11 04:12:51.343787|2017-10-11 04:12:51.343787
NCT01359540|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-22|2012-12-12|||November 2009||2009-11-01|December 2012|2012-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|||"Femoral Remodeling Following Total Hip Arthroplasty With Omni Apex Modular™, OMNI Apex ARC™ Stem, and Omni Apex Conical Stem Compared to Competitive Designs"|A Dual Energy X-Ray Absorptiometry (Dxa) Evaluation Of Bone Density Changes After Hip Replacement Performance Of The Omni Apex Modulartm Hip Stem And The Omni Apex Arctm Hip Stem In Primary Total Hip Arthroplasty, Five-Year Clinical And Dxa Analysis|Unknown status|Recruiting|N/A|75|Anticipated|Spokane Joint Replacement Center|||3||f||||t||||||||||2017-10-11 04:12:53.354113|2017-10-11 04:12:53.354113
NCT01359527|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-22|2012-12-12|||December 2008||2008-12-01|December 2012|2012-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Dual Energy X-rayY Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)|A Dual Energy X-Ray Absorptiometry Comparison Of Periprosthetic Bone Loss Between Patients Undergoing Hip Resurfacing Surgery And Total Hip Arthroplasty|Unknown status|Recruiting|N/A|25|Anticipated|Spokane Joint Replacement Center|||2||f||||t||||||||||2017-10-11 04:12:53.434056|2017-10-11 04:12:53.434056
NCT01359501|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-01|2012-10-21|||May 2011||2011-05-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients|Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients|Unknown status|Recruiting|Phase 2|100|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 04:12:53.613518|2017-10-11 04:12:53.613518
NCT01359488|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2012-07-19|||March 2011||2011-03-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||VRS-317 in Adult Subjects With Growth Hormone Deficiency|A Blinded Placebo Controlled Single Ascending Dose Phase 1 for Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Subcutaneous Administration of VRS-317 in Adults With Growth Hormone Deficiency|Completed||Phase 1|50|Actual|Versartis Inc.||5|||f||||f||||||||||2017-10-11 04:12:53.73116|2017-10-11 04:12:53.73116
NCT01359475|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-15|2013-07-02|||April 2010||2010-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|December 2011|Actual|2011-12-01||Interventional|||A Clinical Trial of an Acetal Resin Crown for Restoration of Primary Molars|Phase 3- Clinical Trial on Children. PROTOCOL 465-549|Completed||Phase 3|52|Actual|Barzilai Medical Center||1|||f||||f||||||||||2017-10-11 04:12:53.927556|2017-10-11 04:12:53.927556
NCT01359462|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-05|2011-05-23|||April 2009||2009-04-01|May 2011|2011-05-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis|A Clinical Study of Multiple-dose Pharmacokinetics of Tolvaptan Tablets Administered Orally (15mg Daily) for Consecutively 7 Days in Chinese Patients With Hepatocirrhosis|Completed||Phase 1|11|Actual|Otsuka Beijing Research Institute||1|||f||||f||||||||||2017-10-11 04:12:54.013443|2017-10-11 04:12:54.013443
NCT01359449|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2016-07-20|2013-04-04||May 2011||2011-05-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|||Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations|Safety and Immunogenicity of Two Doses of Menactra® (Meningococcal [Groups A, C, Y, and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) or One Dose of Monovalent Meningococcal Group C Conjugate Vaccine Administered Concomitantly With Routine Immunizations Between 12 and 18 Months of Age in Canada|Completed||Phase 3|123|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 04:12:54.127906|2017-10-11 04:12:54.127906
NCT01359436|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-11-14|||July 2010||2010-07-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer|e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 04:12:55.321215|2017-10-11 04:12:55.321215
NCT01359423|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2014-03-04|||March 2011||2011-03-01|March 2014|2014-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Comparison of Primary Long Full Coverage Stenting vs Primary Short Spot Stenting for Long Femoropopliteal Artery Disease.||Unknown status|Recruiting|N/A|220|Anticipated|Yonsei University||2|||f||||t||||||||||2017-10-11 04:12:55.434732|2017-10-11 04:12:55.434732
NCT01359410|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-03-29|2017-03-29||June 2007||2007-06-01|March 2017|2017-03-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Reinforced Staple Line on Leak Rate in Distal Pancreatectomy|Effect of a Reinforced Staple Line on Leak Rate in Distal Pancreatectomy|Terminated||N/A|112|Actual|Washington University School of Medicine|The investigators were unable to identify any complications directly due to the mesh materials. It is possible these complications are very rare and that the study did not include enough participants to potentially identify these potential harms.|2||The 3rd interim analysis found superiority in the mesh reinforcement arm|f||||t|f|t|f|f|f|||No||2017-10-11 04:12:55.558675|2017-10-11 04:12:55.558675
NCT01358565|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2011-06-21|||November 2010||2010-11-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction|Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction|Completed||Phase 1|16|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:13:19.907719|2017-10-11 04:13:19.907719
NCT01359397|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2015-11-03|||March 2011||2011-03-01|October 2015|2015-10-01||||May 2015|Actual|2015-05-01||Interventional|B-DOCT||Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer|Phase II Study of Docetaxel, Oxaliplatin, Capecitabine With Bevacizumab and Trastuzumab in Case of Human Epidermal Growth Factor Receptor 2 (HER2)-Positivity in Patients With Locally Advanced or Metastatic Gastric Cancer or Adenocarcinoma of the Gastro-oesophageal Junction (B-DOCT Study)|Unknown status|Active, not recruiting|Phase 2|||The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-11 04:12:56.169608|2017-10-11 04:12:56.169608
NCT01359384|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-05-23|||May 2011||2011-05-01|May 2011|2011-05-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Observational|||Bronchial Inflammation in Patients With Severe Immune Deficiency Under Immunoglobulin Treatment||Unknown status|Not yet recruiting|N/A|50|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||||||||Samples With DNA|"     whole blood, serum and sputum   "|||2017-10-11 04:12:56.290632|2017-10-11 04:12:56.290632
NCT01359371|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-04-06|2014-10-28||June 2012||2012-06-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Observational|||Evaluation of Peer Telephone Cessation Counseling for Smokers|Evaluation of Peer Telephone Cessation Counseling for Smokers|Completed||N/A|41|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:12:56.391825|2017-10-11 04:12:56.391825
NCT01359358|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2011-05-23|||July 2011||2011-07-01|May 2011|2011-05-01||||||||Observational|MRSABrazil||Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil|Epidemiological Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients During a Hospital Surveillance Period|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of Sao Paulo|||1||f||||t||||||||||2017-10-11 04:12:56.612687|2017-10-11 04:12:56.612687
NCT01359345|ClinicalTrials.gov processed this data on October 10, 2017|2009-10-26|2012-06-21|||July 2008||2008-07-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|May 2011|Actual|2011-05-01||Interventional|NSF||Nephrogenic Systemic Fibrosis With Gadollinum|The Prevalence and Severity of Nephrogenic Systemic Fibrosis in Patients Whom Underwent Imaging With Gadollinium(MRI/MRA) in University Hospital of Tehran Heart Center in 2003-2008|Unknown status|Enrolling by invitation|Phase 2/Phase 3|200|Anticipated|Imam Khomeini Hospital||1|||f||||t||||||||||2017-10-11 04:12:56.711719|2017-10-11 04:12:56.711719
NCT01359332|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2016-09-28|||December 2010||2010-12-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|HYBERNATUS||Evaluation of Therapeutic Hypothermia in Convulsive Status EPILEPTICUS in Adults in Intensive Care|Evaluation of the Interests of a Therapeutic Hypothermia Procedure in Convulsive Status EPILEPTICUS in Adults in Intensive Care - HYBERNATUS Study|Completed||Phase 3|270|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 04:12:56.964359|2017-10-11 04:12:56.964359
NCT01359319|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-05-17|||July 2011||2011-07-01|February 2012|2012-02-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)|A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Single and Repeat Doses of Sialic Acid Extended Release (SA-ER) Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)|Completed||Phase 1|26|Actual|Ultragenyx Pharmaceutical Inc||5|||f||||f||||||||||2017-10-11 04:12:57.180875|2017-10-11 04:12:57.180875
NCT01359306|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2011-05-23|||February 2006||2006-02-01|May 2011|2011-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Right Ventricular Damage in Cardiovascular Magnetic Resonance|Right Ventricular Damage in ST-Elevation Myocardial Infarction. Risk Stratification by Visualization of Wall Motion, Edema and Delayed Enhancement Cardiovascular Magnetic Resonance|Completed||N/A|524|Actual|University of Leipzig|||1||f||||f||||||Samples Without DNA|"     serum for assessment of creatine kinase myocardial band   "|||2017-10-11 04:12:57.292566|2017-10-11 04:12:57.292566
NCT01359280|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2014-12-02|||July 2011||2011-07-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|PIU||Nurse Delivered Cell Phone Adherence Intervention (Pick It UP)|Nurse Delivered Cell Phone Adherence Intervention|Completed||Phase 1/Phase 2|600|Actual|University of Connecticut||4|||f||||f||||||||||2017-10-11 04:12:57.36817|2017-10-11 04:12:57.36817
NCT01359254|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-04-10|2015-04-10||April 2010||2010-04-01|April 2015|2015-04-01|June 2012|Actual|2012-06-01|September 2011|Actual|2011-09-01||Interventional|||Cord Blood Transplantation for Patients With Cancer|Combined Transplantation of Unmanipulated Haploidentical and a SingleCord Blood Unit for Patients With Hematologic Malignancies|Terminated||Phase 2|1|Actual|University of Chicago||2||did not accrue enough patients.|f||||f||||||||||2017-10-11 04:12:57.543935|2017-10-11 04:12:57.543935
NCT01359241|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-11-09|||November 2011||2011-11-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|Angie01||Achieving Normal Glucose In Hospital Settings|An Open-label, Single-centre, Randomised, Two-period Crossover Study to Assess the Efficacy and Safety of 24-hour Closed-loop Glucose Control in Comparison With Conventional Treatment in Adults With Type 2 Diabetes on Non-insulin Glucose-lowering Agents|Completed||N/A|16|Actual|University of Cambridge||2|||f||||f||||||||||2017-10-11 04:12:57.813056|2017-10-11 04:12:57.813056
NCT01359228|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2014-04-25|||April 2013||2013-04-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Rifaximin Treatment of Papulopustular Rosacea|Rifaximin Treatment of Papulopustular Rosacea: Double- Blinded, Placebo-Controlled, Crossover Study|Withdrawn||Phase 2|0|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 04:12:57.928717|2017-10-11 04:12:57.928717
NCT01359215|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-12-11|||March 2011||2011-03-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|UCSF-Anes-01||Childhood Anesthesia and Cognitive Function|Is Pediatric Anesthesia Associated With Long-term Hippocampal Dysfunction?|Completed||N/A|30|Actual|University of California, San Francisco|||2||f||||f||||||||||2017-10-11 04:12:58.020142|2017-10-11 04:12:58.020142
NCT01359202|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2016-06-22|||May 2011||2011-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|SPOTLIGHT||"Spot Sign Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy"|"Spot Sign Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy: SPOTLIGHT"|Active, not recruiting||Phase 2|50|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-11 04:12:58.119448|2017-10-11 04:12:58.119448
NCT01359189|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-08-31|||May 2011||2011-05-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer|Initial Exploratory Evaluation of a Transrectal Scintigraphic Detector (ProxiScanTM) for Detection of Primary Prostate Cancer Utilizing a Prostate Specific Membrane Antigen (PSMA) Based Radiotracer (ProstaScint®)|Completed||Phase 1|4|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:12:58.276564|2017-10-11 04:12:58.276564
NCT01359176|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-04-24|||May 2010||2010-05-01|May 2010|2010-05-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Observational|||Capnography Data Collection From Healthy Participants|The Capnography Library: Data Collection From Healthy Participants|Completed||N/A|160|Actual|Shaare Zedek Medical Center|||1||f||||f||||||||||2017-10-11 04:12:58.370573|2017-10-11 04:12:58.370573
NCT01359163|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-04-03|||June 2011||2011-06-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female Subjects|An Open Label, Randomized, Single Dose, Crossover Pivotal Bioequivalence Study Of Commercial Femulen Tablets Versus Reformulated Femulen Tablets In Healthy Female Subjects|Completed||Phase 1|20|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:12:58.447297|2017-10-11 04:12:58.447297
NCT01359150|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-02-20|2013-01-07||September 2011||2011-09-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo|A Randomized, Double Blind, Placebo Controlled Phase 2 Study To Assess The Immune Response Following Administration Of Influenza And Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving Cp-690,550 Or Placebo Cp-690,550 With And Without Background Methotrexate|Completed||Phase 2|223|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 04:12:58.592359|2017-10-11 04:12:58.592359
NCT01359137|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2011-06-10|||January 2011||2011-01-01|May 2011|2011-05-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|||An Assessment of SAFE (Swift Accountable Fair Enforcement) in Cochise County|An Assessment of Arizona's SAFE (Swift Accountable Fair Enforcement) Program in Cochise County|Unknown status|Enrolling by invitation|N/A|105|Anticipated|Pepperdine University||3|||f||||f||||||||||2017-10-11 04:12:59.674465|2017-10-11 04:12:59.674465
NCT01359124|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-02-25|||May 2011||2011-05-01|February 2015|2015-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Reaching Exercise Goals: Comparison of Exercise Means in Patients With Knee Osteoarthritis|Reaching Exercise Goals: Comparison of the Underwater Treadmill, Land Based Treadmill, and Exercise Cycle in Patients With Knee Osteoarthritis|Completed||N/A|60|Actual|Milton S. Hershey Medical Center|||3||f||||f||||||||||2017-10-11 04:12:59.882195|2017-10-11 04:12:59.882195
NCT01359111|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2012-05-10|2012-04-16||May 2011||2011-05-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Performance and Safety Evaluation of an Intradermal Delivery Device|Phase I Performance and Safety Evaluation of an Intradermal Delivery Device|Completed||Phase 1|20|Actual|PATH||1|||f||||f||||||||||2017-10-11 04:12:59.992935|2017-10-11 04:12:59.992935
NCT01359098|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2011-11-01|||July 2011||2011-07-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|Ciprodexa Foam||Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa|Safety and Efficacy of Once-Daily Dosing of Ciprodexa Otic Foam (Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Foam) Compared to Twice-Daily Dosing of Ciprodex (0.3% Ciprofloxacin and Dexamethasone 0.1% Otic Suspension) in Patients With Acute Otitis Externa|Completed||Phase 2|100|Anticipated|Otic Pharma||2|||f||||f||||||||||2017-10-11 04:13:00.222403|2017-10-11 04:13:00.222403
NCT01359085|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-06-06|||June 2011||2011-06-01|June 2011|2011-06-01||||June 2012|Anticipated|2012-06-01||Interventional|||Pain Relief Following Arthroscopic Rotator Cuff Repair: Perioperative Pregabalin Administration Versus Interscalene Brachial Plexus Block|Pain Relief Following Arthroscopic Rotator Cuff Repair: Perioperative Pregabalin Administration Versus Interscalene Brachial Plexus Block. a Prospective, Randomized, Double Blinded, Multicenter Trial|Unknown status|Not yet recruiting|N/A|56|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 04:13:00.350728|2017-10-11 04:13:00.350728
NCT01359072|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-08-21|||June 2011||2011-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Enhancing Coping Skills in Patients With Cancer|Enhancing Coping Skills in Patients With Cancer - a Randomized Controlled Study|Terminated||N/A|1|Actual|McGill University Health Center||2||This study is currently terminated due to low recruitment rate.|f||||f||||||||||2017-10-11 04:13:00.454072|2017-10-11 04:13:00.454072
NCT01359059|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-06-09|||June 2011||2011-06-01|June 2011|2011-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Pre- Versus Post-incisional Pregabalin for Postoperative Pain Attenuation and Analgesics Spare in Orthopedic Oncologic Patients|Pre- vs. Post-incisional Pregabalin for Postoperative Pain Attenuation and Analgesics Spare in Orthopedic Oncologic Patients: A Comparative, Randomized, Double Blind Study Protocol|Unknown status|Not yet recruiting|N/A|80|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-10-11 04:13:00.551661|2017-10-11 04:13:00.551661
NCT01359046|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-08-07|||July 2011||2011-07-01|August 2017|2017-08-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology|Randomized Control Trial of Silver-alloy Impregnated Suprapubic Catheters in Urogynecology Patients|Recruiting||N/A|444|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-10-11 04:13:00.666714|2017-10-11 04:13:00.666714
NCT01359033|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2014-02-03|||March 2011||2011-03-01|February 2014|2014-02-01|December 2020|Anticipated|2020-12-01|December 2014|Anticipated|2014-12-01||Observational|||MI Mortality Risk and Between-hospital Risk Variation in the United Kingdom and Sweden|Compare the Patient Risk and Between-hospital Variation in Myocardial Infarction Mortality in the United Kingdom and Sweden|Active, not recruiting||N/A|370000|Anticipated|University College, London|||2||f||||t||||||||||2017-10-11 04:13:00.774349|2017-10-11 04:13:00.774349
NCT01359020|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2011-05-23|||January 2007||2007-01-01|May 2011|2011-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Ibuprofen, Acetaminophen and Dipyrone to Fever Control in Children|Randomized, Open Label, Comparative, Parallel, Multicenter Trial to Determinate the Efficacy Anf Tolerability of Ibuprofen, Acetaminophen and Dipyrone Drops to Fever Control in Children|Completed||Phase 4|396|Actual|Mantecorp Industria Quimica e Farmaceutica Ltd.||3|||f||||t||||||||||2017-10-11 04:13:00.881097|2017-10-11 04:13:00.881097
NCT01358994|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-05-20|||January 2011||2011-01-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Observational|||Metformin Treatment, Renal Function and Lactic Acidosis|Metformin Treatment, Renal Function and Lactic Acidosis. A Population Based|Completed||N/A|4500|Actual|Skane University Hospital|||1||f||||f||||||||||2017-10-11 04:13:01.127555|2017-10-11 04:13:01.127555
NCT01358981|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2011-08-26|||May 2011||2011-05-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study of LY2881835 in Healthy People and People With Diabetes|Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Oral Doses of LY2881835 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|40|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 04:13:01.202475|2017-10-11 04:13:01.202475
NCT01358968|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-01-16|||June 2011||2011-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine|A Study in Cancer Patients to Evaluate the Ability of LY2603618 to Act as an Inhibitor of CYP2D6 Using Desipramine as a Probe Substrate|Completed||Phase 1|60|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:13:01.294984|2017-10-11 04:13:01.294984
NCT01358955|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-08-27|||March 2011||2011-03-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|CogMCI||Efficacy Study of Cognitive Intervention in Amnestic Mild Cognitive Impairment|A Multicenter, Randomized Trial to Assess Efficacy of Home-based and Group Cognitive Intervention Programs in Amnestic Mild Cognitive Impairment|Completed||N/A|293|Actual|Inha University Hospital||3|||f||||f||||||||||2017-10-11 04:13:01.415811|2017-10-11 04:13:01.415811
NCT01358942|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2016-11-01|||May 2011||2011-05-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab)|Observational, Epidemiological and Non Interventional Study Evaluating the Evolution of Lung Cancer Related Symptoms and Its Correlation With Disease Control Rate in Patients With Non-Small Cell Lung Cancer (NSCLC) Initiating First-line Treatment With Platinum Based Standard Chemotherapy.|Completed||N/A|156|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:13:01.57866|2017-10-11 04:13:01.57866
NCT01358929|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-11-01|||April 2011||2011-04-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study of RO6807952 in Patients With Diabetes Mellitus Type 2|A Randomized, Placebo-Controlled, Sequential, Multiple-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MAR701/RO6807952 in Type 2 Diabetic Patients|Completed||Phase 1|45|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:13:01.726753|2017-10-11 04:13:01.726753
NCT01358916|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-03-27|||November 2010||2010-11-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SAPI||Intervention Study to Improve Antibiotic Prescription in Outpatient Care|Improvement of Antibiotic Prescription in Outpatient Care: a Cluster-randomised Intervention Study Using a Sentinel Surveillance Network of Physicians|Completed||N/A|140|Actual|University of Bern||2|||f||||f||||||||||2017-10-11 04:13:01.829774|2017-10-11 04:13:01.829774
NCT01358903|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-11-01|||June 2011||2011-06-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors|Open-Label Multicenter 2-Arm Phase I Study of RO5429083 With Dose-Escalation and Extension Cohorts, and Imaging Cohorts With RO5429083 and 89Zr-labeled RO5429083, in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors|Completed||Phase 1|65|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:13:01.966483|2017-10-11 04:13:01.966483
NCT01358890|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2012-02-27|||May 2011||2011-05-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Low-Carbohydrate Diet Intervention on Body Weight|Effect of Low-Carbohydrate or Restricted-Calories Diet on Body Weight|Completed||Phase 2/Phase 3|50|Actual|Chinese Academy of Sciences||2|||f||||||||||||||2017-10-11 04:13:02.115572|2017-10-11 04:13:02.115572
NCT01358877|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-07-18|||November 8, 2011|Actual|2011-11-08|July 2017|2017-07-01|December 1, 2023|Anticipated|2023-12-01|December 19, 2016|Actual|2016-12-19||Interventional|APHINITY||A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer|A Randomized Multicenter, Double-Blind, Placebo-Controlled Comparison of Chemotherapy Plus Trastuzumab Plus Placebo Versus Chemotherapy Plus Trastuzumab Plus Pertuzumab as Adjuvant Therapy in Patients With Operable HER2-Positive Primary Breast Cancer|Active, not recruiting||Phase 3|4805|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:13:02.28539|2017-10-11 04:13:02.28539
NCT01358864|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-23|2016-07-28|2015-07-03|2014-04-30|June 2011||2011-06-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|February 2013|Actual|2013-02-01||Interventional||Full Analysis Set (FAS)|Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)|A Phase III, Randomised, Double-blind and Placebo Controlled Study of Once Daily BI 201335, 240 mg for 12 or 24 Weeks in Combination With Pegylated interferon-a (PegIFNa) and Ribavirin (RBV) in Patients With Genotype 1 Chronic Hepatitis C Infection Who Failed a Prior PegIFN/RBV Treatment|Completed||Phase 3|678|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 04:13:04.166086|2017-10-11 04:13:04.166086
NCT01358851|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2015-05-28|||April 2011||2011-04-01|May 2015|2015-05-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||LAS41005 in Hyperkeratotic Actinic Keratosis|A Prospective Comparator Controlled Randomized Exploratory Study on the Efficacy of LAS 41005 Compared to Cryotherapy in Subjects With Hyperkeratotic Actinic Keratosis|Completed||Phase 2|67|Actual|Almirall, S.A.||2|||f||||||||||||||2017-10-11 04:13:07.312111|2017-10-11 04:13:07.312111
NCT00000564|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2005-06-23|||July 1976||1976-07-01|May 2002|2002-05-01||||||||Interventional|||Nocturnal Oxygen Therapy||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.833602|2017-10-11 04:19:04.833602
NCT01358838|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-02-06|||May 2010||2010-05-01|May 2010|2010-05-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Ablative 10600 nm Fractional Laser Therapy for the Treatment of Scars|Ablative 10600 nm Fractional Laser Therapy for the Treatment of Scars; a Randomized Controlled Trial|Completed||N/A|25|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||||||||||||2017-10-11 04:13:07.42908|2017-10-11 04:13:07.42908
NCT01358825|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-02-03|2016-11-02||May 2011||2011-05-01|February 2017|2017-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™|Antibody Persistence in Children Previously Vaccinated With Three Doses of Infanrix Hexa™ or Infanrix-IPV/Hib™|Completed||Phase 4|58|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:13:07.542366|2017-10-11 04:13:07.542366
NCT01358812|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-03-10|||March 2010||2010-03-01|March 2015|2015-03-01||||October 2011|Actual|2011-10-01||Interventional|TRIP||FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer|Phase II Trial of FOLFOXIRI Plus Panitumumab as First-Line Treatment for Kras and Braf Wild-Type Metastatic Colorectal Cancer|Completed||Phase 2|37|Actual|Gruppo Oncologico del Nord-Ovest||1|||f||||t||||||||||2017-10-11 04:13:07.925186|2017-10-11 04:13:07.925186
NCT01358799|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-03-08|||November 2010||2010-11-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System|Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System|Withdrawn||N/A|0|Actual|Gen-Probe, Incorporated|||1|Assay not evaluated for purpose of clearance|f||||f||||||Samples With DNA|"     4 specimens will be collected from each female subject in the following order: 1 first-catch     urine specimen, 1 vaginal swab specimen (patient or clinician-collected), 1 cervical specimen     (using a broomlike collection device or a brush/spatula combination), and 1 endocervical swab     specimen. An additional cervical specimen may be collected from female subjects for other     clinical trial purposes or research studies. Up to 2 specimens will be collected from each     male subject in the following order: 1 urethral swab specimen and 1 first-catch urine     specimen.   "|||2017-10-11 04:13:08.035284|2017-10-11 04:13:08.035284
NCT01358786|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-25|||April 2009||2009-04-01|June 2009|2009-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|STRAMQUSG||Seroma at the Donor Site of the TRAM Flap, With or Without Quilting Suture: A Comparative Study Using Ultrasound|Seroma at the Donor Site of the TRAM Flap, With or Without Quilting Suture.|Completed||Phase 1|48|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-10-11 04:13:08.236848|2017-10-11 04:13:08.236848
NCT01358773|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-03|2016-06-29|||February 2004||2004-02-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2004|Actual|2004-12-01||Interventional|||The Effect of 1 Year of Multiprofessional Therapy on Obesity|Multiprofessional Impact on Body Composition, Central and Peripheric Adiposity, Lipid Profile, Hormonal Regulation, Lung, Sleep and Humor Disorders in Adolescents|Recruiting||Early Phase 1|150|Anticipated|Federal University of São Paulo||1|||f||||t||||||||||2017-10-11 04:13:08.316745|2017-10-11 04:13:08.316745
NCT01358760|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-06-08|2017-03-17|2013-05-01|June 2011||2011-06-01|June 2017|2017-06-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional||Baseline Analysis Population corresponds to the Safety Population which includes all subjects who received any amount of DHEA (prasterone) or placebo, and who have any safety information available.|Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy||Completed||Phase 3|450|Actual|EndoCeutics Inc.||3|||f||||t||||||||||2017-10-11 04:13:08.436589|2017-10-11 04:13:08.436589
NCT01358747|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2014-05-20|||May 2011||2011-05-01|January 2013|2013-01-01||||||||Interventional|AHL 2011||Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL|Randomized Phase III Study of a Treatment Driven by Early PET Response Compared to a Treatment Not Monitored by Early PET in Patients With Ann Arbor Stage III-IV or High Risk IIB Hodgkin Lymphoma|Completed||Phase 3|||Centre Hospitalier Universitaire Dijon||2|||f||||t||||||||||2017-10-11 04:13:09.333441|2017-10-11 04:13:09.333441
NCT01358734|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-02-02|2016-04-04||April 2012||2012-04-01|February 2017|2017-02-01|May 2018|Anticipated|2018-05-01|April 2015|Actual|2015-04-01||Interventional||Intent To Treat (ITT) includes all randomized participants|A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia|A Phase 2, Multicenter, Randomized, Open-label, Parallel-group Study of a Lenalidomide (Revlimid®) Regimen or a Sequential Azacitidine (Vidaza®) Plus Lenalidomide (Revlimid®) Regimen Versus an Azacitidine (Vidaza®) Regimen for Therapy of Older Subjects With Newly Diagnosed Acute Myeloid Leukemia|Active, not recruiting||Phase 2|88|Actual|Celgene||3|||f||||t||||||||||2017-10-11 04:13:09.643043|2017-10-11 04:13:09.643043
NCT01358721|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-08-03|||August 11, 2011|Actual|2011-08-11|August 2017|2017-08-01|November 17, 2017|Anticipated|2017-11-17|December 1, 2014|Actual|2014-12-01||Interventional|||Phase I Biomarker Study (BMS-936558)|An Exploratory Study to Investigate the Immunomodulatory Activity of Various Dose Levels of Anti Programmed-Death-1 (PD-1) Antibody (BMS-936558) in Subjects With Metastatic Clear Cell Renal Cell Carcinoma (RCC).|Active, not recruiting||Phase 1|119|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 04:13:12.34994|2017-10-11 04:13:12.34994
NCT01358708|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-16|2017-02-14|2013-06-20||June 2010||2010-06-01|February 2017|2017-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||Analysis conducted on the Intent-to-Treat population defined as all randomized subjects|Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg|Treatment of Diarrhea-predominant Irritable Bowel Syndrome With LACTEOL® 340 mg: A Pilot Study Evaluating Safety and Efficacy|Terminated||Phase 3|26|Actual|Forest Laboratories|Because of early termination of this trial, the number of subjects analyzed was too small to perform statistical analyses and draw conclusions relative to the efficacy and safety of LACTEOL®.|2||Administrative reasons|f||||f||||||||||2017-10-11 04:13:12.491938|2017-10-11 04:13:12.491938
NCT01358695|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-06-21||2013-06-21|May 2011||2011-05-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet|Clinical Trial To Evaluate ANT-1207 In Subjects With Lateral Canthal Lines|Completed||Phase 2|111|Actual|Anterios Inc.||6|||f||||t||||||||||2017-10-11 04:13:13.075825|2017-10-11 04:13:13.075825
NCT01357590|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-03-01||||||March 2012|2012-03-01||||||||Interventional|||Evaluation of Thoraflex in the Treatment of Aneurysm or Penetrating Ulcer of the Descending Thoracic Aorta|Evaluation of the Vascutek Ltd. Thoracic Endovascular Stent Graft System (ThoraflexTM)in the Treatment of Aneurysm or Penetrating Ulcer of the Descending Thoracic Aorta|Withdrawn||N/A|0|Actual|Vascutek Ltd.||1|||f||||t||||||||||2017-10-11 04:13:13.18608|2017-10-11 04:13:13.18608
NCT01357577|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-07-20|||January 1, 2013|Actual|2013-01-01|July 2017|2017-07-01|October 31, 2017|Anticipated|2017-10-31|October 31, 2017|Anticipated|2017-10-31||Interventional|CBT||Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs|CBT for PTSD in Veterans With Co-Occurring Substance Use Disorders|Active, not recruiting||N/A|160|Anticipated|VA Office of Research and Development||2|||f||||t|f|f|||f|||||2017-10-11 04:13:13.321379|2017-10-11 04:13:13.321379
NCT01357551|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-09-13|2016-09-13||August 2012||2012-08-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|MAINTAIN||Maintenance After Initiation of Nutrition TrAINing|Maintenance After Initiation of Nutrition TrAINing (MAINTAIN)|Completed||N/A|222|Actual|VA Office of Research and Development|May not generalize to other populations; relatively short length of follow-up; use of self-reported secondary outcome measures|2|||f||||f||||||||||2017-10-11 04:13:13.529889|2017-10-11 04:13:13.529889
NCT01357538|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-05-19|||February 2009||2009-02-01|May 2011|2011-05-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis|Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis - a Multi-centre, Randomised, Double-masked, Parallel-group, Phase IV Comparison|Completed||Phase 4|197|Actual|Ursapharm Arzneimittel GmbH||2|||f||||f||||||||||2017-10-11 04:13:14.106199|2017-10-11 04:13:14.106199
NCT01357525|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-04-24|||July 2011||2011-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Radiosurgery for Resected Pancreas|SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma A Prospective Evaluation in Select Patients With Resected Pancreas Cancer|Recruiting||Phase 2|50|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 04:13:14.185081|2017-10-11 04:13:14.185081
NCT01358682|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-02-15|||December 2011||2011-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 04:13:14.279955|2017-10-11 04:13:14.279955
NCT01358669|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-05-04|||December 2011|Actual|2011-12-01|May 2017|2017-05-01|July 2020|Anticipated|2020-07-01|December 2019|Anticipated|2019-12-01||Interventional|||Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip Arthroplasty|Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip|Recruiting||Phase 2|30|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-10-11 04:13:14.318232|2017-10-11 04:13:14.318232
NCT01358656|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-05-23|||January 2010||2010-01-01|May 2011|2011-05-01|January 2012|Anticipated|2012-01-01|July 2011|Anticipated|2011-07-01||Interventional|KR||Anterior Cruciate Ligament Reconstruction Using Single Bundle and Double Bundle Techniques|Comparison of the Anterior Cruciate Ligament Reconstruction Using Single Bundle and Double Bundle Techniques: Prospective Clinical Study|Unknown status|Recruiting|N/A|40|Anticipated|Vita Care||2|||f||||t||||||||||2017-10-11 04:13:14.589295|2017-10-11 04:13:14.589295
NCT01358643|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-06-01|||January 2011||2011-01-01|May 2011|2011-05-01|May 2012|Anticipated|2012-05-01|January 2012|Anticipated|2012-01-01||Interventional|||Operations Enduring Freedom and Iraqi Freedom (OEF/OIF)Veteran Preferences for Automated Physical Activity Interventions|Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) Veteran Preferences for and Feasibility of Automated Physical Activity Interventions: A Pilot Study|Unknown status|Enrolling by invitation|N/A|30|Anticipated|VA Ann Arbor Healthcare System||3|||f||||f||||||||||2017-10-11 04:13:14.697255|2017-10-11 04:13:14.697255
NCT01358630|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-05-23|||October 2008||2008-10-01|November 2010|2010-11-01|October 2015|Anticipated|2015-10-01|March 2011|Actual|2011-03-01||Observational|||Vascular and Periodontal Disease - Microbial, Genetic and Histological Causalities|Periodontal-, Cardiovascular- and Aneurysmal Diseases.|Unknown status|Recruiting|N/A|100|Anticipated|University of Oslo|||1||f||||t||||||Samples With DNA|"     Whole blood, samples from vascular tissues (atherosclerotic plaques and aneurysmal wall),     saliva   "|||2017-10-11 04:13:14.785589|2017-10-11 04:13:14.785589
NCT01358617|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-05-11|||May 2011||2011-05-01|May 2015|2015-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma|Observational - Expression of Ubiquitin Carboxyl-Terminal Hydrolase 1 (UCHL1) in Neuroblastoma Cancer Stem Cells and Its Relationship to Patient Prognosis|Completed||N/A|90|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Tumor Tissue   "|||2017-10-11 04:13:14.863161|2017-10-11 04:13:14.863161
NCT01358604|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-04-14|||May 2011||2011-05-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Biomarkers in Samples From Young Patients With Neuroblastoma|ROR1 as a Novel Target for Neuroblastoma|Completed||N/A|20|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:13:14.960743|2017-10-11 04:13:14.960743
NCT01358591|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-06-02|||May 2011||2011-05-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Effect of a High Calcium Breakfast on Exercise Metabolism and Appetite||Completed||N/A|9|Actual|Northumbria University||2|||f||||||||||||||2017-10-11 04:13:15.057479|2017-10-11 04:13:15.057479
NCT01358578|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2016-01-19|2015-02-16||June 2011||2011-06-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|FIXTURE||Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis|A Randomized, Double-blind, Double-dummy, Placebo Controlled, Multicenter Study of Subcutaneous Secukinumab to Demonstrate Efficacy After Twelve Weeks of Treatment, Compared to Placebo and Etanercept, and to Assess the Safety, Tolerability and Long-term Efficacy up to One Year in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis|Completed||Phase 3|1306|Actual|Novartis||6|||f||||t||||||||||2017-10-11 04:13:15.239485|2017-10-11 04:13:15.239485
NCT00000565|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||November 1976||1976-11-01|May 2002|2002-05-01||||||||Interventional|||Clinical Study of Intermittent Positive Pressure Breathing (IPPB)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.892137|2017-10-11 04:19:04.892137
NCT01358552|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2013-04-30|||January 2011||2011-01-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)|Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)|Terminated||N/A|53|Actual|Pamlab, Inc.|||1|Insufficient number of participants|f||||f||||||||||2017-10-11 04:13:19.977427|2017-10-11 04:13:19.977427
NCT01358539|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-06-23|||September 2010||2010-09-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PEEP||Palliation: the Effect of Education on Pain|Pain Education for Patients With Painful Bone Metastases Undergoing Palliative Radiotherapy: Reducing Pain by Increasing Patient's Knowledge and Self-management|Completed||Phase 3|354|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-10-11 04:13:20.057791|2017-10-11 04:13:20.057791
NCT01358526|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-10-14|2014-07-29||May 2011||2011-05-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain|A Randomized, Double-blind, Placebo-controlled, Multicenter Trial With an Enriched Study Design to Assess the Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Pain Due to Chronic Low Back Pain Who Require Around-the-clock Opioid Therapy|Completed||Phase 3|1095|Actual|Purdue Pharma LP||2|||f||||t||||||||||2017-10-11 04:13:20.41643|2017-10-11 04:13:20.41643
NCT01358513|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-01-09|||July 2010||2010-07-01|January 2015|2015-01-01|July 2015|Anticipated|2015-07-01|July 2014|Actual|2014-07-01||Observational|||Role of Active Valvular Calcification and Inflammation in Patients With Aortic Stenosis|An Observational PET/CT Study Examining the Role of Active Valvular Calcification and Inflammation in Patients With Aortic Stenosis|Unknown status|Active, not recruiting|N/A|168|Anticipated|University of Edinburgh|||5||f||||t||||||Samples With DNA|"     In patients undergoing aortic valve replacement during the course of the trial we will retain     samples of their aortic valve for histological studies.   "|||2017-10-11 04:13:21.640777|2017-10-11 04:13:21.640777
NCT01358500|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2013-02-04|||February 2012||2012-02-01|February 2013|2013-02-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|FEN001||An Assessment of Fentanyl Dose Requirements in Opioid-maintained Individuals|An Assessment of Fentanyl Dose Requirements in Opioid-maintained Individuals|Unknown status|Recruiting|N/A|24|Anticipated|University of Adelaide||1|||f||||f||||||||||2017-10-11 04:13:21.730451|2017-10-11 04:13:21.730451
NCT01358487|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-12|2013-03-11|||July 2011||2011-07-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Healthy Mood Internet Intervention Research Project|Internet Intervention to Prevent Major Depressive Episodes|Completed||Phase 1|116|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 04:13:21.836661|2017-10-11 04:13:21.836661
NCT01358474|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-01-26|||July 2011||2011-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|October 2014|Actual|2014-10-01||Observational|||Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism|Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism|Active, not recruiting||N/A|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||3||f||||f||||||||||2017-10-11 04:13:21.922651|2017-10-11 04:13:21.922651
NCT01358461|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-09-07|||March 2011|Actual|2011-03-01|September 2017|2017-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Validation of a Non Invasive Blood Marker of SIDS and Vagal Disorders|Circulating Biomarker(s) of Muscarinic Receptor Overexpression and Vagal Disorders.|Completed||N/A|240|Actual|University Hospital, Strasbourg, France|||2||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 04:13:22.000381|2017-10-11 04:13:22.000381
NCT01358448|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-07-14|||April 2011|Actual|2011-04-01|July 2017|2017-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Pilot Study of the Efficacy and Program Cost-effectiveness of Prevention Plus for Childhood Obesity|A Pilot Study of the Efficacy and Program Cost-effectiveness of Prevention Plus for Childhood Obesity|Completed||N/A|22|Actual|University of Tennessee||3|||f||||||||||||||2017-10-11 04:13:22.091533|2017-10-11 04:13:22.091533
NCT01358435|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2012-12-26|||January 2011||2011-01-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects|Randomized,Single Center,Double Blind,Two-period,Crossover Glucose Clamp Trial Study to Test Bioequivalence Between Two Recombinant Human Mixed Insulins-Wockhardt's Human/Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects|Completed||Phase 1|53|Actual|Wockhardt||2|||f||||f||||||||||2017-10-11 04:13:22.207297|2017-10-11 04:13:22.207297
NCT01358422|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2015-10-12|||October 2011||2011-10-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|OBTAIN||Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery|Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery. A Prospective Observational Study (OBTAIN Study)|Completed||N/A|830|Actual|European Society of Anaesthesiology|||1||f||||f||||||||||2017-10-11 04:13:22.308048|2017-10-11 04:13:22.308048
NCT01358409|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-20|2017-07-12|||April 1, 2011||2011-04-01|July 2017|2017-07-01|February 11, 2013|Actual|2013-02-11|February 11, 2013|Actual|2013-02-11||Interventional|||Regression of Myocardial Steatosis by Nebivolol|Regression of Myocardial Steatosis by Nebivolol|Completed||Early Phase 1|31|Actual|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-10-11 04:13:22.426464|2017-10-11 04:13:22.426464
NCT01358396|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-05-20|||January 2010||2010-01-01|January 2010|2010-01-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Observational|||Glycemic Control and Diabetic Macular Edema|The Effect of Glycemic Control on Visual and Anatomical Outcomes in Response to Therapy for Diabetic Macular Edema.|Completed||Phase 1|52|Actual|Cairo University|||1||f||||f||||||||||2017-10-11 04:13:22.52714|2017-10-11 04:13:22.52714
NCT01358383|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2012-06-21|||May 2011||2011-05-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers|A Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of a Single Oral Dose of VIMOVO (250 mg Naproxen/20 mg Esomeprazole)in Healthy Adult Subjects|Completed||Phase 1|28|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 04:13:22.611891|2017-10-11 04:13:22.611891
NCT01358370|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2016-06-23|||November 2010||2010-11-01|June 2016|2016-06-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Observational|||A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype|A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype|Completed||N/A|40|Actual|Alexion Pharmaceuticals|||1||f||||f||||||||No||2017-10-11 04:13:22.713361|2017-10-11 04:13:22.713361
NCT01358357|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-07-29|2016-03-24||June 2011||2011-06-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|PERSIST||Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex|A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder|Completed||Phase 3|965|Actual|Sunovion||2|||f||||t||||||||||2017-10-11 04:13:22.863678|2017-10-11 04:13:22.863678
NCT01358344|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-09-28|||August 2010||2010-08-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)|A Study to Determine the Bioequivalence of SCH 530348 2.5 mg Tablets Containing a High and Low Percentage of Drug as the Free Base Within the Range Used in the Pivotal Phase 3 Efficacy and Safety Trials. (Protocol No. P06558)|Completed||Phase 1|173|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:13:24.490576|2017-10-11 04:13:24.490576
NCT01358331|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-06-05|||November 2011||2011-11-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)|A Phase 1 Study to Evaluate the Safety, Tolerability and Efficacy of MK-8353 (Formerly SCH 900353) in Subjects With Advanced Solid Tumors (Protocol No. 001 (Formerly P06203))|Terminated||Phase 1|26|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 04:13:24.572281|2017-10-11 04:13:24.572281
NCT01358318|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-06-06|||February 2011||2011-02-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|May 2011|Actual|2011-05-01||Interventional|||Effects of Soy Protein/Soy Fiber on Measures of Satiety|Effect of Addition of Soy Protein and Soy Fiber to a Snack Bar on Satiety and Food Intake|Completed||N/A|40|Actual|Solae, LLC||4|||f||||||||||||||2017-10-11 04:13:24.63416|2017-10-11 04:13:24.63416
NCT01358305|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-12-04|||January 2011||2011-01-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|August 2012|Actual|2012-08-01||Interventional|||Protein Blends (Soy, Whey and Casein) for Muscle Synthesis|A Randomized, Controlled Double Blind Acute Study: Effects of Protein Blends on Muscle Protein Synthesis and Breakdown|Completed||N/A|19|Actual|Solae, LLC||2|||f||||t||||||||||2017-10-11 04:13:24.708175|2017-10-11 04:13:24.708175
NCT01358292|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-14|2016-06-16|||February 2011||2011-02-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2015|Actual|2015-09-01||Interventional|TrigenMETA||Efficacy Study of Surgical Technique in Intramedullary Tibia Nailing, Using Trigen META Tibia Nails|Semi-extended Position vs. 90 Degrees of Flexion for Intramedullary Nailing of the Tibia: a Randomized Clinical Trial|Completed||Phase 4|95|Actual|Smith & Nephew, Inc.||2|||f||||t||||||||No||2017-10-11 04:13:24.789241|2017-10-11 04:13:24.789241
NCT01358279|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-10-23|||January 2009||2009-01-01|October 2016|2016-10-01|March 2011|Actual|2011-03-01|October 2009|Actual|2009-10-01||Interventional|||Transcranial Direct Current Stimulation for Migraine Attack|Manho Kim, MD, PhD Professor, Neurology Seoul National University Hospital,|Completed||N/A|32|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-10-11 04:13:24.870365|2017-10-11 04:13:24.870365
NCT01358266|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-09-26|||May 2011||2011-05-01|September 2017|2017-09-01|December 2016|Actual|2016-12-01|September 2016|Actual|2016-09-01||Interventional|SAKURA||Study Assessing Double-masked Uveitis Treatment|A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis|Completed||Phase 3|592|Actual|Santen Inc.||3|||f||||t||||||||||2017-10-11 04:13:24.935716|2017-10-11 04:13:24.935716
NCT01358253|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2014-05-19|||December 2010||2010-12-01|May 2011|2011-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia|Prospective Study of Rituximab Combined With Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia|Completed||Phase 4|100|Actual|Ruijin Hospital||2|||f||||t||||||||||2017-10-11 04:13:26.91904|2017-10-11 04:13:26.91904
NCT01358240|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-09-27|||June 2011||2011-06-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis|A Multi-Center, Randomized, Double-Blind, Vehicle Controlled, Parallel Group Comparison of Econazole Nitrate Foam 1% vs Foam Vehicle and an Evaluator-Blinded Comparison of Econazole Nitrate Foam 1% and Econazole Nitrate Cream 1% in Subjects With Interdigital Tinea Pedis|Completed||Phase 3|336|Actual|AmDerma||4|||f||||f||||||||||2017-10-11 04:13:27.020501|2017-10-11 04:13:27.020501
NCT01358227|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-05-23|||December 2006||2006-12-01|May 2011|2011-05-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors|A Phase I, Multi-center, Open-label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR104 Given Weekly in Subjects With Solid Tumors|Completed||Phase 1|26|Actual|Proacta, Incorporated||1|||f||||f||||||||||2017-10-11 04:13:27.27703|2017-10-11 04:13:27.27703
NCT01358214|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2012-08-22|||May 2011||2011-05-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape)|Single-center, Non-randomized, Comparative, Post-marketing Surveillance Cohort Study on Validation of a Questionnaire on Quality of Life After Surgical Stabilization of the Urethra With Titanized Polypropylene Mesh (TiLOOP® Tape)|Terminated||N/A|21|Actual|pfm medical ag|||3|major recruitment failure|f||||f||||||||||2017-10-11 04:13:27.370831|2017-10-11 04:13:27.370831
NCT01358201|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-12-08|||May 2010||2010-05-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years|Treatment Protocol For All Fragile Patients Ph' Negative Over 55 Years|Recruiting||Phase 4|100|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-10-11 04:13:27.495932|2017-10-11 04:13:27.495932
NCT01358188|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-04-03|||April 2011||2011-04-01|April 2017|2017-04-01|May 2, 2016|Actual|2016-05-02|May 2, 2016|Actual|2016-05-02||Observational|||Exploration of Immunity in Gaucher Disease|Prospective Study of Macrophage Activation and Cross Talk Between Immune System Elements in Subjects With Gaucher Disease|Completed||N/A|33|Actual|O & O Alpan LLC|||2||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 04:13:27.886827|2017-10-11 04:13:27.886827
NCT01358175|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-01-27|2015-12-14||October 2011||2011-10-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MEASURE 1||16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis|A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Secukinumab to Demonstrate the 16 Week Efficacy and to Assess the Long Term Safety, Tolerability and Efficacy up to 2 Years in Patients With Active Ankylosing Spondylitis|Completed||Phase 3|371|Actual|Novartis||3|||f||||t||||||||||2017-10-11 04:13:28.009997|2017-10-11 04:13:28.009997
NCT01358162|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-18|2013-05-10|||November 2010||2010-11-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||Phase IC Study of Safety and PK of SQ109 300mg Daily|A Phase 1C, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate the Safety, Tolerability and Pharmacokinetics of 300 mg of SQ109 Given Once Daily for 14 Days in Normal, Healthy Male and Female Volunteers|Completed||Phase 1|10|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:13:30.497665|2017-10-11 04:13:30.497665
NCT01358149|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2013-10-29|||May 2011||2011-05-01|October 2013|2013-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Trial of Cocoa-based Food in Children|Double Blind Controlled Trial of Cocoa-based Food in Children|Completed||N/A|25|Actual|Nestlé||2|||f||||t||||||||||2017-10-11 04:13:30.587668|2017-10-11 04:13:30.587668
NCT01358136|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2012-04-24|||May 2011||2011-05-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|August 2012|Anticipated|2012-08-01||Observational|ThyrOp||ThyrOp: A Study of Individual Subclinical Hypothyroidism After Hemithyroidectomy for Benign Nontoxic Goiter|ThyrOp: Individual Subclinical Hypothyroidism After Hemithyroidectomy for Benign Nontoxic Goiter - Focus on Weight Gain and Mitochondrial Dysfunction|Unknown status|Recruiting|N/A|30|Anticipated|Naestved Hospital|||1||f||||f||||||||||2017-10-11 04:13:30.653017|2017-10-11 04:13:30.653017
NCT01358123|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-09-24|||September 2006||2006-09-01|September 2015|2015-09-01|June 2016|Anticipated|2016-06-01|May 2016|Anticipated|2016-05-01||Observational|||Value of Von Willebrand Factor in Portal Hypertension|Von Willebrand Factor As Non-Invasive Predictor Of Clinically Significant Portal Hypertension And Mortality In Patients With Liver Cirrhosis|Unknown status|Recruiting|N/A|300|Anticipated|Medical University of Vienna|||1||f||||||||||||||2017-10-11 04:13:30.723374|2017-10-11 04:13:30.723374
NCT01358110|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-06-25|||May 2011||2011-05-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Emergency Department-Based Palliative Care for Advanced Cancer Patients|Emergency Department-Based Palliative Care for Advanced Cancer Patients|Completed||N/A|136|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 04:13:30.804662|2017-10-11 04:13:30.804662
NCT01358097|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-04-08|||October 2010||2010-10-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy|Biomarkers of Immune Function as Predictors of Head and Neck Squamous Cell Carcinoma (HNSCC) in Response to Therapy|Completed||N/A|33|Actual|Icahn School of Medicine at Mount Sinai|||3||f||||f||||||Samples With DNA|"     Serum, peripheral blood mononuclear cells   "|||2017-10-11 04:13:31.067243|2017-10-11 04:13:31.067243
NCT01358084|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-05-27|||March 2011||2011-03-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|NGR019||Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma|NGR019: Randomized Double-blind Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma (MPM)|Recruiting||Phase 2|100|Anticipated|MolMed S.p.A.||2|||f||||f||||||||||2017-10-11 04:13:31.228874|2017-10-11 04:13:31.228874
NCT01358071|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-10-08|||June 2011||2011-06-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|NGR018||Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer|NGR018: Randomized Phase II Study of NGR-hTNF Plus an Anthracycline Versus an Anthracycline Alone in Platinum-resistant Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|124|Anticipated|MolMed S.p.A.||2|||f||||f||||||||||2017-10-11 04:13:31.427483|2017-10-11 04:13:31.427483
NCT01358058|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-07-18|||May 2011||2011-05-01|July 2017|2017-07-01|May 2019|Anticipated|2019-05-01|December 2017|Anticipated|2017-12-01||Interventional|||Proton Radiation Therapy for Gliomas|Phase II Study of Proton Radiation Therapy for Low Grade and Favorable Grade 3 Gliomas|Recruiting||Phase 2|50|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 04:13:31.581973|2017-10-11 04:13:31.581973
NCT01358045|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2015-01-12|||November 2011||2011-11-01|January 2015|2015-01-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma|Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma|Completed||Phase 2|128|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-10-11 04:13:31.707654|2017-10-11 04:13:31.707654
NCT01358032|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-07-09|||March 2009||2009-03-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Evaluating an In-home Multicomponent Program to Manage Concerns About Falling in Frail Community Dwelling Older People|Evaluating the Effectiveness of an In-home Self-management Intervention to Prevent Psychological Distress in Frail Older People Living in the Community|Completed||N/A|389|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-10-11 04:13:31.862211|2017-10-11 04:13:31.862211
NCT01358019|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-01-25|||May 2011||2011-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|2523355-001||A Study of LY2523355 in Patients With Solid Cancer|A Phase 1 Study of LY2523355 in Patients With Solid Cancer|Completed||Phase 1|18|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||||||||||||2017-10-11 04:13:31.99989|2017-10-11 04:13:31.99989
NCT01358006|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-07-08|||November 2010||2010-11-01|July 2013|2013-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Dose-Ranging Study of JNJ-40411813 in Healthy Male Volunteers|An Open Label Dose-Ranging Study in Healthy Male Subjects to Investigate the Binding Potential of JNJ-40411813 to Serotonin 2A Receptors in the Central Nervous System|Completed||Phase 1|13|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 04:13:32.10799|2017-10-11 04:13:32.10799
NCT01357993|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2014-03-27|||May 2011||2011-05-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder|An Open-Label, Dose-Titration, Long-Term Study to Evaluate the Safety of JNS001 in Adults With Attention-Deficit/Hyperactivity Disorder at Doses of 18 mg, 27 mg, 36 mg, 45 mg, 54 mg, 63 mg or 72 mg Per Day|Completed||Phase 3|253|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-10-11 04:13:32.251099|2017-10-11 04:13:32.251099
NCT01357811|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-03-19|||August 2011||2011-08-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy Adults|A Single-site, Open-label, Fixed-sequence Phase 1 Study Evaluating the Effect of Eliglustat (Genz-112638) on the Pharmacokinetics and Safety and Tolerability of Digoxin in Healthy Adult Subjects|Completed||Phase 1|28|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 04:13:38.122056|2017-10-11 04:13:38.122056
NCT01357980|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2014-08-21|2014-03-27||May 2011||2011-05-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Demographic characteristics of the Intent to Treat (ITT) population: All randomised subjects who received at least one injection of study treatment and had an assessment for the averaged daily IEF both at Baseline and Day 84.|Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis|A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.|Completed||Phase 2|47|Actual|Ipsen||4|||f||||f||||||||||2017-10-11 04:13:32.441446|2017-10-11 04:13:32.441446
NCT01357967|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-10-31|||May 2011||2011-05-01|October 2012|2012-10-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|||The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope|The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope|Unknown status|Recruiting|Phase 4|60|Anticipated|Inje University||2|||f||||f||||||||||2017-10-11 04:13:33.816783|2017-10-11 04:13:33.816783
NCT01357954|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2013-03-19|||June 2010||2010-06-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|May 2012|Actual|2012-05-01||Interventional|||The Efficacy of Targeted Training on the Postural Control and Gross Motor Function in Children With Cerebral Palsy||Unknown status|Active, not recruiting|N/A|28|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 04:13:34.01738|2017-10-11 04:13:34.01738
NCT01357941|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-06-02|||September 2011||2011-09-01|June 2011|2011-06-01|September 2014|Anticipated|2014-09-01|September 2013|Anticipated|2013-09-01||Observational|ROCITP2||Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)|Prospective Study Assessing the Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism|Unknown status|Not yet recruiting|N/A|203|Anticipated|Hamilton Health Sciences Corporation|||2||f||||t||||||||||2017-10-11 04:13:34.131679|2017-10-11 04:13:34.131679
NCT01357928|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-09-04|||April 2011||2011-04-01|September 2012|2012-09-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Observational|||Thromboelastography (TEG) Reference Range Study|Procedure for the Reference Range Study for Haemoscope Reagents|Completed||N/A|159|Actual|Haemonetics Corporation|||1||f||||f||||||||||2017-10-11 04:13:34.243325|2017-10-11 04:13:34.243325
NCT01357915|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-05-12|2017-05-12||June 24, 2011|Actual|2011-06-24|May 2017|2017-05-01|September 13, 2012|Actual|2012-09-13|September 13, 2012|Actual|2012-09-13||Interventional|||Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine|A Follow-up Study to Evaluate the Long-term Persistence of GSK Biologicals' Candidate CMV Vaccine Administered to Male Adults|Completed||N/A|47|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 04:13:34.323831|2017-10-11 04:13:34.323831
NCT01357902|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-09-18|||April 18, 2011|Actual|2011-04-18|September 2017|2017-09-01|May 23, 2011|Actual|2011-05-23|May 23, 2011|Actual|2011-05-23||Interventional|||Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China|An Open Label, Randomized, Cross-Over Study to Investigate the Single Dose Bioequivalence of Lamotrigine Dispersible/Chewable Tablets (5mg) Compared to Lamotrigine Compressed/Standard Tablets (25mg) in Chinese Healthy Male Subjects|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 04:13:34.749835|2017-10-11 04:13:34.749835
NCT01357889|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-11-18|2014-04-24|2013-05-02|July 2011||2011-07-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Pharmacokinetics/Pharmacodynamics of Albiglutide|A Multidose Study in Subjects With Type 2 Diabetes Mellitus to Assess the Pharmacokinetics and Pharmacodynamics of Albiglutide|Completed||Phase 2|283|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:13:34.87965|2017-10-11 04:13:34.87965
NCT01357876|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-04|2017-06-21|||October 1, 2010|Actual|2010-10-01|June 2017|2017-06-01|July 7, 2011|Actual|2011-07-07|July 7, 2011|Actual|2011-07-07||Interventional|||Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics|Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics|Completed||Phase 1|8|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 04:13:35.984489|2017-10-11 04:13:35.984489
NCT01357863|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-05-23|||July 2010||2010-07-01|May 2017|2017-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|(TYCO1)||Role of Early Versus Late Switch to Lapatinib-Capecitabine|Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab Progression: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO1) - Brazil|Terminated||N/A|3|Actual|GlaxoSmithKline|||2|This study was terminated because the National Ethics Committee has not approved the protocol.|f||||f||||||||||2017-10-11 04:13:36.057038|2017-10-11 04:13:36.057038
NCT01357850|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-11|2017-07-14|2014-04-17|2013-04-05|September 15, 2010|Actual|2010-09-15|July 2017|2017-07-01|September 18, 2012|Actual|2012-09-18|September 18, 2012|Actual|2012-09-18||Interventional|||A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure|A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure|Completed||Phase 2|82|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 04:13:36.196414|2017-10-11 04:13:36.196414
NCT01357837|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-01-22|||May 2011||2011-05-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Assessment of GRT6005 in Painful Osteoarthritis of the Knee|A Randomized 4 Week Phase IIa Trial Evaluating the Efficacy, Safety, and Tolerability of GRT6005, a New Centrally Acting Analgesic, in Subjects With Moderate to Severe Pain Due to Osteoarthritis (OA) of the Knee|Completed||Phase 2|207|Actual|Grünenthal GmbH||4|||f||||f||||||||||2017-10-11 04:13:37.808811|2017-10-11 04:13:37.808811
NCT01357824|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2012-01-29|||June 2011||2011-06-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Observational|||Fibreoptic Intubation With and Without Sellick´s Maneuver|View af Larynx and Intubation With a Flexible Fibreoptic Scope With and Without Sellick´s Maneuver.|Completed||N/A|50|Anticipated|Glostrup University Hospital, Copenhagen|||1||f||||f||||||||||2017-10-11 04:13:37.98928|2017-10-11 04:13:37.98928
NCT01357798|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2011-05-20|||December 2010||2010-12-01|May 2011|2011-05-01||||April 2011|Actual|2011-04-01||Interventional|||Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache|Botulinum Toxin Type A Versus 0,9% Saline in Treatment of Cranial Allodynia in Patients With Headache|Completed||Phase 3|40|Anticipated|Federal University of Bahia||2|||f||||f||||||||||2017-10-11 04:13:38.224523|2017-10-11 04:13:38.224523
NCT01357772|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2015-08-03|||November 2008||2008-11-01|August 2015|2015-08-01|December 2023|Anticipated|2023-12-01|December 2019|Anticipated|2019-12-01||Interventional|TAM-01||Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia|Randomized Placebo-controlled Phase III Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia|Active, not recruiting||Phase 3|1400|Anticipated|Ente Ospedaliero Ospedali Galliera||2|||f||||t||||||||||2017-10-11 04:13:38.452562|2017-10-11 04:13:38.452562
NCT01357759|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-11-13|||May 2013||2013-05-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Trial of MORAb-022 in Healthy Subjects and Subjects With Rheumatoid Arthritis|Completed||Phase 1|20|Actual|Morphotek||2|||f||||f||||||||||2017-10-11 04:13:38.630599|2017-10-11 04:13:38.630599
NCT01357746|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-08-17|||July 2011||2011-07-01|May 2011|2011-05-01||||June 2012|Actual|2012-06-01||Interventional|||Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)|Detection, Estimation and Characterization of Pulmonary Blood Pressure by Transthoracic Parametric Doppler (TPD)|Terminated||Phase 1|60|Actual|Echosense Ltd.||1||Low recruitment|f||||f||||||||||2017-10-11 04:13:38.740169|2017-10-11 04:13:38.740169
NCT01357733|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2012-04-09|||March 2012||2012-03-01|April 2012|2012-04-01|March 2016|Anticipated|2016-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients|Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma|Unknown status|Recruiting|N/A|130|Anticipated|The Catholic University of Korea||1|||f||||t||||||||||2017-10-11 04:13:38.832293|2017-10-11 04:13:38.832293
NCT01357720|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-08-29|2013-03-27||May 2011||2011-05-01|August 2013|2013-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination|A Phase IV, Single-blind, Randomized, Controlled, Monocentric Study to Assess the Interchangeability of Quinvaxem (DTwP-HepB-Hib) as the 2nd and 3rd Dose After Initial Vaccination With Tritanrix HB+Hib (DTwP-HepB/Hib) With Respect to Safety and Immunogenicity in Healthy Infants at 6, 10 and 14 Weeks of Age|Completed||Phase 4|400|Actual|Crucell Holland BV||2|||f||||f||||||||||2017-10-11 04:13:38.993525|2017-10-11 04:13:38.993525
NCT01357707|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2013-07-05|||July 2010||2010-07-01|July 2013|2013-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Clinical-genetic Investigations in Children With Early Infantile Epilepsies|Clinical-genetic Investigations in Children With Early Infantile Epilepsies|Unknown status|Recruiting|N/A|50|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"     DNA isolated from blood cells or from saliva   "|||2017-10-11 04:13:39.450504|2017-10-11 04:13:39.450504
NCT01357694|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-01-23|||May 2011||2011-05-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|February 2013|Actual|2013-02-01||Interventional|BRIA||BRIA - Bridging Intervention in Anesthesiology|Open Monocentric Randomized Clinical Trial on the Efficacy of the Psychotherapeutic Bridging Intervention in Anesthesiology (BRIA)|Completed||N/A|220|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-10-11 04:13:39.553349|2017-10-11 04:13:39.553349
NCT01357681|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2015-06-15|||September 2011||2011-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|ETON||Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)|Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease The ETON-Study - A Randomized, Double-blind, Stratified, Placebo-controlled Prospective Investigator Initiated Multicenter Trial -|Completed||Phase 2|54|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 04:13:39.675478|2017-10-11 04:13:39.675478
NCT01357668|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2017-10-03|||January 31, 2013|Actual|2013-01-31|October 2017|2017-10-01|December 31, 2029|Anticipated|2029-12-31|December 31, 2029|Anticipated|2029-12-31||Observational|||An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis|An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis|Recruiting||N/A|900|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 04:13:39.808105|2017-10-11 04:13:39.808105
NCT01357655|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-01-24|2017-01-24||September 2011||2011-09-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional||All Treated Participants|Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)|An Open-Label, Randomized, Multicenter Phase 2 Trial of Dasatinib (SPRYCEL®) vs. Dasatinib Plus Smoothened Antagonist (BMS-833923) in the Treatment of Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia (CML).|Terminated||Phase 2|70|Actual|Bristol-Myers Squibb|No recommended phase 2 dose of the SMO antagonist was determined (in a separate trial). It was decided to discontinue enrollment and end this trial early. The decision was not made due to any new safety signals for dasatinib or the SMO antagonist.|2||"No participants enrolled in this trial could receive the SMO antagonist as a recommended phase   2 dose was not determined by a different, concurrently-run trial."|f||||f||||||||||2017-10-11 04:13:40.182881|2017-10-11 04:13:40.182881
NCT01357642|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-19|2016-02-11||2016-02-11|July 2011||2011-07-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients|Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients|Completed||Phase 3|373|Actual|Amphastar Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-10-11 04:13:40.681481|2017-10-11 04:13:40.681481
NCT01357629|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-21|2013-12-10|||July 2011||2011-07-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Observational|||Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease|Observational Follow-up Extension Study to Evaluate Long-term Safety and Tolerability of Immunizations With AFFITOPE AD02 Applied During AFFiRiS002 and AFF004A in Patients With Alzheimer's Disease|Terminated||N/A|11|Actual|Affiris AG|||1|"The Study could not be done for every potential participant as planned in the protocol for   organizational reasons."|f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 04:13:41.027238|2017-10-11 04:13:41.027238
NCT01357616|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2014-03-13|2014-01-30||November 2010||2010-11-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||This reporting group includes all subjects who received study medication, satisfied pre-randomization inclusion/exclusion criteria and completed at least 1 scheduled on-therapy study visit.|Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension|Comparison of Efficacy and Safety of Brinzolamide/Timolol Fixed Combination (AZARGA™) vs Brinzolamide (AZOPT®) and Timolol in Chinese Subjects With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|328|Actual|Alcon Research||2|||f||||f||||||||||2017-10-11 04:13:41.105686|2017-10-11 04:13:41.105686
NCT01357603|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2013-01-24|||June 2011||2011-06-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM|A Randomized, Double-blind, Two Period, Cross Over Glucose Clamp Study to Test for Bioeqivalence Between Two Long Acting Insulin Analogs-Wockhardt's Glaritus™ (Insulin Glargine) and Lantus (Insulin Glargine) in Subjects With Type 1 Diabetes|Completed||Phase 1|111|Actual|Wockhardt||2|||f||||f||||||||||2017-10-11 04:13:41.445179|2017-10-11 04:13:41.445179
NCT01357512|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2015-12-02|2015-06-01||April 2011||2011-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional||Population with protocol violations excluded|Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer|Evaluation of Diagnostic Value of 3-T MRI in Suspected Prostate Cancer|Active, not recruiting||N/A|130|Actual|University of Oulu||2|||f||||f||||||||||2017-10-11 04:13:41.54233|2017-10-11 04:13:41.54233
NCT01357499|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2016-11-15|||December 2010||2010-12-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|REMOTE||Lower Leg Remote Ischemic Preconditioning in Elective Percutaneous Coronary Intervention (PCI)|Effects of Lower Leg Remote Ischemic Preconditioning in Combination With Electric Muscle Stimulation in Elective Coronary Artery Revascularisation|Withdrawn||Early Phase 1|0|Actual|University Medicine Greifswald|||3|PI left center|f||||f||||||Samples Without DNA|"     venous blood samples (10 ml) will be taken from the femoral vein of the preconditioned leg     immediately before and after the preconditioning cycles.      Also arterial blood samples (10 ml)will be taken immediately before and after the     preconditioning cycle.   "|||2017-10-11 04:13:41.922762|2017-10-11 04:13:41.922762
NCT01357486|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-04-28|||November 14, 2011|Actual|2011-11-14|April 2017|2017-04-01|April 12, 2017|Actual|2017-04-12|April 12, 2017|Actual|2017-04-12||Interventional|PRODIGE 21||Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis|Phase II Randomized Trial Evaluating the Administration of Sorafenib or Pravastatin or Association Sorafenib-pravastatin or Best Supportive Care for the Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis|Completed||Phase 2|160|Actual|University Hospital, Bordeaux||4|||f||||t||||||||||2017-10-11 04:13:42.053721|2017-10-11 04:13:42.053721
NCT01357473|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-19|||November 2009||2009-11-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|February 2010|Actual|2010-02-01||Observational|||Stop Menstruation and Pregnancy Rates in Antagonist Protocol|Is Hormonal Exposure of Endometrium on the First Day After Menstruation Associated With the Probability of Pregnancy in Patients Treated With Rec-FSH/ GnRH Antagonist? A Prospective Trial|Completed||N/A|90|Anticipated|Universitair Ziekenhuis Brussel|||1||f||||f||||||||||2017-10-11 04:13:42.279646|2017-10-11 04:13:42.279646
NCT01357460|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-19|||May 2011||2011-05-01|May 2011|2011-05-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency|Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency|Unknown status|Recruiting|Phase 2/Phase 3|25|Anticipated|Heidelberg University||1|||f||||||||||||||2017-10-11 04:13:42.361141|2017-10-11 04:13:42.361141
NCT01357447|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2012-03-29|||May 2011||2011-05-01|March 2012|2012-03-01||||May 2012|Anticipated|2012-05-01||Interventional|||Pulmozyme for Sjogren's Associated Cough|A Double-blind, Placebo-controlled Cross-over Trial of Pulmozyme for Sjogren's Associated Cough|Withdrawn||Phase 1|0|Actual|UConn Health||2||No patients enrolled.|f||||f||||||||||2017-10-11 04:13:42.474036|2017-10-11 04:13:42.474036
NCT01357434|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-06-23|||May 2011||2011-05-01|May 2011|2011-05-01||||May 2011|Actual|2011-05-01||Observational|||Comparing Calories at Fast Food Restaurants|Rating Fast Food on Healthiness|Completed||N/A|97|Actual|University of California, Los Angeles|||1||f||||f||||||||||2017-10-11 04:13:42.579474|2017-10-11 04:13:42.579474
NCT01357421|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2013-06-04|||May 2011||2011-05-01|June 2013|2013-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effects of TT301 on Cytokine Levels Post Endotoxin Challenge|A Phase 1 Double-blind, Randomized, Placebo-controlled Study Evaluating the Effects of a Single Intravenous Dose of TT301 on LPS-induced Changes in Blood Cytokine Levels in Healthy Male Volunteers|Completed||Phase 1|18|Actual|Transition Therapeutics||2|||f||||f||||||||||2017-10-11 04:13:42.683988|2017-10-11 04:13:42.683988
NCT01357408|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2013-01-04|||May 2011||2011-05-01|January 2013|2013-01-01||||December 2012|Actual|2012-12-01||Observational|HF-RADAR||Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters|Phase 4 Registry Study Will Evaluate the Ability of Cardiac Rhythm (Cardiac Compass) Data to Predict Future Cardiac Events in Heart Failure (HF) Patients Recently Discharged After a Hospitalization for Heart Failure Who Have or Plan to Have a Implanted Loop Recorder (ILR), Specifically, the Reveal XT Device.|Terminated||N/A|40|Actual|Thomas Jefferson University|||1|enrollment futility|f||||f||||||||||2017-10-11 04:13:42.784036|2017-10-11 04:13:42.784036
NCT01357395|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-10-17|||May 2011||2011-05-01|September 2012|2012-09-01|May 2013|Anticipated|2013-05-01|November 2012|Anticipated|2012-11-01||Interventional|ESCAPE||A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer|A Phase 2, Open-Label, Multi-Center Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer Subjects Who Have Not Responded to Standard Treatment or Relapsed After Standard Treatment|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Astex Pharmaceuticals||1|||f||||f||||||||||2017-10-11 04:13:42.869933|2017-10-11 04:13:42.869933
NCT01357382|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2011-05-19|||June 2011||2011-06-01|April 2011|2011-04-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|||The ACT-OUT Trial: ACTivity OUTcomes Based on High Carbohydrate or High Fat Diet in Metabolic Syndrome|The ACT-OUT Trial: ACTivity OUTcomes Based on the Consumption of a High Carbohydrate or High Fat Diet in Patients With Metabolic Syndrome|Unknown status|Not yet recruiting|Phase 4|72|Anticipated|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 04:13:43.056674|2017-10-11 04:13:43.056674
NCT01357369|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2016-04-19|||January 2011||2011-01-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates|Pharmacokinetics and Placental Transfer of Ondansetron and Cefazolin: A Preliminary Analysis|Completed||N/A|20|Actual|Stanford University|||1||f||||||||||Samples Without DNA|"     Blood samples for pharmacokinetics.   "|||2017-10-11 04:13:43.156999|2017-10-11 04:13:43.156999
NCT01357356|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-11-23||2015-11-23|May 2011||2011-05-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|October 2012|Actual|2012-10-01||Interventional|||Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia|A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of SER120 Nasal Spray Formulations in Patients With Nocturia|Completed||Phase 2/Phase 3|816|Actual|Serenity Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-10-11 04:13:43.238744|2017-10-11 04:13:43.238744
NCT01357343|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-22|2015-06-24|||February 2011||2011-02-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Integrated Chiropractic and Acupuncture Treatment for Low Back Pain|Effect of an Integrative Approach of Chiropractic and Traditional Chinese Medicine Care on Low Back Pain: A Randomized Controlled Trial|Completed||Phase 2|103|Actual|Southern California University of Health Sciences||3|||f||||f||||||||||2017-10-11 04:13:43.322217|2017-10-11 04:13:43.322217
NCT01357330|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-03-31|||May 2011||2011-05-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors|A Phase 1 Dose Escalation Study of Combination Therapy With Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|18|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 04:13:43.415188|2017-10-11 04:13:43.415188
NCT01357317|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-04|2012-06-11|||June 2011||2011-06-01|April 2011|2011-04-01|March 2014|Anticipated|2014-03-01|October 2013|Anticipated|2013-10-01||Interventional|||Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction|Changes in Biochemical and Vascular Parameters w/Lanthanum Carbonate & Calcium Acetate Therapy Compared to Dietary Intervention in Pts w/Stage 3 & 4 Chronic Kidney Disease & Abnormal Phosphorus Homeostasis: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|120|Anticipated|Salem Veterans Affairs Medical Center||3|||f||||t||||||||||2017-10-11 04:13:43.503289|2017-10-11 04:13:43.503289
NCT01357304|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2012-11-23|||March 2011||2011-03-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|10PAR||10 Prescriptions an Hour. Group Treatment and Physical Activity Referral in a Primary Health Care Setting|Randomized Controlled Trial of Group Treatment With Physical Activity Referral in a Primary Health Care Setting|Completed||N/A|105|Actual|Region Skane||2|||f||||f||||||||||2017-10-11 04:13:43.606273|2017-10-11 04:13:43.606273
NCT01357291|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-05-19|||March 2011||2011-03-01|May 2011|2011-05-01|May 2012|Anticipated|2012-05-01|March 2012|Anticipated|2012-03-01||Interventional|RRP||Evaluating New Mexico's Recidivism Reduction Program|Evaluating New Mexico's Prison-Based Recidivism Reduction Program|Unknown status|Enrolling by invitation|N/A|159|Anticipated|Pepperdine University||2|||f||||f||||||||||2017-10-11 04:13:43.680008|2017-10-11 04:13:43.680008
NCT01357278|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-21|2015-10-14|||January 2007||2007-01-01|October 2015|2015-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|ARO||Active Rehabilitation in Osteoporotic Patients|Effect of Active Rehabilitation on Risk Factors for Fall, Bone Mineral Density, and the Quality of Life in Osteoporotic Patients. A Randomized, Controlled Intervention Study|Completed||N/A|80|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-10-11 04:13:43.769368|2017-10-11 04:13:43.769368
NCT01357265|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2011-12-06|||May 2011||2011-05-01|December 2011|2011-12-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects|A Phase II Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface, Antigen, Inactivated, Influenza Vaccine, Formulation 2011/2012, When Administered to Adult and Elderly Subjects|Completed||Phase 2|125|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:13:43.880109|2017-10-11 04:13:43.880109
NCT01357252|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-04-02|||April 2011||2011-04-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes|A Multicenter, Double-blind, Randomized, Parallel-group Study to Compare the Effect of 24 Weeks Treatment With Vildagliptin 50mg qd to Placebo as add-on Therapy to Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy.|Completed||Phase 3|279|Actual|Novartis||2|||f||||t||||||||||2017-10-11 04:13:43.958512|2017-10-11 04:13:43.958512
NCT01357239|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-05-10|2014-12-29||May 2011||2011-05-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AFQ056 in Adolescent Patients With Fragile X Syndrome|Completed||Phase 2|139|Actual|Novartis||4|||f||||||||||||||2017-10-11 04:13:44.264953|2017-10-11 04:13:44.264953
NCT01357213|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2014-12-04|||May 2011||2011-05-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|||Phase 1 PK Study of XOMA 3AB|A Phase I, Blinded, Placebo-controlled, Dose-escalation Study of the Safety and Pharmacokinetics of XOMA 3AB Administered Intravenously in Healthy Adults|Completed||Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:13:45.41419|2017-10-11 04:13:45.41419
NCT01357200|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-15|2014-01-29|||May 2011||2011-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Feeding Trial in the Obese Critical Care Population|Enteral Formula Tolerance in the Obese Critical Care Population|Completed||N/A|26|Actual|Nestlé|||1||f||||f||||||Samples Without DNA|"     serum   "|||2017-10-11 04:13:45.4972|2017-10-11 04:13:45.4972
NCT01357005|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-29|2011-05-19|||October 2010||2010-10-01|May 2011|2011-05-01||||December 2013|Anticipated|2013-12-01||Observational|||Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan|Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan|Unknown status|Recruiting|N/A|300|Anticipated|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-10-11 04:13:50.676776|2017-10-11 04:13:50.676776
NCT01357187|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-03-16|||September 2011||2011-09-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||An Evaluation of the Effect of the AmnioFix Amniotic Membrane Allograft in Patients Undergoing Posterior Instrumentation Removal|An Evaluation of the Effect of the AmnioFix™ Amniotic Membrane Allograft on Scar Tissue and Adhesions in Patients Undergoing Posterior Instrumentation Removal|Completed||N/A|5|Actual|MiMedx Group, Inc.||2|||f||||||||||||||2017-10-11 04:13:45.598987|2017-10-11 04:13:45.598987
NCT01357174|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-10-29|||October 2007||2007-10-01|October 2015|2015-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||ROTATEQ™ Post-Marketing Surveillance in the Philippines|Protocol for ROTATEQ™ Post-Marketing Surveillance|Terminated||N/A|915|Actual|Merck Sharp & Dohme Corp.|||1|"Merck Sharp & Dohme Corp (MSD) received exemption from PFDA on conduct of post-marketing   surveillance (PMS) study"|f||||f||||||||||2017-10-11 04:13:45.679961|2017-10-11 04:13:45.679961
NCT01357161|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-08-08|2017-08-08||July 26, 2011|Actual|2011-07-26|August 2017|2017-08-01|August 8, 2016|Actual|2016-08-08|August 8, 2016|Actual|2016-08-08||Interventional||All enrolled participants|A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004)|A Randomized, Phase II Study Evaluating MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Adult Patients With Platinum Sensitive p53 Mutant Ovarian Cancer|Completed||Phase 2|136|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 04:13:45.759659|2017-10-11 04:13:45.759659
NCT01357148|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-08-07|2012-02-01||March 2009||2009-03-01|August 2015|2015-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)|Sitagliptin Phosphate/Metformin HCl (JANUMET®) Post Marketing Surveillance Protocol|Terminated||N/A|143|Actual|Merck Sharp & Dohme Corp.|||1|"Completion of MK-0431A-235 was rendered unnecessary, as the local oversight authority accepted   in its stead the results of another study [MK-0431-234]."|f||||f||||||||||2017-10-11 04:13:48.572561|2017-10-11 04:13:48.572561
NCT01357135|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-05-04|2014-11-14||July 15, 2009|Actual|2009-07-15|May 2017|2017-05-01|August 31, 2013|Actual|2013-08-31|August 31, 2013|Actual|2013-08-31||Observational||Baseline gender data is missing for 8 participants in the Metformin + Sitagliptin group.|An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)|Observational Study of the Treatment and Follow-up of Patients With Type II Diabetes Receiving Bitherapy With or Without Sitagliptin (Januvia®/Xelevia®).|Completed||N/A|3453|Actual|Merck Sharp & Dohme Corp.|The adverse events in this study were not systematically collected or assessed and therefore no direct comparison can be made between adverse events in the 3 study groups/arms.||3||f||||f||||||||||2017-10-11 04:13:48.86142|2017-10-11 04:13:48.86142
NCT01357122|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-19|||July 2009||2009-07-01|May 2011|2011-05-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Evaluating Results of Neusidl Corneal Inserter in Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)|A Randomized, Observer-masked, Clinical Trial Comparing the Neusidl Corneal Inserter Corneal Transplant Technique to the Standard Forceps Insertion Technique for Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)|Unknown status|Active, not recruiting|Phase 4|100|Actual|Legacy Health System||2|||f||||t||||||||||2017-10-11 04:13:49.90372|2017-10-11 04:13:49.90372
NCT01357109|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-05-18|||November 2007||2007-11-01|October 2007|2007-10-01|January 2011|Actual|2011-01-01|April 2010|Actual|2010-04-01||Interventional|BANDY||Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes|Effect of Bosentan on Macro- and Microvascular Function in Patients With Type 2 Diabetes|Completed||Phase 2|56|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 04:13:49.985427|2017-10-11 04:13:49.985427
NCT01357096|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-05-19|||January 2011||2011-01-01|July 2010|2010-07-01||||January 2012|Anticipated|2012-01-01||Interventional|||Development and Efficacy Evaluation of Integrated Chronic Care and Health Promotion Model for Patients With Coronary Artery Disease in Taiwan||Unknown status|Recruiting|N/A|400|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||||||||||||2017-10-11 04:13:50.085843|2017-10-11 04:13:50.085843
NCT01357070|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2016-11-10|||May 2011||2011-05-01|May 2011|2011-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Broccoli Sprout on Blood Levels of Sulforaphane to Reduce Responsiveness of Immune System|Does Broccoli Sprout Consumption Result in Plasma Sulforaphane Levels That Can Attenuate Leukocyte Activation Ex-vivo in Healthy Human Volunteers?|Completed||N/A|6|Actual|Imperial College London||2|||f||||t||||||||||2017-10-11 04:13:50.249851|2017-10-11 04:13:50.249851
NCT01357057|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-12-27|||January 2003||2003-01-01|May 2011|2011-05-01|September 2011|Actual|2011-09-01|January 2011|Actual|2011-01-01||Observational|ABCSAH||Admission Bio-clinical Score to Predict One-year Outcomes in Coiled Subarachnoid Hemorrhage (SAH)|Biological Markers in Patients Presenting Aneurism Coiling for Subarachnoid Hemorrhage|Completed||N/A|530|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||||||2017-10-11 04:13:50.329462|2017-10-11 04:13:50.329462
NCT01357044|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2014-10-08|||May 2011||2011-05-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Plant Extracts on Semen Quality|An Extract of Pomegranate Fruit and Galangal Rhizome Increases the Numbers of Motile Sperm: A Prospective, Randomised, Controlled, Double-Blinded Trial|Completed||N/A|70|Actual|Horsens Hospital||2|||f||||f||||||||||2017-10-11 04:13:50.420898|2017-10-11 04:13:50.420898
NCT01357031|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-14|2015-12-29|||May 2010||2010-05-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|EDUMAP||Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine|Double Blind Randomized Study Controlled by Placebo and Amitriptylin to Evaluate the Efficacy of Melatonin in the Preventive Treatment of Migraine|Completed||Phase 3|192|Actual|Hospital Israelita Albert Einstein||3|||f||||t||||||||||2017-10-11 04:13:50.515893|2017-10-11 04:13:50.515893
NCT01357018|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-07|2014-02-19|||November 2010||2010-11-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Observational|||Quality of Life in Chronic Arthritis|A Study on Quality of Life in Patients With Chronic Arthritis|Completed||N/A|139|Actual|Far Eastern Memorial Hospital|||2||f||||f||||||||||2017-10-11 04:13:50.612141|2017-10-11 04:13:50.612141
NCT01356992|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-06-17|||July 2012||2012-07-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|VECOR||Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation|A Multicenter, Randomized, Open-label, Non-inferiority Phase III Study, Between Low-Molecular Weight Heparins, Versa® (Enoxaparin - Eurofarma) and Clexane® (Enoxaparin - Sanofi-Aventis), in Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation.|Terminated||Phase 3|62|Actual|Eurofarma Laboratorios S.A.||2||Change in strategy regarding the product by the company|f||||f||||||||||2017-10-11 04:13:50.746854|2017-10-11 04:13:50.746854
NCT01356979|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2012-09-24|||February 2002||2002-02-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Observational|||Outcome of Patients Undiagnosed Under Medical Thoracoscopy|Outcome of Patients Who Could Not Have Been Diagnosed by Medical Thoracoscopy|Completed||N/A|355|Anticipated|Eskisehir Osmangazi University|||1||f||||t||||||||||2017-10-11 04:13:50.829723|2017-10-11 04:13:50.829723
NCT01356966|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-05-29|2015-05-11||May 2011||2011-05-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|EIRF|All subjects that were randomized in the study are included in baseline analysis.|Exercise Intolerance in Renal Failure|The Role of Neurovascular Dysfunction and Oxidative Stress in the Exercise Intolerance of Renal Failure|Completed||Phase 2|74|Actual|Emory University||2|||f||||f||||||||||2017-10-11 04:13:51.099523|2017-10-11 04:13:51.099523
NCT01356953|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-19|||October 2008||2008-10-01|September 2008|2008-09-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|EIT2D||Exercise Intensity and Type 2 Diabetics|Effects of Exercise Intensity on 24-h Ambulatory Blood Pressure in Type 2 Diabetics|Completed||N/A|10|Actual|Catholic University of Brasília||1|||f||||t||||||||||2017-10-11 04:13:51.556873|2017-10-11 04:13:51.556873
NCT01356940|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2015-04-08|2014-12-09||November 2010||2010-11-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis|A Randomized Controlled Double-blind Cross-over Trial of Dalfampridine ER for Effect on Ambulatory Activity in People With Multiple Sclerosis|Completed||Phase 4|43|Actual|Brown, Theodore R., M.D., MPH||2|||f||||f||||||||||2017-10-11 04:13:51.682732|2017-10-11 04:13:51.682732
NCT01356927|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-04-06|||May 2011||2011-05-01|April 2017|2017-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|SaLMA||Same-day Long-acting Reversible Contraception for Medication Abortion|Etonogestrel Implant or Depot Medroxyprogesterone Acetate for Medication Abortion|Completed||N/A|40|Actual|Boston University|||2||f||||f|f|f||||||No||2017-10-11 04:13:51.94755|2017-10-11 04:13:51.94755
NCT01356914|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2015-09-23||2015-09-23|May 2011||2011-05-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden|Randomized, Double-Blind, Placebo-Controlled, 4-Way Crossover Study to Evaluate the Safety, Tolerability and Effect on Atrial Fibrillation Burden of BMS-914392 in Patients With Paroxysmal Atrial Fibrillation and Permanent Pacemaker|Completed||Phase 2|20|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 04:13:52.043769|2017-10-11 04:13:52.043769
NCT01356901|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2015-07-03|||January 2011||2011-01-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients|Persistence, Adherence and Clinical Effectiveness in Patients With Chronic Hepatitis B Viral Infection Treated With Entecavir in Real Life|Completed||N/A|230|Actual|Bristol-Myers Squibb|||1||f||||f||||||||||2017-10-11 04:13:52.154939|2017-10-11 04:13:52.154939
NCT01356888|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-08-29|||May 2011||2011-05-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|July 2013|Actual|2013-07-01||Interventional|BIOFLOW-II||Study of the Orsiro Drug Eluting Stent System|BIOTRONIK-Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With Single de Novo Coronary Artery Lesions - II|Active, not recruiting||Phase 4|440|Anticipated|Biotronik AG||2|||f||||t||||||||||2017-10-11 04:13:52.241105|2017-10-11 04:13:52.241105
NCT01356875|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-05-19|||September 2011||2011-09-01|April 2011|2011-04-01|January 2015|Anticipated|2015-01-01|September 2014|Anticipated|2014-09-01||Interventional|||Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy|Phase II Clinical Trial for Treatment of Myelodysplastic Syndromes Comparing Hydralazine / Ac.Valproico and Supportive Care in Patients Not Candidates, Refractory and / or Intolerant to Intensive Chemotherapy|Unknown status|Not yet recruiting|Phase 2|42|Anticipated|Basque Health Service||2|||f||||f||||||||||2017-10-11 04:13:52.396646|2017-10-11 04:13:52.396646
NCT01356862|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-01-24|||September 2010||2010-09-01|January 2017|2017-01-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|SOM 230||Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer|Evaluation of the Effect of Pasireotide LAR Administration in the Lymphocele Prevention After Axillary Node Dissection for Breast Cancer|Completed||Phase 2|91|Actual|Alliance Pour La Recherche en Cancerologie||2|||f||||t||||||||||2017-10-11 04:13:52.491064|2017-10-11 04:13:52.491064
NCT01356849|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-19|2013-08-20||2013-08-20|April 2011||2011-04-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|RADAR||Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor|RADAR: Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With AtRasentan - A Phase 2b, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Efficacy|Completed||Phase 2|149|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 04:13:52.591825|2017-10-11 04:13:52.591825
NCT01356836|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-05-19|||January 2011||2011-01-01|March 2011|2011-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||The Association Between Different Monocyte Subsets and Coronary Collateral Development||Completed||N/A|105|Actual|Yuksek Ihtisas Hospital|||2||f||||t||||||||||2017-10-11 04:13:53.055248|2017-10-11 04:13:53.055248
NCT01356823|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-01-03|||March 2011||2011-03-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|December 2011|Actual|2011-12-01||Interventional|||Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine|A Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine (E.Coli)in Healthy Female Subjects Aged 18 to 25 Years|Completed||Phase 2|1600|Actual|Xiamen University||4|||f||||f||||||||||2017-10-11 04:13:53.119396|2017-10-11 04:13:53.119396
NCT01356797|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-09-07|||May 2011||2011-05-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Selective Unilateral Spinal Anesthesia Versus Selective Sensory Spinal Anesthesia for Knee Arthroscopy Surgery|Selective Unilateral Spinal Anesthesia Versus Selective Sensory Spinal Anesthesia for Knee Arthroscopy Surgery|Completed||Phase 4|54|Actual|USP Hospital La Colina||2|||f||||t||||||||||2017-10-11 04:13:53.30754|2017-10-11 04:13:53.30754
NCT01356784|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-04-22|||May 2011||2011-05-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|July 2013|Actual|2013-07-01||Interventional|||"Returning to Work. Efficacy of Tailored Physical Activity or Chronic Pain Self-management Program in Sicklisted Citizens With Chronic Musculoskeletal Pain"|"Efficacy of Tailored Physical Activity or Chronic Pain Self-management Program on Returning to Work: a Randomized Controlled Trial in Sicklisted Citizens With Chronic Pain Related to the Spine or Upper Body"|Completed||Phase 1/Phase 2|141|Actual|University of Southern Denmark||3|||f||||t||||||||||2017-10-11 04:13:53.403541|2017-10-11 04:13:53.403541
NCT01356771|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2016-08-17|||May 2011||2011-05-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PennSCAPE||Melanoma Risk Assessment & Tailored Intervention|Melanoma Risk Assessment and Skin Cancer Awareness, Prevention, and Education in a Primary Care Setting|Completed||N/A|323|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 04:13:53.494068|2017-10-11 04:13:53.494068
NCT01356758|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2015-12-18|||March 2011||2011-03-01|August 2014|2014-08-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Observational|||Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents|Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents|Completed||N/A|126|Actual|University of Aarhus|||4||f||||f||||||Samples With DNA|"     blood and skin samples.   "|Undecided||2017-10-11 04:13:53.574028|2017-10-11 04:13:53.574028
NCT01356745|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-22|2017-05-10|||February 2010||2010-02-01|May 2017|2017-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|MEOPA||Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain|Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain: a Randomized Double-blind Study|Completed||Phase 4|60|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 04:13:53.661499|2017-10-11 04:13:53.661499
NCT01356732|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-19|2017-05-10|||January 2010||2010-01-01|May 2017|2017-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|REANURSUF||Determination of the 90% Effective Dose of a Sufentanil Bolus in Analgesia During Lateral Decubitus of Mechanically Ventilated Patients|Determination of the 90% Effective Dose of a Sufentanil Bolus in Analgesia During Lateral Decubitus of Mechanically Ventilated Patients.|Completed||Phase 4|25|Actual|University Hospital, Toulouse||1|||f||||f||||||||No||2017-10-11 04:13:53.742671|2017-10-11 04:13:53.742671
NCT01356719|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-18|||July 2011||2011-07-01|May 2011|2011-05-01|February 2012|Anticipated|2012-02-01|November 2011|Anticipated|2011-11-01||Observational|||Scoring Method for Describing the Position of a Tracheostomy Tube|LUNAR Study - Develop and Validate a Bedside Scoring Method for Describing the Position and Orientation of a Tracheostomy Tube Tip When Viewed Endoscopically From a Standardised Position|Unknown status|Not yet recruiting|N/A|20|Anticipated|University Hospital of South Manchester NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 04:13:53.928452|2017-10-11 04:13:53.928452
NCT01356706|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-07-01|||October 2002||2002-10-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|December 2008|Actual|2008-12-01||Observational|||Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors||Completed||N/A|274|Actual|University Hospital, Gasthuisberg|||1||f||||f||||||Samples With DNA|"     Tissue samples for histopathology diagnosis & staging   "|||2017-10-11 04:13:54.005366|2017-10-11 04:13:54.005366
NCT01356680|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-05-02|||December 2011||2011-12-01|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||HD17 for Intermediate Stage Hodgkin Lymphoma|HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma|Active, not recruiting||Phase 3|1100|Actual|University of Cologne||2|||f||||t||||||||||2017-10-11 04:13:54.199688|2017-10-11 04:13:54.199688
NCT01356667|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2016-01-26|2014-05-19||September 2010||2010-09-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Drum-Assisted Therapy for Native Americans|Drum-Assisted Recovery Therapy for Native Americans|Terminated||Phase 1|10|Actual|University of California, Los Angeles||2||Study period is over and recruitment was stopped due to time constraints.|f||||t||||||||||2017-10-11 04:13:54.305282|2017-10-11 04:13:54.305282
NCT01356654|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-18|||March 2010||2010-03-01|May 2011|2011-05-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|||Transcranial Direct Current Stimulation in Stroke Rehabilitation|The Use of Transcranial Direct Current Stimulation in the Recovery of Postural Control in Stroke|Unknown status|Recruiting|N/A|34|Anticipated|Universiteit Antwerpen||2|||f||||t||||||||||2017-10-11 04:13:54.612353|2017-10-11 04:13:54.612353
NCT01356641|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2017-01-12|||September 2012||2012-09-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Antibiotic Treatment Alone for Acute Simple Appendicitis in Children|Antibiotic Treatment Alone for Acute Simple Appendicitis in Children; a Prospective Cohort Study Part of the Antibiotic Versus Primary Appendectomy in Children (APAC) Trial|Completed||N/A|50|Actual|VU University of Amsterdam||2|||f||||t||||||||||2017-10-11 04:13:54.715563|2017-10-11 04:13:54.715563
NCT01356628|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2016-10-18|||June 2011||2011-06-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer|A Phase II Study of PD-0332991 in Adult Patients With Advanced Hepatocellular Carcinoma|Active, not recruiting||Phase 2|19|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 04:13:54.82381|2017-10-11 04:13:54.82381
NCT01356615|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2011-05-18|||March 2011||2011-03-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Low Molecular Weight Heparin for Hemodialysis Anticoagulation|Low Molecular Weight Heparin (Enoxaparin Sodium) and Standard Unfractionated Heparin for Hemodialysis Anticoagulation|Completed||N/A|27|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-10-11 04:13:54.921055|2017-10-11 04:13:54.921055
NCT01356602|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-12-10|2013-09-06||May 2011||2011-05-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients|A Randomized, Double-blind, Active-controlled Study of Canakinumab Prefilled Syringes or Reconstituted Lyophilizate Versus Triamcinolone Acetonide for Treating Acute Gouty Arthritis Flares in Frequently Flaring Patients|Completed||Phase 3|397|Actual|Novartis||3|||f||||||||||||||2017-10-11 04:13:55.046514|2017-10-11 04:13:55.046514
NCT01356589|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2017-06-13|2015-11-23||September 30, 2010|Actual|2010-09-30|May 2017|2017-05-01|July 31, 2012|Actual|2012-07-31|July 31, 2012|Actual|2012-07-31||Observational||Analysis population included all treated participants.|A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL)|Retrospective Study on Intrapatient VAriabiLity of the Hemoglobin Levels in Anemic CKD Patients in Predialysis (Stage 3-4) and Dialysis (Stage 5) Treated With MIRCERA® (RIVAL Study)|Completed||N/A|1288|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:13:56.261827|2017-10-11 04:13:56.261827
NCT01356576|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-02-06|||September 2010||2010-09-01|February 2014|2014-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Effect of Hemodialysis Membranes on Platelet Count|Effect of Hemodialysis Membranes on Platelet Count|Completed||N/A|99|Actual|Northwell Health|||1||f||||f||||||||||2017-10-11 04:13:56.694587|2017-10-11 04:13:56.694587
NCT01356563|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-14|2011-05-18|||May 2011||2011-05-01|May 2011|2011-05-01|May 2012|Anticipated|2012-05-01|December 2011|Anticipated|2011-12-01||Interventional|||Efficacy Study of Pharmacist Intervention on Medication-related Problems in Hemodialysis Patients|Effects of Pharmacist on Medication-related Problems in Hemodialysis Patients: a Randomized,Controlled, Double-blind Study|Unknown status|Recruiting|N/A|150|Anticipated|Sin-Lau Hospital||2|||f||||t||||||||||2017-10-11 04:13:56.753117|2017-10-11 04:13:56.753117
NCT01356550|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2016-11-01|||June 2011||2011-06-01|November 2016|2016-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838||Completed||Phase 1|35|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:13:56.848033|2017-10-11 04:13:56.848033
NCT01356537|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-02-01|||April 2011||2011-04-01|February 2017|2017-02-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|||Home Therapy With VPRIV in Gaucher's Disease|Non Interventional Study of VPRIV® (Velaglucerase Alfa) Home Therapy in Patients With Gaucher's Disease|Recruiting||N/A|50|Anticipated|Shire|||1||f||||f||||||||||2017-10-11 04:13:56.924456|2017-10-11 04:13:56.924456
NCT01356524|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2011-05-18|||July 2011||2011-07-01|May 2011|2011-05-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Relationship Between Mid-luteal Serum Progesterone Levels to Pregnancy Rates in Assisted Reproductive Techniques (ART)||Unknown status|Not yet recruiting|N/A|160|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-10-11 04:13:57.037198|2017-10-11 04:13:57.037198
NCT01356511|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2016-04-18|||September 2010||2010-09-01|September 2010|2010-09-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)|High-dose Dexamethasone and Conventional Dose Prednisone, for the First-line Treatment of Adults With ITP: a Multicenter, Randomized Controlled, Clinical Trial|Completed||Phase 4|261|Actual|Shandong University||2|||f||||t||||||||No||2017-10-11 04:13:57.135235|2017-10-11 04:13:57.135235
NCT01356498|ClinicalTrials.gov processed this data on October 10, 2017|2008-10-27|2011-10-28|2011-08-05||December 2006||2006-12-01|October 2011|2011-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout|Multicenter, Open Label Extension Study of 8 mg PEG-uricase in Subjects Who Completed Protocols C0405 or C0406 for Symptomatic Gout|Completed||Phase 3|151|Actual|Savient Pharmaceuticals||3|||f||||f||||||||||2017-10-11 04:13:57.408419|2017-10-11 04:13:57.408419
NCT01356485|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-08-15|||January 2012||2012-01-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety Study of MP4CO in Adult Sickle Cell Patients|A Multi-center, Randomized, Double Blind, Dose Escalation Safety Study of MP4CO in Clinically Stable Adult Sickle Cell Patients|Completed||Phase 1|32|Actual|Sangart||2|||f||||t||||||||||2017-10-11 04:14:00.048212|2017-10-11 04:14:00.048212
NCT01356472|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-05-18|||June 2011||2011-06-01|April 2011|2011-04-01||||June 2013|Anticipated|2013-06-01||Interventional|||Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia|Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Vitro and in Ventilator-associated Pneumonia|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Ruijin Hospital||1|||f||||t||||||||||2017-10-11 04:14:00.178106|2017-10-11 04:14:00.178106
NCT01356459|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2015-05-08|||June 2011||2011-06-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||Pressure Ulcer Prevention in Intensive Care Unit (ICU)|A Prospective Randomised Controlled Trial of the Effectiveness of Absorbent Silicone Self Adherent Dressings in the Prevention of Sacral and Heel Pressure Ulcers in Trauma and Critically Ill ED/ICU Patients|Completed||N/A|440|Actual|Melbourne Health||2|||f||||t||||||||||2017-10-11 04:14:00.258323|2017-10-11 04:14:00.258323
NCT01356446|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2015-05-04|||June 2010||2010-06-01|May 2015|2015-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Checklist Application and Mortality|Impact of the Surgical Checklist on 30-day and 90-day Mortality in Elective Non-cardiac Surgery|Withdrawn||N/A|0|Actual|Regional Hospital of Bolzano||2|||f||||t||||||||||2017-10-11 04:14:00.330058|2017-10-11 04:14:00.330058
NCT01356433|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2012-09-19|||August 2011||2011-08-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Influence of Oral Vitamin C Supplement on the Inflammation Status in Dialysis Patients|Effect of Oral Vitamin C on The Inflammatory Biomarkers in Hemodialysis|Completed||Phase 4|128|Actual|Peking University First Hospital||2|||f||||t||||||||||2017-10-11 04:14:00.408653|2017-10-11 04:14:00.408653
NCT01356420|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2012-09-18|||January 2011||2011-01-01|September 2012|2012-09-01||||January 2016|Anticipated|2016-01-01||Interventional|STAIR-SLOS||Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome|Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation|Unknown status|Recruiting|N/A|100|Anticipated|Oregon Health and Science University||1|||f||||t||||||||||2017-10-11 04:14:00.487957|2017-10-11 04:14:00.487957
NCT01354873|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-01-08|||January 2011||2011-01-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging|Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging|Completed||N/A|556|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 04:14:25.055741|2017-10-11 04:14:25.055741
NCT01356407|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-18|2012-12-17|2012-09-19||January 2011||2011-01-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy|A Multi-center, Randomized, Single-blind Clinical Study of the Efficacy and Safety of PICOPREP and Polyethylene Glycol-electrolyte 4000 Powder for Oral Solution (PEG-ELS) for the Bowel Preparation Prior Colonoscopy|Completed||Phase 3|300|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 04:14:00.603973|2017-10-11 04:14:00.603973
NCT01356394|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-05-18|||January 2010||2010-01-01|January 2010|2010-01-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Weight Loss Improves Renal Hemodynamics|Weight Loss Improves Renal Hemodynamics in Patients With Metabolic Syndrome|Completed||Phase 4|58|Actual|Nucleus of Education Interdisciplinary Research and Treatment in Nephrology||1|||f||||f||||||||||2017-10-11 04:14:01.154407|2017-10-11 04:14:01.154407
NCT01356381|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-08-29|||April 2011||2011-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes|A Single-center,Double-blind,Randomised,Placebo-controlled,Parallel-group Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin on Insulin Sensitivity and Its Underlying Mechanism in Patients With T2DM Treated With Metformin|Completed||Phase 4|43|Actual|Novartis||2|||f||||f||||||||||2017-10-11 04:14:01.244792|2017-10-11 04:14:01.244792
NCT01356368|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-19|2014-01-19|||May 2010||2010-05-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|Customizing||Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer|A Pilot Study of Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer Based on Molecular Markers|Terminated||Phase 2|3|Actual|National Guard Health Affairs||1||slow accrual rate|f||||f||||||||||2017-10-11 04:14:01.323472|2017-10-11 04:14:01.323472
NCT01356355|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-01-04|||April 2012||2012-04-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Study of Herbmed Plus in Ureteral Stent Discomfort|Double Blind Exploratory Three Arm Randomized Trial to Evaluate the Safety and Efficacy of Herbal Preparation 'Herbmed Plus' in Ureteral Stent Discomfort|Completed||Phase 2|140|Actual|Amai Charitable Trust||3|||f||||f||||||||||2017-10-11 04:14:01.401647|2017-10-11 04:14:01.401647
NCT01356342|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2012-12-27|||July 2010||2010-07-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old||Completed||Phase 4|181|Actual|Adimmune Corporation||3|||f||||||||||||||2017-10-11 04:14:01.483904|2017-10-11 04:14:01.483904
NCT01356329|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-19|2016-05-12|||October 2009||2009-10-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|Lovenox||Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients|A Randomized, Controlled, Open Label Study of the Efficacy and Safety of the Low Molecular Weight Heparin (LMWH), LovenoxTM (Enoxaparin) Versus HeparinTM (Unfractionated Heparin) for Prevention of Venous Thromboembolism (VTE) in Gynecologic Oncology Patients|Suspended||Phase 3|150|Anticipated|National Guard Health Affairs||2||Difficulty in enrolling patients|f||||f||||||||||2017-10-11 04:14:01.561129|2017-10-11 04:14:01.561129
NCT01356316|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-12-27|||August 2010||2010-08-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|August 2010|Actual|2010-08-01||Interventional|||Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects||Completed||Phase 4|120|Actual|Adimmune Corporation||1|||f||||||||||||||2017-10-11 04:14:01.6568|2017-10-11 04:14:01.6568
NCT01356303|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-19|2016-05-12|||March 2009||2009-03-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|TAXIS01||Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer|A Phase II Study of Docetaxel Combined With Cisplatin as the First Line Chemotherapy in Patients With Metastatic Non-small Cell Lung Cancer|Suspended||Phase 2|50|Anticipated|National Guard Health Affairs||1||Difficulty in enrolling patients|f||||f||||||||||2017-10-11 04:14:01.736132|2017-10-11 04:14:01.736132
NCT01356290|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-05-15|||April 2014||2014-04-01|May 2017|2017-05-01|April 2022|Anticipated|2022-04-01|April 2019|Anticipated|2019-04-01||Interventional|MEMMAT||Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma|A Phase II Study of Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma|Recruiting||Phase 2|40|Anticipated|Medical University of Vienna||1|||f||||t||||||||||2017-10-11 04:14:01.831834|2017-10-11 04:14:01.831834
NCT01356277|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2016-06-27|||February 2012||2012-02-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|TAKE-IT||Intervention to Improve Adherence in Teen Kidney Transplant|TAKE-IT: Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial|Completed||Phase 3|170|Actual|McGill University Health Center||2|||f||||t||||||||||2017-10-11 04:14:02.100173|2017-10-11 04:14:02.100173
NCT01356264|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2015-09-26|||July 2011||2011-07-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Multimodal Prehabilitation for Colorectal Surgery|Multimodal Prehabilitation to Enhance Functional Recovery After Colorectal Surgery: a Randomized Controlled Trial|Completed||Phase 2|89|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 04:14:02.207177|2017-10-11 04:14:02.207177
NCT01356251|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-04-17|||May 2011|Actual|2011-05-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma|Mesothelioma From a Patient Perspective: A Survey of Psychosocial Needs and Exploration of Online Support for Patients|Active, not recruiting||N/A|107|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 04:14:02.288963|2017-10-11 04:14:02.288963
NCT01356238|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-05-18|||November 2009||2009-11-01|October 2009|2009-10-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Application of Two Different Synthetic Sequential Media for the Human IVF-Embryo Transfer (IVF-ET) Program|Application of Two Different Synthetic Sequential Media for the Human IVF-ET Program|Completed||N/A|360|Actual|Maria Fertility Hospital||2|||f||||t||||||||||2017-10-11 04:14:02.390183|2017-10-11 04:14:02.390183
NCT01356225|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-02-07|||February 2004||2004-02-01|February 2017|2017-02-01||||March 2004|Actual|2004-03-01||Interventional|||A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery|A Randomized, Double-blind, Placebo-controlled, Parallel, Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery|Completed||Phase 2|80|Actual|Egalet Ltd||2|||f||||f||||||||||2017-10-11 04:14:02.471816|2017-10-11 04:14:02.471816
NCT01356212|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-02-06|||September 2002||2002-09-01|February 2017|2017-02-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device|Scintigraphic Assessment of Nasal Deposition and Clearance of 99mTc DTPA Ketorolac Solution Administered Using the Valois Nasal Spray Device|Completed||Phase 1|13|Actual|Egalet Ltd||3|||||||||||||||||2017-10-11 04:14:02.57322|2017-10-11 04:14:02.57322
NCT01356199|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2014-03-17|||October 2011||2011-10-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|||Effect of Artronat on the Quality of Life of Patient With Osteoarthritis|Effet du complément Alimentaire ARTRONAT(R) Sur la réduction de la Gonalgie Chez Des Sujets Arthrosiques|Completed||N/A|7|Actual|Lescuyer Laboratory||2|||f||||f||||||||||2017-10-11 04:14:02.686078|2017-10-11 04:14:02.686078
NCT01356186|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-06-12|||July 2008||2008-07-01|June 2017|2017-06-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|CDMRP||Pilot Trial of Inpatient Cognitive Therapy for the Prevention of Suicide in Military Personnel|Pilot Trial of Inpatient Cognitive Therapy for the Prevention of Suicide in Military Personnel With Acute Stress Disorder of Post Traumatic Stress Disorder|Active, not recruiting||N/A|50|Anticipated|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||t||||||||No||2017-10-11 04:14:02.820134|2017-10-11 04:14:02.820134
NCT01356173|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2016-11-01|||June 2011||2011-06-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma|An Open-Label, Phase I, Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma|Completed||Phase 1|10|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 04:14:02.922283|2017-10-11 04:14:02.922283
NCT01356160|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2014-01-02||2013-11-26|July 2011||2011-07-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy With GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Naïve Subjects With Chronic Genotype 1 Hepatitis C Virus Infection|Completed||Phase 2|351|Actual|Gilead Sciences||2|||f||||||||||||||2017-10-11 04:14:03.007098|2017-10-11 04:14:03.007098
NCT01356147|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-29|2017-05-18|2016-12-15||May 2011||2011-05-01|May 2017|2017-05-01|April 30, 2017|Actual|2017-04-30|January 2015|Actual|2015-01-01||Interventional|PVAIN||Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)|Pilot Study of Dornase Alfa (Pulmozyme) Therapy for Acquired Ventilator Associated Infection in Preterm and Late Preterm Infants in the Neonatal Intensive Care Unit|Completed||Phase 4|11|Actual|Georgetown University||2|||f||||f||||||||Undecided||2017-10-11 04:14:03.163828|2017-10-11 04:14:03.163828
NCT01356134|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-04-02|||May 2011||2011-05-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI)|Vascular Fundus Changes in Patients With High Probability of CCSVI (Chronic Cerebrospinal Venous Insufficiency)|Completed||N/A|60|Actual|Genetic Disease Investigators|||2||f||||t||||||||||2017-10-11 04:14:03.459392|2017-10-11 04:14:03.459392
NCT01356121|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-17|||November 2010||2010-11-01|March 2011|2011-03-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Interventional|||Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics|Randomized Controlled Trial Comparing Effects of Sedation for Upper Gastrointestinal Endoscopy With Propofol Versus Midazolam on Psychometric Tests and Critical Flicker Frequency in Cirrhotics|Unknown status|Recruiting|Phase 4|120|Anticipated|Govind Ballabh Pant Hospital||3|||f||||t||||||||||2017-10-11 04:14:03.563924|2017-10-11 04:14:03.563924
NCT01356108|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-04-11|||January 2011|Actual|2011-01-01|April 2017|2017-04-01|April 2018|Anticipated|2018-04-01|July 2013|Actual|2013-07-01||Observational|PREMIER||Pulmonic Valve REplacement Multi-discIpline EMEA Registry|Implantation of the SAPIEN™ Transcatheter Heart Valve (THV) in the Pulmonic Position|Active, not recruiting||N/A|127|Actual|Edwards Lifesciences|||1||f||||t|f|t|f|f|t|||||2017-10-11 04:14:04.027955|2017-10-11 04:14:04.027955
NCT01356095|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-08-28|||March 2011||2011-03-01|May 2011|2011-05-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi|A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi|Completed||N/A|28|Actual|Dignitas International||3|||f||||f||||||||||2017-10-11 04:14:04.162207|2017-10-11 04:14:04.162207
NCT01356082|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-05-01|||May 2011||2011-05-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||CNAP™ Monitor Study|Accuracy of the CNAP™ Monitor in Providing Beat-to-beat Non-invasive Blood Pressure Readings|Completed||N/A|46|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 04:14:04.245097|2017-10-11 04:14:04.245097
NCT01356069|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-18|||January 2004||2004-01-01|May 2011|2011-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|HUMSH||Efficacy of Time-limited Psychodynamic Psychotherapy and Informed Clinical Management in BPD High MHS Users|Sequential Brief Adlerian Psychodynamic Psychotherapy in Heavy Users of a Mental Health Service With Borderline Personality Disorder: a Two Years Follow-up Preliminary Randomized Study.|Completed||N/A|35|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-10-11 04:14:04.318091|2017-10-11 04:14:04.318091
NCT01356056|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-03-11|||May 2011||2011-05-01|March 2013|2013-03-01||||December 2011|Actual|2011-12-01||Observational|||Tele-diagnostics for Remote Parkinson's Monitoring||Completed||N/A|12|Actual|Great Lakes NeuroTechnologies Inc.|||2||f||||||||||||||2017-10-11 04:14:04.389993|2017-10-11 04:14:04.389993
NCT01356043|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-08-29|||May 2011||2011-05-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||CKD-828 Drug Interaction Study (S-amlodipine)|A Randomized, Open-label, Multiple Doses, Crossover Study to Evaluate the Pharmacokinetic Drug Interaction and Safety of S-amlodipine Between Free Combination of S-amlodipine and Telmisartan and S-amlodipine Monotherapy in Healthy Male Volunteers|Completed||Phase 1|24|Actual|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 04:14:04.474516|2017-10-11 04:14:04.474516
NCT01355861|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-14|2015-06-25|||June 2011||2011-06-01|June 2015|2015-06-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|REPAiRS||Resistance Exercise for the Prevention of Age-related Sarcopenia|Negative Work Exercise as a Novel Treatment for Sarcopenia in Older Men|Withdrawn||N/A|0|Actual|VA Office of Research and Development||2||Project has been withdrawn from funding consideration|f||||f||||||||||2017-10-11 04:14:06.411481|2017-10-11 04:14:06.411481
NCT01356030|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2013-07-08|||May 2011||2011-05-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer|Prospective Comparison of EUS-guided FNA and ERCP Tissue Sampling for the Diagnosis of Suspected Pancreato-biliary Neoplasms|Completed||N/A|51|Actual|California Pacific Medical Center Research Institute||2|||f||||f||||||||||2017-10-11 04:14:04.561365|2017-10-11 04:14:04.561365
NCT01356017|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-09-04|||June 2011||2011-06-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||CKD-828 Drug Interaction Study (Telmisartan)|A Randomized, Open-label, Multiple Doses, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction and Safety of Telmisartan Between Free Combination of Telmisartan and S-amlodipine and Telmisartan Monotherapy in Healthy Male Volunteers|Completed||Phase 1|32|Anticipated|Chong Kun Dang Pharmaceutical||2|||f||||f||||||||||2017-10-11 04:14:04.66908|2017-10-11 04:14:04.66908
NCT01356004|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-05-18|||January 2010||2010-01-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Interventional|||Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis|Live Attenuated Varicella Vaccine: A New Effective Adjuvant Weapon in the Battlefield Against Severe Resistant Psoriasis, a Randomized Controlled Trial|Completed||Phase 4|35|Actual|Cairo University||2|||f||||t||||||||||2017-10-11 04:14:04.76058|2017-10-11 04:14:04.76058
NCT01355991|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-10-22|||August 2011||2011-08-01|October 2015|2015-10-01|August 2016|Anticipated|2016-08-01|March 2016|Anticipated|2016-03-01||Interventional|||Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI|Acute and Chronic Effects of an Anticholinergic Agent or a Long-Acting Beta 2 Agonist on Levels of Exhaled Nitric Oxide and Pulmonary Function in Persons With Tetraplegia|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-11 04:14:04.840399|2017-10-11 04:14:04.840399
NCT01355978|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2016-08-18|2015-03-07||August 2011||2011-08-01|August 2016|2016-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|PRIDE|Adult subjects with chronic obstructive lung disease.|Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)|Acceptability, Comfort, and Exercise Tolerance Using a Non-invasive Ventilation System in Patients With Moderate-to-Severe COPD (PRIDE)|Completed||N/A|22|Actual|Breathe Technologies, Inc.||1|||f||||f||||||||||2017-10-11 04:14:05.039175|2017-10-11 04:14:05.039175
NCT01355965|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-09-16|||May 2011||2011-05-01|September 2017|2017-09-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Autologous Redirected RNA Meso-CIR T Cells|Phase 1 Clinical Trial of Autologous Mesothelin Re-Directed T Cells Administered Intravenously in Patients With Progressive Malignant Pleural Mesothelioma|Completed||Phase 1|18|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 04:14:05.311507|2017-10-11 04:14:05.311507
NCT01355952|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2015-11-04|||May 2011||2011-05-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ALA||An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia|An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia|Completed||N/A|17|Actual|Yale University||1|||f||||f||||||||||2017-10-11 04:14:05.407098|2017-10-11 04:14:05.407098
NCT01355939|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2015-02-19|||May 2011||2011-05-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Comparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair Mesh|A Prospective Multicenter Trial to Evaluate Adhesion Characteristics and Adhesiolysis-related Complications of Barrier-coated and Non-barrier-coated Intraperitoneal Mesh During Abdominal Re-exploration After Prior Ventral Hernia Repair|Completed||N/A|173|Actual|Washington University School of Medicine|||4||f||||t||||||||||2017-10-11 04:14:05.503577|2017-10-11 04:14:05.503577
NCT01355926|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-10-03|||May 2011|Actual|2011-05-01|October 2017|2017-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery|Flexible Fiber-based CO2 Laser Versus Monopolar Cautery for Resection of Benign, Pre-malignant And Malignant Oral Cavity Lesions: A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery|Recruiting||N/A|68|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 04:14:05.669557|2017-10-11 04:14:05.669557
NCT01355913|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2014-08-07|||October 2008||2008-10-01|August 2014|2014-08-01|October 2019|Anticipated|2019-10-01|October 2016|Anticipated|2016-10-01||Observational|||Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells|Screening and Genetic Monitoring of Patients With MDS Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells|Active, not recruiting||N/A|300|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH|||1||f||||f||||||||||2017-10-11 04:14:05.7943|2017-10-11 04:14:05.7943
NCT01355887|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-17|||January 2008||2008-01-01|January 2008|2008-01-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||A Trial to Compare Pringle Maneuver With Either Infrahepatic Inferior Vena Cava Clamping or Low Central Venous Pressure|A Prospective Randomized Comparative Trial to Compare Pringle Maneuver With Either Infrahepatic Inferior Vena Cava Clamping or Low Central Venous Pressure in Complex Liver Resections|Unknown status|Recruiting|Phase 3|192|Anticipated|Huazhong University of Science and Technology|||1||f||||t|||||||"     No biospecimens   "|||2017-10-11 04:14:06.055216|2017-10-11 04:14:06.055216
NCT01355848|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2015-03-06|||May 2011||2011-05-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Improving Care Provided to Patients Treated in a Level 1 Trauma Center Post-suicide Attempt|Improving Care Provided to Patients Treated in a Level 1 Trauma Center Post-suicide Attempt|Completed||Phase 1|40|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 04:14:06.503558|2017-10-11 04:14:06.503558
NCT01355835|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2012-08-07|||February 2011||2011-02-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|STN/SNr||Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease|Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease: Design of a Two-armed Double-blind Cross-over Study|Completed||Phase 2|12|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-11 04:14:06.589708|2017-10-11 04:14:06.589708
NCT01355822|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-26|||April 2002||2002-04-01|May 2011|2011-05-01||||January 2008|Actual|2008-01-01||Interventional|||Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies|Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies: a Prospective Randomized Pilot Study|Completed||Phase 1/Phase 2|111|Actual|University of Jena||2|||f||||f||||||||||2017-10-11 04:14:06.703513|2017-10-11 04:14:06.703513
NCT01355809|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2014-08-08|||December 2009||2009-12-01|August 2014|2014-08-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|rehabilitate||Six-Minute Walk Test Comparing Helium/Oxygen to Nitrogen/Oxygen for COPD Rehabilitation|Single Centre, Exploratory, Phase II, Cross-over, Randomised Trial, Evaluating the Effect of Spontaneously Breathing He/O2 65%/35% to Either Spontaneously Breathing N2/O2 65%35% or Non-Invasive Ventilated N2/O2 65%/35% on a 6 Minute Walk Test in Severe COPD Patients|Terminated||Phase 2|3|Actual|Air Liquide SA||3||Due to low recruitment rate the sponsor decided to discontinue the study.|f||||t||||||||||2017-10-11 04:14:06.784757|2017-10-11 04:14:06.784757
NCT01355783|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-11-14|||March 2011||2011-03-01|November 2013|2013-11-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Interventional|||A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma|A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma|Withdrawn||Phase 3|0|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 04:14:06.967142|2017-10-11 04:14:06.967142
NCT01355757|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-05-16|||June 2011||2011-06-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Post-Operative Quality of Life Evaluation for Different Anesthesia Techniques for Arthroscopic Shoulder Surgery|Post-Operative Quality of Life Evaluation for Different Anesthesia Techniques for Arthroscopic Shoulder Surgery|Completed||Early Phase 1|70|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||||||||||||2017-10-11 04:14:07.053137|2017-10-11 04:14:07.053137
NCT01355744|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2013-10-01|||June 2011||2011-06-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Observational|SSSB||Swiss Study on Spider Bites|Swiss Study on Spider Bites|Completed||N/A|17|Actual|University of Zurich|||1||f||||f||||||None Retained|"     Species of biting spider will be assessed if specimen is sent to us.   "|||2017-10-11 04:14:07.630095|2017-10-11 04:14:07.630095
NCT01355731|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-09-14|||May 2011||2011-05-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Observational|EBABN||Evaluating Therapeutic Boundaries Among Bedside Nurses At A Pediatric Hematology/Oncology Research Hospital|Evaluating Therapeutic Boundaries Among Bedside Nurses At A Pediatric Hematology/Oncology Research Hospital|Completed||N/A|121|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 04:14:07.71027|2017-10-11 04:14:07.71027
NCT01355718|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-08-08|||August 2011||2011-08-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea|A 26-week, Multicentre, Open-labelled, Non-randomised, Non-interventional, Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea|Completed||N/A|120|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 04:14:07.78835|2017-10-11 04:14:07.78835
NCT01355705|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-04-28|2017-01-11||August 2011||2011-08-01|April 2017|2017-04-01|July 2017|Anticipated|2017-07-01|July 2016|Actual|2016-07-01||Interventional|||Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma|A Phase 1 Study of Amrubicin in Combination With Lenalidomide and Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|14|Actual|Stanford University||1|||f||||t|t|f||||||No||2017-10-11 04:14:08.058503|2017-10-11 04:14:08.058503
NCT01355692|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-15|2016-09-06|||December 2009||2009-12-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|SRT||Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema|Phase III Multi Center Study Study of the Effects of Selective Retinal Photocoagulation for the Treatment of Diabetic Macular Edema|Completed||Phase 2/Phase 3|32|Actual|Lumenis Ltd.||1|||f||||f||||||||||2017-10-11 04:14:08.358496|2017-10-11 04:14:08.358496
NCT01355679|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-06-16|2015-05-18||May 2011||2011-05-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|September 2013|Actual|2013-09-01||Interventional||Multiply relapsed or refractory neuroblastoma.|Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma|A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma|Completed||N/A|16|Actual|Spectrum Health Hospitals||1|||f||||t||||||||||2017-10-11 04:14:08.461824|2017-10-11 04:14:08.461824
NCT01355666|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2011-05-17|||September 2010||2010-09-01|May 2011|2011-05-01|June 2011|Anticipated|2011-06-01|May 2011|Anticipated|2011-05-01||Interventional|||Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting|Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting|Unknown status|Recruiting|N/A|75|Anticipated|Precision Fabrics Group, Inc.||1|||f||||f||||||||||2017-10-11 04:14:08.76331|2017-10-11 04:14:08.76331
NCT01355653|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2011-08-26|||April 2011||2011-04-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Heat Wrap Device Safety With Age and Body Fat|An Open Label Study To Compare The Effects Of Age And Body Fat On The Safety Of Two Heat Wrap Devices In Healthy Subjects|Completed||N/A|57|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 04:14:08.901258|2017-10-11 04:14:08.901258
NCT01355640|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2012-01-26|||April 2008||2008-04-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||Two Methods of Analgesia for Chinese Term Infants Receiving Heel Lance|A Randomized Controlled Trial of Breast-feeding and/or Non-nutritive Sucking as Analgesia for Chinese Term Infants Receiving Heel Lance|Completed||N/A|90|Actual|Peking Union Medical College||3|||f||||t||||||||||2017-10-11 04:14:08.996602|2017-10-11 04:14:08.996602
NCT01355627|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2014-06-26|2014-06-26||April 2011||2011-04-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Baseline Measures were based on the Full Analysis Set that included all enrolled randomized patients.|TASALL - TachoSil® Against Liquor Leak|TachoSil® Versus Current Practice in Dura Sealing Techniques for the Prevention of Post-operative Cerebrospinal Fluid (CSF) Leaks in Patients Undergoing Skull Base Surgery: An Open Label, Randomised, Controlled, Multi-centre, Parallel Group Efficacy and Safety Trial.|Completed||Phase 3|726|Actual|Takeda||2|||f||||t||||||||||2017-10-11 04:14:09.195169|2017-10-11 04:14:09.195169
NCT01355614|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-02-20|||June 2011||2011-06-01|February 2017|2017-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients|A Multi-center, Randomized, Double-blind, Active Controlled Study to Assess Efficacy, Safety and Tolerability of the Anti-IL13 Monoclonal Antibody QAX576 in the Treatment of Perianal Fistulas in Patients Suffering From Crohn's Disease|Completed||Phase 2|10|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:14:10.881533|2017-10-11 04:14:10.881533
NCT01355601|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-02-26|||January 2012||2012-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effect of Carbohydrates From Nutritional Beverages in Children|Effect of Carbohydrates From Nutritional Beverages in Children|Terminated||N/A|88|Anticipated|Mead Johnson Nutrition||2||Terminated due to slow recruitment. 41 of 50 participants had enrolled at time of termination.|f||||||||||||||2017-10-11 04:14:10.993027|2017-10-11 04:14:10.993027
NCT01355588|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-02-07|2012-11-16||August 2005||2005-08-01|February 2017|2017-02-01|March 2006|Actual|2006-03-01|September 2005|Actual|2005-09-01||Interventional|||Tolerability, Safety and Pharmacokinetics of Four Formulations of Ketorolac Tromethamine in Healthy Volunteers|A Phase 1, Double-blind, 4-way Crossover Study of the Tolerability, Safety and Pharmacokinetics of 4 Formulations of Ketorolac Tromethamine by Intranasal Administration in Healthy Volunteers|Completed||Phase 1|16|Actual|Egalet Ltd||4|||f||||f||||||||||2017-10-11 04:14:11.079998|2017-10-11 04:14:11.079998
NCT01355562|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2012-10-03|||March 2011||2011-03-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer|Phase II Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer|Withdrawn||Phase 2|0|Actual|Loma Linda University||1||Primary Investigator is no longer employed at LLU as of 02/29/12.|f||||f||||||||||2017-10-11 04:14:11.838905|2017-10-11 04:14:11.838905
NCT01355549|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-01-14|||May 2011||2011-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Platelet-Rich Plasma Therapy for Shoulder Pain in Persons With Spinal Cord Injury|A Pilot Study to Evaluate the Feasibility of Platelet-Rich Plasma Therapy as a Treatment for Chronic Shoulder Pain in Persons With Spinal Cord Injury|Completed||Phase 1|6|Actual|Kessler Foundation||1|||f||||f||||||||||2017-10-11 04:14:11.925853|2017-10-11 04:14:11.925853
NCT01355536|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-17|||October 2006||2006-10-01|May 2011|2011-05-01||||April 2008|Actual|2008-04-01||Observational|||Metabolic and Endocrine Status in Women With Prior Preterm Birth|Metabolic and Endocrine Status in Women With Prior Preterm Birth. A Cross Sectional, Case- Control Study|Completed||N/A|262|Actual|Namsos Hospital|||2||f||||f||||||Samples With DNA|"     Whole blood, serum,endometrial biopsy   "|||2017-10-11 04:14:12.026794|2017-10-11 04:14:12.026794
NCT01355523|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-04-04|2013-08-14||July 2011||2011-07-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|MELODY||The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients|The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients|Terminated||Phase 2/Phase 3|54|Actual|Herlev Hospital|Premature termination (54/260). Only included about 8% (54/703) of the patients assessed for eligibility.|2||Inclusion rate not as expected. Not financially possible to involve other centres.|f||||f||||||||||2017-10-11 04:14:12.145206|2017-10-11 04:14:12.145206
NCT01355510|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-09-18|||January 2011||2011-01-01|September 2013|2013-09-01||||||||Observational|CVRX-ReSy||Effects of Electrical Baroreflex Stimulation on Sympathetic Activity, Renal Hemodynamics, and Insulin Sensitivity|Electrical Baroreflex Stimulation - Sympathetic Activity|Unknown status|Recruiting|N/A|30|Anticipated|Hannover Medical School|||1||f||||f||||||||||2017-10-11 04:14:13.319173|2017-10-11 04:14:13.319173
NCT01355484|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2016-02-04|2016-02-04||July 2011||2011-07-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|May 2013|Actual|2013-05-01||Interventional||Subjects included in the Full Analysis Set|Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)|Phase III, Randomized, Double-Blind, Placebo Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer on First Line Platinum Plus a Taxane Chemotherapy|Completed||Phase 3|321|Actual|GTx||2|||f||||t||||||||||2017-10-11 04:14:13.658813|2017-10-11 04:14:13.658813
NCT01355081|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-11-04|2014-11-04||May 2011||2011-05-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase III Study to Assess the Efficacy and Safety of Lu AA21004 in Patients With Major Depressive Disorder|Completed||Phase 3|366|Actual|Takeda||3|||f||||f||||||||||2017-10-11 04:14:20.210604|2017-10-11 04:14:20.210604
NCT01355471|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-09-19|2013-09-19|2012-07-23|May 2011||2011-05-01|September 2013|2013-09-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea|A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Safety of CD07805/47 Gel Applied Topically Once Daily in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea|Completed||Phase 3|293|Actual|Galderma||2|||f||||f||||||||||2017-10-11 04:14:14.613236|2017-10-11 04:14:14.613236
NCT01355458|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-09-19|2013-09-19|2012-07-23|May 2011||2011-05-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea|A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Safety of CD07805/47 Gel Applied Topically Once Daily in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea|Completed||Phase 3|260|Actual|Galderma||2|||f||||f||||||||||2017-10-11 04:14:15.003924|2017-10-11 04:14:15.003924
NCT01355445|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-07-19|||January 2012||2012-01-01|July 2017|2017-07-01|September 2021|Anticipated|2021-09-01|December 2017|Anticipated|2017-12-01||Interventional|VIT-0910||Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma|International Randomized Phase II Trial of the Combination of Vincristine and Irinotecan With or Without Temozolomide (VI or VIT) in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma|Recruiting||Phase 2|120|Anticipated|Centre Oscar Lambret||2|||f||||t||||||||||2017-10-11 04:14:15.335518|2017-10-11 04:14:15.335518
NCT01355432|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2012-05-01|||May 2011||2011-05-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Heart Rate Changes With Propofol|Changes in Heart Rate Following Administration of Propofol After Inhalational Induction|Completed||N/A|40|Actual|Nationwide Children's Hospital|||1||f||||f||||||||||2017-10-11 04:14:15.528477|2017-10-11 04:14:15.528477
NCT01355419|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2015-04-27|2015-02-20||August 2010||2010-08-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Sleep Schedules Modifications in Sleep Apnea Patients Treated by nCPAP|Evaluation of Sleep Schedules Modifications in Moderate to Severe Sleep Apnea Patients Treated by nCPAP|Completed||N/A|150|Actual|Centre Hospitalier Universitaire Saint Pierre|||1||f||||f||||||||||2017-10-11 04:14:15.611081|2017-10-11 04:14:15.611081
NCT01355406|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-11-16|||September 2011||2011-09-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|January 2016|Actual|2016-01-01||Interventional|OPEN||Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System|Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System Study|Active, not recruiting||N/A|257|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 04:14:15.849168|2017-10-11 04:14:15.849168
NCT01355393|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-04-11||2017-04-03|July 2011||2011-07-01|April 2017|2017-04-01||||November 2013|Actual|2013-11-01||Interventional|||Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer|Phase I-II Study of HER2 Vaccination With Poly(I) • Poly(C12U) (Ampligen®) as an Adjuvant in Optimally Treated Breast Cancer Patients|Active, not recruiting||Phase 1/Phase 2|50|Actual|University of Washington||3|||f||||f||||||||||2017-10-11 04:14:15.962683|2017-10-11 04:14:15.962683
NCT01355380|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2017-09-20|||August 5, 2010|Actual|2010-08-05|September 2017|2017-09-01|September 22, 2016|Actual|2016-09-22|April 28, 2016|Actual|2016-04-28||Observational|SPHERA||Efficacy of Ventavis Used in Real-life Setting.|"The Efficacy of Inhaled Iloprost in Patients Treated Within the Pulmonary Arterial Hypertension Therapeutic Programme."|Completed||N/A|52|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:14:16.087901|2017-10-11 04:14:16.087901
NCT01355367|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2014-01-28|||January 2011||2011-01-01|January 2014|2014-01-01|April 2012|Actual|2012-04-01|September 2011|Actual|2011-09-01||Interventional|||High Dose BAYA1040 CR: a Long Term Extension Study|A Multicenter, Open Label, Long Term Extension Study of Oral BAYA1040 CR 80 mg (40 mg Bid) for 44 Weeks in Patients With Essential Hypertension (Extension From Study 13176)|Completed||Phase 3|120|Actual|Bayer||1|||f||||f||||||||||2017-10-11 04:14:16.190764|2017-10-11 04:14:16.190764
NCT01355354|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-17|2011-10-05|||June 2011||2011-06-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects|An Open-Label, Non-Randomised, 2-Period, Single Centre Study to Assess the Pharmacokinetics of Digoxin in Healthy Subjects When Administered Alone and in Combination With Fostamatinib 100 mg Twice Daily|Completed||Phase 1|21|Anticipated|AstraZeneca||2|||f||||||||||||||2017-10-11 04:14:16.309018|2017-10-11 04:14:16.309018
NCT01355328|ClinicalTrials.gov processed this data on October 10, 2017|2010-05-24|2011-05-17|||February 2009||2009-02-01|February 2009|2009-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Evaluating Light-tissue Reaction and Transdermal Drug Delivery by Multiphoton Microscopy|Evaluating Light-tissue Reaction and Transdermal Drug Delivery by Multiphoton Microscopy|Unknown status|Recruiting|N/A|||Far Eastern Memorial Hospital||2|||f||||||||||||||2017-10-11 04:14:16.485503|2017-10-11 04:14:16.485503
NCT01355315|ClinicalTrials.gov processed this data on October 10, 2017|2008-06-18|2011-05-17|||April 2006||2006-04-01|June 2008|2008-06-01||||December 2007|Actual|2007-12-01||Observational|||Enhanced External Counterpulsation|Enhanced External Counterpulsation for Ischemic Cardiomyopathy|Completed||N/A|19|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||Samples Without DNA|"     serum and plasma   "|||2017-10-11 04:14:16.562189|2017-10-11 04:14:16.562189
NCT01355302|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-04-07|2017-01-19|2013-05-21|November 2011||2011-11-01|March 2017|2017-03-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer|An Open-Label, Multicenter, Randomized, Phase Ib/II Study of E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer|Terminated||Phase 1/Phase 2|7|Actual|Eisai Inc.|The study was terminated prior to enrollment in Phase 2.|2||Sites not recruiting|f||||f||||||||||2017-10-11 04:14:16.629951|2017-10-11 04:14:16.629951
NCT01355289|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2015-08-27||2015-06-29|November 2011||2011-11-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501|A Phase II, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study, With an Open-Label Extension, to Evaluate the Efficacy, Safety, and Pharmacokinetics of E5501 in Subjects With Chronic Hepatitis C Virus Related Thrombocytopenia Who Are Potential Candidates for Antiviral Treatment|Completed||Phase 2|65|Actual|Eisai Inc.||4|||f||||t||||||||||2017-10-11 04:14:17.287564|2017-10-11 04:14:17.287564
NCT01355276|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-11-29|||October 2010||2010-10-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia|A Randomized, Double-blind, Double-dummy, Active Drug Parallel Controlled, Multi-center Clinical Trial on the Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia|Completed||Phase 3|400|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 04:14:17.37939|2017-10-11 04:14:17.37939
NCT01355263|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-02-18|||July 2011||2011-07-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Effect of Vitamin A Supplementation on Iron Metabolic Homeostasis of Preschool Children in Sichuan,China|Effect of Vitamin A Supplementation on Iron Metabolic Homeostasis of Preschool Children in Sichuan,China|Completed||N/A|450|Actual|Chengdu Maternal and Children's Health Care Hospital||1|||f||||t||||||||||2017-10-11 04:14:17.474674|2017-10-11 04:14:17.474674
NCT01355237|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-06-12|||February 2012||2012-02-01|June 2017|2017-06-01|December 2015|Actual|2015-12-01|April 2015|Actual|2015-04-01||Observational|||Observational Cohort Study of Chronic Low Back Pain|Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital: Study II - Observational Cohort Study of Chronic Low Back Pain|Completed||N/A|309|Actual|Brigham and Women's Hospital|||2||f||||t||||||||||2017-10-11 04:14:17.54749|2017-10-11 04:14:17.54749
NCT01355224|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-01-24|2016-08-08||September 2011||2011-09-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||Based on participants who completed the baseline survey|Communicating Risk Information for Obesity|Communicating Genetic Information for Obesity|Completed||N/A|798|Actual|Boston University||4|||f||||f||||||||No|No plan to share data|2017-10-11 04:14:17.63107|2017-10-11 04:14:17.63107
NCT01355211|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2012-02-29|||April 2011||2011-04-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Putting Electroencephalography (EEG) in the Emergency Department|Diagnostic Utility of Emergency Electroencephalography in Identifying Non-convulsive Seizure and Subclinical Status Epilepticus in Patients With Altered Mental Status|Completed||N/A|261|Actual|Bio-Signal Group Corp.|||1||f||||t||||||||||2017-10-11 04:14:18.430606|2017-10-11 04:14:18.430606
NCT01355198|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-30|2013-02-05|||August 2010||2010-08-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Role of HIV on Glutathione Synthesis and Oxidative Stress|Role of HIV on Glutathione Synthesis and Oxidative Stress|Completed||Phase 1|10|Actual|Baylor College of Medicine||1|||f||||f||||||||||2017-10-11 04:14:18.551494|2017-10-11 04:14:18.551494
NCT01355185|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-10-01|||August 2011||2011-08-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences|Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences|Unknown status|Recruiting|N/A|20|Anticipated|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 04:14:18.689486|2017-10-11 04:14:18.689486
NCT01355172|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-15|2012-07-12|||November 2010||2010-11-01|July 2012|2012-07-01||||September 2011|Actual|2011-09-01||Interventional|||Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old|Clinical Study Protocol Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011， in Infants Aged Between 6-12months Old|Completed||Phase 4|59|Actual|Adimmune Corporation||1|||f||||t||||||||||2017-10-11 04:14:18.820545|2017-10-11 04:14:18.820545
NCT01355159|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-08-28|||April 2011||2011-04-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|FACT||High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia Prevention|Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia-Folic Acid Clinical Trial (FACT)|Completed||Phase 3|2464|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 04:14:18.947516|2017-10-11 04:14:18.947516
NCT01355146|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-02-01|||May 2011||2011-05-01|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|May 2019|Anticipated|2019-05-01||Observational|||Home Therapy With Replagal in Fabry Disease|Non Interventional Study of Replagal® Home Therapy in Patients With Fabry Disease|Recruiting||N/A|50|Anticipated|Shire|||1||f||||f||||||||||2017-10-11 04:14:19.361267|2017-10-11 04:14:19.361267
NCT01355133|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-05-16|||August 2009||2009-08-01|May 2011|2011-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence|Transurethral Ultrasound-directed Injection of Autologous Myoblasts in Combination With Functional Electrical Stimulation in Patients With Intrinsic Urinary Sphincter Deficiency|Completed||Phase 1/Phase 2|40|Actual|University Medical Centre Ljubljana||1|||f||||f||||||||||2017-10-11 04:14:19.705534|2017-10-11 04:14:19.705534
NCT01355120|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-29|2014-06-20|||October 2011||2011-10-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|DeCOG||THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease|THE IPI - Multibasket Trial in Advanced Melanoma: Prospective Clinical Phase II Multibasket Study in Melanoma Patients With Advanced Disease (DeCOG MM-PAL11)|Completed||Phase 2|171|Actual|University Hospital, Essen||1|||f||||t||||||||||2017-10-11 04:14:19.807769|2017-10-11 04:14:19.807769
NCT01355107|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-12-13|||April 2011||2011-04-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease|Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease - a Pilot Trial|Completed||N/A|32|Actual|University Hospital Freiburg|||3||f||||f||||||Samples Without DNA|"     whole blood   "|||2017-10-11 04:14:19.949204|2017-10-11 04:14:19.949204
NCT01355094|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2016-08-15|||June 2011||2011-06-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|SAD||Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis/Injury|Peritoneal Vacuum Therapy to Reduce the Systemic Inflammatory Insult From Intraperitoneal Sepsis/Injury/Hypertension: A Randomized Comparison of Baseline Wall Suction Versus the KCI AbThera™ Abdominal Dressing|Active, not recruiting||Phase 3|50|Anticipated|University of Calgary||2|||f||||f||||||||No|No plan|2017-10-11 04:14:20.05156|2017-10-11 04:14:20.05156
NCT01355068|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-11-10|2011-11-10||May 2011||2011-05-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia|An Open Label, Randomized, Single Dose, Crossover Pivotal Bioequivalence Study of Epanutin Infatabs 50 mg (Sourced From Germany) Verses Dilantin Infatabs 50 mg (Sourced From Australia) in Healthy Subjects|Completed||Phase 1|26|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:14:21.609862|2017-10-11 04:14:21.609862
NCT01355055|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-16|||March 2011||2011-03-01|March 2011|2011-03-01||||||||Observational|ReD||Sympathetic Activity and Renal Denervation|Influences of Catheter-based Renal Denervation on Central Sympathetic Nervous System Regulation in Refractory Hypertension|Unknown status|Recruiting|N/A|26|Anticipated|Hannover Medical School|||1||f||||f||||||||||2017-10-11 04:14:21.904906|2017-10-11 04:14:21.904906
NCT01355042|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-09-19|||November 2010|Actual|2010-11-01|September 2017|2017-09-01|September 2016|Actual|2016-09-01|June 2012|Actual|2012-06-01||Observational|DYNAMICS||Studies of Blood DNA in Patients With Severe Infection DYNAMICS|DYNAMICS: DNA as a Prognostic Marker in ICU Patients Study|Completed||N/A|792|Actual|Hamilton Health Sciences Corporation|||2||f||||f||||||Samples With DNA|"     plasma   "|||2017-10-11 04:14:21.975511|2017-10-11 04:14:21.975511
NCT01355029|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-03-14|||February 2011||2011-02-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|FICSS||Evaluation of the Stroke Caregiver Education and Support Program|A Pilot Study of the Evaluation of the Family Informal Caregiver Stroke Self Management (FICSS) Research Project: Impact on Caregiver Psychosocial, Emotional and Health Needs|Completed||N/A|43|Actual|March of Dimes, Canada||1|||f||||f||||||||||2017-10-11 04:14:22.057071|2017-10-11 04:14:22.057071
NCT01355016|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2012-04-10|||September 2011||2011-09-01|April 2012|2012-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled MDT-637 in Healthy Volunteers|Completed||Phase 1|48|Anticipated|MicroDose Therapeutx, Inc||2|||f||||||||||||||2017-10-11 04:14:22.133865|2017-10-11 04:14:22.133865
NCT01355003|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2015-08-11|||February 2008||2008-02-01|August 2015|2015-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)|Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™) Post Marketing Surveillance Protocol|Terminated||N/A|1080|Actual|Merck Sharp & Dohme Corp.|||1|"Merck Sharp & Dohme Corp (MSD) received exemption from PFDA on conduct of post-marketing   surveillance (PMS) study"|f||||f||||||||||2017-10-11 04:14:22.206727|2017-10-11 04:14:22.206727
NCT01354990|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2015-08-26|2012-02-01||February 2009||2009-02-01|August 2015|2015-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)|Sitagliptin (JANUVIA®) Post Marketing Surveillance Protocol|Completed||N/A|2974|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-10-11 04:14:22.278325|2017-10-11 04:14:22.278325
NCT01354977|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-05-16|||March 2008||2008-03-01|May 2011|2011-05-01||||March 2015|Anticipated|2015-03-01||Interventional|||Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans|Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans|Unknown status|Recruiting|Phase 2|80|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 04:14:22.465337|2017-10-11 04:14:22.465337
NCT01354964|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-05-16|||March 2009||2009-03-01|May 2011|2011-05-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation|Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation|Unknown status|Recruiting|Phase 2|25|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-10-11 04:14:22.550404|2017-10-11 04:14:22.550404
NCT01354951|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2017-07-24|||May 2011||2011-05-01|July 2017|2017-07-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer|Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy Early Stage, Low Volume in Prostate Cancer|Terminated||Phase 2|3|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-10-11 04:14:22.647926|2017-10-11 04:14:22.647926
NCT01354938|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-02-01|2012-12-20||May 2011||2011-05-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis|Outcome Study to Evaluate the Role of Klaricid XL (Clarithromycin Modified Release) in the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB) and Its Impact on Quality of Life Measured by St. George's Respiratory Questionnaire (SGRQ)|Completed||N/A|220|Actual|Abbott|||1||f||||f||||||||||2017-10-11 04:14:22.733285|2017-10-11 04:14:22.733285
NCT01354925|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-04-11|||September 2011||2011-09-01|April 2013|2013-04-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|DMR||Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan|Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan An Interventional, Community Based, Comparative Study|Completed||Phase 4|245|Actual|Meir Medical Center||2|||f||||||||||||||2017-10-11 04:14:24.55944|2017-10-11 04:14:24.55944
NCT01354912|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2013-03-10|||May 2011||2011-05-01|March 2012|2012-03-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||The Incidence of Nontuberculous Mycobacterial Pulmonary Infection in Bilateral Bronchiectasis and Bronchiolitis||Unknown status|Recruiting|N/A|150|Anticipated|Meir Medical Center|||1||f||||f||||||||||2017-10-11 04:14:24.705992|2017-10-11 04:14:24.705992
NCT01354899|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-04-05|2016-02-25||May 2011||2011-05-01|April 2016|2016-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||A Open Study to Evaluate the Performance of Dressing on Subject With High Risk of Skin Breakdown|A Multi-Centre, Post CE Mark, Open Study to Evaluate the Performance of Thin Self-adherent Dressing Coated With a Soft Silicone Layer on Subjects With a High Risk of Skin Breakdown|Completed||N/A|24|Actual|Molnlycke Health Care AB|||1||f||||f||||||||||2017-10-11 04:14:24.785845|2017-10-11 04:14:24.785845
NCT01354886|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-11-25|||April 2011||2011-04-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Single Dose FSH-GEX™ in Healthy Volunteers|A Phase I, Monocenter, Randomized, Placebo and Comparator Controlled, Single Blind, Rising Dose, Clinical Study to Determine Single Dose Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Four Doses of FSH-GEX™ According to Adaptive Design (25, 75, 150 and 300 IU) Administered Subcutaneously in Healthy Pituitary-suppressed Female Volunteers|Completed||Phase 1|18|Anticipated|Glycotope GmbH|||||f||||f||||||||||2017-10-11 04:14:24.966498|2017-10-11 04:14:24.966498
NCT01354860|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-05-16|||December 2010||2010-12-01|September 2010|2010-09-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||Moxibustion for Knee Osteoarthritis|Moxibustion for Knee Osteoarthritis: a Randomized Pilot Clinical Trial|Completed||Phase 1/Phase 2|40|Actual|Korea Institute of Oriental Medicine||2|||f||||t||||||||||2017-10-11 04:14:25.129814|2017-10-11 04:14:25.129814
NCT01354847|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2013-10-25|||June 2011||2011-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Influence of Extracorporeal Circulation on Platelet Function of Patients Undergoing Cardiac Surgery|Influence of Extracorporeal Circulation on Platelet Function of Patients Undergoing Cardiac Surgery - a Prospective Observational Study|Completed||N/A|25|Actual|Goethe University|||1||f||||f||||||||||2017-10-11 04:14:25.2357|2017-10-11 04:14:25.2357
NCT01354834|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2011-05-16|||March 2004||2004-03-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|December 2005|Actual|2005-12-01||Observational|||Assessment of the Effectiveness of Menopur in Intrauterine Insemination|Assessment of the Clinical Efficacy of Menopur® in Intrauterine Artificial Insemination (From Partner or From Donor)|Completed||N/A|207|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:14:25.315242|2017-10-11 04:14:25.315242
NCT01354821|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2014-10-29|||November 2009||2009-11-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|January 2014|Actual|2014-01-01||Interventional|Windows2||Medical & Economical Evaluation of Fenestrated & Branched Stent-grafts to Treat Complex Thoracal Abdominal Aneurysms|Medical & Economical Evaluation of Endovascular Therapy of Complex Thoracal Abdominal Aneurysms (Type 1-3 Thoracal Abdominal Aneurysms) by Fenestrated & Branched Stent-grafts|Unknown status|Active, not recruiting|N/A|49|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 04:14:25.418894|2017-10-11 04:14:25.418894
NCT01354808|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-15|2013-09-23|||July 2010||2010-07-01|September 2013|2013-09-01||||July 2012|Actual|2012-07-01||Interventional|||ACCEL-LOADING-ACS Study|ACCELerated Inhibition of Platelet Aggregation, Inflammation and Ischemia-reperfusion Injury by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome|Completed||Phase 4|220|Anticipated|Gyeongsang National University Hospital||2|||f||||t||||||||||2017-10-11 04:14:27.047265|2017-10-11 04:14:27.047265
NCT01354795|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-24|2011-05-16|||September 2010||2010-09-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|EUS-FNA||Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic Mass|Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic Mass|Completed||N/A|80|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 04:14:27.175911|2017-10-11 04:14:27.175911
NCT01354782|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-10-24|||May 2011||2011-05-01|September 2016|2016-09-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects|An Open, Single Centre, Single and Repeated Dose Study to Investigate the Pharmacokinetic Profile of Roflumilast and Roflumilast N-oxide After Administration of 500 μg Dose of Roflumilast in Healthy Chinese Subjects|Completed||Phase 1|32|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 04:14:27.265405|2017-10-11 04:14:27.265405
NCT01354769|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2016-04-24|||June 2011||2011-06-01|May 2011|2011-05-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Observational|||Capnography Library - Data Collection in the Critical Care Environment Stage 2|Capnography Library - Data Collection in the Critical Care Environment Stage 2|Completed||N/A|75|Actual|Shaare Zedek Medical Center|||2||f||||f||||||||Undecided||2017-10-11 04:14:27.345214|2017-10-11 04:14:27.345214
NCT01354756|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2015-03-09|||October 2010||2010-10-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Validation of Apnea LinkTM for Sleep Apnea Syndrome Screening in a Bariatric Population|Validation of Apnea LinkTM (ResMed Corporation, Poway, California) for Sleep Apnea Syndrome Screening in a Bariatric Population|Terminated||N/A|9|Actual|Centre Hospitalier Universitaire Saint Pierre|||1|device was stolen|f||||f||||||||||2017-10-11 04:14:27.435881|2017-10-11 04:14:27.435881
NCT01354743|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-09-24|||December 2010||2010-12-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|DPL-2010||Upper Facial Remodeling With Perlane-L and Dysport|Upper Facial Remodeling With Perlane-L and Dysport.|Completed||Phase 4|20|Actual|Beer, Kenneth R., M.D., PA||1|||f||||f||||||||||2017-10-11 04:14:27.499591|2017-10-11 04:14:27.499591
NCT01354730|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-15|2011-05-16|||June 2010||2010-06-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Observational|||A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women||Completed||Phase 4|398|Actual|Adimmune Corporation|||2||f||||||||||||||2017-10-11 04:14:27.595645|2017-10-11 04:14:27.595645
NCT01354717|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-14|2014-10-09||2014-09-07|September 2010||2010-09-01|October 2014|2014-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo|Phase 3 Study of Brand Generic and Placebo in Treatment of Actinic Keratosis|Completed||Phase 3|377|Actual|Spear Pharmaceuticals||3|||f||||f||||||||||2017-10-11 04:14:27.677023|2017-10-11 04:14:27.677023
NCT01354704|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-14|2015-11-02|||March 2011||2011-03-01|February 2012|2012-02-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|PRENOXA||Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin|Echo-Doppler Assessment of the Occurrence of Asymptomatic Deep Vein Thrombosis (DVT) in Orthopedic Replacement Surgery Under Enoxaparine (PRENOXA)|Completed||Phase 4|153|Actual|Les Laboratoires des Médicaments Stériles||4|||f||||t||||||||||2017-10-11 04:14:27.788071|2017-10-11 04:14:27.788071
NCT01354691|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-01|2013-07-22|||February 2011||2011-02-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease|A 6-Month Prospective, Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Adaptive-Trial-Design Study to Evaluate the Safety and Efficacy of 80mg b.i.d Ladostigil in Patients With Mild to Moderate Probable Alzheimer's Disease With a 6-Month Open Label Follow-Up Period|Completed||Phase 2|201|Actual|Avraham Pharmaceuticals Ltd||1|||f||||t||||||||||2017-10-11 04:14:27.874481|2017-10-11 04:14:27.874481
NCT01354678|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-08-01|||May 2011||2011-05-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|August 2018|Anticipated|2018-08-01||Interventional|IMPI||Intramyocardial Multiple Precision Injection of Bone Marrow Mononuclear Cells in Myocardial Ischemia|Phase 1 Study to Evaluate the Efficacy and Safety of Intramyocardial Multiple Precision Injection of Bone Marrow Mononuclear Cells in Myocardial Ischemia|Active, not recruiting||Phase 1|30|Anticipated|Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health||2|||f||||f||||||||||2017-10-11 04:14:28.157924|2017-10-11 04:14:28.157924
NCT01354665|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-16|2015-01-19|||May 2010||2010-05-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|FADO||Depression and Fatigue in MS Patients Treated With Betaferon.|The Short-term Effect of Immunomodulatory Treatment With Interferon Beta-1b (Betaferon) on Fatigue and Depression in First-time Treated Patients With Relapsing-remitting Multiple Sclerosis.|Completed||N/A|567|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:14:28.254769|2017-10-11 04:14:28.254769
NCT01354652|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-03-03|2015-01-18||May 2011||2011-05-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ETV||Lactic Acidosis During Entecavir(ETV)Treatment|The Incidence of Lactic Acidosis During Entecavir Treatment in Chronic Hepatitis B Patients With Severe Cirrhosis or Hepatic Failure|Terminated||Phase 4|5|Actual|Asan Medical Center||3||Tenofovir has become available in Korea.|f||||t||||||||||2017-10-11 04:14:28.356662|2017-10-11 04:14:28.356662
NCT01354639|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-02-04|||April 2011||2011-04-01|February 2014|2014-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Comparative Study of Surgical Completeness After Robotic Thyroidectomy Versus Conventional Open Thyroidectomy|Comparative Study of Surgical Completeness After Robotic Thyroidectomy Versus Conventional Open Thyroidectomy|Completed||N/A|150|Actual|Yonsei University|||2||f||||f||||||||||2017-10-11 04:14:28.807589|2017-10-11 04:14:28.807589
NCT01354626|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2012-03-14|||August 2011||2011-08-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|LiF-Pro||Dietary Protein and Hepatic Fat Accumulation|Influence of Increasing Dietary Protein on Hepatic Fat Accumulation and Postprandial Metabolism|Completed||N/A|29|Actual|Wageningen University||2|||f||||f||||||||||2017-10-11 04:14:28.886093|2017-10-11 04:14:28.886093
NCT01354613|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2015-10-06|||April 2011||2011-04-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)|Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction|Completed||N/A|14|Actual|University of Wisconsin, Madison||4|||f||||t||||||||||2017-10-11 04:14:28.97478|2017-10-11 04:14:28.97478
NCT01354600|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2013-07-22|||May 2009||2009-05-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Effects of Positive Energy Balance and Exercise on Appetite Hormones in Sedentary Men and Women|Short-term Positive Energy Balance and Exercise on 24-hour Plasma Levels of Hunger and Satiety Hormones in Sedentary Lean and Obese Men and Women|Completed||N/A|13|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 04:14:29.063834|2017-10-11 04:14:29.063834
NCT01354587|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-18|2012-07-16|||October 2010||2010-10-01|July 2012|2012-07-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Evaluation of Efficacy and Tolerability of Hizentra®|Evaluation of Efficacy and Tolerability of Hizentra® in Subjects Transitioning From Vivaglobin® (16% SCIG Product) to Hizentra® (20% SCIG Product)|Unknown status|Recruiting|N/A|50|Anticipated|University of South Florida||1|||f||||t||||||||||2017-10-11 04:14:29.160666|2017-10-11 04:14:29.160666
NCT01354574|ClinicalTrials.gov processed this data on October 10, 2017|2010-08-13|2011-07-12|||October 2002||2002-10-01|July 2011|2011-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|FL33||Thermic & Lipemic Properties of Dietary Carbohydrates|Thermic & Lipemic Properties of Dietary Carbohydrates|Completed||N/A|28|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-10-11 04:14:29.249739|2017-10-11 04:14:29.249739
NCT01354561|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-13|||February 2007||2007-02-01|May 2011|2011-05-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Respiratory Physical Therapy on the Cardiac Autonomic Modulation Paediatric Patients|Effect of Airway Clearance Therapy on the Cardiac Autonomic Modulation in Hospitalized Paediatric Patients|Completed||N/A|24|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-10-11 04:14:29.345031|2017-10-11 04:14:29.345031
NCT01354548|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2016-04-13|||February 2010||2010-02-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|April 2016|Actual|2016-04-01||Interventional|||Prevention of Trismus During Radiotherapy and Quality of Life in Head and Neck Cancer Patients|Prophylactic Training for the Prevention of Radiotherapy-induced Trismus - a Randomised Study. Health-related Quality of Life up to One Year After Radiotherapy in Patients With Head and Neck Cancer|Active, not recruiting||N/A|60|Anticipated|University Hospital, Linkoeping||2|||f||||t||||||||||2017-10-11 04:14:29.439459|2017-10-11 04:14:29.439459
NCT01354535|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-07-27|||February 2013||2013-02-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Types of Fixation of Vancouver B1 Periprosthetic Fractures|Isolated Locked Compression Plating Versus Cable Plating and Strut Allografts With Cerclage Wiring for Vancouver B1 Periprosthetic Femoral Fractures: A Randomized Controlled Trial|Recruiting||N/A|89|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-10-11 04:14:29.520032|2017-10-11 04:14:29.520032
NCT01354522|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2014-01-14|||May 2011||2011-05-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||TAC Versus TCX as Adjuvant Treatment for Node-Positive Her2-Negative Breast Cancer|A Randomized, Phase III Study Comparing TAC (Docetaxel, Doxorubicin, Cyclophosphamide) With TCX ( Docetaxel, Cyclophosphamide, Capecitabine) as Adjuvant Treatment for Node-Positive Her2-Negative Breast Cancer|Unknown status|Recruiting|Phase 3|400|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-10-11 04:14:29.61436|2017-10-11 04:14:29.61436
NCT01354509|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-05-17|||May 2011||2011-05-01|May 2011|2011-05-01|May 2013|Anticipated|2013-05-01|May 2012|Anticipated|2012-05-01||Observational|||Normothermia Protocol for Traumatic Brain Injury Patients|Normothermia Protocol for Traumatic Brain Injury Patients: An Outcome Study|Unknown status|Recruiting|N/A|80|Anticipated|Medivance, Inc.|||2||f||||t||||||||||2017-10-11 04:14:29.699445|2017-10-11 04:14:29.699445
NCT01354496|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2011-11-07|||April 2011||2011-04-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of LY2409021 Formulations and the Effect of Food|LY2409021 Formulation Bridging and Food Effect Study|Completed||Phase 1|42|Anticipated|Eli Lilly and Company||6|||f||||f||||||||||2017-10-11 04:14:29.776085|2017-10-11 04:14:29.776085
NCT01354483|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-14|2014-08-20|||September 2011||2011-09-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury|Feasibility and Safety of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord: an Open-Labeled, Dose-Escalating Clinical Trial|Completed||Phase 1/Phase 2|20|Actual|China Spinal Cord Injury Network||5|||f||||f||||||||||2017-10-11 04:14:30.00745|2017-10-11 04:14:30.00745
NCT00000566|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-14|||September 1983||1983-09-01|June 2002|2002-06-01|December 1989||1989-12-01|||||Interventional|||Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:04.95574|2017-10-11 04:19:04.95574
NCT01354470|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2013-07-01|||October 2011||2011-10-01|July 2013|2013-07-01||||February 2013|Actual|2013-02-01||Interventional|||A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence|A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence|Completed||Phase 2|72|Anticipated|California Pacific Medical Center Research Institute||2|||f||||||||||||||2017-10-11 04:14:30.125859|2017-10-11 04:14:30.125859
NCT01354457|ClinicalTrials.gov processed this data on October 10, 2017|2009-07-17|2014-06-24|||November 2010||2010-11-01|May 2011|2011-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|RIT 90YEpra||Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+|Evaluation of the Efficacy and Tolerance of Fractionated Radio-immunotherapy With 90Y-Epratuzumab (90Y-hLL2) for Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukaemia Patients|Unknown status|Active, not recruiting|Phase 1/Phase 2|21|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 04:14:30.227429|2017-10-11 04:14:30.227429
NCT01354418|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2015-02-20|||May 2011||2011-05-01|February 2015|2015-02-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)|A Randomized Crossover Bioequivalence Study Comparing a Single Dose of Phenylephrine HCl 30 mg Extended Release Tablet to Three Phenylephrine HCl 10 mg Immediate Release Tablets Each Consecutively Dosed Four Hours Apart Under Fed and Fasting Conditions|Completed||Phase 1|24|Actual|Bayer||4|||f||||f||||||||||2017-10-11 04:14:32.302579|2017-10-11 04:14:32.302579
NCT01354405|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-07-08|||May 2011||2011-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|RESOLVE||Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)|The Effect of Lanreotide on Volume of Polycystic Liver and Kidney in Autosomal Dominant Polycystic Kidney Disease|Completed||N/A|43|Actual|Radboud University|||1||f||||t||||||Samples With DNA|"     Blood samples   "|||2017-10-11 04:14:32.372978|2017-10-11 04:14:32.372978
NCT01354392|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-07-01|||September 2011||2011-09-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||AZD1152 in Diffuse Large B-cell Lymphoma|A Phase 2 Trial of AZD1152 in Relapsed/Refractory Diffuse Large B-cell Lymphoma|Completed||Phase 1/Phase 2|15|Actual|Oxford University Hospitals NHS Trust||1|||f||||t||||||||||2017-10-11 04:14:32.489147|2017-10-11 04:14:32.489147
NCT01354379|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2013-03-26|||May 2011||2011-05-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer|A Phase 1 Randomized, Observer-Blind, Controlled, Safety, Tolerability and Immunogenicity Study of Intranasal NB-1008 in Healthy Adult Volunteers Administered by Nasal Sprayer and Pipette|Completed||Phase 1|125|Actual|NanoBio Corporation||5|||f||||t||||||||||2017-10-11 04:14:32.573758|2017-10-11 04:14:32.573758
NCT01354366|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2013-08-28|||July 2011||2011-07-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Growth and Tolerance of Hypoallergenic Formulas|The Effects on Growth and Tolerance of Hypoallergenic Formulas Fed to Term Infants|Completed||N/A|511|Actual|Mead Johnson Nutrition|||3||f||||f||||||||||2017-10-11 04:14:32.666298|2017-10-11 04:14:32.666298
NCT01354353|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2012-08-09|||May 2011||2011-05-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study of Safety and Tolerability in Subjects With Schizophrenia|Safety and Tolerability of Multiple Ascending Doses of LY2140023 in Subjects With Schizophrenia|Completed||Phase 1|120|Anticipated|Eli Lilly and Company||7|||f||||f||||||||||2017-10-11 04:14:32.929284|2017-10-11 04:14:32.929284
NCT01354340|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2012-04-18|||April 2011||2011-04-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Dose Effect of Limicol on (LDL)-Cholesterol Levels|Dose Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia|Completed||N/A|45|Actual|Lescuyer Laboratory||3|||f||||f||||||||||2017-10-11 04:14:33.018312|2017-10-11 04:14:33.018312
NCT01354327|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2011-05-13|||December 2008||2008-12-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effects of Limicol on LDL-cholesterol|Study of the Effects of Limicol (a Food Supplement) on LDL-cholesterol in Moderate Hypercholesterolemia Subjects|Completed||N/A|47|Actual|Lescuyer Laboratory||2|||f||||t||||||||||2017-10-11 04:14:33.096811|2017-10-11 04:14:33.096811
NCT01354314|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-05-11|2017-04-03||November 2010||2010-11-01|May 2017|2017-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|ParaFlu||Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder|Pilot Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder (HAND)|Completed||Phase 1/Phase 2|45|Actual|Johns Hopkins University||4|||f||||t||||||||||2017-10-11 04:14:33.246057|2017-10-11 04:14:33.246057
NCT01354301|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2015-03-20|||May 2011||2011-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|||Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate|Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate|Completed||Phase 4|300|Actual|Hospital do Rim e Hipertensão||3|||f||||f||||||||||2017-10-11 04:14:35.491768|2017-10-11 04:14:35.491768
NCT01354288|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-04-20|||October 2011||2011-10-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|December 2015|Anticipated|2015-12-01||Interventional|DIAB-EDUC||Therapeutic Education in Very Young Children With Diabetes Mellitus|Therapeutic Education in Very Young Children With Diabetes Mellitus. Evaluation of the Impact of a Specific Tool for Parents on Glycemic Control and Prevention of Acute Events (Hypoglycemia and Ketosis)|Unknown status|Active, not recruiting|N/A|24|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 04:14:35.61156|2017-10-11 04:14:35.61156
NCT01354275|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2012-02-01|||March 2009||2009-03-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|PCOS and ivf||In Vitro Fertilization Outcomes of Two Treatment Protocols in Women With Polycystic Ovary Syndrome|IVF/ICSI Outcomes of OCP Plus GnRH Agonist Protocol Versus OCP Plus GnRH Antagonist Fixed Protocol in Women With PCOS|Terminated||N/A|300|Actual|Baskent University||2||". The trial would be continued if there was a difference of ≥3 % between trial arms. However,   the difference between ongoing pregnancy rates was <1 %"|f||||t||||||||||2017-10-11 04:14:35.703678|2017-10-11 04:14:35.703678
NCT01354262|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2015-04-22|||March 2011||2011-03-01|April 2015|2015-04-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Vitamin D Supplementation on Hemoglobin A1c|Does Vitamin D Supplement Alter Serum Level of Glycosylated Hemoglobin in Adult Patients Between 34-74 Years With Type 2 Diabetes Mellitus and Vitamin D Deficiency?|Completed||Phase 2|150|Actual|Genesys Regional Medical Center||3|||f||||f||||||||||2017-10-11 04:14:35.815019|2017-10-11 04:14:35.815019
NCT01354249|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-13|||July 2010||2010-07-01|May 2011|2011-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Preoperative Feeding With a Whey Protein Plus Carbohydrate Drink on the Acute Phase Response and Insulin Resistance|Effects of Preoperative Feeding With a Whey Protein Plus Carbohydrate Drink on the Acute Phase Response and Insulin Resistance.|Completed||N/A|20|Actual|Federal University of Mato Grosso do Sul||2|||f||||t||||||||||2017-10-11 04:14:35.921516|2017-10-11 04:14:35.921516
NCT01354236|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-05-13|||January 2011||2011-01-01|May 2011|2011-05-01||||||||Observational|||Mental Health Related to School Dropout in Luxembourg|Psychosocial Risk- and Protective Factors of Secondary School Dropout in Luxembourg: an Exploratory Case-control Study|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Public Research Centre Health, Luxembourg|||2||f||||t||||||||||2017-10-11 04:14:36.011493|2017-10-11 04:14:36.011493
NCT01354223|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-10|2014-02-04|2013-10-23||October 2010||2010-10-01|January 2014|2014-01-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Clinical Evaluation of Stenfilcon A Soft Contact Lens When Compared to Ocufilcon B Soft Contact Lens|Evaluation of the CooperVision Stenfilcon A Soft Contact Lens for Daily Wear When Compared to the CooperVision Ocufilcon B Soft Contact Lens|Completed||Early Phase 1|90|Actual|Coopervision, Inc.||2|||f||||t||||||||||2017-10-11 04:14:36.109404|2017-10-11 04:14:36.109404
NCT01354210|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-01-26|||October 2010||2010-10-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|March 2013|Actual|2013-03-01||Interventional|TXTXT||Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth|Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth|Completed||N/A|110|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-11 04:14:36.497928|2017-10-11 04:14:36.497928
NCT01354197|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-02-05|2016-10-04||April 2011||2011-04-01|February 2017|2017-02-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Observational|THAI-SICU||The Thai Surgical Intensive Care Study (Thai-SICU Study)|Multicenter Study of Outcome and Adverse Events in Surgical Intensive Care Unit of Thai University Hospital|Completed||N/A|4652|Actual|Royal College of Anesthesiologists of Thailand|||1||f||||t||||||||Yes|All the data was managed by the the Medical Research Network of the Consortium of Thai Medical Schools (MedResNet)|2017-10-11 04:14:36.586427|2017-10-11 04:14:36.586427
NCT01354184|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2012-11-05||||||November 2012|2012-11-01||||||||Interventional|||CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)|An International, Multi-centre, Randomised, Stratified, Double-blinded, Placebo-controlled, 4-parallel Group Trial Investigating the Efficacy and Safety of Three Different Dose Levels of CRD007 (The AORTA Trial)|Completed||Phase 2|||RSPR Pharma AB||4|||f||||||||||||||2017-10-11 04:14:37.106396|2017-10-11 04:14:37.106396
NCT01354171|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-10-13|||November 2011||2011-11-01|March 2012|2012-03-01|December 2017|Anticipated|2017-12-01|September 2016|Actual|2016-09-01||Interventional|ASIST||Active Surveillance Magnetic Resonance Imaging Study|Active Surveillance Magnetic Resonance Imaging Study|Active, not recruiting||Phase 3|250|Anticipated|Canadian Urology Research Consortium||2|||f||||t||||||||||2017-10-11 04:14:37.216711|2017-10-11 04:14:37.216711
NCT01354158|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2013-07-29|||May 2011||2011-05-01|May 2011|2011-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Dose Titration of Droxidopa in Patients With Spinal Cord Injury|A Dose Response Trial of Droxidopa to Treat Hypotension in Persons With SCI|Completed||Phase 1|11|Actual|Bronx VA Medical Center||1|||f||||f||||||||||2017-10-11 04:14:37.297675|2017-10-11 04:14:37.297675
NCT01354145|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-07-12|2016-02-18||June 2011||2011-06-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|MOSAIC||Study of the Effect of Chondroitin Sulfate on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI|Twenty-four Month Exploratory Study of the Effect of Chondroitin Sulphate on Structural Changes in Knee Osteoarthritis Patients as Assessed by MRI|Completed||Phase 3|194|Actual|Bioiberica||2|||f||||t||||||||No||2017-10-11 04:14:37.403855|2017-10-11 04:14:37.403855
NCT01354132|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2017-06-13|2017-03-17||May 2011||2011-05-01|June 2017|2017-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|NACPSY||N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis|Effects of Oral N-Acetyl-Cysteine (NAC) in the Early Phase of Schizophrenia Spectrum Psychosis: Randomized, Parallel, Double- Blind, Placebo Controlled Trial|Completed||Phase 2|20|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-11 04:14:38.257815|2017-10-11 04:14:38.257815
NCT01354119|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2015-01-13|||January 2011||2011-01-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Long-term Benefit of Aortic Stent-graft in Patients With Distal Aortic Dissection||Terminated||Phase 4|7|Actual|Asan Medical Center||2||Not enough participants enrolled|f||||f||||||||||2017-10-11 04:14:39.320866|2017-10-11 04:14:39.320866
NCT01354106|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2012-10-10|2012-07-20||May 2011||2011-05-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Adhesive Tape Trauma Evaluation of Two Gentle Tapes|Adhesive Tape Trauma Evaluation of Two Gentle Tapes in Healthy Human Infant Subjects|Completed||N/A|26|Actual|3M||2|||f||||f||||||||||2017-10-11 04:14:39.397744|2017-10-11 04:14:39.397744
NCT01354093|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-06-21|||November 2011||2011-11-01|June 2017|2017-06-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)|Utah Center for the Collaborative Study of the Role of the Macular Pigment Carotenoids in the Pathogenesis and Treatment of MacTel|Completed||N/A|8|Actual|University of Utah|||2||f||||t||||||||||2017-10-11 04:14:39.608712|2017-10-11 04:14:39.608712
NCT00000567|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||August 1984||1984-08-01|December 2005|2005-12-01||||||||Interventional|||High Frequency Ventilation in Premature Infants (HIFI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:05.018845|2017-10-11 04:19:05.018845
NCT01354080|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2011-05-13|||June 2007||2007-06-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||The Effectiveness of Massage in Treating Constipation|Comparison of the Effectiveness of Massage Based on the Tensegrity Rule and Classical Abdominal Massage in Persons With Constipation|Completed||N/A|29|Actual|University School of Physical Education in Wroclaw||2|||f||||f||||||||||2017-10-11 04:14:39.720862|2017-10-11 04:14:39.720862
NCT01354067|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2012-06-19|||May 2011||2011-05-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|COPD||Single Limb Resistance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Effects of High-repetitive Single Limb Training on Exercise Capacity and Quality of Life in Patients With COPD Compared to a Control Group - A Prospective, Single Blind, Randomized Controlled Multicenter Trial|Completed||N/A|44|Actual|Umeå University||2|||f||||f||||||||||2017-10-11 04:14:39.827944|2017-10-11 04:14:39.827944
NCT01354054|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-12|||November 2006||2006-11-01|May 2011|2011-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TOPS||TENS Effectiveness and Knee Osteoarthritis in Humans|Effects of a Single Treatment of High or Low Frequency TENS on Pain, Hyperalgesia and Function in Patients With Knee Osteoarthritis|Completed||N/A|100|Actual|University of Iowa||4|||f||||t||||||||||2017-10-11 04:14:39.947374|2017-10-11 04:14:39.947374
NCT01354041|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-24|2014-01-23|||March 2011||2011-03-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|WiLLoW||Fear of Recurrence Pilot Intervention for Women With Breast Cancer|A Pilot Intervention to Address Fear of Recurrence in Breast Cancer Survivors|Completed||Phase 1|28|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 04:14:40.104713|2017-10-11 04:14:40.104713
NCT01354028|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2013-04-25|2013-01-30||March 2011||2011-03-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effects of Massage Therapy to Induce Sleep in Preterm Infants|Effects of Massage Therapy to Induce Sleep in Preterm Infants|Completed||N/A|30|Actual|University of Arkansas|The sample size was small. 30 infants were enrolled, but 7 infants were discharged or became ineligible and could not start the study.|2|||f||||t||||||||||2017-10-11 04:14:40.198078|2017-10-11 04:14:40.198078
NCT01354015|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-03-25|2014-12-30||May 2011||2011-05-01|March 2017|2017-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|DRMS||Diabetes Remote Care Management System|Diabetes Remote Care Management System|Completed||N/A|98|Actual|Tulane University||2|||f||||f||||||||||2017-10-11 04:14:40.473274|2017-10-11 04:14:40.473274
NCT01354002|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-03-31|||September 1, 2009|Actual|2009-09-01|October 2016|2016-10-01|December 31, 2030|Anticipated|2030-12-31|December 31, 2030|Anticipated|2030-12-31||Observational|||Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility|Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility|Recruiting||N/A|100000|Anticipated|St. Jude Children's Research Hospital|||1||f||||f|f|f||||Samples With DNA|"     Samples collected and processed from patients include any tumor or non-tumor sample,     including blood, ascites, pleural effusion, bone marrow, solid tumors, brain tumors, tissue     uninvolved by tumor, cerebrospinal fluid, and urine samples. Non-tumor samples are also     collected and processed from patients' relatives and controls. Samples are processed under     sterile conditions whenever possible, and tumor cells and tissues are cryopreserved viable.     Cellular subfractions are also isolated including DNA, RNA, and protein.   "|||2017-10-11 04:14:40.77743|2017-10-11 04:14:40.77743
NCT01353989|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-21|2016-06-27|||July 2010||2010-07-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Hepatitis A Vaccination in the Elderly|Hepatitis A Vaccination in the Elderly|Completed||N/A|60|Actual|Rijnstate Hospital|||2||f||||f||||||Samples With DNA|"     5 times 7 ml of blood will be collected   "|||2017-10-11 04:14:41.07222|2017-10-11 04:14:41.07222
NCT01353976|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2012-12-05|2012-12-05||May 2011||2011-05-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis|A Multi-Center, Randomized, Double-Blind, Vehicle Controlled, Parallel Group Comparison Study of the Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Interdigital Tinea Pedis|Completed||Phase 3|264|Actual|AmDerma||2|||f||||f||||||||||2017-10-11 04:14:41.162171|2017-10-11 04:14:41.162171
NCT01353963|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-12-04|2015-12-04||March 2012||2012-03-01|December 2015|2015-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational||Safety population included all participants who received at least 1 dose of study medication during the observation period.|Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients|An Open Label, Non-interventional Study Of The Safety Of Desvenlafaxine Succinate (Pristiq) In The Treatment Of Major Depressive Disorder (Mdd) And Vasomotor Symptoms (Vms) Associated With Menopause In Filipino Adult Patients: A Post Marketing Surveillance Study|Terminated||Phase 4|13|Actual|Pfizer|Due to the low number of subjects with data available, only descriptive summaries have been presented. The outcomes measures were prioritized as per study team's discretion.||1||f||||f||||||||||2017-10-11 04:14:41.541246|2017-10-11 04:14:41.541246
NCT01353950|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-04-04|||July 2011||2011-07-01|April 2017|2017-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Costimulatory Molecules as Biomarkers in Cystic Fibrosis|Costimulatory Molecules as Biomarkers in Cystic Fibrosis|Completed||N/A|40|Actual|Oregon Health and Science University|||1||f||||f||||||Samples Without DNA|"     Plasma, Serum, urine   "|||2017-10-11 04:14:41.792294|2017-10-11 04:14:41.792294
NCT01353937|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2016-03-02|||April 2014||2014-04-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|March 2016|Anticipated|2016-03-01||Interventional|AMD3100||Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers|Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers|Withdrawn||Phase 1|0|Actual|New York University School of Medicine||3||Never Activated|f||||t||||||||||2017-10-11 04:14:41.871057|2017-10-11 04:14:41.871057
NCT01353924|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-12|||August 2011||2011-08-01|April 2011|2011-04-01|December 2013|Anticipated|2013-12-01|August 2012|Anticipated|2012-08-01||Interventional|||Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1|Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 04:14:41.971139|2017-10-11 04:14:41.971139
NCT01352676|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2014-07-08|||May 2011||2011-05-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|Prospective||Limit Computed Tomography (CT) Scanning in Suspected Renal Colic|Validation of a Decision Rule to Limit CT Scanning in Suspected Renal Colic|Completed||N/A|635|Actual|Yale University|||1||f||||f||||||||||2017-10-11 04:15:14.356784|2017-10-11 04:15:14.356784
NCT01353911|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-03-01|2016-02-03||June 2011||2011-06-01|March 2017|2017-03-01|March 2015|Actual|2015-03-01|January 2013|Actual|2013-01-01||Interventional||Full Analysis Set (FAS); all randomized/enrolled participants who received ≥1 dose of study treatment. Results for participants who received grazoprevir 400 or 800 mg and were then down-dosed to receive grazoprevir 100 mg are reported separately from participants who completed the 400 mg and 800 mg regimens.|Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)|A Randomized, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Genotype 1 Hepatitis C Virus Infection|Completed||Phase 2|368|Actual|Merck Sharp & Dohme Corp.||8|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:14:42.122136|2017-10-11 04:14:42.122136
NCT01353898|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-02-23|2016-01-06||June 2011||2011-06-01|February 2017|2017-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||All randomized participants|Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)|A Multiple Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-1972 in HIV-1 Infected Patients|Terminated||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-10-11 04:14:44.791599|2017-10-11 04:14:44.791599
NCT01353885|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2014-08-12|||February 2013||2013-02-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|AAP||Outcomes Following Anterior Approach to Total Hip Arthroplasty|Outcomes Following Anterior Approach to Total Hip Arthroplasty: A Multi-Centre Observational Cohort Study|Terminated||N/A|50|Actual|McMaster University|||3||f||||f||||||||||2017-10-11 04:14:45.358863|2017-10-11 04:14:45.358863
NCT01353872|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2011-05-13|||October 2010||2010-10-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Nutrition Effects on Fatigue During Tennis Playing|Effects of Ingestion of Different Sports Drinks on Fatigue During Playing Tennis|Completed||N/A|8|Actual|Lescuyer Laboratory||2|||f||||t||||||||||2017-10-11 04:14:45.444406|2017-10-11 04:14:45.444406
NCT01353859|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-05-08|2014-04-22||March 2011||2011-03-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Intent to treat (ITT) population: all participants included in the study who received at least one dose of study medication. Participants prematurely withdrawn from the study will be considered as nonresponders at the end of the study in all analyses of treatment response variables.|A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs|An Open Label, Local, Multicenter , Phase IIIb Interventional Study to Assess the Efficacy of Tocilizumab (TCZ) in Combination With Methotrexate (MTX) in Indonesian Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs|Completed||Phase 3|39|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:14:45.536727|2017-10-11 04:14:45.536727
NCT01353846|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2012-03-30|||May 2011||2011-05-01|March 2012|2012-03-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients|Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients|Unknown status|Recruiting|Phase 4|70|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-10-11 04:14:46.082673|2017-10-11 04:14:46.082673
NCT01353833|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2012-04-20|||May 2011||2011-05-01|May 2011|2011-05-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|DF-IL2||Dose-effect Relationship of Low-dose IL-2 in Type 1 Diabetes|Dose-effect Relationship of Repeated Administration of Low-dose IL-2 Versus Placebo on the Kinetic of Regulatory T Cells in Patients With Type 1 Diabetes|Completed||Phase 1/Phase 2|25|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||t||||||||||2017-10-11 04:14:46.193927|2017-10-11 04:14:46.193927
NCT01353820|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2016-10-26|||September 2008||2008-09-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults|Proof of Concept -Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults.|Completed||N/A|100|Actual|Danone Research||2|||f||||f||||||||||2017-10-11 04:14:46.293463|2017-10-11 04:14:46.293463
NCT01353807|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2014-02-27|||November 1989||1989-11-01|February 2014|2014-02-01|May 2011|Actual|2011-05-01|December 1990|Actual|1990-12-01||Interventional|||Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health|Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health|Completed||N/A|533|Actual|Centre for Fetal Programming, Denmark||3|||f||||t||||||||||2017-10-11 04:14:46.386905|2017-10-11 04:14:46.386905
NCT01353794|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2015-01-29|||December 2014||2014-12-01|January 2015|2015-01-01|April 2018|Anticipated|2018-04-01|September 2017|Anticipated|2017-09-01||Observational|POWER-NEXT||Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney Cancer|Prospective, Multicentric, Large Scale Observational Study to Evaluate Effectiveness and Safety of Nexavar® in Advanced Renal Cell Carcinoma|Withdrawn||Phase 4|0|Actual|Bayer|||1||f||||f||||||||||2017-10-11 04:14:46.500383|2017-10-11 04:14:46.500383
NCT01353781|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-11|2016-04-25|||June 2011||2011-06-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies|A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD5363 Under Adaptable Dosing Schedules in Japanese Patients With Advanced Solid Malignancies|Completed||Phase 1|39|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-10-11 04:14:46.595159|2017-10-11 04:14:46.595159
NCT01353768|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2016-11-21|||July 2011||2011-07-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study|Medical Record Review and Data Abstraction for Pediatric, Adolescent and Pregnant Patients Treated With IV Zanamivir in the Relenza Compassionate Use Program|Completed||N/A|113|Actual|GlaxoSmithKline|||1||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:14:46.691211|2017-10-11 04:14:46.691211
NCT00000568|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||September 1984||1984-09-01|August 2005|2005-08-01|January 2005||2005-01-01|||||Interventional|||Lung Health Study (LHS) I and III||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:05.082137|2017-10-11 04:19:05.082137
NCT01353755|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-13|2014-11-12|||October 2009||2009-10-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|August 2012|Actual|2012-08-01||Interventional|||2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma|Randomised Double Blind Placebo Controlled Pivotal Study to Evaluate Efficacy and Safety of rPhleum in Adult and Adolescent Patients Suffering From Rhinoconjunctivitis +/- Controlled Asthma|Completed||Phase 3|195|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-10-11 04:14:46.782744|2017-10-11 04:14:46.782744
NCT01353742|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-08-02|||February 21, 2011|Actual|2011-02-21|August 2017|2017-08-01|April 12, 2011|Actual|2011-04-12|April 12, 2011|Actual|2011-04-12||Interventional|||Lamivudine and Adefovir Dipivoxil Fixed Dose Combination|A Randomized, Open-label, Single-dose, Two-period, Crossover Study to Demonstrate the Bioequivalence of the Fixed Dose Combination (FDC) of Lamivudine and Adefovir Dipivoxil (100mg/10mg) to Heptodin® (100mg ) and Hepsera® (10mg)|Completed||Phase 1|40|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 04:14:46.878791|2017-10-11 04:14:46.878791
NCT01353729|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-07-18|||May 19, 2011|Actual|2011-05-19|July 2017|2017-07-01|August 2, 2011|Actual|2011-08-02|August 2, 2011|Actual|2011-08-02||Interventional|||A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers|A Phase I, Randomized, Placebo-Controlled, Four-Way Crossover Study to Evaluate the Effect of Intravenous (IV) Zanamivir on Cardiac Conduction as Assessed by 12-lead Electrocardiogram (ECG) With Moxifloxacin as a Positive Control in Healthy Volunteers|Completed||Phase 1|40|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-10-11 04:14:47.022892|2017-10-11 04:14:47.022892
NCT01353716|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2012-04-26|||June 2011||2011-06-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Dolutegravir Renal Impairment Study|A Phase I, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetics and Safety of Dolutegravir in Subjects With Renal Impairment and Healthy Matched Control Subjects (ING113125)|Completed||Phase 1|16|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-10-11 04:14:47.136816|2017-10-11 04:14:47.136816
NCT01353690|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2014-07-28|||May 2011||2011-05-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Autologous Cell Therapy for Ischemic Heart Failure|A Prospective, Multicenter, Feasibility Study of Autologous Muscle-derived Cell (AMDC) Transplantation for Treatment of Advanced Ischemic Heart Failure|Terminated||Phase 1/Phase 2|9|Actual|Cook Group Incorporated||1|||f||||||||||||||2017-10-11 04:14:47.343056|2017-10-11 04:14:47.343056
NCT01353677|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-07-24|||July 2011|Actual|2011-07-01|July 2017|2017-07-01|October 30, 2014|Actual|2014-10-30|October 30, 2014|Actual|2014-10-30||Observational|09-SQOL||Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database|Pilot Study to Assess the Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database|Completed||N/A|390|Actual|Center for International Blood and Marrow Transplant Research|||1||f||||t||||||||||2017-10-11 04:14:47.423915|2017-10-11 04:14:47.423915
NCT01353664|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2016-04-15|2013-10-29||May 2011||2011-05-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Rollover Study for Patients Who Participated in Other Romidepsin Protocols|An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols|Completed||Phase 2|19|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 04:14:47.508294|2017-10-11 04:14:47.508294
NCT01353651|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2015-12-22|||February 2011||2011-02-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|October 2013|Actual|2013-10-01||Interventional|TECCO||Endovascular Versus Open Repair of the Common Femoral Artery|Endovascular Versus Open Repair of the Common Femoral Artery: a Randomized Trial (TECCO)|Completed||Phase 4|120|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 04:14:47.906338|2017-10-11 04:14:47.906338
NCT01353638|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2015-09-09|||April 2011||2011-04-01|September 2015|2015-09-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis|An Open Label, Randomized, Two-Period Crossover Study to Evaluate the Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solutions in Peritoneal Dialysis (PD) (Ala-Gln in PD)|Terminated||Phase 1/Phase 2|25|Actual|Medical University of Vienna||2||"Primary endpoint (HSP) could not be analyzed with the specified method in the planned interim   analysis; a method of increased sensitivity had to be established."|f||||t||||||||||2017-10-11 04:14:48.047783|2017-10-11 04:14:48.047783
NCT01353625|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-05-31|||April 25, 2011|Actual|2011-04-25|May 2017|2017-05-01|November 30, 2018|Anticipated|2018-11-30|September 30, 2018|Anticipated|2018-09-30||Interventional|||Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.|A Phase 1a/1b, Multicenter, Open Label, Dosefinding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Dual Dna-pk and Tor Kinase Inhibitor, Cc-115, Administered Orally to Subjects With Advanced Solid Tumors and Hematologic Malignancies|Active, not recruiting||Phase 1|119|Actual|Celgene||1|||f||||f||||||||||2017-10-11 04:14:48.149344|2017-10-11 04:14:48.149344
NCT01353612|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-02-02|||January 2010||2010-01-01|January 2015|2015-01-01|March 2018|Anticipated|2018-03-01|September 2017|Anticipated|2017-09-01||Observational|||Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes|Correlation Between Coronary and Carotid Atherosclerotic Disease (CAD) and Links With Clinical Outcomes|Active, not recruiting||N/A|300|Anticipated|Canadian Atherosclerosis Imaging Network|||1||f||||f||||||Samples With DNA|"     samples stored for potential correlation with imaging and cardiovascular outcomes endpoints     in subset of patients (optional)   "|||2017-10-11 04:14:48.573441|2017-10-11 04:14:48.573441
NCT01353599|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2015-10-22|||August 2011||2011-08-01|October 2015|2015-10-01||||March 2016|Anticipated|2016-03-01||Interventional|||Acute and Chronic Effects of Inhaled Steroids on Pulmonary Function in Persons With Spinal Cord Injury|Acute and Chronic Effects of Inhaled Steroids on Pulmonary Function in Persons With Spinal Cord Injury|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|James J. Peters Veterans Affairs Medical Center||1|||f||||f||||||||||2017-10-11 04:14:48.735079|2017-10-11 04:14:48.735079
NCT01351363|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-09|||March 2009||2009-03-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Prediction Of Post Operative Pain Following Arthroscopic Shoulder Surgery|PREDICTION OF POST OPERATIVE PAIN FOLLOWING ARTHROSCOPIC SHOULDER SURGERY|Completed||N/A|43|Actual|NHS Fife||1|||f||||f||||||||||2017-10-11 04:15:32.576591|2017-10-11 04:15:32.576591
NCT01353586|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-05-09|2015-09-20||March 1, 2011|Actual|2011-03-01|May 2017|2017-05-01|September 1, 2013|Actual|2013-09-01|September 1, 2013|Actual|2013-09-01||Interventional|REVOLUTION|Safety population (cohort): For the main study, this population includes enrolled subjects who underwent insertion of study catheters. For the NAVISTAR® THERMOCOOL® arm, this population includes enrolled subjects, but excludes two subjects (1 with low pre-ablation international normalized ratio (INR) and 1 missing post procedure neurological exam).|REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation|REVOLUTION (WFCC-133): Clinical Workflow Study for the Evaluation of the Multi-Electrode Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation (PAF)|Completed||Phase 2|186|Actual|Biosense Webster, Inc.||1|||f||||t|f|t|t|f|t|||||2017-10-11 04:14:48.835995|2017-10-11 04:14:48.835995
NCT01353573|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-12|||July 2011||2011-07-01|May 2011|2011-05-01|July 2013|Anticipated|2013-07-01|July 2012|Anticipated|2012-07-01||Interventional|TRICK||Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases|A Randomized Trial of Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Hamilton Health Sciences Corporation||2|||f||||f||||||||||2017-10-11 04:14:49.68959|2017-10-11 04:14:49.68959
NCT01353560|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-06-12|||May 2011||2011-05-01|June 2017|2017-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital: Study 1-Survey|Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital: Study 1-Survey|Completed||N/A|1509|Actual|Brigham and Women's Hospital|||1||f||||t||||||||||2017-10-11 04:14:49.80903|2017-10-11 04:14:49.80903
NCT01353547|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2016-01-26|||March 2010||2010-03-01|January 2016|2016-01-01|March 2020|Anticipated|2020-03-01|March 2018|Anticipated|2018-03-01||Observational|GEMS||Genes and Environment in Multiple Sclerosis|Integrating Genetic and Environmental Risk Scores Into an Algorithm to Predict Multiple Sclerosis Susceptibility|Recruiting||N/A|5000|Anticipated|Brigham and Women's Hospital|||3||f||||t||||||Samples With DNA|"     Saliva Sample (required), Blood Sample (optional)   "|||2017-10-11 04:14:49.88009|2017-10-11 04:14:49.88009
NCT01353534|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2012-10-17|||May 2011||2011-05-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|December 2011|Actual|2011-12-01||Interventional|||Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine|A Phase 1/2, Randomized, Open-Label, Study to Assess the Immunogenicity and Safety of a Vaccine Enhancement Patch (VEP) When Administered With Two Doses of Intramuscular Inactivated Influenza H5N1 Vaccine in Healthy Adults|Completed||Phase 1/Phase 2|276|Actual|Intercell USA, Inc.||4|||f||||t||||||||||2017-10-11 04:14:49.995916|2017-10-11 04:14:49.995916
NCT01353521|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-11|2017-04-04|||December 2013||2013-12-01|April 2017|2017-04-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts|Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts|Recruiting||N/A|40|Anticipated|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||||2017-10-11 04:14:50.101542|2017-10-11 04:14:50.101542
NCT01353508|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-16|2015-10-20|2015-07-15|2014-01-21|March 2011||2011-03-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers|A Randomized, Double-blind, Controlled, Crossover Study to Evaluate the Sodium Excretion of LCZ696 in Patients With Stable Heart Failure, in Patients With Hypertension, and in Healthy Volunteers|Completed||Phase 2|32|Actual|Novartis|Regarding LSM = 1218.56 for LCZ696 HTN cohort arm at Day 1, 1.0 hr post dose, the value was heavily inflated due to one participant with a very high change from baseline.|4|||f||||||||||||||2017-10-11 04:14:50.246633|2017-10-11 04:14:50.246633
NCT01353482|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2012-03-21||||||March 2012|2012-03-01||||||||Interventional|MESO-02||A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma|A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma|Withdrawn||Phase 1/Phase 2|0|Actual|University College, London||2||"UCL CTC were informed by Merck Sharp & Dohme on 22.08.11 that support for the trial had been   withdrawn in light of results from another trial with trial drug."|f||||||||||||||2017-10-11 04:14:52.447809|2017-10-11 04:14:52.447809
NCT01353469|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2013-02-26|||May 2011||2011-05-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|Insuman-C25-CN||Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy|A Multicenter, Randomized, Active-controlled, Parallel-group Study to Assess the Efficacy and Safety of Insuman Comb 25 (Insulin Human) Versus Novolin® 30R Twice Daily Over 24 Weeks in Patients With Type 2 Diabetes Mellitus Who Are Under Insulin Therapy|Completed||Phase 3|485|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 04:14:52.557767|2017-10-11 04:14:52.557767
NCT01353456|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-04-02|||May 2008||2008-05-01|April 2013|2013-04-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|||Multimodal Analgesic Using Morphine and COX-2 With or Without Dexmedetomidine for Colorectal Surgery|Multimodal Analgesic Using Morphine and COX-2 With or Without Dexmedetomidine for Colorectal Surgery|Completed||Phase 3|100|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-10-11 04:14:52.687497|2017-10-11 04:14:52.687497
NCT01353443|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2014-11-18|||February 2011||2011-02-01|November 2014|2014-11-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Prophylactic Mesh Implantation After Abdominal Aortic Aneurysm Repair|Prophylactic Mesh Implantation After Abdominal Aortic Aneurysm Repair. A Prospective, Randomised, Controlled Study|Unknown status|Active, not recruiting|Phase 4|282|Anticipated|Universitätsklinikum Hamburg-Eppendorf||3|||f||||f||||||||||2017-10-11 04:14:52.768829|2017-10-11 04:14:52.768829
NCT01353430|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-26|2011-05-12|||January 2000||2000-01-01|May 2011|2011-05-01||||December 2025|Anticipated|2025-12-01||Observational|||Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)|Characterization of Familial Myopathy and Paget Disease of Bone|Recruiting||N/A|50|Anticipated|University of California, Irvine|||1||f||||f||||||Samples With DNA|"     Whole blood, skin and muscle biopsy, urine sample, if available samples obtained from     previous diagnostic evaluations such as muscle biopsy.   "|||2017-10-11 04:14:53.077537|2017-10-11 04:14:53.077537
NCT01353417|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2017-04-05|||April 2011||2011-04-01|April 2017|2017-04-01|August 31, 2015|Actual|2015-08-31|August 31, 2015|Actual|2015-08-31||Observational|||Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection|A Single-site, Prospective Non-interventional-study With Adport Sandoz© Capsules for Prophylaxis of Graft Rejection in Patients With Stable Kidney Function After Renal Allograft.|Completed||N/A|102|Actual|Sandoz|||1||f||||t||||||Samples Without DNA|"     Retained types of biospecimen: whole blood, serum, urine   "|||2017-10-11 04:14:53.184083|2017-10-11 04:14:53.184083
NCT01353404|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2012-12-16|||June 2011||2011-06-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)|Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) in Normal Healthy Subjects|Completed||Phase 1|24|Actual|Samyang Biopharmaceuticals Corporation||3|||f||||f||||||||||2017-10-11 04:14:53.256541|2017-10-11 04:14:53.256541
NCT01353391|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2016-10-20|||May 2011||2011-05-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|MiTy||Metformin in Women With Type 2 Diabetes in Pregnancy Trial|Metformin in Women With Type 2 Diabetes in Pregnancy Trial|Recruiting||Phase 3|500|Anticipated|Mount Sinai Hospital, Canada||2|||f||||t||||||||||2017-10-11 04:14:53.352637|2017-10-11 04:14:53.352637
NCT01353378|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2017-05-02|||June 2011||2011-06-01|May 2017|2017-05-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|||Use of Dexmedetomidine in Children Undergoing Oral Maxillofacial Surgery to Decrease Emergence Delirium|Use of Dexmedetomidine in Children Undergoing Oral Maxillofacial Surgery to Decrease Emergence Delirium|Withdrawn||Phase 4|0|Actual|Shanghai 9th People's Hospital||1||The study was not approved by Hospital's Medical Ethics Committee.|f||||t||||||||||2017-10-11 04:14:53.459922|2017-10-11 04:14:53.459922
NCT01353365|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2011-05-12|||June 2011||2011-06-01|April 2011|2011-04-01||||||||Observational|||Surfactant Associated Protein - A Novel Marker for the Diagnosis of Pulmonary Embolism|Surfactant Associated Protein - A Novel Marker for the Diagnosis of Pulmonary Embolism|Unknown status|Not yet recruiting|N/A|150|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-10-11 04:14:53.539855|2017-10-11 04:14:53.539855
NCT01353352|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-13|2011-05-12|||January 2008||2008-01-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Evaluation of the Nursing C-Spine (Phase IV)|Evaluation of the Safety of C-Spine Clearance by Emergency Department Triage Nurses (Phase IV)|Completed||Phase 4|3633|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-10-11 04:14:53.601785|2017-10-11 04:14:53.601785
NCT01353339|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2014-10-14|||November 2011||2011-11-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|||Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study|Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study|Completed||Phase 4|154|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-10-11 04:14:53.682463|2017-10-11 04:14:53.682463
NCT01353326|ClinicalTrials.gov processed this data on October 10, 2017|2009-09-30|2014-01-21|||May 2009||2009-05-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bone Mineral Density (BMD) in Cemented Versus Cementless Hip Resurfacing|Randomized Clinical Trial of a Cemented Versus Cementless Femoral Component for Metal on Metal Hip Resurfacing Assessing Bone Mineral Density|Completed||N/A|120|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 04:14:53.81076|2017-10-11 04:14:53.81076
NCT01353313|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2017-06-19|||September 2011||2011-09-01|June 2017|2017-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hydrocortisone for BPD|A Randomized Controlled Trial of the Effect Of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age|Recruiting||Phase 3|800|Anticipated|NICHD Neonatal Research Network||2|||f||||t|t|f||||||Yes|NIH has had a long-standing policy to share and make available to the public the results and accomplishments of the activities that it funds. The NRN plans to share de-identified data after final publication in an NIH supported data repository such as the NICHD Data and Specimen Hub (https://dash.nichd.nih.gov)|2017-10-11 04:14:54.009724|2017-10-11 04:14:54.009724
NCT01353300|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-12|2016-07-07|||May 2011||2011-05-01|July 2016|2016-07-01||||July 2016|Actual|2016-07-01||Observational|||Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer|Investigation of DICER1 in Cystic Nephroma and Cystic Partially Differentiated Nephroblastoma|Completed||N/A|31|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:14:54.240999|2017-10-11 04:14:54.240999
NCT01353287|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-07-30|||May 2011||2011-05-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|VERITAS||Transcatheter Aortic Valve Intervention-Live Transmission|Transcatheter Aortic Valve Intervention-Live Transmission (VERITAS)Study|Completed||N/A|110|Actual|Medstar Health Research Institute|||2||f||||t||||||||||2017-10-11 04:14:54.382279|2017-10-11 04:14:54.382279
NCT01353274|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2014-07-30|2014-07-30||May 2011||2011-05-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension|Survey on Drug Use of Micamlo Combination Tablets AP in Patients With Hypertension|Completed||N/A|1157|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-10-11 04:14:54.608695|2017-10-11 04:14:54.608695
NCT01353261|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-10-31|||December 2010||2010-12-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Platelet Function Monitoring in Patients With Acute Myocardial Infarction|Platelet Function Monitoring in Patients With Acute Myocardial Infarction|Completed||N/A|63|Actual|Medstar Health Research Institute|||3||f||||f||||||||||2017-10-11 04:14:55.493172|2017-10-11 04:14:55.493172
NCT01353248|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2013-11-26||2013-11-26|May 2011||2011-05-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection|A Phase 2 Randomized, Open-Label Study of GS-5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) to Treatment-Naive Subjects With Chronic Genotype 1 HCV Infection|Completed||Phase 2|141|Actual|Gilead Sciences||2|||f||||||||||||||2017-10-11 04:14:55.582992|2017-10-11 04:14:55.582992
NCT01353235|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-07-31|||April 2010||2010-04-01|July 2017|2017-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Oral Prednisolone in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)|A Prospective Randomized Trial of Systemic Corticosteroids (Oral Prednisolone) in Severe Exacerbation of COPD Requiring Ventilatory Assistance|Completed||Phase 3|317|Actual|Hôpital Universitaire Fattouma Bourguiba||2|||f||||f||||||||||2017-10-11 04:14:55.792387|2017-10-11 04:14:55.792387
NCT01353222|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-04-21|2017-03-08||June 2011||2011-06-01|April 2017|2017-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Intent to treat population|DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma|A Randomized, Phase 2, Open-label Study Evaluating DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma|Terminated||Phase 2|142|Actual|Dendreon||2||Administrative reasons.|f||||t||||||||Undecided||2017-10-11 04:14:55.900493|2017-10-11 04:14:55.900493
NCT01353209|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-08-24|||May 2011||2011-05-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|TRAIL||Trial of Aromatase Inhibition in Lymphangioleiomyomatosis|A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS|Completed||Phase 2|17|Actual|University of Cincinnati||2|||f||||t||||||||||2017-10-11 04:14:56.900364|2017-10-11 04:14:56.900364
NCT01353183|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-31|2013-09-18|||November 2010||2010-11-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|ColoBioParker||Analysis of the Enteric Nervous System Using Colonic Biopsies|Analysis of the Enteric Nervous System Using Colonic Biopsies: a Useful Biomarker for the Differential Diagnosis of Parkinsonian Syndromes?|Completed||N/A|34|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-10-11 04:14:57.063824|2017-10-11 04:14:57.063824
NCT01353170|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-11|||January 2010||2010-01-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Calcium Concentration in Bicarbonate Hemodialysis (HD)|Comparison Among Different Dialysate Calcium Concentrations in Bicarbonate Hemodialysis|Completed||N/A|22|Actual|Miulli General Hospital||1|||f||||f||||||||||2017-10-11 04:14:57.136562|2017-10-11 04:14:57.136562
NCT01353157|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-05-11|||March 2010||2010-03-01|February 2010|2010-02-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Observational|||Study of the Clinical Scoring System and Cytokines for Prediction of Inflammatory Response in Major Surgery|Prediction for Systemic Inflammation With Clinical Scoring Systems and Inflammatory Cytokine Levels in Adult Cardiac and Major Abdominal Surgical Patients|Completed||N/A|20|Actual|Khon Kaen University|||1||f||||f||||||Samples Without DNA|"     whole blood taken from arterial line   "|||2017-10-11 04:14:57.196445|2017-10-11 04:14:57.196445
NCT01353144|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2016-09-12|2015-09-14||June 2007||2007-06-01|September 2016|2016-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers|A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers|Completed||Phase 4|178|Actual|Kaohsiung Veterans General Hospital.|The trial was performed in a single country|2|||f||||t||||||||||2017-10-11 04:14:57.260731|2017-10-11 04:14:57.260731
NCT01353131|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-09-01|||May 2010||2010-05-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Observational|PRIMERI||Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI|Personalized Risk Identification and Management for Arrhythmias and Heart Failure by 12 Lead Electrocardiogram and Cardiac Magnetic Resonance Imaging.|Unknown status|Active, not recruiting|N/A|160|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples Without DNA|"     Whole blood, serum, plasma.   "|||2017-10-11 04:14:57.524725|2017-10-11 04:14:57.524725
NCT01353118|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-08-09|||May 2011||2011-05-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|July 2017|Actual|2017-07-01||Interventional|GLUCOSURG2||The Effects of Glycemic Optimization Before Gastric Bypass Surgery|Investigation of the Effects of Glycaemic Optimisation Before Gastric Bypass Surgery on the Glycaemic Remission and Microvascular Complication Rates of Type 2 Diabetes Mellitus|Completed||N/A|50|Actual|Imperial College London||3|||f||||t||||||||||2017-10-11 04:14:57.595072|2017-10-11 04:14:57.595072
NCT01353105|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-05-11|||August 2011||2011-08-01|October 2010|2010-10-01|August 2015|Anticipated|2015-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion|Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|InCor Heart Institute||1|||f||||f||||||||||2017-10-11 04:14:57.698108|2017-10-11 04:14:57.698108
NCT01353092|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2015-08-25|||April 2011||2011-04-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PEMFII||Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant Depression|PEMF Treatment in Patients With Treatment Resistant Depression in On-going Antidepressant Drug Therapy. A Randomized, Double-blind, Clinically Controlled, Dose-response PEMF Trial for a Duration of Eight Weeks|Completed||Phase 3|65|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-10-11 04:14:57.787221|2017-10-11 04:14:57.787221
NCT01353079|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-01-22|2014-09-08||April 2011||2011-04-01|January 2015|2015-01-01|April 2012|Actual|2012-04-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy|Randomized, Double-Blind, Placebo-Controlled, Parallel Group Efficacy And Safety Trial Of Sublingual-Oral Immunotherapy (SLIT) In Adults With Allergic Rhinoconjunctivitis Caused By Ragweed Pollen|Completed||Phase 3|429|Actual|Greer Laboratories||2|||f||||f||||||||||2017-10-11 04:14:57.890734|2017-10-11 04:14:57.890734
NCT01353066|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-05-11||||||May 2011|2011-05-01||||||||Interventional|EURDSS||Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)|Multicenter Randomized Prospective Trial on the Effects of Intensive Medical Treatment of Type 2 Diabetes With and Without Roux-in-Y Gastric Bypass Surgery on Carotid Intima Media Thickness in Grade I Obesity (BMI 30,0-34,9 kg/m2)|Unknown status|Not yet recruiting|Phase 2/Phase 3|240|Anticipated|Hospital Clinic of Barcelona||2|||f||||||||||||||2017-10-11 04:15:00.054513|2017-10-11 04:15:00.054513
NCT01353053|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-05-11|||July 2010||2010-07-01|May 2010|2010-05-01||||||||Observational|||Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection|Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection|Unknown status|Recruiting|N/A|82|Anticipated|Federal University of São Paulo|||1||f||||f||||||||||2017-10-11 04:15:00.145351|2017-10-11 04:15:00.145351
NCT01353040|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2012-05-04|||May 2011||2011-05-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-6003 in Healthy Adult Volunteers|Completed||Phase 1|30|Anticipated|Sarepta Therapeutics||2|||f||||t||||||||||2017-10-11 04:15:00.213016|2017-10-11 04:15:00.213016
NCT01353027|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2012-03-27|||May 2010||2010-05-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus|A Phase I Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-6002 in Healthy Adult Volunteers|Completed||Phase 1|30|Actual|Sarepta Therapeutics||2|||f||||t||||||||||2017-10-11 04:15:00.298314|2017-10-11 04:15:00.298314
NCT01353014|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2014-06-29|||May 2011||2011-05-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Genetic Information and Dietary Intake Behaviour|Genetic Information and Dietary Intake Behaviour|Completed||Early Phase 1|138|Actual|University of Toronto||2|||f||||t||||||||||2017-10-11 04:15:00.386045|2017-10-11 04:15:00.386045
NCT01353001|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2016-01-04|||April 2011||2011-04-01|January 2016|2016-01-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Weight Loss on Cardiovascular Disease Risk Factors in Obese Women|The Effect of Weight Loss and Exercise on Cardiovascular Disease Risk Factors in Class II and III Obese Women|Completed||N/A|24|Actual|University of Pittsburgh||3|||f||||f||||||||||2017-10-11 04:15:00.486173|2017-10-11 04:15:00.486173
NCT01352988|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2014-02-27|||July 2011||2011-07-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional|FumaCLE||Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus|Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus: A Mono-Centre, Open-Label, Prospective Pilot Study|Completed||Phase 2|11|Actual|University Hospital Muenster||1|||f||||f||||||||||2017-10-11 04:15:00.628727|2017-10-11 04:15:00.628727
NCT01352962|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-08-22|||April 5, 2011||2011-04-05|August 4, 2017|2017-08-04|August 1, 2020|Anticipated|2020-08-01|February 7, 2017|Actual|2017-02-07||Interventional|||Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors|A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients With Advanced/Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors|Active, not recruiting||Phase 1|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:15:00.820177|2017-10-11 04:15:00.820177
NCT01352949|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-06-30|||April 6, 2011||2011-04-06|March 28, 2017|2017-03-28||||||||Observational|||Stereophotogrammetry of the Torso in Healthy Individuals and Patients With Scoliosis, Chest Wall Deformations, or Obesity|Stereophotogrammetry of the Torso in Normal Individuals and Patients With Scoliosis, Chest Wall Deformations, or Obesity|Recruiting||N/A|525|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:15:00.944384|2017-10-11 04:15:00.944384
NCT01352936|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-05-11|||January 2011||2011-01-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|||||Observational|||Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy|Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy|Unknown status|Active, not recruiting|N/A|190|Anticipated|Taipei Medical University WanFang Hospital|||2||f||||f||||||||||2017-10-11 04:15:02.479748|2017-10-11 04:15:02.479748
NCT01352923|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-05-11|||May 2011||2011-05-01|May 2011|2011-05-01||||May 2012|Anticipated|2012-05-01||Interventional|||Study of Polymorphisms in pear1 Gene Link to Platelet Activation and Signaling Pathway Variations|Study of Polymorphisms in pear1 Gene Link to Platelet Activation and Signaling Pathway Variations|Unknown status|Recruiting|N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-10-11 04:15:02.562852|2017-10-11 04:15:02.562852
NCT01352910|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2016-08-16|||September 2011||2011-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|PARALYSTIM||rTMS and Functional Paralysis||Completed||N/A|66|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-10-11 04:15:02.650424|2017-10-11 04:15:02.650424
NCT01352897|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-11|||August 2010||2010-08-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia|A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects With Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings|Completed||N/A|800|Actual|AstraZeneca|||1||f||||f||||||||||2017-10-11 04:15:02.731751|2017-10-11 04:15:02.731751
NCT01352884|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2016-09-02|||March 2011||2011-03-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional|||Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer||Completed||Phase 1|44|Actual|MedImmune LLC||2|||f||||||||||||||2017-10-11 04:15:02.803425|2017-10-11 04:15:02.803425
NCT01352871|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-26|2011-06-06|||March 2011||2011-03-01|February 2011|2011-02-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Observational|||The Effects of Concentration/Meditation on the Innate Immune Response During Human Endotoxemia|The Effects of Concentration/Meditation on the Innate Immune Response During|Completed||Phase 1|1|Anticipated|Radboud University|||1||f||||t||||||||||2017-10-11 04:15:02.894773|2017-10-11 04:15:02.894773
NCT01352858|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-03-10|||February 2012||2012-02-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|AutoDECRA||Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA)|Phase 1 Study of Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis|Unknown status|Recruiting|Phase 1|12|Anticipated|Newcastle University||2|||f||||t||||||||||2017-10-11 04:15:02.985444|2017-10-11 04:15:02.985444
NCT00000591|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-14|||November 1993||1993-11-01|November 2005|2005-11-01|February 2005||2005-02-01|||||Interventional|||T-Cell Depletion in Unrelated Donor Marrow Transplantation||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.400774|2017-10-11 04:19:07.400774
NCT01352845|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2016-01-26|2016-01-26||May 2013||2013-05-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|B1971016|Safety population included all the participants who received at least 1 dose of the investigational product (rLP2086 or saline) and had safety data available.|A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.|A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years|Completed||Phase 3|3301|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 04:15:03.181715|2017-10-11 04:15:03.181715
NCT01352832|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-03-08|||May 2011||2011-05-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||The Alabama NSAIDs Patient Safety Survey, Phase II: Reducing Disparities in Risk Awareness and Communication|Phase II of The Alabama NSAID Patient Safety Survey: Reducing Disparities in Risk Awareness and Communication|Completed||N/A|422|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 04:15:06.344755|2017-10-11 04:15:06.344755
NCT01352819|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2015-08-06|||May 2011||2011-05-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Observational|||Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease Study|A Post Market Clinical Evaluation of Deep Brain Stimulation as an Adjunctive Treatment for Reducing Some of the Symptoms of Advanced, Levodopa-responsive Parkinson's Disease That Are Not Adequately Controlled With Medication|Completed||N/A|21|Actual|St. Jude Medical|||1||f||||||||||||||2017-10-11 04:15:06.475257|2017-10-11 04:15:06.475257
NCT01352806|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2011-05-11|||September 2011||2011-09-01|April 2011|2011-04-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Identification of the Lumbar Interspinous Spaces; Palpation Versus Ultrasound Versus Fluoroscopy|Identification of the Lumbar Interspinous Spaces; Palpation Versus Ultrasound Versus Fluoroscopy|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-10-11 04:15:06.568357|2017-10-11 04:15:06.568357
NCT01352793|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-02-25|2015-02-25||November 2012||2012-11-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Intent-to-treat (ITT) population included all participants who were randomized.|A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years|A Phase 3, Randomized, Active-controlled, Observer-blinded Trial To Assess The Safety And Tolerability Of A Meningococcal Serogroup B Bivalent Recombinant Lipoprotein (rlp2086) Vaccine Given In Healthy Subjects Aged Greater Than Or Equal To 10 To Less Than 26 Years|Completed||Phase 3|5715|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 04:15:06.719254|2017-10-11 04:15:06.719254
NCT01352780|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-05-28|||September 2011||2011-09-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|December 2012|Actual|2012-12-01||Interventional|||Psoriasis and Climate Therapy- Effect of Motivational Follow- up Calls on Clinical and Health Economic Parameters|Psoriasis and Climate Therapy- Effect of Motivational Follow- up Calls on Clinical and Health Economic Parameters|Unknown status|Active, not recruiting|Phase 3|169|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 04:15:08.756725|2017-10-11 04:15:08.756725
NCT01352767|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2014-09-04|||July 2011||2011-07-01|May 2012|2012-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||The InsuPad in Daily Life Study - Effect of Local Heating on Postprandial Glucose Excursions Using the InsuPad Device|A Randomised, Controlled, Cross-over Study With Inpatient and Outpatient Phases|Completed||Phase 4|20|Actual|Insuline Medical Ltd.||2|||f||||f||||||||||2017-10-11 04:15:08.894872|2017-10-11 04:15:08.894872
NCT01352754|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2013-12-11|||April 2011||2011-04-01|December 2013|2013-12-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Observational|||Troponin T Elevation in Patient Undergoing Hip Fracture Surgery|Prognosis Significance of Troponin T Elevation as Detected by Highly Sensitive Assay in Patient Undergoing Hip Fracture Surgery|Unknown status|Active, not recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-10-11 04:15:09.038228|2017-10-11 04:15:09.038228
NCT01352741|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-12|2016-06-29|2016-05-10||March 2011||2011-03-01|June 2016|2016-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin|Evaluation of the Effectiveness, Safety, and Tolerability of Tapentadol PR Versus a Combination of Tapentadol PR and Pregabalin in Subjects With Severe Chronic Low Back Pain With a Neuropathic Pain Component|Completed||Phase 4|622|Actual|Grünenthal GmbH||2|||f||||f||||||||||2017-10-11 04:15:09.341257|2017-10-11 04:15:09.341257
NCT01352728|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2017-07-05|||May 18, 2011|Actual|2011-05-18|July 2017|2017-07-01|May 31, 2018|Anticipated|2018-05-31|May 31, 2018|Anticipated|2018-05-31||Interventional|||Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib|A Phase II Study of Transarterial Chemoembolisation and Axitinib for the Treatment of Unresectable Hepatocellular Carcinoma|Active, not recruiting||Phase 2|50|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 04:15:12.784776|2017-10-11 04:15:12.784776
NCT01352715|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-12|2015-12-02|2015-10-29||January 2012||2012-01-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|SELECT|Intention to treat: All 512 participants without a major eligibility violation.|Study of Options for Second-Line Effective Combination Therapy (SELECT)|Multicenter Study of Options for Second-Line Effective Combination Therapy (SELECT)|Completed||Phase 3|515|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 04:15:12.919239|2017-10-11 04:15:12.919239
NCT01352702|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2015-02-04|||May 2011||2011-05-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|Dabi-ADP-2||Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation|Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation|Terminated||Phase 4|46|Actual|Deutsches Herzzentrum Muenchen||2||Slow recruitment; Study was terminated for futility reasons|f||||f||||||||||2017-10-11 04:15:14.127031|2017-10-11 04:15:14.127031
NCT01352689|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-11|2011-06-06|||April 2011||2011-04-01|April 2011|2011-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||CKD-828(80/2.5mg) Pharmacokinetic Study_2nd|Open Label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Characteristics of Telmisatan 80mg and S-Amlodipine 2.5mg as a Fixed Dose Combination Tablet Compared With Combination Therapy in Healthy Volunteers|Completed||Phase 1|67|Actual|Chong Kun Dang Pharmaceutical||2|||f||||||||||||||2017-10-11 04:15:14.258864|2017-10-11 04:15:14.258864
NCT00000592|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-12-21|||July 1994||1994-07-01|November 2005|2005-11-01|August 2000||2000-08-01|||||Interventional|||Stroke Prevention in Sickle Cell Anemia (STOP 1)||Completed||Phase 3|||Augusta University|||||f||||||||||||||2017-10-11 04:19:07.45759|2017-10-11 04:19:07.45759
NCT01352663|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2014-05-28|||May 2015||2015-05-01|May 2014|2014-05-01|January 2017|Anticipated|2017-01-01|July 2016|Anticipated|2016-07-01||Interventional|||Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients|An Open Label, Randomized Comparison of Wockhardt's Recombinant Insulin Analogue With Innovator's Glargine in Type 1 Diabetic Patients.|Unknown status|Not yet recruiting|Phase 3|500|Anticipated|Wockhardt||2|||f||||f||||||||||2017-10-11 04:15:14.438712|2017-10-11 04:15:14.438712
NCT01352650|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2017-03-01|||June 17, 2011|Actual|2011-06-17|March 2017|2017-03-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)|Induction Therapy With Decitabine and Plerixafor Priming for Patients ≥ 60 Years With Acute Myeloid Leukemia|Active, not recruiting||Phase 1|71|Actual|Weill Medical College of Cornell University||4|||f||||t||||||||No||2017-10-11 04:15:14.519318|2017-10-11 04:15:14.519318
NCT01352637|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-18|2017-06-23|||May 2011||2011-05-01|June 2017|2017-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer|Enhancing Exposure Therapy for PTSD: Virtual Reality and Imaginal Exposure With a Cognitive Enhancer|Recruiting||Phase 3|300|Anticipated|Weill Medical College of Cornell University||4|||f||||t||||||||||2017-10-11 04:15:14.62134|2017-10-11 04:15:14.62134
NCT01352624|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2014-09-05|||April 2011||2011-04-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Improving Money Management Skills for Veterans With Psychiatric Disabilities|Improving Money Management Skills for Veterans With Psychiatric Disabilities|Completed||N/A|183|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 04:15:14.73452|2017-10-11 04:15:14.73452
NCT01352611|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2016-10-05|||September 2014||2014-09-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen|Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen|Withdrawn||N/A|0|Actual|University of Missouri-Columbia||1||No subjects enrolled.|f||||f||||||||No||2017-10-11 04:15:14.81736|2017-10-11 04:15:14.81736
NCT01352598|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-03-21|||June 2011||2011-06-01|March 2017|2017-03-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Stereotactic Body Radiotherapy for Prostate Cancer|Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer|Recruiting||Phase 4|30|Anticipated|Mercy Research||1|||f||||f||||||||||2017-10-11 04:15:14.913023|2017-10-11 04:15:14.913023
NCT01352585|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2014-06-27|2014-06-27||July 2011||2011-07-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|EMIX||Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®|An Exploratory, Observational, Multicentre Study to Investigate the Impact of the Presence of JAK2 (V617F) Mutation on Treatment Response in Patients With Essential Thrombocythaemia Treated With XAGRID® (Anagrelide Hydrochloride)|Completed||N/A|47|Actual|Shire|||1||f||||f||||||||||2017-10-11 04:15:14.987766|2017-10-11 04:15:14.987766
NCT01352572|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2015-12-30|||January 2002||2002-01-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients|Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients|Active, not recruiting||N/A|300|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 04:15:15.27139|2017-10-11 04:15:15.27139
NCT01352559|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2015-12-30|||November 2001||2001-11-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|March 2007|Actual|2007-03-01||Interventional|||Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype|Prediction of Antidepressant Response Using Pharmacogenetics of Bioamine Transporter and Peripheral Lymphocytic Phenotype|Active, not recruiting||N/A|1000|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-10-11 04:15:15.365476|2017-10-11 04:15:15.365476
NCT01352546|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-08-01|2017-08-01||August 2010||2010-08-01|August 2017|2017-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Botox Injection for Treatment of Vaginismus|Open Label, Single Center, Pilot Study of the Use of BOTOX Injections, Sensorcaine Injections and Progressive Dilation Under Anesthesia for the Treatment of Primary Vaginismus|Completed||Phase 1|31|Actual|Plastic Surgery Professional Association||1|||f||||t||||||||||2017-10-11 04:15:15.453434|2017-10-11 04:15:15.453434
NCT01352533|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2016-10-06|||July 2016||2016-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Closure Techniques and Scar Appearance|A Randomized Prospective Trial of 2-Octyl Cyanoacrylate (Derma-Bond) Tissue Adhesive Versus Running Subcuticular Suture Combined With Tissue Adhesive Versus Epidermal Sutures in Dermatologic Surgery Procedures of the Head and Neck|Withdrawn||N/A|0|Actual|Northwestern University||3|||f||||t||||||||||2017-10-11 04:15:15.635081|2017-10-11 04:15:15.635081
NCT01352520|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-08-02|||June 2011|Actual|2011-06-01|August 2017|2017-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)|Phase II Trial of Brentuximab Vedotin (SGN-35) at Dose of 1.8 mg/kg IV Every 3 Weeks in Patients With CD30-positive Lymphoproliferative Disorders (Cutaneous Anaplastic Large T-cell Lymphoma (ALCL), Mycosis Fungoides, and Extensive Lymphomatoid Papulosis (LyP)|Active, not recruiting||Phase 2|84|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 04:15:15.744163|2017-10-11 04:15:15.744163
NCT01352507|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2013-03-13|2013-03-13||June 2011||2011-06-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional||All randomized participants.|A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China|An Evaluation of Tadalafil and Sildenafil Treatment in Men With Erectile Dysfunction in China|Completed||Phase 4|383|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 04:15:15.896713|2017-10-11 04:15:15.896713
NCT01352494|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-25|||May 2011||2011-05-01|May 2011|2011-05-01|May 2015|Anticipated|2015-05-01|May 2013|Anticipated|2013-05-01||Interventional|NeoTG||Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer|A Multi-center Phase II Trial to Evaluate the Efficacy and Safety of Neoadjuvant Chemotherapy With DoceTaxel(Doxotel) and Gemcitabine(Gemcibine)in Locally Advanced Breast Cancer|Unknown status|Not yet recruiting|Phase 2|99|Anticipated|Korean Breast Cancer Study Group||1|||f||||t||||||||||2017-10-11 04:15:17.075151|2017-10-11 04:15:17.075151
NCT01352481|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-11|||April 2011||2011-04-01|May 2011|2011-05-01||||April 2013|Anticipated|2013-04-01||Interventional|||Early Intervention in Very Preterm Children|Early Intervention for Speech Sound Disorder in Very Preterm Children|Unknown status|Recruiting|N/A|25|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-10-11 04:15:17.194862|2017-10-11 04:15:17.194862
NCT01352468|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-24|2017-06-19|2017-01-19||April 2011||2011-04-01|June 2017|2017-06-01|June 2016|Actual|2016-06-01|December 2013|Actual|2013-12-01||Interventional|||Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD)|Development of a Multi-faceted Cognitive Training Program for Children With ADHD|Completed||N/A|44|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-10-11 04:15:17.297342|2017-10-11 04:15:17.297342
NCT01352455|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-12-27|||March 2011||2011-03-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||More Frequent In-Center Hemodialysis in Pediatric End Stage Renal Disease|A Pilot Study of More Frequent In-Center Hemodialysis to Improve Outcomes in Pediatric End Stage Renal Disease|Completed||N/A|7|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-11 04:15:17.706996|2017-10-11 04:15:17.706996
NCT01352442|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-02-27|2015-08-19||May 2011||2011-05-01|February 2017|2017-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Safety and Effectiveness of the AcuFocus Corneal Inlay ACI7000PDT in Presbyopes|A Prospective Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the AcuFocus Corneal Inlay ACI 7000PDT Implanted Intrastromally for Modified Monovision in Presbyopic Subjects|Completed||N/A|151|Actual|AcuFocus, Inc.||1|||f||||f||||||||No||2017-10-11 04:15:17.911143|2017-10-11 04:15:17.911143
NCT01352429|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-09-23|||August 2009||2009-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Observational|||Mild Hypofractionation With Proton Therapy or Intensity Modulated Radiation Therapy (IMRT) for Intermediate-Risk Prostate Cancer|A Phase II Trial of Proton Radiation Therapy or Intensity-Modulated Radiation Therapy Using Mild Hypofractionation for Low-and Intermediate -Risk Adenocarcinoma of the Prostate|Recruiting||N/A|200|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||2||f||||t||||||||||2017-10-11 04:15:18.245414|2017-10-11 04:15:18.245414
NCT01352416|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2016-11-08|2016-06-14||September 2010||2010-09-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||Subjects scheduled/undergoing cardiac surgery.|Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery|Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery|Terminated||Phase 3|15|Actual|William Beaumont Hospitals|Early termination due to lack of enrollment. 15 pts enrolled, 6 withdrawn due breathing tube not removed by 10 pm day of surgery. 1 withdrawn after day 3 as he was in afib and placed on amio. All pts were male.|4||lack of enrollment|f||||t||||||||Undecided||2017-10-11 04:15:18.345961|2017-10-11 04:15:18.345961
NCT01352403|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-10|||May 2011||2011-05-01|December 2008|2008-12-01|June 2016|Anticipated|2016-06-01|||||Interventional|WAS||Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention|Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention Wurzburg Adipositas Study - WAS|Unknown status|Recruiting|N/A|60|Anticipated|University of Wuerzburg||2|||f||||f||||||||||2017-10-11 04:15:18.763965|2017-10-11 04:15:18.763965
NCT01352390|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-05-03|||May 2011|Actual|2011-05-01|May 2017|2017-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||The Effect of a Coloring Prompt on Health Engagement|The Effect of a Coloring Prompt on Health Engagement|Completed||N/A|8711|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 04:15:18.860428|2017-10-11 04:15:18.860428
NCT01352377|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-10|||May 2011||2011-05-01|April 2011|2011-04-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Observational|||Impact of New CLSI Guidelines on Antibiotic Susceptability Pattern|A STUDY ASSESSING THE IMPACT OF THE NEW CLSI GUIDELINES ON ANTIBIOTIC SUSCEPTABILITY TESTING PATTERNS|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Southern Nevada|||1||f||||t||||||||||2017-10-11 04:15:18.944094|2017-10-11 04:15:18.944094
NCT01352364|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-26|||July 2009||2009-07-01|July 2009|2009-07-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Analysis Of Equilibrium And Motor Coordination Of Deaf Children's Pre And Post Intervention Physiotherapeutic|Analysis Of Equilibrium And Motor Coordination Of Deaf Children's Pre And Post Intervention Physiotherapeutic|Completed||N/A|10|Actual|University of the Sinos Valley||1|||f||||f||||||||||2017-10-11 04:15:18.995845|2017-10-11 04:15:18.995845
NCT01352351|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2013-02-06|||May 2011||2011-05-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Linking Microcredit, Technology, and Promotion of IYCF Breastfeeding Guidelines in Bauchi State, Nigeria|Linking Microcredit, Technology, and Promotion of IYCF Breastfeeding Guidelines in Bauchi State, Nigeria|Completed||N/A|485|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 04:15:19.071387|2017-10-11 04:15:19.071387
NCT01352338|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2016-02-25|||August 2011||2011-08-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|November 2014|Actual|2014-11-01||Interventional|REPEAT||Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)|A Phase 1 and Phase 2 Study of Lenalidomide (Revlimid) in Combination With Cyclophosphamide (Endoxan) and Prednison (REP) in Relapsed/Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|82|Actual|UMC Utrecht||1|||f||||t||||||||||2017-10-11 04:15:19.147281|2017-10-11 04:15:19.147281
NCT01352325|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2012-02-08|||February 2011||2011-02-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy of System Constellations in a General Population|Randomized Controlled Trial on the Efficacy of System Constellations on Psychological Well-being in a General Population Based Sample|Completed||Phase 2/Phase 3|216|Actual|Heidelberg University||2|||f||||t||||||||||2017-10-11 04:15:19.270298|2017-10-11 04:15:19.270298
NCT01352312|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2016-10-18|||May 2011||2011-05-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|August 2015|Actual|2015-08-01||Interventional|||Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma|Phase I Trial With Cohort Expansion of Pentostatin, Bendamustine and Ofatumumab (PBO) for the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1|10|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 04:15:19.383957|2017-10-11 04:15:19.383957
NCT01352299|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-10|||August 2008||2008-08-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Glottic Visualization & Ease of Intubation With Different Laryngoscope Blades|Comparison of Visualisation of Laryngeal Inlet and Ease of Intubation With Different Laryngoscope Blades.|Completed||N/A|120|Actual|Tata Memorial Hospital||4|||f||||f||||||||||2017-10-11 04:15:19.47468|2017-10-11 04:15:19.47468
NCT01352286|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-03-09|||March 2011||2011-03-01|March 2017|2017-03-01|April 2031|Anticipated|2031-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Redirected Auto T Cells for Advanced Myeloma|A Phase I/IIa, Dual-cohort, Two-site, Clinical Trial Evaluating the Safety and Activity of Redirected Autologous T Cells Expressing a High Affinity TCR Specific for NY-ESO-1 Administered Post ASCT in Patients With Advanced Myeloma|Active, not recruiting||Phase 1/Phase 2|26|Anticipated|Adaptimmune||1|||f||||t||||||||||2017-10-11 04:15:19.552256|2017-10-11 04:15:19.552256
NCT01352273|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2016-02-11|||June 2011||2011-06-01|February 2016|2016-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations|A Phase Ib Open-label Dose Escalation Study of MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations|Completed||Phase 1|69|Actual|Array BioPharma||1|||f||||||||||||||2017-10-11 04:15:19.628652|2017-10-11 04:15:19.628652
NCT01352260|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2012-05-18|||May 2011||2011-05-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Near-Infrared Spectroscopy Comparison Study|Validation of Near-Infrared Spectroscopy for Neuromonitoring During Moderate Hypothermic Circulatory Arrest for Total Aortic Arch Replacement: A Comparison of Two Technologies With Jugular Venous Bulb Oximetry|Completed||N/A|17|Actual|Nonin Medical, Inc|||1||f||||f||||||||||2017-10-11 04:15:19.724776|2017-10-11 04:15:19.724776
NCT01352247|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2016-05-27|||January 2010||2010-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Interventional|TOPKAT||Total or Partial Knee Arthroplasty Trial|Total or Partial Knee Arthroplasty Trial|Active, not recruiting||N/A|500|Anticipated|University of Oxford||2|||f||||t||||||||No||2017-10-11 04:15:19.786389|2017-10-11 04:15:19.786389
NCT01352234|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-01|2016-12-13|||September 2011||2011-09-01|July 2014|2014-07-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia|Evaluation of Dose-response Effect of Acetylsalicylic Acid on Placental Development, Preterm Birth, Fetal Growth and Hypertension in Pregnancy in Women With Previous History of Preeclampsia|Completed||Phase 4|104|Actual|CHU de Quebec-Universite Laval||2|||f||||t||||||||Undecided||2017-10-11 04:15:19.859368|2017-10-11 04:15:19.859368
NCT01352208|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-14|2014-03-21|||March 2011||2011-03-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients|Phase I/II, Multi-center, Open Label, Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti Tumor Activity of ASP9521 in Patients With Metastatic Castrate-resistant Prostate Cancer|Terminated||Phase 1/Phase 2|13|Actual|Astellas Pharma Inc||1||It was decided to discontinue the development in consideration of the results of a P1 study|f||||f||||||||||2017-10-11 04:15:20.049124|2017-10-11 04:15:20.049124
NCT01352195|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-05-12|||January 23, 2009|Actual|2009-01-23|May 2017|2017-05-01|June 30, 2019|Anticipated|2019-06-30|February 18, 2014|Actual|2014-02-18||Interventional|||Extended Self-Help for Smoking Cessation|Extended Self-Help for Smoking Cessation|Active, not recruiting||N/A|2124|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f||||||||||2017-10-11 04:15:20.132412|2017-10-11 04:15:20.132412
NCT01352182|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-23|2017-01-05|||October 2011||2011-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|May 2016|Actual|2016-05-01||Interventional|||Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock|Pharmacokinetic Characteristics of Pioglitazone and Preliminary Biomarker Response in Adolescents Aged 12 to 17 Years With Severe Sepsis and Septic Shock|Completed||Phase 1/Phase 2|12|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 04:15:20.204919|2017-10-11 04:15:20.204919
NCT01352143|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2013-11-19|||March 2011||2011-03-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Thrombin Generation in Neonatal Plasma After Cardiopulmonary Bypass|Measurements of Thrombin Generation in Response to Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Neonatal Plasma After Cardiopulmonary Bypass|Completed||N/A|24|Actual|Emory University|||1||f||||t||||||Samples Without DNA|"     Blood samples only   "|||2017-10-11 04:15:20.295174|2017-10-11 04:15:20.295174
NCT01352130|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-10|||March 2007||2007-03-01|May 2011|2011-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Granisetron Versus Ondansetron: Comparative Effects on ECG, QTc|Comparative Electrocardiographic Effects of Intravenous Ondansetron and Granisetron in Patients Undergoing Surgery for Carcinoma Breast: A Prospective Single Blind Randomised Trial|Completed||Phase 4|70|Actual|Tata Memorial Hospital||2|||f||||f||||||||||2017-10-11 04:15:20.381208|2017-10-11 04:15:20.381208
NCT01352117|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-03|2017-05-12|2017-03-17||November 18, 2011|Actual|2011-11-18|May 2017|2017-05-01|December 2019|Anticipated|2019-12-01|March 18, 2016|Actual|2016-03-18||Interventional|REACT-KS|All eligible participants who initiated study treatment.|Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma|A Randomized Evaluation of Antiretroviral Therapy Alone or With Delayed Chemotherapy Versus Antiretroviral Therapy With Immediate Adjunctive Chemotherapy for Treatment of Limited Stage AIDS-KS in Resource-Limited Settings (REACT-KS) AMC 067|Active, not recruiting||Phase 3|192|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||Undecided||2017-10-11 04:15:20.495303|2017-10-11 04:15:20.495303
NCT01352104|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-10|||January 2004||2004-01-01|April 2011|2011-04-01|December 2006|Actual|2006-12-01|March 2005|Actual|2005-03-01||Interventional|PEP-TE||Effectiveness of the Teacher Module of the Prevention Program for Externalizing Problem Behaviour in Preschoolers|Effectiveness of Guiding Teachers in Individualized Behavioral Intervention Strategies With Preschool Children Indicated for Externalizing Problem Behavior|Completed||N/A|144|Actual|German Research Foundation||1|||f||||f||||||||||2017-10-11 04:15:21.987494|2017-10-11 04:15:21.987494
NCT01352091|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-10|||May 2008||2008-05-01|April 2008|2008-04-01|April 2018|Anticipated|2018-04-01|May 2015|Anticipated|2015-05-01||Interventional|||Adjuvant AI Combined With Zoladex|A Randomized ,Open Label Study Comparing the Efficacy of Zoladex® Combined With Arimidex® for 3-2 Years After Selective Estrogen Receptor Modulators (SERMs) as an Adjuvant Therapy for 2-3 Years Versus Continuing Tamoxifen up to 5 Years for Premenopausal Early Breast Cancer Patients With Hormone Receptor Positive, Lymph Node Positive or Tumor≥ 4cm.|Recruiting||Phase 3|670|Anticipated|Fudan University||2|||f||||t||||||||||2017-10-11 04:15:22.061965|2017-10-11 04:15:22.061965
NCT00000593|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||November 1994||1994-11-01|December 2005|2005-12-01|March 2001|Actual|2001-03-01|||||Interventional|||Viral Activation Transfusion Study (VATS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.529077|2017-10-11 04:19:07.529077
NCT01352078|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-08-28|||May 2011||2011-05-01|August 2017|2017-08-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|WE-HEAL||Wound Etiology and Healing Study|The Wound Etiology and Healing Study|Recruiting||N/A|1000|Anticipated|George Washington University|||1||f||||f||||||Samples With DNA|"     1. Residual tissue left over after routine debridement surgery        2. Wound fluid that would otherwise be discarded        3. Residual blood/ serum samples left over after pre-surgery blood tests have been          performed.        4. Wound biofilm        5. Wound photographs   "|||2017-10-11 04:15:22.276997|2017-10-11 04:15:22.276997
NCT01352065|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-05-07|||January 2011||2011-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|ERAATH||Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration|Phase 3 Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration|Completed||Phase 2/Phase 3|30|Actual|Center for Health, Exercise and Sport Sciences, Serbia||3|||f||||t||||||||||2017-10-11 04:15:22.404197|2017-10-11 04:15:22.404197
NCT01352052|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2016-08-09|||May 2011||2011-05-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|IMPROvE||Interdisciplinary Rehabilitation of Patients With Chronic Widespread Pain|Interdisciplinary Rehabilitation and Evaluation Programme for Patients With Chronic Widespread Pain: Randomized Controlled Trial, the IMPROvE Study|Completed||N/A|192|Actual|Frederiksberg University Hospital||2|||f||||f||||||||||2017-10-11 04:15:22.516067|2017-10-11 04:15:22.516067
NCT01352039|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2012-10-15|||October 2011||2011-10-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional|HEP-SC||A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery|A Phase III, Non-inferiority, Randomized, Double-blind Trial Comparing Eurofarma Unfractionated Sodium Heparin 5,000 IU to APP Pharmaceuticals Unfractionated Sodium Heparin 5,000 IU in the Thromboprophylaxis of Geriatric Patients Who Underwent Hip Fracture Surgery.|Terminated||Phase 3|544|Actual|Eurofarma Laboratorios S.A.||2|||f||||t||||||||||2017-10-11 04:15:22.608101|2017-10-11 04:15:22.608101
NCT01352026|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2012-08-03|||May 2011||2011-05-01|August 2012|2012-08-01||||||||Interventional|MetHTAP||Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)||Withdrawn||Phase 2|0|Actual|Nantes University Hospital||1||"Several therapeutic have been developed making more difficult the eligibility of patients -   Recruitment of new centers wasn't possible due to competing trials"|f||||||||||||||2017-10-11 04:15:22.722718|2017-10-11 04:15:22.722718
NCT01352013|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2015-04-15|||January 2012||2012-01-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||The Impact of Omega-3 Fatty Acid Supplements on Fibromyalgia Symptoms|The Impact of Omega-3 Fatty Acid Supplements on Fibromyalgia (FM) Symptoms: A Randomized, Double-blind, Placebo-controlled Exploratory Study.|Completed||Phase 2|19|Actual|McGill University Health Center||2|||f||||f||||||||||2017-10-11 04:15:22.807573|2017-10-11 04:15:22.807573
NCT01352000|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-02-21|||December 2008||2008-12-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||"Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline(Quitline)"|Relapse-Prevention Booklets as an Adjunct to a Tobacco Quitline|Completed||N/A|3830|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f||||||||||2017-10-11 04:15:22.926131|2017-10-11 04:15:22.926131
NCT01351987|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-10|||December 2010||2010-12-01|May 2011|2011-05-01|December 2013|Anticipated|2013-12-01|||||Observational|||An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL|An Observational Study of Dutasteride and Alpha-Blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL|Unknown status|Active, not recruiting|N/A|855|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-10-11 04:15:23.046747|2017-10-11 04:15:23.046747
NCT01351974|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2011-05-27|||September 2000||2000-09-01|June 2000|2000-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Observational|||Sentinel Node Biopsy in Breast Cancer Patients|Cohort Study of Axillary Recurrences and Survival After Negative Negative Sentinel Node Biopsy Without Completion Axillary Clearance|Completed||N/A|3369|Actual|Uppsala University|||1||f||||f||||||Samples Without DNA|"     Routine specimens from the surgery are kept at the respective pathology departments   "|||2017-10-11 04:15:23.148101|2017-10-11 04:15:23.148101
NCT01351961|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2014-02-24|||April 2011||2011-04-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ADELAHYDE2||Vascular Alteration and Evolution of Cognitive Impairment|Arterial Function and Structure and Evolution of Cognitive Impairment in Elderly Hypertensive Subjects With Subjective Memory Complaints|Completed||N/A|131|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-10-11 04:15:23.256423|2017-10-11 04:15:23.256423
NCT01351948|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-03-13|||June 2011||2011-06-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909|A Phase Ia Study to Assess the Safety and Immunogenicity of Novel Schedules for Vaccination With the Candidate Malaria Vaccines; AdCh63 AMA1, MVA AMA1 & AMA1-C1/Alhydrogel® +/- CPG 7909|Completed||Phase 1|35|Actual|University of Oxford||5|||f||||t||||||||||2017-10-11 04:15:23.378299|2017-10-11 04:15:23.378299
NCT01351935|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2015-08-25|||July 2011||2011-07-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia|Phase 1b, Escalating Dose Study of AVL-292, a Bruton's Tyrosine Kinase (Btk) Inhibitor, as Monotherapy in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia|Completed||Phase 1|113|Actual|Celgene||1|||f||||f||||||||||2017-10-11 04:15:23.469474|2017-10-11 04:15:23.469474
NCT01351922|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-01-18|||April 2011||2011-04-01|January 2017|2017-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|DiabCare India||A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India|A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in India and to Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in India (DiabCare India 2011)|Completed||N/A|12000|Anticipated|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 04:15:23.624897|2017-10-11 04:15:23.624897
NCT00000594|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2012-04-26|||November 1971||1971-11-01|April 2012|2012-04-01|November 1976|Actual|1976-11-01|||||Interventional|||NHLBI Type II Coronary Intervention Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.703412|2017-10-11 04:19:07.703412
NCT01351909|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-09-19|||May 2, 2011|Actual|2011-05-02|September 2017|2017-09-01||||November 25, 2016|Actual|2016-11-25||Interventional|||Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer|Phase I Trial of Low-Dose Cyclophosphamide in Combination With Veliparib (ABT-888) in HER2/Neu-Negative Metastatic Breast Cancer|Active, not recruiting||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:15:23.744476|2017-10-11 04:15:23.744476
NCT01351896|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-04-24|||September 2011||2011-09-01|April 2017|2017-04-01||||July 31, 2016|Actual|2016-07-31||Interventional|||Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase II Study of Lenalidomide to Repair Immune Synapse Response and Humoral Immunity in Early-Stage, Asymptomatic Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) With High-Risk Genomic Features|Active, not recruiting||Phase 2|48|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 04:15:23.876088|2017-10-11 04:15:23.876088
NCT01351883|ClinicalTrials.gov processed this data on October 10, 2017|2011-01-31|2011-05-10|||January 2010||2010-01-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|January 2011|Actual|2011-01-01||Interventional|ANOM||Enteric Immune-nutrition Formula (ANOM®) for Patients Receiving Major Upper Gastrointestinal Surgery|Peri-operative Usage of Enteric Immune-nutrition Formula (ANOM®) Versus Standard Formula for Patients Received Major Upper Gastrointestinal Surgery|Unknown status|Recruiting|Phase 3|64|Anticipated|National Cheng-Kung University Hospital||1|||f||||t||||||||||2017-10-11 04:15:24.00166|2017-10-11 04:15:24.00166
NCT01351870|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-09-15|||April 2004||2004-04-01|September 2017|2017-09-01|February 2021|Anticipated|2021-02-01|December 2008|Actual|2008-12-01||Interventional|SIOP-PNET-4||Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma|A Prospective Randomised Controlled Trial of Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma|Active, not recruiting||Phase 3|52|Actual|Institut Curie||2|||f||||t||||||||||2017-10-11 04:15:24.092339|2017-10-11 04:15:24.092339
NCT01351857|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-03-21|||April 2012||2012-04-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|May 2017|Anticipated|2017-05-01||Interventional|TransClin||Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes|Multicentre Randomized Controlled Trial of Structured Transition on Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes|Active, not recruiting||Phase 4|188|Anticipated|Western University, Canada||2|||f||||t||||||||||2017-10-11 04:15:24.178763|2017-10-11 04:15:24.178763
NCT01351844|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-08-28|||May 2011||2011-05-01|August 2017|2017-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|CEASE||The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer|Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer|Terminated||N/A|12|Actual|George Washington University||2||Unable to recruit sufficient patients|f||||f||||||||||2017-10-11 04:15:24.26423|2017-10-11 04:15:24.26423
NCT01351831|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2013-09-10|||January 2011||2011-01-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|TKA||The Difference Between Rehabilitation With or Without Strength Training After Total Knee Replacement|The Difference Between Rehabilitation With or Without Progressive Strength Training After Fast-track Total Knee Arthroplasty: A Randomized Controlled Trial|Completed||Phase 2|72|Actual|Copenhagen University Hospital, Hvidovre||2|||f||||t||||||||||2017-10-11 04:15:24.341575|2017-10-11 04:15:24.341575
NCT01351818|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2011-05-10|||May 2005||2005-05-01|May 2011|2011-05-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Observational|FAYDS||Adipocyte Function and Somtropin Deficiency|The Fayds Project: Adipocyte Function and Somtropin Deficiency|Completed||N/A|62|Actual|Ferring Pharmaceuticals|||1||f||||f||||||||||2017-10-11 04:15:24.417295|2017-10-11 04:15:24.417295
NCT01351805|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-07-11|||January 2011||2011-01-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain|Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain|Active, not recruiting||N/A|25876|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 04:15:24.5391|2017-10-11 04:15:24.5391
NCT01351792|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2017-03-28|||September 2011||2011-09-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|FAIR||A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR)|A 12-week, Multicentre, Randomised, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster® 100/6 (Beclomethasone Dipropionate 100 µg Plus Formoterol 6 µg/Actuation), 2 Puffs b.i.d., Versus Symbicort® 200/6 (Budesonide 200 µg Plus Formoterol 6 µg/Actuation), 2 Inhalations b.i.d., on Parameters of Small Airway Function in Patients With Chronic Obstructive Pulmonary Disease.|Terminated||Phase 3|113|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 04:15:24.635473|2017-10-11 04:15:24.635473
NCT01351779|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-09|||May 2011||2011-05-01|May 2011|2011-05-01||||May 2012|Anticipated|2012-05-01||Observational|||The Effect of Body Posture on Intraocular Pressure in Progressive Glaucoma|The Effect of Body Posture on Intraocular Pressure in Progressive Glaucoma|Unknown status|Recruiting|N/A|20|Anticipated|University of Toronto|||1||f||||t||||||||||2017-10-11 04:15:24.723889|2017-10-11 04:15:24.723889
NCT01351766|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-06-10|||April 2010||2010-04-01|June 2011|2011-06-01|April 2013|Anticipated|2013-04-01|March 2013|Anticipated|2013-03-01||Interventional|||Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation|Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation|Unknown status|Recruiting|Phase 3|30|Anticipated|University of Maryland||1|||f||||f||||||||||2017-10-11 04:15:24.964665|2017-10-11 04:15:24.964665
NCT01351753|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-08-22|||March 2011||2011-03-01|August 2017|2017-08-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|REVIVE||Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity|Does Reversal of Visceral Obesity by Drug Therapy Improve Vascular Function?|Suspended||Phase 2|150|Anticipated|University of Iowa||6||Change of staff|f||||f||||||||||2017-10-11 04:15:25.063965|2017-10-11 04:15:25.063965
NCT01351740|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2016-06-16|||July 2011||2011-07-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|SUAT||Switch to Unboosted Atazanavir With Tenofovir Study|Switch to Unboosted Atazanavir With Tenofovir (SUAT) Study|Completed||Phase 4|50|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 04:15:25.156326|2017-10-11 04:15:25.156326
NCT00000595|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||January 1978||1978-01-01|May 2000|2000-05-01|September 1994|Actual|1994-09-01|||||Interventional|||Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.771241|2017-10-11 04:19:07.771241
NCT01351727|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-01-14|||January 2011||2011-01-01|January 2013|2013-01-01|October 2014|Anticipated|2014-10-01|December 2013|Anticipated|2013-12-01||Observational|||Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors|Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors From Different Ethnic Groups|Unknown status|Recruiting|N/A|560|Anticipated|University of Arizona|||1||f||||f||||||||||2017-10-11 04:15:25.26158|2017-10-11 04:15:25.26158
NCT01351714|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-04-26|||May 2011||2011-05-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Safe D3 Right Hemicolectomy for Cancer Through Multidetector Computed Tomography (MDCT) Angio|Safe D3 Right Hemicolectomy for Cancer Through 3D MDCT Angiography Reconstruction|Recruiting||N/A|700|Anticipated|Sykehuset i Vestfold HF||1|||f||||t||||||||||2017-10-11 04:15:25.345997|2017-10-11 04:15:25.345997
NCT01351701|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2011-05-10|||June 2011||2011-06-01|April 2011|2011-04-01||||||||Observational|||Bacteriological Study of Diabetic Foot and Antibiotic Sensitivity Pattern in Eastern India|An Observational, Prospective, Multicentre Study in Eastern India to Understand the Bacteriological Epidemiology in Diabetic Foot and Sensitivity Pattern of Antibiotics Along With the Pattern of Empirical Therapy|Unknown status|Not yet recruiting|N/A|200|Anticipated|Sun Valley Hospital, Guwahati|||1||f||||f||||||||||2017-10-11 04:15:25.445094|2017-10-11 04:15:25.445094
NCT01351688|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-11|2013-07-02|||August 2011||2011-08-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||An Open Label Prostate Cancer Study in Japanese Patients|A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD3514 in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer|Completed||Phase 1|13|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 04:15:25.518015|2017-10-11 04:15:25.518015
NCT01351675|ClinicalTrials.gov processed this data on October 10, 2017|2010-12-03|2014-04-28||2014-04-28|June 2011||2011-06-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|BEACON||Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes|Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)|Terminated||Phase 3|2185|Actual|Reata Pharmaceuticals, Inc.||2||IDMC recommendation for safety concerns|f||||t||||||||||2017-10-11 04:15:25.596822|2017-10-11 04:15:25.596822
NCT01351662|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-04-18|||August 2010||2010-08-01|April 2013|2013-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|BLESS||Balancing Lupus Experiences With Stress Strategies|An Intervention to Reduce Psychosocial and Biological Indicators of Stress in African American Lupus Patients: The Balancing Lupus Experiences With Stress Strategies (BLESS) Study|Completed||Phase 1/Phase 2|30|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 04:15:25.676778|2017-10-11 04:15:25.676778
NCT01351649|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2015-09-17|||April 2009||2009-04-01|September 2015|2015-09-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Middle School Physical Activity Intervention for Girls|Middle School Physical Activity Intervention for Girls|Completed||Phase 1/Phase 2|90|Actual|Michigan State University||2|||f||||t||||||||||2017-10-11 04:15:25.754954|2017-10-11 04:15:25.754954
NCT01351636|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2015-11-19|||April 2011||2011-04-01|November 2015|2015-11-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|AHOCEP||Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients|Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients: An Open Labelled, Randomized, Multicentered, Controlled Trial|Active, not recruiting||Phase 4|300|Anticipated|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.||2|||f||||t||||||||||2017-10-11 04:15:25.859234|2017-10-11 04:15:25.859234
NCT01351623|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-03-15|2017-01-03||May 9, 2011||2011-05-09|March 2017|2017-03-01|January 26, 2016|Actual|2016-01-26|January 26, 2016|Actual|2016-01-26||Interventional|||Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma|Phase II Study of Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|44|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:15:25.937724|2017-10-11 04:15:25.937724
NCT01351610|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-10|2015-12-14|||March 2011||2011-03-01|December 2015|2015-12-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|||Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia|Open, Randomized, Mono-Centre, Two-Parallel Group Clinical Phase I/II Trial on the Evaluation of Tolerability and Efficacy of an Intravenous Infusion of Human Bone Marrow Derived Autologous, CD34-Negative Mesenchymal Stem Cells for the Treatment of Critical Limb Ischemia in Patients With Advanced Peripheral Arterial Occlusive Disease Subsequent to Percutaneous Transluminal Angioplasty|Completed||Phase 1/Phase 2|25|Actual|Apceth GmbH & Co. KG||2|||f||||t||||||||||2017-10-11 04:15:26.223007|2017-10-11 04:15:26.223007
NCT01351597|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-10|||April 2011||2011-04-01|May 2011|2011-05-01|September 2013|Anticipated|2013-09-01|April 2013|Anticipated|2013-04-01||Interventional|STORM||A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer|An Open-label, Multi-center Phase II Trial to Evaluate the Efficacy and Safety of Combination Chemotherapy With DoceTaxel(Detaxel) and Oxaliplatin(Oxalitin)in Recurrent or Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|51|Anticipated|Korean Breast Cancer Study Group||1|||f||||t||||||||||2017-10-11 04:15:26.29571|2017-10-11 04:15:26.29571
NCT01351584|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-08-24|||February 2007||2007-02-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|June 2019|Anticipated|2019-06-01||Observational|TMK||Tumour Registry Breast Cancer|Clinical Registry to Present Treatment and Sequences of Treatments in Routine Practice in Germany|Active, not recruiting||N/A|4500|Anticipated|iOMEDICO AG|||1||f||||f||||||||||2017-10-11 04:15:26.39192|2017-10-11 04:15:26.39192
NCT01351571|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-10-02|||August 2010||2010-08-01|October 2017|2017-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma|An Open Label, Prospective, Observational, Non-interventional Study of Bevacizumab in Combination With Interferon Alpha-2a for the First-line Treatment of Patients With Advanced and/or Metastatic Renal Cell Carcinoma|Completed||N/A|5|Actual|Hoffmann-La Roche|||1||f||||||||||||||2017-10-11 04:15:26.464838|2017-10-11 04:15:26.464838
NCT01351558|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2012-10-04|||May 2011||2011-05-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Exercise and Pain Sensitivity|Exercise and Alterations in Pain Sensitivity|Terminated||N/A|33|Actual|Frederiksberg University Hospital||4||Recruitment difficulties.|f||||f||||||||||2017-10-11 04:15:26.538605|2017-10-11 04:15:26.538605
NCT01351532|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2012-01-30|||April 2011||2011-04-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Behavior Change on Oral Cancer Patients After a Localized Behavior Change Model Intervention|Behavior Change on Oral Cancer Patients After a Localized Behavior Change Model Intervention|Completed||N/A|67|Actual|China Medical University Hospital||2|||f||||||||||||||2017-10-11 04:15:29.032238|2017-10-11 04:15:29.032238
NCT01351519|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-07|2016-03-15|||May 2011||2011-05-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors|A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain|Terminated||Phase 2|16|Actual|MultiCare Health System Research Institute||1||Limited staff available for enrollment and limited availability of drug|f||||t||||||||||2017-10-11 04:15:29.093306|2017-10-11 04:15:29.093306
NCT01351506|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2014-11-03|2014-11-03||May 2011||2011-05-01|November 2014|2014-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Effect of Body Weight Change to Surgical ICU Outcomes|Effect and Determinant Level of Admission Body Weight and Daily Weight Change and Prognoses of Critically and High Risk Surgical Patients|Completed||N/A|465|Actual|Chiang Mai University|||1||f||||t||||||||||2017-10-11 04:15:29.186731|2017-10-11 04:15:29.186731
NCT01351493|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2012-07-10|||July 2012||2012-07-01|July 2012|2012-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Pressure Sore|A Randomized, Double-blind, Placebo-controlled Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Pressure Sore|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 04:15:29.413275|2017-10-11 04:15:29.413275
NCT01351480|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-01-23|2015-10-01||June 2011|Actual|2011-06-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients|Assessment of Structural Benefits of Injectable Abatacept as Measured by MRI in RA Patients Who Have Failed Prior Anti-Tumor Necrosis (TNF) Therapy and Correlated With Clinical Outcomes|Completed||Phase 3|34|Actual|Arthritis & Rheumatic Disease Specialties Research||1|||f||||t||||||||||2017-10-11 04:15:29.524045|2017-10-11 04:15:29.524045
NCT01351467|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-05-30|||April 2009||2009-04-01|May 2017|2017-05-01|January 2025|Anticipated|2025-01-01|May 30, 2017|Anticipated|2017-05-30||Observational|||Web-based Genetic Research on Parkinson's Disease|Ongoing, Web-Based Genome-Wide Association Studies for Targeted Disease Initiatives|Active, not recruiting||N/A|25000|Anticipated|23andMe, Inc.|||1||f||||f||||||Samples With DNA|"     Saliva samples are collected for DNA analysis   "|||2017-10-11 04:15:29.802203|2017-10-11 04:15:29.802203
NCT01351454|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-04-10|||September 2008||2008-09-01|May 2011|2011-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Behavioral Depression Treatment for African American HIV-infected Substance Users|Behavioral Depression Treatment for African American HIV-infected Substance Users|Completed||N/A|122|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 04:15:29.891951|2017-10-11 04:15:29.891951
NCT01351441|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-09|||May 2011||2011-05-01|May 2011|2011-05-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice|Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice|Unknown status|Recruiting|N/A|50|Anticipated|VascuScript Pharmacy||1|||f||||f||||||||||2017-10-11 04:15:30.155389|2017-10-11 04:15:30.155389
NCT01351428|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2012-11-08|||December 2010||2010-12-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia|Non-invasive Hemodynamic Monitoring and Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia|Completed||N/A|20|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||1|||f||||f||||||||||2017-10-11 04:15:30.258028|2017-10-11 04:15:30.258028
NCT01351415|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-08-17|2017-06-20||June 25, 2011|Actual|2011-06-25|August 2017|2017-08-01|June 25, 2016|Actual|2016-06-25|June 25, 2016|Actual|2016-06-25||Interventional||Intent-to-treat population includes all randomized participants.|A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)|An Open-label, Randomized, Phase IIIb Trial Evaluating the Efficacy and Safety of Standard of Care +/- Continuous Bevacizumab Treatment Beyond Progression of Disease (PD) in Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) After First Line Treatment With Bevacizumab Plus a Platinum Doublet-containing Chemotherapy|Completed||Phase 3|485|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:15:30.397227|2017-10-11 04:15:30.397227
NCT01351402|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-05-09|||June 2006||2006-06-01|August 2005|2005-08-01|January 2007|Actual|2007-01-01|August 2006|Actual|2006-08-01||Interventional|||Effects of Massage Versus Rest on Hormones|Investigating the Effects of Massage vs. Rest on Oxytocin, ACTH, and B-endorphins|Completed||N/A|95|Actual|Claremont Graduate University|||||f||||f||||||||||2017-10-11 04:15:32.240437|2017-10-11 04:15:32.240437
NCT01351389|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2014-09-12|||May 2011||2011-05-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|November 2013|Actual|2013-11-01||Interventional|SAFER||Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk|Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk|Completed||N/A|400|Actual|Brown University||2|||f||||t||||||||||2017-10-11 04:15:32.328274|2017-10-11 04:15:32.328274
NCT01351376|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-09-08|||May 2011||2011-05-01|September 2017|2017-09-01|July 2017|Actual|2017-07-01|June 2016|Actual|2016-06-01||Interventional|||LLLT Combined With CDT in Breast Cancer-Related Lymphedema|The Effectiveness of Low Level Laser Therapy (LLLT)Combined With Complex Decongestive Therapy (CDT) in the Treatment of Breast Cancer-Related Lymphedema: A Double-Blind, Randomized, Placebo-Controlled Study|Completed||N/A|150|Actual|New York University School of Medicine||2|||f||||f|f|t|f|f||||||2017-10-11 04:15:32.452105|2017-10-11 04:15:32.452105
NCT01351350|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-21|2015-04-07|||March 2011||2011-03-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Interventional|||Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies|A Phase I, Open Label, Dose Escalation Study of Oral Administration of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies|Completed||Phase 1|67|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 04:15:32.713189|2017-10-11 04:15:32.713189
NCT01351337|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2015-04-04|2014-02-24||October 2008||2008-10-01|April 2015|2015-04-01|February 2013|Actual|2013-02-01|June 2009|Actual|2009-06-01||Interventional||Age (range), y 44 (10-72) Female/male, n/n 21/37|Functional Monitoring for Motor Pathway in Brain Tumor Surgery Within Eloquent Area|Clinical Efficiency of Motor Pathway Mapping Using Diffusion Tensor Imaging Tractography and Intraoperative Subcortical Stimulation in Cerebral Glioma Surgery|Completed||N/A|58|Actual|Huashan Hospital|The imaged motor pathway was reconstructed based on pre-opimages. An additional study that integrates real-time DTI tractography with high-field intraoperative MRI and DsCS for eloquent cerebral glioma surgery is currently underway in our department.|1|||f||||t||||||||||2017-10-11 04:15:32.856439|2017-10-11 04:15:32.856439
NCT01351324|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-05-09|||March 2009||2009-03-01|April 2011|2011-04-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|eFAIRE||A Study of Different Types of Fatty Acid on Risk Factors for Heart Disease|Acute Elevation of Non-esterified Fatty Acids on Endothelial Function and Insulin Sensitivity: A Comparison of Saturated and Long Chain n-3 Polyunsaturated Fatty Acids During the Postprandial Phase|Completed||N/A|59|Actual|University of Reading||2|||f||||f||||||||||2017-10-11 04:15:33.11283|2017-10-11 04:15:33.11283
NCT01351311|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2012-11-29|||March 2011||2011-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Resistance Training Exercise Using the Swiss Ball in Ankylosing Spondylitis|Assessment of Effectiveness of Resistance Training Exercise Using the Swiss Ball in Patients With Ankylosing Spondylitis|Completed||N/A|60|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-10-11 04:15:33.200546|2017-10-11 04:15:33.200546
NCT01351298|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2012-12-04|||June 2011||2011-06-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Nasal Prep for Nasendoscopy in Children|Intra-nasal Topical Local Anesthetic and Decongestant for Flexible Nasendoscopy in Children: a Randomised Double-blind Placebo Controlled Trial|Completed||Phase 4|69|Actual|Children's & Women's Health Centre of British Columbia||3|||f||||f||||||||||2017-10-11 04:15:33.303842|2017-10-11 04:15:33.303842
NCT01351285|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-06-01|||April 2011||2011-04-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Comparison of Effect-site Concentration of Remifentanil for Preventing Cough Against Endotracheal Tube During Anesthetic Emergence According to Anesthetics (Sevoflurane, Desflurane, and Propofol)||Completed||N/A|78|Actual|Yonsei University||3|||f||||f||||||||||2017-10-11 04:15:33.387419|2017-10-11 04:15:33.387419
NCT01351272|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2014-12-09|||May 2011||2011-05-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|BEAS||Genetic Modulation of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)|Genetic Modulation of Functional Brain Activity of Attention-deficit/Hyperactivity Disorder-related Working Memory Processes|Completed||Phase 3|41|Actual|Wuerzburg University Hospital||1|||f||||t||||||||||2017-10-11 04:15:33.46444|2017-10-11 04:15:33.46444
NCT01351259|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-08-31|||February 2010||2010-02-01|August 2013|2013-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|Nosten||Continuous Control of Polyurethane Tracheal-cuff Pressure: Efficiency of a Pneumatic Device|Continuous Control of Polyurethane Tracheal-cuff Pressure: Efficiency of a Pneumatic Device|Completed||Phase 4|64|Actual|University Hospital, Lille||4|||f||||t||||||||||2017-10-11 04:15:33.552737|2017-10-11 04:15:33.552737
NCT01351246|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2014-04-14|||May 2010||2010-05-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|||Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)|Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD): A Feasibility and Effectiveness Study|Completed||N/A|300|Actual|University of Cologne||1|||f||||f||||||||||2017-10-11 04:15:33.637898|2017-10-11 04:15:33.637898
NCT01351233|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2012-07-04|||March 2011||2011-03-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Evaluation of the Rotational Stability of The AcrySof Toric Intraocular Lens in the Capsular Bag in High Myopic Subjects|Evaluation of the Rotational Stability of The AcrySof Toric Intraocular Lens in the Capsular Bag in High Myopic Subjects|Completed||N/A|30|Actual|Wenzhou Medical University||1|||f||||t||||||||||2017-10-11 04:15:33.772243|2017-10-11 04:15:33.772243
NCT01351220|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2016-07-28|||July 2010||2010-07-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|||Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening Intervention|Community Dissemination of an Evidence-based CRC Screening Intervention|Completed||N/A|1100|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||No||2017-10-11 04:15:33.847163|2017-10-11 04:15:33.847163
NCT01351207|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2014-11-18|||April 2011||2011-04-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||The Effect of Eggs on Postprandial Metabolism|The Effect of Eggs on Postprandial Metabolism: A Randomized, Controlled Crossover Pilot Study in Older, Overweight Adults|Completed||N/A|20|Actual|Tufts University||3|||f||||||||||||||2017-10-11 04:15:33.952986|2017-10-11 04:15:33.952986
NCT01351194|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-05-24|||March 2010||2010-03-01|March 2010|2010-03-01|May 2013|Anticipated|2013-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm|Radiofrequency Ablation vs. Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm.A Prospective and Randomized Clinical Trial|Unknown status|Recruiting|Phase 4|180|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 04:15:34.047376|2017-10-11 04:15:34.047376
NCT01351181|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-05-09|||June 2011||2011-06-01|May 2011|2011-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|PAADAR||Physical Activity Advice in Diabetics at Annual Review|A Case Control Study to Assess the Effectiveness of Written Advice to Increase Physical Activity Given to Type II Diabetics by Nursing Staff During the Diabetic Annual Review in UK General Practice|Unknown status|Not yet recruiting|N/A|80|Anticipated|Ship Street Surgery||2|||f||||f||||||||||2017-10-11 04:15:34.145386|2017-10-11 04:15:34.145386
NCT01351168|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2012-11-30||||||November 2012|2012-11-01||||||||Interventional|||Use of Zolpidem in Parkinson's Disease|A Randomized, Controlled, Double-Blind, Cross-over Study of Zolpidem for Patients With Parkinson's Disease|Withdrawn||Phase 2|0|Actual|Rush University Medical Center||4||study not funded|f||||f||||||||||2017-10-11 04:15:34.395479|2017-10-11 04:15:34.395479
NCT01351155|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2014-12-29|||December 2011||2011-12-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|May 2015|Anticipated|2015-05-01||Interventional|3PROSNIV||Prevention of Damage Induced by Facial Mask Ventilation|Comparison of Three Devices to Prevent Skin Damage Induced by Facial Mask Ventilation During Acute Respiratory Failure: a Multicenter Randomised Controlled Study|Unknown status|Recruiting|N/A|252|Anticipated|Ospedale San Donato||4|||f||||t||||||||||2017-10-11 04:15:34.488382|2017-10-11 04:15:34.488382
NCT01351142|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2016-10-10|||November 2009||2009-11-01|October 2016|2016-10-01||||November 2013|Actual|2013-11-01||Interventional|||Cytokines and Cognitive Decline in Alzheimer's Disease||Completed||N/A|133|Actual|Poitiers University Hospital||1|||f||||||||||||||2017-10-11 04:15:34.607941|2017-10-11 04:15:34.607941
NCT01351129|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2011-07-05|||May 2011||2011-05-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers|A Phase 1, Single-Dose, Open-Label, Crossover Study To Estimate The Relative Bioavailability Of Two Controlled-Release Formulations Vs. An Immediate Release Formulation Of PF-04991532 In Healthy Adult Subjects|Completed||Phase 1|12|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 04:15:34.7046|2017-10-11 04:15:34.7046
NCT01351116|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2017-01-20|||October 2011||2011-10-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|June 2016|Actual|2016-06-01||Interventional|BRACHY||A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy|A Phase III, Multi-centre, Randomized Trial to Evaluate the Symptomatic and Quality of Life Improvements in Lung Cancer Patients Receiving External Beam Radiation With or Without High Dose Rate Intraluminal Brachytherapy|Completed||Phase 3|134|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-10-11 04:15:34.781577|2017-10-11 04:15:34.781577
NCT01351103|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-09-22|||December 1, 2011|Actual|2011-12-01|September 2017|2017-09-01|January 10, 2020|Anticipated|2020-01-10|September 25, 2018|Anticipated|2018-09-25||Interventional|||A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands|A Phase I, Open-label, Dose Escalation Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands|Recruiting||Phase 1|170|Anticipated|Novartis||2|||f||||f|t|f||||||||2017-10-11 04:15:34.877393|2017-10-11 04:15:34.877393
NCT01351090|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2012-09-14|2012-09-14|||||September 2012|2012-09-01|October 2007|Actual|2007-10-01|||||Interventional|||Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine (IN) for Postoperative Pain|A Phase 2, Double-blind, Randomized Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain|Completed||Phase 2|127|Actual|Luitpold Pharmaceuticals||3|||||||||||||||||2017-10-11 04:15:35.006302|2017-10-11 04:15:35.006302
NCT01351077|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2017-04-10|2016-12-08||May 2011||2011-05-01|April 2017|2017-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The CHICA Developmental Screening Study|A Study to Determine if CHICA Can Improve Developmental Screening|Completed||N/A|360|Actual|Indiana University||2|||f||||f||||||||No||2017-10-11 04:15:35.531058|2017-10-11 04:15:35.531058
NCT01351064|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2015-12-18|2015-11-17||July 2010||2010-07-01|December 2015|2015-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Using Computers to Assist in the Diagnosis and Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)|Using Computers to Assist in the Diagnosis and Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)|Completed||N/A|84|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 04:15:35.867275|2017-10-11 04:15:35.867275
NCT01351051|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-08|2013-05-29|||May 2011||2011-05-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|FEELING||A Study of the Potential Risk Factors Linked to the Development of Severe Forms of Endometriosis|A Multi-centre, Multinational, Cross-sectional, Incident Case-control Study on Factors Associated With the Development of Endometrioma and Deep Infiltrating Endometriosis|Completed||N/A|1008|Actual|Ipsen|||4||f||||f||||||||||2017-10-11 04:15:36.214753|2017-10-11 04:15:36.214753
NCT01351038|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2013-06-03||||||June 2013|2013-06-01||||||||Interventional|||Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma|A Two Stage Multicenter Phase II Trial of Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma|Terminated||Phase 2|43|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1||REAL trial showed a significant difference in OS for reduced EOX and standard EOX|f||||t||||||||||2017-10-11 04:15:36.312898|2017-10-11 04:15:36.312898
NCT01351025|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-08|2016-05-18|2015-05-01||April 2011||2011-04-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Participants who started study treatment are included|Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells|A Pilot Study Evaluating the Effect of Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis, and T-lymphocyte Activation in HIV-1 Infected Individuals With Suppressed HIV-1 RNA and LDL Cholesterol < 130 mg/dL|Completed||Phase 2|98|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 04:15:36.43672|2017-10-11 04:15:36.43672
NCT01351012|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-14|2014-02-18|||September 2010||2010-09-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|COMIT||Canola Oil Multicentre Intervention Trial|Canola and Flax Oils in Modulation of Vascular Function and Biomarkers of Cardiovascular Disease Risk|Completed||N/A|140|Actual|University of Manitoba||5|||f||||f||||||||||2017-10-11 04:15:37.312175|2017-10-11 04:15:37.312175
NCT01350999|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2016-07-28|2016-06-01||November 2009||2009-11-01|July 2016|2016-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia|A Phase 3 Long-term Study of TAK-085 in Subjects With Hypertriglyceridemia|Completed||Phase 3|503|Actual|Takeda||3|||f||||f||||||||||2017-10-11 04:15:37.447507|2017-10-11 04:15:37.447507
NCT01350986|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-05-09|||May 2011||2011-05-01|May 2011|2011-05-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|FLOH||Guided Self-Help for Parents of Children With Externalizing Problem Behavior|Efficacy of Cognitive-Behavioral Based Guided Self-Help for Parents of Children With Externalizing Problem Behavior|Unknown status|Recruiting|N/A|146|Anticipated|German Research Foundation||2|||f||||f||||||||||2017-10-11 04:15:39.345306|2017-10-11 04:15:39.345306
NCT01350973|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2016-07-28|2016-06-01||November 2009||2009-11-01|July 2016|2016-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Efficacy of TAK-085 in Participants With Hypertriglyceridemia|A Phase 3, Multicenter, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of TAK-085 in Subjects With Hypertriglyceridemia.|Completed||Phase 3|611|Actual|Takeda||3|||f||||f||||||||||2017-10-11 04:15:39.470848|2017-10-11 04:15:39.470848
NCT01350960|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2011-11-21|||May 2011||2011-05-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH|A First-in-Human (FIH), Randomized, Dose-Escalation, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SPC5001 Administered to Healthy Subjects and Subjects With Familial Hypercholesterolemia (FH)|Terminated||Phase 1|24|Actual|Santaris Pharma A/S||6|||f||||||||||||||2017-10-11 04:15:41.028216|2017-10-11 04:15:41.028216
NCT01350947|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2016-05-10|2015-09-28||April 2011||2011-04-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia|A Phase II Study of the Efficacy, Safety and Determinants of Response to 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia (CMML)|Completed||Phase 2|11|Actual|University of Utah||1|||f||||t||||||||||2017-10-11 04:15:41.131377|2017-10-11 04:15:41.131377
NCT01350921|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2012-03-29|||May 2011||2011-05-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers|A Sequential, Open Label Study to Compare the Pharmacokinetics, Safety and Tolerability of Ticagrelor and Venlafaxine Given Concomitantly in Healthy Subjects Aged 18 to 45 Years|Completed||Phase 1|22|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 04:15:41.989238|2017-10-11 04:15:41.989238
NCT01350908|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-01-20|||April 2011||2011-04-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Study of Circulating Tumoral DNA in Ovarian Cancer|Development and Validation of a Circulating Tumor DNA Detection Technique in Patients With Ovarian Cancer|Completed||N/A|25|Actual|Institut Curie||1|||f||||f||||||||||2017-10-11 04:15:42.054847|2017-10-11 04:15:42.054847
NCT01350882|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-04|2011-12-22|||October 2008||2008-10-01|December 2011|2011-12-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|RITUX-ERAH||Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation|Phase III Study of Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation|Unknown status|Active, not recruiting|Phase 3|64|Anticipated|University Hospital, Tours||2|||f||||f||||||||||2017-10-11 04:15:42.176479|2017-10-11 04:15:42.176479
NCT01350869|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2015-11-10|||June 2008||2008-06-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|December 2011|Actual|2011-12-01||Observational|||Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)|Evaluation of Effectiveness and Safety of Everolimus-Eluting Stents in Routine Clinical Practice|Completed||Phase 4|3000|Anticipated|CardioVascular Research Foundation, Korea|||1||f||||t||||||||||2017-10-11 04:15:42.286209|2017-10-11 04:15:42.286209
NCT01350856|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-19|2015-05-29|||May 2011||2011-05-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|TRAC||Tracking Resistance to Artemisinin (TRAC)|A Multicentre, Randomised Trial to Detect in Vivo Resistance of Plasmodium Falciparum to Artesunate in Patients With Uncomplicated Malaria.|Completed||Phase 4|1700|Actual|University of Oxford||2|||f||||t||||||||||2017-10-11 04:15:42.361607|2017-10-11 04:15:42.361607
NCT01350843|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2016-04-26|||May 2011||2011-05-01|April 2016|2016-04-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||The Effects of Orange Juice on Plasma Lipids|An Investigation Into the Effects of Orange Juice on Plasma Lipids - an Extension to J/06/2010|Completed||N/A|36|Actual|University of Nottingham||2|||f||||f||||||||No||2017-10-11 04:15:42.480959|2017-10-11 04:15:42.480959
NCT01350830|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2011-05-09|||November 2007||2007-11-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|December 2008|Actual|2008-12-01||Interventional|PPTHR||Preperitoneal Versus Pre-trasversalis Hernia Repair|Early and Late Results of Transinguinal Preperitoneal Patch Repair Versus Anterior Pre-Trasversalis Mesh Repair. A Randomised Study|Completed||Phase 4|253|Actual|San Bonifacio Hospital||2|||f||||t||||||||||2017-10-11 04:15:42.569496|2017-10-11 04:15:42.569496
NCT01350817|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2015-04-01|||May 2011||2011-05-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|March 2013|Actual|2013-03-01||Interventional|TARSEQ||Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer|Randomized Open Non Comparative Multicenter Phase II Study of Sequential Erlotinib With Docetaxel Versus Docetaxel Alone in Second Line of Treatment in Patients With Non Small Cell Lung Cancer After Failure of First Line Chemotherapy|Completed||Phase 2|156|Actual|University Hospital, Limoges||2|||f||||t||||||||||2017-10-11 04:15:42.649415|2017-10-11 04:15:42.649415
NCT01350622|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2016-12-19|||December 2011||2011-12-01|December 2016|2016-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Efficacy of PENNSAID® for Pain Management in the Emergency Department|Efficacy of PENNSAID® for Pain Management in the Emergency Department|Withdrawn||N/A|0|Actual|University of Utah||2||Study never initiated|f||||f||||||||||2017-10-11 04:15:48.484281|2017-10-11 04:15:48.484281
NCT00000167|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2010-03-23|||May 1999||1999-05-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|CAPT||Complications of Age-Related Macular Degeneration Prevention Trial|Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)|Completed||Phase 3|1052|Actual|National Eye Institute (NEI)||1|||f||||t||||||||||2017-10-11 04:17:34.540151|2017-10-11 04:17:34.540151
NCT01350804|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2016-05-04|2016-01-26||September 2011||2011-09-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|NURTURE 1||Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)|A Randomized, Double-blind, Placebo- and Active-controlled Study of Secukinumab to Demonstrate the Efficacy at 24 Weeks and to Assess the Safety, Tolerability and Long Term Efficacy up to 1 Year in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNFα Agents (CAIN457F2309) and A Four Year Extension Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Rheumatoid Arthritis (CAIN457F2309E1)|Completed||Phase 3|551|Actual|Novartis||4|||f||||t||||||||||2017-10-11 04:15:43.114566|2017-10-11 04:15:43.114566
NCT01350791|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2017-07-19|||May 2010|Actual|2010-05-01|July 2017|2017-07-01|December 2016|Actual|2016-12-01|October 2013|Actual|2013-10-01||Observational|||Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )|Evaluation of Effectiveness and Safety of PROMUS Element™ in Routine Clinical Practice; A Multicenter, PROSPECTIVE OBSERVATIONAL STUDY|Completed||N/A|3001|Actual|CardioVascular Research Foundation, Korea|||1||f||||t||||||||||2017-10-11 04:15:47.281286|2017-10-11 04:15:47.281286
NCT01350778|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2016-12-11|||May 2010||2010-05-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|July 2018|Anticipated|2018-07-01||Observational|||Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)|Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Active, not recruiting||N/A|1000|Anticipated|CardioVascular Research Foundation, Korea|||1||f||||t||||||||||2017-10-11 04:15:47.439944|2017-10-11 04:15:47.439944
NCT01350765|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2016-07-14|||March 2010||2010-03-01|July 2016|2016-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|AKU||Naushero Feroze Neonatal Survival Project|Naushero Feroze Neonatal Survival Project: A Cluster Randomized Trial to Determine the Effectiveness of Package of Community Based Interventions to Reduce Neonatal Deaths Due to Birth Asphyxia, Low Birth Weight & Neonatal Sepsis|Completed||N/A|37201|Actual|Aga Khan University||2|||f||||t||||||||Yes||2017-10-11 04:15:47.529486|2017-10-11 04:15:47.529486
NCT01350752|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2016-09-08|||May 2011||2011-05-01|October 2013|2013-10-01|January 2015|Actual|2015-01-01|September 2012|Actual|2012-09-01||Interventional|REACT||Research on the Economics of Artemisinin Combination Therapy (ACTs) for the Treatment of Malaria|A Cost-effectiveness Analysis of Alternative Strategies for the Deployment of ACTs at the Community Level in Cameroon and Nigeria|Completed||N/A|6513|Actual|London School of Hygiene and Tropical Medicine||3|||f||||f||||||||||2017-10-11 04:15:47.615941|2017-10-11 04:15:47.615941
NCT01350739|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-08|2015-11-17|||May 2015||2015-05-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Umbilical Access in Laparoscopic Surgery|Comparative, Randomized, Open-label Study: Different Incisions to Access the Abdominal Cavity Within the Umbilicus|Withdrawn||N/A|0|Actual|St John of God Hospital, Vienna||2|||f||||f||||||||||2017-10-11 04:15:47.717205|2017-10-11 04:15:47.717205
NCT01350726|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-08|2011-05-09|||January 2008||2008-01-01|May 2011|2011-05-01|July 2011|Anticipated|2011-07-01|May 2011|Actual|2011-05-01||Observational|GSA||Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT Scan|Functional-three-dimensional Reconstruction and Functional Evaluation of Liver by 99MTc-GSA-SPECT Scintigraphy|Unknown status|Recruiting|N/A|0|Anticipated|Peking Union Medical College Hospital|||2||f||||t||||||||||2017-10-11 04:15:47.784802|2017-10-11 04:15:47.784802
NCT01350713|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-08|2011-05-09|||July 2011||2011-07-01|May 2011|2011-05-01|July 2013|Anticipated|2013-07-01|July 2012|Anticipated|2012-07-01||Interventional|||The Counter-irritating Efficacy of Topical Povidone-iodine in Thermal Burns|Testing the Counter-irritating Efficacy of Topical Povidone-iodine in Thermal Burns; Comparison to Conventional Treatments|Unknown status|Not yet recruiting|N/A|280|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-10-11 04:15:47.865522|2017-10-11 04:15:47.865522
NCT01350700|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-08|2011-05-09|||June 2011||2011-06-01|May 2011|2011-05-01|January 2012|Anticipated|2012-01-01|December 2011|Anticipated|2011-12-01||Observational|||Long Term Follow up of Scars Formation and Quality of Life Assessment Study|Scar Formation and Quality of Life Assessment in Subjects (Adults & Children) Following Treatment With Debrase Compared to Standard of Care (SOC)|Unknown status|Not yet recruiting|N/A|148|Anticipated|MediWound Ltd|||2||f||||f||||||||||2017-10-11 04:15:47.981554|2017-10-11 04:15:47.981554
NCT01350687|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-08|2011-05-09|||June 2011||2011-06-01|April 2011|2011-04-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Observational|||Pulmonary Hypertension Prevention in Hemodialysis|New Phosphore Binders in Prevention of Pulmonary Hypertension|Unknown status|Not yet recruiting|N/A|40|Anticipated|The Baruch Padeh Medical Center, Poriya|||1||f||||f||||||||||2017-10-11 04:15:48.094801|2017-10-11 04:15:48.094801
NCT01350661|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-09|2015-08-07|||June 2010||2010-06-01|August 2015|2015-08-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Observational|||Correlation Between Five Asthma Control Questionnaires|Assessment of Correlation Between Five Asthma Control Questionnaires|Completed||N/A|99|Actual|Centre Hospitalier Universitaire Saint Pierre|||1||f||||f||||||||||2017-10-11 04:15:48.256271|2017-10-11 04:15:48.256271
NCT01350648|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-07|2017-08-22|||May 4, 2011||2011-05-04|August 16, 2017|2017-08-16||||||||Observational|||Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection|The Natural History of Liver Disease in a Cohort of Participants With Hepatitis B and/or Hepatitis C With or Without HIV Infection|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:15:48.31392|2017-10-11 04:15:48.31392
NCT01350635|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-07|2015-12-17|||May 2011||2011-05-01|December 2015|2015-12-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Skin Test Study of BM32|Evaluation of BM32, a Recombinant Hypoallergenic Grass Pollen Vaccine, by Skin Testing|Completed||Phase 1/Phase 2|60|Actual|Biomay AG||1|||f||||f||||||||||2017-10-11 04:15:48.416971|2017-10-11 04:15:48.416971
NCT00000194|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-05-05|||January 1993||1993-01-01|August 2015|2015-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 3 - 3|Neurobiology of Opioid Dependence: 3|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-10-11 04:17:38.127978|2017-10-11 04:17:38.127978
NCT01350609|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2015-12-08|||April 2011||2011-04-01|December 2015|2015-12-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed|Single Dose Study to Compare the Pharmacokinetics as Well as Safety and Tolerability of a Novel Fixed Dose Combination of Nifedipine GITS and Candesartan and the Loose Combination of Both Components and to Investigate the Bioequivalence Between the Fixed Dose and the Loose Combination in Healthy Male Subjects Under Fed Conditions in an Open Label, Randomized, 2-way-crossover Design|Completed||Phase 1|49|Actual|Bayer||2|||f||||f||||||||||2017-10-11 04:15:48.578727|2017-10-11 04:15:48.578727
NCT01350596|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-08-02|||May 2011||2011-05-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|B4371004||A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.|An Open Label, Randomized, 2x2 Crossover, Single Dose, Phase 4 Study To Determine The Pharmaceutical Bioequivalence Of Ibuprofen 50mg/Ml (Laboratórios Pfizer Ltda) Oral Suspension Versus Alivium ® 50mg/Ml (Mantecorp Indústria Química E Farmacêutica Ltda.) Oral Suspension, In Healthy Fasting Volunteers.|Completed||Phase 4|24|Anticipated|Pfizer||2|||f||||f||||||||||2017-10-11 04:15:48.67316|2017-10-11 04:15:48.67316
NCT01350583|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2013-08-07|2013-06-05||August 2010||2010-08-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Bicarbonate for Tumor Related Pain|A Pilot Study of Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain|Terminated||N/A|2|Actual|H. Lee Moffitt Cancer Center and Research Institute|This Pilot Supportive Care study ended prematurely due to slow accrual and the initiating principal investigator leaving the institution. The outcome measures were based on 25 evaluable participants and there were only 2 participants enrolled.|1||PI Left Moffitt|f||||t||||||||||2017-10-11 04:15:48.7619|2017-10-11 04:15:48.7619
NCT01350570|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2015-04-09|||August 2011||2011-08-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Interventional|||Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial|Acupuncture for Functional Bowel Disease|Completed||Phase 2/Phase 3|449|Actual|Chengdu University of Traditional Chinese Medicine||4|||f||||t||||||||||2017-10-11 04:15:49.275332|2017-10-11 04:15:49.275332
NCT01350557|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-02-02|||January 2005||2005-01-01|February 2017|2017-02-01|July 2010|Actual|2010-07-01|September 2005|Actual|2005-09-01||Interventional|||Three Care Models for Elderly Patients With Hip Fracture|Three Care Models for Elderly Patients With Hip Fracture|Completed||N/A|299|Actual|Chang Gung Memorial Hospital||3|||f||||t||||||||No||2017-10-11 04:15:49.393385|2017-10-11 04:15:49.393385
NCT01350544|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-04-07|2016-05-19||April 2013||2013-04-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|TA|One participant was administratively withdrawn from the intervention condition because it was found that she was ineligible (not on medications) after being randomized to the intervention.|Treatment Advocacy Intervention for HIV-Positive African Americans|Treatment Advocacy Intervention for HIV-Positive African Americans|Completed||N/A|216|Actual|Boston Children’s Hospital|We did not assess long-term effects, as the 6-month follow-up assessment occurred immediately after the last booster session. In addition, we did not assess the effects of the intervention on viral suppression.|2|||f||||f||||||||No||2017-10-11 04:15:49.497651|2017-10-11 04:15:49.497651
NCT01350531|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2011-05-06|||September 2009||2009-09-01|January 2011|2011-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Interventionist Procedures for Adherence to Weight Loss Recommendations in Black Adolescents|Interventionist Procedures for Adherence to Weight Loss Recommendations in Black Adolescents, Phase Two|Unknown status|Recruiting|N/A|200|Anticipated|Wayne State University||2|||f||||t||||||||||2017-10-11 04:15:50.227281|2017-10-11 04:15:50.227281
NCT01350518|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-08-30|||February 2011||2011-02-01|August 2017|2017-08-01|July 2018|Anticipated|2018-07-01|March 2013|Actual|2013-03-01||Interventional|DIVA-Pilot||Dietary Intervention for Visceral Adiposity|Dietary Intervention for Visceral Adiposity-Pilot|Active, not recruiting||N/A|30|Anticipated|Wake Forest University Health Sciences||4|||f||||t|f|f||||||||2017-10-11 04:15:50.375103|2017-10-11 04:15:50.375103
NCT01350505|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-03-30|||October 15, 2013|Actual|2013-10-15|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|January 31, 2017|Actual|2017-01-31||Interventional|||Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia|Toileting at Night in Older Adults: Light to Maximize Vision, Minimize Insomnia|Active, not recruiting||N/A|40|Anticipated|VA Office of Research and Development||5|||f||||f||||||||Yes|All relevant summary data is presented in a publication under review. Anonymized, individual participant data would be made available upon request and completion of necessary documentation.|2017-10-11 04:15:50.488282|2017-10-11 04:15:50.488282
NCT01350492|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-07-18|||April 16, 2013|Actual|2013-04-16|July 2017|2017-07-01|December 30, 2017|Anticipated|2017-12-30|August 29, 2017|Anticipated|2017-08-29||Interventional|||Impact of Exericse Training on Pain and Brain Function in Gulf War Veteans|Impact of Exercise Training on Pain and Brain Function in Gulf War Veterans|Recruiting||N/A|68|Anticipated|VA Office of Research and Development||2|||f||||f|f|f|||f|||||2017-10-11 04:15:50.67008|2017-10-11 04:15:50.67008
NCT01350479|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-09-06|2016-11-16||October 1, 2012|Actual|2012-10-01|September 2017|2017-09-01|November 1, 2016|Actual|2016-11-01|January 15, 2016|Actual|2016-01-15||Observational|||Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers|Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers|Completed||N/A|203|Actual|VA Office of Research and Development|||2||f||||f||||||Samples Without DNA|"     Swabs of the gowns and gloves of health care workers that interact with the participants will     be tested for MRSA and other types of bacteria. Swabs from body sites (e.g. nose) of     participants will be tested for MRSA and other types of bacteria.   "|||2017-10-11 04:15:50.789392|2017-10-11 04:15:50.789392
NCT01350466|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-05-06|||August 2011||2011-08-01|May 2011|2011-05-01|September 2013|Anticipated|2013-09-01|March 2013|Anticipated|2013-03-01||Observational|||Prospective Study Investigating the Role of Occupational Exposure on Sinus Surgery Outcome|Prospective Study Investigating the Role of Occupational Exposure on Sinus Surgery Outcome|Unknown status|Not yet recruiting|N/A|200|Anticipated|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||||||2017-10-11 04:15:51.08183|2017-10-11 04:15:51.08183
NCT01350440|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2013-07-19|||August 2011||2011-08-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia|Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia|Completed||Phase 2|5|Actual|University of South Florida||1|||f||||||||||||||2017-10-11 04:15:51.282979|2017-10-11 04:15:51.282979
NCT01350427|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2013-02-22|||August 2011||2011-08-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Branched-chain Amino Acids, and Resistance Exercise on Skeletal Muscle Signaling Pathways|Effects of Leucine, Branched-chain Amino Acids, and Resistance Exercise on Skeletal Muscle Remodelling Signaling Pathways: a Randomized, Double-blind, and Placebo-controlled Study|Completed||N/A|18|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-10-11 04:15:51.384368|2017-10-11 04:15:51.384368
NCT01350414|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-28|2016-08-03|2015-06-17||October 2005||2005-10-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|PAS1|AIR2 Extension Subjects Completing Follow-up at Year 1|AIR2 Extension Study to Demonstrate Longer-term (> 1 Year) Durability of Effectiveness|AIR2 Extension Study to Demonstrate Longer-term (> 1 Year) Durability of Effectiveness|Completed||N/A|181|Actual|Boston Scientific Corporation|||1||f||||t||||||||||2017-10-11 04:15:51.525364|2017-10-11 04:15:51.525364
NCT01350401|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2017-05-11|||May 2011||2011-05-01|May 2017|2017-05-01|May 2031|Anticipated|2031-05-01|March 2018|Anticipated|2018-03-01||Interventional|||Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma|Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma|Active, not recruiting||Phase 1/Phase 2|4|Actual|Adaptimmune||1|||f||||t||||||||||2017-10-11 04:15:52.613637|2017-10-11 04:15:52.613637
NCT01350388|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2016-08-09|2016-06-06||May 2011||2011-05-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease|Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease|Completed||N/A|80|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 04:15:52.709477|2017-10-11 04:15:52.709477
NCT01350375|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-05-06|||September 2009||2009-09-01|April 2011|2011-04-01||||||||Interventional|||Safety and Efficacy Study of Botox in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder|A Randomized Double-Blind Placebo Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Botulinum Neurotoxin Type A in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder|Unknown status|Recruiting|Phase 2/Phase 3|30|Anticipated|The Research Center of Southern California||2|||f||||f||||||||||2017-10-11 04:15:53.165799|2017-10-11 04:15:53.165799
NCT01350362|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2012-10-01|||April 2011||2011-04-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|ARGO||Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients|A Multicenter, Randomized, Double-blind, Placebo-controlled, 4-arm, 26 Week Parallel-Group Study to Evaluate Efficacy, Safety and Tolerability of 2 Oral Doses and 2 Regimes of Tideglusib vs Placebo in Mild-to-Moderate AD Patients|Completed||Phase 2|306|Actual|Noscira SA||4|||f||||t||||||||||2017-10-11 04:15:53.26147|2017-10-11 04:15:53.26147
NCT01350349|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-01-10|||April 2011||2011-04-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Home-delivered Intervention for Depressed, Cognitively Impaired Elders|Home-delivered Intervention for Depressed, Cognitively Impaired Elders|Recruiting||N/A|176|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-10-11 04:15:53.604425|2017-10-11 04:15:53.604425
NCT01350336|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2017-06-29|||April 2011||2011-04-01|June 2017|2017-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|PAS2||Bronchial Thermoplasty in Severe Persistent Asthma|Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma|Active, not recruiting||N/A|284|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-10-11 04:15:53.705943|2017-10-11 04:15:53.705943
NCT01350323|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2011-05-06|||May 2009||2009-05-01|March 2009|2009-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization|Aqueous Humor Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Bevacizumab in Type 3 Versus Type 1 and 2 Neovascularization. A Prospective, Case-control Study.|Completed||N/A|33|Actual|University of Molise||4|||f||||f||||||||||2017-10-11 04:15:53.848894|2017-10-11 04:15:53.848894
NCT01350310|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2015-04-05|||March 2011||2011-03-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|NOGA-DCM||Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy|Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy|Completed||Phase 2|110|Actual|University Medical Centre Ljubljana||3|||f||||f||||||||||2017-10-11 04:15:53.940994|2017-10-11 04:15:53.940994
NCT01350297|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-02|2013-06-17|||March 2010||2010-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|TETRADIA-UNI||Diaphragmatic Reinnervation of Tetraplegic Patients With Respiratory Insufficiency|Phrenic Reinnervation in Central Ventilatory Paralysis Due to Medullary Trauma With Phrenic Motoneuron Destruction|Completed||Phase 4|5|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-10-11 04:15:54.02611|2017-10-11 04:15:54.02611
NCT01350284|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2011-05-06|||June 2009||2009-06-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|July 2009|Actual|2009-07-01||Interventional|CinnGastEmpt||The Effect of Natural Food Flavourings on Gastrointestinal and Cardiovascular Physiological Responses.|Effect of Cinnamon on Gastric Emptying, Arterial Stiffness, Postprandial Lipaemia, Glycaemia, and Appetite Responses to High-fat Breakfast|Completed||N/A|9|Actual|University of Limerick||1|||f||||f||||||||||2017-10-11 04:15:54.130548|2017-10-11 04:15:54.130548
NCT01350271|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2013-04-18|2011-08-23||May 2011||2011-05-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||All those found positive for hookworm infection, from among the population screened at baseline|Comparative Efficacy of Different Mebendazole Polymorphs in the Treatment of Soil-transmitted Helminth Infections|Comparative Efficacy of Different Mebendazole Polymorphs in the Treatment of Soil-transmitted Helminth Infections|Completed||Phase 3|214|Actual|University of Kelaniya|Small sample size owing to limitation in available funds.|3|||f||||f||||||||||2017-10-11 04:15:54.240818|2017-10-11 04:15:54.240818
NCT01349543|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2015-06-03|||May 2011||2011-05-01|June 2012|2012-06-01|September 2014|Actual|2014-09-01|October 2013|Actual|2013-10-01||Interventional|||The Development of a Human Model of Respiratory Syncytial Virus Infection|The Development of a Human Model of Respiratory Syncytial Virus Infection|Completed||N/A|40|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 04:16:14.441863|2017-10-11 04:16:14.441863
NCT01350258|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2016-11-28|2014-10-21||April 2011||2011-04-01|October 2016|2016-10-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|||Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps|A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies Using Melphalan for T-Cell Tolerization|Terminated||Phase 1/Phase 2|8|Actual|Thomas Jefferson University|Study was terminated due to extreme toxicity. The study was closed before any data could be collected.|1||Poor accrual|f||||t||||||||||2017-10-11 04:15:54.845177|2017-10-11 04:15:54.845177
NCT01350245|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2016-10-19|2014-10-07||July 2010||2010-07-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor|A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies in Remission From HLA Partially-Matched Related Donors|Completed||Phase 2|28|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 04:15:55.507334|2017-10-11 04:15:55.507334
NCT01350232|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2016-10-19|2014-11-13||September 2009||2009-09-01|October 2016|2016-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Treatment of Sickle Cell Anemia With Stem Cell Transplant|Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia From HLA Matched or Partially-Matched Related Donors|Terminated||N/A|2|Actual|Thomas Jefferson University|Study was terminated due to poor accrual. No reportable data has been collected.|1||Poor accrual|f||||t||||||||||2017-10-11 04:15:56.139228|2017-10-11 04:15:56.139228
NCT01350219|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-11-25|||September 2010||2010-09-01|November 2013|2013-11-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Stem Cell Educator Therapy in Type 1 Diabetes|Phase 2 Study of Stem Cell Educator Therapy in Type 1 Diabetes|Unknown status|Recruiting|Phase 2|100|Anticipated|Tianhe Stem Cell Biotechnologies Inc.||1|||f||||t||||||||||2017-10-11 04:15:56.498938|2017-10-11 04:15:56.498938
NCT01350206|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2011-05-06|||April 2010||2010-04-01|April 2010|2010-04-01|May 2013|Anticipated|2013-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis|Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis.A Prospective and Randomized Clinical Trial|Unknown status|Recruiting|Phase 4|180|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-10-11 04:15:56.645357|2017-10-11 04:15:56.645357
NCT01350193|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-12-02|||June 2011||2011-06-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Manuka Honey Irrigation After Sinus Surgery|Manuka Honey Irrigation After Endoscopic Sinus Surgery|Completed||Phase 1/Phase 2|78|Actual|St. Paul's Hospital, Canada||2|||f||||f||||||||||2017-10-11 04:15:56.74742|2017-10-11 04:15:56.74742
NCT01350180|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2017-03-16|||September 2010||2010-09-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis|A Prospective Study Assessing the Predictive Value of TMPRSS2-ERG Gene Fusion and PTEN Deletion in High Risk Prostate Cancer Patients|Recruiting||N/A|132|Anticipated|Sir Mortimer B. Davis - Jewish General Hospital|||1||f||||f||||||||||2017-10-11 04:15:56.869162|2017-10-11 04:15:56.869162
NCT01350167|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2011-05-23|||November 2001||2001-11-01|December 2010|2010-12-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease|Screening for Hepatocellular Carcinoma With Triphasic Helical CT vs. US With Alpha-fetoprotein in Patients With Advanced Liver Disease|Recruiting||N/A|300|Anticipated|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-11 04:15:56.969788|2017-10-11 04:15:56.969788
NCT01350154|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-04-09|||November 2011||2011-11-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients|Does Modulation of the nNOS System in Patients With Muscular Dystrophy and Defect nNOS Signalling Affect Cardiac, Muscular or Cognitive Function?|Completed||Phase 2|17|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-10-11 04:15:57.062896|2017-10-11 04:15:57.062896
NCT01350128|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-05-08|2017-05-08|2013-05-16|May 2011||2011-05-01|April 2017|2017-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||Intent-to-Treat (ITT) Population includes all subjects who were randomized, received at least 1 dose of study treatment, and had both baseline and post-baseline efficacy data for that treatment.|PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-Blind, Chronic Dosing (7 Days), Three-Period, Six-Treatment, Placebo-Controlled, Incomplete Block, Cross-Over, Multi-Center Study to Assess Efficacy and Safety of Four Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Atrovent® HFA Inhalation Aerosol (Open-Label) as An Active Control|Completed||Phase 2|103|Actual|Pearl Therapeutics, Inc.||6|||f||||f||||||||||2017-10-11 04:15:57.317484|2017-10-11 04:15:57.317484
NCT01350115|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2015-09-23|2015-08-18||April 2011||2011-04-01|September 2015|2015-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)|A Phase II, Double-blind, Randomized, Proof-of-Concept, Dose-ranging Trial Evaluating the Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Adult Patients With Nevoid Basal Cell Carcinoma Syndrome|Completed||Phase 2|10|Actual|Novartis||2|||f||||f||||||||||2017-10-11 04:15:58.108499|2017-10-11 04:15:58.108499
NCT00000195|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-05-05|||January 1993||1993-01-01|August 2015|2015-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 4 - 4|Neurobiology of Opioid Dependence: 4|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-10-11 04:17:38.193284|2017-10-11 04:17:38.193284
NCT01350089|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-05-06|||January 2011||2011-01-01|May 2011|2011-05-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Possible Effects of Energy Drink Ingestion on Perceived Alcohol Intoxication|A Double Blind, Randomised, Placebo-controlled, Within-subject Crossover Study to Examine the Possible Effects of Energy Drink Ingestion on Perceived Alcohol Intoxication|Unknown status|Active, not recruiting|N/A|52|Anticipated|Medical University of Vienna||4|||f||||f||||||||||2017-10-11 04:15:58.679942|2017-10-11 04:15:58.679942
NCT01350076|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-30|2011-05-06|||October 2011||2011-10-01|May 2011|2011-05-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Interventional|GDT||Liberal Versus Goal-directed Intraoperative Fluid Therapy in Pediatric Patients|Liberal VS Goal-directed Intraoperative Fluid Therapy in Pediatric Patients|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Mahidol University||2|||f||||f||||||||||2017-10-11 04:15:58.761869|2017-10-11 04:15:58.761869
NCT01350063|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-01-01|||February 2011||2011-02-01|May 2011|2011-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Health Impact of Treating and Safely Storing Shallow Tubewell Drinking Water|Health Impact of Treating and Safely Storing Shallow Tubewell Drinking Water|Completed||N/A|1800|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||t||||||||||2017-10-11 04:15:58.838206|2017-10-11 04:15:58.838206
NCT01350050|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2012-07-04|||September 2009||2009-09-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Topical Pharyngeal Anesthesia With Articaine for Gastroscopy|Topical Pharyngeal Anaesthesia With Articaine for Gastroscopy. A Randomized Double-blind Study on Volunteers|Completed||Phase 4|18|Actual|Helsinki University Central Hospital||2|||f||||f||||||||||2017-10-11 04:15:58.906465|2017-10-11 04:15:58.906465
NCT01350037|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2012-07-04|||June 2009||2009-06-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)|Alfentanil vs Remifentanil in Patient-controlled Sedation During ERCP.A Randomized Double-blind Study|Completed||Phase 4|81|Actual|Helsinki University Central Hospital||3|||f||||f||||||||||2017-10-11 04:15:59.087691|2017-10-11 04:15:59.087691
NCT01350024|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-05-24|||May 1, 2011|Actual|2011-05-01|May 2017|2017-05-01|July 30, 2016|Actual|2016-07-30|July 30, 2016|Actual|2016-07-30||Interventional|||Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid|Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid|Completed||N/A|34|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 04:15:59.195875|2017-10-11 04:15:59.195875
NCT01350011|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2014-12-08|||April 2011||2011-04-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|March 2015|Anticipated|2015-03-01||Interventional|IBIS||Tobacco Intervention in Buprenorphine Treatment|Extended Tobacco Dependence Intervention in Buprenorphine Treatment|Unknown status|Active, not recruiting|Phase 3|175|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 04:15:59.291297|2017-10-11 04:15:59.291297
NCT01349998|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-01-22||2013-01-22|May 2011||2011-05-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis|An Open-Label Study to Evaluate the Safety of Long-Term Administration of Product 33525 in Subjects With Tinea Pedis, Tinea Corporis, or Tinea Cruris|Completed||Phase 3|604|Actual|Tinea Pharmaceuticals||1|||f||||f||||||||||2017-10-11 04:15:59.385993|2017-10-11 04:15:59.385993
NCT01349985|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2014-05-09|||July 2011||2011-07-01|May 2014|2014-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|AGATE||Adaptive Goal-Directed Adherence Tracking and Enhancement|"SBIR-PhaseII, Adaptive Goal-Directed Adherence Tracking and Enhancement"|Completed||Phase 2|136|Actual|Talaria, Inc||2|||f||||f||||||||||2017-10-11 04:15:59.549007|2017-10-11 04:15:59.549007
NCT01349972|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2017-07-03|2015-09-04||April 2011||2011-04-01|July 2017|2017-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|"Randomized Phase II Trial of Timed Sequential Therapy (TST) With Alvocidib (Flavopiridol), Ara-C and Mitoxantrone (FLAM) vs. 7+3 for Adults Age 70 and Under With Newly Diagnosed Acute Myelogenous Leukemia (AML)"|Completed||Phase 2|172|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:15:59.659496|2017-10-11 04:15:59.659496
NCT01349959|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2016-12-28|2016-02-19||April 2011||2011-04-01|December 2016|2016-12-01||||March 2014|Actual|2014-03-01||Interventional|||Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer|Phase II Study of Azacitidine and Entinostat (SNDX-275) in Patients With Advanced Breast Cancer|Active, not recruiting||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:16:00.392959|2017-10-11 04:16:00.392959
NCT01349946|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-04-12|||June 2008||2008-06-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|||Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)|Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)|Completed||N/A|138|Actual|Stanford University|||1||f||||||||||||||2017-10-11 04:16:00.700048|2017-10-11 04:16:00.700048
NCT01349933|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-06|2014-12-23|2014-12-23||April 2011||2011-04-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:16:00.811914|2017-10-11 04:16:00.811914
NCT01349920|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-08-04|2016-08-04||November 2012||2012-11-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)|An Open Label Study to Discover Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (CD)|Completed||N/A|15|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||Samples With DNA|"     stool, serum, peripheral blood mononuclear cells (PBMC)   "|||2017-10-11 04:16:01.184714|2017-10-11 04:16:01.184714
NCT01349907|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-09-13|2015-02-24||June 2011||2011-06-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|ADDRESS-98|Participants who received at least one dose of trial medication, and were 17 years old or younger. One 18 year old participant from the Placebo/Asenapine group, was excluded due to being overage.|Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)|A 50-Week Open-Label, Flexible-Dose Trial of Asenapine Extension Treatment to P06107 in Pediatric Subjects With Acute Manic or Mixed Episodes Associated With Bipolar I Disorder|Completed||Phase 3|322|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 04:16:01.648172|2017-10-11 04:16:01.648172
NCT01349894|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2012-12-11|||August 2011||2011-08-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)|Post-Market Clinical Evaluation of the Spiracur SNaP™ Wound Care System for Treatment of Skin Cancer Excision Sites and Split Thickness Skin Grafts|Completed||N/A|7|Actual|Spiracur, Inc.|||1||f||||f||||||||||2017-10-11 04:16:02.374457|2017-10-11 04:16:02.374457
NCT01349881|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-07-13|||March 2013||2013-03-01|July 2017|2017-07-01|June 2029|Anticipated|2029-06-01|June 2024|Anticipated|2024-06-01||Interventional|PACES||S0820, Adenoma and Second Primary Prevention Trial|A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)|Recruiting||Phase 3|1340|Anticipated|Southwest Oncology Group||4|||f||||t||||||||||2017-10-11 04:16:02.727169|2017-10-11 04:16:02.727169
NCT01349868|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2012-09-10||2012-09-10|May 2011||2011-05-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||PT005 MDI Dose Ranging Versus Foradil Aerolizer Study|A Randomized, Double-Blind, Single Dose, Six-Treatment, Placebo-Controlled, Cross-Over, Multi-Center Study to Assess Efficacy and Safety of Three Doses of PT005, in Patients With Moderate to Severe COPD, Compared With Foradil® Aerolizer® (12 and 24 µg Open-Label) as Active Controls|Completed||Phase 2|50|Actual|Pearl Therapeutics, Inc.||6|||f||||f||||||||||2017-10-11 04:16:09.206386|2017-10-11 04:16:09.206386
NCT01349855|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-15|2011-05-31|||March 2011||2011-03-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus|A Randomized, Double-blind, 2x2 Cross-over Euglycemic Clamp Study in Two Parallel Cohorts to Assess the Safety and Tolerability of Two Dose Levels of a New Formulation of Insulin Glargine and to Compare Its Pharmacodynamic and Pharmacokinetic Properties With 0.4 U/kg/Day Lantus® in an 8-days Multiple Dosing Regimen in Patients With Diabetes Mellitus Type 1|Completed||Phase 1|30|Anticipated|Sanofi||2|||f||||f||||||||||2017-10-11 04:16:09.33313|2017-10-11 04:16:09.33313
NCT01349842|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-08-01|||January 2010||2010-01-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|CirCé01||Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer|CirCe01 Study: Evaluation of the Use of Circulating Tumour Cells to Guide Chemotherapy From the 3rd Line of Chemotherapy for Metastatic Breast Cancer|Active, not recruiting||Phase 3|265|Actual|Institut Curie||2|||f||||f||||||||No||2017-10-11 04:16:09.435082|2017-10-11 04:16:09.435082
NCT01349829|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2013-10-25|2013-10-25||March 2010||2010-03-01|August 2013|2013-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children|A Phase IV Open, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of a Pediatric Presentation (0.25 ml) of the Virosomal Hepatitis A Virus (HAV) Vaccine HAVpur in Healthy Young Children Aged Between and Including 18 Months to 47 Months, Using a 0/6 Month Immunization Schedule|Completed||Phase 4|251|Actual|Crucell Holland BV||2|||f||||f||||||||||2017-10-11 04:16:09.559105|2017-10-11 04:16:09.559105
NCT01349816|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-04-26|2016-05-21|2013-05-16|June 2011||2011-06-01|April 2017|2017-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||Analysis population included all randomized subjects|PT003 MDI Dose Confirmation Study|A Randomized, Double Blind, Chronic Dosing (7 Days), Two Period, Six Treatment, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Four Doses of PT003 MDI in Patients With Moderate to Severe COPD, Compared With Its Individual Components (PT005 MDI and PT001 MDI) as Active Controls|Completed||Phase 2|185|Actual|Pearl Therapeutics, Inc.||6|||f||||f||||||||||2017-10-11 04:16:10.123211|2017-10-11 04:16:10.123211
NCT01349803|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-12-07|2016-05-24|2013-05-16|May 2011||2011-05-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||Safety Population (all randomized subjects)|PT003 MDI Cardiovascular Safety Study|A Randomized, Double-blind, Parallel Group, 14-day, Multi-Center Study to Evaluate the Safety of PT003, PT005, PT001 and Foradil® Aerolizer® (12 µg, Open Label) as Evaluated by Holter Monitoring, in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|237|Actual|Pearl Therapeutics, Inc.||4|||f||||f||||||||||2017-10-11 04:16:10.837492|2017-10-11 04:16:10.837492
NCT01349790|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-05-04|2017-03-22|2015-06-05|October 2011||2011-10-01|May 2017|2017-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Safety set: All participants enrolled in the study who received at least part of 1 dose of NewGam.|Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia|Prospective, Open-label, Non-controlled, Multicenter, Phase III Clinical Study to Evaluate the Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia|Completed||Phase 3|40|Actual|Octapharma||1|||f||||t||||||||||2017-10-11 04:16:12.123171|2017-10-11 04:16:12.123171
NCT01349777|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2017-06-15|||March 15, 2010|Actual|2010-03-15|June 2017|2017-06-01|March 14, 2017|Actual|2017-03-14|March 14, 2017|Actual|2017-03-14||Interventional|||Effectiveness of Clopidogrel Resinate in PCI(PRIDE)|Effectiveness of Clopidogrel Resinate(PRegrel®) in Patients Undergoing Percutaneous Coronary Intervention Compared With ClopiDogrEl Bisulfate(Plavix®)|Completed||Phase 4|1056|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||No|This is not a publicly funded trial.|2017-10-11 04:16:12.649299|2017-10-11 04:16:12.649299
NCT01349764|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-05-04|||April 2011||2011-04-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Effect of Vitamin D Replacement in Patients With Urolithiasis|Effect of Vitamin D Replacement in Vitamin D Deficient Patients With History of Urolithiasis: A Randomized Controlled Trial|Terminated||N/A|10|Actual|McGill University Health Center|||2|Unable to recruit required sample size|f||||t||||||||||2017-10-11 04:16:12.793122|2017-10-11 04:16:12.793122
NCT01349751|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2013-11-05|||January 2007||2007-01-01|November 2013|2013-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Clinical Characteristics of Spinal Levobupivacaine: Hyperbaric Compared With Isobaric Solution|Clinical Characteristics of Spinal Levobupivacaine: Hyperbaric Compared With Isobaric Solution|Completed||N/A|20|Actual|Mahidol University||2|||f||||t||||||||||2017-10-11 04:16:12.915095|2017-10-11 04:16:12.915095
NCT01349530|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-01-03|||May 2011||2011-05-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|CREATIF||Evaluating of CREATIF an Anti-coagulation Clinic|Evaluating of the Benefit to the Patient by Managing of His Anticoagulation Treatment by an Anti-coagulation Clinic|Completed||N/A|110|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 04:16:14.51538|2017-10-11 04:16:14.51538
NCT01349738|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-08-31|||May 2011||2011-05-01|August 2011|2011-08-01|May 2013|Anticipated|2013-05-01|||||Observational|ASB||Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants|Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Rice, James C., M.D.|||2||f||||t||||||Samples Without DNA|"     The investgators have a repository of bacteria specimens from transplant patients with UTI     and plan to save bacteria from this study. The investigators will also plan to save discarded     aliquots of supernatent of urine and discarded aliquots of blood, all samples from     centrifuged specimens devoid of human cells.   "|||2017-10-11 04:16:13.039911|2017-10-11 04:16:13.039911
NCT01349725|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2011-10-19|||May 2011||2011-05-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Safety Study of ARRY-502 in Healthy Subjects||Completed||Phase 1|32|Actual|Array BioPharma||2|||f||||f||||||||||2017-10-11 04:16:13.171524|2017-10-11 04:16:13.171524
NCT01349699|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2015-11-16|||February 2010||2010-02-01|November 2015|2015-11-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||Effects of Iron Loading and Iron Chelation Therapy on Innate Immunity During Human Endotoxemia|Effects of Iron Loading and Iron Chelation Therapy on Innate Immunity During Human Endotoxemia|Completed||N/A|30|Actual|Radboud University||3|||f||||t||||||||||2017-10-11 04:16:13.307339|2017-10-11 04:16:13.307339
NCT01349686|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2013-02-17|||September 2011||2011-09-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Fluid Oral Intake During Labour|Fluid Oral Intake vs. Fasting During Labour: A Randomized, Controlled Trial.|Completed||N/A|348|Actual|Saint Thomas Hospital, Panama||2|||f||||f||||||||||2017-10-11 04:16:13.397772|2017-10-11 04:16:13.397772
NCT01349673|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-01-26|||June 2011||2011-06-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|||The Safety and Tolerability of Budesonide Foam in Subjects With Active Ulcerative Proctitis or Proctosigmoiditis|A Phase 3, Open Label, Multicenter Study to Assess the Safety and Tolerability of Budesonide Foam in Subjects With Active Ulcerative Proctitis or Proctosigmoiditis|Completed||Phase 3|114|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-10-11 04:16:13.469052|2017-10-11 04:16:13.469052
NCT01349660|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2017-10-03|||December 2011||2011-12-01|October 2017|2017-10-01|February 2018|Anticipated|2018-02-01|December 2016|Actual|2016-12-01||Interventional|||Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme|Phase I/II Study of the Combination of BKM120 and Bevacizumab in Patients With Refractory Solid Tumors (Phase I) and Relapsed/Refractory Glioblastoma Multiforme (Phase II)|Active, not recruiting||Phase 1/Phase 2|88|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 04:16:13.546747|2017-10-11 04:16:13.546747
NCT01349647|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-01-04|||May 2011||2011-05-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid|Immunization of Small Cell Lung Cancer Patients With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid|Completed||Phase 1|21|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 04:16:13.641072|2017-10-11 04:16:13.641072
NCT01349634|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2016-06-08|||October 2011||2011-10-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effects of Iodized Salt on Cognitive Development in Ethiopia|A Study to Measure the Effect of Switching the Salt Supply From Non-iodized to Iodized on Cognitive Development in Ethiopia|Completed||N/A|5704|Actual|McGill University||2|||f||||f||||||||||2017-10-11 04:16:13.721764|2017-10-11 04:16:13.721764
NCT01349621|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2015-03-09|||April 2011||2011-04-01|September 2012|2012-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Clinical Evaluation of Polarized Light Assisted Colposcopy|Clinical Evaluation of Polarized Light Assisted Colposcopy|Completed||N/A|330|Actual|Augusta University|||1||f||||f||||||||||2017-10-11 04:16:13.799531|2017-10-11 04:16:13.799531
NCT01349608|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2013-04-01|||April 2011||2011-04-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|PACC||Physical Activity Coaching in Chronic Obstructive Pulmonary Disease (COPD)|Physical Activity Coaching in COPD|Completed||N/A|50|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 04:16:13.872498|2017-10-11 04:16:13.872498
NCT01349595|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2015-10-05|2015-08-10||December 2011||2011-12-01|October 2015|2015-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation|Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation|Terminated||Phase 2|4|Actual|Mayo Clinic|Although subjects completed the cycles of drug, long term follow-up visits were not possible due to funding discontinuation.|2||Study halted due to lack of funding|f||||t||||||||||2017-10-11 04:16:13.943212|2017-10-11 04:16:13.943212
NCT01349582|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-08-01|||May 2, 2011|Actual|2011-05-02|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|FIAT||Flow Diversion in Intracranial Aneurysm Treatment|A Randomized Trial Comparing Flow Diversion and Best-standard Treatment - the FIAT Trial|Recruiting||Phase 4|344|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||3|||f||||f||||||||||2017-10-11 04:16:14.186412|2017-10-11 04:16:14.186412
NCT01349569|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-10-12|||January 2012||2012-01-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission|Administration of an Allogeneic Myeloma GM-CSF Vaccine in Conjunction With a Lenalidomide Containing Regimen in Myeloma Patients With Near Complete Remission|Completed||Phase 2|18|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:16:14.294857|2017-10-11 04:16:14.294857
NCT01349556|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2014-04-21|||May 2011||2011-05-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream|Prevention of Epidermal Growth Factor Receptor Inhibitor-Associated Dermatologic Toxicities by Pre-treatment With Topical Tretinoin|Withdrawn||N/A|0|Actual|Johns Hopkins University||1||Study withdrawn due to volunteer disinterest in participating.|f||||||||||||||2017-10-11 04:16:14.37509|2017-10-11 04:16:14.37509
NCT01349517|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2011-11-10|||May 2011||2011-05-01|January 2011|2011-01-01|December 2016|Anticipated|2016-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Health-related Quality of Life of Patients With Esophageal Cancer After Surgery|Health-related Quality of Life of Patients With Esophageal Cancer After Surgery in China: A Prospective Cohort Study From Multi-center|Unknown status|Not yet recruiting|Phase 2|400|Anticipated|Fudan University||4|||f||||t||||||||||2017-10-11 04:16:14.739402|2017-10-11 04:16:14.739402
NCT01349504|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2013-08-16|||April 2011||2011-04-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease|Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease|Completed||N/A|106|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-11 04:16:14.823191|2017-10-11 04:16:14.823191
NCT01349491|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2017-03-16|2017-01-10||March 2012||2012-03-01|March 2017|2017-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|GILEAD||Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion|Ranolazine for the Prevention of Recurrent Persistent Atrial Fibrillation After Electrical Cardioversion: A Pilot Study|Terminated||Phase 3|10|Actual|University of Oklahoma||2||low recruitement rates|f||||t||||||||Undecided||2017-10-11 04:16:14.917175|2017-10-11 04:16:14.917175
NCT01349478|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-12-26|||May 2011||2011-05-01|December 2016|2016-12-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||The Effects of Passive Gait Training in Complete Motor Spinal Cord Injury (SCI)|Electrical Stimulation Induced Lower Limb Exercise Capacity, Cardiorespiratory Response, Cardiovascular Risk Factors and Muscle Activity Patterns in Response to Robotic Assisted Treadmill Gait Training in Individuals With Complete Motor Spinal Cord Injury|Completed||Phase 1/Phase 2|11|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 04:16:15.226855|2017-10-11 04:16:15.226855
NCT01349465|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2017-03-10|2016-12-23||July 4, 2011|Actual|2011-07-04|March 2017|2017-03-01|January 5, 2016|Actual|2016-01-05|January 5, 2016|Actual|2016-01-05||Interventional|||3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection|A Prospective 3-Year Follow-up Study in Subjects Previously Treated in a Phase IIb or Phase III Study With a TMC435-Containing Regimen for the Treatment of Hepatitis C Virus (HCV) Infection|Completed||Phase 3|249|Actual|Janssen R&D Ireland||2|||f||||f||||||||||2017-10-11 04:16:15.405062|2017-10-11 04:16:15.405062
NCT01349452|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2011-05-05|||August 2009||2009-08-01|April 2011|2011-04-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis|Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis|Completed||N/A|33|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-10-11 04:16:16.064813|2017-10-11 04:16:16.064813
NCT01349439|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-31|2014-06-23|||March 2011||2011-03-01|June 2014|2014-06-01||||January 2015|Anticipated|2015-01-01||Interventional|||Reducing Reconsolidation of Trauma Memories With Propranolol|Reduction of the Reconsolidation of the Trauma Memory With Propranolol|Unknown status|Recruiting|Phase 2|76|Anticipated|Douglas Mental Health University Institute||5|||f||||f||||||||||2017-10-11 04:16:16.167161|2017-10-11 04:16:16.167161
NCT01349426|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-07-27|||September 2010||2010-09-01|July 2015|2015-07-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Ligasure II: Standard Stapling Versus Ligasure|Standard Stapling Technique Versus Bipolar Fusion (With The Ligasure Impact and Force Triad Generator) To Complete The Fissure During Major Lung Resection: A Prospective Randomized Controlled Trial|Terminated||Phase 3|172|Actual|Centre Hospitalier Universitaire de Saint Etienne||2||diffculty to include patients|f||||f||||||||||2017-10-11 04:16:16.297943|2017-10-11 04:16:16.297943
NCT01349413|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-04-20|||August 2011||2011-08-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|BD||BRAVO Study for Functional Dyspepsia|Role of Gastroesophageal Acid Reflux at Squamo-columnar Junction in Functional Dyspepsia|Recruiting||Phase 4|130|Anticipated|Chinese University of Hong Kong||2|||f||||||||||||No||2017-10-11 04:16:16.423077|2017-10-11 04:16:16.423077
NCT01349400|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2015-08-14|||November 2011||2011-11-01|August 2015|2015-08-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|AWARE||Watchful Waiting Versus Repair of Oligosymptomatic Incisional Hernias|Watchful Waiting vs. Repair of Oligosymptomatic Incisional Hernias|Recruiting||Phase 3|636|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 04:16:16.524001|2017-10-11 04:16:16.524001
NCT01349387|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2012-02-08|||May 2011||2011-05-01|May 2011|2011-05-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|METFORGENE||Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing|Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing Whose Maturation Depends on the Protein HuR, Including Gene Encoding Insulin Receptor|Completed||N/A|25|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||1|||f||||f||||||||||2017-10-11 04:16:16.623882|2017-10-11 04:16:16.623882
NCT01349374|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2012-07-11|||January 2011||2011-01-01|May 2011|2011-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Skin Samples of Diabetic Patients and Healthy Volunteers Collection|Study Aiming to Collect Skin Samples of Diabetic Patients and Healthy Volunteers for Cellular Reprogramming, Within the Framework of New Therapeutic Strategies in Diabetes Treatment|Terminated||N/A|80|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||4|||f||||f||||||||||2017-10-11 04:16:16.709723|2017-10-11 04:16:16.709723
NCT01349361|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2011-05-05|||March 2011||2011-03-01|March 2011|2011-03-01||||January 2013||2013-01-01||Interventional|||Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight|Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight|Unknown status|Recruiting|Phase 2|||Bispebjerg Hospital||1|||f||||||||||||||2017-10-11 04:16:16.785437|2017-10-11 04:16:16.785437
NCT01349348|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2012-10-10|||October 2010||2010-10-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites|A Randomized, Double-blinded, Multicenter, Placebo Controlled, Parallel Designed Study, to Evaluate the Efficacy and Safety of Tolvaptan Tablet in Treatment of Patients With Cirrhosis Ascites, Using Diuretics as Initial Treatment|Completed||Phase 3|535|Actual|Otsuka Beijing Research Institute||3|||f||||f||||||||||2017-10-11 04:16:16.921447|2017-10-11 04:16:16.921447
NCT01348971|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-09-24|||March 2011||2011-03-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|CABANOS||Coronary Artery Bypass and Nitrate Oral Supplementation|Effects of Oral Nitrate During Coronary Artery Bypass Surgery|Completed||Phase 2|100|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-10-11 04:16:23.043077|2017-10-11 04:16:23.043077
NCT01349335|ClinicalTrials.gov processed this data on October 10, 2017|2010-03-05|2012-10-10|||April 2009||2009-04-01|May 2011|2011-05-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites|A Phase 2 Randomized, Double-blinded, Multicenter and Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Different Doses of Tolvaptan Tablet in Patients With Cirrhotic Ascites|Completed||Phase 2|180|Actual|Otsuka Beijing Research Institute||3|||f||||f||||||||||2017-10-11 04:16:17.055005|2017-10-11 04:16:17.055005
NCT01349322|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2017-05-18|||May 2011|Actual|2011-05-01|May 2017|2017-05-01||||August 2020|Anticipated|2020-08-01||Interventional|||Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery|A Phase III Trial of Accelerated Whole Breast Irradiation With Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer|Active, not recruiting||Phase 3|2354|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:16:17.19552|2017-10-11 04:16:17.19552
NCT01349309|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-28|2015-12-03|||June 2007||2007-06-01|December 2015|2015-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||The Effect of Prophylactic Swallowing Exercises on Head and Neck Cancer Patients|The Effect of Prophylactic Swallowing Exercises on Head and Neck Cancer Patients|Completed||N/A|26|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 04:16:18.247447|2017-10-11 04:16:18.247447
NCT01349296|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2016-05-19|||July 2012||2012-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|October 2014|Actual|2014-10-01||Interventional|BARIS||BIBF 1120 and RAD001 in Solid Tumors - Phase I|BARIS - BIBF1120 and RAD001 in Solid Tumors. A Phase I Trial to Evaluate the Safety and Tolerability of Combined BIBF 1120 and RAD001 in Solid Tumors and to Determine the Maximum Tolerated Dose (MTD) of the Combination|Completed||Phase 1|18|Actual|University of Cologne||1|||f||||t||||||||||2017-10-11 04:16:18.377557|2017-10-11 04:16:18.377557
NCT01349283|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2014-03-03|||May 2011||2011-05-01|January 2013|2013-01-01|November 2013|Actual|2013-11-01|November 2012|Actual|2012-11-01||Interventional|||Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns|A Prospective, Randomized, Double-blind, Parallel-group, Controlled Study of the Immunogenicity and Safety of the Recombinant Hepatitis B Vaccine (Hepavax-Gene TF) and a Comparator Univalent Hepatitis B Vaccine in Neonates|Completed||Phase 3|1738|Actual|Crucell Holland BV||6|||f||||f||||||||||2017-10-11 04:16:18.46622|2017-10-11 04:16:18.46622
NCT01349270|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-05|2014-09-25|||June 2004||2004-06-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PRNC||Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg|Multicentre Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg in Patients With Chronic Inflammatory Demyelinating Polyneuropathy on a One Year Follow up|Completed||Phase 3|40|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-10-11 04:16:18.567099|2017-10-11 04:16:18.567099
NCT01349257|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2017-03-28|||May 2011||2011-05-01|March 2017|2017-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI|Study Title: A Single-dose, Open-label, Randomised, 2-way Crossover, Clinical Pharmacology Study of Four Inhalations of CHF 1535 100/6 NEXT DPI® (Fixed Combination of Beclomethasone Diproponate 100 µg Plus Formoterol Fumarate 6 µg) Versus the Same Dose of CHF 1535 100/6 pMDI Both Administered With Charcoal Block.|Completed||Phase 2|24|Actual|Chiesi Farmaceutici S.p.A.||1|||f||||f||||||||||2017-10-11 04:16:18.669521|2017-10-11 04:16:18.669521
NCT01349244|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2014-07-08|||September 2010||2010-09-01|July 2014|2014-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic|Correlation of Hydronephrosis on Point of Care Ultrasound With CT Finding in Patients With Expected Renal Colic|Completed||N/A|97|Actual|Yale University|||1||f||||f||||||||||2017-10-11 04:16:18.769474|2017-10-11 04:16:18.769474
NCT01349231|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-09|2014-05-08|2014-03-04||February 2009||2009-02-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Ketamine Infusion for Obsessive-Compulsive Disorder|Ketamine Infusion for Obsessive-Compulsive Disorder|Completed||Phase 2|10|Actual|Yale University||1|||f||||f||||||||||2017-10-11 04:16:18.861069|2017-10-11 04:16:18.861069
NCT01349218|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2016-05-12|||March 2014||2014-03-01|May 2016|2016-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|PS||Relationship Between Potassium Level in Venous Blood Samples Drawn and Heel Sticks In Infants and Newborns|In Infants and Newborns, is There a Relation Between the Potassium Level in Blood Samples Drawn From a Vein and Those Drawn From a Heel Stick?|Completed||N/A|31|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 04:16:19.141675|2017-10-11 04:16:19.141675
NCT01349205|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2016-05-12|||March 2010||2010-03-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study|Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study|Terminated||N/A|42|Actual|The University of Texas Health Science Center, Houston||3||The study medication was no longer available in the market|f||||t||||||||||2017-10-11 04:16:19.239835|2017-10-11 04:16:19.239835
NCT01349192|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-04-05|2016-11-02||April 2011|Actual|2011-04-01|April 2017|2017-04-01|May 2015|Actual|2015-05-01|January 2015|Actual|2015-01-01||Interventional|STAR-Too||Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)|Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)|Terminated||Phase 2|47|Actual|University of North Carolina, Chapel Hill|The study was completed prior to reaching the pre-specified number of participants as the Data Safety Monitoring committee observed that efficacy had been reached.|2||"Interim review showed a statistically significant treatment effect and the DMC recommended that   the study be stopped with ongoing follow-up of enrolled subjects"|f||||t||||||||No||2017-10-11 04:16:19.347678|2017-10-11 04:16:19.347678
NCT01349179|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-22|2014-07-04|||December 2010||2010-12-01|July 2014|2014-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ETOSA||Scan Hip Evaluation|Scan Evaluation at 9 Years of the Bone Acetabular Supporting Cups Without Cement (Couple Metal/Metal in Diameter 28 mm)|Completed||N/A|54|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 04:16:19.882736|2017-10-11 04:16:19.882736
NCT01348958|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2017-06-20|||July 2011||2011-07-01|June 2017|2017-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Evaluation of Orthopedic Knee Measurement Using Lunar iDXA|Evaluation of Orthopedic Knee Measurement Using Lunar iDXA|Completed||N/A|36|Actual|GE Healthcare||1|||f||||f||||||||||2017-10-11 04:16:23.164516|2017-10-11 04:16:23.164516
NCT01349166|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-03|2011-05-05|||February 2008||2008-02-01|May 2011|2011-05-01|February 2012|Anticipated|2012-02-01|August 2011|Anticipated|2011-08-01||Interventional|||Effects of 3 Months of Supervised Exercise Training|Effects of 3 Months of Supervised Exercise Training on Cardiometabolic and Inflammatory Biomarkers According to Glucose Tolerance (Normal, Intolerance and Type 2 Diabetes): Measures in Unstimulated and Stimulated Conditions|Unknown status|Active, not recruiting|N/A|45|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-10-11 04:16:19.947779|2017-10-11 04:16:19.947779
NCT01349153|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2011-12-12|||April 2011||2011-04-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|FITNET||Facebook-based Physical Activity Intervention for Young Adult Cancer Survivors: the FITNET Randomized Pilot Study|Facebook-based Physical Activity Intervention for Young Adult Cancer Survivors: the FITNET Randomized Pilot Study|Completed||Early Phase 1|97|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 04:16:20.077351|2017-10-11 04:16:20.077351
NCT01349140|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2012-08-07|||February 2012||2012-02-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks|EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks: A Pharmacodynamics Investigation in Healthy Volunteers|Completed||Phase 1/Phase 2|14|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 04:16:20.159216|2017-10-11 04:16:20.159216
NCT01349127|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2017-05-02|||August 2008||2008-08-01|May 2017|2017-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|DMUMs||Trial to Assess Vitamin D Requirements in Lactating Women|Randomised Placebo-controlled Supplementation Study With Vitamin D and Calcium in Breastfeeding Mothers|Completed||N/A|136|Actual|University College Cork||3|||f||||t||||||||||2017-10-11 04:16:20.218642|2017-10-11 04:16:20.218642
NCT01349114|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-04-05|2013-07-11||June 2011||2011-06-01|April 2017|2017-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects|Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects|Terminated||Phase 4|21|Actual|University of Alabama at Birmingham|Early termination leading to smaller number of subjects analyzed then anticipated, no adverse effects within the aliskiren group|2||Sponsor requested termination.|f||||f||||||||||2017-10-11 04:16:20.31376|2017-10-11 04:16:20.31376
NCT01349101|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2017-05-17|||February 10, 2011|Actual|2011-02-10|May 2017|2017-05-01|February 2020|Anticipated|2020-02-01|January 2019|Anticipated|2019-01-01||Interventional|||A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors|Post Transplant Cyclophosphamide for Unrelated and Related Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies|Recruiting||Phase 2|81|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 04:16:20.629563|2017-10-11 04:16:20.629563
NCT01349088|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2016-10-19|||December 2013||2013-12-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer|Phase I/II Trial of Motesanib in Combination With Ixabepilone and Capecitabine in Women With Locally Recurrent or Metastatic Breast Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-10-11 04:16:20.779793|2017-10-11 04:16:20.779793
NCT01349075|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-09-15|||October 2007||2007-10-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma|A Humanitarian Device Exemption Treatment Protocol of Therasphere for the Treatment of Unresectable Hepatocellular Carcinoma|Recruiting||N/A|500|Anticipated|Thomas Jefferson University|||1||f||||f||||||||||2017-10-11 04:16:20.880424|2017-10-11 04:16:20.880424
NCT01349062|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2017-03-01|||February 27, 2012|Actual|2012-02-27|March 2017|2017-03-01|February 27, 2017|Actual|2017-02-27|February 27, 2017|Actual|2017-02-27||Interventional|||Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS|Phase III Clinical Studies on Traditional CAM Therapy in the Treatment of HIV/AIDS|Completed||Phase 3|1000|Actual|Traditional Alternative Medicine Research, India||1|||f||||t|f|f||||||No||2017-10-11 04:16:20.971815|2017-10-11 04:16:20.971815
NCT01349049|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-09-18|||November 2011||2011-11-01|September 2017|2017-09-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)|A Phase 1/2 Safety and Efficacy Study of Orally Administered PLX3397 in Adults With Relapsed or Refractory FLT3-ITD Positive Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 1/Phase 2|90|Anticipated|Plexxikon||9|||f||||f||||||||||2017-10-11 04:16:21.049909|2017-10-11 04:16:21.049909
NCT01349036|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-04-06||2015-04-06|August 2011||2011-08-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|February 2014|Actual|2014-02-01||Interventional|||A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma|A Phase 2 Study of Orally Administered PLX3397 in Patients With Recurrent Glioblastoma|Completed||Phase 2|38|Actual|Plexxikon||2|||f||||f||||||||||2017-10-11 04:16:22.654819|2017-10-11 04:16:22.654819
NCT01349023|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2012-03-15|||January 2009||2009-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|EDEN||Energy Content and Energy Density of Pre-portioned Entrees|Effects of Energy Density and Energy Content of Pre-portioned entrées on Energy Intake|Completed||N/A|73|Actual|Penn State University||4|||f||||f||||||||||2017-10-11 04:16:22.730342|2017-10-11 04:16:22.730342
NCT01349010|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-24|2013-06-04|||April 2011||2011-04-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia|A Randomized, Double Blind, Placebo Control, Multi-center Clinical Study to Evaluate the Efficacy and Safety of Imported Probucol in Hyperlipidemia Patients|Completed||Phase 3|264|Actual|Otsuka Beijing Research Institute||2|||f||||f||||||||||2017-10-11 04:16:22.796411|2017-10-11 04:16:22.796411
NCT01348997|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2014-10-06|||May 2011||2011-05-01|October 2014|2014-10-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||E-health Intervention for Cancer Survivors 2.0|E-Health Intervention for Cancer Survivors 2.0|Withdrawn||Phase 1|0|Actual|Northwestern University||2||Study ended prior to completion of planning stage. No participants enrolled.|f||||f||||||||||2017-10-11 04:16:22.881409|2017-10-11 04:16:22.881409
NCT01348984|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-05-05|||April 2010||2010-04-01|February 2010|2010-02-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|TFP||Study of Transdermal Fentanyl Patch to Treat Postoperative Pain in Total Knee Arthroplasty|Transdermal Fentanyl Patch for Postoperative Analgesia in Total Knee Arthroplasty|Completed||Phase 4|40|Actual|Khon Kaen University||2|||f||||f||||||||||2017-10-11 04:16:22.951507|2017-10-11 04:16:22.951507
NCT01348945|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-05-05|||May 2011||2011-05-01|December 2010|2010-12-01|February 2012|Anticipated|2012-02-01|December 2011|Anticipated|2011-12-01||Interventional|||Proprioceptive Function, Postural Stability & Clinical Outcome After Stump Preserving Anterior Cruciate Ligament Reconstruction Surgery|Proprioceptive Function, Postural Stability & Clinical Outcome After Stump Preserving Anterior Cruciate Ligament Reconstruction Surgery - A Comparative Study|Unknown status|Active, not recruiting|N/A|48|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 04:16:23.254202|2017-10-11 04:16:23.254202
NCT01348932|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-05-05|||May 2011||2011-05-01|May 2011|2011-05-01|December 2013|Anticipated|2013-12-01|June 2011|Anticipated|2011-06-01||Observational|CHI3L1||The Relationship Between Single Nucleotide Polymorphisms of Chitinase 3-like 1 Gene,YKL-40 Serum Levels and Adult Asthma|The Relationship Between Single Nucleotide Polymorphisms of Chitinase 3-like 1 Gene,YKL-40 Serum Levels and Adult Asthma|Unknown status|Recruiting|N/A|1|Anticipated|China Medical University Hospital|||1||f||||t||||||Samples With DNA|"     The objective of this study was to investigate the relationship between single nucleotide     polymorphism of chitinase 3-like 1 and human asthma. The association between CHI3L1 SNPs and     the continuous outcomes were examined by real time PCR and gene sequencing analysis.   "|||2017-10-11 04:16:23.355936|2017-10-11 04:16:23.355936
NCT01348919|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2016-07-19||2013-08-30|August 2011||2011-08-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma|An Open-Label Study to Determine the Maximum Tolerated Dose and Evaluate the Safety and Efficacy of CEP-18770 in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Terminated||Phase 1/Phase 2|11|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 04:16:23.569452|2017-10-11 04:16:23.569452
NCT01348893|ClinicalTrials.gov processed this data on October 10, 2017|2010-04-29|2016-02-12|||August 2008||2008-08-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Evaluation of a Yoga Program in Schools|Evaluation of Yoga During School as a Behavioral Prevention Program for Adolescent Health|Active, not recruiting||N/A|1800|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 04:16:23.793718|2017-10-11 04:16:23.793718
NCT01348880|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2014-05-16|||May 2011||2011-05-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study|A Double-Blind Study to Evaluate the Pharmacodynamic Interaction Between 10 mg Vardenafil ODT (Orally Disintegrating Tablet) and Procardia XL® (Nifedipine GITS) in Elderly Male Patients With Both Hypertension and Erectile Dysfunction|Completed||Phase 1|42|Actual|Bayer||2|||f||||t||||||||||2017-10-11 04:16:23.903929|2017-10-11 04:16:23.903929
NCT01348867|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-06-23|||March 2009||2009-03-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|||Effectiveness of a Treat-to-target Clinic Led by a Nurse Consultants|A Randomised Study to Evaluate the Effectiveness of a Treat-to-target Clinic Led by a Nurse Consultant in Managing Patients With Type 2 Diabetes in Hong Kong|Completed||N/A|242|Actual|Asia Diabetes Foundation||2|||f||||t||||||||||2017-10-11 04:16:24.019443|2017-10-11 04:16:24.019443
NCT01348854|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2014-05-06|2014-01-31||May 2011||2011-05-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Data analysis was performed for eyes treated. Subjects may have had one or both eyes treated. If both eyes, one eye may have been in Natural Astigmatism group and the other eye in the Post Cataract with Residual Astigmatism group.|Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecond Laser System|A Multi-Center Prospective Study to Evaluate the Safety and Effectiveness of Arcuate Incisions Performed With the IntraLase iFS Femtosecond Laser System|Completed||Phase 2|40|Actual|Abbott Medical Optics|"BSCVA determination in eyes with progressing cataracts was sometimes unevaluable, although data are shown as reported.
The number of eyes in Post Cataract Surgery with Astigmatism Arm was small, limiting data analysis."|2|||f||||f||||||||||2017-10-11 04:16:24.115817|2017-10-11 04:16:24.115817
NCT01348841|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-10-24|||May 2011||2011-05-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|WIT||Wound Interdisciplinary Teams (WIT): A Community- Based Pragmatic Randomized Controlled Trial|Wound Interdisciplinary Teams (WIT): A Community- Based Pragmatic Randomized Controlled Trial|Completed||N/A|451|Actual|University of Toronto||2|||f||||f||||||||||2017-10-11 04:16:24.439074|2017-10-11 04:16:24.439074
NCT01348828|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-06-04|||November 2011||2011-11-01|June 2013|2013-06-01|May 2017|Anticipated|2017-05-01|May 2012|Actual|2012-05-01||Interventional|||Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System|Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Endologix||1|||f||||t||||||||||2017-10-11 04:16:24.543116|2017-10-11 04:16:24.543116
NCT01348802|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-09-22|||August 2011||2011-08-01|September 2015|2015-09-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||"A Randomized Trial Comparing Push Versus Pull Technology for Mobilizing Pain Evidence Into Practice Across Different Health Professions"|"A Randomized Trial Comparing Push Versus Pull Technology for Mobilizing Pain Evidence Into Practice Across Different Health Professions"|Completed||N/A|675|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 04:16:24.637845|2017-10-11 04:16:24.637845
NCT01348789|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-02-15|2012-12-04||March 2011||2011-03-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|OHR-3||Safety for Frequent Use Conditions of Hair Removal Device|Safety of Hair2Go Device in Frequent Use Conditions: A Prospective, Open Label Study With Before-After Design|Completed||N/A|37|Actual|Syneron Medical||1|||f||||t||||||||||2017-10-11 04:16:24.74366|2017-10-11 04:16:24.74366
NCT01348776|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2013-04-02|2012-12-27||March 2011||2011-03-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The Efficiency of the Hair2Go Device: A Prospective, Open, Label Study With Before-After Design|The Efficiency of the Hair2Go Device: A Prospective, Open, Label Study With Before-After Design|Completed||N/A|87|Actual|Syneron Medical||1|||f||||t||||||||||2017-10-11 04:16:25.048888|2017-10-11 04:16:25.048888
NCT01348763|ClinicalTrials.gov processed this data on October 10, 2017|2011-03-25|2014-05-20|||October 2011||2011-10-01|December 2011|2011-12-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study|A Phase 1 Pharmacokinetic Study to Assess the Steady State Pharmacokinetic Profile and Short Term Safety of Maraviroc Dosed With Darunavir/Ritonavir All Once Daily, With and Without Nucleoside Analogues, in HIV-1 Infected Subjects|Completed||Phase 1|12|Actual|Imperial College London||1|||f||||f||||||||||2017-10-11 04:16:25.408517|2017-10-11 04:16:25.408517
NCT01348750|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2011-05-04|||July 2008||2008-07-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Healing Touch & Guided Imagery for Posttraumatic Stress Disorder Symptoms|Healing Touch and Guided Imagery Intervention in Post-deployment Military Personnel With Posttraumatic Stress Disorder Symptoms|Completed||N/A|123|Actual|Scripps Center for Integrative Medicine||2|||f||||f||||||||||2017-10-11 04:16:25.658628|2017-10-11 04:16:25.658628
NCT01348737|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2012-04-05|||June 2011||2011-06-01|April 2012|2012-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers|A Phase I, Randomised, Double-blind, Placebo-controlled, Parallel-group Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Biomarkers of AZD3839 Including an Open-label Food Effect Group in Healthy Male and Female Volunteers of Non-childbearing Potential|Completed||Phase 1|72|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:16:25.74237|2017-10-11 04:16:25.74237
NCT01348724|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-21|2014-10-13|||June 2011||2011-06-01|October 2014|2014-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] NKTR-118|A Phase I, Open-Label, Single-Centre Study to Assess Absorption, Distribution, Metabolism and Excretion (ADME) After [14C]-Labelled Oral Administration of NKTR-118 to Healthy Male Volunteers|Completed||Phase 1|6|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 04:16:25.827305|2017-10-11 04:16:25.827305
NCT01348711|ClinicalTrials.gov processed this data on October 10, 2017|2010-02-02|2011-05-04|||May 2007||2007-05-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Observational|BIODOP-T1||Early Placental Insufficiency Screening|Placental Insufficiency Screening During First Trimester by a Combination of Uterine Artery Dopppler, Maternal PlGF and sFLT-1 in Hight Risk Population|Completed||N/A|300|Anticipated|University Hospital, Tours|||1||f||||t||||||Samples Without DNA|"     SERUM   "|||2017-10-11 04:16:25.933725|2017-10-11 04:16:25.933725
NCT01348698|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-08-09|||April 18, 2011||2011-04-18|August 8, 2017|2017-08-08||||||||Observational|||Evaluation of Molecular Markers in Adrenal Tumors|Evaluation of Diagnostic and Prognostic Molecular Markers in Adrenal Neoplasm|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:16:26.027106|2017-10-11 04:16:26.027106
NCT01348685|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-05-04|||January 2007||2007-01-01|February 2011|2011-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Comparing Liquid Versus Solid Forms of Sugars and Whey Protein|Effect of Drinking Liquid Compared to Eating Solid Treatment of Sugars or Whey Protein on Short-term Appetite and Food Intake|Completed||N/A|43|Actual|University of Toronto|||||f||||t||||||||||2017-10-11 04:16:26.123157|2017-10-11 04:16:26.123157
NCT01348672|ClinicalTrials.gov processed this data on October 10, 2017|2011-02-27|2013-01-16|||March 2012||2012-03-01|January 2013|2013-01-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye|Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye|Unknown status|Recruiting|N/A|381|Anticipated|University of Toronto|||3||f||||f||||||||||2017-10-11 04:16:26.193283|2017-10-11 04:16:26.193283
NCT01348659|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2012-05-04|||May 2011||2011-05-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Hypertonic Saline-HES Solution on Extracellular Water in Cardiac Surgery Patients|Effects of Hypertonic Saline-hydroxyethyl Starch Solution on Extracellular Water in Cardiac Surgery Patients|Completed||Phase 4|48|Actual|Tampere University Hospital||2|||f||||f||||||||||2017-10-11 04:16:26.27845|2017-10-11 04:16:26.27845
NCT01348646|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2011-05-31|||May 2008||2008-05-01|May 2011|2011-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|TuNAMI||Adult Follow-up of Preventive Study With Brief Smoking Intervention for Adolescents||Completed||N/A|2582|Actual|Tampere University Hospital||1|||f||||||||||||||2017-10-11 04:16:26.360873|2017-10-11 04:16:26.360873
NCT01348633|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-01-16|||March 2012||2012-03-01|January 2013|2013-01-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Observational|||Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye|Phase 1. Validation and Calibration Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye|Unknown status|Recruiting|N/A|275|Anticipated|University of Toronto|||5||f||||f||||||||||2017-10-11 04:16:26.447762|2017-10-11 04:16:26.447762
NCT01348620|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-26|2011-05-04|||March 2011||2011-03-01|May 2011|2011-05-01||||January 2012|Anticipated|2012-01-01||Interventional|||Single Port Laparoscopic Cholecystectomy Versus Four Port Laparoscopic Cholecystectomy: Impact on Postoperative Pain||Unknown status|Recruiting|N/A|58|Anticipated|Sacro Cuore Don Calabria General Hospital||2|||f||||t||||||||||2017-10-11 04:16:26.545724|2017-10-11 04:16:26.545724
NCT01348607|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2014-01-23|2013-07-05||July 2010||2010-07-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy|A Randomized, Phase II Placebo-controlled Study of the Use of Extended-release Methylphenidate or Modafinil for the Treatment of Excessive Daytime Sleepiness in Children Following Cancer Therapy|Terminated||Phase 2|1|Actual|University of South Florida|This study was closed prior to completion due to a lack of feasibility and low accrual by the Data Monitoring and Safety Board (DSMB).|3||Study only randomized 1 subject and was determined not feasible by DSMB|f||||t||||||||||2017-10-11 04:16:26.674412|2017-10-11 04:16:26.674412
NCT01348594|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2012-06-18|||April 2011||2011-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Observational|||The Impact of Vitamin D Status on in Vitro Fertilization (IVF) Outcomes|The Impact of Vitamin D on Implantation and Clinical Pregnancy Rates Following in Vitro Fertilization|Completed||N/A|182|Actual|University of Toronto|||2||f||||f||||||||||2017-10-11 04:16:27.014492|2017-10-11 04:16:27.014492
NCT01348581|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-02-28|||November 2010||2010-11-01|May 2011|2011-05-01|January 1, 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing|Chronic Wound Treatment With Extracellular Matrix (ECM) Scaffold Made From Fish Proteins|Completed||N/A|37|Actual|Kerecis Ltd.||1|||f||||t||||||||||2017-10-11 04:16:27.098707|2017-10-11 04:16:27.098707
NCT01348568|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-12-07|||March 2011||2011-03-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|April 2013|Actual|2013-04-01||Interventional|||Low Glycemic Index Diet (With Canola Oil) for Type 2 Diabetics|Effect of Low Glycemic Index Diets (With Canola Oil) on Glucose Control in Non-Insulin Dependent Diabetics|Completed||Phase 2|141|Actual|University of Toronto||2|||f||||t||||||||||2017-10-11 04:16:27.206989|2017-10-11 04:16:27.206989
NCT01348555|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-13|2013-06-03|||April 2011||2011-04-01|May 2011|2011-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162||Completed||Phase 1/Phase 2|108|Actual|Pierre Fabre Medicament||2|||f||||t||||||||||2017-10-11 04:16:27.306937|2017-10-11 04:16:27.306937
NCT01348542|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-20|2017-02-23|||April 2011||2011-04-01|February 2017|2017-02-01||||April 2018|Anticipated|2018-04-01||Interventional|||Study of Trazodone & Cognitive Behavioral Therapy to Treat Insomnia|Efficacy of Trazodone vs. Cognitive Behavioral Therapy in Patients With Chronic Insomnia Associated With Objective Short Sleep Duration|Recruiting||N/A|24|Anticipated|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 04:16:27.398888|2017-10-11 04:16:27.398888
NCT01348529|ClinicalTrials.gov processed this data on October 10, 2017|2010-11-08|2011-05-04|||September 2010||2010-09-01|September 2010|2010-09-01||||May 2011|Anticipated|2011-05-01||Interventional|||Internet Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD)|Internet-based Cognitive Behavior Therapy for Obsessive Compulsive Disorder: A Pilot Study|Unknown status|Active, not recruiting|N/A|24|Anticipated|Karolinska Institutet||1|||f||||f||||||||||2017-10-11 04:16:27.507584|2017-10-11 04:16:27.507584
NCT01348516|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2012-07-24|||May 2011||2011-05-01|July 2012|2012-07-01||||March 2012|Actual|2012-03-01||Interventional|||Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023|A Dose Block-randomized, Double-blind, Placebo-controlled, Single/Multiple Dosing, Dose-escalation Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of KM-023 After Oral Administration in Healthy Subjects|Completed||Phase 1|83|Actual|Kainos Medicine Inc.||2|||f||||||||||||||2017-10-11 04:16:27.600526|2017-10-11 04:16:27.600526
NCT01348503|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-08-28|||May 2011||2011-05-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|December 2012|Actual|2012-12-01||Interventional|||Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma|A Phase I Open-label Dose-escalation Study With Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma|Terminated||Phase 1|5|Actual|Indiana University||1||Treatment was ineffective|f||||t||||||||||2017-10-11 04:16:27.683158|2017-10-11 04:16:27.683158
NCT01348490|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-05-12|||June 2011||2011-06-01|May 2017|2017-05-01|September 2020|Anticipated|2020-09-01|February 2018|Anticipated|2018-02-01||Interventional|||Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis|An Open Label Assessment of Safety and Efficacy of Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis (PPV-MF) and Post Polycythemia Vera-myelofibrosis (PET-MF) Who Have Platelet Counts of 50 x 10^9/L to 100 x 10^9/L|Recruiting||Phase 2|150|Anticipated|Incyte Corporation||1|||t||||t||||||||||2017-10-11 04:16:27.766465|2017-10-11 04:16:27.766465
NCT01348477|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2011-05-04|||October 2010||2010-10-01|September 2010|2010-09-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Comparison Between Elliptical Domed Mesh Technique and Lichtenstein Technique in Inguinal Hernia|Comparison Between Elliptical Domed Mesh Technique and Lichtenstein Technique, to Reduce Postoperative Pain in Open Inguinal Hernia Repair|Unknown status|Recruiting|N/A|168|Anticipated|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-10-11 04:16:27.899221|2017-10-11 04:16:27.899221
NCT01348464|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2012-04-02|||March 2010||2010-03-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|||||Observational|||A Trial on Laparoscopic Appendectomy Versus Single Port Appendectomy|Transumbilical Single Port Laparoscopic Appendectomy Versus Conventional Laparoscopic Appendectomy in Adult Patients: A Prospective Randomized Control Study|Completed||N/A|150|Actual|Gachon University Gil Medical Center|||1||f||||f||||||||||2017-10-11 04:16:28.000199|2017-10-11 04:16:28.000199
NCT01348451|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2016-03-09|||January 2009||2009-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|ALS||Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis|A Phase l, Open-label, First in Human, Feasibility and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis|Active, not recruiting||Phase 1|18|Anticipated|Neuralstem Inc.||1|||f||||t||||||||||2017-10-11 04:16:28.081176|2017-10-11 04:16:28.081176
NCT01348438|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-04-28|||August 2011|Actual|2011-08-01|April 2017|2017-04-01|August 2018|Anticipated|2018-08-01|January 2013|Actual|2013-01-01||Interventional|||Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial|Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial|Active, not recruiting||N/A|150|Anticipated|Medtronic Cardiovascular||1|||f||||t||||||||||2017-10-11 04:16:28.167133|2017-10-11 04:16:28.167133
NCT01348425|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2015-12-29|2013-07-25|2013-03-12|May 2011||2011-05-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Interventional|||Zilver PTX Drug-Eluting Peripheral Stent Study|Evaluation of the Zilver PTX Drug-Eluting Peripheral Stent|Completed||N/A|45|Actual|Cook Group Incorporated||2|||f||||||||||||||2017-10-11 04:16:28.387372|2017-10-11 04:16:28.387372
NCT01348412|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2017-06-19|||December 2010|Actual|2010-12-01|June 2017|2017-06-01|May 18, 2020|Anticipated|2020-05-18|May 18, 2019|Anticipated|2019-05-18||Interventional|HEARTO||Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure|Phase II Randomized Study Comparing the Association of Intraarterial Perfusion of Raltitrexed and Oxaliplatin Versus Standard Chemotherapy Using Intravenous Perfusion for Colorectal Cancer Patient With Metastases Localized to Liver After Failure of Conventional Treatments.|Recruiting||Phase 2|80|Anticipated|Centre Georges Francois Leclerc||2|||f||||t||||||||||2017-10-11 04:16:28.653401|2017-10-11 04:16:28.653401
NCT01348399|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-07-19|||April 2011|Actual|2011-04-01|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|July 2014|Actual|2014-07-01||Observational|||Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)|Evaluation of Effectiveness and Safety of XIENCE PRIME™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study|Active, not recruiting||N/A|2000|Actual|CardioVascular Research Foundation, Korea|||1||f||||t||||||||||2017-10-11 04:16:28.754341|2017-10-11 04:16:28.754341
NCT01348386|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-09-30|||March 2010||2010-03-01|May 2011|2011-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|EKOH-MOL 2008||Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum|Efficacy and Tolerance of the Topical Application of Potassium Hydroxide (10% and 15%) in the Treatment of Molluscum Contagiosum|Completed||Phase 2/Phase 3|53|Actual|Jordi Gol i Gurina Foundation||3|||f||||||||||||||2017-10-11 04:16:28.906983|2017-10-11 04:16:28.906983
NCT01348373|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2015-11-10|||May 2010||2010-05-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Evaluation of Effectiveness and Safety of the GENOUS STENT (IRIS-GENOUS STEMI)|Evaluation of Effectiveness and Safety of the GENOUS STENT in ST-Segment Elevation Myocardial Infarction|Completed||N/A|464|Actual|CardioVascular Research Foundation, Korea|||1||f||||t||||||||||2017-10-11 04:16:28.994365|2017-10-11 04:16:28.994365
NCT01348360|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-07-19|||May 2010|Actual|2010-05-01|July 2017|2017-07-01|April 2020|Anticipated|2020-04-01|May 2016|Actual|2016-05-01||Observational|IRIS-NOBORI||Evaluation of Effectiveness and Safety of NOBORI Stent|Evaluation of Effectiveness and Safety of NOBORI Stent in Routine Clinical Practice; A Multicenter, Prospective, Observational Study|Active, not recruiting||N/A|2000|Actual|CardioVascular Research Foundation, Korea|||1||f||||t||||||||||2017-10-11 04:16:29.14744|2017-10-11 04:16:29.14744
NCT01348347|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2014-08-06|||April 2011||2011-04-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours|An Open-label Phase I Study of Once Every Three Weeks Intravenous Treatment With BI 6727 in Japanese Patients With Advanced Solid Tumours|Completed||Phase 1|15|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-10-11 04:16:29.287708|2017-10-11 04:16:29.287708
NCT01348334|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2011-05-04|||July 2004||2004-07-01|July 2004|2004-07-01|November 2010|Actual|2010-11-01|July 2007|Actual|2007-07-01||Interventional|||Synthetic Mesh Materials In Sling Surgery|Use Of Three Types Of Synthetic Mesh Materials In Sling Surgery: A Prospective Randomized Clinical Trial Evaluating Effectiveness And Complications|Completed||N/A|144|Actual|Ataturk Training and Research Hospital||3|||f||||f||||||||||2017-10-11 04:16:29.36566|2017-10-11 04:16:29.36566
NCT01348321|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-25|2011-05-04|||November 2008||2008-11-01|October 2008|2008-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne|Superior Efficacy of Azithromycin and Levamisole Versus of Azithromycin Alone in the Treatment of Inflammatory Acne Vulgaris: An Investigator Blind Randomized Clinical Trial on 169 Patients|Completed||Phase 2/Phase 3|169|Actual|Ahvaz Jundishapur University of Medical Sciences||2|||f||||t||||||||||2017-10-11 04:16:29.448512|2017-10-11 04:16:29.448512
NCT01348308|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2016-07-11|||September 2011||2011-09-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|OPTIMAL||Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients|Optimized Phase III Trial of Immuno-stimulation With Maraviroc, a CCR5 (Chemokine Receptor 5) Antagonist, Combined With Anti Retroviral Therapy in Advanced, Late Diagnosed HIV-1 Infected Patients With an AIDS-defining Event and/or CD4 (Cluster of Differentiation 4) Counts Below 200 Cells/mm³. ANRS 146 OPTIMAL|Completed||Phase 3|407|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-11 04:16:29.543155|2017-10-11 04:16:29.543155
NCT01348295|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2011-05-04|||March 2010||2010-03-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Pediatric Ventilatory Care in Finland 2010|Pediatric Ventilatory Care in Finland 2010|Completed||N/A|210|Actual|University of Oulu|||1||f||||f||||||||||2017-10-11 04:16:29.633477|2017-10-11 04:16:29.633477
NCT01348282|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2014-03-31|||May 2011||2011-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study|Exploratory Controlled Prospective Randomized Trial to Compare the Efficacy and Safety of Two Different Pharmacology Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study|Completed||Phase 4|33|Actual|Fundacio Lluita Contra la SIDA||3|||f||||f||||||||||2017-10-11 04:16:29.729682|2017-10-11 04:16:29.729682
NCT01348269|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2017-06-07|||May 2011|Actual|2011-05-01|April 2017|2017-04-01|August 26, 2015|Actual|2015-08-26|August 26, 2015|Actual|2015-08-26||Interventional|ZoMARS||Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome|A Prospective, Bi-centric,Randomized, Primary Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome|Completed||Phase 3|63|Actual|Wuerzburg University Hospital||2|||f||||f||||||||||2017-10-11 04:16:29.844042|2017-10-11 04:16:29.844042
NCT01348256|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-05-06|||November 2010||2010-11-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma|Randomized Phase II Study With Dendritic Cell Immunotherapy in Patients With Resected Hepatic Metastasis of Colorectal Carcinoma|Unknown status|Recruiting|Phase 2|58|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||2|||f||||f||||||||||2017-10-11 04:16:29.936462|2017-10-11 04:16:29.936462
NCT01348243|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2017-03-28|||October 2011||2011-10-01|March 2017|2017-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis|MULTICENTRE, RANDOMIZED, OPEN-LABEL, TWO-ARM PARALLEL GROUPS, ACTIVE CONTROLLED STUDY DESIGN TO DEMONSTRATE EFFICACY AND TOLERABILITY OF CLODRONATE 200 MG/4 ML SOLUTION FOR INTRAMUSCULAR USE WITH 1% LIDOCAINE EVERY OTHER WEEK VS CLODRONATE 100 MG/3,3ML SOLUTION FOR INTRAMUSCULAR USE WITH 1% LIDOCAINE ONCE-WEEK IN A 1-YEAR TREATMENT PERIOD OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS|Completed||Phase 3|260|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-10-11 04:16:30.024166|2017-10-11 04:16:30.024166
NCT01348230|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2017-04-19|||May 2011||2011-05-01|April 2017|2017-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Glycoproteomic Analysis of Urine in Women Undergoing Spontaneous Preterm Delivery|Glycoproteomic Analysis of Urine in Women Undergoing Spontaneous Preterm Delivery|Withdrawn||N/A|0|Actual|University of Missouri-Columbia|||3|Investigator left institution|f||||t||||||Samples Without DNA|"     Urine   "|No||2017-10-11 04:16:30.105783|2017-10-11 04:16:30.105783
NCT00000120|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||January 1985||1985-01-01|September 2009|2009-09-01||||||||Interventional|||Clinical Trial of Eye Prophylaxis in the Newborn||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:29.954793|2017-10-11 04:17:29.954793
NCT01348217|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-29|2017-06-20|||June 2011|Actual|2011-06-01|June 2017|2017-06-01|February 2022|Anticipated|2022-02-01|May 2019|Anticipated|2019-05-01||Interventional|CONCORDE||Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus|Prodige 26: Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus|Recruiting||Phase 2/Phase 3|252|Anticipated|Centre Georges Francois Leclerc||2|||f||||t||||||||||2017-10-11 04:16:30.187901|2017-10-11 04:16:30.187901
NCT01348204|ClinicalTrials.gov processed this data on October 10, 2017|2010-06-01|2012-01-27|||March 2010||2010-03-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators|Nasal Potential Studies Utilizing CFTR Modulators (UAB Center for Clinical and Translational Science)|Completed||Phase 2|32|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:16:30.290376|2017-10-11 04:16:30.290376
NCT01348191|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-04|2013-05-23|||November 2011||2011-11-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Observational|||Detection of Thyrotrophin Receptor in Human Myometrium|Detection of Thyrotrophin Receptor in Human Myometrium|Completed||N/A|10|Actual|Catharina Ziekenhuis Eindhoven|||1||f||||t||||||Samples Without DNA|"     Biopsy of human myometrium   "|||2017-10-11 04:16:30.37301|2017-10-11 04:16:30.37301
NCT01348178|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2012-01-06|||March 2010||2010-03-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Retrospective Follow-up Study After Periacetabular Osteotomy in Adults|Retrospective Follow-up Study After Periacetabular Osteotomy in Adults|Completed||N/A|401|Actual|University of Aarhus|||1||f||||t||||||||||2017-10-11 04:16:30.481326|2017-10-11 04:16:30.481326
NCT01348165|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2016-08-04|2014-03-12||May 2011||2011-05-01|August 2016|2016-08-01||||August 2011|Actual|2011-08-01||Interventional||Treated Set which included all subjects who received one dose of trial medication|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers|Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers (A Randomised, Single-blind, Placebo-controlled Phase I Study)|Terminated||Phase 1|40|Actual|Boehringer Ingelheim|The trial was put on hold due to a serious adverse event (post-treatment period) which was evaluated to be not drug related and the trial was subsequently terminated.|10|||f||||||||||||||2017-10-11 04:16:30.568986|2017-10-11 04:16:30.568986
NCT01348152|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-09-09||2013-08-09|September 2011||2011-09-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of TU-100 in Patients With Functional Constipation|A Randomized, Double-Blinded, Placebo-Controlled Exploratory Study of Daikenchuto (TU-100) in Patients With Functional Constipation|Completed||Phase 2|50|Actual|Tsumura USA||2|||f||||t||||||||||2017-10-11 04:16:31.954472|2017-10-11 04:16:31.954472
NCT01348139|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-01-28|2013-01-28||May 2011||2011-05-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Multicentre, 6-way Crossover, Single-dose, Phase IIa Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 Administered Via Single Inhalation Device Compared to AZD3199 Administered Via Turbuhaler™ Inhaler in Patients With Asthma|Completed||Phase 2|39|Actual|AstraZeneca||6|||f||||||||||||||2017-10-11 04:16:32.162961|2017-10-11 04:16:32.162961
NCT01348126|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2015-11-04|||May 2011||2011-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|April 2014|Actual|2014-04-01||Interventional|GALAXY||Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer|A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer|Terminated||Phase 2/Phase 3|385|Actual|Synta Pharmaceuticals Corp.||2|||f||||f||||||||||2017-10-11 04:16:32.937174|2017-10-11 04:16:32.937174
NCT01348113|ClinicalTrials.gov processed this data on October 10, 2017|2010-07-02|2014-04-30|||July 2010||2010-07-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|ITBCHIR||Efficacy of a Brief Alcohol Intervention for Non Dependant Alcohol-misusing Patients Undergoing a Scheduled Surgery|Efficacy of a Brief Alcohol Intervention for Non Dependant Alcohol-misusing Patients Undergoing a Scheduled Surgery: a Randomized Controlled Trial|Terminated||Phase 3|3|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 04:16:33.116548|2017-10-11 04:16:33.116548
NCT01348100|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-28|2013-12-17|2013-07-25||April 2011||2011-04-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Safety population: All participants who received at least 1 dose of study drug and had at least 1 post-baseline safety assessment.|Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients|An Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Two Iloperidone Depot Formulations Followed by a Dose-ranging Phase of One Selected Formulation in Schizophrenic Patients Given Depot Injections Every 28 Days|Completed||Phase 1/Phase 2|81|Actual|Novartis||7|||f||||||||||||||2017-10-11 04:16:33.259123|2017-10-11 04:16:33.259123
NCT01348087|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2016-04-11|2015-09-09||August 2011||2011-08-01|April 2016|2016-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome|An Open-label Study to Evaluate the Long-term Safety, Tolerability and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome|Terminated||Phase 2|148|Actual|Novartis|The sponsor decided to terminate this study prematurely, as the study treatment failed to demonstrate efficacy in target population in two other clinical studies: CAFQ056B2214 (NCT01357239) and CAFQ056A2212 (NCT01253629).|1||"Study treatment AFQ056 failed to demonstrate efficacy in the adult patient with Fragile X   Syndrome in 2 other clinical studies (CAFQ056B2214 and CAFQ056A2212)"|f||||t||||||||||2017-10-11 04:16:35.531517|2017-10-11 04:16:35.531517
NCT01348074|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2016-04-01|||April 2011||2011-04-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|DOSIDO||Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist|Phase II Study of Double Versus Single Reinitiation Dose of Warfarin After Interruption for Surgery|Completed||Phase 2|104|Actual|McMaster University||2|||f||||f||||||||No||2017-10-11 04:16:35.971964|2017-10-11 04:16:35.971964
NCT01348061|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2014-10-22|||July 2011||2011-07-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls|Experimental Medicine Study to Evaluate the Kinetics of Cerebrospinal Fluid Biomarkers in Subjects With Alzheimer's Disease and Progressive Supranuclear Palsy Compared to Healthy Subjects Using a Heavy Water Labeling Method|Completed||N/A|16|Actual|KineMed|||3||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 04:16:36.074196|2017-10-11 04:16:36.074196
NCT01348048|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2015-03-02|||May 2011||2011-05-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|DanPaCT||A Trial Investigating the Effect of Specialised Palliative Care on Symptoms, Survival, Economical Factors and Satisfaction|Danish Palliative Care Trial (DanPaCT): A Randomised Clinical Multi-centre Trial Investigating the Effect of Specialised Palliative Care on Symptoms, Survival, Economical Factors and Satisfaction in Patients With Cancer Reporting Palliative Needs|Completed||Phase 4|306|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 04:16:36.148172|2017-10-11 04:16:36.148172
NCT01348035|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-12-21|||April 2011||2011-04-01|May 2012|2012-05-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Observational|ESWP||Efficacy Study of Water Drinking on PKD Progression.|Efficacy Study of Long-term Water Intake on the Progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD).|Completed||N/A|30|Anticipated|Kyorin University|||2||f||||f||||||Samples Without DNA|"     Urine   "|||2017-10-11 04:16:36.355108|2017-10-11 04:16:36.355108
NCT01348022|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-22|2015-11-18|||August 2009||2009-08-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|December 2012|Actual|2012-12-01||Observational|||Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)|Prospective Evaluation of Outcomes of Everolimus-Eluting Stent (XIENCE V) Implantation for Unprotected Left Main Coronary Artery Stenosis: Multicenter Trial|Completed||N/A|397|Actual|CardioVascular Research Foundation, Korea|||1||f||||t||||||||||2017-10-11 04:16:36.446253|2017-10-11 04:16:36.446253
NCT01348009|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-18|2012-03-11|||May 2011||2011-05-01|March 2012|2012-03-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Interventional|||Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer|A Phase I-II Study of Tesetaxel Plus Capecitabine and Cisplatin in Subjects With Advanced Gastric Cancer|Unknown status|Recruiting|Phase 1/Phase 2|63|Anticipated|Genta Incorporated||1|||f||||t||||||||||2017-10-11 04:16:36.563207|2017-10-11 04:16:36.563207
NCT01347996|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2014-06-12|||July 2009||2009-07-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia|Open-Label, Multicenter, Effects of Remission Maintenance Therapy With Ceplene® , Given in Conjunction With Low-Dose Interleukin-2, on Immune Response and Minimal Residual Disease in Adult Patients With AML in First Complete Remission|Completed||Phase 4|84|Actual|MEDA Pharma GmbH & Co. KG||1|||f||||f||||||||||2017-10-11 04:16:36.659676|2017-10-11 04:16:36.659676
NCT01347983|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-04-03|||May 2011||2011-05-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients|Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients|Completed||Phase 3|72|Actual|Chugai Pharma Taiwan||1|||f||||f||||||||||2017-10-11 04:16:36.741803|2017-10-11 04:16:36.741803
NCT01347970|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-02|2017-08-17|||May 2012||2012-05-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Congestive Heart Failure (PREVENT-CHF): A Phase IIB Randomized Placebo-Controlled Trial|Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Congestive Heart Failure (PREVENT-CHF): A Phase IIB Randomized Placebo-Controlled Trial|Active, not recruiting||Phase 2|250|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 04:16:36.838001|2017-10-11 04:16:36.838001
NCT01347957|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-02-12|||August 2012||2012-08-01|February 2013|2013-02-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Safety and Efficacy of Nitric Oxide Gel in Promoting Hair Growth in Male Human Subjects With Androgenetic Alopecia||Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-10-11 04:16:36.961179|2017-10-11 04:16:36.961179
NCT01347944|ClinicalTrials.gov processed this data on October 10, 2017|2010-10-29|2016-03-23|||January 2011||2011-01-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|MORE||MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry|Observational, Non-interventional, Multicenter Study Aimed at Collecting Retrospective/Prospective 648/96 Italian Registry Data Related to Lenalidomide (Revlimid®) Prescription to Patients With Myelodysplastic Syndromes|Completed||N/A|149|Actual|Celgene Corporation|||1||f||||t||||||||||2017-10-11 04:16:37.03458|2017-10-11 04:16:37.03458
NCT01347931|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2016-08-17|2015-03-08||May 2011||2011-05-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||Per protocol|In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency|In-home Evaluation of the Breathe Technologies Noninvasive Open Ventilation (NIOV™) System in Patients With Severe Respiratory Insufficiency|Completed||N/A|30|Actual|Breathe Technologies, Inc.||2|||f||||f||||||||||2017-10-11 04:16:37.181127|2017-10-11 04:16:37.181127
NCT01347918|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2015-04-08|||July 2011||2011-07-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||1H-19F Gastrointestinal MRI in Health and IBS|Small Intestinal Transit and Motor Function in Health and IBS Patients Studied by Combined 1H and 19F Magnetic Resonance Imaging|Suspended||N/A|24|Anticipated|University of Zurich|||2|Technical problems|f||||f||||||||||2017-10-11 04:16:37.440407|2017-10-11 04:16:37.440407
NCT01347905|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2015-06-05|||February 2011||2011-02-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Observational|||Changes in Iron Absorption and Availability Before and After Weight Loss in Obese Pre-menopausal Women and Men.|Changes in Iron Absorption and Availability Before and After Weight Loss in Obese Pre-menopausal Women and Men.|Completed||N/A|43|Actual|Wageningen University|||1||f||||t||||||Samples With DNA|"     whole blood and serum   "|||2017-10-11 04:16:37.536896|2017-10-11 04:16:37.536896
NCT01347892|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2017-01-25|||March 2011||2011-03-01|January 2017|2017-01-01|September 2019|Anticipated|2019-09-01|July 2019|Anticipated|2019-07-01||Observational|||DeNovo NT Ankle LDC Study|Post Market, Longitudinal Data Collection Study of Articular Cartilage Lesions in the Ankle Treated With DeNovo(R) NT Natural Tissue Graft|Active, not recruiting||N/A|205|Actual|Zimmer Orthobiologics, Inc.|||1||f||||f||||||||||2017-10-11 04:16:37.613895|2017-10-11 04:16:37.613895
NCT01347879|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2013-12-02|2013-09-23||May 2011||2011-05-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris|PCTA206/11 A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi Center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris.|Completed||Phase 2|153|Actual|Photocure||2|||f||||f||||||||||2017-10-11 04:16:37.729448|2017-10-11 04:16:37.729448
NCT01347853|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2017-02-06|||June 2003||2003-06-01|February 2017|2017-02-01|June 2007|Actual|2007-06-01|June 2005|Actual|2005-06-01||Interventional|||Safety and Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain|A Phase 3, Double-blind, Randomized Study of the Safety, Tolerability, and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain|Completed||Phase 3|300|Actual|Egalet Ltd||2|||f||||f||||||||||2017-10-11 04:16:38.587786|2017-10-11 04:16:38.587786
NCT01347840|ClinicalTrials.gov processed this data on October 10, 2017|2011-05-03|2012-04-19|2012-04-19||April 2011||2011-04-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|Cassini||Metabolic Factors of Outcomes From Gastric Bypass Surgery|Metabolic Factors of Outcomes From Gastric Bypass Surgery|Terminated||N/A|1|Actual|Ethicon Endo-Surgery|Trial termination due to business needs. One subject enrolled and withdrew consent. Zero subjects completed study. No subject data analyzed.||1|Study was terminated for business reasons.|f||||f||||||||||2017-10-11 04:16:38.910073|2017-10-11 04:16:38.910073
NCT01347827|ClinicalTrials.gov processed this data on October 10, 2017|2011-04-27|2013-01-09|||June 2011||2011-06-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Tissue Oxygenation During Heart Surgery|Comparison of Cerebral Tissue Oxygen Desaturation in Patients Undergoing On-pump or Off-pump Coronary Artery Bypass Grafting|Completed||N/A|60|Actual|University Medical Center Groningen|||2||f||||f||||||||||2017-10-11 04:16:39.155055|2017-10-11 04:16:39.155055
NCT00000102|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets||Completed||Phase 1/Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:17:27.130504|2017-10-11 04:17:27.130504
NCT00000104|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Does Lead Burden Alter Neuropsychological Development?||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:17:27.189672|2017-10-11 04:17:27.189672
NCT00000105|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2012-11-06|||July 2002||2002-07-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Vaccination With Tetanus and KLH to Assess Immune Responses.|Vaccination With Tetanus Toxoid and Keyhole Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses|Terminated||N/A|112|Actual|Masonic Cancer Center, University of Minnesota|||3|Replaced by another study.|f||||t||||||Samples With DNA|"     analysis of blood samples before and 4 weeks postvaccination   "|||2017-10-11 04:17:29.038562|2017-10-11 04:17:29.038562
NCT00000106|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2005-06-23||||||November 2000|2000-11-01||||||||Interventional|||41.8 Degree Centigrade Whole Body Hyperthermia for the Treatment of Rheumatoid Diseases||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:17:29.127015|2017-10-11 04:17:29.127015
NCT00000107|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Body Water Content in Cyanotic Congenital Heart Disease||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:17:29.183404|2017-10-11 04:17:29.183404
NCT00000108|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:17:29.227889|2017-10-11 04:17:29.227889
NCT00000110|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Influence of Diet and Endurance Running on Intramuscular Lipids Measured at 4.1 TESLA||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:17:29.276359|2017-10-11 04:17:29.276359
NCT00000111|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2005-06-23||||||September 2000|2000-09-01||||||||Interventional|||Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites||Unknown status|Active, not recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:17:29.321919|2017-10-11 04:17:29.321919
NCT00000112|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Prevalence of Carbohydrate Intolerance in Lean and Obese Children||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:17:29.377266|2017-10-11 04:17:29.377266
NCT00000113|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2016-04-14|||September 1997||1997-09-01|April 2016|2016-04-01|September 2013|Actual|2013-09-01|October 2001|Actual|2001-10-01||Interventional|||Correction of Myopia Evaluation Trial (COMET)|Correction of Myopia Evaluation Trial (COMET)|Completed||Phase 3|469|Actual|Stony Brook University||2|||f||||t||||||||||2017-10-11 04:17:29.428311|2017-10-11 04:17:29.428311
NCT00000114|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||May 1984||1984-05-01|September 2009|2009-09-01|June 1987|Actual|1987-06-01|||||Interventional|||Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:29.517744|2017-10-11 04:17:29.517744
NCT00000115|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||December 1990||1990-12-01|September 2009|2009-09-01|June 1994|Actual|1994-06-01|||||Interventional|||Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema||Completed||Phase 2|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:29.582195|2017-10-11 04:17:29.582195
NCT00000116|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||May 1996||1996-05-01|September 2009|2009-09-01|September 1997||1997-09-01|||||Interventional|||Randomized Trial for Retinitis Pigmentosa|Randomized Trial for Retinitis Pigmentosa|Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:29.625526|2017-10-11 04:17:29.625526
NCT00000117|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||August 1995||1995-08-01|September 2009|2009-09-01|December 1997|Actual|1997-12-01|||||Interventional|||Intravenous Immunoglobulin Therapy in Optic Neuritis||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:29.681264|2017-10-11 04:17:29.681264
NCT00000118|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||October 1992||1992-10-01|September 2009|2009-09-01|December 1993|Actual|1993-12-01|||||Interventional|||Ganciclovir Implant Study for Cytomegalovirus Retinitis||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:29.837872|2017-10-11 04:17:29.837872
NCT00000119|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||March 1994||1994-03-01|September 1999|1999-09-01||||||||Interventional|||Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis||Unknown status|Active, not recruiting|Phase 2|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:29.894963|2017-10-11 04:17:29.894963
NCT00000125|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2016-12-15|2015-03-06||February 1994||1994-02-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|June 2002|Actual|2002-06-01||Interventional|OHTS|1636 ocular hypertensive patients were randomized to either close observation or ocular hypertensive medication.|Ocular Hypertension Treatment Study (OHTS)|Ocular Hypertension Treatment Study (OHTS)|Active, not recruiting||Phase 3|1636|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 04:17:30.345689|2017-10-11 04:17:30.345689
NCT00000126|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-05-25|||October 1994||1994-10-01|October 2003|2003-10-01||||||||Observational|||Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)||Unknown status|Active, not recruiting|N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.657787|2017-10-11 04:17:30.657787
NCT00000127|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2010-03-23|||October 1992||1992-10-01|September 2009|2009-09-01|October 1994|Actual|1994-10-01|||||Interventional|||Ischemic Optic Neuropathy Decompression Trial (IONDT)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.757504|2017-10-11 04:17:30.757504
NCT00000128|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||June 1996||1996-06-01|June 2002|2002-06-01||||||||Interventional|||A Trial of Bifocals in Myopic Children With Esophoria||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.813082|2017-10-11 04:17:30.813082
NCT00000129|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||April 1981||1981-04-01|September 2009|2009-09-01|October 1983|Actual|1983-10-01|||||Interventional|||Prospective Evaluation of Radial Keratotomy (PERK) Study||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.866349|2017-10-11 04:17:30.866349
NCT00000130|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||February 1990||1990-02-01|September 2009|2009-09-01|January 1995|Actual|1995-01-01|||||Interventional|||Endophthalmitis Vitrectomy Study (EVS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.937098|2017-10-11 04:17:30.937098
NCT00000131|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||August 1988||1988-08-01|September 2009|2009-09-01|February 1994|Actual|1994-02-01|||||Interventional|||Central Vein Occlusion Study (CVOS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:30.995258|2017-10-11 04:17:30.995258
NCT00000132|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||October 1992||1992-10-01|October 2001|2001-10-01||||||||Interventional|||Early Manifest Glaucoma Trial (EMGT)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:31.047048|2017-10-11 04:17:31.047048
NCT00000133|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2014-02-03|||January 1986||1986-01-01|October 2003|2003-10-01|August 2003|Actual|2003-08-01|||||Interventional|||Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity||Completed||N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:31.104423|2017-10-11 04:17:31.104423
NCT00000134|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2015-08-11|2015-06-15||December 1992||1992-12-01|August 2015|2015-08-01|March 1995|Actual|1995-03-01|March 1995|Actual|1995-03-01||Interventional|CRRT||Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)|Cytomegalovirus Retinitis Retreatment Trial|Completed||Phase 3|279|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-10-11 04:17:31.323263|2017-10-11 04:17:31.323263
NCT00000135|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2015-10-14|2015-06-12||September 1995||1995-09-01|July 2015|2015-07-01|August 1996|Actual|1996-08-01|August 1996|Actual|1996-08-01||Interventional|MACRT||Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)|Monoclonal Antibody CMV Retinitis Trial (MACRT)|Completed||Phase 2/Phase 3|209|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 04:17:31.640333|2017-10-11 04:17:31.640333
NCT00000136|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2015-09-22|2015-06-22||March 1990||1990-03-01|July 2015|2015-07-01|October 1991|Actual|1991-10-01|October 1991|Actual|1991-10-01||Interventional|FGCRT||Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)|Foscarnet-Ganciclovir CMV Retinitis Trial|Completed||Phase 3|234|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 04:17:31.920234|2017-10-11 04:17:31.920234
NCT00000137|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||May 1986||1986-05-01|September 2009|2009-09-01|September 1989|Actual|1989-09-01|||||Interventional|||Collaborative Corneal Transplantation Studies (CCTS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:32.214278|2017-10-11 04:17:32.214278
NCT00000138|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-09-16|||May 1989||1989-05-01|September 2009|2009-09-01||||||||Interventional|||Herpetic Eye Disease Study (HEDS) I||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:32.268787|2017-10-11 04:17:32.268787
NCT00000139|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2010-03-23|||October 1992||1992-10-01|September 2009|2009-09-01||||||||Interventional|||Herpetic Eye Disease Study (HEDS) II||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:32.35107|2017-10-11 04:17:32.35107
NCT00000140|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||September 1985||1985-09-01|October 1999|1999-10-01||||||||Interventional|||The Silicone Study||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:32.432017|2017-10-11 04:17:32.432017
NCT00000142|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2015-10-14|2015-06-02||April 1994||1994-04-01|July 2015|2015-07-01|February 1996|Actual|1996-02-01|February 1996|Actual|1996-02-01||Interventional|HPCRT||Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)|Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)|Completed||Phase 2/Phase 3|64|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-10-11 04:17:32.494872|2017-10-11 04:17:32.494872
NCT00000143|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2016-02-18|2015-07-01||May 1997||1997-05-01|July 2015|2015-07-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|GCCRT||Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)|Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)|Completed||Phase 3|61|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||Yes||2017-10-11 04:17:32.774379|2017-10-11 04:17:32.774379
NCT00000144|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-06-02|||January 1984||1984-01-01|October 2003|2003-10-01||||||||Interventional|||Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.018788|2017-10-11 04:17:33.018788
NCT00000145|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2009-01-21|||September 1990||1990-09-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|October 2001|Actual|2001-10-01||Interventional|||Age-Related Eye Disease Study (AREDS)|Age-Related Eye Disease Study (AREDS)|Completed||Phase 3|4757|Actual|National Eye Institute (NEI)||4|||f||||t||||||||||2017-10-11 04:17:33.078033|2017-10-11 04:17:33.078033
NCT00000146|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-06-02|||July 1988||1988-07-01|October 2003|2003-10-01||||||||Interventional|||Optic Neuritis Treatment Trial (ONTT)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.182142|2017-10-11 04:17:33.182142
NCT00000147|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2006-05-26|||July 1988||1988-07-01|October 1999|1999-10-01||||||||Interventional|||Longitudinal Optic Neuritis Study (LONS)||Unknown status|Active, not recruiting|N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:33.29053|2017-10-11 04:17:33.29053
NCT00000168|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2015-06-10|||August 1998||1998-08-01|June 2015|2015-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|LSOCA||Longitudinal Study of Ocular Complications of AIDS (LSOCA)|Studies of Ocular Complications of AIDS (SOCA)|Completed||N/A|2392|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||t||||||Samples With DNA|"     Laboratory studies will include hematology serum chemistry and lymphocyte subset analysis for     all patients. The amount of blood for hematology, serum chemistry, and lymphocyte subset     analysis is restricted to no more than a total of 17 mL per draw. Data existing on HIV viral     load analysis at the clinic will be collected. If HIV data are not available from medical     records within the visit time window, blood should be collected for local HIV viral load     determination.   "|||2017-10-11 04:17:35.182807|2017-10-11 04:17:35.182807
NCT00000169|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2005-06-23|||April 1999||1999-04-01|June 2001|2001-06-01||||||||Observational|||The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study||Unknown status|Recruiting|N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:17:35.33498|2017-10-11 04:17:35.33498
NCT00000170|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-23|2014-03-05|||April 1999||1999-04-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|November 2001|Actual|2001-11-01||Interventional|||Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia|Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia|Completed||Phase 3|419|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-11 04:17:35.43386|2017-10-11 04:17:35.43386
NCT00000171|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2005-06-23||||||March 2005|2005-03-01||||||||Interventional|||Study of Melatonin: Sleep Problems in Alzheimer's Disease||Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:35.549399|2017-10-11 04:17:35.549399
NCT00000172|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2005-06-23||||||November 2002|2002-11-01||||||||Interventional|||Evaluation of Galantamine in the Treatment of Alzheimer's Disease|Placebo Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy Under a Slow-Titration Regimen|Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:35.688215|2017-10-11 04:17:35.688215
NCT00000173|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2009-12-10|||March 1999||1999-03-01|June 2009|2009-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Memory Impairment Study (Mild Cognitive Impairment Study)|A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin E and Donepezil HCL (Aricept) to Delay Clinical Progression From Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD)|Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:35.893276|2017-10-11 04:17:35.893276
NCT00000174|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2005-12-08||||||January 2000|2000-01-01||||||||Interventional|||Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)||Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:36.314315|2017-10-11 04:17:36.314315
NCT00000175|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2009-12-10||||||March 2004|2004-03-01|June 2005|Anticipated|2005-06-01|June 2005|Anticipated|2005-06-01||Interventional|||The Effects of Sex Hormones on Cognition and Mood in Older Adults||Terminated||N/A|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:36.918186|2017-10-11 04:17:36.918186
NCT00000176|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2010-11-03||||||November 2010|2010-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Alzheimer's Disease Prevention Trial|Alzheimer's Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimer's Disease and Loss of Memory in Women.|Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:37.012026|2017-10-11 04:17:37.012026
NCT00000177|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2009-12-10|||October 1995||1995-10-01|September 2009|2009-09-01|January 1999|Actual|1999-01-01|January 1999|Actual|1999-01-01||Interventional|||Estrogen Hormone Protocol||Completed||Phase 3|120||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:37.14116|2017-10-11 04:17:37.14116
NCT00000178|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2005-06-23||||||February 2005|2005-02-01||||||||Interventional|||Multicenter Trial of Prednisone in Alzheimer's Disease|Multicenter Trial of Prednisone in Alzheimer's Disease|Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:37.274011|2017-10-11 04:17:37.274011
NCT00000179|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2005-06-23||||||March 2005|2005-03-01||||||||Interventional|||Agitation in Alzheimer's Disease||Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:37.415183|2017-10-11 04:17:37.415183
NCT00000180|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-29|2009-12-10||||||February 2005|2005-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||AIT-082 Phase 1B Study||Completed||Phase 1|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:17:37.54046|2017-10-11 04:17:37.54046
NCT00000187|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||July 1992||1992-07-01|May 2015|2015-05-01||||June 1994|Actual|1994-06-01||Interventional|||Ritanserin in Treatment of Cocaine Dependence - 1|Ritanserin in Treatment of Cocaine Dependence|Completed||Phase 2|80|Actual|University of Pennsylvania||1|||f||||||||||||||2017-10-11 04:17:37.612523|2017-10-11 04:17:37.612523
NCT00000188|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||September 1994||1994-09-01|May 2015|2015-05-01|October 1995|Actual|1995-10-01|October 1995|Actual|1995-10-01||Interventional|||Selegiline in Treatment of Cocaine Dependence - 2|Selegiline in Treatment of Cocaine Dependence|Completed||Phase 2|50|Actual|University of Pennsylvania||1|||f||||||||||||||2017-10-11 04:17:37.682769|2017-10-11 04:17:37.682769
NCT00000189|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||January 1990||1990-01-01|May 2015|2015-05-01|February 1991|Actual|1991-02-01|February 1991|Actual|1991-02-01||Interventional|||Gepirone vs Placebo in Treatment of Cocaine Dependence - 3|Gepirone vs Placebo in Treatment of Cocaine Dependence|Completed||Phase 2|41|Actual|University of Pennsylvania||1|||f||||||||||||||2017-10-11 04:17:37.748479|2017-10-11 04:17:37.748479
NCT00000190|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||January 1991||1991-01-01|May 2015|2015-05-01|February 1992|Actual|1992-02-01|February 1992|Actual|1992-02-01||Interventional|||Cocaine in Parotid Saliva, Blood and Urine - 4|Cocaine in Parotid Saliva, Blood and Urine|Completed||Phase 1|0||University of Pennsylvania|||||f||||||||||||||2017-10-11 04:17:37.820232|2017-10-11 04:17:37.820232
NCT00000191|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||January 1991||1991-01-01|May 2015|2015-05-01|February 1994|Actual|1994-02-01|February 1994|Actual|1994-02-01||Interventional|||Carbamazepine Treatment for Cocaine Dependence - 5|Carbamazepine Treatment for Cocaine Dependence|Completed||Phase 2|0||University of Pennsylvania|||||f||||||||||||||2017-10-11 04:17:37.892638|2017-10-11 04:17:37.892638
NCT00000192|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-08-05|||January 1993||1993-01-01|August 2015|2015-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 1 - 1|Neurobiology of Opioid Dependence: 1|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-10-11 04:17:37.97092|2017-10-11 04:17:37.97092
NCT00000193|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-08-05|||January 1993||1993-01-01|August 2015|2015-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 2 - 2|Neurobiology of Opioid Dependence: 2|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-10-11 04:17:38.057638|2017-10-11 04:17:38.057638
NCT00000210|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||September 1989||1989-09-01|December 2002|2002-12-01|February 1996|Actual|1996-02-01|February 1996|Actual|1996-02-01||Interventional|||Treatment Efficacy for Drug Abuse and AIDS Prevention - 1|Treatment Efficacy for Drug Abuse and AIDS Prevention|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:39.347511|2017-10-11 04:17:39.347511
NCT00000211|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||September 1989||1989-09-01|December 2002|2002-12-01|February 1996|Actual|1996-02-01|February 1996|Actual|1996-02-01||Interventional|||Treatment Efficacy for Drug Abuse and AIDS Prevention - 2|Treatment Efficacy for Drug Abuse and AIDS Prevention|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:39.407871|2017-10-11 04:17:39.407871
NCT00000212|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-08-27|||July 1987||1987-07-01|December 2012|2012-12-01|July 1988|Actual|1988-07-01|July 1988|Actual|1988-07-01||Interventional|||IV Cocaine Abuse: A Laboratory Model - 1|IV Cocaine Abuse: A Laboratory Model|Completed||Phase 2|0||New York State Psychiatric Institute|||||f||||||||||||||2017-10-11 04:17:39.465912|2017-10-11 04:17:39.465912
NCT00000213|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-08-27|||April 1990||1990-04-01|December 2012|2012-12-01|April 1991|Actual|1991-04-01|April 1991|Actual|1991-04-01||Interventional|||IV Cocaine Abuse: A Laboratory Model - 2|IV Cocaine Abuse: A Laboratory Model|Completed||Phase 2|0||New York State Psychiatric Institute|||||f||||||||||||||2017-10-11 04:17:39.527261|2017-10-11 04:17:39.527261
NCT00000214|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-08-27|||January 1992||1992-01-01|December 2012|2012-12-01|January 1993|Actual|1993-01-01|January 1993|Actual|1993-01-01||Interventional|||IV Cocaine Abuse: A Laboratory Model - 3|IV Cocaine Abuse: A Laboratory Model|Completed||Phase 2|0||New York State Psychiatric Institute|||||f||||||||||||||2017-10-11 04:17:39.586576|2017-10-11 04:17:39.586576
NCT00000215|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11||||||October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||IV Cocaine Abuse: A Laboratory Model - 4|IV Cocaine Abuse: A Laboratory Model|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:39.725074|2017-10-11 04:17:39.725074
NCT00000216|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16||||||December 2002|2002-12-01||||||||Interventional|||Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1|Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts|Completed||Phase 3|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:39.801479|2017-10-11 04:17:39.801479
NCT00000217|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-04-15|||September 1990||1990-09-01|April 2015|2015-04-01||||October 1996|Actual|1996-10-01||Interventional|||Pharmacotherapy and Intensive Treatment of Drug Abuse - 1|Pharmacotherapy and Intensive Treatment of Drug Abuse|Completed||Phase 2|||University of Kansas Medical Center|||||f||||||||||||||2017-10-11 04:17:39.869694|2017-10-11 04:17:39.869694
NCT00000218|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11||||||October 2016|2016-10-01|June 2005|Actual|2005-06-01|||||Interventional|||Pharmacotherapy and Intensive Treatment - 2|Pharmacotherapy and Intensive Treatment|Completed||Phase 4|353||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.00914|2017-10-11 04:17:40.00914
NCT00000219|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-05-05|||December 1991||1991-12-01|April 1992|1992-04-01|July 2001||2001-07-01|||||Interventional|||Buprenorphine Dose Alteration Study - 1|Buprenorphine Dose Alteration Study|Completed||Phase 1|0||University of Vermont|||||f||||||||||||||2017-10-11 04:17:40.097912|2017-10-11 04:17:40.097912
NCT00000220|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-06-23|||June 1991||1991-06-01|September 1991|1991-09-01|July 2001||2001-07-01|||||Interventional|||Gradual Vs. Rapid Buprenorphine Detoxification - 2|Gradual Vs. Rapid Buprenorphine Detoxification|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.171157|2017-10-11 04:17:40.171157
NCT00000221|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-06-23|||April 1992||1992-04-01|November 1993|1993-11-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase I - 3|Alternate-Day Buprenorphine Administration. Phase I|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.236075|2017-10-11 04:17:40.236075
NCT00000222|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-06-23|||July 1992||1992-07-01|December 1993|1993-12-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase II - 4|Alternate-Day Buprenorphine Administration. Phase II|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.30376|2017-10-11 04:17:40.30376
NCT00000223|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-06-23|||June 1993||1993-06-01|September 1994|1994-09-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase IV - 5|Alternate-Day Buprenorphine Administration. Phase IV|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.374381|2017-10-11 04:17:40.374381
NCT00000224|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-06-23|||February 1993||1993-02-01|April 1996|1996-04-01||||||||Interventional|||Alternate-Day Buprenorphine. Phase V - 6|Alternate-Day Buprenorphine. Phase V|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.444317|2017-10-11 04:17:40.444317
NCT00000225|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-06-23|||December 1992||1992-12-01|June 2004|2004-06-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase VI - 7|Alternate-Day Buprenorphine Administration. Phase VI|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.517973|2017-10-11 04:17:40.517973
NCT00000226|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-06-23|||November 1994||1994-11-01|July 1996|1996-07-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase VII - 8|Alternate-Day Buprenorphine Administration. Phase VII|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.58244|2017-10-11 04:17:40.58244
NCT00000227|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-05-05|||August 1994||1994-08-01|July 1996|1996-07-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase VIII - 9|Alternate-Day Buprenorphine Administration. Phase VIII|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-10-11 04:17:40.661362|2017-10-11 04:17:40.661362
NCT00000228|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16|||August 1994||1994-08-01|July 1996|1996-07-01||||||||Interventional|||Buprenorphine Detox With Two Types of Treatment. BBD I - 10|Buprenorphine Detox With Two Types of Treatment. BBD I|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.736064|2017-10-11 04:17:40.736064
NCT00000229|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-05-05|||October 1995||1995-10-01|September 1996|1996-09-01||||||||Interventional|||Buprenorphine Detox With Two Types of Treatment. BBD II - 11|Buprenorphine Detox With Two Types of Treatment. BBD II|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-10-11 04:17:40.802786|2017-10-11 04:17:40.802786
NCT00000230|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-05-05|||January 1995||1995-01-01|August 1996|1996-08-01||||||||Interventional|||Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12|Buprenorphine Detoxification With Two Types of Treatment. BBD III|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-10-11 04:17:40.868082|2017-10-11 04:17:40.868082
NCT00000231|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-08-16|||February 1992||1992-02-01|March 1994|1994-03-01||||||||Interventional|||Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13|Buprenorphine Detoxification With Two Types of Treatment. BBD IV|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:40.938217|2017-10-11 04:17:40.938217
NCT00000240|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-06-02|||April 1999||1999-04-01|April 1999|1999-04-01||||||||Interventional|||Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22|Combined Buprenorphine and Behavioral Treatment Without Contingent Reinforcement|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-10-11 04:17:41.551533|2017-10-11 04:17:41.551533
NCT00000268|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||May 1995||1995-05-01|November 2016|2016-11-01|November 1998||1998-11-01|||||Interventional|||Cocaine Abuse and Attention Deficit Disorder - 3|Cocaine Abuse and Attention Deficit Disorder|Completed||N/A|32||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:17:41.618809|2017-10-11 04:17:41.618809
NCT00000269|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||October 1995||1995-10-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Pergolide Treatment for Substance Abusers - 4|Pergolide Treatment for Substance Abusers|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:41.696713|2017-10-11 04:17:41.696713
NCT00000270|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-08-01|||December 30, 1995|Actual|1995-12-30|July 2017|2017-07-01|December 30, 1995|Actual|1995-12-30|December 30, 1995|Actual|1995-12-30||Interventional|||Brain Imaging: Cocaine Effects & Medication Development - 5|Brain Imaging: Cocaine Effects & Medication Development|Withdrawn||Phase 4|0|Actual|New York State Psychiatric Institute||||Study never opened; never enrolled participants|f|||||f|f||||||||2017-10-11 04:17:41.760398|2017-10-11 04:17:41.760398
NCT00000271|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-07-03|||January 1995|Actual|1995-01-01|June 2017|2017-06-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||New Approaches to Cocaine Abuse Medications (A) - 6|New Approaches to Cocaine Abuse Medications (A)|Completed||Phase 2|111|Actual|New York State Psychiatric Institute||2|||f||||f|t|f|||f|||||2017-10-11 04:17:41.82266|2017-10-11 04:17:41.82266
NCT00000273|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-07-03|||August 1995||1995-08-01|June 2017|2017-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Laboratory Model for Heroin Abuse Medications - 8|A Laboratory Model for Heroin Abuse Medications|Completed||Phase 2|8|Actual|New York State Psychiatric Institute||1|||f||||t|t|f||||||||2017-10-11 04:17:41.899744|2017-10-11 04:17:41.899744
NCT00000274|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||March 1997||1997-03-01|November 2016|2016-11-01|May 1999||1999-05-01|||||Interventional|||Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9|Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics|Completed||Phase 2|60||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:41.999733|2017-10-11 04:17:41.999733
NCT00000275|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||November 1996||1996-11-01|November 2016|2016-11-01|March 1998||1998-03-01|||||Interventional|||Cocaine Abuse and ADHD - 10|Cocaine Abuse and ADHD|Completed||Phase 2|16||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:42.064919|2017-10-11 04:17:42.064919
NCT00000276|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2008|2008-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Dopamine Reuptake Inhibitors of Cocaine Abuse - 1|Dopamine Reuptake Inhibitors of Cocaine Abuse|Terminated||Phase 1|0||Yale University|||||f||||||||||||||2017-10-11 04:17:42.127761|2017-10-11 04:17:42.127761
NCT00000277|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Mazindol for Cocaine Abuse - 2|Mazindol for Cocaine Abuse|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-10-11 04:17:42.194449|2017-10-11 04:17:42.194449
NCT00000278|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Disulfiram for Cocaine-Alcohol Abuse - 3|Disulfiram for Cocaine-Alcohol Abuse|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-10-11 04:17:42.262129|2017-10-11 04:17:42.262129
NCT00000279|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Novel Medications for Opiate Detoxification - 4|Novel Medications for Opiate Detoxification|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-10-11 04:17:42.330779|2017-10-11 04:17:42.330779
NCT00000280|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-04-21|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Glutaminergic Agents for Cocaine Abuse - 5|Glutaminergic Agents for Cocaine Abuse|Completed||Phase 1|0||Yale University|||||f||||||||||||||2017-10-11 04:17:42.408545|2017-10-11 04:17:42.408545
NCT00000281|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-12-13|||September 1994||1994-09-01|December 2016|2016-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Pharmacotherapy for Schizophrenic Drug Users - 6|Pharmacotherapy for Schizophrenic Drug Users|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-10-11 04:17:42.482332|2017-10-11 04:17:42.482332
NCT00000282|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-12-13|||September 1994||1994-09-01|December 2016|2016-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Pemoline for Cocaine Abuse - 7|Pemoline for Cocaine Abuse|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-10-11 04:17:42.548361|2017-10-11 04:17:42.548361
NCT00000284|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||February 1995||1995-02-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Role of Metabolites in Nicotine Dependence (1) - 1|Role of Metabolites in Nicotine Dependence (1)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:42.614024|2017-10-11 04:17:42.614024
NCT00000285|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||May 1996||1996-05-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Effects of Phenytoin on Cocaine Use in Humans - 2|Effects of Phenytoin on Cocaine Use in Humans|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:42.689458|2017-10-11 04:17:42.689458
NCT00000286|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||December 1996||1996-12-01|October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3|Effects of Nefazodone on Treatment of Female Cocaine Abusers|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:42.784297|2017-10-11 04:17:42.784297
NCT00000287|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||February 1995||1995-02-01|October 2016|2016-10-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Observational|||Relapse Patterns in Female Cocaine Users - 4|Relapse Patterns in Female Cocaine Users|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:42.868374|2017-10-11 04:17:42.868374
NCT00000288|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||December 1995||1995-12-01|November 2016|2016-11-01|December 2002||2002-12-01|||||Interventional|||Role of Metabolites in Nicotine Dependence (2) - 5|Role of Metabolites in Nicotine Dependence (2)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:42.947385|2017-10-11 04:17:42.947385
NCT00000289|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||May 1998||1998-05-01|December 1998|1998-12-01|December 2001||2001-12-01|||||Interventional|||Role of Metabolites in Nicotine Dependence (3) - 6|Role of Metabolites in Nicotine Dependence (3)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.020571|2017-10-11 04:17:43.020571
NCT00000299|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-01-27|||October 2008||2008-10-01|January 2016|2016-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2|Rapid Opiate Detoxification & Naltrexone Induction Using Bup.|Completed||Phase 2|12|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-10-11 04:17:43.773493|2017-10-11 04:17:43.773493
NCT00000300|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-11-03|||March 1995||1995-03-01|March 1995|1995-03-01||||||||Interventional|||Feasibility Study of Take-Home LAAM Medication - 3|Feasibility Study of Take-Home LAAM Medication|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:43.855128|2017-10-11 04:17:43.855128
NCT00000301|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-07-07|||March 1996||1996-03-01|July 2016|2016-07-01||||June 1998|Actual|1998-06-01||Interventional|||Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4|Rapid Evaluation of Cocaine Pharmacotherapies (Amantadine)|Completed||Phase 2|0||University of California, Los Angeles|||||f||||||||||||||2017-10-11 04:17:43.971932|2017-10-11 04:17:43.971932
NCT00000302|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-11-03||||||December 2002|2002-12-01||||||||Interventional|||Study Comparing Liquid and Tablet Buprenorphine Formulations - 5|Expanded Steady-State Pharmacokinetic Study, Comparing Liquid and Tablet Buprenorphine Formulations|Completed||Phase 3|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:44.070763|2017-10-11 04:17:44.070763
NCT00000303|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-07-07|||October 1997||1997-10-01|July 2016|2016-07-01||||May 1999|Actual|1999-05-01||Interventional|||Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6|Rapid Evaluation of Cocaine Pharmacotherapies (Baclofen)|Completed||Phase 2|0||University of California, Los Angeles|||||f||||||||||||||2017-10-11 04:17:44.149581|2017-10-11 04:17:44.149581
NCT00000304|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||August 1997||1997-08-01|October 2016|2016-10-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Dextroamphetamine as an Adjunct in Cocaine Treatment - 1|Dextroamphetamine as an Adjunct in Cocaine Treatment|Completed||Phase 2|120|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 04:17:44.234996|2017-10-11 04:17:44.234996
NCT00000305|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Amphetamine Cocaine Interaction Study - 2|Amphetamine Cocaine Interaction Study|Terminated||Phase 1|0||The University of Texas Health Science Center, Houston||||Original P.I. left the institution|f||||t||||||||||2017-10-11 04:17:44.324842|2017-10-11 04:17:44.324842
NCT00000306|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||September 1994||1994-09-01|October 2016|2016-10-01|September 2001||2001-09-01|||||Interventional|||Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3|Dextroamphetamine as an Adjunct in Cocaine/Opiate Dependent Patients|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:44.394829|2017-10-11 04:17:44.394829
NCT00000307|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||April 2003||2003-04-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4|Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:17:44.474072|2017-10-11 04:17:44.474072
NCT00000308|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||September 1995||1995-09-01|October 2016|2016-10-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Dextroamphetamine-Cocaine Behavioral Intervention - 5|D-amphetamine-Cocaine Behavioral Intervention|Completed||Phase 2|54|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 04:17:44.555429|2017-10-11 04:17:44.555429
NCT00000309|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-07-23|||August 1994||1994-08-01|July 2015|2015-07-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1|Serotonin/Dopamine Antagonism of Cocaine Effect|Terminated||Phase 2|0||Butler Hospital||||Unable to recruit adequate number of subjects|f||||||||||||||2017-10-11 04:17:44.654084|2017-10-11 04:17:44.654084
NCT00000310|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-13|||January 1996||1996-01-01|January 1996|1996-01-01|March 1996|Actual|1996-03-01|March 1996|Actual|1996-03-01||Interventional|||Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2|Serotonin/Dopamine Antagonism of Cocaine Effect|Terminated||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:44.750052|2017-10-11 04:17:44.750052
NCT00000311|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2008-10-27|||September 1999||1999-09-01|October 2008|2008-10-01||||||||Interventional|||Combining Behavioral Treatment With Agonist Maintenance - 1|Combining Behavioral Treatment With Agonist Maintenance|Unknown status|Active, not recruiting|Phase 3|168||National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-10-11 04:17:44.840224|2017-10-11 04:17:44.840224
NCT00000312|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2005-06-23||||||December 2002|2002-12-01||||||||Interventional|||Alterations in Serotonergic Functions in Cocaine Addicts - 1|Alterations in Serotonergic Functions in Cocaine Addicts|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:44.934085|2017-10-11 04:17:44.934085
NCT00000313|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11||||||December 2002|2002-12-01||||||||Interventional|||Predictive Values of Serotonergic Alterations for Outcome - 2|Predictive Values of Serotonergic Alterations for Outcome|Terminated||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:45.065282|2017-10-11 04:17:45.065282
NCT00000314|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-17|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||M-CPP and Fenfluramine in Cocaine Addicts - 3|To Study Predictive Values of M-CPP and Fenfluramine in Cocaine Addicts|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:45.141142|2017-10-11 04:17:45.141142
NCT00000315|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||November 1996||1996-11-01|November 1996|1996-11-01|December 2001||2001-12-01|||||Interventional|||Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1|Human Dopamine Transported Imaging in Cocaine Abuse: 1|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:45.225549|2017-10-11 04:17:45.225549
NCT00000316|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||August 1996||1996-08-01|August 1996|1996-08-01|December 2001||2001-12-01|||||Interventional|||Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2|Human Dopamine Transported Imaging in Cocaine Abuse: 2|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:45.307292|2017-10-11 04:17:45.307292
NCT00000317|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-06-22|||August 1996|Actual|1996-08-01|June 2017|2017-06-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Interventional|||Early Phase II Trials for Cocaine Medication Development - 1|Early Phase II Trials for Cocaine Medication Development|Completed||Phase 2|31|Actual|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-10-11 04:17:45.407104|2017-10-11 04:17:45.407104
NCT00000318|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||December 1994||1994-12-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|March 2004|Actual|2004-03-01||Interventional|||Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1|Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot|Completed||Phase 2|202|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 04:17:45.532451|2017-10-11 04:17:45.532451
NCT00000320|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||October 1997||1997-10-01|January 2009|2009-01-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1|Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution|Completed||Phase 1/Phase 2|120|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 04:17:45.693382|2017-10-11 04:17:45.693382
NCT00000321|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||October 1996||1996-10-01|October 1996|1996-10-01|December 2001||2001-12-01|||||Interventional|||Methamphetamine Abuse Treatment in Patients With AIDS - 1|Methamphetamine Abuse Pharmacology in Patients With AIDS|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:45.807682|2017-10-11 04:17:45.807682
NCT00000322|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||April 1997||1997-04-01|April 1997|1997-04-01|December 2001||2001-12-01|||||Interventional|||Tyrosine for Methamphetamine Dependence - 1|Tyrosine for Methamphetamine Dependence|Completed||Phase 2|89||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:45.891682|2017-10-11 04:17:45.891682
NCT00000323|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||July 1996||1996-07-01|May 2004|2004-05-01|December 1998||1998-12-01|||||Observational|||Therapeutic Potential of Kappa-Opioids Against Cocaine - 1|Therapeutic Potential of Kappa-Opioids Against Cocaine|Completed||Phase 1|10||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:45.973374|2017-10-11 04:17:45.973374
NCT00000324|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||March 1997||1997-03-01|August 2005|2005-08-01|April 2001||2001-04-01|||||Interventional|||Tryptophan and Behavior Therapy for Cocaine Abuse - 1|Tryptophan and Behavior Therapy for Cocaine Abuse|Completed||Phase 2|200||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:17:46.058036|2017-10-11 04:17:46.058036
NCT00000325|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11||||||December 2002|2002-12-01|December 2001||2001-12-01|||||Interventional|||Psychostimulant Abuse - Novel Treatment Approaches - 1|Psychostimulant Abuse - Novel Treatment Approaches|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:46.139796|2017-10-11 04:17:46.139796
NCT00000326|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-05-02|||April 1997||1997-04-01|May 2017|2017-05-01|August 1997|Actual|1997-08-01|August 1997|Actual|1997-08-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1(1)|Withdrawn||Phase 2|0|Actual|University of Colorado, Denver|||||f||||||||||||||2017-10-11 04:17:46.207449|2017-10-11 04:17:46.207449
NCT00000327|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-05-02|||June 1997||1997-06-01|May 2017|2017-05-01|August 1997|Actual|1997-08-01|August 1997|Actual|1997-08-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2)|Withdrawn||Phase 2|0|Actual|University of Colorado, Denver|||||f||||||||||||||2017-10-11 04:17:46.279562|2017-10-11 04:17:46.279562
NCT00000328|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-05-02|||July 1997||1997-07-01|May 2017|2017-05-01|August 1997|Actual|1997-08-01|August 1997|Actual|1997-08-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III|Withdrawn||Phase 2|0|Actual|University of Colorado, Denver|||||f|||||f|f||||||||2017-10-11 04:17:46.342812|2017-10-11 04:17:46.342812
NCT00000329|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-05-02|||April 1999||1999-04-01|May 2017|2017-05-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1|Withdrawn||Phase 2|0|Actual|University of Colorado, Denver|||||f||||||||||||||2017-10-11 04:17:46.410325|2017-10-11 04:17:46.410325
NCT00000330|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-05-02|||October 1999||1999-10-01|May 2017|2017-05-01|November 1999|Actual|1999-11-01|November 1999|Actual|1999-11-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2|Withdrawn||Phase 2|0|Actual|University of Colorado, Denver|||||f||||||||||||||2017-10-11 04:17:46.477434|2017-10-11 04:17:46.477434
NCT00000331|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-05-02|||December 2002||2002-12-01|May 2017|2017-05-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3|Withdrawn||Phase 2|0|Actual|University of Colorado, Denver||2|||f||||||||||||||2017-10-11 04:17:46.544679|2017-10-11 04:17:46.544679
NCT00000332|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-02-23|||May 1998|Actual|1998-05-01|December 2002|2002-12-01|April 2000|Actual|2000-04-01|January 2000|Actual|2000-01-01||Interventional|||High Dose Nimodipine Treatment Adjunct - 1|High Dose Nimodipine Pharmacotherapy Adjunct|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f|||||t|f||||||||2017-10-11 04:17:46.612607|2017-10-11 04:17:46.612607
NCT00000333|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-02-23|||May 2001|Actual|2001-05-01|December 2002|2002-12-01|April 2003|Actual|2003-04-01|January 2003|Actual|2003-01-01||Interventional|||Evaluation of Benztropine for Cocaine Craving - 2|Evaluation of Efficacy of Benztropine for Cocaine Craving|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f|||||t|||||||||2017-10-11 04:17:46.664961|2017-10-11 04:17:46.664961
NCT00000334|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-30|||December 1, 2002|Actual|2002-12-01|December 2002|2002-12-01|January 15, 2005|Actual|2005-01-15|November 1, 2004|Actual|2004-11-01||Interventional|||Comparison of Buprenorphine and Methadone - 3|Pharmacological Comparison of Buprenorphine and Methadone|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:46.726945|2017-10-11 04:17:46.726945
NCT00000335|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-30|||September 30, 1995|Actual|1995-09-30|December 2002|2002-12-01|May 20, 1996|Actual|1996-05-20|March 20, 1996|Actual|1996-03-20||Interventional|||Activity Monitoring Assessment of Opiate Withdrawal - 4|Activity Monitoring Assessment of Opiate Withdrawal|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:46.778216|2017-10-11 04:17:46.778216
NCT00000336|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-13|||January 1995||1995-01-01|January 1996|1996-01-01|March 1996|Actual|1996-03-01|February 1996|Actual|1996-02-01||Interventional|||Selegiline in Outpatient Treatment for Cocaine Dependence - 1|Safety and Efficacy of Selegiline in Outpatient Treatment for Cocaine|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:46.839604|2017-10-11 04:17:46.839604
NCT00000337|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||November 1994||1994-11-01|August 1996|1996-08-01||||||||Interventional|||Infusion Laboratory: Protocol 1 - Selegeline - 2|Infusion Laboratory: Protocol 1 - Selegeline|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:46.902468|2017-10-11 04:17:46.902468
NCT00000338|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-10|||March 1996||1996-03-01|March 1996|1996-03-01||||||||Interventional|||Infusion Laboratory: Protocol 2 (Lisuride) - 3|Infusion Laboratory: Protocol 2 (Lisuride)|Unknown status|Active, not recruiting|Phase 1|2||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.065033|2017-10-11 04:17:47.065033
NCT00000596|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||June 1978||1978-06-01|February 2002|2002-02-01|January 1983|Actual|1983-01-01|||||Interventional|||Diffuse Fibrotic Lung Disease||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.830134|2017-10-11 04:19:07.830134
NCT00000347|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||July 1997||1997-07-01|March 1998|1998-03-01|September 1998|Actual|1998-09-01|August 1998|Actual|1998-08-01||Interventional|||Risperidone for Treatment of Cocaine Dependence in Outpatients - 12|Risperidone for Treatment of Cocaine Dependence in Outpatients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.760099|2017-10-11 04:17:47.760099
NCT00000348|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-10||||||December 2002|2002-12-01||||||||Interventional|||Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13|Infusion Laboratory: Protocol 4 (Dihydrexidine)|Unknown status|Active, not recruiting|Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.822395|2017-10-11 04:17:47.822395
NCT00000349|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-10||||||December 2002|2002-12-01||||||||Interventional|||Infusion Laboratory: Protocol 5 (Flupenthixol) - 14|Infusion Laboratory: Protocol 5 (Flupenthixol)|Unknown status|Active, not recruiting|Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.908543|2017-10-11 04:17:47.908543
NCT00000350|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-10|||March 1999||1999-03-01|March 1999|1999-03-01||||||||Interventional|||Effects of Stimulant Dependence on Human Striatal Dopamine System - 15|Effects of Stimulant Dependence on Human Striatal Dopamine System|Unknown status|Active, not recruiting|Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:47.995052|2017-10-11 04:17:47.995052
NCT00000351|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-10||||||December 2002|2002-12-01||||||||Observational|||Cognitive Correlates of Substance Abuse, Part 2 - 16|Cognitive Correlates of Substance Abuse, Part 2|Unknown status|Active, not recruiting|Phase 4|43||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:48.061606|2017-10-11 04:17:48.061606
NCT00000352|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||December 1996||1996-12-01|August 1997|1997-08-01|April 1998|Actual|1998-04-01|February 1998|Actual|1998-02-01||Interventional|||Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1|Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:49.503361|2017-10-11 04:17:49.503361
NCT00000353|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-17|||October 1996||1996-10-01|December 2002|2002-12-01|October 1997|Actual|1997-10-01|September 1997|Actual|1997-09-01||Interventional|||Trial of Buprenorphine/Naloxone for Opiate Dependence - 2|Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:49.556179|2017-10-11 04:17:49.556179
NCT00000354|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||July 1996||1996-07-01|July 1996|1996-07-01|December 1997|Actual|1997-12-01|September 1997|Actual|1997-09-01||Interventional|||Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3|Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:49.607104|2017-10-11 04:17:49.607104
NCT00000355|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||November 1994||1994-11-01|May 1995|1995-05-01|March 1996|Actual|1996-03-01|January 1996|Actual|1996-01-01||Interventional|||Effects of Buprenorphine and Naloxone in Opiate Addicts - 4|Effects of Buprenophine and Naloxone in Opiate Addicts|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:49.682384|2017-10-11 04:17:49.682384
NCT00000356|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||June 1991||1991-06-01|February 1992|1992-02-01|October 1992|Actual|1992-10-01|August 1992|Actual|1992-08-01||Interventional|||Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5|Pharmacokinetics of LAAM in Methadone Patients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:49.740733|2017-10-11 04:17:49.740733
NCT00000357|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||June 1992||1992-06-01|December 1993|1993-12-01|October 1993|Actual|1993-10-01|August 1993|Actual|1993-08-01||Interventional|||Buprenorphine Maintenance for Opiate Dependence - 6|Buprenorphine Maintenance for Opiate Dependence|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:49.796591|2017-10-11 04:17:49.796591
NCT00000358|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11||||||December 2002|2002-12-01||||||||Interventional|||Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7|Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:17:49.849356|2017-10-11 04:17:49.849356
NCT00000359|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-07-25|||October 1998||1998-10-01|July 2012|2012-07-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Treatments for Benign Paroxysmal Positional Vertigo (BPPV)|Treatments for Benign Paroxysmal Positional Vertigo (BPPV)|Completed||Phase 2|150|Actual|Baylor College of Medicine||5|||f||||f||||||||||2017-10-11 04:17:49.90451|2017-10-11 04:17:49.90451
NCT00000361|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2006-04-21|||March 1998||1998-03-01|April 2006|2006-04-01|November 2002||2002-11-01|||||Interventional|||Autoimmunity in Inner Ear Disease||Terminated||Phase 3|||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-10-11 04:17:49.998353|2017-10-11 04:17:49.998353
NCT00000362|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2006-04-21||||||April 2006|2006-04-01|January 2006||2006-01-01|||||Interventional|||Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects||Terminated||Phase 3|600||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-10-11 04:17:50.102685|2017-10-11 04:17:50.102685
NCT00000363|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2006-04-21||||||April 2006|2006-04-01|June 2001||2001-06-01|||||Interventional|||Acute Otitis Media: Adjuvant Therapy to Improve Outcome||Completed||Phase 3|||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-10-11 04:17:50.1666|2017-10-11 04:17:50.1666
NCT00000367|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-10-25|||September 1998||1998-09-01|October 2013|2013-10-01|August 2003||2003-08-01|||||Interventional|||Prevention of Suicide in the Elderly||Completed||N/A|||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 04:17:50.320989|2017-10-11 04:17:50.320989
NCT00000368|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-03-17|||February 1999||1999-02-01|March 2014|2014-03-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Treatment of Panic Disorder: Long Term Strategies|Treatment of Panic Disorder: Long Term Strategies|Completed||Phase 3|379|Actual|New York State Psychiatric Institute|||||f||||t||||||||||2017-10-11 04:17:50.408454|2017-10-11 04:17:50.408454
NCT00000369|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-06-21|||June 1997||1997-06-01|February 2008|2008-02-01|December 2002|Actual|2002-12-01|||||Interventional|||Maintenance Therapies in Bipolar Disorders||Completed||Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:17:50.532827|2017-10-11 04:17:50.532827
NCT00000370|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-08-05|||May 1998||1998-05-01|August 2013|2013-08-01|February 2003||2003-02-01|||||Interventional|||Treatment of Social Phobia|Treatment of Social Phobia: Mediators And Moderators|Completed||N/A|||Boston University|||||f||||||||||||||2017-10-11 04:17:50.631795|2017-10-11 04:17:50.631795
NCT00000391|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2015-03-02|||January 1988||1988-01-01|April 2002|2002-04-01||||January 1990|Actual|1990-01-01||Interventional|||A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.||Completed||Phase 1|30|Actual|National Institute of Mental Health (NIMH)||1|||f||||||||||||||2017-10-11 04:17:52.953228|2017-10-11 04:17:52.953228
NCT00000371|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-09-03|2014-08-11||August 1996||1996-08-01|September 2014|2014-09-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Trial of D-Cycloserine in Schizophrenia|A Six Month, Placebo-Controlled Trial of D-Cycloserine Co-Administered With Conventional Antipsychotics in Schizophrenia Patients|Completed||Phase 3|60|Actual|Massachusetts General Hospital|A biased sample may have been produced by restricting the analysis to patients with prominent negative symptoms receiving conventional agents (less compliant with study medication). Additionally, Adverse Event data was lost for the study.|2|||f||||||||||||||2017-10-11 04:17:50.710209|2017-10-11 04:17:50.710209
NCT00000372|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-06-11|||March 1998||1998-03-01|June 2014|2014-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Glycine and D-Cycloserine in Schizophrenia|A Placebo Controlled Trial of Glycine Added to Clozapine in Schizophrenia|Withdrawn||Phase 3|0|Actual|Massachusetts General Hospital||3||"Pairing D-Cycloserine with Clozapine was found to worsen negative side effects in patients with   Schizophrenia, so the study was suspended."|f||||||||||||||2017-10-11 04:17:51.024311|2017-10-11 04:17:51.024311
NCT00000373|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-11-26|||September 1992||1992-09-01|November 2013|2013-11-01|July 2003|Actual|2003-07-01|January 2003|Actual|2003-01-01||Interventional|||Treatment of Obsessive-Compulsive Disorder|Neurobiology/Treatment of Obsessive-Compulsive Disorder|Completed||Phase 4|74|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 04:17:51.132013|2017-10-11 04:17:51.132013
NCT00000374|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-01-12|||September 1998||1998-09-01|January 2012|2012-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Treatment for First-Episode Schizophrenia|Preventing Morbidity in First-Episode Schizophrenia|Completed||Phase 4|125|Actual|Northwell Health||1|||f||||t||||||||||2017-10-11 04:17:51.248652|2017-10-11 04:17:51.248652
NCT00000376|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-10-09|||March 1996||1996-03-01|December 2005|2005-12-01|February 1999||1999-02-01|||||Interventional|||Cognitive and Drug Therapy for Drug-Resistant Depression||Completed||N/A|||University of Pennsylvania|||||f||||||||||||||2017-10-11 04:17:51.40309|2017-10-11 04:17:51.40309
NCT00000377|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-06-20|||March 1989||1989-03-01|June 2013|2013-06-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Preventing the Return of Depression in Elderly Patients|Maintenance Therapies in Late-Life Depression|Completed||N/A|||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:17:51.477026|2017-10-11 04:17:51.477026
NCT00000378|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-10-06|2015-04-02||July 1997||1997-07-01|September 2008|2008-09-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Antidepressant Treatment of Melancholia in Late Life|Antidepressant Treatment of Melancholia in Late :Ife|Completed||Phase 4|110|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 04:17:51.547515|2017-10-11 04:17:51.547515
NCT00000379|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-02-19|||January 1999||1999-01-01|February 2014|2014-02-01|December 2003||2003-12-01|||||Interventional|||Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)|Treatment of Outcomes of Fluoxetine vs EMDR in PTSD|Completed||Phase 3|||Boston University|||||f||||||||||||||2017-10-11 04:17:51.805441|2017-10-11 04:17:51.805441
NCT00000380|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-12-01|||June 1996||1996-06-01|December 2015|2015-12-01|July 2007||2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances|Age-Related Sleep Impairment - Treatment w/GHRH|Completed||N/A|||University of Washington||2|||f||||||||||||||2017-10-11 04:17:51.873353|2017-10-11 04:17:51.873353
NCT00000381|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-01-07|||June 1997||1997-06-01|December 2005|2005-12-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Fluoxetine for Anxious Children||Completed||Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:17:51.951104|2017-10-11 04:17:51.951104
NCT00000382|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-11-05|||July 1998||1998-07-01|November 2013|2013-11-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Preventing Child Abuse in Infants|Preventive Intervention for Maltreated Infants|Completed||Phase 3|||University of Rochester|||||f||||t||||||||||2017-10-11 04:17:52.013082|2017-10-11 04:17:52.013082
NCT00000383|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-03-27|||September 1997||1997-09-01|March 2015|2015-03-01|September 2002|Actual|2002-09-01|September 2001|Actual|2001-09-01||Interventional|||Treatment of Post-Traumatic Stress Disorder (PTSD) in Sexually Abused Children|Treatment of PTSD in Sexually Abused Children|Completed||N/A|229|Actual|Allegheny Singer Research Institute||2|||f||||t||||||||||2017-10-11 04:17:52.08593|2017-10-11 04:17:52.08593
NCT00000384|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-08-19|||May 1997||1997-05-01|November 2005|2005-11-01|April 2002||2002-04-01|||||Interventional|||Treatment of Obsessive-Compulsive Disorder (OCD) in Children|Treatment of Pediatric Obsessive-Compulsive Disorder|Completed||Phase 3|||University of Pennsylvania|||||f||||||||||||||2017-10-11 04:17:52.321471|2017-10-11 04:17:52.321471
NCT00000385|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-11-25|||September 1997||1997-09-01|November 2013|2013-11-01|June 2005|Actual|2005-06-01|December 2003|Actual|2003-12-01||Interventional|||Long-Term Lithium Treatment for Aggressive Conduct Disorder|Long-Term Lithium for Aggressive Conduct Disorder|Completed||Phase 3|59|Actual|Drexel University||2|||f||||f||||||||||2017-10-11 04:17:52.408666|2017-10-11 04:17:52.408666
NCT00000386|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-02-08|||December 1998||1998-12-01|February 2008|2008-02-01|November 2003||2003-11-01|||||Interventional|||Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)|Behavior Therapy for Childhood OCD|Completed||Phase 3|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:17:52.513536|2017-10-11 04:17:52.513536
NCT00000388|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-09-28|||September 1998||1998-09-01|September 2015|2015-09-01|November 1999||1999-11-01|||||Interventional|MTA||Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)|Multimodal Treatment Study of Children With ADHD|Completed||Phase 4|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:17:52.682605|2017-10-11 04:17:52.682605
NCT00000389|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-06-13|||October 1996||1996-10-01|November 2005|2005-11-01|November 1999||1999-11-01|||||Interventional|||Treatment for Anxiety in Children|Research Unit on Pediatric Psychopharmacology Anxiety Treatment Study|Completed||Phase 3|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:17:52.81539|2017-10-11 04:17:52.81539
NCT00000392|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2017-02-27|2015-07-17||January 1990||1990-01-01|October 2013|2013-10-01|August 1996|Actual|1996-08-01|August 1996|Actual|1996-08-01||Interventional|||Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.|Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.|Completed||Phase 2|215|Actual|National Institute of Mental Health (NIMH)||2|||f||||||||||||||2017-10-11 04:17:53.02921|2017-10-11 04:17:53.02921
NCT00000393|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2015-02-26|||January 1988||1988-01-01|April 2002|2002-04-01||||January 1990|Actual|1990-01-01||Interventional|||A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).||Completed||Phase 1|6|Actual|National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:17:53.347216|2017-10-11 04:17:53.347216
NCT00000394|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-05-14|||May 1999||1999-05-01|June 2000|2000-06-01|January 2002||2002-01-01|||||Interventional|||Acupuncture for Carpal Tunnel Syndrome|A Controlled Trial of Acupuncture for Carpal Tunnel Syndrome|Completed||Phase 2|144||George Washington University|||||f||||||||||||||2017-10-11 04:17:53.412674|2017-10-11 04:17:53.412674
NCT00000395|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2016-12-14|||September 1996||1996-09-01|June 2013|2013-06-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Antifolate Effectiveness in Arthritis|Mechanisms of Antifolate Efficacy in Arthritis|Completed||Phase 2|40|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-10-11 04:17:53.4795|2017-10-11 04:17:53.4795
NCT00000396|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-06-08|||September 1997||1997-09-01|June 2013|2013-06-01|October 2002|Actual|2002-10-01|March 2001|Actual|2001-03-01||Interventional|||Arthritis Patient Education for Urban African Americans|Evaluating/Reinforcing Arthritis Patient Education for Urban African Americans|Completed||N/A|90|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 04:17:53.584215|2017-10-11 04:17:53.584215
NCT00000397|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2014-07-18|||July 1999||1999-07-01|December 2005|2005-12-01|September 2004|Actual|2004-09-01|||||Interventional|||Behavioral Insomnia Therapy for Fibromyalgia|Behavioral Insomnia Therapy for Fibromyalgia Patients|Completed||N/A|106|Actual|Duke University|||||f||||||||||||||2017-10-11 04:17:53.663237|2017-10-11 04:17:53.663237
NCT00000398|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-11-26|||July 1996||1996-07-01|June 2000|2000-06-01|June 2000||2000-06-01|||||Interventional|||Behavioral Treatment of Fibromyalgia|Behavioral Treatment of Fibromyalgia|Completed||Phase 2|180||Ohio University|||||f||||||||||||||2017-10-11 04:17:53.735025|2017-10-11 04:17:53.735025
NCT00000399|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-05-17|||August 1995||1995-08-01|May 2013|2013-05-01|January 2001||2001-01-01|||||Interventional|||Bone Estrogen Strength Training|Bone Estrogen Strength Training (BEST)|Completed||Phase 2|300||University of Arizona|||||f||||||||||||||2017-10-11 04:17:53.806741|2017-10-11 04:17:53.806741
NCT00000400|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-12-06|||August 1999||1999-08-01|December 2013|2013-12-01|June 2006|Actual|2006-06-01|April 2006|Actual|2006-04-01||Interventional|||Alendronate and/or Parathyroid Hormone for Osteoporosis|Bone Formation-Resorption Coupling and Osteoporosis|Completed||Phase 2|176|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 04:17:53.881478|2017-10-11 04:17:53.881478
NCT00000401|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-05-28|||July 1999||1999-07-01|May 2013|2013-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Oral Collagen for Rheumatoid Arthritis|Open Label Multicenter Induction of CII Tolerance in Patients With Rheumatoid Arthritis|Completed||Phase 2|110|Actual|University of Tennessee||2|||t||||t||||||||||2017-10-11 04:17:53.984932|2017-10-11 04:17:53.984932
NCT00000402|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-05-21|||August 1991||1991-08-01|May 2013|2013-05-01|December 2001||2001-12-01|||||Interventional|||Calcium and Bone Mass in Young Females|Long Term Effects of Calcium on Bone Mass in Young Females|Completed||Phase 2|354||Ohio State University|||||f||||||||||||||2017-10-11 04:17:54.075717|2017-10-11 04:17:54.075717
NCT00000403|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-04-29|||September 1996||1996-09-01|April 2013|2013-04-01|July 2001||2001-07-01|||||Interventional|||Doxycycline and OA Progression|Effect of Doxycycline on Osteoarthritis (OA) Progression|Completed||Phase 3|432||Indiana University|||||||||||||||||||2017-10-11 04:17:54.146586|2017-10-11 04:17:54.146586
NCT00000404|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-04-29|||April 1997||1997-04-01|April 2013|2013-04-01|March 2001||2001-03-01|||||Interventional|||Effects of Comprehensive Care for Knee OA|Effects of Comprehensive Care for Knee Osteoarthritis (OA)|Completed||Phase 2|300||Indiana University|||||f||||||||||||||2017-10-11 04:17:54.226224|2017-10-11 04:17:54.226224
NCT00000405|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2016-06-07|||September 1998||1998-09-01|June 2016|2016-06-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|||Effects of Jumping on Growing Bones|The Effects of Jumping on Growing Bones|Completed||Phase 2|200||Oregon State University|||||f||||||||||||||2017-10-11 04:17:54.304513|2017-10-11 04:17:54.304513
NCT00000406|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-04-29|||September 1977||1977-09-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Effects of Strength Training on Knee Osteoarthritis|Effects of Strength Training on Knee Osteoarthritis (OA)|Completed||Phase 2|280||Indiana University|||||f||||||||||||||2017-10-11 04:17:54.369356|2017-10-11 04:17:54.369356
NCT00000407|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2016-01-05|||January 1997||1997-01-01|September 2015|2015-09-01|December 2001||2001-12-01|||||Interventional|||Improving Vocational Outcomes in Arthritis|Improving Vocational Outcomes in Arthritis|Completed||Phase 2|326|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-10-11 04:17:54.437475|2017-10-11 04:17:54.437475
NCT00000408|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-04-30|||February 1998||1998-02-01|February 2003|2003-02-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Low Back Pain Patient Education Evaluation|Evaluation of a Low Back Pain Patient Education Program|Completed||N/A|580|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 04:17:54.517927|2017-10-11 04:17:54.517927
NCT00000409|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2015-08-03|||March 2000||2000-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SPORT||Spine Patient Outcomes Research Trial (SPORT): Degenerative Spondylolisthesis With Spinal Stenosis|Spine Patient Outcomes Research Trial (SPORT): A Multicenter Randomized Trial for Degenerative Spondylolisthesis (DS) With Spinal Stenosis (SpS) at L4/L5 Level.|Completed||Phase 4|304|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 04:17:54.583488|2017-10-11 04:17:54.583488
NCT00000410|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2015-08-03|||March 2000||2000-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SPORT||Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation|Spine Patient Outcomes Research Trial (SPORT): A Multicenter Randomized Trial for Intervertebral Disc Herniation (IDH)|Completed||Phase 4|501|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 04:17:54.846286|2017-10-11 04:17:54.846286
NCT00000411|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2015-08-03|||March 2000||2000-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Spine Patient Outcomes Research Trial (SPORT): Spinal Stenosis|Spine Patient Outcomes Research Trial (SPORT): A Multicenter Trial for Spinal Stenosis (SpS)|Completed||Phase 4|289|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 04:17:54.987398|2017-10-11 04:17:54.987398
NCT00000414|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-06-19|||July 1996||1996-07-01|November 2004|2004-11-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Patient Education in Rheumatoid Arthritis and Osteoarthritis|Patient Education Strategies for Better Outcomes in Rheumatoid Arthritis (RA) and Osteoarthritis (OA)|Completed||N/A|1200|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 04:17:55.378333|2017-10-11 04:17:55.378333
NCT00000415|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-06-03|||April 1998||1998-04-01|June 2013|2013-06-01|March 2003|Actual|2003-03-01|February 2003|Actual|2003-02-01||Interventional|||Physical Activity, Calcium, and Bone in Children|Calcium Modifies Bone Response to Activity in Children|Completed||Phase 2|224||South Dakota State University|||||f||||||||||||||2017-10-11 04:17:55.463421|2017-10-11 04:17:55.463421
NCT00000416|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-07-24|||September 1997||1997-09-01|July 2017|2017-07-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Prevention of Arthritis-Related Work Disability|Prevention of Arthritis-Related Work Disability: A Trial of Job Retention Services Provided to Employed Persons With Arthritis|Completed||N/A|242|Actual|Boston University Charles River Campus||2|||f||||f||||||||||2017-10-11 04:17:55.544499|2017-10-11 04:17:55.544499
NCT00000417|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-12-23|||April 1997||1997-04-01|December 2013|2013-12-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Psychoeducational Approach to Improve Health in Lupus|A Randomized Controlled Trial of a Psychoeducational Intervention to Improve Outcomes in Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|150||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 04:17:55.63481|2017-10-11 04:17:55.63481
NCT00000418|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-06-04|||September 1977||1977-09-01|June 1999|1999-06-01|March 2001||2001-03-01|||||Interventional|||Psychosocial Treatment for Acute Low Back Pain|Psychosocial Intervention for Acute Low Back Pain (ALBP)|Completed||Phase 2|211||Indiana University|||||f||||||||||||||2017-10-11 04:17:55.700384|2017-10-11 04:17:55.700384
NCT00000419|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-05-01|||April 1996||1996-04-01|May 2013|2013-05-01|August 2002||2002-08-01|||||Interventional|||Safety of Estrogens in Lupus: Hormone Replacement Therapy|Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Hormone Replacement Therapy|Terminated||Phase 3|350||New York University School of Medicine|||||||||||||||||||2017-10-11 04:17:55.777958|2017-10-11 04:17:55.777958
NCT00000420|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-05-01|||June 1997||1997-06-01|May 2013|2013-05-01|August 2003||2003-08-01|||||Interventional|||Safety of Estrogens in Lupus: Birth Control Pills|Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Oral Contraceptives|Completed||Phase 3|350||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:17:55.890829|2017-10-11 04:17:55.890829
NCT00000421|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2016-03-02|||September 1997||1997-09-01|March 2016|2016-03-01|August 2003|Actual|2003-08-01|August 2002|Actual|2002-08-01||Interventional|SACS-SLE||Serologically Active, Clinically Stable Systemic Lupus Erythematosus|Serologically Active, Clinically Stable Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|154|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 04:17:55.99575|2017-10-11 04:17:55.99575
NCT00000422|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-10-29|||July 1998||1998-07-01|October 2013|2013-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Tailored Treatments of Fibromyalgia|Subgroups of FMS: Symptoms, Beliefs and Tailored Treatments|Completed||Phase 2/Phase 3|312||University of Washington|||||f||||||||||||||2017-10-11 04:17:56.104027|2017-10-11 04:17:56.104027
NCT00000423|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-12-03|||September 1996||1996-09-01|March 2001|2001-03-01|February 2001||2001-02-01|||||Interventional|||Support, Health, and Fibromyalgia|Social Support and Health in Fibromyalgia|Completed||Phase 2|600||San Diego State University|||||f||||||||||||||2017-10-11 04:17:56.183312|2017-10-11 04:17:56.183312
NCT00000424|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2006-12-28|||July 1995||1995-07-01|March 2001|2001-03-01|June 2001||2001-06-01|||||Interventional|||Tidal Lavage in Knee Osteoarthritis|Tidal Lavage vs. Sham Lavage in Knee Osteoarthritis (OA)|Completed||Phase 2|180||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:17:56.247062|2017-10-11 04:17:56.247062
NCT00000425|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-04-30|||July 1996||1996-07-01|April 2013|2013-04-01|April 2001||2001-04-01|||||Interventional|||Toward Better Outcomes in Osteoarthritis|Toward Better Outcomes in Osteoarthritis (OA): Finding the Appropriate Role for Nonsteroidal Anti-inflammatory Drugs (NSAIDs)|Completed||Phase 3|900||Stanford University|||||f||||||||||||||2017-10-11 04:17:56.319836|2017-10-11 04:17:56.319836
NCT00000426|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-06-27|||January 1995||1995-01-01|June 2013|2013-06-01|June 2000||2000-06-01|||||Interventional|||Treatment of Calcium Deficiency in Young Women|Treatment of Calcium Deficiency in Young Women|Completed||Phase 2|150||Creighton University|||||f||||||||||||||2017-10-11 04:17:56.414923|2017-10-11 04:17:56.414923
NCT00000427|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2013-12-06|||September 1999||1999-09-01|December 2013|2013-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effects of Parathyroid Hormone in Men With Osteoporosis|Anabolic Actions of Parathyroid Hormone in Osteoporotic Men|Completed||Phase 3|81||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 04:17:56.483979|2017-10-11 04:17:56.483979
NCT00000428|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2013-07-31|||September 2000||2000-09-01|July 2013|2013-07-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Combining N-of-1 Trials to Assess Fibromyalgia Treatments|Combining N-of-1 Trials to Assess Fibromyalgia Therapies|Completed||Phase 4|58|Actual|Tufts Medical Center||1|||f||||t||||||||||2017-10-11 04:17:56.565059|2017-10-11 04:17:56.565059
NCT00000429|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2013-07-31|||June 1996||1996-06-01|July 2013|2013-07-01|May 2001||2001-05-01|||||Interventional|||Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis|Calcium Supplementation for Bone Mineralization in Juvenile Rheumatoid Arthritis (JRA)|Completed||Phase 2|192||Children's Hospital Medical Center, Cincinnati|||||f||||||||||||||2017-10-11 04:17:56.671453|2017-10-11 04:17:56.671453
NCT00000430|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2007-01-02|||October 1999||1999-10-01|February 2004|2004-02-01|September 2004||2004-09-01|||||Interventional|||Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis|Clinical Trial of Continuous Low-Dose Hormone Replacement Therapy Combined With Alendronate in Postmenopausal Women With Low Bone Density|Terminated||Phase 3|240||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:17:56.749856|2017-10-11 04:17:56.749856
NCT00000431|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2013-05-08|||January 2005||2005-01-01|March 2009|2009-03-01|March 2011|Actual|2011-03-01|July 2008|Actual|2008-07-01||Interventional|||Preliminary Testing of New Treatment for Chronic Leg Wounds|Phase I Trial to Evaluate the Safety of Platelet Derived Growth Factor B (PDGF-B) and a Limb Compression Bandage in Venous Leg Ulcers|Completed||Phase 1|24|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 04:17:56.812668|2017-10-11 04:17:56.812668
NCT00000432|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2013-12-23|||April 1997||1997-04-01|December 2013|2013-12-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Lyme Disease Prevention Program|A Controlled Trial of a Primary and Secondary Program for Lyme Disease|Completed||Phase 3|20000||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 04:17:56.899702|2017-10-11 04:17:56.899702
NCT00000433|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2007-01-02|||October 1999||1999-10-01|February 2003|2003-02-01|March 2002||2002-03-01|||||Interventional|||Blocking Tumor Necrosis Factor in Ankylosing Spondylitis|Anti-Tumor Necrosis Factor (TNFR:Fc) in Ankylosing Spondylitis|Completed||Phase 2|42||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:17:56.965514|2017-10-11 04:17:56.965514
NCT00000434|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2007-12-20|||December 1983||1983-12-01|December 2007|2007-12-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Impact of Exercise on Older Persons With Osteoarthritis|Impact of Exercise on Older Persons With Osteoarthritis (OA)|Completed||Phase 2|217|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||1|||f||||f||||||||||2017-10-11 04:17:57.030335|2017-10-11 04:17:57.030335
NCT00000435|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2007-07-30|||September 1999||1999-09-01|July 2007|2007-07-01|September 2004||2004-09-01|||||Interventional|||dnaJ Peptide for Relieving Rheumatoid Arthritis|A Clinical Trial of Shared Epitope Peptides in Rheumatoid Arthritis (RA)|Completed||Phase 2|160|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||2|||||||||||||||||2017-10-11 04:17:57.109476|2017-10-11 04:17:57.109476
NCT00000436|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-29|2007-01-02|||July 1993||1993-07-01|March 2001|2001-03-01|June 2000||2000-06-01|||||Interventional|||Improving Functional Recovery After Hip Fracture|Self-Efficacy and High-Intensity Strength Training to Improve Postoperative Rehabilitation of Hip Fracture Patients|Completed||Phase 3|200||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:17:57.199326|2017-10-11 04:17:57.199326
NCT00000437|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2017-04-18|||September 26, 1997|Actual|1997-09-26|April 2017|2017-04-01|September 15, 2005|Actual|2005-09-15|September 15, 2005|Actual|2005-09-15||Interventional|||Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)|Nalmefene in Nicotine and Alcohol Dependence|Completed||Phase 4|60|Actual|The Scripps Research Institute||4|||f||||f|t|f|||f|||No||2017-10-11 04:17:57.262714|2017-10-11 04:17:57.262714
NCT00000438|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-05-13||||||May 2010|2010-05-01|March 2003||2003-03-01|||||Interventional|||Naltrexone Treatment for Alcoholism|Naltrexone Treatment for Alcoholism: Predicting Outcome|Completed||Phase 4|192||Johns Hopkins University|||||f||||f||||||||||2017-10-11 04:17:57.336499|2017-10-11 04:17:57.336499
NCT00000439|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-24|||October 2000||2000-10-01|February 2009|2009-02-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Drug Treatment for Alcoholics With Bipolar Disorder|Efficacy of Valproate Maintenance in Bipolar Alcoholics|Completed||Phase 2|72|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||f||||||||||2017-10-11 04:17:57.392794|2017-10-11 04:17:57.392794
NCT00000440|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 2004|2004-11-01|September 2002||2002-09-01|||||Interventional|||Sertraline and Naltrexone for Alcohol Dependence|Sertraline and Naltrexone for Alcohol Dependents|Completed||Phase 2|124||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:17:57.461896|2017-10-11 04:17:57.461896
NCT00000441|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01|December 2000||2000-12-01|||||Interventional|||Drug Therapy for Alcohol Detoxification|Carbamazepine and Lorazepam in Outpatient Detoxification|Completed||Phase 4|||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:17:57.515333|2017-10-11 04:17:57.515333
NCT00000442|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-06-17||||||June 2011|2011-06-01|December 2002||2002-12-01|||||Interventional|||Naltrexone for Relapse Prevention|Etiology and Treatment of Alcohol Dependence|Completed||Phase 4|57||UConn Health|||||f||||||||||||||2017-10-11 04:17:57.565604|2017-10-11 04:17:57.565604
NCT00000443|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01|April 2000||2000-04-01|||||Interventional|||Ondansetron Treatment for Alcoholism|Pharmacological Treatment for Alcoholism|Completed||Phase 2|||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:17:57.62184|2017-10-11 04:17:57.62184
NCT00000444|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-10|||September 1997||1997-09-01|January 2008|2008-01-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)|Timing of Smoking Intervention in Alcohol Treatment|Completed||Phase 4|500||Minneapolis Veterans Affairs Medical Center|||||f||||||||||||||2017-10-11 04:17:57.681899|2017-10-11 04:17:57.681899
NCT00000445|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 2003|2003-07-01|September 2002||2002-09-01|||||Interventional|||Use of Naltrexone in a Clinical Setting|Effectiveness of Naltrexone in a Community Setting|Completed||Phase 4|300||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:17:57.732756|2017-10-11 04:17:57.732756
NCT00000446|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2004|2004-04-01|December 2000||2000-12-01|||||Interventional|||Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder|Sertraline Treatment in Comorbid Post-Traumatic Stress Disorder and Alcoholism|Completed||Phase 2|||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:17:57.779562|2017-10-11 04:17:57.779562
NCT00000447|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-09-30|||September 1998||1998-09-01|September 2010|2010-09-01|May 2003|Actual|2003-05-01|||||Interventional|||Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)|Behavioral/Pharmacological Treatments for Alcohol-Nicotine Dependence|Completed||Phase 4|200||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 04:17:57.935491|2017-10-11 04:17:57.935491
NCT00000448|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-05-06|||October 1995||1995-10-01|May 2014|2014-05-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Naltrexone Treatment for Alcoholic Women|Naltrexone: Consummatory Behaviors in Alcoholic Women|Completed||Phase 4|160|Actual|Yale University||2|||f||||f||||||||||2017-10-11 04:17:57.99744|2017-10-11 04:17:57.99744
NCT00000449|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01|March 2000||2000-03-01|||||Interventional|||Behavior and Naltrexone Treatment for Alcoholics|Coping, Exposure, and Naltrexone Treatment With Alcoholics|Completed||Phase 4|160||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:17:58.08014|2017-10-11 04:17:58.08014
NCT00000450|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2017-04-18|||April 10, 1997|Actual|1997-04-10|April 2017|2017-04-01|February 13, 2002|Actual|2002-02-13|February 13, 2002|Actual|2002-02-13||Interventional|||Naltrexone Maintenance Treatment of Alcoholism|Nalmefene Maintenance Treatment of Alcoholism|Completed||Phase 4|159|Actual|The Scripps Research Institute||2|||f||||f|t|f||||||No||2017-10-11 04:17:58.132356|2017-10-11 04:17:58.132356
NCT00000451|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-01-28|||January 2003||2003-01-01|January 2013|2013-01-01|November 2005|Actual|2005-11-01|August 2005|Actual|2005-08-01||Interventional|||Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)|Naltrexone and SSRI Therapy for Alcohol Dependence in Alaska Natives|Completed||Phase 2|198|Actual|Yale University||2|||f||||||||||||||2017-10-11 04:17:58.20106|2017-10-11 04:17:58.20106
NCT00000452|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 2004|2004-11-01|January 2003||2003-01-01|||||Interventional|||Naltrexone Treatment of Alcohol Dependence||Completed||Phase 4|240||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:17:58.274727|2017-10-11 04:17:58.274727
NCT00000456|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-10-01|||September 1992||1992-09-01|October 2010|2010-10-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Behavioral Therapy Plus Naltrexone for Alcoholism|Comparison of Cognitive Behavioral Therapy and Motivational Enhancement Therapy Plus Naltrexone for Alcoholism|Completed||Phase 4|160|Actual|Medical University of South Carolina||2|||f||||||||||||||2017-10-11 04:17:58.447831|2017-10-11 04:17:58.447831
NCT00000457|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-10-18|||June 1998||1998-06-01|October 2013|2013-10-01|August 2007|Actual|2007-08-01|April 2002|Actual|2002-04-01||Interventional|||Pharmacologic Relapse Prevention for Alcoholic Smokers|Pharmacologic Relapse Prevention for Alcoholic Smokers|Completed||Phase 2|195|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 04:17:58.514932|2017-10-11 04:17:58.514932
NCT00000458|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01|January 2002||2002-01-01|||||Interventional|||Sertraline and Cognitive Therapy in Depressed Alcoholics|Sertraline and Cognitive Therapy in Depressed Alcoholics|Completed||Phase 2|100||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:17:58.60612|2017-10-11 04:17:58.60612
NCT00000459|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-04|||December 1986||1986-12-01|March 2005|2005-03-01|January 1999|Actual|1999-01-01|||||Interventional|||Dietary Intervention Study in Children (DISC)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:58.658733|2017-10-11 04:17:58.658733
NCT00000460|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-01-05|||December 1986||1986-12-01|November 2013|2013-11-01|March 1991|Actual|1991-03-01|March 1991|Actual|1991-03-01||Observational|||Training Levels Comparison Trial|Training Levels Comparison (TLC) Trial in Patients With Coronary Heart Disease|Withdrawn||Phase 2|0|Actual|University of Alabama at Birmingham|||2|due to lack of enrollment|f||||||||||||||2017-10-11 04:17:58.722577|2017-10-11 04:17:58.722577
NCT00000461|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-15|||December 1986||1986-12-01|March 2005|2005-03-01|November 1992|Actual|1992-11-01|||||Interventional|||Harvard Atherosclerosis Reversibility Project (HARP)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:58.795979|2017-10-11 04:17:58.795979
NCT00000462|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-12|||April 1987||1987-04-01|March 2005|2005-03-01|November 2004||2004-11-01|||||Interventional|||Bypass Angioplasty Revascularization Investigation (BARI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:58.864422|2017-10-11 04:17:58.864422
NCT00000463|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-12|||April 1987||1987-04-01|August 2004|2004-08-01|December 1998||1998-12-01|||||Interventional|||Post Coronary Artery Bypass Graft (CABG) Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:58.958329|2017-10-11 04:17:58.958329
NCT00000464|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-07-26|||April 1987||1987-04-01|July 2013|2013-07-01||||December 1992|Actual|1992-12-01||Interventional|||Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-10-11 04:17:59.04417|2017-10-11 04:17:59.04417
NCT00000465|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||June 1987||1987-06-01|September 2002|2002-09-01|August 1998|Actual|1998-08-01|||||Interventional|||Emory Angioplasty Versus Surgery Trial (EAST)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.130417|2017-10-11 04:17:59.130417
NCT00000466|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-12|||September 1987||1987-09-01|July 2005|2005-07-01|October 2000|Actual|2000-10-01|||||Interventional|||Postmenopausal Estrogen/Progestin Interventions (PEPI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.19399|2017-10-11 04:17:59.19399
NCT00000467|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||September 1987||1987-09-01|January 2008|2008-01-01|March 1991|Actual|1991-03-01|March 1991|Actual|1991-03-01||Interventional|||Child and Adolescent Trial for Cardiovascular Health (CATCH)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.297758|2017-10-11 04:17:59.297758
NCT00000468|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-08|||April 1988||1988-04-01|June 2001|2001-06-01|March 1992||1992-03-01|||||Interventional|||Myocardial Infarction Triage and Intervention Project (MITI)||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-10-11 04:17:59.417778|2017-10-11 04:17:59.417778
NCT00000469|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-12|||May 1988||1988-05-01|April 2000|2000-04-01|August 1998|Actual|1998-08-01|||||Interventional|||Asymptomatic Carotid Artery Plaque Study (ACAPS)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.505691|2017-10-11 04:17:59.505691
NCT00000470|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-28|||December 1988||1988-12-01|July 2016|2016-07-01|October 1993|Actual|1993-10-01|February 1992|Actual|1992-02-01||Interventional|BCAS||Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest|Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest|Completed||Phase 3|171|Actual|Boston Children’s Hospital||2|||f||||t||||||||No|Not required when trial was performed in 1988-92|2017-10-11 04:17:59.570937|2017-10-11 04:17:59.570937
NCT00000471|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-12|||April 1989||1989-04-01|January 2000|2000-01-01|March 1993|Actual|1993-03-01|||||Interventional|||Lifestyle Heart Trial||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.650676|2017-10-11 04:17:59.650676
NCT00000472|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-15|||April 1989||1989-04-01|July 2000|2000-07-01|June 1995|Actual|1995-06-01|||||Interventional|||Thrombolysis in Myocardial Ischemia Trial (TIMI III)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.709512|2017-10-11 04:17:59.709512
NCT00000473|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-12|||July 1989||1989-07-01|April 2012|2012-04-01|June 1994|Actual|1994-06-01|||||Interventional|||Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.77941|2017-10-11 04:17:59.77941
NCT00000474|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||September 1989||1989-09-01|June 2001|2001-06-01|September 1994|Actual|1994-09-01|||||Interventional|||Prevention and Treatment of Hypertension Study (PATHS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.84251|2017-10-11 04:17:59.84251
NCT00000475|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||April 1990||1990-04-01|December 2005|2005-12-01|March 1995|Actual|1995-03-01|||||Interventional|||Prevention of Early Readmission in Elderly Congestive Heart Failure Patients||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.894099|2017-10-11 04:17:59.894099
NCT00000476|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||June 1990||1990-06-01|November 2005|2005-11-01|June 1998|Actual|1998-06-01|||||Interventional|||Digitalis Investigation Group (DIG)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:17:59.949942|2017-10-11 04:17:59.949942
NCT00000477|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||July 1990||1990-07-01|June 1992|1992-06-01|June 1992|Actual|1992-06-01|||||Interventional|||Cholesterol Reduction in Seniors Program (CRISP)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:00.037391|2017-10-11 04:18:00.037391
NCT00000479|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2012-06-12|2011-12-05||September 1992||1992-09-01|June 2012|2012-06-01|February 2005|Actual|2005-02-01|March 2004|Actual|2004-03-01||Interventional|WHS||Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer|Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women|Completed||Phase 3|39876|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-10-11 04:18:00.218895|2017-10-11 04:18:00.218895
NCT00000480|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2017-01-13|||September 1991||1991-09-01|August 2004|2004-08-01|September 1996|Actual|1996-09-01|||||Interventional|||Multicenter Unsustained Tachycardia Trial (MUSTT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:00.681|2017-10-11 04:18:00.681
NCT00000481|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2017-02-13|||September 1991||1991-09-01|February 2017|2017-02-01|January 1996||1996-01-01|||||Interventional|||Women's Health Trial: Feasibility Study in Minority Populations||Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:18:00.750061|2017-10-11 04:18:00.750061
NCT00000482|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||April 1965||1965-04-01|July 2004|2004-07-01|March 1985|Actual|1985-03-01|||||Interventional|||Coronary Drug Project||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:00.81476|2017-10-11 04:18:00.81476
NCT00000483|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||June 1981||1981-06-01|April 2004|2004-04-01|March 1985|Actual|1985-03-01|||||Interventional|||Coronary Drug Project Mortality Surveillance||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:00.884356|2017-10-11 04:18:00.884356
NCT00000484|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||April 1966||1966-04-01|January 2000|2000-01-01|January 1979|Actual|1979-01-01|||||Interventional|||Treatment of Hypertension||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:00.939945|2017-10-11 04:18:00.939945
NCT00000485|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||May 1971||1971-05-01|December 2005|2005-12-01|May 1982|Actual|1982-05-01|||||Interventional|||Hypertension Detection and Follow-up Program (HDFP)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:01.000525|2017-10-11 04:18:01.000525
NCT00000486|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||January 1972||1972-01-01|January 2000|2000-01-01|January 1980|Actual|1980-01-01|||||Interventional|||Unstable Angina Pectoris Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:01.11182|2017-10-11 04:18:01.11182
NCT00000487|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-24|||June 1972||1972-06-01|February 2016|2016-02-01|July 1998||1998-07-01|||||Interventional|||Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)||Completed||Phase 3|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:18:01.176383|2017-10-11 04:18:01.176383
NCT00000488|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||June 1973||1973-06-01|April 2012|2012-04-01|October 1989|Actual|1989-10-01|||||Interventional|||Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:01.399943|2017-10-11 04:18:01.399943
NCT00000489|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-16|||June 1973||1973-06-01|December 2005|2005-12-01|December 1996||1996-12-01|||||Interventional|||Coronary Artery Surgery Study (CASS)||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-10-11 04:18:01.516646|2017-10-11 04:18:01.516646
NCT00000490|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-24|||June 1973||1973-06-01|February 2016|2016-02-01|December 1997||1997-12-01|||||Interventional|||Program on Surgical Control of Hyperlipidemias (POSCH)||Completed||Phase 3|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:18:01.726319|2017-10-11 04:18:01.726319
NCT00000648|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-24||||||October 2012|2012-10-01|February 1996|Actual|1996-02-01|||||Interventional|||A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals|A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:01.883338|2017-10-11 04:18:01.883338
NCT00000649|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-29||||||June 1993|1993-06-01||||||||Interventional|||An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)|An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:02.052535|2017-10-11 04:18:02.052535
NCT00000650|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients|An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:02.135888|2017-10-11 04:18:02.135888
NCT00000651|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1993|Actual|1993-05-01|||||Interventional|||A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy|A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy|Completed||Phase 3|750||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:02.213287|2017-10-11 04:18:02.213287
NCT00000652|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-31||||||October 2012|2012-10-01|November 1995|Actual|1995-11-01|||||Interventional|||A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection|A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection|Completed||Phase 1|85||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:02.440651|2017-10-11 04:18:02.440651
NCT00000653|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|June 1995|Actual|1995-06-01|||||Interventional|||A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT|A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT|Completed||Phase 2|140||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:02.530394|2017-10-11 04:18:02.530394
NCT00005350|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-21|||April 1991||1991-04-01|December 2015|2015-12-01|January 1993||1993-01-01|||||Observational|||Evaluating Strategies to Control Hypercholesterolemia||Completed||N/A|||National Bureau of Economic Research, Inc.|||||f||||||||||||||2017-10-11 04:28:02.71642|2017-10-11 04:28:02.71642
NCT00000654|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-12-17||||||December 2012|2012-12-01|February 1993|Actual|1993-02-01|||||Interventional|||The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU|The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU|Completed||Phase 2|78||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:02.687978|2017-10-11 04:18:02.687978
NCT00000655|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-25||||||February 2011|2011-02-01||||January 1992|Actual|1992-01-01||Interventional|||A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients|A Randomized, Double-Blind Study of 566C80 Versus Septra (Trimethoprim/Sulfamethoxazole) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:02.776055|2017-10-11 04:18:02.776055
NCT00000656|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|November 1993|Actual|1993-11-01|||||Interventional|||A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease|A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease|Completed||Phase 1|116||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:02.92254|2017-10-11 04:18:02.92254
NCT00000657|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1992|Actual|1992-09-01|||||Interventional|||Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex|Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex|Completed||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.015963|2017-10-11 04:18:03.015963
NCT00000658|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|February 1996|Actual|1996-02-01|||||Interventional|||A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma|A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma|Completed||Phase 3|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.112047|2017-10-11 04:18:03.112047
NCT00000659|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||July 1990|1990-07-01||||July 1990|Actual|1990-07-01||Interventional|||A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)|A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)|Terminated||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.240578|2017-10-11 04:18:03.240578
NCT00000660|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|July 1992|Actual|1992-07-01|||||Interventional|||Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma|Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.306177|2017-10-11 04:18:03.306177
NCT00000661|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-01||||||December 1994|1994-12-01||||||||Interventional|||The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient|The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient|Completed||Phase 1|8||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.38576|2017-10-11 04:18:03.38576
NCT00000662|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-10-27||||||April 1992|1992-04-01|May 1993|Actual|1993-05-01|May 1993|Actual|1993-05-01||Interventional|||A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease|A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.451127|2017-10-11 04:18:03.451127
NCT00000663|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1996|1996-10-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection|A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.51387|2017-10-11 04:18:03.51387
NCT00000664|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-01||||||December 1994|1994-12-01||||||||Interventional|||Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals|Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals|Completed||Phase 1|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.596154|2017-10-11 04:18:03.596154
NCT00000665|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||December 1994|1994-12-01||||April 1992|Actual|1992-04-01||Interventional|||Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component|Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component|Completed||N/A|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.657674|2017-10-11 04:18:03.657674
NCT00000666|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-26||||||October 2012|2012-10-01|March 1992|Actual|1992-03-01|||||Interventional|||A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection|A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection|Completed||N/A|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.731284|2017-10-11 04:18:03.731284
NCT00000667|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|July 1993|Actual|1993-07-01|||||Interventional|||A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells|A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.809773|2017-10-11 04:18:03.809773
NCT00000668|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir|A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.877776|2017-10-11 04:18:03.877776
NCT00000669|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-25||||||October 1996|1996-10-01||||||||Interventional|||A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection|A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection|Completed||Phase 1|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:03.996113|2017-10-11 04:18:03.996113
NCT00000670|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|July 1989|Actual|1989-07-01|||||Interventional|||Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks|Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks|Completed||N/A|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:04.068667|2017-10-11 04:18:04.068667
NCT00000671|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||August 1992|1992-08-01||||March 1992|Actual|1992-03-01||Interventional|||A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment|A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment|Completed||Phase 2|750||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:04.150848|2017-10-11 04:18:04.150848
NCT00000672|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||October 1994|1994-10-01||||February 1993|Actual|1993-02-01||Interventional|||An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex|An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex|Completed||Phase 2|660||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:04.343167|2017-10-11 04:18:04.343167
NCT00000673|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1993|Actual|1993-05-01|||||Interventional|||A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy|A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy|Completed||Phase 1|38||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:05.818889|2017-10-11 04:18:05.818889
NCT00000674|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|August 1992|Actual|1992-08-01|||||Interventional|||A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS|A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS|Completed||N/A|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:05.918928|2017-10-11 04:18:05.918928
NCT00000675|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1991|1991-01-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex|A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.021381|2017-10-11 04:18:06.021381
NCT00000676|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|November 1993|Actual|1993-11-01|||||Interventional|||Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)|Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)|Completed||Phase 3|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.100221|2017-10-11 04:18:06.100221
NCT00000677|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1994|1994-12-01||||||||Interventional|||SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy|SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.225757|2017-10-11 04:18:06.225757
NCT00000678|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||September 1992|1992-09-01||||July 1992|Actual|1992-07-01||Interventional|||Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.|Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.|Completed||Phase 2|320||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.469034|2017-10-11 04:18:06.469034
NCT00000679|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||December 1994|1994-12-01||||February 1994|Actual|1994-02-01||Interventional|||(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC|(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC|Completed||Phase 2|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.560404|2017-10-11 04:18:06.560404
NCT00000680|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|April 1993|Actual|1993-04-01|||||Interventional|||A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC|A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.685107|2017-10-11 04:18:06.685107
NCT00000681|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|October 1993|Actual|1993-10-01|||||Interventional|||A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma|A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.756345|2017-10-11 04:18:06.756345
NCT00000682|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1992|Actual|1992-09-01|||||Interventional|||A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002|A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002|Completed||Phase 3|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.893224|2017-10-11 04:18:06.893224
NCT00000683|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|June 1993|Actual|1993-06-01|||||Interventional|||A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus|A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus|Completed||Phase 1|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:06.99302|2017-10-11 04:18:06.99302
NCT00000684|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|April 1991|Actual|1991-04-01|||||Interventional|||Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals|Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.094761|2017-10-11 04:18:07.094761
NCT00000685|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Study of Zidovudine in HIV-Infected Patients With Kidney Problems|Evaluation of Zidovudine Pharmacokinetics in Patients With Human Immunodeficiency Virus and Varying Degrees of Renal Insufficiency|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.162435|2017-10-11 04:18:07.162435
NCT00000686|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-25||||||May 1999|1999-05-01||||||||Interventional|||A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT|A Phase I Safety Study of BMY-27857 (2',3'-Dideoxy-2',3'-Didehydrothymidine [d4T]) Administered Four Times Daily to AZT-Intolerant Patients With AIDS or AIDS-Related Complex|Terminated||Phase 1|35||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.225843|2017-10-11 04:18:07.225843
NCT00000687|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|July 1993|Actual|1993-07-01|||||Interventional|||Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma|Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.295722|2017-10-11 04:18:07.295722
NCT00000688|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||October 1990|1990-10-01||||February 1995|Actual|1995-02-01||Interventional|||A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS|A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS|Completed||Phase 3|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.389318|2017-10-11 04:18:07.389318
NCT00000689|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|March 1991|Actual|1991-03-01|||||Interventional|||Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma|Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.509065|2017-10-11 04:18:07.509065
NCT00000690|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|October 1989|Actual|1989-10-01|||||Interventional|||Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers|Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.595062|2017-10-11 04:18:07.595062
NCT00000691|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|August 1992|Actual|1992-08-01|||||Interventional|||A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure|A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure|Completed||Phase 2|156||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.663675|2017-10-11 04:18:07.663675
NCT00000692|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 2003|2003-03-01||||||||Interventional|||Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex|Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.885429|2017-10-11 04:18:07.885429
NCT00000693|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|March 1992|Actual|1992-03-01|||||Interventional|||Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS|Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS|Completed||N/A|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:07.970944|2017-10-11 04:18:07.970944
NCT00000694|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|August 1992|Actual|1992-08-01|||||Interventional|||A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma|A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:08.055296|2017-10-11 04:18:08.055296
NCT00000695|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|July 1991|Actual|1991-07-01|||||Interventional|||Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma|Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:08.141732|2017-10-11 04:18:08.141732
NCT00000696|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|November 1993|Actual|1993-11-01|||||Interventional|||A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease|A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:08.239029|2017-10-11 04:18:08.239029
NCT00000697|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-29||||||May 2012|2012-05-01||||||||Interventional|||A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir|A Phase II Randomized Controlled Trial of Immediate Versus Delayed Foscarnet Therapy in AIDS Patients With Non-Immediately Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due to Myelosuppression|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:08.338391|2017-10-11 04:18:08.338391
NCT00000698|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-09-26||||||April 1992|1992-04-01|August 2007|Actual|2007-08-01|||||Interventional|||A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis|A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:09.234531|2017-10-11 04:18:09.234531
NCT00000699|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-25||||||April 2003|2003-04-01||||||||Interventional|||A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients|A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:09.311853|2017-10-11 04:18:09.311853
NCT00000700|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-15||||||February 2012|2012-02-01|May 1990|Actual|1990-05-01|||||Interventional|||A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP|A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP|Completed||Phase 3|482||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:09.39867|2017-10-11 04:18:09.39867
NCT00000701|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC)|A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC)|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:09.531707|2017-10-11 04:18:09.531707
NCT00000702|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-15||||||February 2012|2012-02-01|August 1990|Actual|1990-08-01|||||Interventional|||A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection|A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection|Completed||Phase 3|315||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:09.621995|2017-10-11 04:18:09.621995
NCT00000703|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|March 1990|Actual|1990-03-01|||||Interventional|||Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members|Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members|Completed||N/A|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:09.741814|2017-10-11 04:18:09.741814
NCT00000704|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|April 1990|Actual|1990-04-01|||||Interventional|||A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.|A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.|Completed||Phase 1|64||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:09.873898|2017-10-11 04:18:09.873898
NCT00000705|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-08-04||||||August 2014|2014-08-01|March 1989|Actual|1989-03-01|||||Interventional|||Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia|A Phase I Trial to Evaluate Azidothymidine (AZT) in the Treatment of HIV Infections in Patients With Hemophilia|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:09.962594|2017-10-11 04:18:09.962594
NCT00000706|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|December 1988|Actual|1988-12-01|||||Interventional|||Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine|Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.073245|2017-10-11 04:18:10.073245
NCT00000707|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1991|Actual|1991-06-01|||||Interventional|||Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms|Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms|Completed||N/A|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.154497|2017-10-11 04:18:10.154497
NCT00000708|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||July 1991|1991-07-01||||July 1991|Actual|1991-07-01||Interventional|||Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Completed||N/A|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.238691|2017-10-11 04:18:10.238691
NCT00000709|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts|An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts|Completed||Phase 3|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.325278|2017-10-11 04:18:10.325278
NCT00000710|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex|A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex|Completed||Phase 1|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.418809|2017-10-11 04:18:10.418809
NCT00000711|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-25||||||April 2012|2012-04-01|May 1990|Actual|1990-05-01|||||Interventional|||Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC|Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.49953|2017-10-11 04:18:10.49953
NCT00000712|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|November 1994|Actual|1994-11-01|||||Interventional|||A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3|A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3|Completed||Phase 2|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.573356|2017-10-11 04:18:10.573356
NCT00000713|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1992|Actual|1992-10-01|||||Interventional|||A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects|A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.671303|2017-10-11 04:18:10.671303
NCT00000714|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|July 2004|Actual|2004-07-01|||||Interventional|||An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies|An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.739632|2017-10-11 04:18:10.739632
NCT00000715|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1991|Actual|1991-09-01|||||Interventional|||A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS|A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Pneumonia in AIDS|Completed||Phase 3|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:10.903952|2017-10-11 04:18:10.903952
NCT00000716|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||May 1990|1990-05-01||||January 1991|Actual|1991-01-01||Interventional|||A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection|A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection|Completed||Phase 2|70||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.052285|2017-10-11 04:18:11.052285
NCT00000717|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-18||||||October 2012|2012-10-01|November 1991|Actual|1991-11-01|||||Interventional|||The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS|The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.149396|2017-10-11 04:18:11.149396
NCT00000718|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1991|Actual|1991-09-01|||||Interventional|||A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC|A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC|Completed||N/A|112||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.246304|2017-10-11 04:18:11.246304
NCT00000719|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease|A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease|Completed||N/A|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.321484|2017-10-11 04:18:11.321484
NCT00000720|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|April 1993|Actual|1993-04-01|||||Interventional|||A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine|A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine|Completed||Phase 3|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.420345|2017-10-11 04:18:11.420345
NCT00000721|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|March 1991|Actual|1991-03-01|||||Interventional|||An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive|An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive|Completed||Phase 1|85||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.607667|2017-10-11 04:18:11.607667
NCT00000722|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1991|Actual|1991-06-01|||||Interventional|||Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy|Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy|Completed||N/A|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.680222|2017-10-11 04:18:11.680222
NCT00000723|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-29||||||May 2012|2012-05-01|March 1990|Actual|1990-03-01|||||Interventional|||The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer|Chemotherapy, Radiotherapy, and Azidothymidine for AIDS-Related Primary CNS Lymphoma|Terminated||N/A|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.74843|2017-10-11 04:18:11.74843
NCT00000724|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-12-18||||||December 2012|2012-12-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia|A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.842188|2017-10-11 04:18:11.842188
NCT00000725|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma|A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:11.934538|2017-10-11 04:18:11.934538
NCT00000726|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|February 1992|Actual|1992-02-01|||||Interventional|||Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome|Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome|Completed||Phase 1|53||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.035882|2017-10-11 04:18:12.035882
NCT00000727|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|August 1991|Actual|1991-08-01|||||Interventional|||A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)|A Controlled Comparative Trial of Trimethoprim - Sulfamethoxazole Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)|Completed||Phase 3|322||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.126741|2017-10-11 04:18:12.126741
NCT00000728|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-24||||||April 2012|2012-04-01|April 1990|Actual|1990-04-01|||||Interventional|||Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy|Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.223097|2017-10-11 04:18:12.223097
NCT00000729|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1992|Actual|1992-06-01|||||Interventional|||A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease|A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease|Completed||Phase 1|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.290971|2017-10-11 04:18:12.290971
NCT00000730|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-29||||||May 2012|2012-05-01|March 1989|Actual|1989-03-01|||||Interventional|||Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients|A Randomized, Comparative Trial of Trimetrexate With Leucovorin Rescue Versus Standard Anti-Pneumocystis Therapy Versus Standard Anti-Pneumocystis Therapy With High Dose Steroids for AIDS Patients With Pneumocystis Pneumonia Who Appear to Be Refractory to Conventional Drugs|Terminated||Phase 3|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.375267|2017-10-11 04:18:12.375267
NCT00000731|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||Evaluation of the Interaction Between Acetaminophen and Zidovudine|Evaluation of the Interaction Between Acetaminophen and Zidovudine|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.447639|2017-10-11 04:18:12.447639
NCT00000732|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine|Evaluation of the Interaction Between Low Dose Trimethoprim/Sulfamethoxazole and Zidovudine|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.52651|2017-10-11 04:18:12.52651
NCT00000733|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|October 1991|Actual|1991-10-01|||||Interventional|||Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients|Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients|Completed||Phase 1|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.598448|2017-10-11 04:18:12.598448
NCT00000734|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine|Evaluation of the Interaction Between High Dose Trimethoprim/Sulfamethoxazole and Zidovudine|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.672979|2017-10-11 04:18:12.672979
NCT00000735|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC|A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.739604|2017-10-11 04:18:12.739604
NCT00000736|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals|Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals|Completed||Phase 3|3200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.811484|2017-10-11 04:18:12.811484
NCT00000737|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-22||||||January 1994|1994-01-01||||||||Interventional|||A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome|A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:12.960076|2017-10-11 04:18:12.960076
NCT00000738|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|June 1994|Actual|1994-06-01|||||Interventional|||Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1|Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.049952|2017-10-11 04:18:13.049952
NCT00000739|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|June 1998|Actual|1998-06-01|||||Interventional|||Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection|Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection|Completed||Phase 1|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.147898|2017-10-11 04:18:13.147898
NCT00000740|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1993|Actual|1993-09-01|||||Interventional|||Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects|Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects|Completed||Phase 1|44||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.301582|2017-10-11 04:18:13.301582
NCT00000741|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-24||||||October 2012|2012-10-01||||||||Interventional|||The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS|A Controlled Randomized Trial to Study the Efficacy of Adjunctive Methylprednisolone for the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Pediatric AIDS Patients|Withdrawn||Phase 3|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.369628|2017-10-11 04:18:13.369628
NCT00000742|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1993|Actual|1993-10-01|||||Interventional|||A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)|A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)|Completed||Phase 1|15||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.55518|2017-10-11 04:18:13.55518
NCT00000743|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|May 1995|Actual|1995-05-01|||||Interventional|||A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons|A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons|Completed||Phase 1|64||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.647795|2017-10-11 04:18:13.647795
NCT00000744|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|December 1995|Actual|1995-12-01|||||Interventional|||A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women|A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women|Completed||N/A|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.725193|2017-10-11 04:18:13.725193
NCT00000745|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|May 1991|Actual|1991-05-01|||||Interventional|||A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|Completed||Phase 1|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.830976|2017-10-11 04:18:13.830976
NCT00000746|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|July 1994|Actual|1994-07-01|||||Interventional|||A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines|A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.91505|2017-10-11 04:18:13.91505
NCT00000747|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||December 1994|Actual|1994-12-01||Interventional|||An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3|An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3|Completed||Phase 2|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:13.991743|2017-10-11 04:18:13.991743
NCT00000748|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|November 1996|Actual|1996-11-01|||||Interventional|||A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients|A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients|Completed||Phase 3|2500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:14.071151|2017-10-11 04:18:14.071151
NCT00000749|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-29||||||October 2012|2012-10-01||||||||Interventional|||A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months|Completed||Phase 1|14||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:14.186268|2017-10-11 04:18:14.186268
NCT00000750|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection|A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection|Completed||Phase 3|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:14.265103|2017-10-11 04:18:14.265103
NCT00000751|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-09-26||||||May 2006|2006-05-01|August 2007|Actual|2007-08-01|||||Interventional|||A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)|A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)|Completed||Phase 3|1600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:14.424595|2017-10-11 04:18:14.424595
NCT00000752|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-05-14||||||October 2012|2012-10-01|February 1993|Actual|1993-02-01|||||Interventional|||Preventing Frequent Sinus Infections in HIV-Infected Patients|Management of HIV-Infected Patients at Risk of Recurrent Purulent Sinusitis: Role of Anti-Inflammatory, Antibacterial, and Decongestant Prophylaxis|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:14.615326|2017-10-11 04:18:14.615326
NCT00000753|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC|A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:14.713728|2017-10-11 04:18:14.713728
NCT00000754|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3|A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:14.80484|2017-10-11 04:18:14.80484
NCT00000755|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|March 1993|Actual|1993-03-01|||||Interventional|||A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3|A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3|Completed||Phase 1|168||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:14.89575|2017-10-11 04:18:14.89575
NCT00000756|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|June 2002|Actual|2002-06-01|||||Interventional|||Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3|Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3|Completed||Phase 1|15||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.008896|2017-10-11 04:18:15.008896
NCT00000757|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|October 1992|Actual|1992-10-01|||||Interventional|||A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.08996|2017-10-11 04:18:15.08996
NCT00000758|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|April 1998|Actual|1998-04-01|||||Interventional|||A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women|A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women|Completed||Phase 3|158||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.185266|2017-10-11 04:18:15.185266
NCT00000759|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1998|1998-06-01||||||||Observational|||Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials|Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials|Completed||N/A|675||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.304305|2017-10-11 04:18:15.304305
NCT00000760|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-31||||||November 1998|1998-11-01||||||||Interventional|||A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection|A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection|Completed||Phase 1|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.365641|2017-10-11 04:18:15.365641
NCT00000761|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|October 1997|Actual|1997-10-01|||||Interventional|||Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children|Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.449408|2017-10-11 04:18:15.449408
NCT00000762|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|February 1996|Actual|1996-02-01|||||Interventional|||A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection|A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection|Completed||Phase 1|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.519435|2017-10-11 04:18:15.519435
NCT00000763|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|February 1997|Actual|1997-02-01|||||Interventional|||A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma|A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.653851|2017-10-11 04:18:15.653851
NCT00000764|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|July 1996|Actual|1996-07-01|||||Interventional|||Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.|Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.|Completed||Phase 1|98||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.73774|2017-10-11 04:18:15.73774
NCT00000765|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|June 2002|Actual|2002-06-01|||||Interventional|||Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)|Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)|Completed||N/A|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.811156|2017-10-11 04:18:15.811156
NCT00000767|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|July 1996|Actual|1996-07-01|||||Interventional|||A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:15.993812|2017-10-11 04:18:15.993812
NCT00000768|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|August 1998|Actual|1998-08-01|||||Interventional|||A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients|A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:16.078272|2017-10-11 04:18:16.078272
NCT00000769|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|April 1998|Actual|1998-04-01|||||Interventional|||A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma|A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:16.165224|2017-10-11 04:18:16.165224
NCT00000770|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|November 1994|Actual|1994-11-01|||||Interventional|||A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine|A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine|Completed||Phase 2|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:16.247742|2017-10-11 04:18:16.247742
NCT00000771|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3|A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3|Completed||Phase 2|68||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:16.410815|2017-10-11 04:18:16.410815
NCT00000772|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals|A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals|Completed||Phase 1|15||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:16.630985|2017-10-11 04:18:16.630985
NCT00000773|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children|Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:16.737098|2017-10-11 04:18:16.737098
NCT00000774|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|January 1999|Actual|1999-01-01|||||Interventional|||A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers|A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers|Completed||Phase 1|156|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 04:18:16.866941|2017-10-11 04:18:16.866941
NCT00000775|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)|A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:17.096166|2017-10-11 04:18:17.096166
NCT00000776|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||Dexamethasone in Cryptococcal Meningitis|Dexamethasone in Cryptococcal Meningitis|Completed||Phase 2|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:17.179121|2017-10-11 04:18:17.179121
NCT00000777|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|July 1998|Actual|1998-07-01|||||Interventional|||Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)|Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:17.300394|2017-10-11 04:18:17.300394
NCT00000778|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-06||||||June 1995|1995-06-01||||||||Interventional|||A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin|A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin|Completed||Phase 1|44||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:17.380431|2017-10-11 04:18:17.380431
NCT00000779|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|September 1996|Actual|1996-09-01|||||Interventional|||A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3|A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3|Completed||Phase 1|130||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:17.48365|2017-10-11 04:18:17.48365
NCT00000780|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 2003|2003-03-01||||||||Observational|||"A Pre-Enrollment Protocol for HIV-Infected Adolescents"|"A Pre-Enrollment Protocol for HIV-Infected Adolescents"|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:17.592608|2017-10-11 04:18:17.592608
NCT00000597|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||March 1982||1982-03-01|May 2000|2000-05-01|December 1988|Actual|1988-12-01|||||Interventional|||Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.886604|2017-10-11 04:19:07.886604
NCT00000781|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)|A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)|Completed||Phase 2|1292||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:17.792898|2017-10-11 04:18:17.792898
NCT00000782|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|October 1996|Actual|1996-10-01|||||Interventional|||A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen|A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:18.111832|2017-10-11 04:18:18.111832
NCT00000783|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-10-05|||June 1994||1994-06-01|October 2012|2012-10-01||||November 1999|Actual|1999-11-01||Observational|||Heterosexual HIV Transmission Study (HATS)|Heterosexual HIV Transmission Study (HATS)|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"     Seminal and cervico-vaginal fluids will be collected as well as blood and urine samples.   "|||2017-10-11 04:18:18.199007|2017-10-11 04:18:18.199007
NCT00000784|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28|||October 1994||1994-10-01|September 2013|2013-09-01|September 1996|Actual|1996-09-01|September 1996|Actual|1996-09-01||Observational|||A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols|A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols|Completed||N/A|557|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||||||2017-10-11 04:18:18.282081|2017-10-11 04:18:18.282081
NCT00000785|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28|||August 1992||1992-08-01|September 2013|2013-09-01|June 1994|Actual|1994-06-01|June 1994|Actual|1994-06-01||Observational|||A Registry of Tuberculosis Cases in the CPCRA|A Registry of Tuberculosis Cases in the CPCRA|Completed||N/A|1509|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"     Any sample that can be used to test for M.tuberculosis   "|||2017-10-11 04:18:18.370387|2017-10-11 04:18:18.370387
NCT00000787|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2003|2003-04-01||||||||Interventional|||Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study|Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study|Completed||N/A|1000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:18.453259|2017-10-11 04:18:18.453259
NCT00000788|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|June 1994|Actual|1994-06-01|||||Interventional|||A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone|A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:18.517839|2017-10-11 04:18:18.517839
NCT00000789|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|July 1998|Actual|1998-07-01|||||Interventional|||A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection|A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection|Completed||Phase 2|230||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:18.587867|2017-10-11 04:18:18.587867
NCT00000790|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1998|Actual|1998-10-01|||||Interventional|||Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection|Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection|Completed||Phase 2|164||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:18.802349|2017-10-11 04:18:18.802349
NCT00000791|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|July 1995|Actual|1995-07-01|||||Interventional|||A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV|A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV|Completed||Phase 2|210||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:18.951234|2017-10-11 04:18:18.951234
NCT00000792|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|January 1995|Actual|1995-01-01|||||Interventional|||A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects|A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:19.073776|2017-10-11 04:18:19.073776
NCT00000793|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|October 1997|Actual|1997-10-01|||||Interventional|||A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection|A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection|Completed||Phase 2|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:19.162481|2017-10-11 04:18:19.162481
NCT00000794|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|April 1998|Actual|1998-04-01|||||Interventional|||Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis|Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis|Completed||Phase 2|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:20.592522|2017-10-11 04:18:20.592522
NCT00000795|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-09-08||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects|A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects|Completed||Phase 1|28||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:20.760472|2017-10-11 04:18:20.760472
NCT00000810|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|January 1996|Actual|1996-01-01|||||Interventional|||Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)|Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)|Completed||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.504901|2017-10-11 04:18:22.504901
NCT00000598|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-01-08|||August 1991||1991-08-01|March 2005|2005-03-01|August 1996||1996-08-01|||||Interventional|||Diet and Exercise for Elevated Risk (DEER)||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-10-11 04:19:07.951034|2017-10-11 04:19:07.951034
NCT00000796|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1998|Actual|1998-10-01|||||Interventional|||A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.|A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.|Completed||N/A|525||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:20.850428|2017-10-11 04:18:20.850428
NCT00000797|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2017-04-07|||October 1994||1994-10-01|April 2017|2017-04-01||||April 2019|Anticipated|2019-04-01||Observational|||Women's Interagency HIV Study (WIHS)|Women's Interagency HIV Study (WIHS)|Active, not recruiting||N/A|4982|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||f|f|f||||Samples With DNA|"     Blood, bodily fluid, and hair collection   "|No||2017-10-11 04:18:21.073358|2017-10-11 04:18:21.073358
NCT00000798|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects|A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:21.194862|2017-10-11 04:18:21.194862
NCT00000799|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-31||||||October 2012|2012-10-01|April 1996|Actual|1996-04-01|||||Interventional|||HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol|HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:21.272364|2017-10-11 04:18:21.272364
NCT00000800|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|October 1998|Actual|1998-10-01|||||Interventional|||Methadone Effects on Zidovudine (ZDV, AZT) Disposition|Methadone Effects on Zidovudine (ZDV, AZT) Disposition|Completed||Phase 1|15||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:21.359822|2017-10-11 04:18:21.359822
NCT00000801|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-31||||||October 2012|2012-10-01|April 1998|Actual|1998-04-01|||||Interventional|||Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma|Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma|Completed||Phase 2|33||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:21.440195|2017-10-11 04:18:21.440195
NCT00000802|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|July 1997|Actual|1997-07-01|||||Interventional|||A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides|A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides|Completed||Phase 3|700||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:21.673705|2017-10-11 04:18:21.673705
NCT00000803|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|March 1997|Actual|1997-03-01|||||Interventional|||A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy|A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy|Completed||Phase 2|471||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:21.873148|2017-10-11 04:18:21.873148
NCT00000804|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-12-13||||||April 2003|2003-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)|A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.021261|2017-10-11 04:18:22.021261
NCT00000805|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|March 1998|Actual|1998-03-01|||||Interventional|||A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease|A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.080194|2017-10-11 04:18:22.080194
NCT00000806|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Phase I Randomized Dose/Formulation Comparison Study of SC-52151|A Phase I Randomized Dose/Formulation Comparison Study of SC-52151|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.198518|2017-10-11 04:18:22.198518
NCT00000807|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|July 2000|Actual|2000-07-01|||||Interventional|||Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy|Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy|Completed||Phase 2|41||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.272488|2017-10-11 04:18:22.272488
NCT00000808|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1998|Actual|1998-09-01|||||Interventional|||A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers|A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers|Completed||Phase 1|49||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.372678|2017-10-11 04:18:22.372678
NCT00000809|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01||||||||Interventional|||Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women|A Phase I Trial of the Safety and Immunogenicity of MN rsgp120/HIV-1 With the Adjuvants QS-21 and Alum Compared to MN rsgp120/HIV-1 and QS-21 in Infants Born to HIV-Infected Women|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.454805|2017-10-11 04:18:22.454805
NCT00000811|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|November 2001|Actual|2001-11-01|||||Interventional|||A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children|A Randomized, Phase II/III, Double-Blind, Two-Armed Study of Micronized Atovaquone and Azithromycin (AT/AZ) as Compared to Trimethoprim-Sulfamethoxazole (TMP/SMX) in the Prevention of Serious Bacterial Infections When Used in Children Aged 3 Months to 19 Years With HIV Infection|Completed||Phase 2|690||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:18:22.600594|2017-10-11 04:18:22.600594
NCT00000812|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|July 2000|Actual|2000-07-01|||||Interventional|||A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection|A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.903494|2017-10-11 04:18:22.903494
NCT00000813|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|June 1995|Actual|1995-06-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|28||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:22.974181|2017-10-11 04:18:22.974181
NCT00000814|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|November 1998|Actual|1998-11-01|||||Interventional|||A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease|A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease|Completed||Phase 1|390||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:23.051628|2017-10-11 04:18:23.051628
NCT00000815|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|August 2001|Actual|2001-08-01|||||Interventional|||A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group|A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group|Completed||Phase 2|270|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:18:23.255534|2017-10-11 04:18:23.255534
NCT00000816|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-13||||||April 2012|2012-04-01|September 1996|Actual|1996-09-01|||||Interventional|||Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis|Gradual Initiation of Trimethoprim/Sulfamethoxazole as Primary Pneumocystis Carinii Pneumonia Prophylaxis|Completed||Phase 4|370||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:23.437306|2017-10-11 04:18:23.437306
NCT00000817|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28|||November 1994||1994-11-01|September 2013|2013-09-01|May 1997|Actual|1997-05-01|||||Interventional|||The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients|The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients|Completed||N/A|260|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:18:23.613256|2017-10-11 04:18:23.613256
NCT00000818|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-28||||||May 1996|1996-05-01||||||||Interventional|||Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.|Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:23.717712|2017-10-11 04:18:23.717712
NCT00000819|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-13||||||April 2012|2012-04-01|September 1996|Actual|1996-09-01|||||Interventional|||A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)|A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)|Completed||Phase 2|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:23.782963|2017-10-11 04:18:23.782963
NCT00000820|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-24||||||April 2012|2012-04-01|March 2002|Actual|2002-03-01|||||Interventional|||A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy|A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy|Completed||Phase 2|104||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:23.865205|2017-10-11 04:18:23.865205
NCT00000821|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-11-01||||||October 2012|2012-10-01|March 2002|Actual|2002-03-01|||||Interventional|||Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients|Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients|Completed||Phase 1|78||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:23.937092|2017-10-11 04:18:23.937092
NCT00000822|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|May 1999|Actual|1999-05-01|||||Interventional|||A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells|A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells|Completed||Phase 1|46||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:23.996867|2017-10-11 04:18:23.996867
NCT00000823|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|February 2000|Actual|2000-02-01|||||Interventional|||A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection|A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection|Completed||Phase 2|85||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:24.089378|2017-10-11 04:18:24.089378
NCT00000824|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-12-13||||||April 1995|1995-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients|A Pilot Study of HIV Specific Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients With CD4+ T Cells 100-350 Cells/mm3|Terminated||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:24.183895|2017-10-11 04:18:24.183895
NCT00000825|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-04-08|||May 1998||1998-05-01|April 2014|2014-04-01||||March 2000|Actual|2000-03-01||Interventional|||The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3|A Randomized, Open-Label Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Plus Antiretroviral Therapy vs. Antiretroviral Therapy Alone in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3|Completed||Phase 2|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:24.331906|2017-10-11 04:18:24.331906
NCT00000826|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|May 1999|Actual|1999-05-01|||||Interventional|||Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites|Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:24.401044|2017-10-11 04:18:24.401044
NCT00000827|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|April 1998|Actual|1998-04-01|||||Interventional|||A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children|A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children|Completed||Phase 1|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:24.504894|2017-10-11 04:18:24.504894
NCT00000828|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1997|1997-10-01||||||||Observational|||Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine|Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:24.652195|2017-10-11 04:18:24.652195
NCT00000829|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|October 1999|Actual|1999-10-01|||||Interventional|||A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants|A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:18:24.78827|2017-10-11 04:18:24.78827
NCT00000830|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1998|1998-03-01||||||||Observational|||Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.|Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:24.946307|2017-10-11 04:18:24.946307
NCT00000831|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|May 1998|Actual|1998-05-01|||||Interventional|||Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy|Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy|Completed||Phase 2|280||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:25.031371|2017-10-11 04:18:25.031371
NCT00000832|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|January 1998|Actual|1998-01-01|||||Interventional|||A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers|A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:25.203346|2017-10-11 04:18:25.203346
NCT00000833|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|July 1998|Actual|1998-07-01|||||Interventional|||A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.|A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:25.293086|2017-10-11 04:18:25.293086
NCT00000834|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|June 2002|Actual|2002-06-01|||||Interventional|||A Phase I Study of Methotrexate for HIV Infection|A Phase I Study of Methotrexate for HIV Infection|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:25.415711|2017-10-11 04:18:25.415711
NCT00000835|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01||||||||Observational|||A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:25.505248|2017-10-11 04:18:25.505248
NCT00000836|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-24||||||October 2012|2012-10-01|August 1998|Actual|1998-08-01|||||Interventional|||A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)|A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:25.561734|2017-10-11 04:18:25.561734
NCT00000837|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-02-11||||||February 2015|2015-02-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children|Phase I/II Study of the Safety and Immunogenicity of Live-Attenuated Varicella Vaccine (Varivax) in HIV-Infected Children|Completed||Phase 1|127||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:18:25.639722|2017-10-11 04:18:25.639722
NCT00000838|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|March 1998|Actual|1998-03-01|||||Interventional|||Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine|A Phase II, Randomized Study of the Antiviral Activity and Resistance Interactions of Lamivudine (3TC) in Combination With Zidovudine (AZT), Stavudine (d4T), or Didanosine (ddI) Versus Monotherapy With ddI or d4T in HIV-Infected Individuals With 200 - 600 CD4+ Cells/mm3 and No Previous Nucleoside Experience|Completed||Phase 2|256||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:25.766208|2017-10-11 04:18:25.766208
NCT00000243|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||September 2002||2002-09-01|November 2016|2016-11-01|January 2004||2004-01-01|||||Interventional|||Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone|Transitioning Patients From Methadone to Buprenorphine/Naloxone for Treating Opioid Dependence|Terminated||N/A|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:18:26.050904|2017-10-11 04:18:26.050904
NCT00000244|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||August 1994||1994-08-01|May 2015|2015-05-01|March 1997|Actual|1997-03-01|March 1997|Actual|1997-03-01||Interventional|||Effects of Dynorphin 1-13 on Heroin Addiction - 1|Effects of Dynorphin 1-13 on Heroin Addiction|Completed||Phase 2|0||University of Minnesota - Clinical and Translational Science Institute|||||f||||t||||||||||2017-10-11 04:18:26.115608|2017-10-11 04:18:26.115608
NCT00000245|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||May 1994||1994-05-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1|Evaluation of a Desipramine Ceiling in Cocaine Abuse|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:18:26.183748|2017-10-11 04:18:26.183748
NCT00000246|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2016-09-06|||January 1993||1993-01-01|September 2016|2016-09-01|December 1994|Actual|1994-12-01|December 1994|Actual|1994-12-01||Interventional|||Rapid Benzodiazepine Detoxification Using Flumazenil - 1|Rapid Benzodiazepine Detoxification Using Flumazenil|Completed||Phase 2|10|Actual|Yale University|||||f||||||||||||||2017-10-11 04:18:26.251088|2017-10-11 04:18:26.251088
NCT00000248|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2012-09-11|||February 1996||1996-02-01|May 1997|1997-05-01||||||||Interventional|||Dose Response Trial of Pergolide for Cocaine Dependence - 1|Dose Response Trial of Pergolide for Cocaine Dependence|Completed||Phase 3|0||Medical University of South Carolina|||||f||||||||||||||2017-10-11 04:18:26.313388|2017-10-11 04:18:26.313388
NCT00000249|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||September 1993||1993-09-01|May 2015|2015-05-01|June 1995|Actual|1995-06-01|June 1995|Actual|1995-06-01||Interventional|||Effects of Subanesthetic Concentrations of Nitrous Oxide - 1|Effects of Subanesthetic Concentrations of Nitrous Oxide|Completed||Phase 2|10|Actual|University of Chicago||4|||f||||||||||||||2017-10-11 04:18:26.387116|2017-10-11 04:18:26.387116
NCT00000250|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||December 1993||1993-12-01|May 2015|2015-05-01|May 1995|Actual|1995-05-01|May 1995|Actual|1995-05-01||Interventional|||Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2|Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide|Completed||Phase 2|12|Actual|University of Chicago||2|||f||||||||||||||2017-10-11 04:18:26.473062|2017-10-11 04:18:26.473062
NCT00000251|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-11-30|||April 1994||1994-04-01|November 2015|2015-11-01|January 1996|Actual|1996-01-01|January 1996|Actual|1996-01-01||Interventional|||Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3|Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide|Completed||Phase 2|10|Actual|University of Chicago||6|||f||||||||||||||2017-10-11 04:18:26.553839|2017-10-11 04:18:26.553839
NCT00000252|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||June 1994||1994-06-01|May 2015|2015-05-01|June 1996|Actual|1996-06-01|June 1996|Actual|1996-06-01||Interventional|||Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4|Lack of Acute Tolerance Development to Effects of Nitrous Oxide|Completed||Phase 2|11|Actual|University of Chicago||5|||f||||||||||||||2017-10-11 04:18:26.668543|2017-10-11 04:18:26.668543
NCT00000253|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||November 1994||1994-11-01|May 2015|2015-05-01|March 1996|Actual|1996-03-01|March 1996|Actual|1996-03-01||Interventional|||Effects of Nitrous Oxide: A Dose-Response Analysis - 5|Effects of Nitrous Oxide: A Dose-Response Analysis|Completed||N/A|16|Actual|University of Chicago||4|||f||||||||||||||2017-10-11 04:18:26.793682|2017-10-11 04:18:26.793682
NCT00000254|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||January 1995||1995-01-01|May 2015|2015-05-01|September 1995|Actual|1995-09-01|September 1995|Actual|1995-09-01||Interventional|||Isoflurane at Subanesthetic Concentrations - 6|Isoflurane at Subanesthetic Concentrations|Completed||Phase 2|10|Actual|University of Chicago||4|||f||||||||||||||2017-10-11 04:18:27.073879|2017-10-11 04:18:27.073879
NCT00000255|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||April 1995||1995-04-01|May 2015|2015-05-01|May 1996|Actual|1996-05-01|May 1996|Actual|1996-05-01||Interventional|||Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7|Differential Acute Tolerance Development to Effects of Nitrous Oxide|Completed||Phase 2|10|Actual|University of Chicago||5|||f||||||||||||||2017-10-11 04:18:27.208868|2017-10-11 04:18:27.208868
NCT00000256|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||August 1995||1995-08-01|May 2015|2015-05-01|November 1996|Actual|1996-11-01|November 1996|Actual|1996-11-01||Interventional|||Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8|Reinforcing Effects of Brief Exposures to Nitrous Oxide|Completed||N/A|11|Actual|University of Chicago||4|||f||||||||||||||2017-10-11 04:18:27.338604|2017-10-11 04:18:27.338604
NCT00000257|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||September 1995||1995-09-01|May 2015|2015-05-01|April 1997|Actual|1997-04-01|April 1997|Actual|1997-04-01||Interventional|||Effects of Alcohol History on Effects of Nitrous Oxide - 9|Effects of Alcohol History on Effects of Nitrous Oxide|Completed||N/A|19|Actual|University of Chicago||2|||f||||||||||||||2017-10-11 04:18:27.462961|2017-10-11 04:18:27.462961
NCT00000258|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||April 1996||1996-04-01|May 2015|2015-05-01|November 1997|Actual|1997-11-01|November 1997|Actual|1997-11-01||Interventional|||Role of Instructions in Nitrous Oxide Effects and Choice - 10|Role of Instructions in Nitrous Oxide Effects and Choice|Completed||N/A|22|Actual|University of Chicago||2|||f||||||||||||||2017-10-11 04:18:27.59844|2017-10-11 04:18:27.59844
NCT00000259|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||August 1996||1996-08-01|May 2015|2015-05-01|November 1997|Actual|1997-11-01|November 1997|Actual|1997-11-01||Interventional|||Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11|Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations|Completed||N/A|12|Actual|University of Chicago||5|||f||||||||||||||2017-10-11 04:18:27.733273|2017-10-11 04:18:27.733273
NCT00000260|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||June 1997||1997-06-01|May 2015|2015-05-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12|Effects of Behavioral Contingencies on Effects of Nitrous Oxide|Completed||N/A|18|Actual|University of Chicago|||||f||||||||||||||2017-10-11 04:18:27.868516|2017-10-11 04:18:27.868516
NCT00000261|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||November 1997||1997-11-01|May 2015|2015-05-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13|Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide|Completed||Phase 2|14|Actual|University of Chicago||1|||f||||||||||||||2017-10-11 04:18:27.964309|2017-10-11 04:18:27.964309
NCT00000262|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||November 1996||1996-11-01|May 2015|2015-05-01|February 1999|Actual|1999-02-01|February 1999|Actual|1999-02-01||Interventional|||Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14|Effects of Combined Sevoflurane and Nitrous Oxide Inhalation|Completed||N/A|20|Actual|University of Chicago||3|||f||||||||||||||2017-10-11 04:18:28.074909|2017-10-11 04:18:28.074909
NCT00000264|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||September 1997||1997-09-01|May 2015|2015-05-01|October 1999|Actual|1999-10-01|October 1999|Actual|1999-10-01||Interventional|||Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16|Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide|Completed||N/A|8|Actual|University of Chicago||3|||f||||||||||||||2017-10-11 04:18:28.27153|2017-10-11 04:18:28.27153
NCT00000265|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2015-05-26|||July 1997||1997-07-01|May 2015|2015-05-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Observational|||Subjective Effects of Nitrous Oxide in Dental Patients - 17|Subjective Effects of Nitrous Oxide in Dental Patients|Completed||Phase 2|46|Actual|University of Chicago|||3||f||||||||||||||2017-10-11 04:18:28.362014|2017-10-11 04:18:28.362014
NCT00000266|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11|||August 1994||1994-08-01|October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1|Flupenthixol Treatment in Schizophrenic Cocaine Abusers|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:18:28.434975|2017-10-11 04:18:28.434975
NCT00000267|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-20|2017-01-11||||||October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||Risperidone Treatment in Dually-Diagnosed Individuals - 2|Risperidone Treatment in Dually-Diagnosed Individuals|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:18:28.499176|2017-10-11 04:18:28.499176
NCT00000839|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||August 2004|2004-08-01|June 2001|Actual|2001-06-01|||||Interventional|||A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women|A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:28.578349|2017-10-11 04:18:28.578349
NCT00000840|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Observational|||A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA|A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA|Completed||N/A|70||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:28.67225|2017-10-11 04:18:28.67225
NCT00000841|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|June 1997|Actual|1997-06-01|||||Interventional|||A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months|A Randomized, Double-Blind, Phase III Study of Indinavir Sulfate With Open-Label Zidovudine (AZT) and Lamivudine (3TC) in Subjects With HIV Infection With CD4 Cell Counts <= 200 Cells/mm3 and >= 6 Months of Prior AZT Experience|Completed||Phase 3|1750||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:28.752978|2017-10-11 04:18:28.752978
NCT00000842|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-09||||||May 2012|2012-05-01|February 1999|Actual|1999-02-01|||||Interventional|||A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy|A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy|Completed||Phase 2|270||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.005791|2017-10-11 04:18:29.005791
NCT00000843|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1998|1998-04-01||||||||Interventional|||The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children|A Phase IA Single Dose Pharmacokinetics and Safety Study of the Oral Antiviral Compound, 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA) (Adefovir Dipivoxil) in Children With HIV-1 Infection|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.110988|2017-10-11 04:18:29.110988
NCT00000844|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|June 2002|Actual|2002-06-01|||||Interventional|||A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3|A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3|Completed||N/A|560||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.228245|2017-10-11 04:18:29.228245
NCT00000845|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects|A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.353258|2017-10-11 04:18:29.353258
NCT00000846|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.|A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.432091|2017-10-11 04:18:29.432091
NCT00000847|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|May 1999|Actual|1999-05-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.525499|2017-10-11 04:18:29.525499
NCT00000848|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-13||||||February 2012|2012-02-01|October 1998|Actual|1998-10-01|||||Interventional|||The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year|The Antiviral Effect of Switching From Hard Capsule Saquinavir (SQVhc) to the Soft Gelatin Capsule of Saquinavir (SQVsc) Versus Switching to Indinavir (IDV) After 1 Year of Saquinavir Use|Completed||Phase 2|144|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.647839|2017-10-11 04:18:29.647839
NCT00000849|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|March 2001|Actual|2001-03-01|||||Interventional|||A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children|Phase I/II Trial of Recombinant Interleukin-2 In Symptomatic Human Immunodeficiency Virus-Infected Children|Completed||Phase 1|27||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.770165|2017-10-11 04:18:29.770165
NCT00000850|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|December 2003|Actual|2003-12-01|||||Interventional|||The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy|The Effects of GM-CSF on Plasma HIV-1 RNA and Chemokine Receptor Expression in HIV-1 Infected Subjects Receiving Concomitant Potent Antiretroviral Therapy|Completed||Phase 2|108||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:29.889639|2017-10-11 04:18:29.889639
NCT00000851|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|October 1998|Actual|1998-10-01|||||Interventional|||Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children|Trial of Stavudine (d4T) Plus Didanosine (ddI) in Children on Long-Term Stavudine Monotherapy, and Stavudine Versus Stavudine Plus Didanosine in Children on Long-Term Zidovudine Monotherapy: A Rollover Protocol for ACTG 240 Participants and Children Receiving Prescription Zidovudine|Completed||Phase 2|198||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:30.068927|2017-10-11 04:18:30.068927
NCT00000852|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection|A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:30.41317|2017-10-11 04:18:30.41317
NCT00000853|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|January 1999|Actual|1999-01-01|||||Interventional|||A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults|Completed||Phase 1|37|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:30.52674|2017-10-11 04:18:30.52674
NCT00000854|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-13||||||February 2012|2012-02-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss|A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Trial of Nandrolone Decanoate in Women With HIV-Associated Weight Loss|Completed||Phase 1|38||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:30.654381|2017-10-11 04:18:30.654381
NCT00000855|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 2000|Actual|2000-02-01|||||Interventional|||A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.|The Safety, Tolerance, and Pharmacokinetics of Zidovudine in Premature Infants Exposed to HIV.|Completed||N/A|35||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:30.793992|2017-10-11 04:18:30.793992
NCT00000856|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-29||||||May 2012|2012-05-01||||||||Interventional|||A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.|A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:30.989605|2017-10-11 04:18:30.989605
NCT00000857|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-06-02||||||May 2012|2012-05-01|June 2001|Actual|2001-06-01|||||Interventional|||A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3|A Phase I, Double-Blind, Randomized, Placebo-Controlled Trial of Recombinant Human Interleukin-12 (rhIL-12) in HIV-Infected Subjects With Less Than 50 CD4+ T Cells and Subjects With 300-500 CD4+ T Cells|Completed||Phase 1|65||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:31.109005|2017-10-11 04:18:31.109005
NCT00000858|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Observational|||Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections|Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections|Completed||N/A|350||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:31.285114|2017-10-11 04:18:31.285114
NCT00000859|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|December 2001|Actual|2001-12-01|||||Interventional|||A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3|A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3|Completed||N/A|1300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:31.396885|2017-10-11 04:18:31.396885
NCT00000860|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1999|1999-07-01||||||||Observational|||The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients|Effects of Treatment for MAC Infection on Cytokine Expression in HIV-Infected Persons.|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:31.633171|2017-10-11 04:18:31.633171
NCT00000861|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|March 1997|Actual|1997-03-01|||||Interventional|||The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients|A Randomized Trial of Immediate Versus Deferred Indinavir in Addition to Background Antiretroviral Therapy in HIV-Infected Patients With CD4+ Cell Counts Between 200 and 500/mm3 and Plasma HIV RNA Levels >= 10,000 Copies/ml|Completed||N/A|1900||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:31.767584|2017-10-11 04:18:31.767584
NCT00000862|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women|A Phase I Trial of the Pharmacokinetics and Tolerance of Oral Zidovudine Administered to HIV-1 Infected Pregnant Women During Labor and Delivery|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:31.922398|2017-10-11 04:18:31.922398
NCT00000863|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|July 1998|Actual|1998-07-01|||||Interventional|||A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients|A Phase II Study of WR 6026 for Pneumocystis Carinii Pneumonia in People With HIV Infection|Completed||Phase 2|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:32.066773|2017-10-11 04:18:32.066773
NCT00000864|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|January 2001|Actual|2001-01-01|||||Interventional|||A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women|Phase I Study of Safety, Tolerance, and Pharmacokinetics of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy In Neonates Born to HIV-1 Infected Women|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:18:32.260266|2017-10-11 04:18:32.260266
NCT00000940|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-01-05|||May 1999||1999-05-01|January 2016|2016-01-01|October 2006|Actual|2006-10-01|||||Interventional|||Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV|A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion|Completed||Phase 2|121|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:18:32.38508|2017-10-11 04:18:32.38508
NCT00000941|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|March 2002|Actual|2002-03-01|||||Interventional|||A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood|Evaluation of Potential Pharmacokinetic Interactions Between Protease Inhibitors and Lipid Lowering Agents|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:32.517048|2017-10-11 04:18:32.517048
NCT00000942|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies|A Phase III Randomized, Double-Blinded Study of Nevirapine for the Prevention of Maternal-Fetal Transmission in Pregnant HIV-Infected Women|Completed||Phase 3|1244||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:32.613256|2017-10-11 04:18:32.613256
NCT00000943|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328|A Controlled, Pilot Study of the Immunogenicity of Remune in HIV-Infected Subjects Receiving Either Highly Active Antiretroviral Therapy (HAART) Alone or HAART and Interleukin-2 (IL-2): A Nested Substudy of ACTG 328|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:32.684183|2017-10-11 04:18:32.684183
NCT00000944|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|March 2003|Actual|2003-03-01|||||Interventional|||A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants|A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Indinavir Co-Administered With Lamivudine (3TC) and Zidovudine (ZDV) in HIV-1-Infected Pregnant Women During Gestation and Post Partum, and in Their Infants Post Maternal Dosing|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:18:32.749351|2017-10-11 04:18:32.749351
NCT00000945|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|March 2001|Actual|2001-03-01|||||Interventional|||A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients|A Pilot Study of the Effect of Cidofovir for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in Subjects With Acquired Immunodeficiency Syndrome (AIDS)|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:32.823467|2017-10-11 04:18:32.823467
NCT00000946|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|March 2001|Actual|2001-03-01|||||Interventional|||A Study to Test the Safety of Three Experimental HIV Vaccines|"A Phase I Trial to Evaluate the HIV-1 SF-2 Recombinant p24 Subunit Vaccine [Chiron Vaccines] Administered as a Novel Boost in Prime-Boost Vaccination Regimens With ALVAC-HIV vCP205 [Pasteur Merieux Connaught] and HIV-1 SF-2 rgp120 in MF59 [Chiron Vaccines]"|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:32.940498|2017-10-11 04:18:32.940498
NCT00000947|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|July 2000|Actual|2000-07-01|||||Interventional|||A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients|A Randomized, Double-Blind, Placebo-Controlled Trial of Prophylaxis for Disseminated Mycobacterium Avium Complex Disease and Bacterial Pneumonia Versus Deferred Prophylaxis in HIV-Infected Patients Who Experience Rebound in CD4+ Cell Count Due to Active Antiretroviral Therapy|Completed||N/A|850||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:33.091729|2017-10-11 04:18:33.091729
NCT00000948|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-02-01|||February 1998||1998-02-01|February 2013|2013-02-01||||March 2000|Actual|2000-03-01||Interventional|||Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3|A Randomized, Open Label Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Plus Antiretroviral Therapy vs. Antiretroviral Therapy Alone in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3|Completed||Phase 2|72||National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:18:33.193884|2017-10-11 04:18:33.193884
NCT00000949|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|July 2000|Actual|2000-07-01|||||Interventional|||A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3|A Randomized, Open-Label, Study of the Impact of Two Doses of Subcutaneous Recombinant IL-2 (Proleukin) on Viral Burden and CD4+ Cell Count in Patients With HIV-1 Infection and CD4+ Cell Counts Greater Than or Equal to 300/mm3|Completed||Phase 3|460||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:33.278934|2017-10-11 04:18:33.278934
NCT00000950|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-01||||||March 2011|2011-03-01||||May 2002|Actual|2002-05-01||Interventional|||Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis|Pharmacokinetics of Antituberculosis Agents in HIV-Infected Persons With Tuberculosis|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:33.390743|2017-10-11 04:18:33.390743
NCT00000951|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush|A Phase IV Randomized Study of the Use of Fluconazole as Chronic Suppressive Therapy Versus Episodic Therapy in HIV Positive Subjects With Recurrent Oropharyngeal Candidiasis|Completed||Phase 4|948||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:33.496193|2017-10-11 04:18:33.496193
NCT00000952|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-10-28||||||October 2014|2014-10-01|January 2004|Actual|2004-01-01|||||Interventional|||A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children|A Phase I/II Study of Ritonavir Therapy in HIV-1 Infected Infants and Children|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:34.936439|2017-10-11 04:18:34.936439
NCT00000953|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-25||||||February 2011|2011-02-01||||September 1996|Actual|1996-09-01||Interventional|||Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients|Evaluation of Brovavir ( BV-ara-U; SQ 32,756 ) Versus Acyclovir in the Treatment of Localized Herpes Zoster in HIV-Infected Patients|Completed||Phase 2|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:35.129051|2017-10-11 04:18:35.129051
NCT00000954|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma|Phase I/II Study of Combination Chemotherapy (Adriamycin, Bleomycin, +/- Vincristine) and Dideoxyinosine (ddI) or Dideoxycytidine (ddC) in the Treatment of AIDS-Related Kaposi's Sarcoma|Completed||Phase 1|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:35.285018|2017-10-11 04:18:35.285018
NCT00000955|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|December 1992|Actual|1992-12-01|December 1992|Actual|1992-12-01||Interventional|||Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection|Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection|Completed||N/A|864|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:18:35.395186|2017-10-11 04:18:35.395186
NCT00000956|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|March 1993|Actual|1993-03-01|||||Interventional|||A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|Completed||Phase 1|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:35.502864|2017-10-11 04:18:35.502864
NCT00000957|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|August 1993|Actual|1993-08-01|||||Interventional|||A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules|A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:35.679407|2017-10-11 04:18:35.679407
NCT00000958|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|September 1995|Actual|1995-09-01|||||Interventional|||A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)|A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)|Completed||Phase 1|8||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:35.766243|2017-10-11 04:18:35.766243
NCT00000959|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|June 1996|Actual|1996-06-01|||||Interventional|||Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection|Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection|Completed||N/A|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:35.847307|2017-10-11 04:18:35.847307
NCT00000960|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-05-15||||||March 2012|2012-03-01|June 1994|Actual|1994-06-01|||||Interventional|||The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants|A Phase III Randomized Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerance of Oral Zidovudine (AZT) in Pregnant HIV Infected Women and Their Infants|Completed||Phase 3|1496||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:36.008787|2017-10-11 04:18:36.008787
NCT00000961|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||March 1998|1998-03-01||||May 1991|Actual|1991-05-01||Interventional|||The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants|A Phase II Study to Evaluate the Safety, Tolerance and Efficacy of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HIVIG) and of Zidovudine (ZDV) in Infants With Documented HIV Infections|Terminated||Phase 2|112||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:36.237949|2017-10-11 04:18:36.237949
NCT00000962|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-01||||||December 1994|1994-12-01||||||||Interventional|||The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients|An Open Label, Staggered Rising Dose Cohort Study Assessing Safety, Tolerance, and Activity of BI-RG-587 in Patients With HIV Infection (CD4+ Cell Count < 400 Cells/mm3)|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:36.326384|2017-10-11 04:18:36.326384
NCT00000963|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1995|Actual|1995-09-01|||||Interventional|||A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine|A Randomized Comparative Trial of Two Doses of 2',3'-Dideoxyinosine (ddI) in Children With Symptomatic HIV Infection Who Are Either Unresponsive to Zidovudine and/or Who Are Intolerant to Zidovudine|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:36.398956|2017-10-11 04:18:36.398956
NCT00000964|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|October 1990|Actual|1990-10-01|||||Interventional|||The Effect of Stomach Acid on Foscarnet|The Effect of Increasing Gastric pH Upon the Bioavailability of Orally Administered Phosphonoformic Acid (Foscarnet)|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:36.574036|2017-10-11 04:18:36.574036
NCT00000965|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-25||||||February 2011|2011-02-01||||August 1993|Actual|1993-08-01||Interventional|||The Effects of Zidovudine on the Blood of HIV-Infected Patients|Pharmacokinetics of Total Phosphorylated Zidovudine in Mononuclear Cells From HIV-Infected Patients|Completed||N/A|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:36.650557|2017-10-11 04:18:36.650557
NCT00000966|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-25||||||October 1994|1994-10-01||||||||Interventional|||A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS|A Dose-Escalation, Phase I/II Study of Oral Azithromycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS|Completed||Phase 1|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:36.730697|2017-10-11 04:18:36.730697
NCT00000967|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children|Safety and Tolerance of Zidovudine and Interferon-Alpha in HIV-Infected Children|Completed||Phase 1|52||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:36.954293|2017-10-11 04:18:36.954293
NCT00000968|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|August 1993|Actual|1993-08-01|||||Interventional|||A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)|A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.052747|2017-10-11 04:18:37.052747
NCT00000969|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|September 1992|Actual|1992-09-01|||||Interventional|||A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy|A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy|Completed||N/A|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.167244|2017-10-11 04:18:37.167244
NCT00000970|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|June 1993|Actual|1993-06-01|||||Interventional|||A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir|A Phase I Open-Labeled Study of Long Term Combined or Alternating Foscarnet/Ganciclovir Maintenance Therapy for AIDS Patients With CMV Retinitis After Ganciclovir Induction Therapy|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.290738|2017-10-11 04:18:37.290738
NCT00000971|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-31||||||October 1996|1996-10-01||||||||Interventional|||The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS|A Phase I/II Dose-Ranging, Pharmacokinetic, Drug Interaction, Safety and Preliminary Efficacy Study of Oral Clarithromycin Granules for Suspension, in Combination With Zidovudine or Dideoxyinosine, in the Treatment of Disseminated Mycobacterium Avium Complex Infections in Pediatric Patients With AIDS|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.393007|2017-10-11 04:18:37.393007
NCT00000972|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|April 1992|Actual|1992-04-01|||||Interventional|||A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59|A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59|Completed||Phase 1|64|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.489596|2017-10-11 04:18:37.489596
NCT00000973|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|March 1995|Actual|1995-03-01|||||Interventional|||A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients|Pyrimethamine Pharmacokinetics in HIV Positive Patients Seropositive for Toxoplasma Gondii|Completed||Phase 1|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.582389|2017-10-11 04:18:37.582389
NCT00000974|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia|A Phase I Study of the Safety, Tolerance, and Study of the Pharmacokinetics of Aerosolized Pentamidine and Parenteral Pentamidine in Children With HIV Infection and Suspected Pneumocystis Carinii Pneumonia|Completed||Phase 1|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.671509|2017-10-11 04:18:37.671509
NCT00000975|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1994|Actual|1994-09-01|||||Interventional|||A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS|Pilot Study To Determine the Feasibility of Itraconazole for Primary Treatment and Suppression of Relapse of Disseminated Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome|Completed||Phase 2|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.769592|2017-10-11 04:18:37.769592
NCT00000976|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-05||||||December 1994|1994-12-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex|A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.889207|2017-10-11 04:18:37.889207
NCT00000977|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|May 1993|Actual|1993-05-01|||||Interventional|||Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity|Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity|Completed||Phase 1|52||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:37.977435|2017-10-11 04:18:37.977435
NCT00000978|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-06||||||August 1992|1992-08-01||||||||Interventional|||A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)|An Open-Label, Randomized, Dose-Finding, Multicenter Trial of Dideoxycytidine (ddC) Administered Concurrently With Zidovudine (AZT) in the Treatment of AIDS or Advanced ARC|Completed||Phase 1|68||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:38.056435|2017-10-11 04:18:38.056435
NCT00000979|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||January 2003|2003-01-01||||October 1992|Actual|1992-10-01||Interventional|||Comparison of ddI Versus Zidovudine in HIV-Infected Patients|Comparison of 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine in Therapy of Patients With HIV Infection|Completed||Phase 2|1500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:38.154771|2017-10-11 04:18:38.154771
NCT00000980|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1990|1990-10-01||||||||Interventional|||A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea|Single-Blind Efficacy Evaluation of Intravenous Spiramycin in Subjects With AIDS-Related Cryptosporidial Diarrhea|Completed||Phase 1|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:38.36397|2017-10-11 04:18:38.36397
NCT00000981|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-12-17||||||December 2012|2012-12-01|February 1993|Actual|1993-02-01|||||Interventional|||The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS|Efficacy and Safety of Oral FIAC in AIDS Patients With Cytomegalovirus Infection: A Dose Ranging Study|Completed||Phase 2|78||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:38.446174|2017-10-11 04:18:38.446174
NCT00000982|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||October 1996|1996-10-01||||September 1996|Actual|1996-09-01||Interventional|||A Study of Azidothymidine in HIV-Infected Children|A Randomized Trial To Evaluate the Impact of Maintaining Steady-State Concentrations of Azidothymidine (AZT) Versus an Intermittent Schedule of AZT Delivery in Children With Symptomatic HIV Infection|Completed||Phase 2|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:38.507833|2017-10-11 04:18:38.507833
NCT00000983|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|December 1994|Actual|1994-12-01|||||Interventional|||The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children|A Randomized Blinded Trial To Evaluate the Safety and Tolerance of High Versus Low Dose Zidovudine Administered to Children With Human Immunodeficiency Virus|Completed||Phase 2|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:38.584244|2017-10-11 04:18:38.584244
NCT00000984|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1996|1996-10-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection|A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:38.852018|2017-10-11 04:18:38.852018
NCT00000985|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|October 1990|Actual|1990-10-01|||||Interventional|||Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir|Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Infection in Patients With the Acquired Immunodeficiency Syndrome: A Randomized Multicenter Study of Foscarnet Versus Vidarabine|Completed||Phase 3|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:38.926714|2017-10-11 04:18:38.926714
NCT00000986|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-25||||||April 2012|2012-04-01|January 1994|Actual|1994-01-01|||||Interventional|||The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex|A Safety, Tolerance, and Immunological Study of a Combination of Recombinant Interleukin 2 and Zidovudine in Patients With AIDS or AIDS Related Complex|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.011086|2017-10-11 04:18:39.011086
NCT00000987|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|April 1992|Actual|1992-04-01|||||Interventional|||A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS|A Phase I Study of Combination Chemotherapy (Adriamycin, Bleomycin, and Vincristine) and Azidothymidine in the Treatment of AIDS Related Kaposi's Sarcoma|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.096376|2017-10-11 04:18:39.096376
NCT00000988|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-25||||||December 1994|1994-12-01||||||||Interventional|||A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex|A Phase I Safety and Pharmacokinetics Study of BMY-27857 (2',3'-Didehydro-3'-Deoxythymidine) Administered Twice Daily to Patients With AIDS or AIDS Related Complex|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.177219|2017-10-11 04:18:39.177219
NCT00000989|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|July 1992|Actual|1992-07-01|||||Interventional|||The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS|A Controlled, Randomized Phase II Study of the Safety and Efficacy of Combined Therapy With Ganciclovir and Granulocyte-Macrophage Colony Stimulating Factor Versus Ganciclovir Alone for the Treatment of Sight-Threatening Cytomegalovirus Retinitis in AIDS Patients|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.245204|2017-10-11 04:18:39.245204
NCT00000990|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1992|Actual|1992-09-01|||||Interventional|||The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms|A Multicenter Placebo-Controlled Trial To Evaluate the Safety and Efficacy of Oral Zidovudine in the Treatment of Children Infected With Human Immunodeficiency Virus With Mild to Moderate Symptoms (Including LIP)|Completed||Phase 2|224||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.336737|2017-10-11 04:18:39.336737
NCT00000991|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|April 1994|Actual|1994-04-01|||||Interventional|||A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients|A Randomized Trial of Three Anti-Pneumocystis Agents Plus Zidovudine for the Primary Prevention of Serious Infections in Patients With Advanced HIV Infection|Completed||Phase 3|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.475593|2017-10-11 04:18:39.475593
NCT00000992|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-05-15||||||March 2012|2012-03-01|June 1992|Actual|1992-06-01|||||Interventional|||A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS|Pilot Study to Determine the Feasibility of Itraconazole for Suppression of Relapse of Disseminated Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.616476|2017-10-11 04:18:39.616476
NCT00000599|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-12|||June 1980||1980-06-01|May 2000|2000-05-01|November 1994|Actual|1994-11-01|||||Interventional|||Cholesterol-Lowering Atherosclerosis Study (CLAS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.014426|2017-10-11 04:19:08.014426
NCT00000993|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-11-04||||||April 1991|1991-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus|An Open Protocol for the Use of Zidovudine for Prophylactic Treatment of Individuals After Accidental Massive Exposure to the Human Immunodeficiency Virus (HIV)|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.705846|2017-10-11 04:18:39.705846
NCT00000994|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-15||||||February 2012|2012-02-01|May 1990|Actual|1990-05-01|||||Interventional|||A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma|A Placebo-Controlled Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS-Associated Kaposi's Sarcoma|Completed||Phase 3|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.7898|2017-10-11 04:18:39.7898
NCT00000995|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-15||||||February 2012|2012-02-01|February 1990|Actual|1990-02-01|||||Interventional|||A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection|Phase I Studies of the Combination of AZT and DHPG (Ganciclovir) in Patients With AIDS and Cytomegalovirus Infection|Completed||N/A|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:39.921515|2017-10-11 04:18:39.921515
NCT00000996|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|June 1990|Actual|1990-06-01|||||Interventional|||A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma|Phase II Study of Weekly Doxorubicin Treatment of AIDS Associated Kaposi's Sarcoma|Completed||Phase 2|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.010895|2017-10-11 04:18:40.010895
NCT00000997|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|December 1988|Actual|1988-12-01|||||Interventional|||A Study of Dideoxycytidine in HIV-Infected Patients|Pharmacokinetics and Bioavailability of Dideoxycytidine in Patients With Human Immunodeficiency Virus Infection|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.099036|2017-10-11 04:18:40.099036
NCT00000998|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-12-17||||||December 2012|2012-12-01|April 1989|Actual|1989-04-01|||||Interventional|||A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP|Evaluation of Escalating Doses of Intravenous Trimetrexate as Therapy for Previously Untreated Pneumocystis Carinii Pneumonia in AIDS Patients With Subsequent Comparison of Intravenous and Oral Pharmacokinetics|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.171574|2017-10-11 04:18:40.171574
NCT00000999|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|March 1989|Actual|1989-03-01|||||Interventional|||The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC|A Multicenter Uncontrolled Trial To Evaluate the Long Term Safety and Tolerance of Zidovudine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS and Advanced ARC|Completed||Phase 1|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.258429|2017-10-11 04:18:40.258429
NCT00001000|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-18||||||October 2012|2012-10-01|January 1990|Actual|1990-01-01|||||Interventional|||A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection|Immunologic Effect After Single Dose Atvogen in Healthy Volunteers and Asymptomatic HIV-Infected Patients|Completed||N/A|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.377576|2017-10-11 04:18:40.377576
NCT00001001|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||A Study of Zidovudine in HIV-Infected Patients With Liver Disease|A Clinical Study Examining the Pharmacokinetics and Bioavailability of Azidothymidine (AZT, Zidovudine) in Patients With Human Immunodeficiency Virus (HIV) Infection and Hepatic Disease|Completed||N/A|39||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.444304|2017-10-11 04:18:40.444304
NCT00001002|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1991|Actual|1991-06-01|||||Interventional|||A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time|Intermittent Foscarnet Therapy for Human Immunodeficiency Virus Infection in Patients Receiving Long-Term Zidovudine Therapy|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.525043|2017-10-11 04:18:40.525043
NCT00001003|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|January 1992|Actual|1992-01-01|||||Interventional|||A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia|Aerosols in the Treatment of Pneumocystis Carinii Pneumonia: A Nested Study Quantitating the Delivery of Aerosolized Pentamidine for Prophylaxis of PCP in Protocols ACTG 021 and ACTG 081|Completed||N/A|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.601802|2017-10-11 04:18:40.601802
NCT00001004|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|February 1990|Actual|1990-02-01|||||Interventional|||A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex|A Randomized Multicenter Phase II Trial of Recombinant Tumor Necrosis Factor and Recombinant Human Interferon-gamma in Patients With AIDS Related Complex|Completed||Phase 2|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.672018|2017-10-11 04:18:40.672018
NCT00001005|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-25||||||April 2012|2012-04-01|February 1995|Actual|1995-02-01|||||Interventional|||A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes|Interleukin-2 Augmentation of Specific Anti-HIV Immune Responses: Phase I Trial of the Combination of 3'-Azido-3'-Deoxythymidine (Zidovudine) and Recombinant Interleukin-2 in Patients With Asymptomatic HIV Infection Associated With Lymphadenopathy (Walter Reed Stage II)|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.736348|2017-10-11 04:18:40.736348
NCT00001006|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|March 1993|Actual|1993-03-01|||||Interventional|||A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)|A Phase One Study of AS-101 in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.802903|2017-10-11 04:18:40.802903
NCT00001007|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-11||||||January 2003|2003-01-01||||||||Interventional|||A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth|A Multicenter Phase I Trial To Evaluate the Safety and Pharmacokinetics of Intravenous and Oral Zidovudine in Infants With Perinatal Human Immunodeficiency Virus (HIV) Exposure|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.872191|2017-10-11 04:18:40.872191
NCT00001008|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||August 1991|1991-08-01||||March 1991|Actual|1991-03-01||Interventional|||A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)|Pharmacokinetic Study of the Interaction of Azidothymidine and Methadone in Patients With AIDS and ARC|Completed||N/A|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:40.949573|2017-10-11 04:18:40.949573
NCT00001009|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|April 1990|Actual|1990-04-01|||||Interventional|||A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)|A Phase I/II Dose Ranging Trial of Oral Dextran Sulfate (UA001) in HIV Infected Individuals and in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS Related Complex (ARC)|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:41.035018|2017-10-11 04:18:41.035018
NCT00001010|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|October 1990|Actual|1990-10-01|||||Interventional|||A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients|An Uncontrolled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Zidovudine (AZT) and Acyclovir (ACV) Given Concomitantly to Patients With Human Immunodeficiency Virus Infection|Completed||Phase 1|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:41.139859|2017-10-11 04:18:41.139859
NCT00001011|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex|The Safety and Efficacy of Zidovudine in the Treatment of Patients With Early AIDS Related Complex|Completed||Phase 3|538||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:41.360512|2017-10-11 04:18:41.360512
NCT00001012|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 2002|2002-09-01||||||||Interventional|||A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes|An Open Label, Multiple Dose Ranging Trial of AL721 in Patients With Persistent Generalized Lymphadenopathy and Symptomatic HIV Infection|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:41.555442|2017-10-11 04:18:41.555442
NCT00001013|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1991|Actual|1991-09-01|||||Interventional|||Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS|A Randomized, Comparative, Double-Blind Trial of Trimetrexate (CI-898) With Leucovorin Calcium Rescue Versus Trimethoprim / Sulfamethoxazole for Moderately Severe Pneumocystis Carinii Pneumonia in Patients With AIDS|Completed||Phase 3|364||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:41.657997|2017-10-11 04:18:41.657997
NCT00001014|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1991|Actual|1991-09-01|||||Interventional|||Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS|A Randomized, Comparative, Double-Blind Trial of Trimetrexate (CI-898) With Leucovorin Calcium Rescue Versus Trimethoprim / Sulfamethoxazole for Moderately Severe Pneumocystis Carinii Pneumonia in Patients With AIDS|Completed||Phase 3|302||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:41.793983|2017-10-11 04:18:41.793983
NCT00001015|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1990|Actual|1990-06-01|||||Interventional|||A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems|A Multicenter Phase I Clinical Trial of Ribavirin in the Treatment of Patients With AIDS and Advanced AIDS Related Illnesses|Completed||Phase 1|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:41.885215|2017-10-11 04:18:41.885215
NCT00001016|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-09-26||||||July 1993|1993-07-01|August 2007|Actual|2007-08-01|||||Interventional|||A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies|A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:41.962908|2017-10-11 04:18:41.962908
NCT00001017|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-11||||||September 2002|2002-09-01||||July 1991|Actual|1991-07-01||Interventional|||Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS|Comparison of Fluconazole (UK-49,858) and Amphotericin B for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome|Completed||Phase 3|330||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.039654|2017-10-11 04:18:42.039654
NCT00001018|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1992|1992-10-01||||||||Interventional|||A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea|Blinded, Placebo-Controlled, Single-Dose Pharmacokinetics and Dose Escalation, Efficacy, and Safety Study of Letrazuril for AIDS-Related Cryptosporidial Diarrhea|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.168515|2017-10-11 04:18:42.168515
NCT00001019|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-29||||||October 2012|2012-10-01||||||||Interventional|||Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant|A Phase I Clinical Trial to Evaluate:Part A. The Safety and Immunogenicity of Two Dose Levels of SF-2 gp120 (CHO) With or Without MTP-PE Adjuvant in the MF59 Emulsion Part B. The Safety and Immunogenicity of Five Monthly Doses of 50 mcg gp120 Protein in MF59 Emulsion (Without MTP-PE) Versus the Emulsion Control|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.24539|2017-10-11 04:18:42.24539
NCT00001020|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|February 1995|Actual|1995-02-01|||||Interventional|||A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)|A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)|Completed||Phase 1|28||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.351977|2017-10-11 04:18:42.351977
NCT00001046|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01||||||||Interventional|||Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)|Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.442281|2017-10-11 04:18:45.442281
NCT00001021|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)|A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)|Completed||Phase 1|57||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.450606|2017-10-11 04:18:42.450606
NCT00001022|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|December 1995|Actual|1995-12-01|||||Interventional|||A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients|A Randomized, Comparative Trial of Zidovudine (AZT) Versus AZT Plus Didanosine (ddI) Versus AZT Plus Dideoxycytidine (ddC) in HIV-Infected Patients|Completed||Phase 3|1200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.557096|2017-10-11 04:18:42.557096
NCT00001023|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-29||||||October 2012|2012-10-01|July 1998|Actual|1998-07-01|||||Interventional|||The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients|Evaluation of the Safety, Tolerance and Pharmacokinetics of Rifabutin/Clarithromycin Combination and Rifabutin/Azithromycin Combination in HIV-Infected Patients|Completed||N/A|91||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.687199|2017-10-11 04:18:42.687199
NCT00001024|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|June 2002|Actual|2002-06-01|||||Interventional|||The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS|A Multicenter, Open-Label Study of Viral Burden in Peripheral Blood Versus Lymphoid Tissue Before and After Antiretroviral Therapy in HIV-Infected Individuals Without AIDS (NOTE: One Arm Receives no Treatment)|Completed||N/A|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.79947|2017-10-11 04:18:42.79947
NCT00001025|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1995|Actual|1995-05-01|||||Interventional|||Evaluation of Patients Who Have Not Had Success With Zidovudine|A Study to Evaluate the Short-Term Clinical and Virologic Significance of Zidovudine Resistance|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:42.909338|2017-10-11 04:18:42.909338
NCT00001026|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|December 1994|Actual|1994-12-01|||||Interventional|||A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals|A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:43.029914|2017-10-11 04:18:43.029914
NCT00001027|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole|A Phase I/II Trial of Parenteral Pentamidine for PCP Prophylaxis in HIV-Infected Children Who Are Intolerant to Oral Trimethoprim-Sulfamethoxazole|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:43.125378|2017-10-11 04:18:43.125378
NCT00001028|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1994|Actual|1994-06-01|||||Interventional|||A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides|A Randomized, Comparative, Prospective Study of Monthly Aerosolized Pentamidine and Thrice Weekly Dapsone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant to Trimethoprim and/or Sulfonamides|Completed||Phase 3|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:43.223947|2017-10-11 04:18:43.223947
NCT00001029|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|May 1993|Actual|1993-05-01|||||Interventional|||A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past|A Randomized, Double-Blind, Three-Arm Study Comparing Combination to Monthly Alternating Nucleoside Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3) With a Prior History of Nucleoside Therapy|Completed||Phase 2|654||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:43.339009|2017-10-11 04:18:43.339009
NCT00001030|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-06-02||||||March 2012|2012-03-01|June 1996|Actual|1996-06-01|||||Interventional|||The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients|A Prospective, Randomized, Comparative Study of the Safety and Efficacy of Clarithromycin Versus Rifabutin Versus the Combination of Clarithromycin Plus Rifabutin for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia or Disseminated MAC Disease in HIV-Infected Patients With CD4 Lymphocyte Counts <= 100 Cells/mm3|Completed||Phase 3|1100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:43.507085|2017-10-11 04:18:43.507085
NCT00001031|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|December 1997|Actual|1997-12-01|||||Interventional|||A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults|A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults|Completed||Phase 2|296|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:43.664584|2017-10-11 04:18:43.664584
NCT00001032|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|April 1995|Actual|1995-04-01|||||Interventional|||A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT|A Phase II Study to Evaluate Pharmacokinetics, Safety, Tolerance and Activity of Dideoxycytidine (ddC) Administered in Combination With Zidovudine (AZT) in Stable, AZT-Treated Pediatric Patients With HIV Infection|Completed||Phase 2|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:43.764537|2017-10-11 04:18:43.764537
NCT00001033|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|July 1997|Actual|1997-07-01|||||Interventional|||The Treatment of Tuberculosis in HIV-Infected Patients|The Treatment of Pulmonary Mycobacterium Tuberculosis in HIV Infection|Completed||Phase 3|650||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:43.919563|2017-10-11 04:18:43.919563
NCT00001034|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|August 1995|Actual|1995-08-01|||||Interventional|||The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV|A Randomized, Comparative, Placebo-Controlled Trial of the Safety and Efficacy of Oral Ganciclovir for Prophylaxis of Cytomegalovirus (CMV) Retinal and Gastrointestinal Mucosal Disease in HIV-Infected Individuals With Severe Immunosuppression|Completed||Phase 2|850||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.03234|2017-10-11 04:18:44.03234
NCT00001035|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|September 1996|Actual|1996-09-01|||||Interventional|||The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections|A Phase I Pilot Study of the Safety and Efficacy of Interferon Alfa-2b (IFN Alfa-2b) in Combination With Nucleoside Analog Therapy in Patients With Combined Hepatitis C (HCV) and Advanced Human Immunodeficiency Virus (HIV) Infections|Completed||Phase 1|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.248868|2017-10-11 04:18:44.248868
NCT00001036|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-29||||||October 1996|1996-10-01||||||||Interventional|||The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection|Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine and Thymosin Alpha 1 in HIV-Positive, Asymptomatic and Symptomatic Individuals|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.337246|2017-10-11 04:18:44.337246
NCT00001037|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|May 1995|Actual|1995-05-01|||||Interventional|||A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules|A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules|Completed||Phase 1|22|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.416849|2017-10-11 04:18:44.416849
NCT00001038|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||May 1996|Actual|1996-05-01||Interventional|||A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients|A Randomized, Double-Blind Trial of Valacyclovir Hydrochloride (BW 256U87) Prophylaxis for Opportunistic Cytomegalovirus End-Organ Disease in Patients With Advanced HIV Infection (< 100 CD4+ Lymphocytes)|Completed||Phase 3|1200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.49571|2017-10-11 04:18:44.49571
NCT00001039|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-29||||||October 2012|2012-10-01|June 2002|Actual|2002-06-01|||||Interventional|||Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients|The Effect of Therapy on the Tissue Burden of Disseminated MAC Infection as Measured by Quantitative Bone Marrow Culture and Correlation With Quantitative Blood Culture in HIV-Infected Patients|Completed||Phase 2|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.660813|2017-10-11 04:18:44.660813
NCT00001040|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||May 1994|Actual|1994-05-01||Interventional|||Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC|Double-Blind, Randomized, Phase II Study of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (Dideoxycytidine; ddC) Versus Ro 31-8959 Plus AZT Plus ddC|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.751528|2017-10-11 04:18:44.751528
NCT00001041|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|July 1998|Actual|1998-07-01|||||Interventional|||Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)|Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.854918|2017-10-11 04:18:44.854918
NCT00001042|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|March 1996|Actual|1996-03-01|||||Interventional|||A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals|Completed||Phase 1|112|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:44.94514|2017-10-11 04:18:44.94514
NCT00001043|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|May 1997|Actual|1997-05-01|||||Interventional|||A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules|A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.052357|2017-10-11 04:18:45.052357
NCT00001044|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|May 1995|Actual|1995-05-01|||||Interventional|||A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.|Completed||Phase 1|80|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.146372|2017-10-11 04:18:45.146372
NCT00001045|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1998|Actual|1998-10-01|||||Interventional|||Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease|A Double-Blinded, Randomized Trial Comparing Zidovudine (AZT) Versus AZT Plus Didanosine (ddI) Versus AZT Plus ddI Plus Nevirapine in Asymptomatic Patients on AZT Monotherapy Who Develop a Mutation at Codon 215 of HIV Reverse Transcriptase in Serum/Plasma Viral RNA|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.236586|2017-10-11 04:18:45.236586
NCT00001047|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|August 1996|Actual|1996-08-01|||||Interventional|||Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS|An Open-Label, Randomized Trial of Four Treatment Regimens for Patients With Disseminated Mycobacterium Avium Complex Disease and Acquired Immunodeficiency Syndrome (AIDS)|Completed||Phase 3|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.529382|2017-10-11 04:18:45.529382
NCT00001048|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|April 1997|Actual|1997-04-01|||||Interventional|||Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients|A Phase II Multicenter Study Comparing Antiretroviral Therapy Alone to Antiretroviral Therapy Plus Cytosine Arabinoside (Cytarabine; Ara-C) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in Human Immunodeficiency Virus (HIV)-Infected Subjects|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.640466|2017-10-11 04:18:45.640466
NCT00001049|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|June 1998|Actual|1998-06-01|||||Interventional|||A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV|A Phase I Evaluation of the Safety and Toxicity of Zidovudine and Didanosine in Combination in HIV-Infected or Exposed Infants and a Phase II Study of the Effect of Didanosine vs. Combination Therapy With Zidovudine and Didanosine on HIV-1 RNA in Infants With HIV Infection|Completed||Phase 1|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.728248|2017-10-11 04:18:45.728248
NCT00001050|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1994|1994-03-01||||||||Observational|||Study of Women Who Have AIDS|Women's AIDS Cohort Study (WACS)|Terminated||N/A|1250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.857454|2017-10-11 04:18:45.857454
NCT00001052|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|September 1997|Actual|1997-09-01|||||Interventional|||A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults|Completed||Phase 1|110|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.907691|2017-10-11 04:18:45.907691
NCT00001053|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|March 1996|Actual|1996-03-01|||||Interventional|||A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects|A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects|Completed||Phase 1|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:45.977307|2017-10-11 04:18:45.977307
NCT00001054|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|January 2001|Actual|2001-01-01|||||Interventional|||The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children|A Phase I Trial to Evaluate the Pharmacokinetics, Safety, and Tolerance of Valacyclovir HCl in HIV-1 Infected Children With Herpes Simplex Infections or Varicella/Zoster Infections|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:46.048437|2017-10-11 04:18:46.048437
NCT00001055|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|November 1997|Actual|1997-11-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|76||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:46.109069|2017-10-11 04:18:46.109069
NCT00001056|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|October 1994|Actual|1994-10-01|||||Interventional|||A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose|A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose|Completed||Phase 1|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:46.235349|2017-10-11 04:18:46.235349
NCT00001057|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1995|Actual|1995-05-01|||||Interventional|||The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients|A Phase II Randomized, Double-Blind, Placebo-Controlled Trial of the Virologic Effect of Two Different Nucleoside Treatment Strategies (Zidovudine Versus Zidovudine in Combination With Didanosine) for HIV Infection in Subjects With CD4+ Counts >= 550 Cells/mm3|Completed||Phase 2|105||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:46.305103|2017-10-11 04:18:46.305103
NCT00001058|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|January 1999|Actual|1999-01-01|||||Interventional|||A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS|A Phase II/III Prospective, Multicenter, Randomized, Controlled Trial Comparing the Safety and Efficacy of Three Clarithromycin-Containing Combination Drug Regimens for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Disease in Persons With AIDS|Completed||Phase 2|246||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:46.385397|2017-10-11 04:18:46.385397
NCT00001059|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-13||||||April 2012|2012-04-01|August 1998|Actual|1998-08-01|||||Interventional|||Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS|Comparison Study of Liposomal Doxorubicin With or Without Bleomycin and Vincristine for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:46.514092|2017-10-11 04:18:46.514092
NCT00001060|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-05-03||||||May 2013|2013-05-01|June 2002|Actual|2002-06-01|||||Interventional|||A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons|A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:46.615023|2017-10-11 04:18:46.615023
NCT00005351|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1991||1991-08-01|September 2002|2002-09-01|July 1994|Actual|1994-07-01|||||Observational|||Incidence and Outcomes of Venous Thromboembolism||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.78989|2017-10-11 04:28:02.78989
NCT00001061|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|March 1998|Actual|1998-03-01|||||Interventional|||Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS|A Phase II, Double-Masked, Randomized, Placebo-Controlled Evaluation of Standard Therapy vs. Standard Therapy Combined With Human Monoclonal Anti-Cytomegalovirus Antibody (MSL 109) in the Therapy of AIDS Patients With Cytomegalovirus (CMV) Retinitis|Completed||Phase 2|167||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:46.684211|2017-10-11 04:18:46.684211
NCT00001062|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|January 1998|Actual|1998-01-01|||||Interventional|||A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes|A Phase I Study of a Fixed-Schedule Regimen of Alternating Oral and Intravenous Ganciclovir for Treatment of Cytomegalovirus Retinitis|Completed||Phase 1|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:47.98955|2017-10-11 04:18:47.98955
NCT00001063|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-13||||||April 2012|2012-04-01|November 1997|Actual|1997-11-01|||||Interventional|||The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks|A Phase II Randomized Study of the Virologic and Immunologic Effects of d4T vs Zidovudine Plus d4T vs Zidovudine Plus Ddl in HIV-Infected Patients With CD4 Cell Counts Between 300-600/mm3 and Greater Than 12 Weeks Zidovudine Experience|Completed||Phase 2|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:48.093244|2017-10-11 04:18:48.093244
NCT00001064|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-12-13||||||April 1995|1995-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3|A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3|Terminated||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:48.231231|2017-10-11 04:18:48.231231
NCT00001065|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|April 1998|Actual|1998-04-01|||||Interventional|||A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole|A Phase II Trial of Amphotericin B Oral Suspension for Fluconazole-Resistant Oral Candidiasis in HIV-Infected Patients|Completed||Phase 2|70||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:48.295819|2017-10-11 04:18:48.295819
NCT00001066|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-01||||||March 2011|2011-03-01||||January 2001|Actual|2001-01-01||Interventional|||A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children|A Randomized Comparative Study of Combined Zidovudine-Lamivudine (3TC) vs. the Better of ddI Monotherapy vs. Zidovudine Plus Ddl in Symptomatic HIV-1 Infected Children|Completed||Phase 2|740||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:48.438394|2017-10-11 04:18:48.438394
NCT00001067|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|November 1997|Actual|1997-11-01|||||Interventional|||The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs|A Phase II Randomized Study of the Virologic and Immunologic Effects of Zidovudine Plus Lamivudine (3TC) Versus d4T Versus Zidovudine Plus d4T in HIV-Infected Patients With CD4 Cell Counts Between 300-600/mm3 and No Previous Nucleoside Experience|Completed||Phase 2|105||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:48.83823|2017-10-11 04:18:48.83823
NCT00001068|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|October 1998|Actual|1998-10-01|||||Interventional|||A Study of Disease Progression and Anti-HIV Treatments|Influence of Risk Status for Disease Progression on the Response to Antiretroviral Interventions: A Follow-up Study to ACTG 175|Completed||Phase 2|210||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:48.95172|2017-10-11 04:18:48.95172
NCT00001069|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 2003|2003-01-01||||||||Observational|||A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment|A Randomized Study of the Clinical Effects of Initiating or Changing Antiretroviral Therapy Based on Plasma HIV RNA Quantitation Compared With Initiating or Changing Therapy Based on Current Clinical Practice Alone|Terminated||N/A|1100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:49.136088|2017-10-11 04:18:49.136088
NCT00001070|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-12-28||||||December 2012|2012-12-01||||||||Interventional|||The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients|A Dose Escalation Study to Evaluate Tolerance and Antiviral Effect of Oral Vitamin C in Two Groups of HIV-Infected Adults|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:49.235224|2017-10-11 04:18:49.235224
NCT00001071|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|October 1998|Actual|1998-10-01|||||Interventional|||A Study of Stem Cells and Filgrastim|A Pilot Study of Stem Cell Mobilization and Harvesting From the Peripheral Blood Using Filgrastim|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:49.284835|2017-10-11 04:18:49.284835
NCT00001072|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|January 1999|Actual|1999-01-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|140||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:49.371827|2017-10-11 04:18:49.371827
NCT00001073|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|March 2001|Actual|2001-03-01|||||Interventional|||Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors|A Randomized Phase III Trial of Oral Isotretinoin Versus Observation for Low-Grade Squamous Intraepithelial Lesions in HIV-Infected Women|Completed||Phase 3|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:49.475547|2017-10-11 04:18:49.475547
NCT00001074|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|January 2000|Actual|2000-01-01|||||Interventional|||The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients|A Phase I/II Dosing Study of the Safety and Antiretroviral Activity of Hydroxyurea Alone and in Combination With ddI Compared With ddI Alone in Subjects With HIV Infection|Completed||Phase 1|140||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:49.638405|2017-10-11 04:18:49.638405
NCT00000600|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-12|||June 1995||1995-06-01|October 2006|2006-10-01|May 2000|Actual|2000-05-01|||||Interventional|||Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up|Antioxidants and Prevention of Early Atherosclerosis|Terminated||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.127173|2017-10-11 04:19:08.127173
NCT00001075|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-13||||||February 2012|2012-02-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients|A Pilot Study to Evaluate the Immunologic Consequences of a Highly Active Antiretroviral Therapy Regimen (HAART) Consisting of Ritonavir (ABT-538), Zidovudine (AZT), and Lamivudine (3TC) in Moderately Advanced HIV-1 Disease|Completed||N/A|55||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:49.847281|2017-10-11 04:18:49.847281
NCT00001076|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|December 1997|Actual|1997-12-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules|Completed||Phase 1|34||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:49.956593|2017-10-11 04:18:49.956593
NCT00001077|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28|||June 1996||1996-06-01|September 2013|2013-09-01|April 1998|Actual|1998-04-01|April 1998|Actual|1998-04-01||Observational|||A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements|An Open-Label, Randomized, Three-Arm, Comparative Trial of a Caloric Supplement With Peptides and Medium-Chain Triglycerides Versus a Caloric Supplement With Whole Protein and Long-Chain Triglycerides Versus No Caloric Supplement for the Prevention of Weight Loss in Individuals With AIDS Who Take a Daily Multivitamin and Mineral Supplement|Completed||N/A|536|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||||||||Samples With DNA|"     Blood collection   "|||2017-10-11 04:18:50.073682|2017-10-11 04:18:50.073682
NCT00001078|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-01||||||July 2005|2005-07-01||||May 2005|Actual|2005-05-01||Interventional|||A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications|An Observational Study of the Rate of Opportunistic Infection Events in HIV-Infected Children Who Have Demonstrated Immunologic Reconstitution and Who Have Discontinued OI Prophylaxis|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:50.204518|2017-10-11 04:18:50.204518
NCT00001079|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss|Double-Blind Randomized Comparison Phase II Trial of Megestrol Acetate and Testosterone Enanthate in Combination Versus Megestrol Acetate Plus Testosterone Enanthate Placebo in Human Immunodeficiency Virus (HIV)-Associated Wasting.|Completed||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:50.366949|2017-10-11 04:18:50.366949
NCT00001080|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01||||||||Interventional|||Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals|Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||||as of 4/23/97|f||||||||||||||2017-10-11 04:18:50.518552|2017-10-11 04:18:50.518552
NCT00001081|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|September 1998|Actual|1998-09-01|||||Interventional|||A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium|A Phase II/III Placebo-Controlled Study of Nitazoxanide (NTZ) For Persons With AIDS and Cryptosporidiosis|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:50.616793|2017-10-11 04:18:50.616793
NCT00001082|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28|||December 1996||1996-12-01|September 2013|2013-09-01|August 1999|Actual|1999-08-01|January 1999|Actual|1999-01-01||Interventional|||The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil (Bis-POM PMEA) in Prolonging Survival of HIV-Infected Individuals With a CD4+ Cell Count of <= 100/mm3 or With a CD4+ Cell Count Both > 100 and <= 200/mm3 and a Nadir CD4+ Cell Count of <= 50/mm3|Completed||Phase 3|505|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:18:50.714137|2017-10-11 04:18:50.714137
NCT00001083|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|June 2001|Actual|2001-06-01|||||Interventional|||Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs|A Phase II Rolling Arm Master Protocol (PRAM) of Novel Antiretroviral Therapy in Stable Experienced HIV- Infected Children; PRAM-1: ZDV+3TC vs. d4T+Ritonavir vs. ZDV+3TC+Ritonavir; PRAM-1, Step 2: d4T+Nevirapine+Ritonavir; PRAM-1, Step 3: d4T+Indinavir vs. ZDV+3TC+Indinavir|Completed||Phase 2|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:50.865532|2017-10-11 04:18:50.865532
NCT00001084|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|December 1997|Actual|1997-12-01|||||Interventional|||A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients|A Prospective Randomized Double-Blind Trial of Three Maintenance Regimens for HIV-Infected Subjects Receiving Induction Therapy With Zidovudine, Lamivudine and Indinavir|Completed||Phase 2|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:51.069286|2017-10-11 04:18:51.069286
NCT00001085|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|September 1998|Actual|1998-09-01|||||Interventional|||A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients|A Randomized, Double-Blind, Phase II Study of 141W94 (VX-478) Monotherapy vs. 141W94 (VX-478) Plus ZDV Plus 3TC in HIV Infected Individuals|Completed||Phase 2|94||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:51.238221|2017-10-11 04:18:51.238221
NCT00001086|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|September 1999|Actual|1999-09-01|||||Interventional|||A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients|A Randomized, Phase II, Placebo Controlled Trial of Abacavir (ABC, 1592U89) in Combination With Open-Label Indinavir Sulfate (IDV) and Efavirenz (EFV, DMP-266) in HIV-Infected Subjects With Nucleoside Analog Experience: A Rollover Study for ACTG 320|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:51.359718|2017-10-11 04:18:51.359718
NCT00001132|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2008-09-08|||November 1999||1999-11-01|June 2003|2003-06-01|April 2001||2001-04-01|||||Interventional|||Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination|A Pilot Study of Early Treatment Intensification of Antiretroviral Therapy|Completed||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:56.023194|2017-10-11 04:18:56.023194
NCT00001087|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|July 2000|Actual|2000-07-01|||||Interventional|||The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs|Comparison of the Virologic Efficacy of Nelfinavir and/or DMP 266 (Efavirenz, EFV) in Combination With One or Two New Nucleoside Analogs in Nucleoside Experienced Subjects: A Roll-Over Study to ACTG 302/303|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:51.651647|2017-10-11 04:18:51.651647
NCT00001088|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-09-26|||July 1997||1997-07-01|September 2008|2008-09-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:51.759765|2017-10-11 04:18:51.759765
NCT00001089|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 2003|2003-02-01||||||||Observational|||A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients|Human Immunodeficiency Virus (HIV) and Cytomegalovirus (CMV) Viral Burden and Development of CMV End-Organ Disease: A Prospective Study in HIV-Infected Individuals.|Completed||N/A|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:51.861947|2017-10-11 04:18:51.861947
NCT00001090|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|October 1999|Actual|1999-10-01|||||Interventional|||A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers|A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205, Combined With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Healthy, HIV-1 Uninfected Volunteers|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:52.027189|2017-10-11 04:18:52.027189
NCT00001091|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|October 2000|Actual|2000-10-01|||||Interventional|||Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens|A Phase II Rolling Arm Master Protocol (PRAM) of Novel Antiretroviral Therapy in Stable Experienced HIV-Infected Children. PRAM-2: A Phase I/II Randomized, Multicenter Protocol Comparing Four Antiretroviral Regimens Containing Combinations of Protease Inhibitors, NRTIs and an NNRTI|Completed||Phase 1|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:52.125288|2017-10-11 04:18:52.125288
NCT00001092|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-10-21|||October 1999||1999-10-01|October 2015|2015-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||The Biology of HIV Transmission|The Determinants of the Biology of HIV Transmission to Determine the Immunologic and Virologic Characteristics of Those Who May Have Transmitted HIV to Another Individual|Completed||N/A|20|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"     Blood, genital fluids, and saliva collection   "|||2017-10-11 04:18:52.327314|2017-10-11 04:18:52.327314
NCT00001093|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-26|||October 1999||1999-10-01|October 2012|2012-10-01|June 2007|Actual|2007-06-01|||||Observational|||Outcomes of Anti-HIV Therapy During Early HIV Infection|Outcomes of Antiretroviral Therapy During Primary HIV Infection|Completed||N/A|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:52.414084|2017-10-11 04:18:52.414084
NCT00001094|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-03-05||||||March 2015|2015-03-01||||||||Interventional|||A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients|A Phase II, Randomized, Controlled, Open-Label Trial of Combination Therapy With Nelfinavir (NFV) and Saquinavir (SQV)Sgc With Delavirdine (DLV) or 3TC/ZDV Versus Nelfinavir (NFV) and 3TC/ZDV in Subjects With HIV Infection and > 5,000 HIV RNA Copies/ML|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:52.492486|2017-10-11 04:18:52.492486
NCT00001095|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|October 1999|Actual|1999-10-01|||||Interventional|||A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir|A Phase II Study of 1) Amprenavir (141W94/VX478) Plus 3TC Plus ZDV (or d4T) or 2) IDV Plus NVP Plus 3TC Plus d4T in Subjects Previously Treated With Amprenavir and 3) Other Treatment Regimens (Observational ARM) in Subjects Previously Treated With Amprenavir|Completed||Phase 2|94||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:52.616546|2017-10-11 04:18:52.616546
NCT00001096|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|March 2000|Actual|2000-03-01|||||Interventional|||A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:52.72646|2017-10-11 04:18:52.72646
NCT00001097|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-04-23|||December 1997||1997-12-01|November 2005|2005-11-01||||||||Observational|||Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems|Establishment and Maintenance of Long-Term Undetectable Plasma HIV-1 RNA: Correlation With Immunologic Reconstitution and Viral Dynamics|Completed||N/A|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:52.818852|2017-10-11 04:18:52.818852
NCT00001100|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.|A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.|Completed||Phase 3|130||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.003084|2017-10-11 04:18:53.003084
NCT00000513|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||April 1984||1984-04-01|April 2012|2012-04-01|November 1994|Actual|1994-11-01|||||Interventional|||Trial of Antihypertensive Intervention Management||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:58.740523|2017-10-11 04:18:58.740523
NCT00001101|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-08-26||||||March 2010|2010-03-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease|Completed||Phase 3|194||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.070944|2017-10-11 04:18:53.070944
NCT00001102|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-04-16||||||April 2014|2014-04-01|June 2006|Actual|2006-06-01|||||Observational|||The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients|Metabolic Consequences of Highly Active Antiretroviral Therapy (HAART) in HIV-Positive Individuals|Completed||N/A|460||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.151958|2017-10-11 04:18:53.151958
NCT00001103|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-28||||||May 2006|2006-05-01||||||||Observational|||HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs|Cerebrospinal Fluid Human Immunodeficiency Virus-1 (HIV-1) and Cognitive Function in Individuals Receiving Potent Antiretroviral Therapy|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.245816|2017-10-11 04:18:53.245816
NCT00001104|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia|A Placebo Controlled Trial To Evaluate Zidovudine (ZDV) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Hemophilic Patients|Completed||Phase 3|538||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.350722|2017-10-11 04:18:53.350722
NCT00001105|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|March 1996|Actual|1996-03-01|||||Interventional|||The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV|A Phase I Clinical Trial to Study the Toxicity, Pharmacokinetics, and Efficacy of Human Monoclonal Antibody, F105, for Treating Human Immunodeficiency Virus Infection.|Completed||Phase 1|8||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.455477|2017-10-11 04:18:53.455477
NCT00001106|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-06-02||||||March 2012|2012-03-01|March 1994|Actual|1994-03-01|||||Interventional|||A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children|A Phase I Trial To Evaluate Zidovudine (ZDV) in HIV-1 Infected Pregnant Women and Their Offspring|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.523673|2017-10-11 04:18:53.523673
NCT00001107|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants|Invasive Fungal Infection in Liver Transplant Recipients: A Randomized Double-Blind Trial Comparing AmBisome and Fluconazole in the High Risk Group and an Observational Cohort Study in the Low Risk|Completed||Phase 4|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.604032|2017-10-11 04:18:53.604032
NCT00001108|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|June 2000|Actual|2000-06-01|||||Interventional|||A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses|Multi-Drug Antiretroviral Therapy for Heavily Pretreated Pediatric AIDS Patients: A Phase I Proof of Concept Trial|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.67325|2017-10-11 04:18:53.67325
NCT00001109|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-29||||||October 2004|2004-10-01||||||||Observational|||A Blood Test to Look at Cells of the Immune System in Healthy Children|Mononuclear Cell Phenotyping in Normal Children|Completed||N/A|630||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:53.956755|2017-10-11 04:18:53.956755
NCT00001110|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26|||August 1999||1999-08-01|July 2013|2013-07-01|April 2003|Actual|2003-04-01|||||Interventional|||Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients|Effect of Highly Active Antiretroviral Therapy (HAART) on Viral Burden and Immune Function in the Lungs of HIV-Infected Subjects|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.114277|2017-10-11 04:18:54.114277
NCT00001111|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||June 1995|Actual|1995-06-01||Interventional|||A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children|Pharmacokinetics, Safety, Tolerance, and Activity of Nevirapine (BI-RG-587) Alone and in Combination With AZT in Mildly to Moderately Symptomatic HIV-1 Infected Children|Completed||N/A|35||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.201902|2017-10-11 04:18:54.201902
NCT00001112|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|April 1993|Actual|1993-04-01|||||Interventional|||The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine|A Phase I Study To Determine the Safety of the Optimal Monocyte Activating Administration Schedule of Subcutaneous Human Recombinant Interferon-gamma in ZDV-Treated Patients With AIDS|Completed||Phase 1|5||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.30724|2017-10-11 04:18:54.30724
NCT00001113|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|March 1990|Actual|1990-03-01|||||Interventional|||A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma|A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.390719|2017-10-11 04:18:54.390719
NCT00001114|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|March 2000|Actual|2000-03-01|||||Interventional|||The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma|A Randomized Phase II Trial to Determine the Safety, Tolerance, and Efficacy of Two Doses of Interferon Alfa-2b Combined With Didanosine in Patients With Kaposi's Sarcoma|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.480533|2017-10-11 04:18:54.480533
NCT00001115|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-10-27||||||June 1998|1998-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood|A Pilot Study to Determine the Effect of Acyclovir Treatment for Herpes Simplex Virus (HSV) Infection on Peripheral Blood HIV Viral Load.|Completed||N/A|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.59045|2017-10-11 04:18:54.59045
NCT00001116|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|June 2000|Actual|2000-06-01|||||Interventional|||A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients|Effect of Recombinant Human Soluble Tumor Necrosis Factor Receptor (TNFR:Fc) on Interleukin-6 (IL-6), Tumor Necrosis Factor-Alpha (TNF-alpha) and Markers of Immune Activation in HIV-Infected Subjects|Completed||N/A|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.6909|2017-10-11 04:18:54.6909
NCT00001117|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-30||||||June 2003|2003-06-01||||||||Observational|||A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection|Dynamics of Hepatitis C Infection in Subjects With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Receiving Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.773153|2017-10-11 04:18:54.773153
NCT00001118|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|December 2002|Actual|2002-12-01|||||Interventional|||Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children|A Phase I/II Study of T-20, a Fusion Inhibitor, in HIV-1 Infected Children|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:54.912295|2017-10-11 04:18:54.912295
NCT00001119|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-01|||October 1999||1999-10-01|January 2005|2005-01-01||||June 2004|Actual|2004-06-01||Interventional|||Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV|A Study of the Effects of Combination Antiretroviral Therapy in Acute HIV-1 Infection With an Emphasis on Immunological Responses|Completed||N/A|288||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.05636|2017-10-11 04:18:55.05636
NCT00001120|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-09-11||||||May 2006|2006-05-01||||||||Observational|||A Study of Patients With AIDS Syndrome|Oncogenic Viral Pathogenesis and Cancer Risk Factors Among Patients With the Acquired Immunodeficiency Syndrome: A Prospective Cohort Study|Completed||N/A|5000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.172381|2017-10-11 04:18:55.172381
NCT00001121|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-09-11|||August 1999||1999-08-01|June 2003|2003-06-01||||||||Observational|||A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1|Evaluation of Virologic, Immunologic, and Clinical Parameters of Participants in HIVNET 014 Who Become Infected With HIV-1|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.280235|2017-10-11 04:18:55.280235
NCT00001122|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-01||||||January 2005|2005-01-01||||October 2003|Actual|2003-10-01||Interventional|||A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly|A Phase II, Randomized, Open-Label Study of Maximally Assisted Therapy (MAT) Compared to Self-Administered Therapy (SAT) for the Treatment of HIV Infection in Antiretroviral Naive Subjects With CD4 Greater Than or Equal to 200 Cells/mm3|Completed||Phase 2|74||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.353184|2017-10-11 04:18:55.353184
NCT00001123|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome|A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome|Completed||N/A|130||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.422185|2017-10-11 04:18:55.422185
NCT00001125|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2014-10-28||||||October 2014|2014-10-01|March 2004|Actual|2004-03-01|||||Interventional|||Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox|Use of a Live-Attenuated Varicella-Zoster Virus (VZV) Vaccine to Boost Immunity to VZV in HIV-Infected Children Previously Infected With Varicella|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:18:55.485097|2017-10-11 04:18:55.485097
NCT00001126|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)|A Phase I/II Evaluation of Cidofovir Therapy For Recurrent Laryngeal Papillomatosis in Children|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.586177|2017-10-11 04:18:55.586177
NCT00001127|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Study of a Flu Vaccine in Children|Study of the Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in a Community-Based, Non-Randomized, Open-Label Trial in Children to Assess Safety and Herd Immunity for the Control of Epidemic Influenza|Completed||Phase 3|15000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.636569|2017-10-11 04:18:55.636569
NCT00001128|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2016-12-13||||||June 2003|2003-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Treatment of Chronic Cryptosporidiosis in AIDS Patients|A Pilot, Proof-of-Concept, Dose-Escalating Trial of Recombinant Human Interleukin-12 (rhIL-12) Versus Placebo Along With Paromomycin and Azithromycin for Chronic Cryptosporidiosis in AIDS|Terminated||N/A|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.68916|2017-10-11 04:18:55.68916
NCT00001129|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2013-09-28||||||September 2013|2013-09-01|June 2003|Actual|2003-06-01|||||Interventional|||A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly|Adherence Strategies Using a Medication Manager and an Electronic Medication Reminder System for HIV-Infected Patients Receiving HAART|Completed||N/A|1248||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.761063|2017-10-11 04:18:55.761063
NCT00001130|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2008-09-08||||||January 2005|2005-01-01||||||||Observational|||Identifying Emergency Room Patients Who Have Recently Been Infected With HIV|Increasing Identification of Patients With Primary HIV Infection (PHI) Through a Questionnaire Intervention in an Emergency Department (ED) Setting|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:18:55.856333|2017-10-11 04:18:55.856333
NCT00001131|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2015-05-14|||May 2004||2004-05-01|September 2013|2013-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients|Procedure for Initiation, Administration, and Discontinuation of Interleukin-2 (IL-2) Therapy in Conjunction With Highly Active Antiretroviral Therapy|Completed||N/A|42|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:18:55.910849|2017-10-11 04:18:55.910849
NCT00001133|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2012-05-21||||||May 2012|2012-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir|A Phase I/II, Randomized, Open-Label Study of the Safety and Pharmacokinetics of Indinavir + Ritonavir Therapy in HIV-Infected Subjects Failing Amprenavir, Nelfinavir, Saquinavir, or Nelfinavir/Saquinavir Combination Therapy|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:18:56.132405|2017-10-11 04:18:56.132405
NCT00000491|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-24|||October 1974||1974-10-01|April 2012|2012-04-01|August 1979|Actual|1979-08-01|||||Interventional|||Aspirin-Myocardial Infarction Study (AMIS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:56.225495|2017-10-11 04:18:56.225495
NCT00000492|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||September 1977||1977-09-01|October 1981|1981-10-01|October 1981|Actual|1981-10-01|||||Interventional|||Beta-Blocker Heart Attack Trial (BHAT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:56.310942|2017-10-11 04:18:56.310942
NCT00000493|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||September 1977||1977-09-01|December 1985|1985-12-01|December 1985|Actual|1985-12-01|||||Interventional|||Multicenter Investigation of Limitation of Infarct Size (MILIS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:56.415791|2017-10-11 04:18:56.415791
NCT00000494|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-12|||September 1978||1978-09-01|April 2012|2012-04-01|March 1982|Actual|1982-03-01|||||Interventional|||Management of Patent Ductus in Premature Infants||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:56.49014|2017-10-11 04:18:56.49014
NCT00000495|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-11-21|||December 1978||1978-12-01|January 2000|2000-01-01||||||||Interventional|||Prevention of Hypertension: A Randomized Trial||Completed||Phase 3|||Northwestern University|||||f||||||||||||||2017-10-11 04:18:56.556064|2017-10-11 04:18:56.556064
NCT00000496|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||December 1979||1979-12-01|April 2012|2012-04-01|December 1982|Actual|1982-12-01|||||Interventional|||Platelet Drug Trial in Coronary Disease Progression||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:56.619996|2017-10-11 04:18:56.619996
NCT00000497|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-04-14|||January 1980||1980-01-01|January 2000|2000-01-01|September 1994|Actual|1994-09-01|||||Interventional|||Dietary Intervention Study for Hypertension (DISH)||Completed||Phase 3|||University of Mississippi Medical Center|||||f||||||||||||||2017-10-11 04:18:56.792508|2017-10-11 04:18:56.792508
NCT00000498|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-25|||April 1980||1980-04-01|January 2000|2000-01-01|March 1983|Actual|1983-03-01|||||Interventional|||Control of Hypertension by Non-Pharmacologic Means||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:56.876173|2017-10-11 04:18:56.876173
NCT00000499|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||September 1980||1980-09-01|April 2012|2012-04-01|May 1983|Actual|1983-05-01|||||Interventional|||Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:56.95567|2017-10-11 04:18:56.95567
NCT00000500|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-01-24|||September 1981||1981-09-01|January 2014|2014-01-01|December 1996|Actual|1996-12-01|December 1995|Actual|1995-12-01||Interventional|||Physicians' Health Study||Completed||Phase 3|||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 04:18:57.052413|2017-10-11 04:18:57.052413
NCT00000501|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||September 1981||1981-09-01|April 2012|2012-04-01|August 1986|Actual|1986-08-01|||||Interventional|||Hypertension Prevention Trial (HPT) Feasibility Study||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:57.179|2017-10-11 04:18:57.179
NCT00000502|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||September 1981||1981-09-01|May 2000|2000-05-01|June 1985|Actual|1985-06-01|||||Interventional|||Evaluation of SC-V Versus Conventional CPR||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:57.281941|2017-10-11 04:18:57.281941
NCT00000503|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||August 1982||1982-08-01|January 2000|2000-01-01|October 1987|Actual|1987-10-01|||||Interventional|||Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:57.367903|2017-10-11 04:18:57.367903
NCT00000504|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2012-04-26|||September 1982||1982-09-01|April 2012|2012-04-01|September 1985|Actual|1985-09-01|||||Interventional|||Cardiac Arrhythmia Pilot Study (CAPS)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:57.442169|2017-10-11 04:18:57.442169
NCT00000505|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-15|||April 1983||1983-04-01|July 2000|2000-07-01|December 1990|Actual|1990-12-01|||||Interventional|||Thrombolysis in Myocardial Infarction (TIMI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:57.542536|2017-10-11 04:18:57.542536
NCT00000506|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||May 1983||1983-05-01|January 2000|2000-01-01|April 1988|Actual|1988-04-01|||||Interventional|||Cardiovascular System in Obesity: Effect of Treatment||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:57.686321|2017-10-11 04:18:57.686321
NCT00000507|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-08|||August 1983||1983-08-01|October 1994|1994-10-01|October 1994||1994-10-01|||||Interventional|||Intravenous Streptokinase in Acute Myocardial Infarction||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-10-11 04:18:57.768893|2017-10-11 04:18:57.768893
NCT00000508|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-01-08|||September 1983||1983-09-01|March 1993|1993-03-01|March 1993||1993-03-01|||||Interventional|||Stanford Coronary Risk Intervention Project (SCRIP)||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-10-11 04:18:58.285229|2017-10-11 04:18:58.285229
NCT00000509|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2017-03-14|||September 1983||1983-09-01|March 2017|2017-03-01|September 2003||2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Potassium and Sodium to Control Blood Pressure in Hypertensives||Completed||Phase 3|||University of Minnesota - Clinical and Translational Science Institute|||||f||||f|f|f||||||No||2017-10-11 04:18:58.37742|2017-10-11 04:18:58.37742
NCT00000510|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||September 1983||1983-09-01|March 2005|2005-03-01|September 1988|Actual|1988-09-01|||||Interventional|||Platelet-Inhibitor Drug Trial in Coronary Angioplasty||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:58.467289|2017-10-11 04:18:58.467289
NCT00000511|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-12|||December 1983||1983-12-01|December 2013|2013-12-01|November 1994|Actual|1994-11-01|November 1994|Actual|1994-11-01||Interventional|||Polyunsaturates and KCL to Control Mild Hypertension||Completed||Phase 2|||Brigham and Women's Hospital||1|||f||||||||||||||2017-10-11 04:18:58.537029|2017-10-11 04:18:58.537029
NCT00000512|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-12-01|||January 1984||1984-01-01|December 2015|2015-12-01|August 1989|Actual|1989-08-01|August 1989|Actual|1989-08-01||Interventional|FATS||Familial Atherosclerosis Treatment Study|Familial Atherosclerosis Treatment Study|Completed||Phase 3|146|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 04:18:58.624542|2017-10-11 04:18:58.624542
NCT00000521|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-05-27|||August 1985||1985-08-01|May 2014|2014-05-01|December 1990|Actual|1990-12-01|July 1990|Actual|1990-07-01||Interventional|||Sodium-Potassium Blood Pressure Trial in Children|Sodium-Potassium Blood Pressure Trial in Children|Completed||Phase 4|285|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||||||||||||2017-10-11 04:18:59.577089|2017-10-11 04:18:59.577089
NCT00000522|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-24|||August 1985||1985-08-01|February 2016|2016-02-01|May 1994||1994-05-01|||||Interventional|||Treatment of Mild Hypertension Study (TOMHS)||Completed||Phase 2|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:18:59.644998|2017-10-11 04:18:59.644998
NCT00000523|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2005-06-23|||April 1986||1986-04-01|January 2000|2000-01-01||||||||Interventional|||Optimal Exercise Regimens for Persons at Increased Risk||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:59.718888|2017-10-11 04:18:59.718888
NCT00000524|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||July 1986||1986-07-01|November 2013|2013-11-01|March 1994|Actual|1994-03-01|||||Interventional|||Myocarditis Treatment Trial||Completed||Phase 2|||University of Utah|||||f||||||||||||||2017-10-11 04:18:59.76874|2017-10-11 04:18:59.76874
NCT00000525|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-09-18|||July 1986||1986-07-01|September 2013|2013-09-01||||September 1989|Actual|1989-09-01||Interventional|||Diuretics, Hypertension, and Arrhythmias Clinical Trial||Completed||Phase 3|233|Actual|University of California, San Francisco|||||f||||||||||||||2017-10-11 04:18:59.825117|2017-10-11 04:18:59.825117
NCT00000526|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-05|||August 1986||1986-08-01|August 2004|2004-08-01|March 1998||1998-03-01|||||Interventional|||Cardiac Arrhythmia Suppression Trial (CAST)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:18:59.892461|2017-10-11 04:18:59.892461
NCT00000527|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-09|||August 1986||1986-08-01|December 2013|2013-12-01|November 1998|Actual|1998-11-01|November 1998|Actual|1998-11-01||Interventional|||Recurrent Carotid Stenosis||Completed||Phase 2|||Emory University|||||f||||||||||||||2017-10-11 04:19:00.063644|2017-10-11 04:19:00.063644
NCT00000528|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-15|||September 1986||1986-09-01|December 2005|2005-12-01|June 1998|Actual|1998-06-01|||||Interventional|||Trials of Hypertension Prevention (TOHP)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:00.125757|2017-10-11 04:19:00.125757
NCT00000529|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-11-01|||May 1992||1992-05-01|August 2001|2001-08-01|November 1995||1995-11-01|||||Interventional|||Tamoxifen Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:00.206907|2017-10-11 04:19:00.206907
NCT00000530|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-14|||September 1992||1992-09-01|August 2004|2004-08-01|June 1998||1998-06-01|||||Interventional|||Raynaud's Treatment Study (RTS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:00.259845|2017-10-11 04:19:00.259845
NCT00000531|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-12|||September 1992||1992-09-01|May 2005|2005-05-01|August 2002||2002-08-01|||||Interventional|||Antiarrhythmics Versus Implantable Defibrillators (AVID)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:00.335873|2017-10-11 04:19:00.335873
NCT00000532|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-12|||February 1992||1992-02-01|April 2002|2002-04-01|January 2000|Actual|2000-01-01|||||Interventional|||Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:00.453321|2017-10-11 04:19:00.453321
NCT00000533|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-12-28|||February 1992||1992-02-01|March 2005|2005-03-01|December 1996||1996-12-01|||||Interventional|||Montreal Heart Attack Readjustment Trial (M-HART)|Montreal Heart Attack Readjustment Trial (M-HART)|Completed||Phase 3|||McGill University|||||f||||||||||||||2017-10-11 04:19:00.540553|2017-10-11 04:19:00.540553
NCT00000534|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2017-03-09|||March 1991||1991-03-01|March 2017|2017-03-01|June 2000||2000-06-01|||||Interventional|||Calcium for Pre-Eclampsia Prevention (CPEP)||Completed||Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:19:00.635701|2017-10-11 04:19:00.635701
NCT00000535|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-11-04|||April 1992||1992-04-01|October 2002|2002-10-01|March 1997|Actual|1997-03-01|||||Interventional|||Trial of Nonpharmacologic Interventions in Elderly (TONE)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:00.715673|2017-10-11 04:19:00.715673
NCT00000536|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-24|||July 1992||1992-07-01|February 2016|2016-02-01|June 1997||1997-06-01|||||Interventional|||Sodium Sensitivity in African Americans||Completed||Phase 2|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:19:00.806374|2017-10-11 04:19:00.806374
NCT00000537|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2008-07-23|||July 1992||1992-07-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Stress Reduction & CVD Morbidity and Mortality in Blacks||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:00.891818|2017-10-11 04:19:00.891818
NCT00000538|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-08-11|||September 1992||1992-09-01|August 2014|2014-08-01|May 1995|Actual|1995-05-01|May 1995|Actual|1995-05-01||Interventional|||Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA)||Completed||Phase 3|189|Actual|University of North Carolina, Chapel Hill|||||f||||||||||||||2017-10-11 04:19:02.639581|2017-10-11 04:19:02.639581
NCT00000539|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||September 1992||1992-09-01|January 2006|2006-01-01|March 1999|Actual|1999-03-01|||||Interventional|||Arterial Disease Multifactorial Intervention Trial (ADMIT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:02.710432|2017-10-11 04:19:02.710432
NCT00000540|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-11-04|||December 1992||1992-12-01|August 2004|2004-08-01|December 1998|Actual|1998-12-01|||||Interventional|||Coronary Artery Bypass Graft (CABG) Patch Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:02.77687|2017-10-11 04:19:02.77687
NCT00000541|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2017-07-12|||May 1993||1993-05-01|July 2017|2017-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|WAFACS||Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)|Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)|Completed||Phase 2|||Brigham and Women's Hospital|||||f||||t||||||||||2017-10-11 04:19:02.844667|2017-10-11 04:19:02.844667
NCT00000542|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-28|||August 1993||1993-08-01|February 2009|2009-02-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:02.932888|2017-10-11 04:19:02.932888
NCT00000543|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-12|||August 1993||1993-08-01|April 2002|2002-04-01|July 1999|Actual|1999-07-01|||||Interventional|||Oral Calcium in Pregnant Women With Hypertension||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:03.017667|2017-10-11 04:19:03.017667
NCT00000569|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-10-25|||September 1993||1993-09-01|October 2016|2016-10-01|May 1999|Actual|1999-05-01|May 1999|Actual|1999-05-01||Interventional|LHSII||Lung Health Study II|The Chronic Obstructive Pulmonary Disease Early Intervention Trial|Completed||Phase 3|1116|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-10-11 04:19:05.283597|2017-10-11 04:19:05.283597
NCT00000570|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-12-12|||January 1986||1986-01-01|January 2000|2000-01-01|June 1990|Actual|1990-06-01|||||Interventional|||Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:05.370363|2017-10-11 04:19:05.370363
NCT00000571|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-12-28|||February 1986||1986-02-01|April 2001|2001-04-01||||||||Interventional|||Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease||Completed||Phase 3|||McGill University|||||f||||||||||||||2017-10-11 04:19:05.428166|2017-10-11 04:19:05.428166
NCT00000572|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-04-08|||June 1987||1987-06-01|April 2015|2015-04-01|January 1993|Actual|1993-01-01|April 1991|Actual|1991-04-01||Interventional|||Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome|Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome|Completed||Phase 3|40|Actual|Intermountain Health Care, Inc.||2|||f||||f||||||||||2017-10-11 04:19:05.484755|2017-10-11 04:19:05.484755
NCT00000573|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-12|||January 1990||1990-01-01|April 2002|2002-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Emphysema: Physiologic Effects of Nutritional Support||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:05.583191|2017-10-11 04:19:05.583191
NCT00000574|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-01-28|||September 1990||1990-09-01|January 2016|2016-01-01|July 1995||1995-07-01|||||Interventional|||Ibuprofen in Sepsis Study||Completed||Phase 3|||Vanderbilt University|||||f||||||||||||||2017-10-11 04:19:05.640483|2017-10-11 04:19:05.640483
NCT00000575|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-02-20|2013-10-16||September 1991||1991-09-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|October 1999|Actual|1999-10-01||Interventional|CAMP||Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)|Childhood Asthma Management Program|Completed||Phase 3|1041|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-10-11 04:19:05.719521|2017-10-11 04:19:05.719521
NCT00000576|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||June 1993||1993-06-01|May 2001|2001-05-01|April 1999|Actual|1999-04-01|||||Interventional|||Inhaled Beclomethasone to Prevent Chronic Lung Disease||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:06.275205|2017-10-11 04:19:06.275205
NCT00000577|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2017-01-12|||September 1993||1993-09-01|August 2006|2006-08-01|July 2008||2008-07-01|||||Interventional|||Asthma Clinical Research Network (ACRN)|Asthma Clinical Research Network (ACRN)|Withdrawn||Phase 3|0|Actual|Milton S. Hershey Medical Center||||"Record is an ACRN grant summary & not reflective of an individual trial. All ACTs conducted by   ACRN were individually registered on the PRS."|f||||||||||||||2017-10-11 04:19:06.336697|2017-10-11 04:19:06.336697
NCT00000578|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-11|||April 1994||1994-04-01|February 2005|2005-02-01|October 2000|Actual|2000-10-01|||||Interventional|||NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:06.469216|2017-10-11 04:19:06.469216
NCT00000579|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-22|||September 1994||1994-09-01|August 2006|2006-08-01|July 2004|Actual|2004-07-01|||||Interventional|||Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)|Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)|Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:06.539936|2017-10-11 04:19:06.539936
NCT00000580|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||November 1975||1975-11-01|January 2000|2000-01-01|June 1986|Actual|1986-06-01|||||Interventional|||Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:06.706496|2017-10-11 04:19:06.706496
NCT00000581|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||September 1976||1976-09-01|January 2000|2000-01-01|September 1981|Actual|1981-09-01|||||Interventional|||Granulocyte Transfusion Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:06.778074|2017-10-11 04:19:06.778074
NCT00000582|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2012-04-26|||July 1978||1978-07-01|April 2012|2012-04-01|July 1979|Actual|1979-07-01|||||Interventional|||Cooperative Study of Factor VIII Inhibitors||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:06.846139|2017-10-11 04:19:06.846139
NCT00000583|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||November 1978||1978-11-01|April 2012|2012-04-01|June 1980|Actual|1980-06-01|||||Interventional|||Hepatitis B Vaccine Clinical Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:06.919144|2017-10-11 04:19:06.919144
NCT00000584|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2013-11-25|||July 1983||1983-07-01|December 2005|2005-12-01|June 1988|Actual|1988-06-01|||||Interventional|||Transfusion-Transmitted Cytomegalovirus Prevention in Neonates||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:06.98297|2017-10-11 04:19:06.98297
NCT00000585|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-24|||August 1983||1983-08-01|October 1994|1994-10-01|October 1994||1994-10-01|||||Interventional|||Penicillin Prophylaxis in Sickle Cell Disease (PROPS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.035504|2017-10-11 04:19:07.035504
NCT00000586|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||January 1992||1992-01-01|January 2009|2009-01-01|June 1994|Actual|1994-06-01|June 1994|Actual|1994-06-01||Interventional|||Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)|Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)|Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.102672|2017-10-11 04:19:07.102672
NCT00000587|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2006-01-03|||September 1988||1988-09-01|December 2005|2005-12-01||||||||Interventional|||Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.166359|2017-10-11 04:19:07.166359
NCT00000588|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-02-10|||June 1989||1989-06-01|February 2002|2002-02-01||||||||Interventional|||Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone||Completed||Phase 2|||Case Western Reserve University|||||f||||||||||||||2017-10-11 04:19:07.220435|2017-10-11 04:19:07.220435
NCT00000589|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-11-04|||August 1989||1989-08-01|May 2000|2000-05-01|July 1997|Actual|1997-07-01|||||Interventional|||Trial to Reduce Alloimmunization to Platelets (TRAP)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.286368|2017-10-11 04:19:07.286368
NCT00000590|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||September 1991||1991-09-01|March 2005|2005-03-01|December 1996||1996-12-01|||||Interventional|||Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:07.345208|2017-10-11 04:19:07.345208
NCT00000607|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2015-12-22|||October 1997||1997-10-01|December 2015|2015-12-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH)|The REMATCH Trial: Rationale, Design, and End Points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure|Completed||Phase 3|129|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 04:19:08.637641|2017-10-11 04:19:08.637641
NCT00000608|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-07-28|||February 1997||1997-02-01|January 2008|2008-01-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.739171|2017-10-11 04:19:08.739171
NCT00000609|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-12|||May 1997||1997-05-01|November 2005|2005-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:08.813157|2017-10-11 04:19:08.813157
NCT00000610|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||April 1998||1998-04-01|March 2005|2005-03-01|November 2003||2003-11-01|||||Interventional|||Magnesium in Coronaries (MAGIC)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:09.4606|2017-10-11 04:19:09.4606
NCT00000611|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-14||||||January 2006|2006-01-01||||March 2005|Actual|2005-03-01||Interventional|||Women's Health Initiative (WHI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:09.563215|2017-10-11 04:19:09.563215
NCT00000612|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-05-12|||January 1996||1996-01-01|November 2000|2000-11-01|December 1998|Actual|1998-12-01|||||Interventional|||Soy Estrogen Alternative Study (SEA)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:09.700058|2017-10-11 04:19:09.700058
NCT00000613|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-26|||April 1997||1997-04-01|December 2005|2005-12-01|December 2004|Actual|2004-12-01|||||Interventional|||CVD Risk and Health in Postmenopausal Phytoestrogen Users||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:09.797662|2017-10-11 04:19:09.797662
NCT00000614|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-03-15|||September 1998||1998-09-01|September 2005|2005-09-01|August 2004|Actual|2004-08-01|||||Interventional|||Prevention of Recurrent Venous Thromboembolism (PREVENT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:09.873782|2017-10-11 04:19:09.873782
NCT00000615|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2006-10-02|||August 1999||1999-08-01|April 2005|2005-04-01|November 2006||2006-11-01|||||Interventional|||Girls Health Enrichment Multi-Site Studies (GEMS)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:09.947018|2017-10-11 04:19:09.947018
NCT00000616|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-02-17|||September 1998||1998-09-01|November 2005|2005-11-01|August 2004|Actual|2004-08-01|||||Interventional|||PREMIER: Lifestyle Interventions for Blood Pressure Control||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:10.036138|2017-10-11 04:19:10.036138
NCT00000617|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-11-04|||September 1998||1998-09-01|May 2005|2005-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Azithromycin and Coronary Events Study (ACES)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:10.124974|2017-10-11 04:19:10.124974
NCT00000619|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-04-13|||April 2001||2001-04-01|January 2008|2008-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:10.211885|2017-10-11 04:19:10.211885
NCT00000620|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2016-11-21|2014-09-05||September 1999||1999-09-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|June 2009|Actual|2009-06-01||Interventional|ACCORD||Action to Control Cardiovascular Risk in Diabetes (ACCORD)|Action to Control Cardiovascular Risk in Diabetes (ACCORD)|Completed||Phase 3|10251|Actual|National Heart, Lung, and Blood Institute (NHLBI)||6|||f||||t||||||||||2017-10-11 04:19:10.293759|2017-10-11 04:19:10.293759
NCT00000621|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2008-01-15|||September 1999||1999-09-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:11.107955|2017-10-11 04:19:11.107955
NCT00000622|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2006-08-24|||September 1999||1999-09-01|August 2006|2006-08-01||||||||Interventional|||Childhood Asthma Research and Education (CARE) Network|Childhood Asthma Research and Education (CARE) Network|Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:19:11.158036|2017-10-11 04:19:11.158036
NCT00000623|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-27|2014-03-03|||July 2000||2000-07-01|July 2006|2006-07-01|July 2006|Actual|2006-07-01|||||Observational|||Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)|Thalassemia Clinical Research Network (TCRN)|Completed||N/A|1000|Anticipated|New England Research Institutes|||||f||||||||||||||2017-10-11 04:19:11.230232|2017-10-11 04:19:11.230232
NCT00000625|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|November 1995|Actual|1995-11-01|||||Interventional|||A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3|A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3|Completed||Phase 2|2100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:11.326393|2017-10-11 04:19:11.326393
NCT00000626|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|February 1999|Actual|1999-02-01|||||Interventional|||Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease|Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease|Completed||Phase 2|27||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:11.608661|2017-10-11 04:19:11.608661
NCT00000627|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|November 1994|Actual|1994-11-01|||||Interventional|||Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome|Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome|Completed||N/A|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:11.702255|2017-10-11 04:19:11.702255
NCT00000628|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-29||||||October 1994|1994-10-01||||||||Interventional|||A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine|A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine|Completed||Phase 1|27||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:11.812516|2017-10-11 04:19:11.812516
NCT00000629|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-29||||||October 2003|2003-10-01||||||||Interventional|||The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.|The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:11.893196|2017-10-11 04:19:11.893196
NCT00000630|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|December 1992|Actual|1992-12-01|||||Interventional|||Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)|Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)|Completed||Phase 1|35||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:11.958974|2017-10-11 04:19:11.958974
NCT00000631|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|December 1992|Actual|1992-12-01|||||Interventional|||A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)|A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)|Completed||Phase 1|13||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:12.030593|2017-10-11 04:19:12.030593
NCT00000632|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|May 1992|Actual|1992-05-01|||||Interventional|||A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59|Completed||Phase 1|14|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:12.101581|2017-10-11 04:19:12.101581
NCT00000633|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|October 1998|Actual|1998-10-01|||||Interventional|||A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals|A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals|Completed||Phase 1|55||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:12.172202|2017-10-11 04:19:12.172202
NCT00000634|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-25||||||February 2011|2011-02-01||||June 1995|Actual|1995-06-01||Interventional|||A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children|A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children|Completed||N/A|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:12.246437|2017-10-11 04:19:12.246437
NCT00000635|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|April 1992|Actual|1992-04-01|||||Interventional|||Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine|Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine|Completed||N/A|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:12.310809|2017-10-11 04:19:12.310809
NCT00000636|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|October 1997|Actual|1997-10-01|||||Interventional|||Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection|Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection|Completed||N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:12.409567|2017-10-11 04:19:12.409567
NCT00000637|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children|A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children|Completed||Phase 3|819||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:12.553944|2017-10-11 04:19:12.553944
NCT00000638|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1999|Actual|1999-09-01|||||Interventional|||Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection|Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection|Completed||N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:12.79081|2017-10-11 04:19:12.79081
NCT00000639|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1997|Actual|1997-09-01|||||Interventional|||A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis|A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis|Completed||N/A|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.015684|2017-10-11 04:19:13.015684
NCT00000640|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1994|Actual|1994-09-01|||||Interventional|||A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS|A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Trimethoprim / Sulfamethoxazole in the Treatment of Mild-to-Moderate PCP in Patients With AIDS|Completed||Phase 3|290||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.157064|2017-10-11 04:19:13.157064
NCT00000641|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|December 1994|Actual|1994-12-01|||||Interventional|||A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.|A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.306346|2017-10-11 04:19:13.306346
NCT00001148|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor|Detection of Glioblastoma or Anaplastic Astrocytoma Cells in the Circulation During Surgical Resection|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.071833|2017-10-11 04:19:15.071833
NCT00000642|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 2003|2003-10-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns|A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.422847|2017-10-11 04:19:13.422847
NCT00000643|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|May 1994|Actual|1994-05-01|||||Interventional|||Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients|Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients|Completed||Phase 2|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.496093|2017-10-11 04:19:13.496093
NCT00000644|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-24||||||February 2011|2011-02-01||||November 1997|Actual|1997-11-01||Interventional|||A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS|A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS|Completed||Phase 2|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.742789|2017-10-11 04:19:13.742789
NCT00000645|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|October 1994|Actual|1994-10-01|||||Interventional|||A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes|A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.80978|2017-10-11 04:19:13.80978
NCT00000646|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|March 1993|Actual|1993-03-01|||||Interventional|||Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS|Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS|Completed||Phase 1|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.870373|2017-10-11 04:19:13.870373
NCT00000647|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|December 1994|Actual|1994-12-01|||||Interventional|||An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection|An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection|Completed||N/A|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:13.941313|2017-10-11 04:19:13.941313
NCT00001135|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-23|2012-03-30||||||March 2012|2012-03-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants|A Phase III Randomized, Double-Blinded Study of Nevirapine for the Prevention of Maternal-Fetal Transmission in Pregnant HIV-Infected Women|Completed||Phase 3|2009||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:14.028214|2017-10-11 04:19:14.028214
NCT00001136|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-25|2012-05-11||||||May 2012|2012-05-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine|A Multi-Centered Phase 1 Trial to Evaluate the Memory Responses to a Single Boosting Vaccination With ALVAC-HIV vCP205 in Volunteers Who Have Previously Received Poxvirus-Based Vaccines|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:14.162602|2017-10-11 04:19:14.162602
NCT00001137|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-12-05|||January 2000||2000-01-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Long-Term Data Collection From Participants in Adult AIDS Clinical Trials|Adult AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) Protocol|Completed||N/A|5982|Actual|AIDS Clinical Trials Group|||1||f||||||||||||||2017-10-11 04:19:14.324867|2017-10-11 04:19:14.324867
NCT00001142|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|October 2000|2000-10-01|December 2000||2000-12-01|||||Observational|||Metabolism and Body Shape of Healthy Children and Children With Chronic Infections|Metabolism and Body Composition of Healthy Children and Children With Chronic Infections|Completed||N/A|185||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:14.594543|2017-10-11 04:19:14.594543
NCT00001143|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||Development of the Eye Motor System During the First 7 Months of Life in Infants With and Without a Family History of Cross-Eye|Ocular Motor Development During the First Seven Months of Life in Infants With and Without a Family History of Strabismus|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:14.669029|2017-10-11 04:19:14.669029
NCT00001144|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-10-06|||October 1999||1999-10-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia|Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Chronic Phase CML|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:14.736628|2017-10-11 04:19:14.736628
NCT00001145|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|October 2003|2003-10-01|October 2003||2003-10-01|||||Interventional|||Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome|Study of Immune Responses and Safety of Recombinant CD40 Ligand in Patients With X-Linked Hyper IgM Syndrome|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:14.820388|2017-10-11 04:19:14.820388
NCT00001146|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial|Omega-3 Fatty Acids in the Treatment of Major Depression and Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:14.898445|2017-10-11 04:19:14.898445
NCT00001147|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Blood Sampling for Neurochemical and Genetic Testing|Blood Sampling for Neurochemical and Genetic Testing|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:14.980311|2017-10-11 04:19:14.980311
NCT00001149|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1975||1975-11-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Monitoring Patients With Uncontrolled Epilepsy|Monitoring of Seizures, EEG and Serum Antiepileptic Drug Concentrations in Patients With Uncontrolled Epilepsy|Completed||N/A|900||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.155585|2017-10-11 04:19:15.155585
NCT00001150|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1976||1976-10-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers|Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.235441|2017-10-11 04:19:15.235441
NCT00001151|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-11-21|2010-11-12||March 1976||1976-03-01|June 2013|2013-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Studies With 1,25-Dihydroxycholecalciferol|Studies With 1,25-Dihydroxycholecalciferol|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1||Terminated because of lack of drug supply|f||||f||||||||||2017-10-11 04:19:15.32028|2017-10-11 04:19:15.32028
NCT00001152|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1976||1976-06-01|May 1998|1998-05-01|June 2000||2000-06-01|||||Observational|||Pigment Dispersion Syndrome With and Without Glaucoma|Pigment Dispersion Syndrome With and Without Glaucoma|Completed||N/A|175||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.500474|2017-10-11 04:19:15.500474
NCT00001153|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1976||1976-06-01|May 1999|1999-05-01|May 2000||2000-05-01|||||Observational|||Visual Function and Ocular Pigmentation in Albinism|Visual Function and Ocular Pigmentation in Albinism|Completed||N/A|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.578664|2017-10-11 04:19:15.578664
NCT00001154|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 3, 1976||1976-03-03|October 24, 2016|2016-10-24||||||||Observational|||Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins|Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients|Recruiting||N/A|900|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.643751|2017-10-11 04:19:15.643751
NCT00001155|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1976||1976-02-01|February 2002|2002-02-01|February 2002||2002-02-01|||||Interventional|||Treatment of Wegener's Granulomatosis With Cyclophosphamide|Treatment of Wegener's Granulomatosis With Cyclophosphamide|Completed||Phase 2|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.711526|2017-10-11 04:19:15.711526
NCT00001156|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||January 23, 1976||1976-01-23|February 1, 2010|2010-02-01|February 1, 2010||2010-02-01|||||Observational|||Assessment of Patients With Multiple Sclerosis (MS)|Combined Clinical, Immunological and Virological Assessment of Patients With Multiple Sclerosis (MS)|Completed||N/A|1388|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.772609|2017-10-11 04:19:15.772609
NCT00001158|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||April 1977||1977-04-01|April 1999|1999-04-01|March 2000||2000-03-01|||||Observational|||Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System|Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.834367|2017-10-11 04:19:15.834367
NCT00001159|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||January 14, 1977||1977-01-14|February 22, 2017|2017-02-22||||||||Observational|||Evaluation of Patients With Thyroid Disorders|Evaluation of Patients With Thyroid Function Disorders|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.890186|2017-10-11 04:19:15.890186
NCT00001160|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-09-14|||May 31, 1977||1977-05-31|August 28, 2017|2017-08-28||||||||Observational|||Studies on Tumors of the Thyroid|Studies on Thyroid Nodules and Thyroid Cancer|Recruiting||N/A|99999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:15.958065|2017-10-11 04:19:15.958065
NCT00001161|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1977||1977-07-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens|Anomalies of the Anterior Chamber, Angle, Iris, Cornea and Lens With or Without Glaucoma or Ocular Hypertension|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.026591|2017-10-11 04:19:16.026591
NCT00001162|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||May 23, 1977||1977-05-23|May 31, 2017|2017-05-31|May 31, 2017||2017-05-31|||||Observational|||Parasitic Infections of the Gastrointestinal Tract|Study of Patients With Parasitic Infections of the Gastrointestinal Tract|Terminated||N/A|150|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.10152|2017-10-11 04:19:16.10152
NCT00001163|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 20, 1978||1978-03-20|April 28, 2017|2017-04-28||||||||Observational|||Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer|Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer|Recruiting||N/A|7500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.172883|2017-10-11 04:19:16.172883
NCT00001164|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||July 1978||1978-07-01|June 2000|2000-06-01|June 2000||2000-06-01|||||Observational|||Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers|Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.229701|2017-10-11 04:19:16.229701
NCT00001165|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1978||1978-09-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas|Evaluation of Chemotherapy With Streptozotocin Combined With 5-Fluorouracil and Adriamycin in Patients With Zollinger-Ellison Syndrome and Metastatic Non-Beta-Islet Cell Neoplasm|Completed||Phase 2|999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.276731|2017-10-11 04:19:16.276731
NCT00001486|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 30, 1995||1995-06-30|July 27, 2017|2017-07-27||||||||Observational|||Genetic Study of Schizophrenia|A Neurobiological Investigation of Patients With Schizophrenia Spectrum Disorders and Their Siblings|Recruiting||N/A|6150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.335108|2017-10-11 04:19:16.335108
NCT00001487|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||Treatment of Mid-Life-Related Mood Disorders|Dehydroepiandrosterone Treatment of Mid-Life-Related Mood Disorders in Women and Men|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.395079|2017-10-11 04:19:16.395079
NCT00001489|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1994||1994-10-01|August 1999|1999-08-01|August 2000||2000-08-01|||||Observational|||Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism|The Effect of Vigabatrin on Cerebral Blood Flow and Glucose Metabolism|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.568371|2017-10-11 04:19:16.568371
NCT00001491|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||May 11, 1995||1995-05-11|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Analysis of the Nervous System in Patients With Fabry's Disease|The Natural History and Pathogenesis of Fabry Disease|Completed||N/A|325||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.62351|2017-10-11 04:19:16.62351
NCT00001493|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1995||1995-10-01|August 1999|1999-08-01|June 2000||2000-06-01|||||Interventional|||Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer|Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cance|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.6832|2017-10-11 04:19:16.6832
NCT00001495|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1995||1995-11-01|September 1999|1999-09-01|October 2000||2000-10-01|||||Interventional|||A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors|A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.741114|2017-10-11 04:19:16.741114
NCT00001496|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1996||1996-01-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer|Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.800413|2017-10-11 04:19:16.800413
NCT00001497|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1995||1995-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Observational|||Assessment of Attentional Functioning in Children With HIV-1 Infection|Assessment of Attentional Functioning in Children With HIV-1 Infection|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.851218|2017-10-11 04:19:16.851218
NCT00001498|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1996||1996-02-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer|A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer|Completed||Phase 2|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.904481|2017-10-11 04:19:16.904481
NCT00001499|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1996||1996-03-01|March 2000|2000-03-01|June 2000||2000-06-01|||||Interventional|||Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer|Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:16.971194|2017-10-11 04:19:16.971194
NCT00001500|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|July 2004|2004-07-01|July 2004||2004-07-01|||||Observational|||Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits|Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits|Completed||N/A|4500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.027658|2017-10-11 04:19:17.027658
NCT00001502|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|February 2000|2000-02-01|March 2000||2000-03-01|||||Interventional|||A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors|Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.081237|2017-10-11 04:19:17.081237
NCT00001504|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1996||1996-05-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients|A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients|Completed||Phase 1|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.192376|2017-10-11 04:19:17.192376
NCT00001505|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 3, 1996||1996-06-03|November 8, 2016|2016-11-08||||||||Observational|||The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases|The Acquisition of Blood and Skin Samples From Patient Volunteers to Support Research Activities on Dermatologic and Other Diseases|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.254774|2017-10-11 04:19:17.254774
NCT00001506|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 10, 1996||1996-06-10|December 21, 2016|2016-12-21||||||||Observational|||Evaluation and Treatment of Patients With Dermatologic Diseases|Evaluation and Treatment of Subjects With Dermatologic Diseases|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.323216|2017-10-11 04:19:17.323216
NCT00001507|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||July 12, 1996||1996-07-12|June 20, 2014|2014-06-20|June 20, 2014|Actual|2014-06-20|June 30, 1998|Actual|1998-06-30||Interventional|||Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer|A Multi-Center Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide With Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer|Completed||Phase 1|107|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:17.388539|2017-10-11 04:19:17.388539
NCT00005352|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1992||1992-09-01|August 2004|2004-08-01|August 1996|Actual|1996-08-01|||||Observational|||Chronic Stress as a Risk Factor in the Etiology of Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.847889|2017-10-11 04:28:02.847889
NCT00001509|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1996||1996-07-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Interventional|||A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor|A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.461841|2017-10-11 04:19:17.461841
NCT00001512|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||September 9, 1996||1996-09-09|March 5, 2010|2010-03-05|March 5, 2010|Actual|2010-03-05|March 5, 2010|Actual|2010-03-05||Interventional|||Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines|Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines|Completed||Phase 1|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:17.521147|2017-10-11 04:19:17.521147
NCT00001515|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1995||1995-12-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Diagnostic Effectiveness of Virtual Bronchoscopy|Diagnostic Efficacy of Virtual Bronchoscopy|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.587962|2017-10-11 04:19:17.587962
NCT00001516|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1996||1996-01-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||Evaluating the Personal Computer as a Treatment Activity in Occupational Therapy|Linking Occupational Therapy Process and Patient Performance: The Personal Computer Activity in Occupational Interventions|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.643273|2017-10-11 04:19:17.643273
NCT00001518|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1996||1996-01-01|December 1999|1999-12-01|November 2000||2000-11-01|||||Observational|||A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters|A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters|Completed||N/A|132||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.687941|2017-10-11 04:19:17.687941
NCT00001519|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Observational|||Oxygen Uptake Kinetics During Recovery From Maximal and Submaximal Exercise|Oxygen Uptake Kinetics During Recovery From Maximal and Submaximal Exercise|Completed||N/A|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.737473|2017-10-11 04:19:17.737473
NCT00001520|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1996||1996-09-01|September 1999|1999-09-01|August 2000||2000-08-01|||||Interventional|||The Early Reversibility of Rocuronium After Different Doses of Neostigmine|The Early Reversibility of Rocuronium After Different Doses of Neostigmine|Completed||Phase 4|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.787216|2017-10-11 04:19:17.787216
NCT00001521|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 2, 1996||1996-02-02|June 15, 2017|2017-06-15|January 11, 2017|Actual|2017-01-11|||||Interventional|||Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia|An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children With Congenital Adrenal Hyperplasia|Completed||Phase 1|62|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:17.848349|2017-10-11 04:19:17.848349
NCT00001522|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 4, 1996||1996-06-04|June 16, 2017|2017-06-16||||||||Observational|||Metabolic Differences of Overweight Children and Children of Overweight Parents|Population Differences in the Insulin Sensitivity, Resting Energy Expenditure, and Body Composition of Overweight Children and Children of Overweight Parents|Active, not recruiting||N/A|246|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:17.910466|2017-10-11 04:19:17.910466
NCT00001523|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1996||1996-05-01|June 1999|1999-06-01|March 2000||2000-03-01|||||Observational|||Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation|Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.364065|2017-10-11 04:19:19.364065
NCT00001524|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Thalidomide to Treat Oral Lesions in HIV-Infected Patients|Evaluation of a TNF-Alpha Modulator for the Treatment of Oral Lesions in HIV/AIDS Patients|Completed||Phase 2|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.410497|2017-10-11 04:19:19.410497
NCT00001526|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||June 4, 1996||1996-06-04|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Interventional|||ANTI-TAC THERAPY FOR UVEITIS|Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis With Humanized Anti-Tac Antibody Therapy|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.477853|2017-10-11 04:19:19.477853
NCT00001527|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1995||1995-11-01|November 1999|1999-11-01|September 2000||2000-09-01|||||Observational|||Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension|Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.539362|2017-10-11 04:19:19.539362
NCT00001528|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1996||1996-02-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Observational|||Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease|Post-Stress Left Ventricular Contractile Dysfunction: Does It Represent Persistent Myocardial Ischemia or Stunning?|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.591217|2017-10-11 04:19:19.591217
NCT00001529|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 12, 1996||1996-03-12|June 29, 2017|2017-06-29|May 1, 2030|Anticipated|2030-05-01|May 1, 2026|Anticipated|2026-05-01||Interventional|||Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives|Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections From Healthy Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation|Recruiting||Phase 1|99999999|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:19.648521|2017-10-11 04:19:19.648521
NCT00001530|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|April 1999|1999-04-01|May 2000||2000-05-01|||||Observational|||Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy|Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.719446|2017-10-11 04:19:19.719446
NCT00001531|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|August 1999|1999-08-01|September 2000||2000-09-01|||||Observational|||Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction|Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction|Completed||N/A|355||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.770244|2017-10-11 04:19:19.770244
NCT00001532|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 6, 1996||1996-06-06|August 2, 2017|2017-08-02||||||||Observational|||Role of Genetic Factors in the Development of Lung Disease|Role of Genetic Factors in the Pathogenesis of Lung Disease|Recruiting||N/A|3600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.822301|2017-10-11 04:19:19.822301
NCT00001533|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2006-07-14|||September 1996||1996-09-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Interventional|||Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine|Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.893599|2017-10-11 04:19:19.893599
NCT00001534|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1996||1996-09-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Long Term Effects of Enalapril and Losartan on Genetic Heart Disease|Double-Blind, Placebo-Controlled Study of the Long Term Effects of Angiotensin Converting Enzyme Inhibition (Enalapril) and Angiotensin II Receptor Blockade (Losartan) on Genetically-Induced Left Ventricular Hypertrophy in Non-Obstructive HCM|Completed||N/A|112||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:19.965691|2017-10-11 04:19:19.965691
NCT00001535|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-02-07|||March 1996||1996-03-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Twins Study of Gene Therapy for HIV Infection|Gene Therapy for AIDS Using Retroviral Mediated Gene Transfer to Deliver HIV-1 Anti-Sense TAR and Transdominant Rev Protein Genes to Syngeneic Lymphocytes in HIV-1 Infected Identical Twins|Completed||Phase 1|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.038001|2017-10-11 04:19:20.038001
NCT00001536|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1996||1996-08-01|August 1999|1999-08-01|July 2000||2000-07-01|||||Observational|||Issues Surrounding Prenatal Genetic Testing for Achondroplasia|Issues Surrounding Prenatal Genetic Testing for Achondroplasia|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.10438|2017-10-11 04:19:20.10438
NCT00001538|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1996||1996-03-01|February 2000|2000-02-01|April 2001||2001-04-01|||||Interventional|||Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers|Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers|Completed||Phase 1|41||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.259572|2017-10-11 04:19:20.259572
NCT00001539|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 22, 1996||1996-03-22|August 2, 2017|2017-08-02||||||||Observational|||Evaluation of Lyme Disease: Clinical, Microbiological and Immunological Characteristics|A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Chronic Lyme Infection and Selected Control Populations|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.358083|2017-10-11 04:19:20.358083
NCT00001540|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-01|2008-03-03|||April 1996||1996-04-01|February 1999|1999-02-01|March 2000||2000-03-01|||||Observational|||The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo|The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo|Completed||N/A|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.486335|2017-10-11 04:19:20.486335
NCT00001541|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Observational|||Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis|Analysis of Bronchial and Bronchoalveolar Lavage Fluid and Bronchial Mucosal Biopsies in Patients With Wegener's Granulomatosis|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.575565|2017-10-11 04:19:20.575565
NCT00001542|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1996||1996-07-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Fluconazole Prophylaxis of Thrush in AIDS|Fluconazole Prophylaxis of Thrush in AIDS|Completed||Phase 4|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.67985|2017-10-11 04:19:20.67985
NCT00001543|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1996||1996-03-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Dynamics of Leptin and Endocrine Function|Dynamics of Leptin and Endocrine Function|Completed||N/A|230||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.765443|2017-10-11 04:19:20.765443
NCT00001544|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Genetic Aspects of Neurologic and Psychiatric Disorders|Genetic Aspects of Neurologic and Psychiatric Disorders|Completed||N/A|1227||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.83333|2017-10-11 04:19:20.83333
NCT00001545|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2006-07-12|||May 1996||1996-05-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders|Evaluation of rTMS in the Treatment of Mood Disorders|Completed||Phase 2|91||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.908309|2017-10-11 04:19:20.908309
NCT00001546|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1996||1996-05-01|April 1999|1999-04-01|June 2000||2000-06-01|||||Observational|||Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers|Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers|Completed||N/A|38||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:20.990861|2017-10-11 04:19:20.990861
NCT00001547|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Neuropsychiatric Effects of Interferon-Alpha and Ribavirin|A Magnetic Resonance Spectroscopy Study of Neuropsychiatric Effects Associated With Cytokines|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.060728|2017-10-11 04:19:21.060728
NCT00001548|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||August 22, 1996||1996-08-22|September 29, 2015|2015-09-29|September 29, 2015||2015-09-29|||||Observational|||Genetics of Obsessive-Compulsive Disorder|Genetics of Obsessive-Compulsive Disorder: A Collaborative Study|Completed||N/A|1067|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.138468|2017-10-11 04:19:21.138468
NCT00001549|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1995||1995-10-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Diagnosis and Natural History Study of Patients With Neurological Conditions|Diagnosis and Natural History Protocol for Patients With Neurological Conditions|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.207481|2017-10-11 04:19:21.207481
NCT00001550|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2006-07-13|||April 1996||1996-04-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Interventional|||Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)|The Efficacy of High-Dose Intravenous Immunoglobulin Therapy in Patients With Stiff-Man Syndrome: A Double-Blind, Placebo-Controlled Trial|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.280506|2017-10-11 04:19:21.280506
NCT00001551|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||May 22, 1996||1996-05-22|November 13, 2009|2009-11-13||||November 13, 2009|Actual|2009-11-13||Observational|||Characteristics of Idiopathic Familial Speech Disorders|Characteristics of Idiopathic Familial Speech Disorders|Completed||N/A|375||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.355971|2017-10-11 04:19:21.355971
NCT00001552|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||May 22, 1996||1996-05-22|November 13, 2009|2009-11-13||||November 13, 2009|Actual|2009-11-13||Observational|||Characteristics of Idiopathic Familial Voice Disorders|Characteristics of Idiopathic Familial Voice Disorders|Completed||N/A|270||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.42384|2017-10-11 04:19:21.42384
NCT00001553|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1996||1996-05-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Observational|||Motor Changes Associated With Recovery From Stroke After Therapy|Functional Changes Associated With Recovery of Motor Function in Chronic Ischemic Subcortical Stroke After a Therapeutic Intervention|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.482199|2017-10-11 04:19:21.482199
NCT00001554|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|May 1999|1999-05-01|June 2000||2000-06-01|||||Interventional|||Infrared Camera for Brain Mapping During Surgery|Intraoperative Infrared Functional Brain Mapping|Completed||Phase 1|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.54196|2017-10-11 04:19:21.54196
NCT00001560|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||December 24, 1996||1996-12-24|October 31, 2011|2011-10-31|October 31, 2011||2011-10-31|||||Observational|||Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers|Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.597428|2017-10-11 04:19:21.597428
NCT00001561|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2007-09-21|||November 1996||1996-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation|Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation|Completed||Phase 3|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.653294|2017-10-11 04:19:21.653294
NCT00001563|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||December 10, 1996||1996-12-10|July 15, 2017|2017-07-15|May 5, 2005|Actual|2005-05-05|May 5, 2005|Actual|2005-05-05||Interventional|||EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma|EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma|Completed||Phase 2|39|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:21.715866|2017-10-11 04:19:21.715866
NCT00001564|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||December 23, 1996||1996-12-23|September 4, 2014|2014-09-04|October 25, 2007|Actual|2007-10-25|October 25, 2007|Actual|2007-10-25||Interventional|||A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas|A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:21.791802|2017-10-11 04:19:21.791802
NCT00001565|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy|Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy|Completed||Phase 1|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:21.862377|2017-10-11 04:19:21.862377
NCT00001566|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2012-06-12|2012-03-28||December 1996||1996-12-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas|A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas|Completed||Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:19:21.956634|2017-10-11 04:19:21.956634
NCT00001567|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1997||1997-01-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia|A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia|Completed||Phase 2|56||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:22.758251|2017-10-11 04:19:22.758251
NCT00001568|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities|Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities|Completed||Phase 2|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:22.819965|2017-10-11 04:19:22.819965
NCT00001569|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1997||1997-01-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis|Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis|Completed||Phase 1|74||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:22.890323|2017-10-11 04:19:22.890323
NCT00001570|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer|A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer|Completed||Phase 1|46||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:22.969993|2017-10-11 04:19:22.969993
NCT00001571|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Observational|||A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines|A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:23.040122|2017-10-11 04:19:23.040122
NCT00001572|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||January 30, 1997||1997-01-30|November 2, 2010|2010-11-02|November 2, 2010|Actual|2010-11-02|July 31, 1999|Actual|1999-07-31||Interventional|||Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype|Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype|Completed||Phase 1|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:23.106031|2017-10-11 04:19:23.106031
NCT00001573|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|February 2000|2000-02-01|May 2000||2000-05-01|||||Interventional|||A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy|A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:23.174911|2017-10-11 04:19:23.174911
NCT00001574|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 14, 1997||1997-03-14|July 15, 2017|2017-07-15||||||||Observational|||A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors|A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors|Completed||N/A|40|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:23.239968|2017-10-11 04:19:23.239968
NCT00001575|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2015-10-30|2015-05-14||April 1997||1997-04-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia||Completed||Phase 1/Phase 2|87|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:19:23.327414|2017-10-11 04:19:23.327414
NCT00001576|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver|A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver|Completed||Phase 1|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:23.750796|2017-10-11 04:19:23.750796
NCT00001577|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1997||1997-06-01|April 1999|1999-04-01|March 2000||2000-03-01|||||Interventional|||Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity|Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:23.810673|2017-10-11 04:19:23.810673
NCT00001579|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2006-07-14|||June 1997||1997-06-01|May 2000|2000-05-01|March 2001||2001-03-01|||||Interventional|||A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors|A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:23.86431|2017-10-11 04:19:23.86431
NCT00001580|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1997||1997-06-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Tissue Acquisition for Molecular Diagnostics|Tissue Acquisition for Molecular Diagnostics|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:23.921596|2017-10-11 04:19:23.921596
NCT00001584|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Observational|||Determination of HIV-1 Production by the Prostate|Determination of HIV-1 Production by the Prostate|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:24.057643|2017-10-11 04:19:24.057643
NCT00001586|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2013-03-19|2012-12-18||September 1997||1997-09-01|March 2013|2013-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis|Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis|Completed||Phase 2|105|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:19:24.125341|2017-10-11 04:19:24.125341
NCT00001587|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Interventional|||A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver|A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:24.862695|2017-10-11 04:19:24.862695
NCT00001589|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1997||1997-04-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors|Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:24.939648|2017-10-11 04:19:24.939648
NCT00001591|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy|Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:25.006041|2017-10-11 04:19:25.006041
NCT00001594|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 13, 1997||1997-01-13|September 20, 2017|2017-09-20||||||||Observational|||Evaluation and Intervention for the Effects of Osteogenesis Imperfecta|Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:25.111987|2017-10-11 04:19:25.111987
NCT00001595|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 13, 1997||1997-02-13|June 8, 2017|2017-06-08||||||||Observational|||An Investigation of Pituitary Tumors and Related Hypothalmic Disorders|A Clinical and Genetic Investigation of Pituitary and HYPOTHALAMIC Tumors and Related Disorders|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:25.224887|2017-10-11 04:19:25.224887
NCT00001597|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Pain Measurement in Healthy Volunteers|Pain Measurement in Healthy Volunteers|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:25.89296|2017-10-11 04:19:25.89296
NCT00001598|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||DHEA Treatment for Sjogren's Syndrome|Dehydroepiandrosterone (DHEA) Treatment for Sjogren's Syndrome|Completed||Phase 2|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:25.965531|2017-10-11 04:19:25.965531
NCT00001599|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Pilot Study of Thalidomide to Treat Sjogren's Syndrome|Pilot Study of Thalidomide for Sjogren's Syndrome|Completed||Phase 2|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.056278|2017-10-11 04:19:26.056278
NCT00001600|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Diagnosis and Evaluation of Patients Needing Third Molar (Wisdom Tooth) Extraction and Patients With Chronic Facial Pain|Diagnosis and Evaluation of Patients in Need of Third Molar Removal or Suffering From Chronic Facial Pain|Completed||N/A|4000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.173244|2017-10-11 04:19:26.173244
NCT00001601|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||Evaluation and Treatment of Oral Soft Tissue Diseases|Patient Evaluation and Treatment of Oral Soft Tissue Diseases According to Generally Available, Standard Procedures and Therapeutic Modalities|Completed||N/A|999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.256091|2017-10-11 04:19:26.256091
NCT00001602|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1996||1996-10-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Observational|||Genetic Factors Related to Stuttering|Genetic Linkage Analysis in Developmental Stuttering: Gene Mapping in Extended Kindreds and Candidate Gene Analyses|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.359924|2017-10-11 04:19:26.359924
NCT00001603|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Observational|||The Effects of Upper Airway and Digestive Tract Tumors on the Immune System|A Pilot Study of Immunoregulatory Factor Expression and Immune Responses in Patients With Squamous Cell Carcinoma or Papilloma of the Upper Aerodigestive Tract|Completed||N/A|93||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.444545|2017-10-11 04:19:26.444545
NCT00001604|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 7, 1997||1997-01-07|June 8, 2017|2017-06-08||||||||Observational|||Genetic Linkage Studies of Stuttering|Genetic Studies of Stuttering|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.512808|2017-10-11 04:19:26.512808
NCT00001605|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|April 2000|2000-04-01|April 2001||2001-04-01|||||Interventional|||Vaccination for Middle Ear Infection|Phase I Study to Evaluate the Safety and Immunogenicity of a Nontypeable Haemophilus Influenzae Vaccine for Otitis Media|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.595831|2017-10-11 04:19:26.595831
NCT00001606|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||September 8, 1997||1997-09-08|April 7, 2015|2015-04-07|April 7, 2015||2015-04-07|||||Observational|||Genetic Analysis of Human Hereditary Hearing Impairment|Genetic Analysis of Human Hereditary Hearing Impairment|Terminated||N/A|404|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.654793|2017-10-11 04:19:26.654793
NCT00001609|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1996||1996-10-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Studies of Families With Hereditary Cataracts|Clinical and Molecular Studies in Families With Congenital or Hereditary Cataracts|Completed||N/A|1200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.7279|2017-10-11 04:19:26.7279
NCT00001610|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Normal Human Electro-Oculogram|Normal Human Electro-Oculogram|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.811168|2017-10-11 04:19:26.811168
NCT00001611|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Observational|||Immune Activity Against CVM Retinitis|Efficacy of Elevated CD4 Cell Counts on CMV Retinitis|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.876139|2017-10-11 04:19:26.876139
NCT00001612|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|May 1999|1999-05-01|August 2000||2000-08-01|||||Observational|||Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)|Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)|Completed||N/A|170||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:26.946125|2017-10-11 04:19:26.946125
NCT00001613|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Cataract Surgery to Obtain Human Lens Material for the Study of Nuclear Cataracts|Use of Human Lens Material for the Study of Nuclear Cataracts|Completed||N/A|96||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.010067|2017-10-11 04:19:27.010067
NCT00001614|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Interventional|||The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis|The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis|Completed||Phase 1|13||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.071538|2017-10-11 04:19:27.071538
NCT00001615|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|May 1999|1999-05-01|May 2000||2000-05-01|||||Interventional|||Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration|Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration|Completed||Phase 1|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.159714|2017-10-11 04:19:27.159714
NCT00001617|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|November 1999|1999-11-01|August 2000||2000-08-01|||||Observational|||Test of QLS Device to Detect Early Cataracts|Feasibility Study - Use of Quasielastic Light Scattering (QLS) Device in a Study of the Human Lens and Lens Opacities|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.218978|2017-10-11 04:19:27.218978
NCT00001618|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||November 15, 1996||1996-11-15|May 4, 2017|2017-05-04||||||||Observational|||Segmental Bronchoalveolar Lavage|Bronchoscopy in Patients With Pulmonary Diseases and Research Volunteers|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.282891|2017-10-11 04:19:27.282891
NCT00001619|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||November 5, 1996||1996-11-05|July 20, 2011|2011-07-20|July 20, 2011||2011-07-20|||||Observational|||Magnetic Resonance Imaging at Different Levels of Magnetic Intensity|Magnetic Resonance at 1.5 and 3 Tesla|Completed||N/A|497|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.34877|2017-10-11 04:19:27.34877
NCT00001620|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||December 6, 1996||1996-12-06|May 12, 2017|2017-05-12||||||||Observational|||Screening for Hematology Branch Protocols|Screening Protocol for Subjects Being Evaluated for Hematology Branch Protocols|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.415373|2017-10-11 04:19:27.415373
NCT00001622|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|January 2000|2000-01-01|March 2001||2001-03-01|||||Interventional|||Study of the Response of Human Small Blood Vessels|Study of the Relation Between In Vivo and In Vitro Response of Human Small Vessels|Completed||Phase 1|87||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.548582|2017-10-11 04:19:27.548582
NCT00001623|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 27, 1997||1997-03-27|August 3, 2017|2017-08-03|August 3, 2017|Actual|2017-08-03|January 31, 2008|Actual|2008-01-31||Interventional|||Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia|HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies|Completed||N/A|41|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:27.615102|2017-10-11 04:19:27.615102
NCT00001624|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|February 1999|1999-02-01|March 2000||2000-03-01|||||Interventional|||Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation|Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.684641|2017-10-11 04:19:27.684641
NCT00001625|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||April 3, 1997||1997-04-03|April 11, 2007|2007-04-11|April 11, 2007||2007-04-11|||||Observational|||Methods for Measuring Insulin Sensitivity|Methods for Assessing Insulin Sensitivity In Vivo|Completed||N/A|480||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.743889|2017-10-11 04:19:27.743889
NCT00001627|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 4, 1997||1997-06-04|December 16, 2016|2016-12-16||||||||Observational|||Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes|Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes|Completed||N/A|154|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.906034|2017-10-11 04:19:27.906034
NCT00001628|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|June 1999|1999-06-01|September 2000||2000-09-01|||||Interventional|||The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function|The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function|Completed||Phase 3|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:27.973778|2017-10-11 04:19:27.973778
NCT00001629|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|June 1999|1999-06-01|September 2000||2000-09-01|||||Interventional|||The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function|The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function|Completed||Phase 3|49||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.035489|2017-10-11 04:19:28.035489
NCT00001630|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||July 21, 1997||1997-07-21|March 21, 2011|2011-03-21|June 11, 2009|Actual|2009-06-11|||||Interventional|||Treatment of Autoimmune Thrombocytopenia (AITP)|High-Dose Cyclophosphamide With CD34+ Selected Autologous Hematopoietic Cell Support for Treatment of Refractory Chronic Autoimmune Thrombocytopenia|Completed||Phase 1|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:28.098685|2017-10-11 04:19:28.098685
NCT00001631|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Interventional|||Study of Blood Flow in Heart Muscle|Study of Myocardial Perfusion by MRI|Completed||Phase 2|249||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.164553|2017-10-11 04:19:28.164553
NCT00001632|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease|Myocardial Ultrasonic Tissue Characterization in Patients With a Genetic Predisposition for the Development of Hypertrophic Cardiomyopathy|Completed||N/A|195||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.219302|2017-10-11 04:19:28.219302
NCT00001720|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2016-09-21|||March 1998||1998-03-01|September 2016|2016-09-01|June 2003||2003-06-01|||||Interventional|||Treatment of Childhood Osteoporosis With Alendronate (Fosamax)|Alendronate Versus Placebo for Idiopathic Juvenile Osteoporosis|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.786421|2017-10-11 04:19:33.786421
NCT00001633|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|December 1999|1999-12-01|December 2000||2000-12-01|||||Interventional|||Safety and Effectiveness of Coronary Magnetic Resonance Angiography (CMRA) Imaging|A Phase II Feasibility Study of the Safety and Efficacy of Coronary Magnetic Resonance Angiography (CMRA) Imaging|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.386287|2017-10-11 04:19:28.386287
NCT00001637|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||September 29, 1997||1997-09-29|December 28, 2016|2016-12-28|December 28, 2016|Actual|2016-12-28|July 28, 2008|Actual|2008-07-28||Interventional|||Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults|Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults|Completed||Phase 2|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:28.447053|2017-10-11 04:19:28.447053
NCT00001638|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||September 29, 1997||1997-09-29|August 4, 2009|2009-08-04|August 3, 2009|Actual|2009-08-03|August 3, 2009|Actual|2009-08-03||Observational|||Magnetic Resonance Imaging of the Blood Vessels of the Heart|Cardiovascular Magnetic Resonance Imaging|Completed||N/A|99999999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.529354|2017-10-11 04:19:28.529354
NCT00001639|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|October 1999|1999-10-01|October 2000||2000-10-01|||||Observational|||Evaluation of Patients With Unresolved Chromosome Abnormalities|Evaluation of Patients With Unresolved Chromosome Aberrations|Completed||N/A|263||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.620219|2017-10-11 04:19:28.620219
NCT00001640|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 11, 1997||1997-02-11|February 10, 2009|2009-02-10|February 10, 2009||2009-02-10|||||Observational|||Genetic Analysis of Parkinson's Disease|Genetic Analysis of Parkinson's Disease|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.683298|2017-10-11 04:19:28.683298
NCT00001641|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Study of Heritable Connective Tissue Disorders|Clinical and Molecular Manifestations of Heritable Connective Tissue Disorders|Completed||N/A|900||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.741185|2017-10-11 04:19:28.741185
NCT00001642|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2008-03-03|||May 1997||1997-05-01|May 1999|1999-05-01|March 2000||2000-03-01|||||Observational|||Positional Cloning of the Gene(s) Responsible for Alagille Syndrome|Positional Cloning of the Gene(s) Responsible for Alagille Syndrome|Completed||N/A|225||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.823448|2017-10-11 04:19:28.823448
NCT00001643|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 29, 1997||1997-08-29|August 31, 2009|2009-08-31||||August 31, 2009|Actual|2009-08-31||Observational|||Gene Analysis of Parkinson's Disease|Gene Analysis in Parkinson's Disease|Completed||N/A|320||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:28.890237|2017-10-11 04:19:28.890237
NCT00001644|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 3, 1997||1997-03-03|February 17, 2010|2010-02-17|February 17, 2010|Actual|2010-02-17|February 17, 2010|Actual|2010-02-17||Interventional|||Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection|Use of Combination Antiviral Therapy to Delineate the Identity and Longevity of Persistent Reservoirs of HIV-1 Infection and Replication|Completed||Phase 1|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:28.949981|2017-10-11 04:19:28.949981
NCT00001645|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 19, 1997||1997-03-19|August 9, 2017|2017-08-09||||||||Observational|||Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection|Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.025142|2017-10-11 04:19:29.025142
NCT00001646|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|September 1999|1999-09-01|August 2000||2000-08-01|||||Interventional|||Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis|Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis|Completed||Phase 3|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.096773|2017-10-11 04:19:29.096773
NCT00001647|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||White Blood Cell Infusions to Treat HIV Infection|Effects of Repeated Infusions of Adoptively Transferred Syngeneic Lymphocytes on the Immune Systems of HIV-1 Infected Identical Twins|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.1656|2017-10-11 04:19:29.1656
NCT00001648|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 20, 1997||1997-08-20|April 13, 2010|2010-04-13|April 13, 2010||2010-04-13|||||Observational|||Structure of the Herpes Simplex Virus Receptor|Polymorphism of the Herpes Simplex Virus Receptor|Completed||N/A|60|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.232184|2017-10-11 04:19:29.232184
NCT00001649|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Valaciclovir to Prevent Transmission of Herpes Simplex Virus|A Randomized, Double-Blind, Placebo-Controlled Evaluation of Valaciclovir for the Prevention of Herpes Simplex Virus Transmission in Heterosexual Couples|Completed||Phase 3|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.295045|2017-10-11 04:19:29.295045
NCT00001650|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||September 19, 1997||1997-09-19|May 13, 2011|2011-05-13|May 13, 2011||2011-05-13|||||Observational|||Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients|Studies of Lymphocyte Kinetics Using Bromodeoxyuridine|Completed||N/A|56|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.361314|2017-10-11 04:19:29.361314
NCT00001651|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||September 18, 1997||1997-09-18|September 8, 2017|2017-09-08||||||||Observational|||Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients|Studies of Lymphocyte Kinetics Using Stable Isotopes|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.424607|2017-10-11 04:19:29.424607
NCT00001652|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Observational|||The Evaluation and Follow-up of Patients With Bipolar Disorder|The Evaluation and Naturalistic Follow-up of Patients With Bipolar Disorder|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.502118|2017-10-11 04:19:29.502118
NCT00001654|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||The Role of Emotion in the Development of Psychopathology|The Role of Emotion in the Development of Psychopathology|Completed||N/A|1200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:29.567681|2017-10-11 04:19:29.567681
NCT00001656|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2011-03-11|2011-03-02||June 1997||1997-06-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders|Childhood Onset Psychotic Disorders: Characterization and Treatment With Atypical Neuroleptics|Completed||Phase 4|25|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:19:29.64515|2017-10-11 04:19:29.64515
NCT00001657|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1997||1997-06-01|August 1999|1999-08-01|May 2000||2000-05-01|||||Observational|||Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Chronic Posttraumatic Stress Disorder (PTSD)|Controlled Studies of Repetitive Transcranial Magnetic Stimulation (rTMS) in Chronic Posttraumatic Stress Disorder (PTSD)|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.27949|2017-10-11 04:19:30.27949
NCT00001658|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|August 2000|2000-08-01|June 2001||2001-06-01|||||Interventional|||Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections|A Placebo Controlled Trial of Amoxicillin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections|Completed||Phase 4|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.341162|2017-10-11 04:19:30.341162
NCT00001659|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Consequences of Conjugal Bereavement in Adults|Conjugal Bereavement in Older Adults: Biological, Functional, and Psychological Consequences|Completed||N/A|210||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.407039|2017-10-11 04:19:30.407039
NCT00001661|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Mechanisms of Human Plasticity in the Human System|Mechanisms of Plasticity in the Human Motor System|Completed||N/A|260||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.464947|2017-10-11 04:19:30.464947
NCT00001662|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Treatment of Alzheimer's Disease With CX516 (Ampalex)|Tolerability and Primary Efficacy of CX516 in Alzheimer's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.520943|2017-10-11 04:19:30.520943
NCT00001663|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1997||1997-01-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation|Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.579899|2017-10-11 04:19:30.579899
NCT00001664|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||December 4, 1996||1996-12-04|September 7, 2011|2011-09-07|September 7, 2011||2011-09-07|||||Observational|||Sleep Disorders of Patients With Diseases of the Nervous System|Training Protocol for Various Sleep Disorders in Patients With Neurological Disorders|Completed||N/A|83|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.637768|2017-10-11 04:19:30.637768
NCT00001665|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1997||1997-01-01|December 1999|1999-12-01|September 2000||2000-09-01|||||Observational|||Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease|Can Subthreshold Transcranial Magnetic Stimulation (rTMS) to Motor Cortex and/or to Supplementary Motor Area (SMA) Improve Performance of Complex Motor Sequences in Parkinson's Disease?|Completed||N/A|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.690947|2017-10-11 04:19:30.690947
NCT00001666|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy|Drug Refractory Partial Epilepsy, A Therapeutic Trial With Transcranial Magnetic Stimulation|Completed||N/A|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.745299|2017-10-11 04:19:30.745299
NCT00001667|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|February 1999|1999-02-01|April 2000||2000-04-01|||||Observational|||Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases|Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.805481|2017-10-11 04:19:30.805481
NCT00001668|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1997||1997-04-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Observational|||Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors|Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.862956|2017-10-11 04:19:30.862956
NCT00001669|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|April 1999|1999-04-01|April 2000||2000-04-01|||||Interventional|||A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients|A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.917435|2017-10-11 04:19:30.917435
NCT00001671|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||September 9, 1997||1997-09-09|December 15, 2008|2008-12-15|December 15, 2008||2008-12-15|||||Observational|||The Classification and Cause of Leukodystrophies of Unknown Cause|The Nosology and Etiology of Leukodystrophies of Unknown Cause|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:30.975039|2017-10-11 04:19:30.975039
NCT00001672|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|August 1999|1999-08-01|March 2000||2000-03-01|||||Observational|||Language Localization Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Epilepsy|Language Localization Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Epilepsy|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.035932|2017-10-11 04:19:31.035932
NCT00001673|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||October 2, 1997||1997-10-02|December 15, 2015|2015-12-15|December 15, 2015||2015-12-15|||||Observational|||Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Screening Evaluation for NIAAA Protocols|Completed||N/A|2220|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.110774|2017-10-11 04:19:31.110774
NCT00001675|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 23, 1998||1998-01-23|December 23, 2015|2015-12-23|December 23, 2015||2015-12-23|||||Observational|||The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and Nonalcoholics|Functional Neuroanatomy of Positive and Negative Affect in Alcoholics and Non-Alcoholics|Completed||N/A|1194|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.181|2017-10-11 04:19:31.181
NCT00001676|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1998||1998-01-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Interventional|||Cyclophosphamide and Fludarabine to Treat Lupus Nephritis|Combination of Cyclophosphamide and Fludarabine for Lupus Nephritis: Tolerance, Toxicity, Efficacy and Effects on B and T Lymphocyte Regeneration|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.255844|2017-10-11 04:19:31.255844
NCT00001677|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Interventional|||Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy|Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.321341|2017-10-11 04:19:31.321341
NCT00001678|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||July 7, 1998||1998-07-07|June 20, 2014|2014-06-20|June 20, 2014||2014-06-20|||||Observational|||Genetics of Rheumatoid Arthritis|Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium|Completed||N/A|39|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.391174|2017-10-11 04:19:31.391174
NCT00001679|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1998||1998-08-01|August 1999|1999-08-01|June 2000||2000-06-01|||||Observational|||Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients|Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients|Completed||N/A|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.452364|2017-10-11 04:19:31.452364
NCT00001680|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|September 2000|2000-09-01|July 2001||2001-07-01|||||Interventional|||A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus|A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus|Completed||Phase 2|17||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.507428|2017-10-11 04:19:31.507428
NCT00001681|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Observational|||A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations|A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.56304|2017-10-11 04:19:31.56304
NCT00001683|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer|A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer|Completed||Phase 1|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.613997|2017-10-11 04:19:31.613997
NCT00001685|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Interventional|||Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase|Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase|Completed||Phase 2|114||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.669171|2017-10-11 04:19:31.669171
NCT00001686|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||December 3, 1997||1997-12-03|December 8, 2016|2016-12-08||||||||Observational|||Evaluation, Treatment, and Natural History of Children With Cancer|Treatment of Children With Cancer|Enrolling by invitation||N/A|378|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||||||||||||2017-10-11 04:19:31.725209|2017-10-11 04:19:31.725209
NCT00001688|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1998||1998-01-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine|A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.791778|2017-10-11 04:19:31.791778
NCT00001689|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1998||1998-01-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia|A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia|Completed||Phase 1|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.845356|2017-10-11 04:19:31.845356
NCT00001693|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1998||1998-03-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers|Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.901535|2017-10-11 04:19:31.901535
NCT00001695|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials|Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:31.954683|2017-10-11 04:19:31.954683
NCT00001696|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Interventional|||A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor|A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:32.013013|2017-10-11 04:19:32.013013
NCT00001698|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR|Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR|Completed||Phase 2|57||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:32.074588|2017-10-11 04:19:32.074588
NCT00001699|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|June 1999|1999-06-01|March 2000||2000-03-01|||||Observational|||A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers|A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:32.15433|2017-10-11 04:19:32.15433
NCT00001701|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||July 29, 1998||1998-07-29|October 6, 2009|2009-10-06||||June 21, 2007|Actual|2007-06-21||Observational|||Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection|Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:32.331038|2017-10-11 04:19:32.331038
NCT00001702|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||July 29, 1998||1998-07-29|October 6, 2009|2009-10-06||||June 6, 2007|Actual|2007-06-06||Observational|||Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection|Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:32.402376|2017-10-11 04:19:32.402376
NCT00001703|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2014-07-16|2011-05-17||August 1998||1998-08-01|July 2014|2014-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma|Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|Patients were enrolled to Arm A only due to poor accrual and the lack of peptide vaccine.|1||Due to poor accrual and lack of peptide vaccine|f||||f||||||||||2017-10-11 04:19:32.484728|2017-10-11 04:19:32.484728
NCT00001705|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 2000|2000-07-01|June 2001||2001-06-01|||||Interventional|||Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence|Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence|Completed||Phase 2|141||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:32.838276|2017-10-11 04:19:32.838276
NCT00001711|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||October 28, 1997||1997-10-28|September 26, 2017|2017-09-26||||||||Observational|||Magnetic Resonance Imaging (MRI) Ofl Volunteers|Volunteer Scanning on MR|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:32.934234|2017-10-11 04:19:32.934234
NCT00001712|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Observational|||Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan|Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan|Completed||N/A|3400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.02767|2017-10-11 04:19:33.02767
NCT00001713|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Treatment for Blood Clots in the Veins of the Legs|Treatment of Acute Deep Vein Thrombosis of the Lower Extremity With Intraclot, Pulse-Sprayed Recombinant Tissue Plasminogen Activator, Plus Heparin and Warfarin: A Pilot Study|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.154217|2017-10-11 04:19:33.154217
NCT00001714|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1998||1998-03-01|February 2001|2001-02-01|July 2001||2001-07-01|||||Observational|||Magnetization Transfer Quantitation and Characterization for Clinical Scanners|Magnetization Transfer Quantitation and Characterization for Clinical Scanners|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.272564|2017-10-11 04:19:33.272564
NCT00001715|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 21, 1998||1998-04-21|August 23, 2017|2017-08-23|August 23, 2017||2017-08-23|||||Observational|||Evaluation of Patients With Blood Disorders|Evaluation of Hematologic Patients - Training Protocol|Completed||N/A|898|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.340784|2017-10-11 04:19:33.340784
NCT00001716|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Interventional|||Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia|Physiologic Effects of Inhaled Nitric Oxide, Nitroglycerin, and Placebo in Study Subjects With Sickle Cell Anemia|Completed||Phase 2|58||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.412273|2017-10-11 04:19:33.412273
NCT00001717|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|June 1999|1999-06-01|July 2000||2000-07-01|||||Observational|||Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent|Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent|Completed||N/A|225||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.497233|2017-10-11 04:19:33.497233
NCT00001718|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Interventional|||Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia|Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.579034|2017-10-11 04:19:33.579034
NCT00001719|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1998||1998-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Magnetic Resonance Imaging of Blood Flow in the Liver and Abdomen|Examination of the Hemodynamics of the Portal Venous System in Normal Volunteers Using Magnetic Resonance Imaging|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:33.689781|2017-10-11 04:19:33.689781
NCT00001722|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Fat Tissue Microperfusion to Measure Leptin Secretion and Its Relations With Fat Breakdown in Humans|Adipose Tissue Microperfusion to Assess Leptin Secretion and Its Relations With Lipolysis in Humans|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:34.009578|2017-10-11 04:19:34.009578
NCT00001723|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2012-11-15|2012-10-11||May 1998||1998-05-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases|Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents With Obesity-Related Comorbid Conditions|Completed||Phase 2|200|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:19:34.126422|2017-10-11 04:19:34.126422
NCT00001724|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Local Flurbiprofen to Treat Pain Following Wisdom Tooth Extraction|Evaluation of the Analgesic Effects of Locally Applied Flurbiprofen and Bupivacaine in the Oral Surgery Model|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:34.70989|2017-10-11 04:19:34.70989
NCT00001725|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1997||1997-12-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain|Clinical Trials in Orofacial Neuralgias|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:34.784967|2017-10-11 04:19:34.784967
NCT00001726|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||June 19, 1998||1998-06-19|August 3, 2009|2009-08-03|August 3, 2009|Actual|2009-08-03|August 3, 2009|Actual|2009-08-03||Observational|||Study of the Composition of Dental Plaque|Spatial Organization of Viridans Streptococci in Oral Biofilms|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:34.858721|2017-10-11 04:19:34.858721
NCT00001727|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||August 24, 1998||1998-08-24|July 18, 2017|2017-07-18||||||||Observational|||Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome|Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:34.930086|2017-10-11 04:19:34.930086
NCT00001728|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 24, 1998||1998-08-24|May 2, 2011|2011-05-02|May 2, 2011|Actual|2011-05-02|August 19, 2007|Actual|2007-08-19||Interventional|||Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome|A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome|Completed||Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:35.014105|2017-10-11 04:19:35.014105
NCT00000865|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|April 1998|Actual|1998-04-01|||||Interventional|||The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children|A Phase I Safety and Pharmacokinetic Study of 1592U89 Alone and In Combination With Other Antiretroviral Agents in Infants and Children With HIV Infection|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:35.082362|2017-10-11 04:19:35.082362
NCT00000866|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|July 1999|Actual|1999-07-01|||||Interventional|||A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.|Completed||N/A|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:35.161776|2017-10-11 04:19:35.161776
NCT00000867|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-06-07|||December 1996||1996-12-01|June 2013|2013-06-01|July 2001|Actual|2001-07-01|||||Interventional|||A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)|A Phase II, Randomized, Double Blind, Placebo-Controlled Trial of Memantine for AIDS Dementia Complex (ADC) as Concurrent Treatment With Antiretroviral Therapy|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:35.235969|2017-10-11 04:19:35.235969
NCT00000868|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|May 2000|Actual|2000-05-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers|A Phase I Safety and Immunogenicity Trial of Orally Administered Live Attenuated Recombinant Salmonella Typhi CVD 908 Delta-asd (pW57-asd+) Expressing HIV-1 LAI gp120 (VVG 203) and Parenterally Administered HIV-1 MN rgp120 in Alum in HIV-1-Uninfected Volunteers|Completed||Phase 1|27||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:35.33723|2017-10-11 04:19:35.33723
NCT00000869|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies|A Phase III Randomized, Blinded Study of Nevirapine for the Prevention of Maternal-Fetal Transmission in Pregnant HIV-Infected Women|Completed||Phase 3|2009||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:35.420604|2017-10-11 04:19:35.420604
NCT00000870|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|March 2007|Actual|2007-03-01|||||Interventional|||A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone|A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone|Completed||Phase 2|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:35.722673|2017-10-11 04:19:35.722673
NCT00000871|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|January 2000|Actual|2000-01-01|||||Interventional|||A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers|A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers|Completed||Phase 2|420||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:35.850018|2017-10-11 04:19:35.850018
NCT00000872|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|January 2005|Actual|2005-01-01|||||Interventional|||Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection|Early Intensive Antiretroviral Combination Therapy in HIV-1 Infected Infants and Children|Completed||Phase 2|55|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:35.953458|2017-10-11 04:19:35.953458
NCT00000873|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-10-04||||||October 2013|2013-10-01|September 2005|Actual|2005-09-01|||||Interventional|||A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants|A Randomized, Double-Blind, Controlled Study of an Increased Caloric Density Infant Formula and Its Effect on Growth and Nutritional Status in HIV-Infected Infants|Completed||N/A|2400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:36.078087|2017-10-11 04:19:36.078087
NCT00000874|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28|||August 1997||1997-08-01|September 2013|2013-09-01|March 1999|Actual|1999-03-01|January 1999|Actual|1999-01-01||Observational|||A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART|A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART|Completed||N/A|148|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||||||||Samples With DNA|"     Blood collection   "|||2017-10-11 04:19:37.579122|2017-10-11 04:19:37.579122
NCT00000875|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-12-13||||||April 2003|2003-04-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection|Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection|Terminated||N/A|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:37.68332|2017-10-11 04:19:37.68332
NCT00000876|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|November 2006|Actual|2006-11-01|||||Interventional|||Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children|Phase I/II Trial of CD4-IgG2 in HIV-Infected Children|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:19:37.742045|2017-10-11 04:19:37.742045
NCT00000877|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|October 2000|Actual|2000-10-01|||||Interventional|||Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults|Steady-State Pharmacokinetic Interaction Study of Indinavir and Rifabutin|Completed||Phase 1|31||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:37.811125|2017-10-11 04:19:37.811125
NCT00000878|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|October 2001|Actual|2001-10-01|||||Interventional|||A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants|A Phase I/II, Open-Label Study to Evaluate the Safety, Tolerance and Pharmacokinetics of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Infected Pregnant Women and Their Infants|Completed||Phase 1|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:37.998583|2017-10-11 04:19:37.998583
NCT00000879|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers|A Phase I/II Study to Evaluate the Safety and Immunogenicity of ALVAC HIV Vaccines Alone and With AIDSVAX B/B in Children Born to HIV-Infected Mothers|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:19:38.146716|2017-10-11 04:19:38.146716
NCT00000880|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|May 2000|Actual|2000-05-01|||||Interventional|||A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease|Phase II Study of Cyclosporin (Neoral) in Immune Activation and HIV Expression in Early HIV Disease|Completed||Phase 2|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:38.287458|2017-10-11 04:19:38.287458
NCT00000881|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01||||||||Interventional|||A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease|A Phase I/II Study of Cidofovir for HIV-Infected Children With Invasive CMV (Cytomegalovirus) Disease|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:38.409866|2017-10-11 04:19:38.409866
NCT00000882|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01||||May 1999|Actual|1999-05-01||Interventional|||Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects|Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:38.512549|2017-10-11 04:19:38.512549
NCT00000883|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-10-24|||October 1997||1997-10-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy|Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Complications In Subjects With Past CD4 Cells/mm3 Below 50 Who Increased CD4 Cells/mm3 to Above 100 on HAART|Completed||N/A|636||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:38.690423|2017-10-11 04:19:38.690423
NCT00000884|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|October 2000|Actual|2000-10-01|||||Interventional|||A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers|A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|84|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-10-11 04:19:38.869224|2017-10-11 04:19:38.869224
NCT00000885|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-08-15||||||August 2012|2012-08-01|June 2003|Actual|2003-06-01|||||Interventional|||Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320|A Phase II Study of the Prolongation of Virologic Success (ACTG 372A) and Options for Virologic Failure (ACTG B/C/D) in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320|Completed||Phase 2|440||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:39.022365|2017-10-11 04:19:39.022365
NCT00000886|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-10||||||May 2012|2012-05-01|April 1999|Actual|1999-04-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)|A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)|Completed||Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:39.340872|2017-10-11 04:19:39.340872
NCT00000887|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants|A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Nelfinavir (Viracept) Co-Administered With Zidovudine (ZDV) and Lamivudine (3TC) in HIV Infected Pregnant Women and Their Infants|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:39.418025|2017-10-11 04:19:39.418025
NCT00000888|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|April 2001|Actual|2001-04-01|||||Interventional|||Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies|A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Ritonavir Co-Administered With Lamivudine (3TC) and Zidovudine (ZDV) in HIV-1-Infected Pregnant Women and Their Infants|Completed||Phase 1|14||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:39.527091|2017-10-11 04:19:39.527091
NCT00000889|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-11-07|||October 1997||1997-10-01|April 2014|2014-04-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3|A Randomized, Open-Label, Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Plus Antiretroviral Therapy vs. Antiretroviral Therapy Alone in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3|Completed||Phase 2|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:39.657472|2017-10-11 04:19:39.657472
NCT00000890|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Observational|||A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients|Effect of Highly Active Antiretroviral Therapy (HAART) on Lean Body Mass|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:39.743395|2017-10-11 04:19:39.743395
NCT00000891|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315|Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315|Completed||Phase 2|34||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:39.889117|2017-10-11 04:19:39.889117
NCT00000892|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|August 1999|Actual|1999-08-01|||||Interventional|||A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir|Activity of the Soft Gelatin Capsule of Saquinavir (SQVsgc) in Combination With Ritonavir or Nelfinavir and Combinations of Delavirdine and/or Adefovir Dipivoxil in HIV-Infected Subjects With Prior Indinavir Use and Viral Loads From 2,000 to 200,000 Copies HIV RNA/ml|Completed||N/A|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:39.989366|2017-10-11 04:19:39.989366
NCT00000893|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-06-02|||October 1997||1997-10-01|June 2015|2015-06-01|December 2002|Actual|2002-12-01|||||Interventional|||Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children|A Phase I/II, Open-Label, AUC-Controlled Study to Determine the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in Children|Completed||Phase 1|103|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:19:40.210584|2017-10-11 04:19:40.210584
NCT00000894|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-22||||||June 2003|2003-06-01||||June 2000|Actual|2000-06-01||Interventional|||Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis|Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)|Completed||Phase 4|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:40.352782|2017-10-11 04:19:40.352782
NCT00000895|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|August 2001|Actual|2001-08-01|||||Interventional|||A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection|Pathogenesis of MAC Disease in Advanced HIV-1-Infected Subjects and the Impact of Highly-Active Antiretroviral Treatment (HAART) on Immune Functions Relevant for MAC and Other Opportunistic Infections|Completed||N/A|85||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:40.459132|2017-10-11 04:19:40.459132
NCT00000896|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|October 2000|Actual|2000-10-01|||||Interventional|||A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients|A Randomized Controlled Trial to Compare the Efficacy of a Four Drug Antiretroviral Regimen Alone or in Combination With GM-CSF or IL-12 Administered to HIV-1 Infected Subjects as Measured by the Characteristics of Viral Decay|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:40.588026|2017-10-11 04:19:40.588026
NCT00000897|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-03-01||||||March 2011|2011-03-01||||October 2005|Actual|2005-10-01||Interventional|||A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women|The Effect of Oral and Injectable Contraceptives (Norethindrone/Ethinyl Estradiol, Medroxyprogesterone Acetate) and Gender on Plasma and Intracellular Zidovudine Pharmacokinetics|Completed||N/A|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:40.674914|2017-10-11 04:19:40.674914
NCT00000898|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|May 2000|Actual|2000-05-01|||||Interventional|||The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir|A Prototype Study to Test the Effect of Staggered Dosing on the Pharmacokinetic Interactions Between Paired Combinations of Nelfinavir (NFV), Ritonavir (RTV), and Soft Gelatin Capsule of Saquinavir (SQVsgc)|Completed||N/A|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:40.749507|2017-10-11 04:19:40.749507
NCT00000899|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|October 2001|Actual|2001-10-01|||||Interventional|||A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients|Effect of Cytoreductive Chemotherapy Combined With Highly Active Antiretroviral Therapy on Lymph Node HIV DNA in HIV-Infected Subjects|Completed||Phase 1|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:40.824491|2017-10-11 04:19:40.824491
NCT00000900|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Observational|||The Effects of Illnesses on HIV Levels in the Body|The Impact of Intercurrent Illness on HIV Viral Load|Completed||N/A|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:40.900246|2017-10-11 04:19:40.900246
NCT00000901|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|October 2000|Actual|2000-10-01|||||Interventional|||Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children|A Multicenter, Open-Labeled, 96-Week Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Indinavir in Combination With Stavudine and Lamivudine in Pediatric Patients With HIV-1 Infection|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:40.977709|2017-10-11 04:19:40.977709
NCT00000902|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-09-30||||||October 2012|2012-10-01|April 2002|Actual|2002-04-01|||||Interventional|||A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment|RAD-1: A Phase I/II Antiretroviral Management Algorithm for Pediatric Subjects of Four-Drug Combination Therapies Based on Prior Antiretroviral Experience|Completed||Phase 1|217||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:41.192699|2017-10-11 04:19:41.192699
NCT00000903|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|July 2001|Actual|2001-07-01|||||Interventional|||Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen|A Phase III Randomized, Controlled Trial of Efavirenz (EFV) or Nelfinavir (NFV) in Combination With Fixed-Dose Combination Lamivudine/Zidovudine (3TC/ZDV) and Indinavir (IDV) in HIV-Infected Subjects With Less Than or Equal to 200 CD4 Cells/mm3 or Greater Than or Equal to 80,000 HIV RNA Copies/ml in Plasma|Completed||Phase 3|444||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:41.410044|2017-10-11 04:19:41.410044
NCT00000904|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|August 1999|Actual|1999-08-01|||||Interventional|||Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults|A Phase I Trial to Compare the Safety and Immunogenicity of the Live Recombinant Canarypox ALVAC-HIV Vaccines, vCP205, vCP1433, and vCP1452, in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:41.607064|2017-10-11 04:19:41.607064
NCT00000905|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-28||||||June 2003|2003-06-01||||||||Observational|||A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy|Discontinuation of Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Immune Reconstitution by Potent Antiretroviral Therapy: Safety, Virology, and Immunology Profiles|Completed||N/A|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:41.709513|2017-10-11 04:19:41.709513
NCT00000906|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|September 2000|Actual|2000-09-01|||||Interventional|||Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients|The Effect of HIV Protease Inhibitors on the Stereospecific Metabolism of Methadone in HIV-Infected Subjects|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:41.84364|2017-10-11 04:19:41.84364
NCT00000907|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-29||||||June 2003|2003-06-01||||||||Observational|||A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients|A Study of Discontinuing Maintenance Therapy in Subjects With Disseminated Mycobacterium Avium Complex (DMAC)|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:41.93055|2017-10-11 04:19:41.93055
NCT00000908|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 2003|2003-02-01||||||||Observational|||A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts|Impact of Discontinuing PCP Prophylaxis in Subjects Receiving Antiretroviral Therapies Who Have Had Increases in CD4 Counts to > 200 Cells/mm3|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:42.046792|2017-10-11 04:19:42.046792
NCT00000909|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy|A Randomized, Open Label Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Alone vs No Therapy in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3 Who Do Not Wish to Receive Treatment With Antiretroviral Therapy|Completed||Phase 2|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:42.206325|2017-10-11 04:19:42.206325
NCT00000910|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-10-04||||||October 2013|2013-10-01|June 2004|Actual|2004-06-01|||||Observational|||A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies|Medical Chart Abstraction of HIV-Infected Pregnant Women and Their Infants Receiving Care or Consultation at Study Sites|Completed||N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:42.270553|2017-10-11 04:19:42.270553
NCT00000911|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-10-21|||October 1999||1999-10-01|October 2015|2015-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||A Study to Monitor Patients With Primary or Early HIV Infection|An Observational Study of Subjects With Primary HIV Infection: A Study of the UCSD Acute/Early HIV Infection (AEHIV) Clinical Studies Unit|Completed||N/A|1500|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"     Blood, lymph node tissue, CSF, and semen or vaginal secretion specimens   "|||2017-10-11 04:19:42.32883|2017-10-11 04:19:42.32883
NCT00000912|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-06-02||||||July 2013|2013-07-01|May 2000|Actual|2000-05-01|||||Interventional|||A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients|A Phase II, Randomized Trial of Amprenavir as Part of Dual Protease Inhibitor Regimens (Placebo-Controlled) in Combination With Abacavir, Efavirenz, and Adefovir Dipivoxil Versus Amprenavir Alone in HIV-Infected Subjects With Prior Exposure to Approved Protease Inhibitors and Loss of Virologic Suppression as Reflected by a Plasma HIV-1 RNA Concentration >= 1,000 Copies/ml|Completed||Phase 2|475||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:42.393416|2017-10-11 04:19:42.393416
NCT00000913|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-26||||||March 2012|2012-03-01|April 2001|Actual|2001-04-01|||||Interventional|||A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children|A Randomized Trial of Two Saquinavir-Containing Combination Treatment Regimens in Children With HIV Infection|Completed||Phase 2|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:42.566006|2017-10-11 04:19:42.566006
NCT00000914|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-03-26||||||March 2012|2012-03-01|June 2000|Actual|2000-06-01|||||Interventional|||A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks|A Randomized Study of the Virologic Efficacy of Different Antiretroviral (AR) Treatment Strategies in HIV-Infected Individuals With Detectable Plasma HIV RNA Measurements After at Least 16 Weeks on Their Initial Protease Inhibitor-Containing AR Regimens|Completed||N/A|800||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:42.688254|2017-10-11 04:19:42.688254
NCT00000915|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1999|1999-03-01||||||||Interventional|||An HIV Vaccine Preparedness Study|HIV Vaccine Preparedness Study|Completed||N/A|4892||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:42.773895|2017-10-11 04:19:42.773895
NCT00000916|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood|A Phase II, Randomized Study of the Safety and Efficacy of Hydroxyurea in Subjects on Potent Antiretroviral Therapy With Less Than 200 Copies/ml of HIV RNA in the Plasma|Completed||Phase 2|399||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:42.844325|2017-10-11 04:19:42.844325
NCT00000917|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-07-30|||September 1997||1997-09-01|June 2003|2003-06-01||||||||Observational|||Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants|Establishment of a Cord Blood Bank for Gene Therapy in HIV-Infected Infants|Terminated||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:43.083588|2017-10-11 04:19:43.083588
NCT00000918|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|February 2002|Actual|2002-02-01|||||Interventional|||A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure|A Phase II, Randomized, Open-Label Comparative Trial of Salvage Antiretroviral Therapies for HIV-Infected Individuals With Virological Evidence of Nelfinavir Treatment Failure as Reflected by Plasma HIV RNA Concentration of >= 1,000 Copies/ml|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:43.167662|2017-10-11 04:19:43.167662
NCT00000919|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-06-05||||||June 2012|2012-06-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection|Study of Protease Inhibitor and/or Non-Nucleoside Reverse Transcriptase Inhibitor With Dual Nucleosides in Initial Therapy of HIV Infection|Completed||N/A|900||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:43.340964|2017-10-11 04:19:43.340964
NCT00000920|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|April 2003|Actual|2003-04-01|||||Interventional|||Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns|A Phase I Trial of the Safety and Pharmacokinetics of Fortovase (Saquinavir-SGC) Co-Administered With Low Dose (Ritonavir) RTV, ZDV and 3TC in HIV Seropositive Pregnant Women During Gestation and Postpartum, and in Their Infant's Post-Maternal Dosing|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:19:43.646262|2017-10-11 04:19:43.646262
NCT00000921|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-02-22|||August 1996||1996-08-01|June 2003|2003-06-01||||June 2002|Actual|2002-06-01||Interventional|||The Effects of Prednisone on HIV Levels and the Immune System|A Phase II, Randomized, Placebo-Controlled Study of the Immunologic and Virologic Effects of Prednisone on HIV-1 Infection|Completed||Phase 2|118||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:43.759925|2017-10-11 04:19:43.759925
NCT00000922|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-04-16||||||April 2014|2014-04-01|June 2006|Actual|2006-06-01|January 2003|Actual|2003-01-01||Interventional|||A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)|A Randomized, Open-Label Study of the Long-Term Effectiveness of Three Initial Highly Active Antiretroviral Therapy (HAART) Strategies in HAART-Niave, HIV-Infected Persons|Completed||N/A|1710||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:43.86454|2017-10-11 04:19:43.86454
NCT00000923|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|August 2004|Actual|2004-08-01|||||Interventional|||Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328|Treatment Rollover for Subjects Formerly on ACTG 328 With Subcutaneous Interleukin-2 (IL-2) in Combination With Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|110||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:44.000381|2017-10-11 04:19:44.000381
NCT00000924|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|June 2001|Actual|2001-06-01|||||Interventional|||A Study to Compare Two Different Anti-HIV Drug Regimens|A Phase II Randomized, Multicenter Protocol Evaluating Two Antiretroviral Regimens Containing Combinations of Protease Inhibitors, NRTIs, and an NNRTI|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:44.112608|2017-10-11 04:19:44.112608
NCT00000925|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-07-26|||May 1999||1999-05-01|July 2013|2013-07-01||||June 2003|Actual|2003-06-01||Interventional|||A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss|Evaluation of High Protein Supplementation in HIV-1-Positive Subjects With Stable Weight Loss|Completed||Phase 2|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:44.269671|2017-10-11 04:19:44.269671
NCT00000926|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|February 2001|Actual|2001-02-01|||||Interventional|||A Study of Nonoxynol-9 (N-9) and HIV Infection|Phase III Nonoxynol-9 and HIV Infection|Completed||Phase 3|4400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:44.378308|2017-10-11 04:19:44.378308
NCT00000927|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-01-08||||||March 1999|1999-03-01||||||||Interventional|||A Study of BufferGel in Women|Phase I Vaginal Microbicide Study of BufferGel|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:44.441606|2017-10-11 04:19:44.441606
NCT00000928|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-11-04||||||October 2012|2012-10-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Interventional|||Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples|Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples|Completed||Phase 1|90|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:19:44.507245|2017-10-11 04:19:44.507245
NCT00000929|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|July 1999|Actual|1999-07-01|||||Interventional|||A Study of the Effects of Advantage 24 on the Rectum|Phase I Rectal Microbicide Study|Completed||Phase 1|70||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||t||||||||||2017-10-11 04:19:44.583832|2017-10-11 04:19:44.583832
NCT00000930|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2016-11-04||||||October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||A Study of HIV in Newly Infected Individuals|Infected Participants Protocol: Evaluation of Natural History of HIV Infection in Newly HIV-Infected Persons in HIVNET Target Populations|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"     Specimens appropriate for clinical and laboratory assessments and necessary for evaluation of     study outcome measures   "|||2017-10-11 04:19:44.659639|2017-10-11 04:19:44.659639
NCT00000931|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-09-08||||||November 2006|2006-11-01||||||||Interventional|||HIV Prevention Counseling for Men Who Have Sex With Men|A Randomized Clinical Trial of the Efficacy of a Behavioral Intervention to Prevent Acquisition of HIV Among Men Who Have Sex With Men|Completed||Phase 3|4350||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:44.75665|2017-10-11 04:19:44.75665
NCT00000932|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2014-04-14|||March 1999||1999-03-01|April 2014|2014-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||A Study of the Long-Term Outcomes of HIV-Positive Patients|A Prospective Study of Long-Term Clinical, Virologic, and Immunologic Outcomes in HIV-Infected Individuals|Completed||N/A|3669|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||||||||||||2017-10-11 04:19:44.866214|2017-10-11 04:19:44.866214
NCT00000933|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|July 2000|Actual|2000-07-01|||||Observational|||Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048|Effects of Prophylaxis for Disseminated Mycobacterium Avium Complex (MAC) Disease With Azithromycin Versus Deferred Prophylaxis on Carriage of Antibiotic-Resistant Streptococcus Pneumoniae: A Substudy of the CR-MAC Protocol (CPCRA 048)|Completed||N/A|326||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:45.18788|2017-10-11 04:19:45.18788
NCT00000935|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2017-01-10||||||January 2017|2017-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens|Evaluation of Intravenous Gamma Globulin (IVIG) As an Agent to Lower Allosensitization and Improve Allograft Survival in Highly-Sensitized Adult End-Stage Renal Disease (ESRD) Patients (IG02)|Completed||Phase 3|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 04:19:45.320001|2017-10-11 04:19:45.320001
NCT00000936|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2017-01-10|||November 1999||1999-11-01|January 2017|2017-01-01|March 2004|Actual|2004-03-01|||||Interventional|||A Study To Test An Anti-Rejection Therapy After Kidney Transplantation|Controlled Trial of Induction Therapy in Renal Transplantation|Terminated||Phase 3|292|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 04:19:45.423218|2017-10-11 04:19:45.423218
NCT00000937|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Study and Treatment of Post Lyme Disease (STOP-LD)|Study and Treatment of Post Lyme Disease (STOP-LD)|Completed||Phase 3|55||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:45.52607|2017-10-11 04:19:45.52607
NCT00000938|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease|Completed||Phase 3|66||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:45.598684|2017-10-11 04:19:45.598684
NCT00000939|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|January 2000|Actual|2000-01-01|||||Interventional|||A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible|Phase II Randomized, Open-Label Study of Maintenance of HIV RNA Suppression After Switching to ddI/d4T/HU vs. ddI/d4T/EFV vs. Continuing the Pre-Entry Protease Inhibitor Regimen|Completed||Phase 2|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:19:45.817072|2017-10-11 04:19:45.817072
NCT00001729|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Interventional|||Combination Drug Therapy for Patients With Hepatitis C|Combination of Alpha Interferon With Long Term Ribavirin Therapy for Patients With Chronic Hepatitis C|Completed||Phase 3|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.0174|2017-10-11 04:19:46.0174
NCT00001730|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1997||1997-12-01|November 1999|1999-11-01|April 2000||2000-04-01|||||Interventional|||Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.|A Dosimetry Study of Radioiodine (131-I) Uptake Following the Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal|Completed||Phase 4|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.155806|2017-10-11 04:19:46.155806
NCT00001731|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|October 1999|1999-10-01|October 2000||2000-10-01|||||Interventional|||Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops|A Double-Masked, Randomized, Vehicle-Controlled Pilot Study of the Treatment of Keratoconjunctivitis Sicca With Topical Cyclosporin A 0.1% Emulsion|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.275556|2017-10-11 04:19:46.275556
NCT00001732|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 25, 1998||1998-02-25|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Observational|||Screening for Studies on Inherited Eye Diseases|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Inherited Ophthalmic Diseases|Completed||N/A|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.39129|2017-10-11 04:19:46.39129
NCT00001733|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 6, 1998||1998-03-06|July 2, 2008|2008-07-02|July 2, 2008||2008-07-02|||||Observational|||Screening for Studies on Retinovascular Diseases|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.473767|2017-10-11 04:19:46.473767
NCT00001734|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 23, 1998||1998-03-23|October 3, 2008|2008-10-03|October 3, 2008||2008-10-03|||||Observational|||Screening for NEI Clinical Studies|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Ocular Inflammatory or Immunologic Diseases|Completed||N/A|3000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.56126|2017-10-11 04:19:46.56126
NCT00001735|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|March 2000|2000-03-01|October 2000||2000-10-01|||||Interventional|||Gene Therapy for Gyrate Atrophy|Phase I Study in the Safety and Efficacy of Transduced Keratinocytes for Possible Treatment of Gyrate Atrophy|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.647495|2017-10-11 04:19:46.647495
NCT00001736|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1998||1998-05-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Interventional|||New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis|Safety and Efficacy Trial of a Proposed NDA Formulation of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis|Completed||Phase 1|51||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.7343|2017-10-11 04:19:46.7343
NCT00001737|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1998||1998-05-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Interventional|||Cyclosporin Implant to Treat Uveitis|A Pilot Study of a Sustained-Release Cyclosporine A Implant for Uveitis|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.82468|2017-10-11 04:19:46.82468
NCT00001738|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1998||1998-08-01|August 1999|1999-08-01|June 2000||2000-06-01|||||Observational|||Vascular Endothelial Growth Factor (VEGF) in Uveitis|A Pilot Study to Demonstrate the Presence of Vascular Endothelial Growth Factor (VEGF) in Uveitic Cystoid Macular Edema|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:46.937443|2017-10-11 04:19:46.937443
NCT00001740|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Observational|||Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional Echocardiography|Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional Echocardiography|Completed||N/A|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.02617|2017-10-11 04:19:47.02617
NCT00001741|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Study of Inherited Changes of Receptors Located on Blood Vessels|Study of Vascular Responsiveness in Subjects With Polymorphisms of the Angiotensin II Type I Receptor Gene|Completed||Phase 1|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.095959|2017-10-11 04:19:47.095959
NCT00001742|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Observational|||The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients|The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.166573|2017-10-11 04:19:47.166573
NCT00001746|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||April 1998||1998-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Screening for Inherited Heart Disease|Evaluation of Patients With Known or Suspected Inherited Heart Disease (Screening Protocol)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.230526|2017-10-11 04:19:47.230526
NCT00001747|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1998||1998-05-01|May 2000|2000-05-01|March 2001||2001-03-01|||||Observational|||Racial Differences in Control of Blood Vessel Tone and Blood Flow|Racial Differences in Flow Mediated Vasodilator Function|Completed||N/A|108||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.30272|2017-10-11 04:19:47.30272
NCT00001748|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|August 1999|1999-08-01|May 2000||2000-05-01|||||Interventional|||HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies|HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies|Completed||Phase 1|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.39071|2017-10-11 04:19:47.39071
NCT00001749|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Medical Treatment for Diamond Blackfan Anemia|Treatment of Diamond Blackfan Anemia With Antithymocyte Globulin and Cyclosporine A|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.477302|2017-10-11 04:19:47.477302
NCT00001750|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||Comparing Treatments for Multiple Myeloma|Randomized Trial of Autologous Transplantation With Filgrastim Versus Stem Cell Factor/Filgrastim-Primed CD34-Enriched Peripheral Blood Cells for Multiple Myeloma|Completed||Phase 2|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.547589|2017-10-11 04:19:47.547589
NCT00001752|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|August 1999|1999-08-01|July 2000||2000-07-01|||||Interventional|||Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women|Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.622097|2017-10-11 04:19:47.622097
NCT00001753|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|August 1999|1999-08-01|November 2000||2000-11-01|||||Interventional|||Study of the Effects of Temperature on Metabolism in Human Muscle|Study of Temperature Effects on Skeletal Muscle Aerobic Energy Metabolism|Completed||Phase 1|17||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.70146|2017-10-11 04:19:47.70146
NCT00001754|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|June 2000|2000-06-01|May 2001||2001-05-01|||||Observational|||Study of Skeletal Disorders and Short Stature|Clinical and Molecular Manifestations of Human Skeletal Dysplasias and Short Stature|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.759583|2017-10-11 04:19:47.759583
NCT00001756|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||November 5, 1997||1997-11-05|August 8, 2017|2017-08-08||||||||Observational|||Study of Mast Cell Precursors|The Characterization of CD34+ Derived Mast Cell Precursors Mobilized by Administration of Granulocyte Colony Stimulating Factor and Plerixafor|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.817334|2017-10-11 04:19:47.817334
NCT00001757|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|December 1999|1999-12-01|July 2000||2000-07-01|||||Interventional|||An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections|An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections|Completed||Phase 3|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.897426|2017-10-11 04:19:47.897426
NCT00001758|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz|Continued Salvage Anti-Retroviral Therapy With Abacavir, Amprenavir, and Efavirenz|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:47.949332|2017-10-11 04:19:47.949332
NCT00001759|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1997||1997-12-01|February 2000|2000-02-01|January 2001||2001-01-01|||||Observational|||Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography|Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography|Completed||N/A|95||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.021435|2017-10-11 04:19:48.021435
NCT00001760|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2007-12-12|||January 1998||1998-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals|Determination of Cytokine Production Patterns in the Skin of Patients With Systemic Mastocytosis and Atopic Dermatitis Using the Suction Blister Technique|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.078338|2017-10-11 04:19:48.078338
NCT00001898|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||June 29, 1999||1999-06-29|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Observational|||Microarray Analysis for Human Genetic Disease|Microarray Analysis for Human Genetic Disease|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.136644|2017-10-11 04:19:48.136644
NCT00001899|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||December 16, 1998||1998-12-16|April 8, 2013|2013-04-08|April 8, 2013||2013-04-08|||||Observational|||Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy|Immunologic and Virologic Characterization of HIV-Infected Patients After Cessation of Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.202118|2017-10-11 04:19:48.202118
NCT00001901|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Etanercept to Treat Wegener's Granulomatosis|Phase I/II Trial of TNFR:Fc (Etanercept) in Patients With Wegener's Granulomatosis|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.258813|2017-10-11 04:19:48.258813
NCT00001903|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|March 2000|2000-03-01|May 2001||2001-05-01|||||Interventional|||Prevention of RSV Infections in Bone Marrow Transplant Recipients|Prevention of RSV Infections in Bone Marrow Transplant Recipients|Completed||Phase 4|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.319187|2017-10-11 04:19:48.319187
NCT00001904|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|January 2000|2000-01-01|September 2000||2000-09-01|||||Observational|||Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness|Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.374373|2017-10-11 04:19:48.374373
NCT00001905|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I|Interferon Gamma Administration in Leukocyte Adhesion Deficiency Type I|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.419362|2017-10-11 04:19:48.419362
NCT00001906|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2000|2000-04-01|May 2001||2001-05-01|||||Interventional|||Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants|Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.510321|2017-10-11 04:19:48.510321
NCT00001908|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1999||1999-06-01|July 2001|2001-07-01|July 2001||2001-07-01|||||Observational|||T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma|T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.568933|2017-10-11 04:19:48.568933
NCT00001909|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|May 1999|1999-05-01|May 2000||2000-05-01|||||Interventional|||Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma|Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.616975|2017-10-11 04:19:48.616975
NCT00001910|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Observational|||Mechanisms of Allergen Immunotherapy|Immunologic Mechanism of Allergen Immunotherapy|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.666819|2017-10-11 04:19:48.666819
NCT00001911|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Interventional|||Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections|Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.720389|2017-10-11 04:19:48.720389
NCT00001912|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 10, 1999||1999-08-10|April 4, 2012|2012-04-04|April 4, 2012||2012-04-04|||||Observational|||Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis|Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis|Completed||N/A|6|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.777135|2017-10-11 04:19:48.777135
NCT00001913|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1998||1998-10-01|October 2003|2003-10-01|October 2003||2003-10-01|||||Observational|||The Impact of Familiarity and Emotional Attachment on the Visual Processing of Faces|The Impact of Familiarity and Emotional Attachment on the Visual Processing of Faces|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.834045|2017-10-11 04:19:48.834045
NCT00001915|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation|Cortical Correlates of Subtle Motor Signs in Attention-Deficit/Hyperactivity Disorder and Healthy Controls|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.879811|2017-10-11 04:19:48.879811
NCT00001916|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 1999|1999-02-01|August 2000||2000-08-01|||||Observational|||Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in Depression|Bone Biopsy for Histomorphometry and Analysis of Bone Marrow Derived Osteoblast and Osteoclast Progenitors to Explore Mechanisms of Decreased Bone Mineral Density in Depression|Completed||N/A|17||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.937375|2017-10-11 04:19:48.937375
NCT00001917|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Brain Imaging in Elderly People and Individuals With Alzheimer's Disease|M2 Receptor Measurements in Aging and in Alzheimer's Disease|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:48.990005|2017-10-11 04:19:48.990005
NCT00001918|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|June 1999|1999-06-01|August 2000||2000-08-01|||||Observational|||L-5-HTP-Related EMS|L-5-Hydroxy-Tryptophan-Related Eosinophilia-Myalgia Syndrome (EMS): Clinical Patient Evaluation|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:49.044513|2017-10-11 04:19:49.044513
NCT00001919|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1999||1999-09-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects|Serotonin Transporter Availability and Mood State in Normal Volunteers Taking Hypericum Perforatum (St. John's Wort)|Completed||N/A|13||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:49.097601|2017-10-11 04:19:49.097601
NCT00001920|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 30, 1999||1999-08-30|June 2, 2010|2010-06-02|June 2, 2010||2010-06-02|||||Observational|||Eye Blink Response in Healthy Volunteers and Adults With Schizophrenia|Investigation of Brain Function During Eyeblink Responding in Normal Volunteers and Patients With Schizophrenia (A Study of Behavior and Evoked Potentials)|Completed||N/A|112|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:49.150602|2017-10-11 04:19:49.150602
NCT00001921|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||September 20, 1999||1999-09-20|June 7, 2017|2017-06-07||||||||Observational|||Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings|Integrating EEG/MEG and fMRI: Activity Correlation Between Frontal and Temporal Lobe Structures in Schizophrenic Patients, Their Siblings and Unrelated Normal Volunteers|Enrolling by invitation||N/A|1376|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:49.211321|2017-10-11 04:19:49.211321
NCT00001922|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||November 5, 1998||1998-11-05|September 14, 2009|2009-09-14||||September 14, 2009|Actual|2009-09-14||Observational|||Sensory Function in Idiopathic Voice Disorders|Sensory Function in Idiopathic Voice Disorders|Completed||N/A|370||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:50.566386|2017-10-11 04:19:50.566386
NCT00001923|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1998||1998-12-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Transcranial Magnetic Stimulation for the Treatment of Phantom Pain|Phantom Pain: A Therapeutic Trial Using Transcranial Magnetic Stimulation|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:50.62581|2017-10-11 04:19:50.62581
NCT00001925|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Effect of Alcohol on Tremors|Effect of Alcohol on Physiologic and Pathologic Tremors|Completed||Phase 2|23||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:50.679585|2017-10-11 04:19:50.679585
NCT00001926|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||The Connection Between Areas in the Brain of Blind Patients|Connectivity of Occipital and Somatosensory Cortical Areas in Blind Subjects|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:50.748749|2017-10-11 04:19:50.748749
NCT00001927|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 22, 1999||1999-02-22|May 4, 2011|2011-05-04|May 4, 2011||2011-05-04|||||Observational|||Study of Abnormal Blood Clotting in Children With Stroke|Study of Abnormal Acquired and Genetic Coagulation Factors in Children With Porencephaly and Stroke|Completed||N/A|130|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:50.822116|2017-10-11 04:19:50.822116
NCT00001928|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|March 1999|1999-03-01|July 2000||2000-07-01|||||Observational|||Intravenous Levodopa for the Diagnosis of Parkinson's Disease|Intravenous Levodopa in Parkinsonism|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:50.887983|2017-10-11 04:19:50.887983
NCT00001929|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||Treatment of Parkinson's Disease With Eliprodil|NMDA-Receptor Blockade With Eliprodil in Parkinson's Disease|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:50.957452|2017-10-11 04:19:50.957452
NCT00001930|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2000|2000-04-01|February 2001||2001-02-01|||||Interventional|||Treatment of Huntington's Chorea With Amantadine|NMDA-Receptor Blockade in Huntington's Chorea|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:51.031776|2017-10-11 04:19:51.031776
NCT00001931|ClinicalTrials.gov processed this data on October 10, 2017|2007-07-31|2008-03-03|||May 1999||1999-05-01|June 2000|2000-06-01|January 2001||2001-01-01|||||Interventional|||Treatment of Parkinson's Disease With a Transdermal Skin Patch|Transdermal Application of Dopamine Agonist N-0923 in Parkinson's Disease|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:51.120445|2017-10-11 04:19:51.120445
NCT00001932|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||June 21, 1999||1999-06-21|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Observational|||Serotonin Receptors in Seizure Disorders|PET Imaging of Serotonin Receptors in Seizure Disorders|Completed||N/A|95||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:51.188116|2017-10-11 04:19:51.188116
NCT00001934|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2011-08-04|||September 1999||1999-09-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|August 2005|Actual|2005-08-01||Interventional|||Zenapax to Treat Multiple Sclerosis|Effect of the Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (IL-2R-Alpha; Zenapax(Registered Trademark)) on Inflammatory Activity in the CNS in MS in a Baseline-to-Treatment, Cross-Over, MRI-Controlled Single Center Phase I/II Trial|Completed||Phase 2|22|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:51.315637|2017-10-11 04:19:51.315637
NCT00001936|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||September 28, 1999||1999-09-28|August 18, 2009|2009-08-18||||August 18, 2009|Actual|2009-08-18||Observational|||Electrical Muscle Stimulation to Aid Swallowing in Dysphagia|Feasibility of Neuromuscular Stimulation for Laryngeal Elevation During Swallowing|Completed||N/A|155||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:51.378121|2017-10-11 04:19:51.378121
NCT00001937|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|November 1999|1999-11-01|December 2000||2000-12-01|||||Interventional|||Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients|A Phase III, Randomized, Double-Blind, Comparative Trial of FK463 Versus Fluconazole for Prophylaxis of Fungal Infections in Patients Undergoing a Hematopoetic Stem Cell Transplant|Completed||Phase 3|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:51.542945|2017-10-11 04:19:51.542945
NCT00001938|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2017-10-05|||November 16, 1999||1999-11-16|May 22, 2017|2017-05-22||||||||Observational|||A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)|A Pilot Study of Proteomic Evaluation of Epithelial Ovarian Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile Associated With Relapse|Completed||N/A|26|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:51.617967|2017-10-11 04:19:51.617967
NCT00001940|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|November 2000|2000-11-01|July 2001||2001-07-01|||||Interventional|||Voriconazole to Treat Fungal Infections|An Open Label, Non-Comparative, Multi-Center Phase III Trial of the Efficacy, Safety, and Toleration of Extended Voriconazole in the Treatment of Invasive Fungal Infections|Completed||Phase 3|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:51.692153|2017-10-11 04:19:51.692153
NCT00001941|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2012-08-13|2012-04-23||December 1999||1999-12-01|August 2012|2012-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Anti-Tac for Treatment of Leukemia|A Phase I/II Study of the Efficacy and Toxicity of Humanized Anti-Tac (Zenapax(Trademark)) in the Therapy of Tac-Expressing Adult T-Cell Leukemia|Completed||Phase 1/Phase 2|34|Actual|National Institutes of Health Clinical Center (CC)|Study was closed to accrual since the cessation of the production of daclizumab.|5|||f||||f||||||||||2017-10-11 04:19:51.774524|2017-10-11 04:19:51.774524
NCT00001944|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|December 2000|2000-12-01|June 2001||2001-06-01|||||Interventional|||Vinorelbine and XR9576 to Treat Cancer|A Clinical Trial of the P-Glycoprotein Antagonist, XR9576, in Combination With Vinorelbine in Patients With Cancer: Analysis of the Interaction Between XR9576 and Vinorelbine|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.139337|2017-10-11 04:19:52.139337
NCT00001946|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Interventional|||Comparison of Magnetic Resonance Angiography and Standard Angiography in Diagnosing Atherosclerosis|A Comparison of Contrast Enhanced Magnetic Resonance Angiography (MRA) and Conventional Angiography in the Diagnosis of Atherosclerotic Disease: A Pilot Study|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.207979|2017-10-11 04:19:52.207979
NCT00001948|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|February 2002|2002-02-01|February 2002||2002-02-01|||||Observational|||A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy|A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.271192|2017-10-11 04:19:52.271192
NCT00001950|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2017-10-05|||December 14, 1999||1999-12-14|May 23, 2012|2012-05-23|May 23, 2012||2012-05-23|||||Observational|||The Development of Categorization|The Development of Categorization|Completed||N/A|219|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.334895|2017-10-11 04:19:52.334895
NCT00001951|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2007-02-24|||December 1999||1999-12-01|October 2006|2006-10-01|October 2006||2006-10-01|||||Interventional|||Hormone Replacement in Young Women With Premature Ovarian Failure|Hormone Replacement in Young Women With Premature Ovarian Failure|Completed||Phase 2|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.400492|2017-10-11 04:19:52.400492
NCT00001952|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Observational|||Using a Narcotic to Enhance the Numbing Effect of the Local Anesthetic Lidocaine on Inflamed Molar Teeth|Analgesic Effects of Peripherally Administered Opioids in a Clinical Model of Chronic Inflammation|Completed||N/A|275||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.472373|2017-10-11 04:19:52.472373
NCT00001953|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers|Basal and Stimulated Somatostatin Plasma Levels in Patients With Primary Sjogren's Syndrome and in Control Subjects|Completed||N/A|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.527767|2017-10-11 04:19:52.527767
NCT00001954|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Etanercept Therapy for Sjogren's Syndrome|Etanercept Therapy for Sjogren's Syndrome|Completed||Phase 2|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.588325|2017-10-11 04:19:52.588325
NCT00001955|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)|The Role of Cytokines as Inflammatory Mediators in Painful Temporomandibular Joints|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.645015|2017-10-11 04:19:52.645015
NCT00001956|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2006-06-29|||January 2000||2000-01-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Influence of Genetics in Pain Sensitivity||Completed||Phase 2|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.702307|2017-10-11 04:19:52.702307
NCT00001957|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||Testing a Possible Cause of Reduced Ability of Children to Process Speech in Noise|TEOAE Suppression in Children With Auditory Processing Difficulty|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.774318|2017-10-11 04:19:52.774318
NCT00001958|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|February 2002|2002-02-01|February 2002||2002-02-01|||||Interventional|||Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)|Effect of Hydroxyurea on the Level of Ineffective Erythropoiesis, Transfusion Requirement, and Fetal Hemoglobin Synthesis in Patients With Beta-Thalassemia-Intermedia|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:52.829825|2017-10-11 04:19:52.829825
NCT00001959|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2014-05-16|2010-06-16||December 1999||1999-12-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)|Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study|Completed||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)|No control group, measurement imprecision, results may not applicable to all patients with FSGS, needs histologic evidence to support our findings, Optimal dosage needs to be identified.|1|||f||||f||||||||||2017-10-11 04:19:52.894962|2017-10-11 04:19:52.894962
NCT00001960|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart Muscle|Controlled Cross-Over Study of DDD Pacemaker Therapy in Symptomatic Children With Obstructive Hypertrophic Cardiomyopathy|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:53.257704|2017-10-11 04:19:53.257704
NCT00001961|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||MRI Evaluation of Chest Pain|MRI Evaluation of Chest Pain Compatible With Myocardial Ischemia|Completed||Phase 2|360||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:53.317661|2017-10-11 04:19:53.317661
NCT00001962|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2015-04-28|2011-04-20||November 1999||1999-11-01|April 2015|2015-04-01|September 2010|Actual|2010-09-01|August 2009|Actual|2009-08-01||Interventional|||A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure|A Pilot Study of Recombinant Humanized Anti-Interleukin (IL-2) Receptor Antibody (Daclizumab) in Patients With Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia|Terminated||Phase 2|100|Actual|National Institutes of Health Clinical Center (CC)||1||DSMB recommended closing the study and publishing the results|f||||t||||||||||2017-10-11 04:19:53.416137|2017-10-11 04:19:53.416137
NCT00001963|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects|Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects|Completed||Phase 1|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:53.762844|2017-10-11 04:19:53.762844
NCT00001964|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2017-06-30|||December 1, 1999||1999-12-01|April 26, 2017|2017-04-26|May 12, 2015|Actual|2015-05-12|December 9, 2003|Actual|2003-12-09||Interventional|||Combination Therapy of Severe Aplastic Anemia|Treatment of Severe Aplastic Anemia With Combined Immunosuppression: Antithymocyte Globulin (ATG) and Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF)|Completed||Phase 2|104|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:19:53.825563|2017-10-11 04:19:53.825563
NCT00001965|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|November 1999|1999-11-01|February 2001||2001-02-01|||||Interventional|||Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)|Double Blind Placebo Controlled Study of Cyclosporin A in Patients With Left Ventricular Hypertrophy Caused by Sarcomeric Gene Mutations|Completed||Phase 2|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:53.901891|2017-10-11 04:19:53.901891
NCT00001966|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||January 2000||2000-01-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome|A Pilot Study of Mind-Body Therapy for Chronic Pain in Ehlers-Danlos Syndrome|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:53.979934|2017-10-11 04:19:53.979934
NCT00001967|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Interventional|||Intermittent Versus Continuous Medication in the Treatment of HIV|Immunologic and Virologic Studies of Intermittent Versus Continuous HAART in the Treatment of HIV Disease|Completed||Phase 4|123||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.05137|2017-10-11 04:19:54.05137
NCT00001968|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||January 2000||2000-01-01|December 1999|1999-12-01|November 2000||2000-11-01|||||Interventional|||Once-Daily Drug Regimen for HIV-Infected Patients|A Pilot Study of Once-Daily Therapy With Amprenavir, Ritonavir, Lamivudine and Abacavir in HIV-Infected, Antiretroviral-Naive Patients|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.117792|2017-10-11 04:19:54.117792
NCT00001969|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2017-06-30|||December 30, 1999||1999-12-30|January 19, 2007|2007-01-19|January 19, 2007||2007-01-19|||||Observational|||Heart Disease Risk Factors in Major Depression|Factors in Susceptibility to Ischemic Heart Disease in Major Depression: Documentation of Insulin Resistance in Patients With Major Depression Utilizing the Hyperinsulinemic Euglycemic Glucose Clamp|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.186095|2017-10-11 04:19:54.186095
NCT00001971|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-12|2017-10-03|||September 9, 1991||1991-09-09|September 26, 2017|2017-09-26||||||||Observational|||Evaluation of Patients With Liver Disease|Evaluation of Patients With Liver Disease|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.27202|2017-10-11 04:19:54.27202
NCT00001972|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2008-03-03|||September 1994||1994-09-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||PET Scan of Brain Metabolism in Relation to Age and Disease|Positron Emission Tomography Imaging of Human Brain Phospholipid Metabolism in Relation to Age and Disease|Completed||N/A|123||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.361627|2017-10-11 04:19:54.361627
NCT00001973|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-18|2017-06-30|||December 18, 1996||1996-12-18|December 12, 2008|2008-12-12|December 12, 2008||2008-12-12|||||Observational|||Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome|Studies on Tissues From Patients With Fibrous Dysplasia of Bone/McCune-Albright Syndrome and Other Disorders of Calcified Tissues|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.43004|2017-10-11 04:19:54.43004
NCT00001976|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-20|2008-03-03|||January 2000||2000-01-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection|CMV Real-Time PCR Versus PP65 Antigenemia in Diagnosing Cytomegalovirus Disease in Hematopoietic Stem Cell Transplant Patients|Completed||N/A|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.577919|2017-10-11 04:19:54.577919
NCT00001977|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-20|2008-03-03|||January 2000||2000-01-01|January 2000|2000-01-01|April 2001||2001-04-01|||||Observational|||The Effect of Acetylcholine on Memory and Attention|Cholinergic Modulation of Human Memory and Attention: Functional Neuroimaging Studies|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.639839|2017-10-11 04:19:54.639839
NCT00001978|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-20|2017-10-05|||August 24, 1989||1989-08-24|January 4, 2017|2017-01-04||||||||Observational|||Determination of Kidney Function|Determination of Glomerular Filtration Rate, Effective Renal Plasma Flow and Glomerular Capillary Wall Permselectivity|Recruiting||N/A|9999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.69619|2017-10-11 04:19:54.69619
NCT00001979|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-20|2017-08-04|||April 13, 1992||1992-04-13|July 24, 2017|2017-07-24||||||||Observational|||Immune System Related Kidney Disease|Studies of Immunologically-Mediated Kidney Diseases|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.767104|2017-10-11 04:19:54.767104
NCT00001981|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2017-06-30|||April 15, 1985||1985-04-15|April 24, 2017|2017-04-24||||||||Observational|||The Treatment and Natural History of Acromegaly|Acromegaly Treatment and Natural History|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.844528|2017-10-11 04:19:54.844528
NCT00001982|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2008-03-03|||June 1993||1993-06-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Observational|||History of Hepatitis C in Volunteer Blood Donors|Natural History of Chronic Hepatitis C Among Volunteer Blood Donors|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.904539|2017-10-11 04:19:54.904539
NCT00001983|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-26|2008-03-03|||January 2000||2000-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||Eligibility Screening for National Institute of Dental and Craniofacial Research Studies|Screening Protocol to Evaluate Patients for Approved Studies|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:54.950319|2017-10-11 04:19:54.950319
NCT00001984|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-26|2016-09-22|2010-09-13||November 1999||1999-11-01|September 2016|2016-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys|Tolerance Induction Following Human Renal Transplantation Using Treatment With a Humanized Monoclonal Antibody Against CD52 (Campath-1H)|Completed||Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:19:55.011565|2017-10-11 04:19:55.011565
NCT00001985|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-26|2008-03-04|||January 2000||2000-01-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus|Multi-Center Study to Determine Whether CD 152 Gene Polymorphisms Associated With Susceptibility to Type-1-Diabetes Mellitus (T1DM) Correspond With Abnormalities in T Cell Function|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:55.269984|2017-10-11 04:19:55.269984
NCT00001986|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2008-03-03|||January 2000||2000-01-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||1-Octanol to Treat Essential Tremor|Double-Blind, Placebo-Controlled, Single-Dose Trial of 1-Octanol in Essential Tremor|Completed||Phase 1|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:55.339132|2017-10-11 04:19:55.339132
NCT00001987|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2017-09-12|||January 30, 1976||1976-01-30|August 30, 2017|2017-08-30||||||||Observational|||Genetic Studies of Insulin and Diabetes|Natural History of Disorders of Insulin Resistance|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:19:55.429686|2017-10-11 04:19:55.429686
NCT00001989|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1992|1992-10-01||||||||Interventional|||A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin|A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:55.514034|2017-10-11 04:19:55.514034
NCT00001990|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1993|1993-04-01||||||||Interventional|||An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine|An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:55.595317|2017-10-11 04:19:55.595317
NCT00001991|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2003|2003-04-01||||||||Interventional|||A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia|A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:55.760035|2017-10-11 04:19:55.760035
NCT00001992|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1992|1992-08-01||||||||Interventional|||A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers|A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:55.816883|2017-10-11 04:19:55.816883
NCT00001993|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1992|1992-02-01||||||||Interventional|||Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3|Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3|Completed||Phase 2|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:55.876129|2017-10-11 04:19:55.876129
NCT00002008|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1989|1989-01-01||||||||Interventional|||An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia|An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.003412|2017-10-11 04:19:57.003412
NCT00001994|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1992|1992-03-01||||||||Interventional|||A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine|A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:55.941942|2017-10-11 04:19:55.941942
NCT00001995|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1992|1992-11-01||||||||Interventional|||A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS|A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS|Completed||N/A|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.049098|2017-10-11 04:19:56.049098
NCT00001996|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1992|1992-05-01||||||||Interventional|||A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole|A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.152165|2017-10-11 04:19:56.152165
NCT00001997|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1991|1991-07-01||||||||Interventional|||Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals|Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.247251|2017-10-11 04:19:56.247251
NCT00001998|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1992|1992-11-01||||||||Interventional|||Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)|Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.310814|2017-10-11 04:19:56.310814
NCT00001999|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1993|1993-04-01||||||||Interventional|||A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS|A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.380895|2017-10-11 04:19:56.380895
NCT00002000|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients|A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.454405|2017-10-11 04:19:56.454405
NCT00002001|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1991|1991-09-01||||||||Interventional|||The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease|The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.55782|2017-10-11 04:19:56.55782
NCT00002002|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1992|1992-07-01||||||||Interventional|||A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome|A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.633408|2017-10-11 04:19:56.633408
NCT00002003|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1992|1992-03-01||||||||Interventional|||Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas|Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.696917|2017-10-11 04:19:56.696917
NCT00002004|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex|A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.761286|2017-10-11 04:19:56.761286
NCT00002005|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex|A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.815699|2017-10-11 04:19:56.815699
NCT00002006|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility|A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.874786|2017-10-11 04:19:56.874786
NCT00002007|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia|A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:56.936213|2017-10-11 04:19:56.936213
NCT00002009|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1988|1988-06-01||||||||Interventional|||A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia|A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.062785|2017-10-11 04:19:57.062785
NCT00002010|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1992|1992-02-01||||||||Interventional|||Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis|Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.123063|2017-10-11 04:19:57.123063
NCT00002011|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1990|1990-07-01||||||||Interventional|||The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex|The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.185135|2017-10-11 04:19:57.185135
NCT00002012|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients|Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients|Completed||N/A|45||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.236078|2017-10-11 04:19:57.236078
NCT00002013|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1990|1990-12-01||||||||Interventional|||A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients|A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.289209|2017-10-11 04:19:57.289209
NCT00002014|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)|A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.349417|2017-10-11 04:19:57.349417
NCT00002015|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children|An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children|Completed||N/A|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.412816|2017-10-11 04:19:57.412816
NCT00002016|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1993|1993-04-01||||||||Interventional|||A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis|A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.471188|2017-10-11 04:19:57.471188
NCT00002017|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2|Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.54331|2017-10-11 04:19:57.54331
NCT00002018|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects|Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.600214|2017-10-11 04:19:57.600214
NCT00002019|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome|Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.66305|2017-10-11 04:19:57.66305
NCT00002020|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1992|1992-02-01||||||||Interventional|||Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC|Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.772475|2017-10-11 04:19:57.772475
NCT00002021|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1990|1990-10-01||||||||Interventional|||An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies|An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.848059|2017-10-11 04:19:57.848059
NCT00002022|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1991|1991-02-01||||||||Interventional|||Treatment Program for Anemia in AIDS Patients|Treatment Program for Anemia in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:57.918383|2017-10-11 04:19:57.918383
NCT00002023|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2|An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.000056|2017-10-11 04:19:58.000056
NCT00002024|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections|Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.067695|2017-10-11 04:19:58.067695
NCT00002025|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient|Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.160728|2017-10-11 04:19:58.160728
NCT00002026|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1990|1990-05-01||||||||Interventional|||Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)|Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.237529|2017-10-11 04:19:58.237529
NCT00002027|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1990|1990-06-01||||||||Interventional|||Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)|Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.314125|2017-10-11 04:19:58.314125
NCT00002028|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-08-15||||||August 2007|2007-08-01||||||||Interventional|||A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)|A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:19:58.501183|2017-10-11 04:19:58.501183
NCT00002029|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent|Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent|Completed||N/A|||Abbott|||||f||||||||||||||2017-10-11 04:19:58.570444|2017-10-11 04:19:58.570444
NCT00002030|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1989|1989-11-01||||||||Interventional|||An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients|An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.642743|2017-10-11 04:19:58.642743
NCT00002031|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)|Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.714455|2017-10-11 04:19:58.714455
NCT00002032|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1992|1992-01-01||||||||Interventional|||Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial|Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial|Completed||N/A|750||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.773049|2017-10-11 04:19:58.773049
NCT00002033|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1991|1991-02-01||||||||Interventional|||A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease|A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.916228|2017-10-11 04:19:58.916228
NCT00002034|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1992|1992-01-01||||||||Interventional|||A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS|A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS|Completed||N/A|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:58.984316|2017-10-11 04:19:58.984316
NCT00002035|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-08-04||||||August 2011|2011-08-01|April 1992|Actual|1992-04-01|||||Interventional|||Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine|Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine|Completed||N/A|300||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:19:59.064082|2017-10-11 04:19:59.064082
NCT00002036|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)|Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)|Completed||Phase 1|12||Abbott|||||f||||||||||||||2017-10-11 04:19:59.169342|2017-10-11 04:19:59.169342
NCT00002037|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1991|1991-05-01||||||||Interventional|||Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study|Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study|Completed||N/A|15||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.240349|2017-10-11 04:19:59.240349
NCT00002038|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1996|1996-06-01||||||||Interventional|||Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy|Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.309219|2017-10-11 04:19:59.309219
NCT00002039|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1991|1991-03-01||||||||Interventional|||An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients|An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.373709|2017-10-11 04:19:59.373709
NCT00002040|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.436749|2017-10-11 04:19:59.436749
NCT00002041|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients|Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:19:59.508699|2017-10-11 04:19:59.508699
NCT00002042|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.581022|2017-10-11 04:19:59.581022
NCT00002043|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)|Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.640531|2017-10-11 04:19:59.640531
NCT00002044|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases|A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.703231|2017-10-11 04:19:59.703231
NCT00002045|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Prospective Double-Blind Study of Retrovir in Early HIV Infection|A Prospective Double-Blind Study of Retrovir in Early HIV Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.774509|2017-10-11 04:19:59.774509
NCT00002046|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1990|1990-05-01||||||||Interventional|||A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC|A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.838056|2017-10-11 04:19:59.838056
NCT00002047|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1990|1990-05-01||||||||Interventional|||Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure|Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:19:59.953166|2017-10-11 04:19:59.953166
NCT00002048|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)|The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.051508|2017-10-11 04:20:00.051508
NCT00002049|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.144849|2017-10-11 04:20:00.144849
NCT00002050|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.213419|2017-10-11 04:20:00.213419
NCT00002051|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1989|1989-11-01||||||||Interventional|||Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.272605|2017-10-11 04:20:00.272605
NCT00002052|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients|Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.331907|2017-10-11 04:20:00.331907
NCT00002053|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1989|1989-10-01||||||||Interventional|||A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP|A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.415508|2017-10-11 04:20:00.415508
NCT00002054|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1989|1989-10-01||||||||Interventional|||A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients|A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.47404|2017-10-11 04:20:00.47404
NCT00002055|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP|A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.530755|2017-10-11 04:20:00.530755
NCT00001184|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||November 12, 1982||1982-11-12|July 12, 2017|2017-07-12||||||||Observational|||Immune Regulation in Ulcerative Colitis or Crohn s Disease|Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.233367|2017-10-11 04:20:08.233367
NCT00002056|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS|A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.60419|2017-10-11 04:20:00.60419
NCT00002057|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC|Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC|Completed||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:00.677349|2017-10-11 04:20:00.677349
NCT00002058|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1990|1990-12-01||||||||Interventional|||A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease|A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.740161|2017-10-11 04:20:00.740161
NCT00002059|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers|A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.80952|2017-10-11 04:20:00.80952
NCT00002060|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)|A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.861421|2017-10-11 04:20:00.861421
NCT00002061|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy|A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.930522|2017-10-11 04:20:00.930522
NCT00002062|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1991|1991-10-01||||||||Interventional|||"Open-Label Compassionate Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients"|"Open-Label Compassionate Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients"|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:00.998286|2017-10-11 04:20:00.998286
NCT00002063|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)|Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.054814|2017-10-11 04:20:01.054814
NCT00002064|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse|Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.124576|2017-10-11 04:20:01.124576
NCT00002065|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Depot Disulfiram for AIDS and ARC|Depot Disulfiram for AIDS and ARC|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.182682|2017-10-11 04:20:01.182682
NCT00002066|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1989|1989-11-01||||||||Interventional|||Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.267119|2017-10-11 04:20:01.267119
NCT00002067|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia|Phase III Randomized Double-Blind Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia|Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:01.348692|2017-10-11 04:20:01.348692
NCT00002068|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.432776|2017-10-11 04:20:01.432776
NCT00002069|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1989|1989-07-01||||||||Interventional|||A Study of DTC in Patients With AIDS and AIDS Related Complex|A Study of DTC in Patients With AIDS and AIDS Related Complex|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.50398|2017-10-11 04:20:01.50398
NCT00002070|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1991|1991-05-01||||||||Interventional|||Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis|Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.575235|2017-10-11 04:20:01.575235
NCT00002071|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.67845|2017-10-11 04:20:01.67845
NCT00002072|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.772246|2017-10-11 04:20:01.772246
NCT00002073|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.830989|2017-10-11 04:20:01.830989
NCT00002074|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1990|1990-05-01||||||||Interventional|||Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome|Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:01.89267|2017-10-11 04:20:01.89267
NCT00002075|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.287213|2017-10-11 04:20:02.287213
NCT00002076|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.403386|2017-10-11 04:20:02.403386
NCT00002077|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.503764|2017-10-11 04:20:02.503764
NCT00002078|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1993|1993-11-01||||||||Interventional|||Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection|Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.609104|2017-10-11 04:20:02.609104
NCT00002079|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)|Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.687107|2017-10-11 04:20:02.687107
NCT00002080|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2003|2003-04-01||||||||Interventional|||Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study|Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.779815|2017-10-11 04:20:02.779815
NCT00002081|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1992|1992-06-01||||||||Interventional|||Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease|Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.847786|2017-10-11 04:20:02.847786
NCT00002082|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study|Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.914357|2017-10-11 04:20:02.914357
NCT00002083|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS|Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:02.984141|2017-10-11 04:20:02.984141
NCT00002084|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients|A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:03.073325|2017-10-11 04:20:03.073325
NCT00002085|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy|A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:03.870898|2017-10-11 04:20:03.870898
NCT00002086|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1993|1993-10-01||||||||Interventional|||A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection|A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection|Completed||Phase 2|256||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:03.958301|2017-10-11 04:20:03.958301
NCT00002087|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals|Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.057744|2017-10-11 04:20:04.057744
NCT00002088|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial|Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial|Completed||Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.128003|2017-10-11 04:20:04.128003
NCT00002089|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy|An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.197935|2017-10-11 04:20:04.197935
NCT00002090|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)|An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.261203|2017-10-11 04:20:04.261203
NCT00002091|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1993|1993-10-01||||||||Interventional|||An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent|An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.355897|2017-10-11 04:20:04.355897
NCT00002092|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection|A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.435204|2017-10-11 04:20:04.435204
NCT00002093|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.|A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.519536|2017-10-11 04:20:04.519536
NCT00002094|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1993|1993-02-01||||||||Interventional|||Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E|Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.640724|2017-10-11 04:20:04.640724
NCT00002095|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1993|1993-11-01||||||||Interventional|||A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus|A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus|Completed||N/A|700||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.710096|2017-10-11 04:20:04.710096
NCT00002096|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1993|1993-11-01||||||||Interventional|||A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine|A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine|Completed||Phase 1|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.815228|2017-10-11 04:20:04.815228
NCT00002097|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.|A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:04.928677|2017-10-11 04:20:04.928677
NCT00002098|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1995|1995-03-01||||||||Interventional|||Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients|Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients|Completed||Phase 1|50||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:05.006678|2017-10-11 04:20:05.006678
NCT00002099|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1994|1994-07-01||||||||Interventional|||Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients|Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients|Unknown status|Active, not recruiting|Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:05.109999|2017-10-11 04:20:05.109999
NCT00002100|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||Phase I/II Study of Curdlan Sulfate|Phase I/II Study of Curdlan Sulfate|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:05.202231|2017-10-11 04:20:05.202231
NCT00002101|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo|A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo|Completed||Phase 3|450||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:05.286788|2017-10-11 04:20:05.286788
NCT00002102|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1994|1994-01-01||||||||Interventional|||A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.|A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:05.455695|2017-10-11 04:20:05.455695
NCT00002103|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1994|1994-01-01||||||||Interventional|||A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia|A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:05.608829|2017-10-11 04:20:05.608829
NCT00001166|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1978||1978-01-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Gyrate Atrophy of the Choroid and Retina|The Diagnosis, Pathogenesis and Treatment of Gyrate Atrophy of the Choroid and Retina|Completed||N/A|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:05.672105|2017-10-11 04:20:05.672105
NCT00001167|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1979||1979-08-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Observational|||Ultrasound Evaluation of Tongue Movements in Speech and Swallowing|Exploration of the Diagnostic Capabilities of Ultrasound of the Oropharynx and Larynx|Completed||N/A|570||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:05.728371|2017-10-11 04:20:05.728371
NCT00001168|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||August 6, 1979||1979-08-06|May 4, 2017|2017-05-04||||||||Observational|||Evaluation of Lipoproteins|Teaching Protocol for the Evaluation of Plasma Lipoproteins|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:05.788799|2017-10-11 04:20:05.788799
NCT00001169|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1979||1979-12-01|February 2000|2000-02-01|February 2001||2001-02-01|||||Observational|||Clinical Investigation of Infections Due to Leishmanial Parasites|Clinical Investigation of Infections Due to Leishmanial Parasites|Completed||N/A|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:05.875473|2017-10-11 04:20:05.875473
NCT00001170|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1979||1979-10-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Observational|||Study of the Psychological Development of Children of Parents With and Without Affective Disorders|Affective Disorders and Affective Development: A Study of Child Rearing and Child Development in Normal Families and Families With Affective Disorders|Completed||N/A|1045||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:05.940007|2017-10-11 04:20:05.940007
NCT00001171|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1979||1979-07-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Evaluation of Factors in Human Brain Tumors|Evaluation of Biological, Immunological and Therapeutic Parameters in Brain Tumor Patients|Completed||N/A|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:05.997956|2017-10-11 04:20:05.997956
NCT00001172|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 26, 1980||1980-08-26|August 6, 2008|2008-08-06|August 6, 2008||2008-08-06|||||Observational|||Visual Stimulus and Eye Movement|Visual Motor Coordination in Man|Completed||N/A|225||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:06.070834|2017-10-11 04:20:06.070834
NCT00001173|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1980||1980-06-01|June 1999|1999-06-01|June 2000||2000-06-01|||||Observational|||Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization|Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:06.144317|2017-10-11 04:20:06.144317
NCT00001174|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-08-04|||August 4, 1980||1980-08-04|August 1, 2017|2017-08-01||||||||Observational|||Evaluation of the Genetics of Bipolar Disorder|Bipolar Genetics: A Collaborative Study|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:06.224427|2017-10-11 04:20:06.224427
NCT00001176|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1981||1981-05-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||Effects of Salt Intake on the Nervous Systems of Patients With Salt-Sensitive High Blood Pressure|The Function of Dopaminergic and Noradrenergic Systems in Salt-Sensitive Hypertension: The Effects of Changes in Sodium Intake|Completed||N/A|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:06.316419|2017-10-11 04:20:06.316419
NCT00001177|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-07-18|||August 24, 1981||1981-08-24|July 7, 2017|2017-07-07||||||||Observational|||Study of Premenstrual Syndrome and Premenstrual Dysphoria|The Evaluation of Women With Menstrually Regulated Mood and Behavioral Disorders|Recruiting||N/A|1600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:06.394563|2017-10-11 04:20:06.394563
NCT00001178|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 19, 1981||1981-01-19|December 17, 2012|2012-12-17|December 17, 2012||2012-12-17|||||Observational|||Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders|Regional Cerebral Utilization of Glucose in Patients With a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders|Terminated||N/A|597|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:06.494316|2017-10-11 04:20:06.494316
NCT00001180|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1982||1982-03-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency|Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency|Completed||N/A|2250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:07.956169|2017-10-11 04:20:07.956169
NCT00001181|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1982||1982-10-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Interventional|||Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty|Testolactone Treatment of Girls With LHRH Analog-Resistant Precocious Puberty Due to Autonomous, Non-Neoplastic Ovarian Estrogen Secretion|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.032764|2017-10-11 04:20:08.032764
NCT00001182|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1982||1982-04-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Evaluation of Patients With Unusual Diagnostic or Treatment Considerations|General Dental Diagnostic and Therapeutic Study: A Pilot Program for Evaluating the Research Potential of Referred Subjects|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.101336|2017-10-11 04:20:08.101336
NCT00001186|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 8, 1983||1983-02-08|December 8, 2016|2016-12-08||||||||Observational|||Psychological Benefits of a Normalized Camping Experience for Children With Cancer|Psychological Benefits of a Normalized Camping Experience for Children With Cancer|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.386935|2017-10-11 04:20:08.386935
NCT00001188|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1983||1983-12-01|November 1999|1999-11-01|September 2000||2000-09-01|||||Interventional|||The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities|The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.464529|2017-10-11 04:20:08.464529
NCT00001189|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1983||1983-12-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Interventional|||The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors|The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.527156|2017-10-11 04:20:08.527156
NCT00001190|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1983||1983-11-01|October 2001|2001-10-01|October 2001||2001-10-01|||||Interventional|||Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature|A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.597979|2017-10-11 04:20:08.597979
NCT00001191|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 3, 1983||1983-02-03|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Interventional|||The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid|The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.685556|2017-10-11 04:20:08.685556
NCT00001192|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||October 18, 1983||1983-10-18|December 20, 2006|2006-12-20|December 20, 2006||2006-12-20|||||Observational|||Neuropsychological Evaluation of Psychiatric and Neurological Patients|Neuropsychological Evaluation of Psychiatric and Neurological Patients|Completed||N/A|4300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.752717|2017-10-11 04:20:08.752717
NCT00001193|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1984||1984-11-01|August 1999|1999-08-01|September 2000||2000-09-01|||||Interventional|||A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer|A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer|Completed||Phase 2|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:08.828337|2017-10-11 04:20:08.828337
NCT00001256|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1990||1990-03-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Steroids and Methotrexate to Treat Systemic Vasculitis|An Open Trial of the Efficacy of Glucocorticoids and Methotrexate (MTX) in the Treatment of Systemic Vasculitis|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:09.01922|2017-10-11 04:20:09.01922
NCT00001257|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 24, 1990||1990-04-24|July 12, 2017|2017-07-12||||||||Observational|||Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses|Comparison of Inflammatory Responses in Normal Volunteers and Patients With Abnormal Phagocyte Function Using the Suction Blister Technique|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:09.102504|2017-10-11 04:20:09.102504
NCT00001258|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||October 26, 1989||1989-10-26|September 6, 2017|2017-09-06||||||||Observational|||Studies of Frontal Lobe Brain Functioning in Schizophrenia|Studies of Frontal Lobe Function During Cognitive Stimulation as Measured With Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Patients With Neuropsychiatric Disorders|Completed||N/A|1039|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:09.638965|2017-10-11 04:20:09.638965
NCT00001259|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 9, 1990||1990-03-09|May 2, 2017|2017-05-02||||||||Observational|||A Treatment Study for Premenstrual Syndrome (PMS)|The Treatment of Menstrually-Related Mood Disorders With the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:09.749098|2017-10-11 04:20:09.749098
NCT00001260|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||May 29, 1990||1990-05-29|June 16, 2017|2017-06-16|June 16, 2017||2017-06-16|||||Observational|||Brain Tissue Collection for Neuropathological Studies|Brain Procurement for the Human Brain Collection Core|Terminated||N/A|2161|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:09.854145|2017-10-11 04:20:09.854145
NCT00001261|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1990||1990-05-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies|The Efficacy of High-Dose Intravenous Immunoglobulin in Patients With Inflammatory Myopathies: A Three Month Randomized Trial With Option for Cross-Over|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:09.962743|2017-10-11 04:20:09.962743
NCT00001262|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2015-09-29|2014-08-05||June 1990||1990-06-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Copper Histidine Therapy for Menkes Diseases|Early Copper Histidine Therapy in Menkes Disease|Completed||Phase 1/Phase 2|60|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:20:10.073545|2017-10-11 04:20:10.073545
NCT00001265|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||August 6, 1991||1991-08-06|September 25, 2017|2017-09-25||||||||Observational|||Study and Treatment of Inflammatory Muscle Diseases|Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:10.79058|2017-10-11 04:20:10.79058
NCT00001266|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1990||1990-10-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma|A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:10.878769|2017-10-11 04:20:10.878769
NCT00005353|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||June 1992||1992-06-01|May 2000|2000-05-01|May 1995|Actual|1995-05-01|||||Observational|||Cardiac Autonomic Control in Children of HIV Positive Mothers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.898414|2017-10-11 04:28:02.898414
NCT00001267|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1990||1990-10-01|August 1999|1999-08-01|April 2000||2000-04-01|||||Interventional|||A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine|A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine|Completed||Phase 3|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:10.941327|2017-10-11 04:20:10.941327
NCT00001269|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1991||1991-05-01|April 2000|2000-04-01|February 2001||2001-02-01|||||Interventional|||Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer|Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.003448|2017-10-11 04:20:11.003448
NCT00001270|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1991||1991-06-01|May 1999|1999-05-01|March 2000||2000-03-01|||||Interventional|||Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma|Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma|Completed||Phase 1|85||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.064419|2017-10-11 04:20:11.064419
NCT00001271|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1991||1991-07-01|June 2000|2000-06-01|April 2001||2001-04-01|||||Interventional|||A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma|A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma|Completed||Phase 1|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.122573|2017-10-11 04:20:11.122573
NCT00001272|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1991||1991-09-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Interventional|||A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients|A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.185477|2017-10-11 04:20:11.185477
NCT00001275|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||May 12, 1991||1991-05-12|February 8, 2017|2017-02-08|February 8, 2017||2017-02-08|||||Observational|||Ovarian Follicle Function in Patients With Primary Ovarian Failure|Ovarian Follicle Function in Patients With Primary Ovarian Insufficiency|Completed||N/A|1134|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.239913|2017-10-11 04:20:11.239913
NCT00001276|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 29, 1991||1991-01-29|April 26, 2017|2017-04-26||||||||Observational|||Diagnosing and Treating Low Blood Sugar Levels|Fasting Hypoglycemia: Diagnosis and Treatment|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.314041|2017-10-11 04:20:11.314041
NCT00001277|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 1, 1991||1991-03-01|June 27, 2017|2017-06-27||||||||Observational|||Studies of Elevated Parathyroid Activity|Studies of Hyperparathyroidism and Related Disorders|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.389771|2017-10-11 04:20:11.389771
NCT00001278|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1991||1991-05-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Observational|||Study of Eye Tissue for Sarcoidosis|Immunologic Assay of Conjunctiva and Lacrimal Gland for Sarcoidosis|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.589491|2017-10-11 04:20:11.589491
NCT00001280|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1991||1991-01-01|February 2000|2000-02-01|March 2001||2001-03-01|||||Interventional|||Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease|Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.656379|2017-10-11 04:20:11.656379
NCT00001282|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1991||1991-07-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients|A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients|Completed||Phase 2|73||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.814263|2017-10-11 04:20:11.814263
NCT00001284|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||May 9, 1991||1991-05-09|March 13, 2017|2017-03-13||||||||Observational|||Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers|Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers With 1.5 Tesla MRI|Completed||N/A|2802|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.88326|2017-10-11 04:20:11.88326
NCT00001285|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1991||1991-08-01|October 1999|1999-10-01|June 2000||2000-06-01|||||Observational|||Effects of Sex Hormones on Circadian Rhythm in Men and Women|Chronobiologic Effects of Gonadal Steroid Manipulations in Volunteer Subjects|Completed||N/A|73||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:11.956975|2017-10-11 04:20:11.956975
NCT00001287|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1990||1990-12-01|February 2000|2000-02-01|January 2001||2001-01-01|||||Interventional|||Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)|The Efficacy of High-Dose Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.018459|2017-10-11 04:20:12.018459
NCT00001288|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1991||1991-05-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Observational|||Brain Blood Flow Studies of Language and Memory|Cerebral Blood Flow Studies of Language and Memory|Completed||N/A|303||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.115742|2017-10-11 04:20:12.115742
NCT00005354|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-03-26|||April 1992||1992-04-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Computed Tomography (CT)--An Epidemiologic Study in the Young||Completed||N/A|||University of Iowa|||||f||||||||||||||2017-10-11 04:28:02.951468|2017-10-11 04:28:02.951468
NCT00001289|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||September 23, 1991||1991-09-23|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Effects of Enzyme Replacement in Gaucher's Disease|Clinical and Biochemical Effects of Macrophage-Targeted Glucocerebrosidase on Neurological Involvement in Neuronopathic Gaucher's Disease|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.187852|2017-10-11 04:20:12.187852
NCT00001291|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||December 1991||1991-12-01|December 1999|1999-12-01|January 2001||2001-01-01|||||Observational|||Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions|Investigations of Blood, Synovial Tissue and Synovial Fluids From Patients With Rheumatoid Arthritis and Related Conditions|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.265002|2017-10-11 04:20:12.265002
NCT00001292|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||February 1992||1992-02-01|April 2000|2000-04-01|April 2001||2001-04-01|||||Observational|||Study of Scaling Disorders and Other Inherited Skin Diseases|Clinical and Genetic Studies of the Scaling Disorders and Other Selected Genodermatoses|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.33554|2017-10-11 04:20:12.33554
NCT00001294|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1992||1992-01-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens|Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.392471|2017-10-11 04:20:12.392471
NCT00001295|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 29, 1992||1992-01-29|August 23, 2016|2016-08-23|August 23, 2016||2016-08-23|||||Observational|||Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease|Continuing Treatment for Children and Adults in the Center for Cancer Research|Completed||N/A|2145|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.45015|2017-10-11 04:20:12.45015
NCT00001296|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1992||1992-02-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma|A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma|Completed||Phase 3|122||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.510012|2017-10-11 04:20:12.510012
NCT00001298|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1992||1992-03-01|February 2000|2000-02-01|January 2001||2001-01-01|||||Interventional|||A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction|A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.579964|2017-10-11 04:20:12.579964
NCT00001300|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1992||1992-06-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Interventional|||A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma|A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma|Completed||Phase 3|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.652966|2017-10-11 04:20:12.652966
NCT00001301|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1992||1992-08-01|June 1999|1999-06-01|April 2000||2000-04-01|||||Observational|||Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors|Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors|Completed||N/A|107||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.746346|2017-10-11 04:20:12.746346
NCT00001302|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1992||1992-09-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833|A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833|Completed||Phase 1|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:12.806724|2017-10-11 04:20:12.806724
NCT00001303|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 4, 1992||1992-04-04|July 7, 2017|2017-07-07|March 21, 2007|Actual|2007-03-21|March 21, 2007|Actual|2007-03-21||Interventional|||Effects of Endotoxin in Normal Human Volunteers|The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers|Completed||Phase 1|198|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:12.890527|2017-10-11 04:20:12.890527
NCT00001304|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2015-11-10|2015-03-12||October 1991||1991-10-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34|Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34|Completed||Phase 2|27|Actual|National Institutes of Health Clinical Center (CC)|Study reported here was the primary long-term study for adults with hypoparathyroidism. Subsequent studies included additional patients.|2|||f||||t||||||||||2017-10-11 04:20:12.971183|2017-10-11 04:20:12.971183
NCT00001305|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||November 5, 1991||1991-11-05|May 19, 2017|2017-05-19|May 19, 2017|Actual|2017-05-19|May 19, 2017|Actual|2017-05-19||Interventional|||Growth Hormone Therapy in Osteogenesis Imperfecta|Studies of Growth Deficiency and Growth Hormone Treatment in Children With Osteogenesis Imperfecta Types III and IV|Completed||Phase 3|52|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:13.395761|2017-10-11 04:20:13.395761
NCT00001306|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||July 10, 1992||1992-07-10|December 12, 2011|2011-12-12|December 12, 2011||2011-12-12|||||Observational|||Steroid Therapy in Autoimmune Premature Ovarian Failure|Autoimmune Premature Ovarian Failure: A Controlled Trial of Alternate-Day Prednisone Therapy|Completed||N/A|33|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.477584|2017-10-11 04:20:13.477584
NCT00001307|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1992||1992-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Positron Emission Tomography to Measure Pain and Pain Control|Somatosensory Studies of Pain and Pain Control Measured With Oxygen-15 Water Positron Emission Tomography and Functional MRI in Normals and Patients With Neuropathic or Chronic Pain Conditions|Completed||N/A|273||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.533407|2017-10-11 04:20:13.533407
NCT00005355|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-29|||February 1993||1993-02-01|February 2016|2016-02-01|January 1996||1996-01-01|||||Observational|||Gender Differences in Familial Risk||Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-10-11 04:28:03.015916|2017-10-11 04:28:03.015916
NCT00001308|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 28, 1992||1992-04-28|October 6, 2016|2016-10-06|October 6, 2016||2016-10-06|||||Observational|||Central Mechanisms in Speech Motor Control Studied With H215O PET|Multimodal Studies of Language Production and Comprehension in Normal Volunteers and Patients With Neurologically-Based Language Impairments|Terminated||N/A|1163|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.595203|2017-10-11 04:20:13.595203
NCT00001309|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||October 25, 1991||1991-10-25|March 23, 2017|2017-03-23||||||||Observational|||The Body's Affect on Vitamin C|Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.658229|2017-10-11 04:20:13.658229
NCT00001310|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 5, 1992||1992-03-05|September 16, 2015|2015-09-16|September 16, 2015||2015-09-16|||||Observational|||Tissue Studies of Human Eye Diseases|Immunopathology and Molecular Pathology of Ocular Diseases in Humans|Terminated||N/A|3797|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.727359|2017-10-11 04:20:13.727359
NCT00001311|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1992||1992-04-01|March 2000|2000-03-01|February 2001||2001-02-01|||||Interventional|||Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients|Evaluation of the Efficacy of a Surface Modified Intraocular Lens in Reducing Post-Operative Inflammatory Signs Following Extracapsular Surgery in Uveitis Patients With Cataracts|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.786403|2017-10-11 04:20:13.786403
NCT00001313|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||May 10, 1992||1992-05-10|January 6, 2009|2009-01-06|January 6, 2009||2009-01-06|||||Observational|||Evaluation of Patients With Known or Suspected Heart Disease|Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.839854|2017-10-11 04:20:13.839854
NCT00001314|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1992||1992-05-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Observational|||Investigation of Heart Function in Patients With Heart Valve Defects|Investigation of Myocardial Contractile Reserve by Dobutamine Stress Transesophageal Echocardiography in Aortic and Mitral Regurgitation|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.892413|2017-10-11 04:20:13.892413
NCT00001316|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 18, 1992||1992-03-18|July 12, 2017|2017-07-12||||||||Observational|||Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals|A Study of Viral Burden in Peripheral Blood Versus Lymphoid and Bone Marrow Tissue in HIV-Infected Individuals|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:13.944706|2017-10-11 04:20:13.944706
NCT00001317|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1992||1992-05-01|May 2000|2000-05-01|July 2001||2001-07-01|||||Interventional|||A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood|A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood|Completed||Phase 4|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.078764|2017-10-11 04:20:14.078764
NCT00001318|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1992||1992-08-01|August 1999|1999-08-01|November 2000||2000-11-01|||||Interventional|||Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma|Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.207452|2017-10-11 04:20:14.207452
NCT00001319|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1992||1992-09-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts|Evaluation of the Epidemiology, Clinical Manifestations, Etiologies, and Immunology of Human Immunodeficiency Virus (HIV) Negative CD4 T Lymphocyte Deficient Patients|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.28695|2017-10-11 04:20:14.28695
NCT00001320|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1991||1991-10-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients|I-123 Iodobenzamide (IBZM) SPECT Studies of D2 Receptor Distribution and Function in Patients With Schizophrenia and Normal Volunteers|Completed||N/A|265||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.370901|2017-10-11 04:20:14.370901
NCT00001322|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 25, 1992||1992-04-25|June 29, 2017|2017-06-29||||||||Observational|||The Effects of Reproductive Hormones on Mood and Behavior|The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.442455|2017-10-11 04:20:14.442455
NCT00001323|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1992||1992-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia|Neuropsychiatric Evaluation of Normal Subjects and Psychiatric and Neurologic Contrast Groups|Completed||N/A|810||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.518587|2017-10-11 04:20:14.518587
NCT00001324|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1992||1992-03-01|March 2000|2000-03-01|July 2001||2001-07-01|||||Observational|||PET Scan to Study Brain Control of Human Movement|CNS Control of Human Movement: H215O PET Studies|Completed||N/A|510||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.602701|2017-10-11 04:20:14.602701
NCT00001325|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1992||1992-04-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Observational|||Metabolic Abnormalities in Children With Epilepsy|Natural History of Metabolic Abnormalities in Children With Epilepsy|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.672676|2017-10-11 04:20:14.672676
NCT00001327|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||July 29, 1992||1992-07-29|March 31, 2011|2011-03-31|March 31, 2011||2011-03-31|||||Observational|||Establishing the Physiology of Syringomyelia|Establishing the Physiology of Syringomyelia|Completed||N/A|120|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.741278|2017-10-11 04:20:14.741278
NCT00001328|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 21, 1992||1992-08-21|April 30, 2010|2010-04-30|April 30, 2010|Actual|2010-04-30|April 30, 2010|Actual|2010-04-30||Interventional|||Gene Therapy for the Treatment of Brain Tumors|Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction With the Thymidine Kinase Gene and Intravenous Ganciclovir|Completed||Phase 1|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:14.806727|2017-10-11 04:20:14.806727
NCT00001329|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1992||1992-09-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Observational|||Study of Norepinephrine Levels and Sympathetic Nervous System Activity|Plasma Catecholamine Kinetics|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.880873|2017-10-11 04:20:14.880873
NCT00001330|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1992||1992-11-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Observational|||Study of Silicone-Associated Connective Tissue Diseases|Epidemiologic, Immunologic, and Immunogenetic Factors in Silicone-Associated Connective Tissue Diseases|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.939082|2017-10-11 04:20:14.939082
NCT00001331|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||May 1993||1993-05-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Genetic and Family Studies of Inherited Muscle Diseases|Genetic and Family Studies of Inherited Muscle Diseases|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:14.996141|2017-10-11 04:20:14.996141
NCT00001332|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1992||1992-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis|Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.074459|2017-10-11 04:20:15.074459
NCT00001333|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1993||1993-02-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||Phase I Study of Intrathecal Topotecan|Phase I Study of Intrathecal Topotecan|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.150898|2017-10-11 04:20:15.150898
NCT00001335|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1993||1993-04-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma|New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma|Completed||Phase 2|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.221784|2017-10-11 04:20:15.221784
NCT00001336|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1993||1993-04-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients|In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.29595|2017-10-11 04:20:15.29595
NCT00001338|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1993||1993-06-01|April 2000|2000-04-01|January 2001||2001-01-01|||||Interventional|||A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer|A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer|Completed||Phase 3|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.447078|2017-10-11 04:20:15.447078
NCT00001339|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1993||1993-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection|A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.51145|2017-10-11 04:20:15.51145
NCT00001341|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1993||1993-09-01|August 2000|2000-08-01|June 2001||2001-06-01|||||Interventional|||A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease|A Phase I Trial of ZD1694 (TOMUDEX® (Registered Trademark)), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.574723|2017-10-11 04:20:15.574723
NCT00001342|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1992||1992-11-01|October 1999|1999-10-01|April 2001||2001-04-01|||||Observational|||Study of Glycogen Storage Disease and Associated Disorders|A Study of Collateral Disorders of Glycogen Storage Disease|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.633005|2017-10-11 04:20:15.633005
NCT00001343|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||December 11, 1992||1992-12-11|October 10, 2007|2007-10-10|October 10, 2007||2007-10-10|||||Interventional|||The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome|The Relative Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate, GH Binding Protein, IGF-I, and Cognitive Function in Growth Hormone-Treated Girls With Turner Syndrome|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.692298|2017-10-11 04:20:15.692298
NCT00001344|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1993||1993-03-01|March 2000|2000-03-01|February 2001||2001-02-01|||||Interventional|||Dextromethorphan Versus Placebo for Neuropathic Pain|Dextromethorphan Versus Placebo for Neuropathic Pain|Completed||Phase 2|129||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.762265|2017-10-11 04:20:15.762265
NCT00001345|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 19, 1993||1993-04-19|August 28, 2017|2017-08-28||||||||Observational|||Studies of Inherited Diseases of Metabolism|Family Studies in Metabolic Diseases and Mineral Metabolism|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.83372|2017-10-11 04:20:15.83372
NCT00001346|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1992||1992-11-01|February 2000|2000-02-01|October 2000||2000-10-01|||||Observational|||Diabetic Retinopathy and Visual Function Study|Diabetic Retinopathy and Visual Function Study|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.912167|2017-10-11 04:20:15.912167
NCT00001347|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1993||1993-06-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Study of Usher Syndromes, Type 1 and Type 2|Usher Syndrome - Clinical and Molecular Studies|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:15.970687|2017-10-11 04:20:15.970687
NCT00001349|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||December 15, 1992||1992-12-15|July 12, 2017|2017-07-12||||||||Observational|||Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies|Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.025115|2017-10-11 04:20:16.025115
NCT00001350|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||December 18, 1992||1992-12-18|July 12, 2017|2017-07-12||||||||Observational|||Study of Autoimmune Lymphoproliferative Syndrome (ALPS)|Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated With an Expansion of CD4-8-/TCR Alpha/Beta+ T Cells|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.089561|2017-10-11 04:20:16.089561
NCT00001351|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-12|2017-10-05|||February 5, 1993||1993-02-05|September 1, 2017|2017-09-01||||||||Observational|||Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders|Evaluation and Long Term Follow Up of Patients With Acute or Chronic Inflammatory Disorders|Enrolling by invitation||N/A|292|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.163678|2017-10-11 04:20:16.163678
NCT00001352|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 10, 1993||1993-03-10|July 12, 2017|2017-07-12||||||||Observational|||Evaluation and Follow-up of Patients With Cryptococcosis|Cryptococcosis in Previously Healthy Adults|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.230169|2017-10-11 04:20:16.230169
NCT00001353|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1993||1993-03-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs|A Study of the Safety and Survival of the Adoptive Transfer of Genetically Marked Syngeneic Lymphocytes in HIV-Infected Identical Twins|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.298961|2017-10-11 04:20:16.298961
NCT00001354|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1993||1993-03-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Interleukin-2 Therapy for HIV Infection - Supplemental Procedures|A Randomized Trial of Interleukin-2 Therapy in HIV-Infected Patients|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.358922|2017-10-11 04:20:16.358922
NCT00001355|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 9, 1993||1993-04-09|October 3, 2017|2017-10-03||||||||Observational|||Detection and Characterization of Host Defense Defects|Detection and Characterization of Host Defense Defects|Enrolling by invitation||N/A|1962|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.427255|2017-10-11 04:20:16.427255
NCT00001356|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1993||1993-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Characteristics of Mast Cells in Mastocytosis|Culture and Characteristics of Mastocytosis Mast Cells|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.488505|2017-10-11 04:20:16.488505
NCT00001357|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1993||1993-08-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients|Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.546079|2017-10-11 04:20:16.546079
NCT00001359|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1993||1993-04-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)|A Trial of Prophylaxis for the PANDAS Subgroup|Completed||Phase 2|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.612532|2017-10-11 04:20:16.612532
NCT00001360|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-03|||July 2, 1993||1993-07-02|September 22, 2017|2017-09-22||||||||Observational|||Studies of Blood Flow to the Brain During Thought|Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory|Recruiting||N/A|4100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.684322|2017-10-11 04:20:16.684322
NCT00001361|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1992||1992-10-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Magnetic Resonance Imaging Studies of Motor and Thought Processes|Central Nervous System Motor and Cognitive Processes: Nuclear Magnetic Resonance Imaging at 1.5 to 4 Tesla|Completed||N/A|610||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.747503|2017-10-11 04:20:16.747503
NCT00001362|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1992||1992-12-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders|Structural and Functional Imaging of Neurologically Impaired Patients and Normal Volunteers With 1.5 and 3.0 Tesla MRI|Completed||N/A|830||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.805576|2017-10-11 04:20:16.805576
NCT00001363|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1993||1993-01-01|May 2000|2000-05-01|March 2001||2001-03-01|||||Observational|||PET Scan to Map the Areas of the Brain Involved in Planning|Functional Brain Mapping of Planning Activities With [015] Water PET Blood Flow Technique|Completed||N/A|230||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.862564|2017-10-11 04:20:16.862564
NCT00001364|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||June 2, 1993||1993-06-02|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities|Evaluation and Treatment of Patients With Spinal Vascular Abnormalities|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.917416|2017-10-11 04:20:16.917416
NCT00001365|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2006-07-12|||July 1993||1993-07-01|July 2000|2000-07-01|June 2001||2001-06-01|||||Interventional|||Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System|NMDA Receptor Antagonist Treatment of Neurodegenerative Disease|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:16.997433|2017-10-11 04:20:16.997433
NCT00001366|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1993||1993-08-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Observational|||Mapping the Areas of the Brain Associated With Language in Children With Epilepsy|MRI-Based Functional Language Mapping in Children With Epilepsy|Completed||N/A|230||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.073149|2017-10-11 04:20:17.073149
NCT00001367|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||August 20, 1993||1993-08-20|October 3, 2017|2017-10-03||||||||Observational|||Diagnosis and History Study of Patients With Different Neurological Conditions|Diagnosis and Natural History Protocol for Patients With Different Neurological Conditions|Recruiting||N/A|4100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.124732|2017-10-11 04:20:17.124732
NCT00001368|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1993||1993-10-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Interventional|||Potential Risk Factors for Stroke|Cytokine and Leukocyte Activation Profile as a Risk Factor for Cerebral Vascular Disease and Stroke|Completed||Phase 1|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.183812|2017-10-11 04:20:17.183812
NCT00001371|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1993||1993-12-01|December 1999|1999-12-01|December 2000||2000-12-01|||||Observational|||A Pilot Study of Topical Antiflammin-2 for Psoriasis|A Pilot Study of Topical Antiflammin-2 for Psoriasis|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.238079|2017-10-11 04:20:17.238079
NCT00001372|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 1, 1994||1994-02-01|August 18, 2017|2017-08-18||||||||Observational|||Study of Systemic Lupus Erythematosus|Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.383018|2017-10-11 04:20:17.383018
NCT00001375|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1994||1994-08-01|August 1999|1999-08-01|June 2000||2000-06-01|||||Observational|||The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis|The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.535002|2017-10-11 04:20:17.535002
NCT00001376|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1994||1994-08-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Observational|||Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status|Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status|Completed||N/A|209||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.588044|2017-10-11 04:20:17.588044
NCT00001377|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1993||1993-12-01|December 1999|1999-12-01|December 2000||2000-12-01|||||Observational|||Familial Prostate Cancer|Familial Prostate Cancer|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.642276|2017-10-11 04:20:17.642276
NCT00001378|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1994||1994-01-01|November 1999|1999-11-01|November 2000||2000-11-01|||||Interventional|||A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer|A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer|Completed||Phase 1|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.699041|2017-10-11 04:20:17.699041
NCT00001381|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1994||1994-03-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder|A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder|Completed||Phase 1|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.855801|2017-10-11 04:20:17.855801
NCT00001382|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1994||1994-03-01|March 2000|2000-03-01|March 2000||2000-03-01|||||Interventional|||A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate|A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate|Completed||Phase 1|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.912646|2017-10-11 04:20:17.912646
NCT00001383|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1994||1994-03-01|March 2000|2000-03-01|January 2001||2001-01-01|||||Interventional|||A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833|A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833|Completed||Phase 1|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:17.965822|2017-10-11 04:20:17.965822
NCT00001384|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1994||1994-05-01|April 2000|2000-04-01|February 2001||2001-02-01|||||Interventional|||A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients|A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients|Completed||Phase 2|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.029899|2017-10-11 04:20:18.029899
NCT00001385|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1994||1994-05-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Observational|||Positron Emission Tomography in Patients With Breast Cancer|Positron Emission Tomography in Patients With Breast Cancer|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.09534|2017-10-11 04:20:18.09534
NCT00001386|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1994||1994-06-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection|Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection|Completed||Phase 1|31||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.152798|2017-10-11 04:20:18.152798
NCT00001387|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1994||1994-09-01|August 1999|1999-08-01|July 2000||2000-07-01|||||Interventional|||Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy|Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.213345|2017-10-11 04:20:18.213345
NCT00001390|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||October 22, 1993||1993-10-22|August 17, 2017|2017-08-17||||||||Observational|||Salivary Evaluation in Healthy Volunteers|Salivary Evaluation in Healthy Volunteers|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.269919|2017-10-11 04:20:18.269919
NCT00001391|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 3, 1994||1994-08-03|October 4, 2010|2010-10-04|October 4, 2010||2010-10-04|||||Observational|||Bone Regeneration Using Bone Marrow Stromal Cells|Bone Regeneration Using Bone Marrow Stromal Cells|Completed||N/A|54|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.344929|2017-10-11 04:20:18.344929
NCT00001392|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 7, 1994||1994-04-07|September 22, 2017|2017-09-22||||||||Observational|||Pathogenesis of Glomerulosclerosis|Pathogenesis of Glomerulosclerosis|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.402435|2017-10-11 04:20:18.402435
NCT00001393|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 18, 1994||1994-04-18|August 24, 2017|2017-08-24||||||||Observational|||Genetic Markers for Focal Segmental Glomerulosclerosis|Genetic Markers for Focal Segmental Glomerulosclerosis|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.479102|2017-10-11 04:20:18.479102
NCT00001394|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1994||1994-08-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Using X-Ray Dye to Locate Hidden Parathyroid Tumors|Use of Hypocalcemic Intraarterial Infusion Into the Thyroid/Parathyroid Bed to Localize Occult Parathyroid Adenomas|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.55504|2017-10-11 04:20:18.55504
NCT00001395|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1994||1994-03-01|March 1999|1999-03-01|August 2000||2000-08-01|||||Observational|||Long Term Follow-Up of Diabetic Retinopathy|Long Term Follow-Up of Diabetic Retinopathy|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.614856|2017-10-11 04:20:18.614856
NCT00001396|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||October 6, 1993||1993-10-06|July 23, 2008|2008-07-23|July 23, 2008||2008-07-23|||||Interventional|||Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop...|Obstructive Hypertrophic Cardiomyopathy (HCM) in Children: Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:18.67282|2017-10-11 04:20:18.67282
NCT00001397|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||October 19, 1993||1993-10-19|September 5, 2017|2017-09-05||||||||Observational|||Evaluation, Treatment, and Training for Patients With Blood Disorders|Evaluation, Treatment and Training Protocol for Patients With Bone Marrow Failure States, Isolated or Multilineage Cytopenias, Metastatic Solid Tumors, or Hematologic Malignancies|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.733691|2017-10-11 04:20:18.733691
NCT00001398|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1993||1993-10-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Stem Cell Factor Medication for Aplastic Anemia|A Phase I/II Trial of Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) in Patients Diagnosed With Acquired Aplastic Anemia|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.800782|2017-10-11 04:20:18.800782
NCT00001399|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||December 3, 1993||1993-12-03|February 11, 2009|2009-02-11|February 11, 2009||2009-02-11|||||Interventional|||Gene Therapy for the Treatment of Fanconi's Anemia Type C|Retroviral Mediated Gene Transfer of the Fanconi Anemia Complementation Group C Gene to Hematopoietic Progenitors of Group C Patients|Completed||Phase 1|9||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:18.86482|2017-10-11 04:20:18.86482
NCT00001400|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||December 1993||1993-12-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||Outpatient Evaluation of Patients With Known or Suspected Heart Disease|Outpatient Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.933695|2017-10-11 04:20:18.933695
NCT00001402|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1994||1994-01-01|December 1999|1999-12-01|March 2001||2001-03-01|||||Interventional|||PET Scan to Determine Areas of Blood Flow and Activity in the Hearts of Patients With Heart Disease Taking Beta-Blockers|Assessment of Metabolic Function and Perfusion Using Positron Emission Tomography: An Analysis of Patients With Congestive Cardiomyopathy Before and After Beta-Blockers|Completed||Phase 2|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:18.981277|2017-10-11 04:20:18.981277
NCT00001403|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 18, 1994||1994-04-18|July 24, 2017|2017-07-24||||||||Observational|||Study of Proteus Syndrome and Related Congenital Disorders|The Phenotype and Etiology of Proteus Syndrome and Related Overgrowth Disorders|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.043439|2017-10-11 04:20:19.043439
NCT00001404|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||August 18, 1994||1994-08-18|January 7, 2016|2016-01-07|January 7, 2016||2016-01-07|||||Observational|||Phenotype and Etiology of Pallister-Hall Syndrome|Genetic and Clinical Studies of Congenital Anomaly Syndromes|Completed||N/A|1170|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.112816|2017-10-11 04:20:19.112816
NCT00001405|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 9, 1994||1994-02-09|July 12, 2017|2017-07-12||||||||Observational|||Use of G-CSF to Obtain Blood Cell Precursors|Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells,Mononuclear Cells and Granulocytes|Recruiting||N/A|450|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.186647|2017-10-11 04:20:19.186647
NCT00001406|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 10, 1994||1994-02-10|July 12, 2017|2017-07-12||||||||Observational|||Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia|Eosinophil Activation and Function in Parasitic Infections and Other Conditions With Increased Tissue or Peripheral Blood Eosinophilia in Humans|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.262324|2017-10-11 04:20:19.262324
NCT00001407|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1994||1994-05-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Interventional|||Interferon Gamma for Drug Resistant Tuberculosis|Treatment of Multiply Drug Resistant Tuberculosis With Interferon Gamma: A Phase I/II Dose Escalation Trial|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.327496|2017-10-11 04:20:19.327496
NCT00001408|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||September 14, 1994||1994-09-14|June 25, 2009|2009-06-25|October 1, 1995|Actual|1995-10-01|October 1, 1995|Actual|1995-10-01||Observational|||Role of T-Cells in Asthma|Cytokine Expression in Allergic Asthma|Completed||N/A|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.390575|2017-10-11 04:20:19.390575
NCT00001409|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1994||1994-09-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications|A Phase I/II Pilot Study of the Safety of the Adoptive Transfer of Syngeneic Gene-Modified Cytotoxic T Lymphocytes in HIV Infected Identical Twins|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.445103|2017-10-11 04:20:19.445103
NCT00001410|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1993||1993-10-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||PEG-Glucocerebrosidase for the Treatment of Gaucher Disease|A Phase I and II Study of PEG-Glucocerebrosidase in Patients With Type 1 or Type 3 Gaucher Disease|Completed||Phase 1|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.503517|2017-10-11 04:20:19.503517
NCT00001412|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1993||1993-12-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement|The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.558432|2017-10-11 04:20:19.558432
NCT00001413|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||April 6, 1994||1994-04-06|January 19, 2007|2007-01-19|January 19, 2007||2007-01-19|||||Observational|||Bone Mineral Density in Women With Major Depression|Bone Mineral Density in Patients With Major Depression With Melancholic and Atypical Features: Relation to Stress-System Neurohormonal Function|Completed||N/A|585||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.613011|2017-10-11 04:20:19.613011
NCT00001414|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1994||1994-04-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Mapping Personality Traits to Genes|Mapping Personality Traits to Genes|Completed||N/A|2400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.665532|2017-10-11 04:20:19.665532
NCT00001415|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1994||1994-05-01|April 1999|1999-04-01|July 2000||2000-07-01|||||Observational|||Glucocorticoid Effects on Cellular Cytokine Release|Glucocorticoid Effects on Cellular Cytokine Release|Completed||N/A|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.719108|2017-10-11 04:20:19.719108
NCT00001416|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2016-09-21|||December 1993||1993-12-01|September 2016|2016-09-01|November 2000||2000-11-01|||||Interventional|||Bone Response to Enzyme Replacement in Gaucher's Disease|Skeletal Responses to Macrophage-Targeted Glucocerebrosidase in Patients With Type 1 Gaucher's Disease|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.781642|2017-10-11 04:20:19.781642
NCT00001417|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1994||1994-06-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Direct Injection of Alcohol for the Treatment of Spinal Tumors|Study of the Efficacy of Direct Intratumoral Injection of Absolute Ethanol in Treating Symptomatic Spinal Tumors|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.862937|2017-10-11 04:20:19.862937
NCT00001418|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1994||1994-07-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||PET Scan in Patients With Neurocardiologic Disorders|Positron Emission Tomographic (PET) Scanning of Sympathetic Innervation and Function in Patients With Neurocardiologic Disorders|Completed||N/A|335||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.941523|2017-10-11 04:20:19.941523
NCT00001420|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Study of Psoriatic Arthritis|Studies of the Pathogenesis and Natural History of Psoriatic Arthritis|Completed||N/A|999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:19.99451|2017-10-11 04:20:19.99451
NCT00001421|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Interventional|||Methimazole to Treat Polymyositis and Dermatomyositis|A Pilot Study of the Role of Methimazole in Patients With Polymyositis and Dermatomyositis|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.068636|2017-10-11 04:20:20.068636
NCT00001422|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Interventional|||A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis|A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.136511|2017-10-11 04:20:20.136511
NCT00001424|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1994||1994-11-01|October 1999|1999-10-01|August 2000||2000-08-01|||||Observational|||Evaluation and Natural History of Children With Cancer and AIDS|Evaluation and Natural History of Children With Cancer and AIDS|Completed||N/A|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.20213|2017-10-11 04:20:20.20213
NCT00001426|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 3, 1995||1995-02-03|November 7, 2013|2013-11-07|November 7, 2013|Actual|2013-11-07|October 15, 2007|Actual|2007-10-15||Interventional|||A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer|A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer|Completed||Phase 2|47|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:20.261681|2017-10-11 04:20:20.261681
NCT00001427|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1995||1995-01-01|January 2000|2000-01-01|April 2000||2000-04-01|||||Interventional|||A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin|A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.347177|2017-10-11 04:20:20.347177
NCT00001428|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1995||1995-02-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer|A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer|Completed||Phase 2|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.414147|2017-10-11 04:20:20.414147
NCT00001430|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1995||1995-02-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas|A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas|Completed||Phase 2|49||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.479879|2017-10-11 04:20:20.479879
NCT00001431|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1995||1995-02-01|November 2000|2000-11-01|November 2000||2000-11-01|||||Interventional|||A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas|A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.550873|2017-10-11 04:20:20.550873
NCT00001432|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies|The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.646209|2017-10-11 04:20:20.646209
NCT00001435|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1995||1995-04-01|February 2000|2000-02-01|December 2000||2000-12-01|||||Observational|||Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children|Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children|Completed||N/A|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.707583|2017-10-11 04:20:20.707583
NCT00001436|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1995||1995-05-01|April 2000|2000-04-01|September 2000||2000-09-01|||||Interventional|||A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma|A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma|Completed||Phase 1|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.768978|2017-10-11 04:20:20.768978
NCT00001437|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 1999|1999-05-01|March 2000||2000-03-01|||||Interventional|||Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis|Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.841737|2017-10-11 04:20:20.841737
NCT00001438|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes|A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.912591|2017-10-11 04:20:20.912591
NCT00001439|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Interventional|||A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant|A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant|Completed||Phase 1|255||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:20.97578|2017-10-11 04:20:20.97578
NCT00001440|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-13|2008-03-03|||July 1995||1995-07-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy|Pilot Study of Autologous T Cells and/or IL-2 for the Enhancement of Immune Reconstitution After Dose-Intensive Chemotherapy for Breast Cancer|Completed||Phase 1|51||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.03598|2017-10-11 04:20:21.03598
NCT00001442|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1995||1995-07-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer|A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer|Completed||Phase 1|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.098565|2017-10-11 04:20:21.098565
NCT00001443|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1995||1995-07-01|March 2000|2000-03-01|October 2000||2000-10-01|||||Interventional|||A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection|A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection|Completed||Phase 1|63||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.280718|2017-10-11 04:20:21.280718
NCT00001444|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1995||1995-08-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Interventional|||A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms|A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms|Completed||Phase 1|51||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.358368|2017-10-11 04:20:21.358368
NCT00001445|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1995||1995-08-01|August 2000|2000-08-01|July 2001||2001-07-01|||||Interventional|||Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection|Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection|Completed||Phase 1|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.448228|2017-10-11 04:20:21.448228
NCT00001446|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1995||1995-09-01|August 2000|2000-08-01|July 2001||2001-07-01|||||Interventional|||A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer|A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2|64||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.527595|2017-10-11 04:20:21.527595
NCT00001448|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1995||1995-08-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Observational|||The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection|The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.627526|2017-10-11 04:20:21.627526
NCT00001449|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1995||1995-09-01|September 1999|1999-09-01|April 2000||2000-04-01|||||Interventional|||A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients|A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.700067|2017-10-11 04:20:21.700067
NCT00001450|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1995||1995-09-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Interventional|||Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC|Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC|Completed||Phase 2|58||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.793948|2017-10-11 04:20:21.793948
NCT00001451|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 14, 1995||1995-03-14|February 1, 2011|2011-02-01|February 1, 2011||2011-02-01|||||Observational|||Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)|Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)|Completed||N/A|57|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.871891|2017-10-11 04:20:21.871891
NCT00001452|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 23, 1995||1995-01-23|August 30, 2017|2017-08-30||||||||Observational|||Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex|Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:21.939081|2017-10-11 04:20:21.939081
NCT00001453|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 10, 1995||1995-04-10|October 20, 2014|2014-10-20|October 20, 2014||2014-10-20|||||Observational|||Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome|Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome|Completed||N/A|98|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.026125|2017-10-11 04:20:22.026125
NCT00001454|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 21, 1995||1995-04-21|July 27, 2015|2015-07-27|July 27, 2015||2015-07-27|||||Observational|||Hormonal Effects on the Uterus and Endometrium|Endometrial Mediators of Gonadal Steroid Action|Completed||N/A|129|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.097502|2017-10-11 04:20:22.097502
NCT00001455|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|June 1999|1999-06-01|June 2000||2000-06-01|||||Observational|||Iron Overload in African Americans|Iron Overload in African Americans|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.177773|2017-10-11 04:20:22.177773
NCT00001456|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||September 20, 1995||1995-09-20|March 9, 2017|2017-03-09||||||||Observational|||Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome|Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.24368|2017-10-11 04:20:22.24368
NCT00001457|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1995||1995-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Lamivudine for Chronic Hepatitis B|Lamivudine for Chronic Hepatitis B|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.336716|2017-10-11 04:20:22.336716
NCT00001458|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 6, 1995||1995-01-06|March 22, 2017|2017-03-22||||||||Observational|||Evaluation of Patients With Heart Disease Not Eligible for Research Protocols|Diagnosis and Treatment of Patients With Heart and Vascular Disease (Training Protocol)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.419679|2017-10-11 04:20:22.419679
NCT00001459|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1995||1995-01-01|January 2000|2000-01-01|March 2001||2001-03-01|||||Observational|||Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers|Tomographic Myocardial Wall Motion Analysis in Patients With Myocardial Ischemia and in Normal Subjects|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.496745|2017-10-11 04:20:22.496745
NCT00001460|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||January 1995||1995-01-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||Evaluation and Treatment of Heart Disease in Patients Not Participating in Research|Evaluation and Therapy of Heart Disease in Patients Not Participating in Research (Teaching Protocol)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.574233|2017-10-11 04:20:22.574233
NCT00001461|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|April 2000|2000-04-01|April 2001||2001-04-01|||||Observational|||Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme|Investigation of the Interaction Between the Vascular Endothelium and Angiotensin-Converting Enzyme|Completed||N/A|209||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.639444|2017-10-11 04:20:22.639444
NCT00001462|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1995||1995-05-01|August 1999|1999-08-01|April 2000||2000-04-01|||||Observational|||Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals|Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.717308|2017-10-11 04:20:22.717308
NCT00001465|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||September 25, 1995||1995-09-25|August 7, 2017|2017-08-07||||||||Observational|||Study of the Disease Process of Lymphangioleiomyomatosis|Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.873161|2017-10-11 04:20:22.873161
NCT00001466|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1994||1994-10-01|September 1999|1999-09-01|October 2000||2000-10-01|||||Observational|||Study of Clinical and Molecular Manifestations of Genetic Disorders|Clinical and Molecular Manifestations of Six Categories of Genetic Disorders|Completed||N/A|1200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:22.989783|2017-10-11 04:20:22.989783
NCT00001467|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||January 31, 1995||1995-01-31|July 12, 2017|2017-07-12||||||||Observational|||Genetic Analysis of Immune Disorders|Genetic Analysis of Immune Disorders|Enrolling by invitation||N/A|3360|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.073536|2017-10-11 04:20:23.073536
NCT00001468|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|February 2000|2000-02-01|February 2001||2001-02-01|||||Observational|||Outcomes of Education and Counseling for BRCA1 Testing|Outcomes of Education and Counseling for BRCA1 or BRCA2 Testing|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.157306|2017-10-11 04:20:23.157306
NCT00001469|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||July 14, 1995||1995-07-14|May 10, 2017|2017-05-10||||||||Observational|||Genetic Analysis of Hereditary Prostate Cancer|Genetic Analysis of Hereditary Prostate Cancer|Completed||N/A|70000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.226857|2017-10-11 04:20:23.226857
NCT00001471|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||November 21, 1994||1994-11-21|July 12, 2017|2017-07-12||||||||Observational|||Tissue Biopsy and Imaging Studies in HIV-Infected Patients|Virologic and Immunologic Evaluation of Lymph Node, Tonsillar, and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid|Recruiting||N/A|635|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.318749|2017-10-11 04:20:23.318749
NCT00001473|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides|A Staged Therapeutic Approach Using Cyclophosphamide and Methotrexate in the Treatment of Wegener's Granulomatosis and Related Vasculitides|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.40454|2017-10-11 04:20:23.40454
NCT00001474|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1995||1995-05-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients|Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients|Completed||Phase 2|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.47391|2017-10-11 04:20:23.47391
NCT00001475|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist|A Randomized Trial of Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist in Patients With HIV-1 Infection|Completed||Phase 2|85||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.547379|2017-10-11 04:20:23.547379
NCT00001476|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||June 1, 1995||1995-06-01|December 13, 2010|2010-12-13|December 13, 2010|Actual|2010-12-13|December 13, 2010|Actual|2010-12-13||Interventional|||Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up|Gene Therapy Approach for Chronic Granulomatous Disease|Completed||Phase 1|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:23.611256|2017-10-11 04:20:23.611256
NCT00001477|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1995||1995-08-01|February 2000|2000-02-01|October 2000||2000-10-01|||||Observational|||Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy|Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.67308|2017-10-11 04:20:23.67308
NCT00001478|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1994||1994-10-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Observational|||Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders|Regional Cerebral Blood Flow Correlates of Spontaneous and Drug-Induced Clinical Changes in Mood Disorders|Completed||N/A|170||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.747083|2017-10-11 04:20:23.747083
NCT00001479|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1995||1995-01-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Observational|||Study of the Hypothalmic-Pituitary-Adrenal (HPA) Axis and Its Role in Major Depression|Intensively Sampled Dynamics of ACTH and Cortisol Affective Disorders|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.804297|2017-10-11 04:20:23.804297
NCT00001480|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 21, 1995||1995-03-21|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||The Evaluation and Follow-up of Individuals With Memory Disorder|The Evaluation and Follow-up of Patients With Memory Disorder and Normal Controls|Completed||N/A|750||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.861351|2017-10-11 04:20:23.861351
NCT00001481|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 31, 1995||1995-03-31|July 20, 2017|2017-07-20||||||||Observational|||The Role of Hormones in Postpartum Mood Disorders|An Endocrine Model for Postpartum Mood Disorders|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.918906|2017-10-11 04:20:23.918906
NCT00001482|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1995||1995-05-01|June 2000|2000-06-01|May 2001||2001-05-01|||||Interventional|||New Drugs in the Treatment of Mood Disorders|Evaluation of Lamotrigine (Lamictal® (Registered Trademark)) Monotherapy and Gabapentin (Neurontin® (Registered Trademark)) Monotherapy in the Treatment of Mood Disorders|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:23.998576|2017-10-11 04:20:23.998576
NCT00001483|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Interventional|||Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression|Acute Efficacy of Bupropion, Sertraline, and Venlafaxine as Adjuvant Treatment to Mood Stabilizers in Bipolar Depression: A Randomized, Double-Blind, Comparative Study|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:24.067908|2017-10-11 04:20:24.067908
NCT00001485|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|August 1999|1999-08-01|April 2000||2000-04-01|||||Observational|||Effects of Season on Melatonin Secretion in Healthy Men and Women and Patients With Seasonal Affective Disorder|Gender Differences in the Effects of Season on Patterns of Nocturnal Melatonin Secretion in Healthy Volunteers and Patients With Seasonal Affective Disorder (SAD)|Completed||N/A|116||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:24.130633|2017-10-11 04:20:24.130633
NCT00002104|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV|Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.188679|2017-10-11 04:20:24.188679
NCT00002105|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma|Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma|Completed||Phase 3|220||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.251418|2017-10-11 04:20:24.251418
NCT00002106|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1994|1994-05-01||||||||Interventional|||A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3|A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3|Completed||Phase 2|104||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.319432|2017-10-11 04:20:24.319432
NCT00002107|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1995|1995-03-01||||||||Interventional|||A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients|A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.467672|2017-10-11 04:20:24.467672
NCT00002108|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1995|1995-11-01||||||||Interventional|||3TC (Lamivudine; GR109714X) Open-Label Program|3TC (Lamivudine; GR109714X) Open-Label Program|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.529113|2017-10-11 04:20:24.529113
NCT00002109|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy|Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT/ddI or AZT/ddC) Anti-Retroviral Therapy|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.603307|2017-10-11 04:20:24.603307
NCT00002110|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1995|1995-10-01||||||||Interventional|||A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease|A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease|Completed||Phase 2|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.754585|2017-10-11 04:20:24.754585
NCT00002111|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1995|1995-05-01||||||||Interventional|||A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.|A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.|Completed||Phase 1|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.827582|2017-10-11 04:20:24.827582
NCT00002112|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome|Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.894107|2017-10-11 04:20:24.894107
NCT00002113|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.|A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.|Completed||N/A|64||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:24.966899|2017-10-11 04:20:24.966899
NCT00002114|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1994|1994-01-01|January 1994||1994-01-01|||||Interventional|||A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides|A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides|Completed||Phase 2|125||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:25.036332|2017-10-11 04:20:25.036332
NCT00002115|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1995|1995-11-01||||||||Interventional|||A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.|A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.|Completed||Phase 1|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:26.551155|2017-10-11 04:20:26.551155
NCT00002116|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1995|1995-12-01||||||||Interventional|||A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS|A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS|Completed||Phase 1|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:26.627083|2017-10-11 04:20:26.627083
NCT00002117|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection|A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection|Completed||Phase 3|528||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:26.708163|2017-10-11 04:20:26.708163
NCT00002118|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies|An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies|Completed||N/A|600||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:26.804018|2017-10-11 04:20:26.804018
NCT00002119|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection|A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:26.861937|2017-10-11 04:20:26.861937
NCT00002120|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia|Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia|Completed||Phase 1|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:26.918647|2017-10-11 04:20:26.918647
NCT00002121|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea|Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:26.978252|2017-10-11 04:20:26.978252
NCT00002122|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients|A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients|Completed||Phase 3|720||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:27.03513|2017-10-11 04:20:27.03513
NCT00002123|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1996|1996-11-01||||||||Interventional|||A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3|A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:27.119195|2017-10-11 04:20:27.119195
NCT00002124|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3|A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3|Completed||Phase 3|1250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:27.441546|2017-10-11 04:20:27.441546
NCT00002125|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1997|1997-06-01||||||||Interventional|||A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)|A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)|Completed||Phase 4|112||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:27.701381|2017-10-11 04:20:27.701381
NCT00002126|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.|A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection|Completed||Phase 2|250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:27.790841|2017-10-11 04:20:27.790841
NCT00002127|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome|A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome|Completed||Phase 2|75||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:27.874688|2017-10-11 04:20:27.874688
NCT00002128|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1994|1994-07-01||||||||Interventional|||Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients|Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients|Completed||Phase 1|15||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:27.947068|2017-10-11 04:20:27.947068
NCT00002129|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3|A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3|Completed||Phase 1|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:27.998152|2017-10-11 04:20:27.998152
NCT00002188|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma|Phase II Evaluation of Oral ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma.|Completed||Phase 2|27||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.050013|2017-10-11 04:20:28.050013
NCT00002189|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1998|1998-06-01||||||||Interventional|||Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals|Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.103507|2017-10-11 04:20:28.103507
NCT00002190|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients|A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.255412|2017-10-11 04:20:28.255412
NCT00002191|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis|A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.331796|2017-10-11 04:20:28.331796
NCT00002192|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.|Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.414025|2017-10-11 04:20:28.414025
NCT00002193|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors|A Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Safety and Efficacy of 141W94 Plus Current Nucleoside Therapy Versus Current Nucleoside Therapy Alone in Protease-Naive, HIV-Infected Children|Completed||Phase 3|210||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.486525|2017-10-11 04:20:28.486525
NCT00002329|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1995|1995-05-01||||||||Interventional|||A Study of MDL 28,574A in HIV-Infected Patients|A Randomized, Placebo-Controlled, Double-Blind, Single and Multiple Oral Dose-Tolerance Study of Oral MDL 28,574A Solution in HIV-Positive Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.663297|2017-10-11 04:20:40.663297
NCT00002194|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.|An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.|Completed||Phase 1|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.554584|2017-10-11 04:20:28.554584
NCT00002195|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients|A Phase III Trial to Evaluate the Safety and Antiviral Efficacy of 141W94 in Combination With Retrovir and Epivir Compared to Retrovir and Epivir Alone in Patients With HIV Infection.|Completed||Phase 3|290||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.624394|2017-10-11 04:20:28.624394
NCT00002196|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study of CI-1012 in HIV-Infected Patients|A Phase I Multiple Oral, Rising-Dose, Tolerance and Pharmacokinetic Trial of CI-1012 in HIV-1-Infected Volunteers.|Completed||Phase 1|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.714731|2017-10-11 04:20:28.714731
NCT00002197|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Study of 1592U89 in HIV-Infected Children|1592U89 Open-Label Protocol for Pediatric Patients With HIV Infection.|Completed||N/A|250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.780335|2017-10-11 04:20:28.780335
NCT00002198|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients|A Study to Investigate Whether There is a Pharmacokinetic Interaction Between 1592U89 and Ethanol Following Their Co-Administration to HIV-Infected Subjects.|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.83342|2017-10-11 04:20:28.83342
NCT00002199|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.|A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.|Completed||Phase 3|550||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.891718|2017-10-11 04:20:28.891718
NCT00002200|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Study of 1592U89 in HIV-Infected Adults|A 1592U89 Open-Label Protocol for Adult Patients With HIV-1 Infection.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:28.959976|2017-10-11 04:20:28.959976
NCT00002201|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients|Safety and Efficacy of Ritonavir (ABT-538) in Combination With Nelfinavir in HIV-Infected Subjects.|Completed||N/A|||Abbott|||||f||||||||||||||2017-10-11 04:20:29.019479|2017-10-11 04:20:29.019479
NCT00002202|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Comparison of 141W94 and Indinavir in HIV-Infected Patients|A Phase III Trial to Compare the Safety and Antiviral Efficacy of 141W94 With Indinavir in Combination With Nucleoside Reverse Transcriptase Inhibitor (NRTI) Therapy, in NRTI-Experienced, Protease Inhibitor (PI)-Naive, HIV-1-Infected Patients.|Completed||Phase 3|460||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.081018|2017-10-11 04:20:29.081018
NCT00002203|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Two Anti-HIV Drug Combinations|A Randomized, Multicenter Study of Epivir 150 Mg Bid, Retrovir 200 Mg Tid and a Protease Inhibitor Vs 3TC 150 Mg/ZDV 300 Mg Fixed Dose Tablet Given Bid With a Protease Inhibitor in HIV-Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.194988|2017-10-11 04:20:29.194988
NCT00002204|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults|A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.279717|2017-10-11 04:20:29.279717
NCT00002205|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen|An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.335939|2017-10-11 04:20:29.335939
NCT00002206|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs|A Phase I/II, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance, Pharmacokinetics, and Anti-HIV Activity of 60 Mg Daily Dose of Adefovir Dipivoxil in HIV-Infected Patients Naive to Anti-Retroviral Therapy|Completed||Phase 1|45||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.400385|2017-10-11 04:20:29.400385
NCT00002207|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-13||2011-04-13|February 2004||2004-02-01|April 2011|2011-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients|A Randomized, Double-Blind Study of the Antiviral Activity of Once-Daily and Twice-Daily Dosing of Didanosine in Combination With Twice-Daily Dosing of Stavudine in HIV-Infected Subjects|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:20:29.46057|2017-10-11 04:20:29.46057
NCT00002208|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 2003|2003-02-01||||||||Interventional|||A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC|A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC|Completed||Phase 3|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.558883|2017-10-11 04:20:29.558883
NCT00002298|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1998|1998-03-01||||||||Interventional|||The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection|Long-Term Efficacy and Tolerance of Oral Ribavirin Compared to Placebo as a Preventative in Early Stages of Human Immunodeficiency Virus Infection - United States|Terminated||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.679341|2017-10-11 04:20:36.679341
NCT00002209|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy|Multiple Ascending Dose Pharmacokinetics of CPI-1189 (LU 02-584) in Fasted, HIV Infected, Male Volunteers on Combined Reverse Transcriptase and Protease Inhibitor Therapy|Completed||Phase 1|48||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.640508|2017-10-11 04:20:29.640508
NCT00002210|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1998|1998-01-01||||||||Interventional|||A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies|Phase II Study of the Safety, Tolerance, Pharmacokinetics, and Antiviral Effect of Delavirdine Mesylate (Rescriptor), in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1-Infected Neonates, Infants, and Children|Completed||Phase 2|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.691385|2017-10-11 04:20:29.691385
NCT00002211|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients|An Open-Label Randomized Study of Delavirdine Mesylate (DLV, Rescriptor) Plus Nelfinavir (NFV), Didanosine (ddI), and Stavudine (d4T) in Triple and Quadruple Treatment Regimens in HIV-1 Infected Individuals|Completed||N/A|160||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.742427|2017-10-11 04:20:29.742427
NCT00002212|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma|Phase II Evaluation of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|27||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.80209|2017-10-11 04:20:29.80209
NCT00002213|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1998|1998-03-01||||||||Interventional|||The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors|A Phase II Study Evaluating the Safety and Antiviral Activity of Combination Therapy With 1592U89, 141W94 and DMP 266 in HIV-1 Infected Subjects With Detectable HIV-1 Plasma RNA Despite Treatment With a Protease Inhibitor Containing Regimen|Completed||Phase 2|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.868845|2017-10-11 04:20:29.868845
NCT00002214|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||Phase I Trial of S-1153 in Patients With HIV Infection|Phase I Trial of S-1153 in Patients With HIV Infection|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:29.943144|2017-10-11 04:20:29.943144
NCT00002215|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive|A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.128365|2017-10-11 04:20:30.128365
NCT00002216|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment|A Comparison of a Four-Drug Regimen Comprised of 141W94, 1592U89, and Combivir With a Three-Drug Regimen Comprised of Nelfinavir and Combivir in Antiretroviral-Naive HIV-Infected Patients.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.225595|2017-10-11 04:20:30.225595
NCT00002217|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs|Combivir, 1592U89, 141W94 Triple Antiretroviral, Experienced Patient Trial|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.294666|2017-10-11 04:20:30.294666
NCT00002218|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients|A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.364667|2017-10-11 04:20:30.364667
NCT00002219|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children|A Phase I/II, Open-Label, Multi-Center Study of the Pharmacokinetics, Safety, Tolerance and Activity of Two Dose Levels of Adefovir Dipivoxil (ADF) and Nelfinavir When Added to Antiretroviral Therapy for the Treatment of HIV-Infected Pediatric Patients|Unknown status|Active, not recruiting|Phase 2|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.429651|2017-10-11 04:20:30.429651
NCT00002220|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir|Multi-Center, Open-Label Study of the Effect of Indinavir, Efavirenz, and Adefovir Dipivoxil Combination Therapy in Patients Who Have Failed Nelfinavir|Completed||Phase 3|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.511202|2017-10-11 04:20:30.511202
NCT00002221|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 2003|2003-06-01||||||||Interventional|||Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma|High Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation for HIV Lymphomas: A Phase IIA Study of Comparative Marking Using a Ribozyme Gene and a Neutral Gene|Completed||Phase 2|5||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.605145|2017-10-11 04:20:30.605145
NCT00002222|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS|An Open Label Study of the Safety and Tolerability of Valganciclovir, an Oral Prodrug of Ganciclovir, for the Treatment of Cytomegalovirus Retinitis in Subjects With AIDS|Completed||N/A|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.680269|2017-10-11 04:20:30.680269
NCT00002223|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients|Ritonavir (ABT-538)/Indinavir Combination Treatment in HIV-Infected Patients Previously Receiving Indinavir 800 mg TID|Completed||N/A|||Abbott|||||f||||||||||||||2017-10-11 04:20:30.760102|2017-10-11 04:20:30.760102
NCT00002224|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-13||2011-04-13|March 1999||1999-03-01|April 2011|2011-04-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)|Comparison of HIV RNA Suppression Produced by Triple Regimens Containing Either Didanosine Enteric Coated or Didanosine Formulations Each Administered Once Daily|Completed||Phase 3|120||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:20:30.843534|2017-10-11 04:20:30.843534
NCT00002225|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Efavirenz in Combination With Stavudine and Didanosine|A Phase II, Open-Label, Multicenter Study to Characterize the Effectiveness and Safety of Efavirenz in Combination With Stavudine and Didanosine in Antiretroviral Therapy-Naive HIV-Infected Patients|Completed||Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:30.960638|2017-10-11 04:20:30.960638
NCT00002226|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 2000|2000-06-01||||||||Interventional|||Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma|A Multicenter, Dose Escalating Study in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma|Completed||N/A|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.035752|2017-10-11 04:20:31.035752
NCT00002227|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|A Phase II, Open-Label, Multicenter Study to Characterize the Effectiveness and Safety of Efavirenz in Combination With Stavudine and Lamivudine in Antiretroviral Therapy-Naive HIV-Infected Patients|Completed||Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.117398|2017-10-11 04:20:31.117398
NCT00002228|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of T-20 in HIV-Positive Adults|A Phase II Evaluation of the Safety, Plasma Pharmacokinetics, and Antiviral Activity of T-20 Administered to HIV-1 Positive Adults By Continuous Subcutaneous Infusion or Subcutaneous Injection|Completed||Phase 2|78||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.19886|2017-10-11 04:20:31.19886
NCT00002229|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients|A Phase IV, Non-Comparative Study to Evaluate FORTOVASE (Saquinavir) Soft Gel Capsule (SGC) TID Regimen in Combination With Two NRTI's in HIV-1 Infected Women and Men|Completed||Phase 4|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.290931|2017-10-11 04:20:31.290931
NCT00002230|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients|A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients|Completed||Phase 3|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.407752|2017-10-11 04:20:31.407752
NCT00002231|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 2000|2000-05-01||||||||Interventional|||Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers|GENEVAX-HIV (APL 400-003), a Candidate DNA Vaccine: A Pilot Dose Escalation Study of GENEVAX-HIV Delivered Intramuscularly Using the Biojector 2000 in HIV Seronegative Volunteers|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.47566|2017-10-11 04:20:31.47566
NCT00002232|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Study of GENEVAX-HIV, a Possible Vaccine|GENEVAX-HIV (APL 400-003), a Candidate DNA Vaccine: A Pilot Study of GENEVAX-HIV Given by Intramuscular or Intradermal Administration in HIV Seronegative Volunteers|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.539589|2017-10-11 04:20:31.539589
NCT00002233|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Study of a Combination of Four Drugs in Patients With Recent HIV Infection|A Phase II, 48-Week, Uncontrolled, Open-Label Study Designed to Evaluate the Safety and Efficacy of Quadruple Antiretroviral Therapy (EPIVIR, Abacavir, Amprenavir, and Indinavir) in Subjects Acutely Infected With HIV-1|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.610445|2017-10-11 04:20:31.610445
NCT00002234|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-30|2005-06-23||||||November 2004|2004-11-01||||||||Interventional|||Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients|A Phase II, 48 Week, Open-Label Study Designed to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of a Simplified Dosing Regimen of Preveon (Adefovir Dipivoxil; bis-POM PMEA), Videx (Didanosine; ddI), Sustiva (Efavirenz; DMP-266), and Epivir (Lamivudine; 3TC) Administered Once Daily for the Treatment of HIV-1 Infection|Completed||Phase 2|25||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:31.686844|2017-10-11 04:20:31.686844
NCT00002235|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 2000|2000-03-01||||||||Interventional|||A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors|A Phase II, 48-Week, Open-Label Study Designed to Evaluate the Safety, Tolerability, and Efficacy of a Simplified Dosing Regimen of Viracept (Nelfinavir Mesylate) 1250 Mg BID, Crixivan (Indinavir Sulfate) 1200mg q12h, and Sustiva (Efavirenz; DMP-266) 600 Mg q24h for the Treatment of HIV-1 Infection in Non-Nucleoside Reverse Transcriptase Inhibitor and Protease Inhibitor Naive Patients|Completed||Phase 2|6||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.769395|2017-10-11 04:20:31.769395
NCT00002236|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients|An Open-Label, Parallel Group, Pilot Study of Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of BID and TID Regimens of Delavirdine Mesylate, Zidovudine, and Indinavir Sulfate in HIV-1 Infected Individuals|Completed||N/A|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.843487|2017-10-11 04:20:31.843487
NCT00002237|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1999|1999-09-01||||||||Interventional|||A Study of Peldesine (BCX-34) in HIV-Infected Patients|Phase I Placebo-Controlled Study of Oral BCX-34 (Peldesine) in HIV-Infected Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:31.932826|2017-10-11 04:20:31.932826
NCT00002238|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1991|1991-04-01||||||||Interventional|||Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen|Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:32.036786|2017-10-11 04:20:32.036786
NCT00005356|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1994||1994-07-01|March 2005|2005-03-01|May 1998|Actual|1998-05-01|||||Observational|||Novel Hemostatic Cardiac Risk Factors in Framingham||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.068378|2017-10-11 04:28:03.068378
NCT00002239|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-11-14|||May 1999||1999-05-01|November 2005|2005-11-01||||||||Interventional|||A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults|A Controlled Phase 2 Trial Assessing Three Doses of T-20 in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-1 Infected Adults|Completed||Phase 2|68||Hoffmann-La Roche|||||||||||||||||||2017-10-11 04:20:32.149878|2017-10-11 04:20:32.149878
NCT00002240|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-28||2011-04-13|March 1999||1999-03-01|April 2011|2011-04-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs|Evaluation of the Safety and Antiviral Efficacy of a Novel HIV-1 Protease Inhibitor, BMS-232632, Alone and in Combination With d4T and ddI as Compared to a Reference Combination Regimen|Completed||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:32.295317|2017-10-11 04:20:32.295317
NCT00002241|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 2001|2001-07-01||||||||Interventional|||Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily|A Multicenter, Open-Label, 24-Week Pilot Study to Evaluate the Safety and Efficacy of Indinavir Sulfate 800 Mg b.i.d. in Combination With Ritonavir 100 Mg/d4T/3TC b.i.d. in HIV-Infected Individuals|Unknown status|Active, not recruiting|Phase 2|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:32.401115|2017-10-11 04:20:32.401115
NCT00002243|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 2000|2000-07-01||||||||Interventional|||A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment|A Phase 1B Dose-Range Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV-Positive Patients With No Previous Antiretroviral Therapy|Completed||Phase 1|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:32.506093|2017-10-11 04:20:32.506093
NCT00002244|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 2001|2001-03-01||||||||Interventional|||A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pivotal Clinical Study Evaluating the Safety and Efficacy of WF10 (TCDO) Intravenous Solution in the Management of Patients With Late-Stage HIV Disease|Completed||Phase 3|240||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:32.725856|2017-10-11 04:20:32.725856
NCT00002245|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||April 1999||1999-04-01|August 2000|2000-08-01||||||||Interventional|||A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients|Effect of Amprenavir on Carbohydrate and Lipid Metabolism in Patients With HIV Infection|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:32.852868|2017-10-11 04:20:32.852868
NCT00002246|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-28||2011-04-13|October 1997||1997-10-01|April 2011|2011-04-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex|A Pilot Open Label, Multicenter Study to Evaluate the Role of Stavudine (d4T) in the Treatment of AIDS Dementia Complex|Completed||Phase 3|20||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:32.945209|2017-10-11 04:20:32.945209
NCT00002247|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy|A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy|Completed||N/A|225||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.048401|2017-10-11 04:20:33.048401
NCT00002248|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1993|1993-04-01||||||||Interventional|||A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients|A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.179737|2017-10-11 04:20:33.179737
NCT00002249|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1991|1991-09-01||||||||Interventional|||A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection|A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.262897|2017-10-11 04:20:33.262897
NCT00002250|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura|A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.32593|2017-10-11 04:20:33.32593
NCT00002251|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1991|1991-05-01||||||||Interventional|||A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir|A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir|Completed||N/A|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.379634|2017-10-11 04:20:33.379634
NCT00002252|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1992|1992-08-01||||||||Interventional|||A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea|A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.445482|2017-10-11 04:20:33.445482
NCT00002253|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1992|1992-08-01||||||||Interventional|||"A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either Responders or Non-Responders in a Prior Placebo-Controlled Double-Blind Sandostatin Study."|"A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either Responders or Non-Responders in a Prior Placebo-Controlled Double-Blind Sandostatin Study."|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.549367|2017-10-11 04:20:33.549367
NCT00002254|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1991|1991-05-01||||||||Interventional|||A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)|A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.645027|2017-10-11 04:20:33.645027
NCT00002255|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1991|1991-01-01||||||||Interventional|||An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)|An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.708883|2017-10-11 04:20:33.708883
NCT00002256|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1994|1994-08-01||||||||Interventional|||Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.|Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.789788|2017-10-11 04:20:33.789788
NCT00002257|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1992|1992-07-01||||||||Interventional|||A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS|A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS|Completed||N/A|150||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.850517|2017-10-11 04:20:33.850517
NCT00002258|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1992|1992-11-01||||||||Interventional|||A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia|A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:33.943024|2017-10-11 04:20:33.943024
NCT00002259|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma|Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.00416|2017-10-11 04:20:34.00416
NCT00002260|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1992|1992-03-01||||||||Interventional|||An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects|An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.078355|2017-10-11 04:20:34.078355
NCT00002261|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-09-24||||||September 2007|2007-09-01||||||||Interventional|||A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers|A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers|Completed||Phase 1|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:34.135132|2017-10-11 04:20:34.135132
NCT00002262|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1988|1988-12-01||||||||Interventional|||A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma|A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.199482|2017-10-11 04:20:34.199482
NCT00002263|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine|A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.252303|2017-10-11 04:20:34.252303
NCT00002264|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea|Efficacy of Cow's Milk Immune Globulin in the Treatment of Chronic Intestinal Cryptosporidiosis in Patients With AIDS|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.306578|2017-10-11 04:20:34.306578
NCT00002265|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1994|1994-02-01||||||||Interventional|||An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492|An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.36457|2017-10-11 04:20:34.36457
NCT00002266|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1990|1990-12-01||||||||Interventional|||An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients|An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.431651|2017-10-11 04:20:34.431651
NCT00002314|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1993|1993-12-01||||||||Interventional|||A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma|A Phase II Study of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV-Related Kaposi's Sarcoma|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:38.088003|2017-10-11 04:20:38.088003
NCT00002267|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1992|1992-03-01||||||||Interventional|||Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial|Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial|Completed||N/A|750||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.490109|2017-10-11 04:20:34.490109
NCT00002268|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1991|1991-12-01||||||||Interventional|||A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria|A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.621508|2017-10-11 04:20:34.621508
NCT00002269|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen|A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.680127|2017-10-11 04:20:34.680127
NCT00002270|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1991|1991-03-01||||||||Interventional|||A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection|A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.746116|2017-10-11 04:20:34.746116
NCT00002271|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1991|1991-06-01||||||||Interventional|||An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects|An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.798346|2017-10-11 04:20:34.798346
NCT00002272|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1990|1990-09-01||||||||Interventional|||An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies|An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.853356|2017-10-11 04:20:34.853356
NCT00002273|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS|Double-Blind, Placebo-Controlled Study of Intravenous Ganciclovir (DHPG) for Cytomegalovirus Colitis in Patients With Acquired Immune Deficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:34.911886|2017-10-11 04:20:34.911886
NCT00002274|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine|An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) Exhibiting Significant Deterioration While Taking Zidovudine (Retrovir)|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:20:34.969743|2017-10-11 04:20:34.969743
NCT00002275|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)|Lipid-Based Parenteral Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome and Pneumocystis Carinii Pneumonia. A Comparison of Two Lipid Formulations|Completed||N/A|||Abbott|||||f||||||||||||||2017-10-11 04:20:35.043129|2017-10-11 04:20:35.043129
NCT00002276|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1990|1990-06-01||||||||Interventional|||The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia|Study of Bleeding Tendency, Platelet Function, and Pharmacokinetics of Azidothymidine (AZT) and Motrin (Ibuprofen) in HIV-Infected Hemophiliacs|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.099485|2017-10-11 04:20:35.099485
NCT00002277|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1993|1993-12-01||||||||Interventional|||A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections|Fluconazole Versus Amphotericin B: A Prospective, Randomized, Multicenter Study for Therapy of Fungal Infection|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.15552|2017-10-11 04:20:35.15552
NCT00002278|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1990|1990-07-01||||||||Interventional|||A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS|28 Day Protocol for the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.215845|2017-10-11 04:20:35.215845
NCT00002279|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1991|1991-10-01||||||||Interventional|||A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)|Dideoxycytidine (Ro 24-2027). An Open-Label, Safety Study of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine (AZT) Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.273367|2017-10-11 04:20:35.273367
NCT00002280|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-08-04||||||August 2011|2011-08-01|November 1994|Actual|1994-11-01|||||Interventional|||A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine|An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Children With Acquired Immunodeficiency Syndrome (AIDS) Who Have Demonstrated Significant Deterioration or Intolerance to Zidovudine (Retrovir)|Completed||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:35.328068|2017-10-11 04:20:35.328068
NCT00002281|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex|An Open Label Phase I/II Study of Recombinant Granulocyte Colony-Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With AIDS or ARC|Completed||N/A|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.393692|2017-10-11 04:20:35.393692
NCT00002282|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS|A Randomized Multicenter Study of the Efficacy, Safety, and Toleration of Fluconazole or Clotrimazole Troches in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.450316|2017-10-11 04:20:35.450316
NCT00002283|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS|Randomized Prospective Study of Dapsone Versus Trimethoprim-Sulfamethoxazole in the Treatment of First Episode Pneumocystis Carinii Pneumonia in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.529924|2017-10-11 04:20:35.529924
NCT00002284|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant|A Pilot Study To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients Receiving a Bone Marrow Transplant|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.580534|2017-10-11 04:20:35.580534
NCT00002285|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS|A Phase I/II Pilot Trial To Evaluate Zidovudine (AZT) and T Lymphocyte Transfer in the Treatment of Human Immunodeficiency Virus Type-III (HIV) Infection in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.731734|2017-10-11 04:20:35.731734
NCT00002286|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients|Retrovir Capsules in the Treatment of Psoriasis in HIV Antibody Positive Patients: A Pilot Study|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.798396|2017-10-11 04:20:35.798396
NCT00002287|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus|A Placebo-Controlled Trial to Evaluate Retrovir in Preventing Infection With the Human Immunodeficiency Virus (HIV) in Health Care Workers After Accidental Exposure|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.863233|2017-10-11 04:20:35.863233
NCT00002288|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System|Safety and Efficacy of Retrovir in HIV Infected Patients Having Neuropsychological Impairments|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.930687|2017-10-11 04:20:35.930687
NCT00002289|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients|Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:35.994904|2017-10-11 04:20:35.994904
NCT00002290|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection|A Multi-Center, Double-Blind Trial to Evaluate the Safety and Efficacy of Concurrent Retrovir (Zidovudine) and Zovirax (Acyclovir) Therapy in Patients With Early Symptomatic Human Immunodeficiency Virus (HIV) Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.058571|2017-10-11 04:20:36.058571
NCT00002291|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1989|1989-10-01||||||||Interventional|||The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before|A Double-Blind Group Comparative Study To Evaluate the Safety and Effectiveness of Three Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.163241|2017-10-11 04:20:36.163241
NCT00002292|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS|Inhaled Versus Intravenous Pentamidine in Pneumocystis Carinii Pneumonia in the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.239638|2017-10-11 04:20:36.239638
NCT00002293|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes|Nystatin Pastille for the Prophylaxis of Oral Candidiasis in Patients With AIDS or AIDS Related Syndromes|Completed||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:36.309874|2017-10-11 04:20:36.309874
NCT00002294|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS|Double Blind Placebo Controlled Study of Fluconazole (UK-49,858) for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.40238|2017-10-11 04:20:36.40238
NCT00002295|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Study of Isoprinosine in Patients With Severe AIDS|A Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine (Inosiplex) in Patients With Severe Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.480681|2017-10-11 04:20:36.480681
NCT00002296|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease|A Multi-Center Randomized Double-Blind Placebo-Controlled Study to Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.545129|2017-10-11 04:20:36.545129
NCT00002297|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Study of Isoprinosine in Patients With Lymph Node Disease|A Multi-Center Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine (Inosiplex) in Patients With Unexplained Generalized Lymphadenopathy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.610086|2017-10-11 04:20:36.610086
NCT00002299|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1990|1990-04-01||||||||Interventional|||The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|Combination Therapy With 9-(1,3-Dihydroxy-2-Propoxymethyl) Guanine (DHPG) and Interferon Beta for the Prevention of Relapse of Cytomegalovirus Retinitis in Patients With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.73959|2017-10-11 04:20:36.73959
NCT00002300|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition|Phase II-III Randomized Double-Blind Study Comparing Megestrol Acetate at 100, 400, and 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia|Completed||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:36.823352|2017-10-11 04:20:36.823352
NCT00002301|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1991|1991-03-01||||||||Interventional|||A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir|Foscarnet Treatment of Cytomegalovirus (CMV) Retinitis in AIDS Patients Not Eligible for Ganciclovir Therapy and Ganciclovir Treatment Failures|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.917269|2017-10-11 04:20:36.917269
NCT00002302|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:36.984013|2017-10-11 04:20:36.984013
NCT00002303|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in Patients With AIDS or Advanced ARC and Anemia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:37.062681|2017-10-11 04:20:37.062681
NCT00002304|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems|A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:37.158047|2017-10-11 04:20:37.158047
NCT00002305|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis|Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:37.320448|2017-10-11 04:20:37.320448
NCT00002306|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B|Multi-Center Evaluation of Fluconazole (UK-49,858) as Treatment for Acute Cryptococcal Meningitis in Patients Who Have Failed to Respond or Have Experienced Unacceptable Toxicity During Treatment With Amphotericin B|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:37.471563|2017-10-11 04:20:37.471563
NCT00002307|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-08-04||||||August 2011|2011-08-01|December 1994|Actual|1994-12-01|||||Interventional|||A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients|A Double-Blind Comparison of Zidovudine (AZT) Versus Stavudine (d4T; BMY 27857) for the Treatment of Patients With HIV Infection Who Have Absolute CD4 Lymphocyte Counts Between 50 and 500 Cells/mm3|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:20:37.545971|2017-10-11 04:20:37.545971
NCT00002308|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-08-04||||||August 2011|2011-08-01|November 1991|Actual|1991-11-01|||||Interventional|||A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs|A Randomized Blinded Evaluation of Two Doses of Stavudine (2',3'-Didehydro-2',3'-Dideoxythymidine; d4T) to Make Treatment Available to Severely Immunocompromised Patients With HIV Infection Who Have Failed or Are Intolerant of Alternative Antiretroviral Therapy|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:20:37.66738|2017-10-11 04:20:37.66738
NCT00002309|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients|A Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of Azithromycin as Prophylaxis Against the Development of Mycobacterium Avium Complex Disease in HIV-Infected People|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:37.725151|2017-10-11 04:20:37.725151
NCT00002310|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1993|1993-09-01||||||||Interventional|||SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir|A Pilot Study to Determine the Safety and Efficacy of Topically Applied SP-303T in Patients With Acquired Immunodeficiency Syndrome and Concomitant Herpes Simplex Virus (HSV) Infection Unresponsive to Acyclovir|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:37.781235|2017-10-11 04:20:37.781235
NCT00002311|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1993|1993-05-01||||||||Interventional|||The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients|A Phase I-II Dose Escalation Study to Examine the Safety of Four Doses of Wobenzym in HIV Seropositive Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:37.840287|2017-10-11 04:20:37.840287
NCT00002312|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine|Open-Label Escalating Multiple-Dose Study of the Safety, Tolerance, and Pharmacokinetics of Oral U-90152 in HIV-1 Infected Males and Females With CD4 Counts of 200 - 500 Cells/mm3 Who Are Maintained on a Stable Dose of Zidovudine (AZT)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:37.951587|2017-10-11 04:20:37.951587
NCT00002313|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||A Study of Nystatin in HIV-Infected Patients|Extended Maintenance Protocol for Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection (NOTE: Continuation Study Intended Only for Patients Who Have Completed FDA 103B)|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:38.023445|2017-10-11 04:20:38.023445
NCT00002315|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1994|1994-05-01||||||||Interventional|||A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems|A Double-Blind, Multicenter Study Comparing Oral 882C87 With Oral Acyclovir for Treatment of Localized Herpes Zoster in Immunocompromised Patients|Completed||Phase 3|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:38.145165|2017-10-11 04:20:38.145165
NCT00002316|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1994|1994-12-01||||||||Interventional|||The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis|Phase I Study to Evaluate the Safety and Tolerance of RMP-7 Administered With Amphotericin B to Patients With HIV Infection and Cryptococcal Meningitis|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:38.239404|2017-10-11 04:20:38.239404
NCT00002317|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1993|1993-07-01||||||||Interventional|||A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia|A Study of Neutrexin (Trimetrexate Glucuronate) With Leucovorin Protection for Pediatric Patients (Ages 2-12) With Pneumocystis Carinii Pneumonia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:38.312998|2017-10-11 04:20:38.312998
NCT00002318|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma|Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Adriamycin, Bleomycin, and Vincristine (ABV) in the Treatment of Severe AIDS-Related Kaposi's Sarcoma|Unknown status|Active, not recruiting|Phase 3|225||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:38.373589|2017-10-11 04:20:38.373589
NCT00002319|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma|Open Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:38.482691|2017-10-11 04:20:38.482691
NCT00002320|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-12-08||||||May 1994|1994-05-01||||||||Interventional|||A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past|A Randomized, Double-Blind Multicenter Trial to Compare the Safety and Efficacy of Lamivudine (3TC; GR109714X) Monotherapy Versus Zidovudine (AZT) Monotherapy Versus 3TC Administered With AZT in the Treatment of HIV-1 Infected Patients Who Are AZT Naive (< 4 Weeks) With CD4 Cell Counts of 200-500 Cells/mm3|Completed||Phase 3|320||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:39.859558|2017-10-11 04:20:39.859558
NCT00002321|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1994|1994-10-01||||||||Interventional|||A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis|A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:39.95914|2017-10-11 04:20:39.95914
NCT00002322|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1996|1996-11-01||||||||Interventional|||A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients|Randomized, Double-Blind, Placebo-Controlled Comparative Dose-Response Study of Two Doses of Atevirdine Mesylate (U-87201E) in Combination With Fixed Doses of Zidovudine (AZT) in HIV+ Patients|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.042775|2017-10-11 04:20:40.042775
NCT00002323|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell|A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cells/mm3|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.119337|2017-10-11 04:20:40.119337
NCT00002324|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease|A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Activity, Safety, and Tolerance of 1) 400 Mg Nevirapine in Combination With 500-600 Mg Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 3-24 Months of Prior Zidovudine Therapy and 200-500 CD4 Cells/mm3 and 2) 400 Mg Nevirapine Versus Nevirapine Placebo in Asymptomatic HIV-1 Nucleoside Naive Patients With 200-500 CD4 Cells/mm3|Completed||Phase 2|250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.182557|2017-10-11 04:20:40.182557
NCT00002325|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common|A Double-Blind, Placebo-Controlled Study of Fluconazole in the Prevention of Active Coccidioidomycosis and Other Systemic Fungal Infections in HIV-Infected Patients Living in the Coccidioidal Endemic Area|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.262461|2017-10-11 04:20:40.262461
NCT00002326|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1995|1995-10-01||||||||Interventional|||The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients|A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of Combination Zidovudine (AZT) and 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA; Adefovir) Treatment in HIV-Infected Patients|Completed||Phase 1|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.436149|2017-10-11 04:20:40.436149
NCT00002327|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients|A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Condyloma Acuminatum in Patients With HIV Infection|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.505278|2017-10-11 04:20:40.505278
NCT00002328|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs|Oral/Intravenous Azithromycin in the Treatment of Cryptosporidiosis in Patients Whose Disease Has Not Been Controlled by Conventional Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.606898|2017-10-11 04:20:40.606898
NCT00002330|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|A Randomized Study Comparing the Safety and Efficacy of Three Doses of Oral Ganciclovir to Intravenous Ganciclovir for the Maintenance Treatment of Cytomegalovirus Retinitis in People With AIDS|Completed||N/A|280||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.726163|2017-10-11 04:20:40.726163
NCT00002331|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-01-15|||January 1994||1994-01-01|February 2009|2009-02-01|March 1995|Actual|1995-03-01|March 1995|Actual|1995-03-01||Interventional|||The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS|A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC (dMAC) in Patients With AIDS|Completed||N/A|||Abbott|||||f||||||||||||||2017-10-11 04:20:40.868431|2017-10-11 04:20:40.868431
NCT00002332|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1995|1995-12-01||||||||Interventional|||A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs|Double-Blind Study of the Effect of Timunox (Thymopentin) on Lymphoproliferative Responses and Virus Load in HIV-Infected Subjects Receiving Nucleoside Analog Antiretroviral Therapy|Completed||Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:40.970772|2017-10-11 04:20:40.970772
NCT00002333|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine|A Randomized, Double-Blind, Multicenter, Parallel Study of Ro 31-8959 (Saquinavir; HIV Proteinase Inhibitor) Alone, HIVID (Dideoxycytidine; Zalcitabine, ddC) Alone, and Both in Combination, as Treatment for Advanced HIV Infection (CD4 50-300 Cells/mm3) in Patients Discontinuing or Unable to Take Retrovir (Zidovudine; AZT) Therapy|Completed||Phase 2|900||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.030221|2017-10-11 04:20:41.030221
NCT00002334|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1996|1996-09-01||||||||Interventional|||A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment|A Randomized, Multicenter, Double-Blind, Phase III, Parallel Study of Zidovudine (AZT) Alone Versus AZT Plus Zalcitabine (Dideoxycytidine; ddC) Versus AZT Plus Saquinavir Mesylate (Ro 31-8959 ; HIV Proteinase Inhibitor) Versus AZT Plus ddC Plus Ro 31-8959 in Previously Untreated or Minimally Pretreated HIV-Infected Patients With CD4 Lymphocyte Counts From 50 to <= 350 Cells/mm3|Completed||Phase 3|3000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.16434|2017-10-11 04:20:41.16434
NCT00002335|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||The Safety and Effectiveness of 524W91|A Phase I, Randomized, Single-Dose, Placebo-Controlled Trial to Evaluate the Safety and Pharmacokinetics of 524W91|Completed||Phase 1|18||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.27533|2017-10-11 04:20:41.27533
NCT00002336|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2015-01-15|||November 1992||1992-11-01|February 2009|2009-02-01|November 1994|Actual|1994-11-01|November 1994|Actual|1994-11-01||Interventional|||The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients|A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Clarithromycin for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients With CD4 Counts <= 100 Cells/mm3|Completed||N/A|||Abbott|||||f||||||||||||||2017-10-11 04:20:41.342939|2017-10-11 04:20:41.342939
NCT00002337|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease|A Phase I Safety and Tolerability Study of Four Doses of OPC-8212 (Vesnarinone) in Advanced HIV Disease|Completed||Phase 1|56||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.53212|2017-10-11 04:20:41.53212
NCT00002338|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||The Safety and Effectiveness of 935U83 in HIV-Infected Patients|A Phase I Trial to Evaluate the Safety, Tolerance, and Pharmacokinetics of 935U83 After Multiple Dosing in Patients With HIV Infection|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.598108|2017-10-11 04:20:41.598108
NCT00002339|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems|An Open Multicenter Trial of Fluconazole Oral Suspension in the Treatment of Esophageal Candidiasis in Immunocompromised Patients|Completed||Phase 3|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.685427|2017-10-11 04:20:41.685427
NCT00002340|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX|A Randomized, Open-Label Trial of High Dose Atovaquone Versus Low Dose Atovaquone Versus Aerosolized Pentamidine for Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With HIV Infection Who Are Intolerant of TMP/SMX|Completed||Phase 3|615||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.752071|2017-10-11 04:20:41.752071
NCT00002341|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole|An Open-Label Extension Study of Maintenance Therapy in HIV-Positive Subjects With Fluconazole-Refractory Oropharyngeal Candidiasis Who Have Responded to Itraconazole Oral Solution|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.83644|2017-10-11 04:20:41.83644
NCT00002342|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Tecogalan Sodium|A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Twice Weekly for 21 Days|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.920692|2017-10-11 04:20:41.920692
NCT00002343|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1997|1997-06-01||||||||Interventional|||A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS|An Open-Label Randomized Pharmacokinetic/Pharmacodynamic Study of Mycobutin (Rifabutin) or Rifabutin in Combination With Myambutol (Ethambutol) for Prophylaxis of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts <= 100 Cells/mm3|Completed||Phase 4|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:41.991153|2017-10-11 04:20:41.991153
NCT00005357|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-09|||April 1994||1994-04-01|February 2016|2016-02-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Observational|||Pulmonary Hypertension--Mechanisms and Family Registry|Pulmonary Hypertension--Mechanisms and Family Registry|Completed||N/A|||Vanderbilt University|||||f||||||||||||||2017-10-11 04:28:03.135491|2017-10-11 04:28:03.135491
NCT00002344|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Azithromycin in HIV-Infected Patients|Double-Blind Crossover Study Assessing the Dose Proportionality of Azithromycin Tablets in HIV-Infected Subjects|Completed||Phase 1|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.051801|2017-10-11 04:20:42.051801
NCT00002345|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||The Safety and Effectiveness of Megace in HIV-Infected Women|Phase IV Study on the Safety and Efficacy of Megace Oral Suspension in HIV-Positive Females|Completed||Phase 4|40||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:42.111293|2017-10-11 04:20:42.111293
NCT00002346|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1995|1995-03-01||||||||Interventional|||The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients|A Phase I/II Study of Safety, Tolerance, Pharmacokinetics, and Anti-HIV Activity of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA) and Placebo in HIV-Infected Patients|Completed||Phase 1|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.189182|2017-10-11 04:20:42.189182
NCT00002347|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1995|1995-06-01||||||||Interventional|||The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection|A Master Protocol to Evaluate the Safety and Efficacy of Multi-Drug Combination Antiretroviral Therapy for the Treatment of HIV Infection: Retrovir/HIVID/Nevirapine and Retrovir/HIVID/Invirase|Completed||Phase 2|225||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.257311|2017-10-11 04:20:42.257311
NCT00002348|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma|Phase II Evaluation of Mitoguazone Dihydrochloride in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma Associated With Acquired Immunodeficiency Syndrome|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.347409|2017-10-11 04:20:42.347409
NCT00002349|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-13|||January 1995||1995-01-01|April 2011|2011-04-01|May 1999|Actual|1999-05-01|May 1999|Actual|1999-05-01||Interventional|||A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.|A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.|Completed||N/A|40||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:20:42.412461|2017-10-11 04:20:42.412461
NCT00002350|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients|A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients|Completed||Phase 1|16||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.49126|2017-10-11 04:20:42.49126
NCT00002351|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1995|1995-10-01||||||||Interventional|||A Study of L-735,524 in HIV-Positive Children and Adolescents|An Open-Labeled, Multiple Dose, Multicenter Study to Investigate the Safety, Tolerability, and Plasma Concentration Profile of L-735,524 Capsules in HIV-Seropositive Older Children and Adolescent Patients|Completed||Phase 1|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.562248|2017-10-11 04:20:42.562248
NCT00002352|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of Lobucavir in Patients With AIDS|Pilot Study of the Antiviral Activity of Multiple Doses of Oral Lobucavir in AIDS Patients|Completed||N/A|30||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:42.627045|2017-10-11 04:20:42.627045
NCT00002353|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects|A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.694662|2017-10-11 04:20:42.694662
NCT00002354|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients|One Year Study in HIV-1 Seropositive, AZT-Experienced Patients to Evaluate the Safety and Efficacy of MK-639 Administered Concomitantly With Stavudine (d4T)|Completed||N/A|540||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.756756|2017-10-11 04:20:42.756756
NCT00002355|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes|A Randomized Comparison of Immediate Versus Delayed Treatment With Intravitreal Injections of ISIS 2922 in Patients With Peripheral Cytomegalovirus (CMV) Retinitis|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.834003|2017-10-11 04:20:42.834003
NCT00002356|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes|An Open-Label Study of the Safety and Efficacy of Intravitreal ISIS 2922 in Acquired Immune Deficiency Syndrome (AIDS) Patients With Cytomegalovirus Retinitis (NOTE: Restricted to Patients Who Rollover From Another Controlled ISIS 2922 Trial)|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:42.921485|2017-10-11 04:20:42.921485
NCT00002357|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1997|1997-05-01||||||||Interventional|||The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms|A Multicenter, Randomized, Double-Blinded, Dose-Escalation Study Evaluating the Safety and Antiretroviral Activity of HBY 097 Versus HBY 097 Plus AZT in Patients With Asymptomatic or Mildly Symptomatic HIV Infection|Completed||Phase 2|144||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:43.0485|2017-10-11 04:20:43.0485
NCT00002358|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV|Open-Label BV-araU Treatment of Pediatric HIV-Infected Patients With Cutaneous, Visceral, or Ocular Varicella-Zoster Viral Disease Who Have Failed or Are Intolerant of Standard Therapy|Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:43.122203|2017-10-11 04:20:43.122203
NCT00001208|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-09-12|||November 21, 1985||1985-11-21|August 28, 2017|2017-08-28|October 30, 2019|Anticipated|2019-10-30|||||Interventional|||Botulinum Toxin for the Treatment of Involuntary Movement Disorders|A Training Protocol for the Use of Botulinum Toxin in the Treatment of Neurological Disorders|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:46.010756|2017-10-11 04:20:46.010756
NCT00002359|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1997|1997-06-01||||||||Interventional|||A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega|A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Regardless of Concomitant HIV Therapies|Completed||Phase 3|3000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:43.18509|2017-10-11 04:20:43.18509
NCT00002360|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-13|||March 1999||1999-03-01|April 2011|2011-04-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||A Study Comparing Two Forms of Didanosine in HIV-infected Patients|Pivotal Bioequivalence Study of Videx Chewable/Dispersible Buffered Tablets and an Encapsulated Enteric Coated Bead Formulation of Didanosine in HIV-Infected Subjects|Completed||Phase 1|30||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:20:43.455278|2017-10-11 04:20:43.455278
NCT00002361|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 2000|2000-02-01||||||||Interventional|||Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors|A Multicenter, Open-Label, 24-Week Study to Evaluate the Safety and Activity of Indinavir Sulfate 800 Mg b.i.d. in Combination With Ritonavir 200 Mg b.i.d. and Two NRTIs in HIV-1 Infected Patients Who Failed PI Therapy|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:43.513701|2017-10-11 04:20:43.513701
NCT00002362|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||August 1999||1999-08-01|March 2000|2000-03-01||||||||Interventional|||A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|A Randomized, Open-Label Superiority Trial Comparing Emtricitabine to Abacavir Within a Triple Drug Combination in Antiretroviral-Drug Naive HIV-1 Infected Patients|Suspended||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:43.596306|2017-10-11 04:20:43.596306
NCT00002363|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients|Study of the Safety and Effects of Two Doses of SPC3, Administered Daily Intravenously in HIV-1 Seropositive Patients|Completed||Phase 1|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:43.681409|2017-10-11 04:20:43.681409
NCT00002364|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1997|1997-04-01||||||||Interventional|||A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs|An Exploratory Study of the Antiretroviral Activity of 1592U89 When Administered in Combination With Other Specific Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in NRTI Experienced Patients|Completed||Phase 2|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:43.736954|2017-10-11 04:20:43.736954
NCT00002365|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study of LXR015-1 in HIV-Infected Patients|A Randomized, Parallel, Open-Label Phase I Study of LXR015-1 in HIV-Infected Patients|Completed||Phase 1|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:43.812573|2017-10-11 04:20:43.812573
NCT00002366|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma|A Phase II Safety and Activity Study of Ritonavir in the Treatment of HIV-Associated Cutaneous Kaposi's Sarcoma|Completed||Phase 2|||Abbott|||||f||||||||||||||2017-10-11 04:20:43.873491|2017-10-11 04:20:43.873491
NCT00002367|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs|An Open-Label, Non-Comparative Study of Saquinavir-SGC in Combination With Zidovudine (AZT) and Lamivudine (3TC) in the Treatment of HIV-1 Infected Patients With No Previous Anti-Retroviral Drug Therapy|Completed||Phase 3|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:43.938071|2017-10-11 04:20:43.938071
NCT00002368|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs|An International, Double Blind, Randomized, Phase III Study to Evaluate the Tolerance, Safety, and Effectiveness of Viramune (Nevirapine) in Preventing Clinical AIDS Progression Events or Death When Used in Combination With Lamivudine (3TC) and Stable (>= 4 Weeks) Background Nucleoside Therapy|Completed||Phase 3|2000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:44.010151|2017-10-11 04:20:44.010151
NCT00002369|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|An Open Label, Randomized, Comparative Study of Zerit (d4T) + Epivir (3TC) + Crixivan Versus Retrovir (AZT) + Epivir (3TC) + Crixivan in HIV-Infected, Antiretroviral Naive Subjects With CD4 Cell Counts of 200 - 700 Cells/mm3 and HIV RNA Baseline Copy Number of >= 10,000 Copies/ml|Completed||N/A|200||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:44.16105|2017-10-11 04:20:44.16105
NCT00002370|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||Study of Itraconazole in Patients With Advanced HIV Infection|Pharmacokinetics Study of Intravenous Itraconazole Followed by Oral Dosing at 200 Mg Twice Daily in Patients With Advanced HIV Infection|Completed||N/A|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:44.260269|2017-10-11 04:20:44.260269
NCT00002371|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-28||2011-04-13|June 1996||1996-06-01|April 2011|2011-04-01|December 1997|Actual|1997-12-01|December 1997|Actual|1997-12-01||Interventional|||The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine|A Randomized Double-Blind Study of Safety, Virologic and Immunological Effects of Stavudine Plus Lamivudine (3TC) Versus Zidovudine Plus Lamivudine in HIV-Infected Subjects Following At Least Six Months of Zidovudine Therapy|Completed||Phase 3|80||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:20:44.329724|2017-10-11 04:20:44.329724
NCT00002372|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of 141W94 in Combination With Other Anti-HIV Drugs|A Phase I/II Screening Trial to Identify Potential Partner Compounds to Use in Combination With 141W94|Completed||Phase 1|48||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:44.416096|2017-10-11 04:20:44.416096
NCT00001246|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-08-08|||January 10, 1989||1989-01-10|August 3, 2017|2017-08-03||||||||Observational|||Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers|Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers|Recruiting||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.801734|2017-10-11 04:20:48.801734
NCT00002373|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients|A Phase I/II Trial to Evaluate the Tolerability, Anti-CMV Activity and Pharmacokinetics of 1263W94 Following Multiple Oral Administration of Escalating Doses in HIV-Infected Patients With Asymptomatic CMV Shedding|Completed||Phase 1|56||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:44.48955|2017-10-11 04:20:44.48955
NCT00002374|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients|A Phase IIIB Open-Label Trial Replacing Saquinavir HGC (Ro 31-8959) With Saquinavir SGC (Ro 31-8959) in Combination With Other Antiretroviral Drugs in Patients With HIV-1 Infection|Completed||Phase 3|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:44.557601|2017-10-11 04:20:44.557601
NCT00002375|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 2000|2000-02-01||||||||Interventional|||Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients|A Multicenter, 24-Week Study of the Safety, Pharmacokinetics, and Activity of the Coadministration of Indinavir and Nelfinavir in HIV-1 Seropositive Patients|Completed||N/A|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:44.63528|2017-10-11 04:20:44.63528
NCT00002376|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients|A Randomized Controlled Clinical Study to Determine If the Addition of HIV RNA Viral Load Is an Effective Tool in Determining Treatment Regimens for HIV-Infected Patients|Completed||Phase 4|540||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:44.704068|2017-10-11 04:20:44.704068
NCT00002377|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2017-05-15|||January 1997|Actual|1997-01-01|July 2005|2005-07-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes||Completed||Phase 3|||Hoffmann-La Roche|||||||||||||||||||2017-10-11 04:20:44.789095|2017-10-11 04:20:44.789095
NCT00002378|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients|A Randomized Phase IIIB Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) TID Regimen in Combination With Two NRTIs Versus Saquinavir Soft Gel Capsule (SGC) BID Regimen in Combination With Two NRTIs Versus Saquinavir Soft Gel Capsule (SGC) BID Plus Nelfinavir BID Plus a NRTI in HIV-1 Infected Patients|Completed||Phase 3|825||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:20:44.898021|2017-10-11 04:20:44.898021
NCT00001194|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1984||1984-04-01|March 2000|2000-03-01|February 2001||2001-02-01|||||Observational|||NMR Scanning on Patients|NMR Scanning on Patients|Completed||N/A|99999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:45.173773|2017-10-11 04:20:45.173773
NCT00001195|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||August 28, 1984||1984-08-28|October 20, 2014|2014-10-20|October 20, 2014||2014-10-20|||||Observational|||Endocrine Studies of Healthy Children|Endocrine Studies of Healthy Children|Completed||N/A|1247|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:45.231204|2017-10-11 04:20:45.231204
NCT00001196|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 23, 1984||1984-03-23|September 29, 2015|2015-09-29|September 29, 2015||2015-09-29|||||Observational|||Evaluation of Salivary Gland Dysfunction|Evaluation of Salivary Gland Dysfunction|Terminated||N/A|1740|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:45.280787|2017-10-11 04:20:45.280787
NCT00001197|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 7, 1984||1984-02-07|May 18, 2015|2015-05-18|May 18, 2015|Actual|2015-05-18|December 21, 2003|Actual|2003-12-21||Interventional|||Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia|Effect of Hydroxyurea on Fetal Hemoglobin Synthesis in Patients With Sickle Cell Anemia|Completed||Phase 2|41|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:45.349258|2017-10-11 04:20:45.349258
NCT00001201|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1984||1984-10-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Observational|||Evaluation of Neuromuscular Disease|Evaluation of Neuromuscular Diseases|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:45.579392|2017-10-11 04:20:45.579392
NCT00001202|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1985||1985-01-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Interventional|||Treatment of Boys With Precocious Puberty|Spironolactone and Testolactone Treatment of Boys With Familial Isosexual Precocious Puberty|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:45.636675|2017-10-11 04:20:45.636675
NCT00001203|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||April 22, 1985||1985-04-22|November 9, 2015|2015-11-09|November 9, 2015||2015-11-09|||||Observational|||Deferoxamine for the Treatment of Hemochromatosis|Clinical Course of Patients With Transfusional Hemochromatosis on Deferoxamine|Completed||N/A|151|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:45.702431|2017-10-11 04:20:45.702431
NCT00001204|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||May 28, 1985||1985-05-28|February 22, 2017|2017-02-22||||||||Observational|||Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers|Cardiovascular Evaluation of Homozygous Familial Hypercholesterolemia|Completed||N/A|73|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:45.776786|2017-10-11 04:20:45.776786
NCT00001206|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 5, 1985||1985-06-05|May 15, 2017|2017-05-15|May 15, 2017||2017-05-15|||||Observational|||Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)|Biological Markers in Childhood Psychiatric Disorders|Completed||N/A|347|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:45.94017|2017-10-11 04:20:45.94017
NCT00001209|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1986||1986-10-01|September 1999|1999-09-01|August 2000||2000-08-01|||||Interventional|||A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors|A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.093268|2017-10-11 04:20:46.093268
NCT00001210|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1986||1986-11-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Observational|||Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines|Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.153629|2017-10-11 04:20:46.153629
NCT00001211|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1986||1986-01-01|February 2000|2000-02-01|December 2000||2000-12-01|||||Observational|||Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects|Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.213544|2017-10-11 04:20:46.213544
NCT00001212|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-04-08|||November 1986||1986-11-01|April 2008|2008-04-01|September 2004||2004-09-01|||||Interventional|||Drug Therapy in Lupus Nephropathy|Immunosuppressive Drug Therapy in Membranous Lupus Nephropathy|Completed||Phase 2|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.277963|2017-10-11 04:20:46.277963
NCT00001213|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2014-06-20|2014-06-20||April 1986||1986-04-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis|Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis|Completed||Phase 2|328|Actual|National Institutes of Health Clinical Center (CC)|Due to the progressive nature of the drug's development, this protocol reflects the culmination of cysteamine studies performed at NIH. The combined analyses of the data is presented and not the data or analyses of one individual protocol.|1|||f||||f||||||||||2017-10-11 04:20:46.372291|2017-10-11 04:20:46.372291
NCT00001214|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 30, 1986||1986-04-30|August 16, 2017|2017-08-16||||||||Observational|||Collection of Blood From Patients With Pancytopenia|Lymphocytapheresis of Patients With Pancytopenia|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.667402|2017-10-11 04:20:46.667402
NCT00001215|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||May 16, 1986||1986-05-16|March 1, 2017|2017-03-01||||||||Observational|||Genetic Studies of Lysosomal Storage Disorders|Studies of Genetic Heterogeneity in Patients With Lysosomal Storage Disorders|Enrolling by invitation||N/A|463|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.765835|2017-10-11 04:20:46.765835
NCT00001216|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1986||1986-02-01|December 1999|1999-12-01|February 2001||2001-02-01|||||Observational|||Non-Invasive Electrical Stimulation of the Human Brain|Non-Invasive Stimulation of the Human Central Nervous System (Digitimer)|Completed||N/A|175||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.856058|2017-10-11 04:20:46.856058
NCT00001217|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1987||1987-05-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study|Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study|Completed||Phase 3|260||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.930868|2017-10-11 04:20:46.930868
NCT00001218|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1987||1987-02-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Observational|||Development of Normative Ultrasound Databases of Tongue Surface Configuration|Development of Normative Ultrasound Databases of Tongue Surface Configuration|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:46.997827|2017-10-11 04:20:46.997827
NCT00001219|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-07-11|||June 18, 1987||1987-06-18|July 3, 2017|2017-07-03||||||||Observational|||Comparing Magnetic Resonance Imaging/Spectroscopy Techniques|Magnetic Resonance Imaging at 1.5 and 3.0 Tesla|Enrolling by invitation||N/A|49945|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.052122|2017-10-11 04:20:47.052122
NCT00001220|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1987||1987-10-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders|Comparison of Ultrasound and Videofluoroscopic Imaging Techniques in Diagnosing Oropharyngeal Dysphagia in Neurologically Impaired Subjects|Completed||N/A|750||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.121706|2017-10-11 04:20:47.121706
NCT00001221|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1987||1987-09-01|September 2003|2003-09-01|September 2003||2003-09-01|||||Interventional|||Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome|A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome|Completed||Phase 2|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.180225|2017-10-11 04:20:47.180225
NCT00001223|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 18, 1987||1987-02-18|March 27, 2017|2017-03-27||||||||Observational|||Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders|Diagnosis and Treatment of Patients With Cystic Fibrosis and Other Disorders of the Respiratory System and Pancreas|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.245115|2017-10-11 04:20:47.245115
NCT00001224|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1987||1987-07-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Observational|||Analysis of Eye Tissue|Immunologic Analysis of Intra-Ocular Tissue|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.316357|2017-10-11 04:20:47.316357
NCT00001225|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1987||1987-04-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Family Studies of Inherited Heart Disease|Family Studies of Hypertrophic Cardiomyopathy|Completed||N/A|5880||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.376963|2017-10-11 04:20:47.376963
NCT00001226|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1987||1987-12-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins|Lipoprotein Metabolism in Normal Volunteers and Dyslipoproteinemic Patients (Stable Isotopes)|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.455514|2017-10-11 04:20:47.455514
NCT00001228|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||October 25, 1988||1988-10-25|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Interventional|||Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer|Evaluation of Treatment With Interferon, Octreotide, or Their Combination in Patients With Zollinger-Ellison Syndrome and Progressive Metastatic Non-B Islet Cell Neoplasm|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.521006|2017-10-11 04:20:47.521006
NCT00001229|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1988||1988-10-01|November 1999|1999-11-01|January 2001||2001-01-01|||||Observational|||Diagnosis and Treatment of Pheochromocytoma|Diagnosis and Treatment of Pheochromocytoma|Completed||N/A|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.588081|2017-10-11 04:20:47.588081
NCT00001230|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-08-22|||May 6, 1988||1988-05-06|August 8, 2017|2017-08-08||||||||Observational|||Host Response to Infection and Treatment in Filarial Diseases|Host Response to Infection and Treatment in the Filarial Diseases of Humans|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.646171|2017-10-11 04:20:47.646171
NCT00001231|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-07-18|||July 12, 1988||1988-07-12|July 7, 2017|2017-07-07||||||||Observational|||Perimenopause-Related Mood and Behavioral Disorders|The Evaluation of Women With Perimenopause-Related Mood and Behavioral Disorders|Recruiting||N/A|1900|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.719756|2017-10-11 04:20:47.719756
NCT00001232|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1988||1988-07-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Observational|||The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders|Pituitary Gonadotropin Response to GnRH Stimulation in Menstrual, Climacteric and, Menopause-Related Mood and Behavioral Disorders|Completed||N/A|140||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.793909|2017-10-11 04:20:47.793909
NCT00001233|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1988||1988-12-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Observational|||Study of Children at Risk for Disruptive Behavior Disorders|A Longitudinal Study of Children at Risk for Disruptive Behavior Disorders: Transitions From Early Childhood to Middle Childhood and Adolescence|Completed||N/A|900||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.856832|2017-10-11 04:20:47.856832
NCT00001234|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1988||1988-01-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells|Retroviral-Mediated Transfer and Expression of Glucocerebrosidase and Ceramidtrihexosidase (a-Galactosidase A) cDNA's in Human Hematopoietic Progenitor Cells|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.924375|2017-10-11 04:20:47.924375
NCT00001235|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1988||1988-02-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Genetic Studies in Alzheimer's Disease|Biochemical and Genetic Studies in Familial Alzheimer's Disease|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:47.999859|2017-10-11 04:20:47.999859
NCT00001237|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1989||1989-03-01|January 2000|2000-01-01|April 2000||2000-04-01|||||Interventional|||Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas|Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.075761|2017-10-11 04:20:48.075761
NCT00001238|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 20, 1989||1989-04-20|June 28, 2017|2017-06-28||||||||Observational|||Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders|Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.143179|2017-10-11 04:20:48.143179
NCT00001239|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1989||1989-07-01|April 2000|2000-04-01|January 2001||2001-01-01|||||Interventional|||Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer|Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.297917|2017-10-11 04:20:48.297917
NCT00001240|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||January 1989||1989-01-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Observational|||Evaluating Patients With Abnormal Levels of Gastric Acid|Diagnostic Evaluation of Patients With Suspected Abnormalities of Gastric Secretion|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.365163|2017-10-11 04:20:48.365163
NCT00001241|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||January 27, 1989||1989-01-27|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Treatment of Zollinger-Ellison Syndrome|Medical Therapy of Zollinger-Ellison Syndrome|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.426848|2017-10-11 04:20:48.426848
NCT00001242|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||September 29, 1989||1989-09-29|September 19, 2017|2017-09-19||||||||Observational|||Resistance to Vitamin D or Parathyroid Hormone|Studies of States With Resistance to Vitamin D and Parathyroid Hormone|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.491287|2017-10-11 04:20:48.491287
NCT00001243|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1989||1989-02-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Effects of HIV on the Development and Function of Bone Marrow Cells|Effects of Infection With the Human Immunodeficiency Virus on the Development and Function of Bone Marrow Cells|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.588228|2017-10-11 04:20:48.588228
NCT00001244|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-07-13|||September 14, 1989||1989-09-14|July 12, 2017|2017-07-12||||||||Observational|||Immune Regulation in Patients With Common Variable Immunodeficiency and Related Syndromes|Studies of Immune Regulation in Patients With Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.653044|2017-10-11 04:20:48.653044
NCT00001245|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2009-08-24|||August 1989||1989-08-01|May 2009|2009-05-01||||May 2009|Actual|2009-05-01||Observational|||Study of Patients With Strongyloides Stercoralis Infection|Study of Patients With Known or Suspected Infection With Strongyloides Stercoralis|Completed||N/A|650||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.734341|2017-10-11 04:20:48.734341
NCT00005358|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||April 1994||1994-04-01|January 2016|2016-01-01|March 1999||1999-03-01|||||Observational|||Thrombogenic Factors and Recurrent Coronary Events||Completed||N/A|||University of Rochester|||||f||||||||||||||2017-10-11 04:28:03.217057|2017-10-11 04:28:03.217057
NCT00001248|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-07-18|||March 13, 1989||1989-03-13|July 11, 2017|2017-07-11||||||||Observational|||Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)|Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI)|Recruiting||N/A|1100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:48.982766|2017-10-11 04:20:48.982766
NCT00001249|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1989||1989-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac|Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.176853|2017-10-11 04:20:49.176853
NCT00001250|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1989||1989-12-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial|Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial|Completed||Phase 2|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.239582|2017-10-11 04:20:49.239582
NCT00001251|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-07|2013-08-16|||November 1989||1989-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Phase I Study of Intrathecal Mafosfamide|Phase I Study of Intrathecal Mafosfamide|Completed||Phase 1|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.303348|2017-10-11 04:20:49.303348
NCT00001252|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-09-30|||July 5, 1990||1990-07-05|September 27, 2017|2017-09-27||||||||Observational|||Human Movement Database|A Rigid Body Database on Human Movement|Recruiting||N/A|999999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.382365|2017-10-11 04:20:49.382365
NCT00001253|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1990||1990-05-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Interventional|||The Effects of Estrogen on Cognition in Girls With Turner Syndrome|Estrogen Effects on Cognition in Girls With Turner Syndrome|Completed||Phase 2|950||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.458281|2017-10-11 04:20:49.458281
NCT00001254|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||May 22, 1990||1990-05-22|April 5, 2017|2017-04-05||||||||Observational|||Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome|Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome|Completed||N/A|273|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.52931|2017-10-11 04:20:49.52931
NCT00001255|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1990||1990-09-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Observational|||Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study|Treatment of Severe Combined Immunodeficiency Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency With Autologous Lymphocytes of CD34+ Cells Transduced With a Human ADA Gene: A Natural History Study|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.594665|2017-10-11 04:20:49.594665
NCT00001761|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|January 1999|1999-01-01|April 2000||2000-04-01|||||Interventional|||Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis|Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.656558|2017-10-11 04:20:49.656558
NCT00001762|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 23, 1998||1998-02-23|July 26, 2013|2013-07-26|July 26, 2013||2013-07-26|||||Observational|||Magnetic Resonance Imaging of the Face and Bones|Magnetic Resonance Imaging to Study Avascular Necrosis in HIV-Infected Subjects|Completed||N/A|532|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.711401|2017-10-11 04:20:49.711401
NCT00001763|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|April 1999|1999-04-01|March 2000||2000-03-01|||||Interventional|||Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection|Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.774157|2017-10-11 04:20:49.774157
NCT00001764|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions|Mycophenolate Mofetil in the Treatment of Wegener's Granulomatosis and Related Vasculitides|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.836045|2017-10-11 04:20:49.836045
NCT00001765|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease|Low Intensity Preparative Regimen Followed by HLA-Matched, Mobilized Peripheral Blood Stem Cell Transplantation for Chronic Granulomatous Disease|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.89822|2017-10-11 04:20:49.89822
NCT00001766|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1998||1998-08-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Drug Interactions Among Anti-HIV Agents|Pharmacokinetic Interactions Between Ritonavir, Amprenavir and Efavirenz and Nelfinavir, Amprenavir, and Efavirenz in People Infected With HIV|Completed||Phase 1|22||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:49.968709|2017-10-11 04:20:49.968709
NCT00001768|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|December 1999|1999-12-01|June 2000||2000-06-01|||||Interventional|||Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)|Childhood Onset Psychiatric Disorders: A Placebo Controlled Double-Blind Crossover Trial of Intravenous Immunoglobulin (IVIg)|Completed||Phase 3|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.057283|2017-10-11 04:20:50.057283
NCT00001770|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1998||1998-03-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)|The Phenomenology and Biophysiology of Progestin-Induced Dysphoria|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.122349|2017-10-11 04:20:50.122349
NCT00001771|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1998||1998-05-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers|I-123 Beta-CIT SPECT Studies of Dopamine and Serotonin Transporters in Neuropsychiatric Patients and Normal Volunteers|Completed||N/A|112||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.180732|2017-10-11 04:20:50.180732
NCT00001772|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|August 2000|2000-08-01|July 2001||2001-07-01|||||Observational|||Evaluation of Patients With Rapid Cycling Bipolar Disorder (RCBD)|Evaluation of Patients With Rapid Cycling Bipolar Disorder|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.243245|2017-10-11 04:20:50.243245
NCT00001774|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Observational|||Vasodilation in Patients With Fabry's Disease|An Investigation of Endothelium-Derived Vasodilation in Patients With Fabry's Disease|Completed||N/A|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.297735|2017-10-11 04:20:50.297735
NCT00001776|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||Effects of Brain Stimulation on Learning and Reasoning|Can Stimulation of Frontal Cortical Regions Facilitate Performance on Tests of Procedural Implicit Learning and Analogical Reasoning?|Completed||N/A|122||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.353711|2017-10-11 04:20:50.353711
NCT00001777|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1997||1997-12-01|November 1998|1998-11-01|May 2000||2000-05-01|||||Interventional|||Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD)|A Controlled, Randomized, Double-Blind Trial of Sertraline in Patients With Frontal Lobe Dementia (FLD)|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.42132|2017-10-11 04:20:50.42132
NCT00001778|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||December 23, 1997||1997-12-23|August 2, 2017|2017-08-02||||||||Observational|||Evaluation of Patients With HAM/TSP|Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.480955|2017-10-11 04:20:50.480955
NCT00001780|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Magnetic Stimulation of the Human Nervous System|Stimulation of the Human Central and Peripheral Nervous System With a Magnetic Stimulator|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.552937|2017-10-11 04:20:50.552937
NCT00001781|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)|Open-Label Baseline vs. Treatment Trial Evaluating the Safety, Tolerability and Effect on MRI Lesion and Immunology Parameters of CGP 77116 in Patients With Multiple Sclerosis Mark|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.610835|2017-10-11 04:20:50.610835
NCT00001782|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1998||1998-03-01|November 1999|1999-11-01|December 2000||2000-12-01|||||Observational|||Areas of Brain Responsible for Understanding American Sign Language|Hemispheric Lateralization of Language Receptive Function in the Deaf and in Hearing Individuals Who Learned ASL as First Language|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.668856|2017-10-11 04:20:50.668856
NCT00001783|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical Therapy|Neuroanatomical and Neurophysiological Basis of Motor Recovery Associated With Treatment of Recent Stroke Using Amphetamine and Physical Therapy|Completed||Phase 2|34||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.721502|2017-10-11 04:20:50.721502
NCT00001784|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Mexiletine for the Treatment of Focal Dystonia|Mexiletine for the Treatment of Focal Dystonia|Completed||Phase 2|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.783969|2017-10-11 04:20:50.783969
NCT00001785|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Interventional|||Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)|Combined Virological and Immunological Evaluation of Treatment of Patients With Early HTLV-1-Associated Myelopathy With Recombinant Human Interferon Beta-1a|Completed||Phase 2|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.844763|2017-10-11 04:20:50.844763
NCT00001788|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||October 10, 1998||1998-10-10|September 26, 2017|2017-09-26||||||||Observational|||Genetic Basis of Primary Immunodeficiencies|Molecular Basis of Primary Immunodeficiencies|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.909599|2017-10-11 04:20:50.909599
NCT00001789|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1999||1999-06-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Interventional|||BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis|An Open-Label, Multiple-Dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BG9588 (Anti-CD40L Antibody) in Subjects With Proliferative Lupus Glomerulonephritis (SLE-GN)|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:50.976836|2017-10-11 04:20:50.976836
NCT00001790|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1998||1998-10-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Interventional|||Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia|Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.038408|2017-10-11 04:20:51.038408
NCT00001797|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|December 1999|1999-12-01|September 2000||2000-09-01|||||Interventional|||Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis|Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis|Completed||Phase 2|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.123711|2017-10-11 04:20:51.123711
NCT00001805|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|March 2000|2000-03-01|June 2000||2000-06-01|||||Interventional|||A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab|A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.296368|2017-10-11 04:20:51.296368
NCT00001806|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 3, 1999||1999-04-03|January 4, 2017|2017-01-04|November 4, 2017|Anticipated|2017-11-04|November 4, 2017|Anticipated|2017-11-04||Interventional|||Methods in Education for Breast Cancer Genetics|Methods in Education for Breast Cancer Genetics|Active, not recruiting||Phase 3|170|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:20:51.386859|2017-10-11 04:20:51.386859
NCT00001807|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 15, 1999||1999-04-15|September 1, 2017|2017-09-01||||||||Observational|||(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy|(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy|Active, not recruiting||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.50017|2017-10-11 04:20:51.50017
NCT00001810|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2000|2000-04-01|October 2000||2000-10-01|||||Interventional|||An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections|An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections|Completed||Phase 3|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.565658|2017-10-11 04:20:51.565658
NCT00001812|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2000|2000-04-01|August 2000||2000-08-01|||||Interventional|||A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2|A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2|Completed||Phase 3|84||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.623642|2017-10-11 04:20:51.623642
NCT00001813|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 26, 1999||1999-04-26|September 21, 2017|2017-09-21||||||||Observational|||Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy|Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy|Recruiting||N/A|700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.686183|2017-10-11 04:20:51.686183
NCT00001814|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|February 2000|2000-02-01|January 2001||2001-01-01|||||Observational|||Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples|Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.768255|2017-10-11 04:20:51.768255
NCT00001816|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|May 2000|2000-05-01|February 2001||2001-02-01|||||Observational|||The Impact of Starbright World on Children Being Treated at the NIH|The Impact of Starbright World on Children Being Treated at the NIH|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.823227|2017-10-11 04:20:51.823227
NCT00001818|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||June 1999||1999-06-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Combination Drug Treatment of Pediatric HIV Infection|A Pilot Study of Hydroxyurea in Combination With Stavudine, Didanosine and Efavirenz in Pediatric Patients With HIV-1 Infection|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.876741|2017-10-11 04:20:51.876741
NCT00001823|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 24, 1999||1999-06-24|October 3, 2017|2017-10-03||||||||Observational|||Evaluation for NCI Surgery Branch Clinical Studies|Evaluation for NCI Surgery Branch Clinical Research Protocols|Recruiting||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:51.943455|2017-10-11 04:20:51.943455
NCT00001826|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Observational|||Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor|A Long-Term Observational Study of Immunologic Reconstitution in HIV-1 Infected Children Who Are Receiving Combination Protease Inhibitor and Reverse Transcriptase Inhibitors|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:52.022503|2017-10-11 04:20:52.022503
NCT00001827|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||July 26, 1999||1999-07-26|January 25, 2013|2013-01-25|January 25, 2013|Actual|2013-01-25|December 17, 2007|Actual|2007-12-17||Interventional|||p53 Vaccine for Ovarian Cancer|Vaccine Therapy With Tumor Specific p53 Peptides in Adult Patients With Low Burden Adenocarcinoma of the Ovary|Terminated||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:52.087258|2017-10-11 04:20:52.087258
NCT00001830|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||July 20, 1999||1999-07-20|May 19, 2015|2015-05-19|May 19, 2015|Actual|2015-05-19|||||Interventional|||Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants|Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation|Completed||Phase 1|110|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:52.166446|2017-10-11 04:20:52.166446
NCT00001832|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2012-12-19|2012-11-07||August 1999||1999-08-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma|Treatment of Patients With Metastatic Melanoma Using Cloned Lymphocytes Following the Administration of a Non-Myeloablative But Lymphocyte Depleting Regimen|Completed||Phase 2|170|Actual|National Institutes of Health Clinical Center (CC)||15|||f||||t||||||||||2017-10-11 04:20:52.29619|2017-10-11 04:20:52.29619
NCT00001835|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1999||1999-09-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Oxaliplatin in Cancer Patients With Impaired Kidney Function|A Phase I Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:55.843487|2017-10-11 04:20:55.843487
NCT00001836|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||October 1998||1998-10-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography|Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography|Completed||N/A|213||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:55.909606|2017-10-11 04:20:55.909606
NCT00003098|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-01-29|||August 1997||1997-08-01|January 2016|2016-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Diet and Estrogen Metabolism in Postmenopausal Women|Diet and Estrogen Metabolism in Postmenopausal Women|Completed||N/A|12|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 04:22:32.008775|2017-10-11 04:22:32.008775
NCT00001837|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||November 1998||1998-11-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Observational|||Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients|Sonographic Evaluation of the Effects of Raloxifene on the Uterus and Ovaries in Premenopausal Patients at High Risk for Developing Breast Cancer|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:55.975638|2017-10-11 04:20:55.975638
NCT00001839|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1998||1998-12-01|December 1998|1998-12-01|May 2000||2000-05-01|||||Interventional|||A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome|A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome|Completed||Phase 2|182||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.032009|2017-10-11 04:20:56.032009
NCT00001840|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|January 2001|2001-01-01|July 2001||2001-07-01|||||Observational|||Evaluation of Treated and Untreated Stroke|Evaluation of Treated and Untreated Stroke|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.095087|2017-10-11 04:20:56.095087
NCT00001841|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Observational|||Magnetic Resonance Angiography (MRA) for the Diagnosis of Atherosclerosis|Contrast Enhanced Resonance Angiography (MRA) in the Diagnosis of Atherosclerotic Disease: A Pilot Technical Development Study|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.151176|2017-10-11 04:20:56.151176
NCT00001842|ClinicalTrials.gov processed this data on October 10, 2017|2007-07-31|2008-03-03|||July 1999||1999-07-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||G-CSF for Granulocyte Donation|Kinetics of Intravenous G-CSF-Induced Granulocyte Mobilization in Healthy Apheresis Donors|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.204549|2017-10-11 04:20:56.204549
NCT00001844|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||September 8, 1999||1999-09-08|September 7, 2012|2012-09-07|September 7, 2012||2012-09-07|||||Observational|||Study of New Magnetic Resonance Methods|Functional and Metabolic Imaging Using Magnetic Resonance at 3.0 Tesla|Terminated||N/A|99|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.265179|2017-10-11 04:20:56.265179
NCT00001845|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1999||1999-09-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)|MR Perfusion Imaging in Hypercapnia: Development of Technical Protocols|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.316777|2017-10-11 04:20:56.316777
NCT00001846|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||August 26, 1999||1999-08-26|August 28, 2017|2017-08-28||||||||Observational|||Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use|Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.364278|2017-10-11 04:20:56.364278
NCT00001848|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2016-09-21|||November 1998||1998-11-01|September 2016|2016-09-01|January 2006||2006-01-01|||||Interventional|||The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis|The Safety and Effectiveness of Surgery With or Without Raloxifene (Evista (Trademark), Lilly) for the Treatment of Pelvic Pain Caused by Endometriosis|Completed||Phase 2|612||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.424663|2017-10-11 04:20:56.424663
NCT00001849|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 25, 1999||1999-02-25|September 14, 2017|2017-09-14|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome|New Imaging Modalities in the Evaluation of Patients With Ectopic Cushing's Syndrome|Recruiting||Phase 1/Phase 2|202|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:56.491339|2017-10-11 04:20:56.491339
NCT00001850|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||May 4, 1999||1999-05-04|February 23, 2017|2017-02-23||||||||Observational|||Evaluation of Women With Endocrine and Reproductive-Related Conditions|Evaluation of Women and Men With Endocrine and Reproductive-Related Conditions|Recruiting||N/A|900|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.573276|2017-10-11 04:20:56.573276
NCT00001851|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||December 15, 1998||1998-12-15|June 26, 2009|2009-06-26|April 30, 2002|Actual|2002-04-30|April 30, 2002|Actual|2002-04-30||Observational|||Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome|Evaluation and Treatment to Improve Bone Quality and Prevent Fractures by the Percutaneous Replacement of Diseased Tissue in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.635892|2017-10-11 04:20:56.635892
NCT00001852|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||April 8, 1999||1999-04-08|December 29, 2016|2016-12-29||||||||Observational|||Natural History of Salivary Gland Dysfunction and Sj(SqrRoot)(Delta)Gren s Syndrome|Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome|Completed||N/A|560|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.689307|2017-10-11 04:20:56.689307
NCT00001853|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||October 6, 1998||1998-10-06|May 22, 2017|2017-05-22||||||||Observational|||Diabetes and Heart Disease Risk in Blacks|Diabetes and Heart Disease Risk in Blacks|Recruiting||N/A|1132|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.754668|2017-10-11 04:20:56.754668
NCT00001854|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 12, 1999||1999-02-12|January 15, 2008|2008-01-15|January 15, 2008|Actual|2008-01-15|October 10, 2007|Actual|2007-10-10||Interventional|||Long-Term Therapy With Ribavirin for Chronic Hepatitis C|Long-Term Therapy With Ribavirin for Chronic Hepatitis C|Completed||Phase 4|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.826431|2017-10-11 04:20:56.826431
NCT00001856|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||May 17, 1999||1999-05-17|May 30, 2014|2014-05-30|May 30, 2014||2014-05-30|||||Observational|||Live Donors for Kidney Transplants|Live Donor Renal Donation for Allotransplantation|Completed||N/A|260|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.888973|2017-10-11 04:20:56.888973
NCT00001857|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Interventional|||Study Comparing the Safety of BG9588 (Anti-CD40L Antibody) Against Standard Treatment in Kidney Transplantation|A Multicenter, Open-Label, Study to Determine the Safety of BG9588 (Anti-CD40L Antibody) Therapy Compared to Standard Treatment in Renal Allograft Transplantation|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:56.983689|2017-10-11 04:20:56.983689
NCT00001858|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 8, 1999||1999-06-08|May 30, 2014|2014-05-30|May 30, 2014||2014-05-30|||||Observational|||Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants|Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation|Completed||N/A|294|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.067491|2017-10-11 04:20:57.067491
NCT00001859|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||June 4, 1999||1999-06-04|May 30, 2014|2014-05-30|May 30, 2014||2014-05-30|||||Observational|||Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant|Screening Protocol for Patients Needing a Kidney, Kidney-Pancreas, or Islet Cell Transplant|Completed||N/A|621|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.120199|2017-10-11 04:20:57.120199
NCT00001860|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1999||1999-08-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Sandostatin LAR Depot vs. Surgery for Treating Acromegaly|Sandostatin LAR vs. Surgery in Acromegalics With Macroadenoma|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.178359|2017-10-11 04:20:57.178359
NCT00001861|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||January 29, 1999||1999-01-29|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Screening for Studies on Nystagmus and Strabismus|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Nystagmus or Strabismus|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.233513|2017-10-11 04:20:57.233513
NCT00001862|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis|The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.285204|2017-10-11 04:20:57.285204
NCT00001863|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Interventional|||Leflunomide to Treat Uveitis|Pilot Study of Leflunomide for the Treatment of Uveitis|Completed||Phase 2|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.345605|2017-10-11 04:20:57.345605
NCT00001864|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Amblyopia (Lazy Eye) Treatment Study|Amblyopia Treatment Study|Completed||Phase 3|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.406847|2017-10-11 04:20:57.406847
NCT00001865|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||HAT in Eye Complications of Behcet's Disease|A Study to Investigate the Safety and Efficacy of HAT to Treat the Ocular Complications Related to Behcet's Disease|Completed||Phase 2|26||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.470345|2017-10-11 04:20:57.470345
NCT00001866|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1999||1999-08-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Eye Muscle Surgery to Treat Congenital Nystagmus|Horizontal Rectus Tenotomy in the Treatment of Congenital Nystagmus|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.529794|2017-10-11 04:20:57.529794
NCT00001867|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||September 1999||1999-09-01|September 1999|1999-09-01|September 2000||2000-09-01|||||Observational|||Effect of Pregnancy on Uveitis|Effect of Pregnancy on Uveitis|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.584092|2017-10-11 04:20:57.584092
NCT00001869|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||December 1998||1998-12-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)|Lymphangioleiomyomatosis (LAM) Registry|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.639957|2017-10-11 04:20:57.639957
NCT00001870|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Study of the Effects of Vitamin C on Patients With Type 2 Diabetes|An Exploratory Study of the Effects of Oral Vitamin C Administration on Insulin Sensitivity and Vascular Reactivity in Subjects With Type 2 Diabetes|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:57.700385|2017-10-11 04:20:57.700385
NCT00001871|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|December 1999|1999-12-01|March 2001||2001-03-01|||||Observational|||Study of Muscle Abnormalities in Patients With Specific Genetic Mutations|An Exploratory Study of Skeletal Muscle Abnormalities in Patients With Mutations in Alpha-Tropomyosin and PABP2 Genes|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.096707|2017-10-11 04:20:59.096707
NCT00001872|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 2, 1999||1999-02-02|April 17, 2017|2017-04-17||||||||Observational|||Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease|Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease|Recruiting||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.151044|2017-10-11 04:20:59.151044
NCT00001873|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 22, 1999||1999-02-22|June 13, 2017|2017-06-13|June 13, 2017|Actual|2017-06-13|December 28, 2007|Actual|2007-12-28||Interventional|||The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers|Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine|Completed||Phase 2|102|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:20:59.221114|2017-10-11 04:20:59.221114
NCT00001874|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||February 22, 1999||1999-02-22|August 3, 2009|2009-08-03|August 3, 2009|Actual|2009-08-03|August 3, 2009|Actual|2009-08-03||Observational|||Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy|Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.289052|2017-10-11 04:20:59.289052
NCT00001876|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||February 25, 1999||1999-02-25|June 26, 2017|2017-06-26||||||||Observational|||Lung Disease Associated With Rheumatoid Arthritis|Pulmonary Fibrosis Associated With Rheumatoid Arthritis: Definition of the Natural History of Disease|Completed||N/A|132|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.340344|2017-10-11 04:20:59.340344
NCT00001877|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|May 2004|2004-05-01|May 2004||2004-05-01|||||Interventional|||Treatment of Pulmonary Sarcoidosis With Pentoxifylline|Treatment of Pulmonary Sarcoidosis With Pentoxifylline|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.398584|2017-10-11 04:20:59.398584
NCT00001878|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts|Contribution of Insulin-Like Growth Factor-I (IGF-I) and Its Binding Protein (IGFBP3) to Increased Left Ventricular Mass in Familial Hypertrophic Cardiomyopathy Caused by Distinct Sarcomeric Mutations|Completed||N/A|175||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.465973|2017-10-11 04:20:59.465973
NCT00001879|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|March 2001||2001-03-01|||||Observational|||Collections of Blood and Stool Samples in Patients With Acute Hepatitis|Collection of Blood and Stool Samples in Patients With Acute Hepatitis|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.523061|2017-10-11 04:20:59.523061
NCT00001880|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-03|2017-10-05|||March 11, 1999||1999-03-11|August 18, 2017|2017-08-18||||||||Observational|||Stem Cell Transplantation for Metastatic Solid Tumors|Exploratory Study of Non-Myeloablative Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Metastatic Neoplasms Refractory to Standard Therapy|Completed||N/A|84|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.576884|2017-10-11 04:20:59.576884
NCT00001881|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|April 2001||2001-04-01|||||Observational|||Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease|Clinical Manifestations of Mutations in Genes Linked to Familial Cardiomyopathy|Completed||N/A|9999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.642675|2017-10-11 04:20:59.642675
NCT00001883|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-04|||March 1999||1999-03-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||Quality Control of Cardiopulmonary Exercise Equipment|Quality Control of P-CCMB Cardiopulmonary Exercise Equipment|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.696548|2017-10-11 04:20:59.696548
NCT00001884|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 21, 1999||1999-03-21|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis|Specimen Procurement for Individuals With Pulmonary Fibrosis Associated With Rheumatoid Arthritis|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.746661|2017-10-11 04:20:59.746661
NCT00001885|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||March 21, 1999||1999-03-21|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis|Pulmonary Fibrosis Associated With Rheumatoid Arthritis: Identification of Genetic Polymorphisms|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.795375|2017-10-11 04:20:59.795375
NCT00001886|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|March 2001||2001-03-01|||||Interventional|||Real Time 3-Dimensional Stress Echocardiography|Real Time 3-Dimensional Stress Echocardiography|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:20:59.964292|2017-10-11 04:20:59.964292
NCT00001887|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|February 2001||2001-02-01|||||Observational|||Factors Involved in Asthma and Airway Inflammation|The Role of a Novel Aminopeptidase-Like Protein in Asthma|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:21:00.060552|2017-10-11 04:21:00.060552
NCT00001888|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-10-05|||March 30, 1999||1999-03-30|August 4, 2017|2017-08-04||||||||Observational|||Sample Collections From the Airways of Asthmatic Patients|Asthma Sample Collection Protocol|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:21:00.131017|2017-10-11 04:21:00.131017
NCT00001889|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|March 2001||2001-03-01|||||Interventional|||Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease|Comparison of Myocardial Contrast Echo With Dobutamine Echo in Diagnosis of Coronary Artery Disease|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:21:00.217501|2017-10-11 04:21:00.217501
NCT00001890|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|May 2000|2000-05-01|March 2001||2001-03-01|||||Interventional|||Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections|Immunomodulatory Effects of Hormone Therapy in Postmenopausal Women With Chronic Chlamydia Pneumoniae or Cytomegalovirus Infection|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:21:00.286993|2017-10-11 04:21:00.286993
NCT00001891|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|March 2000|2000-03-01|March 2001||2001-03-01|||||Interventional|||Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle|Assessment of Myocardial Viability Utilizing Myocardial Contrast Echocardiography|Completed||Phase 3|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:21:00.362601|2017-10-11 04:21:00.362601
NCT00001893|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2017-06-30|||August 17, 1999||1999-08-17|June 13, 2008|2008-06-13||||December 31, 2002|Actual|2002-12-31||Interventional|||Study of TNFR:Fc (Enbrel) in the Treatment of Asthma|A Clinical Trial of TNFR:Fc in a Segmental Allergen Challenge Model of Asthma|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:21:00.430588|2017-10-11 04:21:00.430588
NCT00001894|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2006-07-03|||August 1999||1999-08-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Interventional|||A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy|A Randomized Prospective Comparison of DDD Chamber Pacing and Percutaneous Transluminal Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Associated With Severe Drug-Refractory Symptoms|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:21:00.498248|2017-10-11 04:21:00.498248
NCT00001895|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-03|2008-03-03|||August 1999||1999-08-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Electromechanical Mapping to Evaluate Heart Muscle|Evaluation of Electromechanical Endocardial Mapping for Assessment of Myocardial Ischemia and Viability|Completed||Phase 3|71||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:21:00.562334|2017-10-11 04:21:00.562334
NCT00002379|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1998|1998-10-01||||||||Interventional|||The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs|A Phase II, Stratified, Randomized, Open-Label, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil and Indinavir in Combination With Zidovudine, Lamivudine, or Stavudine for the Treatment of Therapy Naive HIV-Infected Patients With CD4 Cell Counts >= 100 Cells/mm3 and HIV-1 RNA Copy Numbers >= 5,000 Copies/Ml|Completed||Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:00.629643|2017-10-11 04:21:00.629643
NCT00002380|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children|A Phase I/II Pharmacokinetic and Safety Study of Saquinavir Soft Gelatin Capsules and Pediatric Pellet Formulations in Combination With Nucleoside Antiretroviral Agents With or Without Nelfinavir, in HIV-Infected Infants and Children|Completed||Phase 1|28||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:00.735726|2017-10-11 04:21:00.735726
NCT00002381|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine|An Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (Viramune) and Nelfinavir (Viracept) and the Efficacy of This Combination Therapy in HIV-1 Infected Adults Treated With Stavudine [d4T] (Zerit)|Completed||Phase 1|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:00.80036|2017-10-11 04:21:00.80036
NCT00002382|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1997|1997-06-01||||||||Interventional|||A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients|An Open Label International Compassionate Treatment Program for the Use of Saquinavir (R0 31-8959) Either As Monotherapy or in Combination With Other Anti-Retroviral Drugs in Patients With Proven HIV Infection|Completed||Phase 3|4000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:00.863387|2017-10-11 04:21:00.863387
NCT00002383|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients|A Randomized, Parallel, Open-Label Study Comparing Saquinavir (Hard Gelatin Formulation, 600 Mg Tid) to Saquinavir Soft Gelatin Formulation [(400 Mg, 800 Mg, 1200 Mg) Tid} x 4 Weeks in HIV Infected Patients|Completed||Phase 1|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:00.922413|2017-10-11 04:21:00.922413
NCT00002384|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:00.990462|2017-10-11 04:21:00.990462
NCT00002385|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients|Multicenter, Rising, Multiple-Dose, Placebo-Controlled, Dose-Response Study to Evaluate the Safety, Tolerability, and Anti-Viral Activity of 4 Weeks of Treatment With 200-800 Mg Fozivudine Tidoxil in Patients With HIV-1 Infection (MF4314).|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:01.041534|2017-10-11 04:21:01.041534
NCT00002386|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia|A Multiclinic, Open Pilot Study to Investigate the Effect of Combination Antiretroviral Therapy Including Indinavir Sulfate on Coagulation Factors, on Platelet Aggregation, and on Factor VIII/IX Half-Life in HIV-1 Seropositive Patients With Hemophilia A or B|Completed||Phase 4|55||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:01.127404|2017-10-11 04:21:01.127404
NCT00002387|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz|A Multicenter, Open, Randomized, Forty-Eight-Week, Pilot Study to Evaluate the Activity, Safety, and Pharmacokinetics of Indinavir Sulfate, 1200 Mg q 12h and DMP 266, 300 Mg q 12h Versus Indinavir Sulfate, 1000 Mg q 8h and DMP 266, 600 Mg q.h.s.|Completed||N/A|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:01.21692|2017-10-11 04:21:01.21692
NCT00002388|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of 1592U89 in HIV-Infected Patients|A Study to Evaluate the Single-Dose and Steady-State Pharmacokinetics/Dynamics of 1592U89 and Its Active Moiety, 1144U88 5'-Triphosphate (1144U88-TP) Following Six Different Dosing Regimens of 1592U89 in HIV-1 Infected Subjects|Completed||Phase 1|48||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:01.289328|2017-10-11 04:21:01.289328
NCT00002389|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs|A Randomized, Double-Blind, Parallel-Group, Multicenter Trial to Evaluate the Safety and Efficacy of 1592U89 in Combination With Lamivudine (3TC) and Zidovudine (ZDV) Versus 3TC/ZDV in HIV-1-Infected, Antiretroviral Therapy-Naive Subjects With CD4+ Counts >= 100 Cells/mm3|Completed||Phase 3|210||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:01.394719|2017-10-11 04:21:01.394719
NCT00002390|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients|A Phase II Randomized, Blinded, Dose-Ranging Multicenter Study to Evaluate the Safety and Efficacy of Different Regimens of 1592U89 Monotherapy Upon Selected Immunological and Virological Markers of HIV-1 Infection in Antiretroviral Therapy-Naive Patients|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:01.674404|2017-10-11 04:21:01.674404
NCT00002391|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs|A Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety and Efficacy of the Combination of 1592U89/Zidovudine (ZDV)/Lamivudine (3TC) Versus the Combination of Zidovudine (ZDV)/Lamivudine (3TC) in HIV-1 Therapy-Experienced Pediatric Patients.|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:01.794015|2017-10-11 04:21:01.794015
NCT00002392|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART|A Study to Investigate the Potential of Thalidomide Treatment to Enhance Immune Responses in HIV-Infected Individuals Who Are Receiving Highly Active Antiretroviral Therapy.|Completed||N/A|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:01.983478|2017-10-11 04:21:01.983478
NCT00002393|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study of Indinavir Taken With or Without DMP 266|A Phase III, Double-Blind, Placebo-Controlled, Multicenter Study to Determine the Effectiveness and Tolerability of the Combination of DMP 266 and Indinavir Versus Indinavir in HIV-Infected Patients Receiving Nucleoside Analogue (NRTI) Therapy|Completed||Phase 3|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:02.085842|2017-10-11 04:21:02.085842
NCT00002394|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment|A Four-Week, Open-Label, Non-Randomized, Multicenter, Dose-Finding, Pilot Study to Evaluate the Safety and Efficacy of Two Daily Doses of Lamisil (1500 Mg and 2000 Mg), Administered for a Maximum of 4 Weeks in HIV-Positive Subjects With Oral Mucosal Candidiasis Not Having Responded to a Minimum of 200 Mg Fluconazole Monotherapy|Completed||N/A|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:02.220146|2017-10-11 04:21:02.220146
NCT00002395|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 2000|2000-07-01||||||||Interventional|||Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)|An Open, Comparative Phase II Study of Immediate Versus Delayed Treatment With Topotecan HCl Given as a Continuous 21-Day Infusion Every 28 Days to Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy|Completed||Phase 2|54||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:02.343058|2017-10-11 04:21:02.343058
NCT00002396|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients|A Phase I/II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance, Pharmacokinetics, and Antiviral Activity of 9-[2-(R)-[[Bis[[(Isopropoxycarbonyl)- Oxy]Methoxy]Phosphinoyl]Methoxy]Propyl]Adenine Fumarate (PMPA Prodrug) in HIV-Infected Patients|Unknown status|Active, not recruiting|Phase 1|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:02.456746|2017-10-11 04:21:02.456746
NCT00002397|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease|An Exploratory Study of Fortovase (Saquinavir) Soft Gelatin Capsules (SGC) Plus d4T and 3TC or Fortovase (Saquinavir) SGC Plus Nelfinavir and d4T in Patients With HIV-1 Associated Nephropathy|Completed||Phase 3|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:02.552508|2017-10-11 04:21:02.552508
NCT00002398|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations|A Randomized, Open-Label Expanded Access Program to Evaluate the Safety of Preveon (Adefovir Dipivoxil) at Two Dose Levels When Used in Combination With Other Antiretroviral Agents for the Treatment of Patients With HIV Infection Who Have Failed Other Antiretroviral Therapy and Have Limited Treatment Options|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:02.666529|2017-10-11 04:21:02.666529
NCT00002399|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1999|1999-01-01||||||||Interventional|||A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients|A Multicenter, Randomized, Double-Blind, Phase II Study to Evaluate the Safety, Tolerance and Efficacy of Multiple Doses of SCH 56592 Versus Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients|Completed||Phase 2|500||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:02.764223|2017-10-11 04:21:02.764223
NCT00002400|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1999|1999-01-01||||||||Interventional|||A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients|An Open-Label Randomized Study of Delavirdine Mesylate (Rescriptor) in Combination With Zidovudine (Retrovir) and Two Doses of Indinavir (Crixivan) Versus Zidovudine, Lamivudine (Epivir), and Indinavir in HIV-1-Infected Individuals|Completed||N/A|45||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.039691|2017-10-11 04:21:03.039691
NCT00002401|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1999|1999-01-01||||||||Interventional|||A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients|An Open-Label Randomized Study of Delavirdine Mesylate (DLV, Rescriptor) in Triple and Quadruple Combinations With Zidovudine (ZDV), Indinavir (IDV), and Lamivudine (3TC) in HIV-1 Infected Individuals|Completed||N/A|160||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.125503|2017-10-11 04:21:03.125503
NCT00002402|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1998|1998-08-01||||||||Interventional|||A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines|Phase I/II Trial to Evaluate the Safety and Immunogenicity of AIDSVAX B/B and B/E Vaccines in the United States|Completed||Phase 1|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.199216|2017-10-11 04:21:03.199216
NCT00002403|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients|A Phase I/II Multiple Dose Study to Evaluate the Safety, Pharmacokinetic Profile and Virologic/Immunologic Activity of Zintevir (AR177) in HIV-1 Patients|Completed||Phase 1|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.274264|2017-10-11 04:21:03.274264
NCT00002404|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-01-24||||||June 1999|1999-06-01||||||||Interventional|||The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients|The Effect of Treatment With Valacyclovir 500 mg BID on the Detection of HIV From Genital HSV Lesions in HIV-Infected Patients: A Double-Blind Crossover Study|Completed||N/A|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.334658|2017-10-11 04:21:03.334658
NCT00002412|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of MKC-442 in Combination With Other Anti-HIV Drugs|A Randomized, Double-Blind Study of MKC-442 Combined With Stavudine, Didanosine, and Hydroxyurea in HIV-Infected Patients Who Are Protease Inhibitor Experienced and Non-Nucleoside Reverse Transcriptase Inhibitor Naive|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.411538|2017-10-11 04:21:03.411538
NCT00002413|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of MKC-442 in HIV-Positive Patients|An Open Label Study of MKC-442 in at Least Triple Drug Combination in Patients Previously Treated With Nucleoside Reverse Transcriptase and Protease Inhibitors and Who Are Naive to Non-Nucleoside Reverse Transcriptase Inhibitors|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.490707|2017-10-11 04:21:03.490707
NCT00002414|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia|Randomized, Double-Blind, Parallel Group, Placebo Controlled, Tolerability, Safety and Pilot Efficacy Study of CPI-1189 in HIV Infected Individuals With Cognitive and Motor Impairment|Unknown status|Active, not recruiting|Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.544124|2017-10-11 04:21:03.544124
NCT00002415|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Antiviral Activity of the Addition of PMPA Prodrug to Combination Antiretroviral Regimens in Treatment-Experienced HIV-Infected Patients|Completed||Phase 2|175||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.60657|2017-10-11 04:21:03.60657
NCT00002416|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 2000|2000-03-01||||||||Interventional|||Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination|A Randomized, Open-Label Equivalence Study of FTC Versus Lamivudine in Patients on a Stable Triple Antiretroviral Therapy Regimen Containing Lamivudine, Stavudine or Zidovudine, and a Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor|Completed||Phase 3|390||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.697994|2017-10-11 04:21:03.697994
NCT00002417|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications|An Open-Label Study to Evaluate the Safety and Tolerance of Amprenavir (141W94) Combination Therapy in Protease Inhibitor Experienced Subjects Who Are Intolerant (Hyperlipidemia With or Without Lipodystrophy) But Not Failing Their Current Protease Inhibitor Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.769538|2017-10-11 04:21:03.769538
NCT00002418|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-13||||||March 2000|2000-03-01||||||||Interventional|||The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors|A Phase II, 24-Week, Open-Label Study Designed to Evaluate the Pharmacokinetics, Safety, Tolerability, and Efficacy of Novel Combination Therapy With Videx (Didanosine), Zerit (Stavudine), Viramune (Nevirapine), and MKC-442 (With or Without Hydroxyurea) for the Treatment of HIV-1 Infection in Non-Nucleoside Reverse Transcriptase Inhibitor Naive Patients Who Failed Previous Protease Inhibitor Treatment|Terminated||Phase 2|25||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:21:03.824233|2017-10-11 04:21:03.824233
NCT00002419|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment|A Phase II, 24-Week, Open-Label Study Designed to Evaluate the Safety, Tolerability, and Efficacy of Novel Quadruple-Combination Therapy With Preveon (Adefovir Dipivoxil; Bis-POM PMEA), Abacavir (1592U89), Sustiva (Efavirenz; DMP-266), and Amprenavir (141W94) for the Treatment of HIV-1 Infection in Patients Who Have Failed Previous Protease Inhibitor Treatment|Completed||Phase 2|25||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:03.88902|2017-10-11 04:21:03.88902
NCT00002420|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-08-13||||||August 2008|2008-08-01||||||||Interventional|||The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors|A Phase II, 24-Week, Open-Label Study Designed to Evaluate the Pharmacokinetics, Safety, Tolerability, and Efficacy of Novel Combination Therapy With Videx (Didanosine), Zerit (Stavudine), Rescriptor (Delavirdine Mesylate), and MKC-442 (With or Without Hydroxyurea) for the Treatment of HIV-1- Infected Patients Who Failed Previous Protease Inhibitor Treatment|Terminated||Phase 2|25||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:21:03.972995|2017-10-11 04:21:03.972995
NCT00002422|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-06-24||||||April 2002|2002-04-01||||||||Interventional|||A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy|A Phase I/II, Open-Label Study of the Safety, Tolerance, Pharmacokinetics, Drug-Interaction and Anti-HIV Activity of Intramuscularly Administered Alpha-Epi-Br (HE2000) in HIV-Infected Patients on Salvage Therapy|Completed||Phase 1|42||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:04.049015|2017-10-11 04:21:04.049015
NCT00002423|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||March 1999||1999-03-01|December 1999|1999-12-01||||||||Interventional|||A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir|A Phase II, Open-Label Trial for Treatment of HIV Infection in Subjects Who Have Failed Initial Combination Therapy With Regimens Containing Indinavir or Nelfinavir: Combination Therapy With 3TC (150 Mg BID), Abacavir (300 Mg BID) and Amprenavir (1200 Mg BID) Plus Either Nelfinavir (1250 Mg BID) or Indinavir (800 Mg TID) for 48 Weeks|Completed||Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:04.246591|2017-10-11 04:21:04.246591
NCT00002424|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine|A Multicenter, Double-Blind, Randomized Pilot Study to Compare the Safety and Activity of L-756423/Indinavir, 1600/800 Mg Qd or 800/400 Mg Bid Versus Indinavir, 800 Mg q8h, All in Combination With Stavudine and Lamivudine|Suspended||Phase 2|186||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:04.367156|2017-10-11 04:21:04.367156
NCT00002425|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1996|1996-12-01||||||||Interventional|||The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs|A Multicenter, Open-Label Study of the Safety and Activity of Saquinavir Soft Gelatin Capsule Formulation (Saquinavir SGC) in Combination With Other Antiretroviral Drugs|Completed||Phase 4|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:04.497921|2017-10-11 04:21:04.497921
NCT00002426|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Adefovir Dipivoxil as Intensification Therapy in Combination With Highly Active Antiretroviral Therapy (HAART) in HIV Infected Patients With HIV-1 RNA > 50 and <= 400 Copies/Ml|Completed||N/A|390||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:04.576245|2017-10-11 04:21:04.576245
NCT00002427|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||May 1999||1999-05-01|August 2000|2000-08-01||||||||Interventional|||Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults|A Phase I/II Study of the Safety and Antiretroviral Activity of Nine Hydroxyurea Regimens in Combination With ddI and d4T in Subjects With HIV Infection|Completed||Phase 1|225||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:04.733251|2017-10-11 04:21:04.733251
NCT00003132|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-08|||January 1998||1998-01-01|November 2009|2009-11-01||||November 2001|Actual|2001-11-01||Interventional|||Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer|Phase I Study of Bryostatin-1 (NSC 339555) and Cisplatin in Advanced Malignancies|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:22:37.384871|2017-10-11 04:22:37.384871
NCT00002428|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects|A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:04.830199|2017-10-11 04:21:04.830199
NCT00002429|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-28||2011-04-13|July 1999||1999-07-01|April 2011|2011-04-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen|Evaluation of HIV RNA Suppression Produced by a Triple Combination Regimen Containing an Enteric Coated Formulation of Didanosine (ddI EC) Administered Once Daily Compared to a Reference Combination Regimen|Completed||Phase 3|500||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:21:04.892226|2017-10-11 04:21:04.892226
NCT00002430|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 2000|2000-02-01||||||||Interventional|||A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations|A Multicenter, Open-Label, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate/d4T/3TC Versus Indinavir Sulfate/Nelfinavir Mesylate/d4T/3TC in HIV-Infected Individuals|Completed||N/A|220||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.017867|2017-10-11 04:21:05.017867
NCT00002431|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1993|1993-11-01||||||||Interventional|||The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients|A Multi-Center Trial to Evaluate the Safety and Effectiveness of Peridex Dosed Twice or Three Times Daily for Preventing or Delaying the Occurrence of Lesions Due to Oral Candidiasis in HIV-Positive Individuals|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.207054|2017-10-11 04:21:05.207054
NCT00002432|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1990|1990-07-01||||||||Interventional|||A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|An Open Study of Foscarnet Treatment of CMV-Retinitis in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.276331|2017-10-11 04:21:05.276331
NCT00002433|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS|Activation of Alveolar Macrophages by Aerosolized r-metHuIFN-Gamma (IFN-Gamma) in Patients With AIDS|Completed||N/A|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.353425|2017-10-11 04:21:05.353425
NCT00002434|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1994|1994-01-01||||||||Interventional|||A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)|A Study of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.4209|2017-10-11 04:21:05.4209
NCT00002435|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1998|1998-02-01||||||||Interventional|||A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients|Study of the Activity of Thymic Humoral Factor (THF Gamma 2) on HIV Load in HIV-Positive Individuals With CD4+ Cell Counts in the Range of 200-500 Cells/mm3|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.502117|2017-10-11 04:21:05.502117
NCT00002436|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1994|1994-05-01||||||||Interventional|||The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT|A Randomized Lamivudine (3TC)/Dideoxycytidine (ddC) Double-Blind Multicenter Trial (With Open-Label AZT) to Evaluate the Safety and Efficacy of Low Dose 3TC Administered Concurrently With AZT Versus High Dose 3TC Administered Concurrently With AZT Versus ddC Administered Concurrently With AZT in the Treatment of HIV-1 Infected, AZT-Experienced (>= 24 Weeks) Patients With CD4 Counts of 100-300 Cells/mm3|Completed||Phase 3|325||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.597726|2017-10-11 04:21:05.597726
NCT00002437|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1994|1994-11-01||||||||Interventional|||The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|A Phase II/III Study of the Safety and Efficacy of 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) for the Treatment of Peripheral Cytomegalovirus Retinitis in Patients With AIDS|Completed||Phase 2|48||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.706671|2017-10-11 04:21:05.706671
NCT00002438|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients|Randomized Study Comparing Itraconazole to Placebo in the Prevention of Histoplasmosis in Patients With Human Immunodeficiency Virus Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.787722|2017-10-11 04:21:05.787722
NCT00002439|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma|Randomized Phase III Vehicle Controlled Trial of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.869608|2017-10-11 04:21:05.869608
NCT00002440|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|An Open-Label, Phase II Trial to Evaluate the Steady-State Pharmacokinetics, Safety, and Efficacy of 1592U89 in Combination With Selected HIV-1 Protease Inhibitors in Antiretroviral-Naive, HIV-1-Infected Patients.|Completed||Phase 2|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:05.92687|2017-10-11 04:21:05.92687
NCT00002441|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 2000|2000-01-01||||||||Interventional|||Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection|A Phase III Trial to Determine the Efficacy of Bivalent AIDSVAX B/B Vaccine in Adults at Risk of Sexually Transmitted HIV-1 Infection in North America|Completed||Phase 3|5000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:06.018437|2017-10-11 04:21:06.018437
NCT00002442|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||June 1999||1999-06-01|August 2000|2000-08-01||||||||Interventional|||A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs|A Phase II, Open-Label, Randomized Study of the Efficacy and Safety of Epivir 150 Mg BID Versus Epivir 300 Mg Once-Daily When Administered for 24 Weeks in Combination With FDA-Approved Dosage Regimens of Zerit and Either Crixivan or Viracept in Subjects With HIV-1 Infection|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:06.221307|2017-10-11 04:21:06.221307
NCT00002443|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1996|1996-09-01|January 1996||1996-01-01|||||Interventional|||The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|Twelve-Month Study in HIV-1 Seropositive Retroviral-Naive Patients to Compare the Safety and Efficacy of MK-639 and Zidovudine (AZT) Administered Concomitantly to MK-639 Alone and Zidovudine (AZT) Alone|Completed||N/A|780||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:06.305112|2017-10-11 04:21:06.305112
NCT00002444|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||October 1995||1995-10-01|February 1996|1996-02-01|February 1996||1996-02-01|||||Interventional|||A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea|Phase I/II Open Label Evaluation of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients|Completed||Phase 1|28||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:06.352806|2017-10-11 04:21:06.352806
NCT00002445|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients|A Phase III Randomized Placebo Controlled and Double Blinded Study of IM862 for Patients With Muco-Cutaneous AIDS Associated Kaposi's Sarcoma|Completed||Phase 3|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:06.411269|2017-10-11 04:21:06.411269
NCT00002446|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||August 1998||1998-08-01|February 2000|2000-02-01||||||||Interventional|||Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients|Randomized, Controlled Trial of SCH 56592 Oral Suspension Versus Fluconazole Suspension in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients|Completed||Phase 3|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:06.668855|2017-10-11 04:21:06.668855
NCT00002447|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||October 1999||1999-10-01|January 2001|2001-01-01||||||||Interventional|||A Study to Compare Two Anti-HIV Drug Combinations|An Open Label, Randomized, Multicenter Study to Evaluate Fortovase (Saquinavir) SGC QD, Norvir (Ritonavir) QD Plus Two NRTIs Vs Sustiva (Efavirenz) QD Plus Two NRTIs in HIV Infected Patients|Completed||Phase 3|146||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:06.789757|2017-10-11 04:21:06.789757
NCT00002448|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||October 1999||1999-10-01|January 2001|2001-01-01||||||||Interventional|||A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients|Evaluation of Immune Reconstitution in HIV Infected Patients Treated With Fortovase (Saquinavir) SGC QD Plus Ritonavir QD Plus 2 NRTIs Vs Efavirenz QD Plus 2 NRTIs|Completed||Phase 3|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:06.929158|2017-10-11 04:21:06.929158
NCT00002449|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||August 1999||1999-08-01|July 2001|2001-07-01||||||||Interventional|||Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy|A Bridging Dose-Escalation Study of the Safety, Pharmacokinetic Properties, and Immunologic Effect of Subcutaneous L2-7001 (Recombinant Human Interleukin-2) in Patients Infected With HIV With CD4+ T-Cell Counts of 300 to 500 Cells/mm3 and Viral Burden Under 10,000 Copies/Ml on Active Antiretroviral Therapy (ART)|Unknown status|Active, not recruiting|Phase 1|212||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:07.011|2017-10-11 04:21:07.011
NCT00002450|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2005-06-23||||||July 2000|2000-07-01||||||||Interventional|||Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Tenofovir Disoproxil Fumarate in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients|Completed||Phase 3|600||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:07.125775|2017-10-11 04:21:07.125775
NCT00002451|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2005-06-23||||||July 2002|2002-07-01||||||||Interventional|||Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs|A Multicenter, Open-Label, 24-Week Pilot Study to Evaluate the Safety and Activity of Indinavir Sulfate 1200 Mg q.d. and Ritonavir 200 Mg q.d. in Combination With Stavudine and Lamivudine in Treatment Naive HIV-1 Infected Patients|Unknown status|Active, not recruiting|Phase 2|8||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:07.355151|2017-10-11 04:21:07.355151
NCT00002452|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-17|2005-06-23||||||February 2000|2000-02-01||||||||Interventional|||A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir|A Multicenter, Open-Label, Pilot Study to Evaluate the Safety and Activity of L-756423/Indinavir Sulfate, 800/400 Mg b.i.d. in Combination With Two nRTIs in HIV-Infected Patients Who Failed an Indinavir Containing Regimen|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:07.453259|2017-10-11 04:21:07.453259
NCT00002453|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-24|2005-06-23|||December 1999||1999-12-01|May 2000|2000-05-01||||||||Interventional|||A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection|An Open-Label, Multicenter, Compassionate Access Study of the Safety of Tenofovir Disoproxil Fumarate Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients|Completed||N/A|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:07.54027|2017-10-11 04:21:07.54027
NCT00002455|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-06|||April 1971||1971-04-01|November 1998|1998-11-01||||||||Interventional|||Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma|Immunotherapy of Colon Cancer With Autologous Perchloric Soluble Tumors Extracts|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:07.665089|2017-10-11 04:21:07.665089
NCT00002456|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-11-28|||May 1986||1986-05-01|November 2011|2011-11-01|April 2002|Actual|2002-04-01|||||Interventional|||Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation|Postgrafting Methotrexate and Cyclosporine for the Prevention of Graft-Versus-Host Disease|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:21:07.747001|2017-10-11 04:21:07.747001
NCT00002160|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1998|1998-03-01||||||||Interventional|||A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain|A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain|Completed||Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.843918|2017-10-11 04:21:38.843918
NCT00002458|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-04|||November 1987||1987-11-01|June 2013|2013-06-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission|Phase II Study of Adjuvant Therapy With Antiganglioside GD2-Specific Mouse Monoclonal Antibody 3F8 for Metastatic Neuroblastoma in Second Remission|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:07.818989|2017-10-11 04:21:07.818989
NCT00002459|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||April 1988||1988-04-01|September 2012|2012-09-01||||August 2001|Actual|2001-08-01||Interventional|||Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus|Phase III Randomized Study of Adjuvant Pelvic Radiotherapy Versus Observation Alone in Patients With Completely Resected, Stage I or II, High-Grade Uterine Sarcoma|Completed||Phase 3|224|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:07.886095|2017-10-11 04:21:07.886095
NCT00002460|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-06|||September 1987||1987-09-01|December 2006|2006-12-01||||||||Interventional|||Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer|Phase III Randomized Study of Adjuvant Therapy With Tamoxifen vs Endocrine Ablation vs Tamoxifen Plus Endocrine Ablation vs No Adjuvant Therapy in Patients Under Age 50 With Operable Breast Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:08.017342|2017-10-11 04:21:08.017342
NCT00002461|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||April 1988||1988-04-01|October 2006|2006-10-01||||||||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma|Phase II Study of Intensive Carmustine and Etoposide With Cisplatin or Cyclophosphamide, Followed By Rescue With Autologous Bone Marrow Treated In Vitro With Etoposide and/or Peripheral Blood Stem Cells Mobilized With Filgrastim (G-CSF) or Sargramostim (GM-CSF) With or Without Radiotherapy in Patients With Resistant Hodgkin's Disease or Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:08.158837|2017-10-11 04:21:08.158837
NCT00002462|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-26|||September 1989||1989-09-01|July 2017|2017-07-01||||May 2000|Actual|2000-05-01||Interventional|||RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease|Phase III Randomized Trial of Adjuvant Involved-Field Radiotherapy vs No Adjuvant Therapy Following Remission Induction With MOPP/ABV Hybrid Chemotherapy in Patients With Stage III/IV Hodgkin's Disease|Active, not recruiting||Phase 3|615|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:08.250421|2017-10-11 04:21:08.250421
NCT00002463|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-14|||February 1989||1989-02-01|February 2013|2013-02-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors|Phase II Study of Methotrexate, Mechlorethamine, Vincristine, Prednisone, and Procarbazine (MMOPP) as Primary Therapy in Infants or Young Children With Primitive Neuroectodermal Tumors or High-Grade Astrocytoma|Completed||Phase 2|4|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:21:08.433354|2017-10-11 04:21:08.433354
NCT00002465|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||December 1987||1987-12-01|July 2007|2007-07-01||||||||Interventional|||High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma|Phase I/II Study of High-Dose Megestrol in Breast or Endometrial Carcinoma or Mesothelioma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:08.528946|2017-10-11 04:21:08.528946
NCT00002466|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-19|||May 1990||1990-05-01|June 2013|2013-06-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer|Phase II Study of Cyclophosphamide, Doxorubicin, Vincristine, Etoposide, and Ifosfamide, Followed by Resection and Radiotherapy in Patients With Peripheral Primitive Neuroectodermal Tumors or Ewing's Sarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:08.591649|2017-10-11 04:21:08.591649
NCT00002470|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-14|||September 1990||1990-09-01|December 2003|2003-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors|A Phase II Study of Protracted Infusional 5-Fluorouracil Plus Alpha Interferon for Advanced Metastatic Carcinoid|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:08.673195|2017-10-11 04:21:08.673195
NCT00002471|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-19|||February 1990||1990-02-01|June 2013|2013-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma|Phase II Trial of Intensive, Short-Course Combination Chemotherapy in the Treatment of Newly Diagnosed Patients With Poor-Risk Nonlymphoblastic Lymphoma and Acute B-Lymphoblastic Leukemia and in Patients With Recurrent Non-Hodgkin's Lymphoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:08.739458|2017-10-11 04:21:08.739458
NCT00002472|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-14|||March 1991||1991-03-01|March 2011|2011-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors|Phase II Pre-Irradiation Chemotherapy for Central Nervous System Germ Cell Malignancies|Completed||Phase 2|||Mayo Clinic|||||f||||||||||||||2017-10-11 04:21:08.839082|2017-10-11 04:21:08.839082
NCT00002473|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-11|||March 1992||1992-03-01|June 2013|2013-06-01||||February 2011|Actual|2011-02-01||Interventional|||Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer|A Prospective Randomized Phase III Study Comparing Radical Surgery to Elective Kidney Sparing Surgery for Low Stage Renal Cell Carcinoma|Completed||Phase 3|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:08.914208|2017-10-11 04:21:08.914208
NCT00002474|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-29|||February 1991||1991-02-01|March 2003|2003-03-01|October 2005|Actual|2005-10-01|||||Interventional|||Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer|Phase II Study of High Dose Cyclophosphamide, Mitoxantrone, and Carboplatin With Autologous Bone Marrow Transplantation in Refractory or Relapsed Ovarian Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:08.984145|2017-10-11 04:21:08.984145
NCT00002475|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09|||April 1991||1991-04-01|November 2008|2008-11-01|June 2009|Actual|2009-06-01|December 2007|Actual|2007-12-01||Interventional|||Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer|A Trial of Active Intralymphatic Immunotherapy With Interferon-Treated Cells and Cyclophosphamide|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:21:09.060841|2017-10-11 04:21:09.060841
NCT00002476|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-01|||January 1990||1990-01-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|||||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer|Phase III Randomized Study of Radiotherapy Alone vs With Concurrent Chemotherapy With MTX or VBMF (VCR/BLEO/MTX/5-FU) vs Subsequent Chemotherapy vs Concurrent and Subsequent Chemotherapy in Patients With Advanced Head and Neck Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:09.15424|2017-10-11 04:21:09.15424
NCT00002477|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||April 1991||1991-04-01|July 2007|2007-07-01||||||||Interventional|||Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer|Phase III Randomized Study of Adjuvant Therapy With a Platinum-Containing Regimen (e.g., CBDCA or CAP: CTX/DOX/CDDP) vs No Adjuvant Therapy in Patients With Fully Resected Early Stage Ovarian Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:09.252312|2017-10-11 04:21:09.252312
NCT00002478|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-07|||June 1993||1993-06-01|November 2000|2000-11-01||||October 2003|Actual|2003-10-01||Interventional|||Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer|Phase II Study of Prolonged Oral VP-16 for Advanced Ovarian Epithelial and Cervical Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:21:09.325248|2017-10-11 04:21:09.325248
NCT00002479|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-17||2011-02-16|October 1991||1991-10-01|May 2012|2012-05-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome|Phase II Trial of Tretinoin (TRA) in Patients With Mycosis Fungoides/Sezary Syndrome|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:21:09.64097|2017-10-11 04:21:09.64097
NCT00002480|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||February 1991||1991-02-01|June 2013|2013-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Radiation Therapy in Treating Patients With Prostate Cancer|Phase I Study of 3-Dimensional Conformal Radiotherapy in Patients With Locally Advanced (Stage T2c and T3) Adenocarcinoma of the Prostate|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:09.753938|2017-10-11 04:21:09.753938
NCT00002481|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||March 1990||1990-03-01|May 2001|2001-05-01||||||||Interventional|||Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Phase II Study of High-Dose Cytarabine, Cisplatin, and Dexamethasone Followed By Cyclophosphamide, Etoposide, Total Body Irradiation, and Autologous Bone Marrow Rescue in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:10.297175|2017-10-11 04:21:10.297175
NCT00002482|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||June 1991||1991-06-01|July 2007|2007-07-01||||||||Interventional|||Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer|A PHASE I-II TRIAL OF MUROMONAB (OKT-3) WITH LOW-DOSE CYCLOPHOSPHAMIDE|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:10.396395|2017-10-11 04:21:10.396395
NCT00002484|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-10-31|||October 1991||1991-10-01|October 2013|2013-10-01||||July 2008|Actual|2008-07-01||Interventional|||Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer|A PHASE I TRIAL OF DOSE ESCALATION OF EXTERNAL BEAM RADIATION THERAPY USING CONFORMAL 3-DIMENSIONAL TREATMENT PLANNING FOR NON-SMALL CELL LUNG CANCER|Completed||Phase 1|104|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:21:10.510347|2017-10-11 04:21:10.510347
NCT00002485|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-12|||February 1992||1992-02-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|July 2003|Actual|2003-07-01||Observational|||Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer|Barriers to Patient Enrollment Onto Frontline Therapeutic Clinical Trials and Development of Intervention Strategies to Increase the Proportion of Enrollment|Completed||N/A|359|Actual|Children's Oncology Group|||2||f||||||||||||||2017-10-11 04:21:10.637948|2017-10-11 04:21:10.637948
NCT00002487|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||July 1991||1991-07-01|April 2000|2000-04-01||||||||Interventional|||Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer|INTRAPERITONEAL METHOTREXATE AND DIPYRIDAMOLE AS SALVAGE TREATMENT FOR ADVANCED OVARIAN CARCINOMA|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:10.87021|2017-10-11 04:21:10.87021
NCT00002488|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||December 1991||1991-12-01|April 2000|2000-04-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy|INTENSIFICATION WITH HIGH DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN FOR INTERMEDIATE OR HIGH GRADE LYMPHOMA PATIENTS WHO FAILED PRIMARY COMBINATION CHEMOTHERAPY|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:10.974349|2017-10-11 04:21:10.974349
NCT00002489|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||October 1991||1991-10-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors|PROTOCOL FOR THE TREATMENT OF MALIGNANT NON-TESTICULAR GERM CELL TUMORS|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:11.062592|2017-10-11 04:21:11.062592
NCT00002490|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||September 1991||1991-09-01|June 2001|2001-06-01||||||||Interventional|||Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer|A RANDOMIZED TRIAL OF RADICAL RADIOTHERAPY IN pT1G3 NXM0 BLADDER CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:11.163567|2017-10-11 04:21:11.163567
NCT00002492|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-14|||November 1991||1991-11-01|December 2016|2016-12-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma|CLINICAL AND PHARMACOLOGICAL STUDY OF CHEMOTHERAPY IN SOFT TISSUE SARCOMA|Completed||Phase 2|||University of Miami|||||f||||||||||||||2017-10-11 04:21:11.265334|2017-10-11 04:21:11.265334
NCT00002493|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-12|||May 1992||1992-05-01|February 2014|2014-02-01||||April 2001|Actual|2001-04-01||Interventional|||Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer|WHOLE ABDOMINAL RADIOTHERAPY VERSUS CIRCADIAN-TIMED COMBINATION DOXORUBICIN-CISPLATIN CHEMOTHERAPY IN ADVANCED ENDOMETRIAL CARCINOMA -- PHASE III|Completed||Phase 3|||Gynecologic Oncology Group|||||f||||t||||||||||2017-10-11 04:21:11.36726|2017-10-11 04:21:11.36726
NCT00002652|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-01|||May 1995||1995-05-01|April 2002|2002-04-01|February 2004|Actual|2004-02-01|||||Interventional|||Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease|A PHASE II PILOT STUDY OF SURAMIN IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA AND PATIENTS WITH CASTLEMAN'S DISEASE|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:44.474017|2017-10-11 04:21:44.474017
NCT00002494|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-30|||May 1992||1992-05-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia|HIGH INTENSITY, BRIEF DURATION CHEMOTHERAPY FOR DIFFUSE SMALL NONCLEAVED CELL LYMPHOMA AND THE L-3 SUBTYPE OF ALL: A PILOT STUDY OF A MULTIDRUG REGIMEN|Completed||Phase 2|134|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:21:11.587385|2017-10-11 04:21:11.587385
NCT00002495|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-02-16|||September 1992||1992-09-01|February 2017|2017-02-01|April 2014|Actual|2014-04-01|November 2000|Actual|2000-11-01||Interventional|||SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease|Randomized Trial of Subtotal Nodal Irradiation Versus Doxorubicin, Vinblastine and Subtotal Nodal Irradiation for Stage I-IIA Hodgkin's Disease|Completed||Phase 3|348|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:11.741583|2017-10-11 04:21:11.741583
NCT00002496|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-23|||August 1992||1992-08-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|August 2002|Actual|2002-08-01||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx|PHASE III TRIAL TO PRESERVE THE LARYNX: INDUCTION CHEMOTHERAPY AND RADIATION THERAPY VERSUS CONCOMITANT CHEMOTHERAPY AND RADIATION THERAPY VERSUS RADIATION THERAPY|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:21:11.869017|2017-10-11 04:21:11.869017
NCT00002498|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||July 1992||1992-07-01|May 2000|2000-05-01||||||||Interventional|||Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer|CMF AND MITOXANTRONE IN ELDERLY PATIENTS WITH ADVANCED BREAST CANCER, A RANDOMIZED PHASE II STUDY|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:11.984874|2017-10-11 04:21:11.984874
NCT00002499|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||January 1990||1990-01-01|May 2000|2000-05-01||||||||Interventional|||Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia|TREATMENT OF ALL IN FIRST BONE MARROW RELAPSE AFTER BFM PROTOCOLS|Unknown status|Active, not recruiting|Phase 2/Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:12.052075|2017-10-11 04:21:12.052075
NCT00002501|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-30|||October 1992||1992-10-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|July 2001|Actual|2001-07-01||Interventional|||Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma|PHASE II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR (rhG-CSF) IN THE TREATMENT OF FOLLICULAR LOW-GRADE NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|29|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:21:12.124998|2017-10-11 04:21:12.124998
NCT00002502|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-26|||July 1992||1992-07-01|June 2013|2013-06-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome|BUSULFAN AND CYCLOPHOSPHAMIDE FOR CYTOREDUCTION OF PATIENTS WITH ACUTE AND CHRONIC LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES UNDERGOING ALLOGENEIC BONE MARROW TRANSPLANTATION WHO CANNOT BE TREATED WITH TOTAL BODY IRRADIATION|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:12.219784|2017-10-11 04:21:12.219784
NCT00002503|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||October 1992||1992-10-01|September 2012|2012-09-01||||November 2000|Actual|2000-11-01||Interventional|||Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases|A PROSPECTIVE MULTICENTER RANDOMIZED STUDY COMPARING STRONTIUM-89 CHLORIDE AND PALLIATIVE LOCAL FIELD RADIOTHERAPY IN PATIENTS WITH HORMONAL ESCAPED ADVANCED PROSTATIC CANCER|Completed||Phase 3|204|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:12.325209|2017-10-11 04:21:12.325209
NCT00002504|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-05-10|||August 1992||1992-08-01|May 2011|2011-05-01|February 1999|Actual|1999-02-01|February 1998|Actual|1998-02-01||Interventional|||Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer|OUTPATIENT SUBCUTANEOUS IL-2 AND ALPHA INTERFERON IN THE MANAGEMENT OF METASTATIC CANCER|Completed||Phase 2|||Hoag Memorial Hospital Presbyterian|||||f||||f||||||||||2017-10-11 04:21:12.504466|2017-10-11 04:21:12.504466
NCT00002505|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-05-10|||August 1992||1992-08-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|August 2002|Actual|2002-08-01||Interventional|||Tumor Cell Vaccine in Treating Patients With Advanced Cancer|RANDOMIZED PHASE II TRIAL OF AUTOLOGOUS TUMOR CELL VACCINE|Completed||Phase 2|||Hoag Memorial Hospital Presbyterian|||||f||||f||||||||||2017-10-11 04:21:12.608576|2017-10-11 04:21:12.608576
NCT00002506|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-05-10|||August 1992||1992-08-01|May 2011|2011-05-01|February 1999|Actual|1999-02-01|January 1996|Actual|1996-01-01||Interventional|||Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer|ALPHA INTERFERON AND CIS-RETINOIC ACID FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS|Completed||Phase 2|||Hoag Memorial Hospital Presbyterian|||||f||||f||||||||||2017-10-11 04:21:12.679884|2017-10-11 04:21:12.679884
NCT00002507|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-24|||November 1992||1992-11-01|June 2000|2000-06-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer|RADIATION WITH MITOMYCIN C OR PORFIROMYCIN IN THE TREATMENT OF CANCER OF THE HEAD AND NECK AREA|Completed||Phase 3|||Yale University|||||f||||||||||||||2017-10-11 04:21:12.759228|2017-10-11 04:21:12.759228
NCT00002508|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-30|||November 1990||1990-11-01|September 2010|2010-09-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors|INTENSIVE CHEMOTHERAPY FOR RELAPSED OR REFRACTORY GERM CELL TUMORS EMPLOYING HIGH-DOSE CARBOPLATIN, ETOPOSIDE, AND THIOTEPA WITH AUTOLOGOUS BONE MARROW RESCUE FOR PATIENTS 15 TO 60 YEARS OF AGE|Completed||Phase 1/Phase 2|||Temple University|||||f||||||||||||||2017-10-11 04:21:12.83444|2017-10-11 04:21:12.83444
NCT00002509|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-30|||November 1991||1991-11-01|September 2010|2010-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer|HIGH-DOSE CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CARBOPLATIN FOLLOWED BY RESCUE WITH AUTOLOGOUS BONE MARROW AND AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH POOR PROGNOSIS BREAST CANCER|Completed||Phase 1/Phase 2|||Temple University|||||f||||||||||||||2017-10-11 04:21:12.89311|2017-10-11 04:21:12.89311
NCT00002510|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-30|||April 1992||1992-04-01|September 2010|2010-09-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma|HIGH-DOSE CHEMORADIOTHERAPY FOLLOWED BY RESCUE WITH MOBILIZED AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH LOW-GRADE, TRANSFORMED, OR FOLLICULAR LARGE CELL NON-HODGKIN'S LYMPHOMA|Completed||Phase 1/Phase 2|||Temple University|||||f||||||||||||||2017-10-11 04:21:12.969385|2017-10-11 04:21:12.969385
NCT00002511|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-15|||December 1992||1992-12-01|October 2012|2012-10-01||||December 2001|Actual|2001-12-01||Interventional|||Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer|PHASE III STUDY OF POST-OPERATIVE EXTERNAL RADIOTHERAPY IN PATHOLOGICAL STAGE T3 N0 PROSTATIC CARCINOMA|Completed||Phase 3|1005|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:13.037178|2017-10-11 04:21:13.037178
NCT00002514|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-21|||April 1993||1993-04-01|August 2007|2007-08-01||||December 2006|Actual|2006-12-01||Interventional|||Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission|Phase III Randomized Trial of Autologous and Allogeneic Stem Cell Transplantation Versus Intensive Conventional Chemotherapy in Acute Lymphoblastic Leukemia in First Remission|Completed||Phase 3|1929|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:13.118391|2017-10-11 04:21:13.118391
NCT00002515|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||October 1992||1992-10-01|June 2013|2013-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer|Myeloablative Chemotherapy With Bone Marrow Rescue For Rare Poor-Prognosis Cancers|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:14.904555|2017-10-11 04:21:14.904555
NCT00002516|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||July 1992||1992-07-01|January 2010|2010-01-01||||||||Interventional|||Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma|EUROPEAN INTERGROUP COOPERATIVE EWING'S SARCOMA STUDY [EICESS 92]|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:14.986775|2017-10-11 04:21:14.986775
NCT00002517|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-19|||March 1993||1993-03-01|December 2002|2002-12-01||||May 2010|Actual|2010-05-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome|IDA VS MTZ IN INDUCTION AND INTENSIFICATION TREATMENT OF AML OR MDS IN CHILDREN, A PHASE III RANDOMIZED STUDY|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:15.097031|2017-10-11 04:21:15.097031
NCT00002519|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-01|||January 1997||1997-01-01|April 2011|2011-04-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer|PH I Continuous Infusion Taxol in Combination With Thoracic Radiation Therapy in Untreated Locally Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|6|Actual|National Cancer Institute (NCI)|||||f||||t||||||||||2017-10-11 04:21:15.31467|2017-10-11 04:21:15.31467
NCT00002520|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-06|||June 1992||1992-06-01|October 2015|2015-10-01||||February 2002|Actual|2002-02-01||Interventional|||Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer|Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings|Completed||N/A|434|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-10-11 04:21:15.403914|2017-10-11 04:21:15.403914
NCT00002521|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-30|||February 1993||1993-02-01|September 2010|2010-09-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma|HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN (CEP) WITH RESCUE BY AUTOLOGOUS BONE MARROW OR AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA (INTERMEDIATE AND HIGH-GRADE HISTOLOGIES)|Completed||Phase 2|||Temple University|||||f||||||||||||||2017-10-11 04:21:15.558991|2017-10-11 04:21:15.558991
NCT00002522|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-30|||February 1993||1993-02-01|September 2010|2010-09-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN (CEP) WITH RESCUE BY AUTOLOGOUS BONE MARROW OR AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN'S DISEASE|Completed||Phase 2|||Temple University|||||f||||||||||||||2017-10-11 04:21:15.648043|2017-10-11 04:21:15.648043
NCT00002523|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-09-01|||April 1993||1993-04-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|March 2003|Actual|2003-03-01||Interventional|||Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed|FOUR ARMS PHASE III CLINICAL TRIAL FOR T3-T4 RESECTABLE RECTAL CANCER COMPARING PRE-OPERATIVE PELVIC IRRADIATION TO PRE-OPERATIVE IRRADIATION COMBINED WITH FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT POST-OPERATIVE ADJUVANT CHEMOTHERAPY|Completed||Phase 3|1011|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:15.736297|2017-10-11 04:21:15.736297
NCT00002524|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||June 1993||1993-06-01|July 2012|2012-07-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma|Pilot Study in AIDS-Related Lymphomas|Completed||Phase 2|46|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 04:21:15.882578|2017-10-11 04:21:15.882578
NCT00002525|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|2016-04-08||August 1993||1993-08-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional||The primary analysis population for the study was all randomized patients with Duke's B3 and C disease.|Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed|Phase III Intergroup Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection, Followed by 5-FU/Leucovorin for Patients With Colon Cancer|Terminated||Phase 3|859|Actual|Eastern Cooperative Oncology Group||2||The study was stopped before reaching its accrual goal due to slow accrual|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-10-11 04:21:16.044819|2017-10-11 04:21:16.044819
NCT00002526|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||January 1993||1993-01-01|May 2012|2012-05-01|September 1995|Actual|1995-09-01|September 1995|Actual|1995-09-01||Interventional|||Chemotherapy in Treating Patients With Advanced Sarcoma|Continuous 5 Days Infusion of High Dose Ifosfamide and Adriamycin in Patients With Advanced Sarcoma|Completed||Phase 2|20|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 04:21:16.531981|2017-10-11 04:21:16.531981
NCT00002527|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||May 1993||1993-05-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|March 2003|Actual|2003-03-01||Interventional|||Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed|Colorectal Adenoma Chemoprevention Trial Using Aspirin: A Phase III Study|Completed||Phase 3|635|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:21:16.630003|2017-10-11 04:21:16.630003
NCT00005359|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-11|||July 1994||1994-07-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Genetics of Asthma and Bronchial Hyperresponsiveness||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.282033|2017-10-11 04:28:03.282033
NCT00002528|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||May 1993||1993-05-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|December 2002|Actual|2002-12-01||Interventional|10-93||Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer|Surgical Therapy With or Without Axillary Node Clearance for Breast Cancer in the Elderly Who Receive Adjuvant Therapy With Tamoxifen.|Completed||Phase 3|473|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-10-11 04:21:16.897596|2017-10-11 04:21:16.897596
NCT00002529|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||May 1993||1993-05-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|12-93||Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer|Adjuvant Therapy for Post/Perimenopausal Patients With Node Positive Breast Cancer Who Are Suitable for Endocrine Therapy Alone.|Completed||Phase 3|452|Actual|International Breast Cancer Study Group||6|||f||||t||||||||||2017-10-11 04:21:17.052801|2017-10-11 04:21:17.052801
NCT00002531|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||January 1993||1993-01-01|December 2006|2006-12-01||||||||Interventional|||Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia|MULTICENTRE TRIAL OF INTENSIFIED THERAPY FOR ADULT ALL (O5/93)|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:17.205263|2017-10-11 04:21:17.205263
NCT00002532|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-06|||January 1993||1993-01-01|March 2002|2002-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia|TREATMENT OF ADULT PATIENTS WITH RELAPSING ACUTE LYMPHOCYTIC LEUKEMIA, A MULTICENTER TRIAL|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:17.303296|2017-10-11 04:21:17.303296
NCT00002533|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-14|||February 1993||1993-02-01|December 2016|2016-12-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|||Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer|A PHASE II/III PILOT STUDY OF THE EFFECTS OF PROPHYLACTIC FLUCONAZOLE THERAPY ON MUCOSITIS IN PATIENTS UNDERGOING RADIATION TREATMENT FOR HEAD AND NECK CANCER|Completed||Phase 2/Phase 3|||University of Miami|||||f||||t||||||||||2017-10-11 04:21:17.38435|2017-10-11 04:21:17.38435
NCT00002534|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||May 1993||1993-05-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission|A RANDOMIZED TRIAL OF UNMODIFIED VERSUS T-CELL DEPLETED ALLOGENEIC HLA-IDENTICAL BONE MARROW TRANSPLANTATION FOR THE TREATMENT OF ACUTE LEUKEMIAS|Completed||Phase 3|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:17.479891|2017-10-11 04:21:17.479891
NCT00002535|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||July 1993||1993-07-01|August 2000|2000-08-01|July 2004|Actual|2004-07-01|||||Interventional|||Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma|TUMOR INFILTRATING LYMPHOCYTE THERAPY FOR ADVANCED MELANOMA USING IMMUNOMODULATION, A PHASE II STUDY|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:17.55782|2017-10-11 04:21:17.55782
NCT00002536|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-08|||December 1996||1996-12-01|March 2008|2008-03-01||||August 2007|Actual|2007-08-01||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer|TREATMENT OF PATIENTS WITH SUBOPTIMAL ('BULKY') STAGE IB CARCINOMA OF THE CERVIX: A RANDOMIZED COMPARISON OF RADICAL HYSTERECTOMY AND PELVIC AND PARA-AORTIC LYMPHADENECTOMY WITH OR WITHOUT NEOADJUVANT VINCRISTINE AND CISPLATIN CHEMOTHERAPY, PHASE III|Completed||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:21:17.625764|2017-10-11 04:21:17.625764
NCT00002537|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||September 1993||1993-09-01|May 2006|2006-05-01||||March 2006|Actual|2006-03-01||Interventional|||Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer|A PHASE I STUDY OF PROLONGED LOW-DOSE TOPOTECAN INFUSION COMBINED WITH CHEST IRRADIATION|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:21:17.766633|2017-10-11 04:21:17.766633
NCT00002538|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-19|||September 1993||1993-09-01|August 2013|2013-08-01||||March 2010|Actual|2010-03-01||Interventional|||Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers|LAPAROSCOPIC STAGING IN PATIENTS WITH INCOMPLETELY STAGED CANCERS OF THE OVARY|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||t||||||||||2017-10-11 04:21:17.83875|2017-10-11 04:21:17.83875
NCT00002539|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||August 1993||1993-08-01|September 2012|2012-09-01||||October 2002|Actual|2002-10-01||Interventional|||Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma|A RANDOMISED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT GRANULOCYTE COLONY-STIMULATING FACTOR IN OPERABLE OSTEOSARCOMA|Completed||Phase 3|214|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:17.921356|2017-10-11 04:21:17.921356
NCT00002540|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-06-30|2013-08-30||November 16, 1993|Actual|1993-11-16|June 2017|2017-06-01||||May 21, 2012|Actual|2012-05-21||Interventional|||Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)|Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial|Active, not recruiting||N/A|76685|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:21:18.031806|2017-10-11 04:21:18.031806
NCT00002542|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-03-21|||July 1993||1993-07-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Tamoxifen in Treating Women With High-Risk Breast Cancer|DOUBLE-BLIND RANDOMIZED TRIAL OF TAMOXIFEN VERSUS PLACEBO IN PATIENTS WITH NODE POSITIVE BREAST CANCER WHO HAVE COMPLETED CMF, CEF OR AC ADJUVANT CHEMOTHERAPY|Completed||Phase 3|800|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:21:18.677882|2017-10-11 04:21:18.677882
NCT00002543|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-17|||February 1995||1995-02-01|May 2007|2007-05-01|October 2004|Actual|2004-10-01|||||Interventional|||Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors|GALLIUM NITRATE FOR THE TREATMENT OF MALIGNANT TUMORS, A PHASE I STUDY|Completed||Phase 1|3|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:18.948385|2017-10-11 04:21:18.948385
NCT00002544|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-01|||May 1993||1993-05-01|April 2001|2001-04-01|November 2002|Actual|2002-11-01|||||Interventional|||Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer|MITOXANTRONE (N) VS. 5-FLUOROURACIL, EPIRUBICIN AND CYCLOPHOSPHAMIDE AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC BREAST CANCER AND AN UNFAVORABLE PROGNOSIS|Completed||Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:19.030412|2017-10-11 04:21:19.030412
NCT00002545|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-09|||February 1994||1994-02-01|August 2013|2013-08-01||||December 2004|Actual|2004-12-01||Interventional|||Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme|A PHASE III TRIAL COMPARING THE USE OF RADIOSURGERY FOLLOWED BY CONVENTIONAL RADIOTHERAPY WITH BCNU TO CONVENTIONAL RADIOTHERAPY WITH BCNU FOR SUPRATENTORIAL GLIOBLASTOMA MULTIFORME|Completed||Phase 3|200|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:21:19.138715|2017-10-11 04:21:19.138715
NCT00002546|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-02-10|||December 1993||1993-12-01|February 2016|2016-02-01||||September 2007|Actual|2007-09-01||Interventional|||Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus|A Phase III Randomized Study of Accelerated Hyperfractionated Whole Abdominal Radiotherapy (AHWAR) Versus Combination Ifosfamide-Mesna With Cisplatin in Optimally Debulked Stage I, II, III, or IV Carcinosarcoma (CS) of The Uterus|Completed||Phase 3|216|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:21:19.698788|2017-10-11 04:21:19.698788
NCT00002547|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-06|||August 1987||1987-08-01|August 2012|2012-08-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome|ALLOGENEIC AND SYNGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE NON-LYMPHOCYTIC LEUKEMIA|Completed||Phase 2|280|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||||||||||||2017-10-11 04:21:19.888193|2017-10-11 04:21:19.888193
NCT00002548|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-03-05|||January 1994||1994-01-01|March 2015|2015-03-01|November 2006|Actual|2006-11-01|October 2003|Actual|2003-10-01||Interventional|||SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma|Standard Dose Versus Myeloablative Therapy for Previously Untreated Symptomatic Multiple Myeloma, A Phase III Intergroup Study|Completed||Phase 3|899|Actual|Southwest Oncology Group||4|||f||||t||||||||||2017-10-11 04:21:19.982406|2017-10-11 04:21:19.982406
NCT00002549|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-12-22|||November 1993||1993-11-01|December 2009|2009-12-01||||||||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia|RANDOMIZED PHASE III STUDY OF INDUCTION (ICE VS MICE VS DCE) AND INTENSIVE CONSOLIDATION (IDIA VS NOVIA VS DIA) FOLLOWED BY BONE MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA: AML 10 PROTOCOL|Unknown status|Active, not recruiting|Phase 3|1520|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:20.206868|2017-10-11 04:21:20.206868
NCT00002550|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-11-14|||March 1994||1994-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|June 2004|Actual|2004-06-01||Interventional|||Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer|A Phase III Comparison Between Concurrent Chemotherapy Plus Radiotherapy and Concurrent Chemotherapy Plus Radiotherapy Followed by Surgical Resection for Stage IIIA (N2) Non-Small Cell Lung Cancer|Completed||Phase 3|429|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:20.543824|2017-10-11 04:21:20.543824
NCT00002551|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||March 1994||1994-03-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|August 2006|Actual|2006-08-01||Interventional|||SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed|Postoperative Evaluation of 5-FU by Bolus Injection vs. 5-FU by Prolonged Venous Infusion Prior to and Following Combined Prolonged Venous Infusion Plus Pelvic XRT vs. Bolus 5-FU Plus Leucovorin Plus Levamisole Prior to and Following Combined Pelvic XRT Plus Bolus 5-FU Plus Leucovorin in Patients With Rectal Cancer, Phase III|Completed||Phase 3|1917|Actual|Southwest Oncology Group||3|||f||||t||||||||||2017-10-11 04:21:20.694265|2017-10-11 04:21:20.694265
NCT00002552|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-05|||October 1993||1993-10-01|April 2013|2013-04-01|October 2003|Actual|2003-10-01|September 2001|Actual|2001-09-01||Interventional|||Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma|AUTOLOGOUS, ALLOGENEIC, OR SYNGENEIC BONE MARROW TRANSPLANTATION IN HODGKIN'S DISEASE, NON-HODGKIN'S LYMPHOMA, AND MULTIPLE MYELOMA|Completed||Phase 2|40|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:21:20.874061|2017-10-11 04:21:20.874061
NCT00002553|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-11-28|||August 1990||1990-08-01|November 2011|2011-11-01|June 2003|Actual|2003-06-01|||||Interventional|||Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer|TREATMENT OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES USING MARROW TRANSPLANTATION FROM UNRELATED DONORS MATCHED FOR HLA OR INCOMPATIBLE FOR ONE HLA LOCUS ANTIGEN|Completed||Phase 2|50|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:21:20.969608|2017-10-11 04:21:20.969608
NCT00002554|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-29|||November 1993||1993-11-01|March 2010|2010-03-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse|RADIOLABELED BC8 (ANTI-CD45) ANTIBODY COMBINED WITH BUSULFAN AND CYCLOPHOSPHAMIDE AS TREATMENT FOR ACUTE MYELOGENOUS LEUKEMIA IN FIRST OR SECOND REMISSION OR UNTREATED FIRST RELAPSE FOLLOWED BY HLA-IDENTICAL RELATED MARROW TRANSPLANTATION|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:21:21.058507|2017-10-11 04:21:21.058507
NCT00002555|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||February 1994||1994-02-01|June 2012|2012-06-01||||October 2000|Actual|2000-10-01||Interventional|||High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer|A PHASE III RANDOMIZED STUDY ON POSTOPERATIVE RADIO- AND CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS|Completed||Phase 3|338|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:21.126839|2017-10-11 04:21:21.126839
NCT00002556|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-30|||July 1994||1994-07-01|May 2013|2013-05-01||||January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma|The Treatment of Multiple Myeloma Utilizing VBMCP Chemotherapy Alternating With High-Dose Cyclophosphamide and Alpha2b-Interferon Versus VBMCP: A Phase III Study for Previously Untreated Multiple Myeloma|Completed||Phase 3|312|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:21:21.245178|2017-10-11 04:21:21.245178
NCT00002557|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||June 1993||1993-06-01|August 2000|2000-08-01||||||||Interventional|||Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides|PROTOCOL FOR THE MANAGEMENT OF MYCOSIS FUNGOIDES AND THE SEZARY SYNDROME|Unknown status|Active, not recruiting|Phase 2|3|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:21.350916|2017-10-11 04:21:21.350916
NCT00002558|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-04-11|2015-12-21||January 1994||1994-01-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors|PHASE I/II TRIAL OF SEQUENTIAL TAXOL/IFOSFAMIDE AND DOSEINTENSIVE CARBOPLATIN/ETOPOSIDE WITH STEM CELL SUPPORT IN CISPLATIN-RESISTANT GERM CELL TUMOR PATIENTS WITH UNFAVORABLE PROGNOSTIC FEATURES|Completed||Phase 1/Phase 2|108|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:21:21.423035|2017-10-11 04:21:21.423035
NCT00002559|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||January 1994||1994-01-01|July 2013|2013-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin|PHASE I/II TRIAL OF TAXOL, IFOSFAMIDE, AND CISPLATIN FOR CISPLATIN-RESISTANT GERM CELL TUMOR PATIENTS WITH FAVORABLE PROGNOSTIC FEATURES|Completed||Phase 1/Phase 2|43|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:21.820572|2017-10-11 04:21:21.820572
NCT00002560|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-27|||February 1994||1994-02-01|June 2013|2013-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma|PHASE II TRIAL OF MONOCLONAL ANTIBODY 3F8 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FOR NEUROBLASTOMA|Completed||Phase 2|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:21.881313|2017-10-11 04:21:21.881313
NCT00002561|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-11-25|||January 1994||1994-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease|A PHASE III STUDY OF RADIOTHERAPY OR ABVD PLUS RADIOTHERAPY VERSUS ABVD ALONE IN THE TREATMENT OF EARLY STAGE HODGKIN'S DISEASE|Completed||Phase 3|405|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||Undecided||2017-10-11 04:21:21.947337|2017-10-11 04:21:21.947337
NCT00002562|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-19|||March 1994||1994-03-01|December 2005|2005-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer|EVALUATION OF PACLITAXEL (TAXOL) IN PERSISTENT OR RECURRENT NON-SQUAMOUS CELL CARCINOMA OF THE CERVIX AND VAGINA|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:22.112496|2017-10-11 04:21:22.112496
NCT00002563|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-08|||April 1994||1994-04-01|April 2013|2013-04-01|May 2005|Actual|2005-05-01|September 2003|Actual|2003-09-01||Observational|||SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease|Health Status and Quality of Life in Patients With Early Stage Hodgkin's Disease: A Companion Study to SWOG-9133|Completed||N/A|263|Actual|Southwest Oncology Group|||1||f||||t||||||||||2017-10-11 04:21:22.261927|2017-10-11 04:21:22.261927
NCT00002564|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||April 1994||1994-04-01|February 2010|2010-02-01|December 2006|Actual|2006-12-01|||||Interventional|||Nutrition Intervention in Treating Women With Breast Cancer|A CLINICAL TRIAL TO DETERMINE THE EFFICACY OF A DIETARY FAT REDUCTION PROGRAM PROVIDED IN ADDITION TO SYSTEMIC ADJUVANT THERAPY IN THE MANAGEMENT OF PATIENTS WITH PRIMARY INVASIVE BREAST CANCER|Completed||Phase 3|2500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:22.352054|2017-10-11 04:21:22.352054
NCT00002565|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-05|||May 1994||1994-05-01|October 2012|2012-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma|"RANDOMIZED COMPARISON OF ALTERNATING TRIPLE THERAPY (ATT) VERUS CHOP IN PATIENTS WITH INTERMEDIATE GRADE LYMPHOMAS AND IMMUNOBLASTIC LYMPHOMAS WITH INTERNATIONAL INDEX 2-5"|Completed||Phase 3|61|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:21:22.472653|2017-10-11 04:21:22.472653
NCT00002566|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-02|||February 1994||1994-02-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors|INTERNATIONAL RANDOMIZED STUDY FOR THE SALVAGE TREATMENT OF GERM CELL TUMOURS|Unknown status|Active, not recruiting|Phase 3|280|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:22.579446|2017-10-11 04:21:22.579446
NCT00002567|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||March 1994||1994-03-01|June 2013|2013-06-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission|PHASE II STUDY EVALUATING AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION FOR ACUTE LEUKEMIAS|Completed||Phase 2|45|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:22.641872|2017-10-11 04:21:22.641872
NCT00002568|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-08|||June 1994||1994-06-01|May 2010|2010-05-01||||December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer|A PHASE III RANDOMIZED STUDY OF CISPLATIN (NSC #119875) AND TAXOL (PACLITAXEL) (NSC #125973) WITH INTERVAL SECONDARY CYTOREDUCTION VERSUS CISPLATIN AND PACLITAXEL IN PATIENTS WITH SUBOPTIMAL STAGE III & IV EPITHELIAL OVARIAN CARCINOMA|Completed||Phase 3|470|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:21:22.821386|2017-10-11 04:21:22.821386
NCT00002569|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-11-14|||July 1994||1994-07-01|November 2015|2015-11-01||||February 2005|Actual|2005-02-01||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma|Phase III Intergroup Randomized Comparison of Radiation Alone vs. Pre-Radiation Chemotherapy for Pure and Mixed Anaplastic Oligodendrogliomas|Completed||Phase 3|299|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:23.014813|2017-10-11 04:21:23.014813
NCT00002570|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-11-25|||July 1994||1994-07-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|November 2000|Actual|2000-11-01||Interventional|||Immediate Compared With Delayed Chemotherapy in Treating Patients With Advanced Colorectal Cancer Without Signs or Symptoms of Disease|A PHASE III STUDY OF IMMEDIATE VERSUS DELAYED CHEMOTHERAPY FOR ASYMPTOMATIC ADVANCED COLORECTAL CANCER|Completed||Phase 3|67|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:21:23.278713|2017-10-11 04:21:23.278713
NCT00002571|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-22|||June 1994||1994-06-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|November 2003|Actual|2003-11-01||Interventional|||SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma|Study of Promace-Cytabom With Trimethoprim Sulfamethoxazole, Zidovudine (AZT), and Granulocyte Colony Stimulating Factor (G-CSF) in Patients With AIDS-Related Lymphoma, Phase II|Completed||Phase 2|52|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:21:23.403795|2017-10-11 04:21:23.403795
NCT00002572|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-28|||November 1994||1994-11-01|July 2000|2000-07-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors|Intracavitary Allogenic Cytotoxic T Lymphocytes and Human Recombinant Interleukin-2 Therapy for Recurrent Primary Brain Tumors|Completed||Phase 1|10|Anticipated|University of Colorado, Denver|||||f||||||||||||||2017-10-11 04:21:23.720141|2017-10-11 04:21:23.720141
NCT00003184|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-02|||August 1996||1996-08-01|November 2000|2000-11-01|July 2003|Actual|2003-07-01|||||Interventional|||Vaccine Therapy in Treating Women With Metastatic Breast Cancer|Phase I Trial Using a CD80-Modified Allogeneic Breast Cancer Cell Line to Vaccinate HLA-A2-Positive Women With Breast Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:46.45382|2017-10-11 04:22:46.45382
NCT00002574|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||September 1994||1994-09-01|October 2001|2001-10-01||||June 2001|Actual|2001-06-01||Interventional|||Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia|PHASE II STUDY OF SIMULTANEOUS HOMOHARRINGTONINE (NSC 141633) AND ALPHA INTERFERON (IFN-A) THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA (CML)|Completed||Phase 2|87|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:21:23.797246|2017-10-11 04:21:23.797246
NCT00002575|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-15|||August 1994||1994-08-01|July 2016|2016-07-01|November 2009|Actual|2009-11-01|May 2004|Actual|2004-05-01||Interventional|||Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer|A PHASE III PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC-ASSISTED COLECTOMY VERSUS OPEN COLECTOMY FOR COLON CANCER|Completed||Phase 3|810|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:21:23.902263|2017-10-11 04:21:23.902263
NCT00002576|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-06|||November 1992||1992-11-01|May 2007|2007-05-01|January 2001|Actual|2001-01-01|||||Interventional|||Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma|A RANDOMIZED PROSPECTIVE TRIAL OF CHOP VERSUS MCOP IN ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH GRADE NON-HODGKIN'S LYMPHOMA (AGED 65 YEARS AND OVER)|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:24.425239|2017-10-11 04:21:24.425239
NCT00002577|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-18|||July 1995||1995-07-01|November 2013|2013-11-01||||January 2003|Actual|2003-01-01||Interventional|||Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer|A PHASE I/II DOSE ESCALATION STUDY USING THREE DIMENSIONAL CONFORMAL RADIATION THERAPY POST INDUCTION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED INOPERABLE, NON-SMALL CELL LUNG CANCER|Completed||Phase 1/Phase 2|36|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:21:24.539654|2017-10-11 04:21:24.539654
NCT00002578|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-05|||August 1994||1994-08-01|October 2015|2015-10-01||||January 2007|Actual|2007-01-01||Interventional|||Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma|Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome|Completed||Phase 2|35|Anticipated|Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:21:25.141053|2017-10-11 04:21:25.141053
NCT00002579|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||March 1993||1993-03-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer|PROTOCOL FOR THE SCOTTISH CHEMO-ENDOCRINE TRIAL D|Completed||Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:25.221597|2017-10-11 04:21:25.221597
NCT00002580|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||June 1993||1993-06-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer|PROTOCOL FOR THE SCOTTISH PREMENOPAUSAL CHEMO-ENDOCRINE TRIAL|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:25.320725|2017-10-11 04:21:25.320725
NCT00002581|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||June 1993||1993-06-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer|PROTOCOL FOR THE SCOTTISH POSTMENOPAUSAL CHEMO-ENDOCRINE TRIAL|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:25.424417|2017-10-11 04:21:25.424417
NCT00002582|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-01|||June 1993||1993-06-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer|UKCCCR RANDOMISED TRIAL OF ADJUVANT ENDOCRINE THERAPY AND CHEMOTHERAPY IN WOMEN WITH EARLY BREAST CANCER, THE ADJUVANT BREAST CANCER (ABC) TRIAL|Completed||Phase 3|6000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:25.511911|2017-10-11 04:21:25.511911
NCT00002583|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||July 1994||1994-07-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2003|Actual|2003-12-01||Interventional|||Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed|A PHASE III PROSPECTIVE RANDOMIZED STUDY OF ADJUVANT CHEMOTHERAPY WITH VINORELBINE AND CISPLATIN IN COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER WITH COMPANION TUMOUR MARKER EVALUATION|Completed||Phase 3|482|Actual|Canadian Cancer Trials Group||2|||f||||||||||||||2017-10-11 04:21:25.623736|2017-10-11 04:21:25.623736
NCT00002585|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-09|||February 1994||1994-02-01|March 2012|2012-03-01|January 2001|Actual|2001-01-01|October 1999|Actual|1999-10-01||Interventional|||Pyrazoloacridine in Treating Women With Metastatic Breast Cancer|PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE IN PATIENTS WITH METASTATIC BREAST CANCER|Completed||Phase 2|20|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||f||||||||||2017-10-11 04:21:26.003039|2017-10-11 04:21:26.003039
NCT00002586|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-05|||January 1993||1993-01-01|May 2014|2014-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|13-Cis||13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer|ASSESSMENT OF INTERMEDIATE ENDPOINT BIOMARKERS TO 13-CIS RETINOIC ACID WITH OR WITHOUT ALPHA TOCOPHEROL OR OBSERVATION|Completed||Phase 2|96|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-10-11 04:21:26.062748|2017-10-11 04:21:26.062748
NCT00002587|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-31|||September 1994||1994-09-01|April 2001|2001-04-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors|A PHASE I STUDY OF PROLONGED LOW-DOSE TOPOTECAN INFUSION COMBINED WITH PACLITAXEL (TAXOL)|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:21:26.151452|2017-10-11 04:21:26.151452
NCT00002588|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-09|||August 1994||1994-08-01|June 2010|2010-06-01|January 2001|Actual|2001-01-01|July 2000|Actual|2000-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia|Phase I Trial of Sequential Topotecan(NSC 609699)and Etoposide for Patients With Relapsed, Refractory,or High Risk Acute Myeloid or Lymphoid Leukemia|Completed||Phase 1|30|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:21:26.221946|2017-10-11 04:21:26.221946
NCT00002589|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||July 1994||1994-07-01|December 2005|2005-12-01||||||||Interventional|||Lymphocyte Therapy in Treating Patients With Kidney Cancer|Adjuvant Autolymphocyte Therapy (ALT) For Patients With Non-Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:26.294218|2017-10-11 04:21:26.294218
NCT00002590|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||July 1994||1994-07-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|March 2001|Actual|2001-03-01||Interventional|||Combination Chemotherapy in Treating Children With Lymphoma|A Pilot Study For The Treatment of Newly-Diagnosed Disseminated Anaplastic Large Cell Ki-1 Lymphoma and T-Large Cell Lymphoma|Completed||Phase 2|221|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:21:26.509741|2017-10-11 04:21:26.509741
NCT00002592|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-01-13|||June 1993||1993-06-01|January 2015|2015-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia|AUTOLOGOUS BONE MARROW TRANSPLANTATION USING C-MYB (LR-3001) ANTISENSE OLIGODEOXYNUCLEOTIDE TREATED BONE MARROW IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC OR ACCELERATED PHASE|Completed||Phase 2|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||||||||||||2017-10-11 04:21:26.679323|2017-10-11 04:21:26.679323
NCT00002593|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-02|||December 1994||1994-12-01|January 2013|2013-01-01|March 2005|Actual|2005-03-01|December 1999|Actual|1999-12-01||Interventional|||S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed|Phase III Randomized Trial of 5-FU/Leucovorin/Levamisole Versus 5-FU Continuous Infusion/Levamisole as Adjuvant Therapy for High-Risk Resectable Colon Cancer|Completed||Phase 3|1135|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:26.758016|2017-10-11 04:21:26.758016
NCT00002594|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||September 1994||1994-09-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|September 2003|Actual|2003-09-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors|Dose-Intensive Melphalan and Cyclophosphamide With Autologous Bone Marrow Rescue for Recurrent Medulloblastoma and Germ Cell Tumors|Completed||Phase 2|31|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:21:27.011005|2017-10-11 04:21:27.011005
NCT00002595|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09|||July 1991||1991-07-01|August 2010|2010-08-01|September 2010|Actual|2010-09-01|May 2003|Actual|2003-05-01||Interventional|||Toremifene in Treating Patients With Desmoid Tumors|PHASE II STUDY OF THE SAFETY AND EFFICACY OF TOREMIFENE IN THE THERAPY OF DESMOID TUMORS|Completed||Phase 2|72|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:27.404086|2017-10-11 04:21:27.404086
NCT00002596|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||September 1994||1994-09-01|October 2003|2003-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors|RANDOMIZED MULTIINSTITUTIONAL PHASE III TRIAL OF BEP AND HIGH DOSE CHEMOTHERAPY VERSUS BEP ALONE IN PREVIOUSLY UNTREATED PATIENTS WITH POOR RISK GERM CELL TUMORS|Completed||Phase 3|270|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:27.537911|2017-10-11 04:21:27.537911
NCT00002597|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-05-08|2017-05-08||October 1994||1994-10-01|May 2017|2017-05-01||||July 2011|Actual|2011-07-01||Interventional||All eligible patients.|Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer|A PHASE III TRIAL OF THE STUDY OF ENDOCRINE THERAPY USED AS A CYTOREDUCTIVE AND CYTOSTATIC AGENT PRIOR TO RADIATION THERAPY IN GOOD PROGNOSIS LOCALLY CONFINED ADENOCARCINOMA OF THE PROSTATE|Completed||Phase 3|2028|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:28.120435|2017-10-11 04:21:28.120435
NCT00002598|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||June 1994||1994-06-01|June 2013|2013-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia|A PHASE II STUDY OF MITOXANTRONE AND HIGH-DOSE ARA-C FOLLOWED BY INTENSIVE CONSOLIDATION WITH CYCLOPHOSPHAMIDE AND ETOPOSIDE FOR MYELOID BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA (CML)|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:29.224203|2017-10-11 04:21:29.224203
NCT00002599|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||September 1994||1994-09-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma|MYELOMA VII MEDICAL RESEARCH COUNCIL WORKING PARTY ON LEUKEMIA IN ADULTS: MYELOMATOSIS THERAPY TRIAL|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:29.297477|2017-10-11 04:21:29.297477
NCT00002600|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-04-23|||September 1994||1994-09-01|September 2001|2001-09-01||||||||Interventional|||Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer|A PHASE I TRIAL OF HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE MARROW AND PERIPHERAL BLOOD PROGENITOR CELL RESCUE IN PATIENTS WITH PLATINUM-SENSITIVE, CHEMOTHERAPY-RESPONSIVE EPITHELIAL OVARIAN CARCINOMA|Completed||Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:29.372225|2017-10-11 04:21:29.372225
NCT00002601|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-18|2016-11-21||September 1994||1994-09-01|January 2017|2017-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma|High-Dose Doxorubicin and Ifosfamide Followed by Melphalan and Cisplatin for Patients With High-Risk and Recurrent Sarcoma|Completed||Phase 2|13|Actual|City of Hope Medical Center||1|||f||||f||||||||||2017-10-11 04:21:29.459313|2017-10-11 04:21:29.459313
NCT00002602|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-03-26|||May 1994||1994-05-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|March 2004|Actual|2004-03-01||Interventional|||Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer|A PHASE I/II DOSE ESCALATION STUDY USING THREE DIMENSIONAL CONFORMAL RADIATION THERAPY FOR ADENOCARCINOMA OF THE PROSTATE|Completed||Phase 1/Phase 2|1084|Actual|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-10-11 04:21:29.895581|2017-10-11 04:21:29.895581
NCT00002604|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-07-07|||January 1996||1996-01-01|July 2010|2010-07-01|February 2004|Actual|2004-02-01|July 2000|Actual|2000-07-01||Interventional|||O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors|Phase I Trial of O6 Benzylguanine and BCNU; A Biochemical Modulation Trial Based Upon Depletion of O6 Alkylguanine DNA Alkyltransferase Directed DNA Repair|Completed||Phase 1|28|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:21:32.714112|2017-10-11 04:21:32.714112
NCT00002608|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09|||May 1994||1994-05-01|May 2005|2005-05-01|April 2005|Actual|2005-04-01|||||Interventional|||Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors|Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:32.787444|2017-10-11 04:21:32.787444
NCT00002609|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||August 1994||1994-08-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission|PHASE II TRIAL OF POST-REMISSION THERAPY WITH HuM195 AND CYTOTOXIC CHEMOTHERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA|Completed||Phase 2|40|Actual|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:32.872528|2017-10-11 04:21:32.872528
NCT00002610|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||January 1996||1996-01-01|July 2014|2014-07-01|February 2006|Actual|2006-02-01|June 2002|Actual|2002-06-01||Interventional|||Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors|National Wilms Tumor Study-5 -- Treatment of Relapsed Patients, A National Wilms Tumor Study Group Phase III Study|Completed||Phase 3|203|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:21:32.959634|2017-10-11 04:21:32.959634
NCT00002611|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||July 1995||1995-07-01|July 2014|2014-07-01|August 2003|Actual|2003-08-01|June 2002|Actual|2002-06-01||Interventional|||Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer|NATIONAL WILMS TUMOR STUDY-5 -- THERAPEUTIC TRIAL AND BIOLOGY STUDY|Completed||Phase 3|3031|Actual|Children's Oncology Group||9|||f||||t||||||||||2017-10-11 04:21:33.635944|2017-10-11 04:21:33.635944
NCT00002615|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||June 1994||1994-06-01|August 2001|2001-08-01|December 2003|Actual|2003-12-01|||||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer|A RANDOMISED, CONTROLLED TRIAL OF PRE- AND POST-OPERATIVE CHEMOTHERAPY IN PATIENTS WITH OPERABLE GASTRIC CANCER|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:34.352004|2017-10-11 04:21:34.352004
NCT00002616|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||February 1995||1995-02-01|September 2000|2000-09-01||||||||Interventional|||Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer|A PILOT TRIAL OF INTERLEUKIN-2 WITH G-CSF AS PRIMING THERAPY FOR PERIPHERAL BLOOD STEM CELL HARVESTING IN PATIENTS WITH ADVANCED BREAST CANCER: STAMP V HIGH DOSE CHEMOTHERAPY, STEM CELL INFUSION AND POST-INFUSION G-CSF AND INTERLEUKIN-2|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:34.426851|2017-10-11 04:21:34.426851
NCT00002618|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||December 1994||1994-12-01|July 2014|2014-07-01|September 2006|Actual|2006-09-01|September 2000|Actual|2000-09-01||Interventional|||Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma|A Phase III Study of Large Cell Lymphomas in Children and Adolescents: Comparison of APO vs APO + IDMTX/HDARA-C and Continuous vs Bolus Infusion of Doxorubicin|Completed||Phase 3|242|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:34.497769|2017-10-11 04:21:34.497769
NCT00002619|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-08|||September 1994||1994-09-01|June 2000|2000-06-01||||April 2000|Actual|2000-04-01||Interventional|||Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors|A TRIAL OF INTENSIVE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RECONSTITUTION FOR PATIENTS BETWEEN SIX AND SIXTY YEARS OF AGE, WITH NON-PROGRESSIVE GLIOBLASTOMA MULTIFORME OR DIFFUSE INTRINSIC BRAINSTEM TUMORS, FOLLOWING INITIAL LOCAL-FIELD IRRADIATION|Completed||Phase 2|60|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:21:34.6687|2017-10-11 04:21:34.6687
NCT00002620|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||November 1994||1994-11-01|June 2012|2012-06-01||||June 2000|Actual|2000-06-01||Interventional|||Radiation Therapy in Treating Patients With Brain Cancer|EFFECT OF DIBROMODULCITOL PLUS BCNU ON FREE INTERVAL AND SURVIVAL OF PATIENTS WITH SUPRATENTORIAL MALIGNANT BRAIN GLIOMAS, A PHASE III TYPE STUDY|Completed||Phase 3|212|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:34.745803|2017-10-11 04:21:34.745803
NCT00002621|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||December 1994||1994-12-01|July 2014|2014-07-01|September 2005|Actual|2005-09-01|July 2002|Actual|2002-07-01||Interventional|||Interferon Alfa in Treating Children With HIV-Related Cancer|A Phase II Study of Alpha Interferon (alphaIFN) In HIV-Related Malignancies - A Pediatric Oncology Group Wide Study|Completed||Phase 2|8|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:21:34.836404|2017-10-11 04:21:34.836404
NCT00002622|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-27|||December 1994||1994-12-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|March 2005|Actual|2005-03-01||Interventional|||Talc in Treating Patients With Malignant Pleural Effusion|Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study|Completed||Phase 3|501|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:21:34.964951|2017-10-11 04:21:34.964951
NCT00002623|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||December 1994||1994-12-01|June 2012|2012-06-01||||December 2002|Actual|2002-12-01||Interventional|||Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer|RANDOMIZED TRIAL OF SURGERY VERSUS RADIOTHERAPY IN PATIENTS WITH STAGE IIIa NON-SMALL CELL LUNG CANCER AFTER A RESPONSE TO INDUCTION-CHEMOTHERAPY|Completed||Phase 3|640|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:35.652226|2017-10-11 04:21:35.652226
NCT00002624|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||December 1994||1994-12-01|July 2016|2016-07-01|August 2005|Actual|2005-08-01|April 2005|Actual|2005-04-01||Interventional|||Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function|VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY|Completed||Phase 2|66|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:21:35.796807|2017-10-11 04:21:35.796807
NCT00002625|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||March 1995||1995-03-01|January 2013|2013-01-01|September 2000|Actual|2000-09-01|April 2000|Actual|2000-04-01||Interventional|||Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma|PHASE I STUDY OF TOPOTECAN AND THORACIC RADIATION|Completed||Phase 1|5|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:21:35.96078|2017-10-11 04:21:35.96078
NCT00002627|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-09|||November 1994||1994-11-01|July 2000|2000-07-01||||||||Interventional|||Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer|PHASE I/II TRIAL OF THE ADDITION OF TAXOL TO HIGH DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL SUPPORT IN PATIENTS WITH HIGH RISK STAGE II AND III BREAST CANCER|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:36.098206|2017-10-11 04:21:36.098206
NCT00002628|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-09|||November 1994||1994-11-01|April 2000|2000-04-01||||||||Interventional|||Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer|PHASE I/II TRIAL OF THE ADDITION OF TAXOL TO THE HIGH DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL SUPPORT IN PATIENTS WITH BREAST CANCER|Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:36.193908|2017-10-11 04:21:36.193908
NCT00003185|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||August 1997||1997-08-01|December 2008|2008-12-01|July 1998|Actual|1998-07-01|||||Interventional|||Biological Therapy in Treating Patients With Glioblastoma Multiforme|Adoptive Immunotherapy of Glioblastoma Multiforme With Tumor-Sensitized, Ex Vivo Activated T Lymphocytes|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:46.52587|2017-10-11 04:22:46.52587
NCT00002630|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-05-10|||June 1993||1993-06-01|May 2011|2011-05-01|May 2001|Actual|2001-05-01|February 1999|Actual|1999-02-01||Interventional|||High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse|HIGH-DOSE MELPHALAN CHEMOTHERAPY AND TOTAL BODY RADIATION WITH PERIPHERAL BLOOD STEM-CELL RECONSTITUTION FOR PATIENTS WITH RELAPSING MULTIPLE MYELOMA|Completed||Phase 2|50|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-10-11 04:21:36.295732|2017-10-11 04:21:36.295732
NCT00002130|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons|A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.384957|2017-10-11 04:21:36.384957
NCT00002131|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma|A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|28||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.443279|2017-10-11 04:21:36.443279
NCT00002132|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.|Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.518512|2017-10-11 04:21:36.518512
NCT00002133|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.|An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.608783|2017-10-11 04:21:36.608783
NCT00002134|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis|A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis|Completed||N/A|450||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.697669|2017-10-11 04:21:36.697669
NCT00002135|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1995|1995-11-01||||||||Interventional|||An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access|An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.790446|2017-10-11 04:21:36.790446
NCT00002136|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days|A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.844329|2017-10-11 04:21:36.844329
NCT00002137|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4|A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.891255|2017-10-11 04:21:36.891255
NCT00002138|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.|A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.940152|2017-10-11 04:21:36.940152
NCT00002139|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.|Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:36.989799|2017-10-11 04:21:36.989799
NCT00002140|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients|A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.039645|2017-10-11 04:21:37.039645
NCT00002141|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||July 1994||1994-07-01|October 1994|1994-10-01||||||||Interventional|||A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89|A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89|Completed||Phase 1|18||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.237465|2017-10-11 04:21:37.237465
NCT00002142|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1995|1995-10-01||||||||Interventional|||An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS|An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS|Completed||N/A|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.311351|2017-10-11 04:21:37.311351
NCT00002143|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||Treatment of Psoriasis Using Acitretin in HIV-Positive Patients|Treatment of Psoriasis Using Acitretin in HIV-Positive Patients|Completed||Phase 3|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.387388|2017-10-11 04:21:37.387388
NCT00002144|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment|The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment|Completed||Phase 1|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.459141|2017-10-11 04:21:37.459141
NCT00002145|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease|Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease|Completed||Phase 3|145||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.549419|2017-10-11 04:21:37.549419
NCT00002146|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1997|1997-01-01||||||||Interventional|||Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study|Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study|Completed||Phase 4|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.655277|2017-10-11 04:21:37.655277
NCT00002147|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.|Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.719089|2017-10-11 04:21:37.719089
NCT00002148|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia|Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia|Completed||Phase 1|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.778296|2017-10-11 04:21:37.778296
NCT00002149|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1997|1997-09-01||||||||Interventional|||Acupuncture and Herbal Treatment of Chronic HIV Sinusitis|Acupuncture and Herbal Treatment of Chronic HIV Sinusitis|Completed||N/A|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.885998|2017-10-11 04:21:37.885998
NCT00002150|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients|A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients|Completed||Phase 2|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:37.967593|2017-10-11 04:21:37.967593
NCT00002151|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients|A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients|Completed||Phase 2|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.075872|2017-10-11 04:21:38.075872
NCT00002152|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study of WF 10 IV Solution in Patients With Advanced HIV Disease|Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of WF 10 IV Solution ( TCDO ) in the Management of Patients With Advanced HIV Disease|Completed||Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.184699|2017-10-11 04:21:38.184699
NCT00002153|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders|Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders|Completed||Phase 1|25||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.246497|2017-10-11 04:21:38.246497
NCT00002154|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia|Parallel Group, Placebo-Controlled, Tolerability and Safety Study of Thioctic Acid and Deprenyl in HIV Dementia|Completed||Phase 2|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.310912|2017-10-11 04:21:38.310912
NCT00002155|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1996|1996-06-01||||||||Interventional|||A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC|A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC|Completed||N/A|600||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.394544|2017-10-11 04:21:38.394544
NCT00002156|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )|A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )|Completed||Phase 2|194||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.472279|2017-10-11 04:21:38.472279
NCT00002157|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome|Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.571773|2017-10-11 04:21:38.571773
NCT00002158|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-07-09||||||July 2007|2007-07-01||||||||Interventional|||A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis|Open-Label Compassionate Use of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.634912|2017-10-11 04:21:38.634912
NCT00002159|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1997|1997-12-01||||||||Interventional|||A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis|A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis|Completed||Phase 3|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:38.723908|2017-10-11 04:21:38.723908
NCT00002161|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1997|1997-05-01||||||||Interventional|||A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3|Completed||N/A|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.022532|2017-10-11 04:21:39.022532
NCT00002162|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs|A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs|Completed||Phase 2|140||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.137284|2017-10-11 04:21:39.137284
NCT00002163|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex|A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.254797|2017-10-11 04:21:39.254797
NCT00002164|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants|Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants|Completed||Phase 1|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.345532|2017-10-11 04:21:39.345532
NCT00002165|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1996|1996-10-01||||||||Interventional|||Viracept Expanded Access Program|Viracept Expanded Access Program|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.408311|2017-10-11 04:21:39.408311
NCT00002166|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease|An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.458716|2017-10-11 04:21:39.458716
NCT00002167|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.|Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.|Completed||Phase 2|78||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.512266|2017-10-11 04:21:39.512266
NCT00002168|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients|An Open Label, Randomized, Comparative Study of Zerit (d4T) + Videx (ddI) + Crixivan Versus Retrovir (AZT) + Epivir (3TC) + Crixivan in HIV-Infected, Antiretroviral Naive Subjects With CD4 Cell Counts of 200 - 700/mm3 and HIV RNA Baseline Copy Number of >= 10,000 Copies/ml|Completed||N/A|200||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:21:39.574767|2017-10-11 04:21:39.574767
NCT00002169|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis|A Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Cytomegalovirus (CMV) Retinitis in AIDS Patients Who Are Receiving Standard Induction and Maintenance Therapy for This Infection|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.671574|2017-10-11 04:21:39.671574
NCT00002170|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)|A Pilot, Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Disseminated Mycobacterium Avium Complex Disease (MAC) in AIDS Patients Who Are Receiving Standard Acute Treatment for This Opportunistic Infection|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.756844|2017-10-11 04:21:39.756844
NCT00002171|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Study of Viracept in HIV-Positive Women|A Phase II, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Viracept in Combination With Antiretroviral Therapy in HIV Positive Women With <= 1 Month of Prior Treatment With d4T and/or 3TC|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:39.981523|2017-10-11 04:21:39.981523
NCT00002172|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1995|1995-06-01||||||||Interventional|||An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml|An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.088422|2017-10-11 04:21:40.088422
NCT00002173|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1998|1998-06-01||||||||Interventional|||An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.|An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.155742|2017-10-11 04:21:40.155742
NCT00002174|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients|Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients|Completed||N/A|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.218706|2017-10-11 04:21:40.218706
NCT00002175|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||January 1999|1999-01-01||||||||Interventional|||Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.|Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.|Completed||Phase 1|46||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.287418|2017-10-11 04:21:40.287418
NCT00002767|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||January 1996||1996-01-01|May 2007|2007-05-01||||||||Interventional|||Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma|PHASE III TRIAL OF MELACINE PLUS INTERFERON ALFA-2B VERSUS INTERFERON ALFA-2B IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMA|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:50.095869|2017-10-11 04:21:50.095869
NCT00002176|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-13|||May 1997||1997-05-01|April 2011|2011-04-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection|A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:21:40.365033|2017-10-11 04:21:40.365033
NCT00002177|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-13|||May 1997||1997-05-01|April 2011|2011-04-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection|A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection|Completed||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:21:40.469112|2017-10-11 04:21:40.469112
NCT00002178|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients|A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients|Completed||Phase 3|375||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.544607|2017-10-11 04:21:40.544607
NCT00002179|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection|A Multiclinic, Open Study to Evaluate the Ability of the Combination of Indinavir, Zidovudine and Lamivudine to Result in Sustained Suppression of HIV-1 in Asymptomatic HIV-1 Seropositive Patients|Completed||Phase 4|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.621293|2017-10-11 04:21:40.621293
NCT00002180|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||September 1999|1999-09-01||||||||Interventional|||A Study of PMPA in HIV-Infected Patients|A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance, and Pharmacokinetics, and Antiviral Activity of 9-[(R)-2-(Phosphonomethoxy)Propyl] Adenine (PMPA) in HIV-Infected Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.728176|2017-10-11 04:21:40.728176
NCT00002181|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1997|1997-11-01||||||||Interventional|||Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS|Open-Label Study of Cidofovir Gel for Acyclovir-Unresponsive Mucocutaneous Herpes Simplex Disease in Patients With AIDS.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.794364|2017-10-11 04:21:40.794364
NCT00002182|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study of Megestrol Acetate in HIV-Infected Children|Megestrol Acetate For Failure To Thrive In Pediatric HIV|Completed||N/A|25||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.895696|2017-10-11 04:21:40.895696
NCT00002183|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection|A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection|Completed||Phase 1|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:40.969267|2017-10-11 04:21:40.969267
NCT00002184|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||October 1998|1998-10-01||||||||Interventional|||A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient|A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 100/mm3 and HIV-1 RNA Copy Numbers >= 5,000 Copies/Ml and Prior RTI Therapy But No Prior PI Therapy|Completed||Phase 2|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:41.050914|2017-10-11 04:21:41.050914
NCT00002185|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3|A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3|Completed||Phase 2|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:41.149467|2017-10-11 04:21:41.149467
NCT00002186|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||February 1998|1998-02-01||||||||Interventional|||Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)|Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)|Completed||N/A|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:41.234752|2017-10-11 04:21:41.234752
NCT00002187|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis|A Randomized Comparison of Two Dosage Schedules of Intravitreal ISIS 2922 for Patients With Advanced Cytomegalovirus Retinitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:21:41.369656|2017-10-11 04:21:41.369656
NCT00002631|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-18|||June 1995||1995-06-01|November 2013|2013-11-01||||September 1999|Actual|1999-09-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus|A PHASE III INTERGROUP RANDOMIZED COMPARISON OF COMBINED MODALITY THERAPY FOR CARCINOMA OF THE ESOPHAGUS: HIGH-DOSE VS CONVENTIONAL-DOSE RADIATION THERAPY|Completed||Phase 3|298|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:21:41.484378|2017-10-11 04:21:41.484378
NCT00002632|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-28|||March 1995||1995-03-01|August 2013|2013-08-01||||May 2002|Actual|2002-05-01||Interventional|||Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer|PHASE II TRIAL OF TAXOL IN ADVANCED OR METASTATIC SALIVARY GLAND MALIGNANCIES|Completed||Phase 2|32|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:21:41.605633|2017-10-11 04:21:41.605633
NCT00002633|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-31|||March 1995||1995-03-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer|Phase III Randomized Trial Comparing Total Androgen Blockade Versus Total Androgen Blockade Plus Pelvic Irradiation in Clinical Stage T3-4, N0, M0 Adenocarcinoma of the Prostate|Completed||Phase 3|361|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:21:41.747829|2017-10-11 04:21:41.747829
NCT00002634|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||February 1995||1995-02-01|July 2013|2013-07-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma|N7: EVALUATION OF MAXIMAL CHEMOTHERAPY DOSE INTENSITY PLUS MONOCLONAL ANTIBODY 3F8 IN THE TREATMENT OF NEUROBLASTOMA|Completed||Phase 2|45|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:41.904435|2017-10-11 04:21:41.904435
NCT00002635|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-24|||May 1995||1995-05-01|March 2001|2001-03-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Aminocamptothecin in Treating Patients With T-cell Lymphoma|PHASE II TRIAL OF 9-AMINOCAMPTOTHECIN IN ADVANCED CUTANEOUS T CELL LYMPHOMA|Completed||Phase 2|12|Actual|Yale University||1|||f||||f||||||||||2017-10-11 04:21:42.016793|2017-10-11 04:21:42.016793
NCT00002637|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||January 1995||1995-01-01|June 2013|2013-06-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Biological Therapy in Treating Patients With Prostate Cancer|PHASE I/II STUDY OF IMMUNIZATION WITH MHC CLASS I MATCHED ALLOGENEIC HUMAN PROSTATIC CARCINOMA CELLS ENGINEERED TO SECRETE INTERLEUKIN-2 AND INTERFERON-GAMMA|Completed||Phase 1/Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:42.10816|2017-10-11 04:21:42.10816
NCT00002638|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09|||March 1995||1995-03-01|September 2002|2002-09-01|March 2005|Actual|2005-03-01|||||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia|HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR CHILDREN WITH RELAPSED ACUTE LYMPHOCYTIC LEUKEMIA|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:42.183843|2017-10-11 04:21:42.183843
NCT00002639|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||July 1995||1995-07-01|February 2001|2001-02-01|May 2004|Actual|2004-05-01|||||Interventional|||Suramin in Treating Patients With Recurrent Primary Brain Tumors|ANALYSIS OF THE EFFICACY OF SURAMIN IN RECURRENT MALIGNANT PRIMARY BRAIN TUMORS|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:42.260889|2017-10-11 04:21:42.260889
NCT00002641|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-07|||February 1995||1995-02-01|July 2002|2002-07-01|June 2012|Actual|2012-06-01|February 2006|Actual|2006-02-01||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma|RANDOMISED TRIAL OF ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE DOXORUBICIN, IFOSFAMIDE AND LENOGRASTIM IN HIGH GRADE SOFT TISSUE SARCOMA|Completed||Phase 3|350|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:42.337857|2017-10-11 04:21:42.337857
NCT00002642|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-05|||April 1995||1995-04-01|October 2012|2012-10-01|July 2004|Actual|2004-07-01|January 2001|Actual|2001-01-01||Interventional|||SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer|Induction Chemoradiotherapy Followed by Surgical Resection for Non-small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors): A Phase II Trial|Completed||Phase 2|116|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:21:42.511933|2017-10-11 04:21:42.511933
NCT00002643|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-31|||April 1995||1995-04-01|March 2007|2007-03-01||||June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor|INTENSIVE THERAPY WITH GROWTH FACTOR SUPPORT FOR PATIENTS WITH EWING'S TUMOR METASTATIC AT DIAGNOSIS: A PEDIATRIC ONCOLOGY GROUP PHASE II STUDY|Completed||Phase 2|130|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:21:42.610513|2017-10-11 04:21:42.610513
NCT00002644|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||January 1994||1994-01-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|||||Interventional|||Tamoxifen for the Prevention of Breast Cancer in High-Risk Women|INTERNATIONAL BREAST CANCER INTERVENTION STUDY: A MULTICENTRE TRIAL OF TAMOXIFEN TO PREVENT BREAST CANCER|Completed||Phase 3|7000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:42.819954|2017-10-11 04:21:42.819954
NCT00002646|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-01-04|||October 1995||1995-10-01|October 2010|2010-10-01||||February 2004|Actual|2004-02-01||Interventional|||Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer|PHASE III DOUBLE-BLIND, PLACEBO-CONTROLLED, PROSPECTIVE RANDOMIZED COMPARISON OF ADJUVANT THERAPY WITH TAMOXIFEN VS. TAMOXIFEN AND FENRETINIDE IN POSTMENOPAUSAL WOMEN WITH INVOLVED AXILLARY LYMPH NODES AND POSITIVE RECEPTORS|Completed||Phase 3|1500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:42.887917|2017-10-11 04:21:42.887917
NCT00002647|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||May 1994||1994-05-01|June 2009|2009-06-01||||||||Interventional|||Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors|Photodynamic Therapy For Childhood Brain Tumors, A Phase I Study|Unknown status|Recruiting|Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:43.257109|2017-10-11 04:21:43.257109
NCT00002649|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-27|||May 1995||1995-05-01|February 2013|2013-02-01||||November 2006|Actual|2006-11-01||Interventional|||Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma|Total Body Irradiation, Etoposide, Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation Followed by Randomization to Therapy With Interleukin-2 Versus Observation for Patients With Non-Hodgkin's Lymphoma|Completed||Phase 3|206|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:21:43.368511|2017-10-11 04:21:43.368511
NCT00002650|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-06|||April 1995||1995-04-01|May 2007|2007-05-01||||||||Interventional|||High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed|PHASE II DOUBLE-BLIND CHEMOPREVENTION TRIAL OF HIGH DOSE FOLIC ACID VERSUS PLACEBO IN PATIENTS WITH RESECTED COLORECTAL POLYPS|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:43.521871|2017-10-11 04:21:43.521871
NCT00002651|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-03|2016-11-15||May 1995||1995-05-01|March 2017|2017-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Randomized and eligible patients (After induction, Patients with stable or declining PSA levels of 4.0 ng per milliliter or lower at months 6 and 7 were eligible for randomization).|SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer|Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III|Completed||Phase 3|3040|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:43.64819|2017-10-11 04:21:43.64819
NCT00002653|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||September 1993||1993-09-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma|VIIITH MYELOMATOSIS TRIAL: A RANDOMISED TRIAL OF TREATMENT FOR INDUCING FIRST PLATEAU PHASE ABCM VS 3 COURSES OF ABCM FOLLOWED BY ORAL WEEKLY CYCLOPHOSPHAMIDE|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:44.548826|2017-10-11 04:21:44.548826
NCT00002654|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-06|||April 1994||1994-04-01|March 2013|2013-03-01|July 2000|Actual|2000-07-01|March 1999|Actual|1999-03-01||Interventional|||Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer|Phase III Study of Hyperfractionated Radiation Therapy With or Without Simultaneaous Application of CIS-Platinum in Patients With Moderately Advanced to Advanced Cancers of the Head and Neck|Completed||Phase 3|224|Actual|Swiss Group for Clinical Cancer Research|||||f||||f||||||||||2017-10-11 04:21:44.628|2017-10-11 04:21:44.628
NCT00002655|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-19|||March 1995||1995-03-01|July 2013|2013-07-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases|Cryosurgical Destruction of Surgically Incurable Liver Tumors|Completed||Phase 2|||University of Colorado, Denver|||||f||||t||||||||||2017-10-11 04:21:44.70715|2017-10-11 04:21:44.70715
NCT00002656|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-25|||October 1995||1995-10-01|April 2013|2013-04-01|February 2008|Actual|2008-02-01|December 2001|Actual|2001-12-01||Interventional|||Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer|PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA|Completed||Phase 2|20|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-10-11 04:21:44.773822|2017-10-11 04:21:44.773822
NCT00002657|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-22|||May 1995||1995-05-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|November 2003|Actual|2003-11-01||Interventional|||SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant|Phase II Trial of Sequential Modification of Immunosuppression, Interferon Alpha, and Promace-Cytabom For Treatment of Post-Cardiac Transplant Lymphoproliferation.|Completed||Phase 2|20|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:21:44.854023|2017-10-11 04:21:44.854023
NCT00002658|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||January 1994||1994-01-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia|ACUTE MYELOID LEUKAEMIA TRIAL 12|Unknown status|Active, not recruiting|Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:45.10259|2017-10-11 04:21:45.10259
NCT00002659|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||May 1995||1995-05-01|May 2007|2007-05-01||||||||Interventional|||Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer|A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF CISPLATIN/EPINEPHRINE INJECTABLE GEL (PRODUCT MPI 5010) WHEN ADMINISTERED INTRATUMORALLY FOR ACHIEVEMENT OF TREATMENT GOALS IN RECURRENT OR REFRACTORY SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:45.19828|2017-10-11 04:21:45.19828
NCT00002662|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-01|||August 1994||1994-08-01|April 2004|2004-04-01|June 2004|Actual|2004-06-01|||||Interventional|||Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer|PHASE III COMPARISON OF TAXOTERE (DOCETAXEL) AND TAXOL (PACLITAXEL) IN PATIENTS WITH ADVANCED BREAST CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:45.373259|2017-10-11 04:21:45.373259
NCT00002745|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||April 1996||1996-04-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|April 2003|Actual|2003-04-01||Interventional|||Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma|PHASE II STUDY OF 9-AMINOCAMPTOTHECIN (9-AC/DMA, NSC# 603071) IN PREVIOUSLY TREATED HODGKIN'S DISEASE AND NON-HODGKIN'S LYMPHOMA: IWF GRADES A-H|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:21:45.49272|2017-10-11 04:21:45.49272
NCT00002746|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-12-12|||January 1996||1996-01-01|December 2012|2012-12-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Interleukin-2 in Treating Patients With Myelodysplastic Syndrome|A PHASE I TRIAL OF SUBCUTANEOUS, OUTPATIENT INTERLEUKIN-2 FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)|Completed||Phase 1|24|Actual|University of Washington||1|||f||||||||||||||2017-10-11 04:21:45.57527|2017-10-11 04:21:45.57527
NCT00002747|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||September 1992||1992-09-01|May 2007|2007-05-01||||||||Interventional|||Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer|RANDOMIZED TRIAL OF NEOADJUVANT CHEMOTHERAPY AND SURGERY +/- RADIOTHERAPY VERSUS SURGEERY +/- RADIOTHERAPY IN OPERABLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY|Unknown status|Active, not recruiting|Phase 3|240|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:45.650532|2017-10-11 04:21:45.650532
NCT00002748|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-10-03|||December 1991||1991-12-01|October 2011|2011-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma|Phase I Study of Cytokine-Gene Modified Autologous or Partially Matched Allogeneic Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma|Completed||Phase 1|38|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-10-11 04:21:45.710317|2017-10-11 04:21:45.710317
NCT00002749|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-10-12|||February 1993||1993-02-01|October 2009|2009-10-01|March 2000|Actual|2000-03-01|||||Interventional|||Carboplatin in Patients With Progressive Gliomas|PHASE II STUDY OF CARBOPLATIN (CBDCA) IN THE TREATMENT OF CHILDREN AND ADULTS WITH PROGRESSIVE LOW GRADE GLIOMAS|Completed||Phase 2|25|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:21:45.780083|2017-10-11 04:21:45.780083
NCT00002750|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||December 1992||1992-12-01|February 2013|2013-02-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Melphalan in Patients With Neoplastic Meningitis|Phase I of Intrathecal Melphalan in Patients With Recurrent Neoplastic Meningitis|Completed||Phase 1|6|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:21:45.849501|2017-10-11 04:21:45.849501
NCT00002751|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-19|||July 1989||1989-07-01|October 2009|2009-10-01|May 2004|Actual|2004-05-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Brain Metastases|PROTOCOL FOR A PHASE I STUDY OF INTRATHECAL MONOCLONAL ANTIBODY FRAGMENT 131I Me1-14 F(ab')2 IN PATIENTS WITH NEOPLASMS METASTATIC TO THE LEPTOMENINGES|Completed||Phase 1/Phase 2|6|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:21:45.935825|2017-10-11 04:21:45.935825
NCT00005360|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||August 1992||1992-08-01|December 2001|2001-12-01|July 1997|Actual|1997-07-01|||||Observational|||HIV Diversity and Pathogenesis in Donor-Recipient Clusters||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.353235|2017-10-11 04:28:03.353235
NCT00002752|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-15|||February 1993||1993-02-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|January 2003|Actual|2003-01-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers|PHASE I STUDY OF ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT BRAIN TUMORS|Completed||Phase 1/Phase 2|||Duke University|||||f||||||||||||||2017-10-11 04:21:47.470427|2017-10-11 04:21:47.470427
NCT00002753|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||November 1991||1991-11-01|February 2013|2013-02-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas|PROTOCOL FOR A PHASE I STUDY OF INTRACYSTIC ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 IN THE TREATMENT OF PATIENTS WITH RECURRENT CYSTIC GLIOMAS|Completed||Phase 1|6|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:21:47.543096|2017-10-11 04:21:47.543096
NCT00002754|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||February 1993||1993-02-01|February 2013|2013-02-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors|PHASE I STUDY OF MONOCLONAL ANTIBODY FRAGMENT 131I MEL-14 F(AB')2 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT MELANOMA AND OTHER BRAIN TUMORS|Completed||Phase 1|6|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:21:47.61173|2017-10-11 04:21:47.61173
NCT00002755|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||November 1995||1995-11-01|May 2007|2007-05-01|June 1999|Actual|1999-06-01|||||Interventional|||Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer|PROSPECTIVE RANDOMISED EVALUATION OF HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL BLOOD PROGENITOR SUPPORT IN PATIENTS WITH HIGH RISK BREAST CANCER|Completed||Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:47.690318|2017-10-11 04:21:47.690318
NCT00002756|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-12|||June 1996||1996-06-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|September 2007|Actual|2007-09-01||Interventional|||Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia|Induction Intensification in Infant ALL: A Children's Oncology Group Study|Completed||Phase 2|221|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:21:47.819811|2017-10-11 04:21:47.819811
NCT00002757|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||June 2001||2001-06-01|July 2014|2014-07-01|October 2009|Actual|2009-10-01|October 2003|Actual|2003-10-01||Interventional|||TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma|FAB LMB 96 -- Treatment of Mature B-CELL Lymphoma/Leukemia: A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study|Completed||Phase 3|1148|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-10-11 04:21:48.325308|2017-10-11 04:21:48.325308
NCT00002759|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||June 1996||1996-06-01|May 2006|2006-05-01||||April 2002|Actual|2002-04-01||Interventional|||Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma|A PHASE I STUDY OF IRINOTECAN (CPT-11) WITH PHARMACOKINETIC MODULATION BY CYCLOSPORINE A AND PHENOBARBITAL|Completed||Phase 1|3|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:21:48.501014|2017-10-11 04:21:48.501014
NCT00002760|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-27|||August 1996||1996-08-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|March 2004|Actual|2004-03-01||Interventional|||Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer|A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER|Completed||Phase 3|260|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:21:48.60604|2017-10-11 04:21:48.60604
NCT00002761|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-16|||February 1996||1996-02-01|November 2012|2012-11-01|October 2007|Actual|2007-10-01|February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia|CAMP-010: PHASE I/II STUDY OF IN VIVO PURGING FOLLOWED BY HIGH DOSE CHEMOTHERAPY, AUTOLOGOUS HEMATOPOIETIC STEM CELL INFUSION AND IMMUNOTHERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA|Withdrawn||Phase 1/Phase 2|0|Actual|Columbia University||||PI left institution|f||||||||||||||2017-10-11 04:21:48.690968|2017-10-11 04:21:48.690968
NCT00002762|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-11|||June 1996||1996-06-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer|MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER|Completed||N/A|1118|Actual|Alliance for Clinical Trials in Oncology|||1||f||||t||||||||||2017-10-11 04:21:48.773097|2017-10-11 04:21:48.773097
NCT00002763|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-11-15|||April 1996||1996-04-01|November 2011|2011-11-01||||||||Interventional|||High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma|POST-OPERATIVE ADJUVANT INTERFERON-ALFA-2B (INTRON-A) TREATMENT AFTER RESECTION OF THICK PRIMARY MELANOMA AND/OR REGIONAL LYMPHNODE METASTASES 'INTERMEDIATE-HIGH DOSE' VS INTERMEDIATE-LOW DOSE' IFN-ALFA VS OBSERVATION: A 3-ARM MULTICENTER RANDOMIZED PHASE III TRIAL|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:48.950902|2017-10-11 04:21:48.950902
NCT00002764|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||April 1996||1996-04-01|July 2012|2012-07-01||||November 2000|Actual|2000-11-01||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma|METASTASECTOMY AND CHEMOTHERAPY FOR LUNG METASTASES FROM SOFT TISSUE SARCOMA: A RANDOMIZED PHASE III STUDY (AN INTERGROUP STUDY WITH THE SCANDINAVIAN SARCOMA GROUP)|Completed||Phase 3|340|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:49.28245|2017-10-11 04:21:49.28245
NCT00002765|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-04-28|||April 1996||1996-04-01|March 2003|2003-03-01||||||||Interventional|||Immunotoxin in Treating Patients With Leukemia or Lymphoma|PHASE I STUDY OF ANTI-TAC(Fv)-PE38 (LMB-2), A RECOMBINANT SINGLE-CHAIN IMMUNOTOXIN FOR TREATMENT OF TAC-EXPRESSING MALIGNANCIES|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:49.375353|2017-10-11 04:21:49.375353
NCT00002766|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-01-25|2015-12-17||March 1996||1996-03-01|January 2016|2016-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma|"A Phase III Trial Comparing ARA-C/High-Dose Mitoxantrone (ALL-2') to A Standard Vincristine/Prednisone Based Regimen ('L-20') as Induction Therapy For Adult Patients With Acute Lymphoblastic Leukemia (ALL): The ALL-4 Protocol"|Completed||Phase 3|170|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 04:21:49.460974|2017-10-11 04:21:49.460974
NCT00002768|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-27|||June 1996||1996-06-01|June 2016|2016-06-01|March 2009|Actual|2009-03-01|February 2003|Actual|2003-02-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission|AUTOLOGOUS STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN SECOND REMISSION: A PHASE II STUDY|Completed||Phase 2|51|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:21:50.188995|2017-10-11 04:21:50.188995
NCT00002771|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-01|||January 1995||1995-01-01|July 2000|2000-07-01||||||||Interventional|||Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia|PROSPECTIVE CONTROLLED STUDY FOR THE OPTIMIZATION OF THERAPY IN CHRONIC MYELOID LEUKEMIA (CML): MULTICENTRIC STUDY FOR THE EVALUATION OF INTERFERON ALPHA VS ALLOGENIC BM TRANSPLANTATION WITH CHEMOTHERAPY IN CML|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:50.272828|2017-10-11 04:21:50.272828
NCT00002772|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-22|||July 1996||1996-07-01|January 2013|2013-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer|A Comparison of Intensive Sequential Chemotherapy Using Doxorubicin Plus Paclitaxel Plus Cyclophosphamide With High Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Support for Primary Breast Cancer in Women With 4-9 Involved Axillary Lymph Nodes|Terminated||Phase 3|602|Actual|Southwest Oncology Group||2||poor accrual|f||||t||||||||||2017-10-11 04:21:50.339105|2017-10-11 04:21:50.339105
NCT00002773|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09|||May 1996||1996-05-01|April 2007|2007-04-01|April 2004|Actual|2004-04-01|||||Interventional|||Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer|A CLINICAL TRIAL FOR PANCREAS CANCER USING ACTIVE INTRALYMPHATIC IMMUNOTHERAPY WITH INTERFERON-TREATED PANCREAS CANCER TISSUE CULTURE CELLS, GMCSF, AND LOW-DOSE CYCLOPHOSPHAMIDE|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:50.434792|2017-10-11 04:21:50.434792
NCT00002774|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-06-19|||June 1996||1996-06-01|June 2014|2014-06-01|June 2005|Actual|2005-06-01|June 2000|Actual|2000-06-01||Interventional|||Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Randomized Phase 2 Trial of Tirapazamine and the Role of Tumor Hypoxia in Advanced Squamous Head and Neck Cancer|Completed||Phase 2|63|Actual|Stanford University||2|||f||||||||||||||2017-10-11 04:21:50.489971|2017-10-11 04:21:50.489971
NCT00002775|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||February 1998||1998-02-01|April 2000|2000-04-01||||||||Interventional|||Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer|PHASE I/II STUDY OF DOCETAXEL (TAXOTERE) AND ESTRAMUSTINE COMBINATION CHEMOTHERAPY IN PATIENTS WITH PROSTATE CANCER|Unknown status|Active, not recruiting|Phase 1/Phase 2|37|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:50.569388|2017-10-11 04:21:50.569388
NCT00002777|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||May 1996||1996-05-01|June 2012|2012-06-01||||December 2002|Actual|2002-12-01||Interventional|||Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer|RANDOMIZED PHASE II STUDY IN FIRST LINE HORMONAL TREATMENT FOR METASTATIC BREAST CANCER WITH EXEMESTANE OR TAMOXIFEN IN POSTMENOPAUSAL PATIENTS|Completed||Phase 3|342|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:50.626386|2017-10-11 04:21:50.626386
NCT00002778|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-07-19|||February 1995||1995-02-01|April 2011|2011-04-01|July 2010|Actual|2010-07-01|February 2005|Actual|2005-02-01||Interventional|||Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia|GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (Rhu-GM-CSF) FOR REDUCTION OF LEUKEMIC RELAPSE AFTER T-LYMPHOCYTE DEPLETED ALLOGENEIC BMT FOR CHRONIC MYELOID LEUKEMIA|Terminated||Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||||subject accrual and data analysis is completed.|f||||||||||||||2017-10-11 04:21:50.864244|2017-10-11 04:21:50.864244
NCT00002779|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-14|||February 1998||1998-02-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|July 2000|Actual|2000-07-01||Interventional|||Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma|PHASE II TRIAL OF FLUDARABINE AND SANDOSTATIN FOR RELAPSED LOW-GRADE NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|34|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:21:50.930534|2017-10-11 04:21:50.930534
NCT00002780|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||May 1996||1996-05-01|February 2001|2001-02-01||||||||Interventional|||Biological Therapy in Treating Women With Metastatic Breast Cancer|INFUSION OF ACTIVATED T CELLS AND LOW DOSE INTERLEUKIN 2 COMBINED WITH PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR THE TREATMENT OF WOMEN WITH METASTATIC BREAST CANCER: PHASE I/II|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:51.059731|2017-10-11 04:21:51.059731
NCT00002781|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||April 1996||1996-04-01|April 2000|2000-04-01||||||||Interventional|||Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma|PROCEDURES FOR BNCT PHASE-I STUDY OF MELANOMA IN THE EXTREMITIES|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:51.131252|2017-10-11 04:21:51.131252
NCT00002783|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||May 1996||1996-05-01|July 2013|2013-07-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer|A PHASE II TRIAL OF NEOADJUVANT CISPLATIN-FLUOROURACIL CHEMOTHERAPY, SURGERY, AND INTRAPERITONEAL (IP) FLOXURIDINE (FUdR) PLUS LEUCOVORIN IN PATIENTS WITH GASTRIC CANCER|Completed||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:51.188342|2017-10-11 04:21:51.188342
NCT00002784|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||June 1996||1996-06-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|15-95||High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer|Randomized Trial of High-dose Epirubicin and Cyclophosphamide x 3 Supported by Peripheral Blood Progenitor Cells Versus Anthracycline and Cyclophosphamide x 4 Followed by Cyclophosphamide, Methotrexate, and 5-fluorouracil x 3 as Adjuvant Treatment for High Risk Operable Stage ii and Stage Iii Breast Cancer in Premenopausal and Young Postmenopausal (Less Than or Equal to 65 Yrs) Patients.|Completed||Phase 3|344|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-10-11 04:21:51.255093|2017-10-11 04:21:51.255093
NCT00002785|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||July 1996||1996-07-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|August 2000|Actual|2000-08-01||Interventional|||Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia|Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Infants Less Than 1 Year of Age.|Completed||Phase 2|||Children's Oncology Group|||||f||||t||||||||||2017-10-11 04:21:51.396732|2017-10-11 04:21:51.396732
NCT00002786|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-05-06|||October 1995||1995-10-01|May 2010|2010-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Biological Therapy in Treating Patients With Metastatic Melanoma|PHASE I STUDY TO EVALUATE THE SAFETY OF CELLULAR ADOPTIVE IMMUNOTHERAPY USING GENETICALLY MODIFIED AND UNMODIFIED AUTOLOGOUS CD8+ TYROSINASE-SPECIFIC T CELLS FOR PATIENTS WITH METASTATIC MELANOMA|Completed||Phase 1/Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:21:51.571207|2017-10-11 04:21:51.571207
NCT00002787|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-05-01|||March 1996||1996-03-01|May 2017|2017-05-01||||December 2002|Actual|2002-12-01||Interventional|||Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation|Phase I Trial of Post Transplant Immunization With Autologous Myeloma Idiotype-KLH/GM-CSF In Myeloma Patients Following Autologous or Allogeneic Marrow or Stem Cell Transplantation|Active, not recruiting||Phase 1|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-10-11 04:21:51.637062|2017-10-11 04:21:51.637062
NCT00002788|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2010-09-13|||October 1995||1995-10-01|September 2010|2010-09-01|September 2002||2002-09-01|||||Interventional|||High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia|A PILOT STUDY OF TOTAL BODY IRRADIATION AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION WITH CD34 SELECTED PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA|Completed||Phase 1|15|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:21:51.726512|2017-10-11 04:21:51.726512
NCT00002789|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-29|||May 1996||1996-05-01|March 2010|2010-03-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia|A PHASE III RANDOMIZED STUDY COMPARING G-CSF MOBILIZED PERIPHERAL BLOOD STEM CELLS WITH MARROW AS THE SOURCE OF STEM CELLS FOR ALLOGENEIC TRANSPLANTS FROM HLA IDENTICAL, RELATED DONORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA|Completed||Phase 3|100|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:21:51.802319|2017-10-11 04:21:51.802319
NCT00002790|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-03-04|||March 1996||1996-03-01|March 2015|2015-03-01||||||||Interventional|||Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant|A PHASE I/II STUDY OF RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH METHOTREXATE (MTX) AND CYCLOSPORINE (CPS) IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FROM RELATED DONORS MISMATCHED FOR ONE HLA ANTIGEN IN THE DIRECTION OF GRAFT-VERSUS-HOST DISEASE (GVHD)|Withdrawn||Phase 1/Phase 2|0|Actual|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:21:51.886581|2017-10-11 04:21:51.886581
NCT00002791|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-23|||February 1997||1997-02-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|May 2002|Actual|2002-05-01||Interventional|||Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma|A PHASE II STUDY OF NEOADJUVANT CHEMOTHERAPY AND RADIATION THERAPY IN THE MANAGEMENT OF HIGH-RISK, HIGH-GRADE, SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND BODY WALL|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:21:51.988466|2017-10-11 04:21:51.988466
NCT00002792|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-31|||June 1996||1996-06-01|March 2010|2010-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders|ALLOGENEIC MARROW OR PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA WITH MYELOFIBROSIS|Completed||Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:21:52.699458|2017-10-11 04:21:52.699458
NCT00002793|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||January 1991||1991-01-01|May 2007|2007-05-01||||||||Interventional|||Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer|PALLIATIVE LOCAL CHEMOTHERAPY FOR NON-RESECTABLE LIVER METASTASES FROM COLORECTAL CARCINOMA, A RANDOMISED PHASE III STUDY|Unknown status|Active, not recruiting|Phase 3|336|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:52.77924|2017-10-11 04:21:52.77924
NCT00002794|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-10-03|||February 1996||1996-02-01|October 2011|2011-10-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Carboplatin Plus Vincristine in Treating Children With Retinoblastoma|Evaluation of Chemotherapy as Initial Treatment for Retinoblastoma|Completed||Phase 2|25|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-10-11 04:21:52.841169|2017-10-11 04:21:52.841169
NCT00002796|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-31|||May 1997||1997-05-01|January 2013|2013-01-01||||December 2004|Actual|2004-12-01||Interventional|||Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer|Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate, Indomethacin and Recombinant Human Interferon-Gamma in Advanced Colorectal Cancer|Terminated||Phase 1/Phase 2|46|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:21:52.907531|2017-10-11 04:21:52.907531
NCT00002798|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-24|2013-01-15|||August 1996||1996-08-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|A PHASE III STUDY IN CHILDREN WITH UNTREATED ACUTE MYELOGENOUS LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)|Completed||Phase 3|880|Actual|National Cancer Institute (NCI)||5|||f||||||||||||||2017-10-11 04:21:53.003604|2017-10-11 04:21:53.003604
NCT00002800|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||July 1996||1996-07-01|July 2013|2013-07-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome|PHASE II STUDY OF HIGH DOSE CYTARABINE COMBINED WITH A SINGLE HIGH DOSE OF IDARUBICIN FOR NEWLY DIAGNOSED PATIENTS WITH AML: THE AML-3 PROTOCOL|Completed||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:53.19767|2017-10-11 04:21:53.19767
NCT00002801|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||April 1996||1996-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer|PHASE I TRIAL OF POST-OPERATIVE COMBINED ORAL UFT PLUS LEUCOVORIN AND RADIATION THERAPY FOR RECTAL CANCER|Completed||Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:53.267972|2017-10-11 04:21:53.267972
NCT00002802|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||July 1990||1990-07-01|May 2007|2007-05-01|September 2003|Actual|2003-09-01|||||Interventional|||Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma|PHASE III MULTICENTRE TRIAL OF TREATMENT OF NEUROBLASTOMA IN CHILDREN AND ADOLESCENTS|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:53.34213|2017-10-11 04:21:53.34213
NCT00002803|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||July 1995||1995-07-01|April 2008|2008-04-01|February 2002|Actual|2002-02-01|||||Interventional|||Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma|COOPERATIVE MULTICENTER TRIAL FOR THE TREATMENT OF INFANTS WITH NEUROBLASTOMA|Completed||Phase 2|44|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:53.453063|2017-10-11 04:21:53.453063
NCT00002804|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-24|||September 1996||1996-09-01|July 2014|2014-07-01|April 2006|Actual|2006-04-01|June 2000|Actual|2000-06-01||Interventional|||Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma|Phase II Study of Neoadjuvant Vincristine, Ifosfamide, Doxorubicin, and AND G-CSF in Children With Advanced Stage Non-Rhabdomyosarcoma Soft Tissue Sarcomas|Completed||Phase 2|43|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:21:53.54181|2017-10-11 04:21:53.54181
NCT00002805|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||August 1997||1997-08-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|May 2001|Actual|2001-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome|Acute Myeloid Leukemia Salvage Therapy for Patients in First Relapse or Who Fail to Achieve an Initial Remission or Who Develop AML as a Second Malignant Neoplasm|Completed||Phase 2|115|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:21:53.701412|2017-10-11 04:21:53.701412
NCT00002806|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||July 1996||1996-07-01|July 2016|2016-07-01|July 2004|Actual|2004-07-01|January 2003|Actual|2003-01-01||Interventional|||Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma|PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS|Completed||Phase 2|43|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:21:53.953586|2017-10-11 04:21:53.953586
NCT00002807|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-11-25|||July 1996||1996-07-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|March 2007|Actual|2007-03-01||Interventional|||Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery|A Phase III Randomized Trial Comparing TAH BSO Versus TAH BSO Plus Adjuvant Pelvic Irradiation in Intermediate Risk Carcinoma of the Endometrium|Completed||Phase 3|116|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:21:54.074593|2017-10-11 04:21:54.074593
NCT00002809|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-30|||August 1996||1996-08-01|September 2010|2010-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer|Unrelated Bone Marrow Transplantation With Cyclophosphamide and Total Body Irradiation For Hematologic Malignancies and Bone Marrow Failure States|Completed||Phase 2|10|Anticipated|Temple University|||||f||||||||||||||2017-10-11 04:21:54.190791|2017-10-11 04:21:54.190791
NCT00002810|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-30|||May 1996||1996-05-01|September 2010|2010-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis|Autologous Peripheral Blood Stem Cell Transplantation With High Dose Melphalan For Treatment Of Primary Amyloidosis (AL)|Completed||Phase 2|||Temple University|||||f||||||||||||||2017-10-11 04:21:54.282482|2017-10-11 04:21:54.282482
NCT00002811|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||July 1996||1996-07-01|May 2007|2007-05-01||||||||Interventional|||T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum|A RANDOMIZED, DOUBLE BLIND, MULTI-CENTER CLINICAL STUDY TO TEST THE SAFETY AND EFFICACY OF T4N5 LIPOSOME LOTION ON PATIENTS WITH XERODERMA PIGMENTOSUM IN THE PROTECTION AGAINST ACTINIC KERATOSES|Unknown status|Active, not recruiting|Phase 3|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:54.359911|2017-10-11 04:21:54.359911
NCT00002812|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-23|||September 1996||1996-09-01|August 2013|2013-08-01||||March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia|Treatment of Patients With Acute Lymphoblastic Leukemia With Unfavorable Features: A Phase III Group-wide Study|Completed||Phase 3|2078|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:21:54.447498|2017-10-11 04:21:54.447498
NCT00002813|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-24|||August 1997||1997-08-01|March 2008|2008-03-01||||October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer|A LIMITED ACCESS PHASE II TRIAL OF CISPLATIN AND NAVELBINE (VINORELBINE) IN ADVANCED AND RECURRENT SQUAMOUS CELL CARCINOMA OF THE CERVIX|Completed||Phase 2|62|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:21:54.746386|2017-10-11 04:21:54.746386
NCT00002814|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-10-26|||August 1996||1996-08-01|October 2011|2011-10-01|December 2001|Actual|2001-12-01|April 2001|Actual|2001-04-01||Interventional|||Combination Chemotherapy for Patients With Brain Cancer|A Phase II Trial of Paclitaxel and Topotecan With Filgrastim in Patients With Recurrent or Refractory Glioblastoma Multiforme or Anaplastic Astrocytoma|Completed||Phase 2|20|Actual|Dartmouth-Hitchcock Medical Center|||||f||||t||||||||||2017-10-11 04:21:54.823681|2017-10-11 04:21:54.823681
NCT00002816|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-21|||December 1996||1996-12-01|August 2013|2013-08-01|April 2006|Actual|2006-04-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia|EXTRAMEDULLARY RELAPSE AND OCCULT BONE MARROW INVOLVEMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE III GROUP-WIDE STUDY|Completed||Phase 3|120|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:54.994562|2017-10-11 04:21:54.994562
NCT00002817|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-09|||April 1996||1996-04-01|May 2002|2002-05-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|INTRALESIONAL IMMUNOTHERAPY WITH A VACCINIA/GM-CSF RECOMBINANT VIRUS IN PATIENTS WITH METASTATIC MELANOMA|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:55.195517|2017-10-11 04:21:55.195517
NCT00002818|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2015-12-10|||February 1995||1995-02-01|December 2015|2015-12-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies|Phase I and Clinical Pharmacokinetic De-Escalation Study of 2'-Deoxycitidine Administered as a Continuous Infusion in Conjunction With a Continuous Infusion of High-Dose ARA-C in Patients With Refractory Acute Myelogenous Leukemia|Completed||Phase 1|15|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-10-11 04:21:55.288398|2017-10-11 04:21:55.288398
NCT00002819|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-10|||November 1996||1996-11-01|May 2007|2007-05-01||||February 2000|Actual|2000-02-01||Interventional|||Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer|A RANDOMIZED, CONTROLLED TRIAL OF SALVAGE THERAPY WITH PACLITAXEL AND CARBOPLATIN VERSU SALVAGE THERAPY WITH STEM CELL SUPPORTED HIGH-DOSE CARBOPLATIN, MITOXANTRONE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH PERSISTENT LOW VOLUME OVARIAN CANCER AND RESPONSE TO PRIMARY THERAPY|Terminated||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:21:55.407288|2017-10-11 04:21:55.407288
NCT00002822|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||March 1996||1996-03-01|December 2000|2000-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer|RANDOMISED CLINICAL TRIAL OF IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITH MID-CYCLE VINCRISTINE (VICE) VERSUS STANDARD PRACTICE CHEMOTHERAPY IN PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER (SCLC) AND GOOD PERFORMANCE STATUS|Completed||Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:55.625856|2017-10-11 04:21:55.625856
NCT00002823|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-26|||February 1995||1995-02-01|April 2011|2011-04-01||||January 2001|Actual|2001-01-01||Interventional|||Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer|A LARGE-SCALE TRIAL EVALUATING ADJUVANT CHEMOTHERAPY AFTER CURATIVE RESECTION OF NON-SMALL CELL LUNG CANCER|Completed||Phase 3|3300|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 04:21:55.751312|2017-10-11 04:21:55.751312
NCT00002824|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||February 1996||1996-02-01|July 2000|2000-07-01||||||||Interventional|||Gene Therapy in Treating Patients With Primary Brain Tumors|A PHASE I TRIAL OF HSV-TK ADENOVIRUS GENE THERAPY FOR PRIMARY BRAIN TUMORS|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:56.059842|2017-10-11 04:21:56.059842
NCT00002825|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||January 1997||1997-01-01|May 2006|2006-05-01||||December 2004|Actual|2004-12-01||Interventional|||Docetaxel in Treating Children With Recurrent Solid Tumors|A PHASE II STUDY OF DOCETAXEL (TAXOTERE) (NSC# 628503) IN CHILDREN WITH RECURRENT SOLID TUMORS|Completed||Phase 2|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:21:56.158496|2017-10-11 04:21:56.158496
NCT00002826|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-28|||June 1997||1997-06-01|August 2013|2013-08-01||||November 2003|Actual|2003-11-01||Interventional|||Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer|A PILOT PHASE II TRIAL OF PSC 833 MODULATION OF MULTIDRUG RESISTANCE TO PACLITAXEL IN THE TREATMENT OF METASTATIC CARCINOMA OF THE BREAST|Completed||Phase 2|36|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:21:56.34499|2017-10-11 04:21:56.34499
NCT00002827|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||October 1996||1996-10-01|August 2013|2013-08-01|June 2008|Actual|2008-06-01|October 2004|Actual|2004-10-01||Interventional|||Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease|RESPONSE DEPENDENT TREATMENT OF STAGES IA, IIA AND IIIA HODGKIN'S DISEASE WITH DBVE AND LOW DOSE INVOLVED FIELD IRRADIATION WITH OR WITHOUT ZINECARD: A PEDIATRIC ONCOLOGY GROUP PHASE III STUDY|Completed||Phase 3|294|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:21:56.462509|2017-10-11 04:21:56.462509
NCT00002828|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||April 1995||1995-04-01|June 2013|2013-06-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer|PHASE I TRIAL OF SEQUENTIAL TOMUDEX AND 5-FLUOROURACIL IN SUBJECTS WITH ADVANCED COLORECTAL CARCINOMA|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:21:56.672251|2017-10-11 04:21:56.672251
NCT00002829|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-26|||February 1994||1994-02-01|July 2012|2012-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Lymphoma|Autologous and Allogeneic Bone Marrow Transplantation for Low Grade Lymphoma|Completed||Phase 2|45|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:21:56.751329|2017-10-11 04:21:56.751329
NCT00002831|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||July 1994||1994-07-01|July 2012|2012-07-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia|A Phase I/II Study of High-Dose Deoxyazacytidine, Busulfan, and Cyclophosphamide With Allogeneic Stem Cell Transplantation for Hematologic Malignancies|Completed||Phase 1/Phase 2|24|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:21:56.85289|2017-10-11 04:21:56.85289
NCT00002832|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||August 1995||1995-08-01|July 2012|2012-07-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia|Phase I/II Trial of Decitabine and Allogeneic Peripheral Blood Stem Cells Transplantation for Treatment of Relapse Post Allogeneic Bone Marrow Transplantation|Completed||Phase 1/Phase 2|14|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:21:56.965665|2017-10-11 04:21:56.965665
NCT00002833|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||October 1994||1994-10-01|July 2012|2012-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia|Use of G-CSF Stimulated HLA-Identical Allogeneic Peripheral Blood Stem Cells for Patients With High Risk Acute Myelogenous Leukemia or CML in Blast Crisis|Completed||Phase 2|53|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:21:57.080832|2017-10-11 04:21:57.080832
NCT00002835|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||July 1995||1995-07-01|July 2012|2012-07-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Lymphoma|A Randomized Prospective Study of Early Intensification Versus Alternating Triple Therapy for Patients With Poor Prognosis Lymphoma|Completed||Phase 3|116|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:21:57.201747|2017-10-11 04:21:57.201747
NCT00002836|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||May 1995||1995-05-01|July 2012|2012-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer|A Phase III Randomized Comparison of High Dose Chemotherapy G-CSF To G-CSF For Mobilization of Peripheral Blood Stem Cells For Autologous Transplantation For Patients With Responsive Metastatic Breast Cancer Or High Risk Stage II-III Patients|Completed||Phase 3|184|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:21:57.342919|2017-10-11 04:21:57.342919
NCT00002837|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||September 1995||1995-09-01|July 2012|2012-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer|Phase I-II Study of Dose Intense Doxorubicin, Paclitaxel And Cyclophosphamide With Peripheral Blood Progenitor Cells (PBPC) And Cytokine Support In Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:21:57.53915|2017-10-11 04:21:57.53915
NCT00002944|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-06|||April 1997||1997-04-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|February 2006|Actual|2006-02-01||Interventional|||Combination Chemotherapy in Treating Children With Progressive Brain Tumors|Chemotherapy for Progressive Low Grade Astrocytoma in Children Less Than Ten Years Old|Completed||Phase 3|428|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:13.54547|2017-10-11 04:22:13.54547
NCT00002838|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||December 1995||1995-12-01|July 2012|2012-07-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia|Phase I/II Pilot Study of Allogeneic Peripheral Blood Stem Cell Infusion For Patients With High Risk Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|13|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:21:57.625455|2017-10-11 04:21:57.625455
NCT00002839|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-07|||July 1996||1996-07-01|January 2013|2013-01-01||||May 2004|Actual|2004-05-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx|PHASE II STUDY ON LARYNX PRESERVATION COMPARING INDUCTION CHEMOTHERAPY AND RADIOTHERAPY VERSUS ALTERNATING CHEMO-RADIOTHERAPY IN RESECTABLE HYPOPHARYNX AND LARYNX CANCERS|Completed||Phase 3|564|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:57.745923|2017-10-11 04:21:57.745923
NCT00002840|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-06|||August 1996||1996-08-01|July 2012|2012-07-01||||March 2002|Actual|2002-03-01||Interventional|||Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma|PHASE III STUDY OF ADJUVANT PROCARBAZINE, CCNU AND VINCRISTINE CHEMOTHERAPY IN PATIENTS WITH HIGHLY ANAPLASTIC OLIGODENDROGLIOMA|Completed||Phase 3|350|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:21:57.936817|2017-10-11 04:21:57.936817
NCT00002842|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-02-28|2017-02-28||September 1994||1994-09-01|February 2017|2017-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer|Hepatic Resection Followed by Concurrent Adjuvant Portal Vein Infusion of Fluorodeoxyuridine and Systemic 5-Fluorouracil and Folinic Acid for Metastatic Colorectal Carcinoma|Completed||Phase 2|49|Actual|City of Hope Medical Center||1|||f||||||||||||||2017-10-11 04:21:58.135515|2017-10-11 04:21:58.135515
NCT00002844|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||March 1991||1991-03-01|July 2012|2012-07-01|June 2002|Actual|2002-06-01|July 2000|Actual|2000-07-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia|Bone Marrow Transplantation for Chronic Lymphocytic Leukemia|Completed||Phase 2|49|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:21:58.469359|2017-10-11 04:21:58.469359
NCT00002845|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||September 1995||1995-09-01|May 2000|2000-05-01||||||||Interventional|||Interleukin-2 in Treating Patients With Metastatic Melanoma|TREATMENT OF METASTATIC MELANOMA WITH RECOMBINANT INTERLEUKIN-2|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:58.579282|2017-10-11 04:21:58.579282
NCT00002846|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||September 1995||1995-09-01|December 2003|2003-12-01||||||||Interventional|||Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer|TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH LOW-DOSE INTRAVENOUS RECOMBINANT INTERLEUKIN-2|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:58.649457|2017-10-11 04:21:58.649457
NCT00002847|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||September 1995||1995-09-01|December 2003|2003-12-01||||||||Interventional|||Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON ALPHA|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:58.733072|2017-10-11 04:21:58.733072
NCT00002848|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-04|||April 1997||1997-04-01|March 2013|2013-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Group Therapy Compared With Educational Materials in Patients With Prostate Cancer|SUPPORTIVE-EXPRESSIVE GROUP THERAPY FOR MEN WITH PRIMARY PROSTATE CANCER|Completed||N/A|480|Anticipated|University of Rochester|||||f||||f||||||||||2017-10-11 04:21:58.810222|2017-10-11 04:21:58.810222
NCT00002849|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-03-05|||November 1996||1996-11-01|March 2015|2015-03-01|July 2000|Actual|2000-07-01|December 1998|Actual|1998-12-01||Interventional|||S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis|Phase II Study of Dexamethasone/Alpha-Interferon in AL Amyloidosis|Completed||Phase 2|93|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:21:58.898808|2017-10-11 04:21:58.898808
NCT00002850|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-13|2014-07-10||March 1997||1997-03-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional||Patients with symptomatic and untreated MM receiving chemotherapy without an active infection during the 7 days prior to initiation of chemotherapy and off antibiotics for the prior 7 days were eligable for this study. They were required to receive myelosuppressive and/or immunosuppressive chemotherapy, and were randomized on a 1:1 basis.|Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy|Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma|Completed||Phase 3|212|Actual|University of Rochester||3|||f||||t||||||||||2017-10-11 04:21:59.078866|2017-10-11 04:21:59.078866
NCT00002851|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-28|||July 1996||1996-07-01|December 2004|2004-12-01||||||||Interventional|||Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed|PHASE III RANDOMISED TRIAL INVESTIGATING THE ROLE OF INTERNAL MAMMARY AND MEDIAL SUPRACLAVICULAR (IM-MS) LYMPH NODE CHAIN IRRADIATION IN STAGE I-III BREAST CANCER|Unknown status|Active, not recruiting|Phase 3|4000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:21:59.580769|2017-10-11 04:21:59.580769
NCT00002852|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-02|||October 1996||1996-10-01|July 2013|2013-07-01||||July 2004|Actual|2004-07-01||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer|A PHASE III STUDY OF ADJUVANT CHEMOTHERAPY AFTER RESECTION FOR PATIENTS WITH T2N0 STAGE I NON-SMALL CELL CARCINOMA OF THE LUNG|Completed||Phase 3|500|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:21:59.714975|2017-10-11 04:21:59.714975
NCT00002854|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-08-24|||December 1994||1994-12-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer|PHASE I PILOT STUDY OF SEQUENTIAL HIGH DOSE CYCLES OF CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE AND IFOSFAMIDE, CARBOPLATIN AND TAXOL WITH AUTOLOGOUS STEM CELL SUPPORT|Completed||Phase 1|33|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 04:21:59.805671|2017-10-11 04:21:59.805671
NCT00002912|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-31|||January 1997||1997-01-01|August 2010|2010-08-01||||March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia|A PHASE I COOPERATIVE AGREEMENT PEDIATRIC TRIAL OF MITOXANTRONE, ETOPOSIDE AND PSC-833 (PSC-ME) THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY ACUTE LEUKEMIA|Completed||Phase 1|3|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:08.655731|2017-10-11 04:22:08.655731
NCT00002855|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||August 1996||1996-08-01|July 2012|2012-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer|A Phase 3 Trial of Androgen Ablation Alone vs. Chemo/Hormonal Therapy as Initial Treatment of Unresectable/Metastatic Adenocarcinoma of the Prostate|Completed||Phase 3|306|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:21:59.983835|2017-10-11 04:21:59.983835
NCT00002858|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||March 1993||1993-03-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer|PHASE III STUDY COMPARING TWO DOSES OF INDUCTION CHEMOTHERAPY FOLLOWED BY ALTERNATION OF CHEMOTHERAPY AND RADIOTHERAPY IN LIMITED SMALL CELL LUNG CANCER|Unknown status|Active, not recruiting|Phase 3|280|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:00.117251|2017-10-11 04:22:00.117251
NCT00002860|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-01-11|||November 1996||1996-11-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2006|Actual|2006-12-01||Interventional|||SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma|A Phase II Trial of Complete Surgical Resection For Stage IV Melanoma -- Surgical Resection With Biological Evaluation and Clinical Follow-Up|Completed||Phase 2|77|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:22:00.236572|2017-10-11 04:22:00.236572
NCT00002862|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||October 1996||1996-10-01|September 2000|2000-09-01||||April 2001|Actual|2001-04-01||Interventional|||Perillyl Alcohol in Treating Patients With Refractory Cancer|A PHASE I STUDY OF PERILLYL ALCOHOL IN PATIENTS WITH REFRACTORY MALIGNANCIES (NSC #641066)|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:00.531742|2017-10-11 04:22:00.531742
NCT00002863|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||June 1996||1996-06-01|May 2014|2014-05-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Cryosurgery in Treating Patients With Soft Tissue Sarcoma|PHASE I FEASIBILITY TRIAL OF CRYOSURGICAL ABLATION OF SOFT TISSUE SARCOMAS OF THE EXTREMETY|Terminated||Phase 1|19|Actual|University of Southern California||1||Insufficient Accrual|f||||t||||||||||2017-10-11 04:22:01.913371|2017-10-11 04:22:01.913371
NCT00002864|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||August 1996||1996-08-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|October 2007|Actual|2007-10-01||Interventional|||Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer|A RANDOMIZED TRIAL OF ANTIESTROGEN THERAPY VERSUS COMBINED ANTIESTROGEN AND OCTREOTIDE LAR THERAPY IN THE ADJUVANT TREATMENT OF BREAST CANCER IN POST-MENOPAUSAL WOMEN|Completed||Phase 3|667|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:22:01.983932|2017-10-11 04:22:01.983932
NCT00002865|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-12|||April 1995||1995-04-01|September 2015|2015-09-01|August 2001|Actual|2001-08-01|June 2000|Actual|2000-06-01||Interventional|||High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia|HIGH INTENSITY, BRIEF DURATION CHEMOTHERAPY FOR RELAPSED OR REFRACTORY ALL: A PHASE II STUDY OF A MULTIDRUG REGIMEN|Completed||Phase 2|25|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-10-11 04:22:02.16576|2017-10-11 04:22:02.16576
NCT00002866|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-07|||August 1996||1996-08-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|||||Interventional|||Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer|A PHASE I/II STUDY OF DOCETAXEL AND EPIRUBICIN AS FIRST LINE THERAPY FOR METASTATIC BREAST CANCER|Completed||Phase 1|50|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:22:02.249109|2017-10-11 04:22:02.249109
NCT00002868|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-02-09|||January 1996||1996-01-01|June 2005|2005-06-01||||March 2004|Actual|2004-03-01||Interventional|||Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia|PROSPECTIVE RANDOMISED STUDY TO COMPARE INTERFERON-ALPHA-n1 (WELLFERON) VS 'IDAC' CHEMOTHERAPY AND AUTOGRAFTING FOLLOWED BY INTERFERON ALPHA-n1 (WELLFERON) IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA|Completed||Phase 3|744|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:22:02.352787|2017-10-11 04:22:02.352787
NCT00002869|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||April 1995||1995-04-01|February 2008|2008-02-01||||||||Interventional|||Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia|PROSPECTIVE RANDOMISED STUDY TO COMPARE LOW-DOSE INTERFERON-ALPHA-n1 (WELLFERON) +/- HYDROXYUREA VS HIGH-DOSE INTERFERON-ALPHA-n1 (WELLFERON) +/- HYDROXYUREA IN PATIENTS WITH NEWLY DIAGONISED CHRONIC PHASE CHRONIC MYELOID LEUKAEMIA|Unknown status|Active, not recruiting|Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:02.450578|2017-10-11 04:22:02.450578
NCT00002870|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-12-14|||December 1994||1994-12-01|December 2014|2014-12-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer|A RANDOMIZED, MULTI-CENTRE PHASE III TRIAL TO EVALUATE THE ROLE OF INTENSIFIED THERAPY WITH AUTOLOGOUS TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN ADVANCED OR METASTATIC BREAST CANCER RESPONDING TO INDUCTION CHEMOTHERAPY|Completed||Phase 3|180|Anticipated|UNICANCER|||||f||||t||||||||||2017-10-11 04:22:02.51305|2017-10-11 04:22:02.51305
NCT00002872|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-28|||November 1996||1996-11-01|August 2013|2013-08-01||||February 2003|Actual|2003-02-01||Interventional|||Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions|A PROSPECTIVE RANDOMIZED TRIAL OF BLEOMYCIN VS. DOXYCYCLINE VS. TALC FOR THE INTRAPLEURAL TREATMENT OF MALIGNANT PLEURAL EFFUSIONS|Completed||Phase 3|480|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:22:02.754457|2017-10-11 04:22:02.754457
NCT00002873|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-17|||May 1997||1997-05-01|February 2008|2008-02-01||||June 2007|Actual|2007-06-01||Interventional|||Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer|A PHASE I/II TRIAL TO EVALUATE BRACHYTHERAPY AS THE SOLE METHOD OF RADIATION THERAPY FOR STAGE I AND II BREAST CARCINOMA|Completed||Phase 1/Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:22:02.863918|2017-10-11 04:22:02.863918
NCT00002874|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-18|2017-06-06||February 1998||1998-02-01|July 2017|2017-07-01||||August 2015|Actual|2015-08-01||Interventional||Eligible patients who have not withdrawn|Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy|A PHASE III TRIAL OF RADIATION THERAPY WITH OR WITHOUT CASODEX IN PATIENTS WITH PSA ELEVATION FOLLOWING RADICAL PROSTATECTOMY FOR pT3N0 CARCINOMA OF THE PROSTATE|Active, not recruiting||Phase 3|840|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:03.395249|2017-10-11 04:22:03.395249
NCT00005361|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1993||1993-04-01|June 2000|2000-06-01|March 1998|Actual|1998-03-01|||||Observational|||Determinants of Respiratory Health in Young Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.407199|2017-10-11 04:28:03.407199
NCT00002875|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-31|||December 1996||1996-12-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|February 2006|Actual|2006-02-01||Interventional|||Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma|Phase III Prospective Randomized Study of Craniospinal RT Followed by One of Two Adjuvant Chemotherapy Regimens (CCNU, CDDP, VCR OR CPM, CDDP, VCR) for Newly-Diagnosed Average Risk MedulloblastomaMEDULLOBLASTOMA|Completed||Phase 3|421|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:04.683318|2017-10-11 04:22:04.683318
NCT00002876|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-05-10|||October 1991||1991-10-01|May 2011|2011-05-01|January 2005|Actual|2005-01-01|April 1998|Actual|1998-04-01||Interventional|||Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas|A PHASE II TRIAL OF ETOPOSIDE AND CISPLATIN IN THE TREATMENT OF RECURRENT EPENDYMOMAS|Completed||Phase 2|35|Anticipated|Mayo Clinic|||||f||||||||||||||2017-10-11 04:22:04.926035|2017-10-11 04:22:04.926035
NCT00002878|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-28|||March 1997||1997-03-01|August 2013|2013-08-01||||April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma|A PHASE III STUDY OF PSC-833 IN COMBINATION WITH VINCRISTINE, DOXORUBICIN AND DEXAMETHASONE (PSC-833/VAD) VERSUS VAD ALONE IN PATIENTS WITH RELAPSING OR REFRACTORY MULTIPLE MYELOMA|Completed||Phase 3|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:22:05.031285|2017-10-11 04:22:05.031285
NCT00002879|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-05|||November 1996||1996-11-01|December 2016|2016-12-01|December 2008|Actual|2008-12-01|April 2005|Actual|2005-04-01||Interventional|||Cladribine in Patients With Mantle Cell Lymphoma|A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)|Completed||Phase 2|51|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:22:05.397978|2017-10-11 04:22:05.397978
NCT00002880|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-27|||November 1996||1996-11-01|June 2016|2016-06-01|January 2008|Actual|2008-01-01|January 2001|Actual|2001-01-01||Interventional|||Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|PHASE II STUDY OF ORAL ETOPOSIDE WITH PHARMACODYNAMIC MODELING IN RELAPSED NON-HODGKIN'S LYMPHOMA (IWF GRADES A-H)|Completed||Phase 2|53|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:05.596039|2017-10-11 04:22:05.596039
NCT00002881|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-06|||October 1996||1996-10-01|May 2007|2007-05-01||||April 1998|Actual|1998-04-01||Interventional|||Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer|PHASE III TRIAL OF ORCHIECTOMY/LHRH ANALOG + FLUTAMIDE + SURAMIN + HYDROCORTISONE VS ORCHIECTOMY/LHRH ANALOG + FLUTAMIDE IN PATIENTS WITH METASTATIC PROSTATE CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:05.728761|2017-10-11 04:22:05.728761
NCT00002882|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-12-12|||November 1995||1995-11-01|December 2011|2011-12-01|April 2006|Actual|2006-04-01|August 2003|Actual|2003-08-01||Interventional|||Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma|Adjuvant Therapy for Melanoma Patients With Regional Lymph Node Metastases With Interferon Alfa-2B vs. Biochemotherapy Using Cisplatin + Vinblastine + DTIC + Interferon Plus IL-2|Completed||Phase 3|140|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 04:22:05.845091|2017-10-11 04:22:05.845091
NCT00002883|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||October 1996||1996-10-01|April 2001|2001-04-01||||||||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus|A PROSPECTIVE RANDOMISED TRIAL OF INDUCTION CHEMOTHERAPY WITH 5-FU CONTINUOUS IV INFUSION AND CISPLATIN VERSUS SURGERY IN RESECTABLE ADENOCARCINOMA OF THE LOW THIRD OF THE ESOPHAGUS AND CARDIOESOPHAGEAL JUNCTION|Unknown status|Active, not recruiting|Phase 3|250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:05.999156|2017-10-11 04:22:05.999156
NCT00002884|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-06|||March 1996||1996-03-01|May 2007|2007-05-01||||||||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus|A PROSPECTIVE RANDOMISED NON SURGICAL TREATMENT OF OESOPHAGEAL CANCER WITH COMBINED CHEMOTHERAPY AND EXTERNAL BEAM IRRADIATION WITH VS WITHOUT HIGH-DOSE BRACHYTHERAPY|Unknown status|Active, not recruiting|Phase 3|326|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:06.077127|2017-10-11 04:22:06.077127
NCT00002887|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||July 1995||1995-07-01|October 2001|2001-10-01||||||||Interventional|||Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer|PHASE I TRIAL OF HYDROXYUREA FOR SALVAGE OF INCURABLE NON-SMALL CELL LUNG CANCER|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:06.158841|2017-10-11 04:22:06.158841
NCT00002888|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||March 1997||1997-03-01|May 2007|2007-05-01|August 2004|Actual|2004-08-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer|A RANDOMIZED PHASE III EVALUATION OF PACLITAXEL + G-CSF + CISPLATIN VERSUS CISPLATIN + 5-FU IN ADVANCED HEAD AND NECK CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:06.232489|2017-10-11 04:22:06.232489
NCT00002889|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-27|||May 1997||1997-05-01|June 2016|2016-06-01|June 2009|Actual|2009-06-01|January 2004|Actual|2004-01-01||Interventional|||Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer|PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY|Completed||Phase 2|180|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:06.464798|2017-10-11 04:22:06.464798
NCT00002890|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||October 1996||1996-10-01|June 2013|2013-06-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia|PHASE I DOSE-ESCALATION TRIAL OF YTTRIUM-90-LABELED HuM195 (HUMANIZED ANTI-CD33) IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:06.575438|2017-10-11 04:22:06.575438
NCT00002892|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||October 1995||1995-10-01|May 2007|2007-05-01|December 2001|Actual|2001-12-01|||||Interventional|||Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma|A RANDOMISED STUDY OF OBSERVATION VERSUS ADJUVANT LOW DOSE EXTENDED DURATION INTERFERON ALPHA-2A IN COMPLETELY RESECTED HIGH RISK MALIGNANT MELANOMA|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:06.648322|2017-10-11 04:22:06.648322
NCT00002893|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||June 1995||1995-06-01|May 2007|2007-05-01||||||||Interventional|||Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer|CHEMOTHERAPY CHOICES IN ADVANCED COLORECTAL CANCER: A RANDOMISED TRIAL COMPARING 2 DURATIONS AND 3 SYSTEMIC CHEMOTHERAPY REGIMENS IN THE PALLIATIVE TREATMENT OF ADVANCED COLORECTAL CANCER|Unknown status|Active, not recruiting|Phase 3|900|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:06.733395|2017-10-11 04:22:06.733395
NCT00002894|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||March 1996||1996-03-01|February 2001|2001-02-01|June 2003|Actual|2003-06-01|||||Interventional|||Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer|A RANDOMISED TRIAL OF PACLITAXEL (TAXOL) IN COMBINATION WITH PLATINUM CHEMOTHERAPY VS. CONVENTIONAL PLATINUM-BASED CHEMOTHERAPY IN THE TREATMENT OF WOMEN WITH RELAPSED OVARIAN CANCER|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:06.812486|2017-10-11 04:22:06.812486
NCT00002895|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||June 1996||1996-06-01|September 2005|2005-09-01|October 2010|Actual|2010-10-01|||||Interventional|||Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer|A Randomised Trial in Relapsed Ovarian Cancer: Early Treatment Based on CA 125 Levels Alone Vs. Delayed Treatment Based On Conventional Clinical Indicators|Completed||Phase 3|1400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:06.890434|2017-10-11 04:22:06.890434
NCT00002896|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||September 1993||1993-09-01|February 2008|2008-02-01||||||||Interventional|||Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer|RANDOMIZED TRIAL OF CONCOMITANT PREOPERATIVE RADIO-CHEMOTHERAPY WITH OR WITHOUT POSTOPERATIVE CHEMOTHERAPY IN LOCALLY ADVANCED RECTAL CARCINOMA|Unknown status|Active, not recruiting|Phase 3|774|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:07.000644|2017-10-11 04:22:07.000644
NCT00002897|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||July 1992||1992-07-01|May 2007|2007-05-01|June 2001|Actual|2001-06-01|||||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus|RANDOMIZED STUDY OF PREOPERATIVE CHEMOTHERAPY VERSUS SURGERY ALONE IN ESOPHAGUS CANCER|Completed||Phase 3|240|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:07.066112|2017-10-11 04:22:07.066112
NCT00002898|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||January 1995||1995-01-01|May 1999|1999-05-01|December 2009|Actual|2009-12-01|||||Interventional|||Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma|MMT 95 Study For Rhabdomyosarcoma and Other Malignant Soft Tissue Tumors of Childhood|Completed||Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:07.133176|2017-10-11 04:22:07.133176
NCT00002899|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||November 1996||1996-11-01|June 2012|2012-06-01||||November 2007|Actual|2007-11-01||Interventional|||Adjuvant Radiation Therapy in Treating Patients With Brain Metastases|Phase III Trial on Convergent Beam Irradiation of Cerebral Metastases|Terminated||Phase 3|340|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||Low accrual|f||||||||||||||2017-10-11 04:22:07.217064|2017-10-11 04:22:07.217064
NCT00002900|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-15|||February 1997||1997-02-01|October 2015|2015-10-01||||March 2008|Actual|2008-03-01||Observational|||SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial|A STUDY OF THE LATE CARDIAC EFFECTS OF TWO DIFFERENT ADJUVANT CHEMOTHERAPY REGIMENTS IN WOMEN WITH NODE NEGATIVE BREAST CANCER TREATED ON SWOG-8897|Completed||N/A|180|Actual|Southwest Oncology Group|||1||f||||||||||||||2017-10-11 04:22:07.461251|2017-10-11 04:22:07.461251
NCT00002901|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-11|||December 1996||1996-12-01|January 2010|2010-01-01||||||||Interventional|||Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function|PHASE I STUDY OF TAXOTERE IN PATIENTS WITH ADVANCED MALIGNANCIES AND VARYING DEGREES OF LIVER DYSFUNCTION|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:22:07.714825|2017-10-11 04:22:07.714825
NCT00002902|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||April 1997||1997-04-01|July 2002|2002-07-01||||||||Interventional|||Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors|PHASE I TRIAL OF IRINOTECAN AND TOMUDEX IN COMBINATION ON AN EVERY THREE WEEK SCHEDULE|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:07.79698|2017-10-11 04:22:07.79698
NCT00002903|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||July 1995||1995-07-01|June 2012|2012-06-01||||||||Interventional|||Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer|PHASE II TRIAL WITH DOCETAXEL IN PATIENTS WITH RELAPSING GERM CELL CANCER|Completed||Phase 2|25|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:07.858305|2017-10-11 04:22:07.858305
NCT00002904|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||February 1996||1996-02-01|June 2012|2012-06-01||||||||Interventional|||Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors|PHASE I CLINICAL AND PHARMACOKINETIC STUDY TO DETERMINE THE SAFETY OF ECTEINASCIDIN-743 (ET-743) ADMINISTERED AS A SINGLE INTRAVENOUS INFUSION OVER 60 MINUTES EVERY 21 DAYS IN PATIENTS WITH SOLID TUMORS|Completed||Phase 1|40|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:08.055125|2017-10-11 04:22:08.055125
NCT00002905|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||June 1995||1995-06-01|September 2011|2011-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma|PROSPECTIVE NON-RANDOMIZED STUDY WITH CHEMOTHERAPY FOR RELAPSED OR REFRACTORY HIV-RELATED NON-HODGKIN'S LYMPHOMA: VMP REGIMEN FOR RELAPSED PATIENTS, CDE REGIMEN FOR REFRACTORY PATIENTS|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:08.214499|2017-10-11 04:22:08.214499
NCT00002907|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||January 1997||1997-01-01|April 2013|2013-04-01|November 2000|Actual|2000-11-01|January 1999|Actual|1999-01-01||Interventional|||Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma|PHASE II CLINICAL EVALUATION OF BRYOSTATIN 1 IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:22:08.283476|2017-10-11 04:22:08.283476
NCT00002908|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||December 1996||1996-12-01|April 2013|2013-04-01|November 2001|Actual|2001-11-01|February 2000|Actual|2000-02-01||Interventional|||Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|PHASE II CLINICAL EVALUATION OF BRYOSTATIN 1 IN PATIENTS WITH RELAPSED NON-HODGKIN'S LYMPHOMA AND CLL|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:22:08.347393|2017-10-11 04:22:08.347393
NCT00002909|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||February 1997||1997-02-01|February 2001|2001-02-01||||October 2000|Actual|2000-10-01||Interventional|||Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma|A PHASE I CLINICAL AND PHARMACOLOGIC EVALUATION OF PHENYLBUTYRATE IN PATIENTS WITH REFRACTORY SOLID TUMORS: STUDY OF CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE ON A THREE TIMES DAILY SCHEDULE|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:08.415933|2017-10-11 04:22:08.415933
NCT00002911|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||December 1996||1996-12-01|May 2007|2007-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer|A PHASE III, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MARIMASTAT IN PATIENTS WITH MINIMAL DISEASE STAGE III NON-SMALL CELL LUNG CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:08.511892|2017-10-11 04:22:08.511892
NCT00002913|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-23|||December 1996||1996-12-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer|PHASE I STUDY OF PACLITAXEL COMBINED WITH TOPOTECAN AND CISPLATIN AND G-CSF IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED OVARIAN EPITHELIAL MALIGNANCIES|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:08.812495|2017-10-11 04:22:08.812495
NCT00002914|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-25|||May 1997||1997-05-01|January 2010|2010-01-01|March 2004|Actual|2004-03-01|June 2001|Actual|2001-06-01||Interventional|||Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract|PHASE II STUDY OF PIRITREXIM IN ADVANCED CARCINOMA OF THE UROTHELIUM|Completed||Phase 2|40|Anticipated|Eastern Cooperative Oncology Group|||||||||f||||||||||2017-10-11 04:22:08.914402|2017-10-11 04:22:08.914402
NCT00002915|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-08-05|||December 1996||1996-12-01|August 2010|2010-08-01||||||||Interventional|||Penclomedine in Treating Patients With Advanced Solid Tumors|A PHASE I AND PHARMACOLOGICAL STUDY OF PENCLOMEDINE (NSC#338720, IND#43409) ADMINISTERED DAILY BY MOUTH FOR FIVE CONSECUTIVE DAYS IN PATIENTS WITH ADVANCED SOLID TUMOR MALIGNANCIES|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:22:09.028605|2017-10-11 04:22:09.028605
NCT00002916|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||November 1996||1996-11-01|June 2012|2012-06-01||||||||Interventional|||Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer|A Phase II Trial in Patients With Early Cervical Cancer to Study The Safety and The Immunological Effects of Vaccination With TA-HPV, A Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins|Completed||Phase 2|44|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:09.109122|2017-10-11 04:22:09.109122
NCT00002917|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-14|||November 1996||1996-11-01|January 2001|2001-01-01|May 2004|Actual|2004-05-01|||||Interventional|||Paclitaxel in Treating Patients With Early-Stage Bladder Cancer|A PHASE I/II INSTITUTIONAL STUDY OF INTRAVESICAL TAXOL (PACLITAXEL) INSTILLATION FOR THE TREATMENT OF SUPERFICIAL BLADDER CANCER|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:09.211394|2017-10-11 04:22:09.211394
NCT00002919|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||November 1996||1996-11-01|July 2013|2013-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer|PHASE II TRIAL OF THE COMBINATION OF TRANSURETHRAL RESECTION AND NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH INVASIVE UROTHELIAL TRACT TUMORS SELECTED BY STAGE AND P53 NUCLEAR EXPRESSION|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:09.261896|2017-10-11 04:22:09.261896
NCT00002920|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-30|||March 1997||1997-03-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2006|Actual|2006-12-01||Interventional|||S9630, Medroxyprogesterone in Treating Women With Breast Cancer|A Randomized Comparison Of Medroxyprogesterone Acetate (MA) And Observation For Prevention Of Endometrial Pathology In Postmenopausal Breast Cancer Patients Treated With Tamoxifen, Phase III|Completed||Phase 3|313|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:09.342077|2017-10-11 04:22:09.342077
NCT00002921|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-03|||March 1997||1997-03-01|October 2012|2012-10-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery|Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II|Terminated||Phase 2|13|Actual|Southwest Oncology Group||1||Permanently Closed Due to Lack of Accrual|f||||f||||||||||2017-10-11 04:22:09.772695|2017-10-11 04:22:09.772695
NCT00002922|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-28|||January 1997||1997-01-01|August 2013|2013-08-01||||September 2001|Actual|2001-09-01||Interventional|||Paclitaxel in Treating Patients With Advanced Head and Neck Cancer|Phase II Evaluation of Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:22:10.382711|2017-10-11 04:22:10.382711
NCT00002923|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-04-24|||May 1997||1997-05-01|April 2014|2014-04-01|October 2000|Actual|2000-10-01|January 2000|Actual|2000-01-01||Interventional|||KRN5500 in Treating Patients With Metastatic Solid Tumors|Phase I Evaluation of KRN5500 (NSC650426)|Completed||Phase 1|27|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 04:22:10.511047|2017-10-11 04:22:10.511047
NCT00002924|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||January 1997||1997-01-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy|Androgen Receptor Mutations in Hormone Refractory Prostate Cancer|Completed||N/A|184|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Bone marrow biopsies were obtained from 164 patients enrolled on CALGB 9583 and from 20     patients enrolled on CALGB chemotherapy trials (CALGB 9480, 9680, 9780).   "|||2017-10-11 04:22:10.588235|2017-10-11 04:22:10.588235
NCT00002925|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-29|||February 1997||1997-02-01|March 2011|2011-03-01|June 2010|Actual|2010-06-01|November 2003|Actual|2003-11-01||Interventional|||Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia|Phase I Study of MDR Modulation With PSC-833 (NSC# 648265) With a Pilot Study of Cytogenetic Risk-Adapted Consolidation Followed by a Phase II Pilot Study of Immunotherapy With RIL-2 (NSC # 373364) in Previously Untreated Patients With AML< 60 Years|Completed||Phase 1/Phase 2|410|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 04:22:10.803343|2017-10-11 04:22:10.803343
NCT00002926|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-05-26|||December 1996||1996-12-01|May 2001|2001-05-01||||||||Interventional|||Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia|Autologous Peripheral Blood Stem Cell Transplantation (PSCT) Versus a Second Intensive Consolidation Course After a Common Induction and Consolidation Course in Patients With Bad Prognosis Myelodysplastic Syndromes (MDS) and Acute Myelogenous Leukemia Secondary (SAML) to MDS of More Acute Than 6 Months Duration|Unknown status|Active, not recruiting|Phase 3|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:10.972711|2017-10-11 04:22:10.972711
NCT00002928|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||January 1997||1997-01-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer|A Phase II Trial of Paclitaxel Administered Weekly in Patients With Advanced Ovarian Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:11.131713|2017-10-11 04:22:11.131713
NCT00005362|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1992||1992-09-01|May 2000|2000-05-01|August 1995|Actual|1995-08-01|||||Observational|||Dose Estimation for Studies of Acute Respiratory Effects||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.456699|2017-10-11 04:28:03.456699
NCT00002930|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-17|||December 1996||1996-12-01|January 2013|2013-01-01||||October 2002|Actual|2002-10-01||Interventional|||PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery|Whole-Body 18F-Fluorodeoxyglucose Positron Emission Tomography to Measure the Response to Induction Chemotherapy of Potentially Resectable Lung and Esophageal Carcinomas|Completed||Phase 2/Phase 3|75|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:11.193304|2017-10-11 04:22:11.193304
NCT00002931|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-06|2016-11-04||February 1997||1997-02-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer|Tandem High-Dose Chemotherapy With Autologous Stem Cell Rescue for Poor-Prognosis Germ Cell Cancer|Completed||Phase 2|48|Actual|City of Hope Medical Center||1|||f||||||||||||||2017-10-11 04:22:11.277565|2017-10-11 04:22:11.277565
NCT00002932|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-11-19|||May 1997||1997-05-01|November 2014|2014-11-01|March 2005|Actual|2005-03-01|March 2001|Actual|2001-03-01||Interventional|||Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck|Phase II Multi-Institutional Trial of Targeted Supradose Cisplatin Chemoradiation for Stage IV Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|60|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:22:11.698645|2017-10-11 04:22:11.698645
NCT00002933|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-09|||September 1996||1996-09-01|June 2010|2010-06-01|January 2001|Actual|2001-01-01|July 2000|Actual|2000-07-01||Interventional|||Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer|CWRU 1296: Biochemical and Pharmacokinetic Predictors of Colon Cancer Response to a Topoisomerase I Directed Treatment With Irinotecan|Completed||Phase 2|21|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:22:11.782212|2017-10-11 04:22:11.782212
NCT00002934|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-06|||April 1997||1997-04-01|October 2015|2015-10-01|October 2012|Actual|2012-10-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ|Local Excision Alone for Selected Patients With DCIS of the Breast|Terminated||Phase 2|711|Actual|Eastern Cooperative Oncology Group||1||"This study was terminated when the accrual goal for the low/intermediate grade stratum was   reached. The high grade stratum was closed due to slow accrual."|f||||f||||||||||2017-10-11 04:22:11.845439|2017-10-11 04:22:11.845439
NCT00002935|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-12-22|||October 1995||1995-10-01|December 2011|2011-12-01|September 2007|Actual|2007-09-01|August 2006|Actual|2006-08-01||Interventional|||Photodynamic Therapy in Treating Patients With Early Esophageal Cancer|A Phase II Study of the Safety and Efficacy of Photodynamic Therapy in Carcinoma in Situ of the Esophagus|Completed||Phase 2|30|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:22:11.956242|2017-10-11 04:22:11.956242
NCT00002936|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-01|||July 1996||1996-07-01|February 2013|2013-02-01||||January 2007|Actual|2007-01-01||Interventional|||Altretamine and Etoposide in Treating Patients With HIV-Related Cancer|Hexamethylamine and VP-16 an Oral Regimin for HIV Malignancies: A Phase I/II Trial|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:22:12.005294|2017-10-11 04:22:12.005294
NCT00002937|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-04|||June 1996||1996-06-01|January 2010|2010-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer|A Phase II Randomized Study of Paclitaxel Versus Paclitaxel + PSC833 for Advanced Breast Cancer (Recurring Less Than 6 Months Since Adjuvant or as Second Line for Advanced Disease|Completed||Phase 2|70|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:22:12.062908|2017-10-11 04:22:12.062908
NCT00002938|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||May 1997||1997-05-01|July 2016|2016-07-01|January 2010|Actual|2010-01-01|February 2005|Actual|2005-02-01||Interventional|||Surgery in Treating Patients With Prostate Cancer|The Role of Salvage Prostatectomy for Radiation Failure in Prostate Carcinoma: A Phase II Trial|Completed||Phase 2|49|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:12.144754|2017-10-11 04:22:12.144754
NCT00002939|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-04|||November 1996||1996-11-01|September 2013|2013-09-01|April 2002|Actual|2002-04-01|February 2001|Actual|2001-02-01||Interventional|||Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer|A Phase I Trial of Dose Escalated Irinotecan (CPT-11) With Paclitaxel in Patients With Metastatic or Recurrent Malignancies|Completed||Phase 1|21|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:22:12.331267|2017-10-11 04:22:12.331267
NCT00002940|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-18|||October 1996||1996-10-01|June 2002|2002-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS|Hydroxyurea Treatment of EBV-Associated Primary CNS Lymphoma in Children and Adults With AIDS|Completed||Phase 2|||St. Jude Children's Research Hospital|||||f||||f||||||||||2017-10-11 04:22:12.393114|2017-10-11 04:22:12.393114
NCT00002941|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-31|||April 1998||1998-04-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma|A Pilot Study of Peripheral Blood Stem Cell Transplantation (PBSCT) After Preparative Therapy Consisting of Cyclophosphamide, BCNU, and Etoposide (CBV) for Recurrent and Primarily Refractory Hodgkin's and Non-Hodgkin's Lymphoma|Completed||Phase 2|69|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:22:12.597607|2017-10-11 04:22:12.597607
NCT00002942|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-18|||June 1996||1996-06-01|July 2012|2012-07-01|December 2003|Actual|2003-12-01|January 2000|Actual|2000-01-01||Interventional|||Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer|Randomized Phase III Trial of G-CSF Primed Autologous Bone Marrow Versus Peripheral Blood Progenitor Cells (PBPC) as Hematopoietic Support for High-Dose Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) Therapy in Poor Prognosis Breast Cancer|Completed||Phase 3|136|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-10-11 04:22:13.333166|2017-10-11 04:22:13.333166
NCT00002943|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-18|||February 1993||1993-02-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|October 2003|Actual|2003-10-01||Interventional|||Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer|High Dose Carboplatin, Etoposide, Cyclophosphamide and Autologous Bone Marrow Transplantation for Relapsed and Refractory Germ Cell Cancer: A Phase II Pilot Study|Completed||Phase 2|11|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-10-11 04:22:13.442449|2017-10-11 04:22:13.442449
NCT00002730|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-30|||June 1996||1996-06-01|January 2017|2017-01-01||||||||Interventional|||Chemotherapy in Treating Children With Neuroblastoma|PILOT STUDY OF BUTHIONINE SULFOXIMINE (BSO) IN COMBINATION WITH MELPHALAN FOR HIGH RISK NEUROBLASTOMA PATIENTS|Completed||Phase 1|||Children's Hospital Los Angeles|||||f||||||||||||||2017-10-11 04:23:01.420765|2017-10-11 04:23:01.420765
NCT00002945|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-04-12|||December 1996||1996-12-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2001|Actual|2001-08-01||Interventional|||High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia|High-Dose Cytarabine and Idarubicin Induction, High Dose Etoposide and Cyclophosphamide Intensification, Autologous Stem Cell Transplantation and Interleukin-2 Immune Modulation in Previously Untreated De Novo and Secondary Adult Myeloid Leukemia|Completed||Phase 3|61|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:22:14.036499|2017-10-11 04:22:14.036499
NCT00002946|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||October 1997||1997-10-01|January 2013|2013-01-01||||April 2002|Actual|2002-04-01||Interventional|||Penclomedine in Treating Patients With Solid Tumors or Lymphoma|A Phase I Trial of Oral Penclomedine|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:14.121912|2017-10-11 04:22:14.121912
NCT00002947|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-01|||October 1996||1996-10-01|July 2014|2014-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer|A Phase I Study of [111In-DTPA-D-Phe]-Octreotide in Patients With Refractory Malignancies Expressing Somatostatin Receptors|Terminated||Phase 1|35|Anticipated|Yale University|||||f||||f||||||||||2017-10-11 04:22:14.218242|2017-10-11 04:22:14.218242
NCT00002948|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-01|||October 1996||1996-10-01|July 2014|2014-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer|A Phase I Study of High Dose Topotecan With Filgrastim and Peripheral Blood Stem Cell Support for Patients With Refractory Malignancies|Terminated||Phase 1|||Yale University|||||f||||f||||||||||2017-10-11 04:22:14.308398|2017-10-11 04:22:14.308398
NCT00002949|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-04|||July 1996||1996-07-01|September 2013|2013-09-01|May 2001|Actual|2001-05-01|November 2000|Actual|2000-11-01||Interventional|||Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis|Phase I Study of Concomitant Chemoradiotherapy With Vinorelbine and Paclitaxel in Patients With Advanced Pelvic Malignancies|Completed||Phase 1|33|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:22:14.391078|2017-10-11 04:22:14.391078
NCT00002950|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||September 1996||1996-09-01|October 2001|2001-10-01||||||||Interventional|||Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer|Phase I/II Study of Topotecan (SKF 104864) With Recombinant GM-CSF (Sargramostim) Used as a Priming Agent in Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1/Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:14.47471|2017-10-11 04:22:14.47471
NCT00002951|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-04|||June 1996||1996-06-01|September 2013|2013-09-01|July 2006|Actual|2006-07-01|June 2004|Actual|2004-06-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer|Hyperfractionated Radiotherapy With Concomitant Fluorouracil and Hydroxurea for Intermediate Stage Cancer of the Head and Neck|Completed||Phase 2|53|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:22:14.538471|2017-10-11 04:22:14.538471
NCT00002952|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-04|||January 1997||1997-01-01|September 2013|2013-09-01|November 2002|Actual|2002-11-01|August 2002|Actual|2002-08-01||Interventional|||Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma|Phase I/II Study of Immunization With MAGE-3 Peptide-Pulsed Autologous PBMC Plus rhIL-12 in Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|20|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:22:14.620023|2017-10-11 04:22:14.620023
NCT00002953|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||December 1996||1996-12-01|December 2005|2005-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer|A Radomized Trial of Epirubicin & Cyclophosphamide vs. Epirubicin & Paclitaxel in the Treatment of Women With Metastatic Breast Cancer|Completed||Phase 3|704|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:14.743507|2017-10-11 04:22:14.743507
NCT00002955|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||August 1995||1995-08-01|May 2014|2014-05-01|June 2006|Actual|2006-06-01|May 2000|Actual|2000-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas|Modulation of 5-Fluorouracil With Trimetrexate and Leucovorin in Advanced Pancreatic Cancer|Completed||Phase 2|21|Actual|University of Southern California|||||f||||t||||||||||2017-10-11 04:22:14.836417|2017-10-11 04:22:14.836417
NCT00002956|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-03-18|||November 1996||1996-11-01|November 2012|2012-11-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants|A Phase I Pilot Trial to Evaluate the Toxicity of Allogeneic Epstein-Barr Virus Specific T-Lymphocytes for the Treatment of EBV-Associated Lymphoproliferative Diseases in Organ Transplant Recipients|Withdrawn||Phase 1|0|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:22:14.904006|2017-10-11 04:22:14.904006
NCT00002960|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-02-03|||June 1999||1999-06-01|February 2016|2016-02-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)|A Phase I Study in Patients With Peritoneal Carcinomatosis Using SCH 58500 (rAd/p53) Administered by Single Intraperitoneal Instillation|Completed||Phase 1|59|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:22:14.989226|2017-10-11 04:22:14.989226
NCT00002961|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-10-14|||October 1995||1995-10-01|October 2013|2013-10-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia|Randomized Trial of Busulfan or Total Body Irradiation Conditioning Regimens for Children With Acute Lymphoblastic Leukemia|Terminated||Phase 3|43|Actual|Children's Hospital of Philadelphia||2||poor accrual|f||||f||||||||||2017-10-11 04:22:15.061441|2017-10-11 04:22:15.061441
NCT00002963|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-30|||November 1993||1993-11-01|January 2013|2013-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Photodynamic Therapy in Treating Patients With Skin Cancer|Cutaneous Absorption and Intralesional Penetration of Topical Amino-Levulinic Acid in Basal Cell Carcinoma and Squamous Cell Carcinoma as Measured by In Situ Fluorescence and Intensified Video Fluorescence Microscopy|Completed||Phase 2|||Roswell Park Cancer Institute|||||||||t||||||||||2017-10-11 04:22:15.172581|2017-10-11 04:22:15.172581
NCT00002964|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||February 1995||1995-02-01|February 2013|2013-02-01||||April 2004|Actual|2004-04-01||Interventional|||Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer|Pilot Study for the Diagnosis of Head and Neck Cancer: Photofrin and Visible Light|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:22:15.231268|2017-10-11 04:22:15.231268
NCT00002965|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||January 1997||1997-01-01|July 2012|2012-07-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas|Phase II Study to Evaluate the Efficacy of Recombinant Interferon-Alpha in the Treatment of Recurrent Unresectable Meningiomas and Malignant Meningiomas|Completed||Phase 2|16|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:22:15.288141|2017-10-11 04:22:15.288141
NCT00002967|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||May 1997||1997-05-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|||||Interventional|||Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer|A Clinical Trial to Evaluate the Benefit of Adding Octreotide (SMS 201-995 PA LAR) to Tamoxifen Alone or to Tamoxifen and Chemotherapy in Patients With Axillary Node-Negative, Estrogen-Receptor-Positive, Primary Invasive Breast Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:15.383179|2017-10-11 04:22:15.383179
NCT00002968|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-04|||May 1997||1997-05-01|June 2013|2013-06-01||||July 2003|Actual|2003-07-01||Interventional|||Edrecolomab in Treating Patients With Stage II Colon Cancer|Phase III Randomized Study of Adjuvant Immunotherapy With Monoclonal Antibody 17-1A Versus No Adjuvant Therapy Following Resection for State II (Modified Astler-Coller B2) Adenocarcinoma of the Colon|Completed||Phase 3|2100|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:22:16.829418|2017-10-11 04:22:16.829418
NCT00002969|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-20|||May 1997||1997-05-01|July 2012|2012-07-01|January 2007|Actual|2007-01-01|January 2004|Actual|2004-01-01||Interventional|||S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Phase II Trial of Paclitaxel by 96-Hour Infusion in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)|Completed||Phase 2|60|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:22:16.920324|2017-10-11 04:22:16.920324
NCT00002970|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||June 1997||1997-06-01|July 2013|2013-07-01||||January 2005|Actual|2005-01-01||Interventional|||506U78 in Treating Patients With Refractory Hematologic Cancer|A Phase II Study of Compound 506U78 in Patients With Refractory T-Cell Malignancies-POG/CCG Intergroup Study|Completed||Phase 2|148|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:18.189488|2017-10-11 04:22:18.189488
NCT00002971|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-12-13|||April 1997||1997-04-01|March 2003|2003-03-01||||||||Interventional|||O(6)-Benzylguanine in Treating Patients With Malignant Glioma|A Phase I Trial of Pre-Surgical O6-Benzylguanine in the Treatment of Patients With Malignant Glioma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:18.27485|2017-10-11 04:22:18.27485
NCT00002972|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||January 1997||1997-01-01|June 2012|2012-06-01||||August 2002|Actual|2002-08-01||Interventional|||Paclitaxel in Treating Patients With Lung Cancer|Phase II Study on TAXOL in Bronchioalveolar Carcinoma|Completed||Phase 2|25|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:18.347652|2017-10-11 04:22:18.347652
NCT00002405|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Amprenavir in HIV-Infected Patients|Amprenavir (141W94) Open Label Protocol for Subjects With HIV-1 Infection Who Have Experienced Treatment Failure or Are Intolerant to Previous Protease Inhibitor Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:22:18.415663|2017-10-11 04:22:18.415663
NCT00002406|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients|A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulphate, 800 Mg q 8h Versus 1,200 Mg q 12h in HIV-Infected Individuals Having Plasma Viral RNA Less Than 400 Copies/Ml, on Concomitant Therapy With 2 Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTI)|Completed||Phase 3|350||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:22:18.472144|2017-10-11 04:22:18.472144
NCT00002407|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs|A Randomized Open-Label Strategic Study to Evaluate the Safety and Efficacy of 3 Different Convergent and Divergent Drug Combination Therapies in Anti-Retroviral Naive HIV-1 Infected Patients With CD4+ Counts Above 200/mm3|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:22:18.687742|2017-10-11 04:22:18.687742
NCT00002408|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients|Completed||Phase 3|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:22:18.765359|2017-10-11 04:22:18.765359
NCT00002409|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||The Effect of Teaching HIV-Infected Patients About HIV and Treatment|A Phase IIIB, Open-Label, Randomized Study of the Effect of an Education Intervention on Virological Outcomes, Adherence, Immunological Outcome, and Health Outcomes in HIV-Infected Subjects From Under-Represented Populations Treated With Triple Nucleoside Therapy (Combivir, Lamivudine 150 Mg/Zidovudine 300 Mg PO BID Plus Abacavir 300 Mg PO BID) for Twenty-Four Weeks|Completed||Phase 3|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:22:18.888639|2017-10-11 04:22:18.888639
NCT00002410|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients|A Phase III, Multicenter, Randomized, Open-Label Study to Compare Antiretroviral Activity and Tolerability of Three Different Combination Regimens (DMP 266 + Indinavir, DMP 266 + Zidovudine + Lamivudine, Indinavir + Zidovudine + Lamivudine) in HIV-Infected Patients|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:22:19.009349|2017-10-11 04:22:19.009349
NCT00002411|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2011-04-13||2011-04-13|March 1998||1998-03-01|April 2011|2011-04-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs|A Randomized Study of the Long-Term Suppression of Plasma HIV RNA Levels by Triple Combination Regimens in Treatment Naive Subjects|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:22:19.169595|2017-10-11 04:22:19.169595
NCT00002973|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-09-30|||December 1995||1995-12-01|September 2015|2015-09-01|December 2000|Actual|2000-12-01|May 2000|Actual|2000-05-01||Interventional|||Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma|Phase II Evaluation of IV Melphalan (L-PAM) and Whole Body Hyperthermia (WBH) for Malignant Melanoma|Completed||Phase 2|34|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:22:19.287008|2017-10-11 04:22:19.287008
NCT00002974|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-09-30|||July 1996||1996-07-01|May 2011|2011-05-01|April 2003|Actual|2003-04-01|July 2001|Actual|2001-07-01||Interventional|||Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma|A Phase II Study of Whole Blood Hyperthermia and Ice Chemotherapy in Sarcoma Patients|Completed||Phase 2|34|Anticipated|University of Wisconsin, Madison|||||f||||f||||||||||2017-10-11 04:22:19.344568|2017-10-11 04:22:19.344568
NCT00002975|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-02|2013-06-28||February 1997||1997-02-01|August 2013|2013-08-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional||Treated Patients|Photodynamic Therapy in Treating Patients With Skin Cancer|A Phase II Trial of 4-5 Hour and 18-24 Hour Applications of 20% Topical ALA for Photodynamic Therapy of Cutaneous Carcinomas and Actinic Keratoses|Completed||Phase 2|180|Actual|Roswell Park Cancer Institute|Study was activated prior to RPCI putting a system in place to centralize data entry and data management. Data entry was done by PI's staff. PI died and left incomplete data. Efficay and safety data were not analyzed.|1|||f||||t||||||||||2017-10-11 04:22:19.407952|2017-10-11 04:22:19.407952
NCT00002976|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-10|||June 1997||1997-06-01|April 2003|2003-04-01||||July 2006|Actual|2006-07-01||Interventional|||Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer|A Randomized Double-Blinded Trial of Estrogen Replacement Therapy Versus Placebo in Women With Stage I or II Endometrial Adenocarcinoma|Terminated||Phase 3|2108|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:22:19.592683|2017-10-11 04:22:19.592683
NCT00002977|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-13|||January 1997||1997-01-01|September 2010|2010-09-01||||November 2001|Actual|2001-11-01||Interventional|||Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission|A Phase I Trial of Melphalan and Thiotepa Followed by Autologous or Syngeneic Peripheral Blood Stem Cell (PBSC) Rescue in Patients With a Complete Response Following Standard Therapy for Stage III/IV Epithelial Ovarian Cancer|Completed||Phase 1|45|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:22:20.020164|2017-10-11 04:22:20.020164
NCT00002980|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-13|||May 1997||1997-05-01|May 2007|2007-05-01||||||||Interventional|||Decitabine in Treating Patients With Melanoma or Other Advanced Cancer|A Phase I Study of the Biologic and Clinical Effects of 5-AZA-2'Deoxycytidine (DAC) in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:20.12307|2017-10-11 04:22:20.12307
NCT00002981|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-02-02|||January 1997||1997-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||PET Scan in Treating Patients With Metastatic Prostate Cancer|11C-Methionine and 2-18F-Fluoro-2-Deoxy-D-Glucose PET Imaging in Patients With Progressive Prostate Cancer|Active, not recruiting||N/A|173|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:22:20.24123|2017-10-11 04:22:20.24123
NCT00002982|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||January 1997||1997-01-01|July 2013|2013-07-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma|A Phase II Trial of ICE Chemotherapy Followed by High Dose BEAM Chemotherapy With Autologous Peripheral Blood Progenitor Cell Transplantation in Patients >= 60 Years Old With Refractory or Relapsed Intermediate Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:20.345315|2017-10-11 04:22:20.345315
NCT00002984|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-22|||March 1997||1997-03-01|May 2012|2012-05-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus|Paclitaxel Combined With 5-FU and Cisplatin Concomitant With Radiotherapy in the Management of Locally Advanced or Metastatic Esophageal Cancer (Adenocarcinoma and Squamous Histologies) - A Phase I/Modified Phase II Trial|Completed||Phase 1/Phase 2|26|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:22:20.435509|2017-10-11 04:22:20.435509
NCT00002985|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-01|||November 1996||1996-11-01|February 2013|2013-02-01||||January 2007|Actual|2007-01-01||Interventional|||Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma|Double-Blind Randomized Evaluation of Clinical Benefits of DOXIL in Patients With AIDS-Related Kaposi's Sarcoma Treated With DOXIL or DaunoXome|Completed||Phase 3|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:22:20.525897|2017-10-11 04:22:20.525897
NCT00002986|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||February 1997||1997-02-01|February 2013|2013-02-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Chemotherapy in Treating Patients With Recurrent Malignant Glioma|Phase I Treatment of Adults With Primary Malignant Glioma With Topotecan (NSC #609699) Plus BCNU (NSC #409962)|Completed||Phase 1|36|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:22:20.591905|2017-10-11 04:22:20.591905
NCT00002987|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||January 1997||1997-01-01|March 2005|2005-03-01||||||||Interventional|||Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease|"Minimal Initial Therapy (MIT) for Early Supradiaphragmatic Hodgkin's Disease: A Multicenter Randomized Trial of Short Neoadjuvant Chemotherapy (VAPEC-B) Plus Involved Field Radiotherapy (MIT) Versus Mantle Radiotherapy"|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:20.686488|2017-10-11 04:22:20.686488
NCT00002988|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-19|||April 1997||1997-04-01|February 2013|2013-02-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma|Phase I Treatment of Adults With Primary Malignant Glioma With Irinotecan (CPT-11) (NSC #6616348) Plus BCNU (NSC #409962)|Completed||Phase 1|36|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:22:20.804804|2017-10-11 04:22:20.804804
NCT00002989|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||March 1997||1997-03-01|July 2007|2007-07-01||||||||Interventional|||Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome|A Randomized Phase III Study to Assess Intensification of the Conditioning Regimen for Allogenic Stem Cell Transplantation (ALLO-SCT) for Leukemia or Myelodysplastic Syndrome With a High Risk of Relapse|Unknown status|Active, not recruiting|Phase 3|207|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:20.870438|2017-10-11 04:22:20.870438
NCT00002990|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-11|||March 1997||1997-03-01|June 2013|2013-06-01||||April 2005|Actual|2005-04-01||Interventional|||Surgery and BCG in Treating Patients With Bladder Cancer|Comparative Study of Intravesical BCG Standard Dose Long-Term Maintenance Versus BCG 1/3 Dose Long-Term Maintenance Versus BCG Standard Dose Short-Term Maintenance Versus BCG 1/3 Dose Short-Term Maintenance in Intermediate and High Risk Ta, T1 Papillary Carcinoma of the Urinary Bladder|Completed||Phase 3|1288|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:20.972232|2017-10-11 04:22:20.972232
NCT00002993|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-08|||August 1997||1997-08-01|May 2006|2006-05-01||||January 2000|Actual|2000-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus|Evaluation of Mitomycin, Doxorubicin and Cisplatin in the Treatment of Recurrent or Advanced Uterine Sarcomas|Terminated||Phase 2|30|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:22:21.138397|2017-10-11 04:22:21.138397
NCT00002994|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-27|||July 1997||1997-07-01|June 2016|2016-06-01|April 2002|Actual|2002-04-01|March 2000|Actual|2000-03-01||Interventional|||Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors|A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors|Completed||Phase 1|355|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:22:21.449266|2017-10-11 04:22:21.449266
NCT00002995|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-12|||August 1997||1997-08-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma|Actinomycin D and Vincristine With or Without Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Rhabdomyosarcoma or Undifferentiated Sarcoma: IRS-V Protocol|Completed||Phase 3|483|Actual|Children's Oncology Group|||||f||||t||||||||||2017-10-11 04:22:21.64218|2017-10-11 04:22:21.64218
NCT00002996|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||February 1998||1998-02-01|January 2010|2010-01-01||||April 2006|Actual|2006-04-01||Interventional|||Flecainide in Treating Patients With Chronic Neuropathic Pain|Flecainide for the Treatment of Chronic Neuropathic Pain: A Phase II Trial|Completed||Phase 2|20|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:22:22.227243|2017-10-11 04:22:22.227243
NCT00002997|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||August 1997||1997-08-01|March 2004|2004-03-01||||||||Interventional|||Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer|Phase II Trial of Cryoablation for Treatment of Unresectable Colorectal Hepatic Metastases|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:22.322066|2017-10-11 04:22:22.322066
NCT00002998|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||August 1997||1997-08-01|July 2016|2016-07-01|May 2006|Actual|2006-05-01|April 2005|Actual|2005-04-01||Interventional|||Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer|Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:22.404948|2017-10-11 04:22:22.404948
NCT00002999|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-05-22||||||May 2015|2015-05-01||||||||Interventional|||S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx|S9715, Study of Patients With Advanced Nasopharyngeal Cancers Treated With Chemo-Radiotherapy, Phase II|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group|||||f||||f||||||||||2017-10-11 04:22:22.517299|2017-10-11 04:22:22.517299
NCT00003000|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-12|||May 1992||1992-05-01|October 2015|2015-10-01|June 2001|Actual|2001-06-01|January 2001|Actual|2001-01-01||Observational|||Morphine for the Treatment of Pain in Patients With Breast Cancer|Peripheral Effects of Opioid Analgesia in Patients Undergoing Axillary Node Dissection|Completed||N/A|18|Anticipated|Roswell Park Cancer Institute|||1||f||||t||||||||||2017-10-11 04:22:22.58641|2017-10-11 04:22:22.58641
NCT00003001|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||April 1997||1997-04-01|April 2002|2002-04-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer|Phase I/II Study of 5-Fluorouracil/Folinic Acid/Gemcitabine in Patients With Advanced Colorectal Carcinoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|63|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:22.645375|2017-10-11 04:22:22.645375
NCT00003002|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-12-12|||April 1996||1996-04-01|December 2012|2012-12-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer|A Phase I Study of a HER-2/Neu Peptide Based Vaccine With GM-CSF as an Adjuvant in Patients With Advanced Stage HER-2/Neu Expressing Cancers|Completed||Phase 1|60|Actual|University of Washington||1|||f||||||||||||||2017-10-11 04:22:22.717812|2017-10-11 04:22:22.717812
NCT00003003|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-01|||September 1996||1996-09-01|June 2000|2000-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia|A Pilot Clinical Trial of Mitomycin C Modulation of Multidrug Resistance Proteins and a Phase I Evaluation of Mitomycin C and Mitoxantrone in Patients With Acute Myelogenous Leukemia|Completed||Phase 1|29|Anticipated|Dartmouth-Hitchcock Medical Center|||||f||||t||||||||||2017-10-11 04:22:22.791588|2017-10-11 04:22:22.791588
NCT00003022|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||April 1997||1997-04-01|July 2013|2013-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer|Phase I Study of Intrathecal 131-I-3F8 Monoclonal Antibody in Patients With GD2 Positive Leptomeningeal Neoplasms|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:22.850892|2017-10-11 04:22:22.850892
NCT00003023|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-17|||March 1997||1997-03-01|January 2013|2013-01-01||||January 2005|Actual|2005-01-01||Interventional|||Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer|Phase I Trial of A1G4 Anti-Idiotypic Monoclonal Antibody With Bacille-Calmette-Guerin (BCG) Adjuvant in High Risk Patients With GD2 Positive Tumors|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:22.926071|2017-10-11 04:22:22.926071
NCT00003025|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||March 1997||1997-03-01|July 2013|2013-07-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer|A Phase I Pilot Trial of Immunotherapy With Autologous Tumor-Derived gp96 Heat Shock Protein - Peptide Complex (HSPPC-96) in Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 1|16|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:22.98993|2017-10-11 04:22:22.98993
NCT00003026|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||April 1997||1997-04-01|June 2012|2012-06-01||||September 2001|Actual|2001-09-01||Interventional|||Hormone Therapy in Treating Patients With Advanced Prostate Cancer|Long Term Adjuvant Hormonal Treatment With LHRH Analogue Versus No Further Treatment in Locally Advanced Prostatic Carcinoma Treated by External Irradiation and a Six Months Combined Androgen Blockade - A Phase III Study|Completed||Phase 3|966|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:23.053676|2017-10-11 04:22:23.053676
NCT00003045|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-04-25|||April 1997||1997-04-01|April 2017|2017-04-01|December 31, 2003|Actual|2003-12-31|December 31, 2001|Actual|2001-12-31||Interventional|||Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer|A Phase II Trial of Hyperthermia and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate|Completed||N/A|38|Actual|Dana-Farber Cancer Institute||1|||f||||t|f|t|f|f||||No||2017-10-11 04:22:24.938134|2017-10-11 04:22:24.938134
NCT00003027|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-28|||October 1997||1997-10-01|January 2010|2010-01-01||||July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma|A Randomized Phase III Trial of Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, IL-2 and Interferon A-2B Versus Cisplatin, Vinblastine, Dacarbazine Alone in Patients With Metastatic Malignant Melanoma|Completed||Phase 3|482|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-10-11 04:22:23.274124|2017-10-11 04:22:23.274124
NCT00003028|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||April 1997||1997-04-01|June 2012|2012-06-01||||||||Interventional|||MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors|Phase I Study to Determine the Safety of MEN-10755 (BMS-195615) in Patients With a Solid Tumor on a Short I.V. Infusion Given Once Every 3 Weeks|Completed||Phase 1|5|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:23.545762|2017-10-11 04:22:23.545762
NCT00003029|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||May 1997||1997-05-01|June 2012|2012-06-01||||July 2003|Actual|2003-07-01||Interventional|||Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas|Infusional 5-Fluorouracil With or Without Cisplatin and With or Without Chronomodulation Against Locally-Advanced or Metastatic Pancreatic Cancer. A Multicenter Randomized Phase III Trial.|Completed||Phase 3|200|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:23.707825|2017-10-11 04:22:23.707825
NCT00003031|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||June 1997||1997-06-01|June 2012|2012-06-01||||October 2000|Actual|2000-10-01||Interventional|||Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis|An Open Randomised Comparative Multicentre Study of the Efficacy, Safety and Toleration of Voriconazole Versus Amphotericin-B in the Treatment of Acute Invasive Aspergillosis in Immunocompromised Patients|Completed||Phase 3|212|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:23.822798|2017-10-11 04:22:23.822798
NCT00003032|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-07|||April 1997||1997-04-01|November 2010|2010-11-01|December 2008|Actual|2008-12-01|||||Interventional|||High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer|A Randomized Trial of High-Dose Chemotherapy and Autologous Stem Cell Therapy Versus Standard Therapy in Women With Metastatic Breast Cancer Who Have Responded to Anthracycline or Taxane-Based Induction Chemotherapy|Completed||Phase 3|192|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:22:24.02337|2017-10-11 04:22:24.02337
NCT00003034|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||May 1997||1997-05-01|October 2007|2007-10-01||||February 2008|Anticipated|2008-02-01||Interventional|||ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen|ONCONASE Plus Doxorubicin Versus Doxorubicin For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:22:24.141526|2017-10-11 04:22:24.141526
NCT00003035|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-22|||March 1997||1997-03-01|December 2006|2006-12-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer|A Pilot Trial Comparing Doxorubicin and Paclitaxel Induced Apoptosis in Locally Advanced Breast Cancer|Completed||Phase 2|40|Anticipated|Georgetown University|||||f||||f||||||||||2017-10-11 04:22:24.271326|2017-10-11 04:22:24.271326
NCT00003037|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||April 1997||1997-04-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer|Phase I/II Trial of the Combination of Docetaxel, Gemcitabine and Cisplatin (DGP) as Induction Chemotherapy in Patients With Stage III Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:24.360671|2017-10-11 04:22:24.360671
NCT00003038|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-08-02|||October 1997||1997-10-01|August 2011|2011-08-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Suramin With Sequential Doxorubicin in Patients With Advanced Solid Tumors|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:22:24.437172|2017-10-11 04:22:24.437172
NCT00003039|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||September 1997||1997-09-01|April 2000|2000-04-01||||April 2000|Actual|2000-04-01||Interventional|||Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma|A Phase II Trial of Flavopiridol (NSC 649890) Administered as a 72-Hour Continuous Infusion Every 2 Weeks in Patients With Previously Treated Intermediate and High Grade Non-Hodgkin's Lymphoma Including Mantle Cell Lymphoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:24.518306|2017-10-11 04:22:24.518306
NCT00003040|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-13|||September 1997||1997-09-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|February 2007|Actual|2007-02-01||Interventional|||S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx|A Phase II Study to Evaluate Transoral CO2 Laser Supraglottic Laryngectomy and Irradiation in Stage I, II and III Squamous Cell Carcinoma of the Supraglottic Larynx|Terminated||Phase 2|42|Actual|Southwest Oncology Group||1||Poor accrual|f||||f||||||||||2017-10-11 04:22:24.605354|2017-10-11 04:22:24.605354
NCT00003041|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-30|||July 1997||1997-07-01|January 2002|2002-01-01|January 2002|Actual|2002-01-01|||||Interventional|||Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer|Phase II Evaluation of Pyrazoloacridine (NSC #366140) in Patients With Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:24.705115|2017-10-11 04:22:24.705115
NCT00003042|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||May 1997||1997-05-01|September 2017|2017-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer|Dose-Intense Chemotherapy and Stem Cell Rescue in the Treatment of Inflammatory Breast Carcinoma|Active, not recruiting||Phase 2|60|Anticipated|City of Hope Medical Center||2|||f||||||||||||||2017-10-11 04:22:24.771857|2017-10-11 04:22:24.771857
NCT00003044|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||September 1996||1996-09-01|April 2000|2000-04-01||||||||Interventional|||Chemotherapy in Treating Patients With Liver Cancer|A Two-Stage Phase II Safety and Efficacy Study of IntraDose (Cisplatin/Epinephrine) Injectable Gel (MPI 5010) Administered to Patients With Unresectable Primary Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 2|55|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:24.879702|2017-10-11 04:22:24.879702
NCT00003046|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||August 1997||1997-08-01|July 2012|2012-07-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Interleukin-12 in Treating Patients With Cancer in the Abdomen|Phase I Study of Intraperitoneal Recombinant Human Interleukin-12 (rhIL-12) in Patients With Peritoneal Carcinomatosis, Associated With Mullerian and Gastrointestinal Carcinomas|Completed||Phase 1|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:22:25.025635|2017-10-11 04:22:25.025635
NCT00003048|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||May 1997||1997-05-01|July 2012|2012-07-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Amifostine in Treating Patients With Myelodysplastic Syndrome|Phase II Study of Intravenous Amifostine in Myelodysplastic Syndrome|Completed||Phase 2|12|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:22:25.105961|2017-10-11 04:22:25.105961
NCT00003049|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-20|||May 1997||1997-05-01|May 2011|2011-05-01|July 2007|Actual|2007-07-01|August 2005|Actual|2005-08-01||Interventional|||Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas|A Prospective, Randomized Trial of Extended Lymphadenectomy in the Management of Resectable Pancreatic Cancer|Completed||Phase 3|100|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-10-11 04:22:25.182026|2017-10-11 04:22:25.182026
NCT00003050|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||April 1997||1997-04-01|May 2014|2014-05-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer|Weekly Paclitaxel During Radiation Therapy for Locally Advanced Breat Cancer|Completed||Phase 2|46|Actual|University of Southern California|||||f||||t||||||||||2017-10-11 04:22:25.243707|2017-10-11 04:22:25.243707
NCT00003052|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||July 1997||1997-07-01|November 2006|2006-11-01|June 2010|Actual|2010-06-01|||||Interventional|||Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma|Randomized Study Comparing Neoadjuvant Chemotherapy Etoposide + Ifosfamide + Adriamycin (EIA) Combined With Regional Hyperthermia (RHT) Versus Neoadjuvant Chemotherapy Alone in the Treatment of High-Risk Soft Tissue Sarcomas in Adults|Completed||Phase 3|340|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:25.316947|2017-10-11 04:22:25.316947
NCT00003053|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||January 1994||1994-01-01|January 2008|2008-01-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed|Adjuvant Treatment of Non Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:25.511504|2017-10-11 04:22:25.511504
NCT00003054|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-10|||August 1997||1997-08-01|May 2003|2003-05-01||||April 2003||2003-04-01||Interventional|||Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus|Evaluation of Paclitaxel (Taxol) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:22:25.755696|2017-10-11 04:22:25.755696
NCT00003055|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||June 1997||1997-06-01|June 2013|2013-06-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer|Phase II Trial of Cisplatin and Irinotecan in Patients With Advanced Esophageal Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:26.012474|2017-10-11 04:22:26.012474
NCT00003056|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-06-26|||April 1997||1997-04-01|May 2013|2013-05-01|June 2003||2003-06-01|June 2003||2003-06-01||Interventional|||Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation|Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis|Terminated||Phase 3|105|Actual|Baxalta US Inc.||2||Interim analysis indicated study should be terminated|||||t||||||||||2017-10-11 04:22:26.101683|2017-10-11 04:22:26.101683
NCT00003057|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-05-09|||November 1996||1996-11-01|January 2009|2009-01-01||||May 2000|Actual|2000-05-01||Interventional|||Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer|Randomized Trial of High-Dose Versus Conventional Dose Octreotide Acetate Versus Loperamide in the Treatment of Chemotherpay-Related Diarrhea in Patients With Colorectal Cancer|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:26.224991|2017-10-11 04:22:26.224991
NCT00003058|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-02-09|||June 1997||1997-06-01|February 2017|2017-02-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Troglitazone in Treating Patients With Liposarcoma|Phase II Clinical Trial of TROGLITAZONE, a Ligand for the Peroxisome Proliferator-Activated Receptor Gamma (PPAR), as Antineoplastic Differentiation Therapy for Patients With Malignant Liposarcoma|Completed||Phase 2|85|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 04:22:26.378577|2017-10-11 04:22:26.378577
NCT00003060|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||March 1995||1995-03-01|June 2002|2002-06-01||||||||Interventional|||Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma|Pilot Study for Matched-Related Allogeneic Bone Marrow Transplantation for Metastatic Malignant Melanoma|Unknown status|Active, not recruiting|Phase 1|6|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:26.452089|2017-10-11 04:22:26.452089
NCT00003061|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||July 1997||1997-07-01|June 2012|2012-06-01||||March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma|Evaluating the MBVP Chemotherapy Schedule Followed by Consolidating Radiotherapy in Non-AIDS Related Primary Central Nervous System Lymphoma (NAPCL)|Completed||Phase 2|50|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:26.525398|2017-10-11 04:22:26.525398
NCT00003062|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||July 1997||1997-07-01|June 2012|2012-06-01||||January 2002|Actual|2002-01-01||Interventional|||Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer|A Phase II Study of TEMOZOLOMIDE in Advanced Non-Small Cell Lung Cancer With and Without Brain Metastases|Completed||Phase 2|70|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:26.62709|2017-10-11 04:22:26.62709
NCT00003063|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||November 1991||1991-11-01|November 2005|2005-11-01||||||||Interventional|||Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer|Adjuvant Chemoimmunotherapy for Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|1050|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:26.720104|2017-10-11 04:22:26.720104
NCT00005363|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1992||1992-08-01|April 2000|2000-04-01|July 1994|Actual|1994-07-01|||||Observational|||Ambulatory Blood Pressure and Prognosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.503199|2017-10-11 04:28:03.503199
NCT00003064|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||January 1997||1997-01-01|December 2002|2002-12-01||||||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer|Phase I-II Study of Tandem Cycles of High Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Support in Women With Persistent, Refractory or Recurrent Advanced (Stage III or IV), Epithelial Ovarian Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:26.947434|2017-10-11 04:22:26.947434
NCT00003065|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||January 1997||1997-01-01|September 2003|2003-09-01|February 2004|Actual|2004-02-01|||||Interventional|||Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix|Phase II Investigation of Topotecan and Taxol in Patients With Recurrent/Metastatic Cancer of the Cervix|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:27.022992|2017-10-11 04:22:27.022992
NCT00003066|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||February 1997||1997-02-01|December 2006|2006-12-01||||||||Interventional|||Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer|Phase II Evaluation of Docetaxel Combined With Estramustine Phosphate in Patients With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:27.086931|2017-10-11 04:22:27.086931
NCT00003067|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||July 1997||1997-07-01|October 2008|2008-10-01||||||||Interventional|||Biological Therapy in Treating Patients With Primary or Advanced Glioma|Intracavitary Interleukin-2 (IL-2) and Lymphokine-Activated Killer (LAK) Cell Therapy for Malignant Gliomas|Suspended||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:27.151029|2017-10-11 04:22:27.151029
NCT00003068|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-30|||June 1997||1997-06-01|May 2006|2006-05-01|November 2002|Actual|2002-11-01|||||Interventional|||High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer|An Out Patient Dose Escalation Trial of High Dose Mitoxantrone, Thiotepa and Cyclophosphamide Plus Autologous Blood Cell Rescue and Amifostine Cytoprotection|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:27.221779|2017-10-11 04:22:27.221779
NCT00003070|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-04|||September 2000||2000-09-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|July 2003|Actual|2003-07-01||Interventional|||Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer|Afterload Reduction Therapy for Late Anthracycline Cardiotoxicity: A Pediatric Oncology Group Cancer Control Study|Completed||Phase 3|13|Actual|Children's Oncology Group||8|||f||||t||||||||||2017-10-11 04:22:27.306704|2017-10-11 04:22:27.306704
NCT00003072|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-19|||May 1997||1997-05-01|September 2012|2012-09-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer|Amifostine (Ethyol) as a Protectant in Metastatic Ovarian and Non-Small Cell Lung Cancer in Paclitaxel/Carboplatin-Treated Patients: A Comparative Trial|Completed||Phase 2|80|Anticipated|University of California, San Francisco|||||f||||||||||||||2017-10-11 04:22:27.506117|2017-10-11 04:22:27.506117
NCT00003073|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-22|||February 1997||1997-02-01|April 2002|2002-04-01||||||||Interventional|||Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors|A Phase I Dose Escalation Study of Intrathecal DepoFoam Encapsulated Cytarabine (DTC 101) in Pediatric Patients With Advanced Meningeal Malignancies|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:27.5769|2017-10-11 04:22:27.5769
NCT00003075|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||September 1992||1992-09-01|July 2012|2012-07-01|May 2001|Actual|2001-05-01|September 2000|Actual|2000-09-01||Interventional|||Fenretinide in Treating Patients With Cervical Neoplasia|A Randomized Double-Blind Study of N-(4-hydroxyphenyl) Retinamide (4-HPR) Versus Placebo in Patients With Cervical Intraepithelial Neoplasia (CIN) Grade 2-3|Completed||Phase 3|39|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:22:27.646903|2017-10-11 04:22:27.646903
NCT00003076|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-12-18|||October 1995||1995-10-01|December 2012|2012-12-01|October 2005|Actual|2005-10-01|June 2002|Actual|2002-06-01||Interventional|||Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus|Phase IIb Chemoprevention Trial of Difluoromethylornithine (DFMO) in Human Subjects With Intestinal-type Barrett's Esophagus|Completed||Phase 2|152|Anticipated|University of Michigan Cancer Center|||||f||||||||||||||2017-10-11 04:22:27.72797|2017-10-11 04:22:27.72797
NCT00003077|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||October 1995||1995-10-01|July 2016|2016-07-01|November 2004|Actual|2004-11-01|July 2004|Actual|2004-07-01||Interventional|||Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss|Phase I/II Trial of Omega-3 Fatty Acids for Cancer Cachexia|Completed||Phase 1/Phase 2|63|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:27.788539|2017-10-11 04:22:27.788539
NCT00003078|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-08|||October 1997||1997-10-01|April 2011|2011-04-01||||November 2005|Actual|2005-11-01||Interventional|||Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix|A Randomized Comparison of Radiation vs Radiation Plus Weekly Cisplatin vs Radiation Plus PVI (Protracted Venous Infusion) 5-FU in Patients With Stage II-B, III-B, and IV-A Carcinoma of the Cervix With Negative Paraaortic Nodes|Completed||Phase 3|870|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:22:27.86864|2017-10-11 04:22:27.86864
NCT00003079|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2010-02-15|||September 1997||1997-09-01|February 2010|2010-02-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma|Phase I Study of Bryostatin 1 (NSC 339555) and High-Dose 1-Beta-D-Arabinofuranosylcytosine (HiDAC) in Patients With Refractory Leukemia|Completed||Phase 1|30|Actual|Virginia Commonwealth University||5|||f||||f||||||||||2017-10-11 04:22:28.179404|2017-10-11 04:22:28.179404
NCT00003080|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-13|||September 1996||1996-09-01|September 2010|2010-09-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer|A Phase I Trial of Sequential High Dose Chemotherapy Regimens Followed by Autologous or Syngeneic Peripheral Blood Stem Cell (PBSC) Rescue in Patients With Persistent Stage III/IV Ovarian Cancer|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:22:28.26467|2017-10-11 04:22:28.26467
NCT00003097|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||April 1989||1989-04-01|October 2007|2007-10-01||||||||Interventional|||Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer|Skin Cancer Prophylaxis by Low-Fat Dietary Intervention|Unknown status|Active, not recruiting|Phase 2|175|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:31.938682|2017-10-11 04:22:31.938682
NCT00003081|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-16|||March 1998||1998-03-01|September 2010|2010-09-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma|A Phase I Trial of Busulfan, Thiotepa and Melphalan Followed by Autologous or Syngeneic Peripheral Blood Stem Cell Transplantation and Followed by Total Marrow (Skeletal) Irradiation (TMI) in Patients With High-Risk Ewing's Sarcoma, PNET or Rhabdomyosarcoma|Completed||Phase 1|16|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:22:28.367303|2017-10-11 04:22:28.367303
NCT00003082|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-12|||December 1997||1997-12-01|May 2007|2007-05-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer|A Phase IA Trial of Combined Murine IgG Monoclonal Anti-Transferrin Receptor Antibodies E2.3 and A27.15 in Cancer Patients|Completed||Phase 1|27|Anticipated|University of Arizona|||||f||||||||||||||2017-10-11 04:22:28.461935|2017-10-11 04:22:28.461935
NCT00003084|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||December 1997||1997-12-01|July 2012|2012-07-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer|A Randomized Phase II Trial of Taxol/VP-16/Estramustine vs. Ketoconazole/Doxorubicin/Vinblastine/Estramustine in Androgen Independent Prostate Cancer|Completed||Phase 2|75|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:22:28.593925|2017-10-11 04:22:28.593925
NCT00003085|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||September 1996||1996-09-01|May 2014|2014-05-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer|Minimal Access Surgery for Pancreas Cancer: A Phase II Trial Study I: Staging of Pancreas Cancer|Terminated||Phase 2|28|Actual|University of Southern California||||Insufficient Accrual|f||||t||||||||||2017-10-11 04:22:28.718735|2017-10-11 04:22:28.718735
NCT00003086|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||March 1997||1997-03-01|December 2006|2006-12-01||||||||Interventional|||Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer|Phase I/II Study of Samarium 153 as Part of a Double (Sequential) Autologous Bone Marrow Transplant (ABMT) for Patients With Stage IV Breast Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:28.809314|2017-10-11 04:22:28.809314
NCT00003087|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||August 1997||1997-08-01|June 2013|2013-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus|Phase II Trial of Preoperative Combined Modality Therapy for Localized Esophageal Carcinoma: Cisplatin-Paclitaxel Followed by Radiation Therapy With Concurrent Cisplatin and Paclitaxel|Completed||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:28.912367|2017-10-11 04:22:28.912367
NCT00003088|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||September 1997||1997-09-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Breast Cancer|A Randomized Phase III Trial of Sequential Chemotherapy Using Doxorubicin, Paclitaxel, and Cyclophosphamide or Concurrent Doxorubicin and Cyclophosphamide Followed by Paclitaxel at 14 or 21 Day Intervals in Women With Node Positive Stage II/IIIA Breast Cancer|Completed||Phase 3|2005|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-10-11 04:22:28.998019|2017-10-11 04:22:28.998019
NCT00003089|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09|||July 1997||1997-07-01|May 2006|2006-05-01|February 2004|Actual|2004-02-01|||||Interventional|||Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer|A Phase II Trial of Induction Paclitaxel Plus Carboplatin Followed by Thoracic Radiation Therapy With Concurrent Weekly Low-Dose Paclitaxel and Twice Weekly Amifostine for Patients With Unresectable Locally Advanced or Partially Resected Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:29.151455|2017-10-11 04:22:29.151455
NCT00003090|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||January 1996||1996-01-01|July 2000|2000-07-01||||||||Interventional|||Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer|Phase II Trial of Bolus Interleukin-2 in Previously Treated Lung Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:29.230301|2017-10-11 04:22:29.230301
NCT00003091|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-05-10|||January 1996||1996-01-01|May 2011|2011-05-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma|Treatment of Metastatic Renal Cell Carcinoma and Melanoma With Subsequential High-Dose Subcutaneous Interferon Alfa-2b and High-Dose Bolus and Continuous Intravenous Interleukin-2|Completed||Phase 2|40|Anticipated|Hoag Memorial Hospital Presbyterian||1|||f||||f||||||||||2017-10-11 04:22:29.320267|2017-10-11 04:22:29.320267
NCT00003092|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||September 1997||1997-09-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|March 2006|Actual|2006-03-01||Interventional|||Paclitaxel in Treating Older Patients With Solid Tumors|Clinical Pharmacology of Paclitaxel in Relation to Patient Age|Completed||Phase 3|120|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:29.413297|2017-10-11 04:22:29.413297
NCT00003093|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-31|||March 1988||1988-03-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy in Treating Children With Neuroblastoma|Treatment for Infants and Children With Intermediate Risk Neuroblastoma: A Phase III Intergroup CCG/POG Study|Completed||Phase 3|573|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:22:29.613406|2017-10-11 04:22:29.613406
NCT00003094|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-19|||October 1997||1997-10-01|August 2007|2007-08-01||||||||Interventional|||Carotenoid Rich Diet in Treating Cervical Dysplasia|Carotenoid-Rich Diet Trial to Reverse CIN II|Withdrawn||Phase 2|0|Actual|University of California, San Diego||||Study was halted prematurely, prior to enrollment of first participant|f||||||||||||||2017-10-11 04:22:30.165874|2017-10-11 04:22:30.165874
NCT00003095|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-23|||November 1997||1997-11-01|October 2015|2015-10-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Observational|||S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer|S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623|Completed||N/A|26|Actual|Southwest Oncology Group|||2||f||||f||||||Samples With DNA|"     tissue and blood   "|||2017-10-11 04:22:30.240159|2017-10-11 04:22:30.240159
NCT00003096|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-05|||December 1996||1996-12-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|March 2006|Actual|2006-03-01||Observational|||Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors|Molecular Biology of Pediatric Brain Tumors|Completed||N/A|88|Actual|Children's Oncology Group|||||f||||f||||||||||2017-10-11 04:22:31.750959|2017-10-11 04:22:31.750959
NCT00003099|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||May 1996||1996-05-01|July 2012|2012-07-01|January 2003|Actual|2003-01-01|June 2000|Actual|2000-06-01||Interventional|||Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer|Phase II Clinical Trial of N-(4-hydroxyphenyl) Retinamide (4-HPR) and Tamoxifen in Breast Neoplasia, Administration During the Period Between the Diagnostic Core Biopsy and Definitive Surgery|Completed||Phase 2|52|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:22:32.078709|2017-10-11 04:22:32.078709
NCT00003100|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||October 1996||1996-10-01|June 2000|2000-06-01||||||||Interventional|||Dietary Soy Isoflavones for the Prevention of Cancer|Metabolic Fate and Plasma Kinetics of Dietary Soy Isoflavones|Unknown status|Active, not recruiting|N/A|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:32.16009|2017-10-11 04:22:32.16009
NCT00003101|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||August 1997||1997-08-01|June 2013|2013-06-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma|A Phase II Trial of Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma|Completed||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:32.351236|2017-10-11 04:22:32.351236
NCT00003102|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-12-02|||July 1997||1997-07-01|December 2009|2009-12-01||||August 2000|Actual|2000-08-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer|Phase I/II Study of 131-I-Labeled Chimeric Antibody G250 (131-I-cG250) in Patients With Advanced Renal Carcinoma|Completed||Phase 1/Phase 2|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:32.467847|2017-10-11 04:22:32.467847
NCT00003103|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||August 1997||1997-08-01|July 2013|2013-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Chemotherapy in Treating Patients With Solid Tumors|A Phase I/IIA Dose-Escalating Trial of BCL-2 Antisense (G3139) Treatment for Patients With Androgen-Independent Prostate Cancer or Other Advanced Solid Tumor Malignancies|Completed||Phase 1/Phase 2|57|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:32.547843|2017-10-11 04:22:32.547843
NCT00003104|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||June 1997||1997-06-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer|A Phase II Study Using High Dose Three Dimensional Conformal Radiation Therapy in Intermediate Prognostic Risk Patients With Adenocarcinoma of the Prostate|Completed||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:32.665648|2017-10-11 04:22:32.665648
NCT00003105|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-02|||September 1997||1997-09-01|July 2013|2013-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer|Phase I/II Trial of Sequential Doxorubicin/Gemcitabine (AG) and Ifosfamide, Paclitaxel, and Cisplatin (ITP) Chemotherapy (AG-ITP) in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium|Completed||Phase 1/Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:32.734137|2017-10-11 04:22:32.734137
NCT00003107|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-09-09|||October 1997||1997-10-01|September 2014|2014-09-01||||||||Interventional|||Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors|A Phase I Trial of Recombinant Human Interleukin-12 After High-Dose Therapy and Autologous Hematopoietic Stem Cell Support|Completed||Phase 1|||Indiana University|||||f||||||||||||||2017-10-11 04:22:32.810933|2017-10-11 04:22:32.810933
NCT00003108|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-17|||October 1997||1997-10-01|July 2004|2004-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer|A Phase I Study of Bryostatin and Cisplatin in Patients With Advanced Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:32.924335|2017-10-11 04:22:32.924335
NCT00003109|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-16|||December 1997||1997-12-01|April 2013|2013-04-01|January 2001|Actual|2001-01-01|October 2000|Actual|2000-10-01||Interventional|||Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors|Phase I Pharmacokinetic and Pharmacodynamic Trial of Irinotecan in Combination With Tomudex in Patients With Refractory Solid Malignancies|Completed||Phase 1|39|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-10-11 04:22:32.983605|2017-10-11 04:22:32.983605
NCT00003110|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-10|||July 1997||1997-07-01|June 2010|2010-06-01|December 2002|Actual|2002-12-01|August 2001|Actual|2001-08-01||Interventional|||Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Trial of 72-Hour Continuous Infusion Bleomycin as Salvage Therapy in AIDS-Related and Immunocompetent Non-Hodgkin's Lymphoma|Completed||Phase 2|5|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:22:33.046167|2017-10-11 04:22:33.046167
NCT00003111|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-23|||April 1997||1997-04-01|August 2009|2009-08-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer|Phase II Clinical and Laboratory Study of Irinotecan/Cisplatin Chemotherapy Followed by Surgery in Stage III NSCLC|Completed||Phase 2|10|Actual|Yale University|||||f||||f||||||||||2017-10-11 04:22:33.117914|2017-10-11 04:22:33.117914
NCT00003113|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-01-13|||July 1997||1997-07-01|January 2011|2011-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas|Oral Combination Chemotherapy in Conjunction With G-CSF in the Treatment of Elderly Patients With Intermediate and High Grade Non-Hodgkin's Lymphoma|Terminated||Phase 2|6|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:22:33.184382|2017-10-11 04:22:33.184382
NCT00003114|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-09|||July 1997||1997-07-01|June 2010|2010-06-01|February 2003|Actual|2003-02-01|June 2002|Actual|2002-06-01||Interventional|||Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease|Oral Combination Chemotherapy in the Treatment of AIDS-Associated Hodgkin's Disease|Completed||Phase 2|5|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:22:33.262382|2017-10-11 04:22:33.262382
NCT00003115|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-02-22|||June 1996||1996-06-01|February 2011|2011-02-01|February 2004|Actual|2004-02-01|January 2003|Actual|2003-01-01||Interventional|||Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy|Spinal Effects of Epidural Hydromorphone|Completed||Phase 3|40|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:22:33.332323|2017-10-11 04:22:33.332323
NCT00003186|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||April 1997||1997-04-01|February 2013|2013-02-01||||March 2005|Actual|2005-03-01||Interventional|||Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer|Dynamic In Vivo Lymphography and Sentinel Node Biopsy in Colorectal Cancer: A Feasibility Study|Completed||N/A|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:22:46.588725|2017-10-11 04:22:46.588725
NCT00003116|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-09|||May 1997||1997-05-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|March 2006|Actual|2006-03-01||Interventional|||High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Allogeneic Peripheral Blood Progenitor Cell Transplantation Using Histocompatible Sibling-Matched Donor Cells After High-Dose Busulfan/Cyclophosphamide as Therapy for Hematologic Malignancies|Completed||Phase 2|66|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:22:33.40026|2017-10-11 04:22:33.40026
NCT00003117|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-28|||October 1997||1997-10-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|December 2004|Actual|2004-12-01||Interventional|||Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer|Single-Agent Versus Combination Chemotherapy in Advanced NSCLC: A CALGB Randomized Trial of Efficacy, Quality of Life, and Cost-Effectiveness|Completed||Phase 3|584|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:22:33.495086|2017-10-11 04:22:33.495086
NCT00003118|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||October 1997||1997-10-01|June 2016|2016-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus|A Prospective Randomized Phase III Trial Comparing Trimodality Therapy (Cisplatin, 5-FU, Radiotherapy, and Surgery) to Surgery Alone for Esophageal Cancer|Completed||Phase 3|56|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:22:33.635878|2017-10-11 04:22:33.635878
NCT00003119|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-09|||March 1998||1998-03-01|March 2017|2017-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Surgery in Treating Children With Neuroblastoma|Primary Surgical Therapy for Biologically Defined Low-Risk Neuroblastoma: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study|Completed||Phase 3|968|Actual|Children's Oncology Group||2|||f||||f||||||||||2017-10-11 04:22:33.959528|2017-10-11 04:22:33.959528
NCT00003120|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-10-07|||November 1997||1997-11-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|June 2003|Actual|2003-06-01||Interventional|||S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission|Phase III Randomized Trial of 12 Months vs. 3 Months of Paclitaxel in Patients With Advanced Ovarian Cancer Who Attain a Clinically Defined Complete Response (CR) Following Platinum/Paclitaxel-Based Chemotherapy|Completed||Phase 3|308|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:34.728219|2017-10-11 04:22:34.728219
NCT00003122|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-23|||December 1994||1994-12-01|July 2007|2007-07-01||||||||Interventional|||Surgery in Treating Patients With Neuroblastoma|Phase II Trial of Surgery as the Only Treatment for INSS Stage 2A & 2B Neuroblastoma|Unknown status|Recruiting|Phase 2|210|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:35.103408|2017-10-11 04:22:35.103408
NCT00003123|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||August 1997||1997-08-01|January 2004|2004-01-01||||||||Interventional|||Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome|A Phase II Trial of Ethyol (Amifostine) in Adult Patients With Advanced Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:35.608597|2017-10-11 04:22:35.608597
NCT00003124|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||May 1997||1997-05-01|December 2002|2002-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer|Phase II Trial of Maximal Androgen Deprivation Followed by Conformal External Beam Radiotherapy With Continued Androgen Deprivation for Clinically Localized Prostate Cancer|Completed||Phase 2|105|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:35.693796|2017-10-11 04:22:35.693796
NCT00003125|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-22|||January 1998||1998-01-01|May 2007|2007-05-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors|A Pilot Study of Sequential Vaccinations With ALVAC-CEA and Vaccinia-CEA With the Addition of IL-2 and GM-CSF in Patients With CEA Expressing Tumors|Completed||Phase 2|24|Anticipated|Georgetown University|||||f||||f||||||||||2017-10-11 04:22:35.786485|2017-10-11 04:22:35.786485
NCT00003126|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-02|||June 1997||1997-06-01|January 2017|2017-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer|A Randomized Controlled Phase III Adjuvant Trial of High-Dose Bolus IL-2 in Patients With High-Risk Renal Cell Carcinoma|Completed||Phase 3|69|Actual|Loyola University||2|||f||||t||||||||No|There is no plan to share individual participant data|2017-10-11 04:22:35.891531|2017-10-11 04:22:35.891531
NCT00003127|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-13|||February 1998||1998-02-01|June 2012|2012-06-01|July 2004|Actual|2004-07-01|April 2003|Actual|2003-04-01||Interventional|||S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer|Phase II Trial of Paclitaxel and Carboplatin With Amifostine in Advanced Recurrent or Refractory Endometrial Adenocarcinoma|Completed||Phase 2|57|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:22:36.026674|2017-10-11 04:22:36.026674
NCT00003128|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-08|||November 1997||1997-11-01|May 2004|2004-05-01||||February 2007|Actual|2007-02-01||Interventional|||Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus|A Phase III Trial of Ifosfamide (NSC #109274) Versus Ifosfamide Plus Paclitaxel (NSC #125973) in Patients With Advanced, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus|Completed||Phase 3|166|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:22:36.305443|2017-10-11 04:22:36.305443
NCT00003129|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-06-06|||July 1998||1998-07-01|January 2002|2002-01-01||||November 2002|Actual|2002-11-01||Interventional|||Chemotherapy in Treating Patients With Early-Stage Bladder Cancer|Phase II Study of Intravesical Therapy With AD 32 in Patients With Papillary Urothelial Carcinoma or Carcinoma in Situ (CIS) Refractory to Prior Therapy With Bacillus Calmette-Guerin|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:36.958343|2017-10-11 04:22:36.958343
NCT00003130|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-15|||November 1997||1997-11-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|January 2002|Actual|2002-01-01||Interventional|||Paclitaxel in Treating Women With Recurrent Solid Tumors|Prospective Evaluation of Body Surface Area (BSA) as a Determinant of Paclitaxel Pharmacokinetics/Pharmacodynamics in Women With Solid Tumors|Completed||Phase 2|32|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:37.043219|2017-10-11 04:22:37.043219
NCT00003131|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-21|||February 1997||1997-02-01|August 2012|2012-08-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse|A Study of the Efficacy and Safety of CMA-676 as Single Agent Treatment of Patients With Acute Myeloid Leukemia (AML) in First Relapse|Completed||Phase 2|55|Anticipated|Pfizer|||||f||||||||||||||2017-10-11 04:22:37.193767|2017-10-11 04:22:37.193767
NCT00003133|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-26|||September 1997||1997-09-01|June 2013|2013-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer|Sequential Gemcitabine, Doxorubicin, Then Paclitaxel Plus Cisplatin Adjuvant Chemotherapy After Complete Resection of Locally Advanced Transitional Cell Carcinoma of the Urothelium|Completed||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:37.451423|2017-10-11 04:22:37.451423
NCT00003134|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-05|||January 1998||1998-01-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|October 2001|Actual|2001-10-01||Interventional|||Irinotecan in Treating Patients With Recurrent Glioma|A Phase II Trial of Irinotecan in Recurrent Glioma|Completed||Phase 2|64|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:22:37.526237|2017-10-11 04:22:37.526237
NCT00003135|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-04-29|||November 1997||1997-11-01|December 2008|2008-12-01||||September 2009|Anticipated|2009-09-01||Interventional|||Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer|A Phase I-II Trial of Mild Whole-Body Hyperthermia Combined With Liposomal Doxorubicin/5-Fluorouracil in Patients With Advanced Malignancy|Unknown status|Recruiting|Phase 2|34|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:37.710546|2017-10-11 04:22:37.710546
NCT00003136|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||December 1996||1996-12-01|February 2013|2013-02-01|October 2001|Actual|2001-10-01|December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer|A Phase I/II Dose Escalation Trial of Carboplatin With Amifostine Pretreatment to Augment High Dose Cyclophosphamide With Autologous Peripheral Blood Stem Cell Support for the Treatment of Patients With Epithelial Ovarian Cancer|Completed||Phase 1/Phase 2|11|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:22:37.805962|2017-10-11 04:22:37.805962
NCT00003137|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||December 1997||1997-12-01|July 2016|2016-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Irinotecan in Treating Patients With Advanced Cancer of the Stomach|A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53|Completed||Phase 2|70|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:22:37.9127|2017-10-11 04:22:37.9127
NCT00003138|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-06|2013-09-11||December 1997||1997-12-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|August 2008|Actual|2008-08-01||Interventional||All patients with complete data are included.|Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes|Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes|Completed||Phase 3|118|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:38.054675|2017-10-11 04:22:38.054675
NCT00003139|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-11-14|||March 1998||1998-03-01|November 2015|2015-11-01|October 2002|Actual|2002-10-01|January 2001|Actual|2001-01-01||Interventional|||Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer|A Phase III Study to Test the Efficacy of the Prophylactic Use of Oral Pilocarpine to Reduce Hyposalivation and Mucositis Associated With Curative Radiation Therapy in Head and Neck Cancer Patients|Completed||Phase 3|249|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:38.835416|2017-10-11 04:22:38.835416
NCT00003140|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-09-18|||August 1998||1998-08-01|March 2012|2012-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Letrozole After Tamoxifen in Treating Women With Breast Cancer|A Phase III Randomized Double Blind Study of Letrozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen|Completed||Phase 3|5187|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:22:39.31017|2017-10-11 04:22:39.31017
NCT00003141|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-03-27|||March 1998||1998-03-01|March 2014|2014-03-01|October 2011|Actual|2011-10-01|December 2007|Actual|2007-12-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors|A Pilot Study of Intensive Chemotherapy With Peripheral Stem Cell Support for Infants With Malignant Brain Tumors|Completed||Phase 1|94|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:22:39.708833|2017-10-11 04:22:39.708833
NCT00003143|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-03|||November 1997||1997-11-01|October 2012|2012-10-01||||December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation|A Randomized Study of Ethyol (Amifostine) With Platinum Based Salvage Chemotherapy in Patients With Lymphoma Undergoing Autologous Stem Cell Transplantation|Completed||Phase 2|20|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-10-11 04:22:39.971803|2017-10-11 04:22:39.971803
NCT00003144|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-25|||August 1997||1997-08-01|March 2011|2011-03-01||||April 2001|Actual|2001-04-01||Interventional|||Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors|Phase I Study of Amifostine (Ethyol) as a Cytoprotector of Gemcitabine/Cisplatin Combination|Completed||Phase 1|44|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:22:40.056548|2017-10-11 04:22:40.056548
NCT00003145|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-04|||August 1997||1997-08-01|January 2017|2017-01-01||||March 2005|Actual|2005-03-01||Interventional|||Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia|Induction of Mixed Hematopoietic Chimerism Using Fludarabine, Low Dose TBI , PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil to be Followed by Donor Lymphocyte Infusion In Patients With Chronic Myeloid Leukemia in Chronic and Accelerated Phases: A Multi-center Study|Active, not recruiting||Phase 2|18|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:22:40.139841|2017-10-11 04:22:40.139841
NCT00003146|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-06-21|||November 1997||1997-11-01|June 2011|2011-06-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase II Trial of Thiotepa, Busulfan, and Melphalan Followed by Autologous or Syngeneic Marrow or Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:22:40.280947|2017-10-11 04:22:40.280947
NCT00005364|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1994||1994-04-01|June 2000|2000-06-01|March 1999|Actual|1999-03-01|||||Observational|||Genetic Epidemiology of CHD Risk Factors in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.558041|2017-10-11 04:28:03.558041
NCT00003147|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-02-04|||February 1998||1998-02-01|May 2000|2000-05-01||||June 2003|Actual|2003-06-01||Interventional|||Gene Therapy in Treating Patients With Cancer of The Liver|Phase I Study of Percutaneous Injections of Adeno-Virus p53 Construct (ADENO-p53) for Hepatocellular Carcinoma|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:22:40.343666|2017-10-11 04:22:40.343666
NCT00003148|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||October 1997||1997-10-01|June 2012|2012-06-01||||April 2001|Actual|2001-04-01||Interventional|||Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia|Phase II Study of the Efficacy of rH Interleukin-2 in Patients With Slowly Progressing Acute Myelogenous Leukemia (AML) and With Limited Bone Marrow Blastosis After Autologous Stem Cell Transplantation or Chemotherapy|Completed||Phase 2|86|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:40.409548|2017-10-11 04:22:40.409548
NCT00003149|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||December 1997||1997-12-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Interleukin-12 in Treating Patients With Multiple Myeloma|Phase II of Interleukin-12 for Plateau Phase Multiple Myeloma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:40.484826|2017-10-11 04:22:40.484826
NCT00003150|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||December 1997||1997-12-01|August 2010|2010-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma|Phase III Trial of CHOP Versus CHOP and Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8) in Older Patients With Diffuse Mixed, Diffuse Large Cell and Immunoblastic Large Cell Histology Non-Hodgkin's Lymphoma|Completed||Phase 3|630|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:40.573745|2017-10-11 04:22:40.573745
NCT00003151|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||September 1997||1997-09-01|June 2012|2012-06-01||||October 1998|Actual|1998-10-01||Interventional|||Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma|A Phase II Clinical Trial of Anti-Helicobacter Pylori Treatment in Endoscopically Diagnosed Low-Grade Localized Gastric Lymphoma|Completed||Phase 2|96|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:40.839234|2017-10-11 04:22:40.839234
NCT00003152|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||March 1997||1997-03-01|June 2012|2012-06-01||||November 1999|Actual|1999-11-01||Interventional|||Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma|Marrow-Ablative Chemo-Radiotherapy and Autologous Stem Cell Transplantation Followed by Interferon-Alpha Maintenance Treatment Versus Interferon-Alpha Maintenance Treatment Alone After a Chemotherapy-Induced Remission in Patients With Stages III or IV Follicular Non-Hodgkin's Lymphoma. A Prospective, Randomized, Phase III Clinical Trial.|Terminated||Phase 3|469|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:22:40.959457|2017-10-11 04:22:40.959457
NCT00003153|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-25|||February 1998||1998-02-01|July 2004|2004-07-01||||February 2007|Actual|2007-02-01||Interventional|||Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation|Phase II Study of Salvage Cellular Immunotherapy for Patients With Persistent or Recurrent Multiple Myeloma After Allogeneic Bone Marrow Transplantation From an HLA-Matched Sibling Donor|Completed||Phase 2|22|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:41.044402|2017-10-11 04:22:41.044402
NCT00003154|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-09|||January 1998||1998-01-01|June 2010|2010-06-01|June 2001|Actual|2001-06-01|April 2001|Actual|2001-04-01||Interventional|||Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer|Phase II Trial of 9-Aminocamptothecin (9-AC) Colloidal Dispersion (CD) 120-Hour Continuous Intravenous Infusion in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|19|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:22:41.119156|2017-10-11 04:22:41.119156
NCT00003156|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-04-10|||June 1998||1998-06-01|January 2006|2006-01-01||||October 2005|Actual|2005-10-01||Interventional|||Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus|Evaluation of Topotecan in the Treatment of Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:22:41.203451|2017-10-11 04:22:41.203451
NCT00003157|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||February 1998||1998-02-01|July 2016|2016-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach|A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer|Completed||Phase 1|26|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:41.34596|2017-10-11 04:22:41.34596
NCT00003158|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-20|||February 1998||1998-02-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2002|Actual|2002-12-01||Interventional|||S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer|A Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol) for Poor-Risk Stage III Non-Small Cell Lung Cancer|Completed||Phase 2|96|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:22:41.459034|2017-10-11 04:22:41.459034
NCT00003159|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||August 1997||1997-08-01|May 2005|2005-05-01|June 2007|Actual|2007-06-01|||||Interventional|||Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer|Randomized Trial of Surgical Resection With or Without Pre-Operative Chemotherapy in Patients With Operable Non-Small Cell Lung Cancer (NSCLC) of Any Stage|Completed||Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:41.726929|2017-10-11 04:22:41.726929
NCT00003160|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-04-19|||September 1997||1997-09-01|January 2001|2001-01-01||||||||Interventional|||Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum|A Phase II Trial of Paclitaxel (Taxol) Administered as a Weekly One Hour Infusion in Patients With Taxol/Platinum-Refractory Stage III and IV Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:41.824309|2017-10-11 04:22:41.824309
NCT00003162|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-11-14|||February 1998||1998-02-01|November 2015|2015-11-01||||July 2003|Actual|2003-07-01||Interventional|||Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer|Randomized Trial of Palliative Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life|Completed||Phase 3|949|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:42.018461|2017-10-11 04:22:42.018461
NCT00003163|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||September 1997||1997-09-01|October 2002|2002-10-01||||||||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers|Myeloblative Therapy With Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma and B-Cell Malignancies|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:42.653086|2017-10-11 04:22:42.653086
NCT00003165|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||December 1997||1997-12-01|April 2010|2010-04-01||||||||Interventional|||Doxorubicin in Treating Women With Advanced Breast Cancer|A Phase II Trial of PK1 in Women With Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:42.76639|2017-10-11 04:22:42.76639
NCT00003166|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-10|||May 1998||1998-05-01|January 2013|2013-01-01||||July 2001|Actual|2001-07-01||Interventional|||Bryostatin and Vincristine in B-Cell Malignancies|A Phase I Trial of Combination Bryostatin 1 (NSC 339555) and Vincristine in B-Cell Malignancies|Completed||Phase 1|18|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:42.866335|2017-10-11 04:22:42.866335
NCT00003167|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-22|||May 1998||1998-05-01|January 2013|2013-01-01||||December 2002|Actual|2002-12-01||Interventional|||Gene Therapy in Treating Patients With Advanced Bladder Cancer|A Phase I Trial of Intravesical Ad-p53 Treatment in Locally Advanced and Metastatic Bladder Cancer|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:42.969151|2017-10-11 04:22:42.969151
NCT00003170|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-13|||February 1998||1998-02-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|May 2003|Actual|2003-05-01||Interventional|||Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer|Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy|Completed||Phase 3|129|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:22:43.042797|2017-10-11 04:22:43.042797
NCT00003171|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||May 1998||1998-05-01|April 2013|2013-04-01|June 2003|Actual|2003-06-01|July 1999|Actual|1999-07-01||Interventional|||Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome|Phase II Clinical Evaluation of Bryostatin 1 in Patients With Myelodysplastic Syndrome|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:22:43.160225|2017-10-11 04:22:43.160225
NCT00003172|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||December 1997||1997-12-01|September 2002|2002-09-01|September 2004|Actual|2004-09-01|||||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer|Randomized Phase II Trial of Either 5-Fluorouracil, Recombinant Alfa-2a-Interferon and Intravenous Hydroxyurea With Filgrastim Support (FHIG) or Doxorubicin/Docetaxel (Dd) in Patients With Advanced Gastric Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:43.237274|2017-10-11 04:22:43.237274
NCT00003173|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-06|||September 1997||1997-09-01|March 2013|2013-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors|High-Dose Thiotepa With Autologous Stem Cell Rescue in Patients With Malignancies Refractory to Conventional Chemotherapy|Completed||Phase 2|36|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:43.354383|2017-10-11 04:22:43.354383
NCT00003174|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-04-22|||May 1998||1998-05-01|April 2014|2014-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia|Phase I Clinical Evaluation of Bryostatin 1 in Combination With 2-CdA in Patients With Relapsed CLL|Completed||Phase 1|80|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:22:43.453588|2017-10-11 04:22:43.453588
NCT00003175|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||December 1997||1997-12-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|||||Interventional|||Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer|A Phase II Study of Continuous 5-Fluorouracil (5-FU) in Recurrent Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urinary Tract|Completed||Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:43.569985|2017-10-11 04:22:43.569985
NCT00003176|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-12-13|||January 1998||1998-01-01|January 2007|2007-01-01||||||||Interventional|||Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma|A Phase II Trial of Temozolomide and BCNU for Anaplastic Gliomas|Unknown status|Active, not recruiting|Phase 2|82|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:43.828943|2017-10-11 04:22:43.828943
NCT00003178|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2014-07-24|||March 1998||1998-03-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|December 2004|Actual|2004-12-01||Interventional|||Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia|Idarubicin and Cladribine in Recurrent and Refractory Acute Myeloid Leukemia: A POG Phase II Study|Completed||Phase 2|120|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-10-11 04:22:43.944718|2017-10-11 04:22:43.944718
NCT00003179|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-07|||November 1998||1998-11-01|July 2006|2006-07-01||||February 2006|Actual|2006-02-01||Interventional|||Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer|A Two-Part Study of the Treatment of Atypical Endometrial Hyperplasia: Part A: A Prospective Study of Immediate Hysterectomy; Part B: A Randomized Phase II Study of Medroxyprogesterone Acetate Versus Depoprovera|Terminated||Phase 2|360|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:22:45.970867|2017-10-11 04:22:45.970867
NCT00003181|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||May 1997||1997-05-01|May 2001|2001-05-01||||||||Interventional|||Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Using Low Dose Subcutaneous IL-2, Vinblastine and GM-CSF in the Treatment of Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:46.184356|2017-10-11 04:22:46.184356
NCT00003182|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||March 1997||1997-03-01|July 2000|2000-07-01||||||||Interventional|||Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck|A Phase I/II Study Using Cisplatin and Gemcitabine (Gemzar) for Advanced Head and Neck Cancer (Squamous Cell Carcinoma)|Unknown status|Active, not recruiting|Phase 1/Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:46.264223|2017-10-11 04:22:46.264223
NCT00003183|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||March 1997||1997-03-01|April 2001|2001-04-01||||||||Interventional|||Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer|A Phase I/II Trial Using Weekly Mitoxantrone Chemotherapy and G-CSF for the Treatment of Metastatic Hormone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|64|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:46.375167|2017-10-11 04:22:46.375167
NCT00003187|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2010-02-23|||May 1995||1995-05-01|February 2010|2010-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma|The Unrelated Donor Marrow Transplantation Trial|Completed||Phase 2/Phase 3|19|Actual|Virginia Commonwealth University|||||f||||f||||||||||2017-10-11 04:22:46.661295|2017-10-11 04:22:46.661295
NCT00003190|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-03|||January 1998||1998-01-01|June 2013|2013-06-01||||August 2002|Actual|2002-08-01||Interventional|||Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia|Phase III Study of MDR Modulation With PSC-833 (NSC #648265) Followed by Immunotherapy With rIL-2 (NSC #373364) vs. No Further Therapy in Previously Untreated Patients With AML &gt;60 Years|Completed||Phase 3|640|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:22:46.79322|2017-10-11 04:22:46.79322
NCT00003191|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-06|||March 1998||1998-03-01|August 2006|2006-08-01||||March 2005|Actual|2005-03-01||Interventional|||Fenretinide in Treating Children With Solid Tumors|A Phase I Study of Fenretinide (NSC #374551) in Children With High Risk Solid Tumors|Completed||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:46.893272|2017-10-11 04:22:46.893272
NCT00003192|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-04|||March 1998||1998-03-01|September 2013|2013-09-01|August 2003|Actual|2003-08-01|February 2002|Actual|2002-02-01||Interventional|||Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus|A Phase II Trial of 9-Aminocamptothecin (NSC 603071) Administered as a 120-Hour Continuous Infusion in Patients With Previously Untreated Gastric Cancer|Completed||Phase 2|15|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:22:47.014304|2017-10-11 04:22:47.014304
NCT00003193|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-12-05|||January 1998||1998-01-01|December 2012|2012-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Phase I/II Study of Escalating Doses of Taxol Used Concurrently With Ethyol and Accelerated Hyperfractionated Radiotherapy in the Treatment of Stage III and IV Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|37|Anticipated|Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 04:22:47.118673|2017-10-11 04:22:47.118673
NCT00003194|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2009-02-06|||July 1997||1997-07-01|March 2003|2003-03-01||||||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors|A Phase I Study of Thiotepa in Combination With Carboplatin and Topotecan With Peripheral Blood Progenitor Cell Support for the Treatment of Children With Recurrent or Refractory Solid Tumors.|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:47.205018|2017-10-11 04:22:47.205018
NCT00003195|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-11-15|||December 1997||1997-12-01|November 2011|2011-11-01|November 2000|Actual|2000-11-01|||||Interventional|||Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma|A Phase II Study of Total Marrow Irradiation, Busulfan, and Alpha-Interferon Followed by Allogeneic Peripheral Blood Stem Cell or Marrow Transplantation for Treatment of Patients With Advanced Multiple Myeloma.|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:22:47.26593|2017-10-11 04:22:47.26593
NCT00003196|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-10-24|||September 1997||1997-09-01|October 2016|2016-10-01||||April 2002|Actual|2002-04-01||Interventional|||Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma|Induction of Mixed Hematopoietic Chimerism in Older Patients With B-Cell Malignancies and in Selected Other Diseases, Using Low Dose TBI , PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil to be Followed by Donor Lymphocyte Infusion: A Pilot Study.|Active, not recruiting||N/A|63|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:22:47.335588|2017-10-11 04:22:47.335588
NCT00003197|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||December 1997||1997-12-01|June 2013|2013-06-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Green Tea Extract in Treating Patients With Advanced Solid Tumors|Phase I Evaluation of Green Tea Extract in Adults With Advanced Solid Tumors|Completed||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:47.614111|2017-10-11 04:22:47.614111
NCT00003198|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||November 1997||1997-11-01|June 2013|2013-06-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors|A Phase I Dose-Escalation Study of Topotecan and Ifosfamide in Patients With Refractory Non-Hematologic Malignancies.|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:47.67842|2017-10-11 04:22:47.67842
NCT00003199|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-06-16|2017-04-10||November 1997|Actual|1997-11-01|June 2017|2017-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer|A Phase II Trial for Patients With Inflammatory (Stage IIIB) and Responsive Metastatic Stage IV Breast Cancer Using Busulfan, Melphalan and Thiotepa Followed by Autologous or Syngeneic PBSC Rescue and 12 Weeks of Post-Engraftment Immunotherapy With Low-Dose IL-2 and GM-CSF|Completed||Phase 2|50|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 04:22:47.748564|2017-10-11 04:22:47.748564
NCT00003200|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-17|||October 1995||1995-10-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|October 2006|Actual|2006-10-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck|Taxotere Plus Concurrent Radiotherapy After Induction Chemotherapy for Squamous Cell Carcinoma of the Head and Neck (TAXT-XRT)|Completed||Phase 1|22|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 04:22:48.040868|2017-10-11 04:22:48.040868
NCT00003202|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-18|||January 1998||1998-01-01|July 2012|2012-07-01|July 2006|Actual|2006-07-01|April 2002|Actual|2002-04-01||Interventional|||Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer|Alternating Phase I/II Trials of Twice-Weekly Infusion Gemcitabine (2'2'-Difluoro-2'-Deoxycytidine) and Concurrent Thoracic Radiation Alone - Or Following 2 Cycles of Cisplatin/Gemcitabine Induction Chemotherapy for the Treatment of Stage IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|40|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-10-11 04:22:48.134382|2017-10-11 04:22:48.134382
NCT00005365|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||February 1993||1993-02-01|August 2004|2004-08-01|January 1998||1998-01-01|||||Observational|||Central Obesity and Disease Risk in Japanese Americans||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:28:03.611701|2017-10-11 04:28:03.611701
NCT00003203|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||March 1998||1998-03-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|October 2007|Actual|2007-10-01||Interventional|||Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors|An Intergroup Pilot Study of Concurrent Carboplatin, Vincristine and Radiotherapy Followed by Adjuvant Chemotherapy in Patients With Newly Diagnosed High-Risk Central Nervous System Embryonal Tumors|Completed||Phase 2|168|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:22:48.216124|2017-10-11 04:22:48.216124
NCT00003204|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-02-26|||March 1998||1998-03-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma|Randomized Phase III Study in Low Grade Lymphoma Comparing Maintenance Anti-CD20 Antibody Versus Observation Following Induction Therapy|Completed||Phase 3|515|Actual|National Cancer Institute (NCI)||4|||f||||||||||||||2017-10-11 04:22:48.400086|2017-10-11 04:22:48.400086
NCT00003205|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-28|||April 1998||1998-04-01|December 2002|2002-12-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Bryostatin 1 in Treating Patients With Stage IV Breast Cancer|A Phase II Trial of Bryostatin-1 for the Treatment of Stage IV Breast Cancer|Completed||Phase 2|||University of Colorado, Denver|||||f||||t||||||||||2017-10-11 04:22:48.499227|2017-10-11 04:22:48.499227
NCT00003206|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||April 1998||1998-04-01|August 2013|2013-08-01||||July 2001|Actual|2001-07-01||Interventional|||Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer|A Phase II Trial of Carboplatin Plus Paclitaxel in the Treatment of Locally Recurrent or Metastatic Nasopharyngeal Carcinoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:22:48.561009|2017-10-11 04:22:48.561009
NCT00003207|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-11|||March 1998||1998-03-01|April 2013|2013-04-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers|Phase I Study on Doxil and SDZ PSC 833 in the Treatment of AIDS-Associated Kaposi's Sarcoma and Other Advanced Malignancies|Completed||Phase 1|14|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 04:22:48.647995|2017-10-11 04:22:48.647995
NCT00003209|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||December 1997||1997-12-01|July 2012|2012-07-01||||December 1999|Actual|1999-12-01||Interventional|||Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer|A Randomized Phase III Study of Chemotherapy and Radiotherapy Versus Radiotherapy Alone as Adjuvant Treatment to Patients With Node Positive Stages IB or IIA Cervix Cancer|Completed||Phase 3|700|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:48.721857|2017-10-11 04:22:48.721857
NCT00003210|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-04-14|||February 1998||1998-02-01|January 2013|2013-01-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease|A Phase II Study of Recombinant Human Interleukin-12 (rhIL-12) for the Treatment of Relapsed Lymphoma and Hodgkin's Disease|Completed||Phase 2|105|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:48.800153|2017-10-11 04:22:48.800153
NCT00003211|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-06|||October 1996||1996-10-01|November 2012|2012-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor|Treatment of Newly Diagnosed Medulloblastoma and Supratentorial PNET in Patients At Least 3 Years With a Phase II Topotecan Window (High-Risk Patients Only), Risk-Adapted Radiation Therapy, and Dose-Intensive Chemotherapy With Peripheral Blood Stem Cell Support|Completed||Phase 2|94|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-10-11 04:22:48.889786|2017-10-11 04:22:48.889786
NCT00003212|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-01-19|||January 1998||1998-01-01|January 2012|2012-01-01||||November 2001|Actual|2001-11-01||Interventional|||Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma|Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma|Completed||Phase 3|780|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:48.997838|2017-10-11 04:22:48.997838
NCT00003213|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||May 1996||1996-05-01|July 2012|2012-07-01|August 1999|Actual|1999-08-01|April 1999|Actual|1999-04-01||Interventional|||Drugs to Reduce the Side Effects of Chemotherapy|A Randomized, Double-Blind Trial to Compare the Clinical Efficacy and Safety of Granisetron vs. Metoclopramide Combined to Dexamethasone in the Prophylaxis of Chemotherapy-Induced Delayed Emesis|Completed||Phase 3|267|Actual|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||||2017-10-11 04:22:49.10177|2017-10-11 04:22:49.10177
NCT00003214|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||July 1996||1996-07-01|May 2012|2012-05-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer|Randomized Trial on Chemosensitivity Testing in Advanced Primary Ovarian Carcinoma (Phase III)|Completed||Phase 3|300|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:22:49.19904|2017-10-11 04:22:49.19904
NCT00003215|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||April 1997||1997-04-01|May 2012|2012-05-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma|Standard Chemotherapy (CHOP Regimen) Versus Sequential High-Dose Chemotherapy With Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas and Poor Prognostic Factors: A Randomized Phase III Study (MISTRAL)|Completed||Phase 3|400|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:22:49.281598|2017-10-11 04:22:49.281598
NCT00003216|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-18|||July 1998||1998-07-01|November 2013|2013-11-01||||October 2005|Actual|2005-10-01||Interventional|||Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas|A Phase III Study of Pre and Post Chemoradiation 5-FU vs. Pre and Post Chemoradiation Gemcitabine for Postoperative Adjuvant Treatment of Resected Pancreatic Adenocarcinoma|Completed||Phase 3|518|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:22:49.493557|2017-10-11 04:22:49.493557
NCT00003237|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||March 1998||1998-03-01|January 2010|2010-01-01||||October 2003|Actual|2003-10-01||Interventional|||Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach|Phase II Trial of Post-Operative Adjuvant Paclitaxel + Cisplatin in Patients With Adenocarcinoma of the Esophagus, Gastro-Esophageal Junction or Cardia|Completed||Phase 2|55|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:22:52.462545|2017-10-11 04:22:52.462545
NCT00003217|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||March 1998||1998-03-01|July 2014|2014-07-01|September 2006|Actual|2006-09-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia|A Pilot Study of Dose Intensification of Methotrexate and Cyclophosphamide in Patients With Advanced-Stage (III/IV) Small Non-Cleaved Non-Hodgkins Lymphoma and B-Cell All- A Limited Institution Phase III Pilot Study|Completed||Phase 1|20|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:22:49.757754|2017-10-11 04:22:49.757754
NCT00003219|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-08|||May 1998||1998-05-01|October 2012|2012-10-01|May 1998|Actual|1998-05-01|May 1998|Actual|1998-05-01||Interventional|||Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer|A Phase II Trial of Perillyl Alcohol (NSC 641066) Administered Daily in Patients With Metastatic Breast Cancer|Completed||Phase 2|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:22:49.889384|2017-10-11 04:22:49.889384
NCT00003220|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||February 1998||1998-02-01|April 2013|2013-04-01|June 2001|Actual|2001-06-01|November 2000|Actual|2000-11-01||Interventional|||Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer|Phase II Study of Bryostatin 1 in Patients With Metastatic Colo-Rectal Adenocarcinoma|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:22:49.964465|2017-10-11 04:22:49.964465
NCT00003222|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-12-18|2013-01-22||April 1998||1998-04-01|December 2014|2014-12-01||||September 2003|Actual|2003-09-01||Interventional|||Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma|Phase II Trial for the Evaluation of the Efficacy of Vaccination With Synthetic Melanoma Peptides Either Pulsed on Dendritic Cells, or Administered With GM-CSF-in-Adjuvant, Plus Administration of Sustemic IL-2, in Patients With Advanced Melanoma.|Completed||Phase 2|40|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 04:22:50.098981|2017-10-11 04:22:50.098981
NCT00003223|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-20|||December 1997||1997-12-01|July 2012|2012-07-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth|A Single Arm, Phase II Study to Determine the Safety and Efficacy of 4-HPRN-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia|Terminated||Phase 2|5|Actual|Southwest Oncology Group||1||Closed due to poor accrual.|f||||f||||||||||2017-10-11 04:22:50.583857|2017-10-11 04:22:50.583857
NCT00003224|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-11-18|2013-01-22||February 1996||1996-02-01|November 2014|2014-11-01||||August 2000|Actual|2000-08-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With a Synthetic Melanoma Peptide in Patients With High Risk Melanoma|Completed||Phase 1|22|Actual|University of Virginia||6|||f||||t||||||||||2017-10-11 04:22:50.696709|2017-10-11 04:22:50.696709
NCT00003225|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-09-30|||July 1997||1997-07-01|July 2012|2012-07-01|June 2001|Actual|2001-06-01|March 2000|Actual|2000-03-01||Interventional|||Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer|Phase I/II Trial to Evaluate Ethyol as a Protective Agent for Irinotecan (CPT-11) Toxicities in Patients With Advanced Colorectal Cancer|Completed||Phase 1/Phase 2|23|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 04:22:51.253678|2017-10-11 04:22:51.253678
NCT00003229|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-22|||July 1997||1997-07-01|March 2013|2013-03-01|February 2005|Actual|2005-02-01|April 2000|Actual|2000-04-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal|A Phase I-II Trial of Antigen-Pulsed Autologous Dendritic Cells for Induction of Anti-Tumor Immunity in Patients Completing Lymphadenectomy for Metastatic Melanoma|Completed||Phase 1/Phase 2|||Duke University|||||f||||||||||||||2017-10-11 04:22:51.340245|2017-10-11 04:22:51.340245
NCT00003230|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||January 1998||1998-01-01|May 2012|2012-05-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia|Paclitaxol (Taxol) for Refractory or Relapsed Acute Leukemia in Elderly Patients, and Blast Crisis of Chronic Myelogenous Leukemia: A Multicenter Phase I/II Study|Completed||Phase 1/Phase 2|33|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:22:51.420081|2017-10-11 04:22:51.420081
NCT00003231|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||April 1997||1997-04-01|May 2012|2012-05-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer|Preoperative Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2)|Completed||Phase 2|40|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:22:51.493773|2017-10-11 04:22:51.493773
NCT00003232|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-07|||November 1997||1997-11-01|November 2010|2010-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer|Randomized Placebo-Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone Alone in Patients With Hormone Refractory Metastatic Prostate Cancer and Pain|Completed||Phase 3|204|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:22:51.575153|2017-10-11 04:22:51.575153
NCT00003234|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-25|||May 1998||1998-05-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|March 2006|Actual|2006-03-01||Interventional|||Vinorelbine in Treating Children With Recurrent or Refractory Cancers|A Phase II Study of Navelbine (Vinorelbine) In Children With Recurrent Or Refractory Malignancies|Completed||Phase 2|50|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-10-11 04:22:51.699711|2017-10-11 04:22:51.699711
NCT00003235|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||April 1998||1998-04-01|January 2010|2010-01-01||||August 2006|Actual|2006-08-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed|A Phase III Trial of Induction Paclitaxel and Carboplatin Followed By Standard Radiotherapy (64 Gy/7 Weeks) vs. Hyperfractionated Accelerated Radiotherapy (HART 57.6 Gy/2.5 Weeks) For Patients With Unresectable Stage IIIA and IIIB Non-Small Cell Lung Cancer|Completed||Phase 3|294|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-10-11 04:22:52.30217|2017-10-11 04:22:52.30217
NCT00003236|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||May 1998||1998-05-01|August 2013|2013-08-01||||June 2002|Actual|2002-06-01||Interventional|||Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer|Randomized Phase II Study of Human C-raf Kinase Antisense Oligonucleotide Isis 5132 (CGP 69846A) or Human Pkc-Alpha Antisence Oligonucleotide ISIS 3521 (CGP 64128A) in Women With Previously Treated Matastatic Breast Cancer|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:22:52.390964|2017-10-11 04:22:52.390964
NCT00003238|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-15|||February 1998||1998-02-01|August 2013|2013-08-01||||October 2001|Actual|2001-10-01||Interventional|||Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of Perillyl Alcohol (NSC 641066) Administered Daily In Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:22:52.586999|2017-10-11 04:22:52.586999
NCT00003239|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||March 1998||1998-03-01|July 2012|2012-07-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Alpha Interferon (IFN-A), Low-Dose Cytosine Arabinoside (ARA-C), and Homoharringtonine (HHT)|Completed||Phase 2|90|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:22:52.665028|2017-10-11 04:22:52.665028
NCT00003240|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||October 1995||1995-10-01|May 2007|2007-05-01||||||||Interventional|||Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer|A Major Randomised Trial to Determine the Value of Cisplatin-Based Chemotherapy For All Patients With Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|1800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:52.760891|2017-10-11 04:22:52.760891
NCT00003241|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||May 1998||1998-05-01|April 2000|2000-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors|Phase II Study of Phenylacetate in Pediatric Patients With Central Nervous System Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:52.833273|2017-10-11 04:22:52.833273
NCT00003242|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||February 1998||1998-02-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors|An Open-Label, Non-Randomized Phase I Study of the Protein Kinase C Inhibitor Bryostatin-1 Administered in Combination With Paclitaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:52.908764|2017-10-11 04:22:52.908764
NCT00003243|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-09|||January 1998||1998-01-01|March 2010|2010-03-01||||||||Interventional|||Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer|A Phase I Trial of Combined Chemotherapy and Donor Lymphocyte Infusion for Aggressive Hematologic Malignancies in Relapse After Allogeneic Bone Marrow Transplantation|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:22:52.978234|2017-10-11 04:22:52.978234
NCT00003245|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-05|||February 1998||1998-02-01|October 2012|2012-10-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma|Phase II Study of Irinotecan for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:22:53.0567|2017-10-11 04:22:53.0567
NCT00002663|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-31|||March 1995|Actual|1995-03-01|March 2017|2017-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies|An Evaluation of the Toxicity and Therapeutic Effects of Epstein-Barr Virus-Immune T-Lymphocytes Derived From a Normal HLA-Compatible or Haplotype-Matched Donor in the Treatment of EBV-Associated Lymphoproliferative Diseases or Malignancies and Patients With Detectable Circulating Levels of EBV DNA Who Are at High Risk for EBV-Associated Lymphoproliferative Diseases|Recruiting||Phase 1/Phase 2|84|Anticipated|Atara Biotherapeutics||1|||t||||||||||||||2017-10-11 04:22:53.125781|2017-10-11 04:22:53.125781
NCT00002664|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-10|||July 1995||1995-07-01|July 2017|2017-07-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Interventional|||Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer|PHASE II STUDY OF MONOCLONAL ANTIBODY 17-1A WITH GM-CSF IN TREATMENT OF 5-FU RESISTANT COLORECTAL CANCER|Withdrawn||Phase 2|0|Actual|George Washington University||1||No recruitment|f||||||||||||||2017-10-11 04:22:53.237605|2017-10-11 04:22:53.237605
NCT00002665|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-03-05|||July 1995||1995-07-01|March 2015|2015-03-01|December 2003|Actual|2003-12-01|December 2001|Actual|2001-12-01||Interventional|||SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia|TREATMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: PHASE II TRIALS OF AN INDUCTION REGIMEN INCLUDING PEG-L-ASPARAGINASE, WITH OR WITHOUT PIXY, IN PREVIOUSLY UNTREATED PATIENTS, FOLLOWED BY ALLOGENEIC BONE MARROW TRANSPLANTATION OR FURTHER CHEMOTHERAPY IN FIRST COMPLETE REMISSION|Completed||Phase 2|50|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-10-11 04:22:53.31645|2017-10-11 04:22:53.31645
NCT00002667|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-02-23|||July 1995||1995-07-01|May 2006|2006-05-01||||||||Interventional|||Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer|EARLY DETECTION OF SECOND PRIMARY LUNG CANCERS BY SPUTUM CYTOLOGY IMMUNOSTAINING|Unknown status|Active, not recruiting|N/A|1100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:53.544763|2017-10-11 04:22:53.544763
NCT00002668|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-30|||October 1995||1995-10-01|November 2012|2012-11-01|September 1998|Actual|1998-09-01|September 1998|Actual|1998-09-01||Interventional|||Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer|PATIENT SKILLS FOR CANCER PAIN CONTROL IN PATIENTS WITH METASTATIC BREAST OR PROSTATE CANCER|Terminated||N/A|13|Actual|Eastern Cooperative Oncology Group||2||Slow accrual|f||||f||||||||||2017-10-11 04:22:53.616029|2017-10-11 04:22:53.616029
NCT00002669|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-06-29|||June 1995||1995-06-01|June 2012|2012-06-01||||August 2002|Actual|2002-08-01||Interventional|||Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma|TREATMENT OF METASTATIC MELANOMA WITH DTIC, CDDP AND IFN ALPHA WITH OR WITHOUT IL-2: A RANDOMIZED PHASE III TRIAL|Completed||Phase 2|90|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:53.720054|2017-10-11 04:22:53.720054
NCT00002670|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-23|||September 1995||1995-09-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|July 2002|Actual|2002-07-01||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery|Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy For Resectable High Risk Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|459|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:53.845992|2017-10-11 04:22:53.845992
NCT00002671|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-08|||December 1995||1995-12-01|May 2006|2006-05-01||||February 2001|Actual|2001-02-01||Interventional|||Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer|PHASE II STUDY OF 9-20-S-AMINO-CAMPTOTHECIN (9-AC) AS SECOND LINE THERAPY IN ADVANCED OVARIAN CARCINOMA|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:22:54.066117|2017-10-11 04:22:54.066117
NCT00002673|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-15|||June 1995||1995-06-01|June 2010|2010-06-01|February 2002|Actual|2002-02-01|||||Interventional|||Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation|A PHASE II STUDY OF CELLULAR ADOPTIVE IMMUNOTHERAPY AS PROPHYLAXIS FOR CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:22:54.156496|2017-10-11 04:22:54.156496
NCT00002674|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-31|||October 1994||1994-10-01|March 2010|2010-03-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia|CYTOREDUCTIVE CHEMOTHERAPY WITH MITOXANTRONE, CYTOSINE ARABINOSIDE AND ETOPOSIDE FOLLOWED BY RECOMBINANT HUMAN G-CSF FOR MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:22:54.26817|2017-10-11 04:22:54.26817
NCT00002675|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-26|||May 1995||1995-05-01|June 2013|2013-06-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Chemotherapy in Treating Patients With Retinoblastoma|A TRIAL OF ADJUVANT CHEMOTHERAPY IN PATIENTS WITH INTRAOCULAR RETINOBLASTOMA|Completed||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:54.336448|2017-10-11 04:22:54.336448
NCT00002676|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||July 1995||1995-07-01|July 2016|2016-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma|PHASE II TRIAL OF CHEMOTHERAPY PLUS RADIOTHERAPY FOR MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM NON-HODGKIN'S LYMPHOMA (PCNSL)|Completed||Phase 2|36|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:22:54.40359|2017-10-11 04:22:54.40359
NCT00002677|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-28|||August 1995|Actual|1995-08-01|March 2017|2017-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors|PHASE I STUDY OF THE ORALLY ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS|Completed||Phase 1|24|Actual|University of Maryland||1|||f||||||||||||||2017-10-11 04:22:54.549443|2017-10-11 04:22:54.549443
NCT00002678|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||May 1995||1995-05-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Multiple Myeloma|A COMPARATIVE STUDY OF DEXAMETHASONE VERSUS PREDNISONE (BOTH IN COMBINATION WITH MELPHALAN) AS INDUCTION THERAPY IN UNTREATED SYMPTOMATIC MYELOMA WITH AN ADDITIONAL ASSESSMENT OF DEXAMETHASONE VERSUS NO ADDITIONAL TREATMENT AS MAINTENANCE THERAPY IN NON-PROGRESSING PATIENTS|Completed||Phase 3|595|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:22:54.637588|2017-10-11 04:22:54.637588
NCT00002679|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-08-24|||February 1994||1994-02-01|August 2009|2009-08-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer|Sequential Adjuvant Chemotherapy With Doxorubicin, Taxol, and Cyclophosphamide for Stage II or III Resectable Breast Cancer With Four or More Involved Axillary Lymph Nodes|Completed||Phase 2|89|Actual|Yale University|||||f||||f||||||||||2017-10-11 04:22:54.810714|2017-10-11 04:22:54.810714
NCT00002680|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-23|||February 1994||1994-02-01|August 2009|2009-08-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer|Phase II Trial of Sequential High-Dose Alkylating Agents in Metastatic Breast Cancer|Completed||Phase 2|40|Actual|Yale University|||||f||||f||||||||||2017-10-11 04:22:54.880818|2017-10-11 04:22:54.880818
NCT00002681|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-06-09|||July 1995||1995-07-01|June 2011|2011-06-01|December 2003|Actual|2003-12-01|September 2003|Actual|2003-09-01||Interventional|||Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma|Humanized Anti-Tac Antibody Therapy In Hodgkin's Disease, A Phase Ib/II Trial|Completed||Phase 1/Phase 2|25|Anticipated|Roger Williams Medical Center|||||f||||||||||||||2017-10-11 04:22:54.967679|2017-10-11 04:22:54.967679
NCT00002682|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||August 1995||1995-08-01|July 2012|2012-07-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach|CURRENT PRACTICE STUDY OF ANTIBIOTIC TREATMENT OF GASTRIC MALT LYMPHOMA|Completed||Phase 2|5|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:22:55.053451|2017-10-11 04:22:55.053451
NCT00002684|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-02|||May 1995||1995-05-01|July 2013|2013-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer|Phase II Trial of Paclitaxel, Cisplatin and Ifosfamide in Patients With Advanced Urothelial Tumors|Completed||Phase 2|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:55.159454|2017-10-11 04:22:55.159454
NCT00002687|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-30|||February 1995||1995-02-01|November 2012|2012-11-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Interleukin-2 in Treating Patients With Mycosis Fungoides|Phase 1 Trial of Subcutaneous [SC]; Outpatient Interleukin-2 for Patients With Advanced Mycosis Fungoides [Stage IIb, III, IV]|Completed||Phase 1|30|Anticipated|University of Washington|||||f||||||||||||||2017-10-11 04:22:55.235841|2017-10-11 04:22:55.235841
NCT00002688|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||February 1995||1995-02-01|May 2007|2007-05-01||||||||Interventional|||Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|AML-MVPCYA: ADDITION OF CYCLOSPORIN A TO THE COMBINATION OF MITOXANTRONE AND ETOPOSIDE (VP 16,213) TO OVERCOME RESISTANCE TO CHEMOTHERAPY IN REFRACTORY AML: A RANDOMIZED PHASE II STUDY|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:55.311396|2017-10-11 04:22:55.311396
NCT00002689|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-17|||September 1995||1995-09-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer|Phase II Interstitial Colloidal 32P Integrated in The Treatment of Non-Resectable Pancreatic Cancer|Completed||Phase 2|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:55.404423|2017-10-11 04:22:55.404423
NCT00002691|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||August 1995||1995-08-01|June 2013|2013-06-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma|LSA5 PROTOCOL FOR THE TREATMENT OF ADVANCED PEDIATRIC AND ADOLESCENT NON-HODGKIN'S LYMPHOMA (NHL)|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:55.470809|2017-10-11 04:22:55.470809
NCT00002692|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||December 1994||1994-12-01|May 2007|2007-05-01||||||||Interventional|||Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver|A RANDOMISED TRIAL OF INTRAVENOUS VERSUS INTRAHEPATIC ARTERIAL 5-FU AND LEUCOVORIN FOR COLORECTAL LIVER METASTASES|Unknown status|Active, not recruiting|Phase 3|312|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:55.537086|2017-10-11 04:22:55.537086
NCT00002693|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-08-02|||October 1995||1995-10-01|August 2011|2011-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia|PHASE I STUDY OF CONTINUOUS INFUSION CARBOPLATIN AND TOPOTECAN IN THE TREATMENT OF RELAPSED ACUTE LEUKEMIA AND BLAST CRISIS CHRONIC MYELOGENOUS LEUKEMIA|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:22:55.615578|2017-10-11 04:22:55.615578
NCT00002695|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-05-18|||January 17, 1996|Actual|1996-01-17|May 2017|2017-05-01|May 27, 2011|Actual|2011-05-27|October 18, 2002|Actual|2002-10-18||Observational|||Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck|CLINICAL EFFICACY OF MOLECULAR ANALYSIS OF SURGICAL MARGINS AND REGIONAL LYMPH NODES IN MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA|Completed||N/A|530|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:22:55.677556|2017-10-11 04:22:55.677556
NCT00002696|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-01|||October 1995||1995-10-01|April 2008|2008-04-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Stage III Breast Cancer|MULTIMODALITY TREATMENT STRATEGY FOR STAGE III BREAST CANCER|Suspended||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:55.780521|2017-10-11 04:22:55.780521
NCT00002697|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||September 1995||1995-09-01|July 2013|2013-07-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma|HIGH DOSE CHEMORADIOTHERAPY WITH PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION FOR PATIENTS WITH PRIMARY REFRACTORY, RELAPSED AND POOR PROGNOSIS NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:55.858307|2017-10-11 04:22:55.858307
NCT00002700|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-11|||August 1995||1995-08-01|June 2013|2013-06-01||||March 2004|Actual|2004-03-01||Interventional|||Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia|A RANDOMIZED PHASE III TRIAL COMPARING DEXAMETHASONE WITH PREDNISONE IN INDUCTION TREATMENT AND BONE MARROW TRANSPLANTATION WITH INTENSIVE MAINTENANCE TREATMENT IN ADOLESCENT AND ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL-4)|Completed||Phase 3|392|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:22:55.928739|2017-10-11 04:22:55.928739
NCT00002701|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||October 1995||1995-10-01|November 2006|2006-11-01||||||||Interventional|||Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia|INDUCTION WITH ALL-TRANS RETINOIC ACID IN COMBINATION WITH IDARUBICIN AND INTENSIVE CONSOLIDATION FOLLOWED BY BONE MARROW TRANSPLANTATION OR A RANDOMIZED MAINTENANCE TREATMENT DEPENDING UPON THE AMOUNT OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:56.143602|2017-10-11 04:22:56.143602
NCT00002702|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-23|||September 1992||1992-09-01|February 2011|2011-02-01||||||||Interventional|||Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx|Multicentre Randomised Trial of Inductive and Adjuvant Perilymphatically Injected Proleukin (rlL-2) in The Treatment of Operable Primary Squamous Cell Carcinoma of The Oral Cavity and Oropharynx|Unknown status|Recruiting|Phase 3|260|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:56.328946|2017-10-11 04:22:56.328946
NCT00002703|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||January 1996||1996-01-01|April 2012|2012-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer|A PHASE III TRIAL EMPLOYING CONFORMAL PHOTONS WITH PROTON BOOST IN EARLY STAGE PROSTATE CANCER: CONVENTIONAL DOSE COMPARED TO HIGH DOSE IRRADIATION|Completed||Phase 3|390|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:56.42532|2017-10-11 04:22:56.42532
NCT00002704|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-31|||January 1996||1996-01-01|November 2007|2007-11-01||||June 2004|Actual|2004-06-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia|TREATMENT OF ISOLATED CNS RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA -- A PEDIATRIC ONCOLOGY GROUP-WIDE PHASE II STUDY|Completed||Phase 2|156|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:57.849731|2017-10-11 04:22:57.849731
NCT00002705|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-31|||April 1996||1996-04-01|May 2001|2001-05-01||||January 2001|Actual|2001-01-01||Interventional|||Topotecan in Treating Children With Refractory Leukemia|TOPOTECAN FOR CHILDREN WITH REFRACTORY LEUKEMIA, A PEDIATRIC ONCOLOGY GROUP PHASE I COOPERATIVE AGREEMENT STUDY|Completed||Phase 1|3|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:22:58.092072|2017-10-11 04:22:58.092072
NCT00002706|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-05-27|||April 1996||1996-04-01|May 2015|2015-05-01||||March 2010|Actual|2010-03-01||Interventional|||Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus|A Phase III Randomized Clinical Trial of Laparoscopic Pelvic and Para-Aortic Node Sampling With Vaginal Hysterectomy and BSO Versus Open Laparotomy With Pelvic and Para-Aortic Node Sampling and Abdominal Hysterectomy and BSO in Endometrial Adenocarcinoma and Uterine Sarcoma, Clinical Stage I, IIA, Grade I, II, III|Completed||Phase 3|2616|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-10-11 04:22:58.206179|2017-10-11 04:22:58.206179
NCT00002707|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-02-02|||December 1995||1995-12-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|June 2002|Actual|2002-06-01||Interventional|||Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed|A RANDOMIZED TRIAL COMPARING PREOPERATIVE DOXORUBICIN (ADRIAMYCIN)/CYCLOPHOSPHAMIDE (AC) TO PREOPERATIVE AC FOLLOWED BY PREOPERATIVE DOCETAXEL (TAXOTERE) AND TO PREOPERATIVE AC FOLLOWED BY POSTOPERATIVE DOCETAXEL IN PATIENTS WITH OPERABLE CARCINOMA OF THE BREAST|Completed||Phase 3|2411|Actual|NSABP Foundation Inc||3|||f||||t||||||||||2017-10-11 04:22:58.298728|2017-10-11 04:22:58.298728
NCT00002708|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-18|||January 1996||1996-01-01|November 2013|2013-11-01|December 2004|Actual|2004-12-01|January 2002|Actual|2002-01-01||Interventional|||Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases|A PHASE III TRIAL COMPARING WHOLE BRAIN IRRADIATION WITH VERSUS WITHOUT STEREOTACTIC RADIOSURGERY BOOST FOR PATIENTS WITH ONE TO THREE UNRESECTED BRAIN METASTASES|Completed||Phase 3|333|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:22:58.806417|2017-10-11 04:22:58.806417
NCT00002711|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||October 1995||1995-10-01|July 2013|2013-07-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus|A PHASE I TRIAL OF COMBINED MODALITY THERAPY FOR LOCALIZED ESOPHAGEAL CANCER: CISPLATIN-PACLITAXEL FOLLOWED BY RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ESCALATING DOSES OF PACLITAXEL|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:22:59.449883|2017-10-11 04:22:59.449883
NCT00002714|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-14|||April 1995||1995-04-01|September 2001|2001-09-01|September 2001|Actual|2001-09-01|||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease|A PHASE II TRIAL OF EIGHT-WEEK STANFORD V CHEMOTHERAPY PLUS MODIFIED INVOLVED FIELD RADIOTHERAPY IN FAVORABLE, LIMITED STAGE HODGKIN'S DISEASE|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:59.529066|2017-10-11 04:22:59.529066
NCT00002715|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-07-01|||April 1989||1989-04-01|June 2009|2009-06-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma|A PHASE II PILOT STUDY OF SHORT TERM (12 WEEK) COMBINATION CHEMOTHERAPY (STANFORD V) IN UNFAVORABLE HODGKIN'S DISEASE|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:22:59.615874|2017-10-11 04:22:59.615874
NCT00002716|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||January 1996||1996-01-01|July 2016|2016-07-01|August 2006|Actual|2006-08-01|March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer|PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER|Completed||Phase 3|135|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:22:59.701238|2017-10-11 04:22:59.701238
NCT00002717|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-24|||March 1996||1996-03-01|January 2010|2010-01-01||||October 2007|Actual|2007-10-01||Interventional|||Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer|A Phase III Randomized Trial of Cisplatin (NSC #119875) With Paclitaxel (NSC #125973) Administered by Either 24 Hour Infusion or 96 Hour Infusion in Patients With Selected Stage III and Stage IV Epithelial Ovarian Cancer and Primary Peritoneal Carcinoma|Completed||Phase 3|324|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:22:59.831154|2017-10-11 04:22:59.831154
NCT00002718|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-12-21|||November 1995||1995-11-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|January 2004|Actual|2004-01-01||Interventional|||T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia|A Phase II Trial of T-Cell Depleted Marrow Grafts Combined With Infusions of G-CSF Stimulated, CD34 Ceprate Stem Cell Column Selected, E-Rosette Depleted Peripheral Blood Progenitor Cells Derived From HLA Haplotype Matched Related Donors for Patients With Leukemia Lacking an HLA-Matched Related or Unrelated Donor|Completed||Phase 2|31|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:22:59.982694|2017-10-11 04:22:59.982694
NCT00002719|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||December 1995||1995-12-01|June 2012|2012-06-01||||November 2001|Actual|2001-11-01||Interventional|||Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia|RANDOMIZED PHASE III STUDY TO EVALUATE THE VALUE OF rHuG-CSF IN INDUCTION AND OF AN ORAL SCHEDULE AS CONSOLIDATION TREATMENT IN ELDERLY PATIENTS WITH ACUTE MYELOGENOUS LEUMEKIA (AML-13 PROTOCOL)|Completed||Phase 3|500|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:23:00.095977|2017-10-11 04:23:00.095977
NCT00002720|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||December 1995||1995-12-01|August 2000|2000-08-01|December 2012|Actual|2012-12-01|||||Interventional|||Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer|QUADRANTECTOMY PLUS AXILLARY DISSECTION VERSUS QUADRANTECTOMY ALONE IN MAMMOGRAPHIC STAGE T1N0 BREAST CANCER PATIENTS AGED OVER 65 YEARS|Completed||Phase 3|642|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:00.17067|2017-10-11 04:23:00.17067
NCT00002721|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||March 1995||1995-03-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer|A PHASE I TRIAL OF ESTRAMUSTINE PHOSPHATE AND DOXORUBICIN IN HORMONE REFRACTORY METASTATIC PROSTATE CANCER|Completed||Phase 1|18|Actual|University of New Mexico||1|||f||||f||||||||||2017-10-11 04:23:00.222449|2017-10-11 04:23:00.222449
NCT00002722|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-02|||January 1996||1996-01-01|March 2012|2012-03-01||||August 1999|Actual|1999-08-01||Interventional|||High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer|RANDOMIZED PHASE II STUDY OF A WEEKLY 24H-INFUSION OF HIGH-DOSE 5-FU PLUS OR MINUS FOLINIC ACID (HD-FU/FA) VERSUS HD-FU/FA PLUS BIWEEKLY CISPLATIN VERSUS FAMTX (5-FU/ADRIAMYCIN/METHOTREXATE) IN ADVANCED GASTRIC CANCER, AN EORTC/AIO INTERGROUP TRIAL|Completed||Phase 2|135|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:23:00.290588|2017-10-11 04:23:00.290588
NCT00002723|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-27|||January 1996||1996-01-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|August 2002|Actual|2002-08-01||Interventional|||Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer|A PHASE III STUDY OF THREE DIFFERENT DOSES OF SURAMIN (NSC #34936) ADMINISTERED WITH A FIXED DOSING SCHEDULE IN PATIENTS WITH ADVANCED PROSTATE CANCER|Completed||Phase 3|390|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-10-11 04:23:00.3597|2017-10-11 04:23:00.3597
NCT00002725|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||August 1996||1996-08-01|October 2000|2000-10-01||||April 2000|Actual|2000-04-01||Interventional|||Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma|PHASE II EVALUATION OF BRYOSTATIN-1 (NSC 339555) IN NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:00.625881|2017-10-11 04:23:00.625881
NCT00002727|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-30|||April 1996||1996-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2005|Actual|2005-10-01||Interventional|||Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord|A RANDOMIZED STUDY OF HYPERFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN T2 SQUAMOUS CELL CARCINOMA OF THE VOCAL CORD|Completed||Phase 3|250|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:23:00.751847|2017-10-11 04:23:00.751847
NCT00002733|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-05-10|||January 1996||1996-01-01|May 2011|2011-05-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Biological Therapy in Treating Patients With Metastatic Cancer|ALPHA INTERFERON, TUMOR INFILTRATING LYMPHOCYTES, AND INTERLEUKIN-2 IN THE TREATMENT OF CANCER|Completed||Phase 2|30|Anticipated|Hoag Memorial Hospital Presbyterian|||||f||||||||||||||2017-10-11 04:23:01.48705|2017-10-11 04:23:01.48705
NCT00002734|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||March 1996||1996-03-01|February 2001|2001-02-01||||April 2001|Actual|2001-04-01||Interventional|||Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer|PHASE I STUDY OF INTERFERON ENHANCED INTRAPERITONEAL RADIOIMMUNO-CHEMOTHERAPY FOR OVARIAN CANCER|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:01.564013|2017-10-11 04:23:01.564013
NCT00002735|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-09-28|||April 1996||1996-04-01|September 2015|2015-09-01|March 2005|Actual|2005-03-01|April 2004|Actual|2004-04-01||Interventional|||SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue|Induction Chemotherapy Followed By Chemoradiation For Organ Preservation In Patients With Advanced Resectable Cancer Of The Hypopharynx And Base Of Tongue, Phase II|Terminated||Phase 2|68|Actual|Southwest Oncology Group||1||Terminated due to poor accrual.|f||||t||||||||||2017-10-11 04:23:01.647795|2017-10-11 04:23:01.647795
NCT00002737|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||March 1996||1996-03-01|July 2012|2012-07-01||||January 2001|Actual|2001-01-01||Interventional|||Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer|A RANDOMIZED PHASE II TRIAL OF INTERFERON ALPHA-2A WITH AND WITHOUT 13-CIS RETINOIC ACID IN PATIENTS WITH PROGRESSIVE MEASURABLE METASTATIC RENAL CELL CARCINOMA. Amendment Protocol: Extension to a Randomized Phase III Trial|Completed||Phase 3|320|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:23:01.759598|2017-10-11 04:23:01.759598
NCT00002738|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-06|||January 1996||1996-01-01|March 2013|2013-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma|Phase II Trial of Trimetrexate and Leucovorin in The Treatment of Recurrent Childhood Acute Lymphoblastic Leukemia|Completed||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:01.858033|2017-10-11 04:23:01.858033
NCT00002740|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||May 1996||1996-05-01|July 2014|2014-07-01|September 2005|Actual|2005-09-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma|Phase I Pilot Study of Multiple Cycles of High Dose Chemotherapy With Peripheral Blood Stem Cell Infusions In Advanced Stage Neuroblastoma|Completed||Phase 1|30|Anticipated|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:02.014773|2017-10-11 04:23:02.014773
NCT00002742|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-25|||January 1996||1996-01-01|July 2007|2007-07-01|September 2007|Actual|2007-09-01|||||Interventional|||Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer|A PROSPECTIVE RANDOMIZED, DOUBLE-BLIND, COMPARATIVE, MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF NYSTATIN AND AMPHOTERICIN B FOR EMPIRIC ANTIFUNGAL TREATMENT IN NEUTROPENIC PATIENTS|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:02.21519|2017-10-11 04:23:02.21519
NCT00002744|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-02-07|||May 1996||1996-05-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia|Randomized Comparisons of Oral Mercaptopurine vs Oral Thioguanine and IT Methotrexate vs ITT for Standard Risk Acute Lymphoblastic Leukemia|Completed||Phase 3|1970|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:23:02.475155|2017-10-11 04:23:02.475155
NCT00003248|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|||March 1998||1998-03-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|April 2003|Actual|2003-04-01||Interventional|||Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia|A Randomized Phase II Study of Concurrent Fludarabine + Chimeric Anti-CD20 Monoclonal Antibody IDEC-C2B8 (Rituximab) [NSC# 687451] Induction Followed By Rituximab Consolidation In Untreated Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|104|Actual|Alliance for Clinical Trials in Oncology||2|||f||||||||||||||2017-10-11 04:23:02.769146|2017-10-11 04:23:02.769146
NCT00003249|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-06|||May 1998||1998-05-01|February 2013|2013-02-01||||December 2001|Actual|2001-12-01||Interventional|||Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers|A Phase I Investigation of Carboxyamido-triazole (CAI) Modulated by Ketoconozole In Patients With Advanced Malignancies|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:02.934577|2017-10-11 04:23:02.934577
NCT00003250|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-04-09|||May 1998||1998-05-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Fenretinide in Treating Patients With Solid Tumors|Phase I Evaluation of Fenretinide (NSC# 374551)|Completed||Phase 1|31|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 04:23:03.002675|2017-10-11 04:23:03.002675
NCT00003251|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||December 1997||1997-12-01|June 2000|2000-06-01||||||||Interventional|||Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer|A Pilot Study of Amifostine and Concomitant Cisplatin, Paclitaxel and Radiotherapy in Previously Irradiated, Recurrent Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|46|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:03.061037|2017-10-11 04:23:03.061037
NCT00003252|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-25|||December 1997||1997-12-01|April 2000|2000-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy|A Phase IV Open Label Study of the Effects of a Five Minute Infusion Time for Ethyol (Amifostine) in Patients Undergoing Chemotherapy|Completed||Phase 4|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:03.136404|2017-10-11 04:23:03.136404
NCT00003253|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||July 1997||1997-07-01|May 2006|2006-05-01||||||||Interventional|||Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer|Assessment of the Predictive Value of the Extreme Drug Resistance (EDR) Assay in Patients Receiving Paclitaxel for Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:03.190237|2017-10-11 04:23:03.190237
NCT00003254|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-06|||April 1998||1998-04-01|March 2012|2012-03-01|October 2003|Actual|2003-10-01|November 2002|Actual|2002-11-01||Interventional|||SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil|A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer|Completed||Phase 2|75|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:23:03.272594|2017-10-11 04:23:03.272594
NCT00003255|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-11|||November 1999||1999-11-01|July 2016|2016-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia|Phase II Study of Continuous Infusion Carboplatin and Topotecan in the Treamtment of Relapsed Acute Myelogenous Leukemia (AML)|Completed||Phase 2|38|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:03.668281|2017-10-11 04:23:03.668281
NCT00003256|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||May 1998||1998-05-01|January 2013|2013-01-01|April 2004|Actual|2004-04-01|July 2002|Actual|2002-07-01||Interventional|||Flavopiridol in Treating Patients With Recurrent Prostate Cancer|A Phase II Trial of Flavopiridol in Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:03.741104|2017-10-11 04:23:03.741104
NCT00003257|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||January 1998||1998-01-01|April 2000|2000-04-01||||||||Interventional|||Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer|A Phase II, Multicenter, Open Label Study to Evaluate Effectiveness and Safety of AdCMV-p53 Administered by Intra-Tumoral Injections in 39 Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Unknown status|Active, not recruiting|Phase 2|39|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:03.81474|2017-10-11 04:23:03.81474
NCT00003259|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||October 1997||1997-10-01|May 2012|2012-05-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Vinorelbine in Treating Patients With Metastatic Prostate Cancer|Master Protocol for Metastatic Hormone-Resistant Prostatic Carcinoma Phase II Trials Protocol 4: Vinorelbine|Completed||Phase 2|40|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:23:03.888309|2017-10-11 04:23:03.888309
NCT00003260|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-01-10|||January 1998||1998-01-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer|Multicentre Phase III Comparing To Therapeutic Sequence: Folfiri Following of Folfox6 (Group A) and Folfox6 Following Of (Group B) For Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|109|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:03.96805|2017-10-11 04:23:03.96805
NCT00003261|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||May 1997||1997-05-01|October 2001|2001-10-01||||||||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma|Treatment of HIV-Related Primary Central Nervous System Lymphoma (HIV-PCNSL): A Phase II Trial With Neoadjuvant Chemotherapy (High-Dose Methotrexate (MTX) Plus High-Dose Zidovudine) and Radiotherapy|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:04.038524|2017-10-11 04:23:04.038524
NCT00003262|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||May 1997||1997-05-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection|"Prospective Non Randomized Study With Chemotherapy in Patients With Hodgkin's Disease and HIV Infection: Stanford V Regimen For Low Risk Patients, EBVP Regimen For High Risk Patients"|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:04.176234|2017-10-11 04:23:04.176234
NCT00003263|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-16|||August 1996||1996-08-01|April 2013|2013-04-01|November 2000|Actual|2000-11-01|December 1999|Actual|1999-12-01||Interventional|||Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma|Phase I Combined Modality Protocol for Malignant Mesothelioma: Cisplatin & rIFN-alpha-2b Followed by Surgical Resection (Debulking), and Post-Op Concurrent Chemoradiotherapy With Cisplatin, +/- rIFN-alpha-2b|Completed||Phase 1|6|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-10-11 04:23:04.259939|2017-10-11 04:23:04.259939
NCT00003264|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-16|||October 1997||1997-10-01|April 2013|2013-04-01|June 2002|Actual|2002-06-01|February 2002|Actual|2002-02-01||Interventional|||Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer|Phase II Evaluation of Weekly Cisplatin and Gemcitabine in the Treatment of Advanced (Recurrent or Metastatic) Carcinoma of the Head and Neck|Completed||Phase 2|22|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-10-11 04:23:04.339556|2017-10-11 04:23:04.339556
NCT00003266|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-06|||June 1999||1999-06-01|March 2008|2008-03-01||||May 2002|Actual|2002-05-01||Interventional|||Methylphenidate in Treating Patients With Melanoma|Double-Blind Randomized Trial of Methylphenidate for Alleviation of Fatigue and Lethargy Associated With Interferon Alpha 2b|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:04.446397|2017-10-11 04:23:04.446397
NCT00003267|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||February 1998||1998-02-01|July 2012|2012-07-01||||July 2000|Actual|2000-07-01||Interventional|||Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer|A Randomized Phase III Trial for Evaluation of Usefulness of Pelvic Drains After Radical Hysterectomy and Node Dissection (RHND)|Completed||Phase 3|214|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:23:04.611706|2017-10-11 04:23:04.611706
NCT00003268|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-01|||January 1998||1998-01-01|October 2003|2003-10-01|December 2003|Actual|2003-12-01|||||Interventional|||Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase I Study of Cytosine Arabinoside, Idarubicin, and Amifostine as Induction Therapy for Patients With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:04.726667|2017-10-11 04:23:04.726667
NCT00003269|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-01-06|||February 1998||1998-02-01|January 2011|2011-01-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors|A Phase II, Open-Label, Trial Evaluating the Efficacy of Amifostine in Patients With Cancers Receiving Outpatient Dose-intensive Cyclophosphamide, Etoposide, and Cisplatin (DICEP) Chemotherapy|Completed||Phase 2|20|Actual|Scripps Health||1|||f||||f||||||||||2017-10-11 04:23:04.799293|2017-10-11 04:23:04.799293
NCT00003270|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-04-24|||September 4, 1997|Actual|1997-09-04|April 2017|2017-04-01|October 1, 2018|Anticipated|2018-10-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer|Cord Blood Transplantation for Hematologic Malignancies and Bone Marrow Failure Syndromes|Active, not recruiting||Phase 2|20|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:23:04.937019|2017-10-11 04:23:04.937019
NCT00003365|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-01-26|||August 1996||1996-08-01|January 2011|2011-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Sulindac and Plant Compounds in Preventing Colon Cancer|The Effect of Plant Phenolic Compounds on Human Colon Epithelial Cells|Terminated||N/A|||Rutgers, The State University of New Jersey||||Study completed|f||||f||||||||||2017-10-11 04:23:06.781025|2017-10-11 04:23:06.781025
NCT00003273|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-11-30|||November 1997||1997-11-01|November 2015|2015-11-01||||||||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor|Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa, Etoposide and Carboplatin) and Autologous Stem Cell Rescue|Withdrawn||Phase 2|0|Actual|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:23:05.082701|2017-10-11 04:23:05.082701
NCT00003274|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||March 1998||1998-03-01|May 2014|2014-05-01|November 2002|Actual|2002-11-01|September 2001|Actual|2001-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery|A Randomized Phase II Trial of a Vaccine Combining Tyrosinase /gp100 Peptides Emulsified With Montanide ISA 51 Alone or With a Block Co-Polymer CRL 1005 or With GM-CSF for Patients With Resected Stages IIA and IIB Melanoma Grant Application Title: MART-1/gp100 Immune Responses to a Melanoma Vaccine|Completed||Phase 2|48|Actual|University of Southern California|||||f||||t||||||||||2017-10-11 04:23:05.198715|2017-10-11 04:23:05.198715
NCT00003276|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||March 1998||1998-03-01|July 2016|2016-07-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer|A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors|Completed||Phase 2|40|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:05.271453|2017-10-11 04:23:05.271453
NCT00003278|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||March 1998||1998-03-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma|Primary Central Nervous System Non-Hodgkins's Lymphoma (PCNSL): A Phase II Clinical Trial of Radiation Therapy and High Dose Corticosteroids for Elderly Patients (70 Years of Age and Older)|Completed||Phase 2|28|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:05.422418|2017-10-11 04:23:05.422418
NCT00003279|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-05|||March 1998||1998-03-01|March 2012|2012-03-01||||January 2000|Actual|2000-01-01||Interventional|SILVA||Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG|Completed||Phase 3|500|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:23:05.531583|2017-10-11 04:23:05.531583
NCT00003353|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||July 1998||1998-07-01|August 2013|2013-08-01||||December 2002|Actual|2002-12-01||Interventional|||High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis|A Phase II Study of High-Dose Melphalan With Hematopoietic Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:23:05.730184|2017-10-11 04:23:05.730184
NCT00003354|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||July 1996||1996-07-01|January 2001|2001-01-01|December 2009|Actual|2009-12-01|||||Interventional|||Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer|Conventional Versus Laparoscopic-Assisted Surgery in Colorectal Cancer|Completed||Phase 3|1200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:05.844726|2017-10-11 04:23:05.844726
NCT00003356|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-10-14|||November 1997||1997-11-01|October 2013|2013-10-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma|A Phase II Study of Rituxan and IL-2 in Patients With Low Grade or Follicular B-Cell Lymphoma|Completed||Phase 1/Phase 2|58|Anticipated|University of Rochester|||||f||||||||||||||2017-10-11 04:23:06.144645|2017-10-11 04:23:06.144645
NCT00003357|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-12-11|||January 1998||1998-01-01|December 2012|2012-12-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease|Vaccination of High Risk Breast Cancer Patients Lacking Identifiable Disease With GM2-KLH Conjugate Plus the Immunological Adjuvant QS21|Completed||Phase 1|9|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:06.235046|2017-10-11 04:23:06.235046
NCT00003358|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-15|||January 1998||1998-01-01|January 2013|2013-01-01||||January 2001|Actual|2001-01-01||Interventional|||Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|Phase I Trial Intraperitoneal Cisplatin With Intraperitoneal Gemcitabine in Patients With Epithelial Ovarian Carcinoma|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:06.309311|2017-10-11 04:23:06.309311
NCT00003359|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||T138067 Sodium in Treating Patients With Advanced Refractory Cancer|Phase I Dose Escalation Study to Evaluate the Safety of T138067-Sodium in Patients With Advanced Refractory Cancer|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:06.405469|2017-10-11 04:23:06.405469
NCT00003360|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-15|||April 1998||1998-04-01|January 2013|2013-01-01||||August 2000|Actual|2000-08-01||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer|Phase I Study of 131I-Labeled Humanized Antibody A33 in Patients With Advanced Colorectal Carcinoma|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:06.465317|2017-10-11 04:23:06.465317
NCT00003361|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||April 1998||1998-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|September 2003|Actual|2003-09-01||Interventional|||Decitabine in Treating Patients With Myelodysplastic Syndrome|Phase II Study With Decitabine (5-aza-2'-Deoxycytidine, DAC) in Myelodysplastic Syndromes|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:06.541748|2017-10-11 04:23:06.541748
NCT00003362|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||May 1998||1998-05-01|June 2013|2013-06-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma|Pilot Trial of Multi-Epitope Melanoma Peptide Vaccine Using GM-CSF, Montanide and QS-21 as Adjuvants|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:06.630139|2017-10-11 04:23:06.630139
NCT00003364|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||January 1993||1993-01-01|May 2007|2007-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer|A Randomised Study of Timing of Thoracic Irradiation in Small Cell Lung Cancer (Study 8)|Completed||Phase 3|398|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:06.695183|2017-10-11 04:23:06.695183
NCT00003367|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Diet and PSA Levels in Patients With Prostate Cancer|The Effect of a Low Fat Diet, High in Soy, Fruits, Vegetables, Green Tea, Vitamin E and Fiber on the PSA in Patients With Prostate Cancer|Completed||Phase 3|154|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:06.851865|2017-10-11 04:23:06.851865
NCT00003368|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-19|||June 1998||1998-06-01|July 2006|2006-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis|Phase I Study of Irinotecan for Patients With Abnormal Liver or Renal Function or With Prior Pelvic Radiation Therapy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:06.983302|2017-10-11 04:23:06.983302
NCT00003369|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-13|||August 1998||1998-08-01|June 2012|2012-06-01|July 2004|Actual|2004-07-01|October 2003|Actual|2003-10-01||Interventional|||S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer|Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer|Completed||Phase 2|56|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:23:07.222651|2017-10-11 04:23:07.222651
NCT00003370|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||August 1998||1998-08-01|May 2006|2006-05-01||||March 2006|Actual|2006-03-01||Interventional|||Irofulven in Treating Children With Recurrent or Refractory Solid Tumors|A Trial of MGI 114 in Children With Solid Tumors: A Pediatric Oncology Group Phase I Cooperative Agreement Study|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:07.512561|2017-10-11 04:23:07.512561
NCT00003372|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-07|||December 1997||1997-12-01|November 2010|2010-11-01|December 2009||2009-12-01|||||Interventional|||Topotecan in Treating Patients With Recurrent Brain Tumors|A Phase II Study of Topotecan in Patients With Anaplastic Oligodendroglioma or Anaplastic Mixed Oligoastrocytoma|Completed||Phase 2|30|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:23:07.721764|2017-10-11 04:23:07.721764
NCT00003375|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-09-28|||October 1998||1998-10-01|September 2016|2016-09-01||||August 2005|Actual|2005-08-01||Interventional|||Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma|A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase II Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma|Active, not recruiting||Phase 2/Phase 3|370|Actual|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-10-11 04:23:07.818358|2017-10-11 04:23:07.818358
NCT00003376|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||September 1998||1998-09-01|January 2010|2010-01-01||||September 2005|Actual|2005-09-01||Interventional|||Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium|Phase III Trial of Methotrexate, Vinblastine, Doxorubicin and Cisplatin vs Carboplatin and Paclitaxel in Advanced Carcinoma of the Urothelium|Completed||Phase 3|330|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-10-11 04:23:07.946676|2017-10-11 04:23:07.946676
NCT00003377|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-12-27|2012-11-23||November 1999||1999-11-01|December 2012|2012-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix|A Phase I Study of Extended Field Radiation Therapy With Concomitant Paclitaxel and Cisplatin Chemotherapy in Patients Cervical Carcinoma Metastatic to the Para-Aortic Lymph Nodes|Completed||Phase 1|29|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:08.167655|2017-10-11 04:23:08.167655
NCT00003378|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-08|||August 1998||1998-08-01|December 2011|2011-12-01||||February 2000|Actual|2000-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer|A Phase I Feasibility Trial of Carboplatin, Paclitaxel, and Gemcitabine in Patients With Previously Untreated Epithelial Ovarian Carcinoma and Primary Peritoneal Carcinoma|Terminated||Phase 1|45|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:23:09.039263|2017-10-11 04:23:09.039263
NCT00003379|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-24|||November 1999||1999-11-01|November 2004|2004-11-01||||January 2007|Actual|2007-01-01||Interventional|||Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer|A Phase I/II Study Of Whole Pelvic Radiation Therapy With Concomitant Paclitaxel and Cisplatin Chemotherapy in Patients With Cervical Carcinoma (Stages I-IV) Limited to the Pelvis|Completed||Phase 1/Phase 2|40|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:23:09.206206|2017-10-11 04:23:09.206206
NCT00003380|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-07|||May 1998||1998-05-01|October 2002|2002-10-01||||July 2002|Actual|2002-07-01||Interventional|||Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer|A Phase I Study of Liposomal Doxorubicin (Doxil) and Prolonged Etoposide As Second Line Therapy in Ovarian, Tubal and Peritoneal Carcinoma|Terminated||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:23:09.443709|2017-10-11 04:23:09.443709
NCT00003381|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||July 1998||1998-07-01|July 2016|2016-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|||Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]|Quality of Life and Cost Analysis of a Prospective Randomized Phase III Trial Comparing Trimodality Therapy to Surgery Alone for Esophageal Cancer [Companion to CALGB-9781]|Terminated||N/A|56|Actual|Alliance for Clinical Trials in Oncology|||1|companion study to CALGB-9781 which closed administratively due to poor accrual|f||||f||||||||||2017-10-11 04:23:09.651465|2017-10-11 04:23:09.651465
NCT00003382|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-07|||May 1998||1998-05-01|May 2006|2006-05-01||||April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer|A Phase I Study of Gemcitabine/Topotecan in Combination in Refractory Ovarian Cancer or Cancer of the Fallopian Tube|Terminated||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:23:10.210466|2017-10-11 04:23:10.210466
NCT00003384|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-05-27|||September 1998||1998-09-01|May 2015|2015-05-01||||January 2011|Actual|2011-01-01||Interventional|||Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer|Expression of the MN Protein in Atypical Glandular Cells of Undetermined Significance (Agus or Agcus) As a Potential Diagnostic Biomarker of Cervical Dysplasia/Neoplasia|Completed||N/A|684|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:23:10.352214|2017-10-11 04:23:10.352214
NCT00003414|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-07-16|||October 1997||1997-10-01|July 2015|2015-07-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease|Randomized Trial of Autologous GVHD for Refractory Lymphoma|Completed||Phase 3|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:23:17.727665|2017-10-11 04:23:17.727665
NCT00003385|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-24|||March 1999||1999-03-01|September 2003|2003-09-01||||January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer|A Phase I Study of Paclitaxel, Carboplatin, and Increasing Doses of Doxil in Untreated Ovarian, Peritoneal, and Tubal Carcinoma|Completed||Phase 1|48|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:23:10.497848|2017-10-11 04:23:10.497848
NCT00003386|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-10|||July 1999||1999-07-01|December 2008|2008-12-01||||April 2001|Actual|2001-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer|Treatment of Ovarian Carcinoma With DNP-Modified Autologous Tumor Vaccine|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:23:10.625802|2017-10-11 04:23:10.625802
NCT00003387|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|||July 1998||1998-07-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|May 2007|Actual|2007-05-01||Interventional|||Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery|Concurrent Carboplatin, Paclitaxel, and Radiation Therapy Versus Induction Carboplatin and Paclitaxel Followed by Concurrent Carboplatin, Paclitaxel and Radiation Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer: A Phase III Trial|Completed||Phase 3|366|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:23:10.907647|2017-10-11 04:23:10.907647
NCT00003388|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||February 1999||1999-02-01|January 2010|2010-01-01||||April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma|A Phase II Study of Doxil (Liposomal Doxorubicin), Cyclophosphamide, Vincristine and Prednisone for AIDS-Related Systemic Lymphoma|Completed||Phase 2|38|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:23:11.124281|2017-10-11 04:23:11.124281
NCT00003389|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-09-25|2015-08-05||April 1999||1999-04-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|September 2011|Actual|2011-09-01||Interventional||Eligible patients are included in the primary analysis.|Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma|A Randomized Phase III Trial of ABVD Versus Stanford V (+/-) Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 3|854|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 04:23:11.31264|2017-10-11 04:23:11.31264
NCT00003390|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||June 1998||1998-06-01|May 2000|2000-05-01|August 2004|Actual|2004-08-01|||||Interventional|||6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer|A Phase II Trial of 6-Hydroxymethylacylfulvene (MGI-114) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:14.615107|2017-10-11 04:23:14.615107
NCT00003391|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-10-09|||June 1998||1998-06-01|October 2009|2009-10-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|Phase I Trial of Monoclonal Antibody muJ591 in Patients With Hormone-Independent Prostate Cancer|Completed||Phase 1|30|Anticipated|Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 04:23:14.709136|2017-10-11 04:23:14.709136
NCT00003392|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-02-19|||September 1997||1997-09-01|February 2012|2012-02-01|January 2003|Actual|2003-01-01|August 2002|Actual|2002-08-01||Interventional|||High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer|Multiple Cycles of High Dose Chemotherapy Supported With Filgrastim and Peripheral Blood Progenitor Cells in Patients With Metastatic Breast Cancer|Completed||Phase 2|61|Actual|UNC Lineberger Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:23:14.78575|2017-10-11 04:23:14.78575
NCT00003394|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||April 1998||1998-04-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer|Phase I/II Study of Weekly Intravenous Estramustine Phosphate in Combination With Paclitaxel and Carboplatin in Patients With Advanced Prostate Cancer|Completed||Phase 1/Phase 2|18|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:14.874564|2017-10-11 04:23:14.874564
NCT00003395|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer|Dose-Ranging Study of Arsenic Trioxide in Advanced Hematologic Cancers|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:14.948524|2017-10-11 04:23:14.948524
NCT00003396|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-09-23|||September 1998||1998-09-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Evaluation of Allogeneic Peripheral Blood Stem Cell Transplants From a Related Donor Without Graft-Versus-Host Prophylaxis in Patients With High Risk of Relapse|Completed||Phase 2|42|Anticipated|University of Maryland|||||f||||||||||||||2017-10-11 04:23:15.129552|2017-10-11 04:23:15.129552
NCT00003397|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-09-23|||September 1998||1998-09-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|Autologous Stem Cell Transplantation for Poor Prognosis, Relapsed, or Refractory Intermediate-High Grade B-Cell Lymphoma Using Gemcitabine Plus High Dose BCNU and Melphalan Followed by Anti-CD20 Moab (IDEC C2B8, Rituximab, Rituxan) and Consolidative Chemotherapy|Completed||Phase 2|25|Anticipated|University of Maryland|||||f||||||||||||||2017-10-11 04:23:15.24684|2017-10-11 04:23:15.24684
NCT00003398|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-09-23|||September 1998||1998-09-01|September 2009|2009-09-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Evaluation of Allogeneic Marrow Transplants Depleted of T-Cells by CD34+ Selection in Patients Undergoing Transplantation With an Unrelated Matched or 1 Antigen Mismatched Donor or a 1 Antigen Mismatched Related Donor|Completed||Phase 4|45|Anticipated|University of Maryland|||||f||||||||||||||2017-10-11 04:23:15.340206|2017-10-11 04:23:15.340206
NCT00003399|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-28|||September 1998|Actual|1998-09-01|March 2017|2017-03-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma|Autologous Transplantation With High Dose BCNU and Melphalan Followed by Consolidation With DCEP and Taxol/Cisplatin in Patients With Multiple Myeloma and < or = 12 Months of Standard Therapy|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-10-11 04:23:16.431956|2017-10-11 04:23:16.431956
NCT00005366|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|April 2001|2001-04-01|August 1998|Actual|1998-08-01|||||Observational|||Biobehavioral Mechanisms of Blood Pressure Regulation||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.792767|2017-10-11 04:28:03.792767
NCT00003400|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-28|||September 1998|Actual|1998-09-01|March 2017|2017-03-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer|High Dose Chemotherapy With Stem Cell Rescue Followed By Consolidation Treatment in Patients With Metastatic Hormone-Refractory Prostate Cancer|Completed||Phase 2|45|Anticipated|University of Maryland|||||f||||||||||||||2017-10-11 04:23:16.508277|2017-10-11 04:23:16.508277
NCT00003401|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-28|||January 1999|Actual|1999-01-01|March 2017|2017-03-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma|Autologous Transplantation With Gemcitabine and High Dose BCNU Plus Melphalan Followed by Consolidation With DCEP Plus Gemcitabine and Taxol/Cisplatin in Patients With Multiple Myeloma and >12 Months of Standard Therapy|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-10-11 04:23:16.575854|2017-10-11 04:23:16.575854
NCT00003402|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-09-23|||January 1999||1999-01-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Autologous Transplantation With and High Dose BCNU and Melphalan Followed by Consolidation With DCEP Plus Taxol/Cisplatin in Patients With Poor Prognosis Low Grade Non-Hodgkin's Lymphoma and Chronic Lymphocyte Leukemia, Who Have Received < or = 12 Months of Standard Therapy|Completed||Phase 2|35|Anticipated|University of Maryland|||||f||||||||||||||2017-10-11 04:23:16.653261|2017-10-11 04:23:16.653261
NCT00003403|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-22|||August 1999||1999-08-01|February 2001|2001-02-01||||||||Interventional|||GPX-100 in Treating Patients With Solid Tumors|Phase I Safety and Efficacy Study of an Intravenous Formulation of the Anthracycline Analog, GPX-100, in the Treatment of Metastatic Breast Cancer|Completed||Phase 1|||Gem Pharmaceuticals|||||f||||||||||||||2017-10-11 04:23:16.728146|2017-10-11 04:23:16.728146
NCT00003404|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-11-25|||January 1998||1998-01-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast|A Prospective Study of Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors|Active, not recruiting||Phase 2|50|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 04:23:16.787532|2017-10-11 04:23:16.787532
NCT00003405|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||April 1998||1998-04-01|February 2001|2001-02-01||||||||Interventional|||Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia|Treatment Protocol for Patients With Standard Risk Acute Myelogenous Leukemia and Its Variants: Induction Using High-Dose Cytarabine, Mitoxantrone and Ethyol; Consolidation With Cytarabine and Idarubicin and Maintenance With 13 Cis Retinoic Acid and Alpha Interferon|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:16.861479|2017-10-11 04:23:16.861479
NCT00003406|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-25|||October 1997||1997-10-01|July 2007|2007-07-01|March 2000|Actual|2000-03-01|||||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer|A Phase I-II Intensive-Dose Ifosfamide, Carboplatin and Taxotere (IC-T) Combination Chemotherapy Followed by Autologous Stem Cell Rescue for Patients With Refractory Malignancies|Completed||Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:16.939298|2017-10-11 04:23:16.939298
NCT00003407|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-05-09|||April 1998||1998-04-01|May 2006|2006-05-01||||||||Interventional|||Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia|Protocol for Treatment of Newly Diagnosed High Risk And Relapsed Acute Myeloid Leukemia and Blastic Crisis Chronic Myelogenous Leukemia With Ethyol and High-Dose Cytarabine + Mitoxantron Followed by Maintenance Phase Using Low-Dose ARA-C, rhGM-CSF, Pentoxifylline, Ciprofloxacin and Decadron|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:17.027287|2017-10-11 04:23:17.027287
NCT00003408|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-25|||April 1998||1998-04-01|April 2003|2003-04-01|March 2000|Actual|2000-03-01|||||Interventional|||Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer|Cytokine-Based Immunotherapy Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:17.102583|2017-10-11 04:23:17.102583
NCT00003409|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||July 1998||1998-07-01|June 2007|2007-06-01||||||||Interventional|||Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I Dose Escalating Study of the Safety and Tolerability of Gadolinium Texaphyrin as a Radiation Sensitizer in Patients With Primary Glioblastoma Multiforme|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:17.340844|2017-10-11 04:23:17.340844
NCT00003410|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||July 1998||1998-07-01|May 2006|2006-05-01|June 2004|Actual|2004-06-01|||||Interventional|||Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas|Pilot Trial of Gadolium Texaphyrin for Magnetic Resonance Imaging-Guided Resection of High Grade Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:17.415321|2017-10-11 04:23:17.415321
NCT00003411|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-01-15|||November 1998||1998-11-01|January 2016|2016-01-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer|Phase I Dose Escalation and Pharmacokinetics Study of the Radiosensitizer, Gadolinium Texaphyrin (Gd-Tex, NSC 695238) With Concurrent Radiotherapy in Advanced Biliary Tree and Pancreatic Cancers|Completed||Phase 1|||University of Pittsburgh|||||f||||t||||||||||2017-10-11 04:23:17.496962|2017-10-11 04:23:17.496962
NCT00003412|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||June 1998||1998-06-01|October 2001|2001-10-01||||||||Interventional|||Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation|Phase I Study of Post Transplant rhIL-12 High Dose Cyclophosphamide, Thiotepa, and Carboplatin in the Treatment of Metastatic Breast Carcinoma|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:17.580149|2017-10-11 04:23:17.580149
NCT00003413|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-09-23|||September 1998||1998-09-01|September 2009|2009-09-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer|High Dose Chemotherapy With Stem Cell Rescue in Recently Diagnosed Patients With Advanced (Stage III and IV) Ovarian Cancer With > 1 cm Residual Disease After Debulking Surgery|Completed||Phase 2|32|Anticipated|University of Maryland|||||f||||||||||||||2017-10-11 04:23:17.643264|2017-10-11 04:23:17.643264
NCT00003415|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-30|||September 1998||1998-09-01|July 2000|2000-07-01|November 2002|Actual|2002-11-01|||||Interventional|||Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome|Phase I/II Study of Combined Treatment With Amifostine (Ethyol) and Topotecan (Hycamtin MS) in Patients With Myelodysplastic Syndrome|Completed||Phase 1/Phase 2|26|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:17.83414|2017-10-11 04:23:17.83414
NCT00003416|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-03-05|||September 1998||1998-09-01|March 2015|2015-03-01|January 2004|Actual|2004-01-01|August 2000|Actual|2000-08-01||Interventional|||S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia|S9805, Phase II Study of Tandem High Dose Melphalan Supported by Peripheral Blood Stem Cell Support in Waldenstrom's Macroglobulinemia (WM)|Completed||Phase 2|9|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:17.921759|2017-10-11 04:23:17.921759
NCT00003417|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-11-14|||September 1998||1998-09-01|November 2015|2015-11-01||||May 2004|Actual|2004-05-01||Interventional|||Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme|Phase I/II Radiation Dose Escalation Study Applying Conformal Radiation Therapy in Supratentorial Glioblastoma Multiforme|Completed||Phase 1/Phase 2|40|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:23:18.196602|2017-10-11 04:23:18.196602
NCT00003418|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||February 1998||1998-02-01|March 2008|2008-03-01||||||||Interventional|||Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer|Randomized Double-Blind Trial in Postmenopausal Women With Primary Breast Cancer Who Have Received Adjuvant Tamoxifen for 2-3 Years, Comparing Subsequent Adjuvant Exemestane Treatment With Further Tamoxifen|Unknown status|Active, not recruiting|Phase 3|4400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:19.028426|2017-10-11 04:23:19.028426
NCT00003419|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||June 1998||1998-06-01|November 2001|2001-11-01||||||||Interventional|||Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma|Treatment of HIV-Related Kaposi's Sarcoma and Stage I-III Slow-Proliferative Disease With Highly Active Antiretroviral Therapy (HAART)|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:19.142721|2017-10-11 04:23:19.142721
NCT00003420|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||July 1997||1997-07-01|December 2002|2002-12-01|April 2010|Actual|2010-04-01|||||Interventional|||CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy|A Study of CT Scan Frequency in Patients With Stage I Testicular Teratoma|Completed||N/A|900|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:19.224747|2017-10-11 04:23:19.224747
NCT00003421|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||June 1998||1998-06-01|May 2007|2007-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease|A UKLG Randomised Trial of Initial Chemotherapy for Advanced Stage Hodgkins Disease|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:19.326706|2017-10-11 04:23:19.326706
NCT00003422|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||January 1998||1998-01-01|March 2007|2007-03-01|June 2010|Actual|2010-06-01|||||Interventional|||Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed|A Randomised Trial Comparing Pre-Operative Radiotherapy and Selective Post-Operative Chemoradiotherapy in Rectal Cancer|Completed||Phase 3|1800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:19.429383|2017-10-11 04:23:19.429383
NCT00003423|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||May 1995||1995-05-01|April 2001|2001-04-01||||||||Interventional|||Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma T Cell Protocol|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:19.563447|2017-10-11 04:23:19.563447
NCT00003424|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||April 1997||1997-04-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|June 2000|Actual|2000-06-01||Interventional|||Tamoxifen in Treating Patients With Primary Liver Cancer|Randomised Trial of Tamoxifen Versus Placebo for the Treatment of Inoperable Hepatocellular Carcinoma|Completed||Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:19.651556|2017-10-11 04:23:19.651556
NCT00003425|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-25|||December 1997||1997-12-01|April 2013|2013-04-01||||July 2002|Actual|2002-07-01||Interventional|||Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect|Phase I/II Study of Escalating Dose Melphalan With Autologous Pluripotent Hematopoietic Stem Cell Support and Amifostine Cytoprotection in Cancer Patients|Completed||Phase 1/Phase 2|25|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-10-11 04:23:19.735599|2017-10-11 04:23:19.735599
NCT00003426|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||April 1998||1998-04-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer|A Phase I Trial of Combined Modality Gemcitabine Plus Radiation Therapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:19.845464|2017-10-11 04:23:19.845464
NCT00003427|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer|Phase I Study to Evaluate the Combination Chemotherapy Regimen of Oxaliplatin Plus Irinotecan in Previously Treated Patients With Metastatic Gastrointestinal Cancer|Completed||Phase 1|36|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:19.901381|2017-10-11 04:23:19.901381
NCT00003428|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||May 1998||1998-05-01|June 2013|2013-06-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Hormone Therapy in Treating Women With Breast Cancer|Phase II Randomized Double-Blind Evaluation of Two Dose Levels of LY353381 Hydrochloride Administered to Women With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|114|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:19.977364|2017-10-11 04:23:19.977364
NCT00003429|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-12-17|||May 1998||1998-05-01|December 2015|2015-12-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery|A Pilot Study of 18F-Flourodeoxyglucose Positron Emission Tomography in the Diagnosis of Primary and Recurrent Cervical Cancer|Completed||N/A|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:20.092091|2017-10-11 04:23:20.092091
NCT00003446|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||December 1997||1997-12-01|September 2001|2001-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer|Phase II Trial of Trimetrexate (Neutrexin), 5-Fluorouracil and Leucovorin in Metastatic Colorectal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:21.538777|2017-10-11 04:23:21.538777
NCT00003430|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors|A Pharmacokinetic Study Evaluating the Safety, Tolerability and Maximally Tolerated Dose of 7-Day Continuous Infusions of L-778,123 in Patients With Recurrent of Refractory Solid Malignancies|Completed||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:20.189088|2017-10-11 04:23:20.189088
NCT00003431|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-04|||June 1998||1998-06-01|March 2013|2013-03-01|May 2001|Actual|2001-05-01|||||Interventional|||Flt3L in Treating Patients With Metastatic Colorectal Cancer|Pilot Study of FLT3 Ligand Prior to Resection of Hepatic Metastases of Colorectal Cancer|Completed||Phase 1|||Duke University|||||f||||||||||||||2017-10-11 04:23:20.26545|2017-10-11 04:23:20.26545
NCT00003432|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||June 1998||1998-06-01|November 2013|2013-11-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Immunotherapy in Treating Patients With Metastatic Breast Cancer|A Phase I/II Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous Cultured Dendritic Cells for Patients With Breast Cancer Who Achieve a Complete Response After High Dose Chemotherapy and Stem Cell Support|Terminated||Phase 1/Phase 2|4|Actual|Duke University||1||low accrual|f||||f||||||||||2017-10-11 04:23:20.334253|2017-10-11 04:23:20.334253
NCT00003433|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||June 1998||1998-06-01|November 2002|2002-11-01|August 2003|Actual|2003-08-01|||||Interventional|||Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer|A Phase I/II Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous, Cultured Dendritic Cells After Complete Resection of Hepatic Metastases of Colorectal Carcinoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:20.42497|2017-10-11 04:23:20.42497
NCT00003434|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-07|||June 1998||1998-06-01|February 2014|2014-02-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer|A Pilot Study of Active Immunotherapy With Carcinoembryonic Antigen Peptide-Pulsed, Autologous Human Cultured Dendritic Cells in Patients With Resected, Stage I, II and III Pancreatic Adenocarcinoma Expressing Carcinoembryonic Antigen|Terminated||Phase 1|8|Actual|Duke University||1|||f||||f||||||||||2017-10-11 04:23:20.492589|2017-10-11 04:23:20.492589
NCT00003435|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-06|||May 1998||1998-05-01|December 2000|2000-12-01||||||||Interventional|||Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer|A Pilot Study Involving Administration of Combination Anti-Retroviral Therapy and Transplantation of HLA-Matched Sibling Peripheral Blood Stem Cells or Partially HLA-Matched Unrelated Umbilical Cord Blood In Adults With HIV Infection and Hematologic Malignancies|Withdrawn||Phase 1|0|Actual|Duke University|||||f||||||||||||||2017-10-11 04:23:20.56112|2017-10-11 04:23:20.56112
NCT00003436|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||July 1998||1998-07-01|December 2000|2000-12-01|December 2005|Actual|2005-12-01|||||Interventional|||Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia|Medical Research Council Working Party on Leukaemia in Childhood Acute Myeloid Leukaemia Trial 12|Completed||Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:20.747628|2017-10-11 04:23:20.747628
NCT00003437|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||January 1997||1997-01-01|February 2003|2003-02-01||||||||Interventional|||Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia|Medical Research Council Working Party on Leukaemia in Children UK National Lymphoblastic Leukaemia (ALL) Trial|Unknown status|Active, not recruiting|Phase 3|1800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:20.835315|2017-10-11 04:23:20.835315
NCT00003439|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-06|||August 1998||1998-08-01|April 2007|2007-04-01||||May 2001|Actual|2001-05-01||Interventional|||Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer|A Phase I Dose-Escalating Study of Recombinant Human Interleukin-12 (NSC # 672423) Administered by Intraperitoneal Infusion in Refractory Advanced Stage Ovarian Cancer and Other Abdominal Carcinomatosis|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:20.958848|2017-10-11 04:23:20.958848
NCT00003440|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-03|||July 1998||1998-07-01|June 2013|2013-06-01||||July 2004|Actual|2004-07-01||Interventional|||Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic|A Phase III Study of Paclitaxel Via Weekly 1 Hour Infusion Versus Standard 3 Hour Infusion Every 3 Weeks With Herceptin (Trastuzumab) (NSC #688097) in the Treatment of Patients With/Without HER-2/Neu-Overexpressing Metastatic Breast Cancer|Completed||Phase 3|580|Actual|National Cancer Institute (NCI)||6|||f||||||||||||||2017-10-11 04:23:21.066765|2017-10-11 04:23:21.066765
NCT00003441|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||August 1998||1998-08-01|July 2012|2012-07-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Irofulven in Treating Patients With Metastatic Colorectal Cancer|Phase II Study of MGI-114 (NSC# 683863) Administered Intravenously for Five Days Every 28 Days to Patients With Metastatic Colorectal Cancer|Completed||Phase 2|26|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:23:21.199949|2017-10-11 04:23:21.199949
NCT00003443|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||July 1998||1998-07-01|June 2013|2013-06-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|A Phase II Trial of Bryostatin-1 In Patients With Metastatic or Recurrent Squamos Cell Carcinoma of the Head and Neck|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:21.29924|2017-10-11 04:23:21.29924
NCT00003444|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||October 1998||1998-10-01|January 2010|2010-01-01||||September 2003|Actual|2003-09-01||Interventional|||Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin|A Prospective Randomized Phase III Clinical Trial Assessing the Role of Post-Operative Radiotherapy Plus Adjuvant Interferon Alpha-2b in Patients With Cervical, Axillary, and Inguinal Nodal Metastasis From Cutaneous Melanoma|Completed||Phase 3|167|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-10-11 04:23:21.367555|2017-10-11 04:23:21.367555
NCT00003445|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||December 1997||1997-12-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Docetaxel in Treating Patients With Advanced Cancer of the Cervix|Neoadjuvant Chemotherapy With Docetaxel in Advanced Cervical Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:21.478525|2017-10-11 04:23:21.478525
NCT00005367|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||February 1993||1993-02-01|March 2005|2005-03-01|January 1995||1995-01-01|||||Observational|||Epidemiology of Long QTand Asian Sudden Death in Sleep||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.853588|2017-10-11 04:28:03.853588
NCT00003447|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||July 1998||1998-07-01|September 2007|2007-09-01||||||||Interventional|||Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|630|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:21.603758|2017-10-11 04:23:21.603758
NCT00003449|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||May 1998||1998-05-01|May 2014|2014-05-01|February 2004|Actual|2004-02-01|June 2002|Actual|2002-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer|Phase II Study of Weekly Paclitaxel and Gemcitabine in Platinum-Resistant Ovarian Cancer|Completed||Phase 2|35|Actual|University of Southern California|||||f||||t||||||||||2017-10-11 04:23:21.672534|2017-10-11 04:23:21.672534
NCT00003450|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||September 1998||1998-09-01|June 2002|2002-06-01||||||||Interventional|||Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer|Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Patients With Advanced Recurrent or Persistent Ovarian Cancer|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:21.739951|2017-10-11 04:23:21.739951
NCT00003451|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-31|||August 1998||1998-08-01|July 2007|2007-07-01||||December 2001|Actual|2001-12-01||Interventional|||Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer|Phase I Trial of Interleukin-12 Followed by Interferon-Alpha|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:21.805756|2017-10-11 04:23:21.805756
NCT00003452|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||May 6, 1996|Actual|1996-05-06|September 2017|2017-09-01|May 4, 1998|Actual|1998-05-04|May 4, 1998|Actual|1998-05-04||Interventional|||Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder|Terminated||Phase 2|4|Actual|Burzynski Research Institute||1||slow enrollment|f||||f|t|f||||||||2017-10-11 04:23:21.914185|2017-10-11 04:23:21.914185
NCT00003453|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-27|||August 21, 1996||1996-08-21|September 2017|2017-09-01|July 5, 2011|Actual|2011-07-05|July 5, 2011|Actual|2011-07-05||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Adrenal Gland|Terminated||Phase 2|6|Actual|Burzynski Research Institute||1||Slow enrollment|f||||f|t|f||||||||2017-10-11 04:23:21.989956|2017-10-11 04:23:21.989956
NCT00003454|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||March 18, 1996|Actual|1996-03-18|September 2017|2017-09-01|December 28, 2002|Actual|2002-12-28|December 28, 2002|Actual|2002-12-28||Interventional|||Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Breast|Terminated||Phase 2|19|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:22.072342|2017-10-11 04:23:22.072342
NCT00003455|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Women With Advanced Breast Cancer|Phase II Study of Oral Antineoplastons A10 and AS2-1 in Women With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:22.146529|2017-10-11 04:23:22.146529
NCT00003457|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-10-25||July 1996||1996-07-01|July 2017|2017-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Antineoplaston Therapy in Treating Patients With Brain Tumors|Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Brain Tumors.|Completed||Phase 2|40|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:22.276509|2017-10-11 04:23:22.276509
NCT00003458|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-09-22||September 1996||1996-09-01|July 2017|2017-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Antineoplaston Therapy in Treating Children With Brain Tumors|Phase II Study of Antineoplastons A10 and AS2-1 in Children With Brain Tumors|Completed||Phase 2|34|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:22.63035|2017-10-11 04:23:22.63035
NCT00003459|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-05-25||March 1996||1996-03-01|July 2017|2017-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Antineoplaston Therapy in Treating Patients With Brain Stem Glioma|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Brain Stem Glioma|Completed||Phase 2|40|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:22.970689|2017-10-11 04:23:22.970689
NCT00003460|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-09-22||April 1996||1996-04-01|July 2017|2017-07-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|PNET||Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors|Phase II Study of Antineoplastons A10 and AS2-1 In Children With Primitive Neuroectodermal Tumors|Completed||Phase 2|13|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:23.296525|2017-10-11 04:23:23.296525
NCT00003461|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-20|||February 1998||1998-02-01|February 2013|2013-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors|Phase I Study of At-Labeled Anti-Tenascin Human/Mouse Chimeric Monoclonal Antibody 81C6 (ch81C6) Via Surgically Created Cystic Resection Cavity in the Treatment of Patients With Primary or Metastatic Brain Tumors|Completed||Phase 1/Phase 2|||Duke University||1|||f||||||||||||||2017-10-11 04:23:23.699269|2017-10-11 04:23:23.699269
NCT00003462|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||April 1998||1998-04-01|February 2013|2013-02-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors|Phase I Study of Intrathecal Spartaject-Busulfan in Patients With Neoplastic Meningitis|Completed||Phase 1|20|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:23:23.76903|2017-10-11 04:23:23.76903
NCT00003463|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||July 1998||1998-07-01|February 2013|2013-02-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas|Phase I Treatment of Adults With Recurrent Supratentorial High Grade Glioma With Gliadel Wafers Plus Irinotecan (CPT-11)|Completed||Phase 1|||Duke University|||||f||||||||||||||2017-10-11 04:23:23.833711|2017-10-11 04:23:23.833711
NCT00005368|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||July 1993||1993-07-01|January 2005|2005-01-01|August 2003||2003-08-01|||||Observational|||Genetic Epidemiology of Hypertriglyceridemia||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:28:03.915325|2017-10-11 04:28:03.915325
NCT00003464|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-19|||September 1997||1997-09-01|October 2009|2009-10-01|August 2003|Actual|2003-08-01|||||Interventional|||Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme|Phase II Treatment of Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme With Temodal|Completed||Phase 2|50|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:23:23.905554|2017-10-11 04:23:23.905554
NCT00003465|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-19|||March 1998||1998-03-01|October 2009|2009-10-01|February 2001|Actual|2001-02-01|||||Interventional|||Temozolomide in Treating Patients With Anaplastic Oligodendroglioma|Phase II Treatment of Adults With Newly Diagnosed, Progressive or Recurrent Primary Malignant Anaplastic Oligodendroglioma With Temodal|Completed||Phase 2|60|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:23:23.973587|2017-10-11 04:23:23.973587
NCT00003466|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-07|||March 1998||1998-03-01|February 2013|2013-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Temozolomide in Treating Patients With Progressive Low-Grade Glioma|Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal|Completed||Phase 2|100|Anticipated|Duke University|||||f||||f||||||||||2017-10-11 04:23:24.043417|2017-10-11 04:23:24.043417
NCT00003467|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-19|||January 1998||1998-01-01|October 2009|2009-10-01|February 2004|Actual|2004-02-01|||||Interventional|||Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma|Phase II Treatment of Adults With Recurrent Supratentorial Low Grade Glioma With Gliadel Wafers|Completed||Phase 2|68|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:23:24.118257|2017-10-11 04:23:24.118257
NCT00003468|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-09-22||July 1996||1996-07-01|July 2017|2017-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma|Phase II Study of Antineoplastons A10 and AS2-1 in Children With Low Grade Astrocytoma|Completed||Phase 2|11|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:24.196977|2017-10-11 04:23:24.196977
NCT00003469|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2017-01-17||February 1996||1996-02-01|July 2017|2017-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System|Phase II Study of Antineoplastons A10 and AS2-1 in Children With Rhabdoid Tumor of the Central Nervous System|Terminated||Phase 2|4|Actual|Burzynski Research Institute||1||Slow accrual|f||||f||||||||||2017-10-11 04:23:24.542765|2017-10-11 04:23:24.542765
NCT00003470|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-10-25||March 1996||1996-03-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|AA||Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Anaplastic Astrocytoma|Completed||Phase 2|27|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:24.784731|2017-10-11 04:23:24.784731
NCT00003473|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-08-24||March 1996||1996-03-01|July 2017|2017-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Mixed Glioma|Completed||Phase 2|20|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:25.285809|2017-10-11 04:23:25.285809
NCT00003475|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-10-26||February 1996||1996-02-01|July 2017|2017-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Primary Malignant Brain Tumors|Completed||Phase 2|40|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:25.69194|2017-10-11 04:23:25.69194
NCT00003476|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-12-28||March 1996||1996-03-01|July 2017|2017-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors|Phase II Study of Antineoplastons A10 and AS2-1 in Children With Primary Malignant Brain Tumors|Terminated||Phase 2|8|Actual|Burzynski Research Institute||1||Slow accrual|f||||f||||||||||2017-10-11 04:23:25.978577|2017-10-11 04:23:25.978577
NCT00003477|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-08-04||June 1996||1996-06-01|July 2017|2017-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|VPG||Antineoplaston Therapy in Treating Children With Visual Pathway Glioma|Phase II Study of Antineoplastons A10 and AS2-1 Infusions in Children With Visual Pathway Glioma|Completed||Phase 2|12|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:26.224377|2017-10-11 04:23:26.224377
NCT00003478|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||October 1997||1997-10-01|February 2013|2013-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors|Phase I Study of Intra-Tumoral, Radiolabeled, Anti-Tenascin Monoclonal Antibody 81C6 in the Treatment of Patients With Malignant Primary Brain Tumors|Completed||Phase 1/Phase 2|10|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:23:26.498489|2017-10-11 04:23:26.498489
NCT00003479|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-12-28||July 1966||1966-07-01|July 2017|2017-07-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|||Antineoplaston Therapy in Treating Patients With Ependymoma|Phase II Study of Antineoplastons A10 and AS2-1 Infusions in Patients With Ependymoma|Terminated||Phase 2|9|Actual|Burzynski Research Institute||1||Slow accrual|f||||f||||||||||2017-10-11 04:23:26.58259|2017-10-11 04:23:26.58259
NCT00003483|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-12-28||June 1998||1998-06-01|July 2017|2017-07-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Antineoplaston Therapy in Treating Patients With Meningioma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Meningioma|Terminated||Phase 2|3|Actual|Burzynski Research Institute||1||Slow accrual|f||||f||||||||||2017-10-11 04:23:26.990296|2017-10-11 04:23:26.990296
NCT00003484|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-04-22|||September 1997||1997-09-01|April 2015|2015-04-01|March 2010|Actual|2010-03-01|November 2003|Actual|2003-11-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors|Phase I Study of Anti-Tenascin Monoclonal Antibody I-Labeled 81C6 Via Surgically Created Cystic Resection Cavity in the Treatment of Patients With Primary Brain Tumors After External Beam Radiotherapy|Completed||Phase 1|21|Actual|Duke University||1|||f||||||||||||||2017-10-11 04:23:27.228667|2017-10-11 04:23:27.228667
NCT00003485|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||April 10, 1996|Actual|1996-04-10|September 2017|2017-09-01|May 11, 2003|Actual|2003-05-11|May 11, 2003|Actual|2003-05-11||Interventional|||Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Adenocarcinoma of the Colon|Terminated||Phase 2|15|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:27.328638|2017-10-11 04:23:27.328638
NCT00003486|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Colon Cancer|Phase II Study of Antineoplastons A10 and AS2-1 Capsules in Patients With Adenocarcinoma of the Colon|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:27.400632|2017-10-11 04:23:27.400632
NCT00003487|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||May 1996||1996-05-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Adenocarcinoma of the Esophagus|Terminated||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1||Withdrawn due to slow enrollment|f||||||||||||||2017-10-11 04:23:27.476892|2017-10-11 04:23:27.476892
NCT00003489|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||May 6, 1996|Actual|1996-05-06|September 2017|2017-09-01|April 3, 1998|Actual|1998-04-03|April 3, 1998|Actual|1998-04-03||Interventional|||Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Head and Neck|Terminated||Phase 2|7|Actual|Burzynski Research Institute||1||slow accrual|f|||||t|f||||||||2017-10-11 04:23:27.564081|2017-10-11 04:23:27.564081
NCT00003490|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||October 1998||1998-10-01|March 2001|2001-03-01|August 2003|Actual|2003-08-01|||||Interventional|||Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma|Phase II to Treat Multiple Myeloma Patients With Cytoxan and Vincristine After Cycling Myeloma Cells With rHuGM-CSF|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:27.675555|2017-10-11 04:23:27.675555
NCT00003491|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-27|||March 20, 1996|Actual|1996-03-20|September 2017|2017-09-01|July 31, 1998|Actual|1998-07-31|July 31, 1998|Actual|1998-07-31||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Adenocarcinoma of the Lung|Terminated||Phase 2|17|Actual|Burzynski Research Institute||1||Slow accrual|f||||f|t|f||||||||2017-10-11 04:23:27.749556|2017-10-11 04:23:27.749556
NCT00003492|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-01-21|||April 1996||1996-04-01|October 2008|2008-10-01||||January 2008|Anticipated|2008-01-01||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Large Cell, Undifferentiated Or Poorly Differentiated Stage IV Carcinoma of the Lung|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:27.839956|2017-10-11 04:23:27.839956
NCT00003493|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-17|||November 1998||1998-11-01|August 2001|2001-08-01|April 2004|Actual|2004-04-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Multiple Myeloma|Phase II Trial of Doxil, Vincristine and Decadron in Multiple Myeloma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:27.919147|2017-10-11 04:23:27.919147
NCT00003494|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Bronchial Alveolar Carcinoma of the Lung|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:27.99194|2017-10-11 04:23:27.99194
NCT00003495|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||March 27, 1996|Actual|1996-03-27|September 2017|2017-09-01|November 4, 2003|Actual|2003-11-04|November 4, 2003|Actual|2003-11-04||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Squamos Cell Carcinoma of the Lung|Terminated||Phase 2|7|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:28.050804|2017-10-11 04:23:28.050804
NCT00003496|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||March 7, 1996|Actual|1996-03-07|September 2017|2017-09-01|February 5, 2004|Actual|2004-02-05|February 5, 2004|Actual|2004-02-05||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Small Cell Carcinoma of the Lung|Terminated||Phase 2|4|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:28.136319|2017-10-11 04:23:28.136319
NCT00003497|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||August 1998|Actual|1998-08-01|September 2017|2017-09-01|May 12, 2004|Actual|2004-05-12|May 12, 2004|Actual|2004-05-12||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 Capsules In Patients With Non Small Cell Lung Cancer|Terminated||Phase 2|||Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:28.226217|2017-10-11 04:23:28.226217
NCT00003498|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-01-21|||December 1996||1996-12-01|October 2008|2008-10-01||||January 2008|Anticipated|2008-01-01||Interventional|||Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:28.328933|2017-10-11 04:23:28.328933
NCT00003499|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-08-12|||March 1996||1996-03-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma Low Grade|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:28.40195|2017-10-11 04:23:28.40195
NCT00003500|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||March 11, 1996|Actual|1996-03-11|September 2017|2017-09-01|June 16, 2000|Actual|2000-06-16|June 16, 2000|Actual|2000-06-16||Interventional|||Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma, Intermediate Grade|Terminated||Phase 2|12|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:28.477175|2017-10-11 04:23:28.477175
NCT00003501|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||April 10, 1996|Actual|1996-04-10|September 2017|2017-09-01|July 2, 2003|Actual|2003-07-02|July 2, 2003|Actual|2003-07-02||Interventional|||Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma, High Grade|Terminated||Phase 2|2|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:28.5606|2017-10-11 04:23:28.5606
NCT00003502|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Stage II, III, or IV Mantle Cell Lymphoma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:28.635537|2017-10-11 04:23:28.635537
NCT00003505|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09||||||October 2006|2006-10-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Primary Central Nervous System Lymphoma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:28.707668|2017-10-11 04:23:28.707668
NCT00003508|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||March 1996||1996-03-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Mesothelioma|Terminated||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1||Withdrawn due to slow enrollment|f||||||||||||||2017-10-11 04:23:28.764006|2017-10-11 04:23:28.764006
NCT00003509|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-05-23|||March 1996||1996-03-01|May 2009|2009-05-01||||February 2005|Actual|2005-02-01||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Melanoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Malignant Melanoma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:28.834087|2017-10-11 04:23:28.834087
NCT00003511|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-01-21|||April 1996||1996-04-01|October 2008|2008-10-01||||January 2008|Anticipated|2008-01-01||Interventional|||Antineoplaston Therapy in Treating Patients With Multiple Myeloma|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:28.901506|2017-10-11 04:23:28.901506
NCT00003512|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-11-16|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Macroglobulinemia of Waldenstrom|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:28.958393|2017-10-11 04:23:28.958393
NCT00003513|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-26|||December 16, 1996|Actual|1996-12-16|September 2017|2017-09-01|March 29, 1999|Actual|1999-03-29|March 29, 1999|Actual|1999-03-29||Interventional|||Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Neuroblastoma|Terminated||Phase 2|3|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:29.01307|2017-10-11 04:23:29.01307
NCT00003514|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Metastatic or Incurable Neuroendocrine Tumors|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:29.08005|2017-10-11 04:23:29.08005
NCT00003515|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-27|||December 12, 1996|Actual|1996-12-12|September 2017|2017-09-01|January 3, 1997|Actual|1997-01-03|January 3, 1997|Actual|1997-01-03||Interventional|||Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Primitive Neuroectodermal Tumor Outside the Central Nervous System|Terminated||Phase 2|1|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:29.15794|2017-10-11 04:23:29.15794
NCT00003516|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer|Phase II Study of Antineoplaston A10 and AS2-1 Capsules In Patients With Incurable, Stage C or D Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:29.238186|2017-10-11 04:23:29.238186
NCT00003517|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer|Phase II Study of Antineoplastons A10 and AS2-1 Capsules With Total Androgen Blockade in Patients With Stage III or IV Adenocarcinoma of the Prostate|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:29.294094|2017-10-11 04:23:29.294094
NCT00003518|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||January 1999||1999-01-01|January 2010|2010-01-01||||July 2002|Actual|2002-07-01||Interventional|||Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors|Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors|Completed||Phase 2|44|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:23:29.374641|2017-10-11 04:23:29.374641
NCT00003519|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-27|||August 1998||1998-08-01|January 2010|2010-01-01||||January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer|Phase III Study of Adriamycin/Taxotere Versus Adriamycin/Cytoxan for the Adjuvant Treatment of Node Positive or High Risk Node Negative Breast Cancer|Completed||Phase 3|2778|Anticipated|Eastern Cooperative Oncology Group|||||||||t||||||||||2017-10-11 04:23:29.574783|2017-10-11 04:23:29.574783
NCT00003520|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-27|||March 27, 1996|Actual|1996-03-27|September 2017|2017-09-01|January 23, 2005|Actual|2005-01-23|January 23, 2005|Actual|2005-01-23||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Kidney|Terminated||Phase 2|15|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:31.096537|2017-10-11 04:23:31.096537
NCT00003521|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-27|||June 14, 1996|Actual|1996-06-14|August 2017|2017-08-01|August 30, 2003|Actual|2003-08-30|August 30, 2003|Actual|2003-08-30||Interventional|||Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Soft Tissue Sarcoma|Terminated||Phase 2|14|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:31.163535|2017-10-11 04:23:31.163535
NCT00005369|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1992||1992-09-01|April 2002|2002-04-01|August 1996|Actual|1996-08-01|||||Observational|||Coronary Artery Disease Mechanisms in High Risk Families--Racial Difference||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:03.987173|2017-10-11 04:28:03.987173
NCT00003522|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-27|||August 13, 1997|Actual|1997-08-13|September 2017|2017-09-01|December 14, 1997|Actual|1997-12-14|December 14, 1997|Actual|1997-12-14||Interventional|||Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Small Intestine|Terminated||Phase 2|1|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:31.239736|2017-10-11 04:23:31.239736
NCT00003523|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-06-20|||January 1999||1999-01-01|June 2005|2005-06-01|October 2007|Actual|2007-10-01|||||Interventional|||Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum|Evaluation of Aminocamptothecin (9-AC, NSC #603071) in Recurrent, Platinum Resistant and Refractory Ovarian Cancer and Primary Peritoneal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:31.323825|2017-10-11 04:23:31.323825
NCT00003524|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-27|||October 4, 1996|Actual|1996-10-04|September 2017|2017-09-01|August 24, 1998|Actual|1998-08-24|August 24, 1998|Actual|1998-08-24||Interventional|||Antineoplaston Therapy in Treating Patients With Stomach Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Adenocarcinoma of the Stomach|Terminated||Phase 2|1|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:31.54229|2017-10-11 04:23:31.54229
NCT00003525|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-09-27|||June 3, 1996|Actual|1996-06-03|September 2017|2017-09-01|January 22, 1998|Actual|1998-01-22|January 22, 1998|Actual|1998-01-22||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Uterine Cervix and/or Vulva|Terminated||Phase 2|8|Actual|Burzynski Research Institute||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:23:31.621986|2017-10-11 04:23:31.621986
NCT00003526|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-10-24|||March 1996||1996-03-01|October 2008|2008-10-01||||February 2008|Anticipated|2008-02-01||Interventional|||Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Adenocarcinoma of Unknown Primary|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:31.821149|2017-10-11 04:23:31.821149
NCT00003528|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-15|||September 1998||1998-09-01|January 2013|2013-01-01||||June 2002|Actual|2002-06-01||Interventional|||Raltitrexed in Treating Children With Refractory Acute Leukemia|A Phase I Trial of Tomudex in Children With Leukemia|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:31.899361|2017-10-11 04:23:31.899361
NCT00003530|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Primary Liver Cancer|Phase II Study of Antineoplaston A10 in Patients With Primary Liver Cancer|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:31.982836|2017-10-11 04:23:31.982836
NCT00003531|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-01-21|||April 1996||1996-04-01|October 2008|2008-10-01||||January 2008|Anticipated|2008-01-01||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Adenocarcinoma of the Pancreas|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:32.069664|2017-10-11 04:23:32.069664
NCT00003532|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Carcinoma of the Ovary|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:32.162599|2017-10-11 04:23:32.162599
NCT00003533|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:32.231576|2017-10-11 04:23:32.231576
NCT00003534|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:32.315147|2017-10-11 04:23:32.315147
NCT00003536|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer|Phase II Randomized Study of Methotrexate With or Without Antineoplaston A10 Capsules in Women With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:32.50659|2017-10-11 04:23:32.50659
NCT00003537|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-24|2016-10-25||April 1995||1995-04-01|July 2017|2017-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|AA||Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Anaplastic Astrocytoma|Completed||Phase 2|19|Actual|Burzynski Research Institute||1|||f||||f||||||||||2017-10-11 04:23:32.623771|2017-10-11 04:23:32.623771
NCT00003538|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-01|||March 1997||1997-03-01|May 2014|2014-05-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation|Stem Cell Augmented, Elutriated Grafts for Allogeneic Bone Marrow Transplantation|Completed||N/A|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:23:33.109234|2017-10-11 04:23:33.109234
NCT00003539|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||April 1998||1998-04-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer|Phase II Study of Weekly 1-Hour Paclitaxel (Taxol) Plus Recombinant Humanized Anti-p185HER2 Monoclonal Antibody (Herceptin) in the Treatment of Patients With Metastatic Breast Cancer|Completed||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:33.254271|2017-10-11 04:23:33.254271
NCT00003540|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||June 1998||1998-06-01|June 2013|2013-06-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel|Phase II Study of Gemcitabine in the Treatment of Patients With Metastatic Breast Cancer Previously Treated With Adriamycin and Taxol|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:33.39099|2017-10-11 04:23:33.39099
NCT00003541|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||June 1998||1998-06-01|June 2013|2013-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma|High Dose Combined Modality Therapy With Peripheral Blood Progenitor Cell Transplantation as Primary Treatment for Patients With Mantle Cell Lymphoma|Completed||Phase 1/Phase 2|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:33.485635|2017-10-11 04:23:33.485635
NCT00003542|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||May 1998||1998-05-01|June 2013|2013-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Interferon Alfa in Treating Patients With Advanced Kidney Cancer|Phase I/II Study of Subcutaneous Administration of Pegylated-Interferon Alpha-2A (RO 25-8310) in Previously Untreated Patients With Locally Advanced or Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|58|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:33.580609|2017-10-11 04:23:33.580609
NCT00003543|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||June 1998||1998-06-01|June 2013|2013-06-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|Phase I Study of Combination Immunochemotherapy in Patients With Advanced Colorectal Carcinoma|Completed||Phase 1|18|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:33.656598|2017-10-11 04:23:33.656598
NCT00003544|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||June 1998||1998-06-01|June 2013|2013-06-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Irinotecan in Treating Patients With Metastatic Colorectal Cancer|A Phase II Trial of Preoperative Irinotecan (CPT-11) in Patients With High-Risk Resectable Metastatic Colorectal Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:33.740525|2017-10-11 04:23:33.740525
NCT00003545|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||August 1998||1998-08-01|April 2007|2007-04-01||||March 2007|Actual|2007-03-01||Interventional|||506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|A Phase II Study of 506U78 in Patients With Refractory or Relapsed T-Lineage Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphomas (LBL)|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:33.923646|2017-10-11 04:23:33.923646
NCT00003546|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|||September 1998||1998-09-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|December 2003|Actual|2003-12-01||Interventional|||Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer|Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas|Completed||Phase 2|43|Actual|Alliance for Clinical Trials in Oncology||1|||f||||||||||||||2017-10-11 04:23:34.192063|2017-10-11 04:23:34.192063
NCT00003548|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2011-03-25|||August 1998||1998-08-01|March 2011|2011-03-01||||December 2001|Actual|2001-12-01||Interventional|||Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity|Phase I Study of Intraperitoneal Administration of 9-Amino-20(S)-Camptothecin to Patients With Cancer Predominantly Confined to the Peritoneal Cavity|Completed||Phase 1|20|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:23:34.396154|2017-10-11 04:23:34.396154
NCT00003549|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-05|||October 1998||1998-10-01|October 2012|2012-10-01|January 2003|Actual|2003-01-01|September 2001|Actual|2001-09-01||Interventional|||S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer|A Phase II Trial of Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)|Completed||Phase 2|80|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:34.509679|2017-10-11 04:23:34.509679
NCT00003551|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||August 1998||1998-08-01|July 2000|2000-07-01|September 2004|Actual|2004-09-01|||||Interventional|||Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer|A Phase II Study of 9-Amino-20(S)-Camptothecin (9-AC) (NSC 603071) and Evaluation of Drug Resistance in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:34.732924|2017-10-11 04:23:34.732924
NCT00003552|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2015-04-27|||January 1999||1999-01-01|December 2001|2001-12-01|October 2002|Actual|2002-10-01|||||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma|Phase I/II Study of HLA-Matched Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation Followed by Allogeneic T-cell Infusion as Adoptive Immunotherapy in Patients With Metastatic Melanoma|Terminated||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:34.794993|2017-10-11 04:23:34.794993
NCT00003553|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-06-23|||January 1999||1999-01-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|||Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer|A Phase II Study of HLA-Matched Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation for Metastatic Renal Cell Carcinoma Followed by Allogeneic T-Cell Infusion as Adoptive Immunotherapy|Unknown status|Recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)||6|||f||||||||||||||2017-10-11 04:23:34.862065|2017-10-11 04:23:34.862065
NCT00003554|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-17|||November 1998||1998-11-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|||||Interventional|||Rituximab in Treating Patients With Multiple Myeloma|Rituxan in the Management of Multiple Myeloma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:34.956762|2017-10-11 04:23:34.956762
NCT00003555|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||July 1998||1998-07-01|May 2006|2006-05-01|May 2003|Actual|2003-05-01|||||Interventional|||Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors|Use of Weekly One Hour Paclitaxel Infusion With Dose Escalation for Recurrent and Resistant Cancers, Using Amifostine as a Cytoprotector|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:35.045007|2017-10-11 04:23:35.045007
NCT00003556|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||January 1999||1999-01-01|February 2013|2013-02-01||||May 2001|Actual|2001-05-01||Interventional|||Vaccine Therapy in Treating Patients With Melanoma|Phase Ib Trial of Intratumoral Injection of a Recombinant Canarypox Virus Encoding Human B7.1 (ALVAC-hB7.1) or a Combination of ALVAC-hB7.1 and a Recombinant Canarypox Virus Encoding Human Interleukin 12 (ALVAC-hIL-12) in Patients With Surgically Incurable Melanoma|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:35.114664|2017-10-11 04:23:35.114664
NCT00003557|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-03-05|||January 1999||1999-01-01|March 2014|2014-03-01|August 2003|Actual|2003-08-01|June 2000|Actual|2000-06-01||Interventional|||Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer|A Phase II Trial of Dolastatin-10 (NSC 376128) Administered as an IV Bolus Every 3 Weeks in Patients With Hepatobiliary Cancer|Completed||Phase 2|16|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:23:35.198312|2017-10-11 04:23:35.198312
NCT00003558|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-06|||August 1998||1998-08-01|February 2003|2003-02-01||||||||Interventional|||Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin|A Randomized Phase III Trial of Paclitaxel, Carboplatin and Etoposide Vs. 5-Fluorouracil and Folinic Acid in the Treatment of Patients With Adenocarcinoma of Unknown Primary Site|Unknown status|Active, not recruiting|Phase 3|140|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:35.299121|2017-10-11 04:23:35.299121
NCT00003560|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||May 1998||1998-05-01|September 2003|2003-09-01||||||||Interventional|||Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Study of Docetaxel and Carboplatin for Suboptimally Debulked Stage III or Stage IV Ovarian and Fallopian Tube Carcinoma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:35.372128|2017-10-11 04:23:35.372128
NCT00003561|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-07-19|||February 1998||1998-02-01|April 2011|2011-04-01|August 2010|Actual|2010-08-01|October 2001|Actual|2001-10-01||Interventional|||Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia|Granulocyte-Macrophage Colony Stimulating Factor (Rhu-GM-CSF) With Interferon-Alpha (IFN-alpha) for Chronic Myeloid Leukemia|Terminated||Phase 2|48|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:23:35.437089|2017-10-11 04:23:35.437089
NCT00003562|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||July 1998||1998-07-01|March 2001|2001-03-01||||||||Interventional|||Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase II Study of Non-Small Cell Cancer of the Lung Utilizing Low-Dose Weekly Therapy of Taxotere and Carboplatin|Unknown status|Active, not recruiting|Phase 2|38|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:35.49473|2017-10-11 04:23:35.49473
NCT00003563|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-10-29|||August 1998||1998-08-01|June 2008|2008-06-01|June 2005|Actual|2005-06-01|September 2001|Actual|2001-09-01||Interventional|||Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases|Phase III Randomized Trial of Gadolinium Texaphyrin (PCI-0120) Injection as a Radiation Sensitizer in Patients Receiving Whole Brain Radiation Therapy for the Treatment of Brain Metastases|Completed||Phase 3|430|Anticipated|Pharmacyclics LLC.||2|||||||||||||||||2017-10-11 04:23:35.563269|2017-10-11 04:23:35.563269
NCT00003564|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-02-17||||||February 2012|2012-02-01||||||||Interventional|||Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas|Phase III Randomized Evaluation of 13-Cis-Retinoic Acid (cRA) Plus Procarbazine Versus Procarbazine Alone in the Treatment of Patients With Recurrent Primary Malignant Gliomas|Withdrawn||Phase 3|0|Actual|M.D. Anderson Cancer Center||2||Study withdrawn.|f||||f||||||||||2017-10-11 04:23:35.854136|2017-10-11 04:23:35.854136
NCT00003565|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||September 1998||1998-09-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2006|Actual|2006-01-01||Interventional|||Docetaxel in Treating Patients With Solid Tumors|A Study of Population Pharmacokinetics of Docetaxel (Taxotere) in Caucasian and African-American Cancer Patients|Completed||Phase 2|109|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:35.96848|2017-10-11 04:23:35.96848
NCT00003566|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||September 1998||1998-09-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer|Pre-Resection Minimally Invasive Surgical Restaging of Stage III (Mediastinal Node Positive) Non-Small Cell Lung Cancer (NSCLC)|Completed||N/A|75|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:36.230964|2017-10-11 04:23:36.230964
NCT00003567|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-09|||May 1999||1999-05-01|June 2010|2010-06-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|Mutant MGMT Gene Transfer Into Human Hematopoietic Progenitors to Protect Hematopoiesis During O6-Benzylguanine (BG, NSC 637037) and Carmustine Followed by Temozolomide Therapy of Advanced Solid Tumors|Terminated||Phase 1|8|Actual|Case Comprehensive Cancer Center||1||slow accrual|f||||t||||||||||2017-10-11 04:23:36.47232|2017-10-11 04:23:36.47232
NCT00003004|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||July 1997||1997-07-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors|An Open-Label, Non-Randomized Phase I Study of the Protein Kinase C Inhibitor Flavopiridol Administered in Combination With Paclitaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|73|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:36.587354|2017-10-11 04:23:36.587354
NCT00003005|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-12|||December 1997||1997-12-01|June 2000|2000-06-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia|A Phase I Study of Cordycepin (NSC 63984) Plus 2'-Deoxycoformycin (NSC 218321) in Patients With Refractory TdT-Positive Leukemia|Completed||Phase 1|14|Actual|Boston Medical Center||1|||f||||t||||||||||2017-10-11 04:23:36.684683|2017-10-11 04:23:36.684683
NCT00003006|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-28|||May 1997||1997-05-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|March 2002|Actual|2002-03-01||Observational|||Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer|Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis|Completed||N/A|501|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Patients enrolled onto CALGB 9761 will have, at the time of thoracotomy (or video assisted     lobectomy) and pulmonary resection, samples of bone marrow, primary tumor, and intrathoracic     lymph nodes harvested.   "|||2017-10-11 04:23:36.817285|2017-10-11 04:23:36.817285
NCT00003007|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||July 1996||1996-07-01|September 2002|2002-09-01|January 2004|Actual|2004-01-01|||||Interventional|||Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma|Interferon Maintenance in Advanced Multiple Myeloma After Using High-Dose Melphalan as Myeloablative Chemotherapy: A Pilot Study|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:36.942499|2017-10-11 04:23:36.942499
NCT00003008|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||June 1997||1997-06-01|January 2010|2010-01-01||||June 2006|Actual|2006-06-01||Interventional|||Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma|Pilot Study to Evaluate the Potential Interactions Between Paclitaxel and Protease Inhibitors in Patients With AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|33|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:23:37.04559|2017-10-11 04:23:37.04559
NCT00003009|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||February 1996||1996-02-01|May 2014|2014-05-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer|A Phase I Study of Inhalation of Interleukin-2 (IL-2) in Patients With Metastatic or Unresectable Cancer|Terminated||Phase 1|16|Actual|University of Southern California||||Insufficient Accrual|f||||t||||||||||2017-10-11 04:23:37.143138|2017-10-11 04:23:37.143138
NCT00003010|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||September 1997||1997-09-01|January 2010|2010-01-01||||December 2004|Actual|2004-12-01||Interventional|||Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy|A Randomized Phase III Trial of Marimastat Versus Placebo in Patients With Metastatic Breast Cancer Who Have Responding or Stable Disease After Induction Chemotherapy|Completed||Phase 3|334|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-10-11 04:23:37.221338|2017-10-11 04:23:37.221338
NCT00003011|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-30|||March 1997||1997-03-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|January 2001|Actual|2001-01-01||Interventional|||Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer|A Phase III Study of Marimastat in Patients With Small Cell Lung Cancer Following a Response to First Line Chemotherapy|Completed||Phase 3|555|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:23:37.36898|2017-10-11 04:23:37.36898
NCT00003012|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||October 1996||1996-10-01|November 2008|2008-11-01||||||||Interventional|||Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer|A Prospective Randomized Comparison of CMF Versus Sequential Epirubicin Followed by SMF as Adjuvant Chemotherapy for Women With Early Breast Cancer|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:37.564167|2017-10-11 04:23:37.564167
NCT00003013|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||October 1996||1996-10-01|June 2000|2000-06-01|March 2009|Actual|2009-03-01|||||Interventional|||Chemotherapy Plus Surgery in Treating Women With Breast Cancer|European Cooperative Study of Chemotherapy and Surgery Comparing Adjuvant Doxorubicin Followed by CMF vs. Adjuvant Doxorubicin/Paclitaxel Followed by CMF vs. Primary Doxorubicin/Paclitaxel Followed by CMF in Women With Operable Breast Cancer and T>2 cm|Completed||Phase 3|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:37.67929|2017-10-11 04:23:37.67929
NCT00003014|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||April 1998||1998-04-01|March 2011|2011-03-01|July 2005|Actual|2005-07-01|||||Interventional|||Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer|Carboplatin in the Adjuvant Treatment of Stage I Seminoma: A Radomized Comparison of Single Agent Carboplatin With Radiotherapy in the Adjuvant Treatment of Stage I Seminoma of the Testis, Following Orchidectomy|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:37.847564|2017-10-11 04:23:37.847564
NCT00003015|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||January 1997||1997-01-01|January 2001|2001-01-01||||||||Interventional|||Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma|Ultimate Low Grade Glioma Study|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:38.149981|2017-10-11 04:23:38.149981
NCT00003016|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||October 1995||1995-10-01|October 2002|2002-10-01||||||||Interventional|||Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer|Reliable Assessment of the Efficacy and Safety of Prolonging the Use of Adjuvant Tamoxifen: A Large, Simple, Randomised Study|Unknown status|Active, not recruiting|Phase 3|20000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:38.223083|2017-10-11 04:23:38.223083
NCT00003017|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||July 1997||1997-07-01|July 2004|2004-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix|Phase II Clinical Trial of Interleukin-12 in Patients With Advanced, Recurrent or Inoperable Carcinoma of the Cervix|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:38.302317|2017-10-11 04:23:38.302317
NCT00003018|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-02|||September 1997||1997-09-01|January 2013|2013-01-01|January 2007|Actual|2007-01-01|January 2002|Actual|2002-01-01||Interventional|||S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer|A Phase II Trial of Infusional 5-Fluorouracil (5-FU), Calcium Leucovorin (LV), Mitomycin-C (Mito-C), and Dipyridamole (D) in Patients With Locally Advanced Unresected Pancreatic Adenocarcinoma|Completed||Phase 2|54|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:38.397924|2017-10-11 04:23:38.397924
NCT00003019|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2014-07-24|||August 1997||1997-08-01|July 2014|2014-07-01|September 2006|Actual|2006-09-01|July 2003|Actual|2003-07-01||Interventional|||Vinblastine and Methotrexate in Treating Children With Desmoid Tumors|Vinblastine and Methotrexate in Children With Desmoid Tumor (Aggressive Fibromatosis) Which is Recurrent or Not Amenable to Surgical Resection or Irradiation - A Pediatric Oncology Group Phase II Study|Completed||Phase 2|28|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:38.733539|2017-10-11 04:23:38.733539
NCT00003020|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||September 1997||1997-09-01|February 2013|2013-02-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases|Protocol for a Phase I Study of Intrathecal LMB-7 (Single-Chain Immunotoxin Constructed From Monoclonal Antibody B3-Pseudomonas Exotoxin PE 38) [IND 5863, NSC 658931] in the Treatment of Patients With Leptomeningeal Neoplasms|Completed||Phase 1|24|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:23:38.916522|2017-10-11 04:23:38.916522
NCT00003021|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-02|||August 1997||1997-08-01|November 2012|2012-11-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Bizelesin in Treating Patients With Advanced Cancer|A Phase I Trial of Bizelesin (NSC 615291) Using a Single Bolus Infusion Given Every Twenty-eight (28) Days in Patients With Advanced Cancer|Completed||Phase 1|||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 04:23:38.982082|2017-10-11 04:23:38.982082
NCT00003568|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||November 1998||1998-11-01|November 2005|2005-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma|A Randomized Phase II Trial of a Mutated gp100 Melanoma Peptide (g209-217(210M) With Hight Dose Interleukin-2 (IL-2) in HLA-A2.1+Patients With Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:39.057193|2017-10-11 04:23:39.057193
NCT00003569|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-30|||March 1998||1998-03-01|January 2013|2013-01-01||||June 2003|Actual|2003-06-01||Observational|||Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel|Phase I Trial of Escalating Doses of BNP7787 in Patients With Solid Tumors Undergoing Treatment With Cisplatin and Taxol|Completed||Phase 1|2|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:23:39.140197|2017-10-11 04:23:39.140197
NCT00003571|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||August 1998||1998-08-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Gene Testing in Patients With Colon Cancer|Tumor Replication Error (RER) Status and Outcome in a Colon Cancer Adjuvant Chemotherapy Trial|Completed||N/A|300|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Samples of tumor and normal tissue   "|||2017-10-11 04:23:39.243265|2017-10-11 04:23:39.243265
NCT00003572|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-01|||August 1998||1998-08-01|May 2014|2014-05-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers|Non-Myeloablative Allogeneic Bone Marrow Transplant for Hematologic Malignancies|Completed||Phase 2|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:23:39.410131|2017-10-11 04:23:39.410131
NCT00003573|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-24|||November 1998||1998-11-01|July 2014|2014-07-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma|A Phase I/II Feasibility Study of Oral Etoposide Given Concurrently With Radiotherapy Followed With Dose Intensive Adjuvant Chemotherapy for Children With Newly Diagnosed High Stage Medulloblastoma|Completed||Phase 2|53|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:23:39.52812|2017-10-11 04:23:39.52812
NCT00003574|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||April 1999||1999-04-01|November 2000|2000-11-01|June 2004|Actual|2004-06-01|||||Interventional|||Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors|A Multi-Center, Open-Label Clinical Study to Evaluate the Safety and Performance of the Proxima GliaSite RTS, a Radiation Delivery System, in Patients With Recurrent Malignant Brain Tumors Undergoing Surgical Resection|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:39.828963|2017-10-11 04:23:39.828963
NCT00003575|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||January 1999||1999-01-01|October 2002|2002-10-01||||April 2002|Actual|2002-04-01||Interventional|||Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma|A Randomized Pre-Phase II Trial of Interleukin-2, Interleukin-12, or No Additional Therapy Following Response to Ifosfamide/Etoposide Chemotherapy for Refractory HIV-Associated Non-Hodgkin's Lymphoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:39.91259|2017-10-11 04:23:39.91259
NCT00003576|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||January 1997||1997-01-01|April 2007|2007-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery|Surgery and Adjuvant Radiotherapy Versus Concurrent Chemo-Radiotherapy for Resectable (Non-Metastatic) Stage III/IV Head and Neck Squamous Cell Cancer|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:40.014747|2017-10-11 04:23:40.014747
NCT00003577|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||March 1996||1996-03-01|February 2001|2001-02-01|September 2008|Actual|2008-09-01|||||Interventional|||Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer|National Breast Cancer Study of Epirubicin + CMF v Classical CMF Adjuvant Therapy|Completed||Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:40.084564|2017-10-11 04:23:40.084564
NCT00003578|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||January 1993||1993-01-01|May 2007|2007-05-01||||||||Interventional|||High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma|A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL|Unknown status|Active, not recruiting|Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:40.162436|2017-10-11 04:23:40.162436
NCT00003580|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||June 1998||1998-06-01|May 2006|2006-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer|Phase II Study - Efficacy of Amifostine in Alleviating Toxicity Associated With Targeted Supradose Cisplatin and Concomitant Radiation Therapy (RADPLAT) in Head and Neck Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:40.344407|2017-10-11 04:23:40.344407
NCT00003582|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-14|||May 1988||1988-05-01|December 2016|2016-12-01|December 1996|Actual|1996-12-01|December 1996|Actual|1996-12-01||Interventional|||Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer|Phase I/II Study to Evaluate Combined Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) and Amifostine (WR 2721, Ethyol) in Stage III and IV Inoperable Head and Neck Carcinomas|Completed||Phase 1/Phase 2|36|Anticipated|University of Miami|||||f||||||||||||||2017-10-11 04:23:40.40754|2017-10-11 04:23:40.40754
NCT00003583|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||June 1997||1997-06-01|May 2006|2006-05-01||||||||Interventional|||Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer|A Phase II Trial Using Amifostine as a Chemo/Radio Protective Agent in the Treatment of Limited Stage Small-Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:40.469213|2017-10-11 04:23:40.469213
NCT00003584|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-05-10|||July 1998||1998-07-01|May 2016|2016-05-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer|A Phase II Trial of Combination Vinorelbine-Estramustine With or Without Prednisone for High Risk and Recurrent, Advanced and Metastatic Renal Cell Carcinoma|Completed||Phase 2|35|Anticipated|University of New Mexico|||||f||||||||||||||2017-10-11 04:23:40.642289|2017-10-11 04:23:40.642289
NCT00003585|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-09|||August 1996||1996-08-01|December 2013|2013-12-01|August 2002|Actual|2002-08-01|August 2001|Actual|2001-08-01||Interventional|||Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer|A Phase I/II Pilot Study of a Novel Four Drug Regimen for the Treatment of Advanced Renal Cell Carcinoma: FUNIL-cRA|Completed||Phase 1/Phase 2|35|Anticipated|University of New Mexico|||||f||||f||||||||||2017-10-11 04:23:40.709515|2017-10-11 04:23:40.709515
NCT00003587|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-05|||October 1998||1998-10-01|October 2012|2012-10-01|January 2007|Actual|2007-01-01|January 2001|Actual|2001-01-01||Interventional|||S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Randomized Phase II Trial of Carboplatin/Gemcitabine Followed By Paclitaxel or Cisplatin/Vinorelbine Followed by Docetaxel in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|204|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:23:40.798008|2017-10-11 04:23:40.798008
NCT00003588|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||September 1998||1998-09-01|June 2002|2002-06-01||||March 2002|Actual|2002-03-01||Interventional|||Gene Therapy in Treating Patients With Ovarian Cancer|A Phase I Study of Ad-p53 (NSC# 683550) for Patients With Platinum- and Paclitaxel-Resistant Epithelial Ovarian Cancer|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:41.098572|2017-10-11 04:23:41.098572
NCT00003589|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-05|||August 1998||1998-08-01|March 2012|2012-03-01||||July 2000|Actual|2000-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer|Randomized Study With New Combination Chemotherapies in Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|450|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:23:41.178504|2017-10-11 04:23:41.178504
NCT00003590|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-04-20|2011-11-07||November 1998||1998-11-01|April 2016|2016-04-01|July 2011|Actual|2011-07-01|December 2008|Actual|2008-12-01||Interventional|||S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma|Phase II Study of Hydroxyurea for Unresectable Meningioma|Completed||Phase 2|29|Actual|Southwest Oncology Group|Early termination leading to fewer than expected subjects analyzed. With 28 eligible patients estimate of response probability can be estimated to within +/- 19%.|1|||f||||f||||||||||2017-10-11 04:23:41.3612|2017-10-11 04:23:41.3612
NCT00003591|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-11|||November 1998||1998-11-01|November 2013|2013-11-01|October 2005|Actual|2005-10-01|June 2001|Actual|2001-06-01||Interventional|||Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer|A Phase II Trial of External Irradiation (50.4 GY) and Weekly Paclitaxel (Taxol) for Non-Metastatic, Unresectable Pancreatic Cancer|Completed||Phase 2|122|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:42.046049|2017-10-11 04:23:42.046049
NCT00003592|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-01-28|||September 1998||1998-09-01|January 2009|2009-01-01||||August 2000|Actual|2000-08-01||Interventional|||Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer|Phase III Randomized Trial of Methotrexate vs. Paclitaxel in Cisplatin-Ineligible Patients With Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|230|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:42.578995|2017-10-11 04:23:42.578995
NCT00003593|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-26|||June 1999||1999-06-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|March 2007|Actual|2007-03-01||Interventional|||Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome|Treatment of Children With Down Syndrome (DS) and Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Transient Myeloproliferative Disorder (TMD): A Phase III Group-Wide Study|Completed||Phase 3|254|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:23:42.740439|2017-10-11 04:23:42.740439
NCT00003594|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||October 1998||1998-10-01|July 2016|2016-07-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum|Completed||Phase 3|1691|Actual|Alliance for Clinical Trials in Oncology||3|||f||||f||||||||||2017-10-11 04:23:44.799897|2017-10-11 04:23:44.799897
NCT00003595|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||January 1999||1999-01-01|May 2007|2007-05-01||||April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma|Randomized Trial of CHOP Chemotherapy With or Without Rituximab (Chimeric Anti-CD20 Antibody) for HIV-Associated Non-Hodgkin's Lymphoma|Completed||Phase 3|120|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:23:45.837947|2017-10-11 04:23:45.837947
NCT00003596|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-30|||October 1998||1998-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2005|Actual|2005-10-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer|A Phase III Randomized Study of 5-Fluorouracil, Mitomycin-C, and Radiotherapy Versus 5-Fluorouracil, Cisplatin, and Radiotherapy in Carcinoma of the Anal Canal|Completed||Phase 3|682|Actual|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:23:46.101948|2017-10-11 04:23:46.101948
NCT00003597|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||November 1998||1998-11-01|July 2014|2014-07-01|September 2005|Actual|2005-09-01|October 2004|Actual|2004-10-01||Interventional|||Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors|A Phase I Study of Thrombopoietin (rhTPO) Plus G-CSF in Children Receiving Ifosfamide, Carboplatin, and Etoposide (I.C.E.) Chemotherapy for Recurrent or Refractory Solid Tumors|Completed||Phase 1|16|Actual|Children's Oncology Group||2|||f||||||||||||||2017-10-11 04:23:47.399512|2017-10-11 04:23:47.399512
NCT00003650|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-01-20|||June 1998||1998-06-01|March 2001|2001-03-01||||||||Interventional|||Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma|Phase III Study of Combination Chemotherapy in Children With T Cell and Pre-B Cell Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:47.606668|2017-10-11 04:23:47.606668
NCT00003652|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||January 1999||1999-01-01|May 2005|2005-05-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer|Intensification Therapy for Locally Advanced Epidermoid Cancer of the Anal Canal - Phase III Intergroup Study|Unknown status|Active, not recruiting|Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:47.758256|2017-10-11 04:23:47.758256
NCT00003653|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-11-25|||January 1999||1999-01-01|August 2012|2012-08-01|January 2013|Actual|2013-01-01|May 2010|Actual|2010-05-01||Interventional|||Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer|A Phase III Randomized Trial Comparing Intermittent Versus Continuous Androgen Suppression for Patients With Prostate-Specific-Antigen Progression in the Clinical Absence of Distant Metastases Following Radiotherapy for Prostate Cancer|Completed||Phase 3|1386|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:23:47.945635|2017-10-11 04:23:47.945635
NCT00005370|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1993||1993-04-01|November 2001|2001-11-01|March 1999|Actual|1999-03-01|||||Observational|||Longitudinal Study of Cortisol and Pulmonary Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.066606|2017-10-11 04:28:04.066606
NCT00003654|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||September 1997||1997-09-01|December 2006|2006-12-01||||||||Interventional|||Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer|Diagnostic Study of Patent Blue V Dye to Identify Sentinel Lymph Nodes in Patients With Stage I or IIA Breast Cancer|Unknown status|Active, not recruiting|N/A|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:48.121324|2017-10-11 04:23:48.121324
NCT00003656|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-02-14|||January 1999|Actual|1999-01-01|February 2017|2017-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer|Phase II Trial of Atragen and Interferon Alfa-2b in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|26|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-10-11 04:23:48.193284|2017-10-11 04:23:48.193284
NCT00003657|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-19|||July 1998||1998-07-01|January 2017|2017-01-01|June 2002|Actual|2002-06-01|November 2000|Actual|2000-11-01||Interventional|||High-dose ICE With Amifostine|High Dose Ifosfamide, Carboplatin and Etoposide With Amifostine Chemoprotection|Completed||Phase 2|24|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 04:23:48.298992|2017-10-11 04:23:48.298992
NCT00003658|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||September 1998||1998-09-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers|A Phase I-II Study of Pentostatin With Cyclophosphamide for Previously Treated Patients With Intermediate and High-Risk Chronic Lymphocytic Leukemia|Completed||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:48.471001|2017-10-11 04:23:48.471001
NCT00003659|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-11|2012-11-28||September 1998||1998-09-01|January 2017|2017-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia|A Phase II Study of Fludarabine Induction With Sequential High Dose Cyclophosphamide and Rituximab as Consolidation Therapy for Previously Untreated Patients With Intermediate and High-Risk Chronic Lymphocytic Leukemia|Completed||Phase 2|39|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:23:48.573776|2017-10-11 04:23:48.573776
NCT00003661|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-03|||June 1998||1998-06-01|March 2011|2011-03-01|March 2006|Actual|2006-03-01|November 1999|Actual|1999-11-01||Interventional|||Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer|A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Children and Adults With Hematologic Malignancies|Completed||Phase 2|3|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:23:48.809169|2017-10-11 04:23:48.809169
NCT00003662|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-03|||August 1998||1998-08-01|March 2011|2011-03-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases|A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Adults and Children With Bone Marrow Failure Syndromes or Inherited Metabolic or Hematologic Diseases|Completed||Phase 2|90|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:23:48.945142|2017-10-11 04:23:48.945142
NCT00003663|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-08-17|||June 1998||1998-06-01|August 2015|2015-08-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma|Rituximab Anti-CD20 Monoclonal Antibody and Dexamethasone in the Treatment of Relapsed Indolent Lymphoma|Withdrawn||Phase 2|0|Actual|Hoag Memorial Hospital Presbyterian||||no patient accrual|f||||f||||||||||2017-10-11 04:23:49.060729|2017-10-11 04:23:49.060729
NCT00003664|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||October 1998||1998-10-01|September 2000|2000-09-01||||||||Interventional|||Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically|Combination Chemobiotherapy With Gemcitabine, 5-Fluorouracil, Interleukin-2 and Alpha Interferon in Patients With Metastatic or Unresectable Renal Cell Cancer. A Phase II Study|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:49.133858|2017-10-11 04:23:49.133858
NCT00003665|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-27|||April 1999||1999-04-01|February 2013|2013-02-01|November 2002|Actual|2002-11-01|October 2002|Actual|2002-10-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|Phase I Trial of a Dendritic Cell Vaccine for Melanoma|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:23:49.20691|2017-10-11 04:23:49.20691
NCT00003666|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|||November 1998||1998-11-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|September 2004|Actual|2004-09-01||Interventional|||Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer|Phase II Trial of 6-Hydroxymethylacylfulvene (HMAF; MGI-114) in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer|Completed||Phase 2|36|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:49.444931|2017-10-11 04:23:49.444931
NCT00003667|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||September 1998||1998-09-01|June 2013|2013-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma|Randomized Phase II Study of Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane With and Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:49.711971|2017-10-11 04:23:49.711971
NCT00003669|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-06|||November 1998||1998-11-01|April 2008|2008-04-01|April 2001|Actual|2001-04-01|||||Interventional|||Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer|Phase II Nonrandomized Study of LY353381-HC1 in Patients With Recurrent or Advanced Endometrial Cancer|Completed||Phase 2|||Eli Lilly and Company|||||f||||||||||||||2017-10-11 04:23:49.809784|2017-10-11 04:23:49.809784
NCT00003670|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-06|||October 1998||1998-10-01|April 2008|2008-04-01|January 2001|Actual|2001-01-01|||||Interventional|||Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer|Phase II Study of LY353381-HC1 Administered to Women With Refractory Ovarian Cancer|Completed||Phase 2|||Eli Lilly and Company|||||f||||||||||||||2017-10-11 04:23:49.903988|2017-10-11 04:23:49.903988
NCT00003671|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-24|||December 1998||1998-12-01|July 2014|2014-07-01|February 2009|Actual|2009-02-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia|Protocol for Patients With Newly Diagnosed Better Risk Acute Lymphoblastic Leukemia (ALL): A POG Pilot Study|Completed||Phase 2|59|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:50.019748|2017-10-11 04:23:50.019748
NCT00003673|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-21|||March 1998||1998-03-01|August 2012|2012-08-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse|A Study of the Safety of CMA-676 in Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) in First Relapse|Completed||Phase 2|55|Anticipated|Pfizer|||||f||||||||||||||2017-10-11 04:23:50.304877|2017-10-11 04:23:50.304877
NCT00003674|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||December 1998||1998-12-01|July 2016|2016-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer|Phase III Double-Blind Trial Comparing Low-Molecular Weight Heparin (LMWH) Versus Placebo in Patients With Advanced Cancer|Completed||Phase 3|141|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:23:50.40882|2017-10-11 04:23:50.40882
NCT00003675|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|||March 1999||1999-03-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|January 2002|Actual|2002-01-01||Interventional|||Topotecan in Treating Patients With Myelodysplastic Syndrome|A Randomized Phase II Trial of Oral Topotecan Given Twice a Day for 5 Days or Once a Day for 10 Days to Patients With Myelodysplastic Syndromes (MDS)|Completed||Phase 2|100|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:23:50.54927|2017-10-11 04:23:50.54927
NCT00003677|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-27|||March 1999||1999-03-01|July 2012|2012-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer|Phase II Study of Dolastatin 10 (NSC# 376128) Administered Intravenously Every 21 Days to Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|9|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:23:50.751504|2017-10-11 04:23:50.751504
NCT00003678|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||May 1991||1991-05-01|March 2007|2007-03-01||||||||Interventional|||Tamoxifen in Treating Women With Breast Cancer|A Large, Uniquely Simple, Randomised Study to Assess Much More Reliably the Balance of Benefits and Risks of Prolonging Adjuvant Tamoxifen Treatment in Early Breast Cancer|Unknown status|Active, not recruiting|Phase 3|20000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:50.861279|2017-10-11 04:23:50.861279
NCT00003679|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||November 1998||1998-11-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer|A Randomised Comparative Trial of Adriamycin + Taxotere vs. Adriamycin + Cyclophosphamide as Primary Medical Therapy for Patients With Potentially Operable Breast Cancer Greater Than or Equal to 3 cm Diameter, Locally Advanced, or Inflammatory Disease|Unknown status|Active, not recruiting|Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:50.936997|2017-10-11 04:23:50.936997
NCT00003680|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||November 1998||1998-11-01|May 2007|2007-05-01||||||||Interventional|||Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer|A Randomised Comparative Trial of Highly Intensive Chemotherapy With Stem Cell Support vs. Relatively Intensive Chemotherapy (CMF 8 Cycles) in Breast Cancer Patients Node Positive Surgery, Having Received Primary Medical Therapy With an Anthracycline Regimen|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:51.03497|2017-10-11 04:23:51.03497
NCT00003681|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-05-09|||August 1998||1998-08-01|July 2000|2000-07-01||||||||Interventional|||Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome|Phase II Multicenter Study of Amifostine in Patients With Myelodysplastic Syndromes at Relatively Low Risk of Developing Acute Leukemia|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:51.128248|2017-10-11 04:23:51.128248
NCT00003682|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-22|||October 1998||1998-10-01|June 2016|2016-06-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer|Treatment of Metastatic Prostate Cancer That is Hormone-Independent: Evaluation of the Role of Chemotherapy on the Quality of Life of Patients. Phase II Study|Terminated||Phase 3|160|Anticipated|UNICANCER||||lack of inclusions|f||||||||||||||2017-10-11 04:23:51.266037|2017-10-11 04:23:51.266037
NCT00003683|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||March 1998||1998-03-01|May 2002|2002-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer|Treatment of Sarcomatous Kidney Cancer That is Metastatic in Adults With Doxorubicin and Ifosfamide. Phase II Study|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:51.406674|2017-10-11 04:23:51.406674
NCT00003684|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-11|||March 1998||1998-03-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|||||Interventional|||Theophylline in Treating Cancer Patients With Shortness of Breath|A Phase III Double-Blind Study of Theophylline Versus Placebo for the Treatment of Dyspnea in Cancer Patients|Completed||Phase 3|60|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:23:51.53814|2017-10-11 04:23:51.53814
NCT00003685|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-07|||December 1998||1998-12-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|||||Interventional|||Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer|A Phase III Trial of Single Versus Fractionated Thoracic Radiation for Palliation of Symptoms in Patients With Non-Small Cell Lung Cancer|Completed||Phase 3|210|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:23:51.654527|2017-10-11 04:23:51.654527
NCT00003686|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-30|||August 1998||1998-08-01|January 2012|2012-01-01|November 1999|Actual|1999-11-01|October 1999|Actual|1999-10-01||Interventional|||Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids|A Double Blind Phase III Study of Oral Pilocarpine for Opioid-Induced Dry Mouth|Terminated||Phase 3|4|Actual|Canadian Cancer Trials Group||2||Terminated due to poor accrual.|f||||t||||||||||2017-10-11 04:23:51.802527|2017-10-11 04:23:51.802527
NCT00003687|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-11-25|||December 1998||1998-12-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|September 2001|Actual|2001-09-01||Interventional|||Treatment for Chronic Pain in Patients With Advanced Cancer|A Phase III Double-Blind Equivalence Study of Two Different Formulations of Slow-Release Morphine Followed by a Randomization Between Dextromethorphan or Placebo Plus Statex SR for Chronic Cancer Pain Relief in Terminally Ill Patients|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-10-11 04:23:51.922755|2017-10-11 04:23:51.922755
NCT00003688|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-07|||October 1999||1999-10-01|December 2003|2003-12-01||||September 2006|Actual|2006-09-01||Interventional|||Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia|Pulse Actinomycin-D as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Neoplasia|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:23:52.064547|2017-10-11 04:23:52.064547
NCT00003690|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-08-02|||December 1998||1998-12-01|August 2011|2011-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors|Phase I Study of Flavopiridol in Combination With Cisplatin in Patients With Advanced Malignancies|Completed||Phase 1|48|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-10-11 04:23:52.361445|2017-10-11 04:23:52.361445
NCT00003691|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-08|||December 1998||1998-12-01|September 2010|2010-09-01||||June 2004|Actual|2004-06-01||Interventional|||Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer|A Randomized Study of Doxorubicin Plus Cisplatin Versus Doxorubicin Plus Cisplatin Plus 3-Hour Paclitaxel With G-CSF Support in Patients With Primary Stage III & IV or Recurrent Endometrial Carcinoma|Completed||Phase 3|240|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:23:52.462997|2017-10-11 04:23:52.462997
NCT00003692|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|||December 1998||1998-12-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer|Video-Assisted Lobectomy for Peripheral (no Greater Than 3 cm), N0, Non-Small Cell Lung Cancer: A Phase II Feasibility Study|Completed||Phase 2|128|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:52.8624|2017-10-11 04:23:52.8624
NCT00003693|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-01|||March 1999||1999-03-01|August 2012|2012-08-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia|Phase I Study of Dolastatin-10 in Acute Leukemias, Myelodysplastic Syndromes and Chronic Myeloid Leukemia in Blast Phase|Completed||Phase 1|30|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:23:53.285984|2017-10-11 04:23:53.285984
NCT00003694|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-04|||March 1999||1999-03-01|June 2013|2013-06-01||||August 2003|Actual|2003-08-01||Interventional|||Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase|A Phase II Study of Newly Diagnosed Patients With BCR/ABL (+) Chronic Myelogenous Leukemia Treated With Combined Homoharringtonine (NSC #141633) and Low-Dose Cytarabine|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:23:53.411917|2017-10-11 04:23:53.411917
NCT00003695|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||May 1998||1998-05-01|May 2007|2007-05-01|January 2001|Actual|2001-01-01|||||Interventional|||Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer|A Randomised Trial of Interval Debulking Surgery in Epithelial Ovarian Cancer Suboptimally Debulked at Primary Surgery|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:53.529008|2017-10-11 04:23:53.529008
NCT00003696|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||October 1998||1998-10-01|November 2001|2001-11-01||||||||Interventional|||Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer|Phase III Study of Cyclophosphamide, Doxorubicin and Etoposide Compared to Carboplatin and Taxol in Patients With Extensive Disease Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:53.639783|2017-10-11 04:23:53.639783
NCT00003697|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||October 1995||1995-10-01|June 2009|2009-06-01|December 1998|Actual|1998-12-01|||||Interventional|||Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors|A Phase I Trial of 5, 6 Dimethyl Xanthenone - 4 - Acetic Acid (DMXAA) in Solid Tumors|Completed||Phase 1|3|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:53.751772|2017-10-11 04:23:53.751772
NCT00003698|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||July 1998||1998-07-01|February 2008|2008-02-01|December 2003|Actual|2003-12-01|||||Interventional|||Chemotherapy in Treating Patients With Solid Tumors|A Phase I Trial of Combretastatin A4 Phosphate in Patients With Solid Tumours Given by Weekly Intravenous Infusion|Completed||Phase 1|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:53.836224|2017-10-11 04:23:53.836224
NCT00003700|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||January 1999||1999-01-01|July 2016|2016-07-01|January 2010|Actual|2010-01-01|February 2004|Actual|2004-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia|Phase II Study in Adults With Untreated Acute Lymphoblastic Leukemia Testing Increased Doses of Daunorubicin During Induction, and Cytarabine During Consolidation, Followed by High-Dose Methotrexate and Intrathecal Methotrexate in Place of Cranial Irradiation|Completed||Phase 2|163|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:53.924983|2017-10-11 04:23:53.924983
NCT00003701|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-11-02|||March 1999||1999-03-01|February 2009|2009-02-01||||August 2001|Actual|2001-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Bladder Cancer|A Phase III Randomized Trial of Either M-VAC or Paclitaxel + Carboplatin as Postoperative Adjuvant Therapy in Patients With Muscle-Invasive Transitional Cell Carcinoma of the Bladder at High-Risk for Relapse|Completed||Phase 3|490|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:54.17775|2017-10-11 04:23:54.17775
NCT00003702|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-02-09|||June 1999||1999-06-01|February 2016|2016-02-01||||July 2010|Actual|2010-07-01||Interventional|||Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia|"A Randomized Phase III Trial of Weekly Parenteral Methotrexate Versus Pulsed Dactinomycin as Primary Management for Low Risk Gestational Trophoblastic Neoplasia"|Completed||Phase 3|240|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-10-11 04:23:54.300378|2017-10-11 04:23:54.300378
NCT00003703|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-25|||January 1999||1999-01-01|September 2002|2002-09-01|March 2004|Actual|2004-03-01|||||Interventional|||Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I and Pharmacokinetics Study of SarCNU in Patients With Advanced Cancers|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:54.433111|2017-10-11 04:23:54.433111
NCT00003704|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||April 1999||1999-04-01|July 2016|2016-07-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer|Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis|Completed||Phase 1|51|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:23:54.513277|2017-10-11 04:23:54.513277
NCT00003705|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||November 1997||1997-11-01|August 2007|2007-08-01||||||||Interventional|||BMS-184476 in Treating Patients With Advanced Solid Tumors|Phase I Study of BMS-184476 in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:54.66608|2017-10-11 04:23:54.66608
NCT00003706|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-26|||April 1998||1998-04-01|June 2012|2012-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function|A Phase I Pharmacokinetic Trial of LY231514 Administered Intravenously Every 3 Weeks in Advanced Cancer Patients With Varying Degrees of Renal Function|Completed||Phase 1|50|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:23:54.742235|2017-10-11 04:23:54.742235
NCT00003707|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-26|||October 1998||1998-10-01|June 2012|2012-06-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I, Maximum Tolerated Dose (MTD) Trial to Determine the Safety and Pharmacokinetics of Chronic Oral Administration of Farnesyl Transferase Inhibitor R115777 in Combination With Gemcitabine in Subjects With Advanced Incurable Cancer|Completed||Phase 1|22|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:23:54.817782|2017-10-11 04:23:54.817782
NCT00003708|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-07|||July 1998||1998-07-01|August 2012|2012-08-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I Study of Cyclic Oral Administration of SCH 52365 for 21 of 28 Days in Patients With Advanced Solid Malignancies|Completed||Phase 1|32|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:23:54.894438|2017-10-11 04:23:54.894438
NCT00003709|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-07|||October 1998||1998-10-01|August 2012|2012-08-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I and Pharmacokinetic Study of FB-642 Administered Orally on a Weekly Schedule to Patients With Advanced Solid Tumors|Completed||Phase 1|25|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:23:54.971637|2017-10-11 04:23:54.971637
NCT00003710|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-07|||August 1998||1998-08-01|June 2012|2012-06-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors|Phase I and Pharmacokinetic Study of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Solid Tumors|Completed||Phase 1|12|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:23:55.047975|2017-10-11 04:23:55.047975
NCT00003711|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-29|||September 1997||1997-09-01|April 2000|2000-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors|A Phase I Trial of LY231514 With Irinotecan Administered Intravenously Every 21 Days in Patients With Metastatic Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:55.113677|2017-10-11 04:23:55.113677
NCT00003712|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-07|||January 2001||2001-01-01|August 2012|2012-08-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||CCI-779 in Treating Patients With Advanced Solid Tumors|A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous CCI-779 Given Once Daily for 5 Days Every 2 Weeks to Patients With Advanced Solid Tumors|Completed||Phase 1|15|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:23:55.193692|2017-10-11 04:23:55.193692
NCT00003713|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||August 1997||1997-08-01|May 2001|2001-05-01||||||||Interventional|||Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I, Pharmacokinetic, and Treatment Duration and Escalation Study of Intravenous Intoplicine Administered as a 5 to 21-Day Continuous Infusion Every 4 Weeks|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:55.261797|2017-10-11 04:23:55.261797
NCT00003714|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-02-20||||||February 2012|2012-02-01||||||||Interventional|||Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer|Phase II Trial of Pyrazoloacridine (PZA) in Previously Untreated Hepatocellular Carcinoma (HCC) Patients|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Withdrawn|f||||f||||||||||2017-10-11 04:23:55.325116|2017-10-11 04:23:55.325116
NCT00003715|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-12-02|||December 1998||1998-12-01|December 2015|2015-12-01||||||||Interventional|||Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma|A Prospective, Randomized, Open-Label, Comparative Clinical Trial in Post-Surgical Melanoma Patients With Either DNP-Modified Autologous Tumor Vaccine or Interferon Alpha-2b|Terminated||Phase 2|425|Anticipated|AVAX Technologies||||"Terminated: recruiting or enrolling participants has halted prematurely and will not resume;   participants are no longer being examined or treated"|f||||||||||||||2017-10-11 04:23:55.411167|2017-10-11 04:23:55.411167
NCT00003716|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-17|||March 1998||1998-03-01|June 2002|2002-06-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy|Phase II Trial of Rituximab in Patients With B-Cell Lymphoproliferative Disorders Associated With Pharmacologic Immunosuppression|Unknown status|Active, not recruiting|Phase 2|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:55.507062|2017-10-11 04:23:55.507062
NCT00003717|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||October 1998||1998-10-01|August 2001|2001-08-01||||||||Interventional|||Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer|A Phase II Trial of Weekly Paclitaxel Plus Oral Estramustine in Patients With Hormone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|17|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:55.569772|2017-10-11 04:23:55.569772
NCT00003718|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||September 1998||1998-09-01|August 2001|2001-08-01||||||||Interventional|||Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma|Phase II Evaluation of Temodal (Temozolomide, Schering) in Previously Treated Advanced Sarcomas|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:55.640576|2017-10-11 04:23:55.640576
NCT00003719|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||July 1997||1997-07-01|August 2001|2001-08-01||||||||Interventional|||Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma|Phase II Evaluation of Irinotecan (CPT-11) in Previously Treated Advanced Sarcomas|Unknown status|Active, not recruiting|Phase 2|27|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:55.712913|2017-10-11 04:23:55.712913
NCT00003720|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-22|||July 1998||1998-07-01|August 2012|2012-08-01||||||||Interventional|||SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma|A Multicenter, Dose Escalating Study in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma|Completed||Phase 1|||Pfizer|||||f||||||||||||||2017-10-11 04:23:55.880641|2017-10-11 04:23:55.880641
NCT00005371|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1993||1993-04-01|March 2005|2005-03-01|March 1995|Actual|1995-03-01|||||Observational|||Epidemiology of Acute Phase Protein and CHD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.137074|2017-10-11 04:28:04.137074
NCT00003721|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-27|||November 1998||1998-11-01|June 2012|2012-06-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I, Pharmacologic and Biologic Study of Col-3 (NSC683551) Administered on a 28-Day Oral Dosing Schedule in Patients With Advanced Solid Tumors|Completed||Phase 1|33|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:23:55.958922|2017-10-11 04:23:55.958922
NCT00003723|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-05|||February 1999||1999-02-01|October 2012|2012-10-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery|Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma|Completed||Phase 2|57|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:23:56.044104|2017-10-11 04:23:56.044104
NCT00003724|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-11|||February 1999||1999-02-01|July 2016|2016-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases|Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases|Completed||Phase 3|530|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:23:56.483266|2017-10-11 04:23:56.483266
NCT00003725|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||December 1996||1996-12-01|May 2007|2007-05-01||||||||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer|Phase III Randomized Study of a Single Adjunctive Instillation of Intravesical AD 32 (N-Trifluoroacetyladriamycin-14-valerate) Versus No Adjunctive Therapy Immediately Following Transurethral Resection in Patients With Multiple Superficial (Ta/T1) Bladder Tumors|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:56.728843|2017-10-11 04:23:56.728843
NCT00003726|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-27|2013-05-16||November 1998||1998-11-01|June 2016|2016-06-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer|A Phase I/II Study of Recombinant Desulfato Hirudin, Lepirudin (Refludan) in Small Cell Lung Cancer Patients Previously Treated With Chemotherapy|Terminated||Phase 1/Phase 2|1|Actual|Dartmouth-Hitchcock Medical Center|The funding of the trial was discontinued and therefore only one participant was enrolled to the trial and experienced no adverse events.|1||Study funding was dropped.|f||||t||||||||||2017-10-11 04:23:56.960403|2017-10-11 04:23:56.960403
NCT00003727|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-09-23|||March 1999||1999-03-01|September 2009|2009-09-01|February 2008|Actual|2008-02-01|March 2005|Actual|2005-03-01||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia|Autotransplantation for Chronic Myelogenous Leukemia (CML) Followed by Immunotherapy With Ex-Vivo Expanded Autologous T Cells|Completed||Phase 2|22|Anticipated|University of Maryland|||||f||||||||||||||2017-10-11 04:23:57.689325|2017-10-11 04:23:57.689325
NCT00003728|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-01-20|||December 1998||1998-12-01|June 2009|2009-06-01||||May 2008|Anticipated|2008-05-01||Interventional|||Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma|The Value of Dexamethasone Versus Prednisolone During Induction and Maintenance Therapy of Prolonged Versus Conventional Duration of L-Asparaginase Therapy During Consolidation and Late Intensification, and of Corticosteroid + VCR Pulses During Maintenance in Acute Lymphoblastic Leukemia and Lymphoblastic Non-Hodgkin Lymphoma of Childhood|Unknown status|Active, not recruiting|Phase 3|1500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:57.798549|2017-10-11 04:23:57.798549
NCT00003729|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||December 1998||1998-12-01|September 2012|2012-09-01||||April 2002|Actual|2002-04-01||Interventional|||Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia|Phase II Study of Fludarabine + Idarubicin + Aracytine in Refractory or Relapsed ALL in Children|Terminated||Phase 2|13|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:23:57.989293|2017-10-11 04:23:57.989293
NCT00003730|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||December 1998||1998-12-01|June 2012|2012-06-01||||November 2004|Actual|2004-11-01||Interventional|||Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer|A Multicenter Randomized Trial, With Direct Individual Benefit, to Determine the Optimal Circadian Time of Vinorelbine Administration Combined With Chronomodulated Infusion of 5-Fluorouracil in Previously Treated Patients With Metastatic Breast Cancer|Completed||N/A|80|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:23:58.123352|2017-10-11 04:23:58.123352
NCT00003731|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||December 1998||1998-12-01|September 2012|2012-09-01||||January 2001|Actual|2001-01-01||Interventional|||Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors|First Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors, a Phase II Trial|Completed||Phase 2|39|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:23:58.238891|2017-10-11 04:23:58.238891
NCT00003732|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-09|||September 1998||1998-09-01|July 2002|2002-07-01|September 2005|Actual|2005-09-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer|A Phase I/II Study to Determine the Maximum Tolerated Doses of Oral Topotecan, Carboplatin and Paclitaxel Administered Every 21 Days to Patients With Epithelial Ovarian Cancer Stages IIb, IIc, III and IV|Completed||Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:58.349065|2017-10-11 04:23:58.349065
NCT00003733|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||December 1997||1997-12-01|December 2000|2000-12-01||||||||Interventional|||Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer|A Phase II Study of Sequential Carboplatin, Paclitaxel and Hycamtin in Patients With Previously Untreated Advanced Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:58.409999|2017-10-11 04:23:58.409999
NCT00003734|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-20|||December 1998||1998-12-01|December 2011|2011-12-01||||||||Interventional|||Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer|A Randomised Comparison of Short and Protracted Neoadjuvant Hormonal Therapy Prior to Radiation Therapy of High Risk Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 3|276|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:58.480856|2017-10-11 04:23:58.480856
NCT00003804|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-06-23|||July 1993||1993-07-01|April 2012|2012-04-01||||||||Interventional|||Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor|Nephroblastoma Clinical Trial and Study|Unknown status|Active, not recruiting|Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:09.758702|2017-10-11 04:24:09.758702
NCT00003735|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-23|||December 1998||1998-12-01|July 2014|2014-07-01|September 2006|Actual|2006-09-01|November 2002|Actual|2002-11-01||Interventional|||Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia|A Phase II Study of Oral Topotecan in Children With Relapsed Acute Leukemia|Completed||Phase 2|11|Actual|Children's Oncology Group||2|||f||||||||||||||2017-10-11 04:23:58.577946|2017-10-11 04:23:58.577946
NCT00003736|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||June 1999||1999-06-01|June 2007|2007-06-01||||||||Interventional|||MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer|Pilot Study: High Risk Breast Cancer Screening Pilot Study|Unknown status|Active, not recruiting|N/A|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:23:58.728447|2017-10-11 04:23:58.728447
NCT00003737|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||January 1999||1999-01-01|June 2013|2013-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma|A Pharmacokinetic-Guided Phase II Trial of the Rebeccamycin Analog NSC# 655649 in Pediatric Patients With Relapsed/Refractory Neuroblastoma|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:23:58.875146|2017-10-11 04:23:58.875146
NCT00003739|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-12|||March 1999||1999-03-01|February 2014|2014-02-01|September 2006|Actual|2006-09-01|December 2002|Actual|2002-12-01||Interventional|||Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy|Randomized Comparison Between Antibiotics Alone and Antibiotics Plus Granulocyte-Colony Stimulating Factor in Pediatric Patients With Chemotherapy Induced Febrile Neutropenia|Completed||Phase 3|67|Actual|Children's Oncology Group|||||f||||t||||||||||2017-10-11 04:23:58.968672|2017-10-11 04:23:58.968672
NCT00003740|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||October 1998||1998-10-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Trastuzumab in Treating Patients With Prostate Cancer|Phase II Study of Herceptin (Recombinant Humanized Anti-p185HER2 Monoclonal Antibody) for the Treatment of Androgen Independent Prostate Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:00.85951|2017-10-11 04:24:00.85951
NCT00003741|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||February 1999||1999-02-01|March 2005|2005-03-01|December 2007|Actual|2007-12-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma|HeFi-1 Antibody Therapy in Ki-1 and Hodgkin's Lymphomas, a Phase I Study|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:00.915145|2017-10-11 04:24:00.915145
NCT00003742|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||October 1998||1998-10-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Phase I Trial of Paclitaxel, Cisplatin, and Irinotecan in Patients With Advanced Solid Tumor Malignancies|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:00.970398|2017-10-11 04:24:00.970398
NCT00003743|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||March 1997||1997-03-01|May 2007|2007-05-01||||||||Interventional|||Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation|Multicenter Observer-Blind Randomized Phase II Parallel Study Comparing Three Doses of Subcutaneous Interleukin 2 After Megatherapy and Peripheral Stem Cell Reinfusion in Stage 4 Neuroblastoma in Patients Over 1 Year of Age|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:01.029763|2017-10-11 04:24:01.029763
NCT00003744|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-17|||November 1998||1998-11-01|January 2017|2017-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery|Gemcitabine for Advanced Salivary Cancer: A Phase II Study|Completed||Phase 2|16|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-11 04:24:01.089304|2017-10-11 04:24:01.089304
NCT00003745|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||May 1999||1999-05-01|April 2003|2003-04-01||||June 2003|Actual|2003-06-01||Interventional|||Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas|A Phase II Study of Continuous 21 Day Infusion of Topotecan (NSC # 609699) in Children With Relapsed Solid Tumors|Completed||Phase 2|125|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:01.214956|2017-10-11 04:24:01.214956
NCT00003746|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||September 1998||1998-09-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|November 2005|Actual|2005-11-01||Interventional|||Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia|Daily Versus Weekly Administration of 2-Chlorodeoxyadenosine (CDA) in Patients With Hairy Cell Leukemia|Completed||Phase 3|100|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 04:24:01.86871|2017-10-11 04:24:01.86871
NCT00003747|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||October 1998||1998-10-01|March 2001|2001-03-01||||||||Interventional|||Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma|Phase I (Tumour Site Specific) Study of Carboplatin and Temozolomide in Patients With Advanced Melanoma|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:01.955909|2017-10-11 04:24:01.955909
NCT00003748|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-28|||August 1998||1998-08-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|June 2000|Actual|2000-06-01||Interventional|||Irinotecan in Treating Patients With Esophageal or Stomach Cancer|Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia|Completed||Phase 2|40|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 04:24:02.021016|2017-10-11 04:24:02.021016
NCT00003749|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||April 1998||1998-04-01|April 1999|1999-04-01|December 2008|Actual|2008-12-01|||||Interventional|||Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer|A Randomised Trial of Lymphadenectomy and of Adjuvant External Beam Radiotherapy in the Treatment of Endometrial Cancer|Completed||Phase 3|2300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:02.292009|2017-10-11 04:24:02.292009
NCT00003750|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-06|||October 2001||2001-10-01|August 2014|2014-08-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors|A Phase I/IB Intergroup Trial of the HU14.18-IL2 Fusion Protein in Children With Refractory Neuroblastoma and Other GD2 Positive Tumors|Completed||Phase 1|28|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:24:02.410734|2017-10-11 04:24:02.410734
NCT00003768|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-01-06|||September 1998||1998-09-01|January 2014|2014-01-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors|A Phase I Pharmacokinetic Study of Single Dose Intravenous CA4P in Patients With Advanced Cancer|Completed||Phase 1|25|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:24:04.538664|2017-10-11 04:24:04.538664
NCT00003751|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-01|||March 1999||1999-03-01|May 2012|2012-05-01|July 2005|Actual|2005-07-01|June 2004|Actual|2004-06-01||Interventional|||Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma|Phase II Study of Penicillamine and Reduction of Copper for Angiosuppressive Therapy of Adults With Newly Diagnosed Glioblastoma|Completed||Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:24:02.667106|2017-10-11 04:24:02.667106
NCT00003752|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-29|||October 1998||1998-10-01|May 2007|2007-05-01|March 2003|Actual|2003-03-01|||||Interventional|||Bexarotene in Treating Patients With Metastatic Breast Cancer|A Multicenter Phase II Evaluation of Targretin (Bexarotene) Capsules in Patients With Advanced Breast Cancer|Completed||Phase 2|180|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:02.76555|2017-10-11 04:24:02.76555
NCT00003753|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||September 1998||1998-09-01|June 2013|2013-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer|A Phase I-II Study of Hepatic Arterial Therapy Via Pump (Protocol D97-063) With Floxuridine (FUDR) and Dexamethasone (DEX) in Combination With Intravenous Irinotecan as Adjuvant Treatment After Resection of Hepatic Metastases From Colorectal Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:02.874981|2017-10-11 04:24:02.874981
NCT00003754|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||September 1998||1998-09-01|June 2013|2013-06-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers|A Phase II Study of Thalidomide and Cyclophosphamide in Patients With Recurrent or Refractory Malignancies|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:02.937245|2017-10-11 04:24:02.937245
NCT00003755|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||October 1998||1998-10-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor|Phase I Study of R031-7453, a Novell Cell Cycle Inhibitor, Administered as Escalating Oral Doses in Adults With Solid Tumors: 4-Day Schedule|Completed||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:02.999308|2017-10-11 04:24:02.999308
NCT00003757|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||February 1998||1998-02-01|May 2012|2012-05-01|July 2007|Actual|2007-07-01|July 2002|Actual|2002-07-01||Interventional|||Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy|Rituximab (IDEC-C2B8, Mabthera) in Patients With Hairy Cell Leukemia Relapsing After Treatment With 2-Chlorodeoxyadenosine (CDA)|Completed||Phase 2|25|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:24:03.090881|2017-10-11 04:24:03.090881
NCT00003758|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||December 1998||1998-12-01|January 2001|2001-01-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia|Treatment of Relapsed Acute Myelogenous Leukemia Consisting of Intermediate Dose Cytosine Arabinoside (ARA-C) Plus Interspaced Continuous Infusion Idarubicin, Followed by Continuous Infusion of Low-Dose ARA-C, A Phase II Study by the EORTC-LCG|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:03.162153|2017-10-11 04:24:03.162153
NCT00003759|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-30|||November 1998||1998-11-01|November 2002|2002-11-01|November 2002|Actual|2002-11-01|||||Interventional|||AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer|Intravesical Treatment of Superficial Bladder Cancer Characterized on the Basis of the Tumor Markers p53 and pRb|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:03.268037|2017-10-11 04:24:03.268037
NCT00003760|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-07|||November 1998||1998-11-01|August 2012|2012-08-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer|A Phase II Trial of MGI 114 in Patients With Advanced Pancreatic Adenocarcinoma|Completed||Phase 2|3|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:24:03.331746|2017-10-11 04:24:03.331746
NCT00003761|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-02-13|||March 3, 1999|Actual|1999-03-03|February 2017|2017-02-01|October 19, 2001|Actual|2001-10-19|April 20, 2001|Actual|2001-04-20||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Breast Cancer|A Phase I Trial of Recombinant Vaccinia Virus That Expresses DF3/MUC1 in Patients With Metastatic Adenocarcinoma of the Breast|Completed||Phase 1|20|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 04:24:03.397454|2017-10-11 04:24:03.397454
NCT00003762|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2016-07-12|||February 1999||1999-02-01|July 2016|2016-07-01|May 2008|Actual|2008-05-01|February 2003|Actual|2003-02-01||Interventional|||Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Randomized Phase II Study of Docetaxel and Gemcitabine for Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|106|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 04:24:03.473288|2017-10-11 04:24:03.473288
NCT00003763|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-04-03|||January 1999||1999-01-01|April 2017|2017-04-01||||||||Interventional|||Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer|A Study to Determine the Ability of Folate Conjugates to Target Folate Receptors in Ovarian Cancer Tumors|Completed||N/A|||Endocyte|||||f||||f|t|f||||||No||2017-10-11 04:24:03.597232|2017-10-11 04:24:03.597232
NCT00003764|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||December 1999||1999-12-01|January 2010|2010-01-01||||November 2005|Actual|2005-11-01||Interventional|||Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia|Phase III Randomized Trial of Fludarabine and Cyclophosphamide Versus Fludarabine for Previously Untreated Chronic Lymphocytic Leukemia|Completed||Phase 3|280|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-10-11 04:24:03.698197|2017-10-11 04:24:03.698197
NCT00003765|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||May 1999||1999-05-01|October 2007|2007-10-01||||March 2006|Actual|2006-03-01||Interventional|||O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors|A Trial of 06-BG and BCNU in Children With CNS Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:04.272406|2017-10-11 04:24:04.272406
NCT00003766|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-03-05|||October 1999||1999-10-01|March 2014|2014-03-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery|Determination of Optimal O6-Benzylguanine Dose to Achieve O6-Alkylguanine-DNA Alkyltransferase Depletion in Patients With Surgically Resectable Solid Tumors|Completed||Phase 1|25|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:24:04.462287|2017-10-11 04:24:04.462287
NCT00003769|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-09-09|||February 1999||1999-02-01|September 2014|2014-09-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer|A Phase II Trial of Perillyl Alcohol in Patients With Resectable Pancreatic Cancer|Completed||Phase 2|||Indiana University|||||f||||||||||||||2017-10-11 04:24:04.600706|2017-10-11 04:24:04.600706
NCT00003771|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||September 1997||1997-09-01|July 2001|2001-07-01|February 2004|Actual|2004-02-01|||||Interventional|||Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer|Protocol for Randomized Clinical Study Concerning Hormonal Replacement Therapy (HRT) After Previous Radical Breast Cancer Treatment|Completed||Phase 3|1300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:04.66812|2017-10-11 04:24:04.66812
NCT00003772|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-24|||January 1999||1999-01-01|August 2012|2012-08-01|February 2003|Actual|2003-02-01|August 2001|Actual|2001-08-01||Observational|||Quality-of-Life Assessment in Patients With Ovarian Cancer|An International Field Study of the Reliability and Validity of a Disease-Specific Questionnaire Module (the QLQ-OV28) in Assessing the Quality of Life of Patients With Ovarian Cancer|Completed||N/A|372|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||||||2017-10-11 04:24:04.752582|2017-10-11 04:24:04.752582
NCT00003773|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||February 1999||1999-02-01|May 2014|2014-05-01|August 2001|Actual|2001-08-01|July 2000|Actual|2000-07-01||Interventional|||IM-862 in Treating Patients With Recurrent Ovarian Cancer|Phase I Study of Escalating Doses of IM-862 in Patients With Ovarian Cancer|Completed||Phase 1|43|Actual|University of Southern California|||||f||||t||||||||||2017-10-11 04:24:04.821295|2017-10-11 04:24:04.821295
NCT00003775|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-12|||December 1998||1998-12-01|September 2012|2012-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse|A Phase II Open Label Study of SU101 for Patients With Anaplastic Astrocytoma in First Relapse|Completed||Phase 2|60|Actual|Pfizer|||||f||||||||||||||2017-10-11 04:24:04.882979|2017-10-11 04:24:04.882979
NCT00003776|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||December 1998||1998-12-01|June 2013|2013-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma|A Phase II Window Study of Trimetrexate With Simultaneous Leucovorin Protection in the Treatment of Newly Diagnosed Patients With Metastatic Osteosarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:05.012662|2017-10-11 04:24:05.012662
NCT00003777|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||December 1998||1998-12-01|November 2002|2002-11-01||||||||Interventional|||Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer|A Pilot Study of Combined Modality Therapy for Recurrent Head and Neck Carcinoma|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:05.078169|2017-10-11 04:24:05.078169
NCT00003778|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||April 1999||1999-04-01|September 2000|2000-09-01||||July 2000|Actual|2000-07-01||Interventional|||Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma|Phase II Trial of Dolastatin-10 in Patients With Previously Untreated Recurrent/Metastatic Sarcoma|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:05.140302|2017-10-11 04:24:05.140302
NCT00003779|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-16|||November 1998||1998-11-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|June 2001|Actual|2001-06-01||Interventional|||Biological Therapy in Treating Patients With Bladder Cancer|A Prospective Randomized Trial for the Comparison of Two BCG Strains (Bacille Calmette-Guerin) in the Prophylaxis of Papollary Bladder Tumors Stage Ta and T1 and Treatment of Carcinoma in Situ|Completed||Phase 3|40|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 04:24:05.209757|2017-10-11 04:24:05.209757
NCT00003780|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||December 1998||1998-12-01|May 2007|2007-05-01||||||||Interventional|||Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas|An Open Label Randomized Trial Comparing the Safety and Efficacy of Systemic Chemotherapy (Gemcitabine) to Immunotherapy (CYTOIMPLANT - Intra Tumor Implants of Allogeneic Peripheral Blood Mononuclear Cells Sensitized Against Patient Alloantigens by Mixed Lymphocyte Culture) as First Line Therapy for Patients With Unresectable Locally Advanced, and Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:05.299642|2017-10-11 04:24:05.299642
NCT00003781|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-04-26|||December 1998||1998-12-01|April 2017|2017-04-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Docetaxel in Treating Patients With Stage IV Prostate Cancer|Phase II Study of Weekly Docetaxel (Taxotere) in Hormone Refractory Metastatic Prostate Cancer|Completed||Phase 2|25|Actual|OHSU Knight Cancer Institute|||||f||||t||||||||||2017-10-11 04:24:05.360301|2017-10-11 04:24:05.360301
NCT00003782|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-11|2012-08-24||March 1999||1999-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2008|Actual|2008-12-01||Interventional|||Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes|A Three-Arm Randomized Trial to Compare Adjuvant Adriamycin and Cyclophosphamide Followed by Taxotere (AC-T); Adriamycin and Taxotere (AT); and Adriamycin, Taxotere, and Cyclophosphamide (ATC) in Breast Cancer Patients With Positive Axillary Lymph Nodes|Completed||Phase 3|5351|Actual|NSABP Foundation Inc||3|||f||||t||||||||||2017-10-11 04:24:05.459899|2017-10-11 04:24:05.459899
NCT00003783|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-24|||March 1999||1999-03-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia|ALinC 17: Continuous Intensification for Very High Risk Acute Lymphocytic Leukemia (A.L.L.): A Pediatric Oncology Group Pilot Study|Completed||Phase 2|36|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:24:06.676978|2017-10-11 04:24:06.676978
NCT00003784|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-23|||May 1999||1999-05-01|January 2013|2013-01-01||||January 2003|Actual|2003-01-01||Interventional|||S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Pilot Trial of CHOP Followed by Iodine-131-Labeled Monoclonal Anti-B1 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas|Completed||Phase 2|102|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:24:07.087693|2017-10-11 04:24:07.087693
NCT00003786|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-03-06|||April 1999||1999-04-01|March 2014|2014-03-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer|A Phase II Trial of MGI-114 (NSC# 683863) Administered as a 5-Minute Infusion Daily for Five Days Every 4 Weeks in Patients With Previously Untreated Advanced Colorectal Cancer|Withdrawn||Phase 2|0|Actual|University of Chicago||1||NO participants|f||||f||||||||||2017-10-11 04:24:07.391951|2017-10-11 04:24:07.391951
NCT00003787|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-05-02|||March 1995||1995-03-01|May 2017|2017-05-01|July 2018|Anticipated|2018-07-01|March 2007|Actual|2007-03-01||Observational|||Women's Healthy Eating and Living Study|Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study|Active, not recruiting||N/A|3000|Anticipated|University of California, San Diego|||2||f||||t||||||Samples With DNA|"     Serum, plasma, buffy coat, RBC, DNA at five time periods   "|||2017-10-11 04:24:07.518708|2017-10-11 04:24:07.518708
NCT00003788|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||April 1998||1998-04-01|September 2003|2003-09-01||||||||Interventional|||Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas|Prospective Clinical Trials in the Use of Photodynamic Therapy (PDT) for the Treatment of Malignant Supratentorial Brain Tumors|Unknown status|Active, not recruiting|Phase 3|270|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:07.671376|2017-10-11 04:24:07.671376
NCT00003789|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-15|||March 1999||1999-03-01|June 2013|2013-06-01||||January 2004|Actual|2004-01-01||Interventional|||Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg|A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion and Melphalan With and Without Tumor Necrosis Factor in Patients With Localized Advanced Extremity Melanoma|Completed||Phase 3|216|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:24:07.752381|2017-10-11 04:24:07.752381
NCT00003790|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-05|||February 1995||1995-02-01|August 2014|2014-08-01|September 2006|Actual|2006-09-01|April 2002|Actual|2002-04-01||Observational|||Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome|Detection of Minimal Residual Disease in Children Receiving Therapy for AML or MDS|Completed||N/A|496|Actual|Children's Oncology Group|||||f||||f||||||||||2017-10-11 04:24:07.849276|2017-10-11 04:24:07.849276
NCT00003792|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||April 1999||1999-04-01|October 2006|2006-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Dendritic Cell Immunotherapy of Metastatic Melanoma - A Phase I Trial|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:08.172147|2017-10-11 04:24:08.172147
NCT00003793|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-04|||December 1998||1998-12-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|December 2005|Actual|2005-12-01||Observational|||Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma|Clinical and Biological Predictors of Therapy-Related Leukemia|Completed||N/A|294|Actual|Children's Oncology Group|||2||f||||f||||||Samples With DNA|"     blood   "|||2017-10-11 04:24:08.28319|2017-10-11 04:24:08.28319
NCT00003794|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-07|||April 1999||1999-04-01|November 2005|2005-11-01||||July 2005|Actual|2005-07-01||Observational|||Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer|Quality of Life in Ovarian Germ Cell Cancer Survivors|Terminated||N/A|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:24:08.66341|2017-10-11 04:24:08.66341
NCT00003795|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-24|||April 1999||1999-04-01|March 2009|2009-03-01||||March 2002|Actual|2002-03-01||Observational|||Quality of Life in Survivors of Gynecologic Cancer|Quality of Life of Gynecologic Cancer Survivors|Completed||N/A|311|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:24:08.751777|2017-10-11 04:24:08.751777
NCT00003796|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||May 1999||1999-05-01|March 2003|2003-03-01||||December 2003|Actual|2003-12-01||Interventional|||Irofulven in Treating Patients With Metastatic Breast Cancer|Phase II Study of MGI-114 in Patients With Metastatic Breast Cancer|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:08.885973|2017-10-11 04:24:08.885973
NCT00003797|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||March 1999||1999-03-01|December 2002|2002-12-01||||||||Interventional|||Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas|Herceptin (NSC #688097) and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/NEU|Unknown status|Active, not recruiting|Phase 2|41|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:08.97675|2017-10-11 04:24:08.97675
NCT00003798|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-13|||April 2000||2000-04-01|November 2012|2012-11-01||||||||Interventional|||Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery|Phase I Study Involving Gadolinium Texaphyrin (NSC 695238) in Patients With Pancreatic and Periampullary Adenocarcinoma Receiving Radiotherapy for Unresectable Disease|Completed||Phase 1|45|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:24:09.081068|2017-10-11 04:24:09.081068
NCT00003799|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-09|||May 1999||1999-05-01|January 2013|2013-01-01||||September 2003|Actual|2003-09-01||Interventional|||Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer|Phase I Study of Preoperative Radiation Therapy With Concurrent Protracted Continuous Infusion 5-FU and Dose Escalating Oxaliplatin Followed by Surgery, 5-FU, and Leucovorin for Locally Advanced (T3 and T4) Rectal Adenocarcinoma|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:09.194918|2017-10-11 04:24:09.194918
NCT00003800|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-30|||May 1999||1999-05-01|November 2012|2012-11-01||||December 2004|Actual|2004-12-01||Interventional|||Diagnostic Study of Patients With Stage I Testicular Cancer|Correlation of Histopathology, Immunohistochemistry and Quantitative Radiology With Outcome in Early Stage Nonseminomatous Germ Cell Tumor|Unknown status|Active, not recruiting|N/A|76|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:24:09.309078|2017-10-11 04:24:09.309078
NCT00003801|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-08-19||||||February 2000|2000-02-01||||||||Interventional|||Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma|Intergroup Rhabdomyosarcoma Study Group: Late Effects After Treatment for Rhabdomyosarcoma|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:09.43363|2017-10-11 04:24:09.43363
NCT00003802|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-12-12|||February 1999||1999-02-01|December 2012|2012-12-01|October 2002|Actual|2002-10-01|||||Interventional|||Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma|A Phase II Trial of Pyrazoloacridine (NSC 366140, IND 36325) in Metastatic Cutaneous and Ocular Melanoma|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:24:09.507508|2017-10-11 04:24:09.507508
NCT00003803|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-17|||February 1999||1999-02-01|July 2012|2012-07-01||||March 2003|Actual|2003-03-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed|A Randomized Phase III Study Comparing Induction Chemotherapy to Daily Low Dose Cisplatin Both Combined With High Dose Radiotherapy Using Concomitant Boost Technique in Patients With Inoperable Non-Small Cell Lung Cancer Stage I, II, and Low Volume Stage III|Terminated||Phase 3|158|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:24:09.591437|2017-10-11 04:24:09.591437
NCT00003805|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||November 1997||1997-11-01|September 2012|2012-09-01||||June 2000|Actual|2000-06-01||Interventional|||Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count|Vancomycin Versus Placebo in Persistently Febrile Granulocytopenic Patients Given Piperacillin/Tazobactam|Completed||Phase 3|859|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:24:10.728939|2017-10-11 04:24:10.728939
NCT00003808|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||May 1999||1999-05-01|August 2013|2013-08-01||||September 2002|Actual|2002-09-01||Interventional|||Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia|Phase II Study of Theophylline in Chronic Lymphocytic Leukemia|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:24:10.953466|2017-10-11 04:24:10.953466
NCT00003809|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||June 1999||1999-06-01|August 2013|2013-08-01||||September 2004|Actual|2004-09-01||Interventional|||Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Randomized, Double Blind, Placebo Controlled Phase III Evaluation of Cisplatin + Placebo Versus Cisplatin + C225 a Mouse/Human Monoclonal Antibody to the Epidermal Growth Factor Receptor, in Patients With Metastatic and/or Recurrent Squamous Cell Cancer of the Head and Neck|Completed||Phase 3|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:24:11.167948|2017-10-11 04:24:11.167948
NCT00003810|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||April 1999||1999-04-01|August 2013|2013-08-01||||May 2002|Actual|2002-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas|A Phase II Study of Gemcitabine and Docetaxel in Pancreatic Adenocarcinoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:24:11.377427|2017-10-11 04:24:11.377427
NCT00003811|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-03|||April 2000||2000-04-01|July 2013|2013-07-01|September 2007|Actual|2007-09-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors|High-Dose Cisplatin, Etoposide and Bleomycin (HD-PEB) Combined With Amifostine in Children With High-Risk Malignant Germ Cell Tumors - A POG Pilot Study|Completed||Phase 2|27|Actual|Children's Oncology Group|||||f||||||||||||||2017-10-11 04:24:11.471147|2017-10-11 04:24:11.471147
NCT00003812|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|||March 1999||1999-03-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|June 2004|Actual|2004-06-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Topotecan/Paclitaxel Induction Followed by Consolidation Chemoradiotherapy for Limited Stage Small Cell Lung Cancer: A Phase II Study|Completed||Phase 2|75|Actual|Alliance for Clinical Trials in Oncology||1|||f||||||||||||||2017-10-11 04:24:11.938552|2017-10-11 04:24:11.938552
NCT00003814|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||February 1999||1999-02-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Eflornithine in Treating Patients With Bladder Cancer|Phase III Randomized, Double-Blind Study of DFMO vs. Placebo in Low Grade Superficial Bladder Cancer|Completed||Phase 3|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:12.150727|2017-10-11 04:24:12.150727
NCT00003815|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||June 1994||1994-06-01|July 2001|2001-07-01||||||||Interventional|||Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma|A Randomised Study of High Dose Chemotherapy/Radiotherapy and Autologous Bone Marrow Transplantation in Patients With High Grade Malignant Non-Hodgkin's Lymphoma (Kiel Classification) According to Prognostic Groups|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:12.361168|2017-10-11 04:24:12.361168
NCT00003816|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-05|||October 19, 1998|Actual|1998-10-19|July 2017|2017-07-01|November 1, 2018|Anticipated|2018-11-01|November 1, 2017|Anticipated|2017-11-01||Interventional|||Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer|Allogeneic Blood or Marrow Transplantation for Hematologic Malignancy and Aplastic Anemia|Active, not recruiting||Phase 2/Phase 3|362|Actual|Roswell Park Cancer Institute||9|||f||||t||||||||||2017-10-11 04:24:12.460206|2017-10-11 04:24:12.460206
NCT00003817|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-13|||October 1999||1999-10-01|October 2015|2015-10-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy|A Randomized Phase II Trial of Acupressure and Acustimulation Wrist Bands for the Prevention of Chemotherapy-Induced Nausea and Vomiting|Completed||Phase 2|700|Anticipated|University of Rochester|||||f||||||||||||||2017-10-11 04:24:12.618356|2017-10-11 04:24:12.618356
NCT00003819|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-18|||June 1998||1998-06-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer|Vaccination of Prostate Cancer Patients With Thompson-Friedenreich [TF(c)]-KLH Conjugate Plus the Immunological Adjuvant QS21: A Trial Comparing TF(c)-KLH Doses|Completed||Phase 1|21|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:24:12.705446|2017-10-11 04:24:12.705446
NCT00003820|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-08|2013-05-29||January 1999||1999-01-01|March 2017|2017-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional||This was a single-arm study with multiple treatment periods added by amendment (ie, Secondary Group), with results reported by treatment period. As this was always considered a single-arm study, there was no intent to report the results for the initial treatment period separately as the Initial Group vs the Secondary Group.|Rituximab in Treating Patients With Hodgkin's Lymphoma|Phase 2 Trial to Evaluate the Efficacy of Anti-CD20 Antibody in Patients With Lymphocyte Predominant Hodgkin's Disease|Completed||Phase 2|39|Actual|Stanford University||1|||f||||f|t|f||||||No||2017-10-11 04:24:12.806572|2017-10-11 04:24:12.806572
NCT00003821|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||January 1998||1998-01-01|July 2000|2000-07-01||||||||Interventional|||Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer|Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:13.178133|2017-10-11 04:24:13.178133
NCT00003822|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|March 2001|2001-03-01||||||||Interventional|||SR-45023A in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacokinetic Study of SR-45023A During a 14-Day Treatment Schedule|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:13.239364|2017-10-11 04:24:13.239364
NCT00003824|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-07|||April 1999||1999-04-01|March 2012|2012-03-01|January 2007|Actual|2007-01-01|July 2001|Actual|2001-07-01||Interventional|||S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer|The Effect of Fluoroquinolones on the Disease-Free Interval in Patients With Stage Ta Transitional Cell Carcinoma of the Bladder|Terminated||Phase 3|114|Actual|Southwest Oncology Group||2||Permanently Closed Due to Poor Accrual|f||||t||||||||||2017-10-11 04:24:13.29927|2017-10-11 04:24:13.29927
NCT00003825|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-09|||June 1999||1999-06-01|August 2013|2013-08-01||||April 2006|Actual|2006-04-01||Interventional|||Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy|Phase III Study of Pentosanpolysulfate (PPS) in Treatment of GI Tract Sequelae of Radiotherapy|Completed||Phase 3|174|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:24:13.588784|2017-10-11 04:24:13.588784
NCT00003827|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||January 1999||1999-01-01|July 2007|2007-07-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome|Treatment of Poor Risk Myelodysplasia With the Combination of Amifostine, Topotecan and ARA-C: A Phase II Study|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:15.518554|2017-10-11 04:24:15.518554
NCT00003828|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-20|||May 1999||1999-05-01|August 2012|2012-08-01|March 2004|Actual|2004-03-01|December 2001|Actual|2001-12-01||Interventional|||S9804: Vinorelbine in Treating Patients With Stage IV Melanoma|Evaluation of Vinorelbine Tartrate (Navelbine) in Patients With Disseminated Malignant Melanoma and One Prior Systemic Therapy|Completed||Phase 2|24|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:24:15.611552|2017-10-11 04:24:15.611552
NCT00003829|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-05|||August 1999||1999-08-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|May 2001|Actual|2001-05-01||Interventional|||Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia|A Phase II Study of Alternating Cycles of Fludarabine and Cyclophosphamide in Previously Untreated Patients With B-cell CLL|Completed||Phase 2|34|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:24:15.876715|2017-10-11 04:24:15.876715
NCT00003831|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||July 1999||1999-07-01|July 2016|2016-07-01|January 2011|Actual|2011-01-01|March 2006|Actual|2006-03-01||Interventional|||Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer|Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma|Completed||Phase 3|1023|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:24:16.397947|2017-10-11 04:24:16.397947
NCT00003832|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-24|||July 1999||1999-07-01|January 2013|2013-01-01||||June 2002|Actual|2002-06-01||Interventional|||Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer|Cell Kinetic Study of Bromodeoxyuridine (BrdU) in Prostate Cancer|Completed||Phase 2|75|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:16.626321|2017-10-11 04:24:16.626321
NCT00003833|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||February 1999||1999-02-01|July 2016|2016-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Genetic Study in Patients With Stage II or Stage III Colon Cancer|The Clinical and Pathological Significance of Allelic Imbalance of 8p in Patients With Colorectal Cancer|Completed||N/A|598|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Normal and tumor tissue   "|||2017-10-11 04:24:16.715716|2017-10-11 04:24:16.715716
NCT00003834|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||March 1999||1999-03-01|July 2016|2016-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer|A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum (Per 04/99 Amendment) Old Title: A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum Confined to the Liver|Completed||Phase 2|44|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:24:16.928361|2017-10-11 04:24:16.928361
NCT00003835|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-10-07|||May 1999||1999-05-01|October 2013|2013-10-01||||August 2007|Actual|2007-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III Colon Cancer|Phase III Intergroup Trial of Irinotecan (CPT-11) (NSC# 616348) Plus Fluorouracil/Leucovorin (5-FU/LV) Versus Fluorouracil/Leucovorin Alone After Curative Resection for Patients With Stage III Colon Cancer|Completed||Phase 3|1260|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:24:17.075335|2017-10-11 04:24:17.075335
NCT00003837|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-18|||September 1999||1999-09-01|December 2005|2005-12-01|November 2007|Actual|2007-11-01|||||Interventional|||506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma|Compound 506U78 (NSC 686673) in Patients With Relapsed or Refractory T-Cell ALL or T-Cell Lymphoblastic Lymphoma|Completed||N/A|25|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:24:17.170947|2017-10-11 04:24:17.170947
NCT00003838|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-10-05|||February 22, 1999||1999-02-22|July 26, 2017|2017-07-26|December 1, 2019|Anticipated|2019-12-01|December 1, 2019|Anticipated|2019-12-01||Interventional|||Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow|Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients With Debilitating Hematologic Diseases|Recruiting||Phase 2|214|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:24:17.241981|2017-10-11 04:24:17.241981
NCT00003840|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-17|||October 2000||2000-10-01|June 2013|2013-06-01|July 2005|Actual|2005-07-01|September 2002|Actual|2002-09-01||Interventional|||DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia|A Phase I Study of DTGM Fusion Protein (IND BB#8153) in Relapsed and Refractory Adult Acute Myeloid Leukemia (AML)|Completed||Phase 1/Phase 2|||Wake Forest University Health Sciences|||||||||||||||||||2017-10-11 04:24:17.322703|2017-10-11 04:24:17.322703
NCT00003842|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-17|||March 1999||1999-03-01|June 1999|1999-06-01||||||||Interventional|||IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma|A Phase I Study of a Recombinant Chimeric Protein Composed of Circularly Permuted IL-4 and a Mutated Form of the Pseudomonas Exotoxin Termed IL-4(38-37)-PE38KDEL (IL-4 Toxin) for the Treatment of Recurrent Malignant Astrocytoma|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:17.39641|2017-10-11 04:24:17.39641
NCT00003843|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-02-13|||October 1998||1998-10-01|September 2013|2013-09-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Observational|||Irinotecan in Treating Patients With Colorectal Cancer|UGT1A1 Polymorphism in Patients With Colorectal Cancer Treated With CPT-11 (Irinotecan)|Terminated||Phase 2|28|Anticipated|California Cancer Consortium||||Study terminated due to poor accrual|||||||||||||||2017-10-11 04:24:17.473753|2017-10-11 04:24:17.473753
NCT00003846|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-25|||July 1999||1999-07-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|October 2004|Actual|2004-10-01||Interventional|||Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors|Treatment of High Risk Central Nervous System Embryonal Tumors With Conventional Radiotherapy and Intensive Consolidation Chemotherapy With Peripheral Blood Progenitor Cell (PBSC) Support|Completed||Phase 2|25|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:24:17.545571|2017-10-11 04:24:17.545571
NCT00003847|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-04|||December 1998||1998-12-01|September 2013|2013-09-01||||February 2001|Actual|2001-02-01||Interventional|||VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer|A Phase II Study of the Safety, Efficacy and Pharmacokinetics of VX-710 in Combination With Doxorubicin and Vincristine in Patients With Small Cell Lung Cancer (SCLC)|Terminated||Phase 2|36|Actual|Vertex Pharmaceuticals Incorporated||1|||f||||||||||||||2017-10-11 04:24:17.669223|2017-10-11 04:24:17.669223
NCT00003849|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||July 1999||1999-07-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|February 2005|Actual|2005-02-01||Interventional|||Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease|A Phase II Trial of C2B8 in Patients With Asymptomatic CD20+ B-Cell Follicular Small Cleaved Low-Grade Non-Hodgkin's Lymphoma or Relapsed CD20+ Hodgkin's Disease|Completed||Phase 2|39|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:24:17.75529|2017-10-11 04:24:17.75529
NCT00003850|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||April 1999||1999-04-01|January 2001|2001-01-01||||June 2003|Actual|2003-06-01||Interventional|||Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Study of Thalidomide in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|47|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:17.987967|2017-10-11 04:24:17.987967
NCT00003851|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-13|||March 1999||1999-03-01|February 2013|2013-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer|Evaluation of Intensive Pancreatic Proteolytic Enzyme Therapy With Ancillary Nutritional Support Versus Gemcitabine Chemotherapy in the Treatment of Inoperable Pancreatic Adenocarcinoma|Terminated||N/A|90|Anticipated|Columbia University||2||Approval lapse|f||||f||||||||||2017-10-11 04:24:18.070565|2017-10-11 04:24:18.070565
NCT00003852|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-22|||March 1998||1998-03-01|June 2016|2016-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors|Phase II Study of Intensive Chemotherapy With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin Resistant Germ Cell Tumors|Terminated||Phase 2|45|Anticipated|UNICANCER||||lack of patient inclusion|f||||||||||||||2017-10-11 04:24:18.156019|2017-10-11 04:24:18.156019
NCT00003853|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-09|||April 1999||1999-04-01|May 2011|2011-05-01|August 2001|Actual|2001-08-01|August 2000|Actual|2000-08-01||Interventional|||4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis|Phase II Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)|Completed||Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:18.262865|2017-10-11 04:24:18.262865
NCT00003854|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||April 1999||1999-04-01|July 2016|2016-07-01|July 2011|Actual|2011-07-01|August 2006|Actual|2006-08-01||Interventional|||Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer|A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer|Completed||Phase 3|4590|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:24:18.353165|2017-10-11 04:24:18.353165
NCT00003855|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||April 1999||1999-04-01|July 2016|2016-07-01|February 2011|Actual|2011-02-01|August 2007|Actual|2007-08-01||Interventional|||Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer|A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node|Completed||Phase 3|605|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:24:18.672046|2017-10-11 04:24:18.672046
NCT00003856|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||October 1998||1998-10-01|January 2001|2001-01-01||||||||Interventional|||Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy|A Multicenter, Multi-National, Open-Label, Single Group, Single and Multiple Dose Study of Foscan-Mediated Photodynamic Therapy (PDT) for the Palliative Treatment of Recurrent, Refractory or Second Primary Squamous Cell Carcinomas of the Head and Neck in Patients Considered to be Incurable With Surgery or Radiotherapy|Unknown status|Active, not recruiting|Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:19.020701|2017-10-11 04:24:19.020701
NCT00003857|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-05-18|||December 1999|Actual|1999-12-01|May 2017|2017-05-01||||February 2004|Actual|2004-02-01||Interventional|||Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ|Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus Radiation Therapy for Good Risk Duct Carcinoma In-Situ (DCIS) of the Female Breast|Active, not recruiting||Phase 3|636|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:24:19.18424|2017-10-11 04:24:19.18424
NCT00003858|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12||||||July 2016|2016-07-01||||||||Interventional|||Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence|A Phase II Trial of Adjuvant Mitoxantrone (NSC #301739) for High Risk Patients Following Radical Prostatectomy|Withdrawn||Phase 2|0|Actual|Alliance for Clinical Trials in Oncology||1||The study was not activated.|f||||||||||||||2017-10-11 04:24:20.202602|2017-10-11 04:24:20.202602
NCT00003859|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||April 1992||1992-04-01|April 2009|2009-04-01|April 2003|Actual|2003-04-01|||||Interventional|||Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS|Trial of Chemotherapy Utilizing Carboplatin, Vincristine, Cyclophosphamide and Etoposide for the Treatment of Central Nervous System Primitive Neurectodermal Tumors of Childhood|Completed||Phase 3|230|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:20.314286|2017-10-11 04:24:20.314286
NCT00003860|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||September 1998||1998-09-01|December 1999|1999-12-01||||||||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer|Intensive Chemotherapy With Peripheral Blood Stem Cell Support for Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:20.433122|2017-10-11 04:24:20.433122
NCT00003861|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-08-07|||April 1999||1999-04-01|August 2017|2017-08-01||||January 2100|Anticipated|2100-01-01||Observational|||Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia|Molecular Genetic Features of Acute Leukemia|Active, not recruiting||N/A|840|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||||||||Samples With DNA|"     Tissue, Blood   "|||2017-10-11 04:24:20.565961|2017-10-11 04:24:20.565961
NCT00003862|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-17|||November 1999||1999-11-01|September 2003|2003-09-01||||November 2004|Actual|2004-11-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer|A Phase II Trial of Preoperative Chemotherapy and Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Stomach|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:24:20.778914|2017-10-11 04:24:20.778914
NCT00003863|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||June 1999||1999-06-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma|Genetic Changes in Diffuse Aggressive Non-Hodgkin's Lymphoma|Completed||N/A|391|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Tissue samples   "|||2017-10-11 04:24:20.968657|2017-10-11 04:24:20.968657
NCT00003864|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||July 1999||1999-07-01|August 2013|2013-08-01||||January 2004|Actual|2004-01-01||Interventional|||Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus|A Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:24:21.213292|2017-10-11 04:24:21.213292
NCT00003865|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-11|||July 22, 1999|Actual|1999-07-22|July 2017|2017-07-01|February 22, 2017|Actual|2017-02-22|February 22, 2017|Actual|2017-02-22||Interventional|||Toremifene in Treating Patients With Ovarian Cancer|Phase II Study of Two Dose Levels of Toremifene in the Treatment of Chemotherapy-Resistant Papillary Carcinoma of the Ovary|Withdrawn||Phase 2|0|Actual|George Washington University||1|||f||||f|f|f|||f|||||2017-10-11 04:24:21.64816|2017-10-11 04:24:21.64816
NCT00003867|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||March 1999||1999-03-01|April 2007|2007-04-01||||||||Interventional|||Irinotecan and Capecitabine in Treating Patients With Solid Tumors|Phase I Clinical Study of Every Three Week Irinotecan With Oral Capecitabine Given Twice Daily for Two Weeks Out of Three in Patients With Gastrointestinal and Other Solid Malignancies|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:21.763752|2017-10-11 04:24:21.763752
NCT00003868|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-08-20|||February 1999||1999-02-01|August 2010|2010-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia|Radiolabeled BC8 (Anti-CD45) Antibody Combined With Cyclophosphamide and Total Body Irradiation Followed by HLA-matched Related or Unrelated Stem Cell Transplantation as Treatment for Advanced Acute Myeloid Leukemia and Myelodysplastic Syndrome|Completed||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:24:21.876257|2017-10-11 04:24:21.876257
NCT00003280|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||January 1998||1998-01-01|May 2012|2012-05-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma|A Randomized, Phase III Trial to Determine the Effect of Consolidation With Rituximab (IDEC C2B8-Mabthera) in Patients With CD20+ Follicular or Mantle Cell Lymphoma Having Received Induction Therapy With Rituximab Weekly x 4|Completed||Phase 3|240|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:24:21.962965|2017-10-11 04:24:21.962965
NCT00003281|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||April 1998||1998-04-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer|Phase II Trial of Topotecan and Paclitaxel in Previously Treated Patients With Relapsed Small Cell Lung Cancer|Completed||Phase 2|84|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:24:22.068803|2017-10-11 04:24:22.068803
NCT00003282|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-15|||March 1998||1998-03-01|January 2013|2013-01-01||||May 2005|Actual|2005-05-01||Interventional|||EF5 in Treating Patients With Solid Tumors|Phase I Trial of EF5, an Agent for the Detection of Hypoxia|Completed||Phase 1|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:22.235635|2017-10-11 04:24:22.235635
NCT00003283|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||July 1998||1998-07-01|January 2010|2010-01-01||||September 2003|Actual|2003-09-01||Interventional|||Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma|Phase II Study of Octreotide Treatment of Advanced, Recurrent Thymoma|Completed||Phase 2|38|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:24:22.334174|2017-10-11 04:24:22.334174
NCT00003284|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||January 1998||1998-01-01|June 2000|2000-06-01||||||||Interventional|||High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer|Tandem Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) After High Dose Paclitaxel Followed by Ifosfamide, Carboplatin, and Etoposide (ICE) for the Treatment of Lung Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:22.483523|2017-10-11 04:24:22.483523
NCT00003287|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-06-29|||March 1998||1998-03-01|June 2012|2012-06-01||||March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer|First Line Infusional 5-Fluorouracil, Folinic Acid and Oxaliplatin for Metastatic Colorectal Cancer or Loco-Regional Recurrency - Role of Chronomodulated Delivery Upon Survival - A Multicenter Randomized Phase III Trial|Completed||Phase 3|554|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:24:22.579425|2017-10-11 04:24:22.579425
NCT00003288|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-04|||August 1998||1998-08-01|April 2000|2000-04-01||||June 2003|Actual|2003-06-01||Interventional|||Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors|A Trial of Tirapazamine and Cyclophosphamide in Children With Refractory Solid Tumors|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:22.762388|2017-10-11 04:24:22.762388
NCT00003289|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-08-05|||June 1998||1998-06-01|August 2010|2010-08-01||||||||Interventional|||UCN-01 in Treating Patients With Advanced Cancer|A Phase I and Pharmacologic Study of UCN-01 (NSC638850)|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:24:22.870962|2017-10-11 04:24:22.870962
NCT00004305|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1998||1998-01-01|April 2002|2002-04-01||||||||Observational|||Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis||Completed||N/A|105||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:01.38981|2017-10-11 04:25:01.38981
NCT00003290|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||January 1998||1998-01-01|July 2001|2001-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Radiation Therapy in Treating Patients With Prostate Cancer|A Randomised Trial of High Dose Therapy in Localised Cancer of the Prostate Using Conformal Radiotherapy Techniques|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:22.952712|2017-10-11 04:24:22.952712
NCT00003291|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-07|||March 1998||1998-03-01|August 2014|2014-08-01||||March 2006|Actual|2006-03-01||Observational|||Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia|Molecular Genetic Lesions and Clinical Outcome in Pediatric ALL Patients|Completed||N/A|200|Anticipated|Children's Oncology Group|||||f||||f||||||||||2017-10-11 04:24:23.05823|2017-10-11 04:24:23.05823
NCT00003292|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-07|||July 1998||1998-07-01|November 2013|2013-11-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||S9624 Ifosfamide in Treating Patients With Meningeal Tumors|S9624: Phase II Study of Ifosfamide in Patients With Aggressive Meningeal Tumors|Terminated||Phase 2|7|Actual|Southwest Oncology Group||1||lack of accrual|f||||t||||||||||2017-10-11 04:24:23.129848|2017-10-11 04:24:23.129848
NCT00003293|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-10|||February 1998||1998-02-01|September 2012|2012-09-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme|A Phase III Randomized Study of SU101 Versus Procarbazine for Patients With Glioblastoma Multiforme in First Relapse|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 04:24:23.399672|2017-10-11 04:24:23.399672
NCT00003294|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-03|||May 1997||1997-05-01|March 2011|2011-03-01|May 2004|Actual|2004-05-01|April 1999|Actual|1999-04-01||Interventional|||Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer|Initial Clinical Evaluation of the Combination of Paclitaxel and Carboplatin With Modulation of Toxicity With GCSF and Amifostine|Completed||Phase 1|24|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:24:23.534323|2017-10-11 04:24:23.534323
NCT00003296|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||January 1998||1998-01-01|September 2000|2000-09-01||||||||Interventional|||Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer|Phase II Study of TLC D-99 for Hepatobiliary Carcinomas|Unknown status|Active, not recruiting|Phase 2|26|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:23.609677|2017-10-11 04:24:23.609677
NCT00003297|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-22|||December 1997||1997-12-01|September 2000|2000-09-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer|Phase I/II Study of High Dose Topotecan, Mitoxantrone and Thiotepa (TMT) Followed by Autologous Stem Cell Transplant in Patients With Recurrent Platinum Resistant Ovarian Cancer|Completed||Phase 1/Phase 2|50|Anticipated|Georgetown University|||||f||||f||||||||||2017-10-11 04:24:23.664843|2017-10-11 04:24:23.664843
NCT00003298|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-06-22|2015-06-02||February 1999||1999-02-01|June 2015|2015-06-01|May 2011|Actual|2011-05-01|February 2010|Actual|2010-02-01||Interventional||Eligible and treated in step 1|Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer|A Phase II Trial of Neoadjuvant Paclitaxel - Cisplatin Chemotherapy, Surgery and Adjuvant Radiation Therapy and 5-FU/Leucovorin for Gastric Cancer|Completed||Phase 2|39|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:24:23.737874|2017-10-11 04:24:23.737874
NCT00003299|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-19|||April 1998||1998-04-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|June 2005|Actual|2005-06-01||Interventional|||Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Randomized Phase III Study Comparing Etoposide and Cisplatin With Etoposide, Cisplatin and Paclitaxel in Patients With Extensive Small Cell Lung Cancer|Completed||Phase 3|587|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:24:25.704521|2017-10-11 04:24:25.704521
NCT00003301|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||July 1998||1998-07-01|September 2005|2005-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Irinotecan in Treating Patients With Recurrent Malignant Glioma|A Dose Finding and Safety/Efficacy Trial of CPT-11 (Irinotecan) in Patients With Recurrent Malignant Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:25.837511|2017-10-11 04:24:25.837511
NCT00003302|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-05-09|||May 1998||1998-05-01|February 2006|2006-02-01||||||||Interventional|||MRI to Detect Breast Tumors in Women|Breast MRI Protocol|Unknown status|Active, not recruiting|N/A|1500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:26.026979|2017-10-11 04:24:26.026979
NCT00003304|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-05|||April 1998||1998-04-01|March 2012|2012-03-01||||March 2000|Actual|2000-03-01||Interventional|||Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors|Second Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors After PCV-Chemotherapy|Completed||Phase 2|29|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:24:26.146912|2017-10-11 04:24:26.146912
NCT00003305|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||July 1997||1997-07-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|||||Interventional|||Aminopterin in Treating Patients With Refractory Leukemia|A Phase II Trial of Aminopterin in Adults and Children With Refractory Acute Leukemia Grant Application Title: A Phase II Trial of Aminopterin in Acute Leukemia|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:26.344763|2017-10-11 04:24:26.344763
NCT00003307|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-12|||March 1998||1998-03-01|May 2006|2006-05-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer|A Phase II Open Label Trial of Amifostine Plus Fractionated Radiotherapy for Primary Prostate Adenocarcinoma (T1a-T3b, NoMo, PSA>10 ng/ml) to Estimate Acute Grade 2 Genitourinary and Gastrointestinal Toxicity|Completed||Phase 2|25|Anticipated|University of Arizona|||||f||||||||||||||2017-10-11 04:24:26.483082|2017-10-11 04:24:26.483082
NCT00003308|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-22|||July 1998||1998-07-01|August 2013|2013-08-01||||September 2004|Actual|2004-09-01||Interventional|||Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma|A Phase II Trial of Radiosurgery for 1 to 3 Newly Diagnosed Brain Metastases From Renal Cell, Melanoma and Sarcoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:24:26.598225|2017-10-11 04:24:26.598225
NCT00003309|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||July 1998||1998-07-01|January 2010|2010-01-01||||March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer|"A Phase II Trial of Preradiation Multiagent Chemotherapy for Adults With Poor Risk Medulloblastoma, PNET, and Disseminated Ependymoma"|Completed||Phase 2|33|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:24:26.731926|2017-10-11 04:24:26.731926
NCT00003311|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-10-05|||March 1999||1999-03-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma|Phase II CCOP Trial of High Dose Methotrexate/ARA-C and HCVAD for Newly Diagnosed Nodular and Diffuse Mantle Cell Lymphoma and Their Blastic Variants|Completed||Phase 2|19|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:24:26.884298|2017-10-11 04:24:26.884298
NCT00003312|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-23|||September 1998||1998-09-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|January 2004|Actual|2004-01-01||Interventional|||Brachytherapy in Treating Patients With Prostate Cancer|Phase II Trial of Transrectal Ultrasound Guided Permanent Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate|Completed||Phase 2|95|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:24:27.041167|2017-10-11 04:24:27.041167
NCT00003313|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-11-19|||September 1998||1998-09-01|November 2014|2014-11-01|June 2010|Actual|2010-06-01|July 2002|Actual|2002-07-01||Interventional|||Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer|A Phase III Randomized Study of Amifostine Mucosal Protection for Patients With Favorable Performance Inoperable Stage II-III A/B Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Induction and Concurrent Hyperfractionated Radiotherapy With Paclitaxel and Carboplatin|Completed||Phase 3|243|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:24:28.012818|2017-10-11 04:24:28.012818
NCT00003315|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||July 1997||1997-07-01|May 2007|2007-05-01|December 1997|Actual|1997-12-01|||||Interventional|||Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection|Supplementary Protocol for Patients With Invasive Fungal Infection, Entered Into AML 11, AML 12 and UKALL XII (Or Their Successors)|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:28.718725|2017-10-11 04:24:28.718725
NCT00003316|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-04-10|||August 1998||1998-08-01|May 2004|2004-05-01||||April 2004|Actual|2004-04-01||Interventional|||Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus|Evaluation of Gemcitabine in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:24:28.79537|2017-10-11 04:24:28.79537
NCT00003317|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||May 1998||1998-05-01|July 2016|2016-07-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer|A Phase III Study of Surgical Resection and Chemotherapy (Paclitaxel and Carboplatin) With or Without Adjuvant Radiotherapy for Resected Stage IIIA Non-Small Cell Lung Cancer|Completed||Phase 3|480|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:24:29.074958|2017-10-11 04:24:29.074958
NCT00003320|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-28|||March 1997||1997-03-01|July 2012|2012-07-01||||August 2006|Actual|2006-08-01||Interventional|||Radiation Therapy Following Surgery to Remove Brain Metastases|Pilot Study of Adjuvant Fractionated Stereotactic Radiotherapy Following Surgical Removal of Cerebral Metastases|Completed||N/A|20|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:24:29.239143|2017-10-11 04:24:29.239143
NCT00003321|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-11|||February 1998||1998-02-01|June 2013|2013-06-01||||August 2001|Actual|2001-08-01||Observational|||Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus|An International Field Study of the Reliability and Validity of the EORTC-QLQ-C30 and a Disease Specific Questionnaire Module (the EORTC OES-24) in Assessing the Quality of Life of Patients With Oesophageal Cancer|Completed||N/A|370|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:24:29.323758|2017-10-11 04:24:29.323758
NCT00003322|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-24|||March 1998||1998-03-01|August 2012|2012-08-01||||January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer|A Phase III Randomized Trial of Intravenous Paclitaxel and Cisplatin Versus Intravenous Paclitaxel, Intraperitoneal Cisplatin and Intraperitoneal Paclitaxel in Patients With Optimal Stage III Epithelial Ovarian Carcinoma or Primary Peritoneal Carcinoma|Completed||Phase 3|384|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:24:29.431576|2017-10-11 04:24:29.431576
NCT00003323|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||May 1998||1998-05-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|May 2002|Actual|2002-05-01||Interventional|||Hormone Therapy in Treating Patients With Prostate Cancer|A Phase II Trial of Potency-Sparing Hormonal Therapy in Patients With Elevated Serum PSA After Radiation Therapy or Radical Prostatectomy for Prostate Cancer|Completed||Phase 2|101|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:24:29.744093|2017-10-11 04:24:29.744093
NCT00003324|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-09-30|||December 1997||1997-12-01|July 2012|2012-07-01||||July 2006|Actual|2006-07-01||Interventional|||Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases|Prognostic Factors Associated With Successful Omission of Whole Brain Radiotherapy in Patients With 4 or Less Cerebral Metastases Treated With Focal Radiation or Surgery|Completed||N/A|61|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:24:29.947202|2017-10-11 04:24:29.947202
NCT00003325|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-05-27|||December 1999||1999-12-01|May 2015|2015-05-01||||July 2013|Actual|2013-07-01||Interventional|||Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva|Intraoperative Lymphatic Mapping in Patients With Stage I and II Squamous Carcinoma of the Vulva|Completed||Phase 3|515|Actual|Gynecologic Oncology Group||1|||f||||f||||||||||2017-10-11 04:24:30.052829|2017-10-11 04:24:30.052829
NCT00003326|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||September 1997||1997-09-01|April 2001|2001-04-01||||||||Interventional|||Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus|A Phase II Trial of Paclitaxel (TAXOL) Administered as a Weekly One Hour Infusion in Patients With Advanced Esophageal Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:30.267119|2017-10-11 04:24:30.267119
NCT00003327|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||September 1997||1997-09-01|November 2001|2001-11-01||||||||Interventional|||Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer|A Phase II Trial of Paclitaxel (TAXOL) Administered as a Weekly One Hour Infusion in Previously Treated Patients With Advanced Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:30.377136|2017-10-11 04:24:30.377136
NCT00003328|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-05-20|||December 1997||1997-12-01|May 2010|2010-05-01||||||||Interventional|||Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer|A Phase III Double-Blind, Randomised, Placebo-Controlled Study of Porfiromycin When Used as an Adjuvant to Radiation Therapy in Patients With Head and Neck Cancer|Completed||Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:30.471753|2017-10-11 04:24:30.471753
NCT00003329|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-02|||January 1998||1998-01-01|March 2008|2008-03-01||||December 2007|Actual|2007-12-01||Observational|||Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer|ECOG Laboratory Study: Mapping Interactive Cancer Susceptibility Loci|Completed||N/A|4000|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:24:30.538944|2017-10-11 04:24:30.538944
NCT00003330|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-08|||July 1998||1998-07-01|May 2001|2001-05-01||||April 2002|Actual|2002-04-01||Interventional|||Interleukin-12 in Treating Patients With Advanced Cancer|Phase I Clinical Trials of IV rhIL-12 With or Without a Test-Dose in Patients With Advanced Malignancies (rhIL-12 NSC# 672423)|Completed||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:30.656509|2017-10-11 04:24:30.656509
NCT00003331|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-25|||January 1998||1998-01-01|March 2011|2011-03-01||||November 2001|Actual|2001-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I Study of Low Dose Continuous Infusion Topotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Malignancies|Completed||Phase 1|30|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:24:30.738359|2017-10-11 04:24:30.738359
NCT00003332|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-25|||July 1997||1997-07-01|March 2011|2011-03-01||||October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer|Phase I/II Study of Induction Chemotherapy With Gemcitabine and Cisplatin Followed by Combined Chemo-radiation and/or Surgical Resection for Locally Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|36|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:24:30.845575|2017-10-11 04:24:30.845575
NCT00003334|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-03-10|||March 1997||1997-03-01|March 2016|2016-03-01||||December 2001|Actual|2001-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract|Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:24:30.921899|2017-10-11 04:24:30.921899
NCT00003335|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-14|||January 1998||1998-01-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|November 2007|Actual|2007-11-01||Interventional|||Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer|A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With High Risk Hematologic Malignancies|Completed||Phase 2|44|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:24:31.178858|2017-10-11 04:24:31.178858
NCT00003336|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-10|||January 1998||1998-01-01|June 2010|2010-06-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions|A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With Severe Aplastic Anemia, Inborn Errors in Metabolism, or Inherited Hematologic Stem Cell Disorders|Completed||Phase 2|6|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:24:31.29872|2017-10-11 04:24:31.29872
NCT00003337|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||March 1997||1997-03-01|December 2001|2001-12-01||||||||Interventional|||Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma|The Utility of LymphoScan Imaging in the Localization and Staging of Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:31.399118|2017-10-11 04:24:31.399118
NCT00003338|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||March 1997||1997-03-01|December 2001|2001-12-01||||||||Interventional|||Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma|The Utility of LymphoScan Imaging in the Dectection of Residual Tumor After Chemotherapy and/or Radiotherapy in Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2/Phase 3|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:31.520361|2017-10-11 04:24:31.520361
NCT00003339|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-20|||November 1998||1998-11-01|May 2014|2014-05-01|September 2004|Actual|2004-09-01|November 1999|Actual|1999-11-01||Interventional|||Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma|A Randomized Phase II Trial of a Vaccine Combining Tyrosinase/gp100 Peptides Emulsified With Montanide ISA 51 With and Without Interleukin-12 for Patients With Resected Stages III and IV Melanoma|Completed||Phase 2|48|Actual|University of Southern California|||||f||||t||||||||||2017-10-11 04:24:31.655581|2017-10-11 04:24:31.655581
NCT00003340|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-01|||November 1997||1997-11-01|May 2014|2014-05-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia|A Phase II Study of Cyclophosphamide Followed by Topotecan in Patients With Refractory or Relapsed Acute Myelogenous Leukemia|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:24:31.775808|2017-10-11 04:24:31.775808
NCT00003341|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-01|||December 1997||1997-12-01|July 2013|2013-07-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy|The Effects of Procrit (Epoetin Alfa) on Hemoglobin Symptom Distress and Quality of Life During Chemotherapy in Lymphoma Patients With Mild to Moderate Anemia A Multicenter Trial|Completed||Phase 3|275|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:31.864009|2017-10-11 04:24:31.864009
NCT00003342|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-02|||December 1997||1997-12-01|July 2013|2013-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer|Phase I Trial of Dose-Dense Gemcitabine, Doxorubicin, Then Paclitaxel Plus Carboplatin In Patients With Transitional Cell Carcinoma of the Urothelium and Impaired Renal Function|Completed||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:32.003289|2017-10-11 04:24:32.003289
NCT00003343|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-08-07|||March 1998||1998-03-01|August 2012|2012-08-01||||January 2001|Actual|2001-01-01||Interventional|||Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Matrix Metalloprotease Inhibitor AG3340 in Combination With Mitoxantrone and Prednisone With Provision for Subsequent Change in Therapy in Patients Having Hormone-Refractory Prostate Cancer|Completed||Phase 3|525|Anticipated|Pfizer|||||f||||||||||||||2017-10-11 04:24:32.091237|2017-10-11 04:24:32.091237
NCT00004333|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1994||1994-11-01|July 2000|2000-07-01||||||||Interventional|||Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I||Completed||Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:03.976314|2017-10-11 04:25:03.976314
NCT00003344|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-04-26|||August 1998||1998-08-01|April 2012|2012-04-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer|Phase I-II Study of Weekly CPT-11 and Radiation Therapy for Unresectable or Locally Recurrent Large Bowel Cancer|Completed||Phase 1/Phase 2|49|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-10-11 04:24:32.17233|2017-10-11 04:24:32.17233
NCT00003345|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||October 1997||1997-10-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer|Phase II Trial of Cisplatin and Irinotecan in Patients With Suboptimally Debulked, Incompletely Responding Ovarian Cancer|Completed||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:32.241568|2017-10-11 04:24:32.241568
NCT00003346|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-24|||November 1997||1997-11-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma|Phase I-II Trial of High-Dose Acetaminophen With Carmustine in Patients With Metastatic Melanoma|Completed||Phase 2|80|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:32.312277|2017-10-11 04:24:32.312277
NCT00003348|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-15|||May 1998||1998-05-01|February 2013|2013-02-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain|Phase I Trial of BCNU Plus O6-Benzylguanine in the Treatment of Patients With Recurrent, Persistent or Progressive Cerebral Anaplastic Gliomas|Completed||Phase 1|56|Anticipated|Duke University|||||f||||||||||||||2017-10-11 04:24:32.382704|2017-10-11 04:24:32.382704
NCT00003350|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-09|||March 1999||1999-03-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma|Phase III Study of Paclitaxel Versus Liposomal Doxorubicin for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma|Completed||Phase 3|240|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:24:32.485205|2017-10-11 04:24:32.485205
NCT00003351|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||August 1998||1998-08-01|July 2016|2016-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer|Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer|Completed||Phase 2|104|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:24:32.634306|2017-10-11 04:24:32.634306
NCT00003352|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-12-10|||June 1998||1998-06-01|December 2012|2012-12-01|December 2002|Actual|2002-12-01|September 2000|Actual|2000-09-01||Interventional|||Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer|A Phase II Study in Patients With Metastatic or Locally Advanced Breast Cancer to Evaluate the Worth of the Combination of Adriamycin (Doxorubicin), Taxotere (Docetaxel), and Cyclophosphamide (ATC)|Completed||Phase 2|89|Actual|NSABP Foundation Inc||1|||f||||t||||||||||2017-10-11 04:24:32.805812|2017-10-11 04:24:32.805812
NCT00003869|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-02|2010-11-24||April 1999||1999-04-01|December 2012|2012-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer|Phase III Randomized, Double-Blind Study of CAI and Placebo in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|186|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:24:33.2803|2017-10-11 04:24:33.2803
NCT00003870|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-31|||February 1999||1999-02-01|March 2010|2010-03-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia|Radiolabeled BC8 (Anti-CD45) Antibody Combined With Cyclophosphamide and Total Body Irradiation Followed by HLA-matched Related or Unrelated Stem Cell Transplantation as Treatment for Advanced Acute Lymphocytic Leukemia|Completed||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:24:34.537249|2017-10-11 04:24:34.537249
NCT00003871|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||August 1999||1999-08-01|January 2010|2010-01-01||||June 2002|Actual|2002-06-01||Interventional|||PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer|Phase II Randomized Study of Vaccine Treatment of Advanced Prostate Cancer|Completed||Phase 2|60|Anticipated|Eastern Cooperative Oncology Group|||||||||f||||||||||2017-10-11 04:24:34.630643|2017-10-11 04:24:34.630643
NCT00003873|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-23|||April 1999||1999-04-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer|Phase III Trial Comparing a 28 Day Schedule of Daily Oral 5-FU Plus Eniluracil to Protracted Intravenous Infusion in Previously Untreated Patients With Advanced Colorectal Cancer|Completed||Phase 3|950|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:24:34.74965|2017-10-11 04:24:34.74965
NCT00003874|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-11-28|||February 1999||1999-02-01|November 2011|2011-11-01|September 2001||2001-09-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia|A Phase I/II Study of Combined Enrichment of CD34+ Cells and Depletion of B-Cells From Peripheral Blood Stem Cell Components for Patients With B-Lymphoid Malignancies|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:24:34.870246|2017-10-11 04:24:34.870246
NCT00003875|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-05-03|2017-03-18||October 13, 1998|Actual|1998-10-13|May 2017|2017-05-01|June 11, 2015|Actual|2015-06-11|June 11, 2015|Actual|2015-06-11||Interventional|||Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia|Treatment of Acute Myelogenous Leukemia With Busulfan and Etoposide Followed by Autologous or Syngeneic Stem Cell Rescue and Low-Dose Interleukin 2 (IL-2) Immunotherapy|Completed||Phase 2|30|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f|t|f||||||No||2017-10-11 04:24:34.976015|2017-10-11 04:24:34.976015
NCT00003876|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||April 1999||1999-04-01|May 2001|2001-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma|A Phase I Study of Concurrent Multi-modality Treatment for Patients With Relapsed Malignant Glioma Using Permanent I-125 Interstitial Seeds and Dose Escalation of Gliadel 3.85% Carmustine (BCNU) Polymer Wafers|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:35.252763|2017-10-11 04:24:35.252763
NCT00004334|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||July 1994||1994-07-01|December 2003|2003-12-01||||||||Observational|||Study of Depression, Peptides, and Steroids in Cushing's Syndrome||Unknown status|Recruiting|N/A|8||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.033586|2017-10-11 04:25:04.033586
NCT00003877|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-03|||September 1998||1998-09-01|March 2011|2011-03-01|December 2000|Actual|2000-12-01|February 2000|Actual|2000-02-01||Interventional|||Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer|A Phase I/II Study in Metastatic Breast Cancer Patients Infused With Stromagen and Isolated, Mobilized, Autologous Peripheral Blood CD34+ Progenitor Cells After High-Dose Chemotherapy|Completed||Phase 1/Phase 2|30|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:24:35.329047|2017-10-11 04:24:35.329047
NCT00003878|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||April 2002||2002-04-01|July 2003|2003-07-01|April 2003|Actual|2003-04-01|||||Interventional|||Carmustine Implants in Treating Patients With Brain Metastases|The Treatment of One or Two Supratentorial Brain Metastases With Surgical Resection and BCNU-Polymer Wafers|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:35.447129|2017-10-11 04:24:35.447129
NCT00003880|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-04-15|||February 1999||1999-02-01|April 2015|2015-04-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer|A Phase II/III Trial of Chemotherapy Alone Versus Chemotherapy Plus SCH 58500 in Newly Diagnosed Stage III Ovarian and Primary Peritoneal Cancer Patients With Greater Than or Equal to 0.5 cm and Less Than or Equal to 2 cm Residual Disease Following Surgery|Terminated||Phase 2/Phase 3|132|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:24:35.53949|2017-10-11 04:24:35.53949
NCT00003881|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||May 1999||1999-05-01|March 2004|2004-03-01|July 2004|Actual|2004-07-01|||||Interventional|||Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer|Phase II Pilot Trial of Carboplatin, Paclitaxel, and Herceptin in HER2/Neu (+) Advanced NSCLC|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:35.640773|2017-10-11 04:24:35.640773
NCT00003882|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-03|||March 1999||1999-03-01|March 2011|2011-03-01|September 2000|Actual|2000-09-01|April 2000|Actual|2000-04-01||Interventional|||Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors|Phase I Dose Finding Study of Anhydrovinblastine Administered as a 1-Hour Infusion Every 3 Weeks to Patients With Advanced Solid Tumors|Completed||Phase 1|10|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:24:35.880024|2017-10-11 04:24:35.880024
NCT00003883|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-31|||October 1998||1998-10-01|March 2010|2010-03-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation|A Randomized, Comparative Study of Itraconazole Versus Fluconazole for Prevention of Aspergillus Infections in Peripheral Blood Stem Cell and Marrow Transplant Recipients|Completed||Phase 3|578|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:24:35.948643|2017-10-11 04:24:35.948643
NCT00003884|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-20|||August 1998||1998-08-01|February 2013|2013-02-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zoledronate (4 and 8 mg) Administered Intravenously as an Adjuvant to Anticancer Therapy to Patients With Any Cancer With Bone Metastases Other Than Breast Cancer, Multiple Myeloma or Prostate Cancer|Completed||Phase 3|600|Anticipated|Novartis|||||f||||||||||||||2017-10-11 04:24:36.061825|2017-10-11 04:24:36.061825
NCT00003885|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||November 1997||1997-11-01|June 2000|2000-06-01||||||||Interventional|||Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma|Phase II Study of Arsenic Trioxide in Relapsed/Refractory Acute Leukemia and Blast Crisis of Chronic Myeloid Leukemia|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:36.252472|2017-10-11 04:24:36.252472
NCT00003887|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-11-28|||August 1998||1998-08-01|November 2011|2011-11-01|February 2003|Actual|2003-02-01|||||Interventional|||Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation|Donor Lymphocyte Infusion (DLI) as Adoptive Immunotherapy for Relapse Malignancies After Allogeneic Hematopoietic Transplantation|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:24:36.322393|2017-10-11 04:24:36.322393
NCT00003888|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-07-16|||April 1999||1999-04-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer|A Randomized Phase III Multicenter Trial of Neoadjuvant Docetaxel (Taxotere) Plus Cisplatin Plus 5-Fluorouracil Versus Neoadjuvant Cisplatin Plus 5-Fluorouracil in Patients With Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|359|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:24:36.44081|2017-10-11 04:24:36.44081
NCT00003890|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2010-11-07|||February 1999||1999-02-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||MG98 in Treating Patients With Advanced Solid Tumors|A Phase I Study of MG98 Given as a 2 Hour Twice Weekly IV Infusion in Patients With Advanced Cancer|Completed||Phase 1|20|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:24:36.608202|2017-10-11 04:24:36.608202
NCT00003891|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2010-11-07|||February 1999||1999-02-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|||||Interventional|||Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors|A Phase I Study of NX211 Given as an IV Infusion Days 1, 2 and 3 Every 3 Weeks in Patients With Solid Tumors|Completed||Phase 1|25|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:24:36.665945|2017-10-11 04:24:36.665945
NCT00003892|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||February 1999||1999-02-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|October 2000|Actual|2000-10-01||Interventional|||ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer|Phase II Study of CGP 69846A (ISIS 5132) in Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|22|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-10-11 04:24:36.740403|2017-10-11 04:24:36.740403
NCT00003893|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||July 1998||1998-07-01|November 2001|2001-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer|Sequencing of Chemotherapy and Radiotherapy in Adjuvant Breast Cancer|Completed||Phase 3|2250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:36.934396|2017-10-11 04:24:36.934396
NCT00003894|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-03|||March 1999||1999-03-01|March 2011|2011-03-01|June 2002|Actual|2002-06-01|January 2000|Actual|2000-01-01||Interventional|||Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant|Thalidomide vs. Placebo for Steroid Dependent or Refractory Chronic Graft vs. Host Disease (cGVHD) IND #42782|Completed||Phase 2|36|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:24:37.016576|2017-10-11 04:24:37.016576
NCT00003895|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-28|2015-04-28||April 1999||1999-04-01|December 2016|2016-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma|A Randomized Phase II Trial to Determine the Immune Response to a Mutated gp100 Melanoma Peptide (209-2M) Vaccine in HLA-A2 Positive Patients With a &gt;1mm Melanoma on Initial Biopsy|Completed||Phase 2|36|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:24:37.102083|2017-10-11 04:24:37.102083
NCT00003896|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-02|2012-10-30||September 1999||1999-09-01|January 2013|2013-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||S9912 Combination Chemo in Stage III Ovarian Cancer,|Phase II Evaluation of Intravenous Paclitaxel, Intraperitoneal Cisplatin, Intravenous Liposomal Doxorubicin and Intraperitoneal Paclitaxel in Women With Optimally-Debulked Stage III Epithelial Ovarian Cancer|Completed||Phase 2|68|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:24:37.66127|2017-10-11 04:24:37.66127
NCT00003897|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-07-22|||May 1999||1999-05-01|July 2015|2015-07-01|December 2006|Actual|2006-12-01|March 2001|Actual|2001-03-01||Interventional|||Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma|Phase I Trial of Immunization Using Particle-Mediated Transfer of Genes for GP-100 and GM-CSF Into Uninvolved Skin of Patients With Melanoma (Summary Last Modified 7/1999)|Completed||Phase 1|18|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:24:38.582272|2017-10-11 04:24:38.582272
NCT00003898|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-02-25|||January 1999||1999-01-01|February 2011|2011-02-01|January 2004|Actual|2004-01-01|June 2003|Actual|2003-06-01||Interventional|||Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation|The Use of Supplemental Oral Glutamine (GLN) to Decrease Morbidity in Patients Undergoing Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Study|Completed||Phase 2|120|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:24:38.696897|2017-10-11 04:24:38.696897
NCT00004138|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2016-07-12|||September 1999||1999-09-01|July 2016|2016-07-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Positron Emission Tomography for Detecting Non-small Cell Lung Cancer|The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma|Completed||N/A|303|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:24:38.799471|2017-10-11 04:24:38.799471
NCT00004139|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2016-07-19|||September 1999||1999-09-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|July 2004|Actual|2004-07-01||Interventional|||Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Phase II Randomized Trial of Gemcitabine/Docetaxel and Gemcitabine/Irinotecan in Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|80|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:24:38.964639|2017-10-11 04:24:38.964639
NCT00004141|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-09-04|||August 1998||1998-08-01|September 2013|2013-09-01|April 2006|Actual|2006-04-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma|Phase II Study of Outpatient CDDP and DTIC Followed by GM-CSF, IFN-a2b, and IL-2 in Patients With Advanced Melanoma|Completed||Phase 2|46|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:24:39.079486|2017-10-11 04:24:39.079486
NCT00004142|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-07-27|||September 1999||1999-09-01|July 2012|2012-07-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver|Phase II Study of Radiofrequency Ablation of Colorectal Cancer Liver Metastases Combined With Post-Ablation Hepatic Arterial Infusion of Floxuridine Alternating With 5-Fluorouracil|Completed||Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:24:39.165247|2017-10-11 04:24:39.165247
NCT00004143|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2014-11-19|2013-09-06||September 1999||1999-09-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|May 2008|Actual|2008-05-01||Interventional|||Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes|Allogeneic Mixed Chimerism Stem Cell Transplantation Utilizing In Vivo and In Vitro Campath for Hemoglobinopathies and Bone Marrow Failure Syndromes|Completed||Phase 2|2|Actual|Duke University|Small number of subjects analyzed|2|||f||||t||||||||||2017-10-11 04:24:39.284232|2017-10-11 04:24:39.284232
NCT00004144|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2014-04-22|||May 2000||2000-05-01|April 2014|2014-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer|Phase I Study of Bryostatin 1 and Gemcitabine (Gemzar)|Completed||Phase 1|36|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 04:24:39.552599|2017-10-11 04:24:39.552599
NCT00004145|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2014-03-06|||November 1998||1998-11-01|March 2014|2014-03-01|August 2011|Actual|2011-08-01|November 2003|Actual|2003-11-01||Interventional|||Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Allogeneic Peripheral Blood Stem Cell Transplantation Using a Non-Myeloablative Preparative Regimen for Patients With Hematologic Malignancies|Completed||Phase 2|16|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:24:39.645542|2017-10-11 04:24:39.645542
NCT00004146|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2015-05-05|2015-03-13||March 2000||2000-03-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM|Phase II Clinical and Pharmacologic Study of Radiation Therapy and CAI (Carboxy-Amido Triazole) in Adults With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:24:39.797512|2017-10-11 04:24:39.797512
NCT00004147|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-20|||July 2000||2000-07-01|May 2003|2003-05-01|November 2006|Actual|2006-11-01|||||Interventional|||COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors|A Phase I/II Study of Col-3 Administered on a Continuous Daily Oral Schedule in Patients With Recurrent High-Grade Astrocytoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:40.12653|2017-10-11 04:24:40.12653
NCT00004148|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-02-08|||October 1999||1999-10-01|June 2006|2006-06-01||||April 2006|Actual|2006-04-01||Interventional|||Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma|A Phase I Trial of Intra Lesional RV-B7.1 Vaccine in the Treatment of Malignant Melanoma|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:40.219458|2017-10-11 04:24:40.219458
NCT00004149|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-07-07|||September 1999||1999-09-01|July 2004|2004-07-01||||||||Interventional|||Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy|A Phase II Trial of Arsenic Trioxide in Advanced Hormone-Refractory Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:40.308253|2017-10-11 04:24:40.308253
NCT00004150|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-11-05|||March 1999||1999-03-01|February 2001|2001-02-01|April 2007|Actual|2007-04-01|||||Interventional|||High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer|Pan-European Trials in Adjuvant Colon Cancer (PETACC-2): Randomized Phase III Intergroup Trial of High-Dose Infusional 5-FU (+ or - Folinic Acid) Versus Standard Bolus 5-FU/Folinic Acid|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:40.400133|2017-10-11 04:24:40.400133
NCT00004151|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-09-20|||September 1999||1999-09-01|September 2012|2012-09-01||||November 2000|Actual|2000-11-01||Interventional|||Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer|Open Label Phase II Study on XR5000 Administered as a 5 Day Infusion in Advanced Non Small Cell Lung Cancer|Completed||Phase 2|15|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:24:40.736274|2017-10-11 04:24:40.736274
NCT00004152|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-01-15|||February 1999||1999-02-01|January 2013|2013-01-01||||December 2002|Actual|2002-12-01||Interventional|||PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma|A Pilot Study to Compare 18F-Fluorodeoxyglucose Positron Emission Tomography (PET) Scanning in Addition to CT Scanning With CT Scanning Alone in the Pre-Operative Evaluation of Patients With Stage III and IV Melanoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:40.82625|2017-10-11 04:24:40.82625
NCT00004153|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-09-04|||June 1998||1998-06-01|September 2013|2013-09-01|January 2005|Actual|2005-01-01|March 2004|Actual|2004-03-01||Interventional|||Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma|Sensitive RT-PCR Analysis for Melanoma Markers From Lymph Nodes and Peripheral Blood in Patients With Melanoma|Completed||N/A|106|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:24:40.898538|2017-10-11 04:24:40.898538
NCT00004154|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2016-06-16|||June 2000||2000-06-01|October 2012|2012-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer|Randomized Chemoprevention Trial With 4-HPR (Fenretinide) in Superficial Bladder Cancer|Completed||Phase 3|111|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 04:24:40.966977|2017-10-11 04:24:40.966977
NCT00004156|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-10-29|||May 1999||1999-05-01|October 2013|2013-10-01||||June 2008|Actual|2008-06-01||Interventional|||Vaccine Therapy in Treating Patients With Breast Cancer|Vaccination of High Risk Breast Cancer Patients With MUC-1 (Glycosylated) Keyhole Limpet Hemocyanin Conjugates Plus the Immunological Adjuvant QS21|Completed||Phase 1|45|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:24:41.053877|2017-10-11 04:24:41.053877
NCT00004157|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2010-03-31|||August 2000||2000-08-01|March 2010|2010-03-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors|Combination of Interleukin 11 (Neumega) With G-CSF to Mobilize Autologous Peripheral Blood Stem Cells (PBSC)|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:24:42.452397|2017-10-11 04:24:42.452397
NCT00004158|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2010-09-17|||June 1999||1999-06-01|September 2010|2010-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase I/II Study of Targeted Radiotherapy Using Holmium-166-DOTMP With Melphalan and Peripheral Blood Stem Cell Transplantation for Treatment of Multiple Myeloma|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:24:42.554261|2017-10-11 04:24:42.554261
NCT00004159|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-11-18|||February 2000||2000-02-01|March 2013|2013-03-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor|Biweekly Gemcitabine and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer and Solid Tumors: A Phase I/IIa Study|Terminated||Phase 1/Phase 2|54|Actual|University of Alabama at Birmingham|||||f||||||||||||||2017-10-11 04:24:42.625552|2017-10-11 04:24:42.625552
NCT00004160|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-11-25|||February 2000||2000-02-01|October 2005|2005-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed|Sequential and Concomitant Chemoradiotherapy With Gemcitabine-Based Chemotherapy for Inoperable Stage IIIa and IIIb Non-Small Cell Lung Cancer: A Phase I/IIa Study|Completed||Phase 1/Phase 2|72|Actual|University of Alabama at Birmingham||5|||f||||t||||||||||2017-10-11 04:24:42.693002|2017-10-11 04:24:42.693002
NCT00004161|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-04-10|||June 1997||1997-06-01|April 2013|2013-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Fenretinide in Treating Patients With Leukoplakia of the Mouth|A Randomized, Double Blind, Placebo-Controlled Phase II Clinical Trial of N(4-Hydroxy-phenyl)Retinamide (Fenretinide, 4HPR) in Oral Leukoplakia|Completed||Phase 2|30|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 04:24:42.78108|2017-10-11 04:24:42.78108
NCT00004162|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-04-10|||June 1997||1997-06-01|April 2013|2013-04-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma|Phase I Trial of Liposomal Doxorubicin (Doxil) Based Combination Chemotherapy Regimen in AIDS-Associated Non-Hodgkin's Lymphoma|Completed||Phase 1|48|Anticipated|University of Alabama at Birmingham||8|||f||||t||||||||||2017-10-11 04:24:42.853926|2017-10-11 04:24:42.853926
NCT00004163|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2017-04-14|||October 1999|Actual|1999-10-01|April 2017|2017-04-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer|Herceptin In Patients With Advanced or Metastatic Salivary Gland Carcinomas|Completed||Phase 2|14|Actual|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-11 04:24:42.95352|2017-10-11 04:24:42.95352
NCT00004164|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2009-02-06|||August 1999||1999-08-01|September 2000|2000-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx|A Phase II Trial of Docetaxel, Cisplatin, 5-FU, and Leucovorin for Carcinoma of the Nasopharnyx|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:43.041178|2017-10-11 04:24:43.041178
NCT00004165|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|Stem Cell Transplant as Standard Therapy for Symptomatic Multiple Myeloma|Completed||Phase 3|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:43.106749|2017-10-11 04:24:43.106749
NCT00004166|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-31||2011-02-18|October 1999||1999-10-01|May 2012|2012-05-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy|Amifostine as a Toxicity Protectant in Ovarian Cancer in Chemotherapy Treated Patients: A Pilot Phase III Randomized Controlled Trial|Completed||Phase 3|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:43.262674|2017-10-11 04:24:43.262674
NCT00004169|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-06-21||2011-07-01|November 1993||1993-11-01|June 2012|2012-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease|High-Dose Chemoradiotherapy With Stem Cell Support in Patients With Relapsed or Refractory Hodgkin's Disease|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:43.337548|2017-10-11 04:24:43.337548
NCT00004171|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma|Autologous Blood Stem Cell Transplantation in Patients With Hodgkin's Disease and Non-Hodgkin's Lymphoma Who Have Had Prior Radiation Therapy|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:43.407183|2017-10-11 04:24:43.407183
NCT00004172|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer|Peripheral Stem Cell Transplantation Protocol for Patients With Previously Treated Advanced Breast Cancer - A Phase II Pilot Study|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:43.487027|2017-10-11 04:24:43.487027
NCT00004173|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-05-14|||October 1999||1999-10-01|July 2003|2003-07-01||||||||Interventional|||Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer|A Phase I Study of Oxaliplatin in Combination With Paclitaxel|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:43.56437|2017-10-11 04:24:43.56437
NCT00004174|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-07-09|||October 1999||1999-10-01|July 2013|2013-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer|High Dose Paclitaxel Added to Cyclophosphamide and Thiotepa Followed by Autologous Stem Cell Rescue: A Phase I Trial in Advanced Breast Cancer|Completed||Phase 1|30|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 04:24:43.63361|2017-10-11 04:24:43.63361
NCT00004175|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-31||2011-07-01|November 1998||1998-11-01|May 2012|2012-05-01|June 2005|Actual|2005-06-01|September 2004|Actual|2004-09-01||Interventional|||Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer|Phase II Study of Taxotere, Doxorubicin and Cyclophosphamide (TAC) Primary Therapy in Stage III Breast Cancer|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:43.710172|2017-10-11 04:24:43.710172
NCT00004176|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-05-14|||October 1998||1998-10-01|May 2013|2013-05-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|A Phase II Evaluation of Ethyol as an Esophageal Mucosal Protectant in the Treatment of Limited Disease Small Cell Lung Cancer With Chemotherapy and Twice-Daily Radiation|Completed||Phase 2|34|Actual|Washington University School of Medicine|||||f||||f||||||||||2017-10-11 04:24:43.787315|2017-10-11 04:24:43.787315
NCT00004177|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2011-06-21|||August 1999||1999-08-01|June 2011|2011-06-01||||May 2002|Actual|2002-05-01||Interventional|||Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer|Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 in Advanced Ovarian Cancer Using Autologous Peripheral Blood Stem Cell Rescue (PBSCR) to Control Myelotoxicity|Completed||Phase 1/Phase 2|15|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||||||||||||2017-10-11 04:24:43.868115|2017-10-11 04:24:43.868115
NCT00004178|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2011-06-09|||April 1998||1998-04-01|May 2006|2006-05-01|December 2001|Actual|2001-12-01|December 2000|Actual|2000-12-01||Interventional|||Gene Therapy in Treating Patients With Cancer|Phase I Study of T Cells Modified With Chimeric AntiCEA Immunoglobulin-T Cell Receptors (IgTCR) in Adenocarcinoma|Completed||Phase 1|||Roger Williams Medical Center|||||f||||||||||||||2017-10-11 04:24:43.963255|2017-10-11 04:24:43.963255
NCT00004179|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2017-07-26|||May 1999||1999-05-01|July 2017|2017-07-01|July 19, 2017|Actual|2017-07-19|April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|Chimeric Anti-CD20 Monoclonal Antibody (Mabthera) in Remission Induction and Maintenance Treatment of Relapsed Follicular Non-Hodgkin's Lymphoma: A Phase III Randomized Clinical Trial - Intergroup Collaborative Study|Completed||Phase 3|475|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:24:44.103077|2017-10-11 04:24:44.103077
NCT00004180|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2017-02-09|||October 1999||1999-10-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|March 2006|Actual|2006-03-01||Interventional|||Rosiglitazone in Treating Patients With Liposarcoma|Phase II Clinical Trial of Rosiglitazone, a Full-Agonist Ligand for the Peroxisome Proliferator-Activated Receptor Gamma (PPAR), as Differentiation Therapy for Patients With Liposarcoma|Completed||Phase 2|32|Actual|Dana-Farber Cancer Institute||4|||f||||f||||||||No||2017-10-11 04:24:44.801475|2017-10-11 04:24:44.801475
NCT00004181|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia|Allogeneic Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in the Chronic Phase or Multiple Myeloma|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:44.90206|2017-10-11 04:24:44.90206
NCT00004182|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer|Phase II Study for the Evaluation of CPT-11 (Irinotecan, Camptosar) in Patients With Metastatic or Recurrent Breast Cancer|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:44.97482|2017-10-11 04:24:44.97482
NCT00004183|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2016-07-12|||November 2000||2000-11-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|December 2003|Actual|2003-12-01||Interventional|||Capecitabine in Treating Patients With Malignant Mesothelioma|Capecitabine (Xeloda) in Malignant Mesothelioma: A Phase II Study|Completed||Phase 2|27|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:24:45.044817|2017-10-11 04:24:45.044817
NCT00004184|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-04-11|||August 1998||1998-08-01|March 2013|2013-03-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase I/II Trial of a Human Anti-Idiotypic Monoclonal Antibody Vaccine (4B5) Which Mimics the GD2 Antigen, in Patients With Melanoma|Completed||Phase 1/Phase 2|50|Anticipated|University of Alabama at Birmingham||2|||||||t||||||||||2017-10-11 04:24:45.238566|2017-10-11 04:24:45.238566
NCT00004186|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-04-10|||December 1996||1996-12-01|April 2013|2013-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer|Phase I/IIA Study of Sequential Ifosfamide and Topotecan in Patients With Small Cell Lung Cancer|Completed||Phase 1/Phase 2|55|Anticipated|University of Alabama at Birmingham|||||f||||t||||||||||2017-10-11 04:24:45.340605|2017-10-11 04:24:45.340605
NCT00004187|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2012-05-14|||June 1999||1999-06-01|May 2012|2012-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer|A Phase I-II Study of Capecitabine and Oxaliplatin in Chemotherapy-Naive and Thymidylate Synthase Inhibitor Pretreated Advanced or Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|||Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:24:45.439698|2017-10-11 04:24:45.439698
NCT00004188|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-05-16|||February 2001||2001-02-01|May 2013|2013-05-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma|A Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplant Following Dose Intensive Induction Therapy for High Risk Neuroblastoma|Completed||Phase 3|495|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:24:45.540655|2017-10-11 04:24:45.540655
NCT00004189|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-02-08|||October 1999||1999-10-01|September 2003|2003-09-01||||July 2003|Actual|2003-07-01||Interventional|||Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer|A Phase I and Pharmacokinetic Study of Sequences of NSC 655649 (Rebeccamycin Analogue) and Cisplatin Without and With Granulocyte Colony-Stimulating Factor Support Every 21 Days|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:45.910065|2017-10-11 04:24:45.910065
NCT00004190|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2016-07-12|||October 1999||1999-10-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|April 2003|Actual|2003-04-01||Interventional|||Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer|A Phase I(Limited)/Phase II Study of Oxaliplatin (OXAL) and Gemcitabine (GEMZAR) in Patients With Metastatic Pancreatic Carcinoma|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:24:46.170589|2017-10-11 04:24:46.170589
NCT00004192|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2010-06-23|||May 2000||2000-05-01|June 2010|2010-06-01|March 2001|Actual|2001-03-01|February 2001|Actual|2001-02-01||Interventional|||Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma|A Randomized, Multicenter, Open-Label Study of Single Dose Filgrastim-SD/01 Versus Daily Filgrastim Following ESHAP Chemotherapy for Non-Hodgkin's Lymphoma|Completed||Phase 2|60|Anticipated|University of Nebraska|||||f||||||||||||||2017-10-11 04:24:46.336355|2017-10-11 04:24:46.336355
NCT00004193|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-04-10|||January 1999||1999-01-01|April 2013|2013-04-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer|Phase II Trial of ISIS 2503, an Antisense Inhibitor of H-ras, in Patients With Advanced Colorectal Cancer|Terminated||Phase 2|25|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:24:46.445786|2017-10-11 04:24:46.445786
NCT00004194|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-12-17||||||April 2000|2000-04-01||||||||Interventional|||Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease|A Phase I-II Study for the Treatment of Steroid Resistant GVHD With Fludarabine|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:46.538171|2017-10-11 04:24:46.538171
NCT00004195|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2015-06-12|||September 1998||1998-09-01|June 2015|2015-06-01|May 2001|Actual|2001-05-01|October 1999|Actual|1999-10-01||Interventional|||Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer|Evaluation of Dihydropyrimidine Dehydrogenase (DPD) Activity in Surgically Resected Primary and Metastatic Colorectal Cancer After 48 hr Pretreatment With Eniluracil|Completed||Phase 2|28|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 04:24:46.605152|2017-10-11 04:24:46.605152
NCT00004196|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2014-01-16|||October 1999||1999-10-01|April 2013|2013-04-01|November 2007|Actual|2007-11-01|October 2004|Actual|2004-10-01||Interventional|||Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis|A Multicenter Trial of Adjuvant Interferon Alfa-2b for Melanoma Patients With Early Lymph Node Metastasis Detected by Lymphatic Mapping and Sentinel Lymph Node Biopsy|Completed||Phase 3|3000|Anticipated|University of Alabama at Birmingham||5|||f||||t||||||||||2017-10-11 04:24:46.716285|2017-10-11 04:24:46.716285
NCT00004197|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2010-06-23|||June 1999||1999-06-01|June 2010|2010-06-01|November 2003|Actual|2003-11-01|January 2002|Actual|2002-01-01||Interventional|||Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma|A Phase II Trial to Evaluate the Rate of Immune Response Using Idiotype Immunotherapies Produced by Molecular Biological Means for Treatment of Aggressive B Cell Lymphoma|Completed||Phase 2|||University of Nebraska|||||f||||||||||||||2017-10-11 04:24:46.828987|2017-10-11 04:24:46.828987
NCT00004198|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2010-06-23|||June 1999||1999-06-01|June 2010|2010-06-01|November 2003|Actual|2003-11-01|January 2002|Actual|2002-01-01||Interventional|||Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma|A Phase II Trial to Evaluate the Rate of Immune Response Using Idiotype Immunotherapies Produced by Molecular Biological Means for Treatment of Indolent B Cell Lymphoma|Completed||Phase 2|||University of Nebraska|||||f||||f||||||||||2017-10-11 04:24:46.950808|2017-10-11 04:24:46.950808
NCT00004199|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2012-08-07|||March 1999||1999-03-01|August 2012|2012-08-01||||July 2001|Actual|2001-07-01||Interventional|||Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Matrix Metalloprotease Inhibitor Prinomastat (AG3340) in Combination With Gemcitabine and Cisplatin in Patients Having Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 04:24:47.059047|2017-10-11 04:24:47.059047
NCT00004335|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||April 1993||1993-04-01|December 2003|2003-12-01||||||||Observational|||Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.101477|2017-10-11 04:25:04.101477
NCT00004200|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2012-08-07|||October 1999||1999-10-01|August 2012|2012-08-01||||January 2002|Actual|2002-01-01||Interventional|||Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Randomized Double-Blind, Placebo-Controlled Phase II Study of the Matrix Metalloprotease Inhibitor Prinomastat in Combination With Temozolomide Following Radiation Therapy in Patients Having Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-10-11 04:24:47.156821|2017-10-11 04:24:47.156821
NCT00004201|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-02-01||||||June 2007|2007-06-01|August 2004|Actual|2004-08-01|||||Interventional|||Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer|A Randomized Phase II Trial of Cisplatin or Carboplatin With Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:47.249097|2017-10-11 04:24:47.249097
NCT00004202|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-05-08|||October 1998||1998-10-01|May 2013|2013-05-01||||||||Interventional|||Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer|A Phase II Study of Induction Chemotherapy With Paclitaxel and Carboplatin Followed by Radiation Therapy With RSR13 for Locally Advanced Inoperable Non-Small Cell Lung Cancer|Completed||Phase 2|||Spectrum Pharmaceuticals, Inc|||||f||||||||||||||2017-10-11 04:24:47.341093|2017-10-11 04:24:47.341093
NCT00004203|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-09-04|||February 2000||2000-02-01|September 2013|2013-09-01|April 2005|Actual|2005-04-01|February 2002|Actual|2002-02-01||Interventional|||Oxaliplatin in Treating Patients With Metastatic Bladder Cancer|A Phase II Study of Oxaliplatin in Urothelial Cancer|Completed||Phase 2|20|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:24:47.460825|2017-10-11 04:24:47.460825
NCT00004204|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2014-01-03|||February 2000||2000-02-01|April 2006|2006-04-01||||||||Interventional|||Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma|A Phase II Study of Temozolomide in the Treatment of Recurrent Malignant Gliomas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:47.587669|2017-10-11 04:24:47.587669
NCT00004205|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2017-08-08|||March 1998||1998-03-01|August 2017|2017-08-01|December 2017|Anticipated|2017-12-01|December 2008|Actual|2008-12-01||Interventional|BIG 1-98||Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer|A Phase III Study to Evaluate Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors|Active, not recruiting||Phase 3|8028|Actual|International Breast Cancer Study Group||4|||f||||t||||||||||2017-10-11 04:24:47.677807|2017-10-11 04:24:47.677807
NCT00004206|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2014-06-23|||September 1999||1999-09-01|July 2002|2002-07-01||||||||Interventional|||Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer|Phase II Study of Oxaliplatin and 5 Fluorouracil in the Treatment of Advanced Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:47.819678|2017-10-11 04:24:47.819678
NCT00004207|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2014-06-23|||December 1997||1997-12-01|July 2000|2000-07-01||||||||Interventional|||Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer|A Phase I Study to Determine the Maximum Tolerated Dose of Daunoxome as Therapy for the Treatment of Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:47.904342|2017-10-11 04:24:47.904342
NCT00004208|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2015-03-10|||August 2000||2000-08-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|October 2006|Actual|2006-10-01||Interventional|||Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome|Antithymocyte Globulin (ATG) and Cyclosporine (CSA) to Treat Patients With Myelodysplastic Syndrome (MDS). A Randomized Trial Comparing ATG + CSA With Best Supportive Care|Completed||Phase 3|86|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 04:24:47.976801|2017-10-11 04:24:47.976801
NCT00004209|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-08-06|||May 1998||1998-05-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Randomized Study of MVP 3 Versus 6 Cycles in Advanced Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:48.076838|2017-10-11 04:24:48.076838
NCT00004210|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2014-10-23|||February 2000||2000-02-01|July 2009|2009-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer|Outcomes in Education and Counseling for HNPCC Testing|Completed||N/A|900|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:48.143149|2017-10-11 04:24:48.143149
NCT00004211|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-21|2013-03-19|||July 1999||1999-07-01|January 2005|2005-01-01|January 2002|Actual|2002-01-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer|A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With RNA Encoding Prostate Specific Antigen, PSA|Completed||Phase 1/Phase 2|17|Actual|Duke University|||||f||||||||||||||2017-10-11 04:24:48.218114|2017-10-11 04:24:48.218114
NCT00004212|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-05-15|||September 1999||1999-09-01|May 2012|2012-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas|A Phase I Dose Escalation Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Pediatric Patients With Advanced Solid Tumors and Lymphomas|Completed||Phase 1|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:24:48.287689|2017-10-11 04:24:48.287689
NCT00004213|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-07-17|||May 1998||1998-05-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors|An Open Label, Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP) in Cancer Patients Using a Single Daily Dose for Five Days|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:48.369711|2017-10-11 04:24:48.369711
NCT00004215|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-06-18|||August 1999||1999-08-01|June 2013|2013-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia|"Clinical Protocol for a Phase II Study of Leridistim (SC-70935) in Adult Patients (Age>55) With Acute Myeloid Leukemia (AML) Receiving Chemotherapy With the Cytarabine and Daunorubicin 7+3 Regimen"|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:48.421378|2017-10-11 04:24:48.421378
NCT00004336|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1995||1995-10-01|April 2002|2002-04-01||||||||Observational|||Pilot Study of Familial Nonsyndromal Mondini Dysplasia||Completed||N/A|2||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.177087|2017-10-11 04:25:04.177087
NCT00004216|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-07-17|||August 1999||1999-08-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy|A Phase I Trial of a Live, Genetically Modified Salmonella Typhimurium (VNP20009) for the Treatment of Cancer by Intratumoral Injection|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:48.485325|2017-10-11 04:24:48.485325
NCT00004217|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2015-03-05|||February 2000||2000-02-01|March 2015|2015-03-01|March 2006|Actual|2006-03-01|May 2001|Actual|2001-05-01||Interventional|||S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase II Study of Daunomycin and ARA-C Given by Continuous IV Infusion With PSC-833 for Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) in Patients of Age 56 or Older|Completed||Phase 2|55|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-10-11 04:24:48.56711|2017-10-11 04:24:48.56711
NCT00004218|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-12-17|||October 1999||1999-10-01|January 2006|2006-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia Trial 4: A Randomized Comparison of Chlorambucil, Fludarabine and Fludarabine Plus Cyclophosphamide|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:48.933138|2017-10-11 04:24:48.933138
NCT00004219|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-08-01||||||June 2007|2007-06-01||||||||Interventional|||Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma|A Study to Investigate the Efficacy and Tolerability of Two Dose Levels of Lerisetron Compared With Granisetron in Patients Receiving Radiotherapy for Stage I Seminoma|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:49.231788|2017-10-11 04:24:49.231788
NCT00004220|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2010-01-11|||October 1999||1999-10-01|January 2010|2010-01-01||||||||Interventional|||Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer|A Phase I Study of Oxaliplatin in Combination With Gemcitabine|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:24:49.309923|2017-10-11 04:24:49.309923
NCT00004221|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2017-08-08|||November 1999||1999-11-01|August 2017|2017-08-01||||February 6, 2002|Actual|2002-02-06||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer|A Phase II Trial Using Multiple Cycles of High Dose Sequential Carboplatin, Paclitaxel and Topotecan With Peripheral Blood Stem Cell (PBSC) Support as Initial Chemotherapy in Patients With Optimally Debulked Stage III Ovarian and Primary Peritoneal Carcinoma|Terminated||Phase 2|12|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:24:49.405315|2017-10-11 04:24:49.405315
NCT00004223|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2010-01-26|||December 1999||1999-12-01|January 2010|2010-01-01||||October 2002|Actual|2002-10-01||Interventional|||Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer|Phase II Trial of Gemcitabine and Docetaxel in Advanced Carcinoma of the Urothelium|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:24:49.61213|2017-10-11 04:24:49.61213
NCT00004224|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-08-23|||January 1999||1999-01-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|||||Interventional|||Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma|SIOP Study of Combined Modality Treatment in Childhood Ependymoma|Completed||Phase 2|65|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:49.913102|2017-10-11 04:24:49.913102
NCT00004225|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2010-07-03|||January 2000||2000-01-01|April 2004|2004-04-01||||||||Interventional|||Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|Phase I Pilot Trial of Adenovirus p53 and Radiotherapy on Nonsmall Cell Lung Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:50.045563|2017-10-11 04:24:50.045563
NCT00004226|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-12-03|||May 2000||2000-05-01|July 2004|2004-07-01||||||||Interventional|||Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy|Phase I/II Study of High Dose Limited Volume Postoperative Reirradiation in Recurrent or Second Primary Carcinoma of the Head and Neck|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:50.131329|2017-10-11 04:24:50.131329
NCT00004227|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2014-02-05|||April 1999||1999-04-01|November 2012|2012-11-01|May 2008|Actual|2008-05-01|March 2007|Actual|2007-03-01||Interventional|||Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx|Randomized Phase III Trial to Compare Radiation Therapy Alone With Radiation Therapy and Concomitant Anti-EGFr Antibody (C225) for Locally Advanced Squamous Cell Carcinomas of the Head and Neck|Terminated||Phase 3|32|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 04:24:50.235643|2017-10-11 04:24:50.235643
NCT00004228|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2016-12-01|2013-10-08||June 2000||2000-06-01|November 2016|2016-11-01||||August 2008|Actual|2008-08-01||Interventional|||Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma|Randomized Phase III Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma|Active, not recruiting||Phase 3|393|Actual|Children's Oncology Group||7|||f||||t||||||||||2017-10-11 04:24:50.482725|2017-10-11 04:24:50.482725
NCT00004229|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-02-08|||October 1999||1999-10-01|December 2002|2002-12-01||||October 2002|Actual|2002-10-01||Interventional|||Endostatin in Treating Patients With Advanced Solid Tumors|A Phase I Surrogate Endpoint Trial of Human Recombinant Endostatin in Patients With Advanced Solid Tumors Amenable to Biopsy|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:54.492784|2017-10-11 04:24:54.492784
NCT00004230|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation|Phase III Study of Captopril in Patients Undergoing Autologous Bone Marrow/Stem Cell Transplantation|Completed||Phase 3|35|Actual|Northwestern University|||||f||||t||||||||||2017-10-11 04:24:54.572669|2017-10-11 04:24:54.572669
NCT00004231|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma|Phase II Study of Multimodality Therapy in Mantle Cell Lymphoma|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:54.692782|2017-10-11 04:24:54.692782
NCT00004338|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1993||1993-10-01|December 2003|2003-12-01||||||||Interventional|||Study of Zinc for Wilson Disease||Completed||Phase 4|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.24654|2017-10-11 04:25:04.24654
NCT00004232|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-05-31|||October 1999||1999-10-01|May 2012|2012-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Augmenting Bone Marrow With CD34 Enriched Peripheral Blood Hematopoietic Stem Cells for Allogeneic Transplantation of Hematologic Malignancies|Completed||Phase 1|||Northwestern University|||||f||||t||||||||||2017-10-11 04:24:54.78934|2017-10-11 04:24:54.78934
NCT00004233|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2011-07-21|||February 2001||2001-02-01|May 2010|2010-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach|A Phase II Study of PN-401, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach|Completed||Phase 2|65|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:24:54.935641|2017-10-11 04:24:54.935641
NCT00004234|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2016-11-25|||August 1999||1999-08-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|March 2005|Actual|2005-03-01||Interventional|||Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx|A Comparison of Acute Oral Mucositis Between Morning and Afternoon Radiotherapy in Patients Receiving Radiation Treatment for Cancer of the Head and Neck|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-10-11 04:24:55.419722|2017-10-11 04:24:55.419722
NCT00004235|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2016-07-12|||January 2000||2000-01-01|July 2016|2016-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach|A Phase II Study of Taxotere and Irinotecan (CPT-11) in Patients With Advanced Adenocarcinoma of the Lower Esophagus, Esophagogastric Junction, and Gastric Cardia|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:24:55.529142|2017-10-11 04:24:55.529142
NCT00004236|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2014-06-23|||August 1998||1998-08-01|December 2000|2000-12-01||||||||Interventional|||Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer|A Phase II Study of Caelyx in the Treatment of Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:55.664424|2017-10-11 04:24:55.664424
NCT00004237|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-11-05|||October 1998||1998-10-01|May 2005|2005-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer|A Randomized Phase II Trial of Navelbine/Epirubicin Versus Navelbine/Mitozantrone Versus Cyclophosphamide/Adriamycin as Preoperative Chemotherapy in Patients With > or = 3cm Diameter Early Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:55.746227|2017-10-11 04:24:55.746227
NCT00004238|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-06-18|||July 1999||1999-07-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase II Study of 10-Propargyl-10-Deazaaminopterin (PDX) in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:55.828286|2017-10-11 04:24:55.828286
NCT00004239|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2016-07-01|||December 1999||1999-12-01|July 2016|2016-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment|A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment|Terminated||Phase 1|10|Actual|Alliance for Clinical Trials in Oncology||1||poor accrual|f||||f||||||||||2017-10-11 04:24:55.930224|2017-10-11 04:24:55.930224
NCT00004241|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-02-06|||October 1999||1999-10-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma|A Phase I Trial of Weekly 17-Allylamino-17 Demethoxygeldanamycin|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:24:56.074265|2017-10-11 04:24:56.074265
NCT00004242|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-02-08|||October 1999||1999-10-01|July 2002|2002-07-01||||December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors|Phase I Study of Oxaliplatin in Combination With 5-Fluorouracil and Gemcitabine in Patients With Solid Tumors|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:56.219214|2017-10-11 04:24:56.219214
NCT00004243|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2010-01-11|||March 2000||2000-03-01|January 2010|2010-01-01||||||||Interventional|||Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor|A Phase I Study of Oxaliplatin in Combination With Docetaxel (Taxotere) Metastatic/Recurrent Solid Tumors|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:24:56.320384|2017-10-11 04:24:56.320384
NCT00004244|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-03-19|||March 2000||2000-03-01|June 2005|2005-06-01|September 2008|Actual|2008-09-01|July 2005|Actual|2005-07-01||Interventional|||Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma|Phase I Trial of rhIL-12 and rHuIFN-a2b in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:24:56.398091|2017-10-11 04:24:56.398091
NCT00004245|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-01-17|||August 1999||1999-08-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia|A Phase I Study of Salicylate for Adult Patients With Advanced Myelodysplastic Disorders or Acute Myelogenous Leukemia|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:56.501043|2017-10-11 04:24:56.501043
NCT00004246|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-07-27|||May 2000||2000-05-01|July 2012|2012-07-01|December 2002|Actual|2002-12-01|February 2001|Actual|2001-02-01||Interventional|||Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx|A Phase I Study of Fludarabine With Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|16|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:24:56.591493|2017-10-11 04:24:56.591493
NCT00004248|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2011-03-03|||July 1999||1999-07-01|March 2011|2011-03-01|May 2001|Actual|2001-05-01|June 2000|Actual|2000-06-01||Interventional|||Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|A Low Dose Schedule of Adriamycin and Protracted Infusion of Recombinant Interleukin-2: A Phase II Study of Immunotherapy in Unresectable Hepatocellular Carcinoma|Completed||Phase 2|24|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:24:56.96844|2017-10-11 04:24:56.96844
NCT00004249|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-06-18|||August 1998||1998-08-01|June 2013|2013-06-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy|Immunization Using Polysialic Acid-KLH or N-Propionylated Polysialic Acid-KLH Conjugate Plus the Immunological Adjuvant QS-21 in Patients With Small Cell Lung Cancer Who Have Achieved a Major Response to Initial Therapy|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:57.043184|2017-10-11 04:24:57.043184
NCT00004250|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-01-15|||August 1999||1999-08-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery|A Phase II Trial of Isolated Limb Infusion With Melphalan and Dactinomycin for Regional Melanoma and Soft Tissue Sarcoma of the Extremity|Completed||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:24:57.117293|2017-10-11 04:24:57.117293
NCT00004251|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-09-20|||January 2000||2000-01-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|September 2002|Actual|2002-09-01||Interventional|||Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer|A Phase II Study of Letrozole in Patients With Advanced or Recurrent Endometrial Cancer|Completed||Phase 2|33|Actual|Canadian Cancer Trials Group||1|||f||||||||||||||2017-10-11 04:24:57.200653|2017-10-11 04:24:57.200653
NCT00004252|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-09-10|||November 1999||1999-11-01|September 2012|2012-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer|A Randomized, Open-Label, Multicenter Phase III Study of 5-FU/Leucovorin With or Without Concomitant SU5416 in Patients With Metastatic Colorectal Cancer|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 04:24:57.287979|2017-10-11 04:24:57.287979
NCT00004253|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-12-17|||March 2000||2000-03-01|November 2002|2002-11-01||||||||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery|A Phase II Study of 3-Dimensional Conformal Hyperfractionation Radiation Therapy (3D-CHRT) With Dose Escalation and Amifostine Mucosal Protection for Patients With Favorable Prognosis Inoperable Stage II-IIIA/B Non-Small Cell Lung Cancer (NSCLC) Receiving Paclitaxel and Carboplatin|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:57.403841|2017-10-11 04:24:57.403841
NCT00004254|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-07-17|||November 1999||1999-11-01|July 2012|2012-07-01||||June 2001|Actual|2001-06-01||Interventional|||Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed|Phase II Study on Tomusex in Malignant Mesothelioma|Completed||Phase 2|25|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:24:57.52601|2017-10-11 04:24:57.52601
NCT00004255|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-07-09|||March 2000||2000-03-01|February 2002|2002-02-01|May 2003|Actual|2003-05-01|||||Interventional|||Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation|A Multi-Center, Open Label, Randomized, Active Controlled Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Processed Unrelated Bone Marrow in Patients With Acute or Chronic Leukemia|Completed||Phase 2/Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:57.651562|2017-10-11 04:24:57.651562
NCT00004256|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-11-05|||October 1997||1997-10-01|August 2006|2006-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer|Randomised Phase II Study of GM-CSF to Reduce Severity of Mucositis Caused by Accelerated Radiotherapy of Laryngeal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:57.863486|2017-10-11 04:24:57.863486
NCT00004257|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-03-25|||January 2000||2000-01-01|December 2007|2007-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer|A Phase I Study of Oxaliplatin in Combination With Continuous Infusion 5-Fluorouracil and Radiation in Esophageal Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:57.998449|2017-10-11 04:24:57.998449
NCT00004258|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2014-09-16|||December 1999||1999-12-01|September 2014|2014-09-01|September 2001|Actual|2001-09-01|August 2001|Actual|2001-08-01||Interventional|||EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer|A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer|Completed||Phase 1|40|Anticipated|Indiana University||1|||f||||||||||||||2017-10-11 04:24:58.16975|2017-10-11 04:24:58.16975
NCT00004260|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2011-08-02|||October 1999||1999-10-01|August 2011|2011-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|Phase I Study of Interleukin-12 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:24:58.977795|2017-10-11 04:24:58.977795
NCT00004261|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2016-05-20|||December 1999||1999-12-01|May 2016|2016-05-01||||June 2002||2002-06-01||Interventional|||EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma|A Phase I Trial of the Hypoxia Detection Agent EF5 (NSC 684681) in Patients With Cervix and Breast and Prostate Carcinomas, and High Grade Soft Tissue Sarcomas|Terminated||Phase 1|||University Health Network, Toronto||||Lack of patient accrual|f||||||||||||||2017-10-11 04:24:59.116783|2017-10-11 04:24:59.116783
NCT00004262|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-06-03|||November 1999||1999-11-01|June 2013|2013-06-01||||May 2005|Actual|2005-05-01||Interventional|||Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme|PHASE I TRIAL OF GADOLINIUM TEXAPHYRIN (PCI -0120) AS A RADIOSENSITIZER DURING STEREOTACTIC RADIOSURGERY BOOST FOR GLIOBLASTOMA MULTIFORME|Completed||Phase 1|12|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:24:59.243805|2017-10-11 04:24:59.243805
NCT00004339|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2006-05-08|||January 1994||1994-01-01|December 2003|2003-12-01||||||||Interventional|||Study of Tetrathiomolybdate in Patients With Wilson Disease||Completed||Phase 3|90||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.343013|2017-10-11 04:25:04.343013
NCT00004263|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2012-07-27|||December 1999||1999-12-01|July 2012|2012-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Phase I Study of UCN-01 and Cytarabine (ARA-C) in Patients With Acute Myelogenous Leukemia, and Myelodysplastic Syndromes|Completed||Phase 1|16|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:24:59.362172|2017-10-11 04:24:59.362172
NCT00004264|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-12-03|||July 1997||1997-07-01|August 2000|2000-08-01||||||||Interventional|||Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer|Phase I/II Trial of Amifostine, High-Dose Cisplatin and Docetaxel in Patients With Advanced Lung Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:59.524269|2017-10-11 04:24:59.524269
NCT00004265|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2013-12-03|||February 1999||1999-02-01|August 2000|2000-08-01||||||||Interventional|||Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer|Phase II Study of Weekly Paclitaxel as Second-Line Therapy in Patients With Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:24:59.610825|2017-10-11 04:24:59.610825
NCT00004266|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2017-05-30|||August 1993||1993-08-01|December 2001|2001-12-01|July 1999||1999-07-01|||||Interventional|||Study of Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes at High Risk of Kidney or Heart Disease|Randomized Study of Antihypertensives and Antilipemics in American Indians With Non-Insulin-Dependent Diabetes Mellitus at High Risk of Developing Nephropathy and Cardiovascular Disease|Completed||N/A|160||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:24:59.706986|2017-10-11 04:24:59.706986
NCT00004268|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||April 2001||2001-04-01|April 2002|2002-04-01||||||||Interventional|||Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension||Completed||Phase 2|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:24:59.804416|2017-10-11 04:24:59.804416
NCT00004274|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||February 1990||1990-02-01|October 2003|2003-10-01||||||||Interventional|||Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome|Controlled Study of Estrogen Effects on Cognitive and Social Function in Girls With Turner's Syndrome|Completed||N/A|260||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:24:59.875972|2017-10-11 04:24:59.875972
NCT00004275|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2008-09-08|||October 1999||1999-10-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome|Phase II Randomized Study of Oxandrolone vs Placebo for Growth Hormone-Treated Girls With Turner's Syndrome|Completed||Phase 2|80||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:24:59.950326|2017-10-11 04:24:59.950326
NCT00004276|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1990||1990-09-01|December 2001|2001-12-01|June 1999||1999-06-01|||||Interventional|||Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections||Completed||Phase 2|50||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:00.087598|2017-10-11 04:25:00.087598
NCT00004278|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||December 1991||1991-12-01|July 2000|2000-07-01||||||||Interventional|||Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection||Completed||Phase 3|130||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:00.17783|2017-10-11 04:25:00.17783
NCT00004284|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||April 1995||1995-04-01|June 2000|2000-06-01||||||||Interventional|||Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria||Completed||Phase 3|300||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:00.244263|2017-10-11 04:25:00.244263
NCT00004285|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2017-09-13|||March 1995|Actual|1995-03-01|September 2017|2017-09-01|December 31, 2001|Actual|2001-12-31|December 31, 2001|Actual|2001-12-31||Interventional|HEMO||Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis|Randomized Study of Standard vs High Amount of Hemodialysis Using Low vs High Flux Dialyzer Membranes for End Stage Renal Disease|Completed||N/A|1846|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||t|f|t|f|f||||||2017-10-11 04:25:00.324431|2017-10-11 04:25:00.324431
NCT00004286|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||February 1996||1996-02-01|January 2000|2000-01-01|November 1999||1999-11-01|||||Interventional|||Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy||Completed||Phase 3|120||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:00.525664|2017-10-11 04:25:00.525664
NCT00004287|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1995||1995-11-01|January 2000|2000-01-01||||||||Interventional|||Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis||Completed||Phase 1|14||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:00.600064|2017-10-11 04:25:00.600064
NCT00004288|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||May 1996||1996-05-01|January 2000|2000-01-01|December 1999||1999-12-01|||||Interventional|||Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis||Completed||Phase 2|4||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:00.675057|2017-10-11 04:25:00.675057
NCT00004293|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1999||1999-11-01|December 2003|2003-12-01||||||||Interventional|||Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease||Unknown status|Recruiting|Phase 2|24||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:00.765647|2017-10-11 04:25:00.765647
NCT00004294|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1999||1999-11-01|December 2003|2003-12-01||||||||Interventional|||Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease||Completed||Phase 1|15||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:01.092125|2017-10-11 04:25:01.092125
NCT00004296|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1995||1995-09-01|January 2000|2000-01-01||||||||Observational|||Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients||Completed||N/A|1000||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:01.182478|2017-10-11 04:25:01.182478
NCT00004297|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1995||1995-11-01|December 2001|2001-12-01|February 1999||1999-02-01|||||Interventional|||Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus||Completed||Phase 3|210||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:01.249016|2017-10-11 04:25:01.249016
NCT00004300|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2010-10-05||||||March 2006|2006-03-01||||||||Interventional|||Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis|Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis|Suspended||Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:01.312317|2017-10-11 04:25:01.312317
NCT00004306|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2012-03-05|||November 1999||1999-11-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)|Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)|Completed||N/A|18|Actual|Office of Rare Diseases (ORD)|||1||f||||f||||||Samples With DNA|"     DNA from blood and skin and muscle biopsy samples.   "|||2017-10-11 04:25:01.447289|2017-10-11 04:25:01.447289
NCT00004307|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||December 1999||1999-12-01|December 2003|2003-12-01||||||||Interventional|||Study of Treatment and Metabolism in Patients With Urea Cycle Disorders|Therapeutic and Metabolic Studies of Urea Cycle Disorders: Part A: Nitrogen Flux and Ureagenesis; Part B (Closed): Phase I Adenovirus Vector-Mediated Gene Therapy for Ornithine Transcarbamylase Deficiency|Unknown status|Recruiting|Phase 1|66||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:01.542565|2017-10-11 04:25:01.542565
NCT00004310|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|December 2003|2003-12-01||||||||Interventional|||Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder||Unknown status|Active, not recruiting|Phase 2|76||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:01.652955|2017-10-11 04:25:01.652955
NCT00004311|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||July 1989||1989-07-01|May 2000|2000-05-01|January 1996||1996-01-01|||||Interventional|||Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome||Completed||Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:01.745315|2017-10-11 04:25:01.745315
NCT00004312|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|December 2003|2003-12-01||||||||Observational|||Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis||Completed||N/A|400||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:01.824702|2017-10-11 04:25:01.824702
NCT00004313|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||August 1995||1995-08-01|January 2000|2000-01-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency||Completed||Phase 3|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:01.899965|2017-10-11 04:25:01.899965
NCT00004314|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||February 1996||1996-02-01|January 2000|2000-01-01||||||||Interventional|||Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease||Completed||Phase 2|2||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:01.97644|2017-10-11 04:25:01.97644
NCT00004315|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1995||1995-11-01|April 2002|2002-04-01||||||||Interventional|||Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease||Unknown status|Active, not recruiting|Phase 2|20||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:02.057782|2017-10-11 04:25:02.057782
NCT00004316|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2008-09-08|||June 1995||1995-06-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis||Completed||Phase 1/Phase 2|139||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:02.255315|2017-10-11 04:25:02.255315
NCT00004317|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2009-05-13|||July 2000||2000-07-01|May 2009|2009-05-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Interventional|||Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis|Phase IV Randomized Study of Pyrimethamine, Sulfadiazine, and Leucovorin Calcium for Congenital Toxoplasmosis|Recruiting||Phase 4|600|Anticipated|Office of Rare Diseases (ORD)||2|||f||||t||||||||||2017-10-11 04:25:02.356519|2017-10-11 04:25:02.356519
NCT00004323|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||February 1995||1995-02-01|April 2002|2002-04-01||||||||Interventional|||Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia||Completed||Phase 2|10||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:02.520433|2017-10-11 04:25:02.520433
NCT00004324|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||December 1989||1989-12-01|January 2004|2004-01-01||||||||Observational|||Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents||Completed||N/A|90||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:02.640586|2017-10-11 04:25:02.640586
NCT00004325|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||December 1988||1988-12-01|January 2004|2004-01-01||||||||Observational|||Study of the Neurobiology of Tourette Syndrome and Related Disorders||Completed||N/A|200||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:02.724528|2017-10-11 04:25:02.724528
NCT00004326|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||August 1994||1994-08-01|April 2002|2002-04-01||||||||Observational|||Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome||Completed||N/A|12||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:02.827309|2017-10-11 04:25:02.827309
NCT00004327|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1995||1995-01-01|June 2000|2000-06-01||||||||Interventional|||Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia||Completed||Phase 2|8||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:02.902414|2017-10-11 04:25:02.902414
NCT00004328|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||December 1992||1992-12-01|May 2000|2000-05-01||||||||Interventional|||Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I||Completed||Phase 2|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:02.965113|2017-10-11 04:25:02.965113
NCT00004329|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1999||1999-11-01|December 2003|2003-12-01||||||||Observational|||Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy||Completed||N/A|12||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:03.038582|2017-10-11 04:25:03.038582
NCT00004330|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||March 1987||1987-03-01|December 2003|2003-12-01||||||||Interventional|||Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:03.128261|2017-10-11 04:25:03.128261
NCT00004331|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1992||1992-11-01|December 2003|2003-12-01||||||||Observational|||Studies in Porphyria I: Characterization of Enzyme Defects||Unknown status|Recruiting|N/A|25||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:03.822822|2017-10-11 04:25:03.822822
NCT00004332|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||May 1993||1993-05-01|January 2000|2000-01-01||||||||Observational|||Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly||Completed||N/A|148||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:03.913524|2017-10-11 04:25:03.913524
NCT00004346|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1996||1996-01-01|December 2003|2003-12-01||||||||Interventional|||Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis|Effects of Diet and Medication in Patients With Cerebrotendinous Xanthomatosis (CTX)|Unknown status|Recruiting|Phase 2|5||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:04.97086|2017-10-11 04:25:04.97086
NCT00004347|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1995||1995-11-01|December 2003|2003-12-01||||||||Interventional|||Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome|The Effects of Dietary Cholesterol in the Smith-Lemli-Opitz Syndrome|Unknown status|Recruiting|Phase 2|5||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:05.077805|2017-10-11 04:25:05.077805
NCT00004348|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1995||1995-09-01|January 2000|2000-01-01||||||||Observational|||Study of Protein Translocation in Patients With Beta-Oxidation Disorders||Unknown status|Active, not recruiting|N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:05.177718|2017-10-11 04:25:05.177718
NCT00004350|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|December 1999|1999-12-01||||||||Observational|||Evaluation of Fanconi Syndrome and Cystinosis||Completed||N/A|12||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:05.260851|2017-10-11 04:25:05.260851
NCT00004351|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1999||1999-09-01|October 2003|2003-10-01||||||||Observational|||Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:05.333661|2017-10-11 04:25:05.333661
NCT00004353|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2008-07-09|||December 1978||1978-12-01|April 2002|2002-04-01||||||||Observational|||Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia||Completed||N/A|35|Anticipated|National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:05.407367|2017-10-11 04:25:05.407367
NCT00004354|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||June 1999||1999-06-01|May 2002|2002-05-01||||||||Observational|||Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:05.490485|2017-10-11 04:25:05.490485
NCT00004356|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||February 1995||1995-02-01|December 2001|2001-12-01|October 2000||2000-10-01|||||Observational|||Study of Homocysteine Metabolism in Homocystinuria||Completed||N/A|60||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:05.584253|2017-10-11 04:25:05.584253
NCT00004357|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2011-07-20|||September 1997||1997-09-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|December 2005|Actual|2005-12-01||Interventional|||Absorption of Corticosteroids in Children With Juvenile Dermatomyositis|Phase II Study of Prednisolone/Methylprednisolone Absorption in Children With Juvenile Dermatomyositis|Completed||Phase 2|6|Actual|Northwestern University||1|||f||||f||||||||||2017-10-11 04:25:05.643906|2017-10-11 04:25:05.643906
NCT00004358|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1992||1992-11-01|December 2003|2003-12-01||||||||Interventional|||Phase II Study of Calcitonin for Tumoral Calcinosis||Completed||Phase 2|9||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:05.733766|2017-10-11 04:25:05.733766
NCT00004359|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||February 1996||1996-02-01|January 2000|2000-01-01||||||||Interventional|||Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita||Completed||Phase 2|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:05.807542|2017-10-11 04:25:05.807542
NCT00004360|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1995||1995-09-01|December 1999|1999-12-01||||||||Observational|||Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:05.879506|2017-10-11 04:25:05.879506
NCT00004361|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||July 1995||1995-07-01|January 2001|2001-01-01||||||||Observational|||Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects||Completed||N/A|150||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:05.949314|2017-10-11 04:25:05.949314
NCT00004363|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||December 1995||1995-12-01|December 2003|2003-12-01||||||||Observational|||Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:06.021686|2017-10-11 04:25:06.021686
NCT00004364|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2006-02-21|||December 1995||1995-12-01|February 2006|2006-02-01||||||||Observational|||Study of Novel Types of Familial Diabetes Insipidus||Unknown status|Active, not recruiting|N/A|5||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:06.094257|2017-10-11 04:25:06.094257
NCT00004365|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1995||1995-09-01|December 2003|2003-12-01|February 2000||2000-02-01|||||Observational|||Study of Pituitary Size and Function in Familial Dwarfism of Sindh||Completed||N/A|4||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:06.380854|2017-10-11 04:25:06.380854
NCT00004366|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||August 1995||1995-08-01|June 2000|2000-06-01|May 2000||2000-05-01|||||Interventional|||Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:06.460597|2017-10-11 04:25:06.460597
NCT00004367|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||May 2000||2000-05-01|December 2003|2003-12-01||||||||Interventional|||Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia||Completed||N/A|165||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:06.534881|2017-10-11 04:25:06.534881
NCT00004368|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||May 1990||1990-05-01|October 2003|2003-10-01||||||||Interventional|||Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis||Unknown status|Active, not recruiting|Phase 1|15||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:06.601957|2017-10-11 04:25:06.601957
NCT00004373|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||March 1997||1997-03-01|May 2003|2003-05-01|March 2001||2001-03-01|||||Interventional|||Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety||Completed||Phase 2|80||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:06.660648|2017-10-11 04:25:06.660648
NCT00004374|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1979||1979-01-01|December 2003|2003-12-01||||||||Observational|||Study of Systemic Amyloidosis Presentation and Prognosis|Study of Systemic Amyloidosis Presentation and Prognosis|Unknown status|Recruiting|N/A|100||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:06.738741|2017-10-11 04:25:06.738741
NCT00004375|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1991||1991-09-01|January 2004|2004-01-01||||||||Interventional|||Ultraviolet Light Therapy for Systemic Lupus Erythematosus||Unknown status|Recruiting|Phase 2|20||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:06.804147|2017-10-11 04:25:06.804147
NCT00004376|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1994||1994-09-01|March 2001|2001-03-01|June 2000||2000-06-01|||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder||Completed||Phase 3|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:06.8718|2017-10-11 04:25:06.8718
NCT00004378|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1995||1995-01-01|April 2002|2002-04-01||||||||Interventional|||Stem Cell Transplantation (SCT) for Genetic Diseases||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:06.92706|2017-10-11 04:25:06.92706
NCT00003598|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-09-20|||January 1999||1999-01-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|March 2001|Actual|2001-03-01||Interventional|IRB 1996-0189||UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia|Retinoids and Intermediate Biomarkers for CIN II and III: Pilot Trial|Completed||N/A|180|Anticipated|University of Michigan Cancer Center|||||f||||t||||||||||2017-10-11 04:25:06.998788|2017-10-11 04:25:06.998788
NCT00003599|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-02-17||||||February 2012|2012-02-01||||||||Interventional|||Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer|A Randomized Study of the Effect of Alpha-tocopherol (AT) on 13-cis-retinoic Acid (13-cRA) Toxicity in a Preliminary Chemoprevention Trial in Former and Current Smokers|Withdrawn||Phase 3|0|Actual|M.D. Anderson Cancer Center||2||Withdrawn study.|f||||f||||||||||2017-10-11 04:25:07.06802|2017-10-11 04:25:07.06802
NCT00003600|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||December 1998||1998-12-01|July 2016|2016-07-01|January 2010|Actual|2010-01-01|December 2001|Actual|2001-12-01||Interventional|||Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy|A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy|Completed||Phase 3|344|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:25:07.148022|2017-10-11 04:25:07.148022
NCT00003601|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||September 1998||1998-09-01|March 2008|2008-03-01||||March 2000|Actual|2000-03-01||Interventional|||Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome|A Phase II Double-Blind Study of Topical Tretinoin With or Without Oral 4-HPR (Fenretinide) in Patients With the Dysplastic Nevus Syndrome|Completed||Phase 2|38|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:07.365182|2017-10-11 04:25:07.365182
NCT00003602|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||March 1998||1998-03-01|January 2001|2001-01-01||||||||Interventional|||Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia|A Randomised Study Comparing an Oral Regimen (Idarubicin and Etoposide) With an Intravenous Regimen (MAE) for Consolidation in Patients Over 55 Years With Acute Myeloid Leukaemia in First Complete Remission|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:07.447419|2017-10-11 04:25:07.447419
NCT00003603|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||March 1998||1998-03-01|February 2001|2001-02-01||||||||Interventional|||Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma|A Randomised Study Comparing CIDEX (CCNU, Oral Idarubicin and Dexamethasone) With Melphalan and Prednisolone in Relapsed Multiple Myeloma|Unknown status|Active, not recruiting|Phase 3|660|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:07.541974|2017-10-11 04:25:07.541974
NCT00003604|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||October 1997||1997-10-01|September 2000|2000-09-01||||||||Interventional|||Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery|A Multi-Center Adjuvant Trial of Outpatient Moderate-Dose Bolus Interleukin-2 for Renal Cancer|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:07.631432|2017-10-11 04:25:07.631432
NCT00003605|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-08-17|||May 1998||1998-05-01|August 2015|2015-08-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma|Rituximab Anti-CD20 Monoclonal Antibody Plus Oral Cyclophosphamide as Initial Treatment of Indolent Lymphoma|Withdrawn||Phase 2|0|Actual|Hoag Memorial Hospital Presbyterian||||no patient accrual|f||||f||||||||||2017-10-11 04:25:07.712782|2017-10-11 04:25:07.712782
NCT00003606|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||March 1998||1998-03-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer|Phase III Randomized Study of Cisplatin and Etoposide With or Without Epirubicin and Cyclophosphamide for Extensive Stage Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|216|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:07.797772|2017-10-11 04:25:07.797772
NCT00003607|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-06-22|||December 1997||1997-12-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|December 2002|Actual|2002-12-01||Interventional|||Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer|Phase III Randomized Study of Radiotherapy to the Prostate With or Without Radiotherapy to the Pelvis in Patients With Stage I, II, or III Adenocarcinoma of the Prostate|Completed||Phase 3|450|Anticipated|UNICANCER|||||f||||||||||||||2017-10-11 04:25:07.897093|2017-10-11 04:25:07.897093
NCT00003610|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||October 1998||1998-10-01|July 2016|2016-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy|Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis|Completed||Phase 3|18|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:25:08.039287|2017-10-11 04:25:08.039287
NCT00003611|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||May 2000||2000-05-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|February 2003|Actual|2003-02-01||Interventional|||Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation|Chemoprevention Trial of Acitretin Versus Placebo in Solid Organ Transplant Recipients With Multiple Prior Treated Skin Cancers|Completed||N/A|129|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:25:08.162295|2017-10-11 04:25:08.162295
NCT00003612|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-08-04|||April 1999||1999-04-01|August 2017|2017-08-01||||December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer|Randomized Phase II Trial of Paclitaxel, Carboplatin and rhuMAb Her-2 (Herceptin) as First-Line Chemotherapy in Patients With Metastatic Breast Cancer Who Overexpress Her-2|Active, not recruiting||Phase 2|92|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:25:08.301565|2017-10-11 04:25:08.301565
NCT00003613|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-10|||April 1999||1999-04-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma|Phase I Trial of O6 Benzylguanine and BCNU in Cutaneous T-cell Lymphoma|Terminated||Phase 1|20|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:25:08.463586|2017-10-11 04:25:08.463586
NCT00003614|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-08-22|||December 1998||1998-12-01|August 2013|2013-08-01||||April 2005|Actual|2005-04-01||Interventional|||Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer|Phase II Study of Weekly Paclitaxel by 1-HR Infusion Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:25:08.577511|2017-10-11 04:25:08.577511
NCT00003615|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-01-26|||March 1999||1999-03-01|January 2010|2010-01-01||||August 2006|Actual|2006-08-01||Interventional|||Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Study of DAB 389 IL-2, an Interleukin-2 Fusion Toxin, for Previously Treated Stage II, III, and IV Follicular Low-Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|77|Anticipated|Eastern Cooperative Oncology Group|||||||||f||||||||||2017-10-11 04:25:08.719461|2017-10-11 04:25:08.719461
NCT00003616|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-12-13|||September 1998||1998-09-01|May 2006|2006-05-01||||||||Interventional|||Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma|Phase I/II Trial of Irinotecan (CPT-11) in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:08.830666|2017-10-11 04:25:08.830666
NCT00003617|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-19|||March 1995||1995-03-01|April 2009|2009-04-01||||||||Interventional|||Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach|Protocol for a Randomised Trial of Observation Versus Chlorambucil After Anti-Helicobacter Therapy in Low Grade Gastric Lymphoma|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:08.924517|2017-10-11 04:25:08.924517
NCT00003619|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||February 1998||1998-02-01|February 2008|2008-02-01|April 2004|Actual|2004-04-01|||||Interventional|||Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia|A Phase I/II Combination Study of Topotecan, Fludarabine, Cytosine Arabinoside and G-CSF (T-FLAG) Induction Therapy in Patients With Poor Prognosis AML, MDS and Relapsed/Refractory ALL Followed by Maintenance of Either PBSC Transplant or 13 Cis-Retinoic Acid|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:09.053234|2017-10-11 04:25:09.053234
NCT00003620|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-16|||June 1999||1999-06-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia|A PHASE II STUDY OF FLAVOPIRIDOL (NSC # 649890) IN PATIENTS WITH PREVIOUSLY TREATED BCELL CHRONIC LYMPHOCYTIC LEUKEMIA|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:25:09.147743|2017-10-11 04:25:09.147743
NCT00003621|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||February 1999||1999-02-01|July 2016|2016-07-01|July 2005|Actual|2005-07-01|February 2005|Actual|2005-02-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma|Phase II Trial of Pre-Irradiation Chemotherapy With BCNU, Cisplatin and Oral Etoposide Combined With Radiation Therapy in the Treatment of Grade 3 Astrocytoma (Anaplastic Astrocytoma)|Completed||Phase 2|29|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:25:09.245904|2017-10-11 04:25:09.245904
NCT00003622|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-07-10|||January 1999||1999-01-01|July 2017|2017-07-01|February 22, 2017|Actual|2017-02-22|May 2008|Actual|2008-05-01||Interventional|||Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy|Phase II Study of Vinorelbine With Paclitaxel in the Treatment of Hormone-Refractory Prostate Cancer|Withdrawn||Phase 2|0|Actual|George Washington University||1||No recruitment|f||||||||||||||2017-10-11 04:25:09.538162|2017-10-11 04:25:09.538162
NCT00003623|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-12|||October 1999||1999-10-01|July 2016|2016-07-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer|Megadose Vitamins as Chemoprevention of Transitional Cell Carcinoma of the Bladder|Completed||Phase 3|21|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:25:09.638651|2017-10-11 04:25:09.638651
NCT00003624|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-10|||December 1998||1998-12-01|May 2006|2006-05-01||||January 2004|Actual|2004-01-01||Interventional|||Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer|A Limited Access Trial Using Amifostine for Protection Against Cisplatin and 3-Hour Paclitaxel-Induced Neurotoxicity|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:25:09.771531|2017-10-11 04:25:09.771531
NCT00003625|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-25|||December 1998||1998-12-01|July 2014|2014-07-01|April 2006|Actual|2006-04-01|February 2001|Actual|2001-02-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma|Vincristine, Etoposide and Cyclosporine A in Concert With Standard Dose Radiation Therapy in Diffuse Intrinsic Brain Stem Glioma - A Phase I Study of Dose Escalation of Vincristine|Completed||Phase 1|7|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:25:09.878048|2017-10-11 04:25:09.878048
NCT00003626|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||October 1998||1998-10-01|April 2013|2013-04-01|May 2000|Actual|2000-05-01|December 1999|Actual|1999-12-01||Interventional|||Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy|Phase II Evaluation of Dolastatin-10 in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:25:10.560113|2017-10-11 04:25:10.560113
NCT00003627|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||October 1998||1998-10-01|January 2001|2001-01-01||||||||Interventional|||Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx|Phase III Randomized Study of Radiotherapy With or Without Cisplatin and Fluorouracil for Locally Advanced, Nonresectable Squamous Cell Cancer of the Oropharynx or Hypopharynx|Unknown status|Active, not recruiting|Phase 3|160|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:10.656556|2017-10-11 04:25:10.656556
NCT00003630|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||August 1998||1998-08-01|June 2013|2013-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Arsenic Trioxide in Treating Patients With Advanced Solid Tumors|Phase I Study of Arsenic Trioxide|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:25:10.760606|2017-10-11 04:25:10.760606
NCT00003631|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-12-17|2015-12-17||August 1998||1998-08-01|December 2015|2015-12-01||||April 2010|Actual|2010-04-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma|High-Dose Chemo-Radiotherapy for Patients With Primary Refractory and Relapsed Hodgkin's Disease|Completed||Phase 2|118|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-11 04:25:10.860035|2017-10-11 04:25:10.860035
NCT00003632|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-15|||September 1998||1998-09-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma|A Phase II Study of Intensive Methotrexate and Cytarabine Followed by High Dose Beam Chemotherapy With Autologous Peripheral Blood Progenitor Cell Transplantation in Patients With Newly Diagnosed Primary Central Nervous System Lymphoma|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:25:11.528727|2017-10-11 04:25:11.528727
NCT00003633|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||August 1998||1998-08-01|March 2005|2005-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer|Treatment of Prostate Cancer by Induction of Alternate Cell Death Pathways: A Phase I Trial of Docetaxel, Estramustine, Mitoxantrone and Prednisone|Unknown status|Active, not recruiting|Phase 1|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:11.628749|2017-10-11 04:25:11.628749
NCT00003634|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||April 1998||1998-04-01|May 2007|2007-05-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy|A Double-Blind Placebo Controlled Trial of Intravenous OvaRex MAb-B43.13 as Post Chemotherapy Consolidation for Ovarian Tubal and Peritoneal Carcinoma|Unknown status|Active, not recruiting|Phase 2|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:11.735838|2017-10-11 04:25:11.735838
NCT00003635|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-07-17|||January 1999||1999-01-01|January 2002|2002-01-01|March 2004|Actual|2004-03-01|||||Interventional|||506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents|A Multicenter Study to Assess the Efficacy of 506U78 in Patients With Chronic Lymphocytic Leukemia Who Are Refractory to Fludarabine and Alkylator Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:13.648404|2017-10-11 04:25:13.648404
NCT00003636|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-08-04|||September 1998||1998-09-01|August 2013|2013-08-01||||January 2009|Actual|2009-01-01||Interventional|||Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer|A Randomized Phase III Study Comparing Upfront Debulking Surgery Versus Neo-Adjuvant Chemotherapy in Patients With Stage IIIC or IV Epithelial Ovarian Carcinoma|Completed||Phase 3|704|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:13.796082|2017-10-11 04:25:13.796082
NCT00003637|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||September 1998||1998-09-01|January 2006|2006-01-01||||||||Interventional|||Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx|Standard Radiotherapy Versus Concurrent Chemo-Radiotherapy Followed by Adjuvant Chemotherapy for Locally Advanced (Non-Metastatic) Nasopharyngeal Cancer|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:14.030602|2017-10-11 04:25:14.030602
NCT00003638|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-25|||January 1999||1999-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|January 2007|Actual|2007-01-01||Interventional|||Vaccine Therapy in Treating Women With Metastatic Breast Cancer|A Multi-Center Phase III Randomized, Controlled Study of Theratope Vaccine for Metastatic Breast Cancer|Completed||Phase 3|950|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:14.332502|2017-10-11 04:25:14.332502
NCT00003639|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-09-16|||November 1993||1993-11-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma|Randomised Controlled Trial of CID (Chlorambucil, Idarubicin, Dexamethasone) Versus CD (Chlorambucil, Dexamethasone) for Induction of Remission in Low Grade Non-Hodgkin's Lymphoma (Kiel Classification) Followed by Randomised Controlled Assessment of Standard Dose Interferon Versus Low Dose Interferon Versus No Further Therapy as Maintenance Treatment After Remission Induction|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:14.423404|2017-10-11 04:25:14.423404
NCT00003640|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-05|||September 1998||1998-09-01|March 2012|2012-03-01||||November 2000|Actual|2000-11-01||Interventional|||Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer|A Feasibility Study of Thorough Transurethral Resection (TURB) and Escalated Dose M-VAC Chemotherapy as Primary Treatment of T2-T3a, N0-Nx, M0 Transitional Cell Carcinoma of the Bladder, With the Intention of Bladder Preservation|Terminated||Phase 2|73|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:25:14.514299|2017-10-11 04:25:14.514299
NCT00003641|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-03-31|2016-02-02||December 1998||1998-12-01|March 2016|2016-03-01|October 2025|Anticipated|2025-10-01|January 2015|Actual|2015-01-01||Interventional||All randomized patients|High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma|Phase III Randomized Study of Four Weeks of High Dose Interferon Alfa-2b in Stage T2bN0, T3a-bN0, T4a-bN0, and T1-4, N1a,2a (Microscopic) Melanoma|Terminated||Phase 3|1150|Actual|Eastern Cooperative Oncology Group||2||"The third interim analysis showed that there was no evidence of benefit from treatment with   interferon."|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy|2017-10-11 04:25:14.716811|2017-10-11 04:25:14.716811
NCT00003642|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-05|||October 1998||1998-10-01|March 2012|2012-03-01||||July 2001|Actual|2001-07-01||Interventional|||Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer|A Phase II Feasibility Study of Combined Accelerated External Radiation and Chemotherapy With 5FU and CDDP Following Transurethral Resection in Patients With Muscle Invasive Transitional Carcinoma of the Bladder - T2-T3, N0, M0 (UICC 1992)|Terminated||Phase 2|43|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:25:16.797295|2017-10-11 04:25:16.797295
NCT00003643|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-05|||October 1998||1998-10-01|March 2012|2012-03-01||||||||Interventional|||Combination Chemotherapy in Treating Men With Germ Cell Cancer|Randomized Phase II/III Study of Taxol/Paclitaxel-BEP Versus BEP in Patients With Intermediate Prognosis Germ Cell Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|498|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:16.888123|2017-10-11 04:25:16.888123
NCT00004410|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||June 1998||1998-06-01|August 1998|1998-08-01|March 2002||2002-03-01|||||Interventional|||Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants||Completed||N/A|50|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.903381|2017-10-11 04:25:19.903381
NCT00003644|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-03-17|||October 1998||1998-10-01|March 2016|2016-03-01||||March 2010|Actual|2010-03-01||Interventional|||Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer|A Randomized Phase III Trial of IV Carboplatin (AUC 6) and Paclitaxel 175 mg/m2 Q 21 Days x 3 Courses Plus Low Dose Paclitaxel 40 mg/m2/wk Versus IV Carboplatin (AUC 6) and Paclitaxel 175 mg/m2 Q 21 Days x 3 Courses Plus Observation in Patients With Early Stage Ovarian Carcinoma|Completed||Phase 3|571|Actual|Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 04:25:17.248818|2017-10-11 04:25:17.248818
NCT00003645|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-21|||June 14, 1999|Actual|1999-06-14|March 2017|2017-03-01|March 20, 2017|Actual|2017-03-20|March 20, 2017|Actual|2017-03-20||Interventional|||Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence|A Phase III Randomized Prospective Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence|Completed||Phase 3|64|Actual|M.D. Anderson Cancer Center||2|||f||||f|t|f||||||||2017-10-11 04:25:17.669281|2017-10-11 04:25:17.669281
NCT00003646|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-07-05|||August 1998||1998-08-01|July 2011|2011-07-01|May 2002|Actual|2002-05-01|March 2002|Actual|2002-03-01||Interventional|||Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma|Phase II Study of Allovectin-7 as an Immunotherapeutic Agent in Patients With Stages III and IV Melanoma|Completed||Phase 2|78|Actual|Vical||1|||f||||t||||||||||2017-10-11 04:25:17.776773|2017-10-11 04:25:17.776773
NCT00003647|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2008-07-23|||July 1998||1998-07-01|July 2008|2008-07-01|September 2002|Actual|2002-09-01|||||Interventional|||Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma|Phase III Randomized Study of Dacarbazine With or Without Allovectin-7 in Patients With Metastatic Melanoma|Completed||Phase 3|||Vical|||||f||||t||||||||||2017-10-11 04:25:17.873212|2017-10-11 04:25:17.873212
NCT00003648|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||July 1998||1998-07-01|July 2016|2016-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Genetic Study of Patients and Families With a History of Colorectal Cancer|The Familial Colorectal Neoplasia Collaborative Group|Completed||N/A|1500|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     blood and tumor samples   "|||2017-10-11 04:25:18.017138|2017-10-11 04:25:18.017138
NCT00003649|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||November 1998||1998-11-01|February 2002|2002-02-01||||||||Interventional|||Gene Therapy in Treating Patients With Non-Small Cell Lung Cancer That Cannot Be Surgically Removed|Phase I Pilot Trial of Adenovirus p53 in Bronchioloalveolar Cell Lung Carcinoma (BAC) Administered by Bronchoalveolar Lavage|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:18.118803|2017-10-11 04:25:18.118803
NCT00004380|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||December 1991||1991-12-01|July 2004|2004-07-01|December 1997||1997-12-01|||||Interventional|||Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis||Completed||Phase 2|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.20413|2017-10-11 04:25:18.20413
NCT00004381|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||December 1999||1999-12-01|October 2003|2003-10-01||||||||Interventional|||Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia||Completed||Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.270433|2017-10-11 04:25:18.270433
NCT00004382|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2008-09-08|||December 1999||1999-12-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns||Completed||Phase 2|80||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.359989|2017-10-11 04:25:18.359989
NCT00004386|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1995||1995-10-01|January 2000|2000-01-01||||||||Interventional|||Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency||Terminated||Phase 1|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.4147|2017-10-11 04:25:18.4147
NCT00004387|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1996||1996-01-01|July 2000|2000-07-01||||||||Interventional|||Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease||Completed||Phase 2|34||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.472636|2017-10-11 04:25:18.472636
NCT00004390|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||February 1995||1995-02-01|February 2000|2000-02-01||||||||Interventional|||Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia||Completed||Phase 3|120||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.552397|2017-10-11 04:25:18.552397
NCT00004392|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||May 1994||1994-05-01|January 2000|2000-01-01|August 1999||1999-08-01|||||Observational|||Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)||Completed||N/A|900||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.635985|2017-10-11 04:25:18.635985
NCT00004393|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||July 1997||1997-07-01|March 2001|2001-03-01|September 2000||2000-09-01|||||Interventional|||Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome||Completed||Phase 2|50||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.709999|2017-10-11 04:25:18.709999
NCT00004396|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||September 1997||1997-09-01|December 2003|2003-12-01||||||||Interventional|||Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias||Completed||Phase 2|32||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:18.765864|2017-10-11 04:25:18.765864
NCT00004397|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1998||1998-01-01|June 2000|2000-06-01|May 2000||2000-05-01|||||Interventional|||Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria||Completed||Phase 1|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.844918|2017-10-11 04:25:18.844918
NCT00004398|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||January 1998||1998-01-01|June 2000|2000-06-01|May 2000||2000-05-01|||||Interventional|||Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria||Completed||Phase 1|24||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:18.905592|2017-10-11 04:25:18.905592
NCT00004399|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1995||1995-09-01|January 2001|2001-01-01|August 2000||2000-08-01|||||Interventional|||Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia||Completed||N/A|2000||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:18.973331|2017-10-11 04:25:18.973331
NCT00004400|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||April 1997||1997-04-01|May 1998|1998-05-01|September 2001||2001-09-01|||||Interventional|||Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women||Completed||Phase 2|56|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:19.049696|2017-10-11 04:25:19.049696
NCT00004761|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||September 1986||1986-09-01|July 2004|2004-07-01||||||||Observational|||Establishment of the National Epidermolysis Bullosa Registry||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.702806|2017-10-11 04:25:21.702806
NCT00004412|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-18|2013-07-22||September 1997||1997-09-01|March 2015|2015-03-01|February 2005|Actual|2005-02-01|December 2002|Actual|2002-12-01||Interventional|||Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers|Phase II Trial of Arginine Butyrate for Treatment of Refractory Leg Ulcers in Sickle Cell Disease or Beta Thalassemia|Completed||Phase 2|23|Actual|Boston University||3|||f||||f||||||||||2017-10-11 04:25:19.995328|2017-10-11 04:25:19.995328
NCT00004414|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|May 1999|1999-05-01|June 2002||2002-06-01|||||Interventional|||Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis||Completed||N/A|252||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:20.508033|2017-10-11 04:25:20.508033
NCT00004415|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-04-06|||May 1991||1991-05-01|September 2002|2002-09-01|September 2000||2000-09-01|||||Interventional|||Study of Combined Intercostal and Diaphragm Pacing for Artificial Respiration in Quadriplegic Patients||Terminated||N/A|5||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:20.581983|2017-10-11 04:25:20.581983
NCT00004416|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||January 1997||1997-01-01|April 2001|2001-04-01|March 2002||2002-03-01|||||Interventional|||Randomized Study of Botulinum Toxin Type A for Achalasia||Completed||N/A|56||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:20.641091|2017-10-11 04:25:20.641091
NCT00004736|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2008-09-10||||||June 2003|2003-06-01||||||||Interventional|||Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis|Viral and Immune Dynamics in HIV-Infected Patients With Tuberculosis|Completed||Phase 1|44||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:25:20.71379|2017-10-11 04:25:20.71379
NCT00004738|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-26|2017-10-05|||February 24, 2000||2000-02-24|September 12, 2017|2017-09-12||||||||Observational|||Genetic Analysis of the Chiari I Malformation|Genetic Analysis of the Chiari I Malformation|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:20.816086|2017-10-11 04:25:20.816086
NCT00004739|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-29|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||The Metabolic Effects of Protease Inhibitors in HIV Infected Children||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:20.89496|2017-10-11 04:25:20.89496
NCT00004740|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||February 1995||1995-02-01|January 1998|1998-01-01||||||||Interventional|||Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users||Unknown status|Active, not recruiting|N/A|300||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:20.95454|2017-10-11 04:25:20.95454
NCT00004744|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2008-09-08|||February 1993||1993-02-01|September 2008|2008-09-01||||September 1998|Actual|1998-09-01||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis||Completed||Phase 3|76||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.015861|2017-10-11 04:25:21.015861
NCT00004747|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||July 1995||1995-07-01|December 2001|2001-12-01||||||||Interventional|||Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis||Completed||Phase 2|170||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.077333|2017-10-11 04:25:21.077333
NCT00004748|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||November 1989||1989-11-01|December 2001|2001-12-01||||||||Interventional|||Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis|Phase III Randomized, Double-Blind, Placebo-Controlled Study of Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis|Completed||Phase 3|90||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.138417|2017-10-11 04:25:21.138417
NCT00004751|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||October 1991||1991-10-01|February 1997|1997-02-01||||||||Interventional|||Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy Alone for Spastic Diplegia||Unknown status|Active, not recruiting|Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.205147|2017-10-11 04:25:21.205147
NCT00004753|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|December 2001|2001-12-01||||||||Observational|||Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease||Completed||N/A|90||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.261182|2017-10-11 04:25:21.261182
NCT00004754|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|December 2001|2001-12-01||||||||Interventional|||Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension||Completed||Phase 4|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.309961|2017-10-11 04:25:21.309961
NCT00004755|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||September 1995||1995-09-01|January 1998|1998-01-01||||||||Interventional|||Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil|Phase II Randomized Study of Allopurinol Versus Glucantime Versus Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil|Completed||Phase 2|375||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.363332|2017-10-11 04:25:21.363332
NCT00004756|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||December 1994||1994-12-01|December 2001|2001-12-01||||||||Interventional|||Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus|Randomized Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus|Completed||N/A|150||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.419481|2017-10-11 04:25:21.419481
NCT00004757|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1992||1992-08-01|January 1998|1998-01-01||||||||Interventional|||Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth||Completed||Phase 3|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.475708|2017-10-11 04:25:21.475708
NCT00004758|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||November 1993||1993-11-01|December 2001|2001-12-01||||||||Interventional|||Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment||Completed||Phase 2|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.535075|2017-10-11 04:25:21.535075
NCT00004759|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2008-09-08|||December 1991||1991-12-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury|Phase III Randomized, Double-Blind Study of Methylprednisolone by 24- Versus 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury|Completed||Phase 3|497||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.596173|2017-10-11 04:25:21.596173
NCT00004760|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||May 1995||1995-05-01|April 1998|1998-04-01|December 1997||1997-12-01|||||Interventional|||Study of Axial Mobility Exercises in Parkinson Disease||Completed||N/A|80||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.65156|2017-10-11 04:25:21.65156
NCT00004763|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||January 1993||1993-01-01|December 2001|2001-12-01||||||||Interventional|||Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism||Completed||Phase 2|45||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.814793|2017-10-11 04:25:21.814793
NCT00004767|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||January 1985||1985-01-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.872335|2017-10-11 04:25:21.872335
NCT00004769|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2013-01-25|||December 1993||1993-12-01|January 2013|2013-01-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Observational|||Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy|Myotonic Dystrophy:Muscle Wasting and Altered Metabolism|Completed||N/A|130|Actual|University of Rochester|||4||f||||f||||||||||2017-10-11 04:25:21.927838|2017-10-11 04:25:21.927838
NCT00004770|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||October 1995||1995-10-01|December 2001|2001-12-01||||||||Interventional|||Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy||Completed||N/A|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:21.986974|2017-10-11 04:25:21.986974
NCT00004771|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||October 1992||1992-10-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease||Completed||Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.040057|2017-10-11 04:25:22.040057
NCT00004772|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||September 1992||1992-09-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy||Completed||Phase 3|90||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.100304|2017-10-11 04:25:22.100304
NCT00004773|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1995||1995-08-01|January 1997|1997-01-01|June 1997||1997-06-01|||||Observational|||Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome||Completed||N/A|95||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.149556|2017-10-11 04:25:22.149556
NCT00004776|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||November 1993||1993-11-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome||Completed||Phase 3|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.196983|2017-10-11 04:25:22.196983
NCT00004778|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery||Completed||Phase 3|1090||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.247079|2017-10-11 04:25:22.247079
NCT00004779|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||January 1993||1993-01-01|December 2001|2001-12-01||||||||Interventional|||Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis||Completed||Phase 1|12||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.371401|2017-10-11 04:25:22.371401
NCT00004781|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||September 1989||1989-09-01|February 1997|1997-02-01||||||||Observational|||Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups||Completed||N/A|250||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.49635|2017-10-11 04:25:22.49635
NCT00004784|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||January 1994||1994-01-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis||Completed||Phase 3|315||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.551274|2017-10-11 04:25:22.551274
NCT00004785|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||November 1995||1995-11-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia||Completed||Phase 3|54||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.614063|2017-10-11 04:25:22.614063
NCT00004786|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||December 1995||1995-12-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis||Completed||Phase 3|200||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.674818|2017-10-11 04:25:22.674818
NCT00004787|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||December 1994||1994-12-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.735681|2017-10-11 04:25:22.735681
NCT00004788|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||May 1988||1988-05-01|December 2001|2001-12-01||||||||Observational|||Study of Nutritional Factors in Porphyria||Completed||N/A|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.802796|2017-10-11 04:25:22.802796
NCT00004789|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||July 1993||1993-07-01|December 2001|2001-12-01||||||||Interventional|||Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria||Completed||Phase 1/Phase 2|59||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.86128|2017-10-11 04:25:22.86128
NCT00004791|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1995||1995-08-01|December 2001|2001-12-01||||||||Observational|||Study of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents With Epidermolysis Bullosa||Completed||N/A|15||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.919238|2017-10-11 04:25:22.919238
NCT00004793|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||June 1995||1995-06-01|December 2001|2001-12-01||||||||Observational|||Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal Children||Completed||N/A|4||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:22.977736|2017-10-11 04:25:22.977736
NCT00004794|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||March 1995||1995-03-01|January 1998|1998-01-01||||||||Interventional|||Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis||Completed||Phase 2|90||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.035565|2017-10-11 04:25:23.035565
NCT00004795|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1994||1994-08-01|December 2001|2001-12-01||||||||Interventional|||Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus||Completed||Phase 2/Phase 3|190||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.104939|2017-10-11 04:25:23.104939
NCT00004796|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||November 1994||1994-11-01|February 1998|1998-02-01|February 1997||1997-02-01|||||Interventional|||Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis||Completed||Phase 2|16||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.174109|2017-10-11 04:25:23.174109
NCT00004802|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||June 1992||1992-06-01|January 1998|1998-01-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders||Completed||Phase 3|64||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.523597|2017-10-11 04:25:23.523597
NCT00004804|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|February 1997|1997-02-01||||||||Interventional|||Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C||Completed||Phase 3|57||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.598997|2017-10-11 04:25:23.598997
NCT00004805|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||September 1991||1991-09-01|February 2001|2001-02-01|August 1997||1997-08-01|||||Interventional|||Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death||Completed||N/A|500||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.658627|2017-10-11 04:25:23.658627
NCT00004806|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2011-03-29|||June 1995||1995-06-01|March 2011|2011-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis||Completed||Phase 1|9||University of Alabama at Birmingham|||||f||||f||||||||||2017-10-11 04:25:23.722863|2017-10-11 04:25:23.722863
NCT00004807|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||January 1995||1995-01-01|December 1998|1998-12-01||||||||Interventional|||Study of the Pathogenesis of Rett Syndrome||Completed||N/A|120||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.785957|2017-10-11 04:25:23.785957
NCT00004808|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2006-06-08|||September 1991||1991-09-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis||Completed||Phase 2|78||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.859802|2017-10-11 04:25:23.859802
NCT00004809|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||June 1992||1992-06-01|December 2001|2001-12-01||||||||Interventional|||Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia||Completed||Phase 1|5||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.930907|2017-10-11 04:25:23.930907
NCT00004810|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||June 1996||1996-06-01|December 2001|2001-12-01||||||||Interventional|||Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis||Completed||Phase 2|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:23.996564|2017-10-11 04:25:23.996564
NCT00004811|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2006-06-08|||March 1985||1985-03-01|December 2001|2001-12-01||||||||Interventional|||Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis||Completed||Phase 1/Phase 2|7||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:24.069825|2017-10-11 04:25:24.069825
NCT00004812|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||July 1995||1995-07-01|December 2001|2001-12-01||||||||Interventional|||Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord Injury||Completed||Phase 2|26||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:24.135893|2017-10-11 04:25:24.135893
NCT00004814|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||October 1991||1991-10-01|January 1997|1997-01-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis||Completed||Phase 3|250||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:24.195382|2017-10-11 04:25:24.195382
NCT00004815|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||May 1992||1992-05-01|July 2004|2004-07-01||||||||Interventional|||Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome||Completed||N/A|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:24.252855|2017-10-11 04:25:24.252855
NCT00004816|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||July 1995||1995-07-01|December 2001|2001-12-01||||||||Interventional|||A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis||Completed||Phase 1|25||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:24.311983|2017-10-11 04:25:24.311983
NCT00004817|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||February 1991||1991-02-01|December 2001|2001-12-01||||||||Interventional|||Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures||Completed||Phase 3|385||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:24.367431|2017-10-11 04:25:24.367431
NCT00004825|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||May 1998||1998-05-01|July 1998|1998-07-01|May 1998||1998-05-01|||||Interventional|||Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism||Completed||N/A|10||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:24.427091|2017-10-11 04:25:24.427091
NCT00004826|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||October 1993||1993-10-01|May 1998|1998-05-01|November 1997||1997-11-01|||||Interventional|||Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease||Completed||N/A|60||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:24.485541|2017-10-11 04:25:24.485541
NCT00004827|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||March 1996||1996-03-01|May 1998|1998-05-01|June 2002||2002-06-01|||||Interventional|||Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa||Completed||N/A|46||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:24.542439|2017-10-11 04:25:24.542439
NCT00004828|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||December 1994||1994-12-01|June 1998|1998-06-01|December 1997||1997-12-01|||||Interventional|||Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure||Completed||Phase 1|28||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:24.59924|2017-10-11 04:25:24.59924
NCT00004829|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||June 1995||1995-06-01|June 1998|1998-06-01|May 1998||1998-05-01|||||Interventional|||Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis||Completed||Phase 3|200||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:24.660255|2017-10-11 04:25:24.660255
NCT00004831|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||October 1996||1996-10-01|August 1998|1998-08-01|July 1998||1998-07-01|||||Interventional|||Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria||Completed||N/A|20||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:24.733556|2017-10-11 04:25:24.733556
NCT00004832|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||August 1994||1994-08-01|July 1998|1998-07-01|June 1998||1998-06-01|||||Interventional|||Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome||Completed||N/A|26||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:24.791503|2017-10-11 04:25:24.791503
NCT00004833|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-04-06|||July 1995||1995-07-01|September 2002|2002-09-01|November 2002||2002-11-01|||||Interventional|||Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome||Terminated||N/A|170||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:24.857908|2017-10-11 04:25:24.857908
NCT00004842|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2017-05-30|||May 1997|Actual|1997-05-01|May 2017|2017-05-01|April 1999|Actual|1999-04-01|April 1999|Actual|1999-04-01||Interventional|||Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis|Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis|Completed||Phase 1|22|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f|||||t|f||||||||2017-10-11 04:25:25.139261|2017-10-11 04:25:25.139261
NCT00004843|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2017-05-25|||April 1997|Actual|1997-04-01|May 2017|2017-05-01|March 30, 1999|Actual|1999-03-30|March 30, 1999|Actual|1999-03-30||Interventional|||A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism|A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic|Completed||N/A|53|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f|||||f|f||||||||2017-10-11 04:25:25.219993|2017-10-11 04:25:25.219993
NCT00004844|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||July 1998||1998-07-01|January 1999|1999-01-01||||||||Interventional|||Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease||Unknown status|Active, not recruiting|N/A|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:25.299739|2017-10-11 04:25:25.299739
NCT00004845|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-28|2009-12-10||||||June 2009|2009-06-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)|A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease|Completed||Phase 2/Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:25:25.369777|2017-10-11 04:25:25.369777
NCT00004846|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-02|2008-03-03|||December 1999||1999-12-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV|Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV|Completed||N/A|30000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:25.524001|2017-10-11 04:25:25.524001
NCT00004847|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-02|2017-10-05|||February 29, 2000||2000-02-29|August 17, 2017|2017-08-17||||||||Observational|||Diagnosis of Pheochromocytoma|Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma|Recruiting||N/A|2400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:25.595879|2017-10-11 04:25:25.595879
NCT00004848|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-02|2008-03-03|||July 1981||1981-07-01|July 1999|1999-07-01|May 2000||2000-05-01|||||Observational|||A Controlled Prospective Study of Transfusion-Associated Hepatitis|A Controlled Prospective Study of Transfusion-Associated Hepatitis|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:25.681003|2017-10-11 04:25:25.681003
NCT00004850|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-02|2017-06-30|||April 25, 1991||1991-04-25|November 10, 2016|2016-11-10||||||||Observational|||Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection|Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:25.758797|2017-10-11 04:25:25.758797
NCT00004851|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-02|2008-03-03|||April 1999||1999-04-01|March 2000|2000-03-01|May 2001||2001-05-01|||||Observational|||Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies|Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies|Completed||N/A|1||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:25.873213|2017-10-11 04:25:25.873213
NCT00004852|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-02|2005-06-23|||September 1999||1999-09-01|August 2000|2000-08-01||||||||Interventional|||Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs|A Phase II/III 48-Week, Randomized, Double-Blind, Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lamivudine 300mg Once Daily Vs. Lamivudine 150mg BID in Combination With Zidovudine 300mg BID and Efavirenz 600mg Once Daily in Antiretroviral-Naive Adults With HIV-1 Infection|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:25.968425|2017-10-11 04:25:25.968425
NCT00004853|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-04|2017-10-05|||March 3, 2000||2000-03-03|January 27, 2016|2016-01-27|May 20, 2009|Actual|2009-05-20|May 20, 2009|Actual|2009-05-20||Interventional|||Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy|A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults With Sarcoma Treated With Dose-Intensive Chemotherapy|Completed||Phase 1|29|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:25:26.365974|2017-10-11 04:25:26.365974
NCT00004854|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-08|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure||Completed||Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:25:26.481756|2017-10-11 04:25:26.481756
NCT00004855|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-29|2012-05-17||||||May 2012|2012-05-01|April 2005|Actual|2005-04-01|||||Interventional|||Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs|A Randomized, Open-Label, Pilot Treatment Trial Evaluating Cellular Dynamics and Immune Restoration in Treatment-Naive HIV-Infected Subjects Receiving Either the Protease Inhibitor LPV/r or the Nucleoside Analogue Reverse Transcriptase Inhibitors d4T/3TC/Abacavir With the Non-Nucleoside Reverse Transcriptase Inhibitor Nevirapine|Completed||N/A|55||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:25:26.560322|2017-10-11 04:25:26.560322
NCT00004856|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-05-01|||July 2002||2002-07-01|May 2013|2013-05-01||||July 2002|Actual|2002-07-01||Interventional|||Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium|A Phase II Trial of Trastuzumab (Herceptin; NSC #688097, IND #6667) in Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma|Terminated||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:25:26.722747|2017-10-11 04:25:26.722747
NCT00004857|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2016-07-01|||January 2000||2000-01-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|March 2003|Actual|2003-03-01||Interventional|||Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia|A Phase II Study of Fludarabine Induction Followed by CAMPATH-1H Consolidation in Untreated Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|86|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:25:26.842607|2017-10-11 04:25:26.842607
NCT00004858|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-09-19|||March 2000||2000-03-01|July 2007|2007-07-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma|A Phase I Study of B43-Genistein Immunoconjugate in Recurrent B-Lineage Acute Lymphoblastic Leukemia and Non Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:27.083299|2017-10-11 04:25:27.083299
NCT00004859|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2014-05-29|2012-02-16||January 2000||2000-01-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer|A Randomized Phase III Trial of Carboplatin, Paclitaxel and Thoracic Radiotherapy, With or Without Thalidomide, in Patients With Stage III Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 3|589|Actual|National Cancer Institute (NCI)||2||Trial was stopped early for futility|f||||t||||||||||2017-10-11 04:25:27.260796|2017-10-11 04:25:27.260796
NCT00004860|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-08-22|||June 2000||2000-06-01|August 2013|2013-08-01||||October 2005|Actual|2005-10-01||Interventional|||Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer|A Phase II Study of ORZEL (UFT + Leucovorin) in Elderly (at Least 75 Years Old) Patients With Colorectal Cancer|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:25:28.616564|2017-10-11 04:25:28.616564
NCT00004861|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-08-08|||October 1999||1999-10-01|August 2012|2012-08-01|September 2001|Actual|2001-09-01|||||Interventional|||Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of CI-994 Capsules Plus Gemcitabine Infusion Versus Placebo Capsules Plus Gemcitabine Infusion in the Treatment of Patients With Advanced Pancreatic Cancer|Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-10-11 04:25:28.827527|2017-10-11 04:25:28.827527
NCT00004862|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-01-31|||October 1999||1999-10-01|May 2002|2002-05-01||||December 2001|Actual|2001-12-01||Interventional|||Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|A Phase I Study of G3139 (NSC 683428) in Combination With Salvage Chemotherapy for Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:25:28.915368|2017-10-11 04:25:28.915368
NCT00004863|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2010-10-25|||July 1999||1999-07-01|October 2010|2010-10-01||||||||Interventional|||Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors|A Phase I Open-Label Safety Study of Escalating Doses of Taxol in Combination With Escalating Doses of GEM231 in Patients With Refractory Solid Tumors|Completed||Phase 1|||Montefiore Medical Center|||||f||||||||||||||2017-10-11 04:25:28.982729|2017-10-11 04:25:28.982729
NCT00004864|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2011-12-29|||July 1999||1999-07-01|July 2008|2008-07-01||||||||Interventional|||Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors|A Phase I Open-Label Safety Study of Escalating Doses of Taxotere in Combination With Escalating Doses of GEM231 in Patients With Refractory Solid Tumors|Completed||Phase 1|||Montefiore Medical Center|||||f||||||||||||||2017-10-11 04:25:29.048145|2017-10-11 04:25:29.048145
NCT00004865|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2009-03-06|||November 1999||1999-11-01|March 2009|2009-03-01||||January 2002|Actual|2002-01-01||Interventional|||Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy|Phase II Study of Cetuximab Anti-Epidermal Growth Factor Receptor (EGFr) Antibody in Combination With Chemotherapy in Patients With Metastatic or Recurrent Squamous Cell Head and Neck Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:29.108454|2017-10-11 04:25:29.108454
NCT00004866|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-15|||January 2000||2000-01-01|May 2012|2012-05-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Advanced or Recurrent Squamous Cell Cancer of the Cervix|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:25:29.19069|2017-10-11 04:25:29.19069
NCT00004867|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2017-01-20|||November 1999||1999-11-01|January 2017|2017-01-01|January 2009|Actual|2009-01-01|July 2005|Actual|2005-07-01||Interventional|||Positron Emission Tomography in Determining Stage of Esophageal Cancer|The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Carcinoma of the Thoracic Esophagus|Completed||N/A|235|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:25:29.28193|2017-10-11 04:25:29.28193
NCT00004868|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2008-11-22|||February 2000||2000-02-01|March 2003|2003-03-01||||||||Interventional|||SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy|A Phase I/II Trial of SU5416 in Patients With Recurrent High Grade Astrocytomas or Mixed Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:30.926297|2017-10-11 04:25:30.926297
NCT00004870|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-02-19|||June 2000||2000-06-01|February 2013|2013-02-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer|A Phase I/II, Pharmacokinetic, and Biologic Correlative Study of G3139, NSC # 683428 (Phosphorothioate Antisense Oligonucleotide Directed to Bcl-2) and Irinotecan in Patients With Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 04:25:31.01282|2017-10-11 04:25:31.01282
NCT00004871|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2010-03-09|||May 2000||2000-05-01|March 2010|2010-03-01||||||||Interventional|||Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome|Phase I, Dose De-Escalation to Minimal Effective Pharmacologic Dose Trial of Sodium Phenylbutyrate (PB, NSC 657802) in Combination With 5-Azacytidine (5-AZA, NSC 102816) in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:25:31.079261|2017-10-11 04:25:31.079261
NCT00004872|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2015-09-30|||March 2000||2000-03-01|September 2015|2015-09-01||||||||Interventional|||Endostatin in Treating Patients With Advanced Refractory Solid Tumors|Phase I Study of Endostatin in Advanced Cancer Patients|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:25:31.156917|2017-10-11 04:25:31.156917
NCT00004873|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-14|||August 1999||1999-08-01|May 2012|2012-05-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer|Taxotere-Cisplatin-5FU (TCF) Versus Taxotere-Cisplatin (TC) Versus Epirubicin-Cisplatin-5FU (ECF) as Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial|Completed||Phase 2|||Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:25:31.21458|2017-10-11 04:25:31.21458
NCT00004874|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-04-17|||November 1998||1998-11-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|April 2002|Actual|2002-04-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|Expanded Access Study of Iodine-131 Anti-B1 Antibody for Relapsed/Refractory Low-Grade and Transformed Low-Grade Non-Hodgkin's Lymphoma|Terminated||Phase 3|31|Actual|University of Nebraska||1||lack of FDA approval|f||||||||||||||2017-10-11 04:25:31.278021|2017-10-11 04:25:31.278021
NCT00004875|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2011-02-18|||July 1996||1996-07-01|February 2011|2011-02-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Observational|||Heparin or Enoxaparin in Patients With Cancer|Release of TFPI by Anticoagulants in Cancer Patients by Standard or LMW Heparin|Completed||N/A|6|Actual|Northwestern University|||2||f||||t||||||||||2017-10-11 04:25:31.359396|2017-10-11 04:25:31.359396
NCT00004876|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-08-23|||August 1999||1999-08-01|November 2011|2011-11-01||||||||Interventional|||Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer|A Randomized Study Comparing Carboplatin and Thalidomide With Carboplatin Alone in Patients With Stage Ic - IV Ovarian Cancer|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:31.465732|2017-10-11 04:25:31.465732
NCT00004877|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2009-12-02|||July 1999||1999-07-01|December 2009|2009-12-01||||April 2001|Actual|2001-04-01||Interventional|||BMS-214662 in Treating Patients With Advanced Solid Tumors|Phase I Study of BMS-214662 Oral Dosing in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:31.558535|2017-10-11 04:25:31.558535
NCT00004878|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-07-27||||||July 2012|2012-07-01||||||||Interventional|||Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia|A Study to Determine the Safety and Efficacy of Using CD8-High Density Microparticles (CD8-HDM) to Deplete CD8+ Cells From Donor Lymphocyte Infusion in Order to Reduce Graft-versus-Host Disease (GvHD) Without Compromising an Anti-Leukemia Effect in Patients With Chronic Myeloid Leukemia Given HLA-Identical Sibling Peripheral Blood Stem Cell Transplants After Non-Myeloablative Conditioning|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||||study never opened|f||||||||||||||2017-10-11 04:25:31.652901|2017-10-11 04:25:31.652901
NCT00004879|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-01-07|||April 2000||2000-04-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer|An Open Label, Multiple Dose, Dose-Rising Clinical Trial of the Safety of ABX-EGF in Patients With Renal, Prostate, Pancreatic, Non-Small-Cell Lung, Colorectal, or Esophageal Cancer|Completed||Phase 1|||Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:25:31.874883|2017-10-11 04:25:31.874883
NCT00004880|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2015-10-01|||June 1997||1997-06-01|July 2012|2012-07-01||||April 2001|Actual|2001-04-01||Interventional|||Vaccine Therapy in Treating Patients With Advanced Kidney Cancer|A Phase I Pilot Trial of a Multi-Antigen Loaded Dendritic Cell Vaccine for the Treatment of Advanced Renal Cell Carcinoma|Completed||Phase 1|14|Actual|Jonsson Comprehensive Cancer Center|||||f||||f||||||||||2017-10-11 04:25:32.079098|2017-10-11 04:25:32.079098
NCT00004881|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-06-25|||April 2000||2000-04-01|February 2001|2001-02-01|May 2004|Actual|2004-05-01|||||Interventional|||Vaccine Therapy in Treating Patients With Advanced Cancer|Phase I Bridging Trial of TG4010 as Antigen-Specific Immunotherapy in Patients With MUC-1 Positive Advanced Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:32.154137|2017-10-11 04:25:32.154137
NCT00004883|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-01-15|||February 2000||2000-02-01|January 2013|2013-01-01||||August 2005|Actual|2005-08-01||Interventional|||Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2|A Phase II Trial of Trastuzumab (Herceptin) for Advanced Stage (IIIB, IV), HER2 Overexpressing, Non-Small Cell Lung Cancer|Completed||Phase 2|84|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:25:32.24116|2017-10-11 04:25:32.24116
NCT00004884|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-09-20|||July 1999||1999-07-01|September 2012|2012-09-01||||March 2001|Actual|2001-03-01||Interventional|||Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer|Randomized Phase II Study of Docetaxel/Gemcitabine vs. Docetaxel/Cisplatin in Metastatic or Locoregionally Advanced Pancreatic Carcinoma|Completed||Phase 2|96|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:32.355362|2017-10-11 04:25:32.355362
NCT00004885|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-09-20|||July 1999||1999-07-01|September 2012|2012-09-01||||July 2001|Actual|2001-07-01||Interventional|||Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer|CPT-11 in Combination With Weekly 24 Hour Infusion 5-FU Plus Folinic Acid Relative to Weekly 24 Hour Infusion 5-FU Plus Folinic Acid Alone in Patients With Advanced Colorectal Cancer|Completed||Phase 3|430|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:32.502829|2017-10-11 04:25:32.502829
NCT00004886|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-09-20|||December 1999||1999-12-01|September 2012|2012-09-01||||June 2002|Actual|2002-06-01||Interventional|||MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors|Phase I Study to Determine the Safety of MS-209 in Combination With Docetaxel in Patients With a Solid Progressive Tumor|Completed||Phase 1|30|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:32.766061|2017-10-11 04:25:32.766061
NCT00004887|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-09-19|||January 1999||1999-01-01|March 2000|2000-03-01||||||||Interventional|||Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery|A Randomized Phase III Comparative Study of Paclitaxel With Carboplatin Versus Mitomycin, Ifosfamide, Cisplatin (MIC) Chemotherapy in Inoperable Advanced Stage Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:32.840873|2017-10-11 04:25:32.840873
NCT00004888|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2014-05-07|2011-06-21||January 2001||2001-01-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|April 2008|Actual|2008-04-01||Interventional|||Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer|A Safety and Efficacy Study of Doxil and Taxotere ± Herceptin in Advanced Breast Cancer|Completed||Phase 2|84|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:25:32.93295|2017-10-11 04:25:32.93295
NCT00004889|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2015-09-30|||December 1999||1999-12-01|July 2012|2012-07-01|July 2005|Actual|2005-07-01|January 2002|Actual|2002-01-01||Interventional|||Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia|Phase II Study of Rituximab (Rituxan, Mabthera) in Waldenstrom's Macroglobulinemia|Completed||Phase 2|8|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 04:25:33.601497|2017-10-11 04:25:33.601497
NCT00004890|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-03-25|||December 2000||2000-12-01|January 2008|2008-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer|Phase IB Open-Label Rising-Dose Study of Biomed 101 in Patients Treated With Interleukin-2 for Malignancy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:33.685488|2017-10-11 04:25:33.685488
NCT00004891|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2015-12-21|||September 1999||1999-09-01|December 2015|2015-12-01||||March 2007|Actual|2007-03-01||Interventional|||PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery|Prospective Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Multimodality Management of Locally Advanced Primary Rectal Cancer|Completed||N/A|149|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:25:33.857995|2017-10-11 04:25:33.857995
NCT00004892|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2009-02-06|||April 2000||2000-04-01|February 2007|2007-02-01||||||||Interventional|||O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma|Phase I GLIADEL and Continuous Infusion of Intravenous O6-Benzylguanine Trial in Patients With Recurrent Malignant Glioma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:33.951713|2017-10-11 04:25:33.951713
NCT00004893|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2016-07-15|||December 1999||1999-12-01|July 2016|2016-07-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer|Evaluation of Novel Therapeutic Agents Against Breast Cancer: An Innovative Randomized Phase II Trial Design|Completed||Phase 2|5|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:25:34.055392|2017-10-11 04:25:34.055392
NCT00004895|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery|Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:34.287924|2017-10-11 04:25:34.287924
NCT00004896|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Phase II Study of High-Dose Busulfan and Cyclophosphamide Followed by Allogeneic Bone Marrow Transplantation for Patients With Acute Myelogenous Leukemia|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:34.404981|2017-10-11 04:25:34.404981
NCT00004897|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-06-08||2011-05-25|October 1999||1999-10-01|June 2012|2012-06-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer|PFL-Alpha Chemotherapy Followed by Surgery or FHX for Early Stage Esophageal Cancer - A Pilot Project|Terminated||Phase 2|||Northwestern University||||Institutional Review Board requested termination - all patients deceased and no new accrual.|f||||||||||||||2017-10-11 04:25:34.500697|2017-10-11 04:25:34.500697
NCT00004898|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia|Dose Escalation of VP-16 With Cyclophosphamide and Total Body Irradiation as Preparative Regimen for Autologous Transplantation for High-Grade Lymphoma and Acute Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|6|Actual|Northwestern University|||||f||||t||||||||||2017-10-11 04:25:34.593674|2017-10-11 04:25:34.593674
NCT00004899|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Autologous Bone Marrow Transplantation for Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome - A Phase II Pilot Study|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:34.700472|2017-10-11 04:25:34.700472
NCT00004900|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-05-29|||October 1999||1999-10-01|October 2007|2007-10-01|August 2004|Actual|2004-08-01|||||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer|A Phase II Pilot Study of Sequential High Dose Chemotherapy and CD 34+ Selected Stem Cell Support Without Conventional-Dose Induction Chemotherapy for Women With Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:34.79075|2017-10-11 04:25:34.79075
NCT00004901|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-06-25|||October 1999||1999-10-01|August 2000|2000-08-01|July 2004|Actual|2004-07-01|||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer|A Phase I Study of Concomitant Chemoradiotherapy With 776C85, 5-FU and Hydroxyurea for Patients With Poor Prognosis Oral Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:34.886533|2017-10-11 04:25:34.886533
NCT00004902|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-17||2011-02-16|January 1998||1998-01-01|May 2012|2012-05-01|November 1999|Actual|1999-11-01|November 1999|Actual|1999-11-01||Interventional|||Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma|Phase II Pilot Evaluation of Infusional 8 Cl-cAMP in the Treatment of Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:34.982678|2017-10-11 04:25:34.982678
NCT00004903|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2014-01-03|||October 1999||1999-10-01|June 2001|2001-06-01||||||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase II Study of High Dose Late Intensification Therapy in Patients With Chemotherapy Sensitive Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:35.08864|2017-10-11 04:25:35.08864
NCT00004904|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-31|||October 1999||1999-10-01|May 2012|2012-05-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Stem Cell Transplantation in Treating Patients With Hematologic Cancer|"Phase I Study of T Cell Depleted (TCD) Partially Matched Related Donor (PMRD) Hematopoietic Stem Cell Transplantation for High Risk Hematologic Diseases Using Intense Pre and Post Transplant Immunosuppression and Megadose CD34 Veto Cells"|Completed||Phase 1|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:35.175144|2017-10-11 04:25:35.175144
NCT00004905|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-05-29|||October 1999||1999-10-01|February 2001|2001-02-01|September 2004|Actual|2004-09-01|||||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia|Pilot Study of Intensive Chemotherapy Followed by Peripheral Blood Stem Cell Harvesting for Autotransplantation of Adults With Chronic Myelogenous Leukemia and High Risk Acute Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:35.316515|2017-10-11 04:25:35.316515
NCT00005137|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-05-27|||July 1992||1992-07-01|May 2014|2014-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|HERITAGE||Heritage Study--Genetics, Exercise and Risk Factors|Health, Risk Factors, Exercise Training, and Genetics|Completed||N/A|||Washington University School of Medicine|||||f||||||||||||||2017-10-11 04:26:31.560184|2017-10-11 04:26:31.560184
NCT00004906|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-05-29|||October 1999||1999-10-01|November 2007|2007-11-01|June 2001|Actual|2001-06-01|||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer|A Phase II Multi-Institution Study of Docetaxel and Doxorubicin as Induction Therapy Followed by Sequential High Dose Chemotherapy and CD 34+ Selected Stem Cell Support for Women With Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:35.42385|2017-10-11 04:25:35.42385
NCT00004907|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma|High-Dose Chemoradiotherapy With Stem Cell Allogeneic Cellular Rescue in Patients With Relapsed or Refractory Hematologic Malignancy - A Phase I/II Study|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:35.5157|2017-10-11 04:25:35.5157
NCT00004908|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2011-08-25||2011-08-23|November 1999||1999-11-01|August 2011|2011-08-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma|Autologous Blood Stem Cell Transplantation in Patients With Hodgkin's Disease and Non-Hodgkin's Lymphoma With High-Dose Cyclophosphamide, Total Body Irradiation and Involved-Field Radiation Therapy|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:35.598413|2017-10-11 04:25:35.598413
NCT00004909|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2011-02-18|||November 1999||1999-11-01|February 2011|2011-02-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Observational|||Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer|The Impact of Oral Chemotherapy on Quality of Life in Patients With Recurrent Epithelial Ovarian Cancer|Completed||N/A|40|Actual|Northwestern University|||2||f||||t||||||||||2017-10-11 04:25:35.67038|2017-10-11 04:25:35.67038
NCT00004910|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-31||2011-02-18|January 2000||2000-01-01|May 2012|2012-05-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction|A Pilot Phase I/II Trial of Enteral Wallstents for Duodenal Obstruction in the Setting of Malignancy|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:35.73034|2017-10-11 04:25:35.73034
NCT00004911|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-31||2011-02-18|January 2000||2000-01-01|May 2012|2012-05-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction|A Pilot Phase I/II Trial of Enteral Wallstents for Colonic Obstruction in the Setting of Malignancy|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:35.801367|2017-10-11 04:25:35.801367
NCT00004912|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-17||2011-02-18|January 2000||2000-01-01|May 2012|2012-05-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss|Phase II Trial of Progressive Resistance Training With Megestrol Acetate for the Treatment of Cancer-Related Weight Loss|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:35.889962|2017-10-11 04:25:35.889962
NCT00004913|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-31|||January 2000||2000-01-01|May 2012|2012-05-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I Study of Docetaxel Plus 5-FU, Cisplatin and Leucovorin in Patients With Advanced Solid Tumors|Completed||Phase 1|||Northwestern University|||||f||||||||||||||2017-10-11 04:25:35.963761|2017-10-11 04:25:35.963761
NCT00004914|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-31||2011-04-08|January 2000||2000-01-01|May 2012|2012-05-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue|A Phase II Trial of Progressive Resistance Training (PRT) Plus Procrit for the Treatment of Anemia-Related Fatigue in Cancer Patients|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:36.03397|2017-10-11 04:25:36.03397
NCT00004915|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-31||2011-02-16|November 1998||1998-11-01|May 2012|2012-05-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer|Phase II Study of Raloxifene in Recurrent Endometrial Cancer|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:36.095717|2017-10-11 04:25:36.095717
NCT00004916|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-05-31||2011-07-01|February 1999||1999-02-01|May 2012|2012-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|Phase I/II Study of Mesna, Ifosfamide, Teniposide and Weekly Taxol (MITTen) in Relapsed Lymphoma|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:25:36.156393|2017-10-11 04:25:36.156393
NCT00004917|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2016-12-30|||June 2000||2000-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2007|Actual|2007-11-01||Interventional|||Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer|A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:25:36.399787|2017-10-11 04:25:36.399787
NCT00004918|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-01-04|||December 1999||1999-12-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome|A Phase I/II Study of PR1 (NSC 698102) Human Leukemia Peptide Vaccine With Montanide ISA 51 (NSC 675756) or Montanide ISA 51 VG (NSC 737063) Adjuvant|Completed||Phase 1/Phase 2|69|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:25:36.957427|2017-10-11 04:25:36.957427
NCT00004919|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-07-01|||December 1999||1999-12-01|July 2013|2013-07-01||||March 2003|Actual|2003-03-01||Interventional|||Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy|A Trial of Irinotecan and Cisplatin in Children With Refractory Solid Tumors|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:25:37.074138|2017-10-11 04:25:37.074138
NCT00004920|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-07-17|||November 1999||1999-11-01|July 2012|2012-07-01||||January 2003|Actual|2003-01-01||Interventional|||Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura|Phase III Study of Tomudex and Cisplatin Versus Cisplatin in Malignant Pleural Mesothelioma|Completed||Phase 3|256|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:37.176643|2017-10-11 04:25:37.176643
NCT00004921|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-09-16|||September 1998||1998-09-01|July 2002|2002-07-01|September 2007|Actual|2007-09-01|||||Interventional|||High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery|A Randomized Phase III Trial of Sequential High Dose Chemotherapy or Standard Chemotherapy for Optimally Debulked FIGO Stage III and IV Ovarian Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:37.307797|2017-10-11 04:25:37.307797
NCT00004922|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-06-18|||June 1999||1999-06-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors|A Phase II Clinical Trial of Irinotecan (CPT-11) in Patients With Advanced High Grade Neuroendocrine Tumors|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:25:37.432806|2017-10-11 04:25:37.432806
NCT00004923|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2009-08-21|||April 1999||1999-04-01|August 2009|2009-08-01|May 2006|Actual|2006-05-01|||||Interventional|||Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors|Dose Escalation Trial of Docetaxel Plus Irinotecan in Patients With Advanced Cancer|Completed||Phase 1/Phase 2|47|Actual|Yale University|||||f||||f||||||||||2017-10-11 04:25:37.501398|2017-10-11 04:25:37.501398
NCT00004924|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2009-08-21|||March 1999||1999-03-01|August 2009|2009-08-01|February 2006|Actual|2006-02-01|||||Interventional|||Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer|Phase II Trial of Irinotecan Plus Paclitaxel in Patients With Advanced Nonsmall Cell Lung Cancer|Completed||Phase 2|28|Actual|Yale University|||||f||||f||||||||||2017-10-11 04:25:37.566035|2017-10-11 04:25:37.566035
NCT00004925|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-06-18|||August 1999||1999-08-01|June 2013|2013-06-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer|Phase I/II Study of TLC D-99 Plus Herceptin as First or Second Line Therapy for Patients With Locally Advanced Inflammatory or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:25:37.63184|2017-10-11 04:25:37.63184
NCT00004926|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-05-29|||October 1999||1999-10-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|August 2002|Actual|2002-08-01||Interventional|||ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy|A Phase I Study of Oral ILX23-7553 in Patients With Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:37.69577|2017-10-11 04:25:37.69577
NCT00004927|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2017-01-27|||July 1999||1999-07-01|January 2017|2017-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy|Phase I Study of BMS-247550 Given Every Three Weeks in Patients With Advanced Malignancies|Completed||Phase 1|||R-Pharm|||||f||||||||||||||2017-10-11 04:25:37.757874|2017-10-11 04:25:37.757874
NCT00004928|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-06-18|||October 1999||1999-10-01|June 2013|2013-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer|A Phase I Study of 1,25 Dihydroxy-Vitamin D3 (Calcitriol) in Patients With Prostate Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:25:37.818903|2017-10-11 04:25:37.818903
NCT00004929|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-01-30|||September 1999||1999-09-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer|Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21: A Trial Examining the Immunogenicity of Glycosylated MUC-2-KLH Peptide Conjugate Vaccine|Completed||Phase 1|15|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:25:37.888391|2017-10-11 04:25:37.888391
NCT00004930|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-06-18|||July 1999||1999-07-01|June 2013|2013-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases|Phase I and Clinical Pharmacologic Study of Inhaled Doxorubicin in Adults With Advanced Solid Tumors Affecting the Lungs|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:25:37.958689|2017-10-11 04:25:37.958689
NCT00004931|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-01-10|||February 2000||2000-02-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer|A Clinical Trial Comparing 5-Fluorouracil (5-FU) Plus Leucovorin (LV) and Oxaliplatin With 5-FU Plus LV for the Treatment of Patients With Stages II and III Carcinoma of the Colon|Completed||Phase 3|2472|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:25:38.026817|2017-10-11 04:25:38.026817
NCT00004932|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2014-02-20|||January 2002||2002-01-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||STI571 in Treating Patients With Recurrent Leukemia|A Phase I Study of STI571 in Ph+ Leukemia|Completed||Phase 1|31|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:25:38.147321|2017-10-11 04:25:38.147321
NCT00004933|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2016-07-01|||January 2000||2000-01-01|July 2016|2016-07-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa|A Phase III Study of Interferon-Refractory Patients With BCR/ABL(+) Chronic Myelogenous Leukemia (CML) Treated With Homoharringtonine (NSC #141633) vs. Hydroxyurea|Terminated||Phase 3|5|Actual|Alliance for Clinical Trials in Oncology||2||Poor accrual|f||||t||||||||||2017-10-11 04:25:38.810756|2017-10-11 04:25:38.810756
NCT00004934|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-02-01|||August 1999||1999-08-01|May 2003|2003-05-01|May 2003|Actual|2003-05-01|||||Interventional|||Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|A Randomized Trial of Paclitaxel/Epirubicin/Carboplatin Combination (TEC) Versus Paclitaxel/Carboplatin (TC) in the Treatment of Women With Advanced Ovarian Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:39.122793|2017-10-11 04:25:39.122793
NCT00004935|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2016-09-30|||August 1999||1999-08-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|May 2013|Actual|2013-05-01||Interventional|||Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2|Randomized Phase III Trial of Herceptin® Followed by Chemotherapy Plus Herceptin® Versus the Combination of Herceptin® and Chemotherapy as Palliative Treatment in Patients With HER2- Overexpressing Advanced/Metastatic Breast Cancer.|Active, not recruiting||Phase 3|175|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 04:25:39.256391|2017-10-11 04:25:39.256391
NCT00004936|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2013-01-25|||April 2000||2000-04-01|January 2013|2013-01-01|October 2002|Actual|2002-10-01|May 2001|Actual|2001-05-01||Interventional|ACRIN 6651||MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients|Role of Radiology in the Pretreatment Evaluation of Invasive Cervical Cancer|Completed||N/A|||American College of Radiology Imaging Network|||||f||||t||||||||||2017-10-11 04:25:39.406431|2017-10-11 04:25:39.406431
NCT00004937|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2012-07-10|||October 1999||1999-10-01|July 2012|2012-07-01||||May 2000|Actual|2000-05-01||Interventional|||Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme|Open Label Phase II Study on XR5000 Administered as a 5 Day Infusion in Patients With Glioblastoma Multiforme|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:39.481275|2017-10-11 04:25:39.481275
NCT00004938|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2006-06-08|||August 1996||1996-08-01|April 2000|2000-04-01|August 1996||1996-08-01|||||Interventional|||Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis||Completed||Phase 2|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:39.542898|2017-10-11 04:25:39.542898
NCT00004939|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1996||1996-08-01|December 2001|2001-12-01|August 1996||1996-08-01|||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy||Completed||Phase 3|34||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:25:39.599583|2017-10-11 04:25:39.599583
NCT00004940|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||May 1996||1996-05-01|April 2000|2000-04-01|September 2001||2001-09-01|||||Interventional|||Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria||Completed||Phase 3|50||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:39.656645|2017-10-11 04:25:39.656645
NCT00004941|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||July 1996||1996-07-01|April 2000|2000-04-01|July 1996||1996-07-01|||||Interventional|||Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease||Completed||Phase 3|94||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:25:39.710534|2017-10-11 04:25:39.710534
NCT00004978|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-10|2013-05-01|2011-01-20|2009-10-16|March 2000||2000-03-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|ESPRIT||An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy|A Randomized, Open-Label, Phase III, International Study of Subcutaneous Recombinant IL-2 in Patients With HIV-1 Infection and CD4+ Cell Counts 300/mm^3 or Greater: Evaluation of Subcutaneous Proleukin in a Randomized International Trial|Completed||Phase 3|4150|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 04:25:39.828093|2017-10-11 04:25:39.828093
NCT00004979|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-07|2014-01-03||||||January 2001|2001-01-01|September 2000|Actual|2000-09-01|||||Interventional|||Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors|Phase I/II Study of Oral Topotecan and Intravenous Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (Phases I and II) and Other Advanced Solid Tumors (Phase I Only)|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:42.056654|2017-10-11 04:25:42.056654
NCT00004980|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-10|2013-08-05|2008-11-25||December 1999||1999-12-01|August 2013|2013-08-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|||"Repetitive Transcranial Magnetic Stimulation for Voices"|"Repetitive Transcranial Magnetic Stimulation of Speech Processing Brain Areas in Schizophrenic Patients Who Hear Voices"|Completed||Phase 2|50|Actual|Yale University||2|||f||||t||||||||||2017-10-11 04:25:42.13035|2017-10-11 04:25:42.13035
NCT00004981|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-13|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)|A Phase IIIB Randomized, Multicenter Study of the Efficacy and Safety of Combivir 1 Tablet Po Bid Plus Ziagen 300mg Po Bid Versus an Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg Combination Tablet Po Bid, Administered for 24 Weeks in Subjects With HIV-1 Infection|Unknown status|Active, not recruiting|Phase 3|230||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:42.533755|2017-10-11 04:25:42.533755
NCT00004982|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-13|2010-01-12|||December 1998||1998-12-01|January 2010|2010-01-01|November 2002||2002-11-01|||||Interventional|||Combination Iron Chelation Therapy||Completed||Phase 1|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:25:42.662288|2017-10-11 04:25:42.662288
NCT00004983|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-13|2010-02-12|||September 1999||1999-09-01|February 2010|2010-02-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Education and Group Support for Diabetic Hispanics||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:25:42.736546|2017-10-11 04:25:42.736546
NCT00004984|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-13|2010-01-14|||February 1994||1994-02-01|January 2010|2010-01-01|June 2003||2003-06-01|||||Interventional|||The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)||Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 04:25:42.893509|2017-10-11 04:25:42.893509
NCT00004985|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-15|2005-06-23|||January 2000||2000-01-01|March 2001|2001-03-01||||||||Interventional|||Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy|A Phase II, Single-Blind, Randomized, Placebo-Controlled Study of Capravirine (AG1549) in Combination With Viracept and Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Subjects Who Failed an Initial Nonnucleoside Reverse Transcriptase Inhibitor Containing Regimen|Completed||Phase 2|75||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:43.034275|2017-10-11 04:25:43.034275
NCT00004986|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-16|2005-06-23|||February 2000||2000-02-01|August 2000|2000-08-01||||||||Interventional|||Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients|Open Label, Multi-Center Evaluation of Nitazoxanide for the Treatment of Cryptosporidiosis in Subjects With AIDS in the United States|Terminated||Phase 3|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:43.167419|2017-10-11 04:25:43.167419
NCT00004987|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-16|2005-06-23|||October 1999||1999-10-01|June 2001|2001-06-01||||||||Interventional|||Treatment of Advanced AIDS Patients With Dextrin Sulfate|Intraperitoneal Dextrin Sulfate in Patients With Advanced HIV Disease: A Phase I Trial|Unknown status|Active, not recruiting|Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:43.238263|2017-10-11 04:25:43.238263
NCT00004988|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-18|2008-03-03|||March 2000||2000-03-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria|A Phase I Trial of a Live, Genetically Modified Salmonella Typhimurium (VNP20009) for the Treatment of Cancer by Intravenous Administration|Completed||Phase 1|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:43.326185|2017-10-11 04:25:43.326185
NCT00004990|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-18|2008-03-03|||March 2000||2000-03-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis|Pulse Dexamethasone in Focal Segmental Glomerulosclerosis|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:43.401764|2017-10-11 04:25:43.401764
NCT00004991|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-18|2017-06-30|||March 14, 2000||2000-03-14|August 31, 2009|2009-08-31||||August 31, 2009|Actual|2009-08-31||Observational|||Study of Brain Activity During Speech Production and Speech Perception|Brain Activation During Developmental Speech Production and Speech Perception|Completed||N/A|411||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:43.480483|2017-10-11 04:25:43.480483
NCT00004992|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-17|2011-02-03|||July 1996||1996-07-01|February 2011|2011-02-01|April 2001||2001-04-01|||||Interventional|||Diabetes Prevention Program||Completed||N/A|3819||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 04:25:43.541333|2017-10-11 04:25:43.541333
NCT00004993|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-17|2010-03-01|||August 1999||1999-08-01|March 2010|2010-03-01|August 2001||2001-08-01|||||Interventional|||Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis|Can PTH Reverse Glucocorticoid-induced Osteoporosis|Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:25:45.102067|2017-10-11 04:25:45.102067
NCT00004994|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-22|2008-03-03|||October 1999||1999-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant|A Study Comparing Quality of Life in Patients Undergoing a Non-Myeloablative Versus a Myeloablative Peripheral Blood Stem Cell Transplant for Hematological Diseases|Completed||N/A|106||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:45.182899|2017-10-11 04:25:45.182899
NCT00004996|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-22|2017-10-05|||March 20, 2000||2000-03-20|April 22, 2015|2015-04-22|April 22, 2015||2015-04-22|||||Observational|||Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections|Langherhans' Cell Function and Inflammatory Responses in Skin of Volunteers Using the Suction Blister Technique|Completed||N/A|90|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:45.239023|2017-10-11 04:25:45.239023
NCT00004997|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-22|2008-03-03|||April 1998||1998-04-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Leucovorin for the Treatment of 5 q Minus Syndrome|The Experimental Treatment of Transfusion Dependent 5q Minus Syndrome With Leucovorin|Completed||Phase 2|14||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:45.295408|2017-10-11 04:25:45.295408
NCT00004998|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-21|2005-06-23|||November 1999||1999-11-01|March 2001|2001-03-01||||||||Interventional|||Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients|A Phase II, Open-Label Study of AG1549 in Combination With Other Antiretroviral Agents in Treatment-Naive HIV-Infected Patients|Suspended||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:45.356555|2017-10-11 04:25:45.356555
NCT00004999|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-21|2005-06-23|||August 1999||1999-08-01|March 2001|2001-03-01||||||||Interventional|||Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients|A Randomized, Double-Blind, Placebo-Controlled Study of AG1549 in Combination With Viracept (Nelfinavir Mesylate) and Combivir (Zidovudine + Lamivudine) in Treatment-Naive HIV-Infected Patients|Suspended||Phase 2|350||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:45.441341|2017-10-11 04:25:45.441341
NCT00005000|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-21|2005-06-23|||December 1999||1999-12-01|July 2002|2002-07-01||||||||Interventional|||Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs|A Randomized, Open-Label, Study of Nelfinavir or Efavirenz in HIV-1 Infected, Antiretroviral Naive Patients|Unknown status|Active, not recruiting|Phase 4|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:45.600292|2017-10-11 04:25:45.600292
NCT00005001|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-21|2005-06-23||||||March 2001|2001-03-01||||||||Interventional|||Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)|A Pilot, Phase II, Double-Blind Study to Assess the Virologic Effect of Remune Versus Incomplete Freund's Adjuvant (IFA) in Patients Who Are Infected With Human Immunodeficiency Virus Type I (HIV-1), Have a Plasma HIV-1 RNA Level Less Than 50 Copies/Ml, Are Receiving Highly Active Antiretroviral Therapy (HAART), and Who Subsequently Discontinue Their HAART Regimen|Completed||Phase 2|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:45.669807|2017-10-11 04:25:45.669807
NCT00005002|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-21|2005-06-23||||||August 2001|2001-08-01||||||||Interventional|||Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)|A Randomized, Double-Blind, Adjuvant-Controlled, Multicenter Study to Compare the Virologic and Immunologic Effect of Highly Active Antiretroviral Therapy (HAART) Plus Remune Versus HAART Plus Incomplete Freund's Adjuvant (IFA) in Antiretroviral-Naive Patients Infected With Human Immunodeficiency Virus Type 1 (HIV-1)|Unknown status|Active, not recruiting|Phase 3|688||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:25:45.836678|2017-10-11 04:25:45.836678
NCT00005003|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-23|2008-03-03|||March 2000||2000-03-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Observational|||Genetic Component of Handedness|Mapping the Genetic Component of Hand-Use Preference|Completed||N/A|1400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:45.905502|2017-10-11 04:25:45.905502
NCT00005004|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-23|2008-03-03|||March 2000||2000-03-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Brain Processing of Language Meanings|Investigations in Discourse Processes|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:25:45.974874|2017-10-11 04:25:45.974874
NCT00003899|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-10-03|||January 1999||1999-01-01|September 2010|2010-09-01|November 2001|Actual|2001-11-01|||||Interventional|||Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors|High-Dose Consolidation With Escalating Doses of Melphalan and Thiotepa for Stage IV Breast Cancer|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:25:46.064039|2017-10-11 04:25:46.064039
NCT00003900|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||October 1999||1999-10-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer|A Phase II Study of Irinotecan (CPT-11) and Docetaxel (Taxotere) in Patients With Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:25:46.135939|2017-10-11 04:25:46.135939
NCT00003901|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-22|2016-12-22||July 1999||1999-07-01|December 2016|2016-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery|A Prospective Study of the Prognostic Significance of Occult Metastases in the Patient With Resectable Non-Small Cell Lung Carcinoma|Completed||Phase 3|1310|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:25:46.273725|2017-10-11 04:25:46.273725
NCT00003902|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-14|||March 1999||1999-03-01|May 2012|2012-05-01|September 2005|Actual|2005-09-01|December 2004|Actual|2004-12-01||Interventional|||Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement|Phase I/II of Capecitabine and Vinorelbine in Elderly Patients (At Least 65 Years) With Metastatic Breast Cancer With or Without Bone Involvement|Completed||Phase 1/Phase 2|110|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-10-11 04:25:46.747172|2017-10-11 04:25:46.747172
NCT00003903|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-10-14|||July 1999||1999-07-01|October 2013|2013-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer|An Evaluation of the Effect of Androgen Ablation on Bone Resorption in Prostate Cancer Patients|Completed||N/A|150|Anticipated|University of Rochester|||||f||||||||||||||2017-10-11 04:25:46.811077|2017-10-11 04:25:46.811077
NCT00003906|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-05|||May 1999||1999-05-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|December 2005|Actual|2005-12-01||Interventional|||Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women|Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer|Completed||Phase 3|19747|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-10-11 04:25:46.949378|2017-10-11 04:25:46.949378
NCT00003907|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-12|2013-01-07||August 1999||1999-08-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|May 2011|Actual|2011-05-01||Interventional|||Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver|Chemoembolization in Hepatocellular Carcinoma or Neuroendocrine Hepatic Metastases: A Phase II Multi-Center Trial|Completed||Phase 2|50|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-10-11 04:25:48.323223|2017-10-11 04:25:48.323223
NCT00003908|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-17|||November 1999||1999-11-01|April 2013|2013-04-01|January 2007|Actual|2007-01-01|June 2004|Actual|2004-06-01||Interventional|||S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Evaluation of the Combination of Docetaxel (Taxotere)/ Carboplatin in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|68|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:25:48.955591|2017-10-11 04:25:48.955591
NCT00003909|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-15|||August 1999||1999-08-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma|A Phase I Study of Motexafin Gadolinium (Xcytrin, NSC 695238) and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:25:49.350251|2017-10-11 04:25:49.350251
NCT00003910|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-06|2012-10-16||July 1999||1999-07-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|December 2010|Actual|2010-12-01||Interventional|||Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia|A Phase II Study of Initial Treatment With Methotrexate in Large Granular Lymphocytic (LGL) Leukemia|Terminated||Phase 2|59|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:25:49.455006|2017-10-11 04:25:49.455006
NCT00003911|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-30|||July 1999||1999-07-01|January 2013|2013-01-01|August 2007|Actual|2007-08-01|August 2002|Actual|2002-08-01||Interventional|||S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases|A Phase II Pilot Study of Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases|Terminated||Phase 2|2|Actual|Southwest Oncology Group||1||Poor accrual|f||||f||||||||||2017-10-11 04:25:50.110106|2017-10-11 04:25:50.110106
NCT00003912|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||June 1998||1998-06-01|December 2000|2000-12-01|October 2009|Actual|2009-10-01|||||Interventional|||Chemotherapy in Treating Children With Liver Cancer|Liver Tumour Studies - Hepatoblastoma and Hepatocellular Carcinoma|Completed||Phase 3|260|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:50.329068|2017-10-11 04:25:50.329068
NCT00003913|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-31|||December 1998||1998-12-01|March 2010|2010-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease|A Multicenter Study of Unrelated Umbilical Cord Blood as an Alternate Source of Stem Cells for Transplantation|Completed||Phase 2|390|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:25:50.420465|2017-10-11 04:25:50.420465
NCT00003914|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-05-10|||August 1999||1999-08-01|May 2011|2011-05-01|May 2009|Actual|2009-05-01|August 2002|Actual|2002-08-01||Interventional|||Dolastatin 10 in Treating Patients With Advanced Kidney Cancer|Phase II Study of Dolastatin-10 in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|30|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-10-11 04:25:50.543586|2017-10-11 04:25:50.543586
NCT00003915|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-01|||May 1999||1999-05-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer|Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment|Active, not recruiting||Phase 2|63|Actual|University of Massachusetts, Worcester||1|||f||||t||||||||||2017-10-11 04:25:50.61179|2017-10-11 04:25:50.61179
NCT00003916|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||April 1999||1999-04-01|September 2012|2012-09-01||||December 2001|Actual|2001-12-01||Interventional|||Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma|Focal Fractionated Conformal Stereotactic Boost Following Conventional Radiotherapy of High Grade Gliomas: A Randomized Phase III Study|Completed||Phase 3|25|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:50.700458|2017-10-11 04:25:50.700458
NCT00003917|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-08|||March 1999||1999-03-01|January 2014|2014-01-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer|An Open Label, Multicenter, Randomized, Phase III Comparator Study of Oral Topotecan Versus Intravenous Topotecan for Second Line Therapy in Patients With Small Cell Lung Cancer Who Have Relapsed Greater Than or Equal to 90 Days After Completion of First Line Therapy|Completed||Phase 3|4|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:25:50.789342|2017-10-11 04:25:50.789342
NCT00003920|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-06|||April 1996||1996-04-01|November 2000|2000-11-01||||||||Interventional|||Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer|Pharmacokinetic/Dosimetry/MTNTD Study of 111In/90Y-2IT-BAD-m170 for Therapy in Metastatic Breast Cancer Patients With Post Therapy Support of Autologous Pretherapy Apheresed Peripheral Blood Stem Cells and Cyclosporin A Given for Suppression of HAMA Response|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:51.063882|2017-10-11 04:25:51.063882
NCT00003923|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-03-01|||March 1999||1999-03-01|March 2013|2013-03-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas|Phase II Study of Photodynamic Therapy With PHOTOFRIN (Porfimer Sodium) for Injection in Patients With Malignant Bile Duct Obstruction|Completed||Phase 2|4|Actual|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:25:51.127279|2017-10-11 04:25:51.127279
NCT00003924|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-08-06|||October 1995||1995-10-01|May 2007|2007-05-01||||||||Interventional|||Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma|A European Randomized Multicenter Study of Interferon Alfa-2b Versus No Treatment After Intensive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Relapsing Lymphoma Patients (Non-Hodgkin Lymphomas and Hodgkin's Disease)|Unknown status|Active, not recruiting|Phase 3|360|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:51.191359|2017-10-11 04:25:51.191359
NCT00003925|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-05|||May 1998||1998-05-01|April 2013|2013-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combination Chemotherapy In Treating Patients With Advanced Cancer|Phase I Study of Gemcitabine (Gemzar) and UFT/Leucovorin|Completed||Phase 1|36|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:25:51.256291|2017-10-11 04:25:51.256291
NCT00003926|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-08-20|||November 1998||1998-11-01|August 2010|2010-08-01|August 2003|Actual|2003-08-01|August 2002|Actual|2002-08-01||Interventional|||Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors|A Phase I Study of the Chemoprotectant Amifostine With Autologous Stem Cell Transplantation for High Risk or Relapsed Pediatric Solid Tumors and Brain Tumors|Terminated||Phase 1|13|Actual|Masonic Cancer Center, University of Minnesota||2||Withdrawn due to slow accrual|f||||t||||||||||2017-10-11 04:25:51.318967|2017-10-11 04:25:51.318967
NCT00003927|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-04-24|||April 22, 1999|Actual|1999-04-22|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer|High-Dose Infusional Taxol, Amifostine, Doxorubicin, and Cyclophosphamide Followed by Stem Cell Rescue for High Risk Primary and Responsive Metastatic Breast Cancer|Active, not recruiting||N/A|15|Anticipated|City of Hope Medical Center||1|||f||||||||||||||2017-10-11 04:25:51.423966|2017-10-11 04:25:51.423966
NCT00003928|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-06-09|||January 1999||1999-01-01|June 2010|2010-06-01|April 2006|Actual|2006-04-01|February 2005|Actual|2005-02-01||Interventional|||Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Utilizing Gemcitabine and Cisplatinum in Patients With Renal Cell Carcinoma|Completed||Phase 2|32|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:25:51.503641|2017-10-11 04:25:51.503641
NCT00003929|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-03-16|||June 1998||1998-06-01|March 2012|2012-03-01||||March 2000|Actual|2000-03-01||Interventional|||Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma|Combined Modality Therapy of AIDS-Related and Immunocompetent Primary CNS Lymphoma (PCL) Using Filgrastim (G-CSF)|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:25:51.5742|2017-10-11 04:25:51.5742
NCT00003930|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-10-13|||September 1999||1999-09-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|July 2003|Actual|2003-07-01||Interventional|||Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer|A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy|Completed||Phase 1/Phase 2|84|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:25:51.670948|2017-10-11 04:25:51.670948
NCT00003931|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-07-01|||February 1999||1999-02-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia|Assessment of the Partial Tandem Duplication of ALL1 (MLL) in Patients With Acute Myeloid Leukemia- A CALGB Leukemia Tissue Bank Project|Completed||N/A|9769|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     blood or bone marrow samples   "|||2017-10-11 04:25:52.305344|2017-10-11 04:25:52.305344
NCT00003933|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-06|||April 1999||1999-04-01|August 2014|2014-08-01||||April 2006|Actual|2006-04-01||Interventional|||Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia|The Incidence and Prognostic Significance of P16 INK4A/ P15 INK4B Gene Alterations in Children With Relapsed ALL Treated on CCG-1941|Completed||N/A|||Children's Oncology Group|||||f||||f||||||||||2017-10-11 04:25:52.488381|2017-10-11 04:25:52.488381
NCT00003934|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-04|||June 1999||1999-06-01|June 2013|2013-06-01||||November 2006|Actual|2006-11-01||Interventional|||Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia|Phase III Randomized Study of Concurrent Tretinoin and Chemotherapy With or Without Arsenic Trioxide (AS2O3) (NSC # 706363) as Initial Consolidation Therapy Followed by Maintenance Therapy With Intermittent Tretinoin Versus Intermittent Tretinoin Plus Mercaptopurine and Methotrexate for Patients With Untreated Acute Promyelocytic Leukemia|Completed||Phase 3|420|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:25:52.648784|2017-10-11 04:25:52.648784
NCT00003935|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-07-25|||September 1999||1999-09-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|October 2003|Actual|2003-10-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma|Treatment of Children With Diffuse Intrinsic Brain Stem Glioma With Standard Dose Irradiation and Vincristine Plus Oral VP-16, A POG Pilot Study|Completed||Phase 1|31|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:25:52.812003|2017-10-11 04:25:52.812003
NCT00005138|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||June 1976||1976-06-01|May 2000|2000-05-01|June 1989|Actual|1989-06-01|||||Observational|||High Blood Pressure in the Young||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:31.690954|2017-10-11 04:26:31.690954
NCT00003936|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-04-09|||June 1999||1999-06-01|April 2014|2014-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease|Phase II Clinical Evaluation of Bryostatin 1 in Patients With Hodgkin's Disease|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:25:53.07321|2017-10-11 04:25:53.07321
NCT00003937|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-08-04|||September 1999||1999-09-01|August 2014|2014-08-01|June 2008|Actual|2008-06-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma|Protocol for Patients With Newly-Diagnosed Non-Metastatic Osteosarcoma - A POG/CCG Pilot Intergroup Study|Completed||Phase 3|253|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-10-11 04:25:53.333528|2017-10-11 04:25:53.333528
NCT00003938|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||June 1999||1999-06-01|September 2012|2012-09-01||||May 2003|Actual|2003-05-01||Interventional|||Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients|A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy With Ambisome in Granulocytopenic Cancer Patients With Unexplained Fever Refractory to Empirical Antibacterials|Completed||Phase 3|115|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:53.865961|2017-10-11 04:25:53.865961
NCT00003939|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20||||||September 2012|2012-09-01||||November 2000|Actual|2000-11-01||Interventional|||Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma|Phase II Study on ET-743 in Advanced Soft Tissue Sarcomas of the Adult|Completed||Phase 2|132|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:54.072134|2017-10-11 04:25:54.072134
NCT00003941|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-09-20|||April 1999||1999-04-01|September 2012|2012-09-01||||June 2007|Actual|2007-06-01||Interventional|||Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer|A Randomized Phase III Study of Sequential High-Dose Cisplatinum/Etoposide/Ifosfamide Plus Stem Cell Support Versus BEP in Patients With Poor Prognosis Germ Cell Cancer|Completed||Phase 3|222|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:54.165512|2017-10-11 04:25:54.165512
NCT00003942|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-03|||November 1998||1998-11-01|August 2000|2000-08-01||||||||Interventional|||Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma|A Phase I/II Study of the Safety and Feasibility of REVM10 or REVM10/ANTISENSE POL 1 Transduced Hematopoietic Stem Cells (HSC) in HIV-1 Related Non-Hodgkin's Lymphoma Patients Already Being Treated With High Dose Chemotherapy and Peripheral Blood Stem Cell Support|Unknown status|Active, not recruiting|Phase 1/Phase 2|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:54.369937|2017-10-11 04:25:54.369937
NCT00003943|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-16|||September 1998||1998-09-01|April 2013|2013-04-01|February 2003|Actual|2003-02-01|November 2000|Actual|2000-11-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.|A Phase II Trial of High Dose Paclitaxel, Carboplatin and Topotecan With Peripheral Blood Stem Cell Support in Extensive Stage Small Cell Cancer|Completed||Phase 2|3|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-11 04:25:54.456234|2017-10-11 04:25:54.456234
NCT00003944|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-16|||August 1998||1998-08-01|April 2013|2013-04-01|February 2003|Actual|2003-02-01|December 1999|Actual|1999-12-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Trial Using Multiple Cycles of High Dose Sequential Carboplatin, Paclitaxel and Topotecan With Peripheral Blood Stem Cell (PBSC) Support as Initial Chemotherapy in Patients With Suboptimally Debulked Stage III or IV Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Completed||Phase 2|3|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-10-11 04:25:54.553832|2017-10-11 04:25:54.553832
NCT00003945|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-24|||June 1999||1999-06-01|September 2004|2004-09-01||||January 2007|Actual|2007-01-01||Interventional|||Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer|A Randomized Phase III Study of Cisplatin Versus Cisplatin Plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix|Completed||Phase 3|400|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:25:54.638024|2017-10-11 04:25:54.638024
NCT00003946|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-07|||August 1999||1999-08-01|July 2004|2004-07-01||||June 2003|Actual|2003-06-01||Interventional|||Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer|Phase II Study of Danazol in Advanced or Recurrent Endometrial Cancer|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:25:54.738336|2017-10-11 04:25:54.738336
NCT00003950|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-03-06|||January 2000||2000-01-01|March 2014|2014-03-01|January 2005|Actual|2005-01-01|December 2001|Actual|2001-12-01||Interventional|||Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer|A Phase II Trial of Irinotecan (CPT-11) and Cyclosporine in Patients With 5-FU Refractory Advanced Colorectal Cancer|Completed||Phase 2|16|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:25:55.02737|2017-10-11 04:25:55.02737
NCT00003951|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-05-15|||June 1999||1999-06-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Metastatic Carcinoma of the Pancreas|Completed||Phase 2|37|Anticipated|Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:25:55.157592|2017-10-11 04:25:55.157592
NCT00003953|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-25|||February 1999||1999-02-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|November 2001|Actual|2001-11-01||Interventional|||Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer|A Phase II Study of Preoperative Dose-Dense Chemotherapy With Sequential Doxorubicin and Docetaxel for Initial Treatment of Operable and Inoperable Stage II-IIIB Breast Cancer|Completed||Phase 2|39|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:25:55.409285|2017-10-11 04:25:55.409285
NCT00003954|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-05-22|||March 1999||1999-03-01|May 2017|2017-05-01||||December 2002|Actual|2002-12-01||Interventional|||Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma|Allogeneic Stem Cell Transplantation For Multiple Myeloma: A Two Step Approach To Reduce Toxicity Involving High Dose Melphalan and Autologous Stem Cell Transplant Followed By PBSC Allografting After Low Dose TBI|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-10-11 04:25:55.559715|2017-10-11 04:25:55.559715
NCT00003955|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-12|||September 1999||1999-09-01|February 2014|2014-02-01|October 2009|Actual|2009-10-01|January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma|"A Phase II Up-Front Window Study of Irinotecan (CPT-11) Followed by Multimodal, Multiagent, Therapy for Selected Children and Adolescents With Newly Diagnosed Stage 4/Clinical Group IV Rhabdomyosarcoma: An IRS-V Study"|Completed||Phase 2|77|Actual|Children's Oncology Group|||||f||||||||||||||2017-10-11 04:25:55.782583|2017-10-11 04:25:55.782583
NCT00003956|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-02|||April 1999||1999-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|January 2001|Actual|2001-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I Study of Continuous Oral Administration of SCH 66336 and 5-Fluorouracil/Leucovorin (5FU/LV) in Patients With Advanced Cancer|Completed||Phase 1|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:57.786667|2017-10-11 04:25:57.786667
NCT00003957|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-16|||December 1998||1998-12-01|April 2013|2013-04-01|August 2001|Actual|2001-08-01|September 2000|Actual|2000-09-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|A Phase II Trial of Multiple Cycles of Sequential High Dose Chemotherapy for Patients With Chemotherapy Sensitive Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 2|3|Actual|Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:25:57.856967|2017-10-11 04:25:57.856967
NCT00003958|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-13|||September 2002||2002-09-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma|Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma|Completed||Phase 3|702|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:25:57.937125|2017-10-11 04:25:57.937125
NCT00003959|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-15|||June 1999||1999-06-01|January 2013|2013-01-01||||December 2001|Actual|2001-12-01||Interventional|||Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome|Vaccination of Patients With Myelodysplastic Syndrome Against Mutated RAS Proteins: A Pilot Trial|Completed||Phase 1|1|Actual|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:25:58.071428|2017-10-11 04:25:58.071428
NCT00003960|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-01|||April 1998||1998-04-01|May 2014|2014-05-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Matched Unrelated and Haploidentical Bone Marrow Transplantation for Hematologic Malignancies|Completed||Phase 2|36|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:25:58.145347|2017-10-11 04:25:58.145347
NCT00003961|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-04-16|||April 1999||1999-04-01|April 2014|2014-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome|Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) After T-Lymphocyte Depleted Allogeneic BMT for Myelodysplastic Syndromes|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:25:58.229868|2017-10-11 04:25:58.229868
NCT00003962|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-05-01|||April 1998||1998-04-01|May 2014|2014-05-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Dose Finding Study of Toxicity and Immunomodulatory Effects of Interleukin-2 Following Allogeneic Bone Marrow Transplantation in Patients at High Risk for Relapse|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:25:58.30454|2017-10-11 04:25:58.30454
NCT00003963|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-09-30|||May 1999||1999-05-01|July 2012|2012-07-01|February 2005|Actual|2005-02-01|September 2003|Actual|2003-09-01||Interventional|||Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation|Treatment of B-Cell NHL Relapsing After Transplant With a Rituxan Vinorelbine Combination|Completed||Phase 2|14|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:25:58.378711|2017-10-11 04:25:58.378711
NCT00003966|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-01-19|||April 2000||2000-04-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|February 2006|Actual|2006-02-01||Interventional|||Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation|Defibrotide for Hematopoietic Stem Cell Transplant Patients With Severe Hepatic Venocclusive Disease: A Phase I/II Study to Determine the Minimal Effective Dose|Completed||Phase 2|151|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-11 04:25:58.458876|2017-10-11 04:25:58.458876
NCT00003967|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-24|||September 1999||1999-09-01|March 2008|2008-03-01||||April 2006|Actual|2006-04-01||Interventional|||Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer|A Phase I Study of Sequential Prolonged Oral Topotecan (IND# 58,131) and Prolonged Oral Etoposide as Second Line Therapy in Ovarian, Peritoneal or Tubal Carcinoma|Completed||Phase 1|24|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:25:58.669594|2017-10-11 04:25:58.669594
NCT00003968|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||June 1999||1999-06-01|January 2004|2004-01-01||||December 2003|Actual|2003-12-01||Interventional|||Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer|Phase II Study of Bryostatin-1 in Metastatic Renal Cell Carcinoma(Summary Last Modified 8/1999)|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:25:58.757978|2017-10-11 04:25:58.757978
NCT00003969|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||August 1998||1998-08-01|December 2000|2000-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Geldanamycin Analogue in Treating Patients With Advanced Cancer|A Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino-17-Demethoxygeldanamycin (17-AAG) (NSC 330507) Via Intravenous Administration in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:58.858877|2017-10-11 04:25:58.858877
NCT00003970|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-23|||January 1999||1999-01-01|January 2013|2013-01-01||||October 2003|Actual|2003-10-01||Interventional|||Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma|A Phase I Clinical Trial to Investigate the Correlation Between UGT1A1 Genotype and Irinotecan (CPT-11) Pharmacokinetics and Toxicity in Cancer Patients|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:25:58.933501|2017-10-11 04:25:58.933501
NCT00003994|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-13|||March 1999||1999-03-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer|Intergroup Protocol for Treatment of Children With Hepatoblastoma|Completed||Phase 3|277|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:26:01.032315|2017-10-11 04:26:01.032315
NCT00003972|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-31|||July 1998||1998-07-01|March 2010|2010-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer|A Phase III Study of High-Dose Chemotherapy Using Busulfan, Melphalan and Thiotepa Versus Cyclophosphamide,Thiotepa, Carboplatin Followed by Autologous Stem Cell Transplantation in Patients With High-Risk Primary Stage II or III (Non-Inflammatory) Breast Cancer|Completed||Phase 3|280|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:25:59.064973|2017-10-11 04:25:59.064973
NCT00003974|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-03-03|||August 1997||1997-08-01|March 2011|2011-03-01|November 2000|Actual|2000-11-01|June 1998|Actual|1998-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma|An Evaluation of the Immunological Parameters Associated With a Skin-Test and Immunization of Lung and Mesothelioma Cancer Patients With Autologous Lung Tumor Associated Antigen: Characterization of the Patients' Cytolytic and Helper T Cell Reactivity for Identification of the Specific Antigen(s): A Pilot Study|Completed||Phase 1|20|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:25:59.142207|2017-10-11 04:25:59.142207
NCT00003976|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||March 1998||1998-03-01|July 2012|2012-07-01||||||||Interventional|||E7070 in Treating Patients With Solid Tumors|Phase I Study to Determine the Safety of E7070 in Patients With a Solid Tumor on a Single IV Infusion Repeated Every 3 Weeks|Completed||Phase 1|30|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:59.211214|2017-10-11 04:25:59.211214
NCT00003977|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||November 1999||1999-11-01|December 2003|2003-12-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer|A Phase I Study of Immunization With Alternating Human Papillomavirus E7 Lipopeptide Epitope Vaccine and Dendritic Cells Presenting the E7 Epitope for the Treatment of Recurrent or Persistent Cervical Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:25:59.313718|2017-10-11 04:25:59.313718
NCT00003979|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||April 1999||1999-04-01|July 2012|2012-07-01||||||||Interventional|||CHS 828 in Treating Patients With Solid Tumors|Phase I and Pharmacokinetics Study to Determine the Safety of CHS 828 in Patients With a Solid Tumor on a Single Oral Dose Repeated Every 3 Weeks|Withdrawn||Phase 1|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:59.386086|2017-10-11 04:25:59.386086
NCT00003980|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||February 1999||1999-02-01|July 2012|2012-07-01||||||||Interventional|||BIBX 1382 in Treating Patients With Solid Tumors|Phase I and Pharmacokinetics Study to Determine the Safety of BIBX 1382 in Patients With a Solid Tumor on a Continuous Daily Oral Administration Schedule and After Single Oral and Intravenous Doses|Suspended||Phase 1|80|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:59.505998|2017-10-11 04:25:59.505998
NCT00003981|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||April 1998||1998-04-01|July 2012|2012-07-01||||||||Interventional|||E7070 in Treating Patients With Solid Tumors|Phase I Study to Determine the Safety of E7070 in Patients With a Solid Tumor as a Single IV Infusion Weekly X 4, Repeated Every 6 Weeks|Completed||Phase 1|30|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:59.616724|2017-10-11 04:25:59.616724
NCT00003982|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||June 1997||1997-06-01|July 2012|2012-07-01||||||||Interventional|||MEN-10755 in Treating Patients With Solid Tumors|Phase I Study to Determine the Safety of MEN-10755 (BMS-195615) in Patients With a Solid Tumor on a Short I.V. Infusion Given Once Every Week for 3 Consecutive Weeks, Followed by One Week's Rest|Completed||Phase 1|30|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:59.713286|2017-10-11 04:25:59.713286
NCT00003984|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||February 1999||1999-02-01|July 2012|2012-07-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome|Phase II Trial With a Recombinant Humanized Anti-CD33 Monoclonal Antibody (HuM195) in Patients With High Risk Primary Myelodysplastic Syndromes|Withdrawn||Phase 2|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:25:59.963352|2017-10-11 04:25:59.963352
NCT00003985|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||September 1998||1998-09-01|July 2012|2012-07-01||||||||Interventional|||KRN7000 in Treating Patients With Solid Tumors|Phase I Study of KRN7000 in Patients With Solid Tumor Treated With a Weekly Intravenous Administration Schedule|Withdrawn||Phase 1|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:26:00.112605|2017-10-11 04:26:00.112605
NCT00003989|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-10|||June 1998||1998-06-01|July 2012|2012-07-01||||||||Interventional|||ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma|Phase II Trial With ISIS 3521/CGP 64128A in Patients With Malignant Melanoma and Non Small Cell Lung Cancer|Completed||Phase 2|50|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:26:00.238387|2017-10-11 04:26:00.238387
NCT00003991|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-11-05|||July 1998||1998-07-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|||||Interventional|||Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia|Multi-Center, Randomized Open-Label Study to Evaluate the Safety and Efficacy of Immunotherapy With Subcutaneous Maxamine (Histamine Dihydrochloride) Plus Proleukin (Interleukin-2) Versus No Treatment (Standard of Care) in Patients With Acute Myeloid Leukemia in First or Subsequent Complete Remission (CR)|Completed||Phase 3|360|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:00.363065|2017-10-11 04:26:00.363065
NCT00003992|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-05-31|||August 1999||1999-08-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|January 2007|Actual|2007-01-01||Interventional|||Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2|Pilot Trial of Paclitaxel-Herceptin Adjuvant Therapy for Early Stage Breast Cancer|Completed||Phase 2|200|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:26:00.722508|2017-10-11 04:26:00.722508
NCT00003993|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2015-04-28|||September 1999||1999-09-01|May 2006|2006-05-01||||July 2008|Actual|2008-07-01||Interventional|||Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma|A Phase lb Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting Cells|Completed||Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:26:00.918629|2017-10-11 04:26:00.918629
NCT00005112|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-15|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Growth Hormone Use in Cystic Fibrosis - a Multicenter Study||Completed||Phase 3|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.88737|2017-10-11 04:26:27.88737
NCT00003995|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||September 1999||1999-09-01|June 2007|2007-06-01||||March 2006|Actual|2006-03-01||Interventional|||Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2|Phase II and Pharmacokinetic Study of CPT-11 and Trastuzumab (RhuMab HER2, Herceptin) in Advanced Colo-Rectal Cancer With p185 HER 2 Overexpression|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:01.168712|2017-10-11 04:26:01.168712
NCT00003996|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2016-12-05|||May 1999||1999-05-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|August 2001|Actual|2001-08-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase II Trial of Pre-irradiation Chemotherapy With BCNU, Cisplatin and Oral Etoposide Combined With Radiation Therapy in the Treatment of Grade 4 Astrocytoma (Glioblastoma)|Completed||Phase 2|93|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:26:01.26458|2017-10-11 04:26:01.26458
NCT00003997|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-02-07|||July 1999||1999-07-01|January 2001|2001-01-01||||October 2000|Actual|2000-10-01||Interventional|||6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia|Phase I Study of MGI-114 (NSC#683863) in Patients With Refractory Myelodysplastic Syndromes, Acute Leukemia and Chronic Myelogenous Leukemia in Blastic Phase (CML-BP)|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:01.367696|2017-10-11 04:26:01.367696
NCT00003998|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-12-18|||October 1998||1998-10-01|October 2007|2007-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer|A Randomized, Prospective Phase III Comparison of Paclitaxel-Carboplatin Versus Docetaxel-Carboplatin as First Line Chemotherapy in Stage Ic-IV Epithelial Ovarian Cancer|Completed||Phase 3|1050|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:01.444511|2017-10-11 04:26:01.444511
NCT00004001|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-21|||October 1999||1999-10-01|February 2014|2014-02-01|January 2007|Actual|2007-01-01|July 2006|Actual|2006-07-01||Interventional|||S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy|Docetaxel and Estramustine Versus Mitoxantrone and Prednisone for Advanced, Hormone Refractory Prostate Cancer|Completed||Phase 3|770|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:26:01.516108|2017-10-11 04:26:01.516108
NCT00004002|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-11-08|||July 1999||1999-07-01|September 2005|2005-09-01||||October 2001|Actual|2001-10-01||Interventional|||PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma|Phase I Trial of PS-341 in Advanced Cancers|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:26:01.642442|2017-10-11 04:26:01.642442
NCT00004003|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||April 1999||1999-04-01|April 2013|2013-04-01|August 2003|Actual|2003-08-01|November 2001|Actual|2001-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery|A Study of Gemcitabine, Cisplatin, and 5-Fluorouracil in the Treatment of Advanced Pancreatic Cancer|Completed||Phase 2|30|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:26:01.882664|2017-10-11 04:26:01.882664
NCT00004004|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||July 1999||1999-07-01|May 2007|2007-05-01|August 2003|Actual|2003-08-01|||||Interventional|||Procarbazine in Treating Patients With Recurrent Brain Tumor|A Phase I/II Study of Oral Procarbazine in the Treatment of Recurrent High Grade Astrocytomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:01.972591|2017-10-11 04:26:01.972591
NCT00004005|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-04-24|||September 1998||1998-09-01|October 2011|2011-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin|Irinotecan and 5-Fluorouracil/Leucovorin for Patients With Colorectal Carcinoma and Other Refractory Tumors|Completed||Phase 2|12|Actual|St. Jude Children's Research Hospital|||||f||||f|t|f||||||||2017-10-11 04:26:02.078241|2017-10-11 04:26:02.078241
NCT00004006|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2011-10-03|||November 1997||1997-11-01|October 2011|2011-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma|Treatment for Extrachoroidal or Metastatic Retinoblastoma|Completed||Phase 2|4|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-10-11 04:26:02.182744|2017-10-11 04:26:02.182744
NCT00004008|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-25|||July 1999||1999-07-01|November 1999|1999-11-01|May 2003|Actual|2003-05-01|||||Interventional|||Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer|A Phase II Trial of Bryostatin 1 in Ovarian Cancer Administered by Weekly 24 Hour Intravenous Infusion|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:02.27867|2017-10-11 04:26:02.27867
NCT00004009|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2017-03-28|||June 1999|Actual|1999-06-01|March 2017|2017-03-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia|A Phase I Study to Determine Biological Endpoints of Up to 21 Day Dosing of the Farnesyltransferase Inhibitor R115777 (IND# 52,302) for Refractory and Relapsed Adult Leukemias (Summary Last Modified 9/1999)|Completed||Phase 1|||University of Maryland|||||f||||||||||||||2017-10-11 04:26:02.372181|2017-10-11 04:26:02.372181
NCT00004010|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-02-25|||October 1999||1999-10-01|February 2014|2014-02-01|June 2008|Actual|2008-06-01|October 2003|Actual|2003-10-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease|Pilot Study for the Treatment of Children With Newly Diagnosed Advanced Stage Hodgkin's Disease: Upfront Dose Intensive Chemotherapy|Completed||Phase 2|99|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:26:02.508061|2017-10-11 04:26:02.508061
NCT00004011|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-01-30|||October 1999||1999-10-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|May 2005|Actual|2005-05-01||Interventional|||S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer|A Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|354|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:26:02.830197|2017-10-11 04:26:02.830197
NCT00004012|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-20|||December 1998||1998-12-01|June 2013|2013-06-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Trial of Oral Capecitabine in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:03.591007|2017-10-11 04:26:03.591007
NCT00004013|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-03-31|||January 1999||1999-01-01|March 2010|2010-03-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer|Treatment of Refractory Stage IV Metastatic Breast Cancer With Weekly Paclitaxel or Weekly Paclitaxel and Herceptin Following Autologous/Syngeneic Stem Cell Transplant|Completed||Phase 2|60|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:26:03.662417|2017-10-11 04:26:03.662417
NCT00004014|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2010-08-13|||April 1999||1999-04-01|August 2010|2010-08-01|November 2001|Actual|2001-11-01|January 2000|Actual|2000-01-01||Interventional|||Liposomal Doxorubicin in Treating Patients With Prostate Cancer|Liposome-Encapsulated Doxorubicin (LED) in Hormone Refractory Prostate Carcinoma, Phase II|Completed||Phase 2|10|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:26:03.737988|2017-10-11 04:26:03.737988
NCT00004015|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2012-07-17|||June 2002||2002-06-01|July 2012|2012-07-01||||July 2003|Actual|2003-07-01||Interventional|||Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery|Postoperative Treatment of Glioblastoma With BNCT at the Petten Irradiation Facility|Completed||Phase 1|36|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:26:03.808713|2017-10-11 04:26:03.808713
NCT00004016|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-06-05|||April 1999||1999-04-01|June 2013|2013-06-01||||||||Interventional|||Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors|Phase I Trial of Immunotherapy With Adenovirus-Interferon- Gamma (TG1041) in Patients With Malignant Melanoma|Completed||Phase 1|||University of Rochester|||||f||||||||||||||2017-10-11 04:26:03.903342|2017-10-11 04:26:03.903342
NCT00004017|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||February 2000||2000-02-01|March 2003|2003-03-01||||||||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma|Phase II Open-Label, Non-Randomized, Multicenter Study of Interstitial 131I-chTNT-1/B for the Treatment of Newly Diagnosed or Recurrent Malignant Glioma|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:03.96242|2017-10-11 04:26:03.96242
NCT00004022|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||June 1997||1997-06-01|April 2013|2013-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma|Immunotherapy for Malignant Melanoma - Phase II Trial of Autologous Cancer Antigen Specific Immunotherapy|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 04:26:04.102937|2017-10-11 04:26:04.102937
NCT00004024|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2013-04-03|||June 1997||1997-06-01|April 2013|2013-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma|Immunotherapy for Malignant Glioma - Phase II Trial of Autologous Cancer Antigen Specific Immunotherapy|Completed||Phase 2|60|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:26:04.179027|2017-10-11 04:26:04.179027
NCT00004025|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2014-01-03|||March 1999||1999-03-01|July 2002|2002-07-01||||||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma|Phase I/II Trial of the Safety, Immunogenicity, and Efficacy of Autologous Dendritic Cells Transduced With Adenoviruses Encoding the MART-1 and gp100 Melanoma Antigens Administered With or Without Low Dose Recombinant Interleukin-2 (rIL-2) in Patients With Stage IV Melanoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:04.262869|2017-10-11 04:26:04.262869
NCT00004026|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-01|2009-02-06|||December 1998||1998-12-01|June 2007|2007-06-01||||||||Interventional|||CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy|A Phase II Study of CT-2584 Mesylate in Patients With Hormone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:04.332464|2017-10-11 04:26:04.332464
NCT00004028|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2009-02-06|||September 1996||1996-09-01|January 1999|1999-01-01||||||||Interventional|||Carmustine in Treating Patients With Recurrent Malignant Glioma|PHASE I, OPEN LABEL, MULTICENTER DOSE ESCALATION STUDY OF GLIADEL IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:04.419442|2017-10-11 04:26:04.419442
NCT00004029|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-02-08|||December 1996||1996-12-01|June 2006|2006-06-01||||May 2006|Actual|2006-05-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer|A PHASE I TRIAL OF RECOMBINANT VACCINIA VIRUS THAT EXPRESSES PSA IN PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:04.506507|2017-10-11 04:26:04.506507
NCT00004030|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-03-22|||March 1996||1996-03-01|January 2001|2001-01-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin|A Phase I/II Study of the Pharmacokinetics, Tolerability and Safety of Administration of VX-853 to Patients Receiving Single Agent Therapy With Doxorubicin HCI|Completed||Phase 1/Phase 2|45|Anticipated|Georgetown University|||||f||||f||||||||||2017-10-11 04:26:04.595972|2017-10-11 04:26:04.595972
NCT00004031|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-05-22|||July 1997||1997-07-01|May 2013|2013-05-01||||July 2010|Actual|2010-07-01||Interventional|||SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma|SWOG-9704 A Randomized Phase III Trial Comparing Early High Dose Chemoradiotherapy and an Autologous Stem Cell Transplant to Conventional Dose CHOP Chemotherapy Plus Rituximab for CD20+ B Cell Lymphomas (With Possible Late Autologous Stem Cell Transplant) for Patients With Diffuse Aggressive Non-Hodgkin's Lymphoma in the High-Intermediate and High Risk International Classification Prognostic Groups|Completed||Phase 3|397|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:26:04.672365|2017-10-11 04:26:04.672365
NCT00004032|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-01-22|||October 1997||1997-10-01|January 2013|2013-01-01||||April 2004|Actual|2004-04-01||Interventional|||Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer|Intraperitoneal (IP) Autologous Therapeutic Tumor Vaccine AUT-OV-ALVAC-h.B7.1 Plus IP rIFN-gamma for Patients With Ovarian Cancer. A Pilot Study|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:04.859064|2017-10-11 04:26:04.859064
NCT00004033|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-03-25|||September 1998||1998-09-01|March 2011|2011-03-01||||May 2001|Actual|2001-05-01||Interventional|||Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma|Phase II Clinical Study of a Liposome Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|30|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:26:04.970293|2017-10-11 04:26:04.970293
NCT00004036|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-12-18|||November 1997||1997-11-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer|Phase I Trial of High Dose Chemotherapy Using Amifostine for In-Vivo Protection of GM-CSF Primed Progenitor Cells|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:05.062285|2017-10-11 04:26:05.062285
NCT00004037|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-04-10|||June 1998||1998-06-01|May 2003|2003-05-01||||April 2003|Actual|2003-04-01||Interventional|||Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer|Evaluation of Docetaxel in Recurrent, Platinum Resistant, Refractory and Paclitaxel Refractory Ovarian Cancer and Primary Peritoneal Carcinoma|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:26:05.194694|2017-10-11 04:26:05.194694
NCT00004038|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-02-06|||January 1999||1999-01-01|June 2001|2001-06-01||||May 2001|Actual|2001-05-01||Interventional|||Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer|Pilot Study of p53 Intralesional Gene Therapy With Chemotherapy in Breast Cancer|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:05.425762|2017-10-11 04:26:05.425762
NCT00004039|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2015-08-17|||June 1998||1998-06-01|August 2015|2015-08-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma|Phase II Trials of CHOP Chemotherapy and Interferon Alpha or Rituximab Anti-CD20 Monoclonal Antibody as Initial Treatment of Patients With Stage III and IV High-Risk Indolent B-Cell Lymphoma and Intermediate Grade B-Cell Lymphoma|Withdrawn||Phase 2|0|Actual|Hoag Memorial Hospital Presbyterian||||No patient accruals|f||||f||||||||||2017-10-11 04:26:05.507918|2017-10-11 04:26:05.507918
NCT00004040|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2015-08-17|||June 1998||1998-06-01|August 2015|2015-08-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy|Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma Whose Disease Has Been Controlled With Chemotherapy: Rituximab Anti-CD20 Monoclonal Antibody or Interferon Alpha 2-b as Maintenance Therapy|Withdrawn||Phase 2|0|Actual|Hoag Memorial Hospital Presbyterian||||no patient accruals|f||||f||||||||||2017-10-11 04:26:05.61191|2017-10-11 04:26:05.61191
NCT00004041|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2009-02-06|||March 1999||1999-03-01|December 2002|2002-12-01||||||||Interventional|||Gene Therapy in Treating Patients With Recurrent Malignant Gliomas|Phase I Trial of Adenovirus-Mediated Wild-Type P53 Gene Therapy for Malignant Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:05.695564|2017-10-11 04:26:05.695564
NCT00004042|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-07-17|||November 1998||1998-11-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|July 2001|Actual|2001-07-01||Interventional|||Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer|A Phase I Dose-Escalation Study of BIBH-1 in Patients With Advanced or Metastatic Fibroblast Activation Protein-Positive Cancer|Completed||Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:05.782668|2017-10-11 04:26:05.782668
NCT00004043|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2017-04-26|||February 1999||1999-02-01|April 2017|2017-04-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer|Phase II Study of Pulse Calcitriol in Patients With Rising PSA After Definitive Treatment for Prostate Cancer|Completed||Phase 2|25|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 04:26:05.855596|2017-10-11 04:26:05.855596
NCT00004045|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-15|||June 1999||1999-06-01|May 2012|2012-05-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Chemotherapy in Treating Patients With Prostate Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:26:05.926349|2017-10-11 04:26:05.926349
NCT00004046|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-05-15|||June 1999||1999-06-01|May 2012|2012-05-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Chemotherapy in Treating Women With Metastatic Breast Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Metastatic Adenocarcinoma of the Breast|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:26:06.000016|2017-10-11 04:26:06.000016
NCT00004047|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-15|||June 1999||1999-06-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Chemotherapy in Treating Patients Who Have Hematologic Cancer|A Phase I Study of Intravenous DX-8951f in Patients With Advanced Myelodysplastic Syndromes, Refractory Acute Leukemia, Refractory or Transformed Chronic Lymphocytic Leukemia, and Chronic Myelogenous Leukemia in Blastic Phase|Completed||Phase 1|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:26:06.074215|2017-10-11 04:26:06.074215
NCT00004048|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-06-21|||September 1998||1998-09-01|June 2011|2011-06-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer|Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 Alone or Combined With Doxorubicin and Peripheral Blood Stem Cell Rescue (PBSCR) in Medullary Thyroid Cancer (MTC) Grant Application Title: Radioimmunotherapy of MTC With Y-90 Humanized MN14 Anti-CEA Mab and Doxorubicin|Completed||Phase 1/Phase 2|30|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology|||||f||||||||||||||2017-10-11 04:26:06.161542|2017-10-11 04:26:06.161542
NCT00004049|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2008-07-23|||April 1999||1999-04-01|May 2001|2001-05-01||||||||Interventional|||SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I and Pharmacokinetic Study of SR-45023A Administered Once Every 7 Days|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:06.243013|2017-10-11 04:26:06.243013
NCT00004050|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2014-07-25|||June 1999||1999-06-01|July 2014|2014-07-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer|Phase II Study Evaluating the Safety and Efficacy of Neoadjuvant Leuvectin Immunotherapy for the Treatment of Prostate Cancer|Terminated||Phase 2|13|Actual|Vical||1||Development in prostate cancer indication halted|f||||f||||||||||2017-10-11 04:26:06.29548|2017-10-11 04:26:06.29548
NCT00004051|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-12-18|||August 1998||1998-08-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|July 2001|Actual|2001-07-01||Interventional|||Irinotecan in Treating Patients With Advanced Solid Tumors|A Phase I Study to Evaluate Orally Administered Irinotecan HCL (CPT-11) Given as a Powder-Filled Capsule Formulation Daily for 14 Days Every Three Weeks in Patients With Advanced Solid Tumors|Completed||Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:06.370104|2017-10-11 04:26:06.370104
NCT00004052|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-24|||March 1999||1999-03-01|June 2013|2013-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia|Phase II, Multicenter Vaccination of Patients With Chronic Myelogenous Leukemia With a Multivalent Tumor Specific Breakpoint Peptide Vaccine|Completed||Phase 2|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:06.555511|2017-10-11 04:26:06.555511
NCT00004054|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2014-12-24|2014-12-24||January 2000||2000-01-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|April 2010|Actual|2010-04-01||Interventional||All eligible patients|Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer|A Phase III Protocol of Androgen Suppression (AS) and Radiation Therapy (RT) vs AS and RT Followed by Chemotherapy With Paclitaxel, Estramustine, and Etoposide (TEE) for Localized, High-Risk, Prostate Cancer|Completed||Phase 3|397|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:26:06.63124|2017-10-11 04:26:06.63124
NCT00004055|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2016-07-12|||November 1999||1999-11-01|July 2016|2016-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|38|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:26:07.368156|2017-10-11 04:26:07.368156
NCT00004056|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2014-07-24|||October 1999||1999-10-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|October 2002|Actual|2002-10-01||Interventional|||Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia|Treatment of Newly Diagnosed Childhood AML Using a Timed-Sequential Remission Induction and Consolidation Followed by Single Dose Melphalan With Peripheral Stem Cell Rescue: A POG Pilot Study|Completed||Phase 1|35|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:26:07.526073|2017-10-11 04:26:07.526073
NCT00004057|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-20|||December 1998||1998-12-01|June 2013|2013-06-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas|A Phase I and Pharmacokinetic Study Evaluating the Safety, Tolerability, and Maximally Tolerated Dose of Combination Therapy With Paclitaxel and L-778,123 in Patients With Recurrent or Refractory Solid Malignancies|Completed||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:07.698557|2017-10-11 04:26:07.698557
NCT00004058|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2010-01-25|||December 1998||1998-12-01|January 2010|2010-01-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder|Phase I Study of 12-O-tetradecanoylphorbol-13-acetate (TPA) in Patients With Refractory Hematologic Malignancies/Bone Marrow Disorders|Terminated||Phase 1|||Rutgers, The State University of New Jersey||||At this time it is felt that we will not gain further information from an additional patients.|f||||t||||||||||2017-10-11 04:26:07.770791|2017-10-11 04:26:07.770791
NCT00004059|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-20|||July 1999||1999-07-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors|A Phase I Study of the Cyclin-Dependent Kinase (CDK)/Protein Kinase C (PKC) Inhibitor UCN-01 (NSC 638850) in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:07.880896|2017-10-11 04:26:07.880896
NCT00004060|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-15|||July 1999||1999-07-01|May 2012|2012-05-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane and Topotecan|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:26:07.950252|2017-10-11 04:26:07.950252
NCT00004061|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-25|||May 1999||1999-05-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|May 2003|Actual|2003-05-01||Interventional|||Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer|A Randomized Double-Blind, Placebo-Controlled Trial of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Patients With Hematologic Malignancies Undergoing Total Body Irradiation (TBI) and High-Dose Chemotherapy With Autologous Peripheral Blood|Completed||Phase 2|111|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:08.023192|2017-10-11 04:26:08.023192
NCT00004062|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-12-18|||July 1999||1999-07-01|May 2004|2004-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer|Restoration of Radioiodine Uptake in Thyroid Carcinoma: A Clinical Trial|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:08.142175|2017-10-11 04:26:08.142175
NCT00004063|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2009-04-29|||August 1999||1999-08-01|December 2008|2008-12-01||||November 2011|Anticipated|2011-11-01||Interventional|||Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer|A Phase I-II Clinical Trial of Cisplatin (Platinol) Followed by Gemcitabine HCl (Gemzar) in Combination With Mild, Fever-Range Whole Body Hyperthermia (LL-WBH) at 40C in Patients With Advanced Malignancies|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:08.209806|2017-10-11 04:26:08.209806
NCT00004064|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-11-05|||November 1998||1998-11-01|June 2007|2007-06-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase IIB Study of the Safety and Efficacy of OVAREX MabB43.13 in Ovarian Cancer Patients With an Elevated Serum CA 125 But Without Other Evidence of Disease|Unknown status|Active, not recruiting|Phase 2|102|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:08.293863|2017-10-11 04:26:08.293863
NCT00004065|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-20|||July 1999||1999-07-01|June 2013|2013-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer|A Phase I Trial of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AAG, NSC #330507) Daily X 5 in Patients With Advanced Cancer Therapeutic Protocol|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:08.391354|2017-10-11 04:26:08.391354
NCT00005139|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-19|||July 1977||1977-07-01|January 2016|2016-01-01|December 1991||1991-12-01|||||Observational|||Characterization Of Coronary Prone Pedigrees||Completed||N/A|||University of Utah|||||f||||||||||||||2017-10-11 04:26:31.748405|2017-10-11 04:26:31.748405
NCT00004066|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-03-06|||June 1999||1999-06-01|March 2013|2013-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma|A Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma|Completed||Phase 2|82|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:08.496296|2017-10-11 04:26:08.496296
NCT00004067|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2016-03-22|||February 2000||2000-02-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2005|Actual|2005-03-01||Interventional|||Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2|A Randomized Trial Comparing the Safety and Efficacy of Adriamycin and Cyclophosphamide Followed by Taxol (AC-T) to That of Adriamycin and Cyclophosphamide Followed by Taxol Plus Herceptin (AC-T+H) in Node-Positive Breast Cancer Patients Who Have Tumors That Overexpress HER2|Active, not recruiting||Phase 3|2130|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-10-11 04:26:08.601125|2017-10-11 04:26:08.601125
NCT00004068|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-10-03|||March 1999||1999-03-01|October 2011|2011-10-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor|Treatment of Newly Diagnosed High-Grade Gliomas in Patients Ages Greater Than or Equal to 3 and Less Than or Equal to 21 Years With a Phase II Irinotecan Window Followed by Radiation Therapy and Temozolomide|Completed||Phase 2|53|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-10-11 04:26:08.970859|2017-10-11 04:26:08.970859
NCT00004070|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2017-04-19|||July 1999|Actual|1999-07-01|April 2017|2017-04-01|December 2000|Actual|2000-12-01|November 2000|Actual|2000-11-01||Interventional|||Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer|A Multi-Center, Open-Label, Multiple Administration, Rising Dose Study of the Safety, Tolerability, and Efficacy of IL-12 Gene Medicine in Patients With Unresectable or Recurrent/Refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 1/Phase 2|7|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||No||2017-10-11 04:26:09.045451|2017-10-11 04:26:09.045451
NCT00004071|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-09-10|||August 1999||1999-08-01|September 2012|2012-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer|A Randomized, Open-Label Phase II/III Study of SU101 Plus Mitoxantrone/Prednisone Compared to Mitoxantrone/Prednisone Alone in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2/Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 04:26:09.154122|2017-10-11 04:26:09.154122
NCT00004072|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2010-06-09|||September 1999||1999-09-01|June 2010|2010-06-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma|Phase II Trial of O6-Benzylguanine (NSC 637037) and BCNU in Patients With Multiple Myeloma|Completed||Phase 2|17|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:26:09.218433|2017-10-11 04:26:09.218433
NCT00004073|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-01|||December 1999||1999-12-01|May 2012|2012-05-01|June 2004|Actual|2004-06-01|May 2003|Actual|2003-05-01||Interventional|||Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study of Suramin and Concurrent Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|54|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:26:09.288482|2017-10-11 04:26:09.288482
NCT00004074|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-02-27|||August 1999||1999-08-01|February 2013|2013-02-01||||February 2009|Actual|2009-02-01||Interventional|||Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu|A Phase I Trial of Herceptin and Interleukin-12|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:09.37671|2017-10-11 04:26:09.37671
NCT00004075|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-08-02|||August 1999||1999-08-01|August 2011|2011-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery|A Phase I Trial of 17-Allylaminogeldanamycin (17-AAG) in Solid Tumor and Lymphoma Patients|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:26:09.611947|2017-10-11 04:26:09.611947
NCT00004076|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-12-18|||June 1999||1999-06-01|November 2000|2000-11-01||||||||Interventional|||PNU 166148 in Treating Patients With Metastatic Solid Tumors|A Phase I Study to Evaluate MAG-CPT (PNU 166148) Given as One Single Intravenous Administration Every 4 Weeks in Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:09.674923|2017-10-11 04:26:09.674923
NCT00004077|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-12-18|||May 1996||1996-05-01|January 2001|2001-01-01|July 2005|Actual|2005-07-01|||||Interventional|||Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer|A Study of Paclitaxel, Cisplatin and Ifosfamide as Induction Therapy in the Treatment of Patients Relapsing After BEP Chemotherapy for Metastatic Germ Cell Tumors|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:09.736661|2017-10-11 04:26:09.736661
NCT00004078|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-13|||October 1999||1999-10-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||Irinotecan in Treating Children With Refractory Solid Tumors|Phase II Trial of Irinotecan in Children With Refractory Solid Tumors|Completed||Phase 2|181|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:26:09.801097|2017-10-11 04:26:09.801097
NCT00004079|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-01-31|||August 1999||1999-08-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Trial of Sarcosinamide Nitrosourea (SarCNU) in Patients With Solid Tumors|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:09.888125|2017-10-11 04:26:09.888125
NCT00004080|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2009-02-06|||December 1999||1999-12-01|August 2001|2001-08-01||||||||Interventional|||Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors|Assessment of the Safety and Transduction Efficiency of SCH58500, An Adenoviral Vector p53 Delivery System, to Patients With Recurrent Malignant Brain Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:09.976453|2017-10-11 04:26:09.976453
NCT00004081|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-08-09|||July 1999||1999-07-01|August 2012|2012-08-01|March 2003|Actual|2003-03-01|January 2002|Actual|2002-01-01||Interventional|||Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Trial of Weekly, Low-Dose Docetaxel (Taxotere) in Patients With Platinum-Resistant Epithelial Ovarian or Primary Peritoneal Serous Cancer|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute|||||f||||f||||||||||2017-10-11 04:26:10.039644|2017-10-11 04:26:10.039644
NCT00004082|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-25|||July 1999||1999-07-01|November 2010|2010-11-01|December 2010|Actual|2010-12-01|September 2003|Actual|2003-09-01||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors|A Phase I Study of Docetaxel (Taxotere), Carboplatin, and Gemcitabine (DoCaGem) as First-Line Therapy for Patients With High-Risk Epithelial Tumors of Mullerian Origin|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:10.220836|2017-10-11 04:26:10.220836
NCT00004083|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-03-25|||February 1999||1999-02-01|March 2011|2011-03-01||||December 1999|Actual|1999-12-01||Interventional|||Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer|A Phase II Pilot Study of SPI-77 (Stealth Liposomal Cisplatin) in Patients With Recurrent Platinum-Sensitive Ovarian Cancer|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:26:10.796665|2017-10-11 04:26:10.796665
NCT00004084|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-06-21|||April 1998||1998-04-01|June 2011|2011-06-01||||May 2002|Actual|2002-05-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia|Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immu-LL2: Treatment With 90Y-hLL2 IgG|Completed||Phase 1/Phase 2|21|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||||||||||||2017-10-11 04:26:10.890382|2017-10-11 04:26:10.890382
NCT00004085|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-06-21|||May 1998||1998-05-01|June 2011|2011-06-01||||May 2002|Actual|2002-05-01||Interventional|||Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer|Phase I/II Trial of High-Dose Radioimmunotherapy With a 90Y-Humanized MN-14 Anti-Carcinoembryonic Antigen (CEA) Antibody for the Treatment of Stage IV Breast Cancer|Completed||Phase 1/Phase 2|15|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||||||||||||2017-10-11 04:26:11.011167|2017-10-11 04:26:11.011167
NCT00004086|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2009-06-06|||June 1997||1997-06-01|December 2001|2001-12-01||||||||Interventional|||Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer|A Phase I Trial of a Combined Regimen of Chemotherapy and 90Y-Labeled, Humanized LL2 (Anti-CD22) Antibody With Peripheral Stem Cell Rescue for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:11.123924|2017-10-11 04:26:11.123924
NCT00004087|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-06-21|||March 1997||1997-03-01|June 2011|2011-06-01||||May 2001|Actual|2001-05-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer|Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 in Advanced Metastatic Colorectal Cancer and Pancreatic Cancers Using Autologous Peripheral Blood Stem Cell Rescue (PBSCR) to Control Myelotoxicity|Completed||Phase 1/Phase 2|15|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||f||||||||||2017-10-11 04:26:11.245551|2017-10-11 04:26:11.245551
NCT00004088|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2017-03-01|||April 13, 1999|Actual|1999-04-13|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma|Sequential High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Peripheral Blood Progenitor Cell Rescue, Interferon/Thalidomide and Pamidronate for Patients With Multiple Myeloma|Active, not recruiting||Phase 2|70|Anticipated|City of Hope Medical Center||1|||f||||||||||||||2017-10-11 04:26:11.350011|2017-10-11 04:26:11.350011
NCT00004089|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-07-09|||August 1999||1999-08-01|January 2011|2011-01-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer|A Multicenter Phase II Study of Intensified Concomitant Chemoradiotherapy for Patients With Anaplastic Thyroid Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:11.470435|2017-10-11 04:26:11.470435
NCT00004090|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-07-09|||August 1999||1999-08-01|January 2011|2011-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors|Gemcitabine (10 mg/m2/Min) and Cisplatin: A Phase I Study|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:11.570091|2017-10-11 04:26:11.570091
NCT00004091|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-01-27|||August 1999||1999-08-01|January 2011|2011-01-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Observational|||Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results|Development of Antibody-Based Diagnostic Markers for Abnormal Cervical Cells|Completed||N/A|100|Anticipated|Northwestern University|||1||f||||||||||||||2017-10-11 04:26:11.653694|2017-10-11 04:26:11.653694
NCT00004092|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2015-07-07|2015-07-07||May 1999||1999-05-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer|Randomized Phase II Study of Adriamycin/Cytoxan/Taxol (ACT) vs. Cytoxan, Thiotepa, Carboplatin (STAMP V) in Patients With High-Risk Primary Breast Cancer|Completed||Phase 2|72|Actual|City of Hope Medical Center||2|||f||||||||||||||2017-10-11 04:26:11.748526|2017-10-11 04:26:11.748526
NCT00004093|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-31||2011-05-25|August 1999||1999-08-01|May 2012|2012-05-01|March 2002|Actual|2002-03-01|February 2002|Actual|2002-02-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer|A Phase I-II Study of Induction Chemotherapy With Carboplatin and Gemcitabine, Followed by Chemoradiotherapy With Paclitaxel and Vinorelbine for Patients With Locally Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|36|Actual|Northwestern University||1||Original Principal Investigator left the institution.|f||||||||||||||2017-10-11 04:26:12.537972|2017-10-11 04:26:12.537972
NCT00004094|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2014-01-03|||August 1999||1999-08-01|December 2002|2002-12-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx|A Phase II Study of Induction Chemotherapy Followed by Concomitant Paclitaxel (1 Hour Infusion), Fluorouracil, Hydroxyurea and Hyperfractionated Radiotherapy for Advanced Oral, Pharynx and Larynx Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:12.633374|2017-10-11 04:26:12.633374
NCT00004095|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2017-04-14|||August 1999||1999-08-01|April 2017|2017-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors|Phase I Trial of Irinotecan (CPT-11) and Gemcitabine in Patients With Solid Tumors|Completed||Phase 1|38|Actual|Northwestern University||1|||f||||||||||||||2017-10-11 04:26:12.72183|2017-10-11 04:26:12.72183
NCT00004096|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-31||2011-01-28|August 1999||1999-08-01|May 2012|2012-05-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase I/II Study of Carboplatin and Navelbine for Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:26:12.824417|2017-10-11 04:26:12.824417
NCT00004097|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-09-19|||August 1999||1999-08-01|October 2001|2001-10-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer|A Phase I Study of Concomitant Chemoradiotherapy With Gemcitabine, Paclitaxel, and 5-FU for Patients With Advanced and/or Recurrent Cancer of the Head and Neck|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:12.906979|2017-10-11 04:26:12.906979
NCT00004099|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-09-20|||July 1999||1999-07-01|September 2012|2012-09-01||||February 2004|Actual|2004-02-01||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer|Randomized Phase III Study of Preoperative Chemotherapy Followed by Surgery Versus Surgery Alone in Locally Advanced Gastric Cancer (cT3 and cT4NxM0)|Terminated||Phase 3|144|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:26:13.000138|2017-10-11 04:26:13.000138
NCT00004100|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-12-17|||November 1998||1998-11-01|June 2008|2008-06-01||||||||Interventional|||Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Gemcitabine and Vinorelbine vs Standard Chemotherapy Containing Cisplatin for Stage IIIB/IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:13.14507|2017-10-11 04:26:13.14507
NCT00004101|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-02-08|||November 1999||1999-11-01|May 2001|2001-05-01||||June 2005|Actual|2005-06-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma|Phase I Trial of Humanized 1D10 Monoclonal Antibody (Hu1D10) In Patients With Relapsed Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:13.420218|2017-10-11 04:26:13.420218
NCT00004102|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-03-25|||January 1999||1999-01-01|March 2011|2011-03-01||||November 2001|Actual|2001-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|A Phase II Trial of Eloxatin in Combination With 5-Fluorouracil and Leucovorin in Patients With Advanced Colorectal Carcinoma|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:26:13.516938|2017-10-11 04:26:13.516938
NCT00004103|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-04-05|||July 1998||1998-07-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|March 2007|Actual|2007-03-01||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer|A Phase II Study of Systemic Therapy With CPT-11 (Camptosar HCl) and Cisplatin in Patients With Advanced Gastric Cancer to be Followed by Surgical Resection and Postoperative Intraperitoneal Chemotherapy|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:26:13.591159|2017-10-11 04:26:13.591159
NCT00004104|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2016-03-30|||June 1998||1998-06-01|March 2016|2016-03-01||||July 2000|Actual|2000-07-01||Interventional|||Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma|Phase II Trial of the Effects of Interferon Alfa-2b on the Immunogenicity of a Polyvalent Melanoma Antigen Vaccine in Patients With Stage III Malignant Melanoma|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:26:13.658444|2017-10-11 04:26:13.658444
NCT00004105|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-03-25|||September 1998||1998-09-01|March 2011|2011-03-01||||April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I/II Study of Paclitaxel, Estramustine Phosphate, and Vinorelbine (PaclEVin)|Completed||Phase 1/Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:26:13.718994|2017-10-11 04:26:13.718994
NCT00004106|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-31||2011-07-01|May 1998||1998-05-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome|Phase II Trial of Temozolomide for the Treatment of Mycosis Fungoides and the Sezary Syndrome|Terminated||Phase 2|29|Actual|Northwestern University||1||Per Data Monitoring Committee given the poor/inadequate accrual.|f||||||||||||||2017-10-11 04:26:13.798146|2017-10-11 04:26:13.798146
NCT00004107|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2011-06-21|||February 1998||1998-02-01|June 2011|2011-06-01||||May 2001|Actual|2001-05-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia|Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With High-Dose 90Y-Labeled Humanized LL2 Anti-CD-22 Antibody and Peripheral Blood Stem Cell Rescue|Completed||Phase 1/Phase 2|18|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||||||||||||2017-10-11 04:26:13.89886|2017-10-11 04:26:13.89886
NCT00004108|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-05-15|||September 1999||1999-09-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||DX-8951f in Treating Patients With Liver Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Hepatocellular Carcinoma|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:26:13.984063|2017-10-11 04:26:13.984063
NCT00004109|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-08-01|||March 1998||1998-03-01|August 2012|2012-08-01|April 2011|Actual|2011-04-01|September 2001|Actual|2001-09-01||Interventional|||Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma|A Phase I Study of Preoperative Concurrent Chemoradiation for High-Risk Extremity and Trunk Soft Tissue Sarcomas|Completed||Phase 1|30|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:26:14.05248|2017-10-11 04:26:14.05248
NCT00004110|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-10-30|||August 1999||1999-08-01|October 2013|2013-10-01||||September 2004|Actual|2004-09-01||Interventional|||Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma|Monoclonal Antibody 3F8 and Oral Etoposide for the Treatment of Neuroblastoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:14.14132|2017-10-11 04:26:14.14132
NCT00004112|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2010-04-13|||September 1999||1999-09-01|April 2010|2010-04-01|March 2003|Actual|2003-03-01|December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma|A Phase III Randomized Trial of CHOP Chemotherapy Plus Rituxan (IDEC-C2B8) Versus CHOP Chemotherapy Alone for Newly Diagnosed, Previously Untreated, Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 3|||University of Nebraska|||||f||||f||||||||||2017-10-11 04:26:14.201328|2017-10-11 04:26:14.201328
NCT00005136|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-03-14|||June 1992||1992-06-01|March 2014|2014-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Family Heart Study (FHS)||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:26:31.459804|2017-10-11 04:26:31.459804
NCT00004113|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-18|||June 1999||1999-06-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Temozolomide in Treating Patients With Recurrent Malignant Glioma|A Phase II Study of Temozolomide (SCH 52365, Temodal(R)) for the Treatment of Recurrent Malignant Glioma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:14.279661|2017-10-11 04:26:14.279661
NCT00004114|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2015-09-30||||||July 2012|2012-07-01||||||||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer|Non-Myeloablative Chemotherapy Followed by Unrelated Allogeneic Stem Cell Transplantation in Patients With Advanced Hematologic Malignancies: A Pilot Study|Withdrawn||Phase 1|0|Actual|Jonsson Comprehensive Cancer Center||||Study never opened|f||||||||||||||2017-10-11 04:26:14.339417|2017-10-11 04:26:14.339417
NCT00004115|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-09-16|||December 1998||1998-12-01|April 2003|2003-04-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy|Multicenter Randomized Survival Study of Monoclonal Antibody Radioimmunotherapy: A Multinational Study in Patients With Ovarian Carcinoma Using the HMFG1 Antibody Labeled With 90Yttrium|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:14.4164|2017-10-11 04:26:14.4164
NCT00004122|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-01-31|||July 1999||1999-07-01|January 2013|2013-01-01||||April 2001|Actual|2001-04-01||Interventional|||BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer|A National Phase II Trial of Intron (Interferon-alfa 2b) Plus BCG for Treatment of Superficial Bladder Cancer|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:26:14.474876|2017-10-11 04:26:14.474876
NCT00004123|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-07-27|||July 1997||1997-07-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|July 2001|Actual|2001-07-01||Interventional|||Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma|A Phase I Study of Preoperative Chemoradiation and Intraoperative Radiation Therapy in the Treatment of Retroperitoneal Sarcoma|Completed||Phase 1|36|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:26:14.543043|2017-10-11 04:26:14.543043
NCT00004124|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2017-07-13|||October 1999||1999-10-01|July 2017|2017-07-01|June 1, 2022|Anticipated|2022-06-01|June 2017|Actual|2017-06-01||Interventional|||S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer|Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High-Risk Prostate Cancer Patients Following Radical Prostatectomy|Terminated||Phase 3|983|Actual|Southwest Oncology Group||2||Permanently Closed Due to Safety Issue|f||||t||||||||||2017-10-11 04:26:16.114293|2017-10-11 04:26:16.114293
NCT00004125|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2010-01-28|||October 1999||1999-10-01|January 2010|2010-01-01||||May 2007|Actual|2007-05-01||Interventional|||Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes|A Phase III Study of Doxorubicin-Cyclophosphamide Therapy Followed by Paclitaxel or Docetaxel Given Weekly or Every 3 Weeks in Patients With Axillary Node-Positive Breast Cancer|Completed||Phase 3|||Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-10-11 04:26:16.863476|2017-10-11 04:26:16.863476
NCT00004126|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-02-08|||November 1999||1999-11-01|February 2013|2013-02-01|August 2003|Actual|2003-08-01|January 2001|Actual|2001-01-01||Interventional|||Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer|A Phase II Study of Oxaliplatin in Combination With Paclitaxel in Non-Small Cell Lung Cancer|Completed||Phase 2|38|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:26:17.033253|2017-10-11 04:26:17.033253
NCT00004127|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-02-08|||February 2000||2000-02-01|February 2013|2013-02-01|August 2003|Actual|2003-08-01|October 2002|Actual|2002-10-01||Interventional|||Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach|A Phase II Study of Oxaliplatin in Combination With Fluorouracil and Leucovorin in Carcinoma of the Esophagus and Gastric Cardia|Completed||Phase 2|35|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:26:17.138899|2017-10-11 04:26:17.138899
NCT00004128|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2009-12-22|||September 1999||1999-09-01|April 2008|2008-04-01||||January 2008|Anticipated|2008-01-01||Interventional|||Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia|The Value of High Dose Versus Standard Dose ARA-C During Induction and of IL-2 After Intensive Consolidation/Autologous Stem Cell Transplantation in Patients (Age 15-60 Years) With Acute Myelogenous Leukemia. A Randomized Phase II Trial of the EORTC and the GIMEMA-ALWP|Unknown status|Active, not recruiting|Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:17.247021|2017-10-11 04:26:17.247021
NCT00004129|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-09-16|||September 1999||1999-09-01|April 2008|2008-04-01||||||||Interventional|||Phosphorus 32 in Treating Patients With Glioblastoma Multiforme|Phase I/II Study of Interstitial Colloidal 32P for the Treatment of Recurrent Malignant Central Nervous System Tumors and Primary Central Nervous System Tumors With Poor Prognostic Factors|Unknown status|Recruiting|Phase 1|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:17.342548|2017-10-11 04:26:17.342548
NCT00004132|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-06-25|||January 2000||2000-01-01|June 2007|2007-06-01|May 2004|Actual|2004-05-01|||||Interventional|||Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer|A Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Patients With Hematologic Malignancies Undergoing Total Body Irradiation (TBI) and High-Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell (PBPC) Transplantation|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:17.524317|2017-10-11 04:26:17.524317
NCT00004135|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2014-03-06|||February 1999||1999-02-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|October 2004|Actual|2004-10-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer|Allogeneic Stem Cell Transplantation of Renal Cell Cancer and Metastatic Melanoma After Non-Myeloablative Chemotherapy|Completed||Phase 2|19|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:26:17.653067|2017-10-11 04:26:17.653067
NCT00004136|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2012-07-27|||November 1999||1999-11-01|July 2012|2012-07-01|January 2006|Actual|2006-01-01|April 2000|Actual|2000-04-01||Interventional|||Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer|A Phase II Study of Radiofrequency Ablation of Unresectable Liver Tumors|Completed||Phase 2|59|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:26:17.742343|2017-10-11 04:26:17.742343
NCT00005372|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-15|||January 1994||1994-01-01|January 2016|2016-01-01|February 2005||2005-02-01|||||Observational|||Intimal Thickening and Antioxidants in Hispanics and Anglos (Los Angeles Atherosclerosis Study)||Completed||N/A|||University of Southern California|||||f||||||||||||||2017-10-11 04:28:04.193188|2017-10-11 04:28:04.193188
NCT00004137|ClinicalTrials.gov processed this data on October 10, 2017|1999-12-10|2013-02-12|||October 1999||1999-10-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|March 2004|Actual|2004-03-01||Interventional|||S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Paclitaxel, Carboplatin and Topotecan With G-CSF in Untreated Patients With Extensive Small Cell Lung Cancer|Completed||Phase 2|88|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:26:17.834458|2017-10-11 04:26:17.834458
NCT00005005|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-24|2013-02-04|||October 1999||1999-10-01|February 2013|2013-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis|Clinical Trial of Parathyroid Hormone (PTH) and Alendronate in Combination in the Treatment of Osteoporosis|Completed||Phase 2|238|Actual|University of California, San Francisco||4|||f||||||||||||||2017-10-11 04:26:18.109634|2017-10-11 04:26:18.109634
NCT00005006|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-24|2015-08-17|||September 1987||1987-09-01|August 2015|2015-08-01|December 2006|Actual|2006-12-01|February 2003|Actual|2003-02-01||Interventional|||Parathyroid Hormone (PTH) With Alendronate for Osteoporosis|Cyclical vs Daily Continuous PTH in Combination With Alendronate vs Alendronate Alone|Completed||Phase 2|140|Actual|Helen Hayes Hospital||3|||f||||f||||||||||2017-10-11 04:26:18.203094|2017-10-11 04:26:18.203094
NCT00005007|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-24|2007-12-19|||June 2000||2000-06-01|December 2007|2007-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Etanercept for Wegener's Granulomatosis|Wegener's Granulomatosis Etanercept Trial (WGET)|Completed||Phase 2/Phase 3|181||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-10-11 04:26:18.307047|2017-10-11 04:26:18.307047
NCT00005009|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-28|2017-02-14|||February 1998||1998-02-01|February 2017|2017-02-01|June 16, 2001|Actual|2001-06-16|June 16, 2001|Actual|2001-06-16||Interventional|||Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients|Evaluation of the Safety and Immunogenicity of Varivax® (Live-Attenuated Varicella-Zoster Virus Vaccine) in Pediatric Renal Transplant Recipients|Terminated||Phase 1|7|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Slow enrollment|f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 04:26:18.409938|2017-10-11 04:26:18.409938
NCT00005010|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-28|2013-01-23||||||January 2013|2013-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Prevention of Kidney Transplant Rejection|An Interventional Trial in Established Chronic Renal Allograft Rejection|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||t||||||||||2017-10-11 04:26:18.5104|2017-10-11 04:26:18.5104
NCT00005011|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-29|2017-10-05|||March 28, 2000||2000-03-28|October 28, 2016|2016-10-28|October 28, 2016||2016-10-28|||||Observational|||Combined Hormone Replacement in Menstrually-Related Mood Disorders|The Treatment of Menstrually-Related Mood Disorders With Continuous Gonadal Steroid Replacement|Completed||N/A|22|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:18.571347|2017-10-11 04:26:18.571347
NCT00005012|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-29|2005-06-23|||March 2000||2000-03-01|August 2000|2000-08-01|September 2000||2000-09-01|||||Interventional|||Safety and Effectiveness of PEG-Intron in HIV-Infected Patients|Antiviral Activity and Tolerability of PEG-Intron in HIV-Infected Subjects Failing HAART|Completed||Phase 2|250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:18.633253|2017-10-11 04:26:18.633253
NCT00005013|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-31|2014-04-07|||December 1998||1998-12-01|March 2006|2006-03-01|July 2001|Actual|2001-07-01|||||Interventional|||Treatment of Major Depression With St. John's Wort (Hypericum)|A Placebo Controlled Clinical Trial of a Standardized Extract of Hypericum Perforatum in Major Depressive Disorder|Completed||N/A|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:26:18.730063|2017-10-11 04:26:18.730063
NCT00005014|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-31|2014-04-16|||October 1997||1997-10-01|August 2010|2010-08-01|February 2001||2001-02-01|||||Interventional|||Treatment of Autism in Children and Adolescents|Placebo-Controlled Study of Risperidone for the Treatment of Children and Adolescents With Autism and Negative Behavioral Symptoms|Completed||Phase 3|101|Actual|National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:26:18.819095|2017-10-11 04:26:18.819095
NCT00005015|ClinicalTrials.gov processed this data on October 10, 2017|2000-03-31|2005-11-17||||||November 2000|2000-11-01|September 2000||2000-09-01|||||Interventional|||Treatment of Depression in Youth With Bipolar Disorders|Fluoxetine for the Treatment of Major Depression in Youth With Bipolar Disorder _|Terminated||Phase 3|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:26:18.891928|2017-10-11 04:26:18.891928
NCT00005016|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-04|2008-03-03|||March 2000||2000-03-01|March 2000|2000-03-01|February 2001||2001-02-01|||||Observational|||Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly|The Experiences and Needs of Parents Continuing a Pregnancy Following Abnormal Prenatal Results: The Case of Holoprosencephaly|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:18.962894|2017-10-11 04:26:18.962894
NCT00005017|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-03|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment|A Phase IV, Open-Label, Randomized Study to Compare the Efficacy and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) for 96 Weeks in the Treatment of HIV-1 Infected Subjects Who Are Antiretroviral Therapy Naive|Unknown status|Active, not recruiting|Phase 4|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:19.179644|2017-10-11 04:26:19.179644
NCT00005018|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-04|2005-06-23|||July 1999||1999-07-01|August 2000|2000-08-01|October 2000||2000-10-01|||||Interventional|||Safety and Effectiveness of a Combination Anti-HIV Drug Treatment|A Phase IV 48-Week, Randomized, Open-Label, Multicenter Trial of Abacavir (300mg BID)/Efavirenz (600mg QD)/Didanosine (400mg QD) +/- Hydroxyurea (500mg BID) in HIV-1 Infected Subjects Failing Initial Therapy With 3TC/ZDV (or d4T) +/- Protease Inhibitor(s)|Completed||Phase 4|150||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:19.255715|2017-10-11 04:26:19.255715
NCT00005020|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2010-03-24||||||December 2004|2004-12-01||||||||Observational|||Observing Patients With Early HIV Infection|An Observational Study of Viral and Immune Dynamics in Subjects With Acute HIV Infection: A Study of the UCSD Acute/Early HIV Infection (AEHIV) Clinical Studies Unit|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:26:19.374329|2017-10-11 04:26:19.374329
NCT00005140|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1977||1977-09-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:31.830532|2017-10-11 04:26:31.830532
NCT00005021|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-07-10|||July 1996||1996-07-01|July 2013|2013-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma|Phase I Evaluation of Topotecan in Combination With Paclitaxel and Carboplatin|Completed||Phase 1|17|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 04:26:19.432578|2017-10-11 04:26:19.432578
NCT00005022|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-10-31|||February 1998||1998-02-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|October 2002|Actual|2002-10-01||Interventional|||Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer|A Phase I/II Escalation Study of Thoracic Irradiation With Concurrent Chemotherapy for Patients With Limited Small Cell Lung Cancer|Completed||Phase 1|64|Actual|Radiation Therapy Oncology Group||6|||f||||t||||||||||2017-10-11 04:26:19.563285|2017-10-11 04:26:19.563285
NCT00005023|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-12-12|||March 1999||1999-03-01|December 2012|2012-12-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer|A Phase I Vaccine Trial of a HER-2/Neu Peptide Incorporated Into PLG Microspheres in Patients With Advanced Stage HER2-Expressing Cancers|Completed||Phase 1|||University of Washington|||||f||||||||||||||2017-10-11 04:26:20.345883|2017-10-11 04:26:20.345883
NCT00005024|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-01-03||||||June 2007|2007-06-01||||||||Interventional|||Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease|A Double-blind, Multicenter, Parallel Study Comparing the Efficacy and Safety of Kytril Tablets With Placebo, in the Prevention of Nausea and Vomiting During the Days Following Administration of IV Cyclophosphamide-based or Carboplatin-based Chemotherapy in Patients With Malignant Disease|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:20.417656|2017-10-11 04:26:20.417656
NCT00005025|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-11-05|||June 2000||2000-06-01|March 2003|2003-03-01||||||||Interventional|||Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer|A Phase II Trial of In Vivo Gene Therapy With the Herpes Simplex Thymidine Kinase for the Treatment of Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:20.482189|2017-10-11 04:26:20.482189
NCT00005026|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-05-24|||February 2000||2000-02-01|July 2008|2008-07-01||||January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer|A Phase I Feasibility Trial of Carboplatin and Topotecan Followed by Carboplatin and Paclitaxel (Sequential Doublets) in Patients With Previously Untreated Epithelial Ovarian Carcinoma and Primary Peritoneal Carcinoma|Completed||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:26:20.56643|2017-10-11 04:26:20.56643
NCT00005027|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-04-03|||June 2000||2000-06-01|April 2013|2013-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer|A Phase II Study of Rebeccamycin Analog in Renal Cell Cancer|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:26:20.734295|2017-10-11 04:26:20.734295
NCT00005028|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2017-03-28|||May 2000|Actual|2000-05-01|March 2017|2017-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer|Phase II Study of Weekly Paclitaxel and Bryostatin-1 in Hormone Refractory Prostate Cancer|Completed||Phase 2|46|Actual|University of Maryland||1|||f||||||||||||||2017-10-11 04:26:20.802409|2017-10-11 04:26:20.802409
NCT00005029|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-04-10|||February 2000||2000-02-01|July 2004|2004-07-01||||January 2004||2004-01-01||Interventional|||Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer|Phase II Evaluation of Three-Day Topotecan (NSC 609699) in Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:26:20.896971|2017-10-11 04:26:20.896971
NCT00005030|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-10-05|||June 2000||2000-06-01|October 2012|2012-10-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver|A Phase IB Study of Oral Administration of SCH 66336 Preoperatively in Patients With Colorectal Carcinoma Metastatic to the Liver Scheduled for Exploratory Laparotomy and/or Resection|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||2||No enrollment.|f||||f||||||||||2017-10-11 04:26:21.247406|2017-10-11 04:26:21.247406
NCT00005031|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-05-24|||August 2000||2000-08-01|March 2008|2008-03-01||||October 2004|Actual|2004-10-01||Interventional|||Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer|A Phase II Evaluation of MGI-114 in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:26:21.338628|2017-10-11 04:26:21.338628
NCT00005032|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-02-08|||April 2000||2000-04-01|February 2013|2013-02-01|September 2001|Actual|2001-09-01|January 2001|Actual|2001-01-01||Interventional|||Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer|A Phase I/II Study of G3139, a BCL-2 Antisense Oligonucleotide, Combined With Paclitaxel for the Treatment of Recurrent Small Cell Lung Cancer|Completed||Phase 1/Phase 2|12|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:26:21.499765|2017-10-11 04:26:21.499765
NCT00005059|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2016-07-12|||January 2000||2000-01-01|July 2016|2016-07-01|April 2006|Actual|2006-04-01|July 2003|Actual|2003-07-01||Interventional|||Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer|A Phase II Study of Carboplatin and Paclitaxel in Elderly Patients With Metastatic or Recurrent Unresectable Non-Small Cell Lung Cancer|Completed||Phase 2|51|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:26:21.61128|2017-10-11 04:26:21.61128
NCT00005060|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-05-14|||November 1999||1999-11-01|May 2012|2012-05-01|March 2006|Actual|2006-03-01|November 2005|Actual|2005-11-01||Interventional|||Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer|A Phase III Trial of Preoperative vs. Postoperative Chemotherapy With Taxotere-Cisplatin-5FU (TCF) in Patients With Locally Advanced Operable Gastric Carcinoma|Completed||Phase 3|240|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 04:26:21.742935|2017-10-11 04:26:21.742935
NCT00005061|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-07-17|||December 1999||1999-12-01|July 2012|2012-07-01||||June 2001|Actual|2001-06-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors|A Phase I, Open Label Multiple Dose, Safety and Pharmacokinetic Study of Intravenously Administered Humanized Anti-VEGF Monoclonal Antibody (HuMV833) to Patients With Relapsed or Refractory Solid Tumors|Completed||Phase 1|20|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:26:21.84202|2017-10-11 04:26:21.84202
NCT00005062|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-03-12|||September 1999||1999-09-01|March 2014|2014-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission|A Phase III Trial Comparing High Versus Standard Dose of Prophylactic Cranial Irradiation (PCI) in Limited Small Cell Lung Cancer Complete Responders|Completed||Phase 3|||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 04:26:21.926451|2017-10-11 04:26:21.926451
NCT00005064|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-01-22|||February 2000||2000-02-01|January 2013|2013-01-01||||October 2002|Actual|2002-10-01||Interventional|||PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome|Phase I Study of PS-341 in Acute Myeloid Leukemias, Myelodysplastic Syndromes and Chronic Myeloid Leukemia in Blast Phase|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:22.193431|2017-10-11 04:26:22.193431
NCT00005065|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-06-03|||January 2000||2000-01-01|June 2013|2013-06-01||||December 2003|Actual|2003-12-01||Interventional|||Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer|A Phase I Study of Induction Carboplatin / Paclitaxel Chemotherapy, Pre-operative Radiotherapy With Gadolinium Texaphyrin (Gd-Tex), and Surgical Resection in Stage IIIA (N2) Non-small Cell Lung Carcinoma.|Completed||Phase 1|12|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:22.277525|2017-10-11 04:26:22.277525
NCT00005066|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-09-04|||June 2000||2000-06-01|September 2013|2013-09-01|October 2002|Actual|2002-10-01|September 2001|Actual|2001-09-01||Interventional|||O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma|A Phase II Trial of O6-Benzylguanine (NSC 637037) and BCNU (Carmustine) in Patients With Advanced Soft Tissue Sarcoma|Completed||Phase 2|12|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:26:22.369808|2017-10-11 04:26:22.369808
NCT00005067|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-01-15|||February 2000||2000-02-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer|A Phase I Trial of Photodynamic Therapy With Lutetium Texaphyrin in Patients With Locally Recurrent Prostate Carcinoma|Terminated||Phase 1|24|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:26:22.474244|2017-10-11 04:26:22.474244
NCT00005068|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2011-08-02|||January 2000||2000-01-01|August 2011|2011-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Oxaliplatin, CPT-11, 5-FU and Leucovorin in Patients With Solid Tumors|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:26:22.569812|2017-10-11 04:26:22.569812
NCT00005069|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer|Phase II Trial of Arsenic Trioxide (NSC #706363) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:22.642046|2017-10-11 04:26:22.642046
NCT00005070|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer|A Phase II Trial of 6-Hydroxymethylacylfulvene (HMAF; MGI-114) in Patients With Advanced Cervical Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:26:22.70248|2017-10-11 04:26:22.70248
NCT00005071|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-11-05|||October 1998||1998-10-01|June 2007|2007-06-01||||||||Interventional|||Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer|A Pilot Study Leading to a Randomized Trial Comparing Outcomes in Patients With Suspected Lung Cancer Investigated in the Conventional Locally (LO) Based (BA) Chest Clinic Compared With a Centralized 2 Stop Pathway (LOBA 2STOP)|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:22.772394|2017-10-11 04:26:22.772394
NCT00005072|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-07-25|||November 2000||2000-11-01|July 2014|2014-07-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer|Phase I/II Study Evaluating the Safety and Efficacy of Leuvectin Immunotherapy for the Treatment of Locally Recurrent Prostate Cancer Following Radiation Therapy (Summary Last Updated: 02/2001)|Terminated||Phase 1/Phase 2|25|Actual|Vical||1||Development in prostate cancer indication halted|f||||f||||||||||2017-10-11 04:26:22.838828|2017-10-11 04:26:22.838828
NCT00005073|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-04-30|||September 1999||1999-09-01|April 2013|2013-04-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms|A Randomized Double-Blind Placebo Controlled Phase III Trial Evaluating Zoledronate Plus Standard Therapy Versus Placebo Plus Standard Therapy in Patients With Recurrent Carcinoma of the Prostate Who Are Asymptomatic With Castrate Levels of Testosterone and Have Rising PSA Levels Without Radiologically-Evident Metastatic Disease|Terminated||Phase 3|544|Actual|Novartis|||||f||||||||||||||2017-10-11 04:26:22.925945|2017-10-11 04:26:22.925945
NCT00005074|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2010-11-07|||January 2000||2000-01-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma|A Phase II Study of Flavopiridol (HMR 1275; NSC 649890) in Patients With Untreated or Relapsed Mantle Cell Lymphoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:26:22.997665|2017-10-11 04:26:22.997665
NCT00005075|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-11-05|||July 1999||1999-07-01|May 2009|2009-05-01||||||||Interventional|||Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer|Evaluation of the Ablatherm High Intensity Focused Ultrasound Device After Failed Radiation Therapy for Localized Prostate Cancer|Terminated||Phase 3|||National Cancer Institute (NCI)||||Withdrawn because Ablatherm devices were not available anymore at trial centers|f||||||||||||||2017-10-11 04:26:23.080247|2017-10-11 04:26:23.080247
NCT00005076|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-04-10|||October 1999||1999-10-01|April 2013|2013-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer|Phase II Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody Cetuximab in Combination With Chemotherapy in Patients With Advanced Colorectal Carcinoma|Completed||Phase 2|110|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:26:23.152104|2017-10-11 04:26:23.152104
NCT00005141|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1977||1977-09-01|June 2000|2000-06-01|May 1997|Actual|1997-05-01|||||Observational|||Minneapolis Children's Blood Pressure Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:32.059528|2017-10-11 04:26:32.059528
NCT00005077|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2010-01-04|||February 2000||2000-02-01|January 2010|2010-01-01||||||||Interventional|||Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction|Phase I Study of Oxaliplatin in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction (Summary Last Modified 04/2000)|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:26:23.25444|2017-10-11 04:26:23.25444
NCT00005078|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2015-06-03|||March 2000||2000-03-01|June 2015|2015-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors|Phase I Dose Escalation Study of Tirapazamine (NSC 130181) in Combination With Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors|Completed||Phase 1|44|Actual|City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:26:23.361026|2017-10-11 04:26:23.361026
NCT00005079|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-05-14|||January 1999||1999-01-01|April 2003|2003-04-01|October 2004|Actual|2004-10-01|||||Interventional|||Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer|Timing of Breast Cancer Surgery, Menstrual Cycle and Prognosis|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:23.436282|2017-10-11 04:26:23.436282
NCT00005080|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-01-15|||May 2000||2000-05-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||506U78 in Treating Patients With Lymphoma|A Phase II Study of 506U78 in Patients With Previously Systemically Untreated Cutaneous T-cell Lymphoma (CTCL) or With Refractory or Relapsed Non-cutaneous Peripheral T-cell Lymphoma (PTCL)|Completed||Phase 2|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:23.494185|2017-10-11 04:26:23.494185
NCT00005081|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-08-20|||August 2000||2000-08-01|February 2013|2013-02-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma|Phase II Trial of BCNU Plus O6-Benzylguanine in the Treatment of Patients With Recurrent or Progressive Cerebral Anaplastic Gliomas|Completed||Phase 2|||Duke University|||||f||||||||||||||2017-10-11 04:26:23.757488|2017-10-11 04:26:23.757488
NCT00005082|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-01-07|||November 1998||1998-11-01|January 2013|2013-01-01||||November 2000|Actual|2000-11-01||Interventional|||Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma|Magnetic Resonance Correlates of Glioma Tumor Burden|Completed||N/A|1|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:26:23.831389|2017-10-11 04:26:23.831389
NCT00005083|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-10-02|||March 1998||1998-03-01|October 2012|2012-10-01||||||||Interventional|||Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors|Defining Functional Tissue in Brain Tumors With Integrated Neuroimaging (Pilot Study)|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||||no participants enrolled|f||||||||||||||2017-10-11 04:26:23.896768|2017-10-11 04:26:23.896768
NCT00005084|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-12-17|||February 1999||1999-02-01|February 2008|2008-02-01||||||||Interventional|||Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma|Pediatric Low Grade Astrocytoma: Treatment Guidance|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:23.971396|2017-10-11 04:26:23.971396
NCT00005085|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-02-08|||February 2000||2000-02-01|December 2002|2002-12-01||||June 2002|Actual|2002-06-01||Interventional|||Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer|A Phase II Study of Rebeccamycin Analogue NSC 655649 in Patients With Metastatic Colorectal Cancer (IMT Codes 23988, 23989, 23993)|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:26:24.063313|2017-10-11 04:26:24.063313
NCT00005086|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-09-04|||August 1999||1999-08-01|September 2013|2013-09-01|April 2005|Actual|2005-04-01|August 2002|Actual|2002-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer|"A Phase II Trial of Sequential Doublets Chemotherapy in Patients With Locally Advanced or Metastatic Bladder Cancer"|Completed||Phase 2|6|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:26:24.148817|2017-10-11 04:26:24.148817
NCT00005087|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2015-11-14|||March 2000||2000-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|November 2004|Actual|2004-11-01||Interventional|||Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer|Phase II Study of Paclitaxel and Cisplatin in Combination With Split Course Concomitant Hyperfractionated Re-Irradiation in Patients With Recurrent Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|105|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:26:24.286546|2017-10-11 04:26:24.286546
NCT00005088|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-11-18|||April 2000||2000-04-01|November 2013|2013-11-01||||January 2002|Actual|2002-01-01||Interventional|||Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer|A Phase II Trial of Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:26:24.865875|2017-10-11 04:26:24.865875
NCT00005089|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2017-01-12|||April 2000||2000-04-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|November 2004|Actual|2004-11-01||Interventional|||S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma|Evaluation of CHOP Plus Rituximab Plus Involved Field Radiotherapy for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High-Risk Localized Aggressive Histologies of Non-Hodgkin's Lymphoma|Completed||Phase 2|71|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:26:25.515371|2017-10-11 04:26:25.515371
NCT00005090|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease|A Randomized Phase III Trial Comparing Early High Dose Chemotherapy and an Autologous Stem Cell Transplant to Conventional Dose ABVD Chemotherapy for Patients With Advanced Stage Poor Prognosis Hodgkin's Disease as Defined by the International Prognostic Factors Project on Advanced Hodgkin's Disease|Terminated||Phase 3|11|Actual|Southwest Oncology Group||2||poor accrual|f||||t||||||||||2017-10-11 04:26:25.854441|2017-10-11 04:26:25.854441
NCT00005091|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-07-09|||February 1999||1999-02-01|January 2008|2008-01-01|August 2003|Actual|2003-08-01|||||Interventional|||DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Stage IIIb or Stage IV Non-Small Cell Lung Cancer as First Line Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:26:26.094657|2017-10-11 04:26:26.094657
NCT00005092|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-07-27|||March 1999||1999-03-01|July 2012|2012-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|A Phase I Study of Photochemically Treated Donor T-Cell Supplements in HLA Haplotype Mismatched Hematopoietic Stem Cell Transplantation|Completed||Phase 1|7|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:26:26.191305|2017-10-11 04:26:26.191305
NCT00005093|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-08-08|||December 1999||1999-12-01|August 2012|2012-08-01|May 2001|Actual|2001-05-01|||||Interventional|||Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer|A Randomized Double-Blind, Placebo-Controlled, Multicenter Study of CI-994 Capsules Plus Gemcitabine Infusion Versus Placebo Capsules Plus Gemcitabine Infusion as Second-Line Treatment of Patients With Advanced Nonsmall Cell Lung Cancer|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 04:26:26.374723|2017-10-11 04:26:26.374723
NCT00005094|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-04-11|||March 2000||2000-03-01|April 2013|2013-04-01||||April 2006|Actual|2006-04-01||Interventional|||Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps|Prevention of Sporadic Colorectal Adenomas With Celecoxib|Completed||Phase 3|1170|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:26:26.525172|2017-10-11 04:26:26.525172
NCT00005095|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2016-09-29|||March 2000||2000-03-01|September 2016|2016-09-01||||December 2020|Anticipated|2020-12-01||Observational|||Specimen and Data Study for Ovarian Cancer Early Detection and Prevention|Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study|Recruiting||N/A|6000|Anticipated|Northwestern University|||1||f||||t||||||Samples With DNA|"     Subjects blood and other specimens are collected their follow-up clinic appointments.   "|||2017-10-11 04:26:26.674203|2017-10-11 04:26:26.674203
NCT00005096|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2017-07-12|||December 1999|Actual|1999-12-01|July 2017|2017-07-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer|Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer|Completed||Phase 2|19|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 04:26:26.792369|2017-10-11 04:26:26.792369
NCT00005097|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-04-17|||August 1999||1999-08-01|April 2014|2014-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Green Tea Extract in Treating Patients With Actinic Keratosis|A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Polyphenon E Against Various Endpoints of Actinic Keratosis Pathobiology|Terminated||Phase 2|88|Actual|University of California, Irvine||1||terminated due to the low conditional power for a positive study|f||||t||||||||||2017-10-11 04:26:26.881535|2017-10-11 04:26:26.881535
NCT00005098|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2005-06-23|||March 1999||1999-03-01|May 2002|2002-05-01||||||||Observational|||Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency||Terminated||N/A|160||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:26.968094|2017-10-11 04:26:26.968094
NCT00005100|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2005-06-23|||September 1999||1999-09-01|December 2003|2003-12-01||||||||Observational|||Measurement of Outcome of Surgical Treatment in Patients With Acromegaly||Unknown status|Recruiting|N/A|165||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.020436|2017-10-11 04:26:27.020436
NCT00005101|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2005-06-23|||February 1998||1998-02-01|December 2003|2003-12-01||||||||Observational|||Study of Low Bone Mass in Premenopausal or Perimenopausal Women||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.074166|2017-10-11 04:26:27.074166
NCT00005102|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2005-06-23|||January 1995||1995-01-01|December 2003|2003-12-01||||||||Observational|||Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome|Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome|Unknown status|Recruiting|N/A|11||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.130606|2017-10-11 04:26:27.130606
NCT00005103|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2005-06-23|||November 2000||2000-11-01|December 2003|2003-12-01||||||||Observational|||Study of the Pathogenesis of Porphyria Cutanea Tarda||Completed||N/A|120||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.192345|2017-10-11 04:26:27.192345
NCT00005104|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2005-06-23|||January 2000||2000-01-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome||Completed||N/A|99||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.253056|2017-10-11 04:26:27.253056
NCT00005105|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2005-06-23|||January 1997||1997-01-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation||Unknown status|Recruiting|N/A|75||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.321745|2017-10-11 04:26:27.321745
NCT00005106|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2005-06-23|||September 1999||1999-09-01|November 2000|2000-11-01||||||||Interventional|||A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients|A 96-Week, Randomized, Open-Label, Multicenter Trial to Evaluate the Safety and Tolerability of the Antiretroviral Activity of Stavudine (40mg BID) Plus Lamivudine (150mg BID) Plus Nelfinavir (1250mg BID) Versus Abacavir (300mg BID) Plus Combivir (3TC 150mg/ZDV 300mg BID) Versus Combivir (3TC 150mg/ZDV 300mg BID) Plus Nelfinavir (1250mg BID) in HIV-1 Infected Subjects|Completed||Phase 4|230||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:27.398231|2017-10-11 04:26:27.398231
NCT00005107|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-11|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia||Unknown status|Recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.637039|2017-10-11 04:26:27.637039
NCT00005108|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-11|2008-03-03|||April 2000||2000-04-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls|Effects of Hormone Therapy on Vascular Inflammation and Compliance|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:27.716282|2017-10-11 04:26:27.716282
NCT00005110|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-13|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis||Suspended||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:27.777711|2017-10-11 04:26:27.777711
NCT00005111|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-13|2008-03-03|||April 2000||2000-04-01|March 2000|2000-03-01|March 2001||2001-03-01|||||Observational|||PET Scans in Normal Volunteers and Patients With Fabry Disease|(18)Fluorodeoxyglucose Positron Emission Tomography in Patients With Fabry Disease|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:27.82875|2017-10-11 04:26:27.82875
NCT00005113|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-14|2012-03-12|||July 1999||1999-07-01|March 2012|2012-03-01|March 2006|Actual|2006-03-01|July 2004|Actual|2004-07-01||Interventional|||A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant|An Open-Label, Comparative Study of the Effect of Sirolimus Versus Standard Treatment on Clinical Outcomes and Histologic Progression of Allograft Nephropathy in High Risk Pediatric Renal Transplant Patients|Terminated||Phase 3|102|Actual|Boston Children’s Hospital||2||Inability to meet the accrual target of 213.|f||||t||||||||||2017-10-11 04:26:27.943063|2017-10-11 04:26:27.943063
NCT00005116|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-13|2010-03-01||||||March 2010|2010-03-01||||||||Interventional|||Depression In Juvenile Diabetics||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:26:28.020223|2017-10-11 04:26:28.020223
NCT00005117|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-18|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Effect of Pravastatin on Endothelial Dysfunction Following a Single High Fat Meal||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:28.071759|2017-10-11 04:26:28.071759
NCT00005118|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-07|2005-06-23||||||July 2001|2001-07-01||||||||Interventional|||The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment|A Multicenter, Open-Label, 24-Week Study to Evaluate the Efficacy and Safety of Indinavir Sulfate 800 Mg and Ritonavir 200 Mg b.i.d. Plus 2 NRTIs b.i.d. in HIV-1 Infected Individuals Who Require Early Treatment Intervention|Unknown status|Active, not recruiting|Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:28.128548|2017-10-11 04:26:28.128548
NCT00005119|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-19|2010-03-01|||May 2000||2000-05-01|March 2010|2010-03-01|October 2003||2003-10-01|||||Interventional|||Altered Calcium and Vitamin D in PMDD or Severe PMS|Altered Calcium And Vitamin D Metabolism in PMDD|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:26:28.266289|2017-10-11 04:26:28.266289
NCT00005120|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-20|2005-06-23|||April 2000||2000-04-01|June 2001|2001-06-01||||||||Interventional|||The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|A Phase IB Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV-Positive Patients With No Previous Antiretroviral Therapy|Unknown status|Active, not recruiting|Phase 1|16||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:28.326563|2017-10-11 04:26:28.326563
NCT00005121|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-13|||July 1948||1948-07-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Framingham Heart Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:28.39115|2017-10-11 04:26:28.39115
NCT00005122|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1958||1958-07-01|June 2000|2000-06-01|August 1995|Actual|1995-08-01|||||Observational|||Evans County Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:28.44716|2017-10-11 04:26:28.44716
NCT00005123|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-13|||July 1965||1965-07-01|September 2004|2004-09-01|September 2002||2002-09-01|||||Observational|||Honolulu Heart Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:28.589483|2017-10-11 04:26:28.589483
NCT00005124|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1969||1969-07-01|May 2000|2000-05-01|November 1998|Actual|1998-11-01|||||Observational|||National Heart, Lung, and Blood Institute Twin Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:30.001475|2017-10-11 04:26:30.001475
NCT00005125|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-06-02|||July 1970||1970-07-01|June 2001|2001-06-01|September 1988||1988-09-01|||||Observational|||NAS-NRC Twin Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:30.071039|2017-10-11 04:26:30.071039
NCT00005126|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-11|||April 1989||1989-04-01|May 2000|2000-05-01|March 1991|Actual|1991-03-01|||||Observational|||Vietnam Era Twin (VET) Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:30.170099|2017-10-11 04:26:30.170099
NCT00005127|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||June 1971||1971-06-01|July 2000|2000-07-01|November 1991|Actual|1991-11-01|||||Observational|||Muscatine Heart Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:30.217142|2017-10-11 04:26:30.217142
NCT00005128|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-13|||July 1972||1972-07-01|April 2004|2004-04-01|December 1994||1994-12-01|||||Observational|||Lipid Research Clinics Population Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:30.32464|2017-10-11 04:26:30.32464
NCT00005129|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-12-05|||June 1972||1972-06-01|December 2016|2016-12-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Bogalusa Heart Study||Active, not recruiting||N/A|12000|Actual|Tulane University|||1||f||||f||||||Samples With DNA|"     Blood samples collected at screening for biochemical cardiovascular risk factors, as well as     genomic and DNA methylation analyses.   "|Yes|Biolink|2017-10-11 04:26:30.497043|2017-10-11 04:26:30.497043
NCT00005130|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-12|||January 1984||1984-01-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Coronary Artery Risk Development in Young Adults (CARDIA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||||||2017-10-11 04:26:31.024575|2017-10-11 04:26:31.024575
NCT00005131|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-12|||July 1985||1985-07-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Atherosclerosis Risk in Communities (ARIC)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:31.093746|2017-10-11 04:26:31.093746
NCT00005132|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-13|||September 1985||1985-09-01|January 2006|2006-01-01|March 2000||2000-03-01|||||Observational|||National Growth and Health Study (NGHS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:31.161995|2017-10-11 04:26:31.161995
NCT00005133|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-10-24|||June 1988||1988-06-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Cardiovascular Health Study (CHS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:31.251368|2017-10-11 04:26:31.251368
NCT00005134|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||September 1988||1988-09-01|May 2009|2009-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Strong Heart Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:31.301436|2017-10-11 04:26:31.301436
NCT00005135|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-08-05|||September 1991||1991-09-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Insulin Resistance Atherosclerosis Study (IRAS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:31.362414|2017-10-11 04:26:31.362414
NCT00005145|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-03|||April 1979||1979-04-01|February 2016|2016-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|MHS||Minnesota Heart Survey - Risk Factor Survey|Study of Trends in Cardiovascular Risk Factors in an Urban Population.|Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||1||f||||||||||||||2017-10-11 04:26:32.470429|2017-10-11 04:26:32.470429
NCT00005146|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-07|||May 1979||1979-05-01|March 2016|2016-03-01|August 2002|Actual|2002-08-01|||||Observational|||Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)|Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)|Completed||N/A|||The University of Texas Health Science Center at San Antonio|||||f||||f||||||||No||2017-10-11 04:26:32.616821|2017-10-11 04:26:32.616821
NCT00005147|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1979||1979-09-01|April 2000|2000-04-01|June 1991|Actual|1991-06-01|||||Observational|||Epidemiology of Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:32.819997|2017-10-11 04:26:32.819997
NCT00005148|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1979||1979-09-01|April 2000|2000-04-01|August 1991|Actual|1991-08-01|||||Observational|||Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:32.924317|2017-10-11 04:26:32.924317
NCT00005149|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-19|||February 1980||1980-02-01|January 2016|2016-01-01|November 1992||1992-11-01|||||Observational|||Genetic and Environmental Determinants of Hypertension||Completed||N/A|||University of Utah|||||f||||||||||||||2017-10-11 04:26:33.018102|2017-10-11 04:26:33.018102
NCT00005150|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-24|||July 1980||1980-07-01|February 2016|2016-02-01|June 1993||1993-06-01|||||Observational|||Minnesota Heart Health Program||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:26:33.146354|2017-10-11 04:26:33.146354
NCT00005151|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||August 1980||1980-08-01|July 2000|2000-07-01|July 1997|Actual|1997-07-01|||||Observational|||Pawtucket Heart Health Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:33.322905|2017-10-11 04:26:33.322905
NCT00005152|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-07-12|||August 1980||1980-08-01|July 2017|2017-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Nurses' Health Study (Cardiovascular Component)|Nurses' Health Study (Cardiovascular Component)|Completed||N/A|121700|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-10-11 04:26:33.448118|2017-10-11 04:26:33.448118
NCT00005153|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||December 1980||1980-12-01|October 2001|2001-10-01|November 1998|Actual|1998-11-01|||||Observational|||Etiologic Risk Factors of Cardiovascular Malformations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:33.632027|2017-10-11 04:26:33.632027
NCT00005154|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2009-04-13|||July 1981||1981-07-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||National Health and Nutrition Examination Survey IV (NHANES (IV)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:33.723326|2017-10-11 04:26:33.723326
NCT00005155|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||February 1982||1982-02-01|May 2000|2000-05-01|January 1989|Actual|1989-01-01|||||Observational|||Physiological and Psychosocial Correlates of Type A Behavior||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:33.787557|2017-10-11 04:26:33.787557
NCT00005156|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-29|||April 1982||1982-04-01|February 2016|2016-02-01|July 1996||1996-07-01|||||Observational|||Mortality Surveillance of MRFIT Screenees||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:26:33.865285|2017-10-11 04:26:33.865285
NCT00005157|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1982||1982-07-01|May 2000|2000-05-01|November 1989|Actual|1989-11-01|||||Observational|||Speech Characteristics in Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:33.959025|2017-10-11 04:26:33.959025
NCT00005158|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1982||1982-07-01|June 2000|2000-06-01|June 1991|Actual|1991-06-01|||||Observational|||Segregation/Linkage Analysis for Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:34.032089|2017-10-11 04:26:34.032089
NCT00005159|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-08-05|||July 1983||1983-07-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|||||Observational|||National Longitudinal Mortality Study (NLMS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:34.131698|2017-10-11 04:26:34.131698
NCT00005160|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-12|||April 1983||1983-04-01|January 2016|2016-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Epidemiology of Cardiovascular Risk Factors in Women (Healthy Women Study)|Epidemiology of Cardiovascular Risk Factors in Women (Healthy Women Study)|Completed||N/A|532|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"     Plasma and serum samples from baseline and follow up exams stored at -80 degrees Celsius in     the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh.   "|||2017-10-11 04:26:34.214127|2017-10-11 04:26:34.214127
NCT00005161|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-04|||August 1983||1983-08-01|March 2016|2016-03-01|July 1993||1993-07-01|||||Observational|||Longitudinal Twin Study - Cohort Study of Blood Pressure||Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-10-11 04:26:34.345136|2017-10-11 04:26:34.345136
NCT00005162|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1983||1983-08-01|May 2000|2000-05-01|November 1996|Actual|1996-11-01|||||Observational|||Epidemiology of Decline in Heart Disease Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:34.672781|2017-10-11 04:26:34.672781
NCT00005163|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1983||1983-09-01|May 2000|2000-05-01|May 1989|Actual|1989-05-01|||||Observational|||Validation and Field Test for Risk Appraisal Instruments||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:34.765546|2017-10-11 04:26:34.765546
NCT00005164|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1983||1983-09-01|June 2000|2000-06-01|August 1991|Actual|1991-08-01|||||Observational|||Insulin Resistance and Blood Pressure Regulation in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:34.83745|2017-10-11 04:26:34.83745
NCT00005165|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||January 1984||1984-01-01|April 2000|2000-04-01|March 1995|Actual|1995-03-01|||||Observational|||Charleston Heart Study - Predictors of Coronary Disease in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:34.921799|2017-10-11 04:26:34.921799
NCT00005166|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1984||1984-04-01|May 2000|2000-05-01|March 1996|Actual|1996-03-01|||||Observational|||Sodium Transport: Genetics and Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.019581|2017-10-11 04:26:35.019581
NCT00005176|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-10-20|||August 1985||1985-08-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|LQTS||Long QT Syndrome-Population Genetics and Cardiac Studies|Long QT Syndrome-Population Genetics and Cardiac Studies|Completed||N/A|2125|Actual|University of Rochester|||1||f||||f||||||Samples With DNA|"     DNA   "|||2017-10-11 04:26:35.688847|2017-10-11 04:26:35.688847
NCT00005177|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1985||1985-09-01|June 2000|2000-06-01|November 1996|Actual|1996-11-01|||||Observational|||Reno Diet Heart Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:35.814564|2017-10-11 04:26:35.814564
NCT00005178|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-21|||September 1985||1985-09-01|December 2000|2000-12-01|August 1991||1991-08-01|||||Observational|||Study of Children's Activity and Nutrition (SCAN)||Completed||N/A|||Augusta University|||||f||||||||||||||2017-10-11 04:26:35.865978|2017-10-11 04:26:35.865978
NCT00005179|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-21|||September 1985||1985-09-01|April 2000|2000-04-01|June 1990||1990-06-01|||||Observational|||Diet, Exercise and Cardiovascular Health Among Ethnic Children||Completed||N/A|||Augusta University|||||f||||||||||||||2017-10-11 04:26:35.955749|2017-10-11 04:26:35.955749
NCT00005180|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1985||1985-09-01|May 2000|2000-05-01|June 1995|Actual|1995-06-01|||||Observational|||End-organ Pathology in Childhood Essential Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.009934|2017-10-11 04:26:36.009934
NCT00005181|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-02-24|||July 2000||2000-07-01|February 2014|2014-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Observational|||Blood Pressure Control in Juveniles - Longitudinal Study||Completed||N/A|||Indiana University|||||f||||||||||||||2017-10-11 04:26:36.078464|2017-10-11 04:26:36.078464
NCT00005182|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-03-30|||December 1985||1985-12-01|March 2013|2013-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Health Professionals Follow-up Study||Completed||N/A|50000|Actual|Harvard School of Public Health|||1||f||||||||||Samples With DNA|"     plasma, RBC, WBC   "|||2017-10-11 04:26:36.153416|2017-10-11 04:26:36.153416
NCT00005183|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||December 1985||1985-12-01|April 2000|2000-04-01|November 1988||1988-11-01|||||Observational|||Apolipoprotein A-I Gene Polymorphism and Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.313258|2017-10-11 04:26:36.313258
NCT00005184|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||December 1985||1985-12-01|May 2000|2000-05-01|November 1989|Actual|1989-11-01|||||Observational|||Immunogenetic Factors of Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.390351|2017-10-11 04:26:36.390351
NCT00005185|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1986||1986-04-01|May 2000|2000-05-01|March 1990|Actual|1990-03-01|||||Observational|||Myocardial Infarction and Non-contraceptive Estrogen Use||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.451233|2017-10-11 04:26:36.451233
NCT00005186|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1986||1986-04-01|March 2005|2005-03-01|June 1992|Actual|1992-06-01|||||Observational|||Epidemiology of Cardiovascular Diseases in The Elderly||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.503499|2017-10-11 04:26:36.503499
NCT00005187|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||April 1986||1986-04-01|April 2000|2000-04-01|March 1991||1991-03-01|||||Observational|||Cardiovascular Risk Profile Among Mexican-Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.564125|2017-10-11 04:26:36.564125
NCT00005188|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1986||1986-07-01|August 2004|2004-08-01|June 1991|Actual|1991-06-01|||||Observational|||Quantitative Genetic Analysis of Lipid Research Clinic Family Data||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.624978|2017-10-11 04:26:36.624978
NCT00005189|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1986||1986-07-01|November 2002|2002-11-01|April 1999|Actual|1999-04-01|||||Observational|||Carotid Atherosclerosis Follow-up Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.695775|2017-10-11 04:26:36.695775
NCT00005190|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1986||1986-07-01|October 2001|2001-10-01|December 1998|Actual|1998-12-01|||||Observational|||Reproduction and Survival After Cardiac Defect Repair||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.751735|2017-10-11 04:26:36.751735
NCT00005191|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1986||1986-07-01|April 2002|2002-04-01|March 2001|Actual|2001-03-01|||||Observational|||Clinical Course of Coronary Artery Disease Among Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.804672|2017-10-11 04:26:36.804672
NCT00005192|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||July 1986||1986-07-01|January 2016|2016-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Psychophysiology of Cardiovascular Reactivity||Completed||N/A|||University of Miami|||||f||||||||||||||2017-10-11 04:26:36.85835|2017-10-11 04:26:36.85835
NCT00005193|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1986||1986-09-01|September 2002|2002-09-01|August 1990|Actual|1990-08-01|||||Observational|||Prospective Study of Diabetes-related Vascular Disease in Oklahoma Indians||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.927003|2017-10-11 04:26:36.927003
NCT00005194|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1986||1986-09-01|June 2000|2000-06-01|August 1991|Actual|1991-08-01|||||Observational|||Insulin and Biogenic Amines in Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:36.98201|2017-10-11 04:26:36.98201
NCT00005195|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1986||1986-09-01|September 2002|2002-09-01|August 1991|Actual|1991-08-01|||||Observational|||Catheter Ablation Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.045344|2017-10-11 04:26:37.045344
NCT00005196|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||December 1986||1986-12-01|May 2009|2009-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||Worcester Heart Attack Community Surveillance Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.100727|2017-10-11 04:26:37.100727
NCT00005197|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||December 1986||1986-12-01|May 2000|2000-05-01|November 1991|Actual|1991-11-01|||||Observational|||Predictors of Perioperative Cardiac Morbidity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.203171|2017-10-11 04:26:37.203171
NCT00005198|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1987||1987-04-01|August 2001|2001-08-01|March 1998|Actual|1998-03-01|||||Observational|||Survival After Myocardial Infarction in A Biethnic Texas Community (Corpus Christi Heart Project)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.302512|2017-10-11 04:26:37.302512
NCT00005199|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||June 1987||1987-06-01|May 2000|2000-05-01|November 1994||1994-11-01|||||Observational|||Balloon Valvuloplasty Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.374311|2017-10-11 04:26:37.374311
NCT00005205|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-07|||August 1987||1987-08-01|March 2016|2016-03-01|July 2003||2003-07-01|||||Observational|||Incidence of Diabetes and Cardiovascular Disease in Mexican Americans|Incidence of Diabetes and Cardiovascular Disease in Mexican Americans|Completed||N/A|||The University of Texas Health Science Center at San Antonio|||||f||||f||||||||No||2017-10-11 04:26:37.826261|2017-10-11 04:26:37.826261
NCT00005206|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1987||1987-09-01|April 2002|2002-04-01|August 1991|Actual|1991-08-01|||||Observational|||Calcium Intake, Metabolism, and Gestational Blood Pressure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:37.944753|2017-10-11 04:26:37.944753
NCT00005207|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1987||1987-09-01|May 2000|2000-05-01|July 1992|Actual|1992-07-01|||||Observational|||Renin and Prorenin in Pregnancy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.010423|2017-10-11 04:26:38.010423
NCT00005208|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||September 1987||1987-09-01|May 2000|2000-05-01|July 1992|Actual|1992-07-01|||||Observational|||Regulation of Placental Vascular Reactivity in Pregnancy-induced Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.103814|2017-10-11 04:26:38.103814
NCT00005209|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||August 1987||1987-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Genetic Epidemiology of Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.18998|2017-10-11 04:26:38.18998
NCT00005210|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||September 1987||1987-09-01|June 2000|2000-06-01|September 1992|Actual|1992-09-01|||||Observational|||Sex Steroids, Obesity and Lipids in Adolescent Females||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.326217|2017-10-11 04:26:38.326217
NCT00005211|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-11|||October 1987||1987-10-01|November 2001|2001-11-01|September 1990|Actual|1990-09-01|||||Observational|||Cardiovascular Mortality Among Tunnel and Bridge Workers Exposed To Carbon Monoxide||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.383109|2017-10-11 04:26:38.383109
NCT00005212|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||March 1988||1988-03-01|May 2000|2000-05-01|February 1993|Actual|1993-02-01|||||Observational|||Work Organization and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.431163|2017-10-11 04:26:38.431163
NCT00005213|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||March 1988||1988-03-01|June 2000|2000-06-01|February 1990|Actual|1990-02-01|||||Observational|||Lithium Countertransport and Blood Pressure In CARDIA and TOMHS||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.490773|2017-10-11 04:26:38.490773
NCT00005214|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||April 1988||1988-04-01|May 2000|2000-05-01|March 1993||1993-03-01|||||Observational|||Epidemiology of Genetic Factors in Lipid Metabolism||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.541418|2017-10-11 04:26:38.541418
NCT00005215|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||April 1988||1988-04-01|May 2000|2000-05-01|March 1992|Actual|1992-03-01|||||Observational|||Lipoprotein Subfractions and Coronary Heart Disease During 25 Year Follow-up||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.608924|2017-10-11 04:26:38.608924
NCT00005216|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||April 1988||1988-04-01|January 2016|2016-01-01|December 1994||1994-12-01|||||Observational|||Multicenter Study of Silent Myocardial Ischemia (MSSMI)||Completed||N/A|||University of Rochester|||||f||||||||||||||2017-10-11 04:26:38.658116|2017-10-11 04:26:38.658116
NCT00005217|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-27|||April 1988||1988-04-01|January 2016|2016-01-01|March 1991||1991-03-01|||||Observational|||Intermittent ST Depression and Prognosis After Myocardial Infarction||Completed||N/A|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:26:38.7195|2017-10-11 04:26:38.7195
NCT00005218|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1988||1988-04-01|April 2002|2002-04-01|March 1990|Actual|1990-03-01|||||Observational|||Epidemiological Tool To Detect Angina Pectoris in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.773572|2017-10-11 04:26:38.773572
NCT00005219|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||April 1988||1988-04-01|May 2000|2000-05-01|March 1990||1990-03-01|||||Observational|||Predicting Physical Activity Change: an Epidemiologic Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:38.82033|2017-10-11 04:26:38.82033
NCT00005220|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||April 1988||1988-04-01|June 2000|2000-06-01|January 1999||1999-01-01|||||Observational|||Postmenopausal Progestins, MI and Stroke||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:26:38.870137|2017-10-11 04:26:38.870137
NCT00005221|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2012-05-15|||April 1988||1988-04-01|May 2012|2012-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Analysis of Longitudinal Cardiopulmonary Data||Completed||N/A|60000|Actual|Brigham and Women's Hospital|||1||f||||||||||||||2017-10-11 04:26:38.927541|2017-10-11 04:26:38.927541
NCT00005222|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1988||1988-04-01|April 2000|2000-04-01|March 1996|Actual|1996-03-01|||||Observational|||Decline in Cardiovascular Mortality: Framingham 1950-1984||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.000857|2017-10-11 04:26:39.000857
NCT00005223|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1988||1988-04-01|April 2001|2001-04-01|March 1993|Actual|1993-03-01|||||Observational|||Epidemiology of APO- and Lipoproteins in Elderly Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.056604|2017-10-11 04:26:39.056604
NCT00005224|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1988||1988-04-01|March 2005|2005-03-01|March 1990|Actual|1990-03-01|||||Observational|||Gender Response To Coronary Risk||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.125765|2017-10-11 04:26:39.125765
NCT00005225|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-19|||April 1988||1988-04-01|January 2016|2016-01-01|March 1991||1991-03-01|||||Observational|||Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease||Completed||N/A|||University of Utah|||||f||||||||||||||2017-10-11 04:26:39.186834|2017-10-11 04:26:39.186834
NCT00005226|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-24|||July 1988||1988-07-01|February 2016|2016-02-01|June 1992||1992-06-01|||||Observational|||Epidemiology of Plasma Fatty Acids and Atherosclerosis||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:26:39.248505|2017-10-11 04:26:39.248505
NCT00005227|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1988||1988-07-01|March 2005|2005-03-01|June 1993|Actual|1993-06-01|||||Observational|||AIDS-Associated Cardiomyopathy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.301073|2017-10-11 04:26:39.301073
NCT00005228|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1988||1988-07-01|December 2001|2001-12-01|June 1993|Actual|1993-06-01|||||Observational|||AIDS-Associated Heart Disease -- Incidence and Etiology||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.363766|2017-10-11 04:26:39.363766
NCT00005235|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-22|||December 1988||1988-12-01|December 2015|2015-12-01|September 1993|Actual|1993-09-01|September 1993|Actual|1993-09-01||Observational|||Heart Rate Variability and Sudden Cardiac Death|The Ability of Several Short-term Measures of RR Variability to Predict Mortality After Myocardial Infarction|Completed||N/A|715|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 04:26:39.773762|2017-10-11 04:26:39.773762
NCT00005236|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||December 1988||1988-12-01|April 2000|2000-04-01|November 1994|Actual|1994-11-01|||||Observational|||Atherosclerosis and Omega-3 Fatty Acids in Alaskan Natives||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.859905|2017-10-11 04:26:39.859905
NCT00005237|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||December 1988||1988-12-01|May 2000|2000-05-01|November 1993|Actual|1993-11-01|||||Observational|||Epidemiology of Symptomatic Arrhythmias||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:39.920531|2017-10-11 04:26:39.920531
NCT00005238|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-21|||December 1988||1988-12-01|December 2004|2004-12-01|December 2001||2001-12-01|||||Observational|||Antecedents of Hypertension: Role of Race and Stress||Completed||N/A|||Augusta University|||||f||||||||||||||2017-10-11 04:26:39.996459|2017-10-11 04:26:39.996459
NCT00005239|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||January 1989||1989-01-01|June 2004|2004-06-01|December 1991|Actual|1991-12-01|||||Observational|||Genetic Epidemiology of Coronary Heart Disease Risk in Women Twins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.083472|2017-10-11 04:26:40.083472
NCT00005240|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-22|||October 1989||1989-10-01|December 2015|2015-12-01|December 1992|Actual|1992-12-01|June 1991|Actual|1991-06-01||Observational|||Epidemiology of Hypertensive Emergency|Correlates of Nonadherence to Hypertension Treatment in an Inner-City Minority Population|Completed||N/A|210|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 04:26:40.144756|2017-10-11 04:26:40.144756
NCT00005241|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1989||1989-04-01|June 2001|2001-06-01|December 1999|Actual|1999-12-01|||||Observational|||Myocardial Infarction and Current Oral Contraceptive Use||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.213641|2017-10-11 04:26:40.213641
NCT00005242|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||April 1989||1989-04-01|February 2016|2016-02-01|June 1994||1994-06-01|||||Observational|||Childhood Passive Smoking: Cohort Study of Cardiac Risk||Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-10-11 04:26:40.295805|2017-10-11 04:26:40.295805
NCT00005243|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||April 1989||1989-04-01|December 2005|2005-12-01|August 2004|Actual|2004-08-01|||||Observational|||Triggers of Ventricular Arrhythmias (TOVA) Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.360228|2017-10-11 04:26:40.360228
NCT00005244|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||April 1989||1989-04-01|March 2005|2005-03-01|March 1991|Actual|1991-03-01|||||Observational|||Anger Expression, Self-focus and Coronary Heart Disease Risk Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.437951|2017-10-11 04:26:40.437951
NCT00005245|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-04|||June 1989||1989-06-01|February 2016|2016-02-01|May 1993|Actual|1993-05-01|May 1993|Actual|1993-05-01||Observational|||Community Structure and Cardiovascular Mortality Trends|Community Structure and Cardiovascular Mortality Trends|Completed||N/A|||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-10-11 04:26:40.493038|2017-10-11 04:26:40.493038
NCT00005246|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1989||1989-08-01|May 2000|2000-05-01|July 1991|Actual|1991-07-01|||||Observational|||Epidemiology of Insulin and Dehydroepiandrosterone Sulfate and Coronary Heart Disease Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.565419|2017-10-11 04:26:40.565419
NCT00005247|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1989||1989-08-01|May 2000|2000-05-01|July 1992|Actual|1992-07-01|||||Observational|||Nutritional Determinants of Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.629102|2017-10-11 04:26:40.629102
NCT00005248|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1989||1989-08-01|May 2002|2002-05-01|July 1992|Actual|1992-07-01|||||Observational|||Adiposity and Fat Patterning in Black Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.690994|2017-10-11 04:26:40.690994
NCT00005249|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1989||1989-09-01|April 2000|2000-04-01|August 1991|Actual|1991-08-01|||||Observational|||Epidemiology of Blood Pressure, Insulin, Salt Transport||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.758358|2017-10-11 04:26:40.758358
NCT00005250|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||January 1990||1990-01-01|November 2001|2001-11-01|December 1992|Actual|1992-12-01|||||Observational|||Linkage Study of Long QT Syndrome In An Amish Kindred||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.820584|2017-10-11 04:26:40.820584
NCT00005251|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||January 1990||1990-01-01|June 2000|2000-06-01|March 1995|Actual|1995-03-01|||||Observational|||Genetic Analysis of Familial Hypertrophic Cardiomyopathy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.871694|2017-10-11 04:26:40.871694
NCT00005252|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||January 1990||1990-01-01|August 2004|2004-08-01|December 1992|Actual|1992-12-01|||||Observational|||Physicians' Health Study: Study of Low Cardiovascular Disease Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:40.95138|2017-10-11 04:26:40.95138
NCT00005253|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||January 1990||1990-01-01|January 2006|2006-01-01|January 2000||2000-01-01|||||Observational|||Proarrhythmic Medicines and Primary Cardiac Arrest||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:26:41.016153|2017-10-11 04:26:41.016153
NCT00004419|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||April 1998||1998-04-01|June 1999|1999-06-01|September 2000||2000-09-01|||||Interventional|||Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance||Completed||N/A|18|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.148797|2017-10-11 04:26:41.148797
NCT00004420|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1994||1994-09-01|January 2000|2000-01-01|August 1999||1999-08-01|||||Interventional|||Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis||Completed||N/A|50||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.209415|2017-10-11 04:26:41.209415
NCT00004421|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|March 2000|2000-03-01|September 2000||2000-09-01|||||Interventional|||Deep Brain Stimulation in Treating Patients With Dystonia|Phase II/III Study of Deep Brain Stimulation in Patients With Dystonia|Completed||Phase 2/Phase 3|15|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.267681|2017-10-11 04:26:41.267681
NCT00004422|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||August 1997||1997-08-01|June 2000|2000-06-01|September 2002||2002-09-01|||||Interventional|||Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection||Completed||Phase 3|174||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.333102|2017-10-11 04:26:41.333102
NCT00004423|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||December 1995||1995-12-01|January 2000|2000-01-01|March 1998||1998-03-01|||||Interventional|||Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease||Completed||N/A|80||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.408573|2017-10-11 04:26:41.408573
NCT00004424|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||July 1996||1996-07-01|April 2000|2000-04-01|March 2000||2000-03-01|||||Interventional|||Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy||Completed||N/A|120||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.467462|2017-10-11 04:26:41.467462
NCT00004426|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-25|||August 1994||1994-08-01|January 2000|2000-01-01|September 1998||1998-09-01|||||Interventional|||Leuprolide in Determining the Cause of Gonadotropin Deficiency|Study of Gonadotropin Releasing Hormone Agonist Test Using Leuprolide Acetate in Patients With Gonadotropin Deficiency|Completed||N/A|90|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.53557|2017-10-11 04:26:41.53557
NCT00004428|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|January 2000|2000-01-01|October 1999||1999-10-01|||||Interventional|||Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis||Completed||Phase 1|35||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.607817|2017-10-11 04:26:41.607817
NCT00004429|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||December 1999||1999-12-01|October 2007|2007-10-01|February 2005|Actual|2005-02-01|||||Interventional|||Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis||Completed||N/A|25|Actual|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.810925|2017-10-11 04:26:41.810925
NCT00004430|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1994||1994-09-01|August 2000|2000-08-01|September 1998||1998-09-01|||||Interventional|||Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization||Completed||N/A|150|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:41.912305|2017-10-11 04:26:41.912305
NCT00004431|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||June 1998||1998-06-01|April 2000|2000-04-01|September 1999||1999-09-01|||||Interventional|||Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia||Completed||N/A|30|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.017123|2017-10-11 04:26:42.017123
NCT00004433|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||December 1994||1994-12-01|March 2000|2000-03-01|September 2002||2002-09-01|||||Interventional|||Randomized Study of Pergolide in Children With Tourette Syndrome||Completed||N/A|74||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.08883|2017-10-11 04:26:42.08883
NCT00004436|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||July 1993||1993-07-01|August 2000|2000-08-01|June 2000||2000-06-01|||||Interventional|||Randomized Study of Hormonal Regulation of Infantile Hemangioma||Completed||N/A|30||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.161975|2017-10-11 04:26:42.161975
NCT00004437|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||October 1999||1999-10-01|January 2001|2001-01-01|October 2000||2000-10-01|||||Interventional|||Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2||Completed||Phase 2|||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.257548|2017-10-11 04:26:42.257548
NCT00004438|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|June 1998|1998-06-01|September 2002||2002-09-01|||||Interventional|||Leuprolide in Treating Adults With Hypogonadotropism|Study of Leuprolide in Adults With Hypogonadotropism|Completed||N/A|45|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.350034|2017-10-11 04:26:42.350034
NCT00004440|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||August 1996||1996-08-01|April 2000|2000-04-01|June 1999||1999-06-01|||||Interventional|||Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis||Completed||N/A|75||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.4396|2017-10-11 04:26:42.4396
NCT00004441|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|July 1998|1998-07-01|September 2001||2001-09-01|||||Interventional|||Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis||Completed||N/A|39|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.523445|2017-10-11 04:26:42.523445
NCT00004442|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24||||||November 2000|2000-11-01|April 1999||1999-04-01|||||Interventional|||Study of Bile Acids in Patients With Peroxisomal Disorders||Terminated||N/A|25|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.607735|2017-10-11 04:26:42.607735
NCT00004443|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|April 2000|2000-04-01|September 2006||2006-09-01|||||Interventional|||Study of NTBC for Tyrosinemia I||Completed||N/A|20|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.698647|2017-10-11 04:26:42.698647
NCT00004444|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||November 1994||1994-11-01|February 2001|2001-02-01|January 2001||2001-01-01|||||Interventional|||Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis||Completed||N/A|24||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:42.787349|2017-10-11 04:26:42.787349
NCT00004445|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2013-07-31|||September 1996||1996-09-01|July 2013|2013-07-01||||September 2009|Actual|2009-09-01||Interventional|||Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries||Completed||N/A|17|Actual|Case Western Reserve University||1|||f||||||||||||||2017-10-11 04:26:42.865167|2017-10-11 04:26:42.865167
NCT00004446|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||April 1998||1998-04-01|March 2005|2005-03-01||||||||Interventional|||Study of Fluoxetine in Patients With Depersonalization Disorder||Completed||N/A|80||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:26:42.955765|2017-10-11 04:26:42.955765
NCT00004448|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2008-09-08|||November 1997||1997-11-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy||Completed||Phase 2|123||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:43.024826|2017-10-11 04:26:43.024826
NCT00004449|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-05-26|||May 1998||1998-05-01|May 2015|2015-05-01|April 2006|Actual|2006-04-01|September 2004|Actual|2004-09-01||Interventional|||Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children With Autism|Randomized Study of Intensive One-on-one Behavioral Treatment Versus Individualized Parent Training in Preschool Aged Children With Autism|Completed||N/A|102|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-10-11 04:26:43.096265|2017-10-11 04:26:43.096265
NCT00004450|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||August 1998||1998-08-01|January 2001|2001-01-01|November 2000||2000-11-01|||||Interventional|||Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy||Completed||N/A|60||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:43.173667|2017-10-11 04:26:43.173667
NCT00004451|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-11-29|||March 1998||1998-03-01|November 2005|2005-11-01||||||||Interventional|||Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients||Completed||N/A|120||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:26:43.245576|2017-10-11 04:26:43.245576
NCT00004454|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||October 1996||1996-10-01|October 2003|2003-10-01||||||||Interventional|||Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome)||Completed||Phase 1/Phase 2|2||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:43.335945|2017-10-11 04:26:43.335945
NCT00004457|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||March 1998||1998-03-01|January 2001|2001-01-01||||||||Observational|||Determinants of Disease Severity in Amyotrophic Lateral Sclerosis||Unknown status|Active, not recruiting|N/A|75||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:43.423691|2017-10-11 04:26:43.423691
NCT00004458|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||May 1997||1997-05-01|October 2003|2003-10-01||||||||Observational|||Longitudinal and Biological Study of Childhood Disintegrative Disorder||Terminated||N/A|220||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:43.50731|2017-10-11 04:26:43.50731
NCT00004464|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2007-03-28|||February 1996||1996-02-01|March 2007|2007-03-01||||||||Interventional|||Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria||Unknown status|Active, not recruiting|N/A|25||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:43.585727|2017-10-11 04:26:43.585727
NCT00004465|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2017-05-30|||July 27, 1997|Actual|1997-07-27|May 2017|2017-05-01|April 14, 2001|Actual|2001-04-14|April 14, 2001|Actual|2001-04-14||Interventional|||Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome|Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated|Terminated||Phase 3|145|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2||Lack of efficacy at review by DSMB using pre-specified monitoring criteria|f||||t|t|f||||||No||2017-10-11 04:26:43.665913|2017-10-11 04:26:43.665913
NCT00004466|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2017-09-14|||October 1998|Actual|1998-10-01|September 2017|2017-09-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome||Terminated||Phase 2|5|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2||Very poor enrollment|f|||||t|f||||||||2017-10-11 04:26:43.822774|2017-10-11 04:26:43.822774
NCT00004468|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2017-05-30|||October 1998||1998-10-01|July 2004|2004-07-01||||||||Interventional|||Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis||Completed||N/A|500||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:26:44.029372|2017-10-11 04:26:44.029372
NCT00004471|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2011-03-28|||August 1995||1995-08-01|March 2011|2011-03-01||||May 2001|Actual|2001-05-01||Interventional|||Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer||Completed||Phase 1|9||University of Alabama at Birmingham|||||f||||||||||||||2017-10-11 04:26:44.083562|2017-10-11 04:26:44.083562
NCT00004474|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2008-10-01|||September 1998||1998-09-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia|Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia|Completed||Phase 3|224||Office of Rare Diseases (ORD)||2|||f||||t||||||||||2017-10-11 04:26:44.138558|2017-10-11 04:26:44.138558
NCT00004475|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2006-09-05|||December 1998||1998-12-01|September 2006|2006-09-01||||||||Observational|||Genetic Linkage Study for Hereditary Pancreatitis||Unknown status|Recruiting|N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:44.223781|2017-10-11 04:26:44.223781
NCT00004478|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2008-09-17|||March 1999||1999-03-01|September 2008|2008-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Droxidopa in Treating Patients With Neurogenic Hypotension|Study of Droxidopa in Patients With Neurologic Hypotension|Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:44.310926|2017-10-11 04:26:44.310926
NCT00004479|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||March 1999||1999-03-01|July 2004|2004-07-01||||||||Interventional|||Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:44.392102|2017-10-11 04:26:44.392102
NCT00004480|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||July 1999||1999-07-01|July 2004|2004-07-01||||||||Interventional|||Study of Botulinum Toxin in Patients With Primary Hyperhidrosis||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:44.466998|2017-10-11 04:26:44.466998
NCT00004481|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-06-23|||November 1999||1999-11-01|January 2004|2004-01-01||||||||Observational|||Genetic Study of Sitosterolemia||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:44.543418|2017-10-11 04:26:44.543418
NCT00004482|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2010-09-08|||December 1999||1999-12-01|September 2010|2010-09-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis||Completed||Phase 2|40||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:26:44.60739|2017-10-11 04:26:44.60739
NCT00004483|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2005-09-27|||January 2002||2002-01-01|September 2005|2005-09-01||||||||Observational|||NF2 Natural History Consortium||Unknown status|Active, not recruiting|N/A|100||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:44.6742|2017-10-11 04:26:44.6742
NCT00004485|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2008-09-08|||December 1999||1999-12-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Bone Marrow Transplantation in Treating Children With Sickle Cell Disease|Phase I/II Study of Induction of Stable Mixed Chimerism After Bone Marrow Transplantation From HLA-Identical Donors in Children With Sickle Cell Disease|Completed||Phase 1/Phase 2|50||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:44.731187|2017-10-11 04:26:44.731187
NCT00004486|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1998||1998-09-01|December 2000|2000-12-01|December 2002||2002-12-01|||||Interventional|||Randomized Study of Fluoxetine in Children and Adolescents With Autism||Completed||N/A|45||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:44.811087|2017-10-11 04:26:44.811087
NCT00004487|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||May 1999||1999-05-01|April 2001|2001-04-01||||||||Interventional|||Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux||Unknown status|Active, not recruiting|Phase 3|60||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:44.876838|2017-10-11 04:26:44.876838
NCT00004488|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|March 2000|2000-03-01|September 2002||2002-09-01|||||Interventional|||Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease||Completed||Phase 2|82|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:44.985437|2017-10-11 04:26:44.985437
NCT00004489|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|January 2000|2000-01-01|September 2002||2002-09-01|||||Interventional|||Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis||Completed||N/A|60|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:45.062538|2017-10-11 04:26:45.062538
NCT00004490|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|April 2000|2000-04-01|September 2002||2002-09-01|||||Interventional|||Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic Acidosis||Completed||Phase 3|45||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:45.124083|2017-10-11 04:26:45.124083
NCT00004492|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||October 1999||1999-10-01|January 2001|2001-01-01|September 2001||2001-09-01|||||Interventional|||Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia||Completed||Phase 1/Phase 2|20|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:45.176881|2017-10-11 04:26:45.176881
NCT00004493|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||September 1998||1998-09-01|May 2000|2000-05-01|September 2003||2003-09-01|||||Interventional|||Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia||Completed||Phase 2|75|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:45.23199|2017-10-11 04:26:45.23199
NCT00004494|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2013-03-07|||September 1998||1998-09-01|August 1999|1999-08-01||||||||Interventional|||Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis||Unknown status|Recruiting|Phase 1|18|Anticipated|Stony Brook University|||||f||||||||||||||2017-10-11 04:26:45.283346|2017-10-11 04:26:45.283346
NCT00004495|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||June 1999||1999-06-01|August 1999|1999-08-01|September 2000||2000-09-01|||||Interventional|||Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis||Completed||N/A|84|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:45.359716|2017-10-11 04:26:45.359716
NCT00004496|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||February 1999||1999-02-01|August 1999|1999-08-01|September 2003||2003-09-01|||||Interventional|||Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure||Completed||Phase 1|45|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:45.414875|2017-10-11 04:26:45.414875
NCT00004497|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|September 1999|1999-09-01|September 2000||2000-09-01|||||Interventional|||Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension||Completed||Phase 3|||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:45.475842|2017-10-11 04:26:45.475842
NCT00004498|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2015-03-24|||July 1998||1998-07-01|February 2000|2000-02-01|September 2000||2000-09-01|||||Interventional|||Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency||Terminated||Phase 1|21||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:45.560811|2017-10-11 04:26:45.560811
NCT00004500|ClinicalTrials.gov processed this data on October 10, 2017|1999-10-18|2012-05-01|2012-04-02||March 2000||2000-03-01|May 2012|2012-05-01|November 2004|Actual|2004-11-01|November 2002|Actual|2002-11-01||Interventional|||Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome|A Multicenter, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Bronchoalveolar Lavage With Lucinactant to Standard Care for the Treatment of the Meconium Aspriation Syndrome (MAS) in Newborn Infants|Terminated||Phase 3|69|Actual|Windtree Therapeutics|Early termination led to a small number of subjects analyzed. Results should be interpreted with caution.|2||Slow enrollment and administrative reasons|f||||t||||||||||2017-10-11 04:26:45.617769|2017-10-11 04:26:45.617769
NCT00004533|ClinicalTrials.gov processed this data on October 10, 2017|2000-01-28|2017-05-30|||August 1999||1999-08-01|May 2017|2017-05-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis|Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis|Completed||Phase 1|19||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:26:47.391047|2017-10-11 04:26:47.391047
NCT00004547|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-03|2015-10-19|2011-08-30||January 2000||2000-01-01|September 2015|2015-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy|Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis|Completed||Phase 2|188|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-10-11 04:26:47.458758|2017-10-11 04:26:47.458758
NCT00004549|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-03|2008-03-03|||January 2000||2000-01-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty|MRI Detection of Vascular Inflammation in Patients Undergoing Peripheral Angioplasty|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:47.896735|2017-10-11 04:26:47.896735
NCT00004550|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-03|2017-06-30|||January 28, 2000||2000-01-28|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions|The Evaluation and Follow-up of Patients With Obsessive-Compulsive Disorder and OC Spectrum Disorders|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:47.949365|2017-10-11 04:26:47.949365
NCT00004551|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-03|2010-09-28|||February 1999||1999-02-01|September 2010|2010-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)|Mood Management Training for Alcohol Dependent Smokers|Completed||Phase 4|144|Actual|Mayo Clinic|||||f||||||||||||||2017-10-11 04:26:48.10985|2017-10-11 04:26:48.10985
NCT00004552|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-03|2015-06-30||||||June 2015|2015-06-01|December 2002||2002-12-01|||||Interventional|||Acamprosate Treatment: Mechanisms of Action|Etiology and Treatment of Alcohol Dependence|Completed||Phase 2|120||Yale University|||||f||||||||||||||2017-10-11 04:26:48.171818|2017-10-11 04:26:48.171818
NCT00004553|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-04|2008-03-03|||February 2000||2000-02-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Electromyography to Diagnose Neuromuscular Disorders|Diagnosis of Neuromuscular Disorders With Specialized Electromyographic Studies|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:48.226665|2017-10-11 04:26:48.226665
NCT00004554|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-04|2015-10-02|||January 2000||2000-01-01|September 2013|2013-09-01|February 2006|Actual|2006-02-01|August 2005|Actual|2005-08-01||Interventional|||Sertraline for Alcohol Dependence and Depression|Sertraline for Alcohol Dependence and Depression|Completed||Phase 4|171|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 04:26:48.289992|2017-10-11 04:26:48.289992
NCT00004556|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-08|2017-10-05|||September 27, 1991||1991-09-27|June 2, 2017|2017-06-02||||||||Observational|||The Effects of Dextroamphetamine on Brain Function|Mechanisms of Individual Variation of Dextroamphetamine Effects in Normal Human Subjects|Completed||N/A|108|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:48.377448|2017-10-11 04:26:48.377448
NCT00004557|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-08|2008-03-03|||January 1992||1992-01-01|February 1999|1999-02-01|April 2000||2000-04-01|||||Observational|||Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders|Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders|Completed||N/A|650||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:48.447113|2017-10-11 04:26:48.447113
NCT00004558|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-09|2016-02-17|||February 1999||1999-02-01|December 2005|2005-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Antiarrhythmic Effects of N-3 Fatty Acids||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:48.507607|2017-10-11 04:26:48.507607
NCT00004559|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-09|2016-03-15|||March 1999||1999-03-01|November 2005|2005-11-01|February 2002|Actual|2002-02-01|||||Interventional|||Fatty Acid Antiarrhythmia Trial (FAAT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:48.562466|2017-10-11 04:26:48.562466
NCT00004560|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-09|2016-04-13|||September 1999||1999-09-01|November 2005|2005-11-01|February 2004||2004-02-01|||||Interventional|||Public Access Defibrillation (PAD) Community Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:48.614838|2017-10-11 04:26:48.614838
NCT00004561|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-09|2016-05-12|||June 1997||1997-06-01|August 2004|2004-08-01|May 2003|Actual|2003-05-01|||||Interventional|||Treatment of Hypertension With Two Exercise Intensities||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:48.695358|2017-10-11 04:26:48.695358
NCT00004562|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-09|2014-04-03|2010-05-07||September 1999||1999-09-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional|OAT||Occluded Artery Trial (OAT)|Occluded Artery Trial (OAT) - Randomized Comparative Effectiveness Trial of PCI and Medical Therapy Only Post MI|Completed||Phase 3|2201|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 04:26:48.758412|2017-10-11 04:26:48.758412
NCT00004563|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-09|2015-03-05|2015-02-19||August 1999||1999-08-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SLS||Scleroderma Lung Disease|Cyclophosphamide Versus Placebo in Scleroderma Lung Study|Completed||Phase 3|158|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 04:26:49.296932|2017-10-11 04:26:49.296932
NCT00004564|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-11|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:49.602487|2017-10-11 04:26:49.602487
NCT00004565|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-11|2017-10-05|||February 8, 2000||2000-02-08|May 4, 2012|2012-05-04|May 4, 2012||2012-05-04|||||Observational|||Susceptibility to Breast Cancer|Susceptibility to Breast Cancer|Completed||N/A|49|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:49.683861|2017-10-11 04:26:49.683861
NCT00004566|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-11|2008-03-03|||February 2000||2000-02-01|May 2004|2004-05-01|May 2004||2004-05-01|||||Observational|||Study of Fetal Swallowing|Pilot Study: Ultrasonic Evaluation of the Development of the Fetal Upper Aerodigestive Tract: Establishing Clinical Indicators of Deglutitive Function|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:49.751655|2017-10-11 04:26:49.751655
NCT00004567|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-11|2008-03-03|||February 2000||2000-02-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes|A Randomized Trial Comparing Methotrexate Versus Mycophenolate Mofetil for Remission Maintenance in Wegener's Granulomatosis and Related Vasculitides|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:49.814714|2017-10-11 04:26:49.814714
NCT00004568|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-11|2017-10-05|||February 4, 2000||2000-02-04|June 13, 2017|2017-06-13||||||||Observational|||Study of Inherited Neurological Disorders|Clinical and Molecular Manifestations of Inherited Neurological Disorders|Recruiting||N/A|2500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:49.906161|2017-10-11 04:26:49.906161
NCT00004569|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-12|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Incorporating Flow Limitation Into the Diagnosis and Quantification of Sleep Disordered Breathing||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:49.983942|2017-10-11 04:26:49.983942
NCT00004570|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-14|2017-10-05|||February 8, 2000||2000-02-08|September 7, 2017|2017-09-07||||||||Observational|||Hereditary Deficits in Auditory Processing Leading to Language Impairment|Identification of Hereditary Auditory Temporal Processing Deficits|Completed||N/A|875|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:50.062198|2017-10-11 04:26:50.062198
NCT00004571|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-15|2017-10-05|||February 11, 2000||2000-02-11|July 28, 2017|2017-07-28||||||||Observational|||Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers|Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers With 3.0 Tesla MRI and Magnetoencephalography|Recruiting||N/A|2920|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:50.31109|2017-10-11 04:26:50.31109
NCT00004575|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-17|2008-03-03|||February 2000||2000-02-01|October 2001|2001-10-01|October 2001||2001-10-01|||||Interventional|||Effects of Miconazole on Blood Flow|Investigation of Miconazole as an Inhibitor of Endothelium-Derived Hyperpolarizing Factor|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:50.595537|2017-10-11 04:26:50.595537
NCT00004576|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-17|2008-03-03|||February 2000||2000-02-01|February 2000|2000-02-01|August 2000||2000-08-01|||||Interventional|||Study of LY300164 for the Treatment of Parkinson's Disease|AMPA Receptor Blockade With LY300164 in the Treatment of Parkinson's Disease|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:50.66684|2017-10-11 04:26:50.66684
NCT00004577|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-18|2017-10-05|||February 17, 2000||2000-02-17|August 23, 2017|2017-08-23||||||||Observational|||Study of New Magnetic Resonance Imaging Methods of the Brain|Characterization of Brain Morphology and Activity Using Functional and Anatomical MRI Contrast|Recruiting||N/A|650|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:26:50.750722|2017-10-11 04:26:50.750722
NCT00004578|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2008-04-02|||November 1997||1997-11-01|April 2008|2008-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects|Phase I/II Study of ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naive HIV-Infected Patients|Completed||Phase 1/Phase 2|100|Actual|Abbott||2|||f||||f||||||||||2017-10-11 04:26:50.842438|2017-10-11 04:26:50.842438
NCT00004579|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23|||April 1998||1998-04-01|June 2003|2003-06-01||||||||Interventional|||A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection|A Phase I, Dose-Ranging Trial of the Pasteur Merieux Connaught (PMC) Oligomeric HIV-1 gp160MN/LAI-2 Vaccine Alone or Primed With Live Recombinant ALVAC-HIV (vCP205) in HIV Seronegative Adults|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:50.980945|2017-10-11 04:26:50.980945
NCT00004580|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors|Phase I/II Study of ABT-378/Ritonavir in Protease Inhibitor Experienced HIV-Infected Patients|Completed||Phase 1|||Abbott|||||f||||||||||||||2017-10-11 04:26:51.082796|2017-10-11 04:26:51.082796
NCT00004581|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment|A Randomized, Open-Label, Phase III Study of ABT-378/Ritonavir in Combination With Nevirapine and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) vs. Investigator Selected Protease Inhibitor(s) in Combination With Nevirapine and Two NRTIs in Antiretroviral-Experienced HIV-Infected Subjects|Completed||Phase 3|300||Abbott|||||f||||||||||||||2017-10-11 04:26:51.176322|2017-10-11 04:26:51.176322
NCT00004582|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2005-06-23||||||August 2000|2000-08-01||||||||Interventional|||ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past|A Phase II Study of ABT-378/Ritonavir and Efavirenz in Multiple Protease Inhibitor-Experienced Subjects|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:51.461803|2017-10-11 04:26:51.461803
NCT00004583|ClinicalTrials.gov processed this data on October 10, 2017|1999-11-02|2009-02-19|||March 1999||1999-03-01|February 2009|2009-02-01||||||||Interventional|||A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy|A Randomized, Double-Blind, Phase III Study of ABT-378/Ritonavir Plus Stavudine and Lamivudine vs Nelfinavir Plus Stavudine and Lamivudine in Antiretroviral Naive HIV-Infected Subjects|Completed||Phase 3|660||Abbott|||||f||||||||||||||2017-10-11 04:26:51.536532|2017-10-11 04:26:51.536532
NCT00004584|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-10|2011-04-28||2011-04-13|December 1999||1999-12-01|April 2011|2011-04-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment|Safety and Antiviral Efficacy of a Novel HIV-1 Protease Inhibitor, BMS-232632, in Combination Regimen(s) as Compared to a Reference Combination Regimen(s) in Antiretroviral-Experienced HIV-Infected Subjects|Completed||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:26:51.773493|2017-10-11 04:26:51.773493
NCT00004585|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-15|2005-06-23|||October 1999||1999-10-01|November 2000|2000-11-01||||||||Interventional|||A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults|A Phase IV, Open-Label, Multicenter Study of the Efficacy and Safety of Quadruple Combination Antiretroviral Therapy With Combivir (Lamivudine 150mg/Zidovudine 300mg) BID, Ziagen (Abacavir) 300mg BID, and Sustiva (Efavirenz) 600mg QD for 24 Weeks, Followed by the Triple Nucleoside Combination Tablet (Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg) BID Plus Sustiva (Efavirenz) 600mg QD for 24 Weeks in HIV-Infected Adults|Completed||Phase 4|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:26:51.939144|2017-10-11 04:26:51.939144
NCT00004604|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-02-21|||February 1997||1997-02-01|February 2013|2013-02-01|July 2002|Actual|2002-07-01|June 2001|Actual|2001-06-01||Interventional|||Biological Therapy in Treating Patients With Metastatic Cancer|A Phase I Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous Human Cultured Dendritic Cells in Patients With Metastatic Malignancies Expressing Carcinoembryonic Antigen|Completed||Phase 1|24|Actual|Duke University||1|||f||||f||||||||||2017-10-11 04:26:52.025822|2017-10-11 04:26:52.025822
NCT00004635|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-19|2012-08-13|2012-03-30||February 2000||2000-02-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer|A Double Blinded Randomized Crossover Phase III Study of Oral Thalidomide Versus Placebo in Patients With Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation|Completed||Phase 3|159|Actual|National Institutes of Health Clinical Center (CC)|A total of 159 participants were accrued beginning in March 2000 until January 2005. Accrual rates were less than anticipated and the study was closed to further entry by the Independent Data Safety and Monitoring Board for the NCI CCR.|2|||f||||f||||||||||2017-10-11 04:26:52.25407|2017-10-11 04:26:52.25407
NCT00004637|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-23|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Double-Blind, Placebo-Controlled Trial of Vitamin E as Add-on Therapy for Children With Epilepsy||Completed||Phase 4|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:54.339705|2017-10-11 04:26:54.339705
NCT00004638|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-23|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Immunologic Aspects of the Pathogenesis of Chronic Sinusitis in Children||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:26:54.390487|2017-10-11 04:26:54.390487
NCT00005373|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1992||1992-09-01|July 2000|2000-07-01|August 1998|Actual|1998-08-01|||||Observational|||Racial Differences in the Coronary Microcirculation||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.266267|2017-10-11 04:28:04.266267
NCT00004639|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-17|2011-09-16|||February 1996||1996-02-01|June 2011|2011-06-01|April 2007|Actual|2007-04-01|March 2006|Actual|2006-03-01||Interventional|||Cleft Palate Surgery and Speech Development|Velopharyngeal Function for Speech After Palatal Surgery|Completed||Phase 2|475|Actual|University of Florida||1|||f||||t||||||||||2017-10-11 04:26:54.442187|2017-10-11 04:26:54.442187
NCT00004640|ClinicalTrials.gov processed this data on October 10, 2017|1999-09-17|2012-06-19|||May 1998||1998-05-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||"Clinical Trials to Enhance Elders' Oral Health (TEETH)"|Trials to Enhance Elders' Teeth and Oral Health|Completed||Phase 3|1101|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-11 04:26:54.536939|2017-10-11 04:26:54.536939
NCT00004642|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||February 1995||1995-02-01|March 1999|1999-03-01||||||||Interventional|||Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease|Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease|Completed||Phase 1/Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:54.629696|2017-10-11 04:26:54.629696
NCT00004643|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||February 1995||1995-02-01|March 1999|1999-03-01||||||||Interventional|||Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus||Completed||Phase 2|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:54.704007|2017-10-11 04:26:54.704007
NCT00004644|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||February 1995||1995-02-01|March 1999|1999-03-01||||||||Interventional|||Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection||Completed||Phase 1/Phase 2|25||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:54.784044|2017-10-11 04:26:54.784044
NCT00004645|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||January 1995||1995-01-01|March 1999|1999-03-01||||||||Interventional|||Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone||Unknown status|Active, not recruiting|Phase 3|22||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:54.8411|2017-10-11 04:26:54.8411
NCT00004646|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||April 1995||1995-04-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy||Completed||Phase 3|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:54.911372|2017-10-11 04:26:54.911372
NCT00004647|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||March 1993||1993-03-01|March 1999|1999-03-01|February 1999||1999-02-01|||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy||Completed||Phase 3|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:54.975998|2017-10-11 04:26:54.975998
NCT00004648|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||May 1996||1996-05-01|December 2001|2001-12-01||||||||Observational|||Studies of Hereditary Hemorrhagic Telangiectasia|Studies of Hereditary Hemorrhagic Telangiectasia: Screening Methods for Pulmonary Arteriovenous Malformations; Prevalence of Pulmonary and Cerebral Arteriovenous Malformations; Prevalence of Cardiac Valve Abnormalities; and Identification of Modifier Genes|Completed||N/A|65||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.083363|2017-10-11 04:26:55.083363
NCT00004649|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||May 1995||1995-05-01|December 2001|2001-12-01||||||||Observational|||Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.14231|2017-10-11 04:26:55.14231
NCT00004650|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|June 1999|1999-06-01||||||||Interventional|||Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss||Completed||Phase 3|150||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.255544|2017-10-11 04:26:55.255544
NCT00004652|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||February 1993||1993-02-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.318369|2017-10-11 04:26:55.318369
NCT00004654|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||January 1996||1996-01-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia||Completed||Phase 3|60||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.396553|2017-10-11 04:26:55.396553
NCT00004656|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||May 1993||1993-05-01|February 1999|1999-02-01||||||||Interventional|||Nutritional Aspects of Rett Syndrome||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.459174|2017-10-11 04:26:55.459174
NCT00004658|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||March 1995||1995-03-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity||Completed||Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.520547|2017-10-11 04:26:55.520547
NCT00004659|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||November 1994||1994-11-01|March 1999|1999-03-01||||||||Interventional|||Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors||Unknown status|Active, not recruiting|Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.583166|2017-10-11 04:26:55.583166
NCT00004660|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2017-05-25|||June 1993||1993-06-01|May 2017|2017-05-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy|Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy|Completed||N/A|42|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f|||||f|f||||||||2017-10-11 04:26:55.649816|2017-10-11 04:26:55.649816
NCT00004661|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||May 1993||1993-05-01|December 2001|2001-12-01||||||||Observational|||Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.73125|2017-10-11 04:26:55.73125
NCT00004662|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||March 1996||1996-03-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus||Completed||Phase 3|300||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.777492|2017-10-11 04:26:55.777492
NCT00004663|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2005-06-23|||February 1994||1994-02-01|July 2004|2004-07-01||||||||Observational|||Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus||Completed||N/A|480||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:26:55.832795|2017-10-11 04:26:55.832795
NCT00004700|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||August 1995||1995-08-01|March 1999|1999-03-01|January 1999||1999-01-01|||||Interventional|||Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism||Completed||Phase 2|16||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:57.194923|2017-10-11 04:26:57.194923
NCT00004705|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-24|2015-03-24|||September 1996||1996-09-01|March 1999|1999-03-01|January 1999||1999-01-01|||||Interventional|||Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis||Completed||N/A|||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:26:57.254015|2017-10-11 04:26:57.254015
NCT00004727|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2005-06-23||||||June 2003|2003-06-01||||||||Interventional|||Antiplatelet Therapy to Prevent Stroke in African Americans|African American Antiplatelet Stroke Prevention Study|Completed||Phase 4|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:26:57.311815|2017-10-11 04:26:57.311815
NCT00004728|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2006-06-05||||||June 2006|2006-06-01|July 2003||2003-07-01|||||Interventional|||Aspirin Or Warfarin To Prevent Stroke|Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study|Terminated||Phase 3|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:26:57.418354|2017-10-11 04:26:57.418354
NCT00004729|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2006-12-21|||July 1997||1997-07-01|December 2006|2006-12-01||||||||Interventional|||Ketogenic Diet for Child Epilepsy and Seizure Control|Efficacy of the Ketogenic Diet -- a Blinded Study|Completed||N/A|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:26:57.503214|2017-10-11 04:26:57.503214
NCT00004730|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2011-10-26|||August 1998||1998-08-01|October 2011|2011-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Magnesium Sulfate For Brain Injury|Magnesium Sulfate for Neuroprotection After Brain Trauma|Completed||Phase 3|||University of Washington|||||f||||t||||||||||2017-10-11 04:26:57.56996|2017-10-11 04:26:57.56996
NCT00004731|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2005-06-23|||September 1998||1998-09-01|December 2003|2003-12-01|October 2003||2003-10-01|||||Interventional|||Parkinson's Disease Treatment With Coenzyme Q10|Effects of Coenzyme Q10 in Early Parkinson's Disease|Completed||Phase 2|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:26:57.636864|2017-10-11 04:26:57.636864
NCT00004732|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2017-04-13|2013-09-26||December 2000||2000-12-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|February 2011|Actual|2011-02-01||Interventional|CREST||Carotid Revascularization Endarterectomy Versus Stenting Trial|Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)|Completed||N/A|2502|Actual|Rutgers, The State University of New Jersey||2|||f||||t|f|t|f|||||No||2017-10-11 04:26:57.74843|2017-10-11 04:26:57.74843
NCT00004733|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2005-06-23|||January 1998||1998-01-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Timing of Levodopa Treatment in Parkinson's Disease|Earlier Versus Later L-Dopa in Parkinson's Disease|Completed||Phase 3|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:26:58.694382|2017-10-11 04:26:58.694382
NCT00004734|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2005-06-23|||September 1996||1996-09-01|April 2004|2004-04-01|February 2004||2004-02-01|||||Interventional|||Vitamin Therapy for Prevention of Stroke|Vitamin Intervention for Stroke Prevention|Completed||Phase 3|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:26:58.769981|2017-10-11 04:26:58.769981
NCT00004735|ClinicalTrials.gov processed this data on October 10, 2017|2000-02-25|2013-10-04|||February 2000||2000-02-01|October 2013|2013-10-01|September 2006|Actual|2006-09-01|||||Interventional|||The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV|The Effects of Highly Active Antiretroviral Therapy (HAART) on the Recovery of Immune Function in HIV-Infected Children and Young Adults|Completed||N/A|81|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:26:58.871377|2017-10-11 04:26:58.871377
NCT00005254|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||April 1990||1990-04-01|June 2000|2000-06-01|March 1995|Actual|1995-03-01|||||Observational|||Natural History of Peripheral Arterial Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:58.996361|2017-10-11 04:26:58.996361
NCT00005255|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||May 1990||1990-05-01|May 2000|2000-05-01|April 1995|Actual|1995-04-01|||||Observational|||Ischemic Heart Disease Incidence and Indices of Body-fat Distribution||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.067732|2017-10-11 04:26:59.067732
NCT00005256|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||May 1990||1990-05-01|April 2000|2000-04-01|August 1996|Actual|1996-08-01|||||Observational|||Coronary Screening in a High Risk Subset||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.126681|2017-10-11 04:26:59.126681
NCT00005257|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||May 1990||1990-05-01|March 2005|2005-03-01|April 1992|Actual|1992-04-01|||||Observational|||Diet and Plasma Cholesterol - Secular Trend Analysis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.184792|2017-10-11 04:26:59.184792
NCT00005258|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||June 1990||1990-06-01|November 2001|2001-11-01|May 1993|Actual|1993-05-01|||||Observational|||Family Study of Congenital Cardiovascular Malformations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.239465|2017-10-11 04:26:59.239465
NCT00005259|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-10-28|||July 1990||1990-07-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Polyunsaturated Fats and Risk of Primary Cardiac Arrest||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:26:59.290088|2017-10-11 04:26:59.290088
NCT00005260|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1990||1990-07-01|July 2005|2005-07-01|August 2002|Actual|2002-08-01|||||Observational|||Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.35814|2017-10-11 04:26:59.35814
NCT00005261|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-19|||July 1990||1990-07-01|January 2016|2016-01-01|June 1993||1993-06-01|||||Observational|||Urinary Kallikrein and Hypertension: A Prospective Study||Completed||N/A|||University of Utah|||||f||||||||||||||2017-10-11 04:26:59.478193|2017-10-11 04:26:59.478193
NCT00005262|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1990||1990-07-01|May 2000|2000-05-01|June 1996|Actual|1996-06-01|||||Observational|||Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.530073|2017-10-11 04:26:59.530073
NCT00005263|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-22|||July 1990||1990-07-01|December 2015|2015-12-01|November 1995|Actual|1995-11-01|November 1995|Actual|1995-11-01||Observational|||Postprandial Lipoproteins and Atherosclerosis|Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Newly Diagnosed Exercise-induced Myocardial Ischemia in Middle-aged Men and Women|Completed||N/A|205|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 04:26:59.594725|2017-10-11 04:26:59.594725
NCT00005267|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-10-06|||September 1995||1995-09-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Family Blood Pressure Program - HyperGEN||Completed||N/A|3604|Actual|University of Alabama at Birmingham|||1||f||||||||||Samples With DNA|"     Tissue suitable for DNA extraction   "|||2017-10-11 04:26:59.826227|2017-10-11 04:26:59.826227
NCT00005268|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-08-05|||September 1995||1995-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Family Blood Pressure Program - GenNet Network||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.906634|2017-10-11 04:26:59.906634
NCT00005269|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2008-08-20|||September 1995||1995-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Family Blood Pressure Program - GENOA||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:26:59.975248|2017-10-11 04:26:59.975248
NCT00005270|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-09-01|||September 1995||1995-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Family Blood Pressure Program - SAPPHIRe Network||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:00.073508|2017-10-11 04:27:00.073508
NCT00005271|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-11|||July 1995||1995-07-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|August 2009|Actual|2009-08-01||Observational|||INTERMAP: International Population Study on Macronutrients and BP|INTERMAP: International Population Study on Macronutrients and BP|Completed||N/A|4680|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"     24 hour urine collection among all participants   "|||2017-10-11 04:27:00.135839|2017-10-11 04:27:00.135839
NCT00005272|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-26|||September 1990||1990-09-01|May 2000|2000-05-01|September 1992||1992-09-01|||||Observational|||Smoking and Body Weight: Analysis of HHANES||Completed||N/A|||University of Memphis|||||f||||||||||||||2017-10-11 04:27:00.422817|2017-10-11 04:27:00.422817
NCT00005273|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1987||1987-09-01|March 2005|2005-03-01|May 1997|Actual|1997-05-01|||||Observational|||Pulmonary Complications of HIV Infection Study (PACS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:00.470597|2017-10-11 04:27:00.470597
NCT00005274|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-13|||May 1989||1989-05-01|October 2005|2005-10-01|March 2003||2003-03-01|||||Observational|||Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:00.548124|2017-10-11 04:27:00.548124
NCT00005275|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-05-19|||September 1994||1994-09-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|SHHS||Sleep Heart Health Study (SHHS) Data Coordinating Center|The Sleep Heart Health Study (SHHS) Was a Multi-site Prospective Cohort Study to Investigate Obstructive Sleep Apnea (OSA) and Other Sleep-disordered Breathing (SDB) as Risk Factors for Cardiovascular Diseases and Hypertension|Completed||N/A|6441|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||f||||||||||2017-10-11 04:27:00.652241|2017-10-11 04:27:00.652241
NCT00005276|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-24|||June 1995||1995-06-01|December 2005|2005-12-01|March 2003||2003-03-01|||||Observational|||A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:00.772711|2017-10-11 04:27:00.772711
NCT00005277|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1977||1977-09-01|August 2004|2004-08-01|December 2000||2000-12-01|||||Observational|||Cooperative Study of The Clinical Course of Sickle Cell Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:00.841195|2017-10-11 04:27:00.841195
NCT00005278|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-14|||July 1989||1989-07-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Retrovirus Epidemiology Donor Study I (REDS I)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:00.918972|2017-10-11 04:27:00.918972
NCT00005279|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||June 1971||1971-06-01|May 2002|2002-05-01|November 1997|Actual|1997-11-01|||||Observational|||Tucson Epidemiology Study of Chronic Obstructive Lung Diseases||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.036344|2017-10-11 04:27:01.036344
NCT00005404|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||February 1991||1991-02-01|May 2000|2000-05-01|January 1993|Actual|1993-01-01|||||Observational|||Compliance in the Physicians' Health Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.380735|2017-10-11 04:27:01.380735
NCT00005405|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-19|||September 1991||1991-09-01|January 2016|2016-01-01|September 1993|Actual|1993-09-01|September 1993|Actual|1993-09-01||Observational|||Parity and Serum Lipids in White and Hispanic Women||Completed||N/A|||University of Pennsylvania|||||f||||||||||||||2017-10-11 04:27:01.454856|2017-10-11 04:27:01.454856
NCT00005406|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||May 1991||1991-05-01|April 2000|2000-04-01|April 1992|Actual|1992-04-01|||||Observational|||Change in Coronary Heart Disease Risk Factors in Young Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.528015|2017-10-11 04:27:01.528015
NCT00005407|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||February 1991||1991-02-01|May 2000|2000-05-01|January 1993|Actual|1993-01-01|||||Observational|||Statistical Analysis of Pediatric Task Force Data Base||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.599802|2017-10-11 04:27:01.599802
NCT00005408|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1992||1992-07-01|May 2000|2000-05-01|April 1994|Actual|1994-04-01|||||Observational|||Reanalysis of CVD Risk Factors Via Likelihood Methods||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.686156|2017-10-11 04:27:01.686156
NCT00005409|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||May 1991||1991-05-01|June 2000|2000-06-01|April 1993|Actual|1993-04-01|||||Observational|||Longitudinal Studies of Blood Pressure in the Elderly||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.756417|2017-10-11 04:27:01.756417
NCT00005410|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||June 1991||1991-06-01|May 2000|2000-05-01|May 1993|Actual|1993-05-01|||||Observational|||Epidemiology of Coronary Heart Disease in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.8384|2017-10-11 04:27:01.8384
NCT00005411|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1991||1991-09-01|March 2005|2005-03-01|September 1993|Actual|1993-09-01|||||Observational|||Study of Children's Activity and Nutrition (SCAN)--Extended Analyses||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.906542|2017-10-11 04:27:01.906542
NCT00005412|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1992||1992-07-01|June 2000|2000-06-01|June 1995|Actual|1995-06-01|||||Observational|||Dietary Antioxidants and Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:01.967338|2017-10-11 04:27:01.967338
NCT00005433|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-04-20|||April 1996||1996-04-01|April 2017|2017-04-01|April 1997|Actual|1997-04-01|April 1997|Actual|1997-04-01||Observational|||Correlates of Angiographic Changes and Coronary Events|Correlates of Angiographic Changes and Coronary Events: The Cholesterol-Lowering Atherosclerosis Study (CLAS)|Completed||N/A|188|Actual|University of Southern California|||1||f|||||f|f||||||No||2017-10-11 04:27:03.460479|2017-10-11 04:27:03.460479
NCT00005434|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1992||1992-04-01|May 2000|2000-05-01|March 1997|Actual|1997-03-01|||||Observational|||Opioid Compromise in Hypertension--Modulating Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.526892|2017-10-11 04:27:03.526892
NCT00005435|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1991||1991-07-01|June 2000|2000-06-01|June 1997|Actual|1997-06-01|||||Observational|||Hostility and Pathogenic Mechanisms of Coronary Heart Disease in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.582452|2017-10-11 04:27:03.582452
NCT00005436|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1991||1991-09-01|May 2000|2000-05-01|August 1996|Actual|1996-08-01|||||Observational|||Lupus Cohort--Thrombotic Events and Coronary Artery Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.634495|2017-10-11 04:27:03.634495
NCT00005437|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||February 1992||1992-02-01|August 2004|2004-08-01|January 1998||1998-01-01|||||Observational|||Physical Activity and Cardiovascular Risk in Black Girls||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.725161|2017-10-11 04:27:03.725161
NCT00005438|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||February 1993||1993-02-01|November 2001|2001-11-01|January 1998|Actual|1998-01-01|||||Observational|||Neuropsychological Studies of Children With Sickle Cell||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.780976|2017-10-11 04:27:03.780976
NCT00005439|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1992||1992-04-01|May 2000|2000-05-01|March 1997|Actual|1997-03-01|||||Observational|||Evaluation of Childhood Blood Pressure and Lipid Screening||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.841676|2017-10-11 04:27:03.841676
NCT00005440|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1992||1992-09-01|May 2000|2000-05-01|January 1997|Actual|1997-01-01|||||Observational|||Disability Among Adults With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:03.899507|2017-10-11 04:27:03.899507
NCT00005441|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-04|||April 1993||1993-04-01|February 2016|2016-02-01|March 1998|Actual|1998-03-01|October 1997|Actual|1997-10-01||Observational|||Lifestyle Management for Women With CHD and NIDDM||Completed||N/A|||Oregon Research Institute|||||f||||f||||||||Undecided||2017-10-11 04:27:03.949171|2017-10-11 04:27:03.949171
NCT00005442|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||June 1994||1994-06-01|March 2005|2005-03-01|May 2000|Actual|2000-05-01|||||Observational|||Re-evaluating Triglycerides in Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.003908|2017-10-11 04:27:04.003908
NCT00005443|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||January 1994||1994-01-01|July 2000|2000-07-01|December 1997|Actual|1997-12-01|||||Observational|||Race, Class, and Gender--Studies of Health Effects||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.059101|2017-10-11 04:27:04.059101
NCT00005444|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1995||1995-08-01|July 2004|2004-07-01|July 2001|Actual|2001-07-01|||||Observational|||Hypertension in Families of African Origin||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.112465|2017-10-11 04:27:04.112465
NCT00005445|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-05|||April 1994||1994-04-01|January 2016|2016-01-01|February 1999||1999-02-01|||||Observational|||Epidemiology of Pediatric Asthma Hospitalization||Completed||N/A|||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 04:27:04.170506|2017-10-11 04:27:04.170506
NCT00005446|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-30|||April 1994||1994-04-01|December 2015|2015-12-01||||March 1999|Actual|1999-03-01||Observational|||Endogenous Estrogen and Coronary Heart Disease in Women||Completed||N/A|||New York University School of Medicine|||2||f||||||||||||||2017-10-11 04:27:04.224731|2017-10-11 04:27:04.224731
NCT00005447|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1995||1995-08-01|April 2002|2002-04-01|July 2001|Actual|2001-07-01|||||Observational|||Physical Activity and Cardiovascular Disease Prevention||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.278337|2017-10-11 04:27:04.278337
NCT00005448|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-09-07|||July 1996||1996-07-01|August 2016|2016-08-01|June 2002|Anticipated|2002-06-01|June 2002|Anticipated|2002-06-01||Observational|||Adverse Events With Magnesium Sulfate||Withdrawn||N/A|0|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||||||2017-10-11 04:27:04.341953|2017-10-11 04:27:04.341953
NCT00005449|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-07|||August 1996||1996-08-01|January 2016|2016-01-01|June 2001||2001-06-01|||||Observational|||Social Support and Myocardial Ischemia||Completed||N/A|||University of Florida|||||f||||||||||||||2017-10-11 04:27:04.417247|2017-10-11 04:27:04.417247
NCT00005450|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||May 1991||1991-05-01|July 2000|2000-07-01|November 1991|Actual|1991-11-01|||||Observational|||Health Promotion in the Elderly--Prevention of Cardiovascular Disorders||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.463689|2017-10-11 04:27:04.463689
NCT00005451|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|July 2000|2000-07-01|July 1999||1999-07-01|||||Observational|||WINCATI Software Tool for Survey Research||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.503684|2017-10-11 04:27:04.503684
NCT00005452|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1991||1991-09-01|June 2000|2000-06-01|April 1996|Actual|1996-04-01|||||Observational|||Ti PC Software for Analyzing Longitudinal Data||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.544803|2017-10-11 04:27:04.544803
NCT00005453|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1992||1992-09-01|September 2002|2002-09-01|June 1997|Actual|1997-06-01|||||Observational|||Adherence in Clinical Trials-Induction Strategies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.590563|2017-10-11 04:27:04.590563
NCT00005455|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-14|||January 1993||1993-01-01|November 2001|2001-11-01|December 1993|Actual|1993-12-01|||||Observational|||Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.632163|2017-10-11 04:27:04.632163
NCT00005456|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||December 1990||1990-12-01|March 2005|2005-03-01|November 1995|Actual|1995-11-01|||||Observational|||Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.898139|2017-10-11 04:27:04.898139
NCT00005457|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||January 1991||1991-01-01|June 2000|2000-06-01|June 1994|Actual|1994-06-01|||||Observational|||Model-Free Time Curves for Longitudinal Data Analysis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:04.949269|2017-10-11 04:27:04.949269
NCT00005474|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-04-13|||September 1996||1996-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Markers and Mechanisms of Macrovascular Disease in IDDM||Completed||N/A|1063|Actual|Medical University of South Carolina|||1||f||||||||||Samples Without DNA|"     Both DNA samples as well as plasma, serum and urine samples were collected from the DCCT/EDIC     cohort.   "|||2017-10-11 04:27:06.133585|2017-10-11 04:27:06.133585
NCT00005475|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||August 1996||1996-08-01|May 2009|2009-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Longitudinal Study of Asthma From Birth to Adulthood||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:06.213834|2017-10-11 04:27:06.213834
NCT00005476|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||September 1996||1996-09-01|May 2009|2009-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Sociodemographic Regulation of Cardiovascular Function and Structure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:06.311872|2017-10-11 04:27:06.311872
NCT00005477|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-08|||September 1996||1996-09-01|April 2002|2002-04-01|August 1998||1998-08-01|||||Observational|||Hispanic and White Women's Cardiovascular Health||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 04:27:06.385257|2017-10-11 04:27:06.385257
NCT00005478|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1996||1996-09-01|March 2004|2004-03-01|September 1998|Actual|1998-09-01|||||Observational|||Precursors of CVD Risk Factors--Project Heartbeat||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:06.438374|2017-10-11 04:27:06.438374
NCT00005479|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-23|||September 1996||1996-09-01|December 2015|2015-12-01|September 2009|Actual|2009-09-01|August 2001|Actual|2001-08-01||Observational|||Diabetes, Lipoproteins and Accelerated Vascular Disease|Measures of Postprandial Lipoproteins Are Not Associated With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus|Completed||N/A|164|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 04:27:06.497561|2017-10-11 04:27:06.497561
NCT00005480|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1996||1996-09-01|October 2001|2001-10-01|August 1998|Actual|1998-08-01|||||Observational|||Cardiovascular Disease Knowledge/Morbidity--Socioeconomic Cohort Outcomes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:06.573376|2017-10-11 04:27:06.573376
NCT00005481|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1996||1996-09-01|July 2004|2004-07-01|July 2002|Actual|2002-07-01|||||Observational|||Epidemiology of Impaired Coagulant Balance in Diabetes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:06.627045|2017-10-11 04:27:06.627045
NCT00005482|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||September 1995||1995-09-01|June 2000|2000-06-01|March 1999||1999-03-01|||||Observational|||Homocyst(e)Ine, Vitamin Status, and CVD Risk||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:27:06.695781|2017-10-11 04:27:06.695781
NCT00005483|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-06|||December 1994||1994-12-01|January 2016|2016-01-01|July 1999||1999-07-01|||||Observational|||Plasma Homocysteine Distribution in the United States||Completed||N/A|||Tufts University|||||f||||||||||||||2017-10-11 04:27:06.757095|2017-10-11 04:27:06.757095
NCT00005484|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1992||1992-04-01|March 2004|2004-03-01|March 1997|Actual|1997-03-01|||||Observational|||Predictors of Hospital-Based Care in Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:06.811394|2017-10-11 04:27:06.811394
NCT00005485|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-27|||September 2000||2000-09-01|April 2016|2016-04-01||||||||Observational|JHS||Jackson Heart Study (JHS) of Cardiovascular Diseases in African Americans|Environmental and Genetic Factors That Influence Cardiovascular Disease in African Americans|Active, not recruiting||N/A|5306|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||Samples With DNA|"     Serum, plasma, urine, DNA   "|Yes||2017-10-11 04:27:06.875932|2017-10-11 04:27:06.875932
NCT00005486|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1997||1997-07-01|December 2005|2005-12-01|June 2003|Actual|2003-06-01|||||Observational|||Lymphangioleiomyomatosis (LAM) Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:06.96831|2017-10-11 04:27:06.96831
NCT00005487|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||January 1999||1999-01-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|August 2015|Anticipated|2015-08-01||Observational|||Multi-Ethnic Study of Atherosclerosis (MESA)|Multi-Ethnic Study of Atherosclerosis (MESA)|Unknown status|Active, not recruiting|N/A|6000|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||||||2017-10-11 04:27:07.039976|2017-10-11 04:27:07.039976
NCT00005488|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||July 1998||1998-07-01|January 2005|2005-01-01|August 2002||2002-08-01|||||Observational|||Common Variants in Candidate Genes and Premature MI Risk||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:27:07.190969|2017-10-11 04:27:07.190969
NCT00005489|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-28|||January 1998||1998-01-01|December 2015|2015-12-01|December 2001||2001-12-01|||||Observational|||Salt Sensitivity, Cardiovascular and Metabolic Disease||Completed||N/A|||Indiana University|||||f||||||||||||||2017-10-11 04:27:07.240461|2017-10-11 04:27:07.240461
NCT00005490|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-11-04|||August 1997||1997-08-01|February 2005|2005-02-01|June 2003|Actual|2003-06-01|||||Observational|||Modeling DNA Diversity in Cardiovascular Health/Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.302684|2017-10-11 04:27:07.302684
NCT00005492|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1997||1997-08-01|March 2005|2005-03-01|July 2000|Actual|2000-07-01|||||Observational|||Pooled Analysis of NHANES I/II--Race, Gender, and CHD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.363478|2017-10-11 04:27:07.363478
NCT00005493|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||April 1998||1998-04-01|August 2004|2004-08-01|March 2001|Actual|2001-03-01|||||Observational|||Observational Aspirin Use and CVD in the Physicians' Health Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.409963|2017-10-11 04:27:07.409963
NCT00005494|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||June 1998||1998-06-01|July 2005|2005-07-01|May 2004|Actual|2004-05-01|||||Observational|||Prospective Study of Health in Runners and Walkers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.468464|2017-10-11 04:27:07.468464
NCT00005495|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1998||1998-07-01|November 2002|2002-11-01|June 1999|Actual|1999-06-01|||||Observational|||Primary Prevention of CHD Risk Factors Occurring in US||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.528039|2017-10-11 04:27:07.528039
NCT00005496|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1998||1998-09-01|February 2005|2005-02-01|August 2002|Actual|2002-08-01|||||Observational|||Inflammation, Infection, and Future Cardiovascular Risk||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.590745|2017-10-11 04:27:07.590745
NCT00005497|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1998||1998-04-01|October 2005|2005-10-01|March 2004|Actual|2004-03-01|||||Observational|||Risk Factors for Pulmonary Hypertension of the Newborn||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:07.667275|2017-10-11 04:27:07.667275
NCT00005502|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-05-13|||October 2002||2002-10-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Coronary Disease Morbidity and Mortality in a Population|Coronary Disease Morbidity and Mortality in a Population|Completed||N/A|5476|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"     plasma, serum and white blood cells are stored for future research projects   "|||2017-10-11 04:27:08.007014|2017-10-11 04:27:08.007014
NCT00005503|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1997||1997-09-01|October 2002|2002-10-01|August 1999|Actual|1999-08-01|||||Observational|||Epidemiology of Cardiac Development in Youth||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:08.107687|2017-10-11 04:27:08.107687
NCT00005504|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-05-23|||February 1998|Actual|1998-02-01|May 2017|2017-05-01|April 2030|Anticipated|2030-04-01|April 2030|Anticipated|2030-04-01||Observational|LITE||Epidemiology of Venous Thrombosis and Pulmonary Embolism|Longitudinal Investigation of Thromboembolism Etiology|Active, not recruiting||N/A|21680|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples With DNA|"     DNA, serum, plasma   "|No||2017-10-11 04:27:08.160295|2017-10-11 04:27:08.160295
NCT00005505|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||December 1997||1997-12-01|August 2004|2004-08-01|November 2002|Actual|2002-11-01|||||Observational|||Neighborhood Environments and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:08.454286|2017-10-11 04:27:08.454286
NCT00005506|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||January 1998||1998-01-01|April 2004|2004-04-01|June 2000|Actual|2000-06-01|||||Observational|||Vascular Disease--Structure/Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:08.529742|2017-10-11 04:27:08.529742
NCT00005507|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||March 1998||1998-03-01|April 2002|2002-04-01|March 2000|Actual|2000-03-01|||||Observational|||Race and the Use of Cardiovascular Surgical Procedures||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:08.616377|2017-10-11 04:27:08.616377
NCT00005508|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1998||1998-08-01|August 2004|2004-08-01|June 2003|Actual|2003-06-01|||||Observational|||Determinants of Coronary Disease in High Risk Families||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:08.676472|2017-10-11 04:27:08.676472
NCT00005509|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||April 1998||1998-04-01|December 2004|2004-12-01|March 2002|Actual|2002-03-01|||||Observational|||Cardiovascular Risk Factors in a Cohort of Latina Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:08.737921|2017-10-11 04:27:08.737921
NCT00005510|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1998||1998-04-01|November 2001|2001-11-01|March 1999|Actual|1999-03-01|||||Observational|||Strong Heart Study Analyses Obesity and Lipoproteins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:08.807349|2017-10-11 04:27:08.807349
NCT00005511|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-19|||September 1998||1998-09-01|January 2016|2016-01-01||||August 2003|Actual|2003-08-01||Observational|||SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea||Completed||N/A|||University of Pennsylvania|||||f||||||||||||||2017-10-11 04:27:08.878484|2017-10-11 04:27:08.878484
NCT00005512|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-29|||August 1998||1998-08-01|February 2016|2016-02-01|July 2002||2002-07-01|||||Observational|||Genetic Epidemiology--Development of Cardiovascular Risk||Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-10-11 04:27:08.951919|2017-10-11 04:27:08.951919
NCT00005513|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1998||1998-09-01|August 2004|2004-08-01|July 2002|Actual|2002-07-01|||||Observational|||Framingham Nutrition Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.015854|2017-10-11 04:27:09.015854
NCT00005514|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-03-18|||August 1998||1998-08-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Dietary Patterns and Risk of Cardiovascular Disease||Completed||N/A|120000|Actual|Harvard School of Public Health|||1||f||||||||||Samples With DNA|"     Plasma and buffy coat   "|||2017-10-11 04:27:09.132656|2017-10-11 04:27:09.132656
NCT00005515|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||September 1998||1998-09-01|July 2005|2005-07-01|August 2003||2003-08-01|||||Observational|||Mutations, Hormone Therapy (HRT) and Venous Thromboembolism||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:27:09.216992|2017-10-11 04:27:09.216992
NCT00005516|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1998||1998-07-01|March 2005|2005-03-01|June 2002|Actual|2002-06-01|||||Observational|||Epidemiology of Sleep Disordered Breathing in Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.291365|2017-10-11 04:27:09.291365
NCT00005517|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||August 1998||1998-08-01|November 2005|2005-11-01|June 2004|Actual|2004-06-01|||||Observational|||Community Surveillance of Congestive Heart Failure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.361867|2017-10-11 04:27:09.361867
NCT00005518|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||June 1998||1998-06-01|August 2004|2004-08-01|August 2003|Actual|2003-08-01|||||Observational|||Epidemiology and Immunology of Hemophilia A Inhibitors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.430521|2017-10-11 04:27:09.430521
NCT00005519|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1998||1998-09-01|August 2004|2004-08-01|August 2001|Actual|2001-08-01|||||Observational|||Prospective Study of Diet and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.492124|2017-10-11 04:27:09.492124
NCT00005520|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-01-15|||February 1997||1997-02-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|GERA||Genetic Epidemiology of Responses to Antihypertensives|Genetic Epidemiology of Responses to Antihypertensives|Completed||N/A|1200|Actual|Mayo Clinic|||4||f||||f||||||Samples With DNA|"     Serum, plasma, buffy coat, urine.   "|||2017-10-11 04:27:09.573658|2017-10-11 04:27:09.573658
NCT00005521|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||June 1998||1998-06-01|December 2004|2004-12-01|July 2004|Actual|2004-07-01|||||Observational|||Exercise and Blood Pressure in Children: A Meta-Analysis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.700098|2017-10-11 04:27:09.700098
NCT00005522|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||May 1998||1998-05-01|October 2005|2005-10-01|April 2004|Actual|2004-04-01|||||Observational|||Social Dominance, Gender, and Cardiovascular Reactivity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.752959|2017-10-11 04:27:09.752959
NCT00005523|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1998||1998-08-01|January 2006|2006-01-01|December 2003|Actual|2003-12-01|||||Observational|||Home Based Environmental Adherence Trial||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:09.802181|2017-10-11 04:27:09.802181
NCT00005524|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-08|||September 1998||1998-09-01|July 2005|2005-07-01|August 2003||2003-08-01|||||Observational|||Mental Stress, Autonomic Function, and Heart Disease||Completed||N/A|||Hebrew Rehabilitation Center, Boston|||||f||||||||||||||2017-10-11 04:27:09.855716|2017-10-11 04:27:09.855716
NCT00005539|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-05|||February 1999||1999-02-01|February 2016|2016-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|WESCID||Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes|Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes|Completed||N/A|||University of Wisconsin, Madison|||1||f||||||||||||||2017-10-11 04:27:12.903693|2017-10-11 04:27:12.903693
NCT00005540|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-03-29|||July 1999||1999-07-01|March 2017|2017-03-01|May 2002||2002-05-01|||||Observational|||Physical Fitness and Cardiovascular Mortality in Firefighters||Completed||N/A|3403|Actual|University of Southern California|||1||f||||f|f|f||||||No||2017-10-11 04:27:12.967181|2017-10-11 04:27:12.967181
NCT00005541|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-13|||January 2000||2000-01-01|April 2009|2009-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Hemochromatosis and Iron Overload Screening Study (HEIRS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.024567|2017-10-11 04:27:13.024567
NCT00005542|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||May 1999||1999-05-01|October 2005|2005-10-01|April 2005|Actual|2005-04-01|||||Observational|||Sarcoid Genetic Analysis (SAGA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.079774|2017-10-11 04:27:13.079774
NCT00005543|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-29|||April 1999||1999-04-01|December 2015|2015-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Observational|||Genetic Epidemiology of Venous Thromboembolism||Completed||N/A|3135|Actual|Mayo Clinic|||1||f||||||||||||||2017-10-11 04:27:13.128169|2017-10-11 04:27:13.128169
NCT00005544|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||February 1999||1999-02-01|May 2005|2005-05-01|January 2005|Actual|2005-01-01|||||Observational|||Community Based Study of Adult Onset Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.183693|2017-10-11 04:27:13.183693
NCT00005545|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-12-10|||December 1998||1998-12-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Arterial Endothelial Function--An Epidemiologic Study|Arterial Endothelial Function--An Epidemiologic Study|Completed||N/A|600|Actual|University of Iowa|||1||f||||||||||Samples With DNA|"     Stored plasma and DNA samples   "|||2017-10-11 04:27:13.227232|2017-10-11 04:27:13.227232
NCT00005546|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||January 1999||1999-01-01|December 2004|2004-12-01|December 2004|Actual|2004-12-01|||||Observational|||Molecular Genetic Epidemiology of Three Cardiac Defects -SCOR in Pediatric Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.287866|2017-10-11 04:27:13.287866
NCT00005547|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1999||1999-04-01|January 2005|2005-01-01|June 2003|Actual|2003-06-01|||||Observational|||Infection and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.431303|2017-10-11 04:27:13.431303
NCT00005548|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1999||1999-04-01|January 2005|2005-01-01|March 2001|Actual|2001-03-01|||||Observational|||Green Tea Consumption and Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.504542|2017-10-11 04:27:13.504542
NCT00005549|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-03-13|||January 1999||1999-01-01|March 2014|2014-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Isocyanate Antigens and T Cells That Cause Asthma||Completed||N/A|||Yale University|||||f||||||||||||||2017-10-11 04:27:13.575688|2017-10-11 04:27:13.575688
NCT00005550|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-08-08|||January 1999||1999-01-01|August 2014|2014-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Endotoxin and Bronchial Inflammation in Asthma||Completed||N/A|||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-10-11 04:27:13.644825|2017-10-11 04:27:13.644825
NCT00005551|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1999||1999-04-01|August 2004|2004-08-01|March 2002|Actual|2002-03-01|||||Observational|||Sleep Apnea in a Non-Clinical Population||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.70866|2017-10-11 04:27:13.70866
NCT00005552|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||January 1999||1999-01-01|August 2004|2004-08-01|December 2001|Actual|2001-12-01|||||Observational|||Isocyanate Dermal Exposures in Autobody Shops||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.769021|2017-10-11 04:27:13.769021
NCT00005553|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-08|||May 1998||1998-05-01|October 2005|2005-10-01|April 2004||2004-04-01|||||Observational|||Prospective Assessment After Pediatric Cardiac Ablation (PAPCA)||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 04:27:13.825348|2017-10-11 04:27:13.825348
NCT00005554|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||February 1999||1999-02-01|December 2004|2004-12-01|January 2004|Actual|2004-01-01|||||Observational|||Biobehavioral Predictors of Coronary Angioplasty Outcome||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:13.914022|2017-10-11 04:27:13.914022
NCT00005555|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-07|||May 1998||1998-05-01|January 2016|2016-01-01|April 2003||2003-04-01|||||Interventional|||Dose Response to Exercise and Cardiovascular Health||Completed||N/A|||University of Florida|||||f||||||||||||||2017-10-11 04:27:13.99335|2017-10-11 04:27:13.99335
NCT00005556|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||May 1997||1997-05-01|August 2004|2004-08-01|April 2003|Actual|2003-04-01|||||Observational|||Retention of Bone Marrow Donors in a National Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:14.063303|2017-10-11 04:27:14.063303
NCT00005557|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-10-31|||April 1999||1999-04-01|October 2016|2016-10-01|April 2023|Anticipated|2023-04-01|April 2022|Anticipated|2022-04-01||Observational|||Epidemiology of Sleep-Disordered Breathing in Adults|Epidemiology of Sleep-Disordered Breathing in Adults|Enrolling by invitation||N/A|1545|Actual|University of Wisconsin, Madison|||1||f||||f||||||Samples With DNA|"     Blood   "|Undecided||2017-10-11 04:27:14.129534|2017-10-11 04:27:14.129534
NCT00005559|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1997||1997-07-01|March 2004|2004-03-01|June 2000|Actual|2000-06-01|||||Observational|||Statistical Basis for Hemochromatosis Screening||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:14.219016|2017-10-11 04:27:14.219016
NCT00005560|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||August 1999||1999-08-01|January 2008|2008-01-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Observational|||Prevalence and Correlates of Childhood Sleep Apnea||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:14.28045|2017-10-11 04:27:14.28045
NCT00005562|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-03-12|||September 1999||1999-09-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Coronary Artery Calcium, Exercise Tests, and CHD Outcome||Completed||N/A|||The Cooper Institute|||||f||||||||||||||2017-10-11 04:27:14.352316|2017-10-11 04:27:14.352316
NCT00005563|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1999||1999-07-01|September 2002|2002-09-01|June 2001|Actual|2001-06-01|||||Observational|||Multicenter Asthma Research Collaboration||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:14.417995|2017-10-11 04:27:14.417995
NCT00005570|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-22|2008-03-03|||April 2000||2000-04-01|April 2000|2000-04-01|July 2000||2000-07-01|||||Observational|||An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers|An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:14.809955|2017-10-11 04:27:14.809955
NCT00005571|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-25|2008-03-03|||April 2000||2000-04-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis|A Randomized, Third-Party-Blind, Placebo-Controlled Pilot Study of the Effect of h5G1.1-mAb on Dermatomyositis Patients|Completed||Phase 2|17||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:14.875924|2017-10-11 04:27:14.875924
NCT00005572|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-28|2008-07-31||||||June 2003|2003-06-01||||||||Observational|||A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection|Study of Pathogen-Specific Immune Responses and General Immune Competence in Opportunistic Infections|Completed||N/A|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:27:14.942772|2017-10-11 04:27:14.942772
NCT00005574|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2008-03-03|||February 2000||2000-02-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||Gentamicin Treatment of Muscular Dystrophy|Gentamicin Treatment of Patients With Muscular Dystrophy Due to Nonsense Mutations in Dystrophin|Completed||Phase 1|4||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:15.057228|2017-10-11 04:27:15.057228
NCT00005575|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-01|2010-01-12|||January 1999||1999-01-01|January 2010|2010-01-01|December 2002||2002-12-01|||||Interventional|||Treatment of Non-Cardiac Chest Pain With Imipramine or Cognitive-Behavioral Therapy|Psychophysiological Interactions in Non-Cardiac Chest Pain|Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:27:15.149193|2017-10-11 04:27:15.149193
NCT00005576|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-01-15|||January 2001||2001-01-01|January 2013|2013-01-01||||March 2002|Actual|2002-03-01||Interventional|||Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma|A PHASE I STUDY OF CHIMERIC HUMAN/MURINE ANTI-GD2 MONOCLONAL ANTIBODY (ch14.18) WITH GM-CSF AND INTERLEUKIN-2 (IL-2) IN CHILDREN WITH NEUROBLASTOMA IMMEDIATELY POST AUTOLOGOUS BMT OR PBSC RESCUE|Completed||Phase 1|6|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:15.227039|2017-10-11 04:27:15.227039
NCT00005577|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-02-04|||August 1996||1996-08-01|December 2002|2002-12-01||||September 2002|Actual|2002-09-01||Interventional|||Gemcitabine in Treating Children With Refractory Solid Tumors|A PEDIATRIC PHASE I STUDY OF GEMCITABINE (NSC# 613327) IN SOLID TUMORS|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:15.425751|2017-10-11 04:27:15.425751
NCT00005578|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2014-07-23|||March 1997||1997-03-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease|Advanced Stage Hodgkins Disease - A Pediatric Oncology Group Phase III Study|Completed||Phase 3|219|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:27:15.538432|2017-10-11 04:27:15.538432
NCT00005579|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-25|||June 1998||1998-06-01|November 2002|2002-11-01|February 2003|Actual|2003-02-01|||||Interventional|||Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia|Phase II Trial of Dolastin 10 in Indolent Lymphoma and Chronic Lymphocytic Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:15.800899|2017-10-11 04:27:15.800899
NCT00005580|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2010-02-23|||September 1998||1998-09-01|February 2010|2010-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma|Phase I Study of Bryostatin 1 (NSC 339555) and Fludarabine in Patients With Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin's Lymphoma|Completed||Phase 1|54|Actual|Virginia Commonwealth University||8|||f||||f||||||||||2017-10-11 04:27:15.886784|2017-10-11 04:27:15.886784
NCT00005581|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-12-17|||June 2000||2000-06-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer|Epirubicin Plus Paclitaxel Versus Cyclophosphamide, Epirubicin and 5-Fluorouracil as Adjuvant Treatment of Node Positive Breast Cancer Patients: A Controlled Randomized Phase III Study|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:15.971178|2017-10-11 04:27:15.971178
NCT00005583|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-08-01|||January 2000||2000-01-01|November 2006|2006-11-01|July 2010|Actual|2010-07-01|||||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer|A Randomized Trial of Adjuvant Treatment With Radiation Plus Chemotherapy Versus Radiation Alone in High Risk Endometrial Carcinoma|Completed||Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:16.143091|2017-10-11 04:27:16.143091
NCT00005584|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2017-07-26|||October 1998||1998-10-01|July 2017|2017-07-01||||May 2004|Actual|2004-05-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma|Prospective Controlled Trial in Clinical Stages I-II Supradiaphragmatic Hodgkin's Disease: Evaluation of Treatment Efficacy, (Long Term) Toxicity and Quality of Life in Two Different Prognostic Subgroups|Active, not recruiting||Phase 3|1649|Actual|European Organisation for Research and Treatment of Cancer - EORTC||3|||f||||||||||||||2017-10-11 04:27:16.287166|2017-10-11 04:27:16.287166
NCT00005585|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-07|||April 2000||2000-04-01|June 2013|2013-06-01||||July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia|ALINC #17 Treatment for Patients With Low Risk Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Phase III Study|Completed||Phase 3|838|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:27:16.615898|2017-10-11 04:27:16.615898
NCT00005586|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-12-17|||October 1997||1997-10-01|March 2007|2007-03-01||||||||Interventional|||Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed|A UKCCCR Study of Adjuvant Chemotherapy for Colorectal Cancer|Completed||Phase 3|2500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:17.072812|2017-10-11 04:27:17.072812
NCT00005922|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-22|2013-09-20|||August 2000||2000-08-01|September 2013|2013-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Conditioning, the Placebo Effect, and Psoriasis|Role of Conditioning in the Pharmacotherapy of Psoriasis|Completed||N/A|138|Actual|University of Rochester||3|||f||||t||||||||||2017-10-11 04:27:43.685125|2017-10-11 04:27:43.685125
NCT00005587|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-12-18|||January 1999||1999-01-01|July 2001|2001-07-01|June 2004|Actual|2004-06-01|||||Interventional|||Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer|Standardization of Breast Radiotherapy: Trial B - A Randomized Comparison of Fractionation Regimens After Local Excision or Mastectomy in Women With Early Stage Breast Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:17.159958|2017-10-11 04:27:17.159958
NCT00005588|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-12-18|||January 1999||1999-01-01|June 2000|2000-06-01|December 2004|Actual|2004-12-01|||||Interventional|||Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer|Standardization of Breast Radiotherapy: Trial A - A Randomized Comparison of Fractionation Regimens After Local Excision or Mastectomy in Women With Early Stage Breast Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:17.288486|2017-10-11 04:27:17.288486
NCT00005589|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-09-16|||October 1999||1999-10-01|March 2007|2007-03-01|April 2013|Actual|2013-04-01|||||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|Randomized Study of Rituximab (Mabthera) in Patients With Relapsed Follicular Lymphoma Prior to High-Dose Therapy as In Vivo Purging and to Maintain Remission Following High-Dose Therapy|Completed||Phase 3|460|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:17.424586|2017-10-11 04:27:17.424586
NCT00005590|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-08-01|||August 1999||1999-08-01|July 2002|2002-07-01|September 2005|Actual|2005-09-01|||||Interventional|||Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma|A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:17.770779|2017-10-11 04:27:17.770779
NCT00005591|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-12-11|||October 1999||1999-10-01|April 2007|2007-04-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas|Phase II Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody C225 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer|Withdrawn||Phase 2|0|Actual|University of Alabama at Birmingham|||||f||||t||||||||||2017-10-11 04:27:17.894|2017-10-11 04:27:17.894
NCT00005592|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2015-10-20|||November 1999||1999-11-01|October 2015|2015-10-01|November 2005|Actual|2005-11-01|March 2002|Actual|2002-03-01||Interventional|||Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Multicenter, Open-Label, Trial to Evaluate the Efficacy and Safety of IDEC-Y2B8 Radioimmunotherapy of Relapsed or Refractory Low-Grade or Follicular Transformed B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|23|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:27:17.954669|2017-10-11 04:27:17.954669
NCT00005593|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2010-06-09|||September 1998||1998-09-01|June 2010|2010-06-01|March 2003|Actual|2003-03-01|April 2002|Actual|2002-04-01||Interventional|||Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome|Phase I Study of Fludarabine, Carboplatin, and Topotecan for Patients With Relapsed/Refractory Acute Leukemia and Advanced Myelodysplastic Syndromes|Completed||Phase 1|31|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:27:18.043166|2017-10-11 04:27:18.043166
NCT00005594|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2010-12-30|||July 2000||2000-07-01|December 2010|2010-12-01||||December 2000|Actual|2000-12-01||Interventional|||ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas|Phase II Trial of ISIS 2503, an Antisense Inhibitor of H-Ras, in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|4|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:27:18.129931|2017-10-11 04:27:18.129931
NCT00005595|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-06-07||2011-02-18|June 2000||2000-06-01|June 2012|2012-06-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease|Multicenter Phase II Trial of Arsenic Trioxide in Relapsed and Refractory Hodgkin's Disease|Terminated||Phase 2|2|Actual|Northwestern University||||Unable to accrue subjects in a timely fashion.|f||||t||||||||||2017-10-11 04:27:18.205847|2017-10-11 04:27:18.205847
NCT00005596|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2016-05-11|||April 2000||2000-04-01|May 2016|2016-05-01|July 2007|Actual|2007-07-01|July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia|ALinC 17: Protocol for Patients With Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL): A Phase III Study|Completed||Phase 3|1076|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:27:18.300696|2017-10-11 04:27:18.300696
NCT00005597|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-01-02|||April 2000||2000-04-01|January 2013|2013-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors|Phase II Study of Temozolomide in Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 2|25|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:27:18.679297|2017-10-11 04:27:18.679297
NCT00005598|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-12-19|||October 2000||2000-10-01|December 2012|2012-12-01|March 2002|Actual|2002-03-01|December 2001|Actual|2001-12-01||Interventional|||Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome|A Phase II Trial of 5-Azacytidine (NSC #102816) and Ethyol (Amifostine) in the Treatment of Adults With Myelodysplastic Syndromes|Completed||Phase 2|||University of Michigan Cancer Center|||||f||||t||||||||||2017-10-11 04:27:19.078981|2017-10-11 04:27:19.078981
NCT00005599|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-20|||February 2000||2000-02-01|August 2004|2004-08-01|August 2004|Actual|2004-08-01|||||Interventional|||Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer|Phase II Trail of Bryostatin-1 and Paclitaxel in Patients With Advanced Esophageal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:19.1533|2017-10-11 04:27:19.1533
NCT00005600|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-11-05|||November 1997||1997-11-01|December 2005|2005-12-01||||||||Interventional|||Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer|Optimum Drainage of the Axilla After Lymph Node Dissection: A Randomized Prospective Study|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:19.244575|2017-10-11 04:27:19.244575
NCT00005601|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2016-12-05|||October 2000||2000-10-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|July 2003|Actual|2003-07-01||Interventional|||Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|A Phase II Trial of Cisplatinum, Cytosine Arabinoside, Dexamethasone (DHAP) With Rituxan in Patients With Relapsed CD20+ B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|58|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:27:19.324015|2017-10-11 04:27:19.324015
NCT00005033|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-06-20|||December 1999||1999-12-01|August 2004|2004-08-01|August 2004|Actual|2004-08-01|||||Interventional|||Trastuzumab in Treating Patients With Recurrent Osteosarcoma|Phase II Study of Recombinant Humanized Monoclonal Antibody Against HER2 for the Treatment of Recurrent Osteosarcoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:19.501946|2017-10-11 04:27:19.501946
NCT00005035|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-01-30|||December 1999||1999-12-01|February 2002|2002-02-01|March 2004|Actual|2004-03-01|||||Interventional|||Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer|A Phase II Study of Oxaliplatin in Patients With Advanced Carcinoma of the Head and Neck|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:19.586273|2017-10-11 04:27:19.586273
NCT00005036|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-05-01|||November 1999||1999-11-01|May 2013|2013-05-01||||December 2006|Actual|2006-12-01||Interventional|||Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|A Randomized Phase III Equivalence Trial of Irinotecan (CPT-11) Versus Oxaliplatin (OXAL)/5-Fluorouracil (5-FU)/Leucovorin (CF) in Patients With Advanced Colorectal Carcinoma Previously Treated With 5-FU|Completed||Phase 3|560|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:27:19.696808|2017-10-11 04:27:19.696808
NCT00005037|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-05-05|||January 2000||2000-01-01|May 2014|2014-05-01|April 2008|Actual|2008-04-01|October 2002|Actual|2002-10-01||Interventional|||Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer|Temozolomide in the Treatment of Advanced Non-Small Cell Lung Carcinoma: Phase II Evaluation in Previously Treated and Chemo-Naive Patients|Completed||Phase 2|51|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-10-11 04:27:19.850322|2017-10-11 04:27:19.850322
NCT00005038|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-09-19|||June 1999||1999-06-01|June 2001|2001-06-01||||||||Interventional|||Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer|A Randomized Phase II Study to Evaluate the Efficacy of Combined Immunotherapy With Subcutaneous Interleukin-2 and Maxamine in Patients With Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:19.950417|2017-10-11 04:27:19.950417
NCT00005039|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-01-23|||January 2000||2000-01-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)|A Phase II Randomized Trial of Recombinant Fowlpox and Recombinant Vaccinia Virus Expressing PSA in Patients With Adenocarcinoma of the Prostate|Terminated||Phase 2|86|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:27:20.014889|2017-10-11 04:27:20.014889
NCT00005040|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma|Phase II Study of Arsenic Trioxide (NSC #706363) in Relapsed and Refractory Intermediate and High-Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:27:20.12018|2017-10-11 04:27:20.12018
NCT00005041|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-11-08|||September 1999||1999-09-01|November 2000|2000-11-01||||May 2000|Actual|2000-05-01||Interventional|||R115777 in Treating Patients With Relapsed Small Cell Lung Cancer|A Phase II Study to Determine the Antitumor Activity of Farnesyltransferase Inhibitor R115777 in Subjects With Relapsed Small Cell Lung Cancer|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:27:20.193039|2017-10-11 04:27:20.193039
NCT00005042|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2014-08-28|||January 2000||2000-01-01|August 2014|2014-08-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma|A Multicenter, Open-Label, Phase II Study of SU5416 in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|||AIDS Malignancy Consortium|||||f||||f||||||||||2017-10-11 04:27:20.305375|2017-10-11 04:27:20.305375
NCT00005045|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-06-20|||March 2000||2000-03-01|December 2005|2005-12-01|June 2004|Actual|2004-06-01|||||Interventional|||Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer|Phase II Study of Carboxyamidotriazole (CAI, NSC #609974) in Patients With Advanced Renal Cell Carcinoma Refractory to Immunotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:21.139446|2017-10-11 04:27:21.139446
NCT00005046|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-05-24|||April 2000||2000-04-01|July 2008|2008-07-01||||January 2007|Actual|2007-01-01||Interventional|||Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer|A Phase I Open Label Assessment of the Safety and Pharmacokinetics of Intraperitoneal PACLIMER Microspheres (Polilactofate/Paclitaxel) in Patients With Ovarian Cancer|Completed||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:27:21.454645|2017-10-11 04:27:21.454645
NCT00005047|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2017-05-10|2017-03-23||August 1997|Actual|1997-08-01|May 2017|2017-05-01|December 2014|Actual|2014-12-01|March 2011|Actual|2011-03-01||Interventional|||4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer|MVAC (Methotrexate, Vinblastine, Adriamycin, and Cisplatin) in Organ-Confined Bladder Cancer Based on p53 Status|Terminated||Phase 3|521|Actual|Southwest Oncology Group||4||"Accrual was halted on the basis of the Data and Safety Monitoring Board review of a futility   analysis."|f||||t||||||||||2017-10-11 04:27:21.579856|2017-10-11 04:27:21.579856
NCT00005048|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-11-08|||April 1997||1997-04-01|November 2000|2000-11-01||||August 2000|Actual|2000-08-01||Interventional|||Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|Safety and Efficacy of One Hour Weekly Taxol Infusion and Estramustine in Hormone Refractory Prostate Cancer|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:27:22.736582|2017-10-11 04:27:22.736582
NCT00005049|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2011-04-04|||May 1997||1997-05-01|April 2011|2011-04-01||||November 2006|Actual|2006-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer|Pilot Study of Intraperitoneal (IP) Therapy With Cisplatin or Carboplatin and Floxuridine (FUdR) as Consolidation for Ovarian and Gastrointestinal Malignancies|Completed||Phase 2|45|Actual|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:27:22.824379|2017-10-11 04:27:22.824379
NCT00005923|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-23|2005-06-23||||||November 2001|2001-11-01||||||||Observational|||The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:27:43.793468|2017-10-11 04:27:43.793468
NCT00005050|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2011-03-25|||August 1999||1999-08-01|March 2011|2011-03-01||||June 2001|Actual|2001-06-01||Interventional|||Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer|A Phase I/II Study of Eniluracil Plus Oral 5-Fluorouracil Combined With Oxaliplatin (FOX-E) in Patients With Previously-Treated Colorectal Cancer|Completed||Phase 1/Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:27:22.906362|2017-10-11 04:27:22.906362
NCT00005051|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-11-08|||August 1999||1999-08-01|December 2003|2003-12-01||||March 2003|Actual|2003-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer|Phase II Study of First-Line Therapy of Ovarian Cancer With Sequential Regimens: Cisplatin-Prolonged Oral Topotecan (C-PORT) Followed by Paclitaxel/Carboplatin (PC)|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:27:22.975799|2017-10-11 04:27:22.975799
NCT00005052|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2009-02-06|||December 1999||1999-12-01|January 2006|2006-01-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Primary Stage II Melanoma|Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination: Post-Operative Adjuvant Ganglioside GM2-KLH/QS-21 (BMS-248479) Vaccination Treatment After Resection of Primary Cutaneous Melanoma Thicker Than 1.5mm (AJCC/UICC Stage II, T3-T4N0M0), a 2-Arm Multicenter Randomized Phase III Trial vs. Observation|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:23.075897|2017-10-11 04:27:23.075897
NCT00005053|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-09-20|||December 1999||1999-12-01|September 2012|2012-09-01||||March 2001|Actual|2001-03-01||Interventional|||Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer|Open Label Phase II Study on Glufosfamide Administered as a 60 Minute Infusion Every 3 Weeks in Advanced Pancreatic Cancer|Completed||Phase 2|35|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:27:23.315172|2017-10-11 04:27:23.315172
NCT00005054|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-09-19|||May 1998||1998-05-01|January 2001|2001-01-01||||||||Interventional|||Temozolomide in Treating Women With Advanced Breast Cancer|Phase II Trial of Temodal 4 Hourly in Progressive Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:23.445377|2017-10-11 04:27:23.445377
NCT00005055|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2012-09-20|||January 2000||2000-01-01|September 2012|2012-09-01||||March 2001|Actual|2001-03-01||Interventional|||Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer|Open Label Phase II Study on Glufosfamide Administered as a 60 Minute Infusion Every 3 Weeks in Advanced Non Small Cell Lung Cancer|Completed||Phase 2|39|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:27:23.505258|2017-10-11 04:27:23.505258
NCT00005056|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-06-25|||March 1999||1999-03-01|June 2006|2006-06-01|July 2006|Actual|2006-07-01|||||Interventional|||Bryostatin 1 In Treating Patients With Progressive Kidney Cancer|A Phase II Trial of Bryostatin-1 in Hypernephroma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:23.568183|2017-10-11 04:27:23.568183
NCT00005057|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2015-04-28|||March 2000||2000-03-01|December 2002|2002-12-01||||||||Interventional|||Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma|A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination With Escalating Doses of Ganciclovir in Patients With Cutaneous Metastatic Malignant Melanoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:23.634591|2017-10-11 04:27:23.634591
NCT00005058|ClinicalTrials.gov processed this data on October 10, 2017|2000-04-06|2013-11-05|||August 1997||1997-08-01|April 2005|2005-04-01||||||||Interventional|||Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer|A Direct Comparison of Contrast Enhanced Power Doppler Ultrasound in Primary Breast Cancer and Axillary Nodal Status With Histopathological Variables and Clinical Outcome|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:23.706328|2017-10-11 04:27:23.706328
NCT00005602|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2014-02-19|||February 2001||2001-02-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas|Phase I Study of Concurrent Cereport and Carboplatin With Radiation Therapy for Children With Newly-Diagnosed Brain Stem Gliomas|Completed||Phase 1|13|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:27:23.765832|2017-10-11 04:27:23.765832
NCT00005603|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2014-02-18|||March 2000||2000-03-01|February 2014|2014-02-01||||September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia|ALinC 17: Protocol for Patients With Newly Diagnosed High Risk Acute Lymphoblastic Leukemia (ALL) - Evaluation of the Augmented BFM Regimen: A Phase III Study|Completed||Phase 3|276|Actual|Children's Oncology Group|||||f||||t||||||||||2017-10-11 04:27:23.892981|2017-10-11 04:27:23.892981
NCT00005604|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-01-31|||March 2000||2000-03-01|January 2013|2013-01-01||||July 2003|Actual|2003-07-01||Interventional|||Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors|Phase I Trial of Twice Weekly IV IL-12 Plus Low-Dose Subcutaneous IL-2 in Patients With Advanced Malignancies|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:24.029356|2017-10-11 04:27:24.029356
NCT00005605|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2011-02-18|||February 2000||2000-02-01|February 2011|2011-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer|Does Tamoxifen Prevent the Skeletal and Cardiovascular Morbidity of Chemotherapy in Premenopausal Women?|Completed||N/A|79|Actual|Northwestern University|||2||f||||||||||||||2017-10-11 04:27:25.433569|2017-10-11 04:27:25.433569
NCT00005606|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-05-31||2011-02-16|February 2000||2000-02-01|May 2012|2012-05-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation|Adoptive Immunotherapy of Epstein Barr Virus Induced Lymhoproliferative Disease. A Comparison of Allogeneic and Autologous Lymphocyte Responses ex Vivo and Use of Highly Selected Reactive Cells as an Alternative to Chemotherapy in Vivo.|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:27:25.495101|2017-10-11 04:27:25.495101
NCT00005607|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-12-18|||February 2000||2000-02-01|July 2000|2000-07-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus|A Phase II Study of CPT-11 and 5-FU/LCV in Patients With Previously Untreated Gastric Adenocarcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:25.579877|2017-10-11 04:27:25.579877
NCT00005608|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-05-31||2011-02-18|February 2000||2000-02-01|May 2012|2012-05-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer|Orzel (UFT+Leucovorin) as First-Line Therapy for Metastatic Breast Cancer|Terminated||Phase 2|||Northwestern University||||Drug was pulled from the market.|f||||||||||||||2017-10-11 04:27:25.658971|2017-10-11 04:27:25.658971
NCT00005609|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-08-14|||April 2000||2000-04-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|||||Interventional|||Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia|Rituximab for Waldenstrom's Macroglobulinemia (WM): A Phase II Pilot Study for Untreated or Previously Treated Patients|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:25.737575|2017-10-11 04:27:25.737575
NCT00005610|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2016-07-12|||September 2000||2000-09-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung|Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung|Completed||Phase 2|28|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:27:25.949889|2017-10-11 04:27:25.949889
NCT00005611|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2008-07-23||||||August 2000|2000-08-01||||||||Interventional|||BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment|Phase I Study of BMS-188797 in Patients With Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:26.167795|2017-10-11 04:27:26.167795
NCT00005612|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-09-24|||August 1999||1999-08-01|September 2012|2012-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|ETC||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer|A Phase I/II Study of Intensive-Dose Etoposide, Topotecan and Carboplatin (ETC) Followed by Autologous Stem Cell Rescue in Chemosensitive Ovarian Cancer Patients With Either Minimal Residual Disease or at First Relapse|Terminated||Phase 1/Phase 2|3|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||Low accrual|f||||f||||||||||2017-10-11 04:27:26.227145|2017-10-11 04:27:26.227145
NCT00005613|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-03|||March 1996||1996-03-01|June 2013|2013-06-01|June 2010|Actual|2010-06-01|October 2006|Actual|2006-10-01||Interventional|CBV||Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease|A Prospective, Comparative Trial of Allogeneic Versus Autologous Stem Cell Transplantation for High Risk Lymphoma|Completed||Phase 2|147|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-11 04:27:26.313114|2017-10-11 04:27:26.313114
NCT00005614|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-09-21|||August 1999||1999-08-01|September 2012|2012-09-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Management of Metastatic Breast Cancer in Frail Patients|Management of Metastatic Breast Cancer in Frail Patients|Withdrawn||Phase 2|0|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||no accrual|f||||f||||||||||2017-10-11 04:27:26.419654|2017-10-11 04:27:26.419654
NCT00005615|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-09-21|||July 1997||1997-07-01|September 2012|2012-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa|The Florida Melanoma Trial: A Phase I/II Trial of Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa in the Treatment of Advanced Stage III Melanoma: Study Site & Coordinating Center|Completed||Phase 1/Phase 2|24|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:27:26.496552|2017-10-11 04:27:26.496552
NCT00005616|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-18|||September 1999||1999-09-01|June 2013|2013-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer|A Phase I Single Dose-Escalation Study of BIBH-1 in Patients With Colorectal Cancer Scheduled for Surgical Resection|Completed||Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:27:26.588222|2017-10-11 04:27:26.588222
NCT00005617|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2015-10-28|||July 1997||1997-07-01|July 2012|2012-07-01||||June 2002|Actual|2002-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma|A Phase I Trial Testing Mart-1 Peptide Immunization in Malignant Melanoma|Completed||Phase 1|||Jonsson Comprehensive Cancer Center||6|||f||||t||||||||||2017-10-11 04:27:26.68243|2017-10-11 04:27:26.68243
NCT00005618|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-20|||February 2000||2000-02-01|October 2001|2001-10-01|March 2004|Actual|2004-03-01|||||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia|Phase II Study of Arsenic Trioxide, NSC 706363, in Relapsed of Refractory Chronic Myelogenous Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:26.778976|2017-10-11 04:27:26.778976
NCT00005619|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2011-02-18|||February 2000||2000-02-01|February 2011|2011-02-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Observational|||Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia|Detection of Hairy Cell Leukemia Minimal Residual Disease: Detection by Flow Cytometry|Completed||N/A|16|Actual|Northwestern University|||1||f||||||||||||||2017-10-11 04:27:26.83991|2017-10-11 04:27:26.83991
NCT00005622|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-10-24|||May 1996||1996-05-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|September 2005|Actual|2005-09-01||Interventional|||Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders|Allogeneic Bone Marrow Transplantation Using Closely Matched Related and Unrelated Donors|Completed||Phase 2|72|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:27:26.898568|2017-10-11 04:27:26.898568
NCT00005623|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-03-25|||December 1999||1999-12-01|December 2003|2003-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer|A Phase III, Randomized, Multicenter, Placebo-Controlled, Double-Blind Clinical Trial to Study the Efficacy and Safety of CyPat (Cyproterone Acetate [CA]) for the Treatment of Hot Flashes Following Surgical or Chemical Castration of Prostate Cancer Patients and Its Impact on the Quality of Life in These Patients|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:26.99204|2017-10-11 04:27:26.99204
NCT00005624|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-09-21|||August 1997||1997-08-01|September 2012|2012-09-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||CI-994 in Treating Patients With Advanced Myeloma|A Multicenter Phase 2 Study of Oral N-Acetyl Dinaline (CI-994) in the Treatment of Patients With Advanced Myeloma|Completed||Phase 2|6|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:27:27.085028|2017-10-11 04:27:27.085028
NCT00005374|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||January 1994||1994-01-01|March 2005|2005-03-01|May 2004||2004-05-01|||||Observational|||Genetics of the Metabolic Syndrome in Japanese Americans||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:28:04.325083|2017-10-11 04:28:04.325083
NCT00005625|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-18|||December 1999||1999-12-01|June 2013|2013-06-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma|Phase II Study of ET-743 Therapy in Metastatic Osteosarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:27:27.172295|2017-10-11 04:27:27.172295
NCT00005626|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-09-24|||February 1998||1998-02-01|September 2012|2012-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)|Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11) in Newly Diagnosed and Relapsed Indolent Lymphoproliferative Malignancies|Completed||Phase 2|10|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:27:27.236762|2017-10-11 04:27:27.236762
NCT00005627|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-07-17|||March 1999||1999-03-01|April 2003|2003-04-01|April 2003|Actual|2003-04-01|||||Interventional|||Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase I Study of Estramustine, Taxotere and Carboplatin (ETP) in Patients With Horomone Refractory Prostate Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:27.347038|2017-10-11 04:27:27.347038
NCT00005628|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-18|||November 1999||1999-11-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma|A Phase II Trial of Active Specific Immunotherapy in Patients With Recurrent Soft Tissue Sarcoma Using Autologous Tumor-derived Heat Shock Protein-Peptide Complex (HSPPC-96)|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:27:27.429211|2017-10-11 04:27:27.429211
NCT00005629|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2015-09-30|||July 1999||1999-07-01|July 2012|2012-07-01|June 2002|Actual|2002-06-01|May 2002|Actual|2002-05-01||Interventional|||Vaccine Therapy in Treating Patients With Liver Cancer|Phase I/II Trial Testing Alpha Fetoprotein (AFP) Peptide Immunization in Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|6|Actual|Jonsson Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 04:27:27.501421|2017-10-11 04:27:27.501421
NCT00005795|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-06-07||2011-02-16|February 2000||2000-02-01|June 2012|2012-06-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia|Phase II Trial of Arsenic Trioxide in Relapsed and Refractory Acute Myeloid Leukemia, Secondary Leukemia, and/or Newly-Diagnosed Patients Greater Than or Equal to 65 Years Old|Completed||Phase 2|11|Actual|Northwestern University|||||f||||t||||||||||2017-10-11 04:27:27.635292|2017-10-11 04:27:27.635292
NCT00005796|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2015-03-23|||February 2000||2000-02-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors|A Pilot Study of Dose-Intensified Procarbazine, CCNU, Vincristine (PCV) for Poor Prognosis Pediatric and Adult Brain Tumors Utilizing Fibronectin-Assisted, Retroviral-Mediated Modification of CD34+ Peripheral Blood Cells With O6-Methylguanine DNA Methyltransferase|Completed||Phase 1|10|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 04:27:27.764456|2017-10-11 04:27:27.764456
NCT00005797|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-10-24|||March 1993||1993-03-01|October 2012|2012-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Bone Marrow Transplant in Treating Patients With Hematologic Cancers|Allogeneic Bone Marrow Transplantation for Hematologic Malignancies: A Treatment Approach Based on Risk of Relapse and Toxicity|Completed||Phase 2|125|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-11 04:27:28.047479|2017-10-11 04:27:28.047479
NCT00005798|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-10-24|||July 1995||1995-07-01|October 2012|2012-10-01|July 2007|Actual|2007-07-01|August 2001|Actual|2001-08-01||Interventional|CTC||Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer|A Phase II Study of Cyclophosphamide, Thiotepa, and Carboplatin (CTC) as a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Patients With Breast Cancer|Completed||Phase 2|209|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:27:28.179599|2017-10-11 04:27:28.179599
NCT00005800|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-09-24|||April 1999||1999-04-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|January 2006|Actual|2006-01-01||Interventional|||Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer|A Phase II Neoadjuvant Trial of Sequential Doxorubicin and Docetaxel for the Treatment of Stage III Breast Cancer Measuring STAT Activation as a Predictor of Response to Therapy|Completed||Phase 2|45|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:27:28.556565|2017-10-11 04:27:28.556565
NCT00005801|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-11-14|||November 1999||1999-11-01|September 2001|2001-09-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia|A Phase II Study of Allografting to Establish Mixed or Full Donor Chimerism as Consolidative Immunotherapy for Older Patients With AML in Complete Remission Using Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Completed||Phase 2|||University of Colorado, Denver|||||f||||||||||||||2017-10-11 04:27:28.692336|2017-10-11 04:27:28.692336
NCT00005802|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2010-03-31|||June 1999||1999-06-01|March 2010|2010-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia|Chemotherapy (CT) Followed by Donor Lymphocyte Infusion (DLI) Plus Interleukin 2 (IL-2) for Patients With Relapse Acute Myeloid or Lymphoid Leukemia After Allogeneic Hematopoietic Transplant|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:27:28.792107|2017-10-11 04:27:28.792107
NCT00005804|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2010-03-31|||October 1999||1999-10-01|March 2010|2010-03-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Treatment of Patients With Hematological Malignancies Using Marrow Transplantation From Unrelated Donors Incompatible for One HLA Locus Antigen|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:27:29.193327|2017-10-11 04:27:29.193327
NCT00005805|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-01-17|||December 1999||1999-12-01|January 2013|2013-01-01||||June 2000|Actual|2000-06-01||Interventional|||St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer|Does Hypericum Reduce Fatigue in Cancer Patients on Chemotherapy? A Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 3|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:27:29.309475|2017-10-11 04:27:29.309475
NCT00005806|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-06-17|||September 1999||1999-09-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer|A Pilot Trial of Daily Oral ZD1839 (Iressa) With Standard Doses of Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:27:29.447121|2017-10-11 04:27:29.447121
NCT00005807|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2008-07-23|||July 2000||2000-07-01|September 2003|2003-09-01||||||||Interventional|||BMS-247550 in Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer|A Phase I Scientific Exploratory Study of Epothilone B Analog (BMS-247550; NSC #710428) in Patients With Solid Tumors and Gynecological Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:29.526557|2017-10-11 04:27:29.526557
NCT00005808|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-02-06|||December 2000||2000-12-01|February 2013|2013-02-01||||April 2004|Actual|2004-04-01||Interventional|||Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia|Phase I Study Photodynamic Therapy Using Lutrin (Lutetium Texaphyrin) in the Treatment of Patients With Cervical Intraepithelial Neoplasia|Terminated||Phase 1|54|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:27:29.612177|2017-10-11 04:27:29.612177
NCT00005809|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-02-01|||July 2000||2000-07-01|February 2013|2013-02-01|January 2003|Actual|2003-01-01|October 2000|Actual|2000-10-01||Interventional|ACRIN 6656||Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia|Computerized Tomographic Colonography: Performance Evaluation in a Multicenter Setting|Completed||N/A|||American College of Radiology Imaging Network|||||f||||t||||||||||2017-10-11 04:27:29.740713|2017-10-11 04:27:29.740713
NCT00005810|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2016-07-12|||March 2000||2000-03-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer|Completed||Phase 2|40|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:27:29.825715|2017-10-11 04:27:29.825715
NCT00005811|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-02-20|||April 2000||2000-04-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|April 2006|Actual|2006-04-01||Interventional|||Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment|A Phase II Study of Intrathecal Topotecan (NSC #609699) in Patients With Refractory Meningeal Malignancies|Completed||Phase 2|77|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:29.919817|2017-10-11 04:27:29.919817
NCT00005812|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-05-13|||January 2000||2000-01-01|May 2013|2013-05-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma|A Pilot Phase II Trial of Temozolomide in Leptomeningeal Metastases|Terminated||Phase 2|12|Actual|Dartmouth-Hitchcock Medical Center||1||No objective response documented, protocol terminated after 12 patients.|f||||t||||||||||2017-10-11 04:27:30.023711|2017-10-11 04:27:30.023711
NCT00005813|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2011-10-26|||March 1997||1997-03-01|October 2011|2011-10-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme|A Phase I Trial of Intratumoral Bispecific Antibody and Activated Monocytes in Patients With Recurrent or Refractory Glioblastoma Multiforme|Completed||Phase 1|||Dartmouth-Hitchcock Medical Center|||||f||||t||||||||||2017-10-11 04:27:30.099327|2017-10-11 04:27:30.099327
NCT00005814|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-06-17|||December 1999||1999-12-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer|Phase II Study of C225 in Combination With Cisplatin and Standard/Delayed Accelerated Hyperfractionated Radiation Therapy in Patients With Advanced Head & Neck Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:27:30.161228|2017-10-11 04:27:30.161228
NCT00005815|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-06-17|||December 1999||1999-12-01|June 2013|2013-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma|A Phase I/II Study of Temozolamide and Thalidomide in the Treatment of Advanced Melanoma|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:27:30.233301|2017-10-11 04:27:30.233301
NCT00005816|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-03-19|||February 2000||2000-02-01|December 2008|2008-12-01|August 2002|Actual|2002-08-01|||||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer|Active Immunotherapy of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA|Completed||Phase 1|15|Actual|Duke University|||||f||||||||||||||2017-10-11 04:27:30.303452|2017-10-11 04:27:30.303452
NCT00005817|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-01-31|||March 2000||2000-03-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer|A Randomized Phase 2 Study of Rebeccamycin Analog in Advanced Breast Cancer|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:27:30.385425|2017-10-11 04:27:30.385425
NCT00005818|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-01-22|||March 2000||2000-03-01|January 2013|2013-01-01||||March 2003|Actual|2003-03-01||Interventional|||SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer|A Phase I/II Study of Escalating Doses of SU5416 (NSC 696819) in Combination With CPT-11 in Patients With Advanced Colorectal Carcinoma|Completed||Phase 1/Phase 2|68|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:30.467344|2017-10-11 04:27:30.467344
NCT00005819|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2010-06-09|||April 2000||2000-04-01|June 2010|2010-06-01|August 2006|Actual|2006-08-01|May 2005|Actual|2005-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Fenretinide in Combination With Paclitaxel and Cisplatin|Completed||Phase 1|21|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:27:30.677484|2017-10-11 04:27:30.677484
NCT00005820|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2016-07-12|||May 2000||2000-05-01|July 2016|2016-07-01|September 2006|Actual|2006-09-01|September 2004|Actual|2004-09-01||Interventional|||Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer|Completed||Phase 2|35|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:27:30.763946|2017-10-11 04:27:30.763946
NCT00005821|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-11-05|||December 1998||1998-12-01|March 2003|2003-03-01||||||||Interventional|||Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer|Sentinel Lymph Node Biopsy in the Assessment of Axillary Nodal Status in Operable Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:30.942748|2017-10-11 04:27:30.942748
NCT00005822|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2010-06-10|||April 2000||2000-04-01|June 2010|2010-06-01|October 2003|Actual|2003-10-01|December 2002|Actual|2002-12-01||Interventional|||SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer|A Phase I Pharmacokinetic, Pharmacodynamic, and Clinical Study of the Combination of the Angiogenesis Inhibitor SU5416 and Doxorubicin in Inflammatory Breast Cancer|Completed||Phase 1|21|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:27:31.018024|2017-10-11 04:27:31.018024
NCT00005823|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-17|||December 1998||1998-12-01|September 2006|2006-09-01|December 2007|Actual|2007-12-01|||||Interventional|||Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome|A Randomized Trial for Patients With Acute Myeloid Leukemia or High Risk Myelodysplatic Syndrome Aged 60 or Over|Completed||Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:31.098844|2017-10-11 04:27:31.098844
NCT00005824|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2016-02-01|||November 2000||2000-11-01|February 2016|2016-02-01|April 2006|Actual|2006-04-01|July 2004|Actual|2004-07-01||Interventional|||Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma|Pilot Study of the Safety and Feasibility of Autologous Peripheral Blood Stem Cell Transplantation for Patients With Relapsed AIDS-Related Lymphoma|Completed||Phase 2|||AIDS Malignancy Consortium|||||f||||||||||||||2017-10-11 04:27:31.209548|2017-10-11 04:27:31.209548
NCT00005825|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-17|||September 1998||1998-09-01|July 2003|2003-07-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Trans Retinoic Acid (Vesanoid) With Chemotherapy in Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:31.288443|2017-10-11 04:27:31.288443
NCT00005826|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-09-20|||March 2000||2000-03-01|September 2012|2012-09-01||||September 2000|Actual|2000-09-01||Interventional|||Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme|"Open Label Phase II Study on RFS 2000 (9-Nitro-Camptothecin, 9-NC) Administered as a 5 Days On-2 Days Off Oral Treatment in Glioblastoma Multiforme"|Completed||Phase 2|17|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:27:31.372937|2017-10-11 04:27:31.372937
NCT00005827|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-04-20|||December 1999||1999-12-01|April 2012|2012-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer|Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical Study of Genistein in Normal Volunteers and in Prostate Neoplasia (Multiple Dose Safety and Pharmacokinetic Clinical Study of Genistein in Prostate Neoplasia)|Withdrawn||Phase 1|0|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:27:31.460344|2017-10-11 04:27:31.460344
NCT00005828|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2016-07-12|||December 2000||2000-12-01|July 2016|2016-07-01|June 2008|Actual|2008-06-01|March 2003|Actual|2003-03-01||Interventional|||Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of Green Tea Extract in the Treatment of Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|54|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:27:31.533561|2017-10-11 04:27:31.533561
NCT00005829|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2016-12-05|||February 2000||2000-02-01|December 2016|2016-12-01|April 2008|Actual|2008-04-01|October 2002|Actual|2002-10-01||Interventional|||Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia|Phase II Study of Gemcitabine for Relapsed B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|22|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:27:31.650659|2017-10-11 04:27:31.650659
NCT00005830|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2014-12-29|||July 2000||2000-07-01|December 2014|2014-12-01||||July 2009|Actual|2009-07-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer|Phase I Toxicity Trial of Doxorubicin-Cisplatin Followed by Whole Abdominal Irradiation for Advanced Endometrial Carcinoma|Completed||Phase 1|31|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:27:31.736082|2017-10-11 04:27:31.736082
NCT00005831|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-01-11|||March 2000||2000-03-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer|Phase II Evaluation of Trastuzumab (Herceptin), Paclitaxel, Carboplatin, and Gemcitabine in the Treatment of Advanced Urothelial Cancer|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:31.834021|2017-10-11 04:27:31.834021
NCT00005832|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2015-11-16|||June 2000||2000-06-01|November 2015|2015-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase II Trial of R115777 (NSC #702818) in Patients With Advanced Pancreas Cancer|Completed||Phase 2|58|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:27:31.951855|2017-10-11 04:27:31.951855
NCT00005833|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-06-12|||June 2000||2000-06-01|June 2012|2012-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||S9923 R115777 in Treating Patients With Advanced Colorectal Cancer|A Phase II Trial of R115777 (NSC #702818) in Patients With Advanced Colorectal Cancer|Completed||Phase 2|62|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:27:32.070365|2017-10-11 04:27:32.070365
NCT00005375|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2008-01-25|||September 1993||1993-09-01|January 2008|2008-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Smoking Onset in a Biethnic Population||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.394757|2017-10-11 04:28:04.394757
NCT00005834|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2015-03-05|||April 2000||2000-04-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2003|Actual|2003-11-01||Interventional|||S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma|A Phase III Trial of Dexamethasone, Cyclophosphamide, Etoposide, Cisplatin (DCEP) and G-CSF With or Without Thalidomide (NSC #66847) as Salvage Therapy for Patients With Refractory Multiple Myeloma|Terminated||Phase 3|19|Actual|Southwest Oncology Group||2||poor accrual|f||||t||||||||||2017-10-11 04:27:32.216252|2017-10-11 04:27:32.216252
NCT00005835|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2016-08-27|||August 2001||2001-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Interventional|BSO||N99-02: Melphalan and Buthionine Sulfoximine|Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BSO) Autologous Stem Cell Support for Resistant or Recurrent High-Risk Neuroblastoma (IND 69-112)|Completed||Phase 1|30|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-10-11 04:27:32.506766|2017-10-11 04:27:32.506766
NCT00005836|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-06-20|||February 2000||2000-02-01|March 2003|2003-03-01|July 2004|Actual|2004-07-01|||||Interventional|||Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy|Phase II Evaluation of Oxaliplatin in Recurrent, Platinum Resistant and Refractory Ovarian Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:32.620785|2017-10-11 04:27:32.620785
NCT00005837|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-06-20|||February 2000||2000-02-01|July 2004|2004-07-01|June 2004|Actual|2004-06-01|||||Interventional|||Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer|Phase II Evaluation of Oxaliplatin in Persistent or Recurrent Squamous Cell Carcinoma of the Cervix|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:33.033662|2017-10-11 04:27:33.033662
NCT00005838|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-01-22|||March 2000||2000-03-01|January 2013|2013-01-01||||February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery|Multicenter, Open-Ended, Double-Blind, Placebo-Controlled, Phase III Study of AE-941 in Addition to Combined Modality Treatment (Chemotherapy/Radiotherapy) for Locally Advanced Unresectable Non-Small Cell Lung Cancer|Completed||Phase 3|756|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:27:33.278757|2017-10-11 04:27:33.278757
NCT00005839|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2015-06-03|||August 2000||2000-08-01|June 2015|2015-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor|A Phase I Study of Oxaliplatin in Combination With Capecitabine in Metastatic/Recurrent Solid Tumors|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:27:33.408755|2017-10-11 04:27:33.408755
NCT00005840|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2014-12-29|||July 2000||2000-07-01|December 2014|2014-12-01||||July 2009|Actual|2009-07-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer|Phase I Trial of the Treatment of Advanced Endometrial Cancer With Concurrent Weekly Paclitaxel and Cisplatin and Whole Abdominal Radiation Therapy|Completed||Phase 1|35|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:27:33.476141|2017-10-11 04:27:33.476141
NCT00005841|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2014-05-20|||June 2000||2000-06-01|May 2014|2014-05-01|October 2002|Actual|2002-10-01|December 2000|Actual|2000-12-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase I Trial of a Vaccine Combining Tyrosinase/GP100/Mart-1 Peptides Emulsified With Montanide ISA 51 With ProGP for Patients With Resected Stages III and IV Melanoma|Terminated||Phase 1|15|Actual|University of Southern California||||Toxicity/Side Effects|f||||t||||||||||2017-10-11 04:27:33.563781|2017-10-11 04:27:33.563781
NCT00005842|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-02-08|||June 2000||2000-06-01|April 2007|2007-04-01||||February 2004|Actual|2004-02-01||Interventional|||Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer|A Phase I, Pharmacokinetic, and Biologic Correlative Study of R115777 (NSC 702818) and Herceptin in Patients With Advanced Cancer|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:33.644551|2017-10-11 04:27:33.644551
NCT00005843|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-02-08|||May 2000||2000-05-01|April 2007|2007-04-01||||September 2004|Actual|2004-09-01||Interventional|||R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer|Phase II Trial of R115777 (NSC-702818), an Inhibitor of Farnesyl Protein Transferase, in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:33.758783|2017-10-11 04:27:33.758783
NCT00005844|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-10-22|||April 2000||2000-04-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Oxaliplatin in Treating Children With Advanced Solid Tumors|A Phase I Study of Oxaliplatin in Children With Solid Tumors|Completed||Phase 1|26|Actual|St. Jude Children's Research Hospital|||||f||||f||||||||||2017-10-11 04:27:33.852374|2017-10-11 04:27:33.852374
NCT00005845|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-13|||June 2002||2002-06-01|December 2013|2013-12-01||||September 2009|Actual|2009-09-01||Interventional|||Tipifarnib in Treating Patients With Myelodysplastic Syndromes|Phase I Study of the Farnesyl Transferase Inhibitor R115777 (NSC #702818) in Patients With Myelodysplastic Syndrome|Completed||Phase 1|65|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:33.920717|2017-10-11 04:27:33.920717
NCT00005846|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2011-06-04|||June 2000||2000-06-01|July 2005|2005-07-01||||||||Interventional|||Tipifarnib in Treating Patients With Myeloproliferative Disorders|Phase I/II Study of the Farnesyltransferase Inhibitor R115777 (NSC 702818) in Patients With Myeloproliferative Disorders|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:34.042214|2017-10-11 04:27:34.042214
NCT00005847|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2010-01-26|||January 2001||2001-01-01|January 2010|2010-01-01||||July 2004|Actual|2004-07-01||Interventional|||Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Randomized Phase II Trial of Mitoxantrone, Estramustine and Navelbine or 13-cis Retinoic Acid, Interferon and Paclitaxel in Patients With Metatstatic Hormone Refractory Prostate Cancer|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:27:34.140815|2017-10-11 04:27:34.140815
NCT00005848|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-07-10|||April 2000||2000-04-01|July 2013|2013-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Phase II Trial of R115777 (NSC 702818) an Inhibitor of Farnesyl Protein Transferase, in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|7|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-11 04:27:34.720874|2017-10-11 04:27:34.720874
NCT00005849|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-02-08|||April 2000||2000-04-01|February 2013|2013-02-01|November 2003|Actual|2003-11-01|September 2002|Actual|2002-09-01||Interventional|||Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer|Phase II Study of Bryostatin-1 in Combination With Paclitaxel for Non-Small Cell Lung Cancer|Completed||Phase 2|15|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:27:34.808417|2017-10-11 04:27:34.808417
NCT00005850|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2016-07-01|||August 2001||2001-08-01|July 2016|2016-07-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|Fluoxetine in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC): A Phase II Pilot Study to Improve Quality of Life During Chemotherapy|Completed||Phase 2|21|Actual|Alliance for Clinical Trials in Oncology||1|||f||||||||||||||2017-10-11 04:27:34.933175|2017-10-11 04:27:34.933175
NCT00005851|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2017-07-03|||February 2000||2000-02-01|July 2017|2017-07-01||||July 2004|Actual|2004-07-01||Interventional|||Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer|Phase I/II Study of HLA-Matched Non-Myeloablative Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation as Treatment for Patients With Metastatic Renal Cell Carcinoma. A Multi-Center Trial.|Active, not recruiting||Phase 1/Phase 2|11|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:27:35.163881|2017-10-11 04:27:35.163881
NCT00005852|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-12-10|||June 1996||1996-06-01|December 2012|2012-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant|Allogeneic Bone Marrow Transplantation for Marrow Failure States|Terminated||Phase 2|||H. Lee Moffitt Cancer Center and Research Institute||||low accrual|f||||f||||||||||2017-10-11 04:27:35.29886|2017-10-11 04:27:35.29886
NCT00005853|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2010-03-31|||December 1999||1999-12-01|March 2010|2010-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Biological Therapy in Treating Patients With Myelodysplastic Syndrome|Therapy of Myelodysplastic Syndrome (MDS) With Antithymocyte Globulin (ATG) and TNFR:Fc|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:27:35.402976|2017-10-11 04:27:35.402976
NCT00005854|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2011-11-28|||December 1999||1999-12-01|November 2011|2011-11-01|October 2000|Actual|2000-10-01|||||Interventional|||Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Transplantation of HLA Haploidentical Marrow Cells After Ex Vivo Exposure to Recipient Alloantigen in Presence of CTLA4-Ig - A Phase II Study of Tolerance Induction in Donor T Cells by Blockade of the CD80/CD86:CD28 Costimulatory Signal|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:27:35.486377|2017-10-11 04:27:35.486377
NCT00005855|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-06-20|||July 2000||2000-07-01|December 2003|2003-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma|A Phase I/II Study to Evaluate the Safety and Tolerance of Escalating Doses of RSR13 Administered With a Fixed Dose of BCNU Every Six Weeks in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:35.597412|2017-10-11 04:27:35.597412
NCT00005856|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-01-23|||December 2000||2000-12-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I/II Trial of Oxaliplatin as Neoadjuvant Treatment in Adults With Newly Diagnosed Glioblastoma Multiforme|Terminated||Phase 1/Phase 2|59|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:27:35.716118|2017-10-11 04:27:35.716118
NCT00005857|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2011-10-18|||August 2000||2000-08-01|October 2011|2011-10-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy|Randomized Phase II Trial of Herceptin (NSC 688097) and Weekly Docetaxel (NSC 628503) in Androgen-Independent (Horomone Refractory) Adenocarcinoma of the Prostate (CaP)|Completed||Phase 2|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:27:35.837747|2017-10-11 04:27:35.837747
NCT00005858|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2017-03-28|||April 2000|Actual|2000-04-01|March 2017|2017-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer|Phase I Study of LMB-9, a Recombinant Disulfide Stabilized Anti-Lewis Y Immunotoxin Admistered by Continuous Infusion|Completed||Phase 1|25|Actual|University of Maryland||1|||f||||||||||||||2017-10-11 04:27:35.931676|2017-10-11 04:27:35.931676
NCT00005859|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2008-07-23|||August 2000||2000-08-01|April 2004|2004-04-01||||||||Interventional|||Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma|Phase I/II Trial of R115777 in Patients With Recurrent Malignant Glioma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:36.012467|2017-10-11 04:27:36.012467
NCT00005860|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2011-04-23|||April 2000||2000-04-01|May 2002|2002-05-01||||||||Interventional|||Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum|A Phase I Study of Intraperitoneal Oxaliplatin Alone and in Combination With Intraperitoneal Floxuridine and Leucovorin in Patients With Advanced Metastatic Cancer Confined to the Peritoneal Cavity|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:36.103799|2017-10-11 04:27:36.103799
NCT00005861|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-06-07|||May 2000||2000-05-01|August 2002|2002-08-01||||August 2005|Actual|2005-08-01||Interventional|||Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer|Evaluation of Doxil as First-Line Therapy of Advanced or Recurrent Endometrial Carcinoma|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:27:36.202314|2017-10-11 04:27:36.202314
NCT00005862|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-02-08|||October 2000||2000-10-01|April 2002|2002-04-01||||July 2004|Actual|2004-07-01||Interventional|||SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas|A Phase II Trial of SU5416 (NSC #696819) in Previously Treated Patients With Advanced, Metastatic and/or Locally Recurrent Soft Tissue Sarcomas|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:36.286945|2017-10-11 04:27:36.286945
NCT00005863|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-18|||August 1998||1998-08-01|January 2006|2006-01-01|December 2004|Actual|2004-12-01|||||Interventional|||Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia|Protocol for Patients With High Risk (Resistant, Refractory, Relapsed or Adverse Cytogenetic) AML|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:36.371722|2017-10-11 04:27:36.371722
NCT00005864|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-01-30|||April 2000||2000-04-01|September 2002|2002-09-01|February 2004|Actual|2004-02-01|||||Interventional|||Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer|A Phase II Study of Chloroquinoxaline Sulfonamide (CQS) in Colorectal Cancer Stage IV|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:37.074804|2017-10-11 04:27:37.074804
NCT00005865|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2014-01-03|||April 2000||2000-04-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Research Study Evaluating Oral and Intravenous NAVELBINE as a Single Agent for the Treatment of Chemotherapy-Naive Subjects With Inoperable Stage IIIb or Stage IV Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:37.261211|2017-10-11 04:27:37.261211
NCT00005866|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2015-03-05|||February 2000||2000-02-01|March 2015|2015-03-01|March 2006|Actual|2006-03-01|March 2004|Actual|2004-03-01||Interventional|||S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia|A Phase III Randomized Study Comparing Busulfan-Total Body Irradiation Versus Cyclophosphamide-Total Body Irradiation Preparative Regimen in Patients With Advanced Myelodysplastic Syndrome (MDS) or MDS-Related Acute Myeloid Leukemia (AML) Undergoing HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation, (A BMT Study)|Completed||Phase 3|240|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-10-11 04:27:37.454602|2017-10-11 04:27:37.454602
NCT00005867|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-06-25|||January 1998||1998-01-01|March 2007|2007-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma|Phase III Trial Comparing CHOP ot PMitCEBO in Good Risk Patients With Histologically Aggresive Non Hodgkin's Lymphoma|Completed||Phase 3|310|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:37.702153|2017-10-11 04:27:37.702153
NCT00005868|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-07-17|||March 2000||2000-03-01|July 2012|2012-07-01||||August 2002|Actual|2002-08-01||Interventional|||Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer|Taxotere and Cisplatin as Induction Chemotherapy in Patients With Stage IIIa N2 Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|47|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:27:37.892578|2017-10-11 04:27:37.892578
NCT00005869|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||November 1998||1998-11-01|June 2007|2007-06-01||||||||Interventional|||Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer|Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) Versus Gemcitabine HCl in Chemonaive Pancreatic Cancer Patients|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.015136|2017-10-11 04:27:38.015136
NCT00005870|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||March 1999||1999-03-01|June 2007|2007-06-01||||||||Interventional|||Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas|Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) Versus Most Appropriate Therapy in Refractory Pancreatic Cancer Patients|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.094134|2017-10-11 04:27:38.094134
NCT00005871|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||November 1998||1998-11-01|June 2007|2007-06-01||||||||Interventional|||Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer|Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) Versus 5-Fluorouracil (5-FU) in Pancreatic Cancer Patients That Have Progressive Disease Following Gemcitabine HCl Treatment|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.201344|2017-10-11 04:27:38.201344
NCT00005872|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||May 1999||1999-05-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer|Phase II Study of RFS 2000 in Relapsed NSCLC|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.276217|2017-10-11 04:27:38.276217
NCT00005873|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||September 1999||1999-09-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer|Phase II Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) in Patients With Relapsed Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.352242|2017-10-11 04:27:38.352242
NCT00005874|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||June 1999||1999-06-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas|Phase II Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) in Patients With Soft-Tissue Sarcomas|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.425806|2017-10-11 04:27:38.425806
NCT00005875|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||January 1999||1999-01-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Nitrocamptothecin in Treating Patients With Metastatic Melanoma|Phase II Evaluation of RFS 2000 (9-Nitro-Camptothecin, 9NC) in Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.506519|2017-10-11 04:27:38.506519
NCT00005876|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||April 2000||2000-04-01|June 2002|2002-06-01||||||||Interventional|||Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery|A Phase II Study of RFS 2000 (Rubitecan, 9-Nitro-Camptothecin, 9-NC) in Patients With Advanced Gastric Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.573554|2017-10-11 04:27:38.573554
NCT00005877|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-03|||September 1999||1999-09-01|April 2002|2002-04-01||||||||Interventional|||Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer|Phase II and Pharmacokinetic Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) in Patients With Advanced Colorectal Cancer Who Have Failed Previous 5-FU Based Chemotherapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:38.662022|2017-10-11 04:27:38.662022
NCT00005878|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2016-10-12|||July 2000||2000-07-01|October 2016|2016-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus|Chemoprevention for Barrett's Esophagus Trial (CBET)|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:27:38.741798|2017-10-11 04:27:38.741798
NCT00005924|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-24|2017-06-30|||June 23, 2000||2000-06-23|February 2, 2010|2010-02-02|February 2, 2010||2010-02-02|||||Observational|||Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus|Persistence of Epstein-Barr Virus in Vivo|Completed||N/A|41|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:43.840418|2017-10-11 04:27:43.840418
NCT00005879|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2017-04-19|2017-01-23||August 2000||2000-08-01|April 2017|2017-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||LY353381 in Preventing Breast Cancer in Women With Hyperplasia|A Phase II Clinical Trial of a Selective Estrogen Receptor Modulator (LY353381*HCl) in High Risk Women With Fine Needle Aspiration Cytologic Evidence of Hyperplasia|Completed||Phase 2|199|Actual|University of Kansas Medical Center||2|||f||||f||||||||No|Global results will be published.|2017-10-11 04:27:38.882475|2017-10-11 04:27:38.882475
NCT00005880|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2008-07-23|||July 2000||2000-07-01|July 2007|2007-07-01||||||||Interventional|||Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia|A Phase II Trial of Inhaled Budesonide (Pulmicort Turbuhaler) in Persons With Dysplasia of the Bronchial Epithelium|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:39.428634|2017-10-11 04:27:39.428634
NCT00005881|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-08-22|||April 2000||2000-04-01|August 2013|2013-08-01|September 2006|Actual|2006-09-01|March 2003|Actual|2003-03-01||Observational|||Quality of Life in Children Treated for Cancer|Assessment of Health/Quality of Life in Survivors of Childhood Cancer|Completed||N/A|538|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:27:39.493946|2017-10-11 04:27:39.493946
NCT00005883|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2011-03-25||||||March 2011|2011-03-01||||April 2001|Actual|2001-04-01||Interventional|||Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke|A Phase I - Part B Multiple Dose Trial of Phenethyl Isothiocyanate|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:27:39.612968|2017-10-11 04:27:39.612968
NCT00005884|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2015-09-30||||||September 2015|2015-09-01||||December 2000|Actual|2000-12-01||Interventional|||Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer|Chemoprevention of Skin Cancers With DFMO: A Controlled, Randomized Clinical Trial|Completed||Phase 3|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:27:39.677491|2017-10-11 04:27:39.677491
NCT00005886|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2017-01-12|||July 2000||2000-07-01|January 2017|2017-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer|A Phase IB Randomized Study of an Antiestrogen in Women With Newly Diagnosed Breast Cancer|Completed||Phase 1|||University of Kansas Medical Center|||||f||||||||||||||2017-10-11 04:27:39.742133|2017-10-11 04:27:39.742133
NCT00005887|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-05-08|||February 2000||2000-02-01|May 2013|2013-05-01||||||||Interventional|||Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases|A Phase III, Randomized, Open-Label, Comparative Study of Standard Whole Brain Radiation Therapy With or Without RSR13 in Patients With Brain Metastases|Completed||Phase 3|||Spectrum Pharmaceuticals, Inc|||||f||||||||||||||2017-10-11 04:27:39.835323|2017-10-11 04:27:39.835323
NCT00005888|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||January 1997||1997-01-01|April 2002|2002-04-01||||||||Interventional|||Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants||Completed||N/A|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:27:40.076963|2017-10-11 04:27:40.076963
NCT00005889|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||October 1999||1999-10-01|December 2003|2003-12-01||||||||Interventional|||Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion|Study of Gluconeogenesis in Very Low Birth Weight Infants Receiving Total Parenteral Nutrition|Unknown status|Recruiting|N/A|96||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:27:40.139402|2017-10-11 04:27:40.139402
NCT00005890|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||March 1996||1996-03-01|December 2003|2003-12-01||||||||Interventional|||Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock||Completed||N/A|56||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:27:40.215972|2017-10-11 04:27:40.215972
NCT00005891|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||March 2000||2000-03-01|July 2004|2004-07-01||||||||Interventional|||Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:27:40.273132|2017-10-11 04:27:40.273132
NCT00005892|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||March 2000||2000-03-01|July 2004|2004-07-01||||||||Interventional|||Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:27:40.336978|2017-10-11 04:27:40.336978
NCT00005893|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||June 2000||2000-06-01|July 2004|2004-07-01||||||||Interventional|||Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:27:40.417824|2017-10-11 04:27:40.417824
NCT00005896|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||March 2000||2000-03-01|March 2001|2001-03-01||||||||Interventional|||Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia||Unknown status|Active, not recruiting|Phase 1|6||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:27:40.484694|2017-10-11 04:27:40.484694
NCT00005898|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||February 2000||2000-02-01|July 2004|2004-07-01||||||||Interventional|||Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia||Completed||Phase 1/Phase 2|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:27:40.541667|2017-10-11 04:27:40.541667
NCT00005900|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2005-06-23|||August 1999||1999-08-01|October 2003|2003-10-01||||||||Observational|||Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation||Unknown status|Active, not recruiting|N/A|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:27:40.611637|2017-10-11 04:27:40.611637
NCT00005901|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-06|2016-02-01|2015-11-24||June 2000||2000-06-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||Pamidronate to Treat Osteogenesis Imperfecta in Children|A Trial of Pamidronate in Children With Osteogenesis Imperfecta|Completed||Phase 3|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:27:40.706014|2017-10-11 04:27:40.706014
NCT00005902|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-06|2017-10-05|||June 4, 2000||2000-06-04|August 4, 2017|2017-08-04||||||||Observational|||Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease|A Prospective Natural History Study of VHL Patients With CNS Hemangioblastomas|Active, not recruiting||N/A|250|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:41.393395|2017-10-11 04:27:41.393395
NCT00005293|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||December 1988||1988-12-01|April 2000|2000-04-01|November 1990|Actual|1990-11-01|||||Observational|||Antecedents of Bronchopulmonary Dysplasia||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.208423|2017-10-11 04:27:57.208423
NCT00005903|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-07|2008-03-03|||June 2000||2000-06-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy|Dose-Escalation Trial of Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor for the Treatment of PSP|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:41.479435|2017-10-11 04:27:41.479435
NCT00005905|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-09|2008-03-03|||June 2000||2000-06-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Leptin to Treat Lipodystrophy|Efficacy of Leptin Replacement in Treatment of Lipodystrophy|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:41.57015|2017-10-11 04:27:41.57015
NCT00005906|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-09|2010-04-29|2010-02-26||June 2000||2000-06-01|April 2010|2010-04-01||||April 2008|Actual|2008-04-01||Interventional|||Treatment With Octreotide in Patients With Lymphangioleiomyomatosis|Treatment With Octreotide in Patients With Lymphangioleiomyomatosis|Completed||Phase 2|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:27:41.651226|2017-10-11 04:27:41.651226
NCT00005907|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-09|2008-03-03|||June 2000||2000-06-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers|Evaluation of Hepatitis B Surface Antigen-Specific and Tetanus Toxoid-Specific Lymphocytes|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:41.861826|2017-10-11 04:27:41.861826
NCT00005908|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-13|2013-03-13|2012-02-14||June 2000||2000-06-01|March 2013|2013-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer|A Pilot Trial of Sequential Primary (Neoadjuvant) Combination Chemotherapy With Docetaxel/Capecitabine (TX) and Doxorubicin/Cyclophosphamide (AC) in Primary Breast Cancer With Evaluation of Chemotherapy Effects on Gene Expression|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:27:41.953841|2017-10-11 04:27:41.953841
NCT00005910|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-13|2008-03-03|||June 2000||2000-06-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Laparoscopy to Remove Pancreatic Tumors (Insulinomas)|Use of Laparoscopy for Localization and Resection of Insulinomas of the Pancreas|Completed||N/A|23||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:42.64007|2017-10-11 04:27:42.64007
NCT00005911|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-13|2008-03-03|||June 2000||2000-06-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Magnetic Resonance Imaging to Study the Normal Eye|Refinement of the Magnetic Resonance Imaging Technique for the Study of the Normal Eye, Particularly the Lens and Cataract|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:42.736548|2017-10-11 04:27:42.736548
NCT00005912|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-14|2008-03-03|||June 2000||2000-06-01|June 2000|2000-06-01|January 2001||2001-01-01|||||Interventional|||Voriconazole to Prevent Systemic Fungal Infections in Children|An Open Intravenous Multiple Dose, Multi-Center Study to Investigate the Pharmacokinetics, Safety and Toleration of Voriconazole in Children Aged 2-12 Years Who Require Treatment for the Prevention of Systemic Fungal Infection|Completed||Phase 1|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:42.797845|2017-10-11 04:27:42.797845
NCT00005914|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-15|2009-12-16|||October 1999||1999-10-01|February 2009|2009-02-01|September 2003||2003-09-01|||||Observational|||Genetics of Recurrent Early-Onset Depression||Completed||N/A|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:27:42.879088|2017-10-11 04:27:42.879088
NCT00005915|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-15|2013-09-28||||||September 2013|2013-09-01|June 2004|Actual|2004-06-01|||||Observational|||A Comparison of Two Anti-HIV Treatment Plans|A Randomized Study of a Prescribed 4-Month Structured Treatment Interruption (STI) Followed by Initiation of a New Antiretroviral Regimen Versus Immediate Initiation of a New Antiretroviral Regimen in HIV-Infected Patients With Multidrug Resistant (MDR) Virus|Completed||N/A|480||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:27:42.979057|2017-10-11 04:27:42.979057
NCT00005916|ClinicalTrials.gov processed this data on October 10, 2017|2006-06-30|2017-06-30|||June 13, 2000||2000-06-13|December 22, 2005|2005-12-22|December 22, 2005|Actual|2005-12-22|||||Interventional|||PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer|A Randomized Phase II Study of a PSA-Based Vaccine in Patients With Localized Prostate Cancer Receiving Standard Radiotherapy|Completed||Phase 2|48|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:27:43.085605|2017-10-11 04:27:43.085605
NCT00005918|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-15|2011-04-28||2011-04-13|June 2000||2000-06-01|April 2011|2011-04-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients|The Safety and Antiviral Efficacy of Stavudine Extended Release Formulation as Compared to Stavudine Immediate Release Formulation, Each as Part of Potent Antiretroviral Combination Therapy|Completed||Phase 3|730||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:27:43.244918|2017-10-11 04:27:43.244918
NCT00005919|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-17|2008-03-03|||June 2000||2000-06-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Observational|||Cause of Pigment Dispersion Syndrome|Etiology of Pigment Dispersion Syndrome (PDS)|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:43.443149|2017-10-11 04:27:43.443149
NCT00005920|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-19|2005-06-23||||||June 2000|2000-06-01||||||||Interventional|||Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole|A Multiclinic, Double-Blind, Randomized, Dose-Comparison Study to Evaluate the Safety, Tolerability, and Efficacy of L-743,872 in the Treatment of Fluconazole-Unresponsive Oropharyngeal Candidiasis in Adults|Terminated||Phase 2|70||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:27:43.551438|2017-10-11 04:27:43.551438
NCT00005921|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-19|2005-06-23||||||June 2000|2000-06-01||||||||Interventional|||A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis|An Open, Serial-Panel, Multiple-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of L-743,872 in Patients With Candida Esophagitis|Completed||N/A|18||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:27:43.621994|2017-10-11 04:27:43.621994
NCT00005925|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-24|2017-10-05|||June 23, 2000||2000-06-23|December 24, 2014|2014-12-24|December 24, 2014|Actual|2014-12-24|||||Interventional|||Brain Infusion of Muscimol to Treat Epilepsy|Trial of Intracerebral Infusion in Patients With Medically Intractable Epilepsy|Terminated||Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:27:43.893519|2017-10-11 04:27:43.893519
NCT00005926|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-28|2008-03-03|||June 2000||2000-06-01|June 2000|2000-06-01|December 2000||2000-12-01|||||Interventional|||Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas|A Phase II Trial of Gemcitabine, Herceptin, and Radiation for Regionally Confined Adenocarcinoma of the Pancreas|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:43.969189|2017-10-11 04:27:43.969189
NCT00005927|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-28|2017-10-05|||June 23, 2000||2000-06-23|August 24, 2017|2017-08-24||||||||Observational|||Study of Adrenal Gland Tumors|Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:44.040846|2017-10-11 04:27:44.040846
NCT00005928|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-28|2008-03-03|||June 2000||2000-06-01|February 2002|2002-02-01|February 2002||2002-02-01|||||Interventional|||Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation|Effects of Angiotensin Converting Enzyme Inhibitor Therapy on Vascular Inflammation and Compliance|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:44.136848|2017-10-11 04:27:44.136848
NCT00005931|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-30|2005-06-23||||||December 2000|2000-12-01||||||||Interventional|||SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment|A Multicenter, Open-Label, Phase II Study of SU5416 in Patients With Therapy-Refractory Cutaneous AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:27:44.205164|2017-10-11 04:27:44.205164
NCT00005933|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-04|2008-03-03|||June 2000||2000-06-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders|Cognitive Function in Leukocyte Disorders|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:44.281448|2017-10-11 04:27:44.281448
NCT00005934|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-06|2008-03-03|||June 2000||2000-06-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Interventional|||5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia|A Pilot Study of 5-Azacytidine and Oral Sodium Phenylbutyrate in Severe Thalassemia|Completed||Phase 2|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:44.36522|2017-10-11 04:27:44.36522
NCT00005935|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-06|2008-03-03|||June 2000||2000-06-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia|A Randomized Trial for the Treatment of Relapsing Aplastic Anemia With Mycophenolate Mofetil (MMF) and Cyclosporine (CSA)|Completed||Phase 2|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:44.455391|2017-10-11 04:27:44.455391
NCT00005936|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-06|2008-03-03|||June 2000||2000-06-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Collection of Liver Tissue for Virologic Studies|Collection of Liver Tissue for Virologic Studies|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:27:46.305469|2017-10-11 04:27:46.305469
NCT00005937|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-06|2014-10-20|2010-04-02||June 2000||2000-06-01|October 2014|2014-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia|A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)|Completed||Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:27:46.389579|2017-10-11 04:27:46.389579
NCT00005938|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-05-15|||March 2000||2000-03-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||DX-8951f in Treating Patients With Biliary Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Biliary Tree Cancer (Cholangiocarcinoma and Gallbladder Cancer)|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:27:46.591066|2017-10-11 04:27:46.591066
NCT00005939|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-11-05|||November 1999||1999-11-01|February 2001|2001-02-01||||||||Interventional|||Brachytherapy in Treating Patients With Recurrent Prostate Cancer|Phase I/II Study of Interstitial Colloidal 32P for Locally Recurrent Prostate Cancer Failing Radiation|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:46.683709|2017-10-11 04:27:46.683709
NCT00005940|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2017-08-28|||October 1999||1999-10-01|August 2017|2017-08-01||||January 2006|Actual|2006-01-01||Interventional|||Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission|Phase II Study of Radiolabeled BC8 (Anti-CD45) Antibody Combined With Busulfan and Cyclophosphamide as Treatment for Acute Myelogenous Leukemia in First Remission Followed by HLA-Identical Related Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|18|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 04:27:46.759094|2017-10-11 04:27:46.759094
NCT00005941|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-03-31|||November 1999||1999-11-01|March 2010|2010-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer|Phase II Pilot Trial of Non-Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation Using Fludarabine, Low Dose TBI and Post-Transplant Cyclosporine and Mycophenolate Mofetil Followed by Donor Lymphocyte Infusion for Therapy of Advanced or Metastatic Human Papilloma Virus (HPV) - Associated Cervical Carcinoma Refractory to Standard Therapy|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:27:46.886548|2017-10-11 04:27:46.886548
NCT00005942|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-22|||March 2000||2000-03-01|January 2013|2013-01-01||||December 2000|Actual|2000-12-01||Interventional|||Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy|Phase II Trial of Liposomal Daunorubicin (Daunoxome) and SU5416 (NSC 696819) in Patients With AML, RAEB, RAEB-T or CMML in Transformation Refractory to One Course of Induction Chemotherapy|Completed||Phase 1/Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:46.97255|2017-10-11 04:27:46.97255
NCT00005943|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-28|||February 2000||2000-02-01|October 2001|2001-10-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Gene Therapy in Treating Patients With Metastatic Melanoma|A Phase I Study Using Direct Combination DNA Injections for the Immunotherapy of Metastatic Melanoma|Completed||Phase 1|||University of Colorado, Denver|||||f||||t||||||||||2017-10-11 04:27:47.057144|2017-10-11 04:27:47.057144
NCT00005944|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2011-04-23|||November 1999||1999-11-01|June 2007|2007-06-01||||||||Interventional|||Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer|Study of Second Look Surgery With or Without Chemotherapy Intraperitoneally, in the Event of Risk of Intraperitoneal Recurrence|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:47.143302|2017-10-11 04:27:47.143302
NCT00005945|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-02-19|||June 2000||2000-06-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia|Escalating Dose Intravenous Methotrexate Without Leucovorin Rescue Versus Oral Methotrexate and Single Versus Double Delayed Intensification for Children With Standard Risk Acute Lymphoblastic Leukemia|Completed||Phase 3|3054|Actual|Children's Oncology Group||7|||f||||t||||||||||2017-10-11 04:27:47.42202|2017-10-11 04:27:47.42202
NCT00005946|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2017-03-28|||October 2000|Actual|2000-10-01|March 2017|2017-03-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation|A Pilot Study of Combined Chemotherapy and Donor Lymphocyte Infusion for Hematologic Malignancies in Relapse After Allogeneic Bone Marrow Transplantation|Completed||Phase 1|||University of Maryland|||||f||||||||||||||2017-10-11 04:27:47.863091|2017-10-11 04:27:47.863091
NCT00005947|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-10-08|2010-05-28||November 1999||1999-11-01|October 2010|2010-10-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Randomized, Double Blind, Placebo Controlled Trial of Immunotherapy With Autologous Antigen-Loaded Dendritic Cells (Provenge) for Asymptomatic Metastatic Hormome-Refractory Prostate Cancer|Completed||Phase 3|127|Actual|Dendreon||2|||f||||||||||||||2017-10-11 04:27:47.975218|2017-10-11 04:27:47.975218
NCT00005948|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-03-31|||January 2000||2000-01-01|March 2010|2010-03-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia|A Pilot Study of High Dose Busulfan Combined With IL2/GM-CSF Activated Autologous/Syngeneic PBSC, Sequential IL2/GM-CSF Therapy and Alpha Interferon Maintenance Therapy as Treatment of CML|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:27:48.714375|2017-10-11 04:27:48.714375
NCT00005949|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-15|||March 2001||2001-03-01|January 2013|2013-01-01||||March 2006|Actual|2006-03-01||Interventional|||Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma|Phase II Study of Melanoma Vaccine (NSC #683472/675756, IND #6123) and Low-Dose, Subcutaneous Interleukin-2 in Advanced Melanoma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:48.788545|2017-10-11 04:27:48.788545
NCT00005950|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01||||October 2004|Actual|2004-10-01||Interventional|||506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma|Phase II Study of 506U78 (NSC #686673) for Patients With Relapsed or Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma|Terminated||Phase 2|111|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:27:48.876605|2017-10-11 04:27:48.876605
NCT00005951|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2014-08-20|||August 2000||2000-08-01|February 2013|2013-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma|Phase I Treatment of Adults With Primary Malignant Glioma With Irinotecan (CPT-11) (NSC- #6616348) Plus Temodar (NSC #362856)|Completed||Phase 1|||Duke University|||||f||||||||||||||2017-10-11 04:27:48.969101|2017-10-11 04:27:48.969101
NCT00005952|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-19|||August 2000||2000-08-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors|A Phase I/II Trial of Temodar in Pediatric Patients and Young Adults With High-Risk or Recurrent Solid Tumors|Completed||Phase 1/Phase 2|30|Anticipated|Duke University|||||f||||f||||||||||2017-10-11 04:27:49.057664|2017-10-11 04:27:49.057664
NCT00005954|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-19|||August 2000||2000-08-01|October 2009|2009-10-01|June 2003|Actual|2003-06-01|||||Interventional|||Temozolomide in Treating Patients With Brain Metastases|Phase II Treatment of Adults With Brain Metastases With Temodar|Completed||Phase 2|||Duke University|||||f||||||||||||||2017-10-11 04:27:49.15831|2017-10-11 04:27:49.15831
NCT00005955|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-19|||August 2000||2000-08-01|October 2009|2009-10-01|September 2002|Actual|2002-09-01|||||Interventional|||Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors|Phase II Treatment of Children With Newly Diagnosed Malignant Central Nervous System Tumors With Temozolomide Prior to Radiation Therapy|Completed||Phase 2|||Duke University|||||f||||||||||||||2017-10-11 04:27:49.231187|2017-10-11 04:27:49.231187
NCT00005956|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2014-07-07|||February 2000||2000-02-01|March 2013|2013-03-01|July 2002|Actual|2002-07-01|August 2001|Actual|2001-08-01||Interventional|||Biological Therapy in Treating Patients With Advanced Cancer|A Pilot Study of Active Immunotherapy With HER2/Neu Intracellular Domain (ICD) Protein-Pulsed, Autologous, Cultured Dendritic Cells in Patients With No Evidence of Disease After Standard Treatment for HER2/Neu Expressing Malignancies|Completed||N/A|3|Actual|Duke University||1|||f||||f||||||||||2017-10-11 04:27:49.315652|2017-10-11 04:27:49.315652
NCT00005957|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2017-04-19|2016-04-05||April 2000||2000-04-01|May 2016|2016-05-01|April 19, 2017|Actual|2017-04-19|October 2014|Actual|2014-10-01||Interventional||Intention-to-treat|Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer|A Phase III Study of Regional Radiation Therapy in Early Breast Cancer|Completed||Phase 3|1832|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:27:49.42112|2017-10-11 04:27:49.42112
NCT00005958|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-12-03|||October 1999||1999-10-01|October 2001|2001-10-01||||||||Interventional|||Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer|Treatment of Patients With Transitional-Cell Carcinoma of the Urothelial Tract With Gemcitabine, Docetaxel and Filgrastim|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:49.90695|2017-10-11 04:27:49.90695
NCT00005959|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-12-03|||December 1999||1999-12-01|June 2002|2002-06-01||||||||Interventional|||Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma|Phase II Trial of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated Intermediate or High Grade Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:50.057814|2017-10-11 04:27:50.057814
NCT00005960|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-12-03|||October 1999||1999-10-01|January 2001|2001-01-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study of Doxorubicin and Cyclophosphamide With Sequential Docetaxel in Patients With Hormone-Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:50.24783|2017-10-11 04:27:50.24783
NCT00005961|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-02-08|||June 2000||2000-06-01|April 2003|2003-04-01||||December 2005|Actual|2005-12-01||Interventional|||O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma|A Phase II Trial of O6-Benzylguanine (NSC 637037) and BCNU (Carmustine) in Patients With Metatstatic Melanoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:50.362919|2017-10-11 04:27:50.362919
NCT00005962|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-08-16|||July 2000||2000-07-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|October 2005|Actual|2005-10-01||Interventional|||Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia|A Phase II Randomized Trial of Immunologic and Chemotherapeutic Agents for Treatment of Patients With Relapsed or Refractory Acute Myelogenous Leukemia|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:27:50.507818|2017-10-11 04:27:50.507818
NCT00005963|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-12-05|||November 2000||2000-11-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|October 2002|Actual|2002-10-01||Interventional|||Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer|Phase II Trial of Docetaxel and Carboplatin as First-Line Therapy for Metastatic Breast Cancer|Completed||Phase 2|53|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:27:50.883763|2017-10-11 04:27:50.883763
NCT00005964|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-07-12|||May 2000||2000-05-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|Randomized Phase II Study of Dose-Adjusted EPOCH vs. NHL-15 Chemotherapy for Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:27:51.0708|2017-10-11 04:27:51.0708
NCT00005965|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-07-09|||August 2000||2000-08-01|July 2004|2004-07-01|April 2004|Actual|2004-04-01|||||Interventional|||Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix|Phase II Clinical Trial of Bryostatin-1, NSC 339555, and Cisplatin in Patients With Recurrent and/or Advanced Inoperable Squamous Cell, Adeno or Adenosquamous Cell Carcinoma of the Cervix|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:51.387757|2017-10-11 04:27:51.387757
NCT00005966|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2009-02-04|||October 2000||2000-10-01|September 2002|2002-09-01||||March 2006|Actual|2006-03-01||Interventional|||Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer|Phase III Randomized Trial of Interferon-Alfa2b Alone Versus Interferon-Alfa2b Plus Thalidomide in Patients With Previously Untreated Metastatic or Unresectable Renal Cell Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:51.488926|2017-10-11 04:27:51.488926
NCT00005967|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-02-08|||August 2000||2000-08-01|October 2004|2004-10-01||||April 2004|Actual|2004-04-01||Interventional|||Tipifarnib in Treating Patients With Advanced Hematologic Cancer|A Dose Finding Study of R115777 (NSC 702818) in Patients With Advanced Hematologic Malignancies|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:51.62195|2017-10-11 04:27:51.62195
NCT00005968|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-28|||November 1999||1999-11-01|December 2002|2002-12-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Irofulven in Treating Patients With Stage IV Melanoma|A Multicenter Phase II Trial of MGI-114 in Patients With Stage IV Malignant Melanoma|Completed||Phase 2|||University of Colorado, Denver|||||f||||f||||||||||2017-10-11 04:27:51.745156|2017-10-11 04:27:51.745156
NCT00005969|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-02-17|||September 1999||1999-09-01|February 2012|2012-02-01||||January 2001|Actual|2001-01-01||Interventional|||Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease|Phase II Study of ATRAGEN (Liposomal Tretinoin) in Patients With Relapsed or Refractory Hodgkin's Disease|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Study withdrawn.|f||||f||||||||||2017-10-11 04:27:51.861422|2017-10-11 04:27:51.861422
NCT00005970|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2017-08-21|||May 19, 2000|Actual|2000-05-19|August 2017|2017-08-01||||November 15, 2009|Actual|2009-11-15||Interventional|||Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer|Phase III Trial of Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Paclitaxel With or Without Trastuzumab as Adjuvant Treatment for Women With HER-2 Over-Expressing or Amplified Node Positive or High-Risk Node Negative Breast Cancer|Active, not recruiting||Phase 3|3441|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-10-11 04:27:52.003774|2017-10-11 04:27:52.003774
NCT00005971|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-11-07|||July 2000||2000-07-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||Flavopiridol in Treating Patients With Metastatic Malignant Melanoma|A Phase II Study of Flavopiridol (HMR 1275; NSC 649890) in Patients With Previously Untreated Metastatic Malignant Melanoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:27:52.570112|2017-10-11 04:27:52.570112
NCT00005972|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-07-12|||May 2000||2000-05-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|October 2006|Actual|2006-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer|Phase II Trial of Gemcitabine/Irinotecan as Second Line Therapy for Small Cell Lung Cancer|Completed||Phase 2|73|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:27:52.835871|2017-10-11 04:27:52.835871
NCT00005973|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01||||July 2004|Actual|2004-07-01||Interventional|||BMS-214662 in Treating Patients With Solid Tumors|Phase I Study of Farnesyl Transferase Inhibitor BMS-214662 (NSC 710086D) in Solid Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:27:53.045777|2017-10-11 04:27:53.045777
NCT00005974|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2011-09-27|||July 2000||2000-07-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|November 2002|Actual|2002-11-01||Interventional|||Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma|A Phase II Study of Flavopiridol (HMR 1275; NSC 649890) in Patients With Previously Untreated Metastatic or Locally Advanced Soft Tissue Sarcoma|Completed||Phase 2|18|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-10-11 04:27:53.26385|2017-10-11 04:27:53.26385
NCT00005975|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2015-11-17|||April 1998||1998-04-01|November 2015|2015-11-01|March 2002|Actual|2002-03-01|September 2001|Actual|2001-09-01||Interventional|||S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer|A Phase III Trial of Placebo Versus Megestrol Acetate 20 MG/Day Versus Megestrol Acetate 40 MG/Day as Treatment for Symptoms of Ovarian Failure in Women Treated for Breast Cancer: SWOG Study S9626|Completed||Phase 3|288|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:27:53.480049|2017-10-11 04:27:53.480049
NCT00005976|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-31|||May 2000||2000-05-01|September 2003|2003-09-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma|Phase I/II Trial of Pyrazoloacridine and Carboplatin in Patients With Recurrent Glioma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:27:53.582159|2017-10-11 04:27:53.582159
NCT00005977|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-08-19|||September 2000||2000-09-01|August 2013|2013-08-01|September 2006|Actual|2006-09-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia|A Pilot Study of Dose Intensification of Methotrexate in Patients With Advanced-Stage (III/IV) Small Non-Cleaved Cell Non-Hodgkins Lymphoma and B-Cell All|Completed||Phase 3|83|Actual|Children's Oncology Group||5|||f||||t||||||||||2017-10-11 04:27:53.757629|2017-10-11 04:27:53.757629
NCT00005978|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-10-14|||May 2000||2000-05-01|May 2009|2009-05-01||||December 2004|Actual|2004-12-01||Interventional|||N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma|Dose Escalation Study of 131 I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma - A Phase I Study|Completed||Phase 1|||New Approaches to Neuroblastoma Therapy Consortium|||||f||||t||||||||||2017-10-11 04:27:54.204662|2017-10-11 04:27:54.204662
NCT00005979|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2009-02-03|||February 1998||1998-02-01|September 2000|2000-09-01||||||||Interventional|||Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer|Phase III Randomized Study of Intensive Adjuvant Chemotherapy for Resected Colon Cancer at High Risk of Recurrence|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:54.334341|2017-10-11 04:27:54.334341
NCT00005980|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-07-17|||April 2000||2000-04-01|July 2012|2012-07-01||||July 2002|Actual|2002-07-01||Interventional|||Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer|A Randomized Phase II Study of Two Different Schedules of Caelyx in Metastatic Breast Cancer|Completed||Phase 2|116|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:27:54.483016|2017-10-11 04:27:54.483016
NCT00005981|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-06-09|||June 2000||2000-06-01|June 2010|2010-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer|Phase II Trial of O6Benzylguanine and BCNU in Patients With Colon and Rectal Carcinoma|Completed||Phase 2|13|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:27:54.581832|2017-10-11 04:27:54.581832
NCT00005982|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01||||July 2004|Actual|2004-07-01||Interventional|||506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma|Phase II Study of 506U78 (NSC #686673) in Patients With Previously Treated Cutaneous T-Cell Lymphoma|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:27:54.659715|2017-10-11 04:27:54.659715
NCT00005983|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-22|||June 2000||2000-06-01|January 2013|2013-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer|Randomized Trial of Post-Mastectomy Radiotherapy in Stage II Breast Cancer in Women With One to Three Positive Axillary Nodes Phase III|Terminated||Phase 3|98|Actual|Southwest Oncology Group||2||due to lack of accrual|f||||t||||||||||2017-10-11 04:27:54.765795|2017-10-11 04:27:54.765795
NCT00005984|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2011-05-25|||August 2000||2000-08-01|May 2011|2011-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia|Autologous Marrow Transplantation for Chronic Myelogenous Leukemia Using Stem Cells Obtained After In Vivo Cyclophosphamide/G-CSF Priming|Terminated||Phase 2|22|Actual|Masonic Cancer Center, University of Minnesota||1||Study terminated as principal investigator [PI] left the university.|f||||t||||||||||2017-10-11 04:27:54.857361|2017-10-11 04:27:54.857361
NCT00005985|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-10-16|||August 2000||2000-08-01|October 2012|2012-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma|Primed Peripheral Blood Stem Cell Autologous Transplantation for Lymphoma and Hodgkin's Disease|Completed||Phase 2|213|Actual|Masonic Cancer Center, University of Minnesota|||||f||||t||||||||||2017-10-11 04:27:54.958544|2017-10-11 04:27:54.958544
NCT00005986|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2011-07-13|||August 2000||2000-08-01|July 2011|2011-07-01||||September 2004|Actual|2004-09-01||Interventional|||Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia|Autologous Transplantation for Chronic Myelogenous Leukemia Using Retrovirally Marked Peripheral Blood Progenitor Cells Obtained After In Vivo Cyclophosphamide/G-CSF Priming|Terminated||Phase 2|||Masonic Cancer Center, University of Minnesota||1||Principal investigator left the university.|f||||||||||||||2017-10-11 04:27:55.079106|2017-10-11 04:27:55.079106
NCT00005987|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-10-09|||August 2000||2000-08-01|October 2012|2012-10-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma|Autologous Transplantation for Multiple Myeloma: A Research Study of Multiple Myeloma Using Chemotherapy Plus Growth Factor Primed Peripheral Blood Stem Cells Followed by Autologous Transplantation and Post-Transplant Immunotherapy|Terminated||Phase 2|87|Actual|Masonic Cancer Center, University of Minnesota||||Withdrawn because treatment guidelines changed|f||||t||||||||||2017-10-11 04:27:55.162723|2017-10-11 04:27:55.162723
NCT00005988|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2017-03-30|||February 2000|Actual|2000-02-01|March 2017|2017-03-01|March 8, 2002|Actual|2002-03-08|June 16, 2001|Actual|2001-06-16||Interventional|||Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy|A Phase I Open-Label, Safety Study of Haploidentical Bone Marrow Transplantation (BMT) After Ex Vivo Treatment of Bone Marrow With Anti-B7.1 and Anti-B7.2 Antibodies|Completed||Phase 1|5|Actual|Dana-Farber Cancer Institute||1|||f||||t|f|f||||||No||2017-10-11 04:27:55.24061|2017-10-11 04:27:55.24061
NCT00005989|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2011-08-02|||November 2002||2002-11-01|August 2011|2011-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer|A Phase II Study of Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:27:55.377884|2017-10-11 04:27:55.377884
NCT00005990|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-11-08|||August 2000||2000-08-01|January 2006|2006-01-01||||September 2006|Actual|2006-09-01||Interventional|||R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors|Phase I and Pharmacokinetic Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:27:55.443655|2017-10-11 04:27:55.443655
NCT00005991|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-10-05|||April 2000||2000-04-01|October 2012|2012-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer|Phase I/II Study of Gemcitabine and Doxil Combination Chemotherapy in Patients With Advanced Solid Tumors (Phase I)/Breast Cancer (Phase II)|Completed||Phase 2|76|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:27:55.502276|2017-10-11 04:27:55.502276
NCT00005992|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-08-06|||December 2000||2000-12-01|May 2002|2002-05-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Phase I Clinical Trial of Recombinant Prostate Specific Membrane Antigen (rPSMA)-Loaded Mature Autologous Dendritic Cells (CapPVax) for the Treatment of Metastatic Horomone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:55.564519|2017-10-11 04:27:55.564519
NCT00005993|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-10-09|||May 1999||1999-05-01|October 2012|2012-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer|Immunotherapy With Subcutaneous Il-2 and Stem Cell Factor (SCF) for Patients With Lymphoma or Breast Cancer After Autologous Transplantation|Terminated||Phase 1|||Masonic Cancer Center, University of Minnesota|||||f||||t||||||||||2017-10-11 04:27:55.624863|2017-10-11 04:27:55.624863
NCT00005994|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-03-04|||August 2000||2000-08-01|March 2013|2013-03-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy|Patient Information and Antiemetic Drug Efficacy|Completed||N/A|||University of Rochester|||||f||||||||||||||2017-10-11 04:27:55.711729|2017-10-11 04:27:55.711729
NCT00005995|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-03-04|||October 2000||2000-10-01|February 2008|2008-02-01||||March 2007|Actual|2007-03-01||Interventional|||AE-941 in Treating Patients With Metastatic Kidney Cancer|AE-941 (NEOVASTAT) Versus Placebo in Metastatic Renal Cell Carcinoma Patients Who Are Refractory to Immunotherapy|Completed||Phase 3|||AEterna Zentaris|||||f||||||||||||||2017-10-11 04:27:55.795006|2017-10-11 04:27:55.795006
NCT00005996|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-12-18||||||September 2000|2000-09-01||||||||Interventional|||SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors|A Phase I Study of SU5416 in Combination With Gemcitabine/Cisplatin in Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:27:55.86129|2017-10-11 04:27:55.86129
NCT00005280|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||June 1972||1972-06-01|March 2005|2005-03-01|November 1991|Actual|1991-11-01|||||Observational|||Specialized Center of Research in Occupational and Immunologic Lung Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:55.92778|2017-10-11 04:27:55.92778
NCT00005281|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1977||1977-09-01|April 2001|2001-04-01|November 1998|Actual|1998-11-01|||||Observational|||Early Risk Predictors For Chronic Pulmonary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:56.288031|2017-10-11 04:27:56.288031
NCT00005282|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||December 1981||1981-12-01|April 2001|2001-04-01|November 1997|Actual|1997-11-01|||||Observational|||Prospective Evaluation of Airways Reactivity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:56.392468|2017-10-11 04:27:56.392468
NCT00005283|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1983||1983-07-01|May 2000|2000-05-01|June 1990|Actual|1990-06-01|||||Observational|||Risk Factors For Asthma in Laboratory Animal Allergy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:56.482106|2017-10-11 04:27:56.482106
NCT00005284|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||January 1985||1985-01-01|August 2004|2004-08-01|March 2002|Actual|2002-03-01|||||Observational|||Epidemiology of Airway Responsiveness||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:56.546833|2017-10-11 04:27:56.546833
NCT00005285|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1985||1985-07-01|April 2001|2001-04-01|November 1996|Actual|1996-11-01|||||Observational|||Effect of Maternal Smoking On Neonatal Lung Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:56.628775|2017-10-11 04:27:56.628775
NCT00005286|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||April 1986||1986-04-01|January 2016|2016-01-01|March 1989||1989-03-01|||||Observational|||Epidemiology of Sleep Apnea Syndrome||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-10-11 04:27:56.690355|2017-10-11 04:27:56.690355
NCT00005287|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-08|||July 1986||1986-07-01|January 2016|2016-01-01|June 1989||1989-06-01|||||Observational|||Late Sequelae of Bronchopulmonary Dysplasia||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 04:27:56.752629|2017-10-11 04:27:56.752629
NCT00005288|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-01-13|||December 1986||1986-12-01|April 2001|2001-04-01|November 1991|Actual|1991-11-01|||||Observational|||Epidemiology and Pulmonary Response To Organic Dust Exposure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:56.824851|2017-10-11 04:27:56.824851
NCT00005289|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2008-07-23|||July 1987||1987-07-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:56.90703|2017-10-11 04:27:56.90703
NCT00005290|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||April 1988||1988-04-01|January 2016|2016-01-01|June 1997||1997-06-01|||||Observational|||Epidemiology of Interstitial Lung Disease||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-10-11 04:27:56.982365|2017-10-11 04:27:56.982365
NCT00005291|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1988||1988-07-01|June 2000|2000-06-01|April 2003|Actual|2003-04-01|||||Observational|||Clinical Epidemiology of Asthma in An HMO||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.054417|2017-10-11 04:27:57.054417
NCT00005292|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-24|||September 1988||1988-09-01|August 2004|2004-08-01|November 1999||1999-11-01|||||Observational|||Alpha1-antitrypsin Deficiency Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.132483|2017-10-11 04:27:57.132483
NCT00005299|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-10-26|||August 1990||1990-08-01|October 2016|2016-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Familial Aggregation and Natural History of Sleep Apnea||Completed||N/A|726|Actual|Brigham and Women's Hospital|||1||f||||||||||Samples With DNA|"     Samples stored deidentified   "|||2017-10-11 04:27:57.611049|2017-10-11 04:27:57.611049
NCT00005300|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-12|||October 1988||1988-10-01|May 2000|2000-05-01|June 1995||1995-06-01|||||Observational|||Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.710848|2017-10-11 04:27:57.710848
NCT00005301|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-14|||September 1984||1984-09-01|August 2001|2001-08-01|February 1998||1998-02-01|||||Observational|||Transfusion Safety Study (TSS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.77674|2017-10-11 04:27:57.77674
NCT00005302|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1985||1985-04-01|May 2000|2000-05-01|June 1992|Actual|1992-06-01|||||Observational|||Drug Etiology of Aplastic Anemia and Related Dyscrasias||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.871526|2017-10-11 04:27:57.871526
NCT00005303|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1986||1986-09-01|December 2001|2001-12-01|September 1995||1995-09-01|||||Observational|||Effectiveness of AIDS Antibody Screening||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:57.953253|2017-10-11 04:27:57.953253
NCT00005304|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-08|||September 1986||1986-09-01|December 2015|2015-12-01|September 1991||1991-09-01|||||Observational|||Delta Hepatitis and Liver Disease in Hemophiliacs||Completed||N/A|||Baylor College of Medicine|||||f||||||||||||||2017-10-11 04:27:58.016342|2017-10-11 04:27:58.016342
NCT00005305|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-06-13|||September 1987||1987-09-01|June 2016|2016-06-01|September 1991|Actual|1991-09-01|September 1991|Actual|1991-09-01||Observational|||Hepatitis Delta Infections in Hemophiliacs|Prevalence and Consequences of Hepatitis Delta Virus Infection in Hemophiliacs|Completed||N/A|61|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||No||2017-10-11 04:27:58.082131|2017-10-11 04:27:58.082131
NCT00005306|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-13|||March 1988||1988-03-01|August 2004|2004-08-01|September 2001||2001-09-01|||||Observational|||Natural History of Post-transfusion Non-A, Non-B Hepatitis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:58.155321|2017-10-11 04:27:58.155321
NCT00005307|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||April 1989||1989-04-01|May 2000|2000-05-01|March 1991|Actual|1991-03-01|||||Observational|||Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:58.245252|2017-10-11 04:27:58.245252
NCT00005308|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1990||1990-04-01|November 2001|2001-11-01|March 1995|Actual|1995-03-01|||||Observational|||Anemia and Surgery: Indications For Transfusion||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:58.317479|2017-10-11 04:27:58.317479
NCT00005309|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-05|||July 1990||1990-07-01|February 2016|2016-02-01|March 1995||1995-03-01|||||Observational|||Prospective Study of HIV Infection in Hemophiliacs||Completed||N/A|||Bloodworks (Puget Sound Blood Center)|||||f||||||||||||||2017-10-11 04:27:58.368965|2017-10-11 04:27:58.368965
NCT00005311|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1993||1993-09-01|June 2000|2000-06-01|March 1996||1996-03-01|||||Observational|||Hypertension in Minorities Database-Workshop and Publication||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:58.442323|2017-10-11 04:27:58.442323
NCT00005312|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||January 1990||1990-01-01|July 2004|2004-07-01|August 2002||2002-08-01|||||Observational|||International Programs Collaborative Studies Coordinating Center||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:58.514879|2017-10-11 04:27:58.514879
NCT00005313|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-12-09|||April 2001||2001-04-01|December 2014|2014-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Observational|||Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia|Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia|Completed||N/A|450|Actual|University of Washington|||1||f||||f||||||||||2017-10-11 04:27:58.588875|2017-10-11 04:27:58.588875
NCT00005314|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-03-12|||July 1986||1986-07-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Behavioral Factors in Coronary Heart Disease||Completed||N/A|694|Actual|Duke University|||1||f||||f||||||Samples With DNA|"     Urine and plasma samples and extracted DNA are retained   "|||2017-10-11 04:27:58.690264|2017-10-11 04:27:58.690264
NCT00005315|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-03-07|||September 1993||1993-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Psychosocial Factors and Cardiovascular Disease|Psychosocial Factors and Cardiovascular Disease|Completed||N/A|||Columbia University|||||f||||f||||||||||2017-10-11 04:27:58.872297|2017-10-11 04:27:58.872297
NCT00005316|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||December 1985||1985-12-01|August 2001|2001-08-01|November 1995|Actual|1995-11-01|||||Observational|||White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:58.963373|2017-10-11 04:27:58.963373
NCT00005317|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-11|||December 1986||1986-12-01|May 2000|2000-05-01|November 1996|Actual|1996-11-01|||||Observational|||Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:59.014355|2017-10-11 04:27:59.014355
NCT00005318|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-06-22|||January 1994||1994-01-01|June 2016|2016-06-01|November 2004||2004-11-01|||||Observational|||ARDS - Clinical Epidemiology and the Role of the Inflammatory Response - SCOR in Acute Lung Injury||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:27:59.084259|2017-10-11 04:27:59.084259
NCT00005319|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1985||1985-09-01|May 2002|2002-05-01|December 1996|Actual|1996-12-01|||||Observational|||Epidemiologic Studies of Blood Use in the United States - SCOR in Transfusion Medicine||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:59.144668|2017-10-11 04:27:59.144668
NCT00005320|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-09-27|||September 1988||1988-09-01|March 2005|2005-03-01|August 1998|Actual|1998-08-01|||||Observational|||Regulation of Pharyngeal Muscle Contraction - SCOR in Cardiopulmonary Disorders of Sleep||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:59.212139|2017-10-11 04:27:59.212139
NCT00005321|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-11|||September 1988||1988-09-01|August 2000|2000-08-01|August 1999|Actual|1999-08-01|||||Observational|||Epidemiology of Sleep Disordered Breathing - SCOR in Cardiopulmonary Disorders of Sleep||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:59.274482|2017-10-11 04:27:59.274482
NCT00005323|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||December 1991||1991-12-01|October 2001|2001-10-01|November 1996|Actual|1996-11-01|||||Observational|||Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology and Diseases in Infants and Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:59.418255|2017-10-11 04:27:59.418255
NCT00005324|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-09-27|||January 1992||1992-01-01|May 2000|2000-05-01|November 1996|Actual|1996-11-01|||||Observational|||Genetic and Epidemiologic Studies of Premature Coronary Artery Disease - SCOR in Arteriosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:59.480315|2017-10-11 04:27:59.480315
NCT00005325|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-07-15|||February 1996||1996-02-01|July 2014|2014-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR||Completed||N/A|||Boston University|||||f||||||||||||||2017-10-11 04:27:59.552876|2017-10-11 04:27:59.552876
NCT00005326|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||January 1988||1988-01-01|December 2004|2004-12-01|March 2004|Actual|2004-03-01|||||Observational|||Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:27:59.612763|2017-10-11 04:27:59.612763
NCT00005327|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-03-22|||April 1993||1993-04-01|March 2017|2017-03-01|March 1998||1998-03-01|||||Observational|||Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center||Completed||N/A|||University of Southern California|||||f||||||||||||||2017-10-11 04:28:01.063513|2017-10-11 04:28:01.063513
NCT00005328|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-01-16|||April 1980||1980-04-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Antecedents of the Type A Behavior Pattern||Completed||N/A|184|Actual|University of Pittsburgh|||1||f||||||||||||||2017-10-11 04:28:01.114242|2017-10-11 04:28:01.114242
NCT00005329|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||May 1992||1992-05-01|March 2005|2005-03-01|March 1997|Actual|1997-03-01|||||Observational|||Protein S and Myocardial Infarction||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.18924|2017-10-11 04:28:01.18924
NCT00005330|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1985||1985-09-01|April 2002|2002-04-01|April 2001|Actual|2001-04-01|||||Observational|||Framingham Children's Study - Food and Exercise Habits in Framingham Study Descendents||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.243354|2017-10-11 04:28:01.243354
NCT00005331|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1988||1988-09-01|July 2000|2000-07-01|February 1995|Actual|1995-02-01|||||Observational|||Providers for Smoking Prevention Programs||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.299772|2017-10-11 04:28:01.299772
NCT00005332|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2008-01-25|||September 1991||1991-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Antihypertensive Drug/Gene Interactions and CV Events||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.345302|2017-10-11 04:28:01.345302
NCT00005333|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||January 1991||1991-01-01|August 2004|2004-08-01|August 2001|Actual|2001-08-01|||||Observational|||Epidemic Hypertension in Nigerian Workers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.409688|2017-10-11 04:28:01.409688
NCT00005334|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1991||1991-07-01|June 2000|2000-06-01|June 1995|Actual|1995-06-01|||||Observational|||Effects of Personality and Context on Recovery From Coronary Artery Bypass||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.462397|2017-10-11 04:28:01.462397
NCT00005335|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||May 1991||1991-05-01|July 2004|2004-07-01|March 2002|Actual|2002-03-01|||||Observational|||Genetic Epidemiology of Lipoprotein-Lipid Levels||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.514785|2017-10-11 04:28:01.514785
NCT00005336|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||April 1991||1991-04-01|April 2000|2000-04-01|September 1996||1996-09-01|||||Observational|||Dietary Treatment of Hyperlipidemia in Women vs. Men||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:28:01.578023|2017-10-11 04:28:01.578023
NCT00005337|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1991||1991-04-01|March 2005|2005-03-01|March 1995|Actual|1995-03-01|||||Observational|||Hostility and Coronary Risk--Role of Weak Vagal Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.624988|2017-10-11 04:28:01.624988
NCT00005338|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1991||1991-08-01|December 2004|2004-12-01|August 2004|Actual|2004-08-01|||||Observational|||Homocysteine and Progression of Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.682323|2017-10-11 04:28:01.682323
NCT00005339|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||February 1992||1992-02-01|June 2000|2000-06-01|April 2004|Actual|2004-04-01|||||Observational|||Risk of Post Transfusion Hepatitis C Virus Infection||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.761657|2017-10-11 04:28:01.761657
NCT00005340|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||September 1991||1991-09-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Hypertension in Blacks of West African Origin||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:01.947386|2017-10-11 04:28:01.947386
NCT00005341|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||February 1992||1992-02-01|January 2016|2016-01-01|January 1997||1997-01-01|||||Observational|||Blood Donation--Immune Sequelae and Recruitment||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-10-11 04:28:02.071237|2017-10-11 04:28:02.071237
NCT00005342|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||May 1993||1993-05-01|July 2000|2000-07-01|April 1997|Actual|1997-04-01|||||Observational|||Weight Set-Point and HDL Concentration in Runners||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.135054|2017-10-11 04:28:02.135054
NCT00005343|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||January 1993||1993-01-01|May 2000|2000-05-01|December 1995||1995-12-01|||||Observational|||Social Support and CHD Risk Factors--A Community Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.195555|2017-10-11 04:28:02.195555
NCT00005344|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||May 1992||1992-05-01|August 2004|2004-08-01|April 1998|Actual|1998-04-01|||||Observational|||Mediators of Social Support in Coronary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.271414|2017-10-11 04:28:02.271414
NCT00005345|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||January 1993||1993-01-01|August 2004|2004-08-01|July 2000|Actual|2000-07-01|||||Observational|||Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.366489|2017-10-11 04:28:02.366489
NCT00005346|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||January 1993||1993-01-01|November 2001|2001-11-01|December 1995|Actual|1995-12-01|||||Observational|||Mechanisms Underlying Abnormal Ambulatory BP Patterns||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:02.448168|2017-10-11 04:28:02.448168
NCT00005379|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-28|||August 1994||1994-08-01|December 2015|2015-12-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Observational|||Tuberculosis in a Multiethnic Inner City Population|Tuberculosis in a Multiethnic Inner City Population|Completed||N/A|||New York University School of Medicine|||3||f||||||||||||||2017-10-11 04:28:04.669338|2017-10-11 04:28:04.669338
NCT00005380|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1993||1993-09-01|March 2005|2005-03-01|August 1998|Actual|1998-08-01|||||Observational|||Insulin, Androgen, and Risk in African-American Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.743637|2017-10-11 04:28:04.743637
NCT00005381|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||April 1994||1994-04-01|June 2001|2001-06-01|February 2000||2000-02-01|||||Observational|||Prevalence of Sleep Apnea in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.824226|2017-10-11 04:28:04.824226
NCT00005382|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1995||1995-07-01|November 2001|2001-11-01|May 1998|Actual|1998-05-01|||||Observational|||Sources of Variability in Peak Expiratory Flow||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.873937|2017-10-11 04:28:04.873937
NCT00005383|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||January 1995||1995-01-01|September 2002|2002-09-01|December 1999|Actual|1999-12-01|||||Observational|||Anger and Cardiovascular Risk in Urban Youth||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.919407|2017-10-11 04:28:04.919407
NCT00005384|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||January 1995||1995-01-01|August 2004|2004-08-01|December 2002|Actual|2002-12-01|||||Observational|||Diet/Activity of Mexican American and Anglo Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:04.96629|2017-10-11 04:28:04.96629
NCT00005385|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1994||1994-09-01|October 2005|2005-10-01|July 1999|Actual|1999-07-01|||||Observational|||Seasonal Variation of Blood Cholesterol Levels||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.033475|2017-10-11 04:28:05.033475
NCT00005386|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-26|||September 1995||1995-09-01|August 2004|2004-08-01|August 1998||1998-08-01|||||Observational|||Biobehavioral Determinants of Obesity in Black Women||Completed||N/A|||University of Memphis|||||f||||||||||||||2017-10-11 04:28:05.090169|2017-10-11 04:28:05.090169
NCT00005387|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-11|||September 1995||1995-09-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Genetics of Hypertension in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.160139|2017-10-11 04:28:05.160139
NCT00005388|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|April 2004|2004-04-01|March 2004|Actual|2004-03-01|||||Observational|||Visceral Fat, Metabolic Rate, and CHD Risk in Young Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.230444|2017-10-11 04:28:05.230444
NCT00005389|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-08|||September 1995||1995-09-01|April 2001|2001-04-01|August 1998||1998-08-01|||||Observational|||Effect of Drug Therapy on Reinfarction Risk in Women||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:28:05.284655|2017-10-11 04:28:05.284655
NCT00005390|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1996||1996-08-01|August 2004|2004-08-01|July 2001|Actual|2001-07-01|||||Observational|||Family Process, Adherence, and Child Asthma Outcome||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.335051|2017-10-11 04:28:05.335051
NCT00005391|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-08-05|||September 1995||1995-09-01|January 2014|2014-01-01|May 2010|Actual|2010-05-01|||||Observational|||Pediatric Cardiomyopathy Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.39992|2017-10-11 04:28:05.39992
NCT00005392|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||September 1995||1995-09-01|July 2005|2005-07-01|July 2000|Actual|2000-07-01|||||Observational|||Epidemiology of Venous Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.477027|2017-10-11 04:28:05.477027
NCT00005393|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-05-23|||August 1996||1996-08-01|May 2017|2017-05-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Epidemiology: Oxidative Stress and Early Atherosclerosis|Epidemiology: Oxidative Stress and Early Atherosclerosis|Active, not recruiting||N/A|5115|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples With DNA|"     blood and urine samples and DNA   "|||2017-10-11 04:28:05.541812|2017-10-11 04:28:05.541812
NCT00005394|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1995||1995-08-01|August 2004|2004-08-01|July 2000|Actual|2000-07-01|||||Observational|||Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.610594|2017-10-11 04:28:05.610594
NCT00005395|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|February 2005|2005-02-01|July 2000|Actual|2000-07-01|||||Observational|||Honolulu Heart Program-Study of Stroke and Dementia||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.678456|2017-10-11 04:28:05.678456
NCT00005396|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1994||1994-09-01|April 2002|2002-04-01|August 1999|Actual|1999-08-01|||||Observational|||Motivating Smokers--Reduce Child Environmental Tobacco Smoke Exposure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:05.740402|2017-10-11 04:28:05.740402
NCT00005397|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-06-09|||September 1995||1995-09-01|June 2017|2017-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Epidemiology of Carotid Artery Atherosclerosis in Youth||Completed||N/A|1360|Actual|University of Iowa|||1||f||||||||||Samples With DNA|"     Blood   "|||2017-10-11 04:28:05.789488|2017-10-11 04:28:05.789488
NCT00005398|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-06-29|||May 1996||1996-05-01|June 2017|2017-06-01||||May 2026|Anticipated|2026-05-01||Observational|||University of North Carolina Alumni Heart Study|University of North Carolina Alumni Heart Study|Active, not recruiting||N/A|6340|Actual|Duke University|||1||f||||f||||||||||2017-10-11 04:28:05.852781|2017-10-11 04:28:05.852781
NCT00005399|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-11|||August 1996||1996-08-01|April 2016|2016-04-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Observational|||Cohort Study of Heart Rate Variability|Cohort Study of Heart Rate Variability|Completed||N/A|111654|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 04:28:05.973426|2017-10-11 04:28:05.973426
NCT00005400|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-19|||August 1995||1995-08-01|January 2016|2016-01-01|July 2003||2003-07-01|||||Observational|||Angiotensinogen Variants and Adverse Pregnancy Outcomes||Completed||N/A|||University of Utah|||||f||||||||||||||2017-10-11 04:28:06.061604|2017-10-11 04:28:06.061604
NCT00005401|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||August 1995||1995-08-01|July 2000|2000-07-01|July 1999||1999-07-01|||||Observational|||Validation and Exploration of Sleep and Mood Predictors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:06.12669|2017-10-11 04:28:06.12669
NCT00005997|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-06-09|||April 1999||1999-04-01|June 2010|2010-06-01|November 2005|Actual|2005-11-01|April 2005|Actual|2005-04-01||Interventional|||Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer|Phase II and Pharmacokinetic Trial of Rebeccamycin Analog in Hepatobiliary Cancers|Terminated||Phase 2|72|Actual|Case Comprehensive Cancer Center||1||slow accrual for Cohort II|f||||t||||||||||2017-10-11 04:28:06.304223|2017-10-11 04:28:06.304223
NCT00005998|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-10-09|||January 2000||2000-01-01|October 2012|2012-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease|Autologous Transplantation for Non-Hodgkin's Lymphoma and Hodgkin's Disease Using Retrovirally Marked Peripheral Blood Progenitor Cells Obtained After In Vivo Mobilization Using Hematopoietic Cytokines Plus Chemotherapy|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||||Withdrawn because study never enrolled patients|f||||t||||||||||2017-10-11 04:28:06.403258|2017-10-11 04:28:06.403258
NCT00005999|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-20|||April 2000||2000-04-01|March 2002|2002-03-01|May 2003|Actual|2003-05-01|||||Interventional|||Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer|A Phase II Study of Arsenic Trioxide (NSC #706363) in Patients With Advanced Cervical Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:06.479302|2017-10-11 04:28:06.479302
NCT00006000|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-30|||August 2000||2000-08-01|January 2002|2002-01-01|March 2004|Actual|2004-03-01|||||Interventional|||SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors|Phase I Study of SU5416 in Combination With CPT-11 and Cisplatin in Patients With Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:06.786976|2017-10-11 04:28:06.786976
NCT00006001|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-31|||August 2000||2000-08-01|February 2009|2009-02-01|August 2009|Actual|2009-08-01|February 2007|Actual|2007-02-01||Interventional|||SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer|Phase II Trial of SU5416 (NSC #696819) in Patients With Advanced Colorectal Cancer|Terminated||Phase 2|37|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:28:06.887732|2017-10-11 04:28:06.887732
NCT00006002|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-09-04|||June 2000||2000-06-01|September 2013|2013-09-01|January 2006|Actual|2006-01-01|September 2002|Actual|2002-09-01||Interventional|||SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of SU5416 (NSC# 686819) in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|36|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 04:28:06.991042|2017-10-11 04:28:06.991042
NCT00006003|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-23|||July 2000||2000-07-01|January 2013|2013-01-01||||July 2003|Actual|2003-07-01||Interventional|||SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated|A Phase II Trial of SU5416 (NSC #696819) in Patients With Metastatic Melanoma|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:28:07.161387|2017-10-11 04:28:07.161387
NCT00006004|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-08-16|||May 2000||2000-05-01|August 2013|2013-08-01||||January 2005|Actual|2005-01-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer|A Randomized Phase II Trial of Paclitaxel-Carboplatin or Gemicitabine-Cisplatin in ECOG Performance Status 2 Non-Small Cell Lung Cancer Patients|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:28:07.266889|2017-10-11 04:28:07.266889
NCT00006005|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-20|||September 2000||2000-09-01|August 2004|2004-08-01|August 2006|Actual|2006-08-01|||||Interventional|||Thalidomide in Treating Patients With Gynecologic Sarcomas|Phase II Study of Thalidomide (NSC #66847) in Patients With Sarcomas of Gynecologic Origin|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:07.39226|2017-10-11 04:28:07.39226
NCT00006006|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-02-08|||August 2000||2000-08-01|September 2003|2003-09-01||||March 2005|Actual|2005-03-01||Interventional|||Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed|Thalidomide for Unresectable Hepatocellular Cancer With Optional Interferon Alpha-2a Upon Disease Progression|Completed||Phase 2|38|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:28:07.480886|2017-10-11 04:28:07.480886
NCT00006007|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-12-05|||December 2000||2000-12-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|March 2004|Actual|2004-03-01||Interventional|||LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer|A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:28:07.572281|2017-10-11 04:28:07.572281
NCT00006008|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-20|||June 2000||2000-06-01|August 2002|2002-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|A Phase II Trial of Arsenic Trioxide (NSC #706363) for Relapsed or Refractory Acute Lymphoblastic Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:07.715933|2017-10-11 04:28:07.715933
NCT00006009|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-14|||April 2001||2001-04-01|April 2003|2003-04-01|October 2003|Actual|2003-10-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma|A Phase I, Multiple Dose Escalation Trial of Intravenous Humanized Anti-CD3 Antibody (HuM291) in Patients With CD3+ T-cell Lymphomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:07.933146|2017-10-11 04:28:07.933146
NCT00006010|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-12-05|||September 2001||2001-09-01|December 2016|2016-12-01|April 2008|Actual|2008-04-01|May 2004|Actual|2004-05-01||Interventional|||Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer|Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|25|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:28:08.013724|2017-10-11 04:28:08.013724
NCT00006011|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2015-04-30|2014-05-20||July 2000||2000-07-01|April 2015|2015-04-01||||March 2010|Actual|2010-03-01||Interventional||Total number of eligible participants.|Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer|A Randomized Phase III Study of Tumor Volume Directed Pelvic Plus or Minus Para-Aortic Irradiation Followed by Cisplatin and Doxorubicin or Cisplatin, Doxorubicin and Paclitaxel for Advanced Endometrial Carcinoma|Completed||Phase 3|659|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-10-11 04:28:08.151006|2017-10-11 04:28:08.151006
NCT00006431|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA||Unknown status|Active, not recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:13.234162|2017-10-11 04:28:13.234162
NCT00006012|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-07-01|||February 2001||2001-02-01|July 2016|2016-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer|Completed||Phase 1/Phase 2|73|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:28:08.652559|2017-10-11 04:28:08.652559
NCT00006013|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-07-10|||June 2000||2000-06-01|July 2013|2013-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma|Phase II Trial of SU5416 as Treatment for Refractory/Relapsed Multiple Myeloma|Completed||Phase 2|21|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-10-11 04:28:08.914516|2017-10-11 04:28:08.914516
NCT00006014|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-31|||August 2000||2000-08-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2007|Actual|2007-02-01||Interventional|||SU5416 in Treating Patients With Malignant Mesothelioma|A Phase II Trial of SU5416 (NSC# 696819) in Patients With Malignant Mesothelioma|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:28:08.990983|2017-10-11 04:28:08.990983
NCT00006015|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-01|||May 2000||2000-05-01|June 2011|2011-06-01|February 2003|Actual|2003-02-01|December 2002|Actual|2002-12-01||Interventional|||Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer|Phase II Study Evaluating the Combination of 5-Fluorouracil, Leucovorin, Oxaliplatin, and Herceptin in the Treatment of Patients With Metastatic Colorectal Cancer Who Have Progressed After 5-FU and/or Irinotecan-Containing Therapy|Terminated||Phase 2|26|Actual|National Cancer Institute (NCI)||1||lack of sufficient accrual|f||||t||||||||||2017-10-11 04:28:09.100891|2017-10-11 04:28:09.100891
NCT00006016|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2015-04-14|||May 2000||2000-05-01|January 2013|2013-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery|An Evaluation of Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer|Completed||Phase 2|75|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:28:09.326548|2017-10-11 04:28:09.326548
NCT00006017|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-06-09|||May 2000||2000-05-01|June 2010|2010-06-01|January 2005|Actual|2005-01-01|July 2003|Actual|2003-07-01||Interventional|||Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer|A Randomized Phase II Trial of Two Different Schedules of Administration of Rebeccamycin Analog in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|42|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:28:09.58002|2017-10-11 04:28:09.58002
NCT00006018|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-06-10|||July 2000||2000-07-01|June 2010|2010-06-01|April 2002|Actual|2002-04-01|December 2001|Actual|2001-12-01||Interventional|||Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors|Phase I Study of BMS-214662 and Paclitaxel in Patients With Advanced Malignancies|Completed||Phase 1|5|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:28:09.696957|2017-10-11 04:28:09.696957
NCT00006019|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-20|||May 2000||2000-05-01|October 2002|2002-10-01|August 2003|Actual|2003-08-01|||||Interventional|||Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer|Pilot Study of Sodium Phenylbutyrate Plus Azacytidine|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:09.784513|2017-10-11 04:28:09.784513
NCT00006020|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2015-03-05|||July 2000||2000-07-01|March 2015|2015-03-01|July 2004|Actual|2004-07-01|June 2004|Actual|2004-06-01||Interventional|||S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia|A Phase II Trial of 506U78 (IND 52611) in Patients With Relapsed or Refractory Non T-cell Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2|35|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-10-11 04:28:09.896636|2017-10-11 04:28:09.896636
NCT00006021|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-12-14|||June 2000||2000-06-01|December 2016|2016-12-01|March 2007|Actual|2007-03-01|May 2006|Actual|2006-05-01||Interventional|||Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma|Phase I/II Trial of Arsenic Trioxide (As2O3) With Ascorbic Acid in the Treatment of Relapsed/Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|22|Actual|University of Miami||1|||||||t||||||||||2017-10-11 04:28:10.211507|2017-10-11 04:28:10.211507
NCT00006022|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2015-12-10|||September 2000||2000-09-01|December 2015|2015-12-01|January 2004|Actual|2004-01-01|October 2003|Actual|2003-10-01||Interventional|||Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer|Phase IA/IB Trial of Modulation of the Biological Response to Interleukin-2 (IL-2) With Bryostatin 1 (BRYO; NSC 339555)|Completed||Phase 1|17|Actual|Virginia Commonwealth University||3|||f||||t||||||||||2017-10-11 04:28:10.308062|2017-10-11 04:28:10.308062
NCT00006405|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2008-01-18|||April 2002||2002-04-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||APEX: Adiposity Prevention by Exercise in Black Girls||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:10.394855|2017-10-11 04:28:10.394855
NCT00006406|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2016-03-15|||August 2000||2000-08-01|December 2005|2005-12-01|July 2005|Actual|2005-07-01|||||Observational|||Amino Acids in Urine, Diet, and Blood Pressure: International Population Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:10.467171|2017-10-11 04:28:10.467171
NCT00006407|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2016-03-15|||September 2000||2000-09-01|March 2005|2005-03-01|July 2004|Actual|2004-07-01|||||Observational|||Sex Steroid Hormones and Risk of CHD in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:10.525667|2017-10-11 04:28:10.525667
NCT00006408|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2014-03-27|||August 2000||2000-08-01|March 2014|2014-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Hypertension in Black Americans: A Life Course Approach||Completed||N/A|||Duke University|||||f||||f||||||||||2017-10-11 04:28:10.592478|2017-10-11 04:28:10.592478
NCT00006409|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2015-06-29|2010-02-17||September 2000||2000-09-01|June 2015|2015-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|TAAG||Trial of Activity for Adolescent Girls (TAAG)|Trial of Activity for Adolescent Girls (TAAG)|Completed||Phase 2|8727|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 04:28:11.183605|2017-10-11 04:28:11.183605
NCT00006412|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-13|2013-07-19||||||July 2013|2013-07-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids|A Prospective, Multicenter, Randomized Trial Comparing the Efficacy and Safety of Fenofibrate Versus Pravastatin in HIV-Infected Subjects With Lipid Abnormalities|Completed||Phase 3|630||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:11.866213|2017-10-11 04:28:11.866213
NCT00006413|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-17|2017-06-30|||October 13, 2000||2000-10-13|December 14, 2006|2006-12-14|December 14, 2006||2006-12-14|||||Interventional|||Stem Cell Transplantation to Treat Systemic Mastocytosis|Low Intensity Preparative Regimen Followed by HLA-Matched, Mobilized Peripheral Blood Stem Cell Transplantation for Systemic Mastocytosis|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:12.044683|2017-10-11 04:28:12.044683
NCT00006414|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-17|2008-03-03|||October 2000||2000-10-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Observational|||Hand Exercise and Upper Arm Anesthesia to Improvements Hand Function in Chronic Stroke Patients|Improvements of Hand Function in Chronic Stroke Related to Upper Arm Anesthesia|Completed||N/A|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:12.133261|2017-10-11 04:28:12.133261
NCT00006415|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-19|2015-03-05||||||March 2015|2015-03-01||||||||Observational|||A Study of Patients Who Recently Have Been Infected With HIV|Evaluation of Subjects With Primary or Early Human Immunodeficiency Virus (HIV) Infection|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:12.236005|2017-10-11 04:28:12.236005
NCT00006417|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-24|2008-03-03|||October 2000||2000-10-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Interventional|||Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease|HLA-Matched, Peripheral Blood Stem Cell Transplantation Using Low Intensity Conditioning to Treat Patients With Chronic Granulomatous Disease Who Are Actively Infected|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:12.338111|2017-10-11 04:28:12.338111
NCT00006418|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-25|2014-04-01|||September 2003||2003-09-01|November 2005|2005-11-01|August 2007||2007-08-01|||||Observational|||Molecular Genetics of Schizophrenia||Completed||N/A|10800|Anticipated|NorthShore University HealthSystem|||||f||||||||||||||2017-10-11 04:28:12.420342|2017-10-11 04:28:12.420342
NCT00006419|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-26|2016-03-15|||July 2000||2000-07-01|May 2005|2005-05-01|June 2004|Actual|2004-06-01|||||Observational|||Diet and Chronic Obstructive Pulmonary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:12.505332|2017-10-11 04:28:12.505332
NCT00006420|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-26|2016-02-03|||August 2000||2000-08-01|February 2016|2016-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|MHS||Minnesota Heart Survey - Mortality and Morbidity|Study of Trends of Cardiovascular Disease in a Metropolitan Area.|Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||1||f||||||||||||||2017-10-11 04:28:12.556889|2017-10-11 04:28:12.556889
NCT00006421|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-27|2017-10-05|||October 24, 2000||2000-10-24|June 19, 2017|2017-06-19||||||||Observational|||Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study|Breast Imaging Screening Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study|Completed||N/A|200|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:12.620469|2017-10-11 04:28:12.620469
NCT00006422|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-27|2008-03-03|||October 2000||2000-10-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Evaluation and Treatment of Pediatric Eye Diseases|Evaluation and Treatment Protocol for Patients With Pediatric Eye Diseases and Strabismus|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:12.691318|2017-10-11 04:28:12.691318
NCT00006424|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-28|2008-03-03|||October 2000||2000-10-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Study of Brain Changes Shaped by Experience|fMRI and Spectroscopy Studies of Cortical Plasticity at 1.5 and 3 Tesla|Completed||N/A|153||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:12.749515|2017-10-11 04:28:12.749515
NCT00006425|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-31|2017-10-05|||October 26, 2000||2000-10-26|November 16, 2016|2016-11-16||||||||Observational|||Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study|Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Pilot Study|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:12.806677|2017-10-11 04:28:12.806677
NCT00006426|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-01|2005-06-23|||August 1998||1998-08-01|March 2003|2003-03-01|May 2003||2003-05-01|||||Interventional|||Achilles Tendon Lengthening in Patients With Diabetes to Prevent Foot Ulcers|Controlled Clinical Trial Comparing the Effect of an Achilles Tendon Lengthening Procedure and Casting to Casting Alone for the Treatment of Neuropathic Forefoot Plantar Ulcers in Patients With Diabetes Mellitus|Completed||Phase 1|60||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:12.872664|2017-10-11 04:28:12.872664
NCT00006427|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-01|2016-09-23|||August 1996||1996-08-01|May 2011|2011-05-01||||July 2001|Actual|2001-07-01||Interventional|||Chronic Pain After Amputation|Management of Chronic Pain in Rehabilitation Project II Management of Chronic Pain in Persons With Amputation|Completed||Phase 4|125||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:12.953016|2017-10-11 04:28:12.953016
NCT00006428|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-01|2012-12-14|||August 1996||1996-08-01|March 2003|2003-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Chronic Pain in Spinal Cord Injury|Management of Chronic Pain in Rehabilitation Project I - Management of Chronic Pain in Persons With Spinal Cord Injury|Completed||Phase 4|100||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:13.024203|2017-10-11 04:28:13.024203
NCT00006429|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-01|2016-09-23|||March 1999||1999-03-01|May 2011|2011-05-01|February 2004||2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Treadmill Training for Spinal Cord Injury|Locomotor Therapy Trial for Spinal Cord Injury|Completed||Phase 2|200||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:13.090173|2017-10-11 04:28:13.090173
NCT00006430|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2005-06-23||||||February 2002|2002-02-01||||||||Interventional|||A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA||Unknown status|Active, not recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:13.176183|2017-10-11 04:28:13.176183
NCT00006432|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2007-06-22|||January 2000||2000-01-01|June 2007|2007-06-01||||||||Interventional|||Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:13.281868|2017-10-11 04:28:13.281868
NCT00006433|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2005-06-23|||January 2000||2000-01-01|November 2001|2001-11-01||||||||Interventional|||Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer||Unknown status|Recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:13.33808|2017-10-11 04:28:13.33808
NCT00006434|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Tumor Lysate Pulsed-Dendritic Cell Vaccines After High-Dose Chemotherapy for Non-Hodgkin's Lymphoma||Completed||Phase 3|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:13.406512|2017-10-11 04:28:13.406512
NCT00006435|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2017-10-05|||October 26, 2000||2000-10-26|June 19, 2017|2017-06-19||||||||Observational|||Study of Plexiform Neurofibromas in Neurofibromatosis Type 1|Natural History of Plexiform in Neurofibromatosis Type I|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:13.459727|2017-10-11 04:28:13.459727
NCT00006436|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2017-10-05|||October 30, 2000||2000-10-30|June 6, 2017|2017-06-06|March 31, 2021|Anticipated|2021-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection|Short-Course EPOCH-Rituximab in Untreated CD-20+ HIV-Associated Lymphomas|Recruiting||Phase 2|80|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:28:13.525099|2017-10-11 04:28:13.525099
NCT00006437|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2008-03-03|||October 2000||2000-10-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||Pathophysiology of Chronic Wounds|Pathophysiology of Chronic Wounds: Collection of Blood From Healthy Volunteers|Completed||N/A|999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:13.620695|2017-10-11 04:28:13.620695
NCT00006438|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2005-06-23|||January 1997||1997-01-01|March 2000|2000-03-01|December 1999||1999-12-01|||||Interventional|||How Shoes With Rocker Soles Affect Walking|Rocker Sole Kinetics and Kinematics|Completed||N/A|46||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:13.686154|2017-10-11 04:28:13.686154
NCT00006439|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-04|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Effects of Home Visits on Medication Adherence in Children and Youth With HIV||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:13.908285|2017-10-11 04:28:13.908285
NCT00006440|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2016-10-27|||March 2000||2000-03-01|October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||A Test of Behavioral Intervention for Women at High Risk for HIV Infection|Feasibility Study of a Behavioral Intervention for Women at Persistent High Risk for HIV Infection|Completed||N/A|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:13.974973|2017-10-11 04:28:13.974973
NCT00006441|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2015-03-05|||February 2003||2003-02-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV|A Single Center, Randomized Open Label Study of Initial Interleukin-2 Compared to Delayed Interleukin-2 When Added to Zidovudine, 3TC and Nelfinavir In Order to Modulate Immune Function and to Sustain Suppression of HIV-1 Replication Among Those Persons With Primary or Early HIV Infection|Completed||N/A|398|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:28:14.067601|2017-10-11 04:28:14.067601
NCT00006442|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2008-07-29||||||January 2005|2005-01-01||||||||Observational|||The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients|Quantitative Assessment of Viral and Lymphocyte Dynamics in Blood and Lymphoreticular Tissues of HIV-1 Infected Patients Treated With Antiretroviral Agents|Completed||N/A|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:14.20407|2017-10-11 04:28:14.20407
NCT00006443|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2011-03-01||||||January 2005|2005-01-01||||October 2003|Actual|2003-10-01||Interventional|||Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection|Evaluating Responses to Antiretroviral Drugs in Cells and Tissues (The ERADICATE Study): Comprehensive Comparisons of Viral and Cellular Dynamics Among Previously-Untreated Subjects With Acute HIV Infection (Seroconversion Syndrome) or Recently Acquired HIV Infection Versus the Early, Middle, and Advanced Stages of Seropositive HIV Infection|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:14.282141|2017-10-11 04:28:14.282141
NCT00006444|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-03|2013-11-19|||November 2000||2000-11-01|November 2013|2013-11-01|August 2005|Actual|2005-08-01|||||Observational|||The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women|Assessment of Prevalence and Persistence of Human Papillomavirus (HPV) DNA in HIV-Infected Women Who Are Antiretroviral Naive and Have Initiated HAART|Completed||N/A|160||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:14.367011|2017-10-11 04:28:14.367011
NCT00006445|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-04|2007-02-21||||||March 2003|2003-03-01||||||||Interventional|||Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters|First and 2nd Trimester Evaluation of the Risk of Aneuploidy|Unknown status|Active, not recruiting|N/A|38000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:14.562737|2017-10-11 04:28:14.562737
NCT00006446|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-04|2007-02-21|||July 1996||1996-07-01|April 2003|2003-04-01|June 2001||2001-06-01|||||Interventional|||Preventing Problems in Children's Social Behavior|John F. Kennedy Center for Mental Retardation at Vanderbilt University: Preventing Problems in Children's Social Behavior|Completed||N/A|180||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:14.679326|2017-10-11 04:28:14.679326
NCT00006447|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-04|2016-09-23|||September 1997||1997-09-01|May 2011|2011-05-01||||August 2002|Actual|2002-08-01||Interventional|||Supporting Traumatic Brain Injury (TBI) Caregivers||Completed||Phase 2|64||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:14.761198|2017-10-11 04:28:14.761198
NCT00006448|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-04|2016-09-23|||August 1996||1996-08-01|March 2003|2003-03-01||||July 2001|Actual|2001-07-01||Interventional|||Treatment of Chronic Pain After Spinal Cord Injury (SCI) or Amputation|Spinal Cord Injury (SCI) and Amputation Pain Prevention and Treatment|Completed||N/A|400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:14.829048|2017-10-11 04:28:14.829048
NCT00006449|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2010-05-11|||September 2000||2000-09-01|May 2010|2010-05-01|July 2006||2006-07-01|||||Interventional|||Post-Treatment Effects of Naltrexone|Post-Treatment Effects of Naltrexone|Completed||Phase 4|160||Indiana University|||||f||||||||||||||2017-10-11 04:28:14.941831|2017-10-11 04:28:14.941831
NCT00006450|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-07|2008-03-03|||November 2000||2000-11-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors|Phase II Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Progressive or Recurrent CNS Malignancy|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:15.024357|2017-10-11 04:28:15.024357
NCT00006451|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2012-11-06|||April 1996||1996-04-01|November 2012|2012-11-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Leukemia|T-cell Depletion In Unrelated Donor Marrow Transplantation|Withdrawn||Phase 3|0|Actual|Masonic Cancer Center, University of Minnesota||||Withdrawn due to no accrual|f||||t||||||||||2017-10-11 04:28:15.146699|2017-10-11 04:28:15.146699
NCT00006452|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2011-06-27|||April 1999||1999-04-01|June 2011|2011-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme|A Phase I Trial to Evaluate Repetitive Intravenous Doses of Gadolinium-Texaphyrin as a Radiosensitizer in Patients With Glioblastoma Multiforme|Completed||Phase 1|18|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:28:15.246159|2017-10-11 04:28:15.246159
NCT00006453|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2015-12-22|||September 1999||1999-09-01|December 2015|2015-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy|A Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy|Completed||Phase 3|||AGO Study Group|||||f||||t||||||||||2017-10-11 04:28:15.337337|2017-10-11 04:28:15.337337
NCT00006454|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2015-12-22|||December 1999||1999-12-01|December 2015|2015-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer|Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan|Completed||Phase 3|||AGO Study Group|||||f||||t||||||||||2017-10-11 04:28:15.584223|2017-10-11 04:28:15.584223
NCT00006455|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2011-08-25|||December 1999||1999-12-01|August 2011|2011-08-01||||||||Interventional|||Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma|International Protocol for the Treatment of Childhood Anaplastic Large Cell Lymphoma|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:15.715588|2017-10-11 04:28:15.715588
NCT00006456|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2010-02-23|||February 1999||1999-02-01|February 2010|2010-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid Tumors|Fractionated Stereotactic Body Radiosurgery for Extracranial Tumors|Completed||Phase 2|26|Actual|Virginia Commonwealth University|||||f||||f||||||||||2017-10-11 04:28:15.843085|2017-10-11 04:28:15.843085
NCT00006457|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2012-06-07|||August 2000||2000-08-01|June 2012|2012-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Oltipraz in the Prevention of Lung Cancer in People Who Smoke|Clinical Phase I Multiple-Dose Safety Research Study of Oltipraz in Smokers|Completed||Phase 1|||Northwestern University|||||f||||||||||||||2017-10-11 04:28:15.918931|2017-10-11 04:28:15.918931
NCT00006458|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2009-02-28|||August 2000||2000-08-01|October 2001|2001-10-01||||||||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer|Phase I Non-Myeloablative Trial With 90Y-Humanized MN-14 (Anti-CEA) Antibody for Relapsed or Refractory Advanced Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:15.998341|2017-10-11 04:28:15.998341
NCT00006459|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2012-06-06|||July 2000||2000-07-01|April 2002|2002-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer|Phase III Study of Gemcitabine Plus Paclitaxel Versus Paclitaxel in Patients With Unresectable, Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 3|||Eli Lilly and Company|||||f||||||||||||||2017-10-11 04:28:16.07344|2017-10-11 04:28:16.07344
NCT00006460|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-12-03|||August 2000||2000-08-01|May 2002|2002-05-01||||||||Interventional|||Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I/II Trial of Conformal Radiotherapy and Hyperbaric Oxygen for Patients With Newly Diagnosed Glioblastoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:16.186681|2017-10-11 04:28:16.186681
NCT00006461|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-08-07|||October 2000||2000-10-01|August 2013|2013-08-01||||September 2007|Actual|2007-09-01||Interventional|||Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor|Systemic Chemotherapy, Second Look Surgery and Conformal Radiation Therapy Limited to the Posterior Fossa and Primary Site for Children &gt;/= to 8 Months and &lt;3 Years With Non-metastatic Medulloblastoma: A Children&Apos;s Oncology Group Phase III Study|Completed||Phase 3|82|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:28:16.251087|2017-10-11 04:28:16.251087
NCT00006462|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2014-02-18|||April 2001||2001-04-01|February 2014|2014-02-01|September 2006|Actual|2006-09-01|August 2003|Actual|2003-08-01||Interventional|||Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia|A Phase II Study of Gemcitabine (NSC #613327) in Children With Relapsed Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia|Completed||Phase 2|32|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:28:16.393069|2017-10-11 04:28:16.393069
NCT00006463|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2014-02-19|||October 2000||2000-10-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||Ecteinascidin 743 in Treating Children With Refractory Solid Tumors|Phase I Study of ET-743 in Pediatric Refractory Solid Tumors|Completed||Phase 1|13|Actual|Children's Oncology Group||2|||f||||f||||||||||2017-10-11 04:28:18.515038|2017-10-11 04:28:18.515038
NCT00006464|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2010-01-13|||March 2001||2001-03-01|January 2010|2010-01-01|June 2008|Actual|2008-06-01|January 2005|Actual|2005-01-01||Interventional|||UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors|Phase I Dose Escalation Study of UCN-01 (NSC 638850) Plus Cisplatin in Advanced Malignant Solid Tumors|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:28:18.746928|2017-10-11 04:28:18.746928
NCT00006465|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2010-06-10|||December 2000||2000-12-01|June 2010|2010-06-01|April 2005|Actual|2005-04-01|November 2003|Actual|2003-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I Study of Oxaliplatin (NSC# 266046), Irinotecan, and Capecitabine in Patients With Solid Tumors|Completed||Phase 1|22|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:28:18.865779|2017-10-11 04:28:18.865779
NCT00006466|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-12-17|||August 2000||2000-08-01|September 2002|2002-09-01||||||||Interventional|||Beta Alethine in Treating Patients With Myeloma|Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With Myeloma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:19.012389|2017-10-11 04:28:19.012389
NCT00006467|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2016-07-01|||February 2001||2001-02-01|July 2016|2016-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas|Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:28:19.141957|2017-10-11 04:28:19.141957
NCT00006468|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2009-01-10|||January 2000||2000-01-01|December 2000|2000-12-01||||||||Interventional|||Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer|Phase III Study of An Optimized LV-5FU-Oxaliplatin Regimen in Metastatic Colorectal Cancer. C99-1.|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:19.378245|2017-10-11 04:28:19.378245
NCT00006469|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2009-02-06|||August 1999||1999-08-01|May 2006|2006-05-01||||||||Interventional|||Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer|Phase II Trial of Concurrent Paclitaxel, Carboplatin and External Beam Radiotherapy Followed by Surgical Resection in Stage IIIA (N2) Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:19.456679|2017-10-11 04:28:19.456679
NCT00006470|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-08-09|||March 2001||2001-03-01|August 2013|2013-08-01||||December 2004|Actual|2004-12-01||Interventional|||Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery|Phase II Study of Postoperative Adjuvant Immunotherapy and Radiation in Patients With Completely Resected Stage II and Stage IIIA Non-Small Cell Lung Cancer|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:28:19.581038|2017-10-11 04:28:19.581038
NCT00006471|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2012-07-27|||September 2000||2000-09-01|July 2012|2012-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Study of Fenretinide in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|11|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:28:20.22783|2017-10-11 04:28:20.22783
NCT00006472|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2009-02-06|||January 2000||2000-01-01|February 2002|2002-02-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer|Esophageal Cancer: A Phase II Study of Paclitaxel, Carboplatin and 5-Fluorouracil With Simultaneous Radiotherapy Followed by Surgical Resection|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:20.394563|2017-10-11 04:28:20.394563
NCT00006473|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-01-22|||September 2000||2000-09-01|January 2013|2013-01-01||||February 2006|Actual|2006-02-01||Interventional|||Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Study of Oxaliplatin in Relapsed and Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:28:20.483375|2017-10-11 04:28:20.483375
NCT00006474|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-06-19|||March 2001||2001-03-01|February 2013|2013-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma|Phase I Trial of Temodar Plus O6-Benzylguanine (O6-BG) (NSC 637037) in the Treatment of Patients With Newly Diagnosed (Part 1) or Recurrent/Progressive (Parts 1 and 2) Cerebral Anaplastic Gliomas|Completed||Phase 1|||Duke University|||||f||||f||||||||||2017-10-11 04:28:20.592093|2017-10-11 04:28:20.592093
NCT00006475|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-02-20|||September 2000||2000-09-01|February 2013|2013-02-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis|An Open-Label Study to Determine the Efficacy and Safety of STI571 in Patients With Chronic Myeloid Leukemia in Blast Crisis|Completed||Phase 2|||Novartis|||||f||||||||||||||2017-10-11 04:28:20.717187|2017-10-11 04:28:20.717187
NCT00006476|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-06-25|||October 2000||2000-10-01|March 2007|2007-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Suramin in Treating Patients With Recurrent Bladder Cancer|A Phase I Study of Intravesicular Suramin in Recurrent Superficial Bladder Cancer|Completed||Phase 1|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:20.808324|2017-10-11 04:28:20.808324
NCT00006477|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2012-07-17|||September 2000||2000-09-01|July 2012|2012-07-01||||June 2004|Actual|2004-06-01||Interventional|||Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors|Phase I Clinical Trial of Recombinant Viscumin (rVISCUMIN, rMISTLETOE LECTIN, rML) Administered Twice Weekly by the Subcutanous Route in Patients With Solid Tumors After Failure of Standard Therapy|Completed||Phase 1|26|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:28:20.892377|2017-10-11 04:28:20.892377
NCT00006478|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2011-03-01|2010-10-19||September 2000||2000-09-01|March 2011|2011-03-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma|Pilot Trial to Evaluate Immune Response Using Idiotype Vaccines Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Follicular Lymphoma|Terminated||Phase 2|19|Actual|University of Nebraska|The Sponsor Genitope suspend development of MyVax in light of the decision made by the FDA March 6, 2008, therefore this trial was halted prematurely leaving insufficient data to analyze.|1||"Genitope suspend development of MyVax in light of the decision made by the Food and Drug   Administration (FDA) March 6, 2008"|f||||||||||||||2017-10-11 04:28:20.994704|2017-10-11 04:28:20.994704
NCT00006479|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2011-04-15|||September 2000||2000-09-01|December 2000|2000-12-01||||||||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer|Pre- and Post-Operative Chemotherapy With Oxaliplatin 5FU/LV Versus Surgery Alone in Resectable Liver Metastases From Colorectal Origin - Phase III Study|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:21.225202|2017-10-11 04:28:21.225202
NCT00006480|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2010-09-17|||May 2000||2000-05-01|September 2010|2010-09-01|March 2005|Actual|2005-03-01|||||Interventional|||Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma|Phase I Study to Evaluate the Safety of Cellular Immunotherapy for Recurrent/Refractory Neuroblastoma Using Genetically-Modified Autologous CD8+ T Cell Clones|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:28:21.521009|2017-10-11 04:28:21.521009
NCT00006481|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-11-18|||October 2000||2000-10-01|November 2013|2013-11-01||||August 2002|Actual|2002-08-01||Interventional|||Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer|A Phase III Comparison of Biafine to Declared Institutional Preference for Radiation Induced Skin Toxicity in Patients Undergoing Radiation Therapy for Advanced Squamous Cell Carcinomas of the Head and Neck|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:28:21.623785|2017-10-11 04:28:21.623785
NCT00006482|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-04-10|||October 2000||2000-10-01|May 2004|2004-05-01||||April 2006|Actual|2006-04-01||Interventional|||Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix|A Phase II Evaluation Of Gemcitabine And Cisplatin In Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:28:22.383969|2017-10-11 04:28:22.383969
NCT00006483|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2016-07-12|||October 2000||2000-10-01|July 2016|2016-07-01|January 2013|Actual|2013-01-01|January 2003|Actual|2003-01-01||Interventional|||Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung|A Phase II Study Of Aerosolized GM-CSF In The Treatment Of Metastatic Renal Cell Carcinoma To The Lung|Completed||Phase 2|27|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:28:22.605551|2017-10-11 04:28:22.605551
NCT00006484|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-06-20|||November 2000||2000-11-01|January 2002|2002-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Randomized Phase III Trial Of Carboplatin And Paclitaxel Plus Tirapazamine Versus Carboplatin And Paclitaxel In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:22.769646|2017-10-11 04:28:22.769646
NCT00006485|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2009-12-13|||September 2000||2000-09-01|June 2003|2003-06-01||||December 2003|Actual|2003-12-01||Interventional|||Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study Of Flavopiridol Administered With Irinotecan (CPT-11) In Patients With Advanced Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:23.046953|2017-10-11 04:28:23.046953
NCT00006486|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2013-01-15|||October 2000||2000-10-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer|A Phase II Randomized Discontinuation Trial Of Carboxyaminoimidazole (CAI, NSC 609974) In Metastatic Renal Carcinoma|Completed||Phase 2|335|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:28:23.115531|2017-10-11 04:28:23.115531
NCT00006487|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-06|2012-10-03|||October 2000||2000-10-01|October 2012|2012-10-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer|A Phase I Study Of Tirapazamine/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer|Completed||Phase 1|30|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:28:23.218399|2017-10-11 04:28:23.218399
NCT00006488|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-08|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease||Completed||Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:23.579481|2017-10-11 04:28:23.579481
NCT00006489|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-08|2017-03-10|2016-11-21||December 2000||2000-12-01|March 2017|2017-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)|Naltrexone and Cognitive-Behavioral Therapy for Patients With Alcoholism and Post-Traumatic Stress Disorder|Completed||Phase 4|165|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 04:28:23.659608|2017-10-11 04:28:23.659608
NCT00006490|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-08|2008-09-24||||||July 2004|2004-07-01||||||||Observational|||A Comparison of Two Tests for Anti-HIV Drug Resistance|HIV-1 Resistance Testing During Antiretroviral Failure: Comparison of Sequencing Versus Phenotyping|Completed||N/A|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:24.509784|2017-10-11 04:28:24.509784
NCT00006492|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-09|2008-03-03|||November 2000||2000-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Observational|||Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia|Open Label Controlled Trial of Gluten-Free Diet in Patients With Gluten-Sensitivity and Cerebellar Ataxia|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:24.705736|2017-10-11 04:28:24.705736
NCT00006493|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-14|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia||Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:24.773191|2017-10-11 04:28:24.773191
NCT00006494|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-14|2017-06-30|||November 7, 2000||2000-11-07|September 6, 2011|2011-09-06|September 6, 2011||2011-09-06|||||Observational|||Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs|An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients With Suboptimal Suppression of Plasma Viral Load|Completed||N/A|14|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:24.833286|2017-10-11 04:28:24.833286
NCT00006495|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-15|2013-07-19||||||July 2013|2013-07-01|September 2004|Actual|2004-09-01|||||Interventional|||Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452|Augmentation of HIV-Specific Helper and CTL Responses Through Therapeutic Vaccination in Individuals Receiving Potent Suppressive Antiretroviral Therapies|Completed||Phase 1|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:24.901059|2017-10-11 04:28:24.901059
NCT00006496|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2017-01-13|||February 2000||2000-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Molecular Epidemiology of ARDS|Molecular Epidemiology of Acute Respiratory Distress Syndrome|Recruiting||N/A|4000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"     Blood will be collected for DNA extraction and plasma cytokine measurements   "|No||2017-10-11 04:28:24.996438|2017-10-11 04:28:24.996438
NCT00006501|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2015-12-21|||January 2003||2003-01-01|December 2015|2015-12-01|February 2012|Actual|2012-02-01|December 2009|Actual|2009-12-01||Observational|||Prognostic Significance of T Wave Alternans|The Prevalence and Prognostic Significance of T Wave Alternans in Patients With Severe Congestive Heart Failture|Completed||N/A|549|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 04:28:25.287763|2017-10-11 04:28:25.287763
NCT00006502|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2016-02-26|||September 2000||2000-09-01|July 2005|2005-07-01|June 2005|Actual|2005-06-01|||||Observational|||Myocardial Perfusion, Risk Factors, and Coronary Calcium||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:25.367936|2017-10-11 04:28:25.367936
NCT00006503|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2014-04-29|||August 2000||2000-08-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Prevalence & Progression of Subclinical Atherosclerosis||Completed||N/A|||Rush University Medical Center|||||f||||||||||||||2017-10-11 04:28:25.425356|2017-10-11 04:28:25.425356
NCT00006504|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-16|2016-03-15|||August 2000||2000-08-01|August 2004|2004-08-01|July 2002|Actual|2002-07-01|||||Observational|||Flavonoids and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:25.48093|2017-10-11 04:28:25.48093
NCT00006505|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-17|2017-10-05|||November 15, 2000||2000-11-15|April 25, 2017|2017-04-25|June 1, 2020|Anticipated|2020-06-01|June 30, 2002|Actual|2002-06-30||Interventional|||Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression|Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression|Active, not recruiting||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:28:25.541044|2017-10-11 04:28:25.541044
NCT00006507|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-04|2007-01-16|||March 1999||1999-03-01|December 2004|2004-12-01|February 2002||2002-02-01|||||Interventional|||Occupational Therapy to Treat Children Who Over or Under React to Their Environment|Occupational Therapy (OT) Outcomes: Children With Sensory Modulation Disorders|Completed||Phase 2|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:25.615277|2017-10-11 04:28:25.615277
NCT00006508|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-18|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Disorders of Systemic Glucose Balance||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:25.683833|2017-10-11 04:28:25.683833
NCT00006509|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-17|2015-03-05||||||March 2015|2015-03-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years|A Phase I/II Safety and Immunogenicity Evaluation of a Prime/Boost Vaccine Using ALVAC-HIV (vCP 1452) With Recombinant gp160 LAI/MN-2 in HIV-Infected Subjects Treated With Antiretroviral Therapy for a Minimum of 2 Years|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:28:25.737724|2017-10-11 04:28:25.737724
NCT00006510|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-20|2016-07-28|||September 2000||2000-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Identification of an Asthma Susceptibility Gene on 3P||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:25.817052|2017-10-11 04:28:25.817052
NCT00006511|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-20|2016-02-17|||September 2000||2000-09-01|January 2006|2006-01-01|August 2005|Actual|2005-08-01|||||Observational|||Chromosome 5Q Gene Variants and Asthma-Related Traits||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:25.862904|2017-10-11 04:28:25.862904
NCT00006512|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-20|2016-01-19|||September 2000||2000-09-01|January 2016|2016-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Characterizing a 5P-Linked BHR Susceptibility Locus||Completed||N/A|||University of Chicago|||||f||||||||||||||2017-10-11 04:28:25.913693|2017-10-11 04:28:25.913693
NCT00006513|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-20|2016-03-15|||September 2000||2000-09-01|January 2006|2006-01-01|August 2004|Actual|2004-08-01|||||Observational|||Assessing the Occupation Burden in COPD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:26.099228|2017-10-11 04:28:26.099228
NCT00006514|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-20|2016-02-17|||September 2000||2000-09-01|July 2005|2005-07-01|August 2004|Actual|2004-08-01|||||Observational|||Multivariate Risk of CVD in Diverse Populations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:26.155919|2017-10-11 04:28:26.155919
NCT00006515|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-21|2017-06-30|||November 16, 2000||2000-11-16|November 18, 2011|2011-11-18|November 18, 2011||2011-11-18|||||Observational|||Late Effects of Treatment for Sarcomas in Children|Late Effects of Treatment in Survivors of Pediatric Sarcomas|Completed||N/A|39|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:26.210304|2017-10-11 04:28:26.210304
NCT00006516|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-21|2016-09-23|||September 1999||1999-09-01|May 2011|2011-05-01||||August 2004|Actual|2004-08-01||Interventional|||Home Stimulation for Brain-Asphyxiated Infants|Neuroplasticity of Brain-Asphyxiated Infants: Efficacy of Intervention|Completed||Phase 2|120|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:28:26.272886|2017-10-11 04:28:26.272886
NCT00006517|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-22|2015-06-02|||September 1998||1998-09-01|November 2005|2005-11-01|April 2004|Actual|2004-04-01|June 2003|Actual|2003-06-01||Interventional|||Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)|Light and Ion Therapy for Seasonal Affective Disorder|Completed||N/A|150|Actual|New York State Psychiatric Institute||5|||f||||f||||||||||2017-10-11 04:28:26.350608|2017-10-11 04:28:26.350608
NCT00006519|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-23|2006-07-10|||November 2000||2000-11-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Capravirine to Treat Children With HIV Infection|A Phase I Study of Capravirine (AG 1549), a Novel Non-Nucleoside Reverse Transcriptase Inhibitor in Children With HIV Infection|Completed||Phase 1|96||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:26.566199|2017-10-11 04:28:26.566199
NCT00006526|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-28|2016-03-15|||July 1999||1999-07-01|August 2004|2004-08-01|May 2003|Actual|2003-05-01|||||Observational|||Coronary Calcification Progression Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:26.630936|2017-10-11 04:28:26.630936
NCT00006539|ClinicalTrials.gov processed this data on October 10, 2017|2000-11-28|2016-03-15|||September 1999||1999-09-01|March 2005|2005-03-01|August 2004|Actual|2004-08-01|||||Observational|||Thrombotic, Inflammatory & Gene Markers of CVD in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:26.685118|2017-10-11 04:28:26.685118
NCT00006565|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-01|2016-02-17|||September 2000||2000-09-01|October 2008|2008-10-01|April 2004|Actual|2004-04-01|March 2003|Actual|2003-03-01||Interventional|||Randomized Trial to Reduce Environmental Tobacco Smoke in Children With Asthma|Randomized Trial to Reduce Environmental Tobacco Smoke in Children With Asthma|Completed||Phase 3|225|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||f||||||||||2017-10-11 04:28:26.801127|2017-10-11 04:28:26.801127
NCT00006578|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-01|2015-03-05||||||June 2003|2003-06-01||||||||Interventional|||Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication|Evaluation of the Relationship Between Immunologic Recovery After Highly Active Antiretroviral Therapy and the Ability to Mobilize CD34+ Stem Cells Following G-CSF Administration|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:26.892793|2017-10-11 04:28:26.892793
NCT00006591|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-01|2005-06-23||||||December 2004|2004-12-01||||||||Interventional|||Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment|The Safety and Efficacy of a Ritonavir-Enhanced Agenerase Regimen as Salvage Therapy in HIV-Infected Individuals|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:28:26.967656|2017-10-11 04:28:26.967656
NCT00006604|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2016-03-07|2016-01-29||November 2000||2000-11-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|October 2011|Actual|2011-10-01||Interventional||"Participants accrued and treated at the dose ultimately selected for their groups.
NOTE: (1) Final Dose not established for Grps 1, 2; (2) Grp 5a started with n=12, but (1) participant inadvertently enrolled,never received ATV, final n=11; (3) Grp 8 started with n=15, but (1) participant inadvertently enrolled, never received ATV, final n=14."|Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents|Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS 232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and -Experienced HIV-Infected Infants, Children, and Adolescents|Completed||Phase 1/Phase 2|195|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||9|||f||||f||||||||||2017-10-11 04:28:27.112934|2017-10-11 04:28:27.112934
NCT00006617|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2015-05-14||||||December 2004|2004-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients|An Open-Label, Single Center Trial to Evaluate the Efficacy and Safety of Quadruple Chemotherapy (Zidovudine, EPIVIR, 1592U89, and 141W94) in Subjects Infected With HIV-1 (GW QUAD)|Completed||N/A|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:31.888445|2017-10-11 04:28:31.888445
NCT00006630|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2012-05-11||||||May 2012|2012-05-01||||||||Interventional|||Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection|Open-Label, Multi-Site Study for the Administration of Vaccinia Immune Globulin (Human) To Subjects Who Experience Complications From Vaccinia Virus Vaccinations or To Unprotected Individuals Accidentally Exposed To Vaccinia Virus or Related Orthopox Viruses [During HIV Vaccine Research]|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:28:31.973604|2017-10-11 04:28:31.973604
NCT00006643|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2008-07-29||||||June 2003|2003-06-01||||||||Observational|||Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus|Use of Single Photon Emission Computed Tomography (SPECT) as a Noninvasive Alternative to Liver Biopsies in Assessing Liver Involvement in Subjects Coinfected With HIV and Hepatitis C Virus (HCV)|Completed||N/A|44||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:32.045379|2017-10-11 04:28:32.045379
NCT00006656|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-11-05|||June 2000||2000-06-01|August 2003|2003-08-01||||||||Interventional|||Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme|A Phase I/II Study of the Safety and Tolerability of DTI-015 in Patients With Recurrent Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:32.146983|2017-10-11 04:28:32.146983
NCT00006669|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2009-02-06|||September 1999||1999-09-01|May 2001|2001-05-01||||||||Interventional|||Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma|Phase II Trial of EPOCH and Rituxan Combined Therapy in Patients With Refractory or Relapsed CD20 Positive Intermediate Grade B-Cell Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:32.240992|2017-10-11 04:28:32.240992
NCT00006682|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2008-07-23|||February 2000||2000-02-01|May 2001|2001-05-01||||||||Interventional|||Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer|An Open-Label Phase II Study of Navelbine (Vinorelbine Tartrate) and Taxotere (Docetaxel) as First-Line Therapy for Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:32.315483|2017-10-11 04:28:32.315483
NCT00006695|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2015-05-26|||April 2000||2000-04-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|September 2005|Actual|2005-09-01||Interventional|||Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|BEAM Plus Iodine-131 Anti-B1 Antibody and Autologous Hematopoietic Stem Cell Transplantation for Treatment of Recurrent Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|50|Actual|University of Nebraska||1|||f||||||||||||||2017-10-11 04:28:32.382945|2017-10-11 04:28:32.382945
NCT00006708|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-04-08|||October 2000||2000-10-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2002|Actual|2002-11-01||Interventional|||S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Randomized Phase III Trial of ICE Chemotherapy With or Without Rituximab for the Treatment of Relapsed or Refractory CD20 Expressing Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients Not Suitable for High Dose Therapy and PBSCT|Terminated||Phase 3|7|Actual|Southwest Oncology Group||2||lack of accrual|f||||t||||||||||2017-10-11 04:28:32.490829|2017-10-11 04:28:32.490829
NCT00006721|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2017-07-13|2012-11-02||March 2001||2001-03-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|September 2011|Actual|2011-09-01||Interventional|||S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma|A Phase III Trial of CHOP Plus Rituximab vs CHOP Plus Iodine-131-Labeled Monoclonal Anti-B1 Antibody (Tositumomab) for Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas|Active, not recruiting||Phase 3|571|Actual|Southwest Oncology Group||3|||f||||t|t|f||||||||2017-10-11 04:28:33.000238|2017-10-11 04:28:33.000238
NCT00006734|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-05-16|||May 2001||2001-05-01|May 2013|2013-05-01||||August 2006|Actual|2006-08-01||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor|Trial of Chemotherapy Intensification Through Compression in Ewing's Sarcoma and Related Tumors|Completed||Phase 3|587|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:28:35.187432|2017-10-11 04:28:35.187432
NCT00006747|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2016-07-15|||November 2000||2000-11-01|July 2016|2016-07-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma|Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma|Completed||Phase 2|4|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:28:35.814586|2017-10-11 04:28:35.814586
NCT00006760|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-07-25|||May 2001||2001-05-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma|A Pilot Study of Re-Induction Chemotherapy With Ifosfamide, and Vinorelbine (IV) in Children With Refractory/Relapsed Hodgkin's Disease|Completed||Phase 2|66|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:28:36.001941|2017-10-11 04:28:36.001941
NCT00006773|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-01-23|||May 2001||2001-05-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Bortezomib in Treating Patients With Recurrent Glioma|Phase I Evaluation of the Safety of PS 341 in the Treatment of Recurrent Gliomas|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:28:36.546166|2017-10-11 04:28:36.546166
NCT00006786|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-06-20|||November 2000||2000-11-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer|Phase II Trial of Fluorouracil (5-FU), Leucovorin (LV), Irinotecan (CPT-11) and Bevacizumab (Anti-VEGF) in Previously Untreated Patients With Advanced Colorectal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:36.656254|2017-10-11 04:28:36.656254
NCT00006799|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2017-04-17|||October 2000|Actual|2000-10-01|August 2009|2009-08-01|September 6, 2002|Actual|2002-09-06|September 6, 2002|Actual|2002-09-06||Interventional|||Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer|A Phase III, Double-Blind, Randomized Study Of The Effect Of Megestrol Acetate On Weight And Health Related Quality Of Life In Head And Neck Cancer Patients Receiving Radiation Therapy|Completed||Phase 3|13|Actual|Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:28:36.939226|2017-10-11 04:28:36.939226
NCT00006812|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-04-10|||March 2001||2001-03-01|November 2005|2005-11-01||||July 2005|Actual|2005-07-01||Interventional|||Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer|Phase II Evaluation Of Capecitabine In Recurrent Platinum-Sensitive Ovarian Or Primary Peritoneal Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:28:37.056986|2017-10-11 04:28:37.056986
NCT00006825|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2011-03-25|||July 2000||2000-07-01|March 2011|2011-03-01||||July 2004|Actual|2004-07-01||Interventional|||Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer|A Safety Study Of Doxil And Herceptin In Patients With Advanced Her-2 Overexpressing Breast Cancer|Completed||Phase 1/Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:28:37.185694|2017-10-11 04:28:37.185694
NCT00006864|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2014-01-08|||July 2000||2000-07-01|January 2014|2014-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|Interleukin-2 In An Alternative Dose (The Iliad Trial): Treatment Of Patients With Metastatic Renal Cell Carcinoma With Low Dose Proleukin|Completed||Phase 4|||Case Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:28:37.263087|2017-10-11 04:28:37.263087
NCT00006877|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2014-01-06|||July 2000||2000-07-01|February 2001|2001-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer|A Phase II Study Of Temozolomide In The Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|30|Actual|Case Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:28:37.3485|2017-10-11 04:28:37.3485
NCT00006890|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2011-09-27|||July 2000||2000-07-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|May 2002|Actual|2002-05-01||Interventional|||Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Randomized Phase II Dose Finding Study Of Thalidomide And Prednisone As Maintenance Therapy Following Autologous Stem Cell Transplant In Patients With Multiple Myeloma|Completed||Phase 2|67|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-11 04:28:37.459296|2017-10-11 04:28:37.459296
NCT00006903|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2017-05-03|2014-05-20||August 2004||2004-08-01|May 2017|2017-05-01||||March 2008|Actual|2008-03-01||Interventional||Total number of eligible and treated participants by estrogen receptor status in metastatic tumor|Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer|Phase II Study of Faslodex ® in Recurrent/Metastatic Endometrial Carcinoma|Active, not recruiting||Phase 2|67|Actual|Gynecologic Oncology Group|Accrual was discontinued after completion of the first stage of accrual due to lack of study drug activity.|1|||f||||||||||||||2017-10-11 04:28:37.708539|2017-10-11 04:28:37.708539
NCT00006916|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2015-11-14|2013-06-12||June 2001||2001-06-01|November 2015|2015-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme|A Phase II Trial Of Conventional Radiation Therapy Followed By Intratumoral Bleomycin Delivered Using A Refillable, Sustained Release Device (IND# 46,592) For The Treatment Of Supratentorial Glioblastoma|Terminated||Phase 2|19|Actual|Radiation Therapy Oncology Group|This study stopped accrual early due unmet targeted accrual goals with 19 subjects accrued out of 72 planned. No efficacy analyses were performed since the small number of patients would not have provided meaningful results.|1||Low accrual|f||||t||||||||||2017-10-11 04:28:38.017543|2017-10-11 04:28:38.017543
NCT00006929|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-06-03|||September 2000||2000-09-01|June 2013|2013-06-01||||November 2007|Actual|2007-11-01||Interventional|||Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase I/II Study of Carboplatin / Paclitaxel / Suramin Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|82|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:28:38.351195|2017-10-11 04:28:38.351195
NCT00010699|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-03-21||||||March 2013|2013-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Effect of High Dose Vitamin E on Carotid Atherosclerosis|Effect of High Dose Vitamin E on Carotid Atherosclerosis|Completed||Phase 2|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:08.179482|2017-10-11 04:29:08.179482
NCT00006942|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-08-23|||October 2000||2000-10-01|August 2013|2013-08-01||||March 2004|Actual|2004-03-01||Interventional|||Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Trial of Bryostatin in Combination With Cisplatin in Patients With Recurrent or Persistent Epithelial Ovarian Cancer|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:28:38.464731|2017-10-11 04:28:38.464731
NCT00006968|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2013-01-07|||September 2000||2000-09-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer|Non-Myeloablative Chemotherapy Followed By Related Allogeneic Stem Cell Rescue In Patients With Advanced Renal Cell Carcinoma|Completed||Phase 1/Phase 2|4|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:28:38.560295|2017-10-11 04:28:38.560295
NCT00006981|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2015-04-29|||December 2000||2000-12-01|May 2005|2005-05-01||||||||Interventional|||Immunotoxin Therapy in Treating Patients With Advanced Cancer|Phase I Study Of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion X 10 Days|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:38.632842|2017-10-11 04:28:38.632842
NCT00006994|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2015-11-17|||November 2001||2001-11-01|November 2015|2015-11-01|April 2006|Actual|2006-04-01|April 2005|Actual|2005-04-01||Interventional|||S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat|S9908, A Double-Blind, Placebo-Controlled Trial To Study The Efficacy And Safety Of L-Glutamine (In AES0014 Delivery Vehicle) Upon Radiation Therapy-Induced Oral Mucositis In Head and Neck Cancer Patients, Phase III|Terminated||Phase 3|23|Actual|Southwest Oncology Group||2||Withdrawn due to drug availability and funding|f||||t||||||||||2017-10-11 04:28:38.937125|2017-10-11 04:28:38.937125
NCT00007007|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2015-03-26|||November 2000||2000-11-01|March 2015|2015-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases|A Feasibility Study of Neurocognitive Evaluation in Patients Treated for Brain Metastases|Completed||N/A|59|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:28:39.231466|2017-10-11 04:28:39.231466
NCT00007020|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2015-04-15||2013-05-21|January 1992||1992-01-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid|"Investigation in the Pathogenesis of Liver Disease in Patients With Inborn Errors of Bile Acid Metabolism. This Study Was Previously Registered by the NCRR and Identified as NCRR-M01RR08084-0009"|Completed||Phase 3|79|Actual|Retrophin, Inc.||1|||f||||f||||||||||2017-10-11 04:28:39.819592|2017-10-11 04:28:39.819592
NCT00007033|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2009-01-21|||October 2000||2000-10-01|April 2002|2002-04-01||||||||Interventional|||Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease||Completed||N/A|25||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:39.91107|2017-10-11 04:28:39.91107
NCT00007046|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2005-06-23|||August 2000||2000-08-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:40.000046|2017-10-11 04:28:40.000046
NCT00007059|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-06|2005-06-23|||June 1998||1998-06-01|December 2003|2003-12-01||||||||Interventional|||Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation|Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation|Completed||N/A|20||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:40.071887|2017-10-11 04:28:40.071887
NCT00007085|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-07|2016-07-28|||September 2000||2000-09-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:40.144023|2017-10-11 04:28:40.144023
NCT00007098|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-07|2016-12-06|||May 1995||1995-05-01|December 2016|2016-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Influence of Insulin on BP Change During Adolescence||Completed||N/A|2|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||Undecided||2017-10-11 04:28:40.20682|2017-10-11 04:28:40.20682
NCT00007111|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-07|2015-12-21|||April 1992||1992-04-01|January 2005|2005-01-01|April 2002||2002-04-01|||||Observational|||Children's Activity and Nutrition III||Completed||N/A|||Augusta University|||||f||||||||||||||2017-10-11 04:28:40.286393|2017-10-11 04:28:40.286393
NCT00007124|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-07|2008-03-03|||December 2000||2000-12-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Observational|||Ketogenic Diet in Lafora Disease|A Trial of Ketogenic Diet in Lafora Disease|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:40.37631|2017-10-11 04:28:40.37631
NCT00007137|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-09|2017-06-30|||December 5, 2000||2000-12-05|April 11, 2007|2007-04-11|April 11, 2007||2007-04-11|||||Observational|||Structure and Function of the Human Tongue|Task-Induced Physiological and Biomechanical Changes of the In Vivo Human Tongue|Completed||N/A|165||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:40.45103|2017-10-11 04:28:40.45103
NCT00007150|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-09|2017-10-05|||December 6, 2000||2000-12-06|July 21, 2017|2017-07-21||||||||Observational|||Treatment of Hemochromatosis|Studies of Phlebotomy Therapy in Hereditary Hemochromatosis|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:40.527481|2017-10-11 04:28:40.527481
NCT00007163|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-09|2008-03-03|||December 2000||2000-12-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Interventional|||Monoclonal Antibody Treatment of Crohn's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Safety Study of Two Parallel Dose Levels of Subcutaneously Administered Human Monoclonal Antibody to Interleukin-12 (J695) in Patients With Active Crohn's Disease|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:40.636287|2017-10-11 04:28:40.636287
NCT00007189|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-14|2016-10-18|||January 2001||2001-01-01|October 2016|2016-10-01||||May 2007|Actual|2007-05-01||Interventional|||Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)|Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)|Completed||Phase 3|2625||Seattle Institute for Biomedical and Clinical Research|||||f||||||||||||||2017-10-11 04:28:40.744457|2017-10-11 04:28:40.744457
NCT00010712|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|July 2005||2005-07-01|||||Interventional|||Effects of Black Cohosh on Menopausal Hot Flashes|Effects of Black Cohosh on Menopausal Hot Flashes|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:08.252333|2017-10-11 04:29:08.252333
NCT00007202|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-15|2013-09-20||||||September 2013|2013-09-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients|A Pilot Open-Label Phase II Clinical Trial to Evaluate the Safety and Efficacy of a Compact Three Drug Antiretroviral Treatment Regimen for Subjects With Acute HIV-1 Infection or Recent HIV-1 Seroconversion|Completed||Phase 2|55|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:28:40.867532|2017-10-11 04:28:40.867532
NCT00007215|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-15|2008-03-03|||December 2000||2000-12-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Dynamic Light Scattering Device (DLS) Study of Age-Related Changes in the Lens and Cataracts|A Study of Age-Related Changes in the Human Lens and Cataracts In Vivo Using Dynamic Light Scattering Device (DLS) Combined With Keratoscopy|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:41.003204|2017-10-11 04:28:41.003204
NCT00007228|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-15|2008-03-03|||December 2000||2000-12-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Heart and Skeletal Muscle Problems in Neuroacanthocytosis|Characterization of Cardiac and Skeletal Myopathy, Risk Evaluation, and Phenotype-Genotype Correlation in Patients With Neuroacanthocytosis|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:41.081299|2017-10-11 04:28:41.081299
NCT00007241|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2007-01-02|||September 2001||2001-09-01|February 2003|2003-02-01|July 2002||2002-07-01|||||Interventional|||Muscle Strengthening Device for Knee Osteoarthritis|Osteoarthritic Knee Isometric Exerciser for Home Use|Completed||Phase 2|92||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:28:41.158155|2017-10-11 04:28:41.158155
NCT00007254|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2013-05-17|||March 2000||2000-03-01|May 2013|2013-05-01|February 2003||2003-02-01|||||Interventional|||Morphine Gel for Bedsores|Morphine-Infused Gel for Pressure Ulcer Analgesia|Completed||Phase 1/Phase 2|75||University of Kansas Medical Center|||||f||||||||||||||2017-10-11 04:28:41.23991|2017-10-11 04:28:41.23991
NCT00007267|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2017-08-08|||June 2001||2001-06-01|August 2017|2017-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Psychological Treatments for Scleroderma|Psychosocial Interventions for Scleroderma|Completed||Phase 2|89|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-10-11 04:28:41.336803|2017-10-11 04:28:41.336803
NCT00007280|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2013-08-01|||October 2000||2000-10-01|April 2008|2008-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Bioengineered Skin and Wound Healing|Mechanisms of Bioengineered Skin in Human Wounds|Completed||Phase 1|50|Actual|Roger Williams Medical Center||1|||f||||||||||||||2017-10-11 04:28:41.455866|2017-10-11 04:28:41.455866
NCT00007293|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2007-01-02|||August 2000||2000-08-01|February 2003|2003-02-01|July 2002||2002-07-01|||||Interventional|||Scalp Psoriasis Treatment With a Fiber Optic Comb|Phototherapy of Psoriasis of the Scalp With a UV-B Emitting Fiber Optic Comb|Completed||Phase 1/Phase 2|30||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:28:41.546653|2017-10-11 04:28:41.546653
NCT00007306|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2007-01-02|||January 2000||2000-01-01|March 2003|2003-03-01|April 2005||2005-04-01|||||Interventional|||Treatment of Psoriasis With Parathyroid Hormone|Evaluation of the Therapeutic Efficacy & Safety of Topical Administration of Parathyroid Hormone (PTH) in Psoriasis|Completed||Phase 1/Phase 2|40||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-10-11 04:28:41.61338|2017-10-11 04:28:41.61338
NCT00007319|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2008-09-16||||||May 2006|2006-05-01||||||||Observational|||Carotid Artery Thickness in HIV Infected and Uninfected Adults|Carotid Artery Intima-Media Thickness in HIV-Infected and Uninfected Adults: A Pilot Study|Completed||N/A|132||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:41.7056|2017-10-11 04:28:41.7056
NCT00007332|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2012-05-16||||||May 2012|2012-05-01|April 2003|Actual|2003-04-01|||||Interventional|||Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B|A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of a Combined Regimen Using ALVAC vCP1452 and AIDSVAX B/B|Completed||Phase 2|330||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:41.994059|2017-10-11 04:28:41.994059
NCT00007345|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-16|2017-04-13|2016-01-14||March 8, 2001|Actual|2001-03-08|April 2017|2017-04-01|July 27, 2015|Actual|2015-07-27|January 26, 2015|Actual|2015-01-26||Interventional||Although 7 cohorts were written in the protocol, the cohorts were consolidated for submission to the Food and Drug Administration (FDA) into the peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) groups, thus they are presented in this format.|Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma|Phase II Trial of Depsipeptide in Patients With Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma|Completed||Phase 2|131|Actual|National Institutes of Health Clinical Center (CC)|7 cohorts were consolidated for submission to the Food and Drug Administration (FDA) into the peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) groups, thus they are presented in this format.|2|||f||||f|t|f||||||No||2017-10-11 04:28:42.130662|2017-10-11 04:28:42.130662
NCT00007358|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-19|2016-03-10|||October 2000||2000-10-01|March 2016|2016-03-01|October 2008|Actual|2008-10-01|April 2007|Actual|2007-04-01||Interventional|||Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus|Study of Dexamethasone in Neonatal Lupus Congenital Heart Block; PRIDE (PR Interval and Dexamethasone Evaluation) in Congenital Heart Block|Completed||N/A|150|Anticipated|New York University School of Medicine||1|||f||||||||||||||2017-10-11 04:28:43.492139|2017-10-11 04:28:43.492139
NCT00007371|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-19|2016-09-22|||September 1999||1999-09-01|January 2005|2005-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Observational|||Hepatitis C in Clinically Discordant Hemophilic Siblings|Hepatitis C in Clinically Discordant Hemophilic Siblings|Completed||N/A|||University of North Carolina, Chapel Hill|||||f||||f||||||||No||2017-10-11 04:28:43.619259|2017-10-11 04:28:43.619259
NCT00007384|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-19|2016-02-17|||July 2000||2000-07-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Longitudinal LDL-C Studies in Black and White Families||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:43.706518|2017-10-11 04:28:43.706518
NCT00007397|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-19|2016-05-12|||February 2000||2000-02-01|December 2005|2005-12-01|January 2004|Actual|2004-01-01|||||Observational|||Age, Risk Factors for CVD and Cognitive Functioning||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:43.780086|2017-10-11 04:28:43.780086
NCT00007410|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-19|2016-07-28|||September 2000||2000-09-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Genetic Architecture of Plasma T-PA and PAI-1||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:43.871466|2017-10-11 04:28:43.871466
NCT00007423|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-19|2012-05-16||||||May 2012|2012-05-01|September 2001|Actual|2001-09-01|||||Interventional|||Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda|A Phase I Study of the Safety and Immunogenicity of Live Recombinant ALVAC-HIV vCP205 in HIV-1 Uninfected Adult Volunteers in Uganda|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:43.946701|2017-10-11 04:28:43.946701
NCT00007436|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-19|2005-06-23||||||July 2001|2001-07-01||||||||Interventional|||The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients|A Phase 3, Open-Label, Multicenter Study of the Safety of Tenofovir Disoproxil Fumarate Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients|Unknown status|Active, not recruiting|Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:28:44.068812|2017-10-11 04:28:44.068812
NCT00007449|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-19|2005-06-23||||||June 2002|2002-06-01||||||||Interventional|||Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors|A Phase II, Open Label, Multicenter Study to Assess the Safety and Efficacy of 100 Mg DPC 083 Once Daily in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Subjects Who Are Failing Treatment With a Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimen|Unknown status|Active, not recruiting|Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:28:44.195137|2017-10-11 04:28:44.195137
NCT00007475|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-22|2016-02-08|2015-06-19||December 2000||2000-12-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Permeability Factor in Focal Segmental Glomerulosclerosis|Permeability Factor in Focal Segmental Glomerulosclerosis|Completed||Phase 1/Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)|Note: definitive FSGS Permeability Factor (FPF) assays still in development. Data/samples transferred to the NIH-CC Glomerulosclerosis Consolidation protocol: focus on cardiotrophin like cytokine 1 & antibodies to a panel of podocyte proteins as FPF.|1|||f||||f||||||||||2017-10-11 04:28:44.288293|2017-10-11 04:28:44.288293
NCT00007488|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-23|2013-11-19|||November 2000||2000-11-01|November 2013|2013-11-01|August 2004|Actual|2004-08-01|||||Observational|||HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs|Virologic Studies in Compartmental Samples From HIV-Infected Subjects Changing or Initiating Potent Antiretroviral Therapy|Completed||N/A|164||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:44.89569|2017-10-11 04:28:44.89569
NCT00007501|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2013-07-02|||November 1998||1998-11-01|July 2013|2013-07-01|February 2011|Actual|2011-02-01|April 2004|Actual|2004-04-01||Interventional|SPS||Shingles Prevention Study|CSP #403 - Trial of Varicella Zoster Vaccine for the Prevention of Herpes Zoster and Its Complications|Completed||Phase 3|38456|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:28:45.035062|2017-10-11 04:28:45.035062
NCT00007514|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-01-20|||March 2000||2000-03-01|February 2003|2003-02-01|February 2001||2001-02-01|||||Observational|||Investigate Olfactory Functioning as a Possible Proxy for Neurotoxic Exposure in Cohorts of Deployed and Non-Deployed Gulf War-Era Veterans.|Olfactory Functioning in Gulf War Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:28:45.390967|2017-10-11 04:28:45.390967
NCT00007527|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-01-20|||August 1999||1999-08-01|February 2003|2003-02-01|January 2002||2002-01-01|||||Interventional|||Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice|A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence|Completed||Phase 4|600||VA Office of Research and Development|||||||||||||||||||2017-10-11 04:28:45.46122|2017-10-11 04:28:45.46122
NCT00007540|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-01-20|||April 1998||1998-04-01|February 2003|2003-02-01|September 2000||2000-09-01|||||Observational|||Study of Prostate Cancer in Black and White U.S. Veterans|Study of Prostate Cancer in Black and White U.S. Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:28:45.544363|2017-10-11 04:28:45.544363
NCT00007579|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2008-10-16|||February 1998||1998-02-01|February 2003|2003-02-01||||||||Observational|||To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population.|Prostate Cancer Case-Control Study: Black Versus White: VA Versus Private Sector|Completed||N/A|||VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:28:45.606301|2017-10-11 04:28:45.606301
NCT00007592|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-01-20|||June 1989||1989-06-01|February 2003|2003-02-01||||||||Observational|||Hypertension Screening and Treatment Program|VA HYPERTENSION SCREENING AND TREATMENT PROGRAM (PILOT STUDY)|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:28:45.681356|2017-10-11 04:28:45.681356
NCT00007605|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2011-06-13|||April 1998||1998-04-01|June 2011|2011-06-01|December 2003|Actual|2003-12-01|October 2002|Actual|2002-10-01||Interventional|||Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm|CSP #399 - The Effects of Antiarrhythmic Therapy in Maintaining Stability of Sinus Rhythm in Atrial Fibrillation|Completed||Phase 3|706|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:28:45.782741|2017-10-11 04:28:45.782741
NCT00007618|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2011-02-02|||January 1998||1998-01-01|February 2011|2011-02-01||||||||Observational|||The Identification of Prognostic Factors of Late Stage Disease, Particularly Those That Are Modifiable, That Might Explain the Worsened Prognosis With Colorectal Cancer Among Veterans.|CSP #707D - Colorectal Cancer-Risk Factors for Advanced Disease|Completed||N/A|||VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:28:45.928115|2017-10-11 04:28:45.928115
NCT00007631|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-01-29|||March 1998||1998-03-01|January 2009|2009-01-01|July 2006|Actual|2006-07-01|November 2004|Actual|2004-11-01||Interventional|||Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer|CSP #402 - VA Topical Tretinoin Chemoprevention Trial|Completed||Phase 3|1131|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:28:45.999657|2017-10-11 04:28:45.999657
NCT00007644|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2014-04-24|2013-08-15||November 1994||1994-11-01|April 2014|2014-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|PIVOT||Prostate Cancer Intervention Versus Observation Trial (PIVOT)|CSP #407 - Prostate Cancer Intervention Versus Observation Trial (PIVOT): A Randomized Trial Comparing Radical Prostatectomy Versus Palliative Expectant Management for the Treatment of Clinically Localized Prostate Cancer|Completed||Phase 3|731|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:28:46.12585|2017-10-11 04:28:46.12585
NCT00007657|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-06-12|||December 1998||1998-12-01|June 2009|2009-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation|CSP #424 - Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation|Completed||Phase 3|3260|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:28:46.485342|2017-10-11 04:28:46.485342
NCT00005630|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-18|||July 1999||1999-07-01|June 2013|2013-06-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer|Vaccination of Non-Small Cell Lung Cancer Patients Against Mutated K-Ras: A Pilot Trial|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:28:46.73347|2017-10-11 04:28:46.73347
NCT00005631|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-18|||November 1999||1999-11-01|June 2013|2013-06-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma|Cytoreduction and Stem Cell Mobilization With Rituximab and ICE for Patients With Refractory or Relapsed CD20+ B-Cell IGL Eligible for ASCT: The RICE Protocol|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:28:48.585402|2017-10-11 04:28:48.585402
NCT00005632|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-01-30|||June 1999||1999-06-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer|Vaccination of Prostate Cancer Patients With MUC-1-KLH Conjugate Plus the Immunological Adjuvant QS21: A Trial Examining the Immunogenicity of MUC-1 Glycopeptide Conjugate|Completed||Phase 1|27|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:28:48.664851|2017-10-11 04:28:48.664851
NCT00005633|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-18|||June 1999||1999-06-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|Vaccination of Melanoma Patients With Tyrosinase YMD and gp100 IMD-Javelin Fusion Peptides/HSP70 Complexes: A Trial Comparing the Immunogenicity of Three Doses|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:28:48.732374|2017-10-11 04:28:48.732374
NCT00005634|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy|Phase I Clinical and Pharmacological Study of Suberoylanilide Hydroxamic Acid- SAHA (MSK390) in Patients With Advanced Solid Tumors|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:28:48.791465|2017-10-11 04:28:48.791465
NCT00005635|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-08-16|||January 2000||2000-01-01|August 2013|2013-08-01||||November 2001|Actual|2001-11-01||Interventional|||Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2|A Phase II Trial to Investigate the Pharmacokinetics, Safety, and Tolerability of Herceptin Administered Subcutaneously in Combination With Paclitaxel in Women With HER2 Overexpressing Metastatic Breast Cancer|Completed||Phase 2|||Genentech, Inc.|||||f||||||||||||||2017-10-11 04:28:48.868039|2017-10-11 04:28:48.868039
NCT00005636|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-17|||November 1999||1999-11-01|June 2013|2013-06-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery|A Single-Blind Randomized Phase III Trial of MTA Plus Cisplatin Versus Cisplatin in Patients With Malignant Pleural Mesothelioma|Completed||Phase 3|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:28:48.9285|2017-10-11 04:28:48.9285
NCT00005637|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-04-02|||December 1999||1999-12-01|March 2003|2003-03-01|December 2009|Actual|2009-12-01|June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma|A Phase I Study of Extended Low Dose Temozolomide (SCH 52365, Temodar (R)) and Carmustine (BCNU) in the Treatment of Malignant Gliomas After Radiation Therapy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:48.997479|2017-10-11 04:28:48.997479
NCT00005638|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-17|||October 1999||1999-10-01|June 2013|2013-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer|Phase I Trial of Combined Modality Irinotecan, Cisplatin, and Concurrent Radiation Therapy for Patients With Locally Advanced Esophageal Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:28:49.085947|2017-10-11 04:28:49.085947
NCT00005639|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2010-03-13|||June 2000||2000-06-01|December 2005|2005-12-01||||||||Interventional|||Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment|A Phase I Dose Escalation to Maximally Tolerated Dose Trial of 5-Azacytidine (5 AC, NSC 102816) in Combination With Sodium Phenylbutyrate (PB, NSC 657802) in Patients With Refractory Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:28:49.176888|2017-10-11 04:28:49.176888
NCT00005640|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-09-24|||June 1999||1999-06-01|September 2012|2012-09-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer|Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer: A Feasibility Study|Completed||N/A|17|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:28:49.27852|2017-10-11 04:28:49.27852
NCT00005641|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-12-10|||September 1997||1997-09-01|December 2012|2012-12-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation|T-Cell Depletion for Graft-Versus-Host Disease (GVHD) Prevention in High Risk Matched and Mismatched Allogeneic Bone Marrow Transplantation|Terminated||Phase 2|||H. Lee Moffitt Cancer Center and Research Institute||||low study accrual|f||||f||||||||||2017-10-11 04:28:49.365132|2017-10-11 04:28:49.365132
NCT00005642|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2010-06-09|||May 2000||2000-05-01|June 2010|2010-06-01|November 2005|Actual|2005-11-01|December 2002|Actual|2002-12-01||Interventional|||SU5416 in Treating Patients With Advanced Solid Tumors|A Phase I Pharmacodynamic Trial of SU5416 (NSC 696819)|Completed||Phase 1|19|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:28:49.584105|2017-10-11 04:28:49.584105
NCT00005643|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2013-06-07|||May 2000||2000-05-01|November 2005|2005-11-01||||March 2005|Actual|2005-03-01||Interventional|||Chemotherapy in Treating Patients With Sarcoma of the Uterus|Evaluation of Doxil in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:28:49.673928|2017-10-11 04:28:49.673928
NCT00005644|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2012-09-29|||May 2000||2000-05-01|July 2002|2002-07-01||||February 2003|Actual|2003-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function|Phase II Trial of Paclitaxel Plus Gemcitabine in Patients With Advanced Urothelial Carcinoma With Renal Insufficiency|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:49.875755|2017-10-11 04:28:49.875755
NCT00005645|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2014-01-03|||May 1999||1999-05-01|February 2001|2001-02-01||||||||Interventional|||ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment|Phase II Trial of ILX295501 Administered Orally Once Weekly x 3 Repeated Every 6 Weeks in Patients With Stage III/IV Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:28:49.992859|2017-10-11 04:28:49.992859
NCT00005646|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2016-07-12|||April 2000||2000-04-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|January 2004|Actual|2004-01-01||Interventional|||Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|36|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:28:50.083586|2017-10-11 04:28:50.083586
NCT00005647|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2010-06-09|||May 2000||2000-05-01|June 2010|2010-06-01|October 2003|Actual|2003-10-01|December 2002|Actual|2002-12-01||Interventional|||SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck|A Phase I Pharmacokinetic, Pharmacodynamic, and Clinical Study of the Combination of the Angiogenesis Inhibitor SU5416 and Paclitaxel in Recurrent or Metastatic Carcinoma of the Head and Neck|Completed||Phase 1|12|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:28:50.184571|2017-10-11 04:28:50.184571
NCT00005648|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2011-05-17|||November 1999||1999-11-01|October 2010|2010-10-01|November 2003|Actual|2003-11-01|||||Interventional|||Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer|A Phase III, Double-Blind, Placebo Controlled Trial of Gemcitabine Plus Placebo Versus Gemcitabine Plus R115777 in Patients With Advanced Pancreatic Cancer|Completed||Phase 3|688|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-10-11 04:28:50.273186|2017-10-11 04:28:50.273186
NCT00005649|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2017-08-15|||July 1998||1998-07-01|August 2017|2017-08-01|July 4, 2002||2002-07-04|July 4, 2002|Actual|2002-07-04||Interventional|||Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer|An Open-Label Combination Study of Capecitabine and Standard Paclitaxel Therapy as First or Second Line Therapy in Women With Metastatic Breast Carcinoma|Completed||Phase 2|||Hoffmann-La Roche|||||f||||||||||||||2017-10-11 04:28:50.357494|2017-10-11 04:28:50.357494
NCT00005650|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2005-06-23|||February 2000||2000-02-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of Patients With Primary Ciliary Dyskinesia|Genetic Study of Patients With Primary Ciliary Dyskinesia|Completed||N/A|180||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:50.429553|2017-10-11 04:28:50.429553
NCT00005652|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2008-09-08|||December 2000||2000-12-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:28:50.493662|2017-10-11 04:28:50.493662
NCT00005654|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-02|2005-06-23|||January 2000||2000-01-01|April 2000|2000-04-01||||||||Interventional|||Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome||Completed||N/A|88||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:28:50.574298|2017-10-11 04:28:50.574298
NCT00005655|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-04|2017-10-05|||April 28, 2000||2000-04-28|March 2, 2017|2017-03-02|March 2, 2017|Actual|2017-03-02|October 6, 2010|Actual|2010-10-06||Interventional|||Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer|A Phase I Investigation of IL-12/Pulse IL-2 in Adults With Advanced Solid Tumors|Terminated||Phase 1|39|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:28:50.635207|2017-10-11 04:28:50.635207
NCT00005657|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-06|2017-06-30|||May 4, 2000||2000-05-04|April 19, 2011|2011-04-19|April 19, 2011||2011-04-19|||||Observational|||Genetics of Hepatitis C Virus Infection|Immunogenetics of Hepatitis C Virus Infection|Completed||N/A|870|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:50.724808|2017-10-11 04:28:50.724808
NCT00005658|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-09|2008-03-03|||May 2000||2000-05-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Glycine to Treat Psychotic Disorders in Children|Childhood Onset Psychotic Disorders: An Open Trial With the Amino Acid Glycine|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:50.786071|2017-10-11 04:28:50.786071
NCT00005660|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-12|2008-03-03|||October 1977||1977-10-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases|The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases|Completed||N/A|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:50.853935|2017-10-11 04:28:50.853935
NCT00005663|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-11|2005-06-23|||June 1999||1999-06-01|July 2001|2001-07-01||||||||Interventional|||A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients|An International, Randomized, Double-Blind, Placebo-Controlled Study of Valacyclovir for the Suppression of Recurrent Ano-Genital HSV Infections in HIV-Infected Subjects|Unknown status|Active, not recruiting|Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:28:50.951462|2017-10-11 04:28:50.951462
NCT00005664|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-17|2017-10-05|||May 9, 2000||2000-05-09|August 25, 2017|2017-08-25||||||||Observational|||Evaluation of Patients With Endocrine-Related Conditions|Evaluation of Patients With Endocrine-Related Conditions|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:51.073476|2017-10-11 04:28:51.073476
NCT00005665|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-19|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||"Ingested Interferon Alpha: Prolongation or Permanence of the Honeymoon Phase in Newly Diagnosed Type 1 Diabetes Mellitus"||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:51.307018|2017-10-11 04:28:51.307018
NCT00005666|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-19|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:51.371883|2017-10-11 04:28:51.371883
NCT00005667|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-19|2005-06-23||||||November 2001|2001-11-01||||||||Observational|||Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of Colonization||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:51.451569|2017-10-11 04:28:51.451569
NCT00005668|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-18|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma|A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma|Completed||Phase 2|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:51.533683|2017-10-11 04:28:51.533683
NCT00005669|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-19|2015-04-21|2010-04-07||May 2000||2000-05-01|April 2015|2015-04-01|May 2011|Actual|2011-05-01|August 2009|Actual|2009-08-01||Interventional|||Metformin to Treat Obesity in Children With Insulin Resistance|Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children With Insulin Resistance|Completed||Phase 2|100|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:28:51.627959|2017-10-11 04:28:51.627959
NCT00005671|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-24|2008-03-03|||May 2000||2000-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Quality of Life in Patients With Chronic Ischemic Heart Disease|Quality of Life in Chronic Ischemic Heart Disease With Left Ventricular Dysfunction|Completed||N/A|105||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:52.030543|2017-10-11 04:28:52.030543
NCT00005673|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-24|2008-03-03|||May 2000||2000-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Interventional|||Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs|Safety and Pharmacokinetic Study of Capravirine. Part I. Pharmacokinetics of Capravirine in HIV-Negative Volunteers. Part II. Antiviral Activity of Capravirine, Efavirenz, and Abacavir in HIV-Infected Patients|Completed||Phase 1|46||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:52.11469|2017-10-11 04:28:52.11469
NCT00005674|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-26|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]||Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:52.181318|2017-10-11 04:28:52.181318
NCT00005675|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-26|2010-05-24|||April 2000||2000-04-01|March 2008|2008-03-01||||May 2005|Actual|2005-05-01||Interventional|||Oral Type I Collagen for Relieving Scleroderma|Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma|Completed||Phase 2|168|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||2|||t||||t||||||||||2017-10-11 04:28:52.257647|2017-10-11 04:28:52.257647
NCT00005676|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2014-03-03|||April 2000||2000-04-01|March 2014|2014-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||High Density Lipoprotein Subspecies and Coronary Disease|High Density Lipoprotein Subspecies and Coronary Disease|Completed||N/A|2700|Actual|Tufts University|||1||f||||f||||||||||2017-10-11 04:28:52.417949|2017-10-11 04:28:52.417949
NCT00005677|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-12|||August 1980||1980-08-01|January 2016|2016-01-01|January 2013|Actual|2013-01-01|December 2011|Actual|2011-12-01||Observational|||Percutaneous Transluminal Coronary Angioplasty (PTCA) Registries I, II, and III and the Dynamic Registry|Dynamic Evaluation of Coronary Intervention|Completed||N/A|4290|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 04:28:52.536561|2017-10-11 04:28:52.536561
NCT00005678|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||July 1984||1984-07-01|May 2000|2000-05-01|April 1996||1996-04-01|||||Observational|||Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:52.685386|2017-10-11 04:28:52.685386
NCT00005679|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||June 1985||1985-06-01|January 2008|2008-01-01|July 1993|Actual|1993-07-01|July 1993|Actual|1993-07-01||Observational|||Pathobiological Determinants of Atherosclerosis in Youth (PDAY)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:52.751233|2017-10-11 04:28:52.751233
NCT00005680|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-07-28|||September 1993||1993-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Whitehall II - Social and Occupational Influences On Health and Illness||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:52.863124|2017-10-11 04:28:52.863124
NCT00005681|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||August 1989||1989-08-01|October 2005|2005-10-01|July 2001|Actual|2001-07-01|||||Observational|||Vascular Basis for the Treatment of Ischemia||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.004062|2017-10-11 04:28:53.004062
NCT00005682|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1988||1988-09-01|May 2000|2000-05-01|August 1994|Actual|1994-08-01|||||Observational|||Aplastic Anemia Epidemiology: Incidence and Case-control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.086651|2017-10-11 04:28:53.086651
NCT00005683|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||December 1986||1986-12-01|January 2016|2016-01-01|November 1997||1997-11-01|||||Observational|||Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children||Completed||N/A|||University of Rochester|||||f||||||||||||||2017-10-11 04:28:53.164367|2017-10-11 04:28:53.164367
NCT00005684|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||March 1996||1996-03-01|February 2005|2005-02-01|January 2001|Actual|2001-01-01|||||Observational|||Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.255596|2017-10-11 04:28:53.255596
NCT00005685|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1983||1983-09-01|January 2006|2006-01-01|July 2002|Actual|2002-07-01|||||Observational|||Blood Pressure Control--Racial and Psychosocial Influences||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.336737|2017-10-11 04:28:53.336737
NCT00005686|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-29|||April 1989||1989-04-01|February 2016|2016-02-01|April 2003||2003-04-01|||||Observational|||Dietary Intervention Methods for Clinical Trials||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:28:53.399554|2017-10-11 04:28:53.399554
NCT00005687|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||April 1989||1989-04-01|July 2000|2000-07-01|April 1999|Actual|1999-04-01|||||Observational|||Recycling Attempters and Relapsers in Smoking Cessation||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.462392|2017-10-11 04:28:53.462392
NCT00005688|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||July 1989||1989-07-01|July 2000|2000-07-01|February 1997|Actual|1997-02-01|||||Observational|||Cardiac Arrhythmias and the Perception of Symptoms||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:53.512982|2017-10-11 04:28:53.512982
NCT00005699|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-10|||September 1993||1993-09-01|February 2016|2016-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Improving Hypertension Control in the Inner City|Improving Hypertension Control in the Inner City|Completed||N/A|2000|Actual|Medical College of Wisconsin|||2||f||||f||||||||Undecided|to be published|2017-10-11 04:28:54.279657|2017-10-11 04:28:54.279657
NCT00005700|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|May 2001|2001-05-01|August 1998|Actual|1998-08-01|||||Observational|||Fat Reduction Intervention Trial in African-Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.344423|2017-10-11 04:28:54.344423
NCT00005701|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||July 1994||1994-07-01|April 2000|2000-04-01|June 1997|Actual|1997-06-01|||||Observational|||Acute Cardiac Ischemia in Women in the ACI/TIPI Trial||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.392663|2017-10-11 04:28:54.392663
NCT00005702|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-29|||May 1996||1996-05-01|February 2016|2016-02-01|April 2000||2000-04-01|||||Observational|||Promoting Smoking Cessation in Hospital Patients||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:28:54.443078|2017-10-11 04:28:54.443078
NCT00005703|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||July 1995||1995-07-01|March 2005|2005-03-01|July 1998|Actual|1998-07-01|||||Observational|||Hemostasis in Sickle Cell Disease--Infancy to Adulthood||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.499057|2017-10-11 04:28:54.499057
NCT00005704|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-26|||July 1991||1991-07-01|July 2000|2000-07-01|June 1997||1997-06-01|||||Observational|||Pharmacologic Intervention for Postcessation Weight Gain||Completed||N/A|||University of Memphis|||||f||||||||||||||2017-10-11 04:28:54.566655|2017-10-11 04:28:54.566655
NCT00005705|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1992||1992-09-01|September 2002|2002-09-01|June 1996|Actual|1996-06-01|||||Observational|||Adherence in the Childhood Asthma Management Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.64664|2017-10-11 04:28:54.64664
NCT00005706|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|May 2002|2002-05-01|August 1998|Actual|1998-08-01|||||Observational|||Urban African-American Community Hypertension Control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.725114|2017-10-11 04:28:54.725114
NCT00005707|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-08|||September 1993||1993-09-01|December 2015|2015-12-01|August 1998||1998-08-01|||||Observational|||Improving Hypertension Care for Inner City Minorities||Completed||N/A|||Baylor College of Medicine|||||f||||||||||||||2017-10-11 04:28:54.79863|2017-10-11 04:28:54.79863
NCT00005708|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|July 2000|2000-07-01|August 1997|Actual|1997-08-01|||||Observational|||Improving Adherence to Interventions for Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.870523|2017-10-11 04:28:54.870523
NCT00005709|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1993||1993-09-01|June 2001|2001-06-01|August 1998|Actual|1998-08-01|||||Observational|||Lipoprotein Metabolism in Hypertensive African-Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:54.925067|2017-10-11 04:28:54.925067
NCT00005710|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-06-22|||July 1990||1990-07-01|June 2016|2016-06-01|June 1995||1995-06-01|||||Observational|||Recycling of Chronic Smokers to Sustained Abstinence||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:28:54.984979|2017-10-11 04:28:54.984979
NCT00005711|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-06|||August 1990||1990-08-01|May 2016|2016-05-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|||Intervention for Hispanic Children With Asthma|Intervention for Hispanic Children With Asthma|Completed||N/A|145|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||No||2017-10-11 04:28:55.060749|2017-10-11 04:28:55.060749
NCT00005712|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-14|||August 1990||1990-08-01|January 2016|2016-01-01|July 1996||1996-07-01|||||Observational|||Self Management Education Asthma||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-10-11 04:28:55.161574|2017-10-11 04:28:55.161574
NCT00005713|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-22|||August 1990||1990-08-01|December 2015|2015-12-01|February 1997|Actual|1997-02-01|February 1997|Actual|1997-02-01||Observational|||Childhood Asthma Program in NYC Health Department Clinics|Improving Care for Minority Children With Asthma: Professional Education in Public Health Clinics|Completed||N/A|1000|Actual|Columbia University|||1||f||||f||||||||||2017-10-11 04:28:55.213388|2017-10-11 04:28:55.213388
NCT00005714|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1990||1990-08-01|August 2004|2004-08-01|July 1996|Actual|1996-07-01|||||Observational|||Development and Evaluation of Community Asthma Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.29431|2017-10-11 04:28:55.29431
NCT00005715|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1990||1990-08-01|May 2000|2000-05-01|July 1995|Actual|1995-07-01|||||Observational|||Community Intervention for Minority Children With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.34955|2017-10-11 04:28:55.34955
NCT00005716|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||August 1994||1994-08-01|May 2002|2002-05-01|July 1999|Actual|1999-07-01|||||Observational|||Asthma Partnership for Minority Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.407454|2017-10-11 04:28:55.407454
NCT00005717|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||August 1990||1990-08-01|June 2001|2001-06-01|July 1995|Actual|1995-07-01|||||Observational|||Medication Adherence in COPD--A Self-Regulation Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.460469|2017-10-11 04:28:55.460469
NCT00005718|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1990||1990-04-01|July 2000|2000-07-01|March 1993|Actual|1993-03-01|||||Observational|||Evaluation of Cholesterol Education for At-Risk Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.511199|2017-10-11 04:28:55.511199
NCT00005719|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||July 1990||1990-07-01|July 2000|2000-07-01|June 1996||1996-06-01|||||Observational|||Sustaining Women's Smoking Cessation Postpartum||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.569946|2017-10-11 04:28:55.569946
NCT00005720|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1990||1990-09-01|April 2001|2001-04-01|August 1996||1996-08-01|||||Observational|||Lay-Led Smoking Cessation Approach for Southeast Asian Men||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.623431|2017-10-11 04:28:55.623431
NCT00005721|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-04-08|||September 1990||1990-09-01|April 2016|2016-04-01|December 1994||1994-12-01|December 1993|Actual|1993-12-01||Observational|||Retaining Donors and Increasing Donation Frequency||Completed||N/A|||Bloodworks (Puget Sound Blood Center)|||||f||||||||||||||2017-10-11 04:28:55.675112|2017-10-11 04:28:55.675112
NCT00005722|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1990||1990-09-01|May 2000|2000-05-01|September 1996||1996-09-01|||||Observational|||Stroke Belt Initiative||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.726242|2017-10-11 04:28:55.726242
NCT00005724|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2017-04-17|||August 1991|Actual|1991-08-01|April 2017|2017-04-01|July 31, 1996|Actual|1996-07-31|July 1995|Actual|1995-07-01||Interventional|||CVD Nutrition Modules Tailored to Low Literacy Skills|CVD Nutrition Modules Tailored to Low Literacy Skills|Completed||N/A|369|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||No||2017-10-11 04:28:55.844884|2017-10-11 04:28:55.844884
NCT00005725|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||August 1991||1991-08-01|May 2000|2000-05-01|May 1996|Actual|1996-05-01|||||Observational|||Low Literacy CVD Diet Education for Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.911016|2017-10-11 04:28:55.911016
NCT00005726|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||August 1991||1991-08-01|May 2000|2000-05-01|May 1995|Actual|1995-05-01|||||Observational|||Evaluation of Low Literacy CVD Nutrition Education||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:55.958535|2017-10-11 04:28:55.958535
NCT00005727|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-08-23|||August 1991||1991-08-01|August 2016|2016-08-01|January 2000|Actual|2000-01-01|December 1995|Actual|1995-12-01||Interventional|||CVD Nutrition Education||Completed||N/A|351|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 04:28:56.012483|2017-10-11 04:28:56.012483
NCT00005728|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||May 1992||1992-05-01|July 2000|2000-07-01|April 1996|Actual|1996-04-01|||||Observational|||Nutrition Education||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.082905|2017-10-11 04:28:56.082905
NCT00005729|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-11|||August 1992||1992-08-01|July 2000|2000-07-01|December 1996||1996-12-01|||||Observational|||CVD Nutrition Education for Low Literacy ESL Students||Completed||N/A|||San Diego State University|||||f||||||||||||||2017-10-11 04:28:56.133392|2017-10-11 04:28:56.133392
NCT00005730|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||January 1989||1989-01-01|March 2005|2005-03-01|December 1995||1995-12-01|||||Observational|||National Marrow Donor Program (NMDP)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.177682|2017-10-11 04:28:56.177682
NCT00005731|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1993||1993-09-01|April 2001|2001-04-01|May 1997||1997-05-01|||||Observational|||Develop and Implement Asthma Controlling Strategies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.240091|2017-10-11 04:28:56.240091
NCT00005732|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1993||1993-09-01|August 2000|2000-08-01|January 1997||1997-01-01|||||Observational|||Develop and Implement Asthma Controlling Strategies (1)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.287642|2017-10-11 04:28:56.287642
NCT00005733|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1993||1993-09-01|September 2002|2002-09-01|March 1997||1997-03-01|||||Observational|||Develop and Implement Asthma Controlling Strategies (2)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.331491|2017-10-11 04:28:56.331491
NCT00005734|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1995||1995-09-01|March 2005|2005-03-01|September 2002||2002-09-01|||||Observational|||Intervention to Improve Asthma Management/Prevention||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.37338|2017-10-11 04:28:56.37338
NCT00005735|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1995||1995-09-01|July 2004|2004-07-01|October 2002|Actual|2002-10-01|||||Observational|||Controlling Asthma at School||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.419596|2017-10-11 04:28:56.419596
NCT00005736|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2005-06-23|||September 1995||1995-09-01|July 2004|2004-07-01|September 2002||2002-09-01|||||Observational|||Interventions to Improve Asthma Management/Prevention at School||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.471223|2017-10-11 04:28:56.471223
NCT00005737|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||September 1995||1995-09-01|April 2004|2004-04-01|August 1999|Actual|1999-08-01|||||Observational|||Tuberculosis Prophylaxis in the Homeless--A Controlled Trial||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.519434|2017-10-11 04:28:56.519434
NCT00005738|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-01-11|||September 1995||1995-09-01|May 2002|2002-05-01|August 2001||2001-08-01|||||Observational|||Promoting Adherence to TB Regimens in Latino Adolescents||Completed||N/A|||San Diego State University|||||f||||||||||||||2017-10-11 04:28:56.564931|2017-10-11 04:28:56.564931
NCT00005739|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2015-12-21|||September 1995||1995-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2004|Actual|2004-12-01||Observational|||Behavioral Interventions for Control of TB|Behavioral Interventions for Control of Tuberculosis|Completed||N/A|145|Actual|Columbia University|||2||f||||f||||||||||2017-10-11 04:28:56.607558|2017-10-11 04:28:56.607558
NCT00005740|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1995||1995-09-01|May 2002|2002-05-01|August 2000|Actual|2000-08-01|||||Observational|||TB Contact Investigation: Behavioral Intervention||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.679997|2017-10-11 04:28:56.679997
NCT00005741|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-05-12|||September 1995||1995-09-01|May 2002|2002-05-01|August 2001|Actual|2001-08-01|||||Observational|||Indigenous Outreach Among Injection Drug Users to Treat and Control TB||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.729828|2017-10-11 04:28:56.729828
NCT00005742|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-26|||September 1995||1995-09-01|May 2005|2005-05-01|August 2001|Actual|2001-08-01|||||Observational|||Behavioral Interventions for Control of Tuberculosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.77745|2017-10-11 04:28:56.77745
NCT00005743|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||May 1996||1996-05-01|August 2004|2004-08-01|April 2001|Actual|2001-04-01|||||Interventional|||Exercise Adherence in a Behavioral Weight Loss Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.833279|2017-10-11 04:28:56.833279
NCT00005744|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||September 1996||1996-09-01|August 2004|2004-08-01|August 2001|Actual|2001-08-01|||||Observational|||Increased Physical Activity in African-American Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.889291|2017-10-11 04:28:56.889291
NCT00005745|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||January 1998||1998-01-01|September 2004|2004-09-01|December 2002|Actual|2002-12-01|||||Observational|||Consequences and Correlates of Weight Fluctuations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:56.958476|2017-10-11 04:28:56.958476
NCT00005746|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||April 1998||1998-04-01|May 2005|2005-05-01|March 2003|Actual|2003-03-01|||||Observational|||Community Site Coronary Risk Control in Black Families||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:57.003868|2017-10-11 04:28:57.003868
NCT00005748|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-02-17|||May 1998||1998-05-01|March 2005|2005-03-01|April 2004|Actual|2004-04-01|||||Observational|||Stress Reduction and Prevention of Hypertension in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:57.059409|2017-10-11 04:28:57.059409
NCT00005758|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-23|2012-05-21||||||May 2012|2012-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination|A Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Effect of Immunization With an HIV Immunogen on the Time to Virologic Relapse in Individuals Receiving Potent, Suppressive Antiretroviral Therapies|Completed||Phase 3|472||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:28:58.443729|2017-10-11 04:28:58.443729
NCT00005760|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-26|2008-03-03|||May 2000||2000-05-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 Diabetes|A Pilot Study of the Metabolic Effects of Large Volume Liposuction in Overweight Women With Hyperinsulinemia, Impaired Glucose Tolerance and/or Type 2 Diabetes|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:58.553471|2017-10-11 04:28:58.553471
NCT00005761|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-26|2017-06-30|||May 23, 2000||2000-05-23|December 7, 2010|2010-12-07|December 7, 2010||2010-12-07|||||Observational|||Blood Factors and Diabetic Retinopathy|Study of Association of Serum Factors With Diabetic Retinopathy|Completed||N/A|173|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:28:58.625484|2017-10-11 04:28:58.625484
NCT00005762|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2013-07-19|||March 2001||2001-03-01|July 2013|2013-07-01|May 2004|Actual|2004-05-01|||||Interventional|||Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers|Pharmacokinetic Interaction Studies of Amprenavir (APV), Efavirenz (EFV), and a Second Protease Inhibitor in HIV-Seronegative Volunteers|Completed||N/A|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:28:58.721667|2017-10-11 04:28:58.721667
NCT00005763|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-25|2016-03-15|||December 1984||1984-12-01|June 2000|2000-06-01|April 1997|Actual|1997-04-01|||||Observational|||INTERSALT: International Study of Sodium, Potassium, and Blood Pressure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:28:58.850251|2017-10-11 04:28:58.850251
NCT00005764|ClinicalTrials.gov processed this data on October 10, 2017|2000-05-30|2005-06-23|||May 2000||2000-05-01|June 2001|2001-06-01||||||||Interventional|||A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients|Glaxo Wellcome Trial to Assess the Regression of Hyperlactatemia and to Evaluate the Regression of Established Lipodystrophy in HIV-1-Positive Subjects (TARHEEL)|Completed||Phase 4|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:28:58.96085|2017-10-11 04:28:58.96085
NCT00005765|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Behavioral Economics of Human Drug Self-Administration||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:59.099264|2017-10-11 04:28:59.099264
NCT00005766|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis||Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:59.16652|2017-10-11 04:28:59.16652
NCT00005767|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Dynamic Aspects of Amino Acid Metabolism||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:59.22589|2017-10-11 04:28:59.22589
NCT00005768|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women||Unknown status|Recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:59.293684|2017-10-11 04:28:59.293684
NCT00005769|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:59.389402|2017-10-11 04:28:59.389402
NCT00005770|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2005-06-23||||||November 2001|2001-11-01||||||||Observational|||Investigation of the Effect of Acupuncture Needling on Connective Tissue Using Ultrasound Elastography||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:59.465839|2017-10-11 04:28:59.465839
NCT00005771|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||The Use of Real Time Ultrasound Feedback in Teaching Abdominal Hollowing Exercises||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:28:59.520326|2017-10-11 04:28:59.520326
NCT00005772|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2017-09-22|||October 1999||1999-10-01|September 2017|2017-09-01|July 2010|Actual|2010-07-01|May 2003|Actual|2003-05-01||Interventional|||Whole-Body Cooling for Birth Asphyxia in Term Infants|Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants|Completed||Phase 3|208|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-10-11 04:28:59.588528|2017-10-11 04:28:59.588528
NCT00005773|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2017-09-22|||August 1998||1998-08-01|September 2017|2017-09-01|August 2003|Actual|2003-08-01|May 2001|Actual|2001-05-01||Interventional|Early iNO||Early Inhaled Nitric Oxide for Respiratory Failure in Newborns|Early Inhaled Nitric Oxide Therapy in Term and Near Term Infants With Respiratory Failure|Terminated||Phase 3|302|Actual|NICHD Neonatal Research Network||2||Halted after 3 years because of a persistent decline in enrollment|f||||t||||||||||2017-10-11 04:28:59.765826|2017-10-11 04:28:59.765826
NCT00005774|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2015-06-03|||May 2000||2000-05-01|June 2015|2015-06-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|Surfactant 2||Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants|Early Surfactant Followed by Nasal CPAP to Reduce the Use of Mechanical Ventilation Without Additional Morbidity in Infants 1250- 2000 Grams With RDS|Terminated||Phase 3|61|Actual|NICHD Neonatal Research Network||2||The trial was stopped after 7 months for lack of recruitment.|f||||t||||||||||2017-10-11 04:28:59.941432|2017-10-11 04:28:59.941432
NCT00005775|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2015-06-03|||July 1999||1999-07-01|June 2015|2015-06-01|August 2001|Actual|2001-08-01|December 2000|Actual|2000-12-01||Interventional|Glutamine||Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants|Randomized Controlled Trial of Parenteral Glutamine Supplementation for Extremely-Low-Birth-Weight (ELBW) Infants|Completed||Phase 3|1433|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-10-11 04:29:00.091814|2017-10-11 04:29:00.091814
NCT00005776|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2017-09-22|||October 1995||1995-10-01|September 2017|2017-09-01|May 1998|Actual|1998-05-01|May 1996|Actual|1996-05-01||Interventional|NINOS||Inhaled Nitric Oxide Study for Respiratory Failure in Newborns|The Randomized Inhaled Nitric Oxide Study (NINOS) in Full-Term and Nearly Full-Term Infants With Hypoxic Respiratory Failure|Terminated||Phase 3|235|Actual|NICHD Neonatal Research Network||2||Results showed statistically significant benefit in the experimental group|f||||t||||||||||2017-10-11 04:29:00.26372|2017-10-11 04:29:00.26372
NCT00005777|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-01|2015-06-03|||February 1998||1998-02-01|June 2015|2015-06-01|September 2002|Actual|2002-09-01|September 1998|Actual|1998-09-01||Interventional|SAVE||Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)|Randomized Trial of Minimal Ventilator Support and Early Corticosteroid Therapy to Increase Survival Without Chronic Lung Disease in Extremely-Low-Birth-Weight Infants|Terminated||Phase 3|220|Actual|NICHD Neonatal Research Network||4||"The trial was halted because of unanticipated nonrespiratory adverse events related to   dexamethasone therapy."|f||||t||||||||||2017-10-11 04:29:00.460925|2017-10-11 04:29:00.460925
NCT00005778|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-03|2008-11-05|||January 2000||2000-01-01|November 2008|2008-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide|Randomized Trial of High-Dose IV Cyclophosphamide Versus Monthly IV Cyclophosphamide|Completed||Phase 3|100|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||1|||f||||||||||||||2017-10-11 04:29:00.630112|2017-10-11 04:29:00.630112
NCT00005779|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-03|2012-05-17||||||May 2012|2012-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy|A Phase I, Limited-Center, Sequential Cohort Trial of HIV Vaccine (Polyvalent Peptide Vaccine C4-V3) in Conjunction With Interleukin-12 in Subjects With Maximal Suppression of HIV Replication and CD4 Count > 400 Cells/mm3|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:00.721153|2017-10-11 04:29:00.721153
NCT00005781|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-03|2008-03-03|||May 2000||2000-05-01|May 2000|2000-05-01|September 2000||2000-09-01|||||Observational|||Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles|Digital Imaging as a Tool for Assessing the Prevalence of Atypical Nevi, Psoriasis and Hand Dermatitis: A Validation Study in Preparation for NHANES IV, Dermatology Section|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:00.882811|2017-10-11 04:29:00.882811
NCT00005782|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-03|2008-03-03|||January 2000||2000-01-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait|Leukapheresis of Volunteers With Sickle Cell Trait to Evaluate Mobilization of Stem Cells With Granulocyte Colony-Stimulating Factor and Stem Cell Collection and Storage for Allogeneic Transplantation|Completed||Phase 3|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:00.951268|2017-10-11 04:29:00.951268
NCT00005783|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-03|2008-03-03|||March 2000||2000-03-01|February 2000|2000-02-01|October 2000||2000-10-01|||||Interventional|||A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders|A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:01.006845|2017-10-11 04:29:01.006845
NCT00005784|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-03|2017-06-30|||May 31, 2000||2000-05-31|August 8, 2008|2008-08-08|August 8, 2008||2008-08-08|||||Observational|||Evaluation and Treatment of Patients With Retinal Disease|Evaluation and Treatment Protocol for Patients With Retinal Disease|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:01.06793|2017-10-11 04:29:01.06793
NCT00005785|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-03|2008-03-03|||September 1999||1999-09-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer|Low Intensity Non-Myeloablative Preparative Conditioning Followed by Transplantation of Genetically Modified HLA-Matched Peripheral Blood Hematopoietic Precursor Cells (PBPC) for Hematologic Malignancies in HIV Positive Adults|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:01.117064|2017-10-11 04:29:01.117064
NCT00005786|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-01-31|||January 2001||2001-01-01|January 2013|2013-01-01||||November 2004|Actual|2004-11-01||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia|A Pilot Study of Arsenic Trioxide in the Treatment of Relapsed and Refractory Indolent Lymphomas|Terminated||N/A|25|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:29:01.19066|2017-10-11 04:29:01.19066
NCT00005787|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-05-31|||September 1999||1999-09-01|May 2012|2012-05-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma|Ex Vivo Expanded Peripheral Blood Mononuclear Cells for the Elimination of Neutropenia Associated With High Dose Chemotherapy|Terminated||Phase 1|3|Actual|Northwestern University||||Per PI due to poor/inadequate accrual.|f||||t||||||||||2017-10-11 04:29:01.278935|2017-10-11 04:29:01.278935
NCT00005788|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-05-31||2011-07-01|April 1997||1997-04-01|May 2012|2012-05-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome|Phase II Trial of Subcutaneous Injections of Interleukin-2 for the Treatment of Mycosis Fungoides or the Sezary Syndrome|Terminated||Phase 2|||Northwestern University||||Low/inadequate rate of accrual.|f||||t||||||||||2017-10-11 04:29:01.357737|2017-10-11 04:29:01.357737
NCT00005790|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-06-08|||April 1996||1996-04-01|June 2012|2012-06-01|May 1999||1999-05-01|May 1999||1999-05-01||Interventional|||Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors|Perfusion Magnetic Resonance Imaging of Brain Tumors: Correlation With Indicators of Angiogenesis|Withdrawn||N/A|0|Actual|Northwestern University||||Unable to accrue subjects.|f||||||||||||||2017-10-11 04:29:01.432727|2017-10-11 04:29:01.432727
NCT00005791|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2013-12-18|||October 1999||1999-10-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|July 2002|Actual|2002-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Phase I Trial of Irinotecan, Cisplatin, and Fluorouracil in Patients With Advanced Solid Tumor Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:01.515658|2017-10-11 04:29:01.515658
NCT00010998|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Yoga: Effect on Attention in Aging & Multiple Sclerosis|Yoga: Effect on Attention in Aging & Multiple Sclerosis|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:10.048586|2017-10-11 04:29:10.048586
NCT00005793|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2012-09-24|||July 1999||1999-07-01|September 2012|2012-09-01|November 2006|Actual|2006-11-01|July 2006|Actual|2006-07-01||Interventional|||A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide|A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide (DATE) for De Novo AML: In the Treatment of Young Patients Ages 16-59|Completed||Phase 1/Phase 2|41|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:29:01.881086|2017-10-11 04:29:01.881086
NCT00005794|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-02|2015-10-15|||February 2000||2000-02-01|October 2015|2015-10-01|July 2003|Actual|2003-07-01|||||Interventional|||Perifosine in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Perifosine on a Loading Dose/Maintenance Dose Schedule in Patients With Advanced Cancer|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:29:02.007916|2017-10-11 04:29:02.007916
NCT00007670|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-01-20|||January 1998||1998-01-01|February 2007|2007-02-01|March 2003||2003-03-01|||||Interventional|||Does Gabapentin and Lamotriginel Have Significantly Fewer Side-Effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly.|CSP #428 - Treatment of Seizures in the Elderly Population|Completed||Phase 3|720||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:02.105171|2017-10-11 04:29:02.105171
NCT00007683|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2011-06-14|||October 1998||1998-10-01|June 2011|2011-06-01|December 2004|Actual|2004-12-01|July 2003|Actual|2003-07-01||Interventional|||Warfarin and Antiplatelet Therapy in Chronic Heart Failure|CSP #442 - Warfarin and Antiplatelet Therapy Study in Patients With Congestive Heart Failure (WATCH)|Completed||Phase 3|1587|Anticipated|VA Office of Research and Development||3|||f||||t||||||||||2017-10-11 04:29:02.282771|2017-10-11 04:29:02.282771
NCT00007696|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2011-02-02|||April 1998||1998-04-01|February 2011|2011-02-01||||||||Observational|||Finding Diabetes Mellitus Among Veterans|CSP #705D - Screening for Diabetes Mellitus in Veterans|Completed||N/A|1276|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:02.693945|2017-10-11 04:29:02.693945
NCT00007709|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2011-02-02|||January 1998||1998-01-01|February 2011|2011-02-01||||||||Observational|||To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI).|CSP #706D - HIV Seroprevalence and Risks in Veterans With Severe Mental Illness|Completed||N/A|||VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:02.760351|2017-10-11 04:29:02.760351
NCT00007722|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-10-07|||July 2000||2000-07-01|October 2009|2009-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Observational|||Amyotrophic Lateral Sclerosis (ALS) Gulf War Study|CSP #500 - An Epidemiological Investigation Into the Occurrence of Amyotrophic Lateral Sclerosis (ALS) Among Gulf War Veterans|Completed||N/A|135|Actual|VA Office of Research and Development|||1||f||||f||||||Samples With DNA|"     DNA samples of blood or mouthwash were collected in veterans' homes by nurses.   "|||2017-10-11 04:29:02.864378|2017-10-11 04:29:02.864378
NCT00007735|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-01-20|||January 1999||1999-01-01|February 2007|2007-02-01|October 2001||2001-10-01|||||Interventional|||Antibiotic Treatment of Gulf War Veterans' Illnesses|CSP #475 - Persian Gulf - Antibiotic Treatment Trial of Gulf War Veterans' Illnesses|Completed||Phase 3|450||VA Office of Research and Development|||||||||||||||||||2017-10-11 04:29:02.960078|2017-10-11 04:29:02.960078
NCT00007748|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2015-06-25|||March 1999||1999-03-01|June 2015|2015-06-01|August 2001||2001-08-01|||||Interventional|||Exercise and Behavioral Therapy Trial (EBT).|CSP#470 - A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans With Gulf War Illnesses|Completed||Phase 3|1064||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:03.096845|2017-10-11 04:29:03.096845
NCT00007761|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-09-22|||July 1997||1997-07-01|September 2009|2009-09-01||||December 2003|Actual|2003-12-01||Interventional|||Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.|CSP #430 - Reducing The Efficacy-Effectiveness Gap In Bipolar Disorder|Completed||Phase 3|382|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:29:03.22545|2017-10-11 04:29:03.22545
NCT00007774|ClinicalTrials.gov processed this data on October 10, 2017|2000-12-29|2009-02-03|||March 1998||1998-03-01|February 2009|2009-02-01||||June 2001|Actual|2001-06-01||Interventional|||To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia|CSP #451 - The Clinical and Economic Impact of Olanzapine in the Treatment of Schizophrenia|Completed||Phase 4|600|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:29:03.353385|2017-10-11 04:29:03.353385
NCT00007787|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-04|2013-01-18|||April 2000||2000-04-01|January 2013|2013-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants|Evaluation of Antibody Plus Delayed CSA vs CSA in Determining Delayed Graft Function in Cadaver Transplant Recipients|Completed||N/A|350|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:29:03.470228|2017-10-11 04:29:03.470228
NCT00007800|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-05|2010-01-12|||May 2000||2000-05-01|January 2010|2010-01-01|May 2002||2002-05-01|||||Interventional|||NEW DAY: Nutrition, Exercise, Weight Loss, Diabetes And You|Obesity Treatment and NIDDM in Black and White Women|Completed||Phase 2|218||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:29:03.559443|2017-10-11 04:29:03.559443
NCT00007813|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2009-02-06|||May 1995||1995-05-01|December 2007|2007-12-01||||||||Interventional|||Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors|TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT/REFRACTORY SOLID TUMORS WITH HIGH DOSE ETOPOSIDE AND CARBOPLATIN PLUS ESCALATING DOSE CYCLOPHOSPHAMIDE, FOLLOWED BY HEMATOPOIETIC RESCUE USING AUTOLOGOUS CD34+ SELECTED BLOOD STEM CELLS: A PILOT STUDY|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:03.638206|2017-10-11 04:29:03.638206
NCT00007826|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-09-19|||April 2000||2000-04-01|February 2005|2005-02-01||||||||Interventional|||Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer|A Phase I/II Trial of an Allogeneic Cell Based Vaccine and an Anti-Idiotypic Antibody Vaccine Approach for Metastatic Adenocarcinoma of the Colon or Rectum|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:03.729912|2017-10-11 04:29:03.729912
NCT00007839|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-12-17|||August 2000||2000-08-01|April 2010|2010-04-01||||||||Interventional|||Beta Alethine in Treating Patients With Low-Grade Lymphoma|Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With B-Cell Lymphoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:03.795599|2017-10-11 04:29:03.795599
NCT00007852|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2012-03-23|||September 2000||2000-09-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|January 2002|Actual|2002-01-01||Interventional|||Rituximab and Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial of Rituxan and BEAM High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Transplant for Lymphoma|Completed||Phase 2|44|Actual|University of Nebraska||1|||f||||f||||||||||2017-10-11 04:29:03.871034|2017-10-11 04:29:03.871034
NCT00007865|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2010-06-25|||September 2000||2000-09-01|June 2010|2010-06-01|April 2008|Actual|2008-04-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial of Ifosfamide, Carboplatin, and Etoposide (ICE) Chemotherapy in Combination With Rituximab as Salvage Therapy|Completed||Phase 2|||University of Nebraska|||||f||||f||||||||||2017-10-11 04:29:03.96995|2017-10-11 04:29:03.96995
NCT00007878|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-12-10|||September 2000||2000-09-01|December 2013|2013-12-01||||January 2008|Actual|2008-01-01||Interventional|||Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery|A Phase I Study of PS-341 in Combination With 5-FU/LV in Solid Tumors|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:04.056263|2017-10-11 04:29:04.056263
NCT00007891|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-05-14|||June 1997||1997-06-01|September 2004|2004-09-01|October 2004|Actual|2004-10-01|||||Interventional|||Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer|Phase I Study of 90-Y-Humanized-BrE-3 Followed by Autologous Hematopoietic Progenitor Cell Support in Patients With Metastatic Breast Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:04.159983|2017-10-11 04:29:04.159983
NCT00007904|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2012-09-28|||July 2000||2000-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|June 2006|Actual|2006-06-01||Interventional|||Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes|A Phase II Study Of Safety And Tolerability Of Adjuvant Chemotherapy With Continuous Infusion Paclitaxel And Dose Intense Cyclophosphamide And Hematopoietic Growth Factor Support Followed By Doxorubicin For Stage II-IIIA Breast Cancer Involving Greater Than or Equal to 10 Lymph Nodes|Completed||Phase 2|16|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:29:04.234969|2017-10-11 04:29:04.234969
NCT00007917|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-02-27|||January 2001||2001-01-01|February 2013|2013-02-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors|A Phase I Trial Of Gemcitabine Followed By Flavopiridol In Patients With Solid Tumors|Completed||Phase 1|58|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:04.338081|2017-10-11 04:29:04.338081
NCT00007930|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-08-23|||August 1999||1999-08-01|December 2006|2006-12-01||||||||Interventional|||Comparison of Two Types of Surgery in Treating Patients With Rectal Cancer|Randomized Trial of Wide Mesorectal Excision Versus Total Mesorectal Excision for Mid Rectal Cancer|Unknown status|Recruiting|Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:04.418499|2017-10-11 04:29:04.418499
NCT00007943|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2017-04-17|||September 2000|Actual|2000-09-01|August 2009|2009-08-01|February 27, 2001|Actual|2001-02-27|February 27, 2001|Actual|2001-02-27||Interventional|||Gemcitabine in Treating Patients With Advanced Colorectal Cancer|A Phase II Study Of Twenty-Four Hour Infusion Gemcitabine For Advanced Colorectal Cancer|Completed||Phase 2|15|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:29:04.586423|2017-10-11 04:29:04.586423
NCT00007956|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2015-04-29|||November 2000||2000-11-01|February 2002|2002-02-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma|A Phase I Study Of Therapy With Mono-dgA-RFB4 In Patients With Relapsed And Refractory CD22+ B-Cell Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:04.671103|2017-10-11 04:29:04.671103
NCT00007969|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-11-05|||October 2000||2000-10-01|August 2008|2008-08-01||||||||Interventional|||Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase 1/2 Uncontrolled, Open Label Study Of Photodynamic Vaccination In Patients With Stage III/IV Malignant Melanoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:04.736786|2017-10-11 04:29:04.736786
NCT00007982|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-02-01|||April 1999||1999-04-01|July 2007|2007-07-01|May 2008|Actual|2008-05-01|February 2005|Actual|2005-02-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer|CAMP 004A - Phase 2 Study Of Intensive Chemotherapy (BET) For Selected Categories Of Malignant Central Nervous System Tumor|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:04.80157|2017-10-11 04:29:04.80157
NCT00007995|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-02-01|||July 1999||1999-07-01|July 2007|2007-07-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis|Phase 2 Study Of High Dose Chemotherapy Followed By Autologous Hematopoietic Stem Cell Support In Patients With Multiple Myeloma And Primary Light Chain Amyloidosis|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:04.876095|2017-10-11 04:29:04.876095
NCT00010322|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2014-03-24|||October 2000||2000-10-01|March 2014|2014-03-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer|Phase III Study of Atamestane Plus Toremifene in Metastatic Breast Cancer|Terminated||Phase 3|||Intarcia Therapeutics||||Withdrawn due to change in standard of care - new protocol required|f||||f||||||||||2017-10-11 04:29:04.950181|2017-10-11 04:29:04.950181
NCT00010335|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2015-03-04|||November 2000||2000-11-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|July 2010|Actual|2010-07-01||Interventional|||Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders|A Pilot Study of High-Dose Immunosuppression Followed by Infusion of CD34-Selected Autologous or Syngeneic Peripheral Blood Stem Cells for Treatment of Refractory Autoimmune Disorders|Completed||Phase 1|6|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:29:05.011953|2017-10-11 04:29:05.011953
NCT00010361|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2014-12-08|||November 2000||2000-11-01|August 2006|2006-08-01||||April 2007|Actual|2007-04-01||Interventional|||Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:05.110795|2017-10-11 04:29:05.110795
NCT00010374|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-09-15|||February 2000||2000-02-01|September 2008|2008-09-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Electrical Activation of The Diaphragm for Ventilatory Assist|Multi-Center Pivotal Study of NeuRx RA/4 Ventilatory Assist Device|Unknown status|Active, not recruiting|N/A|50|Anticipated|Synapse Biomedical||2|||f||||||||||||||2017-10-11 04:29:05.186791|2017-10-11 04:29:05.186791
NCT00010387|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-09-08|||March 1999||1999-03-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease||Completed||Phase 2|32||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:05.289471|2017-10-11 04:29:05.289471
NCT00010400|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2005-06-23|||April 1997||1997-04-01|July 2004|2004-07-01||||||||Interventional|||Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome||Completed||N/A|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:05.373973|2017-10-11 04:29:05.373973
NCT00010413|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-10-01|||April 1999||1999-04-01|October 2008|2008-10-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus||Completed||Phase 2|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:06.826794|2017-10-11 04:29:06.826794
NCT00010426|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2015-03-24|||December 1999||1999-12-01|April 2001|2001-04-01|February 2001||2001-02-01|||||Interventional|||Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis||Completed||N/A|30||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:29:06.88758|2017-10-11 04:29:06.88758
NCT00010439|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2010-10-21|2009-06-03||September 2000||2000-09-01|October 2010|2010-10-01|November 2008|Actual|2008-11-01|October 2003|Actual|2003-10-01||Interventional|||Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis|A Non-Randomized, Open-Label, Prospective, Non-Controlled, 12-Month Clinical Trial to Determine the Effects of Alendronate 35 or 70 mg/Week Depending Upon Body Weight, in Children and Adolescent With IJO|Completed||Phase 2|10|Actual|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 04:29:06.950589|2017-10-11 04:29:06.950589
NCT00010452|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2015-03-24|||April 2000||2000-04-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|June 2006|Actual|2006-06-01||Interventional|||Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations|Treatment of Cystic Hygroma (Lymphangiomas) in Children- Picibanil(OK432) Sclerotherapy-Multicenter Trial|Completed||Phase 2/Phase 3|150|Actual|FDA Office of Orphan Products Development||1|||f||||||||||||||2017-10-11 04:29:07.13761|2017-10-11 04:29:07.13761
NCT00010465|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-03-21||||||March 2013|2013-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Nervous System Manipulation and Botanicals for the Treatment of Recurrent Ear Infections in Children|Osteopathic Manipulation and Echinacea for the Treatment of Recurrent Ear Infections in Children|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:07.235839|2017-10-11 04:29:07.235839
NCT00010478|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17||||||July 2006|2006-07-01||||||||Interventional|||Acupuncture and Hypertension|Acupuncture and Hypertension-Efficacy and Mechanisms|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:07.296606|2017-10-11 04:29:07.296606
NCT00010491|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-03-05|||September 1999||1999-09-01|March 2008|2008-03-01|August 2003||2003-08-01|||||Interventional|||Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients|Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:07.366748|2017-10-11 04:29:07.366748
NCT00010504|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-03-05|||August 2000||2000-08-01|March 2008|2008-03-01|July 2003||2003-07-01|||||Interventional|||Acupuncture in Fibromyalgia|Pilot Study of Acupuncture in Fibromyalgia|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:07.432031|2017-10-11 04:29:07.432031
NCT00010517|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-03-05|||September 1997||1997-09-01|March 2008|2008-03-01|April 2002||2002-04-01|||||Interventional|||Acupuncture in the Treatment of Depression|Acupuncture in the Treatment of Depression|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:07.496528|2017-10-11 04:29:07.496528
NCT00010530|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2009-12-04|||September 1999||1999-09-01|December 2009|2009-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks|Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks|Completed||Phase 1|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:29:07.572785|2017-10-11 04:29:07.572785
NCT00010608|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2009-12-04|||October 1999||1999-10-01|December 2009|2009-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women|Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women|Completed||Phase 2|196|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-10-11 04:29:07.809101|2017-10-11 04:29:07.809101
NCT00010621|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Complementary Medicine Approaches to TMD Pain Management|Complementary Medicine Approaches to TMD Pain Management|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:07.905079|2017-10-11 04:29:07.905079
NCT00010634|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Complementary Naturopathic Medicine for Periodontitis|Complementary Naturopathic Medicine for Periodontitis|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:07.979413|2017-10-11 04:29:07.979413
NCT00010647|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-16|||August 1999||1999-08-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Cost-Effectiveness of and Long-Term Outcomes Following Acupuncture Treatment for Osteoarthritis of the Knee|Cost-Effectiveness of and Long-Term Outcomes Following Acupuncture Treatment for Osteoarthritis of the Knee|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:08.042687|2017-10-11 04:29:08.042687
NCT00010725|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2010-01-11|||September 1999||1999-09-01|January 2010|2010-01-01|August 2004|Actual|2004-08-01|||||Interventional|||Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks|Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks|Completed||Phase 2|138||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:29:08.316287|2017-10-11 04:29:08.316287
NCT00010738|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|July 2006|2006-07-01|August 2002||2002-08-01|||||Interventional|||Effects of Meditation on Mechanism of Coronary Heart Disease|Effects of Meditation on Mechanism of Coronary Heart Disease|Completed||Phase 2|145||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:08.392451|2017-10-11 04:29:08.392451
NCT00010751|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1998||1998-09-01|August 2006|2006-08-01|June 2004||2004-06-01|||||Interventional|||Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors|Chronic Diabetic Painful Neuropathy and Cardiovascular Risk Factors in NIDDM: An Alternative Approach.|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:08.453884|2017-10-11 04:29:08.453884
NCT00010764|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-03-05|||September 2000||2000-09-01|March 2008|2008-03-01|July 2002||2002-07-01|||||Interventional|||Efficacy of Acupuncture in the Treatment of Fibromyalgia|Efficacy of Acupuncture in the Treatment of Fibromyalgia|Completed||Phase 1|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:08.514075|2017-10-11 04:29:08.514075
NCT00010777|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|March 2004||2004-03-01|||||Interventional|||Fibromyalgia: A Randomized Controlled Trial of a Mind/Body Intervention|Fibromyalgia: A Randomized Controlled Trial of a Mind/Body Intervention|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:08.576024|2017-10-11 04:29:08.576024
NCT00010803|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-03-11|2009-03-27||October 2000||2000-10-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|April 2008|Actual|2008-04-01||Interventional|||Ginkgo Biloba Prevention Trial in Older Individuals|Ginkgo Biloba Prevention Trial in Older Individuals|Completed||Phase 3|3069|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-10-11 04:29:08.646732|2017-10-11 04:29:08.646732
NCT00010816|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1998||1998-09-01|August 2006|2006-08-01|June 2003||2003-06-01|||||Interventional|||Herbal Treatment of Hepatitis C in Methadone Maintained Patients|Herbal Treatment of Hepatitis C in Methadone Maintained Patients|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.084838|2017-10-11 04:29:09.084838
NCT00010829|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||January 2001||2001-01-01|August 2006|2006-08-01|December 2005||2005-12-01|||||Interventional|||Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors|Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.169992|2017-10-11 04:29:09.169992
NCT00010842|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Natural Antioxidants in the Treatment of Multiple Sclerosis|Natural Antioxidants in the Treatment of Multiple Sclerosis|Completed||Phase 1/Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.231292|2017-10-11 04:29:09.231292
NCT00010855|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-08-04|||September 1997||1997-09-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Nonpharmacologic Analgesia for Invasive Procedures|Nonpharmacologic Analgesia for Invasive Procedures|Completed||Phase 2/Phase 3|390||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.295888|2017-10-11 04:29:09.295888
NCT00010868|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||July 2000||2000-07-01|July 2006|2006-07-01|July 2004||2004-07-01|||||Interventional|||Omega-3 Fatty Acids in Bipolar Disorder|Omega-3 Fatty Acids in Bipolar Disorder Prophylaxis|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.35805|2017-10-11 04:29:09.35805
NCT00010881|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Oregon Center for Complementary and Alternative Medicine in Neurological Disorders|Oregon Center for Complementary and Alternative Medicine in Neurological Disorders|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.416077|2017-10-11 04:29:09.416077
NCT00010907|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-03-21||||||March 2013|2013-03-01||||||||Interventional|||Preliminary Human Trial of NPI-028||Withdrawn||Phase 2|0|Actual|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.581371|2017-10-11 04:29:09.581371
NCT00010920|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Preventing Cognitive Decline With Alternative Therapies|Preventing Cognitive Decline With Alternative Therapies|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.63172|2017-10-11 04:29:09.63172
NCT00010933|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-16|||September 1998||1998-09-01|August 2006|2006-08-01|June 2004||2004-06-01|||||Interventional|||Treatment of Functional Abdominal Pain in Children: Evaluation of Relaxation/Guided Imagery and Chamomile Tea as Therapeutic Modalities|Treatment of Functional Abdominal Pain in Children: Evaluation of Relaxation/Guided Imagery and Chamomile Tea as Therapeutic Modalities|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.689941|2017-10-11 04:29:09.689941
NCT00010946|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-03-05|||September 1998||1998-09-01|March 2008|2008-03-01|August 2003||2003-08-01|||||Interventional|||Acupuncture Safety/Efficacy in Knee Osteoarthritis|Acupuncture Safety/Efficacy in Knee Osteoarthritis|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.753114|2017-10-11 04:29:09.753114
NCT00010959|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2007-03-01|||February 2001||2001-02-01|March 2007|2007-03-01|February 2002||2002-02-01|||||Interventional|||Single-Dose Study of Black Cohosh and Red Clover|A Phase I Single-Dose Pharmacokinetic Study of Black Cohosh and Red Clover in Healthy Menopausal Women 45-59 Years of Age|Completed||Phase 1|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||f||||||||||2017-10-11 04:29:09.830228|2017-10-11 04:29:09.830228
NCT00010972|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2006-08-17||||||August 2006|2006-08-01||||||||Interventional|||Use of Acupuncture for Dental Pain: Testing a Model|Use of Acupuncture for Dental Pain: Testing a Model|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.908773|2017-10-11 04:29:09.908773
NCT00010985|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-03-05|||September 1999||1999-09-01|March 2008|2008-03-01|August 2003||2003-08-01|||||Interventional|||Usual Care Vs Choice of Alternative Rx: Low Back Pain|Usual Care Vs Choice of Alternative Rx: Low Back Pain|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:09.970894|2017-10-11 04:29:09.970894
NCT00011011|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-08|2013-07-30|||February 2001||2001-02-01|July 2013|2013-07-01|October 2006|Actual|2006-10-01|||||Interventional|||Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV|A Randomized Phase I/II Pilot Study of Intermittent Withdrawal of Antiretroviral Therapy as an Immunization Strategy and Double-Blinded Immunization With ALVAC-HIV vCP1452 in Subjects With Persistent CD4+ Cell Counts Greater Than 400 Cells/mm3 and Plasma HIV-1 RNA Levels Less Than 50 Copies/ml|Completed||Phase 1/Phase 2|94|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:29:10.12548|2017-10-11 04:29:10.12548
NCT00011024|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-08|2006-08-17|||September 1998||1998-09-01|August 2006|2006-08-01|June 2004||2004-06-01|||||Interventional|||Prospective Studies of the Use of Self Hypnosis, Acupuncture and Osteopathic Manipulation on Muscle Tension in Children With Spastic Cerebral Palsy|Prospective Studies of the Use of Self Hypnosis, Acupuncture and Osteopathic Manipulation on Muscle Tension in Children With Spastic Cerebral Palsy|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:29:10.243097|2017-10-11 04:29:10.243097
NCT00011037|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-08|2012-05-17||||||May 2012|2012-05-01|July 2004|Actual|2004-07-01|||||Interventional|||ALVAC-HIV vCP1452 Alone and Combined With MN rgp120|A Multisite Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of ALVAC-HIV vCP1452 Alone and Combined With MN rgp120|Completed||Phase 2|160|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 04:29:10.339759|2017-10-11 04:29:10.339759
NCT00011050|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-09|2008-07-29|||January 2001||2001-01-01|November 2004|2004-11-01||||||||Observational|||Effects of Storage on Lactate in Blood Samples|Effects of Storage on Plasma Lactate Determinations|Completed||N/A|13||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:10.442812|2017-10-11 04:29:10.442812
NCT00011063|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-09|2008-03-03|||February 2001||2001-02-01|January 2001|2001-01-01|April 2001||2001-04-01|||||Interventional|||Effect of Ginkgo Biloba on Phenytoin Elimination|Evaluation of the Effect of Ginkgo Biloba on Phenytoin Pharmacokinetics|Completed||Phase 1|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:10.522496|2017-10-11 04:29:10.522496
NCT00011076|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-09|2008-03-03|||February 2001||2001-02-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Pirfenidone to Treat Hypertrophic Cardiomyopathy|Double-Blind Placebo-Controlled Study of Pirfenidone, A Novel Anti-Fibrotic Drug in Symptomatic Patients With Hypertrophic Cardiomyopathy (HCM) Associated With Left Ventricular Diastolic Function|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:10.599947|2017-10-11 04:29:10.599947
NCT00011089|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-09|2005-06-23|||February 2001||2001-02-01|November 2001|2001-11-01||||||||Interventional|||Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations|US Expanded Access Program of Tenofovir Disoproxil Fumarate in the Treatment of HIV-1 Infected Patients Who Have Limited Treatment Options|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:29:10.6916|2017-10-11 04:29:10.6916
NCT00011102|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-09|2010-01-12|||February 2001||2001-02-01|January 2010|2010-01-01|December 2001||2001-12-01|||||Interventional|||Prevention of Weight Gain|Prevention of Weight Gain in Women Aged 25 Through 44|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:29:11.516641|2017-10-11 04:29:11.516641
NCT00011115|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-09|2010-01-12|||September 2001||2001-09-01|January 2010|2010-01-01|May 2003||2003-05-01|||||Interventional|||Motivations for Weight Loss|Weight Loss Motivations and Long-term Weight Loss|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:29:11.592991|2017-10-11 04:29:11.592991
NCT00011128|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-10|2015-05-15||||||May 2004|2004-05-01||||||||Interventional|||Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment|Phase III Evaluation of the Role of Temporary Cessation of Antiretroviral Treatment and Resistance Testing-Based Selection of Antiretroviral Drugs in the Virologic Response to Salvage Therapy for Heavily Treatment-Experienced HIV-Infected Individuals Failing Current Antiretroviral Therapy|Withdrawn||Phase 3|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:11.66129|2017-10-11 04:29:11.66129
NCT00011141|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-12|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency|Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:11.814002|2017-10-11 04:29:11.814002
NCT00011154|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-12|2006-03-22|||September 1996||1996-09-01|March 2006|2006-03-01|August 2002||2002-08-01|||||Observational|||Exogenous Toxicants and Genetic Susceptibility in ALS||Completed||N/A|525||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:11.878662|2017-10-11 04:29:11.878662
NCT00011167|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-13|2016-02-05|||March 2001||2001-03-01|February 2016|2016-02-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Observational|||Retinal Arteriolar Abnormalities and CV Mortality||Completed||N/A|1380|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-10-11 04:29:11.929129|2017-10-11 04:29:11.929129
NCT00011180|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-13|2012-12-05|||April 2001||2001-04-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Risk Factors for Venous Thromboembolism in the Community|Subtherapeutic Heparin Anticoagulation as a Predictor of Recurrent Venous Thromboembolism: A Population-Based Cohort Study|Completed||N/A|385|Actual|Mayo Clinic|||2||f||||f||||||Samples With DNA|"     Plasma and genomic DNA   "|||2017-10-11 04:29:12.015803|2017-10-11 04:29:12.015803
NCT00011193|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-13|2012-05-25|||January 2001||2001-01-01|May 2012|2012-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|DREW||Dose-Response to Exercise in Women Aged 45-75 Years (DREW)|Dose-response to Exercise in Women Aged 45-75 Years (DREW)|Completed||N/A|464|Actual|Pennington Biomedical Research Center|||4||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 04:29:12.119804|2017-10-11 04:29:12.119804
NCT00011206|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-13|2014-03-14|||January 2001||2001-01-01|March 2014|2014-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Mortality Follow-Up and Analyses of Men in the MRFIT||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-10-11 04:29:12.229085|2017-10-11 04:29:12.229085
NCT00011245|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-14|2017-06-30|||February 8, 2001||2001-02-08|May 18, 2011|2011-05-18|May 18, 2011||2011-05-18|||||Observational|||Study and Surgical Treatment of Syringomyelia|Establishing the Pathophysiology of Primary Spinal Syringomyelia|Completed||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:12.29337|2017-10-11 04:29:12.29337
NCT00011258|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-14|2009-01-20|||March 1997||1997-03-01|January 2004|2004-01-01|September 2003||2003-09-01|||||Observational|||Paraoxonase and LDL Oxidation in Carotid Artery Disease|Paraoxonase and LDL Oxidation in Carotid Artery Disease|Completed||N/A|1000||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:12.35363|2017-10-11 04:29:12.35363
NCT00011284|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-15|2005-06-23||||||September 2002|2002-09-01|November 2001||2001-11-01|||||Observational|||Mechanisms of Inflammatory Liver Injury||Completed||N/A|50||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:12.411765|2017-10-11 04:29:12.411765
NCT00011297|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-15|2006-10-20||||||October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal|Alcohol Research Center - Treatment and Implications|Completed||Phase 2|160||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:29:12.459443|2017-10-11 04:29:12.459443
NCT00011310|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-15|2006-09-01|||March 1999||1999-03-01|September 2006|2006-09-01|February 2002||2002-02-01|||||Observational|||Cardiopulmonary Effects of Particulate Exposure||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:12.529998|2017-10-11 04:29:12.529998
NCT00011323|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-15|2009-01-20|||June 1998||1998-06-01|February 2003|2003-02-01|January 2001||2001-01-01|||||Observational|||Determining the Risk Factors Such as Smoking, Alcohol, and Caffeine and Their Association With Osteoporosis in Men|Prevalence and Determinants of Osteoporosis in Male Veterans|Completed||N/A|1000||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:12.593867|2017-10-11 04:29:12.593867
NCT00011336|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-15|2009-01-20|||July 1998||1998-07-01|February 2003|2003-02-01|June 2002||2002-06-01|||||Observational|||Determine the Association Between the Level of SCI With Chronic Respiratory Symptoms, Measures of Pulmonary Function, and Respiratory Illness.|Prospective Cohort Study of Respiratory Function and Illness in Chronic SCI|Completed||N/A|400||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:12.641559|2017-10-11 04:29:12.641559
NCT00011349|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-15|2013-04-11|||January 2001||2001-01-01|April 2013|2013-04-01|January 2010|Actual|2010-01-01|June 2006|Actual|2006-06-01||Observational|||Early Stage Prostate Cancer Cohort|CSP #719B - Prospective Cohort of Early Stage Prostate Cancer|Completed||N/A|1116|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:12.697734|2017-10-11 04:29:12.697734
NCT00011362|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-15|2015-06-03|||September 1992||1992-09-01|June 2015|2015-06-01|April 1994|Actual|1994-04-01|January 1994|Actual|1994-01-01||Interventional|Dexamethasone||Dexamethasone Therapy in VLBW Infants at Risk of CLD|Randomized Clinical Trial of Dexamethasone Therapy in Very-Low-Birth-Weight Infants at Risk for Chronic Lung Disease (CLD)|Completed||Phase 3|371|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-10-11 04:29:12.945451|2017-10-11 04:29:12.945451
NCT00011375|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-16|2008-03-03|||February 2001||2001-02-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||Rolipram to Treat Multiple Sclerosis|Safety, Tolerability & Effects of Rolipram on Inflammatory Activity in the Central Nervous System in Multiple Sclerosis. A Phase II, Open Label Crossover Trial Using MRI as an Outcome Measure|Completed||Phase 2|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:13.097525|2017-10-11 04:29:13.097525
NCT00011388|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-16|2006-03-22||||||March 2006|2006-03-01||||||||Observational|||Reproductive Effects of Pesticide, PCB and Mercury Exposure in Laotian Immigrants|Organochlorine Compounds and Menstrual Cycle Function|Completed||N/A|50||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:13.173163|2017-10-11 04:29:13.173163
NCT00011414|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-17|2017-10-05|||February 15, 2001||2001-02-15|January 13, 2016|2016-01-13|January 13, 2016|Actual|2016-01-13|November 28, 2007|Actual|2007-11-28||Interventional|||Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors|Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination With Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients With Refractory Solid Tumors Including Brain Tumors|Completed||Phase 1|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:29:13.232475|2017-10-11 04:29:13.232475
NCT00011440|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-20|2006-03-22|||December 1998||1998-12-01|March 2006|2006-03-01|August 2002||2002-08-01|||||Observational|||Pollutant Altered Allergic Responses|Markers of Pollutant Altered Allergic Responses|Completed||N/A|20||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:13.346171|2017-10-11 04:29:13.346171
NCT00011453|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-21|2005-06-23|||July 1998||1998-07-01|July 2002|2002-07-01|June 2001||2001-06-01|||||Observational|||Protection Against Benzene Toxicity|NQO1 in Protection Against Benzene Toxicity|Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:13.407975|2017-10-11 04:29:13.407975
NCT00011466|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-21|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder|Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:13.459481|2017-10-11 04:29:13.459481
NCT00011479|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2012-05-17||||||May 2012|2012-05-01|August 2002|Actual|2002-08-01|||||Interventional|||Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents|Single Dose Pharmacokinetic Study of Abacavir in HIV-Infected Children and Adolescents|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:13.522076|2017-10-11 04:29:13.522076
NCT00011492|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2017-10-05|||February 21, 2001||2001-02-21|January 6, 2017|2017-01-06||||||||Observational|||Patient Evaluation for Head and Neck Surgery Branch Studies|Evaluation for NIDCD Head & Neck Surgery Branch Clinical Research Protocols|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:13.628939|2017-10-11 04:29:13.628939
NCT00011505|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2008-03-03|||February 2001||2001-02-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia|Investigation of G-CSF-Induced Stem Cell Mobilization Potential in Patients With Diamond-Blackfan Anemia|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:13.70815|2017-10-11 04:29:13.70815
NCT00011518|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2006-03-22|||October 1997||1997-10-01|March 2006|2006-03-01|July 2001||2001-07-01|||||Observational|||Bladder Cancer Case Control Study of Arsenic in Water||Completed||N/A|600||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:13.781299|2017-10-11 04:29:13.781299
NCT00011531|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2009-02-05|||January 2000||2000-01-01|January 2001|2001-01-01|December 2001|Actual|2001-12-01|||||Interventional|||Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing|Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing|Completed||Phase 2|120|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:29:13.833287|2017-10-11 04:29:13.833287
NCT00011544|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2009-01-20|||January 1998||1998-01-01|January 2001|2001-01-01|December 2000|Actual|2000-12-01|||||Interventional|||Physical Performance Measures for Manual Wheelchair Users|Physical Performance Measures for Manual Wheelchair Users|Completed||Phase 2|120||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:13.90308|2017-10-11 04:29:13.90308
NCT00011557|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2009-01-20|||January 1998||1998-01-01|January 2001|2001-01-01|December 2000|Actual|2000-12-01|||||Interventional|||Functional Magnetic Micturition in Patients w/SCI|Functional Magnetic Micturition in Patients w/SCI|Completed||Phase 2|36||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:13.972806|2017-10-11 04:29:13.972806
NCT00011570|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2008-04-25|||April 1998||1998-04-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|October 2005|Actual|2005-10-01||Interventional|||Electrical Control of Bladder in Spinal Cord Injury Patients|Electrical Control of Bladder in Spinal Cord Injury Patients|Completed||Phase 2|18|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:29:14.042475|2017-10-11 04:29:14.042475
NCT00011583|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2008-03-10|||January 2000||2000-01-01|March 2008|2008-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Robot Assisted Upper Limb Neuro-Rehabilitation|Robot Assisted Upper Limb Neuro-Rehabilitation|Completed||Phase 2|60|Anticipated|VA Office of Research and Development||2|||f||||||||||||||2017-10-11 04:29:14.110402|2017-10-11 04:29:14.110402
NCT00011596|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2009-01-20|||August 2000||2000-08-01|January 2001|2001-01-01|August 2003|Actual|2003-08-01|||||Interventional|||FNS and Weight Support Treadmill Training for Gait Component Restoration|FNS and Weight Support Treadmill Training for Gait Component Restoration|Completed||Phase 2|36|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:14.200971|2017-10-11 04:29:14.200971
NCT00011609|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2009-01-20|||August 2000||2000-08-01|January 2001|2001-01-01|November 2001|Actual|2001-11-01|||||Interventional|||Clinical Evaluation of a Wheelchair Mounted Robotic Arm|Clinical Evaluation of a Wheelchair Mounted Robotic Arm|Completed||Phase 2|30||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:14.257786|2017-10-11 04:29:14.257786
NCT00011622|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-22|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor|Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:14.319555|2017-10-11 04:29:14.319555
NCT00011635|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-24|2008-03-03|||February 2001||2001-02-01|December 2000|2000-12-01|June 2001||2001-06-01|||||Interventional|||The Effect of Milk Thistle on the Pharmacokinetics of Indinavir|The Effect of Milk Thistle on the Pharmacokinetics of Indinavir|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:14.370476|2017-10-11 04:29:14.370476
NCT00011648|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-24|2017-10-05|||February 8, 2001||2001-02-08|June 15, 2017|2017-06-15||||||||Observational|||Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia|Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients With Sickle Cell Anemia|Completed||N/A|855|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:14.436324|2017-10-11 04:29:14.436324
NCT00011661|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-26|2006-09-01|||June 2000||2000-06-01|September 2006|2006-09-01|August 2005||2005-08-01|||||Interventional|||Social Network Based Intervention to Reduce Lead Exposure Among Native American Children||Completed||N/A|400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:14.51938|2017-10-11 04:29:14.51938
NCT00011674|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-26|2006-03-22|||May 1997||1997-05-01|March 2006|2006-03-01|May 2001||2001-05-01|||||Observational|||Early Exposure to Lead and Adolescent Development||Completed||N/A|300||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:14.580712|2017-10-11 04:29:14.580712
NCT00011687|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-26|2006-03-22|||September 1999||1999-09-01|March 2006|2006-03-01|September 2003||2003-09-01|||||Observational|||Study for Future Families|US Study of Semen Quality in Partners of Pregnant Women|Completed||N/A|2400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:14.641675|2017-10-11 04:29:14.641675
NCT00011700|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-26|2015-04-13|||January 1999||1999-01-01|April 2015|2015-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Stachybotrys Induced Hemorrhage in the Developing Lung||Completed||N/A|50|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:14.721727|2017-10-11 04:29:14.721727
NCT00011713|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-27|2017-03-27|||October 1999||1999-10-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|EARTH||Environment and Reproductive Health; Human Exposure to Bisphenol A, Phthalates and Fertility and Pregnancy Outcomes|Human Exposure to Bisphenol A, Phthalates and Fertility, Pregnancy Outcomes.|Recruiting||N/A|2401|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||f||||||Samples With DNA|"     Whole blood, urine, semen, follicular fluid, amniotic fluid   "|||2017-10-11 04:29:14.827349|2017-10-11 04:29:14.827349
NCT00011726|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-27|2006-03-22|||August 1996||1996-08-01|March 2006|2006-03-01|December 2002||2002-12-01|||||Observational|||Lead Mobilization & Bone Turnover in Pregnancy/Lactation||Completed||N/A|1000||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:14.973646|2017-10-11 04:29:14.973646
NCT00011739|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-27|2009-01-20|||November 1997||1997-11-01|February 2003|2003-02-01|September 2001||2001-09-01|||||Observational|||A Prospective Cohort Study of MR Abnormalities and Back Pain Risk|A Prospective Cohort Study of MR Abnormalities and Back Pain Risk|Completed||N/A|150||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:29:15.043907|2017-10-11 04:29:15.043907
NCT00011752|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-28|2008-03-03|||February 2001||2001-02-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Serotonin in Alcoholism|Effects of Acute Plasma Tryptophan Depletion on Serotonin Receptor Occupancy and Binding Affinity Using PET in Healthy and Alcoholic Human Subjects|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:15.117925|2017-10-11 04:29:15.117925
NCT00011765|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-28|2017-06-30|||February 22, 2001||2001-02-22|June 2, 2010|2010-06-02|February 26, 2007|Actual|2007-02-26|February 26, 2007|Actual|2007-02-26||Interventional|||Effect of Fluoxetine (Prozac) on Domestic Violence|The Effect of Fluoxetine on Measures of Domestic Violence|Completed||Phase 2|104|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:29:15.203328|2017-10-11 04:29:15.203328
NCT00011778|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-28|2017-10-05|||February 22, 2001||2001-02-22|February 8, 2013|2013-02-08|February 8, 2013|Actual|2013-02-08|August 26, 2010|Actual|2010-08-26||Interventional|||PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck|A Phase I Study of Concomitant Therapy With Proteasome Inhibitor PS-341 and Radiation in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|25|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:29:15.290892|2017-10-11 04:29:15.290892
NCT00011791|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-28|2017-06-30|||February 22, 2001||2001-02-22|May 10, 2011|2011-05-10|May 10, 2011||2011-05-10|||||Observational|||Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia|Catecholamine Reserve and Exercise Tolerance in Subjects With Congenital Adrenal Hyperplasia and Healthy Controls|Completed||N/A|61|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:15.373509|2017-10-11 04:29:15.373509
NCT00011804|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-28|2008-03-03|||February 2001||2001-02-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Topiramate in the Treatment of Sciatica|Topiramate in the Treatment of Sciatica|Completed||Phase 2|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:15.438483|2017-10-11 04:29:15.438483
NCT00011817|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-28|2017-06-30|||February 21, 2001||2001-02-21|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||Evaluation and Treatment of Patients With Inherited Eye Diseases|Evaluation and Treatment Protocol for Potential Research Subjects With Inherited Ophthalmic Diseases|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:15.496204|2017-10-11 04:29:15.496204
NCT00011830|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-28|2008-03-03|||February 2001||2001-02-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission|A Pilot Study of G-CSF Induced Stem Cell Mobilization Potential in Patients With Relapsed Severe Aplastic Anemia|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:15.552728|2017-10-11 04:29:15.552728
NCT00011843|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-28|2017-06-30|||February 22, 2001||2001-02-22|February 4, 2009|2009-02-04|February 4, 2009||2009-02-04|||||Observational|||Molecular Analysis of Microphthalmia/Anophthalmia|Molecular Analysis of Microphthalmia/Anophthalmia and Related Disorders|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:15.616239|2017-10-11 04:29:15.616239
NCT00011856|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-01|2008-03-03|||February 2001||2001-02-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Genetic Analysis of Familial Brain Aneurysms|Linkage Analysis of Familial Intracranial Aneurysms|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:15.676666|2017-10-11 04:29:15.676666
NCT00011895|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-02|2005-06-23|||February 2001||2001-02-01|March 2002|2002-03-01||||||||Interventional|||Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|A Phase IV Multicenter Study of the Efficacy and Safety of 48-Week Induction Treatment With TRIZIVIR (Abacavir 300 Mg/Lamivudine 150 Mg/Zidovudine 300 Mg Combination Tablet BID) With Efavirenz (600 Mg QD) Followed by 48-Week Randomized, Open-Label, Maintenance Treatment With TRIZIVIR With or Without Efavirenz in HIV-1 Infected Antiretroviral Therapy Naive Subjects|Unknown status|Active, not recruiting|Phase 4|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:29:15.745515|2017-10-11 04:29:15.745515
NCT00011908|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2008-03-03|||February 2001||2001-02-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Interventional|||Humanized LL2IGG to Treat Systemic Lupus Erythematosus|A Phase I Clinical Trial of Immunotherapy With Humanized LL2 IgG (Epratuzumab) in Patients With Systemic Lupus Erythematosus|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:15.890747|2017-10-11 04:29:15.890747
NCT00011921|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-09-16|||September 1997||1997-09-01|March 2003|2003-03-01||||||||Interventional|||Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer|Phase III Randomized Trial of Sequential High-Dose Chemotherapy Versus Standard Chemotherapy for the Treatment of Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|430|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:15.957527|2017-10-11 04:29:15.957527
NCT00011934|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2014-04-16|||May 1998||1998-05-01|April 2014|2014-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia|Granulocyte-Macrophage Colony Stimulating Factor (Rhu-GM-CSF) and Autologous Bone Marrow Transplantation for Chronic Myeloid Leukemia|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:29:16.144854|2017-10-11 04:29:16.144854
NCT00011960|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2015-11-14|||May 2001||2001-05-01|November 2015|2015-11-01||||May 2006|Actual|2006-05-01||Interventional|||Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery|A Randomized Phase II Comparison Of Two Cisplatin-Paclitaxel Containing Chemoradiation Regimens In Resected Gastric Cancers|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:29:16.241716|2017-10-11 04:29:16.241716
NCT00011973|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-04-03|||December 2000||2000-12-01|April 2013|2013-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Chemotherapy in Treating Patients With Advanced Kidney Cancer|A Phase Two Study Of Fenretinide In Renal Cell Cancer|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:29:16.477752|2017-10-11 04:29:16.477752
NCT00011986|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2016-03-17|2014-02-18||January 2001||2001-01-01|March 2016|2016-03-01||||March 2010|Actual|2010-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma|Completed||Phase 3|3882|Actual|Gynecologic Oncology Group||5|||f||||||||||||||2017-10-11 04:29:16.590229|2017-10-11 04:29:16.590229
NCT00011999|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2015-11-14|||March 2001||2001-03-01|November 2015|2015-11-01|June 2010|Actual|2010-06-01|February 2004|Actual|2004-02-01||Interventional|||Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer|Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck|Completed||Phase 2|70|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:29:18.331105|2017-10-11 04:29:18.331105
NCT00012012|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2014-12-24|2014-12-24||August 2001||2001-08-01|December 2014|2014-12-01|June 2010|Actual|2010-06-01|September 2007|Actual|2007-09-01||Interventional||All eligible patients.|Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer|A Two Part Phase I/II Study Of Extended Field External Irradiation And Intracavitary Brachytherapy Combined With Chemotherapy And Amifostine In Carcinoma Of The Cervix With Positive Para-Aortic Or High Common Iliac Lymph Nodes|Completed||Phase 1/Phase 2|45|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:29:19.053322|2017-10-11 04:29:19.053322
NCT00012025|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2016-07-01|||May 2001||2001-05-01|July 2016|2016-07-01|August 2008|Actual|2008-08-01|March 2006|Actual|2006-03-01||Interventional|||ICI 182780 in Treating Women With Metastatic Breast Cancer|Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy|Completed||Phase 2|80|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:29:19.624366|2017-10-11 04:29:19.624366
NCT00012038|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-06-20|||July 2001||2001-07-01|September 2003|2003-09-01|October 2003|Actual|2003-10-01|||||Interventional|||Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors|A Phase I/II Trial Of MGI114 For Treatment Of Patients With Recurrent Malignant Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:19.774428|2017-10-11 04:29:19.774428
NCT00012051|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-08-09|||September 2000||2000-09-01|March 2007|2007-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|A Randomised Phase III Study On The Effect Of The Chimeric Anti-CD20 Monoclonal Antibody (Mabthera) During Sequential Chemotherapy Followed By Autologous Stem Cell Transplantation In Patients With Relapse B-Cell Non-Hodgkin Lymphoma(HOVON 44 STUDY)|Completed||Phase 3|340|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:19.875482|2017-10-11 04:29:19.875482
NCT00012090|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-06-17|||September 2000||2000-09-01|June 2013|2013-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum|A Phase II Trial Of Oral Bicalutamide With Subcutaneous Goserelin In Patients With Epithelial Ovarian, Fallopian Tube, Or Peritoneal Carcinoma In Second Or Greater Remission|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:29:20.120076|2017-10-11 04:29:20.120076
NCT00012103|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2011-03-25|||September 1999||1999-09-01|March 2011|2011-03-01||||December 2001|Actual|2001-12-01||Interventional|||Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer|Prevention and Early Detection of Lung Cancer in Women|Completed||N/A|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:29:20.187545|2017-10-11 04:29:20.187545
NCT00012116|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2015-10-28|||October 2000||2000-10-01|July 2012|2012-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain|Temozolomide For Patients With Cerebral Metastases Who Have Failed Radiation Therapy|Completed||Phase 2|4|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 04:29:20.259285|2017-10-11 04:29:20.259285
NCT00012129|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2016-03-10|||September 1998||1998-09-01|March 2016|2016-03-01||||May 2001|Actual|2001-05-01||Interventional|||Chemotherapy in Treating Patients With Breast Cancer|Phase I/II Clinical and Pharmacological Study of Liposomal Annamycin in Anthracycline-Resistant Breast Cancer|Completed||Phase 1/Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:29:20.375043|2017-10-11 04:29:20.375043
NCT00012142|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-06-20|||September 2000||2000-09-01|May 2002|2002-05-01|March 2004|Actual|2004-03-01|||||Interventional|||CCI-779 in Treating Patients With Prostate Cancer|Randomized, Double-Blind, Placebo-Controlled, Phase II Study Of Intravenous CCI-779 Administered Weekly To Patients With Androgen-Independent Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:20.441588|2017-10-11 04:29:20.441588
NCT00012155|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-06-25|||October 2000||2000-10-01|November 2002|2002-11-01|December 2009|Actual|2009-12-01|November 2002|Actual|2002-11-01||Interventional|||Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver|A Phase I, Open-Label, Dose-Escalating Study Of The Safety, Tolerability, And Anti-Tumor Activity Of A Single Intrahepatic Arterial Injection Of Genetically Engineered Herpes Simplex Virus, NV1020, In Subjects With Adenocarcinoma Of The Colon With Metastasis To The Liver|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:20.527863|2017-10-11 04:29:20.527863
NCT00012168|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2016-03-10|||May 1999||1999-05-01|March 2016|2016-03-01||||July 2003|Actual|2003-07-01||Interventional|||Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat|Lymphoscintigraphy Assisted Molecular Staging of Head and Neck Cancer|Completed||N/A|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:29:20.607807|2017-10-11 04:29:20.607807
NCT00012181|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-07-01|||April 2001||2001-04-01|July 2013|2013-07-01||||January 2005|Actual|2005-01-01||Interventional|||Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas|A PHASE I STUDY OF FLAVOPIRIDOL (NSC# 649890; IND# 46211) IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC SOLID TUMORS OR LYMPHOMAS|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:20.709778|2017-10-11 04:29:20.709778
NCT00012194|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-07-08|||March 2001||2001-03-01|July 2013|2013-07-01||||January 2007|Actual|2007-01-01||Interventional|||7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors|Phase I Dose Escalation Study of UCN-01 (NSC 638850) Plus Cisplatin in Advanced Malignant Solid Tumors|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:21.01287|2017-10-11 04:29:21.01287
NCT00012207|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2010-08-20|||September 2000||2000-09-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|||||Interventional|||Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I Study To Evaluate The Safety Of Cellular Immunotherapy Using Genetically Modified Autologous Cd20-Specific Cd8+ T Cell Clones For Patients With Relapsed Cd20+ Indolent Lymphomas|Completed||Phase 1|12|Anticipated|Fred Hutchinson Cancer Research Center|||||||||t||||||||||2017-10-11 04:29:21.119446|2017-10-11 04:29:21.119446
NCT00012220|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2016-07-12|||January 2001||2001-01-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|June 2004|Actual|2004-06-01||Interventional|||Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas|A Randomized Phase II Study Of Gemcitabine/Cisplatin, Gemcitabine/Docetaxel, Gemcitabine/Irinotecan, Or Fixed Dose Rate Infusion Gemcitabine In Patients With Metastic Pancreatic Cancer|Completed||Phase 2|259|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-10-11 04:29:21.21184|2017-10-11 04:29:21.21184
NCT00117065|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-04-24||||||April 2013|2013-04-01||||||||Interventional|||Study of Transplant Related Anemia Treated With Aranesp® (STRATA)|Study of Transplant Related Anemia Treated With Aranesp® (STRATA)|Completed||Phase 4|||Amgen|||||f||||||||||||||2017-10-11 05:07:47.217862|2017-10-11 05:07:47.217862
NCT00012246|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-05-15|||July 2002||2002-07-01|May 2013|2013-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract|A Trial Of Vaccination With The Carcinoembryonic Antigen (CEA) Peptide Cap 1-6D With Montanide ISA 51 Adjuvant Or Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) In HLA-A2+ Patients With CEA Producing Adenocarcinomas Of Gastrointestinal (GI) Tract Origin|Terminated||Phase 2|7|Actual|The University of Texas Medical Branch, Galveston||||Administratively Terminated|f||||||||||||||2017-10-11 04:29:21.449871|2017-10-11 04:29:21.449871
NCT00012259|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-05-30|||October 2000||2000-10-01|May 2013|2013-05-01||||February 2002|Actual|2002-02-01||Interventional|||Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia|A Phase II Study Of Troxatyl In Patients With CML Blastic Phase Disease|Completed||Phase 2|31|Actual|Shire||1|||f||||||||||||||2017-10-11 04:29:21.557275|2017-10-11 04:29:21.557275
NCT00012298|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2015-11-04|2015-11-04||April 2001||2001-04-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Phase I/II Study of Two Sequential Doses of IDEC-Y2B8 in Patients With Relapsed Low-Grade and Follicular Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|81|Actual|National Cancer Institute (NCI)||1||Trial completed prematurely.|f||||||||||||||2017-10-11 04:29:21.809944|2017-10-11 04:29:21.809944
NCT00012311|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2014-01-03|||January 2000||2000-01-01|September 2001|2001-09-01||||||||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer|Multi-Cycle High-Dose Chemotherapy Versus Optimized Conventionally-Dosed Chemotherapy in Patients With Metastatic Breast Cancer: A Phase II Prospective Randomized Trial|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:23.605024|2017-10-11 04:29:23.605024
NCT00012324|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-06-25|||September 2000||2000-09-01|October 2005|2005-10-01|November 2005|Actual|2005-11-01|||||Interventional|||Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer|A Phase III Randomized Controlled Study Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma (HCC) Treated With THYMITAQ to Patients Treated With Doxorubicin|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:23.685634|2017-10-11 04:29:23.685634
NCT00012337|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-06-20|||January 2001||2001-01-01|March 2002|2002-03-01|March 2004|Actual|2004-03-01|||||Interventional|||ZD 1839 in Treating Patients With Metastatic Kidney Cancer|A Trial of ZD1839 (Iressa) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:23.832584|2017-10-11 04:29:23.832584
NCT00012350|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2012-10-22|||January 2001||2001-01-01|October 2012|2012-10-01|January 2010|Actual|2010-01-01|September 2003|Actual|2003-09-01||Interventional|||Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma|Phase II Evaluation of FTI (R115777) (NSC 702818) in Treatment of Advanced Multiple Myeloma|Completed||Phase 2|44|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:29:23.891133|2017-10-11 04:29:23.891133
NCT00012363|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2012-06-12|||April 2001||2001-04-01|June 2012|2012-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus|Gemcitabine Plus Irinotecan in Patients With Esophageal Cancer, Phase II|Completed||Phase 2|61|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:29:23.977396|2017-10-11 04:29:23.977396
NCT00012376|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-01-08|||March 2001||2001-03-01|January 2013|2013-01-01||||January 2010|Actual|2010-01-01||Interventional|||Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer|Dose Finding Study of Bryostatin-1 and GM-CSF in Refractory Myeloid Malignancies|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:24.369991|2017-10-11 04:29:24.369991
NCT00012389|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-03|2013-12-18|||December 2000||2000-12-01|October 2002|2002-10-01|October 2008|Actual|2008-10-01|||||Interventional|||Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer|A Multicenter, Open-Label, Randomized, Two-Arm Study of Irinotecan (CPT-11) Versus the Combination of Oxaliplatin + Irinotecan (CPT-11) as Second-Line Treatment of Metastatic Colorectal Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:24.51601|2017-10-11 04:29:24.51601
NCT00012428|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-06|2015-04-13|||September 1999||1999-09-01|April 2015|2015-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Prenatal PCB Exposure|Prenatal PCB Exposure and Cognitive Development|Completed||N/A|224||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:25.037576|2017-10-11 04:29:25.037576
NCT00012441|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-06|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Comparison of Daily Nocturnal Hemodialysis With Daily Hemodialysis|Comparison of Daily Nocturnal Hemodialysis With Daily Hemodialysis|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:25.089257|2017-10-11 04:29:25.089257
NCT00012454|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-09|2010-05-03|||March 2001||2001-03-01|May 2010|2010-05-01|February 2004||2004-02-01|||||Interventional|||E-Selectin Nasal Spray to Prevent Stroke Recurrence|Induction of Mucosal Tolerance to E-Selectin for the Secondary Prevention of Stroke|Terminated||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:25.166012|2017-10-11 04:29:25.166012
NCT00012467|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-09|2009-05-29|||January 2000||2000-01-01|May 2009|2009-05-01|July 2001|Actual|2001-07-01|||||Interventional|||Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase II Study of the Safety and Antifungal Activity of Subcutaneous Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) in Conjunction With Standard Therapy in Patients With Acute Cryptococcal Meningitis|Completed||Phase 2|60||InterMune|||||f||||||||||||||2017-10-11 04:29:25.244413|2017-10-11 04:29:25.244413
NCT00012480|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-09|2015-04-14|||August 2002||2002-08-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm|Human Sperm Zona Acceptor: Environmental Effects|Completed||N/A|400|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:25.353787|2017-10-11 04:29:25.353787
NCT00012493|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-09|2006-09-01|||October 1999||1999-10-01|September 2006|2006-09-01|December 2002||2002-12-01|||||Observational|||Cardiac Vulnerability in Potentially Susceptible Patients||Completed||N/A|100||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:29:25.435201|2017-10-11 04:29:25.435201
NCT00012506|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-10|2005-06-23||||||March 2001|2001-03-01||||||||Interventional|||The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis||Unknown status|Recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:29:25.494659|2017-10-11 04:29:25.494659
NCT00012519|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-10|2012-05-17||||||May 2012|2012-05-01|July 2005|Actual|2005-07-01|||||Interventional|||Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment|A Phase I/II Trial of Ritonavir and Indinavir in Children Failing Other Antiretroviral Therapy|Completed||Phase 1/Phase 2|29|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:29:25.571903|2017-10-11 04:29:25.571903
NCT00012545|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-10|2017-10-05|||March 8, 2001||2001-03-08|April 17, 2017|2017-04-17||||||||Observational|||Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease|Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:25.686097|2017-10-11 04:29:25.686097
NCT00012558|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-13|2007-05-03|||September 1998||1998-09-01|April 2007|2007-04-01|September 2005||2005-09-01|||||Interventional|||Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)|Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)|Completed||N/A|5000||National Institute of Mental Health (NIMH)|||||||||||||||||||2017-10-11 04:29:25.781249|2017-10-11 04:29:25.781249
NCT00012584|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-06-23|||November 2000||2000-11-01|June 2009|2009-06-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Treatment of Youth With ADHD and Anxiety|A Treatment Study of Youth With Comorbid Attention Deficit Hyperactivity Disorder (ADHD) and Anxiety Disorders|Completed||N/A|120||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:29:25.92512|2017-10-11 04:29:25.92512
NCT00012597|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||April 2015|2015-04-01|September 2000|Actual|2000-09-01|||||Interventional|||Pressure Ulcer Assessment Via Telemedicine|Pressure Ulcer Assessment Via Telemedicine|Completed||N/A|128|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:26.324387|2017-10-11 04:29:26.324387
NCT00012610|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||April 2015|2015-04-01|September 2000|Actual|2000-09-01|||||Interventional|||Efficacy of Telepsychiatry in the Treatment of Depression|Efficacy of Telepsychiatry in the Treatment of Depression|Completed||N/A|119|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:26.406681|2017-10-11 04:29:26.406681
NCT00012623|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||April 2015|2015-04-01|March 2002|Actual|2002-03-01|||||Observational|||Improving Service Delivery Through Access Points|Improving Service Delivery Through Access Points|Completed||N/A|39481|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:26.483979|2017-10-11 04:29:26.483979
NCT00012636|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2000|Actual|2000-09-01|||||Interventional|||Guidelines for Drug Therapy of Hypertension: Closing the Loop|Guidelines for Drug Therapy of Hypertension: Closing the Loop|Completed||N/A|36|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:26.567785|2017-10-11 04:29:26.567785
NCT00012649|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||January 2005|2005-01-01|May 2003|Actual|2003-05-01|||||Observational|||Improving Diabetes Care Via Telephone Assessment and Patient Education|Improving Diabetes Care Via Telephone Assessment and Patient Education|Completed||N/A|480|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:26.658483|2017-10-11 04:29:26.658483
NCT00012662|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2002|Actual|2002-12-01|||||Interventional|||Disease Management and Educational Intervention Outcomes in High-Risk Diabetics|Disease Management and Educational Intervention Outcomes in High-Risk Diabetics|Completed||N/A|1800|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:26.741157|2017-10-11 04:29:26.741157
NCT00012675|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2012-05-23||||||May 2012|2012-05-01|December 2003|Actual|2003-12-01|||||Observational|||Developing and Implementing a Quality Measure for Glycemic Control|Developing and Implementing a Quality Measure for Glycemic Control|Withdrawn||N/A|0|Actual|VA Office of Research and Development|||1|This study was withdrawn prior to enrollment.|f||||f||||||||||2017-10-11 04:29:26.824097|2017-10-11 04:29:26.824097
NCT00012688|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||Periodontal Care and Glycemic Control in Diabetes|Periodontal Care and Glycemic Control in Diabetes|Completed||N/A|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:26.90155|2017-10-11 04:29:26.90155
NCT00012701|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||July 2005|2005-07-01|June 2003|Actual|2003-06-01|||||Observational|||Measuring HIV Quality of Care|Measuring HIV Quality of Care|Completed||N/A|1600|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:26.992797|2017-10-11 04:29:26.992797
NCT00012714|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|June 2000|Actual|2000-06-01|||||Interventional|||Evaluation of Subacute Rehabilitative Care|Evaluation of Subacute Rehabilitative Care|Completed||Phase 2|180|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.06401|2017-10-11 04:29:27.06401
NCT00012727|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||July 2005|2005-07-01|August 2001|Actual|2001-08-01|||||Interventional|||Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment|Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment|Completed||Phase 2|236|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.142412|2017-10-11 04:29:27.142412
NCT00012740|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||December 2005|2005-12-01|September 2001|Actual|2001-09-01|||||Interventional|||A Casefinding and Referral System for Older Veterans Within Primary Care|A Casefinding and Referral System for Older Veterans Within Primary Care|Completed||N/A|792|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.324951|2017-10-11 04:29:27.324951
NCT00012753|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 1999|Actual|1999-12-01|||||Interventional|||Automated Calls With Nurse Follow-Up to Improve Diabetes Ambulatory Care|Automated Calls With Nurse Follow-Up to Improve Diabetes Ambulatory Care|Completed||Phase 3|272|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.471183|2017-10-11 04:29:27.471183
NCT00012766|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||December 2005|2005-12-01|March 2001|Actual|2001-03-01|||||Interventional|||Effectiveness of Team Treatment of Depression in Primary Care|Effectiveness of Team Treatment of Depression in Primary Care|Completed||Phase 2|360|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.601281|2017-10-11 04:29:27.601281
NCT00012779|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||June 2005|2005-06-01|March 2003|Actual|2003-03-01|||||Interventional|||Effectiveness of a Health Education Program in a Primary Care Setting|Effectiveness of a Health Education Program in a Primary Care Setting|Completed||Phase 2|288|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.704022|2017-10-11 04:29:27.704022
NCT00012792|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||December 2005|2005-12-01|December 2000|Actual|2000-12-01|||||Interventional|||Randomized Controlled Trial of Exercise Training in Patients With COPD|Randomized Controlled Trial of Exercise Training in Patients With COPD|Completed||Phase 3|130|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.791484|2017-10-11 04:29:27.791484
NCT00012805|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2001|Actual|2001-03-01|||||Interventional|||Effectiveness and Cost Impact of a Telecommunications System in COPD|Effectiveness and Cost Impact of a Telecommunications System in COPD|Completed||Phase 4|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.870521|2017-10-11 04:29:27.870521
NCT00012818|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||Efficacy and Cost Effectiveness of Relaxation and Response to CHF|Efficacy and Cost Effectiveness of Relaxation and Response to CHF|Completed||N/A|90|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:27.94687|2017-10-11 04:29:27.94687
NCT00012831|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||December 2005|2005-12-01|June 2001|Actual|2001-06-01|||||Observational|||Nurse Managed Clinic for Dementia Patients and Family Caregivers|Nurse Managed Clinic for Dementia Patients and Family Caregivers|Completed||N/A|120|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:28.025432|2017-10-11 04:29:28.025432
NCT00012844|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 1999|Actual|1999-12-01|||||Interventional|||Redesigning Patient Handling Tasks to Prevent Nursing Back Injuries|Redesigning Patient Handling Tasks to Prevent Nursing Back Injuries|Completed||N/A|134|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.093687|2017-10-11 04:29:28.093687
NCT00012857|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2001|Actual|2001-03-01|||||Interventional|||Pain Management and Behavioral Outcomes in Patients With Dementia|Pain Management and Behavioral Outcomes in Patients With Dementia|Completed||Phase 2|66|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.174303|2017-10-11 04:29:28.174303
NCT00012870|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2002|Actual|2002-03-01|||||Interventional|||Effect of Behavioral Management on Quality of Life in Heart Failure|Effect of Behavioral Management on Quality of Life in Heart Failure|Completed||N/A|116|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.25673|2017-10-11 04:29:28.25673
NCT00012883|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2001|Actual|2001-12-01|||||Interventional|||Home Walking Exercise Training in Advanced Heart Failure|Home Walking Exercise Training in Advanced Heart Failure|Completed||N/A|110|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.340002|2017-10-11 04:29:28.340002
NCT00012896|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2004|Actual|2004-09-01|||||Interventional|||Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines|Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines|Completed||N/A|320|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.418639|2017-10-11 04:29:28.418639
NCT00012909|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||November 2007|2007-11-01|March 2004|Actual|2004-03-01|||||Interventional|||Development and Evaluation of a Hormone Replacement Therapy Decision-Aid|Development and Evaluation of a Hormone Replacement Therapy Decision-Aid|Completed||N/A|150|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.48719|2017-10-11 04:29:28.48719
NCT00012922|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|April 2003|Actual|2003-04-01|||||Interventional|||Low Literacy Intervention for Colorectal Cancer Screening|Low Literacy Intervention for Colorectal Cancer Screening|Completed||N/A|2400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.594412|2017-10-11 04:29:28.594412
NCT00012935|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2001|Actual|2001-12-01|||||Interventional|||Treatment Decision Intervention for Veterans With Prostate Cancer|Treatment Decision Intervention for Veterans With Prostate Cancer|Completed||N/A|100|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.673452|2017-10-11 04:29:28.673452
NCT00012948|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2004|Actual|2004-09-01|||||Interventional|||Centralized Telephone Outreach to Assist Smoking Cessation Among Veterans|Centralized Telephone Outreach to Assist Smoking Cessation Among Veterans|Completed||Phase 4|800|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.751119|2017-10-11 04:29:28.751119
NCT00012961|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||January 2005|2005-01-01|March 2003|Actual|2003-03-01|||||Observational|||Improving Health Services for Veterans With Schizophrenia|Improving Health Services for Veterans With Schizophrenia|Completed||N/A|300|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:28.825025|2017-10-11 04:29:28.825025
NCT00012974|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06|||November 2005||2005-11-01|December 2005|2005-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas|Innovative Strategies for Implementing New CHF Guideline Recommendations|Completed||Phase 1/Phase 2|60|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.890772|2017-10-11 04:29:28.890772
NCT00012987|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2002|Actual|2002-12-01|||||Interventional|||Implementing Guidelines for Smoking Cessation: A Randomized Trial of Evidence-Based Quality Improvement|Implementing Guidelines for Smoking Cessation: A Randomized Trial of Evidence-Based Quality Improvement|Completed||N/A|2500|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:28.982061|2017-10-11 04:29:28.982061
NCT00013000|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2000|Actual|2000-09-01|||||Interventional|||A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines|A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines|Completed||N/A|400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:29.058488|2017-10-11 04:29:29.058488
NCT00013013|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|August 2001|Actual|2001-08-01|||||Interventional|||A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline|A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline|Completed||Phase 4|4000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:29.132595|2017-10-11 04:29:29.132595
NCT00013026|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2004|Actual|2004-03-01|||||Interventional|||Trial of a Tailored Message Program to Implement CHF Guidelines|Trial of a Tailored Message Program to Implement CHF Guidelines|Completed||N/A|700|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:29.20763|2017-10-11 04:29:29.20763
NCT00013039|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|February 2001|Actual|2001-02-01|||||Interventional|||Computerized Guidelines Enhanced by Symptoms and History: Clinical Effects|Computerized Guidelines Enhanced by Symptoms and History: Clinical Effects|Completed||N/A|1000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:29.279494|2017-10-11 04:29:29.279494
NCT00013052|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2002|Actual|2002-09-01|||||Interventional|||Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program|Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program|Completed||N/A|2068|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:29.360235|2017-10-11 04:29:29.360235
NCT00013065|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||January 2005|2005-01-01|December 2003|Actual|2003-12-01|||||Observational|||A Medication Adherence Intervention for HIV Infected Veterans|A Medication Adherence Intervention for HIV Infected Veterans|Completed||N/A|210|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:29.428378|2017-10-11 04:29:29.428378
NCT00013078|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||June 2005|2005-06-01|June 2001|Actual|2001-06-01|||||Interventional|||Safe-Grip Fall/Injuries Intervention: A Randomized Trial|Safe-Grip Fall/Injuries Intervention: A Randomized Trial|Completed||N/A|210|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:29.512061|2017-10-11 04:29:29.512061
NCT00013091|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06|||October 1997||1997-10-01|May 2009|2009-05-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Treatment of Depression in Patients With PTSD|Treatment of Depression in Patients With PTSD|Completed||N/A|120|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:29.764651|2017-10-11 04:29:29.764651
NCT00013104|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||January 2005|2005-01-01|September 2002|Actual|2002-09-01|||||Observational|||Implementation of Ischemic Heart Disease Clinical Practice Guidelines|Implementation of Ischemic Heart Disease Clinical Practice Guidelines|Completed||N/A|50|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:29:29.838293|2017-10-11 04:29:29.838293
NCT00013117|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||November 2007|2007-11-01|December 2002|Actual|2002-12-01|||||Interventional|||Computer-Assisted Access to Specialist Expertise|Computer-Assisted Access to Specialist Expertise|Completed||N/A|10000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:29:29.912048|2017-10-11 04:29:29.912048
NCT00006023|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-05-14|||March 2000||2000-03-01|May 2012|2012-05-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Master Protocol for Metastatic Hormone-Resistant Prostatic Carcinoma - Phase II Trials - Protocol 5: Capecitabine|Completed||Phase 2|||Swiss Group for Clinical Cancer Research|||||f||||t||||||||||2017-10-11 04:29:29.999848|2017-10-11 04:29:29.999848
NCT00006024|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2014-02-11|||November 2000||2000-11-01|February 2014|2014-02-01|September 2006|Actual|2006-09-01|January 2005|Actual|2005-01-01||Interventional|||Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma|A Phase I Study of Temozolomide and CCNU in Pediatric Patients With Newly Diagnosed Incompletely Resected Non-Brainstem High-Grade Gliomas|Completed||Phase 1|32|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:29:30.123771|2017-10-11 04:29:30.123771
NCT00006025|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2008-11-22|||November 2000||2000-11-01|August 2004|2004-08-01||||May 2008|Actual|2008-05-01||Interventional|||Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma|Phase I-II Trial of CPT-11 and Temozolomide (Temodar) in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:30.781129|2017-10-11 04:29:30.781129
NCT00006026|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-09-20|||May 2000||2000-05-01|September 2012|2012-09-01||||October 2001|Actual|2001-10-01||Interventional|||Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract|"Open Label Phase II Study on RFS 2000 (9-Nitro-Camptothecin, 9-NC) Administered as a 5 Days On-2 Days Off Oral Treatment in Advanced/Metastatic Urothelial Tract Tumors"|Completed||Phase 2|21|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:29:30.883267|2017-10-11 04:29:30.883267
NCT00006027|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-08-09|||August 2000||2000-08-01|August 2013|2013-08-01||||June 2004|Actual|2004-06-01||Interventional|||Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer|A Phase III Study of Adjuvant Postoperative Irradiation With or Without Cisplatin/Taxol Chemotherapy Following TAH/BSO for Patients With Endometrial Cancer|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:29:30.988629|2017-10-11 04:29:30.988629
NCT00006028|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-24|||January 2001||2001-01-01|March 2003|2003-03-01||||January 2007|Actual|2007-01-01||Interventional|||Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy|Evaluation of Gemcitabine and Cisplatin in Recurrent, Platinum Resistant and Refractory Ovarian Cancer|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:29:31.135677|2017-10-11 04:29:31.135677
NCT00006029|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2016-07-12|||July 2000||2000-07-01|July 2016|2016-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease|Completed||Phase 1/Phase 2|91|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:29:31.284402|2017-10-11 04:29:31.284402
NCT00006030|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-08-06|||January 1992||1992-01-01|December 2006|2006-12-01||||||||Interventional|||Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer|Protocol of a Randomized Trial for the Management of Small Well-Differentiated and Special Type Carcinomas of the Breast|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:31.53547|2017-10-11 04:29:31.53547
NCT00006031|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-09-24|||November 1999||1999-11-01|September 2012|2012-09-01|July 2006|Actual|2006-07-01|July 2001|Actual|2001-07-01||Interventional|||Comparison of Two Types of Biopsy in Patients With Breast Lesions|Randomized Prospective Trial Comparing Radioactive Seed Localized Breast Biopsy to Needle Localized Breast Biopsy|Completed||N/A|117|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-10-11 04:29:31.608464|2017-10-11 04:29:31.608464
NCT00006062|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-11|2008-03-03|||July 2000||2000-07-01|June 2000|2000-06-01|May 2001||2001-05-01|||||Interventional|||Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction|Phase I Study of Oxaliplatin in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:34.863883|2017-10-11 04:29:34.863883
NCT00006032|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-12-10|||March 2000||2000-03-01|December 2012|2012-12-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer|A Phase II Study of Intensive-Dose Topotecan, Ifosfamide/Mesna and Etoposide (TIME) Followed by Autologous Stem Cell Rescue in Metastatic Breast Cancer|Terminated||Phase 2|||H. Lee Moffitt Cancer Center and Research Institute||||low accrual|f||||f||||||||||2017-10-11 04:29:31.689268|2017-10-11 04:29:31.689268
NCT00006033|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-29|||June 2000||2000-06-01|January 2001|2001-01-01|June 2004|Actual|2004-06-01|||||Interventional|||Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer|Protocol IL-2001: A Multi-Center, Open-Label, Randomized Study of the Efficacy and Safety of Multiple Intratumoral Injections of hIl-2 Plasmid (1.8 mg) Formulated With DOTMA/Cholesterol [Ratio 1:0.5(-/+)] Liposomes in Patients With Unresctable or Recurrent/Refractory Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:31.780536|2017-10-11 04:29:31.780536
NCT00006034|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-05-14|||June 1998||1998-06-01|January 2006|2006-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer|A Randomized, Multicenter Phase III Trial Evaluating the Efficacy and Safety of BCI-ImmuneActivator Versus Adriamycin in BCG Refractory or Intolerant Patients With Carcinoma in Situ With or Without Resected Superficial Papillary Bladder Cancer|Completed||Phase 3|||National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:29:31.887695|2017-10-11 04:29:31.887695
NCT00006035|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-09-16|||June 2000||2000-06-01|November 2000|2000-11-01||||||||Interventional|||Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma|An Open Label Lesion Controlled Study of Electroporation Therapy (EPT) for the Treatment of Cutaneous Metastatic Melanoma Using the Genetronics, Inc. Medpulser System and Bleomycin|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:31.976603|2017-10-11 04:29:31.976603
NCT00006036|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-11-07|||April 2000||2000-04-01|March 2010|2010-03-01|December 2009||2009-12-01|||||Interventional|||Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I Study of NX 211 in Combination With Cisplatin Given as an IV Infusion Days 1, 2, and 3 Every 3 Weeks in Patients With Solid Tumors|Completed||Phase 1|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:29:32.058758|2017-10-11 04:29:32.058758
NCT00006037|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2014-05-20|||November 1999||1999-11-01|May 2014|2014-05-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer|Phase II Randomized Placebo-Controlled Double-Blinded Study With 5-FU vs. 5-FU With IM862 With Cross-Over to CPT-11 vs. CPT-11 With IM862|Terminated||Phase 2|18|Actual|University of Southern California||||Drug not available|f||||t||||||||||2017-10-11 04:29:32.163019|2017-10-11 04:29:32.163019
NCT00006038|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-17|||February 2000||2000-02-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer|A Phase II Trial of Neoadjuvant Cisplatin-Fluorouracil-Docetaxel Chemotherapy, Surgery, and Intraperitoneal (IP) Floxuridine (FUdR) Plus Leucovorin in Patients With Locally Advanced Gastric Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:29:32.236264|2017-10-11 04:29:32.236264
NCT00006039|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-17|||December 1999||1999-12-01|June 2013|2013-06-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma|Phase II Study of Weekly Administered High-Dose Pegylated Interferon Alfa-2B (PEGIntron) in Advanced Stage Low Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:29:32.310493|2017-10-11 04:29:32.310493
NCT00006040|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-17|||April 2000||2000-04-01|June 2013|2013-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia|Phase I Study of Yttrium-90 Labeled HuM195 Combined With Etoposide as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients With Advanced Myelodysplastic Syndrome and Refractory Leukemia|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:29:32.386108|2017-10-11 04:29:32.386108
NCT00006041|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-17|||February 2000||2000-02-01|June 2013|2013-06-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer|Vaccination of Patients Who Have Ovarian, Fallopian Tube or Peritoneal Cancer With Glycosylated MUC-1-KLH Conjugate Plus the Immunological Adjuvant QS-21|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:29:32.468326|2017-10-11 04:29:32.468326
NCT00006042|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2010-03-09|||December 1999||1999-12-01|March 2010|2010-03-01||||||||Interventional|||Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Non-Myeloablative Allogeneic Bone Marrow Transplantation for Hematologic Malignancies Using Haploidentical Donors: A Phase I Trial of Pre-Transplant Cyclophosphamide|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:29:32.554999|2017-10-11 04:29:32.554999
NCT00006043|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-06-04|||February 2000||2000-02-01|June 2013|2013-06-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin|Phase II Trial of Temozolomide in Patients With Cisplatin-Refractory Germ Cell Tumors|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:29:32.843842|2017-10-11 04:29:32.843842
NCT00006044|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-17|||February 2000||2000-02-01|January 2013|2013-01-01||||February 2005|Actual|2005-02-01||Interventional|||Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy|A Phase I Trial of Testosterone in Patients With Progressive Androgen-Independent Prostate Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:29:32.920242|2017-10-11 04:29:32.920242
NCT00006063|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2005-06-23|||July 1999||1999-07-01|July 2000|2000-07-01|August 1999||1999-08-01|||||Interventional|||Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis||Completed||N/A|24||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:34.950423|2017-10-11 04:29:34.950423
NCT00117078|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-09-29||||||September 2008|2008-09-01||||||||Interventional|||Aranesp® Monthly Preference Study - 2|Aranesp® Monthly Preference Study - 2|Completed||Phase 4|||Amgen|||||f||||||||||||||2017-10-11 05:07:47.298446|2017-10-11 05:07:47.298446
NCT00006045|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-11-05|||March 2000||2000-03-01|February 2010|2010-02-01||||||||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia|Phase III, Randomized, Multicenter Study to Assess the Efficacy and Safety of HuM195 (Recombinant Humanized Anti-CD33 Monoclonal Antibody) in Combination With Standardized Chemotherapy Compared to Standardized Chemotherapy Alone in the Treatment of Patients With Refractory or First-Relapsed Acute Myelogenous Leukemia (AML)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:33.005204|2017-10-11 04:29:33.005204
NCT00006046|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2009-02-06|||January 2000||2000-01-01|March 2003|2003-03-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer|Phase I Study of Humanized 3S193 (Anti-Lewis-Y) Antibody in Patients With Advanced Colorectal Carcinoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:33.189277|2017-10-11 04:29:33.189277
NCT00006047|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2012-09-25|||June 2000||2000-06-01|September 2012|2012-09-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide|Phase I Study of Combination Therapy With Oral 9-Nitrocamptothecin and Oral Etoposide|Completed||Phase 1|44|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:29:33.265335|2017-10-11 04:29:33.265335
NCT00006048|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-12-18|||May 2000||2000-05-01|July 2001|2001-07-01||||||||Interventional|||ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer|A Randomized, Double Blind, Phase III Comparative Trial of 2 Doses of ZD1839 (IRESSA) in Combination With Gemcitabine and Cisplatin Versus Placebo in Combination With Gemcitabine and Cisplatin in Chemotherapy Naive Patients With Advanced (Stage III or IV) Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:33.362116|2017-10-11 04:29:33.362116
NCT00006049|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-12-18|||May 2000||2000-05-01|July 2001|2001-07-01||||||||Interventional|||ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer|A Randomized, Double-Blind, Phase III Comparative Trial of 2 Doses of ZD1839 (IRESSA) in Combination With Paclitaxel and Carboplatin Versus Placebo in Combination With Paclitaxel and Carboplatin in Chemotherapy-Naive Patients With Advanced (Stage III or IV) Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:33.425745|2017-10-11 04:29:33.425745
NCT00006050|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2009-02-06|||January 1999||1999-01-01|September 2005|2005-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver|Chemotherapy Intra-Arterial Hepatic With Oxaliplatin Combined With Leucovorin Calcium and Fluorouracil IV|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:33.592868|2017-10-11 04:29:33.592868
NCT00006051|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2009-02-06|||February 1999||1999-02-01|November 2001|2001-11-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer|Combination Chemotherapy Concurrent With Postoperative Radiotherapy Epidermoid Carcinoma of the Head and Neck at High Risk of Recurrence - Study of Feasibility|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:33.720104|2017-10-11 04:29:33.720104
NCT00006052|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2014-01-30|||June 2000||2000-06-01|January 2014|2014-01-01||||June 2003|Actual|2003-06-01||Interventional|||STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia|A Study to Determine the Efficacy and Safety of STI571 in Patients With Chronic Myeloid Leukemia in Accelerated Phase|Completed||Phase 2|||Novartis|||||f||||f||||||||||2017-10-11 04:29:33.857228|2017-10-11 04:29:33.857228
NCT00006053|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2013-01-16|||June 2000||2000-06-01|January 2013|2013-01-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa|A Study to Determine the Safety and Efficacy of STI571 in Patients With Chronic Myeloid Leukemia Who Are Hematologically or Cytogenetically Resistant or Refractory to Interferon-Alpha, or Intolerant of, Interferon-Alpha|Completed||Phase 2|||Novartis|||||f||||f||||||||||2017-10-11 04:29:33.932534|2017-10-11 04:29:33.932534
NCT00006054|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2009-10-14|||March 2000||2000-03-01|October 2003|2003-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies||Terminated||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:34.034097|2017-10-11 04:29:34.034097
NCT00006055|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2005-06-23|||March 2000||2000-03-01|October 2003|2003-10-01||||||||Interventional|||Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases||Unknown status|Active, not recruiting|N/A|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:34.174383|2017-10-11 04:29:34.174383
NCT00006056|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2005-06-23|||March 2000||2000-03-01|October 2003|2003-10-01||||||||Interventional|||Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders||Unknown status|Active, not recruiting|N/A|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:34.319102|2017-10-11 04:29:34.319102
NCT00006057|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2005-06-23|||December 1999||1999-12-01|April 2002|2002-04-01||||||||Observational|||Diagnostic and Screening Study of Genetic Disorders||Completed||N/A|50||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:34.448642|2017-10-11 04:29:34.448642
NCT00006058|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2005-06-23|||September 1996||1996-09-01|December 2003|2003-12-01||||||||Observational|||Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns|Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns|Completed||N/A|200||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:34.529583|2017-10-11 04:29:34.529583
NCT00006059|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2005-06-23|||January 1997||1997-01-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of Familial Epilepsy||Completed||N/A|898||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:34.609921|2017-10-11 04:29:34.609921
NCT00006060|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2009-03-10|||April 1999||1999-04-01|March 2009|2009-03-01||||||||Observational|||Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis||Unknown status|Recruiting|N/A|100||Office of Rare Diseases (ORD)|||||f||||t||||||||||2017-10-11 04:29:34.698379|2017-10-11 04:29:34.698379
NCT00006061|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-05|2005-06-23|||January 2000||2000-01-01|July 2000|2000-07-01|January 2000||2000-01-01|||||Interventional|||Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency||Completed||N/A|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:34.793166|2017-10-11 04:29:34.793166
NCT00006064|ClinicalTrials.gov processed this data on October 10, 2017|2000-06-16|2014-10-28|||June 2000||2000-06-01|October 2014|2014-10-01|February 2005|Actual|2005-02-01|||||Observational|||The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children|Effect of Antiretroviral Therapy on Body Composition in HIV-Infected Children|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:35.051998|2017-10-11 04:29:35.051998
NCT00006066|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-14|2012-05-17||||||May 2012|2012-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems|Phase I/II Trial of Subcutaneous IL-2 With Highly Active Antiretroviral Therapy in HIV-Infected Children With Immunosuppression|Completed||Phase 1|92||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:29:35.146164|2017-10-11 04:29:35.146164
NCT00006068|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-18|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Does Islet Transplantation Eliminate Hypoglycemia?||Unknown status|Not yet recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:35.254036|2017-10-11 04:29:35.254036
NCT00006070|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-18|2008-03-03|||July 2000||2000-07-01|May 2004|2004-05-01|May 2004||2004-05-01|||||Interventional|||Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction|Safety and Efficacy of a TNF Receptor Fusion Protein for Injury-Induced Inflammation and Sequelae|Completed||Phase 2|86||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:35.314348|2017-10-11 04:29:35.314348
NCT00006071|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-21|2008-03-03|||July 2000||2000-07-01|July 2000|2000-07-01|March 2001||2001-03-01|||||Observational|||Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol|Effects of Rosiglitazone on Endothelium-Dependent Vasodilation and on Endothelin Activity in Patients With Essential Hypertension and in Patients With Hypercholesterolemia|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:35.40634|2017-10-11 04:29:35.40634
NCT00006072|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-25|2005-06-23||||||July 2000|2000-07-01||||||||Interventional|||A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:35.502193|2017-10-11 04:29:35.502193
NCT00006073|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-25|2017-10-05|||July 19, 2000||2000-07-19|August 31, 2016|2016-08-31|August 31, 2016||2016-08-31|||||Observational|||Endocrine Studies in Health and Disease|Endocrine Studies in Health and Disease|Terminated||N/A|3090|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:35.557889|2017-10-11 04:29:35.557889
NCT00006075|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-27|2008-09-26||||||June 2004|2004-06-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies|Phase IIA Study of Tolerance and Safety of Differing Concentrations of Chlorhexidine, for Peripartum Vaginal and Infant Washes, to Prevent Mother to Infant HIV-1 Transmission|Completed||Phase 2|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:35.624303|2017-10-11 04:29:35.624303
NCT00006076|ClinicalTrials.gov processed this data on October 10, 2017|2000-07-28|2017-06-30|||July 26, 2000||2000-07-26|June 29, 2010|2010-06-29|June 29, 2010||2010-06-29|||||Observational|||Genetic Studies of Tone Deafness|Genetic Studies of Tune Deafness|Completed||N/A|968|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:35.710969|2017-10-11 04:29:35.710969
NCT00006077|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-04|2008-03-03|||August 2000||2000-08-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Interventional|||Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease|Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:35.783602|2017-10-11 04:29:35.783602
NCT00006078|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-06-25|||June 2000||2000-06-01|December 2004|2004-12-01|January 2005|Actual|2005-01-01|||||Interventional|||Lycopene In Preventing of Prostate Cancer|Single Dose Pharmacokinetic Study of Lycopene Delivered in a Well Defined Food-Based Lycopene Delivery System (Tomato Paste-oil Mixture) in Healthy Male Volunteers Between 18 and 45 Years of Age|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:35.853671|2017-10-11 04:29:35.853671
NCT00006079|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-07-27|||June 2000||2000-06-01|July 2012|2012-07-01|April 2004|Actual|2004-04-01|February 2003|Actual|2003-02-01||Interventional|||Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia|A Randomized Double-Blind Study of Alpha-Difluromethylornithine (DFMO) Versus Placebo in Patients With Cervical Intraepithelial Neoplasia (CIN) Grade 2-3|Completed||Phase 2|150|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 04:29:35.916674|2017-10-11 04:29:35.916674
NCT00006080|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2008-11-22|||November 2000||2000-11-01|September 2005|2005-09-01||||||||Interventional|||Fenretinide in Treating Patients With Recurrent Malignant Glioma|Phase II Evaluation of Fenretinide NSC (374551) as a Single Agent in the Treatment of Adult Patients With Recurrent Malignant Glioma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:36.0108|2017-10-11 04:29:36.0108
NCT00006081|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-07-27|||June 2000||2000-06-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer|A Phase II Study of Bryostatin-1 (NSC 339555) Plus Paclitaxel in Patients With Metastatic or Unresectable Locally Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction|Completed||Phase 2|37|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:29:36.329044|2017-10-11 04:29:36.329044
NCT00006082|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-09-20|||May 2000||2000-05-01|September 2012|2012-09-01||||August 2002|Actual|2002-08-01||Interventional|||Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer|"Open Label Phase II Study on RFS 2000 (9-Nitro-Camptothecin, 9-NC) Administered as a 5 Days On - 2 Days Off Oral Treatment in Advanced Small Cell Lung Cancer"|Completed||Phase 2|38|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:29:36.418198|2017-10-11 04:29:36.418198
NCT00006083|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2015-10-01|||April 2000||2000-04-01|July 2012|2012-07-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter|A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Fragmin (5,000 IU Subcutaneously) in Preventing Catheter-Related Complications When Given Daily to Cancer Patients With Central Venous Catheters|Completed||Phase 3|||Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:29:36.484507|2017-10-11 04:29:36.484507
NCT00006207|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2008-07-29||||||June 2003|2003-06-01||||||||Interventional|||Safety and Tolerability of the Vaginal Gel PRO 2000/5|A Phase I Multicenter Dose Escalation Safety and Acceptability Study of the Investigational Vaginal Microbicide Agent PRO 2000/5 Gel (P)|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:44.557055|2017-10-11 04:29:44.557055
NCT00006084|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-12-18|||February 2001||2001-02-01|November 2001|2001-11-01||||||||Interventional|||Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia|Phase II, Open-Label Study of HuM195 (Humanized Anti-CD33 Monoclonal Antibody) Administered to Patients With Acute Myelogenous Leukemia (AML) Who Are Documented Regimen Failures (RF) of the Control Arm of Study 195-301|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:36.610054|2017-10-11 04:29:36.610054
NCT00006085|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-12-18|||June 2000||2000-06-01|December 2001|2001-12-01||||||||Interventional|||CP-609,754 in Treating Patients With Advanced Solid Tumors|Phase I Open-Label Study of the Safety, Toleration and Pharmacokinetics of CP-609,754, a Farnesyl Transferase Inhibitor, in Subjects With Advanced Malignant Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:36.700647|2017-10-11 04:29:36.700647
NCT00006086|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2010-09-08|||June 2000||2000-06-01|September 2002|2002-09-01||||February 2003|Actual|2003-02-01||Interventional|||BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer|Phase I Study of BMS-188797 in Combination With Carboplatin in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:36.770896|2017-10-11 04:29:36.770896
NCT00006087|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2009-02-06|||November 1999||1999-11-01|December 2007|2007-12-01||||||||Interventional|||Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer|A Randomized Prospective Study Comparing Annual Chest X-Rays to Annual Spiral Chest CT Scanning in Patients at High-Risk for the Development of Lung Cancer|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:36.836791|2017-10-11 04:29:36.836791
NCT00006088|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-09-19|||June 2000||2000-06-01|November 2000|2000-11-01||||||||Interventional|||Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors|A Phase I Absolute Bioavailability Study of Oral NAVELBINE (Vinorelbine Tartrate) in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:36.902934|2017-10-11 04:29:36.902934
NCT00006089|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2014-01-10|||March 2001||2001-03-01|January 2014|2014-01-01||||September 2007|Actual|2007-09-01||Interventional|||Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer|A Phase II Evaluation of Trastuzumab (MoAb HER2) in Patients With Advanced, Recurrent or Persistent Endometrial Carcinoma With or Without Prior Chemotherapy|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:36.967254|2017-10-11 04:29:36.967254
NCT00006090|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-10-05|||June 2000||2000-06-01|October 2012|2012-10-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia|Phase II Study of Arsenic Trioxide (NSC #706363) Therapy for Fludarabine Refractory or Relapsed Chronic Lymphocytic Leukemia|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||No enrollment.|f||||f||||||||||2017-10-11 04:29:37.052771|2017-10-11 04:29:37.052771
NCT00006091|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-10-05|||June 2000||2000-06-01|October 2012|2012-10-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment|Arsenic Trioxide Therapy for Interferon Alpha Refractory or Intolerant Chronic Phase Chronic Myelogenous Leukemia|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||No enrollment.|f||||f||||||||||2017-10-11 04:29:37.137053|2017-10-11 04:29:37.137053
NCT00006092|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-09-25|||August 2000||2000-08-01|September 2012|2012-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia|A Phase II Study of Arsenic Trioxide for Induction Therapy of Adult Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia and Previously Untreated Chronic Myeloid Leukemia With Blast Crisis|Terminated||Phase 2|2|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||low accrual|f||||f||||||||||2017-10-11 04:29:37.221708|2017-10-11 04:29:37.221708
NCT00006093|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-06-20|||September 2000||2000-09-01|April 2003|2003-04-01|October 2006|Actual|2006-10-01|||||Interventional|||EMD 121974 in Treating Patients With Progressive or Recurrent Glioma|A Phase I/II Trial of EMD 121974 for Treatment of Patients With Recurrent Anaplastic Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:37.31233|2017-10-11 04:29:37.31233
NCT00006094|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-01-15|||July 2000||2000-07-01|January 2013|2013-01-01||||October 2006|Actual|2006-10-01||Interventional|||Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum|A Phase I/II Study of Preoperative Oxaliplatin (NSC# 266046), 5-Fluorouracil, and External Beam Radiation Therapy in Locally Advanced Rectal Cancer|Completed||Phase 1/Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:37.417223|2017-10-11 04:29:37.417223
NCT00006095|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2014-02-20|||July 2000||2000-07-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy|A Trial of Irinotecan (NSC# 616348) Plus Vincristine in Children With Solid Tumors|Completed||Phase 1|20|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:29:37.526352|2017-10-11 04:29:37.526352
NCT00006096|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-06-07|||March 2001||2001-03-01|June 2007|2007-06-01||||January 2003|Actual|2003-01-01||Interventional|||Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva|A Randomized Study of Adjuvant Radiation Treatment Versus Radiation and Chemotherapy in Patients With Vulvar Cancer and Involved Nodes|Terminated||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:29:37.66779|2017-10-11 04:29:37.66779
NCT00006097|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2010-09-21|||August 1999||1999-08-01|May 2001|2001-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia|CC-1088 Therapy for Chronic Lymphocytic Leukemia: A Phase I/II Trial|Completed||Phase 1/Phase 2|||Boston Medical Center|||||f||||t||||||||||2017-10-11 04:29:37.815135|2017-10-11 04:29:37.815135
NCT00006098|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-06-17|||April 2000||2000-04-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||PS-341 in Treating Patients With Hematologic Cancer|A Phase I Study of PS-341 in Patients With Hematologic Malignancies|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:29:37.887401|2017-10-11 04:29:37.887401
NCT00006099|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2009-02-06|||May 2000||2000-05-01|June 2002|2002-06-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer|Pilot Trial of Humanized 3S193 Monoclonal Antibody (hu3S193) in Presurgical Patients With Ovarian Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:39.474166|2017-10-11 04:29:39.474166
NCT00006100|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-12-17|||April 2000||2000-04-01|May 2005|2005-05-01||||||||Interventional|||Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma|A Phase I Pilot Trial to Evaluate the Toxicity of Epstein-Barr Virus Specific T-Lymphocytes or Peripheral Blood Mononuclear Cells for the Treatment of Relapsed/Refractory Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:39.560189|2017-10-11 04:29:39.560189
NCT00006101|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2016-03-23|||October 1998||1998-10-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer|Randomized Placebo-Controlled, Double-Blind Phase IIb Chemoprevention Trial of Difluoromethylornithine in Brothers and First Cousin Males of Familial Prostate Cancer Probands|Completed||Phase 2|140|Actual|University of California, Irvine||2|||f||||t||||||||No||2017-10-11 04:29:39.627125|2017-10-11 04:29:39.627125
NCT00006102|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-02-04|||July 2000||2000-07-01|November 2010|2010-11-01||||June 2006|Actual|2006-06-01||Interventional|||Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma|A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors|Completed||Phase 2|200|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:39.734713|2017-10-11 04:29:39.734713
NCT00006103|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2016-07-01|||July 2000||2000-07-01|July 2016|2016-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Colorectal Cancer|Interracial Study of CPT-11 (Irinotecan) Pharmacokinetics in 5-Fluorouracil Refractory Colorectal Cancer: A Population Pharmacokinetic/Pharmacodynamic Study of CPT-11|Completed||Phase 3|400|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:29:40.51661|2017-10-11 04:29:40.51661
NCT00006104|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-08-10|||September 1998||1998-09-01|August 2012|2012-08-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer|A Multi-Institutional Phase II Pilot Trial With Weekly Docetaxel and Herceptin as First or Second Line Therapy for HER2/Neu Overexpressing Metastatic Breast Cancer|Completed||Phase 2|46|Actual|Vanderbilt-Ingram Cancer Center|||||f||||t||||||||||2017-10-11 04:29:40.604374|2017-10-11 04:29:40.604374
NCT00006105|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-09-04|||June 2000||2000-06-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|November 2004|Actual|2004-11-01||Interventional|||Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer|Phase II Trial of Adjuvant Gemcitabine Plus Cisplatin With Amifostine Cytoprotection in Patients With Locally Advanced Bladder Cancer|Completed||Phase 2|37|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:29:40.700796|2017-10-11 04:29:40.700796
NCT00006106|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-07-09|||July 1999||1999-07-01|December 2006|2006-12-01||||||||Interventional|||ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer|Phase I Study of Intraarterial ONYX-015 in Combination With Intravenous Cisplatin and Fluorouracil in Patients With Advanced Squamous Cell Cancer of the Head and Neck|Withdrawn||Phase 1|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:40.79133|2017-10-11 04:29:40.79133
NCT00006107|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2017-06-15|||July 14, 2000|Actual|2000-07-14|June 2017|2017-06-01|July 3, 2004|Actual|2004-07-03|July 17, 2003|Actual|2003-07-17||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Taxotere Plus Concurrent Concomitant Boost Radiotherapy For Squamous Cell Cancer of the Head and Neck (TAXT-XRT)|Completed||Phase 1|31|Actual|Dana-Farber Cancer Institute||1|||f||||t|t|f||||||No||2017-10-11 04:29:40.882862|2017-10-11 04:29:40.882862
NCT00006108|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-02-03|||August 1999||1999-08-01|February 2012|2012-02-01|July 2002|Actual|2002-07-01|September 2001|Actual|2001-09-01||Interventional|||Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer|A Phase II Trial of Xeloda, Every Three Week Taxol and Herceptin in Metastatic Breast Cancer|Completed||Phase 1/Phase 2|||UNC Lineberger Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:29:41.013278|2017-10-11 04:29:41.013278
NCT00006110|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2017-06-30|2017-04-05||December 1998||1998-12-01|June 2017|2017-06-01|April 2013|Actual|2013-04-01|March 2012|Actual|2012-03-01||Interventional|NRR||Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer|Nonrandomized Ph II Study of Multimodality Therapy for Stg IIB, IIIA/B, or Stg IV Breast Cancer w/4 Cycles of Adriamycin and Cytoxan (AC),Followed by 12 Weeks of Paclitaxel w/ or w/o Herceptin Followed by Local Therapy Followed by Wkly Herceptin or no Additional Therapy|Completed||Phase 2|82|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:29:41.121236|2017-10-11 04:29:41.121236
NCT00006111|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2009-02-06|||April 1999||1999-04-01|May 2002|2002-05-01||||||||Interventional|||Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract|Multicenter Study of the Quality of Life of Patients With Invasive Urothelial Cancer Treated With Conservative Surgery Followed by Cisplatin, Fluorouracil and Radiotherapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:42.093199|2017-10-11 04:29:42.093199
NCT00006112|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2011-04-23|||January 1996||1996-01-01|May 2001|2001-05-01||||||||Interventional|||Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer|Randomized Therapeutic Study Comparing Tumor Resection Followed Immediately by Intraperitoneal Chemotherapy and Systemic Chemotherapy VS Systemic Chemotherapy Alone for the Treatment of Colorectal Cancer Metastatic to the Peritoneum|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:42.19264|2017-10-11 04:29:42.19264
NCT00006113|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2014-05-20|||June 1999||1999-06-01|May 2014|2014-05-01|April 2006|Actual|2006-04-01|May 2003|Actual|2003-05-01||Interventional|||Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase II Trial of a MART-1/gp100/Tyrosinase Peptide-Pulsed Dendritic Cell Vaccine Treated With CD40 Ligand/Gamma Interferon With Subcutaneous IL-2 for Patients With Metastatic Melanoma|Terminated||Phase 2|25|Actual|University of Southern California||||Lack of efficacy|f||||t||||||||||2017-10-11 04:29:42.289659|2017-10-11 04:29:42.289659
NCT00006114|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2011-02-26|||May 1999||1999-05-01|September 2000|2000-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|First Line Treatment of Metastatic Hormone Refractory Prostate Cancer With a Combination of Novantrone-Navelbine|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:42.417553|2017-10-11 04:29:42.417553
NCT00138372|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2008-09-30||||||September 2008|2008-09-01||||||||Observational|||Human Immunity to MSP-1 in Western Kenya|Human Immunity to MSP-1 in Western Kenya|Unknown status|Not yet recruiting|N/A|445||Case Western Reserve University|||||f||||f||||||||||2017-10-11 05:14:24.546536|2017-10-11 05:14:24.546536
NCT00006115|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2009-01-10|||April 1999||1999-04-01|January 2002|2002-01-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer|Alternation of FOLFOX6 (Oxaliplatin - Leucovorin - Fluorouracil) and FOLFIRI (Irinotecan - Leucovorin - Fluorouracil) as Second Line Treatment of Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:42.541536|2017-10-11 04:29:42.541536
NCT00006116|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2008-07-23|||April 1999||1999-04-01|November 2000|2000-11-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|First Line Treatment of Stage IIIb/IV Non Small Cell (NSC) Lung Cancer With a Bimonthly Administration of a Combination of Cisplatin-Gemcitabine|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:42.717403|2017-10-11 04:29:42.717403
NCT00006117|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2009-10-29|||September 1999||1999-09-01|October 2009|2009-10-01||||||||Interventional|||Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|Phase II Study of Gemcitabine Plus Oxaliplatin in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:42.872224|2017-10-11 04:29:42.872224
NCT00006118|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2008-07-23|||July 1999||1999-07-01|November 2001|2001-11-01||||||||Interventional|||Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer|First Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma of the Bladder With a Combination of Cisplatin-Paclitaxel-Gemcitabine|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:42.99985|2017-10-11 04:29:42.99985
NCT00006119|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2008-07-23|||July 1999||1999-07-01|December 2004|2004-12-01||||||||Interventional|||Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma|Phase II Study of Hydroxyurea for the Treatment of Recurrent and/or Nonoperable Meningioma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:43.107672|2017-10-11 04:29:43.107672
NCT00006120|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2008-07-23|||May 2000||2000-05-01|March 2006|2006-03-01||||||||Interventional|||Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer|Phase II Randomized Study of Two Different Schedules of Docetaxel or Paclitaxel for Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:43.203813|2017-10-11 04:29:43.203813
NCT00006121|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-07-23|||May 2000||2000-05-01|July 2012|2012-07-01||||May 2002|Actual|2002-05-01||Interventional|||Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy|Phase II Study of Oxaliplatin Single Agent in Patients With Metastatic Breast Cancer After Failure of Anthracycline/Taxane Based Chemotherapy|Terminated||Phase 2|18|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:29:43.351525|2017-10-11 04:29:43.351525
NCT00006122|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2012-07-13|||June 2000||2000-06-01|July 2012|2012-07-01||||January 2002|Actual|2002-01-01||Interventional|||Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia|Gemtuzumab Ozogamicin (CMA-676) Followed or Not by Intensive Chemotherapy as Initial Treatment for Elderly Patients With Acute Myeloid Leukemia: An EORTC-LG Pilot Phase II Study|Completed||Phase 2|106|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:29:43.480488|2017-10-11 04:29:43.480488
NCT00006123|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2009-02-06|||July 2000||2000-07-01|December 2006|2006-12-01||||||||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer|Autotransplantation and Her 2 Neu Antibody Immunotherapy in Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:43.601691|2017-10-11 04:29:43.601691
NCT00006196|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-07|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||The Relationship Between Vitamin D, Fingernail Thickness and Bone Density||Completed||Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:43.820176|2017-10-11 04:29:43.820176
NCT00006198|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-09|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:43.88485|2017-10-11 04:29:43.88485
NCT00006199|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-09|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)||Unknown status|Recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:43.960393|2017-10-11 04:29:43.960393
NCT00006200|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-09|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Thalidomide and Dacarbazine for Metastatic Melanoma||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:44.028427|2017-10-11 04:29:44.028427
NCT00006202|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-09|2008-03-03|||September 2000||2000-09-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Lutein for Age-Related Macular Degeneration|Dose Ranging Study of Lutein Supplementation in Persons Over Age 60|Completed||Phase 2|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:44.088299|2017-10-11 04:29:44.088299
NCT00006203|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2006-10-20||||||October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||Naltrexone, Craving, and Drinking|Naltrexone, Craving, and Drinking: Ecological Assessment|Completed||Phase 4|186||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:29:44.156911|2017-10-11 04:29:44.156911
NCT00006204|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2007-12-07|||March 2000||2000-03-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)|Combined Pharmacotherapy in Depressed Alcoholics|Completed||Phase 4|106||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:29:44.211993|2017-10-11 04:29:44.211993
NCT00006205|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-03-14|||March 2005||2005-03-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Alcohol Dependency Study: Combining Medication Treatment for Alcoholism|Combining Medications Treatment for Alcoholism|Unknown status|Recruiting|Phase 2|320|Anticipated|University of Virginia||4|||f||||t||||||||||2017-10-11 04:29:44.302041|2017-10-11 04:29:44.302041
NCT00006206|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2010-04-30|||August 1997||1997-08-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||COMBINE (Acamprosate/Naltrexone)|COMBINE: Effect of Combined Pharmacotherapies and Behavioral Interventions|Completed||Phase 3|1375||University of North Carolina, Chapel Hill|||||||||||||||||||2017-10-11 04:29:44.442663|2017-10-11 04:29:44.442663
NCT00006208|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||August 2000||2000-08-01|June 2006|2006-06-01||||||||Interventional|||A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs|A Randomized, Double-Blind, Equivalence Trial Comparing Emtricitabine to Stavudine Within a Triple Drug Combination Containing Didanosine Plus Efavirenz in Antiretroviral-Drug Naive HIV-1 Infected Patients|Unknown status|Active, not recruiting|Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:29:44.642036|2017-10-11 04:29:44.642036
NCT00006209|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||June 2000||2000-06-01|June 2001|2001-06-01||||||||Interventional|||A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs|A Phase I Open-Label Dose Escalation Trial of Tucaresol in HIV-1 Infected Subjects Taking Potent Antiretroviral Therapy|Unknown status|Active, not recruiting|Phase 1|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:29:44.86847|2017-10-11 04:29:44.86847
NCT00006211|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||February 2000||2000-02-01|March 2001|2001-03-01|April 2001||2001-04-01|||||Interventional|||A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments|A Double-Blind, Randomized, Placebo-Controlled Study of Capravirine (AG1549) in Combination With VIRACEPT and Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Subjects Who Failed an Initial Nonnucleoside Reverse Transcriptase Inhibitor Containing Regimen|Completed||Phase 2|350||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:29:44.952432|2017-10-11 04:29:44.952432
NCT00006212|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-09-16|||November 1999||1999-11-01|February 2001|2001-02-01||||||||Interventional|||Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer|Phase I Study of Interstitial Colloidal 32P Integrated With External Radiation Therapy and Chemotherapy in the Treatment of Non-Resectable or Medically Inoperable Non-Small Cell Carcinoma of the Lung|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:45.036212|2017-10-11 04:29:45.036212
NCT00006213|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01||||October 2002|Actual|2002-10-01||Interventional|||BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia|Phase I Study of Farnesyl Transferase Inhibitor BMS-214662 (NSC 710086) in Acute Leukemias, Myelodysplastic Syndromes (RAEB and RAEB-T) and Chronic Myeloid Leukemia in Blast Phase|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:45.111414|2017-10-11 04:29:45.111414
NCT00006214|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2016-07-12|||August 2000||2000-08-01|July 2016|2016-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate|Short-Term Chemoprevention Trial in Men With Prostatic Intraepithelial Neoplasia Using Flutamide as an Androgen Deprivation Agent|Completed||Phase 2|63|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:29:45.209597|2017-10-11 04:29:45.209597
NCT00006215|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-12-18|||October 1999||1999-10-01|December 2001|2001-12-01||||||||Interventional|||Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of Docetaxel and Vinorelbine in Advanced Non-Small Cell Lung Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:45.348983|2017-10-11 04:29:45.348983
NCT00006216|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-09-19|||August 1997||1997-08-01|July 2001|2001-07-01||||||||Interventional|||Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma|Treatment of Malignant Pleural Mesothelioma With Gene Modified Cancer Cell Lines|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:45.463154|2017-10-11 04:29:45.463154
NCT00006218|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-07-17|||May 2000||2000-05-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||3-AP in Treating Patients With Advanced Cancer|A Phase I Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) in Cancer Patients Using a 96-Hour Intravenous Continuous Infusion|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:45.542756|2017-10-11 04:29:45.542756
NCT00006219|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2011-08-02|||August 2000||2000-08-01|August 2011|2011-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma|A Phase II Clinical Trial of Dehydroepiandrosterone and Biaxin in Monoclonal Gammopathy of Undetermined and Borderline Significance|Completed||Phase 2|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:29:45.60697|2017-10-11 04:29:45.60697
NCT00006220|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-02-04|||June 1999||1999-06-01|February 2013|2013-02-01|February 2002|Actual|2002-02-01|November 2000|Actual|2000-11-01||Interventional|||Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy|Arsenic Trioxide Alone or With ATRA (Vesanoid) for Resistant Hematologic Malignancy|Terminated||Phase 1/Phase 2|5|Actual|Washington University School of Medicine||3||Study drug became commercially available.|f||||||||||||||2017-10-11 04:29:45.691498|2017-10-11 04:29:45.691498
NCT00006221|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-02-08|||November 2000||2000-11-01|July 2004|2004-07-01||||June 2005|Actual|2005-06-01||Interventional|||BMS-247550 in Treating Patients With Advanced Cancers|A Phase I Study of BMS-247550 (NSC 710428) Given Weekly X 3 Every 4 Weeks in Patients With Advanced Malignancies|Completed||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:45.801019|2017-10-11 04:29:45.801019
NCT00006222|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-05-31|||September 2000||2000-09-01|April 2001|2001-04-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma|A Phase I Trial of EMD 121974 in Patients With HIV Related Kaposi's Sarcoma|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:29:45.901593|2017-10-11 04:29:45.901593
NCT00006223|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-06-20|||July 2000||2000-07-01|September 2006|2006-09-01|January 2007|Actual|2007-01-01|||||Interventional|||flt3L in Treating Patients With Acute Myeloid Leukemia|A Phase III Study of Flt3 Ligand (Flt3L) Therapy in Acute Myeloid Leukemia (AML) Patients in Remission|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:46.009652|2017-10-11 04:29:46.009652
NCT00006224|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-04-10|||September 2000||2000-09-01|June 2005|2005-06-01||||April 2005|Actual|2005-04-01||Interventional|||Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix|Evaluation of Gemcitabine in Persistent or Recurrent Non-Squamous Cell Carcinoma of the Cervix|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:29:46.224604|2017-10-11 04:29:46.224604
NCT00006271|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||January 1997||1997-01-01|December 2003|2003-12-01||||||||Observational|||Phase I/II Study of Neuroendocrine Dysfunction in Patients With Closed Head Injuries||Unknown status|Active, not recruiting|N/A|100||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:55.444156|2017-10-11 04:29:55.444156
NCT00006225|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2012-05-31||2011-02-18|November 1999||1999-11-01|May 2012|2012-05-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer|Ex Vivo Expanded Megakaryocytes for Supportive Care of Breast Cancer Patients: A Phase I/II Study|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||||||||||||2017-10-11 04:29:46.548101|2017-10-11 04:29:46.548101
NCT00006226|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-10-07|||September 2000||2000-09-01|October 2013|2013-10-01||||December 2007|Actual|2007-12-01||Interventional|||Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia|A Phase II Trial of Thalidomide in Patients With Relapsed Chronic Lymphocytic Leukemia|Completed||Phase 2|41|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:46.679805|2017-10-11 04:29:46.679805
NCT00006227|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2017-08-23|||November 20, 2000|Actual|2000-11-20|August 2017|2017-08-01|July 16, 2016|Actual|2016-07-16|July 16, 2016|Actual|2016-07-16||Interventional|||Paclitaxel in Treating Patients With Ovarian Stromal Cancer|Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy|Completed||Phase 2|31|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:29:46.801601|2017-10-11 04:29:46.801601
NCT00006228|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-10-07|||July 2000||2000-07-01|October 2013|2013-10-01||||July 2003|Actual|2003-07-01||Interventional|||Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer|Phase II Trial of Anti-HER-2 Monoclonal Antibody Trastuzumab (Herceptin) in Combination With Low Dose Interleukin-2 (Proleukin) in Metastatic Breast Cancer Patients Who Have Previously Failed Trastuzumab|Completed||Phase 2|37|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:47.148155|2017-10-11 04:29:47.148155
NCT00006229|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-11-11|||April 2000||2000-04-01|August 2011|2011-08-01|February 2009|Actual|2009-02-01|December 2003|Actual|2003-12-01||Interventional|||Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer|A Phase II/III Double Blind Randomized Trial of BMS-275291 vs. Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-small Cell Lung Cancer|Completed||Phase 2/Phase 3|774|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:29:47.281661|2017-10-11 04:29:47.281661
NCT00006230|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2012-09-20|||May 2000||2000-05-01|September 2012|2012-09-01||||April 2003|Actual|2003-04-01||Interventional|||Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer|"Open Label Phase II Study on RFS 2000 (9-Nitro-camptothecin, 9-NC) Administered as a 5 Days On-2 Days Off Oral Treatment in Advanced Ovarian Cancer"|Completed||Phase 2|51|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:29:47.567388|2017-10-11 04:29:47.567388
NCT00006231|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-12-18|||February 1998||1998-02-01|October 2000|2000-10-01|December 2002|Actual|2002-12-01|||||Interventional|||Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma|A Randomized Study to Assess Whether Radiotherapy Prevents Skin Lumps at Sites Where Needles or Tubes Have Been Inserted in Patients With Malignant Mesothelioma|Completed||Phase 3|44|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:47.664836|2017-10-11 04:29:47.664836
NCT00006232|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-05-14|||October 1996||1996-10-01|March 2007|2007-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma|A Randomized Trial Comparing Z-Dex With VAD as Induction Therapy for Patients With Multiple Myeloma|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:47.75838|2017-10-11 04:29:47.75838
NCT00006233|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2011-11-28|||January 2000||2000-01-01|November 2011|2011-11-01|December 2003|Actual|2003-12-01|||||Interventional|||Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma|Phase II Trial of Non-Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation Using Fludarabine, Low-Dose TBI, and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil (MMF) Followed by Donor Lymphocyte Infusion in Selected Patients With Metastatic Melanoma|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:29:47.868314|2017-10-11 04:29:47.868314
NCT00006234|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2011-11-30|||November 2001||2001-11-01|November 2011|2011-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone|A Phase I/II Study of 166Ho-DOTMP With Peripheral Blood Progenitor Cell Support for Refractory or Recurrent Ewing's Sarcoma Family of Tumors With Bone Disease|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:29:47.950698|2017-10-11 04:29:47.950698
NCT00006235|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-07-08||||||February 2006|2006-02-01||||February 2006|Actual|2006-02-01||Interventional|||Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase I Trial of Combination Carboplatin and Lipsomal Doxorubicin (Doxil) In Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Completed||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:29:48.019227|2017-10-11 04:29:48.019227
NCT00006237|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2015-03-05|2012-08-20||August 2000||2000-08-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma|Phase III Trial of High Dose Interferon Alfa 2-b Versus Cisplatin, Vinblastine, DTIC Plus IL-2 and Interferon in Patients With High Risk Melanoma|Completed||Phase 3|432|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:29:48.193833|2017-10-11 04:29:48.193833
NCT00006239|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2017-09-27|||December 2000||2000-12-01|September 2017|2017-09-01|March 2005|Actual|2005-03-01|February 2005|Actual|2005-02-01||Interventional|||Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer|A Phase I, Dose-Finding Trial of Sodium Phenylbutrate (NSC 657802) in Combination With All Trans-retinoic Acid (ATRA, NSC 122758) in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:29:49.888778|2017-10-11 04:29:49.888778
NCT00006240|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2015-04-27|||October 2000||2000-10-01|November 2002|2002-11-01|August 2001|Actual|2001-08-01|||||Interventional|||Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia|A Pilot Study of Phenylbutyrate, Dexamethasone and GM-CSF in Refractory or Relapsed t(8;21) Acute Myeloid Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:49.966179|2017-10-11 04:29:49.966179
NCT00013130|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|February 2001|Actual|2001-02-01|||||Interventional|||Ambulatory Care Quality Improvement (ACQUIP)|Ambulatory Care Quality Improvement (ACQUIP)|Completed||Phase 2|62487|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:18.7628|2017-10-11 04:30:18.7628
NCT00006241|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2011-11-28|||March 2000||2000-03-01|November 2011|2011-11-01|October 2000|Actual|2000-10-01|||||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma|A Pivotal Study to Determine the Safety and Efficacy of Using B-Cell High Density Microparticles (BCell-HDM) to Deplete B-Cells From Peripheral Blood Stem Cell Collections Without Compromising the Time to Neutrophil and Platelet Engraftment in Patients With Relapsed Low or Intermediate Grade B-Cell Non-Hodgkin's Lymphoma Given Autologous Peripheral Blood Stem Cell Transplants After High-Dose Chemotherapy|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:29:50.04492|2017-10-11 04:29:50.04492
NCT00006242|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-01-31|||July 2000||2000-07-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||BMS-214662 in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Farnesyltransferase Inhibitor BMS-214662 (NSC 710086) Escalating to a 24 Hour Continuous Intravenous Infusion in Patients With Solid Tumors|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:29:50.121493|2017-10-11 04:29:50.121493
NCT00006243|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-01-24|||October 2000||2000-10-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma|Melanoma Vaccines: Differentiation Antigen Peptides (MART-1:27-35, Tyrosinase and Gp-100) as Immune Targets|Completed||N/A|30|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:29:50.205343|2017-10-11 04:29:50.205343
NCT00006244|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2017-06-16|2017-04-12||February 2000||2000-02-01|June 2017|2017-06-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma|Immunotherapy for Autologous/Syngeneic Peripheral Blood Stem Cell (PBSC) Transplant Patients as Treatment for Advanced Multiple Myeloma|Completed||Phase 2|36|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 04:29:50.319263|2017-10-11 04:29:50.319263
NCT00006245|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-06-20|||July 2000||2000-07-01|April 2004|2004-04-01|August 2007|Actual|2007-08-01|||||Interventional|||Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel|Phase II Trial of Flavopiridol and Paclitaxel in Patients With Paclitaxel-Refractory Esophageal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:50.641908|2017-10-11 04:29:50.641908
NCT00006246|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2009-10-06|||November 2000||2000-11-01|October 2009|2009-10-01||||May 2003|Actual|2003-05-01||Interventional|||Busulfan in Treating Children and Adolescents With Refractory CNS Cancer|Phase I Study of Intrathecal Spartaject-Busulfan in Children With Neoplastic Meningitis|Completed||Phase 1|28|Actual|Pediatric Brain Tumor Consortium|||||||||t||||||||||2017-10-11 04:29:50.713279|2017-10-11 04:29:50.713279
NCT00006247|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2009-10-13|||August 2000||2000-08-01|October 2009|2009-10-01|March 2006|Actual|2006-03-01|July 2003|Actual|2003-07-01||Interventional|||SU5416 in Treating Children With Recurrent or Progressive Brain Tumors|A Phase I Study of SU5416 in Pediatric Patients With Recurrent or Progressive Poor Prognosis Brain Tumors|Terminated||Phase 1|33|Actual|Pediatric Brain Tumor Consortium||||The pharmaceutical company discontinued further development of SU5416.|f||||t||||||||||2017-10-11 04:29:50.862083|2017-10-11 04:29:50.862083
NCT00006248|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-04-08|||November 2000||2000-11-01|April 2013|2013-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Evaluation of Three Hour Infusion of Paclitaxel Plus Cisplatin and 5-Fluorouracil in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|78|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:29:50.973788|2017-10-11 04:29:50.973788
NCT00006249|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2015-02-09|||June 2000||2000-06-01|February 2015|2015-02-01||||August 2003|Actual|2003-08-01||Interventional|||Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma|PEG-Intron Observation After Regional Lymph Node Dissection in AJCC Stage III (TxN1-2MO) Melanoma Patients: a Randomized Phase III Trial|Unknown status|Active, not recruiting|Phase 3|1258|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 04:29:51.226267|2017-10-11 04:29:51.226267
NCT00006250|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-09-19|||May 2000||2000-05-01|March 2007|2007-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma|Randomized Trial of MCD Versus FMD in Untreated Advanced Follicular Lymphoma|Unknown status|Active, not recruiting|Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:52.882282|2017-10-11 04:29:52.882282
NCT00006251|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2017-08-09|||May 2000||2000-05-01|August 2017|2017-08-01||||September 2005|Actual|2005-09-01||Interventional|||Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer|Induction of Mixed Hematopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Active, not recruiting||Phase 1/Phase 2|21|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:29:53.195843|2017-10-11 04:29:53.195843
NCT00006252|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2016-07-15|||February 2001||2001-02-01|July 2016|2016-07-01|October 2011|Actual|2011-10-01|January 2007|Actual|2007-01-01||Interventional|||Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma|Minimal Ablation and Cellular Immune Therapy of Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Low-Grade Non-Hodgkin's Lymphoma, and Mantle Cell Lymphoma With Allogeneic Donor Stem Cells|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:29:53.381923|2017-10-11 04:29:53.381923
NCT00006253|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2011-12-06|||March 2003||2003-03-01|December 2011|2011-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Pain and Fatigue Study|Family Home Care for Cancer - A Community-Based Model|Completed||N/A|350|Actual|Michigan State University||2|||f||||f||||||||||2017-10-11 04:29:53.583328|2017-10-11 04:29:53.583328
NCT00006254|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-07-17|||May 2000||2000-05-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||VNP20009 in Treating Patients With Advanced Solid Tumors|A Phase I Trial of a Live, Genetically Modified Salmonella Typhimurium (VNP20009) for the Treatment of Cancer by Intravenous Administration|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:53.665477|2017-10-11 04:29:53.665477
NCT00006272|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||August 1994||1994-08-01|December 2003|2003-12-01||||||||Observational|||Study of Energy Expenditure in Infants With Ventricular Septal Defects|Study of Energy Expenditure in Infants With Ventricular Septal Defects|Unknown status|Recruiting|N/A|20||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:55.513421|2017-10-11 04:29:55.513421
NCT00006255|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2010-06-09|||April 2000||2000-04-01|June 2010|2010-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases|A Phase II Study of Magnetic Resonance Guided and Monitored Interstitial Thermal Radiofrequency Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases|Completed||Phase 2|17|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:29:53.725707|2017-10-11 04:29:53.725707
NCT00006256|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2016-09-15|||June 2000||2000-06-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|November 2005|Actual|2005-11-01||Interventional|||Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer|Concurrent Taxol (Paclitaxel) and Definitive Breast Radiation Therapy in Early Stage Breast Cancer Following Four Cycles of Adriamycin/Cytoxan Chemotherapy|Active, not recruiting||Phase 2|44|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:29:53.798745|2017-10-11 04:29:53.798745
NCT00006257|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2010-01-11|||November 2000||2000-11-01|January 2010|2010-01-01||||||||Interventional|||SU5416 and Paclitaxel in Treating Patients With Advanced Cancer|Phase I Trial of SU5416 in Combination With Weekly Paclitaxel in Patients With Advanced Malignancies|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:29:53.902668|2017-10-11 04:29:53.902668
NCT00006258|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-07-17|||November 1997||1997-11-01|December 2004|2004-12-01|January 2005|Actual|2005-01-01|||||Interventional|||Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma|Dose Intensive Chemotherapy for Patients Greater Than or Equal To 10 Years of Age With Newly Diagnosed High Stage Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumors (PNET) and Ependymoma: A Feasibility Study of an Intensive Induction Chemotherapy Regimen Followed by Standard Irradiation|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:53.979919|2017-10-11 04:29:53.979919
NCT00006259|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2010-06-09|||January 2000||2000-01-01|June 2010|2010-06-01|February 2005|Actual|2005-02-01|November 2001|Actual|2001-11-01||Interventional|||Stereotactic Radiation Therapy in Treating Patients With Brain Metastases|A Phase II Trial of Radiosurgery Alone for Brain Metastases in Elderly Patients or Patients With Poor Performance Status|Completed||Phase 2|10|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:29:54.062222|2017-10-11 04:29:54.062222
NCT00006260|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2010-06-09|||May 1997||1997-05-01|June 2010|2010-06-01||||January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer|A Phase II Study Of An OutPatient Three Day VIP Regimen With Oral Mesna For Metastatic Breast Cancer|Completed||Phase 2|36|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:29:54.144848|2017-10-11 04:29:54.144848
NCT00006261|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2010-06-09|||May 2000||2000-05-01|June 2010|2010-06-01||||||||Interventional|||Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer|Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:29:54.236114|2017-10-11 04:29:54.236114
NCT00006262|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2012-06-07||2011-02-16|July 2000||2000-07-01|June 2012|2012-06-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer|A Phase 2 Study of BMY-27557-14 (a Rebeccamycin Analog) in Patients With Ovarian Cancer|Terminated||Phase 2|||Northwestern University||||Unable to accrue patients to the study.|f||||t||||||||||2017-10-11 04:29:54.322744|2017-10-11 04:29:54.322744
NCT00006263|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2015-08-03|||November 1997||1997-11-01|August 2015|2015-08-01||||||||Interventional|||Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma|Phase II Trial of Temozolomide, Carboplatin and Neupogen in High-Grade Gliomas, Both Newly-Diagnosed and Recurrent|Withdrawn||Phase 2|0|Actual|New York University School of Medicine|||||f||||||||||||||2017-10-11 04:29:54.439684|2017-10-11 04:29:54.439684
NCT00006264|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2016-02-01|||July 2000||2000-07-01|February 2016|2016-02-01|July 2003|Actual|2003-07-01|March 2003|Actual|2003-03-01||Interventional|||Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma|A Phase II Trial Of Induction Therapy With Zidovudine, Interleukin-2, And Ganciclovir In The Treatment Of HIV Positive Primary Central Nervous System Lymphoma|Completed||Phase 2|||AIDS Malignancy Consortium|||||f||||||||||||||2017-10-11 04:29:54.617847|2017-10-11 04:29:54.617847
NCT00006265|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2016-07-12|||March 2001||2001-03-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|December 2004|Actual|2004-12-01||Interventional|||Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Dose Escalation And Phase II Study Of Gemtuzumab Ozogamicin (CMA-676; Mylotarg) With High-Dose Cytarabine For Patients With Refractory Or Relapsed Acute Myeloid Leukemia (AML)|Completed||Phase 2|60|Actual|Alliance for Clinical Trials in Oncology||4|||f||||f||||||||||2017-10-11 04:29:54.719918|2017-10-11 04:29:54.719918
NCT00006267|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-07-08||||||May 2004|2004-05-01||||May 2006|Actual|2006-05-01||Interventional|||Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation Of 9-Nitro-Camptothecin In The Third-Line Treatment Of Recurrent Ovarian Or Primary Peritoneal Cancer|Withdrawn||Phase 2|0|Actual|Gynecologic Oncology Group||||Never activated.|f||||||||||||||2017-10-11 04:29:55.009545|2017-10-11 04:29:55.009545
NCT00006268|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2013-06-20|||October 2000||2000-10-01|March 2005|2005-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Immunotoxin Therapy in Treating Patients With Malignant Glioma|Interstitial Infusion of IL 13-PE38QQR Cytotoxin in Recurrent Malignant Glioma: Phase I/II Study|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:29:55.102729|2017-10-11 04:29:55.102729
NCT00006269|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2012-05-24|||December 1999||1999-12-01|May 2012|2012-05-01||||December 1999|Actual|1999-12-01||Interventional|||Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer|A Prospective, Randomized Trial of Sandostatin LAR Depot for the Prevention of Irinotecan-Induced Diarrhea in Patients With Metastatic Colorectal Cancer|Terminated||Phase 3|89|Actual|Novartis|||||f||||||||||||||2017-10-11 04:29:55.221695|2017-10-11 04:29:55.221695
NCT00006270|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||February 1998||1998-02-01|December 2003|2003-12-01||||||||Observational|||Study of the Approximate Entropy of Adrenocorticotropic Hormone and Cortisol Secretion in Patients With Head Injury||Unknown status|Active, not recruiting|N/A|32||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:55.344429|2017-10-11 04:29:55.344429
NCT00006273|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||June 1996||1996-06-01|December 2003|2003-12-01||||||||Observational|||Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis|Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis|Unknown status|Active, not recruiting|N/A|60||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:55.587263|2017-10-11 04:29:55.587263
NCT00006274|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||March 1997||1997-03-01|December 2003|2003-12-01||||||||Observational|||Study of Energy Requirements in Critically Ill Newborns|Study of Energy Requirements in Critically Ill Newborns|Unknown status|Recruiting|N/A|60||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:29:55.655697|2017-10-11 04:29:55.655697
NCT00006275|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2005-06-23|||July 2000||2000-07-01|September 2000|2000-09-01|July 2000||2000-07-01|||||Interventional|||Study of Topical Calcitriol in Children With Psoriasis||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:29:55.72915|2017-10-11 04:29:55.72915
NCT00006276|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-14|2008-03-03|||September 2000||2000-09-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Micellar Paclitaxel to Treat Severe Psoriasis|A Pilot Open-Label Single-Dose Study Using Intravenous Micellar Paclitaxel for Patients With Severe Psoriasis|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:55.802527|2017-10-11 04:29:55.802527
NCT00006278|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-14|2008-03-03|||September 2000||2000-09-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Observational|||Study of Cushing's Syndrome Not Related to ACTH Production|The Molecular and Cellular Etiology of ACTH-Independent Adrenal Disease|Completed||N/A|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:55.881996|2017-10-11 04:29:55.881996
NCT00006279|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-14|2012-02-13||||||February 2012|2012-02-01|May 2005|Actual|2005-05-01|||||Interventional|||The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months|Phase I/II Study to Assess the Safety and Plasma Concentrations of Nevirapine Given Daily, Twice a Week or Weekly as Prophylaxis in Breastfeeding Infants From Birth to 6 Months|Completed||Phase 1|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:55.953963|2017-10-11 04:29:55.953963
NCT00006280|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-11|2010-03-01|||February 2000||2000-02-01|March 2010|2010-03-01|February 2002||2002-02-01|||||Interventional|||A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis|A Phase II Multicenter Randomized Trial of Tobramycin for Inhalation in Young Children With Cystic Fibrosis|Completed||Phase 2|98||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:29:56.040751|2017-10-11 04:29:56.040751
NCT00006285|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-16|2017-06-30|||September 14, 2000||2000-09-14|June 8, 2009|2009-06-08|April 1, 2002|Actual|2002-04-01|April 1, 2002|Actual|2002-04-01||Observational|||Use of Transcranial Magnetic Stimulation (TMS) and Magnetic Resonance Imaging (MRI) to Study Visual Attention|Transcranial Magnetic Stimulation Studies of Visual Attention|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:56.131398|2017-10-11 04:29:56.131398
NCT00006286|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-14|2014-04-16|||September 1998||1998-09-01|November 2005|2005-11-01|March 2004||2004-03-01|||||Interventional|||Treatment for Adolescents With Depression Study (TADS)|Treatment for Adolescents With Depression Study (TADS)|Completed||Phase 3|432||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:29:56.195852|2017-10-11 04:29:56.195852
NCT00006289|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-21|2017-08-21|2013-06-04||September 2000||2000-09-01|August 2017|2017-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Clinical evaluation includes blood chemistries (acute care, hepatic panel, and mineral panel) as well as measurements of pain (including allodynia, hyperalgesia, and hyperpathia), edema, autonomic dysfunction (altered skin color, temperature, or sudomotor activity) and extent of movement disorders.|Neurotropin to Treat Chronic Neuropathic Pain|Neurotropin for Acute Dental Pain and for Chronic Neuropathic Pain|Terminated||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)|Because of the difficulty in patient recruitment, the interim analysis was performed for the first 16 patients (target was 30). The results are inconclusive due to large variations in pain scores associated with insufficient the number of patients.|2||difficulty in the recruitment of patients|f||||f||||||||||2017-10-11 04:29:56.321713|2017-10-11 04:29:56.321713
NCT00006290|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-21|2008-09-24||||||June 2003|2003-06-01||||||||Observational|||Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs|Perceived Changes in Body Habitus and Body Image Among HIV+ Persons Currently Receiving or Recently Discontinuing Combination Antiretroviral Therapy|Completed||N/A|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:56.82467|2017-10-11 04:29:56.82467
NCT00006291|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-22|2012-05-17||||||May 2012|2012-05-01|October 2005|Actual|2005-10-01|||||Interventional|||Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination|A Phase II, Randomized, Partially Blinded Trial of Combinations of Potent Antiretroviral Therapy, HIV-Specific Immunizations, and Cycles of Interleukin-2 to Promote Efficient Control of Viral Replication|Completed||Phase 2|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:29:56.902147|2017-10-11 04:29:56.902147
NCT00006292|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-23|2008-03-03|||September 2000||2000-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Infliximab for the Treatment of Early Rheumatoid Arthritis|Randomized Double Blind Active Treatment Controlled Trial of the Anti-TNF-Alpha Antibody Infliximab in Patients With Erosive Rheumatoid Arthritis|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:57.044509|2017-10-11 04:29:57.044509
NCT00006294|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-25|2014-03-14|||September 1999||1999-09-01|March 2014|2014-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||GenHAT--Genetics of Hypertension Associated Treatments||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:29:57.117992|2017-10-11 04:29:57.117992
NCT00006295|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-25|2016-08-19|||August 2000||2000-08-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Molecular & Clinical Evaluation of Low HDL Syndromes||Completed||N/A|370|Anticipated|University of Maryland|||12||f||||||||||||||2017-10-11 04:29:57.183494|2017-10-11 04:29:57.183494
NCT00006296|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-25|2016-02-17|||September 2000||2000-09-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||CV Risk Factors at Age 25-64 & Long-Term Medicare Costs||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:57.282267|2017-10-11 04:29:57.282267
NCT00006297|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-25|2016-02-17|||September 2000||2000-09-01|October 2005|2005-10-01|July 2005|Actual|2005-07-01|||||Observational|||Risk Factors for CV Disease in a Dialysis Cohort||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:57.341583|2017-10-11 04:29:57.341583
NCT00006298|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-26|2008-09-24||||||July 2004|2004-07-01||||||||Observational|||Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa|Virological and Immunological Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa|Completed||N/A|125||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:57.416917|2017-10-11 04:29:57.416917
NCT00006299|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-27|2008-03-03|||December 1999||1999-12-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Celebrex for Pain Relief After Oral Surgery|In Vivo Selectivity of Cyclooxygenase Inhibitors in the Oral Surgery Model|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:57.50072|2017-10-11 04:29:57.50072
NCT00006300|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-27|2008-03-03|||April 2000||2000-04-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Observational|||Oral Manifestations of Aplastic Anemia|Oral Manifestations of Aplastic Anemia|Completed||N/A|146||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:57.581319|2017-10-11 04:29:57.581319
NCT00006301|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-27|2017-10-05|||September 24, 2000||2000-09-24|March 24, 2015|2015-03-24|March 24, 2015||2015-03-24|||||Observational|||Immune Response to Hepatitis C Virus|Evaluation of the Immune Response in Humans After Exposure to Hepatitis C Virus|Completed||N/A|46|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:29:57.653909|2017-10-11 04:29:57.653909
NCT00006304|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-27|2013-10-04||||||October 2013|2013-10-01|May 2002|Actual|2002-05-01|||||Observational|||Long-Term Effects of HIV Exposure and Infection in Children|Pediatric Late Outcomes Protocol|Completed||N/A|4150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:57.781691|2017-10-11 04:29:57.781691
NCT00006305|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-01-12|2011-01-27||September 2000||2000-09-01|January 2016|2016-01-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|BARI2D||Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes|Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes|Completed||Phase 3|2368|Actual|University of Pittsburgh||4|||f||||t||||||||||2017-10-11 04:29:58.245138|2017-10-11 04:29:58.245138
NCT00006306|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-02-26|||September 1999||1999-09-01|January 2006|2006-01-01|August 2004|Actual|2004-08-01|||||Observational|||Effects of Chronic Ozone Exposure on Lung Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:59.17711|2017-10-11 04:29:59.17711
NCT00006307|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-02-17|||August 2000||2000-08-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Epidemiology of Body Mass Index Rebound||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:59.248145|2017-10-11 04:29:59.248145
NCT00006308|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2014-05-07|||September 1999||1999-09-01|May 2014|2014-05-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Observational|||Observational Cohort Study of Sodium, Weight and Cardiovascular Disease|Observational Cohort Study of Sodium, Weight and Cardiovascular Disease|Completed||N/A|||Brigham and Women's Hospital|||||f||||f||||||||||2017-10-11 04:29:59.31894|2017-10-11 04:29:59.31894
NCT00006309|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-02-17|||September 1999||1999-09-01|December 2004|2004-12-01|August 2002|Actual|2002-08-01|||||Observational|||Pooling of Cohort Studies on Diet & Coronary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:59.387362|2017-10-11 04:29:59.387362
NCT00006310|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-03-08|||April 1999||1999-04-01|March 2016|2016-03-01|March 2004||2004-03-01|||||Observational|||KSHV Infection in Blood Donors From Texas|KSHV Seroprevalence in Hospital Patients From San Antonio|Completed||N/A|||The University of Texas Health Science Center at San Antonio|||||f||||f||||||||No||2017-10-11 04:29:59.45474|2017-10-11 04:29:59.45474
NCT00006311|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-02-17|||June 1999||1999-06-01|January 2006|2006-01-01|May 2004|Actual|2004-05-01|||||Observational|||Anxiety and Vagal Control of the Heart in Coronary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:59.537428|2017-10-11 04:29:59.537428
NCT00006312|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-01-14|||July 1999||1999-07-01|January 2016|2016-01-01|May 2003||2003-05-01|||||Observational|||Hemochromatosis--Genetic Prevalence and Penetrance||Completed||N/A|||University of Rochester|||||f||||||||||||||2017-10-11 04:29:59.629664|2017-10-11 04:29:59.629664
NCT00006313|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-05-12|||June 1999||1999-06-01|September 2002|2002-09-01|June 2000|Actual|2000-06-01|||||Observational|||Hormone Therapy Effects on CVD Risk Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:59.713503|2017-10-11 04:29:59.713503
NCT00006314|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-05-12|||July 1999||1999-07-01|January 2006|2006-01-01|June 2004|Actual|2004-06-01|||||Observational|||Cytomegalovirus Spread and Reactivation in Blood Cells||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:59.797732|2017-10-11 04:29:59.797732
NCT00006315|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2016-05-12|||September 1999||1999-09-01|May 2005|2005-05-01|August 2004|Actual|2004-08-01|||||Observational|||Dose/Response of Exercise on Long Term Weight Loss||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:29:59.883558|2017-10-11 04:29:59.883558
NCT00006316|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-28|2008-07-30||||||February 2004|2004-02-01||||||||Observational|||Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs|Discontinuation of Antifungal Therapy for Histoplasmosis Following Immunologic Response to Antiretroviral Therapy|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:29:59.964896|2017-10-11 04:29:59.964896
NCT00006318|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-30|2008-03-03|||September 2000||2000-09-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||Role of Prostaglandins in the Regulation of Brain Blood Flow|Role of Prostaglandins in the Control of Cerebral Blood Flow During Hypercapnia and Functional Activation in Humans|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:00.09479|2017-10-11 04:30:00.09479
NCT00006319|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-30|2017-10-05|||September 24, 2000||2000-09-24|June 6, 2017|2017-06-06||||||||Observational|||Molecular and Clinical Studies of Primary Immunodeficiency Diseases|Molecular and Clinical Studies of Primary Immunodeficiency Diseases|Enrolling by invitation||N/A|256|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:00.182249|2017-10-11 04:30:00.182249
NCT00006320|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-30|2008-03-03|||September 2000||2000-09-01|July 2004|2004-07-01|July 2004||2004-07-01|||||Interventional|||Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women|Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:00.304064|2017-10-11 04:30:00.304064
NCT00006321|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-02|2017-04-06|||September 1999|Actual|1999-09-01|April 2017|2017-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Neurocognitive Function in Snoring Children||Terminated||N/A|40|Actual|University of Louisville|||1|PI left the university|f|||||f|f||||||Undecided||2017-10-11 04:30:00.637743|2017-10-11 04:30:00.637743
NCT00006324|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-02|2008-08-06|||December 1999||1999-12-01|November 2006|2006-11-01|December 2002||2002-12-01|||||Interventional|||Hormonal Birth Control and the Risk of Acquiring HIV|Hormonal Contraception and the Risk of HIV Acquisition|Completed||N/A|6360||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:00.882431|2017-10-11 04:30:00.882431
NCT00006325|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-02|2012-05-18||||||May 2012|2012-05-01|March 2004|Actual|2004-03-01|||||Interventional|||Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children|Safety, Tolerability, Antiviral Activity, and Pharmacokinetics of PEG-Intron in HIV-1 Infected Children|Completed||Phase 1|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:30:00.999339|2017-10-11 04:30:00.999339
NCT00006326|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-02|2005-06-23|||August 2000||2000-08-01|July 2002|2002-07-01||||||||Interventional|||Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir|A Randomized, Open-Label Study to Evaluate 3 Salvage Regimens in HIV-Infected Subjects Experiencing Virologic Failure on an Initial HAART Regimen Containing Nelfinavir|Terminated||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:30:01.125644|2017-10-11 04:30:01.125644
NCT00006327|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-02|2005-06-23|||March 1999||1999-03-01|June 2003|2003-06-01|August 2000||2000-08-01|||||Interventional|||Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand|A Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand|Completed||Phase 3|2500||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:30:01.212837|2017-10-11 04:30:01.212837
NCT00006328|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:01.294668|2017-10-11 04:30:01.294668
NCT00006329|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Comparison of Two Methods of Parathyroidectomy for Primary Hyperparathyroidism||Completed||Phase 2/Phase 3|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:01.382436|2017-10-11 04:30:01.382436
NCT00006330|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:01.458491|2017-10-11 04:30:01.458491
NCT00006331|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2005-06-27||||||December 2003|2003-12-01||||||||Observational|||Prospective Controlled Study of Posttransplant Diabetes||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:01.545337|2017-10-11 04:30:01.545337
NCT00006332|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate||Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:01.620261|2017-10-11 04:30:01.620261
NCT00006333|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2017-10-05|||September 26, 2000||2000-09-26|September 26, 2017|2017-09-26||||||||Observational|||Study of Arthritis and Related Conditions|Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:01.714682|2017-10-11 04:30:01.714682
NCT00006334|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2017-10-05|||September 26, 2000||2000-09-26|July 8, 2014|2014-07-08|July 8, 2014||2014-07-08|||||Observational|||Turner Syndrome: Genotype and Phenotype|Turner Syndrome: Genotype and Phenotype|Completed||N/A|1017|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:01.828858|2017-10-11 04:30:01.828858
NCT00006335|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2017-06-30|||September 26, 2000||2000-09-26|September 23, 2009|2009-09-23||||September 25, 2008|Actual|2008-09-25||Observational|||Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID|Decisions of Female Adolescents About Carrier Testing in Families With X-Linked Severe Combined Immunodeficiency (XSCID)|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:01.936835|2017-10-11 04:30:01.936835
NCT00006336|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2008-03-03|||September 2000||2000-09-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Sensory Training to Treat Focal Dystonia|Sensory Training for Treatment of Focal Dystonia|Completed||N/A|22||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:02.063007|2017-10-11 04:30:02.063007
NCT00006337|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2008-03-03|||October 2000||2000-10-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||KW-6002 to Treat Parkinson's Disease|Adenosine A2A Blockade With KW-6002 in Parkinson's Disease|Completed||Phase 2|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:02.19275|2017-10-11 04:30:02.19275
NCT00006339|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection|A Prospective Randomized Open-Label Clinical Trial to Evaluate the Comparative Efficacy and Safety of a Potent Antiretroviral Treatment Regimen With or Without Hydroxyurea for Subjects With Acute HIV-1 Infection or Recent HIV-1 Seroconversion|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:02.310295|2017-10-11 04:30:02.310295
NCT00006340|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-07-25|||December 1994||1994-12-01|July 2013|2013-07-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus|A PHASE I TRIAL OF BUTYRATE AND GANCICLOVIR IN EBV-ASSOCIATED MALIGNANCIES|Completed||Phase 1|||Boston Medical Center|||||f||||||||||||||2017-10-11 04:30:02.467866|2017-10-11 04:30:02.467866
NCT00006341|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2016-01-29|||June 1997||1997-06-01|January 2016|2016-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer|Efficacy of Implant-Supported Maxillofacial Prostheses|Completed||Phase 2|46|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||No||2017-10-11 04:30:02.638484|2017-10-11 04:30:02.638484
NCT00006342|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2015-10-13|||January 1997||1997-01-01|June 2013|2013-06-01|January 2001|Actual|2001-01-01|September 2000|Actual|2000-09-01||Observational|||Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor|Analyses of Mutations Associated With Secondary Leukemia or Non-Hodgkin's Lymphoma in Patients Treated for Hodgkin's Disease or Childhood Brain Tumors|Completed||N/A|19|Actual|Duke University|||1||f||||||||||||||2017-10-11 04:30:02.759026|2017-10-11 04:30:02.759026
NCT00006357|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-09-20|||August 2000||2000-08-01|September 2012|2012-09-01||||April 2001|Actual|2001-04-01||Interventional|||STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma|Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma|Completed||Phase 1/Phase 2|91|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:05.363576|2017-10-11 04:30:05.363576
NCT00006343|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-12-30|||June 2000||2000-06-01|December 2012|2012-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia|A Phase III Study of STI571 Versus Interferon-a (IFN-a) Combined With Cytarabine (Ara-C) in Patients With Newly Diagnosed Previously Untreated Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|Completed||Phase 3|||Novartis|||||f||||f||||||||||2017-10-11 04:30:02.886993|2017-10-11 04:30:02.886993
NCT00006344|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2015-05-15|||May 2000||2000-05-01|May 2015|2015-05-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer|A Randomized, Phase III Dose Response Study of Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Lung|Withdrawn||Phase 3|0|Actual|Virginia Commonwealth University||||PI left institution|f||||f||||||||||2017-10-11 04:30:03.00133|2017-10-11 04:30:03.00133
NCT00006345|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-05-29|||November 1999||1999-11-01|November 2001|2001-11-01|March 2004|Actual|2004-03-01|||||Interventional|||Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma|An Evaluation of Corticosteroid Pretreatment in Cutaneous T-Cell Lymphoma Patients Receiving Ontak (Denileukin Difitox)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:03.089739|2017-10-11 04:30:03.089739
NCT00006346|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-07-09|||August 2000||2000-08-01|March 2010|2010-03-01|September 2003|Actual|2003-09-01|||||Interventional|||Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer|Stress Reduction For Breast Cancer in Women 55 Years of Age or Older: Enhancing Quality of Life and Survival|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:03.216814|2017-10-11 04:30:03.216814
NCT00006347|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2009-02-28|||August 2000||2000-08-01|April 2003|2003-04-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer|Phase I Non-Myeloablative Trial With 90Y-Humanized MN-14 (Anti-CEA) Antibody for Relapsed or Refractory Small Cell Lung Cancer (SCLC)|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:03.810032|2017-10-11 04:30:03.810032
NCT00006348|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2016-07-01|||October 2000||2000-10-01|July 2016|2016-07-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment|Phase III, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Ondansetron in the Control of Chronic Nausea and Vomiting Not Due to Antineoplastic Therapy in Patients With Advanced Cancer|Completed||Phase 3|100|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:30:03.942349|2017-10-11 04:30:03.942349
NCT00006349|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2016-07-12|||February 2001||2001-02-01|July 2016|2016-07-01|January 2007|Actual|2007-01-01|January 2005|Actual|2005-01-01||Interventional|||Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer|An Exploratory Trial of Donepezil and Vitamin E to Prevent Cognitive Dysfunction in Patients With Small Cell Lung Cancer (SCLC) After Cancer Treatment Which Includes Prophylatic Cranial Irradiation (PCI)|Completed||Phase 3|9|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:30:04.186514|2017-10-11 04:30:04.186514
NCT00006350|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2017-03-28|||January 2000|Actual|2000-01-01|March 2017|2017-03-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies After a Non-Myeloablative Conditioning Regimen From HLA-Matched Sibling Donors|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-10-11 04:30:04.402049|2017-10-11 04:30:04.402049
NCT00006351|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-09-20|||June 2000||2000-06-01|September 2012|2012-09-01||||December 2001|Actual|2001-12-01||Interventional|||SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract|Phase II Study on SCH 66336 (Farnesyl Protein Transferase Inhibitor) and Gemcitabine as Second Line Treatment in Advanced Metastatic Urothelial Cancer - EORTC Study 16997|Completed||Phase 2|34|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:04.577517|2017-10-11 04:30:04.577517
NCT00006352|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-07-17|||September 1999||1999-09-01|July 2012|2012-07-01||||October 2002|Actual|2002-10-01||Interventional|||Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer|The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG|Completed||Phase 3|453|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:04.700991|2017-10-11 04:30:04.700991
NCT00006353|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-09-20|||July 2000||2000-07-01|September 2012|2012-09-01||||March 2002|Actual|2002-03-01||Interventional|||Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme - A Randomized Phase III Study|Completed||Phase 3|575|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:04.839688|2017-10-11 04:30:04.839688
NCT00006354|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-07-23|||August 2000||2000-08-01|July 2012|2012-07-01||||March 2003|Actual|2003-03-01||Interventional|||Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy|Phase I Clinical Trial of Recombinant Viscumin (rViscumin, rMistletoe Lectin, rML) Administered Twice Weekly By The Intravenous Route In Patients With Solid Tumors After Failure of Standard Therapy|Completed||Phase 1|41|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:05.047244|2017-10-11 04:30:05.047244
NCT00006355|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-05-01|||May 2000||2000-05-01|May 2012|2012-05-01|October 2006|Actual|2006-10-01|October 2004|Actual|2004-10-01||Interventional|||Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme|Phase I/II Study of Pyrazoloacridine (PZA) in Adults With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1/Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:30:05.133447|2017-10-11 04:30:05.133447
NCT00006356|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-09-20|||August 2000||2000-08-01|September 2012|2012-09-01||||October 2002|Actual|2002-10-01||Interventional|||Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer|A Randomized Phase III Study for the Treatment of Recurrent Epithelial Ovarian Cancer: Chemotherapy Alone Versus Chemotherapy Followed by Secondary Cytoreductive Surgery in Patients With a Treatment-Free Interval of More Than 12 Months|Terminated||Phase 3|38|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:30:05.263109|2017-10-11 04:30:05.263109
NCT00006358|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2008-07-23|||May 2000||2000-05-01|October 2006|2006-10-01||||||||Interventional|||Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor|Phase II Evaluation of Temozolomide (SCH52365) and Thalidomide for the Treatment of Recurrent and Progressive Glioblastoma Multiforme|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:05.518135|2017-10-11 04:30:05.518135
NCT00006359|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2016-07-15|||September 2000||2000-09-01|July 2016|2016-07-01|March 2012|Actual|2012-03-01|October 2007|Actual|2007-10-01||Interventional|||Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer|Phase II Trial of Androgen Suppression for 6 Months Combined With External Beam Radiotherapy (EBRT) With Brachytherapy (BT) Boost for Intermediate Risk Prostate Cancer|Completed||Phase 2|63|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:30:05.775659|2017-10-11 04:30:05.775659
NCT00006360|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2016-12-30|||February 2001||2001-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2005|Actual|2005-11-01||Interventional|||Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer|Conformal and Intensity Modulated Irradiation for Oropharyngeal Cancer|Completed||Phase 1/Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:30:05.97745|2017-10-11 04:30:05.97745
NCT00006361|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2009-12-03|||December 2000||2000-12-01|December 2002|2002-12-01||||January 2003|Actual|2003-01-01||Interventional|||SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck|A Phase II Trial of SU5416 (NSC #696819) in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:06.126538|2017-10-11 04:30:06.126538
NCT00006362|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2011-08-01|||November 1999||1999-11-01|August 2011|2011-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||PS-341 in Treating Patients With Advanced Cancer|A Phase I and Pharmacologic Study of the Proteasome Inhibitor PS-341 in Patients With Advanced Solid Tumors and B-cell Lymphoproliferative Disorders|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:30:06.224463|2017-10-11 04:30:06.224463
NCT00006363|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-06-03|||November 2000||2000-11-01|June 2013|2013-06-01||||June 2005|Actual|2005-06-01||Interventional|||Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia|Phase III Randomized Study of Induction Chemotherapy With or Without MDR-Modulation With PSC-833 (NSC # 648265, IND # 41121) Followed by Cytogenetic Risk-Adapted Intensification Therapy Followed by Immunotherapy With rIL-2 (NSC # 373364, IND # 1969) vs. Observation in Previously Untreated Patients With AML &lt; 60 Years|Completed||Phase 3|720|Actual|National Cancer Institute (NCI)||7|||f||||||||||||||2017-10-11 04:30:06.36028|2017-10-11 04:30:06.36028
NCT00006364|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-01-22|||November 1999||1999-11-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia|Phase I and Pilot Study of Subcutaneous Homoharringtonine in Chronic Myelogenous Leukemia|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:06.597124|2017-10-11 04:30:06.597124
NCT00006365|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2014-01-23|||November 2000||2000-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|December 2006|Actual|2006-12-01||Interventional|||External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer|A Phase II Study of External Beam Radiation Therapy Combined With Permanent Source Brachytherapy for Intermediate Risk Clinically Localized Adenocarcinoma of the Prostate|Completed||Phase 2|138|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:30:06.733175|2017-10-11 04:30:06.733175
NCT00006366|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-07-17|||February 2001||2001-02-01|December 2002|2002-12-01||||December 2003|Actual|2003-12-01||Interventional|||Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum|Randomized Phase II Trial of Preoperative Combined Modality Chemoradiation for Distal Rectal Cancer|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:30:07.584556|2017-10-11 04:30:07.584556
NCT00006367|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2010-06-15|||May 2000||2000-05-01|June 2010|2010-06-01|January 2004|Actual|2004-01-01|||||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis|Autologous Peripheral Blood Stem Cell Mobilization and Transplantation for Myelofibrosis|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:30:08.290473|2017-10-11 04:30:08.290473
NCT00006368|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-04-30|||January 1998||1998-01-01|April 2013|2013-04-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer|A Phase I, Open-Label, Maximum Tolerated Single-Cycle and Four-Cycle Dose-Finding Study to Evaluation the Safety and Tolerability of 90Y-SMT 487 Administered by Intravenous Infusion to Subjects With Refractory Somatostatin-Receptor Positive Tumors|Completed||Phase 1|60|Actual|Novartis|||||f||||||||||||||2017-10-11 04:30:08.514933|2017-10-11 04:30:08.514933
NCT00006369|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-11-05|||June 2000||2000-06-01|October 2001|2001-10-01||||||||Interventional|||ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer|A Phase II, Randomized, Double-Masked, Multicenter Study of Two Dose Levels of ERA-923 for the Treatment of Metastatic Breast Cancer in Postmenopausal Women Who Have Failed Tamoxifen Therapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:08.685792|2017-10-11 04:30:08.685792
NCT00006370|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-04-30|||July 2000||2000-07-01|April 2013|2013-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer|A Phase II, Open-label, Multi-Center Study to Evaluate the Efficacy of 90Y-SMT 487 Administered Intravenously to Patients With Refractory Small Cell Lung or Advanced Metastatic Breast Cancer Expressing Somatostatin Receptors as Determined by OctreoScan Scintigraphy|Completed||Phase 2|275|Actual|Novartis|||||f||||||||||||||2017-10-11 04:30:08.797666|2017-10-11 04:30:08.797666
NCT00006371|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2012-09-25|||May 2000||2000-05-01|September 2012|2012-09-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||"A Phase II Trial of Early Medical Adrenalectomy for D0.5 Prostate Cancer"|"A Phase II Trial of Early Medical Adrenalectomy for D0.5 Prostate Cancer"|Terminated||Phase 2|2|Actual|H. Lee Moffitt Cancer Center and Research Institute||2||low accrual|f||||f||||||||||2017-10-11 04:30:08.901721|2017-10-11 04:30:08.901721
NCT00006372|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2010-06-09|||February 2000||2000-02-01|June 2010|2010-06-01|February 2005|Actual|2005-02-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I Trial of Combination Pegylated Liposomal Doxorubicin (Doxil), Vinorelbine, and Gemcitabine|Completed||Phase 1|10|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:30:09.082505|2017-10-11 04:30:09.082505
NCT00006373|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-06-03|||February 2000||2000-02-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|October 2006|Actual|2006-10-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma|A Phase II Study of Intensive-Dose Topotecan, Ifosfamide/Mesna and Etoposide (Vepesid)(TIME) Followed by Autologous Stem Cell Rescue in High Risk Lymphoma|Completed||Phase 2|27|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:30:09.211333|2017-10-11 04:30:09.211333
NCT00006374|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2014-01-14|||October 1999||1999-10-01|January 2014|2014-01-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|An Open-Label, Multicenter, Randomized, Phase II Study of Topotecan/Paclitaxel vs Etoposide/Cisplatin as First-Line Therapy for Patients With Extensive Disease Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||||Slow accrual|f||||t||||||||||2017-10-11 04:30:09.39432|2017-10-11 04:30:09.39432
NCT00006375|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-06-17|||June 2000||2000-06-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||LY293111 in Treating Patients With Advanced Solid Tumors|A Phase I Clinical and Pharmacokinetic Evaluation of LY293111 in Patients With Solid Tumors (Protocol H6H-MC-JEAI)|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:09.519879|2017-10-11 04:30:09.519879
NCT00006376|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-12-03|||March 2000||2000-03-01|June 2005|2005-06-01|May 2005|Actual|2005-05-01|||||Interventional|||R115777 in Treating Patients With Advanced Bladder Cancer|A Phase II Trial of R115777, an Oral Farnesyltransferase Inhibitor (FTI) in Previously Untreated Patients With Advanced Urothelial Tract Transitional Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:09.625778|2017-10-11 04:30:09.625778
NCT00006377|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-06-17|||June 2000||2000-06-01|June 2013|2013-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer|Phase II Study of Sequential Administration of Doxorubicin, Paclitaxel, and Carboplatin in Patients With Advanced and Recurrent Endometrial Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:09.728846|2017-10-11 04:30:09.728846
NCT00006378|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2014-01-08|||December 1999||1999-12-01|January 2014|2014-01-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer|Phase II Randomized Study of Taxol (PACLITAXEL), Paraplatin (Carboplatin), and Radiation Therapy for Locally Advanced Inoperable Non-Small Cell Lung Cancer|Completed||Phase 2|5|Actual|Case Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:30:09.846433|2017-10-11 04:30:09.846433
NCT00006379|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2011-12-07|||June 2000||2000-06-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|January 2004|Actual|2004-01-01||Interventional|||Non-Ablative Allo HSCT For Hematologic Malignancies or SAA|Purine-Analog-Containing Non-Myeloablative Allogeneic Stem Cell Transplantation for Treatment of Hematologic Malignancies and Severe Aplastic Anemia|Completed||Phase 2|58|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:30:09.955486|2017-10-11 04:30:09.955486
NCT00006380|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-06-17|||September 2000||2000-09-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer|Phase I Evaluation of 131I-J591 Murine Monoclonal Antibody in Patients With Progressive Androgen-Independent Prostate Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:10.102965|2017-10-11 04:30:10.102965
NCT00006381|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-12-18|||June 2000||2000-06-01|December 2003|2003-12-01|February 2004|Actual|2004-02-01|||||Interventional|||Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer|Phase II Study of Celecoxib in HER-2/Neu Overexpressing Metastatic Breast Cancer Patients Who Have Failed Recombinant Humanized Anti-p 185HER Monoclonal Antibody Trastuzumab (HERCEPTIN)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:10.183986|2017-10-11 04:30:10.183986
NCT00006382|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2015-05-01|||August 2000||2000-08-01|June 2010|2010-06-01|December 2002|Actual|2002-12-01|||||Interventional|||Lung Screening Study|Lung Screening Study|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:10.26651|2017-10-11 04:30:10.26651
NCT00006383|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-11-05|||June 2000||2000-06-01|December 2002|2002-12-01|August 2009|Actual|2009-08-01|||||Interventional|||Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma|Pivotal Phase II Multicenter Study of Vincristine Sulfate Liposomes Injection in Diffuse Large B-Cell Non-Hodgkin's Lymphoma That is Refractory or Relapsed After Second-Line Combination Chemotherapy Revised Title Per 03/01 SR Pivotal Phase II Multicenter Study of Vincristine Sulfate Liposomes Injection in Aggressive Non-Hodgkin's Lymphoma That is Refractory to or Relapsed After Second-Line Combination Chemotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:10.375895|2017-10-11 04:30:10.375895
NCT00006384|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2011-10-18|||November 2000||2000-11-01|October 2011|2011-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer|Phase II Trial of SU5416 and Interferon Alfa 2B in Unresectable or Metastatic Renal Cell Carcinoma|Completed||Phase 2|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:30:10.479265|2017-10-11 04:30:10.479265
NCT00006385|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2011-11-05|||September 2000||2000-09-01|December 2002|2002-12-01||||October 2006|Actual|2006-10-01||Interventional|||Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma|Phase II Evaluation of Immunization With an HLA-A2 Multi-Epitope Peptide Vaccine Containing MART-1 (NSC #672643), gp100 (NSC #683472), and Tyrosinase (NSC #699048) Peptides Alone or in Combination With GM-CSF, IFN Alpha-2b, or GM-CSF + IFN Alpha-2b in Patients With Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:10.566268|2017-10-11 04:30:10.566268
NCT00006386|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2015-11-14|||March 2001||2001-03-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|November 2004|Actual|2004-11-01||Interventional|||Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme|A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boosts For Supratentorial Glioblastoma Multiforme|Completed||Phase 2|80|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:30:10.858331|2017-10-11 04:30:10.858331
NCT00006402|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2008-01-18|||August 2000||2000-08-01|January 2008|2008-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Observational|||Lifestyle, Adiposity and Cardiovascular Health in Youths||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:30:18.470967|2017-10-11 04:30:18.470967
NCT00006387|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2013-07-10|||October 2000||2000-10-01|July 2013|2013-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer|A Phase I Study of RAS Peptide Vaccination in Patients With Advanced Pancreatic or Colorectal Adenocarcinoma|Completed||Phase 1|7|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-11 04:30:11.877481|2017-10-11 04:30:11.877481
NCT00006388|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2015-11-14|||December 2000||2000-12-01|November 2015|2015-11-01||||October 2003|Actual|2003-10-01||Interventional|||Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme|A Phase II Trial of High Dose Tamoxifen For The Treatment of Newly Diagnosed Supratentorial Glioblastoma Multiforme (GBM)|Completed||Phase 2|77|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:30:12.033092|2017-10-11 04:30:12.033092
NCT00006389|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2014-09-26|2014-09-26||October 2000||2000-10-01|October 2013|2013-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer|A Phase II Combination Trial of Bryostatin-1 and Cisplatin in the Treatment of Metastatic Gastric Cancer|Completed||Phase 2|12|Actual|National Cancer Institute (NCI)|Of 12 pts accrued\treated, none responded. The initial phase accrual goal was 15, but given the 12 non-responders, we determined the probability of 3 future pts all responding (stochastic curtailed sampling) at 2.7%. Decided to terminate the trial.|1|||f||||||||||||||2017-10-11 04:30:14.487589|2017-10-11 04:30:14.487589
NCT00006390|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2010-01-26|||February 2001||2001-02-01|January 2010|2010-01-01||||December 2004|Actual|2004-12-01||Interventional|||Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia|Phase II Study of Campath-1H (NSC #950010) and Peripheral Blood Stem Cell Transplant for Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||||||f||||||||||2017-10-11 04:30:14.918067|2017-10-11 04:30:14.918067
NCT00006391|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2011-04-04|||August 2000||2000-08-01|April 2011|2011-04-01||||November 2004|Actual|2004-11-01||Interventional|||Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase I Dose-Finding Study of Oxaliplatin (NSC #266046) Combined With Continuous Infusion Topotecan Hydrochloride as Chemotherapy for Patients With Previously Treated Ovarian Cancer|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:30:15.044544|2017-10-11 04:30:15.044544
NCT00006392|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2015-10-23|2012-06-12||July 2001||2001-07-01|October 2015|2015-10-01|September 2012|Actual|2012-09-01|May 2011|Actual|2011-05-01||Interventional|SELECT||S0000 Selenium and Vitamin E in Preventing Prostate Cancer|Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer|Completed||Phase 3|35533|Actual|Southwest Oncology Group||4|||f||||t||||||||||2017-10-11 04:30:15.185949|2017-10-11 04:30:15.185949
NCT00006393|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2005-06-23|||July 1998||1998-07-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis|Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis|Unknown status|Recruiting|N/A|80||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:17.097362|2017-10-11 04:30:17.097362
NCT00006394|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-04|2005-06-23|||April 1997||1997-04-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency||Completed||N/A|72||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:17.186015|2017-10-11 04:30:17.186015
NCT00006395|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-07|2008-03-03|||October 2000||2000-10-01|September 2000|2000-09-01|April 2001||2001-04-01|||||Interventional|||Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers|Evaluation of the Effect of St. John's Wort on Single Dose Carbamazepine Pharmacokinetics in Normal Healthy Volunteers|Completed||Phase 4|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:17.307499|2017-10-11 04:30:17.307499
NCT00006396|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-10|2012-02-13||||||February 2012|2012-02-01|November 2004|Actual|2004-11-01|||||Interventional|||Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns|A Phase III Placebo-Controlled Trial to Determine the Efficacy of Oral AZT and the Efficacy of Oral Nevirapine for the Prevention of Vertical Transmission of HIV-1 Infection in Pregnant Ugandan Women and Their Neonates|Completed||Phase 3|1500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:17.388223|2017-10-11 04:30:17.388223
NCT00006397|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-10|2005-06-23|||August 2000||2000-08-01|June 2001|2001-06-01||||||||Interventional|||Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs|A Study of the Combination of Indinavir, Ritonavir, Enteric-Coated ddI and d4T In Nucleoside and Non-Nucleoside Reverse Transcriptase Inhibitor Experienced Patients: An Open-Label Study Investigating Differences Between Women and Men|Unknown status|Active, not recruiting|Phase 3|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:30:17.519119|2017-10-11 04:30:17.519119
NCT00006398|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-05|2017-05-30|||August 1993|Actual|1993-08-01|May 2017|2017-05-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Prevention of Esophageal Varices by Beta-Adrenergic Blockers|Randomized, Double-Blind Study of Timolol (A Nonselective Beta-Adrenergic Blocker) vs Placebo to Prevent Complications of Hepatic Portal Hypertension in Patients With Cirrhosis|Completed||Phase 3|213|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t|t|f||||||||2017-10-11 04:30:17.674571|2017-10-11 04:30:17.674571
NCT00006399|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-18|2009-01-13|||September 1999||1999-09-01|January 2009|2009-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease|Estrogen Modulation Effects on Cholinergic Function in Normal Post-Menopausal Women and Patients With Alzheimer's Disease|Completed||Phase 2|45||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:30:17.82969|2017-10-11 04:30:17.82969
NCT00006400|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2011-04-15||2011-04-07|August 2000||2000-08-01|April 2011|2011-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia|Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)|Completed||Phase 3|191|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-10-11 04:30:17.947011|2017-10-11 04:30:17.947011
NCT00006401|ClinicalTrials.gov processed this data on October 10, 2017|2000-10-12|2015-10-05|||September 2000||2000-09-01|October 2015|2015-10-01|October 2007|Actual|2007-10-01|September 2005|Actual|2005-09-01||Interventional|||Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants|Inhaled NO for the Prevention of Chronic Lung Disease|Completed||Phase 3|793|Anticipated|University of Colorado, Denver||2|||f||||||||||||||2017-10-11 04:30:18.149295|2017-10-11 04:30:18.149295
NCT00013143|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06|||June 2001||2001-06-01|February 2007|2007-02-01|January 2003|Actual|2003-01-01|||||Interventional|||Patient Profiling and Provider Feedback to Reduce Adverse Drug Events|Patient Profiling and Provider Feedback to Reduce Adverse Drug Events|Completed||N/A|1200|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:18.9251|2017-10-11 04:30:18.9251
NCT00013156|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2000|Actual|2000-03-01|||||Interventional|||Cost-Effectiveness of Lung Volume Reduction Surgery|Cost-Effectiveness of Lung Volume Reduction Surgery|Completed||Phase 2|92|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.041176|2017-10-11 04:30:19.041176
NCT00013169|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2002|Actual|2002-09-01|||||Interventional|||Patient-Centered Alternative to Psychiatric Hospitalization for Veterans|Patient-Centered Alternative to Psychiatric Hospitalization for Veterans|Completed||N/A|220|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.148838|2017-10-11 04:30:19.148838
NCT00013182|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|June 2001|Actual|2001-06-01|||||Interventional|||Effect of Activity on Sleep of Cognitively-Impaired Veterans|Effect of Activity on Sleep of Cognitively-Impaired Veterans|Completed||N/A|90|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.249568|2017-10-11 04:30:19.249568
NCT00013195|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|June 2000|Actual|2000-06-01|||||Interventional|||Nurse Counseling for Physical Activity in Primary Care Patients|Nurse Counseling for Physical Activity in Primary Care Patients|Completed||N/A|210|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.331437|2017-10-11 04:30:19.331437
NCT00013208|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|August 2002|Actual|2002-08-01|||||Interventional|||Proactive Diabetes Case Management|Proactive Diabetes Case Management|Completed||N/A|260|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.419006|2017-10-11 04:30:19.419006
NCT00013221|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2000|Actual|2000-03-01|||||Interventional|||Exercise Effect on Aerobic Capacity and QOL in Heart Failure|Exercise Effect on Aerobic Capacity and QOL in Heart Failure|Completed||Phase 4|84|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.49267|2017-10-11 04:30:19.49267
NCT00013234|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||Health Services Implications of a Teledermatology Consult System|Health Services Implications of a Teledermatology Consult System|Completed||N/A|260|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.575899|2017-10-11 04:30:19.575899
NCT00013247|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2002|Actual|2002-12-01|||||Interventional|||Facilitating Shared Decisionmaking About Prostate Cancer Screening|Facilitating Shared Decisionmaking About Prostate Cancer Screening|Completed||N/A|1152|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.666908|2017-10-11 04:30:19.666908
NCT00013260|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|July 2000|Actual|2000-07-01|||||Interventional|||An Integrated Model of Primary Care in Mental Health|An Integrated Model of Primary Care in Mental Health|Completed||N/A|271|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:30:19.757743|2017-10-11 04:30:19.757743
NCT00013273|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||January 1999||1999-01-01|January 2001|2001-01-01|December 2001|Actual|2001-12-01|||||Interventional|||Physical Conditioning in Management of Chronic Venous Insufficiency|Physical Conditioning in Management of Chronic Venous Insufficiency|Completed||Phase 2|60||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:19.83379|2017-10-11 04:30:19.83379
NCT00013286|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||October 1999||1999-10-01|January 2001|2001-01-01|September 2002|Actual|2002-09-01|||||Observational|||A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk|A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk|Completed||Phase 2|750||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:19.909959|2017-10-11 04:30:19.909959
NCT00013299|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||October 2000||2000-10-01|January 2001|2001-01-01|April 2001|Actual|2001-04-01|||||Interventional|||Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3|Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3|Completed||Phase 2|427||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:19.993186|2017-10-11 04:30:19.993186
NCT00013312|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||April 1999||1999-04-01|January 2001|2001-01-01|March 2001|Actual|2001-03-01|||||Interventional|||Effects of Acute SCI on Colonic Motility & Tone|Effects of Acute SCI on Colonic Motility & Tone|Completed||Phase 2|12||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.09594|2017-10-11 04:30:20.09594
NCT00013325|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||October 1999||1999-10-01|January 2001|2001-01-01|September 2002|Actual|2002-09-01|||||Observational|||Cardiac Disease and the Electrocardiogram in SCI Patients|Cardiac Disease and the Electrocardiogram in SCI Patients|Completed||Phase 2|800||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.167085|2017-10-11 04:30:20.167085
NCT00013338|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||January 2000||2000-01-01|January 2001|2001-01-01|December 2002|Actual|2002-12-01|||||Interventional|||Supported Treadmill Ambulation Training After Spinal Cord Injury|Supported Treadmill Ambulation Training After Spinal Cord Injury|Completed||Phase 2|40||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.245246|2017-10-11 04:30:20.245246
NCT00013351|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||April 1998||1998-04-01|January 2001|2001-01-01|March 2001|Actual|2001-03-01|||||Observational|||Restricted Useful Field View as a Risk Factor in Older Adults|Restricted Useful Field View as a Risk Factor in Older Adults|Completed||Phase 2|150||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.330821|2017-10-11 04:30:20.330821
NCT00013364|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||April 1998||1998-04-01|January 2001|2001-01-01|March 2001|Actual|2001-03-01|||||Observational|||Effects of Stimulus Validity on Speech Recognition|Effects of Stimulus Validity on Speech Recognition|Completed||Phase 2|80||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.417817|2017-10-11 04:30:20.417817
NCT00013377|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||April 1999||1999-04-01|January 2001|2001-01-01|March 2002|Actual|2002-03-01|||||Interventional|||Predictors of Driving Performance and Successful Mobility - Rehabilitation in Patients With Medical Eye Condition|Predictors of Driving Performance and Successful Mobility - Rehabilitation in Patients With Medical Eye Condition|Completed||Phase 2|30||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.491693|2017-10-11 04:30:20.491693
NCT00014521|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2008-07-23|||January 2002||2002-01-01|February 2005|2005-02-01||||||||Interventional|||Karenitecin in Treating Patients With Recurrent Malignant Glioma|Phase I Evaluation Of The Safety Of Karenitecin In The Treatment Of Recurrent Malignant Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:29.034872|2017-10-11 04:30:29.034872
NCT00013390|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2011-05-17|||October 1999||1999-10-01|May 2011|2011-05-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Evaluation of Treatment Methods for Clinically Significant Tinnitus|Evaluation of Treatment Methods for Clinically Significant Tinnitus|Completed||Phase 2|200|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:30:20.56934|2017-10-11 04:30:20.56934
NCT00013403|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2015-06-25|||April 1999||1999-04-01|June 2015|2015-06-01|March 2002|Actual|2002-03-01|||||Interventional|||The Impact of Rehabilitation on Quality of Life in Visually Impaired|The Impact of Rehabilitation on Quality of Life in Visually Impaired|Completed||Phase 2|300||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.666317|2017-10-11 04:30:20.666317
NCT00013416|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||October 1999||1999-10-01|January 2001|2001-01-01|September 2002|Actual|2002-09-01|||||Interventional|||Measurement and Prediction of Outcomes of Amplification|Measurement and Prediction of Outcomes of Amplification|Completed||Phase 2|120||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.750667|2017-10-11 04:30:20.750667
NCT00013429|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||January 2000||2000-01-01|January 2001|2001-01-01|September 2003|Actual|2003-09-01|||||Interventional|||Evaluation of Eye Movement Tracking Systems for Visual Rehabilitation|Evaluation of Eye Movement Tracking Systems for Visual Rehabilitation|Completed||Phase 2|100||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.841607|2017-10-11 04:30:20.841607
NCT00013442|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||January 2000||2000-01-01|January 2001|2001-01-01|December 2002|Actual|2002-12-01|||||Observational|||AERs in Aphasia: Severity and Improvement|AERs in Aphasia: Severity and Improvement|Completed||Phase 2|20||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.921358|2017-10-11 04:30:20.921358
NCT00013455|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||August 2000||2000-08-01|May 2002|2002-05-01|August 2003|Actual|2003-08-01|||||Interventional|||Quantifying Auditory Perceptual Learning Following Hearing Aid Fitting|Quantifying Auditory Perceptual Learning Following Hearing Aid Fitting|Completed||Phase 2|48|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:30:20.998986|2017-10-11 04:30:20.998986
NCT00013728|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-28|2006-03-22|||September 2000||2000-09-01|March 2006|2006-03-01|October 2003||2003-10-01|||||Observational|||Asthma & Exposure to Peaks in Particulate Air Pollution||Completed||N/A|24||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:21.066003|2017-10-11 04:30:21.066003
NCT00013741|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-28|2012-05-23||||||February 2003|2003-02-01||||||||Interventional|||The MI-HEART Project||Completed||N/A|55||National Library of Medicine (NLM)|||||f||||||||||||||2017-10-11 04:30:21.11344|2017-10-11 04:30:21.11344
NCT00013754|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-29|2015-04-13|||March 2001||2001-03-01|April 2015|2015-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Observational|||Pesticide Exposure Pathways for Farmworker Children|Child Environmental Health Center--Reducing Pesticide Exposure in Children of Farmworkers (UW IRB 96-6567-C02, FENSKE, 6/15/00-6/14/01)|Completed||N/A|40|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:21.187239|2017-10-11 04:30:21.187239
NCT00013767|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-29|2015-04-13|||June 1999||1999-06-01|April 2015|2015-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Community Based Prevention/Control Project|Child Environmental Health Center--Reducing Pesticide Exposure in Children of Farmworkers|Completed||N/A|400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:21.254388|2017-10-11 04:30:21.254388
NCT00013780|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-29|2006-03-22|||July 1998||1998-07-01|March 2006|2006-03-01|June 2003||2003-06-01|||||Observational|||Ozone Exposure and Dose Delivered to Human Lungs||Completed||N/A|50||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:21.323702|2017-10-11 04:30:21.323702
NCT00013793|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-29|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Ultrasound and Motivational Enhancement for Prenatal Smoking Cessation|Ultrasound and Motivational Enhancement for Prenatal Smoking Cessation|Completed||N/A|30||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:21.472019|2017-10-11 04:30:21.472019
NCT00013806|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-29|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study|CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study|Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:21.622739|2017-10-11 04:30:21.622739
NCT00013819|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-29|2015-04-13|||February 1997||1997-02-01|April 2015|2015-04-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Observational|||Exposure, Dose, Body Burden and Health Effects of Lead|Exposure, Dose, Body Burden and Health Effects of Lead|Completed||N/A|944||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:21.730032|2017-10-11 04:30:21.730032
NCT00013832|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-30|2017-06-30|||March 28, 2001||2001-03-28|April 11, 2007|2007-04-11|April 11, 2007||2007-04-11|||||Observational|||Study of Tongue Pressures|Effect of Task on Oral Pressure Dynamics During Swallowing|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:21.789717|2017-10-11 04:30:21.789717
NCT00013845|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-30|2017-10-05|||March 28, 2001||2001-03-28|September 22, 2017|2017-09-22||||||||Observational|||Evaluation and Treatment of Patients With Epilepsy|Evaluation and Treatment of Patients With Epilepsy|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:21.860165|2017-10-11 04:30:21.860165
NCT00013858|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-30|2015-04-13|||January 1997||1997-01-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Environmental Contaminants and Infant Development||Completed||N/A|280|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:21.953959|2017-10-11 04:30:21.953959
NCT00013871|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-31|2013-11-25||||||November 2013|2013-11-01|November 2004|Actual|2004-11-01|||||Interventional|||Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs|Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Treated With Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:30:22.041161|2017-10-11 04:30:22.041161
NCT00013884|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-31|2008-03-03|||March 2001||2001-03-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||HIV Maintenance Therapy With T-20 During HAART Interruption|A Pilot Study to Evaluate the Ability of Maintenance Therapy With the HIV Fusion Inhibitor T20 to Prevent Rebound of Plasma HIV RNA Following an Interruption of HAART|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:22.261434|2017-10-11 04:30:22.261434
NCT00013897|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-31|2011-04-28||2011-04-13|February 2001||2001-02-01|April 2011|2011-04-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine|A Phase III Study Comparing the Antiviral Efficacy and Safety of BMS-232632 With Efavirenz; Each in Combination With Fixed Dose Zidovudine-Lamivudine|Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:30:22.405489|2017-10-11 04:30:22.405489
NCT00013910|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-02|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes|NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes|Completed||Phase 1|30||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:22.716143|2017-10-11 04:30:22.716143
NCT00013923|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-02|2009-12-10||||||August 2003|2003-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease|A Nutritional Brain Metabolic Enhancer for Alzheimer Disease|Completed||Phase 2|40||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:30:22.789271|2017-10-11 04:30:22.789271
NCT00013936|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-03|2008-03-03|||March 2001||2001-03-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||A Novel Acuity Testing Method|A Novel Acuity Testing Method|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:22.891871|2017-10-11 04:30:22.891871
NCT00013949|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-03|2006-09-01|||September 1998||1998-09-01|September 2006|2006-09-01|September 2004||2004-09-01|||||Observational|||Cardiovascular Vulnerability to Particulate Exposure|Active Elderly Study|Completed||N/A|200||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:22.969808|2017-10-11 04:30:22.969808
NCT00013962|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-03|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Vitamin D Metabolism and the Williams Syndrome|Vitamin D Metabolism and the Williams Syndrome|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:23.037476|2017-10-11 04:30:23.037476
NCT00013975|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-04|2008-03-03|||March 2001||2001-03-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Endothelial Progenitor Cells and Risk Factors for Coronary Artery Disease|Endothelial Progenitor Cells and Risk Factors for Coronary Artery Disease|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:23.111986|2017-10-11 04:30:23.111986
NCT00014001|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-06|2015-06-16|||December 2000||2000-12-01|October 2006|2006-10-01|December 2004||2004-12-01|||||Interventional|||CATIE- Schizophrenia Trial|Comparative Effectiveness of Antipsychotic Medications in Patients With Schizophrenia (CATIE Schizophrenia Trial)|Completed||Phase 4|1600||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:30:23.226724|2017-10-11 04:30:23.226724
NCT00014014|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-07|2013-10-04||||||October 2013|2013-10-01|August 2002|Actual|2002-08-01|||||Interventional|||Zidovudine and Lamivudine Given Once Versus Twice Daily|A Phase I Pharmacokinetic Study of Once Versus Twice Daily Dosing With Zidovudine and Lamivudine|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:23.457778|2017-10-11 04:30:23.457778
NCT00014027|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-07|2017-06-30|||April 4, 2001||2001-04-04|July 13, 2010|2010-07-13|April 11, 2008|Actual|2008-04-11|April 11, 2008|Actual|2008-04-11||Interventional|||Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress|Polyunsaturated Fatty Acids and the Neurochemistry of Cardiovascular and Behavioral Responses in Aggressive Alcoholics|Completed||Phase 1|97|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:30:23.592717|2017-10-11 04:30:23.592717
NCT00014040|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-07|2008-03-03|||April 2001||2001-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients With Coronary Artery Disease|Nitric Oxide Inhalation Therapy for Myocardial Ischemia in Patients With Coronary Artery Disease|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:23.66576|2017-10-11 04:30:23.66576
NCT00014053|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2008-07-29||||||June 2003|2003-06-01||||||||Observational|||A Study of Immune System Activity in Healthy Adults|A Study of Immune Function in Healthy Adults Aged 18-30 and 45 and Older|Completed||N/A|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:23.779752|2017-10-11 04:30:23.779752
NCT00014066|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-02-04|||March 1993||1993-03-01|February 2013|2013-02-01||||February 2004|Actual|2004-02-01||Interventional|||Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer|A Phase I Study of Photodynamic Therapy (PDT) Combined With High Dose Rate (HDR) Brachytherapy for Patients With Obstructive Bronchogenic Carcinoma|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:30:23.89693|2017-10-11 04:30:23.89693
NCT00014079|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2016-07-12|||September 1997||1997-09-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|July 2003|Actual|2003-07-01||Observational|||Genetic Markers in Patients With Colorectal Cancer|Clinical Significance of Genetic Markers in Colon Cancer|Completed||N/A|675|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 04:30:23.999827|2017-10-11 04:30:23.999827
NCT00014092|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-03-25|||December 1999||1999-12-01|March 2004|2004-03-01|December 2003|Actual|2003-12-01|||||Interventional|||Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery|Treatment of Patients With Metastatic Malignant Melanoma With Chemobiotherapy With Temozolomide, GM-CSF, IL2, and Interferon Alfa-2b Phase II Trial|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:24.144169|2017-10-11 04:30:24.144169
NCT00014105|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-12-03|||December 2000||2000-12-01|May 2002|2002-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme|Phase I/II Trial of Temozolomide and Carboplatin in Recurrent Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:24.255243|2017-10-11 04:30:24.255243
NCT00014118|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2015-10-06|||March 2001||2001-03-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|March 2007|Actual|2007-03-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer|A Phase II Trial OF Chemoradiation For Organ Preservation In Resectable Stage III or IV Squamous Cell Carcinomas Of The Larynx Or Oropharynx|Completed||Phase 2|||Eastern Cooperative Oncology Group||1|||f||||||||||||||2017-10-11 04:30:24.35752|2017-10-11 04:30:24.35752
NCT00014976|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-17|2017-06-30|||April 13, 2001||2001-04-13|November 1, 2010|2010-11-01|November 1, 2010||2010-11-01|||||Observational|||Physiologic Studies of Spasticity|Spasticity: Physiologic Studies|Completed||N/A|48|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:35.269155|2017-10-11 04:30:35.269155
NCT00014131|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2016-05-25|||November 2001||2001-11-01|June 2014|2014-06-01||||December 2009|Actual|2009-12-01||Interventional|||Vaccine Therapy in Treating Patients With Kidney Cancer|Vaccine Biotherapy Of Cancer: Autologous Tumor Cells And Dendritic Cells As Active Specific Immunotherapy In Patients With Stage IV Renal Cell Carcinoma|Terminated||Phase 1/Phase 2|9|Actual|Caladrius Biosciences, Inc.||1|||f||||f||||||||||2017-10-11 04:30:24.615362|2017-10-11 04:30:24.615362
NCT00014144|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2012-10-05|||February 2001||2001-02-01|October 2012|2012-10-01|December 2007|Actual|2007-12-01|May 2003|Actual|2003-05-01||Interventional|||S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract|Evaluation of ZD1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II|Completed||Phase 2|31|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:30:24.851513|2017-10-11 04:30:24.851513
NCT00014170|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-07-15|||March 2001||2001-03-01|June 2013|2013-06-01||||July 2003|Actual|2003-07-01||Interventional|||Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study Of ZD1839 (NSC 715055) In Newly Diagnosed Patients With Glioblastoma (Grade 4 Astrocytoma)|Completed||Phase 2|92|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:25.141406|2017-10-11 04:30:25.141406
NCT00014183|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2009-09-23|||January 2001||2001-01-01|September 2009|2009-09-01|August 2005|Actual|2005-08-01|May 2002|Actual|2002-05-01||Interventional|||ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer|A Phase II Study Of ZD1839 (NSC #715055) In Renal Cell Carcinoma Stage IV And Renal Cell Carcinoma Recurrent|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-10-11 04:30:25.250507|2017-10-11 04:30:25.250507
NCT00014196|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-02-12|||March 2001||2001-03-01|February 2013|2013-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer|Phase II Trial of Concurrent Cisplatin/Docetaxel and Radiotherapy Followed by Consolidation Docetaxel in Stage IIIB Non-Small Cell Lung Cancer|Terminated||Phase 2|33|Actual|Southwest Oncology Group||1||This study was closed early due to poor accrual.|f||||f||||||||||2017-10-11 04:30:25.343199|2017-10-11 04:30:25.343199
NCT00014209|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2016-11-25|||December 2000||2000-12-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|July 2002|Actual|2002-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma That Has Not Responded to Previous Treatment|A Phase II Study Of Gemcitabine, Dexamethasone, And Cisplatin (GDP) In Patients With Either Hodgkin's Disease Or Aggressive Histology Non-Hodgkin's Lymphoma Which Is Relapsed Or Refractory|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-10-11 04:30:25.621042|2017-10-11 04:30:25.621042
NCT00014222|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2014-03-17|||December 2000||2000-12-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|October 2006|Actual|2006-10-01||Interventional|||Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer|A Phase III Adjuvant Trial Of Sequenced EC + Filgrastim + Epoetin Alfa Followed By Paclitaxel Versus Sequenced AC Followed By Paclitaxel Versus CEF As Therapy For Premenopausal Women And Early Postmenopausal Women Who Have Had Potentially Curative Surgery For Node Positive Or High Risk Node Negative Breast Cancer|Completed||Phase 3|2104|Actual|Canadian Cancer Trials Group||3|||f||||t||||||||||2017-10-11 04:30:25.734771|2017-10-11 04:30:25.734771
NCT00014235|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2016-11-28|||December 2000||2000-12-01|November 2016|2016-11-01||||February 2005|Actual|2005-02-01||Interventional|||Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies|Nonmyeloablative PBSC Allografting From HLA Matched Related Donors Using Fludarabine and/or Low Dose TBI With Disease-Risk Based Immunosuppression|Active, not recruiting||N/A|160|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||||||||||||2017-10-11 04:30:26.02531|2017-10-11 04:30:26.02531
NCT00014248|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-03-15|||October 2000||2000-10-01|March 2013|2013-03-01||||November 2002|Actual|2002-11-01||Interventional|||Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors|A Phase I Study And Pharmacokinetics Of Adenosine 5'- Triphosphate (ATP) When Administered By Intravenous Infusion On A Multiple Weekly Dose Schedule To Patients With Advanced Malignancies (Solid Tumors)|Completed||Phase 1|||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 04:30:26.238368|2017-10-11 04:30:26.238368
NCT00014261|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-03-15|||October 2000||2000-10-01|March 2013|2013-03-01||||November 2002|Actual|2002-11-01||Interventional|||Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors|A Phase-I Study Of Cyclical Oral Administration Of Temozolomide In Combination With PEG12000-Interferon Alfa-2B In Patients With Refractory And/Or Advanced Solid Tumors|Completed||Phase 1|||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 04:30:26.319247|2017-10-11 04:30:26.319247
NCT00014274|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-06-11|||January 2001||2001-01-01|June 2013|2013-06-01||||March 2008|Actual|2008-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium|Randomized Phase II/III Study Assessing Gemcitabine/Carboplatin And Methotrexate/Carboplatin/Vinblastine In Previously Untreated Patients With Advanced Urothelial Cancer Ineligible For Cisplatin Based Chemotherapy|Completed||Phase 2/Phase 3|238|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:26.408847|2017-10-11 04:30:26.408847
NCT00014287|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-12-18|||September 2000||2000-09-01|December 2013|2013-12-01||||||||Interventional|||Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer|Intravesical Gemcitabine Therapy for BCG-Refractory Superficial Bladder Cancer: A Phase I and Pharmacokinetic Study|Withdrawn||Phase 1|0|Actual|University of Pittsburgh|||||f||||||||||||||2017-10-11 04:30:26.561448|2017-10-11 04:30:26.561448
NCT00014300|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2012-09-20|||January 2001||2001-01-01|September 2012|2012-09-01||||September 2001|Actual|2001-09-01||Interventional|||Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme|Open Label Phase II Study On Glufosfamide Administered As A 60 Minute Infusion Every 3 Weeks In Recurrent Glioblastoma Multiforme|Completed||Phase 2|32|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:26.633695|2017-10-11 04:30:26.633695
NCT00014313|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2012-09-20|||January 2001||2001-01-01|September 2012|2012-09-01||||December 2002|Actual|2002-12-01||Interventional|||Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor|A Phase II Study to Evaluate the Role of Weekly Cisplatin With Oral Etoposide in Ewing's Sarcoma and Primitive Neuroectodermal Tumor (PNET) With Bone and/or Bone Marrow Metatstatic Disease|Terminated||Phase 2|3|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:30:26.756175|2017-10-11 04:30:26.756175
NCT00014326|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2012-07-13|||January 2001||2001-01-01|July 2012|2012-07-01||||March 2009|Actual|2009-03-01||Interventional|||Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma|A Phase III Randomized Study On Low-Dose Total Body Irradiation And Involved Field Radiotherapy In Patients With Localized, Stages I and II, Low Grade Non-Hodgkin's Lymphoma|Terminated||Phase 3|204|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:30:26.848507|2017-10-11 04:30:26.848507
NCT00014339|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-12-17|||March 2000||2000-03-01|November 2007|2007-11-01||||||||Interventional|||Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma|A Randomized, Phase III, Placebo-Controlled Multicenter Study to Demonstrate the Effectiveness and Safety of the Combination Enzyme Tablet (Wobe-Mugos E) as Adjuvant Therapy to Standard of Care Treatment in Patients With Stages II or III Multiple Myeloma|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:26.975505|2017-10-11 04:30:26.975505
NCT00014352|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-01-15|||September 2000||2000-09-01|January 2013|2013-01-01||||March 2003|Actual|2003-03-01||Interventional|||Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer|Phase II Trial Of Sequential Estramustine/Paclitaxel Followed By Doxorubicin/Ketoconazole In Patients With Androgen-Independent Prostate Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:27.104564|2017-10-11 04:30:27.104564
NCT00014365|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-06-17|||October 2000||2000-10-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Ro 31-7453 in Treating Patients With Metastatic Solid Tumors|The Food-Effect Bioavailability Study of Ro 31-7453, a Novel Cell Cycle Inhibitor, in Stable Patient Volunteers With Solid Tumors|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:27.190029|2017-10-11 04:30:27.190029
NCT00014378|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2015-12-17|||October 2000||2000-10-01|December 2015|2015-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors|A Phase I Study Of The Chinese Herb Huanglian (Coptis Chinesis) In Patients With Advanced Solid Tumors|Completed||Phase 1|34|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:30:27.249877|2017-10-11 04:30:27.249877
NCT00014391|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2010-03-31|||February 1999||1999-02-01|March 2010|2010-03-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation|A Randomized Double-Blind Placebo-Controlled Phase III Study To Evaluate The Safety And Efficacy Of Palivizumab Combined With Aerosolized Ribavirin Compared To Ribavirin Alone To Treat RSV Pneumonia In Patients With Bone Marrow Transplants (BMT)|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:30:27.322049|2017-10-11 04:30:27.322049
NCT00014404|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-01-15|||October 2000||2000-10-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||Celecoxib in Treating Patients With Precancerous Lesions of the Mouth|Phase II Double-Blind, Placebo Controlled, Randomized Study Of Celecoxib, A Selective COX-2 Inhibitor, In Oral Premalignant Lesions|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:27.427004|2017-10-11 04:30:27.427004
NCT00014430|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-03-12|||November 1999||1999-11-01|November 2002|2002-11-01||||September 2002|Actual|2002-09-01||Interventional|||Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer|Phase I Clinical Trial Of Vinorelbine (Navelbine) And Trastuzumab (Herceptin) In Patients With Carcinoma Of The Breast Or Non-Small Cell Lung Cancer And HER-2/NEU Overexpression|Completed||Phase 1|13|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||||||||||||2017-10-11 04:30:27.52241|2017-10-11 04:30:27.52241
NCT00014443|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2008-07-23|||August 2000||2000-08-01|January 2006|2006-01-01||||||||Interventional|||Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma|A Pilot Study Of Hycamtin (Topotecan) And Thalomid (Thalidomide) In Patients With Recurrent Malignant Gliomas|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:27.621745|2017-10-11 04:30:27.621745
NCT00014456|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-08-27|||March 2000||2000-03-01|August 2013|2013-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors|A Dose-Escalation Trial Of The Combination Of Docetaxel, Gemcitabine And Filgrastim (NEUPOGEN) For The Treatment Of Patients With Advanced Solid Tumors|Completed||Phase 1|35|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 04:30:27.728735|2017-10-11 04:30:27.728735
NCT00014469|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-03-06|||December 2000||2000-12-01|March 2013|2013-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer|A Phase II Trial of IV Busulfan (Busulfex) and Melphalan as a Preparatory Regimen Prior to Allogeneic Bone Marrow Transplantation for the Treatment of Advanced and High Risk Hematologic Malignancies|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:27.854558|2017-10-11 04:30:27.854558
NCT00014482|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-06-17|||December 2000||2000-12-01|June 2013|2013-06-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation|Music Therapy for Distress During Autologous Stem Cell Transplantation: A Randomized Trial|Completed||N/A|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:27.953468|2017-10-11 04:30:27.953468
NCT00014495|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2015-12-17|2015-12-17||November 2000||2000-11-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer|Phase I/II Trial Of Sequential Therapy With Cytarabine And Bismuth-213-Labeled HuM195 (Humanized Anti-CD33) In Patients With Advanced Myeloid Malignancies|Completed||Phase 1/Phase 2|32|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:30:28.060085|2017-10-11 04:30:28.060085
NCT00014508|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2009-02-25|||April 2001||2001-04-01|November 2005|2005-11-01||||February 2007|Actual|2007-02-01||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase II Trial Of Autologous Stem Cell Transplant Followed By Mini-Allogeneic Stem Cell Transplant In Lieu Of Standard Allogeneic Bone Marrow Transplantation For Treatment Of Multiple Myeloma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:28.882834|2017-10-11 04:30:28.882834
NCT00014534|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2016-07-12|||March 2004||2004-03-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Bladder Cancer|Phase III Study Comparing Sequential Chemotherapy (AG-ITP) To Cisplatin And Gemcitabine As Adjuvant Treatment After Cystectomy For Transitional Cell Carcinoma Of The Bladder|Completed||Phase 3|42|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:30:29.199357|2017-10-11 04:30:29.199357
NCT00014547|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2008-07-23|||November 2000||2000-11-01|January 2002|2002-01-01||||||||Interventional|||BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment|Phase II Study Of BBR 3464 As Treatment In Patients With Sensitive Or Refractory Small Cell Lung Cancer After One Prior Chemotherapy Regimen|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:29.974058|2017-10-11 04:30:29.974058
NCT00014560|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2015-10-12|2013-04-02||September 2000||2000-09-01|April 2013|2013-04-01||||February 2003||2003-02-01||Interventional|||Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Phase I Trial Of Intravenous Bispecific Antibody (4G7XH22) In Patients With Refractory Or Relapsed Non-Hodgkin's Lymphoma Or Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 1|3|Actual|Dartmouth-Hitchcock Medical Center|This study was prematurely ended by the sponsor Medarex (supplier of BsAb) due to toxicities experienced at other sites on unrelated trials leading to the decision that Medarex would not be manufacturing the investigational product (BsAb).|1||"Medarex (supplier of BsAb) stopped study due to toxicities experienced at other sites on   unrelated trials halting manufacturing of BsAb"|f||||||||||||||2017-10-11 04:30:30.125894|2017-10-11 04:30:30.125894
NCT00014573|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-04-05|||August 1998||1998-08-01|April 2013|2013-04-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer|Phase II Trial Of High Dose Cyclophosphamide, Cisplatin And Carmustine With Stem Cell Reconstitution Followed By Specific Cellular Therapy In Patients With Recurrent Or Refractory Brain Tumors|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-10-11 04:30:30.325639|2017-10-11 04:30:30.325639
NCT00014586|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2012-09-20|||January 2001||2001-01-01|September 2012|2012-09-01||||February 2003|Actual|2003-02-01||Interventional|||Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer|Randomized Phase III Step-Up Study On Initial Antiandrogen Monotherapy In Comparison With Watchful Waiting In Asymptomatic T1-3 Any G (Any Gleason) NO or Nx M0 Prostate Cancer Patients Without Local Treatment With Curative Intent|Terminated||Phase 3|110|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:30:30.434314|2017-10-11 04:30:30.434314
NCT00014599|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2012-09-20|||February 2001||2001-02-01|September 2012|2012-09-01||||February 2005|Actual|2005-02-01||Interventional|||Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva|Phase II Clinical Trial On Taxol As Single Agent In Locally Advanced And/Or Metastatic Or Recurrent Vulva Cancer Not Amenable For Surgery And/Or Radiotherapy|Completed||Phase 2|31|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:30.528935|2017-10-11 04:30:30.528935
NCT00014612|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-10-28|||February 2001||2001-02-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|November 2010|Actual|2010-11-01||Interventional|AMAROS||Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer|After Mapping Of The Axilla: Radiotherapy Or Surgery|Completed||Phase 3|4813|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 04:30:30.656289|2017-10-11 04:30:30.656289
NCT00014625|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2012-07-23|||February 2001||2001-02-01|July 2012|2012-07-01||||November 2001|Actual|2001-11-01||Interventional|||E7070 in Treating Patients With Stage IV Melanoma|Open Label Phase II Study Of E7070 In Patients With Metastatic Melanoma (Stage IV)|Completed||Phase 2|28|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:30.832456|2017-10-11 04:30:30.832456
NCT00014638|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-02-20|||January 2001||2001-01-01|February 2013|2013-02-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer|Open Label, Multicenter Trial Of Femera (Letrozole) 2.5 mg As First-line Therapy In Postmenopausal Women With Metastatic Breast Cancer Relapsing Following Adjuvant Tamoxifen Therapy|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-10-11 04:30:30.934881|2017-10-11 04:30:30.934881
NCT00014651|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2010-08-06|||March 2001||2001-03-01|August 2010|2010-08-01|April 2002|Actual|2002-04-01|March 2001|Actual|2001-03-01||Interventional|||Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection|Vapreotide in Pancreas Surgery: A Double-Blind, Placebo-Controlled, Randomized Study of Vapreotide to Prevent Post-Surgical Complications in Patients Undergoing Elective Pancreatic Resection Grant Application Title: Vapreotide to Prevent Complications of Pancreatic Resection|Terminated||Phase 3|||Mayo Clinic||||"Teminated by the DSMB because there are no differences between the control group and the   Vapreotide group"|f||||||||||||||2017-10-11 04:30:31.139377|2017-10-11 04:30:31.139377
NCT00014664|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-12-17|||October 2000||2000-10-01|September 2002|2002-09-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II, Open-Label, Randomized, Multicenter Trial To Evaluate The Preliminary Safety And Efficacy of Hu1D10 In Patients With Relapsed Or Refractory Grades I, II, or III B-Cell Non-Hodgkin's Lymphoma (Including Follicular, Small Lymphocytic And Marginal Zone/MALT)|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:31.254122|2017-10-11 04:30:31.254122
NCT00014677|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-07-17|||March 2001||2001-03-01|June 2002|2002-06-01|July 2008|Actual|2008-07-01|September 2002|Actual|2002-09-01||Interventional|||NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme|A Randomized, Dose-Ranging, Safety and Tolerability Study of NBI-3001 Administered by Continuous Intratumoral Infusion Followed by Surgical Resection in Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:31.32028|2017-10-11 04:30:31.32028
NCT00015340|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11|||August 1999||1999-08-01|August 2016|2016-08-01|September 2001|Actual|2001-09-01|August 2001|Actual|2001-08-01||Interventional|||Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14|Buprenorphine/Nx Treatment of Heroin Dependence-A Compassionate Use Study|Completed||Phase 4|582|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-10-11 04:30:37.593413|2017-10-11 04:30:37.593413
NCT00014690|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2013-08-01|||March 2001||2001-03-01|December 2004|2004-12-01|February 2004|Actual|2004-02-01|||||Interventional|||ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase II, Open, Randomized Multicenter Trial to Assess the Efficacy and Tolerability of Intravenous ZD9331 Given as Monotherapy (at Two Doses) or in Combination With Topotecan, in Patients With Ovarian Cancer Refractory or Recurrent After Failing Platinum and Paclitaxel in Combination|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:31.389132|2017-10-11 04:30:31.389132
NCT00014729|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2015-03-24|||October 2000||2000-10-01|May 2001|2001-05-01|September 2002||2002-09-01|||||Interventional|||Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa||Completed||Phase 1|20||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:30:31.449604|2017-10-11 04:30:31.449604
NCT00014742|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2015-03-24||||||April 2001|2001-04-01|April 2004||2004-04-01|||||Interventional|||Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease||Completed||Phase 3|72|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:30:31.501837|2017-10-11 04:30:31.501837
NCT00014755|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2005-06-23|||December 1997||1997-12-01|April 2001|2001-04-01||||||||Interventional|||Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis||Completed||Phase 1|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:30:31.552374|2017-10-11 04:30:31.552374
NCT00014768|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2005-06-23|||February 2001||2001-02-01|March 2002|2002-03-01||||||||Observational|||Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis||Terminated||N/A|36||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:31.631875|2017-10-11 04:30:31.631875
NCT00014781|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-10|2009-03-10|||February 2001||2001-02-01|March 2009|2009-03-01||||||||Observational|||Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis||Completed||N/A|39|Anticipated|Office of Rare Diseases (ORD)|||||f||||t||||||||||2017-10-11 04:30:31.697791|2017-10-11 04:30:31.697791
NCT00014794|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-11|2008-03-03|||April 2001||2001-04-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients|H215O Positron Emission Tomography (PET) in the Assessment of Synovial Blood Flow in Rheumatoid Arthritis Patients|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:31.748225|2017-10-11 04:30:31.748225
NCT00014807|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-11|2006-09-01|||July 2000||2000-07-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Reducing Pesticide Exposure in Minority Families|Reducing Pesticide Exposure in Minority Families|Completed||N/A|1000||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:33.33591|2017-10-11 04:30:33.33591
NCT00014820|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-11|2015-12-17|||March 2001||2001-03-01|December 2015|2015-12-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Occupation and Asthma in an Urban Low Income Population|Occupation and Asthma in an Urban Low Income Population|Completed||N/A|800|Actual|New York University School of Medicine|||3||f||||||||||||||2017-10-11 04:30:33.40039|2017-10-11 04:30:33.40039
NCT00014833|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-11|2016-04-09|||March 2001||2001-03-01|April 2016|2016-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Life Course Socioeconomic Status, Social Context and Cardiovascular Disease||Completed||N/A|15872|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||Yes|Data shared through LOINCC and directly by request to the PI|2017-10-11 04:30:33.468488|2017-10-11 04:30:33.468488
NCT00014859|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-11|2015-06-01|||June 2001||2001-06-01|June 2015|2015-06-01|June 2019|Anticipated|2019-06-01|June 2015|Actual|2015-06-01|4 Weeks|Observational [Patient Registry]|||Epidemiology of Surfactant Protein-B Deficiency|Epidemiology of Surfactant Protein-B Deficiency|Recruiting||N/A|5000|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples With DNA|"     DNA and tracheal aspirate samples   "|||2017-10-11 04:30:33.552573|2017-10-11 04:30:33.552573
NCT00014872|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-11|2014-01-09|||May 2001||2001-05-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Genetic Epidemiology and Energy Metabolism in Black Girls||Completed||N/A|600|Actual|University of New Mexico|||1||f||||||||||||||2017-10-11 04:30:33.675935|2017-10-11 04:30:33.675935
NCT00014885|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-12|2006-03-22|||September 1998||1998-09-01|March 2006|2006-03-01|August 2001||2001-08-01|||||Observational|||Bone Lead Levels and College Achievement Scores||Completed||N/A|750||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:33.739806|2017-10-11 04:30:33.739806
NCT00014898|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-12|2005-06-23|||June 1999||1999-06-01|March 2001|2001-03-01|May 2002||2002-05-01|||||Observational|||Attention Deficit Disorder and Exposure to Lead||Completed||N/A|500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:33.788157|2017-10-11 04:30:33.788157
NCT00014911|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-13|2017-02-06|2012-09-13||April 2001||2001-04-01|February 2017|2017-02-01|August 2010|Actual|2010-08-01|June 2005|Actual|2005-06-01||Interventional|||Islet Transplantation for Type 1 Diabetes|Islet Transplantation for Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression (ITN005CT)|Completed||Phase 2|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||Yes|Data access is provided to the public in : 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools available to researchers; and 2.) TrialShare, the Immune Tolerance Network (ITN) portal.|2017-10-11 04:30:33.868302|2017-10-11 04:30:33.868302
NCT00014937|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-14|2013-07-26||||||July 2013|2013-07-01||||December 2004|Actual|2004-12-01||Interventional|||Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen|A Randomized, Controlled Trial of Two Potent, Simplified Regimens Utilizing A Protease Inhibitor-Sparing Regimen Versus A Nucleoside-Sparing Regimen for HIV-Infected Subjects Who Participated in ACTG 388 or Who Responded to A First Potent Combination Regimen and Have 200 or Less HIV-1 RNA Copies/ml|Completed||N/A|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:34.887039|2017-10-11 04:30:34.887039
NCT00014950|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-14|2010-03-01||||||March 2010|2010-03-01||||||||Interventional|||Benefits and Risks of Newborn Screening for Cystic Fibrosis|Pulmonary Benefits of Cystic Fibrosis Neonatal Screening|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:35.107479|2017-10-11 04:30:35.107479
NCT00014963|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-16|2006-03-22||||||March 2006|2006-03-01||||||||Observational|||Biomarkers of Benzene Exposure in Inner City Residents||Completed||N/A|90||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:35.204637|2017-10-11 04:30:35.204637
NCT00014989|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-17|2016-09-26|||December 1997||1997-12-01|September 2016|2016-09-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|BEAM||Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)|Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)|Completed||Phase 3|2136|Actual|The George Washington University Biostatistics Center||1|||f||||t||||||||Yes|The data will be shared after completion and publication of the main analyses in accordance with NIH policy. The dataset can be obtained by email at mfmudatasets@bsc.gwu.edu.|2017-10-11 04:30:35.338178|2017-10-11 04:30:35.338178
NCT00015002|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-17|2016-09-29|||March 2000||2000-03-01|September 2016|2016-09-01|March 2007|Actual|2007-03-01|May 2006|Actual|2006-05-01||Interventional|BEARS||Repeat Antenatal Steroids Trial|A Randomized Placebo-Controlled Trial of Antenatal Corticosteroid Regimens|Terminated||Phase 3|486|Actual|The George Washington University Biostatistics Center||1||Concerns regarding neonatal data|f||||t||||||||Yes|The data will be shared after completion and publication of the main analyses in accordance with NIH policy. The dataset can be obtained by emailing mfmudatasets@bsc.gwu.edu|2017-10-11 04:30:35.500684|2017-10-11 04:30:35.500684
NCT00015015|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-17|2006-09-01|||December 1994||1994-12-01|September 2006|2006-09-01|October 2002||2002-10-01|||||Observational|||Dichloroacetate Kinetics, Metabolism and Toxicology||Completed||N/A|100||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:35.692443|2017-10-11 04:30:35.692443
NCT00015028|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-13|||November 1996||1996-11-01|November 1996|1996-11-01|January 1997|Actual|1997-01-01|December 1996|Actual|1996-12-01||Interventional|||Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1|CS1008A Efficacy/Safety Trial of Buprenorphine/Naloxone|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:35.782331|2017-10-11 04:30:35.782331
NCT00015041|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11|||November 1996||1996-11-01|July 1998|1998-07-01|July 1998|Actual|1998-07-01|June 1998|Actual|1998-06-01||Interventional|||Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2|PK 0396 - Buprenorphine Dose Escalation Trial|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:35.882151|2017-10-11 04:30:35.882151
NCT00015054|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-13|||September 1998||1998-09-01|February 1999|1999-02-01|November 1999|Actual|1999-11-01|October 1999|Actual|1999-10-01||Interventional|||Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3|MPD04961-Methylphendidate Treatment of Cocaine Dependent ADHD Patients|Completed||Phase 2|20||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:35.974485|2017-10-11 04:30:35.974485
NCT00015067|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11|||December 1997||1997-12-01|October 1998|1998-10-01||||||||Interventional|||Cocaine-Methylphendidate Interaction Study - 4|Cocaine-Methylphendidate Interaction Study|Completed||Phase 1|8||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:36.13721|2017-10-11 04:30:36.13721
NCT00015080|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-13|||May 1995||1995-05-01|December 1996|1996-12-01|July 1996|Actual|1996-07-01|June 1996|Actual|1996-06-01||Interventional|||Naltrexone in Treatment of Cocaine Dependence - 5|Naltrexone in Treatment of Cocaine Dependence|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:36.313275|2017-10-11 04:30:36.313275
NCT00015106|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11|||November 1997||1997-11-01|February 1999|1999-02-01|February 1999|Actual|1999-02-01|January 1999|Actual|1999-01-01||Interventional|||Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7|CREST-I: Resperine, Gabapentin, or Lamotrigine vs. Placebo|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:36.399978|2017-10-11 04:30:36.399978
NCT00015132|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11|||March 1999||1999-03-01|March 1999|1999-03-01|November 2000|Actual|2000-11-01|September 2000|Actual|2000-09-01||Interventional|||Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9|CREST-II: Tiagabine, Sertraline, or Donepezil vs. Unmatched Placebo|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:36.490852|2017-10-11 04:30:36.490852
NCT00015171|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-13|||April 1996||1996-04-01|January 1999|1999-01-01|June 1997|Actual|1997-06-01|May 1997|Actual|1997-05-01||Interventional|||Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1|CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence|Completed||Phase 3|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:36.576191|2017-10-11 04:30:36.576191
NCT00015210|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2015-07-29|||February 1997||1997-02-01|July 2015|2015-07-01||||May 1999|Actual|1999-05-01||Interventional|||Nefazodone in the Treatment of Cocaine Dependence and Depression - 4|Efficacy of Nefazodone in Cocaine Dependent Subjects|Completed||Phase 2|69|Actual|Boston Medical Center||2|||f||||||||||||||2017-10-11 04:30:36.680098|2017-10-11 04:30:36.680098
NCT00015223|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-13|||June 1997||1997-06-01|October 2012|2012-10-01|August 1999|Actual|1999-08-01|July 1999|Actual|1999-07-01||Interventional|||Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5|Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:36.810834|2017-10-11 04:30:36.810834
NCT00015236|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11|||March 1997||1997-03-01|June 1998|1998-06-01||||||||Interventional|||Modeling Impaired Judgement in Cocaine Abusers - 6|Modeling Impaired Judgement in Cocaine Abusers|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:36.932729|2017-10-11 04:30:36.932729
NCT00015249|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11|||February 1997||1997-02-01|June 1998|1998-06-01|May 1998|Actual|1998-05-01|April 1998|Actual|1998-04-01||Interventional|||Prepulse Inhibition of Startle in Cocaine Dependence - 7|Prepulse Inhibition of Startle in Cocaine Dependence (Human)|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:37.057141|2017-10-11 04:30:37.057141
NCT00015275|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11||||||December 2002|2002-12-01||||||||Interventional|||Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9|Pathophysiological Subtyping of Abnormalities in Cocaine Dependence|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:37.189374|2017-10-11 04:30:37.189374
NCT00015288|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-01-11|||November 1996||1996-11-01|August 1998|1998-08-01||||||||Interventional|||Buprenorphine and Naloxone Combination Study - 10|PK0496 Pharmacokinetics of Buprenorphine|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:30:37.324883|2017-10-11 04:30:37.324883
NCT00015301|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-02-23|||December 2003|Actual|2003-12-01|December 2002|2002-12-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11|Methylphenidate Raclopride PET Test|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f|||||t|f||||||||2017-10-11 04:30:37.451327|2017-10-11 04:30:37.451327
NCT00015431|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-10-05|||April 16, 2001||2001-04-16|July 10, 2013|2013-07-10|July 10, 2013||2013-07-10|||||Observational|||Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms|The Immune Basis for the Gastrointestinal Complications of Common Variable Immunodeficiency|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:37.769127|2017-10-11 04:30:37.769127
NCT00015444|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2017-10-05|||April 11, 2001||2001-04-11|July 10, 2017|2017-07-10||||||||Observational|||Screening and Natural History: Primary Lateral Sclerosis and Related Disorders|Screening and Natural History: Primary Lateral Sclerosis and Related Disorders|Active, not recruiting||N/A|189|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:37.898056|2017-10-11 04:30:37.898056
NCT00015457|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-18|2013-03-14|2013-03-14||April 2001||2001-04-01|March 2013|2013-03-01||||April 2009|Actual|2009-04-01||Interventional|||Amlodipine Plus Botulinum Toxin for Focal Dystonia|Trial of Amlodipine Combined With Botulinum Toxin Injections for Focal Dystonia|Completed||Phase 2|16|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:30:38.009015|2017-10-11 04:30:38.009015
NCT00015470|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-19|2017-06-30|||April 16, 2001||2001-04-16|May 10, 2007|2007-05-10|May 10, 2007||2007-05-10|||||Observational|||Diagnostic Evaluation of Patients With Neuromuscular Disease|Diagnostic Evaluation of Patients With Neuromuscular Diseases|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:38.293981|2017-10-11 04:30:38.293981
NCT00015483|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-20|2006-09-01||||||September 2006|2006-09-01||||||||Observational|||Hematotoxic Effects of Particulate Exposure|Hematotoxic Effects of Benzene and Doxorubicin|Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:38.355079|2017-10-11 04:30:38.355079
NCT00015548|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-20|2015-06-16|||March 2001||2001-03-01|February 2009|2009-02-01|October 2004||2004-10-01|||||Interventional|||CATIE-Alzheimer's Disease Trial|Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)|Completed||N/A|450||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:30:38.417347|2017-10-11 04:30:38.417347
NCT00015561|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-20|2006-09-01|||September 1996||1996-09-01|September 2006|2006-09-01|August 2001||2001-08-01|||||Observational|||Pesticides--Health Fertility and Reproductive Risk||Completed||N/A|1803||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:38.584008|2017-10-11 04:30:38.584008
NCT00015574|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-20|2006-09-01|||September 1998||1998-09-01|September 2006|2006-09-01|September 2004||2004-09-01|||||Observational|||Air Pollution and Implantable Cardioverter Defibrillators||Completed||N/A|500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:38.652992|2017-10-11 04:30:38.652992
NCT00015587|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-23|2016-10-11|||April 1995||1995-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|CCLS||Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)|Chemical Exposures and Leukemia Risks and Childhood Leukemia and Environmental Exposure|Completed||N/A|3523|Actual|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||f||||||Samples With DNA|"     pre-treatment peripheral blood and bone marrow saliva   "|||2017-10-11 04:30:38.727372|2017-10-11 04:30:38.727372
NCT00015600|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-23|2006-03-22|||October 1997||1997-10-01|March 2006|2006-03-01|September 2002||2002-09-01|||||Interventional|||Community-Based Environmental Health Intervention|Community-Based Environmental Health Intervention|Completed||N/A|500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:38.851805|2017-10-11 04:30:38.851805
NCT00015613|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-23|2005-11-02|||August 1998||1998-08-01|September 2002|2002-09-01|September 2001||2001-09-01|||||Observational|||Farm Work & Preterm Low Birthweight Among Hispanic Women|Study of Hispanic Acculturation Reproduction and the Environment (SHARE)|Completed||N/A|1500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:30:38.917895|2017-10-11 04:30:38.917895
NCT00015626|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-24|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)|A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)|Completed||Phase 2|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:38.986666|2017-10-11 04:30:38.986666
NCT00015639|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-25|2008-03-03|||April 2001||2001-04-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus|Identification of Donors of CD36-Deficient Platelets Among Individuals on the NIH Campus|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:39.06581|2017-10-11 04:30:39.06581
NCT00015652|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-26|2012-05-21||||||May 2012|2012-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection|A Pilot Study of Low Dose Interleukin-2 (IL-2) With the Addition of Pegylated Interferon (PEG-IFN Alfa-2b) and Ribavirin (RBV) for the Treatment of Hepatitis C Infection in Subjects With HIV Coinfection|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:30:39.161717|2017-10-11 04:30:39.161717
NCT00015665|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-28|2008-03-03|||April 2001||2001-04-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections|Open-Label, Non-Comparative Protocol for the Emergency Use of Voriconazole in Patients With Life Threatening, Invasive Mycoses Who Are Failing on Currently Available Antifungal Agents|Completed||Phase 3|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:39.355295|2017-10-11 04:30:39.355295
NCT00015678|ClinicalTrials.gov processed this data on October 10, 2017|2001-04-28|2008-03-03|||April 2001||2001-04-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Observational|||Effects of Flumazenil on Brain Excitability|Effects of Flumazenil on Cortical Excitability in Humans|Completed||N/A|7||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:39.513751|2017-10-11 04:30:39.513751
NCT00015691|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-01|2013-07-19||||||July 2013|2013-07-01||||January 2006|Actual|2006-01-01||Interventional|||Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities|A Randomized, Double-Blind, Placebo-Controlled Study of Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Subjects With Hyperinsulinemia and Elevated Waist/Hip Ratio|Completed||N/A|105||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:39.616222|2017-10-11 04:30:39.616222
NCT00016328|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-07-17|||May 2001||2001-05-01|June 2013|2013-06-01||||August 2005|Actual|2005-08-01||Interventional|||CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme|A Phase II Study of CCI-779 in Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:45.862328|2017-10-11 04:30:45.862328
NCT00015704|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-01|2012-05-21||||||May 2012|2012-05-01|November 2004|Actual|2004-11-01|||||Interventional|||Effect of Interleukin-2 on HIV Treatment Interruption|An Open-Label, Pilot Study Utilizing CD4 T-Cell Counts Lower Than 350 Cells/mm3 as the Threshold for Restarting Therapy With Potent Antiretroviral Therapy With or Without Interleukin-2 to Determine the Effect of Pulse Therapy on the Characteristics of Treatment Interruptions|Completed||N/A|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:30:39.809586|2017-10-11 04:30:39.809586
NCT00015717|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-02|2008-03-03|||April 2001||2001-04-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Magnetic Resonance Imaging to Investigate Silent Strokes During Neck and Skull Angioplasty|Silent Cerebral Ischemia After Cervico-Cranial Angioplasty Detected by Diffusion-Weighted MRI|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:39.953786|2017-10-11 04:30:39.953786
NCT00015756|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-04|2017-06-30|||May 2, 2001||2001-05-02|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Tissue Collection From People With Cystic Fibrosis|Tissue Collection Protocol for Individuals With Cystic Fibrosis|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:40.056018|2017-10-11 04:30:40.056018
NCT00015769|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-04|2008-03-03|||April 2001||2001-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness|Pilot Evaluation of Levetiracetam (Keppra® (Registered Trademark)) in Bipolar Illness|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:40.128352|2017-10-11 04:30:40.128352
NCT00015782|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-04|2017-06-30|||April 27, 2001||2001-04-27|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||The Natural History and Pathogenesis of Mucolipidosis Type IV|The Natural History and Pathogenesis of Mucolipidosis Type IV|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:40.214687|2017-10-11 04:30:40.214687
NCT00015795|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-04|2008-03-03|||May 2001||2001-05-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Interventional|||Study of Air Stream in Voice Production|Laryngeal Resistance in Abductor Spasmodic Dysphonia|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:40.289112|2017-10-11 04:30:40.289112
NCT00015808|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2006-07-11|||May 2001||2001-05-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Safety Study of Idebenone to Treat Friedreich's Ataxia|Phase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenone in Children, Adolescents, and Adults With Friedreich's Ataxia|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:40.396301|2017-10-11 04:30:40.396301
NCT00015821|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-10-07|||May 2000||2000-05-01|October 2013|2013-10-01||||December 2007|Actual|2007-12-01||Interventional|||Thalidomide in Treating Patients With Myelofibrosis|A Pilot Study of Thalidomide as an Inhibitor of Angiogenesis in the Treatment of Myelofibrosis With Myeloid Metaplasia (MMM)|Completed||Phase 2|43|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:40.491753|2017-10-11 04:30:40.491753
NCT00015834|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-23|||May 2001||2001-05-01|January 2013|2013-01-01||||April 2003|Actual|2003-04-01||Interventional|||STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia|A Phase I/II Trial of STI571 and High-Dose Cytarabine in Myeloid Blast Crisis of Chronic Myeloid Leukemia|Completed||Phase 1/Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:40.596964|2017-10-11 04:30:40.596964
NCT00015847|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2012-07-12|2012-06-06||April 2001||2001-04-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia|A Phase I/II Dose-Finding Study to Determine the Safety, Tolerability, and Anti-Leukemic Effects of STI571 (NSC 716051) in Combination With Interferon-alpha in Patients With Chronic Myelogenous Leukemia in Chronic Phase|Terminated||Phase 2|25|Actual|OHSU Knight Cancer Institute|Early termination; 12 month follow-up was not carried out.|1|||f||||t||||||||||2017-10-11 04:30:40.753457|2017-10-11 04:30:40.753457
NCT00015860|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-06-20|||May 2001||2001-05-01|September 2003|2003-09-01|October 2003|Actual|2003-10-01|||||Interventional|||STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia|A Phase I/II Trial of STI-571 and Chemotherapy in Lymphoid Blast Crisis of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoid Leukemia|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:41.117847|2017-10-11 04:30:41.117847
NCT00015873|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2014-02-14|||May 1999||1999-05-01|February 2014|2014-02-01|December 2009|Actual|2009-12-01|February 2006|Actual|2006-02-01||Interventional|||Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia|International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic Leukemia|Completed||Phase 3|350|Anticipated|Dutch Childhood Oncology Group||2|||f||||t||||||||||2017-10-11 04:30:41.265253|2017-10-11 04:30:41.265253
NCT00015886|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2017-05-25|||January 1997||1997-01-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|May 2002|Actual|2002-05-01||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery|Docetaxel (Taxotere) and 5-Fluorouracil As Second- Or Third-Line Chemotherapy In Women With Metastatic Breast Cancer|Completed||Phase 2|25|Actual|Wake Forest University Health Sciences||1|||f||||t|t|f||||||||2017-10-11 04:30:41.548106|2017-10-11 04:30:41.548106
NCT00015899|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2009-10-13|||January 2002||2002-01-01|October 2009|2009-10-01|March 2007|Actual|2007-03-01|September 2005|Actual|2005-09-01||Interventional|||SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors|Phase I Trial Of Escalating Oral Doses Of SCH 66336 In Pediatric Patients With Refractory Or Recurrent Brain Tumors|Completed||Phase 1|53|Actual|Pediatric Brain Tumor Consortium|||||f||||t||||||||||2017-10-11 04:30:41.682538|2017-10-11 04:30:41.682538
NCT00015912|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-24|||July 2001||2001-07-01|January 2013|2013-01-01||||September 2003|Actual|2003-09-01||Interventional|||Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Clinical And Biologic Study Of The Combination Of Low Dose Interferon-Alpha And Thalidomide (NSC #66847) For Patients With Relapsed Or Refractory Low-Grade Follicular Lymphoma|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:30:41.826525|2017-10-11 04:30:41.826525
NCT00015925|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2010-03-09|||February 2001||2001-02-01|March 2010|2010-03-01||||||||Interventional|||MS-275 in Treating Patients With Hematologic Cancer|Phase I Clinical-Labratory Study of the Histone Deacetylase (HDA) Inhibitor MS-275 in Adults With Refractory and Relapsed Hematologic Malignancies|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:30:41.925229|2017-10-11 04:30:41.925229
NCT00015938|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-23|||May 2001||2001-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|February 2005|Actual|2005-02-01||Interventional|||S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer|Docetaxel And Vinorelbine Plus Filgrastim For HER-2 Negative, Stage IV Breast Cancer|Completed||Phase 2|95|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:30:42.037534|2017-10-11 04:30:42.037534
NCT00015951|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2009-09-23|||April 2001||2001-04-01|September 2009|2009-09-01|March 2004|Actual|2004-03-01|April 2003|Actual|2003-04-01||Interventional|||Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers|A Phase II Study of the Recombinant Human Monoclonal Anti-Vascular Endothelial Growth Factor Antibody (rhuMAB VEGF) Bevacizumab (NSC #704865, IND # 7,921) Administered in Times Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Refractory and Relapsed Acute Myelogenous Leukemias (AMLs)|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-10-11 04:30:42.305693|2017-10-11 04:30:42.305693
NCT00015964|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-09-04|||March 2001||2001-03-01|September 2013|2013-09-01|July 2005|Actual|2005-07-01|September 2001|Actual|2001-09-01||Interventional|||ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck|A Phase II Stdy of ZD 1839 in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|51|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:30:42.386019|2017-10-11 04:30:42.386019
NCT00015977|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2014-03-06|||November 2001||2001-11-01|March 2014|2014-03-01|January 2005|Actual|2005-01-01|March 2003|Actual|2003-03-01||Interventional|||Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Phase II Study of Immunization With PSMA Peptide-Pulsed Autologous PBMC Plus rhIL-12 in Patients With Metastatic Prostate Cancer|Completed||Phase 2|13|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:30:42.518605|2017-10-11 04:30:42.518605
NCT00015990|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-23|||April 2001||2001-04-01|January 2013|2013-01-01||||February 2007|Actual|2007-02-01||Interventional|||Thalidomide in Treating Patients With Myelodysplastic Syndrome|Phase II Study of Thalidomide in the Treatment of Myelodysplastic Syndromes in Adults: A Clinical and Biologic Study|Completed||Phase 2|29|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:42.627888|2017-10-11 04:30:42.627888
NCT00016016|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-10-07|||February 2001||2001-02-01|October 2013|2013-10-01||||November 2006|Actual|2006-11-01||Interventional|||Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia|A Phase I/II Study of Flavopiridol (NSC 649890, IND 46,211) in Timed Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Poor-Risk Acute Leukemias|Completed||Phase 1/Phase 2|53|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:42.72522|2017-10-11 04:30:42.72522
NCT00016029|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-03-20|||August 2000||2000-08-01|September 2003|2003-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer|Prospective Comparison of Air Contrast Barium Enema (ACBE), Computed Tomographic Colonography (Virtual Colonoscopy) and Colonoscopy for Evaluation of the Colon in Patients With Fecal Occult Blood|Terminated||N/A|775|Actual|Duke University|||||f||||||||||||||2017-10-11 04:30:43.002582|2017-10-11 04:30:43.002582
NCT00016042|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-09-19|||January 2001||2001-01-01|October 2001|2001-10-01||||||||Interventional|||Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer|Interleukin 12-Primed Activated T Cells For Patients With Metastatic Renal Cell Carcinoma Or Colorectal Carcinoma (Phase I)|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:43.146052|2017-10-11 04:30:43.146052
NCT00016055|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-09-19|||November 2000||2000-11-01|November 2006|2006-11-01||||||||Interventional|||Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma|Interleukin 12-Primed Activated T Cells As Therapy For Patients With Metastatic Melanoma (Phase I)|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:43.266105|2017-10-11 04:30:43.266105
NCT00016068|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2010-05-14|||January 2001||2001-01-01|May 2010|2010-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation|A Phase III Multicenter Study Of Valganciclovir For The Prevention Of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 3|184|Anticipated|Fred Hutchinson Cancer Research Center|||||||||||||||||||2017-10-11 04:30:43.369196|2017-10-11 04:30:43.369196
NCT00016081|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2010-03-26|||March 1998||1998-03-01|March 2010|2010-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation|A Randomized Phase III Study To Evaluate The Safety And Efficacy Or Ribavirin Inhaled Solution In Preventing Progression Of Upper Respiratory Tract Respiratory Syncytial Virus (RSV) Infection To RSV Pneumonia In Blood And Bone Marrow Transplant (BMT) Recipients|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:30:43.470834|2017-10-11 04:30:43.470834
NCT00016094|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-28|||April 2001||2001-04-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|August 2005|Actual|2005-08-01||Interventional|||S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma|Bevacizumab (rhuMab VEGF) (NSC-704865) Therapy for Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:43.572067|2017-10-11 04:30:43.572067
NCT00016107|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-06-04|||June 2001||2001-06-01|June 2013|2013-06-01||||February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer|A Phase II Study Of Estramustine, Docetaxel, And Bevacizumab (IND # 7921, NSC # 704865) In Men With Hormone Refractory Prostate Cancer|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:43.684836|2017-10-11 04:30:43.684836
NCT00016133|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-05-29|||March 2001||2001-03-01|July 2004|2004-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery|A Non-Randomized Multicenter Phase I/II Study Of Active Specific Immunotherapy In Patients With Stage II and Stage III Colon Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:43.82638|2017-10-11 04:30:43.82638
NCT00006138|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||June 1998||1998-06-01|October 2000|2000-10-01|August 2000||2000-08-01|||||Observational|||Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major||Completed||N/A|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:30:53.929738|2017-10-11 04:30:53.929738
NCT00016146|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-03-18|||July 2000||2000-07-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer|Vaccination Of Prostate Cancer Patients With A Bivalent Vaccine Containing MUC-2 Glycopeptide And Globo H Conjugates: A Dose-Escalating Trial Studying The Immunogenicity And Safety Of The Immunological Adjuvant GPI-0100|Completed||Phase 1|34|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:30:43.920278|2017-10-11 04:30:43.920278
NCT00016159|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-15|||November 2000||2000-11-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia|Phase II Study Of Combined Modality Postremission Therapy As Determined By Molecular Response (Adaptive Regulation) In The Treatment Of Acute Promyelocytic Leukemia (APL)|Completed||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:44.022711|2017-10-11 04:30:44.022711
NCT00016172|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-06-17|||November 2000||2000-11-01|June 2013|2013-06-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study of ZD0473 and Doxil in Patients With Advanced Refractory Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:44.153678|2017-10-11 04:30:44.153678
NCT00016185|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-04-03|||March 2001||2001-03-01|April 2013|2013-04-01|December 2005|Actual|2005-12-01|February 2003|Actual|2003-02-01||Interventional|||Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors|Phase I Study Of Flavopiridol And Docetaxel (Taxotere) In Patients With Advanced Cancers|Completed||Phase 1|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:30:44.300405|2017-10-11 04:30:44.300405
NCT00016198|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-06-25|||May 2001||2001-05-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|April 2003|Actual|2003-04-01||Interventional|||Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer|A Randomized, Multicenter, Phase II Study Of Bolus/Infusion 5-FU/LV (de Gramont Regimen) Versus Oxaliplatin And Bolus/Infusion 5-FU/LV (de Gramont Regimen) As Third-Line Treatment Of Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:44.400114|2017-10-11 04:30:44.400114
NCT00016211|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2012-09-20|||February 2001||2001-02-01|September 2012|2012-09-01||||March 2006|Actual|2006-03-01||Interventional|||Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer|Prophylactic Cranial Irradiation In Extensive Disease Small Cell Lung Cancer|Completed||Phase 3|287|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:30:44.66793|2017-10-11 04:30:44.66793
NCT00016224|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-06-17|||January 2001||2001-01-01|June 2013|2013-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer|Phase II Trial of Thalidomide in Patients With Ovarian Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:44.856192|2017-10-11 04:30:44.856192
NCT00016237|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-10-22|||December 2000||2000-12-01|June 2002|2002-06-01||||||||Interventional|||Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment|Phase I Dose-Escalation Study of the Pharmacokinetic, Safety, Tolerability, and Biologic Activity of huKS-IL-2 Administered Daily as a 1-Hour Intravenous Infusion for Five Consecutive Days for Treatment of Refractory Epithelial Cancer|Completed||Phase 1|||EMD Serono|||||f||||||||||||||2017-10-11 04:30:44.92982|2017-10-11 04:30:44.92982
NCT00016250|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-06-17|||December 2000||2000-12-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer|A Randomized Phase II Study of Two Shcedules of Ro 31-7453 in Patients With Metastatic (Dukes' D) Colorectal Carcinoma (CRC) Who Have Failed Both Fluoropyrimidine and Irinotecan Chemotherapy|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:30:44.998498|2017-10-11 04:30:44.998498
NCT00016263|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2014-01-03|||July 2000||2000-07-01|October 2002|2002-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma|Randomized Study Of Dacarbazine Versus Dacarbazine Plus G3139 (Bcl-2 Antisense Oligonucleotide) In Patients With Advanced Malignant Melanoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:45.076539|2017-10-11 04:30:45.076539
NCT00016276|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-15|||May 2001||2001-05-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer|A 2X2X2 Factorial Randomized Phase III Trial Of Multimodality Therapy Comparing 4 Cycles Of Doxorubicin And Cyclophosphamide With Or Without Dexrazoxane (AC+/-Z) Followed By 12 Weeks Of Weekly Paclitaxel With Or Without Trastuzumab (T+/-H) Followed By Local Therapy Followed By 40 Weeks Of Weekly Trastuzumab Or None In Women With HER-2+ STAGE IIIA, IIIB OR REGIONAL STAGE IV BREAST CANCER|Terminated||Phase 3|396|Actual|National Cancer Institute (NCI)||8||Administratively complete.|f||||||||||||||2017-10-11 04:30:45.151511|2017-10-11 04:30:45.151511
NCT00016289|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-22|||July 2001||2001-07-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer|Phase II Study of Intraperitoneal Recombinant Human Interleukin-12 (rhIL-12) in Patients With Peritoneal Carcinomatosis (Residual Disease < 1cm) Associated With Ovarian Epithelial Cancer or Primary Peritoneal Carcinoma|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:30:45.350001|2017-10-11 04:30:45.350001
NCT00016302|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-15|||April 2001||2001-04-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|The Use of Modified BFM +/- Compound 506U78 (Nelarabine) (NSC# 686673, IND #52611) in an Intensive Chemotherapy Regimen for the Treatment of T-Cell Leukemia|Completed||N/A|100|Actual|National Cancer Institute (NCI)||6|||f||||||||||||||2017-10-11 04:30:45.458496|2017-10-11 04:30:45.458496
NCT00016315|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2015-11-14|||May 2001||2001-05-01|November 2015|2015-11-01|June 2010|Actual|2010-06-01|January 2009|Actual|2009-01-01||Interventional|||Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer|A Phase I Study of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Radiation Therapy Followed by Adjuvant Chemotherapy for Patients With Favorable Prognosis Inoperable Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|35|Actual|Radiation Therapy Oncology Group||13|||f||||t||||||||||2017-10-11 04:30:45.697751|2017-10-11 04:30:45.697751
NCT00016341|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-04-10|||May 2001||2001-05-01|June 2007|2007-06-01||||October 2003|Actual|2003-10-01||Interventional|||Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer|Randomized Phase III Crossover Trial of Chemotherapy (Doxorubicin/Cisplatin/Paclitaxel and G-CSF) Versus Hormonal Therapy (Tamoxifen/Megestrol Acetate) in Patients With Stage III & IV or Recurrent Endometrial Cancer|Terminated||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:30:45.970877|2017-10-11 04:30:45.970877
NCT00016354|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-03-18|2012-06-11||March 2001||2001-03-01|March 2013|2013-03-01|September 2006|Actual|2006-09-01|August 2004|Actual|2004-08-01||Interventional|||Benzoylphenylurea in Treating Patients With Advanced Solid Tumors|Phase I Study of Continuous Weekly Dosing of Dimethyl Benzoylphenylurea (BPU) in Patients With Solid Tumors Not Responding to Conventional Therapy|Completed||Phase 1|19|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:30:46.143516|2017-10-11 04:30:46.143516
NCT00016367|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2012-07-27|||May 2001||2001-05-01|July 2012|2012-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Multidose, Single Arm, Multicenter Clinical Trial of Cisplatin and Gemcitabine in Combination With Recombinant Humanized Anti-p185HER2 Monoclonal Antibody (Herceptin) in Patients Who Have Untreated p185HER2 Overexpressing Advanced Local Stage (Stage IIIb Pleural Effusion Only) and Metastatic (Stage IV) Non-Small Cell Lung Cancer|Completed||Phase 2|22|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:30:46.390233|2017-10-11 04:30:46.390233
NCT00016380|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2016-11-25|||February 2001||2001-02-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|April 2004|Actual|2004-04-01||Interventional|||Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen|A Randomized Phase III Double-Blind Study Of Ondansetron And Dexamethasone Versus Ondansetron And Placebo In The Prophylaxis Of Radiation-Induced Emesis|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-10-11 04:30:46.502812|2017-10-11 04:30:46.502812
NCT00016393|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-06-20|||June 2001||2001-06-01|February 2004|2004-02-01|April 2006|Actual|2006-04-01|||||Interventional|||BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) (IND 59699) Administered Every 21 Days in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:30:46.680834|2017-10-11 04:30:46.680834
NCT00016406|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2013-01-23|||May 2001||2001-05-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|September 2006|Actual|2006-09-01||Interventional|||S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer|A Comparative Randomized Study of Standard Doxorubicin and Cyclophosphamide Followed by Weekly Paclitaxel Vs. Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF Followed by Weekly Paclitaxel As Neoadjuvant Therapy For Inflammatory and Locally Advanced Breast Cancer|Completed||Phase 3|399|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:30:46.97809|2017-10-11 04:30:46.97809
NCT00016419|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2015-03-05|||August 2001||2001-08-01|March 2015|2015-03-01|January 2007|Actual|2007-01-01|July 2003|Actual|2003-07-01||Interventional|||S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome|A Phase II Study of Anti-Thymocyte Globulin and Cyclosporine for Patients With Myelodysplastic Syndrome (MDS)|Completed||Phase 2|130|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-10-11 04:30:47.847417|2017-10-11 04:30:47.847417
NCT00016432|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2011-04-18|||May 2001||2001-05-01|April 2011|2011-04-01|February 2011|Actual|2011-02-01|October 2003|Actual|2003-10-01||Interventional|||Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen|A Randomized Trial Evaluating The Effect Of Exemestane In Clinical Stage T1-3 N0-1 M0 Postmenopausal Breast Cancer Patients Completing At Least Five Years Of Tamoxifen Therapy|Completed||Phase 3|1598|Actual|NSABP Foundation Inc||2|||f||||||||||||||2017-10-11 04:30:48.164154|2017-10-11 04:30:48.164154
NCT00016445|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2008-09-08|||February 2001||2001-02-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of Growth Hormone in Children With Cystic Fibrosis||Completed||Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:30:48.609243|2017-10-11 04:30:48.609243
NCT00016458|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-06|2008-09-02|||June 2000||2000-06-01|September 2008|2008-09-01||||||||Interventional|||Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:30:48.692124|2017-10-11 04:30:48.692124
NCT00016471|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-07|2005-06-23|||March 2001||2001-03-01|November 2003|2003-11-01|February 2002||2002-02-01|||||Observational|||A Genetic Analysis of Usher Syndrome in Ashkenazi Jews|A Genetic Analysis of Usher Syndrome in Ashkenazi Jews|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:48.77835|2017-10-11 04:30:48.77835
NCT00016497|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-10|2006-04-21|||February 1997||1997-02-01|April 2006|2006-04-01|January 2007||2007-01-01|||||Interventional|||Adenoidectomy for Otitis Media in 2-3 Year Old Children|Adenoidectomy for Otitis Media in 2-3 Year Old Children|Terminated||Phase 3|||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-10-11 04:30:48.836719|2017-10-11 04:30:48.836719
NCT00016510|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-12|2008-03-03|||May 2001||2001-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Differences in Brain Processing of First and Second Languages (Korean and English)|Differences of Verbal Working Memory and Translation Systems Between First and Second Languages: a Functional MRI Study|Completed||N/A|63||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:48.917359|2017-10-11 04:30:48.917359
NCT00016523|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-14|2017-09-22|||January 2001||2001-01-01|September 2017|2017-09-01|May 2006|Actual|2006-05-01|September 2003|Actual|2003-09-01||Interventional|Preemie iNO||Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure|Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure|Terminated||Phase 3|420|Actual|NICHD Neonatal Research Network||2||Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm|f||||t||||||||||2017-10-11 04:30:48.98672|2017-10-11 04:30:48.98672
NCT00016536|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-16|2012-04-03||||||April 2012|2012-04-01|May 1997|Actual|1997-05-01|||||Interventional|||Effects of BufferGel and PRO 2000/5 Gel in Men|Male Tolerance Study of BufferGel and PRO 2000/5 Gel (P)|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:30:49.164192|2017-10-11 04:30:49.164192
NCT00016549|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-16|2017-06-30|||May 13, 2001||2001-05-13|April 6, 2012|2012-04-06|January 29, 2007|Actual|2007-01-29|January 29, 2007|Actual|2007-01-29||Interventional|||Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer|A Pilot Study to Evaluate Angiogenesis After Treatment With Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients With Inflammatory Breast Cancer or Locally Advanced Breast Cancer|Completed||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:30:49.272194|2017-10-11 04:30:49.272194
NCT00016562|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-16|2017-06-30|||May 13, 2001||2001-05-13|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Cause and Pathogenesis of Neurometabolic Disorders|The Etiology and Pathogenesis of Neurometabolic Disorders|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:49.348746|2017-10-11 04:30:49.348746
NCT00016588|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-17|2005-06-23|||May 2001||2001-05-01|May 2002|2002-05-01||||||||Interventional|||Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs|An Open-Label Study to Assess the Anti-HIV-1 Activity of Tenofovir Disoproxil Fumarate (TDF) in Antiretroviral-Naive Patients Who Are Chronically Infected With HIV-1|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:30:50.820889|2017-10-11 04:30:50.820889
NCT00016601|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-18|2012-10-31|||June 2001||2001-06-01|October 2012|2012-10-01|May 2004|Actual|2004-05-01|||||Interventional|||Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women|An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) and Selected Protease Inhibitor (PI) and Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) Therapies Among HIV-Infected Women|Completed||N/A|76||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:50.918195|2017-10-11 04:30:50.918195
NCT00006124|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2013-02-12|||June 2000||2000-06-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|March 2006|Actual|2006-03-01||Interventional|||Celecoxib in Treating Patients With Bladder Cancer|Phase IIb/III Chemoprevention Trial of Celecoxib to Prevent Recurrence of Superficial Bladder Cancer|Completed||Phase 2/Phase 3|152|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 04:30:51.056182|2017-10-11 04:30:51.056182
NCT00006125|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2016-07-12|||July 2000||2000-07-01|July 2016|2016-07-01||||August 2006|Actual|2006-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma|A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|||Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:30:51.159243|2017-10-11 04:30:51.159243
NCT00006126|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2015-11-10|||September 1999||1999-09-01|November 2015|2015-11-01|April 2001||2001-04-01|April 2001||2001-04-01||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery|Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients With Incurable Solid Tumors: A Phase I Study|Withdrawn||Phase 1|0|Actual|Northwestern University||||Unable to accrue subjects.|f||||||||||||||2017-10-11 04:30:52.678112|2017-10-11 04:30:52.678112
NCT00006127|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||April 2000||2000-04-01|October 2003|2003-10-01||||||||Interventional|||Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia||Unknown status|Active, not recruiting|Phase 1|21||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:30:52.750879|2017-10-11 04:30:52.750879
NCT00006128|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||July 1998||1998-07-01|December 2003|2003-12-01||||||||Observational|||Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries||Unknown status|Recruiting|N/A|374||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:52.813569|2017-10-11 04:30:52.813569
NCT00006129|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||June 2000||2000-06-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Testosterone and Progressive Resistance Exercise in Men With Burn Injury||Unknown status|Recruiting|N/A|60||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:52.885401|2017-10-11 04:30:52.885401
NCT00006130|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2017-02-14|||June 1999||1999-06-01|February 2017|2017-02-01||||||||Interventional|||Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease|Randomized Study of Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease|Completed||N/A|50||Children's Hospital & Research Center Oakland|||||f||||||||||||||2017-10-11 04:30:52.96098|2017-10-11 04:30:52.96098
NCT00006131|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2007-05-22|||January 1997||1997-01-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster||Completed||N/A|66|Anticipated|National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:53.027905|2017-10-11 04:30:53.027905
NCT00006132|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||June 1997||1997-06-01|December 2003|2003-12-01||||||||Interventional|||Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System||Unknown status|Recruiting|Phase 3|132||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:53.096877|2017-10-11 04:30:53.096877
NCT00006133|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||June 2000||2000-06-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus||Completed||N/A|970||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:53.253922|2017-10-11 04:30:53.253922
NCT00006134|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||September 1993||1993-09-01|December 2003|2003-12-01||||||||Observational|||Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture||Completed||N/A|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:53.510407|2017-10-11 04:30:53.510407
NCT00006135|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||June 1997||1997-06-01|December 2003|2003-12-01||||||||Interventional|||Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth||Completed||Phase 3|66||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:30:53.592721|2017-10-11 04:30:53.592721
NCT00006136|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-11-04|||March 1999||1999-03-01|July 2004|2004-07-01||||||||Interventional|||Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia||Completed||Phase 2|15||Office of Rare Diseases (ORD)|||||||||||||||||||2017-10-11 04:30:53.738324|2017-10-11 04:30:53.738324
NCT00006137|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-03|2005-06-23|||May 2000||2000-05-01|September 2000|2000-09-01||||||||Interventional|||Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy||Completed||N/A|43||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:30:53.835169|2017-10-11 04:30:53.835169
NCT00006143|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-07|2012-05-17||||||May 2012|2012-05-01|July 2002|Actual|2002-07-01|||||Interventional|||Growth Hormone Treatment of Children With HIV-Associated Growth Failure|A Randomized, Open-Label Study of Recombinant Human Growth Hormone (r-hGH) in Children With HIV-Associated Growth Failure|Completed||N/A|102||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:30:54.075547|2017-10-11 04:30:54.075547
NCT00006144|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-07|2013-11-06|||October 2000||2000-10-01|November 2013|2013-11-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of HIV-Disease Development in Aging|A Phase II Exploratory Study Examining Immunologic and Virologic Indices in Two Age-Differentiated Cohorts of HIV-Infected Subjects to Explore the Basis of Accelerated HIV-Disease Progression Associated With Aging|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:54.209448|2017-10-11 04:30:54.209448
NCT00006145|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-07|2013-07-08|||August 2000||2000-08-01|July 2013|2013-07-01|February 2006|Actual|2006-02-01|||||Interventional|||Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV|A Phase III, Prospective, Randomized, Double-Blind Trial of Valganciclovir Pre-Emptive Therapy for Cytomegalovirus (CMV) Viremia as Detected by Plasma CMV DNA PCR Assay|Completed||Phase 3|350||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:30:54.397978|2017-10-11 04:30:54.397978
NCT00006146|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-07|2010-08-26|||August 2000||2000-08-01|November 2005|2005-11-01|September 2000||2000-09-01|||||Interventional|||Half-Dose Flu Vaccine Study in Healthy Adults|Evaluation of the Immunogenicity of Low Dose Trivalent Inactivated Influenza Vaccine in Healthy Adults|Completed||Phase 2|840||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:54.631009|2017-10-11 04:30:54.631009
NCT00006148|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2008-03-03|||August 2000||2000-08-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Observational|||Spleen Size in Peripheral Blood Stem Cell Donors|Spleen Size in Peripheral Blood Stem Cell Donors|Completed||N/A|49||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:54.703411|2017-10-11 04:30:54.703411
NCT00006150|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2017-10-05|||August 3, 2000||2000-08-03|August 31, 2017|2017-08-31||||||||Observational|||Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection|Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:54.893446|2017-10-11 04:30:54.893446
NCT00006151|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2015-12-01|2013-06-24||May 1999||1999-05-01|December 2015|2015-12-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Combining a Smoke Ending Aid With Behavioral Treatment - 1|Combining a Smoke Ending Aid With Behavioral Treatment|Completed||N/A|60|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 04:30:54.982703|2017-10-11 04:30:54.982703
NCT00006152|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-07|2012-05-17||||||May 2012|2012-05-01|August 2002|Actual|2002-08-01|||||Interventional|||A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment|A Phase II, Restrictively Randomized, Open-Label, Pilot Study of Treatment Intensification of Early Virologic Failure|Completed||Phase 2|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:30:55.289466|2017-10-11 04:30:55.289466
NCT00006153|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-07|2008-07-29||||||June 2003|2003-06-01||||||||Interventional|||Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination|A Multicenter, Double-Blind, Phase I, Adjuvant Controlled Study to Evaluate the Effect of Remune (HIV-1 Immunogen) Compared to IFA, in Combination With Fully Suppressive Antiviral Drug Therapy on HIV-1-Specific Immunogenicity in Subjects With Acute or Primary HIV-1 Infection|Terminated||Phase 1|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:30:55.402788|2017-10-11 04:30:55.402788
NCT00006154|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-07|2013-09-04||||||September 2013|2013-09-01||||||||Interventional|||A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection|Randomized, Controlled, Open Label, Multi-Center Phase III Trial Comparing the Safety and Antiviral Activity of a Protease-Containing Regimen (d4T/ddI/IDV/RTV) Versus a Protease-Sparing Regimen (d4T/ddI/EFV) and the Ability of Interleukin-2 to Purge HIV From Latent Stores in Patients With Acute/Early HIV Infection|Completed||Phase 3|165|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:30:55.484651|2017-10-11 04:30:55.484651
NCT00006155|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-09|2008-03-03|||August 2000||2000-08-01|June 2000|2000-06-01|April 2001||2001-04-01|||||Interventional|||SU5416 and Carboplatin to Treat Ovarian Cancer|A Phase I Study of SU5416, an Antiangiogenesis Agent, in Combination With Carboplatin in Patients With Platinum-Refractory Ovarian Cancer|Completed||Phase 1|33||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:55.627129|2017-10-11 04:30:55.627129
NCT00006156|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-09|2013-03-28|2013-03-28||August 2000||2000-08-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Feasibility Study for Development of an Early Test for Ovarian Failure|FSH-Stimulated Inhibin B as a Marker for Early Ovarian Insufficiency|Completed||N/A|49|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:30:55.711234|2017-10-11 04:30:55.711234
NCT00006157|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-01-12|||July 1996||1996-07-01|January 2010|2010-01-01|March 2001||2001-03-01|||||Interventional|||Treatment of Functional Bowel Disorders|Multicenter Trial of Functional Bowel Disorders|Completed||Phase 3|300||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:56.136498|2017-10-11 04:30:56.136498
NCT00006158|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-02-12|||September 1998||1998-09-01|February 2010|2010-02-01|December 2004|Actual|2004-12-01|||||Interventional|||AIDS Wasting in Women: Anabolic Effects of Testosterone||Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:56.221028|2017-10-11 04:30:56.221028
NCT00006159|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-02-12|||March 1994||1994-03-01|February 2010|2010-02-01|January 2004|Actual|2004-01-01|||||Interventional|||Family-Centered Diabetes Project|Family-Centered Diabetes Project for Pueblo Native Americans|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:56.313867|2017-10-11 04:30:56.313867
NCT00006160|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-02-12||||||February 2010|2010-02-01||||||||Interventional|||African-American Diabetes Intervention Project||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:56.387801|2017-10-11 04:30:56.387801
NCT00006161|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-01-12|||December 1996||1996-12-01|January 2010|2010-01-01|December 2003||2003-12-01|||||Interventional|||Decompression Intervention of Variceal Rebleeding Trial (DIVERT)|Decompression Intervention of Variceal Rebleeding Trial|Completed||Phase 3|140||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:56.446413|2017-10-11 04:30:56.446413
NCT00006162|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-03-01|||October 1994||1994-10-01|March 2010|2010-03-01|April 1999||1999-04-01|||||Interventional|||Lifestyle Interventions to Reduce Diabetes Risk|Interventions to Reduce Diabetic Risk in Japanese Americans|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:56.532682|2017-10-11 04:30:56.532682
NCT00006163|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-03-01|||September 1997||1997-09-01|March 2010|2010-03-01|June 1999||1999-06-01|||||Interventional|||Computer-assisted Diabetes Self-management Interventions||Completed||Phase 4|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:56.614148|2017-10-11 04:30:56.614148
NCT00006164|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-01-12|2009-06-09||June 2000||2000-06-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|April 2007|Actual|2007-04-01||Interventional|HALT-C||Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment|Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)|Completed||Phase 3|1050|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 04:30:56.716435|2017-10-11 04:30:56.716435
NCT00006165|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-03-01||||||March 2010|2010-03-01||||||||Interventional|||Native Hawaiian Diabetes Intervention Program|Cultural-based Diabetes Program for Native Hawaiians|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:57.689567|2017-10-11 04:30:57.689567
NCT00006166|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-01-12|||March 1997||1997-03-01|January 2010|2010-01-01|October 2001||2001-10-01|||||Interventional|||North American Study for the Treatment of Refractory Ascites (NASTRA)|The North American Study for the Treatment of Refractory Ascites (NASTRA) Clinical Trial|Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:57.781409|2017-10-11 04:30:57.781409
NCT00006167|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-01-12|||January 1998||1998-01-01|January 2010|2010-01-01|August 2000||2000-08-01|||||Interventional|||Nutrition Intervention in AIDS Wasting||Completed||Phase 4|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:57.877563|2017-10-11 04:30:57.877563
NCT00006168|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-01-12|||January 1994||1994-01-01|January 2010|2010-01-01|March 2004||2004-03-01|||||Interventional|||Ursodiol-Methotrexate for Primary Biliary Cirrhosis||Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:57.96609|2017-10-11 04:30:57.96609
NCT00006169|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-08|2010-03-01|||June 1996||1996-06-01|March 2010|2010-03-01|November 1999||1999-11-01|||||Interventional|||Behavioral Treatment of Weight Gain in CF|Behavioral Treatment of Weight Gain in CF|Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:30:58.088252|2017-10-11 04:30:58.088252
NCT00006170|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-09|2016-06-22|2013-06-18||September 2000||2000-09-01|June 2016|2016-06-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Interventional|||Bupropion and Weight Control for Smoking Cessation - 1|Bupropion and Weight Control for Smoking Cessation|Completed||Phase 4|349|Actual|University of Pittsburgh||4|||f||||f||||||||No||2017-10-11 04:30:58.190727|2017-10-11 04:30:58.190727
NCT00006172|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-11|2014-09-30|||April 2000||2000-04-01|March 2008|2008-03-01|February 2004|Actual|2004-02-01|July 2003|Actual|2003-07-01||Interventional|||Clinical Trials of Two Non-drug Treatments for Chronic Depression|Light and Negative Ion Treatment for Chronic Depression|Completed||N/A|32|Actual|New York State Psychiatric Institute||3|||f||||f||||||||||2017-10-11 04:30:58.776244|2017-10-11 04:30:58.776244
NCT00006173|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-11|2008-03-03|||August 2000||2000-08-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Observational|||Magnetic Resonance Imaging for Evaluating Kidney Function|Assessment of Renal Artery Stenosis and Renovascular Hypertension by Contrast Enhanced Magnetic Resonance Imaging: A Pilot Study|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:58.876806|2017-10-11 04:30:58.876806
NCT00006174|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-11|2017-06-30|||August 3, 2000||2000-08-03|May 18, 2009|2009-05-18|May 18, 2009||2009-05-18|||||Interventional|||Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome|Effects of the Aromatase Inhibitor Letrozole on Pubertal Progression and Indices of Bone Turnover in Girls With Precocious Puberty and McCune-Albright Syndrome (MAS)|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:30:58.939201|2017-10-11 04:30:58.939201
NCT00006175|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-12|2008-03-03|||August 2000||2000-08-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Observational|||Cyclooxygenase Levels Following Surgery to Remove Third Molars (Wisdom Teeth)|Cytokine Responses to Acute Inflammation in the Oral Surgery Model|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:59.01697|2017-10-11 04:30:59.01697
NCT00006176|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-12|2017-06-30|||August 10, 2000||2000-08-10|August 4, 2009|2009-08-04|August 4, 2009|Actual|2009-08-04|August 4, 2009|Actual|2009-08-04||Observational|||Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies|Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy With Neuroserpin Inclusion Bodies|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:59.082293|2017-10-11 04:30:59.082293
NCT00006177|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-12|2017-10-05|||August 9, 2000||2000-08-09|August 22, 2017|2017-08-22||||||||Observational|||Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study|The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents With Bipolar Disorder|Recruiting||N/A|2300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:59.152256|2017-10-11 04:30:59.152256
NCT00006178|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-15|2010-06-16|2010-01-14||August 2000||2000-08-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection|Sirolimus Monotherapy to Optimize Activation Induced Cell Death (AICD) in Renal Transplants Following Lymphocyte Depletion Induction With Thymoglobulin|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)|Optimal dose of RATG remains to be determined. Whether other depleting agents are as effective as RATG is unclear.|1|||f||||||||||||||2017-10-11 04:30:59.249829|2017-10-11 04:30:59.249829
NCT00006180|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-17|2017-06-30|||August 10, 2000||2000-08-10|January 19, 2007|2007-01-19|January 19, 2007||2007-01-19|||||Interventional|||Bone Loss in Premenopausal Women With Depression|The P.O.W.E.R. STUDY (Premenopause, Osteopenia/Osteoporosis, Women, Alendronate, Depression)|Completed||Phase 4|220||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:30:59.458993|2017-10-11 04:30:59.458993
NCT00006181|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-19|2014-01-06|||April 1999||1999-04-01|March 2003|2003-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|PHLAME||Promoting Healthy Lifestyles Among Firefighters|PHLAME: Promoting Healthy Lifestyles: Alternative Models' Effects|Completed||Phase 2|600||Oregon Health and Science University|||||f||||||||||||||2017-10-11 04:30:59.544568|2017-10-11 04:30:59.544568
NCT00006182|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-21|2016-02-17|||July 2000||2000-07-01|October 2005|2005-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Stroke Prevention in Sickle Cell Anemia (STOP 2)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:30:59.643371|2017-10-11 04:30:59.643371
NCT00006183|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-21|2016-07-28|||July 2000||2000-07-01|March 2008|2008-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Comparison of Hematocrit Levels in Infant Heart Surgery|Hematocrit Strategy in Infant Heart Surgery|Completed||Phase 3|120||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:30:59.706259|2017-10-11 04:30:59.706259
NCT00006184|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-23|2014-03-24|2012-12-13||August 2000||2000-08-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma|Active Immunization of Sibling Stem Cell Transplant Donors Against Purified Myeloma Protein of the Stem Cell Recipient With Multiple Myeloma in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|20|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:30:59.814026|2017-10-11 04:30:59.814026
NCT00006185|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-22|2010-03-01|||September 1999||1999-09-01|March 2010|2010-03-01|August 2003||2003-08-01|||||Interventional|||Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome|Cellular Mechanisms for Metabolic Dysfunction in HIV|Completed||Phase 1|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:31:00.612887|2017-10-11 04:31:00.612887
NCT00006186|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-25|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Autologous Fresh Whole Blood and Coagulation Following Cardiopulmonary Bypass in Infants||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:00.688797|2017-10-11 04:31:00.688797
NCT00006187|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-25|2009-12-10||||||October 2003|2003-10-01|June 2005|Anticipated|2005-06-01|June 2005|Anticipated|2005-06-01||Interventional|||The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease||Terminated||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:31:00.895976|2017-10-11 04:31:00.895976
NCT00006188|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-26|2017-06-30|||August 19, 2000||2000-08-19|July 25, 2008|2008-07-25|July 25, 2008||2008-07-25|||||Observational|||Evaluation and Treatment of Patients With Inflammatory Eye Diseases|Evaluation and Treatment Protocol for Patients With Intraocular Inflammatory Disease (Uveitis)|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:01.033472|2017-10-11 04:31:01.033472
NCT00006190|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-25|2010-03-01|||November 2000||2000-11-01|March 2010|2010-03-01|November 2001||2001-11-01|||||Interventional|||A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy|The Study of Mechanisms of Lipodystrophy in HIV-Infected Patients|Completed||Phase 4|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:31:01.110175|2017-10-11 04:31:01.110175
NCT00006191|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-29|2008-03-03|||August 2000||2000-08-01|August 2000|2000-08-01|June 2001||2001-06-01|||||Observational|||Effect of Levetiracetam on Brain Excitability|Effects of Levetiracetam on Cortical Excitability in Humans|Completed||N/A|14||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:01.197693|2017-10-11 04:31:01.197693
NCT00006192|ClinicalTrials.gov processed this data on October 10, 2017|2000-08-31|2016-07-28|||August 2000||2000-08-01|May 2009|2009-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Genetics of Coronary Artery Disease in Alaskan Natives (GOCADAN)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:31:01.288528|2017-10-11 04:31:01.288528
NCT00006193|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-07|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Effectiveness of Atkins Diet for Weight Loss||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:01.370511|2017-10-11 04:31:01.370511
NCT00006194|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-07|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Effects of Exercise on Markers of Inflammation in Skeletal Muscle in Elderly Hip Fracture Patients||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:01.470342|2017-10-11 04:31:01.470342
NCT00006195|ClinicalTrials.gov processed this data on October 10, 2017|2000-09-07|2006-10-11||||||December 2003|2003-12-01||||||||Interventional|||Glucose Regulation During Risperidone and Olanzapine Treatment||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:01.567239|2017-10-11 04:31:01.567239
NCT00008008|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-02-01|||September 1997||1997-09-01|July 2007|2007-07-01|May 2008|Actual|2008-05-01|June 2005|Actual|2005-06-01||Interventional|||Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma|CAMP 013:- Tandem Thiotepa Regimen For Selected Malignant Gliomas:1) Primary Or Recurrent Glioblastoma Multiforme (GBM); and 2) Recurrent Anaplastic Astrocytomas (AA), Oligodendrogliomas (O), Oligoastrocytomas (OA), Ependymomas And Primitive Neuroectodermal Tumors (PNET) That Have Either Progressed After Primary Therapy Or Are Refractory To Standard Chemotherapy|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:01.661746|2017-10-11 04:31:01.661746
NCT00008021|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-08-06|||February 2001||2001-02-01|December 2002|2002-12-01||||||||Interventional|||Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma|A Phase I Study of 90Y-DOTA-Peptide-Lym-1 With Peripheral Blood Stem Cell Support, Paclitaxel And Cyclosporin A In Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:01.785195|2017-10-11 04:31:01.785195
NCT00008034|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2012-07-17|||February 2000||2000-02-01|July 2012|2012-07-01||||December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer|A Phase I Study Of Cyclophoshamide And Epirubicin In Combination With Capecitabine (XELODA) (CEX) As Primary Treatment Of Locally Advanced/Inflammatory Or Large Operable Breast Cancer|Completed||Phase 1|15|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:31:01.871426|2017-10-11 04:31:01.871426
NCT00008216|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2014-06-05|||July 1996||1996-07-01|June 2014|2014-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01|36 Months|Observational [Patient Registry]|||Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer|The Use Of Peripheral Blood Stem Cells For Allogeneic Transplantation|Terminated||Phase 2|48|Actual|Columbia University|||1|Poor enrollment|f||||f||||||Samples Without DNA|"     Standard bloodwork that would be required for transplantation patients   "|||2017-10-11 04:31:03.756053|2017-10-11 04:31:03.756053
NCT00008047|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2009-02-06|||August 1999||1999-08-01|February 2001|2001-02-01||||||||Interventional|||Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus|Multicentre Phase II Study Of Concomitant Radio-Chemotherapy Associating Continuous Infusion 5-FU With Hydroxyuree Via Bone Marrow With Or Without Paclitaxel In Treatment Of Inoperable Epidermoid Carcinoma Of Esophagus|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:01.94967|2017-10-11 04:31:01.94967
NCT00008060|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-12-18|||May 2000||2000-05-01|March 2002|2002-03-01|December 2003|Actual|2003-12-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer|Fluorouracil, Oxaliplatin and Irinotecan: Use and Sequencing: A Randomized Trial to Assess the Role of Irinotecan and Oxaliplatin in Advanced Colorectal Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:02.062047|2017-10-11 04:31:02.062047
NCT00008073|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-12-18|||January 1996||1996-01-01|December 2013|2013-12-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Octreotide and Doxorubicin in Treating Patients With Advanced Cancer|Phase I Study Of Octreotide Acetate (Sandostatin) (SMS) As A Biomodulator Of Doxorubicin (DOX)|Completed||Phase 1|||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:31:02.156465|2017-10-11 04:31:02.156465
NCT00008086|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-12-18|||January 1996||1996-01-01|December 2013|2013-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Subcutaneous And/Or Oral Calcitriol [(1,25-COH)2D3] and Carboplatin in Advanced Solid Tumors|Completed||Phase 1|||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:31:02.249512|2017-10-11 04:31:02.249512
NCT00008099|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2016-01-19|||May 1998||1998-05-01|January 2016|2016-01-01|February 2004|Actual|2004-02-01|March 2001|Actual|2001-03-01||Interventional|||Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer|Phase I Dose Escalation Trial of a 100 aa Synthetic Mucin Peptide Admixed With SB-AS2 as Adjuvant in Locally Advanced and Resected Pancreatic Cancer|Completed||Phase 1|25|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 04:31:02.344576|2017-10-11 04:31:02.344576
NCT00008112|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-08-06|||June 2000||2000-06-01|October 2002|2002-10-01||||||||Interventional|||Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer|Feasibility Study of the Combination of Radiotherapy, Chemotherapy and Hyperthermia for the Treatment of Stage IIB-III-IVA Cervical Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:02.423025|2017-10-11 04:31:02.423025
NCT00008125|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2016-01-14|||March 1998||1998-03-01|January 2016|2016-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors|Phase I Study Of Gemcitabine, Docetaxel And Carboplatin, With And Without Filrastim Support, Combination Chemotherapy In Patients With Advanced Non-Hematological Malignancies|Completed||Phase 1|25|Actual|University of Pittsburgh|||||f||||||||||||||2017-10-11 04:31:02.514337|2017-10-11 04:31:02.514337
NCT00008138|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2015-12-08|2012-06-13||March 2001||2001-03-01|December 2015|2015-12-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|S0009||S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer|Phase II Evaluation Of Neoadjuvant Chemotherapy, Interval Debulking Followed By Intraperitoneal Chemotherapy In Women With Stage III And IV Epithelial Ovarian Cancer, Fallopian Tube Cancer Or Primary Peritoneal Cancer|Completed||Phase 2|62|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:31:02.627975|2017-10-11 04:31:02.627975
NCT00008151|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2010-03-31|||October 2000||2000-10-01|March 2010|2010-03-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome|Gemtuzumab Ozogamicin (GO), Fludarabine, And Low-Dose TBI Followed By Donor Stem Cell Transplantation For Patients With Advanced Acute Myeloid Leukemia Or Myelodysplastic Syndrome|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:31:03.102607|2017-10-11 04:31:03.102607
NCT00008164|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-12-17|||January 1997||1997-01-01|January 2007|2007-01-01||||||||Interventional|||Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia|Transplantation Using Umbilical Cord And Placental Blood|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:03.282061|2017-10-11 04:31:03.282061
NCT00008177|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2016-11-14|||July 1999||1999-07-01|November 2016|2016-11-01||||March 2009|Actual|2009-03-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes|A Phase I Study Combining Escalating Doses of Radiolabeled BC8 (Anti-CD45) Antibody With Fludarabine, Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil to Establish Mixed or Full Donor Chimerism for Elderly Patients With Advanced Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome|Active, not recruiting||Phase 1|79|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:31:03.429355|2017-10-11 04:31:03.429355
NCT00008190|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-02-01|||March 1999||1999-03-01|April 2004|2004-04-01|May 2008|Actual|2008-05-01|November 2005|Actual|2005-11-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia|High Dose Chemotherapy And Autologous Peripheral Blood Stem Cell Rescue For High Risk Acute Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:03.571916|2017-10-11 04:31:03.571916
NCT00008203|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-02-01|||May 1996||1996-05-01|May 2003|2003-05-01|May 2008|Actual|2008-05-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer|High-Dose Chemotherapy Followed By Autologous Hematopoietic Stem Cell Support And One Of Two Regimens Aimed At Modifying Immune Reconstitution In Women With High Risk Stage 2 And Stage 3 Breast Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:03.657521|2017-10-11 04:31:03.657521
NCT00008762|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Bone Health of People With Cystic Fibrosis|Bone Health of People With Cystic Fibrosis|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:12.326163|2017-10-11 04:31:12.326163
NCT00008229|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2010-09-17|||August 2000||2000-08-01|September 2010|2010-09-01|September 2001|Actual|2001-09-01|||||Interventional|||Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase III Multicenter, Randomized, Open-Label Trial Evaluating High Dose Melphalan Plus Holmium-166-DOTMP Versus High Dose Melphalan Alone When Given In Conjuction With Peripheral Blood Stem Cell Transplantation In Patients With Multiple Myeloma|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:31:03.914334|2017-10-11 04:31:03.914334
NCT00008242|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-03-06|||August 2000||2000-08-01|March 2013|2013-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma|A Phase II Clinical Trial Of Thalidomide, Adramycin And Dexamethasone (TAD) As Initial Therapy For The Treatment Of Multiple Myeloma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:03.994171|2017-10-11 04:31:03.994171
NCT00008255|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-06-25|||August 2000||2000-08-01|May 2001|2001-05-01|May 2004|Actual|2004-05-01|||||Interventional|||INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer|Evaluation Of Uridine 5-Triphosphate Solution For Inhalation (UTP) As An Adjunct In The Diagnosis Of Lung Cancer By Sputum Cytology|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:04.0748|2017-10-11 04:31:04.0748
NCT00008268|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-06-17|||August 2000||2000-08-01|June 2013|2013-06-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma|A Phase II Study Of Blood Stem Cell Mobilization With Intravenous Melphalan (60 MG/M2) + G-CSF In Patients With Multiple Myeloma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:04.146318|2017-10-11 04:31:04.146318
NCT00008281|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2014-01-03|||October 2000||2000-10-01|April 2002|2002-04-01||||||||Interventional|||Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer|A Multicenter, Open-Label, Randomized, Three-Arm Study Of 5-Fluorouracil (5-FU) Plus Leucovorin (LV) Or Oxaliplatin Or A Combination Of (5-Fu) LV + Oxaliplatin As Second-Line Treatment Of Metastatic Colorectal Carcinoma|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:04.248248|2017-10-11 04:31:04.248248
NCT00008294|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-01-17|||August 2000||2000-08-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer|A Phase I Study Of Hepatic Arterial Infusion With Floxuridine And Dexamethasone In Combination With Intravenous Oxaliplatin Plus 5-Fluorouracil And Leucovorin In Patients With Unresectable Hepatic Metastases From Colorectal Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:04.833606|2017-10-11 04:31:04.833606
NCT00008307|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2014-01-03|||April 1998||1998-04-01|April 2006|2006-04-01||||||||Interventional|||Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders|Non-Ablative Chemotherapeutic Conditioning Before Allogeneic Stem Cell Transplantation|Unknown status|Active, not recruiting|Phase 2|52|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:04.957656|2017-10-11 04:31:04.957656
NCT00008320|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2016-12-02|||January 2001||2001-01-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|April 2002|Actual|2002-04-01||Interventional|||Ceramide Cream in Treating Women With Cutaneous Breast Cancer|A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer|Completed||Phase 2|26|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:31:05.187413|2017-10-11 04:31:05.187413
NCT00008333|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2016-07-12|||April 2001||2001-04-01|July 2016|2016-07-01|July 2007|Actual|2007-07-01|March 2004|Actual|2004-03-01||Interventional|||Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Oral Vinorelbine For The Treatment Of Metastatic Non-Small Cell Lung Cancer In Patients More Than Or Equal To 65 Years Of Age: A Phase II Trial of Efficacy and Patients Perceived Preference for Oral Therapy|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:31:05.327323|2017-10-11 04:31:05.327323
NCT00008346|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2017-07-07|||October 2001|Actual|2001-10-01|July 2017|2017-07-01|June 30, 2005|Actual|2005-06-30|February 2005|Actual|2005-02-01||Interventional|DMIST||Digital Mammography Screening Trial (ACRIN6652)|Screening and Diagnostic Trial to Compare the Effectiveness of Two Types of Mammography in Detecting Breast Cancer in Women|Completed||N/A|49528|Actual|American College of Radiology Imaging Network||2|||f||||||||||||||2017-10-11 04:31:05.473185|2017-10-11 04:31:05.473185
NCT00008359|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-01-17|||August 2000||2000-08-01|January 2013|2013-01-01||||March 2003|Actual|2003-03-01||Interventional|||Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment|A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia|Completed||Phase 3|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:05.697266|2017-10-11 04:31:05.697266
NCT00008372|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2011-10-18|||December 2000||2000-12-01|October 2011|2011-10-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer|Phase II Trial Of CQS (NSC 339004) In Platinum-Refractory Small Cell Lung Cancer|Completed||Phase 2|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:31:05.873358|2017-10-11 04:31:05.873358
NCT00008385|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2016-03-31|2016-02-02||October 2000||2000-10-01|March 2016|2016-03-01|November 2019|Anticipated|2019-11-01|June 2011|Actual|2011-06-01||Interventional||All randomized patients|Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer|Phase III Chemoprevention Trial Of Selenium Supplementation In Persons With Resected Stage I Non-Small Cell Lung Cancer|Terminated||Phase 3|1772|Actual|Eastern Cooperative Oncology Group||2||The trial was stopped based on futility analysis results in November 2009.|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-10-11 04:31:06.104519|2017-10-11 04:31:06.104519
NCT00008398|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2013-11-18|||October 2000||2000-10-01|November 2013|2013-11-01||||March 2004|Actual|2004-03-01||Interventional|||Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer|A Phase III Study to Test the Efficacy and Safety of GM-CSF to Reduce the Severity and Duration of Mucosal Injury and Pain (Mucositis) Associated With Curative Radiation Therapy in Head and Neck Cancer Patients|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:31:09.231075|2017-10-11 04:31:09.231075
NCT00008411|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2012-07-27|||December 1999||1999-12-01|July 2012|2012-07-01|January 2007|Actual|2007-01-01|March 2006|Actual|2006-03-01||Interventional|||Docetaxel in Treating Patients With Metastatic Breast Cancer|Phase III Study Comparing the Use of Docetaxel on a Every Three-Week vs. Weekly Schedule in the Treatment of Patients With Metastatic Breast Cancer|Completed||Phase 3|90|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:31:09.94497|2017-10-11 04:31:09.94497
NCT00008424|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2014-05-02|||October 2000||2000-10-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants|A Phase I Study of Irinotecan in Patients With Refractory Solid Tumors Who Are Concomitantly Receiving Anticonvulsants|Completed||Phase 1|7|Actual|Children's Oncology Group|||||f||||t||||||||||2017-10-11 04:31:10.089136|2017-10-11 04:31:10.089136
NCT00008437|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2012-06-29|||December 2000||2000-12-01|June 2012|2012-06-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer|Pilot Study of MR-Guided Focused Ultrasound for Tissue Coagulation in Women With Breast Cancer: MR Imaging and Histopathic Correlation, An Assessment or Target Accuracy and Patient Acceptance|Completed||Phase 2|||InSightec|||||f||||f||||||||||2017-10-11 04:31:10.308057|2017-10-11 04:31:10.308057
NCT00008450|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-06|2017-07-12|||August 11, 1997|Actual|1997-08-11|July 2017|2017-07-01||||October 25, 2011|Actual|2011-10-25||Interventional|||Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant|Induction of Mixed Hematopoietic Chimerism in Patients With Severe Combined Immunodeficiency Disorders Using Allogeneic Bone Marrow and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Active, not recruiting||Phase 1|6|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:31:10.393318|2017-10-11 04:31:10.393318
NCT00008463|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-09|2013-06-07|||November 2000||2000-11-01|June 2013|2013-06-01|August 2006||2006-08-01|||||Interventional|||A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)|A Prospective, Multicenter, Phase II/III, Open-Label, Controlled, Randomized Trial Evaluating the Efficacy, Safety, and Tolerability of Interferon-alfa-2a Plus Ribavirin Versus PEG-interferon-alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus (HCV) Infection in Individuals Co-Infected With Human Immunodeficiency Virus-1 (HIV-1)|Completed||Phase 2|132||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:10.509712|2017-10-11 04:31:10.509712
NCT00008476|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-09|2008-03-03|||January 2001||2001-01-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Interventional|||Capsaicin to Control Pain Following Third Molar Extraction|Evaluation of Vanilloid Receptor Inactivation for Preemptive Analgesia|Completed||Phase 2|162||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:10.782444|2017-10-11 04:31:10.782444
NCT00008489|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-30|2005-12-08||||||January 2002|2002-01-01||||||||Interventional|||Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults|A Randomized Open-Label Trial Comparing the Tolerability of Videx EC Capsules to Videx Tablets in Adults With HIV Infection|Unknown status|Active, not recruiting|Phase 3|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:31:10.866815|2017-10-11 04:31:10.866815
NCT00008502|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-12|2017-10-05|||January 9, 2001||2001-01-09|January 6, 2017|2017-01-06||||||||Observational|||Genetic Analysis of Familial Keloids|Genetic Analysis of Familial Keloids|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:10.994574|2017-10-11 04:31:10.994574
NCT00008515|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-12|2008-03-03|||January 2001||2001-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Fluocinolone Implant to Treat Macular Degeneration|A Randomized, Prospective Study of Sustained-Release Fluocinolone Acetonide Implant for Choroidal Neovascularization Associated With Age-Related Macular Degeneration|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:11.094945|2017-10-11 04:31:11.094945
NCT00008528|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-12|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs|A Phase III Open-Label, Randomized, Active-Controlled Study Assessing the Efficacy and Safety of T-20 (HIV-1 Fusion Inhibitor) in Combination With an Optimized Background Regimen, Versus Optimized Background Therapy Alone, in Patients With Prior Experience and/or Prior Documented Resistance to Each of the Three Classes of Approved Antiretrovirals (Nucleoside Reverse Transcriptase, Non-Nucleoside Reverse Transcriptase and Protease Inhibitors)|Completed||Phase 3|525||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:31:11.177282|2017-10-11 04:31:11.177282
NCT00008541|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-13|2017-06-30|||January 2, 2001||2001-01-02|March 6, 2009|2009-03-06|March 6, 2009||2009-03-06|||||Observational|||Evaluation and Treatment of Patients With Corneal and External Diseases|Evaluation and Treatment of Corneal and External Diseases and Anterior Segment Disorders|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:11.333221|2017-10-11 04:31:11.333221
NCT00008554|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-13|2005-06-23|||November 2000||2000-11-01|July 2001|2001-07-01||||||||Interventional|||Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy|A Phase III, Randomised, Multicenter, Parallel, Open-Label Study to Compare the Efficacy, Safety, and Tolerability of GW433908 (1400 Mg Bid) and Nelfinavir (1250 Mg Bid) Over 48 Weeks in Antiretroviral Therapy Naive HIV-1 Infected Adults|Unknown status|Active, not recruiting|Phase 3|210||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:31:11.401881|2017-10-11 04:31:11.401881
NCT00008697|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-13|2013-04-11|||November 1998||1998-11-01|April 2013|2013-04-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia|A Phase I/II Trial of Infusional Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia|Completed||Phase 1/Phase 2|13|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 04:31:11.537993|2017-10-11 04:31:11.537993
NCT00008736|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Electrogastrography (EGC) in Premature Infants With Feeding Intolerance|Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide|Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:11.667309|2017-10-11 04:31:11.667309
NCT00008749|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus|Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:12.230833|2017-10-11 04:31:12.230833
NCT00008775|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-16|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Pressure Support Ventilation During CF Exacerbations|Pressure Support Ventilation During CF Exacerbations: A Randomized, Controlled Trial|Suspended||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:12.39261|2017-10-11 04:31:12.39261
NCT00008788|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Osteoporosis in Children and Adults Following Liver Transplantation|Osteoporosis in Children and Adults Following Liver Transplantation|Unknown status|Active, not recruiting|N/A|40||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:12.459963|2017-10-11 04:31:12.459963
NCT00008801|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-16|2005-10-31||||||December 2003|2003-12-01||||||||Interventional|||hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure|hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:12.535544|2017-10-11 04:31:12.535544
NCT00008814|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Functional Magnetic Resonance Imaging in Infants|Functional Magnetic Resonance Imaging (fMRI) in Infants|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:12.634027|2017-10-11 04:31:12.634027
NCT00008827|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-17|2010-01-12|||September 2000||2000-09-01|January 2010|2010-01-01|April 2001||2001-04-01|||||Interventional|||The Use of the Internet to Facilitate Weight Loss and Maintenance.|The Use of the Internet to Facilitate Weight Loss and Maintenance.|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:31:12.735864|2017-10-11 04:31:12.735864
NCT00008840|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-18|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia|A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia|Completed||N/A|866||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:12.82416|2017-10-11 04:31:12.82416
NCT00008853|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-18|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines|Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines|Completed||Phase 1|65||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:12.889233|2017-10-11 04:31:12.889233
NCT00008866|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-18|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy|A Phase II, Double-Blind, Randomized Study to Determine the Effect of Adding Delayed Versus Immediate Hydroxyurea to a Genotypic Based, ddI-Containing, Three-Drug Antiretroviral Regimen on the Recovery of Total CD4+ T-Cell Counts and Suppression of Plasma Viral Load in Advanced HIV-1 Infected Subjects Failing a First or Second Triple Combination Therapy|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:12.977883|2017-10-11 04:31:12.977883
NCT00008892|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-18|2017-06-30|||January 12, 2001||2001-01-12|January 31, 2007|2007-01-31|January 31, 2007||2007-01-31|||||Observational|||Brain Imaging in Children With AD/HD|Anatomic MRI Brain Imaging of White Matter in Children|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:13.051741|2017-10-11 04:31:13.051741
NCT00009009|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-20|2008-03-03|||January 2001||2001-01-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Kidney Transplant for HIV-Infected Patients in Renal Failure|Renal Allotransplantation for Treatment of End Stage Renal Disease in the Setting of Human Immunodeficiency Virus (HIV) Infection|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:13.114333|2017-10-11 04:31:13.114333
NCT00009035|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-23|2017-10-05|||January 19, 2001||2001-01-19|July 25, 2017|2017-07-25||||||||Observational|||Natural History of Patients With Brain and Spinal Cord Tumors|Evaluation of the Natural History of Patients With Tumors of the Central Nervous System|Recruiting||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:13.17931|2017-10-11 04:31:13.17931
NCT00009048|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-23|2008-03-03|||January 2001||2001-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Interventional|||EMD 128130 for the Treatment of Parkinson's Disease|Effect of Serotoninergic Treatment in Parkinson's Disease|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:13.2824|2017-10-11 04:31:13.2824
NCT00009061|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-23|2005-06-23|||November 2000||2000-11-01|March 2002|2002-03-01||||||||Interventional|||Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs|A Randomized, Open-Label, Two Arm Trial to Compare the Safety and Antiviral Efficacy of GW433908/Ritonavir QD to Nelfinavir BID When Used in Combination With Abacavir and Lamivudine for 48 Weeks in Antiretroviral Therapy Naive HIV-1 Infected Subjects|Unknown status|Active, not recruiting|Phase 3|624||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:31:13.429517|2017-10-11 04:31:13.429517
NCT00009178|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-23|2010-01-12|||March 1998||1998-03-01|January 2010|2010-01-01|December 2001||2001-12-01|||||Interventional|||Treatment of Bulimia Nervosa in a Primary Care Setting||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:31:13.667791|2017-10-11 04:31:13.667791
NCT00009191|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-23|2013-09-17|||November 2005||2005-11-01|September 2013|2013-09-01|November 2007|Actual|2007-11-01|November 2006|Actual|2006-11-01||Interventional|||The Depression in Alzheimer's Disease Study (DIADS)||Completed||Phase 4|||Johns Hopkins University|||||f||||||||||||||2017-10-11 04:31:13.763048|2017-10-11 04:31:13.763048
NCT00009204|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-23|2017-06-14|||September 1995||1995-09-01|June 2017|2017-06-01|April 2002|Actual|2002-04-01|April 2000|Actual|2000-04-01||Interventional|SPAD||Serotonergic Pharmacotherapy for Agitation of Dementia|Serotonergic Pharmacotherapy for Agitation of Dementia|Completed||Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:31:13.851664|2017-10-11 04:31:13.851664
NCT00009217|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-23|2016-05-23|||January 1999||1999-01-01|February 2012|2012-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Treatment of Behavioral Symptoms in Alzheimer's Disease|Treatment of Behavioral Symptoms in Alzheimer's Disease|Completed||Phase 4|44|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 04:31:13.947744|2017-10-11 04:31:13.947744
NCT00009230|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-23|2017-05-03|||June 2000|Actual|2000-06-01|May 2017|2017-05-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial||Completed||Phase 3|||University of California, Los Angeles|||||f||||||||||||||2017-10-11 04:31:14.072743|2017-10-11 04:31:14.072743
NCT00009256|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-25|2017-06-30|||April 13, 2000||2000-04-13|March 3, 2009|2009-03-03|March 3, 2009||2009-03-03|||||Observational|||Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy|Analysis of HIV Genetic Variation in Patients Prior to Initiation of Highly Active Antiretroviral Therapy|Completed||N/A|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:14.260689|2017-10-11 04:31:14.260689
NCT00009529|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-27|2009-10-15||||||October 2009|2009-10-01||||||||Observational|||The Contact Lens and Myopia Progression (CLAMP) Study||Completed||N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:31:14.348757|2017-10-11 04:31:14.348757
NCT00009542|ClinicalTrials.gov processed this data on October 10, 2017|2001-01-27|2008-03-03|||January 2001||2001-01-01|January 2001|2001-01-01|April 2001||2001-04-01|||||Interventional|||Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan|Evaluation of the Effect of Kava on Drug Metabolism Enzymes and EEG Measured Beta Amplitude|Completed||Phase 4|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:14.418945|2017-10-11 04:31:14.418945
NCT00009555|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-01|2012-05-17||||||May 2012|2012-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat|A Prospective, Multicenter, Randomized, Placebo-Controlled Trial of Physiologic Testosterone Supplementation for HIV-Positive Men With Mildly to Moderately Reduced Serum Testosterone Levels and Abdominal Obesity|Completed||Phase 4|86||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:31:14.494737|2017-10-11 04:31:14.494737
NCT00009568|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-01|2008-03-03|||January 2001||2001-01-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Platelet Function in Patients Treated With SSRI and Non-SSRI Antidepressants|Platelet Dysfunction in Patients Treated With SSRI Versus Non-SSRI Antidepressants|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:14.636362|2017-10-11 04:31:14.636362
NCT00009581|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-01|2008-03-03|||January 2001||2001-01-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Interventional|||Nitric Oxide to Improve Blood Flow in Sickle Cell Disease|Targeted Delivery of Nitric Oxide by Hemoglobin to Improve Regional Blood Flow in Sickle Cell Disease|Completed||Phase 2|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:14.714139|2017-10-11 04:31:14.714139
NCT00009594|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-01|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Alternative Medicine Approaches for Women With Temporomandibular Disorders|Alternative Medicine Approaches for Women With Temporomandibular Disorders|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:31:14.794314|2017-10-11 04:31:14.794314
NCT00009620|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-01|2015-06-03|||February 1993||1993-02-01|June 2015|2015-06-01|February 1997|Actual|1997-02-01|February 1995|Actual|1995-02-01||Interventional|Phenobarbital||Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage|Randomized Clinical Trial of Antenatal Phenobarbital in the Prevention of Neonatal Intracranial Hemorrhage|Completed||Phase 3|610|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-10-11 04:31:14.874341|2017-10-11 04:31:14.874341
NCT00009633|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-01|2017-06-19|||January 1993||1993-01-01|June 2017|2017-06-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|FU||Follow-up Visit of High Risk Infants|Follow-up Visit of High Risk Infants|Recruiting||N/A|68000|Anticipated|NICHD Neonatal Research Network|||1||f||||f||||||||||2017-10-11 04:31:15.081869|2017-10-11 04:31:15.081869
NCT00009646|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-01|2015-06-03|||November 1993||1993-11-01|June 2015|2015-06-01|March 2001|Actual|2001-03-01|March 1999|Actual|1999-03-01||Interventional|TIPP||Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)|Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)|Completed||Phase 3|1202|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-10-11 04:31:15.407531|2017-10-11 04:31:15.407531
NCT00009659|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-03-03|||January 2001||2001-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause|Biologic Activity of a Selective Progesterone Receptor Modulator, CDB-2914, in Post-Menopausal Women|Completed||Phase 2|58||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:15.563929|2017-10-11 04:31:15.563929
NCT00009672|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2017-06-30|||January 30, 2001||2001-01-30|December 12, 2006|2006-12-12|December 12, 2006||2006-12-12|||||Interventional|||Pain Treatment for Sciatica|Morphine, Nortriptyline and Their Combination in Sciatica Treatment|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:15.645016|2017-10-11 04:31:15.645016
NCT00009685|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-03-03|||January 2001||2001-01-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||HIV-1 Vaccine Test in Uninfected Adult Volunteers|Evaluation of an HIV-1 DNA Vaccine Encoding a Modified Gag-Pol Protein in Uninfected Adult Volunteers|Completed||Phase 1|21||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:15.751845|2017-10-11 04:31:15.751845
NCT00009698|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-06-27|||March 1998||1998-03-01|June 2013|2013-06-01|September 2005|Actual|2005-09-01|June 2001|Actual|2001-06-01||Interventional|||Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia|IL-2 Infusion in AML Patients After Autologous Bone Marrow Transplant: A Pediatric Oncology Group Wide Phase I Trial|Completed||Phase 1|1|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:31:15.884803|2017-10-11 04:31:15.884803
NCT00009711|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-04-29|||March 1996||1996-03-01|April 2013|2013-04-01|August 2005|Actual|2005-08-01|August 2004|Actual|2004-08-01||Observational|||Study of Lung Function in Children Who Have Undergone Bone Marrow Transplantation|The Impact of Pediatric Marrow Transplantation on Late Pulmonary Function|Completed||N/A|280|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:31:16.573974|2017-10-11 04:31:16.573974
NCT00010127|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-03-19|||November 2000||2000-11-01|December 2008|2008-12-01|March 2003|Actual|2003-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer|A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA|Terminated||Phase 1|3|Actual|Duke University|||||||||||||||||||2017-10-11 04:31:22.003858|2017-10-11 04:31:22.003858
NCT00009737|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2016-05-16|2016-05-16||November 1998||1998-11-01|May 2016|2016-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional||All randomized population included all participants who were randomized to one of the two treatment arms, regardless of whether they received any study medication.|A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer|An Open-Label Randomized Phase III Study Comparing Xeloda (Capecitabine) With IV Bolus 5-Fluorouracil in Combination With Low-Dose Leucovorin as Adjuvant Chemotherapy in Patients Who Underwent Surgery for Dukes C Colon Cancer|Completed||Phase 3|1987|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:31:16.76243|2017-10-11 04:31:16.76243
NCT00009750|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-09-19|||March 2001||2001-03-01|November 2003|2003-11-01||||||||Interventional|||Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Combined Modality Radioimmunotherapy For Hormone Refractory Metastatic Prostate Cancer With Two Cycles Of Escalating Dose 90Y-DOTA-Peptide-m170 And Fixed, Low Dose Paclitaxel With Blood Stem Cell Support And Cyclosporin For HAMA Suppression|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:18.589115|2017-10-11 04:31:18.589115
NCT00009763|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-09-19|||March 2001||2001-03-01|November 2003|2003-11-01||||||||Interventional|||Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer|Combined Modality Radioimmunotherapy For Metastatic Breast Adenocarcinoma With Two Cycles Of Escalating Dose 90Y-DOTA-peptide-m170 and Fixed, Low Dose Paclitaxel With Blood Stem Cell Support And Cyclosporin For HAMA Suppression|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:18.666257|2017-10-11 04:31:18.666257
NCT00009776|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-09-19|||March 2001||2001-03-01|October 2001|2001-10-01||||||||Interventional|||Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma|Combined Modality Radioimmunotherapy For Non-Hodgkin's Lymphoma With Three Cycles Of 90Y-DOTA-peptide-Lym-1, Paclitaxel and Cyclosporin A|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:18.73867|2017-10-11 04:31:18.73867
NCT00009789|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2016-07-12|||December 2000||2000-12-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|June 2007|Actual|2007-06-01||Interventional|||Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction|Accelerated Conformal Radiotherapy for Stage I Non-Small Cell Lung Cancer in Patients With Pulmonary Dysfunction: A Phase I Study|Completed||Phase 1|39|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:31:18.827279|2017-10-11 04:31:18.827279
NCT00009802|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-12-18|||June 1998||1998-06-01|December 2013|2013-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors|A Phase I Trial Of Oral Calcitriol [1,25-(OH)2D3] And Paclitaxel In Advanced Solid Tumors|Completed||Phase 1|45|Actual|University of Pittsburgh|||||f||||||||||||||2017-10-11 04:31:18.937528|2017-10-11 04:31:18.937528
NCT00009815|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-12-18|||December 1999||1999-12-01|December 2013|2013-12-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I Study Of Oral Etoposide In Combination With ORZEL (UFT + Leucovorin) For Advanced Non-Hematological Malignancies|Withdrawn||Phase 1|0|Actual|University of Pittsburgh|||||f||||||||||||||2017-10-11 04:31:19.003779|2017-10-11 04:31:19.003779
NCT00009828|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-12-18|||December 1999||1999-12-01|December 2013|2013-12-01||||||||Interventional|||Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors|Phase I Study Of Weekly Paclitaxel In Combination With ORZEL (UFT + Leucovorin) For Advanced Non-Hematological Malignancies|Withdrawn||Phase 1|0|Actual|University of Pittsburgh|||||f||||||||||||||2017-10-11 04:31:19.067225|2017-10-11 04:31:19.067225
NCT00009841|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2016-02-11|||March 1999||1999-03-01|June 2002|2002-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Gene Therapy in Treating Patients With Advanced Head and Neck Cancer|Phase I Trial Of Intratumoral EGFR Antisense DNA And DC-Chol Liposomes In Advanced Oral Squamous Cell Carcinoma|Completed||Phase 1|13|Actual|University of Pittsburgh|||||f||||||||||||||2017-10-11 04:31:19.129493|2017-10-11 04:31:19.129493
NCT00009854|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-11-05|||June 2000||2000-06-01|March 2003|2003-03-01||||||||Interventional|||Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm|Phase I/II Study of Intratumoral Injection of DTI-015 Prior to Tumor Resection in Patients With Recurrent Malignant Glioma or Metastatic Neoplasm to Brain|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:19.208457|2017-10-11 04:31:19.208457
NCT00009867|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-06-03|||December 2000||2000-12-01|June 2013|2013-06-01||||June 2004|Actual|2004-06-01||Interventional|||Arsenic Trioxide in Treating Patients With Urothelial Cancer|A PHASE II STUDY OF ARSENIC TRIOXIDE (NSC #706363, IND #57974) IN UROTHELIAL CANCER|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:19.276476|2017-10-11 04:31:19.276476
NCT00009880|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-07-17|||April 2001||2001-04-01|July 2004|2004-07-01||||July 2006|Actual|2006-07-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach|Non-Operative Therapy Of Local-Regional Carcinoma Of The Esophagus: A Randomizd Phase II Study Of Two Paclitaxel-Based Chemoradiotherapy Regimens|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:31:19.487569|2017-10-11 04:31:19.487569
NCT00009893|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2016-12-05|||May 2001||2001-05-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer|Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma|Completed||Phase 2|42|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:31:19.718238|2017-10-11 04:31:19.718238
NCT00009906|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2014-12-19|||December 2000||2000-12-01|June 2014|2014-06-01|November 2014|Actual|2014-11-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor|Phase III Randomized, Intergroup Trial Assessing the Clinical Activity Of STI-571 at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST) Expressing the Kit Receptor Tyrosine Kinase (CD117)|Terminated||Phase 3|748|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:31:19.877541|2017-10-11 04:31:19.877541
NCT00009919|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-01-22|||December 2000||2000-12-01|January 2013|2013-01-01||||June 2003|Actual|2003-06-01||Interventional|||SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment|Phase II Study of SU5416 (NSC 696819) for Patients With Progressive Metastatic Renal Cancer Failing Prior Biologic Therapy or 5-Fluorouracil Containing Regimens|Terminated||Phase 2|50|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:31:20.292482|2017-10-11 04:31:20.292482
NCT00009932|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-05-14|||January 2001||2001-01-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Solid Tumors|A Phase I Study Of Fenretinide Combined With Paclitaxel And Cisplatin For The Treatment Of Refractory Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:20.405175|2017-10-11 04:31:20.405175
NCT00009945|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2014-04-02|||January 2001||2001-01-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|March 2011|Actual|2011-03-01||Interventional|||Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer|A Clinical Trial Comparing Adjuvant Clodronate Therapy vs Placebo in Early-Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Hormonal Therapy or No Therapy|Completed||Phase 3|3323|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-10-11 04:31:20.476226|2017-10-11 04:31:20.476226
NCT00009958|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-05-15|||November 2000||2000-11-01|May 2013|2013-05-01||||April 2010|Actual|2010-04-01||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer|A Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM (B7.1/ICAM/LFA-3) Alone, and in Combination With Vaccinia-CEA(6D)-TRICOM, and the Role of GM-CSF, in Patients With CEA Expressing Carcinomas|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:31:20.609573|2017-10-11 04:31:20.609573
NCT00009971|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-02-08|||November 2000||2000-11-01|October 2003|2003-10-01||||September 2005|Actual|2005-09-01||Interventional|||Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer|Phase II Trial Of Fenretinide (NSC-374551; IND-40, 294) In Patients With Relapsed Small Cell Lung Cancer|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:20.711366|2017-10-11 04:31:20.711366
NCT00009984|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-06-05|||March 2002||2002-03-01|June 2013|2013-06-01||||November 2006|Actual|2006-11-01||Interventional|||Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer|Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine|Terminated||Phase 2|70|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:31:20.788163|2017-10-11 04:31:20.788163
NCT00009997|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2011-03-25|||March 1999||1999-03-01|March 2011|2011-03-01||||January 2004|Actual|2004-01-01||Interventional|||Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer|Herceptin and Paclitaxel in Locally Advanced Breast Cancer With Her-2 Overexpression|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:31:20.915107|2017-10-11 04:31:20.915107
NCT00010010|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2016-03-10|||June 2000||2000-06-01|March 2016|2016-03-01||||May 2001|Actual|2001-05-01||Interventional|||Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer|A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:31:20.988868|2017-10-11 04:31:20.988868
NCT00010023|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2011-04-04|||August 2000||2000-08-01|April 2011|2011-04-01||||August 2007|Actual|2007-08-01||Interventional|||Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined With Intravenous Cisplatin in Patients With Advanced Cancer of the Digestive System|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:31:21.058039|2017-10-11 04:31:21.058039
NCT00010036|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2011-03-25|||May 1999||1999-05-01|March 2011|2011-03-01||||October 2001|Actual|2001-10-01||Interventional|||Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme|A Phase I/II Trial of CPT-11 With Carboplatin in Patients With Glioblastoma Multiforme Prior to Radiation Therapy|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:31:21.147478|2017-10-11 04:31:21.147478
NCT00010049|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2010-07-31|||November 2002||2002-11-01|December 2003|2003-12-01||||||||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma|Phase I/II Trial of STI571 (NSC 716051) in Patients With Recurrent Malignant Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:21.218937|2017-10-11 04:31:21.218937
NCT00010062|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2009-02-06|||October 2000||2000-10-01|April 2007|2007-04-01||||||||Interventional|||Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer|Study Of Post-Operative Concomitant Radio-Chemotherapy With A Continuous Infusion Of Flourouracil For Adjuvant Treatment Of Resected Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:21.316883|2017-10-11 04:31:21.316883
NCT00010075|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2008-07-23|||January 2000||2000-01-01|June 2003|2003-06-01||||||||Interventional|||Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer|Study Of The Survival Without Degradation To The Quality Of Life During Chemotherapy For Metastatic Breast Cancer In Women|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:21.58487|2017-10-11 04:31:21.58487
NCT00010088|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2009-02-06|||January 1999||1999-01-01|April 2007|2007-04-01||||||||Interventional|||Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct|Study Of Gemcitabine, Leukovorin, And Fluorouracil Used To Treat Locally Advanced And Metastatic Pancreatic And Biliary Adenocarcinomas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:21.683297|2017-10-11 04:31:21.683297
NCT00010101|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2011-07-19|||March 2001||2001-03-01|July 2011|2011-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Observational|||Genetic Study of Brain Tumors in Young Children|INI1 Mutation Analysis and Expression Profiling of Embryonal CNS Tumors|Terminated||N/A|38|Actual|Pediatric Brain Tumor Consortium|||1|Poor accrual|f||||f||||||Samples With DNA|"     Tumor samples   "|||2017-10-11 04:31:21.83907|2017-10-11 04:31:21.83907
NCT00010114|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2011-07-19|||March 2001||2001-03-01|July 2011|2011-07-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Observational|||Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children|Gene Expression Profiling of Infant Embryonal Central Nervous System Tumors by Microarray Gene Chip Analysis: Angiogenesis, Invasion and Metastasis|Completed||N/A|83|Actual|Pediatric Brain Tumor Consortium|||1||f||||f||||||||||2017-10-11 04:31:21.916208|2017-10-11 04:31:21.916208
NCT00010140|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-12-17|||August 1997||1997-08-01|September 2005|2005-09-01||||||||Interventional|||Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer|A Multicenter Randomized Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin in Node Positive Postmenopausal Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:22.062765|2017-10-11 04:31:22.062765
NCT00010153|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2012-07-18|||November 2000||2000-11-01|July 2012|2012-07-01||||October 2001|Actual|2001-10-01||Interventional|||ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer|"A Double-Blind Phase III Clinical Trial to Compare the Effects of a Pre-Operatively Administered Single Dose of Faslodex (Long-Acting ICI 182.780) With Placebo on Tumor Recurrence in Pre- and Postmenopausal Women Treated for Operable First Primary Breast Cancer"|Terminated||Phase 3|||European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:31:22.224257|2017-10-11 04:31:22.224257
NCT00010166|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2017-05-25|||December 2000|Actual|2000-12-01|August 2009|2009-08-01|October 3, 2003|Actual|2003-10-03|October 3, 2003|Actual|2003-10-03||Interventional|||Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas|Phase II Trial Of Adjuvant 2'2'-Difluoro-2'-Deoxycytidine (Gemcitabine) And External Beam Radiation For The Treatment Of Resectable Pancreatic Cancer|Completed||Phase 2|26|Actual|Wake Forest University Health Sciences|||||f|||||t|f||||||||2017-10-11 04:31:22.318972|2017-10-11 04:31:22.318972
NCT00010179|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2010-11-07|||June 2000||2000-06-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer|Randomized Phase II Study Of NX 211 Given By Two Different Intravenous Schedules In Advanced And/Or Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:31:22.40573|2017-10-11 04:31:22.40573
NCT00010192|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-06-05|||December 2000||2000-12-01|June 2013|2013-06-01||||January 2003|Actual|2003-01-01||Interventional|||Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer|A Phase I Trial Of Rituximab And Interleukin-2|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:22.534396|2017-10-11 04:31:22.534396
NCT00010205|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-01-24|||December 2000||2000-12-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Benzoylphenylurea in Treating Patients With Advanced Cancer|Phase I Trial Of Benzoylphenylurea (NSC#639829) In Advanced Malignancy|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:31:22.704382|2017-10-11 04:31:22.704382
NCT00010218|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2016-07-15|||April 2001||2001-04-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|April 2003|Actual|2003-04-01||Interventional|||Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer|Phase II Trial Of Karenitecin (IND 57250) In Patients With Relapsed or Refractory Non-small Cell Lung Cancer|Completed||Phase 2|55|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:31:22.803095|2017-10-11 04:31:22.803095
NCT00010231|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2015-03-27|||June 1999||1999-06-01|March 2015|2015-03-01|November 2002|Actual|2002-11-01|August 2002|Actual|2002-08-01||Interventional|||Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|Phase I Study Of Oral, 1,25 Dihydroxycholecalciferol (Calcitriol) + Dexamethasone In Hormone-refractory Prostate Cancer|Completed||Phase 1|22|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 04:31:23.024075|2017-10-11 04:31:23.024075
NCT00010244|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2011-02-18|||September 1999||1999-09-01|January 2011|2011-01-01||||||||Interventional|||Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer|Conformational, Curative Ratiotherapy For Prostate Cancer (NO, N-): Phase III Multicenter Study Of The Contribution To Survival Without Clinical Or Biological Change With A Dose Variation Of 15% (80 Gy VS 70 Gy)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:23.123931|2017-10-11 04:31:23.123931
NCT00010257|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2015-10-07|2012-09-17||February 2001||2001-02-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|November 2008|Actual|2008-11-01||Interventional|||Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma|Phase II Study Of Carboplatin Plus Paclitaxel Treatment Of Advanced Thymoma Or Thymic Carcinoma|Completed||Phase 2|46|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:31:23.31873|2017-10-11 04:31:23.31873
NCT00010270|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2013-12-18|||April 2001||2001-04-01|January 2007|2007-01-01||||||||Interventional|||LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer|A Phase I Study Of LMB-9, A Recombinant Disulfide Stabilized Anti-Lewis Y Immonutoxin Administered By 5-Days Continuous Infusion For Patients With Colorectal Adenocarcinoma|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:23.961784|2017-10-11 04:31:23.961784
NCT00010283|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2010-03-31|||July 2000||2000-07-01|March 2010|2010-03-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon|Oral Beclomethasone Dipropionate Capsules for Treatment of Intestinal Graft-Versus-Host Disease: Compassionate Use in Patients With Contraindictions to High-Dose Immunosuppressive Therapy|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:31:24.049494|2017-10-11 04:31:24.049494
NCT00010309|ClinicalTrials.gov processed this data on October 10, 2017|2001-02-02|2014-01-03|||November 2000||2000-11-01|July 2002|2002-07-01||||||||Interventional|||Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma|Phase I/II Trial Investigating The Safety And Immunogenicity Of Adenoviruses Encoding The Melan-A/MART-1 And gp 100 Melanoma Antigens Administered Intradermally To Patients With Stage II-IV Melanoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:24.157282|2017-10-11 04:31:24.157282
NCT00016627|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-19|2016-02-17|||August 2000||2000-08-01|November 2005|2005-11-01|July 2005|Actual|2005-07-01|||||Observational|||Linkage Study in Familial Pulmonary Fibrosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:31:24.349896|2017-10-11 04:31:24.349896
NCT00016653|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-21|2011-10-26|||June 2000||2000-06-01|October 2011|2011-10-01|December 2006||2006-12-01|||||Interventional|||Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy|A Multicenter Randomized Placebo-controlled Double-blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy|Completed||Phase 2/Phase 3|48||Cooperative International Neuromuscular Research Group|||||||||||||||||||2017-10-11 04:31:24.408004|2017-10-11 04:31:24.408004
NCT00146497|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2006-06-26|||August 2004||2004-08-01|June 2006|2006-06-01||||||||Interventional|||Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature Infants||Terminated||Phase 4|30||China Medical University Hospital|||||f||||||||||||||2017-10-11 05:20:03.948107|2017-10-11 05:20:03.948107
NCT00016666|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-23|2017-06-30|||May 21, 2001||2001-05-21|January 19, 2007|2007-01-19|January 19, 2007||2007-01-19|||||Interventional|||Clinical Trial of Propranolol for Seasonal Affective Disorder|Treatment of Winter Depression With Pharmacological Suppression of Melatonin Secretion|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:24.506884|2017-10-11 04:31:24.506884
NCT00016679|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-24|2008-03-03|||May 2001||2001-05-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Interventional|||1-Octanol to Treat Essential Tremor|Dose Finding Study of 1-Octanol in Essential Tremor|Completed||Phase 1|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:24.609506|2017-10-11 04:31:24.609506
NCT00016692|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-24|2006-04-26||||||April 2001|2001-04-01||||||||Interventional|||Safety and Tolerability of Z-100 in Patients With Early HIV Infection|A Phase 1b Multicenter Double-Blind, Placebo-Controlled, Randomized Study on the Safety and Tolerability of Z-100 in Early HIV-1 Infected Patients|Terminated||Phase 1|||Zeria Pharmaceutical|||||||||||||||||||2017-10-11 04:31:24.702901|2017-10-11 04:31:24.702901
NCT00016731|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-31|2017-10-05|||May 25, 2001||2001-05-25|January 24, 2017|2017-01-24||||||||Observational|||Adolescence, Puberty, and Emotion Regulation|Adolescence, Puberty, Hormones, and Emotion Regulation: An fMRI Study|Completed||N/A|300|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:24.987012|2017-10-11 04:31:24.987012
NCT00016744|ClinicalTrials.gov processed this data on October 10, 2017|2001-05-31|2009-01-08|||September 2001||2001-09-01|January 2009|2009-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)|A Pilot Trial of Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous Cystic Fibrosis Patients|Completed||Phase 1/Phase 2|12|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 04:31:25.162572|2017-10-11 04:31:25.162572
NCT00016783|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-02|2013-10-04||||||October 2013|2013-10-01|October 2006|Actual|2006-10-01|||||Observational|||Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV|Intensification of HIV-Specific CD4 and CD8 Activity by Cycling Highly Active Antiretroviral Therapy (HAART) in Pediatric/Adolescent Patients With Less Than 50 HIV RNA Copies/ml|Completed||N/A|39||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:25.24931|2017-10-11 04:31:25.24931
NCT00016796|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-02|2008-03-03|||May 2001||2001-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Language Stimuli Screening in Children|Language Stimuli Screening in Children|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:25.370308|2017-10-11 04:31:25.370308
NCT00016835|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-05|2017-07-14|||October 17, 2001|Actual|2001-10-17|July 2017|2017-07-01|September 3, 2004|Actual|2004-09-03|September 3, 2004|Actual|2004-09-03||Interventional|||Treating Periodontal Infection: Effects on Glycemic|Treating Periodontal Infection: Effects on Glycemic Control in People With Type 2 Diabetes|Completed||Phase 2|46|Actual|University of Michigan||3|||f||||t||||||||||2017-10-11 04:31:25.427191|2017-10-11 04:31:25.427191
NCT00016848|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2008-03-03|||June 2001||2001-06-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||Effects of Dietary Carbohydrate and Fat on Hormones|The Effects of Dietary Carbohydrate and Fat on Hormone Regulators of Body Composition and Reproduction|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:25.529988|2017-10-11 04:31:25.529988
NCT00016861|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-25|||September 1998||1998-09-01|November 2004|2004-11-01|January 2005|Actual|2005-01-01|||||Interventional|||Irinotecan in Treating Children With Refractory or Progressive Solid Tumors|Pediatric Phase I and Pharmacokinetic Study of Irinotecan|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:25.586845|2017-10-11 04:31:25.586845
NCT00016874|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-07-17|||December 2000||2000-12-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer|A Phase I Study Of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) In Combination With Cisplatin And Paclitaxel In Patients With Advanced And Metastatic Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:25.650504|2017-10-11 04:31:25.650504
NCT00016887|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-09-16|||December 2000||2000-12-01|August 2003|2003-08-01||||||||Interventional|||Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma|Treatment of Mantle Cell Lymphomas at Advanced Stages: Prospective Randomized Comparison of Myeloablative Radiochemotherapy Followed by Blood Stem Cell Transplantation Versus Maintenance With Interferon Alpha in First Remission After Initial Cytoreductive Chemotherapy With an Anthracycline Containing Combination|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:25.718098|2017-10-11 04:31:25.718098
NCT00016900|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-17|||December 2000||2000-12-01|June 2013|2013-06-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus|A Phase II Multicenter Study of the Efficacy and Safety Study of PNU-93914 (Liposome Encapsulated Paclitaxel) in Patients With Advanced Esophageal Cancer Previously Exposed to Chemotherapy|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:25.831781|2017-10-11 04:31:25.831781
NCT00016913|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2016-07-01|2015-07-31||May 2001||2001-05-01|July 2016|2016-07-01|May 2008|Actual|2008-05-01|July 2007|Actual|2007-07-01||Interventional|||Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer|Phase II Study Of Neo-Adjuvant Paclitaxel, Estramustine And Carboplatin (TEC) Plus Androgen Ablation Prior To Radiation Therapy In Patients With Poor Prognosis Localized Prostate Cancer|Completed||Phase 2|34|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:31:25.950932|2017-10-11 04:31:25.950932
NCT00016926|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-05-24|||April 2001||2001-04-01|May 2004|2004-05-01||||July 2007|Actual|2007-07-01||Interventional|||Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer|A Limited Access Phase II Trial Of Capecitabine In Advanced, Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:31:28.641004|2017-10-11 04:31:28.641004
NCT00016939|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-20|||May 2001||2001-05-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer|A Phase II Study of Flavopiridol 1 Hour Bolus Days 1-3 Q 21 Days in Patients With Advanced Renal Cell Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:28.786303|2017-10-11 04:31:28.786303
NCT00016952|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2016-12-05|||April 2001||2001-04-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|April 2004|Actual|2004-04-01||Interventional|||Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer|Phase II Study in Patients With Metastatic Colorectal Carcinoma Previously Treated With Oxaliplatin (OXAL) or a Combination of Irinotecan (CPT-11) and OXAL|Completed||Phase 2|19|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:31:29.344806|2017-10-11 04:31:29.344806
NCT00016965|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-20|||July 2001||2001-07-01|April 2003|2003-04-01|April 2006|Actual|2006-04-01|||||Interventional|||BMS-247550 in Treating Patients With Advanced Pancreatic Cancer|A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) Every 21 Days in Patients With Advanced Pancreas Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:29.534724|2017-10-11 04:31:29.534724
NCT00016978|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-02-04|||April 2001||2001-04-01|August 2007|2007-08-01||||June 2007|Actual|2007-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan|A Phase II Study of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), and Leucovorin (CF) in Patients With Metastatic Colorectal Carcinoma Previously Treated With Irinotecan (CPT-11)|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:29.841356|2017-10-11 04:31:29.841356
NCT00016991|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-19|||June 2001||2001-06-01|October 2009|2009-10-01|April 2005|Actual|2005-04-01|||||Interventional|||ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse|A Phase II Study of ZD 1839 (NSC 715055) for Patients With First Relapse Glioblastoma Multiforme|Completed||Phase 2|||Duke University|||||f||||||||||||||2017-10-11 04:31:29.980913|2017-10-11 04:31:29.980913
NCT00017004|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2017-08-08|||August 2001||2001-08-01|August 2017|2017-08-01||||May 15, 2004|Actual|2004-05-15||Interventional|||Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia|Phase III Trial to Evaluate the Efficacy of Maintaining Hemoglobin Levels Above 120 g/l With Erythropoietin Versus Above 100 g/l Without Erythropoietin in Anemic Patients Receiving Concurrent Radiation and Cisplatin for Cervical Cancer|Completed||Phase 3|114|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-10-11 04:31:30.063525|2017-10-11 04:31:30.063525
NCT00017017|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-05-29|||February 2001||2001-02-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|February 2003|Actual|2003-02-01||Interventional|||CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer|A Phase I/II Trial fo Intravenous CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.173493|2017-10-11 04:31:30.173493
NCT00017030|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-25|||February 2001||2001-02-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|January 2003|Actual|2003-01-01||Interventional|||Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma|Phase II Study of ET-743 Given as a Three Hour Intravenous Infusion in Patients With Advanced and/or Metastatic Soft Tissue Sarcoma Previously Treated With Chemotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.241926|2017-10-11 04:31:30.241926
NCT00019097|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2013-06-19|||July 1995||1995-07-01|May 2006|2006-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With Multiple Myeloma|Phase II Study of Autologous Myeloma-Derived Immunoglobulin Idiotype Conjugated to Keyhole Limpet Hemocyanin Plus Sargramostim (GM-CSF) in Patients With Multiple Myeloma Undergoing Second Autologous Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.315127|2017-10-11 04:31:30.315127
NCT00019110|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||November 1995||1995-11-01|November 1999|1999-11-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer|VACCINE THERAPY AND DETECTION OF IMMUNOLOGIC RESPONSES WITH HUMAN PAPILLOMAVIRUS 16 E6 AND E7 PEPTIDES IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED CERVICAL CANCER|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.409572|2017-10-11 04:31:30.409572
NCT00019123|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-08-14|||April 1996||1996-04-01|November 2007|2007-11-01|April 2004|Actual|2004-04-01|||||Interventional|||Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma|A PHASE II STUDY OF ORAL THALIDOMIDE FOR PATIENTS WITH HIV INFECTION AND KAPOSI'S SARCOMA|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.501893|2017-10-11 04:31:30.501893
NCT00019136|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||February 1997||1997-02-01|December 2003|2003-12-01||||||||Interventional|||Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer|TREATMENT OF PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER USING ANTI-CD3 STIMULATED PERIPHERAL BLOOD LYMPHOCYTES TRANSDUCED WITH A GENE ENCODING A CHIMERIC T-CELL RECEPTOR REACTIVE WITH FOLATE BINDING PROTEIN|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.721893|2017-10-11 04:31:30.721893
NCT00019175|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||August 1996||1996-08-01|April 2003|2003-04-01||||||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma|PHASE I TRIAL IN PATIENTS WITH METASTATIC MELANOMA OF IMMUNIZATION WITH A RECOMBINANT FOWLPOX VIRUS ENCODING THE GP100 MELANOMA ANTIGEN|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.802021|2017-10-11 04:31:30.802021
NCT00019188|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2013-06-19|||January 1997||1997-01-01|April 2004|2004-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma|Phase I/II Pilot Study of Interleukin-12 in Patients With AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.874095|2017-10-11 04:31:30.874095
NCT00019201|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||August 1996||1996-08-01|February 2000|2000-02-01||||||||Interventional|||Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer|PILOT STUDY OF THE CORRELATION BETWEEN THE FINDINGS OF ATYPICAL/MALIGNANT CELLS IN SPUTUM AND FLUORESCENCE BRONCHOSCOPY IN PATIENTS AT RISK FOR LUNG CANCER OF THE LIFE IMAGING SYSTEM AND WHITE LIGHT BRONCHOSCOPY|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:30.949928|2017-10-11 04:31:30.949928
NCT00023166|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-24|2005-06-23|||May 2001||2001-05-01|March 2004|2004-03-01|May 2002||2002-05-01|||||Interventional|||Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas|Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas|Terminated||Phase 1|||Enzon Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:32:18.3426|2017-10-11 04:32:18.3426
NCT00019214|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-18|||April 1997||1997-04-01|January 2005|2005-01-01|July 2006|Actual|2006-07-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Phase I/II Study in Patients With Metastatic Melanoma of Immunization With Dendritic Cells Presenting Epitopes Derived From The Melanoma Associated Antigens MART-1 and gp 100|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.042323|2017-10-11 04:31:31.042323
NCT00019227|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||October 1996||1996-10-01|March 2003|2003-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Leukemia|PHASE I/II STUDY OF TAC-EXPRESSING ADULT T-CELL LEUKEMIA (ATL) WITH YTTRIUM-90 (90Y)-RADIOLABELED HUMANIZED ANTI-TAC AND CALCIUM-DTPA|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.113968|2017-10-11 04:31:31.113968
NCT00019240|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||November 1996||1996-11-01|November 2007|2007-11-01|April 2004|Actual|2004-04-01|||||Interventional|||Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection|PHASE II PROTOCOL WITH LABORATORY CORRELATES OF 1-[(S)-3-HYDROXY-2-(PHOSPHOMETHOXY)PROPYL]CYTOSINE DIHYDRATE(CIDOFOVIR) IN PATIENTS WITH KAPOSI'S SARCOMA (KS)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.189667|2017-10-11 04:31:31.189667
NCT00019318|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||August 1997||1997-08-01|October 2001|2001-10-01||||||||Interventional|||Depsipeptide in Treating Patients With Solid Tumors|Phase I Trial of a Four Hour Infusion of Depsipeptide (NSC630176) Given on Days 1 and 5 of a 21 Day Cycle in Patients With Refractory Neoplasms|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.269273|2017-10-11 04:31:31.269273
NCT00019331|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||October 1997||1997-10-01|April 2004|2004-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors|Vaccine Therapy With Tumor Specific Mutated Ras Peptides and IL-2 or GM-CSF for Adult Patients With Solid Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.368427|2017-10-11 04:31:31.368427
NCT00019344|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||August 1997||1997-08-01|May 2002|2002-05-01||||||||Interventional|||Flavopiridol in Treating Patients With Refractory Cancer|A Phase I Trial of Daily Bolus Flavopiridol for Five Consecutive Days in Patients With Refractory Neoplasms|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.47557|2017-10-11 04:31:31.47557
NCT00019357|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||June 1998||1998-06-01|August 2001|2001-08-01||||||||Interventional|||Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy|Cellular Immunotherapy With Autologous T Lymphocytes Stimulated With the Patient's Tumor-Specific Mutated Ras Peptides|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.572877|2017-10-11 04:31:31.572877
NCT00019383|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||January 1998||1998-01-01|June 2003|2003-06-01|June 2003|Actual|2003-06-01|||||Interventional|||Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using Immunodominant Peptides From the Tyrosinase Protein or Tyrosinase Related Protein-1 (TRP1)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.660377|2017-10-11 04:31:31.660377
NCT00019396|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2013-06-19|||February 1998||1998-02-01|May 2006|2006-05-01|March 2007|Actual|2007-03-01|||||Interventional|||flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer|Phase II Study of Flt3 Ligand Alone or in Combination With Melanoma Peptide Immunization in Patients With Metastatic Melanoma or Renal Cell Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:31.787571|2017-10-11 04:31:31.787571
NCT00019409|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-21|||October 1999||1999-10-01|March 2012|2012-03-01|July 2001|Actual|2001-07-01|||||Interventional|||Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia|A Randomized Study of Two Methods of CNS Prophylaxis in Patients With Acute Lymphoblastic Leukemia|Withdrawn||Phase 3|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:31.911756|2017-10-11 04:31:31.911756
NCT00019422|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-08-14|||March 1998||1998-03-01|April 2003|2003-04-01|April 2003|Actual|2003-04-01|||||Interventional|||Lobradimil and Carboplatin in Treating Children With Brain Tumors|A Phase II Trial of Intravenous Cereport (RMP-7) and Carboplatin in Childhood Brain Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:32.068066|2017-10-11 04:31:32.068066
NCT00019435|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||May 1998||1998-05-01|April 2007|2007-04-01||||||||Interventional|||LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors|Phase I Study of LMB-9, a Recombinant Disulfide Stabilized Immunotoxin for Advanced Carcinomas That Express Lewis Y Antigen|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:32.79854|2017-10-11 04:31:32.79854
NCT00019448|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2013-06-19|||September 1998||1998-09-01|September 2001|2001-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Phase II Study of DNA Encoding the gp100 Antigen Alone or in Combination With Interleukin-2 in Patients With Recurrent Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:32.894944|2017-10-11 04:31:32.894944
NCT00019461|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||April 1998||1998-04-01|June 2003|2003-06-01|October 2007|Actual|2007-10-01|||||Interventional|||Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Trial of Orally Administered CAI for Patients With Persistent or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:32.974733|2017-10-11 04:31:32.974733
NCT00019474|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2009-02-06|||March 1998||1998-03-01|April 2007|2007-04-01||||||||Interventional|||Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer|Phase II Trial of 2-Fluorouracil Recombinant Alpha-2a-Interferon and Intravenous Hydroxyurea With Filigrastim in Patients With Refractory GI Malignancies Grant Application Title: Parenteral Hydroxyurea: A Modulator in Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:33.057904|2017-10-11 04:31:33.057904
NCT00019487|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||November 1998||1998-11-01|March 2003|2003-03-01|May 2003|Actual|2003-05-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Treatment of Patients With Metastatic Melanoma Using Cloned Peripheral Blood Lymphocytes Sensitized In Vitro to the gp209-2M Immunodominant Peptide|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:33.173749|2017-10-11 04:31:33.173749
NCT00019500|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-18|||December 1998||1998-12-01|April 2009|2009-04-01|June 2005|Actual|2005-06-01|||||Interventional|||Raloxifene in Preventing Breast Cancer in Premenopausal Women|A Randomized Phase II Trial of Two Doses of Raloxifene in Pre-Menopausal Women at High Risk For Developing Invasive Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:33.260925|2017-10-11 04:31:33.260925
NCT00019513|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-21|||August 1998||1998-08-01|March 2012|2012-03-01|June 2004|Actual|2004-06-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas|A Phase I Study of Weekly Gemcitabine in Combination With Infusional 5-Fluorouracil and Oral Calcium Leucovorin in Adult Cancer Patients|Completed||Phase 1|108|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:33.378789|2017-10-11 04:31:33.378789
NCT00019539|ClinicalTrials.gov processed this data on October 10, 2017|2009-01-09|2013-06-19|||November 1998||1998-11-01|October 2004|2004-10-01|November 2004|Actual|2004-11-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer|Phase II Randomized Study of Monoclonal Antibody VEGF in Patients With Unresectable Advanced Renal Cell Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:33.538583|2017-10-11 04:31:33.538583
NCT00019552|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||September 1998||1998-09-01|January 2002|2002-01-01|April 2004|Actual|2004-04-01|||||Interventional|||Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer|A Phase II Study of MGI-114 in Patients With Recurrent or Persistent Epithelial Ovarian Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:33.750523|2017-10-11 04:31:33.750523
NCT00019565|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2016-09-23|||October 1998||1998-10-01|September 2016|2016-09-01||||August 2008|Actual|2008-08-01||Interventional|||PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy|The Use of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Assess the Effects of Anti-neoplastic Therapy on Tumor Associated Vasculature|Completed||Phase 1|53|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:33.823243|2017-10-11 04:31:33.823243
NCT00019578|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2012-03-21|||November 1998||1998-11-01|March 2012|2012-03-01|May 2002|Actual|2002-05-01|||||Interventional|||Stereotactic Radiosurgery in Treating Patients With Brain Tumors|Phase I Pilot Study of Stereotaxic Radiosurgery in Patients With Intracranial Neoplasms|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:33.923841|2017-10-11 04:31:33.923841
NCT00019591|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||March 1999||1999-03-01|November 2005|2005-11-01|November 2005|Actual|2005-11-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer|A Phase I/II Trial of Vaccination With Mutant Ras Peptide-Pulsed Dendritic Cells in the Treatment of HLA A2.1 Positive Patients With Colorectal Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:31:34.02458|2017-10-11 04:31:34.02458
NCT00019604|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2016-12-07|2014-04-01||August 1998||1998-08-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer|The Use of Radiofrequency Ablation to Treat Hepatic Neoplasms|Terminated||Phase 2|44|Actual|National Institutes of Health Clinical Center (CC)|Adverse event data is available but the format is uninterpretable.|1||Principal investigator left the institution.|f||||f||||||||No||2017-10-11 04:31:34.115133|2017-10-11 04:31:34.115133
NCT00019630|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2015-04-27|||July 1999||1999-07-01|June 2002|2002-06-01||||||||Interventional|||Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors|Phase I Study of Doxorubicin HCl Liposome in Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:34.500605|2017-10-11 04:31:34.500605
NCT00019643|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2012-03-28|||August 1999||1999-08-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|||||Observational|||Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer|Prospective Study of Potential Factors Affecting Weight in Breast Cancer Patients Receiving Adjuvant Chemotherapy|Terminated||N/A|26|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:34.593103|2017-10-11 04:31:34.593103
NCT00019656|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||August 1999||1999-08-01|August 2004|2004-08-01||||||||Interventional|||Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer|A Phase I Trial of Oral Perifosine With Different Loading Schedules in Patients With Refractory Neoplasms|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:34.691586|2017-10-11 04:31:34.691586
NCT00019669|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||October 1999||1999-10-01|August 2004|2004-08-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using a Recombinant Fowlpox Virus Encoding a GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:34.804351|2017-10-11 04:31:34.804351
NCT00019695|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2014-04-21|||March 1999||1999-03-01|March 2004|2004-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer|Phase II Randomized Study of High-Dose Ketoconazole With or Without Alendronate Sodium in Patients With Androgen-Independent Metastastic Adenocarinoma of the Prostate|Terminated||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:35.096719|2017-10-11 04:31:35.096719
NCT00019708|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-12-13|||June 1999||1999-06-01|December 2013|2013-12-01||||April 2010|Actual|2010-04-01||Interventional|||Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|A Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (AAG, NSC 330507) in Adult Patients With Solid Tumors|Terminated||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:35.188187|2017-10-11 04:31:35.188187
NCT00019721|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-18|||April 1999||1999-04-01|August 2002|2002-08-01|June 2003|Actual|2003-06-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using MART-1 and GP100 Peptides Modified to Increase Binding to HLA-0201|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:35.314257|2017-10-11 04:31:35.314257
NCT00019734|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||July 1999||1999-07-01|May 2007|2007-05-01|May 2003|Actual|2003-05-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using Recombinant Fowlpox and Vaccinia Viruses Encoding the Tyrosinase Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:35.398767|2017-10-11 04:31:35.398767
NCT00019747|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-10-06|2012-09-25||August 1999||1999-08-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer|A Phase II Trial of Oral Thalidomide as an Adjuvant Agent Following Metastasectomy in Patients With Recurrent Colorectal Cancer|Terminated||Phase 2|39|Actual|National Institutes of Health Clinical Center (CC)||2||DSMB recommended closure of the protocol due to slow accrual.|f||||t||||||||||2017-10-11 04:31:35.635125|2017-10-11 04:31:35.635125
NCT00019760|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2012-03-21|||April 1999||1999-04-01|March 2012|2012-03-01|March 2002|Actual|2002-03-01|||||Interventional|||Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver|Phase II Study of Isolated Hepatic Perfusion With Melphalan Followed By Postoperative Hepatic Arterial Chemotherapy in Patients With Unresectable Colorectal Cancer Metastatic to the Liver|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:36.191796|2017-10-11 04:31:36.191796
NCT00019773|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||July 1999||1999-07-01|April 2003|2003-04-01||||||||Interventional|||Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer|Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:36.284688|2017-10-11 04:31:36.284688
NCT00019786|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-21|||August 1999||1999-08-01|March 2012|2012-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases|A Phase II Study of Isolated Hepatic Perfusion (IHP) With Melphalan for Metastatic Unresectable Cancers of the Liver|Completed||Phase 2|67|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:36.391246|2017-10-11 04:31:36.391246
NCT00019812|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-21|||August 1999||1999-08-01|April 2003|2003-04-01|February 2004|Actual|2004-02-01|||||Interventional|||Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2|Study of Trastuzumab (Herceptin) and Paclitaxel in Patients With HER2-Overexpressing Metastatic Breast Cancer|Completed||Phase 2|55|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:36.498849|2017-10-11 04:31:36.498849
NCT00019825|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||October 1999||1999-10-01|July 2004|2004-07-01||||||||Interventional|||Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura|Phase I Study of Decitabine Mediated Induction of Tumor Antigen and Tumor Suppressor Gene Expression in Lung Cancer Patients|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:36.580374|2017-10-11 04:31:36.580374
NCT00019838|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||July 1999||1999-07-01|February 2005|2005-02-01||||||||Interventional|||UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia|Phase I and Pharmacokinetic Study of UCN-01 and Fludarabine in Relapsed or Refractory Low-Grade Lymphoid Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:31:36.699138|2017-10-11 04:31:36.699138
NCT00019864|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-06-04|||March 2000||2000-03-01|October 2007|2007-10-01|October 2011|Actual|2011-10-01|December 2006|Actual|2006-12-01||Interventional|||Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma|Osteosarcoma: Outcome of Therapy Based on Histologic Response. A Collaborative Effort of the POB/NCI, Texas Children's Hospital and University of Oklahoma.|Terminated||Phase 2|100|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:36.820279|2017-10-11 04:31:36.820279
NCT00019890|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2013-06-19||||||June 2001|2001-06-01|March 2007|Actual|2007-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma|Phase II Randomized Study of CD34+ Derived or Peripheral Monocyte Derived Dendritic Cells Pulsed With MART-1 and gp100 Melanoma Antigens in Patients With High Risk Stage III or Completely Resected Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:36.969573|2017-10-11 04:31:36.969573
NCT00019916|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||June 2000||2000-06-01|December 2005|2005-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer|Vaccine Therapy With Tumor Specific p53 Peptides in Adult Patients With Adenocarcinoma of the Breast or Ovary|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:31:37.063078|2017-10-11 04:31:37.063078
NCT00019929|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-18|||August 2000||2000-08-01|November 2005|2005-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|Phase II Trial of Individualized Mutant p53 Peptide-Pulsed Cultured Autologous Dendritic Cells in the Adjuvant Treatment of Patients With Locally Advanced Non-Small Cell Lung Cancer After Standard Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:31:37.193508|2017-10-11 04:31:37.193508
NCT00019955|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||March 2000||2000-03-01|September 2005|2005-09-01||||||||Interventional|||Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)|A Phase II Study to Evaluate Radiofrequency Ablation of Renal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:37.306561|2017-10-11 04:31:37.306561
NCT00019968|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2012-03-14|||August 1999||1999-08-01|March 2012|2012-03-01|March 2002|Actual|2002-03-01|||||Interventional|||Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg|Phase II Randomized Study of Isolated Limb Perfusion Using Melphalan With or Without Tumor Necrosis Factor in Patients With Unresectable High Grade Soft Tissue Sarcomas of the Extremity|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:37.405292|2017-10-11 04:31:37.405292
NCT00019994|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-17|||October 1999||1999-10-01|March 2003|2003-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using a Class II Restricted Peptide From the GP100 Antigen and Class I Restricted Peptides From the GP100 and MART-1 Antigens|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:37.540156|2017-10-11 04:31:37.540156
NCT00020007|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||December 1999||1999-12-01|January 2006|2006-01-01||||||||Interventional|||Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery|A Phase I Study of Isolated Lung Perfusion With Paclitaxel and Moderate Hyperthermia in Patients With Unresectable Pulmonary Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:37.667238|2017-10-11 04:31:37.667238
NCT00020046|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2012-03-14|||December 1999||1999-12-01|March 2012|2012-03-01|September 2003|Actual|2003-09-01|||||Interventional|||Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer|Phase II Randomized Study of Docetaxel With or Without Thalidomide in Patients With Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:37.795551|2017-10-11 04:31:37.795551
NCT00020072|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||March 2000||2000-03-01|March 2003|2003-03-01||||||||Interventional|||Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells|Gene Expression Analysis in Cutaneous T-Cell Lymphoma|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:37.911751|2017-10-11 04:31:37.911751
NCT00020098|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-28|||June 2000||2000-06-01|March 2012|2012-03-01|September 2001|Actual|2001-09-01|||||Interventional|||Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer|Use of Complementary or Alternative Medicine Practices by Women at Increased Risk for Breast Cancer|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:38.012829|2017-10-11 04:31:38.012829
NCT00020111|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||March 2000||2000-03-01|February 2005|2005-02-01||||||||Interventional|||Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma|Phase I Trial and Pharmacokinetic Study of Arsenic Trioxide in Pediatric Patients With Refractory Leukemia or Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:38.113415|2017-10-11 04:31:38.113415
NCT00020124|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-14|||June 2000||2000-06-01|March 2012|2012-03-01|December 2002|Actual|2002-12-01|||||Interventional|||Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs|Phase I and Clinical Pharmacologic Study of Inhaled Doxorubicin in Adults With Advanced Solid Tumors Affecting the Lungs|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:38.316827|2017-10-11 04:31:38.316827
NCT00020150|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||June 2000||2000-06-01|August 2004|2004-08-01||||||||Interventional|||Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors|Phase I Trial and Pharmacokinetic Study of Temozolomide and O6-Benzylguanine in Childhood Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:38.400948|2017-10-11 04:31:38.400948
NCT00020176|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-18|||June 2000||2000-06-01|November 2004|2004-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer|Allogeneic Breast Protocol 1: T-Cell Depleted Allogeneic Blood Stem Cell Transplantation Using an Immunoablative Conditioning Regimen in Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:31:38.51386|2017-10-11 04:31:38.51386
NCT00020189|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-17|||June 2000||2000-06-01|August 2004|2004-08-01|August 2004|Actual|2004-08-01|||||Interventional|||Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Trial of Daily Bolus Flavopiridol for Five Consecutive Days in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:38.604695|2017-10-11 04:31:38.604695
NCT00020202|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2013-08-14|||June 2000||2000-06-01|June 2006|2006-06-01|March 2007|Actual|2007-03-01|||||Interventional|||FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer|Phase II Study of FR901228 in Patients With Refractory or Progressive Small Cell or Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:38.724498|2017-10-11 04:31:38.724498
NCT00020254|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||June 2000||2000-06-01|April 2003|2003-04-01||||October 2004|Actual|2004-10-01||Interventional|||Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer|A Randomized Phase II Study of Either Immunotherapy With a Regimen of Recombinant Pox Viruses That Express PSA/B7.1 Plus Adjuvant GM-CSF and IL2 or Hormone Therapy With Nilutamide in Patients With Hormone Refractory Prostate Cancer and No Radiographic Evidence of Disease|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:38.842239|2017-10-11 04:31:38.842239
NCT00020267|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2015-04-27|||July 2000||2000-07-01|May 2002|2002-05-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Cancer|Phase I Randomized Study of MAGE-12 Peptide Vaccine in Patients With Refractory Metastatic Cancer Expressing MAGE-12 Antigen|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:38.959236|2017-10-11 04:31:38.959236
NCT00020332|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-14|||October 2000||2000-10-01|July 2002|2002-07-01|March 2003|Actual|2003-03-01|||||Interventional|||Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Phase I/II Trial of Docetaxel Followed by Infusional Flavopiridol Over 72 Hours in Patients With Previously Treated Locally Advanced or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:39.068122|2017-10-11 04:31:39.068122
NCT00020345|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2012-03-07|||September 2000||2000-09-01|March 2012|2012-03-01|March 2002|Actual|2002-03-01|||||Interventional|||Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas|Phase II Study of Neoadjuvant Intraperitoneal Gemcitabine and Intravenous Gemcitabine With Radiotherapy Followed by Surgery and Adjuvant Intraperitoneal Gemcitabine, Intravenous Gemcitabine, and Fluorouracil in Patients With Advanced Adenocarcinoma of the Pancreas|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:39.157492|2017-10-11 04:31:39.157492
NCT00020358|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-18|||September 2000||2000-09-01|March 2003|2003-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy in Treating Patients With Melanoma|Randomized Comparison of Three Schedules of Peptide Immunization in Patients With Stage II or III, or Completely Resected Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:39.277843|2017-10-11 04:31:39.277843
NCT00020371|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2015-04-27|||September 2000||2000-09-01|May 2005|2005-05-01||||||||Interventional|||BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy|Phase I Study of BMS-247550 in Patients With Refractory Neoplasms|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:39.379741|2017-10-11 04:31:39.379741
NCT00020397|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-18|||November 2000||2000-11-01|January 2005|2005-01-01|July 2005|Actual|2005-07-01|||||Interventional|||Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma|Immunization Of HLA-A*0201 or HLA-DPB1*04 Patients With Metastatic Melanoma Using Epitopes From The ESO-1 Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:39.452539|2017-10-11 04:31:39.452539
NCT00020410|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-29|||February 2001||2001-02-01|September 2003|2003-09-01||||||||Interventional|||Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer|Phase I Study Of Yttrium 90-labeled Monoclonal Antibody B3 With Autologous Stem Cell Support For Metastatic Breast Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:39.519643|2017-10-11 04:31:39.519643
NCT00020449|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-18|||January 2001||2001-01-01|March 2004|2004-03-01|May 2004|Actual|2004-05-01|||||Interventional|||Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma|A Phase II Study of Liposomal Doxorubicin and Interleukin-12 in AIDS-Associated Kaposi's Sarcoma Followed by Chronic Administration of Interleukin-12|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:39.776641|2017-10-11 04:31:39.776641
NCT00020462|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-29|||February 2001||2001-02-01|December 2008|2008-12-01||||||||Interventional|||Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma|Active Specific Immunotherapy for Follicular Lymphomas With Liposomes Containing Tumor-Derived Antigen and IL-2|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:39.877551|2017-10-11 04:31:39.877551
NCT00020475|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-02|2013-08-14|||February 2001||2001-02-01|July 2002|2002-07-01|March 2007|Actual|2007-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye|Phase II Study of gp100:209-217 (210M) Antigen and MART-1:26-35 (27L) Antigen Emulsified in Montanide ISA-51 in Patients With Metastatic Ocular Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:39.965058|2017-10-11 04:31:39.965058
NCT00020488|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-29|||February 2001||2001-02-01|September 2003|2003-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors|A Phase I & Pharmacologic Trial Of Sequential Irinotecan As A 24-Hour IV Infusion, Leucovorin, & Flurouracil As A 48-Hour IV Infusion In Adult Cancer Patients|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:40.063237|2017-10-11 04:31:40.063237
NCT00020501|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-07|||March 2001||2001-03-01|March 2012|2012-03-01|January 2005|Actual|2005-01-01|||||Interventional|||Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver|A Phase III Prospective Random Assignment Trial of Regional and Systemic Chemotherapy With or Without Initial Isolated Hepatic Perfusion for Patients With Metastatic Unresectable Colorectal Cancers of the Liver|Completed||Phase 3|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:40.145043|2017-10-11 04:31:40.145043
NCT00020527|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-17|||March 2001||2001-03-01|March 2003|2003-03-01|June 2003|Actual|2003-06-01|||||Interventional|||Caspofungin Acetate in Treating Children With Fever and Neutropenia|A Multicenter, Open, Non-Comparative, Sequential Dose-Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Separate Doses of MK-0991 in Children With New Onset Fever and Neutropenia|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:40.236565|2017-10-11 04:31:40.236565
NCT00020540|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-29|||March 2001||2001-03-01|April 2002|2002-04-01||||||||Interventional|||Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer|Treatment Of Patients With Metastatic Melanoma And Renal Cancer With A Combination Of Flt3L And CD40L|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:40.342355|2017-10-11 04:31:40.342355
NCT00020553|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-09-19|||August 2000||2000-08-01|October 2006|2006-10-01||||||||Interventional|||Video Support Program For Families With a Parent Newly Diagnosed With Cancer|We Can Cope: Family Support When A Parent Has Cancer|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:40.421133|2017-10-11 04:31:40.421133
NCT00020566|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2014-06-23|||February 2001||2001-02-01|June 2012|2012-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma|European Ewing Tumour Working Initiative of National Groups Ewing Tumour Studies 1999 (EURO-E.W.I.N.G.99)|Unknown status|Recruiting|Phase 3|1200|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:31:40.525177|2017-10-11 04:31:40.525177
NCT00020579|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-14|||March 2001||2001-03-01|March 2012|2012-03-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|||MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275, in Refractory Solid Tumors and Lymphomas|Completed||Phase 1|75|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:31:41.092194|2017-10-11 04:31:41.092194
NCT00020605|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2009-05-09|||May 2000||2000-05-01|October 2001|2001-10-01||||||||Interventional|||Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIB Study of Oral Naloxone for the Treatment of Opioid-Induced Constipation in Patients With Chronic, Non-Malignant Pain or Malignant Pain|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:41.265986|2017-10-11 04:31:41.265986
NCT00020618|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-07-17|||March 2001||2001-03-01|February 2002|2002-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain|An Open Label, Randomized, Multicenter, Crossover, Phase II Study to Compare Pain Relief Following Morphine Administration Via AERxPMS vs Orally in Cancer Patients Experiencing Opioid-Sensitive Breakthrough Pain|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:41.342353|2017-10-11 04:31:41.342353
NCT00020631|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-17|||October 2001||2001-10-01|April 2004|2004-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer|A Pilot Study Of Pirfenidone For The Treatment Of Radiation-Induced Fibrosis|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:41.42247|2017-10-11 04:31:41.42247
NCT00020644|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-08-06|||March 2000||2000-03-01|April 2004|2004-04-01||||||||Interventional|||Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer|Phase I Study of Continuous Infusion Gemcitabine|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:41.503399|2017-10-11 04:31:41.503399
NCT00020657|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-10-13|||July 2001||2001-07-01|October 2015|2015-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer|Treatment of Delayed Nausea: What Works Best?|Completed||Phase 3|||University of Rochester|||||f||||||||||||||2017-10-11 04:31:41.604361|2017-10-11 04:31:41.604361
NCT00020670|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2017-06-19|||February 20, 2001|Actual|2001-02-20|June 2017|2017-06-01|July 1, 2003|Actual|2003-07-01|April 1, 2003|Actual|2003-04-01||Interventional|||Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia|A Phase I Study of Vaccination With Autologous CD40-Activated Acute Lymphoblastic Leukemia Cells|Terminated||Early Phase 1|9|Actual|Dana-Farber Cancer Institute||1||Slow accrual|f||||t||||||||No||2017-10-11 04:31:41.777948|2017-10-11 04:31:41.777948
NCT00020683|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-10-07|||March 2003||2003-03-01|October 2013|2013-10-01||||November 2005|Actual|2005-11-01||Interventional|||A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma|A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma|Terminated||Phase 2|70|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:31:41.931131|2017-10-11 04:31:41.931131
NCT00020696|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-01-07|||June 2001||2001-06-01|March 2008|2008-03-01||||April 2006|Actual|2006-04-01||Interventional|||Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation of Tirapazamine (NSC #130181, IND #46,525) in Combination With Cisplatin in Recurrent Platinum Sensitive Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:42.073867|2017-10-11 04:31:42.073867
NCT00020709|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-02-26|||June 2001||2001-06-01|February 2013|2013-02-01||||February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery|A Phase III Trial of Cisplatin/Etoposide/Radiotherapy With Consolidation Docetaxel Followed by Maintenance Therapy With ZD1839 (NSC-715055) or Placebo in Patients With Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer|Completed||Phase 3|840|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:31:42.272857|2017-10-11 04:31:42.272857
NCT00020722|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2016-02-15|2015-02-09||August 2007||2007-08-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer|Treatment of Stage IV Breast Cancer With Activated T Cells After Peripheral Blood Stem Cell Transplant (Pilot Phase II)|Terminated||Phase 2|7|Actual|Barbara Ann Karmanos Cancer Institute|Not enough funding to finish study, cost of immunotherapy infusions for the stem cell transplant portion & of infusions for targeted T cell therapy were limited due to lack of funding, trial was converted into a proof-of-principle or concept trial.|1||Lack of funding to continue study.|f||||t||||||||||2017-10-11 04:31:42.400184|2017-10-11 04:31:42.400184
NCT00020735|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-12-01|||April 2001||2001-04-01|December 2015|2015-12-01|June 2009|Actual|2009-06-01|January 2005|Actual|2005-01-01||Interventional|||Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer|A Phase II Randomized Controlled Clinical Trial Of The Antiestrogen GTx-006 In Subjects With Prostate Cancer|Completed||Phase 2|45|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 04:31:42.600425|2017-10-11 04:31:42.600425
NCT00020748|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2011-03-23|||August 2000||2000-08-01|January 2005|2005-01-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer|A Phase I Study of Epirubicin in Combination With Irinotecan in Patients With Advanced Cancer|Completed||Phase 1|||Georgetown University|||||f||||f||||||||||2017-10-11 04:31:42.686035|2017-10-11 04:31:42.686035
NCT00020761|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-10-28|||April 2000||2000-04-01|July 2012|2012-07-01|August 2005|Actual|2005-08-01|December 2002|Actual|2002-12-01||Interventional|||Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach|A Phase II Study Of Irinotecan (Camptosar) And Paclitaxel (Taxol) In Patients With Adenocarcinoma Of The Upper Gastrointestinal Tract|Completed||Phase 2|51|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:31:42.75777|2017-10-11 04:31:42.75777
NCT00020774|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-10-28|||October 1998||1998-10-01|July 2012|2012-07-01||||January 2003|Actual|2003-01-01||Interventional|||SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer|A Phase IB Clinical Study Of The Farnesyltransferase Inhibitor SCH 66336 And Gemcitabine In Patients With Resectable Primary Liver Neoplasms|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:31:42.859309|2017-10-11 04:31:42.859309
NCT00020787|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-09-30|||July 2001||2001-07-01|July 2012|2012-07-01|December 2002|Actual|2002-12-01|January 2002|Actual|2002-01-01||Interventional|||Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer|An Open Label, Sequential Multi-Center Multi Dose Study Of G17T Immunogen In Combination With Cisplatin (CDDP) And 5-Fluorouracil (5-FU) In Subjects With Metastatic Or Locally Recurrent Gastric Or Gastroesophageal Cancer Previously Untreated With Chemotherapy For Advanced Disease (Stage IV)|Completed||Phase 3|8|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:31:42.930899|2017-10-11 04:31:42.930899
NCT00020800|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-01-07|||September 2001||2001-09-01|January 2013|2013-01-01||||April 2003|Actual|2003-04-01||Interventional|||Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia|Phase II Study of Combination Rituxan (Rituximab, Mabthera) and Fludarabine Therapy in Lymphoplasmacytic Lymphoma (Waldenstrom's Macroglobulinemia)|Completed||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:31:43.03981|2017-10-11 04:31:43.03981
NCT00020826|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-08-24|||April 2001||2001-04-01|August 2012|2012-08-01|January 2004|Actual|2004-01-01|May 2003|Actual|2003-05-01||Observational|||Assessing Quality of Life of Patients With Stomach Cancer|An International Field Study Of The Reliability And Validity Of The EORTC QLQ-C30 And A Disease-Specific Questionnaire Module (The QLQ-STO22) In Assessing The Quality Of Life Of Patients With Gastric Cancer|Completed||N/A|267|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||||||2017-10-11 04:31:43.143296|2017-10-11 04:31:43.143296
NCT00020839|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-09-20|||April 2001||2001-04-01|September 2012|2012-09-01||||May 2003|Actual|2003-05-01||Interventional|||Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain|Temozolomide Versus Temozolomide + Whole Brain Radiation In Stage IV Melanoma Patients With Asymptomatic Brain Metastases|Terminated||Phase 3|23|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:31:43.242357|2017-10-11 04:31:43.242357
NCT00020852|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-05-29|||May 2001||2001-05-01|May 2004|2004-05-01|July 2004|Actual|2004-07-01|||||Interventional|||Cryosurgery in Treating Women With Breast Lesions|Evaluation of Freezing Tumors in the Treatment of Breast Cancer Safety Study - 1-Probe CRYOcare Surgical System for Breast Tumor Ablation|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:43.504792|2017-10-11 04:31:43.504792
NCT00020865|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-12-18|||September 2001||2001-09-01|May 2007|2007-05-01||||||||Interventional|||Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia|Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Levofloxacin With That of Cefepime in the Treatment of Fever and Neutropenia - Phase IIIB|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:43.59145|2017-10-11 04:31:43.59145
NCT00020878|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2016-03-02|||March 2001||2001-03-01|March 2016|2016-03-01|May 2009|Actual|2009-05-01|November 2002|Actual|2002-11-01||Interventional|||Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers|Celecoxib for Chemoprevention of Primary Lung Cancer|Completed||Phase 2|21|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:31:43.747087|2017-10-11 04:31:43.747087
NCT00020891|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-01-17|||March 2001||2001-03-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy|The Use Of Multiple CT Scans To Reduce Target Positioning Errors In Patients Undergoing External Beam Radiotherapy Treatment For Prostate Cancer|Completed||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:43.844947|2017-10-11 04:31:43.844947
NCT00020904|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-17|||February 2001||2001-02-01|June 2013|2013-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||BMS-247550 in Treating Women With Metastatic Breast Cancer|A Phase II Study of Epothilone B Analog BMS-247550 in Patients With Taxane-Resistant Metastatic Breast Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:43.940128|2017-10-11 04:31:43.940128
NCT00020917|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-17|||February 2001||2001-02-01|June 2013|2013-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer|Pilot Study of an Anti-Epidermal Growth Factor Receptor (EGFR) Antibody, Cetuximab, in Combination With Irinotecan, Fluorouracil, and Leucovorin, and in Patients With Newly Diagnosed Stage IV Colorectal Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:44.058609|2017-10-11 04:31:44.058609
NCT00020930|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2009-12-03|||March 2001||2001-03-01|December 2009|2009-12-01||||August 2002|Actual|2002-08-01||Interventional|||Cetuximab in Treating Patients With Stage IV Colorectal Cancer|Phase II Study of an Anti-Epidermal Growth Factor Receptor (EGFR) Antibody, Cetuximab, in Patients With Irinotecan-Refractory, Stage IV Colorectal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:44.158467|2017-10-11 04:31:44.158467
NCT00020943|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2016-07-15|||June 2001||2001-06-01|July 2016|2016-07-01|September 2009|Actual|2009-09-01|December 2006|Actual|2006-12-01||Interventional|||Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma|A Phase II Study Of Intensive Induction Chemotherapy Followed By Autologous Stem Cell Transplantation Plus Immunotherapy For Mantle Cell Lymphoma|Completed||Phase 2|79|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:31:44.269329|2017-10-11 04:31:44.269329
NCT00020969|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2011-05-12|||March 2001||2001-03-01|September 2004|2004-09-01||||||||Interventional|||Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes|Phase Two Multicenter Study Of Arsenic Trioxide In Patients With Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:44.690574|2017-10-11 04:31:44.690574
NCT00020995|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-09-19|||August 2001||2001-08-01|May 2004|2004-05-01|January 2010|Actual|2010-01-01|||||Interventional|||Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer|Effects of a Low Fat Diet on Serum Factors and Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:44.834707|2017-10-11 04:31:44.834707
NCT00021008|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-12-18||||||September 2001|2001-09-01||||||||Interventional|||ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer|A Phase II Open, Multicenter Trial to Assess the Activity and Tolerability of ZD0473 Given Intravenously as Second-line Therapy to Patients With Non-Small Lung Cancer Who Have Failed One Prior Platinum Based Chemotherapy Regimen|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:44.940941|2017-10-11 04:31:44.940941
NCT00021021|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-03-25|||September 2001||2001-09-01|May 2002|2002-05-01|February 2004|Actual|2004-02-01|||||Interventional|||RPI.4610 in Treating Patients With Metastatic Kidney Cancer|A Phase II, Open-Label, Multicenter Trial of Angiozyme in Subjects With Metastatic Renal Cell Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:45.005447|2017-10-11 04:31:45.005447
NCT00021034|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-17|||March 2001||2001-03-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|Phase I Trial of Taurolidine After Positive Second Look Surgery for Recurrent Ovarian Epithelial, Fallopian Tube and Primary Peritoneal Cancers|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:31:45.088171|2017-10-11 04:31:45.088171
NCT00021047|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-07|||July 2001||2001-07-01|March 2012|2012-03-01|June 2004|Actual|2004-06-01|||||Interventional|||Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor|A Phase I/II Trial of Epirubicin, Carboplatin & Capecitabine in Adult Cancer Patients|Completed||Phase 1/Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:45.195488|2017-10-11 04:31:45.195488
NCT00021060|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-02-26|||August 2002||2002-08-01|February 2013|2013-02-01||||September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer|Randomized Phase II/III Trial of Paclitaxel Plus Carboplatin With or Without Bevacizumab (NSC #704865) in Patients With Advanced Nonsquamous NSCLC|Completed||Phase 2/Phase 3|842|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:31:45.32558|2017-10-11 04:31:45.32558
NCT00021073|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-12-10|||May 2001||2001-05-01|December 2013|2013-12-01||||April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|Phase I Study of Flavopiridol in Combination With 5-Fluorouracil, Leucovorin and Irinotecan in Patients With Advanced Malignancies|Completed||Phase 1|90|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:45.481357|2017-10-11 04:31:45.481357
NCT00021099|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-01-23|||June 2001||2001-06-01|January 2013|2013-01-01||||August 2007|Actual|2007-08-01||Interventional|||Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer|A Phase II Study Of Epothilone B Analogue BMS-247550 (NSC #710428) q21 Days In Advanced Carcinoma Of The Urothelium|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:45.62003|2017-10-11 04:31:45.62003
NCT00021112|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-07-17|||April 2001||2001-04-01|July 2012|2012-07-01||||October 2002|Actual|2002-10-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer|Surgical Treatment Of Stage IIIB Non-Small Cell Lung Cancer After Induction-Chemoradiotherapy|Terminated||Phase 2|5|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:31:45.731704|2017-10-11 04:31:45.731704
NCT00021125|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-25|||July 2000||2000-07-01|December 2002|2002-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Radiation Therapy in Treating Patients With Head and Neck Cancer|A Randomized Controlled Trial Of CHARTWEL (a Continuous Hyperfractionated Accelerated Radiotherapy Schedule) Versus Conventional Radiotherapy In Post-Operative Head And Neck Cancer Patients|Completed||Phase 3|460|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:45.833756|2017-10-11 04:31:45.833756
NCT00021138|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-05-14|||April 2001||2001-04-01|March 2011|2011-03-01|March 2004|Actual|2004-03-01|||||Interventional|||Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking|Computerized Scheduling of Nicotine Inhaler Use|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:45.920476|2017-10-11 04:31:45.920476
NCT00021151|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2014-01-07|||January 2000||2000-01-01|January 2014|2014-01-01|May 2002|Actual|2002-05-01|April 2001|Actual|2001-04-01||Interventional|||Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia|CAMPATH-1H Compassionate Treatment In Patients With PLL Who Have Failed At Least One Prior Regimen And CLL Patients Who Have Failed Fludarabine Therapy|Completed||N/A|2|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:31:45.98412|2017-10-11 04:31:45.98412
NCT00021164|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-17|||May 2001||2001-05-01|April 2004|2004-04-01|May 2004|Actual|2004-05-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Cancer|Immunization of HLA-A*0201 Patients With Metastatic Cancer Using a Peptide Epitope From the Telomerase Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:46.062806|2017-10-11 04:31:46.062806
NCT00021216|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-14|||November 2001||2001-11-01|December 2013|2013-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Bortezomib in Treating Children With Advanced Solid Tumors|A Phase I Study Of PS-341 In Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:46.135516|2017-10-11 04:31:46.135516
NCT00021229|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2014-07-25|2010-02-09||May 2001||2001-05-01|February 2013|2013-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma|A Phase I/II Trial Of STI571 In Children With Newly Diagnosed Poor Prognosis Brainstem Gliomas And Recurrent Intracranial Malignant Gliomas|Terminated||Phase 1/Phase 2|85|Actual|National Cancer Institute (NCI)|The phase II component of the trial was terminated because of poor accrual. Only one patient enrolled to the phase II component and did not receive the investigational drug.|1||Poor accrual|f||||t||||||||||2017-10-11 04:31:46.270736|2017-10-11 04:31:46.270736
NCT00021242|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2014-08-07|||August 2002||2002-08-01|August 2014|2014-08-01|September 2006|Actual|2006-09-01|March 2006|Actual|2006-03-01||Interventional|||Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia|A Phase II Study of Docetaxel (Taxotere) (NSC# 628503, IND# 59,761) in Children With Refractory Leukemias|Completed||Phase 2|12|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:31:47.604571|2017-10-11 04:31:47.604571
NCT00021255|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2016-09-26|2016-06-15||April 2001||2001-04-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Intent-To-Treat (ITT) population included all randomized participants.|Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer|Multicenter Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed By Docetaxel (AC-T) With Doxorubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab (Herceptin)(AC-TH) and With Docetaxel, Carboplatin and Trastuzumab (TCH) In The Adjuvant Treatment Of Node Positive and High Risk Node Negative Patients With Operable Breast Cancer Containing The HER2 Alteration|Completed||Phase 3|3222|Actual|Sanofi||3|||f||||||||||||||2017-10-11 04:31:50.381088|2017-10-11 04:31:50.381088
NCT00021268|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-08-01|||April 2001||2001-04-01|October 2002|2002-10-01||||||||Interventional|||Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer|Phase I Study Of Tocladesine In Patients With Colorectal Carcinoma Following Therapy With 5-FU And Irinotecan|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:52.15501|2017-10-11 04:31:52.15501
NCT00021281|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-12-18|||December 2000||2000-12-01|September 2001|2001-09-01||||||||Interventional|||Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer|A Phase III, Randomized, Open-Label Multicenter, International Study Comparing The Combination Of SU5416/Irinotecan/5-Fluorouracil/Leucovorin Versus Irinotecan/Fluorouracil/Leucovorin Alone As First-Line Therapy Of Patient With Previously Untreated Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:52.259584|2017-10-11 04:31:52.259584
NCT00021294|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2010-03-23|||May 2001||2001-05-01|June 2002|2002-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis|Phase IIB Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Safety and Efficacy of Topical Difluoromethylornithine (DFMO) With and Without a Topical Corticosteroid Cream (Triamcinolone 0.1%) in the Therapy of Actinic Keratoses (AK) on the Forearms|Completed||Phase 2|||University of Arizona|||||f||||||||||||||2017-10-11 04:31:52.34081|2017-10-11 04:31:52.34081
NCT00021307|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-07-10||||||July 2013|2013-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme|Phase I/II Trial Of Temozolomide And Carboplatin In Recurrent Glioblastoma Multiforme|Withdrawn||Phase 1/Phase 2|0|Actual|Fox Chase Cancer Center||||Study not activated.|f||||f||||||||||2017-10-11 04:31:52.419917|2017-10-11 04:31:52.419917
NCT00021320|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2014-05-07|||May 2000||2000-05-01|May 2014|2014-05-01|April 2009|Actual|2009-04-01|January 2004|Actual|2004-01-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer|Phase II Evaluation Of Paclitaxel, Cisplatin And 5-Fluorouracil Given In Combination With Radiation Therapy Prior To Surgery In Patients With Resectable Esophageal Cancer|Completed||Phase 2|21|Actual|Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:31:52.499127|2017-10-11 04:31:52.499127
NCT00021333|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-04-16|||September 1999||1999-09-01|April 2013|2013-04-01|May 2008|Actual|2008-05-01|April 2006|Actual|2006-04-01||Interventional|||Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer|Phase II Evaluation Of Paclitaxel And Cisplatin In Combination With Split Course Hyperfractionated Radiation Therapy And Granulocyte-Colony Stimulating Factor In Previously Irradiated Patients With Locally Recurrent Carcinoma Of The Head And Neck, And Lung|Completed||Phase 2|29|Actual|Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:31:52.609709|2017-10-11 04:31:52.609709
NCT00021346|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-04-16|||November 1997||1997-11-01|April 2013|2013-04-01|March 2002|Actual|2002-03-01|July 2001|Actual|2001-07-01||Interventional|||Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors|Phase I Evaluation Of Carboplatin And Gemcitabine|Completed||Phase 1|8|Actual|Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:31:52.739609|2017-10-11 04:31:52.739609
NCT00021359|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-07-09|||August 1999||1999-08-01|July 2013|2013-07-01|October 2005|Actual|2005-10-01|July 2000|Actual|2000-07-01||Interventional|||Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma|A Phase II Trial of Dexamethasone and 13-cis-Retinoic Acid as First-Line Treatment for Multiple Myeloma|Completed||Phase 2|17|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-10-11 04:31:52.823031|2017-10-11 04:31:52.823031
NCT00021372|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-07-09|||February 1996||1996-02-01|July 2013|2013-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Phase II Study of Paclitaxel and Estramustine Phosphate in Patients With Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 2|25|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-10-11 04:31:52.942901|2017-10-11 04:31:52.942901
NCT00021385|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-12-17|||May 2001||2001-05-01|May 2002|2002-05-01||||||||Interventional|||Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer|A Phase IIA Trial of Continuous Five Day Infusions of MSI-1256F (Squalamine Lactate) Plus Carboplatin for Therapy of Refractory and Resistant Stage III and IV Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:53.062108|2017-10-11 04:31:53.062108
NCT00021398|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2016-11-22|||July 1996||1996-07-01|November 2016|2016-11-01||||July 2001|Actual|2001-07-01||Interventional|||Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer|Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer|Active, not recruiting||Phase 2|23|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-11 04:31:53.148508|2017-10-11 04:31:53.148508
NCT00021424|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-29|||June 2001||2001-06-01|August 2002|2002-08-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer|Phase I/Pilot Study of Intralesional Immunotherapy With A Recombinant Avipox Virus Engineered To Express A Triad Of Co-Stimulatory Molecules In Patients With Advanced Squamous Cell Carcinoma Of The Head And Neck|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:53.282555|2017-10-11 04:31:53.282555
NCT00021437|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Biological Significance of the Bloom's Syndrome Protein|Biological Significance of the Bloom's Syndrome Protein|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:53.367301|2017-10-11 04:31:53.367301
NCT00021450|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-13|2016-09-01|||April 2001||2001-04-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|April 2008|Actual|2008-04-01||Interventional|||Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer|Three Dimensional Conformal Radiotherapy / Intensity Modulated Radiotherapy Alone Vs Three Dimensional Conformal Therapy / Intensity Modulated Radiotherapy Plus Adjuvant Hormonal Therapy In Localized T1b-c, T2a, N0, M0 Prostatic Carcinoma. A Phase III Randomized Study|Completed||Phase 3|819|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:31:53.547329|2017-10-11 04:31:53.547329
NCT00021463|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-14|2011-02-24||||||January 2003|2003-01-01||||February 2002|Actual|2002-02-01||Interventional|||Changing to Nonprotease Inhibitor Treatment to Improve Side Effects|Phase II, Randomized, Open-Label Study of Switching to Protease Inhibitor-Sparing Regimens for Improvement of Metabolic Abnormalities|Completed||Phase 2|342||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:53.685939|2017-10-11 04:31:53.685939
NCT00021476|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-16|2013-08-09|||May 2001||2001-05-01|August 2013|2013-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Preventing Chronic Whiplash Pain|Preventing Chronic Whiplash Pain: Biobehavioral Approach|Completed||Phase 3|300||University of Washington|||||f||||||||||||||2017-10-11 04:31:53.788861|2017-10-11 04:31:53.788861
NCT00021489|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-18|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment|A Phase I/II Study of the Safety, Tolerability, and Antiretroviral Activity of Mycophenolate Mofetil As an Adjunct to Abacavir Therapy in HIV-Infected Subjects With Treatment Failure and Extensive Prior Antiretroviral Exposure|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:53.869105|2017-10-11 04:31:53.869105
NCT00021502|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-18|2009-08-13|||March 2001||2001-03-01|August 2009|2009-08-01|May 2004|Actual|2004-05-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)|A Phase 3, Multi-Center, Randomized, Placebo Controlled Study of PHP When Administered by Continuous Infusion in Patients With Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)|Completed||Phase 3|1000||Apex Bioscience|||||||||||||||||||2017-10-11 04:31:53.934522|2017-10-11 04:31:53.934522
NCT00021528|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-20|2009-09-24|||July 2001||2001-07-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Sequenced Treatment Alternatives to Relieve Depression (STAR*D)|Sequenced Treatment Alternatives to Relieve Depression|Completed||Phase 4|4000||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:31:54.018001|2017-10-11 04:31:54.018001
NCT00018005|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-26|2012-10-19|||June 2001||2001-06-01|October 2012|2012-10-01|June 2007|Actual|2007-06-01|||||Interventional|HART||A Self-Management Intervention for Mild to Moderate Heart Failure|Heart Failure Adherence and Retention Trial (HART)|Completed||Phase 3|902|Actual|Rush University Medical Center||1|||f||||t||||||||||2017-10-11 04:33:09.273847|2017-10-11 04:33:09.273847
NCT00021541|ClinicalTrials.gov processed this data on October 10, 2017|2006-06-19|2012-09-24|2012-03-30||July 2001||2001-07-01|September 2012|2012-09-01|November 2010|Actual|2010-11-01|March 2010|Actual|2010-03-01||Interventional|||R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas|A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas|Completed||Phase 2|62|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:31:54.27756|2017-10-11 04:31:54.27756
NCT00021554|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-21|2005-06-23||||||May 2002|2002-05-01||||||||Interventional|||T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs|A Phase III Open-Label, Randomized, Active-Controlled Study Assessing the Efficacy and Safety of T-20 (HIV-1 Fusion Inhibitor) in Combination With an Optimized Background Regimen, Versus Optimized Background Regimen Alone, in Patients With Prior Experience and/or Prior Documented Resistance to Each of the Three Classes of Approved Antiretrovirals (Nucleoside Reverse Transcriptase, Non-Nucleoside Reverse Transcriptase and Protease Inhibitors)|Completed||Phase 3|525||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:31:54.972383|2017-10-11 04:31:54.972383
NCT00021567|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-24|2008-03-03|||July 2001||2001-07-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections|A Randomized, Double-Blinded, Placebo-Controlled, Phase II Study of the Safety and Efficacy of Inhaled Interferon Gamma-1b With Antimycobacterial in Previously Treated or Moderate to Severe Pulmonary Mycobacterium Avium Complex (MAC) Infection|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:55.198497|2017-10-11 04:31:55.198497
NCT00021580|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-24|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||"Modification of the Edmonton Protocol to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the Edmonton Protocol to Kidney Transplant Recipients"|"Modification of the Edmonton Protocol to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the Edmonton Protocol to Kidney Transplant Recipients (Project 1 of JDFI Washington University Center for Islet Transplantation)"|Unknown status|Active, not recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:31:55.309241|2017-10-11 04:31:55.309241
NCT00021632|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-26|2015-05-15||||||July 2013|2013-07-01||||||||Observational|||Effects of Ribavirin on Zidovudine or Stavudine|Pharmacokinetic Evaluation of the Effects of Ribavirin (RBV) on Zidovudine (ZDV) or Stavudine (d4T) Triphosphate (TP) Formation|Completed||N/A|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:55.413077|2017-10-11 04:31:55.413077
NCT00021645|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-26|2008-03-03|||July 2001||2001-07-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Vitamin E to Treat Uveitis-Associated Macular Edema|Randomized Masked Study to Evaluate the Use of Vitamin E in the Treatment of Uveitis-Associated Macular Edema|Completed||Phase 1|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:55.552449|2017-10-11 04:31:55.552449
NCT00021658|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-30|2014-09-26|||October 1999||1999-10-01|July 2014|2014-07-01|September 2003||2003-09-01|||||Interventional|||Effects of Pesticide Exposure on Neurodevelopment/Growth/Respiratory Health||Completed||N/A|550||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:31:55.633835|2017-10-11 04:31:55.633835
NCT00021671|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-31|2012-02-13||||||February 2012|2012-02-01|November 2004|Actual|2004-11-01|||||Interventional|||Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission|Phase III Trial of Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission|Completed||Phase 3|3720||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:55.709484|2017-10-11 04:31:55.709484
NCT00021697|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-01|2016-07-13|||January 2001||2001-01-01|July 2016|2016-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS|A Double-Blind Controlled, Multicenter Phase II/III Study to Assess the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect in Patients With Amyotrophic Lateral Sclerosis|Completed||Phase 3|100||Avanir Pharmaceuticals|||||||||||||||||||2017-10-11 04:31:55.810227|2017-10-11 04:31:55.810227
NCT00021710|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-02|2008-03-03|||July 2001||2001-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Motor Learning in Stroke Patients and Healthy Volunteers|Motor Learning: Behavioral and Physiologic Studies in Normal Volunteers and Stroke Patients|Completed||N/A|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:55.934053|2017-10-11 04:31:55.934053
NCT00021723|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-02|2009-09-22|||September 2001||2001-09-01|November 2001|2001-11-01|September 2003||2003-09-01|||||Interventional|||Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease||Terminated||Phase 2|375||JANSSEN Alzheimer Immunotherapy Research & Development, LLC|||||||||||||||||||2017-10-11 04:31:56.018228|2017-10-11 04:31:56.018228
NCT00021736|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-03|2005-06-23|||July 2001||2001-07-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Phase II/III Study of Anti-VEGF in Neovascular AMD|Phase II/III Randomized, Double-Masked, Trial, to Establish the Safety and Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks for 54 Weeks, in Patients With Exudative AMD).|Completed||Phase 2/Phase 3|540||Eyetech Pharmaceuticals|||||||||||||||||||2017-10-11 04:31:56.234577|2017-10-11 04:31:56.234577
NCT00021749|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-03|2009-11-10|||January 2001||2001-01-01|November 2009|2009-11-01||||January 2003|Actual|2003-01-01||Interventional|||Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia|Phase I-II Multicenter Study of Genasense (Bcl-2 Antisense Oligonucleotide) in Patients With Advanced Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|40|Actual|Genta Incorporated||1|||f||||f||||||||||2017-10-11 04:31:56.326172|2017-10-11 04:31:56.326172
NCT00021762|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-04|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV|A Pilot Phase II Evaluation of the Effects on HIV Replication of Immunization With a gp120-Depleted, Inactivated Whole Virus Vaccine Combined With Exposures to Replicating Autologous HIV by Scheduled Treatment Interruptions, a Rollover Study of A5057|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:31:56.418705|2017-10-11 04:31:56.418705
NCT00021775|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-04|2013-12-31|||April 2002||2002-04-01|December 2013|2013-12-01|February 2004|Actual|2004-02-01|||||Observational|||HIV Prevention Preparedness Study in Russia, China, and India|HIV Prevention Preparedness Study|Completed||N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:31:56.492005|2017-10-11 04:31:56.492005
NCT00021788|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-04|2010-07-07|||July 2000||2000-07-01|July 2010|2010-07-01|December 2001||2001-12-01|||||Interventional|||Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression|Immunomodulation for Islet Transplantation in Diabetes|Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:31:56.567822|2017-10-11 04:31:56.567822
NCT00021801|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-04|2010-03-01|||March 2000||2000-03-01|March 2010|2010-03-01|September 2000||2000-09-01|||||Interventional|||Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen|Pathways to Tolerance in Human Islet Transplantation|Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:31:56.664974|2017-10-11 04:31:56.664974
NCT00021814|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-04|2010-01-12|||December 1995||1995-12-01|January 2010|2010-01-01|March 1998||1998-03-01|||||Interventional|||Medical Therapy of Prostatic Symptoms (MTOPS)||Completed||Phase 3|2931||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 04:31:56.746805|2017-10-11 04:31:56.746805
NCT00021827|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-04|2010-03-01|||June 1999||1999-06-01|March 2010|2010-03-01|December 2001||2001-12-01|||||Interventional|||PTHrP and Osteoporosis|Pathophysiology of PTH-related Protein in Humans.|Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:31:56.90199|2017-10-11 04:31:56.90199
NCT00021840|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-07|2014-08-01|||July 2001||2001-07-01|August 2014|2014-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Genetic Epidemiology of Asthma in Costa Rica|Genetic Epidemiology of Asthma in Costa Rica|Completed||N/A|4245|Actual|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"     Blood (and its components, e.g., serum, WBC, etc.)   "|||2017-10-11 04:31:56.982089|2017-10-11 04:31:56.982089
NCT00021853|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-08|2008-03-03|||August 2001||2001-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||Motor Training to Treat Hand Dystonia|Motor Training as Treatment of Focal Hand Dystonia|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:31:57.103652|2017-10-11 04:31:57.103652
NCT00021866|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-08|2013-11-08|||September 2000||2000-09-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|August 2010|Actual|2010-08-01||Observational|||Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy|Neurodevelopmental Effects of Antiepileptic Drugs II: the NEAD Study|Completed||N/A|331|Actual|Emory University|||4||f||||t||||||Samples With DNA|"     Venous blood for AED levels Cord Blood for G6PD, Homocysteine Saliva for drug metabolizing     enzymes, antioxidant enzymes, DNA repair enzymes, drug membrane transporter proteins and     folate-related genes   "|||2017-10-11 04:31:57.218566|2017-10-11 04:31:57.218566
NCT00021879|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-02-17|||March 2001||2001-03-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Visceral Adiposity and CVD Risk in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:31:57.388895|2017-10-11 04:31:57.388895
NCT00021892|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2014-02-20|||June 2001||2001-06-01|February 2014|2014-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Ventricular Matrix Remodeling: Correlates and Prognosis||Completed||N/A|||Boston University|||||f||||||||||||||2017-10-11 04:31:57.45786|2017-10-11 04:31:57.45786
NCT00021905|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2008-07-23|||July 2002||2002-07-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Atrial Fibrillation Incidence, Risk Factors and Genetics||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:31:57.526979|2017-10-11 04:31:57.526979
NCT00021918|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-02-17|||April 2001||2001-04-01|October 2005|2005-10-01|June 2004|Actual|2004-06-01|||||Observational|||Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:31:57.602413|2017-10-11 04:31:57.602413
NCT00021931|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-03-15|||April 2001||2001-04-01|July 2005|2005-07-01|March 2005|Actual|2005-03-01|||||Observational|||Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:31:57.680837|2017-10-11 04:31:57.680837
NCT00021944|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-07-28|||April 2001||2001-04-01|January 2008|2008-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:31:57.76129|2017-10-11 04:31:57.76129
NCT00021957|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-02-17|||April 2001||2001-04-01|May 2005|2005-05-01|March 2005|Actual|2005-03-01|||||Observational|||ESCAPE Mechanistic Substudies - Ancillary to ESCAPE||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:31:57.8479|2017-10-11 04:31:57.8479
NCT00021970|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-02-29|||April 2001||2001-04-01|February 2016|2016-02-01|March 2005||2005-03-01|||||Observational|||Modifying Oxidative Damage in WAVE - Ancillary to WAVE||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 04:31:57.903891|2017-10-11 04:31:57.903891
NCT00021983|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-04-28|||December 1998||1998-12-01|January 2006|2006-01-01||||||||Interventional|||Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia|Phase I Study of BL22, a Recombinant Immunotoxin for Treatment of CD22+ Leukemias and Lymphomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:57.964482|2017-10-11 04:31:57.964482
NCT00021996|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-07-17|||January 2001||2001-01-01|February 2002|2002-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Valdecoxib in Treating Chronic Pain in Cancer Patients|Clinical Protocol for a Randomized Double-Blind, Placebo-Controlled Comparison of the Analgesic Activity of Valdecoxib (SC-65872) 40mg BID as Add-On Therapy to Opioid Medication in Patients With Chronic Cancer Pain|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:58.046853|2017-10-11 04:31:58.046853
NCT00022009|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-09-19|||July 2001||2001-07-01|October 2002|2002-10-01||||||||Interventional|||Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Phase I/II Randomized Trial Comparing Two Treatment Schedules Of Gemcitabine In Poor Prognosis Status Patients With Advanced Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:58.117232|2017-10-11 04:31:58.117232
NCT00022022|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-12-17|||December 2000||2000-12-01|April 2006|2006-04-01||||||||Interventional|||Docetaxel in Treating Patients With Non-Small Cell Lung Cancer|Docetaxel In Second-Line Treatment Of Advanced Non-Small-Cell Lung Cancer - The Distal Study|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:58.20118|2017-10-11 04:31:58.20118
NCT00022035|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-01-30|||August 2000||2000-08-01|January 2013|2013-01-01||||November 2002|Actual|2002-11-01||Interventional|||Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia|Influenza Vaccine Immunogenicity in Children During and After Therapy for Acute Lymphoblastic Leukemia|Completed||N/A|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:31:58.349465|2017-10-11 04:31:58.349465
NCT00022048|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-05-14|||August 2001||2001-08-01|October 2004|2004-10-01|November 2004|Actual|2004-11-01|||||Interventional|||Bevacizumab in Treating Patients With Myelodysplastic Syndrome|Safety and Efficacy Trial of Bevacizumab: Anti-VEGF Humanized Monoclonal Antibody (NSC 704865) Therapy for Myelodysplastic Syndrome (MDS)|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:58.423404|2017-10-11 04:31:58.423404
NCT00022074|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-10-13|||July 2001||2001-07-01|October 2015|2015-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Gabapentin For the Control of Hot Flashes in Women With Breast Cancer|Control of Vasomotor Symptoms in Women Treated for Breast Cancer|Completed||N/A|||University of Rochester|||||f||||||||||||||2017-10-11 04:31:58.514944|2017-10-11 04:31:58.514944
NCT00022087|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-07-15|||December 2001||2001-12-01|July 2016|2016-07-01|February 2009|Actual|2009-02-01|March 2007|Actual|2007-03-01||Interventional|||Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer|Phase III Trial of Intravenous Zoledronic Acid (Zometa) in the Prevention of Bone Loss in Localized Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure|Completed||Phase 3|439|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:31:58.660573|2017-10-11 04:31:58.660573
NCT00022113|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-01-24|||May 2001||2001-05-01|January 2013|2013-01-01||||May 2005|Actual|2005-05-01||Interventional|||EMD 121974 in Treating Patients With Advanced Solid Tumors|A Phase I Study of EMD 121974 in Patients With Advanced Solid Tumors|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:31:58.953068|2017-10-11 04:31:58.953068
NCT00022126|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2014-02-18|||November 2002||2002-11-01|February 2014|2014-02-01|April 2006|Actual|2006-04-01|January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia|A Study of Modified Augmented BFM Therapy for Infants With Acute Lymphoblastic Leukemia|Completed||Phase 2|6|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:31:59.047644|2017-10-11 04:31:59.047644
NCT00022139|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-12-05|||January 2002||2002-01-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|July 2005|Actual|2005-07-01||Interventional|||Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Trial of Preoperative Radiation and Chemotherapy (Paclitaxel, Carboplatin, and Continuous Infusion 5-FU) for Locally Advanced Esophageal Cancer|Completed||Phase 2|56|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:31:59.436534|2017-10-11 04:31:59.436534
NCT00022152|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-07-01|||November 2001||2001-11-01|July 2016|2016-07-01|August 2007|Actual|2007-08-01|March 2006|Actual|2006-03-01||Interventional|||Vinorelbine in Treating Older Women With Stage IV Breast Cancer|Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy|Completed||Phase 2|25|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:31:59.648793|2017-10-11 04:31:59.648793
NCT00022165|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-08-10|||October 1999||1999-10-01|August 2015|2015-08-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Selenium in the Prevention of Cancer|Prevention Of Cancer By Intervention With Selenium|Completed||N/A|501|Actual|University of Surrey||4|||f||||f||||||||||2017-10-11 04:31:59.782679|2017-10-11 04:31:59.782679
NCT00022178|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-09-19|||December 1998||1998-12-01|February 2002|2002-02-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin|An Open Label Prospective Randomised Study Comparing The Use Of Vincristine, Adriamycin And Cyclophosphamide (VAC) Versus Epirubicin, Cisplatin And Continuous 5-Flourouracil (ECF) In Patients With Unknown Primary Carcinoma (UPC)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:31:59.884859|2017-10-11 04:31:59.884859
NCT00022191|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-06-11|||May 2001||2001-05-01|June 2013|2013-06-01||||June 2004|Actual|2004-06-01||Interventional|||Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer|Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients With Metastatic or Locally Advanced Urothelial Cancer Without Prior Systemic Therapy|Completed||Phase 3|608|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:32:00.009702|2017-10-11 04:32:00.009702
NCT00013468|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||August 2000||2000-08-01|January 2001|2001-01-01|August 2003|Actual|2003-08-01|||||Observational|||Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss|Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss|Completed||Phase 2|50|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:32:00.655692|2017-10-11 04:32:00.655692
NCT00013481|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-11-09|||January 2000||2000-01-01|November 2009|2009-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Coordination of Hemiparetic Movement After Post-Stroke Rehabilitation|Coordination of Hemiparetic Movement After Post-Stroke Rehabilitation|Completed||Phase 2|70|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:32:00.743856|2017-10-11 04:32:00.743856
NCT00013494|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||July 1999||1999-07-01|March 2006|2006-03-01|June 2003|Actual|2003-06-01|||||Interventional|||Video-Based Functional Performance and Assessment Following Stroke|Video-Based Functional Performance and Assessment Following Stroke|Completed||Phase 2|30||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:32:00.844273|2017-10-11 04:32:00.844273
NCT00013507|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-14|2009-01-20|||January 1999||1999-01-01|January 2001|2001-01-01|December 2002|Actual|2002-12-01|||||Interventional|||Effects of Functional Incidental Training in VA NHCU Residents|Effects of Functional Incidental Training in VA NHCU Residents|Completed||Phase 2|24|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:32:00.939502|2017-10-11 04:32:00.939502
NCT00013520|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-16|2012-05-17||||||May 2012|2012-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection|Phase III, Randomized, Double-Blind Comparison of Three Protease Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection|Completed||Phase 3|1125||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:32:01.023986|2017-10-11 04:32:01.023986
NCT00013533|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-20|2017-10-05|||March 14, 2001||2001-03-14|May 7, 2015|2015-05-07|May 7, 2015|Actual|2015-05-07|March 1, 2008|Actual|2008-03-01||Interventional|||Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies|Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies|Completed||Early Phase 1|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:32:01.310991|2017-10-11 04:32:01.310991
NCT00013546|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-20|2008-03-03|||March 2001||2001-03-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Hormone Replacement Therapy to Treat Turner Syndrome|Turner Syndrome: Hormone Replacement Therapy|Completed||Phase 2|92||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:01.443673|2017-10-11 04:32:01.443673
NCT00013559|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-20|2017-10-05|||March 13, 2001||2001-03-13|June 13, 2017|2017-06-13||||||||Observational|||Natural History Study of Smith-Magenis Syndrome|Natural History Study of the Clinical and Molecular Manifestations of Smith-Magenis Syndrome (SMS)|Recruiting||N/A|700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:01.56084|2017-10-11 04:32:01.56084
NCT00013572|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-21|2005-06-23||||||March 2003|2003-03-01||||||||Interventional|||HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults|A Phase I Study of Aventis Pasteur Live Recombinant ALVAC-HIV (vCP205, HIV-1 Env/Gag/Pol) in Seronegative Adults Administered (1) Subcutaneously Via Ex Vivo Transfected, Autologous Dendritic Cells, (2) Intradermally, or (3) Intramuscularly|Unknown status|Active, not recruiting|Phase 1|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:32:01.684539|2017-10-11 04:32:01.684539
NCT00013585|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-22|2012-05-17||||||May 2012|2012-05-01|December 2005|Actual|2005-12-01|||||Interventional|||"Safety and Effectiveness of the Selegiline Patch for Decreased Mental Function in HIV Patients"|Phase II, Placebo-Controlled, Double-Blind Study of the Selegiline Transdermal System (STS) in the Treatment of HIV-Associated Cognitive Impairment|Completed||Phase 2|127|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:32:01.775256|2017-10-11 04:32:01.775256
NCT00013598|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-24|2008-03-03|||March 2001||2001-03-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Interventional|||Treatment of Nonalcoholic Steatohepatitis With Pioglitazone|Treatment of Nonalcoholic Steatohepatitis With Pioglitazone|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:01.926436|2017-10-11 04:32:01.926436
NCT00013611|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-24|2011-08-02|2010-11-08||March 2001||2001-03-01|August 2011|2011-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|SILCAAT||Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)|A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients With Low CD4+ Counts Under Active Antiretroviral Therapy (SILCAAT Amendment 4)|Completed||Phase 3|1695|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 04:32:02.044147|2017-10-11 04:32:02.044147
NCT00013624|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-24|2008-03-03|||March 2001||2001-03-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Riluzole to Treat Parkinson's Disease|Effect of Antiglutamatergic Treatment in Parkinson's Disease|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:03.368963|2017-10-11 04:32:03.368963
NCT00013637|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-26|2006-09-01|||September 1998||1998-09-01|September 2006|2006-09-01|August 2003||2003-08-01|||||Observational|||Lead Exposure, Genetics, and Osteoporosis Epidemiology||Completed||N/A|650||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:32:03.468789|2017-10-11 04:32:03.468789
NCT00013650|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-27|2017-06-30|||March 22, 2001||2001-03-22|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Interventional|||Effects of an Anti-Inflammatory Drug in Alzheimer's Disease|Pilot Study of Immunomodulatory Versus Antiinflammatory Therapy in Alzheimer's Disease|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:03.547295|2017-10-11 04:32:03.547295
NCT00013663|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-27|2012-11-01||||||June 2006|2006-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load|A Randomized Controlled Study Testing the Efficacy of Immunotherapies to Control Plasma HIV RNA Concentrations Upon Interruption of Highly Active Antiretroviral Therapy|Completed||Phase 2|92||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:32:03.648729|2017-10-11 04:32:03.648729
NCT00013689|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-28|2008-03-03|||March 2001||2001-03-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome|Pilot Study of Pyrimethamine and Sulfadoxine (Fansidar) for the Treatment of Individuals With the Autoimmune Lymphoproliferative Syndrome (ALPS)|Completed||Phase 1|8||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:03.740179|2017-10-11 04:32:03.740179
NCT00013702|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-28|2008-03-03|||March 2001||2001-03-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients|Adefovir Dipivoxil for the Treatment of Hepatitis B in Human Immunodeficiency Virus Infected Patients With Decompensated Hepatitis B Liver Disease and a Hepatitis B Viral Load of at Least 1.0 X 10(6) (Copies/mL) Despite 52 Weeks of Lamivudine Therapy|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:03.859129|2017-10-11 04:32:03.859129
NCT00013715|ClinicalTrials.gov processed this data on October 10, 2017|2001-03-28|2008-08-08|||September 1999||1999-09-01|August 2008|2008-08-01|August 2003||2003-08-01|||||Observational|||Ozone and Rhinovirus-Induced Disease in Asthmatics||Completed||N/A|60|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:32:03.975086|2017-10-11 04:32:03.975086
NCT00022204|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-11-05|||January 2000||2000-01-01|May 2007|2007-05-01||||||||Interventional|||Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer|Double-Blind, Placebo-Controlled, Randomised Trial Of Alpha-Tocopherol And Oxpentifylline In Patients With Radiation Fibrosis|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:04.049583|2017-10-11 04:32:04.049583
NCT00022217|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-12-17|||November 2000||2000-11-01|February 2002|2002-02-01||||||||Interventional|||Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer|A Phase II Activity And Safety Study Of IntraDose (Cisplatin/Epinephrine Injectable Gel) When Given In Combination With Systematic Chemotherapy Paclitaxel And Carboplatin In The Treatment Of Patients With Squamous Cell Carcinoma Of The Head And Neck At First Relapse|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:04.181299|2017-10-11 04:32:04.181299
NCT00022230|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-05-04|||January 2000||2000-01-01|May 2015|2015-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer|Combination of Chemotherapy With Taxol, Adriamycin, and Cytoxan (TAC), Multiple Infusions of Activated T Cells (ATC), Interleukin-2 (IL-2) and GM-CSF for High Risk Breast Cancer With and Without Her2/Neu Overexpression. (Phase I/II)|Withdrawn||Phase 1/Phase 2|0|Actual|Roger Williams Medical Center||1||PI left Institution|f||||t||||||||||2017-10-11 04:32:04.323975|2017-10-11 04:32:04.323975
NCT00022243|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2014-01-03|||October 2000||2000-10-01|May 2002|2002-05-01||||||||Interventional|||T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy|A Phase II, Open Label Study Of T138067-Sodium In A Second-Line Setting In Non-Small-Cell Lung Cancer Patients With Locally Advanced Or Metastatic Disease Who Have Failed First-Line Therapy With a Taxane|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:04.472858|2017-10-11 04:32:04.472858
NCT00022256|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-06-17|||April 2001||2001-04-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|An Open-Label Phase II Trial to Evaluate the Safety and Pharmacokinetics of Motexafin Gadolinium and Cranial Irradiation in the Treatment of Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:32:04.57854|2017-10-11 04:32:04.57854
NCT00022282|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-02-27|||April 2001||2001-04-01|February 2008|2008-02-01||||March 2007|Actual|2007-03-01||Interventional|||AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma|Neovastat (AE-941) in Refractory and Early Relapse Multiple Myeloma Patients|Completed||Phase 2|||AEterna Zentaris|||||f||||||||||||||2017-10-11 04:32:04.696286|2017-10-11 04:32:04.696286
NCT00022295|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-03-25|||August 2001||2001-08-01|March 2007|2007-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Phenoxodiol in Treating Patients With Refractory Solid Tumors|Phase IB Study of Phenoxodiol Given by Constant Intravenous Infusion in Patients With Solid Neoplasms (With the Exception of Breast Cancer) Whose Tumors Are Refractory to Standard Therapy|Completed||Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:04.788999|2017-10-11 04:32:04.788999
NCT00022308|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-08-30|||January 1999||1999-01-01|August 2013|2013-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|Phase I Trial of Radical Thoracic Radiation, Weekly CPT-11 (Irinotecan) and Cisplatin in Locally Advanced Non-Small Cell Lung Carcinoma|Completed||Phase 1|||Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:32:04.877632|2017-10-11 04:32:04.877632
NCT00022321|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-12-18|||September 2001||2001-09-01|June 2002|2002-06-01||||||||Interventional|||Gemtuzumab in Treating Patients With Myelodysplastic Syndrome|A Randomized Study Of The Safety And Efficacy Of Two Dose Schedules Of Gemcituzumab Ozogamicin In Patients With Intermediate-2 Or High-Risk Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:05.015051|2017-10-11 04:32:05.015051
NCT00022334|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-10-28|||January 2001||2001-01-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|December 2004|Actual|2004-12-01||Interventional|||Vaccine Therapy in Treating Patients With Liver Cancer|A Phase I/II Trial Testing Immunization With Dendritic Cells Pulsed With Four AFP Peptides in Patients With Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|33|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:32:05.122607|2017-10-11 04:32:05.122607
NCT00022347|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-06-25|||May 2001||2001-05-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|April 2004|Actual|2004-04-01||Interventional|||TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase II Study of TLK 286 in Platinum Resistant Advanced Epithelial Ovarian Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:05.241762|2017-10-11 04:32:05.241762
NCT00022360|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-06-17|||May 2001||2001-05-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Taurolidine in Treating Patients With Recurrent or Progressive Glioma|An Open-Label Dose-Ranging Study of the Safety of Taurolidine 2% Solution Administered Intravenously to Patients With Recurrent or Progressive High Grade Glioma|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:32:05.348307|2017-10-11 04:32:05.348307
NCT00022373|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2014-10-14|||December 2000||2000-12-01|November 2001|2001-11-01||||||||Interventional|||Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer|A Multinational, Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial to Determine the Efficacy and Safety of IB-367 Rinse in Reducing the Severity of Oral Mucositis in Patients Receiving Radiotherapy for Head and Neck Malignancy|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:05.439028|2017-10-11 04:32:05.439028
NCT00022386|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-07-17||||||May 2002|2002-05-01|April 2004|Actual|2004-04-01|||||Interventional|||Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer|An Open-Label Study of PROCRIT (Epoetin Alfa) in Women Undergoing Adjuvant Chemotherapy for Stage I, II, or III Breast Cancer|Completed||Phase 4|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:05.544524|2017-10-11 04:32:05.544524
NCT00022399|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2011-02-18|||September 2001||2001-09-01|October 2004|2004-10-01||||||||Interventional|||Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer|A Randomized, Placebo-Controlled Trial Of Celecoxib In Men Pre-Prostatectomy For Clinically Localized Adenocarcinoma Of The Prostate: Evaluation Of Drug-Specific Biomarker Modulation|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:05.62624|2017-10-11 04:32:05.62624
NCT00022412|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-10-10|||August 2001||2001-08-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|February 2006|Actual|2006-02-01||Interventional|||Doxercalciferol Before Surgery in Treating Localized Prostate Cancer|Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN|Completed||Phase 2|60|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 04:32:05.699815|2017-10-11 04:32:05.699815
NCT00022425|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-12-17|||June 2001||2001-06-01|September 2003|2003-09-01||||||||Interventional|||Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy|Multiple-Dose Phase I and Pharmacokinetic Trial of Perillyl Alcohol|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:05.804067|2017-10-11 04:32:05.804067
NCT00022438|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-06-17|||June 2001||2001-06-01|July 2004|2004-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment|Immunization of HLA-0201 Positive Patients With Metastatic Melanoma Using a Peptide From Tyrosinase-related Protein 2 (TRP-2)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:05.875979|2017-10-11 04:32:05.875979
NCT00022451|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2012-03-14|||June 2001||2001-06-01|March 2012|2012-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Tipifarnib in Treating Young Patients With Refractory Leukemia|A Phase I Trial and Pharmacokinetic Study of R115777 in Pediatric Patients With Refractory Leukemia|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:05.976858|2017-10-11 04:32:05.976858
NCT00022464|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-06-03|||June 2001||2001-06-01|June 2015|2015-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||CCI-779 in Treating Patients With Metastatic Melanoma|A Phase II Study Of CCI-779 (NSC 683864) In Metastatic Melanoma|Completed||Phase 2|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:32:06.32279|2017-10-11 04:32:06.32279
NCT00022477|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-09-04|||September 2001||2001-09-01|September 2013|2013-09-01|December 2004|Actual|2004-12-01|October 2002|Actual|2002-10-01||Interventional|||BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer|A Phase II Study Of Epothilone B Analog BMS-247550 (NSC 710428D) In Patients With Advanced Colorectal Carcinoma|Completed||Phase 2|24|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:32:06.475864|2017-10-11 04:32:06.475864
NCT00022490|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-12-08|2012-06-06||June 2001||2001-06-01|December 2015|2015-12-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia|A Phase II Study To Determine The Anti-Leukemic Effects Of STI571 In Combination With Ara-C In Patients With Chronic Myelogenous Leukemia In Chronic Phase|Terminated||Phase 2|24|Actual|OHSU Knight Cancer Institute|Study was terminated, therefore the 12 month response data was not analyzed.|1|||f||||t||||||||||2017-10-11 04:32:06.587491|2017-10-11 04:32:06.587491
NCT00022516|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-08-05|2015-11-06||November 2000||2000-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|January 2015|Actual|2015-01-01||Interventional|22-00|Patients who started overall study|Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer|"Low-dose Cytotoxics as Anti-angiogenesis Treatment Following Adjuvant Induction Chemotherapy for Patients With ER-negative and PgR-negative Breast Cancer"|Completed||Phase 3|1086|Actual|International Breast Cancer Study Group|This trial collected only Grade 3 or higher Adverse Events.|2|||f||||t||||||||||2017-10-11 04:32:06.796737|2017-10-11 04:32:06.796737
NCT00022529|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-01-24|||July 2001||2001-07-01|January 2013|2013-01-01||||January 2004|Actual|2004-01-01||Interventional|||BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors|Phase I Study of Intravenous BMS-214662 FTI (NSC# 710086) and Herceptin (NSC# 688097) Weekly in Patients With Advanced Malignancies|Completed||Phase 1|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:09.059381|2017-10-11 04:32:09.059381
NCT00022542|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-04-14|||June 2001||2001-06-01|December 2012|2012-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma|A Phase II Study of Epothilone B Analog (BMS-247550) in Advanced Soft Tissue Sarcomas|Terminated||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:09.148337|2017-10-11 04:32:09.148337
NCT00022555|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-01-24|||November 2001||2001-11-01|January 2013|2013-01-01||||July 2003|Actual|2003-07-01||Interventional|||Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma|A Phase I Trial of Combination Bryostatin-1 and Vincristine in HIV-Related B-cell Neoplasms|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:09.258661|2017-10-11 04:32:09.258661
NCT00022646|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-12-05|||August 2001||2001-08-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|November 2003|Actual|2003-11-01||Interventional|||Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|157|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 04:32:09.406355|2017-10-11 04:32:09.406355
NCT00022659|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2015-04-23|2015-04-23||April 2002||2002-04-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||Eligible and treated patients.|Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) (NSC #704865) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|64|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:09.808201|2017-10-11 04:32:09.808201
NCT00022672|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-06-07|2013-04-02||January 2001||2001-01-01|June 2013|2013-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer|A Randomized, Open-label Study of the Effect of Herceptin Plus Arimidex Compared With Arimidex Alone on Progression-free Survival in Patients With HER2-positive and Hormone-receptor Positive Metastatic Breast Cancer|Completed||Phase 3|208|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:32:10.451146|2017-10-11 04:32:10.451146
NCT00022685|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-12-18|||September 2001||2001-09-01|April 2003|2003-04-01||||||||Interventional|||Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma|A Phase III Clinical Trial of Immunotherapy With Humanized LL2 IgG (Epratuzumab) in Patients With Low-Grade Follicular, B-Cell Non-Hodgkin's Lymphoma Refractory to Rituxan (Rituximab)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:11.790874|2017-10-11 04:32:11.790874
NCT00022698|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-03-16|2016-03-16||May 2001||2001-05-01|February 2005|2005-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional||The All Patients Population included participants who received at least one dose of study drug in Cohort 1 or Cohort 2.|Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer|A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer|Completed||Phase 2|67|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:32:11.914406|2017-10-11 04:32:11.914406
NCT00022711|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-07-10|||January 2002||2002-01-01|July 2013|2013-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer|A Phase II Study of Temozolomide (SCH 52365) in the Treatment of Patients With Relapsed Small Cell Lung Cancer|Completed||Phase 2|7|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-11 04:32:14.749563|2017-10-11 04:32:14.749563
NCT00022724|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2008-11-22|||December 2001||2001-12-01|January 2005|2005-01-01||||||||Interventional|||CCI-779 in Treating Patients With Malignant Glioma|Phase I/II Trial Of CCI-779 In Patients With Malignant Glioma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:14.878012|2017-10-11 04:32:14.878012
NCT00022737|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2014-02-26|||October 2002||2002-10-01|November 2012|2012-11-01||||October 2006|Actual|2006-10-01||Interventional|||Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia|A Children's Oncology Group Pilot Study for the Treatment of Very High Risk Acute Lymphoblastic Leukemia in Children and Adolescents (Imatinib (STI571, GLEEVEC) NSC#716051)|Completed||Phase 3|220|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:14.98419|2017-10-11 04:32:14.98419
NCT00022750|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2010-01-14|||October 2000||2000-10-01|January 2010|2010-01-01|May 2005||2005-05-01|||||Interventional|||Randomized Trial of Health Events Costs in Diabetic Blacks|Project Sugar 2: Health Events Costs in Diabetic Blacks|Completed||N/A|800||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:32:15.32028|2017-10-11 04:32:15.32028
NCT00022763|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-11|2016-01-19|2015-12-04||August 2001||2001-08-01|January 2016|2016-01-01||||December 2004|Actual|2004-12-01||Interventional|||T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents|A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents|Completed||Phase 2|52|Actual|Hoffmann-La Roche||1|||||||||||||||||2017-10-11 04:32:15.427418|2017-10-11 04:32:15.427418
NCT00022776|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-13|2013-02-26|||September 2000||2000-09-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Surgical Versus Nonsurgical Treatment for Spinal Stenosis|Randomized Clinical Trial of Treatment for Spinal Stenosis|Completed||Phase 3|178|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 04:32:16.200297|2017-10-11 04:32:16.200297
NCT00022789|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-14|2014-03-12|||August 2001||2001-08-01|March 2014|2014-03-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Observational|||Prevalence of Sleep-Disordered Breathing in Children|Prevalence of Sleep Disordered Breathing in Children|Completed||N/A|700|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-10-11 04:32:16.305028|2017-10-11 04:32:16.305028
NCT00022802|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-14|2009-04-07|||December 2002||2002-12-01|April 2009|2009-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Image Guided System for Orthopaedic Surgery|Image Guided Surgical System for Orthopaedic Trauma|Terminated||Phase 2|40||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||||Grant expired|f||||||||||||||2017-10-11 04:32:16.361634|2017-10-11 04:32:16.361634
NCT00022815|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-14|2008-04-11|||June 2002||2002-06-01|April 2008|2008-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Management of Compartment Syndrome With Ultrafiltration|Management of Compartment Syndrome With Ultrafiltration|Completed||Phase 1|10||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:32:16.423995|2017-10-11 04:32:16.423995
NCT00022828|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-14|2007-01-02|||January 2003||2003-01-01|October 2006|2006-10-01|January 2006||2006-01-01|||||Observational|||3-D Laser Imaging to Analyze Neck Movement|3-D Laser Imaging for Cervical Spine Motion Analysis|Unknown status|Active, not recruiting|Phase 1|134||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:32:16.496059|2017-10-11 04:32:16.496059
NCT00022841|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-14|2007-12-14||||||December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Prevention of Steroid-Induced Osteoporosis in Children|Prevention of Steroid-Induced Osteoporosis in Children|Terminated||Phase 1/Phase 2|40||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||||Inadequate eligible subjects to expect sufficient numbers to analyse outcomes.|||||||||||||||2017-10-11 04:32:16.567546|2017-10-11 04:32:16.567546
NCT00022854|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-14|2013-05-02|||May 2001||2001-05-01|May 2013|2013-05-01|January 2005|Actual|2005-01-01|||||Interventional|||Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction|Outcomes After ACL Reconstruction: The Effect of Femoral Nerve Block Analgesia|Completed||Phase 4|270|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 04:32:16.643164|2017-10-11 04:32:16.643164
NCT00022867|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-14|2015-07-23|||May 2001||2001-05-01|July 2015|2015-07-01|November 2006|Actual|2006-11-01|January 2005|Actual|2005-01-01||Interventional|||Encouraging Calcium Absorption and Bone Formation During Early Puberty|Optimization of Calcium Absorption and Bone Formation During Early Puberty|Completed||Phase 1/Phase 2|100||Baylor College of Medicine|||||f||||t||||||||||2017-10-11 04:32:16.747079|2017-10-11 04:32:16.747079
NCT00022880|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-15|2005-06-23|||July 1999||1999-07-01|August 2004|2004-08-01||||||||Interventional|||Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia|A Phase I, Dose-Escalation, Open-Label, Multicenter Study of Iodine-131, Anti-B1 Antibody for Intermediate- and High-Risk B-Cell Chronic Lymphocytic Leukemia|Unknown status|Active, not recruiting|Phase 1|30||Corixa Corporation|||||||||||||||||||2017-10-11 04:32:16.821677|2017-10-11 04:32:16.821677
NCT00022893|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-15|2005-06-23||||||August 2004|2004-08-01||||||||Interventional|||Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma|Retreatment Study of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti-B1 Antibody.|Unknown status|Active, not recruiting|N/A|||Corixa Corporation|||||||||||||||||||2017-10-11 04:32:16.892452|2017-10-11 04:32:16.892452
NCT00022906|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-15|2005-06-23|||May 1999||1999-05-01|August 2004|2004-08-01||||||||Interventional|||Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement|Phase I, Dose-Escalation Study of Iodine-131 Anti-B1 Antibody For Patients With Previously Treated Non-Hodgkin's Lymphoma With More Than 25% Bone Marrow Involvement|Unknown status|Active, not recruiting|Phase 1|24||Corixa Corporation|||||||||||||||||||2017-10-11 04:32:16.96523|2017-10-11 04:32:16.96523
NCT00022919|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-16|2008-03-03|||August 2001||2001-08-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods|Analysis of Prostate Cancer Short-Term Cultures Utilizing Molecular Cytogenetic Methods|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.036314|2017-10-11 04:32:17.036314
NCT00022932|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-16|2005-06-23|||January 2000||2000-01-01|September 2004|2004-09-01||||||||Interventional|||Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP|Phase II Multicenter Study of Iodine-131 Anti-B1 Antibody Consolidation For Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Following First-Line CHOP|Unknown status|Active, not recruiting|Phase 2|||Corixa Corporation|||||||||||||||||||2017-10-11 04:32:17.11775|2017-10-11 04:32:17.11775
NCT00022945|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-16|2005-06-23||||||January 2005|2005-01-01||||||||Interventional|||Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma|Phase II Study Of Iodine-131 Anti-B1 Antibody Plus CHOP For Patients With Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|||Corixa Corporation|||||||||||||||||||2017-10-11 04:32:17.193963|2017-10-11 04:32:17.193963
NCT00022958|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-16|2005-06-23|||September 1998||1998-09-01|August 2004|2004-08-01||||||||Interventional|||Expanded Access Study of Iodine-131 Anti-B1 Antibody|Expanded Access Study of Iodine-131 Anti-B1 Antibody for Relapsed/Refractory Low-Grade and Transformed Low-Grade Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|N/A|||Corixa Corporation|||||||||||||||||||2017-10-11 04:32:17.273828|2017-10-11 04:32:17.273828
NCT00022971|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-17|2017-10-05|||August 15, 2001||2001-08-15|March 17, 2017|2017-03-17|March 17, 2017|Actual|2017-03-17|January 22, 2010|Actual|2010-01-22||Interventional|||Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia|Combination Antibody Therapy With Apolizumab (1D10) and Rituximab (CD20) in Relapsed Lymphoma and CLL|Terminated||Phase 1|35|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:32:17.343244|2017-10-11 04:32:17.343244
NCT00022984|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-17|2008-03-03|||August 2001||2001-08-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Technology Dependency and Health-Related Quality of Life|Toward a Theory of Technology Dependency and Health Related Quality of Life (HRQL): A Test of a Model in Patients With an Implantable Cardioverter Defibrillator|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.437476|2017-10-11 04:32:17.437476
NCT00022997|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-17|2017-10-05|||August 15, 2001||2001-08-15|September 25, 2017|2017-09-25||||||||Observational|||Study of Taste Deficits|Studies of Deficits in the Sense of Taste|Completed||N/A|450|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.492416|2017-10-11 04:32:17.492416
NCT00023010|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-18|2017-06-30|||August 15, 2001||2001-08-15|December 13, 2010|2010-12-13|December 13, 2010||2010-12-13|||||Observational|||Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)|Follow-Up of a Phase-I Gene Therapy Trial of Patients With Leukocyte Adherence Deficiency|Completed||N/A|2|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.564315|2017-10-11 04:32:17.564315
NCT00023023|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-18|2017-10-05|||August 15, 2001||2001-08-15|August 8, 2017|2017-08-08||||||||Observational|||Study of Transfusion-Transmitted Infections|A Prospective Study of Transfusion-Transmitted Infections|Recruiting||N/A|3200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.629879|2017-10-11 04:32:17.629879
NCT00023036|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-21|2017-10-05|||August 17, 2001||2001-08-17|September 7, 2017|2017-09-07||||||||Observational|||Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts|Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.711148|2017-10-11 04:32:17.711148
NCT00023049|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-21|2017-10-05|||August 17, 2001||2001-08-17|August 22, 2017|2017-08-22||||||||Observational|||Genetic Analysis of Hereditary Disorders of Hearing and Balance|Genetic Analysis of Hereditary Disorders of Hearing and Balance|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.793602|2017-10-11 04:32:17.793602
NCT00023062|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-22|2008-03-03|||August 2001||2001-08-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Observational|||Transcranial Magnetic Stimulation in Parkinson's Disease|TMS Measures in Parkinson's Disease|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.882902|2017-10-11 04:32:17.882902
NCT00023075|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-22|2008-03-03|||August 2001||2001-08-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Observational|||Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis|Nuclear Magnetic Spectroscopy for the Evaluation of Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:17.942768|2017-10-11 04:32:17.942768
NCT00023088|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-22|2017-06-30|||April 13, 1994||1994-04-13|July 9, 2008|2008-07-09|July 9, 2008||2008-07-09|||||Observational|||Screening Study for the Department of Rehabilitation Medicine|Rehabilitation Medicine Screening Protocol|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:18.005477|2017-10-11 04:32:18.005477
NCT00023101|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-22|2006-03-22|||August 1996||1996-08-01|March 2006|2006-03-01||||||||Observational|||Lead, Endocrine Disruption and Reproductive Outcomes||Completed||N/A|800||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:32:18.063746|2017-10-11 04:32:18.063746
NCT00023114|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-22|2006-09-01|||September 2000||2000-09-01|September 2006|2006-09-01|September 2001||2001-09-01|||||Observational|||p450 Mediated Lung Toxicity||Completed||N/A|10||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:32:18.113234|2017-10-11 04:32:18.113234
NCT00023127|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-22|2006-03-22||||||March 2006|2006-03-01||||||||Interventional|||Reducing Indoor Allergen Exposures in Northern Manhattan and the South Bronx||Completed||N/A|40||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:32:18.158452|2017-10-11 04:32:18.158452
NCT00023140|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-22|2015-04-13|||July 1999||1999-07-01|April 2015|2015-04-01|June 2002|Actual|2002-06-01|May 2002|Actual|2002-05-01||Observational|||Collaborative Study of 1,3 Butadiene Biomarkers|Collaborative Study of 1,3 Butadiene Biomarkers|Completed||N/A|80||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:32:18.213116|2017-10-11 04:32:18.213116
NCT00023153|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-24|2008-03-03|||August 2001||2001-08-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection|Studies of the Addition of Adefovir Dipivoxil to Lamivudine for the Treatment of Chronic Hepatitis B: A Randomized, Double-Blind, Placebo Controlled Study in HIV-Infected Patients and an Open-Label Study in HIV-Negative Subjects|Completed||Phase 3|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:18.275353|2017-10-11 04:32:18.275353
NCT00018512|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2004||2004-09-01|||||Interventional|||Biological Specifications for Denture Designs|Biological Specifications for Denture Designs|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.686034|2017-10-11 04:33:12.686034
NCT00023192|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-29|2008-03-03|||August 2001||2001-08-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care|Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care|Completed||Phase 3|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:18.393931|2017-10-11 04:32:18.393931
NCT00023205|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-29|2013-12-23|||November 2002||2002-11-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||Impact of Literacy Level on Patient Education and Health Among People With Arthritis|Literacy in Arthritis Management: A Randomized Controlled Clinical Trial of a Novel Education Intervention|Completed||Phase 2|134|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-10-11 04:32:18.455888|2017-10-11 04:32:18.455888
NCT00023218|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-29|2015-03-05||||||June 2003|2003-06-01||||||||Interventional|||Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis|Effect of Change to a Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimen of Efavirenz (EFV) and Lopinavir/Ritonavir (LPV/r) on Liver Histology in HIV-1-Infected Individuals With Lactic Acidemia and Persistent Alanine Aminotransferase (ALT) Elevations on NRTI-Containing Antiretroviral Therapy|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:32:18.686724|2017-10-11 04:32:18.686724
NCT00023231|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-29|2016-10-19|||February 2001||2001-02-01|October 2016|2016-10-01|August 2006|Actual|2006-08-01|August 2004|Actual|2004-08-01||Interventional|||Pediatric Kidney Transplant Without Calcineurin Inhibitors|Calcineurin Inhibitor Sparing Protocol in Living Donor Pediatric Kidney Transplantation|Completed||N/A|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 04:32:18.766194|2017-10-11 04:32:18.766194
NCT00023244|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-29|2016-10-19|||January 2001||2001-01-01|October 2016|2016-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Steroid Withdrawal in Pediatric Kidney Transplant Recipients|A Double-Blind Randomized Trial of Steroid Withdrawal in Sirolimus- and Cyclosporine-Treated Primary Transplant Recipients|Terminated||Phase 2|274|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2||"Effective August 13, 2004: Unanticipated high incidence of post-transplant lymphoproliferative   disorder"|f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 04:32:18.88299|2017-10-11 04:32:18.88299
NCT00023283|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-30|2008-12-30||||||December 2008|2008-12-01||||||||Interventional|||Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1|Counseling Conditions for Thrice Weekly Buprenorphine in a Primary Care Clinic|Unknown status|Not yet recruiting|Phase 2|0|Anticipated|National Institute on Drug Abuse (NIDA)||3|||f||||||||||||||2017-10-11 04:32:19.095249|2017-10-11 04:32:19.095249
NCT00023296|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-03|2017-10-05|||July 27, 2001||2001-07-27|November 9, 2015|2015-11-09|November 9, 2015|Actual|2015-11-09|November 2, 2006|Actual|2006-11-02||Interventional|||Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension|Inhaled Nitric Oxide and Transfusion Therapy for Patients With Sickle Cell Anemia and Secondary Pulmonary Hypertension|Completed||Phase 1|59|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:32:19.197893|2017-10-11 04:32:19.197893
NCT00023309|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-03|2016-09-22|2011-07-07||August 2001||2001-08-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|April 2010|Actual|2010-04-01||Interventional|||Lamivudine and Adefovir to Treat Chronic Hepatitis B|Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B|Completed||Phase 2|41|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:32:19.30928|2017-10-11 04:32:19.30928
NCT00023322|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-03|2013-07-09|2013-04-15||August 2001||2001-08-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional|||Pegylated Interferon to Treat Chronic Hepatitis D|Treatment of Chronic Delta Hepatitis With Pegylated Interferon|Completed||Phase 2|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:32:19.854472|2017-10-11 04:32:19.854472
NCT00023335|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2005-09-01|||April 1995||1995-04-01|September 2005|2005-09-01|March 2001||2001-03-01|||||Interventional|||TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis|TBTC Study 22: Efficacy and Safety of Once-Weekly Rifapentine and Isoniazid Compared to Efficacy and Safety of Once-Weekly Rifapentine and Isoniazid Compared to Twice-Weekly Rifampin and Isoniazid in the Continuation Phase of Therapy for Pulmonary Tuberculosis|Completed||Phase 3|1000||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 04:32:20.133032|2017-10-11 04:32:20.133032
NCT00023348|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2005-09-09|||July 1999||1999-07-01|September 2005|2005-09-01|November 2002||2002-11-01|||||Interventional|||TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB|TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in USPHS Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen|Completed||Phase 2/Phase 3|150||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 04:32:20.258408|2017-10-11 04:32:20.258408
NCT00023361|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2005-09-01|||February 1999||1999-02-01|September 2005|2005-09-01|February 2003||2003-02-01|||||Interventional|||TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen|TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen|Completed||N/A|215||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 04:32:20.401495|2017-10-11 04:32:20.401495
NCT00023374|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2011-08-02|||August 2000||2000-08-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2006|Actual|2006-12-01||Interventional|||TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance|TBTC Study 24: A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance|Completed||N/A|98|Actual|Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-10-11 04:32:20.537586|2017-10-11 04:32:20.537586
NCT00023387|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2005-09-09|||March 2000||2000-03-01|September 2005|2005-09-01|May 2001||2001-05-01|||||Interventional|||TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine|Intensive Pharmacokinetic Study of Three Doses of Rifapentine (600, 900 and 1200mg) During Continuation Phase Therapy of Tuberculosis in HIV-Negative Adults|Completed||N/A|36||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 04:32:20.685747|2017-10-11 04:32:20.685747
NCT00023400|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2005-09-01|||February 2000||2000-02-01|September 2005|2005-09-01|February 2002||2002-02-01|||||Interventional|||TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB|TBTC Study 23B:Intensive Pharmacokinetics of the Nelfinavir Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen|Completed||Phase 4|20||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 04:32:20.836457|2017-10-11 04:32:20.836457
NCT00023413|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2012-06-04|||November 1999||1999-11-01|June 2012|2012-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz|TBTC Study 23C: Intensive Pharmacokinetic Study of Intermittent Rifabutin and Isoniazid With Daily Efavirenz in Combination With Two Nucleoside Analogs for Treatment of HIV and Tuberculosis Co-infections|Completed||Phase 2|20||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 04:32:20.963944|2017-10-11 04:32:20.963944
NCT00023426|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2005-09-09|||July 1999||1999-07-01|September 2005|2005-09-01|February 2003||2003-02-01|||||Interventional|||TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis|TBTC Study 25:A Prospective, Randomized, Double-Blind Study of the Tolerability of Higher Doses of Rifapentine|Completed||Phase 2|150||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 04:32:21.090508|2017-10-11 04:32:21.090508
NCT00023439|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2011-08-02|||May 2000||2000-05-01|June 2011|2011-06-01||||||||Observational|||TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment|Study of the Performance of Several Nucleic Acid Amplification Methodologies in the Diagnosis and Management of Active TB|Completed||N/A|300|Anticipated|Centers for Disease Control and Prevention|||1||f||||||||||||||2017-10-11 04:32:21.229468|2017-10-11 04:32:21.229468
NCT00023452|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2015-07-30|2012-08-15||June 2001||2001-06-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|October 2010|Actual|2010-10-01||Interventional|PREVENT TB||Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection|TBTC Study 26: Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months Versus Daily Isoniazid for 9 Months for the Treatment of Latent Tuberculosis Infection|Completed||Phase 3|8595|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 04:32:21.372068|2017-10-11 04:32:21.372068
NCT00023465|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-06|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging|Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging|Unknown status|Recruiting|N/A|10||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:32:22.792782|2017-10-11 04:32:22.792782
NCT00023491|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-07|2008-03-03|||September 2001||2001-09-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells|Assessment of the Potential of Hematopoietic Stem Cells to Transdifferentiate Into Salivary Gland and Oral Mucosal Epithelial Cells in Adult Bone Marrow Transplant Patients|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:22.872307|2017-10-11 04:32:22.872307
NCT00023504|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-07|2017-10-05|||September 3, 2001||2001-09-03|July 11, 2017|2017-07-11||||||||Observational|||Antibody Production in Immune Disorders|Evaluation of Immune Response to Vaccines in Primary Immune Disorders|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:22.955689|2017-10-11 04:32:22.955689
NCT00023530|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-07|2016-02-17|||September 2001||2001-09-01|July 2006|2006-07-01|August 2006|Actual|2006-08-01|||||Interventional|||Blood and Marrow Transplant Clinical Research Network|Blood and Marrow Transplant Clinical Research Network|Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:32:23.058713|2017-10-11 04:32:23.058713
NCT00023543|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-07|2013-06-18|||September 2001||2001-09-01|June 2013|2013-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Reduction of Triglycerides in Women on Hormone Replacement Therapy|Reduction of Triglycerides in Women on HRT|Completed||Phase 2|508|Actual|University of Pittsburgh||1|||f||||||||||||||2017-10-11 04:32:23.202682|2017-10-11 04:32:23.202682
NCT00023556|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-07|2016-07-11|||September 2001||2001-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Genetic Architecture of Heart Disease in Rural Brazil||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:32:23.300203|2017-10-11 04:32:23.300203
NCT00023569|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-08|2008-03-03|||September 2001||2001-09-01|September 2003|2003-09-01|September 2003||2003-09-01|||||Observational|||Electrical Stimulation to Improve Hand Function in Patients With Chronic Stroke|Cortical Motor Reorganization in Chronic Stroke Following EMG Triggered NMES Therapy|Completed||N/A|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:23.3552|2017-10-11 04:32:23.3552
NCT00023582|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-10|2008-08-07||||||November 2006|2006-11-01||||||||Observational|||HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru|HIV Prevalence, Incidence and HSV-2 Prevalence Among High-Risk MSM in Lima, Peru|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:32:23.435752|2017-10-11 04:32:23.435752
NCT00023595|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-11|2017-07-20|2016-12-23||January 2002||2002-01-01|July 2017|2017-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|STICH||Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease|Surgical Treatment for Ischemic Heart Failure (STICH)|Completed||Phase 3|2136|Actual|Duke University||4|||f||||t||||||||||2017-10-11 04:32:23.892608|2017-10-11 04:32:23.892608
NCT00023621|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-06-25|||February 2001||2001-02-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome|A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Celecoxib in Subjects With Basal Cell Nevus Syndrome|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:31.912409|2017-10-11 04:32:31.912409
NCT00023634|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2015-03-05|||June 2001||2001-06-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer|An Early Phase Study of an EGFRvIII Peptide Based Vaccine in Patients With EGFRvIII Expressing Cancers|Terminated||Phase 1|14|Actual|Southwest Oncology Group||2||lack of accrual|f||||t||||||||||2017-10-11 04:32:31.992139|2017-10-11 04:32:31.992139
NCT00023647|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2012-07-09|||July 2000||2000-07-01|July 2012|2012-07-01|November 2002|Actual|2002-11-01|April 2002|Actual|2002-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|A Phase I Dose-Ranging Safety Study Using Intranodal Delivery of a Plasmid DNA (Synchrotope TA2M) in Adult Stage IV Melanoma Patients|Completed||Phase 1|26|Actual|Mannkind Corporation||3|||f||||f||||||||||2017-10-11 04:32:32.114856|2017-10-11 04:32:32.114856
NCT00023660|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-11-18|||August 2001||2001-08-01|November 2013|2013-11-01||||January 2005|Actual|2005-01-01||Interventional|||Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer|A Phase I/II Study Of COX-2 Inhibitor, CELEBREX (CELECOXIB), And Chemoradiation In Patients With Locally Advanced Cervical Cancer|Completed||Phase 1/Phase 2|84|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:32:32.215782|2017-10-11 04:32:32.215782
NCT00023673|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2015-11-14|2014-02-12||July 2001||2001-07-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|January 2009|Actual|2009-01-01||Interventional||Eligible patients who started protocol treatment.|Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Phase I/II Dose Intensification Study Using Three Dimensional Conformal Radiation Therapy And Concurrent Chemotherapy For Patients With Inoperable, Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|63|Actual|Radiation Therapy Oncology Group|This study was originally designed to escalate 3DRT via increasing doses per fraction. However, due to excessive toxicity at dose level 1 (75.25 Gy, 2.15 Gy/fraction), the protocol was amended in January 2003 to de-escalate 3DRT dose.|4|||f||||||||||||||2017-10-11 04:32:32.4487|2017-10-11 04:32:32.4487
NCT00023686|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2016-07-01|||October 2001||2001-10-01|July 2016|2016-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer|A Randomized Trial of Radical Prostatectomy Versus Brachytherapy for Patients With T1c or T2a N0 M0 Prostate Cancer|Completed||Phase 3|190|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:32:33.422709|2017-10-11 04:32:33.422709
NCT00023699|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-06-20|||August 2001||2001-08-01|August 2003|2003-08-01|May 2006|Actual|2006-05-01|||||Interventional|||Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Trial of ZD1839 (Iressa) (NSC# 715055) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:33.682781|2017-10-11 04:32:33.682781
NCT00023712|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2014-04-29|2013-09-17||July 2004||2004-07-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Cohort 1: 2 participants were not eligible/evaluable after enrollment. Cohort 2: 1 participant was not eligible/evaluable after enrollment.|Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Bortezomib (Velcade™, PS-341, NSC #681239, IND #58443) in the Treatment of Persistent or Recurrent Platinum-Sensitive Epithelial Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|58|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:33.861076|2017-10-11 04:32:33.861076
NCT00023725|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-06-20|||August 2001||2001-08-01|August 2007|2007-08-01|October 2003|Actual|2003-10-01|||||Interventional|||Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma|A Randomized Phase I/II Study Of Preoperative Radiotherapy With/Without SUGEN 5416 (NSC # 696819; A TK Inhibitor Anti-Angiogenesis Compound) In The Management Of Low To Intermediate Grade Soft Tissue Sarcoma Of The Trunk or Extremity|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:35.177437|2017-10-11 04:32:35.177437
NCT00023738|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-06-20|||August 2001||2001-08-01|December 2010|2010-12-01|October 2003|Actual|2003-10-01|||||Interventional|||Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma|A Phase I/II Study Of Neoadjuvant Chemotherapy, Angiogenesis Inhibitor SU5416 (NSC # 696819; A TK Inhibitor Anti-Angionesises Compound), And Radiation Therapy In The Management Of High Risk, High-Grade, Soft Tissue Sarcomas Of The Extremities And Body Wall|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:36.048809|2017-10-11 04:32:36.048809
NCT00023751|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2016-07-01|||July 2001||2001-07-01|July 2016|2016-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer|A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers|Completed||Phase 2|320|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:32:36.611495|2017-10-11 04:32:36.611495
NCT00023764|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2015-11-02|2013-10-23||June 2001||2001-06-01|December 2012|2012-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Bortezomib in Treating Patients With Lymphoproliferative Disorders|Phase II Study of PS-341 in Low Grade Lymphoproliferative Disorders|Completed||Phase 2|103|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:37.428593|2017-10-11 04:32:37.428593
NCT00023777|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2015-03-05|||August 2001||2001-08-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|June 2003|Actual|2003-06-01||Interventional|||S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia|A Phase II Study Of Daunomycin And ARA-C, Both Given By Continous IV Infusion For Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) In Patients Of Age 56 Or Older|Completed||Phase 2|71|Actual|Southwest Oncology Group||1|||f||||||||||||||2017-10-11 04:32:37.903166|2017-10-11 04:32:37.903166
NCT00023790|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2011-08-23|||August 2001||2001-08-01|August 2011|2011-08-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin|Phase I Trial of PC 4-PDT (NSC 676418) for Cutaneous Malignancies|Terminated||Phase 1|3|Actual|Case Comprehensive Cancer Center||1||slow accrual|f||||t||||||||||2017-10-11 04:32:38.222427|2017-10-11 04:32:38.222427
NCT00023816|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-09-19||||||December 2001|2001-12-01||||||||Interventional|||Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma|Third Phase I and Pharmacokinetic Study Of FB-642 Administered Orally To Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:38.33131|2017-10-11 04:32:38.33131
NCT00023829|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-11-12|||August 2001||2001-08-01|November 2013|2013-11-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer|Phase III Randomized Study of Adjuvant Therapy for High Risk pT3N0 Prostate Cancer|Completed||Phase 3|67|Actual|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-10-11 04:32:38.42872|2017-10-11 04:32:38.42872
NCT00023842|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2012-09-20|||June 2001||2001-06-01|September 2012|2012-09-01||||February 2005|Actual|2005-02-01||Interventional|||BCG With or Without Mitomycin in Treating Patients With Bladder Cancer|A Randomized Phase II Trial of Sequential Chemo-Immunotherapy Versus Immunotherapy Alone in Carcinoma in Situ of the Urinary Bladder|Completed||Phase 2|97|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:32:38.540964|2017-10-11 04:32:38.540964
NCT00023855|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2015-09-30|||June 2001||2001-06-01|September 2015|2015-09-01||||October 2003|Actual|2003-10-01||Interventional|||PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacodynamic Study of Proteasome Inhibitor, PS-341, in Combination With Doxorubicin in Patients With Advanced Solid Tumors|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:32:38.663311|2017-10-11 04:32:38.663311
NCT00023868|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2009-01-03|||November 2001||2001-11-01|December 2003|2003-12-01||||||||Interventional|||Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver|A Randomized Phase I/III Study Of Systematic Chemotherapy With Or Without Hepatic Chemoembolization For Liver-Dominant Metastatic Adenocarcinoma Of The Colon And Rectum|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:38.758285|2017-10-11 04:32:38.758285
NCT00023881|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2012-10-05|||July 2001||2001-07-01|October 2012|2012-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Bortezomib in Treating Patients With Chronic Myelogenous Leukemia|Phase II Study of a Proteasome Inhibitor, PS-341 (NSC 681239) in Chronic Myelogenous Leukemia (CML) in Chronic or Accelerated Phase|Completed||Phase 2|7|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:32:38.874782|2017-10-11 04:32:38.874782
NCT00023894|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-06-20|||July 2001||2001-07-01|May 2004|2004-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Flavopiridol (NSC# 649890) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:38.948176|2017-10-11 04:32:38.948176
NCT00023907|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-04-10|||July 2001||2001-07-01|May 2004|2004-05-01||||April 2006|Actual|2006-04-01||Interventional|||Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum and Paclitaxel-Resistant Ovarian or Primary Peritoneal Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:32:39.139557|2017-10-11 04:32:39.139557
NCT00023920|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-01-22|||July 2001||2001-07-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia|A Phase II Study of Bevacizumab (rhuMab VEGF, NSC 704865), Idarubicin and Cytarabine in Patients With Chronic Myeloid Leukemia in Blast Phase|Terminated||Phase 2|60|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:32:39.442716|2017-10-11 04:32:39.442716
NCT00023933|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-01-24|||October 2001||2001-10-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer|Phase I Trial of 131I-HuCC49^CH2 for Colon Cancer|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:39.539129|2017-10-11 04:32:39.539129
NCT00023946|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2014-05-13|||August 2001||2001-08-01|December 2012|2012-12-01|November 2009|Actual|2009-11-01|July 2005|Actual|2005-07-01||Interventional|||BMS-247550 in Treating Patients With Liver or Gallbladder Cancer|A Phase II Trial Of The Epothilone B Analog BMS-247550 (NSC 710428D) In Patients With Hepatobiliary Cancer|Terminated||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:39.660284|2017-10-11 04:32:39.660284
NCT00023959|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-02-06|||July 2001||2001-07-01|February 2013|2013-02-01||||March 2010|Actual|2010-03-01||Interventional|||Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer|A Phase I Study Of Bevacizumab (Recombinant Humanized Monoclonal Antibody To Vascular Endothelial Growth Factor) In Addition To Flourouracil And Hydroxyurea As Initial Chemotherapy With Concomitant Radiotherapy (B-FHX) For Poor Prognosis Head And Neck Cancer|Completed||Phase 1|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:39.779456|2017-10-11 04:32:39.779456
NCT00023972|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2012-05-15|||July 2001||2001-07-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Randomized, Open-Label, Multicenter Phase III Study Comparing the Efficacy and Safety of a Combination of Intravenous DX-8951f (Exatecan Mesylate) Plus Gemcitabine to Gemcitabine Alone in Patients With Locally Advanced or Metastatic Cancer of the Exocrine Pancreas Who Have Not Received Prior Chemotherapy|Completed||Phase 3|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:32:39.949572|2017-10-11 04:32:39.949572
NCT00023985|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2011-03-03|||January 2001||2001-01-01|March 2011|2011-03-01|August 2003|Actual|2003-08-01|July 2003|Actual|2003-07-01||Interventional|||Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer|Vaccination With Autologous Tumor Lysate-Pulsed Dendritic Cells - Phase I|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:32:40.240402|2017-10-11 04:32:40.240402
NCT00023998|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-02-01|||July 2001||2001-07-01|January 2013|2013-01-01|May 2007||2007-05-01|November 2005|Actual|2005-11-01||Interventional|||Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma|A Groupwide Phase II Study of Trastuzumab (Herceptin) in Metastatic Osteosarcoma Patients With Tumors That Overexpress HER2|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:40.33401|2017-10-11 04:32:40.33401
NCT00024011|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-01-15|||July 2001||2001-07-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||PS-341 in Treating Patients With Metastatic Malignant Melanoma|A Phase II Study of PS-341 in the Treatment of Metastatic Malignant Melanoma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:40.477734|2017-10-11 04:32:40.477734
NCT00024024|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-02-08|||August 2001||2001-08-01|April 2008|2008-04-01||||August 2003|Actual|2003-08-01||Interventional|||BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma|A Phase I-II Trial Of BMS-275291 In Patients With HIV-Related Kaposi's Sarcoma|Completed||Phase 1/Phase 2|59|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:40.572101|2017-10-11 04:32:40.572101
NCT00024037|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2010-06-15|||April 1995||1995-04-01|June 2010|2010-06-01|December 2002|Actual|2002-12-01|||||Interventional|||Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation|A Phase II/III Blinded Randomized Trial to Determine the Efficacy of Low Energy Diode Laser Therapy (650 nm or 780 nm) to Prevent Oral Mucositis Following Bone Marrow Transplantation|Completed||Phase 2/Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:32:40.656042|2017-10-11 04:32:40.656042
NCT00018525|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 2000||2000-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Interventional|||Lung Volume Reductions Surgery (LVRS) Study|Effects of Lung Volume Reduction Surgery in the Treatment of Severe Emphysema|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.746406|2017-10-11 04:33:12.746406
NCT00024050|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2010-05-12|||February 2001||2001-02-01|May 2010|2010-05-01|August 2007|Actual|2007-08-01|||||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome|"Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation for the Treatment of Less Advanced Myelodysplasi"|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:32:40.743986|2017-10-11 04:32:40.743986
NCT00024063|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-12-18||||||April 2007|2007-04-01||||||||Interventional|||SU006668 in Treating Patients With Advanced Solid Tumors|A Phase I Study Of SU006668 Via Twice Daily Oral Administration Under Fed Conditions In Patients With Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:40.844074|2017-10-11 04:32:40.844074
NCT00024076|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2015-10-28|||May 2000||2000-05-01|July 2012|2012-07-01||||December 2006|Actual|2006-12-01||Interventional|||Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer|Radiofrequency Ablation of Pulmonary Malignancy|Completed||Phase 2|30|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:32:40.962096|2017-10-11 04:32:40.962096
NCT00024089|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-02-08|||July 2001||2001-07-01|November 2005|2005-11-01||||March 2006|Actual|2006-03-01||Interventional|||Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer|A Phase II Study of ZD 1839 (Iressa) in Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:41.043862|2017-10-11 04:32:41.043862
NCT00024102|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2016-07-12|2012-11-20||September 2001||2001-09-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|May 2008|Actual|2008-05-01||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer|A Randomized Trial of Adjuvant Chemotherapy With Standard Regimens, Cyclophosphamide, Methotrexate and Fluorouracil - (CMF) or Doxorubicin and Cyclophosphamide - (AC), Versus Capecitabine in Women 65 Years and Older With Node Positive or Node-Negative Breast Cancer|Completed||Phase 3|633|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:32:41.237875|2017-10-11 04:32:41.237875
NCT00024115|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2015-04-27||||||December 2006|2006-12-01||||||||Interventional|||BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Phase I Study of Recombinant BL22 Immunotoxin in Patients With CD22-Positive B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Withdrawn||Phase 1|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:43.414078|2017-10-11 04:32:43.414078
NCT00024128|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2016-02-01|||August 2001||2001-08-01|February 2016|2016-02-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma|Delayed Donor Leukocyte Infusions in Patients Receiving Allogeneic PBSC Following Conditioning With Non-myeloablative Regimen for AIDS-Related Lymphoma (NHL and HD)|Withdrawn||Phase 2|0|Actual|AIDS Malignancy Consortium||1||Withdrawn prior to initiation.|f||||||||||||||2017-10-11 04:32:43.487014|2017-10-11 04:32:43.487014
NCT00024141|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2011-03-03|||May 2001||2001-05-01|March 2011|2011-03-01|January 2003|Actual|2003-01-01|September 2002|Actual|2002-09-01||Interventional|||Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors|5-Flourouracil Preceded by Irinotecan In Patients With Advanced Solid Tumors: A Pilot Study|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:32:43.641726|2017-10-11 04:32:43.641726
NCT00024154|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-01-23|||February 2002||2002-02-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer|A Phase I/II Trial of Herceptin and ZD1839 (Iressa, NSC #715055, IND#61187) in Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu (erbB-2)|Completed||Phase 2|132|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:43.72269|2017-10-11 04:32:43.72269
NCT00024167|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2016-02-19|2016-01-22||April 2002||2002-04-01|February 2016|2016-02-01||||September 2014|Actual|2014-09-01||Interventional||Of the 265 participants enrolled - 133 participants received only induction treatment and 127 were randomized to either the Sr-89 treatment arm or the no Sr-89 treatment arm. 5 participants never received any treatment.|Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer|A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer|Terminated||Phase 3|265|Actual|M.D. Anderson Cancer Center||4||Terminated due to slow accrual|f||||t||||||||||2017-10-11 04:32:43.856985|2017-10-11 04:32:43.856985
NCT00024180|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-01-30|||January 2002||2002-01-01|November 2002|2002-11-01|August 2006|Actual|2006-08-01|||||Interventional|||FR901228 in Treating Patients With Hematologic Cancer|A Phase I Study of Depsipeptide in Selected Hematologic Malignancies (NSC 630176)|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:44.925664|2017-10-11 04:32:44.925664
NCT00024193|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-08-06|||April 1999||1999-04-01|November 2001|2001-11-01||||||||Interventional|||Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma|A Study Of The Treatment Of Metastatic Neuroblastoma In Children More Than One Year Of Age At Diagnosis|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:45.006973|2017-10-11 04:32:45.006973
NCT00024206|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-01-22|||July 2001||2001-07-01|January 2013|2013-01-01||||July 2003|Actual|2003-07-01||Interventional|||SU6668 in Treating Patients With Advanced Solid Tumors|A Phase I Surrogate Endpoint Trial of SU6668 in Patients With Incurable Solid Tumors|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:45.104716|2017-10-11 04:32:45.104716
NCT00024232|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-06-17|||June 2001||2001-06-01|June 2013|2013-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer|Pilot Trial of Humanized Monoclonal Antibody J591 in Patients With Progressive Androgen-Independent Prostate Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:32:45.186866|2017-10-11 04:32:45.186866
NCT00024245|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-06-25|||May 2001||2001-05-01|March 2003|2003-03-01|April 2003|Actual|2003-04-01|||||Interventional|||10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors|Phase I and Clinical Pharamcologic Study of 10-Propargyl-10-Deazaaminopterin (PDX) in Combination With Probenecid in Adults With Advanced Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:45.244121|2017-10-11 04:32:45.244121
NCT00018239|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Interventional|||Aging and Cellular Mechanism for Insulin Action After Exercise Training|Aging and Cellular Mechanism for Insulin Action After Exercise Training|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.164368|2017-10-11 04:33:11.164368
NCT00024258|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2015-10-22|2015-10-22||March 2001||2001-03-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors|Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors|Completed||Phase 2|22|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:32:45.311389|2017-10-11 04:32:45.311389
NCT00024271|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2014-01-03|||May 2001||2001-05-01|January 2004|2004-01-01||||||||Interventional|||Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer|Phase II Trial Of Combined Resection, Intraperitoneal Chemotherapy, And Whole Abdominal Radiation For Treatment Of Peritoneal Mesothelioma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:45.731792|2017-10-11 04:32:45.731792
NCT00024284|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-04-03|||June 2001||2001-06-01|April 2013|2013-04-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors|A Phase I Study Of Carboplatin And Irinotecan In Patients 1-21 Years Of Age With Refractory Solid Tumors|Completed||Phase 1|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:32:45.804848|2017-10-11 04:32:45.804848
NCT00024297|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-08-06|||October 1999||1999-10-01|December 2002|2002-12-01|February 2009|Actual|2009-02-01|||||Interventional|||Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters|A Multicenter Prospective Randomized Controlled Trial of Thrombosis Prophylaxis With Warfarin in Cancer Patients With Central Venous Catheters|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:45.883067|2017-10-11 04:32:45.883067
NCT00024310|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-09-16|||September 2001||2001-09-01|November 2002|2002-11-01||||||||Interventional|||Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Trial of Lometrexol Sodium and Paclitaxel Adminsitered Intravenously Every 21 Days in Conjunction With Oral Folic Acid in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.023731|2017-10-11 04:32:46.023731
NCT00024323|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-07-17|||March 2001||2001-03-01|November 2002|2002-11-01|June 2003|Actual|2003-06-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) Administered Daily x 5 in Combination With Cisplatin|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.102061|2017-10-11 04:32:46.102061
NCT00024336|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-08-06|||August 1999||1999-08-01|December 2006|2006-12-01||||||||Interventional|||Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma|Treatment of Children With Newly Diagnosed Diffuse Pontine Gliomas Using Conventional Radiotherapy and High Dose Tamoxifen|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.191009|2017-10-11 04:32:46.191009
NCT00024349|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-12-17|||June 2001||2001-06-01|May 2007|2007-05-01|April 2012|Actual|2012-04-01|||||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer|2X2 Factorial Randomized Phase III Study Comparing Standard Versus Reduced Volume Radiotherapy With and Without Synchronous Chemotherapy in Muscle Invasive Bladder Cancer|Completed||Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.349566|2017-10-11 04:32:46.349566
NCT00024362|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2008-07-23|||May 2001||2001-05-01|April 2007|2007-04-01||||||||Interventional|||BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery|A Phase II Trial of BBR 3464 as First Line Treatment in Patients With Inoperable, Locally Advanced or Metastatic Adenocarcinoma of the Pancreas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.490855|2017-10-11 04:32:46.490855
NCT00024375|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2009-02-17|||June 2001||2001-06-01|March 2003|2003-03-01||||||||Interventional|||DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer|Phase II Open-Label Study of Taxoperxin (DHA-Paclitaxel) Injection by 2 Hour Intravenous Infusion in Patients With Metastatic Cancer of the Pancreas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.588106|2017-10-11 04:32:46.588106
NCT00024388|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2008-07-23|||April 2001||2001-04-01|June 2002|2002-06-01||||||||Interventional|||Chemotherapy in Treating Patients With Metastatic Kidney Cancer|Phase II Open-Label Study of Taxoprexin (DHA-Paclitaxel) Injection by 2-Hour Intravenous Infusion In Patients With Metastatic, Locally Advanced, or Unresectable Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.68867|2017-10-11 04:32:46.68867
NCT00024401|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2008-07-23|||May 2001||2001-05-01|June 2002|2002-06-01||||||||Interventional|||DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer|Phase II Open-Label Study of Taxoperxin (DHA-Paclitacel) Injection by 2-Hour Intravenous Infusion in Patients With Metastatic Cancer of the Colon/Rectum|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.769726|2017-10-11 04:32:46.769726
NCT00024414|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2008-07-23|||April 2001||2001-04-01|March 2003|2003-03-01||||||||Interventional|||DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer|Phase II Open-Label Study of Taxoprexin (DHA-Paclitaxel) Injection by 2-Hour Intravenous Infusion in Patients With Metastatic Hormone-Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:46.865382|2017-10-11 04:32:46.865382
NCT00024427|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2012-06-27|||February 2001||2001-02-01|May 2010|2010-05-01||||February 2006|Actual|2006-02-01||Interventional|||Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer|An Open Label, Randomized, Controlled, Phase III, Multi-center, Clinical Trial Of PN401 With High Dose 5-Fluorouracil (5FU) Versus Gemcitabine For Treatment Of Patients With Advanced Pancreatic Cancer|Completed||Phase 3|250|Actual|Wellstat Therapeutics||1|||f||||f||||||||||2017-10-11 04:32:46.98953|2017-10-11 04:32:46.98953
NCT00024440|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2014-01-03|||July 2001||2001-07-01|October 2003|2003-10-01|February 2007|Actual|2007-02-01|||||Interventional|||Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Randomized Study Of Fludarabine And Cyclophosphamide With Or Without Genasense (Bcl-2 Antisense Oligonucleotide) In Subjects With Relapsed Or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:49.06246|2017-10-11 04:32:49.06246
NCT00018538|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Interventional|||Calcifidol Therapy in Men With Cancer|Calcifidol Therapy in Men With Cancer|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.81026|2017-10-11 04:33:12.81026
NCT00024453|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2013-08-06|||February 1999||1999-02-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|||Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter|The Use of Teicoplanin in the Treatment of Septicaemia Caused by Coagulase-Negative Staphylococci - A Randomized Study Comparing Bolus Injection With Infused and/or Line-Locked Teicoplanin|Unknown status|Active, not recruiting|N/A|1360|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:49.15583|2017-10-11 04:32:49.15583
NCT00024466|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-13|2014-05-01|||March 2001||2001-03-01|May 2014|2014-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma|Vaccination In Peripheral Stem Cell Transplant Setting For Multiple Myeloma: The Use Of Autologous Tumor Cells/An Allo PSCT|Completed||Phase 1/Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:32:49.271463|2017-10-11 04:32:49.271463
NCT00024479|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-14|2017-10-05|||September 6, 2001||2001-09-06|November 25, 2016|2016-11-25||||||||Observational|||Natural History of Rheumatic Diseases in Minority Communities|Studies of the Natural History of Rheumatic Disease in Minority Communities|Recruiting||N/A|100000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:49.371116|2017-10-11 04:32:49.371116
NCT00024492|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-17|2011-06-02|||August 2001||2001-08-01|August 2004|2004-08-01|June 2004||2004-06-01|||||Interventional|||Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer||Completed||Phase 1|40||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:32:49.447936|2017-10-11 04:32:49.447936
NCT00024505|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-18|2013-01-15|||September 2001||2001-09-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Multidisciplinary Study of Right Ventricular Dysplasia|Multidisciplinary Study of Right Ventricular Dysplasia|Completed||N/A|320|Actual|University of Arizona|||1||f||||t||||||Samples With DNA|"     Blood   "|||2017-10-11 04:32:49.530318|2017-10-11 04:32:49.530318
NCT00024518|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-19|2013-11-18|||September 2001||2001-09-01|November 2013|2013-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Interferon-Alpha for Diabetes Mellitus Type 1|"Ingested Interferon-Alpha: Prolongation or Permanence of the Honeymoon Phase in Newly Diagnosed Diabetes Mellitus"|Completed||Phase 2|57|Actual|The University of Texas Health Science Center, Houston||3|||f||||f||||||||||2017-10-11 04:32:49.638332|2017-10-11 04:32:49.638332
NCT00024531|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-19|2006-11-08|||October 2000||2000-10-01|November 2006|2006-11-01|August 2004||2004-08-01|||||Interventional|||Lipitor as a Treatment for Alzheimer's Disease|Effect of the HMG-CoA Reductase Inhibitor Atorvastatin Calcium, Lipitor, in the Treatment of Alzheimer's Disease|Completed||Phase 2|98||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:32:49.761104|2017-10-11 04:32:49.761104
NCT00024544|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-19|2012-03-06|||August 2001||2001-08-01|March 2012|2012-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Pilot Study in Patients With Symptomatic Steroid-Naive Asthma|A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma|Completed||Phase 2|120||Facet Biotech|||||f||||||||||||||2017-10-11 04:32:50.038224|2017-10-11 04:32:50.038224
NCT00024557|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-20|2011-06-02|||June 2001||2001-06-01|June 2011|2011-06-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients|Phase I Study to Assess the Histologic Effect and Safety of Pre-Operative and Post-Operative Infusions of IL13-PE38QQR Cytotoxin in Patients With Recurrent Resectable Supratentorial Malignant Glioma|Completed||Phase 1|40||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:32:50.227322|2017-10-11 04:32:50.227322
NCT00024570|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-20|2014-11-12|||November 2000||2000-11-01|November 2014|2014-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma|Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma: Phase I/II Study|Completed||Phase 1/Phase 2|60||INSYS Therapeutics Inc|||||f||||||||||||||2017-10-11 04:32:50.338505|2017-10-11 04:32:50.338505
NCT00024583|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-21|2016-02-17|||September 2001||2001-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Prenatal Nutrition and Adult Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:32:50.476721|2017-10-11 04:32:50.476721
NCT00024596|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-21|2015-12-21|||September 2001||2001-09-01|December 2015|2015-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)||Completed||N/A|3389|Actual|Washington University School of Medicine|||2||f||||||||||Samples With DNA|"     Stored DNA, lymphoblasts   "|||2017-10-11 04:32:50.570934|2017-10-11 04:32:50.570934
NCT00024635|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-23|2017-10-05|||September 20, 2001||2001-09-20|September 8, 2017|2017-09-08||||||||Observational|||Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers|The Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers|Recruiting||N/A|16000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:50.816381|2017-10-11 04:32:50.816381
NCT00024648|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-24|2011-04-12|||March 2001||2001-03-01|April 2011|2011-04-01|December 2004||2004-12-01|||||Interventional|||Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies|Phase I Study to Determine the Maximum Tolerated Dose of LErafAON in Combination With Radiotherapy in Patients With Advanced Malignancies|Completed||Phase 1|25||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:32:50.93806|2017-10-11 04:32:50.93806
NCT00024661|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-24|2011-04-12|||March 2001||2001-03-01|April 2011|2011-04-01|October 2004||2004-10-01|||||Interventional|||Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors|Study to Determine the Maximum Tolerated Dose of Liposome-Encapsulated C-RAF Antisense Oligodeoxynucleotide (LErafAON) in Patients With Advanced Solid Tumors|Completed||Phase 1|30||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:32:51.048208|2017-10-11 04:32:51.048208
NCT00024674|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-24|2014-11-13|||February 2001||2001-02-01|November 2014|2014-11-01||||||||Interventional|||Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days||Withdrawn||Phase 1|0|Actual|INSYS Therapeutics Inc||||Support withdrawn - Study continued by NCI - see record NCT00006981|||||||||||||||2017-10-11 04:32:51.166706|2017-10-11 04:32:51.166706
NCT00024687|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-24|2014-11-13|||November 2000||2000-11-01|November 2014|2014-11-01||||||||Interventional|||Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses||Withdrawn||Phase 1|0|Actual|INSYS Therapeutics Inc||||Support withdrawn - Study continued by NCI - see record NCT00006981|||||||||||||||2017-10-11 04:32:51.268997|2017-10-11 04:32:51.268997
NCT00024791|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-27|2008-03-03|||September 2001||2001-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Eye-Hand Coordination in Children With Spastic Diplegia|Neurophysiology of Motor Disorders in Spastic Diplegia|Completed||N/A|144||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:51.346058|2017-10-11 04:32:51.346058
NCT00024804|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-28|2017-10-05|||September 25, 2001||2001-09-25|July 24, 2017|2017-07-24||||||||Observational|||Evaluation and Treatment of Skeletal Diseases|Evaluation and Treatment of Bone and Mineral Disorders|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:51.450862|2017-10-11 04:32:51.450862
NCT00024817|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-28|2016-07-14|||September 1999||1999-09-01|August 2004|2004-08-01|August 2002|Actual|2002-08-01|||||Observational|||Energy Expenditure, Diet and Body Fat in Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:32:51.589417|2017-10-11 04:32:51.589417
NCT00024830|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-28|2016-03-15|||September 1999||1999-09-01|October 2005|2005-10-01|August 2002|Actual|2002-08-01|||||Observational|||Peer-Based Skills Training to Enhance Teen Weight Loss||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:32:51.656779|2017-10-11 04:32:51.656779
NCT00024843|ClinicalTrials.gov processed this data on October 10, 2017|2001-09-28|2016-05-12|||September 1999||1999-09-01|August 2004|2004-08-01|August 2003|Actual|2003-08-01|||||Observational|||Family Based Interventions: Preschool Children and Parent||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:32:51.717674|2017-10-11 04:32:51.717674
NCT00024908|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-04|2017-06-30|||October 1, 2001||2001-10-01|April 7, 2010|2010-04-07|April 7, 2010||2010-04-07|||||Observational|||Test of A Model of Representational Knowledge Stored in the Human Prefrontal Cortex|Testing A Model of the Representational Knowledge Stored in the Human Prefrontal Cortex|Completed||N/A|949|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:51.787497|2017-10-11 04:32:51.787497
NCT00024921|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-05|2013-09-05||||||December 2003|2003-12-01||||||||Observational|||The Genetics of Kidneys in Diabetes (GoKinD) Study|The Genetics of Kidneys in Diabetes (GoKinD) Study|Completed||N/A|2100|Anticipated|National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:32:51.873454|2017-10-11 04:32:51.873454
NCT00024934|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-09|2016-09-21|||October 2001||2001-10-01|September 2016|2016-09-01|August 2004||2004-08-01|||||Interventional|||B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency|A Phase I Dose Escalation Study of B-Lymphocyte Stimulator (BLyS) Administered Subcutaneously in Patients With Selective IgA Deficiency|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:51.923895|2017-10-11 04:32:51.923895
NCT00024960|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-09|2017-06-30|||October 3, 2001||2001-10-03|October 29, 2010|2010-10-29|October 29, 2010||2010-10-29|||||Observational|||Dopamine Function in Developmental Stuttering|Assessment of Pre- and Post-Synaptic Dopamine Function in Developmental Stuttering Using 11C-Raclopride and Positron Emission Tomography|Completed||N/A|12|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:51.993091|2017-10-11 04:32:51.993091
NCT00024986|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-10|2008-03-03|||October 2001||2001-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Tenofovir Disoproxil Fumarate to Treat Pediatric HIV|A Phase I Study of Tenofovir Disoproxil Fumarate (PMPA Prodrug), A Novel Nucleotide Analog Reverse Transcriptase Inhibitor in Children With HIV Infection|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:52.063459|2017-10-11 04:32:52.063459
NCT00024999|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-10|2008-03-03|||October 2001||2001-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||EEG and EMG Analysis of Ideomotor Apraxia|EEG Analysis of Ideomotor Apraxia|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:32:52.155361|2017-10-11 04:32:52.155361
NCT00025012|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-06-17|||June 1991||1991-06-01|November 2007|2007-11-01|February 2004|Actual|2004-02-01|||||Interventional|||Isotretinoin in Preventing Skin Cancer|Use Of Isotretinion For Prevention Of Skin Cancer In Patients With Xeroderma Pigmentosum Or Nevoid Basal Cell Carcinoma Syndrome|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:52.327911|2017-10-11 04:32:52.327911
NCT00025025|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2016-07-01|||October 2001||2001-10-01|July 2016|2016-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Screening Tests in Detecting Colorectal Cancer|Colorectal Cancer Screening: Fecal Blood vs. DNA|Completed||N/A|4482|Actual|Alliance for Clinical Trials in Oncology|||2||f||||f||||||||||2017-10-11 04:32:52.428343|2017-10-11 04:32:52.428343
NCT00025038|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-04-10|||June 2001||2001-06-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia|Phase II Window Evaluation of the Farnesyl Transferase Inhibitor (R115777) Followed by 13-CIS Retinoic Acid, Cytosine Arabinoside and Fludarabine Plus Hematopoietic Stem Cell Transplantation in Children With Juvenile Myelomonocytic Leukemia|Completed||Phase 2|100|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:52.715698|2017-10-11 04:32:52.715698
NCT00025051|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-03-21||||||December 2006|2006-12-01||||||||Interventional|||Celecoxib in Preventing Skin Cancer|A Phase II, Double-Blind, Placebo-Controlled Clinical Trial To Assess Celecoxib As A Chemopreventive Agent Inhibiting UV-Induced Erythema And Cutaneous Carcinogenesis As Assessed Through Surrogate Biological Markers In Biopsied Skin After Exposure Of Skin In Normal Volunteers Ages 20-60 Years Old With Fitzpatrick Type I, II, III And IV Skin To UV-Radiation From Artificial Light Sources|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:52.925308|2017-10-11 04:32:52.925308
NCT00025064|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-08-06|||January 2000||2000-01-01|December 2002|2002-12-01||||||||Interventional|||Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma|Protocol For The Treatment Of Children And Adolescents With Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 2|260|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:53.0198|2017-10-11 04:32:53.0198
NCT00017082|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-25|||April 2001||2001-04-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|June 2003|Actual|2003-06-01||Interventional|||Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer|A Multicenter, Phase II Study Of Oxaliplatin Single Agent As Third-Line Treatment Of Metastatic Colorectal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:00.332039|2017-10-11 04:33:00.332039
NCT00025077|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-08-01|||January 2000||2000-01-01|June 2007|2007-06-01|April 2011|Actual|2011-04-01|||||Interventional|||Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors|Treatment Of Recurrent Central Nervous System Primitive Neuroectodermal Tumors (PNETs) In Children And Adolescents A Strategy Including The Use Of High Dose Thiotepa And High Dose Carboplatin|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:53.19283|2017-10-11 04:32:53.19283
NCT00025090|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-08-23|||March 2001||2001-03-01|March 2007|2007-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer|Second UK Phase III Anal Cancer Trial: A Trial of Chemoradiation and Maintenance Therapy for Patients With Anal Cancer|Completed||Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:53.36489|2017-10-11 04:32:53.36489
NCT00025103|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-08-01|||May 2001||2001-05-01|June 2009|2009-06-01||||November 2008|Anticipated|2008-11-01||Interventional|||Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney|Protocol For The Treatment Of Relapsed And Refractory Wilms Tumour And Clear Cell Sarcoma Of The Kidney (CCSK)|Unknown status|Active, not recruiting|Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:53.518472|2017-10-11 04:32:53.518472
NCT00025116|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2010-11-07|||April 2001||2001-04-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|A Randomized Phase II Study Of ZD1839 (IRESSA) In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:32:53.675103|2017-10-11 04:32:53.675103
NCT00025129|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-07-17|||March 2001||2001-03-01|March 2004|2004-03-01|May 2004|Actual|2004-05-01|||||Interventional|||VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas|A Phase I Trial of VNP4010M, A Novel Alkylating Agent for Patients With Advanced or Metastatic Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:53.762065|2017-10-11 04:32:53.762065
NCT00025142|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-05-14|||July 2001||2001-07-01|February 2005|2005-02-01|November 2006|Actual|2006-11-01|||||Interventional|||Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer|A Study of ZD1839 (Iressa) in Combination With Oxaliplatin, 5-Fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Malignancies (Phase I) and Advanced Colorectal Cancers (Phase II)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:53.844236|2017-10-11 04:32:53.844236
NCT00025155|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2015-06-17|2015-04-29||July 2002||2002-07-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||Patients who were eligible and received any study treatment.|Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy|A Phase II Evaluation of Epothilone-B BMS 247550 (NSC # 710428) in the Treatment of Recurrent or Persistent Platinum and Paclitaxel Refractory Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:53.966153|2017-10-11 04:32:53.966153
NCT00025168|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2017-04-17|||November 2001|Actual|2001-11-01|April 2017|2017-04-01|August 29, 2003|Actual|2003-08-29|August 29, 2003|Actual|2003-08-29||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer|Phase II Trial Of Induction Gemcitabine/CPT-11 Followed By Twice-Weekly Infusion Gemcitabine And Concurrent External Beam Radiation For The Treatment Of Locally Advanced Pancreatic Cancer|Completed||Phase 2|20|Actual|Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:32:54.434049|2017-10-11 04:32:54.434049
NCT00025181|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2014-05-20|||October 2001||2001-10-01|May 2014|2014-05-01|June 2005|Actual|2005-06-01|January 2003|Actual|2003-01-01||Interventional|||Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery|An Open-label Study Of MDX-CTLA4 In Combination With Tyrosinase/gp100/MART-1 Peptides Emulsified With Montanide ISA 51 In The Treatment Of Patients With Resected Stage III Or Stage IV Melanoma|Completed||Phase 1|19|Actual|University of Southern California|||||f||||t||||||||||2017-10-11 04:32:54.530145|2017-10-11 04:32:54.530145
NCT00025194|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-06-20|||July 2001||2001-07-01|November 2005|2005-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer|A Phase I And Randomized Phase 2 Trial Of Epothilone B Analogue BMS 247550 (NSC # 710428) Administered Every 21 Days With Or Without Oral Estramustine Phosphate In Patients With Androgen Independent Prostate Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:54.612323|2017-10-11 04:32:54.612323
NCT00025207|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-01-15|||September 2001||2001-09-01|January 2013|2013-01-01||||February 2006|Actual|2006-02-01||Interventional|||Gefitinib in Treating Patients With Malignant Mesothelioma|A Phase II Study Of ZD 1839 (NSC 715055, IND 61187) In Patients With Malignant Mesothelioma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:54.686531|2017-10-11 04:32:54.686531
NCT00025220|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2015-03-13|||September 2001||2001-09-01|December 2012|2012-12-01|July 2008|Actual|2008-07-01|April 2003|Actual|2003-04-01||Interventional|||Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus|A Phase II Evaluation of Thalidomide (NSC #66847) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:54.894289|2017-10-11 04:32:54.894289
NCT00025233|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2015-06-10|2015-06-10||April 2002||2002-04-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||Eligible and treated patients.|Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix|A Phase II Trial of Bevacizumab (rhuMAB VEGF) (NSC #704865) in the Treatment of Persistent and Recurrent Squamous Cell Carcinoma of the Cervix (Group A)|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:55.033579|2017-10-11 04:32:55.033579
NCT00025246|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-02-19|||September 2001||2001-09-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery|A Phase II Study of Adjuvant STI571 (Gleevec TM) Therapy in Patients Following Completely Resected High-risk Primary GastroIntestinal Stromal Tumor (GIST)|Completed||Phase 2|89|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:32:55.619407|2017-10-11 04:32:55.619407
NCT00025259|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2017-03-15|2016-10-19||September 2002||2002-09-01|May 2016|2016-05-01||||August 2012|Actual|2012-08-01||Interventional|||Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease|A Phase III Groupwide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate Risk Hodgkin Disease|Completed||Phase 3|1734|Actual|Children's Oncology Group||7|||f||||||||||||||2017-10-11 04:32:55.791724|2017-10-11 04:32:55.791724
NCT00025272|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2017-04-17|||November 2001|Actual|2001-11-01|August 2009|2009-08-01|January 18, 2005|Actual|2005-01-18|January 18, 2005|Actual|2005-01-18||Interventional|||Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Study of Sequential Topotecan-Carboplatin-Etoposide in Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|14|Actual|Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:32:58.975085|2017-10-11 04:32:58.975085
NCT00025285|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2017-04-17|||November 2001|Actual|2001-11-01|August 2009|2009-08-01|September 29, 2004|Actual|2004-09-29|September 29, 2004|Actual|2004-09-29||Interventional|||Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Carboplatin, Irinotecan, and Thalidomide in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|46|Actual|Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:32:59.062477|2017-10-11 04:32:59.062477
NCT00025298|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2012-09-20|||July 2001||2001-07-01|September 2012|2012-09-01||||October 2002|Actual|2002-10-01||Interventional|||Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx|A Feasibility Study Of Primary Chemotherapy Followed By Concomitant Chemoradiation With And Without Amifostine In Patients With Locally Advanced Undifferentiated Nasopharyngeal Cancer (UNPC)|Terminated||Phase 2|5|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:32:59.15731|2017-10-11 04:32:59.15731
NCT00025311|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2012-11-08|||May 2001||2001-05-01|March 2003|2003-03-01||||October 2003|Actual|2003-10-01||Interventional|||Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain|A Phase I Study Of Seven Day Continuous Intrathecal/Intraventricular Infusion Of Topotecan For Patients With Recurrent, Progressive Or Refractory Leptomingeal Disease|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:32:59.274281|2017-10-11 04:32:59.274281
NCT00025324|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-12-17|||December 2000||2000-12-01|December 2004|2004-12-01||||||||Interventional|||Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors|Clinical Correlative Studies In Primary Central Nervous System Germ Cell Tumors: The Third International CNS Germ Cell Tumor Study Group Protocol|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:59.353715|2017-10-11 04:32:59.353715
NCT00025337|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-01-23|||September 2001||2001-09-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated|Phase III Trial of Bevacizumab (NSC 704865), Oxaliplatin (NSC 266046), Fluorouracil and Leucovorin Versus Oxaliplatin, Fluorouracil and Leucovorin Versus Bevacizumab Alone in Previously Treated Patients With Advanced Colorectal Cancer|Completed||Phase 3|880|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:32:59.451491|2017-10-11 04:32:59.451491
NCT00025350|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-06-20|||October 2001||2001-10-01|January 2006|2006-01-01|June 2006|Actual|2006-06-01|||||Interventional|||Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer|A Randomized Phase II Trial of Two Dose Levels of ZD1839 (Iressa) (NSC 715055, IND 61187) in Patients With Recurrent Colorectal Adenocarcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:32:59.573043|2017-10-11 04:32:59.573043
NCT00025363|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-01-16|||November 2001||2001-11-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma|A Groupwide Randomized Phase II Window Study of Two Different Schedules of Irinotecan in Combination With Vincristine And Pilot Assessment of Safety and Efficacy of Tirapazamine Combined With Multiagent Chemotherapy for First Relapse or Progressive Disease in Rhabdomyosarcoma and Related Tumors|Completed||Phase 2|150|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:32:59.682537|2017-10-11 04:32:59.682537
NCT00025376|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-09-04|||October 2001||2001-10-01|September 2013|2013-09-01|March 2006|Actual|2006-03-01|September 2002|Actual|2002-09-01||Interventional|||PS-341 in Treating Patients With Metastatic Kidney Cancer|A Phase II Trial of PS-341 in Patients With Renal Cell Cancer|Completed||Phase 2|23|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 04:32:59.826257|2017-10-11 04:32:59.826257
NCT00025389|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-02-08|||November 2001||2001-11-01|February 2013|2013-02-01|August 2007|Actual|2007-08-01|December 2005|Actual|2005-12-01||Interventional|||Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer|A Phase 2 Study Of Neoadjuvant rhuMAb VEGF (Bevacizumab) In Combination With Paclitaxel And Carboplatin In Surgically Resectable Non-Small Cell Lung Cancer|Completed||Phase 2|8|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:32:59.926309|2017-10-11 04:32:59.926309
NCT00017043|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-04-03|||February 2001||2001-02-01|April 2013|2013-04-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy|A Phase II Study of Epothilone Analog BMS-247550 in Patients With Metastatic Gastric Adenocarcinoma Previously Treated With a Taxane|Completed||Phase 2|||Bristol-Myers Squibb||1|||f||||||||||||||2017-10-11 04:33:00.06275|2017-10-11 04:33:00.06275
NCT00017056|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-17|||February 2001||2001-02-01|June 2013|2013-06-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy|A Phase II Study Of Epothilone Analog BMS-247550 In Patients With Metastatic Gastric Adenocarcinoma Previously Treated With A Fluoropyrimidine And/Or Platinum|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:33:00.158347|2017-10-11 04:33:00.158347
NCT00017069|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2008-11-16|||February 2001||2001-02-01|April 2004|2004-04-01||||||||Interventional|||Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma|CTI 1060: A Phase II Clinical Trial of Arsenic Trioxide and Dexamethasone as Therapy for Relapsed or Refractory Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:00.233258|2017-10-11 04:33:00.233258
NCT00017095|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-10-23|||March 2001||2001-03-01|October 2013|2013-10-01||||November 2006|Actual|2006-11-01||Interventional|||Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer|First Prospective Intergroup Translational Research Trial Assessing the Potential Predictive Value of p53 Using a Functional Assay in Yeast in Patients With Locally Advanced/Inflammatory or Large Operable Breast Cancer Prospectively Randomised to a Taxane Versus a Non Taxane Regimen|Completed||Phase 3|1856|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 04:33:00.581747|2017-10-11 04:33:00.581747
NCT00017108|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2008-07-23|||March 2001||2001-03-01|June 2004|2004-06-01||||||||Interventional|||Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia|Low Dose Chlorambucil Maintenance Vs. No Treatment Following High-Dose Chlorambucil Induction In Patients With Advanced B-Chronic Lymphocytic Leukemia. A Randomized Phase III Study Of The EORTC LG (CLL-3)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:00.796465|2017-10-11 04:33:00.796465
NCT00017121|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2016-07-01|||May 2002||2002-05-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung|Dose Finding Study of Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung|Completed||Phase 1|40|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:33:00.905638|2017-10-11 04:33:00.905638
NCT00017134|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-07|||September 2002||2002-09-01|November 2006|2006-11-01||||December 2006|Actual|2006-12-01||Interventional|||Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk|An Exploratory Evaluation of Fenretinide (4-HPR) as a Chemopreventive Agent for Ovarian Carcinoma|Terminated||N/A|71|Anticipated|Gynecologic Oncology Group||||Withdrawn due to poor accrual|||||||||||||||2017-10-11 04:33:01.194714|2017-10-11 04:33:01.194714
NCT00017147|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-01-28|||September 2001||2001-09-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|May 2006|Actual|2006-05-01||Interventional|||S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma|A Phase III Study of Radiation Therapy (RT) and O6-Benzylguanine (O6-BG) Plus BCNU Versus RT and BCNU Alone for Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma|Completed||Phase 3|183|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:33:01.647082|2017-10-11 04:33:01.647082
NCT00017160|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-25||||||June 2013|2013-06-01||||||||Interventional|||Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma|Phase II Study of Neoadjuvant Doxorubicin and Ifosfamide, Radiotherapy, and Surgical Resection in Patients With Primary or Recurrent Retroperitoneal Sarcoma|Withdrawn||Phase 2|0|Actual|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:33:02.170993|2017-10-11 04:33:02.170993
NCT00017173|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2012-06-12|||February 2003||2003-02-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|May 2007|Actual|2007-05-01||Interventional|||S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat|Phase II Trial Of Surgery With Perioperative RPR/INGN 201 (Ad5CMV-p53) Gene Therapy Followed By Chemoradiotherapy For Advanced, Resectable Squamous Cell Carcinoma Of The Oral Cavity, Oropharynx, Larynx, and Pharynx|Terminated||Phase 2|13|Actual|Southwest Oncology Group||1||Terminated for poor accrual.|f||||f||||||||||2017-10-11 04:33:02.689116|2017-10-11 04:33:02.689116
NCT00017186|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2016-12-05|||July 2001||2001-07-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|August 2004|Actual|2004-08-01||Interventional|||Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma|Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma|Completed||Phase 2|69|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:33:02.784521|2017-10-11 04:33:02.784521
NCT00017199|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-01-30|||April 2001||2001-04-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors|Phase II Study of PS-341 in Metastatic Neuroendocrine Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:02.903349|2017-10-11 04:33:02.903349
NCT00017212|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2012-05-15|||April 2001||2001-04-01|May 2012|2012-05-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||DX-8951f in Treating Patients With Metastatic Stomach Cancer|A Phase II Study Of Intravenous Exatecan Mesylate (DX-891F) Administered Daily For Five Days Every Three Weeks To Patients With Previously Untreated Metastatic Gastric Cancer|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:33:03.116019|2017-10-11 04:33:03.116019
NCT00017225|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-08-01|||May 1997||1997-05-01|August 2002|2002-08-01|February 2002|Actual|2002-02-01|||||Interventional|||Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma|Neuroblastoma Study Phase II Study of Various Therapies in Patients With Neuroblastoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:03.21397|2017-10-11 04:33:03.21397
NCT00017238|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-01-10|||February 2002||2002-02-01|January 2013|2013-01-01||||November 2008|Actual|2008-11-01||Interventional|||KRN5500 in Treating Patients With Solid Tumors|A Phase I Trial of KRN5500 (NSC 650426) Given as a 72 Hour Continuous IV Infusion Every 21 Days in Patients With Solid Tumors|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:03.461661|2017-10-11 04:33:03.461661
NCT00017251|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-01-23|||April 2001||2001-04-01|January 2013|2013-01-01||||January 2004|Actual|2004-01-01||Interventional|||Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer|A Phase I Study Of Genasense, A Bcl-2 Antisense Oligonucleotide, Combined With Carboplatin And Etoposide In Patients With Small Cell Lung Cancer|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:03.53655|2017-10-11 04:33:03.53655
NCT00017264|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2009-01-10|||June 2002||2002-06-01|August 2004|2004-08-01||||||||Interventional|||Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma|A Phase I Evaluation of the Safety and Pharmacokinetics of ABT-627 in Adults With Recurrent Malignant Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:03.73026|2017-10-11 04:33:03.73026
NCT00017277|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2012-09-20|||March 2001||2001-03-01|September 2012|2012-09-01||||April 2003|Actual|2003-04-01||Interventional|||Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer|A Phase III Double-Blind, Randomized, Placebo-Controlled Study of Erythropoietin When Used as an Adjuvant to Radiation Therapy in Patients With Head and Neck Squamous Cell Carcinoma|Terminated||Phase 3|47|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:33:03.830054|2017-10-11 04:33:03.830054
NCT00017290|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-12-03|||November 2000||2000-11-01|August 2002|2002-08-01||||||||Interventional|||Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma|A Phase III Trial To Evaluate The Safety And Efficacy Of Specific Immunotherapy, Recombinant Idiotype Conjugated To KLH With GM-CSF, Compared To Non-Specific Immunotherapy, KLH With GM-CSF, In Patients With Follicular Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:03.976216|2017-10-11 04:33:03.976216
NCT00017303|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-11-05|||January 2001||2001-01-01|February 2002|2002-02-01||||||||Interventional|||Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer|A Phase II Trial Of IM862 Combined With Paclitaxel And Carboplatin In Newly Diagnosed Advanced Epithelial Ovarian Or Primary Peritoneal Carcinoma Followed By IM862 Consolidation Therapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:04.131174|2017-10-11 04:33:04.131174
NCT00017316|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-02-08|||March 2001||2001-03-01|August 2002|2002-08-01||||September 2003|Actual|2003-09-01||Interventional|||Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma|A Phase II, Pharmacologic and Biologic Study of Escalating Doses of Thalidomide (NSC #66847) Administered Orally Once a Day in Combination With a Fixed Dose of SU5416 (NSC #696819) in Patients With Metastatic Melanoma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:04.29209|2017-10-11 04:33:04.29209
NCT00017329|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2009-12-13|||April 2001||2001-04-01|December 2009|2009-12-01||||April 2004|Actual|2004-04-01||Interventional|||PS-341 in Treating Patients With Metastatic Kidney Cancer|Phase II Trial of PS341 (NSC 681239) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:04.383173|2017-10-11 04:33:04.383173
NCT00017342|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2010-02-26|||July 2001||2001-07-01|February 2010|2010-02-01|June 2005|Actual|2005-06-01|September 2004|Actual|2004-09-01||Interventional|||Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia|Phase II Study Of Bryostatin 1 (NSC 339555) And High-Dose 1-B-D-Arabinofuranosylcytosine (HiDAC) In Patients With Refractory Leukemia|Completed||Phase 2|||Virginia Commonwealth University|||||f||||t||||||||||2017-10-11 04:33:04.455272|2017-10-11 04:33:04.455272
NCT00017355|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-09-16|||April 2001||2001-04-01|March 2003|2003-03-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Mature Dendritic Cell Immunotherapy Of Metastatic Melanoma- A Phase I Trial|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:04.546956|2017-10-11 04:33:04.546956
NCT00017368|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2014-02-12|||April 2001||2001-04-01|February 2014|2014-02-01|January 2012|Actual|2012-01-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma|A Pilot Study Of Tandem High Dose Chemotherapy With Stem Cell Rescue Following Induction Therapy In Children With High Risk Neuroblastoma|Completed||Phase 2|42|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:33:04.635312|2017-10-11 04:33:04.635312
NCT00017381|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-01-08|||April 2001||2001-04-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma|Dose Finding Study of IDEC-Y2B8 With Autologous Stem Cell Support|Completed||Early Phase 1|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:04.772717|2017-10-11 04:33:04.772717
NCT00017394|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-01-16|||March 2001||2001-03-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer|A Phase II Study of Bevacizumab in Combination With Vinorelbine in Stage IV Breast Cancer|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:04.908966|2017-10-11 04:33:04.908966
NCT00017407|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2009-02-06|||October 2000||2000-10-01|December 2006|2006-12-01||||||||Interventional|||Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer|A Prospective, Randomized, Open-Label, Phase III Trial of Chemotherapy With Carboplatin And Paclitaxel, Versus Carboplatin And Paclitaxel In Combination With ISIS-3521, An Antisense Inhibitor Of Protein Kinase C Alpha In Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:05.017595|2017-10-11 04:33:05.017595
NCT00017433|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2008-11-16|||January 2001||2001-01-01|June 2002|2002-06-01||||||||Interventional|||Arsenic Trioxide in Treating Patients With Multiple Myeloma|Phase II Study of Arsenic Trioxide in Patients With Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:05.100104|2017-10-11 04:33:05.100104
NCT00017446|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2014-01-03|||October 2000||2000-10-01|September 2002|2002-09-01||||||||Interventional|||CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma|Phase II Evaluation Of CP4071 In Previously Treated Advanced Sarcomas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:05.188644|2017-10-11 04:33:05.188644
NCT00017459|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-08-01|||July 2000||2000-07-01|February 2010|2010-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|The International Tirazone Triple Trial (i3T): A Phase III, Randomized Efficacy And Safety Study Of The Combination Chemotherapy With Tirapazamine+Cisplatin+Vinorelbine Versus Cisplatin+Vinorelbine In Subjects With Inoperable, Previously Untreated, Non-Small Cell Lung Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:05.261547|2017-10-11 04:33:05.261547
NCT00017472|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-06-03|||April 2001||2001-04-01|June 2013|2013-06-01||||April 2006|Actual|2006-04-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia|Phase I Study of Thrice Weekly Hu1D10*in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Acute Leukemia|Completed||Phase 1|35|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:05.41021|2017-10-11 04:33:05.41021
NCT00017485|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2011-03-03|||January 2000||2000-01-01|March 2011|2011-03-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer|A Phase I Study Of Photodynamic Therapy (PDT) For The Treatment Of Basal Cell Carcinoma (BCC): A Drug/Light Dose Finding Study Utilizing 2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A (HPPH-PHOTOCLOR)|Completed||Phase 1|6|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:33:05.520008|2017-10-11 04:33:05.520008
NCT00017498|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2012-09-20|||February 2001||2001-02-01|September 2012|2012-09-01||||April 2003|Actual|2003-04-01||Interventional|||Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck|Phase II Study On Gemcitabine In Recurrent Or Metastatic Adenoid Cystic Carcinoma Of The Head And Neck|Completed||Phase 2|21|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:33:05.599697|2017-10-11 04:33:05.599697
NCT00017511|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2012-05-15|||June 2001||2001-06-01|May 2012|2012-05-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region|Completed||Phase 3|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:33:05.688852|2017-10-11 04:33:05.688852
NCT00017524|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-12-12|||March 2001||2001-03-01|November 2012|2012-11-01|November 2004|Actual|2004-11-01|||||Interventional|||AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors|A Phase I Dose-Escalation Study of AG2037 Administered Once Weekly for Three Weeks to Patients With Advanced Cancer|Completed||Phase 1|22|Actual|University of Alabama at Birmingham|||||f||||t||||||||||2017-10-11 04:33:06.079184|2017-10-11 04:33:06.079184
NCT00017537|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2013-08-02|||March 2000||2000-03-01|November 2012|2012-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer|Phase IB Trial of Active Specific Immunotherapy With MVF-HER-2(628-647) and CRL1005 Copolymer Adjuvant in Patients With Metastatic Cancer|Withdrawn||Phase 1|0|Actual|University of Alabama at Birmingham||5|||f||||t||||||||||2017-10-11 04:33:06.163902|2017-10-11 04:33:06.163902
NCT00017550|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2009-02-06|||August 2001||2001-08-01|March 2003|2003-03-01||||||||Interventional|||Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome|An Open Label, Prospective, Stratified, Randomized, Controlled, Multi-Center, Phase IIB Study of the Impact of Thymoglobulin Therapy on Transfusion Needs of Patients With Early Myelodysplastic Syndrome (MDS)|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:06.255967|2017-10-11 04:33:06.255967
NCT00017563|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2017-04-26|2011-05-31||September 2000||2000-09-01|April 2017|2017-04-01||||May 2010|Actual|2010-05-01||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer|Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer|Completed||Phase 2|57|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 04:33:06.380472|2017-10-11 04:33:06.380472
NCT00017576|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2017-04-26|||December 2000||2000-12-01|April 2017|2017-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy|Phase II Study of Calcitrol Enhanced Carboplatin in Hormone Refractory Prostate Cancer|Completed||Phase 2|19|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 04:33:06.697854|2017-10-11 04:33:06.697854
NCT00017589|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2014-01-03|||December 2000||2000-12-01|April 2003|2003-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia|Phase II Study of Genasense (Bcl-2 Antisense) Combined With Mylotarg (Gemtuzumab Ozogamicin) in Elderly Patients With Relapsed Acute Myeloid Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:06.78899|2017-10-11 04:33:06.78899
NCT00017602|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2014-01-03|||December 2000||2000-12-01|August 2003|2003-08-01|April 2009|Actual|2009-04-01|||||Interventional|||Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma|Randomized Phase III Study of Dexamethasone With or Without Genasense (Bcl-2 Antisense Oligonucleotide) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:06.879413|2017-10-11 04:33:06.879413
NCT00017628|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2005-06-23|||April 2001||2001-04-01|July 2004|2004-07-01||||||||Interventional|||Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis||Completed||Phase 1|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:33:06.972161|2017-10-11 04:33:06.972161
NCT00017641|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2005-06-23|||April 2001||2001-04-01|November 2003|2003-11-01||||||||Interventional|||Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus||Unknown status|Active, not recruiting|Phase 1|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:33:07.058171|2017-10-11 04:33:07.058171
NCT00017654|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2005-06-23|||April 2001||2001-04-01|October 2003|2003-10-01||||||||Interventional|||Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia||Unknown status|Active, not recruiting|N/A|3||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-10-11 04:33:07.149154|2017-10-11 04:33:07.149154
NCT00017680|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-06|2008-06-06|||July 1999||1999-07-01|June 2008|2008-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis|Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in|Completed||Phase 2|25||Office of Rare Diseases (ORD)||1|||f||||||||||||||2017-10-11 04:33:07.24373|2017-10-11 04:33:07.24373
NCT00017693|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-07|2016-03-03|||May 1998||1998-05-01|March 2016|2016-03-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Recombinant Human IL-4 Receptor Used in Treatment of Asthma|Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma|Completed||Phase 2|62|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 04:33:07.343597|2017-10-11 04:33:07.343597
NCT00017706|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-07|2010-01-12||||||January 2010|2010-01-01|May 2001||2001-05-01|||||Interventional|||Effectiveness of Primary Care Physicians in Delivering Weight Control Counseling|Treatment of Obesity in the Primary Care Setting|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:33:07.438779|2017-10-11 04:33:07.438779
NCT00017719|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-08|2013-11-25|||May 2002||2002-05-01|November 2013|2013-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy|Randomized Trial of Protease Inhibitor-Including vs. Protease Inhibitor-Sparing Regimens for Women Who Initiate Therapy of HIV Infection During Pregnancy|Completed||Phase 3|440||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:33:07.52611|2017-10-11 04:33:07.52611
NCT00017732|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-08|2008-03-03|||June 2001||2001-06-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Estimation of the Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans|Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:07.738411|2017-10-11 04:33:07.738411
NCT00017745|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-08|2017-06-30|||June 1, 2001||2001-06-01|May 10, 2007|2007-05-10|May 10, 2007||2007-05-10|||||Observational|||Phenotype/Genotype Correlations in Neuromuscular Disorders|Phenotype/Genotype Correlations in Inherited Myopathies|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:07.818842|2017-10-11 04:33:07.818842
NCT00017758|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-11|2006-03-13||||||February 2004|2004-02-01||||||||Interventional|||The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs|The Effect of Efavirenz and Nelfinavir on the Pharmacokinetics of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:33:07.886803|2017-10-11 04:33:07.886803
NCT00017771|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-11|2013-07-26|||June 2001||2001-06-01|July 2013|2013-07-01|July 2004|Actual|2004-07-01|||||Observational|||Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs|A Pathophysiologic Study of Development of Distal Symmetrical Polyneuropathy in Individuals With Advanced HIV-1 Infection and Prior Antiretroviral Exposure|Completed||N/A|100|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"     Blood collection   "|||2017-10-11 04:33:08.002057|2017-10-11 04:33:08.002057
NCT00017784|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-11|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection|Open-Label Safety Study of Valganciclovir in Patients With CMV Retinitis and AIDS Who Have Complications Due to IV Treatment|Unknown status|Active, not recruiting|Phase 3|500||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:33:08.110934|2017-10-11 04:33:08.110934
NCT00017797|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-12|2006-08-03||||||August 2006|2006-08-01||||||||Observational|||Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women|Evaluation of Metabolic Complications Associated With Antiretroviral Medications in HIV-1-Infected Pregnant Women|Completed||N/A|160||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:33:08.214408|2017-10-11 04:33:08.214408
NCT00017810|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-13|2005-12-08||||||April 2001|2001-04-01||||||||Interventional|||The Healthy Life Choices Project in HIV-Positive Patients||Unknown status|Recruiting|Phase 1|||National Institute of Nursing Research (NINR)|||||f||||||||||||||2017-10-11 04:33:08.391781|2017-10-11 04:33:08.391781
NCT00017823|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-13|2010-04-20||||||April 2001|2001-04-01||||||||Interventional|||Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients|The Acupressure Study|Completed||Phase 1|||National Institute of Nursing Research (NINR)|||||f||||||||||||||2017-10-11 04:33:08.45455|2017-10-11 04:33:08.45455
NCT00017836|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-15|2014-05-28|||June 2001||2001-06-01|May 2014|2014-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Mechanisms Linking Depression to Cardiovascular Risk||Completed||N/A|||Emory University|||||f||||||||||||||2017-10-11 04:33:08.509979|2017-10-11 04:33:08.509979
NCT00017862|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-15|2008-03-03|||June 2001||2001-06-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Interventional|||Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome|A Pilot Phase II Study of the Efficacy of Humanized Anti-IL5 Antibody (SCH55700) in Reducing Eosinophilia in Patients With Hypereosinophilic Syndrome or Eosinophilic Gastroenteritis Refractory to or Intolerant of Conventional Therapy|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:08.562275|2017-10-11 04:33:08.562275
NCT00017875|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-15|2008-03-03|||June 2001||2001-06-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Transcranial Magnetic Stimulation (TMS) Studies of Dystonia|Neurophysiological Studies of Focal and Generalized Forms of Dystonia Using Transcranial Magnetic Stimulation (TMS)|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:08.632385|2017-10-11 04:33:08.632385
NCT00017914|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-19|2017-10-05|||June 8, 1994||1994-06-08|September 11, 2017|2017-09-11||||||||Observational|||Adult and Juvenile Myositis|Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies|Recruiting||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:08.70636|2017-10-11 04:33:08.70636
NCT00017927|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-20|2008-03-03|||June 2001||2001-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome|A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome|Completed||Phase 3|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:08.790598|2017-10-11 04:33:08.790598
NCT00017940|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-20|2009-12-10||||||July 2005|2005-07-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Gene Therapy for Alzheimer's Disease Clinical Trial|A Phase I Study of Ex Vivo Nerve Growth Factor Gene Therapy for Alzheimer's Disease|Completed||Phase 1|8||National Institute on Aging (NIA)|||||||||||||||||||2017-10-11 04:33:08.856042|2017-10-11 04:33:08.856042
NCT00017953|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-21|2016-11-04|||June 2001||2001-06-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|LookAHEAD||Look AHEAD: Action for Health in Diabetes|Look AHEAD: Action for Health in Diabetes|Active, not recruiting||N/A|5145|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||Yes|We plan to share data sets through the NIDDK repository, baseline data sets are currently available. Outcome data will be available approximately 1 year after the study is over.|2017-10-11 04:33:08.926844|2017-10-11 04:33:08.926844
NCT00017966|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-23|2008-03-03|||June 2001||2001-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Brain Excitability During Self-Paced Voluntary Movements|Cortical Excitability During Self-Paced Voluntary Movements|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:09.045711|2017-10-11 04:33:09.045711
NCT00017979|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-23|2008-03-03|||June 2001||2001-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Study of Brain Control of Movement|Effect of Volitional Inhibition on Cortical Inhibitory Mechanisms|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:09.121703|2017-10-11 04:33:09.121703
NCT00017992|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-23|2005-06-23||||||March 2003|2003-03-01||||||||Interventional|||Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV|An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV-Infected Pediatric Patients|Unknown status|Recruiting|Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:33:09.181967|2017-10-11 04:33:09.181967
NCT00018018|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-27|2017-10-05|||June 20, 2001||2001-06-20|September 17, 2014|2014-09-17|September 17, 2014|Actual|2014-09-17|||||Interventional|||Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency|Treatment of SCID Due to ADA Deficiency With Autologous Cord Blood or Bone Marrow CD34+ Cells Transduced With a Human ADA Gene|Completed||Phase 1|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:33:09.343914|2017-10-11 04:33:09.343914
NCT00018031|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-27|2014-09-25|2013-01-18||June 2001||2001-06-01|September 2014|2014-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|HEPCPR||Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients|A Non-Randomized, Open Label, Study to Assess Hepatitis C Viral Kinetics in Predicting the Clinical Response in Patients With Hepatitis C Infection Coinfected With HIV-1 Treated With Peginterferon Alpha-2b and Ribavirin|Completed||Phase 2|36|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:33:09.596263|2017-10-11 04:33:09.596263
NCT00018044|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-28|2017-10-05|||June 27, 2001||2001-06-27|September 13, 2017|2017-09-13||||||||Observational|||Study of Mycobacterial Infections|Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:09.811367|2017-10-11 04:33:09.811367
NCT00018057|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-29|2017-10-05|||June 26, 2001||2001-06-26|September 28, 2017|2017-09-28||||||||Observational|||Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes|Fluoxetine's Effects on Attention and Emotional Memory in Anxious and Depressed Youth and Adults|Recruiting||N/A|2530|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:09.917871|2017-10-11 04:33:09.917871
NCT00018070|ClinicalTrials.gov processed this data on October 10, 2017|2001-06-30|2017-06-30|||June 28, 2001||2001-06-28|August 30, 2006|2006-08-30|August 30, 2006||2006-08-30|||||Interventional|||Identification and Treatment of Feeder Vessels in Macular Degeneration|Feasibility Study of the Identification and Treatment of Feeder-Vessels of Choroidal Neovascularization in Age-Related Macular Degeneration|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:10.023036|2017-10-11 04:33:10.023036
NCT00018083|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-02|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen|Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:33:10.104327|2017-10-11 04:33:10.104327
NCT00018096|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-02|2008-05-05|||June 2001||2001-06-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Genetics of Environmental Asthma|The Genetics of Environmental Asthma|Completed||N/A|176|Actual|National Institute of Environmental Health Sciences (NIEHS)||1|||f||||f||||||||||2017-10-11 04:33:10.17696|2017-10-11 04:33:10.17696
NCT00018109|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)|A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)|Completed||Phase 3|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:33:10.259794|2017-10-11 04:33:10.259794
NCT00018122|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2005-06-27||||||December 2003|2003-12-01||||||||Observational|||Patterns and Natural History of Insulin Secretion in Islet Cell Transplant Recipients and Controls|Patterns and Natural History of Insulin Secretion in Islet Cell Transplant Recipients and Controls (Project 2 of JDFI Washington University Center for Islet Transplantation, KS Polonsky, PI)|Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:33:10.313002|2017-10-11 04:33:10.313002
NCT00018135|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals|Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:33:10.375809|2017-10-11 04:33:10.375809
NCT00018148|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2010-09-14|||April 1998||1998-04-01|September 2010|2010-09-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation|Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation|Completed||Phase 2|158|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:33:10.452255|2017-10-11 04:33:10.452255
NCT00018161|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||January 1997||1997-01-01|September 2007|2007-09-01|June 2001||2001-06-01|||||Interventional|||Treatment to Quit Smoking|Combined Pharmacologic/Behavioral Treatment for Smoking Cessation|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:10.627394|2017-10-11 04:33:10.627394
NCT00018174|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-02-26|||February 1998||1998-02-01|February 2009|2009-02-01|January 2005|Actual|2005-01-01|January 2003|Actual|2003-01-01||Interventional|||Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers|Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers|Completed||Phase 3|247|Actual|VA Office of Research and Development||2|||f||||||||||||||2017-10-11 04:33:10.707581|2017-10-11 04:33:10.707581
NCT00018187|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||November 1998||1998-11-01|May 2007|2007-05-01|June 2001||2001-06-01|||||Interventional|||Combinations of Pharmacologic Smoking Cessation Treatments|Combinations of Pharmacologic Smoking Cessation Treatments|Completed||Phase 1|||VA Office of Research and Development|||||||||||||||||||2017-10-11 04:33:10.812603|2017-10-11 04:33:10.812603
NCT00018200|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2012-06-04|||April 1999||1999-04-01|June 2012|2012-06-01|March 2004|Actual|2004-03-01|December 2003|Actual|2003-12-01||Interventional|||Effect of Antidepressants on Back Pain|Efficacy of Antidepressants in Chronic Back Pain|Completed||Phase 2|130|Actual|VA Office of Research and Development||3|||f||||t||||||||||2017-10-11 04:33:10.883824|2017-10-11 04:33:10.883824
NCT00018213|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|September 2007|2007-09-01|March 2001||2001-03-01|||||Interventional|||Naltrexone and Patch for Smokers|Naltrexone and Nicotine Replacement Effects on Cue Reactivity of Smokers|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.0179|2017-10-11 04:33:11.0179
NCT00018226|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|December 2004|2004-12-01|March 2001||2001-03-01|||||Interventional|||Effect Of Case Management Following Discharge From Methadone Treatment|Enhanced Outreach Counseling Following Methadone Treatment Discharge|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.096943|2017-10-11 04:33:11.096943
NCT00018252|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1997||1997-04-01|June 2001|2001-06-01|March 2000||2000-03-01|||||Interventional|||The Effect of Exercise Training on Mental Stress-Induced Silent Ischemia|The Effect of Exercise Training on Mental Stress-Induced Silent Ischemia|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.230083|2017-10-11 04:33:11.230083
NCT00018265|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Fitness and Daily Function in Adults|Oxygen Kinetics, Mobility Task Performance, and Task Training in Older Adults|Completed||Phase 3|140||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.310176|2017-10-11 04:33:11.310176
NCT00018278|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2001||2001-09-01|||||Interventional|||Electrophysiologic Measures of Treatment Response in Alzheimer Disease|Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.39955|2017-10-11 04:33:11.39955
NCT00018291|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||January 2001||2001-01-01|December 2004|2004-12-01|January 2005||2005-01-01|||||Interventional|||Specific Interventions for Agitation in Alzheimer's Disease|Specific Interventions for Agitation in Alzheimer's Disease|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.470816|2017-10-11 04:33:11.470816
NCT00018304|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20||||||December 2004|2004-12-01||||||||Observational|||Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow|Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.549354|2017-10-11 04:33:11.549354
NCT00018317|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 2000||2000-10-01|December 2004|2004-12-01|December 2005||2005-12-01|||||Interventional|||Resistance Training and Diet in Patients With Chronic Renal Failure|Resistance Training and Diet in Patients With Chronic Renal Failure|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.613797|2017-10-11 04:33:11.613797
NCT00018330|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2004||2004-03-01|||||Interventional|||Genetics, Metabolism and Weight Loss in Older, Obese Veterans|Genetics, Metabolism and Weight Loss in Older, Obese Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.687677|2017-10-11 04:33:11.687677
NCT00018343|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|December 2004|2004-12-01|March 2001||2001-03-01|||||Interventional|||Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen|Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:11.755151|2017-10-11 04:33:11.755151
NCT00018356|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2011-06-22|||January 1999||1999-01-01|June 2011|2011-06-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly|Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly|Completed||Phase 4|88|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:33:11.85854|2017-10-11 04:33:11.85854
NCT00018369|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||December 2000||2000-12-01|December 2004|2004-12-01|April 2004||2004-04-01|||||Observational|||Age-Related Changes in Stress Hormone Regulation|Mechanism of Aging-Related Changes in (HPA) Hydrocortisone Corticotropin Feedback Function|Completed||Phase 4|||VA Office of Research and Development|||||||||||||||||||2017-10-11 04:33:11.94917|2017-10-11 04:33:11.94917
NCT00018382|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|March 2003||2003-03-01|||||Interventional|||Insulin, Neurogenetics and Memory in Alzheimer's Disease|Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.012293|2017-10-11 04:33:12.012293
NCT00018395|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||August 1997||1997-08-01|December 2004|2004-12-01|June 2002||2002-06-01|||||Observational|||Cardiovascular Mortality Associated With Abnormal Calcium Metabolism|Cardiovascular Mortality Associated With Abnormal Calcium Metabolism|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.073994|2017-10-11 04:33:12.073994
NCT00018408|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2001||2001-09-01|||||Observational|||Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)|Genetic Mechanisms of Chronic Obstructive Pulmonary Disease|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.141156|2017-10-11 04:33:12.141156
NCT00018421|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||July 1997||1997-07-01|December 2004|2004-12-01|June 2001||2001-06-01|||||Interventional|||Effects of Exercise on Patients With Hemiparetic Stroke|Effects of Exercise on Patients With Hemiparetic Stroke|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.218744|2017-10-11 04:33:12.218744
NCT00018434|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2015-06-25|||July 1998||1998-07-01|June 2015|2015-06-01|June 2001||2001-06-01|||||Observational|||The Epidemiology of Infection With Vancomycin-Resistant Enterococci|The Epidemiology of Infection With Vancomycin-Resistant Enterococci|Completed||N/A|||VA Office of Research and Development|||1||f||||||||||||||2017-10-11 04:33:12.292388|2017-10-11 04:33:12.292388
NCT00018447|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||November 1998||1998-11-01|December 2004|2004-12-01|October 2003||2003-10-01|||||Interventional|||Combination Osteogenic Therapy in Established Osteoporosis|Combination Osteogenic Therapy in Established Osteoporosis|Completed||Phase 2|||VA Office of Research and Development|||||||||||||||||||2017-10-11 04:33:12.359502|2017-10-11 04:33:12.359502
NCT00018460|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2002||2002-03-01|||||Interventional|||Anticoagulation, Vitamins, and Endothelial Function|Anticoagulation, Vitamins, and Endothelial Function|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.426878|2017-10-11 04:33:12.426878
NCT00018473|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2004||2004-03-01|||||Observational|||Gene-Environment Interactions in Alzheimer's Disease|Gene-Environment Interactions in Alzheimer's Disease|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.51288|2017-10-11 04:33:12.51288
NCT00018486|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2004||2004-03-01|||||Observational|||Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans|Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.569811|2017-10-11 04:33:12.569811
NCT00018499|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|October 2001||2001-10-01|||||Observational|||Genotype Influence on Recovery After Traumatic Brain Injury|The Influence of APOE Genotype on Recovery After Traumatic Brain Injury|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:12.622543|2017-10-11 04:33:12.622543
NCT00018577|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2008-04-02|||October 2000||2000-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Observational|||The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men|The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:13.038495|2017-10-11 04:33:13.038495
NCT00018590|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||January 2001||2001-01-01|December 2004|2004-12-01||||||||Observational|||Center for the Study of Vascular Disease in Hispanic and Native Americans|Center for the Study of Vascular Disease in Hispanic and Native Americans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:13.100014|2017-10-11 04:33:13.100014
NCT00018603|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||November 1999||1999-11-01|December 2004|2004-12-01|October 2002||2002-10-01|||||Interventional|||Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)|Guanfacine for the Treatment of PTSD|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:13.321609|2017-10-11 04:33:13.321609
NCT00018616|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-09-21|||October 1999||1999-10-01|September 2009|2009-09-01|January 2005|Actual|2005-01-01|January 2004|Actual|2004-01-01||Interventional|||Improving Compliance With Metformin|Improving Compliance With Metformin|Completed||Phase 2|79|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:33:13.382566|2017-10-11 04:33:13.382566
NCT00018629|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-05|||May 2000||2000-05-01|September 2008|2008-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Cognitive - Behavioral Therapy|Rehabilitation of Older Patients With Schizophrenia|Completed||Phase 2|76|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:33:13.460765|2017-10-11 04:33:13.460765
NCT00018642|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1997||1997-04-01|December 2004|2004-12-01|March 2002||2002-03-01|||||Interventional|||Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder|Predicting the Optimal Pharmacotherapy for Outpatients With Schizophrenia|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:13.529896|2017-10-11 04:33:13.529896
NCT00018655|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2014-12-09|||April 2000||2000-04-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2009|Actual|2009-09-01||Interventional|||Integrated Intervention for Substance Abusers With Depressive Disorders|Integrated Intervention for Substance Abusers With Depressive Disorders|Terminated||Phase 2|276|Actual|VA Office of Research and Development||2||"PI has been contacted numerous times for an update, with no response. ORD requested a close out   of this project. 10/2011"|f||||t||||||||||2017-10-11 04:33:13.596949|2017-10-11 04:33:13.596949
NCT00018668|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 2000||2000-10-01|December 2004|2004-12-01|September 2004||2004-09-01|||||Interventional|||Antipsychotic Response in Schizophrenia|Psychopharmacologic Aspects of Motor Slowing in Schizophrenia|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.178663|2017-10-11 04:33:14.178663
NCT00018681|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|December 2004|2004-12-01|January 2002||2002-01-01|||||Observational|||Regulation of Human Intestinal Bile Acid Transport in Health and Disease|Regulation of Human Intestinal Bile Acid Transport in Health and Disease|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.259109|2017-10-11 04:33:14.259109
NCT00018694|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2013-10-11|||October 1999||1999-10-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Cholestanol in Humans|Biologic Significance of Cholestanol in Man|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:33:14.319991|2017-10-11 04:33:14.319991
NCT00018707|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2003||2003-03-01|||||Observational|||Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress|Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.403475|2017-10-11 04:33:14.403475
NCT00018720|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1996||1996-04-01|December 2004|2004-12-01|December 2000||2000-12-01|||||Observational|||Regulation of Sterol Homeostasis|Regulation of Sterol Homeostasis|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.474311|2017-10-11 04:33:14.474311
NCT00018733|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||September 1996||1996-09-01|December 2004|2004-12-01|December 2001||2001-12-01|||||Interventional|||Biological Aspects of Depression and Antidepressant Drugs|Biological Aspects of Depression and Antidepressant Drugs|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.546065|2017-10-11 04:33:14.546065
NCT00018746|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||July 1999||1999-07-01|December 2004|2004-12-01|July 2001||2001-07-01|||||Interventional|||Transcranial Magnetic Stimulation in Depression|Efficacy of Threshold vs. Subthreshold TMS in the Treatment of Depression|Completed||Phase 1|||VA Office of Research and Development|||||||||||||||||||2017-10-11 04:33:14.621905|2017-10-11 04:33:14.621905
NCT00018759|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||March 2001||2001-03-01|December 2004|2004-12-01|October 2003||2003-10-01|||||Interventional|||Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients|Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.696032|2017-10-11 04:33:14.696032
NCT00018772|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|April 2003||2003-04-01|||||Observational|||Risk Factors for Venous Thromboembolism|2779 Epidemiology of Genetic and Acquired Risk Factors for Venous Thrombosis|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.757578|2017-10-11 04:33:14.757578
NCT00018785|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants|Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.815374|2017-10-11 04:33:14.815374
NCT00018798|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 2000||2000-04-01|December 2004|2004-12-01|April 2003||2003-04-01|||||Observational|||Post-Traumatic Stress Disorder (PTSD) Symptom Study|Longitudinal Evaluation of Chronic Combat-Related PTSD|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.870037|2017-10-11 04:33:14.870037
NCT00018811|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2003|2003-12-01|March 2003||2003-03-01|||||Interventional|||Psychological Assessment and Treatment of Chronic Benign Headache|Psychological Assessment and Treatment of Chronic Benign Headache|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:14.926917|2017-10-11 04:33:14.926917
NCT00018824|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-09-21|||October 1999||1999-10-01|September 2009|2009-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Treating Alcohol Use In Older Adults With Depression|The Treatment of Late Life Major Depression Complication by Alcohol|Completed||Phase 4|74|Actual|VA Office of Research and Development||2|||f||||||||||||||2017-10-11 04:33:14.998673|2017-10-11 04:33:14.998673
NCT00018837|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|December 2004|2004-12-01|March 2001||2001-03-01|||||Interventional|||Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome|Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:15.135293|2017-10-11 04:33:15.135293
NCT00018850|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-03|2009-01-20|||June 1998||1998-06-01|December 2004|2004-12-01|June 2003||2003-06-01|||||Interventional|||5HT3 Antagonism and Auditory Gating in Schizophrenia|5HT3 Antagonism and Auditory Gating in Schizophrenia|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:33:15.189936|2017-10-11 04:33:15.189936
NCT00018863|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-05|2013-11-01|||April 2001||2001-04-01|October 2006|2006-10-01||||March 2006|Actual|2006-03-01||Interventional|||Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)|Methylphenidate Efficacy and Safety in ADHD Preschoolers|Unknown status|Active, not recruiting|Phase 3|165||New York State Psychiatric Institute|||||||||||||||||||2017-10-11 04:33:15.250429|2017-10-11 04:33:15.250429
NCT00018876|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-05|2013-06-06|||October 2000||2000-10-01|March 2006|2006-03-01|October 2002||2002-10-01|||||Interventional|||Low-Dose Radiation to Prevent Complications of Back Surgery|Radiotherapy to Prevent Fibrosis After Lumbar Laminectomy|Completed||Phase 1|46||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:33:15.358365|2017-10-11 04:33:15.358365
NCT00018889|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-07|2017-10-05|||July 6, 2001||2001-07-06|September 8, 2017|2017-09-08||||||||Observational|||Phenotype/Genotype Correlations in Movement Disorders|Phenotype/Genotype Correlations in Movement Disorders|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:15.438139|2017-10-11 04:33:15.438139
NCT00018902|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-10|2014-03-11|||January 2001||2001-01-01|March 2014|2014-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|TORDIA||Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)|Treatment of SSRI-Resistant Depression in Adolescents (TORDIA)|Completed||Phase 2/Phase 3|334|Actual|University of Pittsburgh||4|||||||t||||||||||2017-10-11 04:33:15.521534|2017-10-11 04:33:15.521534
NCT00018941|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-14|||April 1991||1991-04-01|March 2003|2003-03-01|May 2003|Actual|2003-05-01|||||Interventional|||Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|Phase III Randomized Study of Intravenous Low Dose Versus Intravenous High Dose Versus Subcutaneous Interleukin-2 for Metastatic Renal Cell Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:17.381605|2017-10-11 04:33:17.381605
NCT00018954|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-02-16|||October 1992||1992-10-01|February 2012|2012-02-01|October 2002|Actual|2002-10-01|||||Interventional|||Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma|PILOT MULTINATIONAL PROTOCOLS IN ACUTE LYMPHOBLASTIC LEUKEMIA AND DIFFUSE NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:17.457277|2017-10-11 04:33:17.457277
NCT00018967|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-29|||November 1993||1993-11-01|April 2007|2007-04-01||||April 2007|Actual|2007-04-01||Interventional|||Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate|A Trial of Carboxypeptidase-G2 (CPDG2) For The Management of Patients With Intrathecal Methotrexate Overdose|Completed||N/A|10|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:33:17.608557|2017-10-11 04:33:17.608557
NCT00019006|ClinicalTrials.gov processed this data on October 10, 2017|2007-03-01|2015-04-27|||March 1995||1995-03-01|May 2005|2005-05-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer|Phase I Pilot Study of Vaccine Therapy With Tumor-Specific Mutated Ras Peptides in the Adjuvant Setting in Patients With Colorectal, Pancreatic, or Lung Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:17.997271|2017-10-11 04:33:17.997271
NCT00019019|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2012-03-14|||October 1994||1994-10-01|March 2012|2012-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas|A PHASE I STUDY OF THE COMBINATION OF CAI AND PACLITAXEL IN ADULT PATIENTS WITH REFRACTORY CANCERS OR LYMPHOMA|Completed||Phase 1|70|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:33:18.12117|2017-10-11 04:33:18.12117
NCT00019032|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-27|||March 1996||1996-03-01|April 2004|2004-04-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia|PHASE I STUDY OF T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA USING THE MIK-BETA 1 MONOCLONAL ANTIBODY DIRECTED TOWARD THE IL-2R BETA SUBUNIT|Completed||Phase 1|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:18.260735|2017-10-11 04:33:18.260735
NCT00019058|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||April 1995||1995-04-01|December 2001|2001-12-01||||||||Interventional|||Radiation Therapy in Treating Patients With Glioblastoma|A PHASE I STUDY OF COMBINED RADIATION RESPONSE MODIFIERS EMPLOYING HYDROXYUREA AND PENTOXIFYLLINE FOR TREATMENT OF GLIOBLASTOMA|Completed||Phase 1|34|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:18.341366|2017-10-11 04:33:18.341366
NCT00019071|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2015-04-28|||March 1995||1995-03-01|May 2002|2002-05-01||||||||Interventional|||Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma|A PHASE I STUDY OF 2-CHLORODEOXYADENOSINE AND RADIATION FOR THE TREATMENT OF HIGH GRADE GLIOMA (CDX)|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:18.431551|2017-10-11 04:33:18.431551
NCT00019084|ClinicalTrials.gov processed this data on October 10, 2017|2001-07-11|2013-06-19|||February 1996||1996-02-01|April 2007|2007-04-01|May 2003|Actual|2003-05-01|||||Interventional|||Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer|VACCINE THERAPY WITH TUMOR SPECIFIC MUTATED P53 OR RAS PEPTIDES ALONE OR IN COMBINATION WITH CELLULAR IMMUNOTHERAPY WITH PEPTIDE ACTIVATED LYMPHOCYTES (PAL CELLS) ALONG WITH SUBCUTANEOUS IL-2|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:18.51586|2017-10-11 04:33:18.51586
NCT00025402|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-12-17|||July 1997||1997-07-01|July 2002|2002-07-01||||||||Interventional|||Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia|Randomized Multicenter Treatment Optimization Study In Chronic Myeloid Leukemia (CML) Interferon-a Vs. Allogeneic Stem Cell Transplantation Vs. High-Dose Chemotherapy Followed By Autografting And Interferon-a Maintainance In Early Chronic Phase|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:18.627413|2017-10-11 04:33:18.627413
NCT00025415|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-02-06|||August 2001||2001-08-01|February 2013|2013-02-01||||January 2005|Actual|2005-01-01||Interventional|||Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction|A Phase I Pharmacokinetic Study of STI571 in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:19.435052|2017-10-11 04:33:19.435052
NCT00025428|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-12-03|||December 2000||2000-12-01|November 2006|2006-11-01|November 2013|Actual|2013-11-01|||||Interventional|||Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma|Treatment Of Children Over The Age Of 1 Year With Unresectable Localized Neuroblastoma Without MYCN Amplification|Completed||Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:19.642967|2017-10-11 04:33:19.642967
NCT00025441|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-12-03|||November 1998||1998-11-01|November 2001|2001-11-01|March 2010|Actual|2010-03-01|||||Interventional|||Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors|MMT 98 Study For Metastatic Disease Rhabdomyosarcoma And Other Malignant Soft Tissue Sarcoma Of Childhood|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:19.783396|2017-10-11 04:33:19.783396
NCT00025454|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2010-02-05|||August 2001||2001-08-01|February 2010|2010-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||R115777 in Treating Patients With Advanced Solid Tumors|Phase I Trial of R115777 (NSA 702818) in Advanced Malignant Solid Tumors|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:33:20.013955|2017-10-11 04:33:20.013955
NCT00025467|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-01-23|||September 2001||2001-09-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Thalidomide (NSC #66847, IND 48832) in the Treatment of Recurrent of Persistent Endometrial Carcinoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:20.132055|2017-10-11 04:33:20.132055
NCT00025480|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2009-02-06|||August 2001||2001-08-01|April 2007|2007-04-01||||||||Interventional|||Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Phase I Trial of Farnesyltransferase Inhibitor, R115777 (NSC # 702818) and Radiotherapy in Patients With Non-Small Cell Lung Cancer|Completed||Phase 1|12|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:33:20.291398|2017-10-11 04:33:20.291398
NCT00025493|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-01-22|||October 2001||2001-10-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer|Single Agent Docetaxel for Metastatic Breast Cancer in Patients Aged 70 Years and Older (and in a Cohort of Patients Younger Than 60 Years)|Terminated||Phase 2|27|Actual|Southwest Oncology Group||1||poor accrual|f||||t||||||||||2017-10-11 04:33:20.388801|2017-10-11 04:33:20.388801
NCT00025506|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2015-05-07|2015-05-07||September 2001||2001-09-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Eligible and treated patients.|Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus|A Phase II Evaluation of Thalidomide (NSC #66847) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:33:20.510733|2017-10-11 04:33:20.510733
NCT00025519|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-07-10|||June 2001||2001-06-01|July 2013|2013-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer|Submyeloablative Allogeneic Blood Stem Cell Transplantation With HLA Identical Donor Lymphocyte Infusions From Matched Related and Matched Unrelated Donors for Treatment of Metastatic Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-10-11 04:33:21.010955|2017-10-11 04:33:21.010955
NCT00025532|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2012-09-13|||April 2001||2001-04-01|September 2012|2012-09-01||||||||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer|A Pre-Phase I Biodistribution Study Of hCC^CH2 Labeled With 131 Iodine In Patients With Gastrointestinal Adenocarcinomas|Withdrawn||Phase 1|0|Actual|University of California, San Francisco|||||f||||||||||||||2017-10-11 04:33:21.087996|2017-10-11 04:33:21.087996
NCT00025545|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2010-05-12|||March 1996||1996-03-01|May 2010|2010-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>|A Phase II Trial to Evaluate the Use of G-CSF-Mobilized Peripheral Blood Progenitor Cells as Hematopoietic Rescue in Patients With Acute Leukemia Undergoing Allografting From an Unrelated Donor|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:33:21.170567|2017-10-11 04:33:21.170567
NCT00025558|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2011-03-25|||October 2000||2000-10-01|March 2011|2011-03-01||||May 2007|Actual|2007-05-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer|Dose Escalation of Temozolomide in Combination With Thiotepa and Carboplatin With Autologous Stem Cell Rescue in Patients With Malignant Brain Tumors With Minimal Residual Disease|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-10-11 04:33:21.247203|2017-10-11 04:33:21.247203
NCT00025571|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2011-03-03|||June 2001||2001-06-01|March 2011|2011-03-01|October 2004|Actual|2004-10-01|October 2002|Actual|2002-10-01||Interventional|||Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer|A Phase I Study of Photodynamic Therapy (PDT) Using 2-(1-hexyloxyethyl)-2 Devinyl Pyropheophorbide-a (HPPH) for Treatment of Early Stage Lung Cancer - A Dose Ranging Study|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:33:21.478011|2017-10-11 04:33:21.478011
NCT00025584|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-01-22|||August 2001||2001-08-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||PS-341 in Treating Women With Metastatic Breast Cancer|Phase II Trial Of PS-341 In Metastatic Breast Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:21.568911|2017-10-11 04:33:21.568911
NCT00025597|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-09-16|||July 1999||1999-07-01|November 2001|2001-11-01|February 2011|Actual|2011-02-01|||||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.|European Infant Neuroblastoma Study - Unresectable Tumors (MYCN Not Amplified)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:21.675929|2017-10-11 04:33:21.675929
NCT00025610|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-09-16|||July 1999||1999-07-01|November 2001|2001-11-01|March 2009|Actual|2009-03-01|||||Interventional|||Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma|European Infant Neuroblastoma Study - Stage 4S and Stage 4 (No Bone, Lung, Pleura or CNS); MYCN Not Amplified|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:21.794511|2017-10-11 04:33:21.794511
NCT00025623|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-09-16|||July 1999||1999-07-01|December 2002|2002-12-01|March 2009|Actual|2009-03-01|||||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma|European Infant Neuroblastoma Study - Stage 4 With Bone, Lung, Pleura or CNS Involvement; MYCN Not Amplified|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:21.922729|2017-10-11 04:33:21.922729
NCT00025636|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-09-16|||July 2001||2001-07-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma|A Randomized Trial Of BEAM Plus PBSCT Versus Single Agent High-Dose Therapy Followed By BEAM Plus PBSCT In Patients With Relapsed Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 3|220|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:22.050665|2017-10-11 04:33:22.050665
NCT00025649|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2013-09-16|||July 1999||1999-07-01|December 2001|2001-12-01|March 2009|Actual|2009-03-01|||||Interventional|||Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma|European Infant Neuroblastoma Study - Stage 2, 3, 4, and 4S; MYCN Amplified Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:22.299136|2017-10-11 04:33:22.299136
NCT00025662|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2016-09-21|2011-04-20||May 2001||2001-05-01|September 2016|2016-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS|"Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA: Reducing GVHD Risk Associated With Matched, Nonmyeloablative, Stem Cell Transplant for Hematologic Malignancies in Older Adults"|Completed||Phase 2|23|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:33:22.442085|2017-10-11 04:33:22.442085
NCT00025675|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2012-05-18|||January 2002||2002-01-01|May 2012|2012-05-01||||June 2009|Actual|2009-06-01||Interventional|||Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors|ZD1839 FOR Treatment Of Recurrent Or Progressive Malignant Astrocytoma Or Glioblastoma And Recurrent Or Progressive Meningioma: A Phase II Study With A Phase I Component For Patients Receiving EIAEDs|Completed||Phase 2|105|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||||2017-10-11 04:33:22.74366|2017-10-11 04:33:22.74366
NCT00025688|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2008-07-23|||January 2001||2001-01-01|September 2006|2006-09-01||||||||Interventional|||Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer|A Randomized, Phase II Trial of Weekly Taxol (Paclitaxel) Versus Weekly Taxol Plus Paraplatin (Carboplatin) as First-Line Chemotherapy in Patients Age 65 Years or Older With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:22.872744|2017-10-11 04:33:22.872744
NCT00025701|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2017-06-30|||October 9, 2001||2001-10-09|October 4, 2010|2010-10-04|October 4, 2010||2010-10-04|||||Observational|||EEG and EMG Studies of Hand Dystonia|EEG Study of Movement-Related Center-Surround Organization in Hand Dystonia|Completed||N/A|75|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:23.042566|2017-10-11 04:33:23.042566
NCT00025714|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-11|2017-10-05|||October 9, 2001||2001-10-09|September 20, 2017|2017-09-20||||||||Observational|||Study of Specimens Obtained During Epilepsy Surgery|Research Study of Specimens Obtained During Epilepsy Surgery|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:23.148146|2017-10-11 04:33:23.148146
NCT00025727|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-15|2005-06-23|||May 2001||2001-05-01|June 2002|2002-06-01||||||||Interventional|||Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure|A Phase III, Randomized, Multicenter, Parallel Group, Open-Label, Three Arm Study to Compare the Efficacy and Safety of Two Dosing Regimens of GW433908/Ritonavir (700mg/100mg Twice Daily or 1400mg/200mg Once Daily) Versus Lopinavir/Ritonavir (400mg/100mg Twice Daily) for 48 Weeks in Protease Inhibitor Experienced HIV-Infected Adults Experiencing Virological Failure|Unknown status|Active, not recruiting|Phase 3|330||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-10-11 04:33:23.244274|2017-10-11 04:33:23.244274
NCT00027248|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-29|2005-09-12|||September 2000||2000-09-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Interventional|||Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections|Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of Topical Administration of MBI 226 1.0% Gel Versus Standard Medical Care in Patients Undergoing Non-Cuffed, Short-Term Arterial and/or Central Venous Catheterization|Completed||Phase 3|1400||BioWest Therapeutics Inc|||||||||||||||||||2017-10-11 04:33:23.369174|2017-10-11 04:33:23.369174
NCT00027261|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-29|2012-05-15||||||May 2012|2012-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults|A Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of High-Dose Live Recombinant Canarypox ALVAC-HIV Vaccine (vCP1452) in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|110|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:33:23.444173|2017-10-11 04:33:23.444173
NCT00027274|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-29|2017-10-05|||November 28, 2001||2001-11-28|July 14, 2017|2017-07-14||||||||Observational|||Cancer in Inherited Bone Marrow Failure Syndromes|Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:23.54227|2017-10-11 04:33:23.54227
NCT00027287|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-29|2008-03-03|||November 2001||2001-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Laser and Medical Treatment of Diabetic Macular Edema|Preliminary Assessment of Laser and Medical Treatment of Diabetic Macular Edema|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:23.618353|2017-10-11 04:33:23.618353
NCT00027300|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-30|2017-01-05|||November 2001||2001-11-01|January 2017|2017-01-01|January 2005|Actual|2005-01-01|November 2004|Actual|2004-11-01||Interventional|||Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Natalizumab in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|900|Actual|Biogen||2|||f||||t||||||||||2017-10-11 04:33:23.69214|2017-10-11 04:33:23.69214
NCT00027781|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2012-07-23|||August 2001||2001-08-01|July 2012|2012-07-01||||March 2003|Actual|2003-03-01||Interventional|||MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy|Open Label Phase II Study of MEN-10755 Administered Every 3 Weeks in Patients With Progressive Hormone Refractory Prostate Cancer|Completed||Phase 2|37|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:33:28.568157|2017-10-11 04:33:28.568157
NCT00027339|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-04|2012-05-17||||||May 2012|2012-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV|A Phase II Study of the Predictive Value of Pharmacokinetic-Adjusted Phenotypic Susceptibility (C12h/IC50) on Antiretroviral Response to Ritonavir-Enhanced Protease Inhibitors in Subjects With Failure of Previous Protease Inhibitor-Based Regimens|Completed||Phase 2|53|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:33:24.211697|2017-10-11 04:33:24.211697
NCT00027352|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-04|2009-11-24||||||December 2008|2008-12-01||||||||Observational|||A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)|A Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)|Completed||N/A|6000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:33:24.37013|2017-10-11 04:33:24.37013
NCT00027365|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-04|2012-05-03||||||May 2012|2012-05-01|June 2003|Actual|2003-06-01|||||Interventional|||An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV|A Phase I Safety and Immunogenicity Trial of a Combination Vaccine (NefTat and gp120w61d) Formulated With AS02A (GlaxoSmithKline Biologicals) Given Intramuscularly in HIV-1 Uninfected Adult Participants|Completed||Phase 1|84||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:33:24.963428|2017-10-11 04:33:24.963428
NCT00027378|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-04|2013-06-17|2012-02-08||July 2001||2001-07-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|FIDAA||Pharmacological Intervention Project (Fluoxetine)|Pharmacological Intervention Project (Fluoxetine)|Completed||Phase 2|50|Actual|University of Pittsburgh|Limited sample size; efficacy of CBT/MET Therapy|2|||f||||f||||||||||2017-10-11 04:33:25.089852|2017-10-11 04:33:25.089852
NCT00027391|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-05|2015-03-24|||September 2001||2001-09-01|November 2001|2001-11-01|August 2004||2004-08-01|||||Interventional|||Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)|Clinical Trials of Albuterol and Oxandrolone in FSH Dystrophy|Completed||N/A|160||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:25.443687|2017-10-11 04:33:25.443687
NCT00027404|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-05|2015-03-24|||September 2001||2001-09-01|November 2002|2002-11-01|August 2005||2005-08-01|||||Interventional|||Study of Fluoxetine in Adults With Autistic Disorder|Fluoxetine vs Placebo in Adult Autistic Disorder|Completed||N/A|48||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:25.535684|2017-10-11 04:33:25.535684
NCT00027417|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-05|2013-08-01|||April 2001||2001-04-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of Triostat in Infants During Heart Surgery|Triostat in Children During CardioPulmonary Bypass (CPB)|Completed||Phase 3|195|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 04:33:25.61533|2017-10-11 04:33:25.61533
NCT00027430|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-05|2015-03-24|||September 2001||2001-09-01|November 2001|2001-11-01|December 2004||2004-12-01|||||Interventional|||Androgen Replacement Therapy in Women With Hypopituitarism|TheraDerm Administration in Women With Hypopituitarism|Completed||N/A|50|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:25.700229|2017-10-11 04:33:25.700229
NCT00027443|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-05|2015-03-24|||August 2001||2001-08-01|October 2001|2001-10-01|July 2007||2007-07-01|||||Interventional|||Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis|Giant Cell Myocarditis Treatment Trial Pilot Study|Completed||N/A|40|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:25.761629|2017-10-11 04:33:25.761629
NCT00027456|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2008-03-03|||November 2001||2001-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Leptin to Treat Severe Insulin Resistance - Pilot Study|Efficacy of Leptin in Severe Insulin Resistance: A Pilot Study|Completed||Phase 2|2||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:25.832459|2017-10-11 04:33:25.832459
NCT00027469|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2008-03-03|||December 2001||2001-12-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery|Evidence of Procedural Embolism Complicating Renal Artery Stenting|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:25.91004|2017-10-11 04:33:25.91004
NCT00027482|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2017-06-30|||December 4, 2001||2001-12-04|August 27, 2008|2008-08-27|August 27, 2008||2008-08-27|||||Observational|||Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers|Studies of Specific Immune Responses in HIV-Infected and HIV-Uninfected Volunteers|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:25.973818|2017-10-11 04:33:25.973818
NCT00027495|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2012-12-19|||December 2001||2001-12-01|December 2012|2012-12-01|September 2007|Actual|2007-09-01|February 2004|Actual|2004-02-01||Interventional|||Curcumin for the Prevention of Colon Cancer|Phase I Pharmacokinetic Trial of Curcuminoids Administered in a Capsule Formulation|Completed||Phase 1|||University of Michigan Cancer Center|||||f||||t||||||||||2017-10-11 04:33:26.045756|2017-10-11 04:33:26.045756
NCT00027508|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2015-02-23|||July 2001||2001-07-01|June 2013|2013-06-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma|Phase II Study Of ET-743 In Patients With Unresectable Malignant Pleural Mesothelioma|Terminated||Phase 2|||PharmaMar||||Enrolment halted prematurely and not resumed. 2 patients enrolled. No data was obtained.|f||||||||||||||2017-10-11 04:33:26.145779|2017-10-11 04:33:26.145779
NCT00027521|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2012-09-17|||December 2000||2000-12-01|September 2012|2012-09-01||||||||Interventional|||Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer|Phase I Study: Electroporation Therapy With Bleomycin For The Treatment Of Pancreatic Cancer|Withdrawn||Phase 1|0|Actual|Ichor Medical Systems Incorporated||||Program terminated|f||||||||||||||2017-10-11 04:33:26.234247|2017-10-11 04:33:26.234247
NCT00027534|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2014-09-04|||January 2002||2002-01-01|September 2014|2014-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer|A Phase I Study Of Active Immunotherapy With Autologous Dendritic Cells Infected With CEA-6D Expressing Fowlpox -Tricom In Patients With Advanced Or Metastatic Malignancies Expressing CEA|Completed||Phase 1|14|Actual|Duke University||1|||f||||f||||||||||2017-10-11 04:33:26.329774|2017-10-11 04:33:26.329774
NCT00027547|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2011-11-28|||July 2001||2001-07-01|November 2011|2011-11-01|July 2004|Actual|2004-07-01|||||Interventional|||Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia|Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation From HLA Matched Sibling Donors For Treatment Of Patients With High Risk Acute Lymphocytic Leukemia In Complete Remission|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:33:26.4928|2017-10-11 04:33:26.4928
NCT00027560|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2012-12-03|2012-11-27||July 2001||2001-07-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer|Phase II Trial Of Non-Myeloablative Regimen Combining Melphalan, Fludarabine, And Anti-CD52 Monoclonal Antibody (CAMPATH-1H) Followed By An Unmodified Hematopoietic Cell Transplant From An HLA Compatible Related Or Unrelated Donor For Treatment Of Lymphohematopoietic Malignancies|Completed||Phase 2|51|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:33:26.625559|2017-10-11 04:33:26.625559
NCT00027573|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2016-07-12|||October 2001||2001-10-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer|Adoptive Immunotherapy by Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Carcinoma: A Phase II Study|Completed||Phase 2|36|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:33:26.970002|2017-10-11 04:33:26.970002
NCT00027586|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2012-07-27|||September 2001||2001-09-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Imatinib Mesylate in Treating Patients With Metastatic Melanoma|Phase II Trial of Gleevec (Imatinib Mesylate, STI-571) in Metastatic Melanoma|Completed||Phase 2|22|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:33:27.211064|2017-10-11 04:33:27.211064
NCT00027599|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-02-08|||December 2001||2001-12-01|December 2003|2003-12-01||||July 2007|Actual|2007-07-01||Interventional|||APC8015 and Bevacizumab in Treating Patients With Prostate Cancer|A Phase II Study Of Prostatic Acid Phosphatase-Pulsed Dendritic Cells (Provenge) In Combination With Bevacizumab In Patients With Serologic Progression Of Prostate Cancer After Definitive Local Therapy|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:27.322172|2017-10-11 04:33:27.322172
NCT00027612|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2016-12-05|||July 2002||2002-07-01|December 2016|2016-12-01|July 2009|Actual|2009-07-01|October 2006|Actual|2006-10-01||Interventional|||Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme|Pilot And Phase II Trial Of Irinotecan And Radiation Followed By Irinotecan And BCNU In Glioblastoma Multiforme Patients|Completed||Phase 1/Phase 2|58|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:33:27.432288|2017-10-11 04:33:27.432288
NCT00027625|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2008-12-13|||January 2002||2002-01-01|September 2003|2003-09-01||||||||Interventional|||Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma|A Phase I Study Of ZD 1839 And Temozolomide For The Treatment Of Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:27.537925|2017-10-11 04:33:27.537925
NCT00027638|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-06-17|||March 2001||2001-03-01|June 2013|2013-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors|Phase II Trial Of Thalidomide In Patients With Low Grade Neuroendocrine Tumors (Carcinoid and Islet Cell Cancers)|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:33:27.654083|2017-10-11 04:33:27.654083
NCT00027664|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-08-06|||February 2001||2001-02-01|March 2002|2002-03-01||||||||Interventional|||Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer|Interferon Alpha In Combination With Thalidomide In The Treatment Of Metastatic Renal Cell Carcinoma A Randomized Phase II Study|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:27.759628|2017-10-11 04:33:27.759628
NCT00027677|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2012-07-23|||August 2001||2001-08-01|July 2012|2012-07-01||||February 2004|Actual|2004-02-01||Interventional|||Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors|Phase I Study To Determine The Safety Of Halofuginone In Patients With A Solid Progressive Tumor|Completed||Phase 1|25|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:33:27.842919|2017-10-11 04:33:27.842919
NCT00027690|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2015-03-13|||June 2002||2002-06-01|December 2012|2012-12-01|July 2013|Actual|2013-07-01|September 2004|Actual|2004-09-01||Interventional|||Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer|A Phase II Trial of ZD 1839 (IRESSA) (NSC #715055) in the Treatment of Persistent or Recurrent Endometrial Carcinoma|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:27.940235|2017-10-11 04:33:27.940235
NCT00027703|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2014-02-10|||October 2001||2001-10-01|December 2012|2012-12-01||||May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma|A Double Blind, Placebo Controlled Randomized Phase II Trial Of Gemcitabine And Cisplatin With Or Without The VEGF Inhibitor Bevacizumab (NSC #704865) In Patients With Malignant Mesotheloma|Completed||Phase 2|106|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:33:28.067573|2017-10-11 04:33:28.067573
NCT00027716|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-06-04|||October 2001||2001-10-01|June 2013|2013-06-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma|A Multi-Institutional, Open-Label, Two-Group, Phase II Study of PS-341 (LDP-341, NSC #681239) in Patients With Advanced or Metastatic Sarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:33:28.20167|2017-10-11 04:33:28.20167
NCT00027729|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-06-04|||June 2001||2001-06-01|June 2013|2013-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer|Phase I/II Study of MEDI-522, A Humanized Monoclonal Antibody Directed Against the Human Alpha V Beta 3 Integrin, in Patients With Irinotecan-Refractory Advanced Colorectal Cancer|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:33:28.295776|2017-10-11 04:33:28.295776
NCT00027742|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-06-04|||May 2001||2001-05-01|June 2013|2013-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma|A Phase II Study of Temozolomide (Temodar) and Peglated Interferon Alfa-2B (PEGIntron) in the Treatment of Advanced Melanoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:33:28.375688|2017-10-11 04:33:28.375688
NCT00027768|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-09-19|||June 2001||2001-06-01|June 2007|2007-06-01||||||||Interventional|||Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer|Randomised Trial of Adjuvant Hepatic Intra-Arterial Iodine-131-Lipiodol Following Curative Resection of Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:28.457983|2017-10-11 04:33:28.457983
NCT00027794|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2012-09-20|||September 2001||2001-09-01|September 2012|2012-09-01||||January 2005|Actual|2005-01-01||Interventional|||Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer|Radical Prostatectomy for Locally Advanced Prostate Cancer. A Feasibility Study|Completed||Phase 2|40|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:33:28.710459|2017-10-11 04:33:28.710459
NCT00027807|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2016-02-15|||October 2001||2001-10-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|September 2010|Actual|2010-09-01||Interventional|||Biological Therapy in Treating Women With Stage IV Breast Cancer|Treatment of Stage IV Breast Cancer With OKT3 x Herceptin Armed Activated T Cells, Low Dose IL-2, And GM-CSF (Phase I Only as of 4-22-09 as Per IRB Approval Date)|Completed||Phase 1|6|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 04:33:28.829208|2017-10-11 04:33:28.829208
NCT00027820|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2016-12-13|||August 2001||2001-08-01|December 2016|2016-12-01||||September 2004|Actual|2004-09-01||Interventional|||Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer|Low-Dose TBI and Fludarabine Followed by Nonmyeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation Using Enhanced Postgrafting Immunosuppression for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial|Active, not recruiting||Phase 1/Phase 2|106|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:33:28.986972|2017-10-11 04:33:28.986972
NCT00027833|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2014-01-03|||December 2001||2001-12-01|September 2003|2003-09-01||||||||Interventional|||Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer|Pilot Phase II Study of Safety and Immunogenicity of an ALVAC-CEA/B7.1 Vaccine Administered With Chemotherapy, Alone or in Combination With Tetanus Toxoid, as Compared to Chemotherapy Alone, in Patients With Metastatic Colorectal Adenocarcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:29.209177|2017-10-11 04:33:29.209177
NCT00027846|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2017-01-11|2016-05-27||August 2003||2003-08-01|January 2017|2017-01-01||||January 2010|Actual|2010-01-01||Interventional|||Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma|A Phase II Trial of Conformal Radiation Therapy for Pediatric Patients With Localized Ependymoma, Chemotherapy Prior to Second Surgery for Incompletely Resected Ependymoma and Observation for Completely Resected, Differentiated, Supratentorial Ependymoma|Active, not recruiting||Phase 2|378|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-10-11 04:33:29.416674|2017-10-11 04:33:29.416674
NCT00027859|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2010-01-26|||May 2003||2003-05-01|January 2010|2010-01-01||||December 2004|Actual|2004-12-01||Interventional|||Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer|A Phase III Randomized Trial for Evaluating Second Line Hormonal Therapy (Ketoconazole/Hydrocortisone) Versus Paclitaxel/Estramustine Combination Chemotherapy on Progression Free Survival in Asymptomatic Patients With a Rising PSA After Hormonal Therapy for Prostate Cancer|Completed||Phase 3|||Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-10-11 04:33:32.339541|2017-10-11 04:33:32.339541
NCT00027872|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-03-22|||October 2001||2001-10-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|July 2007|Actual|2007-07-01||Interventional|||Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|A Phase II Study of Farnesyl Transferase Inhibitor R115777 (Zarnestra) (R115777 ( Zarnestra), Tipifarnib, R115777, NSC #702818) in Elderly Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia|Completed||Phase 2|125|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:32.614892|2017-10-11 04:33:32.614892
NCT00027885|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-06-14|||November 2001||2001-11-01|June 2013|2013-06-01|August 2010|Actual|2010-08-01|December 2005|Actual|2005-12-01||Interventional|||Phase II Bevacizumab + Tax In Advanced Breast Cancer|A Randomized Phase II Study of Bevacizumab in Combination With Docetaxel in Locally Advanced Breast Cancer|Completed||Phase 2|49|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:33:32.723583|2017-10-11 04:33:32.723583
NCT00027898|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-02-06|||January 2002||2002-01-01|February 2013|2013-02-01||||January 2006|Actual|2006-01-01||Interventional|||Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I Study of PS-341 (NSC 681239), Carboplatin, and Etoposide in Patients With Advanced Solid Tumors Refractory to Standard Therapy|Completed||Phase 1|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:32.964607|2017-10-11 04:33:32.964607
NCT00027911|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-02-13|||April 2001||2001-04-01|February 2013|2013-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma|A Pilot Study of NY-ESO-1 Immunization in Patients With NY-ESO-1/LAGE Antigen Expressing Cancer|Terminated||Phase 1|||Columbia University||||Departure of PI|f||||||||||||||2017-10-11 04:33:33.066838|2017-10-11 04:33:33.066838
NCT00027924|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2010-03-31|||October 2001||2001-10-01|March 2010|2010-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome|Fludarabine And Busulfan As Conditioning For Patients With Chronic Myeloid Leukemia Or Myelodysplastic Syndrome Transplanted With Hematopoietic Stem Cells From HLA-Compatible Related Or Unrelated Donors|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:33:33.149436|2017-10-11 04:33:33.149436
NCT00027937|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2010-05-12|||August 2001||2001-08-01|May 2010|2010-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma|A Phase II Study Of Mobilization Chemotherapy With GMCSF And GCSF Followed By High Dose Therapy Combined With IL2 Activated Autologous Peripheral Blood Stem Cells Followed By Sequential IL2 Therapy As Treatment For Solid Tumors And Lymphoma|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:33:33.274372|2017-10-11 04:33:33.274372
NCT00027963|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2016-07-01|||February 2002||2002-02-01|July 2016|2016-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy|The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial|Completed||Phase 3|100|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:33:33.410261|2017-10-11 04:33:33.410261
NCT00032396|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-20|2006-05-25|||November 2001||2001-11-01|December 2002|2002-12-01||||||||Interventional|||"A Study to Evaluate Retisert in the Treatment of Patients With the Wet Form of Age-Related Macular Degeneration"||Unknown status|Active, not recruiting|Phase 2|||Control Delivery Systems|||||||||||||||||||2017-10-11 04:34:06.515175|2017-10-11 04:34:06.515175
NCT00027976|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-08-01|||December 2001||2001-12-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses|A Phase II/III Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Celecoxib In Subjects With Actinic Keratoses|Withdrawn||Phase 2/Phase 3|0|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-10-11 04:33:33.579301|2017-10-11 04:33:33.579301
NCT00027989|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-12-17|||December 2001||2001-12-01|April 2004|2004-04-01||||||||Interventional|||Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer|An Open-Label, Single-Arm, Phase II Study of Liposomal Doxorubicin (Doxil) and Gemcitabine in the Treatment of Women With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:33.725966|2017-10-11 04:33:33.725966
NCT00028002|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2014-05-07|2012-11-29||February 2002||2002-02-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor|A Phase II Trial of Neoadjuvant/Adjuvant STI-571 (Gleevec NSC #716051) for Primary and Recurrent Operable Malignant GIST Expressing the KIT Receptor Tyrosine Kinase (CD117)|Completed||Phase 2|63|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:33.869638|2017-10-11 04:33:33.869638
NCT00028015|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2010-11-07|||October 2001||2001-10-01|March 2010|2010-03-01||||||||Interventional|||SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer|A Phase II Study of Second-Line SarCNU (NSC 364432) in Patients With Recurrent/Metastatic Colorectal Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:33:34.264299|2017-10-11 04:33:34.264299
NCT00028028|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-07|2013-02-27|||February 2002||2002-02-01|February 2013|2013-02-01||||January 2007|Actual|2007-01-01||Interventional|||CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Randomized, Phase II ECOG Trial of Two Dose Levels of CCI-779 in Patients With Extensive-Stage Small Cell Lung Cancer Who Have Responding or Stable Disease After Induction Chemotherapy|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:33:34.344952|2017-10-11 04:33:34.344952
NCT00028067|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-10|2011-04-28||2011-04-13|August 2001||2001-08-01|April 2011|2011-04-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor|A Phase III Study Comparing the Antiviral Efficacy and Safety of Atazanavir With Nelfinavir: Each in Combination With Dual Nucleoside Therapy in HIV-Infected Subjects Who Have Failed a Regimen Not Containing a Protease Inhibitor|Terminated||Phase 3|500||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:33:34.443115|2017-10-11 04:33:34.443115
NCT00028080|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-11|2017-10-05|||November 21, 2001||2001-11-21|July 11, 2017|2017-07-11||||||||Observational|||Evaluation, Treatment, and Follow-up of Patients With Lyme Disease|Evaluation, Treatment and Follow up of Patients With Lyme Disease|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:34.894806|2017-10-11 04:33:34.894806
NCT00028093|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-11|2013-09-04|2011-05-26||December 2001||2001-12-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C With and Without Renal Disease|Completed||Phase 4|50|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:33:34.992181|2017-10-11 04:33:34.992181
NCT00028106|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-11|2017-06-30|||December 5, 2001||2001-12-05|August 21, 2008|2008-08-21|January 8, 2007||2007-01-08|||||Interventional|||131MIBG to Treat Malignant Pheochromocytoma|(131)I-Metaiodobenzylguanidine Treatment of Malignant Pheochromocytoma|Completed||Phase 2|32||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:33:35.440664|2017-10-11 04:33:35.440664
NCT00028119|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-13|2014-08-18|||August 2002||2002-08-01|August 2010|2010-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||HIV Incidence and Participation Retention in Pune, India|HPTN HIV Incidence and Participant Retention Protocol, Pune, India|Completed||N/A|1070||HIV Prevention Trials Network|||2||f||||||||||||||2017-10-11 04:33:35.558044|2017-10-11 04:33:35.558044
NCT00028132|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-13|2012-02-16||||||February 2012|2012-02-01|December 2005|Actual|2005-12-01|||||Interventional|||Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel|Phase I Safety and Acceptability Study of the Vaginal Microbicide Agent PMPA Gel|Completed||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:33:35.646487|2017-10-11 04:33:35.646487
NCT00028145|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-13|2014-10-08|||October 2002||2002-10-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission|Perinatal Core Protocol|Completed||N/A|3090|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|||1||f||||t||||||Samples With DNA|"     Blood and amniotic fluid   "|||2017-10-11 04:33:35.777108|2017-10-11 04:33:35.777108
NCT00028158|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-17|2005-06-23|||December 2001||2001-12-01|December 2001|2001-12-01|October 2003||2003-10-01|||||Interventional|||Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer|An Open-Label Phase Ib/II Study of the Safety, Tolerability and Efficacy of G207, a Genetically Engineered Herpes Simplex Type-1 Virus, Administered Intracerebrally to Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|65||MediGene|||||||||||||||||||2017-10-11 04:33:36.04464|2017-10-11 04:33:36.04464
NCT00028171|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-17|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing|Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:33:36.109524|2017-10-11 04:33:36.109524
NCT00028184|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-17|2008-03-03|||December 2001||2001-12-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Observational|||Role of the Intact Hemisphere in Recovery of Motor Function After Stroke|Role of the Intact Hemisphere in Recovery of Motor Function After Stroke|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:36.168213|2017-10-11 04:33:36.168213
NCT00028197|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-17|2008-03-03|||December 2001||2001-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Comparison of Externally and Self-Initiated Movements|Comparison of Externally and Self-Initiated Movements|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:36.227118|2017-10-11 04:33:36.227118
NCT00028210|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-17|2008-03-03|||December 2001||2001-12-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Enhanced Tactile (Touch) Spatial Acuity in Upper Limb Amputees|Enhancement of Tactile Spatial Acuity in Upper Limb Amputees|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:36.281732|2017-10-11 04:33:36.281732
NCT00028236|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-17|2017-06-30|||December 10, 2001||2001-12-10|July 25, 2011|2011-07-25|July 25, 2011|Actual|2011-07-25|July 25, 2011|Actual|2011-07-25||Interventional|||Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)|Ex Vivo Retroviral Gene Transfer For Treatment of X-Linked Severe Combined Immunodeficiency (XSCID)|Completed||Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:33:36.33766|2017-10-11 04:33:36.33766
NCT00028249|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-17|2008-03-03|||December 2001||2001-12-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Process and Outcomes of Pain Management|A Randomized Study Evaluating the Process and Outcomes of the Pain and Palliative Care Team Intervention|Completed||N/A|298||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:36.406051|2017-10-11 04:33:36.406051
NCT00028262|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-17|2016-09-21|2015-01-09||February 2001||2001-02-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis|A Combination Therapy With Cystagon and N-Acetylcysteine for INCL Patients|Completed||Phase 4|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:33:36.483672|2017-10-11 04:33:36.483672
NCT00028275|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-18|2008-03-03|||December 2001||2001-12-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Gamma Interferon Therapy for Chronic Hepatitis C|Pilot Studies of Gamma Interferon Therapy for Chronic Hepatitis C|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:36.699078|2017-10-11 04:33:36.699078
NCT00028288|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-19|2012-03-09|||September 2001||2001-09-01|March 2012|2012-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study of Daclizumab in Patients With Chronic, Persistent Asthma|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Daclizumab in Patients With Chronic, Persistent Asthma|Completed||Phase 2|120||Facet Biotech|||||f||||||||||||||2017-10-11 04:33:36.793672|2017-10-11 04:33:36.793672
NCT00028301|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-20|2010-09-10||2010-09-10|February 2001||2001-02-01|September 2010|2010-09-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)|A Randomized Open-label Study of the Antiviral Efficacy and Safety of Atazanavir Versus Lopinavir/Ritonavir(LPV/RTV), Each in Combination With Two Nucleosides in Subjects Who Have Experienced Virologic Failure With Prior Protease Inhibitor-Containing HAART Regimen(s)|Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:33:37.058679|2017-10-11 04:33:37.058679
NCT00028314|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-20|2013-07-26|||March 2002||2002-03-01|July 2013|2013-07-01|March 2005|Actual|2005-03-01|||||Interventional|||Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients|A Restrictively Randomized, Open-Label, Controlled, Pilot Study of the Effect of a Thymidine Analogue Substitution or Change to a Nucleoside-Sparing Regimen on Peripheral Fat Wasting|Completed||N/A|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:33:37.403711|2017-10-11 04:33:37.403711
NCT00028327|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-20|2011-02-28||||||July 2004|2004-07-01||||July 2004|Actual|2004-07-01||Interventional|||Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care|Randomized Study to Evaluate Immediate Potent Antiretroviral Therapy for HIV-Infected Subjects With CD4 Cell Counts Less Than 350 Cells/mm3 Admitted to Intensive Care Areas With an AIDS-Defining Illness, Pneumonia, or Sepsis|Completed||Phase 3|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:33:37.538574|2017-10-11 04:33:37.538574
NCT00028340|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-21|2017-10-05|||December 12, 2001||2001-12-12|August 25, 2017|2017-08-25||||||||Observational|||High-Risk Breast Duct Epithelium|Characterization of High Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile|Recruiting||N/A|184|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:37.651986|2017-10-11 04:33:37.651986
NCT00028353|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-22|2013-11-13|||April 2001||2001-04-01|November 2013|2013-11-01|July 2003||2003-07-01|||||Interventional|||A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)||Completed||Phase 2|500||GTx|||||||||||||||||||2017-10-11 04:33:37.754107|2017-10-11 04:33:37.754107
NCT00028366|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-27|2012-08-15||||||August 2012|2012-08-01|July 2005|Actual|2005-07-01|||||Interventional|||Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People|A Randomized, Comparative Study of Lopinavir/Ritonavir Versus GW433908 and Ritonavir Versus Lopinavir/Ritonavir and GW433908 (In Combination With Tenofovir Disoproxil Fumarate and One or Two Nucleoside Reverse Transcriptase Inhibitors) in HIV-1-Infected Subjects With Virologic Treatment Failure|Completed||N/A|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:33:37.869032|2017-10-11 04:33:37.869032
NCT00028379|ClinicalTrials.gov processed this data on October 10, 2017|2001-12-27|2008-03-03|||December 2001||2001-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Enhancement of Use-Dependent Plasticity by Somatosensory Stimulation in Chronic Stroke|Enhancement of Use-Dependent Plasticity by Somatosensory Stimulation in Chronic Stroke|Completed||N/A|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:37.998393|2017-10-11 04:33:37.998393
NCT00028405|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2005-06-23|||November 2001||2001-11-01|March 2003|2003-03-01|December 2002||2002-12-01|||||Interventional|||Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors|A Multicenter Phase I Safety and Tolerability Study of the Oncolux System for Intratumoral Delivery of Non-Coherent Light for the Photoactivation of LS 11 in Patients With Refractory Solid Tumors|Completed||Phase 1|48||Light Sciences LLC|||||||||||||||||||2017-10-11 04:33:38.0786|2017-10-11 04:33:38.0786
NCT00028418|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2015-03-24|||February 1999||1999-02-01|November 2001|2001-11-01|March 2004||2004-03-01|||||Interventional|||Clofarabine in Chronic Lymphocytic Leukemia|Phase I Study of CL-F-ARA-A in Solid and Hematologic Malignancies|Completed||Phase 1|100||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:38.181744|2017-10-11 04:33:38.181744
NCT00028431|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2014-05-20|||August 2001||2001-08-01|May 2014|2014-05-01|June 2005|Actual|2005-06-01|January 2003|Actual|2003-01-01||Interventional|||Novel Adjuvants for Peptide-Based Melanoma Vaccines|An Open Label Study of MDX-CTLA4 in Combination With Tyrosinase/gp100/MART-1 Peptides Emulsified With Montanide ISA 51 in the Treatment of Patients With Resected Stage III or IV Melanoma|Completed||Phase 1|19|Actual|University of Southern California|||||||||||||||||||2017-10-11 04:33:38.26032|2017-10-11 04:33:38.26032
NCT00028483|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2011-10-21|||October 2000||2000-10-01|October 2011|2011-10-01|April 2003|Actual|2003-04-01|||||Interventional|||Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer|A Phase II Study Using SGN-15 (cBR96 - Doxorubicin Immunoconjugate) in Combination With Taxotere for the Treatment of Metastatic or Recurrent Breast Carcinoma|Terminated||Phase 2|||Seattle Genetics, Inc.|||||||||||||||||||2017-10-11 04:33:38.341701|2017-10-11 04:33:38.341701
NCT00028496|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-01-24|||November 2001||2001-11-01|January 2013|2013-01-01||||November 2005|Actual|2005-11-01||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer|Phase I Study of a Recombinant Fowl Pox Vaccine rF-CEA (6D)/TRICOM Alone or With GM-CSF in Patients With Advanced CEA Expressing Adenocarinomas|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:38.41647|2017-10-11 04:33:38.41647
NCT00028509|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2014-02-11|||July 2002||2002-07-01|February 2014|2014-02-01||||July 2011|Actual|2011-07-01||Observational|||Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201|Assessment of Clinical and Neuroradiologic Evidence of Methotrexate Leukoencephalopathy in Children Treated on POG 9605 and 9201|Completed||N/A|66|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:33:38.537275|2017-10-11 04:33:38.537275
NCT00028522|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-12-13|||December 2001||2001-12-01|December 2013|2013-12-01||||September 2009|Actual|2009-09-01||Interventional|||R(+)XK469 in Treating Patients With Advanced Neuroblastoma|Phase I Study Of R(+)XK469 In Patients With Advanced Neuroblastoma|Completed||Phase 1|85|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:38.680911|2017-10-11 04:33:38.680911
NCT00028535|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-06-03|||November 2001||2001-11-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors|Phase I Trial of Interleukin-12 in Combination With Paclitaxel Plus Herceptin in Patients With Her2-positive Malignancies|Completed||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:38.814539|2017-10-11 04:33:38.814539
NCT00028548|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2014-04-24|||January 2002||2002-01-01|April 2014|2014-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||XK469 in Treating Patients With Advanced Solid Tumors|Phase I Study of R(+)-XK469 (NSC 698215) Given Daily, Days 1-5, Repeated Every Three Weeks in Patients With Advanced Malignancies|Completed||Phase 1|22|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 04:33:38.927142|2017-10-11 04:33:38.927142
NCT00028561|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-01-16|||October 2001||2001-10-01|January 2013|2013-01-01||||February 2007|Actual|2007-02-01||Interventional|||BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors|A Phase I Study of Epothilone B Analog BMS 247550 in Combination With Carboplatin in Recurrent and/or Refractory Solid Tumors|Terminated||Phase 1|45|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:33:39.017118|2017-10-11 04:33:39.017118
NCT00028574|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2016-06-27|||December 2001||2001-12-01|June 2016|2016-06-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer|A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men|Completed||Phase 3|223|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-10-11 04:33:39.167153|2017-10-11 04:33:39.167153
NCT00028587|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-01-15|||December 2001||2001-12-01|January 2013|2013-01-01||||April 2006|Actual|2006-04-01||Interventional|||PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacologic Study of the Proteasome Inhibitor PS-341 in Combination With Paclitaxel and Carboplatin in Patients With Advanced Malignancies|Completed||Phase 1|96|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:33:39.749896|2017-10-11 04:33:39.749896
NCT00028600|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2016-07-01|||November 2001||2001-11-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|June 2006|Actual|2006-06-01||Interventional|||Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma|Autologous Followed By Non-Myeloablative Allogeneic Transplant For Multiple Myeloma|Completed||Phase 2|60|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:33:39.868072|2017-10-11 04:33:39.868072
NCT00028613|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2014-01-08|||March 2001||2001-03-01|January 2014|2014-01-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma|Phase I Safety Study Of 131I-Lym-1 For The Treatment Of Previously Treated Diffuse Large B-Cell Lymphoma|Completed||Phase 1|2|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:33:40.037816|2017-10-11 04:33:40.037816
NCT00028626|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-06-04|||August 2001||2001-08-01|June 2013|2013-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer|Clinical Efficacy And Biologic Effects Of Preoperative Portal Vein Embolization In Patients With Colorectal Liver Metastases|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:33:40.132034|2017-10-11 04:33:40.132034
NCT00028639|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2011-07-01||2011-07-01|August 2001||2001-08-01|July 2011|2011-07-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||PS-341 in Treating Women With Metastatic Breast Cancer|A Phase II Study of the Proteasome Inhibitor PS-341 (NSC 681 239) in Patients With Metastatic Breast Cancer|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:33:40.207565|2017-10-11 04:33:40.207565
NCT00028652|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2015-09-30|||January 2002||2002-01-01|September 2015|2015-09-01||||||||Interventional|||Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases|Treament of Spontaneous Tumor Metastases With IL-12 DNA (NSC #709933): A Phase IB Trial|Terminated||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:33:40.278328|2017-10-11 04:33:40.278328
NCT00028665|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2010-06-09|||June 2000||2000-06-01|June 2010|2010-06-01||||March 2005|Actual|2005-03-01||Interventional|||Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma|Randomized Phase II Trial of B-Lymphocyte Purging of Autologous Peripheral Blood Progenitor Cells in Patients With B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|37|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:33:40.357836|2017-10-11 04:33:40.357836
NCT00028678|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2010-01-26|||May 2002||2002-05-01|January 2010|2010-01-01||||July 2006|Actual|2006-07-01||Interventional|||Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme|A Phase II Study to Evaluate the Effect of Dalteparin and Radiation Therapy on Survival Compared to the RTOG RPA Database and on Thromboembolic Events in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||||||f||||||||||2017-10-11 04:33:40.502233|2017-10-11 04:33:40.502233
NCT00028691|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-09-16|||December 2002||2002-12-01|January 2002|2002-01-01||||||||Interventional|||Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma|Chlorambucil Versus 2x2 Gy Involved Field Radiotherapy in Stage III/IV Previously Untreated Follicular Lymphoma Patients. A Prospective, Randomized Phase III Clinical Trial|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:40.612014|2017-10-11 04:33:40.612014
NCT00028704|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2012-07-17|||October 2001||2001-10-01|July 2012|2012-07-01||||December 2003|Actual|2003-12-01||Interventional|||Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy|Conservative Local Treatment Versus Mastectomy After Induction Chemotherapy In Locally Advanced Breast Cancer: A Randomized Phase III Study|Terminated||Phase 3|26|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:33:40.717431|2017-10-11 04:33:40.717431
NCT00028717|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-09-16|||February 2001||2001-02-01|November 2007|2007-11-01||||||||Interventional|||Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma|A Randomized Phase III Study Of Chimeric Anti-CD20 Monoclonal Antibody (Rituximab) With 2-Weekly CHOP Chemotherapy In Elderly Patients With Intermediate Or High-Risk Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:40.843424|2017-10-11 04:33:40.843424
NCT00028730|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2015-12-21|||August 2001||2001-08-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|July 2006|Actual|2006-07-01||Interventional|||Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer|Phase II Trial of T-Cell Depleted Hematopoietic Stem Cell Transplants (SBA-E-BM) From HLA Compatible Related or Unrelated Donors After a Myeloablative Preparative Regimen of Hyperfractionated TBI, Thiotepa and Cyclophosphamide (TBI/Thio/cy) for Treatment of Patients Less Than or Equal to 18 Years With Lymphohematopoietic Disorders|Completed||Phase 2|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:33:40.99396|2017-10-11 04:33:40.99396
NCT00028743|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-10-31|||August 2001||2001-08-01|December 2012|2012-12-01|January 2013|Actual|2013-01-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|A Phase III Study of Cisplatin Plus Topotecan Followed by Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Women With Newly Diagnosed Advanced Epithelial Ovarian Cancer|Completed||Phase 3|819|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:33:41.137385|2017-10-11 04:33:41.137385
NCT00028756|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2016-08-01|||October 2001||2001-10-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium|Randomized Phase III Trial Comparing Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients With pT3-pT4, and/or N+M0 Transitional Cell Carcinoma (TCC) of the Bladder|Completed||Phase 3|285|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 04:33:41.33261|2017-10-11 04:33:41.33261
NCT00028769|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-06-12|2012-11-15||December 2001||2001-12-01|June 2013|2013-06-01|July 2011|Actual|2011-07-01|June 2010|Actual|2010-06-01||Interventional|||S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer|Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination With Hormone Therapy in Patients With High-Risk Metastatic Adenocarinoma of the Prostate|Completed||Phase 2|41|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:33:41.521505|2017-10-11 04:33:41.521505
NCT00028782|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-01-15|||October 2001||2001-10-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer|The Detection of Tumor Hypoxia and Vascularity in Patients Undergoing Intraperitoneal Photodynamic Therapy|Terminated||N/A|80|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:33:42.318576|2017-10-11 04:33:42.318576
NCT00028795|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2014-02-19|||December 2002||2002-12-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|September 2007|Actual|2007-09-01||Interventional|||Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma|A Phase II Study of Temozolomide in the Treatment of Children With High Grade Glioma|Completed||Phase 2|170|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:33:42.475911|2017-10-11 04:33:42.475911
NCT00028821|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-01-15|||January 2002||2002-01-01|January 2013|2013-01-01||||April 2006|Actual|2006-04-01||Interventional|||2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacologic Study of 2-Methoxyestradiol in Patients With Advanced Solid Tumors|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:43.321983|2017-10-11 04:33:43.321983
NCT00028834|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-01-23|||February 2002||2002-02-01|January 2013|2013-01-01||||December 2004|Actual|2004-12-01||Interventional|||Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer|A Phase II Trial Of Bevacizumab (NSC#704865) Plus Gemcitabine In Patients With Advanced Pancreatic Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:43.495378|2017-10-11 04:33:43.495378
NCT00028847|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-09-16|||April 2001||2001-04-01|August 2011|2011-08-01||||||||Interventional|||Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia|A Dose-ranging Phase I/II Study of STI571 in Combination With Cytarabin in Patients With First Chronic Phase Chronic Myeloid Leukemia|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:43.656134|2017-10-11 04:33:43.656134
NCT00028860|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-07-09|||October 2001||2001-10-01|August 2004|2004-08-01|October 2004|Actual|2004-10-01|||||Interventional|||Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer|A Phase II Trial Of Adjuvant Chemotherapy For High Risk Transitional Cell Carcinoma Of The Urothelium|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:43.841024|2017-10-11 04:33:43.841024
NCT00030069|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-30|2016-01-14|||September 2001||2001-09-01|January 2016|2016-01-01|May 2009|Actual|2009-05-01|September 2007|Actual|2007-09-01||Interventional|||Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes|Calcitriol and Dexamethasone for Myelodysplastic Syndromes|Completed||Phase 2|32|Actual|University of Pittsburgh|||||f||||||||||||||2017-10-11 04:33:56.480798|2017-10-11 04:33:56.480798
NCT00028873|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2012-07-17|||September 2001||2001-09-01|July 2012|2012-07-01||||June 2002|Actual|2002-06-01||Interventional|||R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy|An EORTC-IDBBC/ECSG Phase II Study Evaluating The Role Of The Multi-Drug Resistance (MDR) Reversor, R101933, In Patients With Taxane Refractory Metastatic Breast Cancer|Completed||Phase 2|35|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:33:43.952854|2017-10-11 04:33:43.952854
NCT00028886|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-09-16|||March 2001||2001-03-01|October 2012|2012-10-01||||||||Interventional|||Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma|A Randomized Phase III Study On The Effect Of Thalidomide Combined With Adriamycin, Dexamethasone (AD) And High Dose Melphalan In Patients With Multiple Myeloma|Unknown status|Active, not recruiting|Phase 3|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:44.066385|2017-10-11 04:33:44.066385
NCT00028899|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2014-02-18|||July 2002||2002-07-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|September 2006|Actual|2006-09-01||Interventional|||Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes|A Dose Finding Study of the Safety of Gemtuzumab Ozogamicin Combined With Conventional Chemotherapy for Patients With Relapsed or Refractory Acute Myeloid Leukemia|Completed||Phase 1|47|Actual|Children's Oncology Group|||||||||t||||||||||2017-10-11 04:33:44.254447|2017-10-11 04:33:44.254447
NCT00028912|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2011-04-23|||November 2001||2001-11-01|April 2004|2004-04-01||||||||Interventional|||Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|Phase I Trial of Bortezomib (NSC 681239, IND#58443) and Carboplatin in Recurrent or Progressive Epithelial Ovarian Cancer or Primary Peritoneal Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:44.506579|2017-10-11 04:33:44.506579
NCT00028925|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2016-12-05|||November 2001||2001-11-01|December 2016|2016-12-01|August 2008|Actual|2008-08-01|November 2005|Actual|2005-11-01||Interventional|||Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF (Filgrastim) Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|27|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:33:44.610946|2017-10-11 04:33:44.610946
NCT00028938|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2017-04-17|||January 2002|Actual|2002-01-01|August 2009|2009-08-01|November 10, 2002|Actual|2002-11-10|November 10, 2002|Actual|2002-11-10||Interventional|||Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer|A Phase III Randomized Trial Evaluating the Effect of Epoetin Alfa (Procrit) on Local Control in Patients Undergoing Concurrent Chemotherapy and Radiation Therapy for Non-Small Cell Lung Cancer|Completed||Phase 3|1|Actual|Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:33:44.775079|2017-10-11 04:33:44.775079
NCT00028951|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-07-08|||January 2003||2003-01-01|December 2005|2005-12-01||||December 2005|Actual|2005-12-01||Interventional|||Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva|A Phase III Clinical Trial Use of TISSEEL VH Fibrin Sealant to Reduce Lymphedema Incidence After Inguinal Lymph Node Dissection Performed in the Management of Vulvar Malignancies|Completed||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:33:44.880426|2017-10-11 04:33:44.880426
NCT00028964|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2011-02-20|||February 2001||2001-02-01|February 2011|2011-02-01|February 2005|Actual|2005-02-01|||||Interventional|||Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer|A Randomized, Double Blind, Pacebo-Controlled Study to Assess The Feasibility, Toxicity And Efficacy (Phase I/II) Of A Chinese Herbal Therapy (CHT) For Symptom Management In Women Undergoing Chemotherapy For Stage I/II/III Breast Cancer|Completed||Phase 1/Phase 2|||University of California, San Francisco|||||f||||||||||||||2017-10-11 04:33:45.148238|2017-10-11 04:33:45.148238
NCT00028977|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2012-09-13|||August 2001||2001-08-01|September 2012|2012-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Herbal Therapy in Treating Women With Metastatic Breast Cancer|A Pilot Safety, Feasibility, Efficacy And Correlative (Phase I/II) Study Assessing Herba Scutellaria Barbatae (HSB) For Metastatic Breast Cancer|Completed||Phase 1/Phase 2|21|Actual|University of California, San Francisco|||||f||||||||||||||2017-10-11 04:33:45.236388|2017-10-11 04:33:45.236388
NCT00028990|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2012-03-08|||December 2001||2001-12-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|November 2006|Actual|2006-11-01||Interventional|||Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer|A Randomized Phase III Tial Of Paclitaxel Versus Paclitaxel Plus Bevacizumab (rhuMAb VEGF) As First-Line Therapy For Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 3|722|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 04:33:45.35657|2017-10-11 04:33:45.35657
NCT00029003|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2013-02-27|||December 2001||2001-12-01|February 2013|2013-02-01||||December 2004|Actual|2004-12-01||Interventional|||Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Trial of Chronic Oral ZD1839 (Iressa®) (NSC-715055) in Both Previously-Untreated and Previously-Treated Patients With Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)|Completed||Phase 2|90|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:45.564882|2017-10-11 04:33:45.564882
NCT00029029|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2017-05-23|||October 2000||2000-10-01|January 2016|2016-01-01||||October 2002|Actual|2002-10-01||Interventional|||Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases|RF Ablation of Painful Metastases Involving Bone|Active, not recruiting||Phase 2|||Mayo Clinic|||||f||||f|f|f||||||No||2017-10-11 04:33:45.68265|2017-10-11 04:33:45.68265
NCT00029042|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2008-08-26|||January 2002||2002-01-01|August 2008|2008-08-01|October 2005|Actual|2005-10-01|||||Interventional|||Infliximab to Treat Children With Juvenile Rheumatoid Arthritis|A Randomized Double Blind Controlled Intra-Patient Dose Escalation Phase II Trial of Infliximab in Pediatric Patients With Refractory Juvenile Rheumatoid Arthritis|Terminated||Phase 2|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:45.783521|2017-10-11 04:33:45.783521
NCT00029068|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-04|2008-03-03|||January 2002||2002-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||Cortical Excitability in Obsessive-Compulsive and Related Disorders|Studies of Cortical Excitability in Obsessive-Compulsive Disorder, Related Disorder and Healthy Volunteers Using Paired-Pulse Transcranial Magnetic Stimulation|Completed||N/A|145||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:45.863758|2017-10-11 04:33:45.863758
NCT00029107|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-05|2012-04-10|2011-10-26||December 2001||2001-12-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis|Rituximab (Anti-CD20) for the Treatment of Hepatitis C Associated Cryoglobulinemic Vasculitis|Completed||Phase 2|47|Actual|National Institutes of Health Clinical Center (CC)|The study was not blinded. In addition, the study was limited to patients who had failed antiviral therapy.|2|||f||||f||||||||||2017-10-11 04:33:45.956995|2017-10-11 04:33:45.956995
NCT00029120|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-05|2017-06-30|||December 18, 2001||2001-12-18|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder|MRI Contrast Imaging in the Evaluation and Follow-up of Patients With Memory Disorder and Healthy Controls|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:47.954065|2017-10-11 04:33:47.954065
NCT00029133|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-08|2005-06-23|||February 2000||2000-02-01|August 2003|2003-08-01||||||||Interventional|||Hypothermia During Intracranial Aneurysm Surgery Trial||Completed||Phase 3|1000||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:33:48.044941|2017-10-11 04:33:48.044941
NCT00029146|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-08|2012-03-24|2012-01-17||July 2002||2002-07-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|COSS||Carotid Occlusion Surgery Study|Carotid Occlusion Surgery Study|Terminated||Phase 3|700|Actual|University of North Carolina, Chapel Hill||2||Pre-specified futility boundary was reached.|f||||t||||||||||2017-10-11 04:33:48.161012|2017-10-11 04:33:48.161012
NCT00029159|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-08|2012-06-04|||November 1992||1992-11-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|January 2007|Actual|2007-01-01||Interventional|||The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome|The Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate and Cognitive Function of Growth Hormone-treated Girls With Turner Syndrome|Completed||Phase 3|200|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 04:33:48.800004|2017-10-11 04:33:48.800004
NCT00029172|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-08|2009-12-31|2009-08-03||May 1999||1999-05-01|December 2009|2009-12-01|December 2005|Actual|2005-12-01|||||Interventional|||Treatment for Post-Stroke Depression|Treatment for Post-Stroke Depression|Completed||Phase 4|188|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 04:33:48.893323|2017-10-11 04:33:48.893323
NCT00029185|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-08|2015-03-24|||September 2001||2001-09-01|October 2001|2001-10-01|September 2007||2007-09-01|||||Interventional|||Study of Dehydrex in Patients With Corneal Erosion|Topical Dehydrex in Treating Recurrent Corneal Erosion|Completed||N/A|300|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:49.174155|2017-10-11 04:33:49.174155
NCT00029198|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2014-04-09|||April 2003||2003-04-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Preterm Infants' Weight Gain Following Massage Therapy|Preterm Infants' Weight Gain Following Massage Therapy|Completed||Phase 3|139|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 04:33:49.245845|2017-10-11 04:33:49.245845
NCT00029211|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2006-08-17|||April 2000||2000-04-01|August 2006|2006-08-01|March 2003||2003-03-01|||||Interventional|||A Trial of Echinacea in Children|A Randomized Controlled Trial of Echinacea in Children|Completed||Phase 3|600||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:49.338904|2017-10-11 04:33:49.338904
NCT00029224|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2012-01-30|||October 2001||2001-10-01|January 2012|2012-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions|A Prospective, Multicenter, Open-label Clinical Evaluation of the Effect of IV Zoledronic Acid 4mg on PAIN, QUALITY OF LIFE and TIME IN INFUSION CHAIR in Breast Cancer, Multiple Myeloma, and Prostate Cancer Patients With Cancer-related Bone Lesions|Completed||Phase 4|500||Novartis|||||f||||||||||||||2017-10-11 04:33:49.420317|2017-10-11 04:33:49.420317
NCT00029237|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2006-08-17|||September 2000||2000-09-01|August 2006|2006-08-01|May 2005||2005-05-01|||||Interventional|||Alternative Stress Management Approaches in HIV Disease|Alternative Stress Management Approaches in HIV Disease|Completed||Phase 3|392||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:49.535268|2017-10-11 04:33:49.535268
NCT00029250|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2013-03-21|||November 2001||2001-11-01|March 2013|2013-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Garlic in Hyperlipidemia Caused by HAART|Phase II, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study on the Effects of Garlic on Hyperlipidemia Induced by HAART in HIV-positive Individuals|Withdrawn||Phase 2|0|Actual|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:49.612004|2017-10-11 04:33:49.612004
NCT00029263|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2006-08-17|||August 2001||2001-08-01|July 2006|2006-07-01|May 2004||2004-05-01|||||Interventional|||Screening Herbs for Drug Interactions|R-21 Project: Screening Herbs for Drug Interference|Completed||Phase 2|140||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:49.70186|2017-10-11 04:33:49.70186
NCT00029276|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2006-08-16|||August 2000||2000-08-01|August 2006|2006-08-01|April 2005||2005-04-01|||||Interventional|||Magnetic Stimulation for Parkinson Disease|Transcranial Magnetic Stimulation For Treatment Of Depression In Parkinson's Disease|Completed||Phase 1|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:49.764486|2017-10-11 04:33:49.764486
NCT00029289|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2006-08-16|||April 2001||2001-04-01|August 2006|2006-08-01|October 2002||2002-10-01|||||Interventional|||Effects of Lutein in Retinitis Pigmentosa|Effects of Lutein in Retinitis Pigmentosa|Completed||Phase 1/Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:49.830219|2017-10-11 04:33:49.830219
NCT00029302|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-09|2017-06-30|||December 10, 2001||2001-12-10|December 24, 2008|2008-12-24|December 24, 2008||2008-12-24|||||Observational|||Brain Control of Bimanual (Both Hands) Movements|Brain Areas Involved in Temporal Linkage of Bilateral Movements|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:49.89011|2017-10-11 04:33:49.89011
NCT00029315|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-10|2015-03-24|||September 2001||2001-09-01|December 2001|2001-12-01|September 2004||2004-09-01|||||Interventional|||Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage|Intraventricular Rt-PA Pharmacokinetic and Pharmacodynamic Study|Completed||Phase 2|30|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:49.946319|2017-10-11 04:33:49.946319
NCT00029328|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-10|2015-03-24|||September 2001||2001-09-01|November 2001|2001-11-01|September 2003||2003-09-01|||||Interventional|||Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation|Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation|Completed||Phase 1/Phase 2|15||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:50.015381|2017-10-11 04:33:50.015381
NCT00029341|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-10|2008-07-29||||||January 2005|2005-01-01||||||||Interventional|||A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body|A Phase II Study to Demonstrate That Therapy With Efavirenz (EFV) and Other Antiretroviral Drugs Can Be Interrupted Without Selecting for EFV-Resistant Virus, and Relation to Kinetics of Drug Elimination|Completed||Phase 2|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:33:50.099409|2017-10-11 04:33:50.099409
NCT00029380|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-10|2016-07-28|||January 1999||1999-01-01|September 2008|2008-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia|Sibling Donor Cord Blood Banking and Transplantation|Completed||Phase 2|30|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:33:50.187244|2017-10-11 04:33:50.187244
NCT00029393|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-10|2016-07-28|||August 2001||2001-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Induction of Stable Chimerism for Sickle Cell Anemia||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:33:50.319322|2017-10-11 04:33:50.319322
NCT00029406|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-10|2015-12-15|||April 2001||2001-04-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|TRIPPS||Transfusion Infections Pediatric Prospective Study (TRIPPS)|Transfusion Infections Pediatric Prospective Study (TRIPPS)|Completed||N/A|600|Actual|Children's Research Institute|||1||f||||f||||||Samples Without DNA|"     Whole blood and plasma samples   "|||2017-10-11 04:33:50.383516|2017-10-11 04:33:50.383516
NCT00029445|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-11|2017-10-05|||January 2, 2002||2002-01-02|August 31, 2017|2017-08-31||||||||Observational|||Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors|Evaluation of Viral Factors and Immune Parameters to Study HIV-Specific Immunity|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:50.445363|2017-10-11 04:33:50.445363
NCT00029458|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-11|2008-03-03|||January 2002||2002-01-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Clozapine for Treatment-Resistant Mania|A Double Blind Study Examining the Efficacy of Clozapine and a Study of the Pathophysiology in Treatment Resistant Mania|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:50.521794|2017-10-11 04:33:50.521794
NCT00029484|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-11|2006-08-17||||||July 2006|2006-07-01||||||||Interventional|||Tai Chi Chih and Varicella Zoster Immunity|Tai Chi Chih and Varicella Zoster Immunity|Completed||Phase 2|70||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:50.593998|2017-10-11 04:33:50.593998
NCT00029497|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-14|2013-03-21||||||March 2013|2013-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Sham Device, Pill Placebo or Treatment For Arm Pain|Sham Device, Pill Placebo or Treatment For Arm Pain|Completed||Phase 2|240||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:50.650607|2017-10-11 04:33:50.650607
NCT00029510|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-14|2006-08-17|||May 2002||2002-05-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Magnesium and Asthma - Clinical Trials|Magnesium and Asthma - Clinical Trials|Completed||Phase 2|240||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:50.7208|2017-10-11 04:33:50.7208
NCT00029523|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-15|2007-02-27|||April 2001||2001-04-01|February 2007|2007-02-01|November 2004||2004-11-01|||||Interventional|||DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor|A Randomized Clinical Study to Determine the Patient Benefit and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis|Completed||Phase 4|100||Pacira Pharmaceuticals, Inc|||||||||||||||||||2017-10-11 04:33:50.907198|2017-10-11 04:33:50.907198
NCT00029536|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-15|2017-06-02|2017-03-31||October 2000||2000-10-01|June 2017|2017-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Progesterone vs Placebo Therapy for Women With Epilepsy|Phase 3 Study of Progesterone vs Placebo Therapy|Completed||Phase 3|294|Actual|Beth Israel Deaconess Medical Center||4|||f||||t||||||||||2017-10-11 04:33:51.046683|2017-10-11 04:33:51.046683
NCT00029575|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-15|2008-03-03|||January 2002||2002-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Interventional|||Magnetic Resonance Imaging of Narrowed Arteries|Intravascular Narrow Field Magnetic Resonance Arterial Wall Imaging|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:51.630653|2017-10-11 04:33:51.630653
NCT00029588|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-15|2017-10-05|||January 11, 2002||2002-01-11|July 24, 2017|2017-07-24|July 24, 2017||2017-07-24|||||Observational|||Reward-Related Processes and Brain Function|Reward-Related Processes and Brain Function|Completed||N/A|241|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:51.719447|2017-10-11 04:33:51.719447
NCT00029601|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-15|2008-03-03|||January 2002||2002-01-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Observational|||Surround Inhibition in Patients With Dystonia|The Study of Surround Inhibition in Patients With Dystonia|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:51.797049|2017-10-11 04:33:51.797049
NCT00029614|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-16|2010-04-27|||May 2006||2006-05-01|April 2010|2010-04-01|July 2007|Actual|2007-07-01|||||Interventional|||Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD|Psychopharmacology of Adolescents With AUD and ADHD|Completed||Phase 2|24|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 04:33:51.878124|2017-10-11 04:33:51.878124
NCT00029627|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-16|2008-03-03|||January 2002||2002-01-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Observational|||Brain Receptors in Sympathetic Nervous System Regulation|Alpha(2)-Adrenoreceptor (AR) Subtype Polymorphisms and Physiological Responses to Alpha(2)-AR Agonist and Antagonist Drugs|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:51.953773|2017-10-11 04:33:51.953773
NCT00029640|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-16|2008-03-03|||January 2002||2002-01-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||The Treatment of Children and Adolescents With Treatment-Resistant Depression|Clinical and Neurochemical Effects of Pharmacologic Treatment in Pediatric Depression|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:52.020252|2017-10-11 04:33:52.020252
NCT00029653|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-16|2008-03-03|||January 2002||2002-01-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Effect of Transcranial Magnetic Stimulation on Free Will|The Effect of Transcranial Magnetic Stimulation on Free Will|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:52.08305|2017-10-11 04:33:52.08305
NCT00034203|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-23|2005-06-23|||April 2002||2002-04-01|September 2004|2004-09-01|August 2003||2003-08-01|||||Interventional|||Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.||Completed||Phase 2|||XOMA (US) LLC|||||||||||||||||||2017-10-11 04:34:31.055791|2017-10-11 04:34:31.055791
NCT00029666|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-17|2008-03-03|||January 2002||2002-01-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease|Placebo Controlled Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:52.143505|2017-10-11 04:33:52.143505
NCT00029679|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-18|2006-08-16|||September 2000||2000-09-01|August 2006|2006-08-01|July 2005||2005-07-01|||||Interventional|||Borage Oil and Ginkgo Biloba (EGb 761) in Asthma|Borage Oil and Ginkgo Biloba (EGb 761) in Asthma|Completed||Phase 1/Phase 2|280||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:52.230772|2017-10-11 04:33:52.230772
NCT00029692|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-18|2006-07-24|||March 2002||2002-03-01|July 2006|2006-07-01|March 2005||2005-03-01|||||Interventional|||Effects of Ginseng and Ginkgo on Drug Disposition in Man|Effects of Ginseng and Ginkgo on Drug Disposition in Man|Completed||Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:52.293692|2017-10-11 04:33:52.293692
NCT00029718|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-14|2017-06-30|||January 16, 2002||2002-01-16|November 18, 2011|2011-11-18|November 18, 2011||2011-11-18|||||Observational|||Interhemispheric Interactions Associated With Performance of Voluntary Movements in Patients With Stroke Motor Disability|Interhemispheric Interactions Associated With Performance of Voluntary Movements in Patients With Stroke Motor Disability|Completed||N/A|57|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:52.349276|2017-10-11 04:33:52.349276
NCT00029731|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-21|2015-03-24|||August 2001||2001-08-01|January 2002|2002-01-01|July 2005||2005-07-01|||||Interventional|||Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients|Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease|Completed||Phase 2|30|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:52.407606|2017-10-11 04:33:52.407606
NCT00029744|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-21|2012-10-29|||April 2003||2003-04-01|October 2012|2012-10-01|May 2007|Actual|2007-05-01|||||Observational|||A Study to Prepare for Future HIV Vaccine Studies|An HIV Vaccine Preparedness Study|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:33:52.462463|2017-10-11 04:33:52.462463
NCT00029757|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-22|2005-11-04||||||December 2003|2003-12-01||||||||Interventional|||Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women|Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women|Completed||N/A|15||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:33:52.524166|2017-10-11 04:33:52.524166
NCT00029770|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-23|2008-01-23|||September 2001||2001-09-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Chiropractic Care, Medication, and Self-Care for Neck Pain|Chiropractic Care, Medication, and Self-Care for Neck Pain|Completed||Phase 2|270||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:52.576419|2017-10-11 04:33:52.576419
NCT00029783|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-23|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|June 2005||2005-06-01|||||Interventional|||Efficacy of Distant Healing in Glioblastoma Treatment|Efficacy of Distant Healing in Glioblastoma Treatment|Completed||Phase 2|150||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:52.630885|2017-10-11 04:33:52.630885
NCT00029796|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-23|2013-03-21||||||March 2013|2013-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Isoflavones and Acute-phase Response in Chronic Renal Failure|Isoflavones and Acute-phase Response in Chronic Renal Failure|Completed||Phase 2|52||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:52.684189|2017-10-11 04:33:52.684189
NCT00029809|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-23|2006-08-17||||||July 2006|2006-07-01||||||||Interventional|||Chinese Exercise Modalities in Parkinson's Disease|Chinese Exercise Modalities in Parkinson's Disease|Completed||Phase 1/Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:52.750986|2017-10-11 04:33:52.750986
NCT00029822|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-23|2008-06-06|||May 2001||2001-05-01|June 2008|2008-06-01|March 2005|Actual|2005-03-01|||||Interventional|||Clinical Trial in Males With BPH (Enlarged Prostate)|Long-Term, Efficacy and Safety of Alfuzosin 10 MG OD on the Risk of Acute Urinary Retention and the Need for Surgery in Patients With BPH. A Two Year, Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Study.|Completed||Phase 3|1522|Actual|Sanofi|||||||||||||||||||2017-10-11 04:33:52.809705|2017-10-11 04:33:52.809705
NCT00029835|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-23|2009-04-17|||September 2001||2001-09-01|April 2009|2009-04-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|RIO-Lipids||Obese Patients With Untreated Dyslipidemias|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study of Weight-Reducing Effect and Safety in Obese Patients With Untreated Dyslipidemias|Completed||Phase 3|1033|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:33:52.980328|2017-10-11 04:33:52.980328
NCT00029848|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-23|2009-04-17|||October 2001||2001-10-01|April 2009|2009-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|RIO-Diabetes||Obese Patients With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety in Obese Patients With Type 2 Diabetes|Completed||Phase 3|1045|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:33:53.245406|2017-10-11 04:33:53.245406
NCT00029861|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-23|2009-04-17|||August 2001||2001-08-01|April 2009|2009-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Obese Patients With or Without Comorbidities (RIO-North America)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing and Prevention of Weight Regain Effects and Safety in Obese Patients With or Without Comorbidities|Completed||Phase 3|3045|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:33:53.484444|2017-10-11 04:33:53.484444
NCT00029874|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-24|2015-03-24|||September 2001||2001-09-01|December 2004|2004-12-01|August 2003||2003-08-01|||||Interventional|||Minocycline in Patients With Huntington's Disease|Minocycline Dosing and Safety in Huntington's Disease|Completed||Phase 1/Phase 2|63||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:53.672658|2017-10-11 04:33:53.672658
NCT00029900|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-24|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|August 2003||2003-08-01|||||Interventional|||ADI-PEG in Patients With Metastatic Melanoma|Phase I Testing of ADI-PEG in Metastatic Melanoma|Completed||Phase 1|15||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:53.743299|2017-10-11 04:33:53.743299
NCT00032383|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-20|2007-01-19|||April 2001||2001-04-01|July 2006|2006-07-01|April 2003||2003-04-01|||||Interventional|||Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System|Complementary/Alternative Medicine for Vestibulopathy|Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:06.445824|2017-10-11 04:34:06.445824
NCT00029913|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-24|2010-08-31|||April 2002||2002-04-01|August 2010|2010-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials|A Multi-Site Evaluation of Virologic, Immunologic, and Clinical Natural History of Participants Enrolled in Phase I and Phase II HIV-1 Vaccine Protocols or HIV-1 Vaccine Preparedness Cohorts Who Develop HIV-1 Infection Subsequent to Trial Enrollment|Completed||N/A|54|Anticipated|HIV Vaccine Trials Network|||1||f||||||||||||||2017-10-11 04:33:53.815232|2017-10-11 04:33:53.815232
NCT00029926|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-26|2008-03-03|||January 2002||2002-01-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Observational|||Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity|A Pilot Study of F-18FDG Positron Emission Tomography (PET) to Assess the Distribution of Activated Lymphocytes in Systemic Lupus Erythematosus (SLE)|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:53.944198|2017-10-11 04:33:53.944198
NCT00029939|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-26|2017-06-30|||January 22, 2002||2002-01-22|November 23, 2010|2010-11-23|November 23, 2010||2010-11-23|||||Observational|||Brain Activity During Production of Movement|Real-Time Analysis of Scalp Electroencephalography and Magnetoencephalography During Production of Human Voluntary Movement|Completed||N/A|140|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:54.018522|2017-10-11 04:33:54.018522
NCT00029952|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-26|2008-03-03|||July 1993||1993-07-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Observational|||Long Term Post Operative Follow-Up of Cushing Syndrome|Long-Term Post-Operative Follow-Up of Cushing Syndrome|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:54.075137|2017-10-11 04:33:54.075137
NCT00029965|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-27|2017-10-05|||January 23, 2002||2002-01-23|April 14, 2017|2017-04-14||||||||Observational|||Nervous System Degeneration in Glycosphingolipid Storage Disorders|Investigation of Neurodegeneration in the Glycosphingolipid Storage Disorders|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:54.139983|2017-10-11 04:33:54.139983
NCT00029978|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-29|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|January 2004||2004-01-01|||||Observational|||Transfer of Neural Energy Between Humans|Transfer of Neural Energy Between Human Subjects|Completed||N/A|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:54.237211|2017-10-11 04:33:54.237211
NCT00029991|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-29|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||Extract of Ginkgo Biloba (EGB 761) and Vascular Function|Extract of Ginkgo Biloba (Egb 761) and Vascular Function|Completed||Phase 1/Phase 2|100||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:33:54.305368|2017-10-11 04:33:54.305368
NCT00030004|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-29|2006-08-17|||May 2000||2000-05-01|July 2006|2006-07-01|April 2001||2001-04-01|||||Interventional|||Pilot Study of Spinal Manipulation for Chronic Neck Pain|Pilot Study of Spinal Manipulation for Chronic Neck Pain|Terminated||Phase 1|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:54.379893|2017-10-11 04:33:54.379893
NCT00030030|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-30|2006-08-17|||July 2000||2000-07-01|July 2006|2006-07-01|June 2002||2002-06-01|||||Interventional|||Evaluating Silymarin for Chronic Hepatitis C|Evaluating Silymarin for Chronic Hepatitis C|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:33:54.451585|2017-10-11 04:33:54.451585
NCT00030043|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-30|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|August 2003||2003-08-01|||||Interventional|||An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors|Penetrating Auditory Brainstem Implant for Neurofibromatosis 2|Completed||Phase 1|10||FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:33:54.532695|2017-10-11 04:33:54.532695
NCT00022568|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-12-17|||August 2001||2001-08-01|December 2003|2003-12-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|A Phase I Trial of Intra Lesional rV-Tricom Vaccine in the Treatment of Malignant Melanoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:54.6141|2017-10-11 04:33:54.6141
NCT00022581|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-01-04|||July 2001||2001-07-01|January 2013|2013-01-01||||December 2004|Actual|2004-12-01||Interventional|||Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial of Thalidomide (NSC #66847, IND #48832) for Patients With Relapsed or Refractory Low Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|45|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:54.689841|2017-10-11 04:33:54.689841
NCT00022594|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2012-07-23|||May 2001||2001-05-01|July 2012|2012-07-01||||August 2002|Actual|2002-08-01||Interventional|||Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer|Phase II Study Of NX 211 (Liposomal Lurtotecan) Given As An IV Bolus Injection On Days 1 and 8 Every 3 Weeks In Patients With Metastatic Or Loco-Regional Recurrent Squamous Cell Carcinoma Of The Head and Neck With Target Lesions Within Previously Irradiated Fields Or Outside Previously Irradiated Fields|Completed||Phase 2|50|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:33:54.798756|2017-10-11 04:33:54.798756
NCT00022607|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2013-06-20|||January 2002||2002-01-01|October 2004|2004-10-01|May 2006|Actual|2006-05-01|||||Interventional|||Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma|Phase II Randomized Trial of Bevacizumab Versus Bevacizumab and Thalidomide for Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:54.924062|2017-10-11 04:33:54.924062
NCT00022620|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2012-09-20|||June 2001||2001-06-01|September 2012|2012-09-01||||October 2002|Actual|2002-10-01||Interventional|||Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer|Phase II Study On Paclitaxel In Recurrent Uterine Papillary Serous Carcinoma (UPSC)|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:33:55.017417|2017-10-11 04:33:55.017417
NCT00022633|ClinicalTrials.gov processed this data on October 10, 2017|2001-08-10|2016-07-08|2012-11-26||July 2001||2001-07-01|July 2016|2016-07-01|July 2011|Actual|2011-07-01|June 2008|Actual|2008-06-01||Interventional||All eligible patients who started treatment were included in the analysis|S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract|Protocol for Assessment of Gemcitabine and Paclitaxel for Metastatic Urothelial Cancer in Patients Aged 70 Years or Older (and in a Cohort of Patients Younger Than 60 Years)|Terminated||Phase 2|65|Actual|Southwest Oncology Group||1||Permanently Closed Due to Poor Accrual|f||||f||||||||||2017-10-11 04:33:55.179764|2017-10-11 04:33:55.179764
NCT00030056|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-30|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|December 2005||2005-12-01|||||Interventional|||GM-CSF in Patients With Pulmonary Alveolar Proteinosis|Trial of GM-CSF for Alveolar Proteinosis|Terminated||Phase 2|48|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:33:56.392542|2017-10-11 04:33:56.392542
NCT00030082|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-30|2015-04-29|||July 2001||2001-07-01|July 2004|2004-07-01||||||||Interventional|||Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer|A Phase I Study of Hepatic Arterial Infusion of Escalating Dose Melphalan With Venous Filtration for Metastatic Unresectable Cancers of the Liver|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:56.553387|2017-10-11 04:33:56.553387
NCT00030095|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-30|2015-04-29|||September 2001||2001-09-01|July 2006|2006-07-01||||||||Interventional|||2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors|A Phase I Trial Of 2-Methoxyestradiol (2ME2), (NSC-659853) An Angiogenesis Inhibitor, In Patients With Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:33:56.62177|2017-10-11 04:33:56.62177
NCT00030108|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-30|2012-03-14|||November 2001||2001-11-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy|Phase I Trial and Pharmacokinetic Study of BMS-247550 (NSC 710428, Ixabepilone), an Epothilone B Analog, in Pediatric Patients With Refractory Solid Tumors and Leukemias|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:33:56.696013|2017-10-11 04:33:56.696013
NCT00030121|ClinicalTrials.gov processed this data on October 10, 2017|2002-01-31|2008-02-19|||December 1999||1999-12-01|February 2008|2008-02-01||||||||Interventional|||Carperitide in Acute Respiratory Distress Syndrome (ARDS)|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Evaluation of the Safety and Efficacy of Carperitide Infusion in Patients With ARDS|Completed||Phase 2|||Suntory Pharmaceutical|||||||||||||||||||2017-10-11 04:33:56.815514|2017-10-11 04:33:56.815514
NCT00030134|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-02|2008-03-03|||January 2002||2002-01-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||Data Collection in Women With Fabry Disease|A Study to Collect Normative Data in Female Patients With Fabry Disease|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:56.887882|2017-10-11 04:33:56.887882
NCT00030147|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-06|2016-07-18|2016-06-02||February 2002||2002-02-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Raloxifene and Rimostil for Perimenopause-Related Depression|The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression|Completed||Phase 4|65|Actual|National Institutes of Health Clinical Center (CC)|Two participants signed the consent but were not started (did not meet inclusion criteria.) Early termination of Rimostil treatment arm limits the generalizability of treatment response in this arm.|4|||f||||f||||||||No||2017-10-11 04:33:57.005442|2017-10-11 04:33:57.005442
NCT00030160|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-07|2010-01-12|||April 2002||2002-04-01|January 2010|2010-01-01|July 2005||2005-07-01|||||Interventional|||Strength Training for Obesity Prevention|Strength Training for Obesity Prevention|Completed||Phase 2|160||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:33:58.179216|2017-10-11 04:33:58.179216
NCT00030173|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-07|2009-01-07|||October 2001||2001-10-01|January 2009|2009-01-01|June 2003|Actual|2003-06-01|||||Interventional|||A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors|A Phase 1, Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Epothilone D in Patients With Advanced Solid Tumors|Completed||Phase 1|45||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:33:58.243281|2017-10-11 04:33:58.243281
NCT00030186|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-07|2012-08-14||2012-05-03|January 2002||2002-01-01|August 2012|2012-08-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation|An Open-Label Study of CEP-701 in Patients With Refractory, Relapsed, or Poor Risk Acute Myeloid Leukemia Expressing FLT-3 Activating Mutations|Completed||Phase 2|37|Actual|Teva Pharmaceutical Industries||3|||f||||||||||||||2017-10-11 04:33:58.306028|2017-10-11 04:33:58.306028
NCT00030199|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-07|2008-03-03|||February 2002||2002-02-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Brain Control of Blinking|Cortical Control of Voluntary Blinking|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:58.389658|2017-10-11 04:33:58.389658
NCT00030212|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-07|2017-06-30|||February 4, 2002||2002-02-04|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Immune Abnormalities in Sporadic Inclusion Body Myositis|Study of Immune Dysregulation in Patients With Sporadic Inclusion Body Myositis (s-IBM)|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:33:58.454172|2017-10-11 04:33:58.454172
NCT00030225|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-11|2012-07-24|||January 2002||2002-01-01|July 2012|2012-07-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure|Phase 2 Evaluation of the Vitagen Extracorporeal Liver Assist Device (ELAD) System in the Management of the Patients With Fulminant Hepatic Failure|Completed||Phase 2|19|Actual|Vital Therapies, Inc.||2|||f||||t||||||||||2017-10-11 04:33:58.527702|2017-10-11 04:33:58.527702
NCT00030238|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-12|2017-10-05|||February 6, 2002||2002-02-06|October 28, 2014|2014-10-28|December 14, 2007|Actual|2007-12-14|December 14, 2007|Actual|2007-12-14||Interventional|||Supplemental Calcium in Overweight People|Supplemental Calcium in Overweight Out-Patients|Completed||Phase 3|540|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:33:58.630815|2017-10-11 04:33:58.630815
NCT00030264|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2016-06-01|||February 2001||2001-02-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|December 2013|Actual|2013-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas|Vinblastine/Methotrexate For Severe Progressive Plexiform Neurofibromas: A Phase II Study|Completed||Phase 2|25|Actual|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-10-11 04:33:58.720309|2017-10-11 04:33:58.720309
NCT00030277|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-07-09|||October 2001||2001-10-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|October 2007|Actual|2007-10-01||Interventional|||High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer|Feasibility Study for Locally Recurrent Prostate Cancer Treatment With HIFU Using the SONABLATE System|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:58.798638|2017-10-11 04:33:58.798638
NCT00030290|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-07-09|||October 2001||2001-10-01|December 2008|2008-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate|Feasibility Study for Organ Confined Prostate Cancer Treatment With HIFU Using SONABLATE System|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:58.873967|2017-10-11 04:33:58.873967
NCT00146510|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2014-03-12|||March 2004||2004-03-01|March 2014|2014-03-01|February 2006||2006-02-01|||||Interventional|||HealtheTech Lifestyle Program|HealtheLifestyle Behavioral Intervention Clinical Trial|Completed||Phase 1|130||The Cooper Institute|||||f||||||||||||||2017-10-11 05:20:04.04534|2017-10-11 05:20:04.04534
NCT00030303|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2017-04-26|||January 2001|Actual|2001-01-01|April 2017|2017-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia|A Feasibility And Toxicity Study Of Vaccination With HSP70 For The Treatment Of Chronic Myelogenous Leukemia In Chronic Phase|Completed||Phase 1|20|Actual|UConn Health||1|||f|||||t|f|||f|||||2017-10-11 04:33:58.964965|2017-10-11 04:33:58.964965
NCT00030342|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-06-25|||November 2001||2001-11-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer|A Phase I/II Study Of Interleukin-12-Primed Activated T Cells In Combination With 5FU, GM-CSF And Interferon Alfa-2b In Metastatic Renal Cell Carcinoma Or Colorectal Carcinoma|Completed||Phase 1/Phase 2|60|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:59.058571|2017-10-11 04:33:59.058571
NCT00030355|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-03-21||||||September 2007|2007-09-01||||||||Interventional|||Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia|A Phase I/II Open-Label Study Of The Intravenous Administration Of Homoharringtonine (CGX-635) Salvage Therapy For The Treatment Of Refractory Acute Promyelocytic Leukemia|Withdrawn||Phase 1/Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:33:59.139287|2017-10-11 04:33:59.139287
NCT00030368|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-06-03|||November 2001||2001-11-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Study of PS-341 in Combination With Paclitaxel in Metastatic Solid Tumors|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:59.20818|2017-10-11 04:33:59.20818
NCT00030381|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-01-15|||December 2001||2001-12-01|January 2013|2013-01-01||||January 2003|Actual|2003-01-01||Interventional|||Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis|Phase I Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)|Terminated||Phase 1|22|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:33:59.298426|2017-10-11 04:33:59.298426
NCT00030394|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-01-16|||September 2002||2002-09-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A Phase II Study of Gleevec in Ph+ Chronic Phase Chronic Myelogenous Leukemia|Completed||Phase 2|64|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:33:59.385757|2017-10-11 04:33:59.385757
NCT00030407|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-04-25|||October 2001||2001-10-01|April 2013|2013-04-01|April 2009|Actual|2009-04-01|September 2005|Actual|2005-09-01||Interventional|||Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer|Evaluation Of Celecoxib In Combination With Weekly Docetaxel In Elderly (70 Years) Or Poor Performance Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|34|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-10-11 04:33:59.497669|2017-10-11 04:33:59.497669
NCT00030420|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-04-25|||October 2001||2001-10-01|April 2013|2013-04-01|February 2008|Actual|2008-02-01|May 2004|Actual|2004-05-01||Interventional|||Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer|Evaluation Of Celecoxib In Combination With Docetaxel In The Treatment Of Advanced Non-Small Cell Lung Cancer Patients Previously Treated With Platinum Based Chemotherapy|Completed||Phase 2|24|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 04:33:59.585512|2017-10-11 04:33:59.585512
NCT00031811|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2012-05-24|||March 2001||2001-03-01|June 2010|2010-06-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer|Breast Cancer Survivors: Exercise and Raloxifene|Completed||N/A|80|Actual|OHSU Knight Cancer Institute|||||f||||||||||||||2017-10-11 04:33:59.669294|2017-10-11 04:33:59.669294
NCT00031824|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2014-02-12|||April 2002||2002-04-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|May 2005|Actual|2005-05-01||Interventional|||Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease|Phase III Trial of Hydroxychloroquine + Standard Therapy for Chronic Graft-Versus-Host Disease|Completed||Phase 3|82|Actual|Children's Oncology Group|||||f||||t||||||||||2017-10-11 04:33:59.755939|2017-10-11 04:33:59.755939
NCT00031837|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2015-10-13|||October 2002||2002-10-01|October 2015|2015-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer|A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer|Terminated||Phase 3|400|Anticipated|University of Rochester||1|||f||||||||||||||2017-10-11 04:34:00.181375|2017-10-11 04:34:00.181375
NCT00031850|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-06-25|||March 2000||2000-03-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer|A Randomized Trial Of Raloxifene Plus Zoladex For Prevention Of Breast Cancer|Completed||N/A|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:00.321084|2017-10-11 04:34:00.321084
NCT00031863|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-08-01|||February 2001||2001-02-01|June 2002|2002-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer|Phase III, Randomized, Double Blind, Placebo Controlled Study of Rofecoxib in Colorectal Cancer Patients Following Adjuvant Chemotherapy|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:00.426541|2017-10-11 04:34:00.426541
NCT00031876|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2012-05-14|||May 2000||2000-05-01|May 2012|2012-05-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer|Phase I/II Trial of Capecitabine With Weekly Paclitaxel for Advanced Breast Cancer|Completed||Phase 1/Phase 2|34|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 04:34:00.531232|2017-10-11 04:34:00.531232
NCT00031889|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2012-05-14|||August 2001||2001-08-01|May 2012|2012-05-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer|A Randomized Phase II Trial of Exemestane With and Without Bicalutamide as Second Line Therapy After Failure of Androgen Suppression in Advanced Prostate Cancer|Completed||Phase 2|5|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 04:34:00.628348|2017-10-11 04:34:00.628348
NCT00031902|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-09-19|||October 2001||2001-10-01|February 2003|2003-02-01||||||||Interventional|||Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma|Rituxumab Combined With Chemotherapy (PVB) For Poor Prognosis HIV-Related Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:00.736115|2017-10-11 04:34:00.736115
NCT00031915|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-06-17|||June 2002||2002-06-01|October 2003|2003-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma|Phase II Trial of Gleevec (Formerly Known as STI571) in Patients With Soft Tissue and Bone Sarcomas: A Multi-Disciplinary Trial of the North American Sarcoma Study Group of the Connective Tissue Oncology Society|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:00.806221|2017-10-11 04:34:00.806221
NCT00031928|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2015-04-29|||January 2002||2002-01-01|November 2003|2003-11-01||||||||Interventional|||Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors|Phase I Study of Intrathecal Mafosfamide|Completed||Phase 1|3000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:00.904924|2017-10-11 04:34:00.904924
NCT00031941|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2012-03-14|||April 2002||2002-04-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|September 2007|Actual|2007-09-01||Interventional|||CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy|A Multidose Phase I Study of Oral CC5013, a Thalidomide Derivative, in Patients With Refractory Metastatic Cancer|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:34:00.99179|2017-10-11 04:34:00.99179
NCT00031954|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2015-12-22|||August 2001||2001-08-01|December 2015|2015-12-01||||April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|A Phase II Study Of Paclitaxel, Carboplatin And Gemcitabine In Previously Untreated Patients With Epithelial Ovarian Carcinoma FIGO Stage IIB-IV|Completed||Phase 2|105|Actual|AGO Study Group||1|||f||||||||||||||2017-10-11 04:34:01.101118|2017-10-11 04:34:01.101118
NCT00031967|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-11-18|||May 2002||2002-05-01|November 2013|2013-11-01||||March 2004|Actual|2004-03-01||Interventional|||Melatonin and Radiation Therapy in Treating Patients With Brain Metastases|A Randomized Phase II Study of A.M. and P.M. Melatonin for Brain Metastasis in RPA Class II Patients|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:34:01.235323|2017-10-11 04:34:01.235323
NCT00031980|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-07-01|||March 2002||2002-03-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer|Phase II Study of Cyclosporine in T-Cell Large Granular Lymphocytic Leukemia|Completed||Phase 2|30|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:34:02.054438|2017-10-11 04:34:02.054438
NCT00031993|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-01-16|||March 2002||2002-03-01|January 2013|2013-01-01||||November 2005|Actual|2005-11-01||Interventional|||Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix|A Phase II Evaluation Of OSI-774 (NSC #718781) In The Treatment Of Persistent or Recurrent Squamous Cell Carcinoma Of The Cervix|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:02.153438|2017-10-11 04:34:02.153438
NCT00032006|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-07-12|||February 2002||2002-02-01|July 2016|2016-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer|A Trial Of Neoadjuvant Androgen Supression And Dose Escalation Transperineal Ultrasound-Guided Brachytherapy For Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:34:02.341032|2017-10-11 04:34:02.341032
NCT00032019|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-07-15|||February 2002||2002-02-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|Phase II Study Of Dose-Adjusted Epoch-Rituximab (EPOCH-R) Chemotherapy For Patients With Previously Untreated Aggressive CD20+ B-Cell Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|78|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:34:02.478988|2017-10-11 04:34:02.478988
NCT00032032|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-11-30|||May 2002||2002-05-01|November 2016|2016-11-01|January 2010|Actual|2010-01-01|January 2008|Actual|2008-01-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm|Completed||Phase 1|69|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:34:02.762715|2017-10-11 04:34:02.762715
NCT00032045|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-06-18|||January 2002||2002-01-01|March 2003|2003-03-01|August 2006|Actual|2006-08-01|||||Interventional|||Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma|An Open-label Study Of MDX-010 In Combination With gp100 Peptides Emulsified With Montanide ISA 51 In The Treatment Of Patients With Stage IV Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:34:02.977748|2017-10-11 04:34:02.977748
NCT00032058|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2011-02-18|||June 2003||2003-06-01|April 2005|2005-04-01||||June 2006|Actual|2006-06-01||Interventional|||Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer|MR Imaging And MR Spectroscopic Imaging Of Prostate Cancer Prior To Radical Prostatectomy: A Prospective Multi-Institutional Clinicopathological Study|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:03.082166|2017-10-11 04:34:03.082166
NCT00032084|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-03-08|||January 2002||2002-01-01|March 2013|2013-03-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery|Smoking Cessation Intervention (Including Bupropion-Zyban Versus Placebo) for Completely Resected Stage I and II Non-Small Cell Lung Cancer Survivors Who Are Current Smokers|Terminated||Phase 3|10|Actual|Southwest Oncology Group||2||This study was closed early due to poor accrual|f||||t||||||||||2017-10-11 04:34:03.227034|2017-10-11 04:34:03.227034
NCT00032097|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2009-02-06|||April 2002||2002-04-01|January 2004|2004-01-01||||||||Interventional|||Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain|A Phase I Trial To Evaluate Repetitive Intravenous Doses Of Gadolinium-Texaphyrin As A Radiosensitizer In Patients With Glioblastoma Multi Forme|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:03.715021|2017-10-11 04:34:03.715021
NCT00032110|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2015-04-14|||January 2002||2002-01-01|January 2013|2013-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer|A Phase II Study of OSI-774 in Metastatic Colorectal Cancer|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:03.781795|2017-10-11 04:34:03.781795
NCT00032123|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-06-21|||June 2002||2002-06-01|October 2003|2003-10-01|May 2006|Actual|2006-05-01|||||Interventional|||Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer|A Phase II Study Of OSI-774 (NSC 718781) In Unresectable Or Metastatic Adenocarcinoma Of The Stomach And Gastroesophageal Junction|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:03.883495|2017-10-11 04:34:03.883495
NCT00032136|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-08-01|||December 2001||2001-12-01|March 2007|2007-03-01|April 2009|Actual|2009-04-01|||||Interventional|||Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer|An Open Label, Randomized Multicenter Comparative Trial Of 5 Years Adjuvant Exemestane Treatment Versus 5 Years Adjuvant Tamoxifen Treatment In Postmenopausal Women With Early Breast Cancer|Completed||Phase 3|4400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:04.298164|2017-10-11 04:34:04.298164
NCT00032149|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-09-19|||October 2001||2001-10-01|March 2007|2007-03-01||||||||Interventional|||Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma|Pilot Study Of PMitCEBO Plus G-CSF In Good-Prognosis HIV-Related Lymphoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:04.384835|2017-10-11 04:34:04.384835
NCT00032162|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2012-05-29|||August 2001||2001-08-01|May 2012|2012-05-01||||May 2005|Actual|2005-05-01||Interventional|||Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer|Phase I/II Trial, Dose Finding Combination Chemotherapy With PegLiposomal Doxorubicin (PLD) And Carboplatin In Patients With Gynecologic Tumors|Completed||Phase 1/Phase 2|63|Actual|AGO Study Group||1|||f||||t||||||||||2017-10-11 04:34:04.479067|2017-10-11 04:34:04.479067
NCT00032175|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-06-25|||April 2002||2002-04-01|April 2007|2007-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase III Multicenter Randomized Clinical Trial Comparing Gemcitabine Alone Or In Combination With Capecitabine For The Treatment Of Patients With Advanced Pancreatic Cancer|Completed||Phase 3|508|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:04.67926|2017-10-11 04:34:04.67926
NCT00032188|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-01-23|||January 2002||2002-01-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer|A Randomized Phase II Study Of Interluekin-2 In Combination With Three Different Doses Of Bryostatin In Patients With Renal Cell Carcinoma|Completed||Phase 2|65|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:34:04.937957|2017-10-11 04:34:04.937957
NCT00032201|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-09|2017-10-05|||March 6, 2002||2002-03-06|December 3, 2014|2014-12-03|December 3, 2014||2014-12-03|||||Observational|||Cell Lines From High-Risk Breast Tissue|Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository From Breast Tissue From Women at High Risk of Breast Cancer|Completed||N/A|43|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:05.097305|2017-10-11 04:34:05.097305
NCT00032227|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-12|2013-05-04|||August 2002||2002-08-01|May 2013|2013-05-01|April 2008|Actual|2008-04-01|April 2007|Actual|2007-04-01||Interventional|||Carpal Tunnel Syndrome: Diagnosis and Treatment Trial|Carpal Tunnel Syndrome: Diagnosis and Treatment Trial|Completed||N/A|116|Actual|University of Washington||2|||f||||||||||||||2017-10-11 04:34:05.200691|2017-10-11 04:34:05.200691
NCT00032240|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-12|2013-06-02|||February 2002||2002-02-01|June 2013|2013-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Shoe Inserts for Treating Osteoarthritis of the Knee|Randomized Trial of a Wedged Insole for Treatment of Osteoarthritis of the Knee|Completed||Phase 3|90||Boston University|||||f||||||||||||||2017-10-11 04:34:05.368225|2017-10-11 04:34:05.368225
NCT00032279|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-15|2005-06-23|||March 2002||2002-03-01|October 2003|2003-10-01||||||||Interventional|||Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease|A Phase II, Multicenter Clinical Trial Evaluating the Use of Humanized Monoclonal Anti-CD3 Antibody Visilizumab(Nuvion) as Second-line Therapy for Glucocorticoid-Refractory, Acute Graft-Versus-Host Disease|Unknown status|Active, not recruiting|Phase 2|80||Facet Biotech|||||||||||||||||||2017-10-11 04:34:05.471593|2017-10-11 04:34:05.471593
NCT00032292|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-14|2012-03-09|||March 2002||2002-03-01|March 2012|2012-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease|A Phase I/II, Open-Label, Dose-Escalation, Pilot Study to Evaluate Safety and Preliminary Efficacy of Visilizumab as Primary Therapy for Acute Graft-Versus-Host Disease After Hematopoietic Cell Transplantation|Completed||Phase 1/Phase 2|34||Facet Biotech|||||f||||||||||||||2017-10-11 04:34:05.64084|2017-10-11 04:34:05.64084
NCT00032305|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-14|2012-03-06|||March 2002||2002-03-01|March 2012|2012-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Research Study in Patients With Severe Ulcerative Colitis|A Phase I, Dose-Escalation, Pilot Study of Visilizumab in Patients With Severe Ulcerative Colitis That is Refractory to Corticosteroids|Completed||Phase 2/Phase 3|20||Facet Biotech|||||f||||||||||||||2017-10-11 04:34:05.755697|2017-10-11 04:34:05.755697
NCT00032331|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-18|2009-01-20|||January 1999||1999-01-01|January 2004|2004-01-01|June 2003||2003-06-01|||||Interventional|||(PET) Imaging in the Management of Patients With Solitary Pulmonary Nodules|18/F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET) IMAGING IN THE MANAGEMENT OF PATIENTS WITH SOLITARY PULMONARY NODULES|Completed||Phase 3|500||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:34:05.870291|2017-10-11 04:34:05.870291
NCT00032344|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-18|2010-11-19|||October 1993||1993-10-01|November 2010|2010-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps|CSP #380 - Prospective Evaluation of Risk Factors for Large (> 1 CM) Colonic Adenomas in Asymptomatic Subjects|Completed||Phase 3|3200|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-10-11 04:34:05.950772|2017-10-11 04:34:05.950772
NCT00032357|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-19|2013-01-18|||May 1999||1999-05-01|January 2013|2013-01-01|September 2005|Actual|2005-09-01|April 2005|Actual|2005-04-01||Interventional|FeAST||Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?|CSP #410 - The Iron (Fe) and Atherosclerosis Study (FeAST)|Completed||Phase 3|1277|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:34:06.100914|2017-10-11 04:34:06.100914
NCT00032370|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-19|2015-06-25|||August 1997||1997-08-01|June 2015|2015-06-01|May 2004|Actual|2004-05-01|February 2004|Actual|2004-02-01||Interventional|CARP||Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality|CSP #411 - The Coronary Artery Revascularization Prophylaxis (CARP) Trial|Completed||N/A|510|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:34:06.29312|2017-10-11 04:34:06.29312
NCT00032409|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-20|2006-08-17|||August 2001||2001-08-01|July 2006|2006-07-01|June 2004||2004-06-01|||||Interventional|||The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant Recipients|The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant Recipients|Completed||Phase 2|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:06.590959|2017-10-11 04:34:06.590959
NCT00032422|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-20|2006-08-17|||July 2001||2001-07-01|July 2006|2006-07-01|June 2003||2003-06-01|||||Interventional|||Acupuncture in Cardiovascular Disease|Acupuncture in Cardiovascular Disease|Completed||Phase 2|200||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:06.668766|2017-10-11 04:34:06.668766
NCT00032435|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-20|2010-10-14|||May 2001||2001-05-01|October 2010|2010-10-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Homocysteine Study (HOST)|CSP #453 - Homocysteinemia in Kidney and Endstage Renal Disease Study (HOST)|Completed||Phase 3|2003|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:34:06.764919|2017-10-11 04:34:06.764919
NCT00032448|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-20|2011-04-13|||October 1998||1998-10-01|April 2011|2011-04-01|June 2004|Actual|2004-06-01|December 2003|Actual|2003-12-01||Interventional|||Does Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients?|CSP #456 - Tension Free Inguinal Hernia Repair: Comparison of Open and Laparoscopic Surgical Techniques|Completed||Phase 3|2200|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:34:07.194697|2017-10-11 04:34:07.194697
NCT00032461|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-20|2009-01-20|||November 1998||1998-11-01|March 2007|2007-03-01|April 2001||2001-04-01|||||Observational|||Compare the Medical Conditions of Gulf War Veterans to Non-Deployed Veterans|National Health Survey of Gulf War Era Veterans and Their Families - Phase III Physical Examinations|Completed||N/A|2000||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:34:07.306901|2017-10-11 04:34:07.306901
NCT00032474|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-21|2006-08-17|||December 2001||2001-12-01|July 2006|2006-07-01|May 2005||2005-05-01|||||Interventional|||Ginkgo Biloba Extract and the Insulin Resistance Syndrome|Ginkgo Biloba Extract and the Insulin Resistance Syndrome|Completed||Phase 1/Phase 2|150||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:07.379402|2017-10-11 04:34:07.379402
NCT00032487|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-21|2017-02-28|2013-09-10||December 1, 2000|Actual|2000-12-01|February 2017|2017-02-01|May 30, 2008|Actual|2008-05-30|May 30, 2008|Actual|2008-05-30||Interventional|VADT||Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)|CSP #465 - Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)|Completed||Phase 3|1791|Actual|VA Office of Research and Development|Our study had several limitations. Since we were studying veterans, the patients were predominantly men, and extrapolation of our findings to women must be done with caution.Changes in therapeutic agents have occurred since the design of our protocol|2|||f||||t||||||||No||2017-10-11 04:34:07.474106|2017-10-11 04:34:07.474106
NCT00032500|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-22|2006-08-17|||September 2001||2001-09-01|July 2006|2006-07-01|May 2004||2004-05-01|||||Interventional|||Evaluation of Echinacea for the Common Cold|Evaluation of Echinacea in a Human Rhinovirus Challenge|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:08.055436|2017-10-11 04:34:08.055436
NCT00032513|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-22|2017-10-05|||March 15, 2002||2002-03-15|July 11, 2017|2017-07-11||||||||Observational|||Genetic Studies of Chronic Active Epstein-Barr Disease|Genetic Studies of Chronic Active Epstein-Barr Virus Infection|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:08.134358|2017-10-11 04:34:08.134358
NCT00032526|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-25|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Classical Conditioning to Treat Allergic Airway Diseases|Classical Conditioning to Treat Allergic Airway Diseases|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:34:08.236767|2017-10-11 04:34:08.236767
NCT00032539|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2012-03-14|||April 1999||1999-04-01|March 2012|2012-03-01|April 1999|Actual|1999-04-01|April 1999|Actual|1999-04-01||Observational|||EQUIC-CC: Enhancing Quality of Informed Consent - Customized Consent|CSP #476CC - Enhancing Quality of Informed Consent (EQUIC-CC) Customized Consent|Completed||N/A|240|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:34:08.317436|2017-10-11 04:34:08.317436
NCT00032552|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2010-03-23|||April 1999||1999-04-01|March 2010|2010-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Enhancing Quality of Informed Consent (EQUIC-DP) Developmental Phase|CSP #476DP - Enhancing Quality of Informed Consent (EQUIC-DP) Developmental Phase|Completed||N/A|632|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:34:08.401739|2017-10-11 04:34:08.401739
NCT00032565|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2010-09-22|||November 2002||2002-11-01|September 2010|2010-09-01|March 2008|Actual|2008-03-01|July 2007|Actual|2007-07-01||Observational|EQUIC||EQUIC-SM: Enhancing Quality of Informed Consent|CSP #476SM - Enhancing Quality of Informed Consent (EQUIC-SM) Self-Monitoring|Completed||N/A|836|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:34:08.520043|2017-10-11 04:34:08.520043
NCT00032578|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2009-01-20|||January 2000||2000-01-01|June 2006|2006-06-01||||||||Observational|||VA Genetic Tissue Banking|CSP #478 (FeAST-DNA), Genetic Tissue Banking in VA Clinical Research: A Cooperative Studies Program Demonstration Project|Completed||N/A|1000||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:34:08.63161|2017-10-11 04:34:08.63161
NCT00032591|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2014-03-18|2013-06-12||August 2003||2003-08-01|March 2014|2014-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|THINRS|3745 participants were screened for participation|The Home INR Study|CSP #481 - The Home INR Study (THINRS)|Completed||Phase 4|2922|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:34:08.733497|2017-10-11 04:34:08.733497
NCT00032617|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2010-09-22|||August 2002||2002-08-01|September 2010|2010-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Randomized Clinical Trial of Cognitive-Behavioral Treatment for Post-Traumatic Stress Disorders in Women|CSP #494 - A Randomized Clinical Trial of Cognitive-Behavioral Treatment for PTSD in Women (PTSD)|Completed||Phase 3|284|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:34:11.934585|2017-10-11 04:34:11.934585
NCT00032630|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2014-04-18|2013-08-08||April 2002||2002-04-01|April 2014|2014-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|ROOBY||Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass|CSP #517 - Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass|Completed||Phase 3|2203|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:34:12.059253|2017-10-11 04:34:12.059253
NCT00032643|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2013-11-04|||June 2004||2004-06-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)|CSP #526 - A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)|Terminated||Phase 2|150|Anticipated|VA Office of Research and Development||1||Funding support withdrawn (much slower than expected enrollment)|f||||f||||||||||2017-10-11 04:34:12.368774|2017-10-11 04:34:12.368774
NCT00032656|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2006-08-17|||February 2001||2001-02-01|July 2006|2006-07-01|December 2003||2003-12-01|||||Observational|||Adolescents' Use of Complementary and Alternative Medicine|Adolescents' Use of Complementary and Alternative Medicine|Completed||N/A|1400||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:12.454735|2017-10-11 04:34:12.454735
NCT00032669|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2008-03-03|||March 2002||2002-03-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children|Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children|Completed||Phase 1|34||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:12.5149|2017-10-11 04:34:12.5149
NCT00032682|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-27|2008-03-03|||March 2002||2002-03-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Observational|||Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or Narcotics|A Pilot Study Evaluating the Assessment Process for Constipation in Pediatric Oncology Patients Who Are Receiving Vinca Alkaloids and/or Narcotics|Completed||N/A|34||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:12.583716|2017-10-11 04:34:12.583716
NCT00032695|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-28|2006-05-12||||||November 2005|2005-11-01||||||||Interventional|||Treatment of AIDS Vacuolar Myelopathy With Methionine||Completed||Phase 3|56||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:34:12.66019|2017-10-11 04:34:12.66019
NCT00032708|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-28|2010-08-26|||April 2004||2004-04-01|May 2006|2006-05-01|November 2004||2004-11-01|||||Interventional|||Dryvax Dilution-Prev Vacc Adults|A Double Blind, Randomized Dose Response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:34:12.7248|2017-10-11 04:34:12.7248
NCT00032721|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-29|2006-08-17|||March 2002||2002-03-01|July 2006|2006-07-01|September 2003||2003-09-01|||||Interventional|||The Use of Reiki for Patients With Advanced AIDS|The Use of Reiki for Patients With Advanced AIDS|Completed||Phase 2|146||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:12.778029|2017-10-11 04:34:12.778029
NCT00032734|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-29|2008-06-16|||June 2001||2001-06-01|June 2008|2008-06-01|July 2003|Actual|2003-07-01|||||Interventional|||Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation, Multicenter Study Evaluating the Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion.|Completed||Phase 2|35|Actual|Sanofi|||||||||||||||||||2017-10-11 04:34:12.842104|2017-10-11 04:34:12.842104
NCT00032747|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-29|2008-06-16|||August 2001||2001-08-01|June 2008|2008-06-01|February 2003|Actual|2003-02-01|||||Interventional|||Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Effects of Vasopressin V2 Receptor Antagonist on Clinical Improvement in Patients With Severe Chronic Heart Failure|Completed||Phase 2|338|Actual|Sanofi|||||||||||||||||||2017-10-11 04:34:13.051794|2017-10-11 04:34:13.051794
NCT00032760|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-01|2007-09-28|||March 2002||2002-03-01|September 2007|2007-09-01|March 2004|Actual|2004-03-01|||||Interventional|||Meditation-Based Treatment for Binge Eating Disorder|Meditation-Based Treatment for Binge Eating Disorder|Completed||Phase 2/Phase 3|160||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:13.161137|2017-10-11 04:34:13.161137
NCT00032773|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-02|2009-10-12||||||June 2005|2005-06-01||||||||Interventional|||Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD|A Sequentially Adaptive, Open Label, Dose-finding, Phase I/II Trial of Pentostatin in the Treatment of Steroid-refractory Acute Graft Versus Host Disease (aGvHD)|Terminated||Phase 1/Phase 2|36||Astex Pharmaceuticals|||||||||||||||||||2017-10-11 04:34:13.232176|2017-10-11 04:34:13.232176
NCT00032786|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-03|2016-06-14|||March 2002||2002-03-01|March 2012|2012-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease|A Phase 3, International, Multicenter, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Intravenous Antegren (Natalizumab) in Maintaining Clinical Response and Remission in Subjects With Crohn's Disease|Completed||Phase 3|||Biogen|||||||||||||||||||2017-10-11 04:34:13.297791|2017-10-11 04:34:13.297791
NCT00032799|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-03|2016-06-14|||December 2001||2001-12-01|March 2012|2012-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease|A Phase 3 International, Multicenter, Double-blind, Placebo-controlled Study of the Safety, Efficacy, and Tolerability of Intravenous Antegren (Natalizumab) in Subjects With Moderate to Severely Active Crohn's Disease|Completed||Phase 3|905|Actual|Biogen|||||||||||||||||||2017-10-11 04:34:13.358004|2017-10-11 04:34:13.358004
NCT00032812|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-03|2008-03-03|||March 2002||2002-03-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Observational|||The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease|Motor Memory: Study of the Role of Dopamine in Healthy Subjects and Patients With Parkinson's Disease Using PET and EEG|Completed||N/A|64||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:13.416694|2017-10-11 04:34:13.416694
NCT00032825|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-03|2017-10-05|||March 19, 2002||2002-03-19|May 4, 2012|2012-05-04|June 13, 2011|Actual|2011-06-13|||||Interventional|||Ketoconazole Plus Docetaxel to Treat Prostate Cancer|A Phase I Trial of High Dose Ketoconazole Plus Weekly Docetaxel in Metastatic Androgen Independent Prostate Cancer|Completed||Phase 1|480|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:34:13.484142|2017-10-11 04:34:13.484142
NCT00032838|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-03|2008-03-03|||March 2002||2002-03-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Effects of Stress Hormones on Emotion and Cognition|The Effects of Cortisol and Norepinephrine Modulation on Emotional and Nonemotional Processing|Completed||N/A|170||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:13.553181|2017-10-11 04:34:13.553181
NCT00032864|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-04|2009-01-20|||January 1997||1997-01-01|February 2003|2003-02-01|September 2000||2000-09-01|||||Observational|||Clinical Trial of Footwear in Patients With Diabetes|Clinical Trial of Footwear in Patients With Diabetes|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:34:13.615938|2017-10-11 04:34:13.615938
NCT00032877|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-04|2008-03-03|||April 2002||2002-04-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||Genetic Analysis of Fraser Syndrome and Fryns Syndrome|Molecular Genetic Analysis of Fraser Syndrome and Fryns Syndrome|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:13.665386|2017-10-11 04:34:13.665386
NCT00032890|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2009-01-20|||April 2000||2000-04-01|November 2006|2006-11-01|February 2004||2004-02-01|||||Interventional|||Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)|Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)|Completed||Phase 3|1588||VA Office of Research and Development|||||||||||||||||||2017-10-11 04:34:13.733498|2017-10-11 04:34:13.733498
NCT00032903|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2009-06-02|||March 2002||2002-03-01|June 2009|2009-06-01|October 2005|Actual|2005-10-01|||||Interventional|||This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.|Oral ST1481 in Adults With Malignant Glioma: a Phase I-II Clinical Trial|Completed||Phase 1/Phase 2|59|Anticipated|Sigma-Tau Research, Inc.|||||||||||||||||||2017-10-11 04:34:13.841288|2017-10-11 04:34:13.841288
NCT00032916|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-10|||June 2001||2001-06-01|April 2004|2004-04-01|December 2002||2002-12-01|||||Interventional|||Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1|Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers|Unknown status|Active, not recruiting|Phase 1|24||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:34:13.906313|2017-10-11 04:34:13.906313
NCT00032929|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||March 2001||2001-03-01|May 2009|2009-05-01||||December 2002|Actual|2002-12-01||Interventional|||Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1|Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence|Completed||Phase 3|269|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-10-11 04:34:14.471731|2017-10-11 04:34:14.471731
NCT00032942|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||April 2001||2001-04-01|July 2008|2008-07-01||||October 2004|Actual|2004-10-01||Interventional|||Lofexidine for Opiate Withdrawal - 1|A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal|Completed||Phase 3|66||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:34:14.583339|2017-10-11 04:34:14.583339
NCT00032955|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||February 2001||2001-02-01|April 2010|2010-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1|Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification|Completed||Phase 3|163||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:34:14.701405|2017-10-11 04:34:14.701405
NCT00032968|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||January 2001||2001-01-01|April 2010|2010-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1|Buprenorphine/Naloxone Versus Clonidine For Out-patient Opiate Detoxification|Completed||Phase 3|341||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:34:14.808551|2017-10-11 04:34:14.808551
NCT00032981|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||May 2001||2001-05-01|April 2010|2010-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1|Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse|Completed||Phase 3|561||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:34:14.925425|2017-10-11 04:34:14.925425
NCT00032994|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||April 2001||2001-04-01|April 2010|2010-04-01|October 2002||2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1|Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse|Completed||Phase 3|422||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:34:15.020999|2017-10-11 04:34:15.020999
NCT00033007|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||April 2001||2001-04-01|April 2010|2010-04-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1|Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics|Completed||Phase 3|440||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:34:15.113198|2017-10-11 04:34:15.113198
NCT00033020|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||April 2001||2001-04-01|April 2010|2010-04-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1|Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics|Completed||Phase 3|390||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:34:15.232944|2017-10-11 04:34:15.232944
NCT00033033|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||July 2001||2001-07-01|August 2008|2008-08-01|May 2003||2003-05-01|||||Interventional|||Reserpine for the Treatment of Cocaine Dependence - 1|Phase 2, Double-Blind, Placebo-Controlled Trial of Reserpine for the Treatment of Cocaine Dependence|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:34:15.418044|2017-10-11 04:34:15.418044
NCT00033046|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-10|||June 2001||2001-06-01|May 2004|2004-05-01|April 2002||2002-04-01|||||Interventional|||Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1|Safety Evaluation of Cocaine Treatment Medication Modafinil: Interactions With Intravenous Cocaine|Unknown status|Active, not recruiting|Phase 1|12||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:34:15.511679|2017-10-11 04:34:15.511679
NCT00033059|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-10|||July 2001||2001-07-01|August 2003|2003-08-01|March 2002||2002-03-01|||||Interventional|||Assessment of Potential Interactions Between Cocaine and Tolcapone - 1|Assessment of Potential Interactions Between Intravenous Cocaine and Tolcapone|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:34:15.580556|2017-10-11 04:34:15.580556
NCT00033072|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-10|||September 2001||2001-09-01|November 2003|2003-11-01|October 2002||2002-10-01|||||Interventional|||Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1|Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:34:15.642798|2017-10-11 04:34:15.642798
NCT00033085|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||May 2001||2001-05-01|July 2008|2008-07-01|December 2002||2002-12-01|||||Interventional|||Ondansetron for the Treatment of Cocaine Dependence - 1|Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence|Completed||Phase 2|60||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:34:15.8065|2017-10-11 04:34:15.8065
NCT00033098|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-10|||November 2001||2001-11-01|August 2003|2003-08-01|May 2002||2002-05-01|||||Interventional|||Cocaine-Metyrapone Interaction Study - 1|Cocaine-Metyrapone Interaction Study|Unknown status|Active, not recruiting|Phase 1|12||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:34:15.876268|2017-10-11 04:34:15.876268
NCT00033111|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-11|||June 2001||2001-06-01|October 2016|2016-10-01|April 2004|Actual|2004-04-01|||||Interventional|||A Study of Cabergoline for the Treatment of Cocaine Dependence - 1|Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence|Completed||Phase 2|140|Actual|National Institute on Drug Abuse (NIDA)||2|||||||t||||||||||2017-10-11 04:34:16.001207|2017-10-11 04:34:16.001207
NCT00033124|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-01-10|||July 2001||2001-07-01|August 2003|2003-08-01|June 2002||2002-06-01|||||Interventional|||A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1|Behavioral Trial for the Treatment of Methamphetamine Dependence|Unknown status|Active, not recruiting|Phase 2|50||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:34:16.103794|2017-10-11 04:34:16.103794
NCT00033137|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-05|2017-10-05|||April 3, 2002||2002-04-03|February 28, 2017|2017-02-28||||||||Observational|||Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer|The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:16.189189|2017-10-11 04:34:16.189189
NCT00033150|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-08|2006-04-21|||June 2002||2002-06-01|April 2006|2006-04-01|January 2005||2005-01-01|||||Interventional|||A Comparison of Language Intervention Programs|A Comparison of Language Intervention Programs|Completed||Phase 3|216||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-10-11 04:34:16.276119|2017-10-11 04:34:16.276119
NCT00033163|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-08|2012-05-17||||||May 2012|2012-05-01|May 2005|Actual|2005-05-01|||||Interventional|||A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV|A Randomized, Phase II, Controlled Trial Comparing the Efficacy of Adefovir Dipivoxil and Tenofovir Disoproxil Fumarate for the Treatment of Lamivudine-Resistant Hepatitis B Virus in Subjects Who Are Co-Infected With HIV|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:34:16.347551|2017-10-11 04:34:16.347551
NCT00033176|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-08|2006-08-17|||February 2002||2002-02-01|July 2006|2006-07-01|August 2004||2004-08-01|||||Interventional|||Immune Restoration by Lipoic Acid in AIDS|Immune Restoration by Lipoic Acid in AIDS|Completed||Phase 2|33||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:16.477756|2017-10-11 04:34:16.477756
NCT00033189|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-08|2010-11-15|||September 2001||2001-09-01|November 2010|2010-11-01|January 2005||2005-01-01|||||Interventional|||An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy||Completed||Phase 2|15||Cooperative International Neuromuscular Research Group|||||||||||||||||||2017-10-11 04:34:16.575053|2017-10-11 04:34:16.575053
NCT00033202|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2009-06-02|||March 2002||2002-03-01|June 2009|2009-06-01|February 2005|Actual|2005-02-01|||||Interventional|||This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor|Phase I Study of Oral ST1481 Administered Once Weekly Every 3 Out 4 Weeks in Patients With Advanced Solid Malignancies.|Completed||Phase 1|30|Anticipated|Sigma-Tau Research, Inc.|||||||||||||||||||2017-10-11 04:34:16.661974|2017-10-11 04:34:16.661974
NCT00033215|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2005-06-23|||November 2001||2001-11-01|November 2003|2003-11-01|October 2003||2003-10-01|||||Interventional|||A Phase 1 Study of S-3304 in Patients With Solid Tumors|A Phase 1 Study of S-3304 in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|28||Shionogi|||||||||||||||||||2017-10-11 04:34:16.749099|2017-10-11 04:34:16.749099
NCT00033228|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2011-05-11|||January 2002||2002-01-01|May 2011|2011-05-01|April 2003|Actual|2003-04-01|March 2003|Actual|2003-03-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|A Phase I/II Pilot Study Of Intranodal Delivery Of A Plasmid DNA (Synchrovax SEM Vaccine) In Stage IV Melanoma Patients|Completed||Phase 1/Phase 2|19|Actual|Mannkind Corporation||3|||||||f||||||||||2017-10-11 04:34:16.842221|2017-10-11 04:34:16.842221
NCT00033241|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2015-06-12|||June 2001||2001-06-01|June 2015|2015-06-01|April 2004|Actual|2004-04-01|||||Interventional|||Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors|A Phase Ib Multicenter Trial To Determine The Safety, Tolerance And Preliminary Antineoplastic Activity Of Gemcitabine Administered In Combination With Escalating Oral Doses Of OSI-774 To Patient Cohorts With Recently Diagnosed, Gemcitabine-Naive, Advanced Pancreatic Carcinoma Or Other Potentially Responsive Malignancies|Completed||Phase 1|||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:34:16.972351|2017-10-11 04:34:16.972351
NCT00033254|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-06-05|||March 2002||2002-03-01|June 2013|2013-06-01||||May 2006|Actual|2006-05-01||Interventional|||Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases|A Phase III Study of Conventional Radiation Therapy Plus Thalidomide (NSC#66847) Versus Conventional Radiation Therapy for Multiple Brain Metastases|Completed||Phase 3|332|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:34:17.059461|2017-10-11 04:34:17.059461
NCT00033267|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2014-04-02|||April 2002||2002-04-01|December 2012|2012-12-01|February 2008|Actual|2008-02-01|February 2006|Actual|2006-02-01||Interventional|||CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma|A Phase II Study of CCI-779 in Previously Treated Patients With Mantle Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:17.167236|2017-10-11 04:34:17.167236
NCT00033280|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2017-03-09|||July 2002||2002-07-01|March 2017|2017-03-01||||April 2005|Actual|2005-04-01||Interventional|||Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas|A Phase II Trial Of Pre-Irradiation And Concurrent Temozolomide In Patients With Newly Diagnosed Anaplastic Oligodendrogliomas And Mixed Anaplastic Oligoastrocytomas|Active, not recruiting||Phase 2|42|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||No||2017-10-11 04:34:17.281417|2017-10-11 04:34:17.281417
NCT00033293|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2017-04-18|2016-01-28||March 2004||2004-03-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma|A Pilot Study Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone|Completed||Phase 3|53|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:34:17.515064|2017-10-11 04:34:17.515064
NCT00033306|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-08-01|||February 2002||2002-02-01|August 2013|2013-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||BMS-247550 in Treating Patients With Metastatic Colorectal Cancer|A Phase II Study Of Epothilone Analog BMS-247550 In Patients With Metastatic Colorectal Cancer Previously Treated With A Fluoropyrimidine And Irinotecan|Terminated||Phase 2|2|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:34:18.637997|2017-10-11 04:34:18.637997
NCT00033319|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-09-16|||May 1997||1997-05-01|December 2002|2002-12-01||||||||Interventional|||Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps|UKCAP Trial: A Multi-Center Double Blind Randomised Controlled Trial Of Aspirin And/Or Folate Supplementation For the Prevention Of Recurrent Colorectal Adenomas|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:18.875295|2017-10-11 04:34:18.875295
NCT00033332|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2014-04-02|||April 2002||2002-04-01|November 2005|2005-11-01|June 2006|Actual|2006-06-01|March 2006|Actual|2006-03-01||Interventional|||Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma|A Randomized Phase III Trial Of Thalidomide (NSC # 66847) Plus Dexamethasone Versus Dexamethasone In Newly Diagnosed Multiple Myeloma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:19.144348|2017-10-11 04:34:19.144348
NCT00033345|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-08-17|||January 2002||2002-01-01|August 2016|2016-08-01||||July 2008|Actual|2008-07-01||Interventional|||Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer|Multiple Daily Dose Phase I Safety And Pharmacokinetic Clinical Study Of Indole-3-Carbinol|Completed||Phase 1|17|Actual|University of Kansas Medical Center||1|||f||||||||||||||2017-10-11 04:34:19.490481|2017-10-11 04:34:19.490481
NCT00033358|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-05-02|||February 2002||2002-02-01|April 2013|2013-04-01||||October 2007|Actual|2007-10-01||Interventional|||Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer|Modulation Of Putative Surrogate Endpoint Biomarkers In Endometrial Biopsies From Women With HNPCC|Completed||Phase 2|52|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:34:19.635384|2017-10-11 04:34:19.635384
NCT00033371|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-12-28|2015-01-26||December 2001||2001-12-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|April 2009|Actual|2009-04-01||Interventional||According to the protocol, a patient needed to receive at least 80% of intended overall dose AND at least 80% dose during the final 60 days of the study to qualify as evaluable. One participant was randomized to Arm II but withdrew prior to receiving any treatment.|Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis|A Two-Arm Phase II Chemoprevention Trial in Adenomatous Polyposis Coli Patients|Terminated||Phase 2|112|Actual|National Cancer Institute (NCI)|Following reports of COX-2 inhibitor-associated cardiovascular toxicities, trial suspended from December 17, 2004 to March 18, 2005 pending reevaluation of cardiovascular risks, only two sites resumed the trial.|2||Slow recruitment.|f||||t||||||||||2017-10-11 04:34:19.788837|2017-10-11 04:34:19.788837
NCT00033384|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-04-10|||February 2002||2002-02-01|December 2002|2002-12-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer|A Multicenter Phase 2 Study of CI-1040 In Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer Or Pancreatic Cancer|Completed||Phase 2|||University of Alabama at Birmingham|||||f||||t||||||||||2017-10-11 04:34:21.010072|2017-10-11 04:34:21.010072
NCT00033397|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2017-07-11|||February 2002||2002-02-01|July 2017|2017-07-01|May 1, 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery|Contrast-Enhanced Breast MRI, MRS, And Correlative Science Studies To Characterize Tumor Response In Patients Undergoing Neoadjuvant Treatment For Locally Advanced Breast Cancer|Completed||N/A|360|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 04:34:21.124815|2017-10-11 04:34:21.124815
NCT00033410|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2009-02-06|||March 2002||2002-03-01|September 2006|2006-09-01||||||||Interventional|||Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|A Phase I Study Of Tirapazamine (NSC 130181) Paclitaxel And Carboplatin With Concurrent Radiation Followed By Tirapazamine/Paclitaxel/Carboplatin Consolidation For Stage III Non-Small Cell Lung Cancer|Completed||Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:34:21.247221|2017-10-11 04:34:21.247221
NCT00033423|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-12-12|||August 2001||2001-08-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Phase I, Multicenter, Open Label, Dose Escalation Of 90Y-Zevalin Radioimmunotherapy Using A Modified Treatment Regimen For Relapsed Or Refractory CD20+ B-Cell (Follicular/Transformed) Non-Hodgkin's Lymphoma|Terminated||Phase 1|18|Actual|University of Alabama at Birmingham||5|||f||||t||||||||||2017-10-11 04:34:21.327315|2017-10-11 04:34:21.327315
NCT00033436|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-09-19|||October 2000||2000-10-01|December 2002|2002-12-01|November 2008|Actual|2008-11-01|||||Interventional|||Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer|A Multicenter Randomized Trial of Radical Radiotherapy With Carbogen in the Radical Treatment of Locally Advanced Bladder Cancer|Completed||Phase 3|330|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:21.435039|2017-10-11 04:34:21.435039
NCT00033449|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-01-24|||February 2002||2002-02-01|January 2013|2013-01-01||||April 2010|Actual|2010-04-01||Interventional|||Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer|A Phase I Study Of ZD 1839 In Combination With Radiation And Chemotherapy In Locally Advanced Squamous Cell Carcinoma Of The Head And Neck|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:34:21.551744|2017-10-11 04:34:21.551744
NCT00033462|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-06-03|||March 2002||2002-03-01|June 2013|2013-06-01||||November 2006|Actual|2006-11-01||Interventional|||Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer|A Phase II Trial of OSI-774 in Patients With Hepatocellular or Biliary Carcinoma|Completed||Phase 2|78|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:21.664824|2017-10-11 04:34:21.664824
NCT00033475|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-12-18|||March 2001||2001-03-01|June 2002|2002-06-01||||||||Interventional|||Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation|Cytotoxic T Cell Therapy for Post Transplant Lymphoproliferative Disease: Randomized Controlled Trial in Transplant Recipients|Unknown status|Active, not recruiting|Phase 3|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:21.758643|2017-10-11 04:34:21.758643
NCT00033488|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-12-17|||September 2000||2000-09-01|June 2007|2007-06-01|March 2010|Actual|2010-03-01|||||Interventional|||Screening Women at High Genetic Risk for Ovarian Cancer|The UK Familial Ovarian Cancer Screening Study|Completed||N/A|5000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:21.872732|2017-10-11 04:34:21.872732
NCT00033514|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-03-11|2016-02-11||August 2001||2001-08-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||enrolled subjects|Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression|Phase I/II Study Of Herceptin Combined With OSI-774 In The First-Line Treatment Of Metastatic Breast Cancer Associated With HER2/Neu Overexpression|Completed||Phase 1/Phase 2|27|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:34:21.974052|2017-10-11 04:34:21.974052
NCT00033527|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-11-05||||||September 2002|2002-09-01||||||||Interventional|||INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer|A Double-Blinded, Placebo-Controlled, Parallel Group Study Of Uridine 5'-Triphosphate (UTP) Solution For Inhalation As An Adjunct In The Diagnosis Of Lung Cancer By Sputum Cytology|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:22.419035|2017-10-11 04:34:22.419035
NCT00033540|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2017-08-14|2012-06-14||September 2003||2003-09-01|August 2017|2017-08-01|July 2011|Actual|2011-07-01|April 2008|Actual|2008-04-01||Interventional|||S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma|A Phase II Trial of Gemcitabine (NSC-613327) and Capecitabine (NSC-712807) in Patients With Unresectable or Metastatic Gallbladder or Cholangiocarcinoma|Completed||Phase 2|57|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:34:22.519574|2017-10-11 04:34:22.519574
NCT00033553|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-07-15|||March 2002||2002-03-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer|Induction/Concurrent Chemotherapy and Dose-Escalated Three Dimensional Thoracic Radiation for Patients With Stage III Non Small Cell Lung Cancer: A Randomized Phase II Study|Completed||Phase 2|69|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:34:23.442887|2017-10-11 04:34:23.442887
NCT00033566|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2011-03-03|||October 2001||2001-10-01|March 2011|2011-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||S-3304 in Treating Patients With Advanced Solid Tumors|A Phase I Study of S-3304 in Patients With Solid Tumors|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:34:23.664527|2017-10-11 04:34:23.664527
NCT00033592|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-07-12|||February 2002||2002-02-01|July 2016|2016-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking|Phase III Trial Comparing Nicotine Inhaler Versus Bupropion Versus Nicotine Inhaler Plus Bupropion For Smoking Cessation Efficacy And Relapse Prevention|Completed||Phase 3|1708|Actual|Alliance for Clinical Trials in Oncology||15|||f||||f||||||||||2017-10-11 04:34:23.754329|2017-10-11 04:34:23.754329
NCT00033605|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-07-12|||April 2002||2002-04-01|July 2016|2016-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis|Phase III Double-Blind Study Of Depot Octreotide Versus Placebo In The Prevention Of Acute Diarrhea In Patients Receiving Pelvic Radiation Therapy|Completed||Phase 3|130|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:34:23.918896|2017-10-11 04:34:23.918896
NCT00033618|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-02-26|||November 2002||2002-11-01|February 2013|2013-02-01||||January 2007|Actual|2007-01-01||Interventional|||Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck|A Randomized Phase II Study of BMS-247550 (NSC #710428) Given Daily x 5 Days Every 3 Weeks or Weekly in Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|144|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:34:24.032987|2017-10-11 04:34:24.032987
NCT00033631|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-12-16|2016-12-16||March 2002||2002-03-01|December 2016|2016-12-01||||April 2014|Actual|2014-04-01||Interventional||All eligible patients who did not withdraw consent|Radiation Therapy in Treating Patients With Stage II Prostate Cancer|A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer|Active, not recruiting||Phase 3|1532|Actual|Radiation Therapy Oncology Group|The data monitoring committee (DMC) recommended early reporting of the trial when the third interim analysis futility boundary was crossed.|2|||f||||t||||||||||2017-10-11 04:34:24.165797|2017-10-11 04:34:24.165797
NCT00033644|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2013-04-10|||March 2002||2002-03-01|September 2004|2004-09-01||||October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus|A Phase II Evaluation of DMAP Plus GM-CSF in the Treatment of Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:34:25.174347|2017-10-11 04:34:25.174347
NCT00033657|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2012-11-30|2011-06-21||May 2002||2002-05-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer|Randomized Phase II Study of Preoperative Combined Modality Paclitaxel / Cisplatin / RT or Irinotecan / Cisplatin / RT Followed by Postoperative Chemotherapy With the Same Agents in Operable Adenocarcinoma of the Esophagus|Completed||Phase 2|97|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-10-11 04:34:25.409781|2017-10-11 04:34:25.409781
NCT00033683|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2009-02-06|||February 2001||2001-02-01|June 2005|2005-06-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Resected Breast Cancer|A Randomised Trial Of Standard Anthracycline-Based Chemotherapy With Fluorouracil, Epirubicin And Cyclophosphamide (FEC) Or Epirubicin And CMF (Epi-CMF) Versus FEC Followed By Sequential Docetaxel As Adjuvant Treatment For Women With Early Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:26.55672|2017-10-11 04:34:26.55672
NCT00033696|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-07-15|||September 2001||2001-09-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Paclitaxel/Topotecan/Etoposide (EtopoTax) Induction Followed by Consolidation Chemoradiotherapy for Limited Stage Small Cell Lung Cancer: A Phase II Study|Completed||Phase 2|65|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:34:26.810785|2017-10-11 04:34:26.810785
NCT00033709|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2014-01-03|||March 2002||2002-03-01|May 2005|2005-05-01||||||||Interventional|||Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma|A Phase II Study of Combination Therapy of a Protracted Oral Schedule of Temozolomide and Thalidomide as First-Line or Subsequent Therapy for Patients With Metastatic, Locally Advanced or Unresectable Leiomyosarcoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:27.050717|2017-10-11 04:34:27.050717
NCT00033722|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2014-01-03|||February 2002||2002-02-01|November 2002|2002-11-01||||||||Interventional|||Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Multicenter Study Of Lometrexol Sodium And Folic Acid In Subjects With Previously Treated Stage IIIB or IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:27.149812|2017-10-11 04:34:27.149812
NCT00033735|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2012-12-20|||January 2000||2000-01-01|December 2012|2012-12-01||||June 2003|Actual|2003-06-01||Interventional|||Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer|Phase III Trial Of Irofulven Vs. 5-Fluorouracil In Patients With Gemcitabine-Refractory Advanced Pancreatic Adenocarcinoma|Completed||Phase 3|158|Actual|Eisai Inc.||2|||f||||t||||||||||2017-10-11 04:34:27.277748|2017-10-11 04:34:27.277748
NCT00033748|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2016-07-15|||December 2001||2001-12-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|March 2007|Actual|2007-03-01||Interventional|||Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver|Sequential Phase II Study of the Anti-Idiotype Monoclonal Antibody Vaccine CeaVac and TriAb in Patients With Minimal Metastatic Colorectal Cancer|Completed||Phase 2|56|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:34:27.370382|2017-10-11 04:34:27.370382
NCT00033774|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2017-10-05|||April 5, 2002||2002-04-05|September 15, 2017|2017-09-15||||||||Observational|||Stem Cell Collection for Adult Volunteers|Peripheral Blood Stem Cell Collection From Adult Volunteers|Recruiting||N/A|99999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:27.879849|2017-10-11 04:34:27.879849
NCT00033787|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-09|2017-06-30|||April 5, 2002||2002-04-05|June 8, 2009|2009-06-08|April 30, 2005|Actual|2005-04-30|April 30, 2005|Actual|2005-04-30||Observational|||Serotonin Function During Depression|Tryptophan Depletion PET Study in Remitted Depressed Subjects and Healthy Controls, and GABA MRS Study in Remitted and Currently Depressed Subjects and Healthy Controls|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:27.975802|2017-10-11 04:34:27.975802
NCT00033813|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-10|2014-03-07|||January 2002||2002-01-01|March 2014|2014-03-01||||December 2006|Actual|2006-12-01||Interventional|||KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy||Completed||Phase 2|15||Cooperative International Neuromuscular Research Group|||||f||||||||||||||2017-10-11 04:34:28.058304|2017-10-11 04:34:28.058304
NCT00033826|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-10|2013-05-23|||April 2002||2002-04-01|May 2013|2013-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Role of Fat Tissue in Vitamin D Metabolism|The Role of Adipose Tissue in Vitamin D Metabolism|Completed||N/A|41|Actual|Tufts University|||1||f||||f||||||||||2017-10-11 04:34:28.142109|2017-10-11 04:34:28.142109
NCT00033839|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-11|2011-06-08|||January 2002||2002-01-01|June 2011|2011-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache|Completed||Phase 3|60||Winston Laboratories|||||f||||||||||||||2017-10-11 04:34:28.22374|2017-10-11 04:34:28.22374
NCT00033852|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-11|2008-03-05|||April 2002||2002-04-01|March 2008|2008-03-01|May 2004||2004-05-01|||||Interventional|||Treatment of Depression With Massage in HIV|Treatment of Depression With Massage in HIV|Completed||Phase 2|90||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:28.371042|2017-10-11 04:34:28.371042
NCT00033865|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-11|2015-04-27|||April 2001||2001-04-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Yoga as a Treatment for Insomnia|Yoga as a Treatment for Insomnia|Completed||Phase 2|48|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||||||||||||2017-10-11 04:34:28.57341|2017-10-11 04:34:28.57341
NCT00033878|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-11|2007-03-27|||November 2001||2001-11-01|March 2007|2007-03-01|June 2006|Actual|2006-06-01|||||Interventional|||Study of Noni in Cancer Patients|Phase I Study of Noni in Cancer Patients|Completed||Phase 1|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:28.688578|2017-10-11 04:34:28.688578
NCT00033891|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-11|2017-10-05|||April 5, 2002||2002-04-05|March 20, 2017|2017-03-20|May 20, 2010|Actual|2010-05-20|July 31, 2007|Actual|2007-07-31||Interventional|||Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis|A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab in Patients With Dermatomyositis and Polymyositis|Completed||Phase 2|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:34:28.756766|2017-10-11 04:34:28.756766
NCT00033904|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-12|2012-09-06|||June 2000||2000-06-01|September 2012|2012-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer|A Multi-Center, Randomized Phase III Study of Adjuvant Oncophage® Versus Observation in Subjects With High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma|Completed||Phase 3|650||Agenus Inc.|||||||||||||||||||2017-10-11 04:34:28.854131|2017-10-11 04:34:28.854131
NCT00033917|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-12|2013-02-20|2013-01-08||September 1989||1989-09-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial|Randomized Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial|Completed||Phase 3|630|Actual|Yale University||2|||f||||||||||||||2017-10-11 04:34:29.090667|2017-10-11 04:34:29.090667
NCT00033943|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-16|2005-06-23|||January 2001||2001-01-01|October 2002|2002-10-01|September 2002||2002-09-01|||||Interventional|||Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis|A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Two Dosage Levels of OP2000 (75 Mg and 125 Mg) Administered Once Daily by Subcutaneous Injection for the Treatment of Active Ulcerative Colitis|Completed||Phase 2/Phase 3|270||Incara Pharmaceuticals|||||||||||||||||||2017-10-11 04:34:29.41823|2017-10-11 04:34:29.41823
NCT00033956|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-17|2005-06-23|||December 2001||2001-12-01|May 2002|2002-05-01||||||||Interventional|||Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2|Phase I/II Open Label Dose Escalation and Double-Blind, Placebo-Controlled Evaluation of M40403, for the Prevention of the Dose Limiting Toxicities of High Dose IV Bolus IL-2 Treatment of Metastatic Melanoma or Renal Cell Carcinoma.|Suspended||Phase 1/Phase 2|48||MetaPhore Pharmaceuticals|||||||||||||||||||2017-10-11 04:34:29.594141|2017-10-11 04:34:29.594141
NCT00033969|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-17|2017-10-05|||April 15, 2002||2002-04-15|October 23, 2014|2014-10-23|October 23, 2014||2014-10-23|||||Observational|||Study of Proteins Associated With Complex Regional Pain Syndrome|Complex Regional Pain Syndrome Proteomics Study|Terminated||N/A|120|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:29.65979|2017-10-11 04:34:29.65979
NCT00033982|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-18|2017-06-30|||April 11, 2002||2002-04-11|February 20, 2007|2007-02-20|February 20, 2007||2007-02-20|||||Interventional|||Posaconazole to Treat Invasive Fungal Infections|Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections|Completed||Phase 3|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:29.726657|2017-10-11 04:34:29.726657
NCT00033995|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-18|2017-06-30|||April 17, 2002||2002-04-17|February 17, 2009|2009-02-17|February 17, 2009||2009-02-17|||||Observational|||Study of Tics in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder|Study of Tics in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder With [15O]H2O PET in Awake and in Sleep States|Completed||N/A|46||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:29.801459|2017-10-11 04:34:29.801459
NCT00034008|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-19|2006-08-17|||July 2003||2003-07-01|July 2006|2006-07-01|July 2004||2004-07-01|||||Interventional|||Efficacy of Healing Touch in Stressed Neonates|Efficacy of Healing Touch in Stressed Neonates|Completed||Phase 2|13||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:29.872492|2017-10-11 04:34:29.872492
NCT00034021|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-19|2006-08-17|||June 2002||2002-06-01|July 2006|2006-07-01|September 2004||2004-09-01|||||Interventional|||Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction|Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:29.94117|2017-10-11 04:34:29.94117
NCT00034034|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-19|2007-01-04|||June 2002||2002-06-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer|An Intervention to Improve End-of-Life Symptom Distress|Completed||Phase 1|105||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:30.030343|2017-10-11 04:34:30.030343
NCT00034047|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-19|2008-01-23|||September 2002||2002-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Endometriosis : Traditional Medicine vs Hormone Therapy|Endometriosis : Traditional Medicine vs Hormone Therapy|Completed||Phase 1/Phase 2|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:30.118832|2017-10-11 04:34:30.118832
NCT00034060|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-19|2008-03-03|||April 2002||2002-04-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept|Suppression of the Growth Hormone/ Insulin-Like Growth Factor-1 (GH/IGF-1) Axis in Women With Rheumatoid Arthritis|Completed||Phase 2|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:30.21721|2017-10-11 04:34:30.21721
NCT00034073|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-20|2017-06-30|||April 18, 2002||2002-04-18|April 16, 2009|2009-04-16|April 16, 2009||2009-04-16|||||Observational|||Magnetic Resonance Imaging in Children and Adults Using Arterial Spin Tagging Techniques|Quantitative fMRI in Children and Adults Using Arterial Spin Tagging Techniques|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:30.29715|2017-10-11 04:34:30.29715
NCT00034086|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-22|2012-05-17||||||May 2012|2012-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Study of Anti-HIV Therapy Intensification|Immunologic Consequences of Antiretroviral Therapy Intensification in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315/375|Completed||N/A|22||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:34:30.364038|2017-10-11 04:34:30.364038
NCT00034112|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-22|2006-08-17|||April 2001||2001-04-01|July 2006|2006-07-01|March 2002||2002-03-01|||||Interventional|||Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease|Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:30.466419|2017-10-11 04:34:30.466419
NCT00034125|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-23|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.|a Phase 3 Randomized Double Blind Evaluation of LY353381 Compared With Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:30.542757|2017-10-11 04:34:30.542757
NCT00034138|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-23|2007-12-13|||March 2002||2002-03-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma||Terminated||Phase 1/Phase 2|24||Unither Pharmaceuticals||||closed by sponser|||||||||||||||2017-10-11 04:34:30.63135|2017-10-11 04:34:30.63135
NCT00034151|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-23|2009-06-02|||March 2002||2002-03-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer|A Phase IIA Evaluation of Safety and Efficacy of Weekly S-8184 Paclitaxel Injectable Emulsion in Second Line Treatment of Stage III or IV Platinum Resistant Ovarian Cancer or Primary Peritoneal Carcinoma|Completed||Phase 2|52|Actual|Achieve Life Sciences||1|||f||||||||||||||2017-10-11 04:34:30.727817|2017-10-11 04:34:30.727817
NCT00034164|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-23|2009-06-02|||April 2002||2002-04-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer|A Phase IIA Multicenter Evaluation of the Safety and Efficacy of Weekly Administration of S-8184 Paclitaxel Injectable Emulsion in Second Line Treatment of Patients With Relapsed Stage IIIB OR IV Non Small Cell Lung Cancer|Completed||Phase 2|52|Actual|Achieve Life Sciences||1|||f||||f||||||||||2017-10-11 04:34:30.794847|2017-10-11 04:34:30.794847
NCT00034177|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-23|2009-06-02|||April 2002||2002-04-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium|Safety And Efficacy Of Weekly Administration Of S-8184 Paclitaxel Injectable Emulsion In Second Line Treatment Of Patients With Locally Advanced, Metastatic, Or Recurrent Transitional Cell Carcinoma Of The Urothelium|Completed||Phase 2|27|Actual|Achieve Life Sciences||1|||f||||||||||||||2017-10-11 04:34:30.889008|2017-10-11 04:34:30.889008
NCT00034190|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-23|2009-06-02|||March 2002||2002-03-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma|A Phase IIa Multicenter Evaluation of The Safety And Efficacy of Weekly Administration of S-8184 Paclitaxel Injectable Emulsion In Second Line Treatment of Patients With Stage III or IV Colorectal Adenocarcinoma|Completed||Phase 2|28|Actual|Achieve Life Sciences||1|||f||||||||||||||2017-10-11 04:34:30.955306|2017-10-11 04:34:30.955306
NCT00034216|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-24|2017-07-26|||April 18, 2002||2002-04-18|June 6, 2017|2017-06-06||||||||Observational|||Collection of Blood From Patients With Cancer|Biospecimen Acquisition From Human Subjects|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:31.471652|2017-10-11 04:34:31.471652
NCT00034229|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-24|2008-03-03|||April 2002||2002-04-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression|A Double-Blind Randomized Placebo-Controlled Trial of Felbamate in Treatment Resistant Bipolar Depression|Completed||Phase 2|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:31.57996|2017-10-11 04:34:31.57996
NCT00034242|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-24|2008-03-03|||April 2002||2002-04-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration|The Efficacy of High-Dose Intravenous Immunoglobulin Therapy In Patients With Cerebellar Degeneration: A Double Blind, Placebo Controlled Trial|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:31.667219|2017-10-11 04:34:31.667219
NCT00034255|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-24|2005-06-23|||December 2001||2001-12-01|June 2003|2003-06-01||||||||Interventional|||Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients|Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients|Completed||Phase 1/Phase 2|62||GMP Endotherapeutics|||||||||||||||||||2017-10-11 04:34:31.747833|2017-10-11 04:34:31.747833
NCT00034268|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-24|2006-07-18|||March 2002||2002-03-01|July 2006|2006-07-01||||||||Interventional|||A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer|A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:31.826883|2017-10-11 04:34:31.826883
NCT00034281|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-24|2012-01-31|||June 2002||2002-06-01|January 2012|2012-01-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2|A Phase I, Open-Label, Dose Escalating, Multiple Dose Study to Determine the Safety, Tolerability, Maximum Tolerated Dose and Pharmacokinetics of Oral TAK-165 Administered Once Daily to Subjects With Tumors Known to Express HER2.|Completed||Phase 1|16|Actual|Takeda||1|||f||||f||||||||||2017-10-11 04:34:32.208131|2017-10-11 04:34:32.208131
NCT00034294|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-24|2015-03-04|||February 2002||2002-02-01|March 2015|2015-03-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea|A Randomized, Double-Blind Study of GT160-246 Versus Vancomycin in Patients With C. Difficile-Associated Diarrhea|Completed||Phase 2|300||Sanofi|||||||||||||||||||2017-10-11 04:34:32.32955|2017-10-11 04:34:32.32955
NCT00034307|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-24|2005-06-23||||||May 2002|2002-05-01||||||||Interventional|||Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension|A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension|Unknown status|Active, not recruiting|Phase 2/Phase 3|180||ICOS-Texas Biotechnology|||||||||||||||||||2017-10-11 04:34:32.666816|2017-10-11 04:34:32.666816
NCT00034333|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-25|2005-06-23|||March 2002||2002-03-01|May 2004|2004-05-01||||||||Interventional|||Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer|Study of Doxorubicin Hydrochloride Adsorbed to Magnetic Targeted Carriers (MTC-DOX) Administered by Intrahepatic Delivery Versus Intravenous Doxorubicin for Treatment of Patients With Unresectable Hepatocellular Carcinoma|Terminated||Phase 2/Phase 3|240||FeRx|||||||||||||||||||2017-10-11 04:34:32.863209|2017-10-11 04:34:32.863209
NCT00034346|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-25|2007-12-20|||January 2002||2002-01-01|December 2007|2007-12-01||||||||Interventional|||ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)|A Two Part, Multiple Dose Clinical Trial of the Safety and Efficacy of ABX-EGF in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|194||Amgen|||||||||||||||||||2017-10-11 04:34:33.034944|2017-10-11 04:34:33.034944
NCT00034359|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-26|2014-02-18|||February 2002||2002-02-01|February 2014|2014-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection|A Double-Blind, Randomized Trial of Antiviral Activity and Safety of 12 Weeks Oral Treatment With ACH-126,443 (Beta-L-Fd4C) in Treatment-Naive HBV-Infected Adults|Completed||Phase 2|79|Actual|Achillion Pharmaceuticals|||||||||||||||||||2017-10-11 04:34:33.155191|2017-10-11 04:34:33.155191
NCT00034372|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-26|2007-12-13|||September 2000||2000-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma||Terminated||Phase 2|102||Unither Pharmaceuticals||||closed by sponser|||||||||||||||2017-10-11 04:34:33.28534|2017-10-11 04:34:33.28534
NCT00034385|ClinicalTrials.gov processed this data on October 10, 2017|2006-06-19|2017-06-30|||April 24, 2002||2002-04-24|August 20, 2008|2008-08-20|October 30, 2009|Actual|2009-10-30|January 30, 2007|Actual|2007-01-30||Interventional|||Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients|Pharmacokinetics of Valganciclovir in Kidney and Kidney/Pancreas Transplant Recipients|Completed||Phase 4|12||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:34:33.421266|2017-10-11 04:34:33.421266
NCT00034398|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-26|2017-06-30|||April 24, 2002||2002-04-24|March 11, 2010|2010-03-11|March 11, 2010||2010-03-11|||||Observational|||Study of GABA-A Receptors in the Generation of Tics in Patients With Tourette's Syndrome|Evaluation of Density and Pattern of Distribution of GABA A Receptors in Brain of Patients With Tourette's Syndrome Studied With PET Using [11C] Flumazenil|Completed||N/A|26|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:33.5062|2017-10-11 04:34:33.5062
NCT00034424|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-27|2017-10-05|||April 24, 2002||2002-04-24|February 2, 2017|2017-02-02||||||||Observational|||Cause of Familial Testicular Cancer|Multidisciplinary Etiologic Study of Familial Testicular Cancer|Recruiting||N/A|1750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:33.567651|2017-10-11 04:34:33.567651
NCT00034437|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-27|2008-03-03|||April 2002||2002-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Immune Response to Cytomegalovirus|Measurement of Cytomegalovirus (CMV)-Specific T Lymphocytes in CMV-Seropositive Normal Volunteers.|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:33.65069|2017-10-11 04:34:33.65069
NCT00034450|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-29|2006-08-17|||January 2002||2002-01-01|March 2006|2006-03-01|August 2004||2004-08-01|||||Interventional|||Developmental Study on Fatigue in Cancer|Developmental Study on Fatigue in Cancer|Completed||Phase 2|140||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:33.722105|2017-10-11 04:34:33.722105
NCT00034463|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-29|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer|A Phase 1 Trial of ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer|Completed||Phase 1|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:33.798826|2017-10-11 04:34:33.798826
NCT00034476|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-29|2006-07-18|||October 2001||2001-10-01|July 2006|2006-07-01|October 2002||2002-10-01|||||Interventional|||A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis|A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis|Completed||Phase 1/Phase 2|466||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:33.882844|2017-10-11 04:34:33.882844
NCT00025740|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-16|2008-03-03|||October 2001||2001-10-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Interventional|||Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder|Combined Treatment With a Benzodiazepine (Clonazepam) and a Selective Serotonin Reuptake Inhibitor (Paroxetine) for Rapid Treatment of Posttraumatic Stress Disorder (PTSD)|Completed||Phase 4|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:34.261303|2017-10-11 04:34:34.261303
NCT00025753|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-19|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution|Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:34:34.335315|2017-10-11 04:34:34.335315
NCT00025766|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-22|2013-11-25|||September 2001||2001-09-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|April 2006|Actual|2006-04-01||Interventional|TOSCA-2||Angioplasty and Heart Stents to Treat Individuals With an Occluded Artery Following a Heart Attack|TOSCA-2: An Angiographic Substudy (Ancillary) of the Occluded Artery Trial (OAT)|Completed||Phase 4|380|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 04:34:34.402242|2017-10-11 04:34:34.402242
NCT00025779|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-23|2009-07-24|||October 2001||2001-10-01|August 2008|2008-08-01||||November 2003|Actual|2003-11-01||Interventional|||Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders|Methylphenidate for Hyperactivity and Impulsiveness in Children and Adolescents With Pervasive Developmental Disorders|Completed||N/A|60||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 04:34:34.498978|2017-10-11 04:34:34.498978
NCT00025792|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-24|2008-03-03|||October 2001||2001-10-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Clinical Trial of Pramipexole in Bipolar Depression|An Investigation of the Antidepressant Efficacy of a Dopamine Agonist With Neurotrophic Properties in Bipolar Disorder|Completed||Phase 2|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:34.588053|2017-10-11 04:34:34.588053
NCT00025805|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-25|2017-06-30|||October 23, 2001||2001-10-23|June 13, 2008|2008-06-13|June 13, 2008||2008-06-13|||||Interventional|||G-CSF to Treat Crohn's Disease|Granulocyte-Colony Stimulating Factor Treatment for Crohn's Disease: A Pilot Study Assessing Immune and Clinical Response|Completed||Phase 1|23||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:34.660552|2017-10-11 04:34:34.660552
NCT00025818|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-26|2011-05-27|||May 2001||2001-05-01|May 2011|2011-05-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome||Completed||Phase 3|290|Actual|Allergan|||||f||||||||||||||2017-10-11 04:34:34.755351|2017-10-11 04:34:34.755351
NCT00025831|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-26|2008-03-03|||October 2001||2001-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Biological Specimen Collection for Laboratory Methods Development and Training Purposes|Biological Specimen Collection for Laboratory Methods Development and for Training Purposes|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:34.931166|2017-10-11 04:34:34.931166
NCT00025844|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-26|2017-06-30|||October 22, 2001||2001-10-22|April 10, 2012|2012-04-10|April 10, 2012||2012-04-10|||||Observational|||Fear Conditioning Using Computer-Generated Virtual Reality|Fear Conditioning Using Computer-Generated Virtual Reality|Completed||N/A|202|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:35.120693|2017-10-11 04:34:35.120693
NCT00025857|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-26|2017-10-05|||October 22, 2001||2001-10-22|June 29, 2012|2012-06-29|June 29, 2012||2012-06-29|||||Observational|||Brain Function in Mentally Ill Adolescents|Adolescent Medial Temporal Lobe Function in Health and Illness|Completed||N/A|105|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:35.211669|2017-10-11 04:34:35.211669
NCT00025870|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-27|2017-10-05|||October 25, 2001||2001-10-25|June 23, 2016|2016-06-23|June 23, 2016||2016-06-23|||||Observational|||Studies of Children With Metabolic and Other Genetic Disorders|Studies of Pediatric Patients With Metabolic or Other Genetic Disorders|Completed||N/A|1090|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:35.282143|2017-10-11 04:34:35.282143
NCT00025883|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-27|2016-08-12|2016-03-01||October 2001||2001-10-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Leptin to Treat Lipodystrophy|Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy|Completed||Phase 2|103|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||Yes||2017-10-11 04:34:35.359685|2017-10-11 04:34:35.359685
NCT00025896|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-31|2014-11-12|||May 2001||2001-05-01|November 2014|2014-11-01|September 2002|Actual|2002-09-01|||||Interventional|||Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease|A Prospective Multinational, Multicenter, Clinical Trial of the Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase (rhGAA) in Cross-Reacting Immunologic Material-Positive Patients With Classical Infantile Pompe Disease|Completed||Phase 2|8||Sanofi|||||||||||||||||||2017-10-11 04:34:36.087587|2017-10-11 04:34:36.087587
NCT00025909|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-31|2008-03-03|||October 2001||2001-10-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Intermittent vs. Continuous HAART to Treat Chronic HIV Infection|A Randomized, Controlled Trial of Short Cycle Intermittent Versus Continuous HAART for the Treatment of Chronic HIV Infection|Completed||Phase 3|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:36.212892|2017-10-11 04:34:36.212892
NCT00025922|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-31|2008-03-03|||October 2001||2001-10-01|October 2003|2003-10-01|October 2003||2003-10-01|||||Observational|||Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load|Influenza Vaccine in HIV Infection: Immunologic Responses and Effect on HIV Viral Load|Completed||N/A|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:36.331126|2017-10-11 04:34:36.331126
NCT00025935|ClinicalTrials.gov processed this data on October 10, 2017|2001-10-31|2017-10-05|||October 29, 2001||2001-10-29|September 27, 2017|2017-09-27||||||||Observational|||Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder|Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth|Recruiting||N/A|1350|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:36.445693|2017-10-11 04:34:36.445693
NCT00025974|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-02|2017-06-30|||October 31, 2001||2001-10-31|July 21, 2008|2008-07-21|July 21, 2008||2008-07-21|||||Observational|||Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder|Serotonin 1A Receptor Imaging and Benzodiazepine Receptor Imaging in Panic Disorder and Posttraumatic Stress Disorder|Completed||N/A|230||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:38.632149|2017-10-11 04:34:38.632149
NCT00025987|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-02|2008-03-03|||November 2001||2001-11-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Temperature Response to a Head-Neck Cooling System|Thermal Responses In Normal Volunteers To Head-Neck Cooling|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:38.708926|2017-10-11 04:34:38.708926
NCT00026000|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-02|2008-03-03|||November 2001||2001-11-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Brain Activation in Vocal and Motor Tics|Brain Activation in Motor and Vocal Tics in Patients With Tourette's Syndrome or Chronic Motor or Vocal Tic Disorder Using Blood Oxygenation Level Dependent Functional MRI|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:38.777452|2017-10-11 04:34:38.777452
NCT00026013|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-05|2006-08-17|||January 2002||2002-01-01|July 2006|2006-07-01|January 2004||2004-01-01|||||Interventional|||Effects of St. John's Wort on the Effectiveness of Oral Contraceptives|Effects of Hypericum Perforatum on Effectiveness of Oral Contraceptives|Completed||N/A|25||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:38.854916|2017-10-11 04:34:38.854916
NCT00026026|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-06|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Linkage and Identification of (a) Candidate Gene(s) for Tooth Disorders|Linkage and Identification of (a) Candidate Gene(s) for Tooth Disorders|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:34:38.925186|2017-10-11 04:34:38.925186
NCT00026039|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-07|2006-05-12|||December 1993||1993-12-01|November 2005|2005-11-01||||||||Interventional|||Women's Estrogen for Stroke Trial (WEST)||Completed||Phase 3|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:34:38.987266|2017-10-11 04:34:38.987266
NCT00026052|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-08|2008-03-03|||November 2001||2001-11-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Riluzole to Treat Major Depression|An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent With Neurotrophic Properties in Major Depression|Completed||Phase 2|31||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:39.062735|2017-10-11 04:34:39.062735
NCT00026065|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2007-09-28|||February 2000||2000-02-01|August 2006|2006-08-01|March 2006||2006-03-01|||||Interventional|||Hypertension: Prediction of Biofeedback Success|Hypertension: Prediction of Biofeedback Success|Completed||Phase 1|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:39.153407|2017-10-11 04:34:39.153407
NCT00026078|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-08-06|||March 2001||2001-03-01|November 2006|2006-11-01||||||||Interventional|||Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer|Docetaxel (DTX) - Ifosfamide (IFX) As First Line Chemotherapy In Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|42|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:39.241387|2017-10-11 04:34:39.241387
NCT00026091|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-03-22|||September 2001||2001-09-01|February 2013|2013-02-01||||March 2004|Actual|2004-03-01||Interventional|||Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer|Phase II Trial of Fenretinide (NSC 374551) in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:39.35494|2017-10-11 04:34:39.35494
NCT00026104|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-06-05|||November 2001||2001-11-01|June 2013|2013-06-01||||August 2006|Actual|2006-08-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer|A Randomized Phase II Trial of Weekly Gemcitabine, Paclitaxel and External Irradiation (50.4 GY) Followed by the Farnesyl Transferase Inhibitor R115777 (NSC #702818) for Locally Advanced Pancreatic Cancer|Completed||Phase 2|154|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:34:39.452824|2017-10-11 04:34:39.452824
NCT00026117|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2016-07-12|||August 2001||2001-08-01|July 2016|2016-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer|Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer|Completed||Phase 3|88|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:34:39.677673|2017-10-11 04:34:39.677673
NCT00026130|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2016-07-15|||September 2001||2001-09-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer|A Phase II Trial of Gemcitabine, 5-Fluorouracil and Radiation Therapy in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|81|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:34:39.832914|2017-10-11 04:34:39.832914
NCT00026143|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-06-04|||October 2001||2001-10-01|June 2013|2013-06-01||||July 2004|Actual|2004-07-01||Interventional|||Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma|Phase II Trial of Interleukin-12 (NSC #672423, IND #6798) Followed by Interferon Alfa-2B in Patients With Metastatic Malignant Melanoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:40.136849|2017-10-11 04:34:40.136849
NCT00026156|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-02-12|||November 2001||2001-11-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|July 2004|Actual|2004-07-01||Interventional|||S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase II Trial of Sequential Vinorelbine and Docetaxel in Advanced Non-Small Cell Lung Cancer Patients Age Seventy and Older, or With Performance Status 2|Completed||Phase 2|125|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:34:40.25495|2017-10-11 04:34:40.25495
NCT00026169|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-01-09|||September 2001||2001-09-01|January 2013|2013-01-01||||April 2005|Actual|2005-04-01||Interventional|||Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure|A Phase I Pharmacokinetic Study of STI571 in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction for the CTEP-Sponsored Organ Dysfunction Working Group|Completed||Phase 1|69|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:40.517682|2017-10-11 04:34:40.517682
NCT00026182|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-08-23|||October 2001||2001-10-01|August 2013|2013-08-01||||February 2005|Actual|2005-02-01||Interventional|||Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma|Randomized Phase II Study Of Interleukin-12 In Combination With Rituximab In Patients With Non-Hodgkin's Lymphoma|Completed||Phase 2|99|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:34:40.608588|2017-10-11 04:34:40.608588
NCT00026195|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2016-07-01|||September 2001||2001-09-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Irinotecan in Treating Aging Patients With Solid Tumors|Clinical Pharmacology In The Elderly: Prospective Evaluation Of The Pharmacokinetics, Pharmacogenetics And Pharmacodynamics Of CPT-11 And Aging|Completed||Phase 1|140|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:34:40.751984|2017-10-11 04:34:40.751984
NCT00026208|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2017-03-02|||June 2001||2001-06-01|March 2017|2017-03-01|February 13, 2017|Actual|2017-02-13|February 13, 2017|Actual|2017-02-13||Interventional|||Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma|Risk Adapted Stanford V-C With Radiotherapy for Clinical Stage I and IIA Favorable Hodgkin's Disease: The G5 Study|Completed||Phase 2|76|Actual|Stanford University||1|||f|||||t|f||||||||2017-10-11 04:34:41.103029|2017-10-11 04:34:41.103029
NCT00026221|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2016-02-18|2015-12-16||November 2001||2001-11-01|February 2016|2016-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma|A Phase 2 Study of Bevacizumab and Interferon-Alpha-2b in Metastatic Malignant Melanoma|Completed||Phase 2|57|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:34:41.220279|2017-10-11 04:34:41.220279
NCT00026234|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-07-15|||February 2002||2002-02-01|June 2013|2013-06-01||||January 2006|Actual|2006-01-01||Interventional|||Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver|A Phase II Trial Evaluating Multiple Metastasectomy Combined With Hepatic Artery Infusion Of Floxuridine (FUDR) And Dexamethasone (DXM), Alternating With Systemic Oxaliplatin (OXAL) And Capecitabine (CAPCIT) For Colorectal Carcinoma Metastatic To The Liver|Completed||Phase 2|75|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:41.708094|2017-10-11 04:34:41.708094
NCT00026247|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2011-04-07|||November 2001||2001-11-01|March 2006|2006-03-01||||February 2011|Actual|2011-02-01||Interventional|||Radiofrequency Ablation in Treating Patients With Bone Metastases|A Phase I/II Study of Percutaneous Radiofrequency Ablation of Bone Metastases Using CT Guidance|Completed||Phase 1/Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:41.841548|2017-10-11 04:34:41.841548
NCT00026260|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-06-20||||||June 2007|2007-06-01|October 2003|Actual|2003-10-01|||||Interventional|||SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation of SU5416 (NSC 696819) in Persistent or Recurrent Squamous Cell Carcinoma of the Cervix|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:41.950802|2017-10-11 04:34:41.950802
NCT00026273|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2012-08-06|||January 2001||2001-01-01|August 2012|2012-08-01||||September 2004|Actual|2004-09-01||Interventional|||Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer|Multicenter Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone As Adjuvant Treatment Of Stage III Colon Cancer|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 04:34:42.018308|2017-10-11 04:34:42.018308
NCT00026286|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2009-05-09|||September 2000||2000-09-01|March 2008|2008-03-01||||August 2002|Actual|2002-08-01||Interventional|||Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer|A Phase III Prospective, Randomized, Double-Blind Clinical Trial of Hormone Replacement Therapy In Postmenopausal Women With A History Of Node-Negative Or Ductal Carcinoma In Situ Who Are Receiving Adjuvant Tamoxifen|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:42.132397|2017-10-11 04:34:42.132397
NCT00026299|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-09-04|||September 2001||2001-09-01|September 2013|2013-09-01|February 2005|Actual|2005-02-01|December 2002|Actual|2002-12-01||Interventional|||Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer|A Phase I/ Randomized Phase II Trial Of Oxaliplatin (NSC #266046) With Or Without ZD 1839 (NSC # 715055) In Patients With Advanced Colorectal Carcinoma|Completed||Phase 1/Phase 2|14|Actual|University of Chicago||3|||f||||f||||||||||2017-10-11 04:34:42.285504|2017-10-11 04:34:42.285504
NCT00026312|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2017-04-03|2017-02-09||October 2001||2001-10-01|April 2017|2017-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma|Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue|Completed||Phase 3|1449|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 04:34:42.541863|2017-10-11 04:34:42.541863
NCT00026338|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2011-09-28|||August 2001||2001-08-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|September 2004|Actual|2004-09-01||Interventional|||Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer|A Randomized Placebo Controlled Study Of OSI-774 (TARCEVA) Plus Gemcitabine In Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer|Completed||Phase 3|569|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:34:45.618719|2017-10-11 04:34:45.618719
NCT00026351|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-02-01|||December 2000||2000-12-01|July 2002|2002-07-01|June 2003|Actual|2003-06-01|||||Interventional|||Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Phase II Multicenter Trial Of Pentostatin and Rituximab In Patients With Previously Treated and Untreated Low Grade B-Cell Non-Hodgkin's Lymphoma (NHL) Including Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:46.215495|2017-10-11 04:34:46.215495
NCT00026364|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-03-19|||November 2001||2001-11-01|September 2002|2002-09-01||||December 2006|Actual|2006-12-01||Interventional|||ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer|A Phase I Study Of ZD1839 (Iressa) In Combination With Irinotecan, Leucovorin, And 5-Fluorouracil In Previously Untreated, Stage IV Colorectal Cancer|Completed||Phase 1|22|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:34:46.308785|2017-10-11 04:34:46.308785
NCT00037401|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-02-17|||September 2001||2001-09-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.541439|2017-10-11 04:35:31.541439
NCT00026377|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-09-04|||November 2001||2001-11-01|September 2013|2013-09-01|April 2003|Actual|2003-04-01|March 2002|Actual|2002-03-01||Interventional|||SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer|A Phase I Study Of SU5416 With Androgen Ablation And Radiation In Patients With Intermediate and Advanced Stage Prostate Cancer|Completed||Phase 1|3|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:34:46.407115|2017-10-11 04:34:46.407115
NCT00026403|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2016-07-12|||September 2001||2001-09-01|July 2016|2016-07-01|July 2009|Actual|2009-07-01|June 2007|Actual|2007-06-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer|A Phase II Study of Gemcitabine, Cisplatin and Radiation Therapy in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:34:46.504629|2017-10-11 04:34:46.504629
NCT00026416|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2014-01-03|||October 2001||2001-10-01|October 2003|2003-10-01||||||||Interventional|||Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma|Phase II Study of Low-Dose Interferon Alfa 2B (Schering Plough) Plus Thalidomide (Celgene) for Patients With Resected High-Risk Soft Tissue Sarcoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:46.644566|2017-10-11 04:34:46.644566
NCT00026429|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-12-17|||January 2001||2001-01-01|February 2002|2002-02-01||||||||Interventional|||Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma|A Multicenter Phase II Evaluation Of ONTAK (DENILEUKINDIFTITOX) In Patients With Low Or Intermediate Grade-B-Cell Non-Hodgkin's Lymphoma Who Have Been Treated Previously With A Monoclonal Antibody Or Who Are Not Candidates For Monoclonal Antibody Therapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:46.722221|2017-10-11 04:34:46.722221
NCT00026442|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-12-17|||November 2001||2001-11-01|April 2004|2004-04-01||||||||Interventional|||Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer|A Pilot Trial Of Two Different Doses Of Capecitabine (XELODA) In Patients With Advanced And/Or Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:46.827839|2017-10-11 04:34:46.827839
NCT00026468|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-07-23|||July 1999||1999-07-01|July 2013|2013-07-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Interventional|||Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis|Chemoprevention of Duodenal Polyps in Familial Adenomatous Polyposis|Withdrawn||Phase 2/Phase 3|0|Actual|University of Utah||1||Principle Investigator has left the University.|f||||||||||||||2017-10-11 04:34:46.916201|2017-10-11 04:34:46.916201
NCT00026494|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2015-12-15|2015-12-15||July 2001||2001-07-01|December 2015|2015-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases|A Phase I/II Trial Of Temozolomide And Vinorelbine For Patients With Recurrent Brain Metastases|Completed||Phase 1/Phase 2|49|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:34:47.00523|2017-10-11 04:34:47.00523
NCT00026520|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2013-06-20|||November 2001||2001-11-01|April 2003|2003-04-01|April 2006|Actual|2006-04-01|||||Interventional|||Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma|Evaluation of Interferon Alpha-2b and Thalidomide in Patients With Disseminated Malignant Melanoma, Phase II|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:34:47.895034|2017-10-11 04:34:47.895034
NCT00026533|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2017-06-04|||June 2001||2001-06-01|June 2017|2017-06-01|December 2005|Actual|2005-12-01|November 2003|Actual|2003-11-01||Interventional|||Thalidomide in Treating Patients With Thyroid Cancer|Phase II Trial of Thalidomide for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas and Medullary Thyroid Carcinomas|Completed||Phase 2|||University of Kentucky|||||f||||f||||||||||2017-10-11 04:34:48.139859|2017-10-11 04:34:48.139859
NCT00026546|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-09|2017-10-05|||November 5, 2001||2001-11-05|June 7, 2017|2017-06-07||||||||Observational|||Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers|A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control|Completed||N/A|189|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:48.203486|2017-10-11 04:34:48.203486
NCT00026559|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-10|2017-10-05|||June 26, 2001||2001-06-26|July 3, 2017|2017-07-03||||||||Observational|||Effects of Arousal and Stress in Anxiety|Effects of Arousal and Stress on Classical Conditioning|Recruiting||N/A|1427|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:48.277741|2017-10-11 04:34:48.277741
NCT00026585|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-10|2017-06-30|||November 9, 2001||2001-11-09|May 20, 2008|2008-05-20|November 2, 2007||2007-11-02|||||Interventional|||Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder|A Double-Blind Study Examining the Efficacy of the Protein Kinase C Inhibitor Tamoxifen in the Treatment of Acute Mania|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:48.347261|2017-10-11 04:34:48.347261
NCT00026598|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-10|2008-03-03|||October 2001||2001-10-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease|Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:48.413674|2017-10-11 04:34:48.413674
NCT00026611|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-12|2010-08-26||||||March 2010|2010-03-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults|A Multicenter, Double-Blind, Randomized Dose-Response Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults|Completed||Phase 2|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:34:48.571063|2017-10-11 04:34:48.571063
NCT00026624|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-12|2012-05-16||||||May 2012|2012-05-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC|A Phase I/II Study to Evaluate the Safety and Immunogenicity of the Subcutaneous Administration of ALVAC-HIV vCP1452 Infected Autologous Dendritic Cells Versus the Subcutaneous Administration of ALVAC-HIV vCP1452 To HIV-Infected Subjects|Completed||Phase 1|||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:34:48.632571|2017-10-11 04:34:48.632571
NCT00026637|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-01-18|||August 2001||2001-08-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Depression and Health Outcomes in Refractory Epilepsy|Depression and Health Outcomes in Refractory Epilepsy|Terminated||Phase 3|140|Actual|Columbia University||2||The PI left Columbia in 2008. No research related activity has taken place since then.|f||||t|t|f|||f|||No||2017-10-11 04:34:48.69895|2017-10-11 04:34:48.69895
NCT00026650|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||February 4, 2000||2000-02-04|August 17, 2017|2017-08-17||||||||Observational|||Follow Up of Patients Treated With Radiotherapy|Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:48.780466|2017-10-11 04:34:48.780466
NCT00026663|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||February 11, 2000||2000-02-11|February 2, 2017|2017-02-02||||||||Observational|||Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance|Collection of Blood, Fluid, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer or Normal Volunteers|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:48.843894|2017-10-11 04:34:48.843894
NCT00026676|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||May 2000||2000-05-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine|Retrospective Analysis of HIV-1 RNA Levels in Pediatric HIV-Infected Patients Treated With Didanosine|Completed||N/A|82||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.023956|2017-10-11 04:34:49.023956
NCT00026689|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||July 24, 2000||2000-07-24|November 10, 2016|2016-11-10||||||||Observational|||Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols|Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.109438|2017-10-11 04:34:49.109438
NCT00026702|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||April 6, 2000||2000-04-06|June 27, 2017|2017-06-27||||||||Observational|||Search for New Methods to Detect Acute Renal Failure|Search for Novel Methods to Detect Acute Renal Failure|Recruiting||N/A|640|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.191053|2017-10-11 04:34:49.191053
NCT00026715|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||June 2000||2000-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Evaluation of New Test Method to Measure Kidney Function|Validation of Fast Methods to Measure Glomerular Filtration Rate|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.269904|2017-10-11 04:34:49.269904
NCT00026728|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||February 2001||2001-02-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States|The Seroprevalence of Kaposi's Sarcoma Herpesvirus in the United States|Completed||N/A|20169||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.347045|2017-10-11 04:34:49.347045
NCT00026741|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||March 2001||2001-03-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Research in Skin Inflammation|Expression of Chemokine and Chemokine Receptors in Skin in a Model of Delayed-Type Hypersensitivity|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.414011|2017-10-11 04:34:49.414011
NCT00026754|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||March 21, 2001||2001-03-21|September 27, 2017|2017-09-27||||||||Observational|||Screening Patients for NCI Protocol Eligibility|Eligibility Screening and Tissue Procurement for the National Cancer Institute Center for Cancer Research Clinical Protocols|Recruiting||N/A|15000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.492769|2017-10-11 04:34:49.492769
NCT00026767|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||April 9, 2001||2001-04-09|July 17, 2012|2012-07-17|July 17, 2012||2012-07-17|||||Observational|||Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients|Surveillance of Invasive Fungal Infections in Bone Marrow/Stem Cell and Solid Organ Transplantation Recipients and Other Immunocompromised Patients: A Prospective Study|Completed||N/A|217|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.606382|2017-10-11 04:34:49.606382
NCT00026780|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||April 18, 2001||2001-04-18|March 7, 2017|2017-03-07||||||||Observational|||Eligibility Screening for a NCI Pediatric Oncology Branch Research Study|Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols|Enrolling by invitation||N/A|1416|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.693449|2017-10-11 04:34:49.693449
NCT00026806|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||July 2001||2001-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Long-Term Survival With HIV: Psychological and Behavioral Factors Associated With the Transition From Adolescence to Young Adulthood|Long-Term Survival With HIV: A Study of the Psychological and Behavioral Factors Associated With the Transition From Adolescence To Young Adulthood|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:49.928953|2017-10-11 04:34:49.928953
NCT00026819|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||November 2001||2001-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction|Pre-Emptive Analgesic Effects of a Selective COX-2 Inhibitor (Rofecoxib) in the Oral Surgery Model|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.026557|2017-10-11 04:34:50.026557
NCT00026832|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||October 4, 2001||2001-10-04|November 27, 2012|2012-11-27|November 27, 2012||2012-11-27|||||Observational|||Examination of Brain Serotonin Receptors in Patients With Mood Disorders|Serotonin1A Receptor and Serotonin Transporter Imaging In Mood Disorders|Completed||N/A|214|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.122847|2017-10-11 04:34:50.122847
NCT00026858|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||October 1994||1994-10-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Interventional|||Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts|Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.222028|2017-10-11 04:34:50.222028
NCT00026871|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||July 1997||1997-07-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System|Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.310608|2017-10-11 04:34:50.310608
NCT00037414|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-08-19|||September 2001||2001-09-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Joint Determinants of Bone Density and CVD Calcification||Completed||N/A|||University of Maryland|||||f||||||||||||||2017-10-11 04:35:31.590457|2017-10-11 04:35:31.590457
NCT00026884|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2017-10-05|||July 10, 1997||1997-07-10|August 3, 2017|2017-08-03||||||||Observational|||Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease|Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.391177|2017-10-11 04:34:50.391177
NCT00026897|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||December 1997||1997-12-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer|Trafficking of Indium-111-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.520306|2017-10-11 04:34:50.520306
NCT00026910|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||July 1998||1998-07-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma|Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.64994|2017-10-11 04:34:50.64994
NCT00026923|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||January 1999||1999-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||A Phase II Evaluation of Telesurgery Systems|A Phase II Evaluation of Telesurgery Systems|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.767176|2017-10-11 04:34:50.767176
NCT00026936|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||May 1999||1999-05-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning|A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning|Completed||Phase 2|140||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.837095|2017-10-11 04:34:50.837095
NCT00026949|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||August 1999||1999-08-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Study of Etoposide in Breast Cancer Patients|Pharmacokinetics of Etoposide in Patients With Breast Cancer Receiving High-Dose Etoposide|Completed||N/A|33||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.925928|2017-10-11 04:34:50.925928
NCT00026962|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-14|2008-03-03|||September 1999||1999-09-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Effects of Raloxifene on Hormone Levels|Assessment of the Effects of Raloxifene on Salivary Estradiol and Progesterone Levels|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:50.997121|2017-10-11 04:34:50.997121
NCT00026975|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-15|2006-08-17|||September 2000||2000-09-01|August 2006|2006-08-01|August 2005||2005-08-01|||||Interventional|||Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients|Clinical Outcomes Modeling for Laryngectomy Surgery Patients and Efficacy of Hyperbaric Oxygen Therapy|Completed||Phase 2|150||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:51.071519|2017-10-11 04:34:51.071519
NCT00026988|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-15|2006-08-17|||October 2001||2001-10-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Creatine Therapy for Huntington's Disease|Creatine Therapy for Huntington's Disease|Completed||Phase 1/Phase 2|64||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:51.137459|2017-10-11 04:34:51.137459
NCT00027001|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-15|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|June 2003||2003-06-01|||||Interventional|||Qigong Therapy For Heart Device Patients|Qigong Therapy for Heart Device Patients|Completed||N/A|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:51.205711|2017-10-11 04:34:51.205711
NCT00027014|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-15|2007-02-07|||September 2001||2001-09-01|July 2006|2006-07-01|May 2005||2005-05-01|||||Interventional|||Herb-Opioid Interactions|Herb-Opioid Interactions|Completed||Phase 4|54||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:51.270796|2017-10-11 04:34:51.270796
NCT00027027|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-15|2015-07-24|2015-06-26||November 2001||2001-11-01|July 2015|2015-07-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional||The baseline analysis population included all participants that were enrolled into one of the 5 treatment groups.|Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors|A Phase I, Open-Label, Multicenter, Dose-Escalation Study of the Safety and Pharmacokinetics of a Recombinant Humanized Antibody to Her2 (rhuMAb 2C4) Administered Every 3 Weeks to Subjects With Advanced Solid Malignancies|Completed||Phase 1|21|Actual|Genentech, Inc.||5|||f||||||||||||||2017-10-11 04:34:51.395278|2017-10-11 04:34:51.395278
NCT00027040|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-16|2015-01-15||||||October 2012|2012-10-01|June 2005|Actual|2005-06-01|||||Interventional|||A Study of Decreased Mental Function Associated With HIV|HIV-Associated Cognitive Impairment and Oxidative Stress: An In Vivo Proton Magnetic Resonance Spectroscopy Study of Cerebral Injury|Completed||N/A|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:34:53.191554|2017-10-11 04:34:53.191554
NCT00027053|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-19|2010-05-11|||June 2002||2002-06-01|March 2006|2006-03-01|June 2006|Actual|2006-06-01|January 2006|Actual|2006-01-01||Interventional|SIESTA||Trazodone for Sleep Disturbance in Early Alcohol Recovery|Trazodone for Sleep Disturbance - Early Alcohol Recovery|Completed||Phase 2|173|Actual|Rhode Island Hospital||2|||f||||f||||||||||2017-10-11 04:34:53.307787|2017-10-11 04:34:53.307787
NCT00027066|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-20|2011-06-16|||June 1993||1993-06-01|June 2011|2011-06-01|November 2001|Actual|2001-11-01|June 2000|Actual|2000-06-01||Interventional|||Warfarin Versus Aspirin Recurrent Stroke Study|A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke|Completed||Phase 3|2206||Columbia University||2|||f||||f||||||||||2017-10-11 04:34:53.403297|2017-10-11 04:34:53.403297
NCT00027079|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-20|2007-12-07|||September 2001||2001-09-01|December 2007|2007-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)||Completed||Phase 2|360||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:34:53.492555|2017-10-11 04:34:53.492555
NCT00027092|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-20|2008-08-06||||||February 2004|2004-02-01||||||||Observational|||Use of a Test That Evaluates How the Body Handles Insulin and Glucose|AACTG Modified Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT) for the Assessment of Insulin Sensitivity: A Substudy of A5079|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:34:53.547179|2017-10-11 04:34:53.547179
NCT00034554|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-30|2010-04-08|||March 2002||2002-03-01|December 2009|2009-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Study of gp75 Vaccine in Patients With Stage III and IV Melanoma|Phase I Study of gp75 DNA Vaccine in Patients With AJCC Stage III and IV Melanoma|Completed||Phase 1|31|Actual|ImClone LLC||5|||f||||f||||||||||2017-10-11 04:34:56.594891|2017-10-11 04:34:56.594891
NCT00027105|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-20|2017-10-05|||November 16, 2001||2001-11-16|August 17, 2016|2016-08-17|August 17, 2016||2016-08-17|||||Observational|||Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer|Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer: A Multi-Institutional Study Between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the Walter Reed National Military Medical Center (WRNMMC) Breast Care Center|Completed||N/A|165|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:53.617686|2017-10-11 04:34:53.617686
NCT00027118|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-20|2017-10-05|||November 16, 2001||2001-11-16|August 17, 2016|2016-08-17|August 17, 2016||2016-08-17|||||Observational|||Morbidity After Diagnosis and Treatment of Breast Cancer Patients|A Prospective (Cohort) Study to Identify Factors Affecting Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer: A Multi-Institutional Study Between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the Walter Reed National Military Medical Center (WRNMMC) Breast Care Center (BCC)|Completed||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:53.707107|2017-10-11 04:34:53.707107
NCT00027131|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-27|2008-10-07|||December 2000||2000-12-01|October 2008|2008-10-01|October 2002||2002-10-01|||||Interventional|||Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70|Vaccination Against High Risk Breast Cancer With Autologous Tumor-Derived Heat Shock Protein 70-Peptide Complexes (HSP70)|Terminated||Phase 1/Phase 2|15||UConn Health||||difficulty with accrual|||||||||||||||2017-10-11 04:34:53.77818|2017-10-11 04:34:53.77818
NCT00027144|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-27|2005-06-23|||December 2000||2000-12-01|November 2001|2001-11-01|October 2002||2002-10-01|||||Interventional|||Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase|A Feasibility and Toxicity Study of Vaccination With HSP70 for the Treatment of Chronic Myelogenous Leukemia in the Chronic Phase|Completed||Phase 1|10||UConn Health|||||||||||||||||||2017-10-11 04:34:53.842967|2017-10-11 04:34:53.842967
NCT00027157|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-27|2008-03-03|||April 2000||2000-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Determination of Variances in Exhaled Nitric Oxide Output in Normal Healthy Male Volunteers Consuming High and Low Nitrate/Nitrite Diets|The Determination of Variances in Exhaled Nitric Oxide Output in Normal Healthy Male Volunteers Consuming High and Low Nitrate/Nitrite Diets|Completed||N/A|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:53.898782|2017-10-11 04:34:53.898782
NCT00027170|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-27|2017-10-05|||November 16, 2001||2001-11-16|September 25, 2017|2017-09-25||||||||Observational|||Technical Development of Cardiovascular Magnetic Resonance Imaging|Technical Development of Cardiovascular Magnetic Resonance Imaging|Recruiting||N/A|99999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:53.952392|2017-10-11 04:34:53.952392
NCT00027183|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-27|2017-10-05|||February 4, 1998||1998-02-04|March 2, 2017|2017-03-02||||||||Observational|||Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa|Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa|Recruiting||N/A|225|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:55.638119|2017-10-11 04:34:55.638119
NCT00027196|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-27|2008-03-03|||April 1998||1998-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease|Clinical Correlates of Molecular Defects in Familial Cardiomyopathy|Completed||N/A|9999999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:55.710706|2017-10-11 04:34:55.710706
NCT00027209|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-28|2006-05-12||||||November 2005|2005-11-01||||||||Interventional|||Hormone Replacement in Menopausal Women With Epilepsy||Completed||Phase 2|125||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:34:55.774631|2017-10-11 04:34:55.774631
NCT00027222|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-28|2005-06-23|||October 2001||2001-10-01|December 2003|2003-12-01||||||||Interventional|||The Early Treatment for Retinopathy of Prematurity Study (ETROP)|The Early Treatment for Retinopathy of Prematurity Study (ETROP)|Unknown status|Active, not recruiting|Phase 2/Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:34:55.835094|2017-10-11 04:34:55.835094
NCT00027235|ClinicalTrials.gov processed this data on October 10, 2017|2001-11-28|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Popcorn Lung: the Discovery of a New Disease|Popcorn Lung: the Discovery of a New Disease|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:34:55.942384|2017-10-11 04:34:55.942384
NCT00034489|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-29|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.|A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.|Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:56.011191|2017-10-11 04:34:56.011191
NCT00034502|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-29|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.||Completed||Phase 1/Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:56.078011|2017-10-11 04:34:56.078011
NCT00034515|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-29|2015-02-13|||June 2001||2001-06-01|February 2015|2015-02-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||A Study in Adult and Pediatric Patients With Cystic Fibrosis|Ph 1b/2a Study to Assess Levels of INS37217 and Placebo Treatment With Maximum Tolerated Dose Administered by Inhalation Via the Pari LC Star Nebulizer in Adult and Pediatric CF Patients|Completed||Phase 1/Phase 2|63|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:34:56.14974|2017-10-11 04:34:56.14974
NCT00034528|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-30|2013-04-30|||September 2001||2001-09-01|April 2013|2013-04-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia|Allogeneic Stem Cell Transplantation Following Nonmyeloablative Chemotherapy in Patients With Hemoglobinopathies|Terminated||Phase 2|2|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Due to slow recruitment|f||||||||||||||2017-10-11 04:34:56.209225|2017-10-11 04:34:56.209225
NCT00034541|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-30|2010-04-08|||December 2000||2000-12-01|April 2010|2010-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer|Phase Ib/IIa Study of an Anti-Epidermal Growth Factor Receptor (EGFr) Antibody Cetuximab in Combination With Carboplatin-Paclitaxel in Patients With Chemotherapy-Naive Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|32|Actual|ImClone LLC||1|||f||||f||||||||||2017-10-11 04:34:56.304391|2017-10-11 04:34:56.304391
NCT00034567|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-30|2007-09-14||||||September 2007|2007-09-01||||||||Observational|||Healthy Aging and Memory Study|Alzheimer's Disease Prevention Instrument Protocol|Completed||N/A|650||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:34:56.775675|2017-10-11 04:34:56.775675
NCT00034580|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-30|2006-07-18|||August 2001||2001-08-01|July 2006|2006-07-01|August 2002||2002-08-01|||||Interventional|||Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder|Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed|Completed||Phase 4|326||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:57.019431|2017-10-11 04:34:57.019431
NCT00034593|ClinicalTrials.gov processed this data on October 10, 2017|2002-04-30|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:57.167098|2017-10-11 04:34:57.167098
NCT00034606|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||Comparing 3 Schedules of Alimta Plus Gemzar||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:57.251556|2017-10-11 04:34:57.251556
NCT00034619|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:57.319634|2017-10-11 04:34:57.319634
NCT00034632|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2017-03-07|||April 2001||2001-04-01|March 2017|2017-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)|Open Label, Treatment Protocol for the Safety and Efficacy of Posaconazole (SCH 56592) in the Treatment of Invasive Fungal Infections|Completed||Phase 3|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:34:57.435691|2017-10-11 04:34:57.435691
NCT00034645|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2017-03-07|||January 1999||1999-01-01|March 2017|2017-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease||Completed||Phase 3|600|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:34:57.50903|2017-10-11 04:34:57.50903
NCT00034658|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2017-03-07|||December 1998||1998-12-01|March 2017|2017-03-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)|Open Label, Treatment Protocol for the Safety and Efficacy of Posaconazole (SCH 56592) in the Treatment of Invasive Fungal Infections|Completed||Phase 3|336|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:34:57.583342|2017-10-11 04:34:57.583342
NCT00034671|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2015-12-30|||January 2001||2001-01-01|December 2015|2015-12-01|March 2002|Actual|2002-03-01|November 2001|Actual|2001-11-01||Interventional|||PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)|Phase II Study of Safety, Tolerance, Efficacy, and Pharmacokinetics of Posaconazole (SCH 56592) for the Treatment of Invasive Fungal Infections in Immunocompromised Hosts|Completed||Phase 2|98|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:34:57.657184|2017-10-11 04:34:57.657184
NCT00034684|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2015-06-16|||July 2001||2001-07-01|June 2015|2015-06-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)|Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia|Completed||Phase 1/Phase 2|132|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:34:57.750973|2017-10-11 04:34:57.750973
NCT00034697|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2017-05-22|||June 28, 2001|Actual|2001-06-28|May 2017|2017-05-01|January 30, 2003|Actual|2003-01-30|January 30, 2003|Actual|2003-01-30||Interventional|||Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)|A Phase II Study of Temozolomide (SCH 52365) in Subjects With Brain Metastasis From Non-Small-Cell Lung Cancer|Terminated||Phase 2|24|Actual|Merck Sharp & Dohme Corp.||||Slow Enrollment|||||||||||||||2017-10-11 04:34:57.864406|2017-10-11 04:34:57.864406
NCT00034710|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2006-02-06|||March 2002||2002-03-01|February 2006|2006-02-01|October 2002||2002-10-01|||||Interventional|||Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain|A Double-Blind Controlled Pilot Study of High-Dose Capsaicin Patches in the Treatment of Pain Associated With Postherpetic Neuralgia|Completed||Phase 2|42||NeurogesX|||||||||||||||||||2017-10-11 04:34:57.930818|2017-10-11 04:34:57.930818
NCT00034723|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-01|2008-03-03|||April 2002||2002-04-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis|MRI Investigation Of The CNS In HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:58.025583|2017-10-11 04:34:58.025583
NCT00034736|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-06-06|||August 2002||2002-08-01|December 2010|2010-12-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting|A Multicenter, Randomized, Open-Label, Comparative Study to Compare the Efficacy and Safety of Levofloxacin and Standard of Care Therapy in the Treatment of Children With Community-Acquired Pneumonia in the Hospitalized or Outpatient Setting|Completed||Phase 3|691|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:34:58.107783|2017-10-11 04:34:58.107783
NCT00034749|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-06-06|||April 2001||2001-04-01|March 2010|2010-03-01|March 2006|Actual|2006-03-01|||||Interventional|||The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia|The Efficacy and Safety of Risperidone in Adolescents With Schizophrenia: a Comparison of Two Dose Ranges of Risperidone|Completed||Phase 3|279|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:34:58.182669|2017-10-11 04:34:58.182669
NCT00034762|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-01-31|||December 2000||2000-12-01|January 2011|2011-01-01|January 2003|Actual|2003-01-01|||||Interventional|||Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease|Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer's Disease.|Completed||Phase 3|473|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:34:58.245997|2017-10-11 04:34:58.245997
NCT00034775|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-01-07|||August 2001||2001-08-01|January 2011|2011-01-01|October 2002|Actual|2002-10-01|||||Interventional|||A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.|Open-Label Trial Exploring A Switching Regimen From Oral Neuroleptics, Other Than Risperidone, To Risperidone Depot Microspheres|Completed||Phase 3|141|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:34:58.316976|2017-10-11 04:34:58.316976
NCT00034788|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-06-06|||December 2000||2000-12-01|March 2010|2010-03-01|February 2004|Actual|2004-02-01|||||Interventional|||A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX|A Multicenter Clinical Evaluation of the Efficacy and Safety of REGRANEX Gel in the Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers|Terminated||Phase 3|84|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||Slow recruitment; Study did not address safety concern raised by European Medicines Agency|||||f||||||||||2017-10-11 04:34:58.541092|2017-10-11 04:34:58.541092
NCT00034801|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2006-07-18|||September 2001||2001-09-01|July 2006|2006-07-01|March 2003||2003-03-01|||||Interventional|||Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia|A Controlled Trial of Olanzapine Versus Active Comparator in the Treatment of Schizophrenic and Schizoaffective Subjects With Comorbid Depression|Completed||Phase 4|378||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:34:58.632818|2017-10-11 04:34:58.632818
NCT00034814|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-03-15|||January 2002||2002-01-01|March 2011|2011-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Multicenter Trial for Adults With Partial Seizures|Efficacy and Safety of Talampanel as Adjunctive Therapy in Patients With Partial Seizures: A Phase II Clinical Trial.|Completed||Phase 2|190|Actual|Teva Pharmaceutical Industries||6|||f||||||||||||||2017-10-11 04:34:58.779485|2017-10-11 04:34:58.779485
NCT00035386|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2008-03-03|||April 2002||2002-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study|Trans-Right Ventricular Approach to Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Feasibility Study|Completed||Phase 2|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:34:58.870065|2017-10-11 04:34:58.870065
NCT00035399|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2008-08-11|||March 2002||2002-03-01|August 2008|2008-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy of Acupuncture With Physical Therapy for Knee Osteo-Arthritis|Efficacy of Acupuncture With Physical Therapy for Knee Osteo-Arthritis|Completed||Phase 3|300|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:34:58.97206|2017-10-11 04:34:58.97206
NCT00035412|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2006-08-17|||December 2001||2001-12-01|July 2006|2006-07-01|August 2004||2004-08-01|||||Interventional|||St. John's Wort Versus Placebo in Social Phobia|St. John's Wort Versus Placebo in Social Phobia|Completed||Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:59.055538|2017-10-11 04:34:59.055538
NCT00035425|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2009-11-30|||November 2001||2001-11-01|November 2009|2009-11-01|November 2002|Actual|2002-11-01|||||Interventional|||Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection|A Randomized, Double-Blind Trial Comparing Linezolid To Vancomycin In The Empiric Treatment Of Febrile Neutropenic Oncology Patients With Suspected Gram-Positive Infections|Completed||Phase 3|120|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:34:59.135847|2017-10-11 04:34:59.135847
NCT00035438|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2006-08-03|||May 2002||2002-05-01|August 2006|2006-08-01|September 2003||2003-09-01|||||Interventional|||St. John’s Wort Vs. Placebo in Obsessive-Compulsive Disorder.|St. John’s Wort Vs. Placebo in Obsessive-Compulsive Disorder.|Completed||Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:34:59.326155|2017-10-11 04:34:59.326155
NCT00035451|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2011-09-30|||February 2001||2001-02-01|September 2011|2011-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.|Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.|Completed||Phase 3|658|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 04:34:59.443378|2017-10-11 04:34:59.443378
NCT00035464|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2011-09-30|||December 2000||2000-12-01|September 2011|2011-09-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.|Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients|Completed||Phase 3|431|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 04:34:59.807851|2017-10-11 04:34:59.807851
NCT00035477|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2011-09-30|||September 2000||2000-09-01|September 2011|2011-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation|Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation|Completed||Phase 3|446|Actual|Forest Laboratories||2|||f||||f||||||||||2017-10-11 04:35:00.099454|2017-10-11 04:35:00.099454
NCT00035490|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2011-09-30|||September 2001||2001-09-01|September 2011|2011-09-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators|Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators|Completed||Phase 3|633|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 04:35:00.684499|2017-10-11 04:35:00.684499
NCT00035503|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2013-02-20|||January 2002||2002-01-01|February 2013|2013-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Multicenter Trial For Patients With Acute Crohn's Disease||Completed||Phase 2|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 04:35:01.076119|2017-10-11 04:35:01.076119
NCT00035516|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2016-02-09|||February 2001||2001-02-01|February 2016|2016-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy||Completed||Phase 2|||R-Pharm|||||||||||||||||||2017-10-11 04:35:01.171041|2017-10-11 04:35:01.171041
NCT00035529|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2010-12-02||2010-09-03|November 2001||2001-11-01|December 2010|2010-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis|A Phase II,Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Preliminary Efficacy, Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-Remitting Multiple Sclerosis|Terminated||Phase 2|||Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 04:35:01.312531|2017-10-11 04:35:01.312531
NCT00035542|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2011-04-07||2010-02-15|December 2001||2001-12-01|April 2011|2011-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.||Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:35:01.477513|2017-10-11 04:35:01.477513
NCT00035555|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2013-11-27|2013-09-04||March 2001||2001-03-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|January 2004|Actual|2004-01-01||Interventional||Baseline characteristics are provided for all patients who were randomized and received transplants; participant flow is provided for all randomized participants who received treatment.|Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney|Phase II/III, Open-Label, Randomized, Controlled, Multiple-Dose Study of Efficacy and Safety of BMS-224818 (Belatacept) as Part of a Quadruple Drug Regimen in First Renal Transplant Recipients|Completed||Phase 2|230|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 04:35:01.82919|2017-10-11 04:35:01.82919
NCT00035568|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2011-04-07||2010-02-15|February 2002||2002-02-01|April 2011|2011-04-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes||Completed||Phase 4|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:35:05.540343|2017-10-11 04:35:05.540343
NCT00035581|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2013-04-16|||May 2001||2001-05-01|April 2013|2013-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART|A Multi-Center, Randomized, Controlled Study of the Biological Actions of Ampligen as an Adjunct to HAART in HIV Disease|Terminated||Phase 2|16|Actual|Hemispherx Biopharma||2|||f||||f||||||||||2017-10-11 04:35:05.623712|2017-10-11 04:35:05.623712
NCT00035594|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2013-05-07|||February 2002||2002-02-01|May 2013|2013-05-01|June 2004|Actual|2004-06-01|February 2004|Actual|2004-02-01||Interventional|||Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy|A Double-Blind, Placebo-Controlled, Multicenter, Randomized Study Evaluating the Prophylactic Use of Pegfilgrastim on the Incidence of Febrile Neutropenia in Subjects With Advanced Breast Cancer Treated With Single Agent Docetaxel|Completed||Phase 3|928||Amgen||2|||f||||||||||||||2017-10-11 04:35:05.721808|2017-10-11 04:35:05.721808
NCT00035607|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2013-05-09|||December 2001||2001-12-01|May 2013|2013-05-01|April 2003|Actual|2003-04-01|December 2002|Actual|2002-12-01||Interventional|||Chemotherapy Related Anemia|A Randomized, Open-label, Multicenter Study of Subcutaneous and Intravenous Administration of Darbepoetin Alfa (Novel Erythropoiesis Stimulating Protein, NESP) for the Treatment of Anemia in Subjects With Non-myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 2|120|Actual|Amgen||2|||f||||||||||||||2017-10-11 04:35:05.799556|2017-10-11 04:35:05.799556
NCT00035620|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-03|2010-02-25|||April 2000||2000-04-01|February 2010|2010-02-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy|A Study of Single Dose Per Cycle Filgrastim-SD/01 as an Adjunct to VAdriaC/IE Chemotherapy in Pediatric Sarcoma Patients|Completed||Phase 2|44|Actual|Amgen||2|||f||||||||||||||2017-10-11 04:35:05.886251|2017-10-11 04:35:05.886251
NCT00035633|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2011-04-07||2010-01-28|December 2001||2001-12-01|January 2010|2010-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen||Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:35:05.975301|2017-10-11 04:35:05.975301
NCT00035659|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2015-10-26|||April 2002||2002-04-01|October 2015|2015-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Longitudinal Study of the Menopause and Fat Patterning||Completed||N/A|868|Actual|Rush University Medical Center|||1||f||||||||||||||2017-10-11 04:35:06.114977|2017-10-11 04:35:06.114977
NCT00035672|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2008-04-22|||March 2002||2002-03-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Genetic Predictors of Incident Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:06.200211|2017-10-11 04:35:06.200211
NCT00035685|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2016-02-17|||December 2001||2001-12-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|||||Observational|||Exposure of Children With Asthma to Household Environmental Tobacco Smoke||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:06.258961|2017-10-11 04:35:06.258961
NCT00035698|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2017-03-16|||December 2001||2001-12-01|March 2017|2017-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Epidemiological and Genetic Studies of Body Mass Index|Epidemiological and Genetic Studies of Body Mass Index|Completed||N/A|1027|Actual|Boston University|||1||f||||f|f|f||||None Retained|"     This study ended years ago, I do not know why I am being asked to update it as a clinical     trial. It was never a clinical trial.   "|No||2017-10-11 04:35:06.323589|2017-10-11 04:35:06.323589
NCT00035711|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2016-03-15|||September 2001||2001-09-01|November 2005|2005-11-01|August 2004|Actual|2004-08-01|||||Observational|||VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:06.386881|2017-10-11 04:35:06.386881
NCT00035724|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2016-07-28|||April 2002||2002-04-01|May 2009|2009-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Monitoring Community Trends in Heart Failure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:06.445462|2017-10-11 04:35:06.445462
NCT00035737|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2014-02-20|||May 2002||2002-05-01|February 2014|2014-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Vascular Function in the Framingham Third Generation||Completed||N/A|||Boston University|||||f||||||||||||||2017-10-11 04:35:06.504865|2017-10-11 04:35:06.504865
NCT00035750|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2016-01-28|||September 2001||2001-09-01|January 2016|2016-01-01|August 2005||2005-08-01|||||Observational|||Risk Factors for Atherogenesis in Type 1 Diabetes||Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:35:06.567851|2017-10-11 04:35:06.567851
NCT00035763|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2016-03-23|||October 2001||2001-10-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Pain in Sickle Cell Epidemiologic Study|Pain in Sickle Cell Epidemiologic Study|Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-10-11 04:35:06.622803|2017-10-11 04:35:06.622803
NCT00035776|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-04|2016-03-15|||January 2001||2001-01-01|January 2006|2006-01-01|December 2005|Actual|2005-12-01|||||Observational|||Blood Factors and Peripheral Arterial Disease Outcomes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:06.677499|2017-10-11 04:35:06.677499
NCT00035789|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-05|2011-04-07||2010-01-28|November 2001||2001-11-01|January 2010|2010-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen||Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:35:06.737426|2017-10-11 04:35:06.737426
NCT00035802|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2011-06-23|||January 2002||2002-01-01|June 2011|2011-06-01|April 2002|Actual|2002-04-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder|A Randomized, Double-Blind, Multicenter, Placebo-Controlled 4-Week Study of the Safety and Efficacy of Topiramate in Adolescents With Acute Manic or Mixed Episodes of Bipolar I Disorder, With an Optional 6-Month Open-Label Extension|Completed||Phase 3|13|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-10-11 04:35:06.850219|2017-10-11 04:35:06.850219
NCT00035815|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2013-02-13|2009-11-17||June 2003||2003-06-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial|Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 3|330|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 04:35:06.996974|2017-10-11 04:35:06.996974
NCT00035828|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2005-06-23|||December 2001||2001-12-01|July 2003|2003-07-01|December 2002||2002-12-01|||||Interventional|||A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD||Completed||Phase 2|150||Abgenix|||||||||||||||||||2017-10-11 04:35:07.454188|2017-10-11 04:35:07.454188
NCT00035841|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2011-07-21|||April 2002||2002-04-01|June 2011|2011-06-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Phase 2 Study of TLK286 in Metastatic Breast Cancer|Phase 2 Study of TLK286 in Metastatic Breast Cancer|Completed||Phase 2|60||Telik|||||f||||||||||||||2017-10-11 04:35:07.51768|2017-10-11 04:35:07.51768
NCT00035854|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2009-08-13|||February 2002||2002-02-01|August 2009|2009-08-01|May 2004|Actual|2004-05-01|||||Interventional|||New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)|Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children|Completed||Phase 3|13|Actual|Pfizer|||||||||||||||||||2017-10-11 04:35:07.586275|2017-10-11 04:35:07.586275
NCT00035867|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2008-05-30|||April 2002||2002-04-01|June 2005|2005-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome|Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome|Completed||Phase 1/Phase 2|65||Telik|||||||||||||||||||2017-10-11 04:35:07.683953|2017-10-11 04:35:07.683953
NCT00035880|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2005-06-23|||October 1999||1999-10-01|July 2003|2003-07-01|June 2003||2003-06-01|||||Interventional|||Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease|A Phase II/III, Multicenter, Open Label, Randomized Clinical Trial Evaluating ABX-CBL When Compared to Atgam as Second Line Therapy in Patients With Steroid Resistant Acute Graft Versus Host Disease|Completed||Phase 2/Phase 3|95||Abgenix|||||||||||||||||||2017-10-11 04:35:07.753365|2017-10-11 04:35:07.753365
NCT00035893|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2013-04-16|||May 2001||2001-05-01|April 2013|2013-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART|The Role of Ampligen in Strategic Therapeutic Intervention (STI) of Highly Active Anti-Retroviral Therapy (HAART): A Multi-Center, Randomized, Controlled Study of Ampligen Potentiation of the HAART-Free Interval.|Completed||Phase 2|40|Actual|Hemispherx Biopharma||2|||f||||f||||||||||2017-10-11 04:35:07.813334|2017-10-11 04:35:07.813334
NCT00035906|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2011-05-27|||October 2001||2001-10-01|May 2011|2011-05-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Research Study in Patients With Persistent Macular Edema|Research Study in Patients With Persistent Macular Edema Due to Diabetic Retinopathy, Retinal Vein Occlusion, Uveitis, or Irvine-Gass Syndrome|Completed||Phase 2|315|Actual|Allergan|||||f||||||||||||||2017-10-11 04:35:07.915754|2017-10-11 04:35:07.915754
NCT00035919|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2014-05-20|||November 2002||2002-11-01|May 2014|2014-05-01|October 2003||2003-10-01|||||Interventional|||Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver|Tumor Site Specific Phase I Evaluation of Safety of Hepatic Arterial Infusion of a Matrix-Targeted Retroviral Vector Bearing a Dominant Negative Cyclin G1 Construct as Intervention for Colorectal Carcinoma Metastatic to Liver|Withdrawn||Phase 1/Phase 2|0|Actual|University of Southern California||||Never received final IRB approval for amendments, so never opened officially|f||||||||||||||2017-10-11 04:35:07.985867|2017-10-11 04:35:07.985867
NCT00035932|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2010-11-29|2010-10-14||November 2001||2001-11-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|July 2003|Actual|2003-07-01||Interventional|||Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV|Phase III Open Label Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV|Completed||Phase 3|571|Actual|Bristol-Myers Squibb||3|||t||||f||||||||||2017-10-11 04:35:08.116249|2017-10-11 04:35:08.116249
NCT00035945|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-06|2007-10-15||||||October 2007|2007-10-01||||||||Interventional|||ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections||Completed||Phase 2|||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:35:11.532822|2017-10-11 04:35:11.532822
NCT00035958|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2013-07-31|||August 2002||2002-08-01|July 2013|2013-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis|Toward Improved Understanding of Pathogenesis and Treatment of Childhood Onset Dermatomyositis|Terminated||Phase 2/Phase 3|75||Children's Hospital Medical Center, Cincinnati||||"Incorporating the recommendations of the NIH-formed DSMB in the study procedures would make the   project budget over the limit for this funding mechanism."|||||||||||||||2017-10-11 04:35:11.610731|2017-10-11 04:35:11.610731
NCT00035971|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||EVA: Evista Alendronate Comparison||Completed||Phase 4|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:35:11.694603|2017-10-11 04:35:11.694603
NCT00035984|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2015-02-23|||May 2002||2002-05-01|January 2015|2015-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus|A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Twice Daily in Subjects With Type 2 Diabetes Mellitus Treated With Metformin and a Sulfonylurea|Completed||Phase 3|734|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 04:35:12.227569|2017-10-11 04:35:12.227569
NCT00035997|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2009-11-20|||April 2002||2002-04-01|November 2009|2009-11-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis|An Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Mineral Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis|Completed||Phase 4|261|Actual|Novartis|||||||||||||||||||2017-10-11 04:35:12.728682|2017-10-11 04:35:12.728682
NCT00036023|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2009-05-07||||||May 2009|2009-05-01||||||||Interventional|||Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies|A Randomized, Open-Label, Dose-Timing Study of Darbepoetin Alfa Administered Once Every 3 Weeks (Q3W) by Subcutaneous (SC) Injection for Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 2|||Amgen||1|||||||||||||||||2017-10-11 04:35:13.047762|2017-10-11 04:35:13.047762
NCT00036036|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2011-10-14|||July 2001||2001-07-01|October 2011|2011-10-01|July 2003|Actual|2003-07-01|||||Interventional|||Study of CP-461 in Patients With Advanced Renal Cell Cancer|Phase II Study of CP-461 in Patients With Advanced Renal Cell Cancer|Completed||Phase 2|14||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:35:13.164513|2017-10-11 04:35:13.164513
NCT00036062|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2006-07-18|||August 2001||2001-08-01|July 2006|2006-07-01|December 2002||2002-12-01|||||Interventional|||A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury|A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury|Completed||Phase 1/Phase 2|600||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:35:13.269098|2017-10-11 04:35:13.269098
NCT00036075|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2011-10-14|||August 2001||2001-08-01|October 2011|2011-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Study Using CP-461 to Treat Advanced Prostate Cancer||Completed||Phase 2|25||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:35:13.648503|2017-10-11 04:35:13.648503
NCT00036088|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2006-07-18|||August 2001||2001-08-01|July 2006|2006-07-01|July 2002||2002-07-01|||||Interventional|||Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia||Completed||Phase 4|530||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:35:13.748723|2017-10-11 04:35:13.748723
NCT00036101|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2013-11-07|||February 2002||2002-02-01|September 2007|2007-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:35:14.372851|2017-10-11 04:35:14.372851
NCT00036114|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2013-11-07|||March 2000||2000-03-01|April 2011|2011-04-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:35:15.094051|2017-10-11 04:35:15.094051
NCT00036127|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-07|2013-11-07|||April 2002||2002-04-01|September 2007|2007-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders||Completed||Phase 2/Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:35:15.271229|2017-10-11 04:35:15.271229
NCT00036140|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2005-06-23||||||March 2004|2004-03-01||||||||Interventional|||Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma||Completed||Phase 1|||Pfizer|||||||||||||||||||2017-10-11 04:35:15.452472|2017-10-11 04:35:15.452472
NCT00036153|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2012-03-26|||March 2002||2002-03-01|December 2011|2011-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis|A Randomized, Double-Blind Study to Assess the Efficacy of Tacrolimus (Prograf®)+ Methotrexate Vs. Placebo + Methotrexate in the Treatment of Rheumatoid Arthritis in Patients With Partial Response to Methotrexate|Completed||Phase 3|210||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:35:15.547313|2017-10-11 04:35:15.547313
NCT00036166|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2015-06-12|||January 1999||1999-01-01|June 2015|2015-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study of FK463 for the Treatment of Invasive Aspergillosis|An Open-Label, Non-Comparative Study of FK463 for the Treatment of Invasive Aspergillosis|Completed||Phase 2|326|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-10-11 04:35:15.749243|2017-10-11 04:35:15.749243
NCT00036179|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2015-06-12|||February 1999||1999-02-01|June 2015|2015-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis|An Open-Label, Non-Comparative Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis|Completed||Phase 2|75|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-10-11 04:35:15.901979|2017-10-11 04:35:15.901979
NCT00036192|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2011-12-08|||February 2002||2002-02-01|December 2011|2011-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea|A Randomized, Double-Blind, Placebo-Controlled Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea|Completed||Phase 2|200||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:35:16.043778|2017-10-11 04:35:16.043778
NCT00036205|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2007-01-17|||August 2000||2000-08-01|January 2007|2007-01-01|December 2004||2004-12-01|||||Interventional|||Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease|Open-Label, Long Term, Flexible Dose Study Of Safety, Tolerability, And Therapeutic Response In Patients With Parkinson's Disease.|Terminated||Phase 3|984||Pfizer|||||||||||||||||||2017-10-11 04:35:16.204437|2017-10-11 04:35:16.204437
NCT00036218|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2006-06-06|||December 2001||2001-12-01|June 2006|2006-06-01|April 2003||2003-04-01|||||Interventional|||Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.|A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Comparing the Efficacy, Safety, and Tolerability of Sumanirole Versus Placebo or Ropinirole in Patients With Early Parkinson's Disease.|Completed||Phase 3|600||Pfizer|||||||||||||||||||2017-10-11 04:35:16.505921|2017-10-11 04:35:16.505921
NCT00036231|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2005-11-17|||April 2002||2002-04-01|August 2005|2005-08-01||||||||Interventional|||Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism and Gastrointestinal Dysfunction|Terminated||Phase 3|||Repligen Corporation|||||||||||||||||||2017-10-11 04:35:16.974694|2017-10-11 04:35:16.974694
NCT00036244|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2005-08-04|||April 2002||2002-04-01|August 2005|2005-08-01|January 2004||2004-01-01|||||Interventional|||Synthetic Human Secretin in Children With Autism|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism|Completed||Phase 3|||Repligen Corporation|||||||||||||||||||2017-10-11 04:35:17.043359|2017-10-11 04:35:17.043359
NCT00036257|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2011-10-14|||March 2002||2002-03-01|October 2011|2011-10-01|April 2003|Actual|2003-04-01|||||Interventional|||Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia||Completed||Phase 1|15||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:35:17.142035|2017-10-11 04:35:17.142035
NCT00036270|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2015-10-06|2009-10-30||August 2001||2001-08-01|October 2015|2015-10-01|February 2011|Actual|2011-02-01|October 2008|Actual|2008-10-01||Interventional|TEAM||Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane|Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen For 2.5- 3 Years Followed By Exemestane (Aromasin) For A Total Of 5 Years As Adjuvant Therapy For Postmenopausal, Receptor Positive, Node Negative or Node Positive Breast Cancer Patients|Completed||Phase 3|9779|Actual|Pfizer|Overall Survival was reported as number of events which otherwise reported as time.|2|||f||||t||||||||||2017-10-11 04:35:17.357802|2017-10-11 04:35:17.357802
NCT00036283|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2008-09-25|||November 2000||2000-11-01|September 2008|2008-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Chemoprevention of Oral Premalignant Lesions|Clinical Protocol For A Phase II Double-Blind, Placebo-Controlled, Randomized Study Of Celecoxib (Sc-58635) In Oral Premalignant Lesions, Investigator IND|Completed||Phase 2|42||Pfizer|||||f||||||||||||||2017-10-11 04:35:21.967931|2017-10-11 04:35:21.967931
NCT00036296|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2011-04-11|||December 2006||2006-12-01|October 2009|2009-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effects of Talampanel on Patients With Advanced Parkinson's Disease|Effects of Talampanel on Patients With Advanced Parkinson's Disease Who Have Been on Sinemet for More Than 5 Years and Have Dyskinesia (Abnormal Involuntary Movements)|Completed||Phase 1/Phase 2|22|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-10-11 04:35:22.053499|2017-10-11 04:35:22.053499
NCT00036309|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2006-07-18|||May 2002||2002-05-01|July 2006|2006-07-01|July 2003||2003-07-01|||||Interventional|||Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder|Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:35:22.115908|2017-10-11 04:35:22.115908
NCT00036335|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2006-07-18|||March 2002||2002-03-01|July 2006|2006-07-01|January 2003||2003-01-01|||||Interventional|||Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain|Duloxetine Hydrochloride (LY248686) Protocol F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain|Completed||Phase 3|286||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:35:22.192715|2017-10-11 04:35:22.192715
NCT00036348|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2013-11-07|||March 2000||2000-03-01|September 2007|2007-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study of Aripiprazole in Patients With a History of Bipolar Disorder||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:35:22.336485|2017-10-11 04:35:22.336485
NCT00036361|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-08|2013-11-07|||July 2002||2002-07-01|September 2007|2007-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Broad Effectiveness: Study With Aripiprazole|Broad Effectiveness: Study With Aripiprazole|Completed||Phase 3|444||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:35:22.459788|2017-10-11 04:35:22.459788
NCT00036374|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-09|2011-05-16|||October 2001||2001-10-01|April 2010|2010-04-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis|A Randomized, Double-Blind Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate for the Treatment of Patients With Polyarticular Juvenile Rheumatoid Arthritis|Completed||Phase 3|123|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 04:35:22.524948|2017-10-11 04:35:22.524948
NCT00036387|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-09|2011-05-18||||||May 2010|2010-05-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.|A Randomized, Double-blind Trial of the Safety of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis on Standard Disease-modifying Anti-Rheumatic Drug Background Therapy.|Completed||Phase 3|347|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 04:35:22.618359|2017-10-11 04:35:22.618359
NCT00036400|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-09|2011-06-08|||December 2001||2001-12-01|April 2010|2010-04-01|December 2003|Actual|2003-12-01|||||Interventional|||Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing Preoperative Chemoradiation Followed by Surgery|Completed||Phase 3|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:35:22.685755|2017-10-11 04:35:22.685755
NCT00036413|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-09|2011-11-22|||January 2002||2002-01-01|November 2011|2011-11-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis|A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Safety and Dose-ranging Study of Three Oral Doses (0.5 mg, 2.5 mg and 10 mg Once Daily) of TCH346 in Patients With Amyotrophic Lateral Sclerosis.|Completed||Phase 2|44|Actual|Novartis|||||f||||||||||||||2017-10-11 04:35:22.767009|2017-10-11 04:35:22.767009
NCT00036426|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-09|2005-06-23|||March 2001||2001-03-01|October 2004|2004-10-01||||||||Interventional|||Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma|Phase II Study of FavId (Tumor-Specific Idiotype-KLH) and Soluble GM-CSF Immunotherapy in Patients With Stable or Progressive Grade 1 and 2 Follicular B-Cell Lymphomas|Unknown status|Active, not recruiting|Phase 2|22||Favrille|||||||||||||||||||2017-10-11 04:35:22.872972|2017-10-11 04:35:22.872972
NCT00036439|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2011-05-16|||February 2002||2002-02-01|March 2010|2010-03-01|January 2007|Actual|2007-01-01|||||Interventional|||A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis|A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis|Completed||Phase 3|364|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 04:35:22.985823|2017-10-11 04:35:22.985823
NCT00036452|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2012-05-17||||||May 2012|2012-05-01|January 2006|Actual|2006-01-01|||||Interventional|||A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation|A Randomized, Phase II, Open Label Study to Compare Twice Daily and Once Daily Potent Antiretroviral Therapy and to Compare Self-Administered Therapy and Therapy Administered Under Direct Observation|Completed||Phase 2|402|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:35:23.063869|2017-10-11 04:35:23.063869
NCT00037128|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2005-12-08|||March 1998||1998-03-01|May 2004|2004-05-01||||||||Interventional|||Study of GL701 in Men With Systemic Lupus Erythematosus||Unknown status|Active, not recruiting|Phase 3|40||Genelabs Technologies|||||||||||||||||||2017-10-11 04:35:30.156224|2017-10-11 04:35:30.156224
NCT00036465|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2013-07-26||||||July 2013|2013-07-01|September 2005|Actual|2005-09-01|||||Interventional|||Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads|A Phase II, Randomized, Controlled, Pilot Study of Antiretroviral Switch at Lower Versus Higher HIV-1 RNA Levels in Subjects Experiencing Virologic Relapse on a Current HAART Regimen|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:35:23.218944|2017-10-11 04:35:23.218944
NCT00036478|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2017-01-18||||||October 2004|2004-10-01||||||||Observational|||Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients|Pilot Study to Evaluate the Use of Phosphorus P31 Nuclear Magnetic Resonance Spectroscopy as a Non-Invasive Means to Evaluate Mitochondrial Dysfunction in HIV-Infected Subjects|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:35:23.526594|2017-10-11 04:35:23.526594
NCT00036491|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2016-02-12|||January 2001||2001-01-01|February 2016|2016-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Anti-CD20 in Systemic Lupus Erythematosus|An Open-Label Safety and Efficacy Study of an Anti-CD20 Antibody (Rituximab, Rituxan®) for Anti-B Cell Therapy in the Treatment of Systemic Lupus Erythematosus|Completed||Phase 1/Phase 2|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-11 04:35:23.62268|2017-10-11 04:35:23.62268
NCT00036504|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2010-10-12|||August 2001||2001-08-01|October 2010|2010-10-01|August 2002||2002-08-01|||||Interventional|||Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin|Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients New to Insulin Therapy Who Were Inadequately Controlled on Oral Agents|Completed||Phase 4|100||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:35:23.740945|2017-10-11 04:35:23.740945
NCT00036517|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2005-06-23|||February 2002||2002-02-01|September 2004|2004-09-01|March 2003||2003-03-01|||||Interventional|||Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer|A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose Escalation, Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer|Terminated||Phase 1/Phase 2|30||PhytoCeutica|||||||||||||||||||2017-10-11 04:35:23.834573|2017-10-11 04:35:23.834573
NCT00036543|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2006-08-10|||May 2001||2001-05-01|August 2006|2006-08-01||||||||Interventional|||A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of 10 Mg Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer|Completed||Phase 3|1000||Abbott|||||||||||||||||||2017-10-11 04:35:23.949423|2017-10-11 04:35:23.949423
NCT00036556|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2007-08-13|||June 2001||2001-06-01|August 2007|2007-08-01||||||||Interventional|||Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer|A Phase III, Randomized Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer|Completed||Phase 3|941|Actual|Abbott||2|||f||||||||||||||2017-10-11 04:35:25.090687|2017-10-11 04:35:25.090687
NCT00036569|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2012-01-10|2011-09-20||May 2002||2002-05-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas|A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron (TM)) in Children With Diffuse Pontine Gliomas|Completed||Phase 2|32|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:35:25.708299|2017-10-11 04:35:25.708299
NCT00036582|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2008-03-03|||May 2002||2002-05-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents|Clozapine vs Placebo In Treatment-Refractory Bipolar Disorder In Children And Adolescents|Completed||Phase 3|116||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:26.008243|2017-10-11 04:35:26.008243
NCT00036595|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2008-03-03|||May 2002||2002-05-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Observational|||Functional Coupling of Cortico-Cortical and Cortico-Muscular Connections During Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control|Functional Coupling Of Cortico-Cortical and Cortico-Muscular Connections During Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:26.076994|2017-10-11 04:35:26.076994
NCT00036608|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-10|2011-04-07||2010-01-28|January 2002||2002-01-01|January 2010|2010-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine||Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:35:26.146166|2017-10-11 04:35:26.146166
NCT00036621|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-11|2010-02-27||2010-02-27||||August 2007|2007-08-01||||September 2002|Actual|2002-09-01||Interventional|||A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy||Terminated||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:35:26.265607|2017-10-11 04:35:26.265607
NCT00036634|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2014-01-13|||March 2002||2002-03-01|January 2014|2014-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients|A Phase 1/2, Randomized, Double-Blind, Active Controlled, Dose Escalation Study of the Safety, Tolerance, Pharmacokinetic,, and Antiviral Activity of GS-7340-02 in Antiretroviral-Naive Patients Who Are Chronically Infected With HIV-1|Completed||Phase 1/Phase 2|30|Actual|Gilead Sciences||3|||f||||||||||||||2017-10-11 04:35:26.539894|2017-10-11 04:35:26.539894
NCT00036647|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2015-06-12|||October 2001||2001-10-01|June 2015|2015-06-01|January 2003|Actual|2003-01-01|||||Interventional|||OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Randomized Placebo Controlled Study of OSI-774 (Erlotinib HCl, Tarceva[TM]) in Patients With Incurable Stage IIIB/IV Non-small Cell Lung Cancer Who Have Failed Standard Therapy for Advanced or Metastatic Disease|Completed||Phase 3|731|Actual|Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:35:26.650247|2017-10-11 04:35:26.650247
NCT00036660|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2010-11-07|||August 2001||2001-08-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||SarCNU in Treating Patients With Recurrent Malignant Glioma|A Phase II Study of SarCNU (NSC 364432) in Patients With Malignant Glioma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:35:26.901869|2017-10-11 04:35:26.901869
NCT00037427|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-03-15|||September 2001||2001-09-01|May 2005|2005-05-01|July 2004|Actual|2004-07-01|||||Observational|||Airway Responses Following Chlorine Gas Exposure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.63575|2017-10-11 04:35:31.63575
NCT00036686|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2012-09-21|||December 2002||2002-12-01|September 2012|2012-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy|A Clinical Trial of the Action of Isoflavones in Breast Neoplasia: Administration Prior to Mastectomy or Lumpectomy-A Pilot Study|Terminated||N/A|1|Actual|H. Lee Moffitt Cancer Center and Research Institute||2||low accrual|f||||f||||||||||2017-10-11 04:35:26.992345|2017-10-11 04:35:26.992345
NCT00036712|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-09-19|||January 2002||2002-01-01|June 2009|2009-06-01||||August 2009|Anticipated|2009-08-01||Interventional|||Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation|A Multiinstitutional Trial To Evaluate The Prophylactic Use Of NASA-Developed Light Emitting Diodes For The Prevention Of Oral Mucositis In Bone Marrow Transplant Patients|Unknown status|Recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:27.173467|2017-10-11 04:35:27.173467
NCT00036738|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2017-07-24|2017-07-24||July 13, 2001|Actual|2001-07-13|July 2017|2017-07-01||||July 14, 2014|Actual|2014-07-14||Interventional|||Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib|Allogeneic Nonmyeloablative Hematopoietic Stem Cell Transplant for Patients With BCR-ABL Tyrosine Kinase Inhibitor Responsive Ph+ Acute Leukemia ? A Multi-center Trial|Active, not recruiting||Phase 2|28|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:35:27.286928|2017-10-11 04:35:27.286928
NCT00036751|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-01-23|||April 2002||2002-04-01|January 2013|2013-01-01||||August 2007|Actual|2007-08-01||Interventional|||Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Trial Of STI571 For The Treatment Of Platinum And Taxane Refractory Stage III And IV Epithelial Ovarian Cancer And Primary Peritoneal Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:35:27.562779|2017-10-11 04:35:27.562779
NCT00036764|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-01-24|||February 2002||2002-02-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||BMS-247550 in Treating Patients With Stage IV Melanoma|A Phase II Study Of Epothilone B Analog BMS 247550 (NSC # 710428) In Stage IV Malignant Melanoma|Completed||Phase 2|88|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:35:27.656882|2017-10-11 04:35:27.656882
NCT00036777|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-06-28|||March 2002||2002-03-01|June 2013|2013-06-01||||October 2004|Actual|2004-10-01||Interventional|||UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors|A Phase 1 Study of UCN-01 in Combination With Carboplatin in Advanced Solid Tumors|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:35:27.738202|2017-10-11 04:35:27.738202
NCT00036790|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2015-09-30|||February 2002||2002-02-01|September 2015|2015-09-01||||October 2005|Actual|2005-10-01||Interventional|||Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer|An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:35:27.822869|2017-10-11 04:35:27.822869
NCT00036816|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2012-09-20|||February 2002||2002-02-01|September 2012|2012-09-01||||February 2003|Actual|2003-02-01||Interventional|||Vaccine Therapy in Treating Patients With Melanoma of the Eye|Randomized Phase III Study Of Adjuvant Immunization With The NA17.A2 And Melanoma Differentiation Peptites In HLA-A2 Patients With Primary Ocular Melanoma At High Risk Of Relapse|Terminated||Phase 3|13|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:35:27.936462|2017-10-11 04:35:27.936462
NCT00036829|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-07-17|||March 2002||2002-03-01|March 2003|2003-03-01|April 2003|Actual|2003-04-01|||||Interventional|||Improving Pain Management in Patients With Nonhematologic Cancer|Improving Pain Management in Cancer Care|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:27.999932|2017-10-11 04:35:27.999932
NCT00036842|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-06-21|||April 2002||2002-04-01|August 2004|2004-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Arsenic Trioxide in Treating Men With Germ Cell Cancer|Phase II Study Of Arsenic Trioxide In Patients With Refractory Germ Cell Malignancies|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:28.073811|2017-10-11 04:35:28.073811
NCT00036855|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-01-16|||June 2002||2002-06-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma|A Phase I Study Of Yttrium-Ibritumomab Tiuxetan (90Y Zevalin, Yttrium (90)-Anti-CD20, NSC # 710085) Preceded By Rituximab In Children With Recurrent/Refractory CD20 Positive Lymphoma|Terminated||Phase 1|36|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:35:28.305026|2017-10-11 04:35:28.305026
NCT00036868|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-06-06|||February 2002||2002-02-01|June 2013|2013-06-01||||June 2009|Actual|2009-06-01||Interventional|||Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer|A Randomized Phase II Study Of CMF Alone And In Combination With Anti c-erbB2 Antibody (Herceptin) In Women With c-erbB2 Positive Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|90|Actual|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||||||||||||2017-10-11 04:35:28.399714|2017-10-11 04:35:28.399714
NCT00036881|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2016-07-12|||May 2002||2002-05-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer|Phase III Double-Blind, Placebo-Controlled Randomized Comparison Of Zinc Sulfate Versus Placebo For The Prevention Of Altered Taste In Patients With Head And Neck Cancer During Radiation|Completed||Phase 3|173|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:35:28.520914|2017-10-11 04:35:28.520914
NCT00036894|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2015-04-29|||March 2002||2002-03-01|November 2003|2003-11-01||||||||Interventional|||CC-5013 in Treating Patients With Recurrent Glioma|A Phase I Trial Of A Thalidomide Analog, CC-5013, For The Treatment Of Patients With Recurrent High-Grade Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:28.593311|2017-10-11 04:35:28.593311
NCT00036920|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-06-25|||January 2002||2002-01-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|August 2002|Actual|2002-08-01||Interventional|||TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase II Study Of TLK286 For The Treatment Of Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:28.6527|2017-10-11 04:35:28.6527
NCT00036933|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-03-22|||March 2002||2002-03-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer|Vaccination Of Prostate Cancer Patients With A Bivalent Vaccine Containing MUC-2 Glycopeptide And Globo H Conjugates Plus The Immunological Adjuvant QS21|Completed||Phase 1|9|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:35:28.861329|2017-10-11 04:35:28.861329
NCT00036946|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2016-06-01|||November 2001||2001-11-01|June 2016|2016-06-01||||March 2002|Actual|2002-03-01||Interventional|||VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma|An Open-Label, Sequential Cohort Dose-Escalation Safety, Tolerability And Pharmacokinetic Study Of VEGF Trap In Patients With Incurable, Relapsed Or Refractory Solid Tumors Or Lymphoma|Completed||Phase 1|||Regeneron Pharmaceuticals|||||f||||||||||||||2017-10-11 04:35:28.938129|2017-10-11 04:35:28.938129
NCT00036959|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2012-03-14|||March 2002||2002-03-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||ABT-751 in Treating Young Patients With Refractory Solid Tumors|Phase I Trial and Pharmacokinetic Study of ABT-751, an Orally Bioavailable Tubulin Binding Agent, on a 7 Day and 21 Day Dosing Schedule in Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|90|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:35:29.024038|2017-10-11 04:35:29.024038
NCT00036972|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-06-25|||November 2001||2001-11-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|January 2005|Actual|2005-01-01||Interventional|||Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma|Phase I Study to Assess the Histologic Effect and Safety of Pre-Operative and Post-Operative Infusions of IL13-PE38QQR Cytotoxin in Patients With Recurrent Resectable Supratentorial Malignant Glioma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:29.107174|2017-10-11 04:35:29.107174
NCT00036985|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-12-18|||August 2001||2001-08-01|July 2004|2004-07-01||||||||Interventional|||Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer|A Randomized Pivotal Clinical Trial To Assess The Efficacy Of Pre-operative Focused Microwave Thermotherapy Treatment Combined With Pre-operative Chemotherapy For Cytoreduction Of Advanced Breast Cacer In Intact Breast|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:29.172965|2017-10-11 04:35:29.172965
NCT00036998|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-11-05|||August 2001||2001-08-01|July 2004|2004-07-01||||||||Interventional|||Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer|A Randomized Pivotal Clinical Trial In Breast Cancer Patients Of Pre-Operative Focal Microwave Thermotherapy Treatment For Early-Stage Breast Disease In Intact Breast|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:29.251629|2017-10-11 04:35:29.251629
NCT00037011|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-01-17|||November 2001||2001-11-01|January 2013|2013-01-01||||January 2005|Actual|2005-01-01||Interventional|||Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma|Phase I Study of Oral Beta-Glucan and Intravenous Anti-GD2 Monoclonal Antibody 3F8 Among Patients With Metastatic Neuroblastoma|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:35:29.319627|2017-10-11 04:35:29.319627
NCT00037024|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2017-02-21|||April 2002||2002-04-01|November 2012|2012-11-01|October 2004|Actual|2004-10-01|February 2004|Actual|2004-02-01||Interventional|||Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer|Project LEAD: Promoting Health Among Populations With Early Stage Cancers|Completed||N/A|||Duke University|||||f||||t||||||||||2017-10-11 04:35:29.410109|2017-10-11 04:35:29.410109
NCT00037037|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-13|2013-12-17|||October 2001||2001-10-01|May 2004|2004-05-01||||||||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma|A Phase I Study of Peptide Based Vaccine Therapy in Patients With High-Risk or Metastatic Melanoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:29.522459|2017-10-11 04:35:29.522459
NCT00037050|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-14|2009-09-11|||April 2002||2002-04-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|||||Interventional|||Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria|Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram-Positive Bloodstream Infections|Completed||Phase 3|739|Actual|Pfizer|||||||||||||||||||2017-10-11 04:35:29.587664|2017-10-11 04:35:29.587664
NCT00037063|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-14|2015-06-03||||||June 2003|2003-06-01||||||||Interventional|||A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs|A Pilot Study of the Efficacy of a Combination of Antioxidants and B Vitamins in Preventing the Recurrence of Hyperlactatemia in Subjects Who Have Limited Antiretroviral Options|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:35:29.729907|2017-10-11 04:35:29.729907
NCT00037076|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-14|2012-10-30||||||October 2012|2012-10-01|July 2003|Actual|2003-07-01|||||Observational|||Prevalence of Hepatitis C Virus Infection in HIV-Infected Children|Hepatitis C Prevalence in Perinatally Infected HIV-Positive Children Enrolled in PACTG 219C|Completed||N/A|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:35:29.817315|2017-10-11 04:35:29.817315
NCT00037089|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-14|2005-06-23||||||January 2005|2005-01-01||||||||Interventional|||A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer||Unknown status|Active, not recruiting|Phase 2|||Edelman, Martin, M.D.|||||||||||||||||||2017-10-11 04:35:29.952426|2017-10-11 04:35:29.952426
NCT00037102|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-15|2009-06-16|||July 2001||2001-07-01|November 2003|2003-11-01|December 2003||2003-12-01|||||Interventional|MTX01||Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis|An Open Label Study of the Safety and Efficacy of Combination Therapy With AVONEX and Bi-Monthly High Dose Intravenous Methotrexate With Leucovorin Rescue in the Treatment of Multiple Sclerosis|Completed||Phase 4|16|Actual|MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute||1|||||||||||||||||2017-10-11 04:35:30.012573|2017-10-11 04:35:30.012573
NCT00037115|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-15|2009-11-20|||May 2002||2002-05-01|November 2009|2009-11-01||||||||Interventional|||Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.|An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results.|Withdrawn||Phase 4|20|Anticipated|MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute||||Lack of funding|||||||||||||||2017-10-11 04:35:30.080943|2017-10-11 04:35:30.080943
NCT00037141|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-15|2007-10-04|||March 2002||2002-03-01|June 2004|2004-06-01|March 2004||2004-03-01|||||Interventional|||Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)|Evaluation of the Safety and Tolerability of Transurethral Alcohol Injection for the Treatment of BPH (Enlarged Prostate)|Completed||Phase 1/Phase 2|150||American Medical Systems|||||||||||||||||||2017-10-11 04:35:30.211181|2017-10-11 04:35:30.211181
NCT00037154|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2010-01-12|||August 1999||1999-08-01|January 2010|2010-01-01|December 2002||2002-12-01|||||Interventional|||Saw Palmetto Extract in Benign Prostatic Hyperplasia|Saw Palmetto Extract In Benign Prostatic Hyperplasia|Completed||Phase 3|224||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 04:35:30.26694|2017-10-11 04:35:30.26694
NCT00037167|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2009-04-08|||September 2001||2001-09-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Exercise Poles on Older Adults During Exercise Walking|Impact of Running Poles on Older Adult Exercise Walking|Completed||Phase 1/Phase 2|150||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:35:30.356321|2017-10-11 04:35:30.356321
NCT00037180|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2008-09-25|||April 2002||2002-04-01|September 2008|2008-09-01|January 2003|Actual|2003-01-01|||||Interventional|||For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy|Phase II, Randomized, Double-Blind, Multicenter Trial Of Celecoxib Vs Placebo For The Prevention Of Diarrhea Associated With CPT-11/5fu/LV Chemotherapy In Patients With Previously Untreated Metastatic Colorectal Cancer|Terminated||Phase 2|212||Pfizer|||||f||||||||||||||2017-10-11 04:35:30.422562|2017-10-11 04:35:30.422562
NCT00037193|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Acute Regulation of Parathyroid Hormone by Dietary Phosphate|Acute Regulation of Parathyroid Hormone by Dietary Phosphate|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:35:30.520766|2017-10-11 04:35:30.520766
NCT00037206|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2008-10-17|||May 2002||2002-05-01|October 2008|2008-10-01|February 2003|Actual|2003-02-01|||||Interventional|||A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).|An Open Label Non-Comparative Study of the Safety and Efficacy of Intravenous Anidulafungin Plus AmBisome® [(Amphotericin B) Liposome for Injection] as a Treatment for Invasive Aspergillosis.|Completed||Phase 2/Phase 3|30|Actual|Pfizer|||||f||||||||||||||2017-10-11 04:35:30.569669|2017-10-11 04:35:30.569669
NCT00037219|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2008-10-17|||August 2001||2001-08-01|October 2008|2008-10-01|November 2002|Actual|2002-11-01|||||Interventional|||The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.|A Phase 2, Open-Label, Randomized, Dose-Ranging Study of the Safety and Efficacy of Intravenous Anidulafungin (VER002) in the Treatment of Patients With Invasive Candidiasis|Completed||Phase 2|120|Actual|Pfizer|||||f||||||||||||||2017-10-11 04:35:30.637073|2017-10-11 04:35:30.637073
NCT00037232|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-03-15|||April 2001||2001-04-01|May 2005|2005-05-01|March 2005|Actual|2005-03-01|||||Observational|||Failure Time Methods for Family Disease Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:30.712378|2017-10-11 04:35:30.712378
NCT00037245|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-02-08|||September 2001||2001-09-01|December 2005|2005-12-01|July 2005||2005-07-01|||||Observational|||Androgens and Subclinical Atherosclerosis in Young Women - Ancillary to CARDIA||Completed||N/A|||University of Washington|||||f||||||||||||||2017-10-11 04:35:30.779091|2017-10-11 04:35:30.779091
NCT00037258|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2014-03-28|||September 2001||2001-09-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women||Completed||N/A|||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 04:35:30.8687|2017-10-11 04:35:30.8687
NCT00037271|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-02-17|||April 2001||2001-04-01|August 2004|2004-08-01|March 2003|Actual|2003-03-01|||||Observational|||Genome Scan for Obesity in a Multi-Ethnic Sample||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:30.969359|2017-10-11 04:35:30.969359
NCT00037284|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-07-11|||July 2001||2001-07-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Behavioral and Immunological Factors in Coronary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.038424|2017-10-11 04:35:31.038424
NCT00037297|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-07-28|||July 2001||2001-07-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Epidemiology of Cardiovascular Disease in Diabetes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.092867|2017-10-11 04:35:31.092867
NCT00037310|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-07-28|||April 2001||2001-04-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||New CVD Risk Factors for Lowered Cognitive Functioning||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.159514|2017-10-11 04:35:31.159514
NCT00037323|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-03-15|||May 2001||2001-05-01|May 2004|2004-05-01|October 2003|Actual|2003-10-01|||||Observational|||Framingham Offspring Study: Psychosocial Risk Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.219977|2017-10-11 04:35:31.219977
NCT00037336|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2014-03-14|||September 2001||2001-09-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Atherosclerosis in Rheumatoid Arthritis||Completed||N/A|||Vanderbilt University|||||f||||||||||||||2017-10-11 04:35:31.275456|2017-10-11 04:35:31.275456
NCT00037349|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-02-17|||March 2001||2001-03-01|January 2005|2005-01-01|February 2004|Actual|2004-02-01|||||Observational|||Heart Rate Recovery and Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.339238|2017-10-11 04:35:31.339238
NCT00037362|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Measuring Sensitivity to Nonignorability||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.401501|2017-10-11 04:35:31.401501
NCT00037375|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-02-17|||July 2001||2001-07-01|February 2005|2005-02-01|June 2003|Actual|2003-06-01|||||Observational|||Physical Activity, Body Composition, and Prevalent Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.450159|2017-10-11 04:35:31.450159
NCT00037388|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-07-28|||July 2004||2004-07-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.497478|2017-10-11 04:35:31.497478
NCT00037440|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2014-12-01|||September 2001||2001-09-01|December 2014|2014-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Genetic Epidemiology of Change in CVD Risk Factors|Genetic Epidemiology of Change in CVD Risk Factors (HL70568-1)|Completed||N/A|1735|Actual|The University of Texas Health Science Center, Houston|||2||f||||f||||||||||2017-10-11 04:35:31.675479|2017-10-11 04:35:31.675479
NCT00037453|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-03-15|||April 2001||2001-04-01|August 2004|2004-08-01|March 2003|Actual|2003-03-01|||||Observational|||Analysis of Sex Hormones and Lipoproteins in Young Males||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:31.733754|2017-10-11 04:35:31.733754
NCT00037466|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-16|2016-03-01|||September 2000||2000-09-01|February 2005|2005-02-01|November 2002|Actual|2002-11-01|August 2001|Actual|2001-08-01||Observational|||Relation of Diet to Serum Homocysteine Level in Youths|Relation of Diet to Serum Homocysteine Level in Youths|Completed||N/A|2445|Actual|Boston Children’s Hospital|||1||f||||f||||||||No|Data Sharing was not required at the time the study was conducted.|2017-10-11 04:35:31.774653|2017-10-11 04:35:31.774653
NCT00037479|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2005-12-06|||December 1999||1999-12-01|December 2005|2005-12-01||||||||Interventional|||Brain Imaging and Retreatment Study of Persistent Lyme Disease|PET and MRI Imaging of Persistent Lyme Encephalopathy|Completed||Phase 2|65||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:35:31.829588|2017-10-11 04:35:31.829588
NCT00037492|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2007-05-21||||||May 2007|2007-05-01||||||||Interventional|||Families In Recovery From Stroke Trial (F.I.R.S.T.)|Psychological Intervention in Stroke Recovery|Completed||Phase 3|291||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:35:31.900224|2017-10-11 04:35:31.900224
NCT00037505|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Major Depression and Inflammatory Risk Markers for Coronary Heart Disease|Major Depression and Inflammatory Risk Markers for Coronary Heart Disease|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:35:31.973957|2017-10-11 04:35:31.973957
NCT00037518|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2013-05-06|||April 2001||2001-04-01|May 2013|2013-05-01||||||||Interventional|||A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer|An Assessment of the Calcimimetic Agent AMG 073 for the Treatment of Subjects With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism.|Completed||Phase 4|46||Amgen||1|||||||||||||||||2017-10-11 04:35:32.031756|2017-10-11 04:35:32.031756
NCT00037531|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2009-08-17||||||August 2009|2009-08-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients|An Open-label Extension Study of the Safety of Long-term Administration of Sirolimus (Rapamune™) in Solid Organ Transplant Recipients|Completed||Phase 3|769|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:35:32.095602|2017-10-11 04:35:32.095602
NCT00037544|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2008-04-18||||||April 2008|2008-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Study Evaluating ReFacto AF in Severe Hemophilia A|An Open-Label Study to Characterize the Safety and Efficacy of BDDrFVIII Manufactured by the Albumin Free Process (ReFacto AF) in the Treatment of Previously Treated Patients (PTP) With Severe Hemophilia A|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:35:32.194114|2017-10-11 04:35:32.194114
NCT00037557|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2007-12-18|||September 2002||2002-09-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Study Evaluating rFIX; BeneFIX in Severe Hemophilia B|An Open-Label, Single-Arm, Safety and Efficacy Study of Recombinant Human Factor IX (rFIX; BeneFIX®) in Children Less Than 6 Years of Age With Severe Hemophilia B|Completed||Phase 3|20||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:35:32.489443|2017-10-11 04:35:32.489443
NCT00037570|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2013-02-07|||November 2000||2000-11-01|February 2013|2013-02-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage|A Randomized Study of the Effect of Intravenous Pantoprazole on Gastric pH After Successful Hemostasis in Patients With Bleeding Peptic Ulcer|Completed||Phase 2|12|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:35:32.582122|2017-10-11 04:35:32.582122
NCT00037583|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2009-08-20||||||August 2009|2009-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia|A Dose-Ranging Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (go) Given in Combination With Cytarabine and Daunorubicin in Relapsed or Refractory Patients and in Younger de Novo Patients With Acute Myeloid Leukemia (AML)|Completed||Phase 2|69|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:35:32.700819|2017-10-11 04:35:32.700819
NCT00037596|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2013-02-11|||August 2000||2000-08-01|February 2013|2013-02-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia|A Dose Ranging Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) Given in Combination With Cytarabine in Relapsed or Refractory Patients and Alder De Novo Patients With Acute Myeloid Leukemia.|Completed||Phase 2|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:35:32.773508|2017-10-11 04:35:32.773508
NCT00037609|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2012-10-22|||January 2001||2001-01-01|October 2012|2012-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients|Phase I-II Study to Evaluate Safety, Efficacy and Pharmacokinetic Interactions Between Capecitabine (XELODA) and Exisulind (APTOSYN) in Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|35|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:35:32.856462|2017-10-11 04:35:32.856462
NCT00037622|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2009-08-18||||||August 2009|2009-08-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.|An Open-Label Treatment Protocol to Provide Continued ACH-126,443 to Subjects of Previous Achillion-Sponsored Phase 1 and 2 Studies in Chronic Hepatitis B Infection|Terminated||N/A|100||Achillion Pharmaceuticals||||Safety concerns from other studies.|||||||||||||||2017-10-11 04:35:32.968585|2017-10-11 04:35:32.968585
NCT00037635|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2013-05-06|||December 2001||2001-12-01|May 2013|2013-05-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients|A Phase 3 Study to Assess the Efficacy and Safety of an Oral Calcimimetic Agent (AMG 073) in Secondary Hyperparathyroidism of End Stage Renal Disease Treated With Hemodialysis|Completed||Phase 3|400|Anticipated|Amgen||2|||f||||||||||||||2017-10-11 04:35:33.021753|2017-10-11 04:35:33.021753
NCT00037648|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-17|2009-11-25|||July 2000||2000-07-01|February 2008|2008-02-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Juvenile Rheumatoid Arthritis|A Randomized, Multi-center, Blinded, Placebo-controlled Study With an Open-label Run-in Period to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-metHuIL-1ra (Anakinra) in Polyarticular-Course Juvenile Rheumatoid Arthritis|Completed||Phase 2|86|Actual|Swedish Orphan Biovitrum||2|||f||||||||||||||2017-10-11 04:35:33.094022|2017-10-11 04:35:33.094022
NCT00037661|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-18|2015-10-01|||April 2002||2002-04-01|October 2015|2015-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye|Double-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye|Completed||Phase 3|222|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:35:33.157907|2017-10-11 04:35:33.157907
NCT00037674|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2011-05-17|||January 2001||2001-01-01|January 2011|2011-01-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder|A Randomized, Double-Blind, Multicenter, Placebo-Controlled 12-Week Study of the Safety and Efficacy of Two Doses of Topiramate for the Treatment of Acute Manic or Mixed Episodes in Patients With Bipolar I Disorder With an Optional Open-Label Extension|Completed||Phase 3|434|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:35:33.214452|2017-10-11 04:35:33.214452
NCT00037687|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2005-06-23|||April 2001||2001-04-01|January 2003|2003-01-01|December 2004||2004-12-01|||||Interventional|||Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis|A Phase 3 Study to Demonstrate the Safety and Efficacy of Recombinant Platelet-Activating Factor Acetylhydrolase (rPAF-AH, Pafase®) for Reducing 28 Day All Cause Mortality in Patients With Severe Sepsis|Terminated||Phase 3|2500||ICOS Corporation|||||||||||||||||||2017-10-11 04:35:33.28357|2017-10-11 04:35:33.28357
NCT00037700|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2009-11-25|||May 2001||2001-05-01|December 2007|2007-12-01|December 2002||2002-12-01|||||Interventional|||Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis||Completed||Phase 2|||Swedish Orphan Biovitrum|||||||||||||||||||2017-10-11 04:35:33.345769|2017-10-11 04:35:33.345769
NCT00037713|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2010-04-07|||September 1998||1998-09-01|April 2010|2010-04-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG|The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG|Completed||Phase 3|515|Actual|ImClone LLC||2|||f||||f||||||||||2017-10-11 04:35:33.535423|2017-10-11 04:35:33.535423
NCT00037726|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2015-12-21|||April 2001||2001-04-01|December 2005|2005-12-01|March 2004||2004-03-01|||||Observational|||Antibiotics in Infancy--Risk Factor for Childhood Asthma||Completed||N/A|||Augusta University|||||f||||||||||||||2017-10-11 04:35:33.70358|2017-10-11 04:35:33.70358
NCT00037739|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2016-01-19|||April 2001||2001-04-01|January 2016|2016-01-01|March 2004||2004-03-01|||||Observational|||Chronic Obstructive Pulmonary Disease Gene Localization||Completed||N/A|||University of Utah|||||f||||||||||||||2017-10-11 04:35:33.806276|2017-10-11 04:35:33.806276
NCT00037752|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2014-05-20|||September 2002||2002-09-01|May 2014|2014-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|SUCCESS||Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates|Use of Sibutramine in Smoking Cessation|Completed||N/A|436|Actual|University of Tennessee||2|||f||||t||||||||||2017-10-11 04:35:33.889964|2017-10-11 04:35:33.889964
NCT00037765|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2017-09-13|||September 2001||2001-09-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Gene Modifiers of Cystic Fibrosis Lung Disease|Gene Modifiers of Cystic Fibrosis Lung Disease|Active, not recruiting||N/A|600|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 04:35:34.035676|2017-10-11 04:35:34.035676
NCT00037778|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-20|2016-08-29|||September 2001||2001-09-01|August 2016|2016-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Genetic Modifiers of Cystic Fibrosis: Sibling Study|Genetic Modifiers of Cystic Fibrosis: Sibling Study|Completed||N/A|3459|Actual|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 04:35:34.160212|2017-10-11 04:35:34.160212
NCT00037791|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-21|2006-11-08|||December 1999||1999-12-01|September 2006|2006-09-01|September 2002||2002-09-01|||||Interventional|||Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia|Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia in Patients Receiving Myelosuppressive Treatment Regimens Requiring Platelet Transfusion Support.|Completed||Phase 3|180||Pfizer|||||f||||||||||||||2017-10-11 04:35:34.268665|2017-10-11 04:35:34.268665
NCT00037804|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-21|2009-08-13||||||August 2009|2009-08-01||||||||Interventional|||Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction||Completed||Phase 1|||Pfizer|||||||||||||||||||2017-10-11 04:35:34.39311|2017-10-11 04:35:34.39311
NCT00037817|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-21|2017-10-05|||May 17, 2002||2002-05-17|November 30, 2016|2016-11-30|November 9, 2009|Actual|2009-11-09|October 8, 2008|Actual|2008-10-08||Interventional|||Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies|Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies|Completed||Phase 1|34|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 04:35:34.517965|2017-10-11 04:35:34.517965
NCT00037830|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-22|2012-12-18|2011-07-13||November 1999||1999-11-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||GM1 Ganglioside Effects on Parkinson's Disease|The Study of GM1 Ganglioside, A Potential New Parkinson's Disease Medication|Completed||Phase 2|94|Actual|Thomas Jefferson University||3|||f||||f||||||||||2017-10-11 04:35:34.671109|2017-10-11 04:35:34.671109
NCT00037843|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-23|2012-02-20|||December 1988||1988-12-01|February 2012|2012-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening|Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening|Completed||Phase 3|114|Actual|M.D. Anderson Cancer Center||1|||f||||||||||||||2017-10-11 04:35:35.516294|2017-10-11 04:35:35.516294
NCT00037869|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2012-07-31|||November 2001||2001-11-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors|High Dose I-131 Metaiodobenzylguanidine (MIBG) Therapy for Metastatic Neuroendocrine Tumors|Completed||Phase 3|15|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:35:35.581456|2017-10-11 04:35:35.581456
NCT00037882|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2012-07-31|||February 2001||2001-02-01|July 2012|2012-07-01|December 2003|Actual|2003-12-01|October 2003|Actual|2003-10-01||Interventional|||PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron|A Phase II Study of SCH 54031 (Peg Interferon Alpha-2B/PEG-Intron) in Subjects With Interferon-Refractory Chronic Myelogenous Leukemia|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:35:35.652163|2017-10-11 04:35:35.652163
NCT00037895|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2009-01-20|||January 2001||2001-01-01|May 2002|2002-05-01|December 2003|Actual|2003-12-01|||||Interventional|||Stroke Rehabilitation Outcomes With Supported Treadmill Ambulation Training|Stroke Rehabilitation Outcomes With Supported Treadmill Ambulation Training|Completed||Phase 2|48|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:35:35.754921|2017-10-11 04:35:35.754921
NCT00037908|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2009-01-20|||October 2000||2000-10-01|May 2002|2002-05-01|September 2003|Actual|2003-09-01|||||Interventional|||Effects of Strength Training on Upper-Limb Function in Post-Stroke Hemiparesis|Effects of Strength Training on Upper-Limb Function in Post-Stroke Hemiparesis|Completed||Phase 2|60|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:35:35.827978|2017-10-11 04:35:35.827978
NCT00037921|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2010-05-05|||January 2001||2001-01-01|May 2010|2010-05-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||UTI Prophylaxis Using Bacterial Interference Following SCI|UTI Prophylaxis Using Bacterial Interference Following SCI|Completed||Phase 2|40|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:35:35.89592|2017-10-11 04:35:35.89592
NCT00037934|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2011-10-06|||April 2002||2002-04-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|September 2004|Actual|2004-09-01||Interventional|||Robotic Upper-Limb Neurorehabilitation in Chronic Stroke Patient|Evaluation of Robotic Upper Extremity Neuro-Rehabilitation|Completed||Phase 2|30|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:35:35.974589|2017-10-11 04:35:35.974589
NCT00037947|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2008-06-02|||October 2001||2001-10-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Auditory Function in Patients With and Without Multiple Sclerosis|Auditory Function in Patients With and Without Multiple Sclerosis|Completed||Phase 2|300|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:35:36.044879|2017-10-11 04:35:36.044879
NCT00037960|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2009-01-20|||June 2001||2001-06-01|May 2002|2002-05-01|June 2004|Actual|2004-06-01|||||Interventional|||Automated Constraint-Induced Therapy for Restoring Movement After Stroke|Automated Constraint-Induced Therapy for Restoring Movement After Stroke|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:35:36.102673|2017-10-11 04:35:36.102673
NCT00037973|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2010-09-15|||August 2000||2000-08-01|September 2010|2010-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Effect of Ventilation-Feedback Training on Exercise Performance in COPD|Effects of Ventilation-Feedback Training on Exercise Performance in COPD|Completed||Phase 2|108|Anticipated|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 04:35:36.161931|2017-10-11 04:35:36.161931
NCT00037986|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2009-02-09|||July 2001||2001-07-01|February 2009|2009-02-01|June 2004|Actual|2004-06-01|May 2004|Actual|2004-05-01||Interventional|||Functioning, Disability, and Quality of Life in the Adult Hearing Impaired|Functioning, Disability, and Quality of Life in the Adult Hearing Impaired|Completed||Phase 2|330|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 04:35:36.444156|2017-10-11 04:35:36.444156
NCT00030433|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-02-12|||January 2002||2002-01-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|February 2007|Actual|2007-02-01||Interventional|||S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial Of Gemcitabine (NSC-613327) And Irinotecan (NSC-616348) In Patients With Untreated Extensive Stage Small Cell Lung Cancer (SCLC)|Completed||Phase 2|85|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:35:36.546276|2017-10-11 04:35:36.546276
NCT00030446|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2010-11-07|||January 2002||2002-01-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Study Of OSI-774 (NSC 718781) Given In Combination With Carboplatin In Patients With Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:35:36.900219|2017-10-11 04:35:36.900219
NCT00030459|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-08-06|||November 2000||2000-11-01|May 2003|2003-05-01||||||||Interventional|||Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma|Randomized Feasibility Study Of Active Symptom Control With Or Without Chemotherapy In The Treatment Of Patients With Mesothelioma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:37.019562|2017-10-11 04:35:37.019562
NCT00030472|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-04-10|||December 2001||2001-12-01|September 2004|2004-09-01||||October 2006|Actual|2006-10-01||Interventional|||Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix|A Phase II Evaluation of Liposomal Doxorubicin (Doxil) in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:35:37.118346|2017-10-11 04:35:37.118346
NCT00030485|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2014-01-24|||January 2002||2002-01-01|January 2011|2011-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer|A Phase II Study of OSI-774 (NSC 718781) in Patients With Locally Advanced and/or Metastatic Carcinoma of the Endometrium|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:37.250794|2017-10-11 04:35:37.250794
NCT00030498|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-01-15|||December 2001||2001-12-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction|Phase I Study of OSI-774 (NSC 718781) for Solid Tumors in Patients With Hepatic or Renal Dysfunction|Completed||Phase 1|75|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:35:37.337741|2017-10-11 04:35:37.337741
NCT00030511|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2012-07-13|||October 2001||2001-10-01|July 2012|2012-07-01||||July 2003|Actual|2003-07-01||Interventional|||Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer|A Phase II Study of Chronomodulated Preoperative Infusional Chemoradiation for Biliary Tract Cancer|Terminated||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:35:37.452773|2017-10-11 04:35:37.452773
NCT00031135|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-26|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|September 2005||2005-09-01|||||Interventional|||Total Parenteral Nutrition-Associated Liver Disease|Prevention of TPN-Associated Hepatic Steatosis: A Placebo Controlled Trial|Terminated||Phase 2|48|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:35:47.397018|2017-10-11 04:35:47.397018
NCT00030524|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2012-10-26|||January 2002||2002-01-01|October 2012|2012-10-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer|A Phase II Clinical, Biological and Pharmacological Study of ZD1839 in Patients With Advanced Colorectal Carcinoma Refractory to 5-Fluorouracil (5-FU) and Irinotecan Chemotherapy|Completed||Phase 2|||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 04:35:37.538482|2017-10-11 04:35:37.538482
NCT00030537|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-06-17|||November 2001||2001-11-01|October 2002|2002-10-01|March 2003|Actual|2003-03-01|||||Interventional|||Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Pilot Study to Evaluate Epidermal Growth Factor Receptor Signaling After Treatment With Oral OSI-774 in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:37.627371|2017-10-11 04:35:37.627371
NCT00030550|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-01-30|||September 2001||2001-09-01|January 2013|2013-01-01||||June 2003|Actual|2003-06-01||Interventional|||Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome|A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial Assessing The Safety And Efficacy Of Thalidomide (THALOMID) For The Treatment Of Anemia In Red Blood Cell Transfusion-Dependent Patients With Myelodysplastic Syndromes|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:35:37.713125|2017-10-11 04:35:37.713125
NCT00030563|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2017-04-13|||May 2001||2001-05-01|April 2017|2017-04-01|October 2005|Actual|2005-10-01|October 2004|Actual|2004-10-01||Interventional|||Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver|A Phase II Study Of Adjuvant Intravenous Irinotecan Following Resection With Or Without Radiofrequency Ablation (RFA), Of Hepatic Metastases From Colorectal Carcinoma|Completed||Phase 2|||University of Washington|||||f||||||||||||||2017-10-11 04:35:37.788866|2017-10-11 04:35:37.788866
NCT00030576|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2016-04-13|||November 2001||2001-11-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase I/II Study Of OSI-774 In Combination With Cisplatin In Patients With Recurrent Or Metastatic Squamous Cell Cancer Of The Head And Neck|Completed||Phase 1/Phase 2|51|Actual|University Health Network, Toronto||1|||f||||t||||||||No||2017-10-11 04:35:39.751827|2017-10-11 04:35:39.751827
NCT00030589|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-12-17|||February 2001||2001-02-01|October 2003|2003-10-01||||||||Interventional|||Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma|A Muliticenter, Dose-Reandomized Evaluation Of Targretin Capsules Plus PUVA In Patients With Stage IB - IIA Cutaneous T-Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:39.8893|2017-10-11 04:35:39.8893
NCT00030602|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2017-03-28|||January 2000|Actual|2000-01-01|March 2017|2017-03-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer|A Phase 2 Study Of Prostate Specific Antigen-3 (PSA-3) (NSC # 694155) With Montanide (NSC #675756) Vaccination In Patients With Prostate Cancer Recurrent|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-10-11 04:35:40.037963|2017-10-11 04:35:40.037963
NCT00030615|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-02-06|||December 2001||2001-12-01|February 2013|2013-02-01||||September 2008|Actual|2008-09-01||Interventional|||Decitabine in Treating Patients With Advanced Solid Tumors|A Phase I Study Of The Toxicities, Biologic And Clinical Effects Of Daily 5 Aza 2'Deoxycytidine (DAC), NSC 127716 (IND 50733) For Four Weeks In Patients With Advanced Malignancies|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:35:40.128124|2017-10-11 04:35:40.128124
NCT00030628|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2016-07-06|||December 2001||2001-12-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|March 2005|Actual|2005-03-01||Interventional|||Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases|A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases|Completed||Phase 3|480|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:35:40.238168|2017-10-11 04:35:40.238168
NCT00030641|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2014-01-03|||October 2001||2001-10-01|September 2003|2003-09-01||||||||Interventional|||Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer|Randomized Study of Docetaxel Versus Docetaxel Plus Genasense™ (G3139; Bcl-2 Antisense Oligonucleotide) in Patients With Previously Treated Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:40.414437|2017-10-11 04:35:40.414437
NCT00030654|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2017-03-09|||October 2002||2002-10-01|March 2017|2017-03-01|February 4, 2005|Actual|2005-02-04|February 4, 2005|Actual|2005-02-04||Interventional|||Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer|A Phase III Randomized Study of Patients With High Risk, Hormone-Naive Prostate Cancer: Androgen Blockade With 4 Cycles of Immediate Chemotherapy Versus Androgen Blockade With Delayed Chemotherapy|Completed||Phase 3|21|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:35:40.728406|2017-10-11 04:35:40.728406
NCT00030667|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2015-04-14|||May 2002||2002-05-01|December 2013|2013-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood|A Phase II Study of Gleevec (Imatinib Mesylate, NSC 716051 Formerly STI571) in Children With Refractory or Relapsed Solid Tumors|Completed||Phase 2|100|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:35:41.048361|2017-10-11 04:35:41.048361
NCT00030680|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-08-26|||November 2001||2001-11-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Radiation Therapy in Treating Patients With Aggressive Fibromatoses|Phase II Pilot Study Of Moderate Dose Radiotherapy For Inoperable Aggressive Fibromatoses|Completed||Phase 2|44|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:35:41.155689|2017-10-11 04:35:41.155689
NCT00030693|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-01-23|||December 2001||2001-12-01|January 2013|2013-01-01||||April 2010|Actual|2010-04-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Solid Tumors|Intra-Lesional rF-B7.1 Versus rF-Tricom Vaccine In The Treatment Of Metastatic Cancer|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:35:41.296483|2017-10-11 04:35:41.296483
NCT00031148|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-26|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|August 2003||2003-08-01|||||Interventional|||Keratinocyte Growth Factor to Prevent Acute GVHD|Phase I/II Trial of Keratinocyte Growth Factor (rHuKGF) to Prevent Acute GVHD in 6/6 HLA=BMT Recipients|Completed||Phase 1/Phase 2|72||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:35:47.470775|2017-10-11 04:35:47.470775
NCT00030706|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2008-07-23|||November 2004||2004-11-01|February 2006|2006-02-01||||||||Interventional|||Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer|Phase II Study Of Epothilone B Analogue BMS-247550 In Relapse And/Or Refractory Stage III Or IV Ovarian Epithelial Cancer, Following Front-Line Treatment With Platinum Plus Taxane-Based Chemotherapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:41.405064|2017-10-11 04:35:41.405064
NCT00030719|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2014-06-23|||December 2001||2001-12-01|August 2010|2010-08-01||||||||Interventional|||Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma|High Risk Neuroblastoma Study 1 Of Siop-Europe|Unknown status|Recruiting|Phase 3|175|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:41.499442|2017-10-11 04:35:41.499442
NCT00030732|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2012-05-14|||June 2001||2001-06-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|June 2004|Actual|2004-06-01||Interventional|||Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer|Gemcitabine Plus Capecitabine Versus Gemcitabine Alone In Advanced Pancreatic Cancer. A Randomized Phase III Trial|Completed||Phase 3|319|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 04:35:41.738035|2017-10-11 04:35:41.738035
NCT00030745|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2012-05-14|||June 2000||2000-06-01|May 2012|2012-05-01|August 2003|Actual|2003-08-01|May 2003|Actual|2003-05-01||Interventional|||Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung|Preoperative Chemotherapy Of Potentially Resectable Mesothelioma Of The Pleura|Completed||Phase 2|61|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 04:35:42.009|2017-10-11 04:35:42.009
NCT00030758|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-08-06|||October 2001||2001-10-01|June 2007|2007-06-01||||||||Interventional|||Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer|G-CSF (Filgrastim) or Pegfilgrastim Secondary Prophylaxis In The Adjuvant Chemotherapy Of Early Breast Cancer|Unknown status|Active, not recruiting|Phase 4|816|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:42.129598|2017-10-11 04:35:42.129598
NCT00030771|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2017-05-12|||April 2001||2001-04-01|May 2017|2017-05-01|December 2020|Anticipated|2020-12-01|October 2013|Actual|2013-10-01||Interventional|||Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients|Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial|Active, not recruiting||Phase 3|232|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||No||2017-10-11 04:35:42.324221|2017-10-11 04:35:42.324221
NCT00030784|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2012-09-20|||November 2001||2001-11-01|September 2012|2012-09-01||||March 2005|Actual|2005-03-01||Interventional|||Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma|Phase I Study To Determine The Safety Of Caelyx (Doxorubin HCI, Pegylated Liposomal) In Combination With Ifosfamide In Previously Untreated Adult Patients With Advanced And/Or Metastatic Soft Tissues Sarcomas|Completed||Phase 1|28|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:35:42.580835|2017-10-11 04:35:42.580835
NCT00030797|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2012-05-14|||February 2001||2001-02-01|May 2012|2012-05-01|December 2003|Actual|2003-12-01|May 2002|Actual|2002-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer|A Randomized Phase II Trial Of Capecitabine And Different Schedules Of Irinotecan As First Line Treatment For Advanced Or Metastatic Colorectal Cancer|Completed||Phase 2|75|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 04:35:42.689099|2017-10-11 04:35:42.689099
NCT00030810|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2012-05-14|||September 2001||2001-09-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC|Preoperative Chemoradiotherapy In Non-Small Cell Lung Cancer (NSCLC) Patients With Operable Stage IIIB Disease: A Prospective Phase II Trial|Completed||Phase 2|46|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 04:35:42.824082|2017-10-11 04:35:42.824082
NCT00030823|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2015-11-24|2015-10-23||March 2001||2001-03-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence|Vaccination Of High Risk Breast Cancer Patients With Heptavalent Antigen - Keyhole Limpet Hemocyanin Conjugate Plus The Immunological Adjuvant QS21|Completed||N/A|14|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:35:42.956852|2017-10-11 04:35:42.956852
NCT00030849|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-04-02|||October 2001||2001-10-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|September 2004|Actual|2004-09-01||Interventional|||Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma|Phase II Trial Of Oral Bexarotene (Targretin) Combined With Interferon Alfa-2b (Intron-A) For Patients With Cutaneous T-Cell Lymphoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:43.263479|2017-10-11 04:35:43.263479
NCT00030862|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-06-04|||October 2001||2001-10-01|June 2013|2013-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus|Phase II Single-Arm Trial Of CPT-11 (Irinotecan HC1; Camptosar Injection)/Cisplatin In Patients With Advanced Esophageal Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:35:43.378179|2017-10-11 04:35:43.378179
NCT00030875|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2010-11-07|||July 2002||2002-07-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||Bortezomib in Treating Patients With Mantle Cell Lymphoma|A Phase II Study Of PS-341 (NSC 681239) In Patients With Untreated Or Relapsed Mantle Cell Lymphoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:35:43.48436|2017-10-11 04:35:43.48436
NCT00030888|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2014-01-03|||December 2002||2002-12-01|December 2003|2003-12-01||||||||Interventional|||UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer|A Phase 2 Study Of UCN-01 In Advanced Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:43.626735|2017-10-11 04:35:43.626735
NCT00030901|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2013-01-02|2012-11-19||February 2000||2000-02-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate|L-Selenium-Based Chemoprevention Of Prostate Cancer Among Men With High Grade Prostatic Intraepithelial Neoplasia|Completed||Phase 3|619|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:35:43.769076|2017-10-11 04:35:43.769076
NCT00030914|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2016-07-12|||April 2002||2002-04-01|July 2016|2016-07-01|September 2006|Actual|2006-09-01|February 2006|Actual|2006-02-01||Interventional|||Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women|Phase III Comparison of Depomedroxyprogesterone Acetate (DPROV) to Venlafaxine for Managing Hot Flashes|Completed||Phase 3|227|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 04:35:44.452944|2017-10-11 04:35:44.452944
NCT00030940|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2017-06-30|||February 11, 2002||2002-02-11|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Cause, Development, and Progression of Stiff-Person Syndrome|Natural History and Immunopathogenesis of Stiff Person Syndrome (SPS)|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:44.620838|2017-10-11 04:35:44.620838
NCT00030953|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-14|2017-10-05|||February 11, 2002||2002-02-11|February 3, 2015|2015-02-03|February 3, 2015||2015-02-03|||||Observational|||Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome|Evaluation of Tourette's Syndrome With Multimetabolite H-Magnetic Resonance Spectroscopy at 3T|Completed||N/A|100|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:44.71151|2017-10-11 04:35:44.71151
NCT00030966|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-15|2009-06-17|||January 2002||2002-01-01|June 2009|2009-06-01|December 2005|Actual|2005-12-01|April 2005|Actual|2005-04-01||Interventional|||Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Natalizumab, When Added to Avonex® (Interferon Beta-1a), in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|1200|Actual|Biogen||2|||f||||t||||||||||2017-10-11 04:35:44.829568|2017-10-11 04:35:44.829568
NCT00030979|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-15|2008-03-03|||February 2002||2002-02-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Donepezil to Treat Dementia in Parkinson's Disease|Donepezil for Dementia in Parkinson's Disease: A Randomized, Double Blinded Placebo Controlled Crossover Trial|Completed||Phase 4|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:45.340703|2017-10-11 04:35:45.340703
NCT00030992|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-20|2012-08-13|2012-06-06||February 2002||2002-02-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|January 2009|Actual|2009-01-01||Interventional|||BMS 247550 to Treat Kidney Cancer|A Phase II Clinical Trial of BMS-247550 (NSC 710428), an Epothilone B Analog, in Renal Cell Carcinoma|Completed||Phase 2|102|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:35:45.466588|2017-10-11 04:35:45.466588
NCT00031005|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-20|2008-03-03|||February 2002||2002-02-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Interventional|||Stem Cell Transplantation to Treat Leukocyte Adhesion Deficiency|Treatment of Leukocyte Adhesion Deficiency With Allogeneic Stem Cell Transplantation|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:46.251541|2017-10-11 04:35:46.251541
NCT00031018|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-20|2008-02-04||||||February 2008|2008-02-01||||||||Interventional|||Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha|Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha|Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:35:46.330244|2017-10-11 04:35:46.330244
NCT00031031|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-20|2007-11-26|||June 2001||2001-06-01|November 2007|2007-11-01|November 2002|Actual|2002-11-01|||||Interventional|||Kanglaite Injection Phase I Study|Phase I Study of KLT in Patients With Solid Tumors Refractory to Standard Therapy|Completed||Phase 1|16|Actual|KangLaiTe USA|||||||||||||||||||2017-10-11 04:35:46.418368|2017-10-11 04:35:46.418368
NCT00031044|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-20|2012-05-17||||||May 2012|2012-05-01|November 2004|Actual|2004-11-01|||||Interventional|||Adding New Drugs for HIV Infected Patients Failing Current Therapy|A Randomized Phase I/II Placebo-controlled Study of Amdoxovir (DAPD) Versus Placebo Together With Enfuvirtide (T-20) Plus Optimized Background Therapy for HIV-Infected Subjects Failing Current Therapy|Completed||Phase 1/Phase 2|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:35:46.49048|2017-10-11 04:35:46.49048
NCT00031057|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-20|2011-02-25||||||November 2004|2004-11-01||||March 2003|Actual|2003-03-01||Interventional|||Vitamin B Therapy for Hyperlactatemia|A Pilot Study of Oral B Vitamin Therapy for Asymptomatic or Mildly Symptomatic Hyperlactatemia in Patients on NRTIs|Completed||N/A|225||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:35:46.590512|2017-10-11 04:35:46.590512
NCT00031070|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-20|2015-03-05||||||August 2006|2006-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Increasing HAART-Induced Immune Restoration With Cyclosporine|Augmenting the Magnitude of HAART-Induced Immune Restoration With the Use of Cyclosporine|Completed||Phase 2|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:35:46.758412|2017-10-11 04:35:46.758412
NCT00031083|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-20|2012-06-07|||January 2002||2002-01-01|November 2004|2004-11-01|March 2004||2004-03-01|||||Interventional|||Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas|A Multi-center, Open Label, Two Part, Dose Escalation Study to Determine the Tolerability of Interferon-Beta Gene Transfer (BG00001) in the Treatment of Recurrent or Progressive Grade III and Grade IV Gliomas|Suspended||Phase 1|35||Biogen|||||||||||||||||||2017-10-11 04:35:46.913537|2017-10-11 04:35:46.913537
NCT00031096|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-21|2014-02-23|||January 2002||2002-01-01|February 2014|2014-02-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne|A 12-week, Randomized, Double-blind, Multicenter Study Comparing the Clinical Efficacy and Safety of Azelaic Acid 15% Gel (SH H 655 BA) With Its Vehicle (SH H 655 PBA) in Patients With Mild to Moderate Acne.|Completed||Phase 3|879|Actual|Bayer||2|||f||||||||||||||2017-10-11 04:35:47.003694|2017-10-11 04:35:47.003694
NCT00031109|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-25|2012-05-03||||||May 2012|2012-05-01|May 2005|Actual|2005-05-01|||||Interventional|||The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys|An Open-Label, Passive Antibody Trial to Assess Efficacy in the Pathogenic SHIV-89.6P Macaque Model of Human Antibodies Generated by a Candidate HIV-1 Vaccine in a Phase I Clinical Trial|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:35:47.175727|2017-10-11 04:35:47.175727
NCT00031122|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-26|2010-10-04|||September 2000||2000-09-01|May 2009|2009-05-01|September 2012|Anticipated|2012-09-01|September 2011|Anticipated|2011-09-01||Observational|SBRR||Study of Genetic Risk Factors for Spina Bifida and Anencephaly|The Spina Bifida Research Resource|Unknown status|Active, not recruiting|N/A|1100|Anticipated|Office of Rare Diseases (ORD)|||1||f||||f||||||Samples With DNA|"     DNA extracted from whole blood, saliva, buccal swab, and/or amniocytes   "|||2017-10-11 04:35:47.298704|2017-10-11 04:35:47.298704
NCT00031161|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-26|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|September 2005||2005-09-01|||||Interventional|||Prevention of Dichloroacetate Toxicity|Prevention of Dichloroacetate Toxicity|Completed||N/A|30|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:35:47.545031|2017-10-11 04:35:47.545031
NCT00031174|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-26|2017-10-05|||February 21, 2002||2002-02-21|February 22, 2017|2017-02-22||||||||Observational|||Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy Volunteers|Collection Of Blood Components Using Apheresis From Patients With Rheumatic or Kidney Diseases and Healthy Volunteers|Recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:47.613018|2017-10-11 04:35:47.613018
NCT00031187|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-27|2011-10-21|||October 2000||2000-10-01|October 2011|2011-10-01|July 2003|Actual|2003-07-01|||||Interventional|||Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer|Phase II Study of SGN-15 (cBR96 - Doxorubicin Immunoconjugate) Combined With Taxotere in Patients With Hormone Refractory Prostate Carcinoma|Completed||Phase 2|160||Seattle Genetics, Inc.|||||||||||||||||||2017-10-11 04:35:47.704268|2017-10-11 04:35:47.704268
NCT00031200|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-27|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEAD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:47.791456|2017-10-11 04:35:47.791456
NCT00031213|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-27|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEAD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:47.842295|2017-10-11 04:35:47.842295
NCT00031226|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-27|2014-03-12|||September 2004||2004-09-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Biomarkers of Oxidative Stress in LOOK AHEAD - Ancillary to LOOK AHEAD||Completed||N/A|||Arizona State University|||||f||||||||||||||2017-10-11 04:35:47.889309|2017-10-11 04:35:47.889309
NCT00031239|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-27|2016-07-28|||September 2001||2001-09-01|May 2009|2009-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:35:47.939106|2017-10-11 04:35:47.939106
NCT00031252|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-27|2013-06-24|||January 2001||2001-01-01|June 2013|2013-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Neighborhood-Level Influences on All-Cause Mortality||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 04:35:47.987718|2017-10-11 04:35:47.987718
NCT00031265|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-28|2005-10-11|||October 1998||1998-10-01|October 2005|2005-10-01||||||||Interventional|||Efficacy of a Family Telephone Intervention for Stroke||Completed||Phase 2|290||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:35:48.04506|2017-10-11 04:35:48.04506
NCT00031278|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-28|2011-05-26|||October 2001||2001-10-01|May 2011|2011-05-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer|A Phase I/II Open Label, Multi-Center Study For The Evaluation Of The Combination Of CpG 7909 And Herceptin® In Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|12|Actual|Pfizer||4|||||||||||||||||2017-10-11 04:35:48.119386|2017-10-11 04:35:48.119386
NCT00031291|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-28|2008-03-03|||February 2002||2002-02-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin|Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:48.307203|2017-10-11 04:35:48.307203
NCT00031304|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-28|2017-10-05|||February 27, 2002||2002-02-27|April 8, 2013|2013-04-08|April 8, 2013||2013-04-08|||||Observational|||Screening Protocol for HIV Vaccine Studies|Screening Subjects for HIV Vaccine Research Studies|Completed||N/A|1324|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:48.583633|2017-10-11 04:35:48.583633
NCT00031317|ClinicalTrials.gov processed this data on October 10, 2017|2002-02-28|2008-03-03|||February 2002||2002-02-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression|Combined Treatment With A Benzodiazepine (Clonazepam) And A Selective Serotonin Reuptake Inhibitor (Paroxetine) For Rapid Treatment Of Panic Disorder With Depression|Completed||Phase 4|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:48.692202|2017-10-11 04:35:48.692202
NCT00031343|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-02|2008-03-03|||February 2002||2002-02-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin|A Randomized, Controlled Study to Assess the Impact of Highly Active Antiretroviral Therapy to Hepatitis C Therapy in Patients Coinfected With HIV-1 and Treated With Peginterferon Alpha-2b and Ribavirin|Completed||Phase 2|128||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:48.804671|2017-10-11 04:35:48.804671
NCT00031369|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-02|2017-10-05|||February 27, 2002||2002-02-27|March 10, 2015|2015-03-10|March 10, 2015||2015-03-10|||||Observational|||Brain Anatomy in Dystonia|In Vivo Mapping Of Structural and Biochemical Abnormalities In Patients With Primary Focal Dystonia|Terminated||N/A|189|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:48.917563|2017-10-11 04:35:48.917563
NCT00031382|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-02|2008-03-03|||February 2002||2002-02-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Imaging Study of Automatic Movements|A Neuroimaging Study of Automatic Movements|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:49.034709|2017-10-11 04:35:49.034709
NCT00031395|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-04|2009-05-20|||September 1999||1999-09-01|May 2009|2009-05-01|June 2007|Actual|2007-06-01|||||Interventional|||Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children|Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT)|Completed||Phase 3|122|Actual|University of Cincinnati||4|||f||||t||||||||||2017-10-11 04:35:49.13846|2017-10-11 04:35:49.13846
NCT00031408|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-05|2017-01-24|||March 2002||2002-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Consent for Use of Stored Patient Specimens for Future Testing|Plan for Obtaining Informed Consent to Use Stored Human Biological Materials (HBM) for Currently Unspecified Analyses|Recruiting||N/A|30000|Anticipated|AIDS Clinical Trials Group|||1||f||||t||||||Samples With DNA|"     Blood and tissue samples   "|||2017-10-11 04:35:49.289907|2017-10-11 04:35:49.289907
NCT00168961|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-06|||December 2003||2003-12-01|September 2005|2005-09-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||Enteral Nutrition in Liver Cirrhosis||Completed||Phase 4|||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:25:16.096578|2017-10-11 05:25:16.096578
NCT00031421|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-06|2011-08-11|||September 2001||2001-09-01|July 2008|2008-07-01|November 2005||2005-11-01|||||Observational|||Neonatal CMV-Ganciclovir Follow-up Study|A Follow-up Assessment of Subjects Who Received Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) During the Phase I/II Study to Evaluate the Safety and Efficacy of Ganciclovir Treatment for Congenital Cytomegalovirus (CMV) Infections|Completed||N/A|8||National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||||||2017-10-11 04:35:49.685352|2017-10-11 04:35:49.685352
NCT00031434|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-06|2011-02-03|||July 2002||2002-07-01|July 2009|2009-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Valganciclovir in Congenital CMV Infants|A Phase I/II Pharmacokinetic and Pharmacodynamic Evaluation of Oral Valganciclovir in Neonates With Symptomatic Congenital Cytomegalovirus (CMV) Infection (CASG 109)|Completed||Phase 1/Phase 2|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:35:49.793346|2017-10-11 04:35:49.793346
NCT00031447|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-06|2012-05-10|2009-04-01||August 1999||1999-08-01|November 2009|2009-11-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth|A Placebo-Controlled Phase III Evaluation of Suppressive Therapy With Oral Acyclovir Suspension Following Neonatal Herpes Simplex Virus Infections Limited to the Skin, Eye, and Mouth|Completed||Phase 3|29|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:35:49.96565|2017-10-11 04:35:49.96565
NCT00031460|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-06|2012-05-10|2009-04-02||December 1997||1997-12-01|October 2009|2009-10-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates|A Placebo-Controlled Phase III Evaluation of Suppressive Therapy With Oral Acyclovir Suspension Following Neonatal Herpes Simplex Virus Infections Involving the Central Nervous System|Completed||Phase 3|46|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:35:50.675323|2017-10-11 04:35:50.675323
NCT00031473|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-06|2010-08-26|||November 1997||1997-11-01|December 2003|2003-12-01|March 2003||2003-03-01|||||Interventional|||Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients|A Randomized Phase III Study to Evaluate the Safety and Efficacy of Ribavirin Inhaled Solution in Preventing Progression of Upper Respiratory Tract Respiratory Syncytial Virus Infection to RSV Pneumonia in Blood and Bone Marrow Transplant (BMT) Recipient|Terminated||Phase 3|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:35:51.316101|2017-10-11 04:35:51.316101
NCT00031499|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-06|2013-04-25|||June 2000||2000-06-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|August 2007|Actual|2007-08-01||Interventional|||Azithromycin/Bicillin Syphilis|A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for the Treatment of Early Syphilis|Completed||Phase 3|593|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:35:52.629425|2017-10-11 04:35:52.629425
NCT00031512|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-06|2013-02-28||2011-07-20|June 2001||2001-06-01|August 2012|2012-08-01|September 2012|Actual|2012-09-01|September 2010|Actual|2010-09-01||Interventional|||Pleconaril Enteroviral Sepsis Syndrome|A Double-Blind, Placebo-Controlled, Virologic Efficacy Trial of Pleconaril in the Treatment of Neonates With Enteroviral Sepsis Syndrome|Completed||Phase 2|61|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:35:52.742446|2017-10-11 04:35:52.742446
NCT00031538|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-06|2017-10-05|||March 1, 2002||2002-03-01|April 29, 2015|2015-04-29|April 29, 2015||2015-04-29|||||Observational|||Genetic Analysis of Brain Tumors|A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative|Terminated||N/A|480|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:35:53.083398|2017-10-11 04:35:53.083398
NCT00031551|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-07|2015-11-24|2015-11-24||March 2002||2002-03-01|November 2015|2015-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury|Evaluation of Efficacy and Mechanisms of an Anti-Inflammatory Intervention for Chemotherapy Related Mucosal Injury|Terminated||Phase 2|27|Actual|National Institutes of Health Clinical Center (CC)||3||It was not feasible to recruit required sample size from two clinical sites.|f||||t||||||||||2017-10-11 04:35:53.19517|2017-10-11 04:35:53.19517
NCT00031564|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2012-09-26|||May 2000||2000-05-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2005|Actual|2005-06-01||Interventional|||Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2|Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 for Patients With Stage IV Renal Cell Carcinoma|Completed||Phase 2|49|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:35:53.926523|2017-10-11 04:35:53.926523
NCT00031577|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2015-03-17|||August 1999||1999-08-01|January 2014|2014-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma|A Phase I Study Of Taxol And Involved Field Radiation Therapy For Newly Diagnosed Intrinsic Gliomas Of Childhood|Terminated||Phase 1|11|Actual|Children's Hospital of Philadelphia||||"Administrative closure 9/22/2006. Decline in enrollment at CHOP. due to competing protocols   with new agents."|f||||||||||||||2017-10-11 04:35:54.044846|2017-10-11 04:35:54.044846
NCT00031590|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2015-09-30|||April 2001||2001-04-01|September 2015|2015-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma|Study Of Reduced Dose Craniospinal Radiotherapy (1800 cGy) And Chemotherapy In Children With Newly-Diagnosed Standard-Risk Posterior Fossa Primitive Neuro-ectodermal Tumor (PNET/Medulloblastoma)|Terminated||Phase 2|30|Actual|Children's Hospital of Philadelphia||1||The study was terminated prematurely due to slow accrual.|f||||t||||||||||2017-10-11 04:35:54.12639|2017-10-11 04:35:54.12639
NCT00031616|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-12-17|||December 2001||2001-12-01|April 2004|2004-04-01||||||||Interventional|||NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer|A Phase I/II Study Of NB1011 Administered Intravenously Daily For 5 Days Every 4 Weeks In Fluoropyrimidine-Resistant Metastatic Or Relapsed Colorectal Cancers|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:35:54.244873|2017-10-11 04:35:54.244873
NCT00031629|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-12-07|||January 2005||2005-01-01|December 2016|2016-12-01||||July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus|A Phase II Evaluation of Docetaxel and Gemcitabine Plus G-CSF in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Completed||Phase 2|51|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:35:54.344197|2017-10-11 04:35:54.344197
NCT00031642|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-12-13|||January 2002||2002-01-01|December 2013|2013-12-01|March 2008|Actual|2008-03-01|November 2005|Actual|2005-11-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma That Has Relapsed After High-Dose Chemotherapy and Autologous Stem Cell Transplantation|Phase I/II Study of IDEC-Y2B8 (Zevalin) for Post Transplant Relapses of B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|26|Actual|University of Nebraska||1|||f||||f||||||||||2017-10-11 04:35:54.456266|2017-10-11 04:35:54.456266
NCT00031655|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2012-12-05|||September 2001||2001-09-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|August 2006|Actual|2006-08-01||Interventional|||Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission|Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation From HLA Matched Unrelated Donors for Treatment of Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission - A Multicenter Trial|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:35:54.565369|2017-10-11 04:35:54.565369
NCT00031668|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-11-11|||January 2001||2001-01-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|||||Interventional|||Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation|A Phase III Study of Involved Field Radiation Therapy (IFRT) in Patients With Histologically Aggressive Non-Hodgkin's Lymphoma Following High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT)|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:35:54.716425|2017-10-11 04:35:54.716425
NCT00031681|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-09-27|||December 2001||2001-12-01|September 2013|2013-09-01||||January 2011|Actual|2011-01-01||Interventional|||7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)|A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II)|Completed||Phase 1|41|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:35:54.837188|2017-10-11 04:35:54.837188
NCT00031694|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2015-04-08|2015-04-08||January 2002||2002-01-01|May 2013|2013-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer|A Phase II Study of Sequential Paclitaxel and Bryostatin-1 for Patients With Advanced Pancreatic Cancer|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:35:55.023218|2017-10-11 04:35:55.023218
NCT00031707|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-07-12|||March 2000||2000-03-01|July 2016|2016-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite|Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia|Completed||Phase 3|429|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-10-11 04:35:55.268572|2017-10-11 04:35:55.268572
NCT00031720|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-07-12|||March 2002||2002-03-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|April 2006|Actual|2006-04-01||Interventional|||Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease|Phase II Study of Soy Protein to Treat Vasomotor Symptoms in Postmenopausal Women Taking Tamoxifen|Completed||Phase 2|112|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:35:55.46987|2017-10-11 04:35:55.46987
NCT00031733|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2014-05-20|||February 2002||2002-02-01|May 2014|2014-05-01|November 2007|Actual|2007-11-01|December 2004|Actual|2004-12-01||Interventional|||Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma|A Phase II Randomized Trial of a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With Interleukin-12 With Alum or GM-CSF for Patients With Resected Stages IIB/C, III and IV Melanoma|Completed||Phase 2|60|Actual|University of Southern California|||||f||||t||||||||||2017-10-11 04:35:55.59491|2017-10-11 04:35:55.59491
NCT00031746|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-07-15|||February 2000||2000-02-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels|Effects of Dietary Soy on Biomarkers of Prostate Cancer: A Prospective Phase II Study|Completed||Phase 2|26|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:35:55.687246|2017-10-11 04:35:55.687246
NCT00031759|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2016-07-12|||June 1999||1999-06-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|July 2004|Actual|2004-07-01||Interventional|||Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia|Phase II Topical Immunomodulatory Therapy With Imiquimod for the Chemoprevention of Recurrent and High-Grade Cervical Intraepithelial Neoplasia (CIN)|Completed||Phase 2|57|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:35:55.781579|2017-10-11 04:35:55.781579
NCT00031772|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2013-02-12|||July 1998||1998-07-01|February 2013|2013-02-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer|Enhancing Well-Being During Breast Cancer Recurrence. SWOG Study S9832.|Completed||N/A|322|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:35:55.945229|2017-10-11 04:35:55.945229
NCT00031785|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2017-04-17|||September 2000|Actual|2000-09-01|August 2009|2009-08-01|September 11, 2002|Actual|2002-09-11|September 11, 2002|Actual|2002-09-11||Interventional|||Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer|A Phase III, Double-Blind, Randomized Study of the Effect of Megestrol Acetate on Weight and Health Related Quality of Life in Lung Cancer Patients Receiving Thoracic Radiation Therapy|Completed||Phase 3|25|Actual|Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:35:56.317995|2017-10-11 04:35:56.317995
NCT00042042|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-22|2005-06-23||||||July 2002|2002-07-01||||||||Interventional|||Screening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic|Screening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic|Unknown status|Recruiting|N/A|400||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:36:29.780262|2017-10-11 04:36:29.780262
NCT00031798|ClinicalTrials.gov processed this data on October 10, 2017|2002-03-08|2017-01-18|||April 2002||2002-04-01|August 2009|2009-08-01|May 2006|Actual|2006-05-01|March 2005|Actual|2005-03-01||Interventional|||Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors|A Phase III, Double-Blind, Prospective Randomized Clinical Trial of the Effect of D-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy|Terminated||Phase 3|||Wake Forest University Health Sciences||||low accrual; loss of funding|f||||||||||||||2017-10-11 04:35:56.403129|2017-10-11 04:35:56.403129
NCT00037999|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2009-01-20|||April 2001||2001-04-01|May 2002|2002-05-01|March 2004|Actual|2004-03-01|||||Interventional|||The Effect of Testosterone Supplementation on Rehabilitation Outcomes|The Effect of Testosterone Supplementation on Rehabilitation Outcomes|Completed||Phase 2|60|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:35:56.491729|2017-10-11 04:35:56.491729
NCT00038012|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2012-07-31|||September 1999||1999-09-01|July 2012|2012-07-01|June 2004|Actual|2004-06-01|October 2002|Actual|2002-10-01||Interventional|||rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin|A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopreserved With Thrombosol and 2% DMSO in Patients With Gynecologic Malignancy Receiving Carboplatin|Completed||N/A|31|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:35:56.556877|2017-10-11 04:35:56.556877
NCT00038025|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2012-08-01|||September 1994||1994-09-01|August 2012|2012-08-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional|||A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies|A Phase II Study of Deoxycoformycin (DCF) in Lymphoid Malignancies|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:35:58.175439|2017-10-11 04:35:58.175439
NCT00038038|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2012-07-31|||January 1994||1994-01-01|July 2012|2012-07-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole|Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||1||No participants enrolled, study terminated.|f||||f||||||||||2017-10-11 04:35:58.267842|2017-10-11 04:35:58.267842
NCT00038051|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-24|2013-04-01|||May 1999||1999-05-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies|Phase I Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies|Completed||Phase 1|28|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:35:58.376349|2017-10-11 04:35:58.376349
NCT00038064|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-28|2008-09-11|||January 2002||2002-01-01|September 2008|2008-09-01|April 2004|Actual|2004-04-01|October 2003|Actual|2003-10-01||Interventional|||Anemia in Patients With a Non-Myeloid Malignancy|A Randomized, Open-Label Study of Darbepoetin Alfa (Novel Erythropoiesis Stimulation Protein, NESP) and rHuEPO for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 3|707|Actual|Amgen||2|||f||||||||||||||2017-10-11 04:35:58.474313|2017-10-11 04:35:58.474313
NCT00038077|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-28|2010-11-17|||August 2001||2001-08-01|November 2010|2010-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Reversal of Ventricular Remodeling With Toprol-XL||Completed||Phase 3|300||AstraZeneca|||||||||||||||||||2017-10-11 04:35:58.566853|2017-10-11 04:35:58.566853
NCT00038090|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-28|2012-07-31|||September 2001||2001-09-01|July 2012|2012-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Thalidomide-Dexamethasone for Multiple Myeloma|Thalidomide-Dexamethasone for Multiple Myeloma|Completed||Phase 2/Phase 3|83|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:35:58.709994|2017-10-11 04:35:58.709994
NCT00038103|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2010-02-11|2009-03-27||January 2002||2002-01-01|February 2010|2010-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen|Open-Label, Multicentre, Controlled Study Of Exemestane (Aromasin®) With Or Without Celecoxib (Celebrex®) In Postmenopausal Women With Advanced Breast Cancer (ABC) Having Progressed On Tamoxifen|Completed||Phase 2|111|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:35:58.817877|2017-10-11 04:35:58.817877
NCT00038116|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2013-02-04|||May 1995||1995-05-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Embryonic Dopamine Cell Implants for Parkinson's Disease|Embryonic Dopamine Cell Implants for Parkinson's Disease: A Double-Blind Study|Completed||Phase 3|40|Actual|University of Colorado, Denver||2|||f||||||||||||||2017-10-11 04:35:59.934095|2017-10-11 04:35:59.934095
NCT00038129|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2013-06-17|||May 2002||2002-05-01|June 2013|2013-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||SPRINT - Randomized Trial of Tibial Fracture Fixation|Study to Prospectively Evaluate Reamed Intramedullary Nails in Tibial Shaft Fractures (SPRINT)|Completed||N/A|1200|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 04:36:00.037372|2017-10-11 04:36:00.037372
NCT00038142|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2016-03-03|||November 1997||1997-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients|Randomized Phase II Study of Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) With or Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma|Terminated||Phase 2|46|Actual|M.D. Anderson Cancer Center||2||Low Accrual|f||||t||||||||||2017-10-11 04:36:00.156461|2017-10-11 04:36:00.156461
NCT00038155|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2010-09-22|||May 2002||2002-05-01|September 2010|2010-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|STAGE||Rehabilitation for Older Adults From Acute Medical Conditions|Rehabilitation for Older Adults From Acute Medical Conditions|Completed||Phase 2|10|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:36:00.245393|2017-10-11 04:36:00.245393
NCT00038168|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2012-07-31|||June 2000||2000-06-01|July 2012|2012-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma|Phase I/II Study of Intravenous Estramustine Phosphate Combined With Taxol in Patients With Hormone Refractory Adenocarcinoma of the Prostate|Completed||Phase 1/Phase 2|14|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:36:00.315577|2017-10-11 04:36:00.315577
NCT00038181|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2012-07-31|||October 2000||2000-10-01|July 2012|2012-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer|A Tolerance and Efficacy Trial of Preoperative Thalidomide Treatment Followed by Radical Retropubic Prostatectomy (RRP) in Select Patients With Locally Advanced Prostate Cancer|Completed||Phase 2|18|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:36:00.38608|2017-10-11 04:36:00.38608
NCT00038194|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2012-07-31|||October 2001||2001-10-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer|Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 1|28|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:36:00.441428|2017-10-11 04:36:00.441428
NCT00038207|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2012-07-27|||June 2000||2000-06-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|September 2004|Actual|2004-09-01||Interventional|||Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies|Phase II Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies|Completed||Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:36:00.51091|2017-10-11 04:36:00.51091
NCT00038220|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2006-07-26|||July 2000||2000-07-01|July 2006|2006-07-01||||||||Interventional|||Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients|A Phase I/II, Open Label Study to Evaluate the Ability of Combination Therapy With ABT-378/Ritonavir (Kaletra), Lamivudine (Epivir), Efavirenz (Sustiva)and Tenofovir DF to Completely Suppress Viral Replication in Subjects Infected With HIV-1|Completed||Phase 2|40||Abbott|||||||||||||||||||2017-10-11 04:36:00.637285|2017-10-11 04:36:00.637285
NCT00038233|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2012-07-27|||May 1999||1999-05-01|July 2012|2012-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Thalidomide for Multiple Myeloma|Thalidomide for Multiple Myeloma|Completed||Phase 3|27|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:36:00.78933|2017-10-11 04:36:00.78933
NCT00038246|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2013-05-31|||October 2000||2000-10-01|May 2013|2013-05-01|December 2004|Actual|2004-12-01|February 2004|Actual|2004-02-01||Interventional|||Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma|Phase I/II Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma (AI-PCa)|Completed||Phase 1/Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:36:00.870983|2017-10-11 04:36:00.870983
NCT00038259|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2012-05-09||||||May 2012|2012-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy|An Exploratory, Open-Label, Randomized Trial to Evaluate the Ability of Interleukin-2 (IL-2) to Enhance HIV-Specific Immunity and Influence the Time to Virologic Relapse Following Withdrawal of Potent Antiretroviral Therapy|Completed||N/A|21||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:36:00.987523|2017-10-11 04:36:00.987523
NCT00038272|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2012-05-17||||||May 2012|2012-05-01|April 2006|Actual|2006-04-01|||||Interventional|||A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection|A Phase I/II Randomized, Double-Blind, Placebo-Controlled Pilot Study of Beta-D-2,6-diaminopurine Dioxolane (DAPD) Versus DAPD Plus Mycophenolate Mofetil (MMF) in Treatment-Experienced Subjects|Completed||Phase 2|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:36:01.101649|2017-10-11 04:36:01.101649
NCT00038285|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2009-01-20|||April 2002||2002-04-01|May 2002|2002-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)|Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:36:01.237185|2017-10-11 04:36:01.237185
NCT00038298|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-29|2011-01-20|||April 2002||2002-04-01|January 2011|2011-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Assess the Efficacy, Safety and Tolerability of AMG 719 in Subjects With Rheumatoid Arthritis Receiving Methothrexate|Completed||Phase 2|53|Actual|Amgen||4|||f||||||||||||||2017-10-11 04:36:01.338016|2017-10-11 04:36:01.338016
NCT00038311|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2015-04-30|||September 2000||2000-09-01|April 2015|2015-04-01|March 2003|Actual|2003-03-01|||||Interventional|||Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia|Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Administered to Patients With High-Risk Sarcoma Receiving Intensive Chemotherapy (Adriamycin and Ifosfamide (AI))|Completed||Phase 3|120||Pfizer|||||f||||||||||||||2017-10-11 04:36:01.450107|2017-10-11 04:36:01.450107
NCT00038337|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2009-01-20|||April 2001||2001-04-01|May 2002|2002-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Improving Functional Health Literacy in Older Veterans|Improving Functional Health Literacy in Older Veterans|Completed||Phase 2|240|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:36:01.541648|2017-10-11 04:36:01.541648
NCT00040404|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2012-05-08||2012-05-03|March 2002||2002-03-01|May 2012|2012-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Efficacy and Safety of CEP-1347 in Patients With Parkinson's Disease|Terminated||Phase 2/Phase 3|806|Actual|Teva Pharmaceutical Industries||4||Unlikely to provide evidence of significant effect|f||||t||||||||||2017-10-11 04:36:01.624412|2017-10-11 04:36:01.624412
NCT00040417|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2007-04-09|||August 2000||2000-08-01|April 2007|2007-04-01||||||||Interventional|||Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies|Allo SCT From HLA Haploidentical Related Donors Using Sub-Myeloablative Conditioning For Patients With High Risk Hemoglobinopathies: Hemo SS, Hemo SC, Hemo SB0/+ Thalassemia, Homozygous B0/+ Thalassemia or Severe B0/+ Thalassemia Variants|Terminated||Phase 2|15||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:36:01.824644|2017-10-11 04:36:01.824644
NCT00040430|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2005-06-23||||||January 2003|2003-01-01||||||||Interventional|||Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer||Unknown status|Active, not recruiting|Phase 1|||Copharos|||||||||||||||||||2017-10-11 04:36:01.888493|2017-10-11 04:36:01.888493
NCT00042055|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-22|2011-10-14|||July 2002||2002-07-01|October 2011|2011-10-01|September 2003|Actual|2003-09-01|||||Interventional|||CP-461 for the Treatment of Crohn's Disease|A Phase II Pilot Study of CP-461 in the Treatment of Moderately to Severely Active Crohn's Disease|Completed||Phase 2|30||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:36:29.858103|2017-10-11 04:36:29.858103
NCT00040456|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2012-11-15|||January 2001||2001-01-01|November 2012|2012-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate|The Effect of Oral Magnesium Pidolate on Incidence of Painful Crises in Patients With Hemoglobin SC Disease|Terminated||Phase 2|12|Actual|Baylor College of Medicine||2||Lack of accrual|f||||t||||||||||2017-10-11 04:36:02.028773|2017-10-11 04:36:02.028773
NCT00040469|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2007-04-09|||August 2000||2000-08-01|April 2007|2007-04-01||||||||Interventional|||Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies|Allogeneic Bone Marrow Transplant From HLA Identical Related Donors for Patients With High Risk Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, Hemoglobin SB0/+ Thalassemia, or Homozygous B0/+ Thalassemia or Severe Variants of B0/+ Thalassemia|Terminated||Phase 2|15||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:36:02.125538|2017-10-11 04:36:02.125538
NCT00040482|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2007-04-09|||April 1999||1999-04-01|April 2007|2007-04-01|August 2005||2005-08-01|||||Interventional|||High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis|Intensive Immunosuppression Followed by Rescue With CD34 Selected, T Cell Depleted, Leukopheresis Products in Patients With Multiple Sclerosis|Completed||Phase 2|10||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:36:02.20132|2017-10-11 04:36:02.20132
NCT00040495|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2013-02-07|||April 2001||2001-04-01|February 2013|2013-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage|An Efficacy and Safety Study of Intravenous Pantoprazole in the Prevention of Recurrent Peptic Ulcer Bleeding After Successful Hemostasis|Completed||Phase 3|149|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:36:02.271394|2017-10-11 04:36:02.271394
NCT00040508|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2008-03-03|||June 2002||2002-06-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Sirolimus for Focal Segmental Glomerulosclerosis|Sirolimus for Focal Segmental Glomerulosclerosis|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:02.335458|2017-10-11 04:36:02.335458
NCT00040521|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-27|2013-02-07|||April 2002||2002-04-01|September 2005|2005-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study Evaluating rhIL-11 in Active Crohn's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Orally Administered Recombinant Human Interleukin-11 (rhIL-11) for the Treatment of Patients With Active Crohn's Disease|Completed||Phase 2|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:36:02.406748|2017-10-11 04:36:02.406748
NCT00040534|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-28|2015-02-13|||January 2001||2001-01-01|February 2015|2015-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)||Terminated||Phase 1|22|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:36:02.479047|2017-10-11 04:36:02.479047
NCT00040547|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-28|2015-02-16|||June 2001||2001-06-01|February 2015|2015-02-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED)|Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors|Completed||Phase 1|29|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:36:02.53356|2017-10-11 04:36:02.53356
NCT00040560|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-28|2005-06-23||||||January 2003|2003-01-01||||||||Interventional|||Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer||Unknown status|Active, not recruiting|Phase 1|||Copharos|||||||||||||||||||2017-10-11 04:36:02.601688|2017-10-11 04:36:02.601688
NCT00040573|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-29|2009-03-30|||June 2002||2002-06-01|March 2009|2009-03-01|August 2003||2003-08-01|||||Interventional|||Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.|A Phase I/II Open Label, Single Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients With Recurrent High-Grade Glioma.|Completed||Phase 1/Phase 2|18||TransMolecular|||||||||||||||||||2017-10-11 04:36:02.660455|2017-10-11 04:36:02.660455
NCT00040586|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-01|2007-01-19||||||July 2002|2002-07-01||||||||Interventional|||Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2|Phase II Trial of Monoclonal Antibody J591 in Combination With Low-Dose Interleukin-2 in Patients With Recurrent Prostate Cancer|Completed||Phase 2|||BZL Biologics|||||||||||||||||||2017-10-11 04:36:02.853735|2017-10-11 04:36:02.853735
NCT00040599|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-01|2008-01-08|||January 2000||2000-01-01|January 2008|2008-01-01|January 2004||2004-01-01|||||Interventional|||Safety Study of 90Y-hMN14 to Treat Colorectal Cancer|A Phase I/II Study of Radioimmunotherapy With 90Y-Humanized MN-14 IgG Administered as a Single Dose to Patients With Refractory Metastatic/Recurrent Colorectal Carcinomas|Completed||Phase 1/Phase 2|72||Immunomedics, Inc.|||||||||||||||||||2017-10-11 04:36:02.924368|2017-10-11 04:36:02.924368
NCT00040625|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-02|2007-03-14||||||March 2007|2007-03-01||||||||Expanded Access|||ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.||Approved for marketing||N/A|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:36:03.024209|2017-10-11 04:36:03.024209
NCT00040638|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-02|2011-07-21|||July 2002||2002-07-01|June 2011|2011-06-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer||Completed||Phase 2|40||Telik|||||f||||||||||||||2017-10-11 04:36:03.09825|2017-10-11 04:36:03.09825
NCT00040651|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-05|2007-12-19|||July 2002||2002-07-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients|Transplantation With T-Cell Depleted Autologous Peripheral Stem Cells for Severe Systemic Sclerosis: A Phase I Dose Escalation Study|Terminated||Phase 1|15||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-10-11 04:36:03.191693|2017-10-11 04:36:03.191693
NCT00040664|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-05|2017-01-19|2009-08-06||July 2002||2002-07-01|January 2017|2017-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years|A 48 Week, Phase II, Open-Label Multi-Cohort, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GW433908/Ritonavir QD and GW433908/Ritonavir BID When Administered to HIV-1 Infected, Antiretroviral Naive and Experienced, Pediatric Subjects 2-18 Years Old|Completed||Phase 2|69|Actual|ViiV Healthcare||3|||f||||||||||||||2017-10-11 04:36:03.317494|2017-10-11 04:36:03.317494
NCT00048659|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-04|2012-06-06||||||June 2012|2012-06-01|June 2004|Actual|2004-06-01|||||Interventional|||YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy||Terminated||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:38:01.19779|2017-10-11 04:38:01.19779
NCT00040677|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2011-07-13||2011-07-07|February 2002||2002-02-01|July 2011|2011-07-01|January 2004|Actual|2004-01-01|November 2003|Actual|2003-11-01||Interventional|||A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.|A Phase II, Multicenter, Twelve-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Efficacy and Safety of ICA-17043 With or Without Hydroxyurea Therapy in Patients With Sickle Cell Anemia|Completed||Phase 2|90|Actual|Icagen||3|||f||||t||||||||||2017-10-11 04:36:04.292472|2017-10-11 04:36:04.292472
NCT00040690|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-12-18|||November 2008||2008-11-01|May 2007|2007-05-01|December 2008|Actual|2008-12-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia|A Clinicopathological Study In Burkitts's And Burkitt-Like Non-Hodgkin's Lymphoma|Completed||Phase 2|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:04.44002|2017-10-11 04:36:04.44002
NCT00040729|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2015-04-24|||March 2002||2002-03-01|May 2003|2003-05-01||||||||Observational|||Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C|Retrospective Analysis Of Promoter Polymorphism Of UGT1A1 Gene In Cancer Patients Enrolled On Clinical Trials With Flavopiridol At National Cancer Institute To Assess The Pharmacokinetics And Pharmacodynamics Of Flavopiridol|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:04.553194|2017-10-11 04:36:04.553194
NCT00040742|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2015-10-13|2014-07-10||March 2003||2003-03-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer|A Phase II/III Randomized, Controlled Clinical Trial Of Ginger (Zingiber Officinale) For Nausea Caused By Chemotherapy For Cancer|Completed||Phase 2/Phase 3|745|Actual|University of Rochester|Two main weaknesses of the study, which should be controlled for in future studies, were not controlling for chemotherapy regimens (i.e., high versus low emetogenic regimens) or the severity level of nausea before enrollment.|4|||f||||t||||||||||2017-10-11 04:36:04.646189|2017-10-11 04:36:04.646189
NCT00040755|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-01-31|||May 2002||2002-05-01|January 2013|2013-01-01||||July 2006|Actual|2006-07-01||Interventional|||BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|Randomized Phase II Trial of BMS-275291 (NSC 713763, IND 62573) in Hormone Refractory Prostate Cancer|Completed||Phase 2|68|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:36:05.655637|2017-10-11 04:36:05.655637
NCT00040768|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-01-15|||April 2002||2002-04-01|January 2013|2013-01-01||||March 2006|Actual|2006-03-01||Interventional|||Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer|A Phase II Study Of PS-341 In Metastatic Non-Small Cell Lung Cancer|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:36:05.739987|2017-10-11 04:36:05.739987
NCT00040781|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-01-22|||June 2002||2002-06-01|January 2013|2013-01-01||||October 2004|Actual|2004-10-01||Interventional|||Gefitinib in Treating Children With Refractory Solid Tumors|A Phase I Study Of ZD1839 (Iressa TM), An Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, In Children With Refractory Solid Tumors|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:36:05.817663|2017-10-11 04:36:05.817663
NCT00040794|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-06-04|||May 2002||2002-05-01|June 2013|2013-06-01||||March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer|ZD1839 (NSC #715055, IND #61187) With Induction Paclitaxel And Carboplatin Followed By Either Radiation Or Concomitant Radiation With Weekly Paclitaxel And Carboplatin In Stage III Non-Small Cell Lung Cancer, A Phase II Study|Completed||Phase 2|144|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:36:05.897577|2017-10-11 04:36:05.897577
NCT00040807|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2009-07-29|||October 2002||2002-10-01|November 2004|2004-11-01||||April 2005|Actual|2005-04-01||Interventional|||Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer|Phase II Trial Of Weekly Irinotecan And Docetaxel In Recurrent Or Metastatic Head And Neck Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:06.002319|2017-10-11 04:36:06.002319
NCT00040820|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2011-03-03|||January 2002||2002-01-01|March 2011|2011-03-01|March 2004|Actual|2004-03-01|August 2003|Actual|2003-08-01||Interventional|||Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer|A Treatment Access Program With Oxaliplatin for Previously Treated Colorectal Cancer Patients|Completed||N/A|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:36:06.291911|2017-10-11 04:36:06.291911
NCT00040833|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-06-04|||February 2002||2002-02-01|June 2013|2013-06-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer|Acupuncture for the Treatment of Pancreatic Cancer Pain: A Single Arm Phase II Study|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:36:06.389421|2017-10-11 04:36:06.389421
NCT00040846|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2017-03-24|2017-01-26||November 2001||2001-11-01|March 2017|2017-03-01||||December 2009|Actual|2009-12-01||Interventional|||Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies|Campath® [Alemtuzumab] Dose Escalation, Low-Dose TBI and Fludarabine Followed by HLA Class I Mismatched Donor Stem Cell Transplantation for Patients With Hematologic Malignancies - A Multi-Center Trial|Active, not recruiting||Phase 2|60|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:36:06.493985|2017-10-11 04:36:06.493985
NCT00040859|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-12-05|||September 2002||2002-09-01|December 2016|2016-12-01|April 2008|Actual|2008-04-01|January 2005|Actual|2005-01-01||Interventional|||Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer|A Phase II Study of Oxaliplatin and Capecitabine in Patients With Measurable Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:36:07.657354|2017-10-11 04:36:07.657354
NCT00040872|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-03-06|||June 2000||2000-06-01|March 2013|2013-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Multiple Therapies in Treating Patients With Advanced Neuroblastoma|N8: Dose-Intensive Chemotherapy Plus Biologics in the Treatment of Neuroblastoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:36:07.772911|2017-10-11 04:36:07.772911
NCT00042029|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-22|2017-05-02|||June 18, 2002|Actual|2002-06-18|May 2017|2017-05-01|October 3, 2003|Actual|2003-10-03|October 3, 2003|Actual|2003-10-03||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)|A Double-Blind, Multicenter, Placebo-Controlled Study of MK0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|324|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:36:29.678989|2017-10-11 04:36:29.678989
NCT00040885|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-12-05|||October 2002||2002-10-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|February 2006|Actual|2006-02-01||Interventional|||Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)|Docetaxel And Infliximab/Placebo In Non-Small Cell Lung Cancer (NSCLC) Patients Greater Than Or Equal To 65 Years Of Age Or In NSCLC Patients With Poor Performance Status: A Double-Blind Randomized, Placebo-Controlled Trial To Prevent And Treat Wasting, Anorexia, And Asthenia In Chemotherapy-Naive And Previously-Treated Patients|Completed||Phase 3|67|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:36:07.924492|2017-10-11 04:36:07.924492
NCT00040898|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-01-17|||January 2001||2001-01-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed|Sho-Saiko-To After Ablation for Non-Resectable Hepatocellular Carcinoma (HCC): A Phase II Trial With Historical Control|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:36:08.463545|2017-10-11 04:36:08.463545
NCT00040911|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-05-29|||April 2005||2005-04-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|October 2009|Actual|2009-10-01||Interventional|||Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma|A Randomized Study Of Electroacupuncture Treatment For Delayed Chemotherapy-Induced Nausea And Vomiting In Patients With Pediatric Solid Tumors|Completed||N/A|17|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:36:08.748733|2017-10-11 04:36:08.748733
NCT00040937|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-10-26|2012-10-31||June 2002||2002-06-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2008|Actual|2008-10-01||Interventional|||S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma|A Phase II Trial Of Thalidomide/Dexamethasone Induction Followed By Tandem Melphalan Transplant And Prednisone/Thalidomide Maintenance (A BMT Study)|Completed||Phase 2|147|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:36:08.931207|2017-10-11 04:36:08.931207
NCT00040950|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-12-18|||March 2002||2002-03-01|July 2003|2003-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Multi-Center, Phase I, Open Label, Two Arm, Non-Randomized, Dose-Escalation, Study Of The Safety And Tolerability Of CPG 7909 In Patients Receiving Rituxan For Relapsed Or Refractory B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:10.258892|2017-10-11 04:36:10.258892
NCT00040989|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer|Phase II Study of BAY 56-3722 in Patients With Recurrent, Unresectable, or Metastatic Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:10.344943|2017-10-11 04:36:10.344943
NCT00041015|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2014-01-08|||September 2001||2001-09-01|January 2014|2014-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment For Chemotherapy-Naive Patients With Extensive Disease - Small Cell Lung|Completed||Phase 3|4|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:36:10.478241|2017-10-11 04:36:10.478241
NCT00041028|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2015-04-30|||May 2002||2002-05-01|September 2006|2006-09-01|April 2014|Actual|2014-04-01|September 2007|Actual|2007-09-01||Interventional|||EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Pilot Phase II Research Study of EF5 to Measure Tumor Hypoxia in Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:36:10.564968|2017-10-11 04:36:10.564968
NCT00041041|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-02-19|||June 2002||2002-06-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation Of Gleevec (Imatinib Mesylate) (IND #61135, NSC #716051) In The Treatment Of Persistent Or Recurrent Epithelial Ovarian Or Primary Peritoneal Carcinoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:36:10.634672|2017-10-11 04:36:10.634672
NCT00041054|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-12-05|||June 2002||2002-06-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|August 2004|Actual|2004-08-01||Interventional|||Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer|Completed||Phase 2|41|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:36:10.735336|2017-10-11 04:36:10.735336
NCT00041067|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-05-20|2012-11-15||September 2002||2002-09-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|January 2008|Actual|2008-01-01||Interventional|||S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer|Docetaxel (NSC-628503) And Vinorelbine (NSC-608210) Plus Filgrastim (NSC-614629) With Weekly Trastuzumab (NSC-688097) For HER-2 Positive, Stage IV Breast Cancer|Completed||Phase 2|76|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:36:11.058773|2017-10-11 04:36:11.058773
NCT00041080|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2014-04-29|2013-07-09||February 2003||2003-02-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||"Description of population is based on eligible patients.
1 patient not included in characteristics due to ineligible primary tumor site."|Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Randomized Study Of Tamoxifen Versus Thalidomide (NSC# 66847) In Patients With Biochemical-Recurrence-Only Epithelial Ovarian Cancer, Cancer Of The Fallopian Tube, And Primary Peritoneal Carcinoma After First Line Chemotherapy|Completed||Phase 3|139|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:36:11.789531|2017-10-11 04:36:11.789531
NCT00041093|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-12-07|||June 2002||2002-06-01|December 2016|2016-12-01||||October 2008|Actual|2008-10-01||Interventional|||Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation Of Docetaxel (NSC #628503) In The Treatment Of Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix|Completed||Phase 2|27|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:36:12.323969|2017-10-11 04:36:12.323969
NCT00041106|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-06-04|||May 2002||2002-05-01|June 2013|2013-06-01||||July 2007|Actual|2007-07-01||Interventional|||Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer|Phase II Study Of Cisplatin, Gemcitabine, And ZD 1839 (IRESSA) (IND #61187; NSC 715055) For The Treatment Of Advanced Urothelial Tract Carcinoma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:36:12.403405|2017-10-11 04:36:12.403405
NCT00041119|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2017-04-12|2017-01-09||May 2002||2002-05-01|April 2017|2017-04-01|June 2014|Actual|2014-06-01|April 2012|Actual|2012-04-01||Interventional||All patients that were eligible and treated for the study were evaluated|Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer|Cyclophosphamide And Doxorubicin (CA) (4 VS 6 Cycles) Versus Paclitaxel (4 VS 6 Cycles) As Adjuvant Therapy For Breast Cancer in Women With 0-3 Positive Axillary Lymph Nodes:A 2X2 Factorial Phase III Randomized Study|Completed||Phase 3|3871|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-10-11 04:36:12.605549|2017-10-11 04:36:12.605549
NCT00041132|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2012-10-03|2012-03-05||September 2002||2002-09-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|November 2007|Actual|2007-11-01||Interventional|||S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma|Pilot Trial of Hyper-CVAD and Methotrexate/ARA C Plus Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|56|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:36:16.759038|2017-10-11 04:36:16.759038
NCT00041171|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-07-11||||||July 2016|2016-07-01||||||||Interventional|||Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery|Phase III Randomized Study of Hypericum Perforatum (St. John's Wort) Combined With Docetaxel in Patients With Unresectable Solid Tumors|Withdrawn||Phase 3|0|Actual|Alliance for Clinical Trials in Oncology||3||The study was not activated.|f||||||||||||||2017-10-11 04:36:17.121764|2017-10-11 04:36:17.121764
NCT00041197|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-07-15|||June 2002||2002-06-01|June 2013|2013-06-01||||April 2007|Actual|2007-04-01||Interventional|||Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery|A Phase III Randomized Double-Blind Study of Adjuvant STI571 (Gleevec™) Versus Placebo in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor (GIST)|Completed||Phase 3|732|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:36:17.232472|2017-10-11 04:36:17.232472
NCT00041210|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-09-19|||October 2001||2001-10-01|April 2009|2009-04-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma|Protocol for a Randomized Phase III Study of the Stanford V Regimen, Compared With ABVD for the Treatment of Advanced Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 3|850|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:17.325568|2017-10-11 04:36:17.325568
NCT00041223|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-11-05|||September 2002||2002-09-01|September 2002|2002-09-01||||||||Interventional|||IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer|Double-Blind, Placebo-Controlled, Randomized Phase II Trial of IH636 Grape Seed Proanthocyanidin Extract (GSPE) in Patients With Adverse Effects of High Dose Breast Radiotherapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:18.910867|2017-10-11 04:36:18.910867
NCT00041236|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2012-07-17|||May 2002||2002-05-01|July 2012|2012-07-01||||December 2004|Actual|2004-12-01||Interventional|||Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma|Exatecan As Second-Line Treatment In Advanced Adult Soft Tissue Sarcoma: A Phase II - Study Of The EORTC Soft Tissue And Bone Sarcoma Group|Completed||Phase 2|39|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:36:19.025261|2017-10-11 04:36:19.025261
NCT00041249|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2012-07-17|||May 2002||2002-05-01|July 2012|2012-07-01||||January 2004|Actual|2004-01-01||Interventional|||Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma|Efficacy And Safety Study Of Brostallicin In Patients With Locally Advanced Or Metastatic Soft Tissue Sarcoma Failing One Prior Chemotherapy Treatment|Completed||Phase 2|64|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:36:19.125143|2017-10-11 04:36:19.125143
NCT00041262|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-08-09|||November 2004||2004-11-01|March 2007|2007-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Esophageal Cancer|A Prospective Randomized Trial Comparing Standard Chemotherapy Followed By Resection Versus Infusional Chemotherapy In Patients With Resectable Adenocarcinoma Of The Oesophagus|Unknown status|Recruiting|Phase 3|1300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:19.216379|2017-10-11 04:36:19.216379
NCT00041275|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-09-19|||May 2002||2002-05-01|September 2002|2002-09-01|August 2011|Actual|2011-08-01|June 2007|Actual|2007-06-01||Interventional|||Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery|Randomized Double Blind Trial Of Megestrol Acetate Versus Placebo For The Treatment Of Inoperable Hepatocellular Carcinoma|Completed||Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:19.300033|2017-10-11 04:36:19.300033
NCT00041288|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2009-02-06|||October 2001||2001-10-01|March 2003|2003-03-01||||||||Interventional|||Comparison of Fludarabine Plus Total-Body Irradiation With Combination Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:19.407704|2017-10-11 04:36:19.407704
NCT00041301|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2012-08-24|||March 2002||2002-03-01|August 2012|2012-08-01|November 2005|Actual|2005-11-01|December 2004|Actual|2004-12-01||Observational|||Assessing Quality of Life of Patients With Prostate Cancer|An International Field Study Of The Reliability And Validity Of The EORTC QLQ-C30 And A Disease-Specific Questionnaire Module (QLQ-PR25) For Assessing Quality Of Life Of Patients With Prostate Cancer|Completed||N/A|625|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||||||2017-10-11 04:36:19.539314|2017-10-11 04:36:19.539314
NCT00041314|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2009-06-06|||August 2002||2002-08-01|August 2002|2002-08-01||||July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer|A Phase II Trial Of Carboplatin And Gemcitabine With Exisulind In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:21.053836|2017-10-11 04:36:21.053836
NCT00173940|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-27||||||July 2002|2002-07-01||||||||Observational|||Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination Services||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:05.695428|2017-10-11 05:26:05.695428
NCT00041327|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-02-01|||October 2002||2002-10-01|February 2016|2016-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma|Phase II Trial Of Induction Therapy With EPOCH Chemotherapy And Maintenance Therapy With Combivir/Interferon ALPHA-2a For HTLV-1 Associated T-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|19|Actual|AIDS Malignancy Consortium||1|||f||||||||||||||2017-10-11 04:36:21.287105|2017-10-11 04:36:21.287105
NCT00041340|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-01-22|||May 2002||2002-05-01|January 2013|2013-01-01||||July 2006|Actual|2006-07-01||Interventional|||Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer|Phase II Study Of Gleevec (Imatinib Mesylate Formerly Known As(STI571) (NSC #716051) In Patients With Colorectal Cancer Stage IV|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:36:21.383725|2017-10-11 04:36:21.383725
NCT00041353|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-07-10||||||July 2013|2013-07-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer|Breast Cancer Biomarkers Based on Fine Needle Aspirates|Withdrawn||N/A|0|Actual|Fox Chase Cancer Center||||Study was not activated at Fox Chase Cancer Center|f||||f||||||||||2017-10-11 04:36:21.589804|2017-10-11 04:36:21.589804
NCT00041379|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-12-17|||March 2002||2002-03-01|December 2005|2005-12-01||||||||Interventional|||Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia|Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With Waldenstrom's Macroglobulinemia|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:21.655567|2017-10-11 04:36:21.655567
NCT00041392|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2013-07-25|2012-08-05||December 2001||2001-12-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|POINT||Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery|PeriOperative Interventional Neuroprotection Trial (POINT)|Completed||Phase 2|389|Actual|Duke University||2|||f||||||||||||||2017-10-11 04:36:21.751365|2017-10-11 04:36:21.751365
NCT00041405|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-05-12|||July 2001||2001-07-01|July 2005|2005-07-01|June 2005|Actual|2005-06-01|||||Observational|||Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:36:22.150118|2017-10-11 04:36:22.150118
NCT00041418|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Cardiac MR of Subclinical CVD: Impact of Age||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:36:22.203867|2017-10-11 04:36:22.203867
NCT00041431|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-05-12|||December 2001||2001-12-01|May 2005|2005-05-01|December 2003|Actual|2003-12-01|||||Interventional|||Estrogen, Cytokines and Heart Failure in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:36:22.246958|2017-10-11 04:36:22.246958
NCT00041444|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2016-02-05|||June 2002||2002-06-01|February 2016|2016-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|MESA-Eye||Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study|Multi-Ethnic Study of Atherosclerosis-Eye Study|Completed||N/A|6176|Actual|University of Wisconsin, Madison|||1||f||||||||||||||2017-10-11 04:36:22.310769|2017-10-11 04:36:22.310769
NCT00041457|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-08|2015-08-05|||July 2002||2002-07-01|August 2015|2015-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Epidemiology of Venous Thromboembolism||Completed||N/A|||Brigham and Women's Hospital|||4||f||||||||||||||2017-10-11 04:36:22.393646|2017-10-11 04:36:22.393646
NCT00041470|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-09|2017-06-19|2017-03-23||March 2001||2001-03-01|June 2017|2017-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial|Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial|Terminated||Phase 1/Phase 2|38|Actual|University of Washington||1||Sponsor withdrew the study|f||||f||||||||No||2017-10-11 04:36:22.461939|2017-10-11 04:36:22.461939
NCT00041483|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-09|2014-06-30|||June 2002||2002-06-01|July 2008|2008-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD|Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD|Completed||Phase 3|530|Actual|Alcon Research||2|||f||||||||||||||2017-10-11 04:36:22.677429|2017-10-11 04:36:22.677429
NCT00041496|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-09|2014-08-07|||November 2001||2001-11-01|August 2014|2014-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Prevention Of Recurrence Of Atrial Fibrillation|A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Safety and Efficacy of SB 207266 in Patients With Symptomatic Persistent Atrial Fibrillation (AF)|Completed||Phase 2|520|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 04:36:22.754507|2017-10-11 04:36:22.754507
NCT00041509|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-09|2017-05-24|||January 2002||2002-01-01|May 2017|2017-05-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|TEMPEST||ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)|ThromboEMbolism Prevention Efficacy and Safety Trial (TEMPEST): A Double-blind Four-week Study to Assess the Efficacy, Safety, and Tolerability of SB-424323 in the Extended Prophylaxis of Patients Following Total Hip Arthroplasty|Completed||Phase 2|343|Actual|GlaxoSmithKline||3|||||||f||||||||||2017-10-11 04:36:22.83386|2017-10-11 04:36:22.83386
NCT00041535|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-09|2017-06-30|||July 5, 2002||2002-07-05|March 3, 2008|2008-03-03|March 21, 2007||2007-03-21|||||Interventional|||OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease|A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:22.912063|2017-10-11 04:36:22.912063
NCT00041548|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-10|2016-10-18|||May 2002||2002-05-01|October 2016|2016-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation|Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation|Terminated||Phase 1/Phase 2|7|Actual|Mallinckrodt||2||slow enrollment|f||||t||||||||||2017-10-11 04:36:23.011732|2017-10-11 04:36:23.011732
NCT00041561|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-10|2016-07-22|||January 2002||2002-01-01|July 2016|2016-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics|The Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) In Pediatrics|Terminated||Phase 3|55|Actual|Mallinckrodt||2||Study stopped due to poor enrollment|f||||t||||||||||2017-10-11 04:36:23.238199|2017-10-11 04:36:23.238199
NCT00041574|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-10|2016-09-08|||April 2002||2002-04-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide|Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases|Terminated||Phase 2|7|Actual|Mallinckrodt||1||Closed for lack of enrollment|f||||t||||||||||2017-10-11 04:36:23.364567|2017-10-11 04:36:23.364567
NCT00041587|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-10|2011-06-02|||July 2002||2002-07-01|June 2011|2011-06-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma|Pre-operative IL13-PE38QQR Infusion in Patients With Recurrent or Progressive Supratentorial Malignant Glioma: A Phase I/II Study|Completed||Phase 1/Phase 2|80||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:36:23.461746|2017-10-11 04:36:23.461746
NCT00041600|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-11|2014-06-27|||April 1996||1996-04-01|June 2014|2014-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Human Epilepsy Genetics--Neuronal Migration Disorders Study|Human Epilepsy Genetics--Neuronal Migration Disorders Study|Recruiting||N/A|3500|Anticipated|Harvard University Faculty of Medicine|||1||f||||f||||||Samples With DNA|"     whole blood, DNA   "|||2017-10-11 04:36:23.544959|2017-10-11 04:36:23.544959
NCT00041613|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-11|2008-03-28||||||March 2008|2008-03-01||||||||Interventional|||Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate||Unknown status|Recruiting|Phase 3|||Introgen Therapeutics|||||||||||||||||||2017-10-11 04:36:23.638959|2017-10-11 04:36:23.638959
NCT00041626|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-11|2007-09-10||||||September 2007|2007-09-01||||||||Interventional|||Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone||Unknown status|Recruiting|Phase 3|||Introgen Therapeutics|||||||||||||||||||2017-10-11 04:36:23.737541|2017-10-11 04:36:23.737541
NCT00041639|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-11|2005-06-23|||January 2000||2000-01-01|January 2004|2004-01-01|December 2003||2003-12-01|||||Interventional|||Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer|A Phase I/II Study of Radioimmunotherapy With 90Y-Humanized MN-14 IgG Administered as a Single Dose to Patients With Refractory Advanced/Metastatic Pancreatic Carcinoma|Completed||Phase 1/Phase 2|75||Immunomedics, Inc.|||||||||||||||||||2017-10-11 04:36:23.840379|2017-10-11 04:36:23.840379
NCT00041652|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-11|2005-10-21|||February 2000||2000-02-01|October 2005|2005-10-01|June 2003||2003-06-01|||||Interventional|||Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer|A Phase I/II Clinical Trial of Immunotherapy With Humanized MN-14 IgG in Recurrent, Metastatic, Unresectable Colorectal and Breast Carcinomas|Completed||Phase 1/Phase 2|30||Immunomedics, Inc.|||||||||||||||||||2017-10-11 04:36:23.925295|2017-10-11 04:36:23.925295
NCT00041665|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-11|2013-05-06||||||May 2013|2013-05-01||||||||Interventional|||Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy|A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Recombinant Human Keratinocyte Growth Factor for Reduction of Mucositis in Patients With Hematologic Malignancies Undergoing Total Body Irradiation and High-dose Chemotherapy With Autologous PBPC Transplantation|Completed||Phase 3|||Amgen|||||||||||||||||||2017-10-11 04:36:24.007881|2017-10-11 04:36:24.007881
NCT00041678|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-12|2013-11-07|||January 2000||2000-01-01|September 2007|2007-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:36:24.085293|2017-10-11 04:36:24.085293
NCT00041691|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-12|2005-06-23||||||January 2003|2003-01-01||||||||Interventional|||Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery|A Phase I, Single Dose Escalating Study to Investigate the Tolerability, Pharmacokinetics and Dosimetry of 90 Y-Humanized MN-14 IgG in Colorectal Cancer Patients With Limited Residual Disease After Primary or Salvage Surgery|Terminated||Phase 1|30||Immunomedics, Inc.|||||||||||||||||||2017-10-11 04:36:24.161753|2017-10-11 04:36:24.161753
NCT00041704|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-12|2008-10-17|||August 2002||2002-08-01|October 2008|2008-10-01|August 2004|Actual|2004-08-01|||||Interventional|||The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)|A Phase 2 Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis.|Completed||Phase 2|19|Actual|Pfizer|||||f||||||||||||||2017-10-11 04:36:24.225979|2017-10-11 04:36:24.225979
NCT00041717|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-12|2013-04-25|2013-02-26||July 2002||2002-07-01|April 2013|2013-04-01|May 2004|Actual|2004-05-01|February 2004|Actual|2004-02-01||Interventional|||Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury|Double-Blind, Placebo-Controlled, 12-Week Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Moderate to Severe Spasticity Resulting From Chronic, Incomplete Spinal Cord Injury|Completed||Phase 3|213|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-10-11 04:36:24.307043|2017-10-11 04:36:24.307043
NCT00041730|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-15|2009-09-29|||July 2002||2002-07-01|October 2004|2004-10-01||||||||Interventional|||Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma|Phase II Trial of Rituxan(R) Plus FavId(TM) (Tumor-Specific Idiotype-KLH) and GM-CSF Immunotherapy in Patients With Grade 1 or 2 Follicular B-Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|90||Favrille|||||||||||||||||||2017-10-11 04:36:24.908439|2017-10-11 04:36:24.908439
NCT00041743|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-16|2010-01-12|||July 2002||2002-07-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Treatment of Binge Eating Disorder|Treatment of Binge Eating Disorder|Completed||N/A|200||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:36:25.030968|2017-10-11 04:36:25.030968
NCT00041756|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-16|2011-11-07|2011-08-03||July 2002||2002-07-01|November 2011|2011-11-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis|Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis|Completed||Phase 2|395|Actual|Procter and Gamble||5|||f||||f||||||||||2017-10-11 04:36:25.142356|2017-10-11 04:36:25.142356
NCT00041769|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-16|2010-07-12|||June 2002||2002-06-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor|A Phase II Randomized Controlled Trial Evaluating the Impact of Therapeutic Drug Monitoring (TDM) on Virologic Response to a Salvage Regimen in Subjects With a Normalized Inhibitory Quotient (NIQ) Less Than or Equal to 1 to One or More Protease Inhibitors|Completed||Phase 3|360||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:36:26.788208|2017-10-11 04:36:26.788208
NCT00041782|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-16|2012-07-27|||October 2000||2000-10-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients|Outpatient Treatment Of Deep Venous Thrombosis (DVT) Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients|Terminated||Phase 2|26|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:36:26.974081|2017-10-11 04:36:26.974081
NCT00041795|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-16|2005-06-23|||January 2002||2002-01-01|July 2002|2002-07-01||||||||Interventional|||Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Neotrofin to Treat Patients With Sensory or Motor Neuropathy Caused by Chemotherapy for Cancer|Completed||Phase 2|50||NeoTherapeutics|||||||||||||||||||2017-10-11 04:36:27.090092|2017-10-11 04:36:27.090092
NCT00041808|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-17|2005-06-23|||July 2001||2001-07-01|February 2003|2003-02-01|April 2003||2003-04-01|||||Interventional|||Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver|A Phase I/II Single Dose Trial to Determine The Safety, Tolerance, Pharmacokinetic Profile, and Preliminary Activity of Intrahepatic Delivery (Via Hepatic Artery Catheterization) of Doxorubicin Hydrochloride Adsorbed to Magnetic Targeted Carriers ( MTC-DOX) in Patients With Metastatic Cancer to the Liver .|Completed||Phase 1/Phase 2|20||FeRx|||||||||||||||||||2017-10-11 04:36:27.16918|2017-10-11 04:36:27.16918
NCT00041821|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-18|2006-03-22|||September 2000||2000-09-01|March 2006|2006-03-01||||||||Interventional|||Nasal Irritation Study: Individual Factors in Nasal Irritant Sensitivity|Individual Factors in Nasal Irritant Sensitivity|Completed||N/A|64||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:27.244268|2017-10-11 04:36:27.244268
NCT00041834|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-18|2005-06-23|||September 2000||2000-09-01|July 2002|2002-07-01|August 2003||2003-08-01|||||Observational|||Geographic Modeling of Traffic and Asthma Rates||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:27.322164|2017-10-11 04:36:27.322164
NCT00041847|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-18|2015-04-14|||July 2001||2001-07-01|April 2015|2015-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||Gene-Environment Interaction in Prostate Cancer|Gene-Environment Interaction in Prostate Cancer|Completed||N/A|881|Actual|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:27.379177|2017-10-11 04:36:27.379177
NCT00041860|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-18|2005-06-23||||||July 2002|2002-07-01||||||||Interventional|||Modulation of Benzene Metabolism by Exposure to Environment||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:27.435548|2017-10-11 04:36:27.435548
NCT00041886|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-18|2008-03-03|||July 2002||2002-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Radiofrequency Ablation of Painful Soft Tissue Neoplasms|Radiofrequency Ablation of Painful Soft Tissue Neoplasms|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:27.48502|2017-10-11 04:36:27.48502
NCT00041899|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-18|2008-03-03|||May 2002||2002-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914|Pharmacokinetic Comparison of Two Preparations of the Selective Progesterone Receptor Modular CDB2914|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:27.543894|2017-10-11 04:36:27.543894
NCT00041925|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-18|2005-07-14|||November 2001||2001-11-01|July 2005|2005-07-01|November 2004||2004-11-01|||||Interventional|||Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures|A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment With CGT003 of Peripheral Vein Grafts in Patients Undergoing Peripheral Arterial Bypass Graft Procedures|Completed||Phase 2/Phase 3|1400||Anesiva, Inc.|||||||||||||||||||2017-10-11 04:36:27.621645|2017-10-11 04:36:27.621645
NCT00041938|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-19|2014-08-29|2013-01-03||October 2002||2002-10-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|August 2011|Actual|2011-08-01||Interventional|WARCEF||Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial|Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial|Completed||Phase 3|2305|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 04:36:28.109207|2017-10-11 04:36:28.109207
NCT00041951|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-19|2016-05-31|||December 1998||1998-12-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study|Search for Genes Influencing Childhood Absence Epilepsy Study|Completed||N/A|185|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||Samples With DNA|"     saliva   "|||2017-10-11 04:36:29.072268|2017-10-11 04:36:29.072268
NCT00041964|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-19|2012-07-23||||||July 2012|2012-07-01||||||||Observational|||A Study of HIV Levels During Pregnancy and After Childbirth|A Prospective Observational Study of Virologic and Immunologic Changes in HIV-Infected Women During the Postpartum Period|Completed||N/A|129||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:36:29.151696|2017-10-11 04:36:29.151696
NCT00041977|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-19|2005-06-23|||June 2002||2002-06-01|November 2003|2003-11-01||||||||Interventional|||Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets [Periostat(R)] Administered Twice Daily for the Treatment of Acne Rosacea|Completed||Phase 3|150||CollaGenex Pharmaceuticals|||||||||||||||||||2017-10-11 04:36:29.286495|2017-10-11 04:36:29.286495
NCT00041990|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-19|2007-12-12|||July 2002||2002-07-01|December 2007|2007-12-01||||||||Interventional|||Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)|A Phase II, Multicenter Study of Decitabine (5-Aza-2'Deoxycytidine) in Chronic Myelogenous Leukemia Accelerated Phase Refractory to Imatinib Mesylate (STI 571)|Completed||Phase 2|40||Astex Pharmaceuticals|||||||||||||||||||2017-10-11 04:36:29.364327|2017-10-11 04:36:29.364327
NCT00042003|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-19|2013-01-22|||July 2002||2002-07-01|June 2008|2008-06-01||||December 2004|Actual|2004-12-01||Interventional|||Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)|A Phase II, Multicenter Study of Decitabine (5-aza-2'Deoxycytidine) in Chronic Myelogenous Leukemia Blast Phase Refractory to Imatinib Mesylate (STI 571)|Completed||Phase 2|40||Astex Pharmaceuticals|||||f||||f||||||||||2017-10-11 04:36:29.446815|2017-10-11 04:36:29.446815
NCT00042016|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-19|2009-10-12|||July 2002||2002-07-01|June 2005|2005-06-01||||||||Interventional|||Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)|A Phase II, Multicenter Study of Decitabine (5-aza-2'Deoxycytidine) in Chronic Myelogenous Leukemia Chronic Phase Refractory to Imatinib Mesylate (STI 571)|Completed||Phase 2|40||Astex Pharmaceuticals|||||||||||||||||||2017-10-11 04:36:29.549106|2017-10-11 04:36:29.549106
NCT00042068|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-22|2013-10-31|||June 2002||2002-06-01|October 2013|2013-10-01|July 2003||2003-07-01|||||Interventional|||A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis|A Multi-center, Double-Blind, Randomized, Parallel-Group Trial to Compare the Efficacy and Safety of Three Doses of Meloxicam (7.5, 15, and 22.5 mg) and Placebo in Patients With Rheumatoid Arthritis|Completed||Phase 3|1000||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 04:36:29.981514|2017-10-11 04:36:29.981514
NCT00042081|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-22|2006-05-04|||July 2002||2002-07-01|July 2005|2005-07-01|February 2005||2005-02-01|||||Interventional|||Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures|A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment With CGT003 of Coronary Vein Grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures|Completed||Phase 3|3000||Anesiva, Inc.|||||||||||||||||||2017-10-11 04:36:30.554725|2017-10-11 04:36:30.554725
NCT00042094|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-23|2011-06-29|||March 2002||2002-03-01|June 2011|2011-06-01|March 2003||2003-03-01|||||Interventional|||Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®|A Phase 1 Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation (Take Rate) of a Cell-Cultured Smallpox Vaccine (CCSV) Compared to a Calf Lymph Vaccine (Dryvax®)|Completed||Phase 1|350||DynPort Vaccine Company LLC, A CSC Company|||||||||||||||||||2017-10-11 04:36:30.909799|2017-10-11 04:36:30.909799
NCT00042107|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2014-09-26|||September 2000||2000-09-01|July 2002|2002-07-01|June 2005||2005-06-01|||||Observational|||Molecular Epidemiology of Parkinson's Disease||Completed||N/A|2022|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:30.984041|2017-10-11 04:36:30.984041
NCT00042120|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2014-09-26|||April 2001||2001-04-01|August 2009|2009-08-01||||July 2011|Actual|2011-07-01||Observational|FAME||Farming and Movement Evaluation Study (FAME)|Pesticides and Risk in the Agricultural Health Study|Completed||N/A|520|Actual|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:31.049783|2017-10-11 04:36:31.049783
NCT00042133|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2015-04-13|||April 2001||2001-04-01|April 2015|2015-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Socio-economic Status and Age-related Disability in a Biracial Community||Completed||N/A|6000|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:31.114142|2017-10-11 04:36:31.114142
NCT00042146|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2013-05-17|||December 2001||2001-12-01|May 2013|2013-05-01||||||||Interventional|||Behavioral and Pharmacological Treatment for Insomnia|Behavioral and Pharmacological Treatment for Insomnia|Completed||Phase 4|160||Laval University|||||f||||||||||||||2017-10-11 04:36:31.179691|2017-10-11 04:36:31.179691
NCT00042159|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2013-08-02|||July 2002||2002-07-01|August 2013|2013-08-01|June 2004|Actual|2004-06-01|July 2003|Actual|2003-07-01||Interventional|||Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations|TMS Intervention Development for Auditory Hallucinations|Completed||N/A|50|Actual|Yale University||1|||f||||t||||||||||2017-10-11 04:36:31.252307|2017-10-11 04:36:31.252307
NCT00042172|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2014-02-27|||June 2002||2002-06-01|February 2014|2014-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Treatment for Early Memory Loss|Cognitive Enhancers Explored With PET Imaging|Completed||Phase 4|40||University of Iowa|||||f||||||||||||||2017-10-11 04:36:31.334167|2017-10-11 04:36:31.334167
NCT00042185|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2013-09-26|||February 2001||2001-02-01|September 2013|2013-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Eating Disorder Prevention Programs|Austin Body Acceptance Study|Completed||N/A|450||University of Texas at Austin||4|||f||||||||||||||2017-10-11 04:36:31.398582|2017-10-11 04:36:31.398582
NCT00042198|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2013-07-01|||December 2001||2001-12-01|July 2013|2013-07-01|August 2006|Actual|2006-08-01|December 2005|Actual|2005-12-01||Interventional|||Treatment of Depression After Coronary Bypass Surgery|Treatment of Depression After Coronary Bypass Surgery|Completed||N/A|123|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 04:36:31.477536|2017-10-11 04:36:31.477536
NCT00042211|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2014-01-07|||February 2001||2001-02-01|February 2008|2008-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Preventing Depression in Patients With Macular Degeneration|Preventing Depression in Macular Degeneration|Completed||Phase 3|206|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-10-11 04:36:31.575807|2017-10-11 04:36:31.575807
NCT00042224|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2017-04-10|2015-04-09||December 2000||2000-12-01|April 2017|2017-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Electroconvulsive Therapy in Clozapine Refractory Schizophrenia|ECT in Clozapine Refractory Schizophrenia|Completed||Phase 1/Phase 2|39|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 04:36:31.68085|2017-10-11 04:36:31.68085
NCT00042237|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2013-08-20|||September 2001||2001-09-01|August 2013|2013-08-01||||||||Interventional|||Treatment of Depressed Women Who Have Been Sexually Abused|Treatment of Women With Depression and Sexual Abuse|Completed||Phase 1|24||Butler Hospital|||||f||||||||||||||2017-10-11 04:36:31.942909|2017-10-11 04:36:31.942909
NCT00042250|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-24|2012-01-20|||May 1992||1992-05-01|January 2012|2012-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||IUdR/BUdR Cell Cycle Labelling|Cell Cycle Kinetics in Vivo in Patients With Hematologic Malignancies Studied by Iododeoxyuridine and Bromodeoxyuridine Labelling|Completed||N/A|28|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-10-11 04:36:32.004554|2017-10-11 04:36:32.004554
NCT00042263|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-25|2006-09-01|||April 2002||2002-04-01|September 2006|2006-09-01||||||||Observational|||Healthy Environments Partnership|Social and Physical Environments and Health Disparities|Completed||N/A|1000||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:32.088824|2017-10-11 04:36:32.088824
NCT00042276|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2017-10-05|||July 14, 2002||2002-07-14|March 15, 2013|2013-03-15|March 15, 2013||2013-03-15|||||Observational|||The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time|The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time|Completed||N/A|88|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:32.148424|2017-10-11 04:36:32.148424
NCT00042289|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2017-10-04|||March 2003||2003-03-01|October 2017|2017-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy|Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and Postpartum|Recruiting||Phase 4|1786|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-10-11 04:36:32.244463|2017-10-11 04:36:32.244463
NCT00042302|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2012-05-22|||June 2002||2002-06-01|May 2012|2012-05-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)||Terminated||Phase 3|540||QLT Inc.|||||f||||||||||||||2017-10-11 04:36:32.7105|2017-10-11 04:36:32.7105
NCT00042315|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2012-05-22|||June 2002||2002-06-01|May 2012|2012-05-01|June 2003||2003-06-01|June 2003||2003-06-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)||Terminated||Phase 3|490||QLT Inc.|||||f||||||||||||||2017-10-11 04:36:32.76138|2017-10-11 04:36:32.76138
NCT00042328|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2015-08-20|||August 2001||2001-08-01|August 2015|2015-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients|A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients|Completed||Phase 2|30||Baylor College of Medicine|||||f||||t||||||||||2017-10-11 04:36:32.811388|2017-10-11 04:36:32.811388
NCT00042341|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2014-03-17|||May 2002||2002-05-01|March 2014|2014-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)|A Phase II, Open Label Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia|Completed||Phase 2|60||Sanofi|||||||||||||||||||2017-10-11 04:36:32.869464|2017-10-11 04:36:32.869464
NCT00042354|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2015-03-04|||May 2002||2002-05-01|March 2015|2015-03-01|August 2004|Actual|2004-08-01|||||Interventional|||Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients|A Phase II, Open Label Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myelogenous Leukemia|Completed||Phase 2|40||Sanofi|||||||||||||||||||2017-10-11 04:36:32.965911|2017-10-11 04:36:32.965911
NCT00042367|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2012-02-10|||April 2000||2000-04-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|December 2005|Actual|2005-12-01||Interventional|BB'98||Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors|Pilot Study of Systemic and Intrathecal Chemotherapy Followed by Conformal Radiation for Infants With Brain Tumors|Completed||N/A|119|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:36:33.061156|2017-10-11 04:36:33.061156
NCT00042380|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-26|2008-03-03|||July 2002||2002-07-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Examination of a Soy-Based Supplement for Major Depression|A Phase 2A Study of Soy Isoflavones in the Treatment of Major Depression|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:33.267875|2017-10-11 04:36:33.267875
NCT00042393|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-27|2014-01-03||||||January 2014|2014-01-01||||||||Expanded Access|||An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options|A Phase 3b, Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B Who Have Limited Treatment Options|Approved for marketing||N/A|||Gilead Sciences|||||||||||||||||||2017-10-11 04:36:33.353999|2017-10-11 04:36:33.353999
NCT00042406|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-29|2012-12-05|||September 2002||2002-09-01|December 2012|2012-12-01||||September 2002|Actual|2002-09-01||Interventional|||Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-alpha Blocker|A Double-Blind, Placebo-Controlled, Randomized, Parallel Group Clinical Trial of Anti-CD4 Receptor Human Monoclonal Antibody (HuMax-CD4) in Patients With Active RA Failing Treatment With Methotrexate and TNF-alpha Blocking Agents|Terminated||Phase 2/Phase 3|75|Actual|Emergent Product Development Seattle LLC||3|||f||||||||||||||2017-10-11 04:36:33.45964|2017-10-11 04:36:33.45964
NCT00042419|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-29|2006-09-01|||March 2002||2002-03-01|September 2006|2006-09-01|July 2003||2003-07-01|||||Observational|||Work and Health Disparities Among Rural Women||Completed||N/A|150||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:33.679704|2017-10-11 04:36:33.679704
NCT00042432|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-29|2013-05-09|2010-11-04||June 2002||2002-06-01|May 2013|2013-05-01|August 2003|Actual|2003-08-01|March 2003|Actual|2003-03-01||Interventional|||Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients|A Study of an Investigational Medication for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients|Completed||Phase 2|54|Actual|Amgen||2|||f||||||||||||||2017-10-11 04:36:33.7679|2017-10-11 04:36:33.7679
NCT00042445|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-30|2006-09-01|||August 2000||2000-08-01|September 2006|2006-09-01|July 2005||2005-07-01|||||Observational|||Brain Neoplasms, Leukemia and Petrochemical Exposures||Completed||N/A|1456||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:34.318797|2017-10-11 04:36:34.318797
NCT00042458|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-30|2015-09-22|||April 2002||2002-04-01|August 2015|2015-08-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control|A Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Investigate the Safety of Pramlintide Treatment Employing Pramlintide Dose-Titration Followed by Insulin Dose Optimization in Subjects With Type 1 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Intensive Insulin Therapy|Completed||Phase 3|296|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:36:34.389909|2017-10-11 04:36:34.389909
NCT00042471|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-30|2015-09-22|||June 2002||2002-06-01|August 2015|2015-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Evaluation of the Bioavailability of Pramlintide||Completed||Phase 2|75|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 04:36:34.581796|2017-10-11 04:36:34.581796
NCT00042484|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-30|2015-04-13||||||April 2015|2015-04-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Community Organizing Network for Environmental Health||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:34.666072|2017-10-11 04:36:34.666072
NCT00042497|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-30|2005-06-23|||July 2002||2002-07-01|September 2002|2002-09-01||||||||Interventional|||Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma|A Phase II, Multicenter, Open-Labeled Study of Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma|Suspended||Phase 2|60||Anosys|||||||||||||||||||2017-10-11 04:36:34.724607|2017-10-11 04:36:34.724607
NCT00042510|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-31|2014-08-27|||August 2000||2000-08-01|August 2014|2014-08-01|July 2004|Actual|2004-07-01|February 2003|Actual|2003-02-01||Interventional|||Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer|Open-Label,Multicenter Study of G17DT Immunogen in Combination w/ Cisplatin and 5-FU in Subjects w/ Metastatic or Locally Recurrent Gastric or Gastroesophageal Cancer Previously Untreated With Chemotherapy.|Completed||Phase 2|103|Actual|Cancer Advances Inc.||1|||f||||f||||||||||2017-10-11 04:36:34.781673|2017-10-11 04:36:34.781673
NCT00042523|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-31|2008-03-03|||July 2002||2002-07-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus|Role of the Antibody Against NR2 Glutamate Receptor in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus|Completed||N/A|61||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:34.861299|2017-10-11 04:36:34.861299
NCT00042536|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-31|2008-03-03|||July 2002||2002-07-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Observational|||Effects of Yohimbine and Naltrexone on Sexual Function|Effects of Alpha-2 Adrenergic and Opiate Receptor Blockade on Sexual Function in Healthy Male Volunteers|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:34.924202|2017-10-11 04:36:34.924202
NCT00042549|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-31|2005-06-23|||May 2002||2002-05-01|June 2003|2003-06-01||||||||Interventional|||Lithotripsy for the Treatment of Gallstones|Biliary Lithotripsy in Combination With Actigall Versus Actigall Monotherapy for the Treatment of Symptomatic Cholesterol Gallstones|Terminated||Phase 4|184||Medstone International|||||||||||||||||||2017-10-11 04:36:34.985127|2017-10-11 04:36:34.985127
NCT00042562|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-31|2006-07-18|||December 2002||2002-12-01|July 2006|2006-07-01|December 2003||2003-12-01|||||Interventional|||Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression|Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:36:35.078888|2017-10-11 04:36:35.078888
NCT00042575|ClinicalTrials.gov processed this data on October 10, 2017|2002-07-31|2006-07-18|||June 2002||2002-06-01|July 2006|2006-07-01|August 2002||2002-08-01|||||Interventional|||Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression|Protocol F1J-US-HMBY Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression|Completed||Phase 3|120||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:36:35.176029|2017-10-11 04:36:35.176029
NCT00042588|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-01|2005-06-23|||May 2002||2002-05-01|January 2004|2004-01-01||||||||Interventional|||A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis|Completed||Phase 2|||ICOS Corporation|||||||||||||||||||2017-10-11 04:36:35.24069|2017-10-11 04:36:35.24069
NCT00042601|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-01|2015-10-20|||July 2002||2002-07-01|October 2015|2015-10-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Evaluation of the Effect of Pramlintide on Satiety and Food Intake|A Single Center, Randomized, Double-blind, Placebo-controlled, Two-period, Crossover Study Evaluating the Acute Effect of Pramlintide on Satiety and Food Intake in Normal-weight and Obese Non-diabetic Subjects and in Insulin Treated Subjects With Type 1 and Type 2 Diabetes Mellitus|Completed||Phase 2|51|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:36:35.301985|2017-10-11 04:36:35.301985
NCT00042614|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-01|2017-10-05|||July 30, 2002||2002-07-30|September 13, 2017|2017-09-13||||||||Observational|||Study of Heart Transplant Rejection|Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy|Recruiting||N/A|482|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:35.382833|2017-10-11 04:36:35.382833
NCT00042627|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-01|2017-06-30|||July 30, 2002||2002-07-30|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Observational|||Prevalence and Risk of Cataracts in Granulocyte Donors|Prevalence and Risks for Posterior Subcapsular Cataracts in Volunteer Granulocytapheresis Donors|Completed||N/A|252||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:35.455859|2017-10-11 04:36:35.455859
NCT00042653|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-02|2013-05-06|||May 2002||2002-05-01|May 2013|2013-05-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis|A Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of an Oral Calcimimetic Agent (AMG 073) in Secondary Hyperparathyroidism of Chronic Kidney Disease (Hemodialysis and Peritoneal Dialysis)|Completed||Phase 3|380|Anticipated|Amgen||2|||f||||||||||||||2017-10-11 04:36:35.513282|2017-10-11 04:36:35.513282
NCT00042666|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-02|2009-10-16||2009-10-16|June 2002||2002-06-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.|A Phase 2 Evaluation of Oral LY317615 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Completed||Phase 2|55|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:36:35.58791|2017-10-11 04:36:35.58791
NCT00042679|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-02|2006-07-18|||June 2002||2002-06-01|July 2006|2006-07-01||||||||Interventional|||A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.|A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.|Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:36:35.727018|2017-10-11 04:36:35.727018
NCT00042692|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2006-03-22|||March 2001||2001-03-01|March 2006|2006-03-01|March 2002||2002-03-01|||||Observational|||Catechol Thioethers in Parkinson's Disease||Completed||N/A|20||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:35.805216|2017-10-11 04:36:35.805216
NCT00042705|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2015-04-13|||May 2000||2000-05-01|April 2015|2015-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Asthma Severity in Children and Environmental Agents||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:35.847468|2017-10-11 04:36:35.847468
NCT00042718|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2010-04-26|||November 2001||2001-11-01|April 2010|2010-04-01|August 2003|Actual|2003-08-01|||||Interventional|||A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.||Completed||Phase 3|659|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 04:36:35.896567|2017-10-11 04:36:35.896567
NCT00042731|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2012-09-21|||July 2002||2002-07-01|September 2012|2012-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy|A Randomized Pilot Clinical Trial Of The Action Of Isoflavones And Lycopene In Localized Prostate Cancer: Administration Prior To Radical Prostatectomy|Completed||N/A|79|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f||||||||||2017-10-11 04:36:35.960755|2017-10-11 04:36:35.960755
NCT00042770|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2016-07-01|||May 2002||2002-05-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|February 2005|Actual|2005-02-01||Interventional|||Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer|Phase III Comparison of Catheter Based Therapy of Pleural Effusions in Cancer Patients (Optimal Pleural Effusion Control, OPEC)|Completed||Phase 3|67|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:36:36.048374|2017-10-11 04:36:36.048374
NCT00042783|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-06-21|||September 2002||2002-09-01|April 2004|2004-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|A Phase II Trial Of A D1/3-MAGE3-HIS Fusion Protein (NSC-719274) With Adjuvant SBAS02B (NSC-719275) For Patients With Stage IV, M1a or M1b Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:36.132435|2017-10-11 04:36:36.132435
NCT00042796|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-01-22|||December 2002||2002-12-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|A Phase I Study Of Decitabine (DAC) (IND # 50733) In Children With Relapsed Or Refractory Acute Leukemia|Terminated||Phase 1|21|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:36:36.210432|2017-10-11 04:36:36.210432
NCT00042809|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-01-23|||May 2002||2002-05-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors|Phase I Study To Determine The Safety, Tolerance And Preliminary Antineoplastic Activity Of Combined EGFR (erbB1) And HER2 (erbB2) Blockade, With OSI-774 And Trastuzumab, In Combination With Weekly Paclitaxel|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:36:36.303339|2017-10-11 04:36:36.303339
NCT00042822|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2011-05-14|||May 2002||2002-05-01|December 2009|2009-12-01||||March 2005|Actual|2005-03-01||Interventional|||FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma|A Pilot Study Of FR901228, Or Depsipeptide (NSC #630176) For Adult Patients With Advanced Hematologic Cancers|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:36.397395|2017-10-11 04:36:36.397395
NCT00042835|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-01-31|||May 2002||2002-05-01|January 2013|2013-01-01||||December 2008|Actual|2008-12-01||Interventional|||Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer|A Phase I Study Of OSI-774 (NSC #718781)-Based Multimodality Therapy For Inoperable Stage III Non Small Cell Lung Cancer|Terminated||Phase 1|48|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:36:37.966086|2017-10-11 04:36:37.966086
NCT00042848|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2015-10-13|||August 2002||2002-08-01|October 2015|2015-10-01|October 2007|Actual|2007-10-01|April 2007|Actual|2007-04-01||Interventional|||Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer|Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of The Effect Of Modafinil On Fatigue In Cancer Patients Receiving Chemotherapy|Completed||Phase 3|837|Anticipated|University of Rochester|||||f||||t||||||||||2017-10-11 04:36:38.086852|2017-10-11 04:36:38.086852
NCT00042861|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2015-04-29|||August 2002||2002-08-01|April 2003|2003-04-01||||||||Interventional|||UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Pharmacologic Trial Of Infusional UCN-01 Given With A Weekly Schedule Of 5-Fluorouracil And Leucovorin|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:38.230142|2017-10-11 04:36:38.230142
NCT00042874|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-06-03|||May 2002||2002-05-01|June 2013|2013-06-01||||January 2009|Actual|2009-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Irinotecan (CPT-11) and Fluorouracil/Leucovorin in Patients With Advanced Solid Tumors|Completed||Phase 1|77|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:36:38.301857|2017-10-11 04:36:38.301857
NCT00042887|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2012-09-20|||May 2002||2002-05-01|September 2012|2012-09-01||||May 2004|Actual|2004-05-01||Interventional|||Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer|Chemoresection With 4 Weekly Intravesical Instillations Of Mitomycin C Versus Transurethral Resection (TUR) Followed By One Single Immediate Instillation Of Mitomycin C In Single, Small, Papillary Stage Ta, T1 Bladder Tumors: A Prospective Randomized Phase III Trial|Terminated||Phase 3|58|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:36:38.408531|2017-10-11 04:36:38.408531
NCT00042900|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Pyroxamide in Treating Patients With Advanced Cancer|A Phase I Clinical And Pharmacological Study Of Pyroxamide (NSC 696085) In Patients With Advanced Malignancies|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:36:38.511589|2017-10-11 04:36:38.511589
NCT00042913|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-12-18|||May 2002||2002-05-01|September 2003|2003-09-01||||||||Interventional|||Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma|A Phase 2 Open Label, Randomized, Dose And Schedule Finding, Clinical Trial Of Immunotherapy With AMG 412 In Subjects With Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:38.622411|2017-10-11 04:36:38.622411
NCT00042926|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2016-12-05|||May 2002||2002-05-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|May 2007|Actual|2007-05-01||Interventional|||Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer|A Trial Of Lymphatic Mapping And Sentinel Node Lymphadenectomy For Patients With T1 or T2 Clinically N0 Oral Cavity Squamous Cell Carcinoma|Completed||N/A|161|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:36:38.742032|2017-10-11 04:36:38.742032
NCT00042939|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-04-02|2011-06-21||July 2003||2003-07-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer|Phase II Trial of Irinotecan/Docetaxel for Advanced Pancreatic Cancer, With Randomization Between Irinotecan/Docetaxel and Irinotecan/Docetaxel Plus C225 a Monoclonal Antibody to the Epidermal Growth Factor Receptor (EGF-r)|Completed||Phase 2|94|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-10-11 04:36:38.921055|2017-10-11 04:36:38.921055
NCT00034866|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2005-09-19|||April 2002||2002-04-01|September 2005|2005-09-01|October 2002||2002-10-01|||||Interventional|||Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals|Double-Blind, Randomized, Dose Optimization Trial of Three Doses of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) in Multiple Antiretroviral Drug-Experienced Subjects.|Completed||Phase 2|165||Boehringer Ingelheim|||||||||||||||||||2017-10-11 04:36:44.95415|2017-10-11 04:36:44.95415
NCT00042952|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-01-15|||June 2002||2002-06-01|January 2013|2013-01-01||||October 2003|Actual|2003-10-01||Interventional|||Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer|A Phase II Study Of Imatinib Mesylate (Gleevec, Formerly Known As STI571; IND 61,135, NSC #716051) In Patients With Refractory Seminoma|Terminated||Phase 2|32|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:36:39.668722|2017-10-11 04:36:39.668722
NCT00042965|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2016-07-12|||October 2002||2002-10-01|July 2016|2016-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Of Capecitabine Plus Gemcitabine For Metastatic Renal Cell Carcinoma|Completed||Phase 2|60|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:36:39.789537|2017-10-11 04:36:39.789537
NCT00042978|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-01-11|||April 2003||2003-04-01|January 2013|2013-01-01||||May 2005|Actual|2005-05-01||Interventional|||Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer|A Randomized Phase II Study Of Carboplatin And Etoposide With Or Without G3139 (NSC #683428, IND #58842) In Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:36:39.984718|2017-10-11 04:36:39.984718
NCT00042991|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2014-05-15|2011-02-09||July 2002||2002-07-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas|Phase I/II Trial of Gefitinib and Radiation in Pediatric Patients Newly Diagnosed With Brain Stem Tumors or Incompletely Resected Supratentorial Malignant Gliomas With Phase II Limited to Brain Stem Tumors|Completed||Phase 1/Phase 2|69|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:36:40.149336|2017-10-11 04:36:40.149336
NCT00043004|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2012-09-20|||May 2002||2002-05-01|September 2012|2012-09-01||||June 2007|Actual|2007-06-01||Interventional|||Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer|CLOCC Trial (Chemotherapy + Local Ablation Versus Chemotherapy) Randomized Phase II Study Of Local Treatment Of Liver Metastases By Radiofrequency Combined With Chemotherapy Versus Chemotherapy Alone In Patients With Unresectable Colorectal Liver Metastases|Terminated||Phase 2|119|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:36:42.922434|2017-10-11 04:36:42.922434
NCT00043017|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-10-07|||May 2002||2002-05-01|October 2013|2013-10-01|March 2011|Actual|2011-03-01|May 2005|Actual|2005-05-01||Interventional|ACRIN 6657||Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer|Contrast-Enhanced Breast MRI For Evaluation Of Patients Undergoing Neoadjuvant Treatment For Locally-Advanced Breast Cancer (I-SPY 1/ACRIN 6657)|Completed||Phase 2|356|Actual|American College of Radiology Imaging Network||1|||f||||t||||||||||2017-10-11 04:36:43.118164|2017-10-11 04:36:43.118164
NCT00043030|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2012-03-14|||June 2002||2002-06-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|December 2006|Actual|2006-12-01||Interventional|||Evaluating Patient Participation in Phase I Clinical Trials|Survey Of Patient's Motivations, Perceptions, And Expectations In Phase I Clinical Trials|Completed||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:43.236979|2017-10-11 04:36:43.236979
NCT00043043|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-06-18|||May 2003||2003-05-01|November 2004|2004-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia|Rectal Abberant Crypt Foci And Other Intermediate Biomarkers For Sporadic Colorectal Neoplasia: Cross-Sectional Prevelance And Modulation By Celecoxib|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:43.345463|2017-10-11 04:36:43.345463
NCT00043069|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2016-12-05|||November 2002||2002-11-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|June 2006|Actual|2006-06-01||Interventional|||Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer|Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study|Completed||Phase 3|71|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-10-11 04:36:43.434956|2017-10-11 04:36:43.434956
NCT00043082|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2015-10-23|||August 2002||2002-08-01|October 2015|2015-10-01|July 2011|Actual|2011-07-01|June 2007|Actual|2007-06-01||Interventional|||S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer|A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy|Completed||Phase 3|61|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:36:43.982298|2017-10-11 04:36:43.982298
NCT00043095|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2008-07-23|||June 2002||2002-06-01|April 2005|2005-04-01||||||||Interventional|||BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors|A Phase I Trial of BMS 247550 (NSC# 710428) and Gemcitabine in Patients With Advanced Solid Tumor Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:44.237739|2017-10-11 04:36:44.237739
NCT00034827|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2007-05-03|||January 2002||2002-01-01|July 2006|2006-07-01|May 2003|Actual|2003-05-01|||||Interventional|||A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer|A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer, or Pancreatic Cancer|Completed||Phase 2|172||Pfizer|||||f||||||||||||||2017-10-11 04:36:44.326563|2017-10-11 04:36:44.326563
NCT00034840|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2013-10-31|||October 2001||2001-10-01|October 2013|2013-10-01|August 2002||2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose|A Prospective, Randomized, Double-Blind, Forced Titration Trial to Compare the Efficacy of MICARDIS® (Telmisartan 80 mg p.o. Once Daily) and Diovan® (Valsartan 160 mg p.o. Once Daily) Using Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Hypertension After Missing One Dose|Completed||Phase 4|490||Boehringer Ingelheim|||||||||||||||||||2017-10-11 04:36:44.660493|2017-10-11 04:36:44.660493
NCT00034853|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2013-10-31|||December 2000||2000-12-01|October 2013|2013-10-01||||June 2003|Actual|2003-06-01||Interventional|||Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)|A 12 Week Double-blind Randomized Trial, With a 12 Week Open-label Extension, to Investigate the Efficacy and Safety of Meloxicam Oral Suspension Administered Once Daily and Naproxen Oral Suspension Administered Twice Daily in Children With Juvenile Rheumatoid Arthritis|Completed||Phase 3|180|Anticipated|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 04:36:44.803023|2017-10-11 04:36:44.803023
NCT00034879|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2013-01-03|||August 2000||2000-08-01|January 2013|2013-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Iressa Expanded Access Program (EAP)|An Expanded Access Clinical Program With ZD1839 (IRESSA®) for Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 3|||AstraZeneca|||||t||||f||||||||||2017-10-11 04:36:45.348744|2017-10-11 04:36:45.348744
NCT00034892|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2013-01-03|||March 2002||2002-03-01|January 2013|2013-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||CAFE Comparison of Atypicals in First Episode of Psychosis|Efficacy and Tolerability of Olanzapine, Quetiapine and Risperidone in the Treatment of First Episode Psychosis: A Randomized Double Blind 52-Week Comparison|Completed||Phase 3|||AstraZeneca|||||||||||||||||||2017-10-11 04:36:46.881128|2017-10-11 04:36:46.881128
NCT00034905|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2013-01-03|||July 2001||2001-07-01|January 2013|2013-01-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Comparison of Seroquel vs. Risperidone in Schizophrenia||Completed||Phase 4|||AstraZeneca|||||||||||||||||||2017-10-11 04:36:47.01229|2017-10-11 04:36:47.01229
NCT00034918|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2016-08-22|||May 2002||2002-05-01|August 2016|2016-08-01|November 2003|Actual|2003-11-01|||||Interventional|||This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer|An Open-label, Multicenter Phase II Study to Assess the Response of Subjects With Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy With or Without Capecitabine to ZD6474 (100-mg or 300-mg Daily Oral Dose).|Completed||Phase 2|44||Sanofi|||||||||||||||||||2017-10-11 04:36:47.184391|2017-10-11 04:36:47.184391
NCT00034944|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-05-02|||January 24, 2002|Actual|2002-01-24|May 2017|2017-05-01|December 17, 2003|Actual|2003-12-17|December 17, 2003|Actual|2003-12-17||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)|A Double-Blind, Multicenter, Placebo Controlled, Acute and Extension Study of 2 Doses of MK0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|495|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:36:47.24793|2017-10-11 04:36:47.24793
NCT00034957|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2012-02-14||||||February 2012|2012-02-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)||Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-10-11 04:36:47.335439|2017-10-11 04:36:47.335439
NCT00034970|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2006-08-17|||April 2002||2002-04-01|July 2006|2006-07-01|December 2003||2003-12-01|||||Interventional|||Mindfulness-Based Art Therapy for Cancer Patients|Mindfulness-Based Art Therapy for Cancer Patients|Completed||N/A|114||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:36:47.544978|2017-10-11 04:36:47.544978
NCT00034983|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-04-24|||October 29, 2001|Actual|2001-10-29|April 2017|2017-04-01|December 29, 2003|Actual|2003-12-29|December 29, 2003|Actual|2003-12-29||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)|A Worldwide, Multicenter, Double-Blind, Parallel, Active-Controlled, Long-Term Safety Study of MK0869 in Outpatients With Major Depressive Disorder|Completed||Phase 3|900|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:36:47.612805|2017-10-11 04:36:47.612805
NCT00035009|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-04-17|||September 20, 2001|Actual|2001-09-20|April 2017|2017-04-01|March 24, 2004|Actual|2004-03-24|December 22, 2003|Actual|2003-12-22||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)|A Double-Blind, Multicenter, Placebo- and Active-Controlled Acute and Extension Study of MK0869 in the Treatment of Patients With Major Depressive Disorder With Melancholic Features|Completed||Phase 3|468|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:36:47.690987|2017-10-11 04:36:47.690987
NCT00035022|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2006-01-12|||August 2001||2001-08-01|February 2005|2005-02-01|March 2004||2004-03-01|||||Interventional|||Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas|Phase I-II Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive (High Grade) T-Cell Malignancies|Completed||Phase 1/Phase 2|71||BioCryst Pharmaceuticals|||||||||||||||||||2017-10-11 04:36:47.765567|2017-10-11 04:36:47.765567
NCT00035035|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.|A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:36:47.840556|2017-10-11 04:36:47.840556
NCT00035048|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-05-02|||November 21, 2001|Actual|2001-11-21|May 2017|2017-05-01|December 31, 2003|Actual|2003-12-31|December 29, 2003|Actual|2003-12-29||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)|A Double-Blind, Placebo-Controlled, Multicenter Study of the Long-Term Efficacy of MK0869 in the Maintenance of Antidepressant Effect in Geriatric Outpatients With Major Depressive Disorder|Completed||Phase 3|540|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:36:48.20868|2017-10-11 04:36:48.20868
NCT00035061|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:36:48.298504|2017-10-11 04:36:48.298504
NCT00035074|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease|A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:36:48.401254|2017-10-11 04:36:48.401254
NCT00035087|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2013-12-03|||May 2002||2002-05-01|December 2013|2013-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||EPO906 Therapy in Patients With Advanced Colorectal Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Colorectal Cancer|Completed||Phase 2|62|Actual|Novartis|||||f||||||||||||||2017-10-11 04:36:48.462454|2017-10-11 04:36:48.462454
NCT00035100|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2012-04-13|||September 2001||2001-09-01|April 2012|2012-04-01||||June 2003|Actual|2003-06-01||Interventional|||EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer|Completed||Phase 2|54|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:36:48.542304|2017-10-11 04:36:48.542304
NCT00035113|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-02-07|||January 2002||2002-01-01|February 2017|2017-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||EPO906 Therapy in Patients With Prostate Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Androgen-independent Prostate Cancer|Completed||Phase 2|48|Actual|Novartis|||||f||||||||||||||2017-10-11 04:36:48.653325|2017-10-11 04:36:48.653325
NCT00035126|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-02-07|||January 2002|Actual|2002-01-01|February 2017|2017-02-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||EPO906 Therapy in Patients With Advanced Breast Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Breast Cancer|Completed||Phase 2|46|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:36:48.740443|2017-10-11 04:36:48.740443
NCT00035139|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery|Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery|Completed||Phase 4|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:36:48.819155|2017-10-11 04:36:48.819155
NCT00035152|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2016-09-16|||June 2000||2000-06-01|September 2016|2016-09-01|December 2004||2004-12-01|||||Interventional|||Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer|A Multicenter, Randomized Trial for Stage IIIB or IV NSCLC Comparing Weekly Taxol(Paclitaxel) and Carboplatin(Paraplatin) Regimen Versus Standard Taxol and Carboplatin Administered Every Three Weeks, Followed by Weekly Taxol.|Completed||Phase 3|444||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:36:48.879817|2017-10-11 04:36:48.879817
NCT00035165|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2012-04-24|||March 2002||2002-03-01|April 2012|2012-04-01||||May 2003|Actual|2003-05-01||Interventional|||EPO906 Therapy in Patients With Advanced Melanoma|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Melanoma|Completed||Phase 2|51|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:36:49.072235|2017-10-11 04:36:49.072235
NCT00035178|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2005-06-23|||May 2002||2002-05-01|December 2003|2003-12-01|November 2002||2002-11-01|||||Interventional|||Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis|Pharmacokinetics and Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease (ESRD) Patients Undergoing Hemodialysis|Completed||Phase 4|12||Encysive Pharmaceuticals|||||||||||||||||||2017-10-11 04:36:49.176598|2017-10-11 04:36:49.176598
NCT00035191|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-06-06|||October 2001||2001-10-01|November 2010|2010-11-01|September 2003|Actual|2003-09-01|||||Interventional|||A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia|A Randomized 26-Week, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia|Completed||Phase 3|254|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:36:49.260057|2017-10-11 04:36:49.260057
NCT00035204|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-06-06||||||April 2010|2010-04-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease|A Double-blind, Randomized Pilot Study to Evaluate the Effects of Galantamine and Donepezil on Sleep and Attention and Gastrointestinal (GI) Tolerance in Patients With Mild to Moderate Alzheimer's Disease (AD)|Completed||Phase 4|63|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 04:36:49.340831|2017-10-11 04:36:49.340831
NCT00035217|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program|Follow-Up Study for Men Diagnoses With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:36:49.407732|2017-10-11 04:36:49.407732
NCT00035230|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-06-06|||July 2001||2001-07-01|January 2011|2011-01-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder|A Randomized, Double-Blind, Multicenter, Placebo-Controlled 12-Week Study of the Safety and Efficacy of Topiramate in Patients With Acute Manic or Mixed Episodes of Bipolar I Disorder With an Optional Open-Label Extension|Completed||Phase 3|338|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:36:49.460027|2017-10-11 04:36:49.460027
NCT00035243|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2012-04-16|||April 2002||2002-04-01|April 2012|2012-04-01||||August 2003|Actual|2003-08-01||Interventional|||EPO906 Therapy in Patients With Advanced Kidney Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Renal Cancer|Completed||Phase 2|53|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:36:49.530793|2017-10-11 04:36:49.530793
NCT00035256|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2007-05-11|||October 2001||2001-10-01|May 2007|2007-05-01|July 2005|Actual|2005-07-01|||||Interventional|||Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis|Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 4|330||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:36:49.621542|2017-10-11 04:36:49.621542
NCT00035269|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2011-04-25|||December 2001||2001-12-01|April 2011|2011-04-01|May 2003|Actual|2003-05-01|||||Interventional|||New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)|Linezolid in the Treatment of Penicillin-Resistant Streptococcus Pneumoniae Pneumonia: An Open-Label, Non-Comparator Study|Completed||Phase 3|230|Actual|Pfizer|||||||||||||||||||2017-10-11 04:36:49.698891|2017-10-11 04:36:49.698891
NCT00035282|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2015-02-06|||September 2001||2001-09-01|February 2015|2015-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)|A Double-Blind, Placebo- and Active-Controlled Acute and Extension Study of MK0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|450|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:36:49.992215|2017-10-11 04:36:49.992215
NCT00035295|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-04-17|||November 8, 2001|Actual|2001-11-08|April 2017|2017-04-01|December 5, 2003|Actual|2003-12-05|December 5, 2003|Actual|2003-12-05||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)|A Double-Blind, Multicenter, Placebo-and Active-Controlled Acute and Extension Study of 2 Doses of MK-0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|584|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:36:50.064335|2017-10-11 04:36:50.064335
NCT00047788|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-18|2016-08-22|||October 2002||2002-10-01|August 2016|2016-08-01|May 2004|Actual|2004-05-01|||||Interventional|||Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer|A Phase Two Study of ZD6474 in Patients With Relapsed Multiple Myeloma|Completed||Phase 2|30||Sanofi|||||||||||||||||||2017-10-11 04:37:16.372881|2017-10-11 04:37:16.372881
NCT00035308|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2006-09-22||||||December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Safety and Efficacy Trial of LJP 394 in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease|Completed||Phase 3|330||La Jolla Pharmaceutical Company|||||||||||||||||||2017-10-11 04:36:50.158347|2017-10-11 04:36:50.158347
NCT00035321|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2006-07-21|||April 2002||2002-04-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression|The Study of Olanzapine Plus Fluoxetine in Combination for Treatment-Resistant Depression Without Psychotic Features|Completed||Phase 3|600||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:36:50.371387|2017-10-11 04:36:50.371387
NCT00035334|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2006-02-13|||October 2001||2001-10-01|February 2006|2006-02-01|December 2004||2004-12-01|||||Interventional|||Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis|A Phase II/III Study of the Safety and Efficacy of NC-503 in Patients Suffering From Secondary (AA) Amyloidosis|Completed||Phase 2/Phase 3|150||Bellus Health Inc|||||||||||||||||||2017-10-11 04:36:50.602914|2017-10-11 04:36:50.602914
NCT00035347|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-03-07|||January 2001||2001-01-01|March 2017|2017-03-01|June 2002|Actual|2002-06-01|||||Interventional|||Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia|A Randomized, Multicenter, Open Label Trial Comparing Intravenous Zithromax® (Azithromycin) Plus Intravenous Rocephin® (Ceftriaxone) Followed By Oral Zithromax® (Azithromycin) With Intravenous Levaquin® (Levofloxacin) Followed By Oral Levaquin® (Levofloxacin) For The Treatment Of Moderate To Severely Ill Hospitalized Subjects With Community-Acquired Pneumonia|Completed||Phase 4|219|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 04:36:50.743747|2017-10-11 04:36:50.743747
NCT00035360|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-03-07|||March 2002||2002-03-01|March 2017|2017-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Phase III PEG-Intron in HIV-infected Patients (Study P00738)|Phase 3 Study of PEG-Intron in Heavily Treatment-experienced, HIV-infected Patients|Completed||Phase 3|49|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:36:50.916718|2017-10-11 04:36:50.916718
NCT00035373|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-02|2017-10-05|||April 19, 2002||2002-04-19|April 29, 2015|2015-04-29|April 29, 2015||2015-04-29|||||Observational|||Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols|Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute (NCI) Clinical Research Protocols|Terminated||N/A|767|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:50.982352|2017-10-11 04:36:50.982352
NCT00043108|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2016-11-23|||July 2002||2002-07-01|November 2016|2016-11-01||||December 2006|Actual|2006-12-01||Interventional|||Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|Trimodality Protocol for the Treatment of Locally Advanced, Potentially Resectable Non-Small Cell Lung Cancer Targeting|Active, not recruiting||Phase 2|57|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:36:51.057888|2017-10-11 04:36:51.057888
NCT00043121|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-12-10|||June 2002||2002-06-01|December 2013|2013-12-01||||August 2008|Actual|2008-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery|A Phase I Study of Oxaliplatin, 5-Fluorouracil, and Leucovorin in Combination With Oral Capecitabine in Patients With Advanced Malignancy|Completed||Phase 1|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:36:51.144567|2017-10-11 04:36:51.144567
NCT00043134|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2010-04-10|||May 2002||2002-05-01|April 2008|2008-04-01||||May 2008|Anticipated|2008-05-01||Interventional|||Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome|Intravenous Low-Dose Decitabine Versus Supportive Care in Elderly Patients With Primary Myelodysplastic Syndrome (MDS) (>10% Blasts or High-Risk Cytogenetics), Secondary MDS or Chronic Myelomonocytic Leukemia (CMML) Who Are Not Eligible for Intensive Therapy: An EORTC-German MDS Study Group Randomized Phase III Study|Unknown status|Active, not recruiting|Phase 3|220|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:51.247998|2017-10-11 04:36:51.247998
NCT00043147|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-05|2013-05-29|||April 2002||2002-04-01|December 2004|2004-12-01|January 2005|Actual|2005-01-01|||||Interventional|||Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease|A Phase III, Randomized, Placebo-Controlled, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Oral Beclomethasone 17, 21-Dipropionate (BDP) in Conjunction With Ten Days of High-Dose Prednisone Therapy in the Treatment of Patients With Grade II Graft vs. Host Disease With Gastrointestinal Symptoms|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:36:51.437761|2017-10-11 04:36:51.437761
NCT00043186|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-06|2013-09-06|2009-12-22|2009-11-23|May 2002||2002-05-01|September 2013|2013-09-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density|A Randomized, Double-Blind, Placebo-controlled, Multi-dose Phase 2 Study to Determine the Efficacy, Safety and Tolerability of AMG 162 in the Treatment of Postmenopausal Women With Low Bone Mineral Density|Completed||Phase 2|412|Actual|Amgen||9|||f||||||||||||||2017-10-11 04:36:51.712627|2017-10-11 04:36:51.712627
NCT00043199|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-06|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies|A Phase II Study of Aroplatin in Subjects With Recurrent, Unresectable and Metastatic Colorectal Cancer Refractory to 5-Fluorouracil (5-FU)/Leucovorin or Capecitabine, and Irinotecan|Unknown status|Active, not recruiting|Phase 2|40||Aronex Pharmaceuticals|||||||||||||||||||2017-10-11 04:36:58.793087|2017-10-11 04:36:58.793087
NCT00043212|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-06|2013-04-30||||||April 2013|2013-04-01||||||||Interventional|||Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.|A Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating DCVax(tm)-Prostate, Autologous Dendritic Cells Loaded With Recombinant PSMA for the Treatment of Metastatic Hormone Refractory Prostate Cancer|Withdrawn||Phase 3|0|Actual|Northwest Biotherapeutics||||Redirection of company goals|f||||||||||||||2017-10-11 04:36:58.859349|2017-10-11 04:36:58.859349
NCT00043225|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-13|2017-10-05|||June 19, 2001||2001-06-19|August 9, 2017|2017-08-09||||||||Observational|||The Role of Bacteria and Genetic Variations in Cystic Fibrosis|Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:36:58.942781|2017-10-11 04:36:58.942781
NCT00043238|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-07|2015-04-13||||||April 2015|2015-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||Mohawk Culture, Behavior, Toxicant Exposure and Health|Mohawk Culture, Behavior, Toxicant Exposure and Health|Completed||N/A|220|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:36:59.033107|2017-10-11 04:36:59.033107
NCT00043264|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-07|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis|Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis|Completed||Phase 2|40||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-10-11 04:36:59.087735|2017-10-11 04:36:59.087735
NCT00043277|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-07|2006-01-31|||August 2002||2002-08-01|January 2006|2006-01-01|December 2004||2004-12-01|||||Interventional|||Study Of Angiomax In Infants Under Six Months With Thrombosis|Pilot Dose Finding And Efficacy Study Of Angiomax® (Bivalirudin) As Primary Anticoagulation In Infants Under Six Months With Thrombosis|Completed||Phase 2|25||The Medicines Company|||||||||||||||||||2017-10-11 04:36:59.141795|2017-10-11 04:36:59.141795
NCT00043303|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-07|2007-10-29|||September 2001||2001-09-01|October 2007|2007-10-01|November 2003|Actual|2003-11-01|||||Interventional|||Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis|A Multicenter Study of the Safety and Anti-Fibrotic Efficacy of Interferon-Gamma 1b (Actimmune) in Patients With Severe Lever Fibrosis or Compensated Cirrhosis Due to Hepatitis C.|Completed||Phase 2|502|Actual|InterMune||1|||f||||||||||||||2017-10-11 04:36:59.200978|2017-10-11 04:36:59.200978
NCT00043316|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-07|2007-10-29|||February 2001||2001-02-01|October 2007|2007-10-01|October 2002|Actual|2002-10-01|||||Interventional|||Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis|A Phase I/II Study of Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis|Completed||Phase 1/Phase 2|66|Actual|InterMune||1|||f||||||||||||||2017-10-11 04:36:59.255571|2017-10-11 04:36:59.255571
NCT00043329|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-07|2007-10-30|||January 2002||2002-01-01|October 2007|2007-10-01|September 2005|Actual|2005-09-01|||||Observational|||Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis|Post-Marketing Surveillance Study of Actimmune (Interferon Gamma-1b) in Patients With Severe Malignant Osteopetrosis|Completed||Phase 4|6|Actual|InterMune|||1||f||||||||||||||2017-10-11 04:36:59.361838|2017-10-11 04:36:59.361838
NCT00043342|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-07|2007-10-29|||April 2002||2002-04-01|October 2007|2007-10-01|March 2003|Actual|2003-03-01|||||Interventional|||Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis|A Phase I/II Study of Interferon Gamma-1b by Subcutaneous Injection for the Treatment of Patients With Cystic Fibrosis|Completed||Phase 1/Phase 2|51|Actual|InterMune||1|||f||||||||||||||2017-10-11 04:36:59.432872|2017-10-11 04:36:59.432872
NCT00043355|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-07|2007-10-30|||December 2000||2000-12-01|October 2007|2007-10-01|February 2003|Actual|2003-02-01|||||Interventional|||Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection|A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Safety and Efficacy of Inhaled Interferon Gamma-1b With Antimycobacterials in Previously Treated or Mod-to-Sev Pulmonary Mycobacterium Avium Complex Infection|Terminated||Phase 2|100|Actual|InterMune||1||Futility|f||||||||||||||2017-10-11 04:36:59.493754|2017-10-11 04:36:59.493754
NCT00043368|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-08|2009-03-11|||September 2002||2002-09-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)|A Continuation Study Of PF-3512676 (CPG 7909) Injection In Patients With Metastatic Or Recurrent Malignancies Who Have Stable Disease Or Who Have Responded To Pf-3512676 Injection Therapy|Completed||Phase 2|31|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 04:36:59.559301|2017-10-11 04:36:59.559301
NCT00043381|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-08|2013-01-22|||April 2001||2001-04-01|June 2011|2011-06-01|April 2003|Actual|2003-04-01|November 2002|Actual|2002-11-01||Interventional|||Decitabine Versus Supportive Care in Adults With Advanced-stage MDS|A Randomized, Open-label, Phase III Trial of Decitabine (5-aza-2'Deoxycytidine) Versus Supportive Care in Adults With Advanced-stage Myelodysplastic Syndrome|Completed||Phase 3|160||Astex Pharmaceuticals|||||f||||||||||||||2017-10-11 04:37:01.491292|2017-10-11 04:37:01.491292
NCT00043394|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-08|2009-03-11|||September 2002||2002-09-01|March 2009|2009-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer|A Phase I/II Open Label, Multi-Center, Dose-Escalation Study Of Subcutaneous CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer|Completed||Phase 2|16|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 04:37:01.60306|2017-10-11 04:37:01.60306
NCT00043407|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-08|2009-02-11|||March 2002||2002-03-01|February 2009|2009-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||CPG 7909 in Patients Wih Stage IV Renal Cell Cancer|A Phase I/II, Open Label, Multi-Center Study For The Evaluation Of CPG 7909 In Patients With Stage Iv Renal Cell Carcinoma|Completed||Phase 1/Phase 2|42|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 04:37:01.740066|2017-10-11 04:37:01.740066
NCT00043420|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-08|2009-02-11|||January 2003||2003-01-01|February 2009|2009-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||CPG 7909 in Patients With Cutaneous T-Cell Lymphoma|A Phase I/II Open Label, Multi-Center Study For The Evaluation Of Pf-3512676 (CPG 7909) In Patients With Stage Ib To Iva Cutaneous T-Cell Lymphoma|Completed||Phase 1/Phase 2|42|Actual|Pfizer||8|||f||||f||||||||||2017-10-11 04:37:01.833435|2017-10-11 04:37:01.833435
NCT00043433|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-08|2005-06-23|||July 2002||2002-07-01|April 2004|2004-04-01||||||||Interventional|||Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.||Unknown status|Active, not recruiting|Phase 2|35||Tularik|||||||||||||||||||2017-10-11 04:37:01.950049|2017-10-11 04:37:01.950049
NCT00043446|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-08|2005-06-23|||July 2002||2002-07-01|April 2004|2004-04-01||||||||Interventional|||Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.||Unknown status|Active, not recruiting|Phase 2|35||Tularik|||||||||||||||||||2017-10-11 04:37:02.036124|2017-10-11 04:37:02.036124
NCT00043459|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-08|2005-06-23|||July 2002||2002-07-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.||Terminated||Phase 2|35||Tularik|||||||||||||||||||2017-10-11 04:37:02.120033|2017-10-11 04:37:02.120033
NCT00043472|ClinicalTrials.gov processed this data on October 10, 2017|2006-06-19|2017-06-30|||August 1, 2002||2002-08-01|November 25, 2016|2016-11-25||||||||Observational|||Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk|Prospective Study of Prophylactic Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer|Completed||N/A|40|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:02.311684|2017-10-11 04:37:02.311684
NCT00043498|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2014-10-14|||August 1997||1997-08-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Health Effects of Early-Life Exposure to Urban Pollutants in Minority Children|Health Effects of Early-Life Exposure to Urban Pollutants in Minority Children|Completed||N/A|727|Actual|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||t||||||Samples With DNA|"     We collected maternal urine during the third trimester of pregnancy, maternal blood at     delivery, umbilical cord blood, meconium, blood and urine from the child at ages 24, 36, and     60 months.   "|||2017-10-11 04:37:02.441042|2017-10-11 04:37:02.441042
NCT00046930|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2015-06-01|2010-08-17||July 2002||2002-07-01|June 2015|2015-06-01||||June 2009|Actual|2009-06-01||Interventional|||Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia|A Randomized, Placebo-Controlled, Double Blind, Trial of the Administration of the MDR Modulator, Zosuquidar Trihydrochloride (LY335979), During Conventional Induction and Post-Remission Therapy in Patients Greater Than 60 Years of Age With Newly Diagnosed Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation or High-Risk Refractory Anemia With Excess Blasts|Completed||Phase 3|449|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 04:37:02.581886|2017-10-11 04:37:02.581886
NCT00046943|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2011-02-18|||September 2002||2002-09-01|September 2003|2003-09-01||||June 2007|Actual|2007-06-01||Interventional|||Atrasentan in Treating Patients With Prostate Cancer|A Phase III Extension Study to Evaluate the Safety of 10 mg Atrasentan in Men With Hormone-Refractory Prostate Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:37:05.304982|2017-10-11 04:37:05.304982
NCT00046969|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-05-29|||July 2002||2002-07-01|March 2007|2007-03-01|June 2007|Actual|2007-06-01|||||Interventional|||Epoetin Beta in Treating Anemia in Patients With Cervical Cancer|Management Of Anemia Under RadioChemotherapy (MARCH): An Open, Randomized Multicenter Study Of The Effect Of NeoRecormon On Treatment Outcome In Patients With Advanced Cervical Cancer Stage IIB -IVA Treated With Primary Simultaneous Radiochemotherapy (Radiotherapy Plus Cisplatin)|Completed||Phase 4|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:37:05.394656|2017-10-11 04:37:05.394656
NCT00046995|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-09-19|||May 2001||2001-05-01|November 2002|2002-11-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Colon Cancer|5-Fluorouracil-Leucovorin With or Without Carboplatin as Adjuvant Treatment for Primary Dukes B2-C Colon Cancer; Chronomodulated Versus Standard Administration. A Multicenter Randomized Phase III Trial of the GRECCR-Belgium (Study 03).|Unknown status|Active, not recruiting|Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:37:05.535181|2017-10-11 04:37:05.535181
NCT00047008|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2017-05-18|2014-07-28||July 2002|Actual|2002-07-01|May 2017|2017-05-01||||June 2010|Actual|2010-06-01||Interventional||Eligible patients who did not withdraw consent.|Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer|A Phase III Trial of Concurrent Radiation and Chemotherapy for Advanced Head and Neck Carcinomas|Active, not recruiting||Phase 3|743|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||No||2017-10-11 04:37:05.706184|2017-10-11 04:37:05.706184
NCT00047021|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2010-06-10|||November 2001||2001-11-01|June 2010|2010-06-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma|A Pilot Study Of Cytarabine And High-Dose Mitoxantrone For Relapsed Or Refractory Hematologic Malignancies|Completed||Phase 2|3|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:37:07.319129|2017-10-11 04:37:07.319129
NCT00047034|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-01-04|||August 2002||2002-08-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||E7389 in Treating Patients With Advanced Solid Tumors|Phase I Trial of E7389 (Halichondrin B Analog) (NSC# 707389) in Patients With Advanced Solid Tumors|Completed||Phase 1|31|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:37:07.447474|2017-10-11 04:37:07.447474
NCT00047047|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-06-03|||August 2002||2002-08-01|June 2013|2013-06-01||||September 2007|Actual|2007-09-01||Interventional|||Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors|A Phase I Trial Of Gemcitabine, 17-Allylaminogeldanamycin (17-AAG) And Cisplatin In Advanced Solid Tumor Patients|Completed||Phase 1|78|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:37:07.52967|2017-10-11 04:37:07.52967
NCT00047060|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2017-10-05|||July 30, 2002||2002-07-30|March 31, 2017|2017-03-31|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome|A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning With Campath-1H|Active, not recruiting||Phase 1|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:37:07.633422|2017-10-11 04:37:07.633422
NCT00047073|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2012-07-27|||July 2002||2002-07-01|July 2012|2012-07-01|October 2007|Actual|2007-10-01|June 2005|Actual|2005-06-01||Interventional|||Sirolimus in Treating Patients With Glioblastoma Multiforme|A Modified Phase I/II Trial Of Rapamycin In Patients With Glioblastoma Multiforme|Completed||Phase 1/Phase 2|13|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:37:07.726135|2017-10-11 04:37:07.726135
NCT00047099|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-05-29|||August 2001||2001-08-01|December 2002|2002-12-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer|A Randomized Phase III Trial Comparing FEC-Chemotherapy vs. EC-Doc-Chemotherapy in Patients With Primary Breast Cancer|Completed||Phase 3|446|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:37:07.840918|2017-10-11 04:37:07.840918
NCT00047112|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2016-05-27|||May 2002||2002-05-01|May 2016|2016-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer|Randomized Study of Pre-Operative Radio-Chemotherapy Versus Surgery Alone in Thoracic Esophageal Cancer Deemed to be Resectable|Completed||Phase 3|195|Actual|Federation Francophone de Cancerologie Digestive||2|||f||||||||||||||2017-10-11 04:37:07.959201|2017-10-11 04:37:07.959201
NCT00047125|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2012-06-19|||July 2002||2002-07-01|June 2012|2012-06-01||||July 2004|Actual|2004-07-01||Interventional|||Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor|Randomized Phase III Study On The Selection Of The Target Volume In Postoperative Radiotherapy For Cervical Lymph Node Metastases Of Squamous Cell Carcinoma From And Unknown Primary (CUP)|Completed||Phase 3|600|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 04:37:08.253312|2017-10-11 04:37:08.253312
NCT00047138|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2014-06-23|||January 2001||2001-01-01|June 2009|2009-06-01||||||||Interventional|||Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor|Nephroblastoma (Wilms Tumour) Clinical Trial And Study|Unknown status|Recruiting|Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:37:09.018882|2017-10-11 04:37:09.018882
NCT00047164|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2016-09-23|||September 2002||2002-09-01|March 2012|2012-03-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy|A Pilot Study of Ipilimumab (MDX-CTLA4, MDX-010) in Lymphoma|Completed||Phase 1|89|Actual|National Institutes of Health Clinical Center (CC)||1|||||||||||||||||2017-10-11 04:37:09.157758|2017-10-11 04:37:09.157758
NCT00047177|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2009-10-14|||October 2002||2002-10-01|October 2009|2009-10-01|July 2007|Actual|2007-07-01|August 2004|Actual|2004-08-01||Interventional|||Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor|A Phase II Study of Oxaliplatin in Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumors and Atypical Teratoid Rhabdoid Tumors|Completed||Phase 2|43|Actual|Pediatric Brain Tumor Consortium|||||f||||t||||||||||2017-10-11 04:37:09.266755|2017-10-11 04:37:09.266755
NCT00047190|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-06-03|||August 2002||2002-08-01|June 2013|2013-06-01||||April 2007|Actual|2007-04-01||Interventional|||Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia|A Phase II Trial of R115777 in Myelofibrosis With Myeloid Metaplasia (MMM)|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:37:09.379044|2017-10-11 04:37:09.379044
NCT00047203|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-01-15|||September 2002||2002-09-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Study of Flavopiridol in Patients With Relapsed and Refractory Multiple Myeloma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:37:09.470454|2017-10-11 04:37:09.470454
NCT00047216|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2015-07-22|||November 2002||2002-11-01|July 2015|2015-07-01||||March 2006|Actual|2006-03-01||Interventional|||Tipifarnib in Treating Patients With Recurrent Bladder Cancer|A Phase II Study of R115777 (Zarnestra) in Superficial Transitional Cell Carcinoma of Bladder|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 04:37:09.566598|2017-10-11 04:37:09.566598
NCT00047229|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2009-04-04|||October 2002||2002-10-01|August 2005|2005-08-01||||January 2009|Actual|2009-01-01||Interventional|||Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)|A Phase II Study of G3139 in Combination With Doxorubicin in Advanced Hepatocellular Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:37:09.675723|2017-10-11 04:37:09.675723
NCT00047242|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2010-08-05|||August 2002||2002-08-01|August 2010|2010-08-01||||February 2006|Actual|2006-02-01||Interventional|||UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors|The Pharmacokinetic and Safety Profile of UCN-01 in Combination With Irinotecan in Solid Tumors (Primarily Lung, Ovarian and GI Cancers)|Completed||Phase 1|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||||||||||||||||2017-10-11 04:37:09.793853|2017-10-11 04:37:09.793853
NCT00047255|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2016-02-11|||May 2002||2002-05-01|February 2016|2016-02-01|April 2010|Actual|2010-04-01|January 2006|Actual|2006-01-01||Interventional|||Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer|A Multicenter Phase III Randomized Trial Comparing Docetaxel (Taxotere) and Trastuzumab (Herceptin) With Docetaxel (Taxotere), Carboplatin and Trastuzumab (Herceptin) as First Line Chemotherapy for Patients With Advanced Breast Cancer Containing the HER2 Gene Amplification|Completed||Phase 3|263|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:37:09.884123|2017-10-11 04:37:09.884123
NCT00047268|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-09-16|||July 1998||1998-07-01|July 2007|2007-07-01||||||||Interventional|||Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome|Prospective Study of the Diagnosis and Treatment of Myelodysplastic Syndromes (MDS) in Childhood|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:37:09.990911|2017-10-11 04:37:09.990911
NCT00047281|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2017-07-06|||March 2004|Actual|2004-03-01|July 2017|2017-07-01|February 2006|Actual|2006-02-01|August 2005|Actual|2005-08-01||Interventional|||Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma|Trial Of Oral Thalidomide, Celecoxib, Etoposide And Cyclophosphamide In Adult Patients With Relapsed Or Progressive Malignant Gliomas|Completed||Phase 2|||Dana-Farber Cancer Institute|||||f||||t|t|f||||||||2017-10-11 04:37:10.097855|2017-10-11 04:37:10.097855
NCT00047294|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2017-07-06|||April 2001|Actual|2001-04-01|May 2005|2005-05-01|September 2007|Actual|2007-09-01|March 2005|Actual|2005-03-01||Interventional|||Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study Of Temozolomide, Thalidomide And Celecoxib In Patients With Newly Diagnosed Glioblastoma Multiforme In The Post-Radiation Setting|Completed||Phase 2|||Dana-Farber Cancer Institute|||||f||||t|t|f||||||||2017-10-11 04:37:10.193148|2017-10-11 04:37:10.193148
NCT00047307|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-06-03|||August 2002||2002-08-01|June 2013|2013-06-01||||August 2008|Actual|2008-08-01||Interventional|||Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer|A Phase 1 Study of Alvocidib (Flavopiridol) in Combination With Radiation in Locally Advanced, Non-Operable Pancreatic and Extrahepatic Bile Duct Cancers|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:37:10.314047|2017-10-11 04:37:10.314047
NCT00047320|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2017-07-18|2014-01-15||January 2004||2004-01-01|February 2017|2017-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors|A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT|Completed||Phase 2|104|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:37:10.441206|2017-10-11 04:37:10.441206
NCT00047333|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-01-22|||August 2002||2002-08-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed|A Phase 2 Open-Label Study Of OSI-774 (NSC 718781) In Unresectable Hepatocellular Carcinoma|Terminated||Phase 2|80|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:37:11.188866|2017-10-11 04:37:11.188866
NCT00047346|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-01-22|||August 2002||2002-08-01|January 2013|2013-01-01||||December 2005|Actual|2005-12-01||Interventional|||Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction|A Dose-Finding, Safety, And Pharmacokinetic Study Of The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor OSI-774 (NSC 718781) In Patients With Unresectable Hepatocellular Carcinoma And Moderate Hepatic Dysfunction|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:37:11.273497|2017-10-11 04:37:11.273497
NCT00047385|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2014-05-02|2012-05-30||August 2002||2002-08-01|October 2012|2012-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|NLST||National Lung Screening Trial (NLST) Screening|National Lung Screening Trial A Randomized Trial Comparing Low-dose Helical CT With Chest Xray for Lung Cancer|Completed||Phase 3|53454|Actual|National Cancer Institute (NCI)|"NLST utilized institutions with special expertise. The healthy volunteer effect may apply. Scanners are now more technologically advanced. Ongoing LDCT screening may reduce the rate of lung cancer deaths more than three rounds done in NLST."|2|||f||||t||||||||||2017-10-11 04:37:11.369093|2017-10-11 04:37:11.369093
NCT00047424|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2009-02-04|||September 2002||2002-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Stop Atherosclerosis in Native Diabetics Study (SANDS)|Stop Atherosclerosis in Native Diabetics Study (SANDS)|Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:37:12.106728|2017-10-11 04:37:12.106728
NCT00047437|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-03-20|||April 2003||2003-04-01|March 2013|2013-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure|Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)|Completed||Phase 3|2331|Actual|Duke University||2|||f||||t||||||||||2017-10-11 04:37:12.181052|2017-10-11 04:37:12.181052
NCT00047450|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-04|2013-08-06|||September 2001||2001-09-01|August 2013|2013-08-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||Antidepressant Treatment in Older Adults With Schizophrenia|Citalopram Augmentation in Older Patients With Schizophrenia|Completed||N/A|212|Actual|Veterans Medical Research Foundation||2|||f||||t||||||||||2017-10-11 04:37:12.481112|2017-10-11 04:37:12.481112
NCT00047463|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-07|2016-07-20|2009-11-18||September 2002||2002-09-01|July 2016|2016-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effects of Treating Obstructive Sleep Apnea in Epilepsy|Effects of Treating Obstructive Sleep Apnea in Epilepsy|Completed||Phase 2|68|Actual|Vanderbilt University|Being a pilot study with a relatively small sample size, we were unable to isolate the effects of specific medications or seizure types on the presence of sleep apnea.|2|||f||||t||||||||||2017-10-11 04:37:12.592578|2017-10-11 04:37:12.592578
NCT00047476|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2005-06-23|||June 2002||2002-06-01|May 2004|2004-05-01|March 2004||2004-03-01|||||Interventional|||D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients|Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of d-MPH in the Treatment of Fatigue and Neurobehavioral Impairment Related to Chemotherapy in Adult Cancer Patients|Completed||Phase 2|160||Celgene|||||||||||||||||||2017-10-11 04:37:12.984607|2017-10-11 04:37:12.984607
NCT00047489|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2012-02-20|||December 2002||2002-12-01|February 2012|2012-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of ABT-751 in Patients With Refractory Hematologic Malignancies|A Phase I Study of ABT-751 in Patients With Refractory Hematologic Malignancies|Completed||Phase 1|32|Actual|M.D. Anderson Cancer Center|||||||||||||||||||2017-10-11 04:37:13.09638|2017-10-11 04:37:13.09638
NCT00047502|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2012-02-20|||November 2002||2002-11-01|February 2012|2012-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia|Phase I Study of Lonafarnib (SCH66336) and Gleevec (Imatinib Mesylate) in Chronic Myelogenous Leukemia (CML)|Completed||Phase 1|23|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:37:13.164982|2017-10-11 04:37:13.164982
NCT00047515|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2008-08-04|||January 2001||2001-01-01|August 2008|2008-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69|Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-69.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-10-11 04:37:13.262538|2017-10-11 04:37:13.262538
NCT00047528|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2008-08-04|||January 2001||2001-01-01|August 2008|2008-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41|Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients (C-02-41).|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-10-11 04:37:13.349732|2017-10-11 04:37:13.349732
NCT00047541|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2008-08-04|||February 2001||2001-02-01|August 2008|2008-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70|Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-70.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-10-11 04:37:13.422961|2017-10-11 04:37:13.422961
NCT00047554|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2013-05-13|||May 2003||2003-05-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Study of TRAVATAN in Subjects With Iris Pigmentation Changes|A Five-Year, Multicenter, Commercial Label Safety Study of TRAVATAN® 0.004% in Patients With TRAVATAN-Induced Iris Pigmentation Changes|Terminated||Phase 4|336|Actual|Alcon Research|||1|Study objectives met|f||||||||||||||2017-10-11 04:37:13.499208|2017-10-11 04:37:13.499208
NCT00047567|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2015-12-10|||July 2002||2002-07-01|December 2015|2015-12-01|July 2002||2002-07-01|||||Interventional|||Open-label Adjunctive Zonisamide for Bipolar Disorder||Terminated||Phase 4|20||Elan Pharmaceuticals|||||||||||||||||||2017-10-11 04:37:13.605758|2017-10-11 04:37:13.605758
NCT00047801|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-18|2011-07-21|||October 2002||2002-10-01|June 2011|2011-06-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer|Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel (Taxotere) in Platinum-Resistant Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|28||Telik|||||f||||||||||||||2017-10-11 04:37:16.525672|2017-10-11 04:37:16.525672
NCT00047580|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2015-12-10|||June 2002||2002-06-01|December 2015|2015-12-01|September 2002||2002-09-01|||||Interventional|||Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.|A Multicenter, Open-Label, Randomized, 4-Way Crossover Trial of the Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex (Tizanidine Hydrochloride) Tablets Taken Under Fed and Fasted Conditions in Patients With Moderate to Severe Spasticity|Completed||Phase 3|120||Elan Pharmaceuticals|||||||||||||||||||2017-10-11 04:37:13.670507|2017-10-11 04:37:13.670507
NCT00047593|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2008-08-04|||January 2000||2000-01-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98|Phase 3 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Japanese Subjects C-01-98.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-10-11 04:37:13.76421|2017-10-11 04:37:13.76421
NCT00047606|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-08|2012-08-16|||August 2002||2002-08-01|August 2008|2008-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32|Phase 4 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Caucasian and Japanese Subjects C-02-32.|Terminated||Phase 4|84|Actual|Alcon Research||||Management Decision|||||||||||||||2017-10-11 04:37:13.837847|2017-10-11 04:37:13.837847
NCT00047619|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-09|2015-09-10|2015-07-08||June 2002||2002-06-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Enhancement of Pressure Healing With Pulsatile Lavage|Enhancement of Pressure Healing With Pulsatile Lavage|Completed||Phase 2|28|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 04:37:13.909766|2017-10-11 04:37:13.909766
NCT00047632|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-09|2007-10-30|||October 2001||2001-10-01|October 2007|2007-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer|Interferon Gamma-1b in Combination With Chemotherapy (Carboplatin/Paclitaxel) for First Line Therapy of Advanced Ovarian or Primary Peritoneal Carcinoma.|Terminated||Phase 3|847|Actual|InterMune||1||futility|f||||||||||||||2017-10-11 04:37:14.166567|2017-10-11 04:37:14.166567
NCT00047645|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-09|2007-11-01|||April 2000||2000-04-01|November 2007|2007-11-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)|A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 3|330|Actual|InterMune||1|||f||||||||||||||2017-10-11 04:37:14.259737|2017-10-11 04:37:14.259737
NCT00047658|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-09|2007-11-02|||November 2001||2001-11-01|November 2007|2007-11-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Biology, and Clinical Effects of Interferon Gamma-1b Administered Subcutaneously to Patients With IPF Followed by an Open-Label Extension|Completed||Phase 2|32|Actual|InterMune||1|||f||||||||||||||2017-10-11 04:37:14.336779|2017-10-11 04:37:14.336779
NCT00047684|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-11|2013-09-09|||November 2001||2001-11-01|September 2008|2008-09-01|November 2002||2002-11-01|||||Interventional|||Brief Integrative Therapy for Post-Traumatic Stress Disorder|Development and Initial Evaluation of Brief Integrative Therapy for PTSD|Completed||N/A|20||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 04:37:14.482237|2017-10-11 04:37:14.482237
NCT00047697|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-11|2017-09-07|2015-03-30||October 2002||2002-10-01|September 2017|2017-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Donepezil HCl & Cognitive Deficits in Autism|Donepezil HCl: Treating Cognitive Deficits in Autism|Completed||Phase 2|34|Actual|University of Pittsburgh|The trial may not have been long enough to obtain clinically significant effects|2|||f||||t||||||||||2017-10-11 04:37:14.562531|2017-10-11 04:37:14.562531
NCT00047710|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-14|2012-07-31|||September 2002||2002-09-01|July 2012|2012-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer|A Phase I Trial of Concurrent RHUMAB VEGF (BEVACIZUMAB) and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 1|48|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:37:14.861142|2017-10-11 04:37:14.861142
NCT00047723|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-16|2007-12-18|||January 2003||2003-01-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Minocycline to Treat Amyotrophic Lateral Sclerosis||Completed||Phase 3|400||National Institute of Neurological Disorders and Stroke (NINDS)|||||||||||||||||||2017-10-11 04:37:15.651667|2017-10-11 04:37:15.651667
NCT00047736|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-16|2013-06-19|||July 2001||2001-07-01|June 2013|2013-06-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer|A Phase III, Randomized, Double Blind, Multicenter Trial of Tarceva (Erlotinib) Plus Chemotherapy (Carboplatin and Paclitaxel) Versus Chemotherapy Alone in Patients With Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy|Completed||Phase 3|||Genentech, Inc.|||||||||||||||||||2017-10-11 04:37:15.805928|2017-10-11 04:37:15.805928
NCT00047749|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-16|2015-12-10|||August 2002||2002-08-01|December 2015|2015-12-01|June 2003||2003-06-01|||||Interventional|||Prialt (Ziconotide) In Severe Chronic Pain|A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults With Severe Chronic Pain|Completed||Phase 3|220||Elan Pharmaceuticals|||||||||||||||||||2017-10-11 04:37:15.918381|2017-10-11 04:37:15.918381
NCT00047762|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-16|2005-06-23|||October 2002||2002-10-01|November 2004|2004-11-01||||||||Interventional|||Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer|Open-Label, Multicenter, Dose-Escalation Study in Subjects w/Advanced Colorectal Cancer to Evaluate the Safety, Efficacy, and Pharmacokinetics of Tarceva in Combination w/5-Fluorouracil, Leucovorin, and Irinotecan and of Bevacizumab in Combination w/Tarceva, 5-Fluorouracil, Leucovorin, and Irinotecan|Completed||Phase 1|||Genentech, Inc.|||||||||||||||||||2017-10-11 04:37:16.198701|2017-10-11 04:37:16.198701
NCT00047775|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-18|2005-06-23|||May 2001||2001-05-01|October 2004|2004-10-01|August 2004||2004-08-01|||||Interventional|||African-American Heart Failure Trial||Completed||Phase 4|1100||Nitromed|||||||||||||||||||2017-10-11 04:37:16.268265|2017-10-11 04:37:16.268265
NCT00047814|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-18|2011-12-08|||October 2002||2002-10-01|December 2011|2011-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection|A Multiple Rising-Dose Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 2|48||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:37:16.647681|2017-10-11 04:37:16.647681
NCT00047827|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-18|2014-08-19|||December 2002||2002-12-01|August 2014|2014-08-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis|A Phase 2, Open-Label, Non-Comparative Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) as First-Line Therapy in the Treatment of Invasive Aspergillosis|Terminated||Phase 2|2|Actual|Astellas Pharma Inc||1||Inadequate enrollment|f||||f||||||||||2017-10-11 04:37:16.757077|2017-10-11 04:37:16.757077
NCT00047840|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-18|2016-08-24|||October 2002||2002-10-01|August 2016|2016-08-01|September 2006|Actual|2006-09-01|||||Interventional|||This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.|A Randomized, Double-blind, Multicenter, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 in Combination With Docetaxel (TAXOTERE™) in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-based Chemotherapy.|Completed||Phase 2|129||Sanofi|||||f||||||||||||||2017-10-11 04:37:16.920945|2017-10-11 04:37:16.920945
NCT00047853|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-22|2017-10-05|||October 11, 2002||2002-10-11|September 27, 2017|2017-09-27||||||||Observational|||Brain Changes in Fear|fMRI Investigation of Explicit Cue and Contextual Fear|Recruiting||N/A|1600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:17.089951|2017-10-11 04:37:17.089951
NCT00047866|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-22|2017-06-30|||October 12, 2002||2002-10-12|June 25, 2010|2010-06-25|June 25, 2010||2010-06-25|||||Observational|||Brain Function in Response to Motivational Stimuli|Brain Activation in Response to Motivational and Affective Stimuli: Pharmacological Manipulations|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:17.195119|2017-10-11 04:37:17.195119
NCT00047879|ClinicalTrials.gov processed this data on October 10, 2017|2006-06-19|2011-09-19|2011-05-24||October 2002||2002-10-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas|A Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults With Recurrent High-Grade Gliomas|Completed||Phase 2|7|Actual|National Institutes of Health Clinical Center (CC)|Registered 7 out of 64 participants and they came off study for progressive disease around 3-4 months after starting the study.|2|||f||||f||||||||||2017-10-11 04:37:17.283013|2017-10-11 04:37:17.283013
NCT00047905|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-22|2008-03-03|||October 2002||2002-10-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Pilot Study of the Process of Prenatal Genetic Counseling|The Process of Prenatal Genetic Counseling Using a Simulated Client - A Pilot Study|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:17.72869|2017-10-11 04:37:17.72869
NCT00047918|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-22|2008-03-03|||October 2002||2002-10-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing|Investigation of Hematologic Parameters in Mastocytosis and Idiopathic Anaphylaxis|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:17.79614|2017-10-11 04:37:17.79614
NCT00047931|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-22|2017-06-30|||October 17, 2002||2002-10-17|May 5, 2009|2009-05-05|May 5, 2009||2009-05-05|||||Interventional|||HIV-1 Vaccine Test in Uninfected Adult Volunteers|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP in Uninfected Adult Volunteers|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:37:17.871941|2017-10-11 04:37:17.871941
NCT00047944|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-22|2017-10-05|||October 12, 2002||2002-10-12|October 27, 2016|2016-10-27|October 27, 2016||2016-10-27|||||Observational|||MRI Study of Brain Activity and Risk for Depression in Adolescents|Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging|Completed||N/A|88|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:17.955431|2017-10-11 04:37:17.955431
NCT00047957|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-22|2008-03-03|||October 2002||2002-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Brain Inhibition of Muscle Movement in Normal Volunteers|The Effect of Peripheral Homotopic and Heterotopic Stimulation on Cortical Excitability|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:18.057963|2017-10-11 04:37:18.057963
NCT00047970|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-23|2015-04-14|||August 2003||2003-08-01|November 2012|2012-11-01|April 2015|Actual|2015-04-01|August 2009|Actual|2009-08-01||Observational|||The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer|The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer|Completed||N/A|50884|Actual|National Institute of Environmental Health Sciences (NIEHS)|||||f||||f||||||||||2017-10-11 04:37:18.123509|2017-10-11 04:37:18.123509
NCT00047983|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-23|2017-01-10||||||January 2017|2017-01-01|April 2004|Actual|2004-04-01|||||Interventional|||Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients|A Randomized Trial of Immunomodulating Diets With Arginine and Omega-3 Fatty Acids in Renal Transplant Recipients|Completed||Early Phase 1|75|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 04:37:18.203179|2017-10-11 04:37:18.203179
NCT00048009|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2017-06-16|||October 25, 2002|Actual|2002-10-25|February 2017|2017-02-01|February 2, 2004|Actual|2004-02-02|February 2, 2004|Actual|2004-02-02||Interventional|||Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids||Completed||Phase 2|||Hoffmann-La Roche|||||||||||||||||||2017-10-11 04:37:18.324095|2017-10-11 04:37:18.324095
NCT00048022|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2017-06-15|||October 25, 2002|Actual|2002-10-25|February 2017|2017-02-01|February 2, 2004|Actual|2004-02-02|February 2, 2004|Actual|2004-02-02||Interventional|||Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma||Completed||Phase 2|||Hoffmann-La Roche|||||||||||||||||||2017-10-11 04:37:18.6337|2017-10-11 04:37:18.6337
NCT00048230|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-28|2012-01-12|||June 2002||2002-06-01|January 2012|2012-01-01|December 2004|Actual|2004-12-01|July 2004|Actual|2004-07-01||Interventional|||PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|An International, Multi-Center, Randomized, Open-Label Study of PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 3|620|Actual|Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-10-11 04:37:29.931161|2017-10-11 04:37:29.931161
NCT00048035|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2016-10-26|2016-05-03||March 2002||2002-03-01|October 2016|2016-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional||The Intent-to-Treat (ITT) population was used for the analysis. It was defined as all randomized participants.|A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia|An Open-label, Multicenter, Randomized Study to Determine Dose Conversion Factors at Different Frequencies of Administration After Switching From Maintenance Treatment With Intravenous Epoetin Alfa to Maintenance Treatment With Intravenous RO0503821 in Hemodialysis Patients With Chronic Renal Anemia.|Completed||Phase 2|91|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-10-11 04:37:18.872085|2017-10-11 04:37:18.872085
NCT00048061|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2016-04-22|2016-02-05||April 2002||2002-04-01|April 2016|2016-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional||The safety population consisted of all participants who were randomized and received at least one dose of the study medication, and who have at least one follow-up data point.|MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis|Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis|Completed||Phase 3|1609|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 04:37:21.894|2017-10-11 04:37:21.894
NCT00048074|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2016-01-04|2016-01-04||June 2002||2002-06-01|January 2016|2016-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional||Safety Population: All participants who were randomized and had at least one dose of study drug, whether withdrawn prematurely or not, and who had at least one follow-up data point were included.|DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis|A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis|Completed||Phase 3|1395|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 04:37:24.539193|2017-10-11 04:37:24.539193
NCT00048087|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2012-07-27|||August 2002||2002-08-01|July 2012|2012-07-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Iressa/Docetaxel in Non-Small-Cell Lung Cancer|A Phase II Study of ZD1839 (Iressa), Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor, in Combination With Docetaxel in Patients With Recurrent or Metastatic Advanced Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-10-11 04:37:26.978234|2017-10-11 04:37:26.978234
NCT00048100|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2012-08-22|||February 2001||2001-02-01|August 2012|2012-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes|Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes for Therapy of Relapsed Leukemia After Allogeneic Stem Cell Therapy|Terminated||Phase 1|2|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-10-11 04:37:27.103995|2017-10-11 04:37:27.103995
NCT00048113|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2007-10-15|||September 2001||2001-09-01|October 2007|2007-10-01||||||||Interventional|||Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease|ISIS 2302-CS20, Phase 3 Double-Masked, Placebo-Controlled Study of Alicaforsen (ISIS 2302), an Antisense Inhibitor of ICAM-1, for the Treatment of Patients With Active Crohn's Disease|Completed||Phase 3|150||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:37:27.216646|2017-10-11 04:37:27.216646
NCT00048126|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2016-11-01|||July 2001||2001-07-01|November 2016|2016-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer|An Open-label Study of the Effect of Continuous Xeloda Therapy in Combination With Irinotecan on Treatment Response in Patients With Advanced and/or Metastatic Colorectal Cancer|Completed||Phase 2|57|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:37:27.338987|2017-10-11 04:37:27.338987
NCT00048139|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2016-11-01|||October 2001||2001-10-01|November 2016|2016-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer|An Open-label Study of the Effect of Intermittent Xeloda in Combination With Irinotecan on Treatment Response in Patients With Advanced and/or Metastatic Colorectal Cancer|Completed||Phase 2|52|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 04:37:27.559554|2017-10-11 04:37:27.559554
NCT00048152|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2016-11-01|||December 2000||2000-12-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients|A Randomized, Open-label Study Comparing the Effects of Low-dose Cyclosporine vs Cyclosporine Withdrawal on Renal Function in Kidney Transplant Patients Treated With CellCept and Daclizumab|Completed||Phase 3|539|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 04:37:27.7228|2017-10-11 04:37:27.7228
NCT00048165|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-24|2016-05-04|2016-05-04||August 1999||1999-08-01|May 2016|2016-05-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional||The randomized population included all participants who were randomized into the study, whether they received the study drug or not.|A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation|A Double-Blind, Placebo -Controlled, Randomized Study to Assess the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation.|Completed||Phase 4|434|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:37:28.012871|2017-10-11 04:37:28.012871
NCT00048217|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-28|2005-06-23||||||July 2004|2004-07-01||||||||Interventional|||A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102||Unknown status|Active, not recruiting|Phase 1/Phase 2|||Trimeris|||||||||||||||||||2017-10-11 04:37:29.862845|2017-10-11 04:37:29.862845
NCT00048256|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-28|2008-03-03|||October 2002||2002-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates|Exploring the Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates|Completed||N/A|57||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:30.298898|2017-10-11 04:37:30.298898
NCT00048282|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-29|2010-05-13||||||January 2006|2006-01-01||||||||Observational|||HIV Prevention Preparedness Study|HIV Prevention Preparedness Study|Completed||N/A|1200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:37:30.372628|2017-10-11 04:37:30.372628
NCT00048295|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-29|2005-06-23|||May 2002||2002-05-01|April 2004|2004-04-01||||||||Interventional|||Alicaforsen (ISIS 2302) in Patients With Active Crohn’s Disease|ISIS 2302-CS21, Phase 3 Double-Masked, Placebo-Controlled Study of Alicaforsen (ISIS 2302), an Antisense Inhibitor of ICAM-1, for the Treatment of Patients With Active Crohn’s Disease|Unknown status|Active, not recruiting|Phase 3|150||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:37:30.477547|2017-10-11 04:37:30.477547
NCT00048308|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-29|2017-02-21|||January 2002|Actual|2002-01-01|February 2017|2017-02-01||||March 2003|Actual|2003-03-01||Interventional|||Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass||Completed||Phase 3|3000||Alexion Pharmaceuticals|||||||||||||||||||2017-10-11 04:37:30.650945|2017-10-11 04:37:30.650945
NCT00048321|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-29|2007-10-15|||January 2002||2002-01-01|October 2007|2007-10-01||||||||Interventional|||ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis|ISIS 104838-CS7, A Double-Blind, Placebo-Controlled, Randomized Trial of the Safety, Efficacy and Pharmacokinetic Profile of ISIS 104838 (TNF-Alpha Antisense Oligonucleotide) Subcutaneous Injections in Active Rheumatoid Arthritis Patients|Completed||Phase 2|160||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:37:31.278079|2017-10-11 04:37:31.278079
NCT00048334|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-29|2017-10-05|||October 26, 2002||2002-10-26|January 7, 2014|2014-01-07|April 1, 2010|Actual|2010-04-01|April 1, 2010|Actual|2010-04-01||Interventional|||Depsipeptide to Treat Thyroid and Other Advanced Cancers|Phase I Trial of Romidepsin Given on Days One, Three, and Five in Patients With Thyroid and Other Advanced Cancers|Completed||Phase 1|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:37:31.396888|2017-10-11 04:37:31.396888
NCT00048347|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-29|2010-08-30|2010-07-06||October 2002||2002-10-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|June 2008|Actual|2008-06-01||Interventional|||Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis|An Open-Label, Pilot Study of Type I Interferon (AVONEX) Treatment of Ulcerative Colitis|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)|While this study was designed as a proof-of-concept pilot trial to correlate changes in IL-13 and other cytokines with clinical response, efficacy was measured. The efficacy estimate is limited by the open-label design.|1|||f||||f||||||||||2017-10-11 04:37:31.47184|2017-10-11 04:37:31.47184
NCT00048360|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-30|2013-02-11|||October 2002||2002-10-01|February 2013|2013-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults|An 8-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Comparison of Extended-Release Bupropion Hydrochloride 300-450 mg/Day to Assess the Efficacy, Safety, and Effects on Health Outcomes in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|162||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:37:31.640524|2017-10-11 04:37:31.640524
NCT00048373|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-30|2006-08-22|||October 2001||2001-10-01|August 2006|2006-08-01|April 2004||2004-04-01|||||Interventional|||Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL|Treatment of Resistant Langerhans Cell Histiocytosis With Etanercept (ENBREL, IMMUNEX, SEATTLE)|Completed||Phase 2|20||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:37:31.740699|2017-10-11 04:37:31.740699
NCT00048386|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-30|2012-07-26|||November 1999||1999-11-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|December 2004|Actual|2004-12-01||Interventional|CYCHE2||Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy|A Pilot Study of Gene Modified Autologous Neuroblastoma Vaccine for the Post-Chemotherapy Treatment of High-Risk Neuroblastoma|Completed||Phase 1|13|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:37:31.991784|2017-10-11 04:37:31.991784
NCT00048399|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-30|2007-04-09|||December 2000||2000-12-01|April 2007|2007-04-01||||||||Interventional|||Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H|Phase I/II Study of Allogeneic Stem Cell Transplantation For Patients With Graft Failure Following Allogeneic Transplantation Using MHC Identical or Near Identical Donors and Submyeloablative Conditioning With CAMPATH 1H (CAMGRAFT)|Terminated||Phase 1/Phase 2|40||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:37:32.065371|2017-10-11 04:37:32.065371
NCT00048412|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-30|2007-04-09|||June 2000||2000-06-01|April 2007|2007-04-01||||||||Interventional|||Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H|Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancy, Using MHC Identical or Near Identical Donors and Sub-Myeloablative Conditioning With CAMPATH 1H (DIMSUM)|Completed||Phase 1/Phase 2|40||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:37:32.129941|2017-10-11 04:37:32.129941
NCT00048425|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-31|2006-12-14|||September 2002||2002-09-01|December 2006|2006-12-01|December 2004||2004-12-01|||||Interventional|||Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.|Randomized, Multicenter Evaluation of Intravenous Levosimendan Efficacy Versus Placebo in the Short Term Treatment of Decompensated Chronic Heart Failure: the REVIVE II Study.|Completed||Phase 3|600||Abbott|||||||||||||||||||2017-10-11 04:37:32.257631|2017-10-11 04:37:32.257631
NCT00048438|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-31|2006-08-10|||February 2002||2002-02-01|August 2006|2006-08-01||||||||Interventional|||Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)|Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)|Completed||Phase 3|68||Abbott|||||||||||||||||||2017-10-11 04:37:32.749247|2017-10-11 04:37:32.749247
NCT00048451|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-31|2006-07-31|||February 2002||2002-02-01|July 2006|2006-07-01||||||||Interventional|||Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)|Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)|Completed||Phase 3|68||Abbott|||||||||||||||||||2017-10-11 04:37:32.861355|2017-10-11 04:37:32.861355
NCT00048464|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-31|2006-11-06|||October 2002||2002-10-01|March 2005|2005-03-01||||||||Interventional|||T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant|A Phase I/II Study of Xcellerated T Cells After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma|Unknown status|Active, not recruiting|Phase 1/Phase 2|35||Xcyte Therapies|||||||||||||||||||2017-10-11 04:37:32.966228|2017-10-11 04:37:32.966228
NCT00048477|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-31|2008-03-03|||October 2002||2002-10-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Effects of Nitrite on Blood Vessel Dilation in Normal Volunteers|Determination of Nitrite as a Source of Bioactive Nitric Oxide in Human Subjects|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:33.054228|2017-10-11 04:37:33.054228
NCT00048490|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-31|2008-03-03|||October 2002||2002-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Transcranial Magnetic Stimulation to Treat Epilepsy|Drug-Refractory Neocortical Epilepsy: rTMS Treatment|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:37:33.125836|2017-10-11 04:37:33.125836
NCT00048503|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-01|2010-04-23|||June 2002||2002-06-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older|An Open-label, Phase 2 Study of the Farnesyl Transferase Inhibitor ZARNESTRA (R115777) as Post-consolidation Therapy for Acute Myeloid Leukemia (AML) in Patients Age 60 Years and Older.|Completed||Phase 2|88|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:37:33.201667|2017-10-11 04:37:33.201667
NCT00048516|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-01|2006-07-31|||February 2002||2002-02-01|July 2006|2006-07-01||||||||Interventional|||Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)|Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)|Completed||Phase 3|68||Abbott|||||||||||||||||||2017-10-11 04:37:33.309261|2017-10-11 04:37:33.309261
NCT00048529|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-01|2005-06-23|||September 2002||2002-09-01|April 2004|2004-04-01||||||||Interventional|||Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus||Suspended||Phase 2|70||Tularik|||||||||||||||||||2017-10-11 04:37:33.413544|2017-10-11 04:37:33.413544
NCT00048542|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-01|2011-08-18|2009-12-07||September 2002||2002-09-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|January 2005|Actual|2005-01-01||Interventional|||Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis|Completed||Phase 3|171|Actual|Abbott||8|||f||||t||||||||||2017-10-11 04:37:33.575736|2017-10-11 04:37:33.575736
NCT00048555|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-01|2013-09-12|||November 2002||2002-11-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma|A Phase I/II Trial of IDEC-114 (Anti-CD80 Monoclonal Antibody) in Combination With Rituxan® for Patients With Relapsed or Refractory, Follicular Lymphoma|Completed||Phase 1/Phase 2|90|Actual|Biogen||1|||f||||f||||||||||2017-10-11 04:37:37.060349|2017-10-11 04:37:37.060349
NCT00048568|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-02|2011-10-26|2011-03-28||December 2002||2002-12-01|October 2011|2011-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy With Methotrexate Versus Methotrexate Alone in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate|Completed||Phase 3|1250|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 04:37:37.843926|2017-10-11 04:37:37.843926
NCT00048581|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-02|2011-11-14|2011-04-07||December 2002||2002-12-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.|A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BMS-188667 in Subjects With Active Rheumatoid Arthritis on Background Disease Modifying Anti-Rheumatic Drugs (DMARDS) Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy|Completed||Phase 3|738|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 04:37:53.135806|2017-10-11 04:37:53.135806
NCT00048594|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-04|2017-05-02|||January 3, 2002|Actual|2002-01-03|May 2017|2017-05-01|December 22, 2003|Actual|2003-12-22|December 18, 2003|Actual|2003-12-18||Interventional|||Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)|A Double-Blind, Placebo-Controlled, Multicenter Study of the Long-Term Efficacy of MK0869 in the Maintenance of Antidepressant Effect in Patients With Major Depressive Disorder|Completed||Phase 3|800|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:38:00.674663|2017-10-11 04:38:00.674663
NCT00048607|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-04|2017-05-02|||July 30, 2002|Actual|2002-07-30|May 2017|2017-05-01|December 31, 2003|Actual|2003-12-31|December 31, 2003|Actual|2003-12-31||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)|A Double-Blind, Multicenter, Placebo and Active-Controlled, Acute Extension Study of 2 Doses of MK-0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|600|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:38:00.876147|2017-10-11 04:38:00.876147
NCT00048620|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-04|2006-11-02|||September 2000||2000-09-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI|Double-Blind,2 Dose Group Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI|Completed||Phase 1|||BioMarin Pharmaceutical|||||||||||||||||||2017-10-11 04:38:00.952474|2017-10-11 04:38:00.952474
NCT00048633|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-04|2012-05-22|||November 2001||2001-11-01|May 2012|2012-05-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer||Completed||Phase 2|30||QLT Inc.||1|||f||||||||||||||2017-10-11 04:38:01.016492|2017-10-11 04:38:01.016492
NCT00048646|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-04|2014-09-17|||May 2002||2002-05-01|September 2014|2014-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Progesterone Treatment of Blunt Traumatic Brain Injury|ProTECT: Single Center, Phase II (Pilot), Double Blind, 4:1 Randomized, Placebo Controlled Clinical Trial for Progesterone Treatment of Moderate and Severe Blunt TBI|Completed||Phase 1/Phase 2|100|Actual|Emory University||2|||f||||t||||||||||2017-10-11 04:38:01.100959|2017-10-11 04:38:01.100959
NCT00048672|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-05|2016-01-19|||March 2001||2001-03-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|November 2002|Actual|2002-11-01||Interventional|||Therapy of Early Chronic Phase CML With Gleevec|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Gleevec (STI571)|Completed||Phase 2|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:01.366109|2017-10-11 04:38:01.366109
NCT00048685|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-05|2008-03-03|||November 2002||2002-11-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Study of Oral Bacteria in Patients With Dry Mouth|Incidence and Frequency of Cariogenic Microflora in Patients With Clinical Xerostomia and Autoimmune Disease|Completed||N/A|44||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:01.463113|2017-10-11 04:38:01.463113
NCT00048698|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-05|2008-03-03|||November 2002||2002-11-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Effects of Direct Current Brain Stimulation on Cognition|A Phase I Trial of Focal DC Brain Polarization|Completed||Phase 1|170||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:01.547862|2017-10-11 04:38:01.547862
NCT00048711|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-06|2009-08-24|||March 2002||2002-03-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|||||Interventional|||Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI|Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI|Completed||Phase 2|||BioMarin Pharmaceutical|||||||||||||||||||2017-10-11 04:38:01.618121|2017-10-11 04:38:01.618121
NCT00048724|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-06|2017-03-07|2009-04-23||June 2002||2002-06-01|March 2017|2017-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)|PEG-Intron as Maintenance Therapy vs. an Untreated Control Group in Adult Subjects With Compensated Cirrhosis (METAVIR F4), Secondary to Chronic Hepatitis C, Who Have Failed to Respond to Therapy With Any Alpha Interferon Plus Ribavirin|Completed||Phase 3|631|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:38:01.7182|2017-10-11 04:38:01.7182
NCT00048737|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-06|2013-06-11|2013-04-22||October 2002||2002-10-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies|Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies|Completed||Phase 1/Phase 2|70|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:03.855591|2017-10-11 04:38:03.855591
NCT00048750|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-06|2012-03-26|||January 2003||2003-01-01|March 2008|2008-03-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU|A Phase 3, Randomized,Double-Blind, Comparative Study of Micafungin (FK463) Versus Placebo as Preemptive Prophylactic Antifungal Therapy in Patients in the Intensive Care Unit|Terminated||Phase 3|104|Actual|Astellas Pharma Inc||2||Inadequate enrollment|f||||t||||||||||2017-10-11 04:38:04.42859|2017-10-11 04:38:04.42859
NCT00048763|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-07|2005-07-14|||October 2001||2001-10-01|July 2005|2005-07-01|June 2003||2003-06-01|||||Interventional|||Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon||Completed||Phase 4|75||Otsuka America Pharmaceutical|||||||||||||||||||2017-10-11 04:38:04.651282|2017-10-11 04:38:04.651282
NCT00048776|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-07|2005-07-14|||October 2001||2001-10-01|July 2005|2005-07-01|June 2003||2003-06-01|||||Interventional|||Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon||Completed||Phase 4|75||Otsuka America Pharmaceutical|||||||||||||||||||2017-10-11 04:38:04.773406|2017-10-11 04:38:04.773406
NCT00048789|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-07|2017-06-30|||November 4, 2002||2002-11-04|January 29, 2009|2009-01-29|January 29, 2009||2009-01-29|||||Interventional|||Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease|Treatment of Chronic Graft Versus Host Disease With Extracorporeal Photopheresis|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:38:04.960594|2017-10-11 04:38:04.960594
NCT00048802|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-08|2014-01-21|||August 2002||2002-08-01|January 2014|2014-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Treatment and Outcome of Early Onset Bipolar Disorder|Treatment and Outcome of Early Onset Bipolar Disorder|Completed||Phase 4|40||Northwell Health|||||f||||||||||||||2017-10-11 04:38:05.045395|2017-10-11 04:38:05.045395
NCT00048828|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-08|2013-07-01|||October 2001||2001-10-01|July 2013|2013-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Treating Drug-Resistant Childhood Schizophrenia|Treating Refractory Childhood Schizophrenia|Completed||Phase 4|41|Actual|Northwell Health||2|||f||||||||||||||2017-10-11 04:38:05.24899|2017-10-11 04:38:05.24899
NCT00048841|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-08|2010-03-01|||May 2002||2002-05-01|March 2010|2010-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Prevention of Osteoporosis in Men With Prostate Cancer|Prevention of Osteoporosis in Men With Prostate Cancer|Completed||Phase 3|112||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:38:05.369503|2017-10-11 04:38:05.369503
NCT00048854|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-08|2016-01-11|||September 2001||2001-09-01|January 2016|2016-01-01|January 2008|Actual|2008-01-01|June 2007|Actual|2007-06-01||Interventional|||Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder|Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder|Completed||Phase 1/Phase 2|66|Actual|Yale University||2|||f||||t||||||||||2017-10-11 04:38:05.449137|2017-10-11 04:38:05.449137
NCT00048880|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-08|2017-06-30|||November 5, 2002||2002-11-05|March 5, 2010|2010-03-05|July 2, 2008|Actual|2008-07-02|July 2, 2008|Actual|2008-07-02||Interventional|||Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein|Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy|Completed||Phase 1|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:38:05.551431|2017-10-11 04:38:05.551431
NCT00049088|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-01-23|||August 2002||2002-08-01|January 2013|2013-01-01||||February 2009|Actual|2009-02-01||Interventional|||Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors|A Phase 1 Study of PS-341 in Combination With Docetaxel in Patients With Advanced Solid Tumors|Terminated||Phase 1|24|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:38:13.719776|2017-10-11 04:38:13.719776
NCT00048893|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-08|2012-03-20|2011-10-25||November 2002||2002-11-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer|A Multicenter Phase I-II Study of Tumor Vaccine Following Chemotherapy in Patients With Metastatic Breast Cancer Untreated With Chemo/Radiation in the Previous 18 Months: Vaccine-Induced Bias of T-Cell Repertoire Reconstitution After T-Cell Re-Infusion|Terminated||Phase 1/Phase 2|37|Actual|National Institutes of Health Clinical Center (CC)|The study was closed to accrual due to very poor enrollment. No meaningful data analysis was possible on the small number of accrued subjects, so none was done.|1||The study was closed to accrual due to very poor enrollment.|f||||t||||||||||2017-10-11 04:38:05.641191|2017-10-11 04:38:05.641191
NCT00048906|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-08|2008-03-03|||November 2002||2002-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Alpha-Galactosidase A Replacement Therapy for Fabry Disease|A Safety and Pharmacokinetic Study of Replagal Enzyme Replacement Therapy in Patients With Fabry Disease|Completed||Phase 2|3||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:06.197181|2017-10-11 04:38:06.197181
NCT00048932|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-11|2011-11-15|2011-04-01||December 2002||2002-12-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis||Completed||Phase 3|1795|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 04:38:06.334562|2017-10-11 04:38:06.334562
NCT00048945|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2017-02-16|||January 2002|Actual|2002-01-01|February 2017|2017-02-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B||Completed||Phase 3|820|Actual|Hoffmann-La Roche|||||||||||||||||||2017-10-11 04:38:10.557921|2017-10-11 04:38:10.557921
NCT00048958|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2017-08-07|||June 1984||1984-06-01|August 2017|2017-08-01||||January 2100|Anticipated|2100-01-01||Observational|||Cytogenetic Studies in Acute Leukemia and Multiple Myeloma|Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients|Active, not recruiting||N/A|9000|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     Institutions must submit patient samples (eg, bone marrow and peripheral blood) at diagnosis,     at complete remission, and at the time of relapse to the Alliance-Approved Institutional     Cytogeneticist.   "|||2017-10-11 04:38:10.841397|2017-10-11 04:38:10.841397
NCT00048971|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2016-07-01|||April 2002||2002-04-01|July 2016|2016-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy|A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin|Completed||N/A|308|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"     blood specimens   "|||2017-10-11 04:38:11.433382|2017-10-11 04:38:11.433382
NCT00048984|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-06-20|||January 2003||2003-01-01|June 2013|2013-06-01||||February 2013|Actual|2013-02-01||Observational|||Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma|A Groupwide Biology and Banking Study for Ewing Sarcoma|Completed||N/A|637|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     Paraffin-embedded blocks of tumor tissue or slides of tumor tissue, and blood specimens   "|||2017-10-11 04:38:11.715664|2017-10-11 04:38:11.715664
NCT00048997|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2016-12-30|2014-09-30||September 2002||2002-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2008|Actual|2008-12-01||Interventional||All eligible patients with consent.|Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer|A Phase III Comparison Of Prophylactic Cranial Irradiation (PCI) Versus Observation In Patients With Locally Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|356|Actual|Radiation Therapy Oncology Group|This study stopped accrual early due to unmet accrual goals.|2|||f||||t||||||||||2017-10-11 04:38:11.835549|2017-10-11 04:38:11.835549
NCT00049010|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2016-06-30|||September 2002||2002-09-01|June 2016|2016-06-01|October 2009|Actual|2009-10-01|March 2006|Actual|2006-03-01||Interventional|||Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma|Prospective Study of Melastatin Expression in Predicting the Risk for Developing Local Regional Metastases of Primary Melanoma|Completed||N/A|314|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:38:12.214421|2017-10-11 04:38:12.214421
NCT00049023|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2016-06-17|||January 2002||2002-01-01|June 2016|2016-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors|A Phase I, Open Label, Maximum Tolerated Dose-Finding Study to Evaluate the Safety and Tolerability of 90Y-DOTA-tyr3-Octreotide Administered by Intravenous Infusion to Children With Refractory Somatostatin-Receptor Positive Tumors|Completed||Phase 1|27|Actual|University of Iowa||1|||f||||t||||||||||2017-10-11 04:38:12.396873|2017-10-11 04:38:12.396873
NCT00049036|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2014-04-28|2011-05-23||March 2003||2003-03-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|A Randomized Phase II Trial of EPOCH Given Either Concurrently or Sequentially With Rituximab in Patients With Intermediate- or High-Grade HIV-Associated B-cell Non-Hodgkin's Lymphoma|Completed||Phase 2|106|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:38:12.524487|2017-10-11 04:38:12.524487
NCT00049062|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-02-19|||September 2002||2002-09-01|February 2013|2013-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer|A Phase II And Biologic Correlative Study Investigating ARIMIDEX In Combination With IRESSA (ZD1839) In Post-Menopausal Patients With Estrogen Receptor-Positive Metastatic Breast Carcinoma Who Have Previously Failed Hormonal Therapy|Completed||Phase 2|||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 04:38:13.476831|2017-10-11 04:38:13.476831
NCT00049075|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2016-11-25|||August 2002||2002-08-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|July 2005|Actual|2005-07-01||Interventional|||Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia|A Phase II Study of Oral Fludarabine Phosphate in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|128|Actual|Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-10-11 04:38:13.577849|2017-10-11 04:38:13.577849
NCT00039845|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-12|2017-06-30|||June 7, 2002||2002-06-07|April 20, 2009|2009-04-20|April 20, 2009||2009-04-20|||||Observational|||MRI Language Studies in Young Children|fMRI Languages Studies In Young Children|Completed||N/A|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:56.086406|2017-10-11 04:38:56.086406
NCT00049101|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-06-21|||August 2002||2002-08-01|April 2004|2004-04-01|August 2004|Actual|2004-08-01|||||Interventional|||Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer|A Phase I/II Study Of OSI-774 In Combination With Oxaliplatin, And 5-Fluourouracil In Patients With Metastatic Colorectal Carcinoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:13.837255|2017-10-11 04:38:13.837255
NCT00049114|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-06-05|||February 2003||2003-02-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer|A Phase I-II Study of R115777 (ZARNESTRA) Plus Doxorubicin and Cyclophosphamide in Patients With Locally Advanced Breast Cancer and Metastatic Breast Cancer|Completed||Phase 2|62|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:13.928232|2017-10-11 04:38:13.928232
NCT00049127|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2017-08-07|2013-11-25||June 2003|Actual|2003-06-01|August 2017|2017-08-01||||August 2011|Actual|2011-08-01||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor|Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma|Active, not recruiting||Phase 1/Phase 2|64|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:38:14.140271|2017-10-11 04:38:14.140271
NCT00049140|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2014-07-24|||August 2002||2002-08-01|February 2013|2013-02-01||||October 2004|Actual|2004-10-01||Interventional|||EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer|Pilot Study of the Relationship Between EF5 Uptake and Concentration of Oxygen-Related Metabolites in Head and Neck Cancer|Completed||Phase 2|8|Actual|Duke University||1|||f||||||||||||||2017-10-11 04:38:19.329171|2017-10-11 04:38:19.329171
NCT00049166|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-09-27|||October 2002||2002-10-01|September 2013|2013-09-01||||July 2007|Actual|2007-07-01||Interventional|||Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer|A Phase I Study of OSI-774 in Combination With Standard Fractionation Radiation Therapy in Patients With Oral Cavity or Oropharyngeal Cancer Stage II or III and in Combination With Standard Fractionation Radiation Therapy and Low Dose Daily Cisplatin in Patients With Oral Cavity or Oropharyngeal Cancer Stage III and IV|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:38:19.439487|2017-10-11 04:38:19.439487
NCT00049179|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2015-03-05|||April 2003||2003-04-01|March 2015|2015-03-01|October 2010|Actual|2010-10-01|December 2005|Actual|2005-12-01||Interventional|||S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia|A Phase II Study of Gemtuzumab Ozogamicin (Mylotarg) and Standard Dose ARA-C for Patients With Relapsed Acute Myeloid Leukemia (AML)|Completed||Phase 2|33|Actual|Southwest Oncology Group||1|||f||||||||||||||2017-10-11 04:38:19.557637|2017-10-11 04:38:19.557637
NCT00049192|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-06-03|||November 2002||2002-11-01|June 2013|2013-06-01||||November 2005|Actual|2005-11-01||Interventional|||Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A PHASE II STUDY OF G3139 (GENASENSE™, NSC # 683428 IND # 58842) + IMATINIB MESYLATE (GLEEVEC®, STI571) IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA|Completed||Phase 2|43|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:20.05794|2017-10-11 04:38:20.05794
NCT00049218|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2014-05-08|||April 2003||2003-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|June 2007|Actual|2007-06-01||Interventional|||Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase I-II Trial Using Dendritic Cells Transduced With An Adenoviral Vector Containing The p53 Gene To Immunize Patients With Extensive Stage Small Cell Lung Cancer After Standard Chemotherapy|Completed||Phase 1/Phase 2|56|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-10-11 04:38:20.168588|2017-10-11 04:38:20.168588
NCT00049231|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-06-21|||June 2003||2003-06-01|June 2005|2005-06-01|August 2005|Actual|2005-08-01|||||Interventional|||EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer|Evaluation of Hypoxia by EF5 (NSC#684681) Binding in Cervix Cancer|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:20.262424|2017-10-11 04:38:20.262424
NCT00049244|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2017-01-27|||September 2002||2002-09-01|January 2017|2017-01-01||||||||Interventional|||BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer|A Phase I Study of BMS-247550 in Combination With Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With a Taxane and an Anthracycline|Active, not recruiting||Phase 1|||R-Pharm|||||f||||||||||||||2017-10-11 04:38:20.328571|2017-10-11 04:38:20.328571
NCT00049257|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2015-10-01|2011-04-28||October 2002||2002-10-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of Paclitaxel and Carboplatin in the Treatment of Hormone-Refractory Prostate Cancer (HRPC)|Completed||Phase 2|58|Actual|Jonsson Comprehensive Cancer Center|The major weakness of the study is, it is a single-arm non-comparative study. With the small sample size of 58 participants who received treatment, the study does not have the statistical power to make categorical assessments or statements.|1|||f||||t||||||||||2017-10-11 04:38:20.418156|2017-10-11 04:38:20.418156
NCT00049283|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2014-06-05|||September 2002||2002-09-01|January 2013|2013-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer|A Phase I Study of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, OSI-774, in Combination With Docetaxel and Radiation in Locally Advanced Squamous Cell Cancer of the Head and Neck|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:20.942541|2017-10-11 04:38:20.942541
NCT00049296|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2010-06-10|||July 2002||2002-07-01|June 2010|2010-06-01|January 2006|Actual|2006-01-01|December 2004|Actual|2004-12-01||Interventional|||Thalidomide and Docetaxel in Treating Patients With Advanced Cancer|Phase I Pharmacokinetic Trial of Thalidomide and Docetaxel: A Regimen Based on Anti-Angiogenic Therapeutic Principles|Completed||Phase 1|26|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:38:21.065075|2017-10-11 04:38:21.065075
NCT00049309|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2017-02-21|||January 2003||2003-01-01|February 2013|2013-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer|Prostate Cancer: Impact Of Fat And Flaxseed - Modified Diets|Completed||Phase 2|161|Actual|Duke University||4|||f||||t||||||||||2017-10-11 04:38:21.190073|2017-10-11 04:38:21.190073
NCT00040339|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-24|2007-12-26|||May 2002||2002-05-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|||||Interventional|||Hypothermia to Treat Severe Brain Injury|The National Acute Brain Injury Study: Hypothermia II (NABISH II)|Completed||N/A|42||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:39:01.441516|2017-10-11 04:39:01.441516
NCT00049322|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2016-02-17|2016-01-20||June 2003||2003-06-01|February 2016|2016-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery|A Phase II Study Of rhuMAb VEGF (BEVACIZUMAB) In Patients With Hepatocellular Carcinoma Receiving Chemoembolization|Completed||Phase 2|30|Actual|Jonsson Comprehensive Cancer Center|Size of study limits any strong conclusions regarding efficacy.Since this study was first designed and implemented, there have been many advances in the field, including confirmation of proof of principal for anti-angiogenic agents in advanced HCC.|2|||f||||t||||||||||2017-10-11 04:38:21.301003|2017-10-11 04:38:21.301003
NCT00049335|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-01-02|||February 2003||2003-02-01|January 2013|2013-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed|Protocol For Assessment Of Capecitabine For Advanced Colorectal Cancer In Patients Aged 70 Years And Older (And In A Cohort Of Patients Younger Than 60 Years)|Completed||Phase 2|29|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:38:21.910863|2017-10-11 04:38:21.910863
NCT00049348|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2010-11-12|||May 2003||2003-05-01|June 2005|2005-06-01||||October 2005|Actual|2005-10-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer|A Randomized Phase II Study Of Gemcitabine Plus Radiotherapy Vs. Gemcitabine, 5-Fluorouracil And Cisplatin Followed By Radiotherapy And 5-Fluoraracil For Patients With Locally Advanced, Potentially Resectable Pancreatic Adenocarcinoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:38:22.204587|2017-10-11 04:38:22.204587
NCT00049361|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2017-04-17|||January 2004|Actual|2004-01-01|April 2017|2017-04-01|December 7, 2004|Actual|2004-12-07|December 7, 2004|Actual|2004-12-07||Interventional|||Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases|A Phase II Study Of Whole-Brain Radiation Therapy With Thalidomide And Temozolomide In Patients With Newly Diagnosed Brain Metastases|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:38:22.658867|2017-10-11 04:38:22.658867
NCT00049374|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2009-09-23|||September 2002||2002-09-01|September 2009|2009-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Study Of Genasense In Combination With Thalidomide And Dexamethasone In Relapsed And Refractory Multiple Myeloma|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-10-11 04:38:22.757641|2017-10-11 04:38:22.757641
NCT00049387|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2015-04-14|||September 2002||2002-09-01|December 2013|2013-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma|Phase I Trial of R115777 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:22.847608|2017-10-11 04:38:22.847608
NCT00049400|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2015-04-01|||October 2003||2003-10-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|September 2006|Actual|2006-09-01||Interventional|||S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction|A Phase I Pharmacokinetic Study Of Epothilone B Analogue BMS-247550 (NSC 710428D) In Patients With Advanced Malignancies And Varying Levels Of Liver Dysfunction|Completed||Phase 1|78|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:38:22.964764|2017-10-11 04:38:22.964764
NCT00049413|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2011-05-10|||June 2002||2002-06-01|May 2011|2011-05-01|December 2005|Actual|2005-12-01|December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma|Pentostatin, Cyclophosphamide And Rituximab (PCR) For B-Cell Chronic Lymphocytic Leukemia (CLL) And Small B-Cell Lymphocytic Lymphoma (SLL): Four Phase II Trials With Patient Stratification Based On Prior Therapy|Completed||Phase 2|||Hoag Memorial Hospital Presbyterian|||||f||||f||||||||||2017-10-11 04:38:23.216793|2017-10-11 04:38:23.216793
NCT00049439|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2010-06-09|||March 1998||1998-03-01|June 2010|2010-06-01|February 2008|Actual|2008-02-01|October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma|Dose-Modified Oral Combination Chemotherapy In Patients With Aids-Related Non-Hodgkin's Lymphoma In The United States And Africa|Completed||Phase 2|54|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:38:23.320396|2017-10-11 04:38:23.320396
NCT00049452|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2014-01-03|||December 2001||2001-12-01|April 2007|2007-04-01|August 2008|Actual|2008-08-01|||||Interventional|||Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer|A Randomized, Placebo Controlled Trial Of Zoledronic Acid For The Prevention Of Bone Loss In Premenopausal Women With Early Stage Breast Cancer|Completed||Phase 3|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:23.463257|2017-10-11 04:38:23.463257
NCT00049465|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2010-09-17|||August 1998||1998-08-01|September 2010|2010-09-01||||February 2005|Actual|2005-02-01||Interventional|||Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer|Multi-Site Randomized Clinical Trial Comparing Standard Recovery Preparation to Extended Recovery Preparation to Enhance Long Term Function After Marrow or Stem Cell Transplant|Completed||N/A|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:38:23.55899|2017-10-11 04:38:23.55899
NCT00049504|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2017-04-10|2017-04-10||January 2002|Actual|2002-01-01|April 2017|2017-04-01|February 2014|Actual|2014-02-01|March 2011|Actual|2011-03-01||Interventional|||Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer|Nonmyeloablative Hematopoietic Stem Cell Transplantation for Patients With High-Risk Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression Before and After Transplantation|Completed||Phase 2|53|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||f||||||No|Individual patient data is protected by HIPAA at each participant organization.|2017-10-11 04:38:23.702468|2017-10-11 04:38:23.702468
NCT00049517|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2016-12-01|2013-01-10||December 2002||2002-12-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|March 2009|Actual|2009-03-01||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia|A Phase III Trial in Adult Acute Myeloid Leukemia: Daunorubicin Dose-Intensification Prior to Risk-Allocated Autologous Stem Cell Transplantation|Active, not recruiting||Phase 3|657|Actual|Eastern Cooperative Oncology Group||6|||f||||t||||||||||2017-10-11 04:38:24.105876|2017-10-11 04:38:24.105876
NCT00049530|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2015-10-06|2014-01-30||September 2003||2003-09-01|May 2014|2014-05-01|June 2014|Actual|2014-06-01|August 2012|Actual|2012-08-01||Interventional||The primary analysis population was all eligible (meeting all eligibility criteria listed in protocol) and treated patients (receiving at least one dose of the protocol therapy). All baseline analysis and efficacy endpoints are based on the primary population (n=29).|PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma|Phase II Study of Low Dose Peginterferon Alfa-2b in Patients With Metastatic Melanoma Over-Expressing Basic Fibroblast Growth Factor|Completed||Phase 2|32|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:38:25.279918|2017-10-11 04:38:25.279918
NCT00049543|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2014-12-19|2014-12-19||September 2002||2002-09-01|March 2014|2014-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery|A Phase III Prospective Randomized, Double-Blind, Placebo-Controlled Trial of the Epidermal Growth Factor Receptor Antagonist, ZD1839 (IRESSA) in Completely Resected Primary Stage IB, II and IIIA Non-Small Cell Lung Cancer|Completed||Phase 3|503|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 04:38:25.811498|2017-10-11 04:38:25.811498
NCT00049556|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-06-18|||October 2002||2002-10-01|January 2006|2006-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Gefitinib in Treating Patients With Cervical Cancer|Phase II Pilot Study of Clinical Activity and Proteomic Pathway Profiling of the EGFR Inhibitor, ZD1839 (Iressa; Gefitinib), in Patients With Epithelial Ovarian Cancer or Cervical Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:38:26.862601|2017-10-11 04:38:26.862601
NCT00049569|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-10-07|||January 2003||2003-01-01|October 2013|2013-10-01||||March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia|Intensive Induction Therapy for Children With Acute Lymphoblastic Leukemia (ALL) Who Experience a Bone Marrow Relapse|Completed||N/A|126|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:38:26.965339|2017-10-11 04:38:26.965339
NCT00049582|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-09-27|||September 2002||2002-09-01|September 2013|2013-09-01||||June 2010|Actual|2010-06-01||Interventional|||Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia|Phase I Study of 5-Aza-2'-Deoxycytidine (Decitabine) as a Biologic Modifier of Retinoid Responsive Genes in Patients With High-Risk Myelodysplastic Syndromes and Acute Myelogenous Leukemia (De-novo, Relapsed or Secondary)|Terminated||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:27.102669|2017-10-11 04:38:27.102669
NCT00049595|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2017-07-26|||August 2002||2002-08-01|July 2017|2017-07-01||||January 2010|Actual|2010-01-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma|BEACOPP (4 Cycles Escalated + 4 Cycles Baseline) Versus ABVD (8 Cycles) In Stage III & IV Hodgkin's Lymphoma|Active, not recruiting||Phase 3|552|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 04:38:27.267901|2017-10-11 04:38:27.267901
NCT00049608|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-06-17|||July 2002||2002-07-01|April 2007|2007-04-01|August 2011|Actual|2011-08-01|||||Interventional|||Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors|A Phase I Study Of The Effect Of Mistletoe Extract, A Complementary Medicine Botanical, On Pharmacokinetics, Pharmacodynamics And Safety Of Gemcitabine In Patients With Advanced Solid Tumors|Terminated||Phase 1|51|Anticipated|National Cancer Institute (NCI)||||Principal investigator [PI] has left institution.|f||||||||||||||2017-10-11 04:38:27.770083|2017-10-11 04:38:27.770083
NCT00049634|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2010-09-14|||January 2002||2002-01-01|September 2010|2010-09-01||||February 2007|Actual|2007-02-01||Interventional|||Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder|A Phase I/II Study of Immunologically Engineered rhG-CSF Mobilized Peripheral Blood Stem Cells (PBSC) for Allogeneic Transplant From HLA Identical, Related Donors for Treatment of Myeloid Malignancies|Completed||Phase 1/Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-10-11 04:38:27.885573|2017-10-11 04:38:27.885573
NCT00049660|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2012-07-17|||September 2002||2002-09-01|July 2012|2012-07-01||||December 2004|Actual|2004-12-01||Interventional|||Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer|A Randomized Phase II-III Trial Evaluating the Efficacy of Capecitabine and Vinorelbine in Anthracycline and Taxane Pre-Treated Metastatic Breast Cancer|Terminated||Phase 2/Phase 3|47|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:38:28.005911|2017-10-11 04:38:28.005911
NCT00049673|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2015-10-05|||September 2002||2002-09-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|February 2010|Actual|2010-02-01||Interventional|||Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Randomized Phase III Study Of Thalidomide And Prednisone As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients With Multiple Myeloma|Completed||Phase 3|332|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:38:28.12705|2017-10-11 04:38:28.12705
NCT00049686|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-07-17|||April 2002||2002-04-01|September 2003|2003-09-01|January 2008|Actual|2008-01-01|||||Interventional|||VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome|A Phase I Trial Of VNP40101M, A Novel Alkylating Agent, For Patients With Hematologic Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:28.256603|2017-10-11 04:38:28.256603
NCT00049699|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2013-07-17|||October 2002||2002-10-01|March 2004|2004-03-01|January 2008|Actual|2008-01-01|||||Interventional|||VNP40101M in Treating Patients With Advanced or Metastatic Cancer|A Phase I Trial of VNP40101M, a Novel Alkylating Agent, Administered Weekly for Patients With Advanced or Metastatic Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:28.33736|2017-10-11 04:38:28.33736
NCT00038350|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2008-05-05|||January 2002||2002-01-01|May 2008|2008-05-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Effects of Age and Age-Related Diseases on Swallowing|Effects of Age and Age-Related Diseases on Swallowing|Completed||Phase 2|60|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:38:28.42011|2017-10-11 04:38:28.42011
NCT00038363|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2009-01-20|||April 2001||2001-04-01|May 2002|2002-05-01|March 2004|Actual|2004-03-01|||||Interventional|||Comparison of Subacute and Hospital Based Rehabilitation Care|Comparison of Subacute and Hospital Based Rehabilitation Care|Completed||Phase 2|260|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:38:28.501694|2017-10-11 04:38:28.501694
NCT00038376|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2012-07-27|||May 1990||1990-05-01|July 2012|2012-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies|Phase II Study of Interferon Alpha and Isotretinoin in Patients With T-Cell Malignancies|Terminated||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:28.56421|2017-10-11 04:38:28.56421
NCT00038389|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2012-07-27|||January 2002||2002-01-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|October 2004|Actual|2004-10-01||Interventional|||Study of Vioxx and Radiation Therapy for Brainstem Glioma|Phase I Study of Vioxx and Radiation Therapy for Brainstem Glioma|Terminated||Phase 1|8|Actual|M.D. Anderson Cancer Center||1||Unavailability of study drug.|f||||f||||||||||2017-10-11 04:38:28.658161|2017-10-11 04:38:28.658161
NCT00038402|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2012-07-19|||April 2001||2001-04-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|November 2004|Actual|2004-11-01||Interventional|||Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer|Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer|Completed||Phase 3|74|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:28.744956|2017-10-11 04:38:28.744956
NCT00038415|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2012-08-01|||December 2001||2001-12-01|August 2012|2012-08-01|January 2005|Actual|2005-01-01|July 2004|Actual|2004-07-01||Interventional|||A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach|A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach|Terminated||Phase 1/Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Vaccine unavailable.|f||||t||||||||||2017-10-11 04:38:28.852256|2017-10-11 04:38:28.852256
NCT00038428|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2011-07-21|||June 2001||2001-06-01|June 2011|2011-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer||Completed||Phase 2|40||Telik||1|||f||||||||||||||2017-10-11 04:38:28.95396|2017-10-11 04:38:28.95396
NCT00038441|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2012-07-27|||September 1995||1995-09-01|July 2012|2012-07-01|August 2005|Actual|2005-08-01|February 2003|Actual|2003-02-01||Interventional|||Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas|Phase I Trial of Intratumoral Injection of DTI-015 for Recurrent Malignant Gliomas|Completed||Phase 1/Phase 2|39|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:29.020068|2017-10-11 04:38:29.020068
NCT00038454|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-30|2005-06-23||||||April 2003|2003-04-01||||||||Interventional|||Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery|A Phase II, Randomized, Single-Blind, Controlled Clinical Trial to Evaluate the Efficacy and Safety of Hemolink[Tm] (o-Raffinose Cross-Linked Human Hemoglobin) in Subjects Undergoing Primary Coronary Artery Bypass Grafting Surgery|Suspended||Phase 2/Phase 3|180||Hemosol|||||||||||||||||||2017-10-11 04:38:29.094023|2017-10-11 04:38:29.094023
NCT00038467|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2014-04-21|2014-03-05||February 1998||1998-02-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|June 2003|Actual|2003-06-01||Interventional|IES|Intent-to-treat (ITT) population included all participants assigned to the treatment group to which they were randomized, irrespective of the treatment they actually received.|Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer|Randomized Double-Blind Trial In Postmenopausal Women With Primary Breast Cancer Who Have Received Adjuvant Tamoxifen For 2-3 Years, Comparing Subsequent Adjuvant Exemestane Treatment With Further Tamoxifen|Completed||Phase 3|4740|Actual|Pfizer|Other AEs included both SAEs and AEs. Non-SAE could not be presented separately for this study as AEs were collected in clinical database where SAE flags were not collected.|2|||f||||t||||||||||2017-10-11 04:38:29.619859|2017-10-11 04:38:29.619859
NCT00038480|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2012-05-17||||||May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants|A Phase I/II Study of Lopinavir/Ritonavir in HIV-1 Infected Infants Less Than 6 Months of Age|Completed||Phase 1|31|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:38:35.403472|2017-10-11 04:38:35.403472
NCT00038493|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2012-01-20|||September 2001||2001-09-01|January 2012|2012-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme|Phase II Evaluation Temozolomide and Farnesyl Transferase Inhibitor (SCH66336) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme|Terminated||Phase 2|23|Actual|M.D. Anderson Cancer Center||||Lack of Accrual|f||||f||||||||||2017-10-11 04:38:35.52513|2017-10-11 04:38:35.52513
NCT00038506|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2015-04-06|||March 2002||2002-03-01|October 2010|2010-10-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure|A Phase IV, Open-label, Multicenter Study of Treatment With TRIZIVIR (Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg) Twice Daily and Tenofovir 300mg Once-daily for 48 Weeks in HIV-infected Subjects Experiencing Early Virologic Failure (ZIAGEN Intensification Protocol)|Completed||Phase 4|100||ViiV Healthcare||1|||||||||||||||||2017-10-11 04:38:35.587235|2017-10-11 04:38:35.587235
NCT00038519|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2006-07-27|||April 2001||2001-04-01|July 2006|2006-07-01||||||||Interventional|||Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor|An Open Label, Phase II Study of Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra (Lopinavir/Ritonavir) as Their Second Protease Inhibitor.|Completed||Phase 2/Phase 3|16||Abbott|||||||||||||||||||2017-10-11 04:38:35.706796|2017-10-11 04:38:35.706796
NCT00038532|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2008-03-29|||April 2001||2001-04-01|July 2006|2006-07-01||||||||Interventional|||Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART|An Open Label, Phase II Study of Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART|Completed||Phase 2|24||Abbott|||||||||||||||||||2017-10-11 04:38:36.066829|2017-10-11 04:38:36.066829
NCT00038545|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2012-01-20|||May 2001||2001-05-01|January 2012|2012-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Patients With Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|25|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-10-11 04:38:36.248732|2017-10-11 04:38:36.248732
NCT00049881|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2016-02-17|||April 2002||2002-04-01|January 2005|2005-01-01|March 2004|Actual|2004-03-01|||||Observational|||Genetic Determinants:Low HDL, High Triglycerides, Obesity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:39:05.721784|2017-10-11 04:39:05.721784
NCT00038558|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2012-07-27|||November 2001||2001-11-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|February 2004|Actual|2004-02-01||Interventional|||Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy|Prophylactic Use of Filgrastim SD/01 In Patients With Hodgkin's Disease Receiving ABVD Chemotherapy|Completed||Phase 3|25|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:38:36.326686|2017-10-11 04:38:36.326686
NCT00038571|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2012-07-27|||May 2002||2002-05-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy|Phase II Study of Proteasome Inhibitor PS-341 For Patients With Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 04:38:36.447944|2017-10-11 04:38:36.447944
NCT00038584|ClinicalTrials.gov processed this data on October 10, 2017|2002-05-31|2012-07-31|||June 1999||1999-06-01|July 2012|2012-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer|A Phase IB Study of Oral Administration of SCH 66336 Preoperatively in Patients With Head and Neck Squamous Cell Cancer Scheduled for Definitive Therapy|Completed||Phase 1|37|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:36.548235|2017-10-11 04:38:36.548235
NCT00038597|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-03|2012-01-20|||April 2001||2001-04-01|January 2012|2012-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)|Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)|Completed||Phase 2|13|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-10-11 04:38:36.609408|2017-10-11 04:38:36.609408
NCT00038610|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-03|2015-08-19|2015-08-19||March 2001||2001-03-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia|Phase II Study of Hyper-CVAD Plus Imatinib Mesylate (Gleevec, STI571) for Philadelphia-Positive Acute Lymphocytic Leukemia|Completed||Phase 2|54|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:36.798986|2017-10-11 04:38:36.798986
NCT00038623|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-03|2011-10-31|||April 2002||2002-04-01|October 2011|2011-10-01|February 2010|Actual|2010-02-01|December 2007|Actual|2007-12-01||Interventional|||Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma|A Phase II Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma|Completed||Phase 2|35|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:37.162989|2017-10-11 04:38:37.162989
NCT00038636|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-03|2006-08-13|||September 2000||2000-09-01|August 2006|2006-08-01||||||||Interventional|||A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors|A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors|Completed||Phase 3|36||Abbott|||||||||||||||||||2017-10-11 04:38:37.25329|2017-10-11 04:38:37.25329
NCT00038662|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-03|2006-08-10|||May 2002||2002-05-01|August 2006|2006-08-01||||||||Interventional|||Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure|A Phase 2 Study Evaluating the Safety and Efficacy of Atrasentan (ABT-627) in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure|Completed||Phase 2|200||Abbott|||||||||||||||||||2017-10-11 04:38:37.429483|2017-10-11 04:38:37.429483
NCT00038675|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-04|2013-12-10|||June 2001||2001-06-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate|Therapy of Hypereosinophilic Syndrome, Polycythemia Vera, Atypical CML or CMML With Platelet Derived Growth Factor (PDGF-R) Fusion Genes, or Mastocytosis With Imatinib Mesylate (STI571)|Completed||N/A|125|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:38:37.571683|2017-10-11 04:38:37.571683
NCT00038688|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-04|2009-10-29||||||March 2006|2006-03-01||||||||Interventional|||A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts|A Phase III Randomized Study to Evaluate the Efficacy of a Network-Oriented Peer Education Intervention for the Prevention of HIV Transmission Among Injection Drug Users and Their Network Members|Completed||Phase 3|2610||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:38:37.662507|2017-10-11 04:38:37.662507
NCT00038701|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-04|2012-07-27|||August 2000||2000-08-01|July 2012|2012-07-01|May 2004|Actual|2004-05-01|July 2002|Actual|2002-07-01||Interventional|||Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas|Phase II Study of Gemcitabine-Based Chemoradiation and TNP-470 for Patients With Locally Advanced, Nonmetastatic Adenocarcinoma of the Pancreas|Terminated||Phase 2|6|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-10-11 04:38:37.742734|2017-10-11 04:38:37.742734
NCT00038714|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-04|2007-06-26|||November 2001||2001-11-01|June 2007|2007-06-01|January 2004||2004-01-01|||||Interventional|||A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis|A Phase II Trial of SGN-00101 In The Treatment of Pediatric Recurrent Respiratory Papillomatosis|Completed||Phase 2|27|Anticipated|Nventa Biopharmaceuticals Corporation|||||||||||||||||||2017-10-11 04:38:37.82806|2017-10-11 04:38:37.82806
NCT00038753|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-04|2009-10-15||||||October 2009|2009-10-01||||||||Interventional|||Vision In Preschoolers Study (VIP Study)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-10-11 04:38:38.046455|2017-10-11 04:38:38.046455
NCT00038766|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-08-22|||June 2002||2002-06-01|August 2012|2012-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|CD02||CNI-1493 for Treatment of Moderate to Severe Crohn's Disease|A Randomized, Double-Blind, Placebo-controlled Study of CNI-1493 for Treatment of Moderate to Severe Crohn's Disease|Terminated||Phase 2|33|Actual|Ferring Pharmaceuticals||3||Unable to enroll into study.|f||||f||||||||||2017-10-11 04:38:38.131712|2017-10-11 04:38:38.131712
NCT00038779|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-08-03|||August 1996||1996-08-01|August 2012|2012-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States|Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States|Terminated||N/A|7|Actual|M.D. Anderson Cancer Center||1||Lack of Accrual|f||||f||||||||||2017-10-11 04:38:38.26932|2017-10-11 04:38:38.26932
NCT00038792|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-08-01|||October 2000||2000-10-01|August 2012|2012-08-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD|A Phase I/II Trial of Recombinant Human Keratinocyte Growth Factor (rHuKFG) for the Treatment of Steroid Refractory Gastrointestinal Acute Graft-versus-host Disease (aGvHD)|Terminated||Phase 1/Phase 2|7|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-10-11 04:38:38.64727|2017-10-11 04:38:38.64727
NCT00038805|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-07-27|||May 2001||2001-05-01|July 2012|2012-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)|Allogeneic Stem Cell Transplantation Using Mylotarg (CMA-676) Plus Nonmyeloablative Chemotherapy in Older or Medically Infirm Patients With High-Risk Acute Leukemia (ALL), Chronic Myelogenous Leukemia (CML) or Myelodysplastic Syndrome (MDS)|Terminated||Phase 2/Phase 3|3|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:38.724524|2017-10-11 04:38:38.724524
NCT00038818|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-08-22|||May 2001||2001-05-01|August 2012|2012-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation|CD8 Depleted Donor Lymphocyte Infusions for Patients With Relapse Or Residual Disease Following Allogeneic Stem Cell Transplantation|Terminated||N/A|3|Actual|M.D. Anderson Cancer Center||1||Low accrual.|f||||f||||||||||2017-10-11 04:38:38.824227|2017-10-11 04:38:38.824227
NCT00038831|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-07-31|||May 2001||2001-05-01|July 2012|2012-07-01|October 2006|Actual|2006-10-01|March 2005|Actual|2005-03-01||Interventional|||Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS|Phase I/II Evaluation of Safety and Activity of Mylotarg Plus Melphalan and Fludarabine as Preparative Therapy for Older or Medically Infirm Patients Undergoing Allogeneic Bone Marrow and Peripheral Blood Stem Cell Transplantation|Completed||Phase 1/Phase 2|47|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:38.909325|2017-10-11 04:38:38.909325
NCT00038844|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2011-10-31|||June 2001||2001-06-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy of Campath in Nonmyeloablative Transplantation|Safety and Efficacy of Campath in Nonmyeloablative Transplantation|Completed||N/A|65|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:39.064842|2017-10-11 04:38:39.064842
NCT00038857|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-08-07|2012-06-21||September 2001||2001-09-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases|Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases|Completed||Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:39.175721|2017-10-11 04:38:39.175721
NCT00038870|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-08-02|||January 2001||2001-01-01|August 2012|2012-08-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes|Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-10-11 04:38:39.470649|2017-10-11 04:38:39.470649
NCT00038883|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2012-07-27|||April 2001||2001-04-01|July 2012|2012-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies|Campath-1H Snd Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies|Completed||N/A|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:39.555045|2017-10-11 04:38:39.555045
NCT00038896|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2009-08-13|||April 2001||2001-04-01|August 2009|2009-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study Evaluating Venlafaxine ER in Adults With Panic Disorder|A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder|Completed||Phase 3|343|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:38:39.801816|2017-10-11 04:38:39.801816
NCT00038909|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2013-02-07|||September 1994||1994-09-01|February 2013|2013-02-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Study Evaluating ReFacto in Hemophilia A|Factor VIII Mutation Testing Program in Previously Untreated Patients (PUPs) With Hemophilia A Participating in ReFacto® Study|Completed||N/A|103|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:38:39.900409|2017-10-11 04:38:39.900409
NCT00038922|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2006-05-17||||||May 2006|2006-05-01||||||||Interventional|||Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating, Safety and Exploratory Pharmacogenomic Study of Orally Administered Recombinant Human Interleukin Eleven (rhIL-11) in Patients With Mild to Moderate Left-Sided Ulcerative Colitis|Terminated||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:38:39.960241|2017-10-11 04:38:39.960241
NCT00038935|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2008-04-18||||||April 2008|2008-04-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A|A Single Dose, Randomized, Double-Blind, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of B-Domain Deleted Recombinant Human Factor VIII (BDDrFVIII) Manufactured by the Current Process (ReFacto) and by an Albumin Free Manufacturing Process (ReFacto AF)|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:38:40.023836|2017-10-11 04:38:40.023836
NCT00049894|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2016-02-17|||September 2002||2002-09-01|October 2005|2005-10-01|August 2004|Actual|2004-08-01|||||Observational|||Predictors of Recurrent Stroke in the PROGRESS Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:39:05.772012|2017-10-11 04:39:05.772012
NCT00038948|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2010-04-22|2009-05-29||January 2002||2002-01-01|April 2010|2010-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients|A Randomized, Open-label, Comparative Evaluation of Conversion From Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients|Completed||Phase 3|830|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||t||||||||||2017-10-11 04:38:40.148054|2017-10-11 04:38:40.148054
NCT00038961|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2016-08-31|||November 2001||2001-11-01|August 2016|2016-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).|A Multicenter, Randomized, Double-blind, Parallel Group Trial to Demonstrate the Efficacy of Fondaparinux Sodium in Association With Intermittent Pneumatic Compression (IPC) Versus IPC Used Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdomi|Completed||Phase 3|1309|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:38:42.028531|2017-10-11 04:38:42.028531
NCT00038974|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-05|2017-08-02|||August 2002||2002-08-01|August 2017|2017-08-01|November 2005|Actual|2005-11-01|December 2004|Actual|2004-12-01||Interventional|||Hepatitis C Antiviral Resistance in African-Americans|Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)|Completed||Phase 3|401|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t|t|f||||||||2017-10-11 04:38:42.152922|2017-10-11 04:38:42.152922
NCT00038987|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2010-08-26|||May 2002||2002-05-01|December 2003|2003-12-01|August 2002||2002-08-01|||||Interventional|||Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT|A Phase I/II Study to Evaluate the Safety and Preliminary Efficacy of Various Concentrations of Aventis Pasteur's Smallpox Vaccine, USP (APSV) in Vaccinia-naive Adults|Completed||Phase 1/Phase 2|330||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:38:42.278252|2017-10-11 04:38:42.278252
NCT00039000|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2012-09-06|||March 2002||2002-03-01|September 2012|2012-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma|A Phase III Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus Physician's Choice Including Interleukin-2 and/or Dacarbazine/Temozolomide-based Therapy and/or Complete Tumor Resection in Stage IV Melanoma|Completed||Phase 3|350||Agenus Inc.|||||f||||||||||||||2017-10-11 04:38:42.366914|2017-10-11 04:38:42.366914
NCT00039013|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2015-02-23|||March 2002||2002-03-01|January 2015|2015-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin|A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects With Type 2 Diabetes Mellitus Treated With Metformin Alone|Completed||Phase 3|336|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 04:38:42.880372|2017-10-11 04:38:42.880372
NCT00039026|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2015-02-23|||February 2002||2002-02-01|January 2015|2015-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea|A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects With Type 2 Diabetes Mellitus Treated With a Sulfonylurea Alone|Completed||Phase 3|377|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 04:38:43.363745|2017-10-11 04:38:43.363745
NCT00039039|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-12-17|||February 2000||2000-02-01|August 2006|2006-08-01||||||||Interventional|||Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer|Phase III Randomized Study of Paclitaxel and Carboplatin or Cisplatin Followed by Radiotherapy With or Without Concurrent Paclitaxel in Patients With Unresectable Stage III Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:43.704735|2017-10-11 04:38:43.704735
NCT00039052|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-07-17|||January 2002||2002-01-01|March 2003|2003-03-01|July 2008|Actual|2008-07-01|May 2003|Actual|2003-05-01||Interventional|||Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer|An Open Label, Multiple-Dose, Sequential Dose-Escalation Study of NBI-3001 in Patients With Recurrent or Unresponsive Solid Tumors Known to Over-Express IL-4 Receptors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:43.912785|2017-10-11 04:38:43.912785
NCT00039078|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2017-06-22|||August 2000||2000-08-01|June 2017|2017-06-01|August 2000||2000-08-01|August 2000||2000-08-01||Interventional|||Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery|The Use of TheraSphere® for the Treatment of Unresectable Hepatocellular Carcinoma|Withdrawn||Phase 2|0|Actual|University of Pittsburgh||1||Record created in error - not a research study|f|||||f|t|f|f|f|||||2017-10-11 04:38:44.018853|2017-10-11 04:38:44.018853
NCT00039091|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-01-09|||March 2002||2002-03-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer|Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 (Anti-CTLA-4) Humanized Monoclonal Antibody (MDX-CTLA-4 NSC# 732442, Previously 720801) in Patients Previously Vaccinated With GM-CSF-Based Autologous Tumor Vaccines (CTEP Protocol Number P-5708) and Patients With Acute Myelogenous Leukemia/ Myelodysplasia, and Non-Small Cell Lung Cancer Who Have Not Received a Prior Vaccine|Terminated||Phase 1|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:44.123652|2017-10-11 04:38:44.123652
NCT00039104|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01||||January 2005|Actual|2005-01-01||Interventional|||Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer|A Phase II, Open-Label, Randomized Trial of Zoledronic Acid (Zometa™) and BMS-275291 (NSC#713763) in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:38:44.253135|2017-10-11 04:38:44.253135
NCT00049907|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2016-02-17|||September 2002||2002-09-01|January 2006|2006-01-01|August 2004|Actual|2004-08-01|||||Observational|||Cardiac and Renal Disease Study (CARDS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:39:05.820937|2017-10-11 04:39:05.820937
NCT00039117|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2015-12-03|||April 2002||2002-04-01|June 2013|2013-06-01||||September 2003|Actual|2003-09-01||Interventional|||Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia|A Phase I Study of G3139 ( NSC # 683428) in Combination With Cytarabine and Daunorubicin in Previously Untreated Patients With Acute Myeloid Leukemia (AML)&gt;= 60 Years of Age|Completed||Phase 1|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:44.360592|2017-10-11 04:38:44.360592
NCT00039130|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2016-07-01|2014-10-16||May 2002||2002-05-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|September 2010|Actual|2010-09-01||Interventional|||Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia|Phase II Study Of Rituximab And Short Duration, High Intensity Chemotherapy With G-CSF Support In Previously Untreated Patients With Burkitt Lymphoma/Leukemia|Completed||Phase 2|105|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:38:44.793055|2017-10-11 04:38:44.793055
NCT00039156|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2008-07-23|||January 2002||2002-01-01|January 2004|2004-01-01||||||||Interventional|||BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma|An Open Phase II Multi-Center Trial of BAY 59-8862 in Patients With Aggressive Refractory Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:46.205655|2017-10-11 04:38:46.205655
NCT00039169|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2008-07-23|||December 2001||2001-12-01|January 2008|2008-01-01||||||||Interventional|||BAY 59-8862 in Treating Patients With Advanced Kidney Cancer|An Uncontrolled Phase II Multi-Center Trial Evaluating Anti-Tumor Efficacy and Safety of BAY 59-8862 in Patients With Advanced Renal Cell Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:46.316227|2017-10-11 04:38:46.316227
NCT00039182|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-01-23|||May 2002||2002-05-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung|A Phase II Study of Oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:46.441971|2017-10-11 04:38:46.441971
NCT00039195|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2016-06-29|2015-12-15||November 2006||2006-11-01|June 2016|2016-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma|Risk-Adapted Therapy for Patients With Untreated Age-Adjusted International Prognostic Index II or III Diffuse Large B Cell Lymphoma|Completed||Phase 2|98|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:38:46.5894|2017-10-11 04:38:46.5894
NCT00039208|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2012-07-12|||February 2002||2002-02-01|July 2012|2012-07-01||||August 2005|Actual|2005-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Colorectal Cancer|Time Finding Study of Chronomodulated Irinotecan, 5 Fluorouracil, Leucovorin and Oxaliplatin as First or Second Chemotherapy Line Against Metastatic Colorectal Cancer|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:38:46.91241|2017-10-11 04:38:46.91241
NCT00039234|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-12-17|||September 2002||2002-09-01|December 2003|2003-12-01||||||||Interventional|||Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver|A Phase III, Multi-Center Controlled Trial With Stratified Randomization Comparing The Efficacy Of Interleukin-2 (IL-2) Plus Histamine Dihydrochloride (HDC) Versus IL-2 Alone To Increase The Duration Of Survival In Patients With AJCC Stage IV Malignant Melanoma With Hepatic Metastasis|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:47.044642|2017-10-11 04:38:47.044642
NCT00039273|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-01-07|||July 2002||2002-07-01|January 2013|2013-01-01||||May 2003|Actual|2003-05-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer|An Open Label Phase II Clinical Trial To Evaluate The Safety And Efficacy Of ABX-EGF In Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|44|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:38:47.139279|2017-10-11 04:38:47.139279
NCT00039286|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2015-12-23|||October 2001||2001-10-01|December 2015|2015-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer|A Pilot Study To Assess The Utility Of 18F-Fluorodeoxyglucose Positron Emission Tomography (PET) In The Pre-Operative Evaluation Of Patients With Primary And Recurrent Breast Carcinoma|Completed||Phase 1|118|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:38:47.199267|2017-10-11 04:38:47.199267
NCT00039299|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-04-02|||March 2002||2002-03-01|June 2003|2003-06-01|June 2003|Actual|2003-06-01|||||Interventional|||Biological Therapy in Treating Patients With Prostate Cancer|A Phase I Safety Study Of Xcellerate In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:47.288473|2017-10-11 04:38:47.288473
NCT00039312|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2012-07-27|||December 1999||1999-12-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|August 2003|Actual|2003-08-01||Interventional|||Comparison of Screening Tests in Detecting Cervical Neoplasia|Multi-Institutional Prospective Cohort Study For The Comparison Of Different Primary Screening Strategies For The Detection Of Cervical Neoplasia|Completed||N/A|15|Actual|Jonsson Comprehensive Cancer Center|||||f||||f||||||||||2017-10-11 04:38:47.353782|2017-10-11 04:38:47.353782
NCT00039325|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2015-10-01|||March 2002||2002-03-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|September 2005|Actual|2005-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma|A Phase I/II Trial Testing Mart-1 Genetic Immunization In Malignant Melanoma|Completed||Phase 1/Phase 2|28|Actual|Jonsson Comprehensive Cancer Center||5|||f||||t||||||||||2017-10-11 04:38:47.42532|2017-10-11 04:38:47.42532
NCT00039338|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2016-12-02|||March 2002||2002-03-01|December 2016|2016-12-01||||July 2019|Anticipated|2019-07-01||Interventional|||Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer|Randomized Phase III Study Of Neoadjuvant Chemotherapy Followed By Surgery Vs. Concomitant Radiotherapy And Chemotherapy In FIGO Ib2, IIa>4 cm or IIb Cervical Cancer|Active, not recruiting||Phase 3|686|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-10-11 04:38:47.512747|2017-10-11 04:38:47.512747
NCT00039351|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2012-09-20|||March 2002||2002-03-01|September 2012|2012-09-01||||January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma|Diffuse Large B Cell And Peripheral T-Cell Non-Hodgkin's Lymphoma In The Frail Elderly. Progressive And Cautious Treatment Strategy In Poor Status Patients. A Phase II Trial With Emphasis On Geriatric Assessment And Quality Of Life|Completed||Phase 2|32|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:38:47.639871|2017-10-11 04:38:47.639871
NCT00039364|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2012-07-23|||March 2002||2002-03-01|July 2012|2012-07-01||||August 2004|Actual|2004-08-01||Interventional|||Imatinib Mesylate in Treating Patients With Gliomas|Open Label Phase II Study On STI571 (Glivec) Administered As A Daily Oral Treatment In Gliomas|Completed||Phase 2|112|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:38:47.883239|2017-10-11 04:38:47.883239
NCT00039377|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2014-11-13|2013-11-27||April 2002||2002-04-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|April 2012|Actual|2012-04-01||Interventional|||Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|A Phase II Trial of Sequential Chemotherapy, Imatinib Mesylate (Gleevec, STI571) (NSC # 716051), and Transplantation for Adults With Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia by the CALGB and SWOG|Completed||Phase 2|58|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:38:48.032763|2017-10-11 04:38:48.032763
NCT00039390|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-01-24|||April 2002||2002-04-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors|A Phase I Trial of ZD1839 With Capecitabine in Patients With Advanced Solid Tumors (Formerly a Phase I Trial of ZD1839 With Capecitabine and Celecoxib)|Completed||Phase 1|41|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:50.182002|2017-10-11 04:38:50.182002
NCT00039403|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-01-22|||April 2002||2002-04-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer|A Phase I Study Of UCN-01 In Combination With Gemcitabine In Unresectable Or Metastatic Pancreatic Carcinoma|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:50.276206|2017-10-11 04:38:50.276206
NCT00039416|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2014-02-24|||April 2002||2002-04-01|December 2012|2012-12-01||||August 2007|Actual|2007-08-01||Interventional|||Imatinib Mesylate in Treating Patients With Myelofibrosis|A Phase II Study Of Gleevec (Imatinib Mesylate Formerly Known as STI-571) In Patients With Myelofibrosis|Completed||Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:50.373272|2017-10-11 04:38:50.373272
NCT00039429|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2010-01-26|||May 2003||2003-05-01|January 2010|2010-01-01||||April 2006|Actual|2006-04-01||Interventional|||Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer|A Phase II Trial Evaluating Atrasentan In Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|180|Anticipated|Eastern Cooperative Oncology Group|||||||||f||||||||||2017-10-11 04:38:50.533064|2017-10-11 04:38:50.533064
NCT00039442|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2017-08-23|||April 29, 2002|Actual|2002-04-29|August 2017|2017-08-01||||December 7, 2005|Actual|2005-12-07||Interventional|||Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation Of Capecitabine (NSC #712807) In The Treatment Of Persistent Or Recurrent Non-Squamous Cell Carcinoma Of The Cervix|Completed||Phase 2|21|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:38:51.054678|2017-10-11 04:38:51.054678
NCT00039455|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-01-31|||April 2002||2002-04-01|January 2013|2013-01-01||||December 2004|Actual|2004-12-01||Interventional|||Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer|A Phase I Study of Herceptin/Flavopiridol in HER-2 Positive Metastatic Breast Cancer|Terminated||Phase 1|50|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:38:51.14317|2017-10-11 04:38:51.14317
NCT00039468|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2011-10-26|||March 2002||2002-03-01|October 2011|2011-10-01|February 2008|Actual|2008-02-01|September 2007|Actual|2007-09-01||Interventional|||Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy|A Phase II Study Of Thalidomide And CPT-11 (IRINOTECAN) Following Radiotherapy For Glioblastoma Multiforme|Completed||Phase 2|26|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 04:38:51.241415|2017-10-11 04:38:51.241415
NCT00039481|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-01-16|||November 2002||2002-11-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors|A Phase I Trial Of G3139 (BCL-2 Antisense, NSC# 683428, IND# 58842) Combined With Cytotoxic Chemotherapy In Relapsed Childhood Solid Tumors|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:51.328576|2017-10-11 04:38:51.328576
NCT00039494|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-08-01|||December 2002||2002-12-01|August 2013|2013-08-01||||July 2007|Actual|2007-07-01||Interventional|||Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors|A Pilot and Phase II Study of OSI-774 and Temozolomide in Combination With Radiation Therapy in Glioblastoma Multiforme|Completed||Phase 2|171|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:38:51.548454|2017-10-11 04:38:51.548454
NCT00039507|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2010-02-11|||June 2002||2002-06-01|February 2010|2010-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer|Pilot Study: Radiofrequency Ablation Of Resectable Non-Small Cell Lung Cancer|Completed||Phase 2|||Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:38:51.893797|2017-10-11 04:38:51.893797
NCT00039520|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2014-05-05|||January 2002||2002-01-01|May 2014|2014-05-01|July 2008|Actual|2008-07-01|June 2004|Actual|2004-06-01||Interventional|||Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer|A Phase II Trial Of Exisulind With Docetaxel In Patients With Metastatic Adenocarcinoma Of The Breast|Completed||Phase 2|10|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-10-11 04:38:51.961631|2017-10-11 04:38:51.961631
NCT00039546|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-08-06|||August 2001||2001-08-01|May 2005|2005-05-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery|'tAnGo', A Phase III Randomised Trial Of Gemcitabine In Paclitaxel-Containing, Epirubicin-Based, Adjuvant Chemotherapy For ER/PgR-Poor, Early Stage, Breast Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:52.034087|2017-10-11 04:38:52.034087
NCT00039559|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-06-07|||May 2002||2002-05-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer|Ovarian Cancer Screening Pilot Trial in High Risk Women|Unknown status|Active, not recruiting|N/A|2430|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 04:38:52.179563|2017-10-11 04:38:52.179563
NCT00039572|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-06-25|||May 2002||2002-05-01|July 2002|2002-07-01|January 2005|Actual|2005-01-01|||||Interventional|||Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain|A Phase I/II Trial For Neutron Capture Therapy In Glioblastoma Multiforme And Intracranial Melanoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:52.571514|2017-10-11 04:38:52.571514
NCT00039585|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2015-04-29|||May 2002||2002-05-01|February 2007|2007-02-01||||February 2006|Actual|2006-02-01||Interventional|||Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor|Phase II Clinical Trial With Proteomic Profiling Of Imatinib Mesylate (Gleevec; STI571), A PDGFR And C-Kit Inhibitor, In Patients With Refractory Or Relapsed Epithelial Ovarian Cancer, Fallopian Tube And Primary Peritoneal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:38:52.653459|2017-10-11 04:38:52.653459
NCT00039611|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2013-06-18|||May 2002||2002-05-01|July 2002|2002-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|Oxaliplatin (NSC 266046) in Combination With 5-Fluorouracil and Leucovorin (FOLFOX4) for Patients Who Have Not Received Prior Chemotherapy for Advanced Colorectal Cancer|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:38:52.73951|2017-10-11 04:38:52.73951
NCT00039624|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2017-10-05|||May 31, 2002||2002-05-31|September 27, 2017|2017-09-27|June 28, 2010|Actual|2010-06-28|July 29, 2004|Actual|2004-07-29||Interventional|||Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer|A Phase II Study of MR-Guided High Dose Rate Brachytherapy Boosts For Prostate Cancer|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:38:52.844528|2017-10-11 04:38:52.844528
NCT00039650|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2008-03-03|||May 2002||2002-05-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Pilot Study: Effects of G-CSF on T Cell Function|Pilot Study of the Effects of G-CSF on T Cell Function|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:52.935274|2017-10-11 04:38:52.935274
NCT00039663|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2008-03-03|||May 2002||2002-05-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Endothelial Dysfunction as a Risk Factor in HIV Study|Endothelial Dysfunction as a Risk Factor in HIV Study|Completed||Phase 1|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:53.00124|2017-10-11 04:38:53.00124
NCT00039676|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2017-10-05|||June 19, 2002||2002-06-19|June 9, 2017|2017-06-09||||||||Observational|||Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer|Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:53.090592|2017-10-11 04:38:53.090592
NCT00039689|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2017-10-05|||May 20, 2002||2002-05-20|August 23, 2017|2017-08-23||||||||Observational|||Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients|Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-Infected Patients|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:53.175774|2017-10-11 04:38:53.175774
NCT00039702|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2008-03-03|||June 2002||2002-06-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Observational|||Brain Imaging in Alzheimer's Disease|SPECT Imaging of Alpha4beta2 Nicotinic Acetylcholine Receptors Using [123I]5-I-A-85380 in Alzheimer's Disease|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:53.269912|2017-10-11 04:38:53.269912
NCT00039715|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-06|2008-03-03|||June 2002||2002-06-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Observational|||Effects of Hydrocortisone in Patients With Post-Traumatic Stress Disorder|Effect of Hydrocortisone Infusion on Hippocampal Glucose Metabolism, Neuropsychological Test Performance and Reexperiencing Symptoms in Patients With Post-Traumatic Stress Disorder (PTSD)|Completed||N/A|93||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:53.355239|2017-10-11 04:38:53.355239
NCT00039741|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-07|2015-10-26|2011-12-19|2010-08-19|August 2002||2002-08-01|November 2014|2014-11-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children|A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age|Completed||Phase 2/Phase 3|266|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 04:38:53.566469|2017-10-11 04:38:53.566469
NCT00039754|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-07|2009-01-19|||March 2002||2002-03-01|January 2009|2009-01-01||||||||Interventional|||A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma|A Multicenter Dosimetry Trial to Evaluate Radiation Absorbed Dose From Holmium-166-DOTMP in Patients With Multiple Myeloma|Terminated||Phase 1/Phase 2|||Poniard Pharmaceuticals||||business reasons|||||||||||||||2017-10-11 04:38:55.66077|2017-10-11 04:38:55.66077
NCT00039767|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-07|2008-03-03|||May 2002||2002-05-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices|Heparin vs. Lepirudin Flushes in Preventing Withdrawal Occlusion of Tunneled, Open-Ended Venous Access Devices: A Blinded, Randomized, Clinical Trial|Completed||Phase 2|340||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:55.721715|2017-10-11 04:38:55.721715
NCT00039780|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-10|2017-09-20|||September 2001||2001-09-01|September 2017|2017-09-01|September 2014|Actual|2014-09-01|October 2006|Actual|2006-10-01||Interventional|||Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel|BNP7787 vs. Placebo for Prevention of Paclitaxel Neurotoxicity: A Double-Blind Multicenter Randomized Phase 3 Trial in Patients With Metastatic Breast Cancer|Completed||Phase 3|764|Actual|BioNumerik Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-10-11 04:38:55.791127|2017-10-11 04:38:55.791127
NCT00039793|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-11|2006-08-17|||March 2001||2001-03-01|July 2006|2006-07-01|March 2004||2004-03-01|||||Interventional|||Massage Therapy for Cancer-Related Fatigue|Massage Therapy for Cancer-Related Fatigue|Completed||Phase 2|45||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:38:55.878239|2017-10-11 04:38:55.878239
NCT00039819|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-11|2008-03-03|||June 2002||2002-06-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||Nerve Stimulation to Modify a Spinal Reflex|Plasticity of Reciprocal Inhibition|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:55.951778|2017-10-11 04:38:55.951778
NCT00039832|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-12|2011-09-19|||March 2002||2002-03-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|April 2007|Actual|2007-04-01||Interventional|||ReoPro and Retavase to Restore Brain Blood Flow After Stroke|ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation|Completed||Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:38:56.008778|2017-10-11 04:38:56.008778
NCT00039858|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-13|2007-01-10|||September 2003||2003-09-01|January 2007|2007-01-01|March 2006||2006-03-01|||||Interventional|||Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin|Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin|Completed||Phase 4|24||Encysive Pharmaceuticals|||||||||||||||||||2017-10-11 04:38:56.406107|2017-10-11 04:38:56.406107
NCT00039871|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-13|2017-03-07|2008-09-29||May 2002||2002-05-01|March 2017|2017-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)|PEG-Intron Plus REBETOL for the Treatment of Subjects With Chronic Hepatitis C Who Failed to Respond to Previous Combination Therapy (Any Alpha Interferon Treatment in Combination With Ribavirin)|Completed||Phase 3|2333|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:38:56.518795|2017-10-11 04:38:56.518795
NCT00039884|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-13|2005-06-23|||September 2001||2001-09-01|June 2002|2002-06-01|March 2003||2003-03-01|||||Interventional|||Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?|Phase II Study of NESP (Novel Erythropoiesis Stimulating Protein) During Concurrent Chemo-Radiation for the Treatment of Cervical Carcinoma.|Unknown status|Active, not recruiting|Phase 2|64||Mirhashemi, Ramin, M.D.|||||||||||||||||||2017-10-11 04:38:57.737095|2017-10-11 04:38:57.737095
NCT00039910|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-14|2007-05-03|||July 2000||2000-07-01|September 2006|2006-09-01|March 2003|Actual|2003-03-01|||||Interventional|||Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia|Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia in Recurrent or Refractory Non-Burkitt's, Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease Receiving DHAP (Dexamethasone, High-Dose Cytarabine and Cisplatin) Chemotherapy|Completed||Phase 3|240||Pfizer|||||f||||||||||||||2017-10-11 04:38:57.806781|2017-10-11 04:38:57.806781
NCT00039923|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-14|2008-03-03|||June 2002||2002-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria|A Pilot Study to Determine if Transfer of Gpi-Linked Proteins Occurs Following Transfusion of Red Cells to Patients With Paroxysmal Nocturnal Hemoglobinuria|Completed||N/A|7||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:38:57.984137|2017-10-11 04:38:57.984137
NCT00039936|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-17|2010-01-12|||February 2002||2002-02-01|January 2010|2010-01-01||||||||Interventional|||Treatment of Binge Eating Disorder||Completed||N/A|180||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:38:58.06258|2017-10-11 04:38:58.06258
NCT00039962|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-17|2008-01-08|||May 2002||2002-05-01|January 2008|2008-01-01||||||||Interventional|||Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin||Completed||Phase 3|500||SciClone Pharmaceuticals|||||||||||||||||||2017-10-11 04:38:58.143167|2017-10-11 04:38:58.143167
NCT00039975|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-18|2012-05-17||||||May 2012|2012-05-01|April 2004|Actual|2004-04-01|||||Interventional|||Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers|Evaluation of Potential Pharmacokinetic Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:38:58.343947|2017-10-11 04:38:58.343947
NCT00039988|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-18|2016-09-20|||November 2001||2001-11-01|September 2016|2016-09-01|November 2007|Actual|2007-11-01|March 2006|Actual|2006-03-01||Interventional|||Treatment of Multiple Sclerosis With Copaxone and Albuterol|Treatment of Multiple Sclerosis With Copaxone (Glatiramer Acetate) and Albuterol|Completed||N/A|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||Yes|Data access including but not limited to participant level data, is available to the public in the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 04:38:58.461045|2017-10-11 04:38:58.461045
NCT00040001|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-18|2005-06-23||||||February 2003|2003-02-01||||||||Interventional|||Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation||Completed||Phase 2|||Aderis Pharmaceuticals|||||||||||||||||||2017-10-11 04:38:58.572679|2017-10-11 04:38:58.572679
NCT00040014|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-18|2012-02-14|||June 2002||2002-06-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women|Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women With Advanced Breast Cancer Having Progressed on Tamoxifen.|Terminated||Phase 2|100||Pfizer|||||f||||||||||||||2017-10-11 04:38:58.632219|2017-10-11 04:38:58.632219
NCT00040027|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-18|2008-01-08|||April 2002||2002-04-01|January 2008|2008-01-01||||||||Interventional|||Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin||Completed||Phase 3|500||SciClone Pharmaceuticals|||||||||||||||||||2017-10-11 04:38:58.724437|2017-10-11 04:38:58.724437
NCT00040040|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-18|2017-01-10|||June 2002||2002-06-01|August 2003|2003-08-01|September 2003||2003-09-01|||||Interventional|||Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1|Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion|Unknown status|Active, not recruiting|Phase 1|20||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:38:59.112128|2017-10-11 04:38:59.112128
NCT00040053|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-18|2017-01-11|||June 2002||2002-06-01|July 2008|2008-07-01|February 2004|Actual|2004-02-01|||||Interventional|||Ondansetron for the Treatment of Methamphetamine Dependence - 1|Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence.|Completed||Phase 2|154||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:38:59.188164|2017-10-11 04:38:59.188164
NCT00040066|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-18|2017-01-10|||May 2002||2002-05-01|September 2004|2004-09-01|August 2003||2003-08-01|||||Interventional|||Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1|Development of Human Laboratory Study Model of Cocaine Relapse Prevention|Unknown status|Active, not recruiting|Phase 1|32||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:38:59.258193|2017-10-11 04:38:59.258193
NCT00040092|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-19|2008-01-04|||July 2002||2002-07-01|January 2008|2008-01-01||||July 2005|Actual|2005-07-01||Interventional|||A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer||Completed||Phase 3|400||Aptose Biosciences Inc.|||||||||||||||||||2017-10-11 04:38:59.318901|2017-10-11 04:38:59.318901
NCT00040105|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-19|2012-07-31|||October 2002||2002-10-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia|Phase I Study of Zarnestra (R115777.USA30) and Gleevec (Imatinib Mesylate) in Chronic Phase Chronic Myelogenous Leukemia (CML)|Completed||Phase 1|26|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:38:59.373724|2017-10-11 04:38:59.373724
NCT00040131|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-20|2015-10-30|||January 2002||2002-01-01|October 2015|2015-10-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED)||Terminated||Phase 2|316|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:38:59.462233|2017-10-11 04:38:59.462233
NCT00040144|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-21|2009-08-18|||July 2002||2002-07-01|August 2009|2009-08-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B|A Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of 12 Weeks Oral Treatment With ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B|Terminated||Phase 2|85||Achillion Pharmaceuticals||||Safety concerns|||||||||||||||2017-10-11 04:38:59.532074|2017-10-11 04:38:59.532074
NCT00040157|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-21|2015-12-29||||||December 2015|2015-12-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.|A Phase 2 Trial of 4 Weeks of ACH-126,443 in Comparison With Continued Lamivudine in Stable Triple Antiretroviral Combination Therapy in HIV-Infected Subjects With Modestly Detectable Viral Load|Terminated||Phase 2|60||Achillion Pharmaceuticals||||Safety concerns|||||||||||||||2017-10-11 04:38:59.638157|2017-10-11 04:38:59.638157
NCT00040170|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-21|2006-10-31|||May 2002||2002-05-01|October 2006|2006-10-01||||||||Interventional|||Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer|Randomized Multicenter Phase II Study Evaluating Two Dosing Schedules of TG4010(MVA-MUC1-IL2) in Patients With Adenocarcinoma of the Prostate|Terminated||Phase 2|50||Transgene|||||||||||||||||||2017-10-11 04:38:59.838466|2017-10-11 04:38:59.838466
NCT00040183|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-21|2015-06-12|||October 2001||2001-10-01|June 2015|2015-06-01|September 2004|Actual|2004-09-01|||||Interventional|||OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.|A Randomized Placebo Controlled Study of OSI-774 (Tarceva (TM)) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer|Completed||Phase 3|569|Actual|Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:38:59.94815|2017-10-11 04:38:59.94815
NCT00040196|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-21|2017-06-30|||June 19, 2002||2002-06-19|July 9, 2009|2009-07-09|July 9, 2009|Actual|2009-07-09|July 9, 2009|Actual|2009-07-09||Observational|||How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance|Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements|Completed||N/A|133||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:00.35851|2017-10-11 04:39:00.35851
NCT00040209|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-21|2008-03-03|||June 2002||2002-06-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||JP-1730 to Treat Parkinson's Disease|Alpha-2 Adrenergic Antagonist Treatment of Parkinson's Disease|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:00.428094|2017-10-11 04:39:00.428094
NCT00040222|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-22|2017-10-05|||June 20, 2002||2002-06-20|March 27, 2017|2017-03-27||||||||Observational|||Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer|Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer|Active, not recruiting||N/A|377|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:00.530217|2017-10-11 04:39:00.530217
NCT00040235|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-22|2008-03-03|||June 2002||2002-06-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Magnesium Effects in Apheresis|Citrate Effects and Role of Prophylactic Magnesium Administration During Large-Volume Leukapheresis|Completed||Phase 3|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:00.639296|2017-10-11 04:39:00.639296
NCT00040248|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-22|2008-03-03|||June 2002||2002-06-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Daclizumab to Treat Wegener's Granulomatosis|A Randomized Trial Examining the Use of Daclizumab in Wegener's Granulomatosis|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:00.740005|2017-10-11 04:39:00.740005
NCT00040261|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-22|2008-03-03|||June 2002||2002-06-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Clinical Trial of Memantine for Major Depression|An Investigation of the Antidepressant Efficacy of Memantine, an NMDA Antagonist With Neurotrophic Properties in Major Depression|Completed||Phase 3|112||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:00.854242|2017-10-11 04:39:00.854242
NCT00040274|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-24|2005-07-18||||||July 2005|2005-07-01||||||||Interventional|||A Study of DPC 817 in HIV-Infected Males|A Placebo-Controlled, Dose-Escalation Study in HIV-1 Infected Subjects to Characterize the Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of DPC 817|Completed||Phase 1|30||Pharmasset|||||||||||||||||||2017-10-11 04:39:00.963684|2017-10-11 04:39:00.963684
NCT00040287|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-24|2007-05-16|||January 1999||1999-01-01|May 2007|2007-05-01||||||||Interventional|||Theory-Based Interventions for Smoking and Obesity (Challenge) Trial||Completed||Phase 3|1778||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:39:01.037417|2017-10-11 04:39:01.037417
NCT00040300|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-24|2005-07-18|||June 2002||2002-06-01|July 2005|2005-07-01|December 2002||2002-12-01|||||Interventional|||A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males||Completed||Phase 1|18||Pharmasset|||||||||||||||||||2017-10-11 04:39:01.125267|2017-10-11 04:39:01.125267
NCT00040313|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-24|2006-05-02|||October 2002||2002-10-01|May 2006|2006-05-01|February 2005||2005-02-01|||||Interventional|||Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula|A Phase II Randomized, Controlled, Double-Masked, Dose-Finding, Multi-Center, Comparative Trial, in Parallel Groups, to Establish the Safety and Preliminary Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer), Given Every 6 Weeks for 12 to 30 Weeks to Patients With Clinically Significant Diabetic Macular Edema (CSME) Involving the Center of the Macula|Completed||Phase 2|0||Eyetech Pharmaceuticals|||||||||||||||||||2017-10-11 04:39:01.217073|2017-10-11 04:39:01.217073
NCT00040326|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-24|2010-02-22|||July 2002||2002-07-01|February 2010|2010-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|ERSET||Early Surgical Intervention to Treat Epilepsy|Early Randomized Surgical Epilepsy Trial|Completed||Phase 3|200|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 04:39:01.27736|2017-10-11 04:39:01.27736
NCT00040352|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-25|2017-10-05|||June 20, 2002||2002-06-20|August 21, 2017|2017-08-21||||||||Observational|||Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma|Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:01.551915|2017-10-11 04:39:01.551915
NCT00040365|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-25|2012-04-26|2012-01-13||June 2002||2002-06-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer|Amifostine as a Rectal Protector During External Beam Radiotherapy for Prostate Cancer: A Phase II Study|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:39:01.66711|2017-10-11 04:39:01.66711
NCT00040378|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-25|2013-02-21|||May 2002||2002-05-01|February 2013|2013-02-01|August 2014|Anticipated|2014-08-01|January 2014|Anticipated|2014-01-01||Interventional|||Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)|Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)|Unknown status|Active, not recruiting|Phase 3|10400|Anticipated|University of Kentucky||4|||f||||t||||||||||2017-10-11 04:39:02.174582|2017-10-11 04:39:02.174582
NCT00040391|ClinicalTrials.gov processed this data on October 10, 2017|2002-06-26|2016-11-30|||June 2002||2002-06-01|November 2016|2016-11-01||||||||Interventional|||A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer|A Phase II, Randomized, Open-label, Controlled, Dose-elevation, Multicenter Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer|Terminated||Phase 2|||Celgene Corporation|||||||||||||||||||2017-10-11 04:39:02.636842|2017-10-11 04:39:02.636842
NCT00049712|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2015-07-22|||October 2002||2002-10-01|July 2015|2015-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma|A Phase I Study Of Medi 522 In Patients With Advanced Tumors|Completed||Phase 1|||University of Wisconsin, Madison|||||||||||||||||||2017-10-11 04:39:02.754912|2017-10-11 04:39:02.754912
NCT00049725|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-12|2008-03-03|||November 2002||2002-11-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Daclizumab to Treat Chronic Immune Thrombocytopenia|A Study of Daclizumab in Chronic Immune Thrombocytopenia (ITP)|Completed||Phase 2|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:02.919339|2017-10-11 04:39:02.919339
NCT00049751|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-13|2006-08-13|||September 2002||2002-09-01|August 2006|2006-08-01||||||||Interventional|||Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis|A Multicenter Study of the Safety of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis|Completed||Phase 3|3000||Abbott|||||||||||||||||||2017-10-11 04:39:03.157434|2017-10-11 04:39:03.157434
NCT00049764|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-13|2007-11-15|||November 2002||2002-11-01|November 2007|2007-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis|Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis|Completed||Phase 3|474|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 04:39:03.380023|2017-10-11 04:39:03.380023
NCT00049777|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-13|2007-01-24|||December 2002||2002-12-01|January 2007|2007-01-01|August 2005||2005-08-01|||||Interventional|||A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)|A Randomized, Double-Blind, Placebo-Controlled Trial of Prophylactic Heparin in Patients With Severe Sepsis and Higher Disease Severity Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)|Completed||Phase 4|2000||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:39:03.624661|2017-10-11 04:39:03.624661
NCT00049790|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-13|2009-01-08||||||January 2009|2009-01-01|December 2004||2004-12-01|||||Interventional|||Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer||Completed||Phase 2|||CASI Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:39:03.720396|2017-10-11 04:39:03.720396
NCT00049803|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-13|2005-06-23|||December 2000||2000-12-01|July 2004|2004-07-01|April 2004||2004-04-01|||||Interventional|||Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate) With Placebo for the Treatment of Narcolepsy|Completed||Phase 3|200||Orphan Medical|||||||||||||||||||2017-10-11 04:39:03.811967|2017-10-11 04:39:03.811967
NCT00049816|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2013-05-16|||October 2002||2002-10-01|May 2013|2013-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Aerobic Exercise Intervention for Knee Osteoarthritis|Aerobic Exercise Intervention for Knee Osteoarthritis|Completed||N/A|306|Actual|Mayo Clinic||3|||f||||||||||||||2017-10-11 04:39:03.989881|2017-10-11 04:39:03.989881
NCT00049829|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2011-11-01|||January 2002||2002-01-01|November 2011|2011-11-01||||June 2006|Actual|2006-06-01||Interventional|||HORIZON-PFT: Pivotal Fracture Trial|HORIZON-PFT: Pivotal Fracture Trial|Completed||Phase 3|7700||Novartis|||||||||||||||||||2017-10-11 04:39:04.12816|2017-10-11 04:39:04.12816
NCT00049842|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2017-03-07|2010-10-07||October 2002||2002-10-01|March 2017|2017-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)|PEG-Intron(TM) Maintenance Therapy vs. an Untreated Control Group for Prevention of Progression of Fibrosis in Adult Subjects With Chronic Hepatitis C With Hepatic Fibrosis (METAVIR Fibrosis Score of F2 or F3), Who Failed Therapy With PEG-Intron Plus REBETOL(R) (in Protocol No. P02370)|Completed||Phase 3|540|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:39:04.353965|2017-10-11 04:39:04.353965
NCT00049855|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2014-04-15|||September 2002||2002-09-01|April 2014|2014-04-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Novel Approaches in Linkage Analysis for Complex Traits||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-10-11 04:39:05.621256|2017-10-11 04:39:05.621256
NCT00049868|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2016-01-11|||September 2002||2002-09-01|January 2006|2006-01-01|August 2005||2005-08-01|||||Observational|||Enhanced Linkage Maps From Family-Based Genetics Studies||Completed||N/A|||Rutgers University|||||f||||||||||||||2017-10-11 04:39:05.671218|2017-10-11 04:39:05.671218
NCT00049920|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2016-07-28|||September 2002||2002-09-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|May 2006|Actual|2006-05-01||Observational|||The ARIC MRI Study|The ARIC Neurocognitive Longitudinal Study|Completed||N/A|1134|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||Samples With DNA|"     Plasma and DNA   "|||2017-10-11 04:39:05.87403|2017-10-11 04:39:05.87403
NCT00049933|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-14|2012-12-18|||September 2002||2002-09-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Hormone Replacement Therapy and Prothrombotic Variants||Completed||N/A|1000|Actual|University of Washington|||1||f||||||||||||||2017-10-11 04:39:05.928648|2017-10-11 04:39:05.928648
NCT00049946|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-15|2017-08-14|||October 2002||2002-10-01|August 2017|2017-08-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Schizophrenia Study In Adults|A Multicenter, Double-Blind, Double-Dummy, Placebo-Controlled, Randomized, Parallel Group Evaluation of the Efficacy and Safety of a Fixed-Dose of Talnetant Versus Placebo Versus Risperidone in Subjects With Schizophrenia|Completed||Phase 2|231||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:39:05.985798|2017-10-11 04:39:05.985798
NCT00049959|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-15|2011-03-01||2011-03-01||||March 2011|2011-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.|A Randomized, Placebo-Controlled, Masked, Multicenter Phase III Study Of Photodynamic Therapy With Verteporfin For Injection (VFI) For The Treatment Of Multiple Basal Cell Carcinoma|Terminated||Phase 3|||QLT Inc.|||||||||||||||||||2017-10-11 04:39:06.099068|2017-10-11 04:39:06.099068
NCT00049972|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-18|2017-09-08|||September 2002||2002-09-01|September 2017|2017-09-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Major Depressive Disorder Study In Adults|An Open Label Study Assessing Paxil CR (Paroxetine CR) in Patients With Major Depressive Disorder Who Discontinued Treatment With Selective Serotonin Reuptake Inhibitors or a Selective Serotonin/Norepinephrine Reuptake Inhibitor Due to Intolerability|Completed||Phase 4|646||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:39:06.157942|2017-10-11 04:39:06.157942
NCT00049985|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-18|2009-08-06|||July 2002||2002-07-01|August 2009|2009-08-01||||||||Interventional|||Heart Failure and Anemia|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Impact of Subcutaneous (SC) Darbepoetin Alfa Treatment on Exercise Tolerance in Subjects With Symptomatic Heart Failure (CHF) and Anemia.|Completed||Phase 2|300||Amgen||1|||||||||||||||||2017-10-11 04:39:06.339204|2017-10-11 04:39:06.339204
NCT00049998|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-18|2013-03-01|||October 2001||2001-10-01|March 2013|2013-03-01||||April 2004|Actual|2004-04-01||Interventional|||Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer|An Open-Label, Multicentre, Randomised, Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non Small Cell Lung Cancer|Completed||Phase 3|760||GlaxoSmithKline||1|||||||||||||||||2017-10-11 04:39:06.409134|2017-10-11 04:39:06.409134
NCT00050011|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-18|2014-02-21|2013-12-04||September 2002||2002-09-01|February 2014|2014-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy|An Open-Label, Randomized, Multicenter Study to Evaluate the Use of Zoledronic Acid in the Prevention of Cancer Treatment-Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Letrozole as Adjuvant Therapy|Completed||Phase 3|602|Actual|Novartis||2|||f||||f||||||||||2017-10-11 04:39:08.489804|2017-10-11 04:39:08.489804
NCT00050024|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-19|2017-06-30|||November 13, 2002||2002-11-13|September 17, 2008|2008-09-17|September 17, 2008||2008-09-17|||||Observational|||Transcranial Magnetic Stimulation and Electrical Stimulation of Nerves to Study Focal Dystonia|The Effect of Peripheral Heterotopic Stimulation on Cortical Excitability in Dystonia|Completed||N/A|38||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:10.08646|2017-10-11 04:39:10.08646
NCT00050037|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-20|2013-04-10|||April 2001||2001-04-01|April 2013|2013-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Cognitive Therapy for Binge-Eating Disorder|Cognitive Therapy Via CD-Rom for Binge-Eating Disorder|Completed||N/A|60|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-10-11 04:39:10.148338|2017-10-11 04:39:10.148338
NCT00050531|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-12|2016-05-09|||April 2003||2003-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|April 2007|Actual|2007-04-01||Interventional|||High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)|Randomized Trial of Therapy of Early Phase Chronic Myelogenous Leukemia With High-Dose Imatinib Mesylate (Gleevec) Alone or in Combination With Peg-Alpha Interferon (PEG-Intron) and Sargramostim (GM-CSF)|Completed||Phase 3|94|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 04:39:10.233249|2017-10-11 04:39:10.233249
NCT00050557|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-13|2012-05-02|||July 2001||2001-07-01|May 2012|2012-05-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Family Psychoeducation for Children With Mood Disorders|Family Psychoeducation: Efficacy in Child Mood Disorders|Completed||Phase 1|165|Actual|Ohio State University||2|||f||||f||||||||||2017-10-11 04:39:10.44472|2017-10-11 04:39:10.44472
NCT00050570|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-16|2015-04-02|||February 2001||2001-02-01|April 2015|2015-04-01||||April 2012|Actual|2012-04-01||Interventional|||Reducing Eating Disorder Risk Factors|Interventions to Reduce Eating Disorder Risk Factors|Completed||N/A|206|Actual|Stanford University||1|||f||||||||||||||2017-10-11 04:39:10.54801|2017-10-11 04:39:10.54801
NCT00050583|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-16|2014-01-10|||February 2001||2001-02-01|January 2014|2014-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Treatment of Medically Unexplained Physical Ailments (Somatization Disorder)|Treatment of Somatization in Primary Care|Completed||Phase 3|172|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 04:39:10.619982|2017-10-11 04:39:10.619982
NCT00050596|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-16|2011-06-23|||November 2002||2002-11-01|June 2011|2011-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer|A Randomized Study Comparing 4 Monthly Doses of MDX-010 (CTLA-4) as a Single Agent or Used in Combination With a Single Dose of Docetaxel in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:39:10.730534|2017-10-11 04:39:10.730534
NCT00050609|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-16|2007-11-16|||February 2003||2003-02-01|November 2007|2007-11-01|September 2003|Actual|2003-09-01|||||Interventional|||Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying|A Randomized, Double-Blind, Placebo-Controlled, Parallel Study of IC351 (LY450190) in Patients With Diabetic Gastroparesis|Completed||Phase 2|2|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-10-11 04:39:10.874746|2017-10-11 04:39:10.874746
NCT00050622|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-16|2016-08-08|2016-05-31||September 2001||2001-09-01|August 2016|2016-08-01|June 2005|Actual|2005-06-01|August 2004|Actual|2004-08-01||Interventional|||Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)|ADHD Treatment: Comparative and Combined Dosage Effects|Completed||N/A|154|Actual|Florida International University|Highly structured environment and direct observational measures were used. Additional study in natural school and home settings will be necessary.|12|||f||||f||||||||Yes||2017-10-11 04:39:11.044361|2017-10-11 04:39:11.044361
NCT00050635|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2009-11-18|||December 2002||2002-12-01|November 2009|2009-11-01|July 2003||2003-07-01|||||Interventional|||STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea||Completed||Phase 4|150||Novartis|||||f||||||||||||||2017-10-11 04:39:11.601121|2017-10-11 04:39:11.601121
NCT00050648|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2009-03-12|||October 1997||1997-10-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|September 2004|Actual|2004-09-01||Interventional|||To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris|Use of Humanized CD25 (Anti-TAC) Monoclonal Antibody and Cyclosporine for the Treatment of Active Psoriasis.|Completed||Phase 1/Phase 2|20|Actual|Rockefeller University||3|||f||||f||||||||||2017-10-11 04:39:11.750606|2017-10-11 04:39:11.750606
NCT00050661|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2009-03-24|||October 1997||1997-10-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|April 2004|Actual|2004-04-01||Interventional|||To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris|Use of Humanized CD25 (Anti-TAC) Monoclonal Antibody/ Placebo to Prevent Relapse of Psoriasis Vulgaris Following NBUVB Therapy|Completed||Phase 1/Phase 2|6|Actual|Rockefeller University||2|||f||||f||||||||||2017-10-11 04:39:11.855561|2017-10-11 04:39:11.855561
NCT00050674|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2012-12-26|||November 2001||2001-11-01|December 2012|2012-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma|Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma|Completed||Phase 2|40|Actual|Schwartzberg, Lee, M.D.||1|||f||||f||||||||||2017-10-11 04:39:11.954698|2017-10-11 04:39:11.954698
NCT00050687|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2011-01-21||2011-01-11|June 2001||2001-06-01|November 2006|2006-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies|A Randomized, Serum Level-targeted Study Investigating the Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Patients With Various Refractory Malignancies|Terminated||Phase 1/Phase 2|||Titan Pharmaceuticals|||||||||||||||||||2017-10-11 04:39:12.0354|2017-10-11 04:39:12.0354
NCT00050700|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2017-06-30|||December 16, 2002||2002-12-16|May 14, 2010|2010-05-14|May 14, 2010||2010-05-14|||||Observational|||Brain Imaging in Depression|Muscarinic Cholinergic Receptor Imaging in Depression|Completed||N/A|107|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:12.098597|2017-10-11 04:39:12.098597
NCT00050713|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2017-10-05|||December 17, 2002||2002-12-17|July 7, 2015|2015-07-07|August 27, 2007|Actual|2007-08-27|August 27, 2007|Actual|2007-08-27||Interventional|||Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy|Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:39:12.166351|2017-10-11 04:39:12.166351
NCT00050726|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2013-11-19|||May 2001||2001-05-01|November 2013|2013-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2|Substudies of ESPRIT: ESPRIT Influenza Vaccine Substudy (FLUVAC) and ESPRIT Tetanus-Pneumococcal Vaccine Substudy (TEPVAC)|Completed||Phase 2|620||National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:39:12.237972|2017-10-11 04:39:12.237972
NCT00050752|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-17|2017-10-05|||December 17, 2002||2002-12-17|July 25, 2017|2017-07-25||||||||Observational|||Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer|Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:12.316709|2017-10-11 04:39:12.316709
NCT00050765|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-18|2006-03-06|||August 2006||2006-08-01|March 2006|2006-03-01|August 2006||2006-08-01|||||Interventional|||Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection|A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy|Unknown status|Not yet recruiting|Phase 1|15||Bioheart, Inc.|||||||||||||||||||2017-10-11 04:39:12.409849|2017-10-11 04:39:12.409849
NCT00050778|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-19|2015-01-06|2008-11-03||December 2002||2002-12-01|January 2015|2015-01-01|January 2010|Actual|2010-01-01|September 2007|Actual|2007-09-01||Interventional||FAS population included all randomized participants who had correct diagnosis of MS at entry. One participant was included in safety but excluded from efficacy analysis as initial multiple sclerosis diagnosis was incorrect.|A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis|A Phase II, Randomized, Open-Label, Three-Arm Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Subcutaneous Interferon Beta-1a (Rebif®) in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|334|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 04:39:12.557005|2017-10-11 04:39:12.557005
NCT00050791|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-19|2010-10-18|||March 2001||2001-03-01|October 2010|2010-10-01|June 2009|Actual|2009-06-01|November 2006|Actual|2006-11-01||Interventional|||Effects of Leptin Treatment on Weight Loss|Leptin Treatment for Prevention of the Metabolic and Endocrine Sequelae of a Decreased Caloric Intake: Studies of Patients on a Very Low Calorie Diet|Completed||Phase 2|40|Anticipated|Rockefeller University||2|||f||||f||||||||||2017-10-11 04:39:15.022942|2017-10-11 04:39:15.022942
NCT00050804|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-19|2008-03-03|||December 2002||2002-12-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Evaluation of Stress Disorders|Efficacy of an SSRI in Acute Stress Disorder and PTSD|Completed||Phase 4|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:15.09938|2017-10-11 04:39:15.09938
NCT00050817|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-20|2012-04-20|||October 2002||2002-10-01|April 2012|2012-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)|A Phase III, Multicenter, Multinational, Randomized, Parallel Group, Double-blind Trial of Clopidogrel Versus Placebo in High-risk Patients Aged 45 Years and Older, at Risk of Atherothrombotic Events, and Who Are Receiving Background Therapy Including Low-dose ASA.|Completed||Phase 3|15603|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:39:15.17698|2017-10-11 04:39:15.17698
NCT00050830|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-20|2006-11-06|||January 2003||2003-01-01|January 2006|2006-01-01|November 2005||2005-11-01|||||Interventional|||A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer|A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|163||Pfizer|||||f||||||||||||||2017-10-11 04:39:15.329735|2017-10-11 04:39:15.329735
NCT00050843|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-23|2005-06-23|||August 2001||2001-08-01|May 2004|2004-05-01|February 2004||2004-02-01|||||Interventional|||A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes||Completed||Phase 3|220||Celgene|||||||||||||||||||2017-10-11 04:39:15.637123|2017-10-11 04:39:15.637123
NCT00050856|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-23|2008-03-03|||November 2002||2002-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection|Multicenter, Open-Label, Early Acces Program of Fuzeon (Enfuvirtide T-20/Ro 29,9800, HIV-1 Fusion Inhibitor) in Combination With Free Choice Antiretroviral Regimen to Assess Serious Adverse Events, Serious AIDS-Defining Events, and Tolerability in Patient|Completed||Phase 3|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:15.785192|2017-10-11 04:39:15.785192
NCT00050869|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-27|2017-06-30|||December 23, 2002||2002-12-23|November 15, 2007|2007-11-15|November 15, 2007||2007-11-15|||||Observational|||Learning a Motor Task Through Observation|Encoding a Motor Memory by Action Observation|Completed||N/A|56||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:15.85824|2017-10-11 04:39:15.85824
NCT00050882|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-29|2005-06-23||||||February 2004|2004-02-01||||||||Interventional|||Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis|A 12-Week Study Conducted at Multiple Centers, Blinded to Both the Patient and Doctor, Evaluating for Safety and Effectiveness Two Dosages of an Investigational Agent (GM-611) Versus a Placebo, That Are Randomly Assigned to Patients With Diabetic Gastroparesis|Completed||Phase 2|||Chugai Pharma USA|||||||||||||||||||2017-10-11 04:39:15.927146|2017-10-11 04:39:15.927146
NCT00050895|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-30|2012-05-17||||||May 2012|2012-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients|A Phase III, Randomized, Open-Label Comparison of Lopinavir/Ritonavir Plus Efavirenz Versus Lopinavir/Ritonavir Plus 2 NRTIs Versus Efavirenz Plus 2 NRTIs as Initial Therapy for HIV-1 Infection|Completed||Phase 3|775||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:39:16.163336|2017-10-11 04:39:16.163336
NCT00050908|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-30|2013-07-26||||||July 2013|2013-07-01|May 2007|Actual|2007-05-01|||||Observational|||Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs|Endothelial Function in HIV-Infected Subjects Prior To and After Starting a Potent Antiretroviral Regimen|Completed||N/A|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:39:16.860153|2017-10-11 04:39:16.860153
NCT00050921|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-30|2012-05-16||||||May 2012|2012-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs|Improving Immune Reconstitution With Growth Hormone in HIV-infected Subjects With Incomplete CD4+ Lymphocyte Restoration on Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:39:16.962004|2017-10-11 04:39:16.962004
NCT00050934|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-30|2011-11-22|||June 2002||2002-06-01|November 2011|2011-11-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Pediatric Epilepsy Study|A Multicenter, Rater-blind, Randomized, Age-stratified, Parallel-group Study Comparing Two Doses of Oxcarbazepine as Adjunctive Therapy in Pediatric Patients With Inadequately-controlled Partial Seizures.|Completed||Phase 3|132|Actual|Novartis|||||f||||||||||||||2017-10-11 04:39:17.336417|2017-10-11 04:39:17.336417
NCT00050947|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-30|2011-11-22|||July 2002||2002-07-01|November 2011|2011-11-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Pediatric Epilepsy Study|A Multicenter, Rater-blind, Randomized, Age-stratified, Parallel-group Study Comparing Two Doses of Oxcarbazepine as Monotherapy in Pediatric Patients With Inadequately-controlled Partial Seizures.|Completed||Phase 3|94|Actual|Novartis|||||f||||||||||||||2017-10-11 04:39:17.467714|2017-10-11 04:39:17.467714
NCT00050960|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-31|2012-07-07|2010-07-23||May 2002||2002-05-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|July 2004|Actual|2004-07-01||Interventional|||Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer|Randomized Phase III Trial Comparing Targretin Capsules/Carboplatin/Paclitaxel Versus Carboplatin/Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|612|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 04:39:17.639074|2017-10-11 04:39:17.639074
NCT00050973|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-31|2013-05-13||||||July 2008|2008-07-01|March 2005|Actual|2005-03-01|November 2004|Actual|2004-11-01||Interventional|||Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer|Randomized Phase III Trial Comparing Targretin Capsules/Cisplatin/Vinorelbine Versus Cisplatin/Vinorelbine in Chemotherapy-Naive Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|623|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 04:39:18.825342|2017-10-11 04:39:18.825342
NCT00050986|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-31|2012-07-27|2009-09-25||December 2002||2002-12-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme|Phase I/II Evaluation Temozolomide and Farnesyl Transferase Inhibitor ZARNESTRA (R115777) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme|Completed||Phase 1/Phase 2|55|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:39:19.058523|2017-10-11 04:39:19.058523
NCT00050999|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-31|2008-02-29|||June 1995||1995-06-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients|A Multicenter Phase III Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy of Two Dose Levels of DAB389IL-2 (9 and 18 Mcg/kg/Day) in Cutaneous T-Cell Lymphoma (CTCL) Patients With Stage Ia-III Disease Who, Following Less Than or Equal to 3 Previous Therapies, Have Recurrent or Persistent Disease That Has Been Biopsy-Documented to Express CD25|Completed||Phase 4|195||Eisai Inc.|||||f||||||||||||||2017-10-11 04:39:19.309252|2017-10-11 04:39:19.309252
NCT00051220|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-07|2013-06-06|||October 2001||2001-10-01|June 2013|2013-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment for Specific Phobias in Children|One-Session Treatment for Specific Phobias in Children|Completed||Phase 1/Phase 2|150|Actual|Virginia Polytechnic Institute and State University|||||f||||||||||||||2017-10-11 04:39:21.77555|2017-10-11 04:39:21.77555
NCT00051012|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-31|2008-02-29|||September 1995||1995-09-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients|A Multicenter Open-Label Study to Evaluate the Safety and Efficacy of DAB389IL-2 in Cutaneous T-Cell Lymphoma (CTCL) Patients Following Protocol 93-04-10, Protocol 93-04-11, or Protocol 92-04-01 or Who Meet the Requirements for Protocol 93-04-11 Except Have Biopsy-Documented CTCL That Does Not Express CD25|Completed||Phase 4|86||Eisai Inc.|||||f||||||||||||||2017-10-11 04:39:19.593335|2017-10-11 04:39:19.593335
NCT00051025|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-31|2012-07-07|2011-07-07||May 2000||2000-05-01|July 2012|2012-07-01|September 2006|Actual|2006-09-01|January 2001|Actual|2001-01-01||Interventional|||Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)|A Randomized, Multicenter, Phase II Evaluation of ONTAK (Denileukin Diftitox) in Patients With Previously Treated, Indolent, B-Cell, Non-Hodgkin's Lymphoma|Completed||Phase 2|9|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 04:39:19.717661|2017-10-11 04:39:19.717661
NCT00051038|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-31|2011-04-07||2010-01-29|September 2002||2002-09-01|August 2007|2007-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients|A Phase II Study of the Safety and Efficacy of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients Who Have Hepatitis B Viremia While Being Treated With Lamivudine|Completed||Phase 2/Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:39:20.097093|2017-10-11 04:39:20.097093
NCT00051051|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-02|2007-05-03|||December 2002||2002-12-01|September 2006|2006-09-01|May 2005|Actual|2005-05-01|||||Interventional|||A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer|A Phase II, Randomized, Open-Label Study of Single Agent CI-1033 in Patients With Metastatic Breast Cancer|Completed||Phase 2|168||Pfizer|||||f||||||||||||||2017-10-11 04:39:20.241874|2017-10-11 04:39:20.241874
NCT00051077|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2012-05-16||||||May 2012|2012-05-01||||||||Interventional|||Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)|A Phase II Study of Adefovir Dipivoxil, Pegylated Interferon Alfa-2A, and Ribavirin Treatment in HBV and HCV Infected Subjects With HIV Disease|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:39:20.480816|2017-10-11 04:39:20.480816
NCT00051090|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV|Multicenter, Pilot Study of Telbivudine (LdT) Anti-HBV Treatment Prior to the Initiation of Highly Active Antiretroviral Therapy Containing Lamivudine in Subjects Coinfected With HBV and HIV|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:39:20.56075|2017-10-11 04:39:20.56075
NCT00051103|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2015-04-14|||October 2002||2002-10-01|April 2015|2015-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.|An Open-Label, Multicenter, Single Arm Phase II Study of Oral GW572016 as Single Agent Therapy in Subjects With Advanced or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin Containing Regimens|Completed||Phase 2|||GlaxoSmithKline|||||f||||||||||||||2017-10-11 04:39:20.681524|2017-10-11 04:39:20.681524
NCT00051116|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2009-09-22|||May 2002||2002-05-01|September 2009|2009-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma|A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma|Completed||Phase 2|100|Actual|Celgene|||||f||||f||||||||||2017-10-11 04:39:20.82543|2017-10-11 04:39:20.82543
NCT00051129|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2012-11-27||2012-11-27|January 2007||2007-01-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)|An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-Related Macular Degeneration.|Completed||Phase 3|291|Actual|Alcon Research||2|||f||||||||||||||2017-10-11 04:39:20.906772|2017-10-11 04:39:20.906772
NCT00051142|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2008-08-04|||February 2001||2001-02-01|August 2008|2008-08-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)|A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-10-11 04:39:20.990173|2017-10-11 04:39:20.990173
NCT00051155|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2008-08-04|||January 2001||2001-01-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)|A 6-Week Safety and Efficacy Study of TRAVATAN Compared to XALCOM in Subjects With Open-Angle Glaucoma or Ocular Hypertension.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-10-11 04:39:21.070043|2017-10-11 04:39:21.070043
NCT00051168|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2011-10-02|2010-03-22||January 2006||2006-01-01|April 2010|2010-04-01||||March 2009|Actual|2009-03-01||Interventional|||A Long-term Safety Study of Once-daily Travatan|A Long-term Safety Study of Once-daily TRAVATAN|Completed||Phase 3|502|Actual|Alcon Research||1|||f||||||||||||||2017-10-11 04:39:21.149964|2017-10-11 04:39:21.149964
NCT00051181|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2008-08-04|||January 2000||2000-01-01|August 2008|2008-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma|A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-10-11 04:39:21.561127|2017-10-11 04:39:21.561127
NCT00051194|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-03|2012-04-12|||September 2002||2002-09-01|March 2006|2006-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension|A 6-week Safety and Efficacy Study of Combination IOP-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension.|Completed||Phase 2|||Alcon Research|||||||||||||||||||2017-10-11 04:39:21.63463|2017-10-11 04:39:21.63463
NCT00051207|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-07|2013-06-21|||November 2002||2002-11-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Interventional|||Therapy for Depression With Co-occurring Panic or Anxiety Symptoms|Interpersonal Psychotherapy for Depression With Co-occurring Panic and Anxiety Symptoms (IPT-PS)|Completed||Phase 1/Phase 2|36||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:39:21.710727|2017-10-11 04:39:21.710727
NCT00051233|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-07|2014-06-26|||January 2003||2003-01-01|June 2014|2014-06-01|January 2005||2005-01-01|||||Interventional|||Treatment of Schizophrenia Through Internet-Based Psychoeducation|Schizophrenia Patient and Family Continuity of Care|Completed||Phase 2|40||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:39:21.843301|2017-10-11 04:39:21.843301
NCT00051246|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-07|2014-01-23|||January 2002||2002-01-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Group Therapy for Postpartum Depression|Relational Group Intervention for Postpartum Depression|Completed||N/A|147|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 04:39:21.91035|2017-10-11 04:39:21.91035
NCT00051259|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-07|2010-10-01|||January 2003||2003-01-01|October 2010|2010-10-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Effects of Antidepressants on Sexual Functioning|A Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Effects on Sexual Functioning of Extended-Release Bupropion Hydrochloride (300-450mg) and Escitalopram (10-20mg) in Outpatients With Moderate to Severe Major Depression Over an Eight-Week Treatment Period|Completed||Phase 3|420||GlaxoSmithKline||1|||||||||||||||||2017-10-11 04:39:22.017999|2017-10-11 04:39:22.017999
NCT00051272|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-07|2011-03-28|||January 2003||2003-01-01|March 2011|2011-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Effects Of Antidepressants On Sexual Functioning In Adults|A Multicenter, Double-blind Randomized Placebo-controlled Comparison of the Effects on Sexual Functioning of Extended-release Bupropion Hydrochloride (300-450mg) and Escitalopram (10-20mg) in Outpatients With Moderate to Severe Major Depression Over an Eight-Week Treatment Period|Completed||Phase 3|425|Actual|GlaxoSmithKline||1|||||||||||||||||2017-10-11 04:39:22.125314|2017-10-11 04:39:22.125314
NCT00051285|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-07|2014-01-08|||February 2002||2002-02-01|January 2014|2014-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||"ESSENTIAL-The Studies of Oral Enoximone Therapy in Advanced Heart Failure"|ESSENTIAL Protocol No. My-021 and Protocol No. My-026, Each Titled: A Phase III, Randomized, Double-Blind, Multicenter, Parallel Group, Placebo-Controlled Study of Oral Enoximone vs. Placebo in Advanced Chronic Heart Failure Subjects|Terminated||Phase 3|1800||Gilead Sciences||2|||f||||||||||||||2017-10-11 04:39:22.247483|2017-10-11 04:39:22.247483
NCT00051298|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-07|2007-06-11|||November 2002||2002-11-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia|Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia|Completed||Phase 3|107|Actual|Eli Lilly and Company||2|||||||||||||||||2017-10-11 04:39:22.324415|2017-10-11 04:39:22.324415
NCT00051311|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-08|2017-10-05|||January 3, 2003||2003-01-03|September 25, 2014|2014-09-25|September 25, 2014|Actual|2014-09-25|September 25, 2014|Actual|2014-09-25||Interventional|||Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers|A Pilot Study of EPOCH-F/R Induction Chemotherapy and Reduced-Intensity, HLA-Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation, With Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory or Relapsed Hematologic Malignancies|Completed||Phase 2|62|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:39:22.6046|2017-10-11 04:39:22.6046
NCT00051324|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-08|2016-10-27|||August 2002||2002-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|PREDICT-HD||Neurobiological Predictors of Huntington's Disease (PREDICT-HD)|Neurobiological Predictors of Huntington's Disease Trial|Active, not recruiting||N/A|1500|Anticipated|University of Iowa|||1||f||||f||||||Samples With DNA|"     Cerebral spinal fluid acquired and retained since 2012.      Plasma retained from 2000-2007. Urine, plasma and cell lines to be acquired and retained     2008-2013.   "|||2017-10-11 04:39:22.681759|2017-10-11 04:39:22.681759
NCT00051337|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-08|2008-03-03|||January 2003||2003-01-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders|The Physiology of Paroxysmal Hyperkinetic Movement Disorders: A SPECT Study|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:22.80591|2017-10-11 04:39:22.80591
NCT00051350|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-09|2008-04-22|||May 2002||2002-05-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||OmniHeart Trial: Macronutrients and Cardiovascular Risk||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:39:22.868364|2017-10-11 04:39:22.868364
NCT00051376|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-09|2016-02-17|||September 2001||2001-09-01|November 2005|2005-11-01|August 2006|Actual|2006-08-01|||||Interventional|||Vascular Interaction With Age in Myocardial Infarction||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:39:24.476926|2017-10-11 04:39:24.476926
NCT00051389|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-09|2016-02-17|||February 2002||2002-02-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ACE Inhibition and Novel Cardiovascular Risk Factors||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:39:24.538947|2017-10-11 04:39:24.538947
NCT00051402|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-09|2007-10-24|||December 2002||2002-12-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Phytoestrogens and Memory Decline in Menopause|Phytoestrogens and Cognition in Menopause|Completed||Phase 2|96||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:39:24.600087|2017-10-11 04:39:24.600087
NCT00051415|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-09|2006-08-17|||January 2003||2003-01-01|July 2006|2006-07-01|January 2005||2005-01-01|||||Interventional|||Safety and Effectiveness of Flaxseed for Reducing High Cholesterol|A Double Blind, Randomized, Placebo Controlled Trial of Flaxseed in Patients With Hypercholesterolemia|Completed||Phase 2/Phase 3|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:39:24.65918|2017-10-11 04:39:24.65918
NCT00051428|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-09|2006-08-16|||January 2003||2003-01-01|August 2006|2006-08-01|February 2005||2005-02-01|||||Interventional|||The Efficacy of Reiki in the Treatment of Fibromyalgia|The Efficacy of Reiki in the Treatment of Fibromyalgia|Completed||Phase 1|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:39:24.714865|2017-10-11 04:39:24.714865
NCT00051441|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-09|2011-05-17||||||April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx|A Double-Blind, Randomized, Vehicle-Controlled Study Comparing the Safety and Efficacy of Benzydamine HCl 0.15% Oral Rinse Including a Separate Open-Label Standard of Care Arm in Subjects With Radiation-Induced Mucositis|Completed||Phase 3|605|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||||||||||||||||2017-10-11 04:39:24.766707|2017-10-11 04:39:24.766707
NCT00051454|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-10|2007-08-23|||March 2003||2003-03-01|August 2007|2007-08-01|February 2005||2005-02-01|||||Interventional|||Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults|A Randomised, Placebo-Controlled, Double-Blind, Phase I/IIa Clinical Trial to Evaluate the Safety and Immunogenicity of a Candidate Prophylactic DNA Prime-rFPV Boost HIV Vaccination Strategy|Completed||Phase 1/Phase 2|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:39:24.823664|2017-10-11 04:39:24.823664
NCT00051467|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-10|2012-02-22||||||May 2011|2011-05-01||||||||Interventional|||A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer|A Randomized, Phase II/III, Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-line Treatment of Unresectable Locally Advanced Pancreatic Cancer|Completed||Phase 3|||GenVec|||||||||||||||||||2017-10-11 04:39:24.889942|2017-10-11 04:39:24.889942
NCT00051480|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-10|2011-05-11||||||May 2011|2011-05-01||||||||Interventional|||Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer|A Single Arm, Phase II Study of TNFerade™ Biologic Gene Therapy + Radiation + 5-FU and Cisplatin in Locally Advanced, Resectable, Esophageal Cancer|Completed||Phase 2|||GenVec|||||||||||||||||||2017-10-11 04:39:25.129712|2017-10-11 04:39:25.129712
NCT00051493|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-10|2006-07-18|||April 2002||2002-04-01|July 2006|2006-07-01|December 2002||2002-12-01|||||Interventional|||ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.|ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:39:25.210548|2017-10-11 04:39:25.210548
NCT00051506|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-10|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:39:25.270316|2017-10-11 04:39:25.270316
NCT00051519|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-10|2017-06-30|||January 9, 2003||2003-01-09|June 25, 2009|2009-06-25|December 1, 2007|Actual|2007-12-01|December 1, 2007|Actual|2007-12-01||Observational|||Screening HIV-Infected Patients for Vaccine Studies|Screening HIV-Infected Subjects for Vaccine Research Studies|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:25.339277|2017-10-11 04:39:25.339277
NCT00051532|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-13|2007-03-05|||September 1999||1999-09-01|April 2005|2005-04-01|May 2004||2004-05-01|||||Interventional|||Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma|Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5ug) or Placebo in the Treatment of Patients With Hepatocellular Carcinoma Not Amenable to Curative Treatment|Terminated||N/A|700||LEO Pharma|||||||||||||||||||2017-10-11 04:39:25.425869|2017-10-11 04:39:25.425869
NCT00051545|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-13|2007-02-21|||November 1999||1999-11-01|April 2005|2005-04-01|June 2004||2004-06-01|||||Interventional|||Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma|Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5 ug) or Placebo in Prolonging Time to Relapse Following Intended Curative Resection or Percutaneous Ablative Treatment for Hepatocellular Carcinoma|Terminated||Phase 3|608||LEO Pharma|||||||||||||||||||2017-10-11 04:39:25.537348|2017-10-11 04:39:25.537348
NCT00051558|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-13|2009-02-13|2009-01-14||November 2002||2002-11-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis|Comparison of the Effects of Teriparatide With Those of Alendronate Sodium on Lumbar Spine Bone Mineral Density in Glucocorticoid-Induced Osteoporosis|Completed||Phase 3|428|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 04:39:25.727833|2017-10-11 04:39:25.727833
NCT00051571|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-13|2011-10-21||||||October 2011|2011-10-01|October 2003|Actual|2003-10-01|||||Interventional|||Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma|A Phase II Study Using SGN-15 (cBR96-Doxorubicin Immunoconjugate) in Combination With Docetaxel for the Treatment of Advanced Stage or Recurrent Non-Small Cell Lung Carcinoma|Completed||Phase 2|60||Seattle Genetics, Inc.|||||||||||||||||||2017-10-11 04:39:30.112013|2017-10-11 04:39:30.112013
NCT00051584|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-13|2011-10-21||||||October 2011|2011-10-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer|A Phase II Study of SGN-15 (cBR96 - Doxorubicin Immunoconjugate) Combined With Gemzar® Versus Single-Agent Gemzar® in Patients With Advanced Ovarian Cancer|Terminated||Phase 2|60||Seattle Genetics, Inc.|||||||||||||||||||2017-10-11 04:39:30.32189|2017-10-11 04:39:30.32189
NCT00051597|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-13|2011-10-07||||||October 2011|2011-10-01|August 2003|Actual|2003-08-01|||||Interventional|||A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies|A Phase I/II Multi-Dose Study of SGN-30 in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies|Completed||Phase 1/Phase 2|70||Seattle Genetics, Inc.|||||||||||||||||||2017-10-11 04:39:30.403977|2017-10-11 04:39:30.403977
NCT00051623|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-14|2011-05-16|||May 2003||2003-05-01|March 2010|2010-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis|A Multicenter, Randomized, Double-blind Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab) for the Treatment of Patients With Psoriatic Arthritis|Completed||Phase 3|70|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 04:39:30.484216|2017-10-11 04:39:30.484216
NCT00051636|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-14|2012-05-09|2012-04-05||January 2001||2001-01-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period|Randomized, Double-blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget's Disease of Bone Using Risedronate as a Comparator, Including an Extended Observational Period|Completed||Phase 3|172|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:39:30.609936|2017-10-11 04:39:30.609936
NCT00051662|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-14|2005-06-23||||||September 2004|2004-09-01|February 2004||2004-02-01|||||Interventional|||Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Efficacy and Pharmacokinetics of Efalizumab in Subjects With Psoriatic Arthritis|Completed||Phase 1|45||XOMA (US) LLC|||||||||||||||||||2017-10-11 04:39:31.373486|2017-10-11 04:39:31.373486
NCT00051675|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-14|2005-06-23|||July 2002||2002-07-01|September 2004|2004-09-01|September 2003||2003-09-01|||||Interventional|||Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas|An Open-Label, Multi-Dose, Phase I, Dose-Escalating Study of a Subcutaneously Administered Human-Engineered Monoclonal Antibody, ING-1(heMAb), in Subjects With Advanced Adenocarcinomas|Completed||Phase 1|30||XOMA (US) LLC|||||||||||||||||||2017-10-11 04:39:31.442723|2017-10-11 04:39:31.442723
NCT00051688|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-15|2006-07-10|||June 2003||2003-06-01|July 2006|2006-07-01|August 2004||2004-08-01|||||Interventional|||Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer||Terminated||Phase 2|||Chiron Corporation|||||||||||||||||||2017-10-11 04:39:31.532933|2017-10-11 04:39:31.532933
NCT00051701|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-15|2015-03-04|||December 2002||2002-12-01|March 2015|2015-03-01|August 2005|Actual|2005-08-01|||||Interventional|||Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma|Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|61||Sanofi|||||||||||||||||||2017-10-11 04:39:31.61486|2017-10-11 04:39:31.61486
NCT00051714|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-15|2013-07-12|||March 1997||1997-03-01|July 2013|2013-07-01||||December 2012|Actual|2012-12-01||Interventional|||Early Prevention of Conduct Problems|Early Primary Prevention of Conduct Problems|Completed||Phase 4|1050|Actual|New York University School of Medicine||1|||f||||||||||||||2017-10-11 04:39:31.72206|2017-10-11 04:39:31.72206
NCT00051727|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-15|2012-01-06|||October 2002||2002-10-01|January 2012|2012-01-01||||||||Interventional|||Prevention of School Dropout for Mexican American Adolescents|Preventive Intervention for Mexican American Adolescents|Completed||Phase 2|480||Arizona State University|||||f||||||||||||||2017-10-11 04:39:31.784497|2017-10-11 04:39:31.784497
NCT00051740|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-15|2013-04-05|||February 2002||2002-02-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Treating Thought Problems in Patients With Schizophrenia|Compensating for Cognitive Deficits in Schizophrenia|Completed||N/A|120|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||||||||||||2017-10-11 04:39:31.839771|2017-10-11 04:39:31.839771
NCT00051753|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2011-01-07|||November 2002||2002-11-01|January 2011|2011-01-01|May 2005|Actual|2005-05-01|||||Interventional|||Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media|A Multicenter, Randomized, Comparative Study to Evaluate the Efficacy and Safety of Levofloxacin in the Treatment of Children Who Have Recurrent and/or Persistent Acute Otitis Media|Completed||Phase 3|1643|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:39:31.984031|2017-10-11 04:39:31.984031
NCT00051766|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2005-06-23||||||May 2005|2005-05-01||||||||Interventional|||Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs|A Computer-Based HIV Medication Adherence Intervention|Terminated||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:39:32.056446|2017-10-11 04:39:32.056446
NCT00051779|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2005-06-23||||||February 2004|2004-02-01||||||||Interventional|||An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer|A 24-Week Blinded Study Conducted at Multiple Centers, Evaluating the Safety and Effectiveness of Various Doses of the Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) When Randomly Assigned to Patients With Breast Cancer That Has Metastasized to Bone|Completed||Phase 1|||Chugai Pharma USA|||||||||||||||||||2017-10-11 04:39:32.208286|2017-10-11 04:39:32.208286
NCT00051792|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2006-08-16|||January 2003||2003-01-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)|Efficacy of Yoga for Self-Management of Dyspnea in COPD|Completed||Phase 1/Phase 2|36||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:39:32.355139|2017-10-11 04:39:32.355139
NCT00051805|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2007-09-17|||August 2002||2002-08-01|August 2007|2007-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Promoting Adherence to Anti-HIV Drug Regimens|Promoting Adherence to Antiretroviral Regimens|Completed||N/A|119||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:39:32.428375|2017-10-11 04:39:32.428375
NCT00051818|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2016-02-08|||September 2000||2000-09-01|December 2005|2005-12-01|July 2003|Actual|2003-07-01|May 2003|Actual|2003-05-01||Interventional|||Immune and Viral Outcomes of HIV-1 Therapy Interruption|Immune and Viral Outcomes of HIV-1 Therapy Interruption|Completed||Phase 1|20|Actual|The Wistar Institute||2|||f||||t||||||||||2017-10-11 04:39:32.506347|2017-10-11 04:39:32.506347
NCT00051831|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2015-05-29|||October 2003||2003-10-01|May 2015|2015-05-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Interventional|||Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults|A Pilot Study to Measure the Clearance of Replication-Competent HIV-1 in Resting Memory CD4+ Cells in HIV-1-Infected Subjects Who Receive Enfuvirtide Plus Oral Combination Antiretroviral Therapy|Completed||N/A|19|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:39:32.614548|2017-10-11 04:39:32.614548
NCT00051844|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2011-05-09|||August 2002||2002-08-01|May 2011|2011-05-01|November 2004|Actual|2004-11-01|||||Interventional|||Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen|A Double Blind- Randomized, Placebo-controlled Study of Two Doses of Capravirine (AG1549) in Combination With Viracept and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Infected Patients Who Failed an Initial Nonnucleoside Reverse Transcriptase Inhibitor Containing Regimen|Completed||Phase 2|179|Actual|Pfizer|||||||||||||||||||2017-10-11 04:39:32.789713|2017-10-11 04:39:32.789713
NCT00051857|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2017-10-05|||January 14, 2003||2003-01-14|September 21, 2017|2017-09-21||||||||Observational|||MRI Study of Musculoskeletal Function|Virtual Functional Anatomy (VFA)|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:32.961122|2017-10-11 04:39:32.961122
NCT00051870|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-16|2008-03-03|||January 2003||2003-01-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Brain Encoding for Memory|Role of the Prefrontal Cortex in Successful Memory Encoding|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:33.041004|2017-10-11 04:39:33.041004
NCT00044902|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2007-12-20||||||December 2007|2007-12-01||||||||Interventional|||Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)||Completed||Phase 2|||Amgen|||||||||||||||||||2017-10-11 04:39:58.420432|2017-10-11 04:39:58.420432
NCT00051883|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-17|2017-01-11|||December 1999||1999-12-01|October 2016|2016-10-01|February 2005|Actual|2005-02-01|||||Observational|||Chemical Dependency and Smoking Cessation: Patient's Views - 1|Chemical Dependency and Smoking Cessation: Patient's Views|Completed||Phase 4|125|Actual|National Institute on Drug Abuse (NIDA)|||1||f||||f||||||||||2017-10-11 04:39:33.106351|2017-10-11 04:39:33.106351
NCT00051896|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-17|2017-01-10|||August 2002||2002-08-01|March 2005|2005-03-01||||||||Interventional|||Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1|Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers|Unknown status|Active, not recruiting|Phase 1|24||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:39:33.160435|2017-10-11 04:39:33.160435
NCT00051909|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-17|2006-07-18|||November 2002||2002-11-01|July 2006|2006-07-01|June 2003||2003-06-01|||||Interventional|||Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease|Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease|Completed||Phase 2|200||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:39:33.245161|2017-10-11 04:39:33.245161
NCT00051922|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-17|2011-06-06|||October 1997||1997-10-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|July 2006|Actual|2006-07-01||Interventional|||Development of a New HIV Vaccine|Evaluation of the Safety of a Polyvalent Vaccinia Virus HIV-1 Envelope Recombinant Vaccine (PolyEnv1) in Healthy Adults|Completed||Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:39:33.34848|2017-10-11 04:39:33.34848
NCT00051935|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-17|2014-02-04|||January 2003||2003-01-01|February 2014|2014-02-01|October 2003|Actual|2003-10-01|April 2003|Actual|2003-04-01||Interventional|||A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II|Open-Label, Pilot Study of the Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Human Acid Alpha-Glucosidase (rhGAA) as Enzyme Replacement Therapy in Siblings With Glycogen Storage Disease Type II (GSD-II).|Completed||Phase 2|2|Actual|Sanofi||1|||f||||||||||||||2017-10-11 04:39:33.462027|2017-10-11 04:39:33.462027
NCT00051948|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-17|2011-07-21|||January 2003||2003-01-01|February 2007|2007-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer|Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer|Completed||Phase 1/Phase 2|28||Telik|||||f||||||||||||||2017-10-11 04:39:33.554528|2017-10-11 04:39:33.554528
NCT00051961|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-17|2017-06-30|||January 14, 2003||2003-01-14|October 18, 2007|2007-10-18|October 18, 2007||2007-10-18|||||Observational|||Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome|Effects of Dopaminergic Agonist Treatment on Spinal Cord Excitability in Restless Legs Syndrome|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:33.629847|2017-10-11 04:39:33.629847
NCT00051974|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-21|2008-02-07|||December 2002||2002-12-01|February 2008|2008-02-01||||September 2004|Actual|2004-09-01||Interventional|||Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer|A Randomized, Multicenter, Open-Label, Phase 2 Study of VELCADE Alone or VELCADE Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|155||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:39:33.707914|2017-10-11 04:39:33.707914
NCT00051987|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-21|2008-02-07|||December 2002||2002-12-01|February 2008|2008-02-01||||March 2004|Actual|2004-03-01||Interventional|||Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma|A Randomized, Multicenter, Open-Label, Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma|Completed||Phase 2|175||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:39:33.82831|2017-10-11 04:39:33.82831
NCT00052000|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-21|2007-02-28|||November 2002||2002-11-01|February 2007|2007-02-01||||||||Interventional|||A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer|A Phase 1 Single Ascending Dose Trial of MLN2704 (DM1 Conjugated Monoclonal Antibody MLN591) in Subjects With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 1|29||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-10-11 04:39:33.935215|2017-10-11 04:39:33.935215
NCT00052013|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-21|2017-03-02|||February 2003||2003-02-01|February 2011|2011-02-01||||June 2006|Actual|2006-06-01||Interventional|||Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584|A Phase II Open-Label Study of Oral, Continuous, Once Daily PTK787/ZK 222584 in Patients With Von Hippel-Lindau Disease (VHL) and Hemangioblastoma (HB)|Completed||Phase 2|11|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:39:33.997433|2017-10-11 04:39:33.997433
NCT00052026|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-21|2008-12-24|||May 2000||2000-05-01|December 2008|2008-12-01|July 2006|Actual|2006-07-01|June 2005|Actual|2005-06-01||Interventional|||Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure|A Multicenter, Placebo-Controlled, 8-Month Study of the Effect of Twice Daily Carvedilol in Children With Congestive Heart Failure Due to Systemic Ventricular Systolic Dysfunction|Completed||Phase 3|161|Actual|Shaddy, Robert, M.D.||3|||f||||t||||||||||2017-10-11 04:39:34.100802|2017-10-11 04:39:34.100802
NCT00052039|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-21|2007-11-02|||April 2002||2002-04-01|November 2007|2007-11-01|June 2002|Actual|2002-06-01|||||Interventional|||A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone|A Randomized, Double-Blind, Three-Arm, Phase IIIb Study Comparing the Safety and Efficacy of Interferon Gamma-1b Alone, IFN-Gamma 1b With Azathioprine, and Azathioprine Alone in Patients With Idiopathic Pulmonary Fibrosis Receiving Prednisone|Terminated||Phase 3|0|Actual|InterMune||1||Study design changes were needed based on GIPF-001 results|f||||||||||||||2017-10-11 04:39:34.33561|2017-10-11 04:39:34.33561
NCT00052052|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-21|2007-11-02|||September 2002||2002-09-01|November 2007|2007-11-01|September 2004|Actual|2004-09-01|||||Interventional|||An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)|An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis.|Completed||Phase 2|210|Actual|InterMune||1|||f||||||||||||||2017-10-11 04:39:34.521524|2017-10-11 04:39:34.521524
NCT00052065|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-21|2011-07-21|||February 2003||2003-02-01|June 2011|2011-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer|Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer|Completed||Phase 1/Phase 2|28||Telik|||||f||||||||||||||2017-10-11 04:39:34.611532|2017-10-11 04:39:34.611532
NCT00052078|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-22|2017-08-21|2016-07-29||January 2003||2003-01-01|August 2017|2017-08-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Child and Adolescent Anxiety Disorders (CAMS)|Child/Adolescent Anxiety Multimodal Treatment Study|Completed||Phase 3|488|Actual|Johns Hopkins University||4|||f||||||||||||||2017-10-11 04:39:34.689967|2017-10-11 04:39:34.689967
NCT00052091|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-22|2013-09-20|||September 2002||2002-09-01|September 2013|2013-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Therapy for Depressed Elders With Thought Problems|PST in Geriatric Depression With Executive Dysfunction|Completed||Phase 3|221|Actual|University of California, San Francisco||2|||f||||||||||||||2017-10-11 04:39:35.46|2017-10-11 04:39:35.46
NCT00052104|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-22|2013-08-07|||December 2001||2001-12-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Telephone-Based Support for Caregivers of Patients With Dementia|A Telephone Intervention for Dementia Caregivers|Completed||Phase 2/Phase 3|85||Rhode Island Hospital|||||f||||||||||||||2017-10-11 04:39:35.59883|2017-10-11 04:39:35.59883
NCT00052117|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-22|2007-10-05|||January 2003||2003-01-01|October 2007|2007-10-01|May 2005||2005-05-01|||||Interventional|||Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens|A Phase 2, Randomized, Double-Blind, Dose-Ranging Study Of Capravirine (AG1549) In Combination With Kaletra (Trademark) and At Least 2 Nucleoside Reverse Transcriptase Inhibitors in Hiv-Infected Subjects Who Have Failed Antiretroviral Regimens Containing Protease Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Nucleoside Reverse Transcriptase Inhibitors|Completed||Phase 2|300||Pfizer|||||||||||||||||||2017-10-11 04:39:35.677683|2017-10-11 04:39:35.677683
NCT00052130|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-22|2005-06-23||||||September 2004|2004-09-01||||||||Interventional|||Vaccine Therapy for Patients With Stage III Melanoma|Phase III Randomized Double-Blind Pivotal Trial of Immunotherapy With BCG Plus a Polyvalent Melanoma Vaccine, CancerVax™ Vaccine Versus BCG Plus a Placebo as a Post-Surgical Treatment for Stage III Melanoma|Unknown status|Active, not recruiting|Phase 3|1118||CancerVax Corporation|||||||||||||||||||2017-10-11 04:39:35.778415|2017-10-11 04:39:35.778415
NCT00052143|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-23|2009-04-15|||July 1999||1999-07-01|February 2008|2008-02-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|PHAROS||Prospective Huntington At Risk Observational Study|Prospective Huntington At Risk Observational Study (PHAROS)|Unknown status|Active, not recruiting|N/A|1001|Actual|Huntington Study Group|||1||f||||t||||||Samples With DNA|"     Blood sample   "|||2017-10-11 04:39:36.054364|2017-10-11 04:39:36.054364
NCT00052156|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-23|2005-06-23||||||April 2005|2005-04-01||||||||Interventional|||Vaccine Therapy for Patients With Stage IV Melanoma|A Phase III Randomized Double-Blind Pivotal Trial of Immunotherapy With a Polyvalent Melanoma Vaccine, CancerVax™ Vaccine Plus BCG Versus Placebo Plus BCG as a Post-Surgical Treatment for Stage IV Melanoma|Unknown status|Active, not recruiting|Phase 3|670||CancerVax Corporation|||||||||||||||||||2017-10-11 04:39:36.254427|2017-10-11 04:39:36.254427
NCT00052169|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2007-12-13|||January 2003||2003-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer|A Phase 2, Multi-Center Trial of ZD1839 (IRESSA) in Combination With Docetaxel as First-Line Treatment in Patients With Advanced Breast Cancer|Completed||Phase 2|33|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-10-11 04:39:36.495193|2017-10-11 04:39:36.495193
NCT00052182|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2007-10-22|||October 2002||2002-10-01|September 2007|2007-09-01||||||||Interventional|||Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients|A Single Center Phase I Safety and Immunogenicity Study of Epimmune HIV-1 CTL Epitope-Based DNA Vaccine (EP HIV-1090) for Immunotherapy of HIV-1 Infected Individuals Receiving Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:39:36.595721|2017-10-11 04:39:36.595721
NCT00052195|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2016-02-17|||September 2001||2001-09-01|February 2016|2016-02-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People|DARDAR Health Project (Disseminated Tuberculosis and HIV Infection)|Completed||Phase 2/Phase 3|1975|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 04:39:36.690585|2017-10-11 04:39:36.690585
NCT00052208|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-06-11|||March 2002||2002-03-01|May 2013|2013-05-01||||June 2005|Actual|2005-06-01||Interventional|||Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme|A Phase I/II Study of an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), ZD 1839 (Iressa), [NSC #715055] With Radiation Therapy in Glioblastoma Multiforme|Completed||Phase 1/Phase 2|158|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:39:36.790704|2017-10-11 04:39:36.790704
NCT00052221|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2016-04-05|||May 2003||2003-05-01|October 2012|2012-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy|A Placebo Controlled Trial Of Short-Term, High-Dose Epoetin Alfa In Advanced Cancer Outpatients With Mild Fatigue|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:39:36.887397|2017-10-11 04:39:36.887397
NCT00052273|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2015-10-28|||December 2002||2002-12-01|August 2012|2012-08-01|October 2005|Actual|2005-10-01|November 2004|Actual|2004-11-01||Interventional|||LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors|A Phase I Dose Escalation Study With Oral LY317615 in Combination With Capecitabine in Advanced Cancer Patients|Completed||Phase 1|16|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:39:36.982464|2017-10-11 04:39:36.982464
NCT00052286|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2016-02-05|||September 2002||2002-09-01|February 2016|2016-02-01|August 2010|Actual|2010-08-01|July 2006|Actual|2006-07-01||Interventional|||Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer|A Pilot Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Adult Brain Tumor Patients|Completed||N/A|29|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:39:37.057337|2017-10-11 04:39:37.057337
NCT00052299|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2012-08-24|||September 2002||2002-09-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|January 2008|Actual|2008-01-01||Interventional|AML-17||Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia|Gemtuzumab Ozogamicin (GO) Combined With Standard Intensive Chemotherapy Versus Standard Intensive Chemotherapy Alone For Induction/Consolidation In Patients 61-75 Years Old With Previously Untreated AML: A Randomized Phase III Trial (AML-17) Of The EORTC-LG and the GIMEMA-ALWP|Completed||Phase 3|472|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 04:39:37.153408|2017-10-11 04:39:37.153408
NCT00052312|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2012-09-20|||September 2002||2002-09-01|September 2012|2012-09-01||||September 2006|Actual|2006-09-01||Interventional|||Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer|Randomized Trial Of Adriamycin (A) Cisplatin (P) Chemotherapy Versus Paclitaxel (T) Adriamycin (A) And Cisplatin (P) In Patients With Metastatic/Relapsed Or Locally Advanced Inoperable Endometrial Cancer|Completed||Phase 2|141|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:39:37.632427|2017-10-11 04:39:37.632427
NCT00052325|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-12-17|||October 2002||2002-10-01|July 2005|2005-07-01||||||||Interventional|||Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy|Iscar For Supplemental Care In Advanced Non-Small Cell Lung Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:37.800724|2017-10-11 04:39:37.800724
NCT00052338|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-01-22|||September 2002||2002-09-01|January 2013|2013-01-01||||May 2004|Actual|2004-05-01||Interventional|||Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|A Phase I Study Of PS-341 In Combination With Gemcitabine And Carbloplatin In Selected Stage IIIB Or IV Non-Small Cell Lung Cancer|Completed||Phase 1|34|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:39:37.869635|2017-10-11 04:39:37.869635
NCT00052351|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-06-17|||September 2002||2002-09-01|May 2003|2003-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer|A Pilot Study Of Sequential Vaccinations With Recombinant Vaccinia-CEA(6D)-TRICOM, And Recombinant Fowlpox-CEA(6D)-TRICOM (B7.1/ICIAM-1/LFA-3) With Sargramostim (GM-CSF), In Conjunction With Standard Adjuvant Chemotherapy In High Risk Breast Cancer Patients Status Post Surgery With 4+ Or More Lymph Nodes And CEA Expressing Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:37.971151|2017-10-11 04:39:37.971151
NCT00052364|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-06-17|||September 2002||2002-09-01|June 2013|2013-06-01||||January 2006|Actual|2006-01-01||Interventional|||Oxaliplatin in Treating Patients With Liver Cancer|A Phase II Study of Oxaliplatin in Hepatocellular Cancer|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:39:38.049024|2017-10-11 04:39:38.049024
NCT00052377|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-01-15|||September 2002||2002-09-01|January 2013|2013-01-01||||June 2005|Actual|2005-06-01||Interventional|||Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides|A Phase II Open-Label Study Of Recombinant Human Interleukin-12 (NSC 672423) In Mycosis Fungoides (MF) Patients With Cross-Over To Phase I Evaluation Of Escalating Doses Of Interleukin-2 (NSC 373364) Administered With Interleukin-12|Terminated||Phase 1/Phase 2|46|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:39:38.145179|2017-10-11 04:39:38.145179
NCT00052390|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-06-21|||October 2002||2002-10-01|February 2004|2004-02-01|October 2005|Actual|2005-10-01|||||Interventional|||Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma|A Multi-Institutional, Open-Label, Phase II Study Of Doxorubicin And Bevacizumab (Anti-VEFG Monoclonal Antibody, NSC 704865) For Patients With Advanced Or Metastatic Soft-Tissue Sarcoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:38.248654|2017-10-11 04:39:38.248654
NCT00052403|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2014-01-15|||February 2002||2002-02-01|January 2014|2014-01-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors|Phase I Study of Monoclonal Antibody Anti-Anb3 Integrin in Patients With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|Barbara Ann Karmanos Cancer Institute||1||Study was not successful at recruiting particpants|f||||t||||||||||2017-10-11 04:39:38.333066|2017-10-11 04:39:38.333066
NCT00052416|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-06-25|||October 2002||2002-10-01|April 2003|2003-04-01|January 2003|Actual|2003-01-01|||||Interventional|||Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Thalidomide in Indolent Non-Hodgkin's Lymphoma: A Feasibility Study|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:38.410497|2017-10-11 04:39:38.410497
NCT00052429|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2016-01-22|2015-12-15||September 2002||2002-09-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer|Phase I/II Study of Dose-Painting Using Intensity Modulated Radiation Therapy Plus Chemotherapy in Patients With Stage II-IVB Nasopharyngeal Carcinoma|Completed||Phase 1/Phase 2|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:39:38.509184|2017-10-11 04:39:38.509184
NCT00052455|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-12-17|||October 2002||2002-10-01|May 2007|2007-05-01|September 2010|Actual|2010-09-01|||||Interventional|||Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma|A Prospective Randomised Trial Comparing Temozolomide With PCV In The Treatment Of Recurrent WHO Astrocytic Tumours Grades III And IV|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:38.964305|2017-10-11 04:39:38.964305
NCT00052468|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2014-06-24|||August 2002||2002-08-01|June 2014|2014-06-01|January 2011|Actual|2011-01-01|July 2009|Actual|2009-07-01||Interventional|AGO-OVAR9||Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer|A Multi-National Randomized Phase-III GCIG Intergroup-Study Comparing 1st-line Chemotherapy With Gemcitabine/Paclitaxel/Carboplatin vs Paclitaxel/Carboplatin In Previously Untreated Patients With Epithelial Ovarian Cancer FIGO Stages I-IV|Completed||Phase 3|1742|Actual|AGO Study Group||2|||f||||t||||||||||2017-10-11 04:39:39.067574|2017-10-11 04:39:39.067574
NCT00052481|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2016-07-01|||September 2002||2002-09-01|July 2016|2016-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Observational|||Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer|Health-Related Quality Of Life In Patients With Low Risk, Localized Prostate Cancer Randomized To Radical Prostatectomy Or Brachytherapy|Completed||N/A|500|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 04:39:39.223722|2017-10-11 04:39:39.223722
NCT00046605|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2008-07-23|||August 2002||2002-08-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:40:44.10265|2017-10-11 04:40:44.10265
NCT00052494|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2015-07-22|||April 2003||2003-04-01|July 2015|2015-07-01||||February 2009|Actual|2009-02-01||Interventional|||Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase I Study Of STI 571 (Gleevec) In Combination With Cisplatin/Irinotecan In Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 1|9|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 04:39:39.334123|2017-10-11 04:39:39.334123
NCT00052507|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2015-07-22|||January 2003||2003-01-01|July 2015|2015-07-01||||August 2005|Actual|2005-08-01||Interventional|||Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer|A Phase II Study Of PS-341 In Patients With Metastatic Colorectal Cancer|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 04:39:39.414917|2017-10-11 04:39:39.414917
NCT00052520|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2017-03-27||2017-03-27|September 2002||2002-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|April 2011|Actual|2011-04-01||Interventional|||Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation|Phase I/II Study of Adoptive Immunotherapy With CD8+ WT1-Specific CTL Clones for Patients With Advanced MDS, CML, AML or ALL After Allogeneic Hematopoietic Stem Cell Transplant|Completed||Phase 1/Phase 2|37|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 04:39:39.512849|2017-10-11 04:39:39.512849
NCT00052559|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-06-04|||August 2002||2002-08-01|June 2013|2013-06-01||||April 2003|Actual|2003-04-01||Interventional|||Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer|A Phase I Study Of The Antiangiogenic Agent Bevacizumab In Combination With 5-Fluourouracil And External Beam Radiation Therapy In Rectal Cancer|Completed||Phase 1|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:39:39.672336|2017-10-11 04:39:39.672336
NCT00052572|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-06-21|||October 2002||2002-10-01|April 2006|2006-04-01|July 2007|Actual|2007-07-01|||||Interventional|||Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders|A Multicenter Phase II Study Of BMS 247550 (Epothilone B Analogue) In Indolent Lymphoproliferative Disorders|Completed||Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:39:39.779323|2017-10-11 04:39:39.779323
NCT00052585|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-01-15|||October 2002||2002-10-01|January 2013|2013-01-01||||November 2004|Actual|2004-11-01||Interventional|||Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer|A Phase II Trial Of IRESSA (NSC 715055, IND 61187) In Combination With 5-FU/LV/ CPT-11 In Patients With Advanced Or Recurrent Colorectal Cancer|Terminated||Phase 2|50|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:39:39.876324|2017-10-11 04:39:39.876324
NCT00052598|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2017-02-13||2017-02-13|September 2002||2002-09-01|February 2017|2017-02-01|June 2011|Actual|2011-06-01|November 2009|Actual|2009-11-01||Interventional|||Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant|Phase I/II Study of Adoptive Immunotherapy With CD8+ Proteinase 3 (Myeloblastin)-Specific CTL Clones for HLA-A2+ Patients With Relapse or Progression of Disease After Allogeneic Hematopoietic Stem Cell Transplant for High Risk Myeloid Leukemias|Terminated||Phase 1/Phase 2|7|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 04:39:39.985144|2017-10-11 04:39:39.985144
NCT00052611|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2008-07-23|||June 2002||2002-06-01|January 2005|2005-01-01||||||||Interventional|||Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia|Celecoxib In Biomarker Modulation Of Oral Precancerous Lesions: A Pilot Study|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:40.12418|2017-10-11 04:39:40.12418
NCT00052624|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2009-02-06|||July 2002||2002-07-01|April 2004|2004-04-01||||||||Interventional|||Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma|A Phase I Multicenter Trial Of Intratumoral/Interstitial Therapy With HN66000, NC66000 (TransMID) In Patients Between 5 and 18 Years Of Age With Progressive Or Recurrent Glioblastoma Multiforme Or Anaplastic Astrocytoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:40.223752|2017-10-11 04:39:40.223752
NCT00052637|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-10-22|||September 2001||2001-09-01|October 2013|2013-10-01||||May 2002|Actual|2002-05-01||Interventional|||Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer|An Open, Comparative, Within Patient, Controlled Phase III, Multicenter Study Of HEXVIX Fluorescence Cystoscopy And White Light Cystoscopy In the Detection Of Carcinoma In Situ In Patients With Bladder Cancer|Completed||Phase 3|||Photocure|||||f||||f||||||||||2017-10-11 04:39:40.295317|2017-10-11 04:39:40.295317
NCT00052676|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-05-14|||October 2002||2002-10-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer|French Randomized Sentinel Node Multicentric Study|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:40.3867|2017-10-11 04:39:40.3867
NCT00052689|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-10-07|||December 2002||2002-12-01|October 2013|2013-10-01||||October 2007|Actual|2007-10-01||Interventional|||Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer|A Randomized Phase II Trial of PS-341 and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|88|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:39:40.474901|2017-10-11 04:39:40.474901
NCT00052715|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2017-01-26|2017-01-26||November 2002||2002-11-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|April 2008|Actual|2008-04-01||Interventional|Poly-ICLC||Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Trial Of Poly-ICLC For Glioblastoma|Terminated||Phase 2|31|Actual|Sidney Kimmel Comprehensive Cancer Center|Enrollment was prematurely discontinued after the results of the EORTC phase-3 study defined the standard of care for newly diagnosed glioblastoma patients as radiotherapy plus concomitant and adjuvant temozolomide|1||"prematurely discontinued after results of the EORTC phase-3 study defined the SOC for newly   diagnosed GMB pts as RT plus concomitant and adjuvant TMZ"|f||||t||||||||No||2017-10-11 04:39:40.583463|2017-10-11 04:39:40.583463
NCT00052728|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-06-18|||December 2002||2002-12-01|May 2005|2005-05-01|July 2006|Actual|2006-07-01|||||Interventional|||Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer|A Phase II Trial Of Tipifarnib (R15777, ZARNESTRA) In Combination With Tamoxifen In Subjects With Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:40.907764|2017-10-11 04:39:40.907764
NCT00052754|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2012-09-20|||October 2002||2002-10-01|September 2012|2012-09-01||||October 2005|Actual|2005-10-01||Interventional|||Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma|Phase II Study Of Iressa (ZD 1839) In Locally Advanced And/Or Metastatic Synovial Sarcoma Expressing HER1/EGFR1|Completed||Phase 2|48|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:39:40.975651|2017-10-11 04:39:40.975651
NCT00052780|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-09-27|||October 2002||2002-10-01|September 2013|2013-09-01||||November 2007|Actual|2007-11-01||Interventional|||Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors|Phase I Trial of Temozolomide and O6-Benzylguanine in Pediatric Patients With Recurrent Brain Tumors|Completed||Phase 1|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:39:41.085136|2017-10-11 04:39:41.085136
NCT00052832|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2015-09-30|||September 2002||2002-09-01|September 2015|2015-09-01||||July 2005|Actual|2005-07-01||Interventional|||Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia|Phase II Study of Doxercalciferol for the Treatment of Myelodysplastic Syndromes|Completed||Phase 2|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:39:41.277755|2017-10-11 04:39:41.277755
NCT00052845|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2016-06-30|||November 2002||2002-11-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|January 2006|Actual|2006-01-01||Interventional|||Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer|Completed||Phase 2|80|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:39:41.47238|2017-10-11 04:39:41.47238
NCT00052884|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2012-11-30|||October 2003||2003-10-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|September 2007|Actual|2007-09-01||Interventional|||Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation|A Phase I Study of Amifostine Followed by High-Dose Escalation of Melphalan With Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis|Terminated||Phase 1|8|Actual|Eastern Cooperative Oncology Group||1||Slow accrual and changes in clinical practice|f||||f||||||||||2017-10-11 04:39:41.786225|2017-10-11 04:39:41.786225
NCT00052897|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-02-08|||December 2002||2002-12-01|April 2004|2004-04-01||||July 2005|Actual|2005-07-01||Interventional|||SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia|A Phase I/II Trial of SGN-00101 in the Treatment of High-Grade Anal Intraepithelial Neoplasia (AIN) in HIV-Positive Individuals|Completed||Phase 1/Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:39:41.947898|2017-10-11 04:39:41.947898
NCT00052923|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2009-02-06|||March 2003||2003-03-01|June 2006|2006-06-01||||June 2006|Actual|2006-06-01||Interventional|||Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma|Randomized Phase III Trial Of Rituximab (NSC #687451) And Autologous Stem Cell Transplantation For B Cell Diffuse Large Cell Lymphoma|Completed||Phase 3|427|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:39:43.402993|2017-10-11 04:39:43.402993
NCT00052936|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2010-03-11|||January 2001||2001-01-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma|Randomised Study Comparing 6 And 8 Cycles Of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) At 14-Day Intervals (CHOP-14), Both With Or Without The Monoclonal Anti-CD20 Antibody Rituximab In Patients Aged 61 To 80 Years With Aggressive Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|1580|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:43.503208|2017-10-11 04:39:43.503208
NCT00052949|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-24|2013-10-07|||May 2003||2003-05-01|October 2013|2013-10-01||||October 2007|Actual|2007-10-01||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer|Phase II Trial of STI571 in Patients With Relapsed Small Cell Lung Cancer|Completed||Phase 2|91|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:39:45.438269|2017-10-11 04:39:45.438269
NCT00052962|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-26|2012-11-16|2012-09-04||January 2003||2003-01-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis|A Prospective Random Assignment Trial to Study Operative Debulking and Systemic Chemotherapy With or Without Intra-and Peri-Operative Intraperitoneal Chemotherapy for Subjects With Peritoneal Carcinomatosis From Low Grade Gastrointestinal Adenocarcinoma|Completed||Phase 3|30|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:39:45.532024|2017-10-11 04:39:45.532024
NCT00053001|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2013-06-25|||June 2001||2001-06-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome|A Phase II Study on the Effectiveness of Thalomid (Thalidomide) Combined With Procrit (Erythropoietin) for the Treatment of Anemia in Patients With Low and Intermediate Risk-1 (IPSS Score Less Than or Equal to 1.5) Myelodysplastic Syndromes|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:45.941301|2017-10-11 04:39:45.941301
NCT00053014|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2015-03-05|2013-01-02||April 2003||2003-04-01|March 2015|2015-03-01|June 2006|Actual|2006-06-01|June 2005|Actual|2005-06-01||Interventional|||S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia|S0125, A Phase II Study Of Chimerism-Mediated Immunotherapy (CMI) Using Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation In Older Patients With Acute Myeloid Leukemia (AML) In First Complete Remission (A BMT Study)|Terminated||Phase 2|5|Actual|Southwest Oncology Group||1||Poor accrual|f||||t||||||||||2017-10-11 04:39:46.029901|2017-10-11 04:39:46.029901
NCT00053027|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2016-12-05|||February 2003||2003-02-01|December 2016|2016-12-01|November 2009|Actual|2009-11-01|January 2006|Actual|2006-01-01||Interventional|||Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma|Phase II Trial of Rituximab and 2-Chlorodeoxyadenosine (2-CDA) in Newly Diagnosed Mantle Cell Lymphoma (MCL)|Completed||Phase 2|30|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:39:47.668276|2017-10-11 04:39:47.668276
NCT00053040|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2010-09-23|||October 2005||2005-10-01|September 2010|2010-09-01||||||||Interventional|||Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas|Phase I/II Trial Of Intracerebral IL13-PE38QQR Infusions In Pediatric Patients With Recurrent Malignant Glioma|Withdrawn||Phase 1/Phase 2|0|Actual|Pediatric Brain Tumor Consortium||1||Withdrawal of pharmaceutical company support for the investigational drug|f||||t||||||||||2017-10-11 04:39:47.750671|2017-10-11 04:39:47.750671
NCT00053053|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2016-12-06|||December 2002||2002-12-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|March 2005|Actual|2005-03-01||Interventional|||Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer|A Double-Blind Study Of Nutritional Intervention For The Treatment Of Cancer Cachexia Using Juven® Nutritional Supplement|Completed||Phase 3|472|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:39:47.887204|2017-10-11 04:39:47.887204
NCT00053092|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2013-12-17|||October 2002||2002-10-01|June 2007|2007-06-01|February 2009|Actual|2009-02-01|||||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma|National Mantle Cell Lymphoma Trial - Phase II Randomized Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma|Completed||Phase 2|82|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:48.639845|2017-10-11 04:39:48.639845
NCT00053105|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2009-07-04|||February 2002||2002-02-01|March 2003|2003-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase I Trial of BBR 2778 in Combination With Cytarabine, Methylprednisolone and Cisplatin in the Treatment of Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:48.722473|2017-10-11 04:39:48.722473
NCT00053118|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2011-02-25|||March 2002||2002-03-01|February 2011|2011-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer|High Dose Carboplatin Combined With Oral VP-16 In The Treatment Of Pediatric CNS Malignancies|Completed||Phase 1|1|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:39:48.820032|2017-10-11 04:39:48.820032
NCT00053131|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2011-03-07|||January 1999||1999-01-01|March 2011|2011-03-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|High Dose Cytarabine And Mitoxantrone Therapy For Relapsed And Refractory Acute Myeloid And Lymphocytic Leukemia: Effects Of GM-CSF Versus G-CSF On Dendritic Cells And Leukemia Associated Antigen-Specific T-Lymphocytes|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:39:48.90166|2017-10-11 04:39:48.90166
NCT00053144|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2011-03-07|||November 1999||1999-11-01|March 2011|2011-03-01|March 2003|Actual|2003-03-01|February 2003|Actual|2003-02-01||Interventional|||Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia|Irinotecan And Cytarabine In Refractory or Relapsed Acute Myeloid Leukemia And In Chronic Myelogenous Leukemia In Myeloid Blast Transformation: Efficacy And In Vitro Correlates|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:39:49.01399|2017-10-11 04:39:49.01399
NCT00053157|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2013-01-30|||June 2002||2002-06-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia|Use Of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) To Mobilize Donor Peripheral Blood Stem Cells Along With GM-CSF Administration Post Allogeneic Transplant - A Pilot Study|Completed||N/A|10|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:39:49.16812|2017-10-11 04:39:49.16812
NCT00053183|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2009-02-06|||October 2003||2003-10-01|July 2004|2004-07-01||||||||Interventional|||Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I Brachytherapy Dose Escalation Using The GliaSite RTS In Newly Diagnosed Glioblastoma Multiforme In Conjunction With External Beam Radiation Therapy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:49.289266|2017-10-11 04:39:49.289266
NCT00053196|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2016-06-30|||December 2002||2002-12-01|June 2016|2016-06-01|August 2010|Actual|2010-08-01|November 2006|Actual|2006-11-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer|Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation For Patients With Disease Relapse Or Myelodysplasia After Prior Autologous Transplantation|Completed||Phase 2|82|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:39:49.393524|2017-10-11 04:39:49.393524
NCT00053209|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2012-11-30|||April 2004||2004-04-01|November 2012|2012-11-01|May 2009|Actual|2009-05-01|September 2007|Actual|2007-09-01||Interventional|||Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium|Phase II Trial Of Pemetrexed Disodium And Gemcitabine In Advanced Urothelial Cancer|Completed||Phase 2|46|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:39:49.574221|2017-10-11 04:39:49.574221
NCT00053222|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2013-09-04|||February 2003||2003-02-01|September 2013|2013-09-01|July 2007|Actual|2007-07-01|January 2005|Actual|2005-01-01||Interventional|||Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine|A Phase II Study Of Arsenic Trioxide In Patients With Adenocarcinoma Of The Pancreas Refractory To Gemcitabine|Completed||Phase 2|13|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:39:49.93619|2017-10-11 04:39:49.93619
NCT00053235|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2015-05-29|||November 2002||2002-11-01|May 2015|2015-05-01||||August 2010|Actual|2010-08-01||Observational|||Research Study in Patients With Advanced Ovarian Epithelial Cancer|A Pilot Study to Correlate DNA Sequence Copy Number Abnormalities With Outcome in Patients With Advanced Epithelial Ovarian Cancer|Withdrawn||N/A|0|Actual|Gynecologic Oncology Group|||1||f||||||||||||||2017-10-11 04:39:50.045461|2017-10-11 04:39:50.045461
NCT00053248|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2012-05-24|||October 2002||2002-10-01|June 2010|2010-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A Phase I/II Study To Determine The Safety, Tolerability, And Anti-Leukemic Effects of Trisenox (Arsenic Trioxide) In Combination With Gleevec (STI571) In Patients With Resistant Chronic Myelogenous Leukemia In Chronic Phase|Completed||Phase 1/Phase 2|16|Actual|OHSU Knight Cancer Institute|||||f||||t||||||||||2017-10-11 04:39:50.137343|2017-10-11 04:39:50.137343
NCT00046618|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2014-02-19|||July 2002||2002-07-01|February 2014|2014-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Mapping Novel Disease Genes for Dilated Cardiomyopathy||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-10-11 04:40:44.171258|2017-10-11 04:40:44.171258
NCT00053261|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2013-05-24|||July 2003||2003-07-01|June 2005|2005-06-01||||January 2007|Actual|2007-01-01||Observational|||Vaginal Changes and Sexual Function in Patients With Cervical Cancer|Vaginal Length, Elasticity, Lubrication And Sexual Function In Women With Stage IB2 Cervix Carcinoma|Completed||N/A|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:39:50.212421|2017-10-11 04:39:50.212421
NCT00053287|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2010-06-09|||September 2002||2002-09-01|June 2010|2010-06-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS|Phase II Study of Fludarabine, Carboplatin, and Topotecan With Thalidomide for Patients With Relapsed/Refractory or High Risk Acute Myelogenous Leukemia, Chronic Myeloid Leukemia and Advanced Myelodysplastic Syndromes|Completed||Phase 2|42|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:39:50.286698|2017-10-11 04:39:50.286698
NCT00053300|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2010-06-09|||August 2002||2002-08-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|November 2005|Actual|2005-11-01||Interventional|||Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Daily Thalidomide in Extensive Stage Small Cell Lung Cancer Patients Achieving a Complete or Partial Response to Induction Chemotherapy|Completed||Phase 2|30|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:39:50.373226|2017-10-11 04:39:50.373226
NCT00053326|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2013-10-07|||May 2003||2003-05-01|October 2013|2013-10-01||||March 2006|Actual|2006-03-01||Interventional|||Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma|A Phase II Study of Fenretinide (NSC# 374551, IND# 40294) in Children With Recurrent/Resistant High Risk Neuroblastoma|Completed||Phase 2|70|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:39:50.441924|2017-10-11 04:39:50.441924
NCT00053339|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2016-07-11||||||July 2016|2016-07-01||||||||Interventional|||Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer|Phase III Randomized Study of Trastuzumab (Herceptin) With or Without Tamoxifen in Women With Progressive, Stage IV, Estrogen or Progesterone Receptor- and HER2/Neu-Positive Breast Cancer|Withdrawn||Phase 3|0|Actual|Alliance for Clinical Trials in Oncology||2||The study was not activated.|f||||f||||||||||2017-10-11 04:39:50.5124|2017-10-11 04:39:50.5124
NCT00044135|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-20|2005-06-23|||August 2002||2002-08-01|November 2002|2002-11-01||||||||Interventional|||A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.|A Phase II, Randomized, Partially-Blinded Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of 12 Weeks of Treatment with Clevudine (10 mg, 30 mg or 50 mg QD) in Patients Infected with Hepatitis B Virus.|Unknown status|Active, not recruiting|Phase 2|30||Triangle Pharmaceuticals|||||f||||||||||||||2017-10-11 04:39:50.635882|2017-10-11 04:39:50.635882
NCT00044148|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-20|2017-01-30|||July 16, 2002|Actual|2002-07-16|January 2017|2017-01-01|April 28, 2004|Actual|2004-04-28|April 28, 2004|Actual|2004-04-28||Interventional|||The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes|The Effect of LY333531 on Albuminuria in Patients With Type 2 Diabetes A Pilot Clinical Trial|Completed||Phase 2|||Chromaderm, Inc.|||||f|||||t|f||||||||2017-10-11 04:39:50.802883|2017-10-11 04:39:50.802883
NCT00044174|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-20|2017-10-05|||August 15, 2002||2002-08-15|August 11, 2017|2017-08-11||||||||Observational|||Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants|Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants|Completed||N/A|850|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:50.895297|2017-10-11 04:39:50.895297
NCT00044187|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-21|2006-07-18|||April 2001||2001-04-01|July 2006|2006-07-01|September 2003||2003-09-01|||||Interventional|||The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder|The Assessment of a Anti-Obesity Agent for the Treatment of Olanzapine-Associated Weight Gain in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder and Bipolar I Disorder|Completed||Phase 4|130||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:39:50.975973|2017-10-11 04:39:50.975973
NCT00044200|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-21|2017-10-05|||January 10, 2000||2000-01-10|June 12, 2015|2015-06-12|June 12, 2015||2015-06-12|||||Observational|||Positron Emission Tomography (PET) to Study Brain Signaling|Positron Emission Tomography Imaging of Activation-Induced Signal Transduction in Human Brain|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:51.080807|2017-10-11 04:39:51.080807
NCT00044226|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-22|2005-06-23|||April 2002||2002-04-01|August 2002|2002-08-01|October 2002||2002-10-01|||||Interventional|||A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia|Unknown status|Recruiting|Phase 2|350||Milkhaus Laboratory|||||||||||||||||||2017-10-11 04:39:51.789436|2017-10-11 04:39:51.789436
NCT00044239|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-22|2017-06-30|||August 20, 2002||2002-08-20|May 18, 2010|2010-05-18|May 18, 2010||2010-05-18|||||Observational|||Characterization of Childhood-Onset Obsessive-Compulsive Disorder|The Characterization of Childhood Onset Obsessive Compulsive Disorder and the PANDAS Subgroup|Completed||N/A|49|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:51.912231|2017-10-11 04:39:51.912231
NCT00044252|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-22|2017-06-30|||July 26, 2002||2002-07-26|January 22, 2008|2008-01-22|January 22, 2008||2008-01-22|||||Observational|||Role of Hormones in Susceptibility to Seizures in Women With Epilepsy|Role of Serum Gonadal and Neuroactive Steroids in the Seizure Susceptibility of Women With Catamenial Epilepsy|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:39:52.000423|2017-10-11 04:39:52.000423
NCT00044265|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-23|2012-06-06|||July 2002||2002-07-01|June 2012|2012-06-01|November 2004||2004-11-01|||||Interventional|||Treatment of Pediatric Hypertension With Altace Trial|A Dose Escalation, Randomized, Double-blind Withdrawal Study of the Efficacy, Dose-response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents|Completed||Phase 4|310||Pfizer|||||||||||||||||||2017-10-11 04:39:52.072245|2017-10-11 04:39:52.072245
NCT00045903|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-13|2014-04-22|||August 2000||2000-08-01|October 2012|2012-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|Aug1||Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder|CBT Augmentation for SRI Pharmacotherapy in OCD|Completed||N/A|136|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 04:40:21.206775|2017-10-11 04:40:21.206775
NCT00044291|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-23|2015-07-29|||June 2002||2002-06-01|July 2015|2015-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer||Completed||Phase 3|865|Actual|Intarcia Therapeutics||2|||f||||||||||||||2017-10-11 04:39:52.460864|2017-10-11 04:39:52.460864
NCT00044317|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-26|2005-06-23||||||August 2002|2002-08-01||||||||Observational|||Health Effects of Particulate Acids in Late Adolescence||Completed||N/A|1500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:39:52.894004|2017-10-11 04:39:52.894004
NCT00044343|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-26|2014-07-09|||September 2002||2002-09-01|July 2014|2014-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin|An Open-Label, Multicenter, Phase II Study of Oral Lapatinib (GW572016) as Single Agent, Second-Line Therapy in Subjects With Metastatic Colorectal Cancer Who Have Progressed on First-Line Therapy With 5-Fluorouracil in Combination With Irinotecan or Oxaliplatin|Completed||Phase 2|80|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 04:39:52.968471|2017-10-11 04:39:52.968471
NCT00044356|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-26|2011-07-05|||February 2001||2001-02-01|July 2011|2011-07-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||Phase II Trial of Allovectin-7® for Metastatic Melanoma|A Phase II Study of High-Dose Allovectin-7® in Patients With Advanced Metastatic Melanoma|Completed||Phase 2|133|Actual|Vical|||||f||||f||||||||||2017-10-11 04:39:53.167205|2017-10-11 04:39:53.167205
NCT00044369|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-27|2006-09-01|||May 2000||2000-05-01|September 2006|2006-09-01|April 2005||2005-04-01|||||Observational|||Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele|Increased Testicular Cd2+ & Infertility With Varicocele ( a Varicose Vein in the Scrotum)|Completed||N/A|400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:39:53.266136|2017-10-11 04:39:53.266136
NCT00044382|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-27|2009-06-16|||February 2002||2002-02-01|June 2009|2009-06-01||||January 2007|Actual|2007-01-01||Interventional|||Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome|A Phase II Open Label Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome|Completed||Phase 2|25||Celgene|||||f||||t||||||||||2017-10-11 04:39:53.370366|2017-10-11 04:39:53.370366
NCT00044395|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-28|2007-11-05|||July 2002||2002-07-01|November 2007|2007-11-01|October 2005|Actual|2005-10-01|||||Interventional|||Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes|LY333531 Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes|Completed||Phase 3|200||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:39:53.463327|2017-10-11 04:39:53.463327
NCT00044408|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-28|2016-07-25|||July 2002||2002-07-01|July 2016|2016-07-01|October 2005|Actual|2005-10-01|||||Interventional|||Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes|LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes|Completed||Phase 3|200||Chromaderm, Inc.|||||||||||||||||||2017-10-11 04:39:53.625733|2017-10-11 04:39:53.625733
NCT00044421|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-28|2007-11-05|||July 2002||2002-07-01|November 2007|2007-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Treatment of Peripheral Neuropathy in Patients With Diabetes|LY333531 Treatment of Peripheral Neuropathy in Patients With Diabetes|Completed||Phase 3|400||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:39:53.790704|2017-10-11 04:39:53.790704
NCT00044434|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-28|2008-01-25|||May 2002||2002-05-01|January 2008|2008-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Bupropion as a Smoking Cessation Aid in Alcoholics|Bupropion as a Smoking Cessation Aid in Alcoholics|Completed||Phase 4|200||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 04:39:54.043164|2017-10-11 04:39:54.043164
NCT00044447|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-28|2008-06-18|||May 2001||2001-05-01|June 2008|2008-06-01|September 2002|Actual|2002-09-01|||||Interventional|||Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione|A Double-Blind, Placebo-Controlled, Parallel Group Comparison Study to Evaluate the Role of the Addition of Amaryl to NIDDM Patients Not Responding to Maximum Dose Metformin and Thiazolidinedione Therapy|Completed||Phase 3|170|Actual|Sanofi|||||||||||||||||||2017-10-11 04:39:54.133672|2017-10-11 04:39:54.133672
NCT00044473|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-29|2011-06-06|||November 2002||2002-11-01|January 2011|2011-01-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to Treat|An Open-Label Study of Levofloxacin to Evaluate Bacteriologic Outcome in the Treatment of Children Who Are at Risk for Acute Otitis Media That is Difficult to Treat|Completed||Phase 3|206|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:39:54.359313|2017-10-11 04:39:54.359313
NCT00044486|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-29|2017-03-07|||July 2002||2002-07-01|March 2017|2017-03-01|April 2005|Actual|2005-04-01|December 2004|Actual|2004-12-01||Interventional|||Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)|A Randomized Controlled Trial of Posaconazole (SCH 56592) vs. Standard Azole Therapy for the Prevention of Invasive Fungal Infections Among High-Risk Neutropenic Patients|Completed||Phase 3|602|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:39:54.454157|2017-10-11 04:39:54.454157
NCT00044512|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-30|2014-03-26|2009-02-20||August 2002||2002-08-01|March 2014|2014-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma|A Phase II Multicenter Uncontrolled Trial of Sorafenib (BAY43-9006) in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 2|137|Actual|Bayer|Subjects had advanced disease and were heavily pretreated. National Cancer Institute-Common Toxicity Criteria (NCI-CTC) was translated to Medical Dictionary for Regulatory Activities (MedDRA) for System Organ Class (SOC) only.|1|||f||||f||||||||||2017-10-11 04:39:54.590166|2017-10-11 04:39:54.590166
NCT00044525|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-30|2014-12-18|||April 2002||2002-04-01|December 2014|2014-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients|An Uncontrolled Phase II Study Evaluating the Efficacy and Safety of Intravenous BAY59-8862 in Patients With Taxane-Resistant Metastatic Breast Cancer|Completed||Phase 2|82|Actual|Bayer||1|||f||||||||||||||2017-10-11 04:39:55.20379|2017-10-11 04:39:55.20379
NCT00044538|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-30|2009-06-19|||December 2001||2001-12-01|June 2009|2009-06-01|June 2004|Actual|2004-06-01|||||Interventional|||Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients|An Uncontrolled, Phase II Study Evaluating Anti-Tumor Efficacy and Safety of BAY 59-8862 in Patients With Taxane Resistant Non-Small Cell Lung Carcinoma (NSCLC)|Completed||Phase 2|102|Actual|Bayer||1|||f||||||||||||||2017-10-11 04:39:55.316127|2017-10-11 04:39:55.316127
NCT00044551|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-30|2013-10-10|||February 2002||2002-02-01|October 2013|2013-10-01|July 2003|Actual|2003-07-01|||||Interventional|||Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma|An Open Phase II, Multi Center Trial of BAY 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|29|Actual|Bayer||1|||f||||||||||||||2017-10-11 04:39:55.654352|2017-10-11 04:39:55.654352
NCT00044564|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-30|2014-12-18|||December 2001||2001-12-01|December 2014|2014-12-01|January 2003|Actual|2003-01-01|||||Interventional|||Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma|An Uncontrolled Phase II, Multi Center Trial Evaluating Antitumor Efficacy and Safety of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|54|Actual|Bayer||1|||||||||||||||||2017-10-11 04:39:55.782432|2017-10-11 04:39:55.782432
NCT00044577|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-30|2011-03-17|||July 2002||2002-07-01|March 2011|2011-03-01||||||||Interventional|||New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects|See Detailed Description|Completed||Phase 3|166||GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:39:55.952006|2017-10-11 04:39:55.952006
NCT00044590|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2017-05-12|||September 1, 2000|Actual|2000-09-01|May 2017|2017-05-01|November 30, 2016|Actual|2016-11-30|November 30, 2016|Actual|2016-11-30||Observational|||Parkinson's Diseases Susceptibility Genes and Pesticides|Parkinson's Diseases Susceptibility Genes and Pesticides|Completed||N/A|1870|Actual|National Institute of Environmental Health Sciences (NIEHS)|||2||f||||f||||||Samples With DNA|"     Blood, saliva, urine, and stool samples   "|Undecided||2017-10-11 04:39:56.204566|2017-10-11 04:39:56.204566
NCT00044603|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2014-10-14|||February 2000||2000-02-01|October 2014|2014-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS.|Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS|Completed||N/A|505|Actual|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||f||||||Samples With DNA|"     Biologic samples were collected from the mothers and their children as follows: maternal     blood (30-35 ml) within 1 day postpartum and umbilical cord blood (30 - 60 ml) collected by     delivery room staff immediately after the cord was cut. Members of the research staff     transported the samples to the laboratory immediately. The buffy coat, packed red blood     cells, and plasma samples were separated and stored at -70°C and then shipped to Columbia     University. Placental tissue and meconium were also collected. The placental tissue and     meconium were sent to Columbia and stored for future analysis under separate funding.   "|||2017-10-11 04:39:56.272525|2017-10-11 04:39:56.272525
NCT00044616|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2015-10-02|||February 2001||2001-02-01|December 2013|2013-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Relapse Prevention for Bipolar Type-II Disorder|Relapse Prevention of Bipolar Type-II Disorder|Completed||Phase 4|180||University of Pennsylvania|||||f||||||||||||||2017-10-11 04:39:56.33761|2017-10-11 04:39:56.33761
NCT00044629|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2013-09-12|||September 2001||2001-09-01|September 2013|2013-09-01|August 2006||2006-08-01|||||Interventional|||Combined Behavioral/Pharmacological Therapy for Insomnia|Combined Behavioral/Pharmacological Therapy for Insomnia|Completed||Phase 2|162|Actual|Duke University||3|||f||||||||||||||2017-10-11 04:39:56.41851|2017-10-11 04:39:56.41851
NCT00044642|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2013-12-05|||December 2000||2000-12-01|December 2013|2013-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Lorazepam-Induced Toxicity in the Aged|Long-Term Lorazepam Use and Acute Toxicity in the Aged|Completed||Phase 4|90|Anticipated|Nathan Kline Institute for Psychiatric Research|||||f||||||||||||||2017-10-11 04:39:56.505226|2017-10-11 04:39:56.505226
NCT00044655|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2016-03-28|2013-09-27||July 2001||2001-07-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Switching Medication to Treat Schizophrenia|Effectiveness of Switching Antipsychotic Medications|Completed||Phase 4|219|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 04:39:56.600633|2017-10-11 04:39:56.600633
NCT00044668|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2015-02-19|||August 2002||2002-08-01|January 2015|2015-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination|An Open-Label Study to Examine the Long-Term Effect on Glucose Control (HbA1c) and Safety of AC2993 Given Two Times a Day to Subjects With Type 2 Diabetes Treated With Metformin, a Sulfonylurea, or Metformin and Sulfonylurea Combination|Completed||Phase 3|155|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 04:39:56.906875|2017-10-11 04:39:56.906875
NCT00044681|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2011-05-17|||October 2002||2002-10-01|November 2010|2010-11-01|March 2004|Actual|2004-03-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression|A Study to Evaluate the Efficacy, Safety and Maintenance Effect of Risperidone Augmentation of SSRI Monotherapy in Young and Older Adult Patients With Unipolar Treatment-Resistant Depression|Completed||Phase 3|258|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:39:56.993515|2017-10-11 04:39:56.993515
NCT00045916|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-13|2013-08-09|||February 2001||2001-02-01|October 2008|2008-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Optimizing Electroconvulsive Therapy for Depression|Optimization of Electroconvulsive Therapy|Completed||Phase 4|340|Actual|New York State Psychiatric Institute||6|||f||||||||||||||2017-10-11 04:40:21.409949|2017-10-11 04:40:21.409949
NCT00044694|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2015-02-19|||August 2002||2002-08-01|January 2015|2015-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus|A Phase 2, Randomized, Triple-Blind, Placebo-Controlled, Short-Term, Dose-Response Study to Examine the Effect on Glucose Control and Safety and Tolerability of AC2993 Given Two Times a Day in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|156|Actual|AstraZeneca||8|||f||||f||||||||||2017-10-11 04:39:57.074579|2017-10-11 04:39:57.074579
NCT00044707|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-03|2015-05-20|||August 2002||2002-08-01|May 2015|2015-05-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide||Completed||Phase 2|24|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:39:57.248042|2017-10-11 04:39:57.248042
NCT00044720|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-04|2009-08-17||||||August 2009|2009-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients|An Open-label, Concentration Controlled, Randomized, 12 Month Study of Prograf + Rapamune + Cor|Completed||Phase 4|484|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:39:57.32278|2017-10-11 04:39:57.32278
NCT00044733|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-04|2006-05-17|||March 2000||2000-03-01|May 2006|2006-05-01|September 2004||2004-09-01|||||Interventional|||Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant|A Dose-Finding Study of the Safety of Gemtuzumab Ozogamicin as Single Agent Treatment of Patients With Relapsed Acute Myelogenous Leukemia After Autologous or Allogenic Hematopoietic Stem Cell Transplant (HSCT)|Completed||Phase 2|38||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:39:57.395104|2017-10-11 04:39:57.395104
NCT00044746|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-04|2013-02-07|||October 2000||2000-10-01|February 2013|2013-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections|An Open-label, Randomized Study Comparing the Efficacy and Safety of Piperacillin/Tazobactam and Ampicillin/Sulbactam Administered Intravenously in the Empirical Treatment of Foot Infections in Diabetic Inpatients|Completed||Phase 4|314|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:39:57.481674|2017-10-11 04:39:57.481674
NCT00044759|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-04|2007-10-08||||||October 2007|2007-10-01|January 2003|Actual|2003-01-01|||||Interventional|||Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma|A Randomized, Open-Label, Multi-Center, Comparative Study of the Efficacy and Safety of Piperacillin/Tazobactam to Cefepime for the Empiric Treatment of Neutropenic Fever in Patients With a Hematologic Malignancy or Lymphoma|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:39:57.549453|2017-10-11 04:39:57.549453
NCT00044772|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-04|2009-08-13|||November 2001||2001-11-01|August 2009|2009-08-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Study Evaluating Venlafaxine ER in Patients With Panic Disorder|A Double-blind, Placebo-controlled, Parallel-group Comparison of Venlafaxine Extended-release Capsules and Paroxetine in Outpatients With Panic Disorder|Completed||Phase 3|653|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:39:57.67788|2017-10-11 04:39:57.67788
NCT00044785|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-04|2005-06-23|||August 2002||2002-08-01|May 2005|2005-05-01|March 2004||2004-03-01|||||Interventional|||Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors|A Phase I Study of Escalating Doses of CPT-11 and 5fluorouracil (5FU) Plus PN401 With a Fixed Dose of Leucovorin in Patients With Solid Tumor Malignancies.|Terminated||Phase 1|24||Wellstat Therapeutics|||||||||||||||||||2017-10-11 04:39:57.74305|2017-10-11 04:39:57.74305
NCT00044798|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-04|2013-09-26|||September 2001||2001-09-01|September 2013|2013-09-01|August 2008|Actual|2008-08-01|March 2007|Actual|2007-03-01||Interventional|rtms||Magnetic Stimulation Therapy for Treating Vascular Depression|Vascular Depression and Magnetic Stimulation Therapy|Completed||Phase 3|132|Anticipated|University of Iowa||2|||f||||t||||||||||2017-10-11 04:39:57.806565|2017-10-11 04:39:57.806565
NCT00044811|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-05|2008-08-20|||March 2002||2002-03-01|August 2008|2008-08-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma|A Multicenter, Double-Blind, Randomized, Parallel Groups Placebo-Controlled Study to Assess the Efficacy and Safety of Fexofenadine 120mg BID in Subjects With Mild to Moderate Persistent Asthma|Completed||Phase 3|1000|Anticipated|Sanofi|||||||||||||||||||2017-10-11 04:39:57.891926|2017-10-11 04:39:57.891926
NCT00044824|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-05|2008-08-20|||February 2002||2002-02-01|August 2008|2008-08-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma|A Multicenter, Double-Blind, Randomized, Parallel Groups Placebo-Controlled Study to Assess the Efficacy and Safety of Fexofenadine 120mg BID in Subjects With Mild to Moderate Persistent Asthma|Completed||Phase 3|1000|Anticipated|Sanofi|||||||||||||||||||2017-10-11 04:39:57.989211|2017-10-11 04:39:57.989211
NCT00044837|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-05|2015-06-03||||||June 2003|2003-06-01||||||||Interventional|||Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women|A Phase I, Pharmacokinetic Study of Hormone Replacement Therapy in HIV-1-Infected, Postmenopausal Women on Nelfinavir, Lopinavir/Ritonavir, or Efavirenz|Terminated||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:39:58.077053|2017-10-11 04:39:58.077053
NCT00044863|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-05|2011-02-21|||August 2002||2002-08-01|February 2011|2011-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma|A Phase II Multicenter Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|250|Actual|ImClone LLC||1|||f||||f||||||||||2017-10-11 04:39:58.154524|2017-10-11 04:39:58.154524
NCT00044876|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-05|2017-10-05|||September 2, 2002||2002-09-02|October 1, 2015|2015-10-01|October 1, 2015|Actual|2015-10-01|June 16, 2007|Actual|2007-06-16||Interventional|||Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist|Treatment of Leiomyomata With the Selective Progesterone Receptor Modulator CDB-2914|Completed||Phase 2|56|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:39:58.244472|2017-10-11 04:39:58.244472
NCT00044889|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2014-03-17|||May 2002||2002-05-01|March 2014|2014-03-01|March 2003|Actual|2003-03-01|||||Interventional|||Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia|A Phase II, Open-Label Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia|Completed||Phase 2|40||Sanofi|||||||||||||||||||2017-10-11 04:39:58.322108|2017-10-11 04:39:58.322108
NCT00044915|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2009-06-09|||December 2000||2000-12-01|June 2009|2009-06-01|September 2004|Actual|2004-09-01|||||Interventional|||Repinotan in Patients With Acute Ischemic Stroke|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic / Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke|Completed||Phase 2|782|Actual|Bayer||2|||f||||||||||||||2017-10-11 04:39:58.488942|2017-10-11 04:39:58.488942
NCT00044928|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-02-07|||July 2002||2002-07-01|February 2013|2013-02-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection|Randomized, Open-label, Comparative Study of Zosyn (Pip/Tazo [12g/1.5g]) Administered by Daily 24hr Continuous Infusion vs Zosyn (Pip/Tazo) [3g/0.375g]) q6h for the Treatment of Hospitalized Patients With Complicated Intra-abdominal Infection|Completed||Phase 4|262|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:39:58.928248|2017-10-11 04:39:58.928248
NCT00044954|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2009-02-06|||November 2001||2001-11-01|February 2005|2005-02-01||||||||Interventional|||Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Low Dose Total-Body Irradiation And Fludarabine Followed By HLA Matched Allogeneic Stem Cell Transplantation For Hematologic Malgnancies - A Multi-Center Study|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:59.022293|2017-10-11 04:39:59.022293
NCT00044967|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2016-07-01|||May 2002||2002-05-01|July 2016|2016-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Genetic Study of Young Patients With Colorectal Cancer|A Prospective Study Of The Prognostic Significance Of Microsatellite Instability In Patients With Early Age-Of-Onset Colorectal Cancer|Completed||N/A|651|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 04:39:59.182418|2017-10-11 04:39:59.182418
NCT00044980|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2017-02-21|||July 2002||2002-07-01|November 2012|2012-11-01|December 2006|Actual|2006-12-01|September 2005|Actual|2005-09-01||Interventional|||Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer|Fresh Start: Promoting Health in Prostate Cancer Survivors|Completed||N/A|||Duke University|||||f||||t||||||||||2017-10-11 04:39:59.423705|2017-10-11 04:39:59.423705
NCT00044993|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-05-29|||February 2002||2002-02-01|July 2004|2004-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer|Phase II, Single Arm, Single Institution Clinical Trial of Docetaxel and Doxorubicin in Combination With Local Administration of INGN 201 (Ad5CMV-p53) in Locally Advanced Breast Cancer (LABC)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:59.540946|2017-10-11 04:39:59.540946
NCT00045006|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-05-29|||July 2001||2001-07-01|October 2003|2003-10-01|July 2008|Actual|2008-07-01|December 2005|Actual|2005-12-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer|Phase I Clinical Trial of Oral Suberoylanilide Hydroxamic Acid - SAHA (MSK390) in Patients With Advanced Solid Tumors and Hematologic Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:39:59.621493|2017-10-11 04:39:59.621493
NCT00045019|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2012-08-24|||May 2002||2002-05-01|August 2012|2012-08-01|March 2005|Actual|2005-03-01|June 2004|Actual|2004-06-01||Observational|||Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care|An International Field-Testing Study Of The Reliability And Validity Of A Patient Satisfaction Module (QLQ-SAT32) Assessing Cancer Patients' Perception Of The Quality Of Care Received Within The Hospital|Completed||N/A|795|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||||||2017-10-11 04:39:59.764341|2017-10-11 04:39:59.764341
NCT00045032|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2017-03-17|2016-10-19||November 2001||2001-11-01|March 2017|2017-03-01|June 2015|Actual|2015-06-01|March 2005|Actual|2005-03-01||Interventional|HERA|Full Analysis Set (FAS) Population: All enrolled/randomized participants who had an available signed Informed Consent Form.|Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer|A Randomized Three-Arm, Multicenter Comparison of 1 Year and 2 Years of Herceptin Versus No Herceptin in Women With HER2-Positive Primary Breast Cancer Who Have Completed Adjuvant Chemotherapy|Completed||Phase 3|5099|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 04:40:00.154871|2017-10-11 04:40:00.154871
NCT00045045|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-12-17|||May 2002||2002-05-01|September 2002|2002-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Positron Emission Tomography in Detecting Testicle Cancer|A Study Of 18 FDG PET In The Prediction Of Relapse In Patients With A Clinical Stage I Non-Seminomatous Germ Cell Tumor|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:07.263165|2017-10-11 04:40:07.263165
NCT00045097|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-18|||May 2002||2002-05-01|January 2007|2007-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Phase II Clinical Trial Of BMS-247550 (NSC 710428), An Epothilone B Analog, In Patients With Breast Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:40:07.358578|2017-10-11 04:40:07.358578
NCT00045110|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2017-07-14|2017-05-04||August 2002||2002-08-01|July 2017|2017-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||enrolled between 8/2002 and 8/2005. All recruited from outpatient setting.|Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma|A Phase I/II Trial of OSI-774 in Patients With Recurrent Malignant Gliomas and Malignant Gliomas Post Radiation Therapy|Completed||Phase 1/Phase 2|136|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 04:40:07.461731|2017-10-11 04:40:07.461731
NCT00045123|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-12-17|||February 2002||2002-02-01|February 2004|2004-02-01||||||||Interventional|||R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence|Phase IIB, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Efficacy of MPC-7869 in Delaying the Systemic Progression of Prostate Cancer in Patients With Intermediate to High Risk of Recurrence With Rising PSA Levels After Prostatectomy, Prostatectomy and Radiotherapy or Radiotherapy Alone for Localized Disease|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:08.535062|2017-10-11 04:40:08.535062
NCT00045136|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2009-04-02|||January 2002||2002-01-01|April 2009|2009-04-01||||January 2003|Actual|2003-01-01||Interventional|||Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Multicenter Dosimetry Trial to Evaluate Radiation Absorbed Dose From Holmium-166-DOTMP in Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:08.730502|2017-10-11 04:40:08.730502
NCT00045149|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2010-05-05|||October 2002||2002-10-01|May 2010|2010-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Biological Therapy in Treating Patients With Metastatic Melanoma|Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen Specific T Cell Clones Targeting Cancer Testis Antigens for Patients With Metastatic Melanoma|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:40:08.810035|2017-10-11 04:40:08.810035
NCT00045162|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-07-03|2013-04-16||November 2002||2002-11-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Interventional||Eleven ineligible patients on the cisplatin + irinotecan arm, and eight ineligible patients on the cisplatin + etoposide arm were excluded from the analysis.|S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer|Randomized Phase III Trial of Cisplatin and Irinotecan (NSC-616348) Versus Cisplatin and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer (E-SCLC)|Completed||Phase 3|671|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:40:08.97747|2017-10-11 04:40:08.97747
NCT00045175|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2016-06-21|||June 2002||2002-06-01|June 2016|2016-06-01||||June 2013|Actual|2013-06-01||Interventional|||UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer|A Phase I Study of UCN-01 in Combination With Topotecan in Patients With Solid Tumors|Completed||Phase 1|33|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 04:40:11.407758|2017-10-11 04:40:11.407758
NCT00045188|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-01-22|||August 2002||2002-08-01|January 2013|2013-01-01||||July 2004|Actual|2004-07-01||Interventional|||Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer|Phase II Trial of STI571 in Metastatic Breast Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:40:11.484091|2017-10-11 04:40:11.484091
NCT00045227|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-18|||August 2002||2002-08-01|December 2003|2003-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer|A Pilot Trial of Pox Vector PSA Vaccine With Concurrent Docetaxel Versus Pox Vector Vaccine Followed by Docetaxel in Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:11.837359|2017-10-11 04:40:11.837359
NCT00045266|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2016-06-01|||April 2002||2002-04-01|June 2016|2016-06-01||||February 2007|Actual|2007-02-01||Interventional|||VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma|An Open-Label, Long Term, Safety, and Tolerability Study of VEGF Trap in Patients With Incurable, Relapsed or Refractory Solid Tumors or Lymphoma|Completed||Phase 1|||Regeneron Pharmaceuticals|||||f||||||||||||||2017-10-11 04:40:11.914556|2017-10-11 04:40:11.914556
NCT00045279|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer|Phase II Trial of PEG-Intron in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:40:11.984958|2017-10-11 04:40:11.984958
NCT00045292|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2010-09-17|||April 2002||2002-04-01|September 2010|2010-09-01|October 2004|Actual|2004-10-01|||||Interventional|||Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation|A Phase III Multicenter Study of Cytomegalovirus Prophylaxis With Valacyclovir for the Prevention of Serious Fungal and Bacterial Infections Among Cytomegalovirus Seronegative Recipients of Cytomegalovirus Seropositive Sx Stem Cell Transplants|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:40:12.063767|2017-10-11 04:40:12.063767
NCT00045305|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2015-01-15|2015-01-09||May 2005||2005-05-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Interventional||eligible and treated patients|Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes|A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplant for the Treatment of Myelodysplastic Syndromes|Completed||Phase 2|17|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:40:12.192184|2017-10-11 04:40:12.192184
NCT00045318|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-07-09|||May 2002||2002-05-01|April 2003|2003-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction|A Phase I Study of DX-8951f (Exatecan Mesylate for Injection) in Patients With Renal Dysfunction|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:12.795419|2017-10-11 04:40:12.795419
NCT00045331|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-18|||August 2002||2002-08-01|October 2004|2004-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer|Are the Proteomic Profiles of Serum and Urine Predictivefor Clinical Outcome After Definitive Radiotherapy for Localized Prostate Cancer? A Preliminary Cohort Study|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:12.890555|2017-10-11 04:40:12.890555
NCT00045357|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2010-09-20|||November 2001||2001-11-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|||||Interventional|||Biological Therapy in Treating Patients With Metastatic Melanoma|Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD4+ Antigen-Specific T Cell Clones for Patients With Metastatic Melanoma|Completed||Phase 1|18|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:40:12.97627|2017-10-11 04:40:12.97627
NCT00045370|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer|A Phase I Study of the Safety, Tolerability, and Antitumor Activity of Escalating Doses of Intravenous CCI-779 Given in Combination With Escalating Doses of Interferon-Alpha to Patients With Advanced Renal Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:40:13.052303|2017-10-11 04:40:13.052303
NCT00045838|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-10|2015-09-30|||August 2002||2002-08-01|September 2015|2015-09-01|April 2003|Actual|2003-04-01|April 2003|Anticipated|2003-04-01||Interventional|||HIV-1 Vaccine Test in Uninfected Adult Volunteers|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA006-00-VP, In Uninfected Adult Volunteers|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||||The study product was revised. PI withdrew the study without enrolling participants..|f||||||||||||||2017-10-11 04:40:20.838569|2017-10-11 04:40:20.838569
NCT00045396|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-01-08|||June 2002||2002-06-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS)|A Phase II Study of the Farnesyltransferase Inhibitor ZARNESTRA (Tipifarnib, R115777, NSC #702818, IND #58,359) in Complete Remission Following Induction and/or Consolidation Chemotherapy in Adults With Poor-Risk Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplasia (MDS).|Completed||Phase 2|44|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:40:13.13848|2017-10-11 04:40:13.13848
NCT00045422|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A Phase II Open Label Study to Determine Safety and Efficacy of Interferon-alpha in Combination With Imantinib Mesylate (Gleevec) in Patients With Chronic Phase Chronic Myelogenous Leukemia Who Have Not Achieved a Complete Cytogenetic Response to Gleevec as a Single Agent|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:40:13.220461|2017-10-11 04:40:13.220461
NCT00045435|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2017-04-11|2017-01-25||April 2002||2002-04-01|April 2017|2017-04-01||||June 2009|Actual|2009-06-01||Interventional|||Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission|Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation From HLA Matched Related Donors for Treatment of Older Patients With De Novo or Secondary Acute Myeloid Leukemia in First Complete Remission|Active, not recruiting||Phase 2|17|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:40:13.302778|2017-10-11 04:40:13.302778
NCT00045448|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-05-29|||April 2002||2002-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|Single Center Open-Label Non-Comparative Phase I Dose Finding Study Of Weekly Flavopiridol In Combination With Weekly Docetaxel In Patients With Advanced Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:13.611662|2017-10-11 04:40:13.611662
NCT00045461|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-08-06|||June 2000||2000-06-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|A Randomized Phase II/III Trial Comparing Carboplatin-Ifosfamide (IC)-Chemotherapy Vs. IC-Chemotherapy Combined With Extreme Whole Body Hyperthermia In Patients With Recurrence Of Epithelial Ovarian Carcinoma: DOLPHIN-1-STUDY|Unknown status|Recruiting|Phase 2/Phase 3|241|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:13.705458|2017-10-11 04:40:13.705458
NCT00045474|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2009-02-06|||October 2002||2002-10-01|April 2003|2003-04-01||||||||Interventional|||Brachytherapy in Treating Patients With Recurrent Malignant Glioma|Phase I Brachytherapy Dose Escalating Study Using the Proxima Therapeutics, Inc. GliaSite RTS in Patients With Recurrent Malignant Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:13.83823|2017-10-11 04:40:13.83823
NCT00045487|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-12-09|2013-05-07||June 2002||2002-06-01|December 2013|2013-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|OSI-774||Erlotinib in Treating Patients With Advanced Kidney Cancer|A Phase II, Pharmacokinetic And Biologic Correlative Study of OSI-774, An EGFR Tyrosine Kinase Inhibitor, In Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|41|Actual|The University of Texas Health Science Center at San Antonio|The PI/responsible party left this institution. Additional records for completion of results entries is not available at our institution. NCI transferred the PRS record to this institution >4.5 years after the PIs left employment.|1|||f||||f||||||||||2017-10-11 04:40:13.926098|2017-10-11 04:40:13.926098
NCT00045500|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2015-04-29|||June 2002||2002-06-01|August 2005|2005-08-01||||January 2010|Actual|2010-01-01||Interventional|||UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma|A Phase I Trial Of UCN-01 And Prednisone In Patients With Refractory Solid Tumors And Lymphomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:40:14.126213|2017-10-11 04:40:14.126213
NCT00045513|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2015-07-22|||June 2002||2002-06-01|July 2015|2015-07-01||||December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma|Phase I/II Study Of UCN-01 In Combination With Fludarabine In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma|Completed||Phase 1/Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 04:40:14.205642|2017-10-11 04:40:14.205642
NCT00045526|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-03|||June 2002||2002-06-01|June 2013|2013-06-01||||February 2007|Actual|2007-02-01||Interventional|||Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer|Phase II Study Of OSI-774 In Advanced Esophageal Cancer|Completed||Phase 2|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:40:14.280121|2017-10-11 04:40:14.280121
NCT00045539|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-21|||October 2002||2002-10-01|December 2005|2005-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma|A Phase II Study of Methotrexate and Thiotepa Chemotherapy for Patients With Newly Diagnosed Primary CNS Lymphoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:14.372666|2017-10-11 04:40:14.372666
NCT00045565|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-04-08|||October 2002||2002-10-01|April 2013|2013-04-01||||November 2008|Actual|2008-11-01||Interventional|||Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma|Phase I Study of Combined Radiotherapy and Arsenic Trioxide for the Treatment of Newly Diagnosed Malignant Glioma|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:40:14.464992|2017-10-11 04:40:14.464992
NCT00045591|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2017-01-09|||February 2003||2003-02-01|January 2017|2017-01-01|January 2010|Actual|2010-01-01|August 2005|Actual|2005-08-01||Interventional|||Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer|Evaluation Of Novel Therapeutic Agents (Celecoxib: NSC # 719627) Against Breast Cancer: An Innovative Randomized Phase II Trial Design|Terminated||Phase 2|39|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:40:14.590221|2017-10-11 04:40:14.590221
NCT00045604|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2008-07-23|||July 2002||2002-07-01|April 2004|2004-04-01||||||||Interventional|||Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase I Study of Imatinib (Gleevec) in Combination With Irinotecan and Cisplatin in Extensive Stage Small Cell Lung Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:15.042882|2017-10-11 04:40:15.042882
NCT00045617|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2012-06-11|||January 2003||2003-01-01|June 2012|2012-06-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer|A Phase II Trial of Patients With Limited Stage Small Cell Lung Cancer Treated With Thoracic Radiation Therapy and Chemotherapy With Cisplatin/Etoposide Followed by Cisplatin/Etoposide and Anti-Idiotype Monoclonal Antibody Vaccines|Terminated||Phase 2|9|Actual|Southwest Oncology Group||1||Closed due to lack of drug availability.|f||||t||||||||||2017-10-11 04:40:15.144736|2017-10-11 04:40:15.144736
NCT00045630|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-04-16|2012-11-15||January 2003||2003-01-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|May 2008|Actual|2008-05-01||Interventional|||S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium|A Sequential Approach to the Treatment of Muscle Invasive, Non-Metastatic Urothelial Carcinoma of the Bladder: A Phase II Trial of Neoadjuvant Gemcitabine, Paclitaxel and Carboplatin With Molecular Correlates|Completed||Phase 2|77|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:40:15.543388|2017-10-11 04:40:15.543388
NCT00045669|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2012-06-11|||July 2002||2002-07-01|June 2012|2012-06-01|January 2005|Actual|2005-01-01|January 2004|Actual|2004-01-01||Interventional|||Imatinib Mesylate in Treating Patients With Salivary Gland Cancer|A Phase 2 Study Of Imatinib Mesylate In Adenoid Cystic, Lymphoepithelioma-Like And Myoepithelial Salivary Gland Carcinomas|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 04:40:17.30355|2017-10-11 04:40:17.30355
NCT00045682|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2017-07-12|||September 2002||2002-09-01|July 2017|2017-07-01||||July 15, 2006|Actual|2006-07-15||Interventional|||CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of CT-2103 in the Third-Line Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|78|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:40:17.435498|2017-10-11 04:40:17.435498
NCT00045695|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-05-16|||August 2002||2002-08-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|March 2006|Actual|2006-03-01||Interventional|||Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia|A Phase II Study Of PS-341 (NSC 681239) In Patients With Untreated Or Relapsed Waldenstrom's Macroglobulinemia|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:40:17.532979|2017-10-11 04:40:17.532979
NCT00045708|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2017-03-28|2016-10-14||October 2002||2002-10-01|March 2017|2017-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas|A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-grade Gliomas|Completed||Phase 1/Phase 2|57|Actual|National Cancer Institute (NCI)|Phase 2 was completed using only nonP450 MTD (6.8mg/m21) as the MTD for P450 was not determined until the Phase 2 accrual had completed.|3|||f||||t||||||||No||2017-10-11 04:40:17.675082|2017-10-11 04:40:17.675082
NCT00045721|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2009-10-15|||March 2003||2003-03-01|October 2009|2009-10-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma|Phase I Trial of GLIADEL and O(6)-Benzylguanine in Pediatric Patients With Recurrent Malignant Gliomas|Terminated||Phase 1|3|Actual|Pediatric Brain Tumor Consortium||||Poor accrual|f||||t||||||||||2017-10-11 04:40:18.622907|2017-10-11 04:40:18.622907
NCT00045734|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2017-05-02|2017-03-10||February 2003||2003-02-01|May 2017|2017-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||23 patients were enrolled and evaluated however 1 patient was found to be ineligible as patient had a second malignancy within 3 years of registration. Demographics for this patient are reported.|Imatinib Mesylate in Treating Patients With Recurrent Meningioma|Phase II Trial of STI571 (NSC 716051) in Patients With Recurrent Meningioma|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)|The study was closed prematurely due to limited activity and slow accrual. Study was designed to enroll (statistically powered) for 30 patients into each group (30 benign; 30 Atypical and 30 Anaplastic) meningioma's. Study enroll only 23 patients.|1|||f||||t||||||||No||2017-10-11 04:40:18.721292|2017-10-11 04:40:18.721292
NCT00045747|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-06|2013-06-21|||July 2002||2002-07-01|August 2004|2004-08-01|September 2004|Actual|2004-09-01|||||Interventional|||UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer|Phase II Study of UCN-01 in Combination With Fluorouracil in Advanced Pancreatic Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:18.99595|2017-10-11 04:40:18.99595
NCT00045760|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-09|2006-07-18|||September 2002||2002-09-01|July 2006|2006-07-01||||||||Interventional|||The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis||Completed||Phase 4|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:40:19.123293|2017-10-11 04:40:19.123293
NCT00045773|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-09|2016-08-29|||April 2001||2001-04-01|August 2016|2016-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Treatment Outcome of Vascular Depression|Treatment Outcome of Vascular Depression|Completed||N/A|208|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 04:40:20.403661|2017-10-11 04:40:20.403661
NCT00045786|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-09|2017-04-24|||October 2001||2001-10-01|April 2017|2017-04-01|November 2003|Actual|2003-11-01|December 2001|Actual|2001-12-01||Interventional|||Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes|A Multi-center, An Open Label, Dose-Escalation Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment for Myelodysplastic Syndromes|Completed||Phase 2|18|Actual|Celgene||4|||||||||||||||||2017-10-11 04:40:20.492001|2017-10-11 04:40:20.492001
NCT00045799|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-09|2014-04-24|||May 2002||2002-05-01|April 2014|2014-04-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill|Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill|Completed||Phase 3|354|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-10-11 04:40:20.587738|2017-10-11 04:40:20.587738
NCT00045812|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-10|2008-03-03|||March 2001||2001-03-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate SCH-58235 in Homozygous Sitosterolemia|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:20.774979|2017-10-11 04:40:20.774979
NCT00045864|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-12|2006-02-02||||||February 2006|2006-02-01||||||||Interventional|||Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.||Completed||Phase 2|||Chiron Corporation|||||||||||||||||||2017-10-11 04:40:20.920437|2017-10-11 04:40:20.920437
NCT00045942|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-16|2017-08-07|2017-05-03||January 30, 2002|Actual|2002-01-30|August 2017|2017-08-01|March 27, 2008|Actual|2008-03-27|March 27, 2008|Actual|2008-03-27||Interventional||The baseline characteristics for PKC412A2104E2 do not include data for the 2 patients who transferred from CPKC412A2104E1 since the data for these 2 patients are included under CPKC412A2104E1.|PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)|An Open-label Phase II (Proof of Concept (POC)) Trial of PKC412 Monotherapy in Participants With Acute Myeloid Leukemia (AML) and Participants With High Risk Myelodysplastic Syndrome (MDS) (CPKC412A2104 Core); An Open-label, Randomized Phase II POC Trial in PKC412 in Participants With AML and Participants With High Risk MDS With Either Wild Type or Mutated FLT3 (CPKC412A2104E1); and An Open-label, Randomized Phase 1/II POC Trial in PKC412 in Participants With AML and Participants With High Risk MDS With Either Wild Type or Mutated FLT3 (CPKC412A2104E2)|Completed||Phase 1/Phase 2|144|Actual|Novartis||9|||f||||f|t|f||||||||2017-10-11 04:40:21.850806|2017-10-11 04:40:21.850806
NCT00045955|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-17|2008-08-20|||February 2002||2002-02-01|August 2008|2008-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Long-Term Safety Performance of Fexofenadine in Asthma|A Multicenter, Open-Label, Randomized, Parallel Groups Study to Assess the Long-Term Safety Performance of Fexofenadine Compared to Montelukast in Subjects With Asthma|Completed||Phase 3|1200|Anticipated|Sanofi|||||||||||||||||||2017-10-11 04:40:34.190461|2017-10-11 04:40:34.190461
NCT00045968|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-17|2016-10-12|||December 2006||2006-12-01|October 2016|2016-10-01||||November 2016|Anticipated|2016-11-01||Interventional|GBM||Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer|A Phase III Clinical Trial Evaluating DCVax®-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen For The Treatment Of Glioblastoma Multiforme (GBM)|Active, not recruiting||Phase 3|348|Anticipated|Northwest Biotherapeutics||2|||f||||t||||||||||2017-10-11 04:40:34.277739|2017-10-11 04:40:34.277739
NCT00045981|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-17|2010-03-25|||October 2001||2001-10-01|August 2007|2007-08-01|August 2006|Actual|2006-08-01|May 2003|Actual|2003-05-01||Interventional|||The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)|Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SAPPHIRE Study|Completed||Phase 2|450||Synvista Therapeutics, Inc|||||||||||||||||||2017-10-11 04:40:34.692503|2017-10-11 04:40:34.692503
NCT00045994|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-17|2009-07-28|||August 2001||2001-08-01|August 2007|2007-08-01|June 2003|Actual|2003-06-01|January 2002|Actual|2002-01-01||Interventional|||The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling|Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SILVER Study|Completed||Phase 2|180||Synvista Therapeutics, Inc|||||||||||||||||||2017-10-11 04:40:34.765434|2017-10-11 04:40:34.765434
NCT00046020|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-18|2009-08-13|||August 2000||2000-08-01|August 2009|2009-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Evaluating Venlafaxine ER in Recurrent Depression|An Acute and Continuation Phase Study of the Comparative Efficacy Study of Venlafaxine ER (Effexor® XR) and Fluoxetine (Prozac®) in Achieving and Sustaining Remission (Wellness) in Patients With Recurrent Unipolar Major Depression; Followed by a Long Term Randomized, Placebo-Controlled Maintenance Treatment Study in Patients Treated Initially With Venlafaxine ER|Completed||Phase 4|1096|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:40:34.845698|2017-10-11 04:40:34.845698
NCT00046033|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-18|2011-02-28||||||May 2005|2005-05-01||||March 2003|Actual|2003-03-01||Interventional|||Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance|A Phase II, Randomized, Open-Label Study Comparing Fixed-Dose Versus Concentration-Adjusted Lopinavir/Ritonavir Therapy in HIV-Infected Subjects on Salvage Therapy|Completed||Phase 2|118||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:40:34.924789|2017-10-11 04:40:34.924789
NCT00046059|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-18|2017-10-05|||February 1, 2000||2000-02-01|January 30, 2017|2017-01-30||||||||Observational|||Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)|Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|3481|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:35.044866|2017-10-11 04:40:35.044866
NCT00046072|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-19|2005-12-08|||October 2001||2001-10-01|December 2005|2005-12-01|April 2005||2005-04-01|||||Interventional|||A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis|A Double-Blind, Placebo-Controlled Study of E5564, A Lipid A Antagonist, Administered by Twice Daily Infusions in Patients With Severe Sepsis|Completed||Phase 2|300||Eisai Inc.|||||||||||||||||||2017-10-11 04:40:35.139881|2017-10-11 04:40:35.139881
NCT00046085|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-19|2016-09-08|||March 2001||2001-03-01|September 2016|2016-09-01|November 2006|Actual|2006-11-01|December 2005|Actual|2005-12-01||Interventional|||Online Family Support and Education for Schizophrenia|Online Family Support and Education for Schizophrenia|Completed||N/A|42|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 04:40:35.245799|2017-10-11 04:40:35.245799
NCT00046111|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-19|2017-05-24|||September 2001||2001-09-01|May 2017|2017-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors|A Study to Determine the Bioequivalence of an Oral Formulation of Topotecan Containing the Drug Substance Manufactured by New Process Relative to the Current Study Formulation of Topotecan in Patients With Advanced Solid Tumors|Completed||Phase 1|1|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 04:40:35.370157|2017-10-11 04:40:35.370157
NCT00046124|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-20|2006-09-01||||||September 2006|2006-09-01||||||||Observational|||Organophosphate Pesticides and Human Reproductive Health||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:40:35.469487|2017-10-11 04:40:35.469487
NCT00046137|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-20|2006-07-19||||||July 2006|2006-07-01||||||||Interventional|||Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis||Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:40:35.54398|2017-10-11 04:40:35.54398
NCT00046150|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-20|2008-06-18|||May 2002||2002-05-01|June 2008|2008-06-01|December 2002|Actual|2002-12-01|||||Interventional|||12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.|12-Week, Multinational, Multicenter, Controlled, Open, 1:1 Randomized, Parallel Clinical Trial Comparing the Safety of HMR1964 and Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion (CSII) in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 3|59|Actual|Sanofi|||||||||||||||||||2017-10-11 04:40:35.635761|2017-10-11 04:40:35.635761
NCT00046163|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-20|2007-11-02|||September 2002||2002-09-01|November 2007|2007-11-01|August 2003|Actual|2003-08-01|||||Interventional|||A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension|A Phase IV, Multi-Center, Double-Blind, Parallel Group, Randomized, Placebo-Controlled Study to Assess the Clinical Benefit of Three Doses of Midodrine Hydrochloride (ProAmatine®) in Subjects With Neurogenic Orthostatic Hypotension|Terminated||Phase 4|150||Shire||||Study was terminated due to poor enrollment|||||||||||||||2017-10-11 04:40:35.701134|2017-10-11 04:40:35.701134
NCT00046176|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-20|2011-06-02|||August 2002||2002-08-01|May 2011|2011-05-01||||||||Interventional|||A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients|A Phase III, 48-Week, Open-Label, Randomized, Multicenter Study of the Safety and Efficacy of the Abacavir/Lamivudine Fixed-Dose Combination Tablet Administered QD Versus Abacavir + Lamivudine Administered BID in Combination With a PI or NNRTI in Antiretroviral Experienced Patients.|Completed||Phase 3|240||GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:40:36.025761|2017-10-11 04:40:36.025761
NCT00046189|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-21|2017-10-05|||September 18, 2002||2002-09-18|August 29, 2017|2017-08-29||||||||Observational|||Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum|Cancer Risk in Xeroderma Pigmentosum Heterozygotes|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:36.234857|2017-10-11 04:40:36.234857
NCT00046202|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-21|2017-10-05|||September 18, 2002||2002-09-18|January 24, 2017|2017-01-24||||||||Observational|||Study of Inborn Errors of Cholesterol Synthesis and Related Disorders|Investigations Into Inborn Errors of Cholesterol Synthesis and Related Disorders|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:36.323591|2017-10-11 04:40:36.323591
NCT00046215|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-21|2008-03-03|||September 2002||2002-09-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||Transcranial Magnetic Stimulation to Study Imagination of Movement|Effect of Transcranial Magnetic Stimulation to Dorsal Premotor Cortex on Motor Imagination|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:36.419674|2017-10-11 04:40:36.419674
NCT00046228|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-24|2014-07-25|2009-03-26||August 2002||2002-08-01|July 2014|2014-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)|A Muticenter, Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy and Safety of Reteplease and Abciximab Combination Therapy With Abciximab Alone Administered Early or Just Prior to Primary Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.|Completed||Phase 3|2461|Actual|Centocor, Inc.|Some AEs were collected separately per protocol and are reported as “Other Pre-Specified Outcomes Measures”.|3|||f||||||||||||||2017-10-11 04:40:36.536935|2017-10-11 04:40:36.536935
NCT00046241|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-24|2017-01-20|||September 2002|Actual|2002-09-01|January 2017|2017-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Prevention of Seasonal Affective Disorder|A 7 Month, Multicenter, Randomized, Double-blind, Placebo-controlled Comparison of 150-300mg/Day of Extended-release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Affective Disorder in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up Phase|Completed||Phase 3|300||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:40:39.352857|2017-10-11 04:40:39.352857
NCT00046254|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-24|2012-05-01|||February 2002||2002-02-01|May 2012|2012-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture||Completed||Phase 3|2127||Novartis|||||||||||||||||||2017-10-11 04:40:39.615576|2017-10-11 04:40:39.615576
NCT00046267|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-24|2011-02-28||||||May 2006|2006-05-01||||December 2006|Actual|2006-12-01||Interventional|||Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients|A Pilot Study of the Safety, Efficacy, and Tolerability of Extended-Release Niacin (Niaspan) for the Treatment of Elevated Non-HDL Cholesterol and Elevated Triglycerides in HIV-Infected Subjects|Completed||N/A|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:40:39.773085|2017-10-11 04:40:39.773085
NCT00046280|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-24|2017-04-07|||April 1984||1984-04-01|April 2017|2017-04-01||||April 2019|Anticipated|2019-04-01||Observational|||Multicenter AIDS Cohort Study (MACS)|Multicenter AIDS Cohort Study (MACS)|Active, not recruiting||N/A|7087|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||f|f|f||||Samples With DNA|"     Blood serum, plasma, and cells   "|||2017-10-11 04:40:39.884317|2017-10-11 04:40:39.884317
NCT00046293|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-25|2017-06-30|||September 24, 2002||2002-09-24|April 8, 2011|2011-04-08|July 20, 2007|Actual|2007-07-20|July 20, 2007|Actual|2007-07-20||Interventional|||ReoPro and Retavase to Treat Acute Stroke|ReoPro Retavase Reperfusion of Stroke Safety Study-Imaging Evaluation With Computed Tomography (ROSIE-CT)|Completed||Phase 2|72|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:40:39.989235|2017-10-11 04:40:39.989235
NCT00046306|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-26|2013-01-11||||||January 2013|2013-01-01|August 2005|Actual|2005-08-01|||||Interventional|||Nevada Environmental Tobacco Smoke and Health Study||Completed||Phase 3|375||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:40:40.09835|2017-10-11 04:40:40.09835
NCT00046319|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-26|2009-04-15|||September 2002||2002-09-01|April 2009|2009-04-01|June 2003||2003-06-01|||||Interventional|||Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension|A Phase II, Randomized, Double-Blind, Dose-Controlled, Dose-Ranging, Multicenter Study of BSF 208075 Evaluating Exercise Capacity in Patients With Moderate to Severe Pulmonary Arterial Hypertension|Completed||Phase 2|60||Gilead Sciences|||||||||||||||||||2017-10-11 04:40:40.172457|2017-10-11 04:40:40.172457
NCT00046332|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-26|2013-02-20|||June 2002||2002-06-01|February 2013|2013-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients|A Phase II, Randomized, Placebo-controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Four Oral Doses of S-1360 Versus Placebo Over 10 Days in ART-naive HIV-1 Infected Adults.|Completed||Phase 2|100||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:40:40.284157|2017-10-11 04:40:40.284157
NCT00046345|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-26|2011-04-13|||May 2002||2002-05-01|April 2011|2011-04-01|July 2003||2003-07-01|||||Expanded Access|||Atazanavir for HIV Infected Individuals: An Early Access Program||No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:40:40.408132|2017-10-11 04:40:40.408132
NCT00046358|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-26|2008-03-03|||September 2002||2002-09-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease|The Effect of Short-Term Statin and NSAID Treatment on CSF Beta-Amyloid|Completed||Phase 4|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:40.83027|2017-10-11 04:40:40.83027
NCT00046371|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-27|2008-01-22|||August 2002||2002-08-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|||||Interventional|||Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients|Open-Label, Phase II Trial of Immunological Response Rate, Safety, and Tolerability of THERATOPE® Vaccine in Subjects With Metastatic Breast Cancer Undergoing Treatment With Aromatase Inhibitors or Faslodex®|Completed||Phase 2|||Oncothyreon Canada Inc.|||||f||||||||||||||2017-10-11 04:40:40.902533|2017-10-11 04:40:40.902533
NCT00046384|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-27|2013-11-07|||June 2002||2002-06-01|September 2007|2007-09-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:40:41.19014|2017-10-11 04:40:41.19014
NCT00046397|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-27|2008-03-03|||September 2002||2002-09-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Phase I Trial of Smallpox Vaccine|A Phase I/II Clinical Trial of Modified Vaccinia Virus Ankara (MVA) to Evaluate Its Safety, Dosing Schedule, Immunogenicity and Protective Efficacy Against Dryvax Challenge in Vaccinia-Naive Individuals|Completed||Phase 1|195||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:41.27719|2017-10-11 04:40:41.27719
NCT00046410|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-27|2017-06-30|||September 25, 2002||2002-09-25|November 15, 2007|2007-11-15|November 15, 2007||2007-11-15|||||Observational|||Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting|Assessing the Risk of New Ischemic Brain Lesions With On- Versus Off-Pump Coronary Artery Bypass Grafting|Completed||N/A|340||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:41.350589|2017-10-11 04:40:41.350589
NCT00046423|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2016-11-23|||April 2000||2000-04-01|November 2016|2016-11-01||||||||Interventional|||A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies|A Phase I Trial of ABI-007 Administered Weekly for Three Doses Every 4 Weeks in Patients With Advanced Non-hematologic Malignancies|Completed||Phase 1|20||Celgene Corporation|||||||||||||||||||2017-10-11 04:40:41.404955|2017-10-11 04:40:41.404955
NCT00046436|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2013-05-31||||||May 2013|2013-05-01|March 2004|Actual|2004-03-01|||||Observational|||Rapid HIV Tests for Women Late in Pregnancy and During Labor|Mother-Infant Rapid Intervention at Delivery (MIRIAD)|Terminated||N/A|7500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:40:41.481366|2017-10-11 04:40:41.481366
NCT00046449|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2015-06-02|||September 2002||2002-09-01|June 2015|2015-06-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Prevention of Seasonal Affective Disorder||Completed||Phase 3|||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:40:41.559155|2017-10-11 04:40:41.559155
NCT00046462|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2011-01-10|||November 2001||2001-11-01|January 2011|2011-01-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment|Substituting Lantus®(Insulin Glargine[rDNAorigin]Inj) for a Thiazolidinedione vs. a 3rd Oral Agent as add-on Therapy in Patients Failing a Thiazolidinedione & Sulfonylurea or Metformin Combination|Completed||Phase 3|240||Sanofi|||||f||||||||||||||2017-10-11 04:40:41.829029|2017-10-11 04:40:41.829029
NCT00046475|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2015-05-13|2015-04-24||January 2002||2002-01-01|November 2007|2007-11-01|October 2004|Actual|2004-10-01|||||Interventional||The intent-to-treat (ITT) population, defined as all patients who were randomly assigned to treatment in the study and have at least one post-randomization Orthostatic Hypotension Questionnaire (OHQ) measurement.|A Study for Patients With Neurogenic Orthostatic Hypotension|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Patients With Neurogenic Orthostatic Hypotension|Completed||Phase 4|140|Actual|Shire|||||||||||||||||||2017-10-11 04:40:41.960454|2017-10-11 04:40:41.960454
NCT00046488|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2013-09-12|||September 2002||2002-09-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|April 2004|Actual|2004-04-01||Interventional|||Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)|A Phase I Multicenter, Dose-Escalation Study of IDEC-152 (Anti-CD23 Monoclonal Antibody) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 1|70|Actual|Biogen||1|||f||||t||||||||||2017-10-11 04:40:42.956124|2017-10-11 04:40:42.956124
NCT00046501|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2011-01-10|||November 2002||2002-11-01|January 2011|2011-01-01||||February 2005|Actual|2005-02-01||Interventional|||Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents|Morning LANTUS v. Intermediate-acting Insulin 2x/Day as Basal Insulin in a Multiple Daily Inj. w/ Humalog in Adolescents w/ Type 1 Diabetes Mellitus: an Active-controlled, Open, Randomized, Gender-stratified, Two-arm, Parallel-group Study|Completed||Phase 3|250||Sanofi|||||f||||||||||||||2017-10-11 04:40:43.037974|2017-10-11 04:40:43.037974
NCT00046514|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2016-12-14|||June 2001||2001-06-01|December 2016|2016-12-01||||||||Interventional|||ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer|A Phase II Clinical Trial of ABI-007 (A Cremophor-Free, Protein Stabilized, Nanoparticle Paclitaxel)Administered Weekly in Taxol Resistant Patients With Metastatic Breast Cancer|Completed||Phase 2|100||Celgene Corporation|||||||||||||||||||2017-10-11 04:40:43.109753|2017-10-11 04:40:43.109753
NCT00046527|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2006-07-12|||June 2001||2001-06-01|October 2004|2004-10-01||||||||Interventional|||Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer|A Controlled, Randomized, Phase III, Multicenter, Open Label Study of ABI-007(a Cremophor Free, Protein Stabilized, Nanoparticle Paclitaxel) and Taxol in Patients With Metastatic Breast Cancer|Completed||Phase 3|460||Celgene Corporation|||||||||||||||||||2017-10-11 04:40:43.190902|2017-10-11 04:40:43.190902
NCT00046540|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2011-06-30|||October 2002||2002-10-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|August 2007|Actual|2007-08-01||Interventional|||Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer||Completed||Phase 1|40||INSYS Therapeutics Inc|||||f||||||||||||||2017-10-11 04:40:43.25485|2017-10-11 04:40:43.25485
NCT00046553|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2008-03-03|||September 2002||2002-09-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Brain Receptor Function in Post-Traumatic Stress Disorder|Glucocorticoid and Mineralocorticoid Receptor Function in Post Traumatic Stress Disorder|Completed||N/A|97||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:43.329874|2017-10-11 04:40:43.329874
NCT00046566|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2017-04-27|2016-11-30||July 2002||2002-07-01|April 2017|2017-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|ProBP||Clinical Trial of Dietary Protein and Blood Pressure|Clinical Trial of Dietary Protein on Blood Pressure|Completed||N/A|352|Actual|Tulane University||3|||f||||t||||||||No||2017-10-11 04:40:43.394837|2017-10-11 04:40:43.394837
NCT00046579|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2016-07-28|||August 2002||2002-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Psychosocial Determinants of Nutrient Intake in Girls||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:40:43.980135|2017-10-11 04:40:43.980135
NCT00046631|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2014-03-11|||August 2002||2002-08-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|TAAG2||Community Characteristics and Physical Activity Among Adolescent Girls - Ancillary to TAAG|Community Characteristics and Physical Activity Among Adolescent Girls|Completed||N/A|1556|Actual|RAND|||1||f||||f||||||||||2017-10-11 04:40:44.221582|2017-10-11 04:40:44.221582
NCT00046644|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2014-04-16|||June 2002||2002-06-01|April 2014|2014-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial||Completed||N/A|||Nemours Children's Clinic|||||f||||||||||||||2017-10-11 04:40:44.30518|2017-10-11 04:40:44.30518
NCT00046657|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2016-07-28|||September 2002||2002-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Longitudinal Study of Neighborhood Predictors of CVD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:40:44.351201|2017-10-11 04:40:44.351201
NCT00046670|ClinicalTrials.gov processed this data on October 10, 2017|2002-09-30|2014-03-04|||September 2002||2002-09-01|March 2014|2014-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Sleep Disordered Breathing, APOE, and Lipid Metabolism||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 04:40:44.39639|2017-10-11 04:40:44.39639
NCT00046683|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-01|2016-07-27|||July 2001||2001-07-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia|A Phase III Study to Evaluate the Efficacy and Safety of Front-Line Therapy With Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 3|284||Sanofi|||||||||||||||||||2017-10-11 04:40:44.454282|2017-10-11 04:40:44.454282
NCT00046696|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-01|2015-05-19|||May 2001||2001-05-01|May 2015|2015-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.|A Phase I and Pharmacokinetic Study of NM-3 Administered Orally Once or Twice Daily on Five Consecutive Days and Repeated Weekly for Six Weeks Every Eight Weeks in Patients With Advanced Solid Tumors.|Completed||Phase 1|32||Sanofi|||||||||||||||||||2017-10-11 04:40:44.56593|2017-10-11 04:40:44.56593
NCT00046709|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-01|2013-10-09|||September 2002||2002-09-01|October 2013|2013-10-01|October 2004|Actual|2004-10-01|||||Interventional|||Marijuana for Cancer Pain|Marijuana in Combination With Opioids for Cancer Pain: A Pilot Study|Terminated||Phase 1/Phase 2|16||Center for Medicinal Cannabis Research||||Discontinued due to non-enrollment.|||||||||||||||2017-10-11 04:40:44.638127|2017-10-11 04:40:44.638127
NCT00046722|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-01|2007-06-12|||January 2003||2003-01-01|June 2007|2007-06-01|April 2005||2005-04-01|||||Interventional|||Marijuana for HIV-Related Peripheral Neuropathy|Effects of Marijuana on Neuropathic Pain in HIV-Related Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.|Completed||Phase 1/Phase 2|50||Center for Medicinal Cannabis Research|||||||||||||||||||2017-10-11 04:40:44.719202|2017-10-11 04:40:44.719202
NCT00046735|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-02|2016-11-22|||June 2002||2002-06-01|November 2016|2016-11-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Phase 1 Study OF CDC-501 in Patients With Solid Tumors|A Single-Center, Open-Label, Between-Patient, Dose-Escalation Phase 1 Study of CDC-501 In Patients With Solid Tumors|Completed||Phase 1|24|Actual|Celgene Corporation||1|||f||||||||||||||2017-10-11 04:40:44.796405|2017-10-11 04:40:44.796405
NCT00046748|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-02|2017-07-31|||December 2001||2001-12-01|July 2017|2017-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma|Ph III, 28-wk, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess Efficacy, Safety, Tolerability of SC Omalizumab in Adults and Adolescents w/ Severe Persist. Allergic Asthma & Are Inadequately Controlled Despite GINA (2002) Step 4 Tx|Completed||Phase 3|484|Actual|Novartis|||||||||||||||||||2017-10-11 04:40:44.874722|2017-10-11 04:40:44.874722
NCT00046761|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-02|2012-10-10|||November 2002||2002-11-01|October 2012|2012-10-01||||May 2005|Actual|2005-05-01||Interventional|||A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke|A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke|Terminated||Phase 2/Phase 3|1320||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 04:40:44.937465|2017-10-11 04:40:44.937465
NCT00046774|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-02|2017-10-05|||September 2, 2002||2002-09-02|September 7, 2017|2017-09-07|September 7, 2017|Actual|2017-09-07|January 1, 2007|Actual|2007-01-01||Interventional|||Monoclonal Antibody Treatment for Systemic Lupus Erythematosus|A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients With Systemic Lupus Erythematosus|Completed||Phase 1|23|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:40:46.91078|2017-10-11 04:40:46.91078
NCT00046787|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2011-10-18|||September 2002||2002-09-01|October 2011|2011-10-01|February 2003|Actual|2003-02-01|||||Interventional|||Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer|Phase II Study to Determine the Efficacy of OSI-211 (Liposomal Lurtotecan) Given on Days 1, 2 & 3 Every 3 Weeks in Patients With Recurrent Small Cell Lung Cancer|Completed||Phase 2|47||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:40:46.984402|2017-10-11 04:40:46.984402
NCT00046800|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2011-10-18|||September 2002||2002-09-01|October 2011|2011-10-01|March 2003|Actual|2003-03-01|||||Interventional|||Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer|A Randomized, Open Label Phase II Study of OSI-211 vs Topotecan in Patients With Advanced and/or Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|80||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:40:47.073078|2017-10-11 04:40:47.073078
NCT00046813|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2017-01-11|||August 2001||2001-08-01|August 2008|2008-08-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1|High-Dose Versus Regular-Dose Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder|Terminated||Phase 4|100||National Institute on Drug Abuse (NIDA)||||Interim data analysis showed no effect between treatment groups|f||||||||||||||2017-10-11 04:40:47.177364|2017-10-11 04:40:47.177364
NCT00046826|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-04-02|||September 2001||2001-09-01|January 2006|2006-01-01|October 2009|Actual|2009-10-01|June 2007|Actual|2007-06-01||Interventional|||Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy|A Phase II Clinical Trial of Taxotere, Emcyt and Thalidomide (TET) for the Treatment of Hormone-Refractory Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:47.253655|2017-10-11 04:40:47.253655
NCT00217776|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-01-16|||February 2003||2003-02-01|January 2013|2013-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|DMSP||School-based Approaches to Help Pre-teens Manage Asthma||Completed||N/A|1292|Actual|University of Michigan||3|||f||||||||||||||2017-10-11 05:38:23.665279|2017-10-11 05:38:23.665279
NCT00046839|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2015-11-14|2014-01-28||July 2002||2002-07-01|November 2015|2015-11-01||||September 2011|Actual|2011-09-01||Interventional||Eligible patients who started protocol treatment.|Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer|A Phase I/II Trial of a COX-2 Inhibitor, Celebrex (Celecoxib), [National Screening Committee# 719627] With Limited Field Radiation for Intermediate Prognosis Patients With Locally Advanced Non-Small Cell Lung Cancer, With Analysis of Prognostic Factors|Completed||Phase 1/Phase 2|21|Actual|Radiation Therapy Oncology Group|This study stopped accrual early with 21 subjects accrued out of 128 planned, therefore only the phase I and phase II primary outcomes were reported.|3|||f||||t||||||||||2017-10-11 04:40:47.358835|2017-10-11 04:40:47.358835
NCT00046852|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2009-09-23|||December 2001||2001-12-01|September 2009|2009-09-01|February 2008|Actual|2008-02-01|November 2004|Actual|2004-11-01||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma|High-Dose Therapy and Autologous Blood Stem Cell Transplantation (ASCT) Followed by Post-Transplant Immunotherapy With Costimulated Autologous T-Cells in Conjunction With Pneumococcal Conjugate Vaccine Immunization for Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|||University of Maryland|||||f||||||||||||||2017-10-11 04:40:47.978261|2017-10-11 04:40:47.978261
NCT00046865|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2012-10-05|||October 2002||2002-10-01|October 2012|2012-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer|Treatment of Chemotherapy-Induced Nausea With Acupressure: A Phase III Trial|Completed||Phase 3|57|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 04:40:48.071208|2017-10-11 04:40:48.071208
NCT00046878|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2013-03-26||||||March 2013|2013-03-01|August 2002|Actual|2002-08-01|||||Interventional|||Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme|Phase 2 Trial of BCNU Plus O6-Benzylguanine (NSC 637037) in the Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme|Withdrawn||Phase 2|0|Actual|Duke University|||||f||||||||||||||2017-10-11 04:40:48.189124|2017-10-11 04:40:48.189124
NCT00046891|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2016-07-01|2015-02-25||December 2002||2002-12-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|October 2006|Actual|2006-10-01||Interventional|||EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer|The Use of Ginkgo Biloba For The Prevention Of Chemotherapy-Related Cognitive Dysfunction|Completed||Phase 3|226|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:40:48.32296|2017-10-11 04:40:48.32296
NCT00046904|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2011-05-04|||May 2003||2003-05-01|May 2011|2011-05-01||||September 2007|Actual|2007-09-01||Interventional|||Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer|Phase III Placebo-Controlled, Randomized, Double-Blind Comparison Of Etanercept (Enbrel) Versus Placebo For The Treatment Of Cancer-Associated Weight Loss And Anorexia|Completed||Phase 3|||Mayo Clinic|||||f||||t||||||||||2017-10-11 04:40:49.701723|2017-10-11 04:40:49.701723
NCT00046917|ClinicalTrials.gov processed this data on October 10, 2017|2002-10-03|2014-02-21|||July 2002||2002-07-01|October 2011|2011-10-01||||March 2010|Actual|2010-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Irinotecan (CPT-11) and Cisplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|13|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:40:49.84773|2017-10-11 04:40:49.84773
NCT00053365|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2014-04-29|2013-08-12||June 2003||2003-06-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional||This is the number of eligible and evaluable participants.|Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation Of Irofulven (IND #55804, NSC #683863) In The Treatment Of Recurrent Or Persistent Platinium-Sensitive Ovarian Or Primary Peritoneal Cancer|Completed||Phase 2|61|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:40:50.449022|2017-10-11 04:40:50.449022
NCT00053378|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2006-07-31|||January 2002||2002-01-01|July 2006|2006-07-01||||||||Interventional|||A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects|A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects|Completed||Phase 2|45||Abbott|||||||||||||||||||2017-10-11 04:40:50.844214|2017-10-11 04:40:50.844214
NCT00053391|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-27|2015-05-11|||October 2002||2002-10-01|May 2015|2015-05-01|June 2007|Actual|2007-06-01|June 2005|Actual|2005-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|Vaccination Of HLA-A1 And/Or -A2+ Stage III or IV Melanoma Patients With Tumor Peptide - Loaded Autologous Dendritic Cells That Are Generated In The Absence Or Presence Of CD40 Ligand|Completed||Phase 1/Phase 2|62|Actual|University Hospital Erlangen|||||f||||f||||||||||2017-10-11 04:40:50.941035|2017-10-11 04:40:50.941035
NCT00053404|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-28|2008-09-25|||March 2003||2003-03-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|December 2006|Actual|2006-12-01||Observational|||Immunologic Control of Drug Resistant HIV|Observational Study of HIV Infected Adults With Detectable Plasma HIV-1 RNA Levels Between 200 and 10,000 Copies/mL While Receiving Stable Antiretroviral Therapy|Unknown status|Active, not recruiting|N/A|50|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"     Blood collection   "|||2017-10-11 04:40:51.022224|2017-10-11 04:40:51.022224
NCT00053417|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-29|2011-08-03|2011-05-16||February 2003||2003-02-01|August 2011|2011-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis|Double-Blind, Placebo-Controlled, 20-Week, Parallel Group Study to Evaluate Safety, Tolerability and Activity of Oral Fampridine-SR in Subjects With Multiple Sclerosis|Completed||Phase 2|206|Actual|Acorda Therapeutics||4|||||||||||||||||2017-10-11 04:40:51.119416|2017-10-11 04:40:51.119416
NCT00053430|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-29|2009-08-06|||April 2001||2001-04-01|August 2009|2009-08-01|February 2006|Actual|2006-02-01|August 2005|Actual|2005-08-01||Interventional|||Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People|Pharmacologic T Cell Costimulation In HIV Disease|Completed||Phase 2|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:40:51.78989|2017-10-11 04:40:51.78989
NCT00053443|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-29|2016-12-13||||||December 2005|2005-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens|Compliance Enhancement In HIV/AIDS Patients|Completed||Phase 2|156||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:40:51.916019|2017-10-11 04:40:51.916019
NCT00053456|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2008-03-03|||January 2003||2003-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||The Effect of Exercise on Stem Cell Mobilization and Heart Function in Patients Undergoing Cardiac Rehabilitation|Stem Cell Mobilization For Improvement in Vascular Function and Myocardial Perfusion in Patients Undergoing Cardiac Rehabilitation|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:51.993018|2017-10-11 04:40:51.993018
NCT00053469|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2017-10-05|||January 28, 2003||2003-01-28|March 30, 2015|2015-03-30|March 30, 2015||2015-03-30|||||Observational|||Infant s Examination and Manipulation of Objects|Early Learning and Development Project|Completed||N/A|350|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:40:52.062234|2017-10-11 04:40:52.062234
NCT00053482|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2012-05-07|2011-01-03||January 2003||2003-01-01|May 2012|2012-05-01|October 2003|Actual|2003-10-01|April 2003|Actual|2003-04-01||Interventional|||Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults|The Effect of Dose on Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults With Previous Smallpox Vaccination|Completed||Phase 2|357|Actual|Sanofi||5|||f||||t||||||||||2017-10-11 04:40:52.147973|2017-10-11 04:40:52.147973
NCT00053495|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2012-05-07|2011-01-03||January 2003||2003-01-01|May 2012|2012-05-01|November 2003|Actual|2003-11-01|June 2003|Actual|2003-06-01||Interventional|||Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination|The Effect of Dose On Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults Without Previous Smallpox Vaccination|Completed||Phase 2|353|Actual|Sanofi||5|||f||||t||||||||||2017-10-11 04:40:53.324152|2017-10-11 04:40:53.324152
NCT00053508|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2014-01-17|||September 2002||2002-09-01|January 2014|2014-01-01|September 2003|Actual|2003-09-01|March 2003|Actual|2003-03-01||Interventional|||Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination|The Effect of Dose On Safety, Tolerability, and Immunogenicity of ACAM1000 Smallpox Vaccine in Adults Without Previous Smallpox Vaccination A Phase 2, Randomized, Double-Blind, Dose-Response Study|Terminated||Phase 2|274|Actual|Sanofi||4||CDC's decision to down-select vaccine development to single candidate, ACAM2000|f||||t||||||||||2017-10-11 04:40:54.573506|2017-10-11 04:40:54.573506
NCT00053521|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2016-11-04|||January 2003||2003-01-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Genetic Epidemiology of CVD Risk Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:40:54.674321|2017-10-11 04:40:54.674321
NCT00053534|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2014-02-19|||January 2003||2003-01-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Heart Failure in the Community||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-10-11 04:40:54.723112|2017-10-11 04:40:54.723112
NCT00053547|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2006-07-31|||January 2002||2002-01-01|July 2006|2006-07-01||||||||Interventional|||Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis|Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis|Completed||Phase 4|28||Abbott|||||||||||||||||||2017-10-11 04:40:54.779393|2017-10-11 04:40:54.779393
NCT00053560|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-30|2007-12-26|||December 2002||2002-12-01|November 2004|2004-11-01|August 2004||2004-08-01|||||Interventional|||To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids|A Randomized, Double-Blind, Multi-Center, Placebo- Controlled Study to Assess Prevention of Bone Loss by Treatment With GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids|Unknown status|Active, not recruiting|Phase 3|155||Genelabs Technologies|||||f||||||||||||||2017-10-11 04:40:54.850247|2017-10-11 04:40:54.850247
NCT00053573|ClinicalTrials.gov processed this data on October 10, 2017|2003-01-31|2014-02-04|||February 2003||2003-02-01|February 2014|2014-02-01|November 2006|Actual|2006-11-01|July 2006|Actual|2006-07-01||Interventional|||rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)|An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of rhGAA Treatment in Patients Greater Than 6 Months and Less Than or Equal to 36 Months Old With Infantile-Onset GSD-II|Completed||Phase 1/Phase 2|20|Actual|Sanofi||1|||f||||||||||||||2017-10-11 04:40:54.968822|2017-10-11 04:40:54.968822
NCT00053599|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-03|2009-07-24|||December 2002||2002-12-01|June 2009|2009-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Slow the Progression of Alzheimer's Disease|Completed||Phase 3|400||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:40:55.072652|2017-10-11 04:40:55.072652
NCT00053612|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-03|2016-12-13||||||August 2007|2007-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission|Prevention of HIV Shedding in Women - Trial of Vitamin A|Completed||Phase 2|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:40:55.236128|2017-10-11 04:40:55.236128
NCT00053625|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-04|2015-04-02|||June 1999||1999-06-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Deep Brain Stimulation for Parkinson's Disease Trial|Deep Brain Stimulation for Parkinson's Disease Trial|Completed||Phase 3|123|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||t||||||||||2017-10-11 04:40:55.299957|2017-10-11 04:40:55.299957
NCT00053638|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-04|2010-10-01|||February 2003||2003-02-01|October 2010|2010-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy|A Phase III, Randomized, Open-label, Multicenter Study of the Safety and Efficacy of Efavirenz Versus Tenofovir When Administered in Combination With the Abacavir/Lamivudine Fixed-dose Combination Tablet as a Once-daily Regimen in Antiretroviral-naive HIV-1 Infected Subjects.|Completed||Phase 3|345||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:40:55.398154|2017-10-11 04:40:55.398154
NCT00053651|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-04|2013-08-20|||September 2001||2001-09-01|August 2013|2013-08-01||||||||Interventional|||Prevention of Postpartum Depression in Low-Income Women|Depression Intervention for Poor Pregnant Women|Completed||Phase 1|250||Butler Hospital|||||f||||t||||||||||2017-10-11 04:40:55.580534|2017-10-11 04:40:55.580534
NCT00053677|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-04|2017-07-31|2017-04-03||December 2002||2002-12-01|July 2017|2017-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Drug Treatment for Pathologic Gambling Disorder|Naltrexone Treatment in Pathologic Gambling Disorder|Completed||Phase 3|83|Actual|University of Chicago|Pathological gambling is a chronic disease that may require long-term therapy. Although this study is one of the longest medication trials for PG, the study did not assess treatment effects beyond the acute 18-week treatment period.|2|||f||||||||||||||2017-10-11 04:40:55.648664|2017-10-11 04:40:55.648664
NCT00053690|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-04|2013-09-09|||January 2002||2002-01-01|February 2009|2009-02-01|December 2004||2004-12-01|||||Interventional|||Treatment of Post Traumatic Stress Disorder in Patients With Other Mental Illnesses|Cognitive-Behavioral Treatment of PTSD in SMI Clients|Completed||N/A|88||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 04:40:55.925187|2017-10-11 04:40:55.925187
NCT00053703|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-04|2014-02-07|2013-09-16||February 2002||2002-02-01|February 2014|2014-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|TEOSS|We are referring to the population of participants who had baseline assessment, took at least one dose of trial medication, and had at least one post-baseline assessment. There were 3 randomized subjects, on in each treatment group, who did not take at least one dose of study medication and are not included.|Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)|Treatment of Schizophrenia and Related Disorders in Children and Adolescents|Completed||Phase 4|116|Actual|University of North Carolina, Chapel Hill|The most significant weakness of this study was the sample size, which was sufficient only to detect large differences across the three treatments and limited our ability to identify predictors of response or adverse effects.|3|||f||||t||||||||||2017-10-11 04:40:56.01232|2017-10-11 04:40:56.01232
NCT00057928|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-06-11|||April 2003||2003-04-01|June 2012|2012-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer|Phase III Randomized Trial of Cisplatin/Paclitaxel Versus Cisplatin/Gemcitabine in Recurrent, Persistent or Metastatic Carcinoma of the Cervix|Withdrawn||Phase 3|0|Actual|Southwest Oncology Group||||lack of accrual|f||||t||||||||||2017-10-11 04:40:56.593819|2017-10-11 04:40:56.593819
NCT00057941|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2014-04-22|2011-04-11||September 2003||2003-09-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer|A Randomized Phase II Trial of Combination Anastrozole (NSC #719344) Plus ZD1839 (Iressa, NSC #715055, IND #61187) and of Combination Fulvestrant (NSC #719276) Plus ZD1839 in the Treatment of Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer|Completed||Phase 2|148|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:40:57.004255|2017-10-11 04:40:57.004255
NCT00057954|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-02-11|2013-01-07||June 2005||2005-06-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|April 2008|Actual|2008-04-01||Interventional|||Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma|A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplantation for the Treatment of Relapsed Non-Hodgkin and Hodgkin Lymphoma|Terminated||Phase 2|6|Actual|Eastern Cooperative Oncology Group||1||Slow accrual|f||||f||||||||||2017-10-11 04:40:57.690875|2017-10-11 04:40:57.690875
NCT00057967|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2017-09-06|||July 2000||2000-07-01|September 2017|2017-09-01|August 2020|Anticipated|2020-08-01|August 18, 2019|Anticipated|2019-08-18||Interventional|||Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome|Phase II Trial Of Campath-1H In Patients With Relapsed/Refractory Advanced Mycosis Fungoides or Sezary Syndrome|Active, not recruiting||Phase 2|37|Anticipated|Northwestern University||1|||f||||t||||||||||2017-10-11 04:40:58.151908|2017-10-11 04:40:58.151908
NCT00057980|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-06-07||2011-02-18|October 2002||2002-10-01|June 2012|2012-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma|Phase I/II Study of Epirubicin and Celecoxib for Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|8|Actual|Northwestern University|||||f||||t||||||||||2017-10-11 04:40:58.284271|2017-10-11 04:40:58.284271
NCT00057993|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-06-07||2011-02-16|July 2002||2002-07-01|June 2012|2012-06-01|August 2004||2004-08-01|August 2004||2004-08-01||Interventional|||Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer|Phase II Study Of Herceptin And Exemestane For Treatment Of Postmenopausal Women With Metastatic Hormone-Responsive, HER2/NEU Positive Breast Cancer|Withdrawn||Phase 2|0|Actual|Northwestern University||||"Unable to accrue subjects to the study after 2 years - closed per request by Data Monitoring   Committee."|f||||t||||||||||2017-10-11 04:40:58.383047|2017-10-11 04:40:58.383047
NCT00058006|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-06-07|||September 2002||2002-09-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer|Pilot Randomized Trial Of Adjuvant Celecoxib In Patients With Early Stage Head And Neck And Non-Small Cell Lung Cancers|Completed||Phase 2|||Northwestern University|||||f||||||||||||||2017-10-11 04:40:58.45783|2017-10-11 04:40:58.45783
NCT00058019|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2014-05-07|2013-08-19||February 2003||2003-02-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase II Study of Epothilone B Analog BMS-247550 (NSC 710428) in Patients With Relapsed Aggressive Non-Hodgkin's Lymphomas|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:40:58.557722|2017-10-11 04:40:58.557722
NCT00058032|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-12-03|||February 2003||2003-02-01|September 2005|2005-09-01|March 2009|Actual|2009-03-01|||||Interventional|||CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women|United Kingdom Collaborative Trial Of Ovarian Cancer Screening|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:59.124738|2017-10-11 04:40:59.124738
NCT00058045|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-01-30|||August 2002||2002-08-01|January 2013|2013-01-01||||November 2003|Actual|2003-11-01||Interventional|||Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer|A Phase I Study Of Low-Dose Subcutaneous Interleukin 2 (IL-2) And Stem Cell Factor (r-metHuSCF) For Patients With AIDS And AIDS-Associated Malignancy|Completed||Phase 1|1|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:40:59.195823|2017-10-11 04:40:59.195823
NCT00058058|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-10-23|||February 2001||2001-02-01|April 2004|2004-04-01||||March 2007|Actual|2007-03-01||Interventional|||Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer|MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:59.259247|2017-10-11 04:40:59.259247
NCT00058071|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-07-08|||March 2003||2003-03-01|July 2007|2007-07-01||||December 2007|Actual|2007-12-01||Interventional|||Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer|A Randomized Phase III Trial of Amifostine vs. No Treatment for Platinum Induced Peripheral Neuropathy|Completed||Phase 3|100|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:40:59.363599|2017-10-11 04:40:59.363599
NCT00058084|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2017-02-21|||March 2003||2003-03-01|February 2017|2017-02-01||||October 1, 2007|Actual|2007-10-01||Interventional|||Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer|A Randomized Phase II Study Of BMS 247550 Or Mitoxantrone And Prednisone In Patients With Taxane Resistant Hormone Refractory Prostate Cancer|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:40:59.528377|2017-10-11 04:40:59.528377
NCT00058097|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-04-08|||August 2003||2003-08-01|April 2013|2013-04-01||||January 2007|Actual|2007-01-01||Interventional|||Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study of R115777 for the Treatment of Adults With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|54|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:40:59.616681|2017-10-11 04:40:59.616681
NCT00058149|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2011-09-20|||March 2003||2003-03-01|April 2004|2004-04-01||||July 2006|Actual|2006-07-01||Interventional|||Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:40:59.913793|2017-10-11 04:40:59.913793
NCT00058188|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2017-03-15|||March 2003||2003-03-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation|A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation|Active, not recruiting||Phase 3|70|Anticipated|Northwestern University||2|||f||||t||||||||||2017-10-11 04:41:00.236797|2017-10-11 04:41:00.236797
NCT00058201|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-12-17|||July 2001||2001-07-01|May 2008|2008-05-01|September 2010|Actual|2010-09-01|April 2008|Actual|2008-04-01||Interventional|||Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer|European Study Group For Pancreatic Cancer - Trial 3|Completed||Phase 3|1030|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:41:00.356651|2017-10-11 04:41:00.356651
NCT00058214|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2015-02-09|2015-02-09||March 2003||2003-03-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Perifosine in Treating Patients With Recurrent Prostate Cancer|A Phase II Trial of Perifosine (IND 58,156; NSC# 639966) in Biochemically Recurrent, Hormone Sensitive Prostate Cancer|Terminated||Phase 2|25|Actual|National Cancer Institute (NCI)|Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results.|1||Did not meet interim stopping criteria for continuation to the second stage.|f||||||||||||||2017-10-11 04:41:00.54256|2017-10-11 04:41:00.54256
NCT00058227|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-06-03|||April 2003||2003-04-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma|A Phase I Study of Flavopiridol, Fludarabine and Rituximab in Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma|Completed||Phase 1|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:00.858871|2017-10-11 04:41:00.858871
NCT00058240|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2017-06-02|2015-04-07||April 2003|Actual|2003-04-01|June 2017|2017-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional||52 unique patients due to 6 patients being|Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma|A Dose-Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)|Completed||Phase 1/Phase 2|52|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:01.004802|2017-10-11 04:41:01.004802
NCT00058253|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2014-06-16|||February 2003||2003-02-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|January 2008|Actual|2008-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AAG, NSC# 330507) in Combination With Docetaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:41:01.417016|2017-10-11 04:41:01.417016
NCT00058266|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-07-10||2011-05-19|December 2002||2002-12-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|November 2006|Actual|2006-11-01||Interventional|||Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy|A Phase II Study Of Genistein In Patients With Localized Prostate Cancer (Molecular Correlates of Soy In Humans)|Terminated||Phase 2|36|Actual|Northwestern University||2||Data Monitoring Committee cited poor accrual.|f||||t||||||||||2017-10-11 04:41:01.52009|2017-10-11 04:41:01.52009
NCT00058279|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-06-18|||February 2003||2003-02-01|August 2006|2006-08-01|August 2006|Actual|2006-08-01|||||Interventional|||Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma|MDX-CTLA4 Combined With IL-2 for Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:41:01.650553|2017-10-11 04:41:01.650553
NCT00058292|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-05-31|||April 2000||2000-04-01|May 2012|2012-05-01|March 2009|Actual|2009-03-01|June 2006|Actual|2006-06-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I Trial Combining IDEC-Y2B8 And High-Dose Beam Chemotherapy With Hematopoietic Progenitor Cell Transplant In Patients With Relapsed Or Refractory B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1|44|Actual|Northwestern University||1|||f||||||||||||||2017-10-11 04:41:01.720718|2017-10-11 04:41:01.720718
NCT00058305|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-01-09|||March 2003||2003-03-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation|A Phase II Study of Bryostatin 1 and Vincristine in Patients With Low or Intermediate Grade Non-Hodgkin's Lymphoma Progressing or Relapsing After a Prior Autologous Bone Marrow or Stem Cell Transplant|Completed||Phase 2|28|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:01.832218|2017-10-11 04:41:01.832218
NCT00058318|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-10-31|||December 2004||2004-12-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|May 2007|Actual|2007-05-01||Interventional|||S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer|A Phase II Study of IV Gemcitabine and Oral Capecitabine in Patients With Advanced Renal Cell Cancer|Completed||Phase 2|43|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:41:01.920688|2017-10-11 04:41:01.920688
NCT00058331|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2016-07-15|||June 2003||2003-06-01|July 2016|2016-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Epoetin Alfa in Treating Anemia in Patients With Solid Tumors|A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer|Completed||Phase 3|365|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:41:01.998478|2017-10-11 04:41:01.998478
NCT00058357|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2016-06-27|||May 2004||2004-05-01|June 2016|2016-06-01|July 2007|Actual|2007-07-01|July 2006|Actual|2006-07-01||Interventional|||Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery|The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study|Completed||Phase 3|30|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:41:02.131571|2017-10-11 04:41:02.131571
NCT00058370|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2017-03-13|||February 2003|Actual|2003-02-01|March 2017|2017-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma|A Trial Of Radioimmunotherapy, Reduced-Dose External Beam Craniospinal Radiation Therapy With IMRT Boost, And Chemotherapy For Patients With Standard-Risk Medulloblastoma|Active, not recruiting||N/A|6|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:41:02.570149|2017-10-11 04:41:02.570149
NCT00058396|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-05-29|||October 2002||2002-10-01|December 2009|2009-12-01||||October 2004|Actual|2004-10-01||Interventional|||Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase I Study Of IDEC-152 (Anti-CD23 Monoclonal Antibody) In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:02.655643|2017-10-11 04:41:02.655643
NCT00058422|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2017-08-09|||February 2003|Actual|2003-02-01|August 2017|2017-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma|A Phase II Study of R-CHOP and Ibritumomab Tiuxetan (Zevalin) for Elderly Patients With Previously Untreated Diffuse Large B-Cell Lymphoma|Active, not recruiting||Phase 2|65|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:41:02.723138|2017-10-11 04:41:02.723138
NCT00058435|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-06-04|||December 2002||2002-12-01|June 2013|2013-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|Phase I Trial of the Monoclonal Anti-Idiotype Antibody ACA125 in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:41:02.815644|2017-10-11 04:41:02.815644
NCT00058448|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-04-16|||October 2004||2004-10-01|April 2013|2013-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)|Phase II Study Of Weekly Docetaxel In Patients With Advanced Epidermoid Carcinoma Of The Penis|Terminated||Phase 2|1|Actual|Southwest Oncology Group||1||Study terminated due to poor patient recruitment.|f||||f||||||||||2017-10-11 04:41:02.885647|2017-10-11 04:41:02.885647
NCT00058461|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-10-07|||November 2003||2003-11-01|October 2013|2013-10-01||||March 2007|Actual|2007-03-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia|A Phase II Study of Rituximab (IND #7028) and Ifosfamide, Carboplatin and Etoposide (ICE) Chemotherapy in Children With Recurrent/Refractory B-cell (CD20+) Non-Hodgkin Lymphoma and B-cell Acute Lymphoblastic Leukemia|Terminated||Phase 2|82|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:04.601146|2017-10-11 04:41:04.601146
NCT00058474|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2016-03-22|||July 2004||2004-07-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|August 2013|Actual|2013-08-01||Interventional|||Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer|A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine With or Without Oxaliplatin With Preoperative Radiation Therapy And Continuous Intravenous Infusion Of 5-Fluorouracil With or Without Oxaliplatin In The Treatment Of Patients With Operable Carcinoma Of The Rectum|Active, not recruiting||Phase 3|1608|Actual|NSABP Foundation Inc||4|||f||||t||||||||||2017-10-11 04:41:04.725683|2017-10-11 04:41:04.725683
NCT00058487|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-07-17|||December 2001||2001-12-01|October 2006|2006-10-01|January 2007|Actual|2007-01-01|||||Interventional|||Epirubicin and Thalidomide in Treating Patients With Liver Cancer|A Phase II Study Of Epirubicin And Thalidomide In Unresectable Or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:04.850506|2017-10-11 04:41:04.850506
NCT00058526|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2017-05-12|||March 20, 2003|Actual|2003-03-20|May 2017|2017-05-01|September 6, 2006|Actual|2006-09-06|September 6, 2006|Actual|2006-09-06||Interventional|||A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer|A Multicenter Phase I Open-label Dose-escalation Vaccine Trial of dHER2 Protein With AS15 Adjuvant in HER2-overexpressing Patients With High-risk Breast Cancer|Completed||Phase 1|61|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-10-11 04:41:04.958406|2017-10-11 04:41:04.958406
NCT00058786|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2012-05-21|||December 2002||2002-12-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|CLIMAT||Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells|Treatment of Chronic Lymphocytic B-Leukemia (B-CLL) With Human IL-2 Gene Modified and Human CD40 Ligand-Expressing Autologous Tumor Cells|Completed||Phase 1|9|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:41:07.533922|2017-10-11 04:41:07.533922
NCT00058539|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-08|2015-06-02|2015-06-02||April 2003||2003-04-01|June 2015|2015-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional||All the participants who received at least 1 dose of study drug were included in the analysis.|Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer|A Phase II, Open-Label, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Omnitarg (Pertuzumab) in Subjects With Castration-Resistant Prostate Cancer|Completed||Phase 2|42|Actual|Genentech, Inc.|||||||||||||||||||2017-10-11 04:41:05.085507|2017-10-11 04:41:05.085507
NCT00058552|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-08|2017-01-25|2015-06-02||May 2003|Actual|2003-05-01|January 2017|2017-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional||All the participants who received at least 1 dose of study drug were included in the analysis.|A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer|A Phase II, Open-label, Multicenter Study to Evaluate the Effect of Tumor-based HER2 Activation on the Efficacy of rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced, Refractory or Recurrent Ovarian Cancer|Completed||Phase 2|129|Actual|Genentech, Inc.|||||||||||||||||||2017-10-11 04:41:05.591782|2017-10-11 04:41:05.591782
NCT00058578|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-08|2007-04-09|||June 1999||1999-06-01|April 2007|2007-04-01|June 2004||2004-06-01|||||Interventional|||Stem Cell Transplant to Treat Patients With Systemic Sclerosis|Autologous T-Cell Depleted Peripheral Blood Stem Cell Transplantation for the Treatment of Selected Patients With Systemic Sclerosis|Completed||Phase 1|24||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:41:06.27104|2017-10-11 04:41:06.27104
NCT00058591|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-08|2009-04-09|||January 2000||2000-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|SCAEBV||Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)|Autologous EBV Specific CTLs for Therapy of Severe Chronic EBV Infection|Completed||Phase 1|18|Anticipated|Baylor College of Medicine||1|||t||||t||||||||||2017-10-11 04:41:06.372535|2017-10-11 04:41:06.372535
NCT00058604|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-08|2009-04-09|||January 2001||2001-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|EUCLID||Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).|Autologous EBV Specific CTLs for Prophylaxis and Therapy of EBV Lymphoma Post Solid Organ Transplant|Completed||Phase 1|14|Anticipated|Baylor College of Medicine||1|||t||||t||||||||||2017-10-11 04:41:06.472467|2017-10-11 04:41:06.472467
NCT00058617|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-08|2017-02-13|||January 1996||1996-01-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|August 2011|Actual|2011-08-01||Interventional|||Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL|Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma|Completed||Phase 1|13|Actual|Baylor College of Medicine||1|||f||||t|t|f||||||||2017-10-11 04:41:06.563301|2017-10-11 04:41:06.563301
NCT00058656|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-08|2006-11-20|||March 2003||2003-03-01|January 2005|2005-01-01||||||||Interventional|||Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients|A Phase I/II Study of Xcellerated T Cells(tm) in Patients With Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 1/Phase 2|18||Xcyte Therapies|||||||||||||||||||2017-10-11 04:41:06.656196|2017-10-11 04:41:06.656196
NCT00058669|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-10|2016-01-04|||March 2003||2003-03-01|January 2016|2016-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||CVD Risk Factors and Sexual Identity in Women|CVD Risk Factors and Sexual Identity in Women|Completed||N/A|1174|Actual|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"     urine, plasma,   "|||2017-10-11 04:41:06.73415|2017-10-11 04:41:06.73415
NCT00058682|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2008-03-03|||April 2003||2003-04-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Anidulafungin Versus Fluconazole in the Treatment of Candidemia|A Phase III, Double Blind, Randomized, Multi-Center Study of the Safety and Efficacy of Anidulafungin VS. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis and Prevention of Complications|Completed||Phase 3|248||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:06.801798|2017-10-11 04:41:06.801798
NCT00058695|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2017-10-05|||April 4, 2003||2003-04-04|October 21, 2015|2015-10-21|October 21, 2015||2015-10-21|||||Observational|||Genetic Factors in Age-Related Macular Degeneration|Evaluation of Single Nucleotide Polymorphism (SNP) in Patients With and Subjects Without Age-Related Macular Degeneration (AMD)|Terminated||N/A|477|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:06.862201|2017-10-11 04:41:06.862201
NCT00058721|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2008-03-03|||April 2003||2003-04-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease|SPECT Evaluation of Nicotinic Cholinergic Receptors in Parkinson's Disease|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:06.930589|2017-10-11 04:41:06.930589
NCT00058734|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2007-08-23|||November 2000||2000-11-01|August 2007|2007-08-01||||||||Interventional|||Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients|Immune Responses to Antigen-Bearing Dendritic Cells in HIV-Infected Individuals|Completed||Phase 1|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:41:06.993827|2017-10-11 04:41:06.993827
NCT00058747|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2012-09-06|||March 2003||2003-03-01|September 2012|2012-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™|Phase II Exploratory Study Of AG-858 Plus Gleevec™ In Patients With Chronic Myelogenous Leukemia (CML) In Chronic Phase Who Are Cytogenetically Positive After Treatment With Gleevec™|Terminated||Phase 2|40||Agenus Inc.||||Business decision of the sponsor|||||||||||||||2017-10-11 04:41:07.058744|2017-10-11 04:41:07.058744
NCT00058760|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2005-06-23|||February 2001||2001-02-01|March 2003|2003-03-01|January 2006||2006-01-01|||||Interventional|||Delaying Sexual Activity in African American Adolescent Girls|A Randomized Controlled Trial of the NIA Intervention|Unknown status|Recruiting|Phase 1|240||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:07.346254|2017-10-11 04:41:07.346254
NCT00058773|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2012-11-05|||January 1996||1996-01-01|November 2012|2012-11-01|August 2006|Actual|2006-08-01|April 2002|Actual|2002-04-01||Interventional|ANGELA||Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease|Administration of Autologous Neomycin Resistant Gene Marked EBV Specific Cytotoxic T-Lymphocytes as Therapy for Patients Receiving Autologous Bone Marrow Transplant for Relapsed EBV-Positive Lymphoma.|Terminated||Phase 1|5|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:41:07.441536|2017-10-11 04:41:07.441536
NCT00058799|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2010-07-27|||June 1999||1999-06-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine|Treatment of High Risk Acute Leukemia With CD40 Ligand and IL-2 Gene Modified Autologous Skin Fibroblasts and Tumor Cells|Completed||Phase 1|11|Actual|Baylor College of Medicine||1|||t||||f||||||||||2017-10-11 04:41:07.616149|2017-10-11 04:41:07.616149
NCT00058812|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2015-01-27|||May 1993||1993-05-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ETNA||Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts|Administration of EBV Specific Cytotoxic T Lymphocytes to Recipients of Mismatched-Related or Phenotypically Similar Unrelated Donor Marrow Grafts|Completed||Phase 1|69|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:41:07.697083|2017-10-11 04:41:07.697083
NCT00058825|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-11|2016-09-20|2015-09-23||August 2000||2000-08-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|HIMSUM||Stem Cell Transplant for Hematologic Diseases|Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients With Hematologic Diseases Using Haploidentical Family Donors and Sub-Myeloablative Conditioning With Campath 1H|Terminated||Phase 1/Phase 2|27|Actual|Baylor College of Medicine||1||Slow accrual due to practice changes meant study would take too long to finish|f||||t||||||||||2017-10-11 04:41:07.786559|2017-10-11 04:41:07.786559
NCT00058838|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-14|2006-06-06|||April 2003||2003-04-01|June 2006|2006-06-01|September 2004||2004-09-01|||||Interventional|||Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease|A Phase III, Double-Blind, Placebo-Controlled, Fixed-Dose Response Study Comparing the Efficacy and Safety of Sumanirole Versus Placebo in Patients With Early Parkinson's Disease.|Completed||Phase 3|854||Pfizer|||||||||||||||||||2017-10-11 04:41:08.153331|2017-10-11 04:41:08.153331
NCT00058851|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-14|2009-08-17|||January 2003||2003-01-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|||||Interventional|||Massage Therapy for Breast Cancer Treatment-Related Swelling of the Arms|Massage Therapy for Breast Cancer-Related Lymphedema|Completed||Phase 2|88|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:41:08.47853|2017-10-11 04:41:08.47853
NCT00058864|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-14|2009-02-26|||September 2001||2001-09-01|February 2009|2009-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The HIP Impact Protection Program (HIP PRO)|Trochanteric Padding to Prevent Hip Fractures|Completed||N/A|546||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:41:08.549849|2017-10-11 04:41:08.549849
NCT00058903|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-14|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01|March 2005||2005-03-01|||||Interventional|||Treatment of Cholestatic Pruritus With Sertraline|Treatment of Cholestatic Pruritus With Sertraline|Completed||Phase 2|40|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 04:41:08.715441|2017-10-11 04:41:08.715441
NCT00058929|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-14|2013-03-05|||October 2002||2002-10-01|March 2013|2013-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension|A Multicenter, Randomized, Parallel Placebo-Controlled Study of the Safety and Efficacy of Subcutaneous Remodulin® Therapy After Transition From Flolan® in Patients With Pulmonary Arterial Hypertension|Completed||Phase 4|39||United Therapeutics|||||f||||f||||||||||2017-10-11 04:41:08.782989|2017-10-11 04:41:08.782989
NCT00058942|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-15|2009-12-09|||January 2000||2000-01-01|November 2006|2006-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Trial of Tap Water Treatment in the Elderly|A Randomized Trial of Tap Water Treatment in the Elderly|Completed||N/A|810||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:41:08.856868|2017-10-11 04:41:08.856868
NCT00058955|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-15|2008-09-09|||August 2003||2003-08-01|September 2008|2008-09-01|March 2005||2005-03-01|||||Interventional|||Physiological, Behavioral and Subjective Effects of Drugs (GHB)|Physiological, Behavioral and Subjective Effects of Drugs (GHB)|Completed||Phase 1|20|Anticipated|Orphan Medical||4|||f||||f||||||||||2017-10-11 04:41:08.928447|2017-10-11 04:41:08.928447
NCT00058968|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-15|2007-05-16|||October 2002||2002-10-01|May 2007|2007-05-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study for the Treatment of Painful Diabetic Neuropathy|Duloxetine Versus Placebo in the Treatment of Patients With Painful Diabetic Neuropathy|Completed||Phase 3|660||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:41:09.015032|2017-10-11 04:41:09.015032
NCT00058981|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-15|2009-03-18|||October 2002||2002-10-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|March 2007|Actual|2007-03-01||Interventional|||Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Tolerability as Well as the Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in LADA Subjects|Terminated||Phase 2|100||DeveloGen Israel, Ltd.|||||||||||||||||||2017-10-11 04:41:09.224767|2017-10-11 04:41:09.224767
NCT00058994|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-15|2012-11-28|||March 2003||2003-03-01|August 2008|2008-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD|An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-related Macular Degeneration|Completed||Phase 3|||Alcon Research|||||f||||f||||||||||2017-10-11 04:41:09.313493|2017-10-11 04:41:09.313493
NCT00059020|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-16|2008-03-03|||April 2003||2003-04-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Observational|||The Role of Gene Changes in Brain Tumor Formation and Growth|EGF Polymorphisms and Gliomagenesis|Completed||N/A|344||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:09.397544|2017-10-11 04:41:09.397544
NCT00059046|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-16|2008-03-03|||April 2003||2003-04-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Brain Imaging of Serotonin Transporters in the Brain|Kinetic Studies in Whole Body and Brain of [11C]DASB PET Imaging of Serotonin Transporters|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:09.603815|2017-10-11 04:41:09.603815
NCT00059098|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-17|2016-07-11|||March 2003||2003-03-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Identification of Genes Predisposing to Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:41:09.679587|2017-10-11 04:41:09.679587
NCT00059111|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-17|2017-05-02|||April 2003||2003-04-01|May 2017|2017-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Mechanisms Mediating Cardiovascular Disease in Children With Obstructive Sleep Apnea||Completed||N/A|||Children's Hospital Medical Center, Cincinnati|||||f||||||||||||||2017-10-11 04:41:09.749599|2017-10-11 04:41:09.749599
NCT00059124|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-17|2013-07-10|||March 2003||2003-03-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Aortic Calcium: Epidemiology and Progression -- Ancillary to MESA|Aortic Calcium: Epidemiology and Progression|Completed||N/A|1980|Actual|University of California, San Diego|||1||f||||f||||||||||2017-10-11 04:41:09.831314|2017-10-11 04:41:09.831314
NCT00059137|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-18|2008-03-03|||April 2003||2003-04-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Observational|||Breathing Cycle Biofeedback During Computed Tomography Procedures|Respiratory Cycle Biofeedback During CT Guided Procedures|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:09.905688|2017-10-11 04:41:09.905688
NCT00059189|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-19|2008-03-03|||April 2003||2003-04-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Brain Plasticity of Verbal Memory in the Blind|Cross-Modal Plasticity of Verbal Memory in the Blind|Completed||N/A|85||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:09.989005|2017-10-11 04:41:09.989005
NCT00059202|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-21|2013-10-31||||||October 2013|2013-10-01||||||||Interventional|||Trial of High-dose Urso in Primary Sclerosing Cholangitis|Multicentered Randomized Trial of High-dose Urso in Primary Sclerosing Cholangitis|Completed||Phase 2/Phase 3|150||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:41:10.123738|2017-10-11 04:41:10.123738
NCT00059215|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-21|2010-05-21|2010-04-19||April 2003||2003-04-01|May 2010|2010-05-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)|A Double-Blind, Randomized, Multicenter, Dose-Ranging Trial of CS-747 Compared With Clopidogrel in Subjects Undergoing Percutaneous Coronary Intervention|Completed||Phase 2|905|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 04:41:10.260667|2017-10-11 04:41:10.260667
NCT00059228|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-22|2017-10-05|||April 17, 2003||2003-04-17|November 15, 2016|2016-11-15|November 15, 2016|Actual|2016-11-15|November 15, 2016|Actual|2016-11-15||Interventional|||Clinical Trial of Estrogen for Postpartum Depression|The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness|Terminated||Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:41:11.701844|2017-10-11 04:41:11.701844
NCT00059241|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-22|2005-06-23|||July 2000||2000-07-01|April 2003|2003-04-01||||||||Interventional|||"The Reach For Health Program: Delaying Sexual Activity in Children"|Reach For Health--Middle Childhood Risk Prevention Study|Unknown status|Recruiting|Phase 2|1200||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:11.819205|2017-10-11 04:41:11.819205
NCT00059267|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-22|2010-01-12|||June 2001||2001-06-01|January 2010|2010-01-01||||||||Observational|||Prevention of Recurrent Hepatitis B After Liver Transplantation|Prevention of Recurrent Hepatitis B After Liver Transplantation|Completed||N/A|500||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:41:11.952965|2017-10-11 04:41:11.952965
NCT00059280|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-22|2014-02-04|||April 2003||2003-04-01|July 2006|2006-07-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|||A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease|An Open-label, Multicenter, Multinational Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Acid Alpha-glucosidase Treatment in Patients Less Than 6 Months Old With Infantile-onset Pompe Disease|Completed||Phase 2/Phase 3|16|Actual|Sanofi||1|||f||||||||||||||2017-10-11 04:41:12.009116|2017-10-11 04:41:12.009116
NCT00059293|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-22|2008-07-23|||September 2002||2002-09-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:41:12.095594|2017-10-11 04:41:12.095594
NCT00059306|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-23|2013-04-02|||February 2003||2003-02-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|SPS3||Secondary Prevention of Small Subcortical Strokes Trial|Secondary Prevention of Small Subcortical Strokes (SPS3) Trial|Completed||Phase 3|3020|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 04:41:12.158066|2017-10-11 04:41:12.158066
NCT00059319|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-23|2007-05-18|||January 1999||1999-01-01|May 2007|2007-05-01||||||||Interventional|||Reduced Manipulation of the Aorta and Neurobehavioral Outcome Trial||Completed||Phase 3|300||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-10-11 04:41:12.56676|2017-10-11 04:41:12.56676
NCT00059332|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-23|2015-07-24|2015-06-09||January 2005||2005-01-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|FAST-MAG||Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial|Field Administration of Stroke Therapy-Magnesium Trial: A Randomized, Double-Blind, Placebo Controlled Trial of Neuroprotective Magnesium Sulfate Therapy for Acute Stroke Initiated Within 2 Hours of Onset by Paramedics in the Field|Completed||Phase 3|1700|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 04:41:12.665398|2017-10-11 04:41:12.665398
NCT00059345|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-23|2013-11-15|||September 2002||2002-09-01|November 2013|2013-11-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Interaction Between Patient and Healthcare Provider: Response to Acupuncture in Knee Osteoarthritis|The Impact of Patient-Provider Interaction on Response to Acupuncture|Completed||N/A|639|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 04:41:14.291694|2017-10-11 04:41:14.291694
NCT00059358|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-23|2009-08-06|||September 2001||2001-09-01|August 2009|2009-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Zidovudine Levels in HIV Infected Patients Being Treated for HCV|Pharmacological Interactions Between Zidovudine and Ribavirin in HCV-HIV Co-Infected Patients Treated With Rebetron or Peg-Intron Plus Ribavirin|Completed||Phase 1/Phase 2|16|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:41:14.414342|2017-10-11 04:41:14.414342
NCT00059371|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-23|2008-05-28|||February 2002||2002-02-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Male Circumcision and HIV Rates in Kenya|Trial of Male Circumcision to Reduce HIV Incidence|Completed||Phase 3|2887|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||f||||||||||2017-10-11 04:41:14.508093|2017-10-11 04:41:14.508093
NCT00059384|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-23|2008-09-16|||January 2003||2003-01-01|July 2007|2007-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Alternative Dosing Strategy for Anti-HIV Drugs|Concentration-Controlled Antiretroviral Therapy in Persons Experiencing Persistent Viremia|Completed||Phase 4|66||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:41:14.58729|2017-10-11 04:41:14.58729
NCT00059397|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-24|2010-03-17|||April 2003||2003-04-01|March 2010|2010-03-01||||||||Observational|||Hepatitis C: Grading and Staging by MR|Hepatitis C: Grading and Staging by MR|Completed||N/A|80|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:41:14.65513|2017-10-11 04:41:14.65513
NCT00059410|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-24|2009-12-10|||January 2003||2003-01-01|February 2008|2008-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II|Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II|Completed||N/A|210||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:41:14.709901|2017-10-11 04:41:14.709901
NCT00059423|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-25|2017-10-05|||April 22, 2003||2003-04-22|August 1, 2017|2017-08-01||||||||Observational|||Natural History Study for BEN|Natural History and Molecular Characterization of Benign Ethnic Neutropenia in Individuals of African Descent|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:14.792466|2017-10-11 04:41:14.792466
NCT00059436|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-25|2016-09-23|||October 1999||1999-10-01|May 2011|2011-05-01||||September 2004|Actual|2004-09-01||Interventional|||Mental Effort and Muscle Strength|Mental-effort Effect on Large Muscle Strengthening|Completed||Phase 1|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:14.90401|2017-10-11 04:41:14.90401
NCT00059449|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-25|2010-01-12||||||January 2010|2010-01-01||||||||Observational|||Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis|Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis|Completed||N/A|372|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:41:14.996228|2017-10-11 04:41:14.996228
NCT00059462|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-25|2014-12-18|||December 2002||2002-12-01|December 2014|2014-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection|Phase I/II Randomized, Double Blind, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Subcutaneous Bay 50-4798 Administration in Patients With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to Patients on HAART Alone.|Completed||Phase 1/Phase 2|56|Actual|Bayer||2|||f||||||||||||||2017-10-11 04:41:15.066416|2017-10-11 04:41:15.066416
NCT00059475|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-26|2012-10-17|2012-03-30||April 2003||2003-04-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Peptide Vaccination for Patients at High Risk for Recurrent Melanoma|Randomized Comparison of Peptide Immunization in Patients at High Risk for Recurrence of Melanoma|Completed||Phase 2|138|Actual|National Institutes of Health Clinical Center (CC)||8|||f||||f||||||||||2017-10-11 04:41:15.193822|2017-10-11 04:41:15.193822
NCT00059501|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-26|2008-03-03|||April 2003||2003-04-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Postural Control in the Elderly|Cortical Control of Postural Stability in the Elderly|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:16.351122|2017-10-11 04:41:16.351122
NCT00059514|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-28|2017-04-03|||May 2000|Actual|2000-05-01|April 2017|2017-04-01|May 2006|Actual|2006-05-01|April 2005|Actual|2005-04-01||Observational|||Tobacco Use Among Arab American Youth|Arab American Youth: Tobacco Use and Intervention|Completed||N/A|2300|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||t|f|f||||||No||2017-10-11 04:41:16.536184|2017-10-11 04:41:16.536184
NCT00059527|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-28|2014-10-28|||March 1999||1999-03-01|August 2005|2005-08-01|May 2003||2003-05-01|||||Interventional|||Healthy Youth Places: A Program to Promote Nutrition and Physical Activity in Adolescents|Youth Environments Promoting Nutrition and Activity|Completed||Phase 4|2000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:16.609775|2017-10-11 04:41:16.609775
NCT00059540|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-28|2016-09-20|||May 1993||1993-05-01|September 2016|2016-09-01|March 2011|Actual|2011-03-01|March 1995|Actual|1995-03-01||Observational|MLS||The Maternal Lifestyle Study (MLS)|The Maternal Lifestyle Study|Completed||Phase 4|11811|Actual|NICHD Neonatal Research Network|||1||f||||t||||||||||2017-10-11 04:41:16.689095|2017-10-11 04:41:16.689095
NCT00059553|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-28|2009-06-17|||May 2000||2000-05-01|August 2005|2005-08-01|January 2005||2005-01-01|||||Interventional|||Retraining Walking After Spinal Cord Injury|Activity-Dependent Plasticity After Spinal Cord Injury|Unknown status|Active, not recruiting|Phase 2/Phase 3|16||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:16.840284|2017-10-11 04:41:16.840284
NCT00059579|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-29|2017-06-30|||April 24, 2003||2003-04-24|November 12, 2010|2010-11-12|November 12, 2010||2010-11-12|||||Observational|||Brain Regulation of Emotions in People With Depression and Anhedonia|Functional MRI Study of Brain Mechanism Mediating Anhedonia in Major Depression|Completed||N/A|163|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:16.91849|2017-10-11 04:41:16.91849
NCT00059592|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-29|2005-06-23|||May 1998||1998-05-01|May 2005|2005-05-01||||||||Interventional|||Valacyclovir in Immunocompromised Children|Valacyclovir in Immunocompromised Children|Completed||Phase 1|30||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:41:17.505914|2017-10-11 04:41:17.505914
NCT00059605|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-29|2012-02-21|||March 2003||2003-03-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer|Phase I Study Of Intravenous DOTAP:Cholesterol-Fus1 Liposome Complex (DOTAP:Chol-fus1) In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy|Completed||Phase 1|32|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:41:17.568083|2017-10-11 04:41:17.568083
NCT00059826|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2016-12-05|||March 2003||2003-03-01|December 2016|2016-12-01|February 2011|Actual|2011-02-01|July 2007|Actual|2007-07-01||Interventional|||Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer|A Phase II Study of Interferon-Based Adjuvant Chemoradiation in Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 2|89|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:41:19.826762|2017-10-11 04:41:19.826762
NCT00059618|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-29|2012-08-01|||April 2003||2003-04-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer|A Phase I Study Evaluating the Safety and Tolerability of PS-341(Bortezomib)and Carboplatin in Patients With Platinum- and Taxane-Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer|Completed||Phase 1|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:41:17.680065|2017-10-11 04:41:17.680065
NCT00059631|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-29|2015-06-19|||March 2003||2003-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone|Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone in Patients With Advanced Androgen-Independent Prostate Cancer (AI-PCa)|Completed||Phase 1|42|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:41:17.788852|2017-10-11 04:41:17.788852
NCT00059644|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-29|2005-06-23|||July 2001||2001-07-01|June 2005|2005-06-01|June 2004||2004-06-01|||||Interventional|||Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease|A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of CirculaseTM for the Treatment of Critical Leg Ischemia|Terminated||Phase 3|560||Mitsubishi Tanabe Pharma Corporation|||||||||||||||||||2017-10-11 04:41:17.911413|2017-10-11 04:41:17.911413
NCT00059657|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-29|2006-05-17|||August 2001||2001-08-01|May 2006|2006-05-01|November 2005||2005-11-01|||||Interventional|||Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease|A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of CirculaseTM in Conjunction With Peripheral Revascularization for the Treatment of Critical Leg Ischemia|Completed||Phase 3|280||Mitsubishi Tanabe Pharma Corporation|||||||||||||||||||2017-10-11 04:41:18.057037|2017-10-11 04:41:18.057037
NCT00059670|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-01|2010-01-12||||||January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia|Comparison of Two Therapies for UES Dysphagia|Completed||N/A|204||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:41:18.176673|2017-10-11 04:41:18.176673
NCT00059683|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-01|2014-09-29|||January 2003||2003-01-01|September 2014|2014-09-01|October 2009|Actual|2009-10-01|November 2007|Actual|2007-11-01||Interventional|||Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women|Vaginal Ultrasound Cerclage Trial|Completed||N/A|300|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-10-11 04:41:18.262555|2017-10-11 04:41:18.262555
NCT00059696|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-01|2016-09-23|||December 1999||1999-12-01|May 2011|2011-05-01||||November 2004|Actual|2004-11-01||Interventional|||Treatment for Movement Problems in Elderly Stroke Patients|A Treatment for Excess Motor Disability in the Aged|Completed||Phase 2|80|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:18.355336|2017-10-11 04:41:18.355336
NCT00059709|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-02|2007-04-02|||August 2000||2000-08-01|January 2006|2006-01-01||||||||Interventional|||Learning to Resolve Family Conflict|Understanding and Learning How to Resolve Family Conflict|Completed||N/A|360||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:18.431766|2017-10-11 04:41:18.431766
NCT00059722|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-02|2016-08-22|||May 2003||2003-05-01|August 2016|2016-08-01|June 2007|Actual|2007-06-01|||||Interventional|||This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.|A Phase II, Randomized Double-blind, 2-part, Multicenter Study to Compare the Efficacy of ZD6474 With the Efficacy of ZD1839 (Iressa™) in Subjects With Locally Advanced or Metastatic (IIIB/IV) Non-small Cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy and to Assess the Activity of ZD6474 in Subjects Following Failure of Treatment With ZD1839.|Completed||Phase 2|160||Sanofi|||||||||||||||||||2017-10-11 04:41:18.500345|2017-10-11 04:41:18.500345
NCT00059735|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-05|2008-02-29|||May 2002||2002-05-01|February 2008|2008-02-01|December 2003|Actual|2003-12-01|||||Interventional|||A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma|A Phase II Study of E7070 in Patients With Progressive Inoperable and/or Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 2|30|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 04:41:18.736502|2017-10-11 04:41:18.736502
NCT00059748|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-05|2017-10-05|||April 30, 2003||2003-04-30|February 8, 2017|2017-02-08||||||||Observational|||Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID / CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)|Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, CRMO, Still s Disease, Behcet s Disease, and Other Undifferentiated Autoinflammatory Diseases)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:18.812559|2017-10-11 04:41:18.812559
NCT00059761|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2015-11-14|||March 2003||2003-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|March 2009|Actual|2009-03-01||Interventional|||Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Phase I Study of Irinotecan and Cisplatin in Combination With Twice Daily Thoracic Radiotherapy (45 Gy) or Once Daily Thoracic Radiotherapy (70 Gy) for Patients With Limited Stage Small Cell Lung Cancer|Completed||Phase 1|36|Actual|Radiation Therapy Oncology Group||6|||f||||t||||||||||2017-10-11 04:41:18.904041|2017-10-11 04:41:18.904041
NCT00059787|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2015-10-29|2015-04-29||April 2003||2003-04-01|May 2013|2013-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma|Phase II Study of Erlotinib Plus Carboplatin and Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:41:19.358697|2017-10-11 04:41:19.358697
NCT00059800|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-06-25|||May 2002||2002-05-01|December 2005|2005-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Boron Neutron Capture Therapy in Treating Patients With Melanoma|A Phase II Trial For Neutron Capture Therapy In Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:19.657242|2017-10-11 04:41:19.657242
NCT00059813|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-08-23|||August 2003||2003-08-01|August 2013|2013-08-01||||June 2005|Actual|2005-06-01||Interventional|||Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer|A Phase II Trial of G3139 (Genasense) Anti-Bcl-2 Antisense Oligonucleotide Plus Alpha-Interferon in Metastatic Renal Cancer|Completed||Phase 2|41|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:19.732973|2017-10-11 04:41:19.732973
NCT00059839|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2014-09-10|2013-06-28||November 2003||2003-11-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|December 2009|Actual|2009-12-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma|A Phase III Trial of Treatment of Advanced-Stage Anaplastic Large Cell Lymphoma (ALCL) With Standard APO (Doxorubicin, Prednisone, Vincristine) Versus Consolidation With a Regimen Including Vinblastine|Completed||Phase 3|129|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:41:20.111363|2017-10-11 04:41:20.111363
NCT00059852|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2016-12-05|||June 2003||2003-06-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|August 2006|Actual|2006-08-01||Interventional|||Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane|A Phase II Study of OSI-774 (Tarceva) and Gemcitabine for Patients With Metastatic Breast Cancer|Completed||Phase 2|61|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:41:21.376277|2017-10-11 04:41:21.376277
NCT00059865|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2016-12-05|||January 2004||2004-01-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer|Phase I/II Trial Of Gemcitabine And ALIMTA In Patients With Measurable Or Evaluable, Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Or Vater) And Gallbladder Carcinoma|Completed||Phase 1/Phase 2|68|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:41:21.546072|2017-10-11 04:41:21.546072
NCT00059878|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-06-17|||August 2003||2003-08-01|July 2004|2004-07-01|January 2005|Actual|2005-01-01|||||Interventional|||Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections|A Prospective, Randomized, Double-Blind, Multicenter Pilot Study Of The Safety And Efficacy Of Interferon Gamma- 1b (IFN-y 1b) Plus Voriconazole Versus Placebo Plus Voriconazole In The Treatment Of Invasive Aspergillosis And Other Filamentous Fungal Infections|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:21.732446|2017-10-11 04:41:21.732446
NCT00059891|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-02-26|||January 2003||2003-01-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer|Total Anorectal Reconstruction With The American Medical Systems, Inc. Acticon Neosphincter Prosthesis After Abdominoperineal Resection|Completed||N/A|4|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:41:21.811259|2017-10-11 04:41:21.811259
NCT00059904|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-07-17|||January 2003||2003-01-01|July 2004|2004-07-01|June 2004|Actual|2004-06-01|||||Interventional|||Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma|An Open-Labeled, Phase II Study of Rituximab in Combination With Recombinant IL-2 for Relapsed or Refractory Non-Hodgkin's Lymphoma of Intermediate- or High-Grade Histology|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:21.896426|2017-10-11 04:41:21.896426
NCT00059917|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-05-29|||January 2003||2003-01-01|April 2005|2005-04-01|May 2005|Actual|2005-05-01|||||Interventional|||Polyglutamate Camptothecin in Treating Patients With Advanced Cancer|Phase I Study of CT-2106 in Patients With Advanced Malignancy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:21.973535|2017-10-11 04:41:21.973535
NCT00059930|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2017-07-05|||January 2003|Actual|2003-01-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer|A Phase I Study Of Hepatic Arterial Infusion With Floxuridine And Dexamethasone In Combination With Intravenous Oxaliplatin Plus 5-Fluorouracil And Leucovorin As Adjuvant Treatment After Resection Of Hepatic Metastases From Colorectal Cancer|Active, not recruiting||Phase 1|38|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:41:22.054395|2017-10-11 04:41:22.054395
NCT00059943|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-01-15|||September 2002||2002-09-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer|Pharmacokinetics of Weekly Docetaxel in Patients Age 65 and Older With Metastatic Breast or Lung Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:41:22.162844|2017-10-11 04:41:22.162844
NCT00059982|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-06-21|||July 2003||2003-07-01|August 2004|2004-08-01|August 2005|Actual|2005-08-01|||||Interventional|||Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer|Phase II Trial Of Perifosine In Locally Advanced, Unresectable Or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:22.46793|2017-10-11 04:41:22.46793
NCT00059995|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-05-29|||January 2003||2003-01-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|October 2007|Actual|2007-10-01||Interventional|||MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma|Phase I/II Open Label, Dose-Escalating Study of MDX-060 Administered Weekly for 4 Weeks in Patients With Refractory/Relapsed CD30 Lymphoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:22.576851|2017-10-11 04:41:22.576851
NCT00060008|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2014-04-03|2014-04-01||April 2002||2002-04-01|April 2014|2014-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma|Novel Imaging Modalities For Plexiform Neurofibromas|Terminated||N/A|18|Actual|Children's Hospital of Philadelphia|The sample size was modest. It is possible that with increased sample size, if the correlation estimate holds, it will become statistically significant.|1||Study was closed early due to poor accrual.|f||||f||||||||||2017-10-11 04:41:22.688971|2017-10-11 04:41:22.688971
NCT00060021|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2015-04-29|||March 2003||2003-03-01|April 2004|2004-04-01||||||||Interventional|||Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation|A Randomized, Placebo-Controlled, Blinded Study Of Acupuncture Therapy In Mucositis-Related Pain In Patients Undergoing Hematopoietic Stem Cell Transplantation|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:22.880047|2017-10-11 04:41:22.880047
NCT00060099|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-11-05|||May 2003||2003-05-01|March 2005|2005-03-01||||||||Interventional|||SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia|Phase II Randomized, Double-Blinded Trial Of SGN-00101 (HSP-E7) For Treatment Of CIN II/III|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:23.076631|2017-10-11 04:41:23.076631
NCT00060112|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-01-24|||March 2003||2003-03-01|January 2013|2013-01-01||||December 2009|Actual|2009-12-01||Interventional|||Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma|A Phase I Study of Oblimersen (Genasense™, G3139) in Combination With Gemcitabine in Advanced Malignancies|Terminated||Phase 1|15|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:41:23.145679|2017-10-11 04:41:23.145679
NCT00060125|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-06-04|||May 2003||2003-05-01|June 2013|2013-06-01||||June 2006|Actual|2006-06-01||Interventional|||Tipifarnib in Treating Patients With Metastatic Malignant Melanoma|PHASE II TRIAL OF R115777 IN PATIENTS WITH METASTATIC MALIGNANT MELANOMA|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:23.238857|2017-10-11 04:41:23.238857
NCT00060138|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-05-13|||November 2002||2002-11-01|May 2013|2013-05-01||||September 2004|Actual|2004-09-01||Interventional|||Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases|A Phase I-II, 24-Week, Multi-Center, Double-Blind, Randomized, Dose-Ranging Study To Evaluate The Safety And Efficacy Of A Humanized Monoclonal Antibody To PTHrP Versus Zoledronic Acid In Patients With Breast Cancer Metastatic To Bone|Completed||Phase 1/Phase 2|||Chugai Pharmaceutical|||||f||||||||||||||2017-10-11 04:41:23.310763|2017-10-11 04:41:23.310763
NCT00060151|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-09-19|||December 2002||2002-12-01|April 2006|2006-04-01|June 2009|Actual|2009-06-01|||||Interventional|||GW786034 in Treating Patients With Advanced Solid Tumors|A Phase I, Open Label, Multiple Dose, Dose Escalation Study OF GW786034 In Patients With Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:23.369745|2017-10-11 04:41:23.369745
NCT00060203|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2014-01-14|||December 2002||2002-12-01|January 2014|2014-01-01|April 2004|Actual|2004-04-01|March 2003|Actual|2003-03-01||Interventional|||Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma|A Phase I/II Study of the Safety and Efficacy of Brostallicin (PNU-166196A) in Adult Patients With Multiple Myeloma That Has Progressed on Prior Chemotherapy|Completed||Phase 1/Phase 2|3|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:41:23.545579|2017-10-11 04:41:23.545579
NCT00060242|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2010-06-10|||February 2003||2003-02-01|June 2010|2010-06-01|January 2008|Actual|2008-01-01|February 2007|Actual|2007-02-01||Interventional|||Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer|Phase II Trial Of Combretastatin A-4 Phosphate (CA4P) In Advanced Anaplastic Carcinoma Of The Thyroid|Completed||Phase 2|26|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:41:23.636086|2017-10-11 04:41:23.636086
NCT00060255|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-05-07|||December 1991||1991-12-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|August 2006|Actual|2006-08-01||Interventional|||High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors|Autologous Blood and Marrow Transplantation for Hematologic Malignancy and Selected Solid Tumors|Completed||Phase 2|451|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:41:23.7207|2017-10-11 04:41:23.7207
NCT00060268|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2011-03-07|||January 1997||1997-01-01|March 2011|2011-03-01|June 2004|Actual|2004-06-01|September 2003|Actual|2003-09-01||Interventional|||Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors|A Phase I/II Trial for Treatment of Obstructive Esophageal Tumors by Photodynamic Therapy (PDT) Using 2-(1-Hydroxyethyl)-2-Devinylpyropheophorbide-a (HPPH)|Completed||Phase 1/Phase 2|11|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:41:23.836724|2017-10-11 04:41:23.836724
NCT00060294|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-01-07|||April 2003||2003-04-01|January 2013|2013-01-01||||June 2004|Actual|2004-06-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia|Phase I Study of Zevalin (90Y-Ibritumomab Tiuxetan) in Waldenstrom's Macroglobulinemia (Lymphoplasmacytic Lymphoma)|Terminated||Phase 1|||Jonsson Comprehensive Cancer Center||||no accrual|f||||t||||||||||2017-10-11 04:41:23.908694|2017-10-11 04:41:23.908694
NCT00060307|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-02-27|||May 2003||2003-05-01|February 2013|2013-02-01||||May 2007|Actual|2007-05-01||Interventional|||Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer|A Phase II Study of OSI-774 (NSC-718781) in Patients With Locally Advanced or Metastatic Papillary Histology Renal Cell Cancer|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:23.9862|2017-10-11 04:41:23.9862
NCT00060320|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2016-07-12|||October 2003||2003-10-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer|A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes|Completed||Phase 3|132|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:41:24.083041|2017-10-11 04:41:24.083041
NCT00060333|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2017-01-30|2017-01-30||July 2003||2003-07-01|January 2017|2017-01-01|April 2016|Actual|2016-04-01|June 2011|Actual|2011-06-01||Interventional|||Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma|Phase II Trial Evaluating Resection Followed By Adjuvant Radiation Therapy (RT) For Patients With Desmoplastic Melanoma|Completed||Phase 2|20|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:41:24.22833|2017-10-11 04:41:24.22833
NCT00060346|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-02-11|2013-01-10||June 2004||2004-06-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|December 2011|Actual|2011-12-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia|Phase II Pilot Study Of Rituximab Plus CHOP In Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia|Terminated||Phase 2|16|Actual|Eastern Cooperative Oncology Group||1||slow accrual|f||||f||||||||||2017-10-11 04:41:24.603199|2017-10-11 04:41:24.603199
NCT00060359|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2015-05-07|||April 2003||2003-04-01|May 2015|2015-05-01||||January 2009|Actual|2009-01-01||Interventional|||Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer|A Dose-Escalating Phase I Study With an Expanded Cohort to Assess the Feasibility of CT-2103 and Carboplatin (NSC #214240) in Patients With Previously Untreated Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma|Completed||Phase 1|32|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:41:25.531519|2017-10-11 04:41:25.531519
NCT00060372|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-03-26|||April 2003||2003-04-01|March 2013|2013-03-01||||April 2008|Actual|2008-04-01||Interventional|||Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer|CTLA-4 Blockade With MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:25.640342|2017-10-11 04:41:25.640342
NCT00060385|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2012-09-20|||March 2003||2003-03-01|September 2012|2012-09-01||||August 2004|Actual|2004-08-01||Interventional|||Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma|Diffuse Large B Cell And Peripheral T Cell Non-Hodgkin's Lymphomas (NHL) In The Elderly. Influence Of Prolonged Oral Etoposide Added To CHOP Combination Chemotherapy In Patients With Good Physiological Status. An EORTC Randomized Phase II-III Trial Including Geriatric Assessment And Quality Of Life|Terminated||Phase 2/Phase 3|3|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:41:25.772054|2017-10-11 04:41:25.772054
NCT00060398|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2009-05-09|||June 2004||2004-06-01|July 2006|2006-07-01||||June 2006|Actual|2006-06-01||Interventional|||Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer|Study Of Epoetin Alfa Vs Epoetin Alfa With Dexamethasone In Hormone Refractory Prostate Cancer Patients: Impact On Fatigue, Anemia, Functional Status And Quality Of Life|Completed||Phase 3|282|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:25.885428|2017-10-11 04:41:25.885428
NCT00060411|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-09-27|||June 2003||2003-06-01|September 2013|2013-09-01||||July 2007|Actual|2007-07-01||Interventional|||A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer|A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:41:26.311827|2017-10-11 04:41:26.311827
NCT00060437|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2013-06-18|||October 2003||2003-10-01|April 2004|2004-04-01|April 2004|Actual|2004-04-01|||||Interventional|||Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer|A Phase II Trial Of Oral Perifosine In Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:41:26.572191|2017-10-11 04:41:26.572191
NCT00060450|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2016-09-08|||August 2001||2001-08-01|September 2016|2016-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation|Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation|Terminated||Phase 3|84|Actual|Mallinckrodt||2||Slow Enrollment|f||||f||||||||||2017-10-11 04:41:26.653145|2017-10-11 04:41:26.653145
NCT00060463|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2005-06-23|||October 2002||2002-10-01|October 2004|2004-10-01|October 2005||2005-10-01|||||Interventional|||Increased Access to Emergency Contraceptive Pills|Increased Access to Emergency Contraceptive Pills|Unknown status|Active, not recruiting|N/A|1490||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:26.766476|2017-10-11 04:41:26.766476
NCT00060476|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2017-05-05|||January 8, 2003|Actual|2003-01-08|May 2017|2017-05-01|December 8, 2004|Actual|2004-12-08|December 8, 2004|Actual|2004-12-08||Interventional|||Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Rofecoxib in Decreasing the Risk of Prostate Cancer (ViP Study)|Completed||Phase 3|15000|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:41:26.838845|2017-10-11 04:41:26.838845
NCT00060489|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-06|2011-01-25|||September 2002||2002-09-01|January 2011|2011-01-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression||Completed||Phase 3|||AstraZeneca|||||||||||||||||||2017-10-11 04:41:26.934064|2017-10-11 04:41:26.934064
NCT00060502|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-07|2011-05-16|||April 2003||2003-04-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia|A Phase II, Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Anti-TNF a Monoclonal Antibody (Infliximab) to Treat Cancer-Related Cachexia in Subjects With Pancreatic Cancer.|Completed||Phase 2|73|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 04:41:27.090737|2017-10-11 04:41:27.090737
NCT00060515|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-07|2005-08-04||||||August 2005|2005-08-01||||||||Interventional|||RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease|An Open-Label Dose-Escalation Phase I Study to Asses the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RG2133 (2',3',5'-Tri-O-Acetyluridine) in the Treatment of Inherited Mitochondrial Diseases|Terminated||Phase 1|12||Repligen Corporation|||||||||||||||||||2017-10-11 04:41:27.171924|2017-10-11 04:41:27.171924
NCT00060528|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-07|2012-06-05|2011-11-30||May 2003||2003-05-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|October 2009|Actual|2009-10-01||Interventional|||Sequential Vaccinations in Prostate Cancer Patients|A Phase I/II Pilot Study of Sequential Vaccinations With rFowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM) Alone, or in Combination With rVaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM), and the Role of GM-CSF, in Men With Prostate Cancer|Completed||Phase 1/Phase 2|32|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||f||||||||||2017-10-11 04:41:27.255436|2017-10-11 04:41:27.255436
NCT00060541|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-07|2017-10-05|||May 5, 2003||2003-05-05|December 6, 2016|2016-12-06||||||||Observational|||Evaluation and Treatment of Neurosurgical Disorders|Evaluation and Treatment of Neurosurgical Disorders|Recruiting||N/A|1600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:28.157224|2017-10-11 04:41:28.157224
NCT00060554|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-07|2009-11-02|||April 2003||2003-04-01|November 2009|2009-11-01||||||||Interventional|||A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)||Withdrawn||Phase 2|300||Schering-Plough||||"Drug sold to Sanofi-Aventis who sold it to GSK; OBS no longer owns study and does not have   data."|||||||||||||||2017-10-11 04:41:28.237326|2017-10-11 04:41:28.237326
NCT00060567|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-07|2013-06-05|||March 2003||2003-03-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Dose-Finding Study of E7070 in Combination With Irinotecan|Phase I Dose-Finding Study of E7070 in Combination With Irinotecan|Completed||Phase 1|88|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-11 04:41:28.343303|2017-10-11 04:41:28.343303
NCT00060580|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-07|2008-03-03|||May 2003||2003-05-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Raman Scattering Spectroscopy to Measure Macular Pigment|Measurement of Macular Pigment With Resonant Raman Backscattering Spectroscopy|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:28.421892|2017-10-11 04:41:28.421892
NCT00060593|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-07|2008-03-03|||May 2003||2003-05-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Observational|||MRI Study of Self-Perception of Postural Stability|Self-Perception of Postural Stability: Event-Related fMRI Study|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:28.488813|2017-10-11 04:41:28.488813
NCT00060606|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-08|2017-06-20|||February 2003||2003-02-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|February 2014|Actual|2014-02-01||Interventional|MOMS||Management of Myelomeningocele Study (MOMS)|Myelomeningocele Repair Randomized Trial|Completed||N/A|183|Actual|The George Washington University Biostatistics Center||2|||f||||t|f|f||||||Yes|The dataset will be shared per NIH policy after the completion and publication of the main analyses.|2017-10-11 04:41:28.550688|2017-10-11 04:41:28.550688
NCT00060619|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-08|2005-06-23|||May 1999||1999-05-01|March 2003|2003-03-01|June 2004||2004-06-01|||||Interventional|||Migraine and Recurrent Abdominal Pain in Children|Treatment of Recurrent Pain Syndromes in Children|Unknown status|Recruiting|N/A|180|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:28.900961|2017-10-11 04:41:28.900961
NCT00060632|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-08|2015-08-26|||April 2003||2003-04-01|August 2015|2015-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)|A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Weekly Administration of AP23573, an mTOR Inhibitor, in Patients With Refractory or Advanced Malignancies|Completed||Phase 1|46|Actual|Merck Sharp & Dohme Corp.||6|||f||||||||||||||2017-10-11 04:41:28.989843|2017-10-11 04:41:28.989843
NCT00060645|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-08|2015-08-26|||May 2003||2003-05-01|August 2015|2015-08-01|February 2009|Actual|2009-02-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)|A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily x 5 Administration of AP23573, an mTOR Inhibitor, in Patients With Refractory or Advanced Malignancies|Completed||Phase 1|33|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-10-11 04:41:29.09203|2017-10-11 04:41:29.09203
NCT00060658|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-08|2008-03-03|||May 2003||2003-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Magnetic Resonance Imaging of Calculus Problem Solving|Functional Neuroimaging of Calculus Problem Solving|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:29.178758|2017-10-11 04:41:29.178758
NCT00060671|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-09|2015-01-15|||January 2005||2005-01-01|May 2013|2013-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma|An Open-Label, Randomized, Phase III Comparative Trial of BBR 2778 + Rituximab Versus Rituximab in the Treatment of Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma (NHL)|Terminated||Phase 3|800||CTI BioPharma|||||f||||||||||||||2017-10-11 04:41:29.24381|2017-10-11 04:41:29.24381
NCT00060684|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-09|2015-01-15|||December 2001||2001-12-01|September 2008|2008-09-01|May 2007|Actual|2007-05-01|January 2005|Actual|2005-01-01||Interventional|||Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma|A Phase I Trial of BBR 2778 in Combination With Fludarabine, Dexamethasone and Rituximab in the Treatment of Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|Completed||Phase 1|30||CTI BioPharma|||||||||||||||||||2017-10-11 04:41:29.403686|2017-10-11 04:41:29.403686
NCT00060697|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-09|2005-06-23|||December 2000||2000-12-01|May 2003|2003-05-01|May 2005||2005-05-01|||||Interventional|||A Mother's Role in Delaying Onset of Sexual Activity in Her Children|Family Intervention to Promote Health in Children|Unknown status|Recruiting|Phase 2|1300||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:29.504674|2017-10-11 04:41:29.504674
NCT00060710|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-09|2011-10-14|||January 2003||2003-01-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|||||Interventional|||CP-461 in the Treatment of Patients With Advanced Melanoma|Phase II Study of CP-461 in the Treatment of Patients With Advanced Melanoma|Terminated||Phase 2|35||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:41:29.568463|2017-10-11 04:41:29.568463
NCT00060723|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-09|2016-12-03|||August 1999||1999-08-01|December 2016|2016-12-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Observational|||Behavioral Effects of Obstructive Sleep Apnea in Children|Behavioral Effect of Obstructive Sleep Apnea in Children|Completed||N/A|106|Actual|University of Michigan|||2||f||||f||||||||||2017-10-11 04:41:29.746713|2017-10-11 04:41:29.746713
NCT00060736|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-09|2017-10-05|||May 5, 2003||2003-05-05|April 27, 2016|2016-04-27|April 27, 2016||2016-04-27|||||Observational|||The Effects of Estrogen Withdrawal on Mood Symptoms in Women|The Effects of Acute Withdrawal of Estradiol on Mood Symptoms in Women With Perimenopausal Depression|Completed||N/A|60|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:29.861423|2017-10-11 04:41:29.861423
NCT00060749|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-09|2017-06-30|||May 5, 2003||2003-05-05|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Interventional|||Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy|Investigation of the Effect of Dietary Docosahexaenoic Acid (DHA) Supplementation on Macular Function in Subjects With Autosomal Dominant Stargardt-Like and Autosomal Recessive Stargardt Macular Dystrophy|Completed||Phase 1|22||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:29.97389|2017-10-11 04:41:29.97389
NCT00060762|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-12|2014-05-14|||April 2002||2002-04-01|May 2014|2014-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effectiveness of Binge Eating Disorder Treatments|Effectiveness of Psychological Treatments for BED|Completed||Phase 4|205|Actual|Stanford University||3|||f||||t||||||||||2017-10-11 04:41:30.116129|2017-10-11 04:41:30.116129
NCT00060775|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-12|2017-10-05|||May 9, 2003||2003-05-09|September 25, 2017|2017-09-25||||||||Observational|||The Psychobiology of Childhood Temperament|The Psychobiology of Temperament: An fMRI Study|Recruiting||N/A|1010|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:30.273476|2017-10-11 04:41:30.273476
NCT00060788|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-13|2006-03-06|||September 2001||2001-09-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Observational|||Antisocial Behavior: Passing From Parent to Child to Grandchild|Intergenerational Transmission of Antisocial Behavior|Unknown status|Recruiting|N/A|663||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:30.374297|2017-10-11 04:41:30.374297
NCT00060801|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-13|2013-10-30|||May 2003||2003-05-01|October 2013|2013-10-01||||July 2004|Actual|2004-07-01||Interventional|||Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult (75 mg, 150 mg) and Pediatric (75 mg) Cystic Fibrosis Patients|Terminated||Phase 2|420||Boehringer Ingelheim|||||||||||||||||||2017-10-11 04:41:30.461054|2017-10-11 04:41:30.461054
NCT00060814|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-14|2017-01-11|||June 2002||2002-06-01|October 2016|2016-10-01|December 2002|Actual|2002-12-01|September 2002|Actual|2002-09-01||Interventional|||Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients|Pilot Study Examining the Effects of Combined Pharmacotherapy (Zyban/NRT)/Behavioral Treatment on Smoking Cessation Among MMT Patients.|Completed||Phase 2|28|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-10-11 04:41:30.7123|2017-10-11 04:41:30.7123
NCT00060827|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-14|2014-10-28||||||March 2004|2004-03-01||||||||Observational|||Measuring Head Impacts in Sports|Head Impact Recording Technology for Field Applications|Withdrawn||Phase 2|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||f||||||||||2017-10-11 04:41:30.797484|2017-10-11 04:41:30.797484
NCT00060840|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-14|2016-07-22|2010-08-25||July 2003||2003-07-01|July 2016|2016-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation|The Effects of Nitric Oxide for Inhalation During Left Ventricular Assist Device (LVAD) Implantation|Completed||Phase 2|150|Actual|Mallinckrodt||2|||f||||t||||||||||2017-10-11 04:41:30.884249|2017-10-11 04:41:30.884249
NCT00060853|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-14|2008-03-03|||May 2003||2003-05-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Observational|||Magnetic Resonance Imaging of the Brain in Social and Emotional Reasoning|Reasoning About Social and Economic Knowledge: Identifying the Role of the Human Prefrontal Cortex Using Functional Neuroimaging|Completed||N/A|330||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:31.325561|2017-10-11 04:41:31.325561
NCT00060866|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-14|2008-03-03|||May 2003||2003-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance|Propranolol for Syncope With Sympathoadrenal Imbalance|Completed||Phase 4|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:31.396567|2017-10-11 04:41:31.396567
NCT00043511|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2012-05-03||||||May 2012|2012-05-01|April 2003|Actual|2003-04-01|||||Interventional|||Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults|A Phase I Trial to Evaluate the Safety and Immunogenicity of the HIV-1 pGA2/JS2 Plasmid DNA Vaccine Given Intramuscularly (IM) in HIV-1 Uninfected Adults|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:41:31.477659|2017-10-11 04:41:31.477659
NCT00043537|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2013-07-31|||April 2001||2001-04-01|July 2013|2013-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment of Childhood Social Phobia|Treatment of Childhood Social Phobia|Completed||Phase 3|139|Actual|University of Central Florida||3|||f||||t||||||||||2017-10-11 04:41:31.552523|2017-10-11 04:41:31.552523
NCT00043550|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2017-04-28|2015-08-26||November 2001||2001-11-01|April 2017|2017-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Treatments for Depression: Drug Versus Psychotherapy|Efficacy of Dynamic Therapy Versus Selective Serotonin Reuptake Inhibitor for Depression|Completed||Phase 3|156|Actual|University of Pennsylvania|Two limitations are the relatively high level of attrition and small sample size for specific combinations within our moderation analysis.|3|||f||||t||||||||||2017-10-11 04:41:31.64536|2017-10-11 04:41:31.64536
NCT00043563|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2015-12-15|||January 2001||2001-01-01|December 2015|2015-12-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Cognitive Behavioral Treatment of Pediatric Trichotillomania|Cognitive Behavioral Treatment of Pediatric Trichotillomania|Completed||N/A|24|Actual|University of Pennsylvania|||||f||||t||||||||||2017-10-11 04:41:31.997147|2017-10-11 04:41:31.997147
NCT00043576|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2009-03-10|||August 2002||2002-08-01|February 2005|2005-02-01|December 2005||2005-12-01|||||Interventional|||ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere|A Phase 2/3 Multicenter, Randomized, Double Blind Study of Docetaxel (Taxotere) Plus DN-101 or Placebo in Androgen Independent Prostate Cancer (AIPC)|Unknown status|Active, not recruiting|Phase 2/Phase 3|250||Novacea|||||||||||||||||||2017-10-11 04:41:32.067018|2017-10-11 04:41:32.067018
NCT00043589|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2013-12-03|||June 2002||2002-06-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Memory and Mental Health in Aging|Memory and Mental Health in Aging|Completed||N/A|200||Stanford University|||||f||||f||||||||||2017-10-11 04:41:32.404366|2017-10-11 04:41:32.404366
NCT00043602|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2013-09-25|||September 2001||2001-09-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Clinician Managed Interpersonal Psychotherapy|Clinician Managed Interpersonal Psychotherapy|Completed||Early Phase 1|140|Actual|University of Iowa||2|||f||||f||||||||||2017-10-11 04:41:32.482592|2017-10-11 04:41:32.482592
NCT00043615|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2017-06-30|||July 29, 2002||2002-07-29|April 10, 2012|2012-04-10|April 10, 2012||2012-04-10|||||Observational|||Collection of Blood, Bone Marrow, Tumor or Tissue Samples|Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples|Completed||N/A|74|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:32.590188|2017-10-11 04:41:32.590188
NCT00043628|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2008-03-03|||August 2002||2002-08-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Stem Cell Mobilization to Treat Chest Pain and Shortness of Breath in Patients With Coronary Artery Disease|Stem Cell Mobilization as Therapy for Chronic Myocardial Ischemia in Patients With Coronary Artery Disease|Completed||Phase 2|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:32.660714|2017-10-11 04:41:32.660714
NCT00043641|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2017-10-05|||July 26, 2002||2002-07-26|February 7, 2013|2013-02-07|February 7, 2013||2013-02-07|||||Observational|||HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)|HIV Expression in Patients With Viral Loads Suppressed on HAART|Completed||N/A|73|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:32.780257|2017-10-11 04:41:32.780257
NCT00043654|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-09|2017-06-30|||August 7, 2002||2002-08-07|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Interventional|||Clinical Trial of Mifepristone for Bipolar Depression|Antiglucocorticoid Therapy in Bipolar Depression With Mifepristone (RU486)|Completed||Phase 2|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:32.867755|2017-10-11 04:41:32.867755
NCT00043667|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-10|2008-03-03|||August 2002||2002-08-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis|Evaluation of Subcutaneous Daclizumab Treatments in Patients With Non-Infectious Sight-Threatening Uveitis: A Multicenter, Open-Label, Phase II Study|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:32.942358|2017-10-11 04:41:32.942358
NCT00043680|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-10|2008-03-03|||August 2002||2002-08-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy|Multi-Center Randomized Phase I/II Trial to Study the Effects of Cyclooxygenase-2 Inhibition on the Response to Photodynamic Therapy in Patients With Age-Related Macular Degeneration|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:33.027303|2017-10-11 04:41:33.027303
NCT00043693|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-12|2012-08-07|||April 2002||2002-04-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Family Intervention for Mental Illness and Substance Abuse|Family Intervention for SMI and Substance Use Disorder|Completed||N/A|108|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||||||||||||2017-10-11 04:41:33.102432|2017-10-11 04:41:33.102432
NCT00043706|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-12|2015-03-04||||||March 2015|2015-03-01|September 2003|Actual|2003-09-01|||||Interventional|||Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis|A Phase 1/2 Double Blind, Placebo Controlled, Randomized, Dose Ranging, Repeat Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of CAT-192 Human Anti-TGF-Beta1 Monoclonal Antibody in Patients With Early Stage Diffuse Systemic Sclerosis|Completed||Phase 1/Phase 2|||Sanofi|||||||||||||||||||2017-10-11 04:41:33.2108|2017-10-11 04:41:33.2108
NCT00043732|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-12|2010-04-26||||||April 2010|2010-04-01|September 2003|Actual|2003-09-01|||||Interventional|||Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study of SCIO-469 in Patients in Active Rheumatoid Arthritis Receiving Methotrexate|Completed||Phase 2|120|Actual|Scios, Inc.|||||||||||||||||||2017-10-11 04:41:33.395802|2017-10-11 04:41:33.395802
NCT00043745|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-13|2013-02-06|||March 2003||2003-03-01|February 2013|2013-02-01||||April 2008|Actual|2008-04-01||Interventional|SIRBL||Bone Response to Soy Isoflavones in Women|Bone Response to Soy Isoflavones in Women|Completed||Phase 2|224|Actual|Iowa State University||3|||f||||t||||||||||2017-10-11 04:41:33.494079|2017-10-11 04:41:33.494079
NCT00043758|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-13|2005-06-23|||July 2002||2002-07-01|June 2005|2005-06-01|July 2004||2004-07-01|||||Interventional|||Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients||Completed||Phase 2|170||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:41:33.590171|2017-10-11 04:41:33.590171
NCT00043771|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-13|2005-06-23|||May 2002||2002-05-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Interventional|||Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients|Multi-Center, Double-Blind Study to Compare the Effects of 30mg Qd Versus 15 Mg Bid of Tolvaptan in Congestive Heart Failure Patients|Completed||Phase 2|40||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:41:33.726645|2017-10-11 04:41:33.726645
NCT00043784|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-13|2008-09-15|||August 2001||2001-08-01|September 2008|2008-09-01||||February 2005|Actual|2005-02-01||Interventional|||SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes|A Prospective, Randomized, Open-Label, Multicenter Study in Patients Presenting With Acute Coronary Syndromes (ACS)|Completed||Phase 3|8000||Sanofi|||||f||||||||||||||2017-10-11 04:41:33.798191|2017-10-11 04:41:33.798191
NCT00043797|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-13|2005-06-23||||||December 2002|2002-12-01||||||||Interventional|||Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy||Unknown status|Active, not recruiting|Phase 2|||The Institute for Diabetes Discovery, LLC|||||||||||||||||||2017-10-11 04:41:33.88084|2017-10-11 04:41:33.88084
NCT00043810|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2012-07-27|||July 2002||2002-07-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study of Gelonin Purging of Autologous Stem Cells for Transplantation|Dose Finding Study of Gelonin Purging of Autologous Stem Cells for Transplantation of Patients With AML/MDS in First or Subsequent Remission|Terminated||Phase 1/Phase 2|3|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:41:33.987001|2017-10-11 04:41:33.987001
NCT00043823|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2012-04-18|||August 2002||2002-08-01|April 2012|2012-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer|Safety and Efficacy of Recombinant Humanized Monoclonal Anti-VEGF Antibody rhuMAb VEGF and EGFR Tyrosine Kinase Inhibitor OSI-774 for Locally Advanced or Metastatic Non-Squamous Cell NSCLC in Patients Who Have Been Previously Treated|Completed||Phase 1/Phase 2|41|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:41:35.70217|2017-10-11 04:41:35.70217
NCT00043836|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2009-09-01|||July 2002||2002-07-01|August 2007|2007-08-01|October 2005|Actual|2005-10-01|February 2003|Actual|2003-02-01||Interventional|||The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure|A Pilot Study Of ALT-711 In Elderly Patients With Isolated Diastolic Heart Failure: The DIAMOND Study|Completed||Phase 2|20||Synvista Therapeutics, Inc|||||||||||||||||||2017-10-11 04:41:35.851145|2017-10-11 04:41:35.851145
NCT00043849|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2009-12-10|||July 2002||2002-07-01|August 2006|2006-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)|Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)|Completed||Phase 4|60||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:41:35.943523|2017-10-11 04:41:35.943523
NCT00063375|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2013-10-24|||January 2002||2002-01-01|October 2013|2013-10-01||||February 2007|Actual|2007-02-01||Interventional|||Interactive Computer Treatment for Panic Disorder|Interactive Computer Treatment for Panic Disorder|Completed||Phase 1|60|Anticipated|Florida State University|||||f||||||||||||||2017-10-11 04:42:29.989819|2017-10-11 04:42:29.989819
NCT00043862|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2017-05-30|||August 2002||2002-08-01|March 2013|2013-03-01||||November 2005|Actual|2005-11-01||Interventional|(SCLC)||The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)|A Phase II Trial of Twice Daily Oral Topotecan as a Radiation Sensitizer With Twice Daily Radiotherapy for Newly Diagnosed Small Cell Lung Cancer|Completed||Phase 2|60|Actual|GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:41:36.066114|2017-10-11 04:41:36.066114
NCT00043875|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2016-09-13|||May 2000||2000-05-01|September 2016|2016-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Pediatric Epilepsy Trial in Subjects 1-24 Months|A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)|Completed||Phase 2|177|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:41:36.249095|2017-10-11 04:41:36.249095
NCT00043888|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2013-02-11|||January 2002||2002-01-01|February 2013|2013-02-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR|A Phase IIIb/IV, Randomized, Open Label, Multicenter, Pilot Trial to Explore the Safety and Tolerability of GW433908 +/- Ritonavir (1400mg Twice Daily or 700mg/100mg Twice Daily) When Used in Combination With a Zidovudine-containing Regimen (TRIZIVIR or COMBIVIR Twice Daily) Over a 24 Week Period in Antiretroviral Therapy Naive HIV-1 Infected Subjects.|Completed||Phase 3|60||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:41:36.67|2017-10-11 04:41:36.67
NCT00043901|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2017-03-31|||December 1, 2000||2000-12-01|March 2017|2017-03-01|March 1, 2005|Actual|2005-03-01|November 1, 2003|Actual|2003-11-01||Interventional|||Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects Wtih Primary Generalized Tonic-Clonic Seizures|Completed||Phase 4|141|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:41:36.84669|2017-10-11 04:41:36.84669
NCT00043927|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2013-08-20|||April 2001||2001-04-01|August 2013|2013-08-01||||January 2004|Actual|2004-01-01||Interventional|||Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults|An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin as Treatment for Chemotherapy-naive Patients With Extensive Disease-Small Cell Lung Cancer.|Completed||Phase 3|760||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:41:37.258725|2017-10-11 04:41:37.258725
NCT00043940|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-14|2011-09-15|||April 1999||1999-04-01|September 2011|2011-09-01||||February 2003|Actual|2003-02-01||Interventional|||Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)|Anticoagulant Therapy With Bivalirudin in the Performance of PCI in Patients With Heparin-Induced Thrombocytopenia|Completed||Phase 3|50|Actual|The Medicines Company||1|||f||||||||||||||2017-10-11 04:41:37.856806|2017-10-11 04:41:37.856806
NCT00043953|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-15|2007-09-26|||August 2002||2002-08-01|September 2007|2007-09-01||||||||Interventional|||Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects|A Phase II Study of Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects|Completed||Phase 2|30|Actual|Abbott||2|||f||||f||||||||||2017-10-11 04:41:37.949463|2017-10-11 04:41:37.949463
NCT00043966|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-15|2006-07-26|||July 2002||2002-07-01|July 2006|2006-07-01||||||||Interventional|||Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects|A Randomized, Open-Label Study of 800 Mg Lopinavir/200 Mg Ritonavir QD in Combination With Tenofovir and Emtricitabine Vs. 400 Mg Lopinavir /100 Mg Ritonavir BID in Combination With Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects|Completed||Phase 3|200||Abbott|||||||||||||||||||2017-10-11 04:41:38.0909|2017-10-11 04:41:38.0909
NCT00043979|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-15|2017-04-11|2013-04-03||September 19, 2002|Actual|2002-09-19|April 2017|2017-04-01|December 14, 2011|Actual|2011-12-14|May 1, 2009|Actual|2009-05-01||Interventional|||Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas|Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas|Completed||Phase 2|60|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f|f|f||||||No||2017-10-11 04:41:38.41366|2017-10-11 04:41:38.41366
NCT00043992|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2006-09-01|||July 2001||2001-07-01|September 2006|2006-09-01||||||||Observational|||Outdoor Allergen Exposure, Sensitivity, and Acute Asthma||Completed||N/A|1000||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 04:41:40.788181|2017-10-11 04:41:40.788181
NCT00044005|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2014-03-31|2011-02-16||September 2002||2002-09-01|March 2014|2014-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Safety and Tolerability Study of Drug to Treat Schizophrenia|A Randomized, Open-Label, Dose-Blinded, Multicenter, 6-Month Study of Safety and Tolerability of 3 Dose Levels of SM-13496 (Lurasidone) in Patients With Schizophrenia|Completed||Phase 2|98|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 04:41:40.890377|2017-10-11 04:41:40.890377
NCT00044018|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2009-09-22|||April 2002||2002-04-01|September 2009|2009-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma|An Open-Label Study to Evaluate the Efficacy and Safety of Two CDC-501 Dose Regimens When Used Alone or in Combination With Dexamethasone for the Treatment Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|102|Actual|Celgene|||||f||||f||||||||||2017-10-11 04:41:41.565905|2017-10-11 04:41:41.565905
NCT00050128|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-21|2017-06-30|||November 18, 2002||2002-11-18|October 24, 2007|2007-10-24|October 24, 2007||2007-10-24|||||Interventional|||Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation|Repetitive Transcranial Magnetic Stimulation in Chronic Stroke Patients. Dose Effect on Motor Cortex Excitability, Motor Performance, and Safety Using Different Stimulation Parameters|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:49.111373|2017-10-11 04:41:49.111373
NCT00044031|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2014-04-16|||February 2001||2001-02-01|April 2014|2014-04-01|October 2007|Actual|2007-10-01|April 2004|Actual|2004-04-01||Interventional|||Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma|Prospective, Randomized, Controlled, Double-Blind, Multi-National, Multi-Center Study of G17DT Immunogen in Combination With Gemcitabine Versus Placebo in Combination With Gemcitabine in Previously Untreated Subjects With Locally Advanced (Nonresectable Stage II and III), Recurrent Disease Following Primary Resection, or Metastatic (Stage IV) Adenocarcinoma of the Pancreas (Protocol No. PC4)|Completed||Phase 3|394|Actual|Cancer Advances Inc.||2|||t||||f||||||||||2017-10-11 04:41:41.675025|2017-10-11 04:41:41.675025
NCT00044044|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2014-03-31|2011-02-01||July 2002||2002-07-01|March 2014|2014-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia|A 6-Week, Double-Blind, Randomized, Fixed-Dose, Parallel-Group Study of the Efficacy and Safety of Three Dose Levels of SM-13496 Compared to Placebo and Haloperidol in Patients With Schizophrenia Who Are Experiencing an Acute Exacerbation of Symptoms|Completed||Phase 2|356|Actual|Sunovion||5|||f||||f||||||||||2017-10-11 04:41:41.795051|2017-10-11 04:41:41.795051
NCT00044057|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2006-03-31|||December 2000||2000-12-01|March 2006|2006-03-01|January 2003||2003-01-01|||||Interventional|||A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)|A Multicenter, Stratified, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Neurologic Function and Disability in Patients With Acute Ischemic Stroke Given Tissue Plasminogen Activator Plus YM872 or Tissue Plasminogen Activator Plus Placebo|Completed||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:41:42.736065|2017-10-11 04:41:42.736065
NCT00044070|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2006-03-31|||December 2000||2000-12-01|March 2006|2006-03-01|January 2003||2003-01-01|||||Interventional|||A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Effects of YM872 on Lesion Volume as Measured by Diffusion, Perfusion, and FLAIR Magnetic Resonance Imaging in Patients With Acute Ischemic Stroke|Completed||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:41:43.167959|2017-10-11 04:41:43.167959
NCT00044083|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2016-08-31|||August 2002||2002-08-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Clinical Trial of Tolcapone for Cognition in Schizophrenia|Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype|Completed||Phase 2|213|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:41:43.400978|2017-10-11 04:41:43.400978
NCT00044096|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-16|2017-10-05|||August 15, 2002||2002-08-15|September 17, 2013|2013-09-17|September 17, 2013||2013-09-17|||||Observational|||Psychopharmacology of Fear-Potentiated Startle in Humans|Psychopharmacology of Fear-Potentiated Startle in Humans|Completed||N/A|225|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:43.495745|2017-10-11 04:41:43.495745
NCT00044109|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-17|2006-06-23|||August 2002||2002-08-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Magnets in the Treatment of Sciatica|Static Magnets In The Treatment of Sciatica|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:43.571917|2017-10-11 04:41:43.571917
NCT00044122|ClinicalTrials.gov processed this data on October 10, 2017|2002-08-17|2017-10-05|||August 16, 2002||2002-08-16|September 12, 2017|2017-09-12||||||||Observational|||Study of Factors Regulating Mast Cell Proliferation|Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells|Recruiting||N/A|550|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:43.640526|2017-10-11 04:41:43.640526
NCT00050050|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-20|2014-05-23|||September 2001||2001-09-01|May 2014|2014-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder|CBT for Residual ADHD Symptoms in Adults|Completed||Phase 1|40|Actual|Massachusetts General Hospital|||||f||||f||||||||||2017-10-11 04:41:43.733779|2017-10-11 04:41:43.733779
NCT00050063|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-20|2012-05-17||||||May 2012|2012-05-01|May 2004|Actual|2004-05-01|||||Observational|||Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs|A Rollover Study of A5058s: A Phase II Trial to Evaluate the Ability of Vaccine-Induced Helper and CTL Responses to Control Viremia in the Absence of Antiretroviral Therapy|Completed||N/A|78||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:41:43.830081|2017-10-11 04:41:43.830081
NCT00050076|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-20|2012-01-31|||August 2002||2002-08-01|January 2012|2012-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.|A Phase II, Double-Blind, Randomized, Exploratory, Placebo-Controlled Study of Efficacy, Safety, and Tolerability of MCC-135 Comparing QD vs BID Doses in Subjects With Congestive Heart Failure, NYHA Class II/III|Completed||Phase 2|204|Actual|Takeda||4|||f||||f||||||||||2017-10-11 04:41:43.97997|2017-10-11 04:41:43.97997
NCT00050089|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-20|2015-04-03|2013-09-11||January 2001||2001-01-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|OPTIMA|HIV-positive patients with a CD4 count <=300 cells/ul who had prior anti-retroviral treatment failure requiring retreatment|CSP #512 - Options in Management With Anti-Retrovirals|CSP #512 - Options in Management With Anti-Retrovirals (OPTIMA), Management of Patients With HIV Infection for Whom First and Second-line Highly Active Anti-Retroviral Therapy Has Failed|Completed||N/A|368|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-10-11 04:41:44.5518|2017-10-11 04:41:44.5518
NCT00050102|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-21|2011-01-20||2011-01-12|October 2002||2002-10-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma|A Randomized Study Comparing MDX-010 (CTLA-4) Alone or in Combination With DTIC in the Treatment of Patients With Chemotherapy Naїve Metastatic Melanoma.|Completed||Phase 2|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:41:48.754007|2017-10-11 04:41:48.754007
NCT00050115|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-21|2017-10-05|||November 16, 2002||2002-11-16|March 29, 2017|2017-03-29||||||||Observational|||Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia|Collection of Blood, Stool, Bone Marrow and/or Tissue Samples From Subjects With Hepatitis-Associated Aplastic Anemia|Completed||N/A|9|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:49.025488|2017-10-11 04:41:49.025488
NCT00056212|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-07|2006-08-17|||July 2002||2002-07-01|July 2006|2006-07-01|October 2004||2004-10-01|||||Interventional|||Evaluating Yoga for Chronic Low Back Pain|Evaluating Yoga for Chronic Low Back Pain|Completed||N/A|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:43:01.458378|2017-10-11 04:43:01.458378
NCT00050141|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-22|2013-01-31|||September 2002||2002-09-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|October 2005|Actual|2005-10-01||Interventional|||Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer|A Randomised, Blinded, Phase 2 Study of Letrozole Plus the Farnesyl Transferase Inhibitor ZARNESTRA TM (R115777) and Letrozole Plus Placebo in the Treatment of Advanced Breast Cancer After Antiestrogen Therapy.|Completed||Phase 2|121|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:41:49.210014|2017-10-11 04:41:49.210014
NCT00050154|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-22|2010-04-23|||July 2002||2002-07-01|April 2010|2010-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)|An Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of the Farnesyl-Transferase Inhibitor ZARNESTRA(tm) (R115777) in Subjects With High-Risk Myelodysplastic Syndrome (MDS)|Completed||Phase 2|82|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:41:49.366531|2017-10-11 04:41:49.366531
NCT00050167|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-25|2011-08-25|2011-07-07||November 2002||2002-11-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer|Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer|Completed||Phase 1|603|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:41:49.478536|2017-10-11 04:41:49.478536
NCT00050180|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-25|2017-06-30|||November 22, 2002||2002-11-22|May 3, 2012|2012-05-03|August 24, 2007|Actual|2007-08-24|August 24, 2007|Actual|2007-08-24||Interventional|||Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers|Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers|Completed||Phase 4|81|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:41:49.868483|2017-10-11 04:41:49.868483
NCT00050193|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-25|2017-10-05|||November 22, 2002||2002-11-22|March 10, 2014|2014-03-10|March 10, 2014||2014-03-10|||||Observational|||Cause and Natural Course of Pediatric-Onset Mastocytosis|Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis|Completed||N/A|103|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:50.09494|2017-10-11 04:41:50.09494
NCT00050206|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-26|2007-06-11|||November 2002||2002-11-01|June 2007|2007-06-01|May 2005|Actual|2005-05-01|||||Interventional|||Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder|Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder|Completed||Phase 4|130||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:41:50.162729|2017-10-11 04:41:50.162729
NCT00050219|ClinicalTrials.gov processed this data on October 10, 2017|2002-11-29|2008-03-03|||November 2002||2002-11-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Observational|||Role of Dopamine in Response to Alcohol|Striatal Dopamine and Alcohol Risk|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:50.259673|2017-10-11 04:41:50.259673
NCT00050232|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-02|2016-07-13|||December 2002||2002-12-01|July 2016|2016-07-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients||Completed||Phase 3|96||Avanir Pharmaceuticals|||||f||||f||||||||||2017-10-11 04:41:50.327131|2017-10-11 04:41:50.327131
NCT00050245|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-02|2017-06-30|||November 27, 2002||2002-11-27|October 17, 2007|2007-10-17|October 17, 2007||2007-10-17|||||Interventional|||Rituximab to Treat Neuropathy With Anti-MAG Antibodies|Safety, Tolerability, and Efficacy of Rituximab in Patients With Anti-Glycoconjugate Antibody-Mediated Demyelinating Neuropathy: A Double-Blind Placebo-Controlled Randomized Trial|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:50.44468|2017-10-11 04:41:50.44468
NCT00050271|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-03|2012-05-17||||||May 2012|2012-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy|An Open-Label, Dose-Escalation Pilot Study of Acetyl-L-Carnitine for the Treatment of Dideoxynucleoside-Associated Distal Symmetric Peripheral Neuropathy|Completed||N/A|27|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:41:50.523764|2017-10-11 04:41:50.523764
NCT00050284|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-03|2010-11-05||||||November 2010|2010-11-01||||||||Observational|||Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection|Predictors of Immunologic and Clinical Progression in Subjects With CD4+ Cell Counts Greater Than 350 Cells/mm3 Who Discontinue Antiretroviral Therapy|Completed||N/A|158||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:41:50.634676|2017-10-11 04:41:50.634676
NCT00050297|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-03|2012-06-06||||||June 2012|2012-06-01|February 2004|Actual|2004-02-01|||||Interventional|||YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer||Terminated||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:41:50.764418|2017-10-11 04:41:50.764418
NCT00050310|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-03|2017-10-05|||February 27, 2002||2002-02-27|July 11, 2017|2017-07-11||||||||Observational|||Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients|Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:50.856768|2017-10-11 04:41:50.856768
NCT00050323|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-04|2015-03-04|||November 2002||2002-11-01|March 2015|2015-03-01|March 2004|Actual|2004-03-01|||||Interventional|||Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer|Phase 1/2 Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusion in Patients With AJCC Stage IV Renal Cell Carcinoma|Completed||Phase 1/Phase 2|30||Sanofi|||||||||||||||||||2017-10-11 04:41:50.936597|2017-10-11 04:41:50.936597
NCT00050336|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-04|2015-08-26|||December 2002||2002-12-01|August 2015|2015-08-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Interventional|||Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)|A Phase 3 Randomized Study of Lonafarnib in Combination With Paclitaxel and Carboplatin vs. Placebo in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer|Terminated||Phase 3|702|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:41:51.006947|2017-10-11 04:41:51.006947
NCT00050349|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-04|2017-02-28|||July 2002||2002-07-01|March 2013|2013-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||EPO906 in Carcinoid and Other Neuroendocrine Tumors|EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors|Completed||Phase 2|33|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:41:51.075736|2017-10-11 04:41:51.075736
NCT00050362|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-04|2008-03-03|||December 2002||2002-12-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction|Evaluation of a Long-Acting Local Anesthesia (Bupivacaine) and a Selective COX-2 Inhibitor (Rofecoxib) in Suppression of Central Sensitization|Completed||Phase 2|136||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:51.519338|2017-10-11 04:41:51.519338
NCT00050375|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-05|2007-12-13|||December 2002||2002-12-01|June 2006|2006-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Clinical Trial for Ovarian Cancer (OvaRex®)|A Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of Intravenous OvaRex® MAb-B43.13 as Post Chemotherapy Consolidation for Epithelial Carcinoma of Ovarian, Tubal or Peritoneal Origin|Terminated||Phase 3|354||Unither Pharmaceuticals||||Study closed by sponser|||||||||||||||2017-10-11 04:41:51.607251|2017-10-11 04:41:51.607251
NCT00050388|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-06|2008-06-20||||||June 2008|2008-06-01|June 2002||2002-06-01|||||Interventional|||Phase II Trial of Allovectin-7® for Head and Neck Cancer|Phase II Study of the Safety and Efficacy of Allovectin-7® Immunotherapy for the Treatment of Primary, Resectable Squamous Cell Carcinoma of the Oral Cavity or Oropharynx|Completed||Phase 3|||Vical|||||||||||||||||||2017-10-11 04:41:51.786527|2017-10-11 04:41:51.786527
NCT00050401|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-08|2017-08-31|||July 2002||2002-07-01|August 2017|2017-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support|Impact of Aggressive Empiric Antibiotic Therapy on the Emergence of Antimicrobial Resistance During the Treatment of Ventilator-associated Pneumonia|Completed||Phase 3|500||Pfizer|||||||||||||||||||2017-10-11 04:41:51.89448|2017-10-11 04:41:51.89448
NCT00050414|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-09|2013-01-09|||October 2002||2002-10-01|January 2013|2013-01-01|September 2005|Actual|2005-09-01|||||Interventional|||A Study of Trabectedin in Patients With Advanced Ovarian Cancer|Phase 2 Study of Efficacy and Safety of Trabectedin in Subjects With Advanced Ovarian Cancer|Completed||Phase 2|147|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 04:41:52.005215|2017-10-11 04:41:52.005215
NCT00050427|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-09|2011-04-26|||December 2002||2002-12-01|April 2011|2011-04-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer|A Phase 2 Study of ET-743 in Subjects With Advanced Breast Cancer|Completed||Phase 2|53|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-10-11 04:41:52.210689|2017-10-11 04:41:52.210689
NCT00050440|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-09|2013-01-07|||July 2002||2002-07-01|January 2013|2013-01-01|July 2004|Actual|2004-07-01|||||Interventional|||Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma|A Phase 2 Study of ET-743 as Second-Line Therapy in Subjects With Persistent or Recurrent Endometrial Carcinoma|Completed||Phase 2|50|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 04:41:52.310345|2017-10-11 04:41:52.310345
NCT00050466|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-09|2008-03-03|||December 2002||2002-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Dynamic Light Scattering and Keratoscopy for Corneal Examination|A Pilot Study Using the Dynamic Light Scattering Device (DLS) Combined With Keratoscopy on the Cornea in Vivo|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:52.470683|2017-10-11 04:41:52.470683
NCT00050479|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-09|2006-07-18|||December 2002||2002-12-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Laser and Medical Treatment of Diabetic Macular Edema|Preliminary Multi-Center Assessment of Laser and Medical Treatment of Diabetic Macular Edema|Completed||Phase 3|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:52.55211|2017-10-11 04:41:52.55211
NCT00050492|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-09|2017-06-30|||December 6, 2002||2002-12-06|September 19, 2006|2006-09-19|September 19, 2006||2006-09-19|||||Observational|||Biological Markers in Retinal Vasculitis|Identification of Biological Markers in Retinal Vasculitis|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:52.630525|2017-10-11 04:41:52.630525
NCT00050505|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-10|2014-12-04|||October 2002||2002-10-01|July 2009|2009-07-01|December 2003|Actual|2003-12-01|||||Interventional|||Expanded Dryvax Dilution Study in Previously Vaccinated Adults|A Multicenter, Double Blind, Randomized Dose-response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults|Completed||Phase 2|927|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 04:41:52.706154|2017-10-11 04:41:52.706154
NCT00050518|ClinicalTrials.gov processed this data on October 10, 2017|2002-12-11|2010-08-26||||||March 2010|2010-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||APSV in Vaccinia Naive Adults|A Multicenter, Double-Blind, Randomized Study of the Safety and Efficacy of Aventis Pasteur's Smallpox Vaccine, USP (APSV) in Vaccinia-Naive Adults.|Completed||Phase 2|444||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:41:52.820708|2017-10-11 04:41:52.820708
NCT00060892|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-15|2008-01-09|||April 2003||2003-04-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|||Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia|A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Leg Ischemia|Completed||Phase 2|104|Actual|AnGes USA, Inc.||4|||f||||t||||||||||2017-10-11 04:41:52.910084|2017-10-11 04:41:52.910084
NCT00060905|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-15|2006-08-02|||January 2003||2003-01-01|August 2006|2006-08-01||||||||Interventional|||An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder|An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder|Completed||Phase 3|370||Abbott|||||||||||||||||||2017-10-11 04:41:53.05866|2017-10-11 04:41:53.05866
NCT00060918|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-15|2015-04-14|||June 2001||2001-06-01|June 2012|2012-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension|A Randomized, Double-Blind, Multicenter Study Comparing the Glycemic Control Characteristics of Carvedilol and Metoprolol in Hypertensive Patients With Type II Diabetes Mellitus.|Completed||Phase 4|1210||GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:41:53.187955|2017-10-11 04:41:53.187955
NCT00060931|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-15|2015-04-13|||June 2001||2001-06-01|April 2015|2015-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension|A Randomized, Double-Blind, Multicenter Study Comparing the Effects of Carvedilol and Metoprolol on Glycemic Control in Hypertensive Patients With Type II Diabetes Mellitus.|Completed||Phase 4|501|Actual|GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:41:53.389345|2017-10-11 04:41:53.389345
NCT00060944|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-16|2014-08-28|2014-01-14|2011-08-12|May 2003||2003-05-01|August 2014|2014-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer|A Randomized, Multicenter, Open-label Study of Yondelis (ET-743 Ecteinascidin) Administered by 2 Different Schedules (Weekly for 3 of 4 Weeks vs. q3 Weeks) in Subjects With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma Following Treatment With an Anthracycline and Ifosfamide|Completed||Phase 2|271|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 04:41:53.89161|2017-10-11 04:41:53.89161
NCT00060957|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-16|2016-09-23|||July 1997||1997-07-01|May 2011|2011-05-01||||June 2002|Actual|2002-06-01||Interventional|||Botulinum Toxin (BOTOX) for Cerebral Palsy|Botulinum Toxin for Spasticity in Cerebral Palsy|Completed||Phase 2|40||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:55.192629|2017-10-11 04:41:55.192629
NCT00060970|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-16|2005-06-23|||September 1995||1995-09-01|March 2003|2003-03-01|August 2000||2000-08-01|||||Observational|||Evaluating Muscle Function After Ankle Surgery|Restoration of Muscle Function During Rehabilitation|Completed||N/A|30||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:55.28009|2017-10-11 04:41:55.28009
NCT00060983|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-16|2005-06-23|||May 1998||1998-05-01|May 2003|2003-05-01|April 2002||2002-04-01|||||Interventional|||Improving Gait in Patients With Spinal Cord Injuries|Effects of Sensory Motor Input on Gait in SCI (Spinal Cord Injured) Subjects|Completed||Phase 2|36||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:55.387208|2017-10-11 04:41:55.387208
NCT00060996|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-19|2013-03-05|||February 2003||2003-02-01|March 2013|2013-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures|A Randomized Placebo-Controlled, 12-Week Multicenter Study of the Safety and Efficacy of Continuous or Daily Administration of Remodulin® (Treprostinil Sodium) Injection in Patients With CLI With No Planned Revascularization Procedures|Terminated||Phase 3|30||United Therapeutics|||||f||||||||||||||2017-10-11 04:41:55.486123|2017-10-11 04:41:55.486123
NCT00061009|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-19|2008-03-03|||May 2003||2003-05-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Hypnosis in Autonomic Function|Relationship of Autonomic Function to Hypnotic Susceptibility|Completed||N/A|93||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:55.596787|2017-10-11 04:41:55.596787
NCT00061022|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-20|2010-11-10|||May 2003||2003-05-01|November 2010|2010-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke|SAINT (Stroke - Acute Ischemic - NXY Treatment) A Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter, Phase IIb/III Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke|Completed||Phase 3|3200||AstraZeneca|||||||||||||||||||2017-10-11 04:41:55.708525|2017-10-11 04:41:55.708525
NCT00061035|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-20|2008-08-26|||April 2003||2003-04-01|August 2008|2008-08-01||||||||Interventional|||Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma|A Phase 1, Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma|Completed||Phase 1|18|Anticipated|Cosmo Bioscience|||||||||||||||||||2017-10-11 04:41:56.325153|2017-10-11 04:41:56.325153
NCT00061048|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-20|2012-10-26|2011-05-17||May 2003||2003-05-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2009|Actual|2009-07-01||Interventional|||Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma|Phase II Study of the Efficacy and Toxicity of Campath-1H in the Therapy of Adult T-Cell Leukemia|Completed||Phase 2|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:41:56.420515|2017-10-11 04:41:56.420515
NCT00061061|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2015-12-01|||March 1997||1997-03-01|December 2015|2015-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Tobacco Cessation in Postmenopausal Women (Part I) - 1|The Effects of ERT on Appetitive Behavior and Withdrawal in Short-term Smoking Cessation Compared to Smoking ad Lib in Postmenopausal Female Smokers.|Completed||Phase 4|0||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-10-11 04:41:57.044267|2017-10-11 04:41:57.044267
NCT00061074|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2015-12-01|||March 1993||1993-03-01|December 2015|2015-12-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Tobacco Cessation in Postmenopausal Women (Part II) - 2|The Effects of ERT on Appetitive Behavior and Withdrawal in Short-term Smoking Cessation in Postmenopausal Females on Transdermal Nicotine Replacement|Completed||Phase 1|1|Actual|University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-10-11 04:41:57.126932|2017-10-11 04:41:57.126932
NCT00061087|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2012-10-24|||February 1998||1998-02-01|October 2012|2012-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1|Treatment of Adult ADHD in Methadone Patients|Completed||Phase 2/Phase 3|115|Actual|New York State Psychiatric Institute||3|||f||||t||||||||||2017-10-11 04:41:57.187515|2017-10-11 04:41:57.187515
NCT00061100|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2015-03-30|||October 1999||1999-10-01|March 2015|2015-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||HIV Counseling Intervention for Methadone-Maintained Patients - 2|HIV Counseling Intervention for Methadone-Maintained Patients|Completed||Phase 1|50|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 04:41:57.289466|2017-10-11 04:41:57.289466
NCT00061113|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2017-01-11|||February 2001||2001-02-01|September 2008|2008-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Substance Dependent Teens - Impact of Treating Depression Study 1 - 1|Substance Dependent Teens - Impact of Treating Depression Study 1|Completed||Phase 4|126|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 04:41:57.374326|2017-10-11 04:41:57.374326
NCT00061126|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2005-06-23|||April 2003||2003-04-01|September 2004|2004-09-01||||||||Interventional|||ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body|A Clinical Trial Evaluating the Safety and Efficacy of ABX-EGF in Patients With Hormone Resistant Prostate Cancer With or Without Metastasis|Completed||Phase 2|50||Abgenix|||||||||||||||||||2017-10-11 04:41:57.471842|2017-10-11 04:41:57.471842
NCT00061139|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2005-06-23|||September 2002||2002-09-01|April 2003|2003-04-01|September 2006||2006-09-01|||||Interventional|||Constraint-Based Therapy to Improve Motor Function in Children With Cerebral Palsy|Randomized Controlled Trial of Pediatric CI Therapy|Unknown status|Recruiting|Phase 2|52||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:57.569602|2017-10-11 04:41:57.569602
NCT00061152|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2007-09-12||||||September 2007|2007-09-01||||||||Interventional|||Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy|An Open-Label Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy|Unknown status|Active, not recruiting|Phase 2|||NeurogesX|||||||||||||||||||2017-10-11 04:41:57.645505|2017-10-11 04:41:57.645505
NCT00061165|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2010-01-12|||February 2003||2003-02-01|January 2010|2010-01-01||||||||Interventional|||Obesity Prevention in African American School Children||Completed||N/A|900|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:41:57.814312|2017-10-11 04:41:57.814312
NCT00061178|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2016-10-18||||||October 2016|2016-10-01||||||||Interventional|||Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma|Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy & Safety of rhuMAb VEGF in Previously Treated Metastatic Renal Cell Carcinoma|Withdrawn||Phase 3|0|Actual|Genentech, Inc.||||No patients were enrolled, study cancelled before start|||||||||||||||2017-10-11 04:41:57.904546|2017-10-11 04:41:57.904546
NCT00061204|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-21|2008-03-03|||May 2003||2003-05-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Observational|||Magnetic Resonance Imaging of the Brain in Emotional Processing|Functional Neuroimaging of Social Cognitive and Emotional Processing: Technical and Cognitive Issues|Completed||N/A|38||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:57.968571|2017-10-11 04:41:57.968571
NCT00061217|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-22|2005-06-23|||April 2001||2001-04-01|October 2004|2004-10-01|March 2005||2005-03-01|||||Interventional|||Prosthetic Limbs After Leg Amputation: Alternative Method of Socket Design|Comparison of Rectified and Unrectified Amputee Sockets|Unknown status|Active, not recruiting|Phase 2|59||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:58.038303|2017-10-11 04:41:58.038303
NCT00061230|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-22|2005-06-23|||March 2003||2003-03-01|April 2003|2003-04-01|March 2006||2006-03-01|||||Interventional|||Relaxation Training to Decrease Pain and Improve Function in Adolescents With Cerebral Palsy|Efficacy of Relaxation Training|Unknown status|Recruiting|N/A|60||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:41:58.11727|2017-10-11 04:41:58.11727
NCT00061477|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-28|2007-01-24|||December 2002||2002-12-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma|ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma: A Phase II Clinical Trial|Completed||Phase 2|48||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:41:58.215498|2017-10-11 04:41:58.215498
NCT00061490|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-28|2017-09-22|||September 2002|Actual|2002-09-01|September 2017|2017-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||The Effect of Weight Loss and Exercise on Knee Osteoarthritis|The Impact of Weight Loss and Exercise on Knee Osteoarthritis|Completed||N/A|160|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 04:41:58.374597|2017-10-11 04:41:58.374597
NCT00061503|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-28|2008-08-04|||April 2003||2003-04-01|August 2008|2008-08-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension|A Double-Masked, Placebo-Controlled, Paired Comparison Study of the Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension|Completed||Phase 4|||Alcon Research|||||||||||||||||||2017-10-11 04:41:58.501783|2017-10-11 04:41:58.501783
NCT00061516|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-28|2016-11-16|||January 2003||2003-01-01|August 2008|2008-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension|Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension|Completed||Phase 3|78|Actual|Alcon Research||2|||||||||||||||||2017-10-11 04:41:58.586659|2017-10-11 04:41:58.586659
NCT00061529|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-28|2008-08-04|||January 2003||2003-01-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension|A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-10-11 04:41:58.682061|2017-10-11 04:41:58.682061
NCT00061542|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-28|2016-11-16|||January 2003||2003-01-01|August 2008|2008-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension|Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension|Completed||Phase 3|105|Actual|Alcon Research||3|||||||||||||||||2017-10-11 04:41:58.777319|2017-10-11 04:41:58.777319
NCT00061568|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-29|2017-10-05|||May 19, 2003||2003-05-19|October 3, 2017|2017-10-03|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias|Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease (SCD) and Beta-Thalassemia|Recruiting||Phase 2|150|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:41:58.876353|2017-10-11 04:41:58.876353
NCT00061581|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-29|2017-10-05|||May 19, 2003||2003-05-19|June 14, 2017|2017-06-14|June 14, 2017|Actual|2017-06-14|December 28, 2007|Actual|2007-12-28||Interventional|||Experimental Bone Marrow Transplant Protocol|Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Irradiated Donor Lymphocytes on Chimerism|Completed||Phase 2|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:41:59.010668|2017-10-11 04:41:59.010668
NCT00061594|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-29|2014-03-18|||May 2003||2003-05-01|March 2014|2014-03-01|September 2006|Actual|2006-09-01|||||Interventional|||A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration|A Phase III, Multicenter, Randomized, Double Masked, Active Treatment-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne) Photodynamic Therapy in Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration|Completed||Phase 3|426||Genentech, Inc.|||||f||||||||||||||2017-10-11 04:41:59.114954|2017-10-11 04:41:59.114954
NCT00100724|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-05|2006-01-10|||April 2004||2004-04-01|January 2006|2006-01-01|July 2005||2005-07-01|||||Interventional|||Trial of rPA-102 Vaccine in Healthy Adult Volunteers|A Phase 2 Multi-Center, Randomized Dose-Finding Trial of rPA-102 Vaccine in Healthy Adult Volunteers|Completed||Phase 2|480||VaxGen|||||||||||||||||||2017-10-11 05:00:06.655953|2017-10-11 05:00:06.655953
NCT00061607|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-29|2017-10-05|||May 19, 2003||2003-05-19|April 4, 2017|2017-04-04|April 4, 2017||2017-04-04|||||Observational|||Measuring Levels of SMN in Blood Samples of SMA Patients|SMN Levels in Peripheral Blood Samples of SMA Patients and the Effects of Pharmacological Compounds In Vitro|Completed||N/A|73|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:41:59.389218|2017-10-11 04:41:59.389218
NCT00061620|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-30|2012-07-27|||September 2001||2001-09-01|July 2012|2012-07-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies|Phase I Study of Continuous Infusion Schedule of (E)-2'-Deoxy-2'-(Fluoromethylene) Cytidine (Tezacitabine, FMdC) in Hematologic Malignancies|Completed||Phase 1|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:41:59.466481|2017-10-11 04:41:59.466481
NCT00061633|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-30|2010-01-27|2009-12-02||June 2003||2003-06-01|January 2010|2010-01-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|FAST||Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)|A Phase 2, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Standard Therapy for Treatment of Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)|Completed||Phase 2|169|Actual|Theravance Biopharma Antibiotics, Inc.||2|||||||t||||||||||2017-10-11 04:41:59.611652|2017-10-11 04:41:59.611652
NCT00061646|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-02|2007-08-10|||March 2003||2003-03-01|August 2007|2007-08-01||||||||Interventional|||Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)|A Phase II Single-Arm Study Evaluating the Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|25|Actual|Abbott||1||"Enrollment suspended based upon interim analysis; subjects allowed to stay on study until   disease progression."|f||||f||||||||||2017-10-11 04:42:00.733678|2017-10-11 04:42:00.733678
NCT00061659|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-02|2007-11-28|||May 2003||2003-05-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma|A Phase II Randomized Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma|Completed||Phase 2|88|Actual|Abbott||2|||f||||f||||||||||2017-10-11 04:42:00.828186|2017-10-11 04:42:00.828186
NCT00061672|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-02|2007-08-13|||April 2003||2003-04-01|August 2007|2007-08-01||||||||Interventional|||Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma|A Phase II Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma|Completed||Phase 2|67|Actual|Abbott||2|||f||||f||||||||||2017-10-11 04:42:00.906609|2017-10-11 04:42:00.906609
NCT00061698|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-03|2015-06-11|||April 2002||2002-04-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Treatment for Depressed Preadolescent Girls|CBT vs CBT Plus Parent Training for Girls With Depression|Completed||Phase 1|153|Actual|University of Texas at Austin||3|||f||||f||||||||||2017-10-11 04:42:01.001231|2017-10-11 04:42:01.001231
NCT00061711|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-03|2009-12-09|||July 2000||2000-07-01|December 2009|2009-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Alternative Therapies for Menopause: A Randomized Trial||Completed||N/A|355||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:42:01.072548|2017-10-11 04:42:01.072548
NCT00061724|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-03|2010-01-12||||||January 2010|2010-01-01||||||||Observational|||Medical and Surgical Treatment of Esophageal Reflux||Completed||N/A|175|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:42:01.13419|2017-10-11 04:42:01.13419
NCT00061737|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-03|2010-01-12|||January 2003||2003-01-01|January 2010|2010-01-01||||||||Observational|||Quality of Life in Pediatric Inflammatory Bowel Disease||Completed||N/A|350|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:42:01.185154|2017-10-11 04:42:01.185154
NCT00061750|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-03|2012-04-18|||May 2003||2003-05-01|April 2012|2012-04-01||||November 2004|Actual|2004-11-01||Interventional|||Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions|A Randomized, Comparative, Open Label Phase III Trial on Efficacy & Safety of Long-term Treatment With ICL670 Compared to Deferoxamine in Beta-thalassemia Patients With Transfusional Hemosiderosis|Completed||Phase 3|595|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:42:01.261781|2017-10-11 04:42:01.261781
NCT00061763|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-03|2017-08-17|||May 2003||2003-05-01|August 2017|2017-08-01||||November 2004|Actual|2004-11-01||Interventional|||Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias|Phase II Study of Safety & Efficacy of Deferasirox Given for 1 Year in Patients With Chronic Anemias and Transfusional Hemosiderosis Unable to be Treated With Deferoxamine|Completed||Phase 2|175|Actual|Novartis|||||||||||||||||||2017-10-11 04:42:01.363942|2017-10-11 04:42:01.363942
NCT00061776|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-03|2008-03-04||||||March 2008|2008-03-01||||||||Interventional|||NGX-4010 for the Treatment of Postherpetic Neuralgia|A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|Completed||Phase 2/Phase 3|300||NeurogesX|||||||||||||||||||2017-10-11 04:42:01.46257|2017-10-11 04:42:01.46257
NCT00061789|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-04|2008-03-03|||February 2003||2003-02-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Interventional|||Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia|SPECT Imaging of Alpha 4 Beta 2 Nicotinic Acetylcholine Receptors Using [(123)I]5-I-A-85380 in Schizophrenia|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:01.580458|2017-10-11 04:42:01.580458
NCT00061802|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-04|2012-02-06|||June 2003||2003-06-01|February 2012|2012-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder|A Randomized, Double Blind Study to Evaluate the Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|225|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:42:01.655168|2017-10-11 04:42:01.655168
NCT00061815|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-04|2010-04-08|||March 2003||2003-03-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|December 2004|Actual|2004-12-01||Interventional|||Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer|A Phase 3 Randomized Multicenter Study of Cetuximab, Oxaliplatin, 5-Fluorouracil, and Leucovorin vs. Oxaliplatin, 5-Fluorouracil, and Leucovorin in Subjects With Previously Treated Metastatic, EGFR-Positive Colorectal Carcinoma|Completed||Phase 3|102|Actual|ImClone LLC||2|||f||||f||||||||||2017-10-11 04:42:01.75132|2017-10-11 04:42:01.75132
NCT00061828|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2017-09-06|||May 2004||2004-05-01|September 2017|2017-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|PROBE||PROBE: A Prospective Database of Infants With Cholestasis|Childhood Liver Disease Research and Education Network (CHILDREN): A Prospective Database of Infants With Cholestasis|Recruiting||N/A|1000|Anticipated|Arbor Research Collaborative for Health|||2||f||||t||||||Samples With DNA|"     Samples of blood, urine and liver tissue samples will be collected for research purposes.   "|||2017-10-11 04:42:03.653635|2017-10-11 04:42:03.653635
NCT00061841|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2010-01-12||||||January 2010|2010-01-01||||||||Interventional|||Medical College of Georgia FitKid Project||Completed||Phase 2|685|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:42:03.832855|2017-10-11 04:42:03.832855
NCT00061854|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2012-05-15|||April 2003||2003-04-01|May 2012|2012-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II Study Of Intravenous TZT-1027, Administered Weekly Times Two, Every Three Weeks, To Patients With Progressive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) Following Treatment With Platinum-Based Chemotherapy|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:42:03.880635|2017-10-11 04:42:03.880635
NCT00061867|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-05-29|||March 2003||2003-03-01|July 2005|2005-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer|A Dose Escalation, Pharmacokinetics, and Safety Study of Doxorubicin Encapsulated in Temperature Sensitive Liposomes Released Through Microwave Therapy in the Treatment of Prostate Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:03.950052|2017-10-11 04:42:03.950052
NCT00061880|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-05-29|||February 2003||2003-02-01|July 2004|2004-07-01|January 2008|Actual|2008-01-01|January 2005|Actual|2005-01-01||Interventional|||BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma|Phase 1-2 Multi-Center Study of Intravenous BCX-1777 in Patients With Refractory Cutaneous T-Cell Lymphoma (CTCL)|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:04.041543|2017-10-11 04:42:04.041543
NCT00061893|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2014-09-16|2013-01-17||April 2004||2004-04-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|April 2008|Actual|2008-04-01||Interventional|||Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors|A Pilot Study of Low-Dose Antiangiogenic Chemotherapy in Combination With Standard Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma Family of Tumors|Completed||Phase 2|38|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:42:04.168346|2017-10-11 04:42:04.168346
NCT00061906|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2014-02-10|||January 2003||2003-01-01|February 2014|2014-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer|Phase II Study Of Celecoxib In Metastatic Differentiated Thyroid Carcinoma|Completed||Phase 2|25|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:42:05.066977|2017-10-11 04:42:05.066977
NCT00061919|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2012-03-15|||April 2003||2003-04-01|March 2012|2012-03-01|July 2007|Actual|2007-07-01|February 2007|Actual|2007-02-01||Interventional|||Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer|A Phase III Randomized, Double Blind, Placebo Controlled Trial Of Carboplatin/Etoposide With Or Without Thalidomide In Small Cell Lung Cancer (Study 12)|Completed||Phase 3|724|Actual|University College, London||2|||f||||t||||||||||2017-10-11 04:42:05.154679|2017-10-11 04:42:05.154679
NCT00061932|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2015-05-15|2015-05-15||April 2003||2003-04-01|June 2013|2013-06-01|November 2013|Actual|2013-11-01|December 2009|Actual|2009-12-01||Interventional|||Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach|A Phase II Study of PS-341 Alone or in Combination With Irinotecan in Patients With Adenocarcinoma of the Gastroesophageal Junction (GEJ) or Stomach|Completed||Phase 2|41|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 04:42:05.249949|2017-10-11 04:42:05.249949
NCT00061945|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2014-03-20|2013-12-05||June 2003||2003-06-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|December 2007|Actual|2007-12-01||Interventional|||Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia|A Phase I/II Dose Escalation Study of Subcutaneous Campath-1H (NSC #715969, IND #10864) During Intensification Therapy in Adults With Untreated Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1/Phase 2|302|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:05.721288|2017-10-11 04:42:05.721288
NCT00061958|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-01-22|||June 2003||2003-06-01|January 2013|2013-01-01||||April 2005|Actual|2005-04-01||Interventional|||Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Study of Arsenic Trioxide (NSC 706363) in Patients With Advanced Adenocarcinoma of the Esophagus or Gastroesophageal Junction|Terminated||Phase 2|50|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:42:08.328884|2017-10-11 04:42:08.328884
NCT00061984|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2014-10-24|||April 2003||2003-04-01|October 2014|2014-10-01|July 2012|Actual|2012-07-01|May 2010|Actual|2010-05-01||Interventional|||Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma|Randomised Trial Of Single Agent Doxorubicin Versus Doxorubicin Plus Ifosfamide In The First Line Treatment Of Advanced Or Metastatic Soft Tissue Sarcoma|Completed||Phase 3|455|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:42:08.417995|2017-10-11 04:42:08.417995
NCT00061997|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2010-02-01|||May 2003||2003-05-01|November 2005|2005-11-01||||||||Interventional|||Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers|A Phase I Study Of The Safety Of Myo-Inositol As A Chemopreventive Agent|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:08.573229|2017-10-11 04:42:08.573229
NCT00062010|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2015-10-06|2012-12-01||February 2004||2004-02-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|May 2011|Actual|2011-05-01||Interventional|||Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer|Interferon Alpha (NSC# 377523) Plus 13-Cis-Retinoic Acid Modulation Of BCL-2 Plus Paclitaxel For Recurrent Small Cell Lung Cancer|Completed||Phase 2|37|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:42:08.775795|2017-10-11 04:42:08.775795
NCT00062023|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2012-07-27|||June 2003||2003-06-01|July 2012|2012-07-01|May 2006|Actual|2006-05-01|April 2005|Actual|2005-04-01||Interventional|||Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer|Phase II Study Of Colorectal ACF Screening, Regression And Prevention In High Risk Participants|Terminated||Phase 2|12|Actual|M.D. Anderson Cancer Center||4||Study closed by the NCI.|f||||t||||||||||2017-10-11 04:42:09.276509|2017-10-11 04:42:09.276509
NCT00062036|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2017-06-30|||June 2003||2003-06-01|March 2012|2012-03-01|September 2008|Actual|2008-09-01|February 2007|Actual|2007-02-01||Interventional|||Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma|Tumor Infiltrating Lymphocytes (TIL Cells) Transduced With An Interleukin-2 (SBIL-2) Gene Following The Administration Of A Nonmyeloablative But Lymphocyte Depleting Regimen in Metastatic Melanoma|Completed||Phase 1/Phase 2|33|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:42:09.387426|2017-10-11 04:42:09.387426
NCT00062049|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2012-03-07|||April 2003||2003-04-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|||||Interventional|||Interleukin-7 in Treating Patients With Refractory Solid Tumors|"A Phase I Study of Subcutaneous CYT 99 007 (Interleukin-7) in Patients With Refractory Non Hematologic Malignancy"|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:42:09.473729|2017-10-11 04:42:09.473729
NCT00062062|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2016-12-12|||October 2004||2004-10-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|August 2006|Actual|2006-08-01||Interventional|||Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer|Parallel Phase II Trials of ZD1839 (Iressa) Alone or Weekly Carboplatin and Paclitaxel Followed by ZD1839 (Iressa) (Oncologists Must Choose) for Metastatic Non-Small Cell Lung Cancer in Patients > or = 65 Years of Age|Completed||Phase 2|65|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:42:09.573762|2017-10-11 04:42:09.573762
NCT00062075|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2015-12-03|||May 2003||2003-05-01|April 2013|2013-04-01||||March 2007|Actual|2007-03-01||Interventional|||Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 2 Study of Depsipeptide in Patients With Relapsed or Refractory AML|Completed||Phase 2|47|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:10.351586|2017-10-11 04:42:10.351586
NCT00062101|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-06-05|||January 2004||2004-01-01|June 2013|2013-06-01||||January 2006|Actual|2006-01-01||Interventional|||Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer|A Phase II Study of OSI 774 (IND Number 63383) in Combination With Celecoxib (Celebrex, Pharmacia) as Second-Line Therapy in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:42:10.45121|2017-10-11 04:42:10.45121
NCT00062114|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2016-07-01|||April 2004||2004-04-01|July 2016|2016-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Study To Evaluate The Safety And Efficacy Of Zevalin (IND # BB IND 4850) Therapeutic Regimen In Patients With Transformed CD20 + B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|84|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:42:10.576919|2017-10-11 04:42:10.576919
NCT00062127|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-01-23|||April 2003||2003-04-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors|A Phase I Pharmacokinetic Interaction Study of Irinotecan (NSC616348) and Thalidomide (NSC66847) in Patients With Advanced Solid Tumors|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:42:10.986354|2017-10-11 04:42:10.986354
NCT00062140|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2010-09-20|||April 2003||2003-04-01|September 2010|2010-09-01|July 2004|Actual|2004-07-01|||||Interventional|||Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer|A Phase I Trial Of Total Body Irradiation, Cyclophosphamide Dose-Adjustment Based On Its Metabolism, And Hematopoietic Stem Cell Transplantation For Patients With Hematological Malignancy|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:42:11.125461|2017-10-11 04:42:11.125461
NCT00062166|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2017-10-05|||April 10, 2003||2003-04-10|November 29, 2016|2016-11-29||||||||Observational|||Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease|Evaluation of the Natural History and Management of Pancreatic Lesions Associated With Von Hippel-Lindau|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:11.249239|2017-10-11 04:42:11.249239
NCT00062179|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2015-10-01|||March 2003||2003-03-01|August 2012|2012-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer|A Randomized Double Blind Phase II Study of Preoperative Celecoxib/Paclitaxel/Carboplatin for Stage IIIA Non-Small Cell Lung Cancer|Completed||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:42:11.354594|2017-10-11 04:42:11.354594
NCT00062205|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2010-02-05|||June 2002||2002-06-01|February 2010|2010-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor|Phase II Trial of Gleevec (STI571) in Therapy of Ewing's Family of Tumors and Desmoplastic Small Round Cell Tumors|Completed||Phase 2|40|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-10-11 04:42:11.463948|2017-10-11 04:42:11.463948
NCT00062231|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2012-09-20|||April 2002||2002-04-01|September 2012|2012-09-01||||October 2006|Actual|2006-10-01||Interventional|||Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer|Oral Empirical Therapy of Fever in Low-Risk Neutropenic Cancer Patients: A Prospective, Double-Blind, Randomized, Multicenter Trial Comparing Monotherapy (Single Daily Dose Moxifloxacin) With Combination Therapy (Ciprofloxacin Plus Amoxicillin/Clavulanic Acid)|Terminated||N/A|351|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:42:11.545357|2017-10-11 04:42:11.545357
NCT00062244|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-06-03|||May 2003||2003-05-01|June 2013|2013-06-01||||June 2007|Actual|2007-06-01||Interventional|||Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia|Phase I/II Study of G3139 (Genasense) in Patients With Waldenstrom's Macroglobulinemia|Completed||Phase 1/Phase 2|58|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:11.749362|2017-10-11 04:42:11.749362
NCT00062257|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-05-14|||June 2003||2003-06-01|March 2005|2005-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer|A Phase II Study of Irofulven as First Line Therapy in Recurrent or Metastatic Gastric Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:11.858203|2017-10-11 04:42:11.858203
NCT00062673|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-10|2007-05-17|||March 2003||2003-03-01|May 2007|2007-05-01|July 2004|Actual|2004-07-01|||||Interventional|||Study of Duloxetine in Elderly Patients With Major Depressive Disorder|Duloxetine Versus Placebo in the Treatment of Elderly Patients With Major Depressive Disorder|Completed||Phase 3|311||Eli Lilly and Company|||||f||||f||||||||||2017-10-11 04:42:17.873744|2017-10-11 04:42:17.873744
NCT00062270|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2015-10-06|||May 2003||2003-05-01|September 2015|2015-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer|Neoadjuvant Chemoradiotherapy (Gemcitabine/Cisplatin and Taxotere) With or Without Co-Administration of ZD 1839 (Iressa) for Stage IIIA (N2) and Selective Stage IIIB Non-Small Cell Lung Cancer: Phase I-II Study|Completed||Phase 1/Phase 2|||University of Alabama at Birmingham|||||f||||t||||||||||2017-10-11 04:42:11.94729|2017-10-11 04:42:11.94729
NCT00062283|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-06-25|||March 2003||2003-03-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2005|Actual|2005-12-01||Interventional|||Alanosine in Treating Patients With Cancer|A Phase II, Open-Label, Non-Randomized, Multicenter, Single Agent Study of Intravenous SDX-102 for the Treatment of Patients With MTAP-Deficient Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:12.041706|2017-10-11 04:42:12.041706
NCT00062296|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-07-10|||March 2003||2003-03-01|July 2013|2013-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Phase II Study of Epirubicin and Rituximab in Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma and CLL|Completed||Phase 2|5|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-10-11 04:42:12.128215|2017-10-11 04:42:12.128215
NCT00062309|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2016-03-01|||June 2002||2002-06-01|March 2016|2016-03-01||||May 2006|Actual|2006-05-01||Interventional|||Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer|A Phase III Intensity Modulated Radiotherapy Dose Escalation Trial for Prostate Cancer Using Hypofractionation|Completed||Phase 3|307|Actual|Fox Chase Cancer Center||2|||f||||f||||||||||2017-10-11 04:42:12.217591|2017-10-11 04:42:12.217591
NCT00062322|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2010-02-11|||February 2003||2003-02-01|February 2010|2010-02-01|October 2009|Actual|2009-10-01|||||Interventional|||Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer|Phase I Study of Preoperative Chemo/Radiation (Concurrent Irinotecan/Cisplatin/RT) Followed by Surgery in Limited Stage Small Cell Lung Cancer (SCLC-LS)|Completed||Phase 1|||Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:42:12.311705|2017-10-11 04:42:12.311705
NCT00062335|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2012-09-20|||April 2003||2003-04-01|September 2012|2012-09-01||||February 2006|Actual|2006-02-01||Interventional|||High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer|A Phase I Study On The Feasibility Of High Dose Three Dimensional Conformal Radiotherapy In Patients With Inoperable And Locally Advanced Non Small Cell Lung Cancer|Terminated||Phase 1|14|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:42:12.377288|2017-10-11 04:42:12.377288
NCT00062348|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2012-01-19|||April 2003||2003-04-01|January 2012|2012-01-01||||December 2007|Actual|2007-12-01||Interventional|||Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases|B-Uptake In Different Tumours Using The Boron Compounds BSH And BPA|Completed||Phase 1|27|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:42:12.458112|2017-10-11 04:42:12.458112
NCT00062374|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2017-06-07|2014-09-22||June 2003||2003-06-01|June 2017|2017-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction|An Evaluation of Preoperative Chemotherapy With Irinotecan and Cisplatin for Advanced, But Resectable Gastric Cancer: A Coordinated Multidisciplinary, Multicenter Study Linking Functional Imaging, Genomic Expression Profiles and Histopathology|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)|Technical problems with measurement leading to unreliable or uninterpretable data. Data adjudication was invalid, and needs to be re-adjudicated.|1|||f||||||||||||||2017-10-11 04:42:12.548864|2017-10-11 04:42:12.548864
NCT00062387|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-05-31|||May 2003||2003-05-01|October 2004|2004-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Study Of Perifosine In Patients With Recurrent Or Metastatic Head And Neck Cancer|Terminated||Phase 2|46|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:42:13.015401|2017-10-11 04:42:13.015401
NCT00062400|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-10-23|||May 2003||2003-05-01|October 2013|2013-10-01||||June 2008|Actual|2008-06-01||Interventional|||Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer|A Survey of the Breast International Group (B.I.G.) to Assess the Attitude of Patients Aged Less Than 35 Years, With Early Breast Cancer, Toward the Risk of Loss of Fertility Related to Adjuvant Therapies|Completed||N/A|385|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:42:13.134907|2017-10-11 04:42:13.134907
NCT00062426|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-11-05|||May 2003||2003-05-01|April 2004|2004-04-01|February 2011|Actual|2011-02-01|||||Interventional|||Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer|A Randomized, Prospective Study Comparing Three Regimens Of Eloxatin ™ Plus Fluoropyrimidine For Evaluation Of Safety And Tolerability In First Line Treatment Of Patients With Advanced Colorectal Cancer (Tree Study)|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:13.270642|2017-10-11 04:42:13.270642
NCT00062439|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2013-10-30|2012-11-15||July 2003||2003-07-01|October 2013|2013-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors|A Phase II Trial of Induction Chemoradiotherapy With Cisplatin/Etoposide Followed by Surgical Resection, Followed by Docetaxel, for Non-Small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors)|Completed||Phase 2|46|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:42:13.4836|2017-10-11 04:42:13.4836
NCT00062452|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2017-10-05|||May 2002||2002-05-01|January 2010|2010-01-01|July 2005|Actual|2005-07-01|April 2005|Actual|2005-04-01||Observational|||Esophageal Motility and Airway Defenses Among Infants|Esophageal Motility and Airway Defenses Among Infants|Completed||N/A|65|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t|f|f||||||||2017-10-11 04:42:14.706013|2017-10-11 04:42:14.706013
NCT00063128|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-20|2007-12-20|||April 2003||2003-04-01|December 2007|2007-12-01|April 2004|Actual|2004-04-01|||||Interventional|||Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.|Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus|Completed||Phase 2|119|Actual|Eli Lilly and Company||2|||||||f||||||||||2017-10-11 04:42:26.967864|2017-10-11 04:42:26.967864
NCT00062465|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-05|2008-03-03|||June 2003||2003-06-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine|A 24-Week, Double Blind, Randomized Study to Determine the Effects of 24 Weeks of Dosing With Tripterygium Wilfordii Hook F (TwHF) or Sulfasalazine, in Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|157||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:14.779822|2017-10-11 04:42:14.779822
NCT00062478|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-06|2017-09-20|||October 2001||2001-10-01|September 2017|2017-09-01||||August 2002|Actual|2002-08-01||Interventional|||Study of Karenitecin (BNP1350) in Patients With Brain Tumors|Phase 2 Treatment of Adults With Primary Malignant Glioma With Karenitecin|Completed||Phase 2|40|Actual|BioNumerik Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 04:42:14.844562|2017-10-11 04:42:14.844562
NCT00062491|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-06|2017-09-20|||May 2002||2002-05-01|September 2017|2017-09-01|November 2005|Actual|2005-11-01|June 2003|Actual|2003-06-01||Interventional|||Study of Karenitecin (BNP1350) to Treat Malignant Melanoma|Phase 2 Trial of Karenitecin (BNP1350) in Patients With Malignant Melanoma|Completed||Phase 2|46|Actual|BioNumerik Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 04:42:14.922035|2017-10-11 04:42:14.922035
NCT00062504|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-06|2011-05-20|||July 2003||2003-07-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|January 2006|Actual|2006-01-01||Interventional|||Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas|A Phase II Trial of Talampanel in Patients With Recurrent High-Grade Gliomas.|Terminated||Phase 2|30|Actual|Teva Pharmaceutical Industries||3|||f||||||||||||||2017-10-11 04:42:14.994465|2017-10-11 04:42:14.994465
NCT00062517|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-06|2017-10-05|||June 5, 2003||2003-06-05|September 21, 2016|2016-09-21|September 21, 2016||2016-09-21|||||Observational|||Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning|Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning|Completed||N/A|497|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:15.07688|2017-10-11 04:42:15.07688
NCT00062530|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2008-09-25||||||September 2008|2008-09-01||||||||Interventional|||Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers|Development of an Oral Prime-Boost AIDS Vaccine to Elicit Broadly Neutralizing Antibodies Against HIV-1|Unknown status|Not yet recruiting|Phase 1|38|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:42:15.14898|2017-10-11 04:42:15.14898
NCT00062543|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2012-08-01|||May 2002||2002-05-01|August 2012|2012-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Hepatic Artery Infusion of CD34+ Cells|Hepatic Artery Infusion of CD34+ Cells, Isolated by the Isolex 300i Device, in Stem Cell Transplant Recipients With Hepatic Failure Due to Veno-occlusive Disease|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:42:15.238912|2017-10-11 04:42:15.238912
NCT00062556|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2006-10-31|||January 2003||2003-01-01|October 2006|2006-10-01|March 2006||2006-03-01|||||Interventional|||Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication|Effect of Niacin ER/Lovastatin on Peak Walking Time and Claudication Onset Time in Patients With Intermittent Claudication|Completed||Phase 3|366||Kos Pharmaceuticals|||||||||||||||||||2017-10-11 04:42:15.315852|2017-10-11 04:42:15.315852
NCT00062569|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2009-03-10|||September 2002||2002-09-01|March 2009|2009-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Bathing Persons With Alzheimer's Disease aT Home (The BATH Study)|Reminiscence During Bathing Persons With Alzheimer's Disease at Home|Completed||N/A|90|Actual|National Institute of Nursing Research (NINR)||2|||f||||f||||||||||2017-10-11 04:42:15.375657|2017-10-11 04:42:15.375657
NCT00062582|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2016-11-22|||June 2003||2003-06-01|September 2016|2016-09-01||||||||Interventional|||Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)|A 24 Week, Placebo-Controlled, Randomized, Parallel Group Study Comparing Roflumilast 500 mcg Daily vs Placebo on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|1000||AstraZeneca|||||f||||||||||||||2017-10-11 04:42:15.46425|2017-10-11 04:42:15.46425
NCT00062595|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2016-05-16|||September 2000||2000-09-01|May 2016|2016-05-01|October 2004||2004-10-01|||||Interventional|||Vitamin K and Bone Turnover in Postmenopausal Women|Vitamin K and Bone Turnover in Postmenopausal Women|Completed||Phase 3|375||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 04:42:15.597974|2017-10-11 04:42:15.597974
NCT00062608|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2010-01-12||||||January 2010|2010-01-01||||||||Interventional|||Written Self-disclosure for Youth Abdominal Pain|RCT of Written Self-disclosure for Youth Abdominal Pain|Completed||Phase 2/Phase 3|160|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:42:15.665168|2017-10-11 04:42:15.665168
NCT00062621|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2013-02-01|||June 2003||2003-06-01|February 2013|2013-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure|Combined HLA-matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With Renal Failure|Completed||Phase 1|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:42:15.721049|2017-10-11 04:42:15.721049
NCT00062634|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2005-06-23|||June 2003||2003-06-01|October 2004|2004-10-01|August 2005||2005-08-01|||||Interventional|||Education Program to Promote Female Condom Use|Female Condom Intervention Trial|Unknown status|Recruiting|N/A|400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:42:15.820942|2017-10-11 04:42:15.820942
NCT00062647|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-09|2011-03-30|2009-12-02||August 2003||2003-08-01|March 2011|2011-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|ASSURE||Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia|A Phase 2, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Televancin (TD-6424) for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia|Completed||Phase 2|60|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-10-11 04:42:15.922759|2017-10-11 04:42:15.922759
NCT00062660|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-10|2016-11-29|||May 2003||2003-05-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Expanded Access|||Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection|An Open Label Safety Study to Evaluate the Safety of Tipranavir Plus Ritonavir When Used in Combination With Other Agents for the Treatment of Patients With HIV Infection Who Have Failed and/or Are Intolerant to Combination Antiretroviral Therapy and Have Limited Treatment Options|Approved for marketing||N/A|||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 04:42:16.879199|2017-10-11 04:42:16.879199
NCT00062686|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-11|2015-04-14|||November 2003||2003-11-01|April 2015|2015-04-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||GW572016 For Treatment Of Refractory Metastatic Breast Cancer|An Open-Label, Multicenter, Single Arm Phase II Study of Oral GW572016 as Single Agent Therapy in Subjects With Advanced or Metastatic Breast Cancer Who Have Progressed While Receiving HERCEPTIN-Containing Regimens|Completed||Phase 2|200||GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:42:18.009841|2017-10-11 04:42:18.009841
NCT00062699|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-11|2006-07-31|||April 2003||2003-04-01|July 2006|2006-07-01||||||||Interventional|||Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis|A Phase IV, Prospective, Randomized, Active-Controlled, Double-Blind, Double-Dummy, Multi-Center Study to Evaluate the Survival Benefits of Zemplar Relative to Calcijex in Subjects With Stage V Chronic Kidney Disease on Hemodialysis|Terminated||Phase 4|2200||Abbott|||||||||||||||||||2017-10-11 04:42:18.172087|2017-10-11 04:42:18.172087
NCT00062712|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-11|2017-06-30|||June 9, 2003||2003-06-09|March 22, 2007|2007-03-22|March 22, 2007||2007-03-22|||||Interventional|||Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients|Induction of Donor Specific Immunologic Hyporesponsiveness With Thymoglobulin, Sirolimus and Donor Bone Marrow Infusion|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:18.442136|2017-10-11 04:42:18.442136
NCT00062738|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-12|2015-10-27|2012-12-05||June 2003||2003-06-01|October 2015|2015-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Treatment of Depression in Parkinson's Disease Trial|Treatment of Depression in Patients With Parkinson's Disease|Completed||Phase 2|52|Actual|Rutgers, The State University of New Jersey|This was only an eight week trial with relatively few participants.|3|||f||||t||||||||||2017-10-11 04:42:18.538217|2017-10-11 04:42:18.538217
NCT00062751|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-12|2011-04-13|2010-10-27||December 2002||2002-12-01|April 2011|2011-04-01|October 2009|Actual|2009-10-01|April 2005|Actual|2005-04-01||Interventional|||Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms|A Phase 2 Randomized Open-Label Study Of Letrozole In Combination With Two Dose Levels And Schedules Of Oral Temsirolimus (CCI-779), Or Letrozole Alone, In Postmenopausal Women With Locally Advanced Or Metastatic Breast Cancer|Completed||Phase 2|108|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|Clinical development of oral temsirolimus for treatment of locally advanced or metastatic breast cancer was terminated by Wyeth based on the results of a phase 3 clinical study with the combination temsirolimus and letrozole.|3|||f||||f||||||||||2017-10-11 04:42:19.09017|2017-10-11 04:42:19.09017
NCT00062764|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-12|2012-12-14|2011-03-01||June 2003||2003-06-01|December 2012|2012-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Treating Nonalcoholic Steatohepatitis With Pioglitazone|Long-Term Treatment of Nonalcoholic Steatohepatitis With Pioglitazone|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)|"A major limitation of this study was the lack of a concurrently followed control group.
Another important shortcoming of this study was that patients were treated for 48 weeks only."|1|||f||||f||||||||||2017-10-11 04:42:22.410026|2017-10-11 04:42:22.410026
NCT00062777|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-13|2017-06-30|||June 12, 2003||2003-06-12|June 16, 2011|2011-06-16|June 16, 2011||2011-06-16|||||Observational|||The Framingham Study: Examining DNA Markers and Links to Diseases|A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study|Completed||N/A|330|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:22.681496|2017-10-11 04:42:22.681496
NCT00062790|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-16|2016-09-13|||October 2003||2003-10-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|||||Interventional|||Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels|Effects of Dutasteride on Intraprostatic Dihydrotestosterone (DHT) Levels|Completed||Phase 4|50||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:42:22.739987|2017-10-11 04:42:22.739987
NCT00062803|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-16|2009-04-28|||June 2003||2003-06-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism|The Van Gogh-PE Trial, a Multicenter, International, Randomized, Open-Label, Assessor-Blind, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Weekly Subcutaneous SR34006 With the Combination of (LMW)Heparin and Vitamin K Antagonist (VKA) in the Treatment of Acute Symptomatic Pulmonary Embolism|Completed||Phase 3|||Sanofi|||||||||||||||||||2017-10-11 04:42:22.845332|2017-10-11 04:42:22.845332
NCT00062816|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-16|2007-10-15|||May 2004||2004-05-01|October 2007|2007-10-01||||||||Interventional|||Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs||Completed||Phase 1/Phase 2|22||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:42:23.062086|2017-10-11 04:42:23.062086
NCT00062829|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2014-09-24|||September 1998||1998-09-01|September 2014|2014-09-01|September 2005|Actual|2005-09-01|September 2000|Actual|2000-09-01||Interventional|||Young Driver Intervention Study: Preventing Motor Vehicle Crashes|Young Driver Intervention Study: Preventing Motor Vehicle Crashes Among Young Drivers|Completed||N/A|3743|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-10-11 04:42:24.753732|2017-10-11 04:42:24.753732
NCT00062842|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2007-04-09|||November 1998||1998-11-01|April 2007|2007-04-01|May 2005||2005-05-01|||||Interventional|||Study of Irinotecan in Children|Pediatric Phase I and Pharmacokinetic Study of Irinotecan|Completed||Phase 1|25||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:42:24.831695|2017-10-11 04:42:24.831695
NCT00062855|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2012-10-26|||November 1997||1997-11-01|October 2012|2012-10-01|March 2006|Actual|2006-03-01|August 2001|Actual|2001-08-01||Interventional|CYCHE||Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma|Phase I Study of Chemokine and Cytokine Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using an Adenoviral Vector (CYCHE)|Completed||Phase 1|9|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:42:24.887562|2017-10-11 04:42:24.887562
NCT00062868|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2017-08-29|||April 2007|Actual|2007-04-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|April 2014|Actual|2014-04-01||Interventional|ALCI||LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma|Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma (ALCI)|Active, not recruiting||Phase 1|89|Anticipated|Baylor College of Medicine||3|||f||||t|t|f||||||||2017-10-11 04:42:24.966509|2017-10-11 04:42:24.966509
NCT00062881|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2006-08-21|||June 1990||1990-06-01|April 2005|2005-04-01|September 2005||2005-09-01|||||Interventional|||Intrathecal Mafosfamide|Phase I Study of Intrathecal Mafosfamide|Completed||Phase 1|65||Baylor College of Medicine|||||||||||||||||||2017-10-11 04:42:25.082363|2017-10-11 04:42:25.082363
NCT00062894|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2007-09-13|||April 2003||2003-04-01|September 2007|2007-09-01|April 2007||2007-04-01|||||Interventional|||Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab|A Multi-Center Study to Examine the Pharmacokinetics, Whole Body and Organ Dosimetry, and Biodistribution of Fission-Derived Iodine I 131 Tositumomab for Patients With Previously Untreated or Relapsed Follicular or Transformed Follicular Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|12|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 04:42:25.16486|2017-10-11 04:42:25.16486
NCT00062907|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2006-12-05|||May 2003||2003-05-01|November 2004|2004-11-01||||||||Interventional|||Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer|Phase I Open-Label Dose Escalation Trial Evaluating The Safety And Immunogenicity Of Sequential Administration Of Recombinant DNA And Adenovirus Expressing L523S Protein In Patients With Early Stage Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 1|9||Corixa Corporation|||||||||||||||||||2017-10-11 04:42:25.256152|2017-10-11 04:42:25.256152
NCT00062933|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2012-08-17|||June 2003||2003-06-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|||A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma|A Phase II Study of Isolated Hepatic Perfusion (IHP) With Melphalan Followed by Temozolomide for Subjects With Unresectable Hepatic Metastases From Ocular Melanoma|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:25.342071|2017-10-11 04:42:25.342071
NCT00062946|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-17|2017-06-30|||June 17, 2003||2003-06-17|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||PET Imaging of Dopamine in Healthy Study Participants|PET Imaging of Dopamine D2 Receptors and Extracellular Dopamine With (18F)Fallypride, D-amphetamine, and Alpha-Methyl-Para-Tyrosine in Healthy Subjects|Completed||Phase 2|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:25.485537|2017-10-11 04:42:25.485537
NCT00062959|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-18|2005-06-23|||June 1994||1994-06-01|May 2003|2003-05-01|June 2000||2000-06-01|||||Interventional|||Preventing Problem Behavior Among Middle School Students|Preventing Problem Behaviors Among Middle School Students|Completed||N/A|2768||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:42:25.643795|2017-10-11 04:42:25.643795
NCT00062972|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-18|2017-04-21|||September 1999||1999-09-01|May 2011|2011-05-01|August 2002||2002-08-01|||||Interventional|||Improving Memory in Patients With Multiple Sclerosis|Interventions to Improve Memory in Patients With Multiple Sclerosis|Withdrawn||Phase 3|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Study terminated/withdrawn|f||||||||||||||2017-10-11 04:42:25.743812|2017-10-11 04:42:25.743812
NCT00062998|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-18|2010-03-17||||||March 2010|2010-03-01||||||||Observational|||Free-Living Physical Activity and Energy Expenditure||Completed||N/A|15||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:42:25.925327|2017-10-11 04:42:25.925327
NCT00063011|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2005-06-23|||May 1998||1998-05-01|May 2003|2003-05-01||||||||Interventional|||Bone Development in Adolescent Girls: Effects of Calcium and Exercise|Calcium and Exercise Effect on Pubertal Bone Gain|Unknown status|Active, not recruiting|Phase 1/Phase 2|107||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:42:25.985016|2017-10-11 04:42:25.985016
NCT00063024|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2005-06-23|||June 1999||1999-06-01|May 2003|2003-05-01|May 2004||2004-05-01|||||Interventional|||Program to Prevent Osteoporosis in Girls|Behavioral Strategies to Prevent Osteoporosis in Girls|Unknown status|Active, not recruiting|Phase 3|322||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:42:26.074608|2017-10-11 04:42:26.074608
NCT00063037|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2005-06-23|||June 1999||1999-06-01|May 2003|2003-05-01|May 2005||2005-05-01|||||Interventional|||Building Better Bones in Children|Building Better Bones in Children|Unknown status|Active, not recruiting|N/A|139||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:42:26.171452|2017-10-11 04:42:26.171452
NCT00063050|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2011-11-14|||April 2000||2000-04-01|November 2011|2011-11-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Osteoporosis Prevention: Changes to Exercise and Diet in Children|Healthy Children Healthy Families|Completed||Phase 2|155|Actual|San Diego State University|||||f||||f||||||||||2017-10-11 04:42:26.267986|2017-10-11 04:42:26.267986
NCT00063063|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2017-08-11|||January 1987||1987-01-01|August 2017|2017-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|GDB||Generic Database of Very Low Birth Weight Infants|Generic Database: A Survey of Morbidity and Mortality in Very Low Birth Weight Infants|Recruiting||N/A|80000|Anticipated|NICHD Neonatal Research Network|||1||f||||f||||||||||2017-10-11 04:42:26.378904|2017-10-11 04:42:26.378904
NCT00063076|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2012-08-01|||May 2003||2003-05-01|August 2012|2012-08-01|May 2007|Actual|2007-05-01|October 2006|Actual|2006-10-01||Interventional|||Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata|A Two Stage Phase II Randomized Bilateral Comparison of Topical Targretin® Gel 1% in Alopecia Areata|Completed||Phase 2/Phase 3|46|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 04:42:26.663814|2017-10-11 04:42:26.663814
NCT00063089|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2012-05-10|||September 2002||2002-09-01|May 2012|2012-05-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever|Initial Safety and Pharmacokinetics Trial of Immune Globulin to Staphylococcus Aureus Capsule Polysaccharide (Altastaph) in Subjects With S. Aureus Bacteremia and Persistent Fever|Completed||Phase 1/Phase 2|40|Actual|Nabi Biopharmaceuticals||2|||f||||||||||||||2017-10-11 04:42:26.745512|2017-10-11 04:42:26.745512
NCT00063102|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2007-11-28|||November 2002||2002-11-01|November 2007|2007-11-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.|A Phase II Study of ABT-751 in Patients With Breast Cancer Refractory to Taxane Regimens|Completed||Phase 2|40||Abbott||1|||f||||f||||||||||2017-10-11 04:42:26.817183|2017-10-11 04:42:26.817183
NCT00063115|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-19|2017-06-30|||June 16, 2003||2003-06-16|July 2, 2008|2008-07-02|July 2, 2008||2008-07-02|||||Observational|||Using fMRI to Understand the Roles of Brain Areas for Fine Hand Movements|Event-Related fMRI Analysis of Patients With Ideomotor Apraxia During Transitive and Intransitive Hand Gesturing|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:26.904143|2017-10-11 04:42:26.904143
NCT00063141|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-20|2010-04-08|||April 2003||2003-04-01|April 2010|2010-04-01|October 2007|Actual|2007-10-01|June 2006|Actual|2006-06-01||Interventional|||Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer|Revised Protocol 07 to Protocol CA225006 - A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Carcinoma|Completed||Phase 3|1302|Actual|ImClone LLC||2|||f||||||||||||||2017-10-11 04:42:27.110926|2017-10-11 04:42:27.110926
NCT00063154|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-20|2015-06-08|2015-05-26||July 2003||2003-07-01|June 2015|2015-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional||Safety population: All participants who received any amount of pertuzumab.|Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy|A Phase II, Open-label, Multicenter Study to Evaluate the Effect of Tumor-based HER2 Activation on the Efficacy of rhuMAb 2C4 (Pertuzumab) in Subjects With Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|51|Actual|Genentech, Inc.||1|||f||||f||||||||||2017-10-11 04:42:27.708535|2017-10-11 04:42:27.708535
NCT00063180|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-20|2017-06-30|||June 19, 2003||2003-06-19|April 20, 2009|2009-04-20|April 20, 2009||2009-04-20|||||Observational|||Evaluating the Remote Effects of Stroke With MRI and PET Scans|Remote Effects of Stroke on Cerebral Metabolism. Evaluation With Positron Emission Tomography and Proton Magnetic Resonance Spectroscopy|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:28.07257|2017-10-11 04:42:28.07257
NCT00063193|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-23|2016-01-19|||May 2003||2003-05-01|January 2016|2016-01-01|July 2005|Actual|2005-07-01|May 2005|Actual|2005-05-01||Interventional|||National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial|A Multi-center, Double-blind, Pilot Study of Minocycline and Creatine in Subjects With Early Untreated Parkinson's Disease|Completed||Phase 2|195||University of Rochester|||||f||||t||||||||||2017-10-11 04:42:28.13997|2017-10-11 04:42:28.13997
NCT00063206|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-23|2009-08-18||||||August 2009|2009-08-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of a Flexible Dose of DVS-233 SR in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|247|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:42:28.235099|2017-10-11 04:42:28.235099
NCT00063219|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-23|2009-08-20||||||August 2009|2009-08-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy|A Phase 2, Open-label Study of MAC-321 Administered Intravenously as a Single Agent for the Treatment of Non-small Cell Lung Cancer Refractory to Platinum-based Therapy|Completed||Phase 2|48|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:42:28.297473|2017-10-11 04:42:28.297473
NCT00063232|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-23|2011-06-21|2011-03-14||June 2003||2003-06-01|June 2011|2011-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Treating Nonalcoholic Steatohepatitis (NASH) With Metformin|Treatment of Nonalcoholic Steatohepatitis With Metformin|Completed||Phase 2|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:42:28.398925|2017-10-11 04:42:28.398925
NCT00063245|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-23|2008-03-03|||June 2003||2003-06-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Stimulating Deep Brain Regions With a Magnetic Stimulator|Noninvasive Stimulation of Human Deep Brain Regions With a Magnetic Stimulator|Completed||N/A|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:28.660289|2017-10-11 04:42:28.660289
NCT00063258|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-24|2016-04-05|2010-08-25||June 2003||2003-06-01|April 2016|2016-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer|Phase II Randomized Open-Label Trial of the EGFR Tyrosine Kinase Inhibitor OSI-774 (Tarceva™) in Combination With Paclitaxel and Carboplatin Prior to Surgery in Resectable Stage IIIA (N2) and IIIB (T4 N2) NSCLC: A Clinical Outcome and Biological Endpoint Trial|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center|Despite active study recruitment and screening for this study, only 5 subjects were enrolled out of the planned 40 subjects. Of the 5 subjects enrolled, only 1 patient was evaluable for response assessment. The study was subsequently terminated.|2||Low accrual rate|f||||t||||||||||2017-10-11 04:42:28.729561|2017-10-11 04:42:28.729561
NCT00063284|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-24|2017-06-30|||June 18, 2003||2003-06-18|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Interventional|||Investigating the Safety of srTMS in the Treatment of Parkinson's Disease|Safety Study of the Super Rapid Transcranial Magnetic Stimulation in Patients With Parkinson's Disease|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:42:29.003734|2017-10-11 04:42:29.003734
NCT00063297|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2009-08-27|||May 2003||2003-05-01|December 2003|2003-12-01|October 2003||2003-10-01|||||Interventional|||Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia||Completed||Phase 2|180||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:42:29.090499|2017-10-11 04:42:29.090499
NCT00063310|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2009-12-10|||March 2003||2003-03-01|February 2006|2006-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation|Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN)|Completed||Phase 2|90||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:42:29.256101|2017-10-11 04:42:29.256101
NCT00063323|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2017-01-11|||August 2000||2000-08-01|January 2010|2010-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Maintenance Treatment for Abstinent Smokers|Maintenance Treatment for Prevention of Smoking Relapse|Completed||Phase 3|589|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||t||||||||||2017-10-11 04:42:29.407417|2017-10-11 04:42:29.407417
NCT00063336|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2013-11-07|||December 2001||2001-12-01|May 2009|2009-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Treatment Response to Rehabilitation in Patients With Schizophrenia|Treatment Response to Rehabilitation in Schizophrenia|Completed||N/A|46|Actual|Hartford Hospital||2|||f||||||||||||||2017-10-11 04:42:29.524792|2017-10-11 04:42:29.524792
NCT00063362|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2016-10-03|2013-11-04||February 2002||2002-02-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Combination Therapy for the Treatment of Bipolar Disorders|Combination Therapy in Bipolar Rapid Cycling|Terminated||Phase 3|49|Actual|University Hospitals Cleveland Medical Center||2||Funding Expiration|f||||t||||||||||2017-10-11 04:42:29.622559|2017-10-11 04:42:29.622559
NCT00063388|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2010-04-08|||May 2003||2003-05-01|April 2010|2010-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer|A Phase II Trial of Cetuximab (C225) as Therapy for Recurrent Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|66|Actual|ImClone LLC||1|||f||||f||||||||||2017-10-11 04:42:30.052334|2017-10-11 04:42:30.052334
NCT00063401|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2010-04-07|||September 2003||2003-09-01|April 2010|2010-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer|A Phase II Study of Cetuximab (C225)/Paclitaxel/Carboplatin for the Initial Treatment of Advanced Stage Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|Completed||Phase 2|39|Actual|ImClone LLC||1|||f||||f||||||||||2017-10-11 04:42:30.157311|2017-10-11 04:42:30.157311
NCT00063414|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-25|2007-10-15||||||October 2007|2007-10-01||||||||Interventional|||ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis|ISIS 2302-CS22, Phase II, Double-Blinded, Active-Controlled Study of Alicaforsen (ISIS 2302) Enema, an Antisense Inhibitor of ICAM-1, for the Treatment of Patients With Mild to Moderate Active Ulcerative Colitis (Left-Sided Colitis or Pancolitis With Left Sided Disease Flare)|Completed||Phase 2|||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:42:30.267403|2017-10-11 04:42:30.267403
NCT00063427|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-26|2009-08-20||||||August 2009|2009-08-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Study Evaluating MAC-321 in Colorectal Cancer|A Phase 2, Open-Label Study of MAC-321 Administered Intravenously as a Single Agent for the Treatment of Advanced Colorectal Cancer|Completed||Phase 2|45|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:42:30.323936|2017-10-11 04:42:30.323936
NCT00063440|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-26|2013-02-06|||June 2003||2003-06-01|February 2013|2013-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Epidemiology of Carotid IMT Progression in MESA - Ancillary Study||Completed||N/A|5610|Actual|Tufts Medical Center|||1||f||||||||||||||2017-10-11 04:42:30.395894|2017-10-11 04:42:30.395894
NCT00063453|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-26|2013-09-19|||August 2003||2003-08-01|September 2013|2013-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Supplemental Selenium and Vitamin E and Pulmonary Function|The Respiratory Ancillary Study (RAS) to SELECT|Completed||Phase 3|2920|Actual|Cornell University||4|||f||||t||||||||||2017-10-11 04:42:30.478082|2017-10-11 04:42:30.478082
NCT00063479|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-27|2017-05-31|||June 2003||2003-06-01|May 2017|2017-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Bisphosphonate Treatment of Osteogenesis Imperfecta|Bisphosphonate Treatment of Osteogenesis Imperfecta|Completed||Phase 2|158||Novartis|||||||||||||||||||2017-10-11 04:42:30.576072|2017-10-11 04:42:30.576072
NCT00063492|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-30|2013-07-23|||January 2003||2003-01-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Angiotensinogen Gene and Human Hypertension||Completed||N/A|||University of Utah|||||f||||||||||||||2017-10-11 04:42:30.669022|2017-10-11 04:42:30.669022
NCT00063505|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-30|2014-04-22|||December 2002||2002-12-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Genes of Hypertension in African Americans|Genes of Hypertension in African Americans|Completed||N/A|5000|Actual|Medical College of Wisconsin|||1||f||||f||||||Samples With DNA|"     Blood cells and DNA   "|||2017-10-11 04:42:30.737416|2017-10-11 04:42:30.737416
NCT00063518|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-30|2013-09-09|||April 2003||2003-04-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Monitoring Trends in Venous Thromboembolism|Incidence Rates, Clinical Profile, and Outcomes of Patients With Venous Thromboembolism|Completed||N/A|||University of Massachusetts, Worcester|||||f||||f||||||||||2017-10-11 04:42:30.801853|2017-10-11 04:42:30.801853
NCT00063531|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-30|2014-03-01|||June 2003||2003-06-01|March 2014|2014-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Comparison of Two Methods to Diagnose Coronary Artery Disease|Coronary Disease Detection by Thallium SPECT and Fast CT|Completed||N/A|650|Actual|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 04:42:30.87364|2017-10-11 04:42:30.87364
NCT00063544|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-30|2016-05-24|||May 2003||2003-05-01|May 2016|2016-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Physical Activity and Childhood Obesity|Physical Activity and Childhood Obesity|Withdrawn||N/A|0|Actual|University of Bristol|||1|CI left institution|f||||f||||||||||2017-10-11 04:42:30.956159|2017-10-11 04:42:30.956159
NCT00063557|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-30|2016-04-08|||June 2003||2003-06-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Neighborhoods and CVD Risk in a Multiethnic Cohort - Ancillary to MESA||Completed||N/A|||University of Michigan|||||f||||||||||||||2017-10-11 04:42:31.037481|2017-10-11 04:42:31.037481
NCT00063570|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-30|2009-05-12|2009-01-27||July 2003||2003-07-01|May 2009|2009-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy|Phase II Trial of Alimta (Pemetrexed) and Gemzar (Gemcitabine) in Metastatic Breast Cancer Patients Who Have Received Prior Taxane Therapy|Completed||Phase 2|73|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-10-11 04:42:31.117708|2017-10-11 04:42:31.117708
NCT00063583|ClinicalTrials.gov processed this data on October 10, 2017|2003-06-30|2009-11-03|||June 2003||2003-06-01|November 2009|2009-11-01|March 2009|Actual|2009-03-01|November 2007|Actual|2007-11-01||Interventional|||Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes|Pirfenidone: A Novel Anti-Scarring Therapy for Diabetic Nephropathy|Completed||Phase 1/Phase 2|77|Actual|Sharma, Kumar, M.D.||3|||f||||t||||||||||2017-10-11 04:42:32.108631|2017-10-11 04:42:32.108631
NCT00063596|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-01|2005-06-23|||January 2000||2000-01-01|November 2004|2004-11-01|May 2004||2004-05-01|||||Interventional|||Vitamin A Supplementation in Preterm Infants|Vitamin A Therapy in Preterm Infants: Vaccine Response|Unknown status|Active, not recruiting|N/A|220||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:42:32.222292|2017-10-11 04:42:32.222292
NCT00063609|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-01|2017-09-11|||April 2003||2003-04-01|September 2017|2017-09-01|April 2005||2005-04-01|||||Interventional|||The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy|The Effect of Zoledronic Acid Compared to Placebo on Bone Mineral Density in Patients Undergoing Androgen Deprivation Therapy|Completed||Phase 4|200||Novartis|||||||||||||||||||2017-10-11 04:42:32.298531|2017-10-11 04:42:32.298531
NCT00055302|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-25|2015-08-31|||August 2002||2002-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|February 2006|Actual|2006-02-01||Interventional|||Arimidex in McCune Albright Syndrome|An Open-label Study Evaluating the Safety and Efficacy of Anastrozole™ (ARIMIDEX) in the Treatment of Precocious Puberty in Girls With McCune-Albright Syndrome|Completed||Phase 2|40|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 04:42:47.424501|2017-10-11 04:42:47.424501
NCT00063622|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-01|2012-08-27|2012-06-14||January 2005||2005-01-01|August 2012|2012-08-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|PIVENS||Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)|Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)|Completed||Phase 3|247|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-10-11 04:42:32.50989|2017-10-11 04:42:32.50989
NCT00063635|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-01|2012-08-27|2012-06-26||September 2005||2005-09-01|August 2012|2012-08-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional|TONIC||Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)|Clinical Research Network in Nonalcoholic Steatohepatitis: Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)|Completed||Phase 3|173|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-10-11 04:42:33.175421|2017-10-11 04:42:33.175421
NCT00063648|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-01|2010-01-12|||May 2002||2002-05-01|January 2010|2010-01-01|December 2007||2007-12-01|||||Interventional|||Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant||Completed||Phase 1|50||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:42:34.025089|2017-10-11 04:42:34.025089
NCT00063661|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-02|2008-03-03|||June 2003||2003-06-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Observational|||Studying Automatic Movements in Patients With Parkinson's Disease|A Neuroimaging Study of Automatic Movements in Patients With Parkinson's Disease|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:34.096087|2017-10-11 04:42:34.096087
NCT00063674|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-02|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01||||||||Interventional|||Type 2 Diabetes Primary Prevention for At Risk Girls||Completed||Phase 2/Phase 3|240|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:42:34.731884|2017-10-11 04:42:34.731884
NCT00063687|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-02|2005-08-03|||March 2003||2003-03-01|July 2003|2003-07-01|June 2005||2005-06-01|||||Interventional|||Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure|A Phase II-III Prospective, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oxypurinol Added to Standard Therapy in Patients With NYHA Class III-IV Congestive Heart Failure|Completed||Phase 2/Phase 3|400||Cardiome Pharma|||||||||||||||||||2017-10-11 04:42:34.824523|2017-10-11 04:42:34.824523
NCT00063700|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-02|2010-01-12|||September 2002||2002-09-01|January 2010|2010-01-01|July 2005||2005-07-01|||||Interventional|||Impact of Non-Commercialism Policy in Seattle Schools|Impact of Non-Commercialism Policy in Seattle Schools|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:42:34.895104|2017-10-11 04:42:34.895104
NCT00063713|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-02|2008-02-07|||June 2003||2003-06-01|February 2008|2008-02-01||||December 2005|Actual|2005-12-01||Interventional|||VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma|A Phase 2 Study of VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma|Completed||Phase 2|152||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-10-11 04:42:34.967676|2017-10-11 04:42:34.967676
NCT00063726|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-02|2012-01-12|||April 2002||2002-04-01|January 2012|2012-01-01|July 2005|Actual|2005-07-01|May 2005|Actual|2005-05-01||Interventional|||A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039|An International, Non-Comparative, Open-Label Study of PS-341 Administered to Patients With Multiple Myeloma Who Experienced Relapsed or Progressive Disease After Receiving at Least Four Previous Treatment Regimens or Experienced Progressive Disease After Receiving Dexamethasone in Millennium Protocol M34101-039|Completed||Phase 3|600||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-10-11 04:42:35.104976|2017-10-11 04:42:35.104976
NCT00063752|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-03|2005-06-23|||July 2003||2003-07-01|April 2005|2005-04-01|March 2005||2005-03-01|||||Interventional|||Safety Study of PI-0824 to Treat Pemphigus Vulgaris|An Open-Label, Dose-Escalation, Phase I Clinical Study to Assess the Safety of PI-0824 in Patient With Pemphigus Vulgaris Requiring Daily Corticosteroid Therapy|Completed||Phase 1|15||Peptimmune|||||||||||||||||||2017-10-11 04:42:35.33438|2017-10-11 04:42:35.33438
NCT00063765|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-03|2008-03-03|||June 2003||2003-06-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye|A Phase I Study of NT-501-10 and NT-501-6A.02, Implants of Encapsulated Human NTC-210 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Patients With Retinitis Pigmentosa|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:35.428911|2017-10-11 04:42:35.428911
NCT00063778|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-07|2012-06-27|||July 2003||2003-07-01|June 2012|2012-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa|A Phase I Safety and Immunogenicity Trial of an Alphavirus Replicon HIV Subtype C Gag Vaccine (AVX101, Alphavax, Inc.) in Healthy HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|48|Actual|AlphaVax, Inc.||3|||f||||||||||||||2017-10-11 04:42:35.508192|2017-10-11 04:42:35.508192
NCT00063791|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-07|2007-02-13||||||July 2003|2003-07-01||||||||Expanded Access|||A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE|An Open-Labeled, Randomized Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE in Patients With Relapsed Multiple Myeloma Who Have Failed Four or More Lines of Therapy|No longer available||N/A|1000||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:42:35.638442|2017-10-11 04:42:35.638442
NCT00063804|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-07|2012-05-17||||||May 2012|2012-05-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men|A Phase 1, Dose-Rising Study of AMD11070 in HIV-Seronegative Men to Assess the Safety and Pharmacokinetics After Single or Multiple Doses|Completed||Phase 1|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||||||||||||||||2017-10-11 04:42:35.71184|2017-10-11 04:42:35.71184
NCT00063817|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-07|2017-01-10|||June 2003||2003-06-01|January 2017|2017-01-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|||Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant|Renal Allograft Tolerance Through Mixed Chimerism (ITN010ST)|Completed||Phase 1|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||Yes|Data access is provided in TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal that makes data from the consortium's clinical trials publicly available.|2017-10-11 04:42:35.806741|2017-10-11 04:42:35.806741
NCT00220870|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2010-04-07|||January 2003||2003-01-01|April 2010|2010-04-01|August 2005||2005-08-01|||||Interventional|||Shared Decision Making for Schizophrenia|Shared Decision Making in the Therapy of Schizophrenia|Completed||N/A|||Technische Universität München|||||f||||||||||||||2017-10-11 05:39:09.699772|2017-10-11 05:39:09.699772
NCT00063830|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-07|2007-10-15||||||October 2007|2007-10-01||||||||Interventional|||ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.|ISIS 2302-CS27, Phase 2, Double-Blinded, Controlled Study of Four Dosing Regimens of Alicaforsen (ISIS 2302) Enema, an Antisense Inhibitor of ICAM-1, for the Treatment of Patients With Mild to Moderate Active Ulcerative Colitis|Completed||Phase 2|||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:42:35.903913|2017-10-11 04:42:35.903913
NCT00063843|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-07|2010-08-26|||July 2003||2003-07-01|May 2006|2006-05-01|August 2005||2005-08-01|||||Interventional|||Anthrax-rPA: Safety, Tolerability, Immunogenicity|A Phase I, Dose-Escalating Study to Assess the Safety, Tolerability, and Immunogenicity of Recombinant Anthrax Protective Antigen Vaccine (rPA) Administered in Two Intramuscular Doses to Healthy Adults|Completed||Phase 1|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:42:36.095066|2017-10-11 04:42:36.095066
NCT00063856|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-07|2012-02-09|||July 2003||2003-07-01|May 2007|2007-05-01|June 2004||2004-06-01|||||Interventional|||Dressing Preparations for Smallpox|A Comparison of Dressing Preparations for Smallpox Vaccination Sites With a Focus Upon the Risk of Secondary Transmission of Vaccinia Virus|Completed||Phase 1/Phase 2|102|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:42:36.152079|2017-10-11 04:42:36.152079
NCT00063869|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-07|2009-09-03||||||September 2009|2009-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis|A Double-blind, Parallel, Placebo-controlled, Randomized Study of the Efficacy and Safety of Etanercept in Patients With Idiopathic Pulmonary Fibrosis.|Completed||Phase 2|88|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:42:36.208329|2017-10-11 04:42:36.208329
NCT00063882|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2017-05-18|||June 2003||2003-06-01|May 2017|2017-05-01||||May 2017|Actual|2017-05-01||Interventional|||Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer|A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma|Active, not recruiting||Phase 3|588|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:42:36.28714|2017-10-11 04:42:36.28714
NCT00063895|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-01-08|||April 2003||2003-04-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck|A Pharmacogenetic and Pharmacodynamic Study of Erlotinib (OSI-774) Toxicity in Patients With Advanced Solid Tumors|Completed||Phase 1/Phase 2|80|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:36.845204|2017-10-11 04:42:36.845204
NCT00063934|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2014-05-06|2012-07-10||May 2003||2003-05-01|December 2012|2012-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer|A Phase 1/2 Study of Bcl-2 Antisense Oligonucleotide G3139 in Combination With Doxorubicin and Docetaxel in Metastatic and Locally Advanced Breast Cancer|Terminated||Phase 1/Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:37.486013|2017-10-11 04:42:37.486013
NCT00063947|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-06-03|||May 2003||2003-05-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer|A Phase I Study of OSI-774 in Combination With Gemcitabine and Radiation in Locally Advanced, Non-Operable Pancreatic Cancer|Completed||Phase 1|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:37.823212|2017-10-11 04:42:37.823212
NCT00063960|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2016-07-01|||August 2003||2003-08-01|July 2016|2016-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer|A Phase II Trial Of Toxicity Assessment In Two Cohorts Of Patients (Resection Alone Or Ablation With Or Without Resection Of Hepatic Metastases From Colorectal Cancer) Treated With Adjuvant Hepatic Arterial Infusion (HAI) FUDR Plus Systemic CPT-11|Completed||Phase 2|94|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:42:37.95967|2017-10-11 04:42:37.95967
NCT00063973|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-09-27|||July 2003||2003-07-01|September 2013|2013-09-01||||March 2008|Actual|2008-03-01||Interventional|||Cilengitide in Treating Children With Refractory Primary Brain Tumors|Phase I Study of Cilengitide (EMD 121974) in Children With Refractory Brain Tumors|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:38.091133|2017-10-11 04:42:38.091133
NCT00063986|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-02-07|2012-11-29||March 2004||2004-03-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|December 2010|Actual|2010-12-01||Interventional|||Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer|Minimally Invasive Esophagectomy (MIE): A Multicenter Feasibility Study|Completed||Phase 2|110|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:42:38.225086|2017-10-11 04:42:38.225086
NCT00063999|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2016-10-26|||August 2003||2003-08-01|October 2016|2016-10-01||||June 2013|Actual|2013-06-01||Interventional|||Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer|Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF Versus Carboplatin/Paclitaxel in Patients With Stage III &Amp; IV or Recurrent Endometrial Cancer|Active, not recruiting||Phase 3|1331|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-10-11 04:42:38.977856|2017-10-11 04:42:38.977856
NCT00064012|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-03-18|||May 2003||2003-05-01|March 2013|2013-03-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer|A Randomized, Multicenter, Open-Label, Phase II Study Of VELCADE Alone Or VELCADE Plus Docetaxel In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|4|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-11 04:42:40.567341|2017-10-11 04:42:40.567341
NCT00064025|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2016-03-17|2014-01-31||April 2004||2004-04-01|March 2016|2016-03-01||||September 2010|Actual|2010-09-01||Interventional|||Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus|A Phase II Pilot Investigation Of The Relationship Of Short Term Depo-Provera (Medroxyprogesterone Acetate) Exposure To The Morphologic , Biochemical, And Molecular Changes In Primary Endometroid Adenocarcinoma of the Uterine Corpus|Completed||Phase 2|75|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:42:40.773282|2017-10-11 04:42:40.773282
NCT00064038|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2015-03-05|2012-11-19||November 2004||2004-11-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|October 2008|Actual|2008-10-01||Interventional|||S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma|Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients With Previously Untreated Multiple Myeloma|Completed||Phase 3|198|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:42:41.215941|2017-10-11 04:42:41.215941
NCT00064051|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-08-01|||January 2003||2003-01-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2006|Actual|2006-08-01||Interventional|||3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer|A Phase II Study of Triapine in Combination With Gemcitabine in Patients With Pancreatic Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:43.184528|2017-10-11 04:42:43.184528
NCT00064064|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-11-05|||January 2003||2003-01-01|August 2004|2004-08-01|August 2008|Actual|2008-08-01|||||Interventional|||3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer|A Phase II Study of Triapine in Combination With Gemcitabine in Patients With Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:43.278309|2017-10-11 04:42:43.278309
NCT00064077|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2015-05-27|||May 2003||2003-05-01|May 2015|2015-05-01||||January 2011|Actual|2011-01-01||Interventional|||Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix|A Randomized Phase III Trial Of Paclitaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Versus Topotecan Plus Cisplatin In Stage IVB, Recurrent Or Persistent Carcinoma of the Cervix|Completed||Phase 3|513|Actual|Gynecologic Oncology Group||4|||f||||||||||||||2017-10-11 04:42:43.343898|2017-10-11 04:42:43.343898
NCT00064090|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-07-17|||March 2003||2003-03-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|September 2004|Actual|2004-09-01||Interventional|||3-AP and Cytarabine in Treating Patients With Hematologic Cancer|A Phase I Study of Triapine and Cytarabine in Patients With Hematologic Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:43.491514|2017-10-11 04:42:43.491514
NCT00064103|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-01-22|||June 2003||2003-06-01|January 2013|2013-01-01||||August 2007|Actual|2007-08-01||Interventional|||Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx|Clinical Protocol for Wild Type p53 Gene Induction in Premalignancies of Squamous Epithelium of the Oral Cavity and Oral Pharynx Via an Adenoviral Vector [NCI Supplied Agent Ad-p53, (INGN 201) (Advexin®) NSC 683550, IND# 7135]|Completed||Phase 1/Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:43.571867|2017-10-11 04:42:43.571867
NCT00064116|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2014-06-23|||May 2001||2001-05-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|December 2010|Actual|2010-12-01||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|Randomized Intergroup Trial of First Line Treatment for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma With a CHOP-Like Chemotherapy Regimen With or Without the Anti-CD20 Antibody Rituximab (IDEC-C2B8)|Completed||Phase 3|824|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:42:43.662443|2017-10-11 04:42:43.662443
NCT00064142|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-06-04|||May 2003||2003-05-01|June 2013|2013-06-01||||December 2006|Actual|2006-12-01||Interventional|||Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma|A Phase II Trial of Topical Halofuginone in Patients With HIV Related Kaposi's Sarcoma|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:42:43.88765|2017-10-11 04:42:43.88765
NCT00064181|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-09-20|||May 2003||2003-05-01|September 2012|2012-09-01||||January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer|Irinotecan Combined With Infusional 5-FU/Folinic Acid or Capecitabine and the Role of Celecoxib in Patients With Metastatic Colorectal Cancer|Completed||Phase 3|86|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:42:46.048779|2017-10-11 04:42:46.048779
NCT00064194|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2016-11-25|||November 2001||2001-11-01|March 2010|2010-03-01|April 2008|Actual|2008-04-01|||||Interventional|||Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia|A Double-Blind, Placebo-Controlled, Randomized Study Of Combination Vitamin E, Selenium And Soy Protein Product In Subjects With High Grade Prostatic Intraepithelial Neoplasia|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:42:46.221227|2017-10-11 04:42:46.221227
NCT00055237|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-21|2017-08-07|2012-06-19||February 26, 2003|Actual|2003-02-26|August 2017|2017-08-01|March 15, 2010|Actual|2010-03-15|March 15, 2010|Actual|2010-03-15||Interventional|||Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients|Phase II Study of Intravenous Recombinant Humanized Anti-Vascular Endothelial Cell Growth Factor Antibody (Bevacizumab) in Classical (HIV-Negative) and in AIDS-Associated Kaposi's Sarcoma|Completed||Phase 2|19|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f|t|f||||||||2017-10-11 04:42:46.335595|2017-10-11 04:42:46.335595
NCT00055250|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-21|2007-01-24|||January 2003||2003-01-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer|A Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of Gemcitabine Plus LY293111 Compared to Gemcitabine Plus Placebo in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|130||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:42:46.903025|2017-10-11 04:42:46.903025
NCT00055263|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-21|2009-07-24|||March 2002||2002-03-01|February 2003|2003-02-01||||||||Interventional|||A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies|A Phase I, Open Label, Dose Escalation Study of a New Formulation of Calcitriol (DN-101) for Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Malignancies|Completed||Phase 1|60||Novacea|||||||||||||||||||2017-10-11 04:42:47.104834|2017-10-11 04:42:47.104834
NCT00055289|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-22|2008-03-03|||February 2003||2003-02-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Brain Use of Sensory Information to Generate Movement|Role of Multimodal Areas for Sensory-To-Motor Processing|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:47.334158|2017-10-11 04:42:47.334158
NCT00055315|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-25|2017-03-15|||July 2002||2002-07-01|March 2017|2017-03-01|April 2011|Actual|2011-04-01|December 2007|Actual|2007-12-01||Interventional|||Treatment for Borderline Personality Disorder|A Cognitive Group Treatment for Borderline Outpatients|Completed||N/A|383|Actual|University of Iowa||2|||f||||f||||||||No|There is no plan to share individual participant data.|2017-10-11 04:42:47.565607|2017-10-11 04:42:47.565607
NCT00055328|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-25|2013-09-06|||December 2002||2002-12-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Treatment for Depression in the Primary Care Setting|Problem-Solving Treatment for Primary Care Depression|Completed||Phase 4|300||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 04:42:47.715608|2017-10-11 04:42:47.715608
NCT00055341|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-25|2008-07-29|||March 2002||2002-03-01|December 2006|2006-12-01|June 2005||2005-06-01|||||Interventional|||Treatment of Hepatitis C in Hemophilic Patients With HIV|A Prospective Multicenter, Phase II, Open Label, Controlled Trial Evaluating the Response of Hepatitis C Virus (HCV) to Pegylated Interferon Alpha-2A and Ribavirin in Hemophilic Patients With and Without Coinfection With the Human Immunodeficiency Virus (HIV)|Completed||Phase 2|22||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:42:47.808876|2017-10-11 04:42:47.808876
NCT00055354|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-26|2006-08-17|||September 2002||2002-09-01|July 2006|2006-07-01|May 2004||2004-05-01|||||Interventional|||Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD)|Acupuncture Diagnosis and Treatment of DSM-IV PTSD|Completed||N/A|90||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:42:47.911685|2017-10-11 04:42:47.911685
NCT00055367|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-26|2016-06-14|||April 2002||2002-04-01|March 2012|2012-03-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease|A Phase II, International, Multicenter, Open Label Study of the Safety, Tolerability and Effectiveness of Three Intravenous Infusions of Antegren (Natalizumab) in Adolescents With Moderately to Severely Active Crohn's Disease|Completed||Phase 2|30||Biogen|||||||||||||||||||2017-10-11 04:42:47.988322|2017-10-11 04:42:47.988322
NCT00055380|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-28|2008-03-03|||February 2003||2003-02-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients|Molecular, Genetic, and Biochemical Effects Of Novel Therapies In Buccal Mucosal Cells|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:48.093416|2017-10-11 04:42:48.093416
NCT00055393|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-28|2017-03-10|||July 2002||2002-07-01|March 2017|2017-03-01|April 2006|Actual|2006-04-01|May 2005|Actual|2005-05-01||Interventional|||Bupropion in the Treatment of Pathological Gambling|Bupropion Versus Placebo in the Treatment of Pathological Gambling|Completed||N/A|80|Actual|University of Iowa||2|||f||||f|f|||||||No|There is no plan to share individual participant data.|2017-10-11 04:42:48.18508|2017-10-11 04:42:48.18508
NCT00055419|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-28|2010-04-08|||February 2003||2003-02-01|April 2010|2010-04-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer|A Phase II Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer|Completed||Phase 2|744|Actual|ImClone LLC||1|||f||||f||||||||||2017-10-11 04:42:48.301014|2017-10-11 04:42:48.301014
NCT00055432|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-03|2006-09-13||||||September 2006|2006-09-01||||||||Interventional|||Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer||Terminated||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:42:48.453864|2017-10-11 04:42:48.453864
NCT00055445|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-03|2006-08-17|||November 2003||2003-11-01|July 2006|2006-07-01|April 2006||2006-04-01|||||Interventional|||IdB 1016 Treatment for Hepatitis C Disease|IdB 1016 in Hepatitis C|Completed||Phase 1/Phase 2|45||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:42:48.520682|2017-10-11 04:42:48.520682
NCT00055471|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-03|2012-10-23|2011-03-29||June 2003||2003-06-01|October 2012|2012-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer||Completed||Phase 2|22|Actual|AstraZeneca|One patient received one dose of 22.5 mg and was dose reduced to 15 mg thereafter. This patient was classified into the 15 mg dose group, except for the single dose pharmacokinetic results (not posted).|3|||f||||||||||||||2017-10-11 04:42:48.631993|2017-10-11 04:42:48.631993
NCT00055484|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-03|2015-12-10|||March 2002||2002-03-01|December 2015|2015-12-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache|A Double-Blind, Randomized, Multicenter, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150 mg and 300 mg Per Day and Placebo in Subjects With Migraine Headache|Completed||Phase 2|204||Elan Pharmaceuticals|||||||||||||||||||2017-10-11 04:42:49.637841|2017-10-11 04:42:49.637841
NCT00055497|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-03|2011-04-07|2009-12-15||August 2002||2002-08-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|January 2005|Actual|2005-01-01||Interventional|CLASSICII||Remission in Subjects With Crohn's Disease, 1 Year Phase|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Maintenance of Clinical Remission in Subjects With Crohn's Disease|Completed||Phase 3|276|Actual|Abbott||4|||f||||f||||||||||2017-10-11 04:42:49.874171|2017-10-11 04:42:49.874171
NCT00055510|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-04|2005-06-23||||||February 2004|2004-02-01||||||||Interventional|||A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.||Completed||Phase 2/Phase 3|||Chugai Pharma USA|||||||||||||||||||2017-10-11 04:42:52.229912|2017-10-11 04:42:52.229912
NCT00055523|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-04|2006-08-11|||April 2002||2002-04-01|August 2006|2006-08-01||||||||Interventional|||A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease|A Phase II Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease|Completed||Phase 2|300||Abbott|||||||||||||||||||2017-10-11 04:42:52.337985|2017-10-11 04:42:52.337985
NCT00055536|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-04|2016-06-14|||April 2002||2002-04-01|March 2012|2012-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease|A Phase II, Multi-Center, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of Intravenous Antegren (Natalizumab) in Crohn's Disease Subjects Concurrently Receiving Remicade (Infliximab) and Not in Remission|Completed||Phase 2|60||Biogen|||||||||||||||||||2017-10-11 04:42:52.477798|2017-10-11 04:42:52.477798
NCT00055549|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-05|2017-06-30|||March 4, 2003||2003-03-04|November 13, 2009|2009-11-13|November 13, 2009|Actual|2009-11-13|November 13, 2009|Actual|2009-11-13||Interventional|||Dextromethorphan to Treat Patients With Voice Spasms|The Effects of an NMDA-Receptor Antagonist in Idiopathic Voice Disorders|Completed||Phase 1|65||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:42:52.729606|2017-10-11 04:42:52.729606
NCT00055562|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-05|2005-06-23|||January 2003||2003-01-01|May 2004|2004-05-01|December 2004||2004-12-01|||||Interventional|||Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma|Multicenter, Randomized, Controlled, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma Whose Disease Has Progressed on Treatment With DTIC, IL-2 or IFN Based Therapy|Completed||Phase 2/Phase 3|274||Celgene|||||||||||||||||||2017-10-11 04:42:52.835054|2017-10-11 04:42:52.835054
NCT00055575|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2017-10-05|||February 27, 2003||2003-02-27|February 2, 2015|2015-02-02|February 2, 2015|Actual|2015-02-02|February 2, 2015|Actual|2015-02-02||Interventional|||Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies|Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies|Terminated||N/A|197|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:42:52.959878|2017-10-11 04:42:52.959878
NCT00055588|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2017-06-30|||March 4, 2003||2003-03-04|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Interventional|||Nervous System Function in Normal Volunteers During Cycling Training|Spinal Substrates of Training-Dependent Improvements in Locomotor Function|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:42:53.049849|2017-10-11 04:42:53.049849
NCT00055601|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2017-05-03|2016-06-30||December 2002||2002-12-01|May 2017|2017-05-01||||October 2010|Actual|2010-10-01||Interventional||All eligible patients who started protocol treatment.|Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer|A Phase II Randomized Trial for Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery and BID Irradiation Plus Either Paclitaxel and Cisplatin or 5-Fluorouracil and Cisplatin Followed by Selective Bladder Preservation and Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy|Active, not recruiting||Phase 2|97|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:42:53.138437|2017-10-11 04:42:53.138437
NCT00055614|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-06-25|||May 2002||2002-05-01|April 2007|2007-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|Phase I Study of Oral Topotecan as Consolidation for Patients With Mullerian Origin Tumors (Ovary, Tube, Peritoneum)|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:53.931251|2017-10-11 04:42:53.931251
NCT00055640|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2010-06-09|||October 2002||2002-10-01|June 2010|2010-06-01|March 2006|Actual|2006-03-01|April 2005|Actual|2005-04-01||Interventional|||Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma|Molecular Risk Guided Treatment Of Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|9|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:42:53.992608|2017-10-11 04:42:53.992608
NCT00055653|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2011-03-03|||January 2003||2003-01-01|March 2011|2011-03-01|September 2005|Actual|2005-09-01|September 2003|Actual|2003-09-01||Interventional|||Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders|Unrelated Umbilical Cord Blood As An Alternate Source Of Stem Cells Transplantation|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:42:54.080087|2017-10-11 04:42:54.080087
NCT00055666|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2011-03-07|||March 2001||2001-03-01|March 2011|2011-03-01|April 2006|Actual|2006-04-01|February 2005|Actual|2005-02-01||Interventional|||Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract|Compassionate Use Of Oral Beclomethasone Dipropionate For Treatment Of Gastrointestinal Graft Versus Host Disease|Completed||N/A|51|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:42:54.221231|2017-10-11 04:42:54.221231
NCT00055679|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-06-17|||August 2002||2002-08-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Interventional|||Combination Chemotherapy in Treating Women With Stage I Breast Cancer|Phase III Randomized Study Of Adjuvant Fluourouracil, Epirubicin And Cyclophosphamide, In Women With Stage I Breast Cancer|Completed||Phase 3|1512|Actual|UNICANCER||2|||f||||t||||||||||2017-10-11 04:42:54.301781|2017-10-11 04:42:54.301781
NCT00055692|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2016-01-29|2015-08-25||February 2003||2003-02-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|January 2008|Actual|2008-01-01||Interventional|||Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer|Bevacizumab (RhuMAB-VEGF) In Hepatocellular Cancer For Patients With Unresectable Tumor (Without Invasion Of The Main Portal Vein Or Metastatic Disease) A Phase II Study|Completed||Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:42:54.539854|2017-10-11 04:42:54.539854
NCT00055705|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2011-04-23|||January 2003||2003-01-01|August 2004|2004-08-01||||||||Interventional|||PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer|A Phase I Clinical Trial To Assess The Safety And Efficacy Of Intraperitoneal PV701 Administrations In Patients With Advanced Or Recurrent Malignancy Largely Confined To The Peritoneal Cavity|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:55.00011|2017-10-11 04:42:55.00011
NCT00055718|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-12-17|||November 2001||2001-11-01|May 2006|2006-05-01|January 2010|Actual|2010-01-01|||||Interventional|||Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy|A Pilot Study of Silymarin During Maintenance Therapy in Children With Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:55.100808|2017-10-11 04:42:55.100808
NCT00055731|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2012-02-23|||November 2002||2002-11-01|April 2008|2008-04-01||||||||Interventional|||Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse|Phase III Randomized Study Of Adjuvant Hormonal Therapy With And Without Docetaxel And Estramustine In Patients With Advanced Prostate Cancer Or With A High Risk Of Relapse|Unknown status|Active, not recruiting|Phase 3|250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:55.200196|2017-10-11 04:42:55.200196
NCT00055757|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-06-03|||October 2003||2003-10-01|June 2013|2013-06-01||||April 2004|Actual|2004-04-01||Interventional|||Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II Trial of R115777, a Farnesyl Transferase Inhibitor, in Combination With Gemcitabine and Cisplatin in Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:55.387685|2017-10-11 04:42:55.387685
NCT00055770|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-11-21|||October 2002||2002-10-01|November 2013|2013-11-01||||December 2006|Actual|2006-12-01||Interventional|||Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer|A Phase I and Phase II Study of OSI-774 in Combination With Docetaxel in Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|45|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:55.48815|2017-10-11 04:42:55.48815
NCT00055783|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-05-14|||July 2002||2002-07-01|April 2003|2003-04-01|April 2003|Actual|2003-04-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma|A Phase II Study of Hu1D10 in Recurrent Hodgkin's Disease|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:55.698667|2017-10-11 04:42:55.698667
NCT00055809|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-01-22|||January 2003||2003-01-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors|Phase II Study Of Bevacizumab And PEG Interferon Alpha-2b (PEG Intron) In Patients With Metastatic, Or Unresectable Carcinoid Tumors|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:42:55.777961|2017-10-11 04:42:55.777961
NCT00055822|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2012-07-03|||October 2002||2002-10-01|July 2012|2012-07-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer|A Phase I/II Study of Oblimersen Sodium (G3139, Genasense) in Combination With Oxaliplatin, 5FU and Leucovorin (FOLFOX4) Regimen in Advanced Colorectal Cancer|Completed||Phase 1/Phase 2|16|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:42:55.891105|2017-10-11 04:42:55.891105
NCT00055835|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-01-30|||November 2002||2002-11-01|January 2013|2013-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium|Phase II Evaluation of Carboplatin, Paclitaxel and Gemcitabine Followed by Concurrent Cisplatin and Radiation Therapy in Patients With Locally Advanced or Recurrent Urothelial Malignancy|Completed||Phase 2|7|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:42:55.989143|2017-10-11 04:42:55.989143
NCT00055848|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2016-07-12|||December 2001||2001-12-01|July 2015|2015-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Genetic Study of Familial Factors in Patients With Colon Cancer|Familial Factors in the Development of Colon Cancer|Completed||N/A|600|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 04:42:56.292204|2017-10-11 04:42:56.292204
NCT00055861|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-06-03|||July 2002||2002-07-01|June 2013|2013-06-01||||August 2006|Actual|2006-08-01||Interventional|||Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer|PHASE 2 STUDY OF BEVACIZUMAB IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH ADVANCED BREAST CANCER|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:42:56.375812|2017-10-11 04:42:56.375812
NCT00055874|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-08-09|||June 2002||2002-06-01|November 2011|2011-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia|Treatment Optimization Trial in Chronic Myeloid Leukemia (CML) - Randomized Controlled Comparison of Imatinib vs. Imatinib/Interferon-alpha vs. Imatinib/Low-Dose AraC vs. Interferon-alpha Standard Therapy and Determination of the Role of Allografting in Newly Diagnosed Chronic Phase|Unknown status|Recruiting|Phase 3|1600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:56.482573|2017-10-11 04:42:56.482573
NCT00055887|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-05-08|||November 2002||2002-11-01|May 2013|2013-05-01||||||||Interventional|||Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Phase III Randomized, Open-Label Comparative Study of Induction Chemotherapy Followed by Thoracic Radiation Therapy With Supplemental Oxygen, With or Without Concurrent RSR13 (Efaproxiral), in Patients With Locally Advanced Unresectable (Stage IIIA/IIIB) Non-Small Cell Lung Cancer|Withdrawn||Phase 3|0|Actual|Spectrum Pharmaceuticals, Inc||||Study never started. No patients were enrolled.|f||||||||||||||2017-10-11 04:42:56.797596|2017-10-11 04:42:56.797596
NCT00055913|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2014-02-11|||March 2003||2003-03-01|December 2012|2012-12-01||||September 2007|Actual|2007-09-01||Interventional|||Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase I/II Study Of Bevacizumab (rhuMAb VEGF) In Combination With OSI-774 For Patients With Recurrent Or Metastatic Cancer Of The Head And Neck|Completed||Phase 1/Phase 2|58|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:42:56.940448|2017-10-11 04:42:56.940448
NCT00055926|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2015-10-28|||January 2003||2003-01-01|August 2012|2012-08-01|May 2005|Actual|2005-05-01|December 2004|Actual|2004-12-01||Interventional|||CP-724,714 in Treating Patients With Metastatic Breast Cancer|A Phase I Safety and Pharmacokinetic/Pharmacodynamic Study of CP-724, 714 In Patients With Metastatic HER2-Overexpressing Breast Cancer|Completed||Phase 1|9|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:42:57.144037|2017-10-11 04:42:57.144037
NCT00055939|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2012-05-15|||January 2003||2003-01-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma|A Phase II Study Of Intravenous DX-8951f (EXATECAN MESYLATE) Administered Daily For Five Days Every Three Weeks To Pediatric Patients With Relapsed Or Refractory Rhabdomyosarcoma|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:42:57.244681|2017-10-11 04:42:57.244681
NCT00055952|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2012-05-15|||January 2003||2003-01-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor|A Phase II Study Of Intravenous DX-8951f (EXATECAN MESYLATE) Administered Daily For Five Days Every Three Weeks To Pediatric And Young Adult Patients With Ewing's Sarcoma (ES), Primitive Neuroectodermal Tumor (PNET), Or Desmoplastic Small Round Cell Tumor (DSRCT)|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:42:57.345645|2017-10-11 04:42:57.345645
NCT00055965|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-09-19|||November 2002||2002-11-01|January 2009|2009-01-01||||August 2006|Actual|2006-08-01||Interventional|||Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin|A Pragmatic, Randomised Study To Compare The Hospitalisation Rates Of Two Platinum-Based Outpatient Regimens (Gemcitabine/Cisplatin vs. Gemcitabine/Carboplatin) In Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:57.451006|2017-10-11 04:42:57.451006
NCT00055991|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-02-04|||September 2001||2001-09-01|February 2013|2013-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Bexarotene in Preventing Breast Cancer in Women at Genetic Risk|A Multicenter Randomized Double-Blind Trial Of Targretin Capsules Modifying Immunophenotypic Markers Related To Breast Cancer Progression In Breast Tissue From Genetically Identified High Risk Patients|Completed||Phase 1|87|Actual|Baylor Breast Care Center||2|||f||||t||||||||||2017-10-11 04:42:57.655033|2017-10-11 04:42:57.655033
NCT00056004|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-04-25|||June 2003||2003-06-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|September 2006|Actual|2006-09-01||Interventional|||Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia|Phase II Trial Of Zileuton In Persons With Bronchial Dysplasia|Completed||Phase 2|38|Actual|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:42:57.76868|2017-10-11 04:42:57.76868
NCT00056030|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2017-01-20|||December 2004|Actual|2004-12-01|January 2017|2017-01-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer|A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum|Completed||Phase 2|73|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:42:57.869028|2017-10-11 04:42:57.869028
NCT00056056|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2012-06-19|||January 2003||2003-01-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides|A Randomized, Open-Label Phase III Trial to Evaluate the Efficacy and Safety of Bexarotene (Targretin) Capsules Combined With PUVA, Compared to PUVA Treatment Alone in Patients With Mycosis Fungoides|Terminated||Phase 3|93|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2||poor accrual|f||||t||||||||||2017-10-11 04:42:58.386373|2017-10-11 04:42:58.386373
NCT00056069|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2015-05-06|||December 2002||2002-12-01|May 2015|2015-05-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia|Differences in Parental Caregiving Demands in Childhood Acute Lymphoblastic Leukemia by Length of Infusion Therapy|Completed||N/A|172|Actual|Children's Oncology Group||1|||f||||f||||||||||2017-10-11 04:42:58.643566|2017-10-11 04:42:58.643566
NCT00056082|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2017-02-13|||January 2003||2003-01-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2008|Actual|2008-07-01||Interventional|||Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women|A Study to Identify Biomarker Modulation by a Cyclooxygenase-2 (COX-2) Inhibitor in Breast Tissue of Premenopausal Women at High Risk for Estrogen Receptor Negative (ERN) Breast Cancer|Completed||Phase 2|110|Actual|University of Kansas Medical Center||1|||f||||f||||||||No|Global results will be published|2017-10-11 04:42:59.032854|2017-10-11 04:42:59.032854
NCT00056095|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2009-02-06|||December 2002||2002-12-01|December 2006|2006-12-01||||||||Interventional|||Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer|Phase II Trial in Intrafamilial Allogeneic Cell Transplant in Patients With Metastatic Kidney Cancer|Unknown status|Recruiting|Phase 2|170|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:42:59.124434|2017-10-11 04:42:59.124434
NCT00056134|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2013-09-16|||October 2002||2002-10-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|Vaccination of HLA-A1 and/or -A2+ Stage III or IV Melanoma Patients With Tumor Peptide-Loaded Autologous Dendritic Cells With Prior Depletion of CD25-Positive Cells Using Denileukin Difitox (ONTAK)|Completed||Phase 1/Phase 2|23|Actual|University Hospital Erlangen||1|||f||||f||||||||||2017-10-11 04:42:59.33064|2017-10-11 04:42:59.33064
NCT00056147|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2015-01-28|||April 2003||2003-04-01|January 2015|2015-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease|Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of INS37217 Inhalation Solution in Subjects With Mild to Moderate Cystic Fibrosis Lung Disease|Completed||Phase 2|90|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:42:59.418387|2017-10-11 04:42:59.418387
NCT00056160|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2017-01-17|2009-12-24||January 2003||2003-01-01|January 2017|2017-01-01|October 2008|Actual|2008-10-01|November 2005|Actual|2005-11-01||Interventional|||CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma|A Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma|Completed||Phase 3|353|Actual|Celgene|Analyses for efficacy had data cutoff dates of 07 Jun 2005 and a data cutoff date of 23 Jul 2008 for overall survival. Only safety data were collected for 6 subjects ongoing beyond the 23 Jul 2008 data cutoff date.|2|||f||||t||||||||||2017-10-11 04:42:59.556388|2017-10-11 04:42:59.556388
NCT00056173|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-06|2008-01-04|||March 2002||2002-03-01|January 2008|2008-01-01||||December 2004|Actual|2004-12-01||Interventional|||Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma|A Phase I/II Study of GTI-2040 and Capecitabine Combination Therapy in Patients With Advanced or Metastatic Renal Cell Carcinoma (mRCC)|Completed||Phase 1/Phase 2|43|Anticipated|Aptose Biosciences Inc.|||||||||||||||||||2017-10-11 04:43:01.226306|2017-10-11 04:43:01.226306
NCT00056186|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-07|2008-03-03|||March 2003||2003-03-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Observational|||Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling|Exploration of Transitional Life Events in Individuals With Friedreich's Ataxia: Implications for Genetic Counseling|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:01.317089|2017-10-11 04:43:01.317089
NCT00056199|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-07|2008-03-03|||March 2003||2003-03-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome|Pilot Study of Intravitreal Injection of EYE001 (Anti-VEGF Pegylated Aptamer) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:01.385993|2017-10-11 04:43:01.385993
NCT00056225|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-07|2009-06-10|||January 2003||2003-01-01|June 2009|2009-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)|High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)|Completed||Phase 3|340|Actual|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:43:01.523513|2017-10-11 04:43:01.523513
NCT00056238|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-07|2005-06-23|||February 2003||2003-02-01|March 2003|2003-03-01||||||||Interventional|||Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy|A Phase II Pilot Study of the Safety, Tolerability and Pharmacokinetics of Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy|Completed||Phase 2|30||Bellus Health Inc|||||||||||||||||||2017-10-11 04:43:01.686331|2017-10-11 04:43:01.686331
NCT00056251|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-07|2005-06-23|||January 2003||2003-01-01|January 2004|2004-01-01|August 2003||2003-08-01|||||Interventional|||Interstitial Cystitis|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of RTX Topical Solution in Patients With Interstitial Cystitis|Completed||Phase 2|150||ICOS Corporation|||||||||||||||||||2017-10-11 04:43:01.790998|2017-10-11 04:43:01.790998
NCT00056264|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-07|2011-05-16|||December 2002||2002-12-01|April 2010|2010-04-01|December 2004|Actual|2004-12-01|||||Interventional|||A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group, Dose Finding Study Evaluating the Safety and Efficacy of Infliximab Administration in Symptomatic Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|234|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 04:43:01.887744|2017-10-11 04:43:01.887744
NCT00056277|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-10|2017-04-06|||February 27, 2003||2003-02-27|April 2017|2017-04-01|December 14, 2005|Actual|2005-12-14|August 1, 2005|Actual|2005-08-01||Interventional|||Bipolar Disorder Study for Men and Women|Double Blind Placebo Controlled Study of Lamictal in Acute Bipolar Depression|Completed||Phase 3|150|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:43:01.955247|2017-10-11 04:43:01.955247
NCT00056290|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-10|2010-11-10|||December 2002||2002-12-01|November 2010|2010-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||VEGF Gene Transfer for Diabetic Neuropathy|p.VGI.1 (VEGF2) Gene Transfer for Diabetic Neuropathy|Completed||Phase 1/Phase 2|60|Anticipated|Losordo, Douglas, M.D.||2|||t||||t||||||||||2017-10-11 04:43:02.062668|2017-10-11 04:43:02.062668
NCT00056303|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-10|2016-12-19|||December 2002||2002-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mental Health Services for Foster and Adopted Children|Specialized Mental Health Services for Foster Infants|Completed||Phase 1|220|Actual|University of Delaware||2|||f||||t||||||||No||2017-10-11 04:43:03.74439|2017-10-11 04:43:03.74439
NCT00056316|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-10|2014-06-04|2008-10-23||January 2002||2002-01-01|June 2014|2014-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Reducing Depression in Dementia Caregivers|Reducing Depression in Dementia Caregivers|Completed||Phase 1/Phase 2|74|Actual|University of Missouri, St. Louis||2|||f||||t||||||||||2017-10-11 04:43:03.919591|2017-10-11 04:43:03.919591
NCT00056329|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-10|2012-05-02|||April 2002||2002-04-01|May 2012|2012-05-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Vitamin E in Aging Persons With Down Syndrome|Multicenter Vitamin E Trial in Aging Persons With Down Syndrome|Unknown status|Active, not recruiting|Phase 3|350|Actual|New York State Institute for Basic Research||2|||f||||t||||||||||2017-10-11 04:43:04.289746|2017-10-11 04:43:04.289746
NCT00056355|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-10|2008-03-03|||March 2003||2003-03-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease|A Single Arm Study of Extracorporeal Photoimmune Therapy With Uvadex For Corticosteroid Sparing in Patients With Corticosteroid-Dependent Crohn's Disease Who May Also Be Refractory or Intolerant to Immunosuppressants and/or Anti-Tumor Necrosis Factor Agen|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:04.419443|2017-10-11 04:43:04.419443
NCT00056368|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-11|2008-10-17|||March 2003||2003-03-01|October 2008|2008-10-01|October 2004|Actual|2004-10-01|||||Interventional|||The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis|A Phase III, Double-Blind, Randomized, Multi-Center, Study of the Safety and Efficacy of Anidulafungin vs. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis and Prevention of Complications.|Completed||Phase 3|256|Actual|Pfizer|||||||||||||||||||2017-10-11 04:43:04.491308|2017-10-11 04:43:04.491308
NCT00056381|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-11|2008-10-17|||July 2003||2003-07-01|October 2008|2008-10-01|June 2004|Actual|2004-06-01|||||Interventional|||Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17|Phase I/II Study of the Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children With Fever and Neutropenia|Completed||Phase 1/Phase 2|25|Actual|Pfizer|||||||||||||||||||2017-10-11 04:43:04.57001|2017-10-11 04:43:04.57001
NCT00056394|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-11|2014-07-11|||February 2003||2003-02-01|November 2013|2013-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Coping Skills Training for Early Rheumatoid Arthritis|Coping Skills Training for Early Rheumatoid Arthritis|Completed||N/A|105|Actual|Duke University||3|||f||||t||||||||||2017-10-11 04:43:04.64182|2017-10-11 04:43:04.64182
NCT00056407|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-11|2016-08-17|2010-02-01||March 2003||2003-03-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|REDUCE||"REDUCE - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk"|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer|Completed||Phase 3|8231|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:43:05.314584|2017-10-11 04:43:05.314584
NCT00056420|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-12|2017-06-30|||March 10, 2003||2003-03-10|January 22, 2009|2009-01-22|January 22, 2009||2009-01-22|||||Observational|||Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement|Spatiotemporal Dynamics of Cortical Connectivity Involved in Tics and Voluntary Movements in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder: An EEG Study|Completed||N/A|54||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:11.601892|2017-10-11 04:43:11.601892
NCT00056433|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-12|2017-10-05|||March 10, 2003||2003-03-10|December 7, 2015|2015-12-07|December 27, 2006|Actual|2006-12-27|December 27, 2006|Actual|2006-12-27||Interventional|||Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia|Evaluation of Potential Synergy of Combining Hydroxyurea With Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients With Sickle Cell Anemia|Completed||Phase 1|39|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:43:11.659061|2017-10-11 04:43:11.659061
NCT00056446|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-13|2017-03-02|||January 2003||2003-01-01|January 2016|2016-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer|A Randomized, Double-blind, Placebo-controlled, Phase III Study of Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo in Patients With Previously Treated Metastatic Adenocarcinoma of the Colon or Rectum|Completed||Phase 3|855|Actual|Novartis||2|||f||||f||||||||||2017-10-11 04:43:11.769305|2017-10-11 04:43:11.769305
NCT00056459|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-13|2009-11-18|||February 2003||2003-02-01|November 2009|2009-11-01||||January 2007|Actual|2007-01-01||Interventional|||Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.|A Randomized, Double-blind, Placebo-controlled, Phase Lll Study in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Who Are Receiving First-line Chemotherapy With Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo|Completed||Phase 3|1168|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:43:12.479836|2017-10-11 04:43:12.479836
NCT00056472|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-14|2013-06-26|2009-06-16||January 2003||2003-01-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|STOP-PD||Study of Pharmacotherapy of Psychotic Depression|Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression|Completed||Phase 3|259|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 04:43:13.451837|2017-10-11 04:43:13.451837
NCT00056485|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-14|2017-04-11|||April 2002||2002-04-01|April 2017|2017-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Treatment of Depression in Nursing Homes|Behavioral Intervention for Depression in Nursing Homes|Completed||N/A|25|Actual|University of Louisville||2|||f||||f|f|f||||||No||2017-10-11 04:43:13.99645|2017-10-11 04:43:13.99645
NCT00056498|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-14|2017-03-31|2009-03-23||December 2001||2001-12-01|March 2017|2017-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine|Clozapine Treatment of Schizophrenic Patients|Completed||Phase 4|65|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 04:43:14.085277|2017-10-11 04:43:14.085277
NCT00056511|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-14|2006-08-16|||May 2002||2002-05-01|August 2006|2006-08-01|April 2005||2005-04-01|||||Interventional|||Comparing Effects of 3 Sources of Garlic on Cholesterol Levels|Comparing Effects of 3 Sources of Garlic on Serum Lipids|Completed||Phase 2/Phase 3|220||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:43:14.370839|2017-10-11 04:43:14.370839
NCT00056524|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-15|2016-07-13|||February 2003||2003-02-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)|An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.|Completed||Phase 3|600|Anticipated|Avanir Pharmaceuticals|||||||||||||||||||2017-10-11 04:43:14.459338|2017-10-11 04:43:14.459338
NCT00056537|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-16|2014-08-26|||April 2003||2003-04-01|August 2014|2014-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer|An Open-Label, Phase I, Repeat Dose-Escalation Study of ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer|Completed||Phase 1|44|Actual|Active Biotech AB||1|||f||||f||||||||||2017-10-11 04:43:14.611728|2017-10-11 04:43:14.611728
NCT00056550|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-17|2012-09-17|2012-03-19||December 2002||2002-12-01|August 2012|2012-08-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|rhAT||Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.|A Study to Assess the Incidence of Deep Vein Thrombosis (DVT) Following Prophylactic Intravenous Administration of Recombinant Human Antithrombin(rhAT) to Hereditary Antithrombin (AT) Deficient Patients in High Risk Situations.|Completed||Phase 3|14|Actual|rEVO Biologics||1|||f||||f||||||||||2017-10-11 04:43:14.70806|2017-10-11 04:43:14.70806
NCT00056563|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-18|2014-04-24|2013-05-20||April 2002||2002-04-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial|CSP #468 Phase I - A Comparison of Best Medical Therapy and Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus for the Treatment of Parkinson's Disease|Completed||Phase 3|255|Actual|VA Office of Research and Development|A limitation of this study is that the STN and GPi cases are pooled into a single DBS group. When the study was planned, it was thought that differences between STN and GPi at six months would be small, which was tested during the study analysis.|2|||f||||t||||||||||2017-10-11 04:43:15.241781|2017-10-11 04:43:15.241781
NCT00056576|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-18|2011-07-14|||February 2002||2002-02-01|July 2011|2011-07-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy|A Double-Blind, Randomized, Multicenter, Parallel Group Study to Establish Dose-Response, Safety, and Efficacy of Zonegran (Zonisamide) as Monotherapy in Patients With Newly Diagnosed Epilepsy|Completed||Phase 3|165||Eisai Inc.|||||||||||||||||||2017-10-11 04:43:15.786416|2017-10-11 04:43:15.786416
NCT00056589|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-18|2017-01-10|||March 2003||2003-03-01|January 2017|2017-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency|A Phase 1 Escalating Dose Study of the Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor XIII Deficiency|Completed||Phase 1|11|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-10-11 04:43:15.996633|2017-10-11 04:43:15.996633
NCT00056602|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-19|2017-10-05|||March 17, 2003||2003-03-17|February 21, 2017|2017-02-21||||||||Observational|||Clinically Important Changes in Rheumatoid Arthritis|Clinically Important Changes in Rheumatoid Arthritis|Completed||N/A|192|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:16.081842|2017-10-11 04:43:16.081842
NCT00056628|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-19|2006-09-11|||January 2001||2001-01-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||COGNIShunt® System for Alzheimer's Disease|Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System|Completed||Phase 3|250||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:43:16.163074|2017-10-11 04:43:16.163074
NCT00056641|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-19|2013-11-13|||January 2003||2003-01-01|November 2013|2013-11-01||||January 2004|Actual|2004-01-01||Interventional|||Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients|An Open Label, Randomized, Parallel-group Pharmacokinetics Trial of Tipranavir / Ritonavir (TPV/RTV), Alone or in Combination With RTV-boosted Saquinavir (SQV), Amprenavir (APV), or Lopinavir (LPV), Plus an Optimized Background Regimen, in Multiple Antiretroviral (ARV) Experienced Patients.|Completed||Phase 2|328||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 04:43:16.239805|2017-10-11 04:43:16.239805
NCT00056654|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-20|2008-09-16|||March 2003||2003-03-01|September 2008|2008-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer|Pharmacokinetic, Safety and Efficacy Study of a Six-Month Depot Formulation of Leuprolide in Subjects With Prostatic Carcinoma|Completed||N/A|164|Actual|Abbott||1|||f||||f||||||||||2017-10-11 04:43:16.536062|2017-10-11 04:43:16.536062
NCT00056667|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-20|2014-01-15|||July 2001||2001-07-01|January 2014|2014-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Relaxation Response Training for the Treatment of Rheumatoid Arthritis|Relaxation Response, Somatic Style and Rheumatoid Arthritis|Completed||Phase 4|168|Actual|Brigham and Women's Hospital||3|||f||||f||||||||||2017-10-11 04:43:16.73969|2017-10-11 04:43:16.73969
NCT00056680|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-20|2007-06-19|||July 2001||2001-07-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Three-Part Program for Parents With Premature Infants|Adult Attachment and Intervention Efficacy With Preterms|Completed||N/A|173|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-10-11 04:43:16.833179|2017-10-11 04:43:16.833179
NCT00056693|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-20|2008-07-18|||April 2003||2003-04-01|July 2008|2008-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment With SU11248 in Patients With Neuroendocrine Tumors|A Phase II Study Of The Efficacy And Safety Of SU011248 In Patients With Advanced Unresectable Neuroendocrine Tumor|Completed||Phase 2|107|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 04:43:16.921069|2017-10-11 04:43:16.921069
NCT00056706|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-21|2008-03-03|||March 2003||2003-03-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Ischemic Nerve Block to Improve Hand Function in Stroke Patients|Improved Function in the Paretic Hand of Chronic Stroke Patients by Transient Deafferentation of the Intact Upper Extremity|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:17.058425|2017-10-11 04:43:17.058425
NCT00056719|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-21|2017-10-05|||March 17, 2003||2003-03-17|April 26, 2017|2017-04-26||||||||Observational|||Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study|Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study|Recruiting||N/A|999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:17.150528|2017-10-11 04:43:17.150528
NCT00056745|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-21|2007-09-17||||||July 2007|2007-07-01||||||||Interventional|||Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines|The Role of Immunization Site in Eliciting Mucosal Immunity|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:43:17.240872|2017-10-11 04:43:17.240872
NCT00056758|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-21|2007-08-23|||February 2003||2003-02-01|August 2007|2007-08-01||||||||Interventional|||HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs|Randomized Phase I Evaluation of Immunization With Highly Conserved HIV-1 Derived Peptides and Influenza Matrix Peptide in HIV-1-Infected Subjects on Highly Active Antiretroviral Therapy (HAART) Using Autologous Dendritic Cells Derived From Adherent Monocytic Precursors|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:43:17.344494|2017-10-11 04:43:17.344494
NCT00056771|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-22|2017-10-05|||March 18, 2003||2003-03-18|May 25, 2016|2016-05-25|May 25, 2016||2016-05-25|||||Observational|||Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts|Clinical and Molecular Studies in Families With Congenital or Hereditary Cataracts|Completed||N/A|873|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:17.430771|2017-10-11 04:43:17.430771
NCT00056784|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-22|2017-10-05|||March 20, 2003||2003-03-20|June 17, 2014|2014-06-17|June 17, 2014||2014-06-17|||||Observational|||The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation|The Pathogenesis of Chronic Graft Failure After Kidney Transplantation|Completed||N/A|134|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:17.948539|2017-10-11 04:43:17.948539
NCT00056797|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-24|2016-12-13|||March 2002||2002-03-01|July 2007|2007-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV|A Randomized Controlled Study Testing the Efficacy of Immunotherapies to Control Plasma HIV RNA Concentrations Upon Interruption of Highly Active Antiretroviral Therapy (HAART).|Completed||Phase 2|92||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:43:18.03384|2017-10-11 04:43:18.03384
NCT00056810|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-24|2015-03-24|||September 2002||2002-09-01|May 2006|2006-05-01|May 2005||2005-05-01|||||Interventional|||Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine|Assessment of Chronic GBS Improvement With Use of 4-AP|Completed||Phase 2|30||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:43:18.297442|2017-10-11 04:43:18.297442
NCT00056823|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-24|2013-06-19|||March 2003||2003-03-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|||||Interventional|||Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)|A Phase I/II, Single-Masked, Multicenter Study of the Safety, Tolerability, and Efficacy of Multiple-Dose Intravitreal Injections of rhuFab V2 in Combination With Verteporfin (Visudyne(R)) Photodynamic Therapy in Subjects With Neovascular Age Related Macular Degeneration|Completed||Phase 1/Phase 2|168||Genentech, Inc.|||||||||||||||||||2017-10-11 04:43:18.40627|2017-10-11 04:43:18.40627
NCT00057044|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06|||October 2001||2001-10-01|February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||From Research to Practice - Lipid Management for Low HDL-Cholesterol|From Research to Practice - Lipid Management for Low HDL-Cholesterol|Completed||N/A|11700|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:20.387273|2017-10-11 04:43:20.387273
NCT00056836|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-24|2014-05-14|||March 2003||2003-03-01|May 2014|2014-05-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration|A Phase III, Multicenter, Randomized, Double Masked, Sham Injection-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) in Subjects With Minimally Classic or Occult Subfoveal Neovascular Age-Related Macular Degeneration|Completed||Phase 3|720||Genentech, Inc.|||||||||||||||||||2017-10-11 04:43:18.46216|2017-10-11 04:43:18.46216
NCT00056849|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-25|2017-10-05|||March 20, 2003||2003-03-20|February 21, 2017|2017-02-21||||||||Observational|||Genetic Determinants of Ankylosing Spondylitis Severity|Genetic Determinants of Ankylosing Spondylitis Severity - Cross Sectional Study|Completed||N/A|134|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:18.543329|2017-10-11 04:43:18.543329
NCT00056862|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-25|2013-11-13|2010-11-12||March 2003||2003-03-01|November 2013|2013-11-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3|Low Dose Peginterferon and Ribavirin Therapy for Patients With Chronic Hepatitis C Infected With Genotype 2 or 3|Completed||Phase 4|58|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:43:18.656513|2017-10-11 04:43:18.656513
NCT00056875|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-25|2015-03-24|||September 2002||2002-09-01|February 2006|2006-02-01|June 2005||2005-06-01|||||Interventional|||Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants|Safety and Efficacy of Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants|Completed||Phase 1/Phase 2|50||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:43:19.189071|2017-10-11 04:43:19.189071
NCT00056888|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2017-06-30|||March 21, 2003||2003-03-21|February 17, 2009|2009-02-17|February 17, 2009||2009-02-17|||||Observational|||Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders|Neurophysiological Studies in Patients With Psychogenic Movement Disorders|Completed||N/A|115||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:19.247399|2017-10-11 04:43:19.247399
NCT00056901|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2017-10-05|||March 21, 2003||2003-03-21|November 4, 2016|2016-11-04||||||||Observational|||Screening Evaluation for Women With Postpartum Depression|A Screening Protocol to Evaluate Women With Postpartum-Related Mood and Behavioral Disorders|Recruiting||N/A|650|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:19.307829|2017-10-11 04:43:19.307829
NCT00056914|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2017-06-30|||March 21, 2003||2003-03-21|January 5, 2010|2010-01-05|January 5, 2010||2010-01-05|||||Observational|||Development of Techniques for Use in MRI With a Magnetic Field of 7 Tesla|Development of 7 Tesla MRI Methodology for Anatomical Functional and Spectroscopic Imaging of the Brain|Completed||N/A|102|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:19.498389|2017-10-11 04:43:19.498389
NCT00056927|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2006-09-29|||September 1997||1997-09-01|July 2005|2005-07-01|August 2002||2002-08-01|||||Interventional|||Anti-Smoking Program for Parents: Effects on Child Smoking|Preventing Initiation of Smoking by Children|Completed||N/A|1007||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:19.569871|2017-10-11 04:43:19.569871
NCT00056940|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2007-04-23|||September 2001||2001-09-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Interventional|||Prevention of Violent Behavior Among Children|Randomized Controlled Trial to Prevent Child Violence|Completed||N/A|6600||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||t||||||||||2017-10-11 04:43:19.643208|2017-10-11 04:43:19.643208
NCT00056953|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2005-07-27|||September 1999||1999-09-01|July 2005|2005-07-01|November 2004||2004-11-01|||||Interventional|||Peer Mentors for Adolescents in HIV Affected Families|Peer Mentors for Early Adolescents in HIV-Affected Families|Completed||Phase 2|160||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:19.713393|2017-10-11 04:43:19.713393
NCT00056966|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2012-06-27|||November 2002||2002-11-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|May 2005|Actual|2005-05-01||Interventional|||Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases|Phase I/II Study of CD45 Antibodies and Alemtuzumab Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases|Completed||Phase 1/Phase 2|24|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 04:43:19.784219|2017-10-11 04:43:19.784219
NCT00056979|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2015-09-21|||June 2002||2002-06-01|September 2015|2015-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases|Anti-CD45 (YTH-24 & YTH 54) and ANTI-CD52 (CAMPATH-1H) Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases|Terminated||Phase 1/Phase 2|2|Actual|Baylor College of Medicine||1|||f||||||||||||||2017-10-11 04:43:19.899893|2017-10-11 04:43:19.899893
NCT00056992|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2015-03-24|||September 2002||2002-09-01|September 2002|2002-09-01|October 2003||2003-10-01|||||Interventional|||Testing of ADI-PEG in Hepatocellular Carcinoma|Phase II Testing of ADI-PEG in Hepatocellular Carcinoma|Completed||Phase 2|34||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:43:19.99733|2017-10-11 04:43:19.99733
NCT00057005|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2010-01-19|||February 2003||2003-02-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|ADVL||Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation|Phase I Study of Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation (ADVL)|Completed||Phase 1|24|Anticipated|Baylor College of Medicine||1|||t||||t||||||||||2017-10-11 04:43:20.069444|2017-10-11 04:43:20.069444
NCT00057018|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2016-09-23|||April 2000||2000-04-01|May 2011|2011-05-01|January 2006||2006-01-01|March 2005|Actual|2005-03-01||Interventional|||Improving Arm Mobility and Use After Stroke|The Extremity Constraint Induced Therapy Evaluation (EXCITE) Trial|Completed||Phase 3|229||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:20.186881|2017-10-11 04:43:20.186881
NCT00057031|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-26|2006-10-31|||November 2002||2002-11-01|February 2005|2005-02-01|March 2004||2004-03-01|||||Interventional|||Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)|A Phase 2, Multicenter, Open Label Study of the Safety and Efficacy of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome|Unknown status|Active, not recruiting|Phase 2|46||Novacea|||||||||||||||||||2017-10-11 04:43:20.280508|2017-10-11 04:43:20.280508
NCT00057057|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|March 2005|Actual|2005-03-01|||||Interventional|||Telephone Intervention in Heart Failure Patients|Randomized Trial of a Telephone Intervention in Heart Failure Patients|Completed||N/A|438|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:20.469258|2017-10-11 04:43:20.469258
NCT00057070|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06|||October 2001||2001-10-01|February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET|Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET|Completed||N/A|1900|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:20.545528|2017-10-11 04:43:20.545528
NCT00057083|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06|||March 2003||2003-03-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Telemedicine on Physician-Patient Communication|Effect of Telemedicine on Physician-Patient Communication|Completed||N/A|221|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:20.636288|2017-10-11 04:43:20.636288
NCT00057096|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|March 2004|Actual|2004-03-01|||||Interventional|||Onsite Versus Referral Models of Primary Care for Substance Abusing Patients|Onsite Versus Referral Models of Primary Care for Substance Abusing Patients|Completed||N/A|800|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:20.72272|2017-10-11 04:43:20.72272
NCT00057109|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06||||||December 2005|2005-12-01|June 2005|Actual|2005-06-01|||||Observational|||Health Values and Spirituality in Veterans With HIV/AIDS|Health Values and Spirituality in Veterans With HIV/AIDS|Completed||N/A|100|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 04:43:20.812261|2017-10-11 04:43:20.812261
NCT00057122|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2012-10-19|||September 2002||2002-09-01|October 2012|2012-10-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Tuberculosis Prevention for HIV Infected Adults|Novel TB Prevention Regimens for HIV-Infected Adults|Completed||Phase 3|1148|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 04:43:20.889829|2017-10-11 04:43:20.889829
NCT00057135|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06|||November 2002||2002-11-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Improving Antipsychotic Adherence Among Patients With Serious Mental Illness|Improving Antipsychotic Adherence Among Patients With Schizophrenia|Completed||N/A|150|Anticipated|VA Office of Research and Development||1|||f||||t||||||||||2017-10-11 04:43:20.995329|2017-10-11 04:43:20.995329
NCT00057148|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06|||February 2003||2003-02-01|March 2006|2006-03-01|June 2005|Actual|2005-06-01|||||Interventional|||Massage After Surgery To Help Treat Post-Operative Pain|Acute Post-Operative Pain Management Using Massage As Adjuvant Therapy|Completed||N/A|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:21.115129|2017-10-11 04:43:21.115129
NCT00057161|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|June 2004|Actual|2004-06-01|||||Interventional|||Homelessness Prevention: Psychiatric Care With Representative Payeeship|Homelessness Prevention: Psychiatric Care With Representative Payeeship|Completed||N/A|240|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:21.193779|2017-10-11 04:43:21.193779
NCT00057174|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|June 2004|Actual|2004-06-01|||||Interventional|||Economic Impact of Guidelines for Gastroesophageal Reflux Disease|Economic Impact of Guidelines for Gastroesophageal Reflux Disease|Completed||N/A|484|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:21.26782|2017-10-11 04:43:21.26782
NCT00057187|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|January 2005|Actual|2005-01-01|||||Interventional|||Improving Substance Abuse Treatment Aftercare Adherence and Outcome|Improving Substance Abuse Treatment Aftercare Adherence and Outcome|Completed||N/A|157|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:21.36013|2017-10-11 04:43:21.36013
NCT00057200|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|January 2005|Actual|2005-01-01|||||Interventional|||Evaluating Telehealth Home Care for Elderly Veterans With Congestive Heart Failure|Evaluating Telehealth Home Care for Elderly Veterans With Congestive Heart Failure|Completed||N/A|198|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 04:43:21.433535|2017-10-11 04:43:21.433535
NCT00057226|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2015-04-15|||March 2003||2003-03-01|April 2015|2015-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose Study Evaluating Efficacy, Safety, and Tolerability of Once-Daily Oral GW353162 (40-60mg) Versus Placebo in Subjects With Major Depressive Disorder Over an Eight-Week Treatment Period.|Completed||Phase 2|365|Actual|GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:43:21.594077|2017-10-11 04:43:21.594077
NCT00057239|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-27|2010-10-01|||March 2003||2003-03-01|October 2010|2010-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Evaluating the Efficacy, Safety and Tolerability of Two Doses (20mg and 60mg) of a Once-Daily Oral Formulation of GW353162 in Subjects With Major Depressive Disorder for a Treatment Period of Eight Weeks|Completed||Phase 2|546||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:43:21.713441|2017-10-11 04:43:21.713441
NCT00057252|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-13|2017-10-05|||March 7, 2003||2003-03-07|March 8, 2017|2017-03-08||||||||Observational|||Development of Computer-aided Detection and Diagnosis From Imaging Techniques|Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Radiologic Images|Completed||N/A|116862|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:21.870049|2017-10-11 04:43:21.870049
NCT00057265|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-28|2015-03-19|||February 2003||2003-02-01|March 2015|2015-03-01||||April 2006|Actual|2006-04-01||Interventional|||A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B|A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B|Completed||Phase 3|||Novartis|||||||||||||||||||2017-10-11 04:43:21.956964|2017-10-11 04:43:21.956964
NCT00057278|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-28|2007-12-14|||March 2003||2003-03-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Gabapentin in Fibromyalgia Trial (GIFT)|Gabapentin in Fibromyalgia Trial (GIFT)|Completed||Phase 2/Phase 3|150||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-10-11 04:43:22.342262|2017-10-11 04:43:22.342262
NCT00057291|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-31|2014-10-28|||April 2000||2000-04-01|December 2004|2004-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Effect of Improving Caregiving on Early Mental Health|Effect of Improving Caregiving on Early Mental Health|Completed||N/A|1521|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-10-11 04:43:22.445757|2017-10-11 04:43:22.445757
NCT00057304|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-31|2017-02-28|||April 22, 2003|Actual|2003-04-22|February 2017|2017-02-01|March 18, 2004|Actual|2004-03-18|March 18, 2004|Actual|2004-03-18||Interventional|||Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus|A Phase II Randomized, Double-Blind, Dose-Ranging Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|||Hoffmann-La Roche|||||||||||||||||||2017-10-11 04:43:22.557799|2017-10-11 04:43:22.557799
NCT00057317|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-31|2016-08-23|||December 2001||2001-12-01|August 2016|2016-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus|A Phase II, Randomized, Double-blind, Placebo-controlled Dose-ranging Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|||Hoffmann-La Roche|||||||||||||||||||2017-10-11 04:43:22.786823|2017-10-11 04:43:22.786823
NCT00057330|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-31|2016-09-29|2011-09-29||January 2003||2003-01-01|March 2013|2013-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||HerpeVac Trial for Young Women|A Double-Blind, Randomized, Controlled Phase III Study to Assess the Prophylactic Efficacy and Safety of gD-Alum/MPL Vaccine in the Prevention of Genital Herpes Disease in Young Women Who Are HSV-1 and -2 Seronegative|Completed||Phase 3|8323|Actual|GlaxoSmithKline|Out of the 8323 subjects enrolled and vaccinated, 7850 subjects were followed throughout the study, e. a. for safety and adverse event assessment (4488 in the Herpes Simplex Virus Group and 3662 in the Havrix Group).|2|||f||||||||||||||2017-10-11 04:43:23.277524|2017-10-11 04:43:23.277524
NCT00057343|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-31|2006-09-08|||March 2003||2003-03-01|September 2006|2006-09-01||||||||Interventional|||Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma|A Prospectively Randomized, Phase III, Multicenter, Controlled Trial to Evaluate the Safety and Efficacy of the Zevalin Therapeutic Regimen Plus Rituxan Compared With Rituxan Alone in Patients With Relapsed or Refractory Follicular NHL|Terminated||Phase 3|400||Biogen|||||||||||||||||||2017-10-11 04:43:24.948438|2017-10-11 04:43:24.948438
NCT00057356|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-31|2014-04-30|||November 2002||2002-11-01|April 2014|2014-04-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure|A Randomized, Double-blind, Placebo-controlled, Dose-ranging Pilot Study Evaluating the Efficacy and Safety of YM087 in Patients With Decompensated Chronic Heart Failure|Completed||Phase 2|170|Actual|Cumberland Pharmaceuticals||4|||f||||f||||||||||2017-10-11 04:43:25.402323|2017-10-11 04:43:25.402323
NCT00057369|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-31|2005-06-23|||February 2001||2001-02-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Interventional|||Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections|Phase II, Randomized, Open-Label, Multi-Center Study to Evaluate the Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections With Suspected or Confirmed Gram-Positive Bacterial Pathogens|Unknown status|Active, not recruiting|Phase 2|88||Vicuron Pharmaceuticals|||||||||||||||||||2017-10-11 04:43:25.595491|2017-10-11 04:43:25.595491
NCT00057382|ClinicalTrials.gov processed this data on October 10, 2017|2003-03-31|2005-06-23|||March 2003||2003-03-01|September 2004|2004-09-01||||||||Interventional|||T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients||Terminated||Phase 2/Phase 3|750||Tularik|||||||||||||||||||2017-10-11 04:43:25.696715|2017-10-11 04:43:25.696715
NCT00057395|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-01|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies|A Phase I/II Study of Aroplatin™ in Patients With Advanced Solid Malignancies|Unknown status|Active, not recruiting|Phase 1/Phase 2|40||Aronex Pharmaceuticals|||||||||||||||||||2017-10-11 04:43:25.903758|2017-10-11 04:43:25.903758
NCT00057408|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-01|2015-03-24|||May 2003||2003-05-01|September 2011|2011-09-01|September 2005||2005-09-01|||||Interventional|||A Controlled Study of Olanzapine in Children With Autism|A Controlled Study of Olanzapine in Children With Autism|Completed||Phase 2|78|Anticipated|FDA Office of Orphan Products Development||2|||f||||t||||||||||2017-10-11 04:43:25.974573|2017-10-11 04:43:25.974573
NCT00057421|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-01|2007-09-17|||November 1998||1998-11-01|August 2007|2007-08-01|September 2002||2002-09-01|||||Interventional|||Tuberculosis in HIV Infected Patients in Uganda|Impact of Tuberculosis on HIV Infection in Uganda|Completed||Phase 2|190||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:43:26.110523|2017-10-11 04:43:26.110523
NCT00057434|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-01|2007-09-17|||September 1998||1998-09-01|August 2007|2007-08-01||||||||Interventional|||Vitamin A Therapy for Tuberculosis|Adjunct Vitamin A Therapy for Tuberculosis and HIV/AIDS|Completed||Phase 3|1140||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:43:26.199429|2017-10-11 04:43:26.199429
NCT00057447|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-01|2007-10-30|||March 2003||2003-03-01|October 2007|2007-10-01|June 2004|Actual|2004-06-01|||||Interventional|||Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients|Phase I/II Study of the Safety of Subcutaneous Interferon Gamma-1b Combined With Rituximab in Patients With Low Grade/Follicular Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|24|Actual|InterMune||1||administrative reasons|f||||||||||||||2017-10-11 04:43:26.264341|2017-10-11 04:43:26.264341
NCT00057460|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-02|2008-03-03|||April 2003||2003-04-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity|Effects of AMPA Receptor Blockade on Human Cortical Excitability - A Pilot Study|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:26.33376|2017-10-11 04:43:26.33376
NCT00057473|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-02|2011-04-07||2010-02-03|February 2003||2003-02-01|April 2011|2011-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors||Completed||Phase 2|||Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 04:43:26.411494|2017-10-11 04:43:26.411494
NCT00057486|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-02|2016-12-13|||September 1997||1997-09-01|March 2003|2003-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients|A Pilot, Proof-of-Concept, Dose-Escalating Trial of Recombinant Human Interleukin-12 (rhIL-12) Versus Placebo Along With Paromomycin and Azithromycin for Chronic Cryptosporidiosis in AIDS|Terminated||Phase 1/Phase 2|2||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:43:26.518057|2017-10-11 04:43:26.518057
NCT00057499|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-03|2017-02-06|||March 2003||2003-03-01|February 2017|2017-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics|Autoantigen Vaccination in Human Type 1 Newly Diagnosed Diabetes Mellitus|Completed||Phase 1|12|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Data access is provided to the public in : 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools available to researchers; and 2.) TrialShare, the Immune Tolerance Network (ITN) portal.|2017-10-11 04:43:26.594191|2017-10-11 04:43:26.594191
NCT00057512|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-03|2016-02-20|||January 2003||2003-01-01|January 2006|2006-01-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck|Open-Label Phase 1 Dose Escalation Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck|Completed||Phase 1|9|Actual|Erimos Pharmaceuticals||1|||f||||f||||||||No||2017-10-11 04:43:26.716113|2017-10-11 04:43:26.716113
NCT00057525|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-03|2011-06-29|||April 2003||2003-04-01|June 2011|2011-06-01|August 2004|Actual|2004-08-01|April 2004|Actual|2004-04-01||Interventional|||A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults|A Phase 1 Study of Safety and Immunogenicity of E. Coli-Derived Recombinant Protective Antigen (rPA), a New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults|Completed||Phase 1|70|Actual|DynPort Vaccine Company LLC, A CSC Company||2|||f||||t||||||||||2017-10-11 04:43:26.818119|2017-10-11 04:43:26.818119
NCT00057538|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2006-08-16|||May 2003||2003-05-01|August 2006|2006-08-01|May 2003||2003-05-01|||||Interventional|||Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV|Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV|Completed||Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:43:28.707443|2017-10-11 04:43:28.707443
NCT00057551|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2016-05-03|2015-04-07||April 2003||2003-04-01|May 2016|2016-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|REVAMP||Research Evaluating the Value of Augmenting Medication With Psychotherapy|CBASP Augmentation for Treatment of Chronic Depression|Completed||Phase 4|491|Actual|Weill Medical College of Cornell University||3|||f||||t||||||||No||2017-10-11 04:43:28.85592|2017-10-11 04:43:28.85592
NCT00057564|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2015-09-09|||February 2003||2003-02-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma|A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma|Completed||Phase 3|470|Actual|Celgene||2|||f||||t||||||||||2017-10-11 04:43:29.314314|2017-10-11 04:43:29.314314
NCT00057577|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2017-05-22|2013-12-18||October 2002||2002-10-01|May 2017|2017-05-01|March 2014|Actual|2014-03-01|July 2012|Actual|2012-07-01||Interventional|CPT3|All participants met criteria for Major Depressive Disorder (MDD) with exclusions only for psychosis and selected personality disorders|Prevention of Recurrence in Depression With Drugs and CT|Prevention of Recurrence in Depression With Drugs and CT|Completed||Phase 4|452|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 04:43:29.891382|2017-10-11 04:43:29.891382
NCT00057590|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2013-05-03|||March 2003||2003-03-01|May 2013|2013-05-01||||||||Interventional|||Outreach and Treatment for Depression in the Labor Force|Outreach and Treatment for Depression in the Labor Force|Completed||N/A|590||Harvard Medical School|||||f||||||||||||||2017-10-11 04:43:30.625093|2017-10-11 04:43:30.625093
NCT00057603|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2011-11-08|||January 2001||2001-01-01|November 2011|2011-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Deep Brain Stimulation for Treatment-Resistant Obsessive Compulsive Disorder|Pilot Study of DBS for Treatment-Refractory OCD|Completed||N/A|6|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 04:43:30.7165|2017-10-11 04:43:30.7165
NCT00057616|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2017-04-25|||October 2002||2002-10-01|April 2017|2017-04-01|December 2004||2004-12-01|||||Interventional|||Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.|Multicenter, Randomized, Double-blind, Placebo-controlled Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma Whose Disease Has Progressed on Treatment With DTIC, IL-2, or IFN Based Therapy|Completed||Phase 3|274||Celgene|||||||||||||||||||2017-10-11 04:43:30.810069|2017-10-11 04:43:30.810069
NCT00057629|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2015-11-12|||January 2002||2002-01-01|November 2015|2015-11-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|||Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault|Effectiveness of Treatment for PTSD in Community Agencies|Completed||Phase 2/Phase 3|187|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 04:43:30.997092|2017-10-11 04:43:30.997092
NCT00057642|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2013-08-16|||September 2002||2002-09-01|September 2008|2008-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Improving Retention of Hispanics Receiving Antidepressant Therapy|Improving Hispanic Retention in Antidepressant Therapy|Completed||N/A|50|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 04:43:31.083339|2017-10-11 04:43:31.083339
NCT00057655|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2015-12-01|||January 2002||2002-01-01|December 2015|2015-12-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Observational|||Behavioral Health Services for Women Receiving Public Assistance|Access to Behavioral Health Services for Women on TANF|Withdrawn||N/A|0|Actual|University of Pennsylvania||||lack of funding|f||||f||||||||||2017-10-11 04:43:31.18311|2017-10-11 04:43:31.18311
NCT00057668|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2013-11-18|||September 2001||2001-09-01|August 2006|2006-08-01|August 2006||2006-08-01|||||Interventional|||Preventing Behavior Problems in Children With ADHD|Prevention of Behavioral Deficits in Young ADHD Children|Unknown status|Active, not recruiting|Phase 2|200||Lehigh University|||||f||||||||||||||2017-10-11 04:43:31.257936|2017-10-11 04:43:31.257936
NCT00064532|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2014-12-02|||July 2003||2003-07-01|November 2013|2013-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA||Completed||N/A|6173|Actual|Northwestern University|||1||f||||||||||||||2017-10-11 04:43:45.324472|2017-10-11 04:43:45.324472
NCT00057681|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-04|2013-03-27|2012-05-29||February 2003||2003-02-01|March 2013|2013-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|TEAM||Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents|Treatment of Early Age Mania (TEAM) Study|Completed||Phase 3|379|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-10-11 04:43:31.330977|2017-10-11 04:43:31.330977
NCT00057694|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-05|2008-03-03|||April 2003||2003-04-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Observational|||The Value of Genetic Information to Adult Adopted Individuals|Genetic Information: Exploring the Value to Adult Adoptees|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:31.95583|2017-10-11 04:43:31.95583
NCT00057707|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-05|2017-06-30|||March 26, 2003||2003-03-26|June 16, 2017|2017-06-16|June 16, 2017|Actual|2017-06-16|June 16, 2017|Actual|2017-06-16||Interventional|||Effects of Modafinil on Brain Function in Patients With Schizophrenia|Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype|Completed||Phase 1|176|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:43:32.020399|2017-10-11 04:43:32.020399
NCT00057720|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2011-07-21|||June 2003||2003-06-01|May 2006|2006-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer|Phase 3 Randomized Study of TLK286 (Telcyta) Versus Doxil/Caelyx or Hycamtin as Third-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-1 (Assessment of Survival In Solid Tumors-1)]|Completed||Phase 3|440||Telik|||||f||||||||||||||2017-10-11 04:43:32.149923|2017-10-11 04:43:32.149923
NCT00057733|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-05-29|||February 2003||2003-02-01|April 2005|2005-04-01|June 2006|Actual|2006-06-01|April 2005|Actual|2005-04-01||Interventional|||Stress Management Training in Patients Undergoing Radiation Therapy for Cancer|Stress Management Training For Patients Undergoing Radiotherapy|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:43:33.036754|2017-10-11 04:43:33.036754
NCT00057746|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2016-04-18|2016-04-18||February 2003||2003-02-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|May 2009|Actual|2009-05-01||Interventional|||Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer|A Phase II Randomized Trial Of Two Dose Schedules For Delivering Prophylactic Cranial Irradiation For Patients With Limited Disease Small Cell Lung Cancer|Completed||Phase 2|265|Actual|Radiation Therapy Oncology Group|The number of inevaluable patients at one year (e.g., patients dying prior to 1 year, patients not completing the neurocognitive battery at 1 year) was greater than anticipated.|3|||f||||t||||||||||2017-10-11 04:43:33.194048|2017-10-11 04:43:33.194048
NCT00057759|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2015-11-14|||January 2003||2003-01-01|November 2015|2015-11-01||||December 2006|Actual|2006-12-01||Interventional|||Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer|Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life|Completed||N/A|115|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:43:34.069216|2017-10-11 04:43:34.069216
NCT00057785|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2016-12-30|2014-10-08||February 2003||2003-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|February 2007|Actual|2007-02-01||Interventional||All eligible patients|Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer|A Phase II Study Of Intensity Modulated Radiation Therapy (IMRT) +/- Chemotherapy For Nasopharyngeal Cancer|Completed||Phase 2|68|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:43:34.235894|2017-10-11 04:43:34.235894
NCT00057798|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2011-03-07|||March 2000||2000-03-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|May 2003|Actual|2003-05-01||Interventional|||Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery|Molecular And Genetic Changes In Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) Following Neoadjuvant Chemotherapy With Vinorelbine And Gemcitabine - Phase II Study|Completed||Phase 2|21|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:43:34.882226|2017-10-11 04:43:34.882226
NCT00057811|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2014-09-10|2014-01-21||June 2004||2004-06-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|October 2009|Actual|2009-10-01||Interventional|||Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma|A Pilot Study To Determine The Toxicity Of The Addition Of Rituximab To The Induction And Consolidation Phases And The Addition Of Rasburicase To The Reduction Phase In Children With Newly Diagnosed Advanced B-Cell Leukemia/Lymphoma Treated With LMB/FAB Therapy|Completed||Phase 2|97|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:43:34.992953|2017-10-11 04:43:34.992953
NCT00057837|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-01-11|2013-01-11||March 2004||2004-03-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Randomized Phase II Study: Sequencing Topoisomerase Inhibitors for Extensive Stage Small Cell Lung Cancer (SCLC): Topotecan Sequenced With Etoposide/Cisplatin, and Irinotecan/Cisplatin Sequenced With Etoposide|Completed||Phase 2|140|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-10-11 04:43:36.363643|2017-10-11 04:43:36.363643
NCT00057850|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-02-08|||January 2002||2002-01-01|April 2003|2003-04-01||||July 2003|Actual|2003-07-01||Interventional|||BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Phase I/II Trial of the Epothilone B Analogue BMS 247550 (NSC 710428)/Cisplatin in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:43:37.205219|2017-10-11 04:43:37.205219
NCT00057863|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2015-10-16|2015-10-16||January 2003||2003-01-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer|A Phase II Study of Oxaliplatin in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Cervical Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:43:37.311424|2017-10-11 04:43:37.311424
NCT00057876|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2013-02-11|2011-02-28||April 2003||2003-04-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer|A Randomized Phase III Study Of Gemcitabine In Combination With Radiation Therapy Versus Gemcitabine Alone In Patients With Localized, Unresectable Pancreatic Cancer|Completed||Phase 3|74|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 04:43:37.741376|2017-10-11 04:43:37.741376
NCT00057889|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2012-03-14|||February 2003||2003-02-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer|A Phase II Open-Label Study of Single Agent MDX-010 for the Treatment of IL-2 Refractory or IL-2 Ineligible Patients With Stage IV Renal Cancer|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:43:38.953305|2017-10-11 04:43:38.953305
NCT00057915|ClinicalTrials.gov processed this data on October 10, 2017|2003-04-07|2014-09-04|||September 2003||2003-09-01|September 2014|2014-09-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer|A Phase I Study of Active Immunotherapy With CAP-1 (6D) and CMVpp65 Peptide-Pulsed, Autologous Dendritic Cells Produced in the Aastromreplicell Cell Production System in Patients With Stage IV CEA Expressing Malignancies|Completed||Phase 1|4|Actual|Duke University||1|||f||||f||||||||||2017-10-11 04:43:39.025974|2017-10-11 04:43:39.025974
NCT00064207|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-09-20|||May 2003||2003-05-01|September 2012|2012-09-01||||January 2007|Actual|2007-01-01||Interventional|||Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer|Randomized Phase II/III Study Comparing Gemcitabine Followed by Gemcitabine Plus Concomitant Radiation (50.4 Gy) Versus Control After Curative Pancreaticoduodenectomy for Pancreatic Head Cancer|Completed||Phase 2/Phase 3|97|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:43:39.120435|2017-10-11 04:43:39.120435
NCT00064220|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-05-15|||April 2003||2003-04-01|May 2012|2012-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma|A Phase II Study of Intravenous TZT-1027, Administered Weekly Times Two, Every Three Weeks, to Patients With Advanced or Metastatic Soft Tissue Sarcomas (STS) With Prior Exposure to Anthracycline-Based Chemotherapy|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:43:39.544192|2017-10-11 04:43:39.544192
NCT00064233|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2015-10-01|||November 2003||2003-11-01|August 2012|2012-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate|A Phase I Dose-Escalation Study To Determine The Safety, Pharmacokinetics, And Pharmacodynamics Of BMS-354825 In The Treatment Of Patients With Chronic Phase Chronic Myelogenous Leukemia Who Have Hematologic Resistance To Imatinib Mesylate (Gleevec|Completed||Phase 1|42|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:43:39.631232|2017-10-11 04:43:39.631232
NCT00064246|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-01-24|||July 2003||2003-07-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder|A Phase I/II Study: Zevalin Radioimmunotherapy for Patients With Post Transplant Lymphoproliferative Disease Following Solid Organ Transplantation|Completed||Phase 1/Phase 2|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:43:39.718012|2017-10-11 04:43:39.718012
NCT00064259|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2015-06-10|2015-06-10||June 2003||2003-06-01|May 2013|2013-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||Total number of participants at different dose levels of Oblimersen (3, 5, or 7 mg/kg/d) in combination with 5-FU (1000 mg/m2/d or 750 mg/m2/d) and Cisplatin (100 mg/m2 or 75 mg/m2)|A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer|A Phase I/II Study of Oblimersen in Combination With Cisplatin and Fluorouracil in Patients With Advanced Esophageal, Gastro-Esophageal Junction and Gastric Cancer|Terminated||Phase 1/Phase 2|15|Actual|National Cancer Institute (NCI)||1||Discontinued development of G3139 (oblimersen)|f||||t||||||||||2017-10-11 04:43:39.820085|2017-10-11 04:43:39.820085
NCT00064272|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2016-10-20|||May 2003||2003-05-01|October 2016|2016-10-01||||May 2007|Actual|2007-05-01||Interventional|IRB 2003-551||UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer|Phase II Trial Of Encapsulized Ginger As A Treatment For Chemotherapy-Induced Nausea and Vomiting AKA IRB 2003-213|Completed||Phase 2|180|Anticipated|University of Michigan Cancer Center||3|||f||||||||||||||2017-10-11 04:43:40.132759|2017-10-11 04:43:40.132759
NCT00064285|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2010-04-30|||June 2003||2003-06-01|April 2010|2010-04-01||||||||Interventional|||Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer|Phase I Study Of Flavopiridol In Combination With Imatinib Mesylate (STI571, Gleevec) In Bcr/Abl+ Hematological Malignancies|Completed||Phase 1|22|Actual|Virginia Commonwealth University||1|||||||f||||||||||2017-10-11 04:43:40.240304|2017-10-11 04:43:40.240304
NCT00064298|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2017-05-08|2017-05-08||January 2004||2004-01-01|May 2017|2017-05-01|April 2009|Actual|2009-04-01|October 2008|Actual|2008-10-01||Interventional||All randomized participants|Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer|A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients|Completed||N/A|132|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-11 04:43:40.433057|2017-10-11 04:43:40.433057
NCT00064311|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-03-07|||June 2003||2003-06-01|March 2012|2012-03-01|September 2004|Actual|2004-09-01|||||Interventional|||Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation|A Phase I-II Safety, Tolerability And Pharmacokinetic Study Of Ravuconazole For Prophylaxis Of Invasive Fungal Infections In Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 1/Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:41.063668|2017-10-11 04:43:41.063668
NCT00064324|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2013-06-03|||June 2003||2003-06-01|June 2013|2013-06-01||||November 2005|Actual|2005-11-01||Interventional|||Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma|A Phase II Study of Perifosine in Soft Tissue Sarcoma|Completed||Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:43:41.183097|2017-10-11 04:43:41.183097
NCT00064350|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2015-11-25|2012-03-08||May 2004||2004-05-01|November 2015|2015-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer|A Double Blind Phase II Study of BAY 43-9006 in Patients With Non-Small Cell Lung Cancer Who Have Failed at Least Two Prior Chemotherapy Regimens|Completed||Phase 2|342|Actual|Eastern Cooperative Oncology Group||3|||f||||t||||||||||2017-10-11 04:43:41.5045|2017-10-11 04:43:41.5045
NCT00064363|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-03-07|||June 2003||2003-06-01|March 2012|2012-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Talampanel in Treating Patients With Recurrent High-Grade Glioma|A Phase II Trial Of Talampanel In Patients With Recurrent High-Grade Gliomas|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:43:43.420549|2017-10-11 04:43:43.420549
NCT00064376|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2008-07-23|||May 2003||2003-05-01|September 2004|2004-09-01||||||||Interventional|||Paricalcitol in Treating Patients With Myelodysplastic Syndrome|A Phase II Trial Of Paricalcitol In Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:43:43.497732|2017-10-11 04:43:43.497732
NCT00064389|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-02-21|||January 2003||2003-01-01|February 2012|2012-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma|Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 3|746|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 04:43:43.657326|2017-10-11 04:43:43.657326
NCT00064402|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-02-21|||April 2002||2002-04-01|February 2012|2012-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD|A Double-Blind, Double-Dummy, Randomized, Placebo- and Active-Controlled, Multicenter, Parallel-Group Study of (R,R)-Formoterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|741|Actual|Sunovion||5|||f||||t||||||||||2017-10-11 04:43:43.99457|2017-10-11 04:43:43.99457
NCT00064415|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-02-21|||June 2002||2002-06-01|February 2012|2012-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD|A Multicenter, Open-Label, Randomized, Active-Controlled, Parallel Group Chronic Safety Study of (R,R)-Formoterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|799|Actual|Sunovion||2|||f||||t||||||||||2017-10-11 04:43:44.25098|2017-10-11 04:43:44.25098
NCT00064428|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2016-09-22|||August 2003||2003-08-01|September 2016|2016-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction|An International Randomized Study Evaluating the Efficacy and Safety of Fondaparinux Versus Control Therapy in a Broad Range of Patients With ST Segment Elevation Acute Myocardial Infarction.|Completed||Phase 3|12092|Actual|GlaxoSmithKline||4|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:43:44.536813|2017-10-11 04:43:44.536813
NCT00064441|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-05-09|||May 2003||2003-05-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis|FACTS I: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Efficacy and Safety of OPC-6535 Tablets in the Treatment of Subjects With Active Ulcerative Colitis|Completed||Phase 3|375||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:43:44.661082|2017-10-11 04:43:44.661082
NCT00064454|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-05-09|||May 2003||2003-05-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis|FACTS II: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Efficacy and Safety of OPC-6535 Tablets in the Treatment of Subjects With Active Ulcerative Colitis|Completed||Phase 3|375||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:43:44.794961|2017-10-11 04:43:44.794961
NCT00064467|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2017-05-24|||June 2003||2003-06-01|May 2017|2017-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Lethargic Depression Study|An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms|Completed||Phase 3|268||GlaxoSmithKline|||||f||||||||||||||2017-10-11 04:43:44.955245|2017-10-11 04:43:44.955245
NCT00064480|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2008-04-22|||July 2003||2003-07-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Black Pooling Project||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:43:45.070085|2017-10-11 04:43:45.070085
NCT00064493|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2008-07-01|||June 2003||2003-06-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Modeling DNA Diversity in Reverse Cholesterol Transport||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:43:45.120594|2017-10-11 04:43:45.120594
NCT00064506|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2015-01-13|||July 2003||2003-07-01|January 2015|2015-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Gene-Environment Interactions in Complex Disease|Gene-Environment Interactions in Complex Disease|Completed||N/A|15792|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-11 04:43:45.185737|2017-10-11 04:43:45.185737
NCT00064519|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2015-09-22|||July 2003||2003-07-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genetics of CRP in Families With Myocardial Infarction||Completed||N/A|1406|Actual|Medical College of Wisconsin|||1||f||||f||||||Samples With DNA|"     i.) Blood: A blood sample (30 cc, ~2 tablespoons) will be drawn. This will take place in the     catheterization lab at the end of the catheterization procedure or by using standard     venipuncture technique during a clinic visit or at community outreach events when feasible.      ii.) Buccal Swab: The participant uses specially prepared cotton swabs (called buccal swabs)     to rub in a circular motion on the inside of both cheeks. The swabs collect cheek cells that     can be processed to obtain DNA.      iii.) Saliva: A saliva sample is obtained by having the participant spit in a special vial     specifically designed for genetic testing. The participant will continue to spit into the     vial until it contains 2 ml (about 1 teaspoon) of saliva.   "|||2017-10-11 04:43:45.257609|2017-10-11 04:43:45.257609
NCT00064922|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-15|2017-01-11|||January 2002||2002-01-01|May 2008|2008-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Incentive Programs for Female Substance Abusers Who Smoke - 3|Incentive Programs for Female Substance Abusers Who Smoke|Completed||Phase 2/Phase 3|90||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:43:45.405431|2017-10-11 04:43:45.405431
NCT00064935|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-15|2005-06-23|||April 1999||1999-04-01|May 2003|2003-05-01|February 2002||2002-02-01|||||Interventional|||Endometrial Biopsy in Infertile Patients|Utility of the Endometrial Biopsy in the Evaluation of the Luteal Phase|Completed||Phase 3|880||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:45.695991|2017-10-11 04:43:45.695991
NCT00064961|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2009-12-09|||March 2000||2000-03-01|December 2009|2009-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Obesity Prevention After Smoking Cessation in Menopause||Completed||N/A|100||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:43:45.816235|2017-10-11 04:43:45.816235
NCT00064974|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2013-04-03|||June 2003||2003-06-01|April 2013|2013-04-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes|A Multicenter, Single-Arm, Open-Label Study of the Efficacy and Safety of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes|Completed||Phase 2|215|Actual|Celgene||1|||f||||t||||||||||2017-10-11 04:43:45.924753|2017-10-11 04:43:45.924753
NCT00064987|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2017-07-05|2017-04-03||April 2001||2001-04-01|July 2017|2017-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism|Role of FSH in Human Gonadal Development|Terminated||Phase 2|19|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2||Recruitment was at a standstill. We are currently preparing our results for publication.|f||||t||||||||||2017-10-11 04:43:46.353346|2017-10-11 04:43:46.353346
NCT00065000|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2010-01-12||||||January 2010|2010-01-01|August 2003||2003-08-01|||||Interventional|||Impact of Non-Commercialism Policy in Seattle Schools||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:43:46.995066|2017-10-11 04:43:46.995066
NCT00065013|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2010-06-23|||March 2003||2003-03-01|January 2010|2010-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Strength Training Following Gastric Bypass for Obesity|Strength Training Following Gastric Bypass for Obesity|Completed||Phase 2|24|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||f||||||||||2017-10-11 04:43:47.060817|2017-10-11 04:43:47.060817
NCT00065026|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01||||||||Interventional|||Increasing Physical Activity Levels in Low-Income Women|Environmental Approaches to Reducing Obesity: Increasing Physical Activity Levels in Low-Income Women|Completed||N/A|150|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:43:47.138857|2017-10-11 04:43:47.138857
NCT00065039|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01||||||||Interventional|||Wise Mind: Environmental Approach for Obesity Prevention||Completed||Phase 1|1000|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:43:47.208809|2017-10-11 04:43:47.208809
NCT00065052|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2010-01-12|||September 2002||2002-09-01|January 2010|2010-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Modifying the Home Television Watching Environment|Modifying the Home Television Watching Environment|Completed||N/A|70|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-10-11 04:43:47.283122|2017-10-11 04:43:47.283122
NCT00065065|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2015-12-04|2014-07-10||September 2002||2002-09-01|December 2015|2015-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Trial of Rosiglitazone for Ulcerative Colitis|A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis|Completed||Phase 2|105|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 04:43:47.362976|2017-10-11 04:43:47.362976
NCT00065078|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-16|2005-09-09|||June 2003||2003-06-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Providing Birth Control Through Home Health Visits|Effectiveness of Nurse Home Contraceptive Dispensing|Unknown status|Active, not recruiting|N/A|600||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:47.824429|2017-10-11 04:43:47.824429
NCT00065104|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-17|2006-08-16|||October 2000||2000-10-01|August 2006|2006-08-01|April 2003||2003-04-01|||||Interventional|||Dehydroepiandrosterone Effects on HIV-1 Replication|Dehydroepiandrosterone Effects on HIV-1 Replication|Completed||Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:43:47.889674|2017-10-11 04:43:47.889674
NCT00065117|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-17|2011-01-25|||September 2003||2003-09-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.||Terminated||Phase 2|180||AstraZeneca|||||||||||||||||||2017-10-11 04:43:47.949521|2017-10-11 04:43:47.949521
NCT00065130|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-17|2016-12-21|||April 2000||2000-04-01|December 2016|2016-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes|Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Basal/Bolus Therapy for Patients With Gestational Diabetes|Completed||Phase 3|27|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 04:43:48.036741|2017-10-11 04:43:48.036741
NCT00065143|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-17|2012-01-20|||June 2003||2003-06-01|January 2012|2012-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome|A Phase II Study of Clofarabine in Combination With Cytarabine (Ara-C) in Patients >/= 50 Years With Newly Diagnosed and Previously Untreated Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) (>/= 10% Bone Marrow Blasts)|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-10-11 04:43:48.109388|2017-10-11 04:43:48.109388
NCT00065156|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-17|2011-10-05|2009-08-31||June 2003||2003-06-01|October 2011|2011-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality|A Multicenter, Single-arm, Open-label Study of the Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion-dependent Subjects With Myelodysplastic Syndromes Associated With a Del(5q) Cytogenetic Abnormality.|Completed||Phase 2|148|Actual|Celgene||1|||f||||f||||||||||2017-10-11 04:43:48.242724|2017-10-11 04:43:48.242724
NCT00065169|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-17|2017-05-03|||November 2000||2000-11-01|May 2017|2017-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs|Anti-Inflammation in AD: PET Imaging Supplement|Completed||N/A|138||University of California, Los Angeles|||||f||||||||||||||2017-10-11 04:43:49.292327|2017-10-11 04:43:49.292327
NCT00065195|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-18|2008-01-23|||November 2003||2003-11-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||REST: Reducing End-of-Life Symptoms With Touch|Efficacy of Massage at the End of Life|Completed||Phase 2|440||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:43:49.571627|2017-10-11 04:43:49.571627
NCT00065208|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-18|2012-09-20|||April 2005||2005-04-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Reiki/Energy Healing in Prostate Cancer|Effects of Energy Healing on Prostate Cancer|Completed||Phase 1/Phase 2|79|Actual|The Cleveland Clinic||3|||f||||t||||||||||2017-10-11 04:43:49.645015|2017-10-11 04:43:49.645015
NCT00065221|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-18|2008-01-24|||June 2003||2003-06-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Ginger Control of Chemotherapy Induced Nausea and Vomiting|Trial of Encapsulated Ginger as a Treatment for Chemotherapy-Induced Nausea and Vomiting|Completed||Phase 2|180|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:43:51.291176|2017-10-11 04:43:51.291176
NCT00065234|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-18|2017-03-27|||September 2003||2003-09-01|March 2017|2017-03-01|May 2006||2006-05-01|||||Interventional|||Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)|Acupuncture to Prevent Postoperative Paralytic Ileus|Terminated||Phase 2|100||National Center for Complementary and Integrative Health (NCCIH)||||Not available|f||||||||||||||2017-10-11 04:43:51.462391|2017-10-11 04:43:51.462391
NCT00065247|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-18|2005-06-23|||June 1999||1999-06-01|June 2003|2003-06-01|May 2004||2004-05-01|||||Interventional|||The BONES Project: Building Healthy Bones in Children|Beat Osteoporosis: Nourish and Exercise Skeletons (BONES)|Unknown status|Active, not recruiting|N/A|1500||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:51.535815|2017-10-11 04:43:51.535815
NCT00065260|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-18|2016-02-03|2016-02-03||July 2003||2003-07-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia|A Randomized Trial of Immunosuppression in Aplastic Anemia Patients With Refractory Pancytopenia or Suboptimal Hematologic Response After h-ATG/CsA Treatment|Completed||Phase 2|54|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:43:51.601302|2017-10-11 04:43:51.601302
NCT00065273|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2005-06-23|||July 1998||1998-07-01|June 2003|2003-06-01|June 2001||2001-06-01|||||Interventional|||Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay|Severe Aberrant Behavior Among Persons With Mental Retardation. Project III: Behavioral Selectivity of Atypical Neuroleptic Drugs: Effects on Cognitive and Social Behaviors|Completed||Phase 3|50||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:51.858337|2017-10-11 04:43:51.858337
NCT00065286|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2005-06-23|||December 1996||1996-12-01|June 2003|2003-06-01|November 1999||1999-11-01|||||Observational|||Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation|Movement Dynamic Analyses of Akathisia|Completed||Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:51.930782|2017-10-11 04:43:51.930782
NCT00065299|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2005-06-23|||May 1984||1984-05-01|May 2000|2000-05-01|April 2000||2000-04-01|||||Interventional|||Low Phenylalanine Diet for Mothers With Phenylketonuria (PKU)|Effects of Maternal Phenylketonuria (PKU) on Pregnancy Outcome|Completed||N/A|572||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:51.998487|2017-10-11 04:43:51.998487
NCT00065312|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:43:52.080179|2017-10-11 04:43:52.080179
NCT00065325|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2015-02-23|||August 2003||2003-08-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|June 2006|Actual|2006-06-01||Interventional|EFECT||The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer|A Randomized, Double Blind, Multicenter Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX™) vs. Exemestane (AROMASIN™) in Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer With Disease Progression After Prior Non-Steroidal Aromatase Inhibitor (AI) Therapy|Completed||Phase 3|694|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:43:52.392329|2017-10-11 04:43:52.392329
NCT00065338|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2011-04-01|||June 2003||2003-06-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Nutritional Restriction and Activity Thermogenesis|Nutritional Restriction and Activity Thermogenesis|Completed||Phase 1|90|Actual|Mayo Clinic||1|||f||||||||||||||2017-10-11 04:43:52.784928|2017-10-11 04:43:52.784928
NCT00065351|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2016-11-21|||July 2003||2003-07-01|November 2016|2016-11-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma|A Multicenter, Open-label Study to Determine the Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma|Completed||Phase 2|222|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 04:43:52.878421|2017-10-11 04:43:52.878421
NCT00065364|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2005-06-23|||May 2000||2000-05-01|October 2004|2004-10-01||||||||Interventional|||Improving Brain Development in Medically Healthy Premature Infants|Neurodevelopment and Experience: Behavior, Quantitative EEG and MRI|Completed||N/A|90||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:43:53.027598|2017-10-11 04:43:53.027598
NCT00065663|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-30|2007-11-16|||August 2002||2002-08-01|November 2007|2007-11-01|December 2004||2004-12-01|||||Interventional|||Gene Therapy to Improve Wound Healing in Patients With Diabetes|Growth Factor Gene Therapy for Wound Healing|Completed||Phase 1|21||Tissue Repair Company|||||||||||||||||||2017-10-11 04:44:02.930903|2017-10-11 04:44:02.930903
NCT00065377|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2006-06-23|||July 2003||2003-07-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People|An Exploratory Study of the Effects of Oral Glucosamine Administration on Insulin Sensitivity and Capillary Recruitment in Normal and Obese Subjects|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:53.096727|2017-10-11 04:43:53.096727
NCT00065390|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-21|2008-03-03|||July 2003||2003-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome|Pilot (Phase I-II) Study of Pyrimethamine (Daraprim) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)|Completed||Phase 1|8||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:43:53.160501|2017-10-11 04:43:53.160501
NCT00065403|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-22|2006-08-16|||February 2004||2004-02-01|August 2006|2006-08-01|September 2005||2005-09-01|||||Interventional|||Acupuncture for Irritable Bowel Syndrome||Completed||Phase 1/Phase 2|260||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:43:53.222111|2017-10-11 04:43:53.222111
NCT00065416|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-22|2005-06-23||||||October 2004|2004-10-01||||||||Interventional|||Evaluating Therapeutic Massage for Chronic Neck Pain||Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:43:53.284406|2017-10-11 04:43:53.284406
NCT00065429|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-23|2012-07-09|2011-08-03||April 2003||2003-04-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer|A Phase I, Open-Label, Dose Escalation Study of Weekly Dosing With BB-10901, Followed by a Phase II Efficacy Expansion|Completed||Phase 1/Phase 2|64|Actual|ImmunoGen, Inc.||7|||f||||f||||||||||2017-10-11 04:43:53.365074|2017-10-11 04:43:53.365074
NCT00065442|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-23|2010-09-02|2010-05-28||July 2003||2003-07-01|September 2010|2010-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy|A Randomized, Double Blind, Placebo Controlled Phase 3 Trial of Immunotherapy With Autologous Antigen Presenting Cells Loading With PA2024 (Provenge(R), APC8015) in Men With Metastatic Androgen Independent Prostatic Adenocarcinoma|Completed||Phase 3|512|Actual|Dendreon||2|||f||||||||||||||2017-10-11 04:43:54.43566|2017-10-11 04:43:54.43566
NCT00065455|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-23|2017-06-30|||July 17, 2003||2003-07-17|May 6, 2009|2009-05-06|May 6, 2009||2009-05-06|||||Interventional|||Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa|Pilot Study on the Effect of Vitamin A Supplementation on Cone Function in Retinitis Pigmentosa|Completed||Phase 1|11||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:43:55.579916|2017-10-11 04:43:55.579916
NCT00065468|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-24|2012-09-24|2012-03-22||July 2003||2003-07-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|June 2006|Actual|2006-06-01||Interventional|ARCC||Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma|A Phase 3, Three-Arm, Randomized, Open-Label Study Of Interferon Alfa Alone, CCI-779 Alone, And The Combination Of Interferon Alfa And CCI-779 In First-Line Poor-Prognosis Subjects With Advanced Renal Cell Carcinoma.|Completed||Phase 3|626|Actual|Pfizer|Efficacy data was not collected or analyzed after the primary analysis was completed.|3|||f||||t||||||||||2017-10-11 04:43:55.733384|2017-10-11 04:43:55.733384
NCT00065507|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-28|2013-06-17|2010-02-25||August 2003||2003-08-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|October 2008|Actual|2008-10-01||Interventional|||Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation|Comparison of the Efficacy and Safety of Entecavir Versus Adefovir in Subjects Chronically Infected With Hepatitis B Virus and Evidence of Hepatic Decompensation|Completed||Phase 3|195|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 04:43:58.60503|2017-10-11 04:43:58.60503
NCT00065533|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-28|2007-06-21|||May 2003||2003-05-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer|Study of Two Doses of ALIMTA (Pemetrexed) as First Line Chemotherapy for Advanced Breast Cancer|Completed||Phase 2|92|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 04:44:01.778865|2017-10-11 04:44:01.778865
NCT00065546|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-28|2012-01-05|||June 2007||2007-06-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|September 2009|Actual|2009-09-01||Interventional|||Human Requirements for the Nutrient Choline|Human Requirements for the Nutrient Choline|Completed||N/A|43|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-11 04:44:01.917686|2017-10-11 04:44:01.917686
NCT00065559|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-28|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01|December 2004||2004-12-01|||||Interventional|||Treatment of Diabetic Nephropathy||Terminated||N/A|30||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:44:02.031783|2017-10-11 04:44:02.031783
NCT00065572|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-28|2011-01-25|||August 2003||2003-08-01|January 2011|2011-01-01|February 2004|Anticipated|2004-02-01|February 2004|Anticipated|2004-02-01||Interventional|||Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)||Suspended||Phase 2|||AstraZeneca|||||||||||||||||||2017-10-11 04:44:02.11789|2017-10-11 04:44:02.11789
NCT00065585|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-28|2014-02-25|||April 2004||2004-04-01|February 2014|2014-02-01|June 2007|Actual|2007-06-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy of Acupuncture for Chronic Low Back Pain|Efficacy of Acupuncture for Chronic Low Back Pain|Completed||Phase 3|640||Kaiser Permanente||4|||f||||t||||||||||2017-10-11 04:44:02.209561|2017-10-11 04:44:02.209561
NCT00065611|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-28|2011-09-20|2011-09-20||July 2003||2003-07-01|September 2011|2011-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Steroid Treatment for Kidney Disease|Pulse Dexamethasone Over 48 Weeks for Podocyte Disease|Completed||Phase 3|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:44:02.310219|2017-10-11 04:44:02.310219
NCT00065624|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-29|2007-09-28|||November 2003||2003-11-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Antioxidant Functions of Lipoic Acid|Antioxidant Functions of Lipoic Acid|Completed||Phase 2|16||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:02.694033|2017-10-11 04:44:02.694033
NCT00065637|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-29|2013-02-04|||December 2003||2003-12-01|February 2013|2013-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Once Weekly Parathyroid Hormone for Osteoporosis|PTH Once Weekly Research (POWR)|Completed||Phase 3|50||University of California, San Francisco||2|||f||||||||||||||2017-10-11 04:44:02.769456|2017-10-11 04:44:02.769456
NCT00065650|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-30|2015-04-14|||July 2003||2003-07-01|April 2015|2015-04-01|January 2004||2004-01-01|||||Interventional|||Pilot Study of Vedic Medicine for Type 2 Diabetes||Completed||Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:02.853525|2017-10-11 04:44:02.853525
NCT00065676|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-30|2017-10-05|||July 25, 2003||2003-07-25|May 22, 2017|2017-05-22|December 17, 2025|Anticipated|2025-12-17|||||Interventional|||Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes|Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics|Recruiting||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:44:02.995778|2017-10-11 04:44:02.995778
NCT00065689|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2006-07-24|||March 2003||2003-03-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||High Intensity Light Therapy in Alzheimer's Disease|High Intensity Light Therapy in Alzheimer's Disease|Completed||Phase 3|107||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:03.080184|2017-10-11 04:44:03.080184
NCT00065702|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2006-08-17|||October 2000||2000-10-01|August 2006|2006-08-01|September 2002||2002-09-01|||||Interventional|||Biomarkers of Homeopathy in Fibromyalgia||Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:03.140669|2017-10-11 04:44:03.140669
NCT00065715|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2014-12-03|||September 2003||2003-09-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|August 2008|Actual|2008-08-01||Interventional|PEP||Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)|"Placebo: Physician or Pill? A Randomized Trial in a Common Cold Model Funded by NIH NCCAM Under RFA The Placebo Effect in Clinical Practice"|Completed||Phase 3|719|Actual|University of Wisconsin, Madison||4|||f||||t||||||||||2017-10-11 04:44:03.203132|2017-10-11 04:44:03.203132
NCT00065728|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2013-09-04||2012-11-27|June 2003||2003-06-01|May 2009|2009-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD|An Open Label Evaluation of Long Term Efficacy and Safety of Posterior Juxtascleral Injections of Anecortave Acetate 15 mg in Patients With Subfoveal Exudative Age-Related Macular Degeneration (AMD)|Terminated||Phase 3|111|Actual|Alcon Research||1||Management decision|f||||||||||||||2017-10-11 04:44:03.530778|2017-10-11 04:44:03.530778
NCT00065741|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2007-03-21|||September 2003||2003-09-01|March 2007|2007-03-01|March 2006||2006-03-01|||||Interventional|||Botanical/Drug Interactions in HIV: Glucuronidation|Botanical/Drug Interactions in HIV: Glucuronidation|Completed||Phase 1|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:03.618096|2017-10-11 04:44:03.618096
NCT00065754|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2011-09-16|||September 2003||2003-09-01|August 2011|2011-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Brain Imaging and Pain in Irritable Bowel Syndrome|Brain Imaging and Pain: Analysis of Placebo Analgesia|Completed||N/A|50||University of Florida|||||f||||f||||||||||2017-10-11 04:44:03.689064|2017-10-11 04:44:03.689064
NCT00065767|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2015-10-01|||September 2001||2001-09-01|September 2010|2010-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease|Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease|Completed||Phase 2/Phase 3|20||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 04:44:03.771552|2017-10-11 04:44:03.771552
NCT00065780|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2013-10-25|||August 2003||2003-08-01|October 2013|2013-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Ventricular Size and Value Calcification Measures by Computed Tomography - Ancillary to MESA||Completed||N/A|6814|Actual|Los Angeles Biomedical Research Institute|||1||f||||||||||||||2017-10-11 04:44:03.879425|2017-10-11 04:44:03.879425
NCT00065793|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-31|2015-01-30|||July 2003||2003-07-01|January 2015|2015-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||VLDL and LDL Particle Types as Coronary Heart Disease Risk Factors||Completed||N/A|1478|Actual|Brigham and Women's Hospital|||1||f||||||||||||||2017-10-11 04:44:03.947413|2017-10-11 04:44:03.947413
NCT00065806|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2013-07-15|2013-02-11||September 2003||2003-09-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Test the Safety and Efficacy of Lipitor (Atorvastatin) in Reducing the Progression of Carotid IMT in Early Childhood SLE|Completed||Phase 3|221|Actual|Duke University||2|||f||||t||||||||||2017-10-11 04:44:04.033126|2017-10-11 04:44:04.033126
NCT00065819|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2005-06-23|||September 1996||1996-09-01|June 2003|2003-06-01|August 1999||1999-08-01|||||Interventional|||HIV Symptom Management Program for African American Mothers|HIV Symptom Management With African American Mothers|Completed||Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.014513|2017-10-11 04:44:05.014513
NCT00065832|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2015-06-02|||July 1993||1993-07-01|October 2004|2004-10-01|June 2002||2002-06-01|||||Interventional|||Reading Problems in Children Living in Urban Areas|Early Interventions for Children With Reading Problems|Completed||Phase 3|1400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.097599|2017-10-11 04:44:05.097599
NCT00065845|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2011-01-09|||April 2002||2002-04-01|October 2010|2010-10-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|CARE||Colpopexy and Urinary Reduction Efforts (CARE) Protocol|CARE: A Randomized Trial of Colpopexy and Urinary Reduction Efforts|Completed||Phase 3|322|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-10-11 04:44:05.177529|2017-10-11 04:44:05.177529
NCT00065858|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2016-08-17|||September 2001||2001-09-01|August 2016|2016-08-01|April 2005||2005-04-01|||||Interventional|||Effectiveness of BufferGel as a Vaginal Contraceptive|A Randomized, Controlled Trial of the Efficacy, Safety, and Acceptability of BufferGel|Completed||Phase 2/Phase 3|975||Health Decisions|||||||||||||||||||2017-10-11 04:44:05.295287|2017-10-11 04:44:05.295287
NCT00065871|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2007-04-05|||June 2003||2003-06-01|November 2004|2004-11-01|February 2006||2006-02-01|||||Interventional|||The Direct Access Study: Access to Hormonal Birth Control Through Community Pharmacies|Improving Contraceptive Practice and Delivery Through Community Pharmacists: The Direct Access Study|Unknown status|Active, not recruiting|N/A|250||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.385461|2017-10-11 04:44:05.385461
NCT00065884|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2005-06-23||||||June 2003|2003-06-01||||||||Interventional|||Valproate Response in Aggressive Autistic Adolescents|Valproate Response in Aggressive Autistic Adolescents|Unknown status|Recruiting|Phase 3|30||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.483468|2017-10-11 04:44:05.483468
NCT00054834|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-11|2008-01-08|||March 2003||2003-03-01|January 2008|2008-01-01||||||||Interventional|||Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma|A Phase I Clinical Trial of Radiolabeled Immunotherapy With Humanized LL2 in Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma|Terminated||Phase 1|27||Immunomedics, Inc.||||lack of accrual|||||||||||||||2017-10-11 04:45:04.355683|2017-10-11 04:45:04.355683
NCT00065897|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2005-06-23|||September 1996||1996-09-01|June 2003|2003-06-01|August 2000||2000-08-01|||||Interventional|||Prenatal Testing: Amniocentesis Versus Transabdominal Chorionic Villus Sampling (TA CVS)|Randomized Trial of 11-14 Week Amniocentesis and Transabdominal Chorionic Villus Sampling (TA CVS)|Completed||N/A|6400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.558243|2017-10-11 04:44:05.558243
NCT00065910|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2007-06-28|||September 2001||2001-09-01|June 2003|2003-06-01|January 2006||2006-01-01|||||Interventional|||Improving Attention Skills of Children With Autism|A Joint Attention Intervention With Caregivers and Their Children With Autism|Completed||Phase 1/Phase 2|30||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.625679|2017-10-11 04:44:05.625679
NCT00065923|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2013-04-30|||July 2002||2002-07-01|August 2010|2010-08-01||||December 2005|Actual|2005-12-01||Interventional|||Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome|Topiramate Effects on SIB in Prader-Willi Syndrome|Completed||N/A|10|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.692493|2017-10-11 04:44:05.692493
NCT00065936|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2005-06-23|||July 1997||1997-07-01|May 2003|2003-05-01|June 2002||2002-06-01|||||Interventional|||Self-Injury: Diagnosis and Treatment|Behavioral and Biochemical Mechanisms of Self-Injury|Unknown status|Active, not recruiting|Phase 3|37||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.75934|2017-10-11 04:44:05.75934
NCT00065949|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2005-06-23|||August 1987||1987-08-01|May 2003|2003-05-01|February 2003||2003-02-01|||||Interventional|||Magnesium Sulfate to Prevent Brain Injury in Premature Infants|Magnesium Prevention of Brain Injury in Preterm Infants|Unknown status|Active, not recruiting|Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.859056|2017-10-11 04:44:05.859056
NCT00065962|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2005-06-23|||June 1999||1999-06-01|June 2003|2003-06-01|May 2000||2000-05-01|||||Interventional|||Secretin for the Treatment of Autism|Multisite Controlled Secretin Trial in Autism|Completed||Phase 3|85||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:05.953806|2017-10-11 04:44:05.953806
NCT00065975|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2006-08-16|||April 2002||2002-04-01|August 2006|2006-08-01|December 2002||2002-12-01|||||Interventional|||Physical CAM Therapies for Chronic Low Back Pain|Physical CAM Therapies for Chronic Low Back Pain|Completed||Phase 2|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:06.05579|2017-10-11 04:44:06.05579
NCT00065988|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2010-04-27|||September 1997||1997-09-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||The Children's Amalgam Trial|Health Effects of Dental Amalgams in Children|Completed||Phase 3|534||New England Research Institutes|||||f||||||||||||||2017-10-11 04:44:06.142722|2017-10-11 04:44:06.142722
NCT00066001|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2010-11-08|||December 2002||2002-12-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|December 2007|Actual|2007-12-01||Interventional|||Microbial Associations in Periodontal Health and Disease|The Effect of Systemically Administered Metronidazole Alone and in Combination With Professional Supragingival Plaque Removal on Plaque Composition|Completed||Phase 2|154|Actual|The Forsyth Institute||1|||f||||f||||||||||2017-10-11 04:44:06.211654|2017-10-11 04:44:06.211654
NCT00066014|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2012-02-21|||November 1998||1998-11-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Clinical Investigation of Mandibular Implant Overdenture|Clinical Investigation of Mandibular Implant Overdenture|Completed||Phase 2|30|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 04:44:06.330559|2017-10-11 04:44:06.330559
NCT00066027|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2015-12-01|||June 2002||2002-06-01|December 2015|2015-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effects of Low-Dose Doxycycline on Oral Bone Loss|Low-Dose Doxycycline Effects on Osteopenic Bone Loss|Completed||Phase 3|128|Actual|University of Nebraska||2|||f||||t||||||||||2017-10-11 04:44:06.425402|2017-10-11 04:44:06.425402
NCT00066040|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2012-07-16|||January 2001||2001-01-01|July 2012|2012-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Prevention of Transmission of Bacteria That Cause Cavities From Mothers to Their Children|Prevention of Transmission of Mutans Streptococci From Mother to Child|Completed||N/A|280||New York University|||||f||||t||||||||||2017-10-11 04:44:06.534522|2017-10-11 04:44:06.534522
NCT00066053|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2011-08-04|||January 2003||2003-01-01|May 2007|2007-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||"Periodontitis and Cardiovascular Events or PAVE"|Periodontal Intervention for Cardiac Events: A Pilot Trial|Completed||N/A|303|Actual|University at Buffalo||2|||f||||t||||||||||2017-10-11 04:44:06.611238|2017-10-11 04:44:06.611238
NCT00066066|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2013-03-06|2012-12-11||July 2003||2003-07-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers|Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers|Completed||Phase 2|146|Actual|The Forsyth Institute||3|||f||||f||||||||||2017-10-11 04:44:06.710131|2017-10-11 04:44:06.710131
NCT00066079|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-01|2008-08-04|||August 2003||2003-08-01|August 2008|2008-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Home Based Massage and Relaxation for Sickle Cell Pain|Home Based Massage and Relaxation for Sickle Cell Pain|Completed||Phase 2|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:44:07.214917|2017-10-11 04:44:07.214917
NCT00066092|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-04|2008-02-20|||April 2003||2003-04-01|February 2008|2008-02-01|October 2004|Actual|2004-10-01|March 2004|Actual|2004-03-01||Interventional|||Pegfilgrastim PBPC Mobilization Study|Randomized, Double-Blind Study of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Pegfilgrastim or Filgrastim for Autologous Transplantation in Subjects With Hodgkin's or Non-Hodgkin's Lymphoma.|Completed||Phase 2|41|Actual|Amgen||3|||f||||||||||||||2017-10-11 04:44:07.290076|2017-10-11 04:44:07.290076
NCT00066118|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-04|2017-03-20|||August 1996||1996-08-01|March 2017|2017-03-01|February 2011|Actual|2011-02-01|July 2005|Actual|2005-07-01||Interventional|||Health Effects of Silver-Mercury Dental Fillings|The Casa Pia Study of the Health Effects of Dental Amalgam in Children.|Completed||Phase 3|507||University of Washington|||||f||||||||||||||2017-10-11 04:44:07.390058|2017-10-11 04:44:07.390058
NCT00066131|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-04|2015-07-24|||March 2003||2003-03-01|July 2015|2015-07-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|OPT||Obstetrics and Periodontal Therapy (OPT) Study|Effects of Periodontal Therapy on Preterm Birth|Completed||Phase 3|823|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 04:44:07.471323|2017-10-11 04:44:07.471323
NCT00066144|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-04|2007-10-11|||April 2003||2003-04-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms|Black Cohosh and Red Clover Efficacy for the Relief of Menopausal Symptoms|Completed||Phase 2|112|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:44:07.554022|2017-10-11 04:44:07.554022
NCT00066157|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-04|2015-10-01|||September 2001||2001-09-01|September 2010|2010-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Alzheimer's Disease: Therapeutic Potential of Estrogen|Alzheimer's Disease: Therapeutic Potential of Estrogen|Completed||Phase 2/Phase 3|42|Actual|University of Wisconsin, Madison||4|||f||||t||||||||||2017-10-11 04:44:07.616405|2017-10-11 04:44:07.616405
NCT00066170|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-04|2011-12-21|2011-10-21||April 2003||2003-04-01|December 2011|2011-12-01|November 2004|Actual|2004-11-01|July 2004|Actual|2004-07-01||Interventional|||Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy|Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate) and Modafinil With Placebo in Treatment of Daytime Sleepiness in Narcolepsy|Completed||Phase 3|231|Actual|Jazz Pharmaceuticals||4|||f||||f||||||||||2017-10-11 04:44:07.741347|2017-10-11 04:44:07.741347
NCT00066183|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-04|2008-03-03|||August 2003||2003-08-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Studying Phosphorus Metabolism|Studies in Phosphorus Metabolism|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:09.613098|2017-10-11 04:44:09.613098
NCT00066196|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-05|2008-01-14|||August 2003||2003-08-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|April 2007|Anticipated|2007-04-01||Interventional|||Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma|A Phase II, Randomized, Open-Label Study Evaluating The Antitumor Activity Of MEDI-522, A Humanized Monoclonal Antibody Directed Against The Human Alpha V Beta 3 Integrin, ± Dacarbazine In Patients With Metastatic Melanoma|Completed||Phase 2|110||MedImmune LLC||2|||f||||f||||||||||2017-10-11 04:44:09.683552|2017-10-11 04:44:09.683552
NCT00066209|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-05|2017-06-30|||August 4, 2003||2003-08-04|May 24, 2007|2007-05-24|May 24, 2007||2007-05-24|||||Observational|||Investigating Severe Acute Respiratory Syndrome (SARS)|An Investigation of the Inflammatory Response in Severe Acute Respiratory Syndrome (SARS)|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:09.801383|2017-10-11 04:44:09.801383
NCT00066222|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2017-05-03|2014-12-10||June 2003||2003-06-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|May 2012|Actual|2012-05-01||Interventional||Eligible patients who started protocol treatment.|Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|A Phase II Study Of Accelerated High Dose Thoracic Irradiation With Concurrent Chemotherapy For Patients With Limited Small Cell Lung Cancer|Completed||Phase 2|72|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:44:09.889596|2017-10-11 04:44:09.889596
NCT00066248|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2014-01-31|||June 2003||2003-06-01|January 2014|2014-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment|The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia|Completed||Phase 2|70|Actual|University of South Florida||2|||f||||t||||||||||2017-10-11 04:44:10.542557|2017-10-11 04:44:10.542557
NCT00066274|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2009-01-10|||May 2002||2002-05-01|May 2005|2005-05-01||||||||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer|Randomized Phase II Study Evaluating Three Chemotherapies: [Irinotecan + Oxaliplatin (Irinox)], [Irinotecan + LV5FU2] and [Oxaliplatin + LV5FU2] as First Intention Treatment in Subjects With Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:10.728539|2017-10-11 04:44:10.728539
NCT00066313|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2016-08-23|||May 2003||2003-05-01|August 2016|2016-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||ZD6474 in Treating Patients With Small Cell Lung Cancer|A Phase II Study Of ZD6474 Or Placebo In Small Cell Lung Cancer Patients Who Have Complete Or Partial Response To Induction Chemotherapy +/- Radiation Therapy|Completed||Phase 2|||Sanofi|||||||||||||||||||2017-10-11 04:44:12.350015|2017-10-11 04:44:12.350015
NCT00066326|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-04-03|||June 2003||2003-06-01|April 2013|2013-04-01|September 2005|Actual|2005-09-01|October 2004|Actual|2004-10-01||Interventional|||Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia|Phase I Study Of The Combination Of 17-AAG And Imatinib Mesylate (Gleevec) In Patients With Blastic Phase, Accelerated Phase Of Chronic Mesylate Leukemia (CML) Or Patients With Chronic Phase CML Who Have Not Achieved A Cytogenetic Response With Imatinib Mesylate|Completed||Phase 1|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 04:44:12.469185|2017-10-11 04:44:12.469185
NCT00066339|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2012-07-17|||May 2003||2003-05-01|July 2012|2012-07-01||||January 2004|Actual|2004-01-01||Interventional|||Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy|An IDBBC Single Arm Phase II Trial Evaluating The Activity Of Iressa (ZD1839) In Metastatic Breast Cancer Patients Pretreated With An Antiestrogen And A Non-Steroidal Aromatase Inhibitor (Anastrozole Or Letrozole)|Completed||Phase 2|44|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:44:12.546563|2017-10-11 04:44:12.546563
NCT00066352|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2015-07-22|||September 2003||2003-09-01|July 2015|2015-07-01||||September 2003|Actual|2003-09-01||Interventional|||Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter|A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)|Completed||Phase 2|||University Health Network, Toronto|||||||||||||||||||2017-10-11 04:44:12.620141|2017-10-11 04:44:12.620141
NCT00066365|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2015-03-17|2015-02-11||July 2004||2004-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|July 2010|Actual|2010-07-01||Interventional|||Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma|A Phase II Study of Aerosolized GM-CSF (NSC# 613795, IND# 11042) in Patients With First Pulmonary Recurrence of Osteosarcoma|Completed||Phase 2|49|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:44:12.757888|2017-10-11 04:44:12.757888
NCT00067236|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-13|2011-09-27|2011-08-03||September 2003||2003-09-01|September 2011|2011-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of Oral PG-116800 Following a Heart Attack|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral PG-116800 Following a Heart Attack|Completed||Phase 2|253|Actual|Procter and Gamble||2|||f||||f||||||||||2017-10-11 04:44:30.912308|2017-10-11 04:44:30.912308
NCT00066378|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-10-23|||May 2003||2003-05-01|October 2013|2013-10-01||||August 2007|Actual|2007-08-01||Interventional|||Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer|An EORTC Randomized, Double Blind, Placebo-Controlled, Phase II Multi-Center Trial Of Anastrozole (Arimidex) In Combination With ZD 1839 (Iressa) Or Placebo In Patients With Advanced Breast Cancer|Completed||Phase 2|71|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 04:44:13.924465|2017-10-11 04:44:13.924465
NCT00066391|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2012-09-20|||June 2003||2003-06-01|September 2012|2012-09-01||||January 2006|Actual|2006-01-01||Interventional|||Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer|Phase II Study of Irinotecan (CPT 11) and Cisplatin (CDDP) in Metastatic or Locally Advanced Penile Carcinoma|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:44:14.028468|2017-10-11 04:44:14.028468
NCT00066404|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2010-08-07|||April 2003||2003-04-01|December 2005|2005-12-01||||||||Interventional|||Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions|A Phase I Clinical Trial of Intrapleural Adenoviral-Mediated Interferon-beta (IFN-ß) Gene Transfer for Pleural Malignancies|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:14.141971|2017-10-11 04:44:14.141971
NCT00066417|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-04-30||||||November 2006|2006-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia|Pilot Study Of T-Cell-Depleted Peripheral Blood Stem Cell Transplantation From Partially Matched Related Donors For Patients With High-Risk Leukemia|Terminated||Phase 2|51|Anticipated|National Cancer Institute (NCI)||||Trial was withdrawn for drug availability issues.|f||||||||||||||2017-10-11 04:44:14.22212|2017-10-11 04:44:14.22212
NCT00066430|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2014-09-16|||September 2003||2003-09-01|September 2014|2014-09-01|April 2006|Actual|2006-04-01|September 2004|Actual|2004-09-01||Interventional|||Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia|Infrared Coagulator For Treatment Of High Grade Squamous Intraepithelial Neoplasia (HSIL) in the Anal Canal In HIV Infected Individuals: A Pilot Study|Completed||Phase 1|18|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-10-11 04:44:14.335973|2017-10-11 04:44:14.335973
NCT00066443|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2015-11-02|||February 2003||2003-02-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer|A Phase I/II Study Of Increasing Doses Of Epirubicin And Docetaxel Plus Pegfilgrastim For Locally Advanced Or Inflammatory Breast Cancer|Completed||Phase 1/Phase 2|93|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-11 04:44:14.435594|2017-10-11 04:44:14.435594
NCT00066456|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2016-02-10|||September 2003||2003-09-01|February 2016|2016-02-01||||July 2010|Actual|2010-07-01||Interventional|||Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer|A Phase I Study Using Low Dose Abdominal Radiotherapy as A Docetaxel Chemosensitizer for Recurrent , Persistent Or Advanced Ovarian, Peritoneal Or Fallopian Tube Cancer|Completed||Phase 1|13|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:44:14.528286|2017-10-11 04:44:14.528286
NCT00066469|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2016-09-14|2013-09-17||April 2004||2004-04-01|September 2016|2016-09-01||||October 2009|Actual|2009-10-01||Interventional|||Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation|Phase II Study of Cyclophosphamide, Prednisone and Rituximab (CPR) in Children, Adolescents and Young Adults With B-lymphocyte Antigen CD20 (CD20) Positive Post-Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplantation (SOT)|Active, not recruiting||Phase 2|55|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:44:14.652991|2017-10-11 04:44:14.652991
NCT00066482|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-10-15|||July 2004||2004-07-01|October 2013|2013-10-01||||April 2007|Actual|2007-04-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors|Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Malignant Germ Cell Tumors|Completed||N/A|19|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:44:15.383567|2017-10-11 04:44:15.383567
NCT00066508|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-01-07|||May 2003||2003-05-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy|A Phase II Study Of PS-341 (VELCADE) In Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Completed||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:44:15.705267|2017-10-11 04:44:15.705267
NCT00066547|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-12-03|||May 2003||2003-05-01|August 2004|2004-08-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy|An Open Label Phase I/II Study of Humanized Human Milk Fat Globule-1 (THEREX) in Patients With Locally Advanced or Metastatic Breast Cancer Following Prior Anthracycline and Taxane Therapy|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:15.808032|2017-10-11 04:44:15.808032
NCT00066586|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-05-30|||August 2001||2001-08-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|April 2006|Actual|2006-04-01||Interventional|||Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer|A Randomized Study Of The Effect Of Exemestane (Aromasin) Versus Placebo On Breast Density In Postmenopausal Women At Increased Risk For Development Of Breast Cancer|Completed||N/A|98|Actual|Canadian Cancer Trials Group||2|||f||||||||||||||2017-10-11 04:44:16.50556|2017-10-11 04:44:16.50556
NCT00066599|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-06-18|||June 2003||2003-06-01|July 2004|2004-07-01|June 2004|Actual|2004-06-01|||||Interventional|||Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy|An Open-Label, Intravenous To Oral Switch, Multiple Dose, Multi-Center Study To Investigate The Pharmacokinetics, Safety And Tolerability Of Voriconazole In Hospitalized Children Aged 2 - <12 Years Who Require Treatment For The Prevention Of Systemic Fungal Infection|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:16.649818|2017-10-11 04:44:16.649818
NCT00066612|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2012-10-31|||July 2003||2003-07-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|August 2007|Actual|2007-08-01||Interventional|||S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy|Phase II Study of Irinotecan in Patients With Advanced Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|45|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:44:16.760281|2017-10-11 04:44:16.760281
NCT00066625|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-01-31|||July 2003||2003-07-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer|A Phase I and Pharmacokinetic Study of Oxaliplatin (Eloxatin™) in Combination With Bortezomib (PS-341, Velcade™) in Patients With Advanced Malignancy|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:44:16.848414|2017-10-11 04:44:16.848414
NCT00066638|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2015-03-16|||June 2003||2003-06-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|May 2007|Actual|2007-05-01||Interventional|||FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase 2 Study of Depsipeptide in Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:16.984783|2017-10-11 04:44:16.984783
NCT00066651|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2015-04-29|||July 2003||2003-07-01|February 2006|2006-02-01||||||||Interventional|||Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors|Phase I Study Of SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin In Advanced Malignancies: I.V. Infusion QOD Dosing|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:44:17.300657|2017-10-11 04:44:17.300657
NCT00066664|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2012-03-14|||June 2003||2003-06-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|December 2007|Actual|2007-12-01||Interventional|||Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin|Characterization of Serum Proteomic Patterns in Neoplastic and Inflammatory Skin Disease|Completed||N/A|423|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:17.423709|2017-10-11 04:44:17.423709
NCT00066690|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2016-07-29|2015-07-14||August 2003||2003-08-01|July 2016|2016-07-01||||December 2031|Anticipated|2031-12-01||Interventional|SOFT|Intention-to-treat population, excludes 19 patients who immediately withdrew consent.|Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer|A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women With Endocrine Responsive Breast Cancer|Active, not recruiting||Phase 3|3066|Actual|International Breast Cancer Study Group||3|||f||||t||||||||||2017-10-11 04:44:17.80575|2017-10-11 04:44:17.80575
NCT00066703|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2016-09-26|2015-07-14||August 2003||2003-08-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2014|Actual|2014-06-01||Interventional|TEXT|Intention-to-treat population excludes 12 patients who immediately withdrew consent, were at a non-adherent center, or had inadequate documentation of informed consent.|Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer|A Phase III Trial Evaluating The Role Of Exemestane Plus GnRH Analogue As Adjuvant Therapy For Premenopausal Women With Endocrine Responsive Breast Cancer|Active, not recruiting||Phase 3|2672|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-10-11 04:44:21.55706|2017-10-11 04:44:21.55706
NCT00066716|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2009-12-07|||June 2003||2003-06-01|December 2009|2009-12-01||||May 2007|Actual|2007-05-01||Interventional|||Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus|A Phase II Study Of Preoperative Celecoxib/Paclitaxel/Carboplatin For Squamous Cell And Adenocarcinoma Of The Esophagus|Completed||Phase 2|39|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 04:44:23.397206|2017-10-11 04:44:23.397206
NCT00066729|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2011-04-23|||May 2003||2003-05-01|December 2009|2009-12-01||||July 2006|Actual|2006-07-01||Interventional|||Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase I Study Of NY-ESO-1b Peptide Plus Montanide ISA-51 In Patients With Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer Expressing NY-ESO-1 or LAGE-1|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:23.500349|2017-10-11 04:44:23.500349
NCT00066742|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2014-04-29|2012-06-14||September 2003||2003-09-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer|A Phase II Study of Tirapazamine (NSC-130181)/Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:23.594005|2017-10-11 04:44:23.594005
NCT00066768|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-06-03|||July 2003||2003-07-01|June 2013|2013-06-01||||March 2008|Actual|2008-03-01||Interventional|||Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer|A Pilot Study of Low Dose Suramin as Modulator of Docetaxel and Gemcitabine in Patients With Previously Treated Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:44:24.279376|2017-10-11 04:44:24.279376
NCT00066781|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2017-02-17|2017-02-17||February 2004||2004-02-01|February 2017|2017-02-01|March 2009|Actual|2009-03-01|April 2008|Actual|2008-04-01||Interventional|||Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary|A Phase II Study Of Gemcitabine (GEMZAR) And Irinotecan (CPT-11) In Previously Untreated Patients With Measurable Disease With Unknown Primary Carcinoma|Completed||Phase 2|31|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:44:24.45463|2017-10-11 04:44:24.45463
NCT00066794|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2015-03-05|||July 2004||2004-07-01|March 2015|2015-03-01|January 2010|Actual|2010-01-01|February 2007|Actual|2007-02-01||Interventional|||S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|A Phase II Study Of Induction With Daunorubicin, Cytarabine, And Cyclosporine All By Continuous IV Infusion For Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) In Patients Of Age 56 Or Older|Completed||Phase 2|69|Actual|Southwest Oncology Group||1|||f||||||||||||||2017-10-11 04:44:25.092345|2017-10-11 04:44:25.092345
NCT00066807|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2016-09-26|2016-03-11||August 2003||2003-08-01|September 2016|2016-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|PERCHE||Premenopausal Endocrine Responsive Chemotherapy Trial|A Phase III Trial Evaluating the Role of Chemotherapy as Adjuvant Therapy for Premenopausal Women With Endocrine Responsive Breast Cancer Who Receive Endocrine Therapy|Terminated||Phase 3|29|Actual|International Breast Cancer Study Group|Trial terminated early due to poor accrual. Adverse event data is available ONLY for selected Grade 3-5 AEs for chemotherapy arm. 25 of 29 patients were co-enrolled in TEXT (IBCSG 25-02), which reports AEs and outcomes of endocrine therapy.|2||Poor accrual, patients were followed until completion of 5 yrs treatment|f||||t||||||||||2017-10-11 04:44:25.510002|2017-10-11 04:44:25.510002
NCT00066846|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-06-18|||August 2003||2003-08-01|April 2004|2004-04-01|July 2007|Actual|2007-07-01|||||Interventional|||Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy|A Multicenter Study of the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin®) Plus 5-Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancers That Have Progressed After Standard Chemotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:25.885149|2017-10-11 04:44:25.885149
NCT00066859|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2016-12-20|||March 2004||2004-03-01|November 2016|2016-11-01|November 2005|Actual|2005-11-01|April 2005|Actual|2005-04-01||Interventional|||Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression|A Phase III Double-Blind Randomized Trial Comparing Sertraline (Zoloft) And Hypericum Perforatum (St. John's Wort) In Cancer Patients With Mild To Moderate Depression|Completed||Phase 3|2|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-10-11 04:44:26.117691|2017-10-11 04:44:26.117691
NCT00066872|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2013-09-16|||October 2002||2002-10-01|September 2009|2009-09-01|April 2010|Actual|2010-04-01|||||Interventional|||Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer|A Randomized Controlled Trial of Excisional Surgery Versus Imiquimod 5% Cream for Nodular and Superficial Basal Cell Carcinoma|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:26.228304|2017-10-11 04:44:26.228304
NCT00066885|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2007-05-03|||June 2003||2003-06-01|May 2007|2007-05-01|December 2005||2005-12-01|||||Interventional|||Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer|A Phase 1/2 Multicenter, Open Label, Dose Ranging Study of DN-101 and Taxotere® in Patients With Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Previous Therapy With Platinum-Based Chemotherapy|Completed||Phase 1/Phase 2|80||Novacea|||||||||||||||||||2017-10-11 04:44:26.343703|2017-10-11 04:44:26.343703
NCT00066898|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2006-09-29|||June 2003||2003-06-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||ARISE – Aggressive Reduction of Inflammation Stops Events|“Reduction of Vascular Inflammation and Coronary Atherosclerosis With AGI-1067, a V-Protectant, Reduces Cardiovascular Events in Patients With Coronary Artery Disease”|Unknown status|Active, not recruiting|Phase 3|6000||AtheroGenics|||||||||||||||||||2017-10-11 04:44:26.463123|2017-10-11 04:44:26.463123
NCT00066911|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-06|2017-06-30|||August 2, 2003||2003-08-02|November 5, 2009|2009-11-05||||November 5, 2009|Actual|2009-11-05||Observational|||Brain Mapping of Voice Control|Functional Brain Mapping of Laryngeal Sensorimotor Control in Voice Disorders|Completed||N/A|174||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:27.24331|2017-10-11 04:44:27.24331
NCT00066924|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-07|2005-06-23|||September 2003||2003-09-01|May 2005|2005-05-01|June 2004||2004-06-01|||||Observational|||Spirituality, Religiosity, and Immune Functioning||Completed||N/A|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:27.306292|2017-10-11 04:44:27.306292
NCT00066937|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-07|2017-07-21|2017-04-17||November 2002||2002-11-01|July 2017|2017-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)|Pain Management in Temporomandibular Joint Disorders|Completed||Phase 2|140|Actual|Johns Hopkins University||4|||f||||t|t|f|||f|||||2017-10-11 04:44:27.377955|2017-10-11 04:44:27.377955
NCT00066950|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-07|2014-04-30|||March 2003||2003-03-01|April 2014|2014-04-01|August 2005|Actual|2005-08-01|July 2005|Actual|2005-07-01||Interventional|||Prevention Management Model for Early Childhood Caries (MAYA Project)|Prevention Management Model for Early Childhood Caries|Completed||Phase 3|361|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 04:44:28.025969|2017-10-11 04:44:28.025969
NCT00066963|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-07|2014-04-30|2011-04-05||October 2002||2002-10-01|April 2014|2014-04-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Fluoride Varnish Randomized Clinical Trial|Comprehensive Oral Health Center for Discovery: New Strategies for Enhancing Tissue Integrity and Repair Early Childhood Caries: Prevention and Treatment Outcomes|Completed||Phase 3|376|Actual|University of California, San Francisco|In a protocol deviation, children received placebo varnish for 10 months; this would be expected to bias the study toward the null of no difference among groups. The study did not address FV efficacy for children with extant or past caries.|3|||f||||t||||||||||2017-10-11 04:44:28.154048|2017-10-11 04:44:28.154048
NCT00066976|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-07|2017-06-30|||August 5, 2003||2003-08-05|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Studying Fetal Breathing Patterns|Classification of Fetal Breathing Patterns in the Maturing Upper Airway: Spectral Waveform Analysis of Amniotic Fluid Flow Dynamics in Normal Development, Polyhydramnios, and Oligohydramnios|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:28.514381|2017-10-11 04:44:28.514381
NCT00066989|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-08|2012-05-10|||July 2003||2003-07-01|May 2012|2012-05-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates|A Double Blind, Randomized, Multicenter Stratified Study to Assess the Safety of an Intravenous Staphylococcus Aureus Immune Globulin (Human) [Altastaph] in Low-Birth-Weight-Neonates|Completed||Phase 2|200||Nabi Biopharmaceuticals|||||f||||||||||||||2017-10-11 04:44:28.581381|2017-10-11 04:44:28.581381
NCT00067249|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-13|2007-02-26|||April 2001||2001-04-01|February 2007|2007-02-01|September 2001||2001-09-01|||||Observational|||Women's Use of Alternative Medicine: A Multiethnic Study||Completed||N/A|3200||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:31.80214|2017-10-11 04:44:31.80214
NCT00067015|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-08|2015-12-21|||May 2003||2003-05-01|December 2015|2015-12-01|September 2008|Actual|2008-09-01|October 2004|Actual|2004-10-01||Interventional|||Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer|Phase III Randomized Trial Study Comparing the Outcome of High-Dose IMRT (86.4 GY) Alone With IMRT to 75.6 GY Plus Neoadjuvant/Adjuvant Androgen Deprivation in Patients With High Grade Intermediate Risk and Unfavorable Risk Prostate Cancer|Completed||Phase 3|3|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 04:44:28.855821|2017-10-11 04:44:28.855821
NCT00067028|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-08|2013-06-17|||December 2003||2003-12-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML|A Prospective Randomized Phase I/II Study of Clofarabine (Clo) and Ara-C vs Clo and Ida vs Clo Plus Ida and Ara-C in Patients With First Relapse or First Salvage of Primary Refractory AML; and High-Grade MDS(>/= 10% Blasts); or CML in Myeloid Blasts Phase as Front Line Therapy or in First Salvage.|Completed||Phase 2|166|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 04:44:28.984906|2017-10-11 04:44:28.984906
NCT00067041|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-08|2013-03-05|||March 2003||2003-03-01|March 2013|2013-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft|A Randomized Placebo-Controlled, 12-Week Multicenter Study of the Safety and Efficacy of Remodulin in Patients With Critical Limb Ischemia Following an Autogenous Vein Infrainguinal Bypass Graft|Terminated||Phase 2/Phase 3|30||United Therapeutics|||||f||||||||||||||2017-10-11 04:44:29.113517|2017-10-11 04:44:29.113517
NCT00067054|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-08|2017-10-05|||August 6, 2003||2003-08-06|September 12, 2017|2017-09-12||||||||Observational|||Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies|VRC 200: A Multicenter Specimen Collection Protocol to Obtain Human Biological Samples for Research Studies|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:29.184023|2017-10-11 04:44:29.184023
NCT00067067|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-08|2008-03-03|||August 2003||2003-08-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Investigating Endothelial Precursor Cells (EPCs)|Circulating Endothelial Progenitor Cells in Gliomas|Completed||N/A|84||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:29.270767|2017-10-11 04:44:29.270767
NCT00067080|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-11|2017-08-18|||May 2003||2003-05-01|August 2017|2017-08-01||||July 2007|Actual|2007-07-01||Interventional|||Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions|A Randomized, Open Label, Phase II Study on Safety and Efficacy of Long Term Treatment of ICL670 Relative to Deferoxamine in Sickle Cell Disease Patients With Transfusional Hemosiderosis|Completed||Phase 2|195|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:44:29.345991|2017-10-11 04:44:29.345991
NCT00067093|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-11|2011-04-05|||May 2003||2003-05-01|April 2011|2011-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)||Completed||Phase 3|1452|Actual|Sanofi|||||||||||||||||||2017-10-11 04:44:29.517769|2017-10-11 04:44:29.517769
NCT00067106|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-11|2015-05-15|||July 2003||2003-07-01|September 2014|2014-09-01|March 2009|Actual|2009-03-01|March 2007|Actual|2007-03-01||Observational|||Antiviral Therapy and HIV in the Female Genital Tract|Antiviral Therapy and HIV in the Genital Tract of Women|Completed||N/A|130|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||f||||||Samples With DNA|"     Blood and genital tract collection   "|||2017-10-11 04:44:29.63682|2017-10-11 04:44:29.63682
NCT00067119|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-11|2017-09-18|||January 1, 2003|Actual|2003-01-01|September 2017|2017-09-01|January 31, 2008|Actual|2008-01-31|January 31, 2008|Actual|2008-01-31||Interventional|GRAFT||Aggrenox Prevention of Access Stenosis|Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency|Completed||Phase 3|649|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t|t|f||||||||2017-10-11 04:44:29.721099|2017-10-11 04:44:29.721099
NCT00067132|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-11|2010-01-12|||March 2003||2003-03-01|January 2010|2010-01-01||||||||Interventional|||Adjuvant Nutrition for Critically Ill Trauma Patients||Completed||Phase 1|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:44:30.135297|2017-10-11 04:44:30.135297
NCT00067145|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-11|2010-01-12||||||January 2010|2010-01-01||||||||Interventional|||Computer Intervention for Prevention of Weight Regain||Completed||Phase 3|300||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:44:30.200071|2017-10-11 04:44:30.200071
NCT00067158|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-12|2017-01-11|||April 2003||2003-04-01|April 2010|2010-04-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1|Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy|Completed||Phase 3|585||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:44:30.262653|2017-10-11 04:44:30.262653
NCT00067171|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-12|2017-01-11|||January 2003||2003-01-01|October 2016|2016-10-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Telephone Enhancement Procedure for Continuing Care - 1|Telephone Enhancement Procedure (TELE) for Continuing Care|Completed||Phase 3|339||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:44:30.365729|2017-10-11 04:44:30.365729
NCT00067184|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-12|2015-03-30|||September 2002||2002-09-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Fetal Neurobehavioral Development in Methadone Maintained Pregnancies|Methadone, Buprenorphine and Fetal Development|Completed||N/A|157|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 04:44:30.45039|2017-10-11 04:44:30.45039
NCT00067197|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-12|2017-06-30|||August 11, 2003||2003-08-11|July 17, 2008|2008-07-17|July 17, 2008||2008-07-17|||||Observational|||Improving Motor Learning in Stroke Patients|Modulation of Motor Learning in Chronic Stroke Patients by Transcranial DC Stimulation|Completed||N/A|76||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:30.552659|2017-10-11 04:44:30.552659
NCT00067210|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-12|2017-06-30|||August 11, 2003||2003-08-11|June 13, 2008|2008-06-13|May 22, 2007||2007-05-22|||||Interventional|||Reducing Seizure Frequency Using Cooling of the Head and Neck|Cooling of the Head and Neck to Reduce Seizure Frequency: A Pilot Study|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:30.660259|2017-10-11 04:44:30.660259
NCT00067223|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-12|2017-06-30|||August 5, 2003||2003-08-05|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Observational|||Studying Use-Dependent Plasticity|Bi-hemispheric Plasticity Elicited By Unilateral Finger Motor Training|Completed||N/A|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:30.795896|2017-10-11 04:44:30.795896
NCT00067262|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-13|2006-08-02|||March 2003||2003-03-01|August 2006|2006-08-01||||||||Interventional|||An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents|A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Depakote ER for the Treatment of Bipolar Disorder in Children and Adolescents|Completed||Phase 3|150||Abbott|||||||||||||||||||2017-10-11 04:44:31.869761|2017-10-11 04:44:31.869761
NCT00067275|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-13|2017-06-30|||August 8, 2003||2003-08-08|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Observational|||The Effect of Dopamine on Motor Skills Training|Dopamine Release in Use-Dependent Plasticity in Health and Disease|Completed||N/A|98||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:32.007228|2017-10-11 04:44:32.007228
NCT00067288|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-14|2006-08-16|||May 2002||2002-05-01|August 2006|2006-08-01|March 2006||2006-03-01|||||Interventional|||Meaning-Centered Psychotherapy in Advanced Cancer|Meaning-Centered Psychotherapy in Advanced Cancer|Completed||Phase 2|118||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:44:32.085024|2017-10-11 04:44:32.085024
NCT00067301|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-14|2008-01-23|||September 2003||2003-09-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||PUFA Augmentation in Treatment of Major Depression|PUFA Augmentation in Treatment of Major Depression|Completed||Phase 3|60||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:44:32.159274|2017-10-11 04:44:32.159274
NCT00067314|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-15|2012-01-13|||June 2003||2003-06-01|January 2012|2012-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy|A Phase II Study Of Intravenous Edotecarin (PHA-782615) In Patients With Anthracycline- And Taxane Resistant Metastatic Breast Cancer|Completed||Phase 2|65||Pfizer|||||f||||||||||||||2017-10-11 04:44:32.23957|2017-10-11 04:44:32.23957
NCT00067327|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-15|2006-03-16|||February 2002||2002-02-01|March 2006|2006-03-01|September 2005||2005-09-01|||||Interventional|||Treatment of Multiple Sclerosis Using Over the Counter Inosine|Treatment of Multiple Sclerosis Using Over the Counter Inosine|Completed||Phase 2|30||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:44:32.371224|2017-10-11 04:44:32.371224
NCT00067340|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-15|2015-05-29|||April 2003||2003-04-01|April 2010|2010-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Caries Transmission Prevention in Alaska Native Infants|Northwest Alaska Center to Reduce Oral Health Disparity Project 2: Caries Transmission Prevention in Alaska Native Infants|Terminated||Phase 3|250|Anticipated|University of Washington||2||Unable to recruit sufficient number of subjects|f||||t||||||||||2017-10-11 04:44:32.448864|2017-10-11 04:44:32.448864
NCT00067353|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-15|2010-05-06|||November 2003||2003-11-01|May 2010|2010-05-01|August 2005|Actual|2005-08-01|July 2005|Actual|2005-07-01||Interventional|||Yakima Head Start Fluoride Varnish Study|Fluoride Varnish Trial in High Caries Preschoolers|Completed||Phase 3|500||University of Washington|||||f||||t||||||||||2017-10-11 04:44:32.535522|2017-10-11 04:44:32.535522
NCT00067366|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-15|2017-07-27|||October 2003||2003-10-01|July 2017|2017-07-01|September 2011|Actual|2011-09-01|October 2008|Actual|2008-10-01||Interventional|||Brief Treatment for Temporomandibular Pain|Brief Focused Treatment for TMD: Mechanisms of Action|Completed||N/A|116|Actual|UConn Health||2|||f||||||||||||||2017-10-11 04:44:32.61937|2017-10-11 04:44:32.61937
NCT00067379|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-15|2010-06-09|||April 2003||2003-04-01|June 2010|2010-06-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Early Orthodontic Intervention Under Medicaid|Early Orthodontic Intervention Under Medicaid|Unknown status|Active, not recruiting|Phase 1|150|Anticipated|University of Washington||1|||f||||t||||||||||2017-10-11 04:44:32.710639|2017-10-11 04:44:32.710639
NCT00067392|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-15|2010-11-08|||November 2003||2003-11-01|July 2008|2008-07-01|May 2009|Anticipated|2009-05-01|April 2008|Anticipated|2008-04-01||Interventional|||Evaluation of Implants Placed Immediately or Delayed Into Extraction Sites|Prospective Evaluation of Immediate Temporized Implants|Unknown status|Active, not recruiting|Phase 3|90|Anticipated|Louisiana State University Health Sciences Center in New Orleans||1|||f||||||||||||||2017-10-11 04:44:32.797389|2017-10-11 04:44:32.797389
NCT00067405|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-18|2008-04-21|||June 2004||2004-06-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia|Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia|Completed||Phase 1/Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:44:32.872043|2017-10-11 04:44:32.872043
NCT00067418|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-18|2008-03-03|||August 2003||2003-08-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Light Scattering Spectroscopy to Determine Brain Tumors|Spectroscopic Determination of Brain Tumor Cells|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:32.942016|2017-10-11 04:44:32.942016
NCT00067431|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-19|2006-08-02|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children|A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children|Terminated||Phase 3|300||Abbott|||||||||||||||||||2017-10-11 04:44:33.001582|2017-10-11 04:44:33.001582
NCT00067444|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-19|2016-08-30|||June 2003||2003-06-01|August 2016|2016-08-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Depression Study In Elderly Patients|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Evaluating the Efficacy and Safety of Paroxetine CR in Elderly Outpatients Diagnosed With Major Depressive Disorder|Completed||Phase 3|560|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:44:33.082003|2017-10-11 04:44:33.082003
NCT00067457|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-20|2015-04-15|||June 2003||2003-06-01|April 2015|2015-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy|A 12-Week, Randomized, Double-Blind, Placebo- Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects With Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy|Completed||Phase 3|700|Actual|GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:44:33.251447|2017-10-11 04:44:33.251447
NCT00067470|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-20|2009-12-18|2009-02-04||September 2003||2003-09-01|December 2009|2009-12-01|March 2004||2004-03-01|||||Interventional|||Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI||Completed||Phase 3|39|Actual|BioMarin Pharmaceutical||2|||||||||||||||||2017-10-11 04:44:34.107584|2017-10-11 04:44:34.107584
NCT00067483|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-20|2017-06-30|||August 15, 2003||2003-08-15|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Pilot Study: Dynamic Light Scattering Device for Studying Early Changes in Cataract|Pilot Study on the Use of the NASA-NEI Dynamic Light Scattering (DLS) Device in Detecting Lens Changes in the Other Eye of Patients With Pre-Senile Cataracts|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:35.103477|2017-10-11 04:44:35.103477
NCT00067496|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-20|2008-08-26|||August 2003||2003-08-01|May 2005|2005-05-01|August 2006||2006-08-01|||||Interventional|||Modafinil to Treat Fatigue in Post-Polio Syndrome|Modafinil in the Treatment of Fatigue in Post-Polio Syndrome|Terminated||Phase 3|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:35.163628|2017-10-11 04:44:35.163628
NCT00067509|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-21|2005-06-23|||June 2001||2001-06-01|July 2003|2003-07-01|May 2004||2004-05-01|||||Interventional|||Emergency Contraception (ECP): Reducing Unintended Pregnancies|A Second Chance With Emergency Contraception (ECP): Reducing Unintended Pregnancy|Completed||Phase 4|1100||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:35.243518|2017-10-11 04:44:35.243518
NCT00067535|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-21|2017-01-11|||June 2003||2003-06-01|February 2009|2009-02-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|||Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1|Potential Interactions Between IV Cocaine and RPR 102681|Completed||Phase 1|16|Actual|National Institute on Drug Abuse (NIDA)||2|||||||||||||||||2017-10-11 04:44:35.394682|2017-10-11 04:44:35.394682
NCT00067548|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-21|2009-08-20||||||August 2009|2009-08-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer|A Phase 2 Study of EKB-569 in Subjects With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|44|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:44:35.471679|2017-10-11 04:44:35.471679
NCT00067561|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-21|2015-04-15|||June 2003||2003-06-01|April 2015|2015-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy|A Twelve-Week, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 0.5 mg QD, 1 mg QD and 1 mg BID of Alosetron in Female Subjects With Severe Diarrhea-predominant IBS Who Have Failed Conventional Therapy|Completed||Phase 3|702|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 04:44:35.562216|2017-10-11 04:44:35.562216
NCT00067574|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2017-03-02|||July 2003||2003-07-01|July 2016|2016-07-01||||||||Interventional|||Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents|Structured Treatment Interruption as an Autovaccination Approach to Enhance Immune Based HIV-1 Control in an Adolescent/Young Adult Population|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||1||"The study was never opened for enrollment; concept became irrelevant as other study results   became available."|f||||||||||||||2017-10-11 04:44:35.979333|2017-10-11 04:44:35.979333
NCT00067587|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2017-02-27|||July 2003||2003-07-01|February 2016|2016-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Observational|||Metabolic Abnormalities in HIV Infected and Uninfected Young Women|Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women|Completed||N/A|300|Actual|University of North Carolina, Chapel Hill|||5||f||||t||||||||||2017-10-11 04:44:36.092283|2017-10-11 04:44:36.092283
NCT00067600|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2014-10-28|||August 2000||2000-08-01|October 2014|2014-10-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Improving Bone Health in Adolescent Girls: The Youth Osteoporosis and Understanding Total Health (YOUTH) Study|Lifestyle Changes to Increase Bone Density in Teen Girls|Completed||Phase 1|228||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:44:36.213402|2017-10-11 04:44:36.213402
NCT00067613|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2015-06-03|||March 2001||2001-03-01|June 2015|2015-06-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|Benchmarking||Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia|Randomized Controlled Trial of Benchmarking to Reduce Bronchopulmonary Dysplasia to Reduce Bronchopulmonary Dysplasia|Completed||N/A|4095|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-10-11 04:44:36.282946|2017-10-11 04:44:36.282946
NCT00053716|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-04|2007-03-06|||February 2003||2003-02-01|March 2004|2004-03-01|August 2003||2003-08-01|||||Interventional|||Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease|Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease|Unknown status|Recruiting|Phase 2|12||Endovasc|||||||||||||||||||2017-10-11 04:44:36.590397|2017-10-11 04:44:36.590397
NCT00053742|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-04|2008-03-03|||February 2003||2003-02-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox|A Phase I/II Clinical Trial of Modified Vaccinia Virus Ankara (MVA) to Evaluate Its Safety, Immunogenicity and Protective Efficacy Against Dryvax® (Registered Trademark) Challenge in Vaccinia-Immune Individuals|Completed||Phase 1|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:36.668495|2017-10-11 04:44:36.668495
NCT00053768|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2009-02-06|||April 2002||2002-04-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma|Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Prognoses|Unknown status|Active, not recruiting|Phase 3|552|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:36.751999|2017-10-11 04:44:36.751999
NCT00053781|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2010-11-07|||June 2003||2003-06-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma|A Phase II Study Of Perifosine (D-21266) In Previously Untreated Patients With Metastatic Or Recurrent Malignant Melanoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:44:37.320875|2017-10-11 04:44:37.320875
NCT00116077|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2017-06-30|||June 21, 2005||2005-06-21|November 12, 2010|2010-11-12|November 12, 2010||2010-11-12|||||Observational|||Dopamine Receptor Imaging in Mood Disorders|Dopamine Receptor Imaging in Mood Disorders|Completed||N/A|145|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:21.566846|2017-10-11 05:06:21.566846
NCT00053794|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2010-11-07|||May 2003||2003-05-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma|A Phase II Study Of Perifosine (D-21266) In Patients With Previously Untreated Metastatic Or Locally Advanced Soft Tissue Sarcoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:44:37.415477|2017-10-11 04:44:37.415477
NCT00053807|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2012-09-20|||February 1998||1998-02-01|September 2012|2012-09-01||||January 2004|Actual|2004-01-01||Interventional|||Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer|Adjuvant Interleukin-2, Interferon-alpha and 5-Fluorouracil for Patients With High Risk of Relapse After Surgical Treatment for Renal Cell Carcinoma|Completed||Phase 3|96|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:44:37.506788|2017-10-11 04:44:37.506788
NCT00053820|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-12-18|||July 2002||2002-07-01|August 2006|2006-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer|A Randomized Controlled Trial of Interferon-alpha, Interleukin-2 and 5-Fluorouracil vs. Interferon-alpha Alone in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 3|670|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:37.625589|2017-10-11 04:44:37.625589
NCT00053833|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-11-07|||April 2003||2003-04-01|November 2013|2013-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|S0025: Phase II Trial Of Irinotecan (CAMPTOSAR) For Patients With Platinum And Taxane Refractory Ovarian, Peritoneal Or Fallopian Tube Cancer|Terminated||Phase 2|2|Actual|Southwest Oncology Group||1||lack of accrual|f||||t||||||||||2017-10-11 04:44:37.762602|2017-10-11 04:44:37.762602
NCT00053846|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2015-10-27|2014-08-20||November 2002||2002-11-01|October 2015|2015-10-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Interventional|||Buspirone in Reducing Shortness of Breath in Patients With Cancer|Buspirone in Reducing Shortness of Breath in Patients With Cancer|Completed||Phase 2/Phase 3|432|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 04:44:38.113587|2017-10-11 04:44:38.113587
NCT00053872|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2014-06-23|||February 2003||2003-02-01|February 2007|2007-02-01||||||||Interventional|||Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma|A Prospective Randomised Controlled Trial Of Hyperfractionated Versus Conventionally Fractionated Radiotherapy In Standard Risk Medulloblastoma|Unknown status|Active, not recruiting|Phase 3|316|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:38.753001|2017-10-11 04:44:38.753001
NCT00053885|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2016-06-30|||July 2003||2003-07-01|June 2016|2016-06-01|June 2006|Actual|2006-06-01|July 2005|Actual|2005-07-01||Interventional|||PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma|A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:44:38.885584|2017-10-11 04:44:38.885584
NCT00053898|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2016-06-08|||January 2003||2003-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2015|Actual|2015-03-01||Interventional|||Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy|A Clinical Trial Comparing Anastrozole With Tamoxifen in Postmenopausal Patients With Ductal Carcinoma in Situ (DCIS) Undergoing Lumpectomy With Radiation Therapy|Completed||Phase 3|3104|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-10-11 04:44:39.343971|2017-10-11 04:44:39.343971
NCT00053911|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2014-12-14|||November 2002||2002-11-01|December 2014|2014-12-01||||April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer|Randomized And Multicentric Phase III Study Evaluating The Benefit By Using A Chemotherapy With FEC 100 And Docetaxel In Non Metastatic Breast Cancer Which Has Relapsed After A Conservative Surgery|Terminated||Phase 3|||UNICANCER|||||f||||||||||||||2017-10-11 04:44:43.606493|2017-10-11 04:44:43.606493
NCT00053924|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2015-07-22|||May 2003||2003-05-01|July 2015|2015-07-01||||May 2006|Actual|2006-05-01||Interventional|||Perifosine in Treating Patients With Advanced Pancreatic Cancer|A Phase 2 Study Of Perifosine As Second Line Therapy For Advanced Pancreatic Carcinoma|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 04:44:43.73333|2017-10-11 04:44:43.73333
NCT00053937|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2015-04-29|||December 2002||2002-12-01|April 2004|2004-04-01||||||||Interventional|||Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas|Phase I Trial Of Pirfenidone In Children With Neurofibromatosis Type 1 And Plexiform Neurofibromas|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:44:43.81716|2017-10-11 04:44:43.81716
NCT00053950|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-04-08|||December 2002||2002-12-01|April 2013|2013-04-01||||March 2007|Actual|2007-03-01||Interventional|||Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma|A Phase I Study of High-dose Pyrazoloacridine (PZA) (NSC 366140) Supported With Autologous Hematopoietic Stem Cell Rescue in Children With Recurrent or Resistant Neuroblastoma (IND # 36325)|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:44:43.91088|2017-10-11 04:44:43.91088
NCT00053963|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-01-15|||September 2002||2002-09-01|January 2013|2013-01-01||||February 2006|Actual|2006-02-01||Interventional|||FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia|A PHASE I STUDY OF DEPSIPEPTIDE (NSC#630176, IND# 51810) IN PEDIATRIC PATIENTS WITH REFRACTORY SOLID TUMORS AND LEUKEMIAS|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:44.022757|2017-10-11 04:44:44.022757
NCT00053976|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2017-01-19|||January 2001||2001-01-01|January 2017|2017-01-01|November 2004|Actual|2004-11-01|November 2003|Actual|2003-11-01||Interventional|||Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease|Treatment of Acute Graft vs. Host Disease With Steroids Plus Daclizumab (Zenapax) or Placebo|Completed||Phase 3|105|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-11 04:44:44.253816|2017-10-11 04:44:44.253816
NCT00053989|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2017-05-16|||January 29, 2002|Actual|2002-01-29|May 2017|2017-05-01|May 1, 2018|Anticipated|2018-05-01|May 1, 2018|Anticipated|2018-05-01||Interventional|||Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Aplastic Anemia|Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies and Aplastic Anemia|Active, not recruiting||Phase 2|41|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:44:44.41423|2017-10-11 04:44:44.41423
NCT00054002|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2011-02-25|||March 1999||1999-03-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|June 2006|Actual|2006-06-01||Interventional|||Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma|Surgery and Intracavitary Photodynamic Therapy (PDT) for the Treatment of Malignant Pleural Mesothelioma; The Use of Light Delivery Fibers With Large Diffusers|Completed||Phase 2|12|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:44:44.642462|2017-10-11 04:44:44.642462
NCT00054015|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-11-05|||December 2002||2002-12-01|April 2004|2004-04-01|January 2008|Actual|2008-01-01|||||Interventional|||3-AP in Treating Patients With Advanced Prostate Cancer|A Phase II Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) in Patients With Advanced Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:44.755954|2017-10-11 04:44:44.755954
NCT00054028|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2015-03-03|2014-11-17||December 2002||2002-12-01|February 2015|2015-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer|A Phase I/II Study of Suramin in Combination With Paclitaxel in Advanced (Stage IIIB or IV) Metastatic Breast Cancer|Completed||Phase 1/Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:44.862379|2017-10-11 04:44:44.862379
NCT00054041|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-01-23|||June 2004||2004-06-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia|Phase II Evaluation Of SGN-00101 (HSP-E7) Fusion Protein In Women With Cervical Intraepithelial Neoplasia 3, CIN 3|Completed||Phase 2|84|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:44:45.540222|2017-10-11 04:44:45.540222
NCT00054054|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2011-07-21|||April 2003||2003-04-01|July 2011|2011-07-01||||November 2007|Actual|2007-11-01||Interventional|||S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Docetaxel (NSC-628503), Cisplatin (NSC-119875), And 5-Fluorouracil (NSC-19893) Induction Chemotherapy Followed By Accelerated Fractionation/Concomitant Boost Radiation And Concurrent Single Agent Cisplatin (NSC-119875), In Patients With Advanced Squamous Cell Head And Neck Cancer|Completed||Phase 2|||Southwest Oncology Group|||||f||||f||||||||||2017-10-11 04:44:45.679104|2017-10-11 04:44:45.679104
NCT00054067|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-04-10|||February 2003||2003-02-01|April 2013|2013-04-01||||April 2005|Actual|2005-04-01||Interventional|||Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix|Treatment of Patients With Stage IB2 Carcinoma of the Cervix: A Randomized Comparison of Radical Hysterectomy and Tailored Chemo-Radiation Versus Primary Chemo-Radiation|Terminated||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:44:45.969281|2017-10-11 04:44:45.969281
NCT00054106|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2010-11-07|||December 2002||2002-12-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer|A Phase I Study Of Combination Neoadjuvant Hormone Therapy And Weekly OGX-011 (Clusterin Antisense Oligonucleotide) Prior To Radical Prostatectomy In Patients With Localized Prostate Cancer|Completed||Phase 1|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:44:46.135703|2017-10-11 04:44:46.135703
NCT00054119|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2017-07-12|||January 2003||2003-01-01|July 2017|2017-07-01||||September 30, 2005|Actual|2005-09-30||Interventional|||Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Karenitecin in the Third-Line Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|27|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:44:46.213581|2017-10-11 04:44:46.213581
NCT00054132|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2017-06-23|2016-03-09||December 2002||2002-12-01|June 2017|2017-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer|A Phase II Study of OSI-774 in Combination With Bevacizumab in Patients With Stage IV Breast Cancer|Completed||Phase 2|38|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:44:46.436478|2017-10-11 04:44:46.436478
NCT00054145|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2015-07-22|||June 2003||2003-06-01|July 2015|2015-07-01||||April 2007|Actual|2007-04-01||Interventional|||Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer|A Phase 2 Study Of Perifosine In Metastatic Or Advanced Breast Cancer|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 04:44:46.849671|2017-10-11 04:44:46.849671
NCT00054158|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-01-30|||August 2004||2004-08-01|January 2013|2013-01-01||||April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma|A Phase II Study of VAD (Vincristine, Adriamycin, Dexamethasone) Plus Thalidomide (Low Dose) as Frontline Therapy for Newly Diagnosed Patients With Multiple Myeloma (MM)|Completed||Phase 2|24|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:44:46.947168|2017-10-11 04:44:46.947168
NCT00054171|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-01-30|||February 1999||1999-02-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia|A Pilot Study of Short (1-2.5 h), Medium (4-6 h) and Long (18-24 h) Applications of 20% Topical ALA-PDT for Photodynamic Therapy of Cutaneous T and B Cell Lymphomas and Cutaneous Infiltrates of Early CLL|Completed||Phase 2|1|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:44:47.023316|2017-10-11 04:44:47.023316
NCT00054184|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-07-29|||January 2003||2003-01-01|July 2013|2013-07-01||||December 2013|Anticipated|2013-12-01||Interventional|||Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer|CT-2103 vs Docetaxel for the Second-Line Treatment of Non-Small Cell Lung Cancer (NSCLC): A Phase III Study|Unknown status|Active, not recruiting|Phase 3|350|Anticipated|CTI BioPharma||1|||f||||||||||||||2017-10-11 04:44:47.108984|2017-10-11 04:44:47.108984
NCT00054197|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2011-02-23|||January 2003||2003-01-01|July 2004|2004-07-01||||||||Interventional|||Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|CT-2103 vs Gemcitabine or Vinorelbine for the Treatment of PS = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:47.262881|2017-10-11 04:44:47.262881
NCT00054210|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2008-07-23|||January 2003||2003-01-01|July 2004|2004-07-01||||||||Interventional|||Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|CT-2103/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of PS = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:47.3686|2017-10-11 04:44:47.3686
NCT00054223|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2012-03-14|||January 2003||2003-01-01|March 2012|2012-03-01|November 2005|Actual|2005-11-01|||||Interventional|||Study of Decision Making in Patients Participating in Phase I Clinical Trials|Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients|Completed||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:47.517899|2017-10-11 04:44:47.517899
NCT00054236|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2012-09-11|||May 2002||2002-05-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia|Pilot Study Of Multiple Umbilical Cord Blood Unit Transplantation Following Non-Myeloablative Conditioning In Patients With Hematologic Disorders Or Severe Aplastic Anemia|Completed||Phase 1|55|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:44:47.602139|2017-10-11 04:44:47.602139
NCT00054249|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-07-17|||September 2002||2002-09-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|October 2004|Actual|2004-10-01||Interventional|||T900607 in Treating Patients With Gastroesophageal Junction Cancer|A Phase II Study Of Intravenous T900607-Sodium In Subjects With Previously Treated Gastric Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:47.745562|2017-10-11 04:44:47.745562
NCT00054262|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-07-17|||November 2002||2002-11-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|March 2004|Actual|2004-03-01||Interventional|||T900607 in Treating Patients With Unresectable Liver Cancer|A Phase II Study Of Intravenous T900607-Sodium In Subjects With Chemotherapy-Naive Unresectable Hepatocellular Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:47.816393|2017-10-11 04:44:47.816393
NCT00054275|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2016-02-15|2012-02-21||December 2002||2002-12-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|April 2010|Actual|2010-04-01||Interventional|||Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer|A Phase II Study Of The Weekly Administration Of Docetaxel In Combination With The Epidermal Growth Factor Receptor Inhibitor OSI-774 In Recurrent And/Or Metastatic Breast Cancer|Completed||Phase 2|39|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:44:47.895327|2017-10-11 04:44:47.895327
NCT00054288|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2014-01-10|||August 2001||2001-08-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|May 2003|Actual|2003-05-01||Interventional|||Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors|Escalating Irinotecan (CPT-11) Administered 24 Hours Prior To Gemcitabine In Patients With Refractory Solid Tumors|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:44:48.380981|2017-10-11 04:44:48.380981
NCT00054301|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2010-06-10|||November 2002||2002-11-01|June 2010|2010-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer|Intraoperative Radiation Therapy to the Tumor Bed for Boost Treatment After Lumpectomy Prior to Whole Breast Radiation in Breast Conservation Candidates|Completed||Phase 2|2|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:44:48.453156|2017-10-11 04:44:48.453156
NCT00054314|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-01-30|||March 2002||2002-03-01|January 2013|2013-01-01||||April 2003|Actual|2003-04-01||Interventional|||BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer|An Uncontrolled, Phase II Study Evaluating Anti-Tumor Efficacy and Safety of BAY 59-8862 in Patients With Taxane Resistant Non-Small Cell Lung Carcinoma (NSCLC)|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:44:48.539087|2017-10-11 04:44:48.539087
NCT00054327|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-06-19|2013-04-30||November 2000||2000-11-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer|Hematopoietic Stem Cell Transplantation Using Bone Marrow Or Peripheral Blood Stem Cells From Matched, Unrelated, Volunteer Donors|Completed||Phase 2|34|Actual|Case Comprehensive Cancer Center||6|||f||||t||||||||||2017-10-11 04:44:48.610552|2017-10-11 04:44:48.610552
NCT00054340|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2010-05-12|||October 2002||2002-10-01|May 2010|2010-05-01|September 2006|Actual|2006-09-01|||||Interventional|||Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder|Conditioning With Targeted Busulfan, Cyclophosphamide and Thymoglobulin for Allogeneic Marrow or Peripheral Blood Stem Cell (PBSC) Transplantation for Myelodysplasia and Myeloproliferative Disorders|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:44:49.788607|2017-10-11 04:44:49.788607
NCT00054392|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-07-10|||September 2001||2001-09-01|July 2013|2013-07-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Randomized, Phase III Multicenter Trial Of Gemcitabine In Combination With Carboplatin Or Paclitaxel Plus Carboplatin In Patients With Metastatic (Stage IIIB, IV) Non-Small Cell Lung Cancer|Withdrawn||Phase 3|0|Actual|Fox Chase Cancer Center||||Not opened at Fox Chase Cancer Center|f||||||||||||||2017-10-11 04:44:50.023231|2017-10-11 04:44:50.023231
NCT00054405|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-04-08|||December 2002||2002-12-01|April 2013|2013-04-01||||May 2009|Actual|2009-05-01||Interventional|||Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma|A Phase I Investigation of IL-12 (NSC 672423)/Pulse IL-2 (Aldesleukin) in Children With Persistent and/or Refractory Neuroblastoma (13623)|Terminated||Phase 1|40|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:44:50.216301|2017-10-11 04:44:50.216301
NCT00054418|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2016-07-12|||March 2003||2003-03-01|July 2016|2016-07-01|May 2008|Actual|2008-05-01|April 2007|Actual|2007-04-01||Interventional|||Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer|A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma|Completed||Phase 3|216|Actual|Alliance for Clinical Trials in Oncology||2|||f||||||||||||||2017-10-11 04:44:50.351259|2017-10-11 04:44:50.351259
NCT00054431|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-01-22|||January 2003||2003-01-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia|Phase II Study of Imatinib Mesylate (Gleevec, STI-571) (NSC#716051) and Decitabine (5-AZA-2'-Deoxycitidine) (NSC#127716), in Chronic Myelogenous Leukemia in Accelerated and Blastic Phases|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:50.849022|2017-10-11 04:44:50.849022
NCT00054444|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2014-12-29|||September 2007||2007-09-01|December 2014|2014-12-01||||January 2012|Actual|2012-01-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer|A PHASE I STUDY OF PELVIC RADIATION THERAPY WITH CONCOMITANT WEEKLY CISPLATIN AND TOPOTECAN CHEMOTHERAPY IN PATIENTS WITH CERVICAL CARCINOMA WITHOUT EXTRA-PELVIC METASTASIS|Completed||Phase 1|11|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:44:50.964748|2017-10-11 04:44:50.964748
NCT00054457|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2016-12-09|||September 2003||2003-09-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction|A Phase II Study Of Docetaxel And Capecitabine In Patients With Measurable Metastatic Adenocarcinoma Of The Stomach And Gastroesophageal Junction|Completed||Phase 2|46|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:44:51.094409|2017-10-11 04:44:51.094409
NCT00054470|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2012-06-27|||December 2002||2002-12-01|June 2012|2012-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer|A Phase II Evaluation Of The Efficacy And Safety Of R115777 (NSC702818) A Non-Peptidomimetic Farnesyl Transferase Inhibitor, And Trastuzumab In Patients With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 04:44:51.261916|2017-10-11 04:44:51.261916
NCT00054483|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-05-15|||January 2003||2003-01-01|May 2013|2013-05-01||||September 2009|Actual|2009-09-01||Interventional|||Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction|A Phase I Pharmacokinetic Study of PS341 in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction for the CTEP-Sponsored Organ Dysfunction Working Group|Completed||Phase 1|69|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:51.352829|2017-10-11 04:44:51.352829
NCT00054496|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2014-01-09|||August 2002||2002-08-01|December 2006|2006-12-01||||||||Interventional|||Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme|Phase II Study Trial Of Tarceva In Patients With Recurrent/Progressive Glioblastoma Multiforme|Unknown status|Recruiting|Phase 2|73|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:51.470247|2017-10-11 04:44:51.470247
NCT00054522|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2011-03-07|||April 2002||2002-04-01|March 2011|2011-03-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy|Calcitriol + Dexamethasone in Early, Recurrent Prostate Cancer Following Local Therapy, A Phase I/II Trial|Completed||Phase 2|15|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:44:51.563109|2017-10-11 04:44:51.563109
NCT00054535|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-06-18|||January 2003||2003-01-01|July 2004|2004-07-01|September 2004|Actual|2004-09-01|||||Interventional|||Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma|Treatment Of Patients With Metastatic Melanoma Using Recombinant Vaccinia And Fowlpox Viruses Encoding The Tyrosine Antigen In Combination With Interleukin-2|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:51.63725|2017-10-11 04:44:51.63725
NCT00054548|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-05-15|||October 2002||2002-10-01|May 2013|2013-05-01||||May 2008|Actual|2008-05-01||Interventional|||Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors|A Phase I Study of Antisense Bcl-2 Oligonucleotide (G3139) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:51.704329|2017-10-11 04:44:51.704329
NCT00054561|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2009-02-06|||August 2003||2003-08-01|May 2004|2004-05-01||||December 2004|Actual|2004-12-01||Interventional|||Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Phase III Randomized Study of Adjuvant Biologic Therapy in Patients With Stages III/IV Head and Neck Squamous Cell Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:51.806781|2017-10-11 04:44:51.806781
NCT00054574|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2012-08-02|||November 2002||2002-11-01|August 2012|2012-08-01|February 2004|Actual|2004-02-01|September 2003|Actual|2003-09-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer|A Clinical Trial Evaluating The Safety And Efficacy Of ABX-EGF In Patients With Hormone Resistant Prostate Cancer With Elevated PSA Without Metastasis|Completed||Phase 2|||Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:44:52.110116|2017-10-11 04:44:52.110116
NCT00054587|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-07-18|||June 2001||2001-06-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer|Randomized And Multicentric Opened Phase III Study Evaluating The Concomitant Administration Of Docetaxel 75MG/M2 and Epirubicine 75MG/M2 Versus FEC 100 In Non Metastatic With Positive Lymphatic Nodes Breast Cancer Subjects, And The Sequential Addition Of Herceptin In (HER2+++) And (HER2++ And FISH+) Subjects|Completed||Phase 3|3010|Actual|UNICANCER||2|||f||||t||||||||||2017-10-11 04:44:52.3004|2017-10-11 04:44:52.3004
NCT00054600|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2017-08-14|||June 2002||2002-06-01|August 2017|2017-08-01|June 2004||2004-06-01|||||Interventional|||Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease|A Study of Extracorporeal Photopheresis With UVADEX in the Setting of a Standard Myeloablative Conditioning Regimen for the Prevention of Graft-versus-Host Disease in Patients Undergoing an Allogeneic Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant|Completed||Phase 2|60||Mallinckrodt|||||||||||||||||||2017-10-11 04:44:52.519607|2017-10-11 04:44:52.519607
NCT00054613|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2017-08-14|||June 2002||2002-06-01|August 2017|2017-08-01|March 2004||2004-03-01|||||Interventional|||Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease|A Randomized Single-Blind Study of Extracorporeal Photoimmune Therapy With UVADEX in Conjunction With Standard Therapy Alone for the Treatment of Patients With Corticosteroid-Refractory, Corticosteroid-Dependent, or Corticosteroid-Intolerant Chronic Graft-versus-Host Disease|Completed||Phase 2|72||Mallinckrodt|||||||||||||||||||2017-10-11 04:44:52.679148|2017-10-11 04:44:52.679148
NCT00242957|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2009-02-05|||June 2001||2001-06-01|December 2008|2008-12-01|April 2005||2005-04-01|||||Interventional|||The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) Study||Completed||N/A|||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:44:33.816333|2017-10-11 05:44:33.816333
NCT00054626|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2013-12-17|||September 2001||2001-09-01|November 2008|2008-11-01||||June 2008|Anticipated|2008-06-01||Interventional|||Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer|Phase III Study Of Adjuvant Cisplatin-Gemcitabine Vs. Observation After Radical Cystectomy In High-Risk Bladder Cancer|Unknown status|Active, not recruiting|Phase 3|700|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:44:52.900816|2017-10-11 04:44:52.900816
NCT00054639|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2014-05-13|2011-01-24||January 2003||2003-01-01|March 2013|2013-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma|A Phase II Study of G3139 (Bcl-2 Antisense) And Rituximab in Patients With Recurrent B-cell Non-Hodgkinâs Lymphomas|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:44:53.373709|2017-10-11 04:44:53.373709
NCT00054652|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2008-03-03|||February 2003||2003-02-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Observational|||Survey of Sensory and Motor Tricks in Focal Dystonia|Survey of Sensory and Motor Tricks in Focal Dystonia|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:44:53.615158|2017-10-11 04:44:53.615158
NCT00054665|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-05|2012-08-10|2012-06-25||February 2003||2003-02-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|September 2008|Actual|2008-09-01||Interventional|||PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma|PS-341 and PS-341 + Epoch Chemotherapy and Molecular Profiling in Relapsed or Refractory Diffuse Large B-Cell Lymphomas|Completed||Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:44:53.692546|2017-10-11 04:44:53.692546
NCT00054678|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-06|2007-10-11|||February 2003||2003-02-01|October 2007|2007-10-01|October 2007|Anticipated|2007-10-01|||||Interventional|||MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)|A Phase I, Open-Label, Non-Randomized, Dose Escalation, Multi Center Study to Assess the Safety and Cardiovascular Effects of Autologous Skeletal Myoblast Implantation by a Transendocardial Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s) With Previous Placement of ICD|Unknown status|Active, not recruiting|Phase 1|20||Bioheart, Inc.|||||f||||||||||||||2017-10-11 04:44:54.664512|2017-10-11 04:44:54.664512
NCT00054691|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-06|2015-02-24|2015-01-28||May 2004||2004-05-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Out of 40 participants, 2 participants had unmeasurable disease and 1 participant was noncompliant.|ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin|A Phase II Study of ZD1839 (Iressa), Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor, in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Skin|Completed||Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:44:54.763665|2017-10-11 04:44:54.763665
NCT00054704|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-06|2016-05-17|2015-12-10||February 2003||2003-02-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All participants randomized.|Riluzole to Treat Depression in Bipolar Disorder|An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression|Terminated||Phase 2|20|Actual|National Institutes of Health Clinical Center (CC)|The study was terminated due to results suggesting the active drug was leading to worse outcomes than placebo.|2||Placebo was better than active drug.|f||||t||||||||No||2017-10-11 04:44:55.127846|2017-10-11 04:44:55.127846
NCT00054717|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-07|2014-06-23|2009-09-09||January 2003||2003-01-01|April 2014|2014-04-01||||September 2008|Actual|2008-09-01||Interventional||Safety Set, all patients treated with at least one dose of study drug|Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)|Randomized, Open-label, Comparative Safety and Efficacy Study of Tipranavir Boosted With Low-dose Ritonavir (TPV/RTV) Verses Genotypically-defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-experienced Patients.|Completed||Phase 3|630|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 04:44:55.625293|2017-10-11 04:44:55.625293
NCT00054743|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-07|2017-06-30|||February 6, 2003||2003-02-06|April 28, 2011|2011-04-28|April 28, 2011|Actual|2011-04-28|||||Interventional|||Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States|Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations|Completed||Phase 4|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:45:02.850843|2017-10-11 04:45:02.850843
NCT00054756|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-07|2017-10-05|||February 6, 2003||2003-02-06|April 25, 2017|2017-04-25|February 3, 2017|Actual|2017-02-03|February 3, 2017|Actual|2017-02-03||Interventional|||Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities|Study of Thyrotropin Releasing Hormone in Patients With Thyroid or Pituitary Abnormalities|Completed||Phase 2|157|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:45:02.954048|2017-10-11 04:45:02.954048
NCT00054769|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-10|2008-09-16|||March 2002||2002-03-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Diagnosing Tuberculosis in HIV Infected Children in Peru|Diagnostics For AIDS-Related Pediatric TB, Peru|Completed||N/A|760||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:45:03.086382|2017-10-11 04:45:03.086382
NCT00054795|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-10|2007-05-04||||||May 2007|2007-05-01||||||||Interventional|||Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)|Randomized Phase III Trial of Xcytrin® (Motexafin Gadolinium) Injection for the Treatment of Brain Metastases in Patients With Non-Small Cell Lung Cancer Undergoing Whole Brain Radiation Therapy|Completed||Phase 3|550||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 04:45:03.211978|2017-10-11 04:45:03.211978
NCT00054808|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-10|2006-02-07|||June 2002||2002-06-01|February 2006|2006-02-01||||||||Interventional|||Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Multicenter Study of Gallium Nitrate in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|40||Genta Incorporated|||||||||||||||||||2017-10-11 04:45:04.106848|2017-10-11 04:45:04.106848
NCT00054821|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-11|2017-03-16|||November 2002||2002-11-01|March 2017|2017-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Prevention of Post-Traumatic Osteoarthritis (OA)|Pathogenesis-Prevention of Post-Traumatic Osteoarthritis (OA): Effects of Distraction and Motion on OA|Completed||N/A|40|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 04:45:04.236528|2017-10-11 04:45:04.236528
NCT00054847|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-11|2014-04-18|2014-01-31||February 2003||2003-02-01|April 2014|2014-04-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|||Radial Artery Versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery|CSP #474 - Radial Artery vs. Saphenous Vein Grafts in Coronary Artery Bypass Surgery (Radial Artery)|Completed||N/A|733|Actual|VA Office of Research and Development|There was more disease in the radial artery grafts at 1 week and at 1 year. There is more spasm or string sign in radial artery grafts. Study was conducted predominantly in men. Data show lower vein graft patency when endoscopic harvesting was used.|2|||f||||t||||||||||2017-10-11 04:45:04.690913|2017-10-11 04:45:04.690913
NCT00054860|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-11|2015-04-13||||||April 2015|2015-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults|A Phase I Dose-Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of the EP HIV-1090 DNA Vaccine in Healthy, HIV-1-Uninfected Adult Participants|Completed||Phase 1|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:45:07.822328|2017-10-11 04:45:07.822328
NCT00054873|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-12|2006-07-10|||November 2003||2003-11-01|June 2006|2006-06-01|December 2004||2004-12-01|||||Interventional|||Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer||Completed||Phase 2|||Chiron Corporation|||||||||||||||||||2017-10-11 04:45:07.929092|2017-10-11 04:45:07.929092
NCT00054886|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-12|2007-05-04|||January 2003||2003-01-01|July 2006|2006-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer|Phase II Study Of Single-Agent SU011248 In The Second-Line Treatment Of Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|63||Pfizer|||||f||||||||||||||2017-10-11 04:45:08.04605|2017-10-11 04:45:08.04605
NCT00054899|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-12|2010-03-23|||January 2003||2003-01-01|April 2004|2004-04-01||||||||Interventional|||An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer|An Open Label, Multi-center Safety and Tolerance Study of EP2101 Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|18||Epimmune|||||||||||||||||||2017-10-11 04:45:08.139023|2017-10-11 04:45:08.139023
NCT00054912|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-12|2008-04-07|||February 2003||2003-02-01|April 2004|2004-04-01||||||||Interventional|||An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer|An Open Label, Multi-Center Safety and Tolerance Study of EP2101 Peptide Vaccine in Patients With Stage III Colon Cancer|Completed||Phase 1|18||Epimmune|||||||||||||||||||2017-10-11 04:45:08.209482|2017-10-11 04:45:08.209482
NCT00054925|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-13|2012-03-06|||January 2003||2003-01-01|March 2012|2012-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|WLM||Weight Loss Maintenance (WLM)|Weight Loss Maintenance (WLM)|Completed||N/A|1685|Actual|Duke University||2|||f||||t||||||||||2017-10-11 04:45:08.518746|2017-10-11 04:45:08.518746
NCT00054938|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-13|2013-12-23|||March 2003||2003-03-01|December 2013|2013-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)|A Randomized Controlled Trial of Strategies for the Prevention of Accelerated Atherosclerosis in Systemic Lupus Erythematosus - A Pilot Study|Completed||Phase 2|150||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 04:45:08.639661|2017-10-11 04:45:08.639661
NCT00054951|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-13|2005-06-23|||June 2001||2001-06-01|September 2003|2003-09-01||||||||Interventional|||Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads|A Phase I/II, Open Label, Multicenter, Single-Arm, Safety and Efficacy Study of Doxorubicin Hydrochloride Adsorbed to Magnetic Targeted Carriers (MTC-DOX) Administered by Intrahepatic Delivery (Via Hepatic Artery Catheterization) for the Treatment of Patients With Unresectable Hepatocellular Carcinoma.|Unknown status|Active, not recruiting|Phase 1/Phase 2|30||FeRx|||||||||||||||||||2017-10-11 04:45:08.743122|2017-10-11 04:45:08.743122
NCT00054964|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-14|2017-02-03|||March 2003||2003-03-01|February 2017|2017-02-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique|Comparison of Single-dose Efficacy of Albuterol-HFA-BOI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability|Completed||Phase 2|14|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 04:45:08.839648|2017-10-11 04:45:08.839648
NCT00054977|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-14|2012-03-09|||February 2003||2003-02-01|March 2012|2012-03-01|September 2006|Actual|2006-09-01|April 2005|Actual|2005-04-01||Interventional|||Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors|A Phase I Open-Label Study to Evaluate the Safety and Tolerability of Escalating Doses of GM-CT-01 in the Presence and Absence of 5-Fluorouracil (5-FU) in Subjects With Advanced Solid Tumors|Completed||Phase 1|40|Actual|Galectin Therapeutics Inc.||1|||f||||f||||||||||2017-10-11 04:45:08.927379|2017-10-11 04:45:08.927379
NCT00054990|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-15|2008-03-03|||February 2003||2003-02-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Effects of Antiepileptic Drugs on Brain Excitability|The Effects Of Antiepileptic Drugs On Cortical Excitability|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:09.008202|2017-10-11 04:45:09.008202
NCT00055003|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-15|2017-06-30|||February 13, 2003||2003-02-13|November 18, 2010|2010-11-18|November 18, 2010||2010-11-18|||||Observational|||Effect of Hydrocortisone on the Brain|Effects of Hydrocortisone Infusion on Processing of Facially Expressed Emotion During Functional Magnetic Resonance Imaging|Completed||N/A|80|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:09.063722|2017-10-11 04:45:09.063722
NCT00055016|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-15|2017-06-30|||February 13, 2003||2003-02-13|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Registry of Fabry Disease - A Multicenter Observational Study|Registry of Fabry Disease: A Multicenter, Longitudinal Observational Study|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:09.131491|2017-10-11 04:45:09.131491
NCT00055029|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-15|2017-10-05|||February 12, 2003||2003-02-12|August 17, 2017|2017-08-17||||||||Observational|||Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis|X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:09.187663|2017-10-11 04:45:09.187663
NCT00055042|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-15|2008-03-03|||February 2003||2003-02-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Interventional|||Laser and Antioxidant Treatment of Diabetic Macular Edema|Laser and Antioxidant Treatment of Diabetic Macular Edema|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:09.286948|2017-10-11 04:45:09.286948
NCT00071604|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2013-05-03|||September 2002||2002-09-01|April 2008|2008-04-01|May 2007||2007-05-01|||||Interventional|||Medication Adherence in Older People With Psychosis|Medication Adherence in Older Psychotic People|Unknown status|Active, not recruiting|N/A|240|Anticipated|Veterans Medical Research Foundation|||||f||||||||||||||2017-10-11 04:45:58.882575|2017-10-11 04:45:58.882575
NCT00055055|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-15|2017-10-05|||February 13, 2003||2003-02-13|September 27, 2017|2017-09-27||||||||Observational|||Study of Families With Twins or Siblings Discordant for Rheumatic Disorders|Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders|Recruiting||N/A|1550|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:09.388134|2017-10-11 04:45:09.388134
NCT00055068|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-19|2014-05-06|||March 2002||2002-03-01|February 2008|2008-02-01|February 2006||2006-02-01|||||Interventional|||Family Based Treatment of Early Childhood Obsessive Compulsive Disorder|Family Based Treatment of Early Childhood OCD|Completed||Phase 3|38|Anticipated|Rhode Island Hospital|||||f||||||||||||||2017-10-11 04:45:09.500121|2017-10-11 04:45:09.500121
NCT00055081|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-19|2013-12-05|||July 2002||2002-07-01|December 2013|2013-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||The Impact of Family CTI on Homeless Children|The Impact of Family CTI on Homeless Children|Completed||N/A|320|Actual|Nathan Kline Institute for Psychiatric Research||1|||f||||f||||||||||2017-10-11 04:45:09.581904|2017-10-11 04:45:09.581904
NCT00055094|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-19|2005-06-23|||July 1999||1999-07-01|April 2004|2004-04-01||||||||Observational|||Treatment of Acute HIV Infection to Preserve Immune Function|Immune Control of HIV Replication|Completed||N/A|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:45:09.649733|2017-10-11 04:45:09.649733
NCT00055107|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-19|2012-02-14||||||February 2012|2012-02-01|May 2006|Actual|2006-05-01|||||Interventional|||Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children|A Phase I/II Open Label Study of Nitazoxanide (NTZ) for the Treatment of Cryptosporidium Parvum in HIV Infected Infants, Children, and Adolescents|Completed||Phase 1/Phase 2|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:45:09.714856|2017-10-11 04:45:09.714856
NCT00055120|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-19|2014-10-14|||March 2003||2003-03-01|October 2014|2014-10-01|August 2007|Actual|2007-08-01|September 2006|Actual|2006-09-01||Interventional|||When to Start Anti-HIV Drugs in Patients With Opportunistic Infections|A Phase IV Study of Antiretroviral Therapy for HIV Infected Adults Presenting With Acute Opportunistic Infections: Immediate Versus Deferred Initiation of Antiretroviral Therapy|Completed||Phase 4|283|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:45:09.807903|2017-10-11 04:45:09.807903
NCT00055133|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-19|2008-07-26|||September 2002||2002-09-01|July 2008|2008-07-01|December 2004||2004-12-01|||||Interventional|||A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis|A Phase 2 Open-Label Clinical Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis|Completed||Phase 2|50||Angiotech Pharmaceuticals|||||||||||||||||||2017-10-11 04:45:10.008637|2017-10-11 04:45:10.008637
NCT00055146|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-19|2009-04-16|||March 2003||2003-03-01|April 2009|2009-04-01|May 2006|Actual|2006-05-01|March 2006|Actual|2006-03-01||Interventional|||Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)|A Multicenter, Phase II Study of ONTAK (Denileukin Diftitox) in Patients With Previously-Treated Chronic Lymphocytic Leukemia|Completed||Phase 2|41|Anticipated|Eisai Inc.|||||f||||||||||||||2017-10-11 04:45:10.119467|2017-10-11 04:45:10.119467
NCT00055159|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-20|2017-06-30|||February 19, 2003||2003-02-19|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Interventional|||Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins|Treatment of Jugular, Subclavian, and/or Innominate Vein Thrombosis With Low Dose Recombinant Tissue Plasminogen Activator Plus Anticoagulation|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:10.240202|2017-10-11 04:45:10.240202
NCT00055172|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-20|2017-10-05|||February 14, 2003||2003-02-14|June 1, 2017|2017-06-01||||||||Observational|||Genetic Basis of Immunodeficiency|The Determination of Genetic Basis Of Immunodeficiency|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:10.314593|2017-10-11 04:45:10.314593
NCT00055185|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-20|2008-10-02|||April 2003||2003-04-01|October 2008|2008-10-01|June 2005|Actual|2005-06-01|||||Interventional|||Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients||Completed||Phase 2|24||Progenics Pharmaceuticals, Inc.||2|||f||||||||||||||2017-10-11 04:45:10.414082|2017-10-11 04:45:10.414082
NCT00055198|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-20|2017-06-12|||December 19, 2002|Actual|2002-12-19|June 2017|2017-06-01|January 26, 2004|Actual|2004-01-26|January 26, 2004|Actual|2004-01-26||Interventional|||Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria|A Compassionate Use Protocol for Intravenous Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria That Cannot be Adequately Treated With Currently Available Therapy|Terminated||Phase 3|75||Cubist Pharmaceuticals LLC||||Study terminated due to low enrollment|||||||||||||||2017-10-11 04:45:10.487082|2017-10-11 04:45:10.487082
NCT00055224|ClinicalTrials.gov processed this data on October 10, 2017|2003-02-21|2017-10-05|||February 13, 2003||2003-02-13|August 15, 2017|2017-08-15||||||||Observational|||Expectation of Unpleasant Events in Anxiety Disorders|Predictability and Aversive Expectancies in Anxiety and Depressive Disorders|Recruiting||N/A|1271|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:10.765458|2017-10-11 04:45:10.765458
NCT00061243|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-22|2008-09-25|||April 2004||2004-04-01|December 2005|2005-12-01|April 2010|Anticipated|2010-04-01|April 2005|Actual|2005-04-01||Interventional|||Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Multi-Gene, Polyvalent HIV-1 DNA Plasmid Prime/Env Protein Boost Vaccine Formulation, DP6-001 in Healthy Volunteers|Unknown status|Active, not recruiting|Phase 1|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-10-11 04:45:10.87095|2017-10-11 04:45:10.87095
NCT00061256|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-22|2009-08-06||||||August 2009|2009-08-01|September 2006|Actual|2006-09-01|||||Interventional|||The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Once-Weekly Alendronate in HIV-Infected Subjects With Decreased Bone Mineral Density Receiving Calcium and Vitamin D|Completed||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:45:10.9712|2017-10-11 04:45:10.9712
NCT00061269|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-22|2010-01-12|||September 2003||2003-09-01|January 2010|2010-01-01||||||||Interventional|||Videoendoscopic Drainage of Infected Pancreatic Collections||Completed||Phase 2|40|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:45:11.158733|2017-10-11 04:45:11.158733
NCT00061282|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-23|2017-07-18|||September 2002||2002-09-01|July 2017|2017-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CAPTURE||Clotrimazole Enemas for Pouchitis in Children and Adults|Clotrimazole Enemas for Pouchitis in Children and Adults|Suspended||Phase 1/Phase 2|40|Anticipated|Boston Children’s Hospital||3||Funding Horizon|f||||t||||||||||2017-10-11 04:45:11.237845|2017-10-11 04:45:11.237845
NCT00061295|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-23|2005-06-23|||March 1999||1999-03-01|March 2003|2003-03-01|February 2004||2004-02-01|||||Interventional|||Treadmill Training With Body Weight Support in Patients With Spinal Cord Injury|Body Weight Supported Ambulation Training After Spinal Cord Injury|Unknown status|Recruiting|Phase 1|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:45:11.323653|2017-10-11 04:45:11.323653
NCT00061308|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-23|2017-06-08|||December 2002||2002-12-01|March 2013|2013-03-01||||September 2004|Actual|2004-09-01||Interventional|||Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer|An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer|Completed||Phase 2|75||GlaxoSmithKline|||||f||||||||||||||2017-10-11 04:45:11.398155|2017-10-11 04:45:11.398155
NCT00061321|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-23|2008-07-30|||August 2002||2002-08-01|August 2007|2007-08-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|SWEN||Daily Nevirapine to Prevent Mother to Infant Transmission of HIV|Prevention of Maternal to Infant HIV Transmission in India|Completed||Phase 3|770|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 04:45:11.516774|2017-10-11 04:45:11.516774
NCT00061334|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-23|2017-06-30|||May 7, 2003||2003-05-07|December 29, 2011|2011-12-29|December 29, 2011||2011-12-29|||||Observational|||Investigating the Cognitive Processes That Underlie Social Knowledge and Behavior|Social Knowledge Representation in the Human Prefrontal Cortex|Completed||N/A|222|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:11.732212|2017-10-11 04:45:11.732212
NCT00061347|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-23|2017-10-05|||May 21, 2003||2003-05-21|May 23, 2017|2017-05-23|April 4, 2011|Actual|2011-04-04|May 31, 2004|Actual|2004-05-31||Interventional|||Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment|Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study|Completed||Phase 1|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:45:11.795504|2017-10-11 04:45:11.795504
NCT00061360|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-23|2017-10-05|||May 19, 2003||2003-05-19|August 16, 2017|2017-08-16|September 8, 2015|Actual|2015-09-08|May 31, 2006|Actual|2006-05-31||Interventional|||Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia|A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects With Severe Aplastic Anemia|Completed||Phase 2|77|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:45:11.907244|2017-10-11 04:45:11.907244
NCT00061373|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-23|2012-12-27|2012-12-27||May 2003||2003-05-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|CATALIST||Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)|Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)|All patients enrolled were dosed with aspirin and tinzaparin. None of the patients received iv eptifibatide. The study was closed prior to dosing with eptifibatide due to slow recruitment over the 5-year trial period.|2|||f||||t||||||||||2017-10-11 04:45:12.015584|2017-10-11 04:45:12.015584
NCT00061386|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-27|2005-09-09|||March 2001||2001-03-01|September 2005|2005-09-01|March 2004||2004-03-01|||||Interventional|||Improving Health in Low Income Women Following the Birth of a Child|Reducing Disease Risk in Low Income Postpartum Women|Completed||N/A|680||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:45:12.48699|2017-10-11 04:45:12.48699
NCT00061399|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-27|2014-10-28|||July 2002||2002-07-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Prospective Memory in Children With Traumatic Brain Injury|Prospective Memory in Normal and Head-Injured Children|Completed||N/A|178||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:45:12.557025|2017-10-11 04:45:12.557025
NCT00061412|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-27|2006-09-27|||December 1995||1995-12-01|September 2006|2006-09-01|November 2005||2005-11-01|||||Interventional|||Comprehensive Program to Improve Reading and Writing Skills in At-Risk and Dyslexic Children|Learning Disabilities: Links to Schools and Biology|Completed||N/A|2500||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:45:12.612521|2017-10-11 04:45:12.612521
NCT00061425|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-27|2009-01-08|||August 2000||2000-08-01|January 2009|2009-01-01||||November 2007|Actual|2007-11-01||Interventional|||Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG|Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immuno-LL2: Treatment With 90Y-hLL2 IgG|Completed||Phase 1/Phase 2|||Immunomedics, Inc.|||||f||||f||||||||||2017-10-11 04:45:12.68314|2017-10-11 04:45:12.68314
NCT00061438|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-27|2017-08-31|||February 2003||2003-02-01|August 2017|2017-08-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died|A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis|Completed||Phase 4|240||Pfizer|||||||||||||||||||2017-10-11 04:45:12.741985|2017-10-11 04:45:12.741985
NCT00061451|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-28|2010-12-20|||December 2002||2002-12-01|December 2010|2010-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial|ALIMTA Plus Gemcitabine as Front-line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer: A Phase II Clinical Trial|Completed||Phase 2|48||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:45:12.827399|2017-10-11 04:45:12.827399
NCT00061464|ClinicalTrials.gov processed this data on October 10, 2017|2003-05-28|2007-01-24|||February 2003||2003-02-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.|ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase II Clinical Trial|Completed||Phase 2|48||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:45:12.911707|2017-10-11 04:45:12.911707
NCT00067626|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2010-10-14|||April 2005||2005-04-01|October 2010|2010-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes|Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes|Completed||Phase 2|60|Anticipated|Griffin Hospital||2|||f||||t||||||||||2017-10-11 04:45:12.997537|2017-10-11 04:45:12.997537
NCT00067639|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2012-07-31|||December 2003||2003-12-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma|Pegfilgrastim (Neulasta) for Mobilization of Peripheral Blood Progenitor Cells (PBPC) in Patients With Multiple Myeloma|Completed||Phase 2|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:45:13.095251|2017-10-11 04:45:13.095251
NCT00067652|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01|November 2003||2003-11-01|||||Interventional|||Improving Body Image in Middle Schoolers||Completed||Phase 1|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:45:13.17816|2017-10-11 04:45:13.17816
NCT00067665|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2011-03-25|||August 2003||2003-08-01|January 2011|2011-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Hypertension in Hemodialysis|Hypertension in Hemodialysis|Completed||N/A|150|Anticipated|Indiana University||2|||f||||f||||||||||2017-10-11 04:45:13.233413|2017-10-11 04:45:13.233413
NCT00067678|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2006-08-16|||July 2001||2001-07-01|August 2006|2006-08-01|June 2003||2003-06-01|||||Interventional|||Soy Protein in Early Diabetic Nephropathy|Soy Protein in Early Diabetic Nephropathy|Completed||Phase 1/Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:13.301049|2017-10-11 04:45:13.301049
NCT00067691|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2006-08-16|||November 2001||2001-11-01|August 2006|2006-08-01|November 2003||2003-11-01|||||Interventional|||Acupuncture for Shortness of Breath in Cancer Patients|Acupuncture for Shortness of Breath in Cancer Patients|Completed||N/A|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:13.366919|2017-10-11 04:45:13.366919
NCT00067704|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2015-10-09|||February 2004||2004-02-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Emotional Disclosure in HIV|Efficacy of an Emotional Disclosure Intervention in HIV|Completed||N/A|283|Actual|University of Miami||2|||f||||f||||||||||2017-10-11 04:45:13.431983|2017-10-11 04:45:13.431983
NCT00067717|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2014-10-17|||November 2003||2003-11-01|October 2014|2014-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Distance Healing in Wound Healing|Placebo Effects in Distance Healing of Wounds|Completed||Phase 1/Phase 2|72|Actual|California Pacific Medical Center Research Institute||3|||f||||t||||||||||2017-10-11 04:45:13.50001|2017-10-11 04:45:13.50001
NCT00067730|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-25|2007-12-03|||March 2003||2003-03-01|December 2007|2007-12-01|October 2003|Actual|2003-10-01|||||Interventional|||A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation|A Safety Evaluation of Xigris Drotrecogin Alfa Activated in Hematopoietic Stem Cell Transplant Patients With Severe Sepsis|Completed||Phase 4|7|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:45:13.572461|2017-10-11 04:45:13.572461
NCT00067743|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-26|2007-12-28|||August 2003||2003-08-01|December 2006|2006-12-01|August 2007|Actual|2007-08-01|October 2004|Actual|2004-10-01||Interventional|CRPS||A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)|A Multicenter, Open-Label Study to Evaluate the Preliminary Safety and Efficacy of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)|Completed||Phase 2|40|Actual|Celgene||1|||f||||t||||||||||2017-10-11 04:45:13.653915|2017-10-11 04:45:13.653915
NCT00067756|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-26|2014-01-02|||November 2001||2001-11-01|April 2013|2013-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?|"4 Phenyl Butyrate Mediated Secretion Rescue in Alpha 1-Antitrypsin Deficient Individuals"|Completed||Phase 2|12|Actual|University of Florida||1|||f||||t||||||||||2017-10-11 04:45:13.732458|2017-10-11 04:45:13.732458
NCT00067769|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-27|2015-12-04|||October 2003||2003-10-01|June 2014|2014-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Internet-based Treatment of Early Childhood Fecal Incontinence|Treatment of Early Childhood Constipation/Encopresis|Completed||N/A|91|Actual|University of Virginia||2|||f||||f||||||||||2017-10-11 04:45:13.816844|2017-10-11 04:45:13.816844
NCT00067782|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-27|2011-04-07||2010-01-28|December 2002||2002-12-01|January 2010|2010-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy||Completed||Phase 3|||Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 04:45:13.902545|2017-10-11 04:45:13.902545
NCT00067795|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-27|2010-11-19||||||November 2010|2010-11-01||||||||Observational|||Evaluating Immune Function Tests in People With HIV|"HIV Antigen-Specific Immune Responses - A Comparison of Alternative In Vitro Assays From Subjects Characterized as Either Stable HAART or Efficient Immune Control"|Completed||N/A|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:45:14.009523|2017-10-11 04:45:14.009523
NCT00067808|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-27|2012-08-01|2009-09-25||October 2003||2003-10-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)|Phase II Randomized Study of Three Different Schedules of Low-Dose Decitabine (5-AZA-2'-Deoxycytidine) in Myelodysplastic Syndrome (MDS)|Completed||Phase 2|128|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 04:45:14.083232|2017-10-11 04:45:14.083232
NCT00067821|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-28|2017-10-05|||August 26, 2003||2003-08-26|July 13, 2017|2017-07-13||||||||Observational|||Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity|A Comparative Study of Pediatric CNS Tumor Activity as Assessed by [18]F-FDG PET Imaging and Proton Magnetic Resonance Spectroscopic Imaging ([1]H-MRSI)|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:14.728947|2017-10-11 04:45:14.728947
NCT00067834|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-28|2015-12-22|||November 2003||2003-11-01|December 2015|2015-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Electromagnetic Treatment For Bone Loss After Forearm Fracture|Feasibility and Dosing Study of Bone Density Changes With and Without PEMF Following Immobilization of the Forearm|Completed||Phase 1/Phase 2|80||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:45:14.807808|2017-10-11 04:45:14.807808
NCT00067847|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-28|2010-01-12|||July 2003||2003-07-01|January 2010|2010-01-01|May 2004||2004-05-01|||||Interventional|||Evaluation of California's SB 19 Pupil Nutrition Act||Completed||N/A|5020||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:45:14.874257|2017-10-11 04:45:14.874257
NCT00067860|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-29|2016-05-12|||October 1996||1996-10-01|May 2016|2016-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Diet/Growth Factor Mechanisms of Gut Adaptation|Diet/Growth Factor Mechanisms of Gut Adaptation|Completed||Phase 2|27|Actual|Emory University|||||||||||||||||||2017-10-11 04:45:14.960212|2017-10-11 04:45:14.960212
NCT00067886|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-29|2016-04-12|||March 2003||2003-03-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Matrix Metalloproteinases and Diabetic Nephropathy|Matrix Metalloproteinases and Diabetic Nephropathy|Completed||N/A|330|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-10-11 04:45:15.146126|2017-10-11 04:45:15.146126
NCT00067899|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-29|2013-06-17|||September 2000||2000-09-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Oxidative Stress and Vitamin E Requirements|Oxidative Stress and Vitamin E Requirements|Completed||Phase 2|99||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||f||||||||||2017-10-11 04:45:15.211445|2017-10-11 04:45:15.211445
NCT00067912|ClinicalTrials.gov processed this data on October 10, 2017|2003-08-29|2007-05-17|||April 2003||2003-04-01|May 2007|2007-05-01|March 2004|Actual|2004-03-01|||||Interventional|||Duloxetine vs. Active Comparator for the Treatment of Depression|Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder|Completed||Phase 4|480||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:45:15.286524|2017-10-11 04:45:15.286524
NCT00067925|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-03|2010-10-18|||September 2000||2000-09-01|August 2003|2003-08-01|June 2002||2002-06-01|||||Interventional|||A School-Based Osteoporosis Prevention Program for Adolescent Girls|Incorporating More Physical Activity and Calcium in Teens (IMPACT): A School-Based Osteoporosis Prevention Program for Adolescent Girls|Completed||Phase 1|718||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:45:15.438136|2017-10-11 04:45:15.438136
NCT00067938|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-03|2016-08-31|||August 2003||2003-08-01|August 2016|2016-08-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Bipolar Study in Adults at Least 18 Years of Age|Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness.|Completed||Phase 4|1200|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:45:15.544468|2017-10-11 04:45:15.544468
NCT00067951|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-03|2017-01-16|||October 2003||2003-10-01|January 2017|2017-01-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics|An Open-label Trial to Evaluate the Safety and Efficacy of Fixed Dose Rosiglitazone/Metformin Combination Therapy in Poorly-controlled Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|190|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:45:16.325481|2017-10-11 04:45:16.325481
NCT00069524|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2007-09-25|||June 2004||2004-06-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|||||Interventional|||Antihyperlipidemic Effects of Oyster Mushrooms|Antihyperlipidemic Effects of Oyster Mushrooms|Completed||Phase 1/Phase 2|20||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:45:16.557807|2017-10-11 04:45:16.557807
NCT00069537|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2016-09-02|||May 2002||2002-05-01|September 2016|2016-09-01|November 2002||2002-11-01|||||Interventional|||Continuous Glucose Monitors for Children With Diabetes Mellitus|DirecNet Inpatient Study to Test the Accuracy of Continuous Blood Glucose Monitoring Devices in Children With Type 1 Diabetes|Completed||Phase 4|90||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 04:45:16.636381|2017-10-11 04:45:16.636381
NCT00069550|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2005-06-23|||September 2004||2004-09-01|December 2004|2004-12-01|June 2008||2008-06-01|||||Interventional|||Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome|Pathogenesis of Rett Syndrome: Natural History and Treatment|Unknown status|Recruiting|Phase 3|90||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-10-11 04:45:16.751939|2017-10-11 04:45:16.751939
NCT00069563|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2005-06-23|||September 1995||1995-09-01|October 2003|2003-10-01|September 2000||2000-09-01|||||Interventional|||Improving Mental Health Services for Economically Disadvantaged Children: Training Teachers|John F. Kennedy Center for Mental Retardation: Parent Vs. Teacher-Training in Children's Mental Health Services|Completed||N/A|93||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:45:16.856413|2017-10-11 04:45:16.856413
NCT00069576|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2015-10-19|||October 2002||2002-10-01|October 2015|2015-10-01|October 2013|Actual|2013-10-01|November 2007|Actual|2007-11-01||Interventional|GDM||Gestational Diabetes Mellitus Trial (GDM)|A Randomized Clinical Trial of Treatment for Mild Gestational Diabetes Mellitus|Completed||N/A|1889|Actual|The George Washington University Biostatistics Center||2|||f||||t||||||||||2017-10-11 04:45:17.087364|2017-10-11 04:45:17.087364
NCT00069589|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2017-02-15|||November 2001||2001-11-01|November 2016|2016-11-01|November 2099|Anticipated|2099-11-01|November 2099|Anticipated|2099-11-01||Observational|NAAR||Alopecia Areata Registry|Alopecia Areata Registry and Immunogenetic Mechanisms|Active, not recruiting||N/A|3100|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"     DNA will be analyzed to learn the link between gene markers of traites of alopecia areata.     Sera will be used to analyse cytokins. Lymphocytes will be used for the creation of B-cell     lines.   "|||2017-10-11 04:45:17.224643|2017-10-11 04:45:17.224643
NCT00069602|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2016-09-02|||August 2002||2002-08-01|September 2016|2016-09-01|November 2002||2002-11-01|||||Interventional|||Assessing Continuous Glucose Monitors in Healthy Children|DirecNet Pilot Study to Assess the Accuracy of Continuous Glucose Monitors in Normal Children|Completed||Phase 4|20||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 04:45:17.347391|2017-10-11 04:45:17.347391
NCT00069615|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2016-09-02|||February 2003||2003-02-01|September 2016|2016-09-01|June 2003||2003-06-01|||||Interventional|||Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children|DirecNet Pilot Study to Evaluate the GlucoWatch G2 Biographer in the Management of Type 1 Diabetes in Children|Completed||Phase 4|15||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 04:45:17.44991|2017-10-11 04:45:17.44991
NCT00069628|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2016-09-02|||July 2003||2003-07-01|September 2016|2016-09-01|November 2004||2004-11-01|||||Interventional|||Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer|DirecNet Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer in the Management of Type 1 Diabetes in Children|Completed||Phase 4|200||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 04:45:17.534387|2017-10-11 04:45:17.534387
NCT00069641|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2015-04-27|2014-01-16||September 2003||2003-09-01|January 2014|2014-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional||Intent-to-treat (ITT) population included all randomized participants.|Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)|A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II|Completed||Phase 2/Phase 3|96|Actual|Shire||3|||f||||t||||||||||2017-10-11 04:45:17.699862|2017-10-11 04:45:17.699862
NCT00069654|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2017-06-30|||September 25, 2003||2003-09-25|May 18, 2009|2009-05-18||||May 18, 2009|Actual|2009-05-18||Interventional|||Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease|Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients With Coronary Artery Disease|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:45:19.523799|2017-10-11 04:45:19.523799
NCT00069680|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2017-10-05|||September 25, 2003||2003-09-25|May 10, 2017|2017-05-10||||||||Observational|||Genetic Analysis of Gray Platelet Syndrome|Genetic Analysis of Gray Platelet Syndrome|Completed||N/A|123|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:19.609193|2017-10-11 04:45:19.609193
NCT00069693|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2017-06-30|||September 26, 2003||2003-09-26|August 5, 2008|2008-08-05|August 5, 2008||2008-08-05|||||Observational|||Evaluation of Chronic Orthostatic Intolerance|Clinical Laboratory Evaluation of Chronic Orthostatic Intolerance|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:19.670473|2017-10-11 04:45:19.670473
NCT00069706|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-30|2012-02-11|||July 2003||2003-07-01|February 2012|2012-02-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients|Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients|Completed||Phase 2|118|Actual|Alcon Research||5|||f||||||||||||||2017-10-11 04:45:21.326711|2017-10-11 04:45:21.326711
NCT00069719|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-30|2008-08-04|||February 1999||1999-02-01|August 2008|2008-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients|Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients|Completed||Phase 2|||Alcon Research|||||||||||||||||||2017-10-11 04:45:21.402002|2017-10-11 04:45:21.402002
NCT00069732|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-30|2010-02-11||||||February 2010|2010-02-01||||||||Interventional|||Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss|Pilot of Two CAM Treatments for Maintenance of Weight Loss|Terminated||Phase 2|90||Kaiser Permanente|||||f||||||||||||||2017-10-11 04:45:21.454845|2017-10-11 04:45:21.454845
NCT00069745|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-30|2012-08-01||2012-03-22|September 2003||2003-09-01|August 2012|2012-08-01|March 2007|Actual|2007-03-01|January 2006|Actual|2006-01-01||Interventional|||Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen|A Multi-National Phase III Study of Satraplatin Plus Prednisone or Placebo Plus Prednisone in Patients With Hormone Refractory Prostate Cancer Previously Treated With One Cytotoxic Chemotherapy Regimen|Completed||Phase 3|||Agennix|||||f||||||||||||||2017-10-11 04:45:21.544529|2017-10-11 04:45:21.544529
NCT00069758|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-30|2014-05-08|||September 2003||2003-09-01|May 2014|2014-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma|A Multi-Center Phase II Study to Investigate the Safety and Activity of SDX-105 (Bendamustine) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab|Completed||Phase 2|72||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 04:45:23.024521|2017-10-11 04:45:23.024521
NCT00069784|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-01|2013-01-24|2012-12-18||August 2003||2003-08-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ORIGIN||The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)|A Multicenter, International Randomized, 2x2 Factorial Design Study to Evaluate the Effects of Lantus (Insulin Glargine) Versus Standard Care, and of Omega-3 Fatty Acids Versus Placebo, in Reducing Cardiovascular Morbidity and Mortality in High Risk People With Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes Mellitus: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)|Completed||Phase 3|12537|Actual|Sanofi||4|||f||||t||||||||||2017-10-11 04:45:23.287291|2017-10-11 04:45:23.287291
NCT00069797|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-01|2013-01-14|||September 2003||2003-09-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Epidemiology of Coronary Heart Disease in Men Aged 40 and Over|Epidemiology of Coronary Heart Disease in Men Aged 40 and Over|Completed||N/A|1027|Actual|University of Pittsburgh|||1||f||||||||||Samples With DNA|"     Blood samples (serum and plasma), buffy coat for DNA   "|||2017-10-11 04:45:25.209526|2017-10-11 04:45:25.209526
NCT00069810|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-01|2017-04-04|||August 2003||2003-08-01|April 2017|2017-04-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Role of Chronic Kidney Disease in Cardiovascular Disease|Oxidative Stress in Chronic Kidney Disease|Withdrawn||N/A|0|Actual|University of Washington|||1|The study is not a clinical trial.|f||||f||||||Samples With DNA|"     EDTA tube of whole blood   "|||2017-10-11 04:45:25.286038|2017-10-11 04:45:25.286038
NCT00069823|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-01|2012-12-17|2010-05-14||September 2003||2003-09-01|December 2012|2012-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Acid Reflux in Asthma|The Study of Acid Reflux in Asthma|Completed||Phase 3|403|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 04:45:25.428798|2017-10-11 04:45:25.428798
NCT00069836|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-01|2016-08-31|||October 2003||2003-10-01|August 2016|2016-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.|A 24 Week, Randomised, Double Blind, Parallel Study to Compare the Change in HbA1c With AVANDAMET® (8.0mg / 2.0g) Plus Insulin to Placebo Plus Insulin, in Subjects With Type 2 Diabetes Starting Insulin Therapy|Completed||Phase 3|272|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:45:26.441941|2017-10-11 04:45:26.441941
NCT00069849|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-01|2006-08-31|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease|A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease|Terminated||Phase 2|64||Abbott|||||||||||||||||||2017-10-11 04:45:26.815185|2017-10-11 04:45:26.815185
NCT00069862|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-02|2015-03-04|||September 2003||2003-09-01|March 2015|2015-03-01|November 2005|Actual|2005-11-01|||||Interventional|||Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia|Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia|Completed||Phase 1/Phase 2|25||Sanofi|||||||||||||||||||2017-10-11 04:45:26.885519|2017-10-11 04:45:26.885519
NCT00069875|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-02|2007-12-17|||September 2003||2003-09-01|December 2007|2007-12-01|December 2005||2005-12-01|||||Interventional|||A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer|Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study of Gemcitabine-Cisplatin Combined With Two Different Doses of LY293111 or Placebo in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer|Completed||Phase 2|195||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:45:26.948203|2017-10-11 04:45:26.948203
NCT00069888|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-02|2011-06-07|||November 2001||2001-11-01|June 2011|2011-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy|A Multicenter, Open-Label, Phase II Trial of Adjuvant Taxotere in Patients At High Risk of Relapse Following Prostatectomy|Completed||Phase 2|83|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:45:27.045088|2017-10-11 04:45:27.045088
NCT00069901|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-02|2008-09-18|||February 2003||2003-02-01|September 2008|2008-09-01|September 2006|Actual|2006-09-01|November 2005|Actual|2005-11-01||Interventional|||Phase II CT-2103/Carboplatin in Ovarian Cancer|CT-2103/Carboplatin for Patients With Newly Diagnosed Stage III or IV Ovarian or Primary Peritoneal Cancer: A Phase 2 Study|Completed||Phase 2|82|Actual|CTI BioPharma||1|||||||||||||||||2017-10-11 04:45:27.102897|2017-10-11 04:45:27.102897
NCT00069914|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-02|2008-03-03|||September 2003||2003-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Immune Response to Influenza Vaccine in HIV-Infected Individuals|Immune Response to Influenza Vaccination in HIV-Infected Individuals|Completed||N/A|165||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:27.192228|2017-10-11 04:45:27.192228
NCT00069927|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2014-01-31|||August 2003||2003-08-01|January 2014|2014-01-01|September 2006|Actual|2006-09-01|June 2006|Actual|2006-06-01||Interventional|||Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression|Adderall-XR Versus Concerta For Cancer Treatment-Related Neurocognitive Sequelae And Depression In Pediatric Patients: A Randomized Phase II Study|Terminated||Phase 2|12|Actual|University of South Florida||2||Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility|f||||t||||||||||2017-10-11 04:45:27.249522|2017-10-11 04:45:27.249522
NCT00069940|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2010-12-26|||December 2000||2000-12-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2006|Actual|2006-08-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor|A Phase I Study Of Vaccination With Telomerase Peptide Plus GM-CSF|Completed||Phase 1|||Dana-Farber Cancer Institute|||||f||||t||||||||||2017-10-11 04:45:27.385515|2017-10-11 04:45:27.385515
NCT00069953|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2016-12-30|2014-10-14||September 2003||2003-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2007|Actual|2007-03-01||Interventional||All eligible patients.|Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Study Of Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus|Completed||Phase 2|43|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:45:27.493815|2017-10-11 04:45:27.493815
NCT00069966|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2009-07-04|||April 2003||2003-04-01|November 2004|2004-11-01||||||||Interventional|||Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse|A Phase II Trial of BBR 2778 in Combination With Cytarabine, Methylprednisolone and Cisplatin (BSHAP) as Salvage in Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:28.217141|2017-10-11 04:45:28.217141
NCT00069992|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2012-10-05|||December 2001||2001-12-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|September 2006|Actual|2006-09-01||Interventional|MPDMDSBMT||Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML|Safety And Efficacy of Sub-Myeloablative Allogeneic Stem Cell Transplantation For Patients With Myeloproliferative Disorder (MPD), Myelodysplastic Syndrome (MDS), Acute Myelogenous Leukemia (AML) or Chronic Myelogenous Leukemia|Terminated||Phase 2|7|Actual|Baylor College of Medicine||1||Closed due to competing protocols|f||||t||||||||||2017-10-11 04:45:28.374365|2017-10-11 04:45:28.374365
NCT00070005|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-08-06|||June 2002||2002-06-01|April 2007|2007-04-01||||||||Interventional|||J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal Adenocarcinoma|A Phase III Randomised Study Of J-Pouch Coloanal Anastomosis Versus Side-To-End Coloanal Anastomosis After Preoperative Radiotherapy And Total Mesorectal Excision In Patients With Mid And Distal Rectal Cancer|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:28.4893|2017-10-11 04:45:28.4893
NCT00070018|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2017-04-20|2012-03-05||February 2004||2004-02-01|April 2017|2017-04-01|November 2018|Anticipated|2018-11-01|November 2010|Actual|2010-11-01||Interventional|||S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma|Evaluation of CHOP Plus Involved Field Radiotherapy Followed by Yttrium-90 Ibritumomab Tiuxetan for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High-Risk Localized, Aggressive Histologies of Non-Hodgkin Lymphoma, Phase II|Active, not recruiting||Phase 2|46|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:45:28.70829|2017-10-11 04:45:28.70829
NCT00070031|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-12-18|||June 2003||2003-06-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|April 2006|Actual|2006-04-01||Interventional|||Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy|A Phase II Study of Intravenous Edotecarin (PHA-782615) in Patients With Anthracycline- and Taxane-Refractory or Chemoresistant Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:29.132954|2017-10-11 04:45:29.132954
NCT00070057|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2016-12-28|||April 2003||2003-04-01|December 2016|2016-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer|An Exploratory, Open-Label Phase I Pharmacodynamic Study of COX-2 Inhibition With Celecoxib (Celebrex) and Aromatase Activity in Breast Cancer|Completed||Phase 1|75|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:45:29.205597|2017-10-11 04:45:29.205597
NCT00070070|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-07-18|||May 2003||2003-05-01|July 2013|2013-07-01||||April 2006|Actual|2006-04-01||Interventional|||Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder|NY-ESO-1 Protein Immunization of Post-Cystectomy Patients With Transitional Cell Carcinomas Expressing NY-ESO-1 or LAGE-1 Antigen|Completed||Phase 1|||Ludwig Institute for Cancer Research|||||f||||||||||||||2017-10-11 04:45:29.301675|2017-10-11 04:45:29.301675
NCT00070083|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2009-04-04|||July 2003||2003-07-01|June 2005|2005-06-01||||||||Interventional|||Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma|A Phase I Study Of G3139 Antisense Oligonucleotide (Oblimersen) In Combination With CHOP And Rituximab In Untreated Advanced Stage Diffuse Large B Cell Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:29.376463|2017-10-11 04:45:29.376463
NCT00070096|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-06-21|||August 2003||2003-08-01|April 2006|2006-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors|A Phase II Study of BMS-247550 In Advanced Germ Cell Tumor Patients - THERAPEUTIC/DIAGNOSTIC PROTOCOL|Completed||Phase 2|29|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:45:29.46918|2017-10-11 04:45:29.46918
NCT00070109|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2014-09-16|2013-12-09||January 2008||2008-01-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional|||Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors|A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas|Completed||Phase 2|50|Actual|Children's Oncology Group||5|||f||||t||||||||||2017-10-11 04:45:29.575746|2017-10-11 04:45:29.575746
NCT00070122|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-01-24|||April 2004||2004-04-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer|A Phase III Trial of Modified FOLFOX6 Versus CAPOX, With Bevacizumab (NSC-704865) or Placebo, as First-Line Therapy in Patients With Previously Untreated Advanced Colorectal Cancer|Terminated||Phase 3|2200|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:45:30.639135|2017-10-11 04:45:30.639135
NCT00070135|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2017-03-20|2017-03-20||January 2004||2004-01-01|March 2017|2017-03-01||||December 2013|Actual|2013-12-01||Interventional||Seven (7) participants were excluded from the all analyses after they were deemed ineligible.|Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission|A Phase II Study Of Allogeneic Transplant For Older Patients With AML In First Morphologic Complete Remission Using A Non-Myeloablative Preparative Regimen|Active, not recruiting||Phase 2|121|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:45:30.793439|2017-10-11 04:45:30.793439
NCT00070148|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2016-12-20|||March 2004||2004-03-01|April 2013|2013-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer|A Phase III Randomized Study Comparing The Effects Of Oxandrolone (Oxandrin) And Megestrol Acetate (Megace) On Lean Body Mass, Weight, Body Fat, And Quality Of Life In Patients With Solid Tumors And Weight Loss Receiving Chemotherapy|Completed||Phase 3|155|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||Undecided||2017-10-11 04:45:32.026446|2017-10-11 04:45:32.026446
NCT00070161|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2017-05-25|||July 2001||2001-07-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|May 2005|Actual|2005-05-01||Interventional|||Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor|Donepezil and EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases|Completed||Phase 2|68|Actual|Wake Forest University Health Sciences||2|||f||||t|t|f||||||No||2017-10-11 04:45:32.190295|2017-10-11 04:45:32.190295
NCT00070174|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2014-02-19|||December 2003||2003-12-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|September 2006|Actual|2006-09-01||Interventional|||Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy|Treatment of Newly Diagnosed Childhood Acute Myeloid Leukemia (AML) Using Intensive MRC-Based Therapy and Gemtuzumab Ozogamicin (GMTZ): A COG Pilot Study|Completed||Phase 2|350|Actual|Children's Oncology Group|||||f||||t||||||||||2017-10-11 04:45:32.353359|2017-10-11 04:45:32.353359
NCT00070187|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-10-16|||November 2003||2003-11-01|October 2013|2013-10-01||||June 2005|Actual|2005-06-01||Interventional|||Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma|A Phase II/III Study of Immunomodulation After High Dose Myeloablative Therapy With Autologous Stem Cell Rescue for Refractory/Relapsed Hodgkin Disease|Completed||Phase 2/Phase 3|24|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:45:32.74301|2017-10-11 04:45:32.74301
NCT00070200|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2014-02-12|||March 2004||2004-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|September 2006|Actual|2006-09-01||Interventional|||Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma|A Pilot Induction Regimen Incorporating Topotecan for Treatment of Newly Diagnosed High Risk Neuroblastoma|Completed||Phase 1|31|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:45:33.048919|2017-10-11 04:45:33.048919
NCT00070213|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-09-16|||September 2003||2003-09-01|June 2011|2011-06-01||||||||Interventional|||Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer|Drug Treatment for Bowel Cancer: Making the Best Choices When a Milder Treatment is Needed|Unknown status|Active, not recruiting|Phase 3|460|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:33.184789|2017-10-11 04:45:33.184789
NCT00070239|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-12-13|||August 2003||2003-08-01|December 2013|2013-12-01||||June 2006|Actual|2006-06-01||Interventional|||Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies|A Phase I Clinical, Pharmacokinetic and Pharmacodynamic Study of Flavopiridol in Patients With Refractory Solid Tumors and Hematologic Malignancies|Terminated||Phase 1|100|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:45:33.289764|2017-10-11 04:45:33.289764
NCT00070733|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-07|2005-11-04|||August 2003||2003-08-01|October 2003|2003-10-01|June 2005||2005-06-01|||||Interventional|||The Effect of 5-Alpha Reductase on Testosterone in Men|The Role of 5-Alpha Reductase in Mediating Testosterone Actions|Unknown status|Recruiting|Phase 3|184||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:45:46.555199|2017-10-11 04:45:46.555199
NCT00070252|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2015-05-01|||September 2003||2003-09-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|February 2006|Actual|2006-02-01||Interventional|||Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer|Phase Ib/II Neoadjuvant Trial of the Farnesyltransferase Inhibitor, R115777 With Docetaxel and Capecitabine for Patients With Stage IIIA or IIIB Breast Cancer|Completed||Phase 1/Phase 2|53|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:45:33.406574|2017-10-11 04:45:33.406574
NCT00070265|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-01-23|||August 2003||2003-08-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer|A Multi-Institutional Phase II Trial Of Neoadjuvant Capecitabine (XELODA) And Oxaliplatin (ELOXATIN) For Resectable Colorectal Metastases In The Liver|Terminated||Phase 2|80|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:45:33.752728|2017-10-11 04:45:33.752728
NCT00070278|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-08-06|||January 2005||2005-01-01|January 2009|2009-01-01||||September 2007|Actual|2007-09-01||Interventional|||Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer|A Phase III Randomized Neoadjuvant Study of Sequential Epirubicin/Cyclophosphamide and Paclitaxel + - Gemcitabine in Poor Risk Early Breast Cancer|Unknown status|Active, not recruiting|Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:33.84166|2017-10-11 04:45:33.84166
NCT00070291|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-02-12|2013-01-07||September 2005||2005-09-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|March 2009|Actual|2009-03-01||Interventional|||Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma|A Phase II Study of Cyclosporine in the Treatment of Angioimmunoblastic T-Cell Lymphoma|Terminated||Phase 2|4|Actual|Eastern Cooperative Oncology Group||1||Slow accrual.|f||||f||||||||||2017-10-11 04:45:33.960111|2017-10-11 04:45:33.960111
NCT00070304|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-07-25|||July 2004||2004-07-01|July 2013|2013-07-01||||September 2007|Actual|2007-09-01||Interventional|||Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma|A Phase II Study Of Weekly Gemcitabine And Vinorelbine In Children With Recurrent Or Refractory Hodgkin's Disease|Completed||Phase 2|33|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:45:34.273221|2017-10-11 04:45:34.273221
NCT00070317|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2017-09-08|2017-09-08||June 2004||2004-06-01|June 2015|2015-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Eligible and evaluable patients|Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer|Lymphatic Mapping and Sentinel Node Identification in Patients With Stage1B1 Cervical Carcinoma|Terminated||N/A|102|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:45:34.827439|2017-10-11 04:45:34.827439
NCT00070343|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2014-01-03|||August 2003||2003-08-01|November 2004|2004-11-01||||||||Interventional|||Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301|Continuation Protocol For G3139 (Bcl-2 Antisense Oligonucleotide) And Dacarbazine In Patients With Malignant Melanoma Who Responded To This Combination In Protocol GM301|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:35.201918|2017-10-11 04:45:35.201918
NCT00070382|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2015-10-01|||August 2003||2003-08-01|August 2012|2012-08-01||||November 2003|Actual|2003-11-01||Interventional|||Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer|A Randomized, Open-Label, Multicenter Study Of Darbepoetin Alfa Administered Once Every Two Weeks (Q2W) Compared With rHuEPO Administered Once Every Week (QW) For The Treatment Of Anemia In Subjects With Non-Myeloid Malignancies Receiving Multiple Chemotherapy|Completed||Phase 3|14|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:45:35.262641|2017-10-11 04:45:35.262641
NCT00070421|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-05-14|||April 2003||2003-04-01|December 2004|2004-12-01|January 2005|Actual|2005-01-01|||||Interventional|||Study of @neWorld: A Virtual Community for Children With Cancer|@neWorld: A Virtual Community For Kids With Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:35.414093|2017-10-11 04:45:35.414093
NCT00070434|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2012-06-05|||August 2004||2004-08-01|June 2012|2012-06-01||||February 2006|Actual|2006-02-01||Interventional|||S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum|A Phase II Feasibility Translational Research Trial of Induction Chemotherapy Followed by Concomitant Chemoradiation in Patients With Clinical T4 Rectal Cancer|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||3||poor accrual|f||||t||||||||||2017-10-11 04:45:35.532367|2017-10-11 04:45:35.532367
NCT00070447|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2014-01-27|||November 2003||2003-11-01|October 2004|2004-10-01|June 2006|Actual|2006-06-01|||||Interventional|||Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma|Phase II Study of Rituximab (NSC 687451) + CHOP Followed by 90Y-Ibritumomab Tiuxetan (NSC 710085) in Patients With Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:35.706081|2017-10-11 04:45:35.706081
NCT00070473|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2014-02-19|||October 2003||2003-10-01|February 2014|2014-02-01|June 2008|Actual|2008-06-01|March 2006|Actual|2006-03-01||Interventional|||Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors|A Phase I Study of Pemetrexed (LY231514, Alimta) in Children and Adolescents With Recurrent Solid Tumors|Completed||Phase 1|33|Actual|Children's Oncology Group|||||||||t||||||||||2017-10-11 04:45:36.003673|2017-10-11 04:45:36.003673
NCT00070486|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2016-06-28|||December 2003||2003-12-01|June 2016|2016-06-01|May 2011|Actual|2011-05-01|December 2006|Actual|2006-12-01||Interventional|||Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer|Randomized Phase II Study of Eicosanoid Pathway Modulators and Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|140|Actual|Alliance for Clinical Trials in Oncology||3|||f||||f||||||||||2017-10-11 04:45:36.121944|2017-10-11 04:45:36.121944
NCT00070525|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-10-07|||November 2003||2003-11-01|October 2013|2013-10-01||||September 2006|Actual|2006-09-01||Interventional|||Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma|A Phase II Study of R115777 (Zarnestra) (NSC # 702818, IND# 58,359) in Children With Recurrent or Progressive: High Grade Glioma, Medulloblastoma/PNET or Brainstem Glioma|Completed||Phase 2|90|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:45:39.06974|2017-10-11 04:45:39.06974
NCT00070538|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-07-17|||June 2003||2003-06-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|September 2004|Actual|2004-09-01||Interventional|||VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies|A Phase I Study Of VNP40101M And Cytarabine For Patients With Hematologic Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:45:39.189562|2017-10-11 04:45:39.189562
NCT00070551|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2013-06-03|||September 2003||2003-09-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia|A Phase I Study of GTI2040 (NSC 722929; IND 67368) in Combination With High-dose Cytarabine in Refractory or Relapsed Acute Myeloid Leukemia (AML)|Completed||Phase 1|51|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:45:39.279696|2017-10-11 04:45:39.279696
NCT00070564|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2017-03-03|2017-01-09||November 2003||2003-11-01|March 2017|2017-03-01|January 2027|Anticipated|2027-01-01|January 2015|Actual|2015-01-01||Interventional||Only eligible and analyzable patients were included in the analysis.|S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer|Phase III Trial of Continuous Schedule AC + G vs. Q 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node-Negative Breast Cancer|Active, not recruiting||Phase 3|3294|Actual|Southwest Oncology Group||6|||f||||t||||||||||2017-10-11 04:45:39.643328|2017-10-11 04:45:39.643328
NCT00070577|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-03|2017-06-30|||September 29, 2003||2003-09-29|May 3, 2011|2011-05-03|May 3, 2011||2011-05-03|||||Observational|||Influence of Age and Sex on Alcohol Metabolism and Acute Responses|Influence of Age and Sex on Alcohol Metabolism and Acute Responses|Completed||N/A|65|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:45.045136|2017-10-11 04:45:45.045136
NCT00070590|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-06|2010-02-11||2010-02-11|July 2003||2003-07-01|February 2010|2010-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis|Completed||Phase 2/Phase 3|132||Actelion|||||||||||||||||||2017-10-11 04:45:45.282273|2017-10-11 04:45:45.282273
NCT00070616|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-06|2014-10-23|||December 2001||2001-12-01|October 2014|2014-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support|An Open-label Study of the Pharmacokinetics (PK) of Recombinant Human Keratinocyte Growth Factor (Palifermin; rHuKGF) in Subjects With Hematologic Malignancies Undergoing Total Body Irradiation and High-dose Chemotherapy Followed by Peripheral Blood Progenitor Cell (PBPC) Transplantation|Completed||Phase 1|25|Actual|Swedish Orphan Biovitrum||2|||||||||||||||||2017-10-11 04:45:45.470501|2017-10-11 04:45:45.470501
NCT00070629|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-06|2009-02-09|||May 2003||2003-05-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|||||Interventional|||CPG 7909 Injection in Non-Small Cell Lung Cancer|Promune™ (CPG 7909 Injection) In Combination With Chemotherapy In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer, A Randomized, Multi-Center, Controlled, Phase 2 Study|Completed||Phase 2|116|Actual|Pfizer||2|||f||||||||||||||2017-10-11 04:45:45.585471|2017-10-11 04:45:45.585471
NCT00070642|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-06|2009-02-09|||December 2003||2003-12-01|February 2009|2009-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||CPG 7909 Injection in Melanoma|ProMune™ (CPG 7909 Injection) With or Without Chemotherapy for the Treatment of Stage III b/c or IV Melanoma: A Randomized, Multi-Center, Open Label, Parallel Group, Active-Controlled, Phase II/III Study|Completed||Phase 2|184|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 04:45:45.747602|2017-10-11 04:45:45.747602
NCT00070655|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-06|2011-04-05|||September 2003||2003-09-01|April 2011|2011-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)|The AMADEUS Trial, A Multicenter, Randomized, Open-label, Assessor Blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Idraparinux (SR34006) With Adjusted-dose Oral Vitamin-K Antagonists in the Prevention of Thromboembolic Events in Patients With Atrial Fibrillation|Completed||Phase 3|4673|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:45:45.898291|2017-10-11 04:45:45.898291
NCT00070668|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-06|2008-08-20|||September 2003||2003-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Inflammatory Genomics in Human Carotid Artery Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:45:46.13483|2017-10-11 04:45:46.13483
NCT00070681|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-06|2016-07-28|||September 2003||2003-09-01|April 2009|2009-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Outcomes of Sleep Disorders in Older Men||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:45:46.19812|2017-10-11 04:45:46.19812
NCT00070694|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-06|2008-03-03|||September 2003||2003-09-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression|An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907 in Combination With Escitalopram in Treatment Resistant Depression|Completed||Phase 2|96||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:46.264036|2017-10-11 04:45:46.264036
NCT00070707|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-07|2017-03-27|||April 3, 2003|Actual|2003-04-03|March 2017|2017-03-01|November 26, 2003|Actual|2003-11-26|November 26, 2003|Actual|2003-11-26||Interventional|||Efficacy and Safety of Nasonex vs. Placebo in Subjects With SAR and Concomitant Asthma (Study P03280)||Terminated||Phase 4|188|Actual|Merck Sharp & Dohme Corp.||||Recruitment challenges.|||||||||||||||2017-10-11 04:45:46.359692|2017-10-11 04:45:46.359692
NCT00070720|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-07|2013-12-16|||September 2003||2003-09-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Improving Perinatal Care in Latin America|Clustered Trial for Improving Perinatal Care in Uruguay/Argentina|Completed||Phase 4|21780||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-10-11 04:45:46.444275|2017-10-11 04:45:46.444275
NCT00070746|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-07|2014-07-29|||June 2003||2003-06-01|July 2014|2014-07-01|July 2005||2005-07-01|||||Observational|||Perinatal Infections in Pakistan|Perinatal Infections and Pregnancy Outcomes in Pakistan: A Collaborative Research Project in Partnership With the University of Alabama, USA|Completed||N/A|1500||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-10-11 04:45:46.656888|2017-10-11 04:45:46.656888
NCT00070759|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-07|2017-06-30|||October 6, 2003||2003-10-06|October 2, 2006|2006-10-02|October 2, 2006||2006-10-02|||||Interventional|||Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis|Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study|Completed||Phase 2|6||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:46.742291|2017-10-11 04:45:46.742291
NCT00070785|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-07|2017-06-30|||October 6, 2003||2003-10-06|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations|Comprehensive Epitope Mapping of the Epstein-Barr Virus Latent Membrane Protein-2 in Ethnically Diverse Populations|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:47.034708|2017-10-11 04:45:47.034708
NCT00070811|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-08|2013-07-02|||August 2001||2001-08-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Assessing the Results of Lip Surgery in Patients With Cleft Lip and Palate|Functional Outcomes of Cleft Lip and Lip Revision Surgery|Completed||Phase 2/Phase 3|127|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||||||2017-10-11 04:45:47.11244|2017-10-11 04:45:47.11244
NCT00070824|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-08|2007-09-06|||January 2004||2004-01-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Functional Brain Imaging - Acupuncture and Osteoarthritis|Functional Brain Imaging - Acupuncture and Osteoarthritis|Completed||Phase 2/Phase 3|16|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-10-11 04:45:47.258093|2017-10-11 04:45:47.258093
NCT00070837|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-08|2007-07-12|||October 2003||2003-10-01|July 2007|2007-07-01|October 2004||2004-10-01|||||Interventional|||MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer|A Phase 1/2 Dose Escalation Trial of Multiple Doses of MLN2704 (DM1 Conjugated Monoclonal Antibody MLN591) in Subjects With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 1/Phase 2|46||Millennium Pharmaceuticals, Inc.|||||t||||||||||||||2017-10-11 04:45:47.368325|2017-10-11 04:45:47.368325
NCT00070850|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-08|2007-06-28|||April 2001||2001-04-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Observational|||Prenatal Screening For Smith-Lemli-Opitz Syndrome|The Feasibility of Screening for Smith-Lemli-Opitz Syndrome|Completed||Phase 2|1800||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:45:47.49987|2017-10-11 04:45:47.49987
NCT00070863|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-08|2013-08-19|||June 2002||2002-06-01|August 2013|2013-08-01||||December 2005|Actual|2005-12-01||Interventional|||Treatment for Men Who Are Abusive to Their Partners|Behavior Therapy for Partner Violent Men|Unknown status|Active, not recruiting|Phase 1|60||University of Maryland, Baltimore County|||||f||||||||||||||2017-10-11 04:45:47.591945|2017-10-11 04:45:47.591945
NCT00070876|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-08|2013-04-01|||August 2002||2002-08-01|April 2013|2013-04-01|August 2008|Actual|2008-08-01|August 2005|Actual|2005-08-01||Interventional|||Psychosocial Training for Pediatric Health Care Providers|Trial of Psychosocial Training for Pediatric Generalists|Completed||N/A|350||Johns Hopkins Bloomberg School of Public Health|||||f||||f||||||||||2017-10-11 04:45:47.668359|2017-10-11 04:45:47.668359
NCT00070889|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2006-08-17|||September 1999||1999-09-01|July 2006|2006-07-01|August 2004||2004-08-01|||||Observational|||Brain Cell Injury in Patients With A First Episode of Psychosis|Oxidative Cell Injury: First Episode Psychotic Patients|Completed||N/A|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:47.765094|2017-10-11 04:45:47.765094
NCT00070902|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2006-08-16|||June 2000||2000-06-01|August 2006|2006-08-01|October 2002||2002-10-01|||||Interventional|||Using MRI Scans to Evaluate Spinal Manipulation|The Effects of Positioning and Adjusting on the Z Joint|Completed||Phase 1|64||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:47.967373|2017-10-11 04:45:47.967373
NCT00070928|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2006-07-25|||September 2000||2000-09-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Valerian to Improve Sleep in Patients With Parkinson's Disease|Polysomnographic Assessment of Alternative Treatments for Sleep Disturbance in Parkinson's Disease|Completed||Phase 2|80||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:48.131138|2017-10-11 04:45:48.131138
NCT00070941|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2016-06-02|2013-05-03||July 2003||2003-07-01|June 2016|2016-06-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|||SAM-e for the Treatment of Depression in Patients With Parkinson's Disease|SAM-e Treatment of Depression in Parkinson's Disease.|Completed||Phase 2/Phase 3|29|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-10-11 04:45:48.216645|2017-10-11 04:45:48.216645
NCT00070954|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2011-06-27|||February 2003||2003-02-01|August 2008|2008-08-01|March 2005|Actual|2005-03-01|January 2005|Actual|2005-01-01||Interventional|||Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)|Ginkgo Biloba for ECT-induced Memory Deficits|Terminated||Phase 1/Phase 2|50|Anticipated|Medical University of South Carolina||2|||f||||||||||||||2017-10-11 04:45:48.750787|2017-10-11 04:45:48.750787
NCT00070967|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2006-08-17|||September 2001||2001-09-01|July 2006|2006-07-01|February 2005||2005-02-01|||||Interventional|||Acupuncture to Improve Quality of Life in Patients With Advanced Cancer|Effects of Acupuncture on Pain, Nausea, Quality of Life|Completed||Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:48.838977|2017-10-11 04:45:48.838977
NCT00070980|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2006-08-17|||March 2003||2003-03-01|July 2006|2006-07-01|November 2004||2004-11-01|||||Interventional|||Massage to Increase Well-Being and Immune Function in Dominican Children Infected With HIV|Massage to Enhance Well-Being in HIV-Positive Dominican Children|Completed||N/A|54||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:48.89519|2017-10-11 04:45:48.89519
NCT00070993|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2006-08-03|||December 2002||2002-12-01|August 2006|2006-08-01|May 2006||2006-05-01|||||Interventional|||Creatine for the Treatment of Amyotrophic Lateral Sclerosis|Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis|Completed||Phase 2|110||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:45:48.949578|2017-10-11 04:45:48.949578
NCT00071006|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2012-05-31|2012-02-25||September 2003||2003-09-01|May 2012|2012-05-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)|Phase 2 Study Of AG-013736 In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)|Completed||Phase 2|12|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 04:45:49.035553|2017-10-11 04:45:49.035553
NCT00071019|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2017-04-18|||September 2003||2003-09-01|April 2017|2017-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Dietary Fatty Acids, PPAR Activated Genes, and CHD|Dietary Fatty Acids, PPAR Activated Genes, and CHD|Completed||N/A|4547|Actual|Harvard School of Public Health|||1||f||||f|f|f||||Samples With DNA|"     Whole blood   "|No||2017-10-11 04:45:49.445352|2017-10-11 04:45:49.445352
NCT00071032|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2014-08-14|2014-08-14||July 2003||2003-07-01|August 2014|2014-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|FOCUS|Randomized subjects|Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease|Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)|Completed||Phase 3|2016|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-11 04:45:49.501307|2017-10-11 04:45:49.501307
NCT00071045|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2017-10-05|||October 7, 2003||2003-10-07|September 14, 2017|2017-09-14||||||||Observational|||Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members|Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples From Patients With Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:49.774986|2017-10-11 04:45:49.774986
NCT00071058|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-09|2012-09-12|2012-08-13||October 2003||2003-10-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer|A Study of Combination Chemotherapy & Surgical Resection in the Tx of Adrenocortical Cancer: Mitotane & Continuous Infusion Doxorubicin, Vincristine & Etoposide w/the P-glycoprotein Antagonist, Tariquidar (XR9576), Before & After Surgical Resection|Completed||Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:45:49.847652|2017-10-11 04:45:49.847652
NCT00071071|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-10|2012-12-05|||April 2003||2003-04-01|December 2012|2012-12-01||||May 2004|Actual|2004-05-01||Interventional|||Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.||Completed||Phase 2|25|Actual|Emergent Product Development Seattle LLC||1|||f||||||||||||||2017-10-11 04:45:50.386119|2017-10-11 04:45:50.386119
NCT00071084|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-10|2012-12-05|||May 2003||2003-05-01|November 2012|2012-11-01||||June 2004|Actual|2004-06-01||Interventional|||Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.||Completed||Phase 2|22|Actual|Emergent Product Development Seattle LLC||1|||f||||||||||||||2017-10-11 04:45:50.460928|2017-10-11 04:45:50.460928
NCT00071097|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-10|2016-09-19|||October 2003||2003-10-01|September 2016|2016-09-01|November 2007|Actual|2007-11-01|February 2005|Actual|2005-02-01||Interventional|||TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients|A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose Response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.|Completed||Phase 2|330|Actual|Tibotec Pharmaceuticals, Ireland||5|||f||||t||||||||||2017-10-11 04:45:50.55477|2017-10-11 04:45:50.55477
NCT00071110|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-10|2009-12-04|2009-03-27||March 2004||2004-03-01|December 2009|2009-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Electroacupuncture for Major Depression|Electroacupuncture for Major Depression: A Pilot Study|Completed||Phase 2|57|Actual|National Center for Complementary and Integrative Health (NCCIH)|Four participants were excluded from the analyses because of a protocol violation. In the Sham Acupuncture group, the acupuncturist placed unelectrified needles in GV-20 and Yin tang points instead of placing them laterally.|2|||f||||||||||||||2017-10-11 04:45:50.86706|2017-10-11 04:45:50.86706
NCT00071123|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-10|2017-06-30|||October 9, 2003||2003-10-09|November 15, 2010|2010-11-15|November 15, 2010||2010-11-15|||||Observational|||Evaluating Brain Responses to Facial Expressions in Major Depressive Disorder|The Functional Neuroanatomy of Emotion Regulation in Major Depressive Disorder (MDD)|Completed||N/A|172|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:51.268115|2017-10-11 04:45:51.268115
NCT00071136|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-13|2007-01-24|||December 2003||2003-12-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Phase 1/2 Dose-Escalating Study of Biweekly Alimta and Gemcitabine in Patients With Advanced Cancer|Completed||Phase 1/Phase 2|48||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:45:51.330741|2017-10-11 04:45:51.330741
NCT00071149|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-14|2006-08-17|||November 2001||2001-11-01|July 2006|2006-07-01|April 2004||2004-04-01|||||Observational|||Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis|Consistency of Traditional Chinese Medicine Rheumatoid Arthritis Diagnosis and Herbal Prescriptions|Completed||N/A|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:51.399439|2017-10-11 04:45:51.399439
NCT00071162|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-14|2009-03-31|||September 1999||1999-09-01|March 2009|2009-03-01||||||||Observational|||Genetics of Fibromyalgia|Fibromyalgia Family Study Registry|Unknown status|Active, not recruiting|N/A|560|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||f||||||Samples With DNA|"     DNA, whole blood   "|||2017-10-11 04:45:51.464116|2017-10-11 04:45:51.464116
NCT00071175|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-14|2017-09-15|||October 1995||1995-10-01|September 2017|2017-09-01|November 2013|Actual|2013-11-01|September 2012|Actual|2012-09-01||Observational|LFRR||Lupus Genetics Studies|Lupus Genetic Studies; Lupus Family Registry & Repository|Completed||N/A|3460|Actual|Oklahoma Medical Research Foundation|||1||f||||f||||||Samples With DNA|"     DNA, sera, plasma, cell lines   "|||2017-10-11 04:45:51.565943|2017-10-11 04:45:51.565943
NCT00071188|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-14|2016-08-24|||February 2004||2004-02-01|August 2016|2016-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|A Randomized, Partially Blinded, Phase II Study to Assess the Safety, Tolerability and Efficacy of ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|||Sanofi|||||f||||||||||||||2017-10-11 04:45:51.657858|2017-10-11 04:45:51.657858
NCT00071201|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-15|2013-10-14|||June 2003||2003-06-01|October 2013|2013-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B|A Multi-Center Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Varying Degrees of Renal Impairment|Completed||Phase 3|48||Gilead Sciences|||||||||||||||||||2017-10-11 04:45:51.795433|2017-10-11 04:45:51.795433
NCT00071214|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-15|2006-07-07|||September 2003||2003-09-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis|A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Efficacy of StaphVAX, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adults on Hemodialysis|Completed||Phase 3|3600||Nabi Biopharmaceuticals|||||||||||||||||||2017-10-11 04:45:51.863926|2017-10-11 04:45:51.863926
NCT00071227|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-15|2017-06-30|||October 15, 2003||2003-10-15|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders|Pilot Study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:51.937023|2017-10-11 04:45:51.937023
NCT00071240|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-16|2009-08-14|||October 2002||2002-10-01|August 2009|2009-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Growth Hormone to Increase Immune Function in People With HIV|The Use of Recombinant Growth Hormone to Enhance T-Cell Production in Adults Infected With HIV-1|Completed||Phase 2|22|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 04:45:52.016312|2017-10-11 04:45:52.016312
NCT00071253|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-16|2006-08-02|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness|A Randomized, Double-Blind Study of Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness|Terminated||Phase 4|180||Abbott|||||||||||||||||||2017-10-11 04:45:52.120968|2017-10-11 04:45:52.120968
NCT00071266|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-16|2006-10-31|||October 2003||2003-10-01|October 2006|2006-10-01||||||||Interventional|||The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC|The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - a Matrix Design|Completed||Phase 3|870||Kos Pharmaceuticals|||||||||||||||||||2017-10-11 04:45:52.219279|2017-10-11 04:45:52.219279
NCT00071279|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-16|2011-04-05|||November 2003||2003-11-01|April 2011|2011-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis|The Van Gogh-extension Trial, a Multicenter, International, Randomized, Double-blind, Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous SR34006 With Placebo in the Long-term Prevention of Symptomatic Venous Thromboembolism in Patients With Symptomatic Pulmonary Embolism or Deep-vein Thrombosis Who Completed 6 Months of Treatment With Vitamin K Antagonist or SR34006|Completed||Phase 3|1215|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:45:52.32731|2017-10-11 04:45:52.32731
NCT00071292|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-17|2008-03-05|||July 2003||2003-07-01|March 2008|2008-03-01|March 2005||2005-03-01|||||Interventional|||Meditation-Based Stress Reduction in Rheumatoid Arthritis|Mindfulness Meditation-Based Stress Reduction in Relieving Symptoms Associated With Rheumatoid Arthritis|Completed||Phase 2|80||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:52.514358|2017-10-11 04:45:52.514358
NCT00071305|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-17|2017-06-30|||October 17, 2003||2003-10-17|October 6, 2009|2009-10-06||||October 6, 2009|Actual|2009-10-06||Observational|||Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings|Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:52.581239|2017-10-11 04:45:52.581239
NCT00071331|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-20|2012-05-02|||September 2003||2003-09-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan|Protocol 156-03-236: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized With Worsening Congestive Heart Failure|Completed||Phase 3|3600||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:45:52.672809|2017-10-11 04:45:52.672809
NCT00071344|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-20|2008-03-03|||October 2003||2003-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Analysis of Brain Metastasis in Patients With Lung Cancer|Analysis of Brain Metastasis in Patients With Lung Cancer|Completed||N/A|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:53.548789|2017-10-11 04:45:53.548789
NCT00071357|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-20|2008-03-03|||October 2003||2003-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer|Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer|Completed||N/A|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:53.605705|2017-10-11 04:45:53.605705
NCT00071370|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-20|2008-03-03|||October 2003||2003-10-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Activating Effects of Sleep Deprivation on Synchronized MEG-EEG Recordings of Epilepsy Patients With Non-Diagnostic EEG|Activating Effects of Sleep Deprivation On Synchronized MEG-EEG Recordings Of Epilepsy Patients With Non-Diagnostic EEG|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:53.671606|2017-10-11 04:45:53.671606
NCT00071383|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-20|2008-03-03|||October 2003||2003-10-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Observational|||Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2|Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2|Completed||N/A|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:53.742442|2017-10-11 04:45:53.742442
NCT00071591|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2013-06-13|||July 2001||2001-07-01|June 2013|2013-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Rehabilitative Training for Older People With Schizophrenia|Functional Skills Training for Late Life Schizophrenia|Completed||Phase 2|240||University of California, San Diego|||||f||||||||||||||2017-10-11 04:45:58.824283|2017-10-11 04:45:58.824283
NCT00071396|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-21|2012-08-01|2009-09-25||October 2002||2002-10-01|August 2012|2012-08-01|August 2007|Actual|2007-08-01|September 2006|Actual|2006-09-01||Interventional|||Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders|Continuous Infusion Followed by Subcutaneous Injection of Campath-1H Plus Rituximab in the Treatment of CD52- and CD20-Positive Refractory or Relapsed Chronic Lymphoid Disorders|Completed||Phase 2|48|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:45:53.813137|2017-10-11 04:45:53.813137
NCT00071409|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-22|2014-07-10|||October 2003||2003-10-01|August 2011|2011-08-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes|A Randomized, Double-blind, Placebo-controlled, Rising Dose, Multicenter Study to Evaluate the Efficacy and Safety of 90 Days of 300 or 600 mg Daily Subcutaneous Injections of INGAP Peptide in Type I Diabetes Mellitus Patients|Completed||Phase 2|63|Actual|Exsulin Corporation||3|||f||||f||||||||||2017-10-11 04:45:54.041273|2017-10-11 04:45:54.041273
NCT00071422|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-22|2014-07-10|||October 2003||2003-10-01|August 2011|2011-08-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes|A Randomized, Double-blind, Placebo-controlled, Rising-dose, Multicenter Study to Evaluate the Efficacy and Safety of 90 Days of 300 or 600 mg Daily Subcutaneous Injections of INGAP Peptide in Insulin-using Type 2 Diabetes Mellitus Patients|Completed||Phase 2|126|Actual|Exsulin Corporation||3|||f||||||||||||||2017-10-11 04:45:54.144794|2017-10-11 04:45:54.144794
NCT00071435|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-22|2008-03-03|||October 2003||2003-10-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Observational|||Brain Function in Primary Lateral Sclerosis|Movement Related Cortical Potentials in Primary Lateral Sclerosis|Completed||N/A|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:54.259103|2017-10-11 04:45:54.259103
NCT00071448|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-23|2016-12-21|||June 2002||2002-06-01|December 2016|2016-12-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population|Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes|Completed||Phase 3|378|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 04:45:54.33799|2017-10-11 04:45:54.33799
NCT00071461|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-23|2012-02-22||2010-02-11|August 2003||2003-08-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|September 2005|Actual|2005-09-01||Interventional|BUILD 1||Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Idiopathic Pulmonary Fibrosis, Open Label Extension|Completed||Phase 2/Phase 3|158|Actual|Actelion||2|||f||||t||||||||||2017-10-11 04:45:54.657323|2017-10-11 04:45:54.657323
NCT00071474|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-23|2007-01-22|||August 2003||2003-08-01|January 2007|2007-01-01|May 2005||2005-05-01|||||Interventional|||Shamanic Healing for Women With Temporomandibular Joint Disorders (TMDs)||Completed||Phase 1|25||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:45:54.801278|2017-10-11 04:45:54.801278
NCT00071487|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-24|2013-08-01|2012-02-27||October 2003||2003-10-01|August 2013|2013-08-01|June 2006|Actual|2006-06-01|August 2005|Actual|2005-08-01||Interventional|||Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)|A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|449|Actual|Human Genome Sciences Inc.||4|||f||||t||||||||||2017-10-11 04:45:54.90493|2017-10-11 04:45:54.90493
NCT00071500|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-24|2008-09-25|||October 2003||2003-10-01|September 2008|2008-09-01|June 2009|Anticipated|2009-06-01|June 2007|Actual|2007-06-01||Interventional|||An Electronic Pillbox for People With HIV|A Novel Technology to Improve HIV Medication Compliance|Unknown status|Active, not recruiting|Phase 1|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 04:45:57.92314|2017-10-11 04:45:57.92314
NCT00071513|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-24|2016-07-07|2015-12-06||March 2003||2003-03-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|CAST-T/HSTS|All participants.|Middle School to High School Transition Project: Depression and Substance Abuse Prevention|Middle School to High School Transition Project|Completed||Phase 1|497|Actual|University of Washington|"A significant limitation of this trial was the brief nature of the comparison condition, the Brief Intervention group; findings might reflect dose rather than content of the CAST-T/HSTS intervention."|2|||f||||f||||||||No|Add data has been de-identified. De-identified data is available to share.|2017-10-11 04:45:58.019425|2017-10-11 04:45:58.019425
NCT00071526|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-27|2017-10-05|||October 24, 2003||2003-10-24|September 26, 2017|2017-09-26||||||||Observational|||Urinary Vitamin C Loss in Diabetic Subjects|Urinary Vitamin C Loss in Subjects With and Without Diabetes|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:45:58.346797|2017-10-11 04:45:58.346797
NCT00071539|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-28|2012-01-18|||October 2003||2003-10-01|January 2012|2012-01-01|July 2006|Actual|2006-07-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors||Completed||Phase 2|56|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-10-11 04:45:58.448698|2017-10-11 04:45:58.448698
NCT00071552|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-28|2014-05-09|||January 2004||2004-01-01|May 2014|2014-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients|Evaluation of Clinical Efficacy of HFA-Propelled Beclomethasone Dipropionate Metered-Dose Inhaler Versus Fluticasone Propionate Multidose Dry Powder Inhaler on Small Airways in Poorly Controlled Asthmatic Adolescent and Adult Patients|Terminated||Phase 4|49|Actual|Teva Pharmaceutical Industries||2||Very poor enrollment|f||||f||||||||||2017-10-11 04:45:58.517508|2017-10-11 04:45:58.517508
NCT00071565|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-28|2015-08-17|||September 2002||2002-09-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Familial Intracranial Aneurysm Study II|Familial Intracranial Aneurysm Study II|Completed||N/A|5875|Actual|University of Cincinnati|||1||f||||f||||||Samples With DNA|"     blood sample   "|||2017-10-11 04:45:58.602537|2017-10-11 04:45:58.602537
NCT00071578|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2013-06-26|||October 2003||2003-10-01|June 2013|2013-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparing Two Group Therapy Treatments for Binge Eating Disorder|Comparison of Dialectical Behavior Therapy and Supportive Therapy for Binge Eating Disorder|Completed||N/A|101|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 04:45:58.709345|2017-10-11 04:45:58.709345
NCT00071617|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2013-11-08|||November 2002||2002-11-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Youth-Nominated Support Team Intervention for Suicidal Adolescents|Youth Support Team Intervention for Suicidal Adolescents|Completed||Phase 2|448|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 04:45:58.953853|2017-10-11 04:45:58.953853
NCT00071630|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2013-11-06|||September 2002||2002-09-01|September 2008|2008-09-01|August 2005||2005-08-01|||||Interventional|||Therapeutic Processes and Treatment Outcome in Adolescents With Anxiety Disorders|Process as a Predictor of Outcomes in CBT for Youth|Completed||Phase 4|130||Temple University|||||f||||||||||||||2017-10-11 04:45:59.048462|2017-10-11 04:45:59.048462
NCT00071643|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2017-08-31|||September 2002||2002-09-01|August 2017|2017-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Preventing Post-Stroke Depression|Prevention of Post-Stroke Depression - Treatment Strategy|Completed||N/A|201|Actual|University of Iowa||3|||f||||f|f|f||||||||2017-10-11 04:45:59.150873|2017-10-11 04:45:59.150873
NCT00071656|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2013-08-06|||September 2002||2002-09-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I|Psychosocial Treatment for ADHD Inattentive Type I|Completed||N/A|60||University of California, San Francisco|||||f||||||||||||||2017-10-11 04:45:59.405705|2017-10-11 04:45:59.405705
NCT00071669|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2013-04-12|||November 2001||2001-11-01|November 2005|2005-11-01||||||||Interventional|||Acupuncture as a Supplemental Treatment for Bipolar Depression|Adjunctive Acupuncture as a Treatment for Bipolar Depression|Completed||Phase 2|30||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-10-11 04:45:59.491492|2017-10-11 04:45:59.491492
NCT00071682|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2013-05-13|||October 2007||2007-10-01|May 2013|2013-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Evaulation of Interaction Between Herbal Products and Anticoagulants|Early Identification of Adverse Reactions to Herbs|Withdrawn||N/A|0|Actual|University of California, San Francisco|||||f||||f||||||||||2017-10-11 04:45:59.592075|2017-10-11 04:45:59.592075
NCT00071695|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2007-05-17|||July 2003||2003-07-01|May 2007|2007-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Duloxetine vs. Active Comparator in the Treatment of Patients With Depression|Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder|Completed||Phase 4|320||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:45:59.682355|2017-10-11 04:45:59.682355
NCT00071708|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2008-07-30||||||July 2008|2008-07-01||||||||Expanded Access|||Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial|Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial|No longer available||N/A|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:45:59.769826|2017-10-11 04:45:59.769826
NCT00071721|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2014-09-15|2010-07-06||October 2003||2003-10-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|||Valproate in Dementia (VALID)|A Randomized, Double-Blind, Placebo-Controlled Trial of Valproate to Attenuate the Progression of Alzheimer's Disease (AD)|Completed||Phase 3|313|Actual|Alzheimer's Disease Cooperative Study (ADCS)||2|||f||||t||||||||||2017-10-11 04:45:59.904596|2017-10-11 04:45:59.904596
NCT00071734|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-29|2008-03-03|||October 2003||2003-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Brain Activation During Simple Vocal Behaviors|Brain Activation During Simple Vocal Behaviors|Completed||N/A|37||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:02.458761|2017-10-11 04:46:02.458761
NCT00071747|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-30|2016-08-30|||August 2003||2003-08-01|August 2016|2016-08-01|January 2005|Actual|2005-01-01|||||Interventional|||Clinical Study Of Schizophrenia in Both Men and Women|A Multi-Center, Double Blind, Placebo-controlled, Randomized, Parallel Group Evaluation of the Efficacy of a Flexible Dose of Lamotrigine Versus Placebo As Add-On Therapy In Schizophrenia|Completed||Phase 3|176||GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:46:02.519072|2017-10-11 04:46:02.519072
NCT00071760|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-30|2016-11-28|2012-03-02||October 2003||2003-10-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|July 2011|Actual|2011-07-01||Interventional|||Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects|A 48 Week, Phase II, Open-label, 2-cohort, Multicenter Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Antiviral Activity of GW433908 and GW433908/RTV When Administered to HIV-1 Infected Protease Inhibitor (PI) Naive and PI-experienced Pediatric Subjects Aged 4 Weeks to <2 Years.|Active, not recruiting||Phase 2|75|Actual|ViiV Healthcare||2|||f||||t||||||||||2017-10-11 04:46:02.70606|2017-10-11 04:46:02.70606
NCT00071773|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-30|2016-08-25|||July 2003||2003-07-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|November 2005|Actual|2005-11-01||Interventional|Laser||A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema|A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema|Completed||Phase 2|263|Actual|Jaeb Center for Health Research||2|||f||||f||||||||||2017-10-11 04:46:04.379554|2017-10-11 04:46:04.379554
NCT00071799|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-31|2010-08-24|2010-03-02||November 2003||2003-11-01|August 2010|2010-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care|A Multicenter, Randomized, Open-label, Parallel-group, Phase 3 Trial of Subcutaneous Azacitidine Plus Best Supportive Care Versus Conventional Care Regimens Plus Best Supportive Care for the Treatment of Myelodysplastic Syndromes (MDS)|Completed||Phase 3|358|Actual|Celgene||2|||f||||t||||||||||2017-10-11 04:46:04.770652|2017-10-11 04:46:04.770652
NCT00071812|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-31|2013-08-01|2012-02-27||December 2003||2003-12-01|August 2013|2013-08-01|December 2005|Actual|2005-12-01|January 2005|Actual|2005-01-01||Interventional|||A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)|A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 2|283|Actual|Human Genome Sciences Inc.||4|||f||||t||||||||||2017-10-11 04:46:09.109766|2017-10-11 04:46:09.109766
NCT00073658|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-02|2014-03-07|||January 2000||2000-01-01|March 2014|2014-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Treating Behavioral Disturbances in Individuals With Dementia|Continuation Pharmacotherapy for Agitation of Dementia|Completed||Phase 2|137||University of Pittsburgh|||||f||||||||||||||2017-10-11 04:47:29.905767|2017-10-11 04:47:29.905767
NCT00071838|ClinicalTrials.gov processed this data on October 10, 2017|2003-10-31|2017-06-30|||October 30, 2003||2003-10-30|August 16, 2011|2011-08-16|August 16, 2011|Actual|2011-08-16|October 4, 2007|Actual|2007-10-04||Interventional|||Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis|Zenapax (Daclizumab) Admin to Pts With Multiple Sclerosis (ZAP MS): Effect of Intravenously Admin Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (Daclizumab) on Inflammatory Activity in the Central Nervous System|Completed||Phase 2|16|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:46:10.670989|2017-10-11 04:46:10.670989
NCT00071851|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-03|2015-04-09|||December 2003||2003-12-01|April 2015|2015-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults|A Phase IB Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, Administered at 2 Different Dosing Schedules, in HIV-1-Uninfected Adult Participants|Completed||Phase 1/Phase 2|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:46:10.773027|2017-10-11 04:46:10.773027
NCT00071877|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-03|2008-03-03|||October 2003||2003-10-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease|A Clinical Trial of Replagal Enzyme Replacement Therapy in Children Ages 7 - 17 Years With Fabry Disease|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:10.887808|2017-10-11 04:46:10.887808
NCT00071890|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-03|2010-09-13|2010-09-13||October 2003||2003-10-01|September 2010|2010-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ILIADE||Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx|Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Anti-Retroviral TX in HIV Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm(3) Who Have Received Anti-Retroviral TX|Completed||Phase 2|148|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:46:10.964117|2017-10-11 04:46:10.964117
NCT00071903|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-03|2017-06-30|||October 30, 2003||2003-10-30|July 18, 2008|2008-07-18|July 18, 2008||2008-07-18|||||Observational|||The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study|The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study|Completed||N/A|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:11.28493|2017-10-11 04:46:11.28493
NCT00071916|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2010-10-28|||March 2001||2001-03-01|March 2010|2010-03-01|June 2010|Anticipated|2010-06-01|||||Observational|||Racial Difference in HCV/Host Interactions|African American Response to Therapy for Hepatitis C|Unknown status|Recruiting|N/A|260|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"     Blood. No liver biopsies will be performed specifically for inclusion into the tissue     repository. Only slides or paraffin tissue blocks of previously performed liver biopsies will     be included in the tissue repository.   "|||2017-10-11 04:46:11.356865|2017-10-11 04:46:11.356865
NCT00071929|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-06-20|||November 1999||1999-11-01|September 2004|2004-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer|Phase II Evaluation of Oxaliplatin in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:11.438571|2017-10-11 04:46:11.438571
NCT00071942|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-12-10|||October 2003||2003-10-01|December 2013|2013-12-01||||November 2007|Actual|2007-11-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Breast Cancer|A Phase I Trial of An Admixture of Recombinant Vaccinia Virus That Express DF3/MUC1 and rV-TRICOM (B7.ICAM-1, and LFA-3) in Patients With Metastatic Adenocarcinoma of The Breast|Terminated||Phase 1|22|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:46:11.567667|2017-10-11 04:46:11.567667
NCT00071955|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-12-18|||March 2003||2003-03-01|January 2006|2006-01-01|January 2009|Actual|2009-01-01|||||Interventional|||Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma|A Phase II Study to Evaluate Safety and Efficacy of Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH and GM-CSF Following the Anti-CD20 Antibody, Rituximab, in Previously Treated Patients With Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:11.893114|2017-10-11 04:46:11.893114
NCT00071968|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-01-07|||August 2003||2003-08-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse|An Open-Label Study Of Exploratory Pharmacogenomics And Pharmacologic Effects Of Neoadjuvant Oral CCI-779 In Newly Diagnosed Prostate Cancer Patients Undergoing Radical Prostatectomy Who Have A High Risk Of Relapse|Completed||Phase 2|15|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:46:11.980262|2017-10-11 04:46:11.980262
NCT00071981|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2015-10-06|2012-11-24||March 2005||2005-03-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|August 2011|Actual|2011-08-01||Interventional|||Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma|A Randomized Phase II Trial of Multi-Epitope Vaccination With Melanoma Peptides For Cytotoxic T Cells And Helper T Cells For Patients With Metastatic Melanoma|Completed||Phase 2|175|Actual|Eastern Cooperative Oncology Group||4|||f||||f||||||||||2017-10-11 04:46:12.100382|2017-10-11 04:46:12.100382
NCT00071994|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-02-26|||February 2004||2004-02-01|February 2013|2013-02-01||||May 2005|Actual|2005-05-01||Interventional|||Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)|A Phase II Study of ZD1839 (Iressa, Gefitinib, NSC 715055) in Advanced Unresectable Hepatocellular Carcinoma|Completed||Phase 2|59|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:46:13.183738|2017-10-11 04:46:13.183738
NCT00072007|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2012-05-14|||June 2002||2002-06-01|May 2012|2012-05-01|October 2010|Actual|2010-10-01|March 2003|Actual|2003-03-01||Interventional|||Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL|2-CDA and Rituximab as Remission Induction and Rituximab as In Vivo Purging Prior to Peripheral Stem Cell Mobilization in Patients With Chronic Lymphocytic Leukemia (CLL) - A Prospective Multicenter Phase II Trial|Completed||Phase 2|43|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 04:46:13.272423|2017-10-11 04:46:13.272423
NCT00072020|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-08-01|||August 2003||2003-08-01|January 2006|2006-01-01||||||||Interventional|||Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer|Does Adjuvant Zoledronic Acid Reduce Recurrence in Patients With High Risk Localized Breast Cancer?|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:13.38387|2017-10-11 04:46:13.38387
NCT00072033|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2012-06-02|||March 2003||2003-03-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|March 2003|Actual|2003-03-01||Interventional|||Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer|Docetaxel and Cisplatin Chemo- and Radiochemotherapy Followed by Surgery in Patients With Locally Advanced Esophageal Cancer - A Multicenter Phase II Trial|Completed||Phase 2|66|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 04:46:13.478731|2017-10-11 04:46:13.478731
NCT00072046|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2016-07-01|||October 2003||2003-10-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|January 2004|Actual|2004-01-01||Interventional|||Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)|A Randomized Phase III Trial Of Interferon Alfa-2B Or Interferon Alfa-2B Plus Bevacizumab In Patients With Advanced Renal Carcinoma|Completed||Phase 3|732|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:46:13.630779|2017-10-11 04:46:13.630779
NCT00072059|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-07-17|||July 2003||2003-07-01|January 2005|2005-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer|An Open Label, Randomized, Multicenter, Phase II Study To Determine Hemoglobin Dose Response, Safety And Pharmacokinetic Profile Of Ro 50-3821 Given Subcutaneously Once Weekly Or Once Every 3 Weeks To Anemic Patients With Stage IIIB or IV Non-Small Cell Lung Carcinoma Receiving Antineoplastic Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:14.998367|2017-10-11 04:46:14.998367
NCT00072072|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-09-19|||August 2003||2003-08-01|January 2006|2006-01-01|January 2006|Actual|2006-01-01|||||Interventional|||Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase I Trial Of A COX-2 Inhibitor (Celecoxib) In Combination With An EGFR Inhibitor (OSI-774) In Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:15.086303|2017-10-11 04:46:15.086303
NCT00072085|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-06-18|||September 2003||2003-09-01|May 2005|2005-05-01|July 2006|Actual|2006-07-01|||||Interventional|||Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma|Immunization Of Patients With Metastatic Melanoma Using A Recombinant GP100 Protein (184V) And A Class I Restricted Peptide From The GP100 Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:15.165175|2017-10-11 04:46:15.165175
NCT00072098|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2017-01-10|||September 2003||2003-09-01|January 2017|2017-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer|Phase I Trial Of Adenoviral Vector Delivery Of The Human Interleukin-12 cDNA By Intratumoral Injection In Patients With Metastatic Colorectal Cancer To The Liver|Terminated||Phase 1|22|Actual|Icahn School of Medicine at Mount Sinai||1||limited funding|f||||t||||||||||2017-10-11 04:46:15.234711|2017-10-11 04:46:15.234711
NCT00072111|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2015-04-29|||September 2003||2003-09-01|April 2006|2006-04-01||||||||Interventional|||Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene|Phase I Study of Anakinra Mediated Tumor Regression and Angiogenesis Inhibition in Subjects With Cancers Producing Interleukin-1|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:15.354361|2017-10-11 04:46:15.354361
NCT00072124|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-06-18|||September 2003||2003-09-01|January 2005|2005-01-01|May 2005|Actual|2005-05-01|||||Interventional|||Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma|A Prospective Random Assignment Trial Comparing Complete Metastasectomy to Chemotherapy for Selected Patients With Stage IV Melanoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:15.438841|2017-10-11 04:46:15.438841
NCT00072137|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2014-12-22|||October 2003||2003-10-01|August 2013|2013-08-01|November 2010|Actual|2010-11-01|December 2009|Actual|2009-12-01||Interventional|||Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy|Phase I Study of Intravesical Recombinant Fowlpox - GM-CSF (rF-GM-CSF) and/or Recombinant Fowlpox-TRICOM (rF-TRICOM) in Patients With Bladder Carcinoma Scheduled for Cystectomy|Terminated||Phase 1|21|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:46:15.517746|2017-10-11 04:46:15.517746
NCT00072150|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-06-04|||October 2003||2003-10-01|June 2013|2013-06-01||||March 2006|Actual|2006-03-01||Interventional|||Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma|Phase II Trial of PS-341 (Bortezomib) in Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:46:15.631374|2017-10-11 04:46:15.631374
NCT00072163|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-01-15|||October 2003||2003-10-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma|A Phase II Study Of Temozolomide And Thalidomide In Patients With Metastatic Melanoma In The Brain|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:46:15.727346|2017-10-11 04:46:15.727346
NCT00072176|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2015-02-05|2015-02-05||May 2004||2004-05-01|March 2014|2014-03-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional||All patients received treatment|Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer|A Phase II Study of CCI-779 in Patients With Metastatic and/or Locally Advanced Recurrent Endometrial Cancer|Completed||Phase 2|62|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:46:15.858888|2017-10-11 04:46:15.858888
NCT00072189|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2015-02-17|2015-02-17||November 2003||2003-11-01|October 2013|2013-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase II Study of UCN-01 in Metastatic Melanoma|A Phase II Study of UCN-01 in Metastatic Melanoma|Terminated||Phase 2|17|Actual|National Cancer Institute (NCI)|Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results|1||Early termination for discouraging results|f||||||||||||||2017-10-11 04:46:16.389305|2017-10-11 04:46:16.389305
NCT00073671|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-02|2017-04-07|||March 2003||2003-03-01|April 2017|2017-04-01|January 2009|Actual|2009-01-01|March 2006|Actual|2006-03-01||Interventional|||Prevention of Depression in At-Risk Adolescents|Prevention of Depression in At-Risk Adolescents|Completed||N/A|316|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 04:47:30.038098|2017-10-11 04:47:30.038098
NCT00072215|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2016-07-01|||April 2004||2004-04-01|July 2016|2016-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors|A Randomized Phase III Study of Paclitaxel, Ifosfamide and Cisplatin Versus Vinblastine, Ifosfamide and Cisplatin as Second-Line Therapy for Patients With Relapsed/Resistant Germ Cell Tumors|Terminated||Phase 3|1|Actual|Alliance for Clinical Trials in Oncology||2||poor accrual|f||||t||||||||||2017-10-11 04:46:16.645348|2017-10-11 04:46:16.645348
NCT00072228|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Phase I Study of Soblidotin and Gemcitabine in Patients With Locally Advanced or Metastatic Solid Tumors|Withdrawn||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:17.004334|2017-10-11 04:46:17.004334
NCT00064545|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2012-12-11|||July 2003||2003-07-01|December 2012|2012-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Gene-by-Smoking Interactions and Risk of Atherosclerosis - Ancillary to ARIC||Completed||N/A|1500|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 04:46:17.068864|2017-10-11 04:46:17.068864
NCT00064558|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-08|2017-09-29|||July 2003||2003-07-01|September 2017|2017-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genetic Determinants of Sudden Cardiac Death|Genetic Determinants of Sudden Cardiac Death|Completed||N/A|2500|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-10-11 04:46:17.13706|2017-10-11 04:46:17.13706
NCT00064571|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-09|2006-04-21|||October 2002||2002-10-01|April 2006|2006-04-01|October 2005||2005-10-01|||||Interventional|||Surgery for Vocal Cord Paralysis|Medialization Vs Reinnervation for Vocal Cord Paralysis|Terminated||Phase 3|300||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-10-11 04:46:17.195689|2017-10-11 04:46:17.195689
NCT00064584|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-09|2009-03-23|||May 2002||2002-05-01|March 2009|2009-03-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)|Tolerability and PK/PD of Multiple Oral Doses of CT53518 in Patients With Acute Myelogenous Leukemia|Completed||Phase 1|60||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:46:17.275139|2017-10-11 04:46:17.275139
NCT00064597|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2005-06-23|||December 1987||1987-12-01|June 2003|2003-06-01|December 2003||2003-12-01|||||Observational|||Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood|National Institute of Child Health and Human Development Fetal Cell Isolation Study (NIFTY)|Unknown status|Active, not recruiting|N/A|3500||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:46:17.338692|2017-10-11 04:46:17.338692
NCT00064610|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2008-02-07|||December 2002||2002-12-01|February 2008|2008-02-01||||December 2004|Actual|2004-12-01||Interventional|||Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer|A Phase I/II, Open Label, Dose Escalation Study to Determine the Tolerance and Preliminary Activity of PS-341 Plus Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer Requiring Chemotherapy|Completed||Phase 1/Phase 2|102||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:46:17.442481|2017-10-11 04:46:17.442481
NCT00064623|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2008-03-04|||August 2003||2003-08-01|March 2008|2008-03-01|November 2005||2005-11-01|||||Interventional|||Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy|A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Painful HIV-Associated Distal Symmetrical Polyneuropathy|Completed||Phase 3|300||NeurogesX|||||||||||||||||||2017-10-11 04:46:17.632261|2017-10-11 04:46:17.632261
NCT00064636|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2005-06-23|||December 2002||2002-12-01|September 2003|2003-09-01||||||||Interventional|||Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors|A Phase I, Open Label, Dose Escalation Study of PS-341 Plus Docetaxel in Treatment-Naive or Previously Treated Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors|Terminated||Phase 1|46||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:46:17.791252|2017-10-11 04:46:17.791252
NCT00064649|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2010-01-12|||April 2004||2004-04-01|January 2010|2010-01-01|June 2006|Actual|2006-06-01|||||Interventional|MIST||Minimally Invasive Surgical Therapy for BPH|Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia|Terminated||Phase 3|49|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3||Inability to recruit required sample size.|f||||t||||||||||2017-10-11 04:46:17.847913|2017-10-11 04:46:17.847913
NCT00064662|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2013-05-08|2012-03-26||February 2002||2002-02-01|May 2013|2013-05-01|March 2010|Actual|2010-03-01|June 2006|Actual|2006-06-01||Interventional|SISTEr||Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence|Randomized Clinical Trial of the Burch Modified Tanagho and Autologous Fascia Sling Procedures for Women With Predominantly Stress Urinary Incontinence|Completed||Phase 2/Phase 3|655|Actual|New England Research Institutes|Patients received care at tertiary care centers which could limit the generalizability of the findings. Patients and providers were aware of treatment assignment which could lead to assessment bias.|2|||f||||f||||||||||2017-10-11 04:46:17.976678|2017-10-11 04:46:17.976678
NCT00064675|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2013-04-04|||July 2003||2003-07-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genetics of Cardiovascular Reactivity in Black Youth|Genetics of Cardiovascular Reactivity in Black Youth|Completed||N/A|500|Actual|University of Tennessee|||1||f||||||||||Samples With DNA|"     buccal specimens stored at Med Coll Wisconsin   "|||2017-10-11 04:46:18.963819|2017-10-11 04:46:18.963819
NCT00064688|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2015-09-08|||July 2003||2003-07-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genomic Dissection of a QTL Affecting the Lipid Profile|Genomic Dissection of a QTL Affecting the Lipid Profile|Withdrawn||N/A|0|Actual|Medical College of Wisconsin|||1|This protocol was created to support work as part of an NIH-funded study.|f||||f||||||Samples With DNA|"     DNA   "|||2017-10-11 04:46:19.026022|2017-10-11 04:46:19.026022
NCT00064896|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2017-10-05|||July 11, 2003||2003-07-11|May 19, 2017|2017-05-19|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Technical Development of Cardiovascular Magnetic Resonance Imaging|Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging|Recruiting||Phase 1|140|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:46:26.488751|2017-10-11 04:46:26.488751
NCT00073645|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-02|2013-08-19|||July 2002||2002-07-01|August 2013|2013-08-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Family and Peer Involvement in the Treatment of Anxiety Disorders in Children|Therapy Specificity and Mediation in Family and Group CBT|Completed||Phase 1|241|Actual|Florida International University||2|||f||||t||||||||||2017-10-11 04:47:29.78831|2017-10-11 04:47:29.78831
NCT00064701|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2013-11-12|2013-07-25|2010-09-22|June 2003||2003-06-01|November 2013|2013-11-01|March 2009|Actual|2009-03-01|March 2005|Actual|2005-03-01||Interventional||Full analysis set; all randomized patients who received at least one dose of study drug.|Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients|A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (Cyclosporine)/MMF in de Novo Kidney Transplant Recipients|Completed||Phase 3|668|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|3|||f||||t||||||||||2017-10-11 04:46:19.149204|2017-10-11 04:46:19.149204
NCT00064714|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2015-02-23||2010-08-13|July 2003||2003-07-01|January 2015|2015-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes|Effect of AC 2993 (Synthetic Exendin-4) - Administered Alone or in Combination With Daclizumab - on Islet Function in Patients With Type I Diabetes|Completed||Phase 2|47|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 04:46:24.07064|2017-10-11 04:46:24.07064
NCT00064727|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-10|2017-06-30|||July 9, 2003||2003-07-09|April 11, 2007|2007-04-11|April 11, 2007||2007-04-11|||||Interventional|||Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes|Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:24.182507|2017-10-11 04:46:24.182507
NCT00064740|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-11|2006-08-16|||July 2003||2003-07-01|August 2006|2006-08-01|March 2006||2006-03-01|||||Interventional|||Relaxation Response With Acupuncture for HIV Patients|Relaxation Response With Acupuncture for HIV Patients|Completed||Phase 2|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:46:24.260697|2017-10-11 04:46:24.260697
NCT00064753|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-11|2015-10-26|2015-10-26||May 2002||2002-05-01|October 2015|2015-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|FAVORIT|7273 patients were screened, of whom 2056 and 2054 were randomized to high-dose and low-dose multivitamins, respectively; 34% did not meet eligibility cutpoints for tHey and Cer, and 9% were not enrolled for other reasons. Baseline characteristics were well balanced between treatment groups overall and within country.|Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)|Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)|Completed||Phase 2/Phase 3|4110|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|The B-vitamin pathway for reducing tHcy may not be the optimal one for reducing CVD risk. Also, the duration of follow-up may not have been sufficient to identify a lagged impact on modification of CVD risk.|2|||f||||t||||||||||2017-10-11 04:46:24.352169|2017-10-11 04:46:24.352169
NCT00064766|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-11|2005-06-23|||February 2003||2003-02-01|May 2003|2003-05-01|February 2005||2005-02-01|||||Interventional|||Norplant and Irregular Bleeding/Spotting|A Prospective Randomized Clinical Trial of Doxycycline 20mg Twice a Day Versus Placebo on the Bleeding and Spotting in Women After Insertion of a Levonorgestrel Implant (Norplant) Protocol #2002-1|Unknown status|Recruiting|Phase 4|50||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-10-11 04:46:25.204385|2017-10-11 04:46:25.204385
NCT00064779|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-11|2011-06-02|||July 2003||2003-07-01|June 2011|2011-06-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma|Pilot Imaging Study to Assess the Distribution of IL13-PE38QQR Cytotoxin Infusions in Patients With Recurrent, Resectable, Supratentorial Malignant Glioma|Completed||Phase 1|18||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:46:25.30246|2017-10-11 04:46:25.30246
NCT00064792|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-11|2014-06-04|2012-07-30||July 2003||2003-07-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Simvastatin Therapy in Smith-Lemli-Opitz Syndrome|Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome|Completed||Phase 2|23|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:46:25.377905|2017-10-11 04:46:25.377905
NCT00064805|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2014-08-13|||August 2002||2002-08-01|April 2014|2014-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Therapy for Reading Problems in Adults After Brain Injury|Cognitively-based Treatments of Acquired Dyslexias|Completed||N/A|58|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:46:25.723903|2017-10-11 04:46:25.723903
NCT00064818|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|September 2003||2003-09-01|||||Observational|||Acupuncture Needling on Connective Tissue by Ultrasound|Acupuncture Needling on Connective Tissue by Ultrasound|Completed||N/A|46||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:46:25.817412|2017-10-11 04:46:25.817412
NCT00064831|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2007-12-06|||July 2003||2003-07-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Black Cohosh Extract in Postmenopausal Breast Health|The Effect of Black Cohosh Extract on the Human Breast|Completed||Phase 1/Phase 2|73||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:46:25.885363|2017-10-11 04:46:25.885363
NCT00064844|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2013-03-08|2013-01-31||August 2002||2002-08-01|March 2013|2013-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Combination Nicotine Replacement for Alcoholic Smokers|Combination Nicotine Replacement for Alcoholic Smokers|Completed||Phase 4|96|Actual|Yale University||2|||f||||f||||||||||2017-10-11 04:46:25.96245|2017-10-11 04:46:25.96245
NCT00064857|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2008-04-21|||August 2003||2003-08-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors|Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors|Completed||Phase 2|26||National Center for Complementary and Integrative Health (NCCIH)|||||||||t||||||||||2017-10-11 04:46:26.219564|2017-10-11 04:46:26.219564
NCT00064870|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2016-11-04|||June 2002||2002-06-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|NCRAD||Alzheimer's Disease Genetics Study|National Cell Repository for Alzheimer's Disease (NCRAD)|Recruiting||N/A|3000|Anticipated|Indiana University|||1||f||||f||||||Samples With DNA|"     blood samples   "|||2017-10-11 04:46:26.295647|2017-10-11 04:46:26.295647
NCT00064883|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2017-10-05|||July 10, 2003||2003-07-10|August 25, 2017|2017-08-25||||||||Observational|||Radiation Therapy and the Natural History of Childhood Cancers|The Natural History of Childhood Malignancies Treated With Radiation Therapy|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:26.390372|2017-10-11 04:46:26.390372
NCT00064909|ClinicalTrials.gov processed this data on October 10, 2017|2003-07-14|2008-03-03|||July 2003||2003-07-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Observational|||MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis|Using MR Perfusion Imaging and Hypercapnia to Study Angiogenesis in Multiple Sclerosis Patients|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:26.562233|2017-10-11 04:46:26.562233
NCT00072267|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2015-07-22|||January 2004||2004-01-01|July 2015|2015-07-01||||April 2005|Actual|2005-04-01||Interventional|||UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase II Study of UCN-01 in Combination With Topotecan in Patients With Advanced Ovarian Cancer|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 04:46:26.612633|2017-10-11 04:46:26.612633
NCT00072280|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2014-09-16|2013-09-23||November 2004||2004-11-01|September 2014|2014-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma|A Pilot Phase II Study for Children With Infantile Fibrosarcoma|Terminated||Phase 2|7|Actual|Children's Oncology Group|Study closed early due to slow accrual. Analysis plans were not carried out (lack of statistical precision compromised the ability to draw appropriate conclusions). Reported Primary Outcome Measure data reflects data collection through March 2008.|2||Due to poor accrual|f||||t||||||||||2017-10-11 04:46:26.713964|2017-10-11 04:46:26.713964
NCT00072293|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2017-08-08|2016-02-26||December 2001||2001-12-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|September 2012|Actual|2012-09-01||Interventional|23-01|Intention-to-treat|Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases|A Randomized Trial Of Axillary Dissection Versus No Axillary Dissection For Patients With Clinically Node Negative Breast Cancer And Micrometastases In The Sentinel Node|Active, not recruiting||N/A|931|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-10-11 04:46:27.439899|2017-10-11 04:46:27.439899
NCT00072319|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-03-01|||August 2003||2003-08-01|March 2013|2013-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer|Pilot Study of Epirubicin and Cyclophosphamide Followed by Paclitaxel at 10-11 Days Interval for Women With Early Breast Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:46:27.799266|2017-10-11 04:46:27.799266
NCT00072332|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-12-18|||August 2003||2003-08-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2005|Actual|2005-12-01||Interventional|||Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I Dose Escalation Study of Edotecarin (PHA-782615) and Cisplatin in Adult Patients With Advanced/Metastatic Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:27.876298|2017-10-11 04:46:27.876298
NCT00072345|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-01-17|||July 2003||2003-07-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma|A Phase II Study of Temozolomide, Thalidomide, and Lomustine in the Treatment of Advanced Melanoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:46:27.93474|2017-10-11 04:46:27.93474
NCT00072358|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2017-10-03|||July 2003||2003-07-01|October 2017|2017-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma|Phase II Study of Anti-GD2 3F8 Antibody and GM-CSF for High-Risk Neuroblastoma|Active, not recruiting||Phase 2|340|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 04:46:28.003499|2017-10-11 04:46:28.003499
NCT00072410|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2009-02-06|||June 2003||2003-06-01|August 2005|2005-08-01||||||||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer|Single-Dose, Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Humanized Monoclonal Antibody 3S193 (90Y-hu3S193) in Patients With Advanced Ovarian Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:28.243603|2017-10-11 04:46:28.243603
NCT00072436|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-07-01|||September 2003||2003-09-01|July 2013|2013-07-01||||March 2009|Actual|2009-03-01||Interventional|||Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors|A Phase I Trial of Gemcitabine Followed by a Short Infusion of Flavopiridol in Patients With Solid Tumors|Completed||Phase 1|58|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:46:28.296329|2017-10-11 04:46:28.296329
NCT00072449|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-06-14|2013-06-14||May 2004||2004-05-01|June 2013|2013-06-01|June 2010|Actual|2010-06-01|March 2009|Actual|2009-03-01||Interventional|||Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma|A Phase II Study Of Anti-CD20 Monoclonal Antibody (Rituximab) Therapy For Patients With Refractory Or Relapsed Primary CNS Lymphoma (PCNSL)|Terminated||Phase 2|12|Actual|Sidney Kimmel Comprehensive Cancer Center|Study terminated early due to slow accrual and lack of resources and priority due to NCI mandate of combining two consortia. Unable to fully analyze the data, or objectives, not enough patients. Not able to do statistics|1||slow accrual and lack of resources and priority due to combining 2 consortia|f||||||||||||||2017-10-11 04:46:30.116063|2017-10-11 04:46:30.116063
NCT00072462|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2017-03-31|||September 2003||2003-09-01|March 2017|2017-03-01|January 2022|Anticipated|2022-01-01|December 2015|Actual|2015-12-01||Interventional|IBIS-II DCIS||Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ|International Breast Cancer Intervention Study II (IBIS-II) (DCIS)|Active, not recruiting||Phase 3|2980|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-10-11 04:46:30.41914|2017-10-11 04:46:30.41914
NCT00073203|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-17|2009-08-27||||||May 2004|2004-05-01|May 2004||2004-05-01|||||Interventional|||A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder|A 6- Week, Randomized, Double-Blind, Parallel-Group, Active-and Placebo-Controlled Trial to Assess the Efficacy of R228060 in Adult Subjects With Major Depressive Disorder (MDD)|Completed||Phase 2|488||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:46:35.132812|2017-10-11 04:46:35.132812
NCT00072475|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2016-07-01|2014-05-22||December 2003||2003-12-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|November 2008|Actual|2008-11-01||Interventional||Of the 155 participants recruited, 2 participants cancelled prior to starting treatment; 7 were determined to have AML at registration and 4 had diagnosis other than MDS. Thus 142 participants were evaluable for response|Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes|A Phase II Study of an Oral VEGF Receptor Tyrosine Kinase Inhibitor (PTK787/ZK222584) (IND #66370, NSC #719335) in Myelodysplastic Syndrome (MDS)|Completed||Phase 2|155|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:46:31.884563|2017-10-11 04:46:31.884563
NCT00072488|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2010-06-05|||October 2004||2004-10-01|October 2007|2007-10-01||||December 2005|Anticipated|2005-12-01||Interventional|||Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma|Whole-Body MRI in the Evaluation of Pediatric Malignancies|Unknown status|Active, not recruiting|N/A|226|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:32.982848|2017-10-11 04:46:32.982848
NCT00072501|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2012-10-27|||April 2004||2004-04-01|February 2006|2006-02-01||||April 2012|Actual|2012-04-01||Interventional|||Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer|Screening Breast Ultrasound in High-Risk Women|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:33.095411|2017-10-11 04:46:33.095411
NCT00072514|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2017-05-28|2017-04-14||August 2003||2003-08-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|July 2008|Actual|2008-07-01||Interventional|||Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies|A Phase II Study Evaluating the Efficacy of Gemcitabine, Carboplatin, and Dexamethasone and Rituximab for Previously Treated Lymphoid Malignancies|Completed||Phase 2|55|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 04:46:33.201396|2017-10-11 04:46:33.201396
NCT00072527|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2016-07-01|||November 2003||2003-11-01|July 2016|2016-07-01|January 2013|Actual|2013-01-01|June 2007|Actual|2007-06-01||Interventional|||Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Induction Cisplatin/Irinotecan Followed By Combination Carboplatin, Etoposide And Chest Radiotherapy In Limited Stage Small Cell Lung Cancer: A Phase II Study|Completed||Phase 2|78|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:46:33.457605|2017-10-11 04:46:33.457605
NCT00072540|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2013-11-07||||||November 2013|2013-11-01||||||||Interventional|||S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix|S0212: Phase IIb Randomized Study of Celecoxib in Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||||drug issues|f||||t||||||||||2017-10-11 04:46:33.851145|2017-10-11 04:46:33.851145
NCT00072553|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2009-02-06|||September 2003||2003-09-01|May 2007|2007-05-01||||||||Interventional|||Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer|A Phase II Of An Optimized LV-5FU-Oxaliplatin Strategy With Celebrex In Metastatic Colorectal Cancer, Optimox2-Celecoxib Study|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:46:33.940678|2017-10-11 04:46:33.940678
NCT00072566|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2015-05-08|2015-04-14||December 2003||2003-12-01|December 2012|2012-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer|Phase II Clinical Trial of Bevacizumab (NSC 704865) and Low Dose Oral Cyclophosphamide in Recurrent Ovarian Cancer, Primary Peritoneal Carcinoma|Completed||Phase 2|70|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:46:34.057514|2017-10-11 04:46:34.057514
NCT00072579|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2017-01-17|||May 2003||2003-05-01|June 2013|2013-06-01|December 2007|Actual|2007-12-01|April 2006|Actual|2006-04-01||Interventional|||Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment|Phase II Study of GM-CSF in Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML) Who Are Not in Complete Cytogenetic Remission After Initial Therapy|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:46:34.664286|2017-10-11 04:46:34.664286
NCT00072592|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2008-03-03|||October 2003||2003-10-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies|An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:34.763693|2017-10-11 04:46:34.763693
NCT00072605|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-04|2017-06-30|||October 30, 2003||2003-10-30|August 22, 2007|2007-08-22|August 22, 2007||2007-08-22|||||Interventional|||Experimental Ebola Vaccine Trial|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiple Strain Ebola DNA Plasmid Vaccine, VRC-EBODNA012-00-VP, in Adult Volunteers|Completed||Phase 1|27||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:34.828391|2017-10-11 04:46:34.828391
NCT00072618|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-05|2011-10-18|||October 2001||2001-10-01|October 2011|2011-10-01|August 2003|Actual|2003-08-01|||||Interventional|||Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients|A Phase I/II Multi-Center Study of Weekly Taxotere (Docetaxel) in Combination With Aptosyn (Exisulind) in Non-Small Cell Lung Cancer (NSCLC) Patients Who Have Failed a Prior Platinum-Containing Regimen|Completed||Phase 1/Phase 2|52||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:46:34.891326|2017-10-11 04:46:34.891326
NCT00072631|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-05|2015-06-12|||August 2003||2003-08-01|June 2015|2015-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer|A Phase II, Open-label, Intra-patient Dose-escalation Study of Erlotinib in Patients With Advanced Non-small Cell Lung Cancer Who Have Failed Prior Chemotherapy|Completed||Phase 2|43|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 04:46:34.9608|2017-10-11 04:46:34.9608
NCT00072644|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-06|2017-06-30|||October 30, 2003||2003-10-30|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Observational|||Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-infected Patients Receiving Single-Dose Prednisone|Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-infected Patients Receiving Single-Dose Prednisone|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:46:35.061469|2017-10-11 04:46:35.061469
NCT00073216|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-18|2012-05-03||||||May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Clade B Gag DNA/PLG and Env DNA/PLG Microparticles Vaccine and a Clade B Recombinant, Oligomeric gp140/MF59 Adjuvant Vaccine in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|96|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:46:35.185326|2017-10-11 04:46:35.185326
NCT00073229|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-18|2008-09-25|||July 2000||2000-07-01|September 2008|2008-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Observational|||Immune Function of Infants With HIV|Killer Cells and Viral Load in Vertical HIV Infection|Completed||N/A|80|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||f||||||||||2017-10-11 04:46:35.272385|2017-10-11 04:46:35.272385
NCT00073242|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-18|2015-06-03|||July 2000||2000-07-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Low-Dose Leptin and the Formerly-Obese|Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese|Unknown status|Recruiting|Phase 3|25|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 04:46:35.331464|2017-10-11 04:46:35.331464
NCT00073255|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-18|2010-01-14|||June 2003||2003-06-01|January 2010|2010-01-01|December 2005||2005-12-01|||||Interventional|||Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)|Evaluation of Tolerability, Safety, and Pharmacokinetics of hOKT3g1 (Ala-Ala)|Completed||Phase 1|12||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 04:46:35.420464|2017-10-11 04:46:35.420464
NCT00073268|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-18|2010-01-14|||December 2002||2002-12-01|January 2010|2010-01-01|June 2007||2007-06-01|||||Interventional|||Prevention of Type 2 Diabetes Mellitus in Children|Prevention of Type 2 Diabetes Mellitus in Children|Completed||Phase 1|300|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:46:35.473224|2017-10-11 04:46:35.473224
NCT00073281|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-18|2010-01-14|||August 2003||2003-08-01|January 2010|2010-01-01|December 2004||2004-12-01|||||Interventional|||Islet Transplantation for Patients With Type 1 Diabetes|Islet Transplantation for Patients With Type 1 Diabetes and Stable Renal Allografts Using Steroid Sparing Immunosuppression|Completed||Phase 1|10||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:46:35.534762|2017-10-11 04:46:35.534762
NCT00073294|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-18|2010-01-14||||||January 2010|2010-01-01||||||||Interventional|||Insulin Resistance and Insulin Secretion|Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity|Completed||N/A|200|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:46:35.59811|2017-10-11 04:46:35.59811
NCT00073307|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-19|2014-01-08|2011-08-02||November 2003||2003-11-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|September 2006|Actual|2006-09-01||Interventional|||Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer|A Phase III Randomized Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer.|Completed||Phase 3|903|Actual|Bayer|Per final PFS data (N=769) study unblinded; placebo-randomized subjects switched to sorafenib ~31May2005 (N=216) that diluted final OS, sorafenib treatment effect. Final ITT, N=903, reported safety data include additional data and cleaning.|2|||f||||t||||||||||2017-10-11 04:46:35.846083|2017-10-11 04:46:35.846083
NCT00073320|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-19|2010-04-26|||August 2003||2003-08-01|April 2010|2010-04-01|May 2004|Actual|2004-05-01|||||Interventional|||Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia|Pharmacokinetics, Tolerability, and Safety of Paliperidone After Repeated Intramuscular Injection of Paliperidone Palmitate in the Arm or the Buttock of Subjects With Schizophrenia|Completed||Phase 3|88|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:46:38.434844|2017-10-11 04:46:38.434844
NCT00073333|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-19|2013-07-01|2013-05-14||December 2002||2002-12-01|July 2013|2013-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia|Social Phobia: Assessment and Treatment of Social Skills|Completed||N/A|379|Actual|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-10-11 04:46:38.510303|2017-10-11 04:46:38.510303
NCT00073346|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-19|2013-06-19|||September 2003||2003-09-01|June 2013|2013-06-01|August 2006||2006-08-01|||||Interventional|||Treatment of Compulsive Hoarding|Treatment of Compulsive Hoarding|Completed||Phase 1|52||Boston University|||||f||||||||||||||2017-10-11 04:46:38.846711|2017-10-11 04:46:38.846711
NCT00073359|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-19|2014-05-19|||February 2003||2003-02-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Effects of Therapist Behavior on the Treatment of Depressed Adolescents|Engagement and Alliance in CBT for Depressed Adolescents|Unknown status|Active, not recruiting|Phase 1/Phase 2|40||University of Denver|||||f||||||||||||||2017-10-11 04:46:39.055098|2017-10-11 04:46:39.055098
NCT00073372|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-19|2011-05-16|||October 2003||2003-10-01|June 2010|2010-06-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)|Abciximab (ReoPro) in Acute Ischemic Stroke: A Phase III, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled Trial.|Terminated||Phase 3|808|Actual|Centocor, Inc.||||"Based on the data and observed benefit-risk profile, the trial's independent oversight   committee recommended that enrollment not resume."|||||t||||||||||2017-10-11 04:46:39.156406|2017-10-11 04:46:39.156406
NCT00073385|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-19|2005-08-26|||September 2003||2003-09-01|August 2005|2005-08-01|October 2004||2004-10-01|||||Interventional|||Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer|A Randomized Trial of Pivanex Plus Docetaxel or Docetaxel Monotherapy in Patients With Chemotherapy Resistant Advanced Non-Small Cell Carcinoma of the Lung (NSCLC)|Completed||Phase 2|225||Titan Pharmaceuticals|||||||||||||||||||2017-10-11 04:46:39.270361|2017-10-11 04:46:39.270361
NCT00073398|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-19|2015-06-25||2015-04-07|November 2003||2003-11-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||Vaccine Treatment for Advanced Non-Small Cell Lung Cancer|A Phase I/II Study of Tergenpumatucel-L (HyperAcute Lung) an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Refractory or Recurrent Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|54|Actual|NewLink Genetics Corporation||1|||f||||f||||||||||2017-10-11 04:46:39.367648|2017-10-11 04:46:39.367648
NCT00073411|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-20|2007-07-30|||November 2003||2003-11-01|July 2007|2007-07-01|May 2005|Actual|2005-05-01|||||Interventional|||Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression|Duloxetine Versus Escitalopram and Placebo in the Treatment of Patients With Major Depression|Completed||Phase 3|675||Eli Lilly and Company|||||f||||f||||||||||2017-10-11 04:46:39.458605|2017-10-11 04:46:39.458605
NCT00073424|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-20|2013-05-31|||January 2004||2004-01-01|May 2013|2013-05-01|October 2006|Actual|2006-10-01|||||Observational|||Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents|Cognitive, Behavioral, and Psychosocial Correlates of Medication Adherence in Children and Adolescents With HIV-1 Infection|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:46:39.557426|2017-10-11 04:46:39.557426
NCT00073437|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-20|2011-05-16|||October 2003||2003-10-01|April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of Infliximab in Patients With Sarcoidosis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety and Efficacy of Infliximab (Remicade�) in Subjects With Chronic Sarcoidosis With Pulmonary Involvement.|Completed||Phase 3|139|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 04:47:22.947531|2017-10-11 04:47:22.947531
NCT00073450|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-20|2015-04-20|||September 2003||2003-09-01|April 2015|2015-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)|An Open-Label Phase 2 Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 2|15|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:47:23.030654|2017-10-11 04:47:23.030654
NCT00073463|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-21|2008-01-24|||June 2003||2003-06-01|January 2008|2008-01-01|October 2005||2005-10-01|||||Interventional|||Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis|A Multicenter, Double-Blind, Placebo Controlled, Phase II Study of Aerosolized tgAAVCF for the Treatment of Cystic Fibrosis|Terminated||Phase 2/Phase 3|100||Targeted Genetics Corporation|||||f||||||||||||||2017-10-11 04:47:23.085578|2017-10-11 04:47:23.085578
NCT00073476|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-21|2006-06-20|||September 2003||2003-09-01|June 2006|2006-06-01|February 2005||2005-02-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke|A Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of a 72-Hour Infusion of CP-101,606 in Subjects With Acute Ischemic Stroke.|Terminated||Phase 2|300||Pfizer|||||||||||||||||||2017-10-11 04:47:25.149072|2017-10-11 04:47:25.149072
NCT00073489|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-21|2011-10-14|||May 2001||2001-05-01|October 2011|2011-10-01|December 2003|Actual|2003-12-01|||||Interventional|||A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)|A Pilot Trial of OSI-461 in Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|23||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:47:25.279995|2017-10-11 04:47:25.279995
NCT00073502|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-21|2006-02-17|||October 2003||2003-10-01|October 2003|2003-10-01|October 2003||2003-10-01|||||Interventional|||Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer|A Phase II Study of Single Agent OSI-7904L In Patients With Locally Advanced or Metastatic Adenocarcinoma Of the Stomach or Gastroesophageal Junction|Completed||Phase 2|43||OSI Pharmaceuticals|||||||||||||||||||2017-10-11 04:47:25.383286|2017-10-11 04:47:25.383286
NCT00073515|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-21|2010-02-02||||||June 2005|2005-06-01||||||||Interventional|||Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices|A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Alfimeprase for Restoring Function in Occluded Central Venous Catheters|Completed||Phase 2|115||ARCA Biopharma, Inc.|||||||||||||||||||2017-10-11 04:47:25.445204|2017-10-11 04:47:25.445204
NCT00073528|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-24|2017-05-22|2012-04-19||December 2003||2003-12-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|June 2008|Actual|2008-06-01||Interventional|||Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study Comparing GW572016 and Letrozole Versus Letrozole in Subjects With Estrogen/Progesterone Receptor-Positive Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 3|1285|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:47:25.683211|2017-10-11 04:47:25.683211
NCT00073541|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-24|2017-01-19|||April 2003||2003-04-01|January 2017|2017-01-01|August 2004|Actual|2004-08-01|March 2004|Actual|2004-03-01||Interventional|||A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer|An Open-Label Phase II Study in Subjects With Recurrent EGFR-Positive Ovarian Cancer to Investigate the Safety and Efficacy of EMD 72000 Administered as a Single Agent|Completed||Phase 2|38|Actual|EMD Serono|||||||||||||||||||2017-10-11 04:47:28.995442|2017-10-11 04:47:28.995442
NCT00073554|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-24|2009-12-16|||June 2003||2003-06-01|November 2006|2006-11-01||||||||Interventional|||Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion|A Phase 2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Activity of Alfimeprase in Patients With Acute Peripheral Arterial Occlusion|Completed||Phase 2|100||ARCA Biopharma, Inc.|||||||||||||||||||2017-10-11 04:47:29.226529|2017-10-11 04:47:29.226529
NCT00073580|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-26|2011-11-08|||October 2003||2003-10-01|November 2011|2011-11-01||||September 2005|Actual|2005-09-01||Interventional|||Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)|Angiomax in Patients With HIT/HITTS Type II Undergoing Off-PUMP CABG|Unknown status|Active, not recruiting|Phase 3|88|Actual|The Medicines Company||1|||f||||||||||||||2017-10-11 04:47:29.302886|2017-10-11 04:47:29.302886
NCT00073593|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-26|2011-11-08|||August 2003||2003-08-01|November 2011|2011-11-01||||May 2004|Actual|2004-05-01||Interventional|OPCAB||Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB|A Study Comparing Angiomax (Bivalirudin) to Heparin With Protamine Reversal in Patients Undergoing Coronary Artery Bypass (OPCAB) Surgery|Completed||Phase 3|150|Actual|The Medicines Company||2|||f||||||||||||||2017-10-11 04:47:29.417019|2017-10-11 04:47:29.417019
NCT00073606|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-01|2017-06-30|||December 1, 2003||2003-12-01|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Observational|||Spinal Cord Plasticity|Intraspinal Plasticity Associated With Locomotor Learning|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:29.524691|2017-10-11 04:47:29.524691
NCT00073619|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-02|2016-06-22|||December 2001||2001-12-01|June 2016|2016-06-01|July 2011|Actual|2011-07-01|July 2007|Actual|2007-07-01||Interventional|||Preventing Anxiety Disorders in Urban Youth|Community Violence and Youth: Preventing Anxiety Disorders|Completed||N/A|200|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||No|There is no plan to make individual participant data available.|2017-10-11 04:47:29.611081|2017-10-11 04:47:29.611081
NCT00073632|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-02|2013-11-05|||May 2002||2002-05-01|September 2008|2008-09-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Acceptance-Based Treatment for Generalized Anxiety Disorder|Developing a New Therapy for GAD: Acceptance-Based CBT|Completed||Phase 1|50|Actual|University of Massachusetts, Boston|||||f||||f||||||||||2017-10-11 04:47:29.70712|2017-10-11 04:47:29.70712
NCT00073684|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-02|2014-05-06|||August 2003||2003-08-01|May 2014|2014-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Optimal Treatment Strategies for Sexually Abused Children|Young Sexually Abused Children: Optimal CBT Strategies|Completed||Phase 3|210|Actual|Rowan University||4|||f||||t||||||||||2017-10-11 04:47:30.206376|2017-10-11 04:47:30.206376
NCT00073697|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-02|2012-01-10|||May 2003||2003-05-01|January 2012|2012-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Treatment of Depression in Adults|Depression: The Search for Treatment-Relevant Phenotypes|Completed||Phase 4|290|Actual|University of Pittsburgh||3|||f||||||||||||||2017-10-11 04:47:30.293293|2017-10-11 04:47:30.293293
NCT00073710|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-03|2006-07-31|||September 2004||2004-09-01|July 2006|2006-07-01||||||||Interventional|||Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium|A Phase IV, Single-Center, Active-Controlled Cross-Over Pilot Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium|Completed||Phase 4|30||Abbott|||||||||||||||||||2017-10-11 04:47:30.40576|2017-10-11 04:47:30.40576
NCT00073723|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-03|2016-12-14|||December 2003||2003-12-01|December 2016|2016-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer|An Open-label, Phase I/II Trial of ABI-007 (A Cremophor EL-Free, Protein Stabilized, Nanoparticle, Paclitaxel) Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|75||Celgene Corporation|||||f||||||||||||||2017-10-11 04:47:30.499395|2017-10-11 04:47:30.499395
NCT00073736|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-03|2011-08-10|||September 2003||2003-09-01|August 2011|2011-08-01||||July 2007|Actual|2007-07-01||Interventional|||Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma|A Phase 1/2 Open-Label Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous Infusion of MB07133 in Subjects With Unresectable Hepatocellular Carcinoma and Child-Pugh Class A Liver Function|Completed||Phase 1/Phase 2|28|Actual|Ligand Pharmaceuticals||5|||f||||f||||||||||2017-10-11 04:47:30.598415|2017-10-11 04:47:30.598415
NCT00073762|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-04|2009-08-18||||||August 2009|2009-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Two Fixed Doses (200 Mg, Or 400 Mg) Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|375|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:47:30.915857|2017-10-11 04:47:30.915857
NCT00073775|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-08|2013-08-08|||September 2003||2003-09-01|August 2013|2013-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Epidemiology of Stress and the Metabolic Syndrome|Epidemiology of Stress and the Metabolic Syndrome|Completed||N/A|3075|Actual|University of Florida|||1||f||||f||||||Samples With DNA|"     DNA, blood   "|||2017-10-11 04:47:30.981942|2017-10-11 04:47:30.981942
NCT00073788|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-08|2014-05-30|||September 2003||2003-09-01|May 2014|2014-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Wounded Spirits, Ailing Hearts: Post-Traumatic Stress Disorder and Cardiovascular Disease in Indians|Wounded Spirits, Ailing Hearts: Post-Traumatic Stress Disorder and Cardiovascular Disease in Indians|Completed||N/A|267|Actual|University of Colorado, Denver|||2||f||||f||||||||||2017-10-11 04:47:31.082904|2017-10-11 04:47:31.082904
NCT00073801|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-08|2017-10-05|||December 3, 2003||2003-12-03|February 14, 2017|2017-02-14||||||||Observational|||Pelvic Pain in Women With Endometriosis|The Neural Immune Mechanisms and Genetic Influences on Chronic Pelvic Pain in Women With Endometriosis|Completed||N/A|78|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:31.167099|2017-10-11 04:47:31.167099
NCT00073814|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-09|2012-02-21|||December 2002||2002-12-01|February 2012|2012-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma|An Efficacy, Safety, and Tolerability Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma|Completed||Phase 3|80|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 04:47:31.275219|2017-10-11 04:47:31.275219
NCT00073827|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-09|2012-02-21|||May 2002||2002-05-01|February 2012|2012-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma|An Efficacy and Safety Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 3|445|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 04:47:31.477808|2017-10-11 04:47:31.477808
NCT00073840|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-09|2012-02-21|||December 2002||2002-12-01|February 2012|2012-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma|An Efficacy and Safety Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 3|386|Actual|Sunovion||3|||f||||f||||||||||2017-10-11 04:47:31.770735|2017-10-11 04:47:31.770735
NCT00073853|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2009-08-27|||September 2003||2003-09-01|March 2006|2006-03-01||||||||Interventional|||Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries|A Phase II Multicenter, Randomized-Controlled Study to Evaluate the Safety and Efficacy of Autologous Incubated Macrophages for the Treatment of Patients With Complete Spinal Cord Injuries|Suspended||Phase 2|61||Proneuron Biotechnologies|||||||||||||||||||2017-10-11 04:47:32.002398|2017-10-11 04:47:32.002398
NCT00073866|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2012-07-10||2011-02-16|June 2003||2003-06-01|July 2012|2012-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase I/II Trial Of Weekly Irinotecan And Docetaxel With The Addition Of Celecoxib In Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:47:32.096173|2017-10-11 04:47:32.096173
NCT00073879|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2015-01-27|||April 2003||2003-04-01|January 2015|2015-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation|Allogeneic Adoptive Immunochemotherapy For Treatment Of Renal Cell Carcinoma|Completed||N/A|||Baylor College of Medicine|||||f||||||||||||||2017-10-11 04:47:32.185275|2017-10-11 04:47:32.185275
NCT00073892|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2016-08-29|||January 2004||2004-01-01|August 2016|2016-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma|A Phase I/II Study Of PI-88 In Advanced Malignancies (Phase I), And In Advanced Melanoma(Phase II)|Completed||Phase 1/Phase 2|44|Actual|Medigen Biotechnology Corporation||1|||f||||||||||||Undecided||2017-10-11 04:47:32.263559|2017-10-11 04:47:32.263559
NCT00073905|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2012-06-02|||April 2003||2003-04-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|June 2006|Actual|2006-06-01||Interventional|||Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer|Capecitabine And Gemcitabine In Patients With Advanced Or Metastatic Biliary Tract Cancer, A Multicenter Phase II Trial|Completed||Phase 2|44|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 04:47:32.354089|2017-10-11 04:47:32.354089
NCT00073918|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2017-07-21|2016-12-02||February 1999||1999-02-01|July 2017|2017-07-01|October 2, 2011|Actual|2011-10-02|October 2, 2011|Actual|2011-10-02||Interventional|||Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial Evaluating The Efficacy of Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide Followed by Autologous Transplantation, for Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|111|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 04:47:32.441797|2017-10-11 04:47:32.441797
NCT00073931|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2015-02-03|||October 1999||1999-10-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|May 2007|Actual|2007-05-01||Interventional|||Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial Evaluating: Radioiodinated Anti-B1 (Anti-CD20) Antibody With Autologous Stem Cell Transplantation For Relapsed Or Refractory Non-Hodgkin's Lymphoma In Patients 60 Years Of Age And Older|Completed||Phase 2|25|Actual|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-10-11 04:47:32.755589|2017-10-11 04:47:32.755589
NCT00073944|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2013-05-29|||April 2003||2003-04-01|July 2004|2004-07-01||||January 2005|Actual|2005-01-01||Interventional|||BCX-1777 in Treating Patients With Refractory Cancer|Phase I Pharmacology Study Of Oral And Intravenous BCX-1777 In Patients With Refractory T-Cell And Non-T-Cell Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:47:32.861787|2017-10-11 04:47:32.861787
NCT00073970|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2012-05-21|||April 2003||2003-04-01|May 2012|2012-05-01|January 2006|Actual|2006-01-01|June 2005|Actual|2005-06-01||Interventional|||Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy|A Trial Of COX-2 Inhibitors In PSA Recurrence After Definitive Radiation Or Radical Prostatectomy For Prostate Cancer|Terminated||Phase 2|37|Actual|UNC Lineberger Comprehensive Cancer Center||1||Study stopped due to increased cardiovascular risks associated with Celebrex|f||||t||||||||||2017-10-11 04:47:33.075714|2017-10-11 04:47:33.075714
NCT00073983|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2012-02-08|2011-03-15||October 2006||2006-10-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma|Phase II Study Of Sequential Gemcitabine Followed By Docetaxel For Recurrent Ewing's Sarcoma, Osteosarcoma, Or Unresectable Or Locally Recurrent Chondrosarcoma [SARC Study]|Completed||Phase 2|54|Actual|Sarcoma Alliance for Research through Collaboration|Since this design did not specify a rule for declaring the treatment as “active” a direct comparison to a standard 2 stage phase 2 design is not appropriate.|1|||f||||t||||||||||2017-10-11 04:47:33.170726|2017-10-11 04:47:33.170726
NCT00074009|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2012-02-11|||October 2003||2003-10-01|December 2009|2009-12-01||||April 2005|Actual|2005-04-01||Interventional|||Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma|A Multicenter, Open-Label, Two-Stage, Phase II Study Of PS-341 (LDP-341, NSC # 681239) In Patients With Unresectable Or Metastatic Gastric Adenocarcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:47:33.47925|2017-10-11 04:47:33.47925
NCT00074022|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2013-01-23|||October 2003||2003-10-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors|A Phase I/2 Study of GTI-2040 Combined With Docetaxel In Metastatic Or Unresectable Locally Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:47:33.580481|2017-10-11 04:47:33.580481
NCT00074035|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2017-03-17|2017-01-26||December 2003||2003-12-01|March 2017|2017-03-01||||August 2008|Actual|2008-08-01||Interventional||1 participant cancelled prior to receiving treatment and is excluded from all analyses.|Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease|A Phase II Trial Of Intravenous Pentostatin For The Treatment Of Patients With Refractory Chronic Graft-Versus-Host Disease|Active, not recruiting||Phase 2|39|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:47:33.733906|2017-10-11 04:47:33.733906
NCT00074048|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2010-06-17|||October 2003||2003-10-01|June 2010|2010-06-01|July 2008|Actual|2008-07-01|April 2007|Actual|2007-04-01||Interventional|||BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia|Phase II Trial Of BL22 Immunotoxin In Hairy Cell Leukemia|Completed||Phase 2|36|Actual|MedImmune LLC||1|||f||||f||||||||||2017-10-11 04:47:34.855396|2017-10-11 04:47:34.855396
NCT00074074|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2012-07-13|||October 2003||2003-10-01|July 2012|2012-07-01||||December 2006|Actual|2006-12-01||Interventional|||Infliximab in Treating Patients With Myelodysplastic Syndrome|Randomized Phase II Trial With Infliximab (Remicade) in Patients With Myelodysplastic Syndrome and a Relatively Low Risk of Developing Acute Leukemia|Completed||Phase 2|46|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:47:34.941787|2017-10-11 04:47:34.941787
NCT00074711|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2016-07-05|2012-07-03||August 2004||2004-08-01|July 2016|2016-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Adding Phosphorus to Osteoporosis Drug Treatment|Bone Sparing by Calcium Salts With and Without Extra Phosphorus|Completed||Phase 2|241|Actual|Creighton University||2|||f||||f||||||||||2017-10-11 04:47:45.515563|2017-10-11 04:47:45.515563
NCT00074087|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2015-07-16|||October 2003||2003-10-01|July 2015|2015-07-01|September 2010|Actual|2010-09-01|July 2009|Actual|2009-07-01||Interventional|||Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides|Phase II Clinical Trial With Caelyx Mono-Chemotherapy in Patients With Advanced Mycosis Fungoides Stage IIb, IVa and IVb With or Without Previous Chemotherapy|Completed||Phase 2|49|Actual|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||||||||||||2017-10-11 04:47:35.187566|2017-10-11 04:47:35.187566
NCT00074100|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2013-05-29|||August 2003||2003-08-01|August 2004|2004-08-01|September 2004|Actual|2004-09-01|||||Interventional|||Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy|Amonafide: Individual Phenotype-Adjusted Chemotherapy for Women With Metastatic Breast Cancer Who Have Progressed Despite Prior Chemotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:47:35.315061|2017-10-11 04:47:35.315061
NCT00074139|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2014-03-04|||September 2003||2003-09-01|March 2014|2014-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer|A Pharmacokinetic Interaction Study Of Docetaxel (Taxotere) 75 mg/mIV On The Combination Therapy Doxorubicin (50 mg/m) And Cyclophosphamide (50 mg/m) In The Treatment Of Advanced Breast Cancer|Withdrawn||Phase 1|0|Actual|Case Comprehensive Cancer Center||||No patients were enrolled|f||||t||||||||||2017-10-11 04:47:35.473523|2017-10-11 04:47:35.473523
NCT00074152|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2017-05-23|2015-04-07||July 2002||2002-07-01|May 2017|2017-05-01|August 22, 2016|Actual|2016-08-22|February 2014|Actual|2014-02-01||Interventional|CALOR||Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer|A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer|Completed||Phase 3|162|Actual|International Breast Cancer Study Group|Small sample size|2|||f||||t||||||||||2017-10-11 04:47:35.608503|2017-10-11 04:47:35.608503
NCT00074165|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2017-04-19|2011-10-10||January 2003||2003-01-01|April 2017|2017-04-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen|A Phase II Trial Involving Patients With Recurrent PCNSL Treated With Carboplatin/BBBD, by Adding Rituxan (Rituximab), An Anti CD-20 Antibody, To The Treatment Regimen|Terminated||Phase 2|17|Actual|OHSU Knight Cancer Institute||1||Lack of accrual|f||||t||||||||||2017-10-11 04:47:37.131196|2017-10-11 04:47:37.131196
NCT00074178|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2017-04-19|||January 2000||2000-01-01|April 2017|2017-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|Protocol-B||Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma|Combination Chemotherapy (Methotrexate, Cyclophosphamide, And Etoposide Phosphate) Delivered In Conjunction With Osmotic Blood-Brain Barrier Disruption (BBBD), With Intraventricular Cytarabine +/- Intra-Ocular Chemotherapy, In Patients With Primary Central Nervous System Lymphoma|Completed||Phase 2|22|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 04:47:37.410801|2017-10-11 04:47:37.410801
NCT00074191|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2017-04-19|||January 2000||2000-01-01|April 2017|2017-04-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|Protocol-A||Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma|Combination Chemotherapy (Methotrexate, Procarbazine And CCNU), Intraventricular Cytarabine And Methotrexate, +/- Intra-Ocular Chemotherapy For Patients With Primary Central Nervous System Lymphoma|Completed||Phase 2|1|Actual|OHSU Knight Cancer Institute|||||f||||t||||||||||2017-10-11 04:47:37.500934|2017-10-11 04:47:37.500934
NCT00074204|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2010-08-13|||October 2003||2003-10-01|August 2010|2010-08-01|April 2008|Actual|2008-04-01|August 2005|Actual|2005-08-01||Interventional|||Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase III Study of Delayed vs. Immediate Second-Line Therapy With Docetaxel After Gemcitabine + Carboplatin in Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|17|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:47:37.591265|2017-10-11 04:47:37.591265
NCT00074230|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2015-05-11|||July 2003||2003-07-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma|Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With RNAs Encoding for Mage-3, MelanA, and Survivin Antigens|Completed||Phase 1/Phase 2|82|Actual|University Hospital Erlangen||1|||f||||||||||||||2017-10-11 04:47:37.679289|2017-10-11 04:47:37.679289
NCT00074243|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2015-04-29|||December 2003||2003-12-01|November 2006|2006-11-01||||||||Interventional|||CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas|A Phase I Trial Of CC-8490 For The Treatment Of Patients With Recurrent/Refractory High-Grade Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:47:37.749856|2017-10-11 04:47:37.749856
NCT00074269|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2014-12-02|2014-05-29||July 2003||2003-07-01|November 2014|2014-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||This is a pilot study. The original planned target accrual was 15 male or female patients age 18-60 but due to poor enrollment the study was closed to accrual early after 5 patients had been enrolled.|Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Metastatic Breast Cancer|Pilot Study Of Allogeneic Peripheral Blood Progenitor Cell Transplantation In Patients With Chemotherapy-Refractory Or Poor-Prognosis Metastatic Breast Cancer|Terminated||Phase 2|5|Actual|University of California, San Diego|Terminated early due to small numbers of subjects enrolled on study|1||Terminated early due to poor enrollment|f||||t||||||||||2017-10-11 04:47:37.813558|2017-10-11 04:47:37.813558
NCT00074282|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2012-11-09|||December 2004||2004-12-01|November 2012|2012-11-01||||October 2014|Anticipated|2014-10-01||Interventional|||Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia|Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Lenalidomide for Previously Treated Relapsed or Refractory Patients With Chronic Lymphocytic Leukemia|Unknown status|Recruiting|Phase 2|110|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:47:38.029767|2017-10-11 04:47:38.029767
NCT00074724|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2013-04-16|||May 2003||2003-05-01|April 2013|2013-04-01|April 2016|Anticipated|2016-04-01|December 2008|Actual|2008-12-01||Interventional|DECIPHER||Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization|Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization|Unknown status|Active, not recruiting|N/A|319|Actual|Medstar Health Research Institute||2|||f||||t||||||||||2017-10-11 04:47:46.002824|2017-10-11 04:47:46.002824
NCT00074295|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2012-07-20|||March 2004||2004-03-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer|Phase II Trial of CG8123, an Autologous Cancer Vaccine (GVAX), in Patients With Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)|Terminated||Phase 2|19|Actual|Southwest Oncology Group||1||closed due to lack of availability of vaccine|f||||t||||||||||2017-10-11 04:47:38.72158|2017-10-11 04:47:38.72158
NCT00074321|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2013-06-05|||November 2003||2003-11-01|June 2013|2013-06-01||||July 2010|Actual|2010-07-01||Interventional|||Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors|A Phase I And Pharmacogenetic Study Of CPT-11, Oxaliplatin, And Capecitabine In Patients With Solid Tumors|Completed||Phase 1|84|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:47:38.886207|2017-10-11 04:47:38.886207
NCT00074334|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2009-10-20|||May 2004||2004-05-01|October 2009|2009-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma|A Phase I/II Study Of A Recombinant Chimeric Protein Composed Of Transforming Growth Factor (TGF)-a And A Mutated Pseudomonas Exotoxin Termed PE38 (TP-38) In Pediatric Patients With Recurrent Or Progressive Supratentorial High Grade Gliomas|Terminated||Phase 1/Phase 2|3|Actual|Pediatric Brain Tumor Consortium||||Drug company withdrawal of support for investigational agent in this indication.|f||||t||||||||||2017-10-11 04:47:39.004846|2017-10-11 04:47:39.004846
NCT00074360|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-10|2017-10-05|||December 9, 2003||2003-12-09|December 17, 2012|2012-12-17|December 17, 2012||2012-12-17|||||Observational|||The Effect of Ethanol on Brain Activity|The Effect of Ethanol on Cerebral Blood Flow as Measured by Functional Magnetic Resonance Imaging and the Development of Conditioned Response to Ethanol Administration|Completed||N/A|107|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:39.116689|2017-10-11 04:47:39.116689
NCT00074386|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-11|2014-01-16|||October 2003||2003-10-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Kidney and Liver Transplantation in People With HIV|Solid Organ Transplantation in HIV: Multi-Site Study|Completed||N/A|275|Actual|University of California, San Francisco|||1||f||||t||||||Samples Without DNA|"     Whole Blood, serum, PBMC, kidney and liver biopsy slides, saliva, spleen tissue   "|||2017-10-11 04:47:39.336213|2017-10-11 04:47:39.336213
NCT00074399|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-11|2009-08-06|||February 2001||2001-02-01|August 2009|2009-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV|Nevirapine (NVP) Use to Prevent Maternal-Infant HIV Transmission: A Randomized Clinical Trial of Two Doses of NVP Compared to Six Weeks of NVP for the Prevention of Maternal-Infant HIV Transmission in the Breastfeeding Infant|Completed||Phase 3|775|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:47:39.4647|2017-10-11 04:47:39.4647
NCT00074412|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-11|2013-07-05|2013-05-30||January 2007||2007-01-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding|A Phase III Trial to Determine the Efficacy and Safety of an Extended Regimen of Nevirapine in Infants Born to HIV-Infected Women to Prevent Vertical HIV Transmission During Breastfeeding|Completed||Phase 3|2026|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The rate of maternal highly active antiretroviral therapy use was higher than expected in our study. Thus there were fewer infant infections which decreased the power to detect differences in HIV transmission risks between study groups.|2|||f||||||||||||||2017-10-11 04:47:39.572813|2017-10-11 04:47:39.572813
NCT00074425|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-11|2013-07-05||2009-08-24|January 2005||2005-01-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women|Phase II/IIb Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and 0.5% PRO 2000/5 Gel (P) for the Prevention of HIV Infection in Women|Completed||Phase 2|3101|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 04:47:40.438176|2017-10-11 04:47:40.438176
NCT00074451|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-12|2008-08-20|||September 2003||2003-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Genomewide Search for Loci Underlying Metabolic Syndrome||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:47:40.672804|2017-10-11 04:47:40.672804
NCT00074464|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-12|2013-05-03|||August 2003||2003-08-01|May 2013|2013-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Cholesterol Homeostasis in Framingham Offspring Study||Completed||N/A|3378|Actual|Tufts University|||1||f||||f||||||||||2017-10-11 04:47:40.742029|2017-10-11 04:47:40.742029
NCT00074477|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-12|2011-05-20|||October 2003||2003-10-01|April 2010|2010-04-01|July 2004|Actual|2004-07-01|||||Interventional|||Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 50 and 100 Mg-eq of Paliperidone Palmitate in Patients With Schizophrenia|Completed||Phase 2|250|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:47:40.872263|2017-10-11 04:47:40.872263
NCT00068887|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2015-04-29|||September 1999||1999-09-01|April 2015|2015-04-01|December 2005||2005-12-01|||||Observational|||Regional Fatty Acid Metabolism in Humans|Regional Fatty Acid Metabolism in Humans|Withdrawn||N/A|0|Actual|Mayo Clinic||||NOT A CLINICAL TRIAL|f||||||||||||||2017-10-11 04:48:46.393262|2017-10-11 04:48:46.393262
NCT00074490|ClinicalTrials.gov processed this data on October 10, 2017|2006-06-19|2017-10-05|||December 11, 2003||2003-12-11|August 16, 2017|2017-08-16|August 16, 2017|Actual|2017-08-16|July 20, 2017|Actual|2017-07-20||Interventional|||Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers|Allogeneic HSCT Without Preparative Chemotherapy or With Low-Intensity Preparative Chemotherapy Using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome|Completed||Phase 2|380|Actual|National Institutes of Health Clinical Center (CC)||6|||f||||||||||||||2017-10-11 04:47:40.936697|2017-10-11 04:47:40.936697
NCT00074503|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-12|2017-06-30|||December 12, 2003||2003-12-12|July 13, 2010|2010-07-13|July 13, 2010||2010-07-13|||||Observational|||PET Imaging of DHA Metabolism|Positron Emission Tomography Imaging of Incorporation of Docosahexaenoic Acid (DHA) From Plasma Into Human Brain|Completed||N/A|85|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:41.068203|2017-10-11 04:47:41.068203
NCT00074516|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-12|2017-10-05|||December 10, 2003||2003-12-10|June 11, 2014|2014-06-11|June 11, 2014||2014-06-11|||||Observational|||Kidney Transplantation in Patients With Cystinosis|Renal Transplantation in Recipients With Nephropathic Cystinosis|Completed||N/A|11|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:41.117605|2017-10-11 04:47:41.117605
NCT00074529|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-15|2015-07-23|||October 2003||2003-10-01|July 2015|2015-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in Slowing the Progression of Alzheimer's Disease|Completed||Phase 2|512|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:47:41.171696|2017-10-11 04:47:41.171696
NCT00074542|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-15|2007-02-20|||September 2002||2002-09-01|October 2005|2005-10-01|January 2005||2005-01-01|||||Interventional|||An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease|A Phase III Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Multi-Centre Study to Assess the Efficacy and Safety of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease|Completed||Phase 3|364||Tillotts Pharma AG|||||||||||||||||||2017-10-11 04:47:41.22744|2017-10-11 04:47:41.22744
NCT00074555|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-16|2016-01-05|||January 2001||2001-01-01|January 2016|2016-01-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Observational|CLEAR||Registry for African Americans With Early Rheumatoid Arthritis|Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)|Completed||N/A|357|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||f||||||Samples With DNA|"     serum, DNA   "|||2017-10-11 04:47:41.339943|2017-10-11 04:47:41.339943
NCT00074568|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-16|2016-01-04|||September 2000||2000-09-01|January 2016|2016-01-01||||January 2022|Anticipated|2022-01-01||Observational|Registry||Scleroderma Registry|Scleroderma Family Registry and DNA Repository|Recruiting||N/A|5000|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||2||f||||f||||||Samples With DNA|"     Serum, Plasma, DNA   "|||2017-10-11 04:47:41.406026|2017-10-11 04:47:41.406026
NCT00074581|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-16|2016-11-03|2016-09-09||February 2005||2005-02-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Preventing Sexual Transmission of HIV With Anti-HIV Drugs|A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care Versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples|Completed||Phase 3|3526|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:47:41.539001|2017-10-11 04:47:41.539001
NCT00074607|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-16|2012-11-09|||December 2001||2001-12-01|November 2012|2012-11-01|April 2007|Actual|2007-04-01|July 2005|Actual|2005-07-01||Interventional|||Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine|Intrathecal Gemcitabine Therapy for Neoplastic Meningitis: A Phase I and Pharmacokinetic Study|Terminated||Phase 1|10|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:47:44.818219|2017-10-11 04:47:44.818219
NCT00074620|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-17|2007-10-04|||November 2003||2003-11-01|October 2007|2007-10-01|January 2006||2006-01-01|||||Interventional|||A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis|A Randomised, Multicenter, Open-Label, Parallel Group Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Unfractionated Heparin as Anticoagulant Treatment in Patients Undergoing Haemodialysis Via an Arteriovenous Graft|Completed||Phase 2|260||Speedel Pharma Ltd.|||||||||f||||||||||2017-10-11 04:47:44.956406|2017-10-11 04:47:44.956406
NCT00074633|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-17|2010-01-12|||January 2000||2000-01-01|January 2010|2010-01-01||||||||Interventional|||"Evaluating Health at Every Size(HAES) as an Alternative Obesity Treatment Model"|"Evaluating Health at Every Size(HAES) as an Alternative Obesity Treatment Model"|Completed||N/A|79||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:47:45.063324|2017-10-11 04:47:45.063324
NCT00074646|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-17|2007-01-02|||December 2003||2003-12-01|January 2007|2007-01-01|June 2005||2005-06-01|||||Interventional|||Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas|Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas|Completed||Phase 1|36||Celgene|||||||||||||||||||2017-10-11 04:47:45.144951|2017-10-11 04:47:45.144951
NCT00074672|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-17|2017-06-30|||December 12, 2003||2003-12-12|April 14, 2009|2009-04-14|April 14, 2009||2009-04-14|||||Observational|||Relationship Between Sensory and Motor Systems in Restless Leg Syndrome|Sensorimotor Gating Studies in Restless Legs Syndrome|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:45.214281|2017-10-11 04:47:45.214281
NCT00074685|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-18|2009-04-28|||September 1994||1994-09-01|April 2009|2009-04-01||||||||Observational|||National Registry for Ichthyosis and Related Disorders|Research Registry for Inherited Disorders of Keratinization|Unknown status|Active, not recruiting|N/A|610|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||f||||||Samples With DNA|"     Histology, DNA from participating enrollees   "|||2017-10-11 04:47:45.309574|2017-10-11 04:47:45.309574
NCT00074698|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-18|2007-12-10||||||December 2007|2007-12-01|May 2004||2004-05-01|||||Interventional|||Safety and Tolerability Study of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis|A Phase 1 Study of the Safety, Pharmacokinetics, and Biologic Activity of Escalating Doses of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis|Completed||Phase 1|27||FibroGen|||||f||||||||||||||2017-10-11 04:47:45.425486|2017-10-11 04:47:45.425486
NCT00127478|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2007-11-28|||July 2001||2001-07-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||A Long Term Safety Study With Atrasentan|A Phase II/III Extension Study to Evaluate the Safety and Tolerability of Atrasentan|Completed||Phase 2/Phase 3|166|Actual|Abbott||1|||f||||||||||||||2017-10-11 05:11:54.748107|2017-10-11 05:11:54.748107
NCT00074737|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2014-09-16|||April 2004||2004-04-01|September 2014|2014-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML|Open Label, Phase II Dosing Study of Ara-C Chemotherapy in Combination With EL625 and Idarubicin in Refractory and Relapsed Acute Myelogenous Leukemia (AML)|Completed||Phase 2|53|Actual|Eleos, Inc.||3|||f||||f||||||||||2017-10-11 04:47:46.126331|2017-10-11 04:47:46.126331
NCT00074750|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2012-02-20|||December 2003||2003-12-01|February 2012|2012-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)|A Phase I Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)|Terminated||Phase 1|7|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-10-11 04:47:46.274939|2017-10-11 04:47:46.274939
NCT00074763|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2012-08-01|||July 2003||2003-07-01|August 2012|2012-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets|Randomized Crossover Study Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets|Terminated||Phase 3|4|Actual|M.D. Anderson Cancer Center||1||Terminated due to low recruitment.|f||||f||||||||||2017-10-11 04:47:46.521564|2017-10-11 04:47:46.521564
NCT00074776|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2012-07-19|||May 2003||2003-05-01|July 2012|2012-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Acute Treatment of Bipolar II Depression|Acute Treatment of Bipolar II Depression|Completed||Phase 3|102|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 04:47:46.612303|2017-10-11 04:47:46.612303
NCT00074789|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2013-06-20|||June 2003||2003-06-01|June 2013|2013-06-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Reducing Symptoms of Depression in Low-Income Mothers|Reducing Depressive Symptoms in Low-Income Mothers|Completed||Phase 2|226|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 04:47:46.717403|2017-10-11 04:47:46.717403
NCT00074802|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2017-05-16|2017-02-24||December 2003||2003-12-01|May 2017|2017-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Patients included here were the subset of enrollees completing the open trial as partial responders.|Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder|CBT Augmentation of Paroxetine for Social Anxiety|Completed||Phase 3|150|Actual|Temple University|Limitations include the small size of the randomized sample and the lack of a placebo arm in the randomization phase of the study.|2|||f||||t|t|f||||||No||2017-10-11 04:47:46.846771|2017-10-11 04:47:46.846771
NCT00074815|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2014-07-23|2012-11-15||September 2003||2003-09-01|November 2012|2012-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Treatment of Obsessive Compulsive Disorder in Children|Treatment of Pediatric OCD for SRI Partial Responders|Completed||Phase 3|124|Actual|Duke University||3|||f||||t||||||||||2017-10-11 04:47:47.513952|2017-10-11 04:47:47.513952
NCT00074828|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-19|2008-03-27|||December 2003||2003-12-01|March 2008|2008-03-01|May 2005|Actual|2005-05-01|||||Interventional|||New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery|A Comparison of the Oral Anticoagulant LY517717 Difumarate to Subcutaneous Enoxaparin for the Prevention of Venous Thromboembolic Events (VTE) Post-Total Hip Replacement (THR) and Post-Total Knee Replacement (TKR) Surgery|Completed||Phase 2|511|Actual|Eli Lilly and Company||2|||||||||||||||||2017-10-11 04:47:47.906785|2017-10-11 04:47:47.906785
NCT00074841|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-22|2011-05-09|||September 2003||2003-09-01|May 2011|2011-05-01|January 2005|Actual|2005-01-01|||||Interventional|||Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India|A Phase II/III, Randomized, Comparative Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in India|Completed||Phase 2/Phase 3|230|Actual|Pfizer|||||||||||||||||||2017-10-11 04:47:48.031043|2017-10-11 04:47:48.031043
NCT00074854|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-22|2006-11-08|||May 2002||2002-05-01|July 2006|2006-07-01|March 2005||2005-03-01|||||Interventional|||A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy|A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy (Paclitaxel And Carboplatin) Vs. Chemotherapy Alone For The Treatment Of Advanced Stage Non-Small Cell Lung Cancer.|Completed||Phase 1/Phase 2|87||Pfizer|||||f||||||||||||||2017-10-11 04:47:48.106878|2017-10-11 04:47:48.106878
NCT00074867|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-22|2006-11-06|||October 2003||2003-10-01|July 2006|2006-07-01|September 2004||2004-09-01|||||Interventional|||Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer|A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Recurrent Or Persistent Small-Volume Epithelial Ovarian Cancer, Primary Peritoneal Serous Cancer, Or Fallopian Tube Cancer|Completed||Phase 2|29||Pfizer|||||f||||||||||||||2017-10-11 04:47:48.222795|2017-10-11 04:47:48.222795
NCT00074880|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-22|2008-03-03|||December 2003||2003-12-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||The Role of Heart Stiff and Weak Atrium on Exercise Capacity in Patients With Hypertrophic Cardiomyopathy|The Role of Atrio-Ventricular Coupling in Exercise Tolerance in Non-Obstructive Hypertrophic Cardiomyopathy|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:48.328834|2017-10-11 04:47:48.328834
NCT00074893|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-23|2006-03-06|||November 2003||2003-11-01|March 2006|2006-03-01|February 2004||2004-02-01|||||Interventional|||Protective Brace to Prevent Hand and Arm Injuries|Shock Absorbing Brace for Study of Upper Extremity Musculoskeletal Disorders|Completed||N/A|15||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:47:48.413098|2017-10-11 04:47:48.413098
NCT00074906|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-23|2012-05-04|||November 2003||2003-11-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)|Venticute in Patients With Pneumonia or Aspiration of Gastric Contents Leading to Intubation, Ventilation, and Severe Oxygenation Impairment: A Randomized, Multinational, Multicenter, Parallel Group, Double Blind, Control Group Study|Completed||Phase 3|1200|Anticipated|Takeda||1|||f||||t||||||||||2017-10-11 04:47:48.505476|2017-10-11 04:47:48.505476
NCT00074919|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-23|2014-02-04|||December 2003||2003-12-01|February 2014|2014-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Expanded Access|||Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease|Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease|Approved for marketing||N/A|||Sanofi|||||||||||||||||||2017-10-11 04:47:48.912452|2017-10-11 04:47:48.912452
NCT00074932|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-23|2014-02-04|||November 2004||2004-11-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease|Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease|Completed||N/A|9|Actual|Sanofi||1|||t||||||||||||||2017-10-11 04:47:48.993087|2017-10-11 04:47:48.993087
NCT00074945|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-23|2017-10-05|||December 19, 2003||2003-12-19|February 28, 2013|2013-02-28|February 28, 2013||2013-02-28|||||Observational|||Obesity and Fatty Acid Flux Comparison Trials|A Comparison of Free Fatty Acid Flux in African Americans and Caucasians|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:49.113811|2017-10-11 04:47:49.113811
NCT00074958|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-24|2015-03-13|2009-03-03||October 2002||2002-10-01|March 2015|2015-03-01|July 2005|Actual|2005-07-01|May 2005|Actual|2005-05-01||Interventional|||A Study of Fabrazyme in Pediatric Patients With Fabry Disease|A Multi-center, Phase 2, Open-Label Study of Fabrazyme (Recombinant Human a-Galactosidase A) Replacement Therapy in Pediatric Patients With Fabry Disease|Completed||Phase 2|16|Actual|Sanofi|The trial was not powered to demonstrate clinical benefit.|1|||f||||||||||||||2017-10-11 04:47:49.213324|2017-10-11 04:47:49.213324
NCT00074971|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-24|2013-12-02|||October 1999||1999-10-01|December 2013|2013-12-01|December 2004||2004-12-01|||||Interventional|||A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease|A Multi-center, Open-Label Extension Study of the Safety and Efficacy of Recombinant Human a-Galactosidase A (r-haGAL) Replacement in Patients With Fabry Disease|Completed||Phase 3|58||Sanofi|||||||||||||||||||2017-10-11 04:47:49.601448|2017-10-11 04:47:49.601448
NCT00074984|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-24|2013-12-02|2010-07-21||February 2001||2001-02-01|December 2013|2013-12-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease|Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Fabrazyme on Progression of Renal Disease and Significant Clinical Events in Patients With Fabry Disease|Completed||Phase 4|82|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 04:47:49.806686|2017-10-11 04:47:49.806686
NCT00074997|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-28|2016-06-17||2013-03-15|December 2002||2002-12-01|June 2016|2016-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection|A Randomized Phase II, Double-Blind, Controlled Trial to Evaluate the Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced With Placebo or an Anti-HIV-1 Ribozyme (OZ1) in Patients With HIV-1 Infection|Completed||Phase 2|1|Actual|Janssen-Cilag Pty Ltd||2|||f||||t||||||||||2017-10-11 04:47:52.268901|2017-10-11 04:47:52.268901
NCT00075010|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-29|2012-06-08|||January 2004||2004-01-01|June 2012|2012-06-01|November 2006|Actual|2006-11-01|March 2005|Actual|2005-03-01||Interventional|||Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes|Phase I/II Study of 5-aza-2'-Deoxycytidine and Valproic Acid in Patients With Relapsed/Refractory Leukemia or Myelodysplastic Syndromes|Completed||Phase 1/Phase 2|54|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 04:47:52.39948|2017-10-11 04:47:52.39948
NCT00075023|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-30|2015-10-29|2015-10-29||December 2003||2003-12-01|October 2015|2015-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||The sample size for the proof of concept study was calculated by using the data for aphthous ulcer percentage healing (personal communication with investigator) with topical thalidomide gel at 0 mg and 20 mg. This gave a total sample size of 60 using an alpha level = .05, beta = -.20 and a 2-tailed test. Assuming drop out rate of 10%, total is 66.|Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis|Evaluation of Efficacy and Mechanisms of Topical Thalidomide for Chronic Graft-Versus-Host-Disease Related Stomatitis|Terminated||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)|Small sample size due to difficult enrollment|2||unable to enroll adequate subjects|f||||t||||||||||2017-10-11 04:47:52.621584|2017-10-11 04:47:52.621584
NCT00075036|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-30|2017-10-05|||December 24, 2003||2003-12-24|July 24, 2017|2017-07-24||||||||Observational|||Patient-Provider Trust Among Individuals With End-Stage Kidney Disease|Exploring Patient-Provider Trust Among Individuals With End-Stage Renal Disease|Completed||N/A|68|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:52.978194|2017-10-11 04:47:52.978194
NCT00075049|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-31|2014-08-20|||December 2003||2003-12-01|August 2014|2014-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria|Dbl-Blind, Rand Phase 1/2a Human Challenge Study, to Eval Safety, Reactogenicity, Immunogenicity and Preliminary Efficacy After Sporozoite Challenge/Rechallenge of Vaccines Containing RTS,S|Completed||Phase 1/Phase 2|104||U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-10-11 04:47:53.077902|2017-10-11 04:47:53.077902
NCT00075062|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-31|2008-08-20||||||May 2006|2006-05-01||||||||Observational|||A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials|Characteristics of Baseline Mucosal Indices of Injury and Inflammation in Men For Use in Rectal Microbicide Trials|Completed||N/A|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:47:53.179227|2017-10-11 04:47:53.179227
NCT00075075|ClinicalTrials.gov processed this data on October 10, 2017|2003-12-31|2017-06-30|||December 23, 2003||2003-12-23|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Interventional|||Infliximab to Treat Non-Infectious Scleritis|Pilot Study of the Evaluation of Infliximab in the Treatment of Non-Infectious Scleritis|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:53.267891|2017-10-11 04:47:53.267891
NCT00075088|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-02|2015-05-15|2013-06-08||September 2003||2003-09-01|May 2015|2015-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Tele-Electrocardiography in Emergency Cardiac Care|Tele-electrocardiography in Emergency Cardiac Care|Completed||Phase 3|794|Actual|University of California, San Francisco|Sample size was not powered to detect a statistically significant difference in survival between patients with and without a prehospital ECG|2|||f||||t||||||||||2017-10-11 04:47:53.368961|2017-10-11 04:47:53.368961
NCT00075101|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-02|2008-08-14|||September 2000||2000-09-01|August 2008|2008-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Sleep, Fatigue, and Dexamethosone in Children With Leukemia|Sleep, Fatigue, and Dexamethosone in Childhood Cancer|Completed||Phase 3|134|Anticipated|National Institute of Nursing Research (NINR)||1|||f||||f||||||||||2017-10-11 04:47:53.744947|2017-10-11 04:47:53.744947
NCT00075114|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-02|2015-01-14|||September 2000||2000-09-01|January 2015|2015-01-01|April 2006|Actual|2006-04-01|February 2002|Actual|2002-02-01||Interventional|||Prevent Inability To Control Urination|Promoting Self -Care to Prevent Urinary Incontinence|Completed||Phase 3|417|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 04:47:53.884492|2017-10-11 04:47:53.884492
NCT00075140|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-02|2009-01-15|||September 2001||2001-09-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Family Health After Predictive Huntington Disease (HD) Testing|Family Health After Predictive Huntington Disease Testing|Completed||Phase 3|422|Actual|National Institute of Nursing Research (NINR)|||1||f||||f||||||||||2017-10-11 04:47:53.994707|2017-10-11 04:47:53.994707
NCT00075153|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-02|2014-04-21|||September 2001||2001-09-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Quality of Life in Children With HIV Infection|Quality of Life in Children With HIV Infection|Completed||N/A|1993|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-10-11 04:47:54.073274|2017-10-11 04:47:54.073274
NCT00075166|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-02|2008-03-03|||December 2003||2003-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors|A Prospective, Randomized Trial Comparing Surgery Versus Radiosurgery for the Treatment of Metastatic Brain Tumors|Completed||Phase 4|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:47:54.137706|2017-10-11 04:47:54.137706
NCT00075179|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-05|2012-07-31|||January 2004||2004-01-01|July 2012|2012-07-01|March 2006|Actual|2006-03-01|May 2005|Actual|2005-05-01||Interventional|||Natrecor in Pulmonary Hypertension|Phase IV, Open Labeled Study to Test the Effectiveness of Nesiritide in Reversing Pulmonary Hypertension in Patients Who Will be Undergoing CardioThoracic Surgery|Terminated||Phase 4|7|Actual|M.D. Anderson Cancer Center||1||Low accrual.|f||||f||||||||||2017-10-11 04:47:54.229291|2017-10-11 04:47:54.229291
NCT00075192|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-05|2012-06-05|||March 2004||2004-03-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|||||Interventional|||CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer|A Phase 1, Open Label, Non-Randomized, Dose Escalation Study to Evaluate the Safety of CP-675,206 in Combination With Neoadjuvant Androgen Ablation and a Phase 2, Open Label, Randomized Study to Evaluate the Efficacy of CP-675,206 in Combination With Neoadjuvant Androgen Ablation and Androgen Ablation Alone in Patients With High Risk Prostate Cancer|Completed||Phase 1/Phase 2|8|Actual|AstraZeneca|||||f||||||||||||||2017-10-11 04:47:54.333861|2017-10-11 04:47:54.333861
NCT00075205|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-05|2017-06-30|||December 31, 2003||2003-12-31|June 2, 2010|2010-06-02|March 15, 2007|Actual|2007-03-15|March 15, 2007|Actual|2007-03-15||Interventional|||Rimonabant to Reduce Alcohol Consumption|Clinical Trial of the Cannabinoid CB1 Receptor Antagonist, SR141716 (Rimonabant), to Reduce Voluntary Ethanol Drinking in Healthy, Non-Treatment Seeking Individuals Who Consume Between 20 and 50 Drinks Per Week|Completed||Phase 2|54|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:47:54.454049|2017-10-11 04:47:54.454049
NCT00075218|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-06|2009-08-31|2009-05-06||December 2003||2003-12-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Of SU011248 In The Treatment Of Patients With Imatinib Mesylate (Gleevec Tm, Glivec)-Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor|Completed||Phase 3|361|Actual|Pfizer|Duration of Tumor Response could not be reliably estimated at the time of analysis.|2|||f||||t||||||||||2017-10-11 04:47:54.853944|2017-10-11 04:47:54.853944
NCT00075231|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-06|2006-09-28|||December 2003||2003-12-01|September 2006|2006-09-01||||||||Interventional|||A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects|A Randomized, Open-Label Study Exploring a Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects|Completed||Phase 2|150||Abbott|||||||||||||||||||2017-10-11 04:47:59.956441|2017-10-11 04:47:59.956441
NCT00075244|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-06|2008-03-03|||January 2004||2004-01-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Alternative Dosing and Regimen of Replagal to Treat Fabry Disease|A Phase I-II Pharmacokinetic/Pharmacodynamic Study of Replagal to Assess the Effects of Alternative Dose and Regimen in Patients With Fabry Disease|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:00.025886|2017-10-11 04:48:00.025886
NCT00075257|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-07|2009-08-18||||||August 2009|2009-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of DVS-233 SR For Prevention Of Depressive Relapse In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|603|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:48:00.084541|2017-10-11 04:48:00.084541
NCT00075270|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-07|2015-04-16|2013-03-14||January 2004||2004-01-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|October 2006|Actual|2006-10-01||Interventional|||Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Phase III Study of Oral GW572016 in Combination With Paclitaxel in Subjects Previously Untreated or Advanced or Metastatic Breast Cancer|Completed||Phase 3|580|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 04:48:00.219229|2017-10-11 04:48:00.219229
NCT00075283|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-08|2005-06-23|||November 2002||2002-11-01|January 2004|2004-01-01||||||||Interventional|||Walking Therapy In Hemiparetic Stroke Patients Using Robotic-Assisted Treadmill Training|Gait Restoration In Hemiparetic Stroke Patients Using Goal-Directed, Robotic-Assisted, Treadmill Training|Unknown status|Recruiting|Phase 1|50||U.S. Department of Education|||||f||||||||||||||2017-10-11 04:48:03.375402|2017-10-11 04:48:03.375402
NCT00075296|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-08|2017-06-30|||January 5, 2004||2004-01-05|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression|FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:03.458011|2017-10-11 04:48:03.458011
NCT00075348|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2012-03-14|||December 2003||2003-12-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome|Genetic Mutation Analysis In A VHL Population|Completed||N/A|260|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:03.606075|2017-10-11 04:48:03.606075
NCT00075374|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2014-01-15|||October 2003||2003-10-01|January 2014|2014-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Multicenter, Randomized Phase II Study of Two Schedules of Taxotere (Weekly Versus Every 3 Weeks) in Elderly or Poor Performance (ECOG PS 2), Chemotherapy-Naive Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|6|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:48:03.669405|2017-10-11 04:48:03.669405
NCT00075387|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2017-06-19|||March 7, 2003|Actual|2003-03-07|June 2017|2017-06-01|April 30, 2021|Anticipated|2021-04-30|April 30, 2020|Anticipated|2020-04-30||Interventional|||Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors|Phase II Clinical Trial of Patients With High-Grade Glioma Treated With Intra-arterial Carboplatin-Based Chemotherapy, Randomized to Treatment With or Without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant Against Severe Thrombocytopenia|Recruiting||Phase 2|60|Anticipated|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-10-11 04:48:03.740163|2017-10-11 04:48:03.740163
NCT00075400|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2015-05-06|2015-05-06||January 2004||2004-01-01|March 2014|2014-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional||Eligible and treated patients.|Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer|A Phase II Evaluation of Gleevec(TM) (NCI-Supplied Agent: STI571 [Imatinib Mesylate], NSC# 716051) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus|Completed||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:03.892182|2017-10-11 04:48:03.892182
NCT00075413|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2015-09-30|||November 2002||2002-11-01|September 2015|2015-09-01||||July 2005|Actual|2005-07-01||Interventional|||Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer|A Pilot Phase II Protocol Of Arsenic Trioxide (TRISENOX) In Subjects With Advanced Carcinoma Of The Breast|Withdrawn||Phase 2|0|Actual|The University of Texas Medical Branch, Galveston||||Unable to identify qualified subjects willing to participate in this study|f||||||||||||||2017-10-11 04:48:04.284848|2017-10-11 04:48:04.284848
NCT00075426|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-02-11|||November 2002||2002-11-01|February 2013|2013-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Pilot Phase II Protocol Of Arsenic Trioxide (Trisenox) In Subjects With Advanced Non-Small Cell Carcinoma Of The Lung|Completed||Phase 2|30|Anticipated|The University of Texas Medical Branch, Galveston|||||f||||||||||||||2017-10-11 04:48:04.354227|2017-10-11 04:48:04.354227
NCT00075439|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-06-03|||December 2003||2003-12-01|June 2013|2013-06-01||||May 2007|Actual|2007-05-01||Interventional|||Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors|A Phase II Trial of ZD1839 (Iressa®) in Metastatic Neuroendocrine Tumors|Completed||Phase 2|90|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:04.427088|2017-10-11 04:48:04.427088
NCT00075452|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2008-07-23|||November 2003||2003-11-01|May 2007|2007-05-01||||||||Interventional|||Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma|Phase III Randomized Study Of Gemcitabine Versus Gemcitabine-Oxaliplatine In Patients With Locally Advanced Or Metastatic Pancreatic Carcinoma|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:04.533224|2017-10-11 04:48:04.533224
NCT00075465|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2008-07-23|||April 2001||2001-04-01|July 2007|2007-07-01||||||||Interventional|||Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach|Phase II Study of Docetaxel and Epirubicine as First-Line Treatment in Patients With Advanced or Metastatic Adenocarcinoma of the Stomach|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:04.680406|2017-10-11 04:48:04.680406
NCT00075478|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2017-04-07|2014-04-16||October 2003||2003-10-01|April 2017|2017-04-01|February 2, 2014|Actual|2014-02-02|February 2014|Actual|2014-02-01||Interventional||The randomization will be stratified on institution, disease risk (indolent vs. aggressive), and prior conventional HCT and will be balanced (blocked) over time.|Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer|A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies|Completed||Phase 3|87|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-11 04:48:04.819246|2017-10-11 04:48:04.819246
NCT00075491|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-01-23|||December 2003||2003-12-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme|A Phase II Evaluation With Correlative Studies Of Fenretinide (NSC 374551-4HPR) As A Single Agent In The Treatment Of Adult Patients With Recurrent Glioblastoma Multiforme|Terminated||Phase 2|42|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:48:05.477113|2017-10-11 04:48:05.477113
NCT00075504|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2015-08-31|2015-05-19||November 2003||2003-11-01|May 2013|2013-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer|A Phase II Study of Triapine in Combination With Gemcitabine in Adenocarcinoma of the Biliary Ducts and Gall Bladder|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:48:05.570308|2017-10-11 04:48:05.570308
NCT00075517|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2008-07-23|||September 2003||2003-09-01|July 2007|2007-07-01||||||||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Study Of Gemcitabine And Docetaxel In Patients With Inoperable Stage IIIB Or IIIB or IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:05.91991|2017-10-11 04:48:05.91991
NCT00128089|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2005-12-20|||August 2005||2005-08-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Trial of New Dietary Treatment of Diabetes|Phase 1 Trial of A New Dietary Treatment of Obesity Related Type 2 Diabetes|Terminated||Phase 1|10||Manassas Internal Medicine|||||f||||||||||||||2017-10-11 05:12:06.798041|2017-10-11 05:12:06.798041
NCT00075543|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2008-07-23|||July 2003||2003-07-01|July 2007|2007-07-01||||||||Interventional|||Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer|Phase I-II Study Of Docetaxel And Oxaliplatine In Patients With Stage III-IV Ovarian Epithelial Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:05.997104|2017-10-11 04:48:05.997104
NCT00075556|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2009-02-06|||January 2002||2002-01-01|May 2008|2008-05-01||||||||Interventional|||Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma|Phase II Study Of Radiotherapy And Capecitabine As Pre-Operative Treatment In Patients With Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:06.066823|2017-10-11 04:48:06.066823
NCT00075569|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2010-01-27|||March 2004||2004-03-01|January 2006|2006-01-01||||||||Interventional|||SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia|SGN-00101 (HspE7) Immunotherapy Of CIN III|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:48:06.150399|2017-10-11 04:48:06.150399
NCT00075582|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2016-11-02|2013-12-16||September 2004||2004-09-01|October 2016|2016-10-01||||September 2012|Actual|2012-09-01||Interventional|||Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma|Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients With Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma|Active, not recruiting||Phase 3|390|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:48:06.403327|2017-10-11 04:48:06.403327
NCT00075595|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2009-01-03|||June 2002||2002-06-01|August 2007|2007-08-01||||||||Interventional|||Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer|Phase II Study of 5FU/Folinic Acid and Irinotecan as Second or Third Line Treatment in Patients With Metastatic, Unresectable, Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:07.241504|2017-10-11 04:48:07.241504
NCT00075608|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2016-12-02|2014-08-20||August 2001||2001-08-01|December 2016|2016-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis|Phase II Trial of Second Autologous Transplantation in AL Amyloidosis|Terminated||Phase 2|12|Actual|Boston Medical Center||1||poor accrual|f||||t||||||||No||2017-10-11 04:48:07.342426|2017-10-11 04:48:07.342426
NCT00075621|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2017-04-06|||August 2000||2000-08-01|April 2017|2017-04-01|May 2018|Anticipated|2018-05-01|June 2005|Actual|2005-06-01||Interventional|||Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis|A Phase II Trial of Tandem Transplantation in AL Amyloidosis|Active, not recruiting||Phase 2|62|Actual|Boston Medical Center||1|||f||||f||||||||No||2017-10-11 04:48:09.366124|2017-10-11 04:48:09.366124
NCT00075634|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-09-27|||December 2003||2003-12-01|September 2013|2013-09-01||||September 2007|Actual|2007-09-01||Interventional|||Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma|A Phase I Study of Decitabine (NSC# 127716, IND# 50733) in Combination With Doxorubicin and Cyclophosphamide in the Treatment of Relapsed or Refractory Solid Tumors|Completed||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:09.448981|2017-10-11 04:48:09.448981
NCT00075647|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-01-16|||December 2003||2003-12-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|Phase II Trial of CCI-779 in Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:09.544049|2017-10-11 04:48:09.544049
NCT00075660|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2010-11-07|||January 2004||2004-01-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma|A Phase II Study of Triapine (NSC 663249) in Previously Untreated Patients With Recurrent Renal Cell Carcinoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:48:09.620733|2017-10-11 04:48:09.620733
NCT00075673|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2011-07-21|||November 2003||2003-11-01|July 2011|2011-07-01|February 2005|Actual|2005-02-01|September 2004|Actual|2004-09-01||Interventional|||Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer|A Phase I Study of Weekly Administration of Oral Navelbine in Combination With the COX-2 Inhibitor Celebrex in Relapsed and/or Metastatic Breast Cancer|Terminated||Phase 1|6|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:48:09.707729|2017-10-11 04:48:09.707729
NCT00075686|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2015-11-16|||January 2004||2004-01-01|November 2015|2015-11-01|April 2009|Actual|2009-04-01|May 2007|Actual|2007-05-01||Interventional|||S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer|A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (IMC-C225) Versus Gemcitabine As First-Line Therapy Of Patients With Advanced Pancreas Cancer|Completed||Phase 3|766|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:48:09.819226|2017-10-11 04:48:09.819226
NCT00075699|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-08-06|||September 2003||2003-09-01|June 2008|2008-06-01||||||||Interventional|||Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma|A Randomized Controlled Trial of Active Symptom Control With or Without Chemotherapy in the Treatment of Patients With Malignant Pleural Mesothelioma|Completed||Phase 3|840|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:10.82379|2017-10-11 04:48:10.82379
NCT00075712|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-08-09|||September 2003||2003-09-01|May 2007|2007-05-01||||||||Interventional|||Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer|A Randomized Feasibility Trial to Determine the Impact of Timing of Surgery and Chemotherapy in Newly Diagnosed Patients With Advanced Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Carcinoma|Completed||Phase 2/Phase 3|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:10.925054|2017-10-11 04:48:10.925054
NCT00075725|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2017-02-14|2015-07-10||December 2003||2003-12-01|February 2017|2017-02-01||||December 2010|Actual|2010-12-01||Interventional|||Dexamethasone Compared With Prednisone During Induction Therapy and MTX With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia|High Risk B-Precursor Acute Lymphoblastic Leukemia|Completed||Phase 3|3154|Actual|Children's Oncology Group|The COG SDC reviewed the NLM notification related to ct.gov AE/SAE reporting. The information in ‘Additional Description’ is accurate with respect to data supplied to ct.gov.COG plans to submit data AE/SAE data consistent with the text in this field.|12|||f||||t||||||||||2017-10-11 04:48:11.511174|2017-10-11 04:48:11.511174
NCT00075738|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2008-07-23|||October 2003||2003-10-01|July 2007|2007-07-01||||||||Interventional|||Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer|Phase II Study Of 5FU-Irinotecan-Cisplatin As First-Line Treatment In Patients With Metastatic Carcinoma Of The Esophagus|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:23.45768|2017-10-11 04:48:23.45768
NCT00075751|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-02-27|||January 2004||2004-01-01|February 2013|2013-02-01||||July 2007|Actual|2007-07-01||Interventional|||Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer|A Phase II Trial of Gemcitabine, Carboplatin and PS-341 (NSC-681239) in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|99|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:23.591302|2017-10-11 04:48:23.591302
NCT00075764|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2017-02-15|2016-10-26||April 2004||2004-04-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|December 2012|Actual|2012-12-01||Interventional|||S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer|Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer|Active, not recruiting||Phase 3|695|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:48:23.910995|2017-10-11 04:48:23.910995
NCT00075777|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2014-08-27|||February 2005||2005-02-01|August 2014|2014-08-01|February 2008|Actual|2008-02-01|July 2007|Actual|2007-07-01||Interventional|||Valproic Acid in Treating Patients With Kaposi's Sarcoma|A Pilot Trial Of Valproic Acid In Patients With Kaposi's Sarcoma|Completed||N/A|19|Actual|AIDS Malignancy Consortium||1|||f||||||||||||||2017-10-11 04:48:26.404274|2017-10-11 04:48:26.404274
NCT00075803|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2016-08-01|2013-02-22||November 2003||2003-11-01|August 2016|2016-08-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)|A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)|Completed||Phase 3|600|Actual|Medical College of Wisconsin||2|||f||||t||||||||Yes||2017-10-11 04:48:26.671733|2017-10-11 04:48:26.671733
NCT00075816|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2016-08-01|2015-01-22||January 2004||2004-01-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional||All randomized patients were included in primary, intention-to-treat analysis.|Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)|A Phase III Randomized, Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell With Marrow Transplantation From Human Leukocyte Antigen (HLA) Compatible Unrelated Donors (BMT CTN #0201)|Completed||Phase 3|551|Actual|Medical College of Wisconsin||2|||f||||t||||||||Yes||2017-10-11 04:48:27.645666|2017-10-11 04:48:27.645666
NCT00075829|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2017-08-24|2014-12-17||December 2003||2003-12-01|August 2017|2017-08-01|March 2013|Actual|2013-03-01|June 2012|Actual|2012-06-01||Interventional||Analysis is based on intention-to-treat data. Primary analysis of the clinical trial focused on patients meeting protocol criteria of standard risk multiple myeloma.|Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)|A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy vs Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients With Multiple Myeloma (BMT CTN #0102)|Completed||Phase 3|710|Actual|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||f||||||||||2017-10-11 04:48:28.928136|2017-10-11 04:48:28.928136
NCT00075842|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2016-12-02|||August 2003||2003-08-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|March 2007|Actual|2007-03-01||Interventional|||(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy|"The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer A Phase III Randomized, Placebo-Controlled, Double-Blind Study"|Completed||Phase 3|227|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:48:30.309154|2017-10-11 04:48:30.309154
NCT00075855|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2016-07-12|||April 2004||2004-04-01|July 2016|2016-07-01|October 2007|Actual|2007-10-01|May 2007|Actual|2007-05-01||Interventional|||Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors|The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study|Completed||Phase 3|150|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:48:30.459019|2017-10-11 04:48:30.459019
NCT00075868|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2015-11-14|||December 2003||2003-12-01|November 2015|2015-11-01||||August 2006|Actual|2006-08-01||Interventional|||Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer|A Randomized, Double Blind, Placebo-Controlled Phase III Study To Determine The Efficacy Of Sandostatin LAR® Depot (Octreotide Acetate) In Preventing Or Reducing The Severity Of Chemoradiation-Induced Diarrhea In Patients With Anal Or Rectal Cancer|Completed||Phase 3|233|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:48:30.591084|2017-10-11 04:48:30.591084
NCT00067964|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-03|2010-01-12||||||January 2010|2010-01-01||||||||Interventional|||Diet and Physical Activity Interactions in Obesity||Completed||N/A|90||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:48:30.991117|2017-10-11 04:48:30.991117
NCT00067990|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-03|2017-09-13|2017-03-13||December 2002||2002-12-01|September 2017|2017-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Angiotensin II Blockade for Chronic Allograft Nephropathy|Angiotensin II Blockade for the Prevention of Cortical Interstitial Expansion and Graft Loss in Kidney Transplant Recipients|Completed||Phase 4|153|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 04:48:31.074508|2017-10-11 04:48:31.074508
NCT00068003|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-04|2017-10-05|||August 22, 2003||2003-08-22|August 1, 2017|2017-08-01||||||||Observational|||Harvesting Cells for Experimental Cancer Treatments|Cell Harvest and Preparation for Surgery Branch Adoptive Cell Therapy Protocols|Enrolling by invitation||N/A|1839|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:31.501086|2017-10-11 04:48:31.501086
NCT00068029|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-04|2008-04-03|||October 2003||2003-10-01|April 2008|2008-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Pegvisomant And Sandostatin LAR Combination Study|A Randomized, Parallel Group, Three-Arm Study To Evaluate Treatment With A Combination Of Pegvisomant Plus Sandostatin Lar, Pegvisomant (Alone), And Sandostatin Lar (Alone) In Patients With Acromegaly|Completed||Phase 4|75||Pfizer|||||||||||||||||||2017-10-11 04:48:31.591512|2017-10-11 04:48:31.591512
NCT00068042|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-04|2008-04-03|||April 2003||2003-04-01|April 2008|2008-04-01|May 2006|Actual|2006-05-01|||||Interventional|||A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly|A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly|Completed||Phase 4|100||Pfizer|||||||||||||||||||2017-10-11 04:48:31.749768|2017-10-11 04:48:31.749768
NCT00068055|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-04|2011-02-03|||September 2003||2003-09-01|July 2009|2009-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||IVIG - West Nile Encephalitis: Safety and Efficacy|A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (OMR-IGG-AM) Containing High Anti-West Nile Virus Antibody Titers in Patients With, or at High Risk for Progression to West Nile Virus (WNV) Encephalitis and/or Myelitis|Completed||Phase 1/Phase 2|62|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 04:48:31.921096|2017-10-11 04:48:31.921096
NCT00068068|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-04|2006-09-18|||October 2003||2003-10-01|September 2006|2006-09-01||||||||Interventional|||Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases|Safety and Efficacy of Treating Refractory Cancers With the Litx™ System: Phase II Safety and Efficacy Study in Patients With Liver Metastases From Colorectal Cancer That Have Failed Chemotherapy|Completed||Phase 2|25||Light Sciences LLC|||||||||||||||||||2017-10-11 04:48:32.376052|2017-10-11 04:48:32.376052
NCT00068081|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-05|2008-03-04||||||September 2007|2007-09-01||||||||Interventional|||Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|A Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|Completed||Phase 3|150||NeurogesX|||||||||||||||||||2017-10-11 04:48:32.460131|2017-10-11 04:48:32.460131
NCT00068094|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-05|2006-08-16|||July 2005||2005-07-01|August 2006|2006-08-01|February 2006||2006-02-01|||||Interventional|||The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics|The Effect of a Probiotic on Hepatic Steatosis|Terminated||Phase 1/Phase 2|30||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:48:32.574243|2017-10-11 04:48:32.574243
NCT00068107|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-06|2015-03-19|2015-03-12||September 2003||2003-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Dosing Study of Replagal in Patients With Fabry Disease|Study of Weekly Dosing Regimens of Replagal in Patients With Fabry Disease With Incomplete Clinical Response to Long-Term Therapy|Completed||Phase 2|13|Actual|Baylor Research Institute|Small number of subjects. Single group with comparison to baseline data.|1|||f||||f||||||||||2017-10-11 04:48:32.67717|2017-10-11 04:48:32.67717
NCT00068120|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-08|2010-01-12||||||January 2010|2010-01-01||||||||Observational|||ORWH:SCOR - Sex/Gender Factors Affecting Women's Health|ORWH:SCOR - Sex/Gender Factors Affecting Women's Health|Completed||N/A|200|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:48:33.29089|2017-10-11 04:48:33.29089
NCT00068133|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-08|2005-06-23|||June 2003||2003-06-01|May 2005|2005-05-01|June 2005||2005-06-01|||||Interventional|||Trial of VLTS-589 in Subjects With Intermittent Claudication|A Phase II Multicenter, Double-Blind, Placebo-Controlled, Trial of VLTS-589 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease|Completed||Phase 2|100||Valentis|||||||||||||||||||2017-10-11 04:48:33.360629|2017-10-11 04:48:33.360629
NCT00068146|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-09|2017-10-05|||September 19, 2002||2002-09-19|November 26, 2012|2012-11-26|November 26, 2012||2012-11-26|||||Observational|||Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma|Study of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Evaluation of the Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-Associated Lymphoma|Completed||N/A|77|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:33.482675|2017-10-11 04:48:33.482675
NCT00068159|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-09|2017-10-05|||September 3, 2003||2003-09-03|December 23, 2016|2016-12-23||||||||Observational|||Cardiac Function in Patients With Hereditary Hemochromatosis|Characterization of Cardiac Function in Subjects With Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I|Active, not recruiting||N/A|66|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:33.604698|2017-10-11 04:48:33.604698
NCT00068172|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-09|2016-03-30|||July 2001||2001-07-01|March 2016|2016-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of PI-88 in Patients With Advanced Melanoma|A Phase I/II Study of PI-88 in Advanced Malignancies (Phase I), and in Advanced Melanoma (Phase II)|Completed||Phase 1/Phase 2|88||Medigen Biotechnology Corporation|||||f||||||||||||||2017-10-11 04:48:33.707411|2017-10-11 04:48:33.707411
NCT00068185|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-09|2009-12-09|||August 2003||2003-08-01|December 2009|2009-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of the Pharmacokinetics of Black Cohosh|Interactions Between SERMs, Soy and Black Cohosh|Terminated||Phase 1|12|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||||PI left institution, study did not continue, funding stopped|f||||t||||||||||2017-10-11 04:48:33.795165|2017-10-11 04:48:33.795165
NCT00068198|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-09|2010-08-26||||||May 2006|2006-05-01|November 2004||2004-11-01|||||Interventional|||Human Immune Responses Smallpox|Evaluation of Human Immune Response to Smallpox Vaccine (Vaccinia Virus)|Completed||Phase 1|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:48:33.888213|2017-10-11 04:48:33.888213
NCT00068211|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-09|2015-03-04|||August 2003||2003-08-01|March 2015|2015-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma|A Phase II Study of ILX651 Administered Intravenously Daily for Five Consecutive Days Once Every 3 Weeks in Patients With Inoperable Locally Advanced or Metastatic Melanoma.|Completed||Phase 2|||Sanofi|||||||||||||||||||2017-10-11 04:48:33.972685|2017-10-11 04:48:33.972685
NCT00068224|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-10-05|||September 4, 2003||2003-09-04|June 30, 2017|2017-06-30||||||||Observational|||Clinical and Molecular Investigations Into Ciliopathies|Clinical and Molecular Investigations Into Ciliopathies|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:34.168451|2017-10-11 04:48:34.168451
NCT00068237|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2016-12-30|2013-10-29||August 2003||2003-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|January 2008|Actual|2008-01-01||Interventional||All eligible patients who started study treatment.|Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer|A Phase II Study Of Submandibular Salivary Gland Transfer To The Submental Space Prior To Start Of Radiation Treatment For Prevention Of Radiation-Induced Xerostomia In Head And Neck Cancer Patients|Completed||Phase 2|49|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:48:34.309051|2017-10-11 04:48:34.309051
NCT00068250|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2016-12-30|||July 2003||2003-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma|Phase I/II Study Of Pre-Irradiation Chemotherapy With Methotrexate, Rituximab, And Temozolomide And Post -Irradiation Temozolomide For Primary Central Nervous System Lymphoma|Completed||Phase 1/Phase 2|60|Actual|Radiation Therapy Oncology Group||4|||f||||t||||||||||2017-10-11 04:48:34.747362|2017-10-11 04:48:34.747362
NCT00068263|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2016-12-30|||August 2003||2003-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2005|Actual|2005-06-01||Interventional|||3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection|A Phase I/II Trial to Evaluate Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma|Completed||Phase 1/Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:48:34.920767|2017-10-11 04:48:34.920767
NCT00068276|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-01-17|||July 2003||2003-07-01|June 2013|2013-06-01|September 2006|Actual|2006-09-01|June 2005|Actual|2005-06-01||Interventional|||Cholecalciferol in Treating Patients With Myelodysplastic Syndrome|Orthomolecular Vitamin D3 in Low-Risk Myelodysplastic Syndrome: An Open-Label Clinical Trial|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:48:35.000699|2017-10-11 04:48:35.000699
NCT00068289|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-06-21|||September 2003||2003-09-01|August 2004|2004-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy|A Phase II Trial of PS-341 (NSC-681239) in Patients With Platinum-Treated Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:35.158809|2017-10-11 04:48:35.158809
NCT00068302|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2015-03-11|||January 2003||2003-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|April 2009|Actual|2009-04-01||Interventional|||Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma|A Phase I Trial Of Sirolimus In Relapsed/Refractory Leukemia And Non-Hodgkin's Lymphoma|Terminated||Phase 1|10|Actual|Children's Hospital of Philadelphia||1||Recruiting/enrolling participants halted prematurely but potentially will resume|f||||t||||||||||2017-10-11 04:48:35.395204|2017-10-11 04:48:35.395204
NCT00068315|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-09-27|||July 2003||2003-07-01|September 2013|2013-09-01||||December 2008|Actual|2008-12-01||Interventional|||Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|A Phase I Trial of PS-341 and Fludarabine for Relapsed and Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia|Completed||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:35.490256|2017-10-11 04:48:35.490256
NCT00068328|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-08-07|||August 2003||2003-08-01|August 2017|2017-08-01|December 2016|Actual|2016-12-01|December 2006|Actual|2006-12-01||Observational|||Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer|Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer|Completed||N/A|1706|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 04:48:35.775306|2017-10-11 04:48:35.775306
NCT00068341|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-02-03|2016-02-11||July 2003||2003-07-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer|Neoadjuvant Treatment and Molecular Characterization of Locally Advanced Breast Cancer|Completed||Phase 2|74|Actual|Jonsson Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 04:48:36.021042|2017-10-11 04:48:36.021042
NCT00068380|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2014-10-01|2014-07-21||March 2004||2004-03-01|July 2013|2013-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer|A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)|In the first stage none of the 17 patients responded (CR/PR) to treatment. Due to budget constraints and recent reprioritizations, CTEP closed the study to accrual.|1|||f||||||||||||||2017-10-11 04:48:37.4019|2017-10-11 04:48:37.4019
NCT00068393|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-01-04|2012-11-30||December 2003||2003-12-01|January 2013|2013-01-01|May 2011|Actual|2011-05-01|June 2009|Actual|2009-06-01||Interventional|||Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma|Phase II Trial of Doxorubicin and Gemcitabine in Metastatic Renal Cell Carcinoma With Sarcomatoid Features|Completed||Phase 2|39|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:48:37.691636|2017-10-11 04:48:37.691636
NCT00068419|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-03-23|2013-10-07||February 2004||2004-02-01|March 2017|2017-03-01||||August 2010|Actual|2010-08-01||Interventional|||Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor|A Phase II Study of Sulindac and Tamoxifen in Patients With Desmoid Tumors That Are Recurrent or Not Amenable to Standard Therapy|Active, not recruiting||Phase 2|70|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:48:38.568152|2017-10-11 04:48:38.568152
NCT00068432|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2012-01-09|||December 2003||2003-12-01|January 2012|2012-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer|A Phase II Trial of Gemcitabine and Celecoxib as First-Line Treatment for Patients With Advanced Metastatic Pancreatic Cancer|Completed||Phase 2|28|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:48:40.304543|2017-10-11 04:48:40.304543
NCT00144924|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-06-12|||June 2004||2004-06-01|June 2008|2008-06-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||Open vs Laparoscopic Pyloromyotomy for Pyloric Stenosis||Unknown status|Recruiting|N/A|200|Anticipated|Institute of Child Health||1|||f||||||||||||||2017-10-11 05:15:36.992845|2017-10-11 05:15:36.992845
NCT00068445|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2016-07-12|||February 2004||2004-02-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|May 2006|Actual|2006-05-01||Interventional|||Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer|The Efficacy of Lamotrigine in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double Blind, Placebo-Controlled Trial|Completed||Phase 3|131|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:48:40.406068|2017-10-11 04:48:40.406068
NCT00068458|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-01-18|||September 2003||2003-09-01|April 2013|2013-04-01|January 2005|Actual|2005-01-01|January 2004|Actual|2004-01-01||Interventional|||Survival TRaining for ENhancing Total Health (STRENGTH)|A Phase II Randomized Study to Assess the Feasibility of Distance Medicine Based Exercise and Dietary Approaches to Prevent Body Composition Change Occurring During Adjuvant Chemotherapy for Early Stage Breast Cancer|Completed||Phase 2|39|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||||2017-10-11 04:48:40.54261|2017-10-11 04:48:40.54261
NCT00068471|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-06-18|||July 2003||2003-07-01|April 2004|2004-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Anidulafungin in Treating Immunocompromised Children With Neutropenia|Phase I-II Study of the Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children With Neutropenia|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:48:40.651921|2017-10-11 04:48:40.651921
NCT00068484|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-01-31|||July 2003||2003-07-01|January 2013|2013-01-01||||February 2006|Actual|2006-02-01||Interventional|||A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies|A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:40.72571|2017-10-11 04:48:40.72571
NCT00068497|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-01-11|||August 2003||2003-08-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer|Single Agent ZD-1839 (NSC-715055, IND-61187) in Patients With Advanced Head and Neck Carcinoma or Non-Small Cell Lung Cancer Aged 75 Years and Older (and in a Cohort of Patients 50 Years Old and Younger)|Completed||N/A|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:40.837313|2017-10-11 04:48:40.837313
NCT00068510|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2015-09-30|||June 2003||2003-06-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Vaccine Therapy in Treating Patients With Malignant Glioma|Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas|Completed||Phase 1|28|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:48:40.948861|2017-10-11 04:48:40.948861
NCT00068523|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2010-06-10|||June 2003||2003-06-01|June 2010|2010-06-01||||March 2004|Actual|2004-03-01||Interventional|||Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies|Immunomodulation by Ultraviolet B-Irradiation (UVB) to Facilitate Allogeneic Stem Cell Transplantation for Treatment of Hematologic Malignancies|Completed||N/A|10|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:48:41.121957|2017-10-11 04:48:41.121957
NCT00068549|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2014-12-23|||October 2003||2003-10-01|December 2014|2014-12-01||||January 2008|Actual|2008-01-01||Interventional|||Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer|A Phase I Study of Whole Pelvic Radiation Therapy With Concomitant Cisplatin and Gemcitabine Chemotherapy in Patients With Cervical Carcinoma (Stages I-IV) Limited to the Pelvis|Completed||Phase 1|13|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:48:41.250346|2017-10-11 04:48:41.250346
NCT00068575|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2012-02-13|2012-01-23||May 2002||2002-05-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer|A Phase II Trial of Pancreaticoduodenectomy Plus Postoperative Cisplatin, Interferon Alfa-2b, and 5-FU Combined With Radiation Treatment for Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:48:41.403966|2017-10-11 04:48:41.403966
NCT00068588|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2014-10-24|2014-09-25||October 2003||2003-10-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer|A Phase 2 Study of GTI-2040 (NSC 722929) in Combination With Capecitabine in Metastatic Breast Cancer|Completed||Phase 2|24|Actual|National Cancer Institute (NCI)|In the first stage of the two stage Optimum design, following the dose escalation step, 3 of 15 patients responded for a response rate of 20%. A response rate of less than 25% would not warrant further study.|1|||f||||||||||||||2017-10-11 04:48:41.697434|2017-10-11 04:48:41.697434
NCT00068601|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-02-15|2016-12-16||October 2003||2003-10-01|February 2017|2017-02-01|September 2016|Actual|2016-09-01|January 2014|Actual|2014-01-01||Interventional||Patients who are both eligible and evaluable|S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer|Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer|Completed||Phase 3|257|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:48:42.382243|2017-10-11 04:48:42.382243
NCT00068614|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2014-02-04|||July 2003||2003-07-01|February 2014|2014-02-01||||October 2005|Actual|2005-10-01||Interventional|||HER-2 Protein Vaccine in Treating Women With Breast Cancer|A Phase I Trial Evaluating The Safety Of Intramuscular Injections Of HER-2 Protein AUTOVAC (PX104.1.6) In Patients With Breast Cancer|Completed||Phase 1|||Case Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:48:42.83444|2017-10-11 04:48:42.83444
NCT00068653|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-04-25|||June 2003||2003-06-01|April 2013|2013-04-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer|Phase II Study of the Combination of ZD1839 (Iressa) and Celecoxib in Patients With Platinum Refractory Non-Small Cell Lung Cance|Completed||Phase 2|27|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 04:48:42.922607|2017-10-11 04:48:42.922607
NCT00068666|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2016-12-14|||January 2004||2004-01-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2005|Actual|2005-03-01||Interventional|||Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System|A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System|Terminated||Phase 2|41|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:48:43.048067|2017-10-11 04:48:43.048067
NCT00068692|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-02-26|||October 2003||2003-10-01|February 2013|2013-02-01||||January 2100|Anticipated|2100-01-01||Interventional|||Comparison of Adjuvant Chemotherapy Regimens in Treating Patients With Stage II or Stage III Rectal Cancer Who Are Receiving Radiation Therapy and Fluorouracil Before or After Surgery|Intergroup Randomized Phase III Study of Postoperative Irinotecan, 5-Fluorouracil and Leucovorin vs. Oxaliplatin, 5-Fluorouracil and Leucovorin vs. 5-Fluorouracil and Leucovorin for Patients With Stage II or III Rectal Cancer Receiving Either Preoperative Radiation and 5-Fluorouracil or Postoperative Radiation and 5-Fluorouracil|Terminated||Phase 3|3000|Actual|National Cancer Institute (NCI)||6||Administratively complete.|f||||||||||||||2017-10-11 04:48:43.397902|2017-10-11 04:48:43.397902
NCT00068718|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-03-10|2017-01-20||May 2003||2003-05-01|March 2017|2017-03-01||||May 2013|Actual|2013-05-01||Interventional|||Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant|Donor Lymphocyte Infusion for the Treatment of Malignancy After Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning - A Multi-center Trial|Active, not recruiting||Phase 1/Phase 2|35|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:48:43.580035|2017-10-11 04:48:43.580035
NCT00068731|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2016-07-12|||January 2004||2004-01-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|February 2007|Actual|2007-02-01||Interventional|||Lycopene in Treating Patients With Metastatic Prostate Cancer|A Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA Elevation|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:48:44.01333|2017-10-11 04:48:44.01333
NCT00068744|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2012-09-20|||July 2003||2003-07-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer|Continuous Fluorouracil Plus Mitomycin C Versus Mitomycin C Plus Cisplatin As Chemotherapy Combination In Combined Radiochemotherapy For Locally Advanced Anal Cancer. A Phase II-III Study|Terminated||Phase 2/Phase 3|88|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:48:44.162987|2017-10-11 04:48:44.162987
NCT00068757|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2012-09-11|||August 2003||2003-08-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer|Phase I Study of Lonafarnib (SCH66336) in Combination With Herceptin Plus Paclitaxel in HER 2 NEU Overexpressing Breast Cancer|Completed||Phase 1|23|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:48:44.354153|2017-10-11 04:48:44.354153
NCT00068770|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2015-03-17|2012-11-19||October 2003||2003-10-01|March 2015|2015-03-01|May 2006|Actual|2006-05-01|May 2005|Actual|2005-05-01||Interventional|||Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT|A Pharmacokinetic Study of the Interaction Between Celecoxib and Anticonvulsant Drugs in Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Radiation Therapy|Terminated||Phase 2|35|Actual|Sidney Kimmel Comprehensive Cancer Center|Study ended early when results from another study became available documenting Temozolomide (TMZ) and radiation improved survival, we felt it was unethical to continue this study, our study did not include TMZ.|2||EORTC trail showed TMZ & RT conferred significant survivial in this population|f||||t||||||||||2017-10-11 04:48:44.506303|2017-10-11 04:48:44.506303
NCT00068783|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2013-02-27|||October 2003||2003-10-01|February 2013|2013-02-01||||June 2007|Actual|2007-06-01||Interventional|||S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer|A Phase II Trial of STI-571/Imatinib (Gleevec®) (NSC-716051) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:48:45.120202|2017-10-11 04:48:45.120202
NCT00068809|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2017-02-27|||July 2003||2003-07-01|February 2016|2016-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||4-Day-A-Week Treatment Plan for HIV Infected Adolescents|Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression|Completed||Phase 4|31|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 04:48:45.245413|2017-10-11 04:48:45.245413
NCT00068822|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2012-09-24|2012-08-07||April 2003||2003-04-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Vertebroplasty for the Treatment of Fractures Due to Osteoporosis|Investigational Vertebroplasty Efficacy and Safety Trial (INVEST)|Completed||Phase 3|131|Actual|Mayo Clinic|The possible role of the placebo effect on outcomes remains unclear. Crossover at 1 month was allowed, which complicated the interpretation of between-group outcome differences. Other medical treatments received were not compared to study groups.|2|||f||||t||||||||||2017-10-11 04:48:45.381722|2017-10-11 04:48:45.381722
NCT00068835|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2005-06-23|||June 2000||2000-06-01|November 2004|2004-11-01|May 2005||2005-05-01|||||Interventional|||Using fMRI to Evaluate Instructional Programs for Children With Developmental Dyslexia|Remediation in Developmental Dyslexia|Unknown status|Active, not recruiting|N/A|160||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:48:45.913898|2017-10-11 04:48:45.913898
NCT00068848|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2007-04-09|||February 2003||2003-02-01|April 2007|2007-04-01|March 2005||2005-03-01|||||Interventional|||Quick Start Approach to Birth Control Pills|RCT of a Novel Oral Contraceptive Initiation Method|Completed||Phase 4|2000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:48:45.987952|2017-10-11 04:48:45.987952
NCT00068861|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2007-09-28|||November 2002||2002-11-01|September 2005|2005-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Treatment of Infertility in Women With Polycystic Ovary Syndrome|Pregnancy in Polycystic Ovary Syndrome: A 30 Week Double-Blind Randomized Trial of Clomiphene Citrate, Metformin XR, and Combined Clomiphene Citrate/Metformin XR For the Treatment of Infertility in Women With Polycystic Ovary Syndrome|Completed||Phase 3|678||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-10-11 04:48:46.048195|2017-10-11 04:48:46.048195
NCT00068874|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2009-04-08|||April 2004||2004-04-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Improving Quality of Life for African American Female Adolescents With Lupus|Predictors of Adaptation and a Cognitive Behavioral Intervention for African American Adolescents With Lupus|Completed||Phase 2|120|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||3|||f||||t||||||||||2017-10-11 04:48:46.163375|2017-10-11 04:48:46.163375
NCT00068900|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2015-04-29|||November 2003||2003-11-01|April 2015|2015-04-01|February 2004|Actual|2004-02-01|January 2004|Actual|2004-01-01||Observational|||FFA Metabolism in Different Types of Human Obesity|FFA Metabolism in Different Types of Human Obesity|Withdrawn||N/A|0|Actual|Mayo Clinic||||NOT A CLINICAL TRIAL|f||||||||||||||2017-10-11 04:48:46.468256|2017-10-11 04:48:46.468256
NCT00068913|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-10|2005-06-23|||March 2000||2000-03-01|September 2004|2004-09-01||||||||Interventional|||Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome|Investigation of Clinical Syndromes Associated With mtDNA Point Mutations: MELAS/DCA Clinical Trial|Unknown status|Active, not recruiting|Phase 2|35||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-10-11 04:48:46.535572|2017-10-11 04:48:46.535572
NCT00068926|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-11|2017-06-30|||September 3, 2003||2003-09-03|June 29, 2011|2011-06-29|June 29, 2011||2011-06-29|||||Observational|||VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases|VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases|Completed||N/A|958|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:46.610266|2017-10-11 04:48:46.610266
NCT00068952|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-12|2008-03-27|||August 2003||2003-08-01|March 2008|2008-03-01|March 2006||2006-03-01|||||Interventional|||Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme|A Phase III, Randomized, Open-Label Study Of IV Edotecarin Vs Temozolomide Or Carmustine (BCNU) Or Lomustine (CCNU) In Patients With Glioblastoma Multiforme At First Relapse After Alkylator-Based (NEO) Adjuvant Chemotherapy|Completed||Phase 3|118||Pfizer|||||f||||||||||||||2017-10-11 04:48:46.714317|2017-10-11 04:48:46.714317
NCT00068978|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-12|2007-09-17|||April 2003||2003-04-01|August 2007|2007-08-01||||||||Observational|||Analysis of Immune Responses to HIV Vaccines|Flow Cytometry Study of T Cell Responses to HIV Vaccines|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:48:46.931875|2017-10-11 04:48:46.931875
NCT00068991|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-12|2015-05-29||||||September 2008|2008-09-01|June 2007||2007-06-01|||||Interventional|||HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China|A Cluster-Randomized Trial to Evaluate the Efficacy of a Combined Individual- and Community-Based Behavioral Intervention to Improve Quality of Life for HIV-Positive Villagers in Rural China (China CIPRA Project 2)|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||f||||||||||2017-10-11 04:48:47.027474|2017-10-11 04:48:47.027474
NCT00069004|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-12|2014-01-06|||October 2003||2003-10-01|January 2014|2014-01-01|August 2005|Actual|2005-08-01|||||Observational|||A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth|Prevalence of Morphologic and Metabolic Abnormalities in Vertically HIV-Infected and Uninfected Children and Youth|Completed||N/A|450||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:48:47.146186|2017-10-11 04:48:47.146186
NCT00069017|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-12|2007-11-26|||September 2003||2003-09-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate|A Phase II, Randomized, Double-Blind Study to Evaluate the Effects of MEDI-522, a Humanized MAb to Integrin Alpha V Beta 3, On Disease Activity and Progression of Joint Damage in Pts With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate|Completed||Phase 2|300|Actual|MedImmune LLC||2|||f||||||||||||||2017-10-11 04:48:47.340487|2017-10-11 04:48:47.340487
NCT00069030|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-12|2012-11-07|||December 2003||2003-12-01|November 2012|2012-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the HIV-1 DNA Vaccine VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade Env) With the Plasmid Cytokine Adjuvant VRC-ADJDNA004-IL2-VP (IL-2/Ig)|Completed||Phase 1|70|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:48:47.520292|2017-10-11 04:48:47.520292
NCT00069056|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-13|2017-06-30|||September 10, 2003||2003-09-10|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema|A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema|Completed||Phase 1|4||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:48:47.62901|2017-10-11 04:48:47.62901
NCT00069069|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-12|2017-10-05|||September 10, 2003||2003-09-10|March 23, 2017|2017-03-23|November 20, 2025|Anticipated|2025-11-20|November 20, 2025|Anticipated|2025-11-20||Interventional|||E-Selectin Nasal Instillation to Prevent Secondary Stroke|Induction of Mucosal Tolerance to Human E-Selectin for the Secondary Prevention of Stroke|Not yet recruiting||Phase 1|58|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:48:47.708064|2017-10-11 04:48:47.708064
NCT00069082|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-15|2011-06-08|||August 2003||2003-08-01|June 2011|2011-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Intranasal Civamide for Episodic Cluster Headache|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache|Completed||Phase 3|2|Actual|Winston Laboratories||2|||f||||||||||||||2017-10-11 04:48:47.799715|2017-10-11 04:48:47.799715
NCT00069095|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-15|2016-08-26|2015-12-11||July 2003||2003-07-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|January 2006|Actual|2006-01-01||Interventional||Baseline characteristics were described for the Intent-to-treat (ITT) population.This population included all randomized participants who provided written informed consent.|A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer|"A 2x2 Factorial Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) (XELOX) With/Without Intravenous Bevacizumab (Q3W) Versus Bolus and Continuous Infusion Fluorouracil/Intravenous Leucovorin With Intravenous Oxaliplatin (Q2W) (FOLFOX-4) With/Without Intravenous Bevacizumab (Q2W) as First-line Treatment for Patients With Metastatic Colorectal Cancer"|Completed||Phase 3|2035|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 04:48:48.095824|2017-10-11 04:48:48.095824
NCT00075907|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2013-10-04|||July 2004||2004-07-01|October 2013|2013-10-01|September 2006|Actual|2006-09-01|||||Interventional|||Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents|A Comparative Trial of Protease-Containing and Protease-Sparing HAART Regimens in HIV-Infected Adolescents With an Evaluation of Therapeutic Drug Monitoring|Completed||Phase 3|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:49:04.973814|2017-10-11 04:49:04.973814
NCT00069108|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-15|2016-03-03|2016-01-27||July 2003||2003-07-01|March 2016|2016-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional||All participants with written informed consent who were randomized to one of the two study arms were included in the Intent-to-treat (ITT) population. Participants in this population were analyzed according to the arm to which they were randomized|A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer|"An Open-Label Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) (XELOX) Versus Bolus and Continuous Infusion Fluorouracil/ Intravenous Leucovorin With Intravenous Oxaliplatin (Q2W) (FOLFOX4) as Treatment for Patients With Metastatic Colorectal Cancer Who Have Received Prior Treatment With CPT-11 in Combination With 5-FU/LV as First Line Therapy"|Completed||Phase 3|627|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:48:54.096564|2017-10-11 04:48:54.096564
NCT00069121|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-15|2013-08-13|2011-03-31||January 2003||2003-01-01|August 2013|2013-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer|A Randomized, Open-label Study of the Effect of Intermittent Xeloda in Combination With Eloxatin, Versus Fluorouracil/Leucovorin, on Disease-free Survival in Patients Who Have Undergone Surgery for Colon Cancer.|Completed||Phase 3|1886|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:48:55.586691|2017-10-11 04:48:55.586691
NCT00069134|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-15|2017-07-31|||June 2003||2003-06-01|July 2017|2017-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Study of Antioxidants and Oxidants in Malnourished Children|Glutathione Homeostasis and Oxidant Damage in Kwashiorkor|Completed||N/A|86|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 04:48:58.624599|2017-10-11 04:48:58.624599
NCT00069160|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-15|2012-09-12|2011-06-30||September 2003||2003-09-01|September 2012|2012-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer|A Clinical Trial of the P-Glycoprotein Antagonist, Tariquidar (XR9576), in Combination With Docetaxel in Patients With Lung, Ovarian, Renal and Cervical Cancer: Analysis of the Interaction Between Tariquidar and Docetaxel|Completed||Phase 2|48|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:48:58.746475|2017-10-11 04:48:58.746475
NCT00069173|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-16|2005-06-23|||July 2000||2000-07-01|June 2003|2003-06-01||||||||Interventional|||Preventing Osteoporosis in Adolescent Girls|Prevention of Osteoporosis Among Sedentary Adolescent Females|Unknown status|Recruiting|Phase 1|250||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:48:59.716563|2017-10-11 04:48:59.716563
NCT00069186|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-17|2005-06-23|||June 2003||2003-06-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis|A Phase III, Multi-Center, Double-Blind, Placebo Controlled, Randomized Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis|Unknown status|Active, not recruiting|Phase 3|107||The Avicena Group|||||||||||||||||||2017-10-11 04:48:59.790929|2017-10-11 04:48:59.790929
NCT00069199|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-17|2008-03-03|||September 2003||2003-09-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Optical Coherence Tomography Comparative Study|Optical Coherence Tomography Comparative Study|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:00.104121|2017-10-11 04:49:00.104121
NCT00069212|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-17|2017-10-05|||September 16, 2003||2003-09-16|September 17, 2012|2012-09-17|September 17, 2012||2012-09-17|||||Observational|||Psychobiological Mechanisms of Resilience to Trauma|Psychobiological Mechanisms of Resilience to Trauma|Completed||N/A|210|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:00.168441|2017-10-11 04:49:00.168441
NCT00069225|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-17|2008-03-03|||September 2003||2003-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Brain Structure and Function Before and After Treatment for Post-Traumatic Stress Disorder|Cerebral Structure and Function Before and After Pharmacological and Psychological Treatment for PTSD|Completed||N/A|95||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:00.234768|2017-10-11 04:49:00.234768
NCT00069238|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-17|2016-08-01|2015-10-07||September 2003||2003-09-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|June 2009|Actual|2009-06-01||Interventional|||Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas|Phase 2 Trial of Alemtuzumab and Dose-Adjusted Epoch in Chemotherapy Naive Aggressive T and NK-Cell Lymphomas|Active, not recruiting||Phase 2|31|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:49:00.320433|2017-10-11 04:49:00.320433
NCT00069251|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-18|2017-01-11|||July 2003||2003-07-01|July 2008|2008-07-01|June 2005||2005-06-01|||||Interventional|||Bupropion for the Treatment of Methamphetamine Dependence - 1|Bupropion for the Treatment of Methamphetamine Dependence|Completed||Phase 2|150||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:49:00.816383|2017-10-11 04:49:00.816383
NCT00069264|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-19|2011-11-16|2011-11-16||September 2003||2003-09-01|November 2011|2011-11-01|July 2005|Actual|2005-07-01|March 2005|Actual|2005-03-01||Interventional|||Study of E7389 in Patients With Advanced Solid Tumors|A Phase I Dose-Finding Study of E7389 (Halichondrin B Analog) in Patients With Advanced Solid Tumors|Completed||Phase 1|33|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 04:49:00.901597|2017-10-11 04:49:00.901597
NCT00069277|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-19|2012-04-06|2012-01-09||August 2003||2003-08-01|April 2012|2012-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors|A Phase I Dose-Finding Study of E7389 (Halichondrin B Analog) Administered Once Every Three Weeks in Patients With Advanced Solid Tumors|Completed||Phase 1|21|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 04:49:01.377225|2017-10-11 04:49:01.377225
NCT00069303|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-22|2017-06-30|||September 16, 2003||2003-09-16|February 18, 2011|2011-02-18|February 18, 2011||2011-02-18|||||Observational|||Natural History of West Nile Virus Infection|Investigation of the Natural History of West Nile Virus Infection in Patients With Recently Acquired West Nile Fever or Neuroinvasive Disease|Completed||N/A|110|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:01.755797|2017-10-11 04:49:01.755797
NCT00069316|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-22|2017-06-30|||September 22, 2003||2003-09-22|February 18, 2011|2011-02-18|June 27, 2007|Actual|2007-06-27|June 27, 2007|Actual|2007-06-27||Interventional|||Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease|A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (Omr-IgG-am) Containing High Anti-West Nile Virus Antibody Titers in Patients With, or at High Risk for Progression to West Nile Virus(WNV)|Completed||Phase 2|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:49:01.853746|2017-10-11 04:49:01.853746
NCT00069329|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-22|2016-10-07|2016-05-06||September 2003||2003-09-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease|A Long-Term Outcome Study With the IL-1 Receptor Antagonist Anakinra/Kineret in Patients With Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) A Therapeutic Approach to Study the Pathogenesis of This Disease|Terminated||Phase 1/Phase 2|43|Actual|National Institutes of Health Clinical Center (CC)|Data reported is on 26 patients who completed their 3 year assessment and 20 of these patients also completed their 5 year assessment.|1||data submitted for Food and Drug Administration (FDA) approval|f||||f||||||||Yes|with Swedish Orphan Biovitrum Inc (SOBI)|2017-10-11 04:49:01.959764|2017-10-11 04:49:01.959764
NCT00069342|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-23|2017-10-05|||September 15, 2003||2003-09-15|March 20, 2017|2017-03-20||||||||Observational|||Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases|Health Beliefs and Health Behavior Practices Among Minorities With Rheumatic Diseases|Completed||N/A|140|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:02.851128|2017-10-11 04:49:02.851128
NCT00069355|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-23|2008-03-03|||September 2003||2003-09-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Propranolol for the Treatment of Acute Stress Disorder|Propranolol For the Treatment of Acute Stress Disorder|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:02.93329|2017-10-11 04:49:02.93329
NCT00069368|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-24|2014-09-25|||July 2003||2003-07-01|September 2014|2014-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence|ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence|Completed||N/A|2161|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||f||||||||||2017-10-11 04:49:03.334285|2017-10-11 04:49:03.334285
NCT00069381|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-24|2013-03-27|||April 2002||2002-04-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Treatment for Women With Post-Traumatic Stress Disorder Related to Childhood Abuse|Skills Training, Exposure, and Their Combination in Childhood Abuse PTSD|Completed||N/A|144|Actual|New York University School of Medicine||1|||f||||||||||||||2017-10-11 04:49:03.434432|2017-10-11 04:49:03.434432
NCT00069407|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-24|2014-12-12|||February 2003||2003-02-01|December 2014|2014-12-01|December 2006|Actual|2006-12-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major Depression|Comparing Three Electrode Placements to Optimize ECT|Completed||N/A|230|Actual|Rutgers, The State University of New Jersey||3|||f||||t||||||||||2017-10-11 04:49:03.496332|2017-10-11 04:49:03.496332
NCT00069420|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-24|2013-12-30|||September 2003||2003-09-01|December 2013|2013-12-01|May 2007|Actual|2007-05-01|January 2007|Actual|2007-01-01||Interventional|||Cognitive Motivational Behavior Therapy for Gamblers|Cognitive-Motivational Behavior Therapy for Gamblers|Completed||Phase 1|40||University at Albany|||||f||||f||||||||||2017-10-11 04:49:03.572518|2017-10-11 04:49:03.572518
NCT00069433|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-24|2013-09-23|||April 2001||2001-04-01|September 2013|2013-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Enhancing the Outcome of Skills Training for People With Schizophrenia|Skills Training for Schizophrenia: Enhancing Outcomes|Completed||N/A|60||New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 04:49:03.624757|2017-10-11 04:49:03.624757
NCT00069446|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-25|2017-05-09|||August 2003|Actual|2003-08-01|May 2017|2017-05-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers|An Exploratory, Double-Blind, Randomized, Placebo Controlled Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers|Completed||Phase 1|50||Genentech, Inc.|||||f||||||||||||||2017-10-11 04:49:03.683021|2017-10-11 04:49:03.683021
NCT00069459|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-25|2017-09-21|||September 23, 2003|Actual|2003-09-23|September 2017|2017-09-01|June 3, 2004|Actual|2004-06-03|June 3, 2004|Actual|2004-06-03||Interventional|||Seasonal Affective Depression (SAD) Study|A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up Phase|Completed||Phase 1|250|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 04:49:03.755499|2017-10-11 04:49:03.755499
NCT00069472|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-25|2015-09-09|||October 2002||2002-10-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|NARAC||Genetic Registry for Rheumatoid Arthritis|Genetics of Rheumatoid Arthritis Registry|Completed||N/A|1062|Actual|Northwell Health|||1||f||||f||||||Samples With DNA|"     DNA, plasma, serum and cells   "|||2017-10-11 04:49:03.910594|2017-10-11 04:49:03.910594
NCT00069485|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-26|2007-09-17|||December 1995||1995-12-01|July 2007|2007-07-01||||||||Observational|||Resistance to HIV Infection|Evaluation of HIV-Specific Immunological and Virological Responses of HIV-1 Multiply-Exposed Seronegative Individuals|Unknown status|Recruiting|N/A|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:49:04.047119|2017-10-11 04:49:04.047119
NCT00069498|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-26|2007-05-24|||October 1999||1999-10-01|July 2006|2006-07-01||||||||Interventional|||Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients|Impact of Co-Receptor and HIV Viral Burden on Gut Mucosa|Completed||Phase 1|14||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:49:04.138195|2017-10-11 04:49:04.138195
NCT00069511|ClinicalTrials.gov processed this data on October 10, 2017|2003-09-29|2005-06-23|||July 2003||2003-07-01|June 2004|2004-06-01|December 2004||2004-12-01|||||Interventional|||12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.||Unknown status|Active, not recruiting|Phase 2|72||Unither Pharmaceuticals|||||||||||||||||||2017-10-11 04:49:04.209425|2017-10-11 04:49:04.209425
NCT00075881|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2014-05-29|2012-03-08||January 2004||2004-01-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma|Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:49:04.307127|2017-10-11 04:49:04.307127
NCT00075894|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-09|2009-01-10|||March 2004||2004-03-01|August 2006|2006-08-01||||||||Interventional|||Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas|A Phase I/II, Open-Label, Non-Randomized, Multicenter, Single Agent Study Of Intravenous SDX-102 For The Treatment Of Patients With MTAP-Deficient High Grade Recurrent Malignant Gliomas|Completed||Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:04.865945|2017-10-11 04:49:04.865945
NCT00075920|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-11|2017-06-30|||January 8, 2004||2004-01-08|October 17, 2007|2007-10-17|October 17, 2007||2007-10-17|||||Observational|||Technical Development of Strain Rate Echocardiography|Technical Development of Strain Rate Echocardiography|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:05.107388|2017-10-11 04:49:05.107388
NCT00075933|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-12|2009-04-27|||September 2003||2003-09-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ARQ 501 in Subjects With Cancer|A Phase I Clinical, Pharmacokinetic Study of ARQ 501 in Subjects With Advanced Solid Tumors|Completed||Phase 1|80||ArQule|||||f||||||||||||||2017-10-11 04:49:05.166304|2017-10-11 04:49:05.166304
NCT00075946|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-12|2015-06-03|2015-02-09||November 2003||2003-11-01|June 2015|2015-06-01|September 2023|Anticipated|2023-09-01|September 2013|Actual|2013-09-01||Interventional||As the primary analysis only includes randomized patients, the baseline characteristics were provided among patients who were correctly randomized to one of the two arms for maintenance therapy.|Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma|Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens For Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 3|545|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-10-11 04:49:05.370839|2017-10-11 04:49:05.370839
NCT00075959|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-12|2013-01-03|||August 2004||2004-08-01|January 2013|2013-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke|CHANT (Cerebral Hemorrhage And NXY Treatment) A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter, Phase IIb Study to Assess the Safety and Tolerability of Intravenous Infusion of NXY-059 in Adult Patients With Acute Intracerebral Hemorrhage (ICH)|Completed||Phase 2|600||AstraZeneca|||||||||||||||||||2017-10-11 04:49:07.243569|2017-10-11 04:49:07.243569
NCT00075972|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-12|2015-06-25|||March 2003||2003-03-01|June 2015|2015-06-01|March 2006||2006-03-01|||||Interventional|||Mood and Smoking: A Comparison of Smoking Cessation Treatments|CSP #725 - Mood and Smoking: A Comparison of Smoking Cessation Treatments|Completed||N/A|128||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:49:07.410933|2017-10-11 04:49:07.410933
NCT00075985|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-12|2009-01-20|||May 2000||2000-05-01|April 2007|2007-04-01|April 2006||2006-04-01|||||Observational|||Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist|CSP #716B - The 80+ Hemorrhagic Cohort Study|Completed||N/A|700||VA Office of Research and Development|||||f||||||||||||||2017-10-11 04:49:07.465422|2017-10-11 04:49:07.465422
NCT00075998|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-12|2009-07-01|||December 2003||2003-12-01|July 2009|2009-07-01|May 2007|Actual|2007-05-01|||||Interventional|||The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (The INSPIRE Trial)|Terminated||Phase 3|826|Actual|InterMune||1||test drug showed lack of benefit at interim analysis|f||||t||||||||||2017-10-11 04:49:07.546935|2017-10-11 04:49:07.546935
NCT00076011|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-12|2012-06-20|2012-02-25||October 2003||2003-10-01|June 2012|2012-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma|Phase 2 Study of AG 013736 as Second-Line Treatment in Patients With Metastatic Renal Cell Cancer|Completed||Phase 2|52|Actual|Pfizer|||||f||||||||||||||2017-10-11 04:49:07.784118|2017-10-11 04:49:07.784118
NCT00076024|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-12|2012-06-21|2012-02-25|2009-03-20|February 2004||2004-02-01|June 2012|2012-06-01|November 2008|Actual|2008-11-01|January 2007|Actual|2007-01-01||Interventional|||AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer|Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study Of AG-013736 In Combination With Docetaxel Versus Docetaxel Alone In Patients With Metastatic Breast Cancer Preceded By A Phase 1 Evaluation Of The Combination|Completed||Phase 1/Phase 2|174|Actual|Pfizer|Analysis of TTP (Phase 2, Double-blind) was performed with both discontinuation due to lack of efficacy (LOE) considered a progression and not considered a progression event. Latter was considered primary analysis and former a sensitivity analysis.|2|||f||||t||||||||||2017-10-11 04:49:08.788481|2017-10-11 04:49:08.788481
NCT00076037|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-13|2015-03-03|||April 2004||2004-04-01|March 2015|2015-03-01|June 2006|Actual|2006-06-01|||||Interventional|||Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a CTL Multi-Epitope Peptide HIV Vaccine Formulated With RC529-SE, With or Without GM-CSF, in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|96|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:49:12.20926|2017-10-11 04:49:12.20926
NCT00076050|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-13|2016-10-12|2013-06-26||September 2003||2003-09-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|SPARE||Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms|Bone Sparing Effects of Soy Phytoestrogens in Menopause|Completed||Phase 3|248|Actual|University of Miami||2|||f||||t||||||||||2017-10-11 04:49:12.332118|2017-10-11 04:49:12.332118
NCT00076063|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-13|2015-03-12|||March 2004||2004-03-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines|A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC Prime/LIPO-5 Boost in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1/Phase 2|174|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-10-11 04:49:12.666546|2017-10-11 04:49:12.666546
NCT00076076|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-13|2016-12-01|||December 2003||2003-12-01|September 2016|2016-09-01|June 2005|Actual|2005-06-01|||||Interventional|||The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)|The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma|Completed||Phase 3|822||AstraZeneca|||||f||||||||||||||2017-10-11 04:49:12.782877|2017-10-11 04:49:12.782877
NCT00076089|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-13|2016-12-01|||December 2003||2003-12-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)|Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. A 52-week, Multicenter, Double-blind Study With 500 mcg Roflumilast Once Daily Versus Placebo.|Completed||Phase 3|1100||AstraZeneca|||||f||||||||||||||2017-10-11 04:49:12.917275|2017-10-11 04:49:12.917275
NCT00078052|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-17|2013-03-18|||September 2003||2003-09-01|March 2013|2013-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Genetic Markers of Coronary Heart Disease in Type 2 Diabetes||Completed||N/A|120000|Actual|Harvard School of Public Health|||1||f||||||||||Samples With DNA|"     Plasma and buffy coat   "|||2017-10-11 04:49:16.433759|2017-10-11 04:49:16.433759
NCT00076102|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-13|2013-03-11|2012-01-04||January 2004||2004-01-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas|Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas|Completed||Phase 2|36|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:49:13.208878|2017-10-11 04:49:13.208878
NCT00076115|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-14|2011-06-06|||December 2003||2003-12-01|April 2010|2010-04-01|December 2005|Actual|2005-12-01|||||Interventional|||Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents|Research on the Effectiveness of Risperidone in Bipolar Disorder in Adolescents and Children (REACH): A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Risperidone for the Treatment of Acute Mania in Bipolar I Disorder|Completed||Phase 3|13|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:49:13.728126|2017-10-11 04:49:13.728126
NCT00076141|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-14|2017-08-18|||January 1, 2002|Actual|2002-01-01|August 2017|2017-08-01|January 1, 2021|Anticipated|2021-01-01|January 1, 2014|Actual|2014-01-01||Observational|ACTIVE Health||Relatively Healthy Male Veterans Observed Over Time to See What Types of Diseases Develop|CSP #499A - Selenium and Vitamin E Cancer Prevention Trial - COHORT|Active, not recruiting||N/A|991|Anticipated|VA Office of Research and Development|||1||f||||f|f|f|||f|Samples With DNA|"     PE and buffy coat   "|||2017-10-11 04:49:13.803095|2017-10-11 04:49:13.803095
NCT00076154|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-14|2014-04-18|||January 2003||2003-01-01|April 2014|2014-04-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Observational|ALS Registry||National Registry of Veterans With Amyotrophic Lateral Sclerosis and DNA Bank|CSP #500A - National Registry of Veterans With Amyotrophic Lateral Sclerosis|Completed||N/A|2121|Actual|VA Office of Research and Development|||1||f||||f||||||Samples With DNA|"     DNA samples or blood or mouthwash were collected in veterans' homes by nurses.   "|||2017-10-11 04:49:13.899601|2017-10-11 04:49:13.899601
NCT00076180|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-14|2017-10-05|||January 6, 2004||2004-01-06|March 2, 2017|2017-03-02|November 12, 2010|Actual|2010-11-12|November 12, 2010|Actual|2010-11-12||Interventional|||Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia|Phase I Open-Label Single-Dose Study of Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward the IL-2R/IL-15R-Beta Subunit (CD122) in T Cell Large Granular Lymphocytic Leukemia|Completed||Phase 1|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:49:13.962582|2017-10-11 04:49:13.962582
NCT00076206|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-15|2015-12-07|||December 2003||2003-12-01|December 2015|2015-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy|A Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Efficacy and Safety of 3 Different Oral Dose Levels (1, 2, And 4 Mg) of CCI-779 in Subjects With Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy|Terminated||Phase 2|||Wyeth is now a wholly owned subsidiary of Pfizer||4|||||||||||||||||2017-10-11 04:49:14.062191|2017-10-11 04:49:14.062191
NCT00076219|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-15|2013-08-16|2013-06-12||October 2003||2003-10-01|August 2013|2013-08-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|ATN||Acute Renal Failure Trial Network (ATN) Study|CSP #530 - Intensive vs. Conventional Renal Support in Acute Renal Failure|Completed||Phase 3|1124|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:49:14.313924|2017-10-11 04:49:14.313924
NCT00076232|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-15|2010-12-29|||April 2005||2005-04-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir for the Reduction of HIV Acquisition Among High-Risk HSV-2 Seropositive, HIV Seronegative Individuals|Completed||Phase 3|3682|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:49:15.299892|2017-10-11 04:49:15.299892
NCT00076245|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-16|2014-06-24|2014-02-24||November 2002||2002-11-01|June 2014|2014-06-01|November 2005|Actual|2005-11-01|February 2004|Actual|2004-02-01||Interventional|||Cognitive Behavioral Therapy for the Treatment of Seasonal Affective Disorder (SAD)|Cognitive Behavioral Approaches to Seasonal Depression|Completed||Phase 1|61|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||4|||f||||f||||||||||2017-10-11 04:49:15.511933|2017-10-11 04:49:15.511933
NCT00077987|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-13|2007-01-09|||December 2003||2003-12-01|October 2005|2005-10-01|April 2005||2005-04-01|||||Interventional|||Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.|A Phase II Study Of SU011248 In Patients With Metastatic Colorectal Cancer Who Have Previously Failed Treatment With Irinotecan, Oxaliplatin, And A Fluoropyrimidine, With And Without Bevacizumab|Completed||Phase 2|84||Pfizer|||||f||||||||||||||2017-10-11 04:49:16.0278|2017-10-11 04:49:16.0278
NCT00078000|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-13|2008-11-24|||March 2004||2004-03-01|November 2008|2008-11-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.|A Phase 2 Study Of The Efficacy And Safety Of SU011248 In Patients With Metastatic Breast Cancer|Completed||Phase 2|64|Actual|Pfizer|||||f||||||||||||||2017-10-11 04:49:16.099684|2017-10-11 04:49:16.099684
NCT00078013|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-13|2005-06-23|||April 2003||2003-04-01|March 2005|2005-03-01|August 2004||2004-08-01|||||Interventional|||MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Examine the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Standard Therapy With Primary PCI in Patients Diagnosed as Having an ST Elevation Acute Myocardial Infarction|Completed||Phase 2|414||Mitsubishi Tanabe Pharma Corporation|||||||||||||||||||2017-10-11 04:49:16.195178|2017-10-11 04:49:16.195178
NCT00078026|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-16|2014-02-04|||August 2003||2003-08-01|February 2014|2014-02-01|December 2004||2004-12-01|||||Interventional|||An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass|A Phase I/II Randomized Study of the Short-Term Effects of APOMINE vs Placebo in Postmenopausal Women With Osteoporosis or Low Bone Mass|Terminated||Phase 1/Phase 2|60||Sanofi|||||||||||||||||||2017-10-11 04:49:16.273284|2017-10-11 04:49:16.273284
NCT00078039|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-17|2011-06-06|||March 2004||2004-03-01|April 2010|2010-04-01|January 2005|Actual|2005-01-01|||||Interventional|||Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia|Randomized, Double-blind, Placebo- and Active-controlled Parallel Group, Dose-response Study to Evaluate the Efficacy and Safety of 3 Fixed Dosages of Paliperidone Extended Release (6, 9, and 12 mg/Day) and Olanzapine (10 mg/Day) With Open-label Extension in Treatment of Schizophrenia|Completed||Phase 3|630|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:49:16.358234|2017-10-11 04:49:16.358234
NCT00078065|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-18|2005-11-10|||November 2003||2003-11-01|March 2005|2005-03-01|June 2004||2004-06-01|||||Interventional|||Xcellerated T CellsTM in Patients With Multiple Myeloma|A Randomized Phase II Study of Xcellerated T CellsTM With or Without Prior Fludarabine Therapy in Patients With Multiple Myeloma|Completed||Phase 2|30||Xcyte Therapies|||||||||||||||||||2017-10-11 04:49:16.499392|2017-10-11 04:49:16.499392
NCT00078078|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-18|2017-10-05|||February 17, 2004||2004-02-17|February 24, 2017|2017-02-24||||||||Observational|||Clinical and Laboratory Study of Methylmalonic Acidemia|Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:16.587148|2017-10-11 04:49:16.587148
NCT00078091|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-18|2017-10-05|||February 17, 2004||2004-02-17|February 5, 2016|2016-02-05|February 5, 2016||2016-02-05|||||Observational|||Genetics and Clinical Characteristics of Bardet-Biedl Syndrome|Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics|Terminated||N/A|194|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:16.683697|2017-10-11 04:49:16.683697
NCT00078104|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-18|2008-03-03|||February 2004||2004-02-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Prostanoid Levels After Medication to Prevent Pain Following Third Molar (Wisdom Tooth) Extraction|Proinflammatory Gene Expression and Prostanoid Levels in a Clinical Model of Tissue Injury|Completed||Phase 2|148||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:16.775233|2017-10-11 04:49:16.775233
NCT00078117|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-19|2017-01-11|||June 2003||2003-06-01|April 2010|2010-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1|Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules|Completed||Phase 3|516||National Institute on Drug Abuse (NIDA)|||||||||t||||||||||2017-10-11 04:49:16.848364|2017-10-11 04:49:16.848364
NCT00078130|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-19|2017-01-11|||July 2003||2003-07-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1|Bup/Nx - Facilitated Rehab for Opioid Dependent Adolescents|Completed||Phase 3|223||National Institute on Drug Abuse (NIDA)|||||||||t||||||||||2017-10-11 04:49:16.950676|2017-10-11 04:49:16.950676
NCT00078143|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-19|2017-01-11|||October 2003||2003-10-01|October 2016|2016-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1|Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users|Completed||Phase 3|200||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:49:17.026668|2017-10-11 04:49:17.026668
NCT00078156|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-19|2017-01-11|||January 2004||2004-01-01|October 2016|2016-10-01|October 2005||2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Women's Treatment for Trauma and Substance Use Disorders - 1|Women's Treatment for Trauma and Substance Use Disorders|Completed||Phase 3|409||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:49:17.100282|2017-10-11 04:49:17.100282
NCT00078169|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-19|2017-01-11|||November 2003||2003-11-01|October 2016|2016-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Motivational Enhancement for Spanish Speaking Individuals - 1|Motivational Enhancement for Spanish Speaking Individuals|Completed||Phase 3|463||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:49:17.173626|2017-10-11 04:49:17.173626
NCT00078182|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-19|2016-12-13||||||May 2005|2005-05-01||||||||Interventional|||Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia|Study of Daily Oral Tenofovir (Tenofovir Disoproxil Fumarate) to Prevent HIV-1 Infection Among Sex Workers in Cambodia|Withdrawn||Phase 2/Phase 3|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:49:17.268608|2017-10-11 04:49:17.268608
NCT00078195|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-19|2016-10-14|||April 2003||2003-04-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies|Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered With Omalizumab, an Anti-IgE Monoclonal Antibody (ITN019AD)|Completed||Phase 2|168||National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in: 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research data sharing portal.|2017-10-11 04:49:17.499145|2017-10-11 04:49:17.499145
NCT00078208|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-19|2017-06-30|||February 18, 2004||2004-02-18|August 19, 2010|2010-08-19|August 19, 2010||2010-08-19|||||Observational|||Exhaled Breath Condensate as a Measure of Airway Inflammation in Children With Asthma|Exhaled Breath Condensate as a Measurement of Airway Inflammation in Children With Asthma|Completed||N/A|128|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:17.622734|2017-10-11 04:49:17.622734
NCT00078221|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-20|2008-05-08|||August 1999||1999-08-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)||Unknown status|Active, not recruiting|Phase 3|180||OccuLogix|||||||||||||||||||2017-10-11 04:49:17.682728|2017-10-11 04:49:17.682728
NCT00078234|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-20|2011-11-04|||November 2003||2003-11-01|May 2009|2009-05-01|September 2010|Actual|2010-09-01|September 2008|Actual|2008-09-01||Interventional|||Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia|A Pilot Study of Genasense® (G3139, Oblimersen Sodium, Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated Subjects With Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|25|Actual|Genta Incorporated||1|||f||||||||||||||2017-10-11 04:49:17.763351|2017-10-11 04:49:17.763351
NCT00078247|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-20|2010-08-10|||October 2004||2004-10-01|August 2010|2010-08-01||||||||Interventional|||Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis|Delaying HIV Disease Progression With Punctuated Antiretroviral Therapy in HIV-Associated Tuberculosis|Completed||Phase 3|350|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:49:17.837774|2017-10-11 04:49:17.837774
NCT00078442|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-25|2009-08-06|||May 2006||2006-05-01|August 2009|2009-08-01||||January 2007|Actual|2007-01-01||Interventional|||Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People|A Phase II Open-Label Pilot Trial of the Antiretroviral Activity, Safety, and Tolerability of Pegylated Interferon Alfa-2A (40KD) [PegasysTM] in HIV-1 Infected Subjects|Completed||Phase 2|12|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:49:22.514674|2017-10-11 04:49:22.514674
NCT00078260|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-20|2016-11-21|||December 2003||2003-12-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|October 2006|Actual|2006-10-01||Interventional|||A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer|A Randomized Phase 3 Study of Two Doses of Alimta in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy|Completed||Phase 3|589|Actual|Eli Lilly and Company||2|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 04:49:17.939209|2017-10-11 04:49:17.939209
NCT00078273|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-20|2013-12-10|||July 2003||2003-07-01|December 2013|2013-12-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Indicated Prevention With At-Risk Gamblers|Indicated Prevention With At-Risk Gamblers|Completed||Phase 2|225|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 04:49:18.041744|2017-10-11 04:49:18.041744
NCT00078286|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-20|2013-01-23|2009-05-11||November 2003||2003-11-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|SADHART-CHF||Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure|Safety and Efficacy of Sertraline for Depression CHF|Completed||Phase 2/Phase 3|469|Actual|Duke University|NFS may have limited our ability to detect effect of sertraline on depression scores. Dropout rate was higher than expected. A 12-week duration of therapy may have been insufficient to show potential effects of sertraline on clinical outcomes.|2|||f||||t||||||||||2017-10-11 04:49:18.146571|2017-10-11 04:49:18.146571
NCT00078299|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-20|2008-03-03|||February 2004||2004-02-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Evaluation of the Age-Related Eye Disease Study (AREDS) Clinical Lens Grading System|Evaluation of the Age-Related Eye Disease Study (AREDS) Clinical Lens Grading System|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:18.55777|2017-10-11 04:49:18.55777
NCT00078312|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-23|2013-07-12|2009-06-01||January 2004||2004-01-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder|A 12-Month, Open-Label, Flexible-Dosage (100 to 250 mg/Day) Study of the Safety and Efficacy of CEP-10953 in the Treatment of Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (With an Open-Ended Extension Period)|Completed||Phase 3|328|Actual|Teva Pharmaceutical Industries|||||||||f||||||||||2017-10-11 04:49:18.649568|2017-10-11 04:49:18.649568
NCT00078325|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-23|2013-07-12|2009-06-01||February 2004||2004-02-01|July 2013|2013-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)|A 12 Week, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CEP 10953 (150 and 250 mg/Day) as Treatment for Adults With Residual Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|395|Actual|Teva Pharmaceutical Industries||3|||||||f||||||||||2017-10-11 04:49:19.438287|2017-10-11 04:49:19.438287
NCT00078351|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-23|2008-03-03|||February 2004||2004-02-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Synvisc to Treat Osteoarthritis of the Temporomandibular Joint|The Effects of Viscosupplementation Using Synvisc in Symptomatic Osteoarthritis of the Temporomandibular Joint|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:20.198668|2017-10-11 04:49:20.198668
NCT00078364|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-23|2008-03-03|||February 2004||2004-02-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Pain Pathways in the Brain|Imaging Neural Mechanisms Underlying Pain Modulation|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:20.271976|2017-10-11 04:49:20.271976
NCT00078377|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-24|2013-07-12|2009-06-01||March 2004||2004-03-01|July 2013|2013-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of CEP-10953 (150 and 250 mg/Day) as Treatment for Adults With Excessive Sleepiness Associated With Narcolepsy|Completed||Phase 3|196|Actual|Teva Pharmaceutical Industries||3|||||||||||||||||2017-10-11 04:49:20.343106|2017-10-11 04:49:20.343106
NCT00078390|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-24|2005-06-23|||February 2003||2003-02-01|December 2004|2004-12-01||||||||Interventional|||Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer|A Phase I/II Study of the Safety, Pharmacokinetic Interaction and Efficacy of S-3304 in Combination With Standard Therapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.|Unknown status|Active, not recruiting|Phase 1/Phase 2|90||Shionogi|||||||||||||||||||2017-10-11 04:49:20.770586|2017-10-11 04:49:20.770586
NCT00078403|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-24|2016-11-30|2010-11-05||July 2004||2004-07-01|November 2016|2016-11-01|February 2009|Actual|2009-02-01|May 2007|Actual|2007-05-01||Interventional||All Arm A, B and C participants.|Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)|Suppressive Long-Term Antiviral Management of Hepatitis C Virus (HCV) and HIV-1 Coinfected Subjects (SLAM-C)|Completed||Phase 2|333|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 04:49:20.897079|2017-10-11 04:49:20.897079
NCT00078429|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-25|2008-07-23|||July 2003||2003-07-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Molecular Epidemiology of Myocardial Infarction and Stroke in Older Adults - Ancillary to CHS||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:49:22.47327|2017-10-11 04:49:22.47327
NCT00079703|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-10|2016-07-28|||September 2002||2002-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Diet, Genetics, and CVD Risk Factor Response in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:49:49.527998|2017-10-11 04:49:49.527998
NCT00078455|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-25|2015-03-04|||December 2003||2003-12-01|March 2015|2015-03-01|August 2005|Actual|2005-08-01|||||Interventional|||Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma|A Phase II Study of ILX651 Administered Intravenously Daily for Five Consecutive Days Once Every 3 Weeks in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma|Completed||Phase 2|||Sanofi|||||||||||||||||||2017-10-11 04:49:22.639681|2017-10-11 04:49:22.639681
NCT00078468|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-27|2006-11-08|||December 2003||2003-12-01|August 2006|2006-08-01|September 2004||2004-09-01|||||Interventional|||Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment|A Phase 2 Open-Label Multicenter Study Of The Garft Inhibitor AG2037 In Patients With Metastatic Colorectal Cancer Who Failed Treatment With A 5-Fluorouracil/Leucovorin Regimen.|Completed||Phase 2|56||Pfizer|||||f||||||||||||||2017-10-11 04:49:22.714074|2017-10-11 04:49:22.714074
NCT00078481|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-27|2008-03-03|||February 2004||2004-02-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia|Phase 1B Clinical Trial to Establish the Safety and Tolerability of a Multiple-Dose Regimen of Idebenone Administered to Patients With Friedreich's Ataxia|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:22.789759|2017-10-11 04:49:22.789759
NCT00078494|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-27|2008-03-03|||February 2004||2004-02-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer|Phase I/II Trial of Latent Membrane Protein (LMP) - 2 Immunization for the Assessment of the Natural History and the Immunization-Induced Immunological Response in Patients at High Risk for Recurrence of Anaplastic Nasopharyngeal Cancer|Completed||Phase 1|99||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:22.8668|2017-10-11 04:49:22.8668
NCT00078507|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-01|2010-02-02|||December 2001||2001-12-01|February 2010|2010-02-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Sensory Re-Training Following Facial Surgery for Correction of Facial Skeletal Disharmony|Sensory Re-Training Following Orthognathic Surgery|Completed||Phase 3|186|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 04:49:22.945065|2017-10-11 04:49:22.945065
NCT00078520|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-01|2010-04-21|||January 2003||2003-01-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|CLIPA||Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells|Treatment of Chronic Lymphocytic B-Leukemia (B-CLL) With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (CLIPA)|Completed||Phase 1|21|Anticipated|Baylor College of Medicine||1|||t||||t||||||||||2017-10-11 04:49:23.022048|2017-10-11 04:49:23.022048
NCT00078533|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-01|2014-10-06|||April 2004||2004-04-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|VICTA||Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant|Virus Specific Cytotoxic T-Lymphocytes for the Treatment of CMV After Allogeneic Stem Cell Transplant: A Dose-Finding Trial|Completed||Phase 1|26|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:49:23.1088|2017-10-11 04:49:23.1088
NCT00078546|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-01|2012-07-27|||September 2003||2003-09-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|CLANC||EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)|Administration of EBV-Specific Cytotoxic T Lymphocytes Following CD45 Antibody to Patients With EBV Positive Nasopharyngeal Carcinoma|Completed||Phase 1|12|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:49:23.188379|2017-10-11 04:49:23.188379
NCT00078559|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-01|2012-07-25|2012-04-13||November 2003||2003-11-01|July 2012|2012-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults|Campath-1H/Tacrolimus/Sirolimus Withdrawal in Renal Transplantation (ITN013ST)|Completed||Phase 1/Phase 2|10|Actual|University of Wisconsin, Madison|The absence of a control group in this pilot trial precludes any comparison between alemtuzumab-induced patients with further minimization and patients with more conventional immunosuppressive approaches, and is a limitation of the current study|1|||f||||t||||||||||2017-10-11 04:49:23.303416|2017-10-11 04:49:23.303416
NCT00078585|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-01|2017-09-07|||November 2003||2003-11-01|September 2017|2017-09-01|January 2009|Actual|2009-01-01|January 4, 2006|Actual|2006-01-04||Interventional|||PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy|A Phase II Randomized, Double Blind, Controlled Study to Evaluate the Safety and Efficacy of PROSTVAC®-VF/TRICOM™ in Combination With GM-CSF in Patients With Androgen-Independent Adenocarcinoma of the Prostate|Completed||Phase 2|120||Bavarian Nordic|||||f||||||||||||||2017-10-11 04:49:24.200284|2017-10-11 04:49:24.200284
NCT00078598|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-01|2005-11-08|||April 2004||2004-04-01|October 2004|2004-10-01||||||||Interventional|||A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma|A Multi-Center, Randomized, Phase III Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 3|506||Corixa Corporation|||||||||||||||||||2017-10-11 04:49:24.353711|2017-10-11 04:49:24.353711
NCT00078611|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-01|2016-06-14|||March 2004||2004-03-01|March 2012|2012-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease|A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous Antegren(TM) (Natalizumab) in Subjects With Moderately to Severely Active Crohn's Disease With Elevated C-Reactive Protein|Completed||Phase 3|462||Biogen|||||||||||||||||||2017-10-11 04:49:24.484155|2017-10-11 04:49:24.484155
NCT00078624|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-03|2013-01-23|||April 2004||2004-04-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Knee Stability Training for Knee Osteoarthritis (OA)|Knee Stability Training in Individuals With Knee Osteoarthritis|Completed||Phase 2|231|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 04:49:24.66688|2017-10-11 04:49:24.66688
NCT00154986|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||August 2004||2004-08-01|April 2004|2004-04-01|July 2005||2005-07-01|||||Interventional|||IGFBP-3 in Ovarian Cancer Invasion|Study of IGFBP-3 in the Ovarian Carcinoma Cell Invasion|Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.518011|2017-10-11 05:20:38.518011
NCT00078637|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-03|2014-12-19|||January 2004||2004-01-01|December 2014|2014-12-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Interventional|||Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma|Phase I and Pharmacokinetic Study of E7820 After Oral Administration to Patients With Malignancy|Completed||Phase 1|37|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 04:49:24.750417|2017-10-11 04:49:24.750417
NCT00078663|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-03|2017-06-30|||March 2, 2004||2004-03-02|August 16, 2011|2011-08-16|August 16, 2011|Actual|2011-08-16|December 28, 2007|Actual|2007-12-28||Interventional|||Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients|The Effect of a Systemic Oral Care Program on Reducing Exposure to Oropharyngeal Pathogens in Critically III Patients|Completed||Phase 3|800|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:49:24.803546|2017-10-11 04:49:24.803546
NCT00078689|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-04|2017-06-30|||March 3, 2004||2004-03-03|July 18, 2008|2008-07-18|July 18, 2008||2008-07-18|||||Interventional|||Daclizumab and Sirolimus to Treat Uveitis|Combination Daclizumab/Sirolimus Therapy For the Induction of Immune Tolerance in Non-Infectious Intermediate and Posterior Uveitis|Completed||Phase 1|6||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:49:24.867225|2017-10-11 04:49:24.867225
NCT00078715|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-04|2012-08-16|2012-06-07||March 2004||2004-03-01|August 2012|2012-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Rapid Antidepressant Effects of Yohimbine in Major Depression|An Investigation of a Pharmacologic Strategy to Bring About Rapid (Next Day) Antidepressant Effects|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 04:49:24.940866|2017-10-11 04:49:24.940866
NCT00078728|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-05|2014-03-18|2013-10-24||September 2003||2003-09-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Family-Based Prevention Program for Childhood Anxiety|Family-Based Prevention for Childhood Anxiety|Completed||N/A|40|Actual|Johns Hopkins University|Of the 40 participants in the study, no adverse events occured or were reported.|2|||f||||t||||||||||2017-10-11 04:49:25.157327|2017-10-11 04:49:25.157327
NCT00078741|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-05|2015-08-07|||January 2004||2004-01-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|March 2006|Actual|2006-03-01||Interventional|||Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness|CBT for PTSD and SMI in Community Mental Health Centers|Completed||Phase 2|60||Medical University of South Carolina|||||f||||||||||||||2017-10-11 04:49:25.541261|2017-10-11 04:49:25.541261
NCT00078754|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-05|2014-12-29|2014-02-19||May 2003||2003-05-01|December 2014|2014-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder|Fluoxetine and Divalproex: Treatment Correlates in IED|Completed||Phase 2|90|Actual|University of Chicago||3|||f||||t||||||||||2017-10-11 04:49:25.617468|2017-10-11 04:49:25.617468
NCT00078767|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-05|2017-04-03|2017-02-08||April 2001||2001-04-01|April 2017|2017-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Pharmacologic Treatment of PTSD in Sexually Abused Children|Pharmacologic Treatment of PTSD in Sexually Abused Children|Completed||Phase 3|24|Actual|Allegheny Singer Research Institute||2|||f||||t||||||||||2017-10-11 04:49:25.959662|2017-10-11 04:49:25.959662
NCT00078793|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-05|2013-05-10|||June 2000||2000-06-01|May 2013|2013-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis|Phase IV Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis|Completed||N/A|600|Actual|Amgen|||1||f||||||||||||||2017-10-11 04:49:26.298445|2017-10-11 04:49:26.298445
NCT00078806|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-05|2009-04-30|||June 2001||2001-06-01|April 2009|2009-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis|Phase 3 Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis|Terminated||Phase 3|75|Anticipated|Amgen||2||the study was terminated because of slow enrollment|f||||||||||||||2017-10-11 04:49:26.375193|2017-10-11 04:49:26.375193
NCT00078819|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-05|2013-07-26|||August 2004||2004-08-01|July 2013|2013-07-01|June 2007|Actual|2007-06-01|February 2006|Actual|2006-02-01||Interventional|||Etanercept (Enbrel®) in Psoriasis - Pediatrics|Placebo-controlled Multicenter Study With Etanercept to Determine Safety and Efficacy in Pediatric Subjects With Plaque Psoriasis (PEDS)|Completed||Phase 3|211|Actual|Amgen||2|||f||||||||||||||2017-10-11 04:49:26.45529|2017-10-11 04:49:26.45529
NCT00078832|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2017-03-31|||September 2003||2003-09-01|March 2017|2017-03-01|January 2022|Anticipated|2022-01-01|December 2013|Actual|2013-12-01||Interventional|IBIS II||Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer|International Breast Cancer Intervention Study|Active, not recruiting||Phase 3|3864|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-10-11 04:49:26.610383|2017-10-11 04:49:26.610383
NCT00078845|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2012-10-16|||May 2004||2004-05-01|October 2012|2012-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors|Phase II Trial Of Subcutaneous Amifostine For Reversal Of Persistent Paclitaxel-Induced Peripheral Neuropathy|Completed||Phase 2|24|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:49:26.898427|2017-10-11 04:49:26.898427
NCT00078858|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2017-02-27|||September 2003||2003-09-01|February 2017|2017-02-01||||January 2006|Actual|2006-01-01||Interventional|||Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant|Prolonged Mycophenolate Mofetil and Truncated Cyclosporine Postgrafting Immunosuppression to Reduce Life-Threatening GVHD After Unrelated Donor Peripheral Blood Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-Center Trial|Active, not recruiting||Phase 1/Phase 2|37|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:49:27.040702|2017-10-11 04:49:27.040702
NCT00078897|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2016-05-18|||January 2001||2001-01-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|October 2015|Actual|2015-10-01||Interventional|||Selenium for Prevention of Adenomatous Colorectal Polyps|Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence|Active, not recruiting||Phase 3|1800|Anticipated|University of Arizona||2|||f||||t||||||||||2017-10-11 04:49:27.254102|2017-10-11 04:49:27.254102
NCT00078910|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-06-21|||August 2003||2003-08-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer|A Prospective Phase II Study of Preoperative, Controlled Exisulind Therapy Initiated Prior to Radical Prostatectomy: Effect on Apoptosis|Completed||Phase 2|130|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:27.38389|2017-10-11 04:49:27.38389
NCT00078923|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2014-03-04|||November 2001||2001-11-01|March 2014|2014-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate|Phase II Clinical Trial of Soy Isoflavones Prior to Radical Prostatectomy|Completed||Phase 2|32|Actual|Barbara Ann Karmanos Cancer Institute||4|||f||||t||||||||||2017-10-11 04:49:27.478361|2017-10-11 04:49:27.478361
NCT00078949|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2017-01-23|2014-09-17||August 2003||2003-08-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|May 2013|Actual|2013-05-01||Interventional||ITT population|Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase III Study Of Gemcitabine, Dexamethasone, And Cisplatin Compared To Dexamethasone, Cytarabine, And Cisplatin Plus/Minus Rituximab [(R)-GDP vs (R)-DHAP] As Salvage Chemotherapy For Patients With Relapsed Or Refractory Aggressive Histology Non-Hodgkin's Lymphoma Prior To Autologous Stem Cell Transplant And Followed By Maintenance Rituximab Versus Observation|Active, not recruiting||Phase 3|619|Actual|Canadian Cancer Trials Group||4|||f||||t||||||||||2017-10-11 04:49:27.602302|2017-10-11 04:49:27.602302
NCT00078962|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-01-23|||January 2004||2004-01-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Pharmacokinetics and Pharmacodynamic Study of GTI2040 in Combination With Gemcitabine in Patients With Solid Tumors|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:28.625732|2017-10-11 04:49:28.625732
NCT00078975|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2016-06-21|||April 2004||2004-04-01|June 2016|2016-06-01||||January 2009|Actual|2009-01-01||Interventional|||3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer|A Phase II Study of Triapine in Combination With Gemcitabine in Recurrent/Unresectable/Metastatic Pancreatic Carcinoma|Completed||Phase 2|26|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 04:49:28.706958|2017-10-11 04:49:28.706958
NCT00078988|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2015-05-06|||October 2004||2004-10-01|May 2015|2015-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas|A Phase III Randomized Trial for the Treatment of Pediatric High Grade Gliomas at First Recurrence With a Single High Dose Chemotherapy and Autologous Stem Cell Transplant Versus Three Courses of Intermediate Dose Chemotherapy With Peripheral Blood Stem Cell (PBSC) Support|Completed||Phase 3|1|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 04:49:28.824204|2017-10-11 04:49:28.824204
NCT00079001|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2016-10-27|2014-10-27||January 2004||2004-01-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|July 2012|Actual|2012-07-01||Interventional|||Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases|A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone|Completed||Phase 3|645|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:49:29.29414|2017-10-11 04:49:29.29414
NCT00079014|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-05-15|||January 2004||2004-01-01|May 2013|2013-05-01||||July 2008|Actual|2008-07-01||Interventional|||3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors|A Phase I Study of Triapine® in Combination With Doxorubicin in Refractory Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:33.012849|2017-10-11 04:49:33.012849
NCT00079027|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-12-17|||April 2004||2004-04-01|May 2007|2007-05-01||||||||Interventional|||Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)|A Randomized Clinical Trial Evaluating the Benefits of Doxorubicin Chemoembolization Versus Systemic Doxorubicin in Patients With Unresectable, Advanced Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 3|280|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:33.283508|2017-10-11 04:49:33.283508
NCT00079040|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2014-04-28|2009-11-19||January 2006||2006-01-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer|A Phase II Study of Cisplatin Plus Etoposide (PE) Plus Bevacizumab (NSC #704865) for Previously Untreated Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|65|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:33.410262|2017-10-11 04:49:33.410262
NCT00079053|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2016-11-25|||November 2003||2003-11-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|A Phase I Study of Adjuvant OSI-774 (Tarceva®) in Patients Following Combined Chemo-Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|20|Anticipated|Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-10-11 04:49:33.855143|2017-10-11 04:49:33.855143
NCT00079066|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-10-31|||August 2003||2003-08-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|March 2006|Actual|2006-03-01||Interventional|||Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer|A Phase III Randomized Study of Cetuximab (Erbitux™, C225) and Best Supportive Care Versus Best Supportive Care in Patients With Pretreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Positive Colorectal Carcinoma|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||||||||||||2017-10-11 04:49:33.949651|2017-10-11 04:49:33.949651
NCT00079079|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2016-11-25|||October 2003||2003-10-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor|A Phase II Study of Cisplatin and Gemcitabine in Patients With Locally Advanced/Recurrent or Metastatic Malignant Salivary Gland Tumors|Completed||Phase 2|34|Anticipated|Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-10-11 04:49:34.114067|2017-10-11 04:49:34.114067
NCT00079092|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2017-04-17|||January 2004|Actual|2004-01-01|August 2009|2009-08-01|March 21, 2006|Actual|2006-03-21|March 21, 2006|Actual|2006-03-21||Interventional|||Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma|A Phase II Trial Of Thalidomide And Procarbazine In Adults With Recurrent/Progressive Gliomas|Completed||Phase 2|18|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:49:34.20045|2017-10-11 04:49:34.20045
NCT00079105|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2017-03-29|||January 2004||2004-01-01|March 2017|2017-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years|A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years; Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Treating Older Patients With Hodgkin's Lymphoma|Completed||Phase 2|175|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||No|No IPD were shared, nor will be, for this trial.|2017-10-11 04:49:34.340823|2017-10-11 04:49:34.340823
NCT00079118|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2016-12-09|||April 2004||2004-04-01|December 2016|2016-12-01|December 2010|Actual|2010-12-01|February 2007|Actual|2007-02-01||Interventional|||Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer|Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer|Completed||Phase 2|70|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:49:34.571325|2017-10-11 04:49:34.571325
NCT00079131|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-06-03|||January 2004||2004-01-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||Oblimersen in Treating Patients With Merkel Cell Carcinoma|A Phase II Study of G3139 (Genasense ™) in Patients With Merkel Cell Carcinoma|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:35.08178|2017-10-11 04:49:35.08178
NCT00079144|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-06-18|||January 2004||2004-01-01|May 2005|2005-05-01|August 2005|Actual|2005-08-01|||||Interventional|||Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma|Treatment Of Patients With Metastatic Melanoma Using Nonmyeloablative But Lymphocyte Depleting Regimen Followed By The Administration Of In Vitro Sensitized Lymphocytes Reactive With ESO-1 Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:35.178853|2017-10-11 04:49:35.178853
NCT00079157|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2009-07-29|||February 2004||2004-02-01|July 2009|2009-07-01||||May 2008|Anticipated|2008-05-01||Interventional|||Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer|Phase I Study Of Telomerase Peptide Vaccination For Patients With Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 1|28|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:35.257643|2017-10-11 04:49:35.257643
NCT00079170|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-06-18|||January 2004||2004-01-01|October 2006|2006-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Pilot Study to Evaluate the Influence of Garlic on the Pharmacokinetics of Docetaxel in Patients With Metastatic Breast Cancer|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:35.330176|2017-10-11 04:49:35.330176
NCT00079183|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2017-05-23|2017-03-30||April 2002||2002-04-01|May 2017|2017-05-01|June 10, 2010|Actual|2010-06-10|July 2009|Actual|2009-07-01||Interventional||This includes all 44 consented subjects.|Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment|A Phase II Clinical Trial to Evaluate the Safety and Efficacy of Sirolimus for Secondary Treatment of Chronic Graft-versus-Host Disease|Completed||Phase 2|44|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||No||2017-10-11 04:49:35.414756|2017-10-11 04:49:35.414756
NCT00079222|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-01-07|||November 2003||2003-11-01|January 2013|2013-01-01||||April 2005|Actual|2005-04-01||Interventional|||Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation|Randomized Trial Of Safety And Tolerability Of Intravenous/Oral Voriconazole Versus Intravenous/Oral Itraconazole For Long-Term Antifungal Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplant Recipients|Completed||N/A|||Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:49:35.962004|2017-10-11 04:49:35.962004
NCT00079235|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-07-15|||February 2004||2004-02-01|June 2013|2013-06-01||||June 2007|Actual|2007-06-01||Interventional|||CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of the mTOR Inhibitor, CCI-779 in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:36.053472|2017-10-11 04:49:36.053472
NCT00079248|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2009-05-09|||March 2002||2002-03-01|June 2005|2005-06-01||||||||Interventional|||Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer|UK Trial Of Hormone Replacement Therapy (HRT) In Women With A History Of Early Stage Breast Cancer|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:36.136299|2017-10-11 04:49:36.136299
NCT00079261|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2012-09-20|||January 2004||2004-01-01|September 2012|2012-09-01||||March 2007|Actual|2007-03-01||Interventional|||Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma|Gem-CHOP: A Randomized Phase II Study of Gemcitabine Combined With CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|25|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:49:36.203438|2017-10-11 04:49:36.203438
NCT00079274|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2015-01-23|2013-12-05||February 2004||2004-02-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer|A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer|Completed||Phase 3|3397|Actual|National Cancer Institute (NCI)|Accrual to arms A and D terminated early based on the results of the planned 2nd interim analysis. Sample sizes limit statistical conclusions for data from the irinotecan treated patients as those treatment arms were discontinued early in the study.|7|||f||||t||||||||||2017-10-11 04:49:36.642488|2017-10-11 04:49:36.642488
NCT00079287|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-09-16|||March 2001||2001-03-01|April 2005|2005-04-01|November 2008|Actual|2008-11-01|||||Interventional|||Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:43.377389|2017-10-11 04:49:43.377389
NCT00079300|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-04-25|||January 2004||2004-01-01|April 2013|2013-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer|Double-Blind, Vehicle-Controlled Study to Evaluate Apoptosis in Basal Cell Carcinoma Treated With Aldara™ (Imiquimod) Cream, 5% Applied Once or Twice a Day|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:43.532512|2017-10-11 04:49:43.532512
NCT00079313|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2017-06-30|||January 14, 2004||2004-01-14|September 23, 2011|2011-09-23|October 25, 2010|Actual|2010-10-25|December 30, 2006|Actual|2006-12-30||Interventional|||Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia|A Pilot Study of the Safety and Efficacy of Imatinib in Reducing Monocytosis or Leukocytosis in Patients With Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia, Respectively|Completed||Phase 2|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:49:43.617554|2017-10-11 04:49:43.617554
NCT00079326|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2014-05-29|2013-11-04||January 2004||2004-01-01|January 2013|2013-01-01|October 2010|Actual|2010-10-01|July 2008|Actual|2008-07-01||Interventional|||Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer|A Phase 2 Study of Trastuzumab in Combination With BMS-247550 in Women With Metastatic Breast Cancer|Terminated||Phase 2|39|Actual|National Cancer Institute (NCI)||1||Slow accrual.|f||||||||||||||2017-10-11 04:49:43.708108|2017-10-11 04:49:43.708108
NCT00079339|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2014-04-29|2010-04-30||January 2004||2004-01-01|December 2012|2012-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma|Phase I/II Trial of R115777 and XRT in Pediatric Patients With Newly Diagnosed Non-Disseminated Intrinsic Diffuse Brainstem Gliomas|Completed||Phase 1/Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:44.023405|2017-10-11 04:49:44.023405
NCT00079352|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-01-24|||April 2004||2004-04-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors|A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:45.229802|2017-10-11 04:49:45.229802
NCT00079365|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-12-03|||May 2001||2001-05-01|May 2005|2005-05-01||||||||Interventional|||Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas|A Randomized Trial Comparing 5-Fluorouracil, External Beam Radiation, and Gemcitabine With or Without P Radiopharmaceutical Therapy As A First Line Therapy in Patients With Locally/Regionally Advanced Non-Resectable Adenocarcinoma of the Pancreas|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:49:45.325483|2017-10-11 04:49:45.325483
NCT00079378|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-09-27|||February 2004||2004-02-01|September 2013|2013-09-01||||May 2011|Actual|2011-05-01||Interventional|||Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Selected Hematologic Malignancies|Completed||Phase 1|84|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:45.391012|2017-10-11 04:49:45.391012
NCT00079391|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2015-10-05|2011-04-20||January 2004||2004-01-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|December 2008|Actual|2008-12-01||Interventional|||Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies|Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peri-transplant Cyclosporine on Chimerism|Completed||Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:49:45.485164|2017-10-11 04:49:45.485164
NCT00079404|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-06-03|||March 2004||2004-03-01|June 2013|2013-06-01||||May 2006|Actual|2006-05-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia|A Phase I Study of 17-AAG in Relapsed/Refractory Pediatric Patients With Solid Tumors or Leukemia|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:45.87653|2017-10-11 04:49:45.87653
NCT00079417|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2017-02-07|2013-12-23||December 2005||2005-12-01|February 2017|2017-02-01|January 2010||2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma|Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma|Completed||Phase 3|28|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:49:45.953387|2017-10-11 04:49:45.953387
NCT00079430|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2014-06-18|||June 2004||2004-06-01|June 2014|2014-06-01||||May 2011|Actual|2011-05-01||Interventional|||Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Dose-Escalating Phase I Study With an Expanded Cohort to Assess the Feasibility of Intraperitoneal Carboplatin (NSC #214240) and Intravenous Paclitaxel (NSC # 673089) and Intravenous Paclitaxel, Intraperitoneal Carboplatin and NCI Supplied Intravenous Bevacizumab (NSC #704865) in Patients With Previously Untreated Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma|Completed||Phase 1|113|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:46.17199|2017-10-11 04:49:46.17199
NCT00079443|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-06-28|||January 2004||2004-01-01|June 2013|2013-06-01||||September 2005|Actual|2005-09-01||Interventional|||FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma|A Phase II Study of Single Agent Depsipeptide (NSC 630176) Followed by a Phase I Study of Rituximab/Fludarabine Combination With an Escalating Dose of Depsipeptide in Relapsed or Refractory Low Grade B Cell Lymphomas|Terminated||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:46.310328|2017-10-11 04:49:46.310328
NCT00079456|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2013-10-10|||February 2004||2004-02-01|October 2013|2013-10-01||||February 2007|Actual|2007-02-01||Interventional|||Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Trial of CCI-779 in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:49:46.415858|2017-10-11 04:49:46.415858
NCT00079469|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2012-03-07|||February 2004||2004-02-01|March 2012|2012-03-01|August 2004|Actual|2004-08-01|||||Interventional|||Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke|Contingency Management to Enhance Smoking Cessation for Cancer Survivors: A Proof of Concept Trial|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:46.508846|2017-10-11 04:49:46.508846
NCT00073190|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-17|2013-12-13|||September 2003||2003-09-01|December 2013|2013-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Patient- and Physician-Based Osteoporosis Education|Randomized Controlled Testing of Osteoporosis Education|Completed||Phase 1|30000||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 04:50:12.932525|2017-10-11 04:50:12.932525
NCT00079482|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2016-07-19||2013-08-27|October 2003||2003-10-01|July 2016|2016-07-01|January 2010|Actual|2010-01-01|March 2009|Actual|2009-03-01||Interventional|||Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)|A Randomized, Open-Label Study of Oral CEP-701 Administered in Sequence With Standard Chemotherapy to Patients With Relapsed Acute Myeloid Leukemia (AML) Expressing FLT-3 Activating Mutations|Completed||Phase 2|224|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-10-11 04:49:46.579923|2017-10-11 04:49:46.579923
NCT00079495|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-08|2008-03-20|||July 2003||2003-07-01|September 2007|2007-09-01|April 2005||2005-04-01|||||Interventional|||Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of NBI-5788 in Patients With Relapsing Multiple Sclerosis|Completed||Phase 2|150||Neurocrine Biosciences|||||||||||||||||||2017-10-11 04:49:46.785718|2017-10-11 04:49:46.785718
NCT00079508|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2011-11-08|||April 2004||2004-04-01|November 2011|2011-11-01||||October 2005|Actual|2005-10-01||Interventional|HIT/TS||Angiomax in Patients With HIT/HITTS Type II Undergoing CPB|A Phase III Study of Angiomax (Bivalirudin) in Patients With HIT/HITTS Type II Undergoing Cardiac Surgery on Cardiopulmonary Bypass (CPB)|Completed||Phase 3|125|Actual|The Medicines Company||1|||f||||||||||||||2017-10-11 04:49:46.844184|2017-10-11 04:49:46.844184
NCT00079521|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2006-08-16|||March 2003||2003-03-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Therapeutic Touch for Wrist Fractures in Postmenopausal Women|The Effect of Therapeutic Touch on Bone Formation in Postmenopausal Women After Wrist Fracture|Completed||Phase 2|125||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:49:48.232196|2017-10-11 04:49:48.232196
NCT00079534|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2006-08-16|||December 2000||2000-12-01|August 2006|2006-08-01|December 2003||2003-12-01|||||Interventional|||Distant Healing for HIV/AIDS|"Distant Healing Efforts for AIDS by Nurses and Healers"|Completed||N/A|150||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:49:48.29073|2017-10-11 04:49:48.29073
NCT00079547|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2013-06-28|||April 2003||2003-04-01|January 2008|2008-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Safety and Effectiveness of Low and High Carbohydrate Diets|The Safety and Efficacy of Low and High Carbohydrate Diets|Completed||Phase 4|307|Actual|Temple University||2|||f||||t||||||||||2017-10-11 04:49:48.351927|2017-10-11 04:49:48.351927
NCT00079560|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2017-01-10|||December 2001||2001-12-01|October 2008|2008-10-01|August 2005|Actual|2005-08-01|August 2004|Actual|2004-08-01||Interventional|||Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS|THC and Marijuana--Effects in Individuals With HIV/AIDS|Completed||Phase 1/Phase 2|30|Actual|National Institute on Drug Abuse (NIDA)||1|||t||||f||||||||||2017-10-11 04:49:48.430802|2017-10-11 04:49:48.430802
NCT00079573|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2006-08-16|||July 2002||2002-07-01|August 2006|2006-08-01|June 2004||2004-06-01|||||Interventional|||Comparison of Popular Weight Loss Diets|Benefits & Risks of Popular Weight Loss Diets|Completed||Phase 2|300||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:49:48.493797|2017-10-11 04:49:48.493797
NCT00079586|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2012-01-04|||April 2004||2004-04-01|January 2012|2012-01-01|November 2004|Actual|2004-11-01|||||Interventional|||Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)|A Study Comparing Angiomax (Bivalirudin) to Heparin With Protamine Reversal in Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass (CPB)|Completed||Phase 3|150|Actual|The Medicines Company||2|||f||||||||||||||2017-10-11 04:49:48.558677|2017-10-11 04:49:48.558677
NCT00079599|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2008-09-02|||November 2002||2002-11-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||L-Carnitine to Treat Fatigue in AIDS Patients|Phase II Developmental Study on Fatigue in AIDS Patients|Completed||Phase 2|44|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-10-11 04:49:48.619324|2017-10-11 04:49:48.619324
NCT00079612|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2014-12-18|||September 2002||2002-09-01|December 2014|2014-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer|Randomized Discontinuation Study of BAY 43-9006 in Patients With Advanced Refractory Cancer.|Completed||Phase 2|501|Actual|Bayer||2|||f||||||||||||||2017-10-11 04:49:48.688537|2017-10-11 04:49:48.688537
NCT00079625|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-09|2017-10-05|||March 5, 2004||2004-03-05|August 9, 2013|2013-08-09|August 9, 2013|Actual|2013-08-09|August 9, 2013|Actual|2013-08-09||Interventional|||Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer|Allogeneic Breast Protocol 2: Phase I Trial of T Cell Exchange With Th2/Tc2 Cells for Allogeneic Stem Cell Transplantation After Reduced Intensity Conditioning for Metastatic Breast Cancer|Completed||Phase 1|22|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:49:48.777577|2017-10-11 04:49:48.777577
NCT00079638|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-10|2006-10-31|||April 2004||2004-04-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL|Comparative Efficacy Evaluation of Lipid Levels When Treated With Niaspan and Statin or Other Lipid-Modifying Therapies|Completed||Phase 4|300||Kos Pharmaceuticals|||||||||||||||||||2017-10-11 04:49:48.834918|2017-10-11 04:49:48.834918
NCT00079651|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-10|2013-11-21|||December 2002||2002-12-01|November 2013|2013-11-01|July 2005|Actual|2005-07-01|April 2005|Actual|2005-04-01||Interventional|||Montessori-Based Activities for Elderly Persons With Dementia|Programming for Dementia: Maximizing Abilities|Completed||Phase 2/Phase 3|300||Menorah Park|||||f||||t||||||||||2017-10-11 04:49:48.956776|2017-10-11 04:49:48.956776
NCT00079664|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-10|2013-09-30|||September 2001||2001-09-01|September 2013|2013-09-01|July 2003|Actual|2003-07-01|March 2002|Actual|2002-03-01||Interventional|||Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults|Tai Chi Training and Sleep Enhancement in the Elderly|Completed||Phase 1|100||Oregon Research Institute|||||f||||f||||||||||2017-10-11 04:49:49.08114|2017-10-11 04:49:49.08114
NCT00079677|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-10|2013-07-12|2009-06-01||March 2004||2004-03-01|July 2013|2013-07-01|October 2004||2004-10-01|||||Interventional|||Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of CEP-10953 (150 mg/Day) as Treatment for Adults With Residual Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|263|Actual|Teva Pharmaceutical Industries||2|||||||||||||||||2017-10-11 04:49:49.152683|2017-10-11 04:49:49.152683
NCT00079690|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-10|2016-07-28|||September 2002||2002-09-01|May 2009|2009-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Genetic Epidemiology of Blood Pressure Intervention||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:49:49.47505|2017-10-11 04:49:49.47505
NCT00079716|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-11|2014-12-17|||March 2004||2004-03-01|December 2014|2014-12-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma|A Phase I, Multi-Dose Study of SGN-40 (Anti-huCD40 mAb) in Patients With Refractory or Recurrent Multiple Myeloma|Completed||Phase 1|44|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-10-11 04:49:49.585584|2017-10-11 04:49:49.585584
NCT00079729|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-11|2012-10-26|||April 2004||2004-04-01|October 2012|2012-10-01|July 2004|Actual|2004-07-01|||||Observational|||Directly Observed Therapy in HIV Infected Adolescent Focus Groups|Directly Observed Therapy (DOT) in HIV-Infected Adolescents: Part A-Focus Groups|Completed||N/A|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:49:49.678091|2017-10-11 04:49:49.678091
NCT00079742|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-11|2008-06-05|||September 2003||2003-09-01|June 2008|2008-06-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis|A Phase II, Multicenter, Randomized, Controlled, Open-Label Study of the Safety and Efficacy of Nutropin AQ [Somatropin (DNA Origin) Injection] for the Treatment of Growth Restriction in Children With Cystic Fibrosis|Completed||Phase 2|68|Actual|Genentech, Inc.|||||||||||||||||||2017-10-11 04:49:49.744652|2017-10-11 04:49:49.744652
NCT00079755|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-12|2014-12-17|||February 2004||2004-02-01|December 2014|2014-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma|A Phase II Multi-Dose Study of SGN-30 (Anti-CD30 mAb) in Patients With Refractory or Recurrent Hodgkin's Disease or Anaplastic Large Cell Lymphoma|Completed||Phase 2|80||Seattle Genetics, Inc.|||||||||||||||||||2017-10-11 04:49:49.810596|2017-10-11 04:49:49.810596
NCT00079768|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-12|2010-06-16|||March 2004||2004-03-01|January 2009|2009-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Alemtuzumab to Treat Sporadic Inclusion Body Myositis|Effects of a T Cell-Depleting Monoclonal Antibody, Alemtuzumab, in Patients With Inclusion Body Myositis: A Pilot Clinicopathological Study|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:49:49.905855|2017-10-11 04:49:49.905855
NCT00079781|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-12|2013-12-23|2013-11-06|2012-01-23|January 2004||2004-01-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|May 2006|Actual|2006-05-01||Interventional||Date of birth was not provided for 5 subjects (4 in the Open Label Group and 1 in the Treatment Group), therefore baseline characteristics calculations requiring age/DOB were derived using an N = 60.|RNS® System Feasibility Study|RNS® System Feasibility Clinical Investigation|Completed||Phase 2|70|Actual|NeuroPace||3|||f||||t||||||||||2017-10-11 04:49:50.007419|2017-10-11 04:49:50.007419
NCT00079794|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-15|2008-01-23|||September 2001||2001-09-01|January 2008|2008-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Iscar for Supplemental Care in Stage IV Lung Cancer|Iscar for Supplemental Care in Stage IV Lung Cancer|Completed||Phase 2|36||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:49:51.012776|2017-10-11 04:49:51.012776
NCT00079807|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-15|2008-04-21|||September 2003||2003-09-01|April 2008|2008-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Painful HIV Neuropathy and Alpha-Lipoic Acid|Painful HIV Neuropathy: Treatment With Alpha-Lipoic Acid|Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:49:51.071259|2017-10-11 04:49:51.071259
NCT00079820|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-15|2014-01-09|||April 2004||2004-04-01|January 2014|2014-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults|The Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine, in Adults Without Previous Smallpox Vaccination|Completed||Phase 1|110|Actual|Sanofi||5|||f||||t||||||||||2017-10-11 04:49:51.130869|2017-10-11 04:49:51.130869
NCT00079833|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-16|2010-11-18|||November 2003||2003-11-01|November 2010|2010-11-01|July 2005|Actual|2005-07-01|||||Interventional|||Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome|A Phase III, Multicenter, Open-Label Study To Evaluate the Control of Gastric Acid Secretion With Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome For 12 Months|Completed||Phase 3|25||AstraZeneca|||||||||||||||||||2017-10-11 04:49:51.217967|2017-10-11 04:49:51.217967
NCT00079846|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-17|2005-06-23|||September 2003||2003-09-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy|Safety and Efficacy Study of Implitapide Compared With Placebo in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy|Terminated||Phase 2|60||Medical Research Laboratories International|||||||||||||||||||2017-10-11 04:49:51.302108|2017-10-11 04:49:51.302108
NCT00079859|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-17|2005-06-23|||October 2003||2003-10-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy|Safety and Efficacy Study of Implitapide Compared With Placebo in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy|Terminated||Phase 2|120||Medical Research Laboratories International|||||||||||||||||||2017-10-11 04:49:51.388927|2017-10-11 04:49:51.388927
NCT00079872|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-17|2007-11-05|||February 2004||2004-02-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer|A Randomized Phase 2 Trial of ALIMTA Plus a Comparator Versus Leucovorin Modulated Fluorouracil Plus a Comparator in First Line Treatment of Locally Advanced or Metastatic Colorectal Cancer|Completed||Phase 2|120||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:49:51.473908|2017-10-11 04:49:51.473908
NCT00079885|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-18|2013-02-07|||November 2003||2003-11-01|February 2013|2013-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia|A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Tigecycline Vs Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia|Completed||Phase 3|430|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:49:51.563952|2017-10-11 04:49:51.563952
NCT00079898|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-18|2008-01-23|||July 2002||2002-07-01|January 2008|2008-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Effect of Acupuncture on Human Brain Activity|Modulatory Effect of Acupuncture on Human Brain Activity|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:49:51.629194|2017-10-11 04:49:51.629194
NCT00079911|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-18|2017-08-03|||March 14, 2004|Actual|2004-03-14|August 2017|2017-08-01|October 15, 2004|Actual|2004-10-15|October 15, 2004|Actual|2004-10-15||Interventional|||A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons|An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons With CD4+ Lymphocyte Count <100 Cells/mm3.|Terminated||Phase 4|7|Actual|GlaxoSmithKline||2||Terminated|f|||||t|f||||||||2017-10-11 04:49:51.690753|2017-10-11 04:49:51.690753
NCT00079924|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-18|2007-05-23|||November 2004||2004-11-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Effects of Teriparatide in Postmenopausal Women With Osteoporosis|Effects of Teriparatide in Postmenopausal Women With Osteoporosis Previously Treated With Alendronate or Raloxifene|Completed||Phase 4|200||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:49:51.789597|2017-10-11 04:49:51.789597
NCT00079937|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-18|2012-04-09|2010-12-03||April 2004||2004-04-01|April 2012|2012-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma|A 1 Year, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Evaluation of Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Persistent, Inadequately Controlled Allergic Asthma|Completed||Phase 3|628|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:49:51.894077|2017-10-11 04:49:51.894077
NCT00079950|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-18|2012-09-05|||August 2003||2003-08-01|September 2012|2012-09-01||||||||Interventional|||Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma||Suspended||Phase 2|||Enzon Pharmaceuticals, Inc.|||||f||||||||||||||2017-10-11 04:49:52.536304|2017-10-11 04:49:52.536304
NCT00079963|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-18|2017-09-25|||April 2004||2004-04-01|September 2017|2017-09-01|March 24, 2008|Actual|2008-03-24|March 24, 2008|Actual|2008-03-24||Interventional|||Gender, Obesity, C-Reactive Protein, and Oxidative Stress|Gender, Obesity, C-Reactive Protein, and Oxidative Stress|Completed||N/A|396|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-10-11 04:49:52.5913|2017-10-11 04:49:52.5913
NCT00079976|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-19|2013-02-07|||October 2003||2003-10-01|February 2013|2013-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)|A Clinical Research Study to Evaluate the Safety and Efficacy of Tigecycline in the Treatment of Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)|Completed||Phase 3|174|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:49:52.669424|2017-10-11 04:49:52.669424
NCT00079989|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-19|2013-02-07|||December 2003||2003-12-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms|A Phase 3, Open-label, Noncomparative Study of Tigecycline for the Treatment of Subjects With Selected Serious Infections Due to Resistant Gram-negative Organisms Such as Enterobacter Species, Acinetobacter Baumannii, and Klebsiella Pneumoniae|Completed||Phase 3|115|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:49:52.842347|2017-10-11 04:49:52.842347
NCT00080002|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-19|2012-09-05|||December 2003||2003-12-01|March 2005|2005-03-01||||||||Interventional|||Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction|Effectiveness and Safety Study of Pegamotecan (PEG-Camptothecin) in Patients With Locally Advanced or Metastatic Cancer of the Stomach or Gastroesophageal Junction Who Have Relapsed or Progressed Following a Previous Chemotherapy Treatment|Terminated||Phase 2|||Enzon Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:49:52.916281|2017-10-11 04:49:52.916281
NCT00080015|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-19|2009-07-23|||March 2004||2004-03-01|July 2009|2009-07-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)|A Phase II Open Label Study Investigating the Activity of Diflomotecan (BN80915) Administered at the Fixed Dose of 7mg as a 20 Minute Intravenous Infusion Once Every 3 Weeks in Patients With Sensitive Small Cell Lung Cancer (SCLC) Who Have Failed First-line Treatment With a Platinum Based Regimen.|Completed||Phase 2|40||Ipsen|||||f||||||||||||||2017-10-11 04:49:52.967015|2017-10-11 04:49:52.967015
NCT00080028|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-22|2007-05-04||||||May 2007|2007-05-01||||||||Interventional|||Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer|Phase I Trial of Motexafin Gadolinium and Chemoradiation in Locally Advanced, Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 1|18||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 04:49:53.025914|2017-10-11 04:49:53.025914
NCT00080041|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-22|2007-05-11||||||May 2007|2007-05-01||||||||Interventional|||Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors|Phase I Trial of Motexafin Gadolinium (MGd) and Docetaxel Administered at 3-Week Intervals for Advanced Solid Tumors|Completed||Phase 1|20||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 04:49:53.086067|2017-10-11 04:49:53.086067
NCT00080054|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-22|2009-04-02||||||January 2007|2007-01-01||||||||Interventional|||A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas|Phase I Trial of Motexafin Gadolinium (MGd) in Combination With Temozolomide for Treatment of Malignant Gliomas|Completed||Phase 1|24||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 04:49:53.140399|2017-10-11 04:49:53.140399
NCT00080067|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-23|2017-06-30|||March 22, 2004||2004-03-22|February 23, 2009|2009-02-23|February 23, 2009||2009-02-23|||||Observational|||Rhythm Perception and Generation|fMRI Study on Mechanism of Rhythm Perception and Generation|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:49:53.198352|2017-10-11 04:49:53.198352
NCT00080080|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-23|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|||Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer|Phase 2 Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||Point Therapeutics|||||||||||||||||||2017-10-11 04:49:53.253887|2017-10-11 04:49:53.253887
NCT00080093|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-23|2008-09-25|||January 2006||2006-01-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|October 2007|Actual|2007-10-01||Interventional|||Increasing Condom Use in People at Risk for HIV Infection|Increasing Condom Use With a Stage-Matched Intervention|Unknown status|Active, not recruiting|N/A|534|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:49:53.327636|2017-10-11 04:49:53.327636
NCT00080106|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-23|2013-07-01||2009-08-12|June 2004||2004-06-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|September 2007|Actual|2007-09-01||Interventional|||Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients|A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Antiretroviral Effect of Immunization With the MRK Ad5 HIV-1 Gag Vaccine in HIV-1 Infected Individuals Who Interrupt Antiretroviral Therapy|Completed||Phase 2|114|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:49:53.408544|2017-10-11 04:49:53.408544
NCT00080119|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-23|2011-02-10|2010-07-01||February 2004||2004-02-01|February 2011|2011-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV|A Randomized, Double Blind, Placebo Controlled Trial to Determine the Efficacy of Isoniazid (INH) in Preventing Tuberculosis Disease and Latent Tuberculosis Infection Among Infants With Perinatal Exposure to HIV|Terminated||Phase 2/Phase 3|1354|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|"DSMB recommended stopping study due to futility: no compelling reason to enroll additional infants or to continue to treat participants with the blinded study medication. Week 192 analyses not done as <4% (26%) of HIVpos (HIVneg) reached wk 192"|4||Data Safety Monitoring Board (DSMB) recommended stopping study due to futility|f||||t||||||||||2017-10-11 04:49:53.580158|2017-10-11 04:49:53.580158
NCT00080132|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-23|2005-06-23|||October 2004||2004-10-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy|An Open-Label, Dose-Escalating Efficacy and Safety Study of Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy|Terminated||Phase 2|50||Medical Research Laboratories International|||||||||||||||||||2017-10-11 04:49:55.386989|2017-10-11 04:49:55.386989
NCT00080145|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-24|2013-08-15|||February 2004||2004-02-01|August 2013|2013-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders|Risperidone and Behavioral Therapy in Treatment of Children and Adolescents With Autistic Disorder|Completed||N/A|124|Actual|Yale University||2|||f||||t||||||||||2017-10-11 04:49:55.447042|2017-10-11 04:49:55.447042
NCT00080158|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-24|2013-11-01|||March 2004||2004-03-01|July 2008|2008-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Treatment of Adolescent Suicide Attempters (TASA)||Completed||Phase 2/Phase 3|120||New York State Psychiatric Institute|||||f||||||||||||||2017-10-11 04:49:55.541077|2017-10-11 04:49:55.541077
NCT00080171|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-24|2009-03-31|||February 2004||2004-02-01|March 2009|2009-03-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Osteoarthritis Initiative (OAI): A Knee Health Study|Osteoarthritis Initiative (OAI): A Knee Health Study|Unknown status|Active, not recruiting|N/A|5000|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||||||||Samples With DNA|"     Blood, urine   "|||2017-10-11 04:49:55.633891|2017-10-11 04:49:55.633891
NCT00080184|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-24|2006-08-16|||December 2003||2003-12-01|August 2006|2006-08-01|May 2006||2006-05-01|||||Interventional|||Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia|Effectiveness of EEG Biofeedback in the Treatment of Fibromyalgia|Completed||Phase 1/Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:49:55.704512|2017-10-11 04:49:55.704512
NCT00080197|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-24|2006-10-10|||February 2004||2004-02-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients|An Open-Label Phase II Study of E7070 in Metastatic Breast Cancer Patients Previously Treated With an Anthracycline, a Taxane, and Capecitabine|Completed||Phase 2|250||Eisai Inc.|||||||||||||||||||2017-10-11 04:49:55.782033|2017-10-11 04:49:55.782033
NCT00080210|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-24|2013-05-31|||March 2004||2004-03-01|May 2013|2013-05-01|February 2005||2005-02-01|||||Interventional|||A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy|A Phase II Study of Multiple Doses of Intravenous Puricase in Subjects With Hyperuricemia and Refractory Gout|Completed||Phase 2|40||Savient Pharmaceuticals|||||||||||||||||||2017-10-11 04:49:56.041386|2017-10-11 04:49:56.041386
NCT00080223|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-24|2017-03-20|2016-02-10||August 31, 2003|Actual|2003-08-31|March 2017|2017-03-01|April 30, 2015|Actual|2015-04-30|April 30, 2015|Actual|2015-04-30||Interventional||All treated participants|Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis|An Open-Label, Phase 2 Study of the Safety of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis|Completed||Phase 2|83|Actual|Genentech, Inc.||1|||f||||f||||||||||2017-10-11 04:49:56.147769|2017-10-11 04:49:56.147769
NCT00080236|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-24|2012-08-08|||November 2003||2003-11-01|August 2012|2012-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation|Safety, Tolerability and Efficacy Study of a Caspase Inhibitor, IDN-6556, in Patients Undergoing Orthotopic Liver Transplantation (OLT)|Completed||Phase 2|99|Actual|Conatus Pharmaceuticals Inc.||4|||f||||t||||||||||2017-10-11 04:49:56.764754|2017-10-11 04:49:56.764754
NCT00080262|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-25|2017-01-27|||February 2004||2004-02-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)|Phase II Study of Novel Epothilone (BMS-247550) in Patients With MBC Who Are Refractory to an Anthracycline, a Taxane, and Capecitabine|Completed||Phase 2|125||R-Pharm||1|||f||||||||||||||2017-10-11 04:49:56.876703|2017-10-11 04:49:56.876703
NCT00080275|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-25|2006-10-31|||March 2004||2004-03-01|October 2006|2006-10-01||||||||Interventional|||Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)|An Open-Label Evaluation of the Safety and Efficacy of a Combination of Niacin ER and Simvastatin in Patients With Dyslipidemia (OCEANS)|Completed||Phase 3|600||Kos Pharmaceuticals|||||||||||||||||||2017-10-11 04:49:57.019448|2017-10-11 04:49:57.019448
NCT00080288|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-25|2013-07-12|2009-06-01||March 2004||2004-03-01|July 2013|2013-07-01|December 2004||2004-12-01|||||Interventional|||Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD|A 12 Week, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CEP 10953 (150 mg) as Treatment for Adults With Excessive Sleepiness Associated With Chronic Shift Work Sleep Disorder|Completed||Phase 3|254|Actual|Teva Pharmaceutical Industries||2|||||||||||||||||2017-10-11 04:49:57.084369|2017-10-11 04:49:57.084369
NCT00083798|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2016-08-18|||September 2003||2003-09-01|August 2016|2016-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland||Completed||N/A|2843|Actual|University of Pennsylvania|||1||f||||||||||Samples With DNA|"     Samples with DNA   "|||2017-10-11 04:50:58.729556|2017-10-11 04:50:58.729556
NCT00080301|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-26|2016-02-09|2009-05-01||September 2003||2003-09-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|November 2006|Actual|2006-11-01||Interventional|||Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer|A Phase III Trial of Novel Epothilone BMS-247550 Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With or Resistant to an Anthracycline and Who Are Taxane Resistant|Completed||Phase 3|752|Actual|R-Pharm||2|||f||||t||||||||||2017-10-11 04:49:57.446389|2017-10-11 04:49:57.446389
NCT00080314|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-26|2013-11-07|||January 2004||2004-01-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode|Completed||Phase 3|400||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-10-11 04:49:59.814955|2017-10-11 04:49:59.814955
NCT00080327|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-26|2013-11-07|||November 2003||2003-11-01|August 2008|2008-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia|A Placebo-Controlled Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia|Completed||Phase 4|370||Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||||||||||||2017-10-11 04:49:59.961031|2017-10-11 04:49:59.961031
NCT00080340|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-26|2008-01-10||||||March 2006|2006-03-01|May 2005||2005-05-01|||||Interventional|||Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Phase 3 Randomized Study of TLK286 (Telcyta) Versus Gefitinib (Iressa) as Third-Line Therapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|520||Telik|||||||||||||||||||2017-10-11 04:50:00.0998|2017-10-11 04:50:00.0998
NCT00080353|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-27|2012-06-12|||March 2004||2004-03-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma|Phase II Study in Metastatic Melanoma Using Lymphocytes Reactive With the gp100 Antigen and Immunization Using a Recombinant rF-gp100P209 Virus Encoding a gp100 Peptide Following a Nonmyeloablative Lymphocyte Depleting Regimen|Completed||Phase 2|58|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:00.992114|2017-10-11 04:50:00.992114
NCT00080366|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-27|2007-04-03|||March 2004||2004-03-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||Octanol to Treat Essential Tremor|Treatment Efficacy of 1-Octanol Compared to Placebo in Adults With Essential Tremor|Completed||Phase 2|14||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:01.075721|2017-10-11 04:50:01.075721
NCT00080392|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-30|2017-06-30|||March 27, 2004||2004-03-27|December 29, 2011|2011-12-29|December 29, 2011|Actual|2011-12-29|||||Interventional|||EW-A-401 to Treat Intermittent Claudication|Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication|Completed||Phase 1|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:50:01.151028|2017-10-11 04:50:01.151028
NCT00080405|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-30|2009-03-26|||March 2004||2004-03-01|March 2009|2009-03-01||||June 2005|Actual|2005-06-01||Interventional|||Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma|Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma|Completed||Phase 1|40||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:50:01.229566|2017-10-11 04:50:01.229566
NCT00080418|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-30|2011-06-30|||July 2003||2003-07-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|July 2005|Actual|2005-07-01||Interventional|||Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer|Phase I Study of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Formulation in Patients With Advanced Cancer|Completed||Phase 1|40||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:50:01.300963|2017-10-11 04:50:01.300963
NCT00080431|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-30|2017-06-30|||March 26, 2004||2004-03-26|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Interventional|||Daclizumab to Treat HIV-Infected Patients|An Open Label Trial to Assess Safety and Tolerability of Daclizumab in HIV-Infected Individuals|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:01.434153|2017-10-11 04:50:01.434153
NCT00080444|ClinicalTrials.gov processed this data on October 10, 2017|2004-03-31|2014-08-04|||April 2004||2004-04-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|September 2006|Actual|2006-09-01||Interventional|||Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Emetogenic Chemotherapy in Adolescent Patients|Completed||Phase 3|50|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 04:50:01.513195|2017-10-11 04:50:01.513195
NCT00080457|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-01|2007-11-08|||May 2003||2003-05-01|November 2007|2007-11-01|January 2005|Actual|2005-01-01|||||Interventional|||Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium (Thelin™) Treatment With an Open-Label Bosentan Arm in Patients With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 3|240||Encysive Pharmaceuticals|||||||||||||||||||2017-10-11 04:50:01.656285|2017-10-11 04:50:01.656285
NCT00080470|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-01|2013-10-25|2013-04-11||June 2003||2003-06-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|July 2008|Actual|2008-07-01||Interventional|||An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence|Battery Powered Bion Clinical Investigation: An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence|Completed||Phase 3|148|Actual|Boston Scientific Corporation|This study was limited by poor adherence to the clinical protocol and by incomplete data recovery. Analysis of efficacy-related endpoints was not possible.|2|||f||||f||||||||||2017-10-11 04:50:01.748334|2017-10-11 04:50:01.748334
NCT00080483|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-05|2014-06-12|2013-12-12||March 2004||2004-03-01|December 2013|2013-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Testosterone and Growth Hormone for Bone Loss in Men|Will Testosterone and Growth Hormone Improve Bone Structure?|Completed||Phase 2|35|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 04:50:02.218908|2017-10-11 04:50:02.218908
NCT00073164|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-17|2006-08-02|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia|A Study of the Safety and Efficacy of Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia|Completed||Phase 2|400||Abbott|||||||||||||||||||2017-10-11 04:50:12.576326|2017-10-11 04:50:12.576326
NCT00080496|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-05|2008-07-31|||July 2003||2003-07-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia|A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Tigecycline Vs Imipenem/Cilastatin For The Treatment Of Subjects With Nosocomial Pneumonia|Completed||Phase 3|430||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:50:02.627076|2017-10-11 04:50:02.627076
NCT00080509|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-05|2010-02-02|||December 2003||2003-12-01|November 2009|2009-11-01|November 2004||2004-11-01|||||Interventional|||Effectiveness of KOS-862 in the Treatment of Lung Cancer|A Phase 2 Study of KOS-862, Administered Intravenously Weekly for 3 Weeks Every 4 Weeks, in Patients With Non-Small Cell Lung Cancer Who Have Progressed Following Initial Therapy for Advanced or Metastatic Disease|Terminated||Phase 2|85||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:50:02.769743|2017-10-11 04:50:02.769743
NCT00080522|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-06|2007-09-17|||February 2005||2005-02-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||Strategies for Delivering Anti-HIV Therapy in South Africa|Safeguard the Household: A Study of HIV Antiretroviral Therapy Treatment Strategies Appropriate for a Resource Poor Country|Completed||N/A|813||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:50:02.86779|2017-10-11 04:50:02.86779
NCT00080535|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2012-09-24|2012-09-24||April 2004||2004-04-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas|A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Cutaneous T-Cell Lymphomas|Completed||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:50:03.030827|2017-10-11 04:50:03.030827
NCT00080548|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2017-06-30|||April 6, 2004||2004-04-06|January 6, 2009|2009-01-06|January 6, 2009||2009-01-06|||||Observational|||Timing of Voluntary Movement in Patients With Schizophrenia|Timing of Voluntary Movement in Patients With Schizophrenia Using EEG and Surface EMG|Completed||N/A|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:04.24044|2017-10-11 04:50:04.24044
NCT00080574|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2008-03-03|||April 2004||2004-04-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients|The Effects of Thyroid Hormone on Cytochrome P450 and P-Glycoprotein Activity in Thyroid Cancer Patients|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:04.336264|2017-10-11 04:50:04.336264
NCT00080587|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2008-03-03|||April 2004||2004-04-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Atherosclerosis in the Coronary and Carotid Arteries|Atherosclerosis in the Coronary and Carotid Arteries: Correlations Between Coronary IVUS, Carotid Ultrasound, and Carotid MRI|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:04.441387|2017-10-11 04:50:04.441387
NCT00080600|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2017-06-30|||April 6, 2004||2004-04-06|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Brain Physiology in Polio Survivors|Central Motor Physiology in Polio Survivors|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:04.526079|2017-10-11 04:50:04.526079
NCT00080613|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer|Phase II Study of Neoadjuvant and Adjuvant Exemestane in Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer|Withdrawn||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:04.602489|2017-10-11 04:50:04.602489
NCT00072657|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-07|2013-04-01|||February 2004||2004-02-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis|Behavioral Treatments for Rheumatoid Arthritis|Completed||N/A|106|Actual|University of California, Los Angeles||3|||f||||||||||||||2017-10-11 04:50:04.701385|2017-10-11 04:50:04.701385
NCT00072670|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-07|2014-04-07|||January 2004||2004-01-01|April 2014|2014-04-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer|Phase 2 Study of Yondelis in Men With Advanced Prostate Carcinoma|Completed||Phase 2|59|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||t||||||||||2017-10-11 04:50:04.810003|2017-10-11 04:50:04.810003
NCT00072683|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-07|2007-01-24|||April 2003||2003-04-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||“SALT Trial” Study of Ascending Levels of Tolvaptan in Hyponatremia|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia|Completed||Phase 3|240||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:50:04.913385|2017-10-11 04:50:04.913385
NCT00072709|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-07|2011-11-22|||September 2003||2003-09-01|November 2011|2011-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Randomized, Double-Blind, Placebo-Controlled, Stratified, Parallel-Group, Multicenter, Dose-Ranging Study Evaluating Four Oral Doses of TCH346 (1.0, 2.5, 7.5 and 15 mg) Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis|Completed||Phase 2|551|Actual|Novartis|||||f||||||||||||||2017-10-11 04:50:05.085992|2017-10-11 04:50:05.085992
NCT00072722|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-07|2006-12-18|||September 2003||2003-09-01|December 2006|2006-12-01|April 2005||2005-04-01|||||Interventional|||Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)|Phase II Randomized Open-Label, Two-Arm Study of Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 2|36||Celgene|||||||||||||||||||2017-10-11 04:50:05.181312|2017-10-11 04:50:05.181312
NCT00072735|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-07|2017-06-30|||November 6, 2003||2003-11-06|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Improvement of Use Dependent Plasticity in Chronic Stroke Patients|Improvement of Use Dependent Plasticity in Chronic Stroke Patients|Completed||Phase 1|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:05.246893|2017-10-11 04:50:05.246893
NCT00072748|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-10|2009-08-20||||||August 2009|2009-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Study Evaluating EKB-569 in Advanced Colorectal Cancer||Completed||Phase 2|63|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:50:05.58581|2017-10-11 04:50:05.58581
NCT00083811|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2016-08-05|||January 2004||2004-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||HYPGENE-Genetics Fitness Obesity & Risk of Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:50:58.802214|2017-10-11 04:50:58.802214
NCT00072761|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-10|2016-01-07|2015-05-04||December 2004||2004-12-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SIT||Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial|Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial|Completed||Phase 3|196|Actual|Washington University School of Medicine|The SIT Trial results are not directly applicable to all children with SCA. Those who were on hydroxyurea therapy for severe disease, had abnormally elevated TCDs, were receiving blood transfusion for stroke prevention or had epilepsy were excluded.|2|||f||||t||||||||||2017-10-11 04:50:05.676976|2017-10-11 04:50:05.676976
NCT00072774|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-10|2009-08-18||||||August 2009|2009-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Three Fixed Doses (100 Mg, 200 Mg, Or 400 Mg) Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|480|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:50:06.064562|2017-10-11 04:50:06.064562
NCT00072787|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-10|2009-08-06|||October 2003||2003-10-01|August 2009|2009-08-01|May 2006|Actual|2006-05-01|March 2006|Actual|2006-03-01||Interventional|||Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer|A Phase I/II, Open-Label, Nonrandomized, Dose-Finding Safety, Tolerance, Pharmacokinetic, and Efficacy Study of Orally Administered S-1 in Combination With Cisplatin in Patients With Advanced Gastric Cancer|Completed||Phase 1/Phase 2|41||Taiho Oncology, Inc.|||||||||||||||||||2017-10-11 04:50:06.159639|2017-10-11 04:50:06.159639
NCT00072800|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-10|2008-03-03|||November 2003||2003-11-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Classification of Cerebral Palsy Subtypes|Classification of Cerebral Palsy Subtypes|Completed||N/A|115||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:06.261241|2017-10-11 04:50:06.261241
NCT00072813|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-10|2017-06-30|||November 10, 2003||2003-11-10|November 12, 2009|2009-11-12||||November 12, 2009|Actual|2009-11-12||Observational|||MRI in Autosomal Dominant Partial Epilepsy With Auditory Features|MRI in Autosomal Dominant Partial Epilepsy With Auditory Features|Completed||N/A|72||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:06.341402|2017-10-11 04:50:06.341402
NCT00072826|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-10|2017-10-05|||November 4, 2003||2003-11-04|December 7, 2015|2015-12-07|August 24, 2007|Actual|2007-08-24|August 24, 2007|Actual|2007-08-24||Interventional|||Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease|Atorvastatin Therapy To Improve Endothelial Function in Sickle Cell Disease|Completed||Phase 1|44|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:50:06.406862|2017-10-11 04:50:06.406862
NCT00072839|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-11|2015-11-10|||October 2003||2003-10-01|January 2015|2015-01-01|September 2005|Actual|2005-09-01|July 2005|Actual|2005-07-01||Interventional|||Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease|A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease|Completed||Phase 2|100|Actual|Shire||4|||f||||f||||||||||2017-10-11 04:50:06.515531|2017-10-11 04:50:06.515531
NCT00072852|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-11|2008-10-15|||November 2003||2003-11-01|October 2008|2008-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine|Phase II Trial of Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine|Completed||Phase 2|134|Actual|Pfizer|||||f||||||||||||||2017-10-11 04:50:06.767756|2017-10-11 04:50:06.767756
NCT00072865|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-12|2007-01-24|||June 2003||2003-06-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer|A Phase II Study of Alimta and Carboplatin in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:50:07.007104|2017-10-11 04:50:07.007104
NCT00072891|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-12|2010-02-12||||||February 2010|2010-02-01|December 2005|Actual|2005-12-01|||||Interventional|||Improving Medication Adherence in Comorbid Conditions||Completed||N/A|400||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:50:07.069321|2017-10-11 04:50:07.069321
NCT00072904|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-12|2012-02-27|||June 2001||2001-06-01|February 2012|2012-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Diabetes Therapy to Improve BMI and Lung Function in CF|Diabetes Therapy to Improve BMI and Lung Function in CF|Completed||Phase 3|108|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||||||||||||2017-10-11 04:50:07.140653|2017-10-11 04:50:07.140653
NCT00072917|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-12|2010-01-15|||October 2003||2003-10-01|January 2010|2010-01-01|June 2008||2008-06-01|||||Observational|||The Effects of Overfeeding on Obesity-Prone (OP) and Obesity-Resistant (OR) Women|The Effects of Overfeeding on Obesity-Prone (OP) and Obesity-Resistant (OR) Women|Completed||N/A|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||Samples With DNA|"     Blood and urine   "|||2017-10-11 04:50:07.268303|2017-10-11 04:50:07.268303
NCT00072930|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-12|2008-01-11|||December 2003||2003-12-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|April 2007|Anticipated|2007-04-01||Interventional|||MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer|Phase II, Randomized, Open-Label, Two-Arm, Multicenter Study of MEDI-522, a HuMA Directed Against the Human Alpha V Beta 3 Integrin, in Combination With Docetaxel, Prednisone, and Zoledronic Acid in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 2|150||MedImmune LLC||2|||f||||||||||||||2017-10-11 04:50:07.362177|2017-10-11 04:50:07.362177
NCT00072943|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-12|2012-03-09|||March 2002||2002-03-01|March 2012|2012-03-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease|A Phase II, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) Administered to Patients With Moderate to Severe Crohn's Disease|Completed||Phase 2|175||Facet Biotech|||||f||||||||||||||2017-10-11 04:50:07.631597|2017-10-11 04:50:07.631597
NCT00072956|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-12|2008-03-03|||November 2003||2003-11-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Observational|||The Physiology of Tricks|The Physiology of Tricks|Completed||N/A|49||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:07.769317|2017-10-11 04:50:07.769317
NCT00073177|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-17|2016-10-24|||November 2003||2003-11-01|September 2016|2016-09-01||||||||Interventional|||Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)|A 24 Week, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Roflumilast (250 mcg or 500 mcg) Daily in Patients With Asthma|Completed||Phase 3|819||AstraZeneca|||||f||||||||||||||2017-10-11 04:50:12.788787|2017-10-11 04:50:12.788787
NCT00072969|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-12|2008-03-03|||November 2003||2003-11-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)|A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)|Completed||Phase 2|132||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:07.836316|2017-10-11 04:50:07.836316
NCT00072995|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-13|2013-01-29|||September 2003||2003-09-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Preventing Obesity Using Novel Dietary Strategies|Preventing Overweight Using Novel Dietary Strategies (Pounds Lost)|Completed||N/A|811||Brigham and Women's Hospital|||||f||||t||||||||||2017-10-11 04:50:08.037536|2017-10-11 04:50:08.037536
NCT00073008|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-13|2017-01-16|2009-06-15||November 2003||2003-11-01|January 2017|2017-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer|A Phase 2 Multicenter Trial Comparing Two Schedules of GW572016 as First or Second Line Monotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer With Either Bronchioloalveolar Carcinoma or No Smoking History|Terminated||Phase 2|131|Actual|GlaxoSmithKline|Based on interim analysis and predefined stopping rules for futility, the study was discontinued due to lack of efficacy. At that time, no additional participants were added; enrolled participants could continue on treatment, following the protocol.|1||"Based on interim analysis at the end of Stage 1, and predefined stopping rules for futility,   further enrollment was stopped due to lack of efficacy"|f||||t||||||||||2017-10-11 04:50:08.153379|2017-10-11 04:50:08.153379
NCT00073021|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-13|2015-06-01|2011-03-25||September 2000||2000-09-01|June 2015|2015-06-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis|A Double-Blind, Randomized, 6-Week, Parallel-Group Design Clinical Trial to Assess Safety and Efficacy of Asacol 4.8 g/Day (800 mg Tablet) Versus Asacol 2.4 g/Day (400 mg Tablet) for the Treatment of Moderately Active Ulcerative Colitis|Completed||Phase 3|386|Actual|Warner Chilcott||2|||f||||f||||||||||2017-10-11 04:50:09.230901|2017-10-11 04:50:09.230901
NCT00073034|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-14|2013-02-20|||January 2004||2004-01-01|February 2013|2013-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of 3 Fixed Doses of EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy|Terminated||Phase 2|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:50:09.991686|2017-10-11 04:50:09.991686
NCT00073047|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-14|2009-07-17|||April 2003||2003-04-01|July 2009|2009-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis|A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study of Intravenous Daclizumab in Patients With Moderate-to-severe Ulcerative Colitis|Completed||Phase 2|150||Facet Biotech|||||||||||||||||||2017-10-11 04:50:10.087123|2017-10-11 04:50:10.087123
NCT00073060|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-14|2017-10-05|||November 13, 2003||2003-11-13|March 30, 2017|2017-03-30||||||||Observational|||Citrate Effects and Bone Density in Long-Term Apheresis Donors|Citrate Effects and Bone Density Studies in Long-Term Apheresis Donors|Completed||N/A|273|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:10.225661|2017-10-11 04:50:10.225661
NCT00073086|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-14|2017-06-30|||November 5, 2003||2003-11-05|December 27, 2010|2010-12-27|December 27, 2010||2010-12-27|||||Observational|||Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)|Clinical Evaluation and Management of Persons With Severe Acute Respiratory Syndrome (SARS)|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:12.008663|2017-10-11 04:50:12.008663
NCT00073099|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-14|2017-06-30|||November 14, 2003||2003-11-14|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Observational|||Digital Photography to Evaluate Dry Eye|Digital Image Based Determination of Ocular Surface Vital Dye Staining|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:12.135693|2017-10-11 04:50:12.135693
NCT00073112|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-17|2007-11-28|||August 2003||2003-08-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||A Study of ABT-751 in Patients With Renal Cell Cancer|A Phase 2 Study of ABT-751 in Subjects With Refractory Colorectal Carcinoma|Completed||Phase 2|60||Abbott||1|||f||||f||||||||||2017-10-11 04:50:12.189979|2017-10-11 04:50:12.189979
NCT00073125|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-17|2007-08-13|||May 2003||2003-05-01|August 2007|2007-08-01||||||||Interventional|||Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma|A Phase II Randomized Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma|Completed||Phase 2|103|Actual|Abbott||2|||f||||f||||||||||2017-10-11 04:50:12.306643|2017-10-11 04:50:12.306643
NCT00073138|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-17|2007-11-28|||August 2003||2003-08-01|November 2007|2007-11-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of ABT-751 in Patients With Colorectal Cancer|A Phase 2 Study of ABT-751 in Subjects With Refractory Colorectal Carcinoma|Completed||Phase 2|40||Abbott||1|||f||||f||||||||||2017-10-11 04:50:12.429512|2017-10-11 04:50:12.429512
NCT00073151|ClinicalTrials.gov processed this data on October 10, 2017|2003-11-17|2007-11-28|||September 2003||2003-09-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer|A Phase II Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Refractory to Taxane Regimens|Completed||Phase 2|30|Anticipated|Abbott||1|||f||||f||||||||||2017-10-11 04:50:12.494098|2017-10-11 04:50:12.494098
NCT00154999|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-28|||April 2005||2005-04-01|March 2004|2004-03-01|June 2005||2005-06-01|||||Observational|||The Predictors of the Neonatal Hyperbilirubinemia|The Predictors of the Neonatal Hyperbilirubinemia|Completed||N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.591264|2017-10-11 05:20:38.591264
NCT00080626|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2017-08-28|||July 2003||2003-07-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|April 2006|Actual|2006-04-01||Interventional|||Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer|A Pilot Study Assessing Patterns of Response or Resistance to Preoperative Dose Dense Docetaxel in Women With Newly Diagnosed Breast Cancer|Active, not recruiting||Phase 2|19|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 04:50:13.00221|2017-10-11 04:50:13.00221
NCT00080639|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-08-01|||June 2003||2003-06-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||CA-125 in Screening Patients at High Risk for Ovarian Cancer|Specialized Program Of Research Excellence (SPORE) In Ovarian Cancer/Cancer Genetics Network Collaborative Ovarian Cancer Screening Pilot Trial In High Risk Women|Withdrawn||Phase 2|0|Actual|University of Alabama at Birmingham|||1|Terminated for administrative reasons and becuase there were no enrollments|f||||t||||||||||2017-10-11 04:50:13.121265|2017-10-11 04:50:13.121265
NCT00080665|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2017-05-02|||December 2003||2003-12-01|May 2017|2017-05-01|January 2011|Actual|2011-01-01|January 2007|Actual|2007-01-01||Interventional|||Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Phase I Study Of Weekly Taxotere (Docetaxel) And Gleevec (STI571, Imatinib Mesylate, CGP 57148B) In Locally Advanced Or Metastatic Breast Cancer|Completed||Phase 1|12|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 04:50:13.200605|2017-10-11 04:50:13.200605
NCT00080678|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2012-10-10|||May 2003||2003-05-01|October 2012|2012-10-01|March 2008|Actual|2008-03-01|August 2005|Actual|2005-08-01||Interventional|||Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases|Randomized Double-Blind Phase II Trial of Docetaxel and Imatinib Versus Docetaxel and Placebo in Metastatic Androgen-Independent Prostate Cancer (AIPC) With Bone Metastases|Completed||Phase 2|116|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:50:13.29776|2017-10-11 04:50:13.29776
NCT00080743|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2009-08-04|||January 2004||2004-01-01|August 2009|2009-08-01|November 2005|Actual|2005-11-01|April 2005|Actual|2005-04-01||Interventional|||Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer|ZD1839 (IRESSA) In Tamoxifen-Resistant Metastatic Breast Cancer|Completed||Phase 2|2|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 04:50:13.403832|2017-10-11 04:50:13.403832
NCT00080756|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2017-07-13|||March 11, 2004|Actual|2004-03-11|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease|Biomarkers, Breast Density And Risk Reduction Perspectives In BRCA Carriers|Active, not recruiting||Phase 2|11|Actual|City of Hope Medical Center||2|||f||||f||||||||||2017-10-11 04:50:13.475225|2017-10-11 04:50:13.475225
NCT00080782|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2012-07-27|||February 2002||2002-02-01|August 2010|2010-08-01|January 2005|Actual|2005-01-01|April 2004|Actual|2004-04-01||Interventional|||Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases|A Randomized Phase II Trial of Bone-Targeted Therapy Consisting of Strontium-89 and Doxorubicin With or Without Celecoxib in Androgen-Independent Prostate Cancer|Terminated||Phase 2|14|Actual|M.D. Anderson Cancer Center||2||Low accrual due to competing trial.|f||||f||||||||||2017-10-11 04:50:13.556704|2017-10-11 04:50:13.556704
NCT00080795|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2012-10-18|||July 2001||2001-07-01|October 2012|2012-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium|Phase II Trial of Neoadjuvant, Multi-Agent Chemotherapy For Locally Advanced Urothelial Cancer|Completed||Phase 2|65|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:50:13.63649|2017-10-11 04:50:13.63649
NCT00080808|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2012-07-27|||August 2001||2001-08-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2006|Actual|2006-07-01||Interventional|||Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer|A Randomized Phase II Trial Evaluating the Importance of Early Erectile Dysfunction Rehabilitation and Unilateral Autologous Sural Nerve Sparing Radical Prostatectomy Clinically Localized Prostate Cancer|Completed||Phase 2|111|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:50:13.722138|2017-10-11 04:50:13.722138
NCT00080834|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2012-05-15|||February 2004||2004-02-01|May 2012|2012-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma|A Phase II Study Of Oral DJ-927 Administered As A Single Dose Every Three Weeks To Patients With Advanced Or Metastatic Adenocarcinoma Of The Colon Or Rectum|Completed||Phase 2|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:50:13.819151|2017-10-11 04:50:13.819151
NCT00080847|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-01-04|||March 2004||2004-03-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab, or Rituximab and G3139 Phosphorothioate Oligonucleotide (BCL-2 Antisense - NSC-683428) Therapy for Young Patients (< Age 60) With Advanced Stage Diffuse Large B-Cell NHL of Low and Low-Intermediate IPI Risk|Terminated||Phase 2|160|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:50:13.898467|2017-10-11 04:50:13.898467
NCT00080860|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2012-03-07|||February 2004||2004-02-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer|Efficacy Of Sentinel Lymph Node Biopsy And Primary Tumor Gene Expression Profiling To Detect Axillary Lymph Node Metastases After Neoadjuvant Chemotherapy For Breast Cancer|Completed||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:14.023506|2017-10-11 04:50:14.023506
NCT00080873|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2016-01-05|||April 2004||2004-04-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|November 2006|Actual|2006-11-01||Interventional|||Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation|A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation|Completed||N/A|195|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:50:14.113682|2017-10-11 04:50:14.113682
NCT00080886|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2017-09-29|||May 2002||2002-05-01|September 2017|2017-09-01|March 2015|Actual|2015-03-01|November 2005|Actual|2005-11-01||Interventional|||Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma|A Phase II Trial Of BEAM/Rituximab/Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Patients With CD20 Positive Non-Hodgkin's Lymphoma|Completed||Phase 2|68|Actual|University of Nebraska||1|||f||||t||||||||||2017-10-11 04:50:14.414789|2017-10-11 04:50:14.414789
NCT00080899|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2015-02-19|2015-02-19||June 2004||2004-06-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer|A Phase II Trial of Fenretinide (4-HPR) in Biochemically Recurrent, Hormone Naive Prostate Cancer|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:50:14.537339|2017-10-11 04:50:14.537339
NCT00080912|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2015-02-11|2015-02-11||January 2004||2004-01-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|September 2012|Actual|2012-09-01||Interventional|||Single-Fraction Compared With Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases|A Phase III International Randomized Trial Of Single Versus Multiple Fractions For Re-Irradiation Of Painful Bone Metastases|Completed||Phase 3|850|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 04:50:14.838753|2017-10-11 04:50:14.838753
NCT00080925|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2012-03-07|||February 2004||2004-02-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|||||Interventional|||T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies|T-Cell Depleted, Reduced-Intensity Allogeneic Stem Cell Transplantation From Haploidentical Related Donors For Hematologic Malignancies|Completed||Phase 1|20|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:50:15.120821|2017-10-11 04:50:15.120821
NCT00080938|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-02-12|2010-12-30||October 2005||2005-10-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer|A Phase II Study of Temozolomide and Radiation Therapy in Patients With Brain Metastasis From Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|26|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:50:15.235265|2017-10-11 04:50:15.235265
NCT00080951|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2016-12-05|||March 2004||2004-03-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|April 2005|Actual|2005-04-01||Interventional|||Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer|Phase II Trial Of Irinotecan + 5-Fluorouracil + Leucovorin + Oxaliplatin As First-Line Treatment For Metastatic Colorectal Cancer|Completed||Phase 2|14|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:50:15.538302|2017-10-11 04:50:15.538302
NCT00080977|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-12-18|||June 1998||1998-06-01|June 2005|2005-06-01||||||||Interventional|||High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2|Treatment of Patients With Metastatic Renal Cell Carcinoma Who Have Failed Low Dose Intensity Interleukin-2 With High-Dose Intravenous Recombinant Interleukin-2|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:15.618086|2017-10-11 04:50:15.618086
NCT00080990|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-12-13|||February 2004||2004-02-01|December 2013|2013-12-01||||April 2009|Actual|2009-04-01||Interventional|||Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Oxaliplatin and Fluorouracil/Leucovorin in Patients With Advanced Solid Tumors|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:50:15.691032|2017-10-11 04:50:15.691032
NCT00081003|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2014-07-22|||November 2003||2003-11-01|December 2005|2005-12-01||||||||Interventional|||Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer|The Intraduct Environment: A Novel Approach to Risk Assessment of Women With a Family History of Breast Cancer|Completed||N/A|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:15.790327|2017-10-11 04:50:15.790327
NCT00081029|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2011-03-22|||January 2004||2004-01-01|March 2008|2008-03-01||||January 2013|Anticipated|2013-01-01||Interventional|||Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia|A Multicentre Randomised Study Of Parotid Sparing Intensity Modulated Radiotherapy Versus Conventional Radiotherapy In Patients With Head And Neck Cancer|Unknown status|Active, not recruiting|Phase 3|84|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:15.891418|2017-10-11 04:50:15.891418
NCT00081042|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-12-18|||February 2004||2004-02-01|May 2005|2005-05-01|January 2010|Actual|2010-01-01|||||Interventional|||ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma|An Open-Label, Multicenter, Phase II Trial of ABI-007 (A Cremophor® -Free, Protein Stabilized, Nanoparticle Paclitaxel) in Previously Treated Patients With Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:16.013402|2017-10-11 04:50:16.013402
NCT00081055|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2014-12-03||||||December 2014|2014-12-01||||||||Interventional|||OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies|A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OTI-010 in Subjects Who Receive HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies|Withdrawn||Phase 2|0|Actual|Mesoblast, Ltd.|||||f||||||||||||||2017-10-11 04:50:16.090764|2017-10-11 04:50:16.090764
NCT00081068|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-01-07|||January 2004||2004-01-01|January 2013|2013-01-01||||||||Interventional|||Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia|Phase II Study of Campath-1H in Lymphoplasmacytic Lymphoma (Waldenstrom's Macroglobulinemia)|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:50:16.199451|2017-10-11 04:50:16.199451
NCT00081484|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-13|2016-11-01|||June 2004||2004-06-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients|A Randomized, Open-label Study of the Effect of Maintenance Mircera Administered With Pre-filled Syringes on Hemoglobin Levels in Anemic Dialysis Patients With Chronic Kidney Disease|Completed||Phase 3|336|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:50:16.323305|2017-10-11 04:50:16.323305
NCT00081497|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-14|2015-03-13|2008-12-17||January 2004||2004-01-01|March 2015|2015-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease|Multi-Center, Open-Label Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease That Previously Participated in the AGAL-008-00 Study|Completed||Phase 4|67|Actual|Sanofi|No valid conclusions can be made from the predefined primary efficacy analysis. The sponsor believes that it is more statistically appropriate to compare placebo patients with Fabrazyme patients as they were randomized in the original Phase 4 trial.|1|||f||||||||||||||2017-10-11 04:50:16.792033|2017-10-11 04:50:16.792033
NCT00081510|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-14|2015-03-26||2009-04-17|December 2003||2003-12-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)|A Randomized Double-Blind Phase-2 Study of Anastrozole Plus Lonafarnib (SCH 66336) or Anastrozole Plus Placebo for the Treatment of Subjects With Advanced Breast Cancer|Completed||Phase 2|110|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:50:20.194885|2017-10-11 04:50:20.194885
NCT00081523|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2017-10-05|||April 13, 2004||2004-04-13|September 15, 2017|2017-09-15||||||||Observational|||Natural History of Sickle Cell Disease|Studies of the Natural History of Sickle Cell Disease|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:20.292872|2017-10-11 04:50:20.292872
NCT00081536|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies|A Phase I/II Study of Aroplatin and Capecitabine in Subjects With Unresectable Local Recurrence or Distant Metastases of Colorectal Cancer Refractory to 5-FU/Leucovorin and Irinotecan|Unknown status|Active, not recruiting|Phase 1/Phase 2|105||Aronex Pharmaceuticals|||||||||||||||||||2017-10-11 04:50:20.391592|2017-10-11 04:50:20.391592
NCT00081549|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies|A Phase I/II Study of Aroplatin and Gemcitabine In Subjects With Unresectable, Locally Advanced And/Or Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|111||Aronex Pharmaceuticals|||||||||||||||||||2017-10-11 04:50:20.457524|2017-10-11 04:50:20.457524
NCT00081562|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2008-02-19|||September 1999||1999-09-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Genetics of Ankylosing Spondylitis|Family Studies of the Genetics of Ankylosing Spondylitis|Completed||N/A|1600||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-10-11 04:50:20.522504|2017-10-11 04:50:20.522504
NCT00081575|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2013-02-07|||January 2004||2004-01-01|February 2013|2013-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia|A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Intravenous Tigecycline Vs Intravenous Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia|Completed||Phase 3|434|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:50:20.607722|2017-10-11 04:50:20.607722
NCT00081588|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2014-06-19|||November 2003||2003-11-01|June 2014|2014-06-01|December 2008|Actual|2008-12-01|September 2005|Actual|2005-09-01||Interventional|||An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.|An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.|Completed||Phase 2|555|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||t||||||||||2017-10-11 04:50:20.695422|2017-10-11 04:50:20.695422
NCT00081601|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2012-08-22|||March 2004||2004-03-01|August 2012|2012-08-01|June 2005|Actual|2005-06-01|May 2005|Actual|2005-05-01||Interventional|||Study of CEP-701 in Treatment of Prostate Cancer|An Open-Label Phase 2 Study of Oral CEP-701 in Patients With Asymptomatic Hormone-Refractory Cancer With Rising Prostate Specific Antigen|Completed||Phase 2|30||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 04:50:21.100003|2017-10-11 04:50:21.100003
NCT00081614|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2014-05-14|||March 2004||2004-03-01|May 2014|2014-05-01|July 2005|Actual|2005-07-01|||||Interventional|||A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma|A Phase II, Multicenter, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Tarceva (Erlotinib Hydrochloride) in Combination With Avastin (Bevacizumab) Versus Avastin Alone for Treatment of Metastatic Renal Cell Carcinoma|Completed||Phase 2|100||Genentech, Inc.|||||||||||||||||||2017-10-11 04:50:21.185287|2017-10-11 04:50:21.185287
NCT00081627|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-15|2007-11-26|||April 2004||2004-04-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Clinical Trial in Patients With Metastatic Colorectal Cancer|COFU: A Multi-Center Phase II Clinical Trial to Evaluate the Safety and Efficacy of Weekly Treatment With CoFactor and 5-Fluorouracil in Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|48||Mast Therapeutics, Inc.|||||f||||||||||||||2017-10-11 04:50:21.315316|2017-10-11 04:50:21.315316
NCT00081640|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-16|2009-12-22||||||November 2006|2006-11-01||||||||Interventional|||Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India|Phase I Safety and Acceptability Study of the Investigational Vaginal Microbicide PRO 2000/5 Gel (P)|Completed||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:50:21.392266|2017-10-11 04:50:21.392266
NCT00081653|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-19|2017-07-13|2008-12-22||May 2004||2004-05-01|July 2017|2017-07-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional||Intent -To - Treat (ITT) population: All participants who were randomized into this study, received at least one dose of the trial medication, and had at least one follow-up efficacy data point (BMD or serum C-terminal peptide cross-links of Collagen Type I [CTX]).|A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva|Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549|Completed||Phase 4|719|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:50:21.486243|2017-10-11 04:50:21.486243
NCT00081666|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-19|2016-07-28|||July 2004||2004-07-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Logical Analysis of Data and Cardiac Surgery Risk||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:50:22.676949|2017-10-11 04:50:22.676949
NCT00081679|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-19|2014-04-15|||June 2004||2004-06-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||SES, Health Behaviors and CVD Among Vietnam-Era Twins||Completed||N/A|||The Miriam Hospital|||||f||||||||||||||2017-10-11 04:50:22.737823|2017-10-11 04:50:22.737823
NCT00081692|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-19|2013-08-05|||January 2004||2004-01-01|August 2013|2013-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Longitudinal Cardiac Outcomes and Body Composition|Longitudinal Cardiac Outcomes and Body Composition|Completed||N/A|715|Actual|Virginia Commonwealth University|||1||f||||f||||||None Retained|"     Only receiving data   "|||2017-10-11 04:50:22.801938|2017-10-11 04:50:22.801938
NCT00081705|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-19|2016-07-28|||March 2004||2004-03-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Estrogen Receptor Variants, HDL, and Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:50:22.867957|2017-10-11 04:50:22.867957
NCT00081731|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-19|2015-09-18|2013-12-09||April 2004||2004-04-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|CORAL||Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions|Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)|Completed||Phase 3|947|Actual|Baim Institute for Clinical Research|Patients could be enrolled in the trial with renal artery stenosis > = 60%. Didn't include patients with fibromuscular dysplasia. Some screened and deemed to be eligible were not enrolled because of physician preference.|2|||f||||t||||||||||2017-10-11 04:50:22.942074|2017-10-11 04:50:22.942074
NCT00081744|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-19|2013-02-07|||November 2002||2002-11-01|February 2013|2013-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects|A Multicenter, Double-Blind, Randomized Comparison Study Of the Efficacy and Safety of Tigecycline to Imipenem/ Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Subjects|Completed||Phase 3|850|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:50:23.419522|2017-10-11 04:50:23.419522
NCT00081757|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-19|2010-07-01|||September 1998||1998-09-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||An Open Protocol for the Compassionate Use of Thalidomide|An Open Protocol For The Compassionate Use of Thalidomide For Patients With Advanced Or Refractory Malignancies|Completed||Phase 1/Phase 2|250||University of Arkansas|||||||||||||||||||2017-10-11 04:50:23.604804|2017-10-11 04:50:23.604804
NCT00081770|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-20|2017-03-07|2008-11-03||March 2004||2004-03-01|March 2017|2017-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)|Comparison of PEG-Intron 1.5µg/kg/wk Plus REBETOL vs PEG-Intron 1µg/kg/wk Plus REBETOL vs PEGASYS 180µg/wk Plus COPEGUS in Previously Untreated Adult Subjects With Chronic Hepatitis C Infected With Genotype 1|Completed||Phase 3|4469|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:50:23.734771|2017-10-11 04:50:23.734771
NCT00081783|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-20|2005-06-23|||March 2004||2004-03-01|March 2005|2005-03-01||||||||Interventional|||Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients|A Phase II Study of Xcellerated T CellsTM in Patients With Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma (NHL)|Unknown status|Recruiting|Phase 2|40||Xcyte Therapies|||||||||||||||||||2017-10-11 04:50:26.428869|2017-10-11 04:50:26.428869
NCT00081796|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-20|2008-08-20|||April 2004||2004-04-01|August 2008|2008-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer|A Randomized, Open-Label, Phase III Study of RPR109881 IV Every 3 Weeks Versus Capecitabine (Xeloda) Tablets Twice Daily for 2 Weeks in 3-Week Cycles in Patients With Metastatic Breast Cancer Progressing After Taxanes and Anthracycline Therapy|Completed||Phase 3|438|Actual|Sanofi||2|||||||||||||||||2017-10-11 04:50:26.659092|2017-10-11 04:50:26.659092
NCT00081809|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-20|2012-09-06|||March 2000||2000-03-01|September 2012|2012-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma|A Phase II Trial of Active Specific Immunotherapy in Patients With Indolent Lymphoma Using Autologous Lymphoma-Derived Heat Shock Protein-Peptide Complex (HSPPC-96)|Completed||Phase 2|35||Agenus Inc.|||||f||||||||||||||2017-10-11 04:50:27.127305|2017-10-11 04:50:27.127305
NCT00081822|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-21|2012-04-18|||January 2004||2004-01-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|April 2009|Actual|2009-04-01||Interventional|||Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia|A Phase I Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia|Completed||Phase 1|23|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:50:27.20601|2017-10-11 04:50:27.20601
NCT00081835|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-22|2017-06-30|||April 19, 2004||2004-04-19|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Evaluation and Treatment of Eye Complications of Vaccinia Vaccination|Evaluation and Treatment of Ocular Complications of Vaccinia Vaccination: Suitability of NP-016 Vaccinia Immune Globulin (VIG) for Sight-Threatening Conditions [VIG31]|Completed||Phase 2|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:27.490721|2017-10-11 04:50:27.490721
NCT00081848|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-22|2017-06-30|||April 20, 2004||2004-04-20|January 25, 2012|2012-01-25|August 23, 2007|Actual|2007-08-23|August 23, 2007|Actual|2007-08-23||Interventional|||Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors|A Pilot Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis in Adults With CEA Positive Solid Tumors|Completed||Phase 1|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:50:27.577081|2017-10-11 04:50:27.577081
NCT00081861|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-23|2012-04-02|2009-03-05||March 2004||2004-03-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma|A Phase II Study of Avastin Plus Rituximab for Patients With Relapsed and Chemotherapy- or Rituxan-Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|13|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:50:27.666074|2017-10-11 04:50:27.666074
NCT00081874|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-23|2012-03-20|||April 2004||2004-04-01|March 2012|2012-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma|Phase I/II Study of RAD001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia in Blastic-Phase, Agnogenic Myeloid Metaplasia, Chronic Lymphocytic Leukemia, T-Cell Leukemia, or Mantle Cell Lymphoma|Completed||Phase 1/Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:50:27.896013|2017-10-11 04:50:27.896013
NCT00081887|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-23|2012-07-31|||May 2004||2004-05-01|July 2012|2012-07-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia|Phase I Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia|Terminated||Phase 1|8|Actual|M.D. Anderson Cancer Center||1||low accrual|f||||f||||||||||2017-10-11 04:50:27.992169|2017-10-11 04:50:27.992169
NCT00081900|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-26|2015-04-09|||March 2004||2004-03-01|April 2015|2015-04-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care|A Phase 1/2 Study of DENSPM (N1, N11-diethylnorspermine) in Patients With Unresectable Hepatocellular Carcinoma|Terminated||Phase 1/Phase 2|38|Actual|Sanofi||1||"This study was terminated early by Genzyme because there were insufficient data to support   clinical benefit to HCC patients on the study."|f||||t||||||||||2017-10-11 04:50:28.087462|2017-10-11 04:50:28.087462
NCT00081913|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-26|2008-01-23|||January 2004||2004-01-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|March 2006|Actual|2006-03-01||Interventional|||Stem Cell Study for Patients With Heart Disease|Injection of Autologous CD34-Positive Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia|Completed||Phase 1|24||Losordo, Douglas, M.D.|||||||||||||||||||2017-10-11 04:50:28.256869|2017-10-11 04:50:28.256869
NCT00081926|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-26|2009-11-20|||October 2003||2003-10-01|November 2009|2009-11-01|March 2007||2007-03-01|||||Interventional|||Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia||Completed||Phase 4|112||Novartis|||||||||||||||||||2017-10-11 04:50:28.333493|2017-10-11 04:50:28.333493
NCT00081939|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-27|2015-09-18|2015-09-18||January 2004||2004-01-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||UARK 2003-33, Total Therapy III|A Phase 2 Study Incorporating Bone Marrow Microenvironment (ME) Co-Targeting Bortezomib Into Tandem Melphalan-Based Autotransplants With DT PACE for Induction/Consolidation and Thalidomide + Dexamethasone for Maintenance|Completed||Phase 2|303|Actual|University of Arkansas||1|||f||||t||||||||||2017-10-11 04:50:28.424796|2017-10-11 04:50:28.424796
NCT00081952|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-27|2013-03-21|||October 2003||2003-10-01|March 2013|2013-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Amino Acid Therapy for Hot Flashes in Postmenopausal Women|Amino Acid Therapy for Hot Flashes/Postmenopausal Women|Completed||Phase 1/Phase 2|15||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-10-11 04:50:29.464113|2017-10-11 04:50:29.464113
NCT00081965|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-27|2012-12-11||||||December 2012|2012-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Acupuncture in Treating Hot Flashes in Women With Breast Cancer|Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients: A Randomized Controlled Trial|Completed||N/A|80|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:50:29.537438|2017-10-11 04:50:29.537438
NCT00081978|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-28|2010-04-26|||March 2004||2004-03-01|April 2010|2010-04-01|October 2005|Actual|2005-10-01|||||Interventional|||TMC125-C223: TMC125 in HIV-1 Infected Subjects|A Randomized, Controlled, Partially Blinded Phase IIb Dose-Finding Trial of TMC125 in HIV-1 Infected Subjects With Documented Genotypic Evidence of Resistance to Currently Available NNRTIs and With at Least Three Primary PI Mutations|Completed||Phase 2|211|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-10-11 04:50:29.615105|2017-10-11 04:50:29.615105
NCT00081991|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-28|2008-03-03|||April 2004||2004-04-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Dynamic Light Scattering for Studying Lens Aging and Cataract Formation|A Cross Sectional Clinical Study of Human Lens Aging and Cataract Formation, in Vivo, Using Dynamic Light Scattering (DLS)|Completed||N/A|267||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:29.675354|2017-10-11 04:50:29.675354
NCT00082017|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-28|2017-05-01|2012-06-06||April 5, 2004|Actual|2004-04-05|May 2017|2017-05-01|September 27, 2011|Actual|2011-09-27|September 27, 2011|Actual|2011-09-27||Interventional|||UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas|Phase II Study of UCN-01 in Relapsed or Refractory Systemic Anaplastic Large Cell and Mature T-Cell Lymphomas|Terminated||Phase 2|20|Actual|National Institutes of Health Clinical Center (CC)||2||IND was withdrawn by CTEP due to low accrual and cost of maintaining the IND.|f||||f|t|f|||t|||No||2017-10-11 04:50:30.025935|2017-10-11 04:50:30.025935
NCT00082030|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-28|2017-06-30|||April 19, 2004||2004-04-19|November 18, 2011|2011-11-18|November 18, 2011||2011-11-18|||||Observational|||Function of Catecholamines in the Brain During Depression|Neural Correlates of Depressive Symptoms and Reward Related Mechanisms Following AMPT Depletion in Remitted Depressed Patients Off Treatment and Healthy Controls|Completed||N/A|71|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:30.605098|2017-10-11 04:50:30.605098
NCT00082043|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-28|2017-10-05|||March 31, 2004||2004-03-31|February 5, 2016|2016-02-05|March 6, 2014|Actual|2014-03-06|March 6, 2014|Actual|2014-03-06||Interventional|||Dutasteride to Treat Women With Menstrually Related Mood Disorders|The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women With Menstrual-Related Mood Disorders and Controls|Completed||Phase 1|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:50:30.682044|2017-10-11 04:50:30.682044
NCT00082069|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-28|2015-04-28|||April 2004||2004-04-01|April 2015|2015-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Invaplex 50 Vaccine Dose-Ranging|Safety and Immunogenicity Study of an Intranasal Shigella Flexneri 2a Invaplex 50 Vaccine|Completed||Phase 1|32|Actual|U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-10-11 04:50:30.770262|2017-10-11 04:50:30.770262
NCT00082082|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-28|2008-01-08||||||January 2008|2008-01-01||||||||Interventional|||A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma|A Trial of Thymalfasin With Trans Arterial Chemo-Embolization (TACE) in the Treatment of Adult Patients With Unresectable Hepatocellular Carcinoma: A Phase II Trial|Completed||Phase 2|||SciClone Pharmaceuticals|||||||||||||||||||2017-10-11 04:50:30.853838|2017-10-11 04:50:30.853838
NCT00082095|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-29|2014-10-08|||April 2004||2004-04-01|October 2014|2014-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older|A Randomized, Open-Label Trial Comparing Treatment With Either Pegylated Liposomal Doxorubicin or Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older|Terminated||Phase 3|62|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2||"The study was terminated due to poor recruitment (after enrolling 62 of planned 300 patients in   20 months"|f||||f||||||||||2017-10-11 04:50:30.982775|2017-10-11 04:50:30.982775
NCT00082108|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-29|2017-08-11|||September 2000||2000-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry|National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members|Recruiting||N/A|3000|Anticipated|University of Rochester|||1||f||||f||||||||||2017-10-11 04:50:31.14448|2017-10-11 04:50:31.14448
NCT00082121|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-29|2007-07-19|||April 2004||2004-04-01|July 2007|2007-07-01|December 2005||2005-12-01|||||Interventional|||Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery||Completed||Phase 2|300||Avant Immunotherapeutics|||||||||||||||||||2017-10-11 04:50:31.225032|2017-10-11 04:50:31.225032
NCT00082134|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-29|2015-03-04||||||March 2015|2015-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel|A Phase II Study of ILX651 Administered Intravenously Daily for Five Consecutive Days Every 21 Days in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel|Completed||Phase 2|40||Sanofi|||||||||||||||||||2017-10-11 04:50:31.318125|2017-10-11 04:50:31.318125
NCT00082147|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-30|2017-10-05|||April 28, 2004||2004-04-28|July 5, 2017|2017-07-05|February 21, 2007|Actual|2007-02-21|||||Interventional|||Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer|A Prospective Histopathologic Study of Dynamic Contrast Enhanced MRI for Prostate Cancer Delineation and Characterization With the APT-MRI System|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:50:31.388678|2017-10-11 04:50:31.388678
NCT00082160|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-30|2006-08-03|||July 2001||2001-07-01|August 2006|2006-08-01|June 2005||2005-06-01|||||Observational|||Brain Imaging Technology to Examine the Effects of Meditation|fMRI Investigation of Meditation|Completed||N/A|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:50:31.464876|2017-10-11 04:50:31.464876
NCT00082173|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-30|2013-03-26|2013-03-26||October 2004||2004-10-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Interventional||125 had 8-week data (moxifloxacin n=64, ethambutol n=61)|Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis|Phase 2 Randomized Trial of a Moxifloxacin-Containing Regimen For Treatment of Smear-Positive Pulmonary Tuberculosis in Adults With and Without HIV Infection|Completed||Phase 2|170|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 04:50:31.533752|2017-10-11 04:50:31.533752
NCT00082186|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-30|2010-02-11|||July 2003||2003-07-01|February 2010|2010-02-01|November 2007|Actual|2007-11-01|February 2007|Actual|2007-02-01||Interventional|||The Effect of Tracleer® on Male Fertility|TRACLEER® (Bosentan) Pulmonary Arterial Hypertension A Multicenter, Open-label, Single-arm Safety Study to Investigate the Effects of Chronic TRACLEER® Treatment on Testicular Function in Male Patients With Pulmonary Arterial Hypertension|Completed||Phase 4|22|Actual|Actelion||1|||f||||||||||||||2017-10-11 04:50:31.807996|2017-10-11 04:50:31.807996
NCT00082199|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-30|2013-11-07|||April 2004||2004-04-01|July 2008|2008-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study of Aripiprazole in Subjects With Alcoholism|A Randomized, Multicenter, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Aripiprazole in the Maintenance of Abstinence From Alcohol in Subjects With Alcoholism|Completed||Phase 4|400||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-10-11 04:50:31.914412|2017-10-11 04:50:31.914412
NCT00082212|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-03|2010-04-08|||November 2004||2004-11-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|A Phase II Trial of Single-agent Cetuximab Dose Escalated to Rash in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Terminated||Phase 2|25|Actual|ImClone LLC||1||Due to lack of sufficient efficacy.|f||||f||||||||||2017-10-11 04:50:32.017501|2017-10-11 04:50:32.017501
NCT00082225|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-03|2017-02-03|||October 2003||2003-10-01|February 2017|2017-02-01|January 2008|Actual|2008-01-01|February 2006|Actual|2006-02-01||Interventional|ACDAL||LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)|Administration of LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody to Patients With Relapsed EBV-Positive Hodgkin's or Non-Hodgkin's Lymphoma|Terminated||Phase 1|4|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 04:50:32.117564|2017-10-11 04:50:32.117564
NCT00082238|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-03|2010-03-01|||March 2003||2003-03-01|March 2010|2010-03-01||||||||Interventional|||Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)|Increased Gluconeogenesis is One Cause of CFRD|Completed||N/A|60|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:50:32.206778|2017-10-11 04:50:32.206778
NCT00082251|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-03|2006-10-31||||||October 2006|2006-10-01||||||||Interventional|||Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST|Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST|Completed||Phase 3|||Kos Pharmaceuticals|||||||||||||||||||2017-10-11 04:50:32.267162|2017-10-11 04:50:32.267162
NCT00082277|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-05|2011-01-25|||April 2004||2004-04-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|SABRE||Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer|A Multicentre Phase III/IV Study, of the Effects of Risedronate Sodium (ACTONEL™, 35mg/Week, Oral) on Bone, in Postmenopausal Women, With Hormone-receptor-positive Early Breast Cancer, Treated With Anastrozole (ARIMIDEX™, 1mg/Day Oral) With Risk of Fragility Fracture (High-risk Fragility Fracture-open-label, Non-comparative Stratum; Moderate-risk of Fragility Fracture-randomised, Double-blind Stratum; Low-risk of Fragility Fracture - Open-label, Non-comparative Stratum)Abbreviated|Completed||Phase 4|237|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 04:50:32.351526|2017-10-11 04:50:32.351526
NCT00082290|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-05|2015-12-17|||May 2003||2003-05-01|December 2015|2015-12-01||||February 2011|Actual|2011-02-01||Interventional|||Massage Therapy in Treating Patients With Cancer Pain|Massage for the Treatment of Pain in Cancer: A Randomized Phase II Study|Completed||Phase 2|92|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-10-11 04:50:32.558383|2017-10-11 04:50:32.558383
NCT00082303|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-05|2006-08-16|||July 2002||2002-07-01|August 2006|2006-08-01||||||||Interventional|||Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin’s Lymphoma|Music Imagery for Patients in Protected Environments|Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:50:32.655809|2017-10-11 04:50:32.655809
NCT00168974|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-15|||January 2004||2004-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||Neuropathic Pain and Fabry Disease|Somatosensoric and Autonomic Disturbances in Female Patients With Fabry Disease|Completed||N/A|25||Danish Pain Research Center|||||f||||||||||||||2017-10-11 05:25:16.171146|2017-10-11 05:25:16.171146
NCT00082316|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-05|2008-01-03||||||January 2008|2008-01-01||||||||Interventional|||Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain|A Randomized, Open-Label Study of the Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain|Completed||Phase 2|||NeurogesX|||||||||||||||||||2017-10-11 04:50:32.722142|2017-10-11 04:50:32.722142
NCT00082329|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-06|2014-04-01|2014-04-01||May 2004||2004-05-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers|Peripheral Blood Hematopoietic Progenitor Cell Mobilization Using Granulocyte Colony Stimulating Factor (G-CSF) Combined With AMD3100 Mozobil (Plerixafor) in Healthy Volunteers|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:50:32.837831|2017-10-11 04:50:32.837831
NCT00082342|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-06|2012-11-22|2012-08-31||March 2003||2003-03-01|November 2012|2012-11-01||||February 2009|Actual|2009-02-01||Interventional|||Transcranial Direct Current Stimulation to Treat Symptoms of Parkinson's Disease|Transcranial Direct Current Stimulation for the Treatment of Parkinson's Disease|Completed||Phase 2|25|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:50:33.222848|2017-10-11 04:50:33.222848
NCT00082355|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-06|2014-10-31|2011-02-08||May 2004||2004-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|March 2010|Actual|2010-03-01||Interventional|||Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins|"The Treatment of Deep Vein Thrombosis (DVT) of the Lower Extremities With Low-Dose Alteplase: a Pilot Study"|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)|Small trial of 30 patients does not have statistical power to prove clinical safety (expected to be <1 %)|1|||f||||f||||||||||2017-10-11 04:50:33.684685|2017-10-11 04:50:33.684685
NCT00082368|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-07|2017-08-16|2015-04-15||May 16, 2004|Actual|2004-05-16|August 2017|2017-08-01|April 14, 2014|Actual|2014-04-14|April 14, 2014|Actual|2014-04-14||Interventional|||PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy|A Pilot Study of Tc-94m Sestamibi PET MDR Imaging|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)|The lack of flexibility around patient chemotherapy schedules made the protocol difficult to conduct. Future studies should make imaging integral to the treatment protocol .|1|||f||||f|t|f||||||||2017-10-11 04:50:33.894158|2017-10-11 04:50:33.894158
NCT00082381|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-06|2015-03-19|2009-07-16||June 2003||2003-06-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin|Effect of AC2993 (Synthetic Exendin-4) Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin|Completed||Phase 3|551|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:50:34.229673|2017-10-11 04:50:34.229673
NCT00082394|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-06|2017-05-23|||April 26, 2004|Actual|2004-04-26|May 2017|2017-05-01|March 1, 2006|Actual|2006-03-01|March 1, 2006|Actual|2006-03-01||Interventional|||A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV|A Phase IV Randomized, Multicenter, Open-Label Study to Compare the Safety, Tolerability and Efficacy of Trizivir (Abacavir 300mg, Lamivudine 150mg, and Zidovudine 300mg) BID vs Combivir (Lamivudine 150mg and Zidovudine 300mg) BID Plus Atazanavir 400mg QD in Antiretroviral Naive HIV-1 Infected Subjects Over 48 Weeks|Completed||Phase 4|||GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:50:35.069502|2017-10-11 04:50:35.069502
NCT00082407|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-06|2015-03-19|2009-07-16||November 2003||2003-11-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||IIT population|Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin|Efficacy of Exenatide (AC2993, Synthetic Exendin-4, LY2148568) Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin|Completed||Phase 3|505|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:50:35.270226|2017-10-11 04:50:35.270226
NCT00082420|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-06|2010-01-12|||September 2004||2004-09-01|January 2010|2010-01-01|November 2005|Actual|2005-11-01|||||Observational|||Retinol Equivalence of Plant Carotenoids in Children||Completed||N/A|32|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||||||||||||2017-10-11 04:50:36.188654|2017-10-11 04:50:36.188654
NCT00082433|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-07|2016-02-09|2009-05-01||November 2003||2003-11-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer|A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane|Completed||Phase 3|1221|Actual|R-Pharm||2|||f||||t||||||||||2017-10-11 04:50:36.323673|2017-10-11 04:50:36.323673
NCT00082446|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-10|2014-12-18|||May 2004||2004-05-01|September 2008|2008-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combination Study With MVA BN and Dryvax|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of MVA-BN in a Dose Response Regimen Followed by Administration of Dryvax in Healthy Adult Volunteers|Completed||Phase 1|91|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-10-11 04:50:39.300512|2017-10-11 04:50:39.300512
NCT00082459|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-10|2012-09-06|||July 2002||2002-07-01|September 2012|2012-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma|A Randomized Phase II Study Investigating the Route of Administration of Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|40||Agenus Inc.||||Lack of enrollment|||||||||||||||2017-10-11 04:50:39.414055|2017-10-11 04:50:39.414055
NCT00082472|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-11|2006-04-14|||January 2004||2004-01-01|April 2006|2006-04-01||||||||Interventional|||Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)|Phase I/II Study of Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Locally Advanced or Metastatic Unresectable Non Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|30||Zivena|||||||||||||||||||2017-10-11 04:50:39.473004|2017-10-11 04:50:39.473004
NCT00082485|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-11|2017-01-11|||June 2004||2004-06-01|August 2016|2016-08-01||||July 2006|Actual|2006-07-01||Interventional|||Baclofen for the Treatment of Cocaine Dependence - 1|Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence|Completed||Phase 2|160|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-10-11 04:50:39.540208|2017-10-11 04:50:39.540208
NCT00169403|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-28||||||September 2005|2005-09-01||||||||Interventional|||Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia||Unknown status|Recruiting|Phase 3|||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-10-11 05:25:19.511646|2017-10-11 05:25:19.511646
NCT00082498|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-11|2014-07-22|||May 2004||2004-05-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|December 2005|Actual|2005-12-01||Interventional|||Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients|Phase II, Randomized, Double-Blind Study of the Safety and Efficacy of Vicriviroc (An Orally Administered HIV-1 Entry Inhibitor) in HIV-Infected, Treatment-Experienced Subjects|Completed||Phase 2|119|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 04:50:39.631832|2017-10-11 04:50:39.631832
NCT00082511|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-11|2008-01-10|||July 2003||2003-07-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids|A Multi-Center, Open-Label Study to Assess the Durability and Safety of the Prevention of Bone Loss by Treatment With GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids|Completed||Phase 3|114|Actual|Genelabs Technologies||4|||f||||f||||||||||2017-10-11 04:50:39.775117|2017-10-11 04:50:39.775117
NCT00082524|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-11|2017-02-20|||April 2004||2004-04-01|February 2017|2017-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)|A Multicenter, Open-Label, Noncomparative Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in Children With Documented Candida or Aspergillus Infections|Completed||Phase 2|50|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:50:39.874289|2017-10-11 04:50:39.874289
NCT00082537|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-11|2017-02-20|||April 2004||2004-04-01|February 2017|2017-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)|A Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Versus (Amphotericin B) Liposome for Injection as Empirical Therapy in Pediatric Patients With Persistent Fever and Neutropenia|Completed||Phase 2|100|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:50:39.94064|2017-10-11 04:50:39.94064
NCT00082550|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-12|2017-06-30|||May 10, 2004||2004-05-10|April 9, 2007|2007-04-09|April 9, 2007||2007-04-09|||||Observational|||Serotonin Transporters in Obsessive-Compulsive-Related Disorders|PET Imaging of Monoamine Transporters in OCD-related Disorders|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:40.024128|2017-10-11 04:50:40.024128
NCT00082563|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-12|2011-04-25|||August 2004||2004-08-01|April 2011|2011-04-01|November 2004|Actual|2004-11-01|||||Interventional|||Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum|A Phase II, Randomized, Comparative Trial Of Azithromycin In Combination With Chloroquine Versus Chloroquine In The Eradication Of Asymptomatic Plasmodium Falciparum Infection In Semi-Immune Adults|Terminated||Phase 2|14|Actual|Pfizer|||||||||||||||||||2017-10-11 04:50:40.275376|2017-10-11 04:50:40.275376
NCT00082576|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-12|2011-05-10|||June 2004||2004-06-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa|A Phase II/III, Randomized, Double-Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Mefloquine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Africa|Completed||Phase 2/Phase 3|238|Actual|Pfizer|||||||||||||||||||2017-10-11 04:50:40.347108|2017-10-11 04:50:40.347108
NCT00082589|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-12|2008-05-22|||April 2004||2004-04-01|April 2007|2007-04-01|March 2006||2006-03-01|||||Interventional|REMODEL||The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure|A Randomized, Double-Blind, Multi-Center,Study Evaluating the Effects of Eplerenone Versus Placebo on Ventricular Remodeling in Patient's With Left Ventricular Systolic Dysfunction (EF Less Than or Equal to 35%) and Mild to Moderate Heart Failure|Completed||Phase 4|250||Pfizer|||||||||||||||||||2017-10-11 04:50:40.473773|2017-10-11 04:50:40.473773
NCT00082602|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-12|2011-05-19|||May 2004||2004-05-01|April 2009|2009-04-01|April 2005|Actual|2005-04-01|||||Interventional|||Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease|Galantamine ER Open Label Rapid Dose Escalation Trial in Alzheimer's Disease|Completed||Phase 3|83|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 04:50:40.68696|2017-10-11 04:50:40.68696
NCT00082615|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-13|2017-06-30|||May 11, 2004||2004-05-11|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Neurophysiological Markers in Patients With Craniofacial Dystonia and Their Relatives|Neurophysiological Markers in Patients With Craniofacial Dystonia and Their Relatives|Completed||N/A|210||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:40.758063|2017-10-11 04:50:40.758063
NCT00082641|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-05-14|||January 2004||2004-01-01|May 2013|2013-05-01||||December 2014|Anticipated|2014-12-01||Interventional|||Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant Radiation Therapy in Treating Women With p53-Overexpressing Stage III Breast Cancer|1) Adenovirus p53 Infected DC Vaccine For Breast Cancer, 2) Translation of Biotechnology Into the Clinic|Unknown status|Active, not recruiting|Phase 1/Phase 2|24|Actual|University of Nebraska||2|||f||||t||||||||||2017-10-11 04:50:40.938474|2017-10-11 04:50:40.938474
NCT00082654|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2010-09-17|||March 2002||2002-03-01|September 2010|2010-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients|Emotional Needs of Caregivers and Patient/Spouse Couples During Hematopoietic Stem Cell Transplantation (HSCT)|Completed||N/A|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:50:41.013152|2017-10-11 04:50:41.013152
NCT00082667|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-02-22|||October 2002||2002-10-01|February 2013|2013-02-01|June 2005|Actual|2005-06-01|July 2004|Actual|2004-07-01||Interventional|||Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast|EGFR Pathway Modulation In Patients With Ductal Carcinoma In Situ Of The Breast|Terminated||Phase 2|1|Actual|Vanderbilt-Ingram Cancer Center||||PI left VICC|f||||t||||||||||2017-10-11 04:50:41.119361|2017-10-11 04:50:41.119361
NCT00083824|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2016-04-19|||March 2004||2004-03-01|April 2016|2016-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Estrogen, HDL, and Coronary Heart Disease in Women|Estrogen, HDL, and Coronary Heart Disease in Women|Completed||Phase 2/Phase 3|309|Actual|Tufts University||3|||f||||f||||||||||2017-10-11 04:50:58.861415|2017-10-11 04:50:58.861415
NCT00082706|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2016-12-19|||April 2003||2003-04-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant|Phase II Trial of 5-FU, Leucovorin, Gemcitabine, and Cisplatin for Adenocarcinomas of the Urothelial Tract and Urachal Remnant|Active, not recruiting||Phase 2|46|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:50:41.208932|2017-10-11 04:50:41.208932
NCT00082719|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2015-05-12|||December 2003||2003-12-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium|Modulation of Death Effector Expression By Short-Term Exposure to Low-Dose Interferon|Completed||Phase 1|33|Actual|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-10-11 04:50:41.326444|2017-10-11 04:50:41.326444
NCT00082732|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2012-10-18|||July 2002||2002-07-01|October 2012|2012-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer|Impact of Dietary Intervention in Men With Hormone Refractory Prostate Cancer|Completed||Phase 1|56|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:50:41.438678|2017-10-11 04:50:41.438678
NCT00082745|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2017-08-16|||March 2004||2004-03-01|August 2017|2017-08-01||||January 2100|Anticipated|2100-01-01||Observational|||Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors|Key Adverse Events After Childhood Cancer|Recruiting||N/A|8100|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"     peripheral blood or buccal sample   "|||2017-10-11 04:50:41.558609|2017-10-11 04:50:41.558609
NCT00082758|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2015-01-27|2013-12-02||August 2005||2005-08-01|January 2015|2015-01-01|May 2012|Actual|2012-05-01|February 2008|Actual|2008-02-01||Interventional|||hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma|A Phase II Study Of hu14.18-IL2 In Children With Recurrent Or Refractory Neuroblastoma|Completed||Phase 2|39|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-10-11 04:50:43.762708|2017-10-11 04:50:43.762708
NCT00082784|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2014-12-22|||March 2004||2004-03-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|October 2012|Actual|2012-10-01||Interventional|||Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms|Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol NSC 649890) in Patients With Recurrent or Refractory Indolent B-Cell Neoplasms|Completed||Phase 1|93|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:50:44.863568|2017-10-11 04:50:44.863568
NCT00082797|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2010-01-28|||February 2005||2005-02-01|January 2010|2010-01-01||||May 2007|Actual|2007-05-01||Interventional|||High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase II Study Of Systemic High-Dose Methotrexate For The Treatment Of Glioblastoma Multiforme In Newly Diagnosed Patients With Measurable Disease|Completed||Phase 2|36|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:50:44.973904|2017-10-11 04:50:44.973904
NCT00082810|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2015-08-03|2015-05-04||March 2004||2004-03-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer|A Phase II Trial of Tipifarnib (R115777, Zarnestra™) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Hormone Receptor-Positive Breast Cancer|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:50:45.25278|2017-10-11 04:50:45.25278
NCT00082823|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2016-06-01|||January 2004||2004-01-01|June 2016|2016-06-01||||May 2008|Actual|2008-05-01||Interventional|||Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma|An Open-Label, Long-Term, Safety and Tolerability Study of VEGF Trap Administered Intravenously in Patients With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|25|Actual|Regeneron Pharmaceuticals||1|||f||||||||||||||2017-10-11 04:50:45.577088|2017-10-11 04:50:45.577088
NCT00082836|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-01-15|||December 2004||2004-12-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma|A Pilot Study of Radiolabeled Indium-111 and Yttrium-90 Ibritumomab Tiuxetan in Primary CNS Lymphoma|Completed||N/A|10|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:50:45.698167|2017-10-11 04:50:45.698167
NCT00082862|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2012-02-10|||July 2002||2002-07-01|December 2008|2008-12-01||||November 2012|Anticipated|2012-11-01||Interventional|||Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer|A Phase II Clinical Trial of a Timing/Schedule Optimized Combined-Modality Regimen: Cisplatin + Metronomic Low-Dose Interferon-α (IFN-α) Followed by Gemcitabine HCl (GEMZAR) in Combination With Mild, Fever-Range Whole-Body Hyperthermia (FR-WBH) in Patients With Advanced, Inoperable Pancreatic Cancer|Unknown status|Recruiting|Phase 2|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:50:45.778512|2017-10-11 04:50:45.778512
NCT00082875|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-06-04|||March 2004||2004-03-01|June 2013|2013-06-01||||July 2006|Actual|2006-07-01||Interventional|||Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma|A Phase 2 Study of EMD 121974 (Cilengitide, NSC 707544) in Patients With Metastatic Melanoma|Terminated||Phase 2|56|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:50:45.873136|2017-10-11 04:50:45.873136
NCT00082888|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2017-09-04|2011-11-02||March 24, 2004|Actual|2004-03-24|June 2017|2017-06-01||||May 20, 2009|Actual|2009-05-20||Interventional|||Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma|Phase II Evaluation of FTI (R115777) in Treatment of Relapsed and Refractory Lymphoma|Active, not recruiting||Phase 2|93|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:50:45.999097|2017-10-11 04:50:45.999097
NCT00082914|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-06-18|||March 2004||2004-03-01|December 2005|2005-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer|Phase II Evaluation of Denileukin Diftitox in Patients With Metastatic Melanoma or Metastatic Kidney Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:46.546768|2017-10-11 04:50:46.546768
NCT00082927|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-06-25|||April 2003||2003-04-01|June 2009|2009-06-01|July 2011|Actual|2011-07-01|||||Interventional|||Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain|A Multicentre Randomised Trial Of Single Dose Radiotherapy Compared To Ibandronate For Localised Metastatic Bone Pain|Completed||Phase 3|580|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:46.738387|2017-10-11 04:50:46.738387
NCT00082940|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2017-01-17|||August 2002||2002-08-01|June 2013|2013-06-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|||Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia|A Phase II Study of ONTAK® (Denileukin Diftitox, DABIL-2) in Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 04:50:46.899961|2017-10-11 04:50:46.899961
NCT00082966|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2015-12-03|||March 2004||2004-03-01|June 2013|2013-06-01||||March 2007|Actual|2007-03-01||Interventional|||Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase II Study of PS-341 (Bortezomib) in Patients With Relapsed or Refractory Hodgkin's Lymphoma|Completed||Phase 2|43|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:50:47.014424|2017-10-11 04:50:47.014424
NCT00082979|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-08-23|||October 2003||2003-10-01|December 2005|2005-12-01||||||||Interventional|||Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer|Evaluation of the Role of Duct Endoscopy in the Assessment of Cellular Atypia Within Breast Duct Fluid in High-Risk Women Carrying BRCA1/2 or p53 Gene Mutations|Unknown status|Recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:47.098899|2017-10-11 04:50:47.098899
NCT00083005|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2012-03-14|||March 2004||2004-03-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate|A Phase II Trial Combining Estramustine, Docetaxel And Thalidomide In Patients With Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:47.186172|2017-10-11 04:50:47.186172
NCT00083018|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-08-23|||September 2003||2003-09-01|December 2005|2005-12-01||||||||Interventional|||Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer|Evaluation Of The Role Of Nipple Aspiration, Ductal Lavage And Duct Endoscopy At The Time Of Surgery In Patients With Breast Cancer|Unknown status|Recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:47.269519|2017-10-11 04:50:47.269519
NCT00083031|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2009-02-06|||November 2002||2002-11-01|September 2005|2005-09-01||||||||Interventional|||Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer|Metronomic Chemotherapy in Combination With Bevacizumab for Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:50:47.348862|2017-10-11 04:50:47.348862
NCT00083044|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2012-04-24|||October 2003||2003-10-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy|Surrogate Endpoints in Prevention Studies and Ductal Lavage|Withdrawn||Phase 2|0|Actual|Northwestern University|||1|Funding ended and will not be renewed|f||||f||||||||||2017-10-11 04:50:47.428411|2017-10-11 04:50:47.428411
NCT00083057|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2012-03-14|||May 2004||2004-05-01|March 2012|2012-03-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck|A Pilot Phase I Dose Escalation Study Of The EGFR Tyrosine Kinase Inhibitor Gefitinib (Iressa) Combined With Paclitaxel (Taxol) And External Beam Radiation Therapy In Patients With Advanced Squamous Cell Carcinoma Of The Head And Neck (SCCHN)|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:50:47.526729|2017-10-11 04:50:47.526729
NCT00083070|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2014-02-18|||March 2004||2004-03-01|February 2014|2014-02-01|June 2008|Actual|2008-06-01|September 2004|Actual|2004-09-01||Interventional|||Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia|A Phase I Trial Of Temozolomide In Pediatric Patients With Refractory/Recurrent Leukemias|Completed||Phase 1|16|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:50:47.618871|2017-10-11 04:50:47.618871
NCT00083083|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2011-02-26|||March 2005||2005-03-01|October 2007|2007-10-01||||June 2006|Anticipated|2006-06-01||Interventional|||Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer|Positron Emission Tomography Pre- and Post-treatment Assessment For Locally Advanced Non-Small Cell Lung Carcinoma|Unknown status|Active, not recruiting|Phase 2|250|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:50:47.756586|2017-10-11 04:50:47.756586
NCT00083096|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2015-02-09|||March 2004||2004-03-01|February 2015|2015-02-01||||June 2009|Actual|2009-06-01||Interventional|||Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas|Phase I Study Of SCH66336 (Lonafarnib), A Farnesyl Protein Transferase Inhibitor In Combination With Temozolomide In Gliomas|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:50:47.964186|2017-10-11 04:50:47.964186
NCT00083109|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2015-05-22|||March 2004||2004-03-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|December 2005|Actual|2005-12-01||Interventional|||Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer|Phase I/II Trial Of Low Dose Suramin (CI-1003, NSC#34936) And 5-Fluorouracil In Patients With Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 1/Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:50:48.052224|2017-10-11 04:50:48.052224
NCT00083122|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2014-05-06|2013-03-22||April 2004||2004-04-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|July 2010|Actual|2010-07-01||Interventional|||Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer|Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:50:48.191898|2017-10-11 04:50:48.191898
NCT00083135|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2010-10-14|||March 2004||2004-03-01|May 2009|2009-05-01||||February 2006|Actual|2006-02-01||Interventional|||N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation|I-MIBG Escalating Dose Rapid Sequence Double Infusion Followed By Autologous Stem Cell Infusion For Refractory Neuroblastoma|Completed||Phase 1|18|Anticipated|Children's Hospital Los Angeles|||||f||||t||||||||||2017-10-11 04:50:48.669356|2017-10-11 04:50:48.669356
NCT00083837|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2016-07-11|||May 2004||2004-05-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Gene-Specific Responses to Exercise in Discordant Twins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:50:58.95505|2017-10-11 04:50:58.95505
NCT00083148|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2011-03-07|||November 2002||2002-11-01|March 2011|2011-03-01|September 2006|Actual|2006-09-01|March 2005|Actual|2005-03-01||Interventional|||Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer|Phase I Study of Irinotecan Followed by Capecitabine in Patients With Advanced Breast Carcinoma|Completed||Phase 1|12|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:50:48.758305|2017-10-11 04:50:48.758305
NCT00083161|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2012-09-01|||June 2003||2003-06-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Pilot Study of a Combination of Standard Etoposide/Cisplatin and Metronomic Cyclophosphamide in Patients With Newly Diagnosed Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|8|Actual|Gundersen Lutheran Health System||1|||f||||f||||||||||2017-10-11 04:50:48.826703|2017-10-11 04:50:48.826703
NCT00083187|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2013-07-17|||November 2005||2005-11-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|January 2007|Actual|2007-01-01||Interventional|||VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia|A Phase II Study of VNP40101M For Patients With Acute Myelogenous Leukemia Or High-Risk Myelodysplasia|Completed||Phase 2|230|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:50:49.963101|2017-10-11 04:50:49.963101
NCT00083213|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2016-06-01|||January 2004||2004-01-01|June 2016|2016-06-01||||May 2008|Actual|2008-05-01||Interventional|||Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma|An Open Label, Sequential Cohort Dose-Escalation Safety, Tolerability and Pharmacokinetic Study of VEGF Trap Administered Intravenously in Patients With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|25|Actual|Regeneron Pharmaceuticals||1|||f||||||||||||||2017-10-11 04:50:50.102338|2017-10-11 04:50:50.102338
NCT00083226|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2014-10-24|2014-10-24||March 2004||2004-03-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|February 2011|Actual|2011-02-01||Interventional||The primary population was the 38 eligible and treated patients|Doxorubicin and Bortezomib in Treating Patients With Liver Cancer|A Phase II Trial of Bortezomib Plus Doxorubicin in Hepatocellular Carcinoma|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:50:50.234698|2017-10-11 04:50:50.234698
NCT00083239|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|||Study of Talabostat in Advanced Melanoma||Completed||Phase 2|||Point Therapeutics|||||||||||||||||||2017-10-11 04:50:50.551764|2017-10-11 04:50:50.551764
NCT00083252|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-14|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|||Study of Talabostat and Cisplatin in Advanced Melanoma||Completed||Phase 2|||Point Therapeutics|||||||||||||||||||2017-10-11 04:50:50.625424|2017-10-11 04:50:50.625424
NCT00083265|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-15|2017-10-05|||May 10, 2004||2004-05-10|June 5, 2017|2017-06-05||||||||Observational|||Genetic Causes of Panic Disorder|Association Between Adenosine Receptor Gene Polymorphisms and Physiological Responses to Caffeine in Subjects With Panic Disorder and Healthy Controls|Completed||N/A|117|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:50.718976|2017-10-11 04:50:50.718976
NCT00083278|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-17|2012-04-26|||May 2003||2003-05-01|April 2012|2012-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Study of MDX-010 in Stage IV Breast Cancer|A Phase II Study of MDX-010 in Patients With Stage IV Adenocarcinoma of the Breast|Completed||Phase 2|33|Actual|Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 04:50:50.823766|2017-10-11 04:50:50.823766
NCT00083291|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-18|2008-03-03|||May 2004||2004-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Helicobacter Pylori and Dry Eye|Pilot Study of Helicobacter Pylori and Ocular Surface Disease|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:50.928201|2017-10-11 04:50:50.928201
NCT00083304|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-18|2013-05-08|||February 2004||2004-02-01|May 2013|2013-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|ENRICH||Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer|A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy With Supplemental Oxygen, With or Without Concurrent RSR13 (Efaproxiral), in Women With Brain Metastases From Breast Cancer|Completed||Phase 3|368|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||t||||||||||2017-10-11 04:50:51.002334|2017-10-11 04:50:51.002334
NCT00083317|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-19|2017-06-30|||May 15, 2004||2004-05-15|January 4, 2012|2012-01-04|January 4, 2012||2012-01-04|||||Observational|||Role of the Brain in Making Economic Decisions|The Role of the Prefrontal Cortex in Economic Decision-Making in Reciprocal Trust Games Using Functional Hyperscanning Neuroimaging|Completed||N/A|127|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:51.335751|2017-10-11 04:50:51.335751
NCT00083330|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-20|2017-06-30|||May 18, 2004||2004-05-18|October 1, 2009|2009-10-01|October 1, 2009|Actual|2009-10-01|October 1, 2009|Actual|2009-10-01||Interventional|||Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers|Completed||Phase 1|36||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:50:51.413078|2017-10-11 04:50:51.413078
NCT00083343|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-20|2017-02-20|||May 2004||2004-05-01|February 2017|2017-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)|A Multicenter, Open, Noncomparative Study to Estimate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in the Treatment of Adults With Invasive Candida Infections (Excluding Patients With Candidemia as the Sole Site of Infection)|Completed||Phase 2|48|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:50:51.485909|2017-10-11 04:50:51.485909
NCT00083356|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-21|2008-03-03|||May 2004||2004-05-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Bradykinin Receptors and Pain|Bradykinin-1 Receptor and Kinin Induction in a Clinical Model of Tissue Injury|Completed||Phase 2|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:51.576405|2017-10-11 04:50:51.576405
NCT00083369|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-21|2013-11-16|||September 2002||2002-09-01|November 2013|2013-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Genetic and Environmental Determinants of Triglycerides (GOLDN)||Completed||N/A|1327|Actual|University of Alabama at Birmingham|||1||f||||||||||||||2017-10-11 04:50:51.66029|2017-10-11 04:50:51.66029
NCT00083382|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-21|2015-06-05|2015-06-05||December 1998||1998-12-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide|UARK 98-036, A Phase II Trial of Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide in Patients With Smoldering/Indolent Myeloma|Completed||Phase 2|83|Actual|University of Arkansas||1|||f||||f||||||||||2017-10-11 04:50:51.745072|2017-10-11 04:50:51.745072
NCT00083395|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-22|2008-03-03|||May 2004||2004-05-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy|Utility of Isoproterenol Challenge Test to Detect Disease in Patients With Incomplete Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:52.114169|2017-10-11 04:50:52.114169
NCT00083408|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-24|2010-07-01|||March 1998||1998-03-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide|UARK 99-016, A Phase II Trial of Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide in Patients With Multiple Myeloma and Poor Hematopoietic Stem Cell Reserve|Completed||Phase 2|20||University of Arkansas|||||||||||||||||||2017-10-11 04:50:52.192752|2017-10-11 04:50:52.192752
NCT00083421|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-24|2012-06-12|||June 2004||2004-06-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|||||Interventional|||Effects of ONO-2506PO in Patients With Alzheimer's Disease|Effects of ONO-2506PO in Patients With Alzheimer's Disease|Completed||Phase 2|647|Actual|Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 04:50:52.410372|2017-10-11 04:50:52.410372
NCT00083434|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-24|2011-04-25|||February 2004||2004-02-01|April 2011|2011-04-01|October 2004|Actual|2004-10-01|||||Interventional|||Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy||Terminated||Phase 3|||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||This study was stopped because of an inadequate rate of enrollment.|||||t||||||||||2017-10-11 04:50:52.683043|2017-10-11 04:50:52.683043
NCT00083447|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-24|2009-01-06|||May 2004||2004-05-01|January 2008|2008-01-01|June 2007|Anticipated|2007-06-01|March 2006|Actual|2006-03-01||Interventional|||Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme|A Phase III Multicenter Study of Intratumoral/Interstitial Therapy With TransMID™ Compared to Best Standard of Care in Patients With Progressive and/or Recurrent, Non-Resectable Glioblastoma Multiforme|Withdrawn||Phase 3|323||Xenova Biomedix||||This study has been withdrawn because the drug would not meet trial criteria for efficacy|f||||||||||||||2017-10-11 04:50:52.764549|2017-10-11 04:50:52.764549
NCT00083460|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-24|2010-07-30|||December 2001||2001-12-01|July 2010|2010-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Combination PS-341 and Thalidomide in Multiple Myeloma|UARK 2001-37, A Phase I Exploratory Study of Combination PS-341 and Thalidomide in Refractory Multiple Myeloma|Completed||Phase 1|86|Actual|University of Arkansas||2|||f||||t||||||||||2017-10-11 04:50:52.892869|2017-10-11 04:50:52.892869
NCT00083473|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-24|2005-08-26|||May 2004||2004-05-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia|A Pilot Study of Pivanex, a Histone Deacetylase Inhibitor, in Patients With Chronic Lymphocytic Leukemia|Terminated||Phase 2|28||Titan Pharmaceuticals|||||||||||||||||||2017-10-11 04:50:52.982264|2017-10-11 04:50:52.982264
NCT00083486|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-24|2011-04-25|||February 2004||2004-02-01|April 2011|2011-04-01|October 2004|Actual|2004-10-01|||||Interventional|||Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy||Terminated||Phase 3|||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:50:53.04361|2017-10-11 04:50:53.04361
NCT00083499|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-25|2017-10-05|||May 24, 2004||2004-05-24|September 14, 2017|2017-09-14||||||||Observational|||Mutations in Genes Associated With Pentalogy of Cantrell|Mutations in Genes Associated With Pentalogy of Cantrell|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:53.13433|2017-10-11 04:50:53.13433
NCT00083512|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-25|2017-10-05|||May 21, 2004||2004-05-21|August 25, 2017|2017-08-25||||||||Observational|||Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme|Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:53.221768|2017-10-11 04:50:53.221768
NCT00083525|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-25|2008-01-21|||May 2004||2004-05-01|January 2008|2008-01-01||||||||Interventional|||Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies||Completed||Phase 1|33|Anticipated|Wilex|||||||||||||||||||2017-10-11 04:50:53.344649|2017-10-11 04:50:53.344649
NCT00083538|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-25|2010-07-06|||February 2001||2001-02-01|July 2010|2010-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally|UARK 2000-46, A Phase II Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally in Multiple Myeloma Patients|Completed||Phase 2|40|Actual|University of Arkansas||1|||f||||f||||||||||2017-10-11 04:50:53.410295|2017-10-11 04:50:53.410295
NCT00083551|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-25|2015-10-21|2015-08-24||August 1998||1998-08-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy|UARK 98-026, Total Therapy II - A Phase III Study for Newly Diagnosed Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy|Completed||Phase 3|668|Actual|University of Arkansas||2|||f||||t||||||||||2017-10-11 04:50:53.558899|2017-10-11 04:50:53.558899
NCT00083564|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-25|2009-03-30|||March 2004||2004-03-01|March 2009|2009-03-01||||||||Interventional|||Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma|A Randomized Multicenter Study to Compare the Safety and Efficacy of 166Ho-DOTMP Plus Melphalan to Melphalan Alone as Conditioning for Autologous Peripheral Blood Stem Cell Transplant in Subjects With Primary Refractory Multiple Myeloma|Terminated||Phase 3|240||Poniard Pharmaceuticals||||For business reasons|||||||||||||||2017-10-11 04:50:55.73964|2017-10-11 04:50:55.73964
NCT00083577|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-25|2010-07-01|||February 1998||1998-02-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma|UARK 98-003, A Phase II Pilot Study of Anti-Angiogenesis Therapy Using Thalidomide in Patients With Multiple Myeloma|Completed||Phase 2|250||University of Arkansas|||||||||||||||||||2017-10-11 04:50:55.840965|2017-10-11 04:50:55.840965
NCT00083590|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-26|2008-02-19|||April 2004||2004-04-01|February 2008|2008-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Huperzine A in Alzheimer's Disease|A Multi-Center, Double-Blind, Placebo-Controlled Therapeutic Trial to Determine Whether Natural Huperzine A Improves Cognitive Function|Completed||Phase 2|150|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:50:55.908215|2017-10-11 04:50:55.908215
NCT00083603|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-26|2013-08-21|||September 2004||2004-09-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults|A Phase I Trial to Evaluate the Safety and Immunogenicity of rMVA-HIV (rMVA-HIV Env/Gag + rMVA-HIV Tat/Rev/Nef-RT) and rFPV-HIV (rFPV-HIV Env/Gag + rFPV-HIV Tat/Rev/Nef-RT) Vaccines, Alone or in Combination, in Healthy, Vaccinia Naive HIV-1 Negative Participants|Completed||Phase 1|150|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||16|||f||||||||||||||2017-10-11 04:50:56.024422|2017-10-11 04:50:56.024422
NCT00083616|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-26|2013-12-10|2010-08-06||March 2004||2004-03-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|May 2007|Actual|2007-05-01||Interventional|||Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy|A Phase 2 Multicenter Single Arm Clinical Trial of ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy|Completed||Phase 2|185|Actual|Amgen||1|||f||||t||||||||||2017-10-11 04:50:56.180392|2017-10-11 04:50:56.180392
NCT00083629|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-27|2008-03-03|||May 2004||2004-05-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Use of [18F]FECNT in Positron Emission Tomography|PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Dopamine Transporter Ligand [18F]FECNT|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:56.984919|2017-10-11 04:50:56.984919
NCT00083642|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-27|2017-06-30|||May 25, 2004||2004-05-25|June 13, 2008|2008-06-13|June 13, 2008||2008-06-13|||||Observational|||Observational Learning in Stroke Patients|Neural Correlates of Observational Motor Learning in Chronic Stroke Patients|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:57.096487|2017-10-11 04:50:57.096487
NCT00083668|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-27|2011-06-06|||April 2004||2004-04-01|March 2010|2010-03-01|May 2005|Actual|2005-05-01|||||Interventional|||Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia|A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 3 Fixed Dosages of Paliperidone Extended Release (ER) Tablets and Olanzapine, With Open-label Extension, in the Treatment of Patients With Schizophrenia|Completed||Phase 3|619|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:50:57.172842|2017-10-11 04:50:57.172842
NCT00083681|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-27|2010-07-01|||June 1998||1998-06-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse|UARK 98-018, A Randomized Phase II Trial of DCEP or DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse in Patients With Multiple Myeloma|Completed||Phase 2|180||University of Arkansas|||||||||||||||||||2017-10-11 04:50:57.275734|2017-10-11 04:50:57.275734
NCT00083694|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-27|2010-07-01|||August 1998||1998-08-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia|UARK, 98-032, Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia|Completed||Phase 2|25||University of Arkansas|||||||||||||||||||2017-10-11 04:50:57.392128|2017-10-11 04:50:57.392128
NCT00083707|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-27|2010-07-01|||January 1999||1999-01-01|July 2010|2010-07-01|February 2003||2003-02-01|||||Interventional|||Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia|UARK 99-006, A Phase II Pilot Study of Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia|Completed||Phase 2|40||University of Arkansas|||||||||||||||||||2017-10-11 04:50:57.521598|2017-10-11 04:50:57.521598
NCT00083720|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-28|2011-05-19|2009-04-16||October 2004||2004-10-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy|A Phase II Multicenter Study of Erbitux (Cetuximab) in Patients With Refractory, EGFR-Negative Metastatic Colorectal Carcinoma|Completed||Phase 2|87|Actual|ImClone LLC||1|||f||||f||||||||||2017-10-11 04:50:57.638439|2017-10-11 04:50:57.638439
NCT00083733|ClinicalTrials.gov processed this data on October 10, 2017|2004-05-29|2017-06-30|||May 27, 2004||2004-05-27|November 17, 2010|2010-11-17|November 17, 2010||2010-11-17|||||Observational|||Genetic and Protein Profiling in Normal and Cancerous Breast Tissue|Procurement of Normal Breast Tissue and Metastatic Breast Cancer Tissue for Molecular Profiling|Completed||N/A|216|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:50:58.138255|2017-10-11 04:50:58.138255
NCT00083759|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-01|2016-07-14|2009-01-27||May 2004||2004-05-01|April 2009|2009-04-01||||February 2005|Actual|2005-02-01||Interventional|||Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate|A Phase II, Multicenter, Double-blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Intravenous Natalizumab (300 mg) in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Receiving Concomitant Treatment With Methotrexate (MTX)|Terminated||Phase 2|299|Actual|Biogen|The study was terminated prematurely on 28 February 2005. The biological effect seen with natalizumab was not sufficient to warrant further development in RA.|2||"The biological effect seen with natalizumab was not sufficient to warrant further development   in RA."|||||||||||||||2017-10-11 04:50:58.218392|2017-10-11 04:50:58.218392
NCT00083772|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2012-07-27|||May 2004||2004-05-01|July 2012|2012-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Use of Nesiritide in the Management of Acute Diastolic Heart Failure|The Use of Nesiritide in the Management of Acute Diastolic Heart Failure|Terminated||Phase 4|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:50:58.531976|2017-10-11 04:50:58.531976
NCT00083785|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2007-04-10|||May 2004||2004-05-01|April 2007|2007-04-01||||||||Interventional|||Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases|Safety and Effectiveness of Treating Cancers With the Litx™ System and Chemotherapy. Section A: Phase II Safety and Effectiveness Study in Patients With Liver Metastases From Colorectal Cancer|Completed||Phase 2|25||Light Sciences LLC|||||||||||||||||||2017-10-11 04:50:58.63657|2017-10-11 04:50:58.63657
NCT00083850|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2016-07-28|||June 2004||2004-06-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Genetics and Cardiovascular Reactivity in Young Twins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:50:59.001497|2017-10-11 04:50:59.001497
NCT00083876|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-02|2010-07-01|||September 1998||1998-09-01|July 2010|2010-07-01|November 2007|Actual|2007-11-01|||||Interventional|||D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma|UARK 98-035, A Phase III Study of D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma|Completed||Phase 3|500||University of Arkansas|||||f||||||||||||||2017-10-11 04:50:59.109368|2017-10-11 04:50:59.109368
NCT00083889|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-03|2010-01-19|2009-09-16||August 2004||2004-08-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma|A Phase 3, Randomized Study Of SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 3|750|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 04:50:59.565487|2017-10-11 04:50:59.565487
NCT00083902|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-03|2010-07-01|||June 1998||1998-06-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy|UARK 98-025, A Randomized Phase II Trial of Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy for Low-Risk Post Transplantation Relapse in Patients With Multiple Myeloma|Completed||Phase 2|190||University of Arkansas|||||||||||||||||||2017-10-11 04:51:07.205642|2017-10-11 04:51:07.205642
NCT00083928|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-03|2013-01-22|||May 2004||2004-05-01|January 2013|2013-01-01|December 2006|Actual|2006-12-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels|A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Å6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy|Completed||Phase 2|60|Anticipated|Ångstrom Pharmaceuticals|||||||||||||||||||2017-10-11 04:51:07.641384|2017-10-11 04:51:07.641384
NCT00083941|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-03|2011-06-28|||August 2004||2004-08-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer|Clinical Trial Phase II (Single Centre Study) : A Preliminary Study of the Safety, Immunogenicity, and Clinical Efficacy of TroVax Given in Conjunction With Interleukin 2 (IL-2) in the Treatment of Stage IV Renal Cell Cancer|Completed||Phase 2|25|Anticipated|Oxford BioMedica||1|||f||||||||||||||2017-10-11 04:51:07.921584|2017-10-11 04:51:07.921584
NCT00083954|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-03|2013-01-03|||June 2004||2004-06-01|January 2013|2013-01-01|August 2005|Actual|2005-08-01|||||Interventional|||Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression|A Confirmatory Multicenter, Double-blind, Randomized, Placebo Controlled Study of the Use of Quetiapine Fumarate (SEROQUEL) in the Treatment of Patients With Bipolar Depression|Completed||Phase 3|530||AstraZeneca|||||||||||||||||||2017-10-11 04:51:07.99072|2017-10-11 04:51:07.99072
NCT00083967|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-03|2015-04-09|||June 2004||2004-06-01|April 2015|2015-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment|A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Rhegmatogenous Retinal Detachment|Terminated||Phase 2|23|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:51:08.148921|2017-10-11 04:51:08.148921
NCT00083980|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-04|2012-10-18|||June 2002||2002-06-01|August 2006|2006-08-01|August 2004|Actual|2004-08-01|June 2004|Actual|2004-06-01||Interventional|||Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)|KAVA KAVA in Generalized Anxiety: A Double-Blind Trial|Terminated||Phase 2|16|Actual|National Center for Complementary and Integrative Health (NCCIH)||3||European reports of liver toxicity from kava meant that the study had to stop|f||||f||||||||||2017-10-11 04:51:08.299186|2017-10-11 04:51:08.299186
NCT00083993|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-04|2011-11-07|||May 2004||2004-05-01|November 2011|2011-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer|A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study of Oral CCI-779 Administered in Combination With Letrozole vs. Letrozole Alone as First Line Hormonal Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer|Terminated||Phase 3|1236||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:51:08.396228|2017-10-11 04:51:08.396228
NCT00084019|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-04|2014-06-02|||July 2004||2004-07-01|June 2014|2014-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Atazanavir/Ritonavir Maintenance Therapy|A Prospective, Open-Label, Pilot Trial of Regimen Simplification to Atazanavir/Ritonavir Alone as Maintenance Antiretroviral Therapy After Sustained Virologic Suppression|Completed||N/A|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:51:09.002769|2017-10-11 04:51:09.002769
NCT00084032|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-04|2012-10-26||||||October 2012|2012-10-01||||||||Interventional|||Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV|A Randomized, Multicenter Trial to Determine Whether Induction Therapy Followed by Treatment Interruption is Superior to Induction Therapy Alone in the Treatment of Primary HIV Infection (PHI): The Structured Treatment Interruption (STI) Study|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:51:09.16858|2017-10-11 04:51:09.16858
NCT00084045|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-04|2012-10-26|||November 2004||2004-11-01|October 2012|2012-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission|Mother Infant Rapid Intervention at Delivery (MIRIAD)|Completed||N/A|283|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:51:09.302459|2017-10-11 04:51:09.302459
NCT00084058|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-04|2012-05-17||||||May 2012|2012-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV|A Phase I/II Safety, Tolerability, and Pharmacokinetic Study of High Dose Lopinavir/Ritonavir With or Without Saquinavir in HIV-Infected Pediatric Subjects Previously Treated With Protease Inhibitors|Completed||Phase 1/Phase 2|26|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:51:09.430635|2017-10-11 04:51:09.430635
NCT00084071|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-04|2012-07-12|||May 2004||2004-05-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia|Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) for the Treatment of Patients With Severe Community-Acquired Pneumonia|Completed||Phase 3|2136|Actual|Novartis|||||f||||||||||||||2017-10-11 04:51:09.636935|2017-10-11 04:51:09.636935
NCT00084084|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-05|2014-03-25|2013-08-01||June 2004||2004-06-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Replagal Enzyme Replacement Therapy for Children With Fabry Disease|An Open Label Clinical Trial of Replagal Enzyme Replacement Therapy In Children With Fabry Disease Who Have Completed Study TKT023 or Who Are Naive to Enzyme Replacement Therapy|Completed||Phase 2|17|Actual|Shire||2|||f||||f||||||||||2017-10-11 04:51:10.062538|2017-10-11 04:51:10.062538
NCT00084097|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-05|2017-06-30|||June 2, 2004||2004-06-02|December 23, 2008|2008-12-23|February 5, 2007||2007-02-05|||||Interventional|||Omalizumab to Treat Eosinophilic Gastroenteritis|Pilot Study of Omalizumab in Eosinophilic Gastroenteritis|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:51:10.939847|2017-10-11 04:51:10.939847
NCT00084110|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-07|2006-08-17|||August 1993||1993-08-01|August 2006|2006-08-01|September 2000||2000-09-01|||||Observational|||Use of Complementary and Alternative Medicine Among Older Mexican Americans|Complementary Alternative Medicine|Terminated||N/A|3000||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:51:11.014795|2017-10-11 04:51:11.014795
NCT00084123|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-07|2009-07-09|||September 2002||2002-09-01|July 2009|2009-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Healing Touch and Relaxation Therapies in Cervical Cancer Patients|Healing Touch in Advanced Cervical Cancer Patients: Immune Effects and Mechanisms|Completed||Phase 2|60|Actual|National Center for Complementary and Integrative Health (NCCIH)||3|||f||||t||||||||||2017-10-11 04:51:11.238291|2017-10-11 04:51:11.238291
NCT00084136|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-07|2015-06-01|2011-07-13||May 2005||2005-05-01|June 2015|2015-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|PEARLS||Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings|Randomized, Open-Label Evaluation of Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combinations for Initial Treatment of HIV-1 Infected Persons From Resource-Limited Settings (PEARLS) Trial|Completed||Phase 4|1571|Actual|AIDS Clinical Trials Group||3|||f||||t||||||||||2017-10-11 04:51:11.383606|2017-10-11 04:51:11.383606
NCT00076258|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-16|2016-10-14|2015-11-17||April 2003||2003-04-01|October 2016|2016-10-01|August 2007|Actual|2007-08-01|October 2006|Actual|2006-10-01||Interventional|TREAD||Adding Exercise to Antidepressant Medication Treatment for Depression|Treatment With Exercise Augmentation for Depression (TREAD)|Completed||N/A|126|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 04:51:13.812575|2017-10-11 04:51:13.812575
NCT00076271|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-16|2017-06-30|||January 14, 2004||2004-01-14|October 28, 2008|2008-10-28|October 28, 2008||2008-10-28|||||Observational|||Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye Diseases|Evaluation and Treatment of Pediatric, Developmental and Genetic Eye Diseases|Completed||N/A|350||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:14.230558|2017-10-11 04:51:14.230558
NCT00076284|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-16|2008-03-03|||January 2004||2004-01-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||GW873140 to Treat HIV-1 Infected Adults|A Phase II, Double-Blind RAndomized, Placebo-Controlled Study to Evaluate the Antiviral Activity, Safety, Tolerability, and Pharmacokinetics of GW873130 for 10 Days in HIV-1 Infected Adults|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:14.29195|2017-10-11 04:51:14.29195
NCT00076310|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-20|2017-08-11|||January 2004|Actual|2004-01-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer|A Phase II Study of OSI-774 in Combination With Cisplatin and Docetaxel in Metastatic or Recurrent Head and Neck Squamous Cell Cancer|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 04:51:14.371181|2017-10-11 04:51:14.371181
NCT00076323|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-20|2010-07-26|||December 2003||2003-12-01|July 2010|2010-07-01|November 2006|Actual|2006-11-01|||||Interventional|||A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency|A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency|Completed||N/A|14||Walter Reed Army Institute of Research (WRAIR)|||||f||||||||||||||2017-10-11 04:51:14.479043|2017-10-11 04:51:14.479043
NCT00076336|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-20|2011-08-04|2011-01-03||December 2003||2003-12-01|August 2011|2011-08-01||||December 2009|Actual|2009-12-01||Interventional|||Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis|Randomized, Double-Blind Trial of Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis|Completed||Phase 3|232|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:51:14.589061|2017-10-11 04:51:14.589061
NCT00076349|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-20|2014-05-08|||April 2004||2004-04-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|December 2005|Actual|2005-12-01||Interventional|||SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)|A Multi-Center Phase II Study to Investigate the Safety and Activity of SDX-105 (Bendamustine) in Combination With Rituximab in Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|66|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 04:51:15.806|2017-10-11 04:51:15.806
NCT00076362|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-21|2011-09-08|||March 2004||2004-03-01|September 2011|2011-09-01||||July 2005|Actual|2005-07-01||Interventional|||Pediatric Hypothalamic Obesity||Completed||Phase 4|60|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:51:15.9366|2017-10-11 04:51:15.9366
NCT00076375|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-21|2005-06-23|||November 2003||2003-11-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Two Concentrations of Nanocrystalline Silver Cream (NPI) Applied Twice Daily in Adults With Mild to Moderate Atopic Dermatitis|Completed||Phase 2|180||Nucryst Pharmaceuticals|||||||||||||||||||2017-10-11 04:51:16.092719|2017-10-11 04:51:16.092719
NCT00076388|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-21|2011-05-12|||February 2004||2004-02-01|May 2011|2011-05-01|October 2007|Actual|2007-10-01|March 2007|Actual|2007-03-01||Interventional|||Iressa Versus Docetaxel (Taxotere)|A Randomized, Open-Label, Parallel Group, International, Multicenter, Phase III Study of Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non-Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy|Completed||Phase 3|1440||AstraZeneca|||||||||||||||||||2017-10-11 04:51:16.207116|2017-10-11 04:51:16.207116
NCT00076401|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-21|2014-06-25||||||June 2014|2014-06-01||||||||Interventional|||A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)|Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 2|27||Pharmacyclics LLC.|||||f||||||||||||||2017-10-11 04:51:16.570453|2017-10-11 04:51:16.570453
NCT00076414|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-21|2008-03-03|||January 2004||2004-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||The Effect of Lopinavir/Ritonavir on Endothelial Function|The Effect of Lopinavir/Ritonavir on Endothelial Function in Normal Volunteers|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:16.639401|2017-10-11 04:51:16.639401
NCT00076427|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-21|2017-10-05|||January 14, 2004||2004-01-14|June 9, 2015|2015-06-09|June 9, 2015||2015-06-09|||||Observational|||Leukapheresis for Research on HCV-Coinfected Patients|Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications|Completed||N/A|327|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:16.712557|2017-10-11 04:51:16.712557
NCT00076440|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-22|2009-12-10|||December 2003||2003-12-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study|Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study|Completed||Phase 2|90||National Institute on Aging (NIA)|||||||||||||||||||2017-10-11 04:51:17.101009|2017-10-11 04:51:17.101009
NCT00076453|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-22|2011-09-26|||June 2003||2003-06-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Orthotic Shoe Inserts for Controlling Osteoarthritic Knee Pain|Clinical Effects of Altered Biomechanics in Knee Osteoarthritis|Completed||N/A|100|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-10-11 04:51:17.245693|2017-10-11 04:51:17.245693
NCT00076466|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-22|2017-06-30|||January 22, 2004||2004-01-22|January 14, 2009|2009-01-14|January 14, 2009||2009-01-14|||||Observational|||Brain Changes Associated With Learning a Motor Task|Changes in Intracortical Inhibitory Processes Are Associated With the Development of Implicit Learning of a Motor Task|Completed||N/A|72||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:17.374417|2017-10-11 04:51:17.374417
NCT00076479|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-22|2008-03-03|||January 2004||2004-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Role of the Right Brain in Recovery of Language Function in Chronic Stroke||Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:17.460775|2017-10-11 04:51:17.460775
NCT00076492|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-23|2012-10-31|||January 2004||2004-01-01|October 2012|2012-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485|A Multi-center, Double-blind, Pilot Study of CoQ10 and GPI 1485 in Subjects With Early Untreated Parkinson's Disease|Completed||Phase 2|195||University of Rochester|||||f||||||||||||||2017-10-11 04:51:17.547975|2017-10-11 04:51:17.547975
NCT00076505|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-23|2017-06-30|||January 14, 2004||2004-01-14|November 30, 2006|2006-11-30|November 30, 2006||2006-11-30|||||Observational|||Cell Studies of Parkinson's Disease|Bioenergetic Function in Parkinson's Disease|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:17.632954|2017-10-11 04:51:17.632954
NCT00076518|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-26|2012-05-17||||||May 2012|2012-05-01|September 2005|Actual|2005-09-01|||||Interventional|||The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)|A Phase II Trial of the Effect of Combination Therapy With Fish Oil Supplement and Fenofibrate on Triglyceride (TG) Levels in Subjects on Highly Active Antiretroviral Therapy (HAART) Who Are Not Responding to Either Fish Oil or Fenofibrate Alone|Completed||Phase 2|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:51:17.734271|2017-10-11 04:51:17.734271
NCT00076531|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-26|2008-01-24|||December 2003||2003-12-01|January 2008|2008-01-01||||November 2004|Actual|2004-11-01||Interventional|||Clinical Trial for Prostate Cancer||Completed||Phase 3|||Oakwood Laboratories, LLC|||||||||||||||||||2017-10-11 04:51:17.863841|2017-10-11 04:51:17.863841
NCT00076544|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-26|2015-12-10|||February 2004||2004-02-01|December 2015|2015-12-01||||March 2005|Actual|2005-03-01||Interventional|||Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain|An Open-Label, Long-Term, Multi-Center, Intrathecal Ziconotide (PRIALT) Effectiveness and Safety Trial (ZEST) in Patients With Chronic Severe Pain|Completed||Phase 3|300||Elan Pharmaceuticals|||||||||||||||||||2017-10-11 04:51:17.961746|2017-10-11 04:51:17.961746
NCT00076557|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-26|2007-04-02|||January 2004||2004-01-01|January 2004|2004-01-01||||||||Interventional|||Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B|A Phase I Safety Study in Subjects With Severe Hemophilia B (Factor IX Deficiency) Using Adeno-Associated Viral Vector to Deliver the Gene for Human Factor IX Into the Liver|Terminated||Phase 1/Phase 2|15||Avigen|||||||||||||||||||2017-10-11 04:51:18.281648|2017-10-11 04:51:18.281648
NCT00076570|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-26|2013-08-12|2013-08-07||January 2004||2004-01-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Baseline analysis was performed using the patients who finished study.|Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation|Depletion Induction With Rabbit Anti-Thymocyte Globulin, Followed by Two Approaches Toward Monotherapy Immunosuppression in Kidney Transplant Recipients|Completed||Phase 2|31|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 04:51:18.355764|2017-10-11 04:51:18.355764
NCT00076583|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-26|2008-03-03|||January 2004||2004-01-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Spinal Reflexes in Motor Skill Learning|Motor Skill Learning: Spinal Reflexes|Completed||N/A|22||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:18.715937|2017-10-11 04:51:18.715937
NCT00076596|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-26|2017-06-30|||January 23, 2004||2004-01-23|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Brain Control of Movements in Cerebral Palsy|Brain Reorganization in Cerebral Palsy|Completed||N/A|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:18.784732|2017-10-11 04:51:18.784732
NCT00076609|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-27|2007-03-27|||October 2003||2003-10-01|March 2007|2007-03-01||||||||Interventional|||Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma|A Phase I/II Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|31||PhytoCeutica|||||||||||||||||||2017-10-11 04:51:18.864777|2017-10-11 04:51:18.864777
NCT00169793|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-03-04|||August 2005||2005-08-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2009|Actual|2009-12-01||Interventional|||Nephrolithiasis and Bariatric Surgery|Nephrolithiasis and Bariatric Surgery|Completed||N/A|89|Actual|Indiana Kidney Stone Institute||1|||f||||f||||||||||2017-10-11 05:25:27.166254|2017-10-11 05:25:27.166254
NCT00076635|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-28|2007-11-02|||November 2003||2003-11-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF|An Open-Label Study of the Safety of Subcutaneous Recombinant Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis|Terminated||Phase 3|91|Actual|InterMune||1||program discontinued based on GIPF-007 results|f||||f||||||||||2017-10-11 04:51:19.062485|2017-10-11 04:51:19.062485
NCT00076648|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-28|2006-07-31||||||July 2006|2006-07-01||||||||Interventional|||Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting|A Phase III, Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception From Informed Consent Requirements Designed to Evaluate the Safety and Efficacy of Poly SFH-P Injection [Polymerized Human Hemoglobin (Pyridoxylated), PolyHeme(R)] When Used to Treat Patients in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Prehospital Setting|Unknown status|Active, not recruiting|Phase 3|||Northfield Laboratories|||||||||||||||||||2017-10-11 04:51:19.166354|2017-10-11 04:51:19.166354
NCT00076674|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-28|2016-09-21|||January 2004||2004-01-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Levetiracetam Treatment of L-dopa Induced Dyskinesias|Levetiracetam Treatment of L-dopa Induced Dyskinesias|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:19.868525|2017-10-11 04:51:19.868525
NCT00076687|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-29|2011-08-30|2011-07-28||October 2003||2003-10-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function||Completed||Phase 2|155|Actual|Allergan||3|||f||||||||||||||2017-10-11 04:51:19.989173|2017-10-11 04:51:19.989173
NCT00076700|ClinicalTrials.gov processed this data on October 10, 2017|2004-01-31|2008-03-03|||January 2004||2004-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Enhanced Tactile Memory in the Blind|Enhanced Tactile Memory in the Blind|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:20.630932|2017-10-11 04:51:20.630932
NCT00076713|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-02|2013-02-11|||April 2000||2000-04-01|February 2013|2013-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|APSCORE||Antiphospholipid Syndrome Collaborative Registry (APSCORE)|Antiphospholipid Syndrome Collaborative Registry (APSCORE)|Completed||N/A|860|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"     Serum, plasma, genomic DNA   "|||2017-10-11 04:51:20.9384|2017-10-11 04:51:20.9384
NCT00076726|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-02|2011-05-16|||November 2003||2003-11-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis|A Randomized, Double-Masked, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Infliximab in Subjects With Giant Cell Arteritis|Terminated||Phase 2|44|Actual|Centocor, Inc.||||"Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative   glucocorticosteroid dosage"|||||t||||||||||2017-10-11 04:51:21.017191|2017-10-11 04:51:21.017191
NCT00076739|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-02|2017-06-30|||February 2, 2004||2004-02-02|December 12, 2011|2011-12-12|December 12, 2011||2011-12-12|||||Observational|||Study of Brain Function During Cognitive Tasks|Examining Associative Relations in Structured Event Complexes Using Functional Neuroimaging|Completed||N/A|452|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:21.107305|2017-10-11 04:51:21.107305
NCT00076752|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-02|2017-04-09|2014-03-25||January 30, 2004||2004-01-30|April 2017|2017-04-01|October 15, 2013|Actual|2013-10-15|October 15, 2013|Actual|2013-10-15||Interventional|||Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus|A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Systemic Lupus Erythematosus|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t|t|f||||||No||2017-10-11 04:51:21.214389|2017-10-11 04:51:21.214389
NCT00076791|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-03|2013-07-05|||March 2004||2004-03-01|July 2013|2013-07-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants|A Phase I Study of the Safety, Tolerance, and Pharmacokinetics of Tenofovir Disoproxil Fumarate (TDF) and the Combination of TDF Plus Emtricitabine in HIV-1 Infected Pregnant Women and Their Infants|Completed||Phase 1|66|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:51:22.204474|2017-10-11 04:51:22.204474
NCT00076804|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-03|2015-03-09|2010-06-01||February 2005||2005-02-01|March 2015|2015-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Helping HIV Infected Patients in South Africa Adhere to Drug Regimens|DOT-HAART for HIV-Infected South African Adults|Terminated||Phase 2|274|Actual|Johns Hopkins University|Intervention was stopped at 12 months, transition phase did not ensure that participants developed a set of adherence strategies to replace DOT-ART. Low incidence of AIDS-defining illness and death limit our ability to make final conclusions|2||DSMB stopped trial for futility|f||||t||||||||||2017-10-11 04:51:22.335061|2017-10-11 04:51:22.335061
NCT00076817|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-03|2012-10-26|||June 2006||2006-06-01|October 2012|2012-10-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm|A Phase I Double Blind Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of the Aventis Pasteur ALVAC-HIV (vCP205) Administered to the Groin Area Versus the Deltoid Area|Completed||Phase 1|18|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:51:22.709491|2017-10-11 04:51:22.709491
NCT00076830|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-12|2017-10-05|||February 2, 2004||2004-02-02|February 16, 2017|2017-02-16||||||||Observational|||Evaluation and Treatment of Patients With Connective Tissue Disease|Screening and Diagnosis of Patients With Connective Tissue Disorders|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:22.799785|2017-10-11 04:51:22.799785
NCT00076856|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-04|2017-05-08|||March 31, 2004|Actual|2004-03-31|May 2017|2017-05-01|March 31, 2006|Actual|2006-03-31|March 31, 2006|Actual|2006-03-31||Interventional|||Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)|A Randomized, Open-Label Phase 2 Study of Temozolomide Added to Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone for the Treatment of Brain Metastasis From Non-Small Cell Lung Cancer|Completed||Phase 2|95|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:51:22.980873|2017-10-11 04:51:22.980873
NCT00076869|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-05|2015-01-12|||January 2003||2003-01-01|January 2015|2015-01-01|August 2005|Actual|2005-08-01|September 2004|Actual|2004-09-01||Interventional|||MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)|A Multicenter, Open, Noncomparative Study to Estimate the Safety, Tolerability, and Efficacy of MK0991 in Combination With Amphotericin B, Lipid Formulations of Amphotericin B, or Azoles in the Treatment of Invasive Aspergillus Infection in Adults Who Are Refractory to or Intolerant of Standard Therapy|Completed||Phase 2|55|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:51:23.060284|2017-10-11 04:51:23.060284
NCT00076921|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-06|2013-04-08|||September 2002||2002-09-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Epidemiology & Intervention Research for Tobacco Control|Research on China Tobacco Control Epidemiology and Intervention|Completed||N/A|15705|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||f||||||None Retained|"     No bio-specimens collected. Sampled nicotine from buildings only.   "|||2017-10-11 04:51:23.148584|2017-10-11 04:51:23.148584
NCT00076934|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-06|2017-03-23|||January 2003||2003-01-01|March 2017|2017-03-01|February 2006|Actual|2006-02-01|||||Interventional|||Safety of RG2077 in Patients With Multiple Sclerosis|A Phase I Study: Safety of RG2077 (CTLA4-IgG4m) in Patients With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in: 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal.|2017-10-11 04:51:23.206028|2017-10-11 04:51:23.206028
NCT00076947|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-06|2008-03-20|||August 2003||2003-08-01|March 2005|2005-03-01||||||||Interventional|||Safety of the EnvPro HIV Vaccine in Healthy Volunteers|Evaluation of Tolerability and Safety of a Recombinant Purified HIV Envelope Vaccine|Completed||Phase 1|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:51:23.299918|2017-10-11 04:51:23.299918
NCT00076960|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-06|2016-12-12|||October 2003||2003-10-01|January 2016|2016-01-01||||July 2017|Anticipated|2017-07-01||Expanded Access|||Compassionate Use of Stanate (TM) [Stannsoporfin]|Compassionate Use of Stannsoporfin as an Adjuvant to Phototherapy to Reduce the Need for Exchange Transfusions|No longer available||N/A|||InfaCare Pharmaceuticals Corporation|||||||||||||||||||2017-10-11 04:51:23.371329|2017-10-11 04:51:23.371329
NCT00076973|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-06|2017-03-03|||August 2003||2003-08-01|March 2017|2017-03-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Interventional|||An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)|A Randomized, 2-Period, Multicenter, Dble-Blind, Parallel-Group Study Comparing Effects of 2 Doses of MK0476 and Placebo in the Tx of Respiratory Symptoms Associated w/ Respiratory Syncytial Virus-Induced Bronchiolitis in Children 3 to 24 Mths|Completed||Phase 3|1125|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:51:23.438029|2017-10-11 04:51:23.438029
NCT00076986|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-06|2011-06-02|||February 2004||2004-02-01|June 2011|2011-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme|PRECISE - Phase III Randomized Evaluation of Convection Enhanced Delivery of IL13-PE38QQR Compared to GLIADEL® Wafer With Survival Endpoint in Glioblastoma Multiforme Patients at First Recurrence|Completed||Phase 3|300||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:51:23.527495|2017-10-11 04:51:23.527495
NCT00076999|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-09|2014-04-25|2011-06-27||November 2003||2003-11-01|April 2014|2014-04-01||||June 2010|Actual|2010-06-01||Interventional|||Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children|Multiple-dose, Open-label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination With Low-dose Ritonavir in HIV-infected Pediatric Patients|Completed||Phase 1|115|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 04:51:23.768099|2017-10-11 04:51:23.768099
NCT00077012|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-09|2012-05-22|||March 2003||2003-03-01|May 2012|2012-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia|A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Transurethral Photodynamic Therapy With QLT0074 for Benign Prostatic Hyperplasia|Completed||Phase 1/Phase 2|||QLT Inc.|||||f||||||||||||||2017-10-11 04:51:27.28736|2017-10-11 04:51:27.28736
NCT00077025|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-09|2014-07-15|||January 2004||2004-01-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer|Phase II Multicenter, Double-Blind, Randomized Trial Comparing Anastrozole (ZD1033, Arimidex™)-Placebo to the Combination Anastrozole-ZD1839 (Gefitinib, IRESSA™) in Postmenopausal Patients With Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) Metastatic Breast Cancer|Completed||Phase 2|174|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:51:27.359319|2017-10-11 04:51:27.359319
NCT00077038|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-09|2017-06-30|||February 6, 2004||2004-02-06|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||Brain Activity in Visual-Motor Behavior|Modulation of the Visual Information Processing in the Human Parieto-Frontal Network as Studied by a Frequency Tagging Technique During Visuomotor Tracking|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:27.475608|2017-10-11 04:51:27.475608
NCT00077051|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-12-14|||April 2004||2004-04-01|December 2016|2016-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)|Translational Phase I Trial of Escalating Doses of 5-Chloro-2'-Deoxycytidine (CldC) With a Fixed Dose of Tetrahydrouridine Combined With a Fixed Dose of Cisplatin Concomitant With Definitive Radiation in Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity and Oropharynx|Completed||Phase 1|1|Actual|University of Miami||1|||f||||||||||||||2017-10-11 04:51:27.534775|2017-10-11 04:51:27.534775
NCT00077077|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2012-05-15|||February 2004||2004-02-01|May 2012|2012-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Study Of The Combination Of Oral DJ-927 And Capecitabine In Patients With Advanced Solid Tumors|Completed||Phase 1|||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 04:51:28.000425|2017-10-11 04:51:28.000425
NCT00077090|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-12-17|||April 2004||2004-04-01|September 2007|2007-09-01||||||||Interventional|||Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer|Randomized Phase II Trial Of Hyperbaric Oxygen Therapy In Patients With Chronic Arm Lymphoedema After Radiotherapy For Cancer|Unknown status|Active, not recruiting|Phase 2|63|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:51:28.066452|2017-10-11 04:51:28.066452
NCT00077103|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2010-06-09|||November 2003||2003-11-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|February 2007|Actual|2007-02-01||Interventional|||Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer|Phase II Trial of Combined Modality Combretastatin A-4 Phosphate (CA4P)-Based Therapy for Patients With Newly Diagnosed Anaplastic Thyroid Cancer [Induction Chemotherapy With Doxorubicin/Cisplatin; Combined Modality Therapy With CA4P and Radiation; Followed by 2 Cycles of CA4P Consolidation]|Terminated||Phase 1/Phase 2|4|Actual|Case Comprehensive Cancer Center||1||slow accrual|f||||t||||||||||2017-10-11 04:51:28.151112|2017-10-11 04:51:28.151112
NCT00077116|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2012-07-13|||November 2003||2003-11-01|July 2012|2012-07-01||||November 2006|Actual|2006-11-01||Interventional|||Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome|Idarubicin and Ara-C in Combination With Gemtuzumab-Ozogamicin (IAGO) for Young Untreated Patients, Without an HLA Identical Sibling, With High Risk MDS or AML Developing After a Preceding Period With MDS During 6 Months Duration: A Phase II Study|Completed||Phase 2|31|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:51:28.231706|2017-10-11 04:51:28.231706
NCT00077129|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2010-01-26|||September 2004||2004-09-01|January 2010|2010-01-01||||August 2006|Actual|2006-08-01||Interventional|||Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer|Phase II Trial Of Paclitaxel Plus Carboplatin In Patients With Metastatic Or Locally Advanced Collecting Duct Renal Cell Cancer|Completed||Phase 2|22|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-10-11 04:51:28.346066|2017-10-11 04:51:28.346066
NCT00077142|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2012-07-27|||April 2001||2001-04-01|July 2012|2012-07-01|August 2005|Actual|2005-08-01|July 2005|Actual|2005-07-01||Interventional|||TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)|Phase I/II Dose Escalation, Pharmacokinetic, Safety, and Efficacy Study of Oral TAC-101 in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|37|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:51:28.536452|2017-10-11 04:51:28.536452
NCT00077155|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-01-23|||December 2003||2003-12-01|January 2013|2013-01-01||||June 2010|Actual|2010-06-01||Interventional|||Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study Of Continuous Infusion EMD 121974 In Patients With Solid Tumors|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:28.627297|2017-10-11 04:51:28.627297
NCT00077168|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2009-02-06|||April 2004||2004-04-01|October 2007|2007-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole|Randomised Trial Testing Observation (No Radiotherapy) Against Radiotherapy In Women With Low-Risk Completely Excised ER Positive Ductal Carcinoma In Situ (DCIS) Of The Breast On Adjuvant Endocrine Therapy|Unknown status|Active, not recruiting|Phase 2|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:51:28.725186|2017-10-11 04:51:28.725186
NCT00077181|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-01-23|||January 2004||2004-01-01|January 2013|2013-01-01||||July 2008|Actual|2008-07-01||Interventional|||3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies|A Phase I Study of Triapine in Combination With High Dose Ara-C (Hi-DAC) in Patients With Advanced Hematologic Malignancies|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:28.861136|2017-10-11 04:51:28.861136
NCT00077194|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-02-08|||January 2004||2004-01-01|February 2005|2005-02-01||||December 2005|Actual|2005-12-01||Interventional|||FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Study Of Depsipeptide, A Histone Deacetylase Inhibitor, In Relapsed Or Refractory Mantle Cell Or Diffuse Large Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:28.958681|2017-10-11 04:51:28.958681
NCT00077207|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2014-06-30|2014-01-08||July 2004||2004-07-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|March 2010|Actual|2010-03-01||Interventional|||Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma|A Pilot Study Using Carboplatin, Vincristine And Temozolomide For Children ≤ 10 Years With Progressive/Symptomatic Low-Grade Gliomas|Completed||N/A|66|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 04:51:29.063752|2017-10-11 04:51:29.063752
NCT00077220|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2009-02-06|||June 2002||2002-06-01|May 2007|2007-05-01||||||||Interventional|||Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer|Phase III Randomised Study Of Adjuvant Paclitaxel And Carboplatin (TAXOL-PARAPLATINE) With Concomittant Radiotherapy In Patients With Stage II or III Non-Metastatic Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:51:30.114132|2017-10-11 04:51:30.114132
NCT00077233|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-07-01|||December 2003||2003-12-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|December 2006|Actual|2006-12-01||Interventional|||FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum|A Phase II Trial Of Irinotecan /5-FU/ Leucovorin Or Oxaliplatin /5-FU / Leucovorin With And Without Cetuximab (C225) For Patients With Untreated Metastatic Adenocarcinoma Of The Colon or Rectum|Completed||Phase 2|238|Actual|Alliance for Clinical Trials in Oncology||4|||f||||f||||||||||2017-10-11 04:51:30.441399|2017-10-11 04:51:30.441399
NCT00077246|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-11-05|||September 2003||2003-09-01|December 2009|2009-12-01||||October 2008|Actual|2008-10-01||Interventional|||ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer|An Open-Label, Phase I/II Trial Of ABI-007 (A CREMOPHOR® El-Free, Protein Stabilized, Nanoparticle Paclitaxel) Administered Weekly In Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|64|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:51:30.707518|2017-10-11 04:51:30.707518
NCT00077259|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-01-15|||October 2003||2003-10-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer|A Phase II Study Of KOS-862 (Epothilone D), Administered Intravenously Weekly For 3 Weeks Every 4 Weeks, In The Second-Line Treatment Of Patients With Advanced Or Metastatic Colorectal Carcinoma (CRC)|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:51:30.786705|2017-10-11 04:51:30.786705
NCT00077285|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2017-10-03|||October 2003||2003-10-01|October 2017|2017-10-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma|A Pilot Phase II Trial Of Irinotecan Plus Carboplatin, And Irinotecan Maintenance Therapy (High-Risk Patients Only), Integrated Into The Upfront Therapy Of Newly Diagnosed Patients With Intermediate - And High-Risk Rhabdomyosarcoma|Active, not recruiting||Phase 2|65|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:51:30.889602|2017-10-11 04:51:30.889602
NCT00077298|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2015-04-14|||December 2003||2003-12-01|December 2012|2012-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer|A Randomized Phase II Study of Bevacizumab in Combination With Cetuximab Plus Irinotecan, or in Combination With Cetuximab Alone, in Irinotecan-Refractory Colorectal Cancer|Completed||Phase 2|70|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:51:31.017161|2017-10-11 04:51:31.017161
NCT00077311|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-06-28|||August 2004||2004-08-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|July 2006|Actual|2006-07-01||Interventional|||Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Randomized Study Of Dose-Dense Docetaxel And Cisplatin Every Two Weeks With Pegfilgrastim And Darbepoetin Alfa With And Without The Chemoprotector BNP7787 In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|160|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:51:31.13554|2017-10-11 04:51:31.13554
NCT00077324|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-07-01|||February 2004||2004-02-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions|Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer|Completed||N/A|1000|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 04:51:31.361218|2017-10-11 04:51:31.361218
NCT00077337|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-06-21|||April 2004||2004-04-01|November 2005|2005-11-01|April 2006|Actual|2006-04-01|||||Interventional|||FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer|Phase II Trial of Depsipeptide (NSC-630176) in Colorectal Cancer Patients Who Have Received Either One or Two Prior Chemotherapy Regimens for Metastatic or Locally Advanced, Unresectable Disease|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:51:31.630674|2017-10-11 04:51:31.630674
NCT00077350|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-02-26|||July 2004||2004-07-01|February 2013|2013-02-01||||April 2005|Actual|2005-04-01||Interventional|||A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer|A Phase II Trial of Triapine® (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:32.068216|2017-10-11 04:51:32.068216
NCT00077363|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-02-26|||May 2004||2004-05-01|February 2013|2013-02-01||||February 2007|Actual|2007-02-01||Interventional|||Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer|A Phase II Trial of Capecitabine in Combination With the Farnesyltransferase Inhibitor, R115777 (Tipifarnib, Zarnestra) in Patients With Metastatic Breast Cancer|Completed||Phase 2|70|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:32.182753|2017-10-11 04:51:32.182753
NCT00077376|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2014-05-02|2011-03-04||March 2005||2005-03-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2009|Actual|2009-03-01||Interventional|||Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer|A Phase II Trial of Trastuzumab Plus Weekly Ixabepilone(BMS-247550) and Carboplatin in Patients With HER2/Neu-Positive Metastatic Breast Cancer|Completed||Phase 2|61|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:32.285191|2017-10-11 04:51:32.285191
NCT00077389|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2014-06-23|||January 2004||2004-01-01|December 2009|2009-12-01||||||||Interventional|||Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma|Intensified Pre-Operative Chemotherapy And Radical Surgery For High Risk Hepatoblastoma|Unknown status|Active, not recruiting|Phase 2|57|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:51:32.837704|2017-10-11 04:51:32.837704
NCT00077402|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-05-14|||November 2003||2003-11-01|December 2006|2006-12-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer|A Phase 2 Study Of Fenretinide In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:51:32.981112|2017-10-11 04:51:32.981112
NCT00088153|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-20|2011-10-06|2011-07-06||July 2003||2003-07-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Effects of Anorexia Nervosa on Bone Mass in Adolescents|Effects of Anorexia Nervosa on Peak Bone Mass|Completed||Phase 2/Phase 3|110|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:52:03.335112|2017-10-11 04:52:03.335112
NCT00077415|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-05-14|||April 2004||2004-04-01|August 2006|2006-08-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer|A Randomized Phase II Study Of Triapine® Alone Versus Triapine and Gemcitabine As Second-Line Treatment Of Advanced Non-Small-Cell-Lung Cancer In Patients Who Had Prior Gemcitabine With Evaluation Of The Effect Of Triapine® On Gemcitabine Pharmacokinetics and Cellular Uptake In Peripheral Mononuclear Cells|Completed||Phase 2|31|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:51:33.065364|2017-10-11 04:51:33.065364
NCT00077428|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-01-23|||June 2004||2004-06-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck|Phase II Trial of PS-341 (NSC 681239) Followed by the Addition of Doxorubicin at Progression in Advanced Adenoid Cystic Carcinoma of the Head and Neck|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:33.16798|2017-10-11 04:51:33.16798
NCT00077441|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-06-03|||April 2005||2005-04-01|June 2013|2013-06-01||||June 2006|Actual|2006-06-01||Interventional|||Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)|Phase II Trial of PS-341 in Patients With Hepatocellular Carcinoma|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:33.274541|2017-10-11 04:51:33.274541
NCT00077454|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-06-04|||February 2004||2004-02-01|June 2013|2013-06-01||||September 2007|Actual|2007-09-01||Interventional|||Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors|A Phase I Study of Single Agent OSI-774 (Tarceva) (NSC# 718781, IND# 63383) Followed by OSI-774 With Temozolomide for Patients With Selected Recurrent/Refractory Solid Tumors, Including Brain Tumors|Completed||Phase 1|95|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:33.38387|2017-10-11 04:51:33.38387
NCT00077467|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-06-04|||January 2004||2004-01-01|June 2013|2013-06-01||||March 2006|Actual|2006-03-01||Interventional|||Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia|A Phase I Study of PS-341 (Velcade, Bortezomib) in Pediatric Patients With Refractory/Recurrent Leukemias|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:33.491965|2017-10-11 04:51:33.491965
NCT00077493|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2007-12-21|||January 2004||2004-01-01|December 2007|2007-12-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma|Pediatric Phase I Trial of BL22 for Refractory CD22-Positive Leukemias and Lymphomas|Suspended||Phase 1|95|Anticipated|MedImmune LLC||4||protocol development and Amended protocol revision|f||||f||||||||||2017-10-11 04:51:33.589286|2017-10-11 04:51:33.589286
NCT00077519|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2009-02-06|||January 2004||2004-01-01|April 2007|2007-04-01||||||||Interventional|||Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer|A Phase I Trial of the Farnesyltransferase Inhibitor, R115777 (NSC# 702818) and Radiotherapy in Patients With Locally Advanced Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:51:33.703515|2017-10-11 04:51:33.703515
NCT00077532|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2012-06-21|||March 2004||2004-03-01|June 2012|2012-06-01|February 2008|Actual|2008-02-01|January 2007|Actual|2007-01-01||Interventional|||Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma|A Study of Intra-Patient Escalating Doses of MDX-010 Given Alone or in Combination With Two gp100 Peptides Emulsified With Montanide ISA-51 in the Treatment of Patients With Stage IV Melanoma|Completed||Phase 2|179|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:33.765044|2017-10-11 04:51:33.765044
NCT00077545|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2013-10-07|||January 2004||2004-01-01|October 2013|2013-10-01||||March 2007|Actual|2007-03-01||Interventional|||3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction|A Phase II Study Of Triapine In Combination With Cisplatin Esophageal Carcinoma|Completed||Phase 2|39|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:51:33.841951|2017-10-11 04:51:33.841951
NCT00077558|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2010-03-09|||January 2004||2004-01-01|March 2010|2010-03-01||||||||Interventional|||3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome|A Phase I Trial Of Sequential Administration Of Triapine (3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone) Followed By Fludarabine In Adults With Relapsed And Refractory Leukemias And Myelodysplasias|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:51:33.925353|2017-10-11 04:51:33.925353
NCT00077584|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-10-26|||October 2003||2003-10-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|March 2005|Actual|2005-03-01||Interventional|RAPIDS-2||Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma|A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Effect of Bosentan on Healing and Prevention of Ischemic Digital Ulcers in Patients With Systemic Sclerosis|Completed||Phase 3|188|Actual|Actelion||2|||f||||||||||||||2017-10-11 04:51:34.034139|2017-10-11 04:51:34.034139
NCT00077597|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-11-01|||February 2004||2004-02-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study of Mircera for the Treatment of Anemia in Dialysis Patients|A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease|Completed||Phase 3|182|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:51:34.191338|2017-10-11 04:51:34.191338
NCT00077610|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-11-23|2016-01-29||February 2004||2004-02-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional||The safety population included all participants who received at least one dose of RO0503821 or Epoetin, and a safety follow-up, whether withdrawn prematurely or not.|A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients|A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.|Completed||Phase 3|673|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 04:51:34.42825|2017-10-11 04:51:34.42825
NCT00088387|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2008-03-03|||July 2004||2004-07-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Effect of Lithium and Divalproex in Alzheimer's Disease|Glycogen Synthetase Kinase 3 (GSK-3) Inhibition in Alzheimer's Disease|Completed||Phase 2|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:08.134244|2017-10-11 04:52:08.134244
NCT00077623|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-04-26|2016-03-24||March 2004||2004-03-01|April 2016|2016-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional||The analysis was done on safety population which included all participants who received at least one dose of study drug.|A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.|A Randomized, Controlled, Open-Label, Multi- Center, Parallel-Group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Subcutaneously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis|Completed||Phase 3|572|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 04:51:37.429454|2017-10-11 04:51:37.429454
NCT00077636|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-01-22|2015-12-15||December 2003||2003-12-01|January 2016|2016-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.|A Randomized, Open-label Study of the Effect of PEGASYS and Ribavirin Combination Therapy on Sustained Virologic Response in Interferon-naïve Patients With Chronic Hepatitis C Genotype 2 or 3 Infection|Completed||Phase 4|1469|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:51:39.888304|2017-10-11 04:51:39.888304
NCT00077649|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2016-03-21|2016-02-03||January 2004||2004-01-01|March 2016|2016-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional||The ITT [intent to treat] population which consisted of all participants who were randomized and received at least one dose of either of the study medication|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).|Randomized, Multicenter, Double-blind, Phase IV Pilot Study Evaluating the Effect of PEGASYS Doses of 180 ug or 270 ug in Combination With Copegus Doses of 1200 mg or 1600 mg on Viral Kinetics, Virological Response, Pharmacokinetics, and Safety in Interferon-naïve Patients With Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Body Weight Greater Than 85 kg|Completed||Phase 4|188|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 04:51:43.068205|2017-10-11 04:51:43.068205
NCT00077662|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2015-05-04|||March 2004||2004-03-01|May 2015|2015-05-01|January 2006|Actual|2006-01-01|May 2005|Actual|2005-05-01||Observational|||A Prospective, Observational Study in Patients With Late-Onset Pompe Disease|A Prospective, Observational Study in Patients With Late-Onset Pompe Disease|Completed||N/A|61|Actual|Sanofi|||1||f||||||||||||||2017-10-11 04:51:44.663427|2017-10-11 04:51:44.663427
NCT00077675|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2010-05-13|2009-12-02||February 2004||2004-02-01|May 2010|2010-05-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|FAST2||Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)|A Phase 2, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Standard Therapy for Treatment of Complicated Gram-Positive Skin and Skin Structure Infections (Gram Positive cSSSI)|Completed||Phase 2|201|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||t||||||||||2017-10-11 04:51:44.833265|2017-10-11 04:51:44.833265
NCT00077688|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-10|2009-06-02|||November 2003||2003-11-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|||||Interventional|||TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium|A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(TM) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) in Patients With Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|44||Achieve Life Sciences|||||f||||||||||||||2017-10-11 04:51:45.935298|2017-10-11 04:51:45.935298
NCT00077714|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-11|2011-06-06|||January 2004||2004-01-01|April 2010|2010-04-01|January 2005|Actual|2005-01-01|||||Interventional|||Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia|A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 2 Fixed Dosages of Paliperidone Extended Release Tablets and Olanzapine, With Open-label Extension, in the Treatment of Patients With Schizophrenia|Completed||Phase 3|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:51:46.007227|2017-10-11 04:51:46.007227
NCT00077727|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-11|2011-05-20|||March 2003||2003-03-01|April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.|A Study of Galantamine HBr as an Adjunctive Treatment to Atypical Antipsychotic Medications in Outpatients With Schizophrenia and Associated Cognitive Deficits.|Completed||Phase 3|107|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:51:46.113975|2017-10-11 04:51:46.113975
NCT00077753|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2011-01-10|||February 2002||2002-02-01|January 2011|2011-01-01|February 2007|Actual|2007-02-01|October 2006|Actual|2006-10-01||Interventional|||EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization|A Double-Blind, Placebo-Controlled, Parallel, Multicenter Study on Extended VTE Prophylaxis in Acutely Ill Medical Patients With Prolonged Immobilization|Completed||Phase 4|4726||Sanofi|||||||||||||||||||2017-10-11 04:51:46.201674|2017-10-11 04:51:46.201674
NCT00077766|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2016-09-16|2016-07-27||March 2004||2004-03-01|November 2015|2015-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional||The safety population was defined as all participants who received at least one dose of RO0503821 or darbepoetin alfa and had a safety follow-up, whether withdrawn prematurely or not. There were 4 participants who were excluded from the safety population as they did not receive the study medication.|A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.|A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.|Completed||Phase 3|313|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:51:46.346381|2017-10-11 04:51:46.346381
NCT00077779|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2007-09-23|||July 2003||2003-07-01|September 2007|2007-09-01||||||||Interventional|CHARM||Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease|A Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease|Completed||Phase 3|854|Actual|Abbott|||||||||||||||||||2017-10-11 04:51:48.072454|2017-10-11 04:51:48.072454
NCT00077974|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-13|2010-10-08|2009-09-25||February 2004||2004-02-01|October 2010|2010-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.|A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma|Completed||Phase 2|106|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 04:51:51.225683|2017-10-11 04:51:51.225683
NCT00077792|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2009-04-17|||October 2002||2002-10-01|April 2009|2009-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)|A Randomized, Double-Blind, Double-Dummy , Parallel Group, Multinational, Clinical Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients With Acute ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic Therapy|Completed||Phase 3|20506|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:51:48.23766|2017-10-11 04:51:48.23766
NCT00077805|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2011-01-10|||August 2003||2003-08-01|January 2011|2011-01-01||||July 2006|Actual|2006-07-01||Interventional|||PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)|An Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolism in Patients Following Acute Ischemic Stroke|Completed||Phase 4|||Sanofi|||||f||||||||||||||2017-10-11 04:51:48.409741|2017-10-11 04:51:48.409741
NCT00077818|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2009-10-14|||June 2002||2002-06-01|October 2009|2009-10-01||||February 2005|Actual|2005-02-01||Interventional|||Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)|A Prospective, Open-label, Randomized, Parallel-group Investigation to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome|Completed||Phase 4|||Sanofi|||||t||||||||||||||2017-10-11 04:51:48.522235|2017-10-11 04:51:48.522235
NCT00077831|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2015-07-19|||September 2001||2001-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|April 2014|Actual|2014-04-01||Observational|CILP||Child and Infant Learning Project|Neurobehavioral Correlates of Craniosynostosis|Completed||N/A|535|Actual|Seattle Children's Hospital|||1||f||||f||||||||||2017-10-11 04:51:48.627504|2017-10-11 04:51:48.627504
NCT00077844|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2011-01-10|||January 2004||2004-01-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)|An International Phase 2-3, Stratified, Randomized, Open-label, Parallel-group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients Undergoing Non-emergent Percutaneous Coronary Intervention|Completed||Phase 2/Phase 3|3532|Anticipated|Sanofi|||||f||||||||||||||2017-10-11 04:51:48.775118|2017-10-11 04:51:48.775118
NCT00077857|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2013-03-27|2013-02-13||July 2003||2003-07-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer|A Randomized, Open-label Study of the Effect of Different Dosing Regimens of Xeloda® in Combination With Taxotere® on Disease Progression in Patients With Locally Advanced and/or Metastatic Breast Cancer|Completed||Phase 2|470|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:51:48.923266|2017-10-11 04:51:48.923266
NCT00077870|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2009-09-01|||February 2004||2004-02-01|September 2009|2009-09-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis|A Randomized, Placebo-Controlled, Multicenter, Blinded Phase I/II Study of the Safety of Escalating Doses of Ocrelizumab (PRO70769) in Subjects With Moderate to Severe Rheumatoid Arthritis Receiving Stable Doses of Concomitant Methotrexate|Completed||Phase 1/Phase 2|237||Genentech, Inc.|||||f||||||||||||||2017-10-11 04:51:49.91782|2017-10-11 04:51:49.91782
NCT00077883|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2011-07-21|||February 2004||2004-02-01|June 2005|2005-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Cisplatin as First-Line Therapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|50|Anticipated|Telik||1|||f||||||||||||||2017-10-11 04:51:49.991483|2017-10-11 04:51:49.991483
NCT00077896|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2008-03-03|||February 2004||2004-02-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Direct Current Brain Polarization in Frontotemporal Dementia|Direct Current Brain Polarization in Frontotemporal Dementia|Completed||Phase 1|6||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:50.096046|2017-10-11 04:51:50.096046
NCT00077909|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2017-10-05|||February 10, 2004||2004-02-10|April 10, 2017|2017-04-10||||||||Observational|||Study of Lung Proteins in Patients With Pneumonia|Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage From Patients With Lung Infiltrates|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:50.170293|2017-10-11 04:51:50.170293
NCT00077922|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-12|2012-10-17|2012-10-17||February 2004||2004-02-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia|A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia|Completed||Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 04:51:50.25716|2017-10-11 04:51:50.25716
NCT00077935|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-13|2011-06-06|||November 2003||2003-11-01|February 2004|2004-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Civamide in OA of the Knee(s)|An Open-Label Multicenter Study Evaluating the Safety of Civamide Cream 0.075% as a Treatment in Subjects With Osteoarthritis of the Knee(s)|Completed||Phase 3|351|Actual|Winston Laboratories||1|||f||||f||||||||||2017-10-11 04:51:50.839601|2017-10-11 04:51:50.839601
NCT00077948|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-13|2014-01-08|||July 2003||2003-07-01|January 2014|2014-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure|A Phase III, Randomized, Double-Blind, Double Placebo-Controlled, Multicenter, Three Parallel Group Study of Enoximone Plus Extended-Release Metoprolol Succinate in Advanced CHF Subjects Previously Intolerant to Beta-Blocker Treatment|Terminated||Phase 3|175||Gilead Sciences||3|||f||||||||||||||2017-10-11 04:51:50.983774|2017-10-11 04:51:50.983774
NCT00077961|ClinicalTrials.gov processed this data on October 10, 2017|2004-02-13|2015-03-25|||December 2003||2003-12-01|March 2015|2015-03-01||||February 2006|Actual|2006-02-01||Interventional|||Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL|Phase I/II Study of Rituximab Plus CAMPATH in Patients With Previously Treated Relapsed or Refractory Low-Grade Follicular, CD20-positive, B-cell Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|49||Sanofi|||||||||||||||||||2017-10-11 04:51:51.089455|2017-10-11 04:51:51.089455
NCT00084162|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-08|2017-06-30|||March 30, 2004||2004-03-30|March 17, 2010|2010-03-17|March 17, 2010||2010-03-17|||||Observational|||Neurocardiac Control in Major Depression|Neurocardiac Control in Major Depression|Completed||N/A|41|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:52.458847|2017-10-11 04:51:52.458847
NCT00084175|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-08|2017-01-11|||April 2004||2004-04-01|October 2016|2016-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1|HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs|Completed||Phase 3|630||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:51:52.534459|2017-10-11 04:51:52.534459
NCT00084188|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-08|2017-01-11|||May 2004||2004-05-01|October 2016|2016-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1|HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs|Completed||Phase 3|541||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 04:51:52.648722|2017-10-11 04:51:52.648722
NCT00084201|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-08|2006-11-28|||July 2006||2006-07-01|November 2006|2006-11-01|June 2007||2007-06-01|||||Interventional|||Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections|Cranberry: Interactions With Anti-Infectious Agents|Completed||N/A|18||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:51:52.735012|2017-10-11 04:51:52.735012
NCT00084214|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-09|2014-03-05|||May 2004||2004-05-01|December 2008|2008-12-01||||||||Interventional|||STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma|A Two-Stage Trial of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|103||Synta Pharmaceuticals Corp.|||||f||||||||||||||2017-10-11 04:51:52.806888|2017-10-11 04:51:52.806888
NCT00084227|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-09|2011-05-10|||July 2004||2004-07-01|May 2011|2011-05-01|July 2005|Actual|2005-07-01|||||Interventional|||Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America|A Phase Ii/Iii, Randomized, Double Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America|Completed||Phase 2/Phase 3|244|Actual|Pfizer|||||||||||||||||||2017-10-11 04:51:52.925224|2017-10-11 04:51:52.925224
NCT00084240|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-09|2008-10-30|||March 2004||2004-03-01|October 2008|2008-10-01|April 2005|Actual|2005-04-01|||||Interventional|||Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia|A Phase 2/3, Randomized, Comparative, Double Blind Trial Of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia|Terminated||Phase 2/Phase 3|32|Actual|Pfizer||||See Detailed Description|||||||||||||||2017-10-11 04:51:53.001292|2017-10-11 04:51:53.001292
NCT00084253|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-09|2010-03-04||2010-03-04|June 2004||2004-06-01|June 2008|2008-06-01||||August 2006|Actual|2006-08-01||Interventional|||Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients|Phase IV Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients|Completed||Phase 4|200|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 04:51:53.102838|2017-10-11 04:51:53.102838
NCT00084266|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-09|2012-01-30|2011-03-10||October 2004||2004-10-01|January 2012|2012-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|ZEPHYR||Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)|Linezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 4|1225|Actual|Pfizer|EOS visit window of 15-21 days after last dose as specified in protocol was expanded during blinded evaluability assessments and prior to database lock and unblinding to 7-30 days after last dose in order to better fit the actual study visit days.|2|||f||||f||||||||||2017-10-11 04:51:53.324579|2017-10-11 04:51:53.324579
NCT00084279|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-09|2009-07-01|||April 2004||2004-04-01|July 2009|2009-07-01|April 2006|Actual|2006-04-01|||||Interventional|||CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)|Safety and Tolerability of Consensus Interferon-Alpha (CIFN) Plus Interferon Gamma-1b (IFN-γ 1b) With or Without Ribavirin (RBV) in the Treatment of Patients With Chronic Hepatitis C Who Are Non-Responders to PEG-IFN-a (2a or 2b) Plus RBV|Completed||Phase 2|81|Actual|InterMune||1|||f||||||||||||||2017-10-11 04:51:57.42114|2017-10-11 04:51:57.42114
NCT00084292|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-09|2017-06-22|||January 2003||2003-01-01|June 2017|2017-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|12 Months|Observational [Patient Registry]|||Database for Stroke in Infants and Children|International Pediatric Stroke Study|Recruiting||N/A|12000|Anticipated|The Hospital for Sick Children|||1||f||||f||||||||||2017-10-11 04:51:57.491466|2017-10-11 04:51:57.491466
NCT00084305|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-09|2017-10-05|||June 9, 2004||2004-06-09|August 11, 2017|2017-08-11||||||||Observational|||Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis|Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:51:57.569803|2017-10-11 04:51:57.569803
NCT00084318|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2016-12-30|2016-06-14||April 2004||2004-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2009|Actual|2009-03-01||Interventional||Eligible patients who started protocol treatment and did not withdraw consent.|Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck|A Phase II Randomized Trial Of Surgery Followed By Chemoradiotherapy Plus Cetuximab For Advanced Squamous Cell Carcinoma Of The Head and Neck|Completed||Phase 2|238|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-10-11 04:51:57.703739|2017-10-11 04:51:57.703739
NCT00084344|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-05-17||2011-02-16|April 2003||2003-04-01|May 2012|2012-05-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women|A Prospective, Randomized, Placebo-Controlled Trial of the Effects of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women|Completed||N/A|||Northwestern University|||||f||||t||||||||||2017-10-11 04:52:00.652307|2017-10-11 04:52:00.652307
NCT00084370|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-08-21|||June 2002||2002-06-01|August 2013|2013-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy|Molecular Alterations in Human Ovarian Epithelium Induced by Chemopreventive Agents in Patients at Elevated Inherited Risk of Ovarian Cancer: A Controlled Pilot Study in Ovarian Cancer Chemoprevention|Withdrawn||N/A|0|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 04:52:00.72487|2017-10-11 04:52:00.72487
NCT00084383|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-07-17|2013-03-01||January 2002||2002-01-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|December 2005|Actual|2005-12-01||Interventional|||Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas|A Safety and Efficacy Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected With the GM-CSF Gene in Combination With Adjuvant Chemoradiotherapy for the Treatment of Adenocarcinoma of the Pancreas|Completed||Phase 2|60|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:52:00.820032|2017-10-11 04:52:00.820032
NCT00084396|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2016-09-23|||October 2003||2003-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|March 2007|Actual|2007-03-01||Interventional|||Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer|A Phase 2 Trial Of 4 Months Preoperative Letrozole 2.5 mg Daily For Postmenopausal Women With Estrogen Receptor Positive And/Or Progesterone Receptor Positive T2, T3, T4a-c, N0-2, M0 Breast Cancer- Novel Biomarkers for Aromatase Inhibitor Therapy|Completed||Phase 2|115|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-10-11 04:52:01.046737|2017-10-11 04:52:01.046737
NCT00084409|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-05-05|2012-11-26||November 2001||2001-11-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease|A Randomized Phase II Chemoprevention Study of Iloprost Versus Placebo in Patients at High Risk for Lung Cancer|Completed||Phase 2|152|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 04:52:01.154257|2017-10-11 04:52:01.154257
NCT00084422|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-08-28|||August 2003||2003-08-01|August 2014|2014-08-01|February 2011|Actual|2011-02-01|September 2009|Actual|2009-09-01||Interventional|||N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma|A Phase I Study Of CEP-701 In Patients With Refractory Neuroblastoma (IND # 67,722)|Completed||Phase 1|47|Actual|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-10-11 04:52:01.830198|2017-10-11 04:52:01.830198
NCT00084435|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-06-13|||July 2005||2005-07-01|June 2012|2012-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|S0217||S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer|Adjuvant Chemo-RT With Cisplatin (NSC-119875) and Docetaxel (NSC-628503) After Complete Resection of Locally Advanced (Stage III and IV) Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||1||Poor accrual and suspension of head and neck committee|f||||f||||||||||2017-10-11 04:52:01.967884|2017-10-11 04:52:01.967884
NCT00084448|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-07-08|||April 2004||2004-04-01|June 2005|2005-06-01||||May 2005|Actual|2005-05-01||Interventional|||Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation of Weekly Paclitaxel (NSC #673089) and Celecoxib (Celebrex®, NSC #719627) in the Treatment of Recurrent or Persistent Platinum-Resistant Epithelial Ovarian or Primary Peritoneal Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-10-11 04:52:02.14049|2017-10-11 04:52:02.14049
NCT00084461|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-06-03|||March 2004||2004-03-01|June 2013|2013-06-01||||October 2004|Actual|2004-10-01||Interventional|||Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors|Phase II Study of Depsipeptide in Metastatic Neuroendocrine Tumors|Terminated||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:02.224402|2017-10-11 04:52:02.224402
NCT00084487|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-05-07|2013-11-12||April 2004||2004-04-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||One patient died prior to start of treatment and is not included on any data analysis.|Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy|"Phase II Trial of XL119 (Rebeccamycin Analogue) in Relapsed Sensitive Small Cell Lung Cancer"|Terminated||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:02.339284|2017-10-11 04:52:02.339284
NCT00084513|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2010-02-11|||August 2004||2004-08-01|February 2010|2010-02-01|March 2007|Actual|2007-03-01|||||Interventional|||Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer|Phase I of Trastuzumab and Imatinib Mesylate (Gleevec®, Formerly Known as STI-571) in Patients With Recurrent or Metastatic Her-2/Neu Expressing Cancer|Completed||Phase 1|18|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:52:02.752678|2017-10-11 04:52:02.752678
NCT00084526|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2010-02-11|||November 2003||2003-11-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer|Evaluation of Daily CT Scans Using CT on Rails for Localization in the Treatment of Prostate Cancer|Completed||Phase 1/Phase 2|40|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:52:02.843012|2017-10-11 04:52:02.843012
NCT00088101|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-20|2008-12-03|||February 2004||2004-02-01|December 2008|2008-12-01|December 2004||2004-12-01|||||Interventional|||STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors|Phase I Trial of STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematological Malignancies and Patients With Solid Tumors|Completed||Phase 1|42||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-10-11 04:52:02.948849|2017-10-11 04:52:02.948849
NCT00088114|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-20|2014-03-05|||January 2003||2003-01-01|March 2014|2014-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||STA-4783 and Paclitaxel for Treatment of Solid Tumors|A Phase I Trial of STA-4783 in Patients Receiving Paclitaxel for Treatment of Solid Tumors|Completed||Phase 1|50||Synta Pharmaceuticals Corp.|||||f||||||||||||||2017-10-11 04:52:03.066105|2017-10-11 04:52:03.066105
NCT00088140|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-20|2012-08-09|||July 2004||2004-07-01|August 2012|2012-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients|A Dose Response Study of a Caspase Inhibitor in Hepatitis C Patients|Completed||Phase 2|204|Actual|Conatus Pharmaceuticals Inc.||4|||||||t||||||||||2017-10-11 04:52:03.170143|2017-10-11 04:52:03.170143
NCT00088166|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-20|2014-07-22|2011-10-13||May 2004||2004-05-01|July 2014|2014-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors|A Phase III Randomized, Double-Blind, Dexamethasone-Sparing Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Placebo for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Malignant Brain Tumor Who Require Chronic Administration of High-Dose Dexamethasone|Completed||Phase 3|200|Actual|Celtic Pharma Development Services||2|||f||||t||||||||||2017-10-11 04:52:03.911477|2017-10-11 04:52:03.911477
NCT00088179|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-21|2017-02-15||2017-02-15|July 2004||2004-07-01|February 2017|2017-02-01||||October 2005|Actual|2005-10-01||Interventional|||Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)|A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)|Active, not recruiting||Phase 3|4000||Alexion Pharmaceuticals|||||||||||||||||||2017-10-11 04:52:05.29834|2017-10-11 04:52:05.29834
NCT00088192|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-21|2005-08-29|||July 2004||2004-07-01|August 2005|2005-08-01||||||||Interventional|||Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)|An Open Label, Non-Comparative Protocol for Use of Intravitreous Pegaptanib Sodium Injection Every 6 Weeks in Patients With Exudative Age-Related Macular Degeneration (AMD)|Completed||N/A|||Eyetech Pharmaceuticals|||||||||||||||||||2017-10-11 04:52:05.820032|2017-10-11 04:52:05.820032
NCT00088205|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-22|2009-10-05||2009-06-10|March 2004||2004-03-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma|A Phase 2 Study of Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma|Completed||Phase 2|61|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:52:05.923762|2017-10-11 04:52:05.923762
NCT00088218|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-22|2012-08-01|2009-09-25||July 2004||2004-07-01|April 2011|2011-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).|Randomized Phase II Study of Clofarabine Alone Versus Clofarabine in Combination With Low-Dose Cytarabine in Previously Untreated Patients >= 60 Years With AML and High-Risk MDS|Completed||Phase 2|95|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:52:06.067604|2017-10-11 04:52:06.067604
NCT00088231|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-22|2012-01-19|||July 2004||2004-07-01|January 2012|2012-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP|Ph I/II Study of PTK 787 (Vatalanib) and Gleevec (Imatinib) in Patients With Refractory Acute Myelogenous Leukemia (AML), Agnogenic Myeloid Metaplasia (AMM), and Chronic Myelogenous Leukemia- Blastic Phase (CML-BP)|Completed||Phase 1/Phase 2|9|Actual|M.D. Anderson Cancer Center||2|||f||||||||||||||2017-10-11 04:52:06.72102|2017-10-11 04:52:06.72102
NCT00088257|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2013-12-12|||August 2004||2004-08-01|December 2013|2013-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Maternal Fatty Acids, Child Obesity, and Asthma Immunity|Maternal Fatty Acids, Child Obesity, and Asthma Immunity|Completed||N/A|411|Actual|Harvard Pilgrim Health Care|||1||f||||||||||||||2017-10-11 04:52:06.812937|2017-10-11 04:52:06.812937
NCT00088270|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2006-02-17|||August 2004||2004-08-01|May 2004|2004-05-01|August 2005||2005-08-01|||||Interventional|||A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer|A Randomized, Open Label, Phase II Study of OSI-7904L Versus 5-FU/LV as First-Line Treatment in Patients With Unresectable, Locally Advanced or Metastatic Adenocarcinoma of the Biliary Tract|Completed||Phase 2|58||OSI Pharmaceuticals|||||||||||||||||||2017-10-11 04:52:06.917783|2017-10-11 04:52:06.917783
NCT00088283|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2007-01-17|||May 2004||2004-05-01|January 2007|2007-01-01||||||||Interventional|||Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)|A Phase II Randomized, Dose-Ranging, Double-Masked, Multi-Center Trial, in Parallel Groups, Determining Safety, Efficacy and PK of Intravitreous Injections of Pegaptanib Sodium Compared to Sham Injection for 30 Weeks in Patients With Recent Vision Loss Due to Macular Edema Secondary to CRVO|Completed||Phase 2|90||Eyetech Pharmaceuticals|||||||||||||||||||2017-10-11 04:52:07.02537|2017-10-11 04:52:07.02537
NCT00088296|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2017-06-30|||July 13, 2004||2004-07-13|October 18, 2007|2007-10-18|October 18, 2007||2007-10-18|||||Interventional|||Effects of Osteoarthritis Pain, Morphine, and Placebo on Neuroendocrine Function in Men|Effects of Osteoarthritis Pain, Morphine and Placebo on Neuro-Endocrine Function in Men|Completed||Phase 2|72||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:07.186467|2017-10-11 04:52:07.186467
NCT00088309|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2008-03-03|||June 2004||2004-06-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Effect of Tenofovir DF on Bone Metabolism in Children|Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of Its Effect on Bone Metabolism|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:07.263488|2017-10-11 04:52:07.263488
NCT00088335|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2008-03-03|||July 2004||2004-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Biological Markers in Parkinson's Disease|Investigation of Biomarkers in Parkinson's Disease|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:07.353485|2017-10-11 04:52:07.353485
NCT00088348|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2017-06-30|||July 13, 2004||2004-07-13|August 20, 2008|2008-08-20|August 20, 2008||2008-08-20|||||Observational|||Screening for Research Subjects With Anterior Segment Diseases|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Anterior Segment Disease|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:07.426409|2017-10-11 04:52:07.426409
NCT00088361|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2008-03-03|||July 2004||2004-07-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Observational|||Effect of Respiratory Motion on Positron Emission Tomography Imaging|The Effects of Respiratory Motion on CT Based Attenuation Correction of Positron Emission Tomography Data: Liver and Heart Studies|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:07.50772|2017-10-11 04:52:07.50772
NCT00088374|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2012-07-23|2011-05-24||July 2004||2004-07-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease|A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Von Hippel Lindau Disease and Renal Tumors|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)|Study did not meet accrual.|1|||f||||f||||||||||2017-10-11 04:52:07.599768|2017-10-11 04:52:07.599768
NCT00088400|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2016-09-21|||July 2004||2004-07-01|September 2016|2016-09-01|November 2005||2005-11-01|||||Interventional|||Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors|A Phase III Multicenter Study of Intratumoral/Interstitial Therapy With TransMID Compared to Best Standard of Care in Patients With Progressive and/or Recurrent, Non-Resectable Glioblastoma Multiforme|Completed||Phase 3|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:08.243779|2017-10-11 04:52:08.243779
NCT00088413|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2017-10-05|||July 20, 2004||2004-07-20|July 10, 2017|2017-07-10|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer|An Open Label Pilot Study to Evaluate the Safety and Tolerability of PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Combination With Sargramostim in Adults With Metastatic Carcinoma|Active, not recruiting||Phase 1|51|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-11 04:52:08.343535|2017-10-11 04:52:08.343535
NCT00088426|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-23|2017-10-05|||January 16, 2004||2004-01-16|June 26, 2017|2017-06-26||||||||Observational|||Clinical and Genetic Studies on Holoprosencephaly|Clinical and Genetic Studies on Holoprosencephaly|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:08.505629|2017-10-11 04:52:08.505629
NCT00088452|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-26|2017-02-03|||July 2004|Actual|2004-07-01|February 2017|2017-02-01|August 31, 2016|Actual|2016-08-31|January 2013|Actual|2013-01-01||Interventional|||Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study|Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study|Completed||Phase 3|453|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-10-11 04:52:08.617881|2017-10-11 04:52:08.617881
NCT00088465|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-26|2011-12-09|2011-10-14||August 2004||2004-08-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder|An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|931|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-10-11 04:52:08.890426|2017-10-11 04:52:08.890426
NCT00088478|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-26|2007-06-11|||June 2004||2004-06-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia|A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia|Completed||Phase 3|402|Actual|Eli Lilly and Company||4|||||||||||||||||2017-10-11 04:52:10.163508|2017-10-11 04:52:10.163508
NCT00088491|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-26|2007-06-20|||June 2004||2004-06-01|June 2007|2007-06-01|October 2006|Actual|2006-10-01|||||Interventional|||Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia|A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia|Completed||Phase 3|1205|Actual|Eli Lilly and Company|||||||||||||||||||2017-10-11 04:52:10.320144|2017-10-11 04:52:10.320144
NCT00088504|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-27|2007-12-17|||July 2004||2004-07-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C|A Phase 2b Study of Merimepodib in Combination With Pegylated Interferon Alfa-2a (Pegasys®) and Ribavirin in Subjects With Chronic Hepatitis C Non-Responsive to Prior Therapy With Pegylated Interferon Alfa and Ribavirin|Completed||Phase 2|315||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-10-11 04:52:10.472764|2017-10-11 04:52:10.472764
NCT00088517|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-27|2008-03-03|||July 2004||2004-07-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112|Whole Body Study of [11C]NNC-112 PET Imaging of Dopamine D1 Receptors|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:10.712716|2017-10-11 04:52:10.712716
NCT00088530|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-28|2017-04-27|2017-03-11||July 2004||2004-07-01|April 2017|2017-04-01|July 2010|Actual|2010-07-01|February 2010|Actual|2010-02-01||Interventional|||BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)|Pixantrone (BBR 2778) Versus Other Chemotherapeutic Agents for Third-line Single Agent Treatment of Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma: A Randomized, Controlled, Phase III Comparative Trial|Completed||Phase 3|140|Actual|CTI BioPharma||2|||f||||t||||||||||2017-10-11 04:52:10.821488|2017-10-11 04:52:10.821488
NCT00088543|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-29|2015-03-16|||March 2004||2004-03-01|March 2015|2015-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant|Pilot Trial of Two Dose Levels of Thymoglobulin as Part of a Myeloablative-Conditioning for a Human Leukocyte Antigen (HLA) Identical Matched Related Donor (MRD) Stem Cell Transplant (SCT) With Cyclosporine (CSa) as Post-transplant Graft vs. Host Disease (GvHD) Prophylaxis|Completed||N/A|60|Actual|Sanofi||2|||f||||||||||||||2017-10-11 04:52:12.23056|2017-10-11 04:52:12.23056
NCT00088556|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-29|2012-05-30|||August 2004||2004-08-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer|Phase 1-2a Dose-Ranging Study of the Triplet Combination of Carboplatin, Paclitaxel and TLK286 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|100|Actual|Telik||1|||f||||||||||||||2017-10-11 04:52:12.345751|2017-10-11 04:52:12.345751
NCT00088569|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-29|2008-03-03|||July 2004||2004-07-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Observational|||Effect of Direct Current Polarization on Brain Function|Measuring the Brain Effects of DC Polarization With O-15 PET|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:12.505173|2017-10-11 04:52:12.505173
NCT00088582|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2016-11-03|||March 2004||2004-03-01|November 2016|2016-11-01||||October 2005|Actual|2005-10-01||Interventional|||Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients|A Multicenter, Randomized, Crossover, Open Label Dose Finding Study to Compare the Safety, Efficacy and PK/PD Relationship of Multiple Doses of SOM230 and Sandostatin in Acromegalic Patients|Completed||Phase 2|62|Actual|Novartis||2|||f||||f||||||||||2017-10-11 04:52:12.57123|2017-10-11 04:52:12.57123
NCT00088595|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2012-05-29|2011-01-21||January 2004||2004-01-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors|An Open-label, Multicenter, Phase II Study Evaluating the Safety and Efficacy of Twice Daily Dosing of SOM230 in Patients With Metastatic Carcinoid Tumors|Completed||Phase 2|45|Actual|Novartis|No formal statistical comparisons were performed for this study. Summary statistics were provided to compare the different doses administered for the primary and secondary endpoints.|1|||f||||t||||||||||2017-10-11 04:52:12.697133|2017-10-11 04:52:12.697133
NCT00088608|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2016-11-03|||April 2004||2004-04-01|November 2016|2016-11-01||||June 2006|Actual|2006-06-01||Interventional|||A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease|A Multicenter, Open Label Study to Assess the Safety and Efficacy of 600 µg SOM230, Administered Subcutaneously, b.i.d. in Patients With Cushing's Disease|Completed||Phase 2|26|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:52:13.439455|2017-10-11 04:52:13.439455
NCT00088621|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2014-03-31|2011-02-11||July 2004||2004-07-01|March 2014|2014-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia|An Open-Label, Multicenter, Twelve-Month Study of Safety and Tolerability in the Treatment of Schizophrenia|Completed||Phase 2|61|Actual|Sunovion||1|||f||||f||||||||||2017-10-11 04:52:13.55319|2017-10-11 04:52:13.55319
NCT00088634|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2016-03-10|2011-02-01||May 2004||2004-05-01|March 2016|2016-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia|A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia|Completed||Phase 2|180|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 04:52:13.815143|2017-10-11 04:52:13.815143
NCT00088647|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2006-12-07||||||December 2006|2006-12-01||||||||Interventional|||Study Evaluating MST-997 in Advanced Malignant Solid Tumors|A Phase 1 Dose-Escalation Study of Intravenous MST-997 Formulated in Intralipid 20% Administered Weekly in Subjects With Advanced Malignant Solid Tumors|Terminated||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:52:14.261068|2017-10-11 04:52:14.261068
NCT00088660|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2006-02-07|||June 2004||2004-06-01|February 2006|2006-02-01||||||||Interventional|||PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen|A Phase III Randomized, Controlled Study to Evaluate the Safety and Efficacy of PANVAC™-VF in Combination With GM-CSF Versus Best Supportive Care or Palliative Chemotherapy in Patients With Metastatic (Stage IV) Adenocarcinoma of the Pancreas Who Have Failed a Gemcitabine-Containing Chemotherapy Regimen|Unknown status|Active, not recruiting|Phase 3|250||Therion Biologics Corporation|||||||||||||||||||2017-10-11 04:52:14.338256|2017-10-11 04:52:14.338256
NCT00088673|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2007-02-27|||June 2004||2004-06-01|February 2007|2007-02-01||||||||Interventional|||Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease|A Phase III Study of the Efficacy and Safety of 3APS in Patients With Mild to Moderate Alzheimer’s Disease|Unknown status|Active, not recruiting|Phase 3|950||Bellus Health Inc|||||||||t||||||||||2017-10-11 04:52:14.548078|2017-10-11 04:52:14.548078
NCT00088686|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2008-03-03|||July 2004||2004-07-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Capsaicin to Control Pain Following Third Molar Extraction|Evaluation of Vanilloid Receptor Inactivation for Preemptive Analgesia|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:14.743374|2017-10-11 04:52:14.743374
NCT00088699|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2017-10-05|||July 26, 2004||2004-07-26|July 31, 2017|2017-07-31|July 31, 2017|Actual|2017-07-31|July 31, 2017|Actual|2017-07-31||Interventional|||Rapid Antidepressant Effects of Ketamine in Major Depression|Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist|Completed||Phase 1/Phase 2|233|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:52:14.804536|2017-10-11 04:52:14.804536
NCT00088712|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2017-10-05|||July 26, 2004||2004-07-26|September 19, 2017|2017-09-19||||||||Observational|||Event Related Potentials in Infants and Adults|Event Related Potentials From Infancy to Adulthood Event Related Potentials From Infancy to Adulthood|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:14.877407|2017-10-11 04:52:14.877407
NCT00088738|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-30|2017-06-30|||July 27, 2004||2004-07-27|September 10, 2008|2008-09-10|September 10, 2008||2008-09-10|||||Interventional|||Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ|Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F] SPA-RQ|Completed||Phase 1|84||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:52:14.950348|2017-10-11 04:52:14.950348
NCT00088751|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-31|2017-06-30|||July 23, 2004||2004-07-23|June 1, 2009|2009-06-01|June 1, 2009||2009-06-01|||||Observational|||Treatment Study of Frontotemporal Dementia|Treatment Study for Frontotemporal Dementia|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:15.02783|2017-10-11 04:52:15.02783
NCT00088764|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-08-13|||February 2005||2005-02-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Pain and Stress Management for People With Rheumatoid Arthritis|Disclosure and Skills Training for Rheumatoid Arthritis|Completed||Phase 2|280|Actual|Wayne State University||2|||f||||t||||||||||2017-10-11 04:52:15.096258|2017-10-11 04:52:15.096258
NCT00088777|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2011-08-10|||January 2005||2005-01-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Nondrug Treatment Programs for Adults With Fibromyalgia|Behavioral Preparation for Treating Fibromyalgia|Completed||Phase 2|300|Anticipated|University of Utah||2|||f||||||||||||||2017-10-11 04:52:15.18735|2017-10-11 04:52:15.18735
NCT00088790|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2011-01-25|||July 2004||2004-07-01|January 2011|2011-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||AZD5438 in Patients With Advanced Solid Malignancies|Phase I Study to Assess the Safety and Tolerability of AZD5438 in Patients With Advanced Solid Malignancies|Completed||Phase 1|||AstraZeneca|||||||||||||||||||2017-10-11 04:52:15.253404|2017-10-11 04:52:15.253404
NCT00088803|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2016-05-17|||August 2004||2004-08-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||DNA Variations in the Gene in Young Patients With Wilms' Tumor|The Incidence, Inheritance, and Prognostic Significance of Polymorphisms in the RASSF1A Gene in Children With Wilms Tumors|Completed||N/A|471|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:52:15.33571|2017-10-11 04:52:15.33571
NCT00088816|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-09-16|||April 2003||2003-04-01|March 2008|2008-03-01||||March 2008|Anticipated|2008-03-01||Interventional|||S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer|Phase II Clinical Study of Preoperative S-1/CDDP Combination Chemotherapy in Patients With Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:52:17.420393|2017-10-11 04:52:17.420393
NCT00088829|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2017-07-17|||April 2001||2001-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2015|Actual|2015-12-01||Interventional|||Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer|A Pilot Study to Establish a Standardized Protocol for Gene Microarray Analysis in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer: Identifying Factors Predictive of a Response to Paclitaxel|Terminated||Phase 2|22|Actual|Georgetown University||1||Investigator left institution|f||||f||||||||||2017-10-11 04:52:17.509679|2017-10-11 04:52:17.509679
NCT00088855|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2017-09-04|||June 15, 2004|Actual|2004-06-15|June 2017|2017-06-01||||October 31, 2006|Actual|2006-10-31||Interventional|||Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma|Phase II Study of Bortezomib (PS-341) and Pegylated Liposomal Doxorubicin as Initial Therapy for Adult Patients With Symptomatic Multiple Myeloma|Active, not recruiting||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:17.61095|2017-10-11 04:52:17.61095
NCT00088868|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2012-03-14|||June 2004||2004-06-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma|A Phase I Study Of 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17DMAG) With Evaluation Of Hsp90 Client Proteins In Subjects With Solid Tumors And Lymphomas|Completed||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:52:17.766852|2017-10-11 04:52:17.766852
NCT00088881|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2017-04-20|2014-12-16||December 2004||2004-12-01|April 2017|2017-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional||Eligible and treated patients|Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma|A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for Patients With Previously Untreated Stages I and II CD20+ Diffuse Large Cell Non-Hodgkin's Lymphoma|Terminated||Phase 2|62|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:52:17.87572|2017-10-11 04:52:17.87572
NCT00088894|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-06-04|||June 2004||2004-06-01|June 2013|2013-06-01||||June 2006|Actual|2006-06-01||Interventional|||Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Randomized Phase III Trial Of Gemcitabine Plus Bevacizumab (NSC#704865 IND#7621) Versus Gemcitabine Plus Placebo In Patients With Advanced Pancreatic Cancer|Completed||Phase 3|590|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:52:18.861702|2017-10-11 04:52:18.861702
NCT00088907|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2015-04-21|2015-03-20||August 2004||2004-08-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|May 2009|Actual|2009-05-01||Interventional||The primary population was eligible and treated patients in the study. All study results were based on the primary population except for adverse event results. In total, 136 patients enrolled on arm I, but 19 patients were ineligible/no protocol therapy. 134 patients entered arm II, 12 of them were not eligible/not starting protocol therapy.|Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer|Phase III Randomized, Placebo Controlled, Trial of Docetaxel Versus Docetaxel Plus ZD1839 (Iressa, Gefitinib) in Performance Status 2 or Previously Treated Patients With Recurrent or Metastatic Head and Neck Cancer|Terminated||Phase 3|270|Actual|National Cancer Institute (NCI)||2||"It was unlikely that the primary endpoint would be reached based on the fifth interim analysis   results."|f||||t||||||||||2017-10-11 04:52:19.004759|2017-10-11 04:52:19.004759
NCT00088933|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2014-03-28|||June 2004||2004-06-01|March 2013|2013-03-01||||November 2007|Actual|2007-11-01||Interventional|||Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer|Randomized Single Institution Pilot Study of Vaccinia-CEA(6D)-TRICOM and Fowlpox-CEA(6D)-TRICOM With GM-CSF in Combination With Docetaxel in Patients With CEA-Bearing Cancers|Terminated||Phase 1|60|Actual|National Cancer Institute (NCI)||6|||f||||||||||||||2017-10-11 04:52:20.090184|2017-10-11 04:52:20.090184
NCT00088946|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2015-10-28|||May 2004||2004-05-01|August 2012|2012-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer|Parallel, Randomized, Double-Blind, Placebo Controlled Phase II Adjuvant Studies of Erlotinib and Polyphenon E to Prevent the Recurrence and Progression of Tobacco-Related, Superficial Bladder Cancer|Completed||Phase 2|17|Actual|Jonsson Comprehensive Cancer Center||3|||f||||t||||||||||2017-10-11 04:52:20.216566|2017-10-11 04:52:20.216566
NCT00088959|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2014-10-09|||December 2003||2003-12-01|April 2013|2013-04-01|November 2010|Actual|2010-11-01|January 2009|Actual|2009-01-01||Interventional|||Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase I Study of Erlotinib and Celecoxib in Former Smokers With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:52:20.411641|2017-10-11 04:52:20.411641
NCT00088972|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2015-09-28|2012-11-09||November 2004||2004-11-01|September 2015|2015-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women|Randomized Placebo-Controlled Biomarker Modulation Trial Using Celecoxib in Premenopausal Women at High Risk for Breast Cancer|Terminated||Phase 2|8|Actual|Southwest Oncology Group||2||Study closed due to poor accrual.|f||||t||||||||||2017-10-11 04:52:20.632589|2017-10-11 04:52:20.632589
NCT00088985|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2017-05-26|2017-03-28||January 2004||2004-01-01|May 2017|2017-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer|Phase II Trial Evaluating The Efficacy Of A Multiepitope Dendritic Cell Vaccine Given With Trastuzumab And Vinorelbine For The Treatment Of Women With Metastatic Breast Cancer That Express HLA-A0201|Terminated||Phase 2|56|Actual|UNC Lineberger Comprehensive Cancer Center|Study was terminated due to unavailable funding.|1||Funding unavailable|f||||t||||||||||2017-10-11 04:52:20.952437|2017-10-11 04:52:20.952437
NCT00088998|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2016-12-05|||December 2004||2004-12-01|December 2016|2016-12-01|December 2010|Actual|2010-12-01|August 2006|Actual|2006-08-01||Interventional|||Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer|Phase II Trial Of Docetaxel With Capecitabine And Bevacizumab As First-Line Chemotherapy For Patients With Metastatic Breast Cancer|Completed||Phase 2|46|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:52:21.31488|2017-10-11 04:52:21.31488
NCT00089011|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2017-04-14|2017-04-14||April 2004||2004-04-01|April 2017|2017-04-01||||March 2014|Actual|2014-03-01||Interventional|||Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer|A Multi-Center Study of Nonmyeloablative Conditioning With TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies With Post Grafting Immunosuppression With Tacrolimus and Mycophenolate Mofetil|Active, not recruiting||Phase 2|150|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-11 04:52:21.408456|2017-10-11 04:52:21.408456
NCT00089024|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2010-06-01|||February 2004||2004-02-01|June 2010|2010-06-01||||December 2013|Anticipated|2013-12-01||Interventional|||Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer|A Phase II Study Of Neo-Adjuvant Chemotherapy And Radiation In Patients With Locally Advanced Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-10-11 04:52:21.974322|2017-10-11 04:52:21.974322
NCT00089037|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2011-07-13|||June 2003||2003-06-01|July 2011|2011-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation|A Phase I/II Study of Sirolimus in Addition to Tacrolimus and Methotrexate for the Prevention of Acute-Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation From Unrelated Donors|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:52:22.074495|2017-10-11 04:52:22.074495
NCT00089050|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2011-11-28|||May 2004||2004-05-01|November 2011|2011-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia|A Phase II Trial Combining Gemtuzumab Ozogamicin (Mylotarg) With Cyclosporine for the Treatment of Relapsed Acute Myeloid Leukemia in Adults Over Age 60|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:52:22.238467|2017-10-11 04:52:22.238467
NCT00089063|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2015-04-14|||June 2004||2004-06-01|October 2013|2013-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma|A Randomized Phase II Continuation Booster Trial After A Vaccine Combining Tyrosinase/GP100/Mart-1 Peptides Emulsified With Montanide ISA 51 and ISA 51 VG With Or Without GM-CSF For Patients With Resected Stages IIB/C, III And IV Melanoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:52:22.360145|2017-10-11 04:52:22.360145
NCT00089076|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2014-05-22|2012-05-11||June 2004||2004-06-01|December 2012|2012-12-01|October 2009|Actual|2009-10-01|July 2008|Actual|2008-07-01||Interventional|||MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma|Phase I/II Study of Anti-CTLA-4 Monoclonal Antibody (MDX-010) in B-cell Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:22.518966|2017-10-11 04:52:22.518966
NCT00089089|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-01-04|||September 2004||2004-09-01|January 2013|2013-01-01||||March 2008|Actual|2008-03-01||Interventional|||Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas|Phase I Study of Prolonged Low Dose Decitabine (5-Aza-Deoxycytidine, NSC #127716) in Patients With Biopsiable Advanced Cancers Refractory to Standard Therapy|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:23.004631|2017-10-11 04:52:23.004631
NCT00089102|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2012-04-26|||September 2003||2003-09-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer|Phase II Study of Gemcitabine and CPT-11 (Irinotecan) in Unresectable or Metastatic Renal Cell Carcinoma|Completed||Phase 2|36|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-10-11 04:52:23.102482|2017-10-11 04:52:23.102482
NCT00089115|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-08-01|||July 2004||2004-07-01|February 2006|2006-02-01||||||||Interventional|||Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|Phase III, Randomized, Double Blind, Placebo-Controlled Trial of Favldand GM-CSF Versus Placebo and GM-CSF Following Rituximab in Subjects With Follicular B-Cell Non-Hodgkin's Lymphoma|Terminated||Phase 3|||National Cancer Institute (NCI)||||Withdrawn as company has shut down and filed for bankruptcy|f||||||||||||||2017-10-11 04:52:23.202328|2017-10-11 04:52:23.202328
NCT00089128|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2012-04-26|||November 2001||2001-11-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer|Phase II Study Of Gemcitabine And CPT-11 (Irinotecan) In Locally Advanced Or Metastatic Bladder Cancer|Completed||Phase 2|25|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-10-11 04:52:23.615913|2017-10-11 04:52:23.615913
NCT00089141|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-05-01|2009-07-15||May 2004||2004-05-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)|A Randomized Study to Evaluate The Efficacy of Mycophenolate Mofetil Added to The Systemic Immunosuppressive Regimen First Used For Treatment of Chronic Graft-Versus-Host Disease|Terminated||Phase 3|151|Actual|Fred Hutchinson Cancer Research Center||2||Low probability of positive outcome|f||||t||||||||||2017-10-11 04:52:23.737359|2017-10-11 04:52:23.737359
NCT00089154|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-07-15|||August 2004||2004-08-01|June 2013|2013-06-01||||October 2005|Actual|2005-10-01||Interventional|||Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase II Study of Thrice Weekly Apolizumab in Patients With Chronic Lymphocytic Leukemia : CRC Master Protocol|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:24.325687|2017-10-11 04:52:24.325687
NCT00089167|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-01-15|||May 2002||2002-05-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis|Risk Adapted Intravenous Melphalan and Adjuvant Thalidomide and Dexamethasone for Untreated Patients With Primary Systemic Amyloidosis|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:52:24.422659|2017-10-11 04:52:24.422659
NCT00089180|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2015-12-03|||March 2004||2004-03-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant|A Phase IIb Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topical Bacteriophage T4 Endonuclease V in Renal Allograft Recipients With a History of Non-melanoma Skin Cancer|Completed||Phase 2|100|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:52:24.504399|2017-10-11 04:52:24.504399
NCT00089193|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2014-12-18|||September 2003||2003-09-01|December 2014|2014-12-01||||February 2007|Actual|2007-02-01||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma|Evaluation of GM-CSF-in-Adjuvant and the Number of Vaccine Sites on Immunization With Multiple Synthetic Melanoma Peptides|Completed||Phase 2|||University of Virginia|||||f||||t||||||||||2017-10-11 04:52:24.602361|2017-10-11 04:52:24.602361
NCT00089206|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2014-12-18|||August 2002||2002-08-01|December 2014|2014-12-01||||November 2005|Actual|2005-11-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery|Vaccination With Synthetic Melanoma Peptides Administered With GM-CSF-in-Adjuvant in Patients With Advanced Melanoma|Completed||Phase 2|7|Actual|University of Virginia||1|||f||||t||||||||||2017-10-11 04:52:24.697721|2017-10-11 04:52:24.697721
NCT00089219|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2014-11-18|||July 2003||2003-07-01|November 2014|2014-11-01||||May 2006|Actual|2006-05-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma|Vaccination With Multiple Synthetic Melanoma Peptides Recognized by Helper T-Cells in Patients With Advanced Melanoma|Completed||Phase 1/Phase 2|39|Actual|University of Virginia||3|||f||||t||||||||||2017-10-11 04:52:24.782549|2017-10-11 04:52:24.782549
NCT00089245|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2017-10-03|||July 2004||2004-07-01|October 2017|2017-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer|Phase I Study Of Intrathecal Radioimmunotherapy Using I-8H9 For Central Nervous System/Leptomeningeal Neoplasms|Recruiting||Phase 1|120|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:52:24.88597|2017-10-11 04:52:24.88597
NCT00089258|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-01-15|||July 2004||2004-07-01|January 2013|2013-01-01||||November 2006|Actual|2006-11-01||Interventional|||Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment|Phase II Study of Anti-GD2 3F8 Antibody and Biologic Response Modifiers for High-risk Neuroblastoma|Completed||Phase 2|74|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:52:24.989693|2017-10-11 04:52:24.989693
NCT00089271|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-01-24|||July 2004||2004-07-01|January 2013|2013-01-01||||June 2010|Actual|2010-06-01||Interventional|||17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas|A Phase I Study Of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin, (17-DMAG) (NSC 707545) In Patients With Advanced Solid Tumors|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:25.100485|2017-10-11 04:52:25.100485
NCT00089284|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2011-04-11|||September 2003||2003-09-01|April 2011|2011-04-01|April 2012|Anticipated|2012-04-01|December 2007|Actual|2007-12-01||Interventional|||Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL|A Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20 Positive Non-Hodgkin's Lymphoma (NHL): Combining 90-Yttrium- Zevalin and the Redox- Modulating Agent, Motexafin Gadolinium (MGd)|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Actual|Northwestern University||1|||f||||t||||||||||2017-10-11 04:52:25.233035|2017-10-11 04:52:25.233035
NCT00089297|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-02-07|2012-12-31||December 2004||2004-12-01|December 2012|2012-12-01|February 2011|Actual|2011-02-01|February 2010|Actual|2010-02-01||Interventional|||Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer|Phase II Evaluation of Cetuximab (C225) Combined With Induction Paclitaxel and Carboplatin Followed by C225, Paclitaxel, Carboplatin, and Radiation for Stage III/IV Operable Squamous Cancer of the Head and Neck|Completed||Phase 2|74|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:52:25.360229|2017-10-11 04:52:25.360229
NCT00089310|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2016-06-28|||September 2004||2004-09-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|February 2007|Actual|2007-02-01||Interventional|||Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer|Intraoperative Sentinel Node Mapping In Non-Small Cell Lung Cancer|Completed||N/A|46|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:52:25.803244|2017-10-11 04:52:25.803244
NCT00089323|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2016-06-02|||January 2007||2007-01-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer|Bone Marrow Analysis In Early-Stage Breast Cancer|Active, not recruiting||N/A|1630|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-10-11 04:52:25.9117|2017-10-11 04:52:25.9117
NCT00089349|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-06-04|||July 2004||2004-07-01|June 2013|2013-06-01||||September 2006|Actual|2006-09-01||Interventional|||Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia|A Phase II Study of Campath-1H in Children With Acute Lymphoblastic Leukemia in Second or Greater Relapse or Twice Induction Failure|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:26.077325|2017-10-11 04:52:26.077325
NCT00089362|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-04-09|||July 2004||2004-07-01|April 2013|2013-04-01||||January 2008|Actual|2008-01-01||Interventional|||Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors|Phase 1 Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, NSC #707545) in Patients With Solid Tumors.|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:52:26.190516|2017-10-11 04:52:26.190516
NCT00089388|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2013-01-23|||July 2004||2004-07-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||Cilengitide in Treating Patients With Acute Myeloid Leukemia|A Phase 2 Study of EMD 121974 as Maintenance Therapy for Patinets With Acute Myeloid Leukemia in Complete Remission|Terminated||Phase 2|70|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:52:26.309193|2017-10-11 04:52:26.309193
NCT00089401|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2012-05-11|||July 2004||2004-07-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|November 2006|Actual|2006-11-01||Interventional|||Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver|A Phase II Trial Of Isolated Hepatic Perfusion (IHP) With Melphalan For Subjects With Metastatic Unresectable Colorectal Cancers Of The Liver With Disease Refractory To First Line Systemic Chemotherapy|Completed||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:52:26.399109|2017-10-11 04:52:26.399109
NCT00089414|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-04|2017-07-26|2013-01-14||July 2004||2004-07-01|July 2017|2017-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives|The Treatment of Menstrually-Related Mood Disorders With Extended Versus Interrupted Oral Contraceptives|Terminated||Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)|Protocol terminated after receiving information from manufacturer (Pharma) that CDB-2914 crosses the blood-brain barrier, invalidating Arm #3 due to potential CNS effect of the compound on behavior.|3||"Informed by manufacturer that CDB-2914 crosses blood-brain barrier invalidating Arm #3 of   protocol."|f||||f||||||||||2017-10-11 04:52:26.489495|2017-10-11 04:52:26.489495
NCT00089427|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2011-06-30|||July 2004||2004-07-01|April 2011|2011-04-01||||July 2007|Actual|2007-07-01||Interventional|||IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma|Phase I Study of Convection Enhanced Delivery (CED) of IL13-PE38QQR Infusion After Resection Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma|Completed||Phase 1|24||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 04:52:26.955735|2017-10-11 04:52:26.955735
NCT00089440|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2017-01-10|||June 2004||2004-06-01|July 2005|2005-07-01|March 2005||2005-03-01|||||Interventional|||Assessment of Interactions Between Methamphetamine and Aripiprazole - 1|Assessment of Interactions Between IV Methamphetamine and Aripiprazole|Unknown status|Active, not recruiting|Phase 1|17||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:52:27.049719|2017-10-11 04:52:27.049719
NCT00089453|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2012-04-17|||September 2003||2003-09-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant|UARK 2003-18, A Phase II Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant in Relapsed Multiple Myeloma|Completed||Phase 1|10|Actual|University of Arkansas||1|||f||||f||||||||||2017-10-11 04:52:27.122335|2017-10-11 04:52:27.122335
NCT00089466|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2012-10-26||2009-11-16|November 2004||2004-11-01|October 2012|2012-10-01|January 2009|Actual|2009-01-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients|Phase IB/IIA Dose-Finding Safety and Activity Study of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor) in HIV-Infected Subjects|Completed||Phase 1/Phase 2|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||||||||||||2017-10-11 04:52:27.221006|2017-10-11 04:52:27.221006
NCT00089479|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2012-12-19|2011-03-31||August 2002||2002-08-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|June 2010|Actual|2010-06-01||Interventional|||A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer|A Randomized, Open-label Study of the Effect of Adjuvant Therapy With Adriamycin Plus Cytoxan Followed by Taxotere or Taxotere Plus Xeloda on Overall Survival in Female Patients With High-risk Breast Cancer|Completed||Phase 3|2611|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:52:27.367101|2017-10-11 04:52:27.367101
NCT00089492|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2016-11-01|||July 2004||2004-07-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients|A Phase II Open-label, Randomized, Active-controlled Study Comparing the Efficacy and Safety of Once Daily Enfuvirtide Dosing Versus the Currently Recommended Twice Daily Dosing in HIV-1 Infected Treatment-experienced Patients.|Completed||Phase 2|64|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:52:28.805297|2017-10-11 04:52:28.805297
NCT00089505|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2016-01-04|2010-08-30||November 2006||2006-11-01|January 2016|2016-01-01|February 2011|Actual|2011-02-01|August 2010|Actual|2010-08-01||Interventional|OCTANE||NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission|Optimal Combination Therapy After Nevirapine Exposure|Completed||Phase 3|745|Actual|AIDS Clinical Trials Group||4|||f||||t||||||||||2017-10-11 04:52:29.000966|2017-10-11 04:52:29.000966
NCT00089518|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2015-03-05||||||August 2009|2009-08-01||||||||Interventional|||Optimal Treatment for Kidney Disease in HIV Infected Adults|A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of an Angiotensin Receptor Blocker (Valsartan) and Highly Active Antiretroviral Therapy (HAART) Versus HAART Alone for the Treatment of HIV-Associated Nephropathy|Withdrawn||Phase 3|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:52:30.934428|2017-10-11 04:52:30.934428
NCT00089531|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-05|2017-06-30|||August 2, 2004||2004-08-02|January 15, 2008|2008-01-15|January 15, 2008||2008-01-15|||||Interventional|||Candidate HIV Vaccine|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a 6-Plasmid Multiclade HIV-1 DNA Vaccine, VRC-HIVDNA016-00-VP, in Uninfected Adult Volunteers|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:31.10055|2017-10-11 04:52:31.10055
NCT00089544|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-06|2014-05-29|2013-03-13||June 2004||2004-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|March 2009|Actual|2009-03-01||Interventional||All eligible patients who started treatment.|Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall|A Pilot Phase II Study of Pre-Operative Radiation Therapy and Thalidomide (IND 48832; NSC 66847) for Low Grade Primary Soft Tissue Sarcoma or Pre-Operative MAID/Thalidomide/Radiation Therapy for High/Intermediate Grade Primary Soft Tissue Sarcoma of the Extremity or Body Wall|Terminated||Phase 2|23|Actual|National Cancer Institute (NCI)|This study closed early due to unacceptably high rate of thromboembolic events in Cohort A and due to low accrual in Cohort B. For this reason efficacy endpoints other than response to pre-operative therapy were not reported.|2|||f||||||||||||||2017-10-11 04:52:31.27783|2017-10-11 04:52:31.27783
NCT00089557|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-06|2005-06-23||||||September 2004|2004-09-01||||||||Interventional|||An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain|An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain|Terminated||Phase 2|||NeurogesX|||||||||||||||||||2017-10-11 04:52:32.09688|2017-10-11 04:52:32.09688
NCT00089570|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-06|2013-02-18|||June 2004||2004-06-01|February 2013|2013-02-01|September 2006|Actual|2006-09-01|March 2006|Actual|2006-03-01||Interventional|||Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III Study of Intravenous Terlipressin in Patients With Hepatorenal Syndrome Type 1|Completed||Phase 3|112|Actual|Orphan Therapeutics||2|||f||||t||||||||||2017-10-11 04:52:32.178012|2017-10-11 04:52:32.178012
NCT00089583|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-06|2017-01-20|2012-02-24||July 2004||2004-07-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|March 2011|Actual|2011-03-01||Interventional|||48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection|A 48 Week, Phase II, Non-Comparative, Open-label, Multi-Cohort, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GW433908/Ritonavir BID When Administered to HIV-1 Infected, PI-Naïve and Experienced, Pediatric Subjects, 2 to 18 Years Old and of GW433908 BID Administered to PI-Naïve, Pediatric Subjects 2 to < 6 Years Old|Completed||Phase 2|110|Actual|ViiV Healthcare||2|||f||||t||||||||||2017-10-11 04:52:32.447343|2017-10-11 04:52:32.447343
NCT00089596|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-06|2007-04-11|||March 2004||2004-03-01|April 2007|2007-04-01|October 2006||2006-10-01|||||Interventional|||Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers|A Safety Study of Infusion of Ex Vivo Selectively Amplified Unrelated Cord Blood Stem Cells in Subjects With Hematological Malignancies Receiving Unrelated Cord Blood Transplantation|Completed||Phase 1/Phase 2|10||ViaCell|||||f||||||||||||||2017-10-11 04:52:35.945337|2017-10-11 04:52:35.945337
NCT00089609|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-06|2016-09-16|2012-10-12||August 2004||2004-08-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|December 2011|Actual|2011-12-01||Interventional|||Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer|A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients With Androgen-Independent Prostate Cancer|Active, not recruiting||Phase 2|73|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||No||2017-10-11 04:52:36.055708|2017-10-11 04:52:36.055708
NCT00089622|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-06|2017-06-30|||August 4, 2004||2004-08-04|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Interventional|||Lisuride Patch to Treat Parkinson's Disease|Transcutaneous Lisuride Therapy of Parkinson's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:38.261721|2017-10-11 04:52:38.261721
NCT00089635|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-09|2013-10-07|2010-08-06||August 2004||2004-08-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|May 2007|Actual|2007-05-01||Interventional|||ABX-EGF (Panitumumab) Monotherapy in Subjects With Metastatic Colorectal Cancer|A Phase 2 Multicenter Single Arm Clinical Trial of ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer Whose Tumors Express Low or Negative EGFr Levels of Immunohistochemistry Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy|Completed||Phase 2|203|Actual|Amgen||1|||f||||||||||||||2017-10-11 04:52:38.375192|2017-10-11 04:52:38.375192
NCT00089648|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-09|2010-01-06|2009-11-16||December 2004||2004-12-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|January 2007|Actual|2007-01-01||Interventional|||SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma|A Phase 2 Study Of SU011248 In The Treatment Of Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma|Completed||Phase 2|61|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 04:52:38.964667|2017-10-11 04:52:38.964667
NCT00089661|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-09|2013-07-23|2009-12-22|2009-11-19|October 2004||2004-10-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|June 2006|Actual|2006-06-01||Interventional|||AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer|Completed||Phase 3|252|Actual|Amgen||2|||f||||||||||||||2017-10-11 04:52:39.834924|2017-10-11 04:52:39.834924
NCT00089674|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-09|2016-02-22|2010-07-02|2009-11-23|August 2004||2004-08-01|February 2016|2016-02-01|July 2010|Actual|2010-07-01|June 2008|Actual|2008-06-01||Interventional|||AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer|Completed||Phase 3|1468|Actual|Amgen||2|||f||||||||||||||2017-10-11 04:52:40.496534|2017-10-11 04:52:40.496534
NCT00089687|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-10|2017-01-10|||April 2004||2004-04-01|January 2005|2005-01-01|May 2005||2005-05-01|||||Interventional|||GBR 12909 Study in Cocaine Experienced African American Volunteers - 1|GBR 12909 Study in Cocaine Experienced African American Volunteers|Unknown status|Active, not recruiting|Phase 1|10||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:52:44.248238|2017-10-11 04:52:44.248238
NCT00089700|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-10|2005-06-23|||March 2004||2004-03-01|February 2005|2005-02-01||||||||Interventional|||TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Three-Arm Study of the Anti-CD4 Monoclonal Antibody TNX-355 With Optimized Background Therapy in Treatment-Experienced Subjects Infected With HIV-1|Unknown status|Active, not recruiting|Phase 2|80||Tanox|||||||||||||||||||2017-10-11 04:52:44.440927|2017-10-11 04:52:44.440927
NCT00089713|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-10|2010-02-05|||March 2004||2004-03-01|June 2005|2005-06-01||||||||Interventional|||Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)|Effect of ALT-711 in Combination With Fixed-Dose Hydrochlorothiazide Therapy on Systolic Blood Pressure in Hypertensive Patients|Terminated||Phase 2|392||Synvista Therapeutics, Inc|||||||||||||||||||2017-10-11 04:52:44.566464|2017-10-11 04:52:44.566464
NCT00089726|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-11|2007-12-18|||March 2003||2003-03-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)|A Phase II Randomized Study of GM-CSF Gene-Modified Autologous Tumor Vaccine (CG8123) With and Without Low-Dose Cyclophosphamide in Advanced Stage Non-Small Cell Lung Cancer|Completed||Phase 2|100||Cell Genesys|||||||||||||||||||2017-10-11 04:52:44.665748|2017-10-11 04:52:44.665748
NCT00089739|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-11|2017-06-30|||August 9, 2004||2004-08-09|October 28, 2008|2008-10-28|October 28, 2008||2008-10-28|||||Observational|||Immune Indicators of Uveitis|Use of Immune Cell Markers, Cytokines, Transcription Factors and Surface CD Markers as Markers of Ocular Inflammatory Activity|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:44.741216|2017-10-11 04:52:44.741216
NCT00089752|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-12|2017-06-26|2009-09-18||September 2003||2003-09-01|June 2017|2017-06-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|CATNAP||Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea|Impact of CPAP on Functional Outcomes in Milder Obstructive Sleep Apnea (CATNAP)|Completed||N/A|281|Actual|University of Pennsylvania|Post-randomization adverse events are summarized by treatment arm & body system.The CTC-AE (Publish Date December 12, 2003) was utilized for coding verbatim (raw) adverse event data with a MedDRA code, Body System, AE/Supraordinate term & Grade.|2|||f||||t||||||||Yes|Petition of Principal Investigator with document outlining purpose of secondary analysis and use of the data, which is then reviewed with co-investigators for overall approval.|2017-10-11 04:52:44.830052|2017-10-11 04:52:44.830052
NCT00089765|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-12|2017-06-30|||August 10, 2004||2004-08-10|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome|Pilot Study of Intravitreal Injection of Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:52:45.413358|2017-10-11 04:52:45.413358
NCT00086021|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-21|2007-06-08|||February 2002||2002-02-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Acupuncture for the Treatment of Chronic Daily Headaches|Acupuncture for the Treatment of Chronic Daily Headaches|Completed||N/A|74||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:55:47.572551|2017-10-11 04:55:47.572551
NCT00089778|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-12|2017-07-03|2012-06-25||September 10, 2004|Actual|2004-09-10|July 2017|2017-07-01|August 5, 2008|Actual|2008-08-05|August 5, 2008|Actual|2008-08-05||Interventional|||Vaccine Treatment of Kidney Cancer|Immunization of Patients With Renal Cancer Using HLA-A2 and HLA-A3-Binding Peptides From Fibroblast Growth Factors 5 (FGF-5)|Terminated||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||3||fewer tumors than expected expressed FGF-5, led to end of accrual to cohorts A&B|f||||f|t|f||||||||2017-10-11 04:52:45.539417|2017-10-11 04:52:45.539417
NCT00089791|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-13|2017-05-10|2010-07-02|2009-11-23|August 1, 2004|Actual|2004-08-01|May 2017|2017-05-01|July 1, 2008|Actual|2008-07-01|May 1, 2008|Actual|2008-05-01||Interventional|||A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis|A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis Every 6 Months)|Completed||Phase 3|7808|Actual|Amgen||2|||f||||t||||||||||2017-10-11 04:52:46.564133|2017-10-11 04:52:46.564133
NCT00089804|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-13|2009-03-30|||October 2004||2004-10-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|ASPEN||Study of LJP 394 in Lupus Patients With History of Renal Disease|A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease|Terminated||Phase 3|943|Actual|La Jolla Pharmaceutical Company||3||Interim efficacy analysis indicated it would be futile to continue study.|f||||t||||||||||2017-10-11 04:52:51.40608|2017-10-11 04:52:51.40608
NCT00089830|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-16|2007-11-27|||August 2004||2004-08-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||"A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat Wet Age-Related Macular Degeneration"||Terminated||Phase 2|120||Genaera Corporation|||||||||||||||||||2017-10-11 04:52:51.921488|2017-10-11 04:52:51.921488
NCT00089843|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-16|2012-05-01|2011-11-09||June 2003||2003-06-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Bone Loss in Women With Anorexia Nervosa|IGF-1 and Bone Loss in Women Anorexia Nervosa|Completed||Phase 2/Phase 3|77|Actual|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-11 04:52:51.997046|2017-10-11 04:52:51.997046
NCT00089856|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-16|2008-11-03|||July 2004||2004-07-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer|A Phase III Randomized, Open-Label Study of CG1940 and CG8711 Versus Docetaxel and Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer Who Are Chemotherapy-Naïve|Terminated||Phase 3|626|Actual|Cell Genesys||2||Based on futility analysis showing <30% chance of meeting primary endpoint.|f||||||||||||||2017-10-11 04:52:52.438893|2017-10-11 04:52:52.438893
NCT00089869|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-16|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia||Completed||Phase 1/Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:52:52.943978|2017-10-11 04:52:52.943978
NCT00089882|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-17|2009-07-22|||May 2003||2003-05-01|July 2009|2009-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II|Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II|Completed||N/A|360||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:52:53.097867|2017-10-11 04:52:53.097867
NCT00089895|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-17|2017-04-03|2009-11-13||November 1, 2004|Actual|2004-11-01|April 2017|2017-04-01|November 1, 2008|Actual|2008-11-01|November 1, 2008|Actual|2008-11-01||Interventional|||EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)|Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients With Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS)|Completed||Phase 3|9406|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:52:53.245965|2017-10-11 04:52:53.245965
NCT00089908|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-17|2008-01-17|||September 2004||2004-09-01|January 2008|2008-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults|Phase I Study of the Safety and Immunogenicity of rDEN1delta30, a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 1|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 04:52:54.440932|2017-10-11 04:52:54.440932
NCT00089921|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-17|2010-10-15|||July 2004||2004-07-01|October 2010|2010-10-01|October 2005|Actual|2005-10-01|||||Interventional|||SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate|A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469 in Subjects With Active Rheumatoid Arthritis Who Are Not Receiving DMARDs Other Than Hydroxychloroquine|Completed||Phase 2|302|Actual|Scios, Inc.||4|||f||||||||||||||2017-10-11 04:52:54.5346|2017-10-11 04:52:54.5346
NCT00089947|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-18|2015-03-16|||June 2003||2003-06-01|March 2015|2015-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection|Randomized, Prospective, Phase 2 Study Comparing Thymoglobulin in a Rapid Discontinuation of Corticosteroids Protocol With Standard Corticosteroid Therapy in Living Donor Renal Transplantation Using Mycophenolate Mofetil and Tacrolimus Maintenance Therapy|Completed||Phase 2|150||Sanofi|||||||||||||||||||2017-10-11 04:52:54.629523|2017-10-11 04:52:54.629523
NCT00089960|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-18|2013-04-25|||October 2004||2004-10-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|||Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)|An Open Label Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) Who Developed Progressive Disease or Relapsed While on Imatinib Mesylate|Completed||Phase 2|138|Actual|Amgen||1|||t||||||||||||||2017-10-11 04:52:54.772771|2017-10-11 04:52:54.772771
NCT00170365|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-09-12|||July 2004||2004-07-01|September 2016|2016-09-01|March 2005||2005-03-01|||||Interventional|||Restorative Yoga for Stress Management|Restorative Yoga for Stress Management|Completed||N/A|30||Minneapolis Medical Research Foundation|||||f||||||||||||||2017-10-11 05:25:40.950055|2017-10-11 05:25:40.950055
NCT00089986|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-18|2017-07-14|2017-03-23||September 1, 2004||2004-09-01|July 2017|2017-07-01|April 15, 2007|Actual|2007-04-15|April 1, 2007|Actual|2007-04-01||Interventional|||GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults|A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults|Completed||Phase 2|1415|Actual|GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:52:55.182989|2017-10-11 04:52:55.182989
NCT00089999|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-18|2017-01-16|2014-08-18|2010-10-13|June 2004||2004-06-01|January 2017|2017-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer|A Phase II, Open-Label, Randomized, Parallel-Group Multicenter Trial Comparing Two Schedules of GW572016 as First-Line Monotherapy in Patients With Advanced or Metastatic Breast Cancer|Completed||Phase 2|138|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-10-11 04:52:58.189517|2017-10-11 04:52:58.189517
NCT00090012|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-18|2007-11-05|||July 2004||2004-07-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder|The Comparison of Efficacy and Safety of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder|Completed||Phase 4|340||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:52:59.051827|2017-10-11 04:52:59.051827
NCT00090025|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-19|2009-01-13|||September 2004||2004-09-01|January 2009|2009-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors|A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery|Terminated||Phase 3|248|Actual|Helsinn Healthcare SA||2||Futility reasons after Independent Data Monitoring Committee interim analysis|f||||t||||||||||2017-10-11 04:52:59.207126|2017-10-11 04:52:59.207126
NCT00090038|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-23|2009-10-16|||October 2003||2003-10-01|October 2009|2009-10-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma|A Multicenter Study to Evaluate the Effect of Rituximab (IDEC-102) on Primary Humoral Response, Recall Response, and Maintenance of Acquired Immunity to Specific Antigens|Completed||Phase 4|168|Actual|Biogen||2|||f||||f||||||||||2017-10-11 04:52:59.485514|2017-10-11 04:52:59.485514
NCT00090051|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-23|2017-07-05|2009-12-22|2009-07-09|July 31, 2003|Actual|2003-07-31|July 2017|2017-07-01|May 31, 2012|Actual|2012-05-31|July 23, 2008|Actual|2008-07-23||Interventional|||FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients|Open-label, Multicenter, Randomized, Comparative, Phase III Study to Evaluate the Efficacy and Safety of FCR vs. FC Alone in Previously Treated Patients With CD20 Positive B-cell CLL|Completed||Phase 3|552|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 04:52:59.71561|2017-10-11 04:52:59.71561
NCT00090064|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-24|2015-11-12||2011-07-31|March 2004||2004-03-01|February 2014|2014-02-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||A Test of MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder|Phase II Clinical Trial Testing the Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Chronic Posttraumatic Stress Disorder|Completed||Phase 2|23|Actual|Multidisciplinary Association for Psychedelic Studies||2|||f||||t||||||||||2017-10-11 04:53:01.727695|2017-10-11 04:53:01.727695
NCT00090077|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-24|2006-02-24|||April 2004||2004-04-01|February 2006|2006-02-01||||||||Interventional|||Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults|A Phase I, Multicenter, Randomized, Parallel, Double-Blinded Dose Ranging, Placebo-Controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Four Oral Dosage Regimens of GW695634G Monotherapy Versus Placebo Over 10 Days in ART-Naive HIV-1 Infected Adults.|Completed||Phase 1|50||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:53:01.877462|2017-10-11 04:53:01.877462
NCT00090090|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-24|2008-01-08|||April 2004||2004-04-01|January 2008|2008-01-01|October 2006|Actual|2006-10-01|||||Interventional|||Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma|A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI 28090) In Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|114||Spectrum Pharmaceuticals, Inc|||||f||||f||||||||||2017-10-11 04:53:01.990121|2017-10-11 04:53:01.990121
NCT00090103|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-24|2017-01-16|2010-02-26||November 2003||2003-11-01|January 2017|2017-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment|A Randomized, Double-blind, Parallel Group Study to Investigate the Efficacy and Safety of Treatment With Dutasteride (0.5mg) and Tamsulosin (0.4mg), Administered Once Daily for 4 Years, Alone and Combination, on the Improvement of Symptoms and Clinical Outcome in Men With Moderate to Severe Symptomatic Benign Prostatic Hyperplasia|Completed||Phase 3|4844|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 04:53:02.47032|2017-10-11 04:53:02.47032
NCT00090116|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-24|2012-03-01|||March 2003||2003-03-01|March 2012|2012-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease|A Randomized, Double-Blind,Placebo-Controlled Evaluation of the Safety and Efficacy of Neramexane Monotherapy in Patients With Moderate to Severe Dementia of the Alzheimer's Type|Completed||Phase 3|400||Forest Laboratories|||||||||||||||||||2017-10-11 04:53:09.568081|2017-10-11 04:53:09.568081
NCT00090129|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-24|2013-10-21|||September 2004||2004-09-01|October 2013|2013-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis|A Multicentre, Randomised, Double-blind, Placebo Controlled Phase III Study of Subcutaneously Administered Onercept in the Treatment and Re-treatment of Subjects With Moderate to Severe Plaque Psoriasis|Terminated||Phase 3|854|Actual|EMD Serono||2||"The risk-benefit ratio for the use of onercept in this condition was not sufficiently favorable   to justify continued development"|||||||||||||||2017-10-11 04:53:09.717812|2017-10-11 04:53:09.717812
NCT00090142|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-24|2015-07-29|2009-09-22||May 2004||2004-05-01|July 2015|2015-07-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm|Completed||Phase 3|62|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:53:10.15061|2017-10-11 04:53:10.15061
NCT00090155|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-24|2017-05-02|||September 26, 2003|Actual|2003-09-26|May 2017|2017-05-01|November 24, 2004|Actual|2004-11-24|November 24, 2004|Actual|2004-11-24||Interventional|||2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)|A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting|Completed||Phase 3|805|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:53:10.595184|2017-10-11 04:53:10.595184
NCT00090168|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-04-05|||January 27, 2004|Actual|2004-01-27|April 2017|2017-04-01|November 10, 2004|Actual|2004-11-10|October 20, 2004|Actual|2004-10-20||Interventional|||Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)|A Multicenter Study to Assess the Cholesterol Lowering Level of Switching to an Investigational Drug Compared to Doubling the Dose of an Investigational Drug in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease|Completed||Phase 3|435|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:53:10.677173|2017-10-11 04:53:10.677173
NCT00090181|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2015-11-27|||June 2004||2004-06-01|November 2015|2015-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)|A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain|Completed||Phase 4|401|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:53:10.744297|2017-10-11 04:53:10.744297
NCT00090194|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-01-10|||June 2003||2003-06-01|January 2017|2017-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%|Evaluation of Immune Globulin Intravenous (Human), 10%, Manufactured by Chromatography Process (IGIV-C, 10%), as an Agent to Reduce Anti-HLA Antibodies and Improve Transplantation Results in Cross Match Positive Living Donor Kidney Allograft Recipients|Terminated||Phase 2|56|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 04:53:10.81748|2017-10-11 04:53:10.81748
NCT00090207|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-04-20|||January 13, 2004|Actual|2004-01-13|April 2017|2017-04-01|September 30, 2004|Actual|2004-09-30|September 30, 2004|Actual|2004-09-30||Interventional|||Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)|A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Safety, Tolerability and Efficacy of Aprepitant Regimen Compared to Ondansetron Regimen for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With High Dose Cisplatin in Cycle 1|Completed||Phase 4|477|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:53:11.074221|2017-10-11 04:53:11.074221
NCT00090220|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-03-23|2009-10-30|2009-10-29|June 16, 2004|Actual|2004-06-16|March 2017|2017-03-01|November 12, 2015|Actual|2015-11-12|May 21, 2009|Actual|2009-05-21||Interventional||All randomized participants|A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)|Safety, Immunogenicity, and Efficacy of Gardasil (V501 (Human Papilloma Virus [Types 6, 11, 16, 18] Recombinant Vaccine) in Mid-Adult Women - The FUTURE III (Females United to Unilaterally Reduce Endo/Ectocervical Cancer) Study|Completed||Phase 3|3819|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:53:11.230973|2017-10-11 04:53:11.230973
NCT00090233|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2015-09-18|2009-06-29||January 2001||2001-01-01|September 2015|2015-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Rotavirus Efficacy and Safety Trial (REST)(V260-006)|Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants|Completed||Phase 3|69274|Actual|Merck Sharp & Dohme Corp.|70,301 participants randomized, 69,274 evaluated, when DSMB first recommended ending enrollment.|2|||f||||||||||||||2017-10-11 04:53:13.452695|2017-10-11 04:53:13.452695
NCT00090246|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-05-02|||May 13, 2004|Actual|2004-05-13|May 2017|2017-05-01|April 20, 2005|Actual|2005-04-20|April 6, 2005|Actual|2005-04-06||Interventional|||2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)|A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting|Completed||Phase 3|922|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:53:15.888108|2017-10-11 04:53:15.888108
NCT00090259|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-03-31|2010-06-30||December 19, 2001|Actual|2001-12-19|March 2017|2017-03-01|May 13, 2009|Actual|2009-05-13|March 31, 2009|Actual|2009-03-31||Interventional|||Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)|A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment|Completed||Phase 3|3834|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:53:16.045391|2017-10-11 04:53:16.045391
NCT00090272|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-02-16|||April 2002||2002-04-01|February 2017|2017-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)|A Prospective, Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Dose of Ertapenem Sodium (MK0826) Versus Cefotetan for the Prophylaxis of Surgical Site Infection Following Elective Colorectal Surgery|Completed||Phase 3|952|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:53:20.305485|2017-10-11 04:53:20.305485
NCT00090285|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-04-11|2009-10-14|2009-10-07|September 24, 2004|Actual|2004-09-24|April 2017|2017-04-01|April 3, 2017|Actual|2017-04-03|July 31, 2009|Actual|2009-07-31||Interventional|||An Investigational Study of Gardasil™ (qHPV, V501) Vaccine in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)|An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men|Completed||Phase 3|4065|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 04:53:20.419331|2017-10-11 04:53:20.419331
NCT00090298|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-03-10|||April 2004||2004-04-01|March 2017|2017-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Lipid-Altering Efficacy and Safety of the Ezetimibe/Simvastatin Combination Tablet Versus Rosuvastatin in Patients With Primary Hypercholesterolemia|Completed||Phase 3|2815|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:53:21.51089|2017-10-11 04:53:21.51089
NCT00090311|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2013-01-03|||July 2004||2004-07-01|January 2013|2013-01-01|July 2006|Actual|2006-07-01|||||Interventional|ANCHOR 149||Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania|A 3-wk, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 3b Study of the Efficacy & Safety of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in the Treatment of Children & Adolescents With Bipolar I Mania (Abbreviated)|Completed||Phase 3|220|Actual|AstraZeneca|||||||||||||||||||2017-10-11 04:53:21.618518|2017-10-11 04:53:21.618518
NCT00090324|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2013-01-03|||September 2004||2004-09-01|January 2013|2013-01-01|June 2007|Actual|2007-06-01|||||Interventional|ANCHOR 112||Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia|A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 3b Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets Compared With Placebo in Adolescents With Schizophrenia (Abbreviated)|Completed||Phase 3|249|Anticipated|AstraZeneca|||||f||||||||||||||2017-10-11 04:53:21.837372|2017-10-11 04:53:21.837372
NCT00090337|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2013-03-06|||November 2003||2003-11-01|March 2013|2013-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer|Acupuncture for Pain and Dysfunction Following Neck Dissection: A Randomized, Controlled, Phase III Trial|Completed||Phase 3|73|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 04:53:22.034496|2017-10-11 04:53:22.034496
NCT00090363|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2013-01-03|2012-04-26|2011-05-23|July 2004||2004-07-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|December 2008|Actual|2008-12-01||Interventional|||ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)|Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-centre Study to Assess ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)|Completed||Phase 2|447|Actual|AstraZeneca|‘Final analysis’ results (data cut-off 18th December 2008) should be considered in context with the longevity of the follow-up (median duration approximately 22 months) relative to only approximately 4 months median duration of study treatment.|3|||f||||||||||||||2017-10-11 04:53:22.195006|2017-10-11 04:53:22.195006
NCT00090376|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2008-11-06|||December 2003||2003-12-01|November 2008|2008-11-01||||||||Interventional|||Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy|Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 3 Arm, 12-Month Study to Evaluate the Effects of GPI 1485 on Erectile Function in Patients Undergoing Bilateral Nerve-Sparing Radical Retropubic Prostatectomy for Prostatic Carcinoma|Completed||Phase 2|240||Eisai Inc.|||||f||||||||||||||2017-10-11 04:53:23.617662|2017-10-11 04:53:23.617662
NCT00090389|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2008-01-23|||January 2005||2005-01-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Acupuncture for Women's Health Conditions|New England School of Acupuncture (NESA) Acupuncture Research Collaborative|Completed||Phase 1|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:53:23.800817|2017-10-11 04:53:23.800817
NCT00090402|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-25|2017-06-21|2009-12-02||April 2004|Actual|2004-04-01|June 2017|2017-06-01|August 2007|Actual|2007-08-01|January 3, 2006|Actual|2006-01-03||Interventional|||Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease|Fish Oil and Alpha Lipoic Acid in Mild Alzheimer's Disease|Completed||Phase 1/Phase 2|39|Actual|Oregon Health and Science University||3|||f||||t||||||||No||2017-10-11 04:53:23.89853|2017-10-11 04:53:23.89853
NCT00090415|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2012-06-15|||April 2003||2003-04-01|June 2012|2012-06-01||||April 2008|Actual|2008-04-01||Interventional|||Early Characteristics of Autism|UW STAART Center of Excellence|Completed||Phase 1|48|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 04:53:24.400529|2017-10-11 04:53:24.400529
NCT00090428|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2013-01-31|||January 2004||2004-01-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||Diet and Behavior in Young Children With Autism|Diet and Behavior in Young Children With Autism|Completed||Phase 1|21|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 04:53:24.478488|2017-10-11 04:53:24.478488
NCT00090441|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2013-01-03|||August 2004||2004-08-01|December 2012|2012-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Risk Burden of Lipoprotein Metabolic Gene Haplotypes||Completed||N/A|4303|Actual|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-10-11 04:53:24.856555|2017-10-11 04:53:24.856555
NCT00090454|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2017-07-20|||August 2004||2004-08-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Genetic Markers of CHD Risk in Men and Women||Completed||N/A|||State University of New York at Buffalo|||||f||||||||||||||2017-10-11 04:53:24.929778|2017-10-11 04:53:24.929778
NCT00090467|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2013-07-26|||August 2004||2004-08-01|July 2013|2013-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Biochemical and Genetic Markers of Hypertension in Women||Completed||N/A|1600|Actual|Brigham and Women's Hospital|||1||f||||||||||||||2017-10-11 04:53:24.985439|2017-10-11 04:53:24.985439
NCT00090480|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2009-06-30|||August 2004||2004-08-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Vaccine Treatment for Advanced Breast Cancer|A Phase I/II Study of an Antitumor Vaccination Using Alpha(1,3)Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Relapsed or Refractory Breast Cancer|Terminated||Phase 1/Phase 2|3|Actual|NewLink Genetics Corporation||1||Enrollment goals unable to be reached.|f||||f||||||||||2017-10-11 04:53:25.052543|2017-10-11 04:53:25.052543
NCT00090493|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2013-05-16|2013-01-25||June 2004||2004-06-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|July 2007|Actual|2007-07-01||Interventional|||Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma|UARK 2003-26, A Pilot Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combination With DTPACE Chemotherapy and Autologous Transplantation in Multiple Myeloma|Completed||Phase 2/Phase 3|4|Actual|University of Arkansas||1|||f||||f||||||||||2017-10-11 04:53:25.141668|2017-10-11 04:53:25.141668
NCT00090506|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2008-01-23|||July 2004||2004-07-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression|Yoga, Health, and Meditation|Completed||Phase 1|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:53:25.339681|2017-10-11 04:53:25.339681
NCT00090519|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2016-08-25|2015-12-22|2011-02-25|February 2004||2004-02-01|August 2016|2016-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Reduction in the Occurrence of Center-Involved Diabetic Macular Edema|Reduction in the Occurrence of Center-Involved Diabetic Macular Edema|Completed||Phase 3|731|Actual|Chromaderm, Inc.||2|||f||||f||||||||||2017-10-11 04:53:25.470198|2017-10-11 04:53:25.470198
NCT00090532|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-26|2011-05-26|||January 2004||2004-01-01|May 2011|2011-05-01|August 2006|Actual|2006-08-01|||||Interventional|||A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration|A Phase 1/2, Randomized, Masked, Single and Multiple-Dose, Sequential Dose-Escalation Study of the Safety an Efficacy of AG-013958 in Subjects With Subfoveal Choroidal Neovascularization Associated With Age-related Macular Degeneration|Terminated||Phase 1/Phase 2|155||Pfizer||||This study was terminated due to a lack of efficacy.|||||||||||||||2017-10-11 04:53:29.176963|2017-10-11 04:53:29.176963
NCT00090545|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-27|2012-08-28|2012-07-23||August 2004||2004-08-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer|A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer|Completed||Phase 2|46|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:53:30.447096|2017-10-11 04:53:30.447096
NCT00090558|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-27|2008-03-03|||August 2004||2004-08-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease|Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:31.152689|2017-10-11 04:53:31.152689
NCT00090571|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-27|2009-06-05|||October 1994||1994-10-01|June 2009|2009-06-01||||September 2009|Anticipated|2009-09-01||Observational|||Juvenile Rheumatoid Arthritis Research Registry|Research Registry for Juvenile Arthritis|Unknown status|Recruiting|N/A|200|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||f||||||Samples With DNA|"     whole blood, serum, Pax gene   "|||2017-10-11 04:53:31.213665|2017-10-11 04:53:31.213665
NCT00090584|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-27|2013-05-08|2012-08-27||August 2004||2004-08-01|May 2013|2013-05-01|August 2006|Actual|2006-08-01|December 2005|Actual|2005-12-01||Interventional|BE-DRI||Behavior Enhances Drug Reduction of Incontinence (BE-DRI)|Behavior Enhances Drug Reduction of Incontinence|Completed||N/A|307|Actual|New England Research Institutes|Ony 68% of participants completed assigned treatment.|2|||f||||t||||||||||2017-10-11 04:53:31.30903|2017-10-11 04:53:31.30903
NCT00090610|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-27|2015-02-05|2012-11-21||October 2003||2003-10-01|December 2012|2012-12-01|October 2009|Actual|2009-10-01|March 2009|Actual|2009-03-01||Interventional|||Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer|Multicenter, Randomized, Phase II Comparative Study to Compare Efficacy & Safety of Taxotere®/Carboplatin Combination Therapy vs Sequential Therapy w/ Taxotere® Then Carboplatin as Second-line Treatment of Patients w/ Relapsed, Platinum-sensitive Ovarian Cancer|Completed||Phase 2|150|Actual|Duke University||2|||f||||t||||||||||2017-10-11 04:53:32.022393|2017-10-11 04:53:32.022393
NCT00090623|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-30|2013-06-19|||August 2004||2004-08-01|June 2013|2013-06-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)|A Phase IIIb, Multicenter, Randomized, Double Masked, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab in Subjects With Subfoveal Choroidal Neovascularization (CNV) With or Without Classic CNV Secondary to Age Related Macular Degeneration|Completed||Phase 3|180||Genentech, Inc.|||||||||||||||||||2017-10-11 04:53:32.586369|2017-10-11 04:53:32.586369
NCT00090649|ClinicalTrials.gov processed this data on October 10, 2017|2004-08-31|2009-08-18||||||August 2009|2009-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study Of DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|369|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:53:32.679271|2017-10-11 04:53:32.679271
NCT00090662|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-01|2017-10-05|||August 27, 2004||2004-08-27|July 11, 2017|2017-07-11||||||||Observational|||Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research|Collection of Peripheral Blood, Urine, Sputum, and Bone Marrow From Healthy Donors for Use in In Vitro Research|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:32.741514|2017-10-11 04:53:32.741514
NCT00090675|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-02|2013-01-28|||January 2006||2006-01-01|January 2013|2013-01-01|November 2007|Anticipated|2007-11-01|November 2007|Anticipated|2007-11-01||Interventional|IMAC/Herbst||Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase IIIb Randomized, Double-Blind Study Comparing Maintenance ZD1839 (IRESSA®) or Placebo Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer|Withdrawn||Phase 3|0|Actual|AstraZeneca||||No patients randomised|||||||||||||||2017-10-11 04:53:32.831453|2017-10-11 04:53:32.831453
NCT00090688|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-02|2016-12-27|||August 2004||2004-08-01|January 2006|2006-01-01||||||||Interventional|||Phase 1 meCS6 + LT(R192G) Vaccine Study|Safety and Immunogenicity of Oral Microencapsulated CS6 Vaccine and LT(R192G) Adjuvant in Volunteers|Withdrawn||Phase 1|0|Actual|U.S. Army Medical Research and Materiel Command||||IND was terminated for being inactive for more than five years|||||||||||||||2017-10-11 04:53:32.903669|2017-10-11 04:53:32.903669
NCT00090701|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-02|2012-05-09|||September 2004||2004-09-01|May 2012|2012-05-01||||||||Interventional|||A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer|A Phase 2, Open-Label, Multicenter Study Of The GARFT Inhibitor AG2037 In Patients With MetastatIC Non Small Cell Lung Cancer Who Failed Two Or Three Prior Treatments|Withdrawn||Phase 2|0|Actual|Pfizer|||||f||||||||||||||2017-10-11 04:53:33.019452|2017-10-11 04:53:33.019452
NCT00090714|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-02|2006-04-18|||August 2004||2004-08-01|April 2006|2006-04-01||||||||Interventional|||To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter||Unknown status|Active, not recruiting|Phase 2|404||Corautus Genetics|||||||||||||||||||2017-10-11 04:53:33.121013|2017-10-11 04:53:33.121013
NCT00090727|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-02|2006-10-31|||August 2004||2004-08-01|April 2005|2005-04-01||||||||Interventional|||Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|A Phase 1, Open-Label, Dose-Escalation Study of AQ4N Administered Intravenously in Patients With Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1|45||Novacea|||||||||||||||||||2017-10-11 04:53:33.250466|2017-10-11 04:53:33.250466
NCT00090740|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-03|2013-01-23|||September 2004||2004-09-01|January 2013|2013-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|||Genetic Risk Factors for Severe Asthma|Genetic Risk Factors for Severe Asthma|Completed||N/A|600|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"     40 mL blood   "|||2017-10-11 04:53:33.318446|2017-10-11 04:53:33.318446
NCT00090753|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-03|2012-02-10|2011-12-01||October 2004||2004-10-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia|An Open-label, Multi-center Study to Document the Efficacy, Safety, and Tolerability of Long-term Administration of RO0503821 in Patients With Chronic Renal Anemia|Completed||Phase 3|1228|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:53:33.643603|2017-10-11 04:53:33.643603
NCT00081094|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-04-22|||September 2003||2003-09-01|April 2013|2013-04-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|||Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer|Detection of Hepatocellular Carcinoma by Positron Emission Tomography With C-Acetate-11 and F-fluorodeoxyglucose-18|Completed||N/A|31|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 04:53:37.666609|2017-10-11 04:53:37.666609
NCT00081107|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy|A Phase II Study of KOS-862, Administered Intravenously Weekly for 3 Weeks Every 4 Weeks, in Patients With Non-Small Cell Lung Cancer Who Have Progressed Following Initial Therapy for Advanced or Metastatic Disease|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:53:37.752482|2017-10-11 04:53:37.752482
NCT00081133|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia|A Phase I/II Study to Determine Safety and Efficacy of Arsenic Trioxide (Trisneox™) in Combination With Imatinib (STI571, Gleevec™) in Patients With Chronic Myelogenous Leukemia in Accelerated or Blastic Phase Disease or Ph+ Acute Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:53:37.834207|2017-10-11 04:53:37.834207
NCT00081159|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2016-09-22|2016-09-22||July 2004||2004-07-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases|A Randomized Phase II Study Of Bone-Targeted Therapy In Advanced Androgen-Dependent Prostate Cancer|Completed||Phase 2|80|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 04:53:37.908102|2017-10-11 04:53:37.908102
NCT00081172|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-07-09|||January 2004||2004-01-01|April 2006|2006-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate|A Phase II Trial Of Lu Radiolabeled Monoclonal Antibody HuJ591-GS (Lu-J591) In Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:53:38.292925|2017-10-11 04:53:38.292925
NCT00081211|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-01-23|||April 2004||2004-04-01|January 2013|2013-01-01||||July 2004|Actual|2004-07-01||Interventional|||Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck|A Phase I Study Of PV701 In Patients With Head And Neck Squamous Cell Carcinoma|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:53:38.375725|2017-10-11 04:53:38.375725
NCT00081224|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2016-12-14|||December 2004||2004-12-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|February 2006|Actual|2006-02-01||Interventional|||Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum|A Phase II Trial Of Celecoxib (Celebrex) And Capecitabine (Xeloda) Combined With Pelvic Irradiation As Neoadjuvant Treatment Of Stage II or III Adenocarcinoma Of The Rectum|Terminated||Phase 2|3|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 04:53:38.483529|2017-10-11 04:53:38.483529
NCT00081237|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-06-11|||February 2004||2004-02-01|June 2013|2013-06-01||||August 2005|Actual|2005-08-01||Interventional|||OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer|A Phase I Study of OSI-7904L In Combination With Oxaliplatin In Patients With Advanced Colo-Rectal Cancer|Completed||Phase 1|15|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:53:38.714234|2017-10-11 04:53:38.714234
NCT00081250|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2017-08-04|||December 2004|Actual|2004-12-01|August 2017|2017-08-01|July 2017|Actual|2017-07-01|December 2007|Actual|2007-12-01||Interventional|||Creatine in Treating Patients With Cancer-Associated Weight Loss|Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss|Completed||Phase 3|300|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:53:38.834355|2017-10-11 04:53:38.834355
NCT00081263|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2017-09-13|2016-11-29||June 2005||2005-06-01|August 2017|2017-08-01||||September 2012|Actual|2012-09-01||Interventional|||Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia|A Randomized Double-Blind Phase II Trial of Celecoxib, A COX-2 Inhibitor, in the Treatment of Patients With Cervical Intraepithelial Neoplasia 2/3 or 3 (CIN 2/3 or 3)|Completed||Phase 2|130|Actual|Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 04:53:39.709251|2017-10-11 04:53:39.709251
NCT00081276|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2013-01-23|||July 2005||2005-07-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation Of Triapine (NCI-Supplied Agent: NSC #663249, IND #68338) In Combination With Cisplatin (Commercially Available: NSC # 119875) In The Treatment Of Recurrent Or Persistent Platinum-Resistant Ovarian Or Primary Peritoneal Carcinoma|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:53:40.202516|2017-10-11 04:53:40.202516
NCT00081289|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2016-12-30|2013-05-23||March 2004||2004-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|May 2011|Actual|2011-05-01||Interventional||All eligible patients enrolled after the protocol ammendment.|Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer|Randomized Phase II Trial Of Neoadjuvant Combined Modality Therapy For Locally Advanced Rectal Cancer|Completed||Phase 2|146|Actual|Radiation Therapy Oncology Group|The study was temporarily closed to accrual due to excessive GI AEs in the first 35 pts. The protocol was amended to adjust the chemotherapy and the study reopened (treatment descriptions reflect the revision).|2|||f||||t||||||||||2017-10-11 04:53:40.329809|2017-10-11 04:53:40.329809
NCT00081302|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2015-11-14|||March 2004||2004-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|December 2005|Actual|2005-12-01||Interventional|||Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer|A Phase II Study Of Cetuximab (C225) In Combination With Chemoradiation In Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-10-11 04:53:41.578192|2017-10-11 04:53:41.578192
NCT00081315|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-07|2007-08-20|||November 2003||2003-11-01|August 2007|2007-08-01|August 2006|Actual|2006-08-01|||||Interventional|||Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer|Phase II, Randomized, Double-Blind, Multicenter Trial of Subcutaneous Amifostine (Ethyol®) Versus Placebo in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer|Completed||Phase 2|130||MedImmune LLC|||||||||||||||||||2017-10-11 04:53:41.66244|2017-10-11 04:53:41.66244
NCT00081328|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-08|2017-03-27|2014-09-26||May 2004||2004-05-01|March 2017|2017-03-01|February 2014|Actual|2014-02-01|February 2011|Actual|2011-02-01||Interventional|TODAY|Age 10–17 years with T2D according to American Diabetes Association criteria for less than 2 years, body mass index (BMI) >=85th percentile, negative diabetes autoantibodies, fasting c-peptide >0.6 ng/mL, and an adult caregiver willing to actively support study participation.|Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)|Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Clinical Trial|Completed||Phase 3|699|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-10-11 04:53:41.796842|2017-10-11 04:53:41.796842
NCT00081341|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-08|2010-02-12||||||February 2010|2010-02-01|December 2002|Actual|2002-12-01|||||Observational|||Cognition, Steroids, and Imaging in Cushings Disease|Cognition, Steroids, and Imaging in Cushings Disease|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:53:42.977799|2017-10-11 04:53:42.977799
NCT00081354|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-09|2017-10-05|||April 6, 2004||2004-04-06|June 16, 2017|2017-06-16||||||||Observational|||Early Detection of Barrett's Esophagus|Barrett's Esophagus Early Detection Study|Completed||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:43.02961|2017-10-11 04:53:43.02961
NCT00081367|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-09|2014-06-09|||February 2004||2004-02-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Community-Based Cognitive Therapy for Suicide Attempters|Community-Based Cognitive Therapy for Suicide Attempters|Completed||Phase 3|140|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 04:53:43.101547|2017-10-11 04:53:43.101547
NCT00081380|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-09|2008-12-19|||March 2004||2004-03-01|December 2008|2008-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder|Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo as Adjunct to Mood Stabilizers (Lithium or Divalproex) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)|Completed||Phase 3|710||AstraZeneca|||||||||||||||||||2017-10-11 04:53:43.255176|2017-10-11 04:53:43.255176
NCT00081406|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-09|2014-03-05|||July 2000||2000-07-01|March 2005|2005-03-01||||||||Interventional|||Individual and Family Therapy for Children With Anxiety Disorders|Child and Family Therapy for Anxiety-Disordered Youth|Completed||Phase 2/Phase 3|150||Temple University|||||f||||||||||||||2017-10-11 04:53:43.487454|2017-10-11 04:53:43.487454
NCT00081419|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-10|2017-06-30|||April 8, 2004||2004-04-08|January 12, 2009|2009-01-12|January 12, 2009||2009-01-12|||||Observational|||Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder|Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder Using EEG and Surface EMG|Completed||N/A|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:43.55719|2017-10-11 04:53:43.55719
NCT00081432|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-10|2017-06-30|||April 9, 2004||2004-04-09|April 27, 2010|2010-04-27|April 27, 2010||2010-04-27|||||Observational|||Language and Emotional Function in Patients With Temporal Lobe Epilepsy|Functional MRI (fMRI) and Diffusion Tensor Imaging (DTI) in Temporal Lobe Epilepsy|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:43.637161|2017-10-11 04:53:43.637161
NCT00081458|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-13|2015-11-10|2010-09-24||April 2004||2004-04-01|September 2014|2014-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional||84 subjects were initially randomized; however, one subject never received study therapy. As a result, the total participant who started flow period is 83.|Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome|A Study of the Efficacy and Safety of Teduglutide in Subjects With Parenteral Nutrition-Dependent Short Bowel Syndrome|Completed||Phase 3|84|Actual|Shire||3|||f||||t||||||||||2017-10-11 04:53:43.727038|2017-10-11 04:53:43.727038
NCT00081471|ClinicalTrials.gov processed this data on October 10, 2017|2004-04-13|2016-11-01|||June 2004||2004-06-01|November 2016|2016-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis|A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease|Completed||Phase 3|324|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:53:44.649556|2017-10-11 04:53:44.649556
NCT00090766|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-03|2016-09-14|2016-06-24||May 2004||2004-05-01|March 2016|2016-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional||Safety population included all participants who received at least one dose of valganciclovir|A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients|Safety and Pharmacokinetics of Valganciclovir Syrup Formulation in Pediatric Solid Organ Transplant Recipients|Completed||Phase 2/Phase 3|63|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 04:53:45.11714|2017-10-11 04:53:45.11714
NCT00090779|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-03|2012-11-16|2012-07-02||January 2005||2005-01-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|July 2009|Actual|2009-07-01||Interventional|||Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV|The SETPOINT Study - A Randomized Study of the Effect of Immediate Treatment With Potent Antiretroviral Therapy Versus Observation With Treatment as Indicated in Newly Infected HIV-1 Infected Subjects: Does Early Therapy After the Virologic Setpoint?|Terminated||Phase 2|130|Actual|AIDS Clinical Trials Group||2||"The DSMB concluded that the findings regarding the primary analysis would persist and that no   additional study goals would be achieved by continuing the study."|f||||t||||||||||2017-10-11 04:53:46.700166|2017-10-11 04:53:46.700166
NCT00090818|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-03|2017-06-30|||September 1, 2004||2004-09-01|October 28, 2010|2010-10-28|October 28, 2010||2010-10-28|||||Observational|||Clinical Research Core Dental Screening Protocol|Clinical Research Core Dental Screening Protocol|Completed||N/A|441|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:47.566341|2017-10-11 04:53:47.566341
NCT00090831|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-03|2017-10-05|||August 31, 2004||2004-08-31|September 17, 2012|2012-09-17|September 17, 2012||2012-09-17|||||Observational|||Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion|Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion|Completed||N/A|91|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:47.620288|2017-10-11 04:53:47.620288
NCT00090844|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-01-23|2012-11-30||July 2004||2004-07-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer|Preservation of Ovarian Function in Young Women Treated With (Neo) Adjuvant Chemotherapy for Breast Cancer: A Randomized Trial Using the Gonadotropin-releasing Hormone (GnRH) Agonist (Triptorelin) During Chemotherapy|Terminated||Phase 2|49|Actual|University of South Florida|Study closed to accrual early due to futility|2||Early closure due to low accrual|f||||t||||||||||2017-10-11 04:53:47.700009|2017-10-11 04:53:47.700009
NCT00090857|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2017-05-29|2017-01-18||February 2002|Actual|2002-02-01|May 2017|2017-05-01|March 2013|Actual|2013-03-01|August 2008|Actual|2008-08-01||Interventional|WISE||Letrozole in Preventing Breast Cancer in Postmenopausal Women|A Pilot Study of Aromatase Inhibitors for Women at Increased Risk of Breast Cancer Based on Estradiol Levels|Completed||Phase 2|49|Actual|Dana-Farber Cancer Institute|Results on this study are limited due to the age of the trial and the prior departure of the coordinator who assisted with the data collection. The accrual goal was not met with many participants eligible upon screening declining randomization.|2|||f||||t||||||||No||2017-10-11 04:53:48.221044|2017-10-11 04:53:48.221044
NCT00090870|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2012-04-26|||April 2002||2002-04-01|April 2012|2012-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Of Peg-Intron, GM-CSF And Thalidomide In Metastatic Renal Cell Carcinoma|Completed||Phase 2|25|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-10-11 04:53:48.831984|2017-10-11 04:53:48.831984
NCT00090896|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2015-10-28|||April 2004||2004-04-01|August 2012|2012-08-01|October 2009|Actual|2009-10-01|July 2008|Actual|2008-07-01||Interventional|||CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery|A Phase I, Open Label, Study To Evaluate The Safety And Immune Function Effects Of CP-675,206 In Combination With MART-1 Peptide-Pulsed Dendritic Cells In Patients With Advanced Melanoma|Completed||Phase 1|18|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:53:49.063917|2017-10-11 04:53:49.063917
NCT00090909|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-01-07|||June 2003||2003-06-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase II Study Of Gemcitabine, Cisplatin, and Dexamethasone In Patients With Relapsed Or Refractory Hodgkin Lymphoma|Completed||Phase 2|1|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:53:49.1602|2017-10-11 04:53:49.1602
NCT00090961|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2012-10-31|||September 2004||2004-09-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer|A Randomized Trial Assessing the Effects of Exercise on Patients With Locally Advanced Lung Cancer Undergoing Curative Intent Combined Modality Therapy|Terminated||N/A|2|Actual|Southwest Oncology Group||2||Closed early due to poor accrual.|f||||f||||||||||2017-10-11 04:53:49.238049|2017-10-11 04:53:49.238049
NCT00090974|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2009-08-19|||December 2004||2004-12-01|January 2006|2006-01-01||||||||Observational|||Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer|Quality Of Life Companion Study For JMA27 (NCIC-MA.27): A Randomized Phase III Trial Of Exemestane Versus Anastrozole With Or Without Celecoxib In Postmenopausal Women With Receptor Positive Primary Breast Cancer|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:53:49.447422|2017-10-11 04:53:49.447422
NCT00090987|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2014-08-27|2011-05-25||June 2005||2005-06-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma|A Phase II Trial Of Imatinib Mesylate (Gleevec) In Patients With HIV Related Kaposi's Sarcoma|Completed||Phase 2|30|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-10-11 04:53:49.980158|2017-10-11 04:53:49.980158
NCT00091026|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2014-04-28|2013-08-06||July 2004||2004-07-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||Four patients who never received treatment are excluded.|Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer|A Randomized Phase II Study of Bevacizumab (NSC# 704865) and Gemcitabine in Combination With Either Cetuximab (NSC# 714692) or OSI-774 (NSC# 718781) in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|143|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:53:50.669121|2017-10-11 04:53:50.669121
NCT00091039|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-06-18|||August 2004||2004-08-01|December 2005|2005-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery|A Pilot Trial of a CEA/TRICOM-Based Vaccine in Combination With Combined Chemotherapy/Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)|Completed||N/A|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:53:51.263527|2017-10-11 04:53:51.263527
NCT00091052|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-03-25|||July 2004||2004-07-01|May 2006|2006-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors|Contrast-Enhanced Radiotherapy With GM-CSF Immune Stimulation - Phase I/II Clinical Center Treatment Trial|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:53:51.347218|2017-10-11 04:53:51.347218
NCT00091078|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-06-04|||September 2005||2005-09-01|June 2013|2013-06-01||||July 2006|Actual|2006-07-01||Interventional|||Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery|A Phase IIA Study to Determine the Safety and Efficacy of A NCI-Supplied Agent: G3139 (NSC 683428, IND 58842) and Imatinib Mesylate in Patients With Refractory or Relapsed Gastrointestinal Stromal Tumor|Terminated||Phase 2|96|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:53:51.419184|2017-10-11 04:53:51.419184
NCT00091091|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2017-02-13|||December 2004||2004-12-01|February 2017|2017-02-01||||June 27, 2011|Actual|2011-06-27||Observational|||Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma|Health-Related Outcomes For Hodgkin's Disease Survivors|Completed||N/A|530|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-10-11 04:53:51.526339|2017-10-11 04:53:51.526339
NCT00091104|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2012-03-14|||July 2004||2004-07-01|March 2012|2012-03-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma|A Study in Metastatic Melanoma Using a Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 TCR-Gene Engineered Lymphocytes and Subsequent Peptide Immunization|Completed||Phase 1|136|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:53:51.764302|2017-10-11 04:53:51.764302
NCT00091117|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-12-13|||July 2004||2004-07-01|December 2013|2013-12-01||||March 2013|Actual|2013-03-01||Interventional|||Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction|A Phase I Pharmacokinetic Study of PS-341 in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction for the CTEPSponsored Organ Dysfunction Working Group|Completed||Phase 1|80|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:53:51.879577|2017-10-11 04:53:51.879577
NCT00091130|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-05-31|||September 2004||2004-09-01|March 2013|2013-03-01||||June 2007|Actual|2007-06-01||Interventional|||SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells|An Exploratory Study to Evaluate the Effect of HPV 16 Vaccine on the Reduction of Viral Load in HPV 16 Positive Women With Persistent Viral Infection, But Low Grade Disease (ASCUS/LSIL)|Completed||Phase 2|139|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:53:52.000053|2017-10-11 04:53:52.000053
NCT00091143|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-04-02|||July 2004||2004-07-01|August 2009|2009-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma|A Pilot Trial of Therapeutic Vaccination With a Modified gp100 Melanoma Peptide (gp100:209-217(210M)), Montanide ISA 51, and KLH With Reconstitution After Chemotherapy to Induce Lymphopenia in Patients With Metastatic Melanoma|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:53:52.152451|2017-10-11 04:53:52.152451
NCT00091156|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2012-07-13|||May 2004||2004-05-01|July 2012|2012-07-01||||July 2008|Actual|2008-07-01||Interventional|||Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Randomized Phase III Study of Follow Up With or Without Adjuvant Gefitinib (Iressa™) Following Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 3|598|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:53:52.257456|2017-10-11 04:53:52.257456
NCT00091169|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2016-05-03|2016-02-02||November 2005||2005-11-01|May 2016|2016-05-01|May 2011|Actual|2011-05-01|March 2008|Actual|2008-03-01||Interventional||All randomized patients|Levocarnitine in Treating Fatigue in Cancer Patients|Phase III Randomized Placebo-Controlled Trial to Determine Efficacy of Levocarnitine for Fatigue in Patients With Cancer|Completed||Phase 3|376|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-10-11 04:53:52.461023|2017-10-11 04:53:52.461023
NCT00091182|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-06-04|||October 2004||2004-10-01|June 2013|2013-06-01||||February 2006|Actual|2006-02-01||Interventional|||Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment|A Phase II Study of Oxaliplatin in Children With Recurrent Solid Tumors|Completed||Phase 2|180|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:53:53.357114|2017-10-11 04:53:53.357114
NCT00091195|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2013-03-18|||September 2004||2004-09-01|March 2013|2013-03-01||||March 2007|Actual|2007-03-01||Interventional|||Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer|A Phase II Study Of Single Agent Depsipeptide (FK228) In Recurrent, Platinum Sensitive Adeno-Carcinoma Of The Ovary Or Peritoneum|Terminated||Phase 2|51|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:53:53.463691|2017-10-11 04:53:53.463691
NCT00091234|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2012-07-23|||June 2004||2004-06-01|July 2012|2012-07-01||||December 2013|Anticipated|2013-12-01||Interventional|AML-19||Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|Gemtuzumab Ozogamicin (GO) Monotherapy Versus Standard Supportive Care for Previously Untreated AML in Elderly Patients Who Are Not Eligible for Intensive Chemotherapy: A Randomized Phase II/III Trial (AML-19) of the EORTC-LG and GIMEMA-ALWP|Unknown status|Recruiting|Phase 2/Phase 3|279|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||t||||||||||2017-10-11 04:53:53.574075|2017-10-11 04:53:53.574075
NCT00094484|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-19|2013-05-06|||October 2004||2004-10-01|May 2013|2013-05-01||||||||Interventional|||Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis|A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis|Completed||Phase 3|400||Amgen||1|||||||||||||||||2017-10-11 04:53:53.790942|2017-10-11 04:53:53.790942
NCT00094497|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-19|2016-09-19|2016-09-19||June 2004||2004-06-01|September 2016|2016-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)|First International Randomized Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment|Completed||Phase 3|304|Actual|Collaborative Group for Adrenocortical Carcinoma Treatment||2|||f||||t||||||||||2017-10-11 04:53:53.884535|2017-10-11 04:53:53.884535
NCT00094510|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-19|2017-06-30|||October 14, 2004||2004-10-14|September 3, 2010|2010-09-03|September 3, 2010||2010-09-03|||||Observational|||Effect of Gabapentin on GABA Concentration and Emotional Processing|The Effect of Gabapentin on Prefrontal GABA Concentration and Emotional Processing in Healthy Humans|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:54.507911|2017-10-11 04:53:54.507911
NCT00094523|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-20|2017-06-08|||December 2004||2004-12-01|March 2011|2011-03-01|June 2007|Actual|2007-06-01|||||Interventional|||Fosamprenavir Versus Other Protease Inhibitors|A Phase IIIB/IV, Open-label, Multi-center Trial to Evaluate the Safety, Tolerability, and Efficiency of HIV-1 Infected Subjects Switching Their Current Protease-inhibitor Therapies for a Fosamprenavir Therapy Over 48 Weeks|Completed||Phase 3|312|Actual|ViiV Healthcare|||||||||f||||||||||2017-10-11 04:53:54.580339|2017-10-11 04:53:54.580339
NCT00094536|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-20|2017-03-01|2010-03-09||April 2004||2004-04-01|March 2017|2017-03-01|June 2009|Actual|2009-06-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System|A Study to Evaluate the Effectiveness of Extended Treatment Regimens With the Her Option® Cryoablation Therapy System for Treatment of Menorrhagia|Completed||Phase 4|82|Actual|CooperSurgical Inc.|"The primary endpoint was assessed using a validated diary completed by the subject prior to each visit, which has inherent weaknesses as an objective measure of blood loss.
Use of historical control limits comparison of outcomes across studies."|1|||f||||f||||||||Undecided||2017-10-11 04:53:54.792673|2017-10-11 04:53:54.792673
NCT00094549|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-20|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder|Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated With Bipolar I Disorder|Completed||Phase 4|500||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:53:55.124531|2017-10-11 04:53:55.124531
NCT00094562|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-20|2008-04-21|||June 2004||2004-06-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss|AAFA™ Fish Oil Nutritional Supplementation to Maintain Body Weight in Patients With Disease-Related Weight Loss|Completed||Phase 2|60|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||||||t||||||||||2017-10-11 04:53:55.298527|2017-10-11 04:53:55.298527
NCT00094575|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-20|2016-02-08|2013-09-16||October 2002||2002-10-01|February 2016|2016-02-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|OVER||Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA)|CSP #498 - Open Versus Endovascular Repair (OVER) Trial for Abdominal Aortic Aneurysms|Completed||Phase 4|881|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:53:55.46452|2017-10-11 04:53:55.46452
NCT00094601|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-20|2017-06-30|||October 18, 2004||2004-10-18|January 22, 2008|2008-01-22|January 22, 2008||2008-01-22|||||Observational|||Relationship of Dopamine to Cognitive Function in Parkinson's Disease|Cognitive Function in Parkinson's Disease: Relationship to Cortical Dopamine Synthesis and Dopamine D1 Receptors|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:53:59.371409|2017-10-11 04:53:59.371409
NCT00094614|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2010-03-24|||June 2002||2002-06-01|April 2006|2006-04-01|April 2003||2003-04-01|||||Interventional|||Trial Comparing Daily Atropine Versus Weekend Atropine|A Randomized Trial Comparing Daily Atropine Versus Weekend Atropine|Completed||Phase 4|168||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 04:53:59.439001|2017-10-11 04:53:59.439001
NCT00094627|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2015-01-13|||November 2004||2004-11-01|January 2015|2015-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Adult Patients With Primary Insomnia|Completed||Phase 3|465|Actual|H. Lundbeck A/S|||||f||||||||||||||2017-10-11 04:53:59.517458|2017-10-11 04:53:59.517458
NCT00094640|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||Pharmacokinetic Characterization of Intramuscular Olanzapine Depot||Completed||Phase 1|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:53:59.61981|2017-10-11 04:53:59.61981
NCT00094653|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2011-06-29|2011-04-22|2010-09-10|September 2004||2004-09-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma|A Randomized, Double-Blind, Multicenter Study Comparing MDX-010 Monotherapy, MDX-010 in Combination With a Melanoma Peptide Vaccine, and Melanoma Vaccine Monotherapy in HLA-A2*0201-Positive Patients With Previously Treated Unresectable Stage III or IV Melanoma|Completed||Phase 3|1783|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-10-11 04:53:59.806867|2017-10-11 04:53:59.806867
NCT00094666|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2015-01-13|||November 2004||2004-11-01|January 2015|2015-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Elderly Patients With Primary Insomnia|Terminated||Phase 3|465||H. Lundbeck A/S|||||f||||||||||||||2017-10-11 04:54:04.145201|2017-10-11 04:54:04.145201
NCT00094679|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2010-09-08|||May 2001||2001-05-01|September 2010|2010-09-01|September 2002|Actual|2002-09-01|July 2002|Actual|2002-07-01||Interventional|ATS2B||Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia|A Randomized Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia|Completed||Phase 3|189|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-11 04:54:04.223344|2017-10-11 04:54:04.223344
NCT00094692|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2010-03-23|||October 2002||2002-10-01|May 2007|2007-05-01|December 2005|Actual|2005-12-01|||||Interventional|||An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old|An Evaluation of Treatment of Amblyopia in 7 To <18 Year Olds|Completed||Phase 3|507||Jaeb Center for Health Research|||||f||||t||||||||||2017-10-11 04:54:04.30819|2017-10-11 04:54:04.30819
NCT00094705|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2008-01-18|||January 2005||2005-01-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of rDEN2/4delta30(ME), a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 2|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 04:54:04.393685|2017-10-11 04:54:04.393685
NCT00095667|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2013-05-07|||November 2004||2004-11-01|May 2013|2013-05-01||||November 2007|Actual|2007-11-01||Interventional|||Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer|A Phase 2 Study of GW572016 in Hormone Naive Recurrent or Metastatic Hormone Sensitive Prostate Cancer|Completed||Phase 2|41|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:54:56.312248|2017-10-11 04:54:56.312248
NCT00094718|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2012-12-31|||February 2005||2005-02-01|December 2012|2012-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of West Nile/Dengue-4 3'delta30 Chimeric Virus Vaccine (WN/DEN4-3'delta30), a Live Attenuated Vaccine for West Nile Encephalitis|Completed||Phase 1|56|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-10-11 04:54:04.653813|2017-10-11 04:54:04.653813
NCT00094731|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-21|2009-12-09|||March 2001||2001-03-01|February 2006|2006-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||SeniorWISE: Improving Everyday Memory in At-Risk Elderly|Improving Everyday Memory in At-Risk Elderly|Completed||Phase 3|260||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:54:04.76004|2017-10-11 04:54:04.76004
NCT00094744|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-22|2010-09-08|||May 2001||2001-05-01|September 2010|2010-09-01|September 2003|Actual|2003-09-01|July 2003|Actual|2003-07-01||Interventional|||Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia|A Randomized Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia|Completed||Phase 3|175|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-10-11 04:54:04.827684|2017-10-11 04:54:04.827684
NCT00094757|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-22|2016-11-28|2010-06-22||October 2004||2004-10-01|November 2016|2016-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)|A Multicenter, Randomized, Double-Blind Study of MK0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 3|521|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-10-11 04:54:04.932407|2017-10-11 04:54:04.932407
NCT00094770|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-22|2016-08-25|2009-09-24||September 2004||2004-09-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)|A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK0431 Compared With Sulfonylurea Therapy in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Monotherapy|Completed||Phase 3|1172|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 04:54:05.73861|2017-10-11 04:54:05.73861
NCT00094783|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-22|2017-06-30|||October 20, 2004||2004-10-20|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Interventional|||MRI-Guided Balloon Angioplasty to Treat Blood Flow Blockage in the Legs|Real-Time MRI-Guided Percutaneous Intervention for Aorto-illac and Femoropopliteal, Artery Stenosis|Completed||Phase 1|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:54:07.074547|2017-10-11 04:54:07.074547
NCT00094796|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-22|2017-06-30|||October 20, 2004||2004-10-20|September 3, 2008|2008-09-03|September 3, 2008||2008-09-03|||||Interventional|||Rosiglitazone to Reverse Metabolic Defects in Diabetes|Evaluation of Rosiglitazone in Reversing Metabolic Defects of Pre-Diabetes and Type 2 Diabetes Mellitus|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:54:07.152653|2017-10-11 04:54:07.152653
NCT00094809|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-26|2013-05-10|2010-12-16||February 2003||2003-02-01|May 2013|2013-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer|Chemotherapy Administered Every 2 Weeks With or Without a Single Injection of Pegfilgrastim as First or Second-Line Treatment in Subjects With Locally Advanced or Metastatic Colon Cancer|Completed||Phase 2|252|Actual|Amgen||2|||f||||||||||||||2017-10-11 04:54:07.258835|2017-10-11 04:54:07.258835
NCT00094822|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-27|2009-02-12|||July 2003||2003-07-01|February 2009|2009-02-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Observational|||Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)|Pegfilgrastim Given Same Day as or Day After Carboplatin and Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||N/A|90|Actual|Amgen|||2||f||||||||||||||2017-10-11 04:54:08.30672|2017-10-11 04:54:08.30672
NCT00094835|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-27|2016-02-26|2010-08-13||January 2005||2005-01-01|February 2016|2016-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional||The analysis is based on the Safety Analysis Set which consists of all consented participants who received at least one dose of motesanib.|Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|An Open-label, Dose-finding Study to Evaluate the Safety and Pharmacokinetics (PK) of AMG 706 With Carboplatin/Paclitaxel, AMG 706 With Panitumumab and AMG 706 With Panitumumab and Carboplatin/Paclitaxel in the Treatment of Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|51|Actual|Amgen||3|||f||||||||||||||2017-10-11 04:54:08.461985|2017-10-11 04:54:08.461985
NCT00094848|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-27|2013-08-01|||June 2004||2004-06-01|August 2013|2013-08-01|May 2007|Actual|2007-05-01|December 2006|Actual|2006-12-01||Interventional|||Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)|A Multi-Center, Open-Label, Dose-Escalation Study to Evaluate the Safety, Efficacy, and Exposure to TRM-1 (Fully Human Monoclonal Antibody to the TRAIL-R1) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|||Human Genome Sciences Inc.|||||f||||||||||||||2017-10-11 04:54:11.571457|2017-10-11 04:54:11.571457
NCT00094861|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-27|2017-02-02|2014-01-24||January 2005||2005-01-01|February 2017|2017-02-01|January 2014|Actual|2014-01-01|December 2007|Actual|2007-12-01||Interventional|||Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase 2 Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) in the Reduction of Dysphagia in Patients Receiving Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|100|Actual|Swedish Orphan Biovitrum||2|||f||||t||||||||||2017-10-11 04:54:11.671855|2017-10-11 04:54:11.671855
NCT00094874|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-27|2005-06-23|||September 2004||2004-09-01|October 2004|2004-10-01|September 2005||2005-09-01|||||Interventional|||Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms|A Double-Blind, Randomized Study of Puncturing Versus Non-Puncturing Acupuncture for the Treatment of Interstitial Cystitis Symptoms|Unknown status|Recruiting|Phase 3|60||The Mary Elizabeth Groff Surgical Medical Research and Education Charitable Trust|||||f||||||||||||||2017-10-11 04:54:14.241362|2017-10-11 04:54:14.241362
NCT00094887|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-28|2016-09-29|2009-12-04||October 2004||2004-10-01|September 2016|2016-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises|A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis|Completed||Phase 2|150|Actual|Mallinckrodt||2|||f||||t||||||||||2017-10-11 04:54:14.330535|2017-10-11 04:54:14.330535
NCT00094900|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-28|2014-01-30|2013-03-19||October 2004||2004-10-01|January 2014|2014-01-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Interleukin-1 Trap to Treat Autoinflammatory Diseases|Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects With Autoinflammatory Diseases: A Therapeutic Approach to Study Pathogenesis|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)|"Secondary outcome analyses will be stratified based on primary outcome results - responders and non-responders.
1 subject with Familial Mediterranean Fever (FMF) was recruited but outcomes were not collected due to insufficient accrual of FMF cases."|1|||f||||||||||||||2017-10-11 04:54:14.727726|2017-10-11 04:54:14.727726
NCT00094913|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-28|2009-05-26|||May 2004||2004-05-01|July 2007|2007-07-01|April 2005||2005-04-01|||||Observational|||PET Changes in Alzheimer's Disease (AD)|Clinical Correlates of Longitudinal PET Changes in Alzheimer's Disease (AD)|Unknown status|Active, not recruiting|N/A|105|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:54:16.459353|2017-10-11 04:54:16.459353
NCT00094926|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-28|2011-05-17|||May 2004||2004-05-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|||||Interventional|||A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.|A Prospective, Randomized, Double-blind, Placebo-controlled Study of the Effectiveness and Safety of RISPERDAL CONSTA Augmentation in Adult Patients With Frequently-relapsing Bipolar Disorder|Completed||Phase 3|275|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-10-11 04:54:16.536074|2017-10-11 04:54:16.536074
NCT00094939|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-28|2009-12-10|||September 2003||2003-09-01|September 2009|2009-09-01|August 2008||2008-08-01|||||Observational|||Predictors of Cognitive Decline in Normal Aging|Predictors of Cognitive Decline in Normal Aging|Unknown status|Recruiting|N/A|170|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:54:16.690802|2017-10-11 04:54:16.690802
NCT00094952|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-28|2009-09-16|||April 2003||2003-04-01|September 2009|2009-09-01|March 2008||2008-03-01|||||Observational|||Biomarkers and Early Alzheimer's Disease|Biomarkers and Early Alzheimer's Disease|Unknown status|Recruiting|N/A|80|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:54:16.77808|2017-10-11 04:54:16.77808
NCT00094965|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-28|2009-03-27|||September 2004||2004-09-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|FOLFOX4||Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function|Phase II Trial of Oxaliplatin in Combination With Bolus/Infusional 5FU/LV (FOLFOX4) in Patients With Advanced Gastrointestinal (GI) Cancers With Varying Degrees of Renal Impairment|Completed||Phase 2|43|Actual|Sanofi||1|||f||||||||||||||2017-10-11 04:54:16.899653|2017-10-11 04:54:16.899653
NCT00094978|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-28|2017-10-05|||October 25, 2004||2004-10-25|May 20, 2013|2013-05-20|May 20, 2013|Actual|2013-05-20|May 20, 2013|Actual|2013-05-20||Interventional|||Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum|Phase I Study of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura, Thymus or Mediastinum|Terminated||Phase 1|23|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:54:16.99089|2017-10-11 04:54:16.99089
NCT00094991|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2010-09-10||2010-09-10|May 2004||2004-05-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes|Mechanism of Action and Efficacy of Muraglitazar (BMS298585) in the Treatment of Type 2 Diabetic Patients|Completed||Phase 3|42||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:54:17.072838|2017-10-11 04:54:17.072838
NCT00095004|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2017-03-31|||October 21, 2004|Actual|2004-10-21|March 2017|2017-03-01|April 4, 2005|Actual|2005-04-04|April 1, 2005|Actual|2005-04-01||Interventional|||Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)|A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild|Completed||Phase 3|167|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:54:17.144306|2017-10-11 04:54:17.144306
NCT00095017|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2015-07-29|||November 2004||2004-11-01|July 2015|2015-07-01||||||||Interventional|||Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)|A 4 Week Randomized, Placebo-Controlled, Parallel Group, Double-Blind Pilot Study to Assess the Safety and Efficacy of Etoricoxib 90 mg Versus Placebo in the Treatment of Cancer Pain|Withdrawn||Phase 2|0|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:54:17.219238|2017-10-11 04:54:17.219238
NCT00095030|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2010-09-10||2010-09-10|February 2004||2004-02-01|September 2007|2007-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone|A Phase 3, Randomized, Three-Arm, Double-blind, Active Controlled, Parallel Group, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Subjects Wtih Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone|Completed||Phase 3|1752||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:54:17.326436|2017-10-11 04:54:17.326436
NCT00095043|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2016-11-16|||October 2004||2004-10-01|November 2016|2016-11-01||||June 2006|Actual|2006-06-01||Interventional|||Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)|A 12-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel Groups, Multicenter Long-Term Safety Study of MK0928 in the Treatment of Elderly Outpatients With Primary Insomnia|Completed||Phase 3|320||H. Lundbeck A/S|||||f||||||||||||||2017-10-11 04:54:17.805296|2017-10-11 04:54:17.805296
NCT00095056|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2015-03-12|2010-06-22||October 2004||2004-10-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)|Sitagliptin Study in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency|Completed||Phase 3|91|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 04:54:17.905712|2017-10-11 04:54:17.905712
NCT00095069|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2015-01-13|||October 2004||2004-10-01|January 2015|2015-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Groups Efficacy and Safety Extension Study of MK0928 in the Treatment of Adult Outpatients With Primary Insomnia|Completed||Phase 3|600||H. Lundbeck A/S|||||f||||||||||||||2017-10-11 04:54:18.524954|2017-10-11 04:54:18.524954
NCT00095888|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-01-15|||October 2004||2004-10-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer|A Phase II Trial Of Gemcitabine And Triapine In Refractory Metastatic Breast Cancer|Terminated||Phase 2|68|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:55:00.419047|2017-10-11 04:55:00.419047
NCT00095082|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2017-01-26|||September 2004||2004-09-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes|Efficacy and Safety Comparison of Insulin Detemir Plus Insulin Aspart Versus Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes|Completed||Phase 3|447|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 04:54:18.599522|2017-10-11 04:54:18.599522
NCT00095095|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2012-10-22|||October 2004||2004-10-01|March 2005|2005-03-01|May 2006||2006-05-01|||||Interventional|||Lumbar Interbody Fusion Using the Telamon® Peek™ Versus the Telamon® Hydrosorb™ Fusion Device|Lumbar Interbody Fusion Using The Telamon® Peek™ Versus The Telamon® Hydrosorb™ Fusion Device - A Prospective, Randomized Controlled Trial To Assess Surgical And Clinical Outcomes|Terminated||Phase 4|102||Medtronic|||||f||||||||||||||2017-10-11 04:54:18.982347|2017-10-11 04:54:18.982347
NCT00095108|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2009-03-06|||May 2004||2004-05-01|March 2009|2009-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer|A Phase 1 Open-Label Study of the Safety and Pharmacokinetics of Recombinant Human Interleukin-21 (rIL-21) in Subjects With Metastatic Melanoma or Metastatic Renal Cell Carcinoma|Completed||Phase 1|43|Actual|ZymoGenetics|||||f||||||||||||||2017-10-11 04:54:19.1392|2017-10-11 04:54:19.1392
NCT00095121|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-29|2012-05-16|2011-04-08||June 2004||2004-06-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B|A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents (Age 2 to Less Than 18) With Chronic Hepatitis B|Completed||Phase 3|173|Actual|Gilead Sciences||2|||f||||||||||||||2017-10-11 04:54:19.30931|2017-10-11 04:54:19.30931
NCT00095134|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2011-12-05|||October 2004||2004-10-01|December 2011|2011-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy|A Double-Blind Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy|Completed||Phase 3|630|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:54:22.326639|2017-10-11 04:54:22.326639
NCT00095147|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2015-03-04|2010-10-26||February 2005||2005-02-01|March 2015|2015-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis|A Phase IIIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Comparative Study of Abatacept or Infliximab in Combination With Methotrexate in Controlling Disease Activity in Subjects With Rheumatoid Arthritis Having an Inadequate Clinical Response to Methotrexate|Completed||Phase 3|431|Actual|Bristol-Myers Squibb||5|||f||||||||||||||2017-10-11 04:54:22.691778|2017-10-11 04:54:22.691778
NCT00095160|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2009-10-06|||October 2003||2003-10-01|October 2009|2009-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors|Phase I, Open Label Safety, Pharmacokinetic, and Pharmacodynamic Dose Escalation/De-escalation Study of 852A Administered Intravenously to Subjects With Refractory Solid Organ Tumors|Completed||Phase 1|42||Masonic Cancer Center, University of Minnesota|||||f||||||||||||||2017-10-11 04:54:27.492186|2017-10-11 04:54:27.492186
NCT00095173|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2016-11-22|2016-09-22||December 2003||2003-12-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|June 2006|Actual|2006-06-01||Interventional||All treated participants in the Lead-In Phase (Period A)|BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis|A Phase III, Multi-Center, Multi-National, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of BMS-188667 in Children and Adolescents With Active Polyarticular Juvenile Rheumatoid Arthritis (JRA)|Completed||Phase 3|214|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 04:54:27.614361|2017-10-11 04:54:27.614361
NCT00095186|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2008-04-08|||September 2004||2004-09-01|April 2008|2008-04-01|March 2007||2007-03-01|||||Interventional|||Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma|A Multi-Center, Phase 2, Open Label Study of Safety and Efficacy of Oral Recombinant Human Lactoferrin (rhLF) Monotherapy in Patients With Advanced Renal Cell Carcinoma (RCC), Who Have Failed at Least One Regimen of Systemic Therapy for RCC|Completed||Phase 2|40||Agennix|||||||||||||||||||2017-10-11 04:54:29.48985|2017-10-11 04:54:29.48985
NCT00095199|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2012-09-13|2012-06-19||January 2005||2005-01-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer|Randomized Phase III Study of Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer After Platinum-Based Therapy|Completed||Phase 3|939|Actual|Eli Lilly and Company||4|||f||||t||||||||||2017-10-11 04:54:29.69669|2017-10-11 04:54:29.69669
NCT00095212|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2010-04-09|2010-01-21||September 2004||2004-09-01|April 2010|2010-04-01|February 2009|Actual|2009-02-01|April 2008|Actual|2008-04-01||Interventional|||Androgen Effects in HIV-infected Women|Androgen Effects in HIV-infected Women|Completed||N/A|25|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:54:33.373825|2017-10-11 04:54:33.373825
NCT00095225|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2008-01-23|||July 2004||2004-07-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)|A Phase II, Multicenter, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy (Docetaxel or Pemetrexed) or Tarceva (Erlotinib) Compared With Chemotherapy (Docetaxel or Pemetrexed) Alone for Treatment of Recurrent or Refractory Non-Small Cell Lung Cancer|Completed||Phase 2|122|Actual|Genentech, Inc.|||||||||||||||||||2017-10-11 04:54:34.048323|2017-10-11 04:54:34.048323
NCT00095238|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2015-03-18|2009-12-16||June 2002||2002-06-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)|Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)|Completed||Phase 3|4128|Actual|Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 04:54:34.492499|2017-10-11 04:54:34.492499
NCT00095433|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-04|2014-03-25|||September 2002||2002-09-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)|An Extension Study to Evaluate the Safety and Tolerability of Multiple-Dose Intravitreal Injections of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration Who Have Completed the Treatment Phase of a Genentech-Sponsored Phase I or Phase I/II rhuFab V2 Study|Completed||Phase 3|100||Genentech, Inc.|||||f||||||||||||||2017-10-11 04:54:46.548561|2017-10-11 04:54:46.548561
NCT00095251|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-01|2017-03-22|||August 2004||2004-08-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|August 2007|Actual|2007-08-01||Interventional|||MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status|A Randomized, Double-blind Trial in Ventilated ICU Patients Comparing Treatment With an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status|Active, not recruiting||Phase 2|100|Anticipated|Vanderbilt University Medical Center||2|||f||||t||||||||||2017-10-11 04:54:41.159052|2017-10-11 04:54:41.159052
NCT00095264|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-02|2010-01-14|||October 2004||2004-10-01|January 2010|2010-01-01||||||||Interventional|||A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome|A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome|Completed||Phase 2|209||Amgen||1|||||||||||||||||2017-10-11 04:54:41.33132|2017-10-11 04:54:41.33132
NCT00095277|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-02|2009-03-12|||October 2004||2004-10-01|March 2009|2009-03-01||||||||Interventional|||Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer|Completed||Phase 2|220||Amgen|||||||||||||||||||2017-10-11 04:54:41.421065|2017-10-11 04:54:41.421065
NCT00095290|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-02|2011-04-07||2010-02-15|September 2004||2004-09-01|September 2008|2008-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria|Irbesartan Versus Placebo in Combination With Standard Cardiovascular Protection ACE-I Therapy With Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk|Completed||Phase 4|400||Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 04:54:41.518931|2017-10-11 04:54:41.518931
NCT00095303|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-02|2015-06-10|2014-05-17||August 2004||2004-08-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|January 2008|Actual|2008-01-01||Interventional|BSFT|Main Study|Brief Strategic Family Therapy for Adolescent Drug Abusers|Brief Strategic Family Therapy for Adolescent Drug Abusers|Completed||Phase 3|480|Actual|University of Miami|Main Study: Low rates self-reported drug use leading to only examination of prevention of relapse/escalation of drug use Follow Up Study: Variability between the time of participation in main and follow up, so no direct casuality could be concluded|2|||f||||t||||||||||2017-10-11 04:54:41.887583|2017-10-11 04:54:41.887583
NCT00095316|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-02|2014-12-04|||October 2004||2004-10-01|June 2006|2006-06-01|September 2006||2006-09-01|||||Interventional|||Caspofungin Study for Fungal Infections in Adults in Critical Care Settings|A Randomized, Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting|Terminated||Phase 3|1200|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:54:43.262481|2017-10-11 04:54:43.262481
NCT00095329|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-02|2016-09-20|||May 2003||2003-05-01|September 2016|2016-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor|A Phase I/II, Open-Label Pilot Trial to Evaluate the Safety of Rapamune (Sirolimus) in Patients With Multiple Sclerosis|Terminated||Phase 1/Phase 2|14|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Due to slow recruitment.|f||||t||||||||||2017-10-11 04:54:43.438198|2017-10-11 04:54:43.438198
NCT00095342|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-02|2009-09-08||||||September 2009|2009-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study Evaluating TMI-005 in Active Rheumatoid Arthritis|A Double-Blind, Placebo-Controlled, Parallel, Randomized Study to Evaluate the Efficacy and Safety of 3 Oral Dose Levels of TMI-005 in Subjects With Active Rheumatoid Arthritis on a Background of Methotrexate|Completed||Phase 2|390|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:54:43.553184|2017-10-11 04:54:43.553184
NCT00095355|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-02|2008-03-03|||October 2004||2004-10-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Effects of Lithium and Divalproex`on Brain-Derived Neurotrophic Factor in Huntington's Disease|Stimulation of Tyrosine Kinase and ERK Signaling Pathways in Huntington's Disease|Completed||Phase 2|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:54:43.652498|2017-10-11 04:54:43.652498
NCT00095368|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-03|2006-12-06|||October 2004||2004-10-01|April 2005|2005-04-01|May 2005||2005-05-01|||||Interventional|||APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat|A Phase III, Randomized, Double-Blind, Double-Dummy Multicenter Study to Evaluate the Efficacy and Safety of 775 mg APC-111 MP Tablet QD for 7 Days vs Penicillin VK 250 mg QID for 10 Days in Patients With Streptococcus Pyogenes|Completed||Phase 3|500||Advancis Pharmaceutical Corporation|||||f||||||||||||||2017-10-11 04:54:43.738147|2017-10-11 04:54:43.738147
NCT00095381|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-03|2012-01-18|||March 2004||2004-03-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|||Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia|A Phase II, Multi-Center Open-Label, Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia With an Option of Long-Term Forodesine Hydrochloride (BCX-1777) Use|Completed||Phase 2|20||BioCryst Pharmaceuticals|||||f||||||||||||||2017-10-11 04:54:43.830559|2017-10-11 04:54:43.830559
NCT00095394|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-03|2011-04-07||2010-02-15|September 2004||2004-09-01|August 2008|2008-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension|The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Severe Hypertension|Completed||Phase 3|645|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 04:54:44.031191|2017-10-11 04:54:44.031191
NCT00095407|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-03|2017-06-30|||October 29, 2004||2004-10-29|December 29, 2011|2011-12-29|December 29, 2011||2011-12-29|||||Observational|||The Functional Anatomy of Personality Trait Knowledge: An fMRI Study|The Functional Anatomy of Personality Trait Knowledge: an fMRI Study|Completed||N/A|190|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:54:44.772251|2017-10-11 04:54:44.772251
NCT00095420|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-04|2013-05-13|||September 2003||2003-09-01|May 2013|2013-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Relationship Training for Children With Autism and Their Peers|Peer Related School Interventions in Autism|Completed||N/A|60|Actual|University of California, Los Angeles||4|||f||||t||||||||||2017-10-11 04:54:46.3882|2017-10-11 04:54:46.3882
NCT00095654|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2009-11-09|||July 2001||2001-07-01|November 2009|2009-11-01|October 2006|Actual|2006-10-01|||||Interventional|||The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial|The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial|Completed||Phase 3|5000||Gerstein, Hertzel, MD|||||||||||||||||||2017-10-11 04:54:56.216465|2017-10-11 04:54:56.216465
NCT00095446|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-04|2017-01-02|||July 2004||2004-07-01|January 2017|2017-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes|An Open-Label, Multi Center, Clinical Trial: External Continuous Subcutaneous Infusion of Insulin Using Insulin Aspart (NovoLog®) in Subjects With Type 1 and Insulin Requiring Type 2 Diabetes|Completed||Phase 4|513|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 04:54:46.61016|2017-10-11 04:54:46.61016
NCT00095459|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-04|2017-10-05|||November 2, 2004||2004-11-02|April 23, 2014|2014-04-23|July 20, 2012|Actual|2012-07-20|November 1, 2005|Actual|2005-11-01||Interventional|||BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors|A Phase I Trial of BAY 43-9006 (Sorafenib) and Bevacizumab in Refractory Solid Tumors With Biologic and Proteomic Analysis|Completed||Phase 1|57|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:54:46.690588|2017-10-11 04:54:46.690588
NCT00095472|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-04|2017-10-05|||November 1, 2004||2004-11-01|December 7, 2015|2015-12-07|August 24, 2007|Actual|2007-08-24|August 24, 2007|Actual|2007-08-24||Interventional|||Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease|Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease|Completed||Phase 1|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:54:46.776125|2017-10-11 04:54:46.776125
NCT00095485|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2008-03-03|||November 2004||2004-11-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Impact of Move to Clinical Research Center on Physical Activity of Employees|Impact of Move to CRC on Physical Activity of Employees|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:54:46.855155|2017-10-11 04:54:46.855155
NCT00095498|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2017-02-07|2010-06-25|2009-11-23|August 2004||2004-08-01|February 2017|2017-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis|A Randomized, Double-blind, Placebo-controlled, Multi-dose Phase 2 Study to Determine the Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis|Completed||Phase 2|227|Actual|Amgen||3|||f||||||||||||||2017-10-11 04:54:47.145495|2017-10-11 04:54:47.145495
NCT00095511|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2013-11-07|||June 2004||2004-06-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Aripiprazole in Patients With Acute Mania|A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder|Completed||Phase 3|615||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||f||||||||||||||2017-10-11 04:54:53.612829|2017-10-11 04:54:53.612829
NCT00095524|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2013-11-07|||March 2004||2004-03-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder|A Multicenter, Randomized, Double-Blind Study on the Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|300||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||f||||||||||||||2017-10-11 04:54:53.784475|2017-10-11 04:54:53.784475
NCT00095537|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2010-02-27|||March 2004||2004-03-01|October 2008|2008-10-01||||May 2006|Actual|2006-05-01||Interventional|||BMS-599626 in Patients With Advanced Solid Malignancies|Phase I Study of BMS-599626 in Patients With Advanced Solid Malignancies, Including Malignancies That Express HER2 at the Maximum Tolerated Dose and/or Recommended Phase II Dose|Completed||Phase 1|60||Bristol-Myers Squibb||1|||f||||||||||||||2017-10-11 04:54:53.955112|2017-10-11 04:54:53.955112
NCT00095550|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2011-04-07||2010-02-15|October 2004||2004-10-01|August 2008|2008-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension|The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Patients With Moderate Hypertension|Completed||Phase 3|496|Anticipated|Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 04:54:54.054491|2017-10-11 04:54:54.054491
NCT00095563|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2017-03-06|2015-07-30||September 2004||2004-09-01|March 2017|2017-03-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers|A Phase 2 Study of GW572016 in Recurrent and/or Metastatic Adenoid Cystic Carcinoma, and Other EGFR-and/or erbB2-expressing Malignant Tumors of the Salivary Glands|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:54:54.498512|2017-10-11 04:54:54.498512
NCT00095576|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2015-10-05|2011-07-20||November 2004||2004-11-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Interventional|||Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase II Proof-of-Concept Study to Evaluate the Safety and Efficacy of a 3-Dose Regimen of the Merck Adenovirus Serotype 5 HIV-1 Gag/Pol/Nef Vaccine (MRK AD5 HIV-1 Gag/Pol/Nef) in Adults at High Risk of HIV-1 Infection|Terminated||Phase 2|3000|Actual|Merck Sharp & Dohme Corp.|The DSMB (Data & Safety Monitoring Board) reviewed interim data which demonstrated that the investigational vaccine was not effective, and all vaccinations were halted. Long term follow up was available for participants in V520-030.|2|||f||||t||||||||||2017-10-11 04:54:55.224965|2017-10-11 04:54:55.224965
NCT00095589|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2009-02-26|||August 2004||2004-08-01|February 2009|2009-02-01||||June 2009|Anticipated|2009-06-01||Interventional|||Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer|Detection of Bladder Cancer by Microsatellite Analysis (MSA) of Urinary Sediment: Multi-Institutional Study|Unknown status|Active, not recruiting|N/A|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:54:55.695071|2017-10-11 04:54:55.695071
NCT00095628|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2017-01-13|2015-06-19||January 2005||2005-01-01|January 2017|2017-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional||A total of 21 patients were enrolled onto the study. One patient was ineligible due to disease progression prior to treatment. So a total of 20 evaluable patients were analyzed|SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase 2 Study of SB-715992 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:54:55.803241|2017-10-11 04:54:55.803241
NCT00095641|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2013-11-07||||||November 2013|2013-11-01||||||||Interventional|||S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer|S0225: Phase II Study of Adjuvant Low-Dose Capecitabine After Salvage Surgery in Patients With Locally Recurrent or Persistent Squamous Cell Carcinoma of the Head and Neck|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||||no longer studying this disease site|f||||t||||||||||2017-10-11 04:54:56.148512|2017-10-11 04:54:56.148512
NCT00095680|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2010-10-21|||November 2004||2004-11-01|October 2010|2010-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma|A 24-week, Open-label Extension Study of the Efficacy, Safety, and Tolerability of Oral SCIO-469 in Treatment of Relapsed Refractory Patients With Multiple Myeloma|Completed||Phase 2|30|Actual|Scios, Inc.||2|||f||||||||||||||2017-10-11 04:54:56.42021|2017-10-11 04:54:56.42021
NCT00095693|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2014-01-15|||October 2004||2004-10-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|August 2005|Actual|2005-08-01||Interventional|||Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer|Phase II Study of BAY 43-9006 in Patients With Metastatic Thyroid Carcinoma|Terminated||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:54:56.514088|2017-10-11 04:54:56.514088
NCT00095706|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-05|2015-09-23|||June 2003||2003-06-01|September 2015|2015-09-01|January 2012|Actual|2012-01-01|April 2007|Actual|2007-04-01||Interventional|||Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)|Phase I/II Combined Biological Therapy of Breast Cancer Using Monoclonal Antibodies Directed Against HER2/Neu Proto-Oncogene and Vascular Endothelial Growth Factor|Completed||Phase 1/Phase 2|50|Anticipated|Translational Oncology Research International|||||f||||t||||||||||2017-10-11 04:54:56.632348|2017-10-11 04:54:56.632348
NCT00095719|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-11-07|||December 2003||2003-12-01|August 2008|2008-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia|A Safety & Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia|Completed||Phase 3|125||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-10-11 04:54:56.754753|2017-10-11 04:54:56.754753
NCT00095732|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2014-10-15|||June 2004||2004-06-01|October 2014|2014-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency|A Phase 2, Randomized, Double Blind, Parallel Dose Ranging Study of Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency|Completed||Phase 2|129|Actual|Anthera Pharmaceuticals||3|||f||||t||||||||||2017-10-11 04:54:56.887495|2017-10-11 04:54:56.887495
NCT00095745|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-11-07|||September 2004||2004-09-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder|A Multicenter, Long-Term, Open-label, Study to Assess the Safety and Tolerability of Aripiprazole as an Adjunctive Therapy in the Treatment of Outpatients With Major Depressive Disorder|Completed||Phase 3|1002|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 04:54:57.046105|2017-10-11 04:54:57.046105
NCT00095758|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-11-22|||September 2004||2004-09-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder|A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder|Completed||Phase 3|1200||Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 04:54:57.254153|2017-10-11 04:54:57.254153
NCT00095771|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2011-04-21|||November 2004||2004-11-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas|A Phase I Trial of Arsenic Trioxide in the Treatment of Infiltrating Gliomas of Childhood|Completed||Phase 1|36|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:54:57.568563|2017-10-11 04:54:57.568563
NCT00095784|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2017-09-04|2014-07-09||September 29, 2004|Actual|2004-09-29|June 2017|2017-06-01||||July 1, 2008|Actual|2008-07-01||Interventional|||Decitabine in Treating Patients With Myelofibrosis|A Phase II Study of Decitabine in Myelofibrosis|Active, not recruiting||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:54:57.660628|2017-10-11 04:54:57.660628
NCT00095797|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-02-07|||October 2004||2004-10-01|February 2013|2013-02-01||||March 2007|Actual|2007-03-01||Interventional|||XK469R in Treating Patients With Refractory Hematologic Cancer|A Phase I Study of XK469R (NSC 698215) in Patients With Refractory Hematologic Malignancies|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:54:58.512504|2017-10-11 04:54:58.512504
NCT00095810|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-11-07|||July 2003||2003-07-01|December 2010|2010-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease|An Open-Label Study of Aripiprazole to Evaluate the Safety and Tolerability in Patients With Psychosis Associated With Parkinson's Disease|Completed||Phase 4|50||Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-10-11 04:54:58.764849|2017-10-11 04:54:58.764849
NCT00095823|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-11-22|||June 2004||2004-06-01|November 2013|2013-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Aripiprazole as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder.|Completed||Phase 3|1200||Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 04:54:58.896512|2017-10-11 04:54:58.896512
NCT00095836|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2017-05-02|2017-03-01||March 2003|Actual|2003-03-01|May 2017|2017-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy|A Phase II Study of ZD 1839 (IRESSA®) in Patients With Advanced Thyroid Cancer|Completed||Phase 2|27|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 04:54:59.120437|2017-10-11 04:54:59.120437
NCT00095862|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-12-17|||November 2004||2004-11-01|October 2011|2011-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers|A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor|Suspended||Phase 1/Phase 2|24|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:54:59.804811|2017-10-11 04:54:59.804811
NCT00095875|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-10-25|2013-05-15||August 2004||2004-08-01|October 2013|2013-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)|A Randomized Phase III Comparing Sequential Therapy With TPF/Chemoradiation (ST) To Cisplatinum-Based Chemoradiotherapy [PARADIGM TRIAL]|Completed||Phase 3|145|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 04:54:59.942932|2017-10-11 04:54:59.942932
NCT00095901|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2008-07-23|||June 2004||2004-06-01|December 2005|2005-12-01||||||||Interventional|||Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer|A Phase II Study Of Capecitabine In Previously Treated, Recurrent And/Or Metastatic Nasopharyngeal Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:55:00.542158|2017-10-11 04:55:00.542158
NCT00095914|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2012-03-14|||September 2004||2004-09-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|May 2007|Actual|2007-05-01||Interventional|||Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Randomized, Crossover, Pharmacokinetic Study Of Paclitaxel (Taxol) And ABI-007 (A Cremophor EL-Free, Protein Stabilized, Nanoparticle Paclitaxel) In Patients With Advanced Solid Tumors|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:55:00.633957|2017-10-11 04:55:00.633957
NCT00095927|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2017-01-03|||May 2003||2003-05-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Randomized Amifostine For SCCHN|Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|58|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-10-11 04:55:00.716458|2017-10-11 04:55:00.716458
NCT00095940|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2014-05-07|2011-08-02||October 2004||2004-10-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors|Molecular Biology and Phase II Study of Lapatinib (GW572016) in Pediatric Patients With Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma|Completed||Phase 1/Phase 2|52|Actual|National Cancer Institute (NCI)|Accrual to the Molecular Biology phase (MBP) was contingent upon accrual being open for the Phase II since some participants in the MBP could be counted in the phase II. The phase II enrolled rapidly thus limiting enrollment to the MBP.|1|||f||||||||||||||2017-10-11 04:55:00.88113|2017-10-11 04:55:00.88113
NCT00095953|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-05-16|||November 2004||2004-11-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2006|Actual|2006-09-01||Interventional|||SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma|A Phase II Study of SB-715992 (NSC 727990) in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:55:02.652805|2017-10-11 04:55:02.652805
NCT00095966|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-07-01|||September 2004||2004-09-01|July 2013|2013-07-01||||September 2005|Actual|2005-09-01||Interventional|||Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase II Study of BAY 43-9006/Gemcitabine for Advanced Pancreatic Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:02.74287|2017-10-11 04:55:02.74287
NCT00095979|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2015-05-05|2015-05-05||May 2005||2005-05-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||Eligible and treated patients|Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Ixabepilone (BMS-247550) [NCI-Supplied Agent, NSC #710428]) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|52|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:02.847409|2017-10-11 04:55:02.847409
NCT00095992|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2011-09-26|||November 2004||2004-11-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer|A Phase II Study Of SB-715992 (NSC 727990) In Patients With Locally Advanced, Recurrent Or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|15|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-10-11 04:55:03.756376|2017-10-11 04:55:03.756376
NCT00096005|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2014-02-21|||November 2004||2004-11-01|October 2011|2011-10-01||||March 2010|Actual|2010-03-01||Interventional|||Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas|A Phase I Trial Of 17-Allylaminogeldanamycin (17-AAG) And PS341 In Advanced Malignancies|Terminated||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:03.884242|2017-10-11 04:55:03.884242
NCT00096018|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-09-19|2013-01-28||May 2002||2002-05-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|November 2010|Actual|2010-11-01||Interventional||Treated Patients|Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia|A Phase I/II Study of Fludarabine Plus Thalidomide as Frontline Therapy for Newly Diagnosed Patients With Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|43|Actual|Roswell Park Cancer Institute|The study was stopped early due to low accrual.|1|||f||||t||||||||||2017-10-11 04:55:04.07285|2017-10-11 04:55:04.07285
NCT00096031|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2012-04-04|2012-04-04||October 2004||2004-10-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|January 2008|Actual|2008-01-01||Interventional|||S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer|Cetuximab As Second Line Therapy In Patients With Metastatic Esophageal Cancer - Phase II|Completed||Phase 2|63|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:55:05.231165|2017-10-11 04:55:05.231165
NCT00096044|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2017-06-09|2017-04-24||March 2004||2004-03-01|June 2017|2017-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||All treated and eligible patients|Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|CC-5013 Alone or in Combination With Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|45|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:55:06.217142|2017-10-11 04:55:06.217142
NCT00096057|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-06-25|||May 2004||2004-05-01|April 2007|2007-04-01|December 2007|Actual|2007-12-01|||||Interventional|||Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer|An Open Label Phase I Study of Humanized Human Milk Fat Globule-1 (huHMFG1) Antibody in Patients With Locally Advanced or Metastatic Breast Cancer (TOPCAT)|Completed||Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:55:07.017809|2017-10-11 04:55:07.017809
NCT00096070|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-07-15|||December 2004||2004-12-01|June 2013|2013-06-01||||April 2007|Actual|2007-04-01||Interventional|||Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer|Phase II Study of Oxaliplatin, Continuous 5-Fluorouracil and External Beam Radiation Followed by Gemcitabine in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:07.216522|2017-10-11 04:55:07.216522
NCT00096083|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-10-22|||September 2004||2004-09-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer|A Phase II Study Of Hepatic Arterial Infusion Of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) For Unresectable Primary And Metastatic Cancers Of The Liver|Completed||Phase 2|56|Actual|Delcath Systems Inc.||1|||f||||||||||||||2017-10-11 04:55:07.340965|2017-10-11 04:55:07.340965
NCT00096096|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2010-05-12|||August 2004||2004-08-01|May 2010|2010-05-01||||May 2006|Actual|2006-05-01||Interventional|||Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation|A Phase II Study of the Combination of Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-Versus-Host Disease|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:55:07.431078|2017-10-11 04:55:07.431078
NCT00096109|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2016-11-18|2015-05-11||September 2005||2005-09-01|November 2016|2016-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer|A Phase II Clinical Trial of 17-Allyamino-17-Demethoxygeldanamycin (17-AAG) in Chemotherapy Refractory Metastatic Breast Cancer|Terminated||Phase 2|11|Actual|National Cancer Institute (NCI)|Because of the frequency of toxicities experienced by the pts & lack of response, study closed to accrual before all 17 planned pts were enrolled. It was proposed to analyze outcome by HER2 status,but no HER2 data was collected.|1||Closed to accrual before all 12 planned patients were enrolled.|f||||||||||||||2017-10-11 04:55:07.548637|2017-10-11 04:55:07.548637
NCT00096122|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2014-05-09|2011-06-13||September 2004||2004-09-01|June 2013|2013-06-01|February 2010|Actual|2010-02-01|September 2006|Actual|2006-09-01||Interventional|||Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia|PHASE I-II STUDY OF IDARUBICIN, CYTARABINE AND R115777 (TIPIFARNIB, ZARNESTRA; 702818; IND 58359), A FARNESYLTRANSFERASE INHIBITOR, IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIAS|Completed||Phase 1/Phase 2|95|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:07.878875|2017-10-11 04:55:07.878875
NCT00096135|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2017-02-14|2015-07-10||November 2004||2004-11-01|February 2017|2017-02-01||||September 2013|Actual|2013-09-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes|Treatment of Late Isolated Extramedullary Relapse From Acute Lymphoblastic Leukemia (ALL) (Initial CR1≥ 18 Months)|Completed||N/A|168|Actual|Children's Oncology Group|The COG SDC reviewed the NLM notification related to ct.gov AE/SAE reporting. The information in ‘Additional Description’ is accurate with respect to data supplied to ct.gov.COG plans to submit data AE/SAE data consistent with the text in this field.|2|||f||||t||||||||||2017-10-11 04:55:08.293464|2017-10-11 04:55:08.293464
NCT00096148|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-01-23|||October 2004||2004-10-01|January 2013|2013-01-01||||November 2006|Actual|2006-11-01||Interventional|||Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|Randomized Phase II Trial of Idarubicin + Ara-C +/- Bevacizumab in Patients Age < 60 With Untreated Acute Myeloid Leukemia|Terminated||Phase 2|120|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:55:09.930929|2017-10-11 04:55:09.930929
NCT00096161|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2017-03-24|2017-01-27||May 2003||2003-05-01|March 2017|2017-03-01||||February 2015|Actual|2015-02-01||Interventional|||Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant|Pentostatin and Donor Lymphocyte Infusion for Low Donor T-cell Chimerism After Hematopoietic Cell Transplantation - A Multi-center Trial|Active, not recruiting||Phase 2|36|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:55:10.085275|2017-10-11 04:55:10.085275
NCT00096174|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2015-08-03|2011-02-28||December 2004||2004-12-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2009|Actual|2009-07-01||Interventional|||Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck|Phase II Study of C225 (Erbitux or Cetuximab) in Combination With Cisplatin and Definitive Radiation in Unresectable Stage IV Squamous Cell Carcinoma of the Head and Neck|Unknown status|Active, not recruiting|Phase 2|69|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 04:55:10.81115|2017-10-11 04:55:10.81115
NCT00096187|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-04-10|||July 2005||2005-07-01|May 2007|2007-05-01||||July 2007||2007-07-01||Interventional|||Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy|A Phase II Trial of Pemetrexed (ALIMTA®, LY231514, IND #40061) as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Tumor|Terminated||Phase 2|55|Anticipated|Gynecologic Oncology Group|||||||||||||||||||2017-10-11 04:55:11.356215|2017-10-11 04:55:11.356215
NCT00096200|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2015-04-14|2012-11-08||August 2004||2004-08-01|February 2014|2014-02-01||||August 2012|Actual|2012-08-01||Interventional|||Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|A Phase II Trial Of BAY 43-9006, A Novel Raf Kinase Inhibitor Plus Paclitaxel/Carboplatin In Women With Recurrent Platinum Sensitive Epithelial Ovarian, Peritoneal Or Fallopian Tube Cancer|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)|Principal Investigator did not collect data on secondary outcomes because not relevant.|2|||f||||||||||||||2017-10-11 04:55:11.539902|2017-10-11 04:55:11.539902
NCT00096213|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2012-01-13|||December 2004||2004-12-01|January 2012|2012-01-01|August 2009|Actual|2009-08-01|April 2006|Actual|2006-04-01||Interventional|||S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone|A Phase II Surgical Trial Of Intralesional Resection Of Low-Grade Intracompartmental Chondrosarcoma Of Bone|Completed||Phase 2|60|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 04:55:12.561066|2017-10-11 04:55:12.561066
NCT00096226|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2015-11-14|2014-01-16||September 2004||2004-09-01|November 2015|2015-11-01||||April 2012|Actual|2012-04-01||Interventional||All eligible patients who started protocol treatment.|Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer|A Phase II Trial Of Neoadjuvant Therapy With Concurrent Chemotherapy And High Dose Radiotherapy Followed By Surgical Resection And Consolidative Therapy For Locally Advanced Non-Small Cell Lung Carcinoma|Completed||Phase 2|60|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:55:12.701823|2017-10-11 04:55:12.701823
NCT00085787|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2012-09-28|||June 2004||2004-06-01|September 2012|2012-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study of ARRY-142886 in Patients With Advanced Cancer||Completed||Phase 1|57|Actual|Array BioPharma||1|||f||||||||||||||2017-10-11 04:55:43.777803|2017-10-11 04:55:43.777803
NCT00096239|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-12-18|||December 2004||2004-12-01|February 2005|2005-02-01|February 2005|Actual|2005-02-01|||||Interventional|||CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|Phase II Open-Label, Multi-Center Study of CP-547, 632, an Oral Tyrosine Kinase Inhibitor of VEGFR-2, in Subjects With Recurrent or Persistent Small-Volume Epithelial Ovarian Cancer, Primary Peritoneal Serous Cancer, or Fallopian Tube Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:55:13.581943|2017-10-11 04:55:13.581943
NCT00096265|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2014-05-05|2013-03-05||October 2004||2004-10-01|October 2011|2011-10-01|April 2012|Actual|2012-04-01|June 2011|Actual|2011-06-01||Interventional|||Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer|A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases|Terminated||Phase 3|126|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 04:55:13.737033|2017-10-11 04:55:13.737033
NCT00096278|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2014-05-16|2012-10-31||September 2004||2004-09-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|March 2009|Actual|2009-03-01||Interventional|||Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer|A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks With Bevacizumab to the Same Regimen Without Bevacizumab for the Treatment of Patients With Resected Stages II and III Carcinoma of the Colon|Completed||Phase 3|2710|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:55:15.559407|2017-10-11 04:55:15.559407
NCT00096291|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2017-04-07|||February 2000||2000-02-01|April 2017|2017-04-01||||March 2005|Actual|2005-03-01||Interventional|||Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer|Neoadjuvant Chemotherapy in Palpable Breast Cancer: Evaluation of Physiologic, Radiologic, and Molecular Markers in Predicting Response|Completed||Phase 2|62|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:55:16.736165|2017-10-11 04:55:16.736165
NCT00096304|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2008-12-04|||June 2004||2004-06-01|November 2008|2008-11-01||||March 2008|Actual|2008-03-01||Interventional|||Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer|Phase I Trial of Epirubicin and Taxotere in Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:55:16.818759|2017-10-11 04:55:16.818759
NCT00096317|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2008-11-12|||March 2003||2003-03-01|January 2006|2006-01-01||||||||Interventional|||Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors|Effect Of Ketoconazole On The Pharmacokinetics Of BMS-247550 In Patients With Advanced Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:55:16.890429|2017-10-11 04:55:16.890429
NCT00096330|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2014-01-10|||September 2004||2004-09-01|January 2014|2014-01-01|March 2008|Actual|2008-03-01|February 2007|Actual|2007-02-01||Interventional|||Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer|Phase I Clinical Study of Folate|Completed||Phase 1|20|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:55:16.955229|2017-10-11 04:55:16.955229
NCT00096343|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-12-02|||October 2002||2002-10-01|November 2012|2012-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer|A Phase II Trial of Pre-Operative Taxol and Carboplatin in Women With Newly Diagnosed Locally Advanced Operable Breast Cancer|Completed||Phase 2|31|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-10-11 04:55:17.02191|2017-10-11 04:55:17.02191
NCT00096356|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2017-05-25|2014-09-08||August 2004||2004-08-01|December 2014|2014-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|CoQ10|All participants|Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer|A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients|Completed||N/A|236|Actual|Wake Forest University Health Sciences||2|||f||||t|f|f||||||||2017-10-11 04:55:17.108513|2017-10-11 04:55:17.108513
NCT00096369|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2008-05-23|||February 2002||2002-02-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer|An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer|Unknown status|Active, not recruiting|Phase 2|130|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:55:17.776754|2017-10-11 04:55:17.776754
NCT00096382|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2015-10-06|2012-11-20||September 2004||2004-09-01|September 2015|2015-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma|Treatment of Patients With Metastatic Melanoma Using a Transplant of Autologous Lymphocytes Reactive With Tumor Following a Myeloablative Lymphocyte Depleting Regimen of Chemotherapy, Total Body Irradiation and Reconstitution With CD34+ Cells|Completed||Phase 2|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 04:55:17.866726|2017-10-11 04:55:17.866726
NCT00096395|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-06-11|||September 2004||2004-09-01|May 2013|2013-05-01||||February 2007|Actual|2007-02-01||Interventional|||Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer|A Phase 2 Study of BAY 43-9006 in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:18.522777|2017-10-11 04:55:18.522777
NCT00096408|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2016-09-26|||October 2005||2005-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|April 2016|Actual|2016-04-01||Interventional|||Laparoscopic Approach to Cancer of the Endometrium|LACE - Laparoscopic Approach to Cancer of the Endometrium: An International Multicenter Randomized Phase 3 Clinical Trial|Active, not recruiting||Phase 3|760|Actual|Queensland Centre for Gynaecological Cancer||2|||f||||t||||||||Undecided||2017-10-11 04:55:18.612304|2017-10-11 04:55:18.612304
NCT00096421|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2006-10-24|||July 2003||2003-07-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||Tight Glycemic Control in Critical Care Patients|Tight Glycemic Control in Patients Hospitalized in a Medical-Surgery Intensive Care Unit: A Randomized Study|Completed||Phase 3|504||Hospital Pablo Tobón Uribe|||||f||||||||||||||2017-10-11 04:55:18.800709|2017-10-11 04:55:18.800709
NCT00096434|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-10-07|||September 2004||2004-09-01|October 2013|2013-10-01||||June 2006|Actual|2006-06-01||Interventional|||Sorafenib in Treating Patients With Metastatic Breast Cancer|Phase II Trial of Raf Kinase Inhibitor BAY 43-9006 as Single Oral Agent in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane|Completed||Phase 2|42|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:18.890868|2017-10-11 04:55:18.890868
NCT00096447|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2015-08-18|2015-06-03||November 2004||2004-11-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional||Eligible and treated patients.|Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation Of Lapatinib (GW572016) (NCI-Supplied Agent, NSC #727989) In The Treatment Of Persistent Or Recurrent Endometrial Carcinoma|Completed||Phase 2|31|Actual|National Cancer Institute (NCI)|The clinical trial was a two-stage design, accruing approximately 25 patients in each stage. Results from a planned interim futility analysis resulted in the early closure of the study. This study stopped early for lack of treatment efficacy.|1|||f||||||||||||||2017-10-11 04:55:18.990432|2017-10-11 04:55:18.990432
NCT00096460|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2016-08-01|2011-08-16||August 2004||2004-08-01|August 2016|2016-08-01|March 2009|Actual|2009-03-01|March 2006|Actual|2006-03-01||Interventional|||Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)|Autologous Versus Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response (BMT CTN #0202)|Terminated||Phase 2/Phase 3|30|Actual|Medical College of Wisconsin||2||lower than anticipated accrual|f||||t||||||||Yes||2017-10-11 04:55:19.463266|2017-10-11 04:55:19.463266
NCT00096473|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2011-03-31|||January 2001||2001-01-01|March 2011|2011-03-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease|A 24 Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Donepezil Hydrochloride (E2020) in Patients With Severe Alzheimer's Disease Followed by a 12 Week Open-Label Extension Period|Completed||Phase 3|229|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 04:55:19.907495|2017-10-11 04:55:19.907495
NCT00096486|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2015-12-15|2015-12-15||May 2004||2004-05-01|December 2015|2015-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer|A Phase I/II Trial of Fixed Doses of Daily Gefitinib With Escalating Doses of Daily RAD001 in Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|74|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:55:20.081856|2017-10-11 04:55:20.081856
NCT00096499|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-01-24|||April 2005||2005-04-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel|A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Taxane-Resistant Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:21.384318|2017-10-11 04:55:21.384318
NCT00096512|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-02-27|||October 2004||2004-10-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|Phase II Evaluation of BAY 43-9006 (NSC-724772) in Patients With Recurrent or Metastatic Head and Neck Cancer|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:21.488791|2017-10-11 04:55:21.488791
NCT00096525|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2013-01-15|||July 2004||2004-07-01|January 2013|2013-01-01||||August 2005|Actual|2005-08-01||Interventional|||Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer|Phase II Trial of CC-5013 in Patients With Advanced Renal Cell Carcinoma With Either No Prior Treatment or One Prior Treatment Regimen|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:55:21.602988|2017-10-11 04:55:21.602988
NCT00096538|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-09|2015-10-21|2015-10-21||April 2004||2004-04-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma|Pilot Study Of Valganciclovir In Patients With Classic, Non-HIV-Associated Kaposi's Sarcoma|Completed||N/A|6|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:55:21.699421|2017-10-11 04:55:21.699421
NCT00096551|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-07|2017-06-30|||November 1, 2004||2004-11-01|July 25, 2011|2011-07-25|July 25, 2011|Actual|2011-07-25|December 11, 2009|Actual|2009-12-11||Interventional|||A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy|A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer and Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy|Completed||Phase 1|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:55:21.916728|2017-10-11 04:55:21.916728
NCT00096564|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-10|2017-06-30|||November 9, 2004||2004-11-09|August 20, 2008|2008-08-20|August 20, 2008||2008-08-20|||||Observational|||Brain Activities Associated With Different Facial Expressions Using Blood Oxygenation Level Dependent Functional MRI|Functional MRI Study of Brain Activation With Observation of Facial Expressions|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:21.986316|2017-10-11 04:55:21.986316
NCT00096590|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-11|2009-05-09|||November 2004||2004-11-01|June 2007|2007-06-01||||||||Observational|||Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery|Evaluation of a Novel Blood Test Hypercoagulability in Surgical Patients With Metastatic Carcinoma: A Pilot Study|Completed||N/A|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:55:22.118359|2017-10-11 04:55:22.118359
NCT00096603|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2014-03-19|||October 2002||2002-10-01|March 2014|2014-03-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g|An Open Label, Multicenter Study to Evaluate the Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g|Completed||Phase 3|450||Genentech, Inc.|||||||||||||||||||2017-10-11 04:55:22.193538|2017-10-11 04:55:22.193538
NCT00096616|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2013-10-31|||November 2004||2004-11-01|October 2013|2013-10-01||||March 2006|Actual|2006-03-01||Interventional|||Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma|A Single Dose, Randomized, Double-blind Crossover Comparison of Combivent CFC MDI and Albuterol HFA MDI in Patients With Moderate to Severe Persistent Asthma and Persistent Symptoms Despite Treatment With Inhaled Corticosteroids|Completed||Phase 2|113|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 04:55:22.250071|2017-10-11 04:55:22.250071
NCT00096629|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2017-03-29|||November 2003||2003-11-01|March 2017|2017-03-01|November 2018|Anticipated|2018-11-01|November 2018|Anticipated|2018-11-01||Interventional|||Vaccine Therapy in Treating Patients With Kidney Cancer|Injection of Renal Cell Carcinoma Patients With Human and Mouse Prostate Specific Membrane Antigen (PSMA) DNA: A Phase I Trial to Assess Safety and Immune Response|Active, not recruiting||Phase 1|15|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 04:55:22.372206|2017-10-11 04:55:22.372206
NCT00096642|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2011-08-04|||June 2002||2002-06-01|August 2011|2011-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Cognitive Behavioral Therapy for Early-Onset Depression|Comprehensive Treatment for Depressed Youth: An Outcome Evaluation Study|Completed||N/A|30|Actual|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-10-11 04:55:22.469815|2017-10-11 04:55:22.469815
NCT00096655|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2011-05-16|||May 2002||2002-05-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis|A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis|Completed||Phase 3|364|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 04:55:22.572367|2017-10-11 04:55:22.572367
NCT00096668|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2009-06-02|||October 2004||2004-10-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer|A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(R) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) as Initial Treatment of Patients With Metastatic Breast Cancer|Completed||Phase 2|47|Actual|Achieve Life Sciences||1|||f||||||||||||||2017-10-11 04:55:22.65489|2017-10-11 04:55:22.65489
NCT00096681|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2011-02-17|2011-01-14||February 2005||2005-02-01|February 2011|2011-02-01|February 2006|Actual|2006-02-01|August 2005|Actual|2005-08-01||Observational|||Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa|Protocol for Cross-Sectional Survey of Acid-Fast Bacilli (AFB) Smear Positive and/or Culture Positive Tuberculosis in the Masiphumelele Township|Completed||N/A|762|Actual|CIPRA SA|||1||f||||f||||||Samples With DNA|"     Sputum samples   "|||2017-10-11 04:55:22.762239|2017-10-11 04:55:22.762239
NCT00096694|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2012-05-17||||||May 2012|2012-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women|A Pilot Study Evaluating the Effect of the Levonorgestrel-Releasing Intrauterine Device on Genital HIV Shedding in HIV-1-Infected Women|Completed||N/A|41||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:55:22.944218|2017-10-11 04:55:22.944218
NCT00096707|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2009-04-28|||February 2004||2004-02-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors|Phase I Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) Alone and in Combination With Docetaxel in Subjects With Advanced Solid Malignancies|Completed||Phase 1|50|Anticipated|Threshold Pharmaceuticals|||||||||||||||||||2017-10-11 04:55:23.046249|2017-10-11 04:55:23.046249
NCT00096720|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2010-09-28|||February 2004||2004-02-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease|Investigating Effects of Short-term Treatment With Pramipexole or Levodopa on [123I]B-CIT and SPECT Imaging in Early Parkinson's|Completed||Phase 2|112|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-10-11 04:55:23.13354|2017-10-11 04:55:23.13354
NCT00096733|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-12|2017-08-27|||October 2004||2004-10-01|August 2017|2017-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|A2ALL-1||Adult-to-Adult Living Donor Liver Transplantation Study|Adult-to-Adult Living Donor Liver Transplantation Cohort Study|Completed||N/A|2470|Actual|Arbor Research Collaborative for Health|||2||f||||t||||||Samples With DNA|"     whole blood, serum, fixed tissue samples, frozen tissue samples   "|||2017-10-11 04:55:23.281266|2017-10-11 04:55:23.281266
NCT00096746|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-15|2011-04-12|||November 2004||2004-11-01|April 2011|2011-04-01|September 2006||2006-09-01|September 2006|Actual|2006-09-01||Observational|||Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects|An Exploratory Study of the Effect of the Atazanavir (ATV) I50L Mutation on Subsequent Treatment Response|Completed||N/A|200||Bristol-Myers Squibb|||2||f||||f||||||||||2017-10-11 04:55:23.441459|2017-10-11 04:55:23.441459
NCT00096759|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-15|2013-03-21|||November 2004||2004-11-01|March 2013|2013-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid Arthritis|Efficacy of CAM Interventions in Rheumatoid Arthritis|Completed||Phase 2/Phase 3|100|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:55:23.605526|2017-10-11 04:55:23.605526
NCT00096772|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-15|2014-05-16|||January 2005||2005-01-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Collection of Blood Samples From HIV Infected People|Collection and Use of Blood For Genetic and Other Related Analyses (The GENOMICS Protocol)|Completed||N/A|2502|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"     Whole blood   "|||2017-10-11 04:55:23.712283|2017-10-11 04:55:23.712283
NCT00096785|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-15|2010-08-04|2009-07-02||December 2004||2004-12-01|June 2010|2010-06-01|April 2008|Actual|2008-04-01|January 2006|Actual|2006-01-01||Interventional|||Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection|Randomized, Open-Label, Comparative Study to Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Naive Adults With Chronic Hepatitis B Infection|Completed||Phase 3|69|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 04:55:23.940731|2017-10-11 04:55:23.940731
NCT00096798|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-15|2008-01-15|||September 2001||2001-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression|A Double-Blind, Placebo-Controlled Study of Ethyl Eicosapentanoic Acid (Ethyl-EPA) in Major Depressive Disorder|Completed||Phase 3|80|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:55:24.872481|2017-10-11 04:55:24.872481
NCT00096811|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-15|2016-09-20|||September 2003||2003-09-01|September 2016|2016-09-01|August 2008|Actual|2008-08-01|August 2008|Anticipated|2008-08-01||Expanded Access|||Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program|A Treatment Use Protocol of Entecavir in Subjects With Chronic Hepatitis B Infection Who Have Failed or Who Are Intolerant of Available Therapies|No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:55:24.944609|2017-10-11 04:55:24.944609
NCT00096824|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-15|2015-03-17|||February 2006||2006-02-01|March 2015|2015-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175|International Neurological Study: A Stand Alone Study for Participants of A5175 (A Phase IV, Randomized, Open-Label Evaluation of the Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combination for Initial Treatment of HIV-1 Infected Individuals From Diverse Areas of the World)|Completed||N/A|860|Actual|AIDS Clinical Trials Group|||1||f||||t||||||||||2017-10-11 04:55:25.068407|2017-10-11 04:55:25.068407
NCT00096837|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-16|2006-06-07||||||June 2006|2006-06-01||||||||Interventional|||A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma|An Open-Label Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|25||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 04:55:25.247934|2017-10-11 04:55:25.247934
NCT00096850|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-16|2012-05-17||||||May 2012|2012-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults|Safety, Tolerability, and Pharmacokinetic Interactions of Atazanavir and Rifampin in Healthy Volunteers|Completed||N/A|18|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 04:55:25.353836|2017-10-11 04:55:25.353836
NCT00096863|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-16|2016-01-28|||December 2004||2004-12-01|January 2016|2016-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The MIND Study: Modifying the INcidence of Delirium|Delirium in the ICU: a Prospective, Randomized, Trial of Placebo vs. Haloperidol vs. Ziprasidone|Completed||Phase 2|102|Actual|Vanderbilt University||3|||f||||t||||||||||2017-10-11 04:55:25.525514|2017-10-11 04:55:25.525514
NCT00096876|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-16|2008-06-09|||October 2004||2004-10-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients|Screening Evaluations for Neurologic Syndromes: Olfactory Testing in Relatives of Parkinson's Disease Patients|Completed||N/A|600|Anticipated|Institute for Neurodegenerative Disorders|||||f||||||||||||||2017-10-11 04:55:25.705371|2017-10-11 04:55:25.705371
NCT00096902|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-16|2017-06-30|||November 8, 2004||2004-11-08|September 11, 2006|2006-09-11|September 11, 2006||2006-09-11|||||Interventional|||Non-Pharmacologic Therapy for Neurocardiogenic Syncope|Non-Pharmacologic Therapy for Neurocardiogenic Syncope|Completed||Phase 2|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:25.780774|2017-10-11 04:55:25.780774
NCT00096915|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2009-05-21|||October 2004||2004-10-01|May 2009|2009-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis|A Multicenter, Single-Arm Study Evaluating Once Monthly Darbepoetin Alfa Dosing in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis|Completed||Phase 3|110|Actual|Amgen||1|||f||||||||||||||2017-10-11 04:55:25.869287|2017-10-11 04:55:25.869287
NCT00096928|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2015-07-01|||March 2005||2005-03-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|||||Observational|RESPONSE||A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)|Raptiva Epidemiologic Study of Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)|Completed||Phase 4|1846|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:55:25.987926|2017-10-11 04:55:25.987926
NCT00096941|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2015-05-29|2015-05-27||May 2005||2005-05-01|May 2015|2015-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional||Safety population: Participants who received at least 1 dose of pertuzumab.|A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study|An Open-Label, Multicenter Extension Study of Pertuzumab (rhuMAb 2C4) in Subjects Treated With Pertuzumab in a Previous Genentech-Sponsored Phase II Cancer Study|Completed||Phase 2|3|Actual|Genentech, Inc.||1|||f||||||||||||||2017-10-11 04:55:26.443114|2017-10-11 04:55:26.443114
NCT00096954|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2017-05-16|2011-08-08||February 2006|Actual|2006-02-01|May 2017|2017-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|EXACT||A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)|A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)|Completed||Phase 4|333|Actual|Genentech, Inc.|This is a stand-alone study to fulfill one of the post-marketing commitments.|2|||f||||||||||||||2017-10-11 04:55:26.606693|2017-10-11 04:55:26.606693
NCT00096967|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2014-03-25|||October 2002||2002-10-01|March 2014|2014-03-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study|An Open-Label, Multicenter Extension Study of rhuMAb VEGF (Bevacizumab) in Subjects Treated in a Previous Genentech-Sponsored Cancer Study|Completed||Phase 3|100||Genentech, Inc.|||||||||||||||||||2017-10-11 04:55:26.912319|2017-10-11 04:55:26.912319
NCT00096980|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2013-06-19|||February 2001||2001-02-01|June 2013|2013-06-01|May 2004|Actual|2004-05-01|||||Interventional|||A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies|An Open Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneously Administered Efalizumab Used in Combination With Topical Psoriasis Therapies for Prolonged Maintenance Treatment|Completed||Phase 4|300||Genentech, Inc.|||||||||||||||||||2017-10-11 04:55:26.963218|2017-10-11 04:55:26.963218
NCT00096993|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2015-06-08|2015-05-26||January 2005||2005-01-01|June 2015|2015-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional||Safety population: All participants who received any amount of study treatment.|A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Pertuzumab (rhuMAb 2C4) in Combination With Gemcitabine and the Effect of Tumor-Based HER2 Activation in Subjects With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Completed||Phase 2|131|Actual|Genentech, Inc.||2|||f||||f||||||||||2017-10-11 04:55:27.199065|2017-10-11 04:55:27.199065
NCT00097006|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2016-04-14|||September 2004||2004-09-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Retrovirus Epidemiology Donor Study-II (REDS-II)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:55:28.00907|2017-10-11 04:55:28.00907
NCT00085800|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2008-04-22|||May 2004||2004-05-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Dietary Fiber and Cardiovascular Inflammatory Markers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:55:43.850399|2017-10-11 04:55:43.850399
NCT00097019|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2017-05-15|||February 2005|Actual|2005-02-01|May 2017|2017-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed|A Multicenter, Single-Arm, Phase II Trial of Bevacizumab in Subjects With Platinum-Resistant Epithelial Carcinoma of the Ovary or Primary Peritoneal Carcinoma for Whom Subsequent Doxil or Topotecan Therapy Has Failed|Completed||Phase 2|53||Genentech, Inc.|||||f||||||||||||||2017-10-11 04:55:28.073296|2017-10-11 04:55:28.073296
NCT00097032|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2011-05-20|||October 2004||2004-10-01|March 2010|2010-03-01|May 2005|Actual|2005-05-01|||||Interventional|||Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients|Differences in Cognitive Function Due to Acute Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Out-Patients.|Completed||Phase 3|30|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:55:28.136265|2017-10-11 04:55:28.136265
NCT00085423|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-04-09|2012-01-26||February 2004||2004-02-01|April 2013|2013-04-01|February 2010|Actual|2010-02-01|December 2008|Actual|2008-12-01||Interventional|||Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma|"High Dose Interleukin-2 (IL-2) Therapy In Lymphodepleted Primed Patients With Metastatic Melanoma"|Completed||Phase 2|20|Actual|Dartmouth-Hitchcock Medical Center|This was the first stage of a two-stage phase II study and continuation to next stage required 4 of 18 particpant having an objective response. Only 3 objective responses were noted and the study was terminated at stage 1.|1|||f||||t||||||||||2017-10-11 04:55:28.203273|2017-10-11 04:55:28.203273
NCT00085436|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-04-24|2013-04-24||December 2003||2003-12-01|October 2011|2011-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC|A Phase II Study Of Autologous Tumor/DC Vaccine (DC Vaccine) Combined With Interleukin-2 (IL-2) And Interferon-α-2a (IFNα-2a) In Patients With Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 2|18|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-10-11 04:55:28.400515|2017-10-11 04:55:28.400515
NCT00085449|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2016-07-01|||May 2006||2006-05-01|July 2016|2016-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer|A Trial of Reduced Intensity Conditioning and Transplantation of Haplotype Mismatched and KIR Class I Epitope-Mismatched Highly Purified CD34 Cells|Completed||Phase 1/Phase 2|56|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:55:28.557463|2017-10-11 04:55:28.557463
NCT00085462|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-06-21|||May 2004||2004-05-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|May 2007|Actual|2007-05-01||Interventional|||Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma|Treatment of Patients With Metastatic Melanoma by Lymphodepleting Conditioning Followed by Infusion of TCR-Gene Engineered Lymphocytes and Subsequent Fowlpox gp100 Vaccination|Completed||Phase 1|61|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:55:28.724364|2017-10-11 04:55:28.724364
NCT00085475|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-09-20|||April 2004||2004-04-01|September 2012|2012-09-01||||April 2007|Actual|2007-04-01||Interventional|||Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma|Phase II Study of Glivec (Imatinib) in Locally Advanced and/or Metastatic Soft Tissue Sarcomas Expressing the t(17;22)(q22;q13) Translocation Resulting in a COL1A1/PDGF-beta Fusion Protein i.e. DermatoFibroSarcoma Protuberans (DFSP) and Giant Cell Fibroblastoma (GCF)|Completed||Phase 2|17|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:55:30.216307|2017-10-11 04:55:30.216307
NCT00085488|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-01-30|||February 2004||2004-02-01|October 2005|2005-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|En Vivo Matured Dendritic Cell Therapy in Patients With Melanoma|Completed||Phase 1|||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 04:55:30.370484|2017-10-11 04:55:30.370484
NCT00085501|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-10-30|||July 2004||2004-07-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|August 2007|Actual|2007-08-01||Interventional|||S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Selection Design Trial Of Concurrent Chemotherapy + Cetuximab Vs. Chemotherapy Followed By Cetuximab In Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|242|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-10-11 04:55:30.483422|2017-10-11 04:55:30.483422
NCT00085527|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-09-04|||May 2005||2005-05-01|September 2013|2013-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer|A Phase II Study Of Depsipeptide In Patients With Relapsed Or Refractory Ovarian Carcinoma|Withdrawn||Phase 2|0|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 04:55:31.068232|2017-10-11 04:55:31.068232
NCT00085540|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2016-11-15|2016-09-23||January 2005||2005-01-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional||two patients were removed from the analysis due to one withdrawing consent and one was deemed ineligible.|FR901228 in Treating Patients With Recurrent High-Grade Gliomas|A Phase I-II Trial of Depsipeptide in Patients With Recurrent High-Grade Gliomas|Completed||Phase 1/Phase 2|50|Actual|National Cancer Institute (NCI)|Dose escalation was terminated after 2 dose levels because PK parameters of romidepsin in pts receiving EIAEDs were similar to those reported in Adults not receiving CYP34A inducing drugs, we wanted to avoid the expected dose limiting toxicity.|2|||f||||t||||||||No||2017-10-11 04:55:31.174756|2017-10-11 04:55:31.174756
NCT00085553|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2017-09-04|||May 20, 2004|Actual|2004-05-20|May 2017|2017-05-01||||May 7, 2008|Actual|2008-05-07||Interventional|||Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors|Phase I Trial of R115777 and OSI-774 in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|29|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:55:31.594151|2017-10-11 04:55:31.594151
NCT00085566|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-12-15|2015-12-15||March 2004||2004-03-01|December 2015|2015-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer|A Phase I/II Trial to Assess the Tolerability of RAD 001 With Gefitinib in Patients With Glioblastoma Multiforme and Prostate Cancer and Efficacy in Patients With Castrate Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|61|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:55:31.715087|2017-10-11 04:55:31.715087
NCT00085579|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-12-11|||March 2004||2004-03-01|December 2012|2012-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase II Study of Maintenance Biotherapy With Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor in Patients With Metastatic Melanoma With a Partial Response or Stable Disease After Systemic Therapy|Withdrawn||Phase 2|0|Actual|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:55:32.333328|2017-10-11 04:55:32.333328
NCT00085631|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-07-10|2013-04-10||March 2003||2003-03-01|July 2013|2013-07-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer|An International Multi Center Phase III Study of Chemoradiotherapy Versus Chemoradiotherapy Plus Hyperthermia for Locally Advanced Cervical Cancer|Terminated||Phase 3|101|Actual|Duke University|There are integrity issues with the currently available data, involving international institutions, in that several pieces of information relating to patient accrual and outcomes cannot be verified.|2||Study was closed because of slow accrual|f||||f||||||||||2017-10-11 04:55:32.41664|2017-10-11 04:55:32.41664
NCT00085644|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2011-04-18|2009-11-30||January 2004||2004-01-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|December 2004|Actual|2004-12-01||Interventional|ATLAS||Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis|A Phase 3 Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis|Completed||Phase 3|315|Actual|Abbott|Interim results are shown for subjects after 12 weeks for efficacy parameters and 24 weeks for safety parameters. Subjects who discontinued the study before Week 12 and subjects with missing values were classified as nonresponders for efficacy.|2|||f||||f||||||||||2017-10-11 04:55:33.09283|2017-10-11 04:55:33.09283
NCT00085657|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2017-06-30|||June 9, 2004||2004-06-09|May 21, 2009|2009-05-21|May 21, 2009||2009-05-21|||||Observational|||Brain Electrical Stimulation to Enhance Recovery After Stroke|Enhancement of Rehabilitative Treatment-Dependent Functional Recovery After Stroke by Transcranial Direct Current Stimulation (tDCS)|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:35.494135|2017-10-11 04:55:35.494135
NCT00085683|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2008-03-03|||June 2004||2004-06-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Herpes Virus-6 and Epilepsy|Human Herpesvirus-6 and Its Effect on the GABA/Glutamate Balance in the Cerebrospinal Fluid and in the Brain From Patients With Epilepsy|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:35.656751|2017-10-11 04:55:35.656751
NCT00085696|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-11|2008-02-07|||May 2004||2004-05-01|February 2008|2008-02-01||||April 2006|Actual|2006-04-01||Interventional|||VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma|A Phase 2 Study of VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma|Completed||Phase 2|66||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:55:35.72837|2017-10-11 04:55:35.72837
NCT00085709|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2015-09-25|2012-06-05||July 2004||2004-07-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|March 2010|Actual|2010-03-01||Interventional|||S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML|A Phase III Study of the Addition of Gemtuzumab Ozogamicin (Mylotarg®) During Induction Therapy Versus Standard Induction With Daunomycin and Cytosine Arabinoside Followed by Consolidation and Subsequent Randomization to Post-Consolidation Therapy With Gemtuzumab Ozogamicin (Mylotarg®) or No Additional Therapy For Patients Under Age 61 With Previously Untreated De Novo Acute Myeloid Leukemia (AML)|Completed||Phase 3|637|Actual|Southwest Oncology Group||4|||f||||t||||||||||2017-10-11 04:55:35.933957|2017-10-11 04:55:35.933957
NCT00085722|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2015-10-09|||July 2004||2004-07-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|November 2008|Actual|2008-11-01||Interventional|||Joint Injections for Osteoarthritic Knee Pain|The Efficacy of Prolotherapy in Osteoarthritic Knee Pain|Unknown status|Active, not recruiting|Phase 1/Phase 2|111|Anticipated|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 04:55:39.271392|2017-10-11 04:55:39.271392
NCT00085735|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2017-05-16|2017-02-22||April 2004||2004-04-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional||Only eligible patients are included in each of the 6 groups for baseline characteristics.|Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma|A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial|Completed||Phase 3|549|Actual|Children's Oncology Group||6|||f||||||||||||||2017-10-11 04:55:39.611528|2017-10-11 04:55:39.611528
NCT00085748|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2011-06-06|||August 2004||2004-08-01|November 2010|2010-11-01|May 2005|Actual|2005-05-01|||||Interventional|||Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia|A Randomized, 6-Week Double-Blind, Placebo-Controlled Study With an Optional 24-Week Open-Label Extension to Evaluate the Safety and Tolerability of Flexible Doses of Paliperidone Extended Release in the Treatment of Geriatric Patients With Schizophrenia|Completed||Phase 3|114|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:55:43.422759|2017-10-11 04:55:43.422759
NCT00085761|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2008-03-04||||||March 2008|2008-03-01||||||||Interventional|||Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy|An International, Multicenter, Randomized, Double-Blind, 12-Week Controlled Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy|Terminated||Phase 3|||NeurogesX||||Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes|||||||||||||||2017-10-11 04:55:43.606341|2017-10-11 04:55:43.606341
NCT00085774|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2015-03-19|||June 2004||2004-06-01|March 2015|2015-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma|A Single-Dose Efficacy Comparison of Albuterol Hydrofluoroalkane (HFA) Breath-operated Inhaler (BOI) (Volare Easi-Breathe™) and Albuterol HFA Meter Dose Inhaler (MDI) (Volare™) in Adolescents and Adults With Exercise-Induced Bronchospasm|Completed||Phase 3|24|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 04:55:43.684557|2017-10-11 04:55:43.684557
NCT00085813|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-14|2010-10-01|||December 2003||2003-12-01|October 2010|2010-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer|A Phase II, Open-Label Study of Ispinesib in Subjects With Locally Advanced or Metastatic Platinum-Refractory or Platinum-Relapsed Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|70||GlaxoSmithKline|||||||||||||||||||2017-10-11 04:55:43.906426|2017-10-11 04:55:43.906426
NCT00085826|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-15|2011-10-18|||April 2001||2001-04-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|||||Interventional|||A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients|A Phase III, Randomized, Double-Blind, Multi-Center Study of the Efficacy of Taxotere (Docetaxel) in Combination With Aptosyn (Exisulind) Versus Taxotere (Docetaxel) and Placebo in Non-Small Cell Lung Cancer (NSCLC) Patients After Failure of Prior Platinum-Based Chemotherapy|Completed||Phase 3|600||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:55:44.026114|2017-10-11 04:55:44.026114
NCT00085839|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-15|2012-08-06|2011-03-28||February 2004||2004-02-01|August 2012|2012-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2|A Randomized Phase II Study of Single Agent Erlotinib [Tarceva (TM), OSI-774] Versus Standard Chemotherapy in Patients With Previously Untreated Advanced NSCLC and a Poor Performance Status|Completed||Phase 2|103|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-10-11 04:55:44.700543|2017-10-11 04:55:44.700543
NCT00085852|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-15|2008-02-27|||April 2005||2005-04-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|October 2006|Actual|2006-10-01||Interventional|||US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation|Phase 1 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Heterogeneous Emphysema|Completed||Phase 1|6|Actual|Aeris Therapeutics||1|||f||||t||||||||||2017-10-11 04:55:45.366326|2017-10-11 04:55:45.366326
NCT00085865|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-15|2008-03-03|||June 2004||2004-06-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Observational|||Serotonin Transporters in Alcoholism|PET Evaluation of Serotonin Transporters Using [C-11] DASB in Alcoholism|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:45.452248|2017-10-11 04:55:45.452248
NCT00085878|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-16|2008-10-15|||January 2003||2003-01-01|October 2008|2008-10-01||||||||Interventional|||Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors|A Phase I, Dose Escalation Study to Assess the Safety and Pharmacokinetics of SB- 485232 Administered as Daily Subcutaneous Injections in Adult Patients With Solid Tumors|Completed||Phase 1|25|Actual|GlaxoSmithKline|||||||||||||||||||2017-10-11 04:55:45.59667|2017-10-11 04:55:45.59667
NCT00085891|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-16|2009-03-24|||June 2004||2004-06-01|March 2009|2009-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia|A 6-Week, Multicenter, Double-Blind, Double-Dummy, Randomized Comparison of the Efficacy and Safety of Sustained-Release Formulation Quetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Acutely Ill Patients With Schizophrenia|Completed||Phase 3|535||AstraZeneca|||||||||||||||||||2017-10-11 04:55:45.70753|2017-10-11 04:55:45.70753
NCT00085904|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-16|2008-10-09|||April 2004||2004-04-01|October 2008|2008-10-01||||||||Interventional|||Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas|A Phase I, Dose-Escalation Study to Assess the Safety and Pharmacokinetics of SB- 485232 Administered as Five Daily Intravenous Infusions Repeated Every 28 Days in Adult Patients With Solid Tumors and Lymphomas|Completed||Phase 1|12|Actual|GlaxoSmithKline|||||||||||||||||||2017-10-11 04:55:45.891778|2017-10-11 04:55:45.891778
NCT00085917|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-16|2011-06-21|2010-04-12||June 2004||2004-06-01|June 2011|2011-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|PIFNPK||Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients|A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Twice-Weekly Peginterferon Alpha 2a and Ribavirin Induction Therapy for Chronic Hepatitis C in Patients Who Are Coinfected With HIV-1|Completed||Phase 2|29|Actual|National Institutes of Health Clinical Center (CC)|Small number of enrolled participants|2|||f||||f||||||||||2017-10-11 04:55:45.996655|2017-10-11 04:55:45.996655
NCT00085930|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-17|2017-08-17|||April 2003||2003-04-01|August 2017|2017-08-01|December 2021|Anticipated|2021-12-01|January 2010|Actual|2010-01-01||Interventional|NESTLES||Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients|Administration of Peripheral Blood T-Cells and EBV Specific CTLs Transduced to Express GD-2 Specific Chimeric T Cell Receptors to Patients With Neuroblastoma|Active, not recruiting||Phase 1|19|Actual|Baylor College of Medicine||1|||f||||t|t|f||||||||2017-10-11 04:55:46.595608|2017-10-11 04:55:46.595608
NCT00085943|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-17|2011-05-12|||May 2004||2004-05-01|May 2011|2011-05-01||||||||Interventional|||KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks|See Detailed Description|Completed||Phase 3|866||GlaxoSmithKline|||||||||f||||||||||2017-10-11 04:55:46.726892|2017-10-11 04:55:46.726892
NCT00085956|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-18|2007-03-07|||April 2004||2004-04-01|March 2007|2007-03-01|February 2007||2007-02-01|||||Interventional|||Effects of Arzoxifene on Bone Mass and the Uterus|Effects of Arzoxifene on Bone Mineral Density and Endometrial Histology in Postmenopausal Women.|Completed||Phase 3|300||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:55:47.022484|2017-10-11 04:55:47.022484
NCT00085969|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-18|2015-02-19|||September 2003||2003-09-01|January 2015|2015-01-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus|A Phase 2, Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|99|Actual|AstraZeneca||6|||f||||f||||||||||2017-10-11 04:55:47.27127|2017-10-11 04:55:47.27127
NCT00086034|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-21|2007-05-11||||||May 2007|2007-05-01||||||||Interventional|||Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma|Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|Completed||Phase 2|35||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 04:55:47.637261|2017-10-11 04:55:47.637261
NCT00086047|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-22|2017-08-23|2011-08-12||July 2004||2004-07-01|August 2017|2017-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Coping Skills Training for Adolescents With Fibromyalgia|Randomized Clinical Trial in Juvenile Fibromyalgia|Completed||Phase 3|114|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 04:55:47.726058|2017-10-11 04:55:47.726058
NCT00086060|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-22|2011-10-06|||May 2004||2004-05-01|October 2011|2011-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Pain Management Techniques for Fibromyalgia|Locus of Pain Control: Neural Substrates and Modifiability|Completed||Phase 1/Phase 2|97|Actual|University of Michigan||4|||f||||f||||||||||2017-10-11 04:55:48.000344|2017-10-11 04:55:48.000344
NCT00086073|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-22|2011-02-15|||August 1998||1998-08-01|November 2010|2010-11-01|January 2011|Actual|2011-01-01|||||Observational|PROGENI||Parkinson's Research: The Organized Genetics Initiative|Parkinson's Disease Collaborative Study of Genetic Linkage|Completed||N/A|1800|Anticipated|Indiana University|||1||f||||f||||||Samples With DNA|"     blood sample   "|||2017-10-11 04:55:48.178519|2017-10-11 04:55:48.178519
NCT00086086|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-23|2017-02-07|||August 2003||2003-08-01|February 2017|2017-02-01||||||||Interventional|||Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Effects of Treatment With 2 Regimens of Subcutaneous Darbepoetin Alfa (Weight-based Dosing and Fixed Dosing) on Hemoglobin Concentration Response in Subjects With Symptomatic CHF and Anaemia|Completed||Phase 2|150||Amgen|||||||||||||||||||2017-10-11 04:55:48.374439|2017-10-11 04:55:48.374439
NCT00086099|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-23|2009-01-28|||July 2004||2004-07-01|January 2009|2009-01-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia|A Phase IB/II, Randomized, Open-Label, Multicenter Study Evaluating Whether the Addition of Amifostine (Ethyol®) Will Enable the Safe Increase in Dose Intensity of Idarubicin in Combination With Cytosine Arabinoside in Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|54|Actual|MedImmune LLC||2|||f||||||||||||||2017-10-11 04:55:48.449312|2017-10-11 04:55:48.449312
NCT00086112|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-24|2012-07-19||||||July 2012|2012-07-01|June 2005|Actual|2005-06-01|||||Interventional|||Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.|A Double-blind, Randomized, Prospective Study to Evaluate Adjunctive Risperidone Versus Adjunctive Placebo in Generalized Anxiety Disorder Sub-optimally Responsive to Standard Psychotropic Therapy|Completed||Phase 3|301|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 04:55:48.562111|2017-10-11 04:55:48.562111
NCT00086125|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-24|2015-08-18|||June 2004||2004-06-01|August 2015|2015-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)|A Phase II Study of AP23573, an mTOR Inhibitor, in Patients With Relapsed or Refractory Hematologic Malignancies|Completed||Phase 2|57|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-10-11 04:55:48.62859|2017-10-11 04:55:48.62859
NCT00086138|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-25|2017-02-28|2016-03-08||July 2004||2004-07-01|February 2017|2017-02-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|DIADS-2||Depression in Alzheimer's Disease-2|Depression in Alzheimer's Disease (DIADS-2)|Completed||Phase 2/Phase 3|131|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 04:55:48.746597|2017-10-11 04:55:48.746597
NCT00086151|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-25|2016-07-28|||July 2004||2004-07-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Identifying Low-Risk Patients With Pulmonary Embolism||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:55:49.078827|2017-10-11 04:55:49.078827
NCT00086164|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-25|2005-07-14|||May 2004||2004-05-01|July 2005|2005-07-01||||||||Interventional|||Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis|A Phase 1/2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Pilot Trial to Assess the Effect of Treatment of the Recipient Vein of a Polytetrafluoroethylene (PTFE) Vascular Access Graft With Two Concentrations of E2F Decoy as Compared to Placebo on Neointimal Hyperplasia and the Preservation of Graft Function in Patients With Chronic Renal Failure Requiring Hemodialysis|Terminated||Phase 1/Phase 2|||Anesiva, Inc.|||||||||||||||||||2017-10-11 04:55:49.140445|2017-10-11 04:55:49.140445
NCT00086177|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-25|2010-08-18|||April 2004||2004-04-01|August 2010|2010-08-01|March 2009|Actual|2009-03-01|January 2007|Actual|2007-01-01||Interventional|||Vaginal Progesterone to Reduce the Risk of Another Preterm Birth|A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy, Safety, and Tolerability of 8% Progesterone Vaginal Gel in Preventing Preterm Delivery in Pregnant Women at Increased-Risk for Preterm Delivery|Completed||Phase 3|636|Actual|Juniper Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-10-11 04:55:49.248051|2017-10-11 04:55:49.248051
NCT00086190|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-28|2013-01-03|2012-01-11||June 2005||2005-06-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|SAD-PD||Study of Antidepressants in Parkinson's Disease|Study of Antidepressants in Parkinson's Disease|Completed||Phase 3|115|Actual|University of Rochester||3|||f||||t||||||||||2017-10-11 04:55:49.456905|2017-10-11 04:55:49.456905
NCT00086203|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-28|2015-03-24||||||August 2006|2006-08-01|September 2007||2007-09-01|||||Interventional|||Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)||Completed||Phase 2|||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:55:51.227509|2017-10-11 04:55:51.227509
NCT00086216|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-28|2007-12-20|||May 2004||2004-05-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma|An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Refractory or Relapsed Multiple Myeloma|Completed||Phase 1/Phase 2|30|Actual|Callisto Pharmaceuticals||1|||f||||f||||||||||2017-10-11 04:55:51.360605|2017-10-11 04:55:51.360605
NCT00086229|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-28|2006-08-16|||April 2004||2004-04-01|August 2006|2006-08-01|January 2006||2006-01-01|||||Interventional|||Absorption and Distribution of Glucosamine and Chondroitin|A Pharmacokinetic Study of Glucosamine and Chondroitin|Completed||N/A|70||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:55:51.445392|2017-10-11 04:55:51.445392
NCT00086242|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-28|2009-07-20||||||November 2006|2006-11-01||||||||Interventional|||Telephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stage I, Stage II, or Stage III Cervical Cancer|Stress-Immune Response and Cervical Cancer|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:55:51.516024|2017-10-11 04:55:51.516024
NCT00086255|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-29|2017-01-11|||October 2002||2002-10-01|August 2008|2008-08-01|June 2004||2004-06-01|||||Interventional|||Tiagabine for the Treatment of Cocaine Dependence - 1|Tiagabine for the Treatment of Cocaine Dependence|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:55:51.596795|2017-10-11 04:55:51.596795
NCT00086268|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-29|2017-09-12|||April 2004||2004-04-01|September 2017|2017-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|ZPACT||Non-small Cell Lung Cancer Study US75 (Z-PACT)||Completed||Phase 3|250|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:55:51.77607|2017-10-11 04:55:51.77607
NCT00086281|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-29|2012-01-20|2011-11-11||November 2003||2003-11-01|January 2012|2012-01-01|November 2005|Actual|2005-11-01|June 2005|Actual|2005-06-01||Interventional|||Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients|Randomized, Placebo-Controlled Multicenter Trial of the Effects of Orally Administered Xyrem (Sodium Oxybate) and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients|Completed||Phase 4|60|Actual|Jazz Pharmaceuticals||4|||f||||f||||||||||2017-10-11 04:55:52.07695|2017-10-11 04:55:52.07695
NCT00086294|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-29|2017-06-30|||June 25, 2004||2004-06-25|November 15, 2007|2007-11-15|November 15, 2007||2007-11-15|||||Interventional|||ACP-103 to Treat Parkinson's Disease|5HT2A/C Serotonin Blockade in Parkinson's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:53.379534|2017-10-11 04:55:53.379534
NCT00086307|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-29|2013-01-11|2012-06-07||June 2004||2004-06-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Lexapro and Pramipexole and to Treat Major Depression|Combining a Dopamine Agonist and Selective Serotonin Reuptake Inhibitor for Treatment of Depression: A Double-Blind, Randomized Study|Completed||Phase 2|39|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-10-11 04:55:53.468003|2017-10-11 04:55:53.468003
NCT00086320|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-30|2011-06-06|||March 2004||2004-03-01|April 2010|2010-04-01|August 2005|Actual|2005-08-01|||||Interventional|||A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Evaluating Paliperidone Extended Release Tablets in the Prevention of Recurrence in Subjects With Schizophrenia|Completed||Phase 3|111|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:55:54.011763|2017-10-11 04:55:54.011763
NCT00086333|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-30|2011-10-21|||July 2004||2004-07-01|October 2011|2011-10-01|December 2005|Actual|2005-12-01|||||Interventional|||FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma|A Phase II Study Using FDG-PET to Investigate the Dosing Schedule and Response of Combination SGN-15 (cBR96-Doxorubicin Immunoconjugate) and Docetaxel in Patients With Stage IV or Stage IIIB Non-Small Cell Lung Carcinoma Ineligible for Combined Modality Treatment With Curative Intent|Completed||Phase 2|30||Seattle Genetics, Inc.|||||||||||||||||||2017-10-11 04:55:54.07648|2017-10-11 04:55:54.07648
NCT00086346|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-30|2010-04-20|2009-07-06||December 2002||2002-12-01|April 2010|2010-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients|A Randomized, Open-Label, Comparative Evaluation of Conversion From Calcineurin Inhibitor Treatment to Sirolimus Treatment Versus Continued Calcineurin Inhibitor Treatment in Liver Allograft Recipients Undergoing Maintenance Therapy|Terminated||Phase 3|607|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||t||||||||||2017-10-11 04:55:54.176828|2017-10-11 04:55:54.176828
NCT00086359|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-30|2014-12-22|||July 2004||2004-07-01|December 2014|2014-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV|A Phase III Randomized Trial of the Safety and Antiretroviral Effects of Zidovudine/Lamivudine/Abacavir Versus Zidovudine/Lamivudine/Lopinavir/Ritonavir in the Prevention of Perinatal Transmission of HIV|Completed||Phase 3|19|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:55:55.734832|2017-10-11 04:55:55.734832
NCT00086372|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-30|2012-10-26|||July 2003||2003-07-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|||||Observational|||Long-term Follow-up of HIV Infected Patients Identified During Early Infection|Acute HIV Infection and Early Disease Research Program (AIEDRP) CORE01 Database|Completed||N/A|157|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:55:55.924085|2017-10-11 04:55:55.924085
NCT00086385|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2015-03-03|2013-07-29||September 2001||2001-09-01|March 2015|2015-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Maintaining Nonsmoking: Older Smokers - 1|Maintaining Nonsmoking: Older Smokers|Completed||Phase 3|403|Actual|University of California, San Francisco|The limitations of this study include generalizability, as the population treated was relatively well-educated, willing to participate in research and to attend treatment sessions.|4|||f||||f||||||||||2017-10-11 04:55:56.070946|2017-10-11 04:55:56.070946
NCT00086398|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2005-11-03|||September 2001||2001-09-01|November 2005|2005-11-01||||||||Interventional|||Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1|Psychotherapy Enhancement for TC Retention|Unknown status|Recruiting|Phase 2|100||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 04:55:56.575779|2017-10-11 04:55:56.575779
NCT00086411|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2014-01-24|2013-06-24||September 2003||2003-09-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|April 2008|Actual|2008-04-01||Interventional|||Comparing Smoking Treatment Programs for Lighter Smokers - 1|Comparing Smoking Treatment Programs for Lighter Smokers|Completed||Phase 2|260|Actual|University of Pennsylvania|Missing data from some early terminations from treatment (i.e., 2 or less visits) may reflect dissatisfaction with counseling assignment or medication effects.|4|||f||||t||||||||||2017-10-11 04:55:56.665735|2017-10-11 04:55:56.665735
NCT00086424|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2008-04-22|||July 2004||2004-07-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Epidemiology of Insulin Growth Factor (IGF) and Cardiovascular Events||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:55:57.020306|2017-10-11 04:55:57.020306
NCT00086437|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2015-12-02|||July 2004||2004-07-01|December 2015|2015-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Pharmacogenetics of Hypertriglyceridemia in Hispanics|Pharmacogenetics of Hypertriglyceridemia in Hispanics|Completed||N/A|274|Actual|University of California, Los Angeles|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 04:55:57.06911|2017-10-11 04:55:57.06911
NCT00086450|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2016-12-09|2016-09-13||April 2004||2004-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2012|Actual|2012-07-01||Interventional|||Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM)|Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)|Active, not recruiting||Phase 3|1900|Actual|Icahn School of Medicine at Mount Sinai|Since the trial was not blinded, patients may have been treated differently on the basis of their surgical procedure.|2|||f||||t||||||||||2017-10-11 04:55:57.129852|2017-10-11 04:55:57.129852
NCT00086463|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2011-03-31|||June 2004||2004-06-01|March 2011|2011-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)|A Safety and Pilot Efficacy Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With PAH|Completed||Phase 2|60||Actelion|||||||||||||||||||2017-10-11 04:55:57.470702|2017-10-11 04:55:57.470702
NCT00086476|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2017-06-30|||June 29, 2004||2004-06-29|June 13, 2011|2011-06-13|June 13, 2011||2011-06-13|||||Observational|||Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles|Investigations of Megakaryocytes From Patients With Abnormal Platelet Vesicles|Completed||N/A|3|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:57.572163|2017-10-11 04:55:57.572163
NCT00086489|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-01|2012-06-05|||August 2003||2003-08-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|May 2007|Actual|2007-05-01||Interventional|||CP-675,206 In Patients With Advanced Melanoma|Phase 1 Open Label, Non-Randomized, Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Immune Function Effects, And Efficacy Of Multiple Doses Of CP-675,206 In Patients With Advanced Melanoma, And Phase 2, Open Label, Randomized Study To Evaluate the Efficacy, Safety, Tolerability And Pharmacokinetics Of 2 Regimens Of CP-675,206 In Patients With Advanced Melanoma.|Completed||Phase 2|118|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:55:57.638428|2017-10-11 04:55:57.638428
NCT00086502|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-02|2016-02-04|2010-03-30||June 2004||2004-06-01|February 2016|2016-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus|A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK0431 to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Pioglitazone Therapy|Completed||Phase 3|353|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 04:55:57.771855|2017-10-11 04:55:57.771855
NCT00086515|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-02|2017-03-31|2010-11-19||June 30, 2004|Actual|2004-06-30|March 2017|2017-03-01|February 2, 2007|Actual|2007-02-02|July 20, 2005|Actual|2005-07-20||Interventional|||Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK0431 to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy|Completed||Phase 3|701|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 04:55:58.29865|2017-10-11 04:55:58.29865
NCT00086528|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-02|2011-10-17|||June 2004||2004-06-01|October 2011|2011-10-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors|Completed||Phase 1|41|Actual|Kadmon Corporation, LLC||1|||f||||t||||||||||2017-10-11 04:55:59.153861|2017-10-11 04:55:59.153861
NCT00086541|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-02|2007-05-03|||June 2004||2004-06-01|May 2007|2007-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy|A Phase 3, Randomized, Open-Label Study of the Safety and Efficacy of Two Dose Levels of Interferon Alfacon-1 (Infergen, CIFN) Plus Ribavirin Administered Daily for 48 Weeks Versus No Treatment in Hepatitis C Infected Patients Who Are Nonresponders to Previous Pegylated Interferon Alfa Plus Ribavirin Therapy|Completed||Phase 3|515|Actual|Valeant Pharmaceuticals International, Inc.||3|||||||||||||||||2017-10-11 04:55:59.440425|2017-10-11 04:55:59.440425
NCT00086554|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-02|2017-06-30|||July 1, 2004||2004-07-01|January 8, 2010|2010-01-08|January 8, 2010||2010-01-08|||||Observational|||Collection of Specimens for Study of Inflammatory Bowel Disease|Procurement of Clinical Specimens for Immunologic or Genetic Studies in Inflammatory Bowel Diseases|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:59.503919|2017-10-11 04:55:59.503919
NCT00086567|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-02|2017-10-05|||June 29, 2004||2004-06-29|April 12, 2017|2017-04-12||||||||Observational|||Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers|A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse|Completed||N/A|8|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:55:59.571461|2017-10-11 04:55:59.571461
NCT00086580|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-06|2014-02-10|2011-06-13||July 2004||2004-07-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients|A Phase III Randomized Trial to Evaluate the Efficacy and Safety of Second-Line Therapy With Fludarabine Plus Alemtuzumab vs. Fludarabine Alone in Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 3|335|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 04:55:59.714201|2017-10-11 04:55:59.714201
NCT00086593|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-06|2016-10-05|||May 2004||2004-05-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia|A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of a Flexible Dose of Lamotrigine Compared to Placebo as an Adjunctive Therapy to an Atypical Antipsychotic Agent(s) in Subjects With Schizophrenia|Completed||Phase 3|209|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:56:02.496509|2017-10-11 04:56:02.496509
NCT00086606|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-06|2013-01-17|||June 2004||2004-06-01|January 2013|2013-01-01|April 2006|Actual|2006-04-01|||||Interventional|||A Safety and Efficacy Study of Xolair in Peanut Allergy|A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Oral Food Challenge Trial of Xolair (Omalizumab) in Peanut Allergy|Terminated||Phase 2|150||Genentech, Inc.|||||f||||||||||||||2017-10-11 04:56:02.641799|2017-10-11 04:56:02.641799
NCT00086619|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-07|2013-09-26|2012-06-07||May 2004||2004-05-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women|Evaluation of Factors That Affect Skeletal Responses to PTH|Completed||Phase 2|80|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:56:02.711845|2017-10-11 04:56:02.711845
NCT00086632|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-07|2007-12-13|||July 2004||2004-07-01|January 2006|2006-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment|An Open-Label, Phase II Study of Ovarex® MAb-B43.13 as an Adjuvant Treatment to Platinum-Based Front-Line Chemotherapy of Advanced Epithelial Carcinoma of Ovarian, Tubal, or Peritoneal Origin|Terminated||Phase 2|40||Unither Pharmaceuticals||||closed by sponser|||||||||||||||2017-10-11 04:56:03.049357|2017-10-11 04:56:03.049357
NCT00086645|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-07|2017-03-08|||April 2004||2004-04-01|March 2017|2017-03-01|April 2007|Actual|2007-04-01|October 2006|Actual|2006-10-01||Interventional|||Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)|Citalopram Treatment in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior|Completed||Phase 2|149|Actual|Boston University||2|||f||||t||||||||||2017-10-11 04:56:03.268865|2017-10-11 04:56:03.268865
NCT00086658|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-07|2015-04-16|||March 2004||2004-03-01|April 2015|2015-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)|A Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- Sparing Effects of Mepolizumab in Subjects With Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of Subjects With HES|Completed||Phase 2|86|Actual|GlaxoSmithKline|||||||||||||||||||2017-10-11 04:56:03.361151|2017-10-11 04:56:03.361151
NCT00086671|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-07|2013-01-02||2011-08-24|April 2004||2004-04-01|January 2013|2013-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)|A 24-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Finding, Safety, Tolerability, and Efficacy Study of the Human Anti-IL-12 Antibody ABT-874 in Subjects With Multiple Sclerosis With a 24-Week Double-Blind, Active Extension Phase|Completed||Phase 2|215|Actual|AbbVie||3|||f||||t||||||||||2017-10-11 04:56:03.486858|2017-10-11 04:56:03.486858
NCT00086684|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-07|2014-04-02|2012-05-31||September 2003||2003-09-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis|Randomized, Double-Blind, Placebo-Controlled, Parallel Group Evaluation of the Efficacy and Tolerability of Two Different Doses of ELMIRON for the Treatment of Interstitial Cystitis|Terminated||Phase 4|369|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3||"Interim Analysis showed that study continuation was futile. No safety concerns were raised   during the trial."|f||||f||||||||||2017-10-11 04:56:03.682391|2017-10-11 04:56:03.682391
NCT00086710|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||Study of Enfuvirtide in HIV-Positive Subjects|An Open-label, Randomized, Cross-over Study in HIV-Positive Subjects to Determine and Compare the Single-dose Pharmacokinetics of Enfuvirtide after a Single 90 mg SC Administration|Completed||Phase 1|26||Trimeris|||||||||||||||||||2017-10-11 04:56:06.339839|2017-10-11 04:56:06.339839
NCT00086723|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2012-06-07||2011-02-18|July 2003||2003-07-01|June 2012|2012-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer|Phase I/II Trial of In Vivo Angiostatin Generation With Tissue Plasminogen Activator (tPA) and Captopril in Patients With Progressive, Metastatic Cancer|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-10-11 04:56:06.395689|2017-10-11 04:56:06.395689
NCT00086736|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-11-17|||November 2001||2001-11-01|July 2013|2013-07-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy|A Randomized, Placebo-Controlled Phase IIb Clinical Trial of 2-Difluoromethylornithine (DFMO) Versus Bicalutamide (CASODEX) Alone and in Combination in Patients With Prostate Cancer in the Period Prior to Radical Prostatectomy or Brachytherapy: Modulation of Tissue and Molecular Biomarkers in Human Prostate Tissue Serum|Completed||Phase 2|34|Actual|University of Alabama at Birmingham||4|||f||||t||||||||||2017-10-11 04:56:06.465943|2017-10-11 04:56:06.465943
NCT00086749|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2012-07-10|||February 2003||2003-02-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer|A Prospective Study Of The Effect Of Tamoxifen On Breast Density In Premenopausal Women|Completed||Phase 1|53|Actual|Northwestern University|||1||f||||||||||||||2017-10-11 04:56:06.558369|2017-10-11 04:56:06.558369
NCT00086762|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2017-05-01|||June 2004|Actual|2004-06-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors|Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program|Active, not recruiting||N/A|474|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-10-11 04:56:06.626704|2017-10-11 04:56:06.626704
NCT00086775|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-08-01|||July 2003||2003-07-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|June 2005|Actual|2005-06-01||Interventional|||Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia|Phase II Trial Comparing Combination Treatment With Fludarabine and Alemtuzumab to Fludarabine and Rituximab in Patients With B-Cell Chronic Lymphocytic Leukemia Requiring Treatment After First Line Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:56:06.751738|2017-10-11 04:56:06.751738
NCT00086801|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2016-06-30|||May 2004||2004-05-01|June 2016|2016-06-01|May 2011|Actual|2011-05-01|March 2007|Actual|2007-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma|Phase II Trial of Doxorubicin, Vinblastine, and Gemcitabine (AVG) Chemotherapy for Non-Bulky Stage I and II Hodgkin's Lymphoma|Completed||Phase 2|104|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:56:06.844943|2017-10-11 04:56:06.844943
NCT00086827|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-04-09|||May 2004||2004-05-01|December 2012|2012-12-01||||November 2006|Actual|2006-11-01||Interventional|||Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer|A Phase II Study of Single Agent Depsipeptide (FK228) (NSC 630176; IND 51,810) in Relapsed Small Cell Lung Cancer|Completed||Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:07.159182|2017-10-11 04:56:07.159182
NCT00261664|ClinicalTrials.gov processed this data on October 10, 2017|2005-12-02|2011-07-25|||September 2003||2003-09-01|July 2011|2011-07-01|July 2005|Actual|2005-07-01|||||Interventional|||Empowering Elders Through Technology|Empowering Elders Through Technology|Completed||Phase 1/Phase 2|290||Robert Wood Johnson Foundation|||||f||||||||||||||2017-10-11 05:53:33.827432|2017-10-11 05:53:33.827432
NCT00086840|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-23|||May 2004||2004-05-01|January 2013|2013-01-01||||August 2005|Actual|2005-08-01||Interventional|||CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|A Phase II Study of CCI-779 in Patients With Relapsed, Refractory or Transformed Chronic Lymphocytic Leukemia|Terminated||Phase 2|60|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:56:07.24916|2017-10-11 04:56:07.24916
NCT00086866|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2015-02-09|||May 2004||2004-05-01|February 2015|2015-02-01||||January 2007|Actual|2007-01-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery|Randomized, Open Phase II Study of Immunization With the Recombinant MAGE-3 Protein Combined With Adjuvant AS02B or AS15 in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma|Unknown status|Active, not recruiting|Phase 2|165|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:56:07.342707|2017-10-11 04:56:07.342707
NCT00086879|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2017-07-26|||May 2004||2004-05-01|July 2017|2017-07-01|March 2011|Actual|2011-03-01|March 2006|Actual|2006-03-01||Interventional|||Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme|Randomized Phase II of TARCEVA™ (Erlotinib) Versus Temozolomide Or BCNU in Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|110|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:56:07.460498|2017-10-11 04:56:07.460498
NCT00086892|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-02-12|||June 2004||2004-06-01|February 2014|2014-02-01||||April 2006|Actual|2006-04-01||Interventional|||Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Cetuximab (C225, NSC #714692) in Combination With Carboplatin (NSC #241240) in the Treatment of Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|||Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 04:56:07.567982|2017-10-11 04:56:07.567982
NCT00086931|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-03-07|||September 2003||2003-09-01|March 2013|2013-03-01|May 2010|Actual|2010-05-01|May 2007|Actual|2007-05-01||Interventional|||Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum|A Phase I/II Study of Weekly Intravenous Oxaliplatin in Combination With Oral Daily Capecitabine and Radiation Therapy in the Neoadjuvant Treatment of Rectal Cancer|Completed||Phase 1/Phase 2|37|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:56:07.797427|2017-10-11 04:56:07.797427
NCT00086944|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-23|||May 2004||2004-05-01|January 2013|2013-01-01||||July 2006|Actual|2006-07-01||Interventional|||Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase I/II Study of G3139 (Genasense) in Combination With RICE Chemotherapy in Relapsed B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:07.895364|2017-10-11 04:56:07.895364
NCT00086957|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2017-01-06|2016-11-04||January 2004||2004-01-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer|Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma|Completed||Phase 1/Phase 2|31|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 04:56:08.061391|2017-10-11 04:56:08.061391
NCT00086970|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-23|||June 2004||2004-06-01|January 2013|2013-01-01||||November 2005|Actual|2005-11-01||Interventional|||Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors|A Phase I Study Of BG In Combination With Ifosfamide For Advanced Solid Tumors|Terminated||Phase 1|32|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-10-11 04:56:08.961477|2017-10-11 04:56:08.961477
NCT00086983|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-09|||May 2004||2004-05-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors|A Phase I Study of XL119 (Rebeccamycin Analogue) in Combination With Oxaliplatin in Patients With Refractory Solid Tumors|Terminated||Phase 1|15|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:09.057862|2017-10-11 04:56:09.057862
NCT00086996|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-09-04|2012-03-05||September 2004||2004-09-01|September 2013|2013-09-01|August 2011|Actual|2011-08-01|August 2009|Actual|2009-08-01||Interventional|||S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction|Oxaliplatin (NSC-266046) Plus Protracted Infusion 5-Fluorouracil And Radiation For Potentially Curable Esophageal Cancer: A Phase II Trial With Molecular Correlates|Completed||Phase 2|98|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 04:56:09.215715|2017-10-11 04:56:09.215715
NCT00087009|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-03-18|||May 2004||2004-05-01|March 2013|2013-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation|Phase I Study of Oral ß-Glucan and Intravenous Rituximab Among Children and Adolescents With Relapsed CD20-Positive Lymphoma or Leukemia, or Post-Transplant Lymphoproliferative Disease|Terminated||Phase 1|3|Actual|Memorial Sloan Kettering Cancer Center||2||Lack of Accrual|f||||||||||||||2017-10-11 04:56:10.132466|2017-10-11 04:56:10.132466
NCT00087022|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-01-28||2014-01-28|July 2004||2004-07-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer|A Randomized, Double Blind Phase III Study To Evaluate Adjuvant cG250 Treatment Versus Placebo In Patients With Clear Cell RCC And High Risk of Recurrence (ARISER)|Completed||Phase 3|864|Actual|Wilex||2|||f||||t||||||||||2017-10-11 04:56:10.238635|2017-10-11 04:56:10.238635
NCT00087035|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2015-10-01|||May 2004||2004-05-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|June 2006|Actual|2006-06-01||Interventional|||Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer|Phase II Trial Of TAXOTERE + TARCEVA™ To Treat HRPC In Men ≥ 65 Years Of Age|Completed||Phase 2|1|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:56:10.553387|2017-10-11 04:56:10.553387
NCT00087048|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2016-03-21|||April 2004||2004-04-01|March 2016|2016-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer|The Use Of Weekly Topotecan As Second Line Therapy In Small Cell Lung Cancer|Terminated||Phase 2|1|Actual|Case Comprehensive Cancer Center||1||Slow accrual|f||||t||||||||||2017-10-11 04:56:10.645606|2017-10-11 04:56:10.645606
NCT00087061|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-07-17|||May 2004||2004-05-01|May 2005|2005-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma|Oral ST1481 in Adults With Malignant Glioma: A Phase I-II Clinical Trial|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:56:10.722925|2017-10-11 04:56:10.722925
NCT00087074|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-06-03|||June 2004||2004-06-01|June 2013|2013-06-01||||December 2005|Actual|2005-12-01||Interventional|||CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor|A Trial of CCI-779 in Patients With Soft Tissue Sarcoma.|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:10.793815|2017-10-11 04:56:10.793815
NCT00087087|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-02-12|||July 2004||2004-07-01|February 2014|2014-02-01||||December 2006|Actual|2006-12-01||Interventional|||Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation Of Pemetrexed (ALIMTA LY231514, IND #40061) In The Treatment Of Recurrent Or Persistent Platinum-Resistant Ovarian Or Primary Peritoneal Carcinoma|Completed||Phase 2|51|Anticipated|Gynecologic Oncology Group|||||f||||t||||||||||2017-10-11 04:56:10.887922|2017-10-11 04:56:10.887922
NCT00087100|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-02-12|||May 2006||2006-05-01|February 2014|2014-02-01||||August 2007|Actual|2007-08-01||Interventional|||Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer|A Phase II Evaluation Of Pemetrexed (ALIMTA, LY231514, IND #40061) In The Treatment Of Recurrent Or Persistent Endometrial Carcinoma|Completed||Phase 2|51|Anticipated|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 04:56:11.068565|2017-10-11 04:56:11.068565
NCT00087113|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-02-12|||August 2004||2004-08-01|February 2014|2014-02-01||||June 2006|Actual|2006-06-01||Interventional|||Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix|A Phase II Evaluation Of Pemetrexed (ALIMTA, LY231517, IND #40061) In the Treatment Of Recurrent Carcinoma Of The Cervix|Completed||Phase 2|||Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 04:56:11.22748|2017-10-11 04:56:11.22748
NCT00087126|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2015-05-29|||February 2005||2005-02-01|May 2015|2015-05-01||||January 2010|Actual|2010-01-01||Interventional|||Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation of Weekly Topotecan Hydrochloride (Hycamtin®, NSC #609699) in the Treatment of Persistent or Recurrent Carcinoma of the Cervix|Completed||Phase 2|27|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 04:56:11.361211|2017-10-11 04:56:11.361211
NCT00087139|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-04-21|2012-11-25||September 2004||2004-09-01|April 2013|2013-04-01|February 2011|Actual|2011-02-01|April 2009|Actual|2009-04-01||Interventional|||Ixabepilone in Treating Patients With Metastatic Prostate Cancer|Phase II Study of a Weekly Schedule of BMS-247550 for Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|124|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:11.543045|2017-10-11 04:56:11.543045
NCT00087152|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-05-12|2011-07-13||June 2004||2004-06-01|February 2013|2013-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer|Phase II Trial Of Imatinib Mesylate (Gleevec®) (NSC-716051) In Combination With Capecitabine (Xeloda®) (NSC-712807) In Metastatic Breast Cancer|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)|Two-stage design, but did not have enough confirmed responses after the first stage to launch the second stage.|1|||f||||f||||||||||2017-10-11 04:56:12.385687|2017-10-11 04:56:12.385687
NCT00087178|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2016-06-03|||May 2004||2004-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2014|Actual|2014-03-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer|A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer|Completed||Phase 3|2722|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-10-11 04:56:13.106152|2017-10-11 04:56:13.106152
NCT00087191|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-15|||May 2004||2004-05-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer|Distribution Of The Photosensitizer Motexafin Lutetium And Hypoxia In Patients With Malignancies|Terminated||N/A|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-10-11 04:56:14.921926|2017-10-11 04:56:14.921926
NCT00087204|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-22|||May 2004||2004-05-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia|A Phase I Study Of XL119 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphocytic Leukemia, Or Chronic Myeloid Leukemia In Blastic-Phase|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:15.079756|2017-10-11 04:56:15.079756
NCT00087217|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-24|||May 2004||2004-05-01|January 2013|2013-01-01||||June 2008|Actual|2008-06-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor|Phase I Study of 17- Allylamino-17 Demethoxygeldanamycin (17-AAG) in Combination With Paclitaxel in Advanced Solid Malignancies|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:15.215701|2017-10-11 04:56:15.215701
NCT00087256|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-04|||July 2004||2004-07-01|January 2013|2013-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer|Celecoxib Polyp Prevention Trial in Participants With Resected Stage I Colon Cancer|Terminated||Phase 3|18|Actual|NSABP Foundation Inc||2||For scientific, logistic, and administrative reasons.|f||||f||||||||||2017-10-11 04:56:15.306448|2017-10-11 04:56:15.306448
NCT00087269|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-06-04|||December 2004||2004-12-01|June 2013|2013-06-01||||April 2006|Actual|2006-04-01||Interventional|||Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection|Phase II Study to Evaluate the Tumor Biochemical Effects of the EGFR Tyrosine Kinase Inhibitor OSI-774 (Erlotinib) Administered Prior to Surgical Resection in Patients With Early Stage Non-Small Cell Lung Cancer|Terminated||Phase 2|110|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:15.392182|2017-10-11 04:56:15.392182
NCT00087282|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-06-21|||June 2004||2004-06-01|May 2005|2005-05-01|July 2006|Actual|2006-07-01|||||Interventional|||Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer|A Non-Randomized Phase II Study of Sequential Irinotecan (CPT-11) And Flavopiridol In Patients With Advanced Hepatoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:56:15.492642|2017-10-11 04:56:15.492642
NCT00087295|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2012-10-31|||June 2004||2004-06-01|October 2012|2012-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium|A Phase II Study of Depsipeptide (NSC-630176) In Patients With Advanced Transitional Cell Carcinoma Of The Urinary Tract Who Have Progressed After Receiving One Prior Chemotherapy Regimen For Advanced Disease|Terminated||Phase 2|6|Actual|Southwest Oncology Group||1||Permanently Closed Due to Poor Accrual|f||||f||||||||||2017-10-11 04:56:15.565166|2017-10-11 04:56:15.565166
NCT00087334|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-01-31|||January 2004||2004-01-01|January 2013|2013-01-01||||November 2005|Actual|2005-11-01||Interventional|||Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer|A Phase I/II Study of Capecitabine (XELODA®, Roche) Plus Oxaliplatin (Eloxatin®, Sanofi) Plus ZD 1893 (IRESSA®) in the Treatment of Metastatic Colorectal Cancer|Terminated||Phase 1/Phase 2|10|Actual|Roswell Park Cancer Institute||||Withdrawn due to poor/low accrual|f||||||||||||||2017-10-11 04:56:15.647401|2017-10-11 04:56:15.647401
NCT00087347|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-05-12|||September 2004||2004-09-01|May 2013|2013-05-01||||September 2006|Actual|2006-09-01||Observational|||Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer|An NCI-Sponsored Exploratory Study For Determining Optimum Timing For The Imaging Of Intravenous Superparamagnetic Particle Ferumoxytol (Code7228) For The Differentiation of Metastatic and Non Metastatic Lymph Nodes in Patients With Known Primary Cancer Scheduled For Possible Surgical Lymph Node Biopsy/Dissection|Completed||N/A|14|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-10-11 04:56:15.722686|2017-10-11 04:56:15.722686
NCT00087360|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-07-10|||November 2003||2003-11-01|July 2013|2013-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants|Providing Genetic And Environmental Cancer Risk Assessment In Primary Care|Completed||N/A|||Fox Chase Cancer Center|||||f||||f||||||||||2017-10-11 04:56:15.808439|2017-10-11 04:56:15.808439
NCT00087373|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2014-06-06|||June 2004||2004-06-01|December 2012|2012-12-01||||February 2006|Actual|2006-02-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Phase II Study of Intratumoral Injection of rF-TRICOMTM in Patients With Metastatic Melanoma Who Have Detectable Tumor Associated T Cells|Terminated||Phase 2|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:15.883566|2017-10-11 04:56:15.883566
NCT00087386|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-04-09|||June 2004||2004-06-01|April 2013|2013-04-01||||February 2007|Actual|2007-02-01||Interventional|||Tanespimycin in Treating Patients With Stage III-IV Melanoma|Phase II Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) Diluted in EPL Diluent (NSC #704057) in Metastatic Melanoma Patients|Terminated||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:15.958519|2017-10-11 04:56:15.958519
NCT00087399|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2016-07-12|||November 2004||2004-11-01|July 2016|2016-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy|A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone|Completed||Phase 3|118|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 04:56:16.059159|2017-10-11 04:56:16.059159
NCT00087412|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2013-02-27|||September 2004||2004-09-01|February 2013|2013-02-01||||July 2007|Actual|2007-07-01||Interventional|||S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer|Phase II Trial of OSI-774 (NSC-718781) in Patients With Advanced Non-Small Cell Lung Cancer and a Performance Status of 2|Completed||Phase 2|65|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:56:16.630393|2017-10-11 04:56:16.630393
NCT00087425|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2015-04-29|||July 2004||2004-07-01|January 2007|2007-01-01||||October 2007|Actual|2007-10-01||Interventional|||Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|A Phase II Trial Of Bryostatin-1 In Combination With Rituximab In Rituximab-Refractory Indolent B-cell Non Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia|Completed||Phase 2|48|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-10-11 04:56:16.744098|2017-10-11 04:56:16.744098
NCT00087438|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2016-12-30|2014-02-25||May 2004||2004-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2010|Actual|2010-03-01||Interventional||All eligible patients who received protocol treatment.|Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer|A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients With Medically Inoperable Stage I/II Non-Small Cell Lung Cancer|Completed||Phase 2|59|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:56:16.857318|2017-10-11 04:56:16.857318
NCT00087451|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2015-08-18|||July 2004||2004-07-01|August 2015|2015-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)|A Phase I Sequential Ascending Dose Trial of AP23573 in Patients With Progressive or Recurrent Malignant Glioma|Completed||Phase 1|11|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:56:17.317002|2017-10-11 04:56:17.317002
NCT00087464|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Three Month Course of Anti-HIV Medications for People Recently Infected With HIV|Tenofovir, Emtricitabine, and Nevirapine for Recently HIV-Infected Subjects: Can Short-Course, Once Daily Therapy Reduce the Viral Load at 12 Months From Estimated Date of Infection?|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||||study was withdrawn before any participants were recruited and enrolled|||||||||||||||2017-10-11 04:56:17.420675|2017-10-11 04:56:17.420675
NCT00087477|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-08|2005-08-26|||January 2004||2004-01-01|August 2005|2005-08-01|August 2004||2004-08-01|||||Interventional|||A Pilot Study of Pivanex in Patients With Malignant Melanoma|A Pilot Study of Pivanex, a Histone Deacetylase Inhibitor, in Patients With Malignant Melanoma|Terminated||Phase 1/Phase 2|14||Titan Pharmaceuticals|||||||||||||||||||2017-10-11 04:56:17.49144|2017-10-11 04:56:17.49144
NCT00087828|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-14|2006-08-16|||November 2000||2000-11-01|August 2006|2006-08-01|June 2005||2005-06-01|||||Interventional|||Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections|Cranberry Juice Metabolites in Urine|Completed||N/A|5||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:56:35.502744|2017-10-11 04:56:35.502744
NCT00087490|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-09|2012-06-29|2012-06-29||October 2004||2004-10-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)|Linezolid in the Treatment of Subjects With Complicated Skin and Soft Tissue Infections Proven to be Due to Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 4|1077|Actual|Pfizer|Comparing duration of intravenous (IV) therapy for linezolid (LZD) and vancomycin (VAN) in study, participants in LZD group had option to switch to oral therapy while those in VAN group had to remain on IV therapy until completion of study treatment.||||f||||||||||||||2017-10-11 04:56:17.642543|2017-10-11 04:56:17.642543
NCT00087503|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-09|2008-03-27|||April 2004||2004-04-01|March 2008|2008-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy|A Phase II Efficacy And Safety Study Intravenous Edotecarin In Patients With Advanced Gastric Cancer That Has Progressed Or Recurred After Prior Fluropyrimidine-Based Chemotherapy|Completed||Phase 2|28||Pfizer|||||f||||||||||||||2017-10-11 04:56:20.739734|2017-10-11 04:56:20.739734
NCT00087516|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-09|2015-06-08|2010-05-10||June 2004||2004-06-01|June 2015|2015-06-01|February 2007|Actual|2007-02-01|July 2005|Actual|2005-07-01||Interventional|||Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of MK0431 Monotherapy in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 3|741|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-10-11 04:56:20.856591|2017-10-11 04:56:20.856591
NCT00087529|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-09|2015-08-10|2015-08-10||June 2004||2004-06-01|August 2015|2015-08-01||||October 2007|Actual|2007-10-01||Interventional|OLYMPUS|Intent-to-Treat (ITT) Population: All randomized participants, with groups defined by treatment assigned at randomization.|A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis|A Phase II/III, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis|Completed||Phase 2/Phase 3|439|Actual|Genentech, Inc.||2|||f||||||||||||||2017-10-11 04:56:22.144596|2017-10-11 04:56:22.144596
NCT00087542|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-09|2005-12-05|||March 2004||2004-03-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug||Completed||Phase 2|60||ACADIA Pharmaceuticals Inc.|||||||||||||||||||2017-10-11 04:56:22.969637|2017-10-11 04:56:22.969637
NCT00087555|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2012-01-20|2011-10-17||July 2004||2004-07-01|January 2012|2012-01-01|January 2006|Actual|2006-01-01|April 2005|Actual|2005-04-01||Interventional|||Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem(R) (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia|Completed||Phase 2|195|Actual|Jazz Pharmaceuticals||3|||f||||f||||||||||2017-10-11 04:56:23.09882|2017-10-11 04:56:23.09882
NCT00087568|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2016-05-02|2016-02-03||January 2003||2003-01-01|May 2016|2016-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional||Intent-to-treat (ITT) Population included all enrolled participants who received at least one dose of study medication (Pegasys or ribavirin).|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin|An Open-label, Multicenter, Efficacy and Safety Study of Pegasys® Plus Ribavirin in Patients With Chronic HCV Infection Who Are Unable to Tolerate or Who Do Not Respond to 12 Weeks of Therapy With PEGIntron ® Plus Ribavirin|Completed||Phase 4|57|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:56:24.250835|2017-10-11 04:56:24.250835
NCT00087581|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2016-11-03|||June 2004||2004-06-01|September 2016|2016-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation|An Open-Label, Prospective, Randomized, Controlled, Multi-Center Study Assessing Fixed Dose Versus Concentration Controlled Cellcept® Regimens for Patients Following a Single Organ Renal Transplantation in Combination With Full Dose and Reduced Dose Calcineurin Inhibitors|Completed||Phase 4|720|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 04:56:25.233436|2017-10-11 04:56:25.233436
NCT00087594|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2016-02-04|2015-12-03||November 2003||2003-11-01|February 2016|2016-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional||Intent-to-treat (ITT) Population included all enrolled participants who received at least one dose of study medication.|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.|An Open-Label, Multi-Center, Randomized, Safety, Feasibility and Tolerability Pilot Study of Pegasys® (Peginterferon Alfa-2a) Plus Copegus® (Ribavirin) in Previous Intravenous Drug Users Who Are Currently Enrolled in a Methadone Maintenance Treatment Program.|Completed||Phase 4|48|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:56:25.451254|2017-10-11 04:56:25.451254
NCT00087607|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2016-05-24|2016-04-05||January 2004||2004-01-01|May 2016|2016-05-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional||Baseline characteristics were described for the Intent-to-Treat (ITT) Population, which included all participants who were randomized and received at least one dose of study medication (Pegylated interferon [PEG-IFN] or ribavirin).|Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).|A Prospective, Randomized, Open-label Study Evaluating the Viral Kinetics and Pharmacokinetics of Pegasys® Plus Copegus® and PEG-Intron® Plus Rebetol® in Interferon-naïve Patients With Chronic Hepatitis C.|Completed||Phase 4|385|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:56:26.922507|2017-10-11 04:56:26.922507
NCT00087620|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2017-02-02|||September 2004|Actual|2004-09-01|February 2017|2017-02-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer||Terminated||Phase 4|||Hoffmann-La Roche|||||||||||||||||||2017-10-11 04:56:28.459898|2017-10-11 04:56:28.459898
NCT00087633|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2010-12-22|2009-10-14||October 2004||2004-10-01|December 2010|2010-12-01|October 2008|Actual|2008-10-01|||||Interventional|||PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.|A Randomized, Open-label Study of Prophylactic Administration of PEGASYS Plus Ribavirin After Liver Transplantation on Hepatitis C Recurrence in Patients With Hepatitis C|Completed||Phase 4|115|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:56:28.606819|2017-10-11 04:56:28.606819
NCT00087646|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2015-12-10|2015-12-10||September 2003||2003-09-01|December 2015|2015-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Intent-to-treat analysis population (ITT) included, all participants randomized who received at least one dose of study medication.|REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy|A Randomized, Open-label Study of the Effect of PEGASYS Combined With Ribavirin on Sustained Virologic Response in Patients With Chronic Hepatitis C Who Did Not Respond to Previous Pegintron/Ribavirin Combination Therapy|Completed||Phase 4|948|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 04:56:29.282369|2017-10-11 04:56:29.282369
NCT00087659|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2009-11-20|||December 2003||2003-12-01|November 2009|2009-11-01|May 2007|Actual|2007-05-01|||||Interventional|||A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy||Completed||N/A|||Novartis|||||||||||||||||||2017-10-11 04:56:32.833201|2017-10-11 04:56:32.833201
NCT00087672|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2012-08-01|2009-09-15||July 2004||2004-07-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Phase II Study of CC-5013 in Myelofibrosis|Phase II Study of CC-5013 in Myelofibrosis|Completed||Phase 2|41|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:56:32.925158|2017-10-11 04:56:32.925158
NCT00087685|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2016-01-06|2015-12-01||June 2004||2004-06-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||RAD001 in Recurrent Endometrial Cancer Patients|A Phase II Study of RAD001 in Patients With Recurrent Endometrial Cancer|Completed||Phase 2|35|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:56:33.165382|2017-10-11 04:56:33.165382
NCT00087698|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2009-05-01|2009-02-16||September 2003||2003-09-01|May 2009|2009-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma|A Multicenter Phase II Trial of Neo-Adjuvant Pemetrexed (Alimta) Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma|Completed||Phase 2|77|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 04:56:33.624365|2017-10-11 04:56:33.624365
NCT00087711|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2016-11-21|||July 2004||2004-07-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|January 2007|Actual|2007-01-01||Interventional|||A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer|A Randomized Phase 3 Trial of ALIMTA and Cisplatin Versus GEMZAR and Cisplatin in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|1713|Actual|Eli Lilly and Company||2|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 04:56:34.121463|2017-10-11 04:56:34.121463
NCT00087724|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-12|2012-06-06|||July 2004||2004-07-01|June 2012|2012-06-01|September 2006|Actual|2006-09-01|||||Interventional|||A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of FK962 in Subjects With Mild to Moderate Alzheimer's Disease|Terminated||Phase 2|510||Astellas Pharma Inc|||||||||||||||||||2017-10-11 04:56:34.493916|2017-10-11 04:56:34.493916
NCT00087737|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-13|2009-08-18||||||August 2009|2009-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|369|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:56:34.829712|2017-10-11 04:56:34.829712
NCT00087750|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-13|2017-01-10|||October 2003||2003-10-01|March 2005|2005-03-01||||||||Interventional|||Interaction Between Cocaine and Quetiapine - 1|Interaction Between IV Cocaine and Quetiapine|Unknown status|Active, not recruiting|Phase 1|12||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:56:34.891518|2017-10-11 04:56:34.891518
NCT00087763|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-13|2006-05-02|||March 2004||2004-03-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)|A Phase II Prospective, Randomized, Double-Masked, Sham-Controlled, Dose-Ranging, Multi-Center Trial to Assess the Effect of Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)|Completed||Phase 2|135||Eyetech Pharmaceuticals|||||||||||||||||||2017-10-11 04:56:34.950403|2017-10-11 04:56:34.950403
NCT00087776|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-13|2011-03-16|||October 2002||2002-10-01|March 2011|2011-03-01||||October 2007|Actual|2007-10-01||Interventional|||Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma|Phase III Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma|Completed||N/A|575|Anticipated|Luitpold Pharmaceuticals|||||||||||||||||||2017-10-11 04:56:35.006685|2017-10-11 04:56:35.006685
NCT00087789|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-13|2016-10-27|||June 2004||2004-06-01|October 2016|2016-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease|A Phase I, Dose-Escalating Study to Assess the Safety and Tolerability of CERE-110 [Adeno-Associated Virus (AAV)-Based Vector-Mediated Delivery of Beta-Nerve Growth Factor (NGF)] in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|10|Actual|Sangamo Therapeutics||1|||f||||t||||||||||2017-10-11 04:56:35.095354|2017-10-11 04:56:35.095354
NCT00087802|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-13|2009-04-15|||March 2004||2004-03-01|April 2009|2009-04-01||||May 2007|Actual|2007-05-01||Interventional|||Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)|A Phase III Randomized Trial of Gemcitabine/Oxaliplatin (GEMOX) Versus Carboplatin/Paclitaxel (CP) as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|383|Actual|Sanofi||2|||f||||||||||||||2017-10-11 04:56:35.202669|2017-10-11 04:56:35.202669
NCT00087815|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-14|2013-12-17|||September 2003||2003-09-01|July 2007|2007-07-01|June 2005||2005-06-01|||||Interventional|||Hyperbaric Oxygen Therapy in Treating Patients With Radiation Necrosis of the Brain|Complimentary Hyperbaric Oxygen for Brain Radionecrosis|Unknown status|Active, not recruiting|N/A|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:56:35.413148|2017-10-11 04:56:35.413148
NCT00087841|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-14|2008-01-15|||April 2002||2002-04-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Self-Hypnotic Relaxation Therapy During Invasive Procedures|Midcareer Development of Nonpharmacologic Analgesia|Completed||Phase 2|390||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:56:35.580653|2017-10-11 04:56:35.580653
NCT00087854|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-14|2008-04-21|||March 2004||2004-03-01|April 2008|2008-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of Individualized Amonafide to Treat Prostate Cancer|Dose-Defining Study of a NAT2 Phenotype-Based Dosing Regimen of Intravenous Amonafide L-Malate Administered Weekly in Men With Androgen-Independent Prostate Cancer (AIPC)|Completed||Phase 1/Phase 2|40||Xanthus Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 04:56:35.671323|2017-10-11 04:56:35.671323
NCT00087867|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-14|2010-10-15|||June 2004||2004-06-01|October 2010|2010-10-01|September 2005|Actual|2005-09-01|||||Interventional|||Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma|An Open-label Study of the Efficacy, Safety, and Tolerability of Oral SCIO-469 in Treatment of Relapsed, Refractory Patients With Multiple Myeloma|Completed||Phase 2|62|Actual|Scios, Inc.||2|||f||||||||||||||2017-10-11 04:56:35.777472|2017-10-11 04:56:35.777472
NCT00087880|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-15|2017-01-11|||December 2002||2002-12-01|March 2016|2016-03-01|September 2009|Actual|2009-09-01|January 2005|Actual|2005-01-01||Interventional|||Maintaining Abstinence in Chronic Cigarette Smokers - 1|Maintaining Abstinence in Chronic Cigarette Smokers|Completed||Phase 2|407|Actual|National Institute on Drug Abuse (NIDA)||5|||f||||f||||||||||2017-10-11 04:56:35.872969|2017-10-11 04:56:35.872969
NCT00087893|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-15|2013-09-26|||July 2004||2004-07-01|September 2013|2013-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Epidemiology of Vascular Inflammation & Atherosclerosis||Completed||N/A|931|Actual|University of Vermont|||1||f||||||||||||||2017-10-11 04:56:35.967259|2017-10-11 04:56:35.967259
NCT00087906|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-15|2015-12-22|||July 2004||2004-07-01|December 2015|2015-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Disability and Health Outcomes in COPD|Disability and Health Outcomes in COPD|Completed||N/A|1589|Actual|University of California, San Francisco|||1||f||||f||||||||No||2017-10-11 04:56:36.04885|2017-10-11 04:56:36.04885
NCT00087919|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-15|2008-07-01|||July 2004||2004-07-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Defining an Obesity QTL on Chromosome 3q||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:56:36.108425|2017-10-11 04:56:36.108425
NCT00087932|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-15|2006-08-17|||September 2001||2001-09-01|August 2006|2006-08-01|August 2003||2003-08-01|||||Observational|||Socioeconomic Influences on Complementary and Alternative Medicine Use in Cancer Treatment|Socioeconomic Diversity of CAM Integration in Oncology|Completed||N/A|300||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:56:36.170455|2017-10-11 04:56:36.170455
NCT00087945|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-16|2013-10-04|||July 2004||2004-07-01|October 2013|2013-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Blood Levels of Abacavir in HIV Infected Adolescents|Abacavir Pharmacokinetics During Chronic Therapy in HIV-1 Infected Adolescents and Young Adults|Completed||N/A|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:56:36.229906|2017-10-11 04:56:36.229906
NCT00087958|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-16|2009-04-30|||August 2004||2004-08-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|February 2007|Actual|2007-02-01||Interventional|||Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment|Phase II Multi-Center, Open-Label, Non-Randomized Study of Intravenous RPR109881 Given Every 3 Weeks in Patients With Metastatic Breast Cancer Progressing After Therapy With Anthracyclines, Taxanes and Capecitabine|Completed||Phase 2|168|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:56:36.345569|2017-10-11 04:56:36.345569
NCT00087984|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-16|2013-02-14||2013-01-22|January 2004||2004-01-01|February 2013|2013-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||RNA-Loaded Dendritic Cell Cancer Vaccine|A Phase I/II Study To Examine The Safety, Feasibility, Immunological Response, And Measures Of Clinical Antitumor Activity After Administering Unselected, Autologous, Amplified Tumor Total RNA-Transfected, Dendritic Cell Vaccine (MB-002) To Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|26|Actual|Argos Therapeutics||1|||f||||||||||||||2017-10-11 04:56:36.452394|2017-10-11 04:56:36.452394
NCT00087997|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-19|2006-06-19|||July 2004||2004-07-01|June 2006|2006-06-01|October 2005||2005-10-01|||||Interventional|||A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas||Completed||Phase 2|80||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-10-11 04:56:36.558855|2017-10-11 04:56:36.558855
NCT00088010|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-19|2010-05-27||2010-05-27|June 2004||2004-06-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer|Effects of Arzoxifene on Vertebral Fracture Incidence and on Invasive Breast Cancer Incidence in Postmenopausal Women With Osteoporosis or With Low Bone Density.|Completed||Phase 3|9369|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 04:56:36.660457|2017-10-11 04:56:36.660457
NCT00088023|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-19|2014-03-27|||March 2004||2004-03-01|March 2014|2014-03-01|December 2005||2005-12-01|||||Interventional|||Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness|A Phase I Study of PT-523 in Patients With Solid Tumors|Terminated||Phase 1|40||Spectrum Pharmaceuticals, Inc|||||||||||||||||||2017-10-11 04:56:36.792418|2017-10-11 04:56:36.792418
NCT00088036|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-19|2006-07-21|||February 2004||2004-02-01|July 2006|2006-07-01|January 2006||2006-01-01|||||Interventional|||Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder|Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Double-Blind Comparison With Placebo|Completed||Phase 3|450||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:56:36.914392|2017-10-11 04:56:36.914392
NCT00088049|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-19|2007-07-16|||October 2003||2003-10-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia|A Randomized Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia|Completed||Phase 4|560||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:56:37.070121|2017-10-11 04:56:37.070121
NCT00088062|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-19|2005-06-23|||February 2004||2004-02-01|May 2005|2005-05-01|November 2004||2004-11-01|||||Interventional|||STA-5326 in Crohn's Disease Patients|A Phase I/IIa Trial of STA-5326 in Crohn's Disease Patients With CDAI Scores of 220-450|Completed||Phase 1/Phase 2|48||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-10-11 04:56:37.199727|2017-10-11 04:56:37.199727
NCT00167336|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-12-15|||May 2004||2004-05-01|June 2006|2006-06-01|March 2005||2005-03-01|||||Observational|||Developing an Instrument to Measure Personal Keyboarding Style|Developing an Instrument to Measure Personal Keyboarding Style|Completed||N/A|40||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:17.279038|2017-10-11 05:26:17.279038
NCT00088075|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-19|2011-06-06|||August 2004||2004-08-01|January 2011|2011-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Investigate Risperidone for the Treatment of Schizophrenia in Adolescents|A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Efficacy and Safety of Risperidone for the Treatment of Schizophrenia in Adolescents|Completed||Phase 3|160|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:56:37.288826|2017-10-11 04:56:37.288826
NCT00088088|ClinicalTrials.gov processed this data on October 10, 2017|2004-07-20|2008-12-03|||March 2004||2004-03-01|December 2008|2008-12-01|March 2005||2005-03-01|||||Interventional|||STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)|A Phase I/II Trial of STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|86||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-10-11 04:56:37.36393|2017-10-11 04:56:37.36393
NCT00097045|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2007-08-21|||November 2004||2004-11-01|August 2007|2007-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C|Phase 2 Study of Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C|Completed||Phase 2|90||Intarcia Therapeutics|||||f||||||||||||||2017-10-11 04:56:37.473756|2017-10-11 04:56:37.473756
NCT00097058|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2014-11-17|||August 2003||2003-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Estrogen Use in Protection From Cognitive Decline|Estrogen Use in Protection From Cognitive Decline|Completed||N/A|71|Anticipated|Stanford University|||2||f||||t||||||Samples With DNA|"     whole blood serum urine   "|||2017-10-11 04:56:37.552681|2017-10-11 04:56:37.552681
NCT00097071|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2016-12-21|||October 2004||2004-10-01|December 2016|2016-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents|Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes|Completed||Phase 3|299|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 04:56:37.655643|2017-10-11 04:56:37.655643
NCT00097084|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2017-01-26|||September 2004||2004-09-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes|Efficacy and Safety Comparison of Insulin Detemir Plus Insulin Aspart Versus Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes|Completed||Phase 3|324|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 04:56:37.846402|2017-10-11 04:56:37.846402
NCT00097097|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2014-07-29|||October 2004||2004-10-01|July 2014|2014-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Neonatal Resuscitation in Zambia|Neonatal Resuscitation in Zambia|Completed||Phase 3|40000||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-10-11 04:56:38.049183|2017-10-11 04:56:38.049183
NCT00097110|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2013-11-22|||July 2003||2003-07-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|||||Interventional|||RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil|RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil|Completed||Phase 3|734||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-10-11 04:56:38.146314|2017-10-11 04:56:38.146314
NCT00097123|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2014-07-29|||September 2002||2002-09-01|July 2014|2014-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||RCT of Misoprostol for Postpartum Hemorrhage in India|RCT of Misoprostol for Postpartum Hemorrhage in India|Completed||N/A|1600|Anticipated|NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-10-11 04:56:38.242129|2017-10-11 04:56:38.242129
NCT00097149|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2013-12-16|||May 2003||2003-05-01|December 2013|2013-12-01|May 2006|Actual|2006-05-01|||||Interventional|||Systematic Pediatric Care for Oral Clefts - South America|Systematic Pediatric Care for Oral Clefts - South America|Completed||N/A|696||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-10-11 04:56:38.332164|2017-10-11 04:56:38.332164
NCT00097162|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2006-06-23|||November 2004||2004-11-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Visual Cortex Stimulation in Patients With Amblyopia|Investigation of Visual Plasticity by a Direct Current Stimulation of Occipital Cortex in Adult Amblyopia|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:56:38.419497|2017-10-11 04:56:38.419497
NCT00097175|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-17|2017-10-05|||November 10, 2004||2004-11-10|January 15, 2014|2014-01-15|January 15, 2014||2014-01-15|||||Observational|||Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders|The Effects of Mood and Tryptophan Depletion on the Neural Correlates of Affective Shifting in Mood Disorders|Completed||N/A|95|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:56:38.498183|2017-10-11 04:56:38.498183
NCT00097188|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-18|2014-02-28|||December 2004||2004-12-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis|A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab (Mabthera/Rituxan) in Adults With Relapsing Remitting Multiple Sclerosis|Completed||Phase 2|104|Actual|Genentech, Inc.|||||||||||||||||||2017-10-11 04:56:38.579937|2017-10-11 04:56:38.579937
NCT00097214|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-18|2010-04-08|||November 2004||2004-11-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|A Phase II Trial of Carboplatin Plus Cetuximab for the Treatment of Stage IIIb/IV Non-Small Cell Lung Cancer|Completed||Phase 2|57|Actual|ImClone LLC||1|||f||||f||||||||||2017-10-11 04:56:38.730595|2017-10-11 04:56:38.730595
NCT00097227|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-18|2010-04-08|||November 2004||2004-11-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|A Randomized Phase II Trial of Two Dose Schedules of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-small Cell Lung Cancer|Completed||Phase 2|165|Actual|ImClone LLC||2|||f||||f||||||||||2017-10-11 04:56:38.83763|2017-10-11 04:56:38.83763
NCT00097240|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-19|2010-08-02|||January 2005||2005-01-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|||||Observational|FOLLOW||An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)|The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy|Completed||Phase 4|18|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:56:38.966594|2017-10-11 04:56:38.966594
NCT00177762|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 1999||1999-09-01|September 2005|2005-09-01|December 2002||2002-12-01|||||Interventional|||Dose-Response of Exercise on Long-Term Weight Loss|Dose-Response of Exercise on Long-Term Weight Loss|Completed||Phase 1/Phase 2|200||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:57.283259|2017-10-11 05:26:57.283259
NCT00097253|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-19|2010-02-12|2009-04-23||August 2005||2005-08-01|February 2010|2010-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||The Effects of Smell on Mood and Physical Responses|Psychoneuroimmunology and Mind-Body Medicine: Olfaction, Mood, and Physiological Responses|Completed||Phase 1|56|Actual|National Center for Complementary and Integrative Health (NCCIH)||3|||f||||t||||||||||2017-10-11 04:56:39.034702|2017-10-11 04:56:39.034702
NCT00097266|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-19|2013-11-07|||December 2004||2004-12-01|July 2010|2010-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study of Aripiprazole in Patients With Acute Bipolar Mania|A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder|Completed||Phase 3|615||Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||||||||||||2017-10-11 04:56:39.343806|2017-10-11 04:56:39.343806
NCT00097279|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-19|2017-01-10|||August 2004||2004-08-01|January 2017|2017-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|ACTION||Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes|A Multicenter, Open-Label, Randomised Trial to Compare the Efficacy and Safety of NovoLog Mix 70/30 BID in Combination With Metformin and Pioglitazone to Metformin and Pioglitazone Alone in Insulin Naïve Subjects With Type 2 Diabetes|Completed||Phase 3|230|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 04:56:39.68772|2017-10-11 04:56:39.68772
NCT00097292|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-19|2016-09-04|||February 2004||2004-02-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Pathway to Prevention Study|Natural History Study of the Development of Type 1 Diabetes|Recruiting||N/A|75000|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||t||||||||||2017-10-11 04:56:39.924968|2017-10-11 04:56:39.924968
NCT00097305|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-19|2007-09-07|||September 2002||2002-09-01|August 2006|2006-08-01||||||||Interventional|||Body-Oriented Therapy for Sexual Abuse Recovery|Delving Intervention and Mindbody Integration|Completed||Phase 2|24||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:56:40.154798|2017-10-11 04:56:40.154798
NCT00097318|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-20|2017-06-30|||November 17, 2004||2004-11-17|April 8, 2011|2011-04-08|April 8, 2011|Actual|2011-04-08|||||Interventional|||Safety Study of Interferon Beta 1a to for Acute Stroke|Recombinant Human Interferon Beta-1a in Acute Ischemic Stroke: A Dose Escalation and Safety Study|Completed||Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:56:40.229446|2017-10-11 04:56:40.229446
NCT00097344|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-22|2007-08-21|||December 2004||2004-12-01|August 2007|2007-08-01|August 2006||2006-08-01|||||Interventional|||The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer|Phase 3 Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer|Terminated||Phase 3|842||Intarcia Therapeutics||||Identical study Biomed 777-CLP-029 did not meet superiority endpoint|f||||||||||||||2017-10-11 04:56:40.441418|2017-10-11 04:56:40.441418
NCT00097357|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-22|2010-02-27||2010-02-27|October 2004||2004-10-01|November 2008|2008-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery|A Phase 2 Randomized, Double-Blinded (BMS-562247 and Enoxaparin), Active-Controlled (Enoxaparin and Warfarin), Parallel-Arm, Dose-Response Study of the Oral Factor Xa Inhibitor BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery|Completed||Phase 2/Phase 3|1238|Actual|Bristol-Myers Squibb||8|||f||||||||||||||2017-10-11 04:56:40.763341|2017-10-11 04:56:40.763341
NCT00097370|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-22|2017-06-07|2015-11-09|2012-03-15|September 30, 2004|Actual|2004-09-30|June 2017|2017-06-01|September 29, 2010|Actual|2010-09-29|September 29, 2010|Actual|2010-09-29||Interventional|||Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome|An Open Label Extension Study to Evaluate Safety and Efficacy of Mepolizumab in Patients With Hypereosinophilic Syndromes|Terminated||Phase 3|78|Actual|GlaxoSmithKline||1||"Study terminated by sponsor (29 Sep 2010). Subjects eligible to continue mepolizumab treatment   were transferred into the compassionate use program (MHE104317)"|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 04:56:41.278154|2017-10-11 04:56:41.278154
NCT00097383|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-22|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer|A Phase 2 Study of Alimta and Epirubicin Administered Every 21 Days in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-10-11 04:56:42.195308|2017-10-11 04:56:42.195308
NCT00097396|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-23|2011-06-29|||November 2004||2004-11-01|June 2011|2011-06-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V|A Phase 1, Open-Label, Dose-Escalating Study to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant Plague Vaccine rF1V in Healthy Volunteers|Completed||Phase 1|40||DynPort Vaccine Company LLC, A CSC Company|||||f||||t||||||||||2017-10-11 04:56:42.445223|2017-10-11 04:56:42.445223
NCT00097448|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-23|2017-04-03|2012-11-08||December 2004||2004-12-01|April 2017|2017-04-01|March 2011|Actual|2011-03-01|October 2009|Actual|2009-10-01||Interventional|SSNHL||Sudden Deafness Treatment Trial|Sudden Hearing Loss Multicenter Treatment Trial|Completed||Phase 3|255|Actual|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||||2017-10-11 04:56:42.543149|2017-10-11 04:56:42.543149
NCT00097461|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-23|2017-10-05|||September 28, 2004||2004-09-28|April 18, 2017|2017-04-18|April 18, 2017||2017-04-18|||||Observational|||Revising Employee Benefits for the Sake of Health|Revising Employee Benefits for the Sake of Health|Completed||N/A|408|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:56:42.98978|2017-10-11 04:56:42.98978
NCT00097474|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-23|2017-10-05|||November 22, 2004||2004-11-22|July 27, 2017|2017-07-27|November 14, 2007|Actual|2007-11-14|November 14, 2007|Actual|2007-11-14||Interventional|||Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag|The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag|Completed||Phase 2|57|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-10-11 04:56:43.081142|2017-10-11 04:56:43.081142
NCT00097487|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2005-06-23|||November 2000||2000-11-01|November 2004|2004-11-01|September 2004||2004-09-01|||||Observational|||A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane|Clinical Outcomes in Patients With HER2 Gene-Amplified Metastatic Breast Cancer Treated With First Line Herceptin in Combination With a Taxane: A Phase IV, Prospective, Community Based Study|Unknown status|Active, not recruiting|Phase 4|1000||Genentech, Inc.|||||f||||||||||||||2017-10-11 04:56:43.216996|2017-10-11 04:56:43.216996
NCT00097500|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2015-03-19|2010-12-24||September 2004||2004-09-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes|A Phase 3, Randomized, Open Label, Comparator-Controlled, Parallel Group, Multicenter Study to Compare the Effects of Exenatide and Insulin Glargine on Beta Cell Function and Cardiovascular Risk Markers in Subjects With Type 2 Diabetes Treated With Metformin Who Have Not Achieved Target HbA1c|Completed||Phase 3|69|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:56:43.303291|2017-10-11 04:56:43.303291
NCT00097513|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2010-11-11|||February 2003||2003-02-01|November 2010|2010-11-01|June 2006|Actual|2006-06-01|||||Observational|||National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients|National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Subjects|Completed||Phase 4|||Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:56:44.047672|2017-10-11 04:56:44.047672
NCT00097526|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2012-11-13|||April 2000||2000-04-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)|Bone Mineral Density in Adolescent Subjects With Growth Hormone Deficiency Who Are Completing Treatment With Nutropin AQ, Nutropin, or Protropin in the National Cooperative Growth Study (NCGS)|Completed||Phase 4|125|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:56:44.104771|2017-10-11 04:56:44.104771
NCT00097539|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2016-12-21|2016-10-13||October 1985||1985-10-01|December 2016|2016-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational||Safety evaluable population included all participants enrolled in the study.|National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin|Genentech National Cooperative Growth Study (NCGS) Post-Marketing Surveillance Program For Nutropin AQ® (Somatropin [rDNA Origin] Injection), Nutropin® (Somatropin [rDNA Origin] for Injection), and Protropin® (Somatrem for Injection)|Completed||Phase 4|65205|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:56:44.732379|2017-10-11 04:56:44.732379
NCT00097552|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2012-11-13|||May 1997||1997-05-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone|Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS)|Completed||Phase 4|1696|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:57:09.299855|2017-10-11 04:57:09.299855
NCT00097565|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2017-03-21|||March 2004|Actual|2004-03-01|March 2017|2017-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma|The National Lymphocare Study: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma|Completed||N/A|2740|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:57:09.365898|2017-10-11 04:57:09.365898
NCT00097578|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2013-03-26|||March 2004||2004-03-01|March 2013|2013-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma|An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Adenocarcinoma|Completed||Phase 4|1953|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:57:09.42669|2017-10-11 04:57:09.42669
NCT00097591|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2010-08-25|2010-04-19||November 2004||2004-11-01|August 2010|2010-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention|A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention|Completed||Phase 3|13619|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 04:57:09.558968|2017-10-11 04:57:09.558968
NCT00097604|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2010-07-28|||September 2004||2004-09-01|December 2009|2009-12-01|April 2008|Actual|2008-04-01|April 2006|Actual|2006-04-01||Interventional|||Effects of Valerian on Sleep in Healthy Older Adults|Valerian for Sleep Disturbance in Healthy Older Adults|Completed||Phase 2|18|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 04:57:14.380024|2017-10-11 04:57:14.380024
NCT00097617|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2012-11-13|||March 2002||2002-03-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)|National Cooperative Growth Study (NCGS) of Nutropin AQ, Nutropin, and Protropin in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)|Completed||Phase 4|395|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 04:57:14.471966|2017-10-11 04:57:14.471966
NCT00097630|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2009-12-09|||October 2003||2003-10-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||ABC Trial: Awakening and Breathing Controlled|Cognitive Impairment in the ICU: Evaluation and Outcomes|Completed||N/A|334||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:57:14.537439|2017-10-11 04:57:14.537439
NCT00097643|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2008-08-12|||September 2000||2000-09-01|August 2008|2008-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Problem Solving/Physical Interventions and Aging|Problem Solving/Physical Interventions and Aging|Completed||Phase 3|273||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:57:14.632711|2017-10-11 04:57:14.632711
NCT00097656|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2011-01-03|||February 2004||2004-02-01|January 2011|2011-01-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk|MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk|Completed||Phase 3|1800|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-10-11 04:57:14.707956|2017-10-11 04:57:14.707956
NCT00097682|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-24|2017-06-30|||November 18, 2004||2004-11-18|October 2, 2007|2007-10-02|October 2, 2007||2007-10-02|||||Observational|||Views of Cancer Patients Regarding Financial Conflicts of Interest|Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:57:15.144275|2017-10-11 04:57:15.144275
NCT00097695|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-26|2014-05-22|2011-01-24||August 2004||2004-08-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema|Randomized, Double Blind, Placebo-Controlled, Multicenter Study of a Subcutaneous Formulation of Icatibant for the Treatment of Hereditary Angioedema|Completed||Phase 3|84|Actual|Shire||4|||f||||f||||||||||2017-10-11 04:57:15.23421|2017-10-11 04:57:15.23421
NCT00097708|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-29|2014-10-01|2011-09-14||November 2004||2004-11-01|October 2014|2014-10-01|December 2005||2005-12-01|||||Interventional|||Experimental Medication For the Treatment of Generalized Anxiety Disorder|A Double-Blind, Placebo Controlled Trial of an Experimental Medication For the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|511|Actual|Jazz Pharmaceuticals|||||||||||||||||||2017-10-11 04:57:17.280221|2017-10-11 04:57:17.280221
NCT00097721|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-29|2013-04-03|2012-01-09||September 2004||2004-09-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study of E7389 in Advanced/Metastatic Breast Cancer Patients|A Phase II Open Label Study of E7389 (Halichondrin B Analog) in Patients With Advanced/Metastatic Breast Cancer Previously Treated With Chemotherapy Including An Anthracycline and A Taxane|Completed||Phase 2|104|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 04:57:17.893118|2017-10-11 04:57:17.893118
NCT00097734|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-29|2006-02-12|||July 2004||2004-07-01|February 2006|2006-02-01|June 2007||2007-06-01|||||Interventional|||Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis|A Prospective, Multicenter, Open-Label, Randomized Clinical Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis|Unknown status|Recruiting|Phase 4|540||Klinikum Hanover-Siloah Hospital|||||f||||||||||||||2017-10-11 04:57:19.718066|2017-10-11 04:57:19.718066
NCT00097747|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2012-12-19|||August 2004||2004-08-01|December 2012|2012-12-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers|A Phase 1, Double-blind, Placebo-controlled, Dose Escalation Study of the Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers|Completed||Phase 1|28|Actual|Affymax||4|||f||||f||||||||||2017-10-11 04:57:19.862828|2017-10-11 04:57:19.862828
NCT00097760|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2009-06-17|||June 2003||2003-06-01|June 2009|2009-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis|Safety Study of Natalizumab in Combination With Glatiramer Acetate (GA)|Completed||Phase 2|110|Actual|Biogen||2|||f||||t||||||||||2017-10-11 04:57:19.986325|2017-10-11 04:57:19.986325
NCT00097773|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2014-01-28|2013-06-11||September 2004||2004-09-01|January 2014|2014-01-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|EPIC|Intent to Treat|Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis|Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa Airway Infection in Young Patients With Cystic Fibrosis|Completed||Phase 2|304|Actual|Seattle Children's Hospital||4|||f||||t||||||||||2017-10-11 04:57:20.124602|2017-10-11 04:57:20.124602
NCT00097786|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2011-06-27|2011-01-14||January 2002||2002-01-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|Navigator||Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications|A Multinational, Randomized, Double-blind, Placebo-controlled, Forced-titration, 2 x 2 Factorial Design Study of the Efficacy and Safety of Long-term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects With Impaired Glucose Tolerance (IGT)|Completed||Phase 3|9306|Actual|Novartis||4|||f||||t||||||||||2017-10-11 04:57:23.689287|2017-10-11 04:57:23.689287
NCT00097799|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2016-11-29|||December 2004||2004-12-01|October 2013|2013-10-01||||August 2005|Actual|2005-08-01||Expanded Access|||Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection|An Open Label, Non-randomized Treatment Protocol of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Protease Inhibitor-experienced Patients With HIV-1 Infection (the Tipranavir Expanded Access Program)|Approved for marketing||N/A|||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 04:57:38.555838|2017-10-11 04:57:38.555838
NCT00097812|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2012-04-26|||May 2004||2004-05-01|April 2012|2012-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid|A Study to Assess the Safety, Tolerability, and Efficacy of Switching Patients Currently on Oral Bisphosphonate to Zoledronic Acid|Completed||Phase 3|220||Novartis|||||||||||||||||||2017-10-11 04:57:38.879651|2017-10-11 04:57:38.879651
NCT00097825|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2012-04-26|||April 2004||2004-04-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men|Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men|Completed||Phase 3|288||Novartis|||||||||||||||||||2017-10-11 04:57:38.983333|2017-10-11 04:57:38.983333
NCT00097838|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2012-06-27|||October 2004||2004-10-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults|A Phase I, Dose Escalation, Safety, and Immunogenicity Trial of an Alphavirus Replicon HIV-1 Subtype C Gag Vaccine (AVX101) in Healthy HIV-1 Uninfected Adult Participants|Completed||Phase 1|96|Actual|AlphaVax, Inc.||5|||f||||||||||||||2017-10-11 04:57:39.123865|2017-10-11 04:57:39.123865
NCT00097851|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2016-03-30|||February 2004||2004-02-01|March 2016|2016-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)|Phase II Trial of Docetaxel With PI-88 in Patients With Advanced Non-Small-Cell Lung Cancer|Completed||Phase 2|100||Medigen Biotechnology Corporation|||||||||||||||||||2017-10-11 04:57:39.263497|2017-10-11 04:57:39.263497
NCT00097877|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2017-01-10|||January 2005||2005-01-01|January 2017|2017-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes|Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes|Completed||Phase 3|293|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 04:57:39.388468|2017-10-11 04:57:39.388468
NCT00097890|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-30|2008-03-03|||November 2004||2004-11-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Replagal Enzyme Replacement Therapy for Adults With Fabry Disease|An Open Label Six-Month Maintenance Clinical Trial of Replagal Enzyme Replacement Therapy in Patients With Fabry Disease Who Have Completed TKT027|Completed||Phase 4|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:57:39.657354|2017-10-11 04:57:39.657354
NCT00097903|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2017-09-20|||May 2004||2004-05-01|September 2017|2017-09-01|May 2013|Actual|2013-05-01|October 2011|Actual|2011-10-01||Interventional|||Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer|"Phase 1 Trial of Oral Karenitecin® in Patients With Solid Tumors"|Completed||Phase 1|32|Actual|BioNumerik Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 04:57:39.817935|2017-10-11 04:57:39.817935
NCT00097916|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2012-03-01|||September 2004||2004-09-01|March 2012|2012-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Non-Institutionalized Agitated Patients With Moderate to Severe Alzheimer's Disease|Completed||Phase 3|34|Actual|Forest Laboratories|||||||||||||||||||2017-10-11 04:57:39.910922|2017-10-11 04:57:39.910922
NCT00097929|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2017-04-05|||May 1, 2005|Actual|2005-05-01|April 2017|2017-04-01|July 31, 2006|Actual|2006-07-31|July 31, 2006|Actual|2006-07-31||Interventional|||An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)|A Phase II Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)|Completed||Phase 2|18|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:57:39.998679|2017-10-11 04:57:39.998679
NCT00097942|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2012-03-01|||August 2004||2004-08-01|March 2012|2012-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients|A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients With Persistent Residual Symptoms|Completed||Phase 2|138|Actual|Forest Laboratories|||||||||||||||||||2017-10-11 04:57:40.094949|2017-10-11 04:57:40.094949
NCT00097955|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2017-05-15|||October 2004||2004-10-01|May 2017|2017-05-01|April 2007||2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria|Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria|Completed||Phase 2|496||Novartis|||||f||||||||||||||2017-10-11 04:57:40.194803|2017-10-11 04:57:40.194803
NCT00097968|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2010-07-09|||August 2004||2004-08-01|July 2010|2010-07-01||||April 2005|Actual|2005-04-01||Interventional|||Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy|An Open-Label, Single Arm, Pilot Study of the Renal Safety of Everolimus in Addition to Neoral® in Cardiac Transplant Recipients With Established Allograft Vasculopathy|Completed||Phase 3|||Novartis|||||||||||||||||||2017-10-11 04:57:40.289393|2017-10-11 04:57:40.289393
NCT00097981|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2017-02-20|2008-10-02||January 2005||2005-01-01|February 2017|2017-02-01|October 2009|Actual|2009-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma|A Randomized, Open-Label, Multi-Center Trial Comparing Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Subjects With Newly Diagnosed Multiple Myeloma|Completed||Phase 3|225|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-10-11 04:57:40.396387|2017-10-11 04:57:40.396387
NCT00097994|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2014-05-19|||December 2004||2004-12-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Does Menopause Matter?|Does Menopause Matter?|Completed||N/A|732|Actual|University of Pittsburgh|||1||f||||||||||||||2017-10-11 04:57:43.233542|2017-10-11 04:57:43.233542
NCT00098007|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-01|2017-02-20|||August 9, 2004||2004-08-09|February 2017|2017-02-01|January 8, 2007|Actual|2007-01-08|January 8, 2007|Actual|2007-01-08||Interventional|||A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients|Six-month, Multicenter, Randomized, Open-label Study of the Safety, Tolerability and Efficacy of Two Neoral Doses in Addition to Certican and Steroids in de Novo Heart Transplant Recipients|Completed||Phase 3|199|Actual|Novartis|||||||||||||||||||2017-10-11 04:57:43.325291|2017-10-11 04:57:43.325291
NCT00098033|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-02|2015-03-24|||September 2002||2002-09-01|December 2004|2004-12-01|September 2005||2005-09-01|||||Interventional|||Investigation of Clofarabine in Acute Leukemias|Phase II Clinical and Pharmacodynamic Investigation of Clofarabine in Acute Leukemias|Completed||Phase 2|64||FDA Office of Orphan Products Development|||||||||||||||||||2017-10-11 04:57:43.542864|2017-10-11 04:57:43.542864
NCT00098046|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-02|2007-09-25|||July 2005||2005-07-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection|Pharmacokinetics and Safety of Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection|Completed||Phase 3|76|Anticipated|Novartis|||||||||||||||||||2017-10-11 04:57:43.614565|2017-10-11 04:57:43.614565
NCT00098059|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-02|2013-04-18|2009-02-02||February 2005||2005-02-01|April 2013|2013-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection|A Multicenter, Open-label, Single-arm, Two-step Study to Evaluate the Safety and Single-dose Pharmacokinetics of Famciclovir and Multiple-dose Safety After Administration of Famciclovir Oral Pediatric Formulation to Children 1 to 12 Years of Age With Herpes Simplex Infection|Completed||Phase 3|74|Actual|Novartis||1|||f||||||||||||||2017-10-11 04:57:43.723869|2017-10-11 04:57:43.723869
NCT00098085|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2009-03-06|||September 2003||2003-09-01|March 2009|2009-03-01||||November 2007|Actual|2007-11-01||Interventional|||Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer|A Phase II Study of the Feasibility to Derive Autologous Vaccine (HSPPC-96) From Tumor Tissue for Clinical Administration in Patients With Resectable Non-Small Cell Lung Cancer|Completed||Phase 2|20||Agenus Inc.|||||||||||||||||||2017-10-11 04:57:45.605747|2017-10-11 04:57:45.605747
NCT00098098|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2012-08-22|||August 2004||2004-08-01|August 2012|2012-08-01|August 2005|Actual|2005-08-01|||||Interventional|||Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults|A Phase 1, Open-Label, Dose-Escalating Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults|Completed||Phase 1|44|Anticipated|DynPort Vaccine Company LLC, A CSC Company|||||||||||||||||||2017-10-11 04:57:45.6804|2017-10-11 04:57:45.6804
NCT00098111|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2014-02-19|||April 2005||2005-04-01|February 2014|2014-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease|A Double-Blinded, Randomized, Parallel Arm, Dose Ranging Study of IMURAN in Subjects With Active Crohn's Disease Requiring Treatment With Prednisone: A Crohn's Disease Optimal Range Dose of IMURAN Study (ACORDIS)|Terminated||Phase 3|31|Actual|Massachusetts General Hospital||3||Lack of recruitment|f||||||||||||||2017-10-11 04:57:45.749196|2017-10-11 04:57:45.749196
NCT00098124|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2007-12-18|||November 2004||2004-11-01|December 2007|2007-12-01|December 2006||2006-12-01|||||Interventional|||Study of Milnacipran for the Treatment of Fibromyalgia|A Phase III Pivotal, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Milnacipran for the Treatment of Fibromyalgia|Completed||Phase 3|1200||Forest Laboratories|||||||||||||||||||2017-10-11 04:57:45.851242|2017-10-11 04:57:45.851242
NCT00098150|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2006-08-29|||July 2004||2004-07-01|August 2006|2006-08-01||||||||Observational|||Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis|A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Atopic Dermatitis|Completed||Phase 2|66||Novartis|||||||||||||||||||2017-10-11 04:57:46.262127|2017-10-11 04:57:46.262127
NCT00098163|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2012-05-03||||||May 2012|2012-05-01|May 2009|Actual|2009-05-01|||||Interventional|||Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers|A Phase I Study to Evaluate the Safety and Immunogenicity of ALVAC-HIV vCP1521 in Infants Born to HIV-1 Infected Women in Uganda|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 04:57:46.312104|2017-10-11 04:57:46.312104
NCT00098189|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2006-08-29|||July 2004||2004-07-01|August 2006|2006-08-01||||||||Observational|||Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis|A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis|Completed||Phase 2|||Novartis|||||||||||||||||||2017-10-11 04:57:46.405729|2017-10-11 04:57:46.405729
NCT00098202|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2013-12-16|||March 2003||2003-03-01|December 2013|2013-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala|Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala|Completed||Phase 3|420|Anticipated|NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-10-11 04:57:46.453849|2017-10-11 04:57:46.453849
NCT00098215|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2005-11-09|||March 2001||2001-03-01|December 2004|2004-12-01|February 2006||2006-02-01|||||Interventional|||Pediatric Residency Training On Tobacco|Pediatric Residency Training on Tobacco|Unknown status|Recruiting|Phase 2|4000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 04:57:46.585941|2017-10-11 04:57:46.585941
NCT00098228|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2011-10-24|||July 2004||2004-07-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Dose-Ranging Study in Patients With COPD|Completed||Phase 2|686|Actual|Novartis|||||||||||||||||||2017-10-11 04:57:46.735918|2017-10-11 04:57:46.735918
NCT00098241|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2017-02-21|||June 2000||2000-06-01|February 2017|2017-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients|Multicenter Trial of the Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients|Completed||Phase 3|45|Anticipated|Novartis|||||f||||||||||||||2017-10-11 04:57:46.962525|2017-10-11 04:57:46.962525
NCT00098254|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2012-04-03|2011-10-06||December 2004||2004-12-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|November 2009|Actual|2009-11-01||Interventional|||BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer|Phase II Study of Bay 43-9006 (Sorafenib) With Evaluation of RAS Signal Pathway in Patients With Relapsed Non-Small Cell Lung Cancer|Completed||Phase 2|37|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 04:57:47.059658|2017-10-11 04:57:47.059658
NCT00098267|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-12|2017-06-30|||December 2, 2004||2004-12-02|August 3, 2009|2009-08-03|August 3, 2009|Actual|2009-08-03|August 3, 2009|Actual|2009-08-03||Observational|||Collection of Dental Plaque and Saliva for Studies of Bacterial Colonization of Teeth|Collection of Dental Plaque and Saliva for Studies of Oral Microbial Colonization|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:57:47.878495|2017-10-11 04:57:47.878495
NCT00098280|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-03|2008-03-03|||December 2004||2004-12-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria|A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients|Completed||Phase 3|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:57:47.945191|2017-10-11 04:57:47.945191
NCT00098488|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-06-03|||April 2005||2005-04-01|June 2013|2013-06-01||||April 2008|Actual|2008-04-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia|A Phase 1 Study of 17-allylamino-17-demethoxygeldanamycin (17-AAG) (NSC 330507; IND 57,966) and Rituximab in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:02.702914|2017-10-11 04:58:02.702914
NCT00098293|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-06|2013-08-07|2012-07-09||November 2004||2004-11-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|April 2007|Actual|2007-04-01||Interventional|MERIT||Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine|A Multicenter, Randomized, Double-Blind, Comparative Trial Of A Novel CCR5 Antagonist, UK-427,857, In Combination With Zidovudine/Lamivudine Versus Efavirenz In Combination With Zidovudine/Lamivudine For The Treatment Of Antiretroviral-Naive HIV-1 Infected Subjects|Completed||Phase 3|916|Actual|ViiV Healthcare|Following DSMB decision to discontinue maraviroc 300 mg once daily, inferential statistical analyses was performed between maraviroc 300 mg twice daily and efavirenz 600 mg once daily only. Data at Week 24 was not analyzed as planned in protocol.|3|||f||||t||||||||||2017-10-11 04:57:48.15374|2017-10-11 04:57:48.15374
NCT00098306|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-06|2012-04-02|2012-04-02||November 2004||2004-11-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2007|Actual|2007-04-01||Interventional|MOTIVATE 1||Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced HIV-1 Infected Subjects.|Completed||Phase 2/Phase 3|601|Actual|ViiV Healthcare||3|||f||||t||||||||||2017-10-11 04:57:52.245074|2017-10-11 04:57:52.245074
NCT00098319|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-06|2013-12-16|||January 2004||2004-01-01|December 2013|2013-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Oral Cleft Prevention Trial in Brazil|Oral Cleft Prevention Trial in Brazil|Completed||Phase 3|2200|Anticipated|NICHD Global Network for Women's and Children's Health|||||f||||||||||||||2017-10-11 04:57:57.362315|2017-10-11 04:57:57.362315
NCT00098332|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-07-09|||November 2004||2004-11-01|June 2007|2007-06-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma|A Phase I, Multi-Center, Open-Label, Safety and Pharmacokinetic, Repeat-Dose Study of Oral Forodesine Hydrochloride in Patients With Refractory Cutaneous T-Cell Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:57:57.457307|2017-10-11 04:57:57.457307
NCT00098345|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2017-06-19|2011-04-27||November 2004||2004-11-01|June 2017|2017-06-01|April 19, 2017|Actual|2017-04-19|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer|An Open Label, Two Stage, Phase II Study to Evaluate the Efficacy and Tolerability of ZD6474 in Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Carcinoma.|Completed||Phase 2|40|Actual|Sanofi||1|||f||||||||||||||2017-10-11 04:57:57.554756|2017-10-11 04:57:57.554756
NCT00098358|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2007-02-05|||November 2004||2004-11-01|February 2007|2007-02-01|May 2005||2005-05-01|||||Interventional|||Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Proof of Concept Study of Zileuton IR in Patients With Moderate to Severe Facial Acne Vulgaris|Unknown status|Active, not recruiting|Phase 2|90||Critical Therapeutics|||||||||||||||||||2017-10-11 04:57:58.133932|2017-10-11 04:57:58.133932
NCT00098371|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2016-08-31|2015-07-14||April 2005||2005-04-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|June 2009|Actual|2009-06-01||Interventional|||Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia|A Phase II Study of Flavopiridol Administered as a 30 Minute Loading Dose Followed by a 4-Hour Continuous Infusion in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From CLL|Terminated||Phase 2|64|Actual|National Cancer Institute (NCI)||1||CTEP Initiated Action.|f||||||||||||||2017-10-11 04:57:58.264233|2017-10-11 04:57:58.264233
NCT00098384|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2006-05-08|||June 2003||2003-06-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea|A Randomized, Double-Blind, Single Center, Comparative Dose Ranging Study of Rifaximin Vs. Placebo in the Prevention of Travelers' Diarrhea Due to Enteropathogenic Bacteria|Completed||Phase 2|220||DuPont, Hurbert L., MD|||||||||||||||||||2017-10-11 04:57:58.725508|2017-10-11 04:57:58.725508
NCT00098397|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-01-23|||February 2005||2005-02-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||FR901228 in Treating Patients With Metastatic Breast Cancer|A Phase II Study Of Single Agent Depsipeptide (FK228) In Breast Cancer|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:57:58.81077|2017-10-11 04:57:58.81077
NCT00098423|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-09-27|||November 2004||2004-11-01|September 2013|2013-09-01||||May 2009|Actual|2009-05-01||Interventional|||Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes|A Phase I And Pharmacological Trial Of 17-Allylamino -17-demethoxygeldanamycin (17-AAG) And Cytarabine In Refractory Leukemia And Myelodysplastic Syndrome|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:57:58.901274|2017-10-11 04:57:58.901274
NCT00098436|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-07-17|||September 2004||2004-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|October 2006|Actual|2006-10-01||Interventional|||Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias|A Phase I Study Of Cloretazine™ (VNP40101M) And Temozolomide In Patients With Hematologic Malignancies|Completed||Phase 1|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:57:59.011408|2017-10-11 04:57:59.011408
NCT00098462|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2012-10-02|||October 2004||2004-10-01|October 2012|2012-10-01||||||||Interventional|||Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase I/II Trial of ZD1839 (Iressa®) and Rapamycin (Rapamune) in Patients With Advanced Non Small Cell Lung Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||1||Withdrawn as study never opened|f||||||||||||||2017-10-11 04:57:59.096061|2017-10-11 04:57:59.096061
NCT00098475|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2017-10-03|2013-08-30||October 26, 2004|Actual|2004-10-26|June 2017|2017-06-01||||November 30, 2008|Actual|2008-11-30||Interventional|||Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma|A Randomized Phase III Study of CC-5013 Plus Dexamethasone Versus CC-5013 Plus Low Dose Dexamethasone in Multiple Myeloma With Thalidomide Plus Dexamethasone Salvage Therapy for Non-responders|Active, not recruiting||Phase 3|452|Actual|National Cancer Institute (NCI)||4|||f||||f||||||||||2017-10-11 04:57:59.230318|2017-10-11 04:57:59.230318
NCT00093860|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2008-03-03|||October 2004||2004-10-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance|Propranolol for Syncope With Sympathoadrenal Imbalance in Children|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:59:40.382213|2017-10-11 04:59:40.382213
NCT00098501|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-06-03|||October 2004||2004-10-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors|A Phase 1 Trial of CCI-779 in Combination With EKB-569, an EGFR Inhibitor, in Patients With Solid Tumors|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:02.81539|2017-10-11 04:58:02.81539
NCT00098514|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2008-07-23|||October 2004||2004-10-01|January 2007|2007-01-01||||||||Interventional|||Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors|A Phase I Study Of PT523 In Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:58:02.929967|2017-10-11 04:58:02.929967
NCT00098527|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-07-01|||October 2004||2004-10-01|July 2013|2013-07-01||||September 2005|Actual|2005-09-01||Interventional|||FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer|A Phase 2 Study of Single Agent Depsipeptide (FK228) in Gastric and Esophageal Cancers|Terminated||Phase 2|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:03.012221|2017-10-11 04:58:03.012221
NCT00098540|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2016-12-28|||December 2004||2004-12-01|December 2016|2016-12-01||||May 2007|Actual|2007-05-01||Interventional|||Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Study of the Raf Kinase Inhibitor BAY43-9006 in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:03.107658|2017-10-11 04:58:03.107658
NCT00098553|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2016-07-01|||April 2005||2005-04-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|July 2007|Actual|2007-07-01||Interventional|||Everolimus in Treating Patients With Stage IV Melanoma|Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma|Completed||Phase 2|53|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:58:03.209217|2017-10-11 04:58:03.209217
NCT00098566|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2015-10-13|||December 2002||2002-12-01|October 2015|2015-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Long-Term Follow-Up Study Evaluating the Efficacy and Delayed Toxicities of Radioiodinated Tositumomab (Anti-CD20 Antibody) Followed by Autologous Transplantation for Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|36|Actual|Fred Hutchinson Cancer Research Center|||1||f||||||||||||||2017-10-11 04:58:03.635199|2017-10-11 04:58:03.635199
NCT00098579|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-03-18|||October 2004||2004-10-01|March 2013|2013-03-01||||July 2011|Actual|2011-07-01||Interventional|||Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery|Phase I Trial of Doxorubicin and Alvocidib (Flavopiridol; NCI Supplied Agent, NSC 649890) in the Treatment of Metastatic Sarcoma|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:03.711273|2017-10-11 04:58:03.711273
NCT00098605|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-06-04|||October 2004||2004-10-01|June 2013|2013-06-01||||September 2006|Actual|2006-09-01||Interventional|||Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases|A Phase 2 Study of GW572016 for Brain Metastases in Patients With HER2-Positive Breast Cancer|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:03.799875|2017-10-11 04:58:03.799875
NCT00098618|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2013-07-01|||October 2004||2004-10-01|July 2013|2013-07-01||||January 2006|Actual|2006-01-01||Interventional|||Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer|A Phase 2 Study Of BAY 43-9006 In Combination With Interferon Alfa-2b In Metastatic Renal Cell Cancer|Terminated||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:03.899538|2017-10-11 04:58:03.899538
NCT00098631|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2014-01-06|||October 2004||2004-10-01|January 2014|2014-01-01||||December 2006|Actual|2006-12-01||Interventional|||Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer|A Phase II Study Of GW572016 In Squamous Cell Carcinoma Of The Head And Neck (SCCHN)|Completed||Phase 2|88|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:04.002707|2017-10-11 04:58:04.002707
NCT00098670|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2014-05-06|2012-11-05||October 2004||2004-10-01|December 2012|2012-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia|A Phase II Study of Fludarabine + Rituximab Induction Followed by Alemtuzumab (Campath-1H, NSC #715969, IND #10864) Administered Subcutaneously as Consolidation in Untreated Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|102|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:04.173029|2017-10-11 04:58:04.173029
NCT00098683|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2014-02-11|||January 2005||2005-01-01|February 2014|2014-02-01|October 2009|Actual|2009-10-01|October 2007|Actual|2007-10-01||Interventional|||Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes|A Phase II Study Of Amifostine In Children With Myelodysplastic Syndrome|Completed||Phase 2|10|Actual|Children's Oncology Group|||||f||||t||||||||||2017-10-11 04:58:05.820252|2017-10-11 04:58:05.820252
NCT00098709|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2015-10-19|||May 2002||2002-05-01|October 2015|2015-10-01|February 2005||2005-02-01|||||Interventional|||Fetal Pulse Oximetry Trial (FOX)|A Randomized Clinical Trial of Fetal Pulse Oximetry|Terminated||Phase 3|10000||The George Washington University Biostatistics Center|||||||||||||||||||2017-10-11 04:58:06.304382|2017-10-11 04:58:06.304382
NCT00098722|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2012-04-16|2012-04-16||December 2004||2004-12-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2007|Actual|2007-04-01||Interventional|MOTIVATE 2||Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced HIV-1 Infected Subjects|Completed||Phase 2/Phase 3|474|Actual|ViiV Healthcare||3|||f||||t||||||||||2017-10-11 04:58:06.540751|2017-10-11 04:58:06.540751
NCT00098735|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2016-11-16|||April 2004||2004-04-01|November 2016|2016-11-01||||April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation|Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation|Completed||Phase 3|140||Novartis|||||||||||||||||||2017-10-11 04:58:10.904197|2017-10-11 04:58:10.904197
NCT00098943|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2012-09-20|||September 2004||2004-09-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||NGR-TNF in Treating Patients With Advanced Solid Tumors|Phase I Trial of NGR-TNF Administered Every 3 Weeks as a 1 Hour Intravenous Infusion in Patients With Solid Tumor|Completed||Phase 1|70|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:58:20.37466|2017-10-11 04:58:20.37466
NCT00098748|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-07|2010-11-19|2010-03-25||November 2004||2004-11-01|November 2010|2010-11-01|April 2009|Actual|2009-04-01|December 2005|Actual|2005-12-01||Interventional|||Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects|A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced, Non CCR5-Tropic HIV-1 Infected Subjects|Completed||Phase 2/Phase 3|190|Actual|ViiV Healthcare||3|||f||||t||||||||||2017-10-11 04:58:11.036253|2017-10-11 04:58:11.036253
NCT00098761|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2011-06-29|||February 2005||2005-02-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|October 2006|Actual|2006-10-01||Interventional|||VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors|Phase I Study Of Cloretazine (VNP40101M) In Children With Recurrent, Progressive Or Refractory Primary Brain Tumors|Completed||Phase 1|42|Actual|Pediatric Brain Tumor Consortium||1|||f||||t||||||||||2017-10-11 04:58:13.02598|2017-10-11 04:58:13.02598
NCT00098774|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2016-07-01|2014-06-26||October 2004||2004-10-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|January 2010|Actual|2010-01-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma|Intensive Chemotherapy And Immunotherapy In Patients With Newly Diagnosed Primary CNS Lymphoma|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:58:13.177505|2017-10-11 04:58:13.177505
NCT00098787|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2015-10-06|2014-05-27||July 2005||2005-07-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|November 2013|Actual|2013-11-01||Interventional||Eligible and treated patients|Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer|Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|247|Actual|Eastern Cooperative Oncology Group||3|||f||||t||||||||||2017-10-11 04:58:14.090823|2017-10-11 04:58:14.090823
NCT00098800|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2010-03-23|||October 2004||2004-10-01|November 2006|2006-11-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional|||Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries|A Multicenter Randomized Double-Blinded Trial for Chemoprevention of Ovarian Cancer: Modulation of Biomarkers and Spectral Properties Using Contrast Enhanced Ultrasound in High-Risk Women Using Fenretinide (4-HPR)|Completed||N/A|40|Anticipated|University of Arizona|||||||||||||||||||2017-10-11 04:58:15.417532|2017-10-11 04:58:15.417532
NCT00098813|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2014-05-13|2013-10-29||October 2004||2004-10-01|October 2013|2013-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine|A Phase II Study of Single Agent Depsipeptide (FK228) in Radioiodine (RAI)-Refractory Metastatic Non-medullary (Papillary, Follicular, and Hurthle Cell Variants) Thyroid Carcinoma|Completed||Phase 2|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:15.496309|2017-10-11 04:58:15.496309
NCT00098826|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2013-01-10|||December 2004||2004-12-01|January 2013|2013-01-01||||May 2008|Actual|2008-05-01||Interventional|||SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes|Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemias|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:17.828053|2017-10-11 04:58:17.828053
NCT00098839|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2017-02-07|2015-03-03||February 2005||2005-02-01|February 2017|2017-02-01|April 2011||2011-04-01|April 2011|Actual|2011-04-01||Interventional||Ineligible patients (2) are not included in baseline population.|Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)|A Feasibility Pilot and Phase II Study Of Chemoimmunotherapy With Epratuzumab (IND #12034) for Children With Relapsed CD22-Positive Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1/Phase 2|134|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-10-11 04:58:17.954027|2017-10-11 04:58:17.954027
NCT00098852|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2014-01-03|||October 2004||2004-10-01|January 2009|2009-01-01||||June 2010|Anticipated|2010-06-01||Interventional|||Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer|A Pilot Study of Rosiglitazone in Patients With Incurable Differentiated Thyroid Cancer|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:19.347846|2017-10-11 04:58:19.347846
NCT00098865|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2014-09-28|2012-12-15||September 2002||2002-09-01|September 2014|2014-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||The analysis population represents all enrolled and treated patients.|Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma|A Phase II Pilot Study Of Thalidomide With Temozolomide In Patients With Relapsed Or Progressive Brain Tumors Or Neuroblastoma|Completed||Phase 2|15|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 04:58:19.447865|2017-10-11 04:58:19.447865
NCT00098878|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2013-08-06|||March 2004||2004-03-01|July 2009|2009-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|SCOTROC 4: A Prospective, Multicentre, Randomised Trial Of Carboplatin Flat Dosing Vs Intrapatient Dose Escalation In First Line Chemotherapy Of Ovarian, Fallopian Tube And Primary Peritoneal Cancers|Completed||Phase 3|1300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:58:19.803604|2017-10-11 04:58:19.803604
NCT00098891|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2013-01-23|||October 2004||2004-10-01|January 2013|2013-01-01||||March 2008|Actual|2008-03-01||Interventional|||MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas|A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275 (NSC 706995, IND 61,198), in Combination With 13-Cis-Retinoic Acid in Metastatic Progressive Cancer.|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:20.104087|2017-10-11 04:58:20.104087
NCT00098917|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2008-01-24|||February 2005||2005-02-01|April 2007|2007-04-01||||||||Interventional|||Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer|A Phase I Clinical Trial of Mature Autologous Dendritic Cells Loaded With Irradiated Autologous Tumor Cells for the Treatment of Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|15||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:58:20.292815|2017-10-11 04:58:20.292815
NCT00271661|ClinicalTrials.gov processed this data on October 10, 2017|2005-12-30|2011-12-08|||August 2005||2005-08-01|December 2011|2011-12-01|May 2006||2006-05-01|||||Observational|||Presbyopia in Breast Cancer Survivors|Presbyopia in Breast Cancer Survivors|Withdrawn||N/A|0|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 05:55:13.863316|2017-10-11 05:55:13.863316
NCT00098956|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2015-08-10|2015-08-10||January 2005||2005-01-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer|A Phase II Study of UCN-01 in Combination With Topotecan in Patients With SCLC Who Relapsed or Progressed &gt;= 3 Months After Completing First-Line Platinum-Based Chemotherapy|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:20.498002|2017-10-11 04:58:20.498002
NCT00098969|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2012-12-13|||September 2004||2004-09-01|March 2010|2010-03-01||||||||Interventional|IRB 2004-535||UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants|Phase I Single-Dose Safety and Phamacokinetics Clinical Study of Resveratrol AKA IRB 2003-424|Completed||Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:58:20.718888|2017-10-11 04:58:20.718888
NCT00098982|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2013-06-11|||September 2004||2004-09-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer|Phase I Study of PS-341 (VELCADE) in Combination With 5FU/LV Plus Oxaliplatin in Patients With Advanced Colorectal Cancer|Completed||Phase 1|16|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:58:20.793398|2017-10-11 04:58:20.793398
NCT00098995|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2013-06-25|||December 2004||2004-12-01|November 2006|2006-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer|A Phase I Study Of Tirapazamine In Combination With Radiation And Weekly Cisplatin In Patients With Locally Advanced Cervical Cancer|Completed||Phase 1|22|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:58:20.91667|2017-10-11 04:58:20.91667
NCT00099008|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2013-05-17|||March 2004||2004-03-01|May 2013|2013-05-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women|Phase I Multiple Dose Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women|Completed||Phase 1|30|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 04:58:21.024109|2017-10-11 04:58:21.024109
NCT00099021|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2016-12-28|2009-10-13||June 2003||2003-06-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|September 2008|Actual|2008-09-01||Interventional|||Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia|A Phase IIa Cancer Prevention Trial of the PPAR Gamma Agonist Pioglitazone in Oral Leukoplakia|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)|"Study was closed prior to full accrual because results were very good and funding was discontinued (R-01 application was filed.)
Immunohistochemistry (Outcomes #4 through #12) were not done due to laboratory limitations of time."|1|||f||||||||||||||2017-10-11 04:58:21.563953|2017-10-11 04:58:21.563953
NCT00099047|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2016-12-28|2014-12-16||November 2004||2004-11-01|December 2016|2016-12-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional||Asymptomatic adult patients with a serum monoclonal protein >1g/dL from each of the participating centers between August 2005 and April 2008 were randomized to either celecoxib or placebo in a double-blind, 1:1 fashion|Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma|Biologic and Clinical Role of COX-2 Inhibitor (Celecoxib)in the Management of MGUS and Smoldering Myeloma|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)|No overall limitations or caveats for this trial.|2|||f||||t||||||||||2017-10-11 04:58:22.006322|2017-10-11 04:58:22.006322
NCT00099060|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2014-01-24|||December 2004||2004-12-01|April 2012|2012-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme|A Phase I/II Study of GW572016 in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:58:22.610715|2017-10-11 04:58:22.610715
NCT00099086|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2017-03-21|||July 2010||2010-07-01|March 2017|2017-03-01|December 2017|Anticipated|2017-12-01|January 2011|Actual|2011-01-01||Interventional|||Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer|Phase I Trial of Concurrent Taxotere With Radiation Therapy and Hormonal Therapy For Clinically Localized High Risk Prostate Cancer|Active, not recruiting||Phase 1|20|Actual|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 04:58:22.751674|2017-10-11 04:58:22.751674
NCT00099099|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2009-12-09|||March 2002||2002-03-01|February 2006|2006-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||CALERIE (Tufts) - Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy|Dietary Energy Restriction and Metabolic Aging in Humans|Completed||Phase 1|44||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:58:22.84582|2017-10-11 04:58:22.84582
NCT00099112|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2015-04-29|||February 2004||2004-02-01|November 2005|2005-11-01||||||||Observational|||Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II|Transcriptional Profiling of the Epidermal Response to Solar-Simulated Ultraviolet Radiation|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:58:22.923108|2017-10-11 04:58:22.923108
NCT00099125|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2014-01-23|||November 2004||2004-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|October 2006|Actual|2006-10-01||Interventional|||Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase II Study Of Radiation Therapy Plus Low Dose Temozolomide Followed By Temozolomide Plus Irinotecan For Glioblastoma Multiforme|Completed||Phase 2|170|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:58:23.025733|2017-10-11 04:58:23.025733
NCT00099138|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2009-12-09|||March 2002||2002-03-01|February 2006|2006-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||CALERIE (Washington University): Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy|Caloric Restriction and Aging in Humans|Completed||Phase 1|48||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:58:23.519479|2017-10-11 04:58:23.519479
NCT00099151|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2009-12-09|||March 2002||2002-03-01|December 2004|2004-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy|Metabolic Adaptations to Six Month Caloric Restriction|Completed||N/A|48||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:58:23.593423|2017-10-11 04:58:23.593423
NCT00099528|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-15|2010-07-28|||August 2003||2003-08-01|March 2005|2005-03-01|December 2004||2004-12-01|||||Interventional|||Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia|REN-1654 in Post-Herpetic Neuralgia: a Multi-Center, Placebo Controlled, 3-week Dose-Finding Study, With a 3-Week Active-Treatment Extension|Unknown status|Active, not recruiting|Phase 2|90||Renovis|||||||||||||||||||2017-10-11 04:58:32.460332|2017-10-11 04:58:32.460332
NCT00099164|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-08|2016-09-26|||April 2004||2004-04-01|September 2016|2016-09-01|September 2007|Actual|2007-09-01|August 2006|Actual|2006-08-01||Interventional|||Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)|A Randomized Trial of 17 Alpha-Hydroxyprogesterone Caproate for Prevention of Preterm Birth in Multifetal Gestation (STTARS)|Completed||Phase 3|795|Actual|The George Washington University Biostatistics Center||1|||f||||t||||||||Yes|The data will be shared after completion and publication of the main analyses in accordance with NIH policy. The dataset can be obtained by emailing mfmudatasets@bsc.gwu.edu.|2017-10-11 04:58:23.683864|2017-10-11 04:58:23.683864
NCT00099177|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2017-08-14|||August 2005||2005-08-01|August 2017|2017-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain|A Randomized, Double-blind Study of the Effect of Bondronat Compared With Zoledronic Acid on Pain in Patients With Malignant Bone Disease Experiencing Moderate to Severe Pain|Terminated||Phase 3|96|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:58:23.847628|2017-10-11 04:58:23.847628
NCT00099190|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2009-04-27|||December 2004||2004-12-01|April 2009|2009-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||ARQ 501 in Combination With Docetaxel in Patients With Cancer|A Phase Ib Safety and Pharmacokinetic Study of ARQ 501 in Combination With Docetaxol in Adult Patients With Locally Advanced or Metastatic Carcinoma|Completed||Phase 1|50||ArQule|||||||||||||||||||2017-10-11 04:58:24.011828|2017-10-11 04:58:24.011828
NCT00099203|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2017-08-14|||July 2005||2005-07-01|August 2017|2017-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease|A Randomized, Placebo-controlled, Double-blind Study of the Effect of Bondronat Compared With Zoledronic Acid on Pain in Patients With Malignant Bone Disease Experiencing Moderate to Severe Pain|Terminated||Phase 3|163|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 04:58:24.093554|2017-10-11 04:58:24.093554
NCT00099216|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2011-11-16|||August 2001||2001-08-01|November 2011|2011-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia|Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia|Completed||Phase 3|708|Actual|Novartis|||||f||||||||||||||2017-10-11 04:58:24.360653|2017-10-11 04:58:24.360653
NCT00099229|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2017-02-21|||November 2004||2004-11-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Tolerability of Licarbazepine 1000-2000mg/Day in the Treatment of Manic Episodes of Bipolar I Disorder Over 3 Weeks|Completed||Phase 3|320|Actual|Novartis|||||f||||||||||||||2017-10-11 04:58:24.577996|2017-10-11 04:58:24.577996
NCT00099255|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2014-12-17|||September 2004||2004-09-01|December 2014|2014-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma|A Phase II Multi-Dose Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma, Large Cell Transformation of Mycosis Fungoides, and Lymphomatoid Papulosis|Completed||Phase 2|40||Seattle Genetics, Inc.|||||||||||||||||||2017-10-11 04:58:25.209009|2017-10-11 04:58:25.209009
NCT00099268|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2012-04-19|2010-12-15||September 2004||2004-09-01|April 2012|2012-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|STRIDE-PD||Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy|A Long Term, Double-blind, Randomized, Parallel-group, Carbidopa/Levodopa Controlled, Multi-center Study to Evaluate the Effect of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy|Completed||Phase 3|747|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:58:25.33121|2017-10-11 04:58:25.33121
NCT00099281|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2007-02-27|||May 2004||2004-05-01|February 2007|2007-02-01|June 2006||2006-06-01|||||Interventional|||DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer|A Phase III Study of DPPE Combined With Epirubicin and Cyclophosphamide vs Epirubicin and Cyclophosphamide Alone as First Line Treatment in Metastatic/Recurrent Breast Cancer|Terminated||Phase 3|700||YM BioSciences|||||||||||||||||||2017-10-11 04:58:26.950785|2017-10-11 04:58:26.950785
NCT00099294|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2009-04-28|||September 2004||2004-09-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer|A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine|Completed||Phase 3|300||Threshold Pharmaceuticals|||||||||||||||||||2017-10-11 04:58:27.084358|2017-10-11 04:58:27.084358
NCT00099307|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2017-06-30|||December 8, 2004||2004-12-08|September 28, 2011|2011-09-28|September 28, 2011||2011-09-28|||||Observational|||Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis|An Exploratory Study on Detection of Cortical Damage in Patients With Multiple Sclerosis Using Magnetic Resonance Imaging|Completed||N/A|94|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:27.507216|2017-10-11 04:58:27.507216
NCT00099320|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2015-02-20|||May 2004||2004-05-01|January 2015|2015-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin|Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin|Completed||Phase 3|182|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:58:27.588057|2017-10-11 04:58:27.588057
NCT00099333|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2015-02-20|||February 2004||2004-02-01|January 2015|2015-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents|An Exploratory Study of the Safety of Substituting Exenatide for Insulin in Patients With Type 2 Diabetes Who Have Been Using Insulin in Combination With Oral Antidiabetic Therapy|Completed||Phase 2|49|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:58:27.920977|2017-10-11 04:58:27.920977
NCT00099346|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2015-06-16|||January 2005||2005-01-01|June 2015|2015-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001)|A Phase I/IIa Study Evaluating the Safety/Tolerability, Pharmacokinetics, and Efficacy of MK0457 Administered as a 5-Day Continuous Infusion in Patients With Advanced Colorectal Cancer and Other Solid Tumors|Terminated||Phase 1|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:58:28.022089|2017-10-11 04:58:28.022089
NCT00099359|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2012-10-26|2012-04-25||February 2004||2004-02-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission|Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission|Completed||Phase 3|1735|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||t||||||||||2017-10-11 04:58:28.128982|2017-10-11 04:58:28.128982
NCT00099372|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-10|2013-09-27|||May 2004||2004-05-01|September 2013|2013-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse|Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse: The Extended Colpopexy and Urinary Reduction Efforts (E-CARE) Study|Terminated||N/A|215|Actual|NICHD Pelvic Floor Disorders Network|||2|resource and prioritization change as Network transition to a new funding cycle|f||||t||||||||||2017-10-11 04:58:29.905393|2017-10-11 04:58:29.905393
NCT00099385|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-13|2012-02-15|||September 2004||2004-09-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Comprehensive Elementary School Risk Prevention|Comprehensive Elementary School Risk Prevention|Completed||N/A|2620|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-10-11 04:58:30.027026|2017-10-11 04:58:30.027026
NCT00099411|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-13|2017-04-25|||January 2004|Actual|2004-01-01|April 2017|2017-04-01|June 30, 2007|Actual|2007-06-30|June 30, 2007|Actual|2007-06-30||Observational|||Heart Muscle Viability and Remodeling in Individuals Post-Heart Attack|Myocardial Viability and Remodeling in the Occluded Artery Trial (OAT)-Ancillary to OAT|Completed||N/A|124|Actual|Tufts Medical Center|||1||f||||t|f|f||||||No||2017-10-11 04:58:30.107397|2017-10-11 04:58:30.107397
NCT00099424|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-13|2008-06-04|||February 2004||2004-02-01|June 2008|2008-06-01|August 2005||2005-08-01|||||Interventional|||Exercise Training in Sarcoidosis (EXTRAS Study)|EXercise TRAining in Sarcoidosis (EXTRAS Study): A Prospective, Randomized, Controlled, Crossover Trial|Completed||N/A|30||University Hospital, Gasthuisberg|||||f||||||||||||||2017-10-11 04:58:30.193972|2017-10-11 04:58:30.193972
NCT00099437|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-13|2017-08-24|2010-02-23||February 8, 2005|Actual|2005-02-08|August 2017|2017-08-01|January 5, 2018|Anticipated|2018-01-05|February 27, 2009|Actual|2009-02-27||Interventional|CONFIRM||Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.|A Randomised, Double-Blind, Parallel-group, Multicentre, Phase III Study Comparing the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 500 mg With Fulvestrant (FASLODEX™) 250 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy|Active, not recruiting||Phase 3|736|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:58:30.326299|2017-10-11 04:58:30.326299
NCT00099450|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-14|2015-01-19|||December 2004||2004-12-01|January 2015|2015-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers|Single-Center, Open-Labeled Dose Escalation Followed by Randomized, Double-Blind, Placebo-Controlled Cohort Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers|Completed||Phase 1|48|Anticipated|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 04:58:31.173141|2017-10-11 04:58:31.173141
NCT00099463|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-14|2017-06-30|||December 9, 2004||2004-12-09|August 22, 2007|2007-08-22|August 22, 2007||2007-08-22|||||Interventional|||Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)|A Phase I Study of the Safety and Immunogenicity of a SARS Recombinant DNA Plasmid Vaccine, VRC-SRSDNA015-00-VP, in Healthy Adult Volunteers|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:31.250693|2017-10-11 04:58:31.250693
NCT00099476|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-14|2017-06-30|||December 10, 2004||2004-12-10|April 16, 2009|2009-04-16|April 16, 2009||2009-04-16|||||Interventional|||Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood Pressure|Effects of Cocoa Consumption on Insulin Sensitivity and Capillary Recruitment in Subjects With Essential Hypertension|Completed||Phase 1|65||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:58:31.323181|2017-10-11 04:58:31.323181
NCT00099489|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-15|2010-03-04|||February 2004||2004-02-01|March 2010|2010-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Safety and Efficacy of AVONEX When Used in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)|Completed||Phase 2|67||Biogen|||||||||||||||||||2017-10-11 04:58:31.411137|2017-10-11 04:58:31.411137
NCT00099502|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-15|2008-12-18|||November 2003||2003-11-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|||||Interventional|||BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients|International, Randomized, Multicenter, Phase IIIb Study in Patients With Relapsing-Remitting Multiple Sclerosis Comparing Over a Treatment Period of at Least 104 Weeks: 1. Double-Blinded Safety, Tolerability, and Efficacy of Betaseron/ Betaferon 250 µg (8 MIU) and Betaseron/-Betaferon 500 µg (16 MIU), Both Given Subcutaneously Every Other Day, and 2. Rater-Blinded Safety, Tolerability, and Efficacy of Betaseron/-Betaferon s.c. Every Other Day With Copaxone 20 mg s.c. Once Daily.|Completed||Phase 3|2244|Actual|Bayer||3|||f||||t||||||||||2017-10-11 04:58:31.686152|2017-10-11 04:58:31.686152
NCT00099515|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-15|2007-12-18|||November 2004||2004-11-01|December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|IDAP||Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)|Standard Training Versus Intensive Training for HIIP Delivery System Usage in Insulin-Naïve Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|97|Actual|Eli Lilly and Company||2|||||||f||||||||||2017-10-11 04:58:32.266995|2017-10-11 04:58:32.266995
NCT00094289|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2017-01-10|||August 2004||2004-08-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Interactions Between Cocaine and Ethanol and Disulfiram - 1|Interactions Between IV Cocaine and Ethanol and Oral Disulfiram|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:59:47.140905|2017-10-11 04:59:47.140905
NCT00099541|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-15|2009-11-20|||November 2004||2004-11-01|November 2009|2009-11-01|November 2007||2007-11-01|||||Interventional|||Non-small Cell Lung Cancer Registry|A Dual-Cohort, Prospective, Observational Study of Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer Patients With and Without Bone Metastasis|Completed||Phase 4|300||Novartis|||||f||||||||||||||2017-10-11 04:58:32.638529|2017-10-11 04:58:32.638529
NCT00099554|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-16|2009-11-12|||May 2004||2004-05-01|November 2009|2009-11-01||||||||Interventional|||Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)|A Phase 4, Open-Label, Single Arm, Observational Study Evaluating the Effectiveness and Safety of Enbrel® (Etanercept) 50 mg Once Weekly in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)|Completed||Phase 4|200||Amgen|||||||||||||||||||2017-10-11 04:58:33.288498|2017-10-11 04:58:33.288498
NCT00099567|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-16|2005-10-31|||January 1997||1997-01-01|December 2004|2004-12-01|December 2002||2002-12-01|||||Observational|||Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline|Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline|Completed||N/A|2632||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:58:33.361058|2017-10-11 04:58:33.361058
NCT00099580|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2015-01-16|||March 2005||2005-03-01|December 2014|2014-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure|PROCLAIM: A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Examine the Effects of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure|Completed||Phase 2|61|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:58:33.437361|2017-10-11 04:58:33.437361
NCT00099593|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2015-03-24|||September 2004||2004-09-01|December 2006|2006-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Immunization Against Tumor Cells in Sezary Syndrome|Phase II Evaluation of Immunization Against Tumor Cells in Subjects With Sezary Syndrome Using Autologous Mature Dendritic Cells|Completed||Phase 2|17|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 04:58:33.5662|2017-10-11 04:58:33.5662
NCT00099606|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2011-04-18|||July 2004||2004-07-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Phase I (PH I) Mad Refractory Solid Tumor Study|A Phase I Dose-Escalation Study of BMS-354825 in Patients With Refractory Solid Tumors|Completed||Phase 1|60||Bristol-Myers Squibb||1|||f||||||||||||||2017-10-11 04:58:33.658226|2017-10-11 04:58:33.658226
NCT00099619|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2015-02-20|||September 2004||2004-09-01|January 2015|2015-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy|Efficacy of Exenatide Compared With Insulin Glargine in Patients With Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate Therapy|Completed||Phase 3|138|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 04:58:33.747181|2017-10-11 04:58:33.747181
NCT00099632|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2015-12-29|2011-12-06||March 2006||2006-03-01|December 2015|2015-12-01|November 2011|Actual|2011-11-01|April 2010|Actual|2010-04-01||Interventional|||Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy|Maintaining Options for Mothers Study (MOMS): A Phase II Randomized Comparison of Three Antiretroviral Strategies Administered for 7 or 21 Days to Reduce the Emergence of Nevirapine Resistant HIV-1 Following a Single Intrapartum Dose of Nevirapine|Completed||Phase 2|484|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-10-11 04:58:33.983859|2017-10-11 04:58:33.983859
NCT00099645|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2012-05-17||||||May 2012|2012-05-01|August 2005|Actual|2005-08-01|||||Interventional|||Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People|A Randomized, Placebo-Controlled, Phase I/II Trial of the Anti-HIV Activity and Safety of VGX-410 (Mifepristone) at Three Dose Levels in HIV-1 Infected Subjects|Completed||Phase 1/Phase 2|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:58:35.321829|2017-10-11 04:58:35.321829
NCT00099658|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2011-02-14|||April 2005||2005-04-01|February 2011|2011-02-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children|Evaluation of Quantitative and Qualitative Antibody Responses to Streptococcus Pneumoniae and Haemophilus Influenzae Type b Conjugate Vaccines Amongst HIV-1-Exposed-Infected Children That Are Receiving Vs. Those Not Receiving Antiretroviral Therapy, as Well as Among HIV-1-Exposed-Uninfected Children and HIV-1-Unexposed-Uninfected Children|Unknown status|Active, not recruiting|N/A|579|Actual|CIPRA SA||5|||f||||t||||||||||2017-10-11 04:58:35.440519|2017-10-11 04:58:35.440519
NCT00099671|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2013-07-30|||April 2005||2005-04-01|July 2013|2013-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs|A Phase I, Randomized, Placebo-Controlled, Double-Blind Study Evaluating the Safety of Subcutaneous Single Dose Interleukin-7 in HIV-1-Infected Subjects Who Are Receiving Antiretroviral Treatment|Completed||Phase 1|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:58:35.54672|2017-10-11 04:58:35.54672
NCT00099684|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2012-10-26|||November 2005||2005-11-01|October 2012|2012-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults|A Pilot Study of the Safety, Efficacy, and Tolerability of Ezetimibe (Zetia) in Combination With Statin Therapy for the Treatment of Elevated LDL Cholesterol in HIV-Infected Subjects|Completed||N/A|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:58:35.671768|2017-10-11 04:58:35.671768
NCT00099697|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2009-12-09|||June 2001||2001-06-01|December 2004|2004-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans|Biologic Effects of DHEA in Humans|Completed||N/A|56||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:58:36.042754|2017-10-11 04:58:36.042754
NCT00099710|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2009-12-02|||July 2003||2003-07-01|December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Curcumin in Patients With Mild to Moderate Alzheimer's Disease|A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Two Doses of Curcumin C3 Complex Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|33|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:58:36.13242|2017-10-11 04:58:36.13242
NCT00100113|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-22|2017-01-10|||June 2004||2004-06-01|March 2005|2005-03-01|June 2005||2005-06-01|||||Interventional|||Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1|Study of Interactions Between GBR 12909 and Cocaine|Unknown status|Active, not recruiting|Phase 1|24||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 05:00:00.301674|2017-10-11 05:00:00.301674
NCT00099723|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2010-02-10|||October 2004||2004-10-01|December 2004|2004-12-01|December 2005|Anticipated|2005-12-01|||||Interventional|||The Effect of a Probiotic on Hepatic Steatosis|The Effect of a Probiotic on Hepatic Steatosis|Terminated||Phase 1|30|Anticipated|VSL Pharmaceuticals||||The hypothesis that probiotics would reduce hepatic steatosis in humans was not supported|||||||||||||||2017-10-11 04:58:36.206703|2017-10-11 04:58:36.206703
NCT00099736|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2017-08-17|||May 7, 2003||2003-05-07|August 2017|2017-08-01|September 19, 2005|Actual|2005-09-19|September 19, 2005|Actual|2005-09-19||Interventional|||Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant|Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant|Completed||Phase 3|696|Actual|Novartis||3|||f||||f|t|f||||||||2017-10-11 04:58:36.284423|2017-10-11 04:58:36.284423
NCT00099749|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2017-02-21|||November 2003||2003-11-01|February 2017|2017-02-01||||April 2006|Actual|2006-04-01||Interventional|||Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant|Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant|Completed||Phase 2/Phase 3|255||Novartis|||||||||||||||||||2017-10-11 04:58:36.447607|2017-10-11 04:58:36.447607
NCT00099762|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-17|2017-06-30|||December 15, 2004||2004-12-15|September 2, 2009|2009-09-02||||September 2, 2009|Actual|2009-09-02||Observational|||Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia|Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:36.555445|2017-10-11 04:58:36.555445
NCT00099775|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-18|2008-03-03|||December 2004||2004-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units|A Randomized Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting|Completed||Phase 3|1200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:36.611842|2017-10-11 04:58:36.611842
NCT00099788|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2009-11-24|||October 2004||2004-10-01|November 2009|2009-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes|A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multinational, Clinical Trial to Evaluate the Efficacy and Safety of Ranolazine vs Placebo in Patients With Non-ST Segment Elevation Acute Coronary Syndromes|Completed||Phase 3|6560|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 04:58:36.735088|2017-10-11 04:58:36.735088
NCT00099801|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2017-06-05|||January 2005||2005-01-01|June 2017|2017-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant|Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant|Completed||Phase 3|||Novartis|||||||||||||||||||2017-10-11 04:58:36.843736|2017-10-11 04:58:36.843736
NCT00099814|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2010-06-28|||March 2004||2004-03-01|June 2010|2010-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Periodontal Ligament Stress Level and Tooth Movement|Clinical/Numerical Study of the Effects of Periodontal Ligament Stress Level on the Rate Bodily Tooth Movement|Completed||Phase 1|20||University of Alberta, Graduate Orthodontic Program|||||f||||f||||||||||2017-10-11 04:58:36.907811|2017-10-11 04:58:36.907811
NCT00099827|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2011-10-14|||October 2003||2003-10-01|October 2011|2011-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Teen Depression Awareness Project (TDAP)|Teen Depression Awareness Project- This Project Examines the Services Used by Teens Identified in Primary Care Settings With Depression|Completed||Phase 1|368|Actual|RAND|||||f||||f||||||||||2017-10-11 04:58:36.985075|2017-10-11 04:58:36.985075
NCT00099840|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2007-04-24|||December 2004||2004-12-01|January 2006|2006-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Procalcitonin Guided Antibiotic Use in Acute Respiratory Tract Infections (PARTI)-Study|Procalcitonin Guided Antibiotic Use in Acute Respiratory Tract Infections in Primary Care - A Randomized Controlled Trial|Completed||N/A|400||University Hospital, Basel, Switzerland|||||f||||||||||||||2017-10-11 04:58:37.069846|2017-10-11 04:58:37.069846
NCT00099853|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2013-01-02||2012-12-28|May 2004||2004-05-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes|Completed||Phase 3|362|Actual|Novartis||3|||f||||||||||||||2017-10-11 04:58:37.162044|2017-10-11 04:58:37.162044
NCT00099866|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2012-05-04|||January 2004||2004-01-01|May 2012|2012-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|570|Actual|Novartis||2|||f||||||||||||||2017-10-11 04:58:37.258375|2017-10-11 04:58:37.258375
NCT00099879|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2010-02-27||2010-02-27||||August 2007|2007-08-01||||March 2006|Actual|2006-03-01||Interventional|||Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer|A Randomized, Two-Cohort Phase II Study of Two Doses of BMS-275183 Given on a Weekly Schedule in Patients With Pre-Treated Non-Small Cell Lung Cancer|Terminated||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 04:58:37.351849|2017-10-11 04:58:37.351849
NCT00099892|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2017-07-31|||May 2004||2004-05-01|July 2017|2017-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|544|Actual|Novartis|||||f||||||||||||||2017-10-11 04:58:37.462688|2017-10-11 04:58:37.462688
NCT00099905|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2012-05-01|||April 2004||2004-04-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes|A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes|Completed||Phase 3|639|Actual|Novartis|||||||||||||||||||2017-10-11 04:58:37.537374|2017-10-11 04:58:37.537374
NCT00099918|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2017-05-15|||May 2004||2004-05-01|May 2017|2017-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|717|Actual|Novartis|||||f||||||||||||||2017-10-11 04:58:37.611779|2017-10-11 04:58:37.611779
NCT00271674|ClinicalTrials.gov processed this data on October 10, 2017|2006-01-03|2008-06-02|||January 2006||2006-01-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|||||Interventional|||YAG Laser Versus Punch Biopsy for the Treatment of Tattoo Skin Markers||Completed||N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:55:13.925691|2017-10-11 05:55:13.925691
NCT00099931|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2012-05-04|||May 2004||2004-05-01|May 2012|2012-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes|Completed||Phase 3|254|Actual|Novartis|||||f||||||||||||||2017-10-11 04:58:37.690475|2017-10-11 04:58:37.690475
NCT00099944|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2012-05-03|||May 2004||2004-05-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes|Completed||Phase 3|515|Actual|Novartis||3|||f||||||||||||||2017-10-11 04:58:37.770879|2017-10-11 04:58:37.770879
NCT00099957|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2012-05-01|||September 2003||2003-09-01|May 2012|2012-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes|A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes|Completed||Phase 2|38||Novartis|||||||||||||||||||2017-10-11 04:58:37.8662|2017-10-11 04:58:37.8662
NCT00099970|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2008-08-02|||December 2004||2004-12-01|August 2008|2008-08-01|March 2006||2006-03-01|||||Interventional|||Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy|Phase II Open-Label Study of Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemo|Completed||Phase 2|40||Facet Biotech|||||||||||||||||||2017-10-11 04:58:37.948351|2017-10-11 04:58:37.948351
NCT00099983|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2014-08-05|2013-08-06||October 2006||2006-10-01|August 2014|2014-08-01|January 2011|Actual|2011-01-01|February 2010|Actual|2010-02-01||Interventional|CSP #504|"Valid diagnostic baseline data were collected on 267 patients randomized to receive risperidone (n=133) and placebo (n=134). The 29 patients with missing source documents as reported in Participant Flow were not included in any analyses."|Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder|CSP #504 - Risperidone Treatment for Military Service Related Chronic Post-Traumatic Stress Disorder|Completed||Phase 2|296|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 04:58:38.293261|2017-10-11 04:58:38.293261
NCT00099996|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2008-03-03|||December 2004||2004-12-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia|A Study to Assess Adding Ezetimibe 30 mg to Ongoing Treatment With Ezetimibe 10 mg in Patients With Homozygous Sitosterolemia|Completed||Phase 3|3||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:38.660201|2017-10-11 04:58:38.660201
NCT00100009|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-21|2017-06-30|||December 9, 2004||2004-12-09|December 20, 2006|2006-12-20|December 20, 2006||2006-12-20|||||Interventional|||Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration|Multi-Center, Randomized, Phase II/III Clinical Trial to Study the Effects of Preservative-Free Triamcinolone Acetonide as an Adjunct to Photodynamic Therapy in Participants With Neovascular Age-Related Macular Degeneration|Completed||Phase 3|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:38.754178|2017-10-11 04:58:38.754178
NCT00100035|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-22|2008-04-21|||August 2004||2004-08-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Polarity Therapy for American Indian Caregivers of Dementia Patients|Polarity Therapy for Dementia Caregivers|Completed||Phase 1|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:58:38.870413|2017-10-11 04:58:38.870413
NCT00100048|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-22|2015-09-04|2010-01-21||January 2005||2005-01-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|October 2006|Actual|2006-10-01||Interventional|||A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)|Multicenter, Double-Blind, Randomized, Dose Ranging Study to Compare the Safety and Activity of MK0518 Plus Tenofovir and Lamivudine (3TC) Versus Efavirenz Plus Tenofovir and Lamivudine (3TC) in ART-Naive, HIV-Infected Patients|Completed||Phase 2|206|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-10-11 04:58:39.021748|2017-10-11 04:58:39.021748
NCT00100061|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-22|2013-03-11|||May 2007||2007-05-01|March 2013|2013-03-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)|Dose Response to Cranberry of Women With Recurrent UTIs|Unknown status|Active, not recruiting|Phase 2|350|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-10-11 04:58:41.610336|2017-10-11 04:58:41.610336
NCT00100074|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-22|2017-01-10|||September 2004||2004-09-01|December 2004|2004-12-01|April 2005||2005-04-01|||||Interventional|||To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1|Safety and Tolerability Study of Sublingual Lobeline|Unknown status|Active, not recruiting|Phase 1|8||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:58:41.704896|2017-10-11 04:58:41.704896
NCT00100087|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-22|2005-06-23|||October 2004||2004-10-01|January 2005|2005-01-01||||||||Interventional|||Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System|A Safety and Feasibility Study of the TheraSight(TM) Ocular Brachytherapy System for Treatment of Age-Related Macular Degeneration|Unknown status|Recruiting|Phase 1/Phase 2|30||Theragenics Corporation|||||||||||||||||||2017-10-11 04:58:41.784297|2017-10-11 04:58:41.784297
NCT00084539|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2016-03-01|||November 2003||2003-11-01|March 2016|2016-03-01||||November 2005|Actual|2005-11-01||Interventional|||Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer|Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy (IMRT) With Incorporated Boost in Early Stage Breast Cancer|Completed||Phase 2|78|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-10-11 04:58:42.131527|2017-10-11 04:58:42.131527
NCT00084552|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2016-03-01|||December 2003||2003-12-01|March 2016|2016-03-01||||August 2013|Actual|2013-08-01||Interventional|||Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer|Outcomes Following Intensity Modulated Radiation Therapy With And Without Erectile Tissue Dose Sparing For Favorable To Intermediate Risk Prostate Cancer|Active, not recruiting||Phase 3|200|Anticipated|Fox Chase Cancer Center||2|||f||||f||||||||||2017-10-11 04:58:42.24982|2017-10-11 04:58:42.24982
NCT00084981|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-09-27|||April 2004||2004-04-01|September 2013|2013-09-01||||February 2013|Actual|2013-02-01||Interventional|||Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer|A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Non-Small Cell Lung Cancer|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:46.958823|2017-10-11 04:58:46.958823
NCT00084565|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-07-09|||November 2003||2003-11-01|July 2013|2013-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer|Phase II Study of the Activity of Weekly Paclitaxel, Topotecan Plus Oral Estramustine Phosphate in Metastatic Hormone-Refractory Prostate Carcinoma|Withdrawn||Phase 2|0|Actual|Fox Chase Cancer Center||||Study was never activated at Fox Chase Cancer Center.|f||||f||||||||||2017-10-11 04:58:42.371185|2017-10-11 04:58:42.371185
NCT00084578|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-07-12|||March 2004||2004-03-01|July 2013|2013-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder|A Randomized Trial of Celecoxib and Rosiglitazone, Alone and in Combination, in Patients With Early Stage Non-Invasive Bladder Carcinoma Undergoing Cystoscopic Surveillance and in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy|Withdrawn||N/A|0|Actual|Fox Chase Cancer Center||||Withdrawn due to drug toxicity|f||||f||||||||||2017-10-11 04:58:42.447708|2017-10-11 04:58:42.447708
NCT00084591|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2010-02-11|||December 2003||2003-12-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer|Phase I Study of Preoperative Intensity Modulated Radiation Therapy (IMRT) With Incorporated Boost and Oral Capecitabine in Locally Advanced Rectal Cancer|Completed||Phase 1|||Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 04:58:42.529942|2017-10-11 04:58:42.529942
NCT00084604|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-06-03|||April 2004||2004-04-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|A Multicenter, Open-Label, Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|Completed||Phase 2|47|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:42.657178|2017-10-11 04:58:42.657178
NCT00084617|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-04-15|2015-04-15||March 2004||2004-03-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma|Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma|Completed||Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:42.810855|2017-10-11 04:58:42.810855
NCT00084630|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-02-27|||May 2004||2004-05-01|February 2013|2013-02-01||||July 2007|Actual|2007-07-01||Interventional|||Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans|A Phase II Study of Imatinib (NSC-716051) in Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:43.260276|2017-10-11 04:58:43.260276
NCT00084643|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-03-26|||May 2004||2004-05-01|January 2013|2013-01-01||||April 2008|Actual|2008-04-01||Interventional|||GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors|A Phase I Study of GTI-2040 in Combination With Oxaliplatin and Capecitabine in Patients With Advanced Metastatic Solid Tumors|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:43.351138|2017-10-11 04:58:43.351138
NCT00084656|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2010-04-23|||May 2004||2004-05-01|April 2010|2010-04-01||||October 2009|Actual|2009-10-01||Interventional|||Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma|An Extended Dosing, Two-phase Study of MDX-010 as Monotherapy or in Combination With Tyrosinase/gp100/MART-1 Peptides Emulsified With Montanide ISA 51 VG in the Treatment of Subjects With Resected Stage III or Stage IV Melanoma|Completed||Phase 2|75|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-10-11 04:58:43.45717|2017-10-11 04:58:43.45717
NCT00084669|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2010-04-27|||May 2004||2004-05-01|April 2010|2010-04-01|March 2010|Actual|2010-03-01|October 2007|Actual|2007-10-01||Interventional|||Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer|Targeting Insomnia to Enhance Hot Flush Treatment in Women Receiving Therapy for Breast Cancer or Breast Cancer Risk-Reduction|Completed||N/A|119|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-10-11 04:58:43.554734|2017-10-11 04:58:43.554734
NCT00084682|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-04-29|2015-04-29||April 2004||2004-04-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|November 2008|Actual|2008-11-01||Interventional|||Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|A Phase II Study of Single Agent Depsipeptide (FK228; NSC 630176; IND 51,810) in Patients With Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|14|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 04:58:43.646704|2017-10-11 04:58:43.646704
NCT00084695|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-01-09|||September 2003||2003-09-01|October 2008|2008-10-01||||December 2012|Anticipated|2012-12-01||Interventional|||Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases|The Use Of Umbilical Cord Blood As A Source Of Hematopoietic Stem Cells|Unknown status|Recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)||4|||f||||||||||||||2017-10-11 04:58:43.883126|2017-10-11 04:58:43.883126
NCT00084708|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-01-10|||November 2002||2002-11-01|January 2014|2014-01-01|May 2007|Actual|2007-05-01|October 2006|Actual|2006-10-01||Interventional|||Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors|A Phase I Study of Intravenous (IV) Calcitriol in Combination With ZD1839 (IRESSA®) in Refractory Solid Tumors|Completed||Phase 1|53|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:58:44.017291|2017-10-11 04:58:44.017291
NCT00084721|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-01-30|||March 2005||2005-03-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer|A Phase I Study of Irinotecan in Combination With Fixed Dose Celecoxib in Patients With Advanced Colorectal Cancer|Completed||Phase 1|2|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:58:44.101991|2017-10-11 04:58:44.101991
NCT00084734|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-01-10|||May 2002||2002-05-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacokinetics Study of Docetaxel in Combination With Capecitabine and Cisplatin in Solid Tumors|Completed||Phase 1|61|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:58:44.175191|2017-10-11 04:58:44.175191
NCT00084747|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2016-02-17|2016-01-20||June 2004||2004-06-01|February 2016|2016-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma|Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation With VELCADE Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma|Completed||Phase 1/Phase 2|30|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:58:44.257469|2017-10-11 04:58:44.257469
NCT00084773|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-12-21|||March 2004||2004-03-01|December 2015|2015-12-01|March 2010|Actual|2010-03-01|January 2007|Actual|2007-01-01||Interventional|||Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer|A Pilot Clinical Trial of Preoperative Cetuximab With Concurrent Continuous Infusion Fluorouracil and Pelvic Radiation in Patients With Local-Regionally Advanced Rectal Cancer|Completed||N/A|28|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:58:44.476999|2017-10-11 04:58:44.476999
NCT00084786|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-01-15|||March 2004||2004-03-01|January 2013|2013-01-01||||July 2006|Actual|2006-07-01||Interventional|||Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors|A Phase I Dose Escalation of ZD1839 (Iressa®) (Days 1 and 2) and Docetaxel (Day 3) Every 3 Weeks in Patients With an Advanced Solid Tumor|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 04:58:44.581462|2017-10-11 04:58:44.581462
NCT00084799|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-06-15|||February 2004||2004-02-01|June 2015|2015-06-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer|A Multiple-Dose Targeting Study of hu3S193 in Patients With Small Cell Lung Cancer|Completed||Phase 1|||Ludwig Institute for Cancer Research|||||f||||f||||||||||2017-10-11 04:58:44.64754|2017-10-11 04:58:44.64754
NCT00084812|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-03-21|||March 2004||2004-03-01|March 2013|2013-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study of Safingol Administered With Cisplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|43|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 04:58:44.724269|2017-10-11 04:58:44.724269
NCT00084825|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-10-24|||May 2003||2003-05-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|July 2006|Actual|2006-07-01||Interventional|||Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008|Crossover From Docetaxel and Placebo to Docetaxel and Imatinib in Patients With Androgen-Independent Prostate Cancer With Bone Metastases: Extension Trial to ID03-0008|Completed||Phase 2|23|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:58:44.817419|2017-10-11 04:58:44.817419
NCT00084838|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-12-18|2012-12-14||February 2003||2003-02-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|February 2008|Actual|2008-02-01||Interventional|||Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT|A Phase II Study of Intrathecal and Systemic Chemotherapy With Radiation Therapy for Children With Central Nervous System Atypical Teratoid/Rhabdoid Tumor (AT/RT) Tumor|Completed||Phase 2|25|Actual|Dana-Farber Cancer Institute|None. Trial was completed.|1|||f||||t||||||||||2017-10-11 04:58:45.176689|2017-10-11 04:58:45.176689
NCT00084864|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2017-05-11|2017-03-30||September 2002||2002-09-01|May 2017|2017-05-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional||All treated and eligible patients|Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate|A Pilot Trial of Calcitriol in Localized Prostate Cancer: Investigation of Biologic Effects and Potential Intermediate Endpoints|Terminated||Phase 2|25|Actual|Roswell Park Cancer Institute|Study was activated prior to Roswell Park Cancer Institute (RPCI) putting a system in place to centralize data entry and data management. Data entry was done by PI's staff. PI left institute and left incomplete data.|4||sample size is too small to draw a conclusion|f||||t||||||||||2017-10-11 04:58:45.73133|2017-10-11 04:58:45.73133
NCT00084877|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-05-15|||March 2004||2004-03-01|May 2013|2013-05-01||||July 2008|Actual|2008-07-01||Interventional|||Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Triapine® in Combination With Irinotecan in Refractory Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:46.370565|2017-10-11 04:58:46.370565
NCT00084890|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2017-05-25|||November 2003||2003-11-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|March 2007|Actual|2007-03-01||Interventional|||Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix|Weekly Docetaxel and Carboplatin in Patients With Recurrent Squamous Carcinoma of the Cervix: A Phase I/II Study|Terminated||Phase 1|15|Actual|Wake Forest University Health Sciences||1||slow accrual|f||||f|t|f||||||||2017-10-11 04:58:46.489235|2017-10-11 04:58:46.489235
NCT00084903|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-08-01|||April 1998||1998-04-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|July 2007|Actual|2007-07-01||Interventional|||Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears|Pathological Correlation of Colposcopically Directed Biopsies to Fluorescence EEM of the Normal Human Cervix|Completed||N/A|1070|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:58:46.577411|2017-10-11 04:58:46.577411
NCT00084916|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-01-22|||April 2004||2004-04-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase|A Phase II Study Of CCI-779 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Or Chronic Myeloid Leukemia In Blastic-Phase|Completed||Phase 2|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:46.663429|2017-10-11 04:58:46.663429
NCT00084929|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-10-07|||February 2005||2005-02-01|October 2013|2013-10-01||||September 2008|Actual|2008-09-01||Interventional|ACRIN 6664||Computed Tomographic Colonography in Screening Healthy Participants for Colorectal Cancer|National CT Colonography Trial|Completed||Phase 2/Phase 3|2607|Actual|American College of Radiology Imaging Network||1|||f||||t||||||||||2017-10-11 04:58:46.755057|2017-10-11 04:58:46.755057
NCT00084942|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-01-11|||October 2002||2002-10-01|January 2012|2012-01-01|November 2006|Actual|2006-11-01|May 2004|Actual|2004-05-01||Interventional|||Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder|A Phase II Study of Gemcitabine in Combination With Capecitabine in Advanced Cholangiocarcinoma|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 04:58:46.871764|2017-10-11 04:58:46.871764
NCT00085020|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-10-01|||March 2004||2004-03-01|August 2012|2012-08-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu|A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Trastuzumab [Herceptin†]|Completed||Phase 1|13|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 04:58:47.065303|2017-10-11 04:58:47.065303
NCT00085059|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-07-17|||April 2004||2004-04-01|July 2012|2012-07-01||||October 2006|Actual|2006-10-01||Interventional|||Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma|Early Phase II Study On BNCT In Metastatic Malignant Melanoma Using The Boron Carrier BPA|Terminated||Phase 2|4|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 04:58:47.147313|2017-10-11 04:58:47.147313
NCT00085098|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2017-02-07|2013-06-07||January 2007||2007-01-01|February 2017|2017-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor|Radiotherapy Alone Versus Chemotherapy Followed By Response-Based Radiotherapy For Newly Diagnosed Primary CNS Germinoma|Completed||Phase 3|24|Actual|Children's Oncology Group|Study closed early due to slow accrual. Analysis plans were not carried out (lack of statistical precision compromised the ability to draw appropriate conclusions). Reported Primary Outcome Measure data reflects data collection through May 2009.|2|||f||||t||||||||||2017-10-11 04:58:47.258863|2017-10-11 04:58:47.258863
NCT00085111|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01||||October 2005|Actual|2005-10-01||Interventional|||Bevacizumab in Treating Young Patients With Refractory Solid Tumors|A Phase I Study of Bevacizumab in Refractory Solid Tumors|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:47.881345|2017-10-11 04:58:47.881345
NCT00085124|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01||||June 2007|Actual|2007-06-01||Interventional|||Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia|A Phase III Study of Daunorubicin and Cytarabine +/- G3139 (Genasense, Oblimersen Sodium, NSC #683428, IND #58842), a BCL2 Antisense Oligodeoxynucleotide, in Previously Untreated Patients With Acute Myeloid Leukemia (AML) &gt; / = 60 Years|Completed||Phase 3|500|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:58:47.963198|2017-10-11 04:58:47.963198
NCT00085150|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-04-29|||April 2004||2004-04-01|February 2007|2007-02-01||||||||Interventional|||LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma|Pediatric Phase I Trial of LMB-2 for Refractory CD25-Positive Leukemias and Lymphomas|Completed||Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:58:48.066382|2017-10-11 04:58:48.066382
NCT00085163|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-10-19|||March 2004||2004-03-01|October 2015|2015-10-01||||November 2005|Actual|2005-11-01||Interventional|||Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon|Multicenter, Double-Blind, Placebo-Controlled Randomized Phase III Study of Adjuvant Therapy With Celecoxib in Combination With Chemotherapy in Patients With Curatively Resected Stage III Colon Cancer|Completed||Phase 3|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:58:48.160368|2017-10-11 04:58:48.160368
NCT00085176|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-01-29|||May 2004||2004-05-01|January 2014|2014-01-01|January 2011|Actual|2011-01-01|September 2009|Actual|2009-09-01||Observational|||Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia|Neurobehavioral Outcomes in Childhood Acute Lymphoblastic Leukemia. A Limited Non-Therapeutic Study|Completed||N/A|286|Actual|Children's Oncology Group|||1||f||||t||||||||||2017-10-11 04:58:48.415004|2017-10-11 04:58:48.415004
NCT00085189|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-05-20|||May 2004||2004-05-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma|A PHASE II TRIAL OF A VACCINE COMBINING MULTIPLE CLASS I PEPTIDES WITH MONTANIDE ISA 51 OR ISA 51 VG AND CpG ADJUVANT 7909 FOR PATIENTS WITH RESECTED STAGES IIC/III AND IV MELANOMA|Completed||Phase 2|42|Actual|University of Southern California||2|||f||||||||||||||2017-10-11 04:58:48.821396|2017-10-11 04:58:48.821396
NCT00085202|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2017-03-31|2013-11-04||August 2003||2003-08-01|January 2017|2017-01-01|January 2023|Anticipated|2023-01-01|December 2016|Actual|2016-12-01||Interventional||Participants had a diagnosis of medulloblastoma, supratentorial primitive neuroectodermal tumor (PNET), PNET variants (ependymoblastoma, pineoblastoma, CNS neuroblastoma), or atypical teratoid rhabdoid tumor (ATRT).|Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor|Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor|Active, not recruiting||Phase 3|416|Actual|St. Jude Children's Research Hospital|The study is ongoing. Participant flow and adverse events will be updated as additional outcomes are reported.|2|||f||||f|t|f||||||||2017-10-11 04:58:49.018191|2017-10-11 04:58:49.018191
NCT00085228|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-09-20|||April 2004||2004-04-01|September 2012|2012-09-01||||January 2006|Actual|2006-01-01||Interventional|||Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate|Randomized Phase II Trial of Docetaxel (Taxotere) and Oblimersen (Antisense Oligonucleotide Directed to BCL-2) Versus Taxotere Alone in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2|116|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 04:58:49.589426|2017-10-11 04:58:49.589426
NCT00085254|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2016-01-28|2015-05-05||April 2005||2005-04-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||pt had undergone previous surgery and had histological diagnosis of glioblastoma. All pt 18 years or older and KPS greater or equal to 60%|Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Safety Run-in/Randomized Phase II Trial of EMD 121974 in Conjunction With Concomitant and Adjuvant Temozolomide With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1/Phase 2|112|Actual|National Cancer Institute (NCI)|Study is safety run-in / phase 2 study. Pre-defined doses in safety run-in, 500, 1000 & 2000mg. Safety run-in is under an assumption of low probability of DLT with these dosages. NO actual MTD was defined in the safety run in, all doses were safe.|3|||f||||t||||||||||2017-10-11 04:58:49.839419|2017-10-11 04:58:49.839419
NCT00085280|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-03-28|||September 2004||2004-09-01|January 2013|2013-01-01||||October 2006|Actual|2006-10-01||Interventional|||Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Pilot Study to Determine if Downstream Markers of EGFR Linked Signaling Pathways Predict Response to OSI-774 (Erlotinib) in the First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer|Completed||N/A|129|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:50.644068|2017-10-11 04:58:50.644068
NCT00085293|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-08-20|2014-08-20||May 2004||2004-05-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional||Participants who received at least one dose of therapy.|Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131|Phase II Study of Decitabine in Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Radioiodine|Completed||Phase 2|12|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 04:58:50.771313|2017-10-11 04:58:50.771313
NCT00085306|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2015-10-01|||April 2004||2004-04-01|October 2015|2015-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma|Phase II Trial Of Interferon-B In Patients With Metastatic Cutaneous Melanoma And Metastatic Ocular Melanoma|Completed||Phase 2|21|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:58:51.107857|2017-10-11 04:58:51.107857
NCT00085332|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2014-01-10|||July 2004||2004-07-01|January 2014|2014-01-01||||December 2005|Actual|2005-12-01||Interventional|||Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)|A Phase II Evaluation of Weekly Docetaxel (NSC #628503) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||t||||||||||2017-10-11 04:58:51.232389|2017-10-11 04:58:51.232389
NCT00085345|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-07-09||||||July 2006|2006-07-01||||||||Interventional|||Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma|Phase II Study of Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients With Relapsed or Refractory Multiple Myeloma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:58:51.470026|2017-10-11 04:58:51.470026
NCT00085358|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-03-18|||May 2004||2004-05-01|March 2013|2013-03-01||||May 2011|Actual|2011-05-01||Interventional|||Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)|A Phase I Trial of Intravenous Paclitaxel, Intraperitoneal Carboplatin and Intraperitoneal Paclitaxel or Intravenous Docetaxel, Intraperitoneal Carboplatin and Intraperitoneal Paclitaxel or Intravenous Paclitaxel, Intraperitoneal Carboplatin, Intraperitoneal Paclitaxel and CTEP-Supplied Agent Bevacizumab (NSC 704865, IND 7921) in Patients With Previously Untreated Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:51.7778|2017-10-11 04:58:51.7778
NCT00085371|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2013-10-07|||July 2004||2004-07-01|October 2013|2013-10-01||||July 2006|Actual|2006-07-01||Interventional|||Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas|A Phase II Study Of Triapine For Advanced Adenocarcinoma Of The Pancreas|Completed||Phase 2|116|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:58:51.912141|2017-10-11 04:58:51.912141
NCT00085384|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2012-08-01|||July 2002||2002-07-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|November 2005|Actual|2005-11-01||Interventional|||PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer|A Phase I/II Study to Evaluate the Optimum Dose of Pegylated-Interferon (PEG INTRON) in Patients With Platinum Resistant Ovarian, Peritoneal or Fallopian Tube Cancer|Terminated||Phase 1/Phase 2|30|Actual|M.D. Anderson Cancer Center||3||Terminated due to slow accrual.|f||||f||||||||||2017-10-11 04:58:51.988336|2017-10-11 04:58:51.988336
NCT00085397|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2009-02-06|||March 2004||2004-03-01|April 2008|2008-04-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Randomized Phase II Study of Immunization Against Melanoma Comparing Autologous Dendritic Cells Pulsed With gp100 Peptide to Autologous Dendritic Cells Fused With Autologous Tumor Cells|Unknown status|Recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 04:58:52.103147|2017-10-11 04:58:52.103147
NCT00085410|ClinicalTrials.gov processed this data on October 10, 2017|2004-06-10|2017-06-13|2013-07-09||January 2004||2004-01-01|June 2017|2017-06-01|April 2010|Actual|2010-04-01|August 2008|Actual|2008-08-01||Interventional|||Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder|Phase II and Pharmacodynamic Study of PS-341 in Patients With Unresectable or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder|Terminated||Phase 2|20|Actual|National Cancer Institute (NCI)|The trial was discontinued early due to no confirmed partial responses.|1||The trial was discontinued early due to no confirmed partial responses.|f||||||||||||||2017-10-11 04:58:52.215523|2017-10-11 04:58:52.215523
NCT00091247|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2017-03-14|||December 2004||2004-12-01|March 2017|2017-03-01|July 2009|Actual|2009-07-01|August 2005|Actual|2005-08-01||Interventional|||Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer|An Exploratory, Placebo-Controlled Trial of Prophylactic Tetracycline for Gefitinib-or Cetuximab-Induced Skin Rash (or Other Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Skin Rash)|Completed||N/A|130|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:58:52.664953|2017-10-11 04:58:52.664953
NCT00091260|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2016-12-28|2016-09-09||January 2004||2004-01-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|July 2012|Actual|2012-07-01||Interventional|||CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis|A Phase II Trial of the Immunomodulatory Drug CC-5013 for Patients With AL Amyloidosis|Completed||Phase 2|82|Actual|Boston Medical Center||1|||f||||t||||||||No||2017-10-11 04:58:52.907739|2017-10-11 04:58:52.907739
NCT00091273|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2014-05-19|2014-05-19||June 2004||2004-06-01|May 2014|2014-05-01|June 2007|Actual|2007-06-01|February 2006|Actual|2006-02-01||Interventional|||Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer|Evaluation of Safety and Immunogenicity of a Peptide Vaccine in Patients With Epithelial Ovarian or Primary Peritoneal Cancer|Completed||Phase 1|9|Actual|University of Virginia||1|||f||||t||||||||||2017-10-11 04:58:54.808534|2017-10-11 04:58:54.808534
NCT00091507|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-09|2016-02-03|2012-11-13||November 2006||2006-11-01|February 2016|2016-02-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|IMMEDIATE||IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.|Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care Trial|Completed||Phase 3|911|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-10-11 04:58:58.566362|2017-10-11 04:58:58.566362
NCT00091286|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2010-11-13|||March 2003||2003-03-01|October 2007|2007-10-01||||April 2011|Anticipated|2011-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer|Evaluation of the Immunogenicity of Vaccination With HER-2/Neu and CEA Derived Synthetic Peptides With GM-CSF-in-Adjuvant, in Patients With Stage IIB, III, or IV Colorectal Cancer|Unknown status|Active, not recruiting|N/A|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:58:55.054544|2017-10-11 04:58:55.054544
NCT00091299|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2015-10-01|||May 2004||2004-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors|An Open Label, Non Randomized , One Sequence, Add-On Study to Investigate the Effects of PTK787/ZK 222584 on the Pharmacokinetics and Pharmacodynamics of Warfarin at Steady-States in Cancer Patients|Completed||Phase 1|24|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 04:58:55.12515|2017-10-11 04:58:55.12515
NCT00091312|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2009-02-06|||June 2004||2004-06-01|December 2006|2006-12-01||||||||Interventional|||Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer|Randomized Phase III Intergroup Trial in Resected Stage 2 (Dukes B) Colon Cancer: 6-Month Infusional 5FU-CPT11 (+/- Folinic Acid) Versus Observation - Determination of Biologic Predictive and Response Factors|Unknown status|Active, not recruiting|Phase 3|1976|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:58:55.204371|2017-10-11 04:58:55.204371
NCT00091325|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2010-01-15|||October 2004||2004-10-01|January 2010|2010-01-01||||March 2005|Actual|2005-03-01||Interventional|||Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants|Phase I Drug Interaction Clinical Study of Polyphenon E|Completed||Phase 1|||University of Arizona|||||f||||||||||||||2017-10-11 04:58:55.32141|2017-10-11 04:58:55.32141
NCT00091338|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2015-04-29|||August 2004||2004-08-01|January 2005|2005-01-01||||||||Interventional|||Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma|"A Study of Subcutaneous CYT 99 007 (Interleukin-7) in Conjunction With Peptide Immunization in Patients With Metastatic Melanoma"|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 04:58:55.405227|2017-10-11 04:58:55.405227
NCT00091351|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2016-07-01|||August 2004||2004-08-01|July 2016|2016-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis|A Phase III Randomized Study of Preoperative Radiation Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcomas (RPS)|Completed||Phase 3|370|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 04:58:55.487346|2017-10-11 04:58:55.487346
NCT00091377|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2016-07-13|||August 2004||2004-08-01|July 2016|2016-07-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|Multi-Center, Phase Ib/IIa Safety and Preliminary Efficacy Study of Phenoxodiol (Intravenous) as a Chemo-Sensitizing Agent for Cisplatin and Paclitaxel in Epithelial Ovarian Cancer or Primary Peritoneal Cancer, Platinum- and/or Taxane-Refractory or Resistant|Completed||Phase 1/Phase 2|65|Actual|MEI Pharma, Inc.||2|||f||||f||||||||||2017-10-11 04:58:55.805763|2017-10-11 04:58:55.805763
NCT00091390|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-07|2017-05-03|2014-10-31||July 2004||2004-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|January 2008|Actual|2008-01-01||Interventional||All eligible patients.|Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer|Phase II Trial Of Combined High Dose Rate Brachytherapy And External Beam Radiotherapy For Adenocarcinoma Of The Prostate|Completed||Phase 2|129|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-10-11 04:58:55.942288|2017-10-11 04:58:55.942288
NCT00091416|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-08|2012-05-03||||||May 2012|2012-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052|A Phase I Clinical Trial to Evaluate the Safety of a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Administered to Healthy, HIV-1 Uninfected, Adult Participants Who Received DNA Plasmid Vaccine or Placebo in the HVTN 052 Clinical Trial|Completed||Phase 1|70|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 04:58:56.28358|2017-10-11 04:58:56.28358
NCT00091429|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-08|2009-11-24|||August 2004||2004-08-01|November 2009|2009-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of Ranolazine SR at a Dose of 1000 mg Twice a Day in Patients With Chronic Angina Who Remain Symptomatic Despite Treatment With Amlodipine 10 mg Once a Day|Completed||Phase 3|500||Gilead Sciences|||||f||||||||||||||2017-10-11 04:58:56.411987|2017-10-11 04:58:56.411987
NCT00091442|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-08|2014-04-02|2009-12-15||September 2004||2004-09-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer|A Randomized Controlled Study of Docetaxel Monotherapy or Docetaxel and DOXIL for the Treatment of Advanced Breast Cancer|Completed||Phase 3|751|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-10-11 04:58:56.550471|2017-10-11 04:58:56.550471
NCT00091468|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-09|2008-01-07|||September 2003||2003-09-01|January 2008|2008-01-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||Nicotine Treatment of Mild Cognitive Impairment (MCI)|Double-Blind Treatment of Mild Cognitive Impairment (MCI) With Transdermal Nicotine or Transdermal Placebo|Unknown status|Active, not recruiting|Phase 1|75|Anticipated|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-10-11 04:58:58.218388|2017-10-11 04:58:58.218388
NCT00091481|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-09|2007-09-23|||June 2003||2003-06-01|September 2007|2007-09-01||||||||Interventional|||Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis|A Randomized, Active-Controlled, Double-Blind Multi-Center Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis|Completed||Phase 4|201|Actual|Abbott|||||||||||||||||||2017-10-11 04:58:58.323351|2017-10-11 04:58:58.323351
NCT00091494|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-09|2016-04-08|||September 2004||2004-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA||Completed||N/A|1000|Anticipated|University of Michigan|||1||f||||||||||||||2017-10-11 04:58:58.456237|2017-10-11 04:58:58.456237
NCT00285831|ClinicalTrials.gov processed this data on October 10, 2017|2006-01-31|2008-10-23|||December 2005||2005-12-01|October 2008|2008-10-01||||||||Observational|||Mild Depression 2 Week Observational Study|Dysphoric-Like Disorder of Epilepsy, Is it Unique?|Unknown status|Active, not recruiting|N/A|120||Stanford University|||||f||||||||||||||2017-10-11 05:59:02.055493|2017-10-11 05:59:02.055493
NCT00091520|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-09|2011-05-19|||April 2004||2004-04-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure|Follow-up Serial Infusions of Natrecor(Nesiritide) in the Management of Patients With Heart Failure-FUSION II|Completed||Phase 2|920|Actual|Scios, Inc.|||||||||||||||||||2017-10-11 04:58:59.130273|2017-10-11 04:58:59.130273
NCT00091533|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-09|2017-06-30|||September 3, 2004||2004-09-03|September 2, 2008|2008-09-02|September 2, 2008||2008-09-02|||||Observational|||Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects|Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:59.225259|2017-10-11 04:58:59.225259
NCT00091546|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-10|2016-02-01|||August 2003||2003-08-01|February 2016|2016-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Genetic and Environmental Characteristics of Primary Pulmonary Hypertension|Genetic and Environmental Pathogenesis of PPH|Completed||N/A|3000|Actual|Vanderbilt University|||1||f||||f||||||Samples With DNA|"     Specimens from 100 families affected by PPH   "|Yes||2017-10-11 04:58:59.463521|2017-10-11 04:58:59.463521
NCT00091845|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-17|2009-07-06|||November 2004||2004-11-01|July 2009|2009-07-01|November 2004|Actual|2004-11-01|||||Interventional|||An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease|An Exploratory Study of the Safety, Tolerability, Pharmacokinetics and Potential Effectiveness of AVI-4020 Injection in Patients Presenting With Presumptive Acute Neuroinvasive West Nile Virus (WNV) Disease|Terminated||Phase 1|50|Anticipated|Sarepta Therapeutics||||Due to limited pool of eligble WNV patients|||||||||||||||2017-10-11 04:58:59.585588|2017-10-11 04:58:59.585588
NCT00091858|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-17|2013-05-06|||April 2004||2004-04-01|May 2013|2013-05-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer|Completed||Phase 3|1000||Amgen||2|||f||||||||||||||2017-10-11 04:58:59.668941|2017-10-11 04:58:59.668941
NCT00091871|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-17|2017-10-05|||September 14, 2004||2004-09-14|July 11, 2017|2017-07-11||||||||Observational|||A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression|A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:59.776075|2017-10-11 04:58:59.776075
NCT00091884|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-17|2008-03-03|||July 2004||2004-07-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Efficacy of Elevated CD4 Counts on CMV Retinitis|Efficacy of Elevated CD4 Cell Counts on CMV Retinitis|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:58:59.896088|2017-10-11 04:58:59.896088
NCT00091897|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-18|2011-08-30|||September 2004||2004-09-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|July 2007|Actual|2007-07-01||Interventional|||Rituximab to Treat Stiff Person Syndrome|Efficacy of Rituximab in Patients With Stiff Person Syndrome With Anti-GAD Antibodies: A Randomized Placebo-Controlled Trial|Completed||Phase 2|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:59:00.001988|2017-10-11 04:59:00.001988
NCT00091910|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-19|2011-06-06|||September 2003||2003-09-01|April 2010|2010-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)|A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Epoetin Alfa in Critically Ill Subjects|Completed||Phase 3|1460|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:59:00.123162|2017-10-11 04:59:00.123162
NCT00091923|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-20|2010-03-23|||February 2004||2004-02-01|September 2009|2009-09-01|December 2005|Actual|2005-12-01|||||Interventional|||Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children|A Randomized Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children 3 to <7 Years Old|Completed||Phase 3|268||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 04:59:00.200466|2017-10-11 04:59:00.200466
NCT00091936|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-20|2010-03-26|||August 2009||2009-08-01|January 2007|2007-01-01||||||||Interventional|||Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings|Implementing Anti-Retroviral Therapy in Resource-Constrained Settings: A Randomized Controlled Trial to Assess the Effect of Integrated Tuberculosis and HIV Care on the Incidence of AIDS-Defining Conditions or Mortality in Subjects Co-Infected With Tuberculosis and HIV|Completed||N/A|592|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 04:59:00.290213|2017-10-11 04:59:00.290213
NCT00091949|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-20|2016-09-09|2016-07-19||February 2005||2005-02-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|IRIS||Insulin Resistance Intervention After Stroke Trial|Insulin Resistance Intervention After Stroke (IRIS) Trial|Completed||Phase 3|3876|Actual|Yale University||2|||f||||t||||||||Yes||2017-10-11 04:59:00.456043|2017-10-11 04:59:00.456043
NCT00091962|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-20|2016-03-14|2016-01-25||August 2003||2003-08-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery|Treatment of Depression Following Bypass Surgery|Completed||N/A|453|Actual|University of Pittsburgh|Selection bias if patients with severe depression were less likely to participate in our screening procedure. Also, the trial recruited just from one U.S. region.|3|||f||||t||||||||||2017-10-11 04:59:01.613434|2017-10-11 04:59:01.613434
NCT00091975|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-20|2011-01-17|||August 2004||2004-08-01|July 2006|2006-07-01||||||||Interventional|||Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis|A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Evaluate the Safety and Efficacy of Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis|Completed||Phase 3|78||Abbott|||||||||||||||||||2017-10-11 04:59:02.437592|2017-10-11 04:59:02.437592
NCT00091988|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2010-03-02|||July 2004||2004-07-01|March 2010|2010-03-01|November 2007|Actual|2007-11-01|||||Interventional|||Program to Reduce Incontinence by Diet and Exercise (PRIDE)|Program to Reduce Incontinence by Diet and Exercise|Completed||N/A|330|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 04:59:02.551443|2017-10-11 04:59:02.551443
NCT00092001|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2008-10-15|||January 2005||2005-01-01|October 2008|2008-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer|A Phase 2 Efficacy And Safety Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|111|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 04:59:02.658669|2017-10-11 04:59:02.658669
NCT00092014|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-03-28|||September 1, 2002|Actual|2002-09-01|March 2017|2017-03-01|April 1, 2004|Actual|2004-04-01|April 1, 2004|Actual|2004-04-01||Interventional|FACT||A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)|A 12-Month Extension to: A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Once Weekly Alendronate and Risedronate on Bone Mineral Density in Postmenopausal Women With Osteoporosis|Completed||Phase 3|1053|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:59:02.792183|2017-10-11 04:59:02.792183
NCT00092027|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-03-24|||March 19, 2003|Actual|2003-03-19|March 2017|2017-03-01|March 15, 2004|Actual|2004-03-15|March 15, 2004|Actual|2004-03-15||Interventional|||A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)|A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Compare the Safety and Tolerability of an Oral Buffered Solution of Alendronate Sodium 70 mg Once-Weekly Versus Placebo for the Treatment of Osteoporosis in Postmenopausal Women|Completed||Phase 3|454|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:02.907316|2017-10-11 04:59:02.907316
NCT00092040|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-03-24|||March 18, 2003|Actual|2003-03-18|March 2017|2017-03-01|September 28, 2005|Actual|2005-09-28|October 18, 2004|Actual|2004-10-18||Interventional|||A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)|A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Risedronate on Bone Mineral Density in Postmenopausal Women With Osteoporosis; A 12 Month Extension to: A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Risedronate on Bone Mineral Density in Postmenopausal Women With Osteoporosis|Completed||Phase 3|936|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:02.999873|2017-10-11 04:59:02.999873
NCT00092053|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2016-01-06|||December 2004||2004-12-01|January 2016|2016-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study of Investigational Drug in Osteoporosis (MK-0217-908)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Persistence of the Effect of Oral Monthly Ibandronate on Bone Reception in Postmenopausal Women in Osteoporosis|Completed||Phase 3|203|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 04:59:03.07718|2017-10-11 04:59:03.07718
NCT00092066|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-03-31|||September 24, 2003|Actual|2003-09-24|March 2017|2017-03-01|May 1, 2004|Actual|2004-05-01|May 1, 2004|Actual|2004-05-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)|A 15-Week, Double-Blind, Randomized, Active-Controlled, Multi-Center Study With 24-Week Extension to Evaluate the Safety, Tolerability, Efficacy of Alendronate 70 mg Plus Vitamin D3 2800 IU Combination Tablet in Men and Postmenopausal Women With Osteoporosis|Completed||Phase 3|717|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:03.18972|2017-10-11 04:59:03.18972
NCT00092079|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2014-11-07|||January 2004||2004-01-01|November 2014|2014-11-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)|A 15-Week, Double-Blind, Randomized, Active-Controlled, Multi-Center Study With 24-Week Extension to Evaluate the Safety, Tolerability, Efficacy of Alendronate 70 mg Plus Vitamin D3 2800 IU Combination Tablet in Men and Postmenopausal Women With Osteoporosis|Completed||Phase 3|652|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:03.286297|2017-10-11 04:59:03.286297
NCT00092092|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-03-17|||October 2002||2002-10-01|March 2017|2017-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)|A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, 2-Arm, 2X2 Crossover Study Comparing the Effects of Montelukast, Inhaled Budesonide, and Placebo on Lower Leg Growth in Children (Prepubertal, Tanner Stage I) With Mild Asthma|Completed||Phase 4|71|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 04:59:03.383585|2017-10-11 04:59:03.383585
NCT00092105|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-03-24|||April 1, 2002|Actual|2002-04-01|March 2017|2017-03-01|January 28, 2003|Actual|2003-01-28|January 1, 2003|Actual|2003-01-01||Interventional|||Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)|A Multicenter, Double-Blind, Randomized, Crossover Study Investigating the Clinical Effect of Montelukast in Patients With Concomitant Asthma and Allergic Rhinitis Upon Controlled Exposure to Cat Allergen|Completed||Phase 3|58|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:03.511645|2017-10-11 04:59:03.511645
NCT00092118|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2015-05-25|2009-09-10||October 2003||2003-10-01|May 2015|2015-05-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis|Completed||Phase 3|1992|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:59:03.632416|2017-10-11 04:59:03.632416
NCT00092131|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2015-06-22|2009-09-24||June 2003||2003-06-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm|Completed||Phase 3|51|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:59:04.017929|2017-10-11 04:59:04.017929
NCT00092144|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-09-14|||February 26, 2004|Actual|2004-02-26|September 2017|2017-09-01|June 15, 2004|Actual|2004-06-15|June 15, 2004|Actual|2004-06-15||Interventional|||Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)|A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral MK0476 Vs Placebo During the Allergy Season in Patients With Seasonal Aeroallergen Sensitivity and Chronic Asthma Which is Also Active During Allergy Season|Completed||Phase 3|500|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:04.534279|2017-10-11 04:59:04.534279
NCT00092157|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-04-10|||May 1, 2002|Actual|2002-05-01|April 2017|2017-04-01|March 4, 2003|Actual|2003-03-04|March 3, 2003|Actual|2003-03-03||Interventional|||Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)|A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Tolerability and Efficacy of the Co-Administration of Simvastatin 20 mg/Day and Fenofibrate 160 mg/Day Compared to Simvastatin 20 mg/Day Alone for 12 Weeks of Treatment in Patients With Combined Hyperlipidemia-Simvastatin and Fenofibrate Efficacy Trial (SAFARI)|Completed||Phase 3|571|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:04.622875|2017-10-11 04:59:04.622875
NCT00092170|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-02-16|||March 2002||2002-03-01|February 2017|2017-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)|A Prospective, Multicenter, Randomized, Open-Label, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of Ertapenem Sodium ( MK0826) Versus Ticarcillin/Clavulanate in the Treatment of Hospital-Acquired Pneumonia, Complicated Intra-Abdominal Infections, and Acute Pelvic Infections in Pediatric Patients|Completed||Phase 2|100||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:04.710953|2017-10-11 04:59:04.710953
NCT00092183|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-05-02|||October 10, 2002|Actual|2002-10-10|May 2017|2017-05-01|February 11, 2004|Actual|2004-02-11|December 1, 2003|Actual|2003-12-01||Interventional|||An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)|A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Moderately Emetogenic Chemotherapy|Completed||Phase 4|866|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:04.806922|2017-10-11 04:59:04.806922
NCT00092196|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-05-02|||December 1, 2002|Actual|2002-12-01|May 2017|2017-05-01|December 1, 2004|Actual|2004-12-01|December 1, 2004|Actual|2004-12-01||Interventional|||Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)|Open-label Extension to: A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Moderately Emetogenic Chemotherapy|Completed||Phase 3|820|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:04.907904|2017-10-11 04:59:04.907904
NCT00092209|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2015-03-17|||April 2002||2002-04-01|March 2015|2015-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)|A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of the Anti-Hypertensive Efficacy and Safety of Losartan Monotherapy as Compared to HCTZ Monotherapy and to the Combination of Losartan and HCTZ in Japanese Patients With Essential Hypertension|Completed||Phase 3|840||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:04.987216|2017-10-11 04:59:04.987216
NCT00092235|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-21|2017-10-05|||September 17, 2004||2004-09-17|June 14, 2017|2017-06-14||||||||Observational|||Factors Determining Outcomes in Patients With Graft-Versus-Host Disease|Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease|Recruiting||N/A|550|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:59:05.493282|2017-10-11 04:59:05.493282
NCT00092274|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2015-04-20|||September 2004||2004-09-01|January 2005|2005-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma|An Open-label, International, Multicenter, Dose Escalating, Phase I/II Study of HuMax-CD20 in Patients With Relapsed or Refractory Follicular Lymphoma Grade I-II|Withdrawn||Phase 1/Phase 2|0|Actual|GlaxoSmithKline||||Acquired asset|||||||||||||||2017-10-11 04:59:05.600926|2017-10-11 04:59:05.600926
NCT00092287|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2008-02-25|||July 2004||2004-07-01|February 2008|2008-02-01|October 2004|Actual|2004-10-01|||||Interventional|||Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome|A Phase III, Prospective, Multicenter, Randomized, Open, Parallel Group Comparison of Lanreotide Autogel® (90 and 120 mg) Administered by Deep Subcutaneous Injection Every Four Weeks, With Sandostatin LAR Depot (20 and 30 mg) Administered by Intramuscular Injection, Every Four Weeks for Six Months, in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome|Terminated||Phase 3|196||Ipsen|||||||||||||||||||2017-10-11 04:59:05.701081|2017-10-11 04:59:05.701081
NCT00092300|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2015-07-31|||May 2002||2002-05-01|July 2015|2015-07-01||||September 2002|Actual|2002-09-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)|A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Single Dose Study of the Effect of Rofecoxib 50 mg and Valdecoxib 20 mg in Patients With Postoperative Dental Pain|Completed||Phase 3|450||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:05.807584|2017-10-11 04:59:05.807584
NCT00092313|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2015-11-24|||June 2002||2002-06-01|November 2015|2015-11-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)|A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study to Evaluate the Efficacy of Rofecoxib and a Dosing Regimen of Oxycodone With Acetaminophen Over 24 Hours in Patients With Postoperative Dental Pain|Completed||Phase 3|271|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:05.900982|2017-10-11 04:59:05.900982
NCT00092326|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2016-02-19|||June 2002||2002-06-01|February 2016|2016-02-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)|A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study to Evaluate the Efficacy of Rofecoxib and a Dosing Regimen of Oxycodone With Acetaminophen Over 24 Hours in Patients With Postoperative Dental Pain|Completed||Phase 3|269|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:05.98944|2017-10-11 04:59:05.98944
NCT00092339|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2017-05-05|||August 1, 2002|Actual|2002-08-01|May 2017|2017-05-01|September 15, 2002|Actual|2002-09-15|September 15, 2002|Actual|2002-09-15||Interventional|||A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Effects of Rofecoxib 50 mg and Valdecoxib 40 mg in Patients With Postoperative Dental Pain|Completed||Phase 3|125|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:06.067334|2017-10-11 04:59:06.067334
NCT00094276|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2013-01-18|||September 2004||2004-09-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Intervention for Improving Asthma Care for Minority Children in Head Start|Improving Asthma Care for Minority Children in Head Start|Completed||Phase 3|336|Actual|Johns Hopkins University||4|||f||||t||||||||||2017-10-11 04:59:47.035791|2017-10-11 04:59:47.035791
NCT00092352|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2017-05-05|||April 29, 2003|Actual|2003-04-29|May 2017|2017-05-01|December 1, 2003|Actual|2003-12-01|December 1, 2003|Actual|2003-12-01||Interventional|||A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)|A Randomized, Placebo-Controlled, Parallel-Group, Double -Blind Study to Evaluate the Safety and Efficacy of Rofecoxib 12.5 mg and Celecoxib 200 mg in Patients With Osteoarthritis of the Knee|Completed||Phase 3|395|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:06.178899|2017-10-11 04:59:06.178899
NCT00092365|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2017-05-05|||April 1, 2003|Actual|2003-04-01|May 2017|2017-05-01|November 1, 2003|Actual|2003-11-01|November 1, 2003|Actual|2003-11-01||Interventional|||A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)|A Randomized, Placebo-Controlled, Parallel-Group, Double -Blind Study to Evaluate the Safety and Efficacy of Rofecoxib 12.5 mg and Celecoxib 200 mg in Patients With Osteoarthritis of the Knee|Completed||Phase 3|413|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:06.272215|2017-10-11 04:59:06.272215
NCT00092378|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2017-05-05|||September 1, 2003|Actual|2003-09-01|May 2017|2017-05-01|December 1, 2003|Actual|2003-12-01|December 1, 2003|Actual|2003-12-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)|A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Parallel-Group Study of Rofecoxib and Diclofenac Sodium in the Treatment of Post-Bunionectomy Surgery Pain|Completed||Phase 3|251|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:06.381459|2017-10-11 04:59:06.381459
NCT00092391|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2015-10-22|||February 1999||1999-02-01|October 2015|2015-10-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)|A Study of M-M-R(TM) II at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age|Completed||Phase 3|1997|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-10-11 04:59:06.543131|2017-10-11 04:59:06.543131
NCT00092404|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2017-03-14|||December 2001||2001-12-01|March 2017|2017-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)|A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured With Recombinant Human Albumin (rHA) Versus V205C Manufactured With Pooled-Donor Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age|Completed||Phase 2|1210|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:06.662842|2017-10-11 04:59:06.662842
NCT00092417|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2015-10-06|2010-05-12||October 2003||2003-10-01|October 2015|2015-10-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)|Evaluation of the Safety and Tolerability of a Higher Potency Dose of Varicella Zoster Virus Vaccine Live (Oka/Merck)Among Adults 50 Years of Age or Older|Completed||Phase 3|695|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:59:06.772702|2017-10-11 04:59:06.772702
NCT00092430|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2017-03-15|||September 2002||2002-09-01|March 2017|2017-03-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)|A Comparison of the Safety, Tolerability, and Immunogenicity of a Refrigerator-Stable Measles, Mumps, Rubella, and Varicella Combination Vaccine V221 (Refrigerated) Versus V221 (Frozen) in Healthy Children|Completed||Phase 3|1200||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:07.226344|2017-10-11 04:59:07.226344
NCT00092443|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2015-09-11|2009-05-19||September 2002||2002-09-01|September 2015|2015-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Dose Confirmation Efficacy Study (V260-007)|Study of the Efficacy, Safety, and Immunogenicity of V260 at Expiry|Completed||Phase 3|1312|Actual|Merck Sharp & Dohme Corp.|Safety has been reported in the literature.|2|||f||||||||||||||2017-10-11 04:59:07.311567|2017-10-11 04:59:07.311567
NCT00092456|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2015-09-18|2009-06-19||May 2003||2003-05-01|September 2015|2015-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Consistency Lots Vaccine Study (V260-009)|Comparison of the Immunogenicity and Safety of Three Consistency Lots of V260 in Healthy Infants|Completed||Phase 3|793|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-10-11 04:59:07.97108|2017-10-11 04:59:07.97108
NCT00092469|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2015-10-06|||March 2002||2002-03-01|October 2015|2015-10-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)|A Registration Study of the Safety, Tolerability, and Immunogenicity of V441 in Healthy Infants in Taiwan|Completed||Phase 3|151||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:09.096569|2017-10-11 04:59:09.096569
NCT00092482|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2017-03-20|||June 28, 2002|Actual|2002-06-28|March 2017|2017-03-01|August 15, 2008|Actual|2008-08-15|June 30, 2004|Actual|2004-06-30||Interventional|||Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)|Immunogenicity and Safety of Gardasil (V501) Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Consistency Lots for 16- to 23-Year-Old Women With and Additional Immunogenicity Bridge to the Monovalent HPV 16 Vaccine Pilot Manufacturing Lot Study-The F.U.T.U.R.E. Study (Females United to Unilaterally Reduce Endo/Ectocervical Disease)|Completed||Phase 3|3882|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:09.172352|2017-10-11 04:59:09.172352
NCT00092495|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2014-12-29|2010-02-15||December 2002||2002-12-01|December 2014|2014-12-01|February 2009|Actual|2009-02-01|September 2004|Actual|2004-09-01||Interventional|||Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)|A Study to Demonstrate Immunogenicity and Tolerability of Gardasil (V501) Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Preadolescents, and To Determine End-Expiry Specifications for the Vaccine|Completed||Phase 3|3055|Actual|Merck Sharp & Dohme Corp.|Of note, the number of subjects who completed the Vaccination Period (N=1441) is slightly higher than that specified in the publication by Block, et al (2006; N=1430). The data provided here is based on final data.|4|||f||||||||||||||2017-10-11 04:59:09.269521|2017-10-11 04:59:09.269521
NCT00092508|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-22|2007-06-19|||May 2004||2004-05-01|June 2007|2007-06-01|May 2007||2007-05-01|||||Interventional|||CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission|Phase 3, Multi-Center, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the Efficacy and Safety of 25 mg QD and 50 mg QD of OPC-6335 Oral Tablets and 800 mg BID of Asacol® in the Maintenance of Ulcerative Colitis Remission|Completed||Phase 3|1725|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 04:59:10.711899|2017-10-11 04:59:10.711899
NCT00092521|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2015-09-24|2009-08-03||December 2001||2001-12-01|September 2015|2015-09-01|January 2009|Actual|2009-01-01|July 2007|Actual|2007-07-01||Interventional|||Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)|A Study to Evaluate the Efficacy of Quadrivalent HPV Vaccine in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related CIN, AIS, and Cervical Cancer, and HPV 6-, 11-, 16-, and 18-Related External Genital Warts, Vulvar Intraepithelial Neoplasia Vaginal Intraepithelial Neoplasia, Vulvar Cancer, and Vaginal Cancer in 16- to 23-Year-Old Women|Completed||Phase 3|5759|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-10-11 04:59:10.920879|2017-10-11 04:59:10.920879
NCT00092534|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-04-21|2009-07-20||June 14, 2002|Actual|2002-06-14|April 2017|2017-04-01|March 31, 2017|Actual|2017-03-31|July 31, 2007|Actual|2007-07-31||Interventional|||Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015)|A Randomized, Worldwide, Placebo-Controlled, Double-Blind Study to Investigate the Safety Immunogenicity and Efficacy on the Incidence of HPV 16/18-Related CIN2/3 or Worse of the Quadrivalent HPV (Types 6, 11, 16, 18,) L1 Virus-Like Particle (VLP) Vaccine (V501, Gardasil) in 16- to 23-Year Old Women - The F.U.T.U.R.E. II Study (Females United to Unilaterally Reduce Endo/Ectocervical Disease)|Completed||Phase 3|12167|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 04:59:12.488264|2017-10-11 04:59:12.488264
NCT00092547|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2016-02-09|2009-11-03||October 2003||2003-10-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)|A Safety and Immunogenicity Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Preadolescents and Adolescents (Base Study). A Long Term Immunogenicity, Safety, and Effectiveness Study of GARDASIL (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) Among Adolescents Who Received GARDASIL at 9-18 Years of Age (Extension Study).|Completed||Phase 3|1781|Actual|Merck Sharp & Dohme Corp.|The difference between the prior and final data is a minor change in the definition of the per-protocol immunogenicity population, which was applied down to the base study. Also, protocol violators were identified and excluded from the analysis.|3|||f||||f||||||||||2017-10-11 04:59:13.801362|2017-10-11 04:59:13.801362
NCT00092560|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-02-24|||December 2002||2002-12-01|February 2017|2017-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)|Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia|Completed||Phase 3|587|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:14.898637|2017-10-11 04:59:14.898637
NCT00092573|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-02-24|||April 2003||2003-04-01|February 2017|2017-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)|Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia|Completed||Phase 3|576|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:14.994647|2017-10-11 04:59:14.994647
NCT00092586|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-02-24|||September 2002||2002-09-01|February 2017|2017-02-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)|A Multi-center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe 10 mg/Day When Added to Ongoing Therapy With a Statin Versus Statin Therapy Alone, in Patients With Hypercholesterolemia Who Have Not Reached National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Target LDL-Cholesterol Level|Completed||Phase 3|2904|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:15.081457|2017-10-11 04:59:15.081457
NCT00092599|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-09|||February 2003||2003-02-01|March 2017|2017-03-01|July 2004|Actual|2004-07-01|June 2004|Actual|2004-06-01||Interventional|||Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Co-administered With Existing Simvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease.|Completed||Phase 3|410|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:15.140971|2017-10-11 04:59:15.140971
NCT00092612|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-09|||May 2003||2003-05-01|March 2017|2017-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Co-administered With Existing Simvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease.|Completed||Phase 3|372|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:15.382699|2017-10-11 04:59:15.382699
NCT00092625|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-09|||March 2003||2003-03-01|March 2017|2017-03-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Added to Existing Atorvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease.|Completed||Phase 3|442|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:15.466356|2017-10-11 04:59:15.466356
NCT00092638|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-09|||May 2003||2003-05-01|March 2017|2017-03-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Added to Existing Atorvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease.|Completed||Phase 3|450|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:15.565978|2017-10-11 04:59:15.565978
NCT00092651|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-09|||September 2002||2002-09-01|March 2017|2017-03-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)|"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patients With Primary Hypercholesterolemia"|Completed||Phase 3|1398|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:15.646633|2017-10-11 04:59:15.646633
NCT00092664|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-09|||January 2003||2003-01-01|March 2017|2017-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)|"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Factorial Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patients With Primary Hypercholesterolemia"|Completed||Phase 3|1104|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:15.753384|2017-10-11 04:59:15.753384
NCT00092677|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-09|2009-03-31||January 2001||2001-01-01|March 2017|2017-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effects of Ezetimibe + Simvastatin on Clinical Outcomes in Patients With Aortic Stenosis|Completed||Phase 3|1873|Actual|Merck Sharp & Dohme Corp.|It is important to note that several of the ischemic outcomes making up the composite ischemic endpoint can occur as a causal consequence of aortic stenosis progression itself, or in association with its standard treatment (aortic valve replacement).|2|||f||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:59:15.948631|2017-10-11 04:59:15.948631
NCT00092690|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-10|||June 2003||2003-06-01|March 2017|2017-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)|A Multicenter, Double-Blind, Randomized, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Patients With Hypercholesterolemia|Completed||Phase 3|1902|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 04:59:19.906709|2017-10-11 04:59:19.906709
NCT00092703|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-04-06|||June 27, 2002|Actual|2002-06-27|April 2017|2017-04-01|November 1, 2003|Actual|2003-11-01|November 1, 2003|Actual|2003-11-01||Interventional|||Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)|A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 50 mg t.i.d. in Patients With Osteoarthritis|Completed||Phase 3|6000||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:19.980994|2017-10-11 04:59:19.980994
NCT00092716|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-02-28|||May 2002||2002-05-01|February 2017|2017-02-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)|A Multicenter, Double-Blind, Randomized, Parallel Group, 28-Week Study to Evaluate the Efficacy and Safety of Ezetimibe and Simvastatin Co-administration Versus Atorvastatin in Patients With Hypercholesteremia|Completed||Phase 3|655|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:20.057878|2017-10-11 04:59:20.057878
NCT00092729|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-04-06|||June 7, 2002|Actual|2002-06-07|April 2017|2017-04-01|December 6, 2002|Actual|2002-12-06|December 6, 2002|Actual|2002-12-06||Interventional|||An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)|A Randomized, Placebo-and Active-Comparator-Controlled Study of Etoricoxib 120 mg in the Treatment of Primary Dysmenorrhea|Completed||Phase 3|129|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-10-11 04:59:20.114703|2017-10-11 04:59:20.114703
NCT00092742|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2015-06-29|||February 2003||2003-02-01|June 2015|2015-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)|A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 75 mg b.i.d. in Patients With Rheumatoid Arthritis|Completed||Phase 3|4086|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:20.368474|2017-10-11 04:59:20.368474
NCT00092755|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-04-06|||April 9, 2003|Actual|2003-04-09|April 2017|2017-04-01|November 13, 2003|Actual|2003-11-13|November 13, 2003|Actual|2003-11-13||Interventional|||An Investigational Drug in Patients With Osteoarthritis (0663-073)|A 12-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Ibuprofen 2400 mg in Patients With Osteoarthritis (Study 2)|Completed||Phase 3|548|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:20.493577|2017-10-11 04:59:20.493577
NCT00092768|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-04-06|||March 1, 2004|Actual|2004-03-01|April 2017|2017-04-01|February 1, 2005|Actual|2005-02-01|February 1, 2005|Actual|2005-02-01||Interventional|||A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)|A 26-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind, 2-Part Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Patients With Osteoarthritis (Study 1)|Completed||Phase 3|500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:20.560173|2017-10-11 04:59:20.560173
NCT00092781|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-04-06|||March 1, 2004|Actual|2004-03-01|April 2017|2017-04-01|February 1, 2005|Actual|2005-02-01|February 1, 2005|Actual|2005-02-01||Interventional|||A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)|A 26-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind, 2-Part Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Patients With Osteoarthritis (Study 2)|Completed||Phase 3|500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:20.63144|2017-10-11 04:59:20.63144
NCT00092807|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-05-10|||February 12, 2001|Actual|2001-02-12|May 2017|2017-05-01|November 30, 2004|Actual|2004-11-30|September 18, 2001|Actual|2001-09-18||Interventional|||Sitosterolemia Extension Study (0653-003)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK0653 When Added to Current Regimen in Patients With Homozygous Sitosterolemia - 1 Year Open-Label Extension|Completed||Phase 3|37|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:20.710033|2017-10-11 04:59:20.710033
NCT00092820|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-05-10|||February 12, 2001|Actual|2001-02-12|May 2017|2017-05-01|November 30, 2004|Actual|2004-11-30|September 18, 2001|Actual|2001-09-18||Interventional|||Sitosterolemia Extension Study (0653-004)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK0653 When Added to Current Regimen in Patients With Homozygous Sitosterolemia|Completed||Phase 3|58|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:20.786051|2017-10-11 04:59:20.786051
NCT00092833|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-02-24|||July 2002||2002-07-01|February 2017|2017-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)|An Open-Label, Worldwide, Treatment Use Study to Provide Ezetimibe 10 Mg/Day to Patients With Homozygous Familial Hypercholesterolemia or Homozygous Sitosterolemia|Terminated||Phase 3|49|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-10-11 04:59:20.853869|2017-10-11 04:59:20.853869
NCT00092846|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-09-28|||December 4, 2002|Actual|2002-12-04|September 2017|2017-09-01||||September 1, 2003|Actual|2003-09-01||Interventional|||A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)|A Consumer Use Study of OTC Lovastatin (CUSTOM): A 6-Month Consumer Behavior Study of the Lovastatin OTC Self-Management System|Completed||Phase 3|1000|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:20.949881|2017-10-11 04:59:20.949881
NCT00092859|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2016-12-30|||August 2003||2003-08-01|December 2016|2016-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of MK0557 in Obese Patients|Completed||Phase 3|1500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:21.021665|2017-10-11 04:59:21.021665
NCT00092872|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2015-01-29|||November 2003||2003-11-01|January 2015|2015-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of MK0557 in Obese Patients|Completed||Phase 3|359|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:21.081666|2017-10-11 04:59:21.081666
NCT00092885|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-17|||March 2003||2003-03-01|March 2017|2017-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)|A Multicenter, Double-Blind, Randomized Study Investigating the Clinical Effect of Montelukast on Allergic Rhinitis in Patients With Seasonal Allergic Rhinitis and Chronic Asthma|Completed||Phase 3|831|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:21.582606|2017-10-11 04:59:21.582606
NCT00092898|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-23|2017-03-07|||October 2004||2004-10-01|March 2017|2017-03-01|October 2005|Actual|2005-10-01|September 2005|Actual|2005-09-01||Interventional|||An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to An Ongoing Regimen of Ezetimibe 10 mg in Patients Homozygous Sitosterolemia|Completed||Phase 3|30|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:21.660524|2017-10-11 04:59:21.660524
NCT00092911|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-24|2009-08-18||||||August 2009|2009-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of a Flexible Dose of DVS-233 SR in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|244|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:59:21.767094|2017-10-11 04:59:21.767094
NCT00092924|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-24|2013-08-01||||||August 2013|2013-08-01|March 2005|Actual|2005-03-01|January 2005|Actual|2005-01-01||Interventional|||Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)|A Phase 2, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety, and Tolerability of TRM-1 (Fully Human Monoclonal Antibody To TRAIL-R1) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer|Completed||Phase 2|||Human Genome Sciences Inc.|||||||||||||||||||2017-10-11 04:59:21.824672|2017-10-11 04:59:21.824672
NCT00092937|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-24|2017-06-30|||September 23, 2004||2004-09-23|April 6, 2010|2010-04-06|April 6, 2010|Actual|2010-04-06|April 6, 2010|Actual|2010-04-06||Interventional|||Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant|Secondary Transplantation Using Moderate Dose Busulfan as Conditioning for a Patient With Partial Reconstitution Post Initial Allogeneic Transplantation|Completed||Phase 1|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:59:21.900955|2017-10-11 04:59:21.900955
NCT00092950|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-24|2017-06-30|||September 23, 2004||2004-09-23|September 28, 2011|2011-09-28|December 7, 2009|Actual|2009-12-07|December 7, 2009|Actual|2009-12-07||Interventional|||Exercise in Women at Risk for Breast Cancer|A Pilot Study of a Three Month Intervention for Increasing Physical Activity in Sedentary Women at Risk for Breast Cancer|Completed||Phase 2|88|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:59:21.986237|2017-10-11 04:59:21.986237
NCT00092963|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-28|2017-03-31|||August 17, 2004|Actual|2004-08-17|March 2017|2017-03-01|January 14, 2005|Actual|2005-01-14|January 14, 2005|Actual|2005-01-14||Interventional|||Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)|A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild|Completed||Phase 3|529|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:22.070567|2017-10-11 04:59:22.070567
NCT00092976|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-28|2007-12-19|||February 2003||2003-02-01|May 2006|2006-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery|A Phase IV Study of the Safety and Efficacy of ReFacto® (Moroctocog Alfa, B-Domain Deleted Recombinant Factor VIII) in Subjects With Hemophilia A Undergoing Major Surgery Monitored Using the Chromogenic Substrate Assay at the Local Laboratory|Completed||Phase 4|15|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 04:59:22.149921|2017-10-11 04:59:22.149921
NCT00092989|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-28|2017-03-09|||July 2004||2004-07-01|March 2017|2017-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)|A Multicenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast With Placebo in Patients With Acute Asthma|Completed||Phase 3|650|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 04:59:22.225987|2017-10-11 04:59:22.225987
NCT00093002|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-28|2008-06-11|||June 2004||2004-06-01|June 2008|2008-06-01|July 2007|Actual|2007-07-01|||||Interventional|||Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer|A Randomized, Open-Label, Multicenter, Phase II Study Comparing the Effects on Proliferation and the Efficacy and Tolerability of Fulvestrant (FASLODEX®) 500 mg With Fulvestrant (FASLODEX®) 250 mg When Given as Neoadjuvant Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer (T2, 3, 4b, N0-3, M0).|Completed||Phase 2|179|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 04:59:22.355328|2017-10-11 04:59:22.355328
NCT00093015|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-28|2017-05-16|2010-08-06||August 2004||2004-08-01|May 2017|2017-05-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)|Trial to Reduce Cardiovascular Events With Aranesp® Therapy|Completed||Phase 3|4038|Actual|Amgen|4047 subjects were enrolled, but before unblinding, all information from 9 subjects was excluded from two sites (3 and 6 subjects, respectively) that did not adhere to Good Clinical Practice guidelines. 4038 subjects were analyzed and reported.|2|||f||||||||||||||2017-10-11 04:59:24.085725|2017-10-11 04:59:24.085725
NCT00093028|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-29|2010-07-01|||January 2004||2004-01-01|July 2010|2010-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II|UARK 2003-35, A Phase III Study of Bortezomib Versus Bortezomib in Two Doses in Combination With Revlimid™ for Patients Relapsing or Progressing on Total Therapy II (UARK 98-026)|Completed||Phase 3|315|Actual|University of Arkansas||1|||f||||f||||||||||2017-10-11 04:59:28.938482|2017-10-11 04:59:28.938482
NCT00093041|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-30|2011-11-17|2011-09-12||December 2003||2003-12-01|November 2011|2011-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Zalutumumab in Head and Neck Cancer|An Open, Single Dose Escalation Study Followed by a Multiple Dose Extension of Anti-EGF Receptor Human Monoclonal Antibody (Zalutumumab) in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 1/Phase 2|28|Actual|Genmab|The study comprised a single-dose escalation part for assessment of safety and a repeat dose extension including 4 weekly infusions. Please see the referred publication by Bastholt at al 2007 for detailed results.|6|||f||||||||||||||2017-10-11 04:59:29.038462|2017-10-11 04:59:29.038462
NCT00093054|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-30|2015-04-14||2015-04-14|November 2004||2004-11-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Interventional|||Cranberry Juice for Treatment of Urinary Tract Infections|Cranberry Juice and Urinary Tract Infections|Completed||Phase 2/Phase 3|319|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-10-11 04:59:29.842815|2017-10-11 04:59:29.842815
NCT00093067|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-30|2017-02-09|||March 2002||2002-03-01|February 2017|2017-02-01|February 2005|Actual|2005-02-01|November 2004|Actual|2004-11-01||Interventional|||Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus|A Phase 3, Multicenter, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of Daptomycin Compared to Conventional Therapy In the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to Staph Aureus|Completed||Phase 3|||Cubist Pharmaceuticals LLC|||||f||||||||||||||2017-10-11 04:59:29.911887|2017-10-11 04:59:29.911887
NCT00093080|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-30|2015-02-12|||October 2004||2004-10-01|February 2015|2015-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)|A Phase II Study of AP23573, An mTOR Inhibitor, in Patients With Advanced Sarcoma|Completed||Phase 2|216|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-10-11 04:59:30.092424|2017-10-11 04:59:30.092424
NCT00093093|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-30|2012-06-21|||June 2004||2004-06-01|June 2012|2012-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|VISER2||Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive|Randomized, Double-Blind, Multicenter Study to Compare the Safety and Efficacy of Viramidine to Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C|Completed||Phase 3|900||Valeant Pharmaceuticals International, Inc.|||||f||||||||||||||2017-10-11 04:59:30.20104|2017-10-11 04:59:30.20104
NCT00093119|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-01|2017-04-25|||July 2003||2003-07-01|April 2017|2017-04-01||||February 2005|Actual|2005-02-01||Interventional|||Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma|A Phase II Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma|Completed||Phase 2|75|Actual|Celgene||1|||f||||||||||||||2017-10-11 04:59:30.506292|2017-10-11 04:59:30.506292
NCT00093132|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-01|2012-08-09||2012-08-09|August 2004||2004-08-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy|A Phase 1/2 Study With Satraplatin and Simultaneous Radiation in Locally Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|20|Actual|Agennix||1||Sponsor decided to discontinue study drug development.|f||||||||||||||2017-10-11 04:59:30.616452|2017-10-11 04:59:30.616452
NCT00093145|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-04|2013-07-15|2013-05-07||June 2004||2004-06-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer|A Phase II Study of Weekly Dose-Dense Nanoparticle Paclitaxel (ABI-007), Carboplatin With Herceptin® As First-Line Therapy of Advanced HER-2 Positive Breast Cancer|Completed||Phase 2|32|Actual|Celgene||1|||f||||f||||||||||2017-10-11 04:59:30.709953|2017-10-11 04:59:30.709953
NCT00093158|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-04|2007-08-20|||August 2003||2003-08-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)|The ACUITY Trial: A Randomized Comparison of Angiomax (Bivalirudin) Versus Heparin (Unfractionated Heparin or Enoxaparin) in Patients Undergoing Early Invasive Management for Acute Coronary Syndromes Without ST-Segment Elevation|Completed||Phase 3|13800||The Medicines Company|||||||||||||||||||2017-10-11 04:59:31.296154|2017-10-11 04:59:31.296154
NCT00093171|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-04|2009-08-20||||||August 2009|2009-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study Evaluating rFIX; BeneFIX® in Hemophilia B|An Open-label Safety and Efficacy Study of Recombinant Human Factor IX (rFIX; BeneFIX®) in Previously Treated Patients (PTPs) With Hemophilia B (FIX:C ≤2%)|Completed||Phase 3|23|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:59:31.378013|2017-10-11 04:59:31.378013
NCT00093184|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-04|2006-02-08|||April 2004||2004-04-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI|A Study Evaluating the Safety and Efficacy of Bivalirudin in the Management of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary PCI (BIAMI)|Completed||Phase 3|300||The Medicines Company|||||||||||||||||||2017-10-11 04:59:31.4498|2017-10-11 04:59:31.4498
NCT00093197|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-04|2011-08-31|||September 2004||2004-09-01|August 2011|2011-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack|Intracoronary KAI-9803 for Injection as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction|Completed||Phase 1/Phase 2|154|Actual|KAI Pharmaceuticals||5|||f||||t||||||||||2017-10-11 04:59:31.529137|2017-10-11 04:59:31.529137
NCT00093210|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-04|2007-12-03||||||December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B|A Double-Blind, Randomized, Crossover Evaluation of the Pharmacokinetics of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R); and an Open-Label Safety and Efficacy Evaluation of rFIX-R in Previously Treated Patients With Moderate to Severe (FIX:C≤2%) Hemophilia B|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 04:59:31.843798|2017-10-11 04:59:31.843798
NCT00093223|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-04|2016-03-30|||September 2001||2001-09-01|March 2016|2016-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Safety Study of ABI-007 for In-Stent Restenosis|A Phase II Safety Study of Systemic Nanoparticle Paclitaxel (ABI-007)for In-Stent Restenosis|Completed||Phase 2|76|Actual|Celgene Corporation||2|||f||||t||||||||||2017-10-11 04:59:31.905511|2017-10-11 04:59:31.905511
NCT00093236|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-05|2017-04-19|||September 2004||2004-09-01|April 2017|2017-04-01|December 8, 2012|Actual|2012-12-08|April 2011|Actual|2011-04-01||Interventional|||Impact of Gum Infection on Heart Disease|Systemic Endothelial Consequences of Periodontal Disease|Completed||N/A|174|Actual|Boston University||2|||f||||t||||||||No||2017-10-11 04:59:32.019539|2017-10-11 04:59:32.019539
NCT00093249|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-05|2014-08-21|||January 2004||2004-01-01|August 2014|2014-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|ESCAPE-1||Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)|Efficacy Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)|Completed||Phase 3|105|Actual|The Medicines Company||2|||f||||t||||||||||2017-10-11 04:59:32.106998|2017-10-11 04:59:32.106998
NCT00093262|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-05|2014-05-07|||December 2003||2003-12-01|May 2014|2014-05-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|ESCAPE-2||Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)|Efficacy Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)|Completed||Phase 3|206|Actual|The Medicines Company||2|||||||t||||||||||2017-10-11 04:59:32.214501|2017-10-11 04:59:32.214501
NCT00093275|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-05|2008-08-20|||October 2004||2004-10-01|August 2008|2008-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||HP184 in Chronic Spinal Cord Injury Subjects|A Phase II, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of HP184 Administered Orally Once Daily for Twenty-Four Weeks in Adult Subjects With Chronic Spinal Cord Injury (CSCI)|Completed||Phase 2|262|Actual|Sanofi|||||||||||||||||||2017-10-11 04:59:32.326986|2017-10-11 04:59:32.326986
NCT00093288|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-05|2013-08-29|||June 2004||2004-06-01|August 2013|2013-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Major Depressive Disorder In The Elderly|A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible Dose Study to Evaluate the Efficacy, Safety and Tolerability of Extended-release Bupropion Hydrochloride (150mg-300mg Once Daily) in Elderly Subjects With Major Depressive Disorder|Completed||Phase 3|364||GlaxoSmithKline|||||f||||||||||||||2017-10-11 04:59:32.411955|2017-10-11 04:59:32.411955
NCT00093301|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-05|2005-06-23|||October 2004||2004-10-01|October 2004|2004-10-01|April 2006||2006-04-01|||||Interventional|||Levosimendan Versus Dobutamine in Shock Patients|Efficacy of Levosimendan in the Critically Ill Patients With Unstable Hemodynamics (the LICI Study) - A Double Blind Randomized Pilot Study|Unknown status|Recruiting|Phase 2/Phase 3|40||Wentworth Area Health Services|||||f||||||||||||||2017-10-11 04:59:32.518182|2017-10-11 04:59:32.518182
NCT00093314|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2015-04-20|||October 2004||2004-10-01|January 2007|2007-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||HuMax-CD20 in Chronic Lymphocytic Leukemia|An Open-labeled, International, Multicenter, Dose Escalating, Phase I/II Trial of HuMax-CD20, a Fully Human Monoclonal Anti-CD20 Antibody, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Withdrawn||Phase 1/Phase 2|0|Actual|GlaxoSmithKline||||Acquired asset|||||||||||||||2017-10-11 04:59:32.682496|2017-10-11 04:59:32.682496
NCT00093327|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2006-08-17|||September 2003||2003-09-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Acupuncture for Irritable Bowel Syndrome (IBS)|Acupuncture for Irritable Bowel Syndrome (IBS) Trial|Completed||Phase 2|287||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 04:59:32.770363|2017-10-11 04:59:32.770363
NCT00093353|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2010-10-14|||May 2004||2004-05-01|May 2009|2009-05-01||||July 2006|Actual|2006-07-01||Interventional|||N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma|A Phase I Study Of Oral Irinotecan, Temozolomide, Cefixime In Children With Recurrent/Resistant High-Risk Neuroblastoma|Completed||Phase 1|30|Anticipated|Children's Hospital Los Angeles|||||f||||t||||||||||2017-10-11 04:59:32.84837|2017-10-11 04:59:32.84837
NCT00093366|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2011-11-28|||June 2004||2004-06-01|November 2011|2011-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes|Therapy of Advanced Stage Myelodysplastic Syndrome (MDS) With Arsenic Trioxide Given in Combination With Etanercept: A Phase I/II Study|Completed||Phase 1/Phase 2|32|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 04:59:32.982634|2017-10-11 04:59:32.982634
NCT00093379|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2014-03-12|2013-10-15||April 2004||2004-04-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer|A Phase II Study of Capecitabine (Xeloda)/Oxaliplatin (Eloxatin) With Concomitant Radiotherapy (XRT), XELOX/RT in Squamous Cell Carcinoma of the Anal Canal|Completed||Phase 2|20|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:59:33.09056|2017-10-11 04:59:33.09056
NCT00093405|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-06-21|||August 2004||2004-08-01|November 2005|2005-11-01|November 2005|Actual|2005-11-01|||||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AAG)In Metastatic Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:59:33.530531|2017-10-11 04:59:33.530531
NCT00093418|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-01-14|||September 2004||2004-09-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia|Phase II Studies of Two Different Schedules and Two Different Doses of the Farnesyl Transferase Inhibitor R115777 (Tipifarnib, Zarnestra®, NSC-702818) for Previously Untreated Acute Myeloid Leukemia (AML) in Patients of Age 70 or Older|Completed||Phase 2|296|Actual|National Cancer Institute (NCI)||4|||f||||||||||||||2017-10-11 04:59:33.615032|2017-10-11 04:59:33.615032
NCT00093444|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2012-03-14|||September 2004||2004-09-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|||||Interventional|||Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors|A Phase I Dose Escalation Study Of Heat Activated Liposome Delivery Of Doxorubicin And Radiofrequency Ablation Of Primary And Metastatic Tumors Of The Liver|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 04:59:33.72685|2017-10-11 04:59:33.72685
NCT00093457|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2011-09-27|||July 2004||2004-07-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|September 2006|Actual|2006-09-01||Interventional|||Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer|A Phase II Study Of BAY 43-9006 (NSC 724772; CTEP IND# 69,896) In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|28|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-10-11 04:59:33.828912|2017-10-11 04:59:33.828912
NCT00093470|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2016-11-14|2015-10-13||August 2004||2004-08-01|November 2016|2016-11-01||||February 2015|Actual|2015-02-01||Interventional||All randomized patients|Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission|A Phase III Randomized Study of Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subsequent Remission or in Remission After Primary Induction Failure or Patients Over Age 60 in First Remission|Active, not recruiting||Phase 3|144|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 04:59:33.966078|2017-10-11 04:59:33.966078
NCT00093483|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2014-01-10|||April 2002||2002-04-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia|Arsenic Trioxide, High-Dose Cytarabine and Idarubicin Induction Therapy in Previously Untreated de Novo and Secondary Adult Acute Myeloid Leukemia Patients < 60 Years Old - A Phase I Study|Completed||Phase 1|61|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 04:59:34.891026|2017-10-11 04:59:34.891026
NCT00093496|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2014-05-02|2013-03-22||October 2007||2007-10-01|October 2011|2011-10-01|March 2012|Actual|2012-03-01|April 2010|Actual|2010-04-01||Interventional|||Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer|A Phase II Trial Of Gemcitabine in Combination With 17-Allylaminogeldamycin (17-AAG) In Advanced Epithelial Ovarian And Primary Peritoneal Carcinoma|Completed||Phase 2|29|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:59:34.994175|2017-10-11 04:59:34.994175
NCT00093509|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2014-08-29|||November 1999||1999-11-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|July 2007|Actual|2007-07-01||Interventional|||MRI Sarcoma Non Invasive Thermometry|Magnetic Resonance Based Non-Invasive Thermometry for Hyperthermic Treatment of Extremity Soft Tissue Sarcomas: A Multimodal Phase I/II Study|Completed||Phase 1/Phase 2|15|Actual|Duke University||1|||f||||f||||||||||2017-10-11 04:59:35.495731|2017-10-11 04:59:35.495731
NCT00093522|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-12-18|||August 2004||2004-08-01|May 2007|2007-05-01||||||||Interventional|||Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer|A Phase II Pilot Study of Tumor-Loaded Dendritic Cells Alone or Following a Non-Myeloablative Conditioning Regimen in Patients With Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|28|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:59:35.703016|2017-10-11 04:59:35.703016
NCT00093548|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2012-10-03||||||October 2012|2012-10-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer|A Phase I/II Trial Testing Immunization With AFP + GM-CSF Plasmid Prime And AFP Adenoviral Vector Boost In Patients With Hepatocellular Carcinoma (AFP Prime-Boost Protocol)|Withdrawn||Phase 1/Phase 2|0|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 04:59:35.793988|2017-10-11 04:59:35.793988
NCT00093561|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-06-25|||August 2004||2004-08-01|November 2006|2006-11-01|February 2006|Actual|2006-02-01|||||Interventional|||Lycopene in Preventing Prostate Cancer in Healthy Participants|Phase I Single Dose Pharmacokinetic Study of the Dietary Supplement Lycopene Delivered in Capsule Form to Healthy Male Volunteers Between 18 and 45 Years of Age|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:59:35.916054|2017-10-11 04:59:35.916054
NCT00093587|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-11-05|||August 2004||2004-08-01|January 2006|2006-01-01||||||||Interventional|||Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia|Pilot Trial of Two Dose Levels of Thymoglobulin® as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor (MRD) Stem Cell Transplant With Cyclosporine (CsA) as Posttransplant Graft vs Host Disease (GvHD) Prophylaxis|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:59:36.016307|2017-10-11 04:59:36.016307
NCT00093600|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2015-03-09|||February 2004||2004-02-01|March 2015|2015-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase IB, Open-Label Study to Determine the Safety and Pharmacokinetics of Twice Daily Oral Dosing of PKC412 Administered in Combinations Sequentially and Concomitantly With Daunorubicin and Cytarabine for Standard Induction Therapy, and High Dose Cytarabine for Consolidation in Patients With Acute Myeloid Leukemia (AML)|Completed||Phase 1|69|Actual|Novartis||2|||f||||f||||||||||2017-10-11 04:59:36.125332|2017-10-11 04:59:36.125332
NCT00093613|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2014-05-29|||December 2004||2004-12-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|October 2010|Actual|2010-10-01||Interventional|||Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma|A Phase I Trial of BAY 43-9006 for Patients With Recurrent or Progressive Malignant Glioma|Completed||Phase 1|47|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:59:36.273282|2017-10-11 04:59:36.273282
NCT00093626|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2015-05-18|||October 2004||2004-10-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|September 2007|Actual|2007-09-01||Interventional|||Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer|A Phase II Evaluation of BAY 43-9006 (Sorafenib, Nexavar®, NCI-Supplied Agent, NSC #724772) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|73|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:59:36.421456|2017-10-11 04:59:36.421456
NCT00093847|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2014-10-10|2012-04-25||May 2004||2004-05-01|October 2014|2014-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression|S-adenosyl Methionine (SAMe) Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for Treatment-Resistant Depression (TRD)|Completed||Phase 2|73|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 04:59:39.998857|2017-10-11 04:59:39.998857
NCT00093639|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-04-30|||August 2004||2004-08-01|April 2013|2013-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate|A Phase I-II, Study of RAD001 in Combination With Imatinib (Glivec®/Gleevec™) in Patients With Chronic Myelogenous Leukemia (CML) in Chronic Phase Who Are Not In Complete Cytogenetic Response to Imatinib-Alone at Study Entry|Completed||Phase 1/Phase 2|||Novartis|||||f||||||||||||||2017-10-11 04:59:36.545633|2017-10-11 04:59:36.545633
NCT00093652|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2015-10-05|||May 2003||2003-05-01|October 2015|2015-10-01||||May 2006|Actual|2006-05-01||Interventional|||Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer|ZD1839 (IRESSA®) With Oxaliplatin and Radiotherapy for Esophageal Carcinoma. A Phase I/II Study With Biologic Correlates|Terminated||Phase 1/Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 04:59:36.638715|2017-10-11 04:59:36.638715
NCT00093665|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-05-14|||November 2003||2003-11-01|October 2006|2006-10-01||||||||Interventional|||Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer|A Phase II Study Of Alternating Chemoradiotherapy For Nasopharyngeal Cancer Using Cisplatin And 5-Fluorouracil|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:59:36.729641|2017-10-11 04:59:36.729641
NCT00093678|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2015-10-06||||||October 2015|2015-10-01||||||||Interventional|||Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer|A Randomized, Double Blind, Placebo-Controlled Trial of Celecoxib in Patients With Advanced Cancer|Withdrawn||N/A|0|Actual|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 04:59:36.8438|2017-10-11 04:59:36.8438
NCT00093704|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2015-10-01|||March 2005||2005-03-01|August 2012|2012-08-01||||July 2010|Actual|2010-07-01||Interventional|||Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma|EBV as Therapeutic Target: A Pilot Study of Inducing and Targeting EBV-TK in EBV-Positive Lymphomas by Combination of Bortezomib and Ganciclovir|Terminated||Phase 1|1|Actual|Jonsson Comprehensive Cancer Center||1||study could not recruit any more patients|f||||t||||||||||2017-10-11 04:59:36.959983|2017-10-11 04:59:36.959983
NCT00093730|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2012-10-03|||August 2004||2004-08-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||BMS-599626 in Treating Patients With Metastatic Solid Tumors|Phase I Study Of BMS-599626 In Patients With Advanced Solid Malignancies That Express Her2|Completed||Phase 1|9|Actual|Jonsson Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 04:59:37.058762|2017-10-11 04:59:37.058762
NCT00093743|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2017-02-16|||January 2000||2000-01-01|February 2017|2017-02-01||||September 2007|Actual|2007-09-01||Interventional|||Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia|Low-Dose Total Body Irradiation and Fludarabine Followed By Unrelated Donor Stem Cell Transplantation for Patients With Fanconi Anemia - A Multicenter Trial|Completed||Phase 1|2|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 04:59:37.162981|2017-10-11 04:59:37.162981
NCT00093756|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2014-12-03|2013-11-25||September 2004||2004-09-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|January 2012|Actual|2012-01-01||Interventional|||Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer|Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|52|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:59:37.357588|2017-10-11 04:59:37.357588
NCT00093769|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2012-10-03|||August 2004||2004-08-01|October 2012|2012-10-01||||August 2005|Actual|2005-08-01||Interventional|||Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Study of VELCADE With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma|Completed||Phase 2|15|Actual|Jonsson Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 04:59:38.214184|2017-10-11 04:59:38.214184
NCT00093782|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2016-12-14|2015-06-11||December 2003||2003-12-01|December 2016|2016-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional||Number of participants accrued|Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma|A Phase II Study of CCI-779 in Metastatic Neuroendocrine Carcinomas|Completed||Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:59:38.316672|2017-10-11 04:59:38.316672
NCT00093795|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2016-11-28|||October 2004||2004-10-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2012|Actual|2012-03-01||Interventional|||Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer|A Phase III, Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Node-Positive Breast Cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC); Dose-Dense (DD) Doxorubicin/Cyclophosphamide Followed By DD Paclitaxel (DD AC→P); DD AC Followed By DD Paclitaxel Plus Gemcitabine (DD AC→PG)|Completed||Phase 3|4894|Actual|NSABP Foundation Inc||3|||f||||t||||||||||2017-10-11 04:59:38.761035|2017-10-11 04:59:38.761035
NCT00093808|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2017-01-23|2016-11-28||August 2004||2004-08-01|January 2017|2017-01-01|May 2013|Actual|2013-05-01|December 2008|Actual|2008-12-01||Interventional||Patients who completed the study or deemed a protocol violation were included in all analyses unless otherwise specified.|Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer|Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 04:59:38.924347|2017-10-11 04:59:38.924347
NCT00093821|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-06-03|||September 2004||2004-09-01|June 2013|2013-06-01||||August 2007|Actual|2007-08-01||Interventional|||Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors|A Multicenter Phase I Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) in Patients With Recurrent/Refractory Pediatric Solid Tumors (Ewing's Sarcoma, Desmoplastic Small Round Cell Tumor, Osteosarcoma, Neuroblastoma, and Rhabdomyosarcoma) and Leukemia|Completed||Phase 1|70|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 04:59:39.744757|2017-10-11 04:59:39.744757
NCT00093834|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2011-07-19|||January 2004||2004-01-01|April 2011|2011-04-01||||August 2008|Actual|2008-08-01||Interventional|||Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer|A Phase I Vaccine Safety and Chemotherapy Dose-Finding Trial of an Allogeneic GM-CSF-Secreting Breast Cancer Vaccine Given in a Specifically Timed Sequence With Immunomodulatory Doses of Cyclophosphamide and Doxorubicin|Completed||Phase 1|60|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 04:59:39.888216|2017-10-11 04:59:39.888216
NCT00093873|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-06|2013-05-13|||July 2003||2003-07-01|May 2013|2013-05-01|December 2006|Actual|2006-12-01|February 2006|Actual|2006-02-01||Interventional|||Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors|A Phase 1, First in Human, Open-Label, Dose Finding Study Evaluating the Safety and Pharmacokinetics of AMG 706 in Subjects With Advanced Solid Tumors|Completed||Phase 1|71|Actual|Amgen||1|||f||||||||||||||2017-10-11 04:59:40.46999|2017-10-11 04:59:40.46999
NCT00093886|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-07|2014-05-05|||April 2004||2004-04-01|May 2014|2014-05-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|ECLIPSE-NTG||Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)|Evaluation of Clevidipine in the Perioperative Treatment of Hypertension Assessing Safety Events (With Nitroglycerin as Active Comparator) (ECLIPSE-NTG)|Completed||Phase 3|629|Actual|The Medicines Company||2|||f||||t||||||||||2017-10-11 04:59:40.557231|2017-10-11 04:59:40.557231
NCT00093899|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-07|2017-03-13|||November 2004||2004-11-01|March 2017|2017-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)|A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia|Completed||Phase 3|611|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 04:59:40.717716|2017-10-11 04:59:40.717716
NCT00093912|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-07|2014-05-05|||June 2004||2004-06-01|May 2014|2014-05-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|ECLISPE-SNP||Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)|Evaluation of Clevidipine in the Perioperative Treatment of Hypertension Assessing Safety Events (With Sodium Nitroprusside as Active Comparator) (ECLISPE-SNP)|Completed||Phase 3|739|Actual|The Medicines Company||2|||f||||t||||||||||2017-10-11 04:59:40.799939|2017-10-11 04:59:40.799939
NCT00093925|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-07|2014-05-05|||May 2004||2004-05-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|ECLIPSE-NIC||Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)|Evaluation of Clevidipine in the Postoperative Treatment of Hypertension Assessing Safety Events (With Nicardipine as Active Comparator) (ECLIPSE-NIC)|Completed||Phase 3|739|Actual|The Medicines Company||2|||f||||t||||||||||2017-10-11 04:59:40.950406|2017-10-11 04:59:40.950406
NCT00093938|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-07|2010-01-12|||December 2004||2004-12-01|January 2010|2010-01-01||||||||Interventional|||Cranberry Juice for Preventing Bacteria in Urine During Pregnancy|Cranberry for Prevention of Bacteriuria in Pregnancy|Completed||Phase 1|360|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 04:59:41.054163|2017-10-11 04:59:41.054163
NCT00093951|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-07|2009-12-10|||April 2004||2004-04-01|February 2009|2009-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study of the Efficacy and Safety of SGS742 in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|280||National Institute on Aging (NIA)|||||||||||||||||||2017-10-11 04:59:41.144199|2017-10-11 04:59:41.144199
NCT00093977|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-07|2013-05-22|||October 2004||2004-10-01|May 2013|2013-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease|An Open-label, Single-Arm Study to Assess the Safety of Darbepoetin Alfa Manufactured by a Serum Free Bioreactor Technology in Subjects With Chronic Kidney Disease|Completed||Phase 3|1100|Anticipated|Amgen||1|||f||||||||||||||2017-10-11 04:59:41.578081|2017-10-11 04:59:41.578081
NCT00093990|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-07|2016-09-13|||January 2004||2004-01-01|September 2016|2016-09-01|October 2007|Actual|2007-10-01|||||Interventional|||Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)|A Randomized Study of Tipifarnib Versus Best Supportive Care (Including Hydroxyurea) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Subjects 70 Years or Older (Farnesyl Transferase Inhibition Global Human Trials AML 301 [F.I.G.H.T. AML 301])|Completed||Phase 3|457|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 04:59:41.653225|2017-10-11 04:59:41.653225
NCT00094003|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-08|2005-11-09|||September 2002||2002-09-01|November 2005|2005-11-01||||||||Interventional|||Study of NS-9 in Patients With Liver Metastases|A Phase I, Open-Label, Dose Escalation Study of Intravenously Administered NS-9 in Subjects With Liver Metastases From Various Primary Cancers|Completed||Phase 1|20||NS Pharma, Inc.|||||||||||||||||||2017-10-11 04:59:41.736126|2017-10-11 04:59:41.736126
NCT00094016|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-08|2014-05-09|||October 2004||2004-10-01|May 2014|2014-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children|Safety and Efficacy Evaluation of Two Doses of HFA-Propelled Beclomethasone Dipropionate (QVAR) Versus Placebo by Breath Operated and Metered Dose Inhalers in Mild to Moderate Asthmatic Children|Completed||Phase 3|440||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 04:59:41.814581|2017-10-11 04:59:41.814581
NCT00094029|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-08|2012-03-08|||September 2004||2004-09-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Expanded Access|||A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248|A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate|Approved for marketing||N/A|||Pfizer|||||||||f||||||||||2017-10-11 04:59:41.96031|2017-10-11 04:59:41.96031
NCT00094042|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-08|2010-01-26|||January 2002||2002-01-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Work and Iron Status Evaluation|Work and Iron Status Evaluation (WISE)|Completed||N/A|16000||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 04:59:42.227777|2017-10-11 04:59:42.227777
NCT00094250|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2016-07-28|||July 2006||2006-07-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||HEARTS: Heart, Exercise, and Resistance Training Study|More Effective Exercise Modalities in Older Congestive Heart Failure Patients|Withdrawn||N/A|200|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||||Study was closed due to administrative reasons; study did not enroll any participants.|f||||||||||||||2017-10-11 04:59:46.899773|2017-10-11 04:59:46.899773
NCT00094055|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-08|2012-06-21|2012-02-25|2009-03-20|September 2004||2004-09-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer|Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer Who Are Refractory to or Not Suitable Candidates for 131 I Treatment|Completed||Phase 2|60|Actual|Pfizer|Population pharmacokinetics and plasma concentrations of soluble proteins were not presented, as the data was not available for the single study and data for all the axitinib (AG-013736) Phase 2 studies would be pooled together in a separate report.|1|||f||||f||||||||||2017-10-11 04:59:42.304019|2017-10-11 04:59:42.304019
NCT00094068|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-09|2008-03-03|||October 2004||2004-10-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Observational|||The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients|A Pilot Study to Detect the Effect of Sildenafil Citrate on Cerebral Blood Perfusion in Multiple Sclerosis Patients by Perfusion MRI|Completed||N/A|76||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:59:44.299959|2017-10-11 04:59:44.299959
NCT00094081|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-11|2010-02-12|||October 2002||2002-10-01|February 2010|2010-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer|Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer|Completed||Phase 3|861|Actual|Sanofi|||||f||||||||||||||2017-10-11 04:59:44.369318|2017-10-11 04:59:44.369318
NCT00094094|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-11|2012-06-21|2012-02-25||February 2005||2005-02-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer|Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 as Second- or Later- Line Treatment in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|32|Actual|Pfizer|Population pharmacokinetics and plasma concentrations of soluble proteins were not presented, as the data was not available for the single study and data for all the axitinib Phase 2 studies would be pooled together in a separate report.|1|||f||||||||||||||2017-10-11 04:59:44.477274|2017-10-11 04:59:44.477274
NCT00094107|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-11|2012-06-21|2012-02-25|2009-03-20|December 2004||2004-12-01|June 2012|2012-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma|Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma|Completed||Phase 2|32|Actual|Pfizer|Population pharmacokinetic and plasma concentrations of soluble proteins were not presented, as the data was not available for the single study and data for all the axitinib (AG-013736) Phase 2 studies would be pooled together in a separate report.|1|||f||||t||||||||||2017-10-11 04:59:45.078729|2017-10-11 04:59:45.078729
NCT00094120|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-11|2008-01-08|||October 2004||2004-10-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||"MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With Wet Age-Related Macular Degeneration (AMD)"|"Safety and Efficacy of MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With Wet Age-Related Macular Degeneration (AMD)"|Terminated||Phase 2|60||Genaera Corporation|||||||||||||||||||2017-10-11 04:59:45.739477|2017-10-11 04:59:45.739477
NCT00094133|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-14|2013-09-19|||April 2006||2006-04-01|September 2007|2007-09-01||||||||Interventional|||Hypnosis in Treating Hot Flashes in Breast Cancer Survivors|Hypnosis for Hot Flashes in Breast Cancer Survivors|Unknown status|Recruiting|N/A|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 04:59:45.802245|2017-10-11 04:59:45.802245
NCT00094146|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-14|2009-09-21|||January 2002||2002-01-01|October 2004|2004-10-01|December 2002||2002-12-01|||||Interventional|||Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity||Completed||Phase 2|160||Novartis|||||||||||||||||||2017-10-11 04:59:45.878075|2017-10-11 04:59:45.878075
NCT00094159|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-14|2007-05-09|||October 2004||2004-10-01|May 2007|2007-05-01||||||||Interventional|||Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors|Phase I Open-Label, Multicenter, Dose-Escalation Clinical Study of the Safety and Pharmacokinetic Profiles of Weekly Intravenous Administrations of SNS-595 in Patients With Advanced Malignancies|Completed||Phase 1|||Sunesis Pharmaceuticals|||||||||||||||||||2017-10-11 04:59:45.972558|2017-10-11 04:59:45.972558
NCT00094172|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-14|2017-03-28|2011-09-29||May 2005||2005-05-01|March 2017|2017-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|STAYCIS||Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Atorvastatin in Patients With Clinically Isolated Syndrome and High Risk of Conversion to Multiple Sclerosis (ITN020AI)|Completed||Phase 2|82|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Data access is provided to the public in: 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools available to researchers; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal that makes data from the consortium's clinical trials available to the public.|2017-10-11 04:59:46.056813|2017-10-11 04:59:46.056813
NCT00094185|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2012-12-18|||May 2004||2004-05-01|December 2012|2012-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Clotting Genetic Variants, Hormones, and Venous Thrombosis||Completed||N/A|1000|Actual|University of Washington|||1||f||||||||||||||2017-10-11 04:59:46.587654|2017-10-11 04:59:46.587654
NCT00094198|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2008-08-20|||September 2003||2003-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Pharmacogenetics and Cardiovascular Events||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 04:59:46.711303|2017-10-11 04:59:46.711303
NCT00094237|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2017-04-21|||September 2004||2004-09-01|December 2015|2015-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke|Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke|Completed||N/A|3200|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 04:59:46.845672|2017-10-11 04:59:46.845672
NCT00094302|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2015-02-11|2014-12-01||August 2006||2006-08-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|TOPCAT||Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function|Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)|Completed||Phase 3|3445|Actual|New England Research Institutes||2|||f||||t||||||||||2017-10-11 04:59:47.498683|2017-10-11 04:59:47.498683
NCT00094315|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-15|2017-01-10|||September 2004||2004-09-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1|Cocaine Relapse Prevention II|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 04:59:53.874835|2017-10-11 04:59:53.874835
NCT00094328|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-16|2017-05-25|2009-05-19||November 22, 2004|Actual|2004-11-22|May 2017|2017-05-01|August 11, 2017|Anticipated|2017-08-11|May 22, 2008|Actual|2008-05-22||Interventional|BATT||Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]|An Open-label, Non-comparative, Multi-centre Study to Assess the Efficacy and Safety of Bicalutamide When Used in Combination With Anastrozole for the Treatment of Gonadotropin-independent Precocious Puberty in Boys With Testotoxicosis|Active, not recruiting||Phase 2|14|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 04:59:53.947346|2017-10-11 04:59:53.947346
NCT00094341|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-16|2008-12-04|||October 2004||2004-10-01|December 2008|2008-12-01||||||||Interventional|||Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes|An Open-Label, Randomized, Crossover Study to Assess Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes|Completed||Phase 4|215||Amgen|||||||||||||||||||2017-10-11 04:59:54.264199|2017-10-11 04:59:54.264199
NCT00094354|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-16|2009-03-26|||October 2004||2004-10-01|January 2009|2009-01-01|April 2006|Actual|2006-04-01|March 2005|Actual|2005-03-01||Observational|||HIV Assessment in Fuyang, Anhui Province, China|A Qualitative Study for the Development of an Intervention Among HIV-Positive Former Plasma Donors (FPDs) in Fuyang, Anhui Province, China|Completed||N/A|111|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||f||||||||||2017-10-11 04:59:54.34787|2017-10-11 04:59:54.34787
NCT00094367|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-16|2010-09-29|||July 2004||2004-07-01|September 2010|2010-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)|See Detailed Description|Completed||Phase 3|900||GlaxoSmithKline||1|||||||||||||||||2017-10-11 04:59:54.512343|2017-10-11 04:59:54.512343
NCT00094380|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-16|2017-01-10|||September 2004||2004-09-01|January 2017|2017-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)|Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study|Completed||Phase 1/Phase 2|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||Yes|Participant level data and additional relevant materials are available to the public in 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools available to researchers; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal that makes data from the consortium's clinical trials publicly available.|2017-10-11 04:59:55.013587|2017-10-11 04:59:55.013587
NCT00094393|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-16|2017-10-05|||October 12, 2004||2004-10-12|April 13, 2017|2017-04-13||||||||Observational|||Clinical Studies of Progeria|Clinical Investigations Into Hutchison-Gilford Progeria Syndrome|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 04:59:55.13781|2017-10-11 04:59:55.13781
NCT00094406|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-16|2017-10-05|||October 13, 2004||2004-10-13|April 19, 2016|2016-04-19|March 11, 2010|Actual|2010-03-11|March 11, 2010|Actual|2010-03-11||Interventional|||Carbon Monoxide to Prevent Lung Inflammation|Effects of Inhaled Carbon Monoxide on Pulmonary Inflammatory Responses Following Endotoxin Instillation|Completed||Phase 1|35|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 04:59:55.205495|2017-10-11 04:59:55.205495
NCT00094419|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-18|2008-08-11|||November 2004||2004-11-01|August 2008|2008-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Complementary and Alternative Medicine Use in Low-Income African American and Caucasian Adults With Asthma|The Role of Complementary and Alternative Medicine (CAM), Folk Care and Faith-Based Approaches in the Home Management of Persistent Asthma in Low-Income African American and Caucasian Adults|Completed||N/A|50|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-10-11 04:59:55.295429|2017-10-11 04:59:55.295429
NCT00094432|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-18|2013-11-07|||June 2004||2004-06-01|June 2008|2008-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode. CN138-146 LT is the 26-week Open Label Extension Phase of the Above Titled Protocol, CN138-146 ST.|Completed||Phase 3|650||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-10-11 04:59:55.360345|2017-10-11 04:59:55.360345
NCT00094445|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-18|2014-04-29|||November 2004||2004-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Trial of Curcumin in Advanced Pancreatic Cancer|Phase II Trial of Curcumin in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 04:59:55.519818|2017-10-11 04:59:55.519818
NCT00094458|ClinicalTrials.gov processed this data on October 10, 2017|2004-10-19|2016-12-15|2009-04-30||March 2005||2005-03-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|April 2008|Actual|2008-04-01||Interventional|||Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC|Multicenter, Randomized, Double-Blind, Active Controlled Trial Comparing REMICADE� (Infliximab) and REMICADE Plus Azathioprine to Azathioprine in the Treatment of Patients With Crohn's Disease Naive to Both Immunomodulators and Biologic Therapy|Completed||Phase 3|508|Actual|Centocor Ortho Biotech Services, L.L.C.||3|||f||||f||||||||||2017-10-11 04:59:55.942005|2017-10-11 04:59:55.942005
NCT00100100|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-22|2017-01-11|||October 2004||2004-10-01|July 2008|2008-07-01|December 2006||2006-12-01|||||Interventional|||Modafinil for the Treatment of Cocaine Dependence - 1|Modafinil for the Treatment of Cocaine Dependence|Completed||Phase 2|210||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:00:00.225405|2017-10-11 05:00:00.225405
NCT00100126|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-23|2006-10-23|||December 2004||2004-12-01|April 2005|2005-04-01|June 2005||2005-06-01|||||Interventional|||APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat|A Phase III, Investigator Blind, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of APC-231 Sprinkle QD for 7 Days vs Penicillin VK 10 mg/kg QID for 10 Days in Pediatric Patients With Streptococcus Pyogenes|Completed||Phase 3|500||Advancis Pharmaceutical Corporation|||||||||||||||||||2017-10-11 05:00:00.389178|2017-10-11 05:00:00.389178
NCT00100139|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-23|2011-06-30|||November 2004||2004-11-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer|A Randomized Two-Period Crossover, Clinical Bioequivalence Study Comparing the Pharmacokinetics of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Formulation Versus Taxol® in Patients With Advanced Cancer|Completed||Phase 1|48||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 05:00:00.459317|2017-10-11 05:00:00.459317
NCT00100152|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-23|2015-05-25|||February 2005||2005-02-01|May 2015|2015-05-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)|A Phase I Study of a Gamma Secretase Inhibitor for Adult and Pediatric Patients With Relapsed or Refractory Acute T-Cell Lymphoblastic Leukemia and Lymphoma|Terminated||Phase 1|50||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:00:00.542922|2017-10-11 05:00:00.542922
NCT00100178|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-23|2016-07-07|2016-05-13||May 2004||2004-05-01|July 2016|2016-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial|New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial (Preservation of Pancreatic Production of Insulin Through Immunosuppression-POPPII #1)|Completed||Phase 2|126|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||||||||||||2017-10-11 05:00:00.698209|2017-10-11 05:00:00.698209
NCT00100191|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-23|2005-06-23|||February 2002||2002-02-01|December 2004|2004-12-01|April 2006||2006-04-01|||||Interventional|||Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids|EMMY Trial: a Randomized Comparison of Uterine Artery Embolization and Hysterectomy for the Treatment of Symptomatic Uterine Fibroids|Completed||Phase 3|120||ZonMw: The Netherlands Organisation for Health Research and Development|||||f||||||||||||||2017-10-11 05:00:01.347748|2017-10-11 05:00:01.347748
NCT00100204|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-23|2017-06-30|||December 21, 2004||2004-12-21|April 19, 2011|2011-04-19|April 19, 2011||2011-04-19|||||Observational|||Salivary Proteins in Disease and Health|Salivary Proteomics in Disease and Health|Completed||N/A|264|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:01.464764|2017-10-11 05:00:01.464764
NCT00100217|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-23|2017-06-30|||December 21, 2004||2004-12-21|June 25, 2010|2010-06-25|June 25, 2010||2010-06-25|||||Observational|||Evaluation of Patients With Critical Illness|Evaluation of Patients With Critical Illness: Intensive Care Training Protocol|Completed||N/A|1|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:01.567345|2017-10-11 05:00:01.567345
NCT00100243|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-27|2006-09-18|||May 2004||2004-05-01|September 2006|2006-09-01|September 2005||2005-09-01|||||Interventional|||Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy|Phase 2 Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy|Completed||Phase 2|22||PRAECIS Pharmaceuticals Inc.|||||||||||||||||||2017-10-11 05:00:02.234934|2017-10-11 05:00:02.234934
NCT00100256|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-27|2017-08-11|||January 2004||2004-01-01|August 2017|2017-08-01|April 2020|Anticipated|2020-04-01|June 2004||2004-06-01||Interventional|||Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy|Open Label Study of Single Dose Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy|Active, not recruiting||Phase 1/Phase 2|60|Actual|Andarix Pharmaceuticals||1|||f||||||||||||||2017-10-11 05:00:02.332711|2017-10-11 05:00:02.332711
NCT00100269|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-27|2006-05-01|||December 2004||2004-12-01|June 2005|2005-06-01|March 2006||2006-03-01|||||Interventional|||Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility|A Randomized Control Trial of the Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility|Completed||Phase 3|60||Repromed|||||f||||||||||||||2017-10-11 05:00:02.431036|2017-10-11 05:00:02.431036
NCT00100282|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-27|2006-09-18|||May 2003||2003-05-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease|Single Dose Escalation Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease|Completed||Phase 1|125||PRAECIS Pharmaceuticals Inc.|||||||||||||||||||2017-10-11 05:00:02.524688|2017-10-11 05:00:02.524688
NCT00100295|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-28|2007-10-24|||February 2005||2005-02-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)|Controlled Trial of an Herbal Treatment for Juvenile Attention Deficit Hyperactivity Disorder|Completed||Phase 2|59|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-10-11 05:00:02.59451|2017-10-11 05:00:02.59451
NCT00100308|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-28|2008-01-08|||July 2005||2005-07-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Unfractioned Heparin for Treatment of Sepsis|Unfractioned Heparin for Treatment of Sepsis: A Randomized Clinical Trial (The HETRASE Study)|Completed||Phase 3|319|Actual|Universidad de Antioquia||2|||f||||t||||||||||2017-10-11 05:00:02.680698|2017-10-11 05:00:02.680698
NCT00100321|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-28|2017-10-05|||December 21, 2004||2004-12-21|November 20, 2012|2012-11-20|November 20, 2012||2012-11-20|||||Observational|||Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study|Immunologic Studies of Tumors of the Pancreas|Terminated||N/A|25|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:02.775127|2017-10-11 05:00:02.775127
NCT00100334|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-29|2006-09-18|||December 2004||2004-12-01|September 2006|2006-09-01|August 2005||2005-08-01|||||Interventional|||Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer’s Disease|Multiple Dose Safety and Preliminary Pharmacodynamic Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer’s Disease|Completed||Phase 1/Phase 2|24||PRAECIS Pharmaceuticals Inc.|||||||||||||||||||2017-10-11 05:00:02.85919|2017-10-11 05:00:02.85919
NCT00100347|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-29|2007-07-23|||December 2004||2004-12-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin’s Lymphoma and Solid Tumors|A Phase 1 Dose Escalation Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin’s Lymphoma and Solid Tumors|Terminated||Phase 1|45|Actual|PRAECIS Pharmaceuticals Inc.||1||terminated due to corporate transaction.|f||||f||||||||||2017-10-11 05:00:02.935414|2017-10-11 05:00:02.935414
NCT00100360|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-29|2017-10-05|||December 22, 2004||2004-12-22|December 15, 2016|2016-12-15|December 15, 2016||2016-12-15|||||Observational|||Hormonal Causes of Menstrual-Related Mood Disorders|5HT1A and SERT Imaging During Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement|Completed||N/A|22|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:03.300608|2017-10-11 05:00:03.300608
NCT00100373|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2010-08-26|||September 2004||2004-09-01|February 2007|2007-02-01|May 2005||2005-05-01|||||Interventional|||RSV Challenge in Healthy Adults|Characterization of the Immune Response and Viral Shedding to Experimental Infection With Respiratory Syncytial Virus, Strain A-2, in Healthy Adults Ages 21 to 40 Years Old|Completed||N/A|13||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:00:03.972549|2017-10-11 05:00:03.972549
NCT00100386|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2011-06-09|||March 2005||2005-03-01|October 2007|2007-10-01|August 2006||2006-08-01|||||Interventional|||Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial|Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial|Completed||N/A|30000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:00:04.04112|2017-10-11 05:00:04.04112
NCT00100399|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2010-08-26|||December 2004||2004-12-01|March 2007|2007-03-01|December 2004||2004-12-01|||||Interventional|||Fluarix Immunogenicity and Safety Trial|A Randomized, Double-blinded, Placebo Controlled Phase III Study to Evaluate the Immunogenicity and Safety of GSK Bio Influenza Vaccine (Fluarix) Administered Intramuscularly in Healthy Adults|Completed||Phase 3|1050||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:00:04.161767|2017-10-11 05:00:04.161767
NCT00100412|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Interventional|||Hyporeactivity and Gulf War Illness|Cardiovascular Hyporeactivity and Fatiguing Illness in Gulf War Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:00:04.229077|2017-10-11 05:00:04.229077
NCT00100425|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2009-01-20|||September 2000||2000-09-01|December 2004|2004-12-01||||||||Interventional|||Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome|Central Nervous System Modulation of Visceral Pain in Persian Gulf War Syndrome|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:00:04.303073|2017-10-11 05:00:04.303073
NCT00100620|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-03|2017-05-15|||June 2004||2004-06-01|May 2017|2017-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis|Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis|Completed||Phase 3|802||Novartis|||||||||||||||||||2017-10-11 05:00:04.394185|2017-10-11 05:00:04.394185
NCT00100633|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-04|2008-09-29|||December 2004||2004-12-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|February 2007|Actual|2007-02-01||Interventional|||Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People|Immunologic Effects of CpG ODN Administration to HIV Uninfected and HIV Infected Patients|Completed||Phase 1/Phase 2|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:00:04.47733|2017-10-11 05:00:04.47733
NCT00100646|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-04|2014-08-26|||March 2007||2007-03-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa|A Randomized Clinical Trial Assessing Continuous HAART Versus Interrupted HAART in a Resource Poor Clinic|Completed||N/A|30|Actual|The Wistar Institute||2|||f||||t||||||||||2017-10-11 05:00:04.557217|2017-10-11 05:00:04.557217
NCT00100659|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-04|2013-07-10|2013-05-10||December 2004||2004-12-01|July 2013|2013-07-01|February 2010|Actual|2010-02-01|August 2008|Actual|2008-08-01||Interventional|||PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C|Pegylated Interferon +/- Ribavirin for Children With Hepatitis C|Completed||Phase 3|114|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||||||||||||2017-10-11 05:00:04.676147|2017-10-11 05:00:04.676147
NCT00100672|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-04|2011-06-30|||December 2004||2004-12-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|October 2009|Actual|2009-10-01||Interventional|||Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer|Phase I Study of an Easy-to-Use Intravenous Formulation of Liposome Entrapped C-raf Antisense Oligonucleotide (LErafAON-ETU) Administered on a Weekly Schedule in Patients With Advanced Cancer|Completed||Phase 1|40||INSYS Therapeutics Inc|||||||||||||||||||2017-10-11 05:00:05.230793|2017-10-11 05:00:05.230793
NCT00100685|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-04|2012-04-25|||January 2005||2005-01-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)|Phase 2 Open-Label Study of Volociximab (M200) in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|48|Actual|Abbott||2|||f||||t||||||||||2017-10-11 05:00:05.333305|2017-10-11 05:00:05.333305
NCT00100698|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-04|2010-07-22|2010-04-09||January 2004||2004-01-01|July 2010|2010-07-01|April 2009|Actual|2009-04-01|October 2007|Actual|2007-10-01||Interventional|||Physiologic Growth Hormone Effects in HIV Lipodystrophy|Physiologic Growth Hormone Effects in HIV Lipodystrophy|Completed||N/A|56|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:00:05.484382|2017-10-11 05:00:05.484382
NCT00100711|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-04|2014-05-07||2014-04-14|October 2004||2004-10-01|May 2014|2014-05-01||||February 2010|Actual|2010-02-01||Interventional|||Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma With Refractory or Relapsed Disease|Terminated||Phase 2|27||Pharmacyclics LLC.|||||f||||||||||||||2017-10-11 05:00:06.503129|2017-10-11 05:00:06.503129
NCT00100737|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2006-02-02||||||February 2006|2006-02-01||||||||Interventional|||Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin’s Lymphoma (NHL)|A Phase 2 Randomized, Open-Label, Controlled Trial of the Addition of 8 Weeks SC Administration of Aldesleukin (Rh-Interleukin-2 [IL-2]) to 4 Weeks of IV Administration of Rituximab in the Treatment of Rituximab Naïve Subjects With Follicular Non-Hodgkin’s Lymphoma, Refractory or Relapsed After Previous Chemotherapy|Terminated||Phase 2|300||Chiron Corporation|||||||||||||||||||2017-10-11 05:00:06.814327|2017-10-11 05:00:06.814327
NCT00100750|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2015-01-12|||September 2005||2005-09-01|October 2014|2014-10-01|January 2010|Actual|2010-01-01|October 2007|Actual|2007-10-01||Interventional|||Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer|Gemcitabine and R115777 Combination Therapy for Metastatic Breast Cancer|Completed||Phase 1/Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:00:06.917799|2017-10-11 05:00:06.917799
NCT00100776|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder|Efficacy of High Dose Olanzapine in a Controlled Fixed Dose-Response Trial for the Treatment of Schizophrenia and Schizoaffective Disorder|Completed||Phase 4|600||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:00:07.079124|2017-10-11 05:00:07.079124
NCT00100789|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2012-08-29|2012-07-12||January 2005||2005-01-01|August 2012|2012-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer|A Phase II Study of Biweekly Gemcitabine and Paclitaxel (GEMTAX) Combination in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|67|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 05:00:07.378431|2017-10-11 05:00:07.378431
NCT00100802|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2017-01-12|2016-11-18||July 2005||2005-07-01|November 2016|2016-11-01||||September 2012|Actual|2012-09-01||Interventional|||Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas|A Phase II Study of Concurrent Radiation and Temozolomide Followed By Temozolomide and CCNU in the Treatment of Children With High-Grade Glioma|Active, not recruiting||Phase 2|118|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 05:00:08.76449|2017-10-11 05:00:08.76449
NCT00100815|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2015-11-19|2015-09-28||August 2004||2004-08-01|November 2015|2015-11-01||||August 2008|Actual|2008-08-01||Interventional||All treated and eligible patients|Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer|Multicenter, Open Label, Phase II Clinical Study of Gemcitabine, Capecitabine and Avastin in Pancreatic Cancer|Completed||Phase 2|50|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 05:00:10.151138|2017-10-11 05:00:10.151138
NCT00100841|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2015-06-26|2015-06-26||November 2004||2004-11-01|July 2013|2013-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer|Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer|Completed||Phase 2|66|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:00:11.385596|2017-10-11 05:00:11.385596
NCT00100854|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2016-02-01|||October 2004||2004-10-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2015|Actual|2015-04-01||Interventional|||Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Randomized, Open-Label Phase II Clinical Trial of Combination Erlotinib (Tarceva®) and Fulvestrant (Faslodex®) Versus Erlotinib (Tarceva®) Alone in Advanced Non-Small Cell Lung Cancer Patients|Active, not recruiting||Phase 2|50|Anticipated|Translational Oncology Research International||2|||f||||t||||||||||2017-10-11 05:00:11.713634|2017-10-11 05:00:11.713634
NCT00100867|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2016-03-31|||June 2006||2006-06-01|March 2016|2016-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women|Assessment of Safety and Toxicity Among Infants Born to HIV-1-Infected Women Enrolled in Antiretroviral Treatment Protocols in Diverse Areas of the World|Completed||N/A|236|Actual|AIDS Clinical Trials Group|||1||f||||||||||Samples With DNA|"     Blood and urine collection   "|||2017-10-11 05:00:11.849782|2017-10-11 05:00:11.849782
NCT00100880|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2013-09-27|||November 2004||2004-11-01|September 2013|2013-09-01||||November 2010|Actual|2010-11-01||Interventional|||Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors|A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients With Recurrent or Refractory Primary CNS Tumors|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:00:11.973888|2017-10-11 05:00:11.973888
NCT00100893|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2015-06-03|||January 2005||2005-01-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer|A Phase I Prevention Trial of ACTIVIN Grape Seed Extract as an Aromatase Inhibitor In Healthy Postmenopausal Women at Risk for Breast Cancer|Completed||Phase 1|37|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 05:00:12.29947|2017-10-11 05:00:12.29947
NCT00100906|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2013-08-15|||August 2004||2004-08-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|June 2006|Actual|2006-06-01||Interventional|||Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer|Randomized Phase II Trial Of Sequential ATRA Then IL-2 For Modulation Of Dendritic Cells And Treatment Of Metastatic Renal Cancer|Completed||Phase 2|18|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f||||||||||2017-10-11 05:00:12.439904|2017-10-11 05:00:12.439904
NCT00100919|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-06|2017-06-30|||January 4, 2005||2005-01-04|July 6, 2010|2010-07-06|July 6, 2010||2010-07-06|||||Observational|||Sensing of Leg Position and Movement|Coupled Joint Proprioception and Multi-Joint Movement in the Lower Extremity: A Pilot Study|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:12.577124|2017-10-11 05:00:12.577124
NCT00101140|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2006-07-06||||||July 2006|2006-07-01||||||||Interventional|||Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission|Phase II Study of Haploidentical Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With High-Risk Acute Myeloid Leukemia in First Remission|Withdrawn||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:00:18.857239|2017-10-11 05:00:18.857239
NCT00100932|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2012-03-22|2011-12-26||December 2004||2004-12-01|March 2012|2012-03-01||||June 2008|Actual|2008-06-01||Interventional|||Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy|Phase II Study of E7389, a Halichondrin B Analog, in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC), Who Progressed During or After Platinum-Based Doublet Chemotherapy Stratified for Prior Taxane Therapy|Completed||Phase 2|106|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 05:00:12.681286|2017-10-11 05:00:12.681286
NCT00100945|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2016-12-09|||July 2005||2005-07-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|August 2007|Actual|2007-08-01||Interventional|||Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer|A Phase II Study Of Maintenance ZD1839 (IRESSA) In Patients With Locally Advanced Esophageal Cancer After Treatment Given With Curative Intent|Completed||Phase 2|70|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 05:00:13.818475|2017-10-11 05:00:13.818475
NCT00100958|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2008-07-23|||November 2004||2004-11-01|May 2006|2006-05-01||||||||Interventional|||Indole-3-Carbinol in Preventing Cancer in Healthy Participants|Phase I Ascending Single Dose Pharmacokinetics (PK) and Safety Study of 3,3' Di-Indolymethane (DIM) Nutritional Product|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:00:14.121092|2017-10-11 05:00:14.121092
NCT00100971|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-01-03|||April 2004||2004-04-01|January 2013|2013-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia|Dendritic/Leukemic Fusion Cell Vaccine Therapy For AML Patients In First Remission; A Phase I Clinical Trial|Terminated||Phase 1|9||Boston Medical Center||||Protocol is withdrawn due to inadequate accrual|f||||||||||||||2017-10-11 05:00:15.79298|2017-10-11 05:00:15.79298
NCT00100984|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2017-06-19|||July 21, 2004|Actual|2004-07-21|December 2005|2005-12-01|July 16, 2005|Actual|2005-07-16|July 16, 2005|Actual|2005-07-16||Interventional|||A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1||Terminated||Phase 4|8|Actual|Hoffmann-La Roche||||Insufficient enrollment|||||||||||||||2017-10-11 05:00:15.88694|2017-10-11 05:00:15.88694
NCT00100997|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-07-09|||October 2004||2004-10-01|May 2005|2005-05-01|October 2006|Actual|2006-10-01|||||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate|A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered CNF1010 )17-(Allylamino)-17-Demethoxygeldanamycin [17-AAG]) in Patients With Gleevec-Resistent Chronic Myelogenous Leukemia|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:00:15.976683|2017-10-11 05:00:15.976683
NCT00101010|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2014-09-10|||September 2005||2005-09-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma|A Phase II Study Of Rituximab-CHOP With Pegylated Liposomal Doxorubicin In Patients Older Than 60 Years Of Age With Untreated Aggressive B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|80|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 05:00:16.061343|2017-10-11 05:00:16.061343
NCT00101036|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2014-12-18|2014-07-21||November 2004||2004-11-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery|A Phase II Study of GW572016 (Lapatanib) in Locally Advanced or Metastatic Hepato-Biliary Cancers|Completed||Phase 2|57|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:00:16.217831|2017-10-11 05:00:16.217831
NCT00101062|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2011-06-03|||January 2004||2004-01-01|June 2011|2011-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer|Phase II Study of Letrozole (Femara) and Celecoxib (Celebrex) in Postmenopausal Women With Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer|Terminated||Phase 2|||Rutgers, The State University of New Jersey||||study drug unavailable|f||||t||||||||||2017-10-11 05:00:17.375927|2017-10-11 05:00:17.375927
NCT00101075|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2017-02-24|||October 2004||2004-10-01|February 2017|2017-02-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Title XELOX FOR SALIVARY GLAND CANCERS|Phase II Study of Capecitabine and Oxaliplatin (XELOX) in Patients With Locally Advanced, Incurable, Salivary Gland Cancers|Terminated||Phase 2|9|Actual|Dana-Farber Cancer Institute||1||Slow Accrual|f||||t||||||||No||2017-10-11 05:00:17.510813|2017-10-11 05:00:17.510813
NCT00101088|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-01-11|||April 2005||2005-04-01|January 2013|2013-01-01||||June 2010|Actual|2010-06-01||Interventional|||Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A Phase I Study of CCI-779 in Combination With Imatinib Mesylate in Chronic Myelogenous Leukemia|Terminated||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:00:17.678564|2017-10-11 05:00:17.678564
NCT00101101|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2017-08-16|2013-06-20||July 2004||2004-07-01|August 2017|2017-08-01|April 2018|Anticipated|2018-04-01|October 2012|Actual|2012-10-01||Interventional||All participants who started the study.|Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma|A Phase II Trial Using a Universal GM-CSF-Producing and CD40L-Expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-Based Vaccines for Patients With Mantle Cell Lymphoma|Active, not recruiting||Phase 2|43|Actual|H. Lee Moffitt Cancer Center and Research Institute|With a median follow-up of 67 months, the median overall survival (OS) has not yet been reached.|1|||f||||f||||||||||2017-10-11 05:00:17.851828|2017-10-11 05:00:17.851828
NCT00101114|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-02-27|||September 2004||2004-09-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Phase II Study of the RAF-Kinase Inhibitor BAY 43-9006 (NSC-724772, IND-69,896) in Combination With Interferon-Alpha 2B in Patients With Advanced Renal Cancer|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:00:18.33731|2017-10-11 05:00:18.33731
NCT00101127|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2014-02-12|||December 2003||2003-12-01|February 2014|2014-02-01||||July 2006|Actual|2006-07-01||Interventional|||Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma|A Phase II Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||t||||||||||2017-10-11 05:00:18.49888|2017-10-11 05:00:18.49888
NCT00101153|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2015-07-22|||April 2007||2007-04-01|July 2015|2015-07-01||||March 2010|Actual|2010-03-01||Interventional|||Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia|A Phase I Study Of Therapy With The Farnesyl Transferase Inhibitor R115777 (Zarnestra) Combined With Conventional Induction And Consolidation Chemotherapy For Previously Untreated Patients Over Age 55 With Acute Myeloid Leukemia (AML)|Completed||Phase 1|24|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:00:18.985585|2017-10-11 05:00:18.985585
NCT00101166|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2012-11-16|2012-10-18||October 2004||2004-10-01|September 2012|2012-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma|A Phase II Trial Using a Universal GM-CSF-Producing and CD40L-Expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-Based Vaccines for Patients With Malignant Melanoma|Completed||Phase 2|43|Actual|H. Lee Moffitt Cancer Center and Research Institute|Due to the heterogeneity of the patient population, results were mainly descriptive in nature.|1|||f||||f||||||||||2017-10-11 05:00:19.153513|2017-10-11 05:00:19.153513
NCT00101192|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2014-02-03|2014-02-03||September 2004||2004-09-01|February 2014|2014-02-01||||July 2011|Actual|2011-07-01||Interventional||Eligible and evaluable participants|Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer|A Limited Access Phase II Trial of Cetuximab (C225, NSC #714692) in Combination With Cisplatin (NSC #119875) in the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix|Completed||Phase 2|76|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 05:00:19.886429|2017-10-11 05:00:19.886429
NCT00101205|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2014-02-21|||November 2004||2004-11-01|April 2013|2013-04-01||||January 2012|Actual|2012-01-01||Interventional|||Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma|A Phase I Trial of the Combination of Oxaliplatin (NSC 266046, IND 57004), Ifosfamide, and Etoposide in Recurrent or Refractory Pediatric Solid Tumors and Lymphomas|Terminated||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:00:20.605729|2017-10-11 05:00:20.605729
NCT00101231|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-06-03|||October 2004||2004-10-01|June 2013|2013-06-01||||November 2012|Actual|2012-11-01||Interventional|||Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia|A Dose Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With Relapsed and Refractory Acute Leukemias|Terminated||Phase 1|88|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:00:20.775711|2017-10-11 05:00:20.775711
NCT00101244|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-01-11|||November 2004||2004-11-01|January 2013|2013-01-01||||February 2010|Actual|2010-02-01||Interventional|||SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma|A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Days 1-3 of a 21-Day Cycle in Patients With Solid Tumors|Terminated||Phase 1|31|Actual|National Cancer Institute (NCI)||1||Administratively Complete.|f||||||||||||||2017-10-11 05:00:20.906785|2017-10-11 05:00:20.906785
NCT00101257|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2010-05-05|||October 2004||2004-10-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|||||Interventional|||Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer|Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD4+ Antigen-Specific T Cell Clones for Patients With Advanced Ovarian Cancer|Completed||Phase 1|18|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:00:21.036523|2017-10-11 05:00:21.036523
NCT00101270|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-06-04|||March 2005||2005-03-01|June 2013|2013-06-01||||September 2007|Actual|2007-09-01||Interventional|||Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas|A Phase I Study of Oxaliplatin (NSC# 266046, IND #57004) and Irinotecan in Pediatric Patients With Refractory Solid Tumors and Lymphomas|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:00:21.1105|2017-10-11 05:00:21.1105
NCT00101283|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2012-11-30|2010-02-12||November 2005||2005-11-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|September 2009|Actual|2009-09-01||Interventional|||Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma|Pemetrexed Plus Gemcitabine Or Carboplatin In Patients With Advanced Malignant Mesothelioma: A Randomized Phase II Trial|Completed||Phase 2|32|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-10-11 05:00:21.300784|2017-10-11 05:00:21.300784
NCT00101296|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-02-01|||October 2004||2004-10-01|January 2013|2013-01-01||||May 2011|Actual|2011-05-01||Interventional|||Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|Phase I Trial of R115777 (NSC 702818) in Relapsed, Refractory or High Risk Myeloid Leukemia|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:00:22.852848|2017-10-11 05:00:22.852848
NCT00101309|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-12-17|||November 2004||2004-11-01|November 2007|2007-11-01||||November 2007|Anticipated|2007-11-01||Interventional|||Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma|A Phase I Pilot Study of Tumor Cell - B Lymphoblastoid Cell Line Vaccination in Pediatric Subjects With Relapsed Ewing's Sarcoma and Neuroblastoma|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:00:23.012432|2017-10-11 05:00:23.012432
NCT00101335|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-07-09|||November 2003||2003-11-01|July 2013|2013-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia|A Phase IIb Cancer Prevention Trial of Celecoxib, a Selective COX-2 Inhibitor, in Oral Leukoplakia|Completed||Phase 2|||Fox Chase Cancer Center|||||f||||f||||||||||2017-10-11 05:00:23.141114|2017-10-11 05:00:23.141114
NCT00101530|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2015-09-29|||September 2004||2004-09-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|LUCHAR||Improving Prevention of Heart Disease in Latinos|Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk|Completed||N/A|179|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-10-11 05:00:26.570709|2017-10-11 05:00:26.570709
NCT00101348|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2014-06-10|||January 2005||2005-01-01|December 2012|2012-12-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer|A Phase I, and Biologic Correlative Study of Erlotinib, in Combination With Cetuximab and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|66|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:00:23.272661|2017-10-11 05:00:23.272661
NCT00101361|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2013-11-26|2013-06-27||August 2005||2005-08-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||overall baseline participants were determined by number of participants that were eligible after screening based on a pressure ulcer that is defined as hard-to-heal or worsening at randomization.|Oxandrolone to Heal Pressure Ulcers|CSP #535 - Anabolic Steroid Therapy on Pressure Ulcer Healing in Persons With Spinal Cord Injury|Terminated||Phase 3|212|Actual|VA Office of Research and Development|Selection of severe wounds may have reduced treatment response. The study was terminated after a futility analysis showed a low probability of detecting a significant difference between groups.|2||futility analysis showed low probability of detecting a significant difference|f||||t||||||||||2017-10-11 05:00:23.476078|2017-10-11 05:00:23.476078
NCT00101374|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-07|2017-06-30|||January 5, 2005||2005-01-05|February 2, 2010|2010-02-02|May 21, 2008|Actual|2008-05-21|May 21, 2008|Actual|2008-05-21||Interventional|||Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Leflunomide on HIV-1 Associated Immune Proliferation In Vivo|Completed||Phase 1|41|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:00:23.978602|2017-10-11 05:00:23.978602
NCT00101387|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2011-02-17|||September 2003||2003-09-01|February 2011|2011-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Lumbar PENS and Exercise in Older Adults With Chronic Low Back Pain|Functional Impact of PENS for 65+ Chronic Low Back Pain|Completed||Phase 3|200|Actual|University of Pittsburgh||4|||f||||t||||||||||2017-10-11 05:00:24.084744|2017-10-11 05:00:24.084744
NCT00101400|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2013-11-19|2009-01-30||February 2004||2004-02-01|November 2013|2013-11-01|January 2008|Actual|2008-01-01|January 2006|Actual|2006-01-01||Interventional|||BAY43-9006 - Phase II in Advanced Breast Cancer|A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Subjects With Metastatic Breast Cancer.|Completed||Phase 2|54|Actual|Bayer|Subjects had advanced disease and were heavily pretreated. Not all adverse events mentioned were assessed as drug-related. NCI-CTCAE was translated to Medical Dictionary for Regulatory Activities (MedDRA) for System Organ Classes (SOCs) only.|1|||f||||f||||||||||2017-10-11 05:00:24.21793|2017-10-11 05:00:24.21793
NCT00101413|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2013-09-29|2009-04-17||April 2004||2004-04-01|September 2013|2013-09-01|April 2008|Actual|2008-04-01|June 2005|Actual|2005-06-01||Interventional|||BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)|A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Patients With Relapsed or Refractory Advanced Non-small Cell Lung Carcinoma|Completed||Phase 2|52|Actual|Bayer|Due to rapid enrollment, no IA (interim analysis) was performed.|1|||f||||f||||||||||2017-10-11 05:00:24.79097|2017-10-11 05:00:24.79097
NCT00101426|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2008-01-10|||October 2004||2004-10-01|January 2008|2008-01-01|September 2006||2006-09-01|||||Interventional|||Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy||Completed||Phase 3|500||Sumitomo Dainippon Pharma Co., Ltd.|||||||||||||||||||2017-10-11 05:00:25.385594|2017-10-11 05:00:25.385594
NCT00101439|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2017-03-06|2016-03-15||November 2005||2005-11-01|March 2017|2017-03-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, 2-Period, Crossover Study to Evaluate the Effects of Ezetimibe on the Postprandial Lipoprotein Response in Patients With Primary Hypercholesterolemia|Completed||Phase 3|58|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:00:25.468755|2017-10-11 05:00:25.468755
NCT00101452|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2017-03-06|2012-06-13||April 2005||2005-04-01|March 2017|2017-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression|A Double-Blind, Placebo-Controlled Study of the Alternative Therapy S-Adenosyl-L-Methionine (SAMe) vs Escitalopram in Major Depressive Disorder (MDD)|Completed||N/A|199|Actual|Massachusetts General Hospital||3|||f||||t||||||||Undecided||2017-10-11 05:00:25.764021|2017-10-11 05:00:25.764021
NCT00101465|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2013-07-02|||September 2004||2004-09-01|July 2009|2009-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians|Partnership Programs to Reduce Cardiovascular Disparities - Heart Failure Disparities in Native Hawaiians|Completed||N/A|276|Anticipated|University of Hawaii|||1||f||||||||||||||2017-10-11 05:00:26.16597|2017-10-11 05:00:26.16597
NCT00101478|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2017-03-28|||September 2004|Actual|2004-09-01|March 2017|2017-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Improving Cardiovascular Treatment Approaches Among Minorities|Partnership Programs to Reduce Cardiovascular Disparities - Baltimore Partnership|Completed||N/A|823|Actual|University of Maryland|||1||f||||t||||||||||2017-10-11 05:00:26.243335|2017-10-11 05:00:26.243335
NCT00101491|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2016-07-11|||September 2004||2004-09-01|February 2009|2009-02-01|August 2010|Actual|2010-08-01|September 2009|Actual|2009-09-01||Interventional|||STORIES-Stories to Communicate Risk About Tobacco|Partnership Programs to Reduce Cardiovascular Disparities - Deep South Partnerships for Prevention of CVD Disparities|Completed||N/A|300|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-10-11 05:00:26.341649|2017-10-11 05:00:26.341649
NCT00101504|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2016-07-11|||September 2004||2004-09-01|April 2006|2006-04-01|August 2009|Actual|2009-08-01|||||Observational|||Hypertension Education and Treatment Partnership for Reducing Ethnic Differences in the Risk of Cardiovascular Disease|Partnership Programs to Reduce Cardiovascular Disparities - Hypertension Education and Treatment (HEAT)|Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:00:26.447114|2017-10-11 05:00:26.447114
NCT00101517|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2014-09-12|||September 2004||2004-09-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|META-HEALTH||Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease|Partnership Programs to Reduce Cardiovascular Disparities - Morehouse-Emory Partnership|Completed||N/A|4024|Actual|Emory University|||1||f||||t||||||||||2017-10-11 05:00:26.50229|2017-10-11 05:00:26.50229
NCT00101543|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-10|2009-02-03|||August 2003||2003-08-01|January 2005|2005-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Gait Training For Acute Stroke: Functional Neuromuscular Stimulation (FNS) and Weight Supported Treadmill Training|Gait Training For Acute Stroke: FNS and Weight Supported Treadmill Training|Completed||Phase 4|70|Anticipated|VA Office of Research and Development|||||||||||||||||||2017-10-11 05:00:26.63118|2017-10-11 05:00:26.63118
NCT00101569|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2013-11-07|||March 2004||2004-03-01|July 2008|2008-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Aripiprazole Oral Acceptability Trial|Aripiprazole Oral Acceptability Trial|Completed||Phase 3|59||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-10-11 05:00:26.812183|2017-10-11 05:00:26.812183
NCT00101582|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2016-08-19|2014-01-03||August 2005||2005-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|September 2007|Actual|2007-09-01||Interventional|||Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer|Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (rHuKGF) for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Receiving Radiotherapy With Concurrent Chemotherapy (RT/CT)|Completed||Phase 3|188|Actual|Swedish Orphan Biovitrum||2|||f||||t||||||||||2017-10-11 05:00:26.947377|2017-10-11 05:00:26.947377
NCT00101595|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2011-04-07||2010-02-04|January 2005||2005-01-01|April 2011|2011-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|A Phase II Study of BMS-354825 in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate|Completed||Phase 2|96|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 05:00:28.37779|2017-10-11 05:00:28.37779
NCT00101608|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2010-02-27||2010-02-27|January 2005||2005-01-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium|A Phase II Study of Intravenous (IV) Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium|Completed||Phase 2|150|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 05:00:28.624509|2017-10-11 05:00:28.624509
NCT00101621|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2006-02-08|||August 2004||2004-08-01|February 2006|2006-02-01|August 2005||2005-08-01|||||Interventional|||Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain|A Randomized, Double-Blind, Placebo Controlled, Multi-Center, Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent in a Cancer Pain Model|Terminated||Phase 2|24||MetaPhore Pharmaceuticals|||||||||||||||||||2017-10-11 05:00:28.882802|2017-10-11 05:00:28.882802
NCT00101634|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2011-06-06|||December 2004||2004-12-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mg eq, 50 mg eq, and 100 mg eq) of Paliperidone Palmitate in Patients With Schizophrenia|Completed||Phase 3|518|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:00:28.941807|2017-10-11 05:00:28.941807
NCT00101647|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2011-04-13|2009-12-22||December 2004||2004-12-01|April 2011|2011-04-01|March 2008|Actual|2008-03-01|August 2006|Actual|2006-08-01||Interventional|||Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia|A Phase II Study of BMS-354825 in Subjects With Accelerated Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate|Completed||Phase 2|197|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 05:00:29.082975|2017-10-11 05:00:29.082975
NCT00101660|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2012-02-29|2009-12-22||February 2005||2005-02-01|February 2012|2012-02-01|April 2008|Actual|2008-04-01|September 2006|Actual|2006-09-01||Interventional|||Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib|A Phase II Study to Determine the Activity of BMS-354825 in Subjects With Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Disease That is Resistant to High Dose Imatinib Mesylate (Gleevec) or Who Are Intolerant of Imatinib|Completed||Phase 2|387|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 05:00:31.798367|2017-10-11 05:00:31.798367
NCT00101673|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2012-05-04|||March 2004||2004-03-01|May 2012|2012-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%|Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%|Completed||Phase 3|251|Actual|Novartis|||||f||||||||||||||2017-10-11 05:00:33.887598|2017-10-11 05:00:33.887598
NCT00101686|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2010-01-04|2009-10-20||February 2003||2003-02-01|January 2010|2010-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.|A Randomized, Multi-Center Phase III Trial Of Irinotecan In Combination With Three Different Methods Of Administration Of Fluoropyrimidine: Infusional 5-FU (FOLFIRI), Modified-Bolus 5-FU (Day 1 & 8), And Oral Capecitabine (Day 1-14); With Celecoxib Versus Placebo As First-Line Treatment For Patients With Metastatic Colorectal Cancer Study Amended April 23, 2004 To Include Bevacizumab|Completed||Phase 3|547|Actual|Pfizer||5|||f||||t||||||||||2017-10-11 05:00:34.155552|2017-10-11 05:00:34.155552
NCT00101699|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2006-08-17|||November 2001||2001-11-01|January 2005|2005-01-01|August 2003||2003-08-01|||||Observational|||Effects of Soy Consumption on Symptoms of Menopause|Influence of Soy Consumption on Menopause|Completed||N/A|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:00:38.350994|2017-10-11 05:00:38.350994
NCT00101712|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2012-05-04|||October 2004||2004-10-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia|Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia|Completed||Phase 3|274|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:00:38.451374|2017-10-11 05:00:38.451374
NCT00101725|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2010-11-19|||December 2004||2004-12-01|November 2010|2010-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRN 002 (Crofelemer) for the Symptomatic Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)|Completed||Phase 2|245|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-10-11 05:00:38.57536|2017-10-11 05:00:38.57536
NCT00101738|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2011-01-28|||March 2003||2003-03-01|January 2011|2011-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Freedom Study: Myfortic in Kidney Transplant Patients|Study to Investigate the Clinical Outcomes of Different Regimens of Myfortic® in De Novo Kidney Tx Pts Using Simulect® and Neoral® With or Without Steroids|Completed||Phase 3|342|Actual|Novartis|||||||||||||||||||2017-10-11 05:00:38.768159|2017-10-11 05:00:38.768159
NCT00101751|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2014-10-16|||October 2004||2004-10-01|October 2014|2014-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|INITIATE plus||INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study|Efficacy and Safety of a Standard Titration Algorithm Coupled With a Conventional Dietary Intervention or Intensive Dietary Intervention Versus a Standard Titration Algorithm, Alone, in Patients With Type 2 Diabetes Initiating NovoLog® Mix 70/30 Therapy|Completed||Phase 4|4877|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:00:38.955407|2017-10-11 05:00:38.955407
NCT00101764|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2017-06-30|||January 5, 2005||2005-01-05|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Interventional|||Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders|Phase I Study of Intravitreal Injections Versus Anterior Sub-Tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:39.023652|2017-10-11 05:00:39.023652
NCT00101777|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-12|2008-03-03|||December 2001||2001-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Ventilatory Physiology in Children at Risk for Anxiety|Ventilatory Physiology in Children at Risk for Anxiety|Completed||N/A|479||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:39.093985|2017-10-11 05:00:39.093985
NCT00101790|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-13|2010-01-06|||September 2003||2003-09-01|January 2010|2010-01-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain|A Pilot Trial of IV Pamidronate for Low Back Pain|Unknown status|Active, not recruiting|Phase 1|44|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-10-11 05:00:39.150594|2017-10-11 05:00:39.150594
NCT00101803|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-13|2017-05-15|||January 2005||2005-01-01|May 2017|2017-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|527|Actual|Novartis|||||f||||||||||||||2017-10-11 05:00:39.225238|2017-10-11 05:00:39.225238
NCT00101816|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-13|2010-08-03|2009-12-15||December 2004||2004-12-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|August 2006|Actual|2006-08-01||Interventional|||Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate|A Phase II Study of BMS-354825 in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate|Completed||Phase 2|124|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 05:00:39.361031|2017-10-11 05:00:39.361031
NCT00101829|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-13|2015-11-12|||April 2004||2004-04-01|November 2015|2015-11-01|August 2009|Actual|2009-08-01|August 2006|Actual|2006-08-01||Interventional|||Anti-CD20 Antibody Therapy for Sjogren's Syndrome|An Open-Label, One Arm, Phase I Safety Study of Anti-CD20 Antibody (Rituximab, Rituxan) Therapy in the Treatment of Primary Sjogren's Syndrome|Completed||Phase 1|12|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-10-11 05:00:42.058118|2017-10-11 05:00:42.058118
NCT00101842|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-14|2006-08-24|||December 2004||2004-12-01|August 2006|2006-08-01|July 2006||2006-07-01|||||Interventional|||Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer|Phase I/II Study of Gemzar and Platinol Followed by Alimta and Gemzar in Patients With Advanced or Metastatic Bladder Cancer|Completed||Phase 1/Phase 2|61||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:00:42.208949|2017-10-11 05:00:42.208949
NCT00101855|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-14|2005-06-23|||October 2003||2003-10-01|January 2005|2005-01-01|June 2006||2006-06-01|||||Interventional|||Can Parental Activation Over the Internet Improve Pediatric Preventive Care?|Parent Initiated Prevention Program|Unknown status|Active, not recruiting|N/A|2000||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:00:42.294172|2017-10-11 05:00:42.294172
NCT00101868|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-14|2012-04-16|2012-03-18||December 2004||2004-12-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Value of Technology to Transfer Discharge Information|Value of Technology to Transfer Discharge Information|Completed||N/A|631|Actual|Agency for Healthcare Research and Quality (AHRQ)|Required medication reconciliation in both groups might have reduced the adverse event rates in both groups.|2|||f||||f||||||||||2017-10-11 05:00:42.387206|2017-10-11 05:00:42.387206
NCT00101881|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2008-09-30|||November 2002||2002-11-01|September 2008|2008-09-01|January 2005|Actual|2005-01-01|||||Interventional|||Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)|Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)|Completed||Phase 4|168|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:00:42.916422|2017-10-11 05:00:42.916422
NCT00101894|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2012-09-13|||December 2004||2004-12-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|April 2010|Actual|2010-04-01||Interventional|||Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer|An Open-Label, Dose-Finding Study to Evaluate the Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer|Completed||Phase 1|119|Actual|Amgen||14|||f||||f||||||||||2017-10-11 05:00:43.04273|2017-10-11 05:00:43.04273
NCT00101907|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2014-02-03|2010-08-13||December 2004||2004-12-01|February 2014|2014-02-01|April 2008|Actual|2008-04-01|June 2007|Actual|2007-06-01||Interventional|||Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer|An Open-Label, Dose-Finding Study to Evaluate the Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Subjects With Advanced Cancer|Terminated||Phase 1|41|Actual|Amgen||6||Study terminated per recommendation of Data Review Team|f||||||||||||||2017-10-11 05:00:43.252295|2017-10-11 05:00:43.252295
NCT00101920|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2010-10-14|||June 2003||2003-06-01|October 2010|2010-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)|A Clinical Trial of the Safety and Efficacy of ABX-EGF as Second Line Treatment for Advanced Non-Small Lung Cancer|Completed||Phase 2|50|Actual|Amgen||1|||f||||||||||||||2017-10-11 05:00:47.70381|2017-10-11 05:00:47.70381
NCT00108173|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2013-04-05|||October 2002||2002-10-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|April 2007|Actual|2007-04-01||Interventional|||Brain Reaction to Treatment of Nicotine Dependence|Neural Substrates of Treatment for Nicotine Dependence|Completed||Phase 1|104|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:02:59.938351|2017-10-11 05:02:59.938351
NCT00101933|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2017-03-21|2012-10-01|2009-05-26|December 2003||2003-12-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|June 2008|Actual|2008-06-01||Interventional|||SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy|SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy|Active, not recruiting||Phase 3|157|Actual|MedtronicNeuro|No limitations leading to unreliable data were identified.|2|||f||||t||||||||||2017-10-11 05:00:47.878887|2017-10-11 05:00:47.878887
NCT00101959|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2013-08-04|||November 2004||2004-11-01|August 2013|2013-08-01||||||||Interventional|||Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects|An Implementation Study of Treatment Optimization Recommendations Comparing Subjects Continuing Treatment With IFN-ß-1a 30 Mcg qw IM (Avonex®) or Glatiramer Acetate 20 mg qd SC (Copaxone®) to Those Randomized to IFN-ß-1a 44 Mcg Tiw SC (Rebif®), in a Multicenter Study of Subjects With Relapsing Remitting Multiple Sclerosis Currently on Disease-Modifying Therapy|Withdrawn||Phase 4|0|Actual|EMD Serono|||||||||||||||||||2017-10-11 05:00:48.754604|2017-10-11 05:00:48.754604
NCT00101972|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2012-04-18|||December 2004||2004-12-01|April 2012|2012-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma|A Phase I, Multi-Dose Study of RAV12 (ANTI-RAAG12 MAB) in Patients With Metastatic or Recurrent Adenocarcinoma|Completed||Phase 1|53|Actual|MacroGenics||1|||f||||f||||||||||2017-10-11 05:00:48.81934|2017-10-11 05:00:48.81934
NCT00101985|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2015-04-10|||October 2004||2004-10-01|April 2015|2015-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)|An Eight-week, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate Efficacy and Safety of Talnetant in Subjects With Irritable Bowel Syndrome|Completed||Phase 2|741|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:00:48.953878|2017-10-11 05:00:48.953878
NCT00101998|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2017-08-29|||October 1, 2003|Actual|2003-10-01|August 2017|2017-08-01|May 1, 2006|Actual|2006-05-01|May 1, 2006|Actual|2006-05-01||Interventional|||Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects|Completed||Phase 2|233|Actual|Cubist Pharmaceuticals LLC||4|||||||||||||||||2017-10-11 05:00:49.355957|2017-10-11 05:00:49.355957
NCT00102011|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-18|2017-09-13|||May 2000||2000-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|00-046||Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer|Colonoscopy Screening Trial|Active, not recruiting||Phase 3|4952|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-10-11 05:00:49.962437|2017-10-11 05:00:49.962437
NCT00102024|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-19|2010-08-25|||January 2005||2005-01-01|August 2010|2010-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma|A Phase I/II, Open-Label, Dose-Escalation Study to Evaluate the Safety and Activity of Single Dose 90Y-Labeled IDEC-159, Humanized, Domain Deleted, Anti TAG-72 Monoclonal Antibody, in Subjects With Metastatic Colorectal Adenocarcinoma|Terminated||Phase 1/Phase 2|30||Biogen|||||||||||||||||||2017-10-11 05:00:50.090818|2017-10-11 05:00:50.090818
NCT00102037|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-19|2017-01-12|||July 2004||2004-07-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Use of Activated Recombinant FVII in Spinal Surgery|Evaluation of Safety of Activated Recombinant FVII as an Add-On Therapy in Spinal Surgery|Completed||Phase 2|50|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:00:50.175256|2017-10-11 05:00:50.175256
NCT00102050|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-19|2006-05-17|||April 2003||2003-04-01|May 2006|2006-05-01|April 2006||2006-04-01|||||Interventional|||Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication|A Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of NM-702 in Subjects With Intermittent Claudication|Completed||Phase 2|390||Nissan Chemical Industries|||||||||||||||||||2017-10-11 05:00:50.294566|2017-10-11 05:00:50.294566
NCT00102063|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-19|2012-08-06|2012-05-11||July 2004||2004-07-01|August 2012|2012-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|APEX 239||Aripiprazole in Adolescents With Schizophrenia|Aripiprazole in Adolescents With Schizophrenia|Completed||Phase 3|302|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||||||||||||2017-10-11 05:00:50.420551|2017-10-11 05:00:50.420551
NCT00102076|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-19|2017-06-30|||November 16, 2001||2001-11-16|September 18, 2006|2006-09-18|September 18, 2006||2006-09-18|||||Observational|||Implementing the Assent Requirement for Research With Children|Implementing the Assent Requirement for Research With Children|Completed||N/A|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:51.317591|2017-10-11 05:00:51.317591
NCT00102089|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-20|2017-06-30|||January 18, 2005||2005-01-18|October 10, 2007|2007-10-10|October 10, 2007||2007-10-10|||||Interventional|||HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Booster Dose of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Subjects Who Were Previously Immunized With VRC-HIVDNA009-00-VP in VRC 004|Completed||Phase 1|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:51.3798|2017-10-11 05:00:51.3798
NCT00102102|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-20|2008-03-03|||January 2005||2005-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Role of Substance P in Post-Traumatic Stress Disorder|PET Evaluation of NK1 Receptor Using [18F]SPA-RQ in Post-Traumatic Stress Disorder|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:51.442568|2017-10-11 05:00:51.442568
NCT00102115|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-21|2010-03-11|||December 2004||2004-12-01|December 2005|2005-12-01|January 2006||2006-01-01|||||Interventional|||Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease|Phase 1 Dose Ranging Study to Evaluate Safety and Tolerability of Talaporfin Sodium (LS11) Photodynamic Therapy in Subjects With Advanced Age-Related Macular Disease|Terminated||Phase 1|27||Light Sciences LLC|||||||||||||||||||2017-10-11 05:00:51.525335|2017-10-11 05:00:51.525335
NCT00102128|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-21|2015-05-21|||November 2002||2002-11-01|May 2015|2015-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.|Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure|Terminated||Phase 2|||Sanofi||||DMC recommended stop|f||||||||||||||2017-10-11 05:00:51.714111|2017-10-11 05:00:51.714111
NCT00102141|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-21|2014-12-11|||April 2004||2004-04-01|December 2014|2014-12-01|July 2005|Actual|2005-07-01|||||Interventional|||Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women|A Multicenter, Double-blind, Randomized, Placebo-controlled Study Comparing 3 Continuous Oral Angeliq (Drospirenone 3 mg/17ß-estradiol 1 mg, Drospirenone 2 mg /17ß-estradiol 1 mg, Drospirenone 1 mg /17ß-estradiol 1 mg) Combinations and 17ß-estradiol (1 mg) With Placebo for a Treatment Period of 8 Weeks on Ambulatory and Office Cuff Blood Pressure in Postmenopausal Women With Stage 1 or Stage 2 Essential Hypertension|Completed||Phase 3|750|Actual|Bayer||5|||f||||f||||||||||2017-10-11 05:00:51.831443|2017-10-11 05:00:51.831443
NCT00102154|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-21|2015-01-13|||January 2005||2005-01-01|August 2014|2014-08-01||||||||Interventional|||An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study of MK0928 in Healthy Adult Volunteers Participating in a 4-Hour Phase Advance Model of Transient Insomnia|Withdrawn||Phase 3|0|Actual|H. Lundbeck A/S|||||f||||||||||||||2017-10-11 05:00:51.956121|2017-10-11 05:00:51.956121
NCT00102167|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-21|2015-01-13|||February 2005||2005-02-01|January 2015|2015-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study of MK0928 in Healthy Adult Volunteers Participating in a 4-Hour Phase Advance Model of Transient Insomnia|Completed||Phase 3|663|Actual|H. Lundbeck A/S|||||f||||||||||||||2017-10-11 05:00:52.013877|2017-10-11 05:00:52.013877
NCT00102180|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-21|2015-11-30|||January 2005||2005-01-01|November 2015|2015-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Drug-Induced Sudden Death & Ventricular Arrhythmia||Completed||N/A|31000000|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-10-11 05:00:52.081219|2017-10-11 05:00:52.081219
NCT00102193|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-24|2008-09-05|||July 2004||2004-07-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study for the Treatment of Ulcerative Colitis With Adacolumn|A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Ulcerative Colitis|Completed||Phase 3|168||Otsuka America Pharmaceutical|||||||||||||||||||2017-10-11 05:00:52.209633|2017-10-11 05:00:52.209633
NCT00102206|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-25|2012-05-17||||||May 2012|2012-05-01|May 2007|Actual|2007-05-01|||||Interventional|||A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy|A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Two Antiretroviral Therapeutic Strategies: A Dual PI-Based HAART Regimen Versus a Multi-NRTI ART Regimen, in ART-Experienced Children and Youth Who Have Experienced Virologic Failure|Completed||Phase 2|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:00:52.3574|2017-10-11 05:00:52.3574
NCT00102219|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-25|2007-11-28|||October 2004||2004-10-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer|A Phase 2 Study of ALIMTA Plus Doxorubicin Administered Every 21 Days in Patients With Advanced Breast Cancer|Completed||Phase 2|77|Actual|Eli Lilly and Company|||||||||||||||||||2017-10-11 05:00:52.48442|2017-10-11 05:00:52.48442
NCT00102232|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-25|2005-06-23|||May 2003||2003-05-01|January 2005|2005-01-01|July 2003||2003-07-01|||||Interventional|||Effect of Phosphatidylcholine on Plasma Homocysteine in Healthy Volunteers|Effect of Choline Supplemented as Phosphatidylcholine on Post-Methionine Loading and Fasting Concentrations of Plasma Homocysteine in Healthy Volunteers|Completed||N/A|26||Wageningen Centre for Food Sciences|||||f||||||||||||||2017-10-11 05:00:52.602693|2017-10-11 05:00:52.602693
NCT00102245|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-25|2017-08-05|||January 18, 2005||2005-01-18|August 4, 2017|2017-08-04|August 4, 2017||2017-08-04|||||Observational|||Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes|Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes|Terminated||N/A|334|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:52.710795|2017-10-11 05:00:52.710795
NCT00102258|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-25|2017-06-30|||January 19, 2005||2005-01-19|October 2, 2007|2007-10-02|October 2, 2007||2007-10-02|||||Interventional|||Role of Nutrition and Hormones in Boys With Disordered Growth|Nutrients and Hormones: Effects in Boys With Disordered Growth - Pilot Study|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:52.790228|2017-10-11 05:00:52.790228
NCT00102271|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-25|2017-06-30|||January 19, 2005||2005-01-19|April 12, 2011|2011-04-12|April 12, 2011|Actual|2011-04-12|||||Interventional|||Nitrite Infusion Studies|Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Systemic Nitrite Infusion|Completed||Phase 1|36|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:00:52.869933|2017-10-11 05:00:52.869933
NCT00102284|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-26|2010-01-26|||March 2004||2004-03-01|September 2006|2006-09-01|April 2005||2005-04-01|||||Interventional|||Neuromodulation and Language Acquisition (Project Stage Ia)|Improved Language Acquisition Through Neuromodulation, Project Stage Ia|Terminated||Phase 4|100||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:00:52.962839|2017-10-11 05:00:52.962839
NCT00102297|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-26|2007-12-10|||January 2005||2005-01-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus|A Phase 1 Study of the Safety, Pharmacokinetics, and Biologic Activity of Escalating Doses of FG-3019 in Subjects With Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus|Completed||Phase 1|20|Anticipated|FibroGen|||||f||||||||||||||2017-10-11 05:00:53.060097|2017-10-11 05:00:53.060097
NCT00102310|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-26|2015-06-15|||March 2004||2004-03-01|June 2015|2015-06-01|March 2006|Actual|2006-03-01|||||Interventional|||YM443 in Subjects With Functional Dyspepsia|A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia|Completed||Phase 2|416|Actual|Astellas Pharma Inc|||||||||||||||||||2017-10-11 05:00:53.160062|2017-10-11 05:00:53.160062
NCT00102700|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2009-04-28|||January 2005||2005-01-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer|A Phase II Study of ARQ 501 in Combination With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|66||ArQule|||||||||||||||||||2017-10-11 05:01:02.92366|2017-10-11 05:01:02.92366
NCT00102323|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-27|2009-01-09|||March 2005||2005-03-01|January 2009|2009-01-01|March 2007|Actual|2007-03-01|September 2006|Actual|2006-09-01||Interventional|||AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy|A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy|Completed||Phase 3|63|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:00:53.388722|2017-10-11 05:00:53.388722
NCT00102336|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-27|2009-05-07|||April 2005||2005-04-01|May 2009|2009-05-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy|A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy|Completed||Phase 3|62|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:00:53.476753|2017-10-11 05:00:53.476753
NCT00102349|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-27|2017-01-11|||November 2004||2004-11-01|October 2016|2016-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||HIV and HCV Intervention In Drug Treatment Settings - 1|HIV and HCV Intervention in Drug Treatment Settings|Completed||Phase 3|706||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 05:00:53.567681|2017-10-11 05:00:53.567681
NCT00102362|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-27|2017-01-11|||December 2004||2004-12-01|October 2016|2016-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Job-Seekers Training for Patients With Drug Dependence - 1|Job Seekers Training for Patients With Drug Dependence|Completed||Phase 3|627||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-10-11 05:00:53.663216|2017-10-11 05:00:53.663216
NCT00102375|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2006-08-03|||December 1999||1999-12-01|February 2006|2006-02-01|October 2004||2004-10-01|||||Interventional|||Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer|Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan|Completed||Phase 3|900||AGO Study Group|||||f||||||||||||||2017-10-11 05:00:53.784743|2017-10-11 05:00:53.784743
NCT00102388|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01||||March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|1092|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:00:53.920325|2017-10-11 05:00:53.920325
NCT00102401|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2007-08-13|||September 2003||2003-09-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Internet-Based and Established Dyspnea Self-Management Programs in Chronic Obstructive Pulmonary Disease (COPD) Patients|Comparing the Effects of an Internet-Based to an Established Dyspnea Self-Management Program on Dyspnea, Exercise Behavior, and Pulmonary Exacerbations in Patients With COPD|Completed||N/A|50|Actual|Robert Wood Johnson Foundation|||||f||||||||||||||2017-10-11 05:00:54.033063|2017-10-11 05:00:54.033063
NCT00102414|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2006-11-13|||September 1999||1999-09-01|January 2005|2005-01-01|November 2004||2004-11-01|||||Interventional|||Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer|A Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy|Completed||Phase 3|356||AGO Study Group|||||f||||||||||||||2017-10-11 05:00:54.123089|2017-10-11 05:00:54.123089
NCT00102427|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2014-01-21|||July 2000||2000-07-01|January 2014|2014-01-01|May 2003||2003-05-01|||||Interventional|||Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders|Improving Quality of Primary Care for Anxiety Disorders|Completed||Phase 2/Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:00:54.21316|2017-10-11 05:00:54.21316
NCT00102440|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2012-01-31|2009-03-12||July 2002||2002-07-01|January 2012|2012-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|FACT||Febuxostat Versus Allopurinol Control Trial in Subjects With Gout|A Phase 3, Randomized, Multicenter Study Comparing the Safety and Efficacy of Oral Febuxostat Versus Allopurinol in Subjects With Gout|Completed||Phase 3|760|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:00:54.332661|2017-10-11 05:00:54.332661
NCT00102453|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2011-10-26|||March 2002||2002-03-01|October 2011|2011-10-01|May 2007|Actual|2007-05-01|July 2006|Actual|2006-07-01||Interventional|||Pentoxifylline in Duchenne Muscular Dystrophy|An Open-Label Pilot Study of Pentoxifylline in Steroid-naive Duchenne Muscular Dystrophy|Completed||Phase 1/Phase 2|17|Actual|Cooperative International Neuromuscular Research Group||1|||f||||t||||||||||2017-10-11 05:00:56.180497|2017-10-11 05:00:56.180497
NCT00102466|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2017-05-15||2013-01-02|January 2005||2005-01-01|May 2017|2017-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes|Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|1007|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:00:56.302863|2017-10-11 05:00:56.302863
NCT00102479|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2006-04-13|||July 2004||2004-07-01|April 2006|2006-04-01|July 2005||2005-07-01|||||Interventional|||Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents|A Phase II Study to Test PK Tolerability in Children and Adolescents|Completed||Phase 2|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 05:00:56.401947|2017-10-11 05:00:56.401947
NCT00102505|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2009-04-02|||November 2004||2004-11-01|April 2009|2009-04-01||||||||Interventional|||A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)|Phase I Trial of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|36||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 05:00:56.608291|2017-10-11 05:00:56.608291
NCT00102713|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2007-05-17|||February 2005||2005-02-01|May 2007|2007-05-01||||||||Interventional|||A Study for Treatment of Partial Seizures in Children|An Open Label Study for Treatment of Partial Seizures in Children|Completed||Phase 3|50||Abbott|||||||||||||||||||2017-10-11 05:01:03.020733|2017-10-11 05:01:03.020733
NCT00102518|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2012-07-31|2012-05-16||September 2004||2004-09-01|July 2012|2012-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|APEX 241||Aripiprazole Open-Label, Safety and Tolerability Study|A Multi-Center, Open-Label, Safety and Tolerability Study of Flexible-Dose Oral Aripiprazole (2 Mg-30 mg) in the Treatment of Adolescent Patients With Schizophrenia and Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features|Completed||Phase 3|325|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-10-11 05:00:56.701682|2017-10-11 05:00:56.701682
NCT00102531|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2017-07-05|2017-07-05||January 12, 2005|Actual|2005-01-12|July 2017|2017-07-01|March 17, 2008|Actual|2008-03-17|March 2008|Actual|2008-03-01||Interventional|||Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung|Phase Ib/IIa Study of SLIT Cisplatin by Inhalation in the Treatment of Patients Wtih Relapsed/Progressive Osteosarcoma Metastatic to the Lung|Completed||Phase 1/Phase 2|19|Actual|Insmed Incorporated||2|||f|||||t|f||||||||2017-10-11 05:00:57.368814|2017-10-11 05:00:57.368814
NCT00102544|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2017-10-05|||January 26, 2005||2005-01-26|June 19, 2017|2017-06-19||||||||Observational|||Use of Tracking Devices to Locate Abnormalities During Invasive Procedures|Electromagnetic Tracking of Devices During Interventional Procedures|Recruiting||N/A|3195|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:57.845286|2017-10-11 05:00:57.845286
NCT00102557|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2008-03-03|||January 2005||2005-01-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus|Hydroxychloroquine Versus Clobetasol 0.05% Rinse for the Treatment of Oral Lichen Planus|Completed||Phase 2|74||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:57.944073|2017-10-11 05:00:57.944073
NCT00102570|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2017-06-30|||January 26, 2005||2005-01-26|August 10, 2010|2010-08-10|August 10, 2010||2010-08-10|||||Observational|||Clinical and Immunological Evaluation of Children With Allergies|Clinical and Immunological Evaluation of Children With Allergic Disease|Completed||N/A|270|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:00:58.019911|2017-10-11 05:00:58.019911
NCT00102583|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-29|2017-06-30|||October 14, 2004||2004-10-14|March 15, 2011|2011-03-15|March 15, 2011|Actual|2011-03-15|March 15, 2011|Actual|2011-03-15||Interventional|||Cyclosporine Implant for Ocular Graft-Versus-Host Disease|A Phase I Clinical Trial to Study the Safety of a Sustained-Release Subconjunctival Cyclosporine Implant for Ocular Graft-vs-Host Disease (GVHD1)|Completed||Phase 1|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:00:58.087939|2017-10-11 05:00:58.087939
NCT00102596|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-30|2012-01-31|2010-11-10||January 2005||2005-01-01|January 2012|2012-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor|Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor|Completed||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)|Enrollment to study was ended early, as evidence became available, that a metabolite of the study substance promised significantly higher feasibility for treatment in ET.|1|||f||||f||||||||||2017-10-11 05:00:58.186078|2017-10-11 05:00:58.186078
NCT00102609|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-31|2013-01-09|||April 2005||2005-04-01|January 2013|2013-01-01|October 2007|Actual|2007-10-01|||||Interventional|||A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma|A Phase I Study to Determine the Dose of the Combination of Yondelis and Doxorubicin for Which Neutropenia is Manageable With the Support of Granulocyte-Colony Stimulation Factor in Subjects With Recurrent or Persistent Soft Tissue Sarcoma|Completed||Phase 1|41|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-10-11 05:00:58.717296|2017-10-11 05:00:58.717296
NCT00102622|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-31|2014-06-04|||December 2004||2004-12-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer|Phase I of Phase I/II Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer|Terminated||Phase 1|18|Actual|M.D. Anderson Cancer Center||2||Phase I/II study that did not progress to Phase II due to low accrual.|f||||t||||||||||2017-10-11 05:00:58.83866|2017-10-11 05:00:58.83866
NCT00102635|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-31|2012-07-27|||January 2005||2005-01-01|July 2012|2012-07-01|November 2006|Actual|2006-11-01|January 2006|Actual|2006-01-01||Interventional|||4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)|A Phase IB Randomized Translational Study of Fenretinide (4-HPR) in Combination With SCH66336, a Farnesyl Transferase Inhibitor, in Patients With Advanced or Recurrent Head and Neck Cancer|Terminated||Phase 1|1|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-10-11 05:00:58.971604|2017-10-11 05:00:58.971604
NCT00102648|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-31|2017-06-16|||December 2004|Actual|2004-12-01|June 2017|2017-06-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Sarasar and Temodar for Glioblastoma Multiforme Patients|Phase I/Ib Study of Sarasar and Temodar in Patients With Recurrent or Temodar-Refractory Glioblastoma Multiforme|Active, not recruiting||Phase 1|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 05:00:59.115973|2017-10-11 05:00:59.115973
NCT00102661|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-31|2012-07-27|||October 2002||2002-10-01|July 2012|2012-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia|Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 05:00:59.259789|2017-10-11 05:00:59.259789
NCT00102674|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-31|2011-08-15|||March 2005||2005-03-01|March 2005|2005-03-01|May 2005||2005-05-01|||||Interventional|||Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor|The Pharmacokinetics and Pharmacodynamics of a Cangrelor Bolus Plus Infusion in Healthy Volunteers|Completed||Phase 1|40||The Medicines Company|||||||||||||||||||2017-10-11 05:00:59.471146|2017-10-11 05:00:59.471146
NCT00102687|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-31|2010-06-22|2010-05-03||January 2005||2005-01-01|June 2010|2010-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes|A Multicenter, Randomized, Open-Label Study Comparing Three Alternative Dosing Regimens of Subcutaneous Azacitidine Plus Best Supportive Care for the Treatment of Myelodysplastic Syndromes|Completed||Phase 2|151|Actual|Celgene||5|||f||||f||||||||||2017-10-11 05:00:59.654346|2017-10-11 05:00:59.654346
NCT00286884|ClinicalTrials.gov processed this data on October 10, 2017|2006-02-03|2006-09-08||||||September 2006|2006-09-01||||||||Observational|||Heart Rate Variability in White Coat Hypertension and Essential Hypertension||Completed||N/A|65||Regional Hospital Holstebro|||||f||||||||||||||2017-10-11 05:59:35.248309|2017-10-11 05:59:35.248309
NCT00102726|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2017-03-21|||February 2005||2005-02-01|March 2017|2017-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel Group, Dose Ranging Study to Assess the Efficacy, Safety, and Pharmacokinetics of an Oral Thrombopoietin Receptor Agonist(SB497115-GR) Administered at 50, 75, and 100 mg to Cancer Patients Receiving Multiple Cycles of Chemotherapy|Completed||Phase 2|183|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-10-11 05:01:03.151052|2017-10-11 05:01:03.151052
NCT00102739|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2013-04-11|||February 2005||2005-02-01|November 2012|2012-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)|See Detailed Description|Completed||Phase 2|99|Actual|GlaxoSmithKline|||||||||f||||||||||2017-10-11 05:01:03.559459|2017-10-11 05:01:03.559459
NCT00102752|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2009-04-28|||December 2004||2004-12-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer|A Phase 1/2 Dose-Escalation Study of the Safety, Efficacy and Pharmacokinetics of Glufosfamide in Combination With Gemcitabine in Advanced Solid Tumors and Pancreatic Adenocarcinoma|Completed||Phase 1/Phase 2|47||Threshold Pharmaceuticals|||||||||||||||||||2017-10-11 05:01:03.798378|2017-10-11 05:01:03.798378
NCT00102765|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2017-01-16|||November 2004||2004-11-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study Of Asthma In Patients Of African Descent|A Multicenter, Randomized, Double-Blind, Parallel Group, 52-Week Comparison of Asthma Control and Measures of Airway Inflammation in Subjects of African Descent Receiving Fluticasone Propionate/Salmeterol 100/50mcg DISKUS® BID or Fluticasone Propionate 100mcg DISKUS® BID Alone|Completed||Phase 4|479|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:01:03.920998|2017-10-11 05:01:03.920998
NCT00102778|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2017-05-25|||December 2004||2004-12-01|May 2017|2017-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||GW873140 In Combination With Kaletra In HIV Infected Subjects|A Phase IIb, 96 Week, Randomized, Open-label Multicenter, Parallel Group, Repeat Dose Study to Evaluate the Safety, Tolerability, PK and Antiviral Effect of Different Doses and Regimens of GW873140 in Combination With Kaletra (Lopinavir and Ritonavir) in HIV-1 Infected Antiretroviral Therapy naïve Subjects|Terminated||Phase 2|175||ViiV Healthcare|||||||||||||||||||2017-10-11 05:01:04.17559|2017-10-11 05:01:04.17559
NCT00102791|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2008-03-26|||February 2005||2005-02-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|ASSERT||A Stratified Sickle Event Randomized Trial (ASSERT)|A Phase III Multicenter, 52-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Clinical Efficacy and Safety of ICA-17043 With or Without HU Therapy in Patients With Sickle Cell Disease Who Have Had =>2 Acute Sickle-Related Painful Crises Within the Preceding 12 Months|Terminated||Phase 3|297|Actual|Icagen||2||Because of the low probability of achieving the primary endpoint.|f||||t||||||||||2017-10-11 05:01:04.408506|2017-10-11 05:01:04.408506
NCT00102804|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2014-12-17|2014-12-17||March 2005||2005-03-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|August 2007|Actual|2007-08-01||Interventional||Participants who signed the ICF and completed the randomized process are reported according to the treatment arm to which they were randomized.|Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)|A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment for Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|663|Actual|Eli Lilly and Company|Four participants (pts) assigned to placebo received pemetrexed; pts analyzed for efficacy as randomized. Three treated pts did not sign ICF, 1 treated pt signed ICF but did not complete entire randomization process; pts excluded from all analyses.|2|||f||||t||||||||||2017-10-11 05:01:05.063417|2017-10-11 05:01:05.063417
NCT00102817|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-01|2017-01-17|||May 2003||2003-05-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children|Somatropin (Norditropin) in Children With Growth Failure Associated With ICF Deficiency.|Completed||Phase 3|149|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:01:07.635904|2017-10-11 05:01:07.635904
NCT00102830|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-03|2010-08-19||||||August 2010|2010-08-01||||||||Interventional|||Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors|A Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of AMG 386 in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|||Amgen||1|||||||||||||||||2017-10-11 05:01:07.781153|2017-10-11 05:01:07.781153
NCT00102843|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-03|2005-08-02|||October 2002||2002-10-01|August 2005|2005-08-01|June 2003||2003-06-01|||||Interventional|||Effect of Betaine and Folic Acid on Vascular Function in Healthy Humans|Effect of Lowering of Fasting Plasma Homocysteine Concentrations Through Supplementation With Betaine or Folic Acid on Vascular Function in Healthy Volunteers|Completed||N/A|40||Wageningen Centre for Food Sciences|||||f||||||||||||||2017-10-11 05:01:07.855797|2017-10-11 05:01:07.855797
NCT00102856|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-03|2010-06-23|||January 2005||2005-01-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Neuromodulation and Language Acquisition (Stage Ib)|Neuromodulation and Language Acquisition (KS-Neuromod_01, Stage Ib)|Suspended||Phase 4|60||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:01:07.931607|2017-10-11 05:01:07.931607
NCT00102882|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-03|2017-02-02|||October 2004||2004-10-01|February 2017|2017-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate|Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone|Completed||Phase 4|547|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:01:08.347518|2017-10-11 05:01:08.347518
NCT00102895|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-03|2010-08-26|||April 2005||2005-04-01|August 2010|2010-08-01|September 2005|Actual|2005-09-01|||||Interventional|||A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer|An Open-Label, Multi-Center, Phase 2 Study Of Cp 724,714 In Patients With Her2 Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy For Metastatic Disease And Is Previously Untreated With A Her2 Inhibitor|Terminated||Phase 2|25||Pfizer||||See Detailed Description|f||||||||||||||2017-10-11 05:01:08.62502|2017-10-11 05:01:08.62502
NCT00102921|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-04|2006-03-12|||August 2004||2004-08-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Interventional|||Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn’s Disease|Pilot, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety Clinical Activity of CCX282-B in Patients With Moderate to Severe Crohn’s Disease|Completed||Phase 2|70||ChemoCentryx|||||||||||||||||||2017-10-11 05:01:08.809903|2017-10-11 05:01:08.809903
NCT00102934|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-04|2008-09-16|||March 2003||2003-03-01|September 2008|2008-09-01|March 2009|Anticipated|2009-03-01|December 2005|Actual|2005-12-01||Interventional|||Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus|Treatment Intensification in HIV-1 Patients With Multi-Drug Resistant Virus|Unknown status|Active, not recruiting|N/A|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 05:01:08.997355|2017-10-11 05:01:08.997355
NCT00102947|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-04|2016-07-22|||January 2005||2005-01-01|July 2016|2016-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections|An Open Label Phase 4 Trial to Further Evaluate the Pharmacokinetic Profile of Intravenous Daptomycin, and a Comparison of the Safety and Efficacy of Daptomycin Versus Comparator in the Treatment of Adult Patients With Renal Impairment and Complicated Skin and Skin Structure Infections Due, at Least in Part, to Gram-positive Bacteria|Terminated||Phase 4|72||Cubist Pharmaceuticals LLC|||||||||||||||||||2017-10-11 05:01:09.110243|2017-10-11 05:01:09.110243
NCT00102973|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-04|2012-05-30|||December 2004||2004-12-01|June 2006|2006-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer|Phase III Randomized Study of TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Liposomal Doxorubicin (Doxil) as Second-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-3]|Completed||Phase 3|244|Actual|Telik||2|||f||||||||||||||2017-10-11 05:01:09.399407|2017-10-11 05:01:09.399407
NCT00102986|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-04|2015-12-02|||October 2005||2005-10-01|December 2015|2015-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women|Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women|Completed||N/A|116|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:01:10.154306|2017-10-11 05:01:10.154306
NCT00102999|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-04|2017-06-30|||January 31, 2005||2005-01-31|January 22, 2009|2009-01-22|January 22, 2009||2009-01-22|||||Observational|||Brain Function in Focal Dystonia|Impaired Motor Learning and LTP/LTD-like Plasticity in Dystonia, Are Associated With Abnormal Modulation of Cortical Excitability by Somatosensory Volleys|Completed||N/A|118||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:01:10.311734|2017-10-11 05:01:10.311734
NCT00103012|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-05|2012-03-13|2011-12-12||January 2005||2005-01-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers|The Influence of Concurrent Administration of Echinacea Purpurea, Ginkgo Biloba, or Panax Ginseng on the Steady State Pharmacokinetic Profile of Lopinavir/Ritonavir in Healthy Volunteers|Completed||Phase 4|47|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-10-11 05:01:10.427742|2017-10-11 05:01:10.427742
NCT00103025|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-05|2017-06-30|||February 4, 2005||2005-02-04|May 10, 2011|2011-05-10|May 10, 2011|Actual|2011-05-10|May 10, 2011|Actual|2011-05-10||Interventional|||Nitrite Infusion in Healthy Volunteers|Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Long-Term Intravenous Nitrite Infusion in Healthy Volunteers|Completed||Phase 1|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:01:11.012678|2017-10-11 05:01:11.012678
NCT00103038|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2017-04-19|||February 2004||2004-02-01|April 2017|2017-04-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases|NCI-Sponsored Multi-Disciplinary Study for MR Imaging of Intravenous Superparamagnetic Crystalline Particle Ferumoxytol in Primary High-Grade Brain Tumors and/or Cerebral Metastases|Active, not recruiting||N/A|155|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 05:01:11.21938|2017-10-11 05:01:11.21938
NCT00103051|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2012-07-13|||December 2004||2004-12-01|July 2012|2012-07-01||||November 2005|Actual|2005-11-01||Interventional|||Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer|Phase II Study With Gefitinib (Sequentially) Following Gemcitabine/Cisplatin as Induction Regimen for Patients With Stage IIIA N2 NSCLC|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 05:01:11.409761|2017-10-11 05:01:11.409761
NCT00103090|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2012-11-12|||January 2005||2005-01-01|November 2012|2012-11-01|November 2006|Actual|2006-11-01|January 2006|Actual|2006-01-01||Interventional|||Fenretinide and Lonafarnib in Treating Patients With Advanced or Recurrent Head and Neck Cancer|A Phase IB Randomized Translational Study of Fenretinide (4-HPR) in Combination With SCH66336, a Farnesyl Transferase Inhibitor, in Patients With Advanced or Recurrent Head and Neck Cancer|Terminated||Phase 1|1|Actual|M.D. Anderson Cancer Center||1||Slow Accrual.|f||||f||||||||||2017-10-11 05:01:11.553922|2017-10-11 05:01:11.553922
NCT00103103|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2010-10-11|||March 2005||2005-03-01|October 2010|2010-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer|A Phase II Combination Trial of PS-341 and 5-FU/LV in Gastric and/or GE Junction Adenocarcinoma|Terminated||Phase 2|||California Cancer Consortium|||||f||||||||||||||2017-10-11 05:01:11.716521|2017-10-11 05:01:11.716521
NCT00103116|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2017-03-30|2013-11-07||October 2004||2004-10-01|March 2017|2017-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer|Autologous Dendritic Cell Vaccines in Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|32|Actual|University of Kentucky||1|||f||||f||||||||||2017-10-11 05:01:11.890975|2017-10-11 05:01:11.890975
NCT00103142|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2015-10-11|2014-01-16||February 2005||2005-02-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|June 2009|Actual|2009-06-01||Interventional||37 PANVAC-V + PANVAC-F + DC arm patients and 37 PANVAC-V + PANVAC-F + GM-CSF arm. One participant in PANVAC-V + PANVAC-F + DC Arm was consented and contributed baseline data, but was not considered to have started or enrolled in the study patients signed consent.|Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer|A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma|Completed||Phase 2|74|Actual|Duke University||2|||f||||t||||||||||2017-10-11 05:01:12.187274|2017-10-11 05:01:12.187274
NCT00103155|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2013-09-19|||September 2004||2004-09-01|August 2005|2005-08-01||||||||Interventional|||Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer|Radiofrequency Ablation for Low Risk Papillary Thyroid Cancer: A Pilot Study|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:01:12.698452|2017-10-11 05:01:12.698452
NCT00103168|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2013-10-28|||December 2004||2004-12-01|October 2013|2013-10-01||||October 2008|Actual|2008-10-01||Interventional|||Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor|Intermediate and High Risk Localized, Completely Resected, Gastrointestinal Stromal Tumors (GIST) Expressing KIT Receptor: A Controlled Randomized Trial on Adjuvant Imatinib Mesylate (Glivec) Versus No Further Therapy After Complete Surgery|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 05:01:12.776506|2017-10-11 05:01:12.776506
NCT00103181|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2017-05-12|||March 2005||2005-03-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer|A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women With Stage 0, I, or II Breast Cancer|Active, not recruiting||N/A|4216|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-10-11 05:01:13.011365|2017-10-11 05:01:13.011365
NCT00103194|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2014-09-19|2011-11-03||September 2005||2005-09-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer|Phase II Trial of GW572016 in Patients With Recurrent Prostate Cancer as Evident by a Rising PSA|Completed||Phase 2|49|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:01:14.174587|2017-10-11 05:01:14.174587
NCT00091559|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-10|2017-04-03|||February 3, 2005|Actual|2005-02-03|April 2017|2017-04-01|March 13, 2006|Actual|2006-03-13|November 23, 2005|Actual|2005-11-23||Interventional|||Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)|Phase IIb Multicenter Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Advanced Cutaneous T-cell Lymphoma|Completed||Phase 2|74|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:01:14.515321|2017-10-11 05:01:14.515321
NCT00091572|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-10|2017-05-12|2008-12-19||October 20, 2004|Actual|2004-10-20|May 2017|2017-05-01|December 31, 2007|Actual|2007-12-31|December 31, 2007|Actual|2007-12-31||Interventional|||Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)|Extended Schedule, Escalated Dose Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma: A Randomized Phase III Study of the EORTC Melanoma Group|Completed||Phase 3|859|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:01:14.662728|2017-10-11 05:01:14.662728
NCT00091585|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-10|2007-05-09|||June 2004||2004-06-01|May 2007|2007-05-01|November 2006||2006-11-01|||||Interventional|||Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.|Phase I Open-Label, Multicenter, Dose-Escalation Clinical Study of the Initial Safety and Pharmacokinetic Profiles of Intravenous Administration of SNS-595 in Patients With Advanced Malignancies|Completed||Phase 1|||Sunesis Pharmaceuticals|||||||||||||||||||2017-10-11 05:01:15.857461|2017-10-11 05:01:15.857461
NCT00091598|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-10|2010-03-04|||January 2004||2004-01-01|March 2010|2010-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)|ARIES 1 and ARIES 2: Ambrisentan in PAH - A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 3|372||Gilead Sciences|||||t||||||||||||||2017-10-11 05:01:15.946805|2017-10-11 05:01:15.946805
NCT00091611|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-11|2012-10-25|||September 2004||2004-09-01|October 2012|2012-10-01|March 2008|Actual|2008-03-01|April 2006|Actual|2006-04-01||Interventional|||Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer|Phase II Study in Metastatic Renal Cell Cancer Using Cultured, Tumor-Reactive Lymphocytes and Interleukin-2|Terminated||Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||||This study was terminated due to low accrual.|f||||||||||||||2017-10-11 05:01:16.419737|2017-10-11 05:01:16.419737
NCT00091624|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-13|2016-11-30|||March 2003||2003-03-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)|A Phase I Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)|Completed||Phase 1|77|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 05:01:16.547997|2017-10-11 05:01:16.547997
NCT00091637|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-14|2011-08-04|||April 2004||2004-04-01|August 2011|2011-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)|APEX-AMI - Pexelizumab in Conjunction With Angioplasty|Completed||Phase 3|5745|Actual|Procter and Gamble||2|||f||||t||||||||||2017-10-11 05:01:16.706122|2017-10-11 05:01:16.706122
NCT00091650|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-14|2006-07-21|||March 2004||2004-03-01|July 2006|2006-07-01|November 2005||2005-11-01|||||Interventional|||Olanzapine in Patients With Borderline Personality Disorder|Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Flexible Dose Double-Blind Comparison With Placebo|Completed||Phase 3|300||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:01:17.562407|2017-10-11 05:01:17.562407
NCT00091663|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-15|2014-02-28|||August 2004||2004-08-01|February 2014|2014-02-01|August 2005|Actual|2005-08-01|||||Interventional|||A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|A Multicenter, Open-Label, Phase IIIb Trial of Tarceva (Erlotinib Hydrochloride) in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|5000||Genentech, Inc.|||||||||||||||||||2017-10-11 05:01:17.737776|2017-10-11 05:01:17.737776
NCT00091676|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-15|2012-02-01|||January 2000||2000-01-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|BiovaxID||Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma|Randomized Trial of Patient-Specific Vaccination With Conjugated Follicular Lymphoma-Derived Idiotype (FNHLId1) With Local GM-CSF in First Complete Remission|Unknown status|Active, not recruiting|Phase 3|629|Anticipated|Biovest International||2|||f||||t||||||||||2017-10-11 05:01:17.988145|2017-10-11 05:01:17.988145
NCT00091689|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-15|2008-10-24|||September 2004||2004-09-01|October 2008|2008-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions||Completed||Phase 1|||Pfizer|||||||||||||||||||2017-10-11 05:01:18.083707|2017-10-11 05:01:18.083707
NCT00091702|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-16|2012-05-16||||||May 2012|2012-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents|A Phase I/II Randomized Trial of the Safety and Immunogenicity of Cold Adapted Influenza Vaccine (FluMist) in HIV-Infected Children and Adolescents|Completed||Phase 1/Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:01:18.161467|2017-10-11 05:01:18.161467
NCT00091715|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-16|2011-08-26|||April 2004||2004-04-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Mildly Symptomatic Pulmonary Arterial Hypertension (PAH)|Completed||Phase 3|185|Actual|Actelion||2|||f||||||||||||||2017-10-11 05:01:18.543117|2017-10-11 05:01:18.543117
NCT00091728|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-16|2005-11-04|||September 1997||1997-09-01|September 2004|2004-09-01|August 2001||2001-08-01|||||Observational|||Hormonal Contraception and Risk of Chlamydia and Gonorrhea|Hormonal Contraception, Cervical Ectopy, and STDs|Terminated||Phase 4|1200||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:01:18.686217|2017-10-11 05:01:18.686217
NCT00091741|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-16|2009-07-21||||||September 2004|2004-09-01|October 2004|Actual|2004-10-01|||||Interventional|||Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects|A Phase I Pilot Study to Evaluate Safety and Efficacy of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects Who Are in Virologic Failure and Who Have Failed to Respond to Standard Antiretroviral Therapy|Completed||Phase 1|10|Anticipated|Georgetown University|||||||||||||||||||2017-10-11 05:01:18.746174|2017-10-11 05:01:18.746174
NCT00091754|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-16|2008-07-23|||September 2004||2004-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Atherosclerosis, Plaque and CVD in Communities||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:01:18.821272|2017-10-11 05:01:18.821272
NCT00091767|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-16|2016-07-11|||September 2004||2004-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genetic Studies in Difficult to Treat Asthma: TENOR||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:01:18.874448|2017-10-11 05:01:18.874448
NCT00091780|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-16|2014-02-19|||September 2004||2004-09-01|February 2014|2014-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Epidemiology of Breast Arterial Calcification||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-10-11 05:01:18.926577|2017-10-11 05:01:18.926577
NCT00091793|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-17|2010-12-22|2009-12-22|2009-11-23|August 2004||2004-08-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis|A Randomized, Double-Blind Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis|Completed||Phase 3|332|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:01:19.075078|2017-10-11 05:01:19.075078
NCT00091806|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-17|2009-07-09|||August 2004||2004-08-01|July 2009|2009-07-01|October 2006|Actual|2006-10-01|April 2006|Actual|2006-04-01||Interventional|||Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors|An Open-Label, Clinical Trial Evaluating the Safety and Pharmacokinetics of Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors|Completed||Phase 1|86|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:01:19.949506|2017-10-11 05:01:19.949506
NCT00091819|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-17|2010-12-10|2009-11-03||January 2005||2005-01-01|December 2010|2010-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|ATLAS1||Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus|A Phase 3, Randomized, Double Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections With a Focus on Patients With Infections Due to Methicillin-resistant Staphylococcus Aureus|Completed||Phase 3|862|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-10-11 05:01:20.133795|2017-10-11 05:01:20.133795
NCT00091832|ClinicalTrials.gov processed this data on October 10, 2017|2004-09-17|2013-12-20|2010-12-09|2009-11-23|September 2004||2004-09-01|December 2013|2013-12-01|October 2006|Actual|2006-10-01|November 2005|Actual|2005-11-01||Interventional|||Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer|A Randomized Active-controlled Study of AMG 162 in Breast Cancer Subjects With Bone Metastasis Who Have Not Previously Been Treated With Bisphosphonate Therapy.|Completed||Phase 2|255|Actual|Amgen||6|||f||||||||||||||2017-10-11 05:01:21.332963|2017-10-11 05:01:21.332963
NCT00097422|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-23|2017-03-23|||November 1, 2004|Actual|2004-11-01|March 2017|2017-03-01|April 1, 2005|Actual|2005-04-01|April 1, 2005|Actual|2005-04-01||Interventional|||OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)|An Open-Label, Dose Ranging, Randomized Clinical Evaluation of OPT-80 in Patients With Clostridium Difficile-Associated Diarrhea (CDAD)|Completed||Phase 2|||Optimer Pharmaceuticals LLC|||||||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:01:25.543437|2017-10-11 05:01:25.543437
NCT00097435|ClinicalTrials.gov processed this data on October 10, 2017|2004-11-23|2013-08-01|||October 2004||2004-10-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C|A Multi-Center, Randomized, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Albuferon (Recombinant Human Albumin-Interferon Alfa Fusion Protein) in Combination With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C|Completed||Phase 2|115|Actual|Human Genome Sciences Inc.|||||f||||||||||||||2017-10-11 05:01:25.61995|2017-10-11 05:01:25.61995
NCT00103207|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2012-12-03|2012-12-03||August 2005||2005-08-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|April 2010|Actual|2010-04-01||Interventional|||Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer|Phase II Study of C225 (Cetuximab) for the Treatment of Patients With Advanced Bronchioalveolar Carcinoma (BAC) or Adenocarcinoma With BAC Features|Completed||Phase 2|72|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 05:01:25.717903|2017-10-11 05:01:25.717903
NCT00103220|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2013-12-10|||November 2004||2004-11-01|December 2013|2013-12-01||||February 2007|Actual|2007-02-01||Interventional|||SJG-136 in Treating Patients With Advanced Solid Tumors|A Phase I Study With SJG-136 (NSC #694501) in Patients With an Advanced Solid Tumor|Completed||Phase 1|36|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:01:28.697997|2017-10-11 05:01:28.697997
NCT00103233|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2013-06-21|||December 2004||2004-12-01|August 2005|2005-08-01|April 2006|Actual|2006-04-01|||||Interventional|||Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer|A Randomized Study of Weekly Vinorelbine (Navelbine®) Alone or in Combination With Trastuzumab (Herceptin®) (NSC-688097) for Patients With HER-2-Positive Metastatic Breast Cancer Whose Tumors Have Progressed After Taxane + Trastuzumab Combination Therapy - Phase III|Completed||Phase 3|||National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 05:01:28.840344|2017-10-11 05:01:28.840344
NCT00103246|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2011-01-19|||September 2004||2004-09-01|January 2011|2011-01-01|August 2010|Actual|2010-08-01|December 2008|Actual|2008-12-01||Interventional|||Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides|Phase I Clinical Trial Using Topical Silicon Phthalocyanine (Pc 4) Photodynamic Therapy (PDT) for the Treatment of Pre-Malignant and Malignant Skin Conditions|Completed||Phase 1|43|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:01:28.961236|2017-10-11 05:01:28.961236
NCT00103259|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2014-05-07|2012-11-24||July 2005||2005-07-01|December 2012|2012-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Phase II Two Arm Trial of the Proteasome Inhibitor, PS-341 (Velcade TM) in Combination With Irinotecan or PS-341 Alone Followed by the Addition of Irinotecan at Time of Progression in Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|71|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:01:29.122064|2017-10-11 05:01:29.122064
NCT00103272|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2013-06-03|||April 2005||2005-04-01|June 2013|2013-06-01||||April 2008|Actual|2008-04-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer|A Phase I Study of PS-341 (Velcade, Bortezomib) in Combination With 17-allylamino-17-demethoxygeldanamycin (17-AAG) in Patients With Relapsed or Refractory Hematologic Malignancies|Terminated||Phase 1|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:01:29.883095|2017-10-11 05:01:29.883095
NCT00103298|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2013-06-18|||December 2004||2004-12-01|February 2006|2006-02-01|July 2006|Actual|2006-07-01|||||Interventional|||Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer|A Phase II Trial of Isolated Hepatic Perfusion (IHP) and Systemic FOLFOX4 for Subjects With Metastatic Unresectable Colorectal Cancers of the Liver With ≥ 40% Hepatic Tumor Burden|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:01:31.283603|2017-10-11 05:01:31.283603
NCT00103311|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2015-02-13|2015-02-13||January 2005||2005-01-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|January 2010|Actual|2010-01-01||Interventional|||SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer|A Randomized Phase II Non-Comparative Study of SB-715992 Given Weekly or Every Three Weeks in Advanced or Metastatic Colorectal Cancer|Completed||Phase 2|64|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:01:31.465815|2017-10-11 05:01:31.465815
NCT00103324|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2013-01-16|||December 2004||2004-12-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer|Phase II Study of GW572016 (NSC-727989) as First Line Therapy in Patients With Advanced or Metastatic Gastric Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:01:32.271435|2017-10-11 05:01:32.271435
NCT00103337|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2013-02-27|||January 2005||2005-01-01|February 2013|2013-02-01||||October 2007|Actual|2007-10-01||Interventional|||Cilengitide in Treating Patients With Metastatic Prostate Cancer|Phase II Evaluation of EMD121974 (NSC 707544, Cilengitide) in Asymptomatic Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|106|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:01:32.383795|2017-10-11 05:01:32.383795
NCT00105716|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||March 2002||2002-03-01|April 2006|2006-04-01|April 2005|Actual|2005-04-01|||||Interventional|||Study to Lower Veterans BP: Patient/Physician Intervention|Study to Lower Veterans Blood Pressure: Patient/Physician Intervention|Completed||N/A|544|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:39.507015|2017-10-11 05:01:39.507015
NCT00103350|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2008-05-16|||January 2005||2005-01-01|May 2008|2008-05-01|January 2008|Actual|2008-01-01|December 2006|Actual|2006-12-01||Interventional|||Safety of TG100-115 for Heart Attack Treated With Angioplasty|A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo Controlled, Prospective Study to Evaluate the Safety and Potential Efficacy of Single, Increasing Doses of TG100-115 in Subjects Undergoing Percutaneous Coronary Intervention for Acute Anterior ST Elevation Myocardial Infarction|Completed||Phase 1/Phase 2|100||TargeGen|||||f||||||||||||||2017-10-11 05:01:32.491183|2017-10-11 05:01:32.491183
NCT00103363|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2014-05-05|||February 1993||1993-02-01|May 2014|2014-05-01|February 1994|Actual|1994-02-01|February 1994|Actual|1994-02-01||Interventional|||Sputum Cytology in Screening Heavy Smokers For Lung Cancer|Lung Cancer Screening and Tissue Procurement|Completed||Phase 2|3270|Actual|University of Colorado, Denver|||||f||||f||||||||||2017-10-11 05:01:32.557225|2017-10-11 05:01:32.557225
NCT00103376|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2012-04-26|||October 2004||2004-10-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer|VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer|Completed||Phase 2|42|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-10-11 05:01:32.716775|2017-10-11 05:01:32.716775
NCT00103389|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2016-08-30|||February 2004||2004-02-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of Docetaxel With PI-88 in Patients With Advanced Non-Small-Cell Lung Cancer|Completed||Phase 2|98|Actual|Medigen Biotechnology Corporation||2|||f||||f||||||||No||2017-10-11 05:01:32.904768|2017-10-11 05:01:32.904768
NCT00103402|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-07|2011-04-25|||February 2005||2005-02-01|April 2011|2011-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome|A Randomized Multicenter Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of 10mg Alfuzosin in the Treatment of Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) in Recently-Diagnosed and/or Newly-Symptomatic Alpha-blocker Naïve Patients|Completed||Phase 3|270|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 05:01:33.092638|2017-10-11 05:01:33.092638
NCT00103415|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-08|2006-07-12|||February 2005||2005-02-01|February 2005|2005-02-01|February 2007||2007-02-01|||||Interventional|||Trial Investigating the Effect of Different Exercise Forms on Depression|Randomized Clinical Trial Investigating the Effect of Different Exercise Forms on Depression|Unknown status|Active, not recruiting|N/A|300||Demostudiet|||||f||||||||||||||2017-10-11 05:01:33.21699|2017-10-11 05:01:33.21699
NCT00103428|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-08|2006-01-31|||August 2004||2004-08-01|January 2006|2006-01-01||||||||Interventional|||Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer|A Phase 1/2a Dose-Escalation Trial of Intravenous CG7870 in Combination With Docetaxel in Chemotherapy-Naïve Patients With Metastatic Hormone-Refractory Prostate Cancer|Terminated||Phase 1/Phase 2|69||Cell Genesys|||||||||||||||||||2017-10-11 05:01:33.330812|2017-10-11 05:01:33.330812
NCT00103454|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-08|2016-09-15|||January 2005||2005-01-01|September 2016|2016-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 4 Weeks in Adult and Adolescent Subjects (12 Years of Age and Older) With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|288|Actual|GlaxoSmithKline||1|||f||||||||||||Yes||2017-10-11 05:01:33.428135|2017-10-11 05:01:33.428135
NCT00103467|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-08|2005-06-23|||June 2003||2003-06-01|February 2005|2005-02-01||||||||Interventional|||Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine|A Phase 1 Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine|Completed||Phase 1|100||VaxGen|||||||||||||||||||2017-10-11 05:01:33.631802|2017-10-11 05:01:33.631802
NCT00103493|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-09|2010-11-19|||October 2004||2004-10-01|July 2009|2009-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Oral Health Education Program|Efficacy of a Tailored Oral Health Education Program|Completed||Phase 3|1021|Actual|Temple University|||||f||||||||||||||2017-10-11 05:01:33.700467|2017-10-11 05:01:33.700467
NCT00103506|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-09|2015-09-28|2015-05-08||December 2004||2004-12-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma|A Randomized Controlled Study of DOXIL/CAELYX (Doxorubicin HCL Liposome Injection) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma|Completed||Phase 3|646|Actual|Janssen Research & Development, LLC|Study stopped in terms of primary endpoint based on its results at planned interim analysis (28 Apr 2006). However, Long-term follow-up for survival continued until 16 May 2014.|2|||f||||t||||||||||2017-10-11 05:01:33.825048|2017-10-11 05:01:33.825048
NCT00103519|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-09|2013-03-27|||December 2004||2004-12-01|November 2006|2006-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of DITPA in Patients With Congestive Heart Failure|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DITPA in Patients With NYHA Class III and IV Congestive Heart Failure Who Have Low Serum T3 Levels|Terminated||Phase 2|86|Actual|Titan Pharmaceuticals||3||Study terminated for reasons unrelated to safety or efficacy.|f||||||||||||||2017-10-11 05:01:35.705934|2017-10-11 05:01:35.705934
NCT00103532|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-09|2017-02-27|||March 2005||2005-03-01|February 2016|2016-02-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth|Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth|Completed||N/A|225|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-10-11 05:01:35.84923|2017-10-11 05:01:35.84923
NCT00103545|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-10|2006-09-29|||July 2003||2003-07-01|February 2006|2006-02-01|August 2004||2004-08-01|||||Interventional|||Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response|A Phase I/II Trial of ACA 125 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer|Completed||Phase 1/Phase 2|36||AGO Study Group|||||f||||||||||||||2017-10-11 05:01:35.949183|2017-10-11 05:01:35.949183
NCT00103558|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-10|2015-09-17||2015-09-17|March 2004||2004-03-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)|A Phase I/II Study of Lumiliximab in Combination With Fludarabine, Cyclophosphamide, and Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|31|Actual|Biogen|||||f||||t||||||||||2017-10-11 05:01:36.058203|2017-10-11 05:01:36.058203
NCT00105534|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-15|2013-10-29|2011-08-01||July 2004||2004-07-01|October 2013|2013-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)|A Study to Evaluate the Clinical and Microbial Efficacy and Safety of 1.0 % AzaSite Compared to Vehicle in the Treatment of Bacterial Conjunctivitis|Completed||Phase 3|685|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:01:36.478139|2017-10-11 05:01:36.478139
NCT00105547|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-15|2009-05-03|||February 2005||2005-02-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|||||Interventional|||Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's|Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment With MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subjects With Mild Dementia of the Alzheimer's Type|Completed||Phase 3|1600|Actual|Myrexis Inc.||2|||f||||t||||||||||2017-10-11 05:01:36.86215|2017-10-11 05:01:36.86215
NCT00105573|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-15|2013-04-29|||January 2004||2004-01-01|April 2013|2013-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Interventions for Depressed Low Income Mothers and Their Infants|Prevention for Infants of Low-Income Depressed Mothers|Completed||N/A|218|Actual|University of Rochester||3|||f||||t||||||||||2017-10-11 05:01:38.106274|2017-10-11 05:01:38.106274
NCT00105586|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-15|2017-05-04|2009-08-03||December 2004||2004-12-01|May 2017|2017-05-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Drug Therapy for Generalized Anxiety Disorder Among the Elderly|Pharmacotherapy of Late-Life Generalized Anxiety Disorder|Completed||Phase 4|177|Actual|University of Pittsburgh||2|||f||||f||||||||Yes|interested investigators should contact the PI directly via email.|2017-10-11 05:01:38.212241|2017-10-11 05:01:38.212241
NCT00105599|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-15|2015-04-06||||||February 2007|2007-02-01|September 2004|Actual|2004-09-01|||||Interventional|||Effectiveness of the FairCare System for Patients With Advanced Illness|Effectiveness of the FairCare System for Patients With Advanced Illness|Completed||Phase 2|140|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:38.623959|2017-10-11 05:01:38.623959
NCT00105612|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-15|2009-12-23|||September 2004||2004-09-01|December 2009|2009-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Memory Aid for Informed Consent in Alzheimer's Research|Improving Informed Consent in Alzheimer's Disease Research|Completed||N/A|110||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:01:38.701581|2017-10-11 05:01:38.701581
NCT00105625|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||March 2003||2003-03-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||VA Nutrition Study on Immune Function|Immunocompetency and Nutritive Status in Inpatient Gero-Rehabilitation|Completed||N/A|100|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:01:38.786655|2017-10-11 05:01:38.786655
NCT00105638|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||September 2005||2005-09-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Telehealth Education Program for Caregivers of Veterans With Dementia|A Telehealth Education Program for Caregivers of Veterans With Dementia|Completed||N/A|160|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:38.887626|2017-10-11 05:01:38.887626
NCT00105651|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06||||||February 2007|2007-02-01|March 2004|Actual|2004-03-01|||||Interventional|||A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer|A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer|Completed||N/A|128|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:38.984744|2017-10-11 05:01:38.984744
NCT00105664|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||October 2004||2004-10-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|C3P||Collaborative Cardiac Care Project|Collaborative Cardiac Care Project (C3P)|Completed||N/A|287|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-10-11 05:01:39.083222|2017-10-11 05:01:39.083222
NCT00105677|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||August 2004||2004-08-01|October 2006|2006-10-01|September 2006|Actual|2006-09-01|||||Observational|||Understanding the Differences in the Management of Patients With Arthritis of the Knee or Hip|Reasons for Disparities in Joint Replacement Utilization|Completed||N/A|980|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:01:39.214919|2017-10-11 05:01:39.214919
NCT00105690|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||April 2003||2003-04-01|September 2006|2006-09-01|October 2004|Actual|2004-10-01|||||Interventional|||TEAM Study to Improve Depression Care in Rural CBOCs|Telemedicine Intervention to Improve Depression Care in Rural CBOCs|Completed||N/A|400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:39.307768|2017-10-11 05:01:39.307768
NCT00105703|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||February 2002||2002-02-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|CHF ENCORE||Evaluation of a Nurse Case Management Model for Chronic Heart Failure|Evaluation of a Nurse Case Management Model for Chronic Heart Failure|Completed||N/A|969|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:39.409747|2017-10-11 05:01:39.409747
NCT00183105|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-05-05|||February 2001||2001-02-01|December 2007|2007-12-01|April 2006|Actual|2006-04-01|||||Interventional|||ASAP Study - Hospital-Based Brief Intervention for Alcohol Problems|Hospital-based Brief Intervention for Alcohol Problems|Completed||Phase 3|350||Boston Medical Center|||||f||||||||||||||2017-10-11 05:30:34.965419|2017-10-11 05:30:34.965419
NCT00105729|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||January 2003||2003-01-01|September 2006|2006-09-01|April 2005|Actual|2005-04-01|||||Interventional|||Substance Abuse Self-Help Group Referral: Outcomes and Services Use|Substance Abuse Self-Help Group Referral: Outcome and Services Use|Completed||N/A|345|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:39.615141|2017-10-11 05:01:39.615141
NCT00105742|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06||||||July 2006|2006-07-01|June 2005|Actual|2005-06-01|||||Interventional|||Audiology Visits After Screening for Hearing Loss: An RCT|Audiology Visits After Screening for Hearing Loss: An RCT|Completed||Phase 2|1400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:39.704643|2017-10-11 05:01:39.704643
NCT00105755|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||January 2003||2003-01-01|April 2015|2015-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Dermal Thermometry and Self-Care of High Risk Diabetic Patients|Dermal Thermometry and Self-Care of High Risk Diabetic Patients|Completed||N/A|400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:39.81414|2017-10-11 05:01:39.81414
NCT00105768|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||July 2002||2002-07-01|March 2007|2007-03-01|October 2005|Actual|2005-10-01|||||Interventional|||Effectiveness of Advisor-Teller Money Manager|Effectiveness of Advisor - Teller Money Manager (ATM)|Completed||Phase 1/Phase 2|120|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:39.906826|2017-10-11 05:01:39.906826
NCT00105781|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||November 2002||2002-11-01|May 2007|2007-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Nurse Physical Activity Counseling in Primary Care|Nurse Physical Activity Counseling in Primary Care|Completed||N/A|240|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:39.9964|2017-10-11 05:01:39.9964
NCT00105794|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||March 2004||2004-03-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Psychiatric Advance Directives for Improved Mental Health Care|Psychiatric Advance Directives for Improved Healthcare|Completed||N/A|360|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:40.093569|2017-10-11 05:01:40.093569
NCT00105807|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||July 2002||2002-07-01|February 2007|2007-02-01|April 2006|Actual|2006-04-01|||||Interventional|||The Effect of Exercise on Muscle, Function and Cost in VA Nursing Home Residents|The Effect of Exercise on Muscle, Function and Cost in VA Nursing Home Residents|Completed||Phase 2|120|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:40.186684|2017-10-11 05:01:40.186684
NCT00105820|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||June 2003||2003-06-01|February 2007|2007-02-01|March 2006|Actual|2006-03-01|||||Interventional|||Evaluation Study of TIDES Depression Care Quality Improvement Intervention|Well-being Among Veterans Enhancement Study (WAVES)|Completed||N/A|750|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:40.273835|2017-10-11 05:01:40.273835
NCT00105833|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-16|2015-04-06|||July 2002||2002-07-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|November 2004|Actual|2004-11-01||Interventional|DEP-PC||Improving Outcomes of Depression in Primary Care|Improving Outcomes of Depression in Primary Care|Completed||N/A|400|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:01:40.369768|2017-10-11 05:01:40.369768
NCT00105846|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-17|2015-04-06||||||February 2007|2007-02-01|June 2004|Actual|2004-06-01|||||Interventional|||An Evaluation of Home-Based Telemedicine Services|An Evaluation of Home-Based Telemedicine Services|Completed||Phase 2|200|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:40.453065|2017-10-11 05:01:40.453065
NCT00105859|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-17|2010-05-06||||||June 2005|2005-06-01||||||||Interventional|||Preventing Pressure Ulcers in Veterans With Spinal Cord Injury (SCI)|Preventing Pressure Ulcers in Veterans With Spinal Cord Injury (SCI)|Terminated||N/A|278|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:40.540656|2017-10-11 05:01:40.540656
NCT00105872|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-17|2015-04-06|||March 2002||2002-03-01|March 2007|2007-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Behavioral Insomnia Therapy in Primary Care|Behavioral Insomnia Therapy in Primary Care|Completed||N/A|100|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:40.630546|2017-10-11 05:01:40.630546
NCT00105885|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-17|2014-02-06|||November 2003||2003-11-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|Telepsych||Telephone Care as a Substitute for Routine Psychiatric Medication|Telephone Care as a Substitute for Routine Psychiatric Medication Management|Completed||N/A|324|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:01:40.70617|2017-10-11 05:01:40.70617
NCT00105898|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-17|2015-04-06|||February 2005||2005-02-01|August 2010|2010-08-01|June 2010|Actual|2010-06-01|April 2007|Actual|2007-04-01||Interventional|||Internet-based Diabetes Education and Case Management|Internet-based Diabetes Education and Case Management|Completed||N/A|152|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 05:01:40.797648|2017-10-11 05:01:40.797648
NCT00105911|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-17|2015-04-06|||July 2002||2002-07-01|February 2007|2007-02-01|June 2005|Actual|2005-06-01|||||Interventional|||A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD|A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD|Completed||N/A|222|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:40.89088|2017-10-11 05:01:40.89088
NCT00105937|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2012-06-27|||April 2004||2004-04-01|May 2007|2007-05-01|November 2006||2006-11-01|||||Interventional|||OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients|Multi-center, Open Label, Long-term Study of OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients|Completed||Phase 3|300||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:01:40.975282|2017-10-11 05:01:40.975282
NCT00105963|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2005-06-23|||January 2005||2005-01-01|March 2005|2005-03-01|August 2006||2006-08-01|||||Interventional|||Prevention of Shaken Baby Syndrome|Parents Helping Infants Study: Preventing Shaken Baby Syndrome and Child Abuse|Unknown status|Recruiting|N/A|3000||Harborview Injury Prevention and Research Center|||||f||||||||||||||2017-10-11 05:01:41.246608|2017-10-11 05:01:41.246608
NCT00106366|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-22|2017-01-30|||March 2005||2005-03-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes|Efficacy and Safety Comparison of Insulin Detemir and Insulin Glargine Plus Insulin Aspart in Patients With Type 2 Diabetes|Completed||Phase 3|389|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:02:01.790696|2017-10-11 05:02:01.790696
NCT00105976|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2008-07-10|||February 2005||2005-02-01|July 2008|2008-07-01||||||||Interventional|||Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)|A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Efficacy and Safety of 3 Different Dose Levels (2.5, 7.5 and 20 mg) of MM-093 in Patients With Active Rheumatoid Arthritis on Stable Doses of Methotrexate|Completed||Phase 2|260||Merrimack Pharmaceuticals|||||||||||||||||||2017-10-11 05:01:41.466301|2017-10-11 05:01:41.466301
NCT00105989|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2009-07-21|2009-01-23||March 2005||2005-03-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder|Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder|Completed||Phase 3|514|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-10-11 05:01:41.816421|2017-10-11 05:01:41.816421
NCT00106002|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2009-05-29|2008-12-23||April 2005||2005-04-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer|A Phase II Study of Alimta as First Line Chemotherapy for Advanced or Metastatic Breast Cancer|Completed||Phase 2|37|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-10-11 05:01:45.956785|2017-10-11 05:01:45.956785
NCT00106015|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2016-12-20|||September 2004||2004-09-01|December 2016|2016-12-01||||April 2019|Anticipated|2019-04-01||Observational|DBAR||Diamond Blackfan Anemia Registry (DBAR)|Diamond Blackfan Anemia Registry (DBAR)|Recruiting||N/A|850|Anticipated|Northwell Health|||1||f||||||||||||||2017-10-11 05:01:46.63678|2017-10-11 05:01:46.63678
NCT00106028|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2013-04-15|2009-04-15||November 2004||2004-11-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children|Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children|Completed||Phase 3|143|Actual|Warner Chilcott|The clinical meaningfulness of new fractures in the thoracic spine scored as Genant Grade I is unclear, thus the morphometric vertebral fracture data are evaluated further.|2|||f||||f||||||||||2017-10-11 05:01:46.821262|2017-10-11 05:01:46.821262
NCT00106041|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2015-04-06|||August 2004||2004-08-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|November 2007|Actual|2007-11-01||Interventional|||Study to Improve Care for Veterans During Serious Illness|Randomized Trial of Care Management to Improve End of Life Care|Completed||N/A|400|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:01:49.007791|2017-10-11 05:01:49.007791
NCT00106054|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2010-08-26|||January 2006||2006-01-01|August 2010|2010-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases|An Open-Label, Multi-Center Phase II Trial of Neoadjuvant Irinotecan in Combination With Infusional 5-FU, Leucovorin (Folfiri) Plus Bevacizumab in Patients With Unresectable Hepatic-Only Metastases of Colorectal Carcinoma|Terminated||Phase 2|2|Actual|Pfizer||||"After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could be   performed."|f||||||||||||||2017-10-11 05:01:49.117892|2017-10-11 05:01:49.117892
NCT00106067|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2015-04-06|||June 2004||2004-06-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|A&SC||Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients|Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients|Completed||N/A|559|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:01:49.189533|2017-10-11 05:01:49.189533
NCT00106080|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-18|2015-04-06|2014-08-06||November 2004||2004-11-01|May 2014|2014-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||42 clinicians were randomized to the intervention group. 50 clinicians were randomized to the control group. 376 patients were enrolled and assigned to their clinician's treatment group.|Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Improving the Quality of End-of-Life Communication for Patients With COPD|Completed||N/A|376|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:01:49.286803|2017-10-11 05:01:49.286803
NCT00106093|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-19|2017-10-05|||March 16, 2005||2005-03-16|September 8, 2015|2015-09-08|September 8, 2015||2015-09-08|||||Observational|||Alcoholism Assessment and Treatment|Assessment and Treatment of People With Alcohol Drinking Problems|Completed||N/A|1192|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:01:49.642668|2017-10-11 05:01:49.642668
NCT00106106|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-19|2012-01-10|2011-11-30||March 2005||2005-03-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Acamprosate to Reduce Symptoms of Alcohol Withdrawal|Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal|Completed||Phase 2|56|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 05:01:49.750994|2017-10-11 05:01:49.750994
NCT00106119|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-19|2015-02-20|2014-11-12||March 2005||2005-03-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Subjects who completed the study|Thyroid and Glucose and Energy Metabolism|Peripheral Thyroid Hormone Conversion and Glucose and Energy Metabolism|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 05:01:50.245405|2017-10-11 05:01:50.245405
NCT00106132|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-19|2008-03-03|||March 2005||2005-03-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage|The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study|Completed||Phase 3|1260||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:01:50.701635|2017-10-11 05:01:50.701635
NCT00106145|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2015-01-29|||April 2005||2005-04-01|January 2015|2015-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)|A Phase I Study of MK0752, a Notch Inhibitor, in Patients With Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors|Completed||Phase 1|103|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-10-11 05:01:50.94972|2017-10-11 05:01:50.94972
NCT00106158|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2010-11-04|||June 2004||2004-06-01|August 2007|2007-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1|Immunization of Patients With Tumors Expressing NY-ESO-1 or LAGE Antigen With Complex of NY-ESO-1 Protein and Cholesterol-bearing Hydrophobized Pullulan (CHP)|Completed||Phase 1|9|Anticipated|Ludwig Institute for Cancer Research|||||f||||||||||||||2017-10-11 05:01:51.070791|2017-10-11 05:01:51.070791
NCT00106171|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2011-02-17|||February 2005||2005-02-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Anti-HIV Medications for People Recently Infected With HIV|A Randomized Trial of HAART in Acute/Early HIV Infection|Completed||Phase 4|180|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:01:51.151333|2017-10-11 05:01:51.151333
NCT00106184|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2015-03-03|2013-10-10||March 2006||2006-03-01|March 2015|2015-03-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Interventional||3 subjects in Group A and 2 subjects in Group B were excluded from analysis due to withdrawing from the study. These subjects either did not receive a full dose of study drug at week 0 or no study drug at all.|Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)|Rituximab Therapy in Refractory Adult and Juvenile Idiopathic Inflammatory Myopathy (IIM)|Completed||Phase 2|200|Actual|University of Pittsburgh|There was an overestimate of the rapidity of the rituximab response and an underestimate of DOI in those receiving placebo.|6|||f||||t||||||||||2017-10-11 05:01:51.31105|2017-10-11 05:01:51.31105
NCT00106197|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2013-08-29|||June 2004||2004-06-01|August 2013|2013-08-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression|Treatment Prediction in Adolescent and Adult Depression|Unknown status|Active, not recruiting|Phase 4|130|Anticipated|Meharry Medical College||1|||f||||t||||||||||2017-10-11 05:01:52.097079|2017-10-11 05:01:52.097079
NCT00106210|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2013-07-03|||May 2003||2003-05-01|July 2013|2013-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||School- and Home-Based Early Intervention for Toddlers With Autism|Early Detection, Intervention, and Neurobiology in Autism: Early Intervention Portion|Completed||N/A|50|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||||2017-10-11 05:01:52.230867|2017-10-11 05:01:52.230867
NCT00106223|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2012-01-03|||April 2004||2004-04-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder|A Randomized Waitlist Controlled Treatment Trial Investigating CBT for Body Dysmorphic Disorder|Completed||N/A|36|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:01:52.384561|2017-10-11 05:01:52.384561
NCT00106236|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2009-07-13|||April 2003||2003-04-01|March 2005|2005-03-01|April 2004||2004-04-01|||||Interventional|||Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction|Sapporo Fitness Club Trial (SFCT): A Randomized Controlled Trial to Test the Efficacy of Exercise at a Fitness Club for the Reduction of Cardiovascular Risk Factors|Completed||Phase 1/Phase 2|561||Sapporo Health Promotion Foundation|||||f||||||||||||||2017-10-11 05:01:52.559982|2017-10-11 05:01:52.559982
NCT00106249|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2016-12-01|2016-09-06||November 2004||2004-11-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||A total of 22 patients with at least 1 follow up were included in the final analyses. Four subjects only had baseline measure. The reason for them to withdraw from the study was their inability to attend daily treatment sessions due to schedule conflict with their job and long commute to the TMS laboratory.|Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)|Treatment of Obsessive Compulsive Disorder (OCD) With Transcranial Magnetic Stimulation (TMS)|Completed||Phase 2|27|Actual|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-10-11 05:01:52.698689|2017-10-11 05:01:52.698689
NCT00106262|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2007-04-17|||March 2005||2005-03-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer|A Phase II Study of VELCADE TM(PS-341) and Irinotecan in the Treatment of Progressive, Recurrent or Metastatic Cervical, Vulvar, or Vaginal Cancer|Terminated||Phase 2|38||Women and Infants Hospital of Rhode Island||||Lack of accrual|f||||||||||||||2017-10-11 05:01:53.230454|2017-10-11 05:01:53.230454
NCT00106275|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-21|2006-01-30|||November 2003||2003-11-01|November 2005|2005-11-01|November 2006||2006-11-01|||||Interventional|||Mindfulness-Based Stress Reduction Program as an Intervention in Patients With Fibromyalgia|Mindfulness-Based Stress Reduction Program as an Intervention in Patients With Fibromyalgia: A Three-Armed Randomized Clinical Study|Unknown status|Active, not recruiting|N/A|180||University Hospital Freiburg|||||f||||||||||||||2017-10-11 05:01:53.334917|2017-10-11 05:01:53.334917
NCT00106288|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-22|2014-09-17|||January 2003||2003-01-01|September 2014|2014-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia|A Multicenter, Double Blind, Comparative, Randomized Study to Evaluate the Efficacy and Safety of Micafungin (FK463) Versus Liposomal Amphotericin B (AmBisome) in the Treatment of Invasive Candidiasis and Candidemia|Completed||Phase 3|637|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 05:01:53.469137|2017-10-11 05:01:53.469137
NCT00106301|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-22|2016-03-30|||April 2004||2004-04-01|March 2016|2016-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228|A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Have Completed a Prior Clinical Study With FK228|Completed||Phase 2|2|Actual|Celgene Corporation||1|||f||||f||||||||||2017-10-11 05:01:53.71849|2017-10-11 05:01:53.71849
NCT00106314|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-22|2007-10-17|||January 2005||2005-01-01|October 2007|2007-10-01|October 2006|Actual|2006-10-01|||||Interventional|||An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease|A Randomized, Double-Blind, Multi-Center, Dose Response, Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Moderately Active Crohn's Disease|Completed||Phase 2|75||Inflabloc Pharmaceuticals|||||||||||||||||||2017-10-11 05:01:53.837956|2017-10-11 05:01:53.837956
NCT00106327|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-22|2012-07-24|||September 2003||2003-09-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|July 2008|Actual|2008-07-01||Interventional|||Improving Functioning in Peripheral Arterial Disease|Improving Functioning in Peripheral Arterial Disease|Completed||N/A|156|Actual|Northwestern University||3|||f||||||||||||||2017-10-11 05:01:54.016422|2017-10-11 05:01:54.016422
NCT00106340|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-22|2012-12-28||2012-10-22|March 2005||2005-03-01|December 2012|2012-12-01||||May 2008|Actual|2008-05-01||Interventional|||Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes|Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|3118|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:01:54.139332|2017-10-11 05:01:54.139332
NCT00106353|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-22|2013-01-04|2010-11-05||March 2005||2005-03-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|October 2009|Actual|2009-10-01||Interventional|||Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors|A Phase I/II Safety and Exploratory Pharmacogenomic/Pharmacodynamic Study of Intravenous Temsirolimus (CCI-779) in Pediatric Subjects With Relapsed/Refractory Solid Tumors|Completed||Phase 1/Phase 2|71|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:01:54.526871|2017-10-11 05:01:54.526871
NCT00106379|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-23|2010-02-01|||October 2004||2004-10-01|April 2008|2008-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients|A Phase 4, Single-Arm Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Tenofovir Disoproxil Fumarate in Combination With Emtricitabine in HIV-1 Infected Patients Experiencing Various Degrees of Renal Impairment|Completed||Phase 4|52||Gilead Sciences|||||||||||||||||||2017-10-11 05:02:02.067497|2017-10-11 05:02:02.067497
NCT00106392|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-23|2010-11-15|2010-09-30||February 2005||2005-02-01|November 2010|2010-11-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|||A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Prograf (Tacrolimus, FK 506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-sparing Radical Prostatectomy|Completed||Phase 4|131|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||t||||||||||2017-10-11 05:02:02.188438|2017-10-11 05:02:02.188438
NCT00106405|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-24|2012-03-01|||February 2005||2005-02-01|March 2012|2012-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder|A Pilot Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder|Completed||Phase 2|35|Actual|Forest Laboratories|||||||||||||||||||2017-10-11 05:02:03.774144|2017-10-11 05:02:03.774144
NCT00106418|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-24|2016-10-28|||May 2003||2003-05-01|October 2016|2016-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Research Study for Patients With Prostate Cancer|An Exploratory Phase II, Multicenter, Open-label Trial Evaluating the Activity and Tolerability of FK228 in Androgen Independent Metastatic Prostate Cancer Patients With Rising PSA|Completed||Phase 2|35|Actual|Celgene Corporation||1|||f||||||||||||||2017-10-11 05:02:03.892454|2017-10-11 05:02:03.892454
NCT00106431|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-24|2011-03-14|2010-03-02|2009-10-01|January 2005||2005-01-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)|A Single Agent Phase II Study of Depsipeptide (FK228) in the Treatment of Cutaneous T-cell Lymphoma|Completed||Phase 2|102|Actual|Celgene||1|||f||||t||||||||||2017-10-11 05:02:04.015917|2017-10-11 05:02:04.015917
NCT00106457|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-24|2016-07-11|||February 2005||2005-02-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:02:04.837873|2017-10-11 05:02:04.837873
NCT00106470|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-24|2012-12-12|||February 2005||2005-02-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics|Genetic Epidemiology of COPD in Costa Rica|Completed||N/A|679|Actual|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"     Serum   "|||2017-10-11 05:02:04.90028|2017-10-11 05:02:04.90028
NCT00106483|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-24|2015-03-18|||February 2005||2005-02-01|March 2015|2015-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Autoimmunity and Coronary Artery Disease - Ancillary to CARDIA||Completed||N/A|3020|Actual|Northwestern University|||1||f||||||||||||||2017-10-11 05:02:04.97211|2017-10-11 05:02:04.97211
NCT00106496|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-25|2014-09-17|||October 2004||2004-10-01|September 2014|2014-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis|A Multi-Center Study to Assess the Impact of Topical Corticosteroids on the Safety and Efficacy of Protopic Ointment in the Short-Term Treatment of Atopic Dermatitis and to Assess Protopic in the Long-term Management of Atopic Dermatitis|Completed||Phase 4|410|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-10-11 05:02:05.151138|2017-10-11 05:02:05.151138
NCT00106509|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-25|2015-03-04|||March 2005||2005-03-01|March 2015|2015-03-01|February 2007|Actual|2007-02-01|||||Interventional|||A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea|A Randomized, Double-Blind Study of GT267-004 Versus Vancomycin, and GT267-004 Versus Metronidazole, in Patients With C.Difficile - Associated Diarrhea|Completed||Phase 3|520||Sanofi|||||||||||||||||||2017-10-11 05:02:05.386871|2017-10-11 05:02:05.386871
NCT00106522|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-25|2016-11-01|||May 2005||2005-05-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy|A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to Anti-TNF Therapy|Completed||Phase 3|499|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 05:02:05.833987|2017-10-11 05:02:05.833987
NCT00106535|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-25|2013-12-18|2010-02-09||January 2005||2005-01-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|May 2007|Actual|2007-05-01||Interventional||Baseline measures are based on the Intent-to-treat population that included all randomized participants who received study drug.|A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)|A Randomized, Double-blind Study of Safety and Prevention of Structural Joint Damage During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|1196|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 05:02:06.688367|2017-10-11 05:02:06.688367
NCT00106548|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-25|2010-06-10||||||June 2010|2010-06-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis|A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|623|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 05:02:12.720551|2017-10-11 05:02:12.720551
NCT00106769|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-29|2017-06-30|||March 22, 2005||2005-03-22|January 15, 2008|2008-01-15|January 15, 2008||2008-01-15|||||Interventional|||Vaccine to Prevent West Nile Virus Disease|A Phase I Study of the Safety and Immunogenicity of a West Nile Virus Recombinant DNA Plasmid Vaccine, VRC-WNVDNA017-00 VP, in Healthy Adult Volunteers|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:20.04877|2017-10-11 05:02:20.04877
NCT00106561|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-25|2005-06-23|||January 2002||2002-01-01|March 2005|2005-03-01|September 2004||2004-09-01|||||Interventional|||Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney|A Double-Blind, Placebo-Controlled Study on the Effect of Spironolactone, in Patients With Persistent Proteinuria on Long-Term Angiotensin Converting Enzyme Inhibitor Therapy, With or With Out an Angiotensin II Receptor Blocker|Completed||Phase 2/Phase 3|60||Melbourne Health|||||f||||||||||||||2017-10-11 05:02:12.989117|2017-10-11 05:02:12.989117
NCT00106574|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-25|2016-11-01|||April 2005||2005-04-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis|A Randomized, Double-blind Study of the Effect of Tocilizumab on Reduction in Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to DMARD Therapy|Completed||Phase 3|1220|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:02:13.100023|2017-10-11 05:02:13.100023
NCT00106587|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-25|2005-11-09|||December 2003||2003-12-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH – ISR I)|Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons|Completed||Phase 1/Phase 2|52||University Hospital, Saarland|||||f||||||||||||||2017-10-11 05:02:13.594151|2017-10-11 05:02:13.594151
NCT00106600|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-28|2007-08-21|||March 2005||2005-03-01|August 2007|2007-08-01|March 2007||2007-03-01|||||Interventional|||Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)|A Phase I/II Study of Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)|Completed||Phase 1/Phase 2|119||CTI BioPharma|||||||||||||||||||2017-10-11 05:02:13.922753|2017-10-11 05:02:13.922753
NCT00106613|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-28|2012-08-30|||May 2003||2003-05-01|August 2012|2012-08-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||A Research Study for Patients With Metastatic Renal Cell Carcinoma|An Exploratory Phase II, Multicenter, Open-label Trial Evaluating the Activity and Tolerability of FK228 in Patients With Metastatic Renal Cell Carcinoma That is Progressive Following or During Immunotherapy|Completed||Phase 2|30|Actual|Celgene||1|||f||||f||||||||||2017-10-11 05:02:13.992325|2017-10-11 05:02:13.992325
NCT00106626|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-28|2009-03-16|2008-11-25||August 2005||2005-08-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors|Phase I Clinical Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Pemetrexed and Cisplatin in Patients With Advanced Cancer|Completed||Phase 1|52|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-10-11 05:02:14.091085|2017-10-11 05:02:14.091085
NCT00106639|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-28|2013-02-06|2012-12-06||May 2005||2005-05-01|February 2013|2013-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients|A 6-Month, Phase 2, Multicenter, Randomized, Open-Label, Comparative Study Of 2 Dose Levels Of CP-690,550 Administered Concomitantly With IL-2 Receptor Antagonist Induction Therapy, Mycophenolate Mofetil And Corticosteroids Versus A Tacrolimus-Based Immunosuppressive Regimen For The Prevention Of Allograft Rejection In De Novo Renal Allograft Recipients|Completed||Phase 2|61|Actual|Pfizer|Results for first BPAR, BPCAN, treatment and efficacy failure, rejection, clinically significant infections, NODM and discontinuation reported as number and not percentage as planned. Stage 2 of study was not conducted due to administrative reasons.|3|||f||||t||||||||||2017-10-11 05:02:14.728145|2017-10-11 05:02:14.728145
NCT00106652|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-28|2017-09-20|||September 2001||2001-09-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Observational|||Childhood Autism Risks From Genetics and the Environment (The CHARGE Study)|Environmental Factors in the Etiology of Autism|Completed||N/A|2000|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-10-11 05:02:18.664772|2017-10-11 05:02:18.664772
NCT00106665|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-28|2016-01-15|||June 2005||2005-06-01|January 2016|2016-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||New Onset Weakness in Critically Ill Patients and the Risk of Death and Recurrent ICU Admission|Intensive Care Unit(ICU)-Acquired Paresis and the Risk for Mortality and Recurrent ICU Admission (Weakness and ICU Readmission Evaluation-WIRE)|Completed||N/A|170|Actual|Ohio State University|||1||f||||f||||||||||2017-10-11 05:02:18.769439|2017-10-11 05:02:18.769439
NCT00106678|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-28|2017-02-27|||June 2004||2004-06-01|February 2016|2016-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Observational|||Typology of Adherence in Adolescents: Phase II|Typology of Adherence in Adolescents: Phase II|Completed||N/A|1200|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-10-11 05:02:18.843834|2017-10-11 05:02:18.843834
NCT00106704|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-29|2015-06-04|2010-11-19||March 2005||2005-03-01|June 2015|2015-06-01|January 2007|Actual|2007-01-01|June 2006|Actual|2006-06-01||Interventional|||Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)|A Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of MK0431 to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Glimepiride Alone or in Combination With Metformin|Completed||Phase 3|441|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:02:19.217295|2017-10-11 05:02:19.217295
NCT00106717|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-29|2008-03-19|||January 2004||2004-01-01|March 2005|2005-03-01|August 2006|Actual|2006-08-01|||||Interventional|||Effectiveness of Narrative Medicine on Pain Intensity and Quality of Life|Effectiveness of Narrative Medicine on Pain Intensity and Quality of Life|Completed||N/A|210||Javeriana University|||||f||||||||||||||2017-10-11 05:02:19.78887|2017-10-11 05:02:19.78887
NCT00106743|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-29|2017-10-05|||March 18, 2005||2005-03-18|June 28, 2017|2017-06-28||||||||Observational|||Natural History and Genetic Studies of Usher Syndrome|Natural History and Genetic Studies of Usher Syndrome|Active, not recruiting||N/A|237|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:19.866144|2017-10-11 05:02:19.866144
NCT00106756|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-29|2017-06-30|||March 18, 2005||2005-03-18|June 26, 2009|2009-06-26|November 1, 2006|Actual|2006-11-01|November 1, 2006|Actual|2006-11-01||Observational|||Clinical and Genetic Studies of Familial Exudative Vitreoretinopathy|Familial Exudative Vitreoretinopathy Clinical and Molecular Studies|Completed||N/A|105||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:19.962072|2017-10-11 05:02:19.962072
NCT00106782|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-29|2017-06-30|||March 18, 2005||2005-03-18|May 14, 2010|2010-05-14|May 14, 2010|Actual|2010-05-14|May 14, 2010|Actual|2010-05-14||Interventional|||Transcranial Electrical Polarization to Treat Focal Hand Dystonia|Placebo Controlled Study of the Therapeutic Effect of the Transcranial Electrical Polarization in Patients With Focal Hand Dystonia|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-10-11 05:02:20.126186|2017-10-11 05:02:20.126186
NCT00106795|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-30|2017-10-05|||March 22, 2005||2005-03-22|April 10, 2014|2014-04-10|April 10, 2014||2014-04-10|||||Observational|||Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS|Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients With HIV/AIDS|Completed||N/A|82|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:20.255679|2017-10-11 05:02:20.255679
NCT00106808|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2010-09-10||2010-09-10|August 2005||2005-08-01|September 2007|2007-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes|A Phase 3, Randomized, Double-blind, Active Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar (BMS-298585) Compared to Pioglitazone in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|Completed||Phase 3|1440||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:02:20.350486|2017-10-11 05:02:20.350486
NCT00106821|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2013-10-31|||June 2004||2004-06-01|October 2013|2013-10-01||||August 2005|Actual|2005-08-01||Interventional|||Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease|An 8 Week Randomized, Placebo Controlled, Double-blind Study to Assess the Efficacy of Tiotropium Inhalation Capsules in Patients of African Descent With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|166|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:02:21.117181|2017-10-11 05:02:21.117181
NCT00106834|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2011-05-18||||||March 2010|2010-03-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Infliximab Induction and Maintenance Therapy in Patients With Moderate to Severe Plaque Psoriasis|Completed||Phase 3|378|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 05:02:21.210089|2017-10-11 05:02:21.210089
NCT00106847|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2011-05-16|||January 2003||2003-01-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Infliximab Induction Therapy Followed by Multiple Regimens of Maintenance InfliximabTherapy in Patients With Plaque-Type Psoriasis|Completed||Phase 3|683|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 05:02:21.296578|2017-10-11 05:02:21.296578
NCT00106860|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2008-01-07|||March 2005||2005-03-01|January 2008|2008-01-01|March 2006||2006-03-01|||||Interventional|||A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder|A Long-Term, Open Label, Safety and Efficacy Study of an Experimental Medication in Adults With Generalized Anxiety Disorder (GAD)|Completed||Phase 3|158||Jazz Pharmaceuticals|||||||||||||||||||2017-10-11 05:02:21.375162|2017-10-11 05:02:21.375162
NCT00106886|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2005-09-16|||December 1999||1999-12-01|March 2005|2005-03-01|October 2005||2005-10-01|||||Interventional|||HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)|HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)|Unknown status|Active, not recruiting|Phase 4|5000||McMaster University|||||f||||||||||||||2017-10-11 05:02:21.471|2017-10-11 05:02:21.471
NCT00106899|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2014-09-15|||July 2005||2005-07-01|September 2014|2014-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||ADNI: Alzheimer's Disease Neuroimaging Initiative|Alzheimer's Disease Neuroimaging Initiative|Completed||N/A|818|Actual|Alzheimer's Disease Cooperative Study (ADCS)|||3||f||||t||||||Samples With DNA|"     blood, urine, cerebrospinal fluid   "|||2017-10-11 05:02:21.57168|2017-10-11 05:02:21.57168
NCT00106912|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2017-06-30|||March 28, 2005||2005-03-28|March 27, 2008|2008-03-27|March 27, 2008||2008-03-27|||||Observational|||Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity|A Study to Collect Normative Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:21.862261|2017-10-11 05:02:21.862261
NCT00106925|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-31|2017-10-05|||March 28, 2005||2005-03-28|September 25, 2017|2017-09-25||||||||Observational|||Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants|Long-Term Evaluation and Follow Up Care of Patients Treated With Allogeneic Stem Cell Transplants|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:21.925296|2017-10-11 05:02:21.925296
NCT00106938|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-01|2017-06-20|2014-04-02||April 2005||2005-04-01|June 2017|2017-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|ACT I||Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)|Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)|Terminated||N/A|1663|Actual|Abbott Vascular||2||Business decision and not a result of any patient or product safety issues.|f||||||||||||||2017-10-11 05:02:22.047199|2017-10-11 05:02:22.047199
NCT00106951|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-01|2012-01-29|||April 2005||2005-04-01|January 2012|2012-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Effects of Neighborhood SES on Coronary Heart Disease Burden in Communities - Ancillary to ARIC|Effects of Neighborhood SES on Coronary Heart Disease Burden in Communities - Ancillary to ARIC|Completed||N/A|12000|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 05:02:24.466893|2017-10-11 05:02:24.466893
NCT00106964|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-01|2017-02-27|2012-10-26||January 2004||2004-01-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth|A Randomized, Open-Label Trial of Three Hepatitis B Vaccination Schemas in HIV-Positive Youth|Completed||Phase 4|371|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-10-11 05:02:24.569264|2017-10-11 05:02:24.569264
NCT00106977|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-01|2017-10-05|||March 30, 2005||2005-03-30|August 14, 2017|2017-08-14||||||||Observational|||Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)|Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:25.293466|2017-10-11 05:02:25.293466
NCT00107003|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-02|2017-10-05|||March 30, 2005||2005-03-30|November 30, 2012|2012-11-30|November 30, 2012|Actual|2012-11-30|December 5, 2007|Actual|2007-12-05||Interventional|||GW572016 to Treat Recurrent Malignant Brain Tumors|A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:02:25.59613|2017-10-11 05:02:25.59613
NCT00107016|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-04|2013-02-28|||March 2005||2005-03-01|February 2013|2013-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women|A Phase 2, Double-blind, Randomized, Placebo-controlled, Multi-center Study Assessing the Value of Adding Everolimus to Letrozole as Preoperative Therapy of Primary Breast Cancer in Postmenopausal Women|Completed||Phase 2|267|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:02:25.693065|2017-10-11 05:02:25.693065
NCT00107029|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-04|2017-02-27|||December 2002||2002-12-01|February 2016|2016-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth|Evaluation of HIV-Specific CD8+ T-Cell Responses and Escape Mutations as Explanations for the Observed Differences in Disease Progression Conferred by HLA Class I Alleles|Completed||N/A|113|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples Without DNA|"     Biomedical HIV-1 related data and samples are available for the time the subjects were     enrolled in REACH. HIV-1 genotyping will certainly be possible from these retrospective     samples and the stored PBMCs will be evaluated for usefulness in the HIV-1 specific assays.     Prospectively, samples will be collected every six months over a two-year period to evaluate     both HIV-1 specific CD8+ T cell responses and the dominant HIV-1 genotype longitudinally.   "|||2017-10-11 05:02:25.8683|2017-10-11 05:02:25.8683
NCT00107042|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-04|2017-02-27|2011-09-05||February 2004||2004-02-01|March 2016|2016-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths|Hepatitis B Vaccination in Youth at Adolescent Trial Network Sites: Effectiveness of Two Strategies and Evaluation of Tools To be Used in Future HIV Prevention Trials.|Completed||Phase 2|123|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 05:02:26.027345|2017-10-11 05:02:26.027345
NCT00107055|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-04|2005-06-23|||December 2003||2003-12-01|June 2005|2005-06-01|April 2005||2005-04-01|||||Interventional|||Study of REN-1654 in Patients With Sciatica Pain|REN-1654 in Sciatica: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study in Subjects With Pain Due to Lumbosacral Radiculopathy|Unknown status|Active, not recruiting|Phase 2|72||Renovis|||||||||||||||||||2017-10-11 05:02:27.75259|2017-10-11 05:02:27.75259
NCT00107068|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-04|2015-12-02|||January 2001||2001-01-01|December 2015|2015-12-01|May 2004|Actual|2004-05-01|March 2003|Actual|2003-03-01||Interventional|||Exercise Training and Walking Ability After Chronic Stroke|Does Aerobic or Resistance Exercise Training Improve Walking Ability in Chronic Stroke Patients?|Completed||N/A|48||University of Sydney|||||f||||||||||||||2017-10-11 05:02:27.899884|2017-10-11 05:02:27.899884
NCT00107081|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-04|2014-12-23|||January 2004||2004-01-01|December 2014|2014-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting|A Prospective Multi-Center Study on Pediatric Patients With Fever in Severe Chemotherapy Induced Neutropenia, Including a Randomized Comparison of Outpatient Management and Oral Antimicrobial Therapy Versus Inpatient Management and Intravenous Antimicrobial Therapy in a Subgroup With Low Risk of Adverse Events (Low-Risk Subgroup Study)|Terminated||Phase 3|70|Actual|Swiss Pediatric Oncology Group||2||Accrual goal for interventional part not achievable|f||||f||||||||||2017-10-11 05:02:27.989276|2017-10-11 05:02:27.989276
NCT00107094|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2007-07-18|||March 2005||2005-03-01|July 2007|2007-07-01||||||||Interventional|||Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer|An Open Label, Pilot Study of Dose-Dense Adriamycin Plus Cyclophosphamide (AC) Followed by ABI-007 as Adjuvant Therapy for Patients With Breast Cancer|Completed||Phase 1|30||Celgene Corporation|||||||||||||||||||2017-10-11 05:02:28.138281|2017-10-11 05:02:28.138281
NCT00107107|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2015-09-22|||November 2002||2002-11-01|August 2015|2015-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus|A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150|Completed||Phase 3|190|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 05:02:28.238375|2017-10-11 05:02:28.238375
NCT00107120|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2012-04-04|2009-04-21||March 2005||2005-03-01|April 2012|2012-04-01||||May 2007|Actual|2007-05-01||Interventional|||The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder|A Double-blind Flexible Dose Study of Escitalopram in Pediatric Patients With Major Depressive Disorder|Completed||Phase 3|312|Actual|Forest Laboratories||2|||f||||||||||||||2017-10-11 05:02:28.439144|2017-10-11 05:02:28.439144
NCT00107159|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2013-11-05|||January 2005||2005-01-01|April 2007|2007-04-01|September 2010|Actual|2010-09-01|||||Interventional|||Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma|A Phase II Study Of Matured Dendritic Cells Pulsed Ex Vivo With 3 Melanoma Cell Line Lysates (IDD-3) in Patients With In-Transit or Metastatic Melanoma|Completed||Phase 2|37|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:02:28.970738|2017-10-11 05:02:28.970738
NCT00107172|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2017-08-29|2015-09-02||July 2005||2005-07-01|August 2017|2017-08-01||||April 2013|Actual|2013-04-01||Interventional||All intent-to-treat (ITT) participants.|Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer|A Randomized Phase III Study of Sublobar Resection Versus Sublobar Resection Plus Brachytherapy in High Risk Patients With Non-Small Cell Lung Cancer (NSCLC), 3cm or Smaller|Active, not recruiting||Phase 3|224|Actual|Alliance for Clinical Trials in Oncology||2|||f||||||||||||||2017-10-11 05:02:29.074196|2017-10-11 05:02:29.074196
NCT00107185|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2012-08-02|||January 2005||2005-01-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Interventional|||Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma|Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients|Completed||Phase 1|7|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:02:30.459256|2017-10-11 05:02:30.459256
NCT00100451|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2009-01-20|||June 1994||1994-06-01|December 2004|2004-12-01|June 2001||2001-06-01|||||Interventional|||Aging, Exercise, and Hormonal Influences of Fat Metabolism|Aging, Exercise, and Hormonal Influences of Fat Metabolism|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:02:57.506594|2017-10-11 05:02:57.506594
NCT00107198|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2016-12-20|2016-06-30||January 2006||2006-01-01|March 2016|2016-03-01||||November 2012|Actual|2012-11-01||Interventional|||Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease|Treatment of Children With Newly-Diagnosed Low Stage Lymphocyte Predominant Hodgkin Disease (LPHD)|Active, not recruiting||N/A|188|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 05:02:30.594507|2017-10-11 05:02:30.594507
NCT00107211|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2014-09-16|||January 2005||2005-01-01|September 2014|2014-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast|A HER-2/Neu Pulsed DC1 Vaccine for Patients With DCIS|Completed||Phase 1|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-10-11 05:02:31.30429|2017-10-11 05:02:31.30429
NCT00107237|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2013-06-11|||October 2003||2003-10-01|June 2013|2013-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme|A Phase IB/II Multicenter, Two-Arm, Dose-Escalation Study of Oral AEE788 Administered in Combination With Oral RAD001 on a Continuous Once Daily Dosing Schedule in Adult Patients With First or Second Recurrent or Relapsing Glioblastoma Multiforme|Completed||Phase 1/Phase 2|16|Actual|Novartis||2|||||||||||||||||2017-10-11 05:02:31.379147|2017-10-11 05:02:31.379147
NCT00107250|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2016-11-25|||January 2005||2005-01-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)|A Phase I, Open-Label, Dose-Seeking Study of AZD2171 Given Daily Orally in Combination With Standard Chemotherapy Regimens (CT) in Patients With Advanced Incurable Non-Small Cell Lung Cancer (NSCLC) or Colorectal Cancer or Other Tumor Types Suitable for Treatment With Capecitabine|Completed||Phase 1|50|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-10-11 05:02:31.489007|2017-10-11 05:02:31.489007
NCT00107263|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2016-12-02|||January 2005||2005-01-01|December 2016|2016-12-01|August 2012|Actual|2012-08-01|March 2007|Actual|2007-03-01||Interventional|||Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer|A Randomized, Controlled, Open-Label Trial of Empiric Prophylactic vs. Delayed Use of Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women With Breast Cancer Initiating Therapy With Letrozole After Tamoxifen|Completed||Phase 3|558|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 05:02:31.611375|2017-10-11 05:02:31.611375
NCT00107276|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2013-07-03|2012-11-15||August 2005||2005-08-01|July 2013|2013-07-01|August 2009|Actual|2009-08-01|March 2008|Actual|2008-03-01||Interventional|||S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer|Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer|Completed||Phase 2|112|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 05:02:31.746009|2017-10-11 05:02:31.746009
NCT00107289|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2017-06-01|||May 2006|Actual|2006-05-01|June 2017|2017-06-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma|Open Access Protocol of Targeted Radiotherapy With I-metaiodobenzylguanidine (I-MIBG) in Patients With Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors|Recruiting||Phase 2|80|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 05:02:32.458527|2017-10-11 05:02:32.458527
NCT00107315|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2014-06-03|2014-01-08||July 2004||2004-07-01|June 2014|2014-06-01||||June 2008|Actual|2008-06-01||Interventional||All treated and eligible patients|Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer|A Phase II Study of Capecitabine and Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|16|Actual|Roswell Park Cancer Institute|Due to the study's early termination, as a result of low accrual, target accrual was not reached and no statistical inference of the primary and secondary aims were carried forth.|1||Terminated due to low accrual|f||||||||||||||2017-10-11 05:02:32.563889|2017-10-11 05:02:32.563889
NCT00107341|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2016-12-09|||August 2005||2005-08-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|February 2007|Actual|2007-02-01||Interventional|||Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Trial of PS-341 in Combination With Paclitaxel and Carboplatin for Metastatic Adenocarcinoma of the Lower Esophagus, Gastroesophageal Junction, and Gastric Cardia|Completed||Phase 2|37|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 05:02:32.916635|2017-10-11 05:02:32.916635
NCT00107354|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2010-09-16|||December 1998||1998-12-01|September 2010|2010-09-01||||August 2009|Actual|2009-08-01||Interventional|||Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant|Phase I Study of Adoptive Immunotherapy With CD8 Minor Histocompatibility (H) Antigen-Specific CTL Clones for Patients With Relapsed of AML or ALL After Allogeneic Hematopoietic Stem Cell Transplant|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||||||||||||||||2017-10-11 05:02:33.022355|2017-10-11 05:02:33.022355
NCT00107367|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2014-01-09|||April 2004||2004-04-01|July 2009|2009-07-01||||April 2010|Anticipated|2010-04-01||Interventional|||Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor|A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis|Unknown status|Recruiting|Phase 1/Phase 2|62|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:02:33.116486|2017-10-11 05:02:33.116486
NCT00107380|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2016-02-04|2013-12-23||November 2005||2005-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2013|Actual|2013-11-01||Interventional||All eligible patients who started treatment were included in the analysis|S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|Iodine-131-Labeled Monoclonal Anti-B1 Antibody (I-131 Tositumomab) in Combination With Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Rituximab Therapy for Patients ≥ Age 60 With Advanced Stage Diffuse Large B-Cell NHL: A Phase II Study|Completed||Phase 2|86|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 05:02:33.408282|2017-10-11 05:02:33.408282
NCT00100464|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2013-09-16|||November 2000||2000-11-01|September 2013|2013-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Serotonin and the Upper Airway in Obstructive Sleep Apnea|Serotonin and the Upper Airway in Obstructive Sleep Apnea|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:02:57.579426|2017-10-11 05:02:57.579426
NCT00107393|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2013-07-09|||June 2003||2003-06-01|October 2006|2006-10-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer|Phase II Study of Trastuzumab (Herceptin) and Capecitabine (Xeloda) in Women With Taxanes and Anthracyclines Refractory Metastatic Breast Cancer and HER2 Over-Expression|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:02:34.088819|2017-10-11 05:02:34.088819
NCT00107419|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2012-01-13|||September 2005||2005-09-01|January 2012|2012-01-01|August 2009|Actual|2009-08-01|May 2007|Actual|2007-05-01||Interventional|||S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma|Phase II Trial of Pemetrexed for Advanced Chondrosarcomas|Completed||Phase 2|75|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 05:02:34.711686|2017-10-11 05:02:34.711686
NCT00107432|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2013-06-04|||October 2004||2004-10-01|June 2013|2013-06-01||||June 2007|Actual|2007-06-01||Interventional|||Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.|A Phase II Study of BAY 43-9006 (NSC #724772) in Patients With Malignant Mesothelioma|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:02:34.900679|2017-10-11 05:02:34.900679
NCT00107445|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2013-01-15|||February 2005||2005-02-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer|Evaluation of Hypoxia by EF5 Binding in Gynecologic Cancer|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:02:35.001998|2017-10-11 05:02:35.001998
NCT00107458|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2014-08-06|||May 2005||2005-05-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|October 2007|Actual|2007-10-01||Interventional|||Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors|A Phase I Study of Valproic Acid in Children With Recurrent/Progressive Solid Tumors Including CNS Tumors|Completed||Phase 1|26|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-10-11 05:02:37.164633|2017-10-11 05:02:37.164633
NCT00107471|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2013-12-09|||October 2005||2005-10-01|December 2013|2013-12-01||||October 2007|Actual|2007-10-01||Interventional|||Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma|A Phase I/II Study of Topotecan With G-CSF and Radiation Therapy in Children With Malignant Intrinsic Pontine Brainstem Gliomas of Childhood|Terminated||Phase 1/Phase 2|7|Actual|Children's Oncology Group||2||"The unpromising experience of the French group with topotecan given at a dosage of 0.4   mg/m2/day over 30 mins w/in 1 hr of radiation (Cancer 2005; 104: 2792)."|f||||t||||||||||2017-10-11 05:02:37.385972|2017-10-11 05:02:37.385972
NCT00107484|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2010-04-30|||September 2005||2005-09-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer|Phase II Study of Combidex in Axillary Node Staging in Breast Cancer|Completed||Phase 2|3|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-10-11 05:02:37.698201|2017-10-11 05:02:37.698201
NCT00107497|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2009-02-06|||January 2005||2005-01-01|May 2007|2007-05-01||||||||Interventional|||Radiation Therapy in Treating Women With Localized Breast Cancer|Prospective Randomised Clinical Trial Testing 5.7 Gy and 6.0 Gy Fractions of Whole Breast Radiotherapy in Terms of Late Normal Tissue Responses and Tumour Control - FAST|Completed||N/A|900|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:02:37.821176|2017-10-11 05:02:37.821176
NCT00107510|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2016-07-01|||August 2005||2005-08-01|July 2016|2016-07-01||||September 2007|Actual|2007-09-01||Interventional|||Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer|Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer|Completed||Phase 2|58|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 05:02:39.014143|2017-10-11 05:02:39.014143
NCT00107523|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2010-09-20|||January 2005||2005-01-01|September 2010|2010-09-01|October 2005|Actual|2005-10-01|||||Interventional|||Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia|A Phase I Trial Evaluating the Effect of the Addition of HMGCoA-Reductase Inhibition With Pravastatin to Salvage Chemotherapy Idarubicin-HDAC in Patients With Relapsed or Refractory Acute Myelogenous Leukemia|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:02:39.531912|2017-10-11 05:02:39.531912
NCT00107536|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2015-04-08|2014-10-24||October 2005||2005-10-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer|A Phase II Study of Efficacy and Tolerability of GW572016 in Patients With Advanced Hepatocellular and Biliary Carcinomas|Completed||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:02:39.653973|2017-10-11 05:02:39.653973
NCT00107549|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2012-05-17||||||May 2012|2012-05-01|February 2009|Actual|2009-02-01|||||Interventional|||Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy|A Phase I, Open-Label Study to Evaluate the Safety and Tolerability of Recombinant HIV-1 Vaccines in HIV-1 Infected Young Adults With Control of HIV-1 Replication and on Stable Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 05:02:40.125234|2017-10-11 05:02:40.125234
NCT00107562|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2017-02-27|||February 2005||2005-02-01|February 2016|2016-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Adolescent Safer Sex Social Network Intervention|Adolescent Safer Sex Social Network Intervention|Completed||N/A|200|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 05:02:40.235974|2017-10-11 05:02:40.235974
NCT00107575|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2016-09-20|2009-11-30||August 2003||2003-08-01|September 2016|2016-09-01|April 2008|Actual|2008-04-01|June 2007|Actual|2007-06-01||Interventional|||Improving Smoking Cessation Outcomes in Heavy Drinkers - 1|Improving Smoking Cessation Outcomes in Heavy Drinkers|Completed||Phase 2|236|Actual|Brown University||2|||f||||f||||||||||2017-10-11 05:02:40.333938|2017-10-11 05:02:40.333938
NCT00107588|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2017-07-27|||February 2007||2007-02-01|July 2017|2017-07-01|August 2012|Actual|2012-08-01|April 2011|Actual|2011-04-01||Interventional|MTP-3||Marijuana Treatment Project - 3|Contingency Management for Marijuana Dependence|Completed||N/A|215|Actual|UConn Health||3|||f||||t||||||||||2017-10-11 05:02:40.797469|2017-10-11 05:02:40.797469
NCT00107601|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2008-06-26|||October 2004||2004-10-01|February 2006|2006-02-01|May 2006||2006-05-01|||||Interventional|||Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients|A Multi-Center Study Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients|Completed||N/A|3500||University Hospital of Liege|||||f||||||||||||||2017-10-11 05:02:40.883144|2017-10-11 05:02:40.883144
NCT00107614|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-05|2011-08-24|2011-04-15||November 2002||2002-11-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients|UARK 2002-10, A Phase II Study of DT PACE Induction, Followed by Tandem Autologous Transplant and Maintenance Therapy for Patients With Advanced and/or Symptomatic Waldenstrom's Macroglobulinemia|Terminated||Phase 2|12|Actual|University of Arkansas|Early termination due to small numbers of subjects enrolled. Only one participant completed the study. Other participants came off study due to death, toxicity, physician choice, or patient choice.|1||Terminated due to poor accrual.|f||||t||||||||||2017-10-11 05:02:40.98569|2017-10-11 05:02:40.98569
NCT00107627|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-06|2009-06-24|||March 2005||2005-03-01|June 2009|2009-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery|Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery|Completed||Phase 3|90|Actual|Queensland Centre for Gynaecological Cancer||3|||f||||f||||||||||2017-10-11 05:02:41.303655|2017-10-11 05:02:41.303655
NCT00107640|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-06|2012-08-11|||May 2005||2005-05-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Project SHARE (Senior Health and Alcohol Risk Education)|Costs of Preventing Alcohol Problems in Older Adults|Completed||Phase 2|1186|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 05:02:41.402337|2017-10-11 05:02:41.402337
NCT00107653|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-06|2016-05-13|2016-03-16||October 2004||2004-10-01|May 2016|2016-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.|A Prospective, Multicenter, Open-label, Comparative, Efficacy Study of Pegasys® Plus Copegus® in Treatment-naïve Latino Patients With Chronic Hepatitis C-genotype 1, as Compared to Treatment-naïve Non- Latino Caucasian Patients With Chronic Hepatitis C-genotype 1|Completed||Phase 4|569|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:02:41.582084|2017-10-11 05:02:41.582084
NCT00107666|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-06|2006-03-15|||April 2005||2005-04-01|March 2006|2006-03-01|April 2006||2006-04-01|||||Interventional|||CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Proof of Concept Clinical Study of CTI-01 in Patients Undergoing Major Cardiac Surgery With Cardiopulmonary Bypass|Terminated||Phase 2|150||Critical Therapeutics|||||||||||||||||||2017-10-11 05:02:43.4176|2017-10-11 05:02:43.4176
NCT00107679|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-06|2014-04-15|||February 2005||2005-02-01|April 2014|2014-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||A Study of Anal Cancer Development in HIV Infected People|Anal Dysplasia: A Substudy of a Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)|Completed||N/A|560||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:02:43.594186|2017-10-11 05:02:43.594186
NCT00107692|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-06|2006-09-11|||March 2005||2005-03-01|September 2006|2006-09-01|October 2007||2007-10-01|||||Interventional|||Can a Physical Activity Skill Development and Parent-Centered Dietary Intervention Help Combat Child Obesity?|Effect of a Weight Management Program for Overweight and Obese Children: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|216||University of Wollongong|||||f||||||||||||||2017-10-11 05:02:43.738278|2017-10-11 05:02:43.738278
NCT00107705|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-07|2010-06-16|||April 2005||2005-04-01|June 2010|2010-06-01|May 2005||2005-05-01|||||Interventional|||Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing|A Single-blind Phase I Study to Assess the Residual Allergenicity of Tree (Birch, Hazel and Alder) Pollen Allergoid Using Skin Prick Testing|Completed||Phase 1|12||Allergy Therapeutics|||||f||||||||||||||2017-10-11 05:02:43.821052|2017-10-11 05:02:43.821052
NCT00107731|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-07|2009-03-24|||April 2004||2004-04-01|March 2009|2009-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder|A Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Valproate) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)|Completed||Phase 3|710||AstraZeneca|||||f||||||||||||||2017-10-11 05:02:44.097552|2017-10-11 05:02:44.097552
NCT00107757|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-07|2016-09-13|||March 2005||2005-03-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Seasonal Allergic Rhinitis In Pediatric Subjects|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50mcg and 100mcg for 2 Weeks in Pediatric Subjects Ages 2 to <12 Years With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 3|576||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:02:44.6206|2017-10-11 05:02:44.6206
NCT00107770|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-07|2010-01-08|||April 2005||2005-04-01|October 2008|2008-10-01|September 2007|Actual|2007-09-01|November 2006|Actual|2006-11-01||Interventional|||Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)|Safety and Dose Escalating Study of Oral Sodium Phenylbutyrate in Subjects With Amyotrophic Lateral Sclerosis|Completed||Phase 1/Phase 2|40|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:02:44.918275|2017-10-11 05:02:44.918275
NCT00107783|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-07|2010-12-20|2010-12-20||January 2005||2005-01-01|December 2010|2010-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Long-Term Study of Nitisinone to Treat Alkaptonuria|Long-Term Clinical Trial of Nitisinone in Alkaptonuria|Completed||Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)|Small number of patients involved in study and several patients dropped out; primary outcome parameter selection possibly inappropriate because hip joint damage that is already present may be irreversible.|2|||f||||t||||||||||2017-10-11 05:02:45.08061|2017-10-11 05:02:45.08061
NCT00107796|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-08|2012-08-22|||October 2004||2004-10-01|May 2006|2006-05-01|September 2005||2005-09-01|||||Interventional|||Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of PROVIGIL ® (Modafinil) Treatment (100, 200, and 400 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy|Completed||Phase 3|140||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:02:45.640693|2017-10-11 05:02:45.640693
NCT00107809|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-08|2014-05-08|||October 2004||2004-10-01|May 2014|2014-05-01|September 2005||2005-09-01|||||Interventional|||Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of PROVIGIL ® (Modafinil) Treatment (100, 200, and 400 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|140||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:02:46.01696|2017-10-11 05:02:46.01696
NCT00107822|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-08|2005-10-05|||April 2005||2005-04-01|October 2005|2005-10-01|May 2005||2005-05-01|||||Interventional|||Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children|An Open-Label Safety Study to Evaluate the Use of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Pediatric Patients Undergoing a Minor or Major Dermal Procedure|Completed||Phase 3|80||ZARS Pharma Inc.|||||||||||||||||||2017-10-11 05:02:46.294721|2017-10-11 05:02:46.294721
NCT00107835|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-08|2012-06-04|||May 2005||2005-05-01|June 2012|2012-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults|An Open-Label Safety Study to Evaluate the Use of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Adult Patients Undergoing a Minor or Major Dermal Procedure|Completed||Phase 3|408|Actual|ZARS Pharma Inc.||1|||f||||f||||||||||2017-10-11 05:02:46.368933|2017-10-11 05:02:46.368933
NCT00107848|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-08|2014-05-08|||October 2004||2004-10-01|May 2014|2014-05-01|September 2005||2005-09-01|||||Interventional|||PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|A 1 Year Open Label, Flexible Dosage Extension Study to Assess the Safety and Continued Effectiveness of PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|280||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:02:46.509871|2017-10-11 05:02:46.509871
NCT00107861|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2009-07-10|||May 2005||2005-05-01|July 2009|2009-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases|A Phase I/II Study of Interferon-Beta Gene Transfer (Ad.hIFN-β) in the Treatment of Refractory Colorectal Carcinoma With Liver Metastases|Completed||Phase 1/Phase 2|44||Biogen|||||||||||||||||||2017-10-11 05:02:46.734941|2017-10-11 05:02:46.734941
NCT00107874|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2005-06-23|||January 1999||1999-01-01|April 2005|2005-04-01|February 2002||2002-02-01|||||Interventional|||Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-Scheduled Cesarean Section|Oral Misoprostol as a Second-Line Alternative to Intravenous Oxytocin in Preventing Postoperative Blood Loss After Non-Scheduled Cesarean Section: a Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|56||Basel Women’s University Hospital|||||f||||||||||||||2017-10-11 05:02:46.833826|2017-10-11 05:02:46.833826
NCT00107887|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2011-06-14|||June 2005||2005-06-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)|Impact of TB Preventive Therapy for HIV/TB Co-infected Patients With Access to Highly Active Antiretroviral Therapy in Rio de Janeiro, Brazil: A Phased Implementation Trial|Completed||Phase 4|17415|Actual|Communicable Disease Program, Brazil||2|||f||||t||||||||||2017-10-11 05:02:46.924939|2017-10-11 05:02:46.924939
NCT00107900|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2015-02-26|2015-02-05||January 2005||2005-01-01|February 2015|2015-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement|A Phase IIa, Multi-center, Multi-national, Open Label, Dose Ranging Study of the Efficacy, Safety, and Tolerability of Oral DU-176b Administered Once or Twice Daily in the Treatment of Adult Patients Undergoing Total Hip Arthroplasty|Completed||Phase 2|606|Actual|Daiichi Sankyo, Inc.||6|||f||||||||||||||2017-10-11 05:02:47.052693|2017-10-11 05:02:47.052693
NCT00107913|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2005-06-23|||September 2001||2001-09-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura|Phase II Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura|Unknown status|Recruiting|Phase 2|10||Hematology and Oncology Specialists|||||f||||||||||||||2017-10-11 05:02:48.713109|2017-10-11 05:02:48.713109
NCT00107926|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2017-03-20|||October 2004||2004-10-01|March 2017|2017-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder|Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder|Completed||Phase 3|343|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:02:48.813841|2017-10-11 05:02:48.813841
NCT00107939|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2017-03-20|||November 2004||2004-11-01|March 2017|2017-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Licarbazepine 750 ¿ 2000 mg/d as Adjunctive Therapy to an Atypical Antipsychotic in the Treatment of Manic Episodes of Bipolar I Disorder Over 6 Weeks|Completed||Phase 3|453|Actual|Novartis|||||f||||||||||||||2017-10-11 05:02:48.991812|2017-10-11 05:02:48.991812
NCT00107952|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2014-08-13|2009-11-03||February 2005||2005-02-01|August 2014|2014-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|ATTAIN1||Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus|A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia With a Focus on Patients With Infections Due to Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 3|761|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||t||||||||||2017-10-11 05:02:49.155256|2017-10-11 05:02:49.155256
NCT00107965|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2015-03-24|||March 2005||2005-03-01|March 2015|2015-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses|A Multi-center, Randomized, Double-blind, Parallel-group, Vehicle-controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Actinic Keratoses|Completed||Phase 2|60||Peplin||8|||f||||||||||||||2017-10-11 05:02:51.107203|2017-10-11 05:02:51.107203
NCT00107978|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2010-12-10|2009-11-03||February 2005||2005-02-01|December 2010|2010-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|ATLAS2||Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus|A Phase 3, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections With a Focus on Patients With Infections Due to Methicillin-resistant Staphylococcus Aureus|Completed||Phase 3|1035|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||t||||||||||2017-10-11 05:02:51.309908|2017-10-11 05:02:51.309908
NCT00107991|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-11|2011-01-04|2011-01-04||April 2005||2005-04-01|January 2011|2011-01-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Etanercept for Treatment of Hidradenitis|A Phase II Open Label Clinical Trial of Etanercept for the Treatment of Hidradenitis Suppurativa|Completed||Phase 2|15|Actual|University of Pennsylvania|This study did not have a control group, and therefore, it is possible that observed benefits could be as a result of natural remission or a placebo effect.|1|||f||||f||||||||||2017-10-11 05:02:52.632429|2017-10-11 05:02:52.632429
NCT00108004|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-12|2015-05-20|||April 2003||2003-04-01|May 2015|2015-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus|A Phase 3B, Multicenter, Open-Label Study Investigating the Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Insulin Therapy|Completed||Phase 3|400|Anticipated|AstraZeneca||1|||f||||||||||||||2017-10-11 05:02:53.138503|2017-10-11 05:02:53.138503
NCT00108017|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-12|2015-05-12|||April 2005||2005-04-01|May 2015|2015-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)|Randomized, Multicenter, Dbl-Masked, Parallel Study Evaluating the 24 Hr. Diurnal Ocular Hypotensive Effect of 2% Dorzolamide Hydrochloride/0.5% Timolol Maleate Combo. Ophthalmic Sol. in Patients w/ Open Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|330|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:02:53.365309|2017-10-11 05:02:53.365309
NCT00108030|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-12|2015-12-02|||March 2004||2004-03-01|December 2015|2015-12-01|December 2006|Actual|2006-12-01|||||Interventional|||PBWST (Partial Body-Weight Supported Treadmill Training) and Muscle Power Training After Sub-acute Stroke|A RCT of Power Training and Treadmill Training to Improve Walking Ability in Sub-acute Stroke Patients|Completed||Phase 2/Phase 3|102|Anticipated|University of Sydney|||||f||||||||||||||2017-10-11 05:02:53.447024|2017-10-11 05:02:53.447024
NCT00108043|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-12|2015-12-02|||March 2004||2004-03-01|December 2015|2015-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Orthostatic Tolerance During FES (Functional Electrical Stimulation)-Walking in Paraplegia|Orthostatic Tolerance During FES-evoked Stepping in Paraplegia: A Safety and Viability Study|Completed||Phase 1|10|Anticipated|University of Sydney|||||f||||||||||||||2017-10-11 05:02:53.553855|2017-10-11 05:02:53.553855
NCT00108056|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-12|2017-10-05|||April 7, 2005||2005-04-07|April 1, 2014|2014-04-01|April 1, 2014|Actual|2014-04-01|April 1, 2014|Actual|2014-04-01||Interventional|||Enzastaurin to Treat Recurrent Brain Tumor|A Phase I Trial of Enzastaurin (LY317615) in Patients With Recurrent Gliomas|Terminated||Phase 1|26|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:02:53.675031|2017-10-11 05:02:53.675031
NCT00108069|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-12|2015-10-13|2014-03-06||April 2005||2005-04-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||One participant in the AG cohort was not evaluable/did not receive study drug.|Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors|A Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas|Completed||Phase 2|43|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 05:02:53.811182|2017-10-11 05:02:53.811182
NCT00108082|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-13|2016-11-04|2009-08-13||January 2005||2005-01-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||The CLEVER Study - Coreg And Left Ventricular Mass Regression|A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).|Completed||Phase 3|287|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:02:55.2622|2017-10-11 05:02:55.2622
NCT00108095|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-13|2017-01-19|||October 2004||2004-10-01|January 2017|2017-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting|A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Oral Neurokinin-1 Receptor Antagonist, GW679769, When Administered With Intravenous Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting (PONV) and Post-discharge Nausea and Vomiting (PDNV) in Female Subjects With Known Risk Factors for PONV Who Are Undergoing Surgical Procedures Associated With an Increased Emetogenic Risk|Completed||Phase 2|701|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:02:56.960006|2017-10-11 05:02:56.960006
NCT00108108|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2012-09-28|||April 2005||2005-04-01|September 2012|2012-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy|An Open-label,Multi-center, Phase l/ll Study of Anti-CD40 Monoclonal Antibody (HCD122) Administered Intravenously to Subjects With Advanced Chronic Lymphocytic Leukemia That is Refractory or Relapsed After at Least One Previous Fludarabine-containing Chemotherapy Regimen|Terminated||Phase 1|26|Actual|Novartis||1||Slow enrollment and minimal preliminary biological and clinical efficacy.|f||||f||||||||||2017-10-11 05:02:57.307937|2017-10-11 05:02:57.307937
NCT00100438|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Observational|||Incidence of Parkinson's Disease Among Veterans|Incidence of Parkinson's Disease Among Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:02:57.42307|2017-10-11 05:02:57.42307
NCT00100477|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2013-09-24|||August 1998||1998-08-01|September 2013|2013-09-01|June 2001|Actual|2001-06-01|January 2001|Actual|2001-01-01||Interventional|||Use of Topotecan in Patients With Refractory Acute Leukemia|Study of Topoisomerase Inhibition in the Treatment of Acute Leukemia|Completed||Phase 2|10|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 05:02:57.672119|2017-10-11 05:02:57.672119
NCT00100490|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-30|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Observational|||Immune and Endocrine Function in Post-Traumatic Stress Disorder|Immune and Endocrine Function in Post-Traumatic Stress Disorder|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:02:57.779387|2017-10-11 05:02:57.779387
NCT00100503|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-31|2017-06-30|||December 27, 2004||2004-12-27|August 30, 2006|2006-08-30|August 30, 2006||2006-08-30|||||Observational|||Brain Reorganization Following Constraint-Induced Therapy in Children With Cerebral Palsy|Cortical Reorganization Following Pediatric Constraint-Induced Therapy|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:57.854181|2017-10-11 05:02:57.854181
NCT00100516|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-31|2017-06-30|||December 23, 2004||2004-12-23|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Observational|||Donor Recipient Kidney Function Following Open Surgical vs. Laparoscopic Kidney Donation|Infrared Image Guided Minimally Invasive Live Donor Kidney Donation for Kidney Transplantation|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:57.937362|2017-10-11 05:02:57.937362
NCT00100529|ClinicalTrials.gov processed this data on October 10, 2017|2004-12-31|2017-10-05|||December 21, 2004||2004-12-21|June 29, 2012|2012-06-29|June 29, 2012||2012-06-29|||||Observational|||Stereo Photogrammetry Imaging in Normal Volunteers and Patients With Head and Facial Malformations|Stereo Photogrammetry Soft Tissue in Normal Individuals and Patients With Craniofacial Dysmorphologies|Completed||N/A|1577|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:02:58.011106|2017-10-11 05:02:58.011106
NCT00100542|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-03|2011-01-20|||April 2005||2005-04-01|January 2011|2011-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||Psychiatric Problems in Children and Adolescents Infected With HIV at Birth|Psychiatric Co-Morbidity in Perinatally HIV-Infected Children and Adolescents|Completed||N/A|800|Anticipated|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|||1||f||||||||||||||2017-10-11 05:02:58.090703|2017-10-11 05:02:58.090703
NCT00100555|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-03|2012-04-26|||June 2004||2004-06-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate|A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate|Completed||Phase 3|120||Novartis|||||||||||||||||||2017-10-11 05:02:58.288698|2017-10-11 05:02:58.288698
NCT00100568|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-03|2013-09-04|||July 2006||2006-07-01|September 2013|2013-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal|A Pilot Study of Safety, Effectiveness, and Adherence of Lamivudine/Zidovudine and Efavirenz (3TC/ZDV + EFV) to Treat HIV-1 Infection in Senegal|Completed||N/A|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-10-11 05:02:58.428696|2017-10-11 05:02:58.428696
NCT00100581|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-03|2012-05-17||||||May 2012|2012-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults|An Open-Label, Randomized Study to Determine the Impact of Antiretroviral Treatment in HCV/HIV-Coinfected Subjects With High CD4+ Cell Count on the Efficacy of Hepatitis C Treatment With Pegylated Interferon Alfa-2A and Ribavirin|Completed||N/A|2|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:02:58.563897|2017-10-11 05:02:58.563897
NCT00100594|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-03|2011-02-22|||May 2005||2005-05-01|February 2011|2011-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China|A Feasibility Study of Lamivudine/Zidovudine (3TC/ZDV) Plus Efavirenz (EFV) as Initial Therapy of HIV-1 Infected Patients in a Rural Area of China|Completed||N/A|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:02:58.707968|2017-10-11 05:02:58.707968
NCT00100607|ClinicalTrials.gov processed this data on October 10, 2017|2005-01-03|2012-05-07|||February 2004||2004-02-01|May 2012|2012-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis|Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis|Completed||Phase 2|676|Actual|Novartis|||||f||||||||||||||2017-10-11 05:02:58.802322|2017-10-11 05:02:58.802322
NCT00108121|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2015-01-16|||March 2005||2005-03-01|January 2015|2015-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma|A Multi-center, Randomized, Double-blind, Parallel-group, Vehicle-controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Nodular Basal Cell Carcinoma|Completed||Phase 2|60||Peplin|||||f||||||||||||||2017-10-11 05:02:58.885346|2017-10-11 05:02:58.885346
NCT00108134|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2008-12-22|||March 2005||2005-03-01|December 2008|2008-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Superficial Basal Cell Carcinoma|Completed||Phase 2|60||Peplin|||||f||||||||||||||2017-10-11 05:02:59.110327|2017-10-11 05:02:59.110327
NCT00108147|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-03-04|||October 2003||2003-10-01|March 2009|2009-03-01||||||||Interventional|||Functional Circuit Training in Older Adults With Congestive Heart Failure|Functional Circuit Training in Older Adults With Congestive Heart Failure|Completed||N/A|||VA Office of Research and Development||3|||f||||||||||||||2017-10-11 05:02:59.2997|2017-10-11 05:02:59.2997
NCT00108160|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2014-03-20|2013-12-16||April 2005||2005-04-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Preventing Staphylococcal (Staph) Infection|Intermittent Mupirocin to Prevent Staphylococcal Infection|Completed||Phase 4|146|Actual|VA Office of Research and Development|The study is underpowered to detect differences between the two treatment arms. We achieved only 75% of target enrollment, and 41.1% dropped out before reaching a primary endpoint. Our re-infection rate was also lower than anticipated (14.4%).|2|||f||||f||||||||||2017-10-11 05:02:59.419452|2017-10-11 05:02:59.419452
NCT00183599|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-17|||April 1999||1999-04-01|November 2011|2011-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Gambling and Brief Interventions|Effect of Type and Duration of Therapy on Treatment for Gambling|Completed||Phase 1|500||UConn Health||3|||f||||t||||||||||2017-10-11 05:30:42.115248|2017-10-11 05:30:42.115248
NCT00108186|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2014-10-28|||October 2004||2004-10-01|October 2014|2014-10-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Celecoxib Treatment for Lung Cancer|Celecoxib-Mediated Inhibition of T Regulatory Cells in Human Lung Cancer|Withdrawn||Phase 1|0|Actual|VA Office of Research and Development||1||Couldn't accrue patients|f||||t||||||||||2017-10-11 05:03:00.110374|2017-10-11 05:03:00.110374
NCT00108199|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-01-20|||October 2001||2001-10-01|May 2007|2007-05-01|September 2004||2004-09-01|||||Interventional|||Generalization of Training in Schizophrenia|Generalization of Training in Schizophrenia|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:00.226669|2017-10-11 05:03:00.226669
NCT00108212|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-01-20|||January 2005||2005-01-01|April 2007|2007-04-01|December 2007||2007-12-01|||||Interventional|||Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests|Clinical Implications of Genetic Alterations in TG Rich Lipoproteins|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:00.304721|2017-10-11 05:03:00.304721
NCT00108225|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2014-06-30|||July 2004||2004-07-01|June 2014|2014-06-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)|2895 Effect of a High Protein Diet on the 24-hr Profile of Ghrelin, GH and IGF-1|Completed||N/A|8|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:03:00.385533|2017-10-11 05:03:00.385533
NCT00108238|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-01-20|||April 2003||2003-04-01|April 2007|2007-04-01|December 2006||2006-12-01|||||Interventional|||Estrogen Alternatives Study|Estrogen Alternatives and Vascular Function in Post-Menopausal Women|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:00.519033|2017-10-11 05:03:00.519033
NCT00108251|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2011-09-07|||August 2004||2004-08-01|September 2011|2011-09-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Aldosterone Antagonism in Diastolic Heart Failure|Aldosterone Antagonism in Diastolic Heart Failure|Completed||Phase 4|48|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:03:00.610398|2017-10-11 05:03:00.610398
NCT00108264|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-01-20||||||May 2007|2007-05-01|September 2005||2005-09-01|||||Interventional|||Tumor RNA Transfected Dendritic Cell Vaccines|Tumor RNA Transfected Dendritic Cell Vaccines|Completed||Phase 1|||VA Office of Research and Development|||||||||||||||||||2017-10-11 05:03:00.783338|2017-10-11 05:03:00.783338
NCT00108277|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2015-01-07|2014-12-16||April 2005||2005-04-01|January 2015|2015-01-01|September 2010|Actual|2010-09-01|December 2008|Actual|2008-12-01||Interventional|||Respiratory Dysregulation and Breathing Training in Anxious Outpatients|Respiratory Dysregulation and Breathing Training in Anxious Outpatients|Completed||N/A|92|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 05:03:00.888093|2017-10-11 05:03:00.888093
NCT00108290|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2008-04-02|||April 2004||2004-04-01|April 2007|2007-04-01|March 2007||2007-03-01|||||Interventional|||Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer|Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:01.317527|2017-10-11 05:03:01.317527
NCT00108303|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2015-12-02|2014-11-03||January 2004||2004-01-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes|Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes in Individuals Extensively Diagnosed and Genotyped|Completed||N/A|538|Actual|VA Office of Research and Development|Genetic linkage and association do not replicate well across studies. This study should be viewed in this context.||1||f||||f||||||Samples With DNA|"     dna   "|||2017-10-11 05:03:01.409565|2017-10-11 05:03:01.409565
NCT00108316|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2013-09-25|||January 2004||2004-01-01|September 2013|2013-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Determinants in Antidepressant Outcomes|SERT Affinity Determinants in Antidepressant Outcomes|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||Study PI resigned|f||||||||||||||2017-10-11 05:03:02.318101|2017-10-11 05:03:02.318101
NCT00108329|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-01-20|||April 2003||2003-04-01|April 2007|2007-04-01|March 2006||2006-03-01|||||Interventional|||Weight Loss in Diabetic, Older Obese Adults|5449 Genetics, Weight Loss and Glucose Metabolism in Older Obese Men|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:02.434242|2017-10-11 05:03:02.434242
NCT00108342|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2014-06-02|2013-12-19||October 2007||2007-10-01|June 2014|2014-06-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|NDS||Nicotine Delivery Systems: Research & Treatment|Nicotine Delivery Systems: Research and Treatment|Terminated||N/A|25|Actual|VA Office of Research and Development|Limitations of the study: early termination of the study occurred due to widespread comorbidities precluding recruitment and enrollment of Veterans in this NRT trial. Specifically, the sample size was too small for any data analyses.|2||Common comorbidities of Veterans precluded sufficient recruitment and enrollment.|f||||f||||||||||2017-10-11 05:03:02.534399|2017-10-11 05:03:02.534399
NCT00108355|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2014-02-03|2013-12-11||December 2003||2003-12-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2010|Actual|2010-08-01||Interventional|||Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis|Vasoconstrictors as Alternatives to Albumin After Large Volume Paracentesis in Cirrhosis|Completed||Phase 4|29|Actual|VA Office of Research and Development|Difficulty to enroll patient population lead to small sample size. Midodrine not titrated for a goal increase in mean arterial pressure. Blood tests for day 6 assessment of post paracentesis circulatory dysfunction not available for all patients.|2|||f||||t||||||||||2017-10-11 05:03:02.847433|2017-10-11 05:03:02.847433
NCT00108368|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-01-20|||October 2003||2003-10-01|September 2007|2007-09-01|March 2006||2006-03-01|||||Interventional|||The Effects of Risperidone and Olanzapine on Thinking|The Cognitive Effects of Risperidone and Olanzapine|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:03.220565|2017-10-11 05:03:03.220565
NCT00108381|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2014-07-01|||January 2004||2004-01-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy of Tailored Cognitive-Behavioral Therapy for Chronic Back Pain|Efficacy of Tailored Cognitive-Behavioral Therapy for Chronic Back Pain|Completed||N/A|162|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:03:03.287531|2017-10-11 05:03:03.287531
NCT00108394|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-01-20|||October 2002||2002-10-01|March 2008|2008-03-01|September 2007||2007-09-01|||||Interventional|||Osteopenia and Renal Osteodystrophy: Evaluation and Management|Osteopenia and Renal Osteodystrophy: Evaluation and Management|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:03.379396|2017-10-11 05:03:03.379396
NCT00108407|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-03-04|||October 2004||2004-10-01|March 2009|2009-03-01||||||||Interventional|||Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse|Integrated CBT for Substance Use and Depressive Disorders|Completed||N/A|||VA Office of Research and Development||2|||f||||||||||||||2017-10-11 05:03:03.544636|2017-10-11 05:03:03.544636
NCT00108420|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-14|2009-01-20|||October 2003||2003-10-01|May 2007|2007-05-01|March 2007||2007-03-01|||||Interventional|||Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance|Prazosin Treatment for Combat Trauma PTSD Nightmares and Sleep Disturbance|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:03.686586|2017-10-11 05:03:03.686586
NCT00108433|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2012-06-28|2012-06-28||September 2005||2005-09-01|June 2012|2012-06-01|September 2006|Actual|2006-09-01|||||Interventional|||Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections|Linezolid vs Vancomycin/Cefazolin in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections|Terminated||Phase 3|61|Actual|Pfizer|Efficacy results were not reported because the study was prematurely terminated.|||See Detailed Description|f||||||||||||||2017-10-11 05:03:03.795677|2017-10-11 05:03:03.795677
NCT00108446|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2009-01-20|||October 2003||2003-10-01|May 2007|2007-05-01|March 2006||2006-03-01|||||Interventional|||Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome|Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:03:04.29193|2017-10-11 05:03:04.29193
NCT00110825|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-13|2017-01-11|||February 2004||2004-02-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|March 2006|Actual|2006-03-01||Interventional|||Behavioral Smoking Cessation Treatment - 1|Behavioral Maintenance Treatment for Smoking Cessation|Completed||N/A|304|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-10-11 05:03:04.370593|2017-10-11 05:03:04.370593
NCT00110838|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-13|2006-07-20|||October 2001||2001-10-01|May 2005|2005-05-01|January 2005||2005-01-01|||||Interventional|||SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia|Study on Omega-3 Fatty Acids and Ventricular Arrhythmia, a Parallel, Placebo-Controlled, Double Blind Intervention Study|Completed||Phase 3|546||Wageningen Centre for Food Sciences|||||f||||||||||||||2017-10-11 05:03:04.456472|2017-10-11 05:03:04.456472
NCT00110851|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-13|2007-08-21|||April 2005||2005-04-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) Therapy|Completed||Phase 2|90|Anticipated|Wellstat Therapeutics|||||||||||||||||||2017-10-11 05:03:06.208526|2017-10-11 05:03:06.208526
NCT00110864|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-13|2007-08-21|||May 2005||2005-05-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes|Completed||Phase 2|90|Anticipated|Wellstat Therapeutics|||||||||||||||||||2017-10-11 05:03:06.348056|2017-10-11 05:03:06.348056
NCT00110877|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-13|2015-07-01|||April 2005||2005-04-01|July 2015|2015-07-01|October 2011|Actual|2011-10-01|January 2007|Actual|2007-01-01||Interventional|||TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients|A Randomized, Controlled, Open-label Trial to Compare the Efficacy, Safety and Tolerability of TMC114/RTV Versus LPV/RTV in Treatment-Experienced HIV-1 Infected Patients|Completed||Phase 3|604|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-10-11 05:03:06.462951|2017-10-11 05:03:06.462951
NCT00110890|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2011-02-11|2010-10-15||May 2004||2004-05-01|February 2011|2011-02-01|September 2007|Actual|2007-09-01|April 2005|Actual|2005-04-01||Interventional|||A Research Study for Patients With End-Stage Renal Disease (ESRD)|An Open-Label, Randomised Study Using Cinacalcet to Improve Achievement of Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With ESRD|Completed||Phase 4|552|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:03:06.967867|2017-10-11 05:03:06.967867
NCT00110903|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2013-04-24||||||April 2013|2013-04-01||||||||Interventional|||Treatment for Subjects With Active Rheumatoid Arthritis (RA)|Open-Label Study to Assess the Safety of Etanercept Liquid Administered Once Weekly in Subjects With Active Rheumatoid Arthritis (RA)|Completed||Phase 3|||Amgen|||||||||||||||||||2017-10-11 05:03:08.097589|2017-10-11 05:03:08.097589
NCT00110916|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2008-02-20|||June 2004||2004-06-01|February 2008|2008-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Treatment for Patients With Osteoarthritis (OA) of the Knee|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Intra-Articular metHuIL-1ra (Anakinra) in Subjects With Osteoarthritis (OA) of the Knee|Completed||Phase 2|165|Anticipated|Amgen||2|||f||||||||||||||2017-10-11 05:03:08.168947|2017-10-11 05:03:08.168947
NCT00110929|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2010-04-22|||November 2002||2002-11-01|April 2010|2010-04-01||||||||Interventional|||Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)|A Study to Compare the Efficacy and Safety of an Oral Calcimimetic Agent (AMG 073) When Two Different Vitamin D Regimens Are Used in Subjects With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)|Completed||Phase 2|850||Amgen||1|||||||||||||||||2017-10-11 05:03:08.243265|2017-10-11 05:03:08.243265
NCT00110942|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2008-06-20|||February 2005||2005-02-01|June 2008|2008-06-01|November 2005|Actual|2005-11-01|June 2005|Actual|2005-06-01||Interventional|||Treatment for Patients With Osteoarthritis (OA)|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Systemic AMG 108 in Subjects With Osteoarthritis (OA)|Completed||Phase 2|160|Actual|Amgen||4|||f||||||||||||||2017-10-11 05:03:08.320907|2017-10-11 05:03:08.320907
NCT00110955|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2010-01-14|||February 2004||2004-02-01|January 2010|2010-01-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|||Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy|A Randomized, Double-Blind, Placebo-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy|Completed||Phase 3|391|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:03:08.403436|2017-10-11 05:03:08.403436
NCT00110968|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2017-02-06|||September 2004||2004-09-01|February 2017|2017-02-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia|A Multicentre, Open-label Extension Phase to Study the Long-term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia|Completed||Phase 3|300||Forest Laboratories|||||f||||||||||||||2017-10-11 05:03:08.589042|2017-10-11 05:03:08.589042
NCT00110981|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2013-05-22|||March 2005||2005-03-01|May 2013|2013-05-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|||Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis|A Multicenter, Open-Label, Pilot Trial to Evaluate the Effectiveness and Safety of ENBREL(r) in Combination With Narrowband UVB Phototherapy for the Treatment of Psoriasis|Completed||Phase 4|86|Actual|Amgen||1|||f||||||||||||||2017-10-11 05:03:08.651792|2017-10-11 05:03:08.651792
NCT00110994|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2015-05-13|2011-01-26||April 2005||2005-04-01|May 2015|2015-05-01|March 2008|Actual|2008-03-01|October 2006|Actual|2006-10-01||Interventional|||Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma|Phase II Randomized, Placebo Controlled Study of Sorafenib in Repeated Cycles of 21 Days in Combination With Dacarbazine (DTIC) Chemotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma|Completed||Phase 2|101|Actual|Bayer||2|||f||||t||||||||||2017-10-11 05:03:08.787158|2017-10-11 05:03:08.787158
NCT00111007|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2014-10-23|2011-01-27||May 2005||2005-05-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|September 2006|Actual|2006-09-01||Interventional|||A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma|Phase III Randomized, Placebo Controlled Study of Sorafenib in Repeated Cycles of 21 Days in Combination With Paclitaxel/Carboplatin Chemotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma.|Completed||Phase 3|270|Actual|Bayer|Metastatic melanoma is notorious for its resistance to chemotherapy. Thus, it is unlikely that inhibition of a single factor or pathway would produce a sustained clinical effect in patients with previously treated, highly refractory disease.|2|||f||||t||||||||||2017-10-11 05:03:09.865815|2017-10-11 05:03:09.865815
NCT00111020|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2014-08-05|||June 2005||2005-06-01|August 2014|2014-08-01|October 2008|Actual|2008-10-01|June 2007|Actual|2007-06-01||Interventional|||Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma|Open Label, Non-Comparative Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 3|2567|Actual|Bayer||1|||t||||f||||||||||2017-10-11 05:03:11.280709|2017-10-11 05:03:11.280709
NCT00111046|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2005-11-09|||February 2001||2001-02-01|May 2005|2005-05-01|February 2004||2004-02-01|||||Interventional|||Pain Relief - Tramadol Versus Ibuprofen|Post-Operative Pain Relief Following Insertion of Radioactive Plaque for Choroidal Melanoma: Randomised Control Trial of Tramadol Vs Ibuprofen: A Pilot Study|Unknown status|Active, not recruiting|Phase 1/Phase 2|40||Royal Liverpool University Hospital|||||f||||||||||||||2017-10-11 05:03:12.286817|2017-10-11 05:03:12.286817
NCT00111059|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2005-06-23|||January 2005||2005-01-01|May 2005|2005-05-01|April 2006||2006-04-01|||||Observational|||Primary Prevention Study: Study on Obesity, Cardiovascular and Psycho-Social Characteristics in the City of Merzig|Cross-Sectional Case-Control Study on Obesity, Cardiovascular and Psycho-Social Characteristics in the City of Merzig|Unknown status|Recruiting|N/A|600||University Hospital, Saarland|||||f||||||||||||||2017-10-11 05:03:12.365577|2017-10-11 05:03:12.365577
NCT00111072|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-16|2008-03-03|||May 2005||2005-05-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Dexamethasone to Treat Oral Lichen Planus|Dexamethasone 0.01% Solution for the Treatment of Oral Lichen Planus|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:03:12.441657|2017-10-11 05:03:12.441657
NCT00111085|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2010-02-11||2010-02-11|January 2005||2005-01-01|February 2010|2010-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|CONSCIOUS-1||Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH)|A Phase IIb, Multi-center, International, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding Study for the Prevention of Cerebral Vasospasm After aSAH by Intravenous Administration of Clazosentan, a Selective ETA Receptor Antagonist|Completed||Phase 2|413|Actual|Actelion|||||||||||||||||||2017-10-11 05:03:12.51648|2017-10-11 05:03:12.51648
NCT00111098|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2008-08-07|||March 2004||2004-03-01|August 2008|2008-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis|A Multicenter, Single Arm Study Evaluating Once Monthly Darbepoetin Alfa Dosing In Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis|Completed||Phase 3|150|Anticipated|Amgen||1|||f||||||||||||||2017-10-11 05:03:12.67183|2017-10-11 05:03:12.67183
NCT00111111|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2009-05-28||||||May 2009|2009-05-01||||||||Interventional|||An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis|A Multicenter, Open-Label, Prospective Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects With Psoriasis|Completed||Phase 3|||Amgen||1|||||||||||||||||2017-10-11 05:03:12.742381|2017-10-11 05:03:12.742381
NCT00111124|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2013-05-13||||||May 2013|2013-05-01||||||||Interventional|||Enbrel® in Psoriatic Arthritis|Enbrel® in Psoriatic Arthritis|Completed||Phase 4|||Amgen|||||||||||||||||||2017-10-11 05:03:12.829115|2017-10-11 05:03:12.829115
NCT00111137|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2008-02-20|||February 2003||2003-02-01|February 2008|2008-02-01|April 2004|Actual|2004-04-01|November 2003|Actual|2003-11-01||Interventional|||Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy|A Randomized, Open Label Study to Assess Time to Hemoglobin Response of a Front Load Dosing Regimen for Darbepoetin Alfa Compared to a Weekly Dose Regimen for Recombinant Human Erythropoietin in Patients With Non-Myeloid Malignancies Receiving Chemotherapy|Completed||Phase 3|718|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:03:12.944101|2017-10-11 05:03:12.944101
NCT00111150|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2007-03-16|||September 2005||2005-09-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Botswana Tenofovir Oral HIV Prophylaxis Trial|Study of the Safety and Efficacy of Daily Tenofovir Disoproxil Fumarate for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana|Terminated||Phase 2/Phase 3|1200||Centers for Disease Control and Prevention||||Consenting participants entered tenofovir/emtricitabine oral prophylaxis trial|f||||t||||||||||2017-10-11 05:03:13.026284|2017-10-11 05:03:13.026284
NCT00111163|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2012-09-26|||March 2004||2004-03-01|September 2012|2012-09-01|March 2008|Actual|2008-03-01|March 2006|Actual|2006-03-01||Interventional|||Intermittent Preventive Treatment With Antimalarials in Kenyan Infants|Efficacy and Safety of Pediatric Immunization-linked Preventive Intermittent Treatment With Antimalarials in Decreasing Anemia and Malaria Morbidity in Rural Western Kenya|Completed||N/A|1516||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:03:13.115888|2017-10-11 05:03:13.115888
NCT00111176|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2014-08-15|||March 2004||2004-03-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|July 2007|Actual|2007-07-01||Interventional|STARZ-TX2||STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft|Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft|Completed||N/A|260|Actual|Cook Group Incorporated||2|||f||||t||||||||||2017-10-11 05:03:13.223738|2017-10-11 05:03:13.223738
NCT00111189|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2014-06-19|||February 2005||2005-02-01|June 2014|2014-06-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.|A Randomized Double-blind Placebo-controlled Parallel Group Study Evaluating Paliperidone Palmitate in the Prevention of Recurrence in Patients With Schizophrenia. Placebo Consists of 20% Intralipid (200 mg/mL) Injectable Emulsion.|Completed||Phase 3|414|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 05:03:13.422328|2017-10-11 05:03:13.422328
NCT00111202|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-17|2005-09-28|||May 2005||2005-05-01|May 2005|2005-05-01|June 2006||2006-06-01|||||Observational|||Schizophrenia and Genetic Counseling|Schizophrenia and Genetic Counseling: A Survey of People With Schizophrenia and Their Relatives|Unknown status|Active, not recruiting|Phase 1|100||Sarah Lawrence College|||||f||||||||||||||2017-10-11 05:03:13.646308|2017-10-11 05:03:13.646308
NCT00111215|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-18|2007-03-12|||January 2001||2001-01-01|June 2006|2006-06-01|September 2006||2006-09-01|||||Interventional|||Treatment and Management of Women With Bleeding Disorders|Treatment and Management of Women With Bleeding Disorders|Completed||N/A|100||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 05:03:13.706695|2017-10-11 05:03:13.706695
NCT00111228|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-18|2006-10-24|||October 2004||2004-10-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-Time Values of Guardian RT|Randomised, Controlled, Multi-Centric, Clinical Study to Assess Whether Type 1 Diabetic Patients in Poor Glycemic Control Can Improve Using the Real-Time Values of Guardian T Versus Conventional Self-Monitoring Blood Glucose|Completed||Phase 4|162||Medtronic|||||f||||||||||||||2017-10-11 05:03:13.791513|2017-10-11 05:03:13.791513
NCT00111254|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-18|2015-05-20|||June 2002||2002-06-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Effects of Microdermabrasion on Skin Remodeling|The Effects of Microdermabrasion on Collagen and Elastin Biosynthesis|Completed||N/A|257|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 05:03:13.966282|2017-10-11 05:03:13.966282
NCT00111267|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-18|2005-06-23|||May 2003||2003-05-01|May 2005|2005-05-01|January 2005||2005-01-01|||||Interventional|||Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People|The Effect of Oral Vitamin B12 Supplementation on Cognitive Performance in Elderly People: the Brain12 Study|Completed||N/A|165||Wageningen University|||||f||||||||||||||2017-10-11 05:03:14.034642|2017-10-11 05:03:14.034642
NCT00111280|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-18|2011-05-18|||September 2004||2004-09-01|April 2010|2010-04-01|March 2007|Actual|2007-03-01|||||Interventional|||TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial|HIV-1 Infected Subjects Who Were Randomized in Any Sponsor-selected TMC125 Trial to an Active Control Arm and Either Virologically Failed or Completed the Entire Treatment Period, or to Placebo Arm and Were Treated for at Least 48 Weeks.|Completed||Phase 2|48|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-10-11 05:03:14.104828|2017-10-11 05:03:14.104828
NCT00111293|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-18|2017-06-30|||May 16, 2005||2005-05-16|May 14, 2010|2010-05-14|May 14, 2010||2010-05-14|||||Observational|||Attention and Visual Perception|Top-Down Attentional Control of Visual Processing|Completed||N/A|8|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:03:14.174326|2017-10-11 05:03:14.174326
NCT00111306|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-19|2011-11-07|||June 2005||2005-06-01|November 2011|2011-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Epratuzumab in Systemic Lupus Erythematosus|A Phase III, Randomized, Double-Blind. Placebo-Controlled, Multi-Center Study of Systemic Lupus Erythematosus With Acute Severe SLE Flares Excluding Renal or Neurological Systems|Terminated||Phase 3|510||UCB Pharma|||||f||||||||||||||2017-10-11 05:03:14.236222|2017-10-11 05:03:14.236222
NCT00111319|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-19|2009-03-25|||December 2004||2004-12-01|March 2009|2009-03-01||||July 2007|Actual|2007-07-01||Interventional|||VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma|An Open-Label, Randomized Study of VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Subjects With Previously Untreated Multiple Myeloma|Completed||Phase 3|||Millennium Pharmaceuticals, Inc.|||||t||||||||||||||2017-10-11 05:03:14.344724|2017-10-11 05:03:14.344724
NCT00111332|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-19|2010-04-12|||November 2002||2002-11-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||Study of Home-Based Resistance and Strength Training in HIV-Infected Women|Exercise Effects in HIV-Infected Women|Completed||N/A|40||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:03:14.611687|2017-10-11 05:03:14.611687
NCT00111345|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-19|2012-05-21|||March 2004||2004-03-01|March 2012|2012-03-01|March 2017|Anticipated|2017-03-01|March 2012|Actual|2012-03-01||Interventional|||Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents|Multicenter Therapy-Optimization Trial AML-BFM 2004 for the Treatment of Acute Myeloid Leukemias in Children and Adolescents|Unknown status|Active, not recruiting|Phase 2/Phase 3|550|Actual|University Hospital Muenster||4|||f||||t||||||||||2017-10-11 05:03:14.706428|2017-10-11 05:03:14.706428
NCT00111358|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-19|2011-04-15|||June 2003||2003-06-01|April 2011|2011-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of Lifestyle Modification in HIV Lipodystrophy|The Effects of a Lifestyle Modification Program (REACH) in Patients With HIV and Metabolic Syndrome|Completed||N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 05:03:14.820055|2017-10-11 05:03:14.820055
NCT00111371|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-19|2014-12-04|||January 2005||2005-01-01|September 2006|2006-09-01|October 2015|Anticipated|2015-10-01|||||Interventional|||Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia|Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Dyslexia)|Unknown status|Recruiting|Phase 4|100|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-10-11 05:03:14.915678|2017-10-11 05:03:14.915678
NCT00111384|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-19|2017-10-05|||May 9, 2005||2005-05-09|September 27, 2017|2017-09-27||||||||Observational|||Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)|Variation in Gene Expression in Neurofibromatosis Type 1|Active, not recruiting||N/A|313|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:03:15.070153|2017-10-11 05:03:15.070153
NCT00111397|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-19|2017-06-30|||May 13, 2005||2005-05-13|August 4, 2010|2010-08-04|August 4, 2010|Actual|2010-08-04|August 4, 2010|Actual|2010-08-04||Interventional|||Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection|A Study of Adjuvant Cytokine Therapy in Pulmonary Mycobacterium Avium Complex and Other Pulmonary Nontuberculous Mycobacterial Infections|Completed||Phase 1|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:03:15.190896|2017-10-11 05:03:15.190896
NCT00111410|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2016-08-10||||||August 2016|2016-08-01|November 2003|Actual|2003-11-01|||||Interventional|||Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)|A Multicenter, Double-Blind, Randomized, Placebo Controlled Study to Estimate the Effect of Anakinra (r-metHuIL-1ra) on Vaccine Antibody Response in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 4|||Swedish Orphan Biovitrum|||||f||||||||||||||2017-10-11 05:03:15.267342|2017-10-11 05:03:15.267342
NCT00111423|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2009-03-04|||August 2002||2002-08-01|December 2007|2007-12-01||||||||Interventional|||Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)|Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI) in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 2|216||Amgen|||||||||||||||||||2017-10-11 05:03:15.366775|2017-10-11 05:03:15.366775
NCT00111436|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2013-04-24|||April 2003||2003-04-01|April 2013|2013-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects|An Open-Label, Long-Term Extension Study to Assess the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects|Completed||Phase 3|912|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:03:15.46294|2017-10-11 05:03:15.46294
NCT00111449|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2013-05-13|||June 2003||2003-06-01|May 2013|2013-05-01||||||||Interventional|||Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis|A Phase 3 Multicenter Study to Assess the Efficacy and Safety of Etanercept 50 mg Twice Weekly in Psoriasis|Completed||Phase 3|600||Amgen|||||||||||||||||||2017-10-11 05:03:15.546723|2017-10-11 05:03:15.546723
NCT00111462|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2013-05-06||||||May 2013|2013-05-01||||||||Interventional|||Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy|A Randomized, Open-Label Study of Darbepoetin Alfa (Novel Erythropoiesis Stimulating Protein, NESP) Using Fixed and Weight-Based Dosing for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 2|||Amgen|||||||||||||||||||2017-10-11 05:03:15.686027|2017-10-11 05:03:15.686027
NCT00111475|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2008-11-20||||||November 2008|2008-11-01||||||||Interventional|||Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)|A Dose-Finding Study Evaluating the Safety and Efficacy of AMG 531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)|Completed||Phase 2|||Amgen|||||||||||||||||||2017-10-11 05:03:15.751081|2017-10-11 05:03:15.751081
NCT00111488|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2016-01-05|||June 2005||2005-06-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation|Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation|Terminated||Phase 3|200||Boston Scientific Corporation||||Slow enrollment|||||||||||||||2017-10-11 05:03:15.822179|2017-10-11 05:03:15.822179
NCT00111501|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2015-03-05|||September 2002||2002-09-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||LGBT Internet Based Smoking Treatment - 1|LGBT Internet Based Smoking Treatment|Completed||Phase 3|792|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 05:03:15.92701|2017-10-11 05:03:15.92701
NCT00111514|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2007-02-13|||July 2004||2004-07-01|February 2007|2007-02-01|May 2006||2006-05-01|||||Interventional|||Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate Safety, Tolerability, and Immunogenicity of Leish-111f + MPL-SE Vaccine in Combination With Pentavalent Antimony in Treatment of Mucosal Leishmaniasis|Completed||Phase 1|48||IDRI|||||||||||||||||||2017-10-11 05:03:16.005495|2017-10-11 05:03:16.005495
NCT00111527|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-20|2010-03-22|||May 2005||2005-05-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation|An Assessment of the Echo-guided Optimal Cardiac Resynchronization Therapy in Patients Undergoing 'Ablate And Pace' Therapy for Permanent Atrial Fibrillation|Completed||Phase 3|458|Anticipated|Arcispedale Santa Maria Nuova-IRCCS||2|||f||||f||||||||||2017-10-11 05:03:16.101931|2017-10-11 05:03:16.101931
NCT00111540|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-23|2015-02-19|||November 2002||2002-11-01|January 2015|2015-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes|An Open Label Study to Examine the Long Term Effect on Glucose Control (HbA1c) and Safety and Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|456|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 05:03:16.225871|2017-10-11 05:03:16.225871
NCT00111553|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-23|2007-02-13|||October 2004||2004-10-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis|Randomized, Double-Blind, Adjuvant- and Placebo-Controlled, Dose-Escalating Study to Evaluate Safety, Tolerability, and Immunogenicity of Leish-111f + MPL-SE Vaccine With Meglumine Antimoniate (Glucantime) in Cutaneous Leishmaniasis|Completed||Phase 1|45||IDRI|||||||||||||||||||2017-10-11 05:03:16.45918|2017-10-11 05:03:16.45918
NCT00111566|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-23|2013-11-27|||December 2004||2004-12-01|November 2013|2013-11-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention|Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention|Completed||Phase 4|624|Actual|Cardiology Research UBC||2|||f||||f||||||||||2017-10-11 05:03:16.556026|2017-10-11 05:03:16.556026
NCT00111579|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-23|2008-07-22|||May 2005||2005-05-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)|A Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With Trivalent Inactivated Vaccine (TIV) in Children 6 to <36 Months of Age|Completed||Phase 2|52||MedImmune LLC||2|||f||||f||||||||||2017-10-11 05:03:16.659601|2017-10-11 05:03:16.659601
NCT00111592|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-23|2016-11-08|||August 2000||2000-08-01|November 2007|2007-11-01|December 2004|Actual|2004-12-01|||||Interventional|||Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice|Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice|Completed||N/A|208|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-10-11 05:03:16.751726|2017-10-11 05:03:16.751726
NCT00111605|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-23|2012-09-07||||||September 2012|2012-09-01|May 2008|Actual|2008-05-01|||||Interventional|||Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine With or Without IL-12 DNA Adjuvant, Boosted With Homologous Plasmids in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|144|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-10-11 05:03:16.836449|2017-10-11 05:03:16.836449
NCT00111618|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2009-01-29|||May 2005||2005-05-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|June 2007|Actual|2007-06-01||Interventional|||Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer|An Open Label, Randomized, Phase II Study of AS1404 in Combination With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer|Completed||Phase 2|70|Anticipated|Antisoma Research|||||||||||||||||||2017-10-11 05:03:16.964342|2017-10-11 05:03:16.964342
NCT00111631|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2016-11-01|||May 2005||2005-05-01|November 2016|2016-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes|A Randomized, Double-blind Study of the Effect of the DPP-IV Inhibitor on HbA1c and Safety in Patients With Type 2 Diabetes Treated With a Stable Dose of Metformin|Completed||Phase 2|218|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-10-11 05:03:17.111228|2017-10-11 05:03:17.111228
NCT00111644|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2016-11-01|||March 2005||2005-03-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia|A Randomized, Double-blind Study of the Effect of Beta-lactam on Treatment Response in Patients Hospitalized With Bacterial Pneumonia|Completed||Phase 2|302|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 05:03:17.295255|2017-10-11 05:03:17.295255
NCT00111657|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2014-09-24|2012-12-12||December 2004||2004-12-01|September 2014|2014-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout|A Phase II Multidose Study of Intravenous PEG-uricase in Patients With Refractory Gout|Completed||Phase 2|30|Actual|Duke University||1|||f||||f||||||||||2017-10-11 05:03:17.496562|2017-10-11 05:03:17.496562
NCT00111670|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2016-11-01|||June 2005||2005-06-01|November 2016|2016-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes|A Randomized, Double-blind Study of the Effect of the DPP-IV Inhibitor on HbA1c and Safety in Patients With Type 2 Diabetes|Completed||Phase 2|291|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-10-11 05:03:17.855604|2017-10-11 05:03:17.855604
NCT00111683|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2015-08-21|||June 2005||2005-06-01|August 2015|2015-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||MK0457 in Patients With Leukemia (0457-003)|A Phase I/II Dose Escalation Study of MK0457 in Patients With Leukemia|Completed||Phase 1|28|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 05:03:18.195379|2017-10-11 05:03:18.195379
NCT00111696|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2012-03-13|||May 2005||2005-05-01|March 2012|2012-03-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma|Phase I Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin), a Humanized Monoclonal Antibody Directed Against the Human Alpha V Beta 3 Integrin, in Patients With Advanced Malignant Melanoma|Completed||Phase 1|18|Actual|MedImmune LLC||1|||f||||f||||||||||2017-10-11 05:03:18.281194|2017-10-11 05:03:18.281194
NCT00111709|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2017-03-31|||May 27, 2005|Actual|2005-05-27|March 2017|2017-03-01|February 26, 2006|Actual|2006-02-26|February 24, 2006|Actual|2006-02-24||Interventional|||Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine|Completed||Phase 3|393|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:03:18.358879|2017-10-11 05:03:18.358879
NCT00111722|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2017-03-31|||May 27, 2005|Actual|2005-05-27|March 2017|2017-03-01|February 23, 2006|Actual|2006-02-23|February 15, 2006|Actual|2006-02-15||Interventional|||Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine|Completed||Phase 3|393|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:03:18.430258|2017-10-11 05:03:18.430258
NCT00111735|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2005-06-23|||April 2003||2003-04-01|May 2005|2005-05-01|March 2005||2005-03-01|||||Interventional|||Thyroxine Titration Study|What is the Optimal Serum TSH Concentration During Thyroxine Treatment for Primary Hypothyroidism? Effects of Fine Titration of Thyroxine Dosage on Wellbeing, Quality of Life and Cognitive Function|Unknown status|Active, not recruiting|Phase 4|55||Sir Charles Gairdner Hospital|||||f||||||||||||||2017-10-11 05:03:18.50593|2017-10-11 05:03:18.50593
NCT00111748|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-24|2015-10-02|||February 2005||2005-02-01|October 2015|2015-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients|UARK 2005-01, A Phase III Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients|Completed||Phase 3|180|Anticipated|University of Arkansas||2|||f||||||||||||||2017-10-11 05:03:18.586779|2017-10-11 05:03:18.586779
NCT00111761|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-25|2013-11-15|2010-08-06||July 2002||2002-07-01|November 2013|2013-11-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Interventional|||Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer|A Clinical Trial of the Safety and Efficacy of ABX-EGF in Combination With Irinotecan, Leucovorin, and 5-Fluorouracil in Subjects With Metastatic Colorectal Cancer|Completed||Phase 2|43|Actual|Amgen||2|||f||||t||||||||||2017-10-11 05:03:18.719492|2017-10-11 05:03:18.719492
NCT00111774|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-25|2013-05-10|||March 2002||2002-03-01|May 2013|2013-05-01||||||||Interventional|||Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma|An Open Label Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of ABX-EGF in Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|150||Amgen|||||||||||||||||||2017-10-11 05:03:20.055971|2017-10-11 05:03:20.055971
NCT00111813|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-25|2015-05-05|2011-03-10||September 2005||2005-09-01|May 2015|2015-05-01|May 2011|Actual|2011-05-01|December 2009|Actual|2009-12-01||Interventional|||Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))|Phase I Clinical Trial of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Advanced Multiple Myeloma|Completed||Phase 1|34|Actual|Merck Sharp & Dohme Corp.||6|||f||||||||||||||2017-10-11 05:03:20.862355|2017-10-11 05:03:20.862355
NCT00111826|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-25|2010-03-30|||January 2003||2003-01-01|November 2007|2007-11-01|December 2005||2005-12-01|||||Interventional|||SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes|Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of the Celacade™ System in Improving Walking Distance in Patients With Intermittent Claudication Secondary to Peripheral Arterial Disease|Terminated||Phase 3|500||Vasogen|||||||||||||||||||2017-10-11 05:03:23.541373|2017-10-11 05:03:23.541373
NCT00111852|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2012-03-19|||April 2005||2005-04-01|March 2012|2012-03-01||||March 2007|Actual|2007-03-01||Interventional|||Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)|A Prospective, Randomized, Double-blind, Placebo-controlled, Single Bolus, Multinational, Multi-center, Parallel Group, Dose-ranging Study of Desmoteplase (INN) in the Indication of Acute Stroke|Completed||Phase 3|193|Actual|Forest Laboratories||3|||f||||f||||||||||2017-10-11 05:03:23.870869|2017-10-11 05:03:23.870869
NCT00111865|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2008-08-22|||April 2005||2005-04-01|August 2008|2008-08-01|April 2009|Anticipated|2009-04-01|August 2008|Actual|2008-08-01||Interventional|HELP||Healthy Exercise for Lymphoma Patients (HELP)|Randomized Controlled Trial of Exercise in Lymphoma Patients|Unknown status|Active, not recruiting|Phase 3|122|Actual|Lance Armstrong Foundation||2|||f||||f||||||||||2017-10-11 05:03:25.70133|2017-10-11 05:03:25.70133
NCT00111878|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2007-07-02|||April 2005||2005-04-01|July 2007|2007-07-01|December 2005||2005-12-01|||||Observational|||Study to Evaluate MEDI-534 in Healthy Adults|Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults|Completed||Phase 1|120||MedImmune LLC|||||||||||||||||||2017-10-11 05:03:25.81624|2017-10-11 05:03:25.81624
NCT00111891|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2017-02-16|||June 2005||2005-06-01|February 2017|2017-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)|A Dose Ranging Study to Evaluate the Tolerability of MK0524 (Niacin (+) Laropiprant) and Its Effects on Niacin-Induced Acute Flushing in Lipid Clinic Patients and/or Normal Healthy Subjects|Completed||Phase 2|575|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:03:25.886661|2017-10-11 05:03:25.886661
NCT00111904|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2011-12-13|||May 2005||2005-05-01|June 2009|2009-06-01||||August 2007|Actual|2007-08-01||Interventional|||Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer|Phase II Clinical Trial of Genexol -PM in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|43|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:03:25.960034|2017-10-11 05:03:25.960034
NCT00111917|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2016-05-03|2013-10-29||February 2005||2005-02-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|BISCIT||Beryllium Infliximab Study: Clinical Interventional Trial|Clinical Efficacy of Remicade in Chronic Beryllium Disease: A Randomized, Double-Blind, Placebo-Controlled, Investigator Initiated Trial|Terminated||Phase 1/Phase 2|13|Actual|Maier, Lisa, M.D.|Although our goal was 20 CBD subjects, only 11 subjects were enrolled, 8:3 in the infliximab:placebo treatment arms as the study was stopped by the sponsor due to slow recruitment.|2||Not enough patients meeting criteria to enroll in the time period|f||||t||||||||||2017-10-11 05:03:26.065289|2017-10-11 05:03:26.065289
NCT00111930|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2009-12-09|||August 2000||2000-08-01|February 2009|2009-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly|Biological Effects of DHEA in the Elderly|Completed||N/A|144||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:03:26.380729|2017-10-11 05:03:26.380729
NCT00111943|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2012-03-26||||||March 2012|2012-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety and Acceptability of a Vaginal Microbicide|Phase II Expanded Safety and Acceptability Study of the Vaginal Microbicide 1% Tenofovir Gel|Completed||Phase 2|200|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:03:26.551505|2017-10-11 05:03:26.551505
NCT00111956|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2017-10-04|||April 2004|Actual|2004-04-01|October 2017|2017-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome|Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome|Completed||Phase 2/Phase 3|56|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2||||||||t|f||||||||2017-10-11 05:03:26.721897|2017-10-11 05:03:26.721897
NCT00111969|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-26|2006-06-28|||June 2003||2003-06-01|June 2006|2006-06-01|November 2005||2005-11-01|||||Interventional|||ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy|A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Effects of the Celacade™ System on Mortality and Morbidity in Patients With Chronic Heart Failure|Completed||Phase 3|2016||Vasogen|||||||||||||||||||2017-10-11 05:03:26.847847|2017-10-11 05:03:26.847847
NCT00111982|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2010-02-25|||December 2003||2003-12-01|February 2010|2010-02-01|February 2006|Actual|2006-02-01|November 2005|Actual|2005-11-01||Interventional|||Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin|Multi-Center, Open-Label Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin (Protocol 20020168)|Completed||Phase 1/Phase 2|34|Actual|Amgen||1|||f||||||||||||||2017-10-11 05:03:26.916588|2017-10-11 05:03:26.916588
NCT00111995|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2008-08-07|||May 2002||2002-05-01|August 2008|2008-08-01||||||||Interventional|||Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis|A Randomized, Double-Blind Study Comparing Aranesp® (Darbepoetin Alfa) and Recombinant Human Erythropoietin (rHuEPO) in the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis|Completed||Phase 4|400||Amgen|||||||||||||||||||2017-10-11 05:03:27.003346|2017-10-11 05:03:27.003346
NCT00112008|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2009-07-09|||May 2004||2004-05-01|July 2009|2009-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis|A Multi-Center, Single-Arm Study Evaluating De Novo Once Every Two Week Darbepoetin Alfa Dosing in Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis|Completed||Phase 3|100|Anticipated|Amgen||1|||f||||||||||||||2017-10-11 05:03:27.090762|2017-10-11 05:03:27.090762
NCT00112021|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2015-04-09|||May 2005||2005-05-01|April 2015|2015-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects|A Phase 2B, Randomized, Double-Blinded, Placebo-Controlled, Dose Ranging, Multicenter Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects|Completed||Phase 2|400|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 05:03:27.19091|2017-10-11 05:03:27.19091
NCT00112034|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2008-05-05|||June 2003||2003-06-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|June 2006|Actual|2006-06-01||Interventional|||"AVONEX® Combination Trial - ACT"|A Multi-Center, Randomized, Blinded, Parallel-Group Study of AVONEX Compared With AVONEX in Combination With Oral Methotrexate, Intravenous Methylprednisolone, or Both in Subjects With Relapsing Remitting MS Who Have Breakthrough Disease on AVONEX Monotherapy.|Completed||Phase 4|350||Biogen|||||f||||||||||||||2017-10-11 05:03:27.339137|2017-10-11 05:03:27.339137
NCT00112047|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2010-10-11|2010-06-22||July 2003||2003-07-01|October 2010|2010-10-01|June 2009|Actual|2009-06-01|February 2005|Actual|2005-02-01||Interventional|||Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects|A Phase 3, Randomized, Multicenter Study of the Treatment of Antiretroviral-Naive HIV-1 Infected Subjects Comparing Tenofovir Disoproxil Fumarate and Emtricitabine in Combination With Efavirenz vs Combivir (Lamivudine/Zidovudine) and Efavirenz|Completed||Phase 3|517|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 05:03:27.514637|2017-10-11 05:03:27.514637
NCT00112060|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2014-03-27|||April 2008||2008-04-01|March 2014|2014-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase I/II, Open-Label, Multicenter Study of Single Agent PT-523 in the Treatment of Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 1/Phase 2|0|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||||||||||||2017-10-11 05:03:30.298407|2017-10-11 05:03:30.298407
NCT00112073|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2012-03-12||2012-03-12|April 2005||2005-04-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||AAB-001 in Patients With Mild to Moderate Alzheimer's Disease|A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD|Completed||Phase 2|234|Actual|JANSSEN Alzheimer Immunotherapy Research & Development, LLC||8|||f||||||||||||||2017-10-11 05:03:30.410608|2017-10-11 05:03:30.410608
NCT00112086|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2016-08-30|||January 2003||2003-01-01|August 2016|2016-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206|Feasibility Study of Neoadjuvant Chemotherapy Followed by Interval Cytoreductive Surgery for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: JCOG0206|Completed||Phase 2|56|Actual|Japan Clinical Oncology Group||1|||f||||t||||||||||2017-10-11 05:03:30.539655|2017-10-11 05:03:30.539655
NCT00112099|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2016-09-20|||June 2002||2002-06-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110|Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110|Completed||Phase 3|500|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:03:30.631357|2017-10-11 05:03:30.631357
NCT00112112|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2017-06-29|2012-02-27||August 1, 2005|Actual|2005-08-01|June 2017|2017-06-01|May 1, 2008|Actual|2008-05-01|March 1, 2008|Actual|2008-03-01||Interventional|||Safety Study to Evaluate FluMist in Immunocompromised Children|A Phase I Randomized, Double-Blind Trial of the Safety and Immunogenicity of FluMist® A Live, Intranasal Influenza Virus Vaccine vs. Placebo in Immunocompromised Children Ages 5 Through 17 Years of Age|Completed||Phase 1|20|Actual|MedImmune LLC||2|||f||||t|t|f||||||||2017-10-11 05:03:30.963821|2017-10-11 05:03:30.963821
NCT00112125|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2016-08-29|||February 2005||2005-02-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of the Safety and Effectiveness of the OPTIMIZER System in Subjects With Heart Failure: FIX-HF-5|Evaluation of the Safety and Efficacy of the OPTIMIZER System With Active Fixation Leads in Subjects With Heart Failure Resulting From Systolic Dysfunction: FIX-HF-5|Active, not recruiting||Phase 2/Phase 3|428|Actual|Impulse Dynamics||2|||f||||t||||||||||2017-10-11 05:03:32.553739|2017-10-11 05:03:32.553739
NCT00192907|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-16|||March 2003||2003-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Inflammation and Infection in Trauma, Role in Posttraumatic Complications||Unknown status|Active, not recruiting|N/A|380||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:50.652975|2017-10-11 05:30:50.652975
NCT00112138|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2011-05-20|||March 2004||2004-03-01|May 2011|2011-05-01|February 2006||2006-02-01|||||Interventional|||Gabapentin for the Treatment of Hot Flashes in Menopausal Women|Effectiveness and Safety of Gabapentin for the Treatment of Hot Flashes in Menopausal Women: A Randomized Controlled Trial|Completed||Phase 3|200||North Toronto Primary Care Research Network|||||f||||||||||||||2017-10-11 05:03:32.639659|2017-10-11 05:03:32.639659
NCT00112151|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2015-12-14|2015-11-04||January 2005||2005-01-01|November 2015|2015-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||TEAM: Testosterone Supplementation and Exercise in Elderly Men|Testosterone Supplementation and Exercise in Elderly Men|Completed||Phase 2|167|Actual|University of Colorado, Denver||6|||f||||t||||||||||2017-10-11 05:03:32.729032|2017-10-11 05:03:32.729032
NCT00112164|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-27|2014-03-11|||January 2005||2005-01-01|March 2014|2014-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Activated Protein C to Treat Acute Lung Injuries|Prospective, Randomized Phase II Clinical Trial of Activated Protein C (Xigris) Versus Placebo for the Treatment of Acute Lung Injury|Terminated||Phase 2|90|Anticipated|University of California, San Francisco||||Per recommendation of the NHLBI DSMB|f||||||||||||||2017-10-11 05:03:33.409868|2017-10-11 05:03:33.409868
NCT00112177|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-31|2017-02-06|||July 2004||2004-07-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal|A Multicentre, Randomized, Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Itopride HCl in Patients Suffering From Functional Dyspepsia|Completed||Phase 3|500||Forest Laboratories|||||f||||f||||||||||2017-10-11 05:03:33.49101|2017-10-11 05:03:33.49101
NCT00112190|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-31|2017-02-06|||July 2004||2004-07-01|February 2017|2017-02-01|March 2006|Actual|2006-03-01|March 2005|Actual|2005-03-01||Interventional|||Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal|A Multicentre, Randomized, Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Itopride HCl in Patients Suffering From Functional Dyspepsia|Completed||Phase 3|645|Actual|Forest Laboratories||2|||f||||t||||||||||2017-10-11 05:03:33.567507|2017-10-11 05:03:33.567507
NCT00112203|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-31|2017-02-06|||November 2004||2004-11-01|February 2017|2017-02-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia|A Multicentre, Open-Label Extension Phase to Study the Long-Term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia|Completed||Phase 3|466|Actual|Forest Laboratories|||||f||||f||||||||||2017-10-11 05:03:33.646702|2017-10-11 05:03:33.646702
NCT00112216|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-31|2013-04-23|||May 1999||1999-05-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Immunotherapy of Melanoma Patients|Specific Immunotherapy of Skin Melanoma Patients With Antigenic Peptides and Immunological Analysis of the Vaccine Site Sentinel Lymph Node|Completed||Phase 1|9|Actual|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||||2017-10-11 05:03:33.723418|2017-10-11 05:03:33.723418
NCT00112229|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-31|2013-04-19|||April 2003||2003-04-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|August 2011|Actual|2011-08-01||Interventional|||Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients|Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients With CpG7909, Tumor Antigenic Peptides and Montanide|Completed||Phase 1|29|Actual|Centre Hospitalier Universitaire Vaudois||4|||f||||||||||||||2017-10-11 05:03:33.865588|2017-10-11 05:03:33.865588
NCT00112242|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-31|2013-04-19|||February 2004||2004-02-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Immunotherapy of Stage III/IV Melanoma Patients|Vaccination of Patients With Stage III or IV Malignant Melanoma With Melanoma Antigen Peptides [Melan-A/Mart-1 Analog (ELA), NY-ESO-1b(A) Analog and MAGE-A10] and Montanide Adjuvant|Completed||Phase 1|38|Actual|Centre Hospitalier Universitaire Vaudois||5|||f||||f||||||||||2017-10-11 05:03:34.017841|2017-10-11 05:03:34.017841
NCT00112255|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-31|2006-05-09|||March 2001||2001-03-01|May 2005|2005-05-01|December 2002||2002-12-01|||||Interventional|||Partner Notification for Chlamydia in Primary Care|Partner Notification for Chlamydia in Primary Care: Randomised Controlled Trial and Economic Evaluation|Completed||Phase 3|214||University of Bristol|||||f||||||||||||||2017-10-11 05:03:34.139505|2017-10-11 05:03:34.139505
NCT00112268|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-01|2006-10-26|||June 2005||2005-06-01|October 2006|2006-10-01|July 2006||2006-07-01|||||Interventional|||Quitlink : A Leveraging Solution to Tobacco Counseling|Quitlink : A Leveraging Solution to Tobacco Counseling|Completed||Phase 3|3200||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:03:34.221776|2017-10-11 05:03:34.221776
NCT00112281|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-01|2006-08-02|||May 2005||2005-05-01|May 2005|2005-05-01|January 2007||2007-01-01|||||Interventional|||A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack|A Phase III International, Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition With Tilarginine Acetate Injection in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction, or the TRIUMPH Trial|Terminated||Phase 3|658||Arginox Pharmaceuticals|||||||||||||||||||2017-10-11 05:03:34.310451|2017-10-11 05:03:34.310451
NCT00112294|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-01|2015-11-24|2010-06-30||December 2004||2004-12-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|April 2007|Actual|2007-04-01||Interventional|||Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|A Randomized Multicenter Phase III Study of Taxane/Carboplatin/Cetuximab Versus Taxane/Carboplatin as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|755|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:03:34.657072|2017-10-11 05:03:34.657072
NCT00112307|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-01|2009-09-15|||March 2003||2003-03-01|September 2009|2009-09-01|October 2005||2005-10-01|||||Interventional|||Magnetic Resonance Imaging Guided Gynecologic Brachytherapy|Pilot Study of Magnetic Resonance Imaging Guided Brachytherapy|Completed||N/A|15||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 05:03:36.840597|2017-10-11 05:03:36.840597
NCT00112320|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-01|2012-12-03|||April 2004||2004-04-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Comparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of Fallot|Randomized Trial of Pulmonary Valve Replacement in Tetralogy of Fallot|Completed||N/A|68|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-10-11 05:03:36.932363|2017-10-11 05:03:36.932363
NCT00112333|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-01|2011-07-19|||October 2003||2003-10-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Defining Central Circuits of Pain|Defining Central Circuits of Visceral Pain|Completed||N/A|60|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 05:03:37.036485|2017-10-11 05:03:37.036485
NCT00112346|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-01|2015-10-26|||January 2005||2005-01-01|October 2015|2015-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|A Randomized Multicenter Phase II Study of Gemcitabine/Platinum/Cetuximab Versus Gemcitabine/Platinum as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|120||Eli Lilly and Company||2|||f||||||||||||||2017-10-11 05:03:37.10493|2017-10-11 05:03:37.10493
NCT00112359|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-01|2011-03-21|2010-09-10||May 2005||2005-05-01|March 2011|2011-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|AIR-CF1||International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa|A Phase 3, Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysinate for Inhalation in Cystic Fibrosis Patients With Pulmonary Pseudomonas Aeruginosa (AIR-CF1)|Completed||Phase 3|166|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 05:03:37.437295|2017-10-11 05:03:37.437295
NCT00112372|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2015-02-11|||May 2005||2005-05-01|February 2015|2015-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)|A Phase I/IIa, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability and Maximum Tolerated Dose of AP23573 When Administered Orally in Patients With Refractory or Advanced Malignancies|Completed||Phase 1|147|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 05:03:38.605603|2017-10-11 05:03:38.605603
NCT00112385|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2011-05-23|2011-04-25||March 2006||2006-03-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Pilot Study of Etanercept in Dermatomyositis|A Pilot Study of Etanercept in Dermatomyositis|Completed||Phase 1|16|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 05:03:38.76416|2017-10-11 05:03:38.76416
NCT00112398|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-03-10|||May 2005||2005-05-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Head Injury Retrieval Trial|Randomised, Controlled Trial of Physician Prehospital Management of Severe Blunt Head Injury|Terminated||N/A|338|Actual|CareFlight||2||"Inadequate recruitment rate combined with a high rate of patients dropping in to the treatment   group from standard care"|f||||t||||||||||2017-10-11 05:03:40.33182|2017-10-11 05:03:40.33182
NCT00112411|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2012-07-03|||June 2005||2005-06-01|December 2005|2005-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics|Dose-ranging Double-blind, Placebo-controlled Efficacy Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics|Completed||Phase 2|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 05:03:40.453477|2017-10-11 05:03:40.453477
NCT00112424|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2008-01-29|||January 2004||2004-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|June 2006|Actual|2006-06-01||Interventional|||Trial of Cardiac Magnetic Resonance Imaging (MRI) Versus Cardiac Catheterization Prior to Glenn Operation|Clinical Trial of Cardiac Magnetic Resonance Imaging in Routine Evaluation Prior to Superior Cavo-Pulmonary Anastomosis|Completed||N/A|80|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 05:03:40.539112|2017-10-11 05:03:40.539112
NCT00112437|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2016-03-03|2010-04-13||June 2005||2005-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of MK0822 in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 2|399|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-10-11 05:03:41.096322|2017-10-11 05:03:41.096322
NCT00112463|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2017-05-18|2017-04-04||January 7, 2005|Actual|2005-01-07|May 2017|2017-05-01|October 23, 2008|Actual|2008-10-23|October 23, 2008|Actual|2008-10-23||Interventional||All registered participants|Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma|A Phase II Study of Single Agent Depsipeptide (FK228) in Metastatic or Unresectable Soft Tissue Sarcomas|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||No||2017-10-11 05:03:54.466678|2017-10-11 05:03:54.466678
NCT00112476|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-05-01|||March 2005||2005-03-01|May 2013|2013-05-01||||July 2010|Actual|2010-07-01||Interventional|||Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors|A Phase I Study of Intravenous CCI-779 in Combination With Bryostatin-1 in Solid Tumors (10038414)|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:03:54.989037|2017-10-11 05:03:54.989037
NCT00112489|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2014-04-11|2014-04-11||May 2005||2005-05-01|April 2014|2014-04-01||||July 2010|Actual|2010-07-01||Interventional||Total eligible and treated participants|Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer|A Phase II Evaluation of Paclitaxel (Taxol, NSC # 673089) and Carboplatin (Paraplatin, NSC #241240) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma|Completed||Phase 2|55|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 05:03:55.120353|2017-10-11 05:03:55.120353
NCT00112502|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2014-09-23|||September 2005||2005-09-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme|A Randomized, Factorial-Design, Phase II Trial of Temozolomide Alone and in Combination With Possible Permutations of Thalidomide, Isotretinoin and/or Celecoxib as Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme|Completed||Phase 2|178|Actual|M.D. Anderson Cancer Center||8|||f||||f||||||||||2017-10-11 05:03:55.929142|2017-10-11 05:03:55.929142
NCT00112515|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2009-08-19|||February 2004||2004-02-01|May 2006|2006-05-01||||||||Interventional|||Modafinil in Treating Fatigue in Patients With Cancer|Pilot Study Evaluating the Safety and Efficacy of Modafinil in Improving Fatigue, Mood, Cognitive Ability, Functional Status, and Quality of Life of Cancer Patients|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:03:56.090391|2017-10-11 05:03:56.090391
NCT00112528|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2016-12-09|||June 2005||2005-06-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|August 2006|Actual|2006-08-01||Interventional|||Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer|Phase II Trial of Bevacizumab, Gemcitabine, Oxaliplatin in Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|53|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 05:03:56.204229|2017-10-11 05:03:56.204229
NCT00112554|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-11-05|||March 2005||2005-03-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia|A Phase III Randomized of Cloretazine™ (VNP40101M) and Cytosine Arabinoside (AraC) in Patients With Acute Myeloid Leukemia in First Relapse|Completed||Phase 3|420|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:03:56.826558|2017-10-11 05:03:56.826558
NCT00112567|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2010-09-17|||April 2003||2003-04-01|September 2010|2010-09-01|July 2007||2007-07-01|||||Interventional|||Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer|A Phase I/II Study of Total Body Irradiation, Thiotepa, and Fludarabine as Conditioning for Haploidentical CD34+ Purified Peripheral Blood Stem Cell Transplants|Completed||Phase 1/Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:03:57.196957|2017-10-11 05:03:57.196957
NCT00112580|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2015-09-23||2015-09-23|July 2005||2005-07-01|September 2015|2015-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery|Phase II Trial of Single Agent Ipilimumab (MDX-010 Anti CTLA-4) for Subjects With Locally Advanced or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|82|Anticipated|Bristol-Myers Squibb||1|||||||||||||||||2017-10-11 05:03:57.312452|2017-10-11 05:03:57.312452
NCT00112593|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2017-04-17|2017-04-17||November 1999||1999-11-01|April 2017|2017-04-01||||November 2014|Actual|2014-11-01||Interventional|||Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer|Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Completed||N/A|5|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 05:03:57.40886|2017-10-11 05:03:57.40886
NCT00112619|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2011-06-29|||August 2005||2005-08-01|June 2011|2011-06-01||||August 2010|Actual|2010-08-01||Interventional|||Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors|A Phase I Pharmacokinetic Optimal Dosing Study of Intraventricular Topotecan for Children With Neoplastic Meningitis|Terminated||Phase 1|19|Actual|Pediatric Brain Tumor Consortium||1||Slow accrual and company withdrawing support to supply the drug|f||||t||||||||||2017-10-11 05:03:57.735382|2017-10-11 05:03:57.735382
NCT00112632|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2012-03-07|||February 2005||2005-02-01|March 2012|2012-03-01||||||||Interventional|||Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor|Open-Label Trial of Neoadjuvant Imatinib Mesylate (Glivec) in Patients With Locally Advanced Malignant Gastrointestinal Stromal Tumors (GIST) Expressing c-Kit or Platelet-Derived Growth Factor Receptor-alpha|Completed||Phase 2|40|Anticipated|Technische Universität München|||||f||||||||||||||2017-10-11 05:03:58.006502|2017-10-11 05:03:58.006502
NCT00112645|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-07-17|||April 2005||2005-04-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|April 2010|Actual|2010-04-01||Interventional|||Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors|A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Pediatric Solid Tumors With Relapsed or Therapy Refractory Disease|Completed||Phase 1|10|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:03:58.101847|2017-10-11 05:03:58.101847
NCT00112658|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2011-05-19|||November 2004||2004-11-01|December 2006|2006-12-01||||||||Interventional|||Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer|Randomized Phase II/III Trial Comparing Folririnox Association [Oxaliplatin / Irinotecan / LV5FU2] Versus Gemcitabine in First Line of Chemotherapy in Metastatics Pancreas Cancers Patients|Unknown status|Active, not recruiting|Phase 2/Phase 3|348|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:03:58.205802|2017-10-11 05:03:58.205802
NCT00112671|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2015-08-04|2015-08-04||April 2005||2005-04-01|May 2013|2013-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||All participants|Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract|A Phase II Study of BAY 43-9006 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter and Renal Pelvis)|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:03:58.460523|2017-10-11 05:03:58.460523
NCT00112684|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2014-02-21|||February 2006||2006-02-01|November 2011|2011-11-01||||July 2012|Actual|2012-07-01||Interventional|||Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Pilot Study of Flavopiridol in Patients With Advanced Solid Tumors|Terminated||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:03:58.76777|2017-10-11 05:03:58.76777
NCT00112697|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2011-11-01|||December 2002||2002-12-01|December 2006|2006-12-01||||||||Interventional|||Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery|Randomized Phase II Trial Evaluating [Radiotherapy-Docetaxel-5 Fluorouracil] Association Versus [Radiotherapy-Docetaxel-Cisplatin] Association in Non Resecables First Line of Chemotherapy in Metastatics Pancreas Cancers Patients|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:03:58.888102|2017-10-11 05:03:58.888102
NCT00112710|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-08-23|||March 2005||2005-03-01|May 2007|2007-05-01||||||||Interventional|||Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A British Thoracic Oncology Group Phase III Trial of Gemcitabine Plus Cisplatin at 80mg/m Versus Gemcitabine Plus Carboplatin At 50 mg/m Versus Gemcitabine Plus Carboplatin AUC 6 in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 3|1350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:03:58.997699|2017-10-11 05:03:58.997699
NCT00112723|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2016-06-27|2015-03-23||December 2005||2005-12-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|February 2011|Actual|2011-02-01||Interventional|||Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma|A Phase I/II Study of Flavopiridol Administered as a 30-Minute Bolus Followed by a 4-Hour Infusion in Lymphomas and Multiple Myeloma|Terminated||Phase 1/Phase 2|46|Actual|National Cancer Institute (NCI)||1||Administratively Complete|f||||||||||||||2017-10-11 05:03:59.112366|2017-10-11 05:03:59.112366
NCT00112736|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2015-05-29|2015-04-28||April 2005||2005-04-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2010|Actual|2010-04-01||Interventional||"pts had to meet eligibility criteria and recieve at least one dose of treatment.
22 eligible pts enrolled in phase 1, but 1 pt declined before starting any treatment and was excluded from analysis - 12 pts were treated at MTD and thus included in the Phase 2 analysis, hence only 9 patients remained for analysis for phase 1"|Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma|Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|69|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 05:03:59.710383|2017-10-11 05:03:59.710383
NCT00112749|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2016-02-12|||February 2005||2005-02-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|January 2007|Actual|2007-01-01||Interventional|||Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer|Does Blocking Proinflammatory Cytokines Diminish Cancer-Related Fatigue?|Terminated||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center||1||"Recruitment stopped due to slow accrual and lack of evidence of need for further continuation   of protocol in inpatient setting."|f||||t||||||||||2017-10-11 05:04:00.295954|2017-10-11 05:04:00.295954
NCT00112775|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2011-06-04|||March 2005||2005-03-01|April 2006|2006-04-01||||||||Interventional|||BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate|A Randomized Multi-Center Open Label Study of BMS-354825 vs Imatinib Mesylate (Gleevec®) 800 mg/d in Subjects With Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Disease That is Resistant to Iamtinib at a Dose of 400-600 mg/d|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:00.438102|2017-10-11 05:04:00.438102
NCT00112827|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2017-05-17|||November 2004|Actual|2004-11-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma|Tandem High-Dose Therapy With Melphalan and Total Marrow Irradiation (TMI) With Peripheral Blood Progenitor Cell Support and Lenalidomide Maintenance in Multiple Myeloma: A Phase I/II Trial|Active, not recruiting||Phase 1/Phase 2|86|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-10-11 05:04:00.583897|2017-10-11 05:04:00.583897
NCT00112840|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2015-10-22|2014-01-06||May 2005||2005-05-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|August 2010|Actual|2010-08-01||Interventional|||CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Phase I/II Trial of CCI-779 and Bevacizumab in Stage IV Renal Cell Carcinoma|Completed||Phase 1/Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:04:00.759727|2017-10-11 05:04:00.759727
NCT00112853|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-01-08|||March 2005||2005-03-01|January 2013|2013-01-01||||May 2009|Actual|2009-05-01||Interventional|||Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase I Trial of Oral Etoposide in Combination With the Farnesyltransferase Inhibitor R115777 (ZARNESTRA, Tipifarnib, NSC #702818, IND #58,359) in Elderly Adults With Newly Diagnosed Acute Myelogenous Leukemia (AML)|Completed||Phase 1|100|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:04:02.306114|2017-10-11 05:04:02.306114
NCT00112866|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2017-05-16|2016-10-07||January 2005||2005-01-01|May 2017|2017-05-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional||26 patients evaluated for toxicity and efficacy. 1 patient deemed ineligible and 3 patients did not re-start treatment post surgery.|Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme|Phase II Trial of EMD 121974 for Recurrent Glioblastoma: A Clinical Trial With Tissue Correlates of Response|Terminated||Phase 2|30|Actual|National Cancer Institute (NCI)|Study closed early due to slow accrual. Molecular analyses evaluating alterations were planned for the study, unfortunately, majority of tumor samples were too small to do analysis and also there were unforeseen freezer issues.|2||due to poor accrual|f||||t||||||||No||2017-10-11 05:04:02.419678|2017-10-11 05:04:02.419678
NCT00112879|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma|Phase II Study of Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Patients With Previously Untreated High-Risk or Relapsed or Refractory Multiple Myeloma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:02.994716|2017-10-11 05:04:02.994716
NCT00112892|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2014-01-10|||August 2004||2004-08-01|January 2014|2014-01-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacokinetic Study of Selenomethionine With Fixed Dose Irinotecan in Advanced Solid Tumors|Completed||Phase 1|36|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-10-11 05:04:03.087314|2017-10-11 05:04:03.087314
NCT00112905|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2014-05-20|2010-12-30||October 2005||2005-10-01|December 2012|2012-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium|Phase II Trial of Sorafenib (BAY 43-9006) (IND 69896; NSC 724772) in Patients With Advanced Urothelial Cancer|Terminated||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:04:03.193732|2017-10-11 05:04:03.193732
NCT00112918|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-06-19|2012-06-01||December 2004||2004-12-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2010|Actual|2010-06-01||Interventional||Baseline Measures are based on the Intent-to-Treat - Stage III Disease Patient Population.|Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer|A Randomized, Three Arm Multinational Phase III Study to Investigate Bevacizumab (q3w or q2w) in Combination With Either Intermittent Capecitabine Plus Oxaliplatin (XELOX) (q3w) or Fluorouracil/Leucovorin With Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 Regimen Alone as Adjuvant Chemotherapy in Colon Carcinoma: The AVANT Study|Completed||Phase 3|3451|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-10-11 05:04:03.613351|2017-10-11 05:04:03.613351
NCT00112931|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2016-11-14|||September 2004||2004-09-01|November 2016|2016-11-01|May 2022|Anticipated|2022-05-01|March 2014|Actual|2014-03-01||Interventional|||Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma|An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy in Patients With Advanced Stage, Asymptomatic, Non-Bulky Follicular Lymphoma|Active, not recruiting||Phase 3|600|Anticipated|University College, London||2|||f||||t||||||||Undecided||2017-10-11 05:04:06.802197|2017-10-11 05:04:06.802197
NCT00112957|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-04-09|||July 2004||2004-07-01|April 2013|2013-04-01|May 2010|Actual|2010-05-01|January 2008|Actual|2008-01-01||Interventional|||Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|Phase II Study of Recombinant Vaccinia-NY-ESO-1 (rF-NY-ESO-1) and Recombinant Fowlpox-NY-ESO-1 (rF-NY-ESO-1) in Patients With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen|Completed||Phase 2|22|Actual|Ludwig Institute for Cancer Research||1|||f||||t||||||||||2017-10-11 05:04:06.994937|2017-10-11 05:04:06.994937
NCT00112983|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2013-05-29|||November 2004||2004-11-01|June 2005|2005-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria|TRIUMPH: A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:07.078118|2017-10-11 05:04:07.078118
NCT00112996|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2014-04-07|||January 2007||2007-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer|Prevention of Cisplatin- or Oxaliplatin-Induced Peripheral Neuropathy With Alpha-Lipoic Acid: A Placebo-Controlled Phase III Trial|Completed||Phase 3|244|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-10-11 05:04:07.148537|2017-10-11 05:04:07.148537
NCT00113009|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2007-11-21|||March 2005||2005-03-01|March 2006|2006-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease|A Phase II, Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease|Completed||Phase 2|148||Valentis|||||||||||||||||||2017-10-11 05:04:07.3819|2017-10-11 05:04:07.3819
NCT00113022|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-02|2012-07-09|2011-04-13||May 2005||2005-05-01|July 2012|2012-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Org 24448 to Treat Major Depression|An Investigation of the Antidepressant Efficacy and Safety of an AMPAkine (Org 24448) in Major Depressive Disorder, A Double-Blind, Placebo-Controlled, Randomized Study|Terminated||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||2||Terminated due to concerns about adverse events in separate study.|f||||t||||||||||2017-10-11 05:04:07.550791|2017-10-11 05:04:07.550791
NCT00113035|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2015-05-04|||May 2005||2005-05-01|May 2015|2015-05-01|October 2005|Actual|2005-10-01|||||Observational|||Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease|Screening Protocol to Evaluate Acid Alpha Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease for Potential Inclusion in Future Clinical Studies With Myozyme (Alglucosidase Alfa)|Completed||N/A|60||Sanofi|||1||||||||||||||||2017-10-11 05:04:07.905163|2017-10-11 05:04:07.905163
NCT00113048|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2014-02-04|||December 2003||2003-12-01|February 2014|2014-02-01|September 2005||2005-09-01|||||Interventional|||Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies|A Phase I Study of Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies|Terminated||Phase 1|24||Sanofi|||||||||||||||||||2017-10-11 05:04:07.974898|2017-10-11 05:04:07.974898
NCT00113061|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2016-07-28|||July 2004||2004-07-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults|INFLAME: Inflammation and Exercise|Completed||N/A|162||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:04:08.051297|2017-10-11 05:04:08.051297
NCT00113074|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2013-01-07|||September 2004||2004-09-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers|Blood Pressure Control in Hypertensive Smokers|Completed||N/A|376|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 05:04:08.115888|2017-10-11 05:04:08.115888
NCT00113087|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2010-09-16|2009-09-04||August 2003||2003-08-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|ISV||Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network|Trial of ACE Inhibition in Infants With Single Ventricle (A Trial Conducted by the Pediatric Heart Network)|Completed||Phase 3|230|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-10-11 05:04:08.369402|2017-10-11 05:04:08.369402
NCT00113100|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2015-05-20|||August 2004||2004-08-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Mechanisms of Skin Repair by Topical Estrogen|Mechanisms of Skin Repair by Topical Estrogen in Vivo|Completed||N/A|152|Actual|University of Michigan|||||f||||||||||||||2017-10-11 05:04:09.746949|2017-10-11 05:04:09.746949
NCT00113113|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2013-01-22|||August 2001||2001-08-01|June 2005|2005-06-01||||||||Interventional|||Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction|Phase I Study of Rubitecan (RFS 2000) in the Treatment of Cancer Patients With Organ Dysfunction|Completed||Phase 1|54|Anticipated|Astex Pharmaceuticals|||||f||||||||||||||2017-10-11 05:04:09.847042|2017-10-11 05:04:09.847042
NCT00113126|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2006-11-28|||January 2002||2002-01-01|June 2005|2005-06-01|October 2005||2005-10-01|||||Interventional|||Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection|A Randomized Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection|Completed||N/A|526||University Hospital, Geneva|||||f||||||||||||||2017-10-11 05:04:09.913995|2017-10-11 05:04:09.913995
NCT00113139|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2014-07-11|||September 2000||2000-09-01|March 2014|2014-03-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|INSPIRE||Investigational Study of Psychological Intervention in Recipients of Lung Transplant (INSPIRE)|An Investigation to Examine a Telephone Based Stress Management and Coping Skills Intervention for Patients Waiting for Lung Transplant|Completed||N/A|389|Actual|Duke University||2|||f||||t||||||||||2017-10-11 05:04:09.988065|2017-10-11 05:04:09.988065
NCT00113152|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-03|2017-06-30|||June 2, 2005||2005-06-02|October 2, 2007|2007-10-02|October 2, 2007||2007-10-02|||||Observational|||Heart Disease in Sickle Cell Anemia|Are Left Ventricular Abnormalities Associated With Pulmonary Hypertension in Sickle Cell Anemia?|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:04:10.075968|2017-10-11 05:04:10.075968
NCT00113321|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2012-08-01|2009-09-25||March 2005||2005-03-01|August 2012|2012-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure|Phase II Study of Low-Dose Decitabine (5-AZA-2'-Deoxycytidine) in Myelodysplastic Syndrome (MDS) Post Azacytidine (AZA) Failure|Terminated||Phase 2|16|Actual|M.D. Anderson Cancer Center||1||Low Accrual|f||||f||||||||||2017-10-11 05:04:18.063384|2017-10-11 05:04:18.063384
NCT00113178|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-06|2011-02-23|||January 2004||2004-01-01|February 2011|2011-02-01|June 2005|Actual|2005-06-01|||||Interventional|||Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter|Clinical Study to Evaluate the Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Cavo-Tricuspid Valve Isthmus-Dependent Atrial Flutter|Completed||Phase 3|160||Boston Scientific Corporation|||||||||||||||||||2017-10-11 05:04:10.944043|2017-10-11 05:04:10.944043
NCT00113191|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-06|2012-07-26||2012-07-26|May 2004||2004-05-01|July 2012|2012-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants|A Phase III, Randomized, Double-blind, Multi-center Clinical Trial Comparing the Safety and Efficacy of Veronate® Versus Placebo for the Prevention of Nosocomial Staphylococcal Sepsis in Premature Infants (Birth Weight 500 - 1250 g)|Completed||N/A|2000||Bristol-Myers Squibb|||||f||||t||||||||||2017-10-11 05:04:11.029057|2017-10-11 05:04:11.029057
NCT00113204|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-06|2008-05-15|||June 2005||2005-06-01|May 2008|2008-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|IPi-504-01||Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma|A Phase 1, Safety Assessment and Pharmacokinetic Study of IPI-504 in Patients With Relapsed, and Relapsed Refractory Multiple Myeloma|Completed||Phase 1|18|Actual|Infinity Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 05:04:11.349406|2017-10-11 05:04:11.349406
NCT00113217|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-06|2013-12-02|2013-09-04||February 2005||2005-02-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma|A Phase II Neoadjuvant Clinical Trial to Evaluate the Efficacy of Recombinant Humanized Monoclonal Anti-VEGF Antibody rhuMab VEGF (Bevacizumab) for Renal Cell Carcinoma|Completed||Phase 2|52|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 05:04:11.469024|2017-10-11 05:04:11.469024
NCT00113230|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-06|2012-07-31|2009-04-17||February 2005||2005-02-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer|Phase II Trial Of Neoadjuvant Concurrent Capecitabine, RHUMAB VEGF (Avastin) And Radiotherapy In Patients Presenting With Locally Advanced Rectal Cancer|Completed||Phase 2|25|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 05:04:11.869374|2017-10-11 05:04:11.869374
NCT00113243|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-06|2005-06-23|||December 2004||2004-12-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease|Phase I Study of Stem Cell Mediated Angiogenesis for Limb Threatening Ischemia|Unknown status|Recruiting|Phase 1|20||Murphy, Michael P., MD|||||||||||||||||||2017-10-11 05:04:12.121505|2017-10-11 05:04:12.121505
NCT00113256|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-06|2013-01-22|||February 2005||2005-02-01|October 2009|2009-10-01||||February 2006|Actual|2006-02-01||Interventional|||Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer|Randomized Trial of Orathecin and Gemcitabine Versus Placebo and Gemcitabine in Patients With Non-Resectable Pancreatic Cancer Who Have Not Already Received Chemotherapy|Terminated||Phase 2/Phase 3|39|Actual|Astex Pharmaceuticals||1|||f||||||||||||||2017-10-11 05:04:12.234986|2017-10-11 05:04:12.234986
NCT00113269|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2011-08-09|2011-06-07||May 2005||2005-05-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|INTAC||Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients|Phase 4, Randomized, Open-label, Comparative, Multicenter Study to Assess the Safety and Efficacy of Induction Agents, Alemtuzumab, Basiliximab or Rabbit Anti-thymocyte Globulin in Combination With Tacrolimus, MMF, and a Rapid Steroid Withdrawal in Renal Transplant Recipients|Completed||Phase 4|501|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|4|||f||||t||||||||||2017-10-11 05:04:12.399944|2017-10-11 05:04:12.399944
NCT00113282|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2011-12-21|||June 2004||2004-06-01|June 2009|2009-06-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)|Study of the Immunological Efficacy of Adding Subcutaneous Interleukin-2 (IL-2) to an Optimized Antiretroviral Regimen in HIV-1-infected Subjects Experiencing Therapeutic Failure on an Ongoing Antiretroviral Combination With a CD4 Cell Count ≤ 200/mm3 ANRS 123 Trial|Completed||Phase 2|57|Actual|French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-10-11 05:04:16.129917|2017-10-11 05:04:16.129917
NCT00113295|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2014-03-20|2013-05-16||February 2004||2004-02-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|February 2007|Actual|2007-02-01||Interventional||Eligible participants were men or women aged 18 and older with a primary diagnosis of DSM-IV GAD.|Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder|Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder|Completed||Phase 4|50|Actual|Massachusetts General Hospital|"Relatively small sample size of the randomized controlled phase (phase 2); conclusions from the study are limited to low power; improvement in Phase I open label paroxetine CR may include placebo response to ancillary aspects of a treatment study."|2|||f||||t||||||||||2017-10-11 05:04:16.219074|2017-10-11 05:04:16.219074
NCT00114491|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2006-10-30|||September 2003||2003-09-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Observational|||Rosuvastatin Affecting Aortic Valve Endothelium|Rosuvastatin Affecting Aortic Valve Endothelium - RAAVE|Completed||Phase 4|200||Hospital Pedro Hispano|||||f||||||||||||||2017-10-11 05:05:41.956192|2017-10-11 05:05:41.956192
NCT00113334|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2014-07-14|2009-04-24||April 2005||2005-04-01|July 2014|2014-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer|A Phase 1b/2 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer|Completed||Phase 1/Phase 2|6|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 05:04:18.294572|2017-10-11 05:04:18.294572
NCT00113347|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2012-02-23|||April 2005||2005-04-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)|Phase I Evaluation of Erlotinib and Docetaxel With Concomitant Boost Radiation for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 05:04:18.484173|2017-10-11 05:04:18.484173
NCT00113360|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2012-08-01|2009-08-12||January 2005||2005-01-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma|Phase II Study of RAD001 Plus Octreotide Depot in Patients With Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma (Carcinoid, Islet Cell)|Completed||Phase 2|67|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 05:04:18.583821|2017-10-11 05:04:18.583821
NCT00113373|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2015-05-28|2015-05-28||May 2005||2005-05-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional||Eligible and treated patients.|Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer|A Phase II Evaluation of Lapatinib (GW572016) (NCI-Supplied Agent, NSC #727989) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|28|Actual|National Cancer Institute (NCI)|The clinical trial was a two-stage design, accruing approximately 25 patients in each stage. Early termination of the study would result if warranted from an interim futility analysis. This study stopped early for lack of treatment efficacy.|1|||f||||||||||||||2017-10-11 05:04:18.915329|2017-10-11 05:04:18.915329
NCT00113386|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2013-06-21|2012-11-27||April 2005||2005-04-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer|Phase III Randomized Trial of Preoperative Chemotherapy Versus Preoperative Concurrent Chemotherapy and Thoracic Radiotherapy Followed by Surgical Resection and Consolidation Chemotherapy in Favorable Prognosis Patients With Stage IIIA (N2) Non-Small Cell Lung Cancer|Terminated||Phase 3|19|Actual|Radiation Therapy Oncology Group|This study terminated early with 19 out of 574 subjects accrued. Therefore no analysis was performed.|2||This study terminated early due to low accrual.|f||||t||||||||||2017-10-11 05:04:19.40788|2017-10-11 05:04:19.40788
NCT00113399|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2013-06-26|2012-11-27||April 2005||2005-04-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery|A Phase III Trial for Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-Irradiation and Chemotherapy Versus Chemotherapy Alone|Terminated||Phase 3|15|Actual|Radiation Therapy Oncology Group|This study terminated early with 15 subjects out of 240 subjects accrued, therefore no analysis was performed.|2||Terminated early due to low accrual.|f||||t||||||||||2017-10-11 05:04:20.288223|2017-10-11 05:04:20.288223
NCT00113412|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2006-03-21|||May 2005||2005-05-01|March 2006|2006-03-01||||||||Interventional|||A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study Of Orally Administered SP01A As Monotherapy Treatment Of HIV-Infected Patients|Unknown status|Active, not recruiting|Phase 2|32||Samaritan Pharmaceuticals, Inc|||||||||||||||||||2017-10-11 05:04:21.253676|2017-10-11 05:04:21.253676
NCT00103571|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-10|2007-11-05|||July 2004||2004-07-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|||||Interventional|||Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia|Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia|Completed||Phase 4|600||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:04:21.341874|2017-10-11 05:04:21.341874
NCT00103584|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-10|2007-01-11|||October 2004||2004-10-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers|A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LC16m8, A Modified Vaccinia Vaccine, in Healthy Volunteers|Unknown status|Active, not recruiting|Phase 1/Phase 2|150||VaxGen|||||||||||||||||||2017-10-11 05:04:21.442596|2017-10-11 05:04:21.442596
NCT00103597|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-11|2005-10-19|||January 2005||2005-01-01|July 2005|2005-07-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy|Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy|Completed||Phase 1|50||Royal Brisbane and Women's Hospital|||||f||||||||||||||2017-10-11 05:04:21.508576|2017-10-11 05:04:21.508576
NCT00103610|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-11|2014-02-10|2009-02-06||January 2005||2005-01-01|February 2014|2014-02-01|December 2007|Actual|2007-12-01|July 2006|Actual|2006-07-01||Interventional|||Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 Plus G-CSF Versus G-CSF Plus Placebo to Mobilize and Collect ≥ 5 * 10^6 CD34+ Cells/kg in Non-Hodgkin's Lymphoma Patients for Autologous Transplantation|Completed||Phase 3|298|Actual|Sanofi||2|||||||||||||||||2017-10-11 05:04:21.688937|2017-10-11 05:04:21.688937
NCT00103623|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-11|2006-09-18|||June 2004||2004-06-01|September 2006|2006-09-01|December 2008||2008-12-01|||||Interventional|||The Plenaxis® Experience Study|Incidence of Immediate Onset Systemic Allergic Reactions in Patients Treated With Plenaxis®|Suspended||Phase 4|2000||PRAECIS Pharmaceuticals Inc.|||||||||||||||||||2017-10-11 05:04:23.871703|2017-10-11 05:04:23.871703
NCT00103636|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-11|2005-06-23|||March 2004||2004-03-01|February 2005|2005-02-01|December 2004||2004-12-01|||||Interventional|||Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change|Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change|Unknown status|Active, not recruiting|Phase 2/Phase 3|200||Royal Brisbane and Women's Hospital|||||f||||||||||||||2017-10-11 05:04:24.09857|2017-10-11 05:04:24.09857
NCT00103649|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-11|2008-08-20|||November 2003||2003-11-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type|Completed||Phase 3|1306|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:04:24.202523|2017-10-11 05:04:24.202523
NCT00103662|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-11|2014-02-10|2009-02-02||January 2005||2005-01-01|February 2014|2014-02-01|January 2008|Actual|2008-01-01|October 2006|Actual|2006-10-01||Interventional|||Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 Plus G-CSF Versus G-CSF Plus Placebo to Mobilize and Collect ≥ 6*10^6 CD34+ Cells/kg in Multiple Myeloma Patients for Autologous Transplantation|Completed||Phase 3|302|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 05:04:24.772642|2017-10-11 05:04:24.772642
NCT00103675|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-11|2007-02-26|||September 2004||2004-09-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Sensor Measurement of Acupuncture Needle Manipulation|Acupuncture Needling Torque Sensor|Completed||Phase 1|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:04:26.305894|2017-10-11 05:04:26.305894
NCT00103701|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2011-04-13|||November 2003||2003-11-01|April 2011|2011-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia|Phase I Study of BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia|Completed||Phase 1|||Bristol-Myers Squibb||1|||f||||||||||||||2017-10-11 05:04:26.378999|2017-10-11 05:04:26.378999
NCT00103714|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2015-10-19|||January 2005||2005-01-01|October 2015|2015-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Patients With Cystic Fibrosis Lung Disease|Completed||Phase 2|72|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:04:26.484261|2017-10-11 05:04:26.484261
NCT00103727|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2015-04-27|||December 2004||2004-12-01|April 2015|2015-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia|A Multicenter, Double-Blind, Double-Dummy, Placebo-Controlled, Randomized, Parallel Group Evaluation of the Efficacy and Safety of a Fixed-Dose of Talnetant Versus Placebo Versus Risperidone in Subjects With Schizophrenia|Completed||Phase 2|282|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-10-11 05:04:26.562369|2017-10-11 05:04:26.562369
NCT00103740|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2012-05-29|2012-04-05||April 2002||2002-04-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|December 2003|Actual|2003-12-01||Interventional|||Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period|Randomized, Double-Blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget's Disease of Bone Using Risedronate as a Comparator, Including an Extended Observation Period|Completed||Phase 3|185|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:04:26.722754|2017-10-11 05:04:26.722754
NCT00103753|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2005-06-23|||May 2004||2004-05-01|February 2005|2005-02-01|June 2005||2005-06-01|||||Interventional|||Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major|A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance|Unknown status|Active, not recruiting|Phase 4|65||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:04:28.136831|2017-10-11 05:04:28.136831
NCT00103766|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2006-07-31|||October 2004||2004-10-01|July 2006|2006-07-01||||||||Interventional|||Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion|Randomized Comparison of Two Dose and Frequency Regimens of Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion|Unknown status|Recruiting|N/A|75||O'Brien, Jeana D., MD, FACP, FCCP|||||||||||||||||||2017-10-11 05:04:28.253093|2017-10-11 05:04:28.253093
NCT00103779|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2014-12-17|||December 2004||2004-12-01|December 2014|2014-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma|A Phase I, Multi-Dose Study of SGN-40 (Anti-huCD40 mAb) in Patients With Non-Hodgkin's Lymphoma|Completed||Phase 1|50|Actual|Seattle Genetics, Inc.||1|||t||||f||||||||||2017-10-11 05:04:28.391005|2017-10-11 05:04:28.391005
NCT00103792|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2009-02-12|||December 2004||2004-12-01|February 2009|2009-02-01|January 2012|Anticipated|2012-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)|Comparative Study of the Efficacy of Induction Therapy With Cyclophosphamide or Mycophenolate Mofetil for Non-Life-Threatening Relapses of PR3- or MPO-ANCA Associated Vasculitis|Unknown status|Recruiting|Phase 3|90|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 05:04:28.552051|2017-10-11 05:04:28.552051
NCT00103805|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-14|2014-05-20|||March 2003||2003-03-01|May 2014|2014-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Improved Language Acquisition With Levodopa|Improved Language Acquisition With Levodopa|Completed||Phase 4|20||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:04:28.71722|2017-10-11 05:04:28.71722
NCT00103818|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-15|2015-01-13|||February 2005||2005-02-01|January 2015|2015-01-01|October 2006|Actual|2006-10-01|||||Interventional|||An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Efficacy Study of MK0928 15 mg and 10 mg in the Treatment of Adult Outpatients With Primary Insomnia|Completed||Phase 3|900|Actual|H. Lundbeck A/S|||||f||||||||||||||2017-10-11 05:04:28.835172|2017-10-11 05:04:28.835172
NCT00103831|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-15|2010-02-27||2010-02-27||||August 2008|2008-08-01||||May 2005|Actual|2005-05-01||Interventional|||Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer|Phase I Alimta Combination With BMS-275183 (Oral Taxane)|Completed||Phase 1/Phase 2|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 05:04:28.935536|2017-10-11 05:04:28.935536
NCT00103844|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-15|2010-08-03|2009-12-02||February 2005||2005-02-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|August 2006|Actual|2006-08-01||Interventional|||Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia|A Randomized Multi-Center Open Label Study of BMS-354825 vs. Imatinib Mesylate (Gleevec) 800 mg/d in Subjects With Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Disease That is Resistant to Imatinib at a Dose at 400 - 600 mg/d|Completed||Phase 2|150|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 05:04:29.137835|2017-10-11 05:04:29.137835
NCT00104273|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2009-07-14|||August 2004||2004-08-01|April 2008|2008-04-01||||March 2007|Actual|2007-03-01||Interventional|||Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)|A 1-Year, Double-Blind, Randomized, Placebo-Controlled, Study of Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Dementia of the Alzheimer's Type|Completed||Phase 2|376|Actual|Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 05:04:41.389264|2017-10-11 05:04:41.389264
NCT00103857|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-15|2017-03-31|2009-02-19||March 17, 2005|Actual|2005-03-17|March 2017|2017-03-01|February 21, 2008|Actual|2008-02-21|July 25, 2006|Actual|2006-07-25||Interventional|||MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)|A Multicenter, Randomized, Double-Blind Factorial Study of the Co-Administration of MK0431 and Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 3|1208|Actual|Merck Sharp & Dohme Corp.|Non-serious adverse experience results represent those events included in the primary safety analysis for this study (i.e., events that occurred prior to the initiation of glycemic rescue therapy).|7|||f||||f||||||||||2017-10-11 05:04:31.136868|2017-10-11 05:04:31.136868
NCT00103870|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-15|2009-12-08|||February 2005||2005-02-01|December 2009|2009-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Mind Engagement With Music for Nondrug Pain Relief|Music Engagement for Non-Pharmacological Analgesia R21 AT001586-01|Completed||Phase 1|120|Anticipated|University of Utah|||||f||||||||||||||2017-10-11 05:04:34.468591|2017-10-11 05:04:34.468591
NCT00103883|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-15|2017-02-27|||February 2003||2003-02-01|February 2016|2016-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||A Novel Method to Determine HIV Incidence Among Youth|A Novel Method to Determine HIV Incidence Among Youth|Completed||N/A|440|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||Samples Without DNA|"     Phenotypic and genotypic testing for antiretroviral drug (ART) resistance will be done on     stored samples from all subjects who are identified as recently infected by the serum based     DV S/LS reference method. An assay for viral replication fitness will also be done on these     same samples. This testing will provide a recent assessment of prevalence of transmitted ART     resistant HIV-1 in this population.   "|||2017-10-11 05:04:34.561771|2017-10-11 05:04:34.561771
NCT00103896|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-15|2017-02-27|||September 2003||2003-09-01|July 2016|2016-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Connect to Protect Partnerships for Youth Prevention Interventions: Phase II|Connect to Protect (C2P) Partnerships for Youth Prevention Interventions: Phase II|Completed||N/A|16706|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||||||2017-10-11 05:04:34.663507|2017-10-11 05:04:34.663507
NCT00103935|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-17|2015-02-23|||February 2005||2005-02-01|January 2015|2015-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine Safety and Pharmacokinetics of Exenatide Long-Acting Release Administered Weekly in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|45|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 05:04:35.357183|2017-10-11 05:04:35.357183
NCT00103948|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-17|2015-11-02|||February 2005||2005-02-01|November 2015|2015-11-01|February 2007|Actual|2007-02-01|October 2006|Actual|2006-10-01||Interventional|||The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment|An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment|Completed||Phase 2|165|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 05:04:35.492207|2017-10-11 05:04:35.492207
NCT00103961|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-17|2008-09-25|||January 2004||2004-01-01|September 2008|2008-09-01|December 2014|Anticipated|2014-12-01|October 2007|Actual|2007-10-01||Observational|||An Observational Study of People Who Have Recently Been Infected With HIV|Primary HIV & Early Disease Research: American Cohort (PHAEDRA) AIEDRP|Unknown status|Active, not recruiting|N/A|500|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"     Blood collection   "|||2017-10-11 05:04:35.568417|2017-10-11 05:04:35.568417
NCT00103974|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-17|2008-04-04|||July 2004||2004-07-01|February 2008|2008-02-01|March 2007||2007-03-01|||||Interventional|||Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis|A Phase I Trial of Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis|Completed||Phase 1|30||Bayhill Therapeutics|||||||||||||||||||2017-10-11 05:04:35.670135|2017-10-11 05:04:35.670135
NCT00103987|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-17|2017-06-30|||February 14, 2005||2005-02-14|November 12, 2010|2010-11-12|November 12, 2010||2010-11-12|||||Observational|||Neurobiological Mechanisms in Panic Disorder|Neurobiological Mechanisms in Panic Disorder: Behavioral, Genetic, & Neural Correlates of Noradrenergic Function|Completed||N/A|54|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:04:35.75369|2017-10-11 05:04:35.75369
NCT00104000|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-17|2008-03-03|||February 2005||2005-02-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Effect of Surface Electrical Stimulation on Movement of the Larynx|The Effect of Surface Electrical Stimulation on Hyo-Laryngeal Movement in Healthy Individuals at Rest and During Swallow|Completed||N/A|47||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:04:35.815119|2017-10-11 05:04:35.815119
NCT00104013|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-18|2008-08-20|||November 2003||2003-11-01|August 2008|2008-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type|Completed||Phase 3|1455|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:04:35.983526|2017-10-11 05:04:35.983526
NCT00104026|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-18|2017-06-30|||February 15, 2005||2005-02-15|April 19, 2011|2011-04-19|April 19, 2011||2011-04-19|||||Observational|||Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth|Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth|Completed||N/A|45|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:04:36.15392|2017-10-11 05:04:36.15392
NCT00104039|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-19|2017-10-05|||February 17, 2005||2005-02-17|July 21, 2016|2016-07-21|July 21, 2016||2016-07-21|||||Observational|||Brain Changes in Children and Adolescents With Behavioral Problems|Investigating the Neuro-Cognitive Underpinnings of the Emotional Dysfunction Linked to Childhood Behavioral Disturbance|Completed||N/A|318|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:04:36.250948|2017-10-11 05:04:36.250948
NCT00104052|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-22|2017-03-07|2008-11-14||February 2005||2005-02-01|March 2017|2017-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)|Assessment of the Safety, Efficacy, Tolerability and Pharmacokinetics of PEG-Intron® Plus REBETOL® in Pediatric Patients With Chronic Hepatitis C|Completed||Phase 3|107|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:04:36.338843|2017-10-11 05:04:36.338843
NCT00104065|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-22|2016-03-14|||January 2005||2005-01-01|February 2016|2016-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of CG53135-05 Administered Intravenously as a Single Dose for the Prevention of Oral Mucositis in Patients Receiving Autologous Hematopoietic Stem Cell Transplant|Completed||Phase 2|||Celldex Therapeutics|||||f||||||||||||||2017-10-11 05:04:36.628145|2017-10-11 05:04:36.628145
NCT00104078|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-22|2007-12-19|||February 2005||2005-02-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Evaluating MYO-029 in Adult Muscular Dystrophy||Completed||Phase 1/Phase 2|108||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:04:36.734331|2017-10-11 05:04:36.734331
NCT00104091|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-22|2011-05-20|||December 2004||2004-12-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors|A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection|Completed||Phase 2|56|Anticipated|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 05:04:36.831818|2017-10-11 05:04:36.831818
NCT00104104|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-22|2011-06-27|2011-01-06||October 2004||2004-10-01|June 2011|2011-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Multiple Myeloma Trial in Patients With Bone Metastases|A Multicenter,Open Label, Randomized Trial Evaluating the Duration of Infusion of Zoledronic Acid 4 mg IV in Multiple Myeloma Patients With Bone Metastases|Completed||Phase 4|179|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:04:36.950548|2017-10-11 05:04:36.950548
NCT00104117|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-23|2010-02-18|||November 2004||2004-11-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Study of XL999 in Adults With Solid Tumors|A Phase 1 Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL999 Administered Intravenously to Subjects With Solid Tumors|Completed||Phase 1|52|Actual|Symphony Evolution, Inc.||1|||f||||t||||||||||2017-10-11 05:04:38.969484|2017-10-11 05:04:38.969484
NCT00104130|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-23|2008-09-16|||December 2004||2004-12-01|September 2008|2008-09-01|February 2005||2005-02-01|||||Interventional|||Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer|A Phase 2 Study of KOS-862 Administered Intravenously Weekly for 3 Weeks Every 4 Weeks, in Patients With Hormone Resistant Prostate Cancer Who Have Progressed Following Initial Therapy for Metastatic Disease|Terminated||Phase 2|53||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:04:39.087537|2017-10-11 05:04:39.087537
NCT00104143|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-23|2016-08-23|||October 2007||2007-10-01|August 2016|2016-08-01||||||||Interventional|||A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.|A Randomized, Double-blind, Placebo Controlled Dose-ranging Study to Determine the Effect on MRI Lesions and Safety of A4I Antagonist in Relapsing Multiple Sclerosis.|Withdrawn||Phase 2|0|Actual|Hoffmann-La Roche|||||f||||||||||||||2017-10-11 05:04:39.225583|2017-10-11 05:04:39.225583
NCT00104156|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-23|2008-01-23|||January 2005||2005-01-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Qigong Therapy for Individuals With Knee Osteoarthritis|Qigong Therapy for Osteoarthritis at Knees|Completed||Phase 2|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:04:39.39684|2017-10-11 05:04:39.39684
NCT00104169|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-23|2008-08-28|||August 2004||2004-08-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Idiopathic Anemia of Aging (IAA)|Pilot Study of Epoetin Alfa in Idiopathic Anemia of Aging (IAA)|Terminated||Phase 2|0|Actual|National Institute on Aging (NIA)||||No subject accrual|f||||||||||||||2017-10-11 05:04:39.517589|2017-10-11 05:04:39.517589
NCT00104182|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-23|2017-01-27|||February 2005||2005-02-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes|Efficacy and Safety Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening as Add-on to Oral Antidiabetic Drug(s) in Patients With Type 2 Diabetes|Completed||Phase 3|503|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:04:39.629368|2017-10-11 05:04:39.629368
NCT00104195|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-23|2014-04-15|||February 2004||2004-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions|Decision-Making Processes and Brain Function in Anxiety-Disordered and Non-Anxious Youth|Completed||Phase 1|127|Actual|New York University School of Medicine|||1||f||||f||||||||||2017-10-11 05:04:39.922898|2017-10-11 05:04:39.922898
NCT00104234|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2010-01-26|2009-02-04||February 2004||2004-02-01|January 2010|2010-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of rhASB in Patients With Mucopolysaccharidosis VI|A Multicenter, Multinational Open-Label Extension Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With Mucopolysaccharidosis VI|Completed||Phase 3|39|Actual|BioMarin Pharmaceutical||2|||||||||||||||||2017-10-11 05:04:40.006766|2017-10-11 05:04:40.006766
NCT00104247|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2014-07-15|2009-01-29||March 2005||2005-03-01|July 2014|2014-07-01|February 2006|Actual|2006-02-01|||||Interventional|||Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels|Completed||Phase 3|89|Actual|BioMarin Pharmaceutical|||||||||||||||||||2017-10-11 05:04:40.875075|2017-10-11 05:04:40.875075
NCT00104260|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2007-04-05|||December 2004||2004-12-01|April 2007|2007-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria|A Phase 2, Multicenter, Open-Label Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels|Completed||Phase 2|700||BioMarin Pharmaceutical|||||||||||||||||||2017-10-11 05:04:41.279017|2017-10-11 05:04:41.279017
NCT00104286|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2006-11-01|||January 2003||2003-01-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors|An Open-Label, Single-Arm, Phase I Study of Troxatyl™ (Troxacitabine) Administered by Continuous Infusion in Subjects With an Advanced Solid Malignancy|Terminated||Phase 1/Phase 2|50||SGX Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 05:04:41.690104|2017-10-11 05:04:41.690104
NCT00104299|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2017-03-23|2011-02-02||January 2005||2005-01-01|March 2017|2017-03-01|January 2010|Actual|2010-01-01|December 2008|Actual|2008-12-01||Interventional|RAVE||Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis|Rituximab Therapy for the Induction of Remission and Tolerance in ANCA-Associated Vasculitis (ITN021AI)|Completed||Phase 2/Phase 3|197|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in: 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal.|2017-10-11 05:04:41.794322|2017-10-11 05:04:41.794322
NCT00104312|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2009-05-28|||April 2001||2001-04-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Osteoarthritis: Weakness From Inflammation|Weakness From Inflammation: A Basis of Disability From Knee Osteoarthritis|Completed||N/A|88|Anticipated|National Institute on Aging (NIA)|||2||f||||||||||Samples Without DNA|"     Synovial fluid and tissue blood serum muscle biopsy   "|||2017-10-11 05:04:43.377416|2017-10-11 05:04:43.377416
NCT00104325|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2017-06-30|||January 31, 2003||2003-01-31|April 13, 2017|2017-04-13||||||||Observational|||Cytapheresis of Volunteer Donors|Cytapheresis of Volunteer Donors|Recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:04:43.457331|2017-10-11 05:04:43.457331
NCT00104338|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-24|2012-06-06|||January 2005||2005-01-01|June 2012|2012-06-01|August 2006|Actual|2006-08-01|||||Interventional|||Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy|A Phase 2, Proof of Concept, Randomized, Open-label, Two-arm, Parallel Group, Multi-center Study to Assess the Efficacy and Safety of FK778 Compared With Standard Care in Renal Transplant Recipients With Untreated BK Nephropathy|Terminated||Phase 2|45||Astellas Pharma Inc|||||||||||||||||||2017-10-11 05:04:43.548542|2017-10-11 05:04:43.548542
NCT00104364|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-25|2015-01-29|||May 2005||2005-05-01|January 2015|2015-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)|An Open-label, Dose Escalation Phase I/II Trial of a KSP Inhibitor Given as a Constant 24-Hour Infusion in Patients With Advanced Solid Tumors|Completed||Phase 1|30|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:04:43.715974|2017-10-11 05:04:43.715974
NCT00104377|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-28|2010-06-16|||March 2005||2005-03-01|September 2009|2009-09-01|November 2005||2005-11-01|||||Interventional|||Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen|A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen|Completed||Phase 2|70||Allergy Therapeutics|||||||||||||||||||2017-10-11 05:04:43.820876|2017-10-11 05:04:43.820876
NCT00104390|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-28|2010-06-09|||March 2005||2005-03-01|June 2010|2010-06-01|April 2005||2005-04-01|||||Interventional|||Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing|A Single-blind Phase 1 Study to Assess the Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing|Completed||Phase 1|14||Allergy Therapeutics|||||||||||||||||||2017-10-11 05:04:43.937162|2017-10-11 05:04:43.937162
NCT00104416|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-28|2016-11-15|2010-04-16||December 2004||2004-12-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures|A Multicenter, Double-blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Patients With Primary Generalized Tonic-Clonic Seizures|Completed||Phase 3|153|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:04:44.751173|2017-10-11 05:04:44.751173
NCT00104429|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-28|2017-05-25|||January 2005||2005-01-01|May 2017|2017-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||GW873140 In Combination With Combivir In HIV Infected Subjects|A PhaseIIb, 96 Week, Randomised, Partially Double-blinded, Multicentre, Parallel Group, Repeat Dose Study to Evaluate the Safety, Tolerability, PK and Antiviral Effect of GW873140 in Combination With COMBIVIR (Lamivudine and Zidovudine) Upon Selected Immunological and Virological Markers of HIV-1 Infection in Antiretroviral Therapy Naive Adults|Terminated||Phase 2|125||ViiV Healthcare|||||f||||||||||||||2017-10-11 05:04:47.036881|2017-10-11 05:04:47.036881
NCT00104442|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-28|2007-12-17|||October 2003||2003-10-01|December 2007|2007-12-01|April 2006|Actual|2006-04-01|||||Interventional|||Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease|Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease|Completed||Phase 4|80||Novartis|||||||||||||||||||2017-10-11 05:04:47.261063|2017-10-11 05:04:47.261063
NCT00104455|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-28|2017-01-11|||June 2004||2004-06-01|January 2017|2017-01-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Dose Response to Recombinant Factor VIIa When Administered for Bleed|Recombinant Activated Factor VII (rFVIIa/NovoSeven) Dose Response Trial in Healthy Volunteers: A Double-Blind, Placebo-Controlled, Cross-over, Dose-Escalation Trial to Investigate the Dose Response to REcombinant Factor VIIa When Administered for Bleeding Following Punch Biopsies in Healthy Volunteers|Completed||Phase 1|64|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:04:47.333147|2017-10-11 05:04:47.333147
NCT00104663|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2015-04-06|||June 2004||2004-06-01|April 2015|2015-04-01|March 2007||2007-03-01|||||Interventional|||PRION-1: Quinacrine for Human Prion Disease|PRION-1: Quinacrine for Human Prion Disease. A Partially Randomized Patient Preference Trial to Evaluate the Activity and Safety of Quinacrine in Human Prion Disease|Completed||N/A|160||Medical Research Council|||||f||||||||||||||2017-10-11 05:04:52.442956|2017-10-11 05:04:52.442956
NCT00104468|ClinicalTrials.gov processed this data on October 10, 2017|2005-02-28|2008-01-14|||April 2003||2003-04-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)|An Open-Label, Single-Arm, Multi-Center, Phase I Study of Troxatyl™ (Troxacitabine) Administered by Continuous Infusion in Subjects With Refractory Acute Myelogenous Leukemia|Terminated||Phase 1/Phase 2|50||SGX Pharmaceuticals, Inc.||||Trial stopped June 2007|||||||||||||||2017-10-11 05:04:47.420575|2017-10-11 05:04:47.420575
NCT00104481|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2011-12-07|||January 2005||2005-01-01|March 2007|2007-03-01|August 2007||2007-08-01|||||Interventional|||Group Counseling for Smoking Cessation|Cognitive Behavior Therapy for Smoking Cessation|Completed||Phase 1/Phase 2|240||American University|||||f||||||||||||||2017-10-11 05:04:47.504836|2017-10-11 05:04:47.504836
NCT00104494|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2015-07-29|||May 2004||2004-05-01|March 2005|2005-03-01|September 2007|Actual|2007-09-01|||||Interventional|||Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)|Zinc Homeostasis and Kinetics in Children With CF|Completed||N/A|30|Actual|Cystic Fibrosis Foundation Therapeutics||3|||f||||t||||||||||2017-10-11 05:04:47.584413|2017-10-11 05:04:47.584413
NCT00104507|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2010-02-01|||December 2004||2004-12-01|December 2006|2006-12-01|May 2005||2005-05-01|||||Interventional|||Safety and Efficacy of APD356 in the Treatment of Obesity|A 4-Week, Dose-ranging, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of APD356 in Obese Patients|Completed||Phase 2|400||Arena Pharmaceuticals|||||||||||||||||||2017-10-11 05:04:47.687008|2017-10-11 05:04:47.687008
NCT00104520|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2011-02-16|2010-09-10||February 2005||2005-02-01|September 2010|2010-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|AIR-CF2||Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa|A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial With Aztreonam Lysinate for Inhalation in Cystic Fibrosis Patients With Pulmonary P. Aeruginosa Requiring Frequent Antibiotics (AIR-CF2)|Completed||Phase 3|211|Actual|Gilead Sciences|The study was designed such that participants were discontinued from study participation upon meeting the primary endpoint (time to need for inhaled or IV antipseudomonal antibiotics).|2|||f||||t||||||||||2017-10-11 05:04:47.794776|2017-10-11 05:04:47.794776
NCT00104533|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2008-03-19|||September 2004||2004-09-01|March 2005|2005-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Effectiveness of Magnetic Therapy on Pain Intensity|Effectiveness of Magnetic Therapy on Pain Intensity|Completed||Phase 3|164||Javeriana University|||||f||||||||||||||2017-10-11 05:04:48.612191|2017-10-11 05:04:48.612191
NCT00104546|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2008-01-23|||September 2004||2004-09-01|January 2008|2008-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Vitamin K Injections for the Treatment of Painful Menstruation|Vitamin K Injection Treatment for Primary Dysmenorrhea: A Controlled Pilot Study|Completed||Phase 1|36||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:04:48.875321|2017-10-11 05:04:48.875321
NCT00104559|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2008-09-25|||January 2005||2005-01-01|September 2008|2008-09-01|March 2009|Anticipated|2009-03-01|July 2007|Anticipated|2007-07-01||Interventional|||Computer-Generated Vs. Standard Informed Consent for HIV Research Studies|Interactive Multimedia Informed Consent (iMIC) for HIV Research|Unknown status|Active, not recruiting|N/A|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 05:04:48.98084|2017-10-11 05:04:48.98084
NCT00104572|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2016-03-11|2015-05-04||March 2004||2004-03-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.|The Effects of Aromatase Inhibition and Testosterone Replacement in Sex Steroids, Pituitary Hormones, Markers of Bone Turnover, Muscle Strength, and Cognition in Older Men|Completed||Phase 2|44|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-10-11 05:04:49.086143|2017-10-11 05:04:49.086143
NCT00104585|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2012-01-18|||July 2004||2004-07-01|January 2012|2012-01-01||||September 2012|Anticipated|2012-09-01||Observational|||Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)|Genetic Epidemiology of Parkinson's Disease|Unknown status|Recruiting|N/A|800|Anticipated|Columbia University|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 05:04:49.710221|2017-10-11 05:04:49.710221
NCT00104598|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-01|2013-08-07|||September 2000||2000-09-01|August 2013|2013-08-01|December 2006|Actual|2006-12-01|September 2004|Actual|2004-09-01||Interventional|||Framing Messages for Smoking Cessation With Bupropion - 6|Framing Messages for Smoking Cessation With Buproprion|Completed||N/A|252|Actual|Yale University||2|||f||||f||||||||||2017-10-11 05:04:49.823808|2017-10-11 05:04:49.823808
NCT00104611|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-02|2013-09-19|||January 2004||2004-01-01|September 2013|2013-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder|A Randomized, Parallel-Group, Sham-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of the Neuronetics Model 2100 CRS Repetitive Transcranial Magnetic Stimulation (rTMS) System in Patients With Major Depression|Completed||Phase 3|286|Actual|Neuronetics||2|||f||||t||||||||||2017-10-11 05:04:49.937511|2017-10-11 05:04:49.937511
NCT00104624|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2013-09-02|||May 2005||2005-05-01|September 2013|2013-09-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Docetaxel in Treating Older Women With Metastatic Breast Cancer|Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy With Biweekly Docetaxel in the Treatment of Metastatic Breast Cancer in Patients Over 70|Terminated||Phase 2|53|Anticipated|UNICANCER||||Toxicity issues|f||||f||||||||||2017-10-11 05:04:50.195995|2017-10-11 05:04:50.195995
NCT00104637|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2012-05-18|2012-04-04||February 2005||2005-02-01|May 2012|2012-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Sildenafil for Chronic Obstructive Pulmonary Disease|A Double-blind, Placebo-controlled, Crossover Study of Sildenafil in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|10|Actual|Kawut, Steven, MD|The study had slow enrollment.|2|||f||||t||||||||||2017-10-11 05:04:50.319833|2017-10-11 05:04:50.319833
NCT00104650|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2011-01-20|2010-12-09|2009-11-19|January 2005||2005-01-01|January 2011|2011-01-01|March 2010|Actual|2010-03-01|January 2008|Actual|2008-01-01||Interventional|||Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates|A Randomized, Open Label, Active Controlled Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous Bisphosphonates|Completed||Phase 2|111|Actual|Amgen||3|||f||||||||||||||2017-10-11 05:04:50.852817|2017-10-11 05:04:50.852817
NCT00192920|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-18|||January 2000||2000-01-01|September 2005|2005-09-01|December 2010||2010-12-01|||||Observational|||Evaluation of the Quality of the Transfusion Practice at Rigshospitalet, Copenhagen University Hospital||Unknown status|Recruiting|N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:50.7237|2017-10-11 05:30:50.7237
NCT00104676|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2009-12-13|||November 2003||2003-11-01|November 2008|2008-11-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors|A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors|Unknown status|Recruiting|Phase 3|260|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:04:52.527138|2017-10-11 05:04:52.527138
NCT00104689|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2008-07-23|||July 2003||2003-07-01|December 2006|2006-12-01||||||||Interventional|||Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer|Phase II Trial Assessing the Impact on the Activity of Daily Living of an Oral Chemotherapy by Capecitabine Associated With an Intravenous Chemotherapy by Oxaliplatin as First Line Treatment of Metastatic Colorectal Adenocarcinoma of Patients Aged Over 70|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:52.707027|2017-10-11 05:04:52.707027
NCT00104702|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2013-09-02|||July 2004||2004-07-01|September 2013|2013-09-01|March 2011|Actual|2011-03-01|April 2008|Actual|2008-04-01||Interventional|GERICO03||Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer|Radio-Surgical Treatment of Breast Cancer of Women Aged Over 70: Phase II Trial of Feasibility and Reproducibility of a Concentrated and Focalized Radiotherapy|Completed||Phase 2|46|Actual|UNICANCER||1|||f||||||||||||||2017-10-11 05:04:52.949346|2017-10-11 05:04:52.949346
NCT00104715|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2010-11-06|||October 2004||2004-10-01|April 2008|2008-04-01||||||||Interventional|||Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer|Randomized Phase III Trial Comparing an Association of Hormonal Treatment and Docetaxel Versus the Hormonal Treatment Alone in Metastatic Prostate Cancers|Unknown status|Active, not recruiting|Phase 3|378|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:53.067449|2017-10-11 05:04:53.067449
NCT00104728|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2012-10-01|2012-10-01||October 2004||2004-10-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|May 2008|Actual|2008-05-01||Interventional|||Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates|Pilot Neoadjuvant Study of ZD1839 (IRESSA®) as Single Agent Preoperative Therapy for Clinical Stage 1A and 1B (T1-2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC) With Molecular Correlates|Terminated||N/A|42|Actual|H. Lee Moffitt Cancer Center and Research Institute|Pilot study. At the time of interim analysis, the second early stopping rule was invoked for lack of activity (not enough responses to continue). Study closed to accrual 5/9/08.|1||Early Stopping Rule: Would not meet interim analysis goal to proceed with enrollment|f||||f||||||||||2017-10-11 05:04:53.279156|2017-10-11 05:04:53.279156
NCT00104741|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2011-02-18|||July 2004||2004-07-01|April 2008|2008-04-01||||||||Interventional|||Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer|Multicentre Randomized Trial Assessing the Efficacy of a Short Neoadjuvant and Concomitant Hormone Therapy to an Exclusive Curative Cornformational Radiotherapy of Locolized Prostate Cancer With Intermediate Prognosis|Unknown status|Recruiting|Phase 3|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:53.54975|2017-10-11 05:04:53.54975
NCT00104754|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2016-07-19||||||July 2016|2016-07-01||||||||Interventional|||Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer|Phase II Trial of Liposome Encapsulated SN38 (LE-SN38) in the Treatment of Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Alliance for Clinical Trials in Oncology||1|||f||||||||||||||2017-10-11 05:04:53.739163|2017-10-11 05:04:53.739163
NCT00104767|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2015-10-01|||January 2009||2009-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|||Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase I Trial to Evaluate Cyclooxygenase 2 Inhibitor-Mediated Modulation of T Regulatory Cells in Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|7|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 05:04:53.84245|2017-10-11 05:04:53.84245
NCT00104780|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2013-11-05|||December 2004||2004-12-01|March 2006|2006-03-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Phase II, Open Label, Multi-center Study of EP2101 Therapeutic Vaccine in Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:53.924486|2017-10-11 05:04:53.924486
NCT00104793|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2013-05-29|||June 2003||2003-06-01|October 2007|2007-10-01|November 2008|Actual|2008-11-01|February 2007|Actual|2007-02-01||Interventional|||Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer|Phase II Study of Weekly Irinotecan and Carboplatin in Extensive-Stage Small-Cell Lung Cancer|Completed||Phase 2|55|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:54.031744|2017-10-11 05:04:54.031744
NCT00104806|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2017-05-25|||November 2004||2004-11-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|January 2006|Actual|2006-01-01||Interventional|||Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes|Phase II Trial of Arsenic Trioxide and Dose-Escalated Cholecalciferol in Myelodysplastic Syndrome|Terminated||Phase 2|5|Actual|Wake Forest University Health Sciences||1||sponsor discontinues support|f||||f|t|f||||||||2017-10-11 05:04:54.12825|2017-10-11 05:04:54.12825
NCT00104819|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2013-08-01|||September 2004||2004-09-01|August 2008|2008-08-01||||June 2011|Anticipated|2011-06-01||Interventional|||Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma|Phase II Trial of FavId™ (Patient-Specific Idiotype/KLH) and GM-CSF in Subjects Who Demonstrated Progressive Disease and Did Not Receive FavId on Study FavId-06|Terminated||Phase 2|238|Anticipated|National Cancer Institute (NCI)||1||Withdrawn as company has shut down and filed for bankruptcy|f||||||||||||||2017-10-11 05:04:54.207654|2017-10-11 05:04:54.207654
NCT00104845|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2013-03-11|||September 2004||2004-09-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma|Injection of AJCC Stage IIB, IIC, III, and IV Melanoma Patients With Human and Mouse gp100 DNA: A Phase I Trial to Assess Safety and Immune Response|Completed||Phase 1|19|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:04:55.982637|2017-10-11 05:04:55.982637
NCT00105222|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-09|2017-10-05|||March 8, 2005||2005-03-08|August 16, 2013|2013-08-16|August 16, 2013|Actual|2013-08-16|August 16, 2013|Actual|2013-08-16||Interventional|||Effect of Nitrite on Exercise Physiology and Metabolism|Evaluation of Systemic Nitrite Infusion and Its Effect on Exercise Physiology and Metabolism|Terminated||Phase 1|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:05:14.154062|2017-10-11 05:05:14.154062
NCT00104858|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2017-03-27|||December 2004|Actual|2004-12-01|March 2017|2017-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Nonmyeloablative Conditioning With Pre- and Post-Transplant Rituximab Followed by Related or Unrelated Donor Hematopoietic Cell Transplantation for Patients With Advanced Chronic Lymphocytic Leukemia: A Multi-Center Trial|Active, not recruiting||Phase 2|94|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 05:04:56.107426|2017-10-11 05:04:56.107426
NCT00104871|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2014-10-24|2013-11-20||December 2004||2004-12-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|May 2010|Actual|2010-05-01||Interventional|||Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy|A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma|Completed||Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 05:04:56.294853|2017-10-11 05:04:56.294853
NCT00104884|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2016-02-01|2015-12-15||January 2005||2005-01-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|May 2006|Actual|2006-05-01||Interventional||All enrolled patients|FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma|Phase II Trial of Depsipeptide (NSC 630176) in Advanced Malignant Melanoma|Terminated||Phase 2|4|Actual|Eastern Cooperative Oncology Group||1||The study was terminated on May 17, 2006 due to slow accrual.|f||||f||||||||No||2017-10-11 05:04:56.782492|2017-10-11 05:04:56.782492
NCT00104897|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2013-06-25|||March 2005||2005-03-01|March 2008|2008-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma|A Phase II Trial to Assess the Activity of 17-allylamino, 17-demethoxygeldanamycin (17-AAG) in Patients With Metastatic (M1, M1b & M1c) Malignant Melanoma|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:04:57.091405|2017-10-11 05:04:57.091405
NCT00104910|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2014-12-29|||January 2005||2005-01-01|December 2014|2014-12-01||||January 2013|Actual|2013-01-01||Interventional|||Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer|A Phase I Trial of Tailored Radiation Therapy With Concomitant Cetuximab (C225, NSC #714692) and Cisplatin (NSC #119875) in the Treatment of Patients With Cervical Cancer|Completed||Phase 1|64|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 05:04:57.208107|2017-10-11 05:04:57.208107
NCT00104923|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2017-07-18|||February 2005||2005-02-01|July 2017|2017-07-01|April 2017|Actual|2017-04-01|April 2017|Actual|2017-04-01||Interventional|||Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer|Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients With Hematologic Malignancies|Completed||Phase 1|29|Actual|California Cancer Consortium||1|||f||||t||||||||||2017-10-11 05:04:57.357951|2017-10-11 05:04:57.357951
NCT00104936|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2012-09-20|||December 2004||2004-12-01|September 2012|2012-09-01||||November 2006|Actual|2006-11-01||Interventional|||Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery|Observation Versus Conventional-Fractionated Radiotherapy or Radiosurgery After Non-radical Surgery for Benign Intracranial Meningiomas: A Phase III Study|Terminated||Phase 3|9|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 05:04:57.474723|2017-10-11 05:04:57.474723
NCT00104949|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2013-06-21|||July 2005||2005-07-01|December 2006|2006-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma|Phase II Study of Trastuzumab (NSC-688097) in Treatment of Locally Advanced or Metastatic Synovial Sarcoma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-10-11 05:04:57.570926|2017-10-11 05:04:57.570926
NCT00104962|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2014-06-10|||March 2005||2005-03-01|December 2012|2012-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes|Phase I Study of CC-5013 (Lenalidomide NSC# 703813) in Pediatric Patients With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:04:57.651904|2017-10-11 05:04:57.651904
NCT00104975|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2016-12-13|||February 2005||2005-02-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer|Reduced Intensity Conditioning Regimen for Haplo-identical Family Donor Stem Cell Transplants for Hematologic Malignancies With Delayed Add-back of Non-alloreactive T Cells|Completed||Phase 1|20|Anticipated|Yale University|||||f||||||||||||||2017-10-11 05:04:57.759117|2017-10-11 05:04:57.759117
NCT00104988|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2012-08-20|||June 2005||2005-06-01|August 2012|2012-08-01|August 2009|Actual|2009-08-01|July 2007|Actual|2007-07-01||Interventional|||S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery|A Phase II Trial of Combination Thalidomide Plus Temozolomide in Patients With Metastatic Malignant Melanoma|Completed||Phase 2|64|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 05:04:57.90661|2017-10-11 05:04:57.90661
NCT00105001|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2016-11-23|2015-08-13||November 2004||2004-11-01|November 2016|2016-11-01||||May 2011|Actual|2011-05-01||Interventional|||Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer|A Randomized Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor G-CSF Mobilized Peripheral Blood Mononuclear Cell (G-PBMC) Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies A Multi-Center Trial|Active, not recruiting||Phase 2|210|Actual|Fred Hutchinson Cancer Research Center||3|||f||||t||||||||||2017-10-11 05:04:58.32759|2017-10-11 05:04:58.32759
NCT00105027|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2012-07-09|2010-11-09||October 2004||2004-10-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|SCORE||The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study|The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study: Two Randomized Trials to Compare the Efficacy and Safety of Intravitreal Injection(s) of Triamcinolone Acetonide With Standard Care to Treat Macular Edema|Completed||Phase 3|682|Actual|The EMMES Corporation||6|||f||||t||||||||||2017-10-11 05:04:59.461639|2017-10-11 05:04:59.461639
NCT00105040|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2015-02-27|||September 2004||2004-09-01|February 2015|2015-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures|A 19-week, Randomized, Double-blind, Multicenter, Placebo-controlled Safety Study to Evaluate the Cognitive and Neuropsychological Effects of Levetiracetam 20 - 60 mg/kg/Day, Divided in Twice Daily Dosing, as Adjunctive Treatment in Children 4 - 16 Years Old, Inclusive, With Refractory Partial Onset Seizures|Completed||Phase 2|87|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 05:05:03.032739|2017-10-11 05:05:03.032739
NCT00105053|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2009-06-30|||March 2005||2005-03-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Vaccine Treatment for Hormone Refractory Prostate Cancer|A Phase I/II Study of an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 1/Phase 2|8|Actual|NewLink Genetics Corporation||1|||f||||f||||||||||2017-10-11 05:05:03.93942|2017-10-11 05:05:03.93942
NCT00105066|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-03|2017-01-12|2013-04-25||January 2004||2004-01-01|January 2017|2017-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of Metformin on Blood Vessel Structure and Function|The Effects of Metformin on Vascular Structure and Function in Subjects With the Metabolic Syndrome (MET Trial)|Completed||Phase 2|77|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-10-11 05:05:04.056875|2017-10-11 05:05:04.056875
NCT00105079|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-04|2011-09-23|2011-03-29||April 2005||2005-04-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|August 2007|Actual|2007-08-01||Interventional|||GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection|A 48-week, Randomized, Open-label, 2-arm Study to Compare the Efficacy of Saquinavir/Ritonavir Twice Daily (BID) Plus Emtricitabine/Tenofovir Once Daily (QD) Versus Lopinavir/Ritonavir BID Plus Emtricitabine/Tenofovir QD in Treatment-naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients (GEMINI Study)|Completed||Phase 3|337|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:05:04.498999|2017-10-11 05:05:04.498999
NCT00105092|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-04|2007-04-27|||March 2005||2005-03-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.|A Phase II Evaluation of Oral Enzastaurin HCl in Second-and Third- Line Treatment of Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:05:05.511708|2017-10-11 05:05:05.511708
NCT00105105|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-04|2009-12-10|||April 2003||2003-04-01|September 2005|2005-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Mifepristone as Adjunctive Therapy in Alzheimer's Disease|A Double-blind, Placebo-controlled Trial of the Safety and Efficacy of C-1073 (Mifepristone) as Adjunctive Therapy in Alzheimer's Disease|Terminated||Phase 2|160||National Institute on Aging (NIA)|||||||||||||||||||2017-10-11 05:05:05.593228|2017-10-11 05:05:05.593228
NCT00105118|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-04|2008-03-03|||March 2005||2005-03-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Observational|||Effect of Transcranial Magnetic Stimulation on Memory|10 Hz rTMS to Subject Specific Regions of Cerebral Cortex Improves Memory in Healthy Subjects|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:05:05.811633|2017-10-11 05:05:05.811633
NCT00105131|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-05|2008-03-03|||March 2005||2005-03-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Genetic Characterization of Parkinson's Disease|Genetic Characterization of Parkinson's Disease|Completed||N/A|2500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:05:05.870967|2017-10-11 05:05:05.870967
NCT00105144|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-07|2014-09-17|||September 2004||2004-09-01|September 2014|2014-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Micafungin in Patients With Invasive Candidiasis or Candidemia|A Phase 3, Randomized, Double-Blind, Comparative Study of Micafungin (FK463) Versus Caspofungin as Antifungal Treatment in Patients With Invasive Candidiasis or Candidemia|Completed||Phase 3|611|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-10-11 05:05:05.961917|2017-10-11 05:05:05.961917
NCT00105157|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-08|2015-12-03|2009-09-14||March 2005||2005-03-01|December 2015|2015-12-01|July 2009|Actual|2009-07-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)|Multicenter Study to Evaluate the Safety and Efficacy of MK0518 in Combination With An Optimized Background Therapy (OBT), Versus OBT Alone, in HIV-Infected Patients With Documented Resistance|Completed||Phase 2|179|Actual|Merck Sharp & Dohme Corp.|Due to a 3:1 randomization of MK-0518 to placebo and more discontinuations for placebo in the doubleblind phase, exposure for MK-0518 and placebo differs significantly with follow-up times of 336.3 and 39.7 patient-years, respectively.|4|||f||||||||||||||2017-10-11 05:05:06.919266|2017-10-11 05:05:06.919266
NCT00105170|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-08|2013-04-25|||January 2005||2005-01-01|April 2013|2013-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid Tumors|A Phase I, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of hCBE-11, a Humanized Monoclonal Antibody, in Subjects With Advanced Solid Tumors|Terminated||Phase 1|13|Actual|Biogen||1|||||||||||||||||2017-10-11 05:05:10.376117|2017-10-11 05:05:10.376117
NCT00105183|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-08|2012-06-07|2012-03-07||January 2005||2005-01-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection|A Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of an Anti-human-T-lymphocyte Immune Globulin (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of Primary Pulmonary Allograft(s)|Completed||Phase 3|223|Actual|Neovii Biotech|Interim analysis: Dropped 5mg/kg arm. Study was insufficiently powered & focus shifted to safety endpoints. Eliminated some secondary endpoints eg. steroid resistant&antibody treated rejection,CNI&antiproliferative agent, bronchiolitis obliterans.|3|||f||||t||||||||||2017-10-11 05:05:10.539245|2017-10-11 05:05:10.539245
NCT00105196|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-09|2013-11-07|2009-03-27||March 2005||2005-03-01|April 2011|2011-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Aripiprazole in Patients With Major Depressive Disorder|A Study of Aripiprazole in Patients With Major Depressive Disorder|Completed||Phase 3|349|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-10-11 05:05:13.329146|2017-10-11 05:05:13.329146
NCT00105209|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-09|2005-06-23|||April 2002||2002-04-01|March 2005|2005-03-01|December 2003||2003-12-01|||||Interventional|||A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension|A Double-Blind, Placebo-Controlled, Three Treatment Cross-Over Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension|Completed||Phase 2|20||Kawut, Steven, MD|||||f||||||||||||||2017-10-11 05:05:13.90944|2017-10-11 05:05:13.90944
NCT00105235|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-10|2012-11-23|2012-03-02||June 2005||2005-06-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|March 2007|Actual|2007-03-01||Interventional|TILT||Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients|A Phase II Multicenter Trial to Assess the Safety and Efficacy of Campath-1H and Tacrolimus Followed By Immunosuppression Withdrawal in Liver Transplantation (ITN024ST)|Completed||Phase 2|27|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|This study was converted to a pilot study on May 23, 2006. Only 27 of the planned 211 participants were enrolled, thus reducing the number of subjects available for analysis.|1|||f||||t||||||||||2017-10-11 05:05:14.244093|2017-10-11 05:05:14.244093
NCT00105248|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-10|2016-05-10|||January 2004||2004-01-01|May 2016|2016-05-01|June 2004||2004-06-01|||||Interventional|||Patient Centered Communication Training to Reduce Antibiotic Use in Acute Respiratory Tract Infections|Multidimensional Intervention Program to Reduce Antibiotic Prescriptions for Acute Respiratory Tract Infections in Adults: a Randomized Controlled Trial in Primary Care|Completed||N/A|900||University Hospital, Basel, Switzerland|||||f||||f||||||||||2017-10-11 05:05:15.111058|2017-10-11 05:05:15.111058
NCT00105274|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-10|2017-06-30|||March 7, 2005||2005-03-07|February 2, 2010|2010-02-02|February 2, 2010||2010-02-02|||||Observational|||Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study|Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:05:15.207581|2017-10-11 05:05:15.207581
NCT00105287|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2014-05-08|||January 2005||2005-01-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients|Multi-center Study Evaluating OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients|Completed||Phase 3|100||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 05:05:15.290756|2017-10-11 05:05:15.290756
NCT00105300|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2006-08-13|||October 2004||2004-10-01|August 2006|2006-08-01||||||||Interventional|||Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Moderate to Severe Crohn's Disease Who Have Lost Response or Are Intolerant to Infliximab|Completed||Phase 3|300||Abbott|||||||||||||||||||2017-10-11 05:05:15.412363|2017-10-11 05:05:15.412363
NCT00105313|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2007-06-12|||February 2005||2005-02-01|June 2007|2007-06-01||||||||Interventional|||Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia|A Phase I Open-Label Dose Escalation Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia|Terminated||Phase 1|80|Anticipated|MedImmune LLC||||"After review of safety events and have decided that further dose escalation of MEDI-507 as a   single agent is not feasible."|||||||||||||||2017-10-11 05:05:15.624207|2017-10-11 05:05:15.624207
NCT00105326|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2010-05-20|||February 2005||2005-02-01|May 2010|2010-05-01|August 2005|Actual|2005-08-01|||||Interventional|||Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients|A Double-blind, Placebo-controlled, Randomized Study Evaluating the Effect of Paliperidone ER Compared With Placebo on Sleep Architecture in Subjects With Schizophrenia|Completed||Phase 2|5|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:05:15.714485|2017-10-11 05:05:15.714485
NCT00105339|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2017-02-27|||December 2003||2003-12-01|February 2016|2016-02-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Observational|||Simplified Consent for HIV Vaccine Trials|Simplified Consent for HIV Vaccine Trials|Completed||N/A|255|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||||||2017-10-11 05:05:15.790373|2017-10-11 05:05:15.790373
NCT00105352|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2016-06-01|||November 2004||2004-11-01|June 2016|2016-06-01|November 2005|Actual|2005-11-01|||||Interventional|||Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials|Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials|Completed||N/A|120||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:05:15.886447|2017-10-11 05:05:15.886447
NCT00105365|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2015-10-20|||March 2004||2004-03-01|October 2015|2015-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Shoe Modification and Knee Osteoarthritis|Shoe Modification and Knee Osteoarthritis|Completed||N/A|40|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:05:16.034306|2017-10-11 05:05:16.034306
NCT00105378|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2007-08-09|||April 2003||2003-04-01|August 2007|2007-08-01|July 2005|Actual|2005-07-01|||||Interventional|||Dutch EASYcare Study|Effectiveness of EASYcare-Based Geriatric Intermediate Care|Completed||N/A|155|Actual|Radboud University||2|||f||||||||||||||2017-10-11 05:05:16.124801|2017-10-11 05:05:16.124801
NCT00105404|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2017-06-30|||March 9, 2005||2005-03-09|October 30, 2006|2006-10-30|October 30, 2006||2006-10-30|||||Interventional|||Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation|A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema|Completed||Phase 3|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:05:16.219499|2017-10-11 05:05:16.219499
NCT00105417|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2008-03-03|||March 2005||2005-03-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment|A Phase I, Randomized, Placebo-Controlled, Double-Blind Study Evaluating the Safety of Subcutaneous Single Dose Interleukin-7 in HIV-1-Infected Subjects Who Are Receiving Antiretroviral Treatment (A5214)|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:05:16.622097|2017-10-11 05:05:16.622097
NCT00105430|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-11|2006-07-04|||March 2005||2005-03-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Deep Brain Stimulation for Cervical Dystonia|Deep Brain Stimulation of the Globus Pallidus Interna or the Subthalamic Nucleus for Treatment of Generalized Primary Dystonia|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:05:16.721361|2017-10-11 05:05:16.721361
NCT00105443|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-14|2014-10-24|2009-12-11||March 2005||2005-03-01|October 2014|2014-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|SHARP||A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma|A Phase III Randomized, Placebo-controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 3|602|Actual|Bayer||2|||f||||t||||||||||2017-10-11 05:05:16.893383|2017-10-11 05:05:16.893383
NCT00105456|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-14|2010-05-04|||March 2003||2003-03-01|May 2010|2010-05-01|May 2009|Actual|2009-05-01|||||Observational|||A Study of Patients With HER2-Positive Metastatic Breast Cancer|registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer|Completed||Phase 4|1000||Genentech, Inc.|||1||f||||||||||||||2017-10-11 05:05:20.592851|2017-10-11 05:05:20.592851
NCT00105469|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-14|2013-11-21|2011-08-01||July 2004||2004-07-01|November 2013|2013-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)|A Study to Evaluate the Clinical and Microbial Efficacy and Safety of 1.0% AzaSite Compared to 0.3% Tobramycin Ophthalmic Solution in the Treatment of Bacterial Conjunctivitis|Completed||Phase 3|743|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:05:20.892204|2017-10-11 05:05:20.892204
NCT00105482|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-14|2013-01-28|2013-01-28||January 2005||2005-01-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Targeted Interventions for Weight-Concerned Smokers|Testing the Effectiveness of Low Dose Naltrexone for Smoking Cessation and Minimization of Post-cessation Weight Gain|Completed||Phase 2|172|Actual|Yale University||2|||f||||t||||||||||2017-10-11 05:05:21.287384|2017-10-11 05:05:21.287384
NCT00105495|ClinicalTrials.gov processed this data on October 10, 2017|2005-03-15|2016-01-04|||December 2002||2002-12-01|October 2006|2006-10-01|October 2004||2004-10-01|||||Interventional|||Efficacy Study in Removing Excess Iron From the Heart|Randomized Trial Comparing the Relative Efficacy of Deferiprone to That of Deferoxamine in Removing Excess Cardiac Iron in Thalassemia Major Patients|Completed||Phase 4|60||ApoPharma|||||f||||||||||||||2017-10-11 05:05:21.758266|2017-10-11 05:05:21.758266
NCT00113425|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2016-08-22|2016-04-07||August 2005||2005-08-01|August 2016|2016-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Non-cutting Laser Therapy in the Treatment of Acne|Photodynamic Therapy in the Treatment of Acne Vulgaris|Completed||Phase 2|44|Actual|University of Michigan||2|||f||||f||||||||No||2017-10-11 05:05:21.863926|2017-10-11 05:05:21.863926
NCT00113438|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2011-10-28||2011-10-28|March 2005||2005-03-01|October 2011|2011-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors|A Randomized Open-Labeled Phase II Study of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin to Evaluate the Safety and Efficacy in Subjects With Advanced Imageable Malignancies|Completed||Phase 2|13|Actual|Mateon Therapeutics||2|||f||||f||||||||||2017-10-11 05:05:22.482609|2017-10-11 05:05:22.482609
NCT00113451|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2005-06-23|||January 2004||2004-01-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Observational|||Radial Artery Bypass Graft Study of Tromsø|Radial Artery Bypass Graft Study of Tromsø|Completed||N/A|119||University Hospital of North Norway|||||f||||||||||||||2017-10-11 05:05:22.577405|2017-10-11 05:05:22.577405
NCT00113464|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-07|2017-06-30|||June 2, 2005||2005-06-02|April 13, 2007|2007-04-13|April 13, 2007||2007-04-13|||||Observational|||Developing Newborn Screening for Infants With Primary Immunodeficiency|Developing Newborn Screening for Infants With Primary Immunodeficiency|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:05:22.649585|2017-10-11 05:05:22.649585
NCT00113477|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-08|2011-06-30|||May 2005||2005-05-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy|A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy|Completed||Phase 4|40|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-10-11 05:05:22.716591|2017-10-11 05:05:22.716591
NCT00113490|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-08|2013-04-03|2013-04-03||May 2005||2005-05-01|April 2013|2013-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children|A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), After Dosing for a Second Season in Children Who Previously Received MEDI-524 in Protocol MI-CP104|Completed||Phase 1/Phase 2|136|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 05:05:22.817995|2017-10-11 05:05:22.817995
NCT00113503|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-08|2017-10-04|||July 2005|Actual|2005-07-01|October 2017|2017-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Imuran Dosing in Crohn's Disease Study|A Multi-site Trial of Azathioprine Dosing in Crohn's Disease|Terminated||Phase 2|50|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2||Insufficient enrollment|f||||t|t|f||||||||2017-10-11 05:05:23.304579|2017-10-11 05:05:23.304579
NCT00113516|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-08|2010-05-14|2010-03-08||September 2005||2005-09-01|May 2010|2010-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer|Phase 2 Study Of SU011248 As Consolidation Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|84|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:05:23.516467|2017-10-11 05:05:23.516467
NCT00113529|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-08|2011-08-25|2010-03-01||October 2004||2004-10-01|August 2011|2011-08-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma|A Phase 1/2 Safety And Pharmacokinetic Study Of SU011248 In Combination With Gefitinib (Iressa) In Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|42|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:05:26.514172|2017-10-11 05:05:26.514172
NCT00113542|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-08|2015-05-20|||June 2004||2004-06-01|August 2008|2008-08-01|June 2005||2005-06-01|||||Interventional|||A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris|An Open Label Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris|Completed||Phase 2|10||University of Michigan|||||||||||||||||||2017-10-11 05:05:28.27987|2017-10-11 05:05:28.27987
NCT00113568|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-08|2010-06-09|2009-12-11||June 2005||2005-06-01|June 2010|2010-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety Study of XP12B in Women With Menorrhagia|Multicenter Study to Evaluate the Safety of XP12B in Women With Heavy Menstrual Bleeding Associated With Menorrhagia|Completed||Phase 3|784|Actual|Ferring Pharmaceuticals||1|||f||||t||||||||||2017-10-11 05:05:28.527303|2017-10-11 05:05:28.527303
NCT00114465|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2009-09-17|||June 2005||2005-06-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease|Randomized, Double-Blind, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohn's Disease|Completed||Phase 4|38|Actual|Orphan Australia||2|||f||||t||||||||||2017-10-11 05:05:41.762356|2017-10-11 05:05:41.762356
NCT00113581|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2014-02-17|||October 2002||2002-10-01|February 2014|2014-02-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer|A Phase I Study to Determine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Three Doses of Humanised EGFR Antibody EMD 72000 in Combination With ECX in Patients With Advanced Oesophagogastric Adenocarcinoma|Completed||Phase 1|26||Merck KGaA|||||f||||||||||||||2017-10-11 05:05:29.195304|2017-10-11 05:05:29.195304
NCT00113594|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2007-11-05|||June 2005||2005-06-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder|Population Pharmacokinetic Study in Adolescent Patients With Schizophrenia or Bipolar I Disorder Treated With Olanzapine|Completed||Phase 3|100||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:05:29.272167|2017-10-11 05:05:29.272167
NCT00113607|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2014-06-18|2013-06-18|2012-04-10|April 2005||2005-04-01|June 2014|2014-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer|An Open-Label Multicenter Randomized Phase 3 Study Comparing the Combination of DOXIL/CAELYX and YONDELIS With DOXIL/CAELYX Alone in Subjects With Advanced Relapsed Ovarian Cancer|Completed||Phase 3|672|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-10-11 05:05:29.414237|2017-10-11 05:05:29.414237
NCT00113620|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2016-07-13|||July 2005||2005-07-01|July 2016|2016-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy|A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine at Two Dose Levels in the Treatment of the Pain of Diabetic Neuropathy|Completed||Phase 3|450|Anticipated|Avanir Pharmaceuticals|||||||||||||||||||2017-10-11 05:05:31.147484|2017-10-11 05:05:31.147484
NCT00113633|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2014-03-03|||September 2003||2003-09-01|March 2014|2014-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma|A Three-part Intervention to Improve Regular Care for Asthma After a Pediatric Emergency Department Visit: A Randomized Clinical Trial|Completed||N/A|439|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 05:05:33.100895|2017-10-11 05:05:33.100895
NCT00113646|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2016-03-04|||November 2002||2002-11-01|March 2016|2016-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies|Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies|Terminated||Phase 2|14|Actual|Massachusetts General Hospital||1||Expiration of MEDI-507. MEDI-507 did not become available again to re-open the trial|f||||||||||||||2017-10-11 05:05:33.189116|2017-10-11 05:05:33.189116
NCT00113659|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2015-02-27|||June 2005||2005-06-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|May 2014|Actual|2014-05-01||Interventional|||Use of a Probiotic Supplement to Prevent Asthma in Infants|Trial of Infant Probiotic Supplementation to Prevent Asthma|Unknown status|Active, not recruiting|N/A|203|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 05:05:33.258712|2017-10-11 05:05:33.258712
NCT00113672|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2013-04-02|||August 2004||2004-08-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|MBC||Make Better Choices Study|Multiple Behavior Change in Diet and Activity|Completed||N/A|204|Actual|Northwestern University||4|||f||||t||||||||||2017-10-11 05:05:33.341607|2017-10-11 05:05:33.341607
NCT00113685|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2016-02-08|||April 2003||2003-04-01|April 2007|2007-04-01|March 2007||2007-03-01|||||Interventional|||Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury|Effect of Hypertonic Resuscitation for Blunt Trauma|Completed||N/A|209||University of Washington|||||f||||||||||||||2017-10-11 05:05:33.438483|2017-10-11 05:05:33.438483
NCT00113698|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2014-03-11|||December 2004||2004-12-01|March 2014|2014-03-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|AceiMR||Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation|Trial of ACE Inhibition in Children With Mitral Regurgitation After Repair of AVSD|Terminated||Phase 3|5|Actual|University of Utah||2||lower than expected enrollment|f||||t||||||||||2017-10-11 05:05:33.53578|2017-10-11 05:05:33.53578
NCT00113711|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2016-05-12|||January 1995||1995-01-01|June 2005|2005-06-01|August 1999|Actual|1999-08-01|||||Interventional|||Promoting Smoking Cessation and Reducing Weight Gain||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:05:33.630596|2017-10-11 05:05:33.630596
NCT00113724|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2009-06-03|||May 2005||2005-05-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study of TPI 287 in Patients With Advanced Malignancies|A Phase I, Open-Label, Dose Escalation, Multi-Center Study of TPI 287 in Patients With Advanced Malignancies|Completed||Phase 1|48|Anticipated|Cortice Biosciences, Inc.|||||t||||f||||||||||2017-10-11 05:05:33.706458|2017-10-11 05:05:33.706458
NCT00113737|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-09|2016-02-17|||February 1998||1998-02-01|June 2005|2005-06-01|January 2002|Actual|2002-01-01|||||Interventional|||Fluoxetine as a Quit Smoking AID for Depression Prone||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:05:33.787079|2017-10-11 05:05:33.787079
NCT00113750|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2010-06-16|||July 2005||2005-07-01|June 2010|2010-06-01|December 2005||2005-12-01|||||Interventional|||Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen|A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Tree MATA in Subjects Allergic to Tree Pollen|Completed||Phase 2|70||Allergy Therapeutics|||||||||||||||||||2017-10-11 05:05:33.923243|2017-10-11 05:05:33.923243
NCT00114036|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2005-06-23|||August 2002||2002-08-01|June 2005|2005-06-01|December 2005||2005-12-01|||||Interventional|||Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE)|Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE)|Unknown status|Active, not recruiting|N/A|||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:05:34.079723|2017-10-11 05:05:34.079723
NCT00114049|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2017-01-18|||December 2004||2004-12-01|January 2017|2017-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Dental Pain (Following Third Molar Tooth Extraction) Study|A Pivotal Phase III, Single Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Investigate the Efficacy and Safety of Single Oral Doses of 10mg, 25mg, 50mg and 70mg GW406381 and 550mg Naproxen Sodium in Subjects With Pain Following Third Molar Tooth Extraction|Completed||Phase 3|300||GlaxoSmithKline|||||||||||||||||||2017-10-11 05:05:34.17052|2017-10-11 05:05:34.17052
NCT00114062|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2016-11-28|||September 2005||2005-09-01|November 2016|2016-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study to Treat Uveitis Associated Macular Edema|A Randomized, Double-Masked, Parallel Group, Multi-Center, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Uveitis Associated Macular Edema|Terminated||Phase 2|15|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:05:34.246952|2017-10-11 05:05:34.246952
NCT00114075|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2012-07-17|||January 2005||2005-01-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Walking Analysis on Surgical Outcomes|Impact of Gait Analysis on Surgical Outcomes|Completed||Phase 2|186|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-10-11 05:05:34.31651|2017-10-11 05:05:34.31651
NCT00114088|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2005-06-23|||November 1997||1997-11-01|June 2005|2005-06-01|January 2004||2004-01-01|||||Interventional|||Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)|Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)|Completed||Phase 3|242||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:05:34.425409|2017-10-11 05:05:34.425409
NCT00114101|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2017-10-02|2013-03-28||December 15, 2004|Actual|2004-12-15|June 2017|2017-06-01||||December 31, 2012|Actual|2012-12-31||Interventional|||Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant|A Phase III Randomized, Double-Blind Study of Maintenance Therapy With CC-5013 (NSC # 703813) or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma|Active, not recruiting||Phase 3|460|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 05:05:34.563714|2017-10-11 05:05:34.563714
NCT00114114|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2016-09-16|||September 2004||2004-09-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Dose-Response of Gonadal Steroids and Bone Turnover in Men|Dose-Response of Gonadal Steroids and Bone Turnover in Men|Recruiting||N/A|900|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 05:05:36.252451|2017-10-11 05:05:36.252451
NCT00114127|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2014-06-05|2012-01-27||June 2004||2004-06-01|June 2014|2014-06-01|July 2010|Actual|2010-07-01|November 2008|Actual|2008-11-01||Interventional|||Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome|Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome|Completed||Phase 3|28|Actual|Massachusetts General Hospital|Open-label in phase Phase 1; Limited power due to small sample size.|3|||f||||||||||||||2017-10-11 05:05:36.393284|2017-10-11 05:05:36.393284
NCT00114153|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2009-11-25|||June 2003||2003-06-01|April 2007|2007-04-01||||||||Interventional|||Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Phase I Trial of Induction Paraplatin® and Xeloda® Followed by Concurrent Paraplatin and Xeloda With Intensity Modulated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:05:37.194829|2017-10-11 05:05:37.194829
NCT00114166|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2014-05-27|2014-05-27||January 2005||2005-01-01|May 2014|2014-05-01||||January 2011|Actual|2011-01-01||Interventional||Total number eligible and evaluable participants from Regimen I and Regimen II|Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|A Randomized Phase II Evaluation of Topotecan (NSC #609699) Administered Daily x 5 Every 3 Weeks vs Weekly Topotecan in the Treatment of Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Completed||Phase 2|81|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-10-11 05:05:37.301939|2017-10-11 05:05:37.301939
NCT00114179|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2015-04-14|||January 2005||2005-01-01|December 2013|2013-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery|A Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab For Locally Advanced Pancreatic Cancer|Completed||Phase 2|82|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:05:38.3041|2017-10-11 05:05:38.3041
NCT00114192|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2010-01-29|||June 2004||2004-06-01|January 2010|2010-01-01||||June 2007|Actual|2007-06-01||Interventional|||Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Docetaxel and Thalidomide as a Second-Line Treatment for Non-Small Cell Lung Cancer|Completed||Phase 2|37|Anticipated|University of Virginia||1|||f||||t||||||||||2017-10-11 05:05:38.432122|2017-10-11 05:05:38.432122
NCT00114205|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2010-03-17|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion|Phase I Trial of Intrapleural Docetaxel Administered Via an Implantable Catheter in Subjects With a Malignant Pleural Effusion|Completed||Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:05:38.531127|2017-10-11 05:05:38.531127
NCT00114218|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2014-12-23|||March 2005||2005-03-01|December 2014|2014-12-01||||July 2010|Actual|2010-07-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer|A Phase II Evaluation of Gemcitabine (NSC #613327) and Docetaxel (NSC # 628503) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus|Completed||Phase 2|28|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 05:05:38.614023|2017-10-11 05:05:38.614023
NCT00114231|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2017-08-07|||May 2006|Actual|2006-05-01|August 2017|2017-08-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer|A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer|Completed||Phase 2|90|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 05:05:38.715262|2017-10-11 05:05:38.715262
NCT00114244|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2015-01-06|2015-01-06||December 2004||2004-12-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer|A Randomized Phase II Study of BAY 43-9006 in Combination With Gemcitabine in Metastatic Pancreatic Carcinoma|Completed||Phase 2|52|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:05:38.977635|2017-10-11 05:05:38.977635
NCT00114257|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2013-02-08|||May 2005||2005-05-01|September 2006|2006-09-01||||September 2006|Actual|2006-09-01||Interventional|||Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders|A Phase I Study of 5-AZA-2'-Deoxycytidine and Depsipeptide in Patients With Relapsed/Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disease|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:05:39.868971|2017-10-11 05:05:39.868971
NCT00114270|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2013-03-25|||May 2004||2004-05-01|April 2006|2006-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density|Evaluating the Effect of Letrozole With or Without Concomitant Zoledronic Acid on Estrogen Responsive Targets in Postmenopausal Women|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:05:39.964258|2017-10-11 05:05:39.964258
NCT00114283|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2015-04-14|||March 2005||2005-03-01|November 2012|2012-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|A Phase 2 Trial of GW572016 in Patients With Metastatic and Recurrent Squamous Cell Carcinomas of the Head and Neck|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:05:40.054471|2017-10-11 05:05:40.054471
NCT00114296|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2013-09-16|||April 2005||2005-04-01|July 2006|2006-07-01||||||||Interventional|||Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer|A Pilot Study to Evaluate the Effects of Omega-3 Fatty Acids on Intermediate Markers of Breast Cancer|Unknown status|Active, not recruiting|N/A|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:05:40.177058|2017-10-11 05:05:40.177058
NCT00114309|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2009-04-01|||November 2004||2004-11-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma|A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131-I-TM-601 in Adult Patients With Recurrent High-Grade Glioma|Unknown status|Active, not recruiting|Phase 2|66|Anticipated|TransMolecular||2|||f||||||||||||||2017-10-11 05:05:40.27505|2017-10-11 05:05:40.27505
NCT00114322|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2007-01-12|||May 2005||2005-05-01|June 2005|2005-06-01||||||||Interventional|||Light-Emitting Diode (LED) Light for Seasonal Affective Disorder (SAD) Treatment|Comparing Wavelengths Using LED Light for SAD Treatment|Unknown status|Recruiting|N/A|24||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 05:05:40.621985|2017-10-11 05:05:40.621985
NCT00114335|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2008-10-09|||May 2005||2005-05-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|||||Observational|||Epidemiologic Data of Patients in a Teaching Hospital|Prevalence of Impaired Renal Function in Medical Inpatients|Completed||N/A|352|Actual|Luzerner Kantonsspital|||1||f||||||||||||||2017-10-11 05:05:40.722345|2017-10-11 05:05:40.722345
NCT00114348|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2013-02-01|||August 2003||2003-08-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia|ALL-REZ BFM 2002: Protocol for the Treatment of Children With Relapsed Acute Lymphoblastic Leukemia|Completed||Phase 4|338|Actual|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 05:05:40.794211|2017-10-11 05:05:40.794211
NCT00114361|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2010-06-18|||March 2005||2005-03-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|May 2008|Actual|2008-05-01||Interventional|||48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection|Peginterferon Alfa-2a and Ribavirin Combination Therapy in Patients With HBeAg-negative Chronic HBV Infection (PARC Study)|Completed||Phase 3|138|Actual|Foundation for Liver Research||2|||f||||t||||||||||2017-10-11 05:05:40.917115|2017-10-11 05:05:40.917115
NCT00114374|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2014-06-05|||June 2005||2005-06-01|June 2014|2014-06-01|June 2007|Actual|2007-06-01|||||Interventional|||SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims|SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and Posttraumatic Stress Disorder in Physical Trauma Victims in the Medical Setting|Terminated||Phase 3|60|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:05:41.035678|2017-10-11 05:05:41.035678
NCT00114387|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2009-12-09|||July 1996||1996-07-01|June 2005|2005-06-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||VEAPS: Vitamin E Atherosclerosis Prevention Study|VEAPS: Vitamin E Atherosclerosis Prevention Study|Completed||Phase 2/Phase 3|353||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:05:41.13193|2017-10-11 05:05:41.13193
NCT00114400|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2009-12-09|||November 2000||2000-11-01|February 2007|2007-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||BVAIT: B-Vitamin Atherosclerosis Intervention Trial|B-Vitamin Atherosclerosis Intervention Trial (BVAIT)|Completed||Phase 2/Phase 3|506||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:05:41.218723|2017-10-11 05:05:41.218723
NCT00114413|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2017-02-08|||August 2004||2004-08-01|February 2017|2017-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents|Asthma Control Evaluation (ACE): A Biomarker-Based Approach to Improving Asthma Control and Mechanistic Studies (DAIT ICAC-02)|Completed||N/A|547|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 05:05:41.313949|2017-10-11 05:05:41.313949
NCT00114426|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2005-08-16|||January 2002||2002-01-01|February 2005|2005-02-01|December 2004||2004-12-01|||||Interventional|||Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )Patients|Effects of Nocturnal Noninvasive Mechanical Ventilation on the Health Status of Patients With COPD|Terminated||Phase 3|40||University of British Columbia|||||f||||||||||||||2017-10-11 05:05:41.458894|2017-10-11 05:05:41.458894
NCT00114439|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2007-09-26|||September 2005||2005-09-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Lithium Cannabis Withdrawal Study|An Open Label Trial of Lithium for the Management of Cannabis Withdrawal|Completed||Phase 2|25|Anticipated|Sydney South West Area Health Service|||||f||||||||||||||2017-10-11 05:05:41.532794|2017-10-11 05:05:41.532794
NCT00114452|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-14|2014-12-02|||February 2005||2005-02-01|December 2014|2014-12-01|February 2009|Actual|2009-02-01|October 2006|Actual|2006-10-01||Interventional|||Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction|A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction|Completed||Phase 1|53|Actual|Mesoblast, Ltd.||1|||f||||||||||||||2017-10-11 05:05:41.616255|2017-10-11 05:05:41.616255
NCT00114504|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2015-05-13|2015-03-31||September 2004||2004-09-01|May 2015|2015-05-01|April 2009|Actual|2009-04-01|April 2007|Actual|2007-04-01||Interventional|||Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation|Detection of Atherosclerotic Plaque Inflammation and Visualization of Anti-inflammatory Effects of Statins on Plaque Inflammation by FDG-PET|Completed||N/A|43|Actual|Kurume University||2|||f||||f||||||||||2017-10-11 05:05:42.051936|2017-10-11 05:05:42.051936
NCT00114517|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2017-06-05|2017-04-17||July 2004||2004-07-01|June 2017|2017-06-01|March 5, 2013|Actual|2013-03-05|February 12, 2013|Actual|2013-02-12||Interventional|||ELITE: Early Versus Late Intervention Trial With Estradiol|Biologic Response of Menopausal Women to 17B-Estradiol|Completed||Phase 2/Phase 3|643|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 05:05:42.391267|2017-10-11 05:05:42.391267
NCT00114530|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2017-08-21|2017-05-05||June 2005||2005-06-01|August 2017|2017-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional||Randomized intent to treat|Scleroderma: Cyclophosphamide or Transplantation (SCOT)|A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)|Completed||Phase 2/Phase 3|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Results are applicable for SSc with severe internal organ disease and may not be generalizable to all those with dcSSc. The hierarchical components of the GRCS are specific to this SSc population and may not be generalizable to other SSc populations.|2|||f||||t||||||||||2017-10-11 05:05:43.206633|2017-10-11 05:05:43.206633
NCT00114543|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2017-09-22|||September 2002||2002-09-01|September 2017|2017-09-01|November 2007|Actual|2007-11-01|April 2005|Actual|2005-04-01||Interventional|Phototherapy||Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight|A Randomized Trial of Aggressive or Conservative Phototherapy for Extremely Low Birth Weight Infants|Completed||Phase 3|1974|Actual|NICHD Neonatal Research Network||4|||f||||t||||||||||2017-10-11 05:05:46.574426|2017-10-11 05:05:46.574426
NCT00114556|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2006-05-08|||February 2000||2000-02-01|December 2004|2004-12-01|August 2004||2004-08-01|||||Interventional|||The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients|The Effect Of The Bisphosphonate, Zoledronic Acid, On Bone Density In Liver Transplant Patients – A Prospective, Randomised, Controlled Clinical Trial|Completed||Phase 4|100||Royal Prince Alfred Hospital, Sydney, Australia|||||f||||||||||||||2017-10-11 05:05:46.73783|2017-10-11 05:05:46.73783
NCT00114569|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2016-05-20|||March 2005||2005-03-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|April 2007|Actual|2007-04-01||Interventional|||Lorazepam for the Treatment of Status Epilepticus in Children|Use of Lorazepam for the Treatment of Status Epilepticus|Completed||Phase 1|69|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||t||||||||||2017-10-11 05:05:46.808789|2017-10-11 05:05:46.808789
NCT00114582|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2009-02-12|||April 2002||2002-04-01|February 2009|2009-02-01|December 2003||2003-12-01|||||Interventional|||Optimizing the Ambiance During Mealtimes in Dutch Nursing Homes|Optimizing the Ambiance During Mealtimes in Dutch Nursing Homes|Completed||Phase 2|120||Wageningen University|||||f||||||||||||||2017-10-11 05:05:46.893497|2017-10-11 05:05:46.893497
NCT00114595|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2005-06-23|||April 2003||2003-04-01|June 2005|2005-06-01|March 2005||2005-03-01|||||Interventional|||Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia|A Double-Blind, Randomised, Parallel-Group Comparison of Ethyl-Eicosapentaenoic Acid (Ethyl-EPA) Versus Placebo as Add-on Medication in Patients With Established Tardive Dyskinesia|Completed||Phase 4|84||University of Stellenbosch|||||f||||||||||||||2017-10-11 05:05:46.967853|2017-10-11 05:05:46.967853
NCT00114608|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2008-03-10|||June 2005||2005-06-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot|Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot|Completed||Phase 1|40|Actual|University at Buffalo||1|||f||||t||||||||||2017-10-11 05:05:47.061362|2017-10-11 05:05:47.061362
NCT00114621|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2017-06-30|||September 8, 2004||2004-09-08|March 16, 2012|2012-03-16|May 25, 2011|Actual|2011-05-25|||||Interventional|||Anthrax Vaccine Clinical Trials|Anthrax Vaccine Clinical Trials|Completed||Phase 1|93|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:05:47.144822|2017-10-11 05:05:47.144822
NCT00114634|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2015-12-24|2010-03-19||June 2005||2005-06-01|December 2015|2015-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome|Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome|Completed||Phase 2|13|Actual|National Institutes of Health Clinical Center (CC)|Poor power due to low enrollment|2|||f||||f||||||||||2017-10-11 05:05:47.235885|2017-10-11 05:05:47.235885
NCT00114647|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-15|2017-07-13|||October 19, 1981||1981-10-19|July 12, 2017|2017-07-12||||||||Observational|||Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies|Procedures to Obtain Plasma, Lymphocytes, or Other Specimens for Research Studies|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:05:47.719596|2017-10-11 05:05:47.719596
NCT00114660|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-16|2009-03-05|||November 2004||2004-11-01|March 2007|2007-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Cocoa Butter for Prevention of Stretch Marks|Topical Application of Cocoa Butter for Prevention of Striae Gravidarum|Completed||N/A|200||American University of Beirut Medical Center|||||f||||||||||||||2017-10-11 05:05:47.848997|2017-10-11 05:05:47.848997
NCT00114673|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-16|2007-02-16|||June 2005||2005-06-01|January 2006|2006-01-01||||||||Observational|||A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling|A Multicenter Study to Validate Cosmetic Outcome Scales Used to Assess Irregular Skin Pigmentation and Wrinkling|Completed||N/A|48||Graceway Pharmaceuticals, LLC|||||f||||||||||||||2017-10-11 05:05:47.964573|2017-10-11 05:05:47.964573
NCT00114686|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-16|2013-01-03|||January 2006||2006-01-01|January 2013|2013-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder|A Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, Phase III Study to Compare the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) Versus Placebo as Adjunct Therapy With Mood Stabilizers (Lithium or Divalproex) for the Treatment of Alcohol Dependence in Patients With Bipolar I Disorder|Completed||Phase 3|350||AstraZeneca|||||f||||||||||||||2017-10-11 05:05:48.057271|2017-10-11 05:05:48.057271
NCT00114699|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-16|2013-08-01|||April 2005||2005-04-01|August 2013|2013-08-01|April 2006|Actual|2006-04-01|||||Interventional|||Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy|A Phase 1, Randomized, Placebo-Controlled, Single-Injection, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ccr5mab004 (Human Monoclonal Igg4 Antibody To Ccr5) in Hiv-1 Seropositive Individuals Who Are Not Receiving Concurrent Antiretroviral Therapy|Completed||Phase 1|40||Human Genome Sciences Inc.|||||||||||||||||||2017-10-11 05:05:48.284765|2017-10-11 05:05:48.284765
NCT00114712|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-16|2017-01-23|||January 2004||2004-01-01|January 2017|2017-01-01|December 2025|Anticipated|2025-12-01|December 2024|Anticipated|2024-12-01|12 Months|Observational [Patient Registry]|RPR||The Ribavirin Pregnancy Registry|The Ribavirin Pregnancy Registry|Recruiting||N/A|600|Anticipated|INC Research|||1||f||||t|f|f||||||Yes|A condensed version of the annual interim report is available to healthcare providers upon request.|2017-10-11 05:05:48.421687|2017-10-11 05:05:48.421687
NCT00114725|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-16|2005-06-23|||March 2004||2004-03-01|June 2005|2005-06-01|October 2004||2004-10-01|||||Interventional|||Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection|Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection|Completed||N/A|60||Shady Grove Fertility Reproductive Science Center|||||f||||||||||||||2017-10-11 05:05:48.52094|2017-10-11 05:05:48.52094
NCT00114738|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2017-10-05|||June 15, 2005||2005-06-15|January 6, 2017|2017-01-06|May 10, 2020|Anticipated|2020-05-10|May 10, 2018|Anticipated|2018-05-10||Interventional|||EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma|Randomized Phase II Study of Dose-Adjusted EPOCH-Rituximab-Bortezomib (EPOCH-R-B) Induction Followed by Bortezomib Maintenance Versus Observation in Untreated Mantle Cell Lymphoma With Microarray Profiling and Proteomics|Active, not recruiting||Phase 2|53|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 05:05:48.611007|2017-10-11 05:05:48.611007
NCT00114764|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2008-10-30|||March 2003||2003-03-01|October 2008|2008-10-01|August 2004|Actual|2004-08-01|April 2004|Actual|2004-04-01||Interventional|||Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)|A Multicentre, Double-Blind, Randomised Phase 2 Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)|Completed||Phase 2|84|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:05:48.702591|2017-10-11 05:05:48.702591
NCT00114790|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2013-05-03|||December 2003||2003-12-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|October 2008|Actual|2008-10-01||Interventional|||Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors|Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Inoperable and Irradiated Head and Neck Tumors: A Feasibility Study|Completed||Phase 1/Phase 2|30|Actual|Boneca Corporation||1|||f||||f||||||||||2017-10-11 05:05:58.694454|2017-10-11 05:05:58.694454
NCT00114803|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2007-12-04|||January 2004||2004-01-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease|Use of Intranasally Administered Calcitonin in the Treatment of Osteopenia and Osteoporosis in Children, Adolescents and Young Adults With IBD: A Pilot Study|Completed||N/A|66||Boston Children’s Hospital|||||||||||||||||||2017-10-11 05:05:58.778941|2017-10-11 05:05:58.778941
NCT00114816|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2007-05-18|||January 2004||2004-01-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer|A Randomized Phase III Study Comparing Docetaxel Followed by Cyclophosphamide, Epirubicin and 5-FU to Docetaxel With Capecitabine Followed by Cyclophosphamide, Epirubicin and Capecitabine as Adjuvant Treatment for Early Breast Cancer|Completed||Phase 3|1500|Anticipated|Finnish Breast Cancer Group|||||f||||||||||||||2017-10-11 05:05:58.858249|2017-10-11 05:05:58.858249
NCT00114829|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2006-03-08|||July 2005||2005-07-01|May 2005|2005-05-01||||||||Interventional|||Preoperative Assessment of Colon Tumor|Preoperative Assessment of Colon Tumor: A Prospective, Blinded Study.|Unknown status|Recruiting|Phase 4|60||Herlev Hospital|||||f||||||||||||||2017-10-11 05:05:59.042217|2017-10-11 05:05:59.042217
NCT00114842|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2007-09-19|||March 2006||2006-03-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Magnetic Resonance (MR) Colonography With Fecal Tagging|MR Colonography With Fecal Tagging: A Prospective, Randomized Study|Completed||Phase 4|60|Anticipated|Herlev Hospital|||||f||||||||||||||2017-10-11 05:05:59.135002|2017-10-11 05:05:59.135002
NCT00114855|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2011-07-03|||March 2005||2005-03-01|February 2009|2009-02-01|June 2006|Actual|2006-06-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose|A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose|Completed||N/A|40||Oslo University Hospital|||||f||||||||||||||2017-10-11 05:05:59.223497|2017-10-11 05:05:59.223497
NCT00114868|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2017-03-01|||June 1998||1998-06-01|January 2010|2010-01-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Vitamin A Supplementation in Newborns Study|Vitamin A Supplementation in Newborns Study|Completed||Phase 3|14035|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-10-11 05:05:59.318508|2017-10-11 05:05:59.318508
NCT00114881|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2017-01-09|||January 2005||2005-01-01|January 2017|2017-01-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|URECA||Urban Environmental Factors and Childhood Asthma|Urban Environment and Childhood Asthma (URECA)|Active, not recruiting||N/A|609|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"     -  Sample of umbilical cord blood (mother)        -  Maternal blood sample        -  Blood and nasal mucus collection (infant through age 14 or 16 years)        -  DNA sample of mother and child        -  Urine sample        -  Saliva sample        -  Induced sputum sample        -  Nasal epithelial cells sample   "|||2017-10-11 05:05:59.423409|2017-10-11 05:05:59.423409
NCT00192933|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-18|||January 2000||2000-01-01|September 2005|2005-09-01|December 2010||2010-12-01|||||Observational|||Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital||Unknown status|Recruiting|N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:50.80325|2017-10-11 05:30:50.80325
NCT00114894|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2009-08-12|||April 2004||2004-04-01|August 2009|2009-08-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Prevention of Jellyfish Stings|Field Study of the Prevention of Jellyfish Stings With a Topical Sting Inhibitor|Completed||Phase 3|12|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 05:05:59.553327|2017-10-11 05:05:59.553327
NCT00114907|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-17|2007-04-05|||June 2005||2005-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Effects of Black Tea on Cardiovascular Disease in the Mauritian Population|Effects of Black Tea on Cardiovascular Disease in the Mauritian Population|Completed||N/A|270||University of Mauritius|||||f||||||||||||||2017-10-11 05:05:59.655676|2017-10-11 05:05:59.655676
NCT00114920|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2007-02-16|||March 2004||2004-03-01|November 2006|2006-11-01||||||||Interventional|||Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults|A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel for the Treatment of Common Warts in Adults|Completed||Phase 2|88||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-10-11 05:05:59.729213|2017-10-11 05:05:59.729213
NCT00114933|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2008-03-20|||January 2005||2005-01-01|September 2005|2005-09-01|May 2007||2007-05-01|||||Interventional|||"OK 2004 Study (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects"|Phase III-IV, Comparative, Randomized, Open-Label, Study to Evaluate Safety and Efficacy of Suspending Nucleosides From a Triple-Drug Therapy Based on Lopinavir/Ritonavir Versus Continuing Triple-Drug Therapy in HIV-Infected Subjects With Undetectable Plasma HIV Viremia for Six Months|Completed||Phase 4|200||Arribas, Jose R., M.D.|||||f||||||||||||||2017-10-11 05:05:59.807084|2017-10-11 05:05:59.807084
NCT00114946|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2006-05-26|||May 2005||2005-05-01|May 2006|2006-05-01|December 2007||2007-12-01|||||Interventional|||A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer|A Randomized, Open-Label Trial Comparing Two Avastin (Bevacizumab)-Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer|Terminated||Phase 4|800||Genentech, Inc.|||||f||||||||||||||2017-10-11 05:05:59.937548|2017-10-11 05:05:59.937548
NCT00114959|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2015-01-08|2015-01-08|2012-05-03|October 2005||2005-10-01|January 2015|2015-01-01|March 2009|Actual|2009-03-01|June 2008|Actual|2008-06-01||Interventional|||Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)|A Phase II Open-Label Study of the Intravenous Administration of Homoharringtonine (CGX-635) Combined With the Oral Administration of Gleevec in the Treatment of Patients With Chronic Myeloid Leukemia (CML) in Chronic, Accelerated, and Blast Phase|Terminated||Phase 2|15|Actual|Teva Pharmaceutical Industries|This study was intended to follow a Simon two stage design to test 18 patients in each stratum (chronic, accelerated and blast phase) for efficacy. Only 15 were enrolled, an insufficient number for a formal statistical analysis of efficacy.|1||Poor enrollment|f||||f||||||||||2017-10-11 05:06:00.026132|2017-10-11 05:06:00.026132
NCT00114972|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2010-05-27|2009-03-27||March 2005||2005-03-01|May 2010|2010-05-01|May 2012|Anticipated|2012-05-01|April 2008|Actual|2008-04-01||Interventional|SYNTAX||SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries|SYNTAX Study: SYNergy Between PCI With TAXUS and Cardiac Surgery|Unknown status|Active, not recruiting|Phase 3|1800|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-11 05:06:00.911818|2017-10-11 05:06:00.911818
NCT00114985|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2017-07-26|||April 2001||2001-04-01|July 2017|2017-07-01|October 2008|Actual|2008-10-01|January 2005|Actual|2005-01-01||Interventional|||Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding|A Phase II Study of Late Rectal Toxicity Following 3-D Conformal External Beam Radiation Therapy Performed Using a Prostate Immobilization Device|Completed||Phase 2|100|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:06:03.512295|2017-10-11 05:06:03.512295
NCT00114998|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2012-07-31|||June 2005||2005-06-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||CV Disease in Adolescents With Type 2 Diabetes|CV Disease in Adolescents With Type 2 Diabetes|Completed||N/A|750|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-10-11 05:06:03.607308|2017-10-11 05:06:03.607308
NCT00115011|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2008-05-19|||September 2002||2002-09-01|May 2008|2008-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Escitalopram for the Treatment of Self-Injurious Skin Picking|Escitalopram for the Treatment of Self-Injurious Skin Picking|Completed||Phase 4|30|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 05:06:03.675322|2017-10-11 05:06:03.675322
NCT00115024|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2009-12-09|||April 1994||1994-04-01|June 2005|2005-06-01|November 1998|Actual|1998-11-01|November 1998|Actual|1998-11-01||Interventional|||EPAT: Estrogen in the Prevention of Atherosclerosis Trial|Estrogen in the Prevention of Atherosclerosis Trial|Completed||Phase 2/Phase 3|222||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:06:03.775733|2017-10-11 05:06:03.775733
NCT00115050|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2011-06-02||2011-06-02|June 2005||2005-06-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options|Open-label Safety Study of TMC114 in Combination With Low Dose RTV and Other ARVs in Highly Experienced HIV-1 Infected Patients With Limited or no Treatment Options.|Completed||Phase 3|260|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-10-11 05:06:04.198503|2017-10-11 05:06:04.198503
NCT00115063|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2016-01-22|2010-03-01||July 2005||2005-07-01|January 2016|2016-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|LOSS||LOSS- Louisiana Obese Subjects Study|Loss - Louisiana Obese Subjects Study|Terminated||Phase 4|390|Actual|Pennington Biomedical Research Center|The study was stopped prematurely for efforts to be focused on assisting the Office of Group Benefits (OGB) in translating a policy that would allow for physician certification in order to offer participants the intensive treatment.|2||ethical issues of continuing control group without treatment|f||||t||||||||||2017-10-11 05:06:04.340572|2017-10-11 05:06:04.340572
NCT00115076|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2012-05-31|||October 2003||2003-10-01|May 2012|2012-05-01||||May 2007|Actual|2007-05-01||Interventional|||Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis|A Phase IIIB Study to Evaluate the Mechanism of Action of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy|Completed||Phase 3|31|Actual|Rockefeller University||1|||f||||f||||||||||2017-10-11 05:06:05.220343|2017-10-11 05:06:05.220343
NCT00115089|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2005-11-09|||July 2005||2005-07-01|November 2005|2005-11-01|September 2005||2005-09-01|||||Interventional|||7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis|A Phase II Multi-Center, Randomized, Double-Blind, Active and Placebo-Controlled 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis|Completed||Phase 2|375||Rigel Pharmaceuticals|||||||||||||||||||2017-10-11 05:06:05.39439|2017-10-11 05:06:05.39439
NCT00115102|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2006-06-15|||March 2004||2004-03-01|June 2006|2006-06-01|October 2005||2005-10-01|||||Interventional|||Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls||Completed||Phase 4|20||University of Aarhus|||||f||||||||||||||2017-10-11 05:06:05.458167|2017-10-11 05:06:05.458167
NCT00115115|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-20|2009-04-22|||March 2004||2004-03-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|December 2007|Actual|2007-12-01||Interventional|||Donor Dopamine and Initial Graft Function|Prospective Randomized Trial to Evaluate the Efficacy of Donor Preconditioning With Dopamine on Initial Graft Function After Kidney Transplantation|Completed||Phase 4|487|Actual|Universitätsmedizin Mannheim||1|||f||||f||||||||||2017-10-11 05:06:05.52947|2017-10-11 05:06:05.52947
NCT00115128|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2013-05-10|||November 2003||2003-11-01|May 2013|2013-05-01|September 2007|Actual|2007-09-01|May 2007|Actual|2007-05-01||Observational|||Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors|Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors|Completed||N/A|309|Actual|Amgen|||1||f||||||||||None Retained|"     none collected   "|||2017-10-11 05:06:05.621633|2017-10-11 05:06:05.621633
NCT00115141|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2007-02-16|||April 2004||2004-04-01|November 2006|2006-11-01||||||||Interventional|||Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults|A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Adults|Completed||Phase 2|88||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-10-11 05:06:05.693991|2017-10-11 05:06:05.693991
NCT00115154|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2007-02-16|||May 2005||2005-05-01|February 2007|2007-02-01|September 2006||2006-09-01|||||Interventional|||Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands|Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Upper Extremities|Completed||Phase 4|270||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-10-11 05:06:05.749965|2017-10-11 05:06:05.749965
NCT00115167|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2009-05-07|||August 2004||2004-08-01|May 2009|2009-05-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study|A Multicenter, Randomised, Double-Blind, Placebo-Controlled Roll Over Study to Protocol 20010103 of Darbepoetin Alfa for the Treatment of Anemia of Cancer|Completed||Phase 3|371|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:06:05.84441|2017-10-11 05:06:05.84441
NCT00115180|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2016-01-05|||September 2003||2003-09-01|November 2005|2005-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Racial and Ethnic Disparities in Acute Pain Control|Racial and Ethnic Disparities in Acute Pain Control|Completed||N/A|285|Actual|Agency for Healthcare Research and Quality (AHRQ)|||3||f||||f||||||||No||2017-10-11 05:06:05.921458|2017-10-11 05:06:05.921458
NCT00115193|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2013-08-27|||February 2003||2003-02-01|August 2013|2013-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma|A Multicenter, Double-Blind, Randomized Study of Pegfilgrastim Administered on the Same Day or the Next Day of R-Chop Chemotherapy in Subjects With Non-Hodgkin's Lymphoma|Completed||Phase 2|77|Actual|Amgen||2|||f||||t||||||||||2017-10-11 05:06:06.020422|2017-10-11 05:06:06.020422
NCT00115206|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2009-04-02|||July 2002||2002-07-01|April 2009|2009-04-01|July 2004||2004-07-01|||||Interventional|||Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy|A Pilot Study of the Effects of Neutropenia on Patient Reported Outcomes During Chemotherapy With or Without Neulasta® (Pegfilgrastim) in Subjects With Advanced NSCLC|Completed||Phase 4|||Amgen|||||||||||||||||||2017-10-11 05:06:06.116114|2017-10-11 05:06:06.116114
NCT00115219|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2013-05-28|||May 2005||2005-05-01|May 2013|2013-05-01||||||||Interventional|||Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)|A Multi-center, Randomized, Double-Blind, Active-Controlled Study Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis Subjects Who Are Sub-optimal Responders to Etanercept 50 mg Once Weekly (QW)|Completed||Phase 4|200||Amgen||1|||||||||||||||||2017-10-11 05:06:06.194352|2017-10-11 05:06:06.194352
NCT00115232|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2008-01-14|||July 2004||2004-07-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Observational|||Inflammatory Profiles of Children at High Risk for Atherosclerosis|Inflammatory Profiles of Children at High Risk for Atherosclerosis|Completed||N/A|300|Actual|Boston Children’s Hospital|||4||f||||f||||||Samples Without DNA|"     Fasting serum samples, frozen.   "|||2017-10-11 05:06:06.292142|2017-10-11 05:06:06.292142
NCT00115245|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2015-05-08|||November 2004||2004-11-01|May 2015|2015-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B|A Randomized, Open-Label Trial of Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-10-11 05:06:06.366671|2017-10-11 05:06:06.366671
NCT00115258|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2013-02-12|||January 2004||2004-01-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Nutrition Support in Pediatric Stem Cell Transplantation|Nutrition Support in Pediatric Stem Cell Transplantation - A Randomized, Controlled Trial|Completed||Phase 3|26|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-10-11 05:06:06.480018|2017-10-11 05:06:06.480018
NCT00115271|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2014-08-22|||January 1999||1999-01-01|August 2014|2014-08-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Antenatal Micronutrient Supplementation and Birth Weight|Maternal Micronutrient Supplementation to Reduce Low Birth Weight and Infant and Maternal Morbidity in Rural Nepal|Completed||Phase 3|5000||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:06:06.573591|2017-10-11 05:06:06.573591
NCT00115284|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2009-02-12|||January 2005||2005-01-01|February 2009|2009-02-01|December 2006|Actual|2006-12-01|July 2006|Actual|2006-07-01||Interventional|||Changes in Physician Performance Through Continuous Professional Development|An Evaluation of Changes in Physician Performance Through Continuous Professional Development|Completed||N/A|40||Henry Ford Health System|||||f||||||||||||||2017-10-11 05:06:06.6676|2017-10-11 05:06:06.6676
NCT00115297|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2017-02-03|2016-12-12||September 2004||2004-09-01|February 2017|2017-02-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Montelukast for Early Life Wheezing|Effects of Montelukast on Early Life Wheezing|Completed||Phase 2/Phase 3|62|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 05:06:06.761838|2017-10-11 05:06:06.761838
NCT00115310|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2008-03-04|||June 2005||2005-06-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|A Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|Completed||Phase 3|400||NeurogesX|||||||||||||||||||2017-10-11 05:06:07.129495|2017-10-11 05:06:07.129495
NCT00115323|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2013-12-20|||May 2005||2005-05-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparison of Two Medication Adherence Strategies to Improve Asthma Treatment Adherence|Individualized Interventions to Improve Asthma Adherence|Completed||N/A|397|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 05:06:07.208393|2017-10-11 05:06:07.208393
NCT00115336|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2013-01-18|||January 2005||2005-01-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease|Ketorolac Versus Ibuprofen for the Painful Crisis of Sickle Cell Disease - Southwestern Comprehensive Sickle Cell Center|Terminated||Phase 4|12|Actual|University of Texas Southwestern Medical Center||2||Poor accrual|f||||t||||||||||2017-10-11 05:06:07.30775|2017-10-11 05:06:07.30775
NCT00115349|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2015-10-05|2013-05-16||June 2005||2005-06-01|January 2014|2014-01-01|April 2009|Actual|2009-04-01|July 2008|Actual|2008-07-01||Interventional|||Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases|Thalassemia Clinical Research Network - Cardiac L1/DFO Trial|Terminated||Phase 2|20|Actual|New England Research Institutes|The study was stopped early by NHLBI when analysis of the interim data confirmed a required sample size of 86 that was not achievable within the required time frame within the participating or planned centres.|2||due to low enrollment|f||||t||||||||||2017-10-11 05:06:07.451398|2017-10-11 05:06:07.451398
NCT00115362|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2007-09-21|||July 2005||2005-07-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Serotonin Effect in Functional Dyspepsia|Serotonin Effect in Non-Ulcer Dyspepsia|Completed||N/A|300|Anticipated|Radboud University|||||f||||||||||||||2017-10-11 05:06:08.015638|2017-10-11 05:06:08.015638
NCT00115375|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2009-03-24|||January 2004||2004-01-01|March 2009|2009-03-01|April 2006|Actual|2006-04-01|||||Interventional|||Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)|Dose-Ranging Pharmacodynamic Assessment of Platelet Aggregation Inhibition With Clopidogrel in Children of Blalock-Taussig Shunt Age Categories (Neonates and Infants/Toddlers)|Completed||Phase 2|92|Actual|Sanofi|||||||||||||||||||2017-10-11 05:06:08.281227|2017-10-11 05:06:08.281227
NCT00115388|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2014-11-21|||September 2004||2004-09-01|November 2014|2014-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|POPI||Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease|Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease|Completed||N/A|2531|Actual|St George's, University of London||1|||f||||f||||||||||2017-10-11 05:06:08.43432|2017-10-11 05:06:08.43432
NCT00115401|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-21|2017-06-30|||June 16, 2005||2005-06-16|October 17, 2007|2007-10-17|October 17, 2007||2007-10-17|||||Observational|||Gait Adaptations to Passive Dynamic Ankle-Foot Orthosis Use|Gait Adaptations to Passive Dynamic Ankle-Foot Orthosis Use|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:08.537599|2017-10-11 05:06:08.537599
NCT00115414|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2008-07-31||||||July 2008|2008-07-01||||||||Interventional|||Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)|A Randomized, Double-Blind, Phase 2 Study Evaluating the Safety of Same Day Versus Next Day Administration of Pegfilgrastim With Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) in Women With Breast Cancer|Completed||Phase 2|||Amgen|||||||||||||||||||2017-10-11 05:06:08.617887|2017-10-11 05:06:08.617887
NCT00115427|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2008-01-10|||March 2003||2003-03-01|January 2008|2008-01-01||||||||Interventional|||Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease|Completed||Phase 1|||Amgen|||||||||||||||||||2017-10-11 05:06:08.735753|2017-10-11 05:06:08.735753
NCT00115440|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2009-01-27|||March 2001||2001-03-01|September 2007|2007-09-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||BNCT to Treat Glioma That Has Progressed Following Radiotherapy|BPA-Mediated Boron Neutron Capture Therapy (BNCT) in the Treatment of Glioblastoma or Anaplastic Astrocytoma Progressing After Conventional External Beam Radiotherapy|Completed||Phase 1/Phase 2|22|Actual|Boneca Corporation||1|||f||||f||||||||||2017-10-11 05:06:08.834268|2017-10-11 05:06:08.834268
NCT00115453|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2008-08-14|||May 1999||1999-05-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma|Boron Neutron Capture Therapy in the Treatment of Glioblastoma Multiforme|Terminated||Phase 1/Phase 2|50|Actual|Boneca Corporation||1||Slow accrual|f||||f||||||||||2017-10-11 05:06:08.932028|2017-10-11 05:06:08.932028
NCT00115466|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2005-06-23|||October 2004||2004-10-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Interventional|||Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula|Phase II Clinical Trial, Multicentre, Randomised and Comparative, to Evaluate the Efficacy and Safety of a New Therapy With Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula|Unknown status|Active, not recruiting|Phase 2|50||Cellerix|||||f||||||||||||||2017-10-11 05:06:09.170807|2017-10-11 05:06:09.170807
NCT00115479|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2006-05-03|||March 2002||2002-03-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients|KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients|Completed||Phase 2|1200||Katholieke Universiteit Leuven|||||f||||||||||||||2017-10-11 05:06:09.301531|2017-10-11 05:06:09.301531
NCT00115674|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2015-10-06|||September 2002||2002-09-01|August 2015|2015-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||To Examine Smoking Behavior of Prisoners - 1|Smoking Research With Incarcerated Females|Completed||N/A|360|Actual|University of Alabama at Birmingham|||1||f||||t||||||||||2017-10-11 05:06:12.064058|2017-10-11 05:06:12.064058
NCT00192985|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-16|||May 2003||2003-05-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||Does a Nitrofurazone Coated Bladder Catheter Reduce the Number of Urinary Tract Infections in Trauma||Unknown status|Active, not recruiting|Phase 3|216||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:51.191959|2017-10-11 05:30:51.191959
NCT00115492|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2017-01-19|||December 2004||2004-12-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations|A Randomized, Double-Blind, Parallel Group, 52-Week Study to Compare the Effect of Fluticasone Propionate/Salmeterol Diskus Combination Product 250/50mcg BID With Salmeterol Diskus 50mcg BID on the Annual Rate of Moderate/Severe Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|797|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:06:09.455063|2017-10-11 05:06:09.455063
NCT00115505|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2017-08-16|||October 2005||2005-10-01|August 2017|2017-08-01|June 2016|Actual|2016-06-01|July 2015|Actual|2015-07-01||Observational|||Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer|Quality of Life, Employment and Informal Care Cost Analysis in Women Receiving Adjuvant Chemotherapy for Breast Cancer With 0-3 Positive Axillary Lymph Nodes|Completed||N/A|307|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-10-11 05:06:10.041834|2017-10-11 05:06:10.041834
NCT00115518|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2011-08-03|||May 2005||2005-05-01|February 2011|2011-02-01|August 2010|Actual|2010-08-01|June 2009|Actual|2009-06-01||Interventional|||Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Locoregional Radiotherapy in Combination With Cetuximab in Inoperable Non-Small Cell Lung Cancer Stage III|Completed||Phase 2|30|Actual|Heidelberg University||1|||f||||f||||||||||2017-10-11 05:06:10.662213|2017-10-11 05:06:10.662213
NCT00115531|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2014-12-18|||April 2005||2005-04-01|February 2007|2007-02-01|November 2005||2005-11-01|||||Interventional|||Eldery High Dose TIV 2005|Comparisons of the Reactogenicity and Immunogenicity in Ambulatory Elderly Subjects of a Standard-Dose Fluzone® (15 µg HA/Virus Strain) and a High-Dose (60 µg HA/Virus Strain) of a Trivalent Inactivated Influenza Virus Vaccine|Completed||Phase 2|414|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:06:10.742217|2017-10-11 05:06:10.742217
NCT00115544|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-22|2016-02-09|||September 2005||2005-09-01|February 2016|2016-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Safety and Pharmacology of Stanate|An Open-Label Study of the Safety and Clinical Pharmacology of Stanate® in Infants At-Risk for Exchange Transfusion|Completed||Phase 2|55|Actual|InfaCare Pharmaceuticals Corporation||3|||f||||t||||||||||2017-10-11 05:06:10.823834|2017-10-11 05:06:10.823834
NCT00115557|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2010-08-11|||October 2004||2004-10-01|September 2007|2007-09-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Delivery of Preventive Services in Primary Care|Delivery of Preventive Services in Primary Care|Completed||N/A|24|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-10-11 05:06:10.920838|2017-10-11 05:06:10.920838
NCT00115570|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2016-05-19|||April 2005||2005-04-01|May 2016|2016-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents|Efficacy and Safety of Insulin Glulisine Compared With Insulin Lispro in Children and Adolescents With Type 1 Diabetes Mellitus: A 26 Week, Multicenter, Open, Parallel Clinical Trial|Completed||Phase 3|572|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 05:06:11.024728|2017-10-11 05:06:11.024728
NCT00115583|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2016-12-08|||November 1998||1998-11-01|December 2016|2016-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries|The Contribution of Endothelin to Vasoreactivity in Atherosclerotic Coronary Arteries|Completed||N/A|200||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 05:06:11.146769|2017-10-11 05:06:11.146769
NCT00115596|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2017-07-18|||June 2005||2005-06-01|July 2017|2017-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Reforming Pediatric Procedural Training|Reforming Pediatric Procedural Training: Developing an Evidence-Based Curriculum|Completed||N/A|38|Actual|Boston Children’s Hospital||2|||f||||||||||||||2017-10-11 05:06:11.232901|2017-10-11 05:06:11.232901
NCT00115609|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2011-12-21|||January 2006||2006-01-01|December 2011|2011-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)|Pilot Trial Evaluating Once Daily Triple Combination Antiretroviral Therapy With Tenofovir-Emtricitabine and Efavirenz in HIV-1 Infected Patients With Mycobacterium Tuberculosis Infection ANRS129 BKVIR|Completed||Phase 3|70|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-10-11 05:06:11.39784|2017-10-11 05:06:11.39784
NCT00115622|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2016-08-30|||December 2004||2004-12-01|August 2016|2016-08-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study In Adults And Adolescents With Seasonal Allergic Rhinitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 14 Days in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|304|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:06:11.513218|2017-10-11 05:06:11.513218
NCT00115635|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2007-10-01|||March 2005||2005-03-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer|A Phase I/II Study With Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|60|Actual|Herlev Hospital||1|||f||||t||||||||||2017-10-11 05:06:11.821468|2017-10-11 05:06:11.821468
NCT00115648|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2014-03-06|||April 2004||2004-04-01|March 2014|2014-03-01|October 2009|Actual|2009-10-01|August 2007|Actual|2007-08-01||Interventional|||Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission|Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission|Completed||Phase 3|3300|Anticipated|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-10-11 05:06:11.885555|2017-10-11 05:06:11.885555
NCT00115661|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2012-10-16|||July 2005||2005-07-01|October 2012|2012-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Use of Rosiglitazone in the Treatment of Endometriosis|Treatment of Endometriosis Pain With Rosiglitazone: A Prospective Phase 2 Clinical Trial|Terminated||Phase 2|25|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1||Due to the meta-analysis about CV adverse effects of rosiglitazone.|f||||||||||||||2017-10-11 05:06:11.980102|2017-10-11 05:06:11.980102
NCT00115687|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2017-01-11|||June 2002||2002-06-01|May 2010|2010-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Nicotine Replacement Treatment for Pregnant Smokers - 1|Nicotine Replacement Treatment for Pregnant Smokers|Terminated||Phase 2|250|Actual|National Institute on Drug Abuse (NIDA)||2||Efficacy rates did not show large enough differences between treatments|f||||t||||||||||2017-10-11 05:06:12.129974|2017-10-11 05:06:12.129974
NCT00115700|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2017-07-10|||February 2000||2000-02-01|July 2017|2017-07-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma|A Randomised Multicentre Trial of Involved Field Radiotherapy Versus Involved Field Radiotherapy Plus Chemotherapy in Combination With Rituximab (Mabthera®) for Stage I - II Low Grade Follicular Lymphoma|Active, not recruiting||Phase 3|150|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-10-11 05:06:12.224015|2017-10-11 05:06:12.224015
NCT00115713|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2007-03-22|||April 2003||2003-04-01|March 2007|2007-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Effects of Aerobic Exercise Versus Weight Training in Breast Cancer Survivors During Chemotherapy|Comparison of Aerobic Versus Resistance Exercise Training in Enhancing Quality of Life in Early Stage Breast Cancer Survivors Receiving Chemotherapy: A Multi-Centre Randomized Trial|Completed||Phase 3|240||University of Alberta, Physical Education|||||f||||t||||||||||2017-10-11 05:06:12.366743|2017-10-11 05:06:12.366743
NCT00115726|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2008-02-20|||September 2000||2000-09-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|February 2006|Actual|2006-02-01||Interventional|||Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure|Randomized Controlled Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure|Completed||Phase 4|198|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 05:06:12.442437|2017-10-11 05:06:12.442437
NCT00115739|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2014-03-19|2012-07-24||February 2004||2004-02-01|March 2014|2014-03-01|August 2010|Actual|2010-08-01|May 2008|Actual|2008-05-01||Interventional||11 patients with Anaplastic thyroid cancer were enrolled and were started on imatinib.|Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma|Phase II Trial Evaluating Gleevec (Imatinib Mesylate Formerly Known as STI571) in Patients With Anaplastic Thyroid Cancer|Terminated||Phase 2|11|Actual|University of Michigan Cancer Center|Study was closed early due to slow accrual. Planned accrual was 28|1||Study was closed early due to slow accrual|f||||t||||||||||2017-10-11 05:06:12.631786|2017-10-11 05:06:12.631786
NCT00115752|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-23|2017-06-30|||June 20, 2005||2005-06-20|October 4, 2006|2006-10-04|October 4, 2006||2006-10-04|||||Interventional|||Genetic Basis For Variation In NSAID Analgesia In A Clinical Model Of Acute Pain|Genetic Basis For Variation In NSAID Analgesia In A Clinical Model Of Acute Pain|Completed||Phase 2|96||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:13.071405|2017-10-11 05:06:13.071405
NCT00115765|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2013-06-13|2010-08-19||June 2005||2005-06-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|March 2007|Actual|2007-03-01||Interventional|||PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study|PACCE: A Randomized, Open-Label, Controlled, Clinical Trial of Chemotherapy and Bevacizumab With and Without Panitumumab in the First-Line Treatment of Subjects With Metastatic Colorectal Cancer|Completed||Phase 3|1053|Actual|Amgen||4|||f||||||||||||||2017-10-11 05:06:13.234987|2017-10-11 05:06:13.234987
NCT00115791|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2008-03-29|||June 2004||2004-06-01|March 2008|2008-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter|A Phase 3, Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Tolerance and Efficacy Study of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter|Completed||Phase 3|276|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 05:06:16.113063|2017-10-11 05:06:16.113063
NCT00115804|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2017-02-06|2012-11-07||June 2005||2005-06-01|February 2017|2017-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia|An Open-Label Clinical Trial of Fluoxetine Treatment of Juvenile Primary Fibromyalgia Syndrome|Completed||Phase 3|6|Actual|University of Cincinnati||1|||f||||f||||||||No||2017-10-11 05:06:16.343389|2017-10-11 05:06:16.343389
NCT00115817|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2007-04-23|||June 2005||2005-06-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||The Effects of Atorvastatin in Patients With Atherosclerosis|The Effects of Atorvastatin on the Rho/Rho Kinase Pathway in Patients With Atherosclerosis|Completed||Phase 3|36||Brigham and Women's Hospital|||||f||||t||||||||||2017-10-11 05:06:16.678194|2017-10-11 05:06:16.678194
NCT00115830|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2007-04-23|||December 2004||2004-12-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Rho Kinase in Patients With Atherosclerosis|Rho Kinase in Patients With Atherosclerosis: Effects of Statins - A Double Blind, Randomized Clinical Trial Comparing Rosuvastatin and Atorvastatin|Completed||Phase 3|40||Brigham and Women's Hospital|||||f||||t||||||||||2017-10-11 05:06:16.767212|2017-10-11 05:06:16.767212
NCT00115843|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2017-04-04|||April 2005||2005-04-01|April 2017|2017-04-01|September 2006||2006-09-01|September 2006||2006-09-01||Interventional|||Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring|Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-10-11 05:06:16.838824|2017-10-11 05:06:16.838824
NCT00115856|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2015-07-31|||January 2001||2001-01-01|July 2015|2015-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Imaging of Plaque With Magnetic Resonance Imaging (MRI)|Imaging of Plaque in Atherosclerosis With Intravascular MRI|Completed||N/A|20|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 05:06:16.934355|2017-10-11 05:06:16.934355
NCT00115869|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2012-10-31|2012-04-30||September 1984||1984-09-01|October 2012|2012-10-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|HSPP||Hutchinson Smoking Prevention Project|Hutchinson Smoking Prevention Project|Completed||Phase 3|8388|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 05:06:17.011902|2017-10-11 05:06:17.011902
NCT00115882|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2016-05-20|||September 2000||2000-09-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|May 2014|Actual|2014-05-01||Interventional|||Hutchinson Study of High School Smoking|Proactive Smoking Cessation for Adolescents|Completed||Phase 3|2151|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 05:06:18.929103|2017-10-11 05:06:18.929103
NCT00115895|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2016-03-18|||January 2000||2000-01-01|March 2016|2016-03-01|September 2020|Anticipated|2020-09-01|October 2004|Actual|2004-10-01||Interventional|||The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy|Effect of the Radioiodine Dose in Thyroid Ablation- A Randomized Comparison of 1110 MBq to 3700 MBq|Active, not recruiting||Phase 3|160|Actual|Helsinki University||2|||f||||f||||||||||2017-10-11 05:06:19.025706|2017-10-11 05:06:19.025706
NCT00115908|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2013-11-05|||May 2005||2005-05-01|November 2013|2013-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1|A Phase 2b, Randomized, Multi-Center, Active-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Albuferon (Recombinant Human Albumin-Interferon Alfa Fusion Protein) in Combination With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 1|Completed||Phase 2|458|Actual|Human Genome Sciences Inc.|||||f||||t||||||||||2017-10-11 05:06:19.132849|2017-10-11 05:06:19.132849
NCT00115921|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2017-01-11|||July 2005||2005-07-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Evaluation of Home-Based Management of Fever in Urban Ugandan Children|Evaluation of Home-Based Management of Fever in Urban Ugandan Children|Completed||N/A|540||London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-10-11 05:06:19.536095|2017-10-11 05:06:19.536095
NCT00115934|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2016-03-22|2010-09-14||May 2005||2005-05-01|August 2013|2013-08-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Comparison of Two Types of Shunts in Infants With Single Ventricle Defect Undergoing Staged Reconstruction--Pediatric Heart Network|Trial of Right Ventricular Versus Modified Blalock-Taussig Shunt in Infants With Single Ventricle Defect Undergoing Staged Reconstruction (A Trial Conducted by the Pediatric Heart Network)|Completed||Phase 3|555|Actual|New England Research Institutes|As in all surgical trials comparing two operations, it was not possible to blind the personnel caring for the subjects to the intervention. However, the components of the primary endpoint, death and transplantation, are discrete objective events.|2|||f||||t||||||||||2017-10-11 05:06:19.659901|2017-10-11 05:06:19.659901
NCT00115947|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2006-03-08|||December 2004||2004-12-01|June 2005|2005-06-01|January 2006||2006-01-01|||||Interventional|||Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites||Completed||Phase 2/Phase 3|||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:06:20.560369|2017-10-11 05:06:20.560369
NCT00115960|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2012-03-26||||||March 2012|2012-03-01|July 2008|Actual|2008-07-01|||||Interventional|||Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Gag DNA Vaccine Alone or With IL-15 DNA, Boosted With HIV-1 Gag DNA + IL-15 DNA or HIV-1 Gag DNA + IL-12 DNA, in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|120|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-10-11 05:06:20.630686|2017-10-11 05:06:20.630686
NCT00115973|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2016-10-17|||June 2005||2005-06-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump|An Open-Label, Stepwise Basal Insulin Dose Titration Study Using Continuous Subcutaneous Insulin Infusion (CSII) in Oral Antidiabetic Drug-Treated Type 2 Diabetes Mellitus Subjects Followed by a 10-Week Out-Patient Maintenance Phase|Completed||Phase 1|71|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:06:20.766301|2017-10-11 05:06:20.766301
NCT00115986|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2013-08-22|||March 2005||2005-03-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||A/H5N1in Adult - Aventis|A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Adults|Completed||Phase 1/Phase 2|452|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:06:20.849193|2017-10-11 05:06:20.849193
NCT00115999|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2008-01-08|||April 2005||2005-04-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries|Phase 3, Multicenter, Multi-National, Randomized, Partial Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects With Acute Peripheral Arterial Occlusion|Completed||Phase 3|300||ARCA Biopharma, Inc.|||||f||||t||||||||||2017-10-11 05:06:20.918394|2017-10-11 05:06:20.918394
NCT00116012|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2006-11-27|||June 2005||2005-06-01|November 2006|2006-11-01||||||||Interventional|||Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32|A Randomized, Double-Blind Placebo-Controlled Study to Assess the Safety of Factor VIIa/Tissue Factor Inhibitor, Recombinant Nematode Anticoagulant Protein c2 (rNAPc2), in Subjects With Non-ST-Elevation Acute Coronary Syndromes - ANTHEM (Anticoagulation With rNAPc2 to Help Eliminate MACE)/TIMI 32. Amendment #3 - A Single Arm, Open-Label Study of rNAPc2 With Reduced Doses of Unfractionated Heparin|Completed||Phase 2|300||ARCA Biopharma, Inc.|||||||||||||||||||2017-10-11 05:06:21.009968|2017-10-11 05:06:21.009968
NCT00116025|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2007-02-27|||March 2005||2005-03-01|February 2007|2007-02-01|January 2006||2006-01-01|||||Interventional|||Pharmacokinetics of Ghrelin|Pharmacokinetics of Ghrelin in Normal Subjects|Completed||N/A|17||University of Aarhus|||||f||||f||||||||||2017-10-11 05:06:21.103724|2017-10-11 05:06:21.103724
NCT00116038|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2009-07-06|||January 2004||2004-01-01|July 2009|2009-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Comparison of Two Metal Surface Finishes on Femoral Components in Hip Arthroplasty|A Comparison of Two Metal Surface Finishes (Proximal-Coated Titanium Surface Versus Mid-Coated Titanium Surface) on Femoral Components in Hip Arthroplasty|Completed||N/A|50||University of Aarhus|||||f||||||||||||||2017-10-11 05:06:21.180318|2017-10-11 05:06:21.180318
NCT00116051|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2009-07-06|||September 2004||2004-09-01|July 2009|2009-07-01|April 2006||2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Comparison of Two Surface Materials (Tantalum Versus Titanium Fiber Mesh) of Acetabular Components in Hip Arthroplasty|A Comparison of Two Surface Materials (Tantalum Versus Titanium Fiber Mesh) of Acetabular Components in Hip Arthroplasty|Completed||N/A|50||University of Aarhus|||||f||||t||||||||||2017-10-11 05:06:21.38384|2017-10-11 05:06:21.38384
NCT00116064|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2006-07-20|||July 2004||2004-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions|A Randomised Trial to Compare the Efficacy and Safety of Intranasal Lorazepam and Intramuscular Paraldehyde in the Treatment of Convulsions in Children|Completed||Phase 3|156||University of Malawi College of Medicine|||||f||||||||||||||2017-10-11 05:06:21.481312|2017-10-11 05:06:21.481312
NCT00116090|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-26|2017-06-30|||June 16, 2005||2005-06-16|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study|Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study|Completed||N/A|6300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:21.655488|2017-10-11 05:06:21.655488
NCT00116103|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2012-06-06|||June 2005||2005-06-01|June 2012|2012-06-01|April 2006|Actual|2006-04-01|||||Interventional|||A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma|A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma|Completed||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-10-11 05:06:21.756734|2017-10-11 05:06:21.756734
NCT00116116|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2011-04-14||2010-01-27|March 2002||2002-03-01|April 2011|2011-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy|Daily Antiretroviral Therapy (DART-II): An Open-Label, Single-Arm, Prospective, Multicenter Clinical Trial To Evaluate the Efficacy and Safety fo Stavudine Extended Release (d4T XR) in Combination With Lamivudine (3TC) and Efavirenz (EFV) Once Daily in Anti-Retroviral Therapy (ART) Naive HIV-Infected Subjects|Completed||Phase 4|70||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:06:21.89295|2017-10-11 05:06:21.89295
NCT00116129|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2012-08-02|||July 2005||2005-07-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in the Treatment of Primary Fibromyalgia|Completed||Phase 2|64|Actual|Bennett, Robert, M.D.||1|||f||||f||||||||||2017-10-11 05:06:22.000457|2017-10-11 05:06:22.000457
NCT00116142|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2017-07-25|||June 2005||2005-06-01|July 2017|2017-07-01|June 2020|Anticipated|2020-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer|Docetaxel Plus 6-month Androgen Suppression and Radiation Therapy Versus 6-month Androgen Suppression and Radiation Therapy for Patients With High Risk Localized or Locally Advanced Prostate Cancer: A Randomized Controlled Trial|Active, not recruiting||Phase 3|350|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 05:06:22.119079|2017-10-11 05:06:22.119079
NCT00116155|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2005-06-27||||||June 2005|2005-06-01||||||||Interventional|||Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer|A Phase I/II Dose Finding Trial of the Intravenous Injection of CV787, a Prostate-Specific Antigen Cytolytic Adenovirus, in Patients With Hormone Refractory Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|||Cell Genesys|||||||||||||||||||2017-10-11 05:06:22.235485|2017-10-11 05:06:22.235485
NCT00116168|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2013-10-17|2013-10-17||June 2005||2005-06-01|October 2013|2013-10-01|July 2006|Actual|2006-07-01|April 2006|Actual|2006-04-01||Interventional|||Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528|A Phase I, Open Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528, a Humanized Monoclonal Anti-Interleukin-9 Antibody, in Healthy Adult Volunteers|Completed||Phase 1|29|Actual|MedImmune LLC||4|||f||||||||||||||2017-10-11 05:06:22.326133|2017-10-11 05:06:22.326133
NCT00116181|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2011-03-16|||October 2004||2004-10-01|March 2011|2011-03-01||||January 2007|Actual|2007-01-01||Interventional|||Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis|A Multicenter, Open-Label, Prospective Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects With Psoriasis-EASE in Psoriasis|Completed||Phase 3|30|Actual|Rockefeller University||2|||f||||f||||||||||2017-10-11 05:06:23.387184|2017-10-11 05:06:23.387184
NCT00116194|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2010-03-24|||April 2004||2004-04-01|December 2008|2008-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot|Physical Exercise to Prevent Disability Pilot Study|Completed||Phase 1/Phase 2|424||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:06:23.507975|2017-10-11 05:06:23.507975
NCT00116207|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2016-06-30|2014-01-06||January 2000||2000-01-01|June 2016|2016-06-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes|Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial|Completed||Phase 3|44|Actual|University of Michigan||2|||f||||t||||||||No||2017-10-11 05:06:23.636693|2017-10-11 05:06:23.636693
NCT00116220|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2017-07-25|||September 1995||1995-09-01|July 2017|2017-07-01|September 2018|Anticipated|2018-09-01|April 2001|Actual|2001-04-01||Interventional|||Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer|A Phase III Trial of External Beam of Radiotherapy +/- Total Androgen Suppression for High Risk Clinically Organ-Confined Prostate Cancer|Active, not recruiting||Phase 3|226|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 05:06:24.783352|2017-10-11 05:06:24.783352
NCT00116233|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2005-06-27||||||June 2005|2005-06-01||||||||Interventional|||Pediatric Multicenter Study of REPEL-CV|Peds. Multicenter Study|Unknown status|Recruiting|Phase 2|||SyntheMed|||||||||||||||||||2017-10-11 05:06:24.891455|2017-10-11 05:06:24.891455
NCT00116246|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2006-09-07|||August 2005||2005-08-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||McRoberts Manoeuvre Or Pushing Study (McMOPS)||Unknown status|Recruiting|Phase 1|222||University of Melbourne|||||f||||||||||||||2017-10-11 05:06:24.966991|2017-10-11 05:06:24.966991
NCT00116259|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-27|2008-08-06|||March 2005||2005-03-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)|Aripiprazole in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Double Blind Placebo Controlled Trial|Completed||N/A|50|Anticipated|Federal University of Rio Grande do Sul|||||f||||||||||||||2017-10-11 05:06:25.110922|2017-10-11 05:06:25.110922
NCT00116272|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2015-08-19|2015-05-29||April 2005||2005-04-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project|OTIS Autoimmune Diseases in Pregnancy Project|Completed||N/A|830|Actual|Amgen|||3||f||||f||||||None Retained|"     This is a prospective & observational, exposure cohort study   "|||2017-10-11 05:06:25.378725|2017-10-11 05:06:25.378725
NCT00124696|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2017-01-11|||December 2002||2002-12-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Cocaethylene as a Treatment for Cocaine Dependence - 1|Cocaethylene Substitution Therapy and Tolerance Induction in Treating Cocaine Dependence|Completed||Phase 1|8||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 05:10:36.453862|2017-10-11 05:10:36.453862
NCT00116285|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2010-06-16|||June 2005||2005-06-01|September 2009|2009-09-01|June 2005||2005-06-01|||||Interventional|||Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing|A Single-Blind Phase I Study to Assess the Residual Allergenicity of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL Using Skin Prick Testing|Completed||Phase 1|12||Allergy Therapeutics|||||f||||||||||||||2017-10-11 05:06:28.685328|2017-10-11 05:06:28.685328
NCT00116298|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2011-04-08||2010-01-28|January 2001||2001-01-01|April 2011|2011-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)|A Study to Compare Long-Term Safety and Tolerability of Stavudine (d4T) Extended Release (ER) Versus Conventional (Immediate Release, IR) Formulations, Each In Combination With Lamivudine (3TC) and Efavirenz (EFV) in Subjects Who Have Completed BMS Studies AI455-096 and AI455-099|Completed||Phase 3|900||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:06:28.805844|2017-10-11 05:06:28.805844
NCT00116311|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2007-03-20|||July 2005||2005-07-01|March 2007|2007-03-01|February 2007||2007-02-01|||||Observational|||Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood|Effects of Allergen Inhalation on Adenosine Receptor Expression and Mast Cell Activation in Peripheral Blood and Sputum of Asthmatics and Healthy Subjects|Unknown status|Active, not recruiting|N/A|20||Groningen Research Institute for Asthma and COPD|||||f||||f||||||||||2017-10-11 05:06:29.038428|2017-10-11 05:06:29.038428
NCT00116324|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2007-04-02|||April 2003||2003-04-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Predicting the Response to Montelukast by Genetic Variation in Asthmatics|Predicting the Bronchoprotective Response to a Leukotriene Modifier by Genetic Polymorphism|Completed||Phase 3|150||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 05:06:29.11696|2017-10-11 05:06:29.11696
NCT00116337|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2015-04-20|||September 2004||2004-09-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Spinal Cord Stimulation to Restore Cough|Spinal Cord Stimulation to Restore Cough|Unknown status|Active, not recruiting|N/A|18|Anticipated|Case Western Reserve University||1|||f||||t||||||||||2017-10-11 05:06:29.20489|2017-10-11 05:06:29.20489
NCT00116350|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2009-03-17|||July 2005||2005-07-01|March 2009|2009-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Misoprostol for the Treatment of Postpartum Hemorrhage|Misoprostol for the Treatment of Primary Postpartum Hemorrhage|Completed||N/A|1786|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 05:06:29.344391|2017-10-11 05:06:29.344391
NCT00116363|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2008-03-28|||March 2005||2005-03-01|March 2008|2008-03-01|December 2006|Anticipated|2006-12-01|||||Interventional|||Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma|Phase II Study Examining the Biological Efficacy of Intratumoral INGN 241 (Ad-mda7) Administration in Patients With In Transit Melanoma|Unknown status|Recruiting|Phase 2|25|Anticipated|Introgen Therapeutics|||||t||||t||||||||||2017-10-11 05:06:29.677817|2017-10-11 05:06:29.677817
NCT00116376|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2015-11-07|||January 2004||2004-01-01|November 2015|2015-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)|A Phase I/II, Two-arm, Multicenter, Dose Escalation Study of Oral AEE788 Administered on a Continuous Once Daily Dosing Schedule in Adult Patients With Recurrent or Relapsing Glioblastoma Multiforme|Completed||Phase 1/Phase 2|64|Actual|Novartis||2|||f||||f||||||||||2017-10-11 05:06:29.769693|2017-10-11 05:06:29.769693
NCT00116389|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|||Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas|An Open-Label Phase 2 Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas|Terminated||Phase 2|60||Point Therapeutics||||FDA Hold May 2007|||||||||||||||2017-10-11 05:06:29.876112|2017-10-11 05:06:29.876112
NCT00116402|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-28|2014-08-04|||January 2005||2005-01-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations|A Pilot Study of the Mechanism of Synergism Between Fluticasone (FP) and Salmeterol in Preventing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations|Completed||Phase 1|15|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 05:06:30.010989|2017-10-11 05:06:30.010989
NCT00116415|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2011-04-08||2010-01-27|March 2002||2002-03-01|April 2011|2011-04-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy|Daily Antiretroviral Therapy (DART 1): An Open-Label, Single-Arm, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Didanosine Enteric Coated (Ddl-EC) in Combination With Lamivudine (3TC) and Efavirenz (EFV) Once Daily in Anti-Retroviral Therapy (ART) Naive HIV-Infected Patients|Completed||N/A|65||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 05:06:30.109676|2017-10-11 05:06:30.109676
NCT00116428|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2013-12-03|2013-02-11||October 2004||2004-10-01|December 2013|2013-12-01|March 2011|Actual|2011-03-01|October 2007|Actual|2007-10-01||Interventional|Afib IDE||NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation|NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation|Completed||Phase 3|167|Actual|Biosense Webster, Inc.||2|||f||||t||||||||||2017-10-11 05:06:30.240198|2017-10-11 05:06:30.240198
NCT00116441|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2007-12-18|||October 2000||2000-10-01|December 2007|2007-12-01|October 2004||2004-10-01|||||Interventional|||Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma|Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line|Completed||Phase 1/Phase 2|22||Cell Genesys|||||||||||||||||||2017-10-11 05:06:30.91816|2017-10-11 05:06:30.91816
NCT00116454|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2013-09-20|||July 2005||2005-07-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|Lipiocis||Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis|A Randomized and Multicenter Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis|Completed||Phase 3|73|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-11 05:06:30.999731|2017-10-11 05:06:30.999731
NCT00116467|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2007-12-18|||March 2001||2001-03-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia|Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line|Completed||Phase 2|55||Cell Genesys|||||||||||||||||||2017-10-11 05:06:31.103989|2017-10-11 05:06:31.103989
NCT00116480|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2009-03-17|||December 2005||2005-12-01|March 2009|2009-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Misoprostol in the Treatment of Postpartum Hemorrhage|Misoprostol in the Treatment of Post Partum Hemorrhage: A Placebo Randomised Controlled Trial in 4 Karachi Hospitals|Completed||N/A|61|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-10-11 05:06:31.184549|2017-10-11 05:06:31.184549
NCT00116493|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2012-04-06|||April 2004||2004-04-01|April 2012|2012-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Severe Anemia Treatment Trials, Pakistan|Evaluation of Anthelminthics and Multivitamins for Treatment of Severe Anemia in Pregnant Women and Children 6-24 Months of Age in Pakistan|Completed||Phase 3|1009|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||t||||||||||2017-10-11 05:06:31.287482|2017-10-11 05:06:31.287482
NCT00116506|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2007-12-19|||January 2005||2005-01-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer|A Phase II Study of Bevacizumab (Avastin™) and Erlotinib (Tarceva™) in Combination With FOLFOX for Patients With Untreated Metastatic Colorectal Cancer|Completed||Phase 2|35||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:06:31.394691|2017-10-11 05:06:31.394691
NCT00108459|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2009-01-20|||September 2004||2004-09-01|July 2007|2007-07-01|December 2007||2007-12-01|||||Interventional|||Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes|Safety and Efficacy of Low Carbohydrate Diet in Obesity and Type 2 DM: RCT|Completed||Phase 3|156|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:06:31.490697|2017-10-11 05:06:31.490697
NCT00108485|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2016-05-17|2015-09-04||April 2005||2005-04-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy|Randomized, Double-blind, Placebo-controlled Trial of Niaspan® in Patients With Overt Diabetic Nephropathy and Moderate Renal Impairment|Terminated||Phase 3|9|Actual|University of Miami|Early termination of study lead to small number of subjects analyzed.|2||Unable to recruit sufficient study subjects|f||||f||||||||||2017-10-11 05:06:31.564546|2017-10-11 05:06:31.564546
NCT00108498|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2009-01-20|||October 2003||2003-10-01|May 2007|2007-05-01|March 2007||2007-03-01|||||Interventional|||New Pharmacological Treatment for Obstructive Sleep Apnea|New Pharmacological Treatment for Obstructive Sleep Apnea|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:06:31.851735|2017-10-11 05:06:31.851735
NCT00108511|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2009-01-20|||October 2004||2004-10-01|May 2007|2007-05-01|September 2007||2007-09-01|||||Interventional|||Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides|Effect of Gemfibrozil on Serum GPI Phospholipase D and Triglycerides|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:06:32.111993|2017-10-11 05:06:32.111993
NCT00108524|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2014-03-26|2013-09-26||July 2004||2004-07-01|March 2014|2014-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional||160 participants were randomized (81 allocated to LCKD, 79 to Orlistat plus LFD). 14 did not receive the intervention. 33 discontinued the intervention. Out of the 146 participants analyzed, 113 completed the intervention.|A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss|A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss|Completed||N/A|146|Actual|VA Office of Research and Development|We provided orlistat at no cost. This could have increased dietary adherence, attendance, and/or retention compared with the LCKD and may lead to different results than what might be seen in patients who must pay for orlistat.|2|||f||||f||||||||||2017-10-11 05:06:32.179225|2017-10-11 05:06:32.179225
NCT00108537|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2008-04-02|||October 2003||2003-10-01|October 2006|2006-10-01|September 2005||2005-09-01|||||Interventional|||Non-Nicotine Agents for Smoking Cessation|Non-Nicotine Agents for Smoking Cessation|Completed||Phase 3|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:06:32.485263|2017-10-11 05:06:32.485263
NCT00108550|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2013-12-20|2013-07-15||October 2004||2004-10-01|December 2013|2013-12-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Chronic Low Back Pain Research Project|Efficacy of Antidepressants in Chronic Back Pain|Completed||Phase 2|108|Actual|VA Office of Research and Development|Limitations include small sample size, high rate of early termination, and moderate baseline levels of pain intensity and disability in everyday function which may have limited ability to detect an effect.|2|||f||||t||||||||||2017-10-11 05:06:32.565714|2017-10-11 05:06:32.565714
NCT00108563|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2009-01-20|||October 2003||2003-10-01|May 2007|2007-05-01|September 2006||2006-09-01|||||Interventional|||VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients|VISN 20 Prophylactic Treatment of IFN-Induced Depression in Hepatitis C|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:06:32.880971|2017-10-11 05:06:32.880971
NCT00108576|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2015-10-20|||October 2003||2003-10-01|October 2015|2015-10-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)|Divalproex Sodium in the Treatment of PTSD: A Placebo-Controlled Study|Completed||Phase 3|101|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:06:32.944129|2017-10-11 05:06:32.944129
NCT00108589|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2009-01-20|||January 2004||2004-01-01|May 2007|2007-05-01|December 2006||2006-12-01|||||Interventional|||S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis|S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis|Completed||Phase 3|||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:06:33.054473|2017-10-11 05:06:33.054473
NCT00108602|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2015-06-25|||May 2007||2007-05-01|June 2015|2015-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Sleep Apnea: Mechanism and Cerebrovascular Consequences|Sleep Apnea: Mechanism and Cerebrovascular Consequences|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||This study of the overall grant was not pursued as the aims were changed|f||||||||||||||2017-10-11 05:06:33.10909|2017-10-11 05:06:33.10909
NCT00108615|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2008-04-23|||January 2004||2004-01-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance|Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance|Completed||Phase 4|48|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:06:33.248131|2017-10-11 05:06:33.248131
NCT00108628|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2015-02-17|2014-12-03||April 2004||2004-04-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|September 2008|Actual|2008-09-01||Interventional|||Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance|7857 Cognitive - Behavioral Treatments for PTSD Sleep Disturbance|Completed||N/A|134|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:06:33.363346|2017-10-11 05:06:33.363346
NCT00108654|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2017-06-30|||April 13, 2005||2005-04-13|January 15, 2008|2008-01-15|January 15, 2008||2008-01-15|||||Interventional|||Vaccine Treatment for HIV-Infection|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Booster Dose of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Subjects Who Where Previously Immunized With VRC-HIVDNA016-00-VP in VRC 00|Completed||Phase 1|14||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:33.889742|2017-10-11 05:06:33.889742
NCT00108667|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-15|2008-03-03|||April 2005||2005-04-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Talampanel to Treat Parkinson's Disease|AMPA Receptor Antagonist Treatment of Parkinson's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:33.972294|2017-10-11 05:06:33.972294
NCT00108680|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-16|2017-06-30|||April 13, 2005||2005-04-13|January 14, 2011|2011-01-14|January 14, 2011||2011-01-14|||||Observational|||Effects of Two Different Kinds of Exercise on Stroke Rehabilitation|Effects of Unilateral and Bilateral Training on Motor Function in Chronic Stroke|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:34.050549|2017-10-11 05:06:34.050549
NCT00108706|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-18|2006-09-11|||December 2004||2004-12-01|September 2006|2006-09-01|September 2007||2007-09-01|||||Interventional|||Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)|Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)|Unknown status|Active, not recruiting|Phase 4|50||City Hospitals Sunderland NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:06:34.114375|2017-10-11 05:06:34.114375
NCT00108732|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-18|2015-06-03|2012-10-19||February 2006||2006-02-01|December 2013|2013-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer|A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:06:34.209797|2017-10-11 05:06:34.209797
NCT00108745|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-18|2017-05-03|||March 2005||2005-03-01|May 2017|2017-05-01||||January 2022|Anticipated|2022-01-01||Interventional|||Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer|A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or CT-2103 Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy|Active, not recruiting||Phase 3|1100|Anticipated|Gynecologic Oncology Group||3|||f||||t||||||||||2017-10-11 05:06:34.557549|2017-10-11 05:06:34.557549
NCT00108758|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-18|2017-01-11|||March 2004||2004-03-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia|Exploratory, Multi-centre, Randomised, Double-blind, Uncontrolled Trial Evaluating the Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in Secondary Bleeding Prophylaxis in Congenital Haemophilia A or B Patients With Inhibitors|Completed||Phase 2|23|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:06:35.46534|2017-10-11 05:06:35.46534
NCT00108771|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-18|2012-06-04|||April 2004||2004-04-01|June 2012|2012-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain|Double-Blind, Parallel, Randomized, Placebo-Controlled 12-Week Efficacy and Safety Assessment of ZR-02-01 in the Treatment of Chronic, Moderate to Severe Osteoarthritis (OA) Pain|Completed||Phase 2|202|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-10-11 05:06:35.615058|2017-10-11 05:06:35.615058
NCT00108784|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-18|2010-01-12|||March 2003||2003-03-01|January 2010|2010-01-01|July 2004||2004-07-01|||||Interventional|||Factors Affecting Caloric Regulation in Human Feeding|The Effect of Decreases in Energy Density on Weight Loss and Weight Maintenance|Completed||N/A|100||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:06:35.791335|2017-10-11 05:06:35.791335
NCT00108797|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-18|2017-01-11|||September 2001||2001-09-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Trial of NovoSeven® in Haemophilia - Joint Bleeds|NovoSeven® (rFVIIa) by Single Dose for Home Treatment of Joint Bleeds in Haemophilia Patients With Inhibitors: A Pilot, Double-Blind Study Versus Standard Multiple Doses of NovoSeven® and Open-Label FEIBA®|Completed||Phase 4|42|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:06:35.886365|2017-10-11 05:06:35.886365
NCT00108810|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-18|2012-05-30||2012-03-14|April 2005||2005-04-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee|Randomized, Double-Blind, Parallel, Placebo Controlled 4 Week Proof-of-Concept Study to Evaluate the Safety and Efficacy of Transdermal Ketoprofen When Administered With Controlled Heat in Patients With Mild to Moderate OA Pain of the Knee|Completed||Phase 2|118|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-10-11 05:06:36.017183|2017-10-11 05:06:36.017183
NCT00108823|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-19|2016-10-24|||October 2004||2004-10-01|September 2016|2016-09-01||||||||Interventional|||The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)|A 24-week, Double Blind, Randomized Study to Investigate the Effect of 500 µg Roflumilast Tablets Once Daily Versus Placebo on Parameters Indicative of Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|550||AstraZeneca|||||f||||||||||||||2017-10-11 05:06:36.124427|2017-10-11 05:06:36.124427
NCT00108836|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-19|2010-05-19|||March 2005||2005-03-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder|Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder|Completed||Phase 2|400||Novartis|||||||||||||||||||2017-10-11 05:06:36.246741|2017-10-11 05:06:36.246741
NCT00108849|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-19|2017-02-06|||March 2005||2005-03-01|February 2017|2017-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms|A 12 Month Double-blind, Randomized, Parallel-group, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of Vagifem Low Dose (10 mcg 17beta-estradiol Vaginal Tablet) for the Treatment of Postmenopausal Atrophic Vaginitis Symptoms|Completed||Phase 3|309|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:06:36.380374|2017-10-11 05:06:36.380374
NCT00110409|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-06|2013-06-07|||January 2005||2005-01-01|June 2013|2013-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Asthma Patient Education in the Emergency Room|Trial of Asthma Patient Education in the Emergency Room|Completed||N/A|296|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-10-11 05:07:18.813298|2017-10-11 05:07:18.813298
NCT00108862|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-19|2016-01-04|2011-09-27||August 2006||2006-08-01|January 2016|2016-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|STRIDE||Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis|A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3|Completed||Phase 4|809|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-10-11 05:06:36.615089|2017-10-11 05:06:36.615089
NCT00108875|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-19|2006-07-27|||April 2003||2003-04-01|June 2005|2005-06-01||||||||Interventional|||Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer|Vaccination of Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer With HLA-A1, -A2 and -B35 Restricted Survivin Peptides|Unknown status|Recruiting|Phase 1/Phase 2|70||Julius-Maximilians University|||||f||||||||||||||2017-10-11 05:06:37.852166|2017-10-11 05:06:37.852166
NCT00108901|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-20|2014-12-22|||June 2003||2003-06-01|December 2014|2014-12-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||The Medical College of Georgia PLAY Project: Exercise Dose and Insulin Sensitivity in Obese Children|Exercise Dose and Insulin Sensitivity in Obese Children|Completed||Phase 2|222|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||f||||||||||2017-10-11 05:06:37.942206|2017-10-11 05:06:37.942206
NCT00108914|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-20|2017-01-18|||February 2005||2005-02-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Perennial Allergic Rhinitis Study In Pediatric Subjects|A Two Week Randomized, Double Blind Placebo Controlled, Parallel Group Study of GW685698X Aqueous Nasal Spray 100mcg and 50mcg QD in Pediatric Subjects With Perennial Allergic Rhinitis|Completed||Phase 3|558|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:06:38.054447|2017-10-11 05:06:38.054447
NCT00108927|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-20|2010-03-01|||December 2003||2003-12-01|March 2010|2010-03-01|December 2005||2005-12-01|||||Observational|||Improving Diabetes in Primary Care (IMPACT)|Improving Diabetes Through Primary Care Translation (IMPACT)|Completed||N/A|6000||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:06:38.2251|2017-10-11 05:06:38.2251
NCT00108940|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-20|2011-09-23|||December 2000||2000-12-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2009|Actual|2009-06-01||Observational|SWISS||Siblings With Ischemic Stroke Study|Siblings With Ischemic Stroke Study|Completed||N/A|900|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"     Whole blood   "|||2017-10-11 05:06:38.440634|2017-10-11 05:06:38.440634
NCT00108953|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-21|2014-10-24|2009-04-23||April 2005||2005-04-01|October 2014|2014-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma|A Randomized Controlled Study of BAY43-9006 in Combination With Doxorubicin Versus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma.|Completed||Phase 2|96|Actual|Bayer|The study had been prematurely terminated by the sponsor because positive results were obtained in another Nexavar trial (Phase 3 study 100554 NCT00105443). NCI-CTC was translated to MedDRA for SOCs only.|2|||f||||f||||||||||2017-10-11 05:06:38.591588|2017-10-11 05:06:38.591588
NCT00108979|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-21|2012-03-01|||March 2005||2005-03-01|March 2012|2012-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study of Escitalopram in Adult Patients With Major Depressive Disorder|Double-Blind Study of Escitalopram in Adult Patients With Major Depressive Disorder|Completed||Phase 3|240||Forest Laboratories|||||||||||||||||||2017-10-11 05:06:39.693598|2017-10-11 05:06:39.693598
NCT00108992|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-21|2007-01-04|||February 2004||2004-02-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis||Completed||Phase 3|750||Nuvo Research Inc.|||||f||||||||||||||2017-10-11 05:06:39.777152|2017-10-11 05:06:39.777152
NCT00109005|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-21|2016-11-14|2012-08-29||April 2005||2005-04-01|November 2016|2016-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma|A Randomized Phase II Study of Oral Lenalidomide (Revlimid [TM]), an Antiangiogenic and Immunomodulatory Agent, in Subjects With Stage IV Ocular Melanoma|Completed||Phase 2|17|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||No||2017-10-11 05:06:39.929782|2017-10-11 05:06:39.929782
NCT00109018|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-21|2017-06-30|||April 19, 2005||2005-04-19|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Observational|||Biomarkers for Cardiovascular Disease|Nitrite as a Marker of Cardiovascular Risk; Development of Novel Biomarkers in Patients With Coronary Artery Disease|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:40.676249|2017-10-11 05:06:40.676249
NCT00109031|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2014-09-12|2014-01-24||January 2005||2005-01-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|February 2006|Actual|2006-02-01||Interventional||Primary Analysis Set (all randomized participants who signed informed consent before invasive, protocol-specified procedures).|Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)|A Randomized, Blinded, Active-control Trial of Palifermin (rHuKGF) to Evaluate Oral Mucositis in Subjects With Hematologic Malignancies Undergoing Fractionated Total Body Irradiation (fTBI) and High Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell (PBPC) Transplantation|Completed||Phase 3|47|Actual|Swedish Orphan Biovitrum||4|||f||||t||||||||||2017-10-11 05:06:40.812721|2017-10-11 05:06:40.812721
NCT00109044|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2012-03-01|||March 2005||2005-03-01|March 2012|2012-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder|Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder|Completed||Phase 3|540||Forest Laboratories|||||f||||||||||||||2017-10-11 05:06:42.865254|2017-10-11 05:06:42.865254
NCT00109057|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2013-06-19|||February 1998||1998-02-01|June 2013|2013-06-01|February 2004|Actual|2004-02-01|||||Interventional|||An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study|An Open-Label, Multicenter Extension Study of Recombinant Humanized Monoclonal Anti-VEGF Antibody (rhuMAb VEGF, Bevacizumab) in Subjects Treated With rhuMAb VEGF in a Previous Genentech-Sponsored Phase I or Phase II Cancer Study|Completed||Phase 2|56|Actual|Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:42.960469|2017-10-11 05:06:42.960469
NCT00109070|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2013-06-19|||September 2000||2000-09-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|||||Interventional|||A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer|A Phase III, Multicenter, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab) in Combination With Standard Chemotherapy in Subjects With Metastatic Colorectal Cancer|Completed||Phase 3|||Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:43.006113|2017-10-11 05:06:43.006113
NCT00109083|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2012-08-01|||March 2002||2002-03-01|August 2012|2012-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging, Multicenter Study of the Efficacy of RWJ-333369 in the Prophylaxis of Migraine|Completed||Phase 2|300||SK Life Science|||||f||||||||||||||2017-10-11 05:06:43.066496|2017-10-11 05:06:43.066496
NCT00109096|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2007-05-16|||June 2005||2005-06-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy|A Randomized, Double-Blind Phase 2 Study of Two Doses of Pemetrexed in the Treatment of Platinum-Resistant, Epithelial Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|100|Anticipated|Eli Lilly and Company|||||||||||||||||||2017-10-11 05:06:43.158508|2017-10-11 05:06:43.158508
NCT00109109|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2017-04-03|||December 1, 2003|Actual|2003-12-01|April 2017|2017-04-01|February 14, 2006|Actual|2006-02-14|February 14, 2006|Actual|2006-02-14||Interventional|||A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)|Phase II Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma|Terminated||Phase 1|60||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:06:43.263041|2017-10-11 05:06:43.263041
NCT00109122|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2017-03-14|||November 2001||2001-11-01|March 2017|2017-03-01|July 2006|Actual|2006-07-01|February 2003|Actual|2003-02-01||Interventional|||Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)|A Double-Blind, Placebo-Controled, Randomized Study to Evaluate Safety, Tolerability, and Immunogenicity After 1 and 2 Doses of Zoster Vaccine|Completed||Phase 2|180|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:06:43.323838|2017-10-11 05:06:43.323838
NCT00109135|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2015-09-24|||January 2005||2005-01-01|September 2015|2015-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)|A Double-Blind, Multicenter, Randomized, Titrated-Dose, Placebo-Controlled, Study of MK0364 (4 mg to 8 mg) in Chronic Cigarette Smokers as an Aid for Smoking Cessation|Completed||Phase 2|300|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:06:43.392582|2017-10-11 05:06:43.392582
NCT00109148|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2015-09-08|||July 2004||2004-07-01|September 2015|2015-09-01|February 2005|Actual|2005-02-01|January 2005|Actual|2005-01-01||Interventional|||An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)|A Study to Assess the Safety and Efficacy of MK0364 in Obese Patients|Completed||Phase 2|500|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:06:43.451096|2017-10-11 05:06:43.451096
NCT00109161|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2008-08-02|||April 2005||2005-04-01|August 2008|2008-08-01|October 2006||2006-10-01|||||Interventional|||Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis|A Phase II Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis|Completed||Phase 2|270||Facet Biotech|||||||||||||||||||2017-10-11 05:06:43.526245|2017-10-11 05:06:43.526245
NCT00109174|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-22|2017-10-05|||April 20, 2005||2005-04-20|July 12, 2017|2017-07-12|April 23, 2018|Anticipated|2018-04-23|January 23, 2018|Anticipated|2018-01-23||Interventional|||MRS Measurement of Glutamate and GABA Metabolism in Brain|MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:06:43.782575|2017-10-11 05:06:43.782575
NCT00109187|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-26|2013-06-19|||June 2002||2002-06-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|||||Interventional|||An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g|Open-Label Extension Study II of Xolair (Omalizumab) in Moderate to Severe, Persistent Asthma Subjects Who Completed Study Q2143g (ALTO)|Completed||Phase 3|0||Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:43.89809|2017-10-11 05:06:43.89809
NCT00109200|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-26|2013-06-19|||May 2003||2003-05-01|June 2013|2013-06-01|September 2003|Actual|2003-09-01|||||Interventional|||A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma|A Continued Access Protocol to Provide Xolair® (Omalizumab) to Subjects With Severe Allergic Asthma Who Have Received Xolair Treatment in a Previous Investigational Study|Completed||Phase 3|||Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:45.909066|2017-10-11 05:06:45.909066
NCT00109213|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-26|2015-12-02|||May 2002||2002-05-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|September 2009|Actual|2009-09-01||Interventional|SLIP||Greenwich Lumbar Stenosis SLIP Study|Greenwich Lumbar Stenosis SLIP Study: A Multi-center, Randomized, Prospective Clinical Trial Comparing Spinal Laminectomy to Laminectomy With Instrumented Pedicle Screw Fusion for Lumbar Stenosis With Grade I Spondylolisthesis|Completed||Phase 3|66|Actual|Greenwich Hospital||2|||f||||t||||||||||2017-10-11 05:06:46.063898|2017-10-11 05:06:46.063898
NCT00109226|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-26|2014-04-07|||August 2000||2000-08-01|April 2014|2014-04-01|September 2003|Actual|2003-09-01|||||Interventional|||A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer|A Phase II, Multicenter, Double-Blind, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab), a Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor, in Combination With 5-Fluorouracil and Leucovorin Chemotherapy in Subjects With Metastatic Colorectal Cancer Who Are Not Optimal Candidates for First Line CPT-11|Completed||Phase 2|||Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:46.219746|2017-10-11 05:06:46.219746
NCT00109239|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-26|2014-06-16|||November 2000||2000-11-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|||||Interventional|||A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer|A Multicenter, Open-Label, Phase III, Randomized, Active-Controlled Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of rhuMAb VEGF (Bevacizumab), in Combination With Capecitabine Chemotherapy, in Subjects With Previously Treated Metastatic Breast Cancer|Completed||Phase 3|||Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:46.320282|2017-10-11 05:06:46.320282
NCT00109252|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-26|2013-06-19|||January 2002||2002-01-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|||||Interventional|||A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g|An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab Followed by Efalizumab Taper in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g|Completed||Phase 3|0||Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:46.407029|2017-10-11 05:06:46.407029
NCT00192998|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-26|||October 2003||2003-10-01|September 2005|2005-09-01||||||||Observational|||The Serotonergic Transmitter System in Dementia and Affective Disorders||Unknown status|Recruiting|N/A|100|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:51.25604|2017-10-11 05:30:51.25604
NCT00109265|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-26|2015-07-01|||May 2001||2001-05-01|June 2013|2013-06-01|October 2002|Actual|2002-10-01|||||Interventional|||A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy|A Phase II, Multicenter, Open-Label Clinical Trial to Evaluate the Efficacy and Safety of OSI-774 in Patients With Advanced or Metastatic Breast Cancer and Disease Progression During or Following Chemotherapy|Completed||Phase 2|||Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:46.495695|2017-10-11 05:06:46.495695
NCT00109278|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-26|2017-03-14|||October 2004||2004-10-01|March 2017|2017-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)|A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured From the 2003 Measles Stock Seed With Recombinant Human Albumin (rHA) Versus Currently Licensed V205C Manufactured From the 1967 Measles Stock Seed With Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age|Completed||Phase 2|1100|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:06:46.589939|2017-10-11 05:06:46.589939
NCT00109291|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2012-12-19|||March 2005||2005-03-01|December 2012|2012-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease|A Phase 2a, Randomized, Double-blind, Placebo-controlled, Sequential Dose Escalation Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Patients With Chronic Kidney Disease Who Are Not on Dialysis and Who Have Not Had Prior Erythropoiesis Stimulating Agent (ESA) Treatment|Terminated||Phase 2|17|Actual|Affymax||4||Due to slow enrollment|f||||f||||||||||2017-10-11 05:06:46.706156|2017-10-11 05:06:46.706156
NCT00109304|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2015-09-17|||July 2005||2005-07-01|September 2015|2015-09-01|December 2006||2006-12-01|||||Interventional|||Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine|Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine VEE IA/B V3526 in VEE-Naive Healthy Volunteers After Single Dose Subcutaneous Administration|Withdrawn||Phase 1|0|Actual|DynPort Vaccine Company LLC, A CSC Company||1||Funding withdrawn|f||||t||||||||||2017-10-11 05:06:46.830587|2017-10-11 05:06:46.830587
NCT00109317|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2013-06-19|||September 2002||2002-09-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|||||Interventional|||A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy|A Phase IIIb, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy|Completed||Phase 3|686|Actual|Genentech, Inc.|||||||||||||||||||2017-10-11 05:06:46.928934|2017-10-11 05:06:46.928934
NCT00109330|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2016-09-08|||November 2002||2002-11-01|September 2016|2016-09-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine|A Phase III, Observer-blinded Randomised, Multi-centre Clinical Study of the Safety, Immunogenicity and Consistency of Three Manufacturing Lots of GSK Biologicals' Candidate Tdap Vaccine as Compared to a US-licensed Td Vaccine When Given as a Booster Dose to Healthy Adolescents (10-18 Years of Age)|Completed||Phase 3|4116|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:06:47.006373|2017-10-11 05:06:47.006373
NCT00109343|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2017-03-15|2009-09-23||March 2006||2006-03-01|March 2017|2017-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)|An Open, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of V221 Given Concomitantly With Pneumococcal Conjugate Vaccine in Healthy Children 12 to 15 Months of Age|Completed||Phase 3|1027|Actual|Merck Sharp & Dohme Corp.|One subject (Group 3-ProQuad™ followed by PREVNAR™) was diagnosed (Day 8) with Stage IV neuroblastoma (considered not related to study vaccine by investigator) and discontinued from the study. Subject died (Day 218) due to neuroblastoma.|3|||f||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:06:47.380607|2017-10-11 05:06:47.380607
NCT00109356|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2007-05-04|||March 2005||2005-03-01|May 2007|2007-05-01|March 2007||2007-03-01|||||Interventional|||Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia|A Phase 1/2, Open Label, Dose Escalation Study of AQ4N for Safety, Tolerability, Pharmacokinetics and Activity in Patients With Lymphoid Neoplasms|Unknown status|Active, not recruiting|Phase 1/Phase 2|55||Novacea|||||||||||||||||||2017-10-11 05:06:48.384634|2017-10-11 05:06:48.384634
NCT00109369|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2011-01-31|||June 2003||2003-06-01|January 2011|2011-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Vermont Diabetes Information System|Vermont Diabetes Information System|Completed||N/A|7500|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 05:06:48.457286|2017-10-11 05:06:48.457286
NCT00109382|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2008-04-07|||May 2003||2003-05-01|June 2007|2007-06-01|February 2007|Actual|2007-02-01|||||Interventional|||Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)|Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)|Completed||Phase 2/Phase 3|500|Anticipated|University of Calgary||4|||f||||||||||||||2017-10-11 05:06:48.558374|2017-10-11 05:06:48.558374
NCT00109395|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2016-05-20|||September 2004||2004-09-01|November 2011|2011-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Lorazepam Sedation for Critically Ill Children|A Randomized Controlled Trial Comparing Lorazepam With Midazolam for Sedation of Mechanically Ventilated Pediatric Patients|Completed||Phase 2/Phase 3|179|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||t||||||||||2017-10-11 05:06:48.676607|2017-10-11 05:06:48.676607
NCT00109408|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2016-11-01|||July 2005||2005-07-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis|A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Monotherapy Versus Methotrexate Monotherapy in Patients With Moderate to Severe Active Rheumatoid Arthritis|Completed||Phase 3|673|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:06:48.787652|2017-10-11 05:06:48.787652
NCT00110422|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-09|2011-04-07||2010-02-15|November 2005||2005-11-01|June 2010|2010-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome|Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome|Completed||Phase 4|400||Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 05:07:18.909422|2017-10-11 05:07:18.909422
NCT00109421|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2017-02-27|||November 2004||2004-11-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Friendship Based HIV/STI (Sexually Transmitted Infections) Intervention for African American Females|PROJECT ÒRÉ: An Innovative Friendship Based HIV/STI Intervention for High Risk African American Females|Completed||N/A|420|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 05:06:49.278875|2017-10-11 05:06:49.278875
NCT00109434|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2016-09-02|||June 2004||2004-06-01|September 2016|2016-09-01|November 2004||2004-11-01|||||Observational|||Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes|The Effect of Exercise on the Development of Hypoglycemia in Children With Type 1 Diabetes; A Study Being Conducted by the Diabetes Research in Children Network|Completed||N/A|50||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 05:06:49.372015|2017-10-11 05:06:49.372015
NCT00109460|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-27|2015-05-11|||March 2003||2003-03-01|May 2015|2015-05-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Tobacco Cessation Field Study for Adults in Recovery - 1|Tobacco Cessation Clinical Field Study for Adults in Alcohol Abuse Recovery|Completed||Phase 2|203|Actual|Inflexxion, Inc.|||||f||||t||||||||||2017-10-11 05:06:49.468511|2017-10-11 05:06:49.468511
NCT00109473|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2017-01-11|2011-06-24||April 2005||2005-04-01|January 2017|2017-01-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Trial of Growth Hormone Therapy in Pediatric Crohn's Disease|A Phase II Randomized Trial of Growth Hormone Therapy in Pediatric Crohn's Disease|Completed||Phase 2|22|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-10-11 05:06:49.579532|2017-10-11 05:06:49.579532
NCT00109486|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2016-09-13|||April 2005||2005-04-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray|A Randomised, Double-Blind, Placebo-Controlled, Two-Week Crossover, Knemometric Assessment of the Effect of Fluticasone Furoate Nasal Spray 100mcg Once Daily on Short-Term Growth in Children Aged 6 to 11 Years With Seasonal and/or Perennial Allergic Rhinitis|Completed||Phase 3|56|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:06:50.519027|2017-10-11 05:06:50.519027
NCT00109499|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2011-05-11||||||May 2011|2011-05-01||||||||Interventional|||Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)|An Open-label, Phase I, Single Administration, Dose- Escalation Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)|Completed||Phase 1|||GenVec|||||||||||||||||||2017-10-11 05:06:50.61738|2017-10-11 05:06:50.61738
NCT00109512|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2012-02-21|||April 2005||2005-04-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Endometriosis Trial: Study of NBI-56418 in Endometriosis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of NBI-56418 in Endometriosis|Completed||Phase 2|76|Actual|Abbott||3|||f||||||||||||||2017-10-11 05:06:50.699865|2017-10-11 05:06:50.699865
NCT00109525|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2017-09-22|||March 2004||2004-03-01|September 2017|2017-09-01|December 2009|Actual|2009-12-01|July 2007|Actual|2007-07-01||Observational|Candida||Early Diagnosis of Candidiasis in Premature Infants|Early Diagnosis of Nosocomial Candidiasis Study|Completed||N/A|1500|Actual|NICHD Neonatal Research Network|||1||f||||f||||||||||2017-10-11 05:06:50.822875|2017-10-11 05:06:50.822875
NCT00109538|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2015-04-09||2009-04-14|May 2005||2005-05-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)|A Pivotal Randomized Study of Lonafarnib Versus Placebo in the Treatment of Subjects With Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) Who Are Platelet Transfusion Dependent With or Without Anemia|Terminated||Phase 3|47|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:06:50.971285|2017-10-11 05:06:50.971285
NCT00109551|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2013-04-30|||October 2001||2001-10-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal|Zinc Supplementation Impact on Child Mortality--Nepal|Completed||Phase 3|58000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:06:51.053427|2017-10-11 05:06:51.053427
NCT00109564|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2008-07-17|||January 2005||2005-01-01|July 2008|2008-07-01|October 2005||2005-10-01|||||Interventional|||A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)|A Safety and Efficacy Study of TC-1734-112 in Subjects With Age Associated Memory Impairment (AAMI)|Completed||Phase 2|174||Targacept Inc.|||||||||||||||||||2017-10-11 05:06:51.14217|2017-10-11 05:06:51.14217
NCT00109577|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-28|2012-09-11|2012-06-25||April 2005||2005-04-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder|Randomized Placebo-controlled Phase II Trial of MCN36 in Adults With Bipolar Disorder|Terminated||Phase 2|40|Actual|University of Calgary||2||Unable to recruit large enough sample; large expectancy effects but no adverse events|f||||t||||||||||2017-10-11 05:06:51.400059|2017-10-11 05:06:51.400059
NCT00109590|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-29|2014-12-30|2012-06-26|2010-01-20|June 2006||2006-06-01|December 2014|2014-12-01|November 2009|Actual|2009-11-01|October 2008|Actual|2008-10-01||Interventional|||Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth|Phase II Study of the Pharmacokinetics of Nevirapine and the Incidence of Nevirapine Resistance Mutations in HIV-Infected Women Receiving a Single Intrapartum Dose of Nevirapine With the Concomitant Administration of Zidovudine/Didanosine or Zidovudine/Didanosine/Lopinavir/Ritonavir|Completed||Phase 2|175|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 05:06:51.788511|2017-10-11 05:06:51.788511
NCT00109603|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-29|2012-10-26|||May 2005||2005-05-01|October 2012|2012-10-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy|A Pilot Study to Determine the Impact on Dyslipidemia of the Addition of Tenofovir to Stable Background Antiretroviral Therapy in HIV-Infected Subjects|Completed||N/A|17|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:06:53.915829|2017-10-11 05:06:53.915829
NCT00109616|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-29|2013-04-30|||October 2002||2002-10-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Community Trial of Newborn Skin and Umbilical Cord Cleansing on Neonatal Mortality in Nepal|Newborn Antiseptic Washing and Neonatal Mortality-Nepal|Completed||Phase 3|17000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:06:54.035876|2017-10-11 05:06:54.035876
NCT00109629|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-29|2017-06-30|||April 26, 2005||2005-04-26|January 22, 2008|2008-01-22|January 22, 2008||2008-01-22|||||Interventional|||"Prime-Boost Vaccine Schedule for Prevention of HIV Infection"|VRC 008: A Phase I Clinical Trial of a Prime-Boost HIV-1 Vaccination Schedule: Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, Followed by Multiclade Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:54.126201|2017-10-11 05:06:54.126201
NCT00109642|ClinicalTrials.gov processed this data on October 10, 2017|2005-04-29|2017-06-30|||April 26, 2005||2005-04-26|June 8, 2009|2009-06-08|March 15, 2009|Actual|2009-03-15|March 15, 2009|Actual|2009-03-15||Observational|||The Role of Norepinephrine in Emotional Processing|Investigating the Role of Norepinephrine in Emotional Processing Through Alpha-2 Adrenergic Receptor Modulation|Completed||N/A|216||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:06:54.196583|2017-10-11 05:06:54.196583
NCT00109655|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-02|2008-10-01|||April 2005||2005-04-01|October 2008|2008-10-01|September 2010|Anticipated|2010-09-01|October 2008|Anticipated|2008-10-01||Interventional|||Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure|A Phase 1 Dose-Escalation Trial of Intravesical CG0070 for Superficial Transitional Cell Carcinoma of the Bladder After Bacillus Calmette-Guerin Failure|Unknown status|Active, not recruiting|Phase 1|75|Anticipated|Cell Genesys||1|||f||||||||||||||2017-10-11 05:06:54.258112|2017-10-11 05:06:54.258112
NCT00109668|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-02|2014-05-09|||July 2004||2004-07-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids||Completed||Phase 3|415||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:06:54.376289|2017-10-11 05:06:54.376289
NCT00109681|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-02|2010-02-11||2010-02-11|April 2005||2005-04-01|February 2010|2010-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis|A Randomized, Double-blind, Placebo-Controlled Phase II Study to Evaluate the Safety and Pilot Efficacy of Iloprost Inhalation Solution in Adults With Abnormal Pulmonary Arterial Pressure and Exercise Limitation Associated With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 2|50||Actelion|||||||||t||||||||||2017-10-11 05:06:54.627631|2017-10-11 05:06:54.627631
NCT00109707|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-02|2016-04-27|||May 2004||2004-05-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers|A Phase IA/II Multicenter, Dose-escalation Study of Oral AMN107 on a Continuous Daily Dosing Schedule in Adult Patients With Imatinib-resistant/Intolerant CML in Chronic or Accelerated Phase or Blast Crisis, Relapsed/Refractory Ph+ ALL, and Other Hematologic Malignancies.|Completed||Phase 1/Phase 2|942|Actual|Novartis||6|||f||||||||||||||2017-10-11 05:06:54.7574|2017-10-11 05:06:54.7574
NCT00109720|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-02|2010-01-14|||August 2002||2002-08-01|January 2010|2010-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Evaluation of Diabetes Self-Management Consultant Care|Evaluation of Diabetes Self-Management Consultant Care|Completed||N/A|310|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 05:06:55.100639|2017-10-11 05:06:55.100639
NCT00109733|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-02|2013-08-04|2010-05-19||January 2005||2005-01-01|August 2013|2013-08-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency|A Phase IIIb, Prospective, Multicenter, Randomized, Open-label Study to Determine the Safety and Efficacy of Two Different Dosing Regimens of Saizen® (Recombinant Human Growth Hormone (r-hGH), Using Cool.Click™ in Subjects With Childhood-onset Growth Hormone Deficiency During the Adolescent Transition Phase (CATS)|Completed||Phase 3|31|Actual|EMD Serono||2|||f||||||||||||||2017-10-11 05:06:55.211497|2017-10-11 05:06:55.211497
NCT00109746|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-02|2016-03-22|||November 2005||2005-11-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|NT||Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults|A Novel Therapy for Glucose Intolerance in HIV Disease|Completed||Phase 1/Phase 2|39|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-10-11 05:06:55.846709|2017-10-11 05:06:55.846709
NCT00109759|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2010-06-16|||May 2005||2005-05-01|June 2010|2010-06-01|June 2005||2005-06-01|||||Interventional|||Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)|A Double-Blind Phase I Study to Evaluate the Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL® in Healthy Volunteers.|Withdrawn||Phase 1|15||Allergy Therapeutics|||||f||||||||||||||2017-10-11 05:06:55.937403|2017-10-11 05:06:55.937403
NCT00109772|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2013-08-26|2013-05-07||February 2005||2005-02-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|CRPS-002|Safety population|Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1|A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1|Terminated||Phase 2|184|Actual|Celgene||2||Interim analysis showed the primary outcome was not reached|f||||t||||||||||2017-10-11 05:06:56.051199|2017-10-11 05:06:56.051199
NCT00109785|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2015-12-23|||March 1997||1997-03-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||PET Scans in Patients With Locally Advanced Breast Cancer|Positron Emitter I-124-Iododeoxyuridine to Follow DNA Metabolism on Scans and in Tumor Samples in Advanced Breast Cancer: Comparison to 18-F-2-Fluoro-2-Deoxy-(D)-Glucose, as a Tracer for Glycolysis|Completed||Phase 1|8|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 05:06:57.049415|2017-10-11 05:06:57.049415
NCT00109798|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2017-09-15|||March 2005||2005-03-01|September 2017|2017-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma|Phase II Trial of Salvage Chemotherapy With Temozolomide in Combination With Topotecan for Primary CNS Lymphoma|Withdrawn||N/A|0|Actual|The Methodist Hospital System||1||Sub-Investigator reloacted to another institution|f||||f||||||||||2017-10-11 05:06:57.124802|2017-10-11 05:06:57.124802
NCT00109811|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2013-01-22|||March 2005||2005-03-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer|A Phase 2 Study of Prostate Specific Antigen Peptide 3A (PSA: 154-163(155L) ) (NSC # 722932, IND#9787) With Montanide ISA-51(NSC #675756, IND #9787) or Montanide® ISA 51 VG (NSC 737063) Vaccination in Prostate Cancer Recurrent|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:06:57.212517|2017-10-11 05:06:57.212517
NCT00109824|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2013-06-03|||March 2006||2006-03-01|June 2013|2013-06-01||||March 2009|Actual|2009-03-01||Interventional|||Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:06:57.32299|2017-10-11 05:06:57.32299
NCT00109837|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2015-03-05|2012-04-04||April 2005||2005-04-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2010|Actual|2010-11-01||Interventional|||S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|A Phase II Study of Double Induction Chemotherapy for Newly Diagnosed Non-L3 Adult Acute Lymphoblastic Leukemia With Investigation of Minimal Residual Disease and Risk of Relapse Following Maintenance Chemotherapy|Completed||Phase 2|79|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 05:06:57.550942|2017-10-11 05:06:57.550942
NCT00109850|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2015-11-16|2012-06-14||May 2005||2005-05-01|November 2015|2015-11-01|May 2012|Actual|2012-05-01|September 2009|Actual|2009-09-01||Interventional|||S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer|Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates|Terminated||Phase 2|22|Actual|Southwest Oncology Group||1||Closed due to poor accrual|f||||t||||||||||2017-10-11 05:06:58.708435|2017-10-11 05:06:58.708435
NCT00109863|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2015-02-13|||May 2005||2005-05-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|July 2007|Actual|2007-07-01||Interventional|||Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma|Phase II Trial of Hu14.18-IL2 (EMD 273063) in Subjects With Advanced Melanoma|Completed||Phase 2|14|Actual|University of Wisconsin, Madison||1|||f||||||||||||||2017-10-11 05:06:59.572766|2017-10-11 05:06:59.572766
NCT00109876|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2017-01-26|2016-11-29||September 2006||2006-09-01|January 2017|2017-01-01|February 2013|Actual|2013-02-01|August 2012|Actual|2012-08-01||Interventional||All enrolled participants who met the eligibility criteria.|Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer|A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer|Completed||N/A|54|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-10-11 05:06:59.687006|2017-10-11 05:06:59.687006
NCT00109889|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2017-04-21|||April 2005||2005-04-01|April 2017|2017-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma|A Prospective Observational Study of Patients With Solitary Plasmacytoma Using a Modified Staging System Supplemented by an MRI and Whole Body FDG-PET Scan|Terminated||Phase 2|2|Actual|Southwest Oncology Group||1||poor accrual|f||||f||||||||||2017-10-11 05:07:00.126784|2017-10-11 05:07:00.126784
NCT00109928|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2014-09-18|2014-06-11||September 2005||2005-09-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|June 2012|Actual|2012-06-01||Interventional||Peripheral T-cell lymphomas (PTCLs) with stage II bulky, III or IV with extra-nodal, nodal and transformed cutaneous presentations were eligible.|S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma|Phase II Trial of Cisplatin Plus Etoposide Plus Gemcitabine Plus Solumedrol (PEGS) in Peripheral T-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|34|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 05:07:00.299553|2017-10-11 05:07:00.299553
NCT00109941|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2013-05-16|||October 2003||2003-10-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|September 2007|Actual|2007-09-01||Interventional|OGF||Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery|Treatment of Advanced Pancreatic Cancer With Opioid Growth Factor (OGF): Phase II|Completed||Phase 2|25|Actual|Penn State University||1|||f||||t||||||||||2017-10-11 05:07:01.208571|2017-10-11 05:07:01.208571
NCT00109954|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2016-01-15|||February 2005||2005-02-01|March 2015|2015-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery|A Prospectively Randomized Controlled Clinical Trial Comparing TheraSphere With Cisplatin-Based TACE (Trans Arterial Chemo Embolization) in the Management of Advanced Stage, Unresectable Hepatocellular Carcinoma (HCC)|Completed||Phase 3|120|Anticipated|University of Pittsburgh|||||f||||t||||||||||2017-10-11 05:07:01.363783|2017-10-11 05:07:01.363783
NCT00109967|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2014-03-21|2013-12-03||May 2005||2005-05-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|September 2009|Actual|2009-09-01||Interventional|||CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Study of CCI-779 in Combination With Rituximab in Patients With Relapsed or Refractory Mantle Cell Lymphoma|Completed||Phase 2|71|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:07:01.562639|2017-10-11 05:07:01.562639
NCT00109980|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2013-10-30|||March 2005||2005-03-01|October 2013|2013-10-01||||July 2011|Actual|2011-07-01||Observational|||Medicinal Plant Use for Treating Inflammation Among Dominicans in New York City and the Dominican Republic|Dominican Herbal Medicine: Plants Used for Inflammation|Completed||N/A|320|Actual|New York Botanical Garden|||1||f||||f||||||||||2017-10-11 05:07:03.547865|2017-10-11 05:07:03.547865
NCT00109993|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2010-06-10|||January 2005||2005-01-01|June 2010|2010-06-01|May 2007|Actual|2007-05-01|June 2006|Actual|2006-06-01||Interventional|||Campath-1H + FK506 and Methylprednisolone for GVHD|Phase II Clinical Trial Incorporating Alemtuzumab (Campath-1H) in Combination With FK506 and Methylprednisolone for Treatment of Severe Acute Graft vs Host Disease|Completed||Phase 2|34|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:07:03.654323|2017-10-11 05:07:03.654323
NCT00110006|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2010-06-10|||December 2004||2004-12-01|June 2010|2010-06-01||||||||Interventional|||Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma|Prognostic Significance of Early Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F] FDG) in Intermediate and High Grade Non-Hodgkin's Lymphoma|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center||1||No accrual|f||||t||||||||||2017-10-11 05:07:03.835638|2017-10-11 05:07:03.835638
NCT00110019|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2015-09-28|2012-08-28||June 2005||2005-06-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|January 2011|Actual|2011-01-01||Interventional|||Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery|A Double-Blind, Randomized, Placebo-Controlled Phase III Trial of Carboplatin, Paclitaxel and Sorafenib Versus Carboplatin, Paclitaxel and Placebo in Patients With Unresectable Locally Advanced or Stage IV Melanoma|Completed||Phase 3|823|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-10-11 05:07:04.035717|2017-10-11 05:07:04.035717
NCT00110032|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2013-01-15|||June 2005||2005-06-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors|Microenvironment: Imaging/Implications in Brain Tumors; A Preliminary Investigation of the Biodistribution of [F-18]-EF5 in Patients With Brain Tumors|Terminated||Phase 1|46|Actual|National Cancer Institute (NCI)||3||Administratively complete.|f||||||||||||||2017-10-11 05:07:05.843642|2017-10-11 05:07:05.843642
NCT00110045|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2012-09-20|||February 2005||2005-02-01|September 2012|2012-09-01||||March 2008|Actual|2008-03-01||Interventional|||Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant|A Multicenter, Open, Phase II Study to Estimate the Activity and Safety of Caspofungin (CASP) in the First-Line Treatment of Probable and Proven Invasive Aspergillosis (IA) in Patients With Hematological Malignancies (HM) or Recipients of Autologous Haematopoietic Stem Cell Transplantation and Those With Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)|Completed||Phase 2|171|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 05:07:05.97237|2017-10-11 05:07:05.97237
NCT00110058|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2011-11-15|||February 2005||2005-02-01|November 2011|2011-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia|A Multi-Center Phase II Study of Nonmyeloablative Conditioning With TBI and Fludarabine for HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Chronic Myeloid Leukemia in Chronic and Accelerated Phase|Completed||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:07:06.137217|2017-10-11 05:07:06.137217
NCT00110071|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2014-08-04|||January 2005||2005-01-01|August 2014|2014-08-01||||June 2011|Actual|2011-06-01||Interventional|||Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma|A Clinical Trial Evaluating I131-Tositumomab (Anti-CD20) With Escalating Doses of Fludarabine Followed by Autologous or Syngeneic Stem Cell Transplantation for Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma in Patients 60 Years of Age and Older|Completed||Phase 1|38|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 05:07:06.257332|2017-10-11 05:07:06.257332
NCT00110084|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2011-05-31|2011-03-29||August 2005||2005-08-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|||ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer|Phase II Trial of Weekly Nab (Nanoparticle Albumin Bound)-Paclitaxel (Nab-paclitaxel) (Abraxane®) in Combination With Gemcitabine in Patients With Metastatic Breast Cancer|Completed||Phase 2|50|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 05:07:06.417165|2017-10-11 05:07:06.417165
NCT00110110|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2017-04-24|||June 2004||2004-06-01|April 2017|2017-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma|Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003)|Active, not recruiting||Phase 2|71|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||No||2017-10-11 05:07:07.415967|2017-10-11 05:07:07.415967
NCT00110123|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2012-09-20|||January 2005||2005-01-01|September 2012|2012-09-01||||June 2011|Actual|2011-06-01||Interventional|||Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma|Intravenous Versus Intra-Arterial Fotemustine Chemotherapy in Patients With Liver Metastases From Uveal Melanoma: A Randomized Phase III Study of the EORTC Melanoma Group|Terminated||Phase 3|171|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-10-11 05:07:07.582914|2017-10-11 05:07:07.582914
NCT00110136|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2017-01-18|2014-09-04||March 2006||2006-03-01|December 2014|2014-12-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional||All registered participants are used in the analysis.|St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer|A Phase II Study of St. John's Wort for the Treatment of Hot Flashes in Women With a History of Breast Cancer|Terminated||Phase 2|9|Actual|Wake Forest University Health Sciences|This study was stopped early due to concerns about the interaction between St. John's wort and tamoxifen.|1||Stopped due to concerns about interaction between St. John's wort and Tamoxifen.|f||||t||||||||||2017-10-11 05:07:07.74696|2017-10-11 05:07:07.74696
NCT00110162|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2013-08-06|||October 2004||2004-10-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|||Androgen Deprivation Therapy in Treating Patients With Prostate Cancer|A Collaborative Randomized Phase III Trial: The Timing of Intervention With Androgen Deprivation in Prostate Cancer Patients With Rising PSA|Unknown status|Recruiting|Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:07:08.281075|2017-10-11 05:07:08.281075
NCT00110175|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-03|2017-06-30|||April 28, 2005||2005-04-28|March 27, 2008|2008-03-27|March 27, 2008||2008-03-27|||||Observational|||Motor Performance in Chronic Stroke Patients|Improvement of Motor Performance in Chronic Stroke Patients by Combined Transcranial DC Stimulation and Somatosensory Stimulation|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:07:08.487151|2017-10-11 05:07:08.487151
NCT00110188|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-04|2015-11-18|||May 2005||2005-05-01|November 2015|2015-11-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)|A Phase II Study of the Efficacy and Safety of AP23573 in Patients With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)|Completed||Phase 2|39|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 05:07:08.561696|2017-10-11 05:07:08.561696
NCT00110201|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-04|2005-06-23|||March 2005||2005-03-01|May 2005|2005-05-01|December 2007||2007-12-01|||||Interventional|||The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure|Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients|Unknown status|Recruiting|Phase 3|124||Ejaz, Abulate A, MD|||||||||||||||||||2017-10-11 05:07:08.674526|2017-10-11 05:07:08.674526
NCT00110214|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-04|2014-04-21|2013-03-07||April 2005||2005-04-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|March 2010|Actual|2010-03-01||Interventional|||Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy|A Randomized Double-Blinded Placebo Controlled Phase III Trial Comparing Doctaxel and Prednisone With and Without Bevacizumab (IND #7921, NSC #704865) in Men With Hormone Refractory Prostate Cancer|Completed||Phase 3|1050|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:07:08.808915|2017-10-11 05:07:08.808915
NCT00110227|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-04|2017-02-23|||September 2005||2005-09-01|February 2017|2017-02-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|NEXT-Heart||Tai Chi Mind-Body Therapy for Chronic Heart Failure|Tai Chi Mind-Body Therapy for Chronic Heart Failure|Completed||Phase 3|100|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-10-11 05:07:10.268636|2017-10-11 05:07:10.268636
NCT00110240|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-04|2012-05-04|||April 2005||2005-04-01|May 2012|2012-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|594|Actual|Novartis|||||f||||||||||||||2017-10-11 05:07:10.39822|2017-10-11 05:07:10.39822
NCT00110253|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-04|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Duration of Skin Numbing Effect Created by the S-Caine™ Peel|A Randomized, Double-Blind, Paired, Placebo Controlled Study Evaluating the Duration of Anesthetic Effect Produced by the S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) When Applied for 30 and 60 Minutes|Completed||Phase 3|40|Actual|ZARS Pharma Inc.||1|||f||||f||||||||||2017-10-11 05:07:10.482801|2017-10-11 05:07:10.482801
NCT00110266|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-04|2016-11-16|||May 2005||2005-05-01|November 2016|2016-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients|An Open Label, Safety and Tolerability Study of Deferasirox for Treatment of Transfusional Iron Overload in Low-risk and INT-1, Myelodysplastic Patients Using Serum Ferritin Monitoring|Completed||Phase 2|176|Actual|Novartis||1|||f||||f||||||||||2017-10-11 05:07:10.622145|2017-10-11 05:07:10.622145
NCT00110279|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-05|2008-01-18|||June 2005||2005-06-01|January 2008|2008-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)|Phase I Inpatient Study of the Safety and Immunogenicity of H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H9N2 Infection in the Event of a Pandemic (Study A)|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 05:07:10.88465|2017-10-11 05:07:10.88465
NCT00110292|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-05|2005-06-23|||March 2002||2002-03-01|May 2005|2005-05-01|February 2006||2006-02-01|||||Interventional|||Preventing Learning Problems in Young Children: A Public Health and Physician-Based Outreach|An RCT of a Low-Intensity Intervention to Reduce Delay|Unknown status|Active, not recruiting|Phase 1|600||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:07:11.007498|2017-10-11 05:07:11.007498
NCT00110305|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-05|2014-06-11|2013-04-26||June 2005||2005-06-01|June 2014|2014-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines|A Phase IIb Randomized, Partially Blinded, Dose-Finding Trial of TMC278 in Antiretroviral-Naive HIV-1 Infected Subjects|Completed||Phase 2|368|Actual|Tibotec Pharmaceuticals, Ireland||4|||f||||t||||||||||2017-10-11 05:07:11.128442|2017-10-11 05:07:11.128442
NCT00110318|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-05|2013-12-09|||March 2002||2002-03-01|December 2013|2013-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Trial of Physiotherapy and Corticosteroid Injections in Lateral Epicondylalgia|A Pragmatic, Randomised Controlled Trial of Physiotherapy and Corticosteroid Injections in Lateral Epicondylalgia|Completed||Phase 3|198||The University of Queensland|||||f||||||||||||||2017-10-11 05:07:12.824978|2017-10-11 05:07:12.824978
NCT00110331|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-05|2017-06-30|||May 3, 2005||2005-05-03|September 9, 2014|2014-09-09|September 9, 2014||2014-09-09|||||Observational|||Central Nervous System Disease in HIV-infected Children on HAART||Completed||N/A|21|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:07:12.915131|2017-10-11 05:07:12.915131
NCT00110344|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-06|2013-10-10|||November 2005||2005-11-01|October 2013|2013-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Research Study for Patients With Metastatic Renal Cell Carcinoma|A Phase II Study of BAY 43-9006 Prior to and Following Nephrectomy in Patients With Metastatic Renal Cell Carcinoma.|Terminated||Phase 2|1|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:07:12.980864|2017-10-11 05:07:12.980864
NCT00110357|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-06|2015-11-24|2009-04-21||August 2005||2005-08-01|November 2015|2015-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors|Phase I Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|48|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:07:13.136483|2017-10-11 05:07:13.136483
NCT00110370|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-06|2007-11-26|||April 2004||2004-04-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes|A Comparison of Prandial Insulin Lispro Mixtures Therapy to Glargine Basal-Bolus Therapy With Insulin Lispro on the Overall Glycemic Control of Patients With Type 2 Diabetes Previously Treated With Oral Agents Combined With Insulin Glargine|Completed||Phase 4|300||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:07:16.586529|2017-10-11 05:07:16.586529
NCT00110383|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-06|2014-03-02|||May 2004||2004-05-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Comparison of School-Based Supervised Versus Parental Supervised Asthma Therapy|Effectiveness of School Based Supervised Asthma Therapy|Completed||N/A|295|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 05:07:18.336154|2017-10-11 05:07:18.336154
NCT00110396|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-06|2015-06-18|2010-04-30||January 2005||2005-01-01|June 2015|2015-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|RNF||Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis|A Multicentre, Single Arm, Open-Label, Phase IIIB Study to Evaluate the Safety and Antigenicity of Rebif® (Interferon-beta-1a) in Subjects With Relapsing Forms of Multiple Sclerosis|Completed||Phase 3|260|Actual|EMD Serono||1|||f||||||||||||||2017-10-11 05:07:18.455344|2017-10-11 05:07:18.455344
NCT00110435|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-09|2017-03-13|||May 2005||2005-05-01|March 2017|2017-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)|A Multicenter, Randomized, Double-blind, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypercholesterolemia|Completed||Phase 3|1229|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:07:19.112574|2017-10-11 05:07:19.112574
NCT00110448|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-09|2016-10-31|||December 2002||2002-12-01|August 2008|2008-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial|Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial|Completed||Phase 4|2539|Actual|Kumamoto University||2|||f||||t||||||||||2017-10-11 05:07:19.250084|2017-10-11 05:07:19.250084
NCT00110461|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-09|2012-04-19|2011-08-11||March 2005||2005-03-01|April 2012|2012-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Aripiprazole in Children and Adolescents With Bipolar I Disorder|A Phase III Trial to Test the Safety and Efficacy of Two Doses of Aripiprazole in Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features|Completed||Phase 3|296|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|Primary efficacy endpoint is change from baseline in Y-MRS total score. Only randomized subjects with both baseline and 1+ post-baseline were included in primary efficacy analysis so # randomized is different from # included in the efficacy analysis.|3|||f||||||||||||||2017-10-11 05:07:19.464261|2017-10-11 05:07:19.464261
NCT00110474|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-09|2006-09-18|||May 2000||2000-05-01|September 2006|2006-09-01|December 2002||2002-12-01|||||Interventional|||Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoarthritis|Efficacy and Safety of Glucosamine Sulfate Versus a Pure Analgesic (Acetaminophen/Paracetamol) and Placebo in Patients Suffering From Osteoarthritis of the Knee|Completed||Phase 3|300||Rottapharm|||||f||||||||||||||2017-10-11 05:07:21.808803|2017-10-11 05:07:21.808803
NCT00110487|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-09|2015-04-30|||January 2005||2005-01-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women|A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study of the Effect of ERB-041 in the Reduction of Symptoms Associated With Endometriosis in Reproductive-Age Women|Completed||Phase 2|200||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:07:21.915056|2017-10-11 05:07:21.915056
NCT00110500|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-09|2011-06-06|||April 2005||2005-04-01|June 2011|2011-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy|A Phase I Dose-Escalation Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy|Completed||Phase 1|12|Anticipated|Sangamo Therapeutics|||||||||||||||||||2017-10-11 05:07:22.101069|2017-10-11 05:07:22.101069
NCT00110513|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2012-08-10|2012-03-19||April 2005||2005-04-01|August 2012|2012-08-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery|A Multicenter, Multinational Study to Assess the Safety and Efficacy of Antithrombin Alfa in Hereditary Antithrombin (AT) Deficient Patients in High-Risk Situations for Thrombosis|Completed||Phase 3|18|Actual|rEVO Biologics||1|||f||||f||||||||||2017-10-11 05:07:22.182654|2017-10-11 05:07:22.182654
NCT00110526|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2013-10-23|||April 2005||2005-04-01|October 2013|2013-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Gene Therapy for Prostate Cancer That Returns After Radiation Therapy|Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients With Radiorecurrent Prostate Cancer|Withdrawn||Phase 1|0|Actual|Icahn School of Medicine at Mount Sinai||1||No participants met eligibility requirements|f||||t||||||||||2017-10-11 05:07:22.530452|2017-10-11 05:07:22.530452
NCT00110539|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2012-05-23|||February 2004||2004-02-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Effectiveness of an Internet-Based Curriculum in Increasing Health Care Providers' Knowledge of Herbs and Dietary Supplements|Internet-Based Curriculum About Herbs and Dietary Supplements|Completed||N/A|1500||National Library of Medicine (NLM)|||||f||||||||||||||2017-10-11 05:07:22.608984|2017-10-11 05:07:22.608984
NCT00110552|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2014-10-27|||July 2005||2005-07-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients|Effects of a Cognitive Enhancer on Memory and Cognitive Performance|Completed||Phase 1|111|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 05:07:22.681911|2017-10-11 05:07:22.681911
NCT00110565|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2008-08-04|||January 2005||2005-01-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal Women|Pulsed Electromagnetic Field (PEMF) Efficacy in Reducing Rheumatoid Arthritis Symptoms|Completed||Phase 2|87||National Center for Complementary and Integrative Health (NCCIH)|||||f||||f||||||||||2017-10-11 05:07:22.764286|2017-10-11 05:07:22.764286
NCT00110578|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2008-08-07|||September 1998||1998-09-01|July 2007|2007-07-01|April 2005||2005-04-01|||||Interventional|||Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults|Safety and Antiviral Efficacy of Cellular Adoptive Immunotherapy With Autologous CD8+ HIV-Specific Cytotoxic T Cells Combined With Interleukin-2 For HIV Seropositive Individuals|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:07:22.840321|2017-10-11 05:07:22.840321
NCT00110591|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2015-12-14|||April 2004||2004-04-01|December 2015|2015-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers|A Phase I, Randomized, Double Blind, Placebo Controlled, Single-Dose, Rising Dose Cohort Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRO 140 in Healthy Volunteers|Completed||Phase 1|20|Actual|CytoDyn, Inc.||5|||f||||f||||||||||2017-10-11 05:07:22.920897|2017-10-11 05:07:22.920897
NCT00110604|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2008-12-29|||September 2000||2000-09-01|May 2005|2005-05-01|December 2004||2004-12-01|||||Interventional|||The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing|The Folic Acid and Carotid Intima-Media Thickness (FACIT) Study: A Randomized Controlled Trial|Completed||N/A|835||Wageningen University|||||f||||||||||||||2017-10-11 05:07:23.011344|2017-10-11 05:07:23.011344
NCT00125073|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2010-06-25|||July 2005||2005-07-01|June 2010|2010-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Postoperative Dietary Counseling After Bariatric Surgery|Postoperative Dietary Counseling After Bariatric Surgery|Completed||N/A|100|Anticipated|University of Pennsylvania|||||f||||||||||||||2017-10-11 05:10:53.648819|2017-10-11 05:10:53.648819
NCT00110617|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-10|2011-05-23|2011-01-11||May 2005||2005-05-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients|A Randomized, Open-label, Multi-center, Phase II Study to Evaluate the Safety and Efficacy of Deferasirox (ICL670) 20 mg/kg/Day Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients With Iron Overload From Repeated Blood Transfusions|Completed||Phase 2|212|Actual|Novartis|Due to severe good clinical practice violations, data from 9 participants recruited for Center 512 was excluded from the main analysis of the study.|2|||f||||||||||||||2017-10-11 05:07:23.155811|2017-10-11 05:07:23.155811
NCT00110630|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-11|2017-01-11|||June 2005||2005-06-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|STOP||Smoking Treatment of Prisoners|"Smoking Treatment of Prisoners: Project STOP"|Completed||Phase 3|250|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-10-11 05:07:25.554212|2017-10-11 05:07:25.554212
NCT00110643|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-11|2015-04-30|||February 2003||2003-02-01|April 2015|2015-04-01|December 2005||2005-12-01|||||Interventional|||Infrared Non-Cutting Laser Therapy for Acne|CoolTouch Non-ablative Laser Therapy for Acne Vulgaris|Completed||Phase 2/Phase 3|50||University of Michigan|||||f||||f||||||||||2017-10-11 05:07:25.641792|2017-10-11 05:07:25.641792
NCT00110656|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2011-01-20|||March 2004||2004-03-01|January 2011|2011-01-01|October 2004|Actual|2004-10-01|September 2004|Actual|2004-09-01||Observational|||Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation|A Retrospective Follow Up Study to Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation|Completed||N/A|38|Actual|Amgen|||1||f||||||||||None Retained|"     Retrospective data collected.   "|||2017-10-11 05:07:25.721555|2017-10-11 05:07:25.721555
NCT00110669|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2011-10-26|||January 2004||2004-01-01|October 2011|2011-10-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||High-dose Prednisone in Duchenne Muscular Dystrophy|A Randomized Study of Daily vs. High-dose Weekly Prednisone Therapy in Duchenne Muscular Dystrophy|Completed||Phase 3|64|Actual|Cooperative International Neuromuscular Research Group||2|||f||||t||||||||||2017-10-11 05:07:25.812286|2017-10-11 05:07:25.812286
NCT00110682|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2008-04-21|||April 2005||2005-04-01|April 2008|2008-04-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses|A Randomized, Parallel-Group, Vehicle-Controlled, Double-Blind Study of Topical Imiquimod 5% Cream Used as an Adjunct to Cryotherapy in the Management of Actinic Keratoses, With a Long-Term (1 Year) Follow-Up|Completed||Phase 4|60||Derm Research @ 888 Inc.|||||f||||t||||||||||2017-10-11 05:07:25.90772|2017-10-11 05:07:25.90772
NCT00110695|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2010-03-24|||April 2005||2005-04-01|March 2010|2010-03-01|July 2008|Actual|2008-07-01|December 2006|Actual|2006-12-01||Interventional|||Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer|A Phase 2 Study of Neoadjuvant Chemotherapy With Sequential Weekly Nanoparticle Albumin Bound Paclitaxel (Abraxane) Followed by 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) in Locally Advanced Breast Cancer|Completed||Phase 2|66|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-10-11 05:07:25.99869|2017-10-11 05:07:25.99869
NCT00110708|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2006-02-20|||April 2005||2005-04-01|February 2006|2006-02-01|June 2006||2006-06-01|||||Interventional|||Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism|A Randomized, Placebo-Controlled Phase II Trial Evaluating Safety and Efficacy of Oral Human Immunoglobulin in the Treatment of Gastrointestinal Dysfunction Associated With Autistic Disorder in Pediatric Patients From 2 to 18 Years of Age|Unknown status|Active, not recruiting|Phase 2|120||PediaMed Pharmaceuticals|||||||||||||||||||2017-10-11 05:07:26.110943|2017-10-11 05:07:26.110943
NCT00110721|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2012-03-05|||May 2005||2005-05-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|June 2007|Actual|2007-06-01||Interventional|||GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer|A Phase II, Multi-Center, Open-Label Trial to Evaluate the Efficacy and Safety of Intravenous GM-CT-01 in Combination With 5-Fluorouracil When Administered in Monthly Cycles as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer|Terminated||Phase 2|20|Actual|Galectin Therapeutics Inc.||1||Study protocol amended to a new treatment regimen: study DAVFU-006.|f||||f||||||||||2017-10-11 05:07:26.271531|2017-10-11 05:07:26.271531
NCT00110734|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2005-09-21||||||September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults|A Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) for Induction of Local Dermal Anesthesia for Laser-Assisted Tattoo Removal in Adults|Completed||Phase 3|60||ZARS Pharma Inc.|||||||||||||||||||2017-10-11 05:07:26.385961|2017-10-11 05:07:26.385961
NCT00110747|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults|A Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating the Efficacy of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Providing Local Dermal Anesthesia for Non-Ablative Facial Laser Resurfacing in Adults|Completed||Phase 3|54|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-10-11 05:07:26.542368|2017-10-11 05:07:26.542368
NCT00110760|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face|Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream)for Induction of Local Dermal Anesthesia for Dermal Filler Injection on the Face of Adults|Completed||Phase 3|70|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-10-11 05:07:26.717851|2017-10-11 05:07:26.717851
NCT00110773|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-12|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults|A Randomized, Double-Blind, Placebo Controlled, Parallel Study Evaluating the Efficacy of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) to Provide Local Dermal Anesthesia for Pulsed Dye Laser Therapy in Adults|Completed||Phase 3|80|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-10-11 05:07:26.826524|2017-10-11 05:07:26.826524
NCT00117091|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-20||||||December 2007|2007-12-01||||||||Interventional|||Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)|An Open-Label Multicentre Study of Anakinra (Kineret®) in Combination With DMARDS in Subjects With Active Rheumatoid Arthritis (RA)|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-10-11 05:07:47.368338|2017-10-11 05:07:47.368338
NCT00110786|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-13|2010-06-16|||May 2005||2005-05-01|September 2009|2009-09-01|December 2005||2005-12-01|||||Interventional|||Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy|A Double Blind Study to Investigate the Clinical Efficacy and Safety of Ragweed MATAMPL (Allergy Therapeutics®), Pollinex®-R (Allergy Therapeutics®) and Placebo in Patients With Seasonal Allergic Rhinitis With Ragweed Allergy, in an Environmental Exposure Chamber (EEC) Model, With Follow-Up During a Natural Ragweed Pollen Season|Completed||Phase 2|240||Allergy Therapeutics|||||f||||||||||||||2017-10-11 05:07:26.929544|2017-10-11 05:07:26.929544
NCT00110799|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-13|2012-05-31|||April 2005||2005-04-01|March 2011|2011-03-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C|A Double-Blind, Randomized, Placebo-Controlled, Multi-Centre, Dose-Ranging, Parallel Group, Phase II Study to Assess Efficacy, Safety/Tolerability, and Pharmacokinetics of a Thrombopoietin Receptor Agonist, SB-497115-GR, When Administered as 30, 50, and 75 mg Once Daily for 12 Weeks in Subjects With|Completed||Phase 2|75|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-10-11 05:07:27.020081|2017-10-11 05:07:27.020081
NCT00110812|ClinicalTrials.gov processed this data on October 10, 2017|2005-05-13|2014-04-07|2012-12-12|2010-01-30|September 2005||2005-09-01|April 2014|2014-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|STALWART||Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People|STALWART: A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 With and Without Concomitant Antiretroviral Therapy in Patients With HIV-1 Infection and CD4+ Cell Counts of 300 Cells/mm3 or More|Completed||Phase 2|267|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|All randomized patients were followed through 28 Feb 2009. A subset of 222 consenting patients were followed 2 additional years, through 28 Feb 2011.|3|||f||||t||||||||||2017-10-11 05:07:27.225511|2017-10-11 05:07:27.225511
NCT00116519|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2007-01-24|||July 2005||2005-07-01|January 2007|2007-01-01|October 2006||2006-10-01|||||Interventional|||A Study in People With Abnormal Fat Levels in the Blood|PPAR Alpha: A Phase 2 Dose-Finding and Safety Study for Atherogenic Dyslipidemia by Eli Lilly|Completed||Phase 2|300||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:07:28.497426|2017-10-11 05:07:28.497426
NCT00116532|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2007-04-23|||October 2002||2002-10-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)|Escitalopram for the Treatment of Obsessive Compulsive Disorder|Completed||Phase 4|30||Massachusetts General Hospital|||||f||||f||||||||||2017-10-11 05:07:28.846934|2017-10-11 05:07:28.846934
NCT00116545|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2009-12-09|||January 1997||1997-01-01|June 2005|2005-06-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||TART - Troglitazone Atherosclerosis Regression Trial|TART - Troglitazone Atherosclerosis Regression Trial|Completed||Phase 2/Phase 3|288||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:07:28.936753|2017-10-11 05:07:28.936753
NCT00116571|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2006-10-02|||May 2005||2005-05-01|May 2006|2006-05-01|December 2006||2006-12-01|||||Interventional|||Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)|A Phase II Randomized, Sham-Controlled, Double-Blind, Dose-Finding Study to Assess the Efficacy and Safety of Transurethral Photodynamic Therapy With Lemuteporfin in Subjects With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia|Terminated||Phase 2|180||QLT Inc.|||||||||||||||||||2017-10-11 05:07:29.195673|2017-10-11 05:07:29.195673
NCT00116597|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2009-12-01|||November 2002||2002-11-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|July 2007|Actual|2007-07-01||Interventional|||Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma|Active Specific Intranodal Immunotherapy With a Recombinant Vaccinia Virus Expressing Three Melanoma Associated Epitopes and Two Costimulatory Molecules, Followed by Immunization With Synthetic Melanoma Associated Epitopes. A Phase I/II Trial in Patients With Stages IIb to IV Melanoma|Completed||Phase 1/Phase 2|15|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-10-11 05:07:29.370937|2017-10-11 05:07:29.370937
NCT00116610|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2009-01-19|||June 2005||2005-06-01|February 2007|2007-02-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer|A Phase II Study of Picoplatin as Second-Line Therapy for Subjects With Resistant or Refractory Small Cell Lung Cancer|Completed||Phase 2|75||Poniard Pharmaceuticals|||||f||||||||||||||2017-10-11 05:07:29.489885|2017-10-11 05:07:29.489885
NCT00116623|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2016-08-12|||February 2003||2003-02-01|August 2016|2016-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Magnesium Sulfate Versus Indomethacin for Preterm Labor||Terminated||Phase 4|||University of Pennsylvania||||Funding completed|f||||||||||||||2017-10-11 05:07:29.837122|2017-10-11 05:07:29.837122
NCT00116636|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-29|2017-04-27|||June 2005||2005-06-01|June 2005|2005-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients|A Phase II, Open Label, Single Arm Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) as a Single Agent in a Cohort of HIV Positive Adult Patients|Completed||Phase 2|40|Anticipated|Therapeutic Concepts||1|||f||||||||||||||2017-10-11 05:07:29.921733|2017-10-11 05:07:29.921733
NCT00116649|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-07-14|2008-10-21||June 2005||2005-06-01|July 2010|2010-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis|Open-Label Safety and Pharmacokinetic Study of AldaraTM (Imiquimod) Cream, 5% for One, Two, or Three Treatment Cycles to Surface Areas Greater Than 25 cm2 With Actinic Keratosis|Completed||Phase 4|551|Actual|Graceway Pharmaceuticals, LLC||1|||f||||f||||||||||2017-10-11 05:07:30.046424|2017-10-11 05:07:30.046424
NCT00116662|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-02-16|||March 2005||2005-03-01|November 2006|2006-11-01||||||||Interventional|||An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects|A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for up to 12 Weeks for the Treatment of Common Warts in Pediatric Subjects|Completed||Phase 2|84||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-10-11 05:07:30.540902|2017-10-11 05:07:30.540902
NCT00116675|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-02-16|||March 2005||2005-03-01|June 2006|2006-06-01|April 2006||2006-04-01|||||Interventional|||Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects|A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Pediatric Subjects|Completed||Phase 2|84||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-10-11 05:07:30.646787|2017-10-11 05:07:30.646787
NCT00116688|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-11-25|2011-03-04||August 2004||2004-08-01|November 2013|2013-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|An Open Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|Completed||Phase 3|313|Actual|Amgen||1|||f||||||||||||||2017-10-11 05:07:30.769285|2017-10-11 05:07:30.769285
NCT00116701|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-05-01|||May 2005||2005-05-01|May 2008|2008-05-01||||||||Interventional|||Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis|A Study to Evaluate the Efficacy of Converting From Intravenous or Subcutaneous rHuEPO to Intravenous Darbepoetin Alfa (Aranesp®) in Subjects With Chronic Kidney Disease Receiving Haemodialysis|Completed||Phase 3|200||Amgen|||||f||||||||||||||2017-10-11 05:07:32.381067|2017-10-11 05:07:32.381067
NCT00116714|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-05-05|||October 2001||2001-10-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|December 2007|Actual|2007-12-01||Observational|||Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy|Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study (RADIUS 1)|Completed||N/A|4968|Actual|Amgen|||1||f||||||||||||||2017-10-11 05:07:32.463207|2017-10-11 05:07:32.463207
NCT00116727|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-05-05|||October 2002||2002-10-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Observational|||Rheumatoid Arthritis DMARD Intervention and UtilizationStudy|Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study (RADIUS 2)|Completed||N/A|5103|Actual|Amgen|||1||f||||||||||||||2017-10-11 05:07:32.54878|2017-10-11 05:07:32.54878
NCT00116740|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-03-24|||June 2005||2005-06-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Safety and Efficacy of APD356 in the Treatment of Obesity|A 12-Week, Dose-Ranging, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of APD356 in Obese Patients|Completed||Phase 2|400||Arena Pharmaceuticals|||||||||||||||||||2017-10-11 05:07:32.809008|2017-10-11 05:07:32.809008
NCT00116753|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-11-12|2010-10-06||January 2005||2005-01-01|November 2010|2010-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer|An Open-label Multi-center, Randomized Parallel Group Comparison of Efficacy and Safety of Degarelix Three-Month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer|Completed||Phase 2|460|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-10-11 05:07:33.002344|2017-10-11 05:07:33.002344
NCT00116766|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2016-09-01|||July 2005||2005-07-01|February 2007|2007-02-01|September 2006|Actual|2006-09-01|||||Interventional|||Field Evaluation of Plant-based Mosquito Control|Field Evaluation of Malaria Vector Control Using Traditional Plant-based Anti-mosquito Measures in Yunnan Province, P.R. China|Completed||Phase 2|240|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 05:07:35.406524|2017-10-11 05:07:35.406524
NCT00116779|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-12-15|2009-01-22||February 2004||2004-02-01|December 2011|2011-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer|An Open-label, Randomized, Multi-center, Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer Dosed for Thirteen 28-day Cycles|Completed||Phase 2|127|Actual|Ferring Pharmaceuticals||2|||f||||t||||||||||2017-10-11 05:07:35.528118|2017-10-11 05:07:35.528118
NCT00116792|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-05-15|||March 2004||2004-03-01|May 2007|2007-05-01||||||||Interventional|||PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions|PROVIDENCE: Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With de Novo Coronary Lesions|Unknown status|Active, not recruiting|Phase 2/Phase 3|120|Anticipated|Gold, Herman K., MD|||||||||||||||||||2017-10-11 05:07:38.378109|2017-10-11 05:07:38.378109
NCT00116805|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-01-26|2010-02-11||June 2005|Actual|2005-06-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|May 2007|Actual|2007-05-01||Interventional||Randomized and Treated Analysis Set: all participants who were randomized and received at least one dose of study medication.|A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B|A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF Versus Adefovir Dipivoxil for the Treatment of HBeAg Positive Chronic Hepatitis B|Completed||Phase 3|266|Actual|Gilead Sciences||2|||f||||t|t|f||||||||2017-10-11 05:07:38.581661|2017-10-11 05:07:38.581661
NCT00116818|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2016-09-13|||January 2005||2005-01-01|September 2016|2016-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults|A Randomized, Double-blind, Parallel Group, Placebo and Active (Prednisone) Controlled, 6-week Study of the Effect of Fluticasone Furoate Aqueous Nasal Spray 100mcg QD on the Hypothalamic Pituitary Adrenocortical (HPA) Axis in Adolescents and Adults 12 to 65 Years of Age With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|90|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:07:41.75803|2017-10-11 05:07:41.75803
NCT00117052|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-05-21|||September 2004||2004-09-01|May 2013|2013-05-01|February 2006|Actual|2006-02-01|November 2005|Actual|2005-11-01||Interventional|||SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism|SENSOR: Study to InvestigatE Cinacalcet TreatmeNt in Haemodialysis Patients With SecOndary HyperparathyRoidism|Completed||Phase 3|673|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:07:47.12659|2017-10-11 05:07:47.12659
NCT00116831|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-03-21|2009-08-07||January 2005||2005-01-01|March 2017|2017-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes|A Phase III, 18 Month, Multicenter, Randomized, Double-Blind, Active-Controlled Clinical Trial to Compare Rosiglitazone Versus Glipizide on the Progression of Atherosclerosis in Subjects With Type 2 Diabetes Mellitus and Cardiovascular Disease (APPROACH)|Completed||Phase 3|672|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:07:41.951176|2017-10-11 05:07:41.951176
NCT00116896|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-01-16|||June 2003||2003-06-01|November 2003|2003-11-01|December 2004||2004-12-01|||||Interventional|||Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors|Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|25||OSI Pharmaceuticals|||||||||||||||||||2017-10-11 05:07:45.919958|2017-10-11 05:07:45.919958
NCT00116909|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-03-13|||August 2004||2004-08-01|March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy|A Phase II Study of Single-Agent OSI-7904L in Patients With Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Have Failed First-Line Therapy|Completed||Phase 2|85||OSI Pharmaceuticals|||||||||||||||||||2017-10-11 05:07:46.001688|2017-10-11 05:07:46.001688
NCT00116922|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-05-22|||June 2004||2004-06-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Lifestyle and Combination Medication Therapy Diabetes Prevention Study|CAnadian Normoglycemia Outcomes Evaluation Study|Completed||Phase 3|207|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||1|||f||||t||||||||||2017-10-11 05:07:46.07082|2017-10-11 05:07:46.07082
NCT00116935|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-12-28|||February 2004||2004-02-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)|Short (12 Months) Versus Long (36 Months) Duration of Adjuvant Treatment With the Tyrosine Kinase Inhibitor Imatinib Mesylate of Operable GIST With a High Risk of Recurrence|Completed||Phase 3|400|Actual|Scandinavian Sarcoma Group||2|||f||||f||||||||||2017-10-11 05:07:46.170062|2017-10-11 05:07:46.170062
NCT00116948|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-12-03|||January 2005||2005-01-01|December 2014|2014-12-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||A Comparison of Two Total Hip Replacements: Hip Resurfacing System Versus Mallory-Head/Exeter|A Comparison of Two Total Hip Replacements: Hip Resurfacing System Versus Mallory-Head/Exeter|Completed||Phase 4|50|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:07:46.286575|2017-10-11 05:07:46.286575
NCT00116961|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-02-05|||June 2005||2005-06-01|February 2012|2012-02-01|December 2007|Actual|2007-12-01|January 2007|Actual|2007-01-01||Interventional|||Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma|A Phase II Study of Combination of Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma|Completed||Phase 2|40|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-10-11 05:07:46.363634|2017-10-11 05:07:46.363634
NCT00116974|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2016-08-12|||October 2004||2004-10-01|August 2016|2016-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Periodontal Infection and Prematurity Study|Periodontal Infection and Prematurity Study|Terminated||Phase 3|2100|Anticipated|University of Pennsylvania||2||Protocol Expired. Terminated by IRB|f||||||||||||||2017-10-11 05:07:46.440187|2017-10-11 05:07:46.440187
NCT00116987|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2015-06-11|||August 2003||2003-08-01|June 2015|2015-06-01|November 2009|Actual|2009-11-01|September 2008|Actual|2008-09-01||Interventional|||Dual Chamber Versus Single Chamber Cardiac Pacing in People 80 Years of Age and Older|Pacing the Octogenarian Plus Population (POPP) A Comparison of Physiologic Versus Ventricular Pacing in Those Who Are 80 Years of Age and Older|Terminated||N/A|800|Anticipated|University of Calgary||2||Unable to recruit adequate number of participants in required time frame.|f||||f||||||||||2017-10-11 05:07:46.531044|2017-10-11 05:07:46.531044
NCT00117000|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2006-09-07|||July 2003||2003-07-01|September 2006|2006-09-01|February 2007||2007-02-01|||||Interventional|||The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly|The Effects of Testosterone and Nutritional Supplementation, Alone and Combined, on the Adverse Effects of Under-Nutrition in the Elderly|Unknown status|Active, not recruiting|Phase 3|200||University of Adelaide|||||f||||||||||||||2017-10-11 05:07:46.75034|2017-10-11 05:07:46.75034
NCT00117013|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-06-30|||June 28, 2005||2005-06-28|August 25, 2011|2011-08-25|October 25, 2010|Actual|2010-10-25|October 25, 2010|Actual|2010-10-25||Interventional|||A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a|A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1 Alpha|Completed||Phase 1|16|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:07:46.880865|2017-10-11 05:07:46.880865
NCT00117026|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-05-08|||August 2005||2005-08-01|May 2013|2013-05-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||Effects of Vitamin B1 in Type 1 Diabetic Patients|Can Oral Benfotiamine Supplementation Influence Progression of Microvascular Complications in Patients With Type 1 Diabetes?|Completed||Phase 1/Phase 2|67|Actual|Oslo University Hospital||2|||f||||||||||||||2017-10-11 05:07:46.962103|2017-10-11 05:07:46.962103
NCT00117039|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-10-14|||January 2004||2004-01-01|August 2008|2008-08-01|April 2005||2005-04-01|||||Interventional|||A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia|SYNCHRONICITY: A Study to Evaluate the Effectiveness of Aranesp® at 300 Mcg Q3W on Clinical Outcomes in Cancer Patients With Anemia Due to Chemotherapy|Completed||Phase 4|1500||Amgen|||||f||||||||||||||2017-10-11 05:07:47.054924|2017-10-11 05:07:47.054924
NCT00117104|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-10-15||||||October 2009|2009-10-01||||||||Interventional|||Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis|A Multicenter Study Evaluating Once Weekly Intravenous Administration of Aranesp® in Subjects With End Stage Renal Disease on Chronic Hemodialysis|Completed||Phase 4|||Amgen|||||f||||||||||||||2017-10-11 05:07:47.453426|2017-10-11 05:07:47.453426
NCT00117117|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-03-24|||September 2002||2002-09-01|March 2009|2009-03-01|December 2003||2003-12-01|||||Interventional|||A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®|A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®|Completed||Phase 4|2423||Amgen|||||f||||||||||||||2017-10-11 05:07:47.5252|2017-10-11 05:07:47.5252
NCT00117130|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-01-20||||||January 2011|2011-01-01||||||||Interventional|||Study to Evaluate Effectiveness of Aranesp®|Aranesp® Monthly Preference Study|Completed||Phase 4|||Amgen||1|||f||||||||||||||2017-10-11 05:07:47.595165|2017-10-11 05:07:47.595165
NCT00117143|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-05-21||||||May 2009|2009-05-01||||||||Interventional|||Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)|An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Efficacy of Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)|Completed||Phase 1/Phase 2|||Amgen||1|||f||||||||||||||2017-10-11 05:07:47.666239|2017-10-11 05:07:47.666239
NCT00117156|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2016-07-28|2014-09-26||December 2003||2003-12-01|July 2016|2016-07-01|January 2012|Actual|2012-01-01|October 2008|Actual|2008-10-01||Interventional|||Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma|A Phase II Study of Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma|Completed||Phase 2|26|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:07:47.748224|2017-10-11 05:07:47.748224
NCT00117169|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-10-12|||January 2005||2005-01-01|October 2012|2012-10-01|October 2006||2006-10-01|||||Interventional|||Multi-Detector Spiral Computed Tomography Alone Versus Combined Strategy With Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary Embolism|Multi-Detector Spiral Computed Tomography Alone Versus Combined Strategy With Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary Embolism: A Randomised Non-Inferiority Trial [CTEP4]|Completed||N/A|1500||University Hospital, Geneva|||||f||||||||||||||2017-10-11 05:07:48.103134|2017-10-11 05:07:48.103134
NCT00117182|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2016-04-18|||July 2005||2005-07-01|April 2016|2016-04-01|August 2006||2006-08-01|||||Interventional|||Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD|A Phase II Study to Investigate Mannitol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD|Completed||Phase 2|140||Pharmaxis|||||f||||||||||||||2017-10-11 05:07:48.175212|2017-10-11 05:07:48.175212
NCT00117195|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-02-08|||May 2003||2003-05-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|||A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease|Open-Label Validation Study of Neurophysiologic Changes in Individuals With Parkinson's Disease, at Risk for Parkinson's Disease and Healthy Controls|Completed||N/A|620|Actual|Institute for Neurodegenerative Disorders|||1||f||||t||||||Samples Without DNA|"     In addition, the study will evaluate serum samples for changes in proteins or metabolites     that may be indicators of early changes associated with Parkinson's disease or parkinsonian     syndrome.   "|||2017-10-11 05:07:48.277437|2017-10-11 05:07:48.277437
NCT00117208|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-01-31|||November 2005||2005-11-01|January 2010|2010-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis|A Cross-Over Comparative Study of Inhaled Mannitol, Alone and in Combination With Daily rhDNase, in Children With Cystic Fibrosis|Completed||Phase 2|20|Actual|Pharmaxis||3|||f||||||||||||||2017-10-11 05:07:48.447687|2017-10-11 05:07:48.447687
NCT00117221|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-02|2017-10-05|||June 28, 2005||2005-06-28|February 11, 2014|2014-02-11|February 11, 2014||2014-02-11|||||Observational|||MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle|MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle|Completed||N/A|56|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:07:48.632419|2017-10-11 05:07:48.632419
NCT00117234|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-12-02|||September 2002||2002-09-01|December 2010|2010-12-01|July 2004||2004-07-01|||||Interventional|||Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia|A Study to Assess the Impact of Subcutaneous (SC) Darbepoetin Alfa Treatment on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia|Completed||N/A|||Amgen||1|||f||||||||||||||2017-10-11 05:07:48.702055|2017-10-11 05:07:48.702055
NCT00117247|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-10-15|||June 2002||2002-06-01|October 2009|2009-10-01|July 2004||2004-07-01|||||Interventional|||A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects|A Study to Assess the Pharmacokinetics and Pharmacodynamics of Repeat-Sose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects|Completed||Phase 1/Phase 2|||Amgen|||||f||||||||||||||2017-10-11 05:07:48.781516|2017-10-11 05:07:48.781516
NCT00117260|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-08-08|||July 2005||2005-07-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a 91-Day Extended-Cycle Combination Oral Contraceptive (Seasonale) for the Treatment of Low Bone Mineral Density in Adolescent Females With Secondary Amenorrhea and Osteopenia|Withdrawn||Phase 3|0|Actual|Teva Pharmaceutical Industries||||Sponsor decision|||||||||||||||2017-10-11 05:07:48.858706|2017-10-11 05:07:48.858706
NCT00117273|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-05-08|||June 2005||2005-06-01|May 2014|2014-05-01|June 2006||2006-06-01|||||Interventional|||A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens|A Prospective, Single-Center, Open-Label, Randomized Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Regimens of Oral Contraceptive Pills|Completed||Phase 3|36|Anticipated|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 05:07:48.932412|2017-10-11 05:07:48.932412
NCT00117286|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-09-29|2010-09-29||March 2005||2005-03-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer|An Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Patients With Prostate Cancer|Completed||Phase 2/Phase 3|57|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:07:49.066371|2017-10-11 05:07:49.066371
NCT00117299|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-05-25|||September 2004||2004-09-01|May 2010|2010-05-01|January 2009|Actual|2009-01-01|September 2007|Actual|2007-09-01||Interventional|||PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib|A Phase II, Open-Label Study of PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors (GISTs) Resistant to Imatinib Mesylate|Completed||Phase 2|45|Actual|Helsinki University||1|||f||||f||||||||||2017-10-11 05:07:50.147238|2017-10-11 05:07:50.147238
NCT00117312|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-05-18|2009-01-22||October 2002||2002-10-01|May 2011|2011-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients|An Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients|Terminated||Phase 2|37|Actual|Ferring Pharmaceuticals||4||After 190 weeks [7 patients left] it was terminated for administrative reasons|f||||t||||||||||2017-10-11 05:07:50.267828|2017-10-11 05:07:50.267828
NCT00117338|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-03-09|2009-03-16||July 2005||2005-07-01|March 2017|2017-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)|A Multicenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast With Placebo in Pediatric Patients (Ages 6 to 14 Years) With Acute Asthma|Completed||Phase 3|276|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:07:52.357198|2017-10-11 05:07:52.357198
NCT00117351|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-02-16|||April 2005||2005-04-01|February 2011|2011-02-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features|A Multicenter, Open-Label, Phase 2 Study of VELCADE (Bortezomib) for Injection in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma and Adenocarcinoma With Bronchioloalveolar Features|Terminated||Phase 2|||Millennium Pharmaceuticals, Inc.||||insufficient efficacy|||||||||||||||2017-10-11 05:07:53.002063|2017-10-11 05:07:53.002063
NCT00117364|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2005-07-05|||January 2005||2005-01-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Effect of SACCHACHITIN on Healing of a Chronic Wound|Effect of SACCHACHITIN on Healing of Chronic Wound ---A Clinical Trial|Unknown status|Recruiting|Phase 2|30||Min-Sheng General Hospital|||||f||||||||||||||2017-10-11 05:07:53.080481|2017-10-11 05:07:53.080481
NCT00117377|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-13|||April 2004||2004-04-01|December 2007|2007-12-01|June 2005|Actual|2005-06-01|||||Interventional|||Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis|Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis|Completed||Phase 4|70||Novartis||2|||||||||||||||||2017-10-11 05:07:53.156836|2017-10-11 05:07:53.156836
NCT00117390|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-19|||June 2004||2004-06-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill Patients|Evaluation of the Optimal Technique for Determination of the Renal Function of Critically Ill Patients|Completed||N/A|50||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:07:53.251872|2017-10-11 05:07:53.251872
NCT00117403|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-04-01|||January 2006||2006-01-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Anti-Oxidant Treatment of Alzheimer's Disease|Evaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease|Completed||Phase 1|75|Anticipated|National Institute on Aging (NIA)||3|||f||||t||||||||||2017-10-11 05:07:53.330416|2017-10-11 05:07:53.330416
NCT00117416|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-19|||February 2003||2003-02-01|December 2007|2007-12-01||||||||Interventional|||Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function|MAP and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function|Suspended||N/A|60||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:07:53.464208|2017-10-11 05:07:53.464208
NCT00117429|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-02-12|||June 2005||2005-06-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|September 2007|Actual|2007-09-01||Interventional|||Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)|A Phase I, Randomized, Double-Blind Clinical Trial of the HIV gp120/NefTat/AS02A Vaccine Candidate in Subjects With Well-Controlled Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1|20|Anticipated|Marcus Altfeld, M.D., Ph.D.|||||f||||||||||||||2017-10-11 05:07:53.534677|2017-10-11 05:07:53.534677
NCT00117442|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-05-09|||August 2002||2002-08-01|May 2013|2013-05-01|December 2004|Actual|2004-12-01|August 2004|Actual|2004-08-01||Interventional|||A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood|An Open-Label, Randomised Study of Multi-Cycle, Dose Intensive Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood|Completed||Phase 2|61|Actual|Amgen||4|||f||||||||||||||2017-10-11 05:07:53.613153|2017-10-11 05:07:53.613153
NCT00117455|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-05-15||||||May 2008|2008-05-01||||||||Interventional|||A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma|A Randomised, Multi-Centre, Double-Blind Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim for Autologous Transplantation in Subjects With Non-Hodgkin's Lymphoma|Completed||Phase 2|||Amgen|||||f||||||||||||||2017-10-11 05:07:53.701524|2017-10-11 05:07:53.701524
NCT00117468|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-05-09|||June 2005||2005-06-01|May 2014|2014-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement|A Phase 2, Single-Center, Open-Label, Randomized, Controlled, Pharmacodynamic Study to Compare DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement|Completed||Phase 2|20|Anticipated|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:07:53.781335|2017-10-11 05:07:53.781335
NCT00117481|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-05-08|||June 2005||2005-06-01|May 2014|2014-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain|A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate DR-2001 for the Management of Moderate to Severe Endometriosis-Related Nonmenstrual Pelvic Pain|Completed||Phase 2|90|Anticipated|Teva Pharmaceutical Industries||3|||f||||||||||||||2017-10-11 05:07:53.893958|2017-10-11 05:07:53.893958
NCT00117494|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-12-21|||October 2005||2005-10-01|December 2011|2011-12-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)|Randomised Comparative Study of the Efficacy and Safety of Rosuvastatin and Pravastatin in Dyslipidemic Patients Treated With Antiretroviral Agents. Anrs 126|Completed||Phase 4|86||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:07:54.092064|2017-10-11 05:07:54.092064
NCT00117507|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-02-28|||April 2005||2005-04-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients|An Open Label, Safety and Tolerability Study of Deferasirox for Treatment of Transfusional Iron Overload in Low-Risk and INT-1 Myelodysplastic Patients|Completed||Phase 2|24|Actual|Novartis||1|||f||||f||||||||||2017-10-11 05:07:54.174917|2017-10-11 05:07:54.174917
NCT00117520|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2006-07-03|||July 2002||2002-07-01|July 2002|2002-07-01|March 2006||2006-03-01|||||Interventional|||The Effect of Caffeine in Elderly Citizens|The Effect of Caffeine as Endurance Enhancing Drug in the Elderly|Completed||Phase 4|30||Herning Hospital|||||f||||||||||||||2017-10-11 05:07:54.264712|2017-10-11 05:07:54.264712
NCT00117533|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2006-05-24|||September 2005||2005-09-01|September 2005|2005-09-01|June 2007||2007-06-01|||||Interventional|||Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta|A Pilot Study to Evaluate the Efficacy and Safety of Pegylated Interferon Alfa-2b Plus Ribavirin in the Treatment of Patients With Dual Chronic Hepatitis B and Delta|Unknown status|Recruiting|Phase 4|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:07:54.337791|2017-10-11 05:07:54.337791
NCT00117546|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-06-07|||September 2005||2005-09-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia|Cardiovascular Performance and Autonomic Reactivity in Formerly Preeclamptic Women With a Contracted Plasma Volume (CAPACITY Trial)|Unknown status|Recruiting|Phase 4|35|Anticipated|Radboud University|||||f||||t||||||||||2017-10-11 05:07:54.432689|2017-10-11 05:07:54.432689
NCT00117559|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-12-09|2014-11-17||July 2005||2005-07-01|December 2014|2014-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Improving Quality of Life for Veterans Undergoing Interferon Treatment|Improving Quality of Life for Veterans Undergoing Interferon Treatment|Completed||N/A|19|Actual|VA Office of Research and Development|Small sample size, all male, no in-person comparison group, reporting bias in self-report measures.|2|||f||||f||||||||||2017-10-11 05:07:54.543389|2017-10-11 05:07:54.543389
NCT00117572|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-10-09|||November 2004||2004-11-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|May 2009|Actual|2009-05-01||Interventional|||Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)|A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients With N2/N3 Locally Advanced Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|University of Chicago||2|||f||||t||||||||||2017-10-11 05:07:54.891817|2017-10-11 05:07:54.891817
NCT00117585|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2016-03-18|2013-11-05||November 2005||2005-11-01|March 2016|2016-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Orthostatic Hypotension in Rehabilitation Patients|Orthostatic Hypotension in Rehabilitation Patients|Completed||N/A|341|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:07:55.042429|2017-10-11 05:07:55.042429
NCT00117611|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-09-27|||July 2005||2005-07-01|September 2013|2013-09-01|January 2009|Actual|2009-01-01|May 2007|Actual|2007-05-01||Interventional|||Xolair in Patients With Chronic Sinusitis|Effects of Anti-IgE Antibody Omalizumab (Xolair) on Patients With Chronic Sinusitis and a Positive Allergen Test|Completed||Phase 4|14|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 05:07:58.190293|2017-10-11 05:07:58.190293
NCT00117624|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-20|||December 2002||2002-12-01|December 2007|2007-12-01|December 2003||2003-12-01|||||Interventional|||A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy|A Randomized, Double-Blind, Study of Front-Loading Darbepoetin Alfa Compared With Standard Weekly Administration for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy and Receiving Multicycle Chemotherapy|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-10-11 05:07:58.306317|2017-10-11 05:07:58.306317
NCT00117637|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-10-24|2010-08-27||June 2005||2005-06-01|October 2014|2014-10-01|March 2009|Actual|2009-03-01|September 2006|Actual|2006-09-01||Interventional|||BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma|A Randomised, Open-label, Multi-centre Phase II Study of BAY43-9006 (Sorafenib) Versus Standard Treatment With Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma.|Completed||Phase 2|189|Actual|Bayer||2|||f||||t||||||||||2017-10-11 05:07:58.442849|2017-10-11 05:07:58.442849
NCT00117650|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2015-03-17||2010-10-02|February 2005||2005-02-01|March 2015|2015-03-01|March 2010|Actual|2010-03-01|September 2008|Actual|2008-09-01||Interventional|WALK||Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-Selection Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 in Patients With Intermittent Claudication|Completed||Phase 2|289|Actual|Sanofi||4|||f||||t||||||||||2017-10-11 05:08:01.190538|2017-10-11 05:08:01.190538
NCT00119548|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2015-04-06|||March 2005||2005-03-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling|Improving HIV Screening by Nurse Rapid Testing, Streamlined Counseling|Completed||N/A|251|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 05:08:58.335216|2017-10-11 05:08:58.335216
NCT00117676|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-01-16|2010-02-11||February 2005||2005-02-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|April 2007|Actual|2007-04-01||Interventional||Randomized and Treated Analysis Set: all participants who were randomized and received at least one dose of study medication|A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B|A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF Versus Adefovir Dipivoxil for the Treatment of Presumed Pre-Core Mutant Chronic Hepatitis B|Completed||Phase 3|382|Actual|Gilead Sciences||2|||f||||t||||||||||2017-10-11 05:08:01.594431|2017-10-11 05:08:01.594431
NCT00117689|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2015-03-17|||April 2005||2005-04-01|March 2015|2015-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection|A Randomized, Controlled, Multi-Center Study of Thymoglobulin Induction Therapy With a Calcineurin Inhibitor Sparing Regimen in Liver Transplant Patients|Completed||Phase 2|75|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:08:05.379592|2017-10-11 05:08:05.379592
NCT00117702|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-06-17|||October 2005||2005-10-01|June 2009|2009-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus|Prophylaxis of the Graft-Versus-Host-Disease in Patients After Allogeneic Stem Cell Transplantation With a Combination of Tacrolimus and Everolimus|Terminated||Phase 2/Phase 3|24|Actual|Technische Universität Dresden||1||safety reasons|f||||t||||||||||2017-10-11 05:08:05.544838|2017-10-11 05:08:05.544838
NCT00117715|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2017-08-11|2017-04-04||October 2000||2000-10-01|August 2017|2017-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Developmental Regulation of Proteins Responsible for Transforming Drugs in the Body|Developmental Regulation of CYPs 1A2, 2D6, 3A4|Completed||N/A|121|Actual|Children's Mercy Hospital Kansas City|Not all enrolled participants were available for evaluation at every milestone.||1||f||||f||||||Samples With DNA|"     Urine DNA (source: blood or saliva)   "|||2017-10-11 05:08:05.693804|2017-10-11 05:08:05.693804
NCT00117728|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2007-06-28|||April 2005||2005-04-01|January 2006|2006-01-01|September 2010|Anticipated|2010-09-01|||||Interventional|||Pediatric Nevirapine Resistance Study|Clinical Relevance of Nevirapine Resistance|Unknown status|Recruiting|Phase 3|250|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:08:06.121387|2017-10-11 05:08:06.121387
NCT00117741|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-01-31|||June 2004||2004-06-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation of DBT Compared to Drug Counseling for Opiate Addicts|Evaluation of Dialectical Behavior Therapy (DBT)|Completed||N/A|86|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 05:08:06.217488|2017-10-11 05:08:06.217488
NCT00117754|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-02-20|||July 2004||2004-07-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Terbinafine Compared to Griseofulvin in Children With Tinea Capitis|Efficacy and Safety of Terbinafine Compared to Griseofulvin in Children With Tinea Capitis|Completed||Phase 3|720||Novartis|||||||||||||||||||2017-10-11 05:08:06.329416|2017-10-11 05:08:06.329416
NCT00117767|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-05-28|||June 2004||2004-06-01|May 2017|2017-05-01||||March 2006|Actual|2006-03-01||Interventional|||Terbinafine Compared to Griseofulvin in Children With Tinea Capitis|Efficacy and Safety of Terbinafine Compared to Griseofulvin in Children With Tinea Capitis|Completed||Phase 3|720||Novartis||2|||||||||||||||||2017-10-11 05:08:06.39527|2017-10-11 05:08:06.39527
NCT00117780|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-06-01|||June 2005||2005-06-01|May 2017|2017-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|ADAPT||Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes|Comparison of Efficacy and Safety of Insulin Detemir Once or Twice Daily in a Basal-Bolus Regimen With Insulin Aspart in Patients With Type 1 Diabetes|Completed||Phase 4|520|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:08:06.470544|2017-10-11 05:08:06.470544
NCT00117793|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2014-07-28|2013-10-24||August 2005||2005-08-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||The sample population descriptors are based on the participants who completed the study protocol.|Vacuum Suspension: Effects on Tissue Oxygenation, Activity and Fit|Vacuum Suspension: Effects on Tissue Oxygenation, Activity and Fit|Completed||N/A|20|Actual|VA Office of Research and Development|The small number of participants who completed the protocol precluded a statistical analysis on the secondary outcome measures.|2|||f||||f||||||||||2017-10-11 05:08:06.57136|2017-10-11 05:08:06.57136
NCT00117806|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2016-02-03|2014-10-24||April 2006||2006-04-01|February 2016|2016-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|SCI-VIP|"AIS DATA-Missing 1 participant for Supported Employment and Treatment As Usual groups.
AIS & Neurologival Level- Missing 1 participant for Supported employment."|Spinal Cord Injury Vocational Integration Program (SCI-VIP)|A Spinal Cord Injury Vocational Integration Program: Implementation and Outcomes|Completed||N/A|249|Actual|VA Office of Research and Development|Majority of sample is male; Potential selection bias (participants who decided to remain in study for second year may be different from those who did not though no statistical significance was detected between groups)|2|||f||||t||||||||||2017-10-11 05:08:07.096924|2017-10-11 05:08:07.096924
NCT00117819|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-04-09||2014-04-09|March 2001||2001-03-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease|Dynamic SPECT Imaging With [123I] B-CIT in Individuals With Parkinsonian Syndrome (PS) and in Individuals at Risk for Parkinsonian Syndrome|Completed||Phase 2|232|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-10-11 05:08:07.808007|2017-10-11 05:08:07.808007
NCT00117832|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-09-04|||March 2005||2005-03-01|September 2013|2013-09-01|October 2006|Actual|2006-10-01|May 2006|Actual|2006-05-01||Interventional|||Nasal Ocular Reflexes Contribute to Eye Symptoms|Nasal Ocular Reflexes Contribute to Eye Symptoms in Patients With Allergic Rhinitis|Completed||N/A|20||University of Chicago|||||f||||f||||||||||2017-10-11 05:08:07.897512|2017-10-11 05:08:07.897512
NCT00118040|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2017-05-23|2015-12-10||June 2005||2005-06-01|May 2017|2017-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer|Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 05:08:14.86069|2017-10-11 05:08:14.86069
NCT00117845|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2013-10-31|2012-09-25||July 2005||2005-07-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|December 2011|Actual|2011-12-01||Interventional|||Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia|Phase II Study of the Efficacy and Toxicity of Ontak (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia|Completed||Phase 2|17|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-10-11 05:08:08.006065|2017-10-11 05:08:08.006065
NCT00117858|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2017-06-30|||June 28, 2005||2005-06-28|May 10, 2007|2007-05-10|May 10, 2007||2007-05-10|||||Interventional|||Double Blind Trial of DC Polarization in FTD|Double Blind Trial of DC Polarization in FTD|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:08:08.491454|2017-10-11 05:08:08.491454
NCT00117871|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-02-16|||October 2004||2004-10-01|November 2006|2006-11-01||||||||Interventional|||Study With a Topical Gel to Treat Common Warts in Adults|A Two-Stage, Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 5 Times Per Week for up to 12 Weeks for the Treatment of Common Warts in Adults|Completed||Phase 2|48||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-10-11 05:08:08.567816|2017-10-11 05:08:08.567816
NCT00117884|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2016-08-16||2016-08-16|April 2006||2006-04-01|August 2016|2016-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.|A Randomized, Double-blind, Placebo-Controlled, Dose Response Study to Evaluate 851B Gel Delivered Intravaginally Twice a Week for Two, Three-Week Cycles in Women Who Are Positive For High-Risk Genotypes of Human Papillomavirus and Have Mild Cytological Abnormalities|Terminated||Phase 2|240|Actual|Takeda||11||Lack of efficacy|f||||f||||||||||2017-10-11 05:08:08.637178|2017-10-11 05:08:08.637178
NCT00117897|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-07-16|||July 2002||2002-07-01|July 2009|2009-07-01|February 2004||2004-02-01|||||Interventional|||Treatment for Subjects With Non-Hodgkin's Lymphoma|An Open-Label, Randomized, Parallel, Phase II Study of CHOP Chemotherapy and Rituximab Administered Every 14 Days, With Pegfilgrastim or Filgrastim Support, for the Treatment of Subjects With Non-Hodgkin's Lymphoma|Completed||Phase 2|||Amgen||1|||f||||||||||||||2017-10-11 05:08:08.806631|2017-10-11 05:08:08.806631
NCT00117910|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-05-15|||October 2002||2002-10-01|May 2008|2008-05-01|May 2004||2004-05-01|||||Interventional|||Treatment for Elderly Patients With High Risk Breast Cancer|An Open Label, Randomised, Multicentre Study of Pegfilgrastim in Primary Versus Secondary Prophylaxis of Neutropenia as an Adjunct to Chemotherapy in Elderly Subjects With High Risk Breast Cancer.|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-10-11 05:08:08.898172|2017-10-11 05:08:08.898172
NCT00117923|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-02-16|||August 2004||2004-08-01|November 2006|2006-11-01||||||||Interventional|||Study With a Topical Gel to Treat Common Warts in Adults|A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 5 Times Per Week for 4 Weeks for the Treatment of Common Warts in Adults|Completed||Phase 2|88||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-10-11 05:08:08.978601|2017-10-11 05:08:08.978601
NCT00117936|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-11-07|||September 2008||2008-09-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|ACORD||Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease|Human Recombinant Fibroblast Growth Factor-1 (FGF-1) for Intramyocardial Injection for the Treatment of Coronary Heart Disease|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|CardioVascular BioTherapeutics, Inc.||4|||f||||t||||||||||2017-10-11 05:08:09.061564|2017-10-11 05:08:09.061564
NCT00117949|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-05-18|2009-01-22||April 2002||2002-04-01|May 2011|2011-05-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486|An Open-Label, Multi-Center, Ascending, Single Dose Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486|Completed||Phase 2|82|Actual|Ferring Pharmaceuticals||4|||f||||t||||||||||2017-10-11 05:08:09.229114|2017-10-11 05:08:09.229114
NCT00117962|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2016-08-29|2012-11-05||September 2005||2005-09-01|August 2016|2016-08-01|September 2012|Actual|2012-09-01|March 2009|Actual|2009-03-01||Interventional|||Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Randomized Phase II Study of Radiation Therapy, Pemetrexed and Carboplatin With or Without Cetuximab in Stage III Non-Small Cell Lung Cancer|Completed||Phase 2|109|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-10-11 05:08:10.631803|2017-10-11 05:08:10.631803
NCT00117975|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2016-07-01|||June 2005||2005-06-01|July 2016|2016-07-01|August 2013|Actual|2013-08-01|June 2007|Actual|2007-06-01||Interventional|||Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|A Phase II Trial of Extended Induction Galiximab (Anti-CD80 Monoclonal Antibody) (IND #12373) Plus Rituximab in Previously Untreated Follicular Non-Hodgkin Lymphoma (NHL)|Completed||Phase 2|62|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 05:08:12.395681|2017-10-11 05:08:12.395681
NCT00117988|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2014-05-21|2011-05-05||February 2005||2005-02-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma|A Phase II Study of 17-AAG in Patients With Relapsed/Refractory CD30+ Anaplastic Large Cell Lymphoma (ALCL), Relapsed/Refractory Mantle Cell Lymphoma (MCL), and Relapsed/Refractory Classical Hodgkin's Lymphoma (HL)|Completed||Phase 2|22|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:08:12.601273|2017-10-11 05:08:12.601273
NCT00118001|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2015-03-31|||October 2001||2001-10-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Interventional|||Psychotherapy of Generalized Anxiety Disorder|Worry Exposure Versus Applied Relaxation in the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|70||German Research Foundation|||||f||||||||||||||2017-10-11 05:08:12.829382|2017-10-11 05:08:12.829382
NCT00118014|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2008-05-19|||January 2000||2000-01-01|May 2008|2008-05-01|August 2004|Actual|2004-08-01|April 2004|Actual|2004-04-01||Interventional|||Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania|Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania|Completed||Phase 4|75|Actual|Massachusetts General Hospital||4|||f||||f||||||||||2017-10-11 05:08:12.906201|2017-10-11 05:08:12.906201
NCT00118027|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-01-11|||May 2003||2003-05-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|||||Interventional|||A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda|A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda|Completed||N/A|2150||London School of Hygiene and Tropical Medicine|||||f||||f||||||||||2017-10-11 05:08:13.007024|2017-10-11 05:08:13.007024
NCT00118053|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2013-09-17|2013-09-17||April 2005||2005-04-01|September 2013|2013-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer|A Phase II Trial of Taxotere, Carboplatin and Herceptin in Locally Advanced or Inflammatory Breast Cancer|Terminated||Phase 2|5|Actual|Rutgers, The State University of New Jersey||1||slow accrual|f||||f||||||||||2017-10-11 05:08:16.389258|2017-10-11 05:08:16.389258
NCT00118066|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2015-05-22|||May 2004||2004-05-01|May 2015|2015-05-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia|A Randomized Phase II Trial Of Calcitriol In Patients With Prostatic Intraepithelial Neoplasia|Terminated||Phase 2|12|Actual|Rutgers, The State University of New Jersey||2||Slow accruaL, lack of scientific progress|f||||f||||||||||2017-10-11 05:08:16.718095|2017-10-11 05:08:16.718095
NCT00118092|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2017-03-20|2016-12-28||January 2005||2005-01-01|March 2017|2017-03-01|February 2008|Actual|2008-02-01|May 2006|Actual|2006-05-01||Interventional|||17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy|A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Patients With Hormone-Refractory Metastatic Prostate Cancer|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:08:16.824468|2017-10-11 05:08:16.824468
NCT00118105|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2013-01-02|||November 2006||2006-11-01|January 2013|2013-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer|A Phase II Trial of Neoadjuvant Capecitabine, Oxaliplatin, and Bevacizumab for Resectable Colorectal Metastases in the Liver|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||1||Budget Constraints|f||||t||||||||||2017-10-11 05:08:17.170936|2017-10-11 05:08:17.170936
NCT00118131|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2013-09-19|2013-09-19||December 2003||2003-12-01|September 2013|2013-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Weekly Docetaxel Together With Weekly Cisplatin in Chemotherapy-Naive Patients With Stage IV or Select Stage IIIB (Malignant Effusion) Non-Small Cell Lung Cancer|Terminated||Phase 2|49|Actual|Rutgers, The State University of New Jersey||1||Slow accrual|f||||f||||||||||2017-10-11 05:08:17.422078|2017-10-11 05:08:17.422078
NCT00118144|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2014-08-04|2014-08-04||June 2005||2005-06-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer|Phase II Study of Bortezomib (PS-341) for Patients With Advanced Bronchiolo-Alveolar Carcinoma (BAC) or Adenocarcinoma With BAC Features|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:08:18.010089|2017-10-11 05:08:18.010089
NCT00118157|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2015-07-28|2014-11-21||May 2005||2005-05-01|April 2014|2014-04-01|September 2014|Actual|2014-09-01|July 2011|Actual|2011-07-01||Interventional|||Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen|A Phase II Study of GW572016 and Tamoxifen in Patients With Metastatic Breast Cancer Resistant to Single-Agent Tamoxifen|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)|The main limitation in this study was poor enrollment. The small number of cases makes the interpretation of results difficult.|1|||f||||||||||||||2017-10-11 05:08:18.755461|2017-10-11 05:08:18.755461
NCT00118170|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2013-01-04|||October 2004||2004-10-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function|Pharmacokinetic and Phase I Study of Sorafenib (BAY 43-9006, NSC 724772, IND 69896) for Solid Tumors and Hematologic Malignancies in Patients With Hepatic or Renal Dysfunction|Completed||Phase 1|150|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:08:19.108873|2017-10-11 05:08:19.108873
NCT00118183|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2013-06-03|||July 2005||2005-07-01|June 2013|2013-06-01||||April 2007|Actual|2007-04-01||Interventional|||Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II Trial of Docetaxel Plus Cetuximab and Docetaxel Plus Bortezomib (NSC #681239, IND #58443) in Advanced Non-Small Cell Lung Cancer Patients With Performance Status (PS) 2|Completed||Phase 2|62|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:08:19.246333|2017-10-11 05:08:19.246333
NCT00118196|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2012-04-26|||April 2005||2005-04-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia|A Phase II Study of Arsenic Trioxide in Combination With 5-Azacitidine in Myelodysplastic Syndromes|Completed||Phase 2|41|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-10-11 05:08:19.362036|2017-10-11 05:08:19.362036
NCT00118209|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2017-08-07|||May 2005|Actual|2005-05-01|August 2017|2017-08-01||||May 2018|Anticipated|2018-05-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Phase III Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R With Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas|Active, not recruiting||Phase 3|523|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 05:08:19.463103|2017-10-11 05:08:19.463103
NCT00118222|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2010-06-09|||March 2005||2005-03-01|June 2010|2010-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||High Light and Low Light Dose PDT in Glioma|A Randomized Prospective Two Arm Clinical Trial of High Light Dose And Low Light Dose PDT in the Treatment of Recurrent Malignant Supratentorial Gliomas Using Porfimer Sodium [Photofrin]|Completed||Phase 3|1|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 05:08:19.686778|2017-10-11 05:08:19.686778
NCT00118235|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2014-06-16|||December 2004||2004-12-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|April 2007|Actual|2007-04-01||Interventional|||Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer|Cisplatin, Irinotecan and Bevacizumab (NSC# 704865) for Untreated Extensive Stage Small Cell Lung Cancer: A Phase II Study|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:08:19.811859|2017-10-11 05:08:19.811859
NCT00118248|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2016-12-28|2013-09-20||December 2004||2004-12-01|December 2016|2016-12-01|April 2012|Actual|2012-04-01|August 2009|Actual|2009-08-01||Interventional|||Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer|A Phase II Trial of 17-Allylaminogeldanamycin (17AAG) in Advanced Medullary and Differentiated Thyroid Carcinoma|Completed||Phase 2|41|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:08:19.944543|2017-10-11 05:08:19.944543
NCT00118261|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2012-08-31|||March 2005||2005-03-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer|A Phase IB Study in Patients With Metastatic Colorectal Cancer to Evaluate Pharmacodynamic Effects of Erlotinib and Safety and Efficacy of Erlotinib in Combination With Modified FOLFOX6 (mFOLFOX6) and Bevacizumab|Completed||Phase 1|17|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:08:20.439093|2017-10-11 05:08:20.439093
NCT00118274|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2017-08-31|||March 2005|Actual|2005-03-01|August 2017|2017-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma|A Multicenter Trial to Evaluate the Effects of Administration of Cyclophosphamide and Melanoma-Derived Helper Peptides on the Immunogenicity of a Class I MHC-Restricted Peptide-Based Vaccine in Participants With Resected Melanoma|Completed||Phase 1/Phase 2|173|Anticipated|University of Virginia||4|||f|||||t|f||||||||2017-10-11 05:08:20.535355|2017-10-11 05:08:20.535355
NCT00118287|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2017-04-17|2017-04-17||April 2005||2005-04-01|April 2017|2017-04-01||||October 2008|Actual|2008-10-01||Interventional|||Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes|Therapy of Myelodysplastic Syndrome (MDS) With Azacitidine Given in Combination With Etanercept: A Phase I/II Study.|Completed||Phase 1/Phase 2|32|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 05:08:20.712509|2017-10-11 05:08:20.712509
NCT00118300|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2011-07-07|||April 2005||2005-04-01|July 2011|2011-07-01||||||||Interventional|||Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer|Phase I Study of Capecitabine (Xeloda) and Radiation Therapy in Patients With Locally Advanced Cervical and Pelvic Malignancies|Withdrawn||Phase 1|0|Actual|Case Comprehensive Cancer Center||1||Competing studies|f||||t||||||||||2017-10-11 05:08:21.128462|2017-10-11 05:08:21.128462
NCT00118313|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2014-12-18|||November 2004||2004-11-01|December 2014|2014-12-01||||November 2007|Actual|2007-11-01||Interventional|||Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma|Evaluation of Different Adjuvants for the Transdermal Administration of a Peptide-Based Vaccine in Participants With High-Risk Melanoma|Completed||Phase 1|||University of Virginia|||||f||||t||||||||||2017-10-11 05:08:21.221735|2017-10-11 05:08:21.221735
NCT00118326|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2010-05-12|||August 2003||2003-08-01|May 2010|2010-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease|Feasibility of Granulocyte-Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow From Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:08:21.321017|2017-10-11 05:08:21.321017
NCT00118339|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2011-08-30|||July 2003||2003-07-01|August 2011|2011-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma|A Prospective Randomized Pilot Study Using Ice Chips Versus Room Temperature Normal Saline Rinses Orally During Administration of Melphalan to Decrease the Severity and Duration of Oral Mucositis in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplant|Completed||N/A|41|Actual|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:08:21.435342|2017-10-11 05:08:21.435342
NCT00118352|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2017-04-25|2017-01-12||March 2005||2005-03-01|April 2017|2017-04-01|May 26, 2015|Actual|2015-05-26|July 2010|Actual|2010-07-01||Interventional|||Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer|Campath (Alemtuzumab) Dose Escalation, Low-Dose TBI and Fludarabine Followed by HLA Class II Mismatched Donor Stem Cell Transplantation for Patients With Hematologic Malignancies: A Multicenter Trial|Completed||Phase 2|12|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 05:08:21.529405|2017-10-11 05:08:21.529405
NCT00118365|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2015-01-12|2014-04-18||July 1998||1998-07-01|February 2014|2014-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional||Randomized participants|Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps|A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Combination of DFMO and Sulindac to Decrease the Rate of Recurrence of Adenomatous Polyps in the Colon|Completed||Phase 3|375|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:08:22.233059|2017-10-11 05:08:22.233059
NCT00118378|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2017-04-03|2012-01-03||December 2004||2004-12-01|March 2017|2017-03-01|November 2010|Actual|2010-11-01|June 2010|Actual|2010-06-01||Interventional|||Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS|Modafinil Treatment for Fatigue in HIV+ Patients|Completed||Phase 4|115|Actual|New York State Psychiatric Institute|This study was conducted at a single site in an urban setting where most patients have good access to medical care. Women were under-represented despite outreach efforts.|2|||f||||t||||||||||2017-10-11 05:08:27.281068|2017-10-11 05:08:27.281068
NCT00118391|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2013-06-28|||November 2002||2002-11-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|CBT/CM||Cognitive-Behavioral Treatment of Gambling|Enhanced Cognitive Behavior Therapy for the Treatment of Pathological Gambling|Completed||Phase 1|120||UConn Health|||||f||||t||||||||||2017-10-11 05:08:27.662572|2017-10-11 05:08:27.662572
NCT00118404|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2014-05-13|2013-12-12||March 2000||2000-03-01|May 2014|2014-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||523 adults with recurrent major depressive disorder began acute phase cognitive therapy; only the 241 eligible higher-risk responders were randomized to the 3 arms above.|Cognitive Therapy for Recurrent Depression|Prophylactic Cognitive Therapy for Depression.|Completed||Phase 3|523|Actual|University of Texas Southwestern Medical Center|"To our knowledge in 2014 this is of the largest, cognitive therapy responders who presented with recurrent MDD and were followed longitudinally
Proficient therapists;competency measured.
Generalizability is limited by design characteristics."|3|||f||||t||||||||||2017-10-11 05:08:27.771891|2017-10-11 05:08:27.771891
NCT00118417|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2014-06-05|2009-06-05||March 1999||1999-03-01|June 2014|2014-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Therapies for Treatment-Resistant Panic Disorder Symptoms|Treatment Refractory Panic Disorder|Completed||Phase 2/Phase 3|46|Actual|Massachusetts General Hospital|Power in Phase 2 limited detection to a large effect size. High drop-out for increased SSRI dose may indicate poor tolerability. Effectiveness of adding an SSRI to initial CBT was unexamined, limiting generalization to community treatment decisions.|2|||f||||||||||||||2017-10-11 05:08:28.536103|2017-10-11 05:08:28.536103
NCT00118430|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2017-03-28|2016-05-23||September 2004||2004-09-01|March 2017|2017-03-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Stepped Care for Depression and Musculoskeletal Pain|Stepped Care for Affective Disorders and Musculoskeletal Pain|Completed||Phase 4|500|Actual|Indiana University||3|||f||||t||||||||Yes|Data has been published in multiple publications. Should others wish access to data for publication reasons, we are willing to share|2017-10-11 05:08:28.893256|2017-10-11 05:08:28.893256
NCT00118443|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2013-06-27|||March 2004||2004-03-01|June 2013|2013-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Evaluation of a School-Based Training Program for Suicide Prevention|RCT of Gatekeeper Training for Suicide Prevention|Completed||Phase 2/Phase 3|50000|Anticipated|University of Rochester|||||f||||||||||||||2017-10-11 05:08:29.457974|2017-10-11 05:08:29.457974
NCT00118456|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2012-01-05|||July 2003||2003-07-01|January 2012|2012-01-01||||January 2008|Actual|2008-01-01||Interventional|||Study of Oral AEE788 in Adults With Advanced Cancer|A Phase I/II, Multicenter, Randomized Dose-Escalation Study of Oral AEE788 on Intermittent Dosing Schedules in Adult Patients With Advanced Cancer (Effective Amendment 5) Previously Entitled A Phase IA, Multicenter, Dose-Escalating Study of Oral AEE788 on a Continuous Daily Dosing Schedule in Adult Patients With Advanced Cancer|Completed||Phase 1|189|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:08:29.532221|2017-10-11 05:08:29.532221
NCT00118469|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2008-04-01|||July 2004||2004-07-01|February 2008|2008-02-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Parent Psychoeducation and Cognitive Behavior Therapy for Latino Adolescents With Depression|Parent Psychoeducation Intervention in CBT for Depressed Latino Youth|Unknown status|Recruiting|Phase 2|144|Anticipated|National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 05:08:29.631491|2017-10-11 05:08:29.631491
NCT00118482|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-05-25|2016-10-26||May 2005||2005-05-01|May 2017|2017-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Median age was 30.5 years and 146 were women.|Clinical Trial for the Prevention of Vasovagal Syncope|A Randomized Clinical Trial of Fludrocortisone for Vasovagal Syncope: The Second Prevention of Syncope Trial (POST II)|Completed||Phase 4|213|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 05:08:29.725084|2017-10-11 05:08:29.725084
NCT00118495|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-07-04|||March 2006||2006-03-01|July 2007|2007-07-01|March 2007||2007-03-01|||||Interventional|||Zestra in Women With Mixed Sexual Dysfunction|A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial of the Efficacy and Safety of Zestra(TM) in Women With Mixed Desire/Interest/Arousal/Orgasm Disorders|Completed||Phase 3|200||QualiLife Pharmaceuticals|||||f||||t||||||||||2017-10-11 05:08:30.02444|2017-10-11 05:08:30.02444
NCT00118508|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2015-08-10|||May 2003||2003-05-01|August 2015|2015-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)|The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)|Completed||N/A|87|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:08:30.13578|2017-10-11 05:08:30.13578
NCT00118521|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2013-12-18|||May 2004||2004-05-01|September 2006|2006-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Clinical Study in the Use of Orthotics in Treating Pain in the Front of the Knee|Foot Orthotics in the Treatment of Patellofemoral Pain Syndrome: A Randomised Clinical Trial in Primary Care|Completed||Phase 3|176||The University of Queensland|||||f||||||||||||||2017-10-11 05:08:30.22528|2017-10-11 05:08:30.22528
NCT00118534|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2014-04-18|2013-08-22||July 2004||2004-07-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder|CSP #519 - Integrating Practice Guidelines for Smoking Cessation Into Mental Health Care for PTSD (SCP)|Completed||N/A|943|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:08:30.374706|2017-10-11 05:08:30.374706
NCT00118547|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2011-08-11|||September 2005||2005-09-01|August 2011|2011-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Health Behavior Change in Chronic Disease Management|Health Behavior Change in Chronic Disease Management|Completed||N/A|20|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:08:33.555402|2017-10-11 05:08:33.555402
NCT00118560|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-03-16|||June 2005||2005-06-01|March 2011|2011-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Exercise Training for Patients With Poor Leg Circulation|Perfusion and Metabolism During Exercise in Peripheral Arterial Disease|Completed||N/A|50|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 05:08:33.642957|2017-10-11 05:08:33.642957
NCT00118573|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2015-12-09|||September 2004||2004-09-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|May 2010|Actual|2010-05-01||Interventional|CAESAR||Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair|Randomized Clinical Trial Comparing Surveillance and Selective Surgical Treatment for Abdominal Aortic Aneurysms Less Than 5.5 cm in Diameter Versus Early Endovascular Treatment|Terminated||Phase 4|360|Actual|University Of Perugia||2||lower than anticipated events;slow recruitment;larger than predicted sample size|f||||t||||||||||2017-10-11 05:08:33.753124|2017-10-11 05:08:33.753124
NCT00118586|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2017-10-05|||July 6, 2005||2005-07-06|November 30, 2016|2016-11-30||||||||Observational|||Neuropathology of Spasmodic Dysphonia|Neuropathological Basis of Spasmodic Dysphonia and Related Voice Disorders|Active, not recruiting||N/A|97|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:08:33.937928|2017-10-11 05:08:33.937928
NCT00118612|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2010-06-16|||July 2005||2005-07-01|June 2010|2010-06-01||||||||Interventional|||Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen|A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Birch + Hazel + Alder Pollen Allergoid With MPL® in Patients Sensitized to Birch, Hazel, Alder Pollen|Completed||Phase 2|68||Allergy Therapeutics|||||||||||||||||||2017-10-11 05:08:34.033306|2017-10-11 05:08:34.033306
NCT00118625|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2010-06-16|||July 2005||2005-07-01|June 2010|2010-06-01|September 2005||2005-09-01|||||Interventional|||Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine|A Double-Blind Phase IIa Study to Demonstrate the Contribution of MPL® to Tyrosine Adsorbed Birch + Hazel + Alder Pollen Allergoid (Tree MATA) With a Single-Blind Portion to Evaluate the Residual Allergenicity in Skin Test in Volunteers Allergic to Birch and Hazel and Alder Pollen|Completed||Phase 2|40||Allergy Therapeutics|||||||||||||||||||2017-10-11 05:08:34.121235|2017-10-11 05:08:34.121235
NCT00118638|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-04-25|||March 2004||2004-03-01|April 2013|2013-04-01|January 2005|Actual|2005-01-01|December 2004|Actual|2004-12-01||Interventional|||A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy|A Randomized, Double Blind, Active-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy|Completed||Phase 3|705|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:08:34.234933|2017-10-11 05:08:34.234933
NCT00118651|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2013-09-25|||October 2004||2004-10-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Observational|||Clinical Indicators of Radiographic Findings in Patients With Suspected Community-Acquired Pneumonia|Clinical Indicators of Radiographic Findings in Patients With Suspected Community-Acquired Pneumonia: Who Needs a Chest X-Ray?|Withdrawn||N/A|0|Actual|David Grant U.S. Air Force Medical Center||||PI location unknown|f||||||||||||||2017-10-11 05:08:34.331492|2017-10-11 05:08:34.331492
NCT00118664|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2016-06-13|||May 2005||2005-05-01|June 2016|2016-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|TAMOF||Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children|Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children|Completed||N/A|86|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||No||2017-10-11 05:08:34.38808|2017-10-11 05:08:34.38808
NCT00118677|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2007-08-29|||February 2003||2003-02-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Long-Term Supervised Treatment Interruption in HIV-Infected Patients|Long-Term Supervised Treatment Interruption in HIV-Infected Patients Who Started Antiretroviral Treatment With CD4 Over 350/mm3 and Plasma HIV RNA Below 50 000/mL ANRS 116 Trial SALTO|Completed||Phase 3|130||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:08:34.659873|2017-10-11 05:08:34.659873
NCT00118690|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2016-09-22|||December 2003||2003-12-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise|A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and Adolescent Subjects With Activity-Induced Bronchospasm|Completed||Phase 4|227|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:08:34.738417|2017-10-11 05:08:34.738417
NCT00118703|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2017-07-14|2017-03-21||July 1, 2005||2005-07-01|March 2017|2017-03-01|February 9, 2006|Actual|2006-02-09|February 1, 2006|Actual|2006-02-01||Interventional|||Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis|A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis|Completed||Phase 3|350|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:08:34.930022|2017-10-11 05:08:34.930022
NCT00118729|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2016-09-13|||April 2005||2005-04-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action|A Randomized, Double Blind, Placebo-Controlled, Single-Dose, Parallel-Group Study to Evaluate the Onset of Action of a Single Dose of Intranasal GW685698X Aqueous Nasal Spray 100mcg in Adolescent and Adult Subjects (12 Years of Age and Older) With Seasonal Allergic Rhinitis Exposed to Ragweed Pollen in an Allergen Challenge Chamber|Completed||Phase 3|380|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:08:35.758644|2017-10-11 05:08:35.758644
NCT00118742|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-07-30|2009-05-13||August 2005||2005-08-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant|A Randomized, Open-label Study of the Effect of a Long-term Calcineurin Inhibitor-free Maintenance Regimen With CellCept and Sirolimus on Preservation of Renal Function and Prevention of Acute Rejection in Recipients of an Orthotropic Liver Transplant|Completed||Phase 4|293|Actual|Hoffmann-La Roche|There were no overall limitations and caveats.|2|||f||||||||||||||2017-10-11 05:08:35.881929|2017-10-11 05:08:35.881929
NCT00118755|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2011-02-09|2010-04-25||July 2005||2005-07-01|February 2011|2011-02-01||||April 2009|Actual|2009-04-01||Interventional|||A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer|A Randomized, Open-label Study of the Effect of 2 Different Treatment Schedules of Xeloda With Eloxatin and Avastin on Progression-free Survival in Treatment-naïve Patients With Locally Advanced or Metastatic Colorectal Cancer|Completed||Phase 2|435|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:08:37.897609|2017-10-11 05:08:37.897609
NCT00118768|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-02-27|||August 2005||2005-08-01|February 2009|2009-02-01||||||||Interventional|||A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C|A Randomized, Phase IIb Clinical Trial to Evaluate the Safety and Antiviral Activity of the Combination of Pegylated Interferon Alfa Plus NM283 (Valopicitabine) in Treatment-Naive Patients With Chronic Hepatitis C|Completed||Phase 2|175||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:08:38.736583|2017-10-11 05:08:38.736583
NCT00118781|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2005-07-11|||September 2003||2003-09-01|July 2005|2005-07-01|June 2004||2004-06-01|||||Interventional|||Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia|Randomized, Double-Blind, Placebo-Controlled, Multinational Phase 3 Trial Of Iseganan In Prevention Of Ventilator-Associated Pneumonia|Terminated||Phase 2/Phase 3|900||IntraBiotics Pharmaceuticals|||||||||||||||||||2017-10-11 05:08:38.90913|2017-10-11 05:08:38.90913
NCT00118794|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2006-01-31|||September 2004||2004-09-01|January 2005|2005-01-01|June 2005||2005-06-01|||||Interventional|||Lapdap and Coartemether for Uncomplicated Malaria|Randomized Trial of the Safety and Effectiveness of Lapdap and Coartemether for Uncomplicated Malaria in Operational Settings|Completed||Phase 3|1200||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:08:38.984884|2017-10-11 05:08:38.984884
NCT00118807|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2006-01-06|||August 2003||2003-08-01|June 2003|2003-06-01|February 2004||2004-02-01|||||Interventional|||Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children|Randomized Trial of the Effectiveness of Amodiaquine-Artesunate, Amodiaquine-Sulfadoxine-Pyrimethamine, and Chloroquine-Sulfadoxine-Pyrimethamine, for Treatment of Uncomplicated Malaria in Gambian Children|Completed||Phase 3|1800||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:08:39.079419|2017-10-11 05:08:39.079419
NCT00118820|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2010-07-14|||March 2004||2004-03-01|July 2010|2010-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Antibiotic Efficacy in Third Molar Surgery|Antibiotic Efficacy in Third Molar Surgery|Completed||Phase 3|132|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:08:39.188188|2017-10-11 05:08:39.188188
NCT00118833|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2007-09-25|||August 2002||2002-08-01|September 2007|2007-09-01|June 2006|Actual|2006-06-01|||||Interventional|||St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)|Placebo-Controlled Trial of Hypericum Perforatum in the Treatment of Generalized Social Anxiety Disorder (GSAD)|Completed||Phase 2/Phase 3|56|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:08:39.298805|2017-10-11 05:08:39.298805
NCT00118846|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2017-03-28|||March 2004||2004-03-01|March 2017|2017-03-01|March 2009|Actual|2009-03-01|September 2005|Actual|2005-09-01||Interventional|||Women's Isoflavone Soy Health (WISH) Trial|Phytoestrogens and Progression of Atherosclerosis|Completed||Phase 2/Phase 3|350|Actual|University of Southern California||2|||f||||t||||||||||2017-10-11 05:08:39.39956|2017-10-11 05:08:39.39956
NCT00118859|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2009-12-10|||July 2004||2004-07-01|December 2009|2009-12-01|April 2006||2006-04-01|||||Interventional|||Pilot Study to Test the Effectiveness of Combining Conventional and Complementary Medicine to Treat Low Back Pain|Model of Integrative Care in an Academic Health Center|Completed||N/A|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:08:39.492308|2017-10-11 05:08:39.492308
NCT00118872|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2014-12-22|||March 2006||2006-03-01|December 2007|2007-12-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Beneficial Bacteria to Prevent Malnutrition and Diarrhea in Pakistani Infants|Feasibility Study of Probiotics for Growth Faltering in Pakistan|Completed||N/A|120|Actual|Tufts University||2|||f||||t||||||||||2017-10-11 05:08:39.58163|2017-10-11 05:08:39.58163
NCT00118885|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2009-12-09|||July 2001||2001-07-01|November 2006|2006-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Shingles: Immune Effects of Tai Chi|Behavioral Intervention for Herpes Zoster Risk in Aging|Completed||Phase 2|140||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:08:39.698768|2017-10-11 05:08:39.698768
NCT00118898|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2016-01-04|2010-01-08||September 2005||2005-09-01|January 2016|2016-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults|A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects|Completed||Phase 3|1864|Actual|AIDS Clinical Trials Group|HIV-1 drug resistance testing and HLA-B*5701 testing were not standard of care during enrollment. EFV and RTV-boosted ATV were open-label, and blinded FTC/TDF vs. ABC/3TC were unblinded in the >=100,000 cp/mL screening viral load stratum Feb 2008.|4|||f||||t||||||||||2017-10-11 05:08:39.84599|2017-10-11 05:08:39.84599
NCT00118911|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2013-03-07|2010-12-10||September 2004||2004-09-01|March 2013|2013-03-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder|Efficacy of CBT for Residual ADHD in Adults|Completed||N/A|86|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:08:42.646168|2017-10-11 05:08:42.646168
NCT00118924|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2008-01-18|||July 2005||2005-07-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of Tick-Borne Langat/Dengue 4 Chimera (LGT(TP21)/DEN4), a Live Attenuated Vaccine for Tick-Borne Encephalitis|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-10-11 05:08:43.022409|2017-10-11 05:08:43.022409
NCT00118937|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2008-12-05|||December 2003||2003-12-01|December 2008|2008-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet|Effect of Metformin On Glycaemic Control and Non-Glycaemic Cardiovascular Risk-Factors in Patients With Type-1 Diabetes, With Long-Standing Inadequate Glycaemic Control by Insulin and Diet|Completed||Phase 4|100|Actual|Steno Diabetes Center||3|||f||||||||||||||2017-10-11 05:08:43.170174|2017-10-11 05:08:43.170174
NCT00118950|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2008-12-05|||March 2001||2001-03-01|December 2008|2008-12-01|March 2003||2003-03-01|||||Interventional|||Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet|Effect of Metformin Versus Repaglinide Treatment on Glycemic Control and Non-Glycaemic Cardiovascular Risk Factors in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet|Completed||Phase 4|100||Steno Diabetes Center||4|||f||||||||||||||2017-10-11 05:08:43.289412|2017-10-11 05:08:43.289412
NCT00118963|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2008-12-05|||January 2003||2003-01-01|December 2008|2008-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes|Effect of Repaglinide Versus Metformin Treatment in Combination With Insulin Biasp30 (Novologmix 70/30) Predinner on Glycemic and Non-Glycemic Cardiovascular Risk-Factors in Non-Obese Patients With Type-2-Diabetes With Unsatisfactory Glycaemic Control With Oral Hypoglycaemic Agents|Completed||Phase 4|102|Actual|Steno Diabetes Center||3|||f||||||||||||||2017-10-11 05:08:43.386871|2017-10-11 05:08:43.386871
NCT00118976|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2006-11-22|||March 2005||2005-03-01|November 2006|2006-11-01|September 2006||2006-09-01|||||Interventional|||Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease|Optimal Dose of ACE Inhibitor for Treatment of Diabetic Nephropathy in Type 1 Diabetic Patients With Hypertension and Diabetic Nephropathy|Completed||N/A|60||Steno Diabetes Center|||||f||||||||||||||2017-10-11 05:08:43.502442|2017-10-11 05:08:43.502442
NCT00118989|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-02|2017-04-18|||July 2005||2005-07-01|April 2017|2017-04-01|July 2012|Actual|2012-07-01|September 2010|Actual|2010-09-01||Interventional|||Curcumin for the Chemoprevention of Colorectal Cancer|Phase II Double Blind Placebo-Controlled Trial of Curcuminoids' Effect on Cellular Proliferation, Apoptosis and COX-2 Expression in the Colorectal Mucosa of Subjects With Recently Resected Sporadic Adenomatous Polyps|Terminated||N/A|56|Actual|University of Pennsylvania||2||Could not be completed due to technology problems and cost constraints|f||||f|f|||||||||2017-10-11 05:08:43.674702|2017-10-11 05:08:43.674702
NCT00119002|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2008-03-13|||January 2004||2004-01-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis|The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis: A Multicenter Randomized Controlled Trial|Completed||Phase 4|598|Actual|University of Utah||2|||f||||t||||||||||2017-10-11 05:08:43.794118|2017-10-11 05:08:43.794118
NCT00119015|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2014-01-27|2012-12-20||July 2005||2005-07-01|January 2014|2014-01-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis|The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis|Terminated||Phase 4|102|Actual|University of Chicago|Early termination of study due to difficulty recruiting|2||Difficulty in recruitment|f||||f||||||||||2017-10-11 05:08:43.93637|2017-10-11 05:08:43.93637
NCT00119028|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2012-04-23|||April 2005||2005-04-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|ReTIDES||Expanding and Testing VA Collaborative Care Models for Depression|Expanding and Testing VA Collaborative Care Models for Depression|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||This study was withdrawn prior to enrollment.|f||||f||||||||||2017-10-11 05:08:44.505247|2017-10-11 05:08:44.505247
NCT00119041|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2015-05-18|2014-07-02||September 2005||2005-09-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional||"Cohort I will consist of high-risk patients referred to a specialist during the 9-month active intervention and enrollment phase.Cohort II will consist of all other patients with diabetes (i.e., all non-Cohort I patients). We didn't collect gender or the complete age data.
Qualitative interviews with providers"|Diabetes Telemedicine Consultation: A Systems Improvement Intervention|Diabetes Telemedicine Consultation: A Systems Improvement Intervention|Completed||N/A|304|Actual|VA Office of Research and Development|A potential factor jeopardizing both internal and external validity relates to fact that the consultation process may be very dependent on the particular individuals involved.|3|||f||||f||||||||||2017-10-11 05:08:44.664198|2017-10-11 05:08:44.664198
NCT00119054|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2015-04-06|||September 2005||2005-09-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Effectiveness of Home-Based Health Messaging for Patients With Hypertension and Diabetes|Effectiveness of Care Coordination in Managing Medically Complex Patients|Completed||N/A|302|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:08:45.028297|2017-10-11 05:08:45.028297
NCT00119080|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2007-03-16|||August 2006||2006-08-01|March 2007|2007-03-01|May 2007||2007-05-01|||||Interventional|||Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage|Evaluation of the Effect of Tetravalent (A, C, Y, W-135) Meningococcal Conjugate Vaccine on Serogroup-Specific Carriage of Neisseria Meningitidis|Completed||Phase 4|4000||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:08:45.273115|2017-10-11 05:08:45.273115
NCT00119093|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2012-09-10|||May 2003||2003-05-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Home-based AIDS Care Project|Home-based AIDS Care Project, Tororo, Uganda|Terminated||N/A|1000|Actual|Centers for Disease Control and Prevention||1||Terminated by IRB for non-compliance with human subject regulations.|f||||f||||||||||2017-10-11 05:08:45.362892|2017-10-11 05:08:45.362892
NCT00119119|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-04|2007-01-11|||February 2002||2002-02-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C|Efficacy and Safety of the Association With Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C|Terminated||Phase 3|100||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:08:45.626826|2017-10-11 05:08:45.626826
NCT00119132|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-04|2017-01-11|||June 2005||2005-06-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effectiveness of Intermittent Preventive Treatment for Malaria in Children|A Study Of Impact Of Intermittent Preventive Treatment In Children With Amodiaquine Plus Artesunate Versus Sulphadoxine-Pyrimethamine On Hemoglobin Levels And Malaria Morbidity In Hohoe District Of Ghana|Completed||Phase 2/Phase 3|2602|Actual|London School of Hygiene and Tropical Medicine||4|||f||||t||||||||||2017-10-11 05:08:45.7165|2017-10-11 05:08:45.7165
NCT00119145|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-04|2017-01-11|||June 2005||2005-06-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Kintampo Trial of Combination Therapy for Malaria|A Non-Inferiority, Open-Labelled, Randomised Trial Of The Efficacy And Safety Of Artesunate-Amodiaquine, Artemether-Lumefantrine, And Artesunate-Lapdap For Treatment Of Uncomplicated P. Falciparum Malaria Among Children In Ghana|Completed||Phase 4|510|Anticipated|London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-10-11 05:08:45.813154|2017-10-11 05:08:45.813154
NCT00119158|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2010-07-23|2010-02-19||October 2004||2004-10-01|July 2010|2010-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Combination Therapy for Atopic Dermatitis|An Exploratory Double-blind, Randomized, Vehicle-controlled, Paired Study to Evaluate the Efficacy and Safety of Concomitant Use of Elidel Cream 1% and Cutivate Cream 0.05% in Patients With Severe Lesions of Atopic Dermatitis (AD)|Completed||Phase 4|90|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-10-11 05:08:45.93428|2017-10-11 05:08:45.93428
NCT00119171|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2008-10-15|||November 2004||2004-11-01|October 2008|2008-10-01||||||||Interventional|||Ispinesib In Combination With Capecitabine In Patients With Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study of the Safety and Tolerability of Ispinesib in Combination With Capecitabine on an Every 21-Day Schedule in Subjects With Advanced Solid Tumors|Completed||Phase 1|30||GlaxoSmithKline|||||||||||||||||||2017-10-11 05:08:46.269157|2017-10-11 05:08:46.269157
NCT00119184|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-03|2008-06-05|||October 2002||2002-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|March 2006|Actual|2006-03-01||Interventional|||Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version|A Prospective Randomized Study to Examine the Success Rate of External Cephalic Version for Breech Presentation at Term Presentation: Spinal Analgesia Versus No Analgesia|Terminated||Phase 1|140|Anticipated|Hadassah Medical Organization||2||"Multiparas study terminated due to poor recruitment. Randomization revealed only after decision   recorded on clinicaltrials.gov"|f||||f||||||||||2017-10-11 05:08:46.347098|2017-10-11 05:08:46.347098
NCT00119197|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-04|2008-06-26|||August 2005||2005-08-01|June 2008|2008-06-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata|Safety and Immunogenicity of a Killed, Oral Cholera Vaccine in Indian Subjects in Eastern Kolkata, West Bengal|Completed||Phase 2|200|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-10-11 05:08:46.431402|2017-10-11 05:08:46.431402
NCT00119210|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2011-04-28|||March 2005||2005-03-01|April 2011|2011-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women|Bupropion for Smoking Cessation in Postpartum Women|Terminated||Phase 4|40|Anticipated|Massachusetts General Hospital||2||"We were unable to recruit sufficient numbers of patients and decided that the study protocol   was not feasible to implement"|f||||||||||||||2017-10-11 05:08:46.521486|2017-10-11 05:08:46.521486
NCT00119236|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2013-06-03|||May 2005||2005-05-01|June 2013|2013-06-01||||October 2008|Actual|2008-10-01||Interventional|||17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors|An Open-Labeled Non-Randomized Phase I Study of 17-N-allylamino-17-demethoxy Geldanamycin (17AAG) Administered With Irinotecan (CPT-11) in Patients With Advanced Solid Tumors|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:08:46.615069|2017-10-11 05:08:46.615069
NCT00119249|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2013-01-14|||June 2005||2005-06-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery|A Phase II Study of BAY 43-9006 (NSC 724772) in Unresectable Stage III and IV Melanoma (IND 69,869)|Completed||Phase 2|74|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:08:46.692119|2017-10-11 05:08:46.692119
NCT00119262|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2014-04-29|2011-04-04||October 2005||2005-10-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer|Phase II Feasibility Trial Incorporating Bevacizumab Into Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Patients With Lymph Node Positive Breast Cancer|Completed||Phase 2|226|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:08:47.01522|2017-10-11 05:08:47.01522
NCT00119301|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2013-01-15|||April 2005||2005-04-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma|Phase I Study of High Dose Methotrexate With Simultaneous Trimetrexate and Leucovorin in Patients With Recurrent Osteosarcoma|Completed||Phase 1|18|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 05:08:47.7801|2017-10-11 05:08:47.7801
NCT00119314|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2015-05-22|||July 2004||2004-07-01|April 2011|2011-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin|Carcinoma Unknown Primary: Treatment With Gemcitabine, Docetaxel and Capecitabine (GTX) an Evaluation and Treatment Study of The Cancer Institute of New Jersey Oncology Group|Withdrawn||Phase 2|0|Actual|Rutgers, The State University of New Jersey||||slow accrual|f||||t||||||||||2017-10-11 05:08:47.864416|2017-10-11 05:08:47.864416
NCT00119340|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2010-09-20|||April 2005||2005-04-01|September 2010|2010-09-01|November 2007|Actual|2007-11-01|||||Interventional|||Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia|Fludarabine and Low-Dose TBI Dose Escalation to Determine the Optimal Regimen for Achieving High Rates Engraftment of Unrelated Donor Peripheral Blood Stem Cell in Patients With Chronic Myeloid Leukemia - A Multi-Center Trial|Completed||Phase 1/Phase 2|75|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-10-11 05:08:47.959994|2017-10-11 05:08:47.959994
NCT00119366|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2017-04-13||2017-04-13|May 2003||2003-05-01|April 2017|2017-04-01||||August 2014|Actual|2014-08-01||Interventional|||Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome|A Phase II Trial Combining Radiolabeled BC8 (Anti-CD45) Antibody With Fludarabine and Low Dose TBI Followed by Related or Unrelated PBSC Infusion and Post-Transplant Immunosuppression for Patients With Advanced AML or High Risk Myelodysplastic Syndrome|Active, not recruiting||Phase 2|15|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 05:08:48.055957|2017-10-11 05:08:48.055957
NCT00119379|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2017-05-15|2016-12-08||April 2005||2005-04-01|May 2017|2017-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults|Reversibility of Mitochondrial Toxicity in HIV Lipoatrophy|Completed||Phase 2|50|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Small sample size; Lack of control arm where tNRTI therapy was continued without any intervention; Adherence measured by sachet/pill count method.|2|||f||||t||||||||No||2017-10-11 05:08:48.190334|2017-10-11 05:08:48.190334
NCT00119392|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2017-04-17|2017-04-17||June 2004||2004-06-01|April 2017|2017-04-01||||July 2009|Actual|2009-07-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial Evaluating the Safety and Efficacy of Non-myeloablative 90Y-Ibritumomab Tiuxetan (Anti-CD20) Antibody With Fludarabine, Low-Dose Total Body Irradiation (TBI) and HLA Matched Allogeneic Transplantation for Relapsed B-cell Lymphoma|Active, not recruiting||Phase 2|42|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 05:08:48.779379|2017-10-11 05:08:48.779379
NCT00119405|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2017-02-10|2016-06-13||April 2005||2005-04-01|December 2007|2007-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)|Role of Mitochondria in the Development of HIV Atrophy|Completed||N/A|18|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||f||||||Samples With DNA|"     Fat and Blood for mitochindrial DNA and different nuclear genes that regulate fat and lipid     metabolism   "|||2017-10-11 05:08:50.925414|2017-10-11 05:08:50.925414
NCT00119418|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-04|2010-10-25|||November 2004||2004-11-01|July 2005|2005-07-01|February 2006||2006-02-01|||||Interventional|||TU 025 Keishi Bukuryo Gan for Post-menopausal Hot Flash Management|TU 025 Keishi Bukuryo Gan for Post-Menopausal Hot Flash Management|Completed||Phase 2|180|Anticipated|Plotnikoff, Gregory A., M.D.|||||||||||||||||||2017-10-11 05:08:51.099468|2017-10-11 05:08:51.099468
NCT00119431|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-04|2009-05-01|||September 2005||2005-09-01|May 2009|2009-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Kinetics, Efficacy and Safety of C1-Esteraseremmer-N|Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema|Completed||Phase 2|12|Anticipated|Sanquin|||||f||||||||||||||2017-10-11 05:08:51.175586|2017-10-11 05:08:51.175586
NCT00119444|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2015-11-19|||January 2004||2004-01-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of Acetabular Perfusion After Ganz Osteotomy by Positron Emission Tomography|Evaluation of Acetabular Perfusion After Ganz Osteotomy by Positron Emission Tomography|Completed||N/A|12|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:08:51.251429|2017-10-11 05:08:51.251429
NCT00119457|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2009-06-02|||January 2005||2005-01-01|June 2009|2009-06-01|April 2006||2006-04-01|||||Interventional|||Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)|A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Weeks Extended VTE Prophylaxis With Daily Oral Doses of TTP889 After One Week of Standard Prophylactic Treatment Following Hip Fracture Surgery|Completed||Phase 2|300||vTv Therapeutics|||||f||||||||||||||2017-10-11 05:08:51.321035|2017-10-11 05:08:51.321035
NCT00113763|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2014-07-15|2010-08-06||January 2004||2004-01-01|July 2014|2014-07-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Interventional|||Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer|An Open-label, Randomized, Phase 3 Clinical Trial of ABX-EGF Plus Best Supportive Care Versus Best Supportive Care in Subjects With Metastatic Colorectal Cancer|Completed||Phase 3|463|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:08:51.470246|2017-10-11 05:08:51.470246
NCT00113776|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2011-01-20||||||January 2011|2011-01-01||||||||Interventional|||Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer|A Multicenter, Open-label, Single Arm Clinical Trial to Determine the Safety of ABX-EGF Extended Therapy in Subjects With Metastatic Colorectal Cancer|Completed||Phase 2|||Amgen||1|||||||||||||||||2017-10-11 05:08:52.916936|2017-10-11 05:08:52.916936
NCT00113789|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2009-02-12|||October 2003||2003-10-01|February 2009|2009-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer|Randomized, Phase 2 Study of Pegfilgrastim Given on the Last Day of a Multi-Day Topotecan Regimen or the Day After in Subjects With Relapsed or Refractory Ovarian Cancer|Completed||Phase 2|21|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:08:53.015258|2017-10-11 05:08:53.015258
NCT00113802|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2008-02-04|||August 2004||2004-08-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia|A Phase II, Single-Arm Trial of Epratuzumab, an Anti-CD22 Humanized Antibody, in Patients With Waldenstrom's Macroglobulinemia|Terminated||Phase 2|31||Immunomedics, Inc.||||low accrual|||||||||||||||2017-10-11 05:08:53.086522|2017-10-11 05:08:53.086522
NCT00113815|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2014-03-25|||May 2005||2005-05-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures|A Randomized, Double-Blind, Placebo-Controlled, Fixed Dose-Ranging Study to Assess the Safety, Tolerability, and Efficacy of Topiramate Oral Liquid and Sprinkle Formulations as an Adjunct to Concurrent Anticonvulsant Therapy for Infants (1-24 Months of Age) With Refractory Partial-Onset Seizures|Completed||Phase 3|118|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||||||||||||2017-10-11 05:08:53.164997|2017-10-11 05:08:53.164997
NCT00113828|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2017-03-28|||December 2004||2004-12-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies|Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies|Terminated||Phase 2|5|Actual|Massachusetts General Hospital||1||Insufficient accrual|f||||t||||||||No||2017-10-11 05:08:53.549215|2017-10-11 05:08:53.549215
NCT00113841|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2011-11-15|2011-09-13||November 2004||2004-11-01|November 2011|2011-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma|Pilot Study of Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma|Completed||N/A|42|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-10-11 05:08:53.661364|2017-10-11 05:08:53.661364
NCT00113854|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2005-06-23|||October 2004||2004-10-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Interventional|||Mannitol as Adjunct Therapy for Childhood Cerebral Malaria|Effect of Mannitol as Adjunct Therapy on the Clinical Outcome of Childhood Cerebral Malaria in Mulago Hospital: A Randomised Clinical Trial|Unknown status|Active, not recruiting|Phase 3|156||Makerere University|||||f||||||||||||||2017-10-11 05:08:53.952515|2017-10-11 05:08:53.952515
NCT00113867|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2009-12-09|||September 2003||2003-09-01|November 2006|2006-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women|Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women|Completed||N/A|80||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:08:54.052571|2017-10-11 05:08:54.052571
NCT00113880|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2012-12-03|2012-04-02||October 2003||2003-10-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|September 2008|Actual|2008-09-01||Observational|||A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults|Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults 5-49 Years of Age|Completed||N/A|63061|Actual|MedImmune LLC|||3||f||||f||||||||||2017-10-11 05:08:54.204537|2017-10-11 05:08:54.204537
NCT00113893|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2013-10-15||2013-09-13|May 2005||2005-05-01|October 2013|2013-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.|A Randomized, MultiCenter, Open-Label, Modified Dose-Ascension, Parallel Study of the Safety, Tolerability, and Efficacy of Oral SCIO-469 in Patients With Myelodysplastic Syndromes|Completed||Phase 2|62|Actual|Scios, Inc.||4|||f||||||||||||||2017-10-11 05:08:56.622885|2017-10-11 05:08:56.622885
NCT00113906|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2014-02-10|||March 2005||2005-03-01|June 2005|2005-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Melatonin Treatment After Laparoscopic Cholecystectomy|The Effect of Melatonin Treatment on Postoperative Fatigue and Sleep Disturbances: A Placebo Controlled Randomized Clinical Trial|Completed||Phase 2/Phase 3|200||University Hospital, Gentofte, Copenhagen|||||f||||t||||||||||2017-10-11 05:08:56.723|2017-10-11 05:08:56.723
NCT00113932|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2011-09-01|||December 2003||2003-12-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|February 2009|Actual|2009-02-01||Interventional|||UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma|UARK 2003-41: A Phase II Study of High-Dose Density Therapy With Tandem Autologous Transplants for Patients With Multiple Myeloma|Completed||Phase 2|140|Actual|University of Arkansas||1|||f||||t||||||||||2017-10-11 05:08:57.027464|2017-10-11 05:08:57.027464
NCT00113945|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2013-05-10|||July 2003||2003-07-01|May 2013|2013-05-01||||||||Interventional|||Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)|TARGET: Treatment Strategies to Achieve Recommended K/DOQI Goals in ESRD Patients on CinacalceT|Completed||Phase 2|360||Amgen|||||||||||||||||||2017-10-11 05:08:57.105032|2017-10-11 05:08:57.105032
NCT00113958|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2013-05-10||||||May 2013|2013-05-01||||||||Interventional|||Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels|Cinacalcet Open Label Study to Reach K/DOQI Levels|Completed||Phase 2|||Amgen|||||||||||||||||||2017-10-11 05:08:57.187135|2017-10-11 05:08:57.187135
NCT00113971|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-10|2012-03-30|||April 2005||2005-04-01|March 2012|2012-03-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)|A Randomized Phase II Pharmacokinetics/Pharmacodynamics Study of Epratuzumab in Patients With Systemic Lupus Erythematosus|Terminated||Phase 2|20||UCB Pharma|||||f||||||||||||||2017-10-11 05:08:57.269577|2017-10-11 05:08:57.269577
NCT00113984|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-11|2017-10-05|||June 8, 2005||2005-06-08|November 7, 2012|2012-11-07|December 1, 2011|Actual|2011-12-01|February 1, 2008|Actual|2008-02-01||Interventional|||Vaccine and Antibody Treatment of Prostate Cancer|Phase I Trial of a PSA Based Vaccine and an Anti-CTLA-4 Antibody in Adults With Metastatic Androgen Independent Prostrate Cancer|Completed||Phase 1|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:08:57.344698|2017-10-11 05:08:57.344698
NCT00113997|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-11|2008-03-03|||June 2005||2005-06-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Safety and Dosing Evaluation of REG1 Anticoagulation System|The Healthy Volunteer Evaluation of an Aptamer-RNA Target to Factor IXa|Completed||Phase 1|106||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:08:57.420641|2017-10-11 05:08:57.420641
NCT00114010|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-11|2017-06-30|||April 1, 2005||2005-04-01|August 19, 2010|2010-08-19|December 22, 2006|Actual|2006-12-22|December 22, 2006|Actual|2006-12-22||Interventional|||Experimental Vaccine for Malaria|Phase 1 Study of the Safety of Immunization of Naive Individuals With AMA1-C1/Alhydrogel [R], an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria, and the Effect of Immunization on Antigen-specific Memory and Plasma B Cells and T Cells|Completed||Phase 1|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:08:57.485469|2017-10-11 05:08:57.485469
NCT00114023|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-13|2007-02-16|||January 2005||2005-01-01|October 2006|2006-10-01||||||||Observational|||1-Year Follow up to the 1473-IMIQ Study|A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1473-IMIQ Study|Completed||Phase 3|84||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-10-11 05:08:57.556627|2017-10-11 05:08:57.556627
NCT00119470|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2007-12-19|||February 2005||2005-02-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer|EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer: A Randomized Trial|Completed||Phase 2|40||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:08:57.620685|2017-10-11 05:08:57.620685
NCT00119483|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2011-09-02|||September 2005||2005-09-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|||||Interventional|||Older Men and Testosterone||Completed||N/A|200||University Hospital of North Norway|||||f||||||||||||||2017-10-11 05:08:57.680306|2017-10-11 05:08:57.680306
NCT00119496|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2010-01-26|||July 2005||2005-07-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Rosiglitazone Versus Theophylline in Asthmatic Smokers|A Clinical Study to Investigate the Effect of Rosiglitazone, Theophylline and Inhaled Corticosteroid, Inflammation and Pulmonary Function in Asthmatic Smokers|Completed||Phase 2/Phase 3|79|Actual|University of Glasgow||4|||f||||f||||||||||2017-10-11 05:08:57.755226|2017-10-11 05:08:57.755226
NCT00119509|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2007-04-24|||January 2004||2004-01-01|April 2007|2007-04-01|April 2008|Anticipated|2008-04-01|||||Interventional|||The IMAP Study Improving Management of Mildly Abnormal Pap Smears|HPV DNA Testing Versus Conventional Management for Women With Minor Atypia on Pap Smear: Psychosocial and Quality of Life Outcomes and Development of a Decision Analytic Model|Unknown status|Active, not recruiting|Phase 3|300||University of Sydney|||||f||||||||||||||2017-10-11 05:08:58.036813|2017-10-11 05:08:58.036813
NCT00119522|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2015-04-06|||April 2004||2004-04-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2006|Actual|2006-03-01||Observational|||Epidemiology and Cost of Falls in Veterans With a Spinal Cord Injury|Epidemiology and Cost of Falls in Veterans With Spinal Cord Injury|Completed||N/A|702|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:08:58.146124|2017-10-11 05:08:58.146124
NCT00119535|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2015-04-06|||August 2004||2004-08-01|April 2006|2006-04-01|December 2005|Actual|2005-12-01|||||Interventional|||Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes|An Evaluation of a Coordinated Proactive Diabetes Eye Care Program|Completed||N/A|2000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:08:58.226486|2017-10-11 05:08:58.226486
NCT00119561|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2015-04-06|||February 2005||2005-02-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|June 2007|Actual|2007-06-01||Interventional|CONNECT||Testing the Effectiveness of Telephone Support for Dementia Caregivers|Testing the Effectiveness of Telephone Support for Dementia Caregivers|Completed||N/A|154|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:08:58.430133|2017-10-11 05:08:58.430133
NCT00119574|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2015-04-06|||January 2002||2002-01-01|July 2005|2005-07-01|December 2004|Actual|2004-12-01|||||Interventional|||Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)|Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)|Completed||N/A|443|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:08:58.513906|2017-10-11 05:08:58.513906
NCT00119587|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-20|||August 2002||2002-08-01|December 2007|2007-12-01|September 2003||2003-09-01|||||Interventional|||Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects|A Double-Blind, Randomized, Comparative Study of Darbepoetin Alfa Given Once Weekly or Once Every Other Week for Treatment of Anemia in Hemodialysis Subjects|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-10-11 05:08:58.625084|2017-10-11 05:08:58.625084
NCT00119600|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2009-05-07||||||May 2009|2009-05-01||||||||Interventional|||A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|A Randomised, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Finding Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|Terminated||Phase 1/Phase 2|||Amgen||1|||f||||||||||||||2017-10-11 05:08:58.707982|2017-10-11 05:08:58.707982
NCT00119613|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2008-08-07|||December 2002||2002-12-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa|A Randomized, Double Blind, Placebo-Controlled Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa|Completed||Phase 3|600|Anticipated|Amgen||2|||f||||||||||||||2017-10-11 05:08:58.784784|2017-10-11 05:08:58.784784
NCT00119626|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2010-11-10|||June 2003||2003-06-01|November 2010|2010-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke|SAINT I (Stroke - Acute Ischemic - NXY Treatment) A Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter, Phase IIb/III Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke.|Completed||Phase 3|1700||AstraZeneca|||||||||||||||||||2017-10-11 05:08:58.930329|2017-10-11 05:08:58.930329
NCT00119639|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2009-01-15|||June 2005||2005-06-01|January 2009|2009-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006|A Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of Sorafenib (BAY 43-9006, Nexavar).|Completed||Phase 1|32|Actual|Bayer||1|||f||||||||||||||2017-10-11 05:08:59.019145|2017-10-11 05:08:59.019145
NCT00119652|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2013-01-03|||May 2005||2005-05-01|January 2013|2013-01-01|May 2007|Actual|2007-05-01|||||Interventional|EMBOLDEN II||Seroquel in Bipolar Depression Versus SSRI|Multicentre, Double-blind, Randomised, Parallel Group, Placebo Controlled, Phase 3 Study of the Efficacy & Safety of Quetiapine Fumarate & Paroxetine as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks & Quetiapine in Continuation (Abbreviated)|Completed||Phase 3|676|Actual|AstraZeneca|||||f||||||||||||||2017-10-11 05:08:59.102463|2017-10-11 05:08:59.102463
NCT00119665|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2007-05-16|||February 2006||2006-02-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes|A Phase II, Double-Blind, Placebo-Controlled, Randomized Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes and Menopausal Symptoms|Completed||Phase 2|180||Bionovo|||||f||||||||||||||2017-10-11 05:08:59.28749|2017-10-11 05:08:59.28749
NCT00119678|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2014-09-11|2011-01-10||September 2005||2005-09-01|September 2014|2014-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone|A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept vs Placebo on a Background of Oral Glucocorticosteroids in the Treatment of Subjects With Systemic Lupus Erythematosus and the Prevention of Subsequent Lupus Flares|Completed||Phase 2|183|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 05:08:59.412492|2017-10-11 05:08:59.412492
NCT00119691|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2013-09-11|||April 2003||2003-04-01|September 2013|2013-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction|Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction|Completed||Phase 2|34|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 05:09:01.267948|2017-10-11 05:09:01.267948
NCT00119704|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2006-05-08|||September 2002||2002-09-01|June 2005|2005-06-01|March 2005||2005-03-01|||||Interventional|||Treatment of Tennis Elbow With Botulinum Toxin|Treatment of Lateral Epicondylitis With Botulinum Toxin: A Randomized Controlled Trial|Completed||Phase 3|60||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:09:01.362397|2017-10-11 05:09:01.362397
NCT00119717|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2011-05-16|||June 2005||2005-06-01|May 2011|2011-05-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|SENTIS||Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)|Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)|Completed||Phase 3|515|Actual|CoAxia||2|||f||||t||||||||||2017-10-11 05:09:01.463462|2017-10-11 05:09:01.463462
NCT00119730|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2014-04-22|||February 2005||2005-02-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2006|Actual|2006-12-01||Interventional|||Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma|Abbreviated Fludarabine / Mitoxantrone / Rituximab Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:09:01.808285|2017-10-11 05:09:01.808285
NCT00121186|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2012-03-05|2012-03-05||July 2005||2005-07-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|January 2008|Actual|2008-01-01||Interventional|||S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma|Nonmyeloablative Allogeneic Stem Cell Transplantation For Relapsed Hodgkin's or Non-Hodgkin's Lymphoma After Autologous Transplantation ( A BMT Study)|Terminated||Phase 2|1|Actual|Southwest Oncology Group||1||poor accrual|f||||f||||||||||2017-10-11 05:09:04.468806|2017-10-11 05:09:04.468806
NCT00119743|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2017-03-21|||October 2000||2000-10-01|March 2017|2017-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine|Assess, in Young Children, the Efficacy in Preventing Acute Otitis Media (AOM) of GSK Biologicals Undecavalent Pneumococcal-protein D Conjugate Vaccine, When Administered as a Three Dose Primary Vaccination Course During the First Year of Life With a Booster Dose in the Second Year of Life.|Terminated||Phase 3|5000||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:09:01.965471|2017-10-11 05:09:01.965471
NCT00119756|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2011-06-06|||June 2005||2005-06-01|April 2010|2010-04-01|November 2006|Actual|2006-11-01|||||Interventional|||A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia|A Randomized, Crossover Study to Evaluate the Overall Safety and Tolerability of Paliperidone Palmitate Injected in the Deltoid or Gluteus Muscle in Patients With Schizophrenia|Completed||Phase 3|253|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:09:02.177496|2017-10-11 05:09:02.177496
NCT00119769|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2008-08-26|||February 2005||2005-02-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|May 2007|Actual|2007-05-01||Interventional|||The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients|The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients on Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 4|46|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 05:09:02.275001|2017-10-11 05:09:02.275001
NCT00119782|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2012-08-21|||September 2004||2004-09-01|August 2012|2012-08-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|PACE||Promoting Activity and Changes in Eating (PACE) to Reduce Obesity|Reducing Obesity at the Workplace: a Randomized Trial|Completed||N/A|3000|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-11 05:09:02.380774|2017-10-11 05:09:02.380774
NCT00119795|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2017-03-21|||August 2005||2005-08-01|March 2017|2017-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|CLIP||Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese|Cooperative Lifestyle Intervention Program (CLIP)|Completed||N/A|288|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||No||2017-10-11 05:09:02.460385|2017-10-11 05:09:02.460385
NCT00121043|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-11-25||||||December 2007|2007-12-01||||||||Interventional|||Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire|An Open Label, Randomized, Crossover Study to Assess Acceptability and Functionality of SimpleJectTM Vs Pre-Filled Syringe(s) Using Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using A Self-Reported Questionnaire|Completed||Phase 4|||Swedish Orphan Biovitrum|||||f||||||||||||||2017-10-11 05:09:02.578991|2017-10-11 05:09:02.578991
NCT00121056|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-12-04|||September 2002||2002-09-01|December 2008|2008-12-01||||||||Observational|||REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations|Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations (REKinDLE)|Completed||N/A|||Amgen|||||f||||||||||||||2017-10-11 05:09:02.661113|2017-10-11 05:09:02.661113
NCT00121069|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2005-07-19|||September 2002||2002-09-01|July 2005|2005-07-01|September 2004||2004-09-01|||||Interventional|||Study of Escitalopram in the Treatment of Specific Phobia|Placebo-Controlled Pilot Study of Escitalopram in the Treatment of Specific Phobia|Completed||Phase 2/Phase 3|12||Connor, Kathryn M., M.D.|||||||||||||||||||2017-10-11 05:09:02.719237|2017-10-11 05:09:02.719237
NCT00121095|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2007-12-17|||July 2005||2005-07-01|December 2007|2007-12-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer|Phase I/II Trial of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Androgen-Independent Prostate Cancer|Unknown status|Recruiting|Phase 1/Phase 2|69|Anticipated|Cytogen Corporation||1|||f||||f||||||||||2017-10-11 05:09:02.784202|2017-10-11 05:09:02.784202
NCT00121108|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2012-06-27||2012-03-08|November 2004||2004-11-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||MEDI-524 (Motavizumab) for the Prevention of Respiratory Syncytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States|A Phase 3 Study of MEDI-524 (Motavizumab) for the Prevention of RSV Disease Among Native American Infants in the Southwestern United States|Completed||Phase 3|2127|Actual|MedImmune LLC||2|||f||||t||||||||||2017-10-11 05:09:02.863179|2017-10-11 05:09:02.863179
NCT00121121|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2007-03-14|||July 2004||2004-07-01|November 2005|2005-11-01|December 2005||2005-12-01|||||Interventional|||Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers|A Phase Ib Vaccine Trial Evaluating the Safety and Immunogenicity of HIV Lipopeptides by Two Administration Routes (Intramuscular And Intradermal) in Healthy Adult Volunteers. ANRS VAC16 Trial|Completed||Phase 1|70||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:09:02.92841|2017-10-11 05:09:02.92841
NCT00121134|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2013-11-26|2013-08-08||June 2005||2005-06-01|November 2013|2013-11-01|May 2011|Actual|2011-05-01|May 2009|Actual|2009-05-01||Interventional|||Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer|Anti-Angiogenesis Treatment After Preoperative Chemotherapy: A Pilot Study in Women With Operable Breast Cancer|Completed||N/A|164|Actual|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-10-11 05:09:03.015658|2017-10-11 05:09:03.015658
NCT00121147|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2006-02-22|||September 2003||2003-09-01|July 2005|2005-07-01|October 2005||2005-10-01|||||Interventional|||Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan|A Comparison of the Additivity of Brinzolamide Ophthalmic Suspension, 1% (Azopt) and Brimonidine Tartrate Ophthalmic Solution, 0.15% (Alphagan P) to Travoprost Ophthalmic Solution, 0.004% (Travatan) in Patients With Elevated IOP on Travoprost. A Three Month Double-Masked, Multi-Center Trial in the United States|Completed||N/A|200||Hermann Eye Center|||||f||||||||||||||2017-10-11 05:09:04.124218|2017-10-11 05:09:04.124218
NCT00121160|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2012-03-26|||September 2005||2005-09-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response|Can Stress Management Improve Vaccine Immune Response|Completed||Phase 1|126|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-10-11 05:09:04.28161|2017-10-11 05:09:04.28161
NCT00121199|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2014-05-06|2012-10-30||June 2005||2005-06-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma|Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell NHL|Completed||Phase 2|73|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:09:04.850673|2017-10-11 05:09:04.850673
NCT00121212|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2015-10-28|||July 2003||2003-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|July 2010|Actual|2010-07-01||Interventional|||Positron Emission Tomography in Prostate Cancer|Positron Emission Tomography in Prostate Cancer|Completed||N/A|179|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-10-11 05:09:05.583012|2017-10-11 05:09:05.583012
NCT00121225|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2014-10-01|2014-10-01||September 2005||2005-09-01|May 2013|2013-05-01|June 2013|Actual|2013-06-01|March 2009|Actual|2009-03-01||Interventional|||Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma|A Phase II Study of Vorinostat in Patients With Advanced Melanoma|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:09:05.684985|2017-10-11 05:09:05.684985
NCT00121238|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2016-03-28|2015-07-29||January 2005||2005-01-01|February 2013|2013-02-01|November 2015|Actual|2015-11-01|November 2010|Actual|2010-11-01||Interventional||16 patients were enrolled but only 13 were analyzed. 1 patient progressed clinically before any treatment.Two patients who received study drug were deemed ineligible as they did not meet entry PSA criteria of three consecutive rises in PSA.|Cilengitide in Treating Patients With Prostate Cancer|Phase II Evaluation of EMD 121974 (NSC 707544, Cilengitide) in Patients With Non-Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|16|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:09:05.991079|2017-10-11 05:09:05.991079
NCT00121251|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2017-09-12|||April 19, 2005|Actual|2005-04-19|September 2017|2017-09-01||||September 30, 2017|Anticipated|2017-09-30||Interventional|||Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer|A Phase I/II Trial of BAY 43-9006 Plus Gemcitabine and Capecitabine in the Treatment of Patients With Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:09:06.317706|2017-10-11 05:09:06.317706
NCT00121264|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2014-06-16|||March 2005||2005-03-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors|A Phase I Dose-Escalation Study of Intravenous 17-Allylaminogeldanamycin (17-AAG) [NSC 330507and Oral BAY 43-9006 [NSC 724772] Administered in Patients With Pretreated Advanced Solid Tumors|Completed||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:09:06.416863|2017-10-11 05:09:06.416863
NCT00121277|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2015-07-22|||September 2005||2005-09-01|July 2015|2015-07-01||||August 2009|Actual|2009-08-01||Interventional|||Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Capecitabine in Patients With Solid Tumors|Completed||Phase 1|28|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:09:06.517147|2017-10-11 05:09:06.517147
NCT00121290|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2014-02-21|||February 2005||2005-02-01|April 2013|2013-04-01||||April 2008|Actual|2008-04-01||Interventional|||SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery|A Phase I Dose Escalation Study of Daily x 3 Intravenous SJG-136 in Patients With Advanced Solid Tumors|Completed||Phase 1|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:09:06.622167|2017-10-11 05:09:06.622167
NCT00121303|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2016-09-19|||January 2005||2005-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|January 2009|Actual|2009-01-01||Interventional|||Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes|Randomised Induction and Post Induction Therapy in Older Patients (≥61 Years of Age) With Acute Myeloid Leukemia (AML) and Refractory Anemia With Excess Blasts (RAEB, RAEB-t)|Completed||Phase 3|600|Anticipated|Stichting Hemato-Oncologie voor Volwassenen Nederland||4|||f||||||||||||||2017-10-11 05:09:06.730305|2017-10-11 05:09:06.730305
NCT00121316|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2008-01-10|||October 2004||2004-10-01|January 2008|2008-01-01|July 2005|Actual|2005-07-01|||||Interventional|||Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients|Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) of Patients Intolerant to, or Dependant on, Topical Corticosteroids|Completed||Phase 4|200||Novartis||2|||f||||||||||||||2017-10-11 05:09:06.838348|2017-10-11 05:09:06.838348
NCT00121329|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2005-07-19||||||July 2005|2005-07-01|December 2004||2004-12-01|||||Interventional|||4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions|4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions|Completed||N/A|80||Oregon Health and Science University|||||f||||||||||||||2017-10-11 05:09:06.916541|2017-10-11 05:09:06.916541
NCT00121355|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2016-10-17|||July 2005||2005-07-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Novofine Autocover Safety Needle Versus BD Safety Glide|An Open-Label, Multi-Center, Prospective Cross-Over Study of Preference and Safety of NovoFine® Autocover(TM) Needles Compared to BD Safety Glide (TM) Syringes in the Hospital Setting|Completed||Phase 4|83|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:09:06.973946|2017-10-11 05:09:06.973946
NCT00121368|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2013-11-22|||February 2004||2004-02-01|November 2013|2013-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||GN Tobacco Use Survey|Survey on Tobacco Use in the GN Sites|Completed||N/A|6000|Actual|NICHD Global Network for Women's and Children's Health|||1||f||||t||||||||||2017-10-11 05:09:07.047791|2017-10-11 05:09:07.047791
NCT00121381|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2008-01-10|||May 2005||2005-05-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|||||Interventional|||Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis|Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis|Completed||Phase 4|400||Novartis||2|||||||||||||||||2017-10-11 05:09:07.140778|2017-10-11 05:09:07.140778
NCT00121394|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2014-07-29|||June 2005||2005-06-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Chlorhexidine Vaginal and Infant Wash in Pakistan|Randomized Trial of Chlorhexidine Vaginal and Infant Wash to Reduce Neonatal Mortality|Completed||Phase 3|5008|Actual|NICHD Global Network for Women's and Children's Health||1|||f||||t||||||||||2017-10-11 05:09:07.2398|2017-10-11 05:09:07.2398
NCT00121407|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2005-07-19|||March 2002||2002-03-01|July 2005|2005-07-01|August 2005||2005-08-01|||||Interventional|||Visudyne® in Occult (VIO)|A Randomized, Placebo-Controlled, Double-Masked, Multicenter, Phase III Study of the Effect of Visudyne Therapy in Occult With No Classic Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD): Visudyne in Occult (VIO)|Completed||Phase 3|364||QLT Inc.|||||||||||||||||||2017-10-11 05:09:07.321745|2017-10-11 05:09:07.321745
NCT00121420|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2014-05-07||||||May 2014|2014-05-01||||||||Interventional|||Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases|Phase II Trial of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases|Terminated||Phase 2|45||Pharmacyclics LLC.|||||f||||||||||||||2017-10-11 05:09:07.386795|2017-10-11 05:09:07.386795
NCT00121433|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2006-06-23|||September 2004||2004-09-01|July 2005|2005-07-01|December 2004||2004-12-01|||||Interventional|||Leptin and Endothelial Function|The Role of Leptin in Modulating Vascular Tone and Endothelial Function in Obese and Normal Weight Adults: A Vascular-Protective Effect of Leptin?|Completed||Phase 4|15||University of Michigan|||||||||||||||||||2017-10-11 05:09:07.480243|2017-10-11 05:09:07.480243
NCT00121446|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2017-05-18|||July 2003||2003-07-01|July 2005|2005-07-01||||||||Interventional|||Which Therapy for Acute Heart Attacks? (The WEST Study)|Which Early ST Elevation Myocardial Infarction Therapy? The WEST Study|Completed||Phase 2/Phase 3|300||University of Alberta|||||f||||||||||||||2017-10-11 05:09:07.527188|2017-10-11 05:09:07.527188
NCT00121459|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2015-03-03|||September 2003||2003-09-01|March 2015|2015-03-01||||||||Interventional|||Effectiveness of the Diaphragm for HIV Prevention|The Latex Diaphragm to Prevent HIV Acquisition Among Women: A Female-Controlled, Physical Barrier of the Cervix|Withdrawn||Phase 3|0|Actual|University of California, San Francisco||||PI left and no data or information is available.|f||||||||||||||2017-10-11 05:09:07.82009|2017-10-11 05:09:07.82009
NCT00121472|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2016-04-08|2009-05-29||March 2005||2005-03-01|April 2016|2016-04-01|May 2010|Actual|2010-05-01|November 2006|Actual|2006-11-01||Interventional|||Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation|The HeartMate II LVAS Pivotal Study Protocol, Bridge to Cardiac Transplantation|Completed||N/A|194|Actual|St. Jude Medical||1|||f||||t||||||||||2017-10-11 05:09:07.923838|2017-10-11 05:09:07.923838
NCT00121485|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2016-04-08|2012-11-13||February 2005||2005-02-01|April 2016|2016-04-01|January 2012|Actual|2012-01-01|June 2009|Actual|2009-06-01||Interventional|||Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy|The HeartMate II LVAS Pivotal Study Protocol, Destination Therapy|Completed||N/A|200|Actual|St. Jude Medical||2|||f||||t||||||||||2017-10-11 05:09:08.49805|2017-10-11 05:09:08.49805
NCT00121498|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2005-09-12|||November 2002||2002-11-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Preemptive Analgesia for Abdominal Hysterectomy|Preemptive Analgesia for Post Abdominal Hysterectomy Pain Management|Completed||N/A|32||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:09:09.575002|2017-10-11 05:09:09.575002
NCT00121511|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2015-05-26|||July 2005||2005-07-01|May 2015|2015-05-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effect of Efudex Treatment on Photoaged Skin|The Effect of Efudex (5-fluorouracil) Treatment on Photoaged Skin|Completed||N/A|21|Actual|University of Michigan|||||f||||f||||||||||2017-10-11 05:09:09.66775|2017-10-11 05:09:09.66775
NCT00121524|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2015-05-28|||January 2003||2003-01-01|May 2015|2015-05-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome|Effects of Epinephrine and I.V. Needle on CPR Outcome|Completed||Phase 2|904|Actual|University of Oslo||2|||f||||t||||||||||2017-10-11 05:09:09.754039|2017-10-11 05:09:09.754039
NCT00121537|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2015-10-07|||July 2005||2005-07-01|October 2015|2015-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes|A Prospective Study to Determine the Utility of Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes With Regards to Lower Extremity Fasciotomy Wound Healing, Complications, Cost and Patient and Nursing Satisfaction|Terminated||N/A|30||The University of Texas Health Science Center at San Antonio||||terminated, due to lack enrollment,|f||||||||||||||2017-10-11 05:09:09.881359|2017-10-11 05:09:09.881359
NCT00121550|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2016-08-10|||October 1999||1999-10-01|August 2016|2016-08-01|September 2002|Actual|2002-09-01|April 2000|Actual|2000-04-01||Interventional|||The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease|The Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease - a Randomized, Placebo Controlled, Double Blinded, Multicentre, Clinical Trial|Completed||Phase 3|4372|Actual|Copenhagen Trial Unit, Center for Clinical Intervention Research||2|||f||||||||||||||2017-10-11 05:09:09.946977|2017-10-11 05:09:09.946977
NCT00121563|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2008-03-03|||July 2005||2005-07-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Evaluation of a TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect|Evaluation of TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect|Completed||Phase 2|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:09:10.052193|2017-10-11 05:09:10.052193
NCT00121589|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2017-06-30|||July 14, 2005||2005-07-14|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60|Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:09:10.11544|2017-10-11 05:09:10.11544
NCT00121602|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2008-02-21|||March 2005||2005-03-01|February 2008|2008-02-01|October 2006|Actual|2006-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease|Randomized, Double-Blind, Equivalence Study of the Efficacy of Darbepoetin Alfa Manufactured by Serum Free Bioreactor Technology and Darbepoetin Alfa Manufactured by Roller-Bottle Technology for the Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis|Completed||Phase 3|446|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:09:10.176422|2017-10-11 05:09:10.176422
NCT00121615|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-03-05|||October 2004||2004-10-01|March 2009|2009-03-01||||||||Interventional|||Study of Etanercept in the Treatment of Psoriasis in Adult Subjects|An Open-Label, Long-Term Extension Study to Assess the Safety and Efficacy of Etanercept in the Treatment of Psoriasis in Adult Subjects|Completed||Phase 3|391||Amgen|||||f||||||||||||||2017-10-11 05:09:10.255371|2017-10-11 05:09:10.255371
NCT00125086|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2005-09-12|||July 2005||2005-07-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Platelets for Acute Wound Healing|Platelets in Acute Wounds: A Punch Biopsy Study (PAWS II)|Completed||N/A|4||Medtronic|||||f||||||||||||||2017-10-11 05:10:53.709932|2017-10-11 05:10:53.709932
NCT00121628|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2013-10-07|||July 2005||2005-07-01|October 2013|2013-10-01|October 2010|Actual|2010-10-01|November 2006|Actual|2006-11-01||Interventional|||A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer|A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer|Completed||Phase 2|184|Actual|Amgen||1|||||||||||||||||2017-10-11 05:09:10.335429|2017-10-11 05:09:10.335429
NCT00121654|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2009-03-09|||July 2005||2005-07-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Spinal Cord Stimulation (SCS) in Refractory Angina|Randomized Study on SCS for the Treatment of Refractory Angina Pectoris|Unknown status|Recruiting|Phase 4|60|Anticipated|Catholic University of the Sacred Heart||3|||f||||f||||||||||2017-10-11 05:09:19.536864|2017-10-11 05:09:19.536864
NCT00121693|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2016-01-26|||December 2003||2003-12-01|January 2016|2016-01-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||The Use of Music Therapy in the Prevention of Falls|Posturographic Changes Associated With Music Therapy and Fall Prevention|Completed||Early Phase 1|266|Actual|Carrick Institute for Graduate Studies||4|||f||||f||||||||No||2017-10-11 05:09:26.816847|2017-10-11 05:09:26.816847
NCT00121706|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2006-02-03|||July 2005||2005-07-01|January 2006|2006-01-01|September 2005||2005-09-01|||||Interventional|||Fast Food Feeding in Youth|Fast Food Feeding in Youth|Completed||N/A|18||Boston Children’s Hospital|||||f||||||||||||||2017-10-11 05:09:26.912428|2017-10-11 05:09:26.912428
NCT00121719|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2016-04-19|2016-04-19||July 2005||2005-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|June 2009|Actual|2009-06-01||Interventional||Intent-to-treat population included all participants who received at least one dose of lenvatinib.|An Open Label Phase I Dose Escalation Study Of E7080|An Open Label Phase I Dose Escalation Study Of E7080|Active, not recruiting||Phase 1|87|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 05:09:27.092813|2017-10-11 05:09:27.092813
NCT00121732|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2015-06-29|||July 2005||2005-07-01|June 2015|2015-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies|A Phase 1, Two-Arm, Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies|Completed||Phase 1|39|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 05:09:35.89289|2017-10-11 05:09:35.89289
NCT00121745|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2007-12-15|||July 2005||2005-07-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer|Phase I Evaluation of Safety of Intravenous Infusion of a Pathotropic Vector Bearing a Cytocidal Cyclin G1 Construct (Rexin-G) as Intervention for Locally Advanced and Metastatic Pancreatic Cancer Refractory to Standard Chemotherapy|Terminated||Phase 1|12|Actual|Epeius Biotechnologies||4||poor enrollment|f||||t||||||||||2017-10-11 05:09:35.980918|2017-10-11 05:09:35.980918
NCT00121758|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2008-06-05|||September 2004||2004-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers|Randomised Double Blinded Phase II AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptide (LIPO-5) Versus Placebo in Non Infected HIV Volunteers (ANRS VAC 18)|Completed||Phase 2|156|Anticipated|French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-10-11 05:09:36.093139|2017-10-11 05:09:36.093139
NCT00121771|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2017-01-11|||January 2004||2004-01-01|January 2017|2017-01-01|July 2004||2004-07-01|||||Interventional|||Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men|A Phase 1 Trial of the Malaria Candidate Vaccines FP9 CS and MVA CS in Adult Gambian Men Aged 18 - 45 Years|Completed||Phase 1|32||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:09:36.182927|2017-10-11 05:09:36.182927
NCT00121784|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2016-11-01|||October 2005||2005-10-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients|A Randomized, Open-label Study of the Effect of Replacing CNI With Sirolimus in a Standard Care Regimen of CNI, CellCept, and Steroids on Renal Function in Heart Transplant Patients|Terminated||Phase 4|12|Actual|Hoffmann-La Roche||1||Poor recruitment|f||||||||||||||2017-10-11 05:09:36.275934|2017-10-11 05:09:36.275934
NCT00121797|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-17|2006-11-06|||January 2004||2004-01-01|July 2005|2005-07-01|June 2005|Anticipated|2005-06-01|||||Interventional|||Peripartum Bacteruria and Urinary Tract Infections (UTI)|Risk Factors for Postpartum Bacteruria, Does Labor Cause UTI?|Unknown status|Recruiting|N/A|1000|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:09:36.427878|2017-10-11 05:09:36.427878
NCT00122733|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2007-07-20|||December 2005||2005-12-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Loxapine and Weaning From Ventilator|Facilitation of Weaning From Ventilator by Loxapine|Completed||N/A|9|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 05:10:02.019797|2017-10-11 05:10:02.019797
NCT00121810|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2011-04-13|2009-11-18||August 2003||2003-08-01|April 2011|2011-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients|An Open Label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Early Calcineurin Inhibitor Withdrawal in Recipients of Primary Renal Allografts Maintained Long-term on Mycophenolate Mofetil (MMF) (CellCept®) and Sirolimus (Rapamune®)|Completed||Phase 4|305|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:09:36.555269|2017-10-11 05:09:36.555269
NCT00121823|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2017-01-11|||June 2004||2004-06-01|January 2017|2017-01-01|December 2004||2004-12-01|||||Interventional|||Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines|Malaria Infection Diagnosed by PCR as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines|Completed||Phase 1/Phase 2|120||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:09:37.989923|2017-10-11 05:09:37.989923
NCT00121836|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2011-04-25|2009-12-16||June 2005||2005-06-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer|An Open-label Study of Xeloda Plus Avastin at Time of Disease Progression in Treatment-naïve Women With HER2-negative Metastatic Breast Cancer|Completed||Phase 4|109|Actual|Hoffmann-La Roche|The primary endpoint TTP was changed to overall survival (OS) due to issues regarding tumor assessment data based on RECIST and poor response from investigators to related queries that developed after the planned interim analysis.|1|||f||||||||||||||2017-10-11 05:09:38.098649|2017-10-11 05:09:38.098649
NCT00121849|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2006-05-04|||August 2005||2005-08-01|May 2006|2006-05-01|February 2006||2006-02-01|||||Interventional|||Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite|A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Leish-111f + MPL-SE Vaccine in Montenegro Skin Test-Positive Healthy Adults|Completed||Phase 1|12||IDRI|||||||||||||||||||2017-10-11 05:09:38.971247|2017-10-11 05:09:38.971247
NCT00121862|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2006-05-04|||August 2005||2005-08-01|May 2006|2006-05-01|March 2006||2006-03-01|||||Interventional|||Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite|A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Leish-111f + MPL-SE Vaccine Compared to the Leish-111f Protein Alone in Montenegro Skin Test-Negative Healthy Adults|Completed||Phase 2|60||IDRI|||||||||||||||||||2017-10-11 05:09:39.040385|2017-10-11 05:09:39.040385
NCT00121875|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2009-09-28|||June 2005||2005-06-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|||||Observational|||Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature|Growth Hormone and Insulin Resistance in Girls With Turner Syndrome or Idiopathic Short Stature|Terminated||Phase 4|1|Actual|Massachusetts General Hospital|||2|Enrollment was too low.|f||||t||||||Samples Without DNA|"     Blood   "|||2017-10-11 05:09:39.113328|2017-10-11 05:09:39.113328
NCT00121888|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2014-06-05|||December 2002||2002-12-01|June 2014|2014-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy|Randomized Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy|Completed||Phase 1/Phase 2|60||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:09:39.21486|2017-10-11 05:09:39.21486
NCT00121901|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-10-16|||October 2004||2004-10-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?||Completed||Phase 3|1600|Anticipated|Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:09:39.313179|2017-10-11 05:09:39.313179
NCT00121914|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2005-10-17|||October 2000||2000-10-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone|Treatment of Hepatocellular Carcinoma: A Randomized Controlled Study With Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone|Unknown status|Active, not recruiting|Phase 3|120||Medical University of Vienna|||||f||||||||||||||2017-10-11 05:09:39.465695|2017-10-11 05:09:39.465695
NCT00121927|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2010-01-26|||June 2004||2004-06-01|February 2007|2007-02-01|June 2007||2007-06-01|||||Interventional|||Use of the Atkins Diet for Adults With Intractable Epilepsy|Use of the Atkins Diet for Adults With Intractable Epilepsy|Completed||N/A|30||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:09:39.569785|2017-10-11 05:09:39.569785
NCT00121940|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2012-04-18|||February 2006||2006-02-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Guided Care: Integrating High Tech and High Touch|Guided Care: Integrating High Tech and High Touch|Completed||N/A|904|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 05:09:39.673142|2017-10-11 05:09:39.673142
NCT00121953|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2012-10-16|||July 2005||2005-07-01|October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis|Endometriosis: Immunomodulation|Withdrawn||Phase 2/Phase 3|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Due to the recent meta-analysis about CV adverse effects.|f||||||||||||||2017-10-11 05:09:39.784756|2017-10-11 05:09:39.784756
NCT00121966|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2008-06-18|||January 2003||2003-01-01|June 2008|2008-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|SDDS||South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus|South Danish Diabetes Study: A Prospective Randomised Multi-Centre Study for the Evaluation of the Optimal Pharmacological Antidiabetic Treatment of Type 2 Diabetes Mellitus|Completed||Phase 4|400||Odense University Hospital|||||f||||||||||||||2017-10-11 05:09:39.978797|2017-10-11 05:09:39.978797
NCT00121979|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2007-07-02|||September 2004||2004-09-01|July 2005|2005-07-01|March 2006||2006-03-01|||||Interventional|||Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects|Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Exploring the Safety, Tolerability, and Antiviral Effect of Substituting 600 mg Racivir for 3TC in HIV-Infected Subjects Who Have the M184V Mutation and Are Currently Failing on a HAART Regimen Containing Lamivudine|Completed||Phase 2|60||Pharmasset|||||||||||||||||||2017-10-11 05:09:40.130475|2017-10-11 05:09:40.130475
NCT00194142|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-15|||July 2007||2007-07-01|August 2016|2016-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Cytomegalovirus (CMV) Infection in Amniotic Fluid||Completed||N/A|37|Actual|University of Pennsylvania|||1||f||||||||||||||2017-10-11 05:31:08.677558|2017-10-11 05:31:08.677558
NCT00121992|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2005-08-08|||June 1999||1999-06-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Docetaxel in Combination With Doxorubicin and Cyclophosphamide (TAC) Versus 5-Fluorouracil in Combination With Doxorubicin and Cyclophosphamide (5 FAC) as Adjuvant Treatment of Breast Cancer Patients|A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination With Doxorubicin and Cyclophosphamide (TAC) Versus 5-Fluorouracil in Combination With Doxorubicin and Cyclophosphamide (FAC) as Adjuvant Treatment of High Risk Operable Breast Cancer Patients With Negative Axillary Lymph Nodes|Completed||Phase 3|1054||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:09:40.254166|2017-10-11 05:09:40.254166
NCT00122005|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2009-02-23|||July 2005||2005-07-01|February 2009|2009-02-01|July 2005|Anticipated|2005-07-01|||||Interventional|||GVAX in Advanced Prostate Cancer Patients Made Lymphopenic|Phase I/II Study of Human GM-CSF Gene-Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (GVAX®) in Advanced Prostate Cancer Patients Made Lymphopenic and Infused With Autologous Peripheral Blood Mononuclear Cells|Unknown status|Active, not recruiting|Phase 1/Phase 2|18|Anticipated|Providence Health & Services|||||||||||||||||||2017-10-11 05:09:40.367701|2017-10-11 05:09:40.367701
NCT00122018|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2014-11-06|||May 2002||2002-05-01|November 2014|2014-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery|N-acetylcysteine and Fenoldopam Protect the Renal Function of Patients With Chronic Renal Insufficiency Undergoing Cardiac Surgery.|Completed||Phase 2|80||Pulmonary Critical Care Associates of Baltimore||4|||f||||f||||||||||2017-10-11 05:09:40.487501|2017-10-11 05:09:40.487501
NCT00122031|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2012-06-13|||July 2005||2005-07-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|April 2009|Actual|2009-04-01||Interventional|||Deep Brain Stimulation for Treatment-Refractory Major Depression|Deep Brain Stimulation for Treatment-Refractory Major Depression|Completed||Phase 1|13|Actual|University Hospital, Bonn||1|||f||||f||||||||||2017-10-11 05:09:40.626204|2017-10-11 05:09:40.626204
NCT00122044|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2014-05-21|||January 2003||2003-01-01|May 2014|2014-05-01|December 2004||2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects|Childhood Hypertonia of Central Origin: An Open Label Trial of Anticholinergic Treatment Effects|Completed||Phase 2|35||University of Southern California|||||f||||||||||||||2017-10-11 05:09:40.744888|2017-10-11 05:09:40.744888
NCT00122057|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2011-05-31|||June 2005||2005-06-01|September 2006|2006-09-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Impact of Antibiotic Treatment on Outcome in Patients With Ventilator-Associated Tracheobronchitis||Completed||N/A|58|Actual|University Hospital, Lille|||||f||||||||||||||2017-10-11 05:09:40.858479|2017-10-11 05:09:40.858479
NCT00122070|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2008-06-09|||May 2005||2005-05-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|September 2007|Actual|2007-09-01||Interventional|||Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder|Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder|Completed||Phase 3|15|Actual|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-10-11 05:09:40.965435|2017-10-11 05:09:40.965435
NCT00122083|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2005-07-25|||April 2004||2004-04-01|March 2004|2004-03-01|June 2004||2004-06-01|||||Interventional|||An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression|A Cluster Randomised Controlled Trial to Assess the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression|Completed||N/A|1680||University of Oxford|||||f||||||||||||||2017-10-11 05:09:41.116466|2017-10-11 05:09:41.116466
NCT00122096|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2008-09-25|||November 2002||2002-11-01|September 2008|2008-09-01|January 2006||2006-01-01|||||Interventional|||Perioperative Inflammation and Cyclooxygenase 2 (COX-2)|Preoperative Valdecoxib: CNS Penetration and Effects on Biochemical Markers of Pain and Sensitization|Completed||Phase 4|30||University of Washington|||||f||||||||||||||2017-10-11 05:09:41.258216|2017-10-11 05:09:41.258216
NCT00122109|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2015-04-06|2014-08-22||August 2005||2005-08-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||Telemedicine and Anger Management Groups With PTSD Veterans in the Hawaiian Islands|Telemedicine and Anger Management Groups for PTSD Veterans in the Hawaiian Islands|Completed||N/A|125|Actual|VA Office of Research and Development|We conservatively excluced participants with acute safety concerns (homicidal or suicidal) and current substance dependence. However other literature suugests that both issues can be safely addressed via telemedicine.|2|||f||||f||||||||||2017-10-11 05:09:41.404011|2017-10-11 05:09:41.404011
NCT00122122|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2015-04-06||||||February 2007|2007-02-01|March 2004|Actual|2004-03-01|||||Interventional|||Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients|Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients|Completed||Phase 3|600|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:09:41.963335|2017-10-11 05:09:41.963335
NCT00122135|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2015-11-16|2015-07-10||December 2004||2004-12-01|November 2015|2015-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|Aim3||A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making|A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making|Completed||N/A|120|Actual|VA Office of Research and Development|Difficulties in recruiting enough surrogates led to abandoning having a surrogate arm.|2|||f||||f||||||||||2017-10-11 05:09:42.069484|2017-10-11 05:09:42.069484
NCT00122148|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2010-02-04|||September 2005||2005-09-01|August 2006|2006-08-01|June 2006|Actual|2006-06-01|||||Interventional|||Can Vignettes Be Used to Improve Practice & Outcome|Can Vignettes be Used to Improve Practice and Outcomes?|Terminated||N/A|||VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:09:42.407388|2017-10-11 05:09:42.407388
NCT00122161|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2015-04-06||||||October 2007|2007-10-01|September 2005|Actual|2005-09-01|||||Interventional|||Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation|Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation|Completed||Phase 3|190|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:09:42.504137|2017-10-11 05:09:42.504137
NCT00122174|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2015-04-06|||July 2004||2004-07-01|January 2007|2007-01-01|June 2006|Actual|2006-06-01|||||Interventional|||Stress-Busting Program for Caregivers of Patients With Neruological Diseases|Stress-Busting Program for Caregivers of Patients With Neurological Diseases|Completed||N/A|50|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:09:42.636183|2017-10-11 05:09:42.636183
NCT00122746|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2011-10-12|||December 2004||2004-12-01|October 2011|2011-10-01||||June 2012|Anticipated|2012-06-01||Interventional|||Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients|Doctoral CRP on Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients|Unknown status|Recruiting|Phase 3|322|Anticipated|International Atomic Energy Agency||2|||f||||t||||||||||2017-10-11 05:10:02.156566|2017-10-11 05:10:02.156566
NCT00122187|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2015-04-06|2013-12-05||August 2005||2005-08-01|September 2013|2013-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||The population is the number of VAMCs that enrolled in the study.|Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention|Translation of Colorectal Cancer Screening Guidelines: A System Intervention|Completed||N/A|8|Actual|VA Office of Research and Development|Half of the sites randomized did not complete the study. GI referral rates should have been nearly 100%, yet were not. Because of programming limitations, we were unable to evaluate the type of diagnostic interventions the patients received.|2|||f||||f||||||||||2017-10-11 05:09:42.722119|2017-10-11 05:09:42.722119
NCT00122213|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2010-04-20|||September 2003||2003-09-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Physical Activity and Diet Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women|An Individual-based Diet and Physical Activity Intervention Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women|Completed||Phase 2|400||Wageningen University|||||f||||||||||||||2017-10-11 05:09:43.289872|2017-10-11 05:09:43.289872
NCT00122226|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2006-04-24|||January 2003||2003-01-01|July 2005|2005-07-01|July 2008||2008-07-01|||||Interventional|||MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)|MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)|Unknown status|Active, not recruiting|Phase 4|50||VU University Medical Center|||||f||||||||||||||2017-10-11 05:09:43.36636|2017-10-11 05:09:43.36636
NCT00122239|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2016-03-14|||January 2005||2005-01-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers|A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers|Active, not recruiting||N/A|13|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-10-11 05:09:43.486265|2017-10-11 05:09:43.486265
NCT00122252|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2011-12-08|||May 2004||2004-05-01|December 2011|2011-12-01|February 2007|Actual|2007-02-01|||||Observational|||Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation|Biological Imaging for Optimising CTV and GTV Contouring in Prostate Cancer to Improve the Possibilities for IMRT Dose Escalation|Terminated||N/A|20||AHS Cancer Control Alberta|||1|Study abandoned.|f||||||||||||||2017-10-11 05:09:43.584098|2017-10-11 05:09:43.584098
NCT00122265|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2016-02-24|||April 2003||2003-04-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer|Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal RT for Prostate Cancer|Terminated||N/A|83|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-10-11 05:09:43.658134|2017-10-11 05:09:43.658134
NCT00122278|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2008-02-15|||July 2005||2005-07-01|February 2008|2008-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines|Parenteral Corticosteroids as Adjuvant Therapy for Migraine Headaches|Completed||Phase 3|205|Actual|Montefiore Medical Center||2|||f||||||||||||||2017-10-11 05:09:43.749848|2017-10-11 05:09:43.749848
NCT00122291|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2012-01-18|||January 2002||2002-01-01|August 2011|2011-08-01||||||||Interventional|||A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer|A Phase 2 Study of Preoperative Radiation Therapy and Capecitabine (an Oral Fluoropyrimidine Carbamate) in Locally Advanced Rectal Cancer|Unknown status|Active, not recruiting|Phase 2|66|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:09:43.859008|2017-10-11 05:09:43.859008
NCT00122304|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2007-02-20|||December 2004||2004-12-01|February 2007|2007-02-01|November 2006||2006-11-01|||||Interventional|||Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab|Safety in Hemolytic PNH Patients Treated With Eculizumab: a Multi-Center Open-Label Research Design Study|Completed||Phase 3|85||Alexion Pharmaceuticals|||||f||||||||||||||2017-10-11 05:09:43.953946|2017-10-11 05:09:43.953946
NCT00122317|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2017-04-24|2017-04-24||May 2005|Actual|2005-05-01|April 2017|2017-04-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)|Open Label Extension Study of Eculizumab in Patients With Transfusion Dependent PNH|Completed||Phase 3|187|Actual|Alexion Pharmaceuticals||1|||f||||f||||||||No||2017-10-11 05:09:44.272594|2017-10-11 05:09:44.272594
NCT00122330|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2006-11-30|||October 2004||2004-10-01|November 2006|2006-11-01|January 2006||2006-01-01|||||Interventional|||Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients|Randomized, Double-Blind, and Placebo-Controlled Study Using Eculizumab in Transfusion Dependent PNH Patients|Completed||Phase 3|75||Alexion Pharmaceuticals|||||||||||||||||||2017-10-11 05:09:44.847199|2017-10-11 05:09:44.847199
NCT00122343|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2015-02-18|||August 2005||2005-08-01|February 2015|2015-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)|A Phase II Study of AP23573, an mTOR Inhibitor, in Female Adult Patients With Recurrent or Persistent Endometrial Cancer|Completed||Phase 2|45|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 05:09:45.172933|2017-10-11 05:09:45.172933
NCT00122356|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2013-03-11|||September 2005||2005-09-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|BATMAN||Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment|Maintaining Skeletal Health in Postmenopausal Women With Surgically Resected Stage I-IIIa Hormone-receptor Positive Breast Cancer Who Are Receiving Anastrozole, Through the Use of Alendronate as Determined by the Osteoporosis Australia Bone Maintenance Algorithm|Completed||Phase 3|303|Actual|Barwon Health||1|||f||||||||||||||2017-10-11 05:09:45.283336|2017-10-11 05:09:45.283336
NCT00122369|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2013-02-23|2012-02-03||March 2002||2002-03-01|February 2013|2013-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy|Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy|Completed||Phase 2|240|Actual|Beth Israel Deaconess Medical Center|For the assessment of the Secondary Outcome parameter we were able to recruit only 19 women whom we could contact early enough on the day of their breast cancer surgery to fill out the IES. This limits the power of the statistical analysis.|3|||f||||t||||||||||2017-10-11 05:09:45.450812|2017-10-11 05:09:45.450812
NCT00122382|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2010-11-03|2010-05-03||July 2005||2005-07-01|November 2010|2010-11-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||Remission and Joint Damage Progression in Early Rheumatoid Arthritis|A Phase IIIB Multi-center, Randomized, Double-Blind Study to Evaluate Remission and Joint Damage Progression in Methotrexate Naive Early Erosive RA Subjects Treated With Abatacept Plus Methotrexate Compared With Methotrexate|Completed||Phase 3|1052|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 05:09:46.756637|2017-10-11 05:09:46.756637
NCT00122395|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2006-05-03|||January 2005||2005-01-01|July 2005|2005-07-01|March 2005||2005-03-01|||||Interventional|||Trial Regarding the Acceptability of Audiotape Intimate Partner Violence (IPV) Screening|A Randomized Clinical Trial Regarding the Acceptability of an Audiotape Questionnaire for Intimate Partner Violence Screening in a Pediatric ED|Completed||N/A|500||Children's Hospital of Philadelphia|||||f||||||||||||||2017-10-11 05:09:48.95876|2017-10-11 05:09:48.95876
NCT00122408|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2010-09-23|||January 2006||2006-01-01|September 2010|2010-09-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Probiotic Enteral Administration in Mechanically Ventilated Patients|Effect of Enterally Administered Probiotics in Mechanically Ventilated Patients: Double-Blind, Prospective Randomized Study Versus Placebo|Terminated||Phase 1|740|Anticipated|Central Hospital, Nancy, France||2|||f||||||||||||||2017-10-11 05:09:49.060787|2017-10-11 05:09:49.060787
NCT00122421|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2012-02-17|||June 2003||2003-06-01|February 2012|2012-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients|The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients|Completed||N/A|300|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-10-11 05:09:49.184309|2017-10-11 05:09:49.184309
NCT00122434|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2013-10-28|||July 2005||2005-07-01|October 2013|2013-10-01||||May 2006|Actual|2006-05-01||Interventional|||Dose Finding Study in COPD|A Randomized, Multiple-dose, Double-blind, Placebo- and Active-controlled, Parallel Group Efficacy and Safety Study to Determine the Optimum Dose of BEA 2180 BR Delivered by the Respimat® Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|389|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:09:49.286546|2017-10-11 05:09:49.286546
NCT00122447|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2013-11-12|2012-05-18||May 2005||2005-05-01|November 2013|2013-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance|CVD Risk and Prevention in Early Glucose Intolerance|Completed||N/A|84|Actual|Emory University|Not fully powered due to under-enrollment and high drop-out rate. Higher than anticipated precision error of FMD measures. Possible Hawthorne effect with lifestyle changes. Short treatment period relative to long-term CVD risk in prediabetes.|4|||f||||f||||||||||2017-10-11 05:09:49.505133|2017-10-11 05:09:49.505133
NCT00122460|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2014-07-11|2011-08-25||December 2004||2004-12-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|March 2007|Actual|2007-03-01||Interventional|||Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)|Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|442|Actual|Merck KGaA|Non-specific outcome measures 'Safety' & 'QOL assessments' were deleted from this entry in error.Replacement outcomes have been created. The 'Safety' outcome refers to adverse events.|2|||f||||t||||||||||2017-10-11 05:09:50.106631|2017-10-11 05:09:50.106631
NCT00122473|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2011-07-28|||January 2004||2004-01-01|July 2011|2011-07-01|January 2007||2007-01-01|||||Interventional|||Imatinib in Dermatofibrosarcoma Protuberans (DFSP)|Open-label Trial of Glivec® (Imatinib Mesylate) in Patients With Primary or Recurrent Dermatofibrosarcoma Protuberans|Completed||Phase 1/Phase 2|30||Dermatologic Cooperative Oncology Group|||||f||||||||||||||2017-10-11 05:09:52.023958|2017-10-11 05:09:52.023958
NCT00122486|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2006-07-28|||July 2004||2004-07-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV|Phase 2 Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV|Completed||Phase 2|1200||FHI 360|||||f||||||||||||||2017-10-11 05:09:52.11385|2017-10-11 05:09:52.11385
NCT00122499|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2005-07-26|||February 2003||2003-02-01|July 2005|2005-07-01|February 2005||2005-02-01|||||Interventional|||A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer|A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer|Completed||Phase 3|||Erasmus Medical Center|||||f||||||||||||||2017-10-11 05:09:52.186391|2017-10-11 05:09:52.186391
NCT00122512|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2006-02-09||||||February 2006|2006-02-01||||||||Interventional|||Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV|Phase 2a Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV – An Extended Safety Evaluation|Terminated||Phase 2|500||FHI 360|||||f||||||||||||||2017-10-11 05:09:52.258702|2017-10-11 05:09:52.258702
NCT00122525|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2009-04-29|||July 2002||2002-07-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|||||Interventional|||Effect of Male Circumcision on HIV Incidence (ANRS 1265)|Effect of Safe Male Circumcision on Incidence of Infection by HIV, HSV-2 and of Genital Ulceration|Terminated||Phase 3|3274|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2||following DSMB recommandation.|f||||t||||||||||2017-10-11 05:09:52.329682|2017-10-11 05:09:52.329682
NCT00122538|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2011-12-02|||February 2006||2006-02-01|December 2011|2011-12-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)|HAART Regimen Comprising 3TC + ddI + EFV in Once-daily Administration in HIV-1 Infected Children in Burkina Faso|Completed||Phase 2|52|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-10-11 05:09:52.397245|2017-10-11 05:09:52.397245
NCT00122551|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2005-07-28|||December 2001||2001-12-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Interventional|||Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)|A Prospective, Randomized, Multicenter Trial of Intermittent Therapy in HIV-Infected Patients With Successful Viral Suppression Under HAART (ANRS 106 Window Trial)|Terminated||Phase 3|400||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:09:52.482391|2017-10-11 05:09:52.482391
NCT00122759|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2007-07-20|||December 2005||2005-12-01|July 2007|2007-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Ketamine Sedation in Mechanically Ventilated Patients|Prospective Study on the Cost-Effectiveness of Adding Ketamine to Midazolam-Sufentanil Sedation Regimen in Mechanically Ventilated Patients|Unknown status|Recruiting|N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 05:10:02.318969|2017-10-11 05:10:02.318969
NCT00122564|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2005-11-10|||June 2003||2003-06-01|November 2005|2005-11-01|April 2005||2005-04-01|||||Interventional|||Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers|Phase I Study Evaluating the Systemic and Mucosal Safety and Immunogenicity of a Recombinant HIV-1 Gp 160 (MN/LAI) Administered by Transmucosal (Nasal or Vaginal) Routes, Alone or Formulated With DC-Chol, in HIV Negative Volunteers (ANRS VAC14)|Terminated||Phase 1|36||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:09:52.551176|2017-10-11 05:09:52.551176
NCT00122577|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2005-07-27|||March 2002||2002-03-01|July 2005|2005-07-01|July 2004||2004-07-01|||||Interventional|||Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients|Randomized Open Label Study Assessing the Antiviral Activity, Toxicity and Pharmacologic Interaction of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir as Part of a Salvage Regimen in HIV Infected Patients With Multiple Treatment Failures (ANRS 107 Trial PUZZLE 2)|Terminated||Phase 2|50||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:09:52.624141|2017-10-11 05:09:52.624141
NCT00122590|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2005-07-29|||July 2002||2002-07-01|July 2005|2005-07-01|March 2005||2005-03-01|||||Interventional|||Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)|Prospective Trial to Evaluate How Therapeutic Drug Monitoring of Protease Inhibitors Increases Virologic Success and Tolerance of HAART (ANRS 111 COPHAR2)|Terminated||N/A|115||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:09:52.764465|2017-10-11 05:09:52.764465
NCT00122603|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2011-12-21|||December 2005||2005-12-01|December 2011|2011-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)|Efficacy and Safety of Regimens Restricted to a Combination of Two Boosted Protease Inhibitors as Potent Antiretroviral Therapy in HIV-1 Infected Patients. ANRS 127 2IP|Completed||Phase 2|61|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||t||||||||||2017-10-11 05:09:52.860768|2017-10-11 05:09:52.860768
NCT00122616|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2012-02-21|||November 2003||2003-11-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C|Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and C Hepatitis Who Failed to Active Treatment for HCV. ANRSHC12 Fibrostop|Completed||Phase 3|52|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||t||||||||||2017-10-11 05:09:52.947791|2017-10-11 05:09:52.947791
NCT00122629|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2005-07-28|||October 2000||2000-10-01|July 2005|2005-07-01|May 2003||2003-05-01|||||Interventional|||Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders|Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous HCV Non Responders ANRSHC03 BITRI|Terminated||Phase 3|405||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:09:54.882564|2017-10-11 05:09:54.882564
NCT00122642|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2009-09-24|||August 2005||2005-08-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Alcohol Locks for the Prevention of Tunneled Catheter-related Infections|Short Daily Alcohol Locks for the Prevention of Tunneled Catheter Infection in Patients With Haematological Disease. Randomised Placebo Controlled Trial|Completed||Phase 2/Phase 3|440|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-10-11 05:09:54.965998|2017-10-11 05:09:54.965998
NCT00122655|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2005-11-14|||January 2001||2001-01-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy|A Randomized Prospective Study Evaluating the Impact on Fat Distribution of NRTI-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy ANRS 108 NONUKE Study|Terminated||Phase 4|100||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:09:55.126744|2017-10-11 05:09:55.126744
NCT00122668|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2005-11-14|||November 2003||2003-11-01|November 2005|2005-11-01|July 2005||2005-07-01|||||Interventional|||Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients|Randomized Comparative Study Evaluating the Rate of Occurrence of a Lipoatrophy Syndrome in ARVnaive HIV-1 Infected Patients Receiving NRTI-Sparing Antiretroviral Regimen (Hippocampe - ANRS 121)|Terminated||Phase 4|112||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:09:55.236695|2017-10-11 05:09:55.236695
NCT00122681|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2017-08-07|2009-11-30||May 6, 2004|Actual|2004-05-06|April 2017|2017-04-01|November 26, 2009|Actual|2009-11-26|November 3, 2006|Actual|2006-11-03||Interventional|||Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18|A Phase III, Double-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy of GlaxoSmithKline Biologicals. HPV-16/18 VLP AS04 Vaccine Compared to Hepatitis A Vaccine as Control in Prevention of Persistent HPV-16 or HPV-18 Cervical Infection and Cervical Neoplasia, Administered Intramuscularly According to a 0, 1, 6 Month Schedule in Healthy Females 15-25 Years of Age.|Completed||Phase 3|18729|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 05:09:55.62273|2017-10-11 05:09:55.62273
NCT00122694|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2006-09-11|||January 2005||2005-01-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)|Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable COPD|Completed||Phase 2|20||Groningen Research Institute for Asthma and COPD|||||f||||||||||||||2017-10-11 05:10:01.60677|2017-10-11 05:10:01.60677
NCT00122707|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2006-03-21|||April 2004||2004-04-01|June 2005|2005-06-01|October 2005||2005-10-01|||||Interventional|||Comparison of Central and Peripheral Venous Catheters|Randomized Controlled Trial of Mechanical and Infectious Complications of Central Versus Peripheral Venous Catheters in ICU Patients|Completed||N/A|300||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:10:01.720475|2017-10-11 05:10:01.720475
NCT00122720|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2006-07-03|||June 2003||2003-06-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery|The Effect of Darbepoetin Alfa Treatment Upon the Rehabilitation Following Planned Surgery for Colorectal Cancer|Completed||Phase 4|200||Herning Hospital|||||f||||||||||||||2017-10-11 05:10:01.827308|2017-10-11 05:10:01.827308
NCT00122772|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2011-10-13|||November 2005||2005-11-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy|CRP on Radiobiological and Clinical Studies on Viral-induced Cancer's Response to Radiotherapy With Comprehensive Morbidity Assessment|Completed||Phase 3|601|Actual|International Atomic Energy Agency||4|||f||||t||||||||||2017-10-11 05:10:02.458235|2017-10-11 05:10:02.458235
NCT00122785|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2005-07-28|||April 2002||2002-04-01|February 2005|2005-02-01|September 2004||2004-09-01|||||Interventional|||Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children|Efficacy of Single Injection of Dexamethasone for Acute Bronchiolitis in Children Younger Than 2 Years Old: A Randomized, Double-Blind, Placebo Controlled Trial|Completed||N/A|170||Khon Kaen University|||||f||||||||||||||2017-10-11 05:10:02.61581|2017-10-11 05:10:02.61581
NCT00122798|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2006-06-23|||January 2002||2002-01-01|December 2004|2004-12-01|January 2005||2005-01-01|||||Observational|||Improved Stroke Outcome at 6 Months|Improved Stroke Outcome at 6 Months Attained by a Chain of Structured Acute Treatment With Integrated Rehabilitation and Supported Discharge|Completed||Phase 4|200||Kantonsspital Baden|||||f||||||||||||||2017-10-11 05:10:02.717871|2017-10-11 05:10:02.717871
NCT00122811|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2007-08-20|||November 2000||2000-11-01|August 2007|2007-08-01|October 2008|Anticipated|2008-10-01|||||Interventional|||The Hypertension in the Very Elderly Trial (HYVET)|The Hypertension in the Very Elderly Trial (HYVET)|Unknown status|Active, not recruiting|Phase 4|4000|Anticipated|Imperial College London||2|||f||||t||||||||||2017-10-11 05:10:02.791766|2017-10-11 05:10:02.791766
NCT00122824|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2007-11-05|||June 2004||2004-06-01|November 2007|2007-11-01|September 2005|Actual|2005-09-01|||||Interventional|||Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder|Duloxetine Hydrochloride 60 mg or 120 mg Once Daily Compared With Placebo in Patients With Generalized Anxiety Disorder.|Completed||Phase 3|480||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:10:02.893379|2017-10-11 05:10:02.893379
NCT00122837|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2007-10-17|||April 2005||2005-04-01|October 2007|2007-10-01|January 2007|Actual|2007-01-01|||||Interventional|||A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder|A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|560||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:10:02.991888|2017-10-11 05:10:02.991888
NCT00122850|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2007-11-05|||October 2004||2004-10-01|November 2007|2007-11-01|November 2005|Actual|2005-11-01|||||Interventional|||A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder|A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder.|Completed||Phase 3|480||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:10:03.13167|2017-10-11 05:10:03.13167
NCT00122863|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2007-08-29|||January 2005||2005-01-01|August 2007|2007-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder|Duloxetine 60 to 120 mg Once Daily Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder|Completed||Phase 3|380||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:10:03.948192|2017-10-11 05:10:03.948192
NCT00122876|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2007-12-05|||April 2005||2005-04-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)|A Phase 1/2 Open-Label Study to Evaluate Safety and Preliminary Evidence of Effectiveness of Tumor Ablation With Talaporfin Sodium (LS11) and Interstitial Light Emitting Diodes (LEDs) in the Treatment of Subjects With Inoperable Hepatocellular Carcinoma (HCC)|Completed||Phase 1/Phase 2|25||Light Sciences LLC|||||||||||||||||||2017-10-11 05:10:04.12741|2017-10-11 05:10:04.12741
NCT00122889|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2009-12-30|||July 2005||2005-07-01|December 2009|2009-12-01|March 2009|Actual|2009-03-01|||||Observational|||Effects of Garlic Supplements on Drug Metabolism|Garlic Metabolism and Cytochrome P450 Modulation|Completed||Phase 4|80|Actual|Fred Hutchinson Cancer Research Center|||1||f||||f||||||Samples With DNA|"     Whole blood, urine   "|||2017-10-11 05:10:04.242127|2017-10-11 05:10:04.242127
NCT00122902|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2006-08-17|||February 2002||2002-02-01|August 2006|2006-08-01|February 2004||2004-02-01|||||Observational|||Spirituality and Will to Live in Patients With HIV/AIDS|Spirituality and Will to Live in Patients With HIV/AIDS|Completed||N/A|350||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:10:04.327409|2017-10-11 05:10:04.327409
NCT00122915|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2015-04-13|||June 2005||2005-06-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain|A Prospective, Randomized, Double Blind, Crossover, Multi-center Study to Evaluate the Safety and the Efficacy of Motor Cortex Stimulation With the Cortical Stimulation Lead Model 2976 in Patients With Neuropathic Pain|Terminated||Phase 3|104|Anticipated|Medtronic||||"Based on a consistently low enrolment rate and procedural challenges that were unknown at study   start. It was not based on safety or efficacy concerns."|f||||||||||||||2017-10-11 05:10:04.410584|2017-10-11 05:10:04.410584
NCT00122928|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2013-11-12|||October 2004||2004-10-01|November 2013|2013-11-01|September 2009|Actual|2009-09-01|March 2008|Actual|2008-03-01||Interventional|||Comparison of Workplace Obesity Management Programs|Environmental Approaches for Obesity Management at Dow|Completed||N/A|5124|Actual|Emory University||3|||f||||t||||||||||2017-10-11 05:10:04.513882|2017-10-11 05:10:04.513882
NCT00122941|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2008-06-13|||June 2005||2005-06-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|MMS||Effect of Multiple Micronutrient Supplementation on Growth, Morbidity, and Mortality of HIV Infected Children in Uganda|Effect of Multiple Micronutrient Supplementation on Growth, Morbidity, and Mortality of HIV Infected Children in Uganda: a Randomised Double Blind Placebo-Controlled Trial|Completed||Phase 3|860|Actual|Makerere University||2|||f||||t||||||||||2017-10-11 05:10:04.617402|2017-10-11 05:10:04.617402
NCT00122954|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2017-05-11|2013-11-25||July 2005||2005-07-01|May 2017|2017-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis|Fish Oil as an Adjunct Therapy for Depression in Multiple Sclerosis|Completed||Phase 1/Phase 2|39|Actual|Oregon Health and Science University||2|||f||||t||||||||Undecided||2017-10-11 05:10:04.74146|2017-10-11 05:10:04.74146
NCT00123188|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2015-01-16|||April 2005||2005-04-01|January 2015|2015-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Ultrasound and Endometrial Hyperplasia|Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort|Terminated||N/A|36|Actual|Milton S. Hershey Medical Center||1||enrollment of participants has halted prematurely; difficulty with recruitment|f||||f||||||||||2017-10-11 05:10:08.827262|2017-10-11 05:10:08.827262
NCT00122980|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2013-01-14|2011-12-28||October 2006||2006-10-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Stroke With Transfusions Changing to Hydroxyurea|Stroke With Transfusions Changing to Hydroxyurea|Terminated||Phase 3|134|Actual|St. Jude Children's Research Hospital|The trial was stopped early due to a projected futility of the liver iron component of the primary endpoint in conjunction with the significantly higher number of strokes in the Hydroxyurea/Phlebotomy arm as compared to the Transfusion/Chelation arm.|2||The study has been stopped due to safety and futility concerns.|f||||t||||||||||2017-10-11 05:10:05.26858|2017-10-11 05:10:05.26858
NCT00122993|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2015-01-23|||September 2004||2004-09-01|January 2015|2015-01-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Worksite Program to Prevent Weight Gain Among Bus Drivers|Worksite Environmental Interventions for Weight Control|Completed||N/A|1200|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 05:10:06.531922|2017-10-11 05:10:06.531922
NCT00123006|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2016-01-12|||January 2006||2006-01-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|June 2009|Actual|2009-06-01||Interventional|||Effectiveness of the DASH Diet at Reducing High Blood Pressure|Cardiovascular and Renal Hemodynamics and the DASH Diet|Completed||N/A|44|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 05:10:06.620374|2017-10-11 05:10:06.620374
NCT00123019|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2016-07-11|||September 2004||2004-09-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Work, Weight, and Wellness Program: The 3W Program|Overweight and Obesity Control in Worksites|Completed||N/A|6100|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||||||||||||2017-10-11 05:10:06.704354|2017-10-11 05:10:06.704354
NCT00123032|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2017-07-20|||January 2005||2005-01-01|July 2017|2017-07-01|December 2011|Anticipated|2011-12-01|August 2008|Actual|2008-08-01||Interventional|||School- and Home-Based Program to Prevent Obesity in American Indian Children|Bright Start: Obesity Prevention in American Indian Children|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 05:10:06.79385|2017-10-11 05:10:06.79385
NCT00123045|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2016-07-28|||September 2001||2001-09-01|July 2011|2011-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Patient-Physician Partnership to Improve High Blood Pressure Adherence|Patient-Physician Partnership to Improve High Blood Pressure Adherence|Completed||Phase 4|279|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||||f||||t||||||||||2017-10-11 05:10:06.88373|2017-10-11 05:10:06.88373
NCT00123058|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2014-09-05|||June 2003||2003-06-01|September 2014|2014-09-01|June 2007|Actual|2007-06-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Two Programs to Improve Blood Pressure Treatment Adherence|Take Control of Your Blood Pressure (TCYB)|Completed||N/A|777|Actual|Duke University||4|||f||||t||||||||||2017-10-11 05:10:06.964197|2017-10-11 05:10:06.964197
NCT00123071|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2013-01-24|||May 2005||2005-05-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Observational|VVV||Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network|Variability of Ventricular Mass, Volume, and Ejection Fraction in Pediatric Cardiomyopathy Patients (A Study Conducted by the Pediatric Heart Network)|Completed||N/A|131|Actual|New England Research Institutes|||1||f||||t||||||||||2017-10-11 05:10:07.104409|2017-10-11 05:10:07.104409
NCT00123084|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2011-05-06|||March 2002||2002-03-01|May 2011|2011-05-01|December 2012|Anticipated|2012-12-01|May 2011|Anticipated|2011-05-01||Interventional|||Efficacy of Voice Treatment for Parkinson's Disease|Efficacy of Voice Treatment for Parkinson's Disease|Unknown status|Recruiting|Phase 2|620|Anticipated|University of Colorado, Boulder||4|||f||||||||||||||2017-10-11 05:10:07.197858|2017-10-11 05:10:07.197858
NCT00123097|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2017-04-05|||February 2005||2005-02-01|April 2017|2017-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Clinical Trial of New Elastomer for Maxillofacial Prosthetics|Multicenter Trial of CPE for Maxillofacial Prosthetics|Completed||Phase 3|42|Actual|University of Louisville||2|||f||||||||||||||2017-10-11 05:10:07.300089|2017-10-11 05:10:07.300089
NCT00123123|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2010-08-12|2010-08-12||March 2004||2004-03-01|August 2010|2010-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients|Oral Health and Ventilator-associated Pneumonia|Completed||Phase 2|175|Actual|State University of New York at Buffalo||3|||f||||||||||||||2017-10-11 05:10:07.6621|2017-10-11 05:10:07.6621
NCT00123136|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2006-06-28|||August 2005||2005-08-01|June 2006|2006-06-01|December 2006||2006-12-01|||||Interventional|||Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy|Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy. Multi-Center, Randomized Placebo Controlled Trial|Unknown status|Recruiting|Phase 4|250||Weintraub, Michael I., MD, FACP, FAAN|||||f||||||||||||||2017-10-11 05:10:08.061254|2017-10-11 05:10:08.061254
NCT00123149|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2016-09-19||||||July 2011|2011-07-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis|An Open-Label (OL) Extension Study to Assess Safety of PROCRIT (Epoetin Alfa) in Patients With Anemia of Chronic Disease (ACD) Due to Rheumatoid Arthritis (RA)|Withdrawn||Phase 2|0|Actual|Ortho Biotech Products, L.P.|||||||||||||||||||2017-10-11 05:10:08.140586|2017-10-11 05:10:08.140586
NCT00123162|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2015-11-18|2015-01-16||May 2007||2007-05-01|November 2015|2015-11-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Viagra in the Treatment of Primary Dysmenorrhea|Sildenafil Citrate in the Treatment of Primary Dysmenorrhea|Completed||Phase 1/Phase 2|25|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 05:10:08.222205|2017-10-11 05:10:08.222205
NCT00123175|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2013-01-07|||September 2009||2009-09-01|January 2013|2013-01-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)|Levonorgestrel Containing Intrauterine Device in the Treatment of Endometrial Hyperplasia Without Atypia|Withdrawn||Phase 1/Phase 2|0|Actual|Milton S. Hershey Medical Center||1||Study has never received funding and has never been initiated|f||||f||||||||||2017-10-11 05:10:08.733091|2017-10-11 05:10:08.733091
NCT00123201|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2015-01-15|||September 2005||2005-09-01|September 2006|2006-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache|A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Efficacy, Safety and Tolerability Study of Dronabinol MDI in the Acute Treatment of Migraine Headache|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:10:08.928477|2017-10-11 05:10:08.928477
NCT00123214|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2006-06-26|||September 2004||2004-09-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Interventional|||A Change in Diet May Decrease the Negative Consequences of Chronic Sleep Deprivation|Pilot Study: A Dietary Intervention May Decrease the Negative Metabolic and Cognitive Consequences of Chronic Sleep Deprivation|Completed||N/A|18||St. Vincent's Medical Center|||||f||||||||||||||2017-10-11 05:10:09.072262|2017-10-11 05:10:09.072262
NCT00123227|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2005-07-29|||October 2002||2002-10-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Rosiglitazone Plaque Study|A Randomised, Double-Blind, Placebo-Controlled, Cardiovascular Magnetic Resonance (CMR) Study to Evaluate the Effect of Rosiglitazone on Carotid Atherosclerotic Plaques in Type 2 Diabetics With Vascular Disease or Hypertension|Unknown status|Active, not recruiting|Phase 3|60||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:10:09.179766|2017-10-11 05:10:09.179766
NCT00123240|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2012-01-10|||July 2004||2004-07-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||High Carbohydrate vs. High Fat Diets in the Treatment of Obesity (JBR 0512)|High Carbohydrate vs. High Fat Diets in the Treatment of Obesity (JBR 0512)|Completed||N/A|40|Anticipated|Rockefeller University||2|||f||||t||||||||||2017-10-11 05:10:09.307121|2017-10-11 05:10:09.307121
NCT00123253|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2013-11-26|||June 2005||2005-06-01|November 2013|2013-11-01|April 2007|Actual|2007-04-01|November 2006|Actual|2006-11-01||Interventional|||TH9507 in Patients With HIV-Associated Lipodystrophy|A Phase 3 Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety of a 2 mg Dose of TH9507, a Growth Hormone Releasing Factor Analog, in HIV Patients With Excess of Abdominal Fat Accumulation|Completed||Phase 3|412|Actual|Theratechnologies|||||||||||||||||||2017-10-11 05:10:09.404668|2017-10-11 05:10:09.404668
NCT00123266|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2014-04-04|||December 2006||2006-12-01|April 2014|2014-04-01|August 2008|Actual|2008-08-01|July 2007|Actual|2007-07-01||Interventional|MITI-IA||Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion|An Open-label, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion|Terminated||Phase 2|2|Actual|ThromboGenics||1||Sponsor's decision not to pursue development of uPLi for vascular conditions.|f||||t||||||||||2017-10-11 05:10:09.588549|2017-10-11 05:10:09.588549
NCT00123279|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2014-04-04|||December 2004||2004-12-01|April 2014|2014-04-01|November 2008|Actual|2008-11-01|February 2007|Actual|2007-02-01||Interventional|||Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy|A Dose-escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy|Completed||Phase 2|60|Actual|ThromboGenics||6|||f||||t||||||||||2017-10-11 05:10:09.686664|2017-10-11 05:10:09.686664
NCT00123292|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2014-04-04|||March 2005||2005-03-01|April 2014|2014-04-01|November 2009|Actual|2009-11-01|June 2007|Actual|2007-06-01||Interventional|||Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion|An Open-label, Ascending-dose, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion|Terminated||Phase 2|19|Actual|ThromboGenics||5||Sponsor's decision not to pursue development of uPLi for vascular conditions|f||||t||||||||||2017-10-11 05:10:09.801278|2017-10-11 05:10:09.801278
NCT00123305|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2014-11-06|||October 2005||2005-10-01|November 2014|2014-11-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke|A Multicentre, Double-Blind, Placebo-Controlled, Ascending-dose, Clinical Trial of Intravenous Microplasmin Administration in Patients With Acute Ischemic Stroke|Completed||Phase 2|40|Actual|ThromboGenics||4|||f||||t||||||||||2017-10-11 05:10:09.947157|2017-10-11 05:10:09.947157
NCT00123318|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2013-06-17|||February 2003||2003-02-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer|A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer|Completed||Phase 3|52|Actual|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||f||||||||||2017-10-11 05:10:10.144872|2017-10-11 05:10:10.144872
NCT00123331|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2005-08-01|||October 2003||2003-10-01|June 2005|2005-06-01|April 2005||2005-04-01|||||Interventional|||Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation|Rapamycin Use in CNI-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation|Completed||Phase 4|40||Heidelberg University|||||f||||||||||||||2017-10-11 05:10:10.310533|2017-10-11 05:10:10.310533
NCT00123344|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2008-12-10|||December 1999||1999-12-01|December 2008|2008-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Atrial Pacing for Termination and Prevention of Atrial Fibrillation|Atrial Pacing for Termination and Prevention of Atrial Fibrillation|Completed||N/A|120|Actual|University of Calgary|||||f||||||||||||||2017-10-11 05:10:10.415466|2017-10-11 05:10:10.415466
NCT00123357|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2015-04-06||||||January 2005|2005-01-01|March 2003|Actual|2003-03-01|||||Observational|||Measuring Health Related Quality of Life in Veterans With Stroke|Measuring Health Related Quality of Life in Veterans With Stroke|Completed||N/A|800|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:10:10.513138|2017-10-11 05:10:10.513138
NCT00123370|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2007-04-29|||July 2006||2006-07-01|July 2006|2006-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Trial of Modafinil for Methamphetamine Dependence|Randomised Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence|Unknown status|Active, not recruiting|Phase 2|87|Anticipated|The University of New South Wales||2|||f||||f||||||||||2017-10-11 05:10:10.587268|2017-10-11 05:10:10.587268
NCT00123383|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2007-04-29|||July 2005||2005-07-01|July 2006|2006-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence|Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|The University of New South Wales||2|||f||||f||||||||||2017-10-11 05:10:10.675026|2017-10-11 05:10:10.675026
NCT00124254|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2017-08-21|||September 2003||2003-09-01|August 2017|2017-08-01|August 2017|Actual|2017-08-01|August 2017|Actual|2017-08-01||Interventional|||Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand|An Outcome Study of Rheumatoid Hand Arthroplasty|Completed||N/A|170|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 05:10:27.70264|2017-10-11 05:10:27.70264
NCT00123396|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2015-04-06|||August 2004||2004-08-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||VHA Clinicians and Bioterror Events: Interactive Web-based Learning|VHA Clinicians and Bioterror Events: Interactive Web-based Learning|Completed||N/A|15|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:10:10.760011|2017-10-11 05:10:10.760011
NCT00123409|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2015-04-06|2014-09-26||January 2004||2004-01-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Telephone Disease Management At-Risk Drinking (TDM II)|Telephone Disease Management At-Risk Drinking (TDM 11)|Completed||N/A|146|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:10:11.078131|2017-10-11 05:10:11.078131
NCT00123422|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2014-10-06|2014-10-02||October 2005||2005-10-01|October 2014|2014-10-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Innovation in Pulmonary Rehabilitation|Innovation Methods to Augment Pulmonary Rehabilitation|Completed||N/A|103|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 05:10:11.426322|2017-10-11 05:10:11.426322
NCT00123435|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-20|2015-08-19|||July 2005||2005-07-01|August 2015|2015-08-01|June 2009|Actual|2009-06-01|November 2007|Actual|2007-11-01||Interventional|VWH||Veterans Walk for Health Study|Does Step Count Feedback Enhance Counseling for Weight Loss?|Completed||N/A|254|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 05:10:11.810206|2017-10-11 05:10:11.810206
NCT00123448|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2017-06-30|||July 20, 2005||2005-07-20|July 2, 2008|2008-07-02|July 2, 2008||2008-07-02|||||Observational|||Mirroring a Movement|Mirroring a Movement|Completed||N/A|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:10:11.90783|2017-10-11 05:10:11.90783
NCT00123461|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2015-05-04|||July 2005||2005-07-01|May 2015|2015-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism|A Phase 4, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Assess the Efficacy and Safety of Doxercalciferol Capsules in Vitamin D-replete Subjects With Chronic Kidney Disease (CKD) Stages 3 or 4 With Secondary Hyperparathyroidism (SHPT).|Completed||Phase 4|70|Anticipated|Sanofi||2|||||||||||||||||2017-10-11 05:10:11.961345|2017-10-11 05:10:11.961345
NCT00123474|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2016-07-25|2015-06-29||July 2005||2005-07-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|September 2006|Actual|2006-09-01||Interventional||All participants randomized to a treatment arm are summarized.|Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML|A Randomized Two-by-Two, Multicenter, Open-Label Phase III Study of BMS-354825 Administered Orally at a Dose of 50 mg or 70 mg Twice Daily or 100 mg or 140 mg Once Daily in Subjects With Chronic Phase Philadelphia Chromosome or BCR-ABL Positive Chronic Myelogenous Leukemia Who Are Resistant or Intolerant to Imatinib Mesylate (Gleevec)|Completed||Phase 3|724|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-10-11 05:10:12.237837|2017-10-11 05:10:12.237837
NCT00123487|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2014-10-30|2014-10-16||June 2005||2005-06-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|November 2006|Actual|2006-11-01||Interventional||Randomized Population analyzed. Baseline data are based on what participants were randomized to receive and not what they actually received.|Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML|A Randomized Two-Arm, Multicenter, Open-Label Phase III Study of BMS-354825 Administered Orally at a Dose of 70 mg Twice Daily or 140 mg Once Daily in Subjects With Chronic Myeloid Leukemia in Accelerated Phase or in Myeloid or Lymphoid Blast Phase or With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Who Are Resistant or Intolerant to Imatinib Mesylate (Gleevec)|Completed||Phase 3|638|Actual|Bristol-Myers Squibb|Amendment 3 (7 March 2007) allowed participants to switch from BID to QD dosing. Therefore, results for BID summarized by treatment group after Year 2 may not be a complete reflection of the BID experience and should be interpreted with this in mind.|2|||f||||f||||||||||2017-10-11 05:10:16.810806|2017-10-11 05:10:16.810806
NCT00123500|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2017-03-24|||September 2004||2004-09-01|March 2017|2017-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Wellness Program for Elementary School Personnel|ACTION! Wellness Program for Elementary School Personnel|Completed||N/A|1202|Actual|Tulane University||2|||f||||t||||||||||2017-10-11 05:10:21.518379|2017-10-11 05:10:21.518379
NCT00123513|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2012-06-12|||September 2004||2004-09-01|June 2012|2012-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Workplace-Sponsored Program to Reduce Obesity|Images of a Healthy Worksite-Preventing Weight Gain in the Workplace|Completed||N/A|3938|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 05:10:21.600747|2017-10-11 05:10:21.600747
NCT00123526|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2013-09-23|||September 2004||2004-09-01|September 2013|2013-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Workplace-Sponsored Diet and Exercise Program to Reduce Obesity|Active Living and Healthy Diet at the Workplace|Completed||Phase 3|899|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-10-11 05:10:21.679057|2017-10-11 05:10:21.679057
NCT00123539|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2016-07-28|||June 2001||2001-06-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Interventional|||Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery|Estradiol for Neurocognitive Dysfunction After CABG|Terminated||N/A|334||National Heart, Lung, and Blood Institute (NHLBI)||||"DSMB stopped the study based on conclusion of likely futility of treatment on the primary   outcome."|f||||||||||||||2017-10-11 05:10:21.749708|2017-10-11 05:10:21.749708
NCT00123552|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2011-11-28|||November 2004||2004-11-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Longitudinal Antimalarial Combinations in Uganda|Longitudinal Comparison of Combination Antimalarial Therapies in Ugandan Children: Evaluation of Safety, Tolerability, and Efficacy|Completed||Phase 3|690|Actual|University of California, San Francisco||3|||f||||||||||||||2017-10-11 05:10:21.821852|2017-10-11 05:10:21.821852
NCT00123565|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2008-08-20|||December 2004||2004-12-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|SHINE||Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction|A Randomized Dose Ranging Study of Hexadecasaccharide Including Active Control, in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Coronary Intervention (SHINE)|Completed||Phase 2|1257|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:10:21.9147|2017-10-11 05:10:21.9147
NCT00116857|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-09-11|2012-07-03||February 2005||2005-02-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors|Omega-3 for Depression and Other Cardiac Risk Factors|Completed||Phase 3|122|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 05:10:22.020371|2017-10-11 05:10:22.020371
NCT00116870|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-12-09|||June 1985||1985-06-01|June 2005|2005-06-01|February 1992|Actual|1992-02-01|February 1992|Actual|1992-02-01||Interventional|||MARS - Monitored Atherosclerosis Regression Study|A Double-Blind, Placebo-Controlled Angiographic Study to Evaluate the Effect of Lovastatin on the Progression Rate of Atherosclerosis in the Coronary Arteries of Patients With Coronary Heart Disease|Completed||Phase 2/Phase 3|270||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:10:22.362975|2017-10-11 05:10:22.362975
NCT00116883|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2016-09-13|||February 2005||2005-02-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics|A Randomized, Double-blind, Parallel Group, Placebo Controlled, 6-week Study of the Effect of GW685698X Aqueous Nasal Spray 100mcg QD on the Hypothalamic Pituitary Adrenocortical (HPA) Axis in Children 2 to 11 Years of Age With Perennial Allergic Rhinitis (PAR).|Completed||Phase 3|90|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:10:22.439059|2017-10-11 05:10:22.439059
NCT00123578|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2016-05-10|||August 2004||2004-08-01|May 2016|2016-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1|GHB: Effects, Withdrawal and Treatment|Withdrawn||Phase 1/Phase 2|0|Actual|University of California, Los Angeles||2||Unable to recruit adaquate number of GHB dependent subjects|f||||t||||||||||2017-10-11 05:10:22.539499|2017-10-11 05:10:22.539499
NCT00123591|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-01-11|||January 2005||2005-01-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury|A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Recombinant Factor VIIa (NovoSeven®/NiaStase®) in Subjects With Brain Contusions|Completed||Phase 2|96|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:10:22.635119|2017-10-11 05:10:22.635119
NCT00123604|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2014-11-17|2012-06-29||June 2004||2004-06-01|November 2014|2014-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes|Effects of Carvedilol and Metoprolol on Endothelial Function in Hypertensive Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|36|Actual|St. Paul Heart Clinic|The sample size was relatively small|2|||f||||f||||||||||2017-10-11 05:10:22.753272|2017-10-11 05:10:22.753272
NCT00123617|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2015-04-21|||January 2003||2003-01-01|April 2015|2015-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||The Impact of Cardiac Rehabilitation Participation on Cardiac Syndrome X|The Impact of Cardiac Rehabilitation on Angina Frequency, Psychological Morbidity and Quality of Life in Women With Syndrome X|Completed||Phase 2|64|Actual|National Heart and Lung Institute||2|||f||||f||||||||||2017-10-11 05:10:23.007443|2017-10-11 05:10:23.007443
NCT00123630|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2016-05-18|2012-09-05||November 2005||2005-11-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab|A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab|Completed||Phase 2|30|Actual|University of Utah|small numbers enrolled|2|||f||||f||||||||||2017-10-11 05:10:23.126679|2017-10-11 05:10:23.126679
NCT00123643|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2013-06-26|2012-07-02||May 2003||2003-05-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients|Comparison of Rosiglitazone Versus Glyburide on Vascular Structure and Function in Type 2 Diabetic Patients|Completed||Phase 4|36|Actual|St. Paul Heart Clinic|Small sample size; unbalanced sex distribution between groups|2|||f||||f||||||||||2017-10-11 05:10:23.414099|2017-10-11 05:10:23.414099
NCT00123656|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2008-01-10|||August 2004||2004-08-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis|Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis|Completed||Phase 2|30|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 05:10:23.691715|2017-10-11 05:10:23.691715
NCT00123669|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2016-10-18|||October 1997||1997-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2009|Actual|2009-12-01||Interventional|||Primary Progesterone Therapy for Operable Breast Cancer|The Primary Progesterone Therapy for Operable Breast Cancer : A Randomized Controlled Trial|Active, not recruiting||Phase 2/Phase 3|1000|Actual|Tata Memorial Hospital||2|||f||||f||||||||||2017-10-11 05:10:23.796956|2017-10-11 05:10:23.796956
NCT00123682|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2015-02-26|2015-01-08||May 2005||2005-05-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||TeleQuit Smoking Cessation Program|Telephone Care Coordination to Improve Smoking Cessation Counseling|Completed||N/A|3120|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-10-11 05:10:23.89919|2017-10-11 05:10:23.89919
NCT00123695|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2008-03-26|||May 2005||2005-05-01|March 2008|2008-03-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Observational|SEAS||Serial Echocardiography After Subarachnoid Hemorrhage|Serial Echocardiography After Subarachnoid Hemorrhage (S.E.A.S.)|Unknown status|Active, not recruiting|N/A|350|Anticipated|VU University Medical Center|||1||f||||t||||||||||2017-10-11 05:10:24.422311|2017-10-11 05:10:24.422311
NCT00123708|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-23|2017-06-30|||July 19, 2005||2005-07-19|November 13, 2009|2009-11-13||||November 13, 2009|Actual|2009-11-13||Observational|||Hypertonia in Patients With Cerebral Palsy|Hypertonia in Patients With Cerebral Palsy|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:10:24.507112|2017-10-11 05:10:24.507112
NCT00123734|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-24|2009-07-09|2009-07-09||March 2005||2005-03-01|July 2009|2009-07-01|May 2006||2006-05-01|||||Interventional|||Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis|Phase II Clinical Trial to Evaluate the Accuracy of Anti-Fibrin Humanized Monoclonal Antibody (DI-DD3B6/22-80B3) Fab' Protein Fragment (ThromboView) Conjugated With Technetium-99m in the Detection of Deep Vein Thrombosis|Completed||Phase 2|94|Actual|Agen Biomedical|||||||||||||||||||2017-10-11 05:10:24.586082|2017-10-11 05:10:24.586082
NCT00123747|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2016-02-24|||August 2005||2005-08-01|March 2012|2012-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer|A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|23|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 05:10:24.931101|2017-10-11 05:10:24.931101
NCT00123760|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2016-02-24|||February 2004||2004-02-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer|A Phase I/II, Phase III and Extended Phase III Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer|Completed||Phase 2/Phase 3|10838|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 05:10:25.020805|2017-10-11 05:10:25.020805
NCT00123773|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2016-02-24|||April 2004||2004-04-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence|A Phase II Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence|Completed||Phase 2|1075|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 05:10:25.13428|2017-10-11 05:10:25.13428
NCT00123786|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2016-02-24|||August 2005||2005-08-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma|A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma|Terminated||Phase 2|4|Actual|AHS Cancer Control Alberta||1||Lack of Enrollment|f||||f||||||||||2017-10-11 05:10:25.205345|2017-10-11 05:10:25.205345
NCT00123799|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2014-06-10|||June 2004||2004-06-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection|A Phase II Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection|Terminated||Phase 2|199|Actual|AHS Cancer Control Alberta||1||sufficient enrollment reached|f||||f||||||||||2017-10-11 05:10:25.418785|2017-10-11 05:10:25.418785
NCT00123812|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2016-02-23|||March 2004||2004-03-01|December 2011|2011-12-01|July 2006||2006-07-01|||||Observational|||Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy|Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy|Withdrawn||N/A|0|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 05:10:25.519878|2017-10-11 05:10:25.519878
NCT00123825|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2007-12-20|||July 2002||2002-07-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer|A Phase II Trial of Gemcitabine and Cisplatin In Unresectable Or Metastatic Biliary Tract and Gallbladder Cancer|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:10:25.59927|2017-10-11 05:10:25.59927
NCT00123838|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2016-04-26|||July 2005||2005-07-01|April 2016|2016-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Positioning and Tracking the Prostate During External Beam Radiation|Beacon® Transponder Implantation and Localization in the Prostate|Completed||N/A|43|Actual|Varian Medical||1|||f||||f||||||||No||2017-10-11 05:10:25.718911|2017-10-11 05:10:25.718911
NCT00123851|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2009-04-27|||March 2003||2003-03-01|April 2009|2009-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer|A Phase II Study of OSI-774 (Tarceva) in Combination With Oxaliplatin and Capecitabine in Previously Treated Patients With Stage IV Colorectal Cancer|Completed||Phase 2|32||Dana-Farber Cancer Institute|||||||||||||||||||2017-10-11 05:10:26.393601|2017-10-11 05:10:26.393601
NCT00123864|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2010-02-08|||January 2000||2000-01-01|July 2005|2005-07-01||||||||Interventional|||Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function|A Phase I/II Feasibility Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function|Completed||Phase 1/Phase 2|25||AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:10:26.525285|2017-10-11 05:10:26.525285
NCT00123877|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-23|2007-01-05|||March 2005||2005-03-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Study of GPX-100 in the Treatment of Metastatic Breast Cancer|Phase II, Open Label, Non-Randomized, Efficacy and Safety Study of an Intravenous Formulation of the Anthracycline Analog, GPX-100, in the Treatment of Metastatic Breast Cancer|Terminated||Phase 2|40||Gem Pharmaceuticals|||||f||||||||||||||2017-10-11 05:10:26.619733|2017-10-11 05:10:26.619733
NCT00123890|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2011-03-28|||June 2005||2005-06-01|March 2011|2011-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140|A Screening Protocol to Determine Eligibility for One of Three Phase III Treatment Studies Evaluating the Efficacy and Safety of GW873140 in R5-tropic and R5/X4-tropic HIV-1 Infected, Treatment-experienced Subjects With Drug-resistant Virus or an Observational Study.|Terminated||Phase 3|0|Actual|GlaxoSmithKline||1||The study was terminated due to hepatoxicity of compound|||||||||||||||2017-10-11 05:10:26.716887|2017-10-11 05:10:26.716887
NCT00123916|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-21|2011-08-01|||November 2004||2004-11-01|June 2005|2005-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|BENEFIT||BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease|Benznidazole Evaluation for Interrupting Trypanosomiasis - The BENEFIT Trial|Unknown status|Recruiting|Phase 3|1000|Anticipated|Population Health Research Institute||2|||f||||t||||||||||2017-10-11 05:10:27.292673|2017-10-11 05:10:27.292673
NCT00124241|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2015-05-08||||||May 2015|2015-05-01|November 2005|Actual|2005-11-01|February 2003|Actual|2003-02-01||Interventional|||An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B|A Phase IIb Extension Study of LdT (Telbivudine), Lamivudine or LdT Plus Lamivudine in Patients With Chronic Hepatitis B Who Have Completed Study NV-02B-003|Completed||Phase 2|||Novartis|||||||||||||||||||2017-10-11 05:10:27.598511|2017-10-11 05:10:27.598511
NCT00124267|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2005-08-03|||September 2003||2003-09-01|July 2005|2005-07-01|January 2004||2004-01-01|||||Interventional|||Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria|Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria: a Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 3|108||Makerere University|||||f||||||||||||||2017-10-11 05:10:27.902943|2017-10-11 05:10:27.902943
NCT00124280|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2016-11-16|||July 2005||2005-07-01|November 2016|2016-11-01||||October 2007|Actual|2007-10-01||Interventional|||Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Open Label, Non-randomized, Phase 2 Study Investigating the Effect of RAD001 Monotherapy in Patients With Advanced NSCLC Previously Treated With Either Chemotherapy Only or With Chemotherapy and EGFR Inhibitor(s)|Completed||Phase 2|85|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:10:28.011211|2017-10-11 05:10:28.011211
NCT00124293|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-02-23|||October 6, 2004|Actual|2004-10-06|February 2017|2017-02-01|November 23, 2005|Actual|2005-11-23|November 23, 2005|Actual|2005-11-23||Observational|||Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury|A Multi Centre Observational Study to Evaluate the Incidence and Magnitude of Haemorrhagic Progression of Cerebral Contusions and the Identification of Important Safety Issues Following Traumatic Brain Injury|Completed||N/A|63|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-10-11 05:10:28.11582|2017-10-11 05:10:28.11582
NCT00124306|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2013-10-28|||February 2005||2005-02-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|IC01||Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)|A Randomized Multicenter Clinical Trial to Evaluate the Efficacy of Amitriptyline for the Treatment of Painful Bladder Syndrome (PBS) in Newly Diagnosed Patients|Completed||Phase 3|271|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||||||||||||2017-10-11 05:10:28.437313|2017-10-11 05:10:28.437313
NCT00124319|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2011-10-03|||June 2005||2005-06-01|May 2009|2009-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Risk Factors for Anterior Cruciate Ligament (ACL) Injury|Epidemiology of Jump-Landing Movements and ACL Injury|Completed||N/A|4800|Anticipated|University of North Carolina, Chapel Hill|||1||f||||||||||||||2017-10-11 05:10:28.5369|2017-10-11 05:10:28.5369
NCT00124332|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2009-04-17|||January 2005||2005-01-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)|Randomized, Multicenter, Double-Blind, Placebo-Controlled, Two-Arm Parallel Group Trial of Rimonabant 20-mg od, for Inhibition of Atherosclerosis Progression Assessed by IVUS (IntraVascular UltraSounds), in Overweight Patients With Clustering Risk Factors|Completed||Phase 3|839|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:10:28.614021|2017-10-11 05:10:28.614021
NCT00124345|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2008-09-24|||June 2005||2005-06-01|September 2008|2008-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Medical Gas Humidification During Noninvasive Mechanical Ventilation|The Humidification During Noninvasive Mechanical Ventilation Delivered by Helmet|Completed||N/A|19|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-10-11 05:10:28.700821|2017-10-11 05:10:28.700821
NCT00124358|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2007-03-23|||August 2005||2005-08-01|March 2007|2007-03-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Buprenorphine and Integrated HIV Care Evaluation|An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings|Unknown status|Recruiting|Phase 4|1350||The New York Academy of Medicine|||||f||||||||||||||2017-10-11 05:10:28.808959|2017-10-11 05:10:28.808959
NCT00124371|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2005-08-04|||January 2003||2003-01-01|July 2005|2005-07-01|October 2005||2005-10-01|||||Interventional|||Programme to Optimise Risk Factors in Patients Waiting for Coronary Artery Bypass Surgery|Fit For Surgery Study: A Randomised Controlled Trial of a Nurse-Led Programme to Optimise Mental and Physical Fitness for Surgery and Coronary Risk Factor Control in Patients Waiting for Coronary Artery Bypass Surgery|Completed||Phase 2/Phase 3|200||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:10:28.975891|2017-10-11 05:10:28.975891
NCT00124384|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2008-04-22|||January 2005||2005-01-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia|Phase 4 Study of the Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia|Completed||Phase 4|40|Anticipated|University of Rochester|||||f||||t||||||||||2017-10-11 05:10:29.063392|2017-10-11 05:10:29.063392
NCT00124397|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2005-08-04|||July 2001||2001-07-01|July 2005|2005-07-01|December 2004||2004-12-01|||||Interventional|||Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)|Effect of High Dose Statin Therapy on Endothelial Function in Patients With Type 2 Diabetes Mellitus Without CAD|Completed||Phase 4|186||University of Southern Denmark|||||f||||||||||||||2017-10-11 05:10:29.141505|2017-10-11 05:10:29.141505
NCT00124410|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2016-02-24|||January 2000||2000-01-01|December 2011|2011-12-01||||December 2008|Actual|2008-12-01||Observational|||Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation|A Pilot Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation|Completed||N/A|100|Actual|AHS Cancer Control Alberta|||1||f||||||||||||||2017-10-11 05:10:29.217585|2017-10-11 05:10:29.217585
NCT00124423|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2016-02-24|||June 2004||2004-06-01|April 2012|2012-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer|Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer|Completed||N/A|5|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 05:10:29.381788|2017-10-11 05:10:29.381788
NCT00124436|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2010-07-16|||March 2005||2005-03-01|July 2010|2010-07-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis|Follow up Efficacy and Safety Study of BAL4979 in the Treatment of Chronic Hand Dermatitis Refractory to Topical Treatment|Completed||Phase 3|300||Basilea Pharmaceutica|||||f||||||||||||||2017-10-11 05:10:29.454401|2017-10-11 05:10:29.454401
NCT00124449|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2015-03-18|2009-05-21||February 2005||2005-02-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|May 2007|Actual|2007-05-01||Interventional|||Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients|A Phase II Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients With Undifferentiated Arthritis Who Are at High Risk for the Development of RA|Completed||Phase 2|56|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 05:10:29.570525|2017-10-11 05:10:29.570525
NCT00124462|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2017-05-30|2017-04-18||March 2008||2008-03-01|May 2017|2017-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Trial of Realignment Therapy for Treatment of Medial Knee Osteoarthritis|A Randomized Trial of Realignment Therapy for Treatment of Medial Knee Osteoarthritis|Completed||N/A|80|Actual|Boston University||2|||f||||f|f|t|f|f|f|||No||2017-10-11 05:10:31.179872|2017-10-11 05:10:31.179872
NCT00124475|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2010-07-16|||December 2004||2004-12-01|July 2010|2010-07-01|September 2007|Actual|2007-09-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis|Efficacy and Safety of BAL4079 in the Treatment of Severe Refractory Chronic Hand Dermatitis|Completed||Phase 3|1035||Basilea Pharmaceutica|||||f||||||||||||||2017-10-11 05:10:31.573657|2017-10-11 05:10:31.573657
NCT00124488|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2011-12-08|||June 2005||2005-06-01|December 2011|2011-12-01|November 2005||2005-11-01|||||Observational|||Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix|Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix|Completed||N/A|10||AHS Cancer Control Alberta|||1||f||||||||||||||2017-10-11 05:10:31.672969|2017-10-11 05:10:31.672969
NCT00124501|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2008-05-29|||October 2004||2004-10-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effectiveness of Biofeedback-Assisted Relaxation Training in Children With Eosinophilic Duodenitis|The Impact of Biofeedback-Assisted Relaxation Training on Pain and Functional Disability in Children Diagnosed With Eosinophilic Duodenitis: Pilot Study|Completed||N/A|20|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-10-11 05:10:31.759816|2017-10-11 05:10:31.759816
NCT00124514|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2014-07-25|||June 2003||2003-06-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Triptorelin for Ovary Protection in Childhood Onset Lupus||Completed||Phase 2|30|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 05:10:31.848933|2017-10-11 05:10:31.848933
NCT00124527|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2008-11-06|||March 2005||2005-03-01|November 2008|2008-11-01||||||||Interventional|||Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer|Phase 2 Clinical Trial of Bi-Weekly Dosing of Irofulven Plus Capecitabine in Patients With Anaplastic or Locally Advanced/Metastatic Differentiated Thyroid Cancer|Completed||Phase 2|35||Eisai Inc.|||||||||||||||||||2017-10-11 05:10:31.977968|2017-10-11 05:10:31.977968
NCT00124540|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2008-05-26|||August 2005||2005-08-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Misoprostol for Preventing Postpartum Hemorrhage|Misoprostol for Preventing Postpartum Hemorrhage|Completed||N/A|1200|Actual|Gynuity Health Projects||2|||f||||||||||||||2017-10-11 05:10:32.069044|2017-10-11 05:10:32.069044
NCT00124553|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2007-03-27|||August 2006||2006-08-01|March 2007|2007-03-01|June 2008|Anticipated|2008-06-01|||||Interventional|||LOADD (Lifestyle Over and Above Drugs in Diabetes) Study|The Potential for Diet Modification to Improve Glycaemic Control and Cardiovascular Risk Factors Over and Above Drug Therapy in Type 2 Diabetes at High Risk of Cardiovascular Disease|Unknown status|Recruiting|N/A|220||Edgar National Centre for Diabetes Research|||||f||||||||||||||2017-10-11 05:10:32.175385|2017-10-11 05:10:32.175385
NCT00124566|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2016-01-15|||June 2004||2004-06-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|January 2006|Actual|2006-01-01||Interventional|||Study of Irofulven in Patients With Hormone-refractory Prostate Cancer|Three-Arm Randomized Phase II Clinical Study of Irofulven/Prednisone, Irofulven/Capecitabine/Prednisone or Mitoxantrone/Prednisone in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer Patients|Completed||Phase 2|135|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-11 05:10:32.281462|2017-10-11 05:10:32.281462
NCT00124579|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2015-03-05|2013-01-02||August 2005||2005-08-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|June 2008|Actual|2008-06-01||Interventional|||S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|S0417 A Phase II Study of Bortezomib (Velcade™, PS-341), Thalidomide, and Dexamethasone in Patients With Refractory Multiple Myeloma|Terminated||Phase 2|7|Actual|Southwest Oncology Group||1||poor accrual|f||||t||||||||||2017-10-11 05:10:32.668065|2017-10-11 05:10:32.668065
NCT00124605|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2013-01-04|||April 2005||2005-04-01|January 2013|2013-01-01||||June 2009|Actual|2009-06-01||Interventional|||Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma|Phase I Trial of Arsenic Trioxide in Combination With Pamidronate Disodium|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:10:33.30975|2017-10-11 05:10:33.30975
NCT00124618|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2016-07-01|2015-03-09||January 2006||2006-01-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|February 2008|Actual|2008-02-01||Interventional|||Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|Cetuximab (C225) and Radiation in Elderly and /or Poor Performance Status Patients With Locally Advanced Non-Small Cell Lung Cancer: A Phase II Study to Evaluate Survival and Toxicity|Completed||Phase 2|58|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 05:10:33.443346|2017-10-11 05:10:33.443346
NCT00124644|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2013-05-01|||March 2006||2006-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase I Study of R115777 (Zarnestra) in Combination With Induction Chemotherapy in Patients With Newly Diagnosed, High Risk Acute Myeloid Leukemia|Terminated||Phase 1|30||National Cancer Institute (NCI)||||"Withdrawn due to toxicity problems"|f||||||||||||||2017-10-11 05:10:34.270245|2017-10-11 05:10:34.270245
NCT00124657|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2015-10-29|2013-09-10||March 2005||2005-03-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|July 2012|Actual|2012-07-01||Interventional|||Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma|A Phase I/II Trial of a New Tyrosine Kinase Inhibitor (Tarceva; Erlotinib Hydrochloride; OSI-774) During and After Radiotherapy in the Treatment of Patients With Newly Diagnosed High Grade Glioma and Unfavorable Low-Grade Glioma|Completed||Phase 1/Phase 2|62|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:10:34.391999|2017-10-11 05:10:34.391999
NCT00124683|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2017-01-11|||September 2001||2001-09-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1|Optimizing Treatment for Schizophrenic Smokers|Completed||Phase 2|59|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 05:10:36.366699|2017-10-11 05:10:36.366699
NCT00188487|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-20|||September 2005||2005-09-01|April 2007|2007-04-01|December 2005||2005-12-01|||||Interventional|||Magnetic Resonance (MR) in Asthmatic Patients|MR Perfusion Imaging in Asthmatic Patients|Suspended||Phase 1|80||University Health Network, Toronto||||no funding|f||||||||||||||2017-10-11 05:31:32.392203|2017-10-11 05:31:32.392203
NCT00124709|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2011-02-25|2010-12-08||October 2003||2003-10-01|February 2011|2011-02-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification|An Investigation of the Safety and Efficacy of Elidel® 1% Cream in Atopic Disease Modification, Assessed in a 3-year Randomized Double-blind Vehicle Controlled Phase to Evaluate Effects on Atopic Dermatitis in Infants, and a 2-3 Year Open-label Phase to Evaluate the Effect of Early Intervention Versus Delayed Intervention With Elidel® on the Incidence of Asthma in Children|Terminated||Phase 4|1091|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:10:36.553445|2017-10-11 05:10:36.553445
NCT00124722|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2015-05-29|||December 2004||2004-12-01|May 2015|2015-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study to Compare Different Intubating Doses of Zemuron in Pediatric and Adolescent Subjects Under General Anesthesia|A Randomized, Assessor-blind, Dose-ranging, Phase IIIB, Multicenter Trial Comparing the Intubating Conditions and Time Course of Block of Three Different Intubating Doses (0.45 mg/kg, 0.6 mg/kg, and 1.0 mg/kg) of Zemuron® in Pediatric and Adolescent Subjects Under General Anesthesia|Completed||Phase 3|207|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 05:10:37.505717|2017-10-11 05:10:37.505717
NCT00124735|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2016-07-14|2008-12-05||October 2004||2004-10-01|June 2016|2016-06-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)|An Open-label, Randomized, Phase IIIB, Multicenter Trial to Evaluate the Pharmacodynamic Parameters of Intubation Bolus, and Bolus and Infusion Maintenance Doses of Zemuron® in Pediatric and Adolescent Subjects|Completed||Phase 3|149|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:10:37.596924|2017-10-11 05:10:37.596924
NCT00124748|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-01-05|2011-11-02||June 2005||2005-06-01|January 2012|2012-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|TOPS||Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)|A Randomized Open-label Study of 400 mg Versus 800 mg of Imatinib Mesylate in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Using Molecular Endpoints.|Terminated||Phase 3|476|Actual|Novartis||2||"This study was prematurely discontinued because no improvement was observed in the 800mg dose   compared to 400mg dose"|f||||||||||||||2017-10-11 05:10:38.815296|2017-10-11 05:10:38.815296
NCT00124761|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2010-09-02|||December 2002||2002-12-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases|A Randomised Trial of Surgery Plus Whole Brain Radiotherapy (WBRT) Versus Radiosurgery Plus WBRT for Solitary Brain Metastases|Completed||Phase 3|22|Actual|Royal Adelaide Hospital||2|||f||||f||||||||||2017-10-11 05:10:41.258079|2017-10-11 05:10:41.258079
NCT00124774|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2008-03-28|||November 2004||2004-11-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|||||Interventional|||Nucleoplasty for Contained Herniated Lumbar Discs|Nucleoplasty for Contained Herniated Lumbar Discs: A Randomised, Double Blind, Prospective Comparison With Sham Treatment|Completed||Phase 3|50|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-10-11 05:10:41.341216|2017-10-11 05:10:41.341216
NCT00124787|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2012-02-29|||April 2005||2005-04-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|GAG||A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Gastroenteritis|A Randomized Double-blind Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Moderate Vomiting Due to Acute Gastroenteritis|Completed||Phase 4|150|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-10-11 05:10:41.421186|2017-10-11 05:10:41.421186
NCT00124800|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2009-09-23|||November 2005||2005-11-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus|The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus|Completed||Phase 1|41|Actual|Tinnitus Research Consortium||1|||f||||||||||||||2017-10-11 05:10:41.52893|2017-10-11 05:10:41.52893
NCT00124813|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2010-02-01|||August 2002||2002-08-01|February 2010|2010-02-01|November 2010|Anticipated|2010-11-01|May 2010|Anticipated|2010-05-01||Interventional|||Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma|Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) as Induction Therapy and a Randomized Trial of Thalidomide vs Thalidomide Plus Oral Idarubicin as Maintenance Therapy in Patients With Multiple Myeloma|Unknown status|Recruiting|Phase 2|80|Anticipated|University Hospital, Bonn||1|||f||||||||||||||2017-10-11 05:10:41.627908|2017-10-11 05:10:41.627908
NCT00124826|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2006-01-31|||May 2004||2004-05-01|July 2005|2005-07-01||||||||Interventional|||SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points|Spectroscopic Evaluation of Lesion Evolution in Stroke: Trial of Insulin for Acute Lactic Acidosis (SELESTIAL)|Completed||Phase 2|45||University of Glasgow|||||f||||||||||||||2017-10-11 05:10:41.715343|2017-10-11 05:10:41.715343
NCT00124839|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2008-04-14|||October 2005||2005-10-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Naltrexone in Borderline Personality Disorder|Evaluation of the Efficacy of the Opioid Antagonist Naltrexone on the Incidence and Intensity of Flashbacks and Dissociative States in Patients With Borderline Personality Disorder|Terminated||Phase 3|48|Anticipated|Central Institute of Mental Health, Mannheim||4||Difficulties in recruiting enough subjects|f||||f||||||||||2017-10-11 05:10:41.791103|2017-10-11 05:10:41.791103
NCT00124852|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2011-01-11|||October 2005||2005-10-01|January 2011|2011-01-01|July 2007|Actual|2007-07-01|December 2006|Actual|2006-12-01||Interventional|||The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People|The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People: a Double-blind Placebo-controlled Trial|Completed||N/A|302|Actual|Wageningen University||3|||f||||f||||||||||2017-10-11 05:10:42.026569|2017-10-11 05:10:42.026569
NCT00124865|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2017-09-25|||July 2005||2005-07-01|September 2017|2017-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study|Safety and Immunogenicity Evaluation of an Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) in Volunteers|Withdrawn||Phase 1|0|Actual|U.S. Army Medical Research and Materiel Command||||Sponsor|f||||||||||||||2017-10-11 05:10:42.127049|2017-10-11 05:10:42.127049
NCT00188916|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-11||||||September 2006|2006-09-01||||||||Observational|||A Clinical Comparison of Three Bronchial Blockers for One-Lung Ventilation in Thoracic Surgery||Unknown status|Recruiting|Phase 4|120|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:35.67821|2017-10-11 05:31:35.67821
NCT00124878|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2007-08-09|||August 2003||2003-08-01|July 2005|2005-07-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community|Trial of Male Circumcision: HIV, STD and Behavioral Effects in Men, Women and the Community|Unknown status|Active, not recruiting|Phase 3|5200|Actual|Wawer, Maria J., M.D.||2|||f||||t||||||||||2017-10-11 05:10:42.201689|2017-10-11 05:10:42.201689
NCT00124891|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2007-12-06|||June 2005||2005-06-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Study Evaluating GAP-486 in Non-Sustained Ventricular Tachycardia|Study Evaluating Subjects With Non-Sustained Ventricular Tachycardia|Terminated||Phase 2|500||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:10:42.294933|2017-10-11 05:10:42.294933
NCT00124904|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2010-01-12|||September 1999||1999-09-01|January 2010|2010-01-01|December 2006||2006-12-01|||||Interventional|||Biofeedback for Fecal Incontinence|Biofeedback for Fecal Incontinence and Constipation|Completed||N/A|165||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:10:42.522859|2017-10-11 05:10:42.522859
NCT00124917|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2017-10-05|||July 21, 2005||2005-07-21|May 9, 2017|2017-05-09|May 9, 2017|Actual|2017-05-09|March 6, 2011|Actual|2011-03-06||Interventional|||Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer|A Phase I Study of Image Guided Dose Escalation With Intensity Modulated Radiation Therapy (IMRT) to Histologically Confirmed Regions of Prostate Cancer|Completed||Phase 1|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:10:42.627148|2017-10-11 05:10:42.627148
NCT00124930|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-01-18|||May 2005||2005-05-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer|A Randomized Double-blind, Parallel Group Study Comparing Olanzapine (Zyprexa) With Haloperidol (Novo-peridol) for the Relief of Nausea and Vomiting in Patients With Advanced Cancer|Terminated||Phase 3|80|Anticipated|AHS Cancer Control Alberta||||Study suspended due to low enrollment|f||||||||||||||2017-10-11 05:10:42.733903|2017-10-11 05:10:42.733903
NCT00124943|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-03-28|2012-02-21||July 2005||2005-07-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|SNAPIST-III||Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis|A Phase I/II Safety Trial of Intracoronary Administration of Systemic Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis|Completed||Phase 1/Phase 2|112|Actual|Celgene||4|||f||||f||||||||||2017-10-11 05:10:42.837545|2017-10-11 05:10:42.837545
NCT00124956|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2017-09-07|||June 2003||2003-06-01|September 2017|2017-09-01||||||||Interventional|||Doxorubicin Pharmacokinetic (PK) Study|Impact of Body Composition on Pharmacokinetics of Doxorubicin in Pediatric Patients|Withdrawn||Phase 1/Phase 2|0|Actual|Boston Children’s Hospital|||||f||||||||||||||2017-10-11 05:10:45.406545|2017-10-11 05:10:45.406545
NCT00124969|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-05-07|||January 2002||2002-01-01|October 2006|2006-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure|Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure (ADAM [Amlodipine and Dialysis Patients, Action on Mortality])|Completed||Phase 4|356|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 05:10:45.472882|2017-10-11 05:10:45.472882
NCT00124982|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-02-23|2011-02-18||April 2005||2005-04-01|February 2012|2012-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy|A Phase III, Multi-Center, Open Label Study to Evaluate the Efficacy, Tolerability and Safety of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-Biologic DMARDs Who Have an Inadequate Response to Anti-TNF Therapy and Have Limited Therapeutic Options|Completed||Phase 3|1286|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-10-11 05:10:45.86857|2017-10-11 05:10:45.86857
NCT00124995|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2013-02-12|||October 2003||2003-10-01|February 2013|2013-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Trial of Terbutaline for the Treatment of Status Asthmaticus in Children|Double-blinded Randomized Trial of Terbutaline to Shorten ICU Length of Stay in the Treatment of Status Asthmaticus in Children|Completed||Phase 4|40||Connecticut Children's Medical Center|||||f||||||||||||||2017-10-11 05:10:51.469666|2017-10-11 05:10:51.469666
NCT00125008|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2008-08-25|||May 2003||2003-05-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever|Randomized Controlled Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever in Eastern Kolkata, West Bengal, India|Completed||Phase 4|37673|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-10-11 05:10:51.559848|2017-10-11 05:10:51.559848
NCT00125021|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2009-10-30|||October 2003||2003-10-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|June 2004|Actual|2004-06-01||Interventional|||Tarceva and Capecitabine for Pancreatic Cancer|A Phase II Study of OSI-774 (Tarceva) in Combination With Capecitabine in Previously Treated Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|32|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:10:51.689167|2017-10-11 05:10:51.689167
NCT00125034|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2014-08-05|2011-08-23||July 2005||2005-07-01|August 2011|2011-08-01|November 2010|Actual|2010-11-01|March 2007|Actual|2007-03-01||Interventional|OPUS||Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)|Open, Randomized, Controlled, Multicenter Phase II Study Comparing 5-FU/FA Plus Oxaliplatin (FOLFOX-4) Plus Cetuximab Versus 5-FU/FA Plus Oxaliplatin (FOLFOX-4) as First-line Treatment for Epidermal Growth Factor Receptor-expressing Metastatic Colorectal Cancer|Completed||Phase 2|344|Actual|Merck KGaA|A non-specific outcome measure 'Safety' was deleted from this entry in error. A replacement outcome has been created. The 'Safety' outcome refers to adverse events and these are shown in the 'Adverse Events' section.|2|||f||||f||||||||||2017-10-11 05:10:51.838087|2017-10-11 05:10:51.838087
NCT00125047|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2008-08-25|||October 2001||2001-10-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood|Effectiveness of a Combined Vi Vaccination and Health Education Program on Reducing the Burden of Typhoid During Childhood: A Demonstration Project in Karachi|Completed||Phase 4|27231|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-10-11 05:10:53.276645|2017-10-11 05:10:53.276645
NCT00125060|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2017-08-23|||August 2000||2000-08-01|August 2017|2017-08-01|April 2004||2004-04-01|||||Interventional|||Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures|Transesophageal MRI in Conjunction With Lipid Lowering Measures|Completed||N/A|72||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:10:53.414264|2017-10-11 05:10:53.414264
NCT00125099|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-05-16||||||May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection|Safety and Immunogenicity of the HIV-1 DNA Vaccine VRC-HIVDNA009-00-VP (GAG-POL-NEF-MULTICLADE ENV) in HIV-1 Infected Subjects Treated During Acute HIV Infection|Completed||Phase 1/Phase 2|21|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:10:53.774927|2017-10-11 05:10:53.774927
NCT00125112|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2010-01-15|||February 2005||2005-02-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Internet Weight Control for Bingeing Adolescents|Internet Weight Control for Bingeing Adolescents|Completed||Phase 1|120|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:10:53.863383|2017-10-11 05:10:53.863383
NCT00125125|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2017-05-15|||May 2005||2005-05-01|May 2017|2017-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Fluvastatin in Adults With Dislipidemia With History of Muscle Problems|Efficacy and Tolerability of Fluvastatin in Adults With Dislipidemia With History of Muscle Problems Due to Other Previous Statin Intake|Completed||Phase 4|218|Actual|Novartis|||||||||||||||||||2017-10-11 05:10:53.922423|2017-10-11 05:10:53.922423
NCT00125138|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2011-05-17|2011-04-11||July 2005||2005-07-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease|Safety and Efficacy of Melperone in the Treatment of Patients With Psychosis Associated With Parkinson's Disease|Completed||Phase 2|90|Actual|Lundbeck LLC||4|||f||||t||||||||||2017-10-11 05:10:54.086902|2017-10-11 05:10:54.086902
NCT00125151|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2009-05-01|||February 2006||2006-02-01|May 2009|2009-05-01|April 2007|Actual|2007-04-01|||||Interventional|||C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema|Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema|Completed||Phase 3|15|Anticipated|Sanquin|||||f||||||||||||||2017-10-11 05:10:54.610579|2017-10-11 05:10:54.610579
NCT00125164|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-06-14|2009-07-08||March 2004||2004-03-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency|Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Prepubertal Children With Growth Failure Associated With Primary IGF-1 Deficiency: A Phase 3, Randomized, Open Label, Observation-Controlled, Multicenter, Parallel-Dose Comparison Trial|Completed||Phase 3|137|Actual|Ipsen||4|||f||||t||||||||||2017-10-11 05:10:54.728902|2017-10-11 05:10:54.728902
NCT00125177|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2010-11-09|||January 2003||2003-01-01|July 2005|2005-07-01|April 2008|Actual|2008-04-01|||||Interventional|||IRIS: Incontinence Research Intervention Study|Office for Research on Women's Health (ORWH): Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women's Health. Project 3: Selection Criteria For Muscle Therapy in SUI|Completed||Phase 1/Phase 2|320|Anticipated|University of Michigan|||||f||||||||||||||2017-10-11 05:10:55.853103|2017-10-11 05:10:55.853103
NCT00125190|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-06-14|2010-03-23||July 2005||2005-07-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency|Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With Primary IGF-1 Deficiency: A Multi-Center, Open Label, Concentration-Controlled Study|Completed||Phase 2/Phase 3|45|Actual|Ipsen||1|||f||||t||||||||||2017-10-11 05:10:55.955555|2017-10-11 05:10:55.955555
NCT00125203|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-03-13|||July 2003||2003-07-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Randomized, Double-Blind, Placebo-Controlled Study of Safety and Efficacy of Botulinum Toxin Type B (Myobloc) in Sialorrhea in Amyotrophic Lateral Sclerosis|Completed||Phase 2/Phase 3|20||The University of Texas Health Science Center at San Antonio|||||f||||t||||||||||2017-10-11 05:10:56.355363|2017-10-11 05:10:56.355363
NCT00125216|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2014-04-04|||December 2004||2004-12-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of the Effects of Response Elaboration Training for Aphasia|Evaluation of the Effects of Response Elaboration Training for Aphasia|Completed||N/A|47|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:10:56.45054|2017-10-11 05:10:56.45054
NCT00125229|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-06-22|||August 2005||2005-08-01|June 2012|2012-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients|Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients|Terminated||Phase 4|10|Anticipated|The University of Texas Health Science Center at San Antonio|||1|Dr. Hladky died Sept 2006 prior to study completion|f||||||||||||||2017-10-11 05:10:56.536984|2017-10-11 05:10:56.536984
NCT00125242|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2014-12-22|2014-11-21||July 2005||2005-07-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|February 2009|Actual|2009-02-01||Interventional||SFA Treatment Participants = Stroke survivors with chronic aphasia. Non Treatment Stimuli Development Participants = non-brain-damaged persons who were enrolled for purposes of stimuli development.|Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis|Word-Retrieval for Aphasia: Facilitation of Generalization|Completed||N/A|110|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:10:56.612927|2017-10-11 05:10:56.612927
NCT00125255|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children|A Randomized, Double-blind, Placebo Controlled, Parallel Study Evaluating the Efficacy of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) for Induction of Local Dermal Anesthesia Before Vascular Access Procedures in Children|Completed||Phase 3|81|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-10-11 05:10:56.80345|2017-10-11 05:10:56.80345
NCT00125268|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2012-08-02|2012-08-02||July 2005||2005-07-01|August 2012|2012-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Near Infrared Light for the Treatment of Painful Peripheral Neuropathy|A Phase III, Double Blind, Randomized, Placebo-controlled Study to Assess the Efficacy of Adjunct Monochromatic Near-infrared Photoenergy (MIRE) in Patients With Painful Axonal Peripheral Neuropathy|Terminated||Phase 3|30|Actual|Mayo Clinic|This study was terminated early because the study was unable to enroll enough patients.|2||Unable to enroll enough patients|f||||t||||||||||2017-10-11 05:10:56.889469|2017-10-11 05:10:56.889469
NCT00125281|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2017-06-30|||July 25, 2005||2005-07-25|July 2, 2008|2008-07-02|July 2, 2008|Actual|2008-07-02|July 31, 2007|Actual|2007-07-31||Interventional|||SAMe to Treat Biliary Cirrhosis Symptoms|S-Adenosyl Methionine for Symptomatic Treatment of Primary Biliary Cirrhosis|Terminated||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:10:57.131889|2017-10-11 05:10:57.131889
NCT00125294|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2017-09-21|||September 2003||2003-09-01|August 2011|2011-08-01|January 2007|Actual|2007-01-01|June 2006|Actual|2006-06-01||Interventional|||Sublingual Methadone for the Management of Cancer Breakthrough Pain|Evaluation of a Dose Titration Protocol for Sublingual Methadone Hydrochloride for the Management of Cancer-related Breakthrough Pain|Completed||Phase 1|10|Actual|AHS Cancer Control Alberta||1|||f||||||||||||||2017-10-11 05:10:57.304367|2017-10-11 05:10:57.304367
NCT00125307|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2015-07-31|||January 2004||2004-01-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis|Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis|Completed||Phase 4|20||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:10:57.376471|2017-10-11 05:10:57.376471
NCT00125320|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2007-12-19|||June 2004||2004-06-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery|A Phase III Study of the Conversion Efficacy and Safety of Repeated Intravenous Doses of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter Following Valvular and/or Coronary Artery Bypass Graft Surgery|Completed||Phase 3|190|Actual|Astellas Pharma Inc|||||f||||t||||||||||2017-10-11 05:10:57.460718|2017-10-11 05:10:57.460718
NCT00125333|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2008-11-18|||March 2005||2005-03-01|November 2008|2008-11-01|November 2005||2005-11-01|||||Interventional|||Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis|A Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Safety of Repeated Topical Application of Three Concentrations of NF-kappaB Decoy in Adults With Mild-to-Moderate Atopic Dermatitis|Completed||Phase 1/Phase 2|75||Anesiva, Inc.|||||||||||||||||||2017-10-11 05:10:57.564644|2017-10-11 05:10:57.564644
NCT00125346|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2011-10-10|||September 2005||2005-09-01|October 2011|2011-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|EVOLVE||Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Trial to Assess the Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis (CF) Subjects|Terminated||Phase 3|98|Actual|Novartis||||per Data Monitoring Committee recommendation|||||||||||||||2017-10-11 05:10:57.731452|2017-10-11 05:10:57.731452
NCT00125359|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2014-11-11|||August 2005||2005-08-01|July 2013|2013-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer|A Phase II Clinical Study of Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Patients With Advanced Non-small Cell Lung Cancer|Completed||Phase 2|42|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 05:10:57.895584|2017-10-11 05:10:57.895584
NCT00125372|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2014-07-14|||December 2005||2005-12-01|July 2014|2014-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Study of Tarceva and Targretin in Stage I-II Lung Cancer|A Clinical and Pharmacologic Study of the Combination of Erlotinib and Bexarotene in Resectable Clinical Stage I-II Non-Small Cell Lung Cancer|Completed||N/A|15|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 05:10:57.975743|2017-10-11 05:10:57.975743
NCT00125385|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2015-04-09|||July 2005||2005-07-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Phase I, Open-Label, Multi-Center, Single-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic of GC1008 in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 1|25|Actual|Sanofi||5|||f||||t||||||||||2017-10-11 05:10:58.070422|2017-10-11 05:10:58.070422
NCT00125398|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2008-11-06|||July 2005||2005-07-01|November 2008|2008-11-01|May 2007|Actual|2007-05-01|||||Interventional|||GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting|A Phase II, Randomized, Open-Label Study to Examine the Safety and Efficacy of GPI 15715 for Sedation of Patients Requiring Intubation and Mechanical Ventilation in the Intensive Care Unit Setting|Completed||Phase 2|60||Eisai Inc.|||||f||||||||||||||2017-10-11 05:10:58.176574|2017-10-11 05:10:58.176574
NCT00125411|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2012-03-22|||March 2007||2007-03-01|March 2012|2012-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of Satraplatin (JM-216) in Combination With Docetaxel|Phase I Study of the Oral Platinum Agent Satraplatin (JM-216) in Combination With Docetaxel in Treatment of Advanced Malignancies|Terminated||Phase 1|28|Actual|Agennix||1||Sponsor decided to discontinue study drug development.|f||||||||||||||2017-10-11 05:10:58.282318|2017-10-11 05:10:58.282318
NCT00125424|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-27|2008-11-06|||July 2005||2005-07-01|November 2008|2008-11-01|September 2005|Actual|2005-09-01|||||Interventional|||Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy|A Randomized, Double-Blind, Dose-Response Study to Assess the Efficacy and Safety of AQUAVAN® Injection for Procedural Sedation in Patients Undergoing Colonoscopy|Completed||Phase 2/Phase 3|125||Eisai Inc.|||||||||||||||||||2017-10-11 05:10:58.365855|2017-10-11 05:10:58.365855
NCT00125437|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2009-07-13|||September 2005||2005-09-01|December 2008|2008-12-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy|Safety and Efficacy of Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy|Terminated||N/A|200|Anticipated|Hebei Medical University||||Poor compliance with the therapy and lot of patients were lost to follow up.|f||||||||||||||2017-10-11 05:10:58.487475|2017-10-11 05:10:58.487475
NCT00125450|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2008-05-26|||September 2004||2004-09-01|October 2006|2006-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|BRONKINOU||Evaluation of Chest Physiotherapy for Acute Bronchiolitis in Toddlers (BRONKINOU)|Efficacy and Safety of Chest Physiotherapy With Forced Expiratory Technique for Acute Bronchiolitis in Toddlers|Completed||N/A|500|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:10:58.566607|2017-10-11 05:10:58.566607
NCT00125463|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2005-08-08|||September 2001||2001-09-01|April 2005|2005-04-01|December 2005||2005-12-01|||||Interventional|||Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients|Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients|Unknown status|Active, not recruiting|Phase 3|3200||The Japanese Society of Hypertension|||||f||||||||||||||2017-10-11 05:10:58.721328|2017-10-11 05:10:58.721328
NCT00125476|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2006-10-10|||July 2004||2004-07-01|October 2006|2006-10-01||||||||Interventional|||Effects of Exercise Training on Diastolic Heart Function in Postmenopausal Women|Training and Diastolic Function in Postmenopausal Women|Completed||N/A|215||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:10:58.808077|2017-10-11 05:10:58.808077
NCT00125489|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2010-08-26|||May 2005||2005-05-01|March 2007|2007-03-01|December 2005||2005-12-01|||||Interventional|||CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi|Chloroquine and Sulfadoxine-Pyrimethamine Efficacy for the Treatment of Uncomplicated Falciparum Malaria in Blantyre, Malawi|Completed||Phase 4|210||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:10:58.878382|2017-10-11 05:10:58.878382
NCT00125502|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2011-09-16|||August 1999||1999-08-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|June 2007|Actual|2007-06-01||Interventional|||Recombinant CMV gB Vaccine in Postpartum Women|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Recombinant CMV gB Vaccine in Postpartum Women|Completed||Phase 2|464|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 05:10:58.952904|2017-10-11 05:10:58.952904
NCT00125515|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2013-01-28|2012-12-18||June 2005||2005-06-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|NAMHS-1||Memantine and Naltrexone Treatment for Opioid Dependence|Evaluation of NMDA Antagonist for Opiate Dependence|Completed||Phase 2|81|Actual|New York State Psychiatric Institute|It is possible that concomitant naltrexone might have exacerbated protracted withdrawal, thus masking the potential ameliorative effects of memantine that have been previously observed in other trials.|3|||f||||t||||||||||2017-10-11 05:10:59.063686|2017-10-11 05:10:59.063686
NCT00125528|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2016-12-16|2015-02-03||July 2012||2012-07-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||D-cycloserine in the Management of Chronic Low Back Pain|D-Cycloserine in the Management of Chronic Low Back Pain: A Double-Blind, Randomized, Placebo-Controlled Pilot Study|Completed||Phase 2|41|Actual|Northwestern University|It is not clear whether observed effects are due to escalating dose or duration of D-cycloserine use. A larger population and longer duration of treatment would be needed to determine this.|2|||f||||f||||||||||2017-10-11 05:10:59.439735|2017-10-11 05:10:59.439735
NCT00125541|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2009-05-01|||November 2006||2006-11-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema|Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema|Completed||Phase 2/Phase 3|6|Anticipated|Sanquin||1|||f||||||||||||||2017-10-11 05:10:59.768306|2017-10-11 05:10:59.768306
NCT00125554|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2005-08-11|||May 1998||1998-05-01|July 2005|2005-07-01|July 2001||2001-07-01|||||Interventional|||Metyrapone as Additive Treatment in Major Depression|Double-Blind, Placebo Controlled Trial of Metyrapone as Augmenting Agent in the Treatment of Major Depression|Completed||Phase 2|63||Universitätsklinikum Hamburg-Eppendorf|||||f||||||||||||||2017-10-11 05:10:59.851585|2017-10-11 05:10:59.851585
NCT00125567|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2009-06-19|||August 2005||2005-08-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|SEWOP||Stalevo in Early Wearing-Off Patients|Multicentre, Randomised, Double-Blind Study to Compare Stalevo to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off|Completed||Phase 4|223|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-10-11 05:10:59.930028|2017-10-11 05:10:59.930028
NCT00125580|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2007-11-30|||August 2005||2005-08-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Healthy Sleeping and Feeding During Infancy|Healthy Sleeping and Feeding During Infancy: Pilot Study for the Primary Prevention of Obesity in Primary Care|Completed||Phase 1|40|Actual|Penn State University||1|||f||||||||||||||2017-10-11 05:11:00.049947|2017-10-11 05:11:00.049947
NCT00125593|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2012-01-31|2011-08-19||June 2003||2003-06-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|SHARP||Study of Heart and Renal Protection|Study of Heart and Renal Protection (SHARP): The Effects of Lowering LDL-cholesterol With Simvastatin 20mg Plus Ezetimibe 10mg in Patients With Chronic Kidney Disease: a Randomized Placebo-controlled Trial|Completed||Phase 4|9438|Actual|University of Oxford||3|||f||||t||||||||||2017-10-11 05:11:00.162277|2017-10-11 05:11:00.162277
NCT00125606|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2012-12-17|||October 2004||2004-10-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide|Randomized Phase 3 Trial for Patients With AML in CR2 Comparing Total Body Irradiation (TBI) With 8Gy/Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide|Terminated||Phase 3|30|Actual|University Hospital Muenster||2||insufficient patient recruitement|f||||t||||||||||2017-10-11 05:11:00.582972|2017-10-11 05:11:00.582972
NCT00125619|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2016-12-23|2015-04-17||September 2005||2005-09-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Internally Versus Externally Guided Body Weight-Supported Treadmill Training (BWSTT) for Locomotor Recovery Post-stroke|Internally v. Externally Guided BWSTT for Locomotor Recovery Post-stroke|Completed||N/A|16|Actual|VA Office of Research and Development|Small sample size, but consistent with intent of pilot study Inclusion criterion was >6 months post-event, allowing for large heterogeneity in chronicity Intervention was limited (12 sessions distributed over 4 weeks)|2|||f||||f||||||||||2017-10-11 05:11:00.697264|2017-10-11 05:11:00.697264
NCT00125632|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2009-02-03|||August 2005||2005-08-01|December 2006|2006-12-01|May 2008|Actual|2008-05-01|||||Interventional|||Measuring Reading Rehabilitation Outcomes|Measuring Reading Rehabilitation Outcomes|Completed||N/A|90|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:11:01.386815|2017-10-11 05:11:01.386815
NCT00125645|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2011-08-15|||March 2005||2005-03-01|April 2007|2007-04-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)|Global Left Ventricular Function After Acute Myocardial Infarction. Treatment With the Angiotensin 2-Receptor Blocker Irbesartan|Suspended||Phase 4|200|Anticipated|University of Southern Denmark||1||Study terminated due to lack of patients|f||||||||||||||2017-10-11 05:11:01.468869|2017-10-11 05:11:01.468869
NCT00125658|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-28|2017-06-21|2015-04-20||February 2008||2008-02-01|June 2017|2017-06-01|September 2011|Actual|2011-09-01|June 2009|Actual|2009-06-01||Interventional|||Mechanisms of Upper-Extremity Motor Recovery in Post-stroke Hemiparesis|Mechanisms of Upper-Extremity Motor Recovery in Post-stroke Hemiparesis|Completed||N/A|14|Actual|VA Office of Research and Development|This was a small clinical trial (total n = 14).|2|||f||||f||||||||Undecided||2017-10-11 05:11:01.578166|2017-10-11 05:11:01.578166
NCT00125671|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2009-09-27|||January 2000||2000-01-01|September 2009|2009-09-01|April 2006||2006-04-01|||||Interventional|||Warfarin and Antiplatelet Vascular Evaluation|A Phase III Randomized Trial of Warfarin Plus Antiplatelet Therapy Versus Antiplatelet Therapy Alone in Patients With Peripheral Vascular Disease|Unknown status|Active, not recruiting|Phase 3|2400||Warfarin and Antiplatelet Vascular Evaluation|||||f||||||||||||||2017-10-11 05:11:02.233142|2017-10-11 05:11:02.233142
NCT00125684|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2012-01-18|||July 2003||2003-07-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Bioavailability and Effectiveness of Transdermally Administered Morphine|Bioavailability and Effectiveness of Transdermally Administered Morphine|Completed||Phase 1|6|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:11:02.33443|2017-10-11 05:11:02.33443
NCT00125697|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2016-07-14|||May 2005||2005-05-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy|Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy|Completed||N/A|49|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-10-11 05:11:02.441312|2017-10-11 05:11:02.441312
NCT00125710|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2016-07-14|||June 1998||1998-06-01|June 2014|2014-06-01||||August 2012|Actual|2012-08-01||Observational|||Comparative 2-D Tumor Analysis in Familial Gliomas|Comparative 2-D Tumor Analysis in Familial Gliomas|Completed||N/A|5|Anticipated|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-10-11 05:11:02.561372|2017-10-11 05:11:02.561372
NCT00125723|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2010-12-22|||May 2004||2004-05-01|December 2010|2010-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy|A Multicenter, Open-label, Phase 4 Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy|Completed||Phase 4|2252|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:11:02.689876|2017-10-11 05:11:02.689876
NCT00125736|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2010-01-28|||August 2005||2005-08-01|January 2010|2010-01-01||||September 2008|Actual|2008-09-01||Interventional|||A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium|A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium|Completed||Phase 4|520||Eisai Inc.|||||f||||||||||||||2017-10-11 05:11:02.839169|2017-10-11 05:11:02.839169
NCT00125749|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2017-06-09|||July 2005||2005-07-01|June 2017|2017-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Vaccination of Patients With Stage IV Melanoma With Dendritic Cells|Vaccination of Patients With Stage IV Melanoma With Dendritic Cells Generated Ex Vivo From Monocytes and Loaded With Heat Treated Killed Allogeneic Melanoma Cells|Completed||Phase 1/Phase 2|30|Actual|Baylor Research Institute||1|||f||||f||||||||||2017-10-11 05:11:03.110901|2017-10-11 05:11:03.110901
NCT00125775|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2010-01-06|||May 2005||2005-05-01|July 2009|2009-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?|Phase 4 Study of Recombinant Hepatitis B Vaccine in Peritoneal Dialysis Subjects|Completed||Phase 4|130|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 05:11:03.373574|2017-10-11 05:11:03.373574
NCT00125788|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2017-08-07||2011-11-17|March 2004||2004-03-01|August 2017|2017-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia|A Phase II, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of L Glutamine Therapy for Sickle Cell Anemia and Sickle ß0-Thalassemia|Completed||Phase 2|81|Actual|Emmaus Medical, Inc.||2|||f||||f||||||||||2017-10-11 05:11:03.502672|2017-10-11 05:11:03.502672
NCT00125801|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2008-10-13|||August 2005||2005-08-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Pain Pen for Breakthrough Cancer Pain|Breakthrough Cancer Pain: A Randomized Trial Comparing Oral Morphine Immediate Release and Self-Administration of Subcutaneous Hydromorphone Using an Injection Pen|Terminated||Phase 3|50|Anticipated|Erasmus Medical Center||1||Lack of patients|f||||t||||||||||2017-10-11 05:11:03.662593|2017-10-11 05:11:03.662593
NCT00125814|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2005-08-15|||December 2001||2001-12-01|August 2005|2005-08-01|January 2005||2005-01-01|||||Interventional|||Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression|Multi-Center Trial to Evaluate the Efficacy and Safety of Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression (ANRS 105 INTERVAC)|Terminated||Phase 3|200||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:11:03.767112|2017-10-11 05:11:03.767112
NCT00125827|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2014-03-17|||October 2003||2003-10-01|March 2014|2014-03-01|February 2006|Actual|2006-02-01|October 2004|Actual|2004-10-01||Interventional|||Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors|A Phase I Dose Escalation and Pharmacokinetic Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors|Completed||Phase 1|24|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:11:03.860979|2017-10-11 05:11:03.860979
NCT00125840|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2014-02-04|||August 2002||2002-08-01|February 2014|2014-02-01|August 2007|Actual|2007-08-01|||||Interventional|||Clofarabine in Adult Patients With Advanced Solid Tumors|A Phase I and Pharmacokinetic Study of Clofarabine in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|||Sanofi|||||||||||||||||||2017-10-11 05:11:03.963418|2017-10-11 05:11:03.963418
NCT00125853|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2014-04-07|||July 2006||2006-07-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Nebivolol on Insulin Sensitivity|A Trial to Compare the Effects of Nebivolol Versus Atenolol on Various Cardiovascular Measurements Including Insulin Sensitivity|Completed||N/A|54|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 05:11:04.055078|2017-10-11 05:11:04.055078
NCT00125866|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2015-05-27|||September 2005||2005-09-01|April 2007|2007-04-01|January 2006|Actual|2006-01-01|||||Interventional|||The Effect of Cocoa Flavonoids on Blood Pressure|The Effect of Cocoa Polyphenols on Various Cardiovascular Measurements Including Blood Pressure|Completed||N/A|50||Imperial College London|||||f||||||||||||||2017-10-11 05:11:04.177963|2017-10-11 05:11:04.177963
NCT00125879|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2014-02-04|||June 2005||2005-06-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Interventional|||Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602|A Long-Term Continuation Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602|Completed||Phase 2/Phase 3|16|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:11:04.265914|2017-10-11 05:11:04.265914
NCT00125892|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2007-05-16|||July 2005||2005-07-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study of Duloxetine in the Treatment of Fibromyalgia|A 1-Year Safety Study of Duloxetine in Patients With Fibromyalgia Syndrome|Completed||Phase 3|320||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:11:04.443524|2017-10-11 05:11:04.443524
NCT00125905|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2009-09-29|||October 2003||2003-10-01|November 2003|2003-11-01|July 2006||2006-07-01|||||Interventional|||ISTAPS: A Stepped Primary Care Smoking Cessation Intervention|Effectiveness of a Stepped Primary Care Smoking Cessation Intervention Based on an Evidence Based Clinical Practice Guideline (ISTAPS Project)|Unknown status|Active, not recruiting|N/A|3012||Jordi Gol i Gurina Foundation|||||f||||||||||||||2017-10-11 05:11:04.581491|2017-10-11 05:11:04.581491
NCT00125918|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2008-02-13|||August 2005||2005-08-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension|PHIRST-1: Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment in Patients With Pulmonary Arterial Hypertension|Completed||Phase 3|406|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-10-11 05:11:04.676133|2017-10-11 05:11:04.676133
NCT00125931|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2014-08-25|2012-10-22||September 2005||2005-09-01|August 2014|2014-08-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional||Inpatients with manic symptoms.|Effects of Pentazocine on Manic Symptoms|Inpatient Clinical Trial Examining the Effects of Pentazocine on Manic Symptoms|Completed||Phase 2|10|Actual|Mclean Hospital|Small number of participants in open-label trial.|1|||f||||f||||||||||2017-10-11 05:11:04.803366|2017-10-11 05:11:04.803366
NCT00125944|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2007-05-08|||July 2005||2005-07-01|May 2007|2007-05-01|January 2006||2006-01-01|||||Interventional|||Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|Completed||Phase 3|300||MedImmune LLC|||||||||||||||||||2017-10-11 05:11:05.069402|2017-10-11 05:11:05.069402
NCT00125957|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2014-08-05|2014-06-11||August 2005||2005-08-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|January 2010|Actual|2010-01-01||Interventional|||The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression|The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression|Completed||Phase 3|32|Actual|Mclean Hospital||2|||f||||f||||||||||2017-10-11 05:11:05.305427|2017-10-11 05:11:05.305427
NCT00125970|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-11-07||2010-01-30|September 2005||2005-09-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|February 2008|Actual|2008-02-01||Interventional|||Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults|A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed By a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRC-HIVADV014-00-VP, in HIV-1 Uninfected Adult Participants|Completed||Phase 2|480|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:11:05.718832|2017-10-11 05:11:05.718832
NCT00125983|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2012-05-17||||||May 2012|2012-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women|A Phase II Pharmacokinetic Study of the Transdermal Contraceptive System and Oral Contraceptive in HIV-1 Infected Women on Lopinavir/Ritonavir|Completed||Phase 2|32|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:11:05.853042|2017-10-11 05:11:05.853042
NCT00125996|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2005-08-16|||July 2004||2004-07-01|January 2005|2005-01-01|February 2006||2006-02-01|||||Interventional|||Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure|A Randomised Controlled Study to Assess the Acute and Chronic Effects of Intravenous Iron Supplementation in Anaemic and Non-Anaemic Iron Deficient Patients With Chronic Heart Failure|Unknown status|Recruiting|Phase 1/Phase 2|42||National Heart and Lung Institute|||||f||||||||||||||2017-10-11 05:11:05.965714|2017-10-11 05:11:05.965714
NCT00126009|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-18|2008-04-08|||May 2004||2004-05-01|April 2008|2008-04-01||||||||Interventional|||SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients|A 3-Month, Open, Randomised Trial Comparing the Efficacy and Safety of the Association Valproate-Amisulpride to the Association Valproate-Haloperidol in Bipolar I Patients Suffering From a Manic Episode|Completed||Phase 2|120||Sanofi|||||f||||||||||||||2017-10-11 05:11:06.065132|2017-10-11 05:11:06.065132
NCT00126022|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2015-01-15|||December 2004||2004-12-01|March 2006|2006-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus Rhythm in Female Subjects With Recent Onset Atrial Fibrillation|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:11:06.155324|2017-10-11 05:11:06.155324
NCT00126035|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2005-08-16|||February 2004||2004-02-01|July 2005|2005-07-01|December 2004||2004-12-01|||||Interventional|||Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura|Open, Randomised, Multi-Centre, Cross-Over Study to Investigate the Efficacy of the Migraid Device Compared With No Device Treatment in the Acute, Early Treatment of Migraine With Typical Aura|Completed||N/A|134||Profess Medical Consultancy|||||f||||||||||||||2017-10-11 05:11:07.902391|2017-10-11 05:11:07.902391
NCT00126048|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2010-03-17|||July 2005||2005-07-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma|Randomised Controlled Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma|Completed||Phase 2/Phase 3|54|Actual|University of Glasgow||2|||f||||t||||||||||2017-10-11 05:11:07.978095|2017-10-11 05:11:07.978095
NCT00126607|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2013-02-27|||July 2005||2005-07-01|February 2013|2013-02-01||||May 2007|Actual|2007-05-01||Interventional|||Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer|Phase II Study of Trastuzumab (NSC-688097) in Advanced High Grade Salivary Gland Carcinoma|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Poor accrual.|f||||||||||||||2017-10-11 05:11:19.43382|2017-10-11 05:11:19.43382
NCT00126061|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2015-01-15|||October 2004||2004-10-01|March 2006|2006-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus Rhythm in Male Subjects With Recent Onset Atrial Fibrillation or Flutter|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:11:08.090865|2017-10-11 05:11:08.090865
NCT00126074|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2015-01-15|||October 2004||2004-10-01|March 2006|2006-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus Rhythm in Female Subjects With Recent Onset Atrial Fibrillation or Flutter|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:11:08.207756|2017-10-11 05:11:08.207756
NCT00126087|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-31|2013-01-18|||July 2005||2005-07-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2007|Actual|2007-12-01||Interventional|||Potentiation of Procedural Motor Learning in Health and Disease|Potentiation of Procedural Motor Learning by Pharmacological Neuromodulation and Transcranial Direct Current Stimulation in Health and Disease|Terminated||Phase 4|18|Actual|University Hospital Muenster||||no further funding available for recruiting and testing participants|f||||||||||||||2017-10-11 05:11:08.375905|2017-10-11 05:11:08.375905
NCT00126100|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2007-11-23|||February 2004||2004-02-01|November 2007|2007-11-01|July 2005|Actual|2005-07-01|||||Interventional|||Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)|A Randomized Clinical Trial of Stem Cell Mobilization by Granulocyte-Colony-Stimulating Factor in Patients With Acute Myocardial Infarction. Regenerate Vital Myocardium by Vigorous Activation of Bone Marrow Stem Cells (REVIVAL-2) Trial|Completed||Phase 4|114|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:11:08.505438|2017-10-11 05:11:08.505438
NCT00126113|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2014-10-06|2014-09-26||August 2005||2005-08-01|October 2014|2014-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|PPT||The Performance-Perceptual Test as a Counseling Tool|The Performance-Perceptual Test as a Counseling Tool|Completed||N/A|74|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:11:08.649598|2017-10-11 05:11:08.649598
NCT00126126|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2015-09-21|2014-11-24||January 2005||2005-01-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|EBAR||Evidence Based Amputee Rehabilitation (EBAR) Program|Evidence Based Amputee Rehabilitation (EBAR) Program|Completed||N/A|20|Actual|VA Office of Research and Development|Recruitment was challenging. We screened over 350 veterans and non-veterans with lower limb loss and we were only able to enroll 20.|2|||f||||t||||||||||2017-10-11 05:11:09.359716|2017-10-11 05:11:09.359716
NCT00126139|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2007-05-01|||April 2004||2004-04-01|May 2007|2007-05-01|May 2005|Actual|2005-05-01|||||Interventional|||Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis|Abciximab Versus Aspirin for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic >50% Carotid Stenosis: A Pilot Study (ASTERICS)|Terminated||Phase 3|100||University of Zurich||||Higher hemorrhage rates of Abciximab in ABESST II trial|f||||t||||||||||2017-10-11 05:11:09.790588|2017-10-11 05:11:09.790588
NCT00126152|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-29|2005-07-29|||September 2003||2003-09-01|July 2005|2005-07-01|May 2005||2005-05-01|||||Interventional|||Senior Falls Prevention Study|Targeted Injury Prevention Program: Preventing Falls Among Older Adults|Completed||N/A|453||Washington State, Department of Health|||||f||||||||||||||2017-10-11 05:11:09.927161|2017-10-11 05:11:09.927161
NCT00126165|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2012-01-18|||September 2004||2004-09-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|||||Interventional|||Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer|A Phase I/II Study of Escalated-dose Short-course Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer|Completed||Phase 1/Phase 2|72|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:11:10.022116|2017-10-11 05:11:10.022116
NCT00126178|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2012-09-06|||May 2005||2005-05-01|September 2012|2012-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer|A Multi-Center, Randomized, Phase 3 Study of Adjuvant Oncophage® Versus Observation in Patients With High Risk After Surgical Treatment for Renal Cell Carcinoma|Terminated||Phase 3|600||Agenus Inc.|||||||||||||||||||2017-10-11 05:11:10.109402|2017-10-11 05:11:10.109402
NCT00126191|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2013-04-17|2012-11-30||July 2005||2005-07-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional|||Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma|Phase II Study of Intensive Chemotherapy and Rituximab in Burkitt Lymphoma|Terminated||Phase 2|10|Actual|Dana-Farber Cancer Institute|Early termination leading to small numbers of subjects analyzed.|2||closed due to slow accrual|f||||t||||||||||2017-10-11 05:11:10.215751|2017-10-11 05:11:10.215751
NCT00126204|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2010-03-03|||March 2004||2004-03-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Adjunctive Treatment With Doxycycline to Enhance the Durability of Endovascular Aortic Aneurysm Repair|Adjunctive Treatment With Doxycycline in Endovascular Aneurysm Repair|Completed||N/A|75||Barnes-Jewish Hospital|||||f||||||||||||||2017-10-11 05:11:10.716786|2017-10-11 05:11:10.716786
NCT00126217|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2008-10-20|||July 2002||2002-07-01|October 2008|2008-10-01|September 2006|Actual|2006-09-01|May 2006|Actual|2006-05-01||Interventional|||Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine|BCG Vaccination and Childhood Morbidity and Mortality: Interventions With Possible Implications for the Immunisation Policy in Developing Countries. Revaccination of Young Children With BCG Vaccine.|Terminated||Phase 4|2871|Actual|Bandim Health Project||2||A cluster of deaths in the BCG-arm compared with controls|f||||||||||||||2017-10-11 05:11:10.800513|2017-10-11 05:11:10.800513
NCT00126230|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2006-09-07|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Interventional|||Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer|A Prospective Phase II Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer Who Achieve a Response or a Stabilization to Docetaxel-Estramustine|Terminated||Phase 2|55||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:11:10.908999|2017-10-11 05:11:10.908999
NCT00120094|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2006-04-10|||June 2002||2002-06-01|July 2005|2005-07-01|June 2005||2005-06-01|||||Observational|||International Study on Syncope of Uncertain Etiology|ISSUE 2. The Management of Patients With Suspected or Certain Neurally-Mediated Syncope After the Initial Evaluation|Terminated||Phase 4|400||Arcispedale Santa Maria Nuova-IRCCS|||||f||||||||||||||2017-10-11 05:11:24.319492|2017-10-11 05:11:24.319492
NCT00126243|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2005-08-16|||January 1999||1999-01-01|August 2005|2005-08-01|October 2003||2003-10-01|||||Interventional|||Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin’s Lymphoma|Multicenter, Open Label, Phase II Trial to Evaluate the Efficacy and Safety of Treatment With Rituximab + CHOP Regimen in Patients With HIV Related Non-Hodgkin’s Lymphomas. ANRS 085 Rituximab|Terminated||Phase 2|60||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:11:10.981905|2017-10-11 05:11:10.981905
NCT00126256|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2015-08-11|||February 2002||2002-02-01|August 2015|2015-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer|Randomized Trial of Treatment Strategy for Chemotherapy in Colorectal Cancer, FFCD 2000-05|Completed||Phase 3|570|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:11:11.060112|2017-10-11 05:11:11.060112
NCT00126269|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2006-09-07|||May 2003||2003-05-01|September 2006|2006-09-01||||||||Interventional|||Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary|A Randomized Phase III Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary and a Predicted Favorable Prognosis|Unknown status|Recruiting|Phase 3|192||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:11:11.15879|2017-10-11 05:11:11.15879
NCT00126282|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2009-07-27|||December 2003||2003-12-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Interventional|||A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder|A Randomized, Double-blind, Placebo-controlled Medication Trial With D-Cycloserine for Individuals With Obsessive-compulsive Disorder Currently Receiving Behavior Therapy|Completed||N/A|50|Anticipated|Massachusetts General Hospital|||||f||||t||||||||||2017-10-11 05:11:11.37913|2017-10-11 05:11:11.37913
NCT00126295|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2005-08-18|||June 2003||2003-06-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||Evaluation of an Individualised Written Education Package for Stroke Patients|Evaluation of a Computer-Generated Individualised Written Education Package for Patients Following Stroke and Their Carers|Completed||Phase 2|130||Medical Benefits Fund of Australia|||||f||||||||||||||2017-10-11 05:11:11.459901|2017-10-11 05:11:11.459901
NCT00126308|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2009-03-31|||November 2005||2005-11-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy|A Multi-Centre, Open-Label, Randomised Study to Assess the Efficacy, Durability and Safety of Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy (FLASH)|Terminated||Phase 4|100|Actual|Kirby Institute||2||no change in primary endpoint at week 48|f||||f||||||||||2017-10-11 05:11:11.548026|2017-10-11 05:11:11.548026
NCT00126321|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2010-02-01|||November 2004||2004-11-01|February 2010|2010-02-01|March 2011|Anticipated|2011-03-01|November 2010|Anticipated|2010-11-01||Interventional|||Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)|Phase II Study of Cladribine, High-dose Cytarabine and Idarubicin in Patients With Relapsed Acute Myeloid Leukemia|Unknown status|Recruiting|Phase 2|50|Anticipated|University Hospital, Bonn||1|||f||||f||||||||||2017-10-11 05:11:11.697451|2017-10-11 05:11:11.697451
NCT00126334|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2011-07-20|||April 2003||2003-04-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|CRIT||Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot||Completed||Phase 4|45|Actual|Medstar Health Research Institute||2|||f||||t||||||||||2017-10-11 05:11:11.793135|2017-10-11 05:11:11.793135
NCT00126347|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2005-08-17|||August 2002||2002-08-01|August 2005|2005-08-01|July 2003||2003-07-01|||||Interventional|||Effect of Betaine, Serine and Folic Acid on Vascular Function in Healthy Volunteers|Effect of Lowering of Plasma Homocysteine Concentrations After an Oral Methionine Load on Vascular Function in Healthy Volunteers|Completed||N/A|40||Wageningen Centre for Food Sciences|||||f||||||||||||||2017-10-11 05:11:11.893475|2017-10-11 05:11:11.893475
NCT00126360|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2005-11-07|||August 2005||2005-08-01|August 2005|2005-08-01|May 2016||2016-05-01|||||Interventional|||STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)|Pilot for a Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Ant-Oestrogen Therapy Delayed Until After Radiotherapy|Unknown status|Recruiting|Phase 4|100||St George Hospital, Australia|||||f||||||||||||||2017-10-11 05:11:11.98512|2017-10-11 05:11:11.98512
NCT00126373|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2012-01-19|||May 2005||2005-05-01|January 2012|2012-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Trial of Wellbutrin for Crohn's Disease|A Randomized Controlled Trial of Wellbutrin for Crohn's Disease|Completed||Phase 2/Phase 3|1|Actual|Altschuler, Eric, M.D.||2|||f||||||||||||||2017-10-11 05:11:12.093473|2017-10-11 05:11:12.093473
NCT00126386|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2011-11-18|||January 2004||2004-01-01|August 2011|2011-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community|Zoledronic Acid (Zometa) for the Management of Tumor-induced Hypercalcemia (TIH) and Malignant Bone Pain (MBP) in the Community: A Feasibility Study|Completed||N/A|11|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 05:11:12.203262|2017-10-11 05:11:12.203262
NCT00126399|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2005-08-18|||June 2004||2004-06-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea||Completed||Phase 3|528||CollaGenex Pharmaceuticals|||||||||||||||||||2017-10-11 05:11:12.286608|2017-10-11 05:11:12.286608
NCT00126412|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2007-05-15|||July 2005||2005-07-01|May 2007|2007-05-01||||||||Interventional|||Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma||Completed||Phase 3|185||GE Healthcare|||||||||||||||||||2017-10-11 05:11:12.350095|2017-10-11 05:11:12.350095
NCT00126425|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2016-10-19|2015-06-30||July 2005||2005-07-01|October 2016|2016-10-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional||All participants who received IMP manufactured by the sponsor.|Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease|An Open-Label, Multicenter, Phase 3 Study Evaluating the Prognostic Usefulness of I-123 mIBG Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event|Completed||Phase 3|587|Actual|GE Healthcare||1|||f||||t||||||||||2017-10-11 05:11:12.426161|2017-10-11 05:11:12.426161
NCT00120107|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2017-03-10|||July 2003||2003-07-01|March 2017|2017-03-01|April 2005|Actual|2005-04-01|||||Interventional|||Tea's Effect on Atherosclerosis Pilot Study (TEA Study)|Tea's Effect on Atherosclerosis Pilot Study (TEA Study)|Completed||N/A|30||Beth Israel Deaconess Medical Center||2|||f||||f|f|f||||||Undecided||2017-10-11 05:11:24.400719|2017-10-11 05:11:24.400719
NCT00126438|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-03-24|2015-06-30||July 2005||2005-07-01|March 2017|2017-03-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional||All participants who received IMP manufactured by the sponsor.|Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease|An Open-Label, Multicenter, Phase 3 Study Evaluating the Prognostic Usefulness of I-123 mIBG Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event|Completed||Phase 3|515|Actual|GE Healthcare||1|||f||||t||||||||||2017-10-11 05:11:12.683074|2017-10-11 05:11:12.683074
NCT00126451|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2017-04-06|||December 1, 2004|Actual|2004-12-01|April 2017|2017-04-01|October 11, 2005|Actual|2005-10-11|October 11, 2005|Actual|2005-10-11||Interventional|||A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)|A Phase II Clinical Study of Oral Suberoylanilide Hydroxamic Acid in Patients With Relapsed or Refractory Breast, Colorectal, and Non-small Cell Lung Cancer.|Terminated||Phase 2|16|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:11:12.968213|2017-10-11 05:11:12.968213
NCT00126464|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2013-11-05|||November 2004||2004-11-01|July 2006|2006-07-01||||||||Interventional|||Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast|A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant (Faslodex) in Breast Ductal Carcinoma (DCIS)|Unknown status|Active, not recruiting|N/A|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:11:13.041233|2017-10-11 05:11:13.041233
NCT00126477|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2013-04-29|||March 1996||1996-03-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|April 2007|Actual|2007-04-01||Observational|||Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer|The Quality of Life of Adult Survivors Who Received a Marrow Transplant as a Child|Completed||Phase 2|750|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:11:13.126063|2017-10-11 05:11:13.126063
NCT00126490|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2015-06-03|2013-05-29||March 2005||2005-03-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|June 2012|Actual|2012-06-01||Interventional||18 of the 19 who started treatment were evaluable. One participant had to withdraw after only one infusion because they fell and broke both wrists.|Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|Phase 2 Trial of Sequential Bevacizumab Then Subcutaneous Interleukin-2 in Metastatic Renal Cancer|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)|"Investigators planned to have 38 participants treated on this study. 0 had to be entered for Other (not including Serious) Adverse Events, because they were not tabulated for treatment 3/30/05 through 1/24/07."|1|||f||||||||||||||2017-10-11 05:11:13.206062|2017-10-11 05:11:13.206062
NCT00126503|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2015-01-06|2012-11-16||May 2005||2005-05-01|September 2014|2014-09-01|February 2012|Actual|2012-02-01|October 2011|Actual|2011-10-01||Interventional|||Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer|A Phase I/II Trial of BAY 43-9006 in Combination With Bevacizumab in Patients With Advanced Renal Cancer|Completed||Phase 1/Phase 2|73|Actual|National Cancer Institute (NCI)|To depict results of this Phases I/II study accurately, each phase was entered as an ARM to enable separation of the data by phase. Events reported in the Adverse Event and Serious Adverse Event sections include AEs and SAEs from Phase I and Phase II|1|||f||||||||||||||2017-10-11 05:11:13.532398|2017-10-11 05:11:13.532398
NCT00126516|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2013-10-28|||May 2004||2004-05-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline|Effects of Angiotensin II Receptor Blockers (ARB) and Angiotensin Converting Enzyme Inhibitors (ACEI) on Progression of Silent Brain Infarction and Cognitive Decline in Japanese Patients With Essential Hypertension in the Elderly|Completed||Phase 4|395|Actual|Nara Medical University||2|||f||||t||||||||||2017-10-11 05:11:14.689441|2017-10-11 05:11:14.689441
NCT00126542|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2014-05-13|||April 2005||2005-04-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|January 2007|Actual|2007-01-01||Interventional|||Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer|A Phase II Trial of Bevacizumab (NSC# 704865) and OSI-774 (NSC# 718781) In Recurrent Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:11:14.782424|2017-10-11 05:11:14.782424
NCT00126555|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2014-12-16|2014-12-16||March 2005||2005-03-01|September 2014|2014-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Of the 23 participants enrolled, one participant who was not evaulable for response withdrew before beginning treatment.|Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer|A Phase II Study of ZD1839 and Radiation in Patients With Squamous Cell Carcinoma of the Skin|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 05:11:14.906108|2017-10-11 05:11:14.906108
NCT00126568|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2014-05-07|2012-05-23||June 2005||2005-06-01|December 2012|2012-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer|Phase II Trial of BAY 43-9006 in Patients With Advanced Anaplastic Carcinoma of the Thyroid|Terminated||Phase 2|20|Actual|National Cancer Institute (NCI)|The study met the pre-specified criteria for enrollment of all planned 32 patients. However due to poor accrual the study was halted.|1|||f||||||||||||||2017-10-11 05:11:15.743701|2017-10-11 05:11:15.743701
NCT00126581|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2017-09-04|2013-10-07||August 15, 2005|Actual|2005-08-15|August 2017|2017-08-01||||June 30, 2010|Actual|2010-06-30||Interventional|||Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer|A Phase II Randomized Study of OSI-774 (Erlotinib) (NSC #718781) With or Without Carboplatin/Paclitaxel in Patients With Previously Untreated Adenocarcinoma of the Lung Who Never Smoked or Were Former Light Smokers|Active, not recruiting||Phase 2|188|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-10-11 05:11:16.309845|2017-10-11 05:11:16.309845
NCT00126594|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2016-07-28|2016-02-09||June 2005||2005-06-01|July 2016|2016-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer|A Phase II Clinical Trial to Evaluate the Efficacy of BAY 43-9006 With or Without Low Dose Interferon in Metastatic Renal Cell Carcinoma|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:11:18.231062|2017-10-11 05:11:18.231062
NCT00126620|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2015-07-22|||September 2005||2005-09-01|July 2015|2015-07-01||||May 2011|Actual|2011-05-01||Interventional|||Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib; Tarceva) in Advanced Solid Tumors|Completed||Phase 1|17|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:11:19.529197|2017-10-11 05:11:19.529197
NCT00126633|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2012-09-13|||April 2004||2004-04-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|September 2006|Actual|2006-09-01||Interventional|||Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer|A Study of Fixed-Dose Rate Gemcitabine, Cisplatin, and Bevacizumab in Previously Untreated Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|53|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 05:11:19.644645|2017-10-11 05:11:19.644645
NCT00126646|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2010-06-17|||June 2005||2005-06-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma|Phase I Study of BL22, A Recombinant Immunotoxin for Chronic Lymphocytic Leukemia and CD22+ Lymphomas|Completed||Phase 1|24|Anticipated|MedImmune LLC||4|||f||||f||||||||||2017-10-11 05:11:19.733723|2017-10-11 05:11:19.733723
NCT00126659|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2014-04-21|2012-09-28||January 2006||2006-01-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer|A Phase II Neoadjuvant Clinical Trial to Evaluate the Efficacy of BAY 43-9006 (Sorafenib) in Metastatic Renal Cell Carcinoma|Terminated||Phase 2|10|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 05:11:19.818134|2017-10-11 05:11:19.818134
NCT00126672|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2010-02-01|||June 2005||2005-06-01|October 2008|2008-10-01||||April 2010|Anticipated|2010-04-01||Interventional|||Sirolimus in Treating Patients With Angiomyolipoma of the Kidney|A Phase II Multi-Center Study of Rapamycin for Treating Kidney Angiomyolipomas in TSC or LAM Patients|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:11:20.193461|2017-10-11 05:11:20.193461
NCT00126685|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2013-09-16|||April 2005||2005-04-01|June 2007|2007-06-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With Unselected Autologous Amplified Tumor-RNA|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:11:20.286673|2017-10-11 05:11:20.286673
NCT00126698|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2007-04-18|||January 2005||2005-01-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Prophylactic Antibiotics on Urethral Catheter Withdrawal|Use of Antibiotic Prophylaxis on Urethral Catheter Withdrawal: A Randomized Double-Blind Placebo-Controlled Trial|Completed||Phase 4|100||St. Antonius Hospital|||||f||||||||||||||2017-10-11 05:11:20.356542|2017-10-11 05:11:20.356542
NCT00126724|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2009-07-27|||August 2005||2005-08-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|||Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects|A Phase I/II Study of Repeat Intra-articular Administration of tgAAC94, a Recombinant Adeno-Associated Vector Containing the TNFR:Fc Fusion Gene, in Inflammatory Arthritis Subjects With and Without Concurrent TNF-alpha Antagonists|Completed||Phase 1/Phase 2|120|Anticipated|Targeted Genetics Corporation||4|||f||||t||||||||||2017-10-11 05:11:20.433301|2017-10-11 05:11:20.433301
NCT00126737|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2014-12-30|2014-12-02||October 2002||2002-10-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee|Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee|Completed||N/A|110|Actual|VA Office of Research and Development|Due to the small number of females, the results may not be generalizable to females. Limitations include requirement of having good upper body strength, shoulder range, hand eye coordination, and an investment of purchasing poles of $30 per pair.|4|||f||||f||||||||||2017-10-11 05:11:20.752703|2017-10-11 05:11:20.752703
NCT00126750|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2015-06-24|2015-01-27||September 2003||2003-09-01|June 2015|2015-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|VA MI Plus||Web-Enhanced Guideline Implementation for Post MI CBOC Patients|MI-Plus: Web-enhanced Guideline Implementation for Post MI CBOC Patients|Completed||N/A|847|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:11:21.623382|2017-10-11 05:11:21.623382
NCT00126763|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2012-06-04|||July 2005||2005-07-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain|An Open-Label, Long-Term Safety Study to Evaluate the Safety of the ZR-02-01 Matrix Transdermal Fentanyl Patch for the Treatment of Moderate to Severe Non-Malignant Chronic Pain|Terminated||Phase 3|105|Actual|ZARS Pharma Inc.||1||PK results suggested product did not meet requirement for further development.|f||||f||||||||||2017-10-11 05:11:21.951973|2017-10-11 05:11:21.951973
NCT00119821|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2015-11-30|||September 2004||2004-09-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Strategies to Reduce Weight Gain in Hypertensive Smokers|Weight Gain Prevention in Hypertensive Smokers|Completed||N/A|459|Actual|University of Tennessee||3|||f||||t||||||||||2017-10-11 05:11:22.038846|2017-10-11 05:11:22.038846
NCT00119834|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2017-06-16|||June 2005||2005-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)|Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)|Recruiting||N/A|22000|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t|f|f||||Samples With DNA|"     DNA sample collection was an optional portion of the project during the first contract period     (2005-2010). Tissue and Blood specimens were collected at the time of implant, explant or     exchange of the mechanical circulatory assist device. Intermacs no longer collects blood or     tissue specimens.   "|Yes|Individual participant data (IPD) is not available. De-identified datasets may be available upon approval.|2017-10-11 05:11:22.116885|2017-10-11 05:11:22.116885
NCT00119847|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2006-02-22|||September 2002||2002-09-01|February 2006|2006-02-01||||||||Interventional|||Balloon Catheters and Stents to Prevent Heart Rhythm Irregularities in Individuals Post-Heart Attack|Electrophysiologic Effects of Late PCI (OAT-EP)|Unknown status|Active, not recruiting|N/A|300||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:11:22.198121|2017-10-11 05:11:22.198121
NCT00119873|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2015-03-03||||||March 2015|2015-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults|A Phase I Dose-Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade, Multivalent Recombinant Adenoviral Vector HIV Vaccine, VRC-HIVADV014-00-VP, in Healthy, HIV-1 Uninfected Adult Participants Who Have Low Titers of Pre-Existing Ad5 Neutralizing Antibodies|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:11:22.30256|2017-10-11 05:11:22.30256
NCT00119886|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2007-04-18|||April 2005||2005-04-01|April 2007|2007-04-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Botox on Vulvar Vestibulitis||Unknown status|Recruiting|Phase 4|64||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:11:22.392847|2017-10-11 05:11:22.392847
NCT00119899|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2005-08-30|||March 2002||2002-03-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases|Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases|Completed||Phase 3|150||Radboud University|||||f||||||||||||||2017-10-11 05:11:22.507814|2017-10-11 05:11:22.507814
NCT00119912|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2017-09-13|||January 1999||1999-01-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||NORCCAP: Norwegian Colorectal Cancer Prevention Trial|Norwegian Colorectal Cancer Prevention Trial|Active, not recruiting||N/A|100000|Actual|Norwegian Department of Health and Social Affairs||3|||f||||t||||||||||2017-10-11 05:11:22.593587|2017-10-11 05:11:22.593587
NCT00119925|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2008-10-28|||October 2005||2005-10-01|October 2008|2008-10-01|May 2009|Anticipated|2009-05-01|February 2009|Anticipated|2009-02-01||Interventional|||"'SPRING'-Study: Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"|Cost Effectiveness of Two Different Strategies to Implement the NVOG Guideline Programme on Subfertility|Unknown status|Recruiting|N/A|5200|Anticipated|Radboud University||2|||f||||||||||||||2017-10-11 05:11:22.704722|2017-10-11 05:11:22.704722
NCT00119938|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2008-08-19|||September 2004||2004-09-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||An Online System to Improve Diabetes Self-Care|D-STAR (Diabetes-System To Access Records): An Online Patient Portal to Improve and Sustain Diabetes Self-Care|Completed||N/A|331|Actual|Robert Wood Johnson Foundation||2|||f||||f||||||||||2017-10-11 05:11:22.872762|2017-10-11 05:11:22.872762
NCT00119951|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2007-08-02|||September 2003||2003-09-01|August 2007|2007-08-01|August 2006||2006-08-01|||||Observational|||Health eCommunities - The Impact of Listservs on Cancer Patients|Health eCommunities - The Impact of Listservs on Cancer Patients|Completed||N/A|3360||Robert Wood Johnson Foundation|||||f||||||||||||||2017-10-11 05:11:23.118648|2017-10-11 05:11:23.118648
NCT00119964|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2011-07-25|||September 2004||2004-09-01|July 2011|2011-07-01|August 2007|Actual|2007-08-01|||||Interventional|||The Healthy Lifestyle Study|Weight Management for a Defined Employee Population Using an Interactive eHealth Portal|Completed||Phase 1|500|Anticipated|Robert Wood Johnson Foundation|||||f||||||||||||||2017-10-11 05:11:23.200557|2017-10-11 05:11:23.200557
NCT00119977|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2008-01-31|||October 2003||2003-10-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Periacetabular Osteotomy.A Prospective Study With Reference to Cartilage, Migration and Bone Density|Periacetabular Osteotomy. A Prospective Study With Reference to Cartilage, Migration and Bone Density|Completed||N/A|35|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:11:23.282385|2017-10-11 05:11:23.282385
NCT00119990|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2008-12-05|||January 2006||2006-01-01|December 2008|2008-12-01|January 2010|Anticipated|2010-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis|Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis; the Effect of Different Dialysates|Terminated||N/A|15|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:11:23.379215|2017-10-11 05:11:23.379215
NCT00120003|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2011-06-30|||June 2005||2005-06-01|September 2006|2006-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Scandinavian Candesartan Acute Stroke Trial (SCAST)|Scandinavian Candesartan Acute Stroke Trial|Completed||Phase 3|2500|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 05:11:23.445468|2017-10-11 05:11:23.445468
NCT00120016|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2012-12-19|||January 2004||2004-01-01|November 2008|2008-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Design and Feasibility of a Mediterranean Diet|Design and Feasibility of a Mediterranean Diet|Completed||N/A|80|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 05:11:23.54202|2017-10-11 05:11:23.54202
NCT00120029|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2008-09-04|||January 2004||2004-01-01|June 2008|2008-06-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Peer Counseling for Weight Loss|Peer Counseling for Weight Loss in African American Breast Cancer Survivors|Unknown status|Recruiting|N/A|100|Anticipated|Wayne State University|||||f||||||||||||||2017-10-11 05:11:23.626659|2017-10-11 05:11:23.626659
NCT00120042|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-05|2009-06-29|2009-04-01||February 2005||2005-02-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption|Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption|Completed||N/A|251|Actual|The University of Western Australia|Planned interim analysis not performed as mifepristone became available in Australia. Study ceased at 251 women and enough power available to calculate the groups as a single stage analysis.|3|||f||||f||||||||||2017-10-11 05:11:23.70826|2017-10-11 05:11:23.70826
NCT00120055|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2014-12-02|||February 2005||2005-02-01|December 2014|2014-12-01|April 2005||2005-04-01|||||Interventional|||Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity||Completed||Phase 4|||University of Oslo School of Pharmacy|||||f||||||||||||||2017-10-11 05:11:23.999043|2017-10-11 05:11:23.999043
NCT00120068|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2015-04-06|||November 2004||2004-11-01|February 2007|2007-02-01|July 2005|Actual|2005-07-01|March 2005|Actual|2005-03-01||Interventional|||Improving Care for Nursing Home Pneumonia in NHCUs and Veterans' Homes|Improving Care for Nursing Home Pneumonia in NHCUs and Veterans' Homes|Completed||Phase 2|100|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:11:24.063782|2017-10-11 05:11:24.063782
NCT00120081|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2017-05-30|||April 2005||2005-04-01|May 2017|2017-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection|Phase 1, Single-Center, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study to Compare the Safety, Tolerability, and Immunogenicity of Three Intramuscular Administrations of Na-ASP-2 Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection|Completed||Phase 1|36|Actual|Baylor College of Medicine||4|||f||||t||||||||||2017-10-11 05:11:24.207023|2017-10-11 05:11:24.207023
NCT00120120|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2009-09-22|||January 2005||2005-01-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy|A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy|Completed||Phase 2/Phase 3|181|Actual|Celgene||2|||f||||t||||||||||2017-10-11 05:11:24.479945|2017-10-11 05:11:24.479945
NCT00120133|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2008-05-19|||December 2004||2004-12-01|July 2005|2005-07-01|December 2007|Actual|2007-12-01|||||Interventional|||Atorvastatin (Lipitor) to Prevent Bone Pain|Use of Atorvastatin (Lipitor) to Prevent Bone Pain Following Infusion of Pamidronate or Zoledronic Acid|Completed||N/A|12|Actual|Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:11:24.606369|2017-10-11 05:11:24.606369
NCT00120159|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-01-14|||December 2003||2003-12-01|January 2006|2006-01-01||||||||Observational|||Necrotizing Enterocolitis (NEC) Surgical Database|GPRN Neonatal Surgical Database: Necrotizing Enterocolitis (NEC) Protocol|Unknown status|Active, not recruiting|N/A|300|Anticipated|Boston Children’s Hospital|||||f||||||||||||||2017-10-11 05:11:24.681427|2017-10-11 05:11:24.681427
NCT00120172|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2007-11-15|||May 2005||2005-05-01|November 2007|2007-11-01|June 2006|Actual|2006-06-01|||||Interventional|||Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer|A Phase II Study of Oxaliplatin, Capecitabine, and Bevacizumab in the Treatment of Elderly Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|40|Anticipated|Geriatric Oncology Consortium||||positive results from a larger study with same regimen was released.|f||||||||||||||2017-10-11 05:11:24.742668|2017-10-11 05:11:24.742668
NCT00120185|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2011-12-21|||December 2003||2003-12-01|December 2011|2011-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)|Study of the Immunological Efficacy of Using Subcutaneous Interleukin-2 (IL-2) in Antiretroviral Naïve HIV-1-Infected Subjects With a CD4 Cell Count Above 300/mm3. ANRS 119 Trial INTERSTART|Completed||Phase 2|130||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-10-11 05:11:24.835076|2017-10-11 05:11:24.835076
NCT00120198|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2007-11-15|||March 2005||2005-03-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients|A Pilot Study of Cyclophosphamide/Pegylated Liposomal Doxorubicin/Vincristine/Prednisone (CDOP) Plus Rituximab for Treatment of Elderly Patients With Previously Untreated Non-Hodgkin's Lymphoma|Terminated||Phase 2|50|Anticipated|Geriatric Oncology Consortium||||slow accrual|f||||||||||||||2017-10-11 05:11:24.917718|2017-10-11 05:11:24.917718
NCT00120211|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2011-10-12|||September 1998||1998-09-01|October 2011|2011-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer|Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer|Completed||Phase 3|855|Actual|International Atomic Energy Agency||2|||f||||||||||||||2017-10-11 05:11:25.002697|2017-10-11 05:11:25.002697
NCT00120224|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-04-25|||May 2005||2005-05-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Observational|||De-Medicalizing Mifepristone Medical Abortion|De-Medicalizing Mifepristone Medical Abortion|Completed||N/A|4410||Gynuity Health Projects|||||f||||||||||||||2017-10-11 05:11:25.080664|2017-10-11 05:11:25.080664
NCT00120237|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2009-03-17|||July 2005||2005-07-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan|A Placebo-Controlled Randomized Trial of Misoprostol in the Management of the Third Stage of Labor in the Home Delivery Setting in Rural Pakistan|Completed||N/A|1600|Actual|Gynuity Health Projects||1|||f||||t||||||||||2017-10-11 05:11:25.16079|2017-10-11 05:11:25.16079
NCT00120250|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2016-03-24|2013-07-19||June 2005||2005-06-01|March 2016|2016-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional||Baseline data are unavailable for the 3 participants that did not complete the study, and therefore, the baseline data will only reflect the information of the 24 completed participants, instead of the 27 that began baseline.|Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder|Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder|Completed||Phase 4|27|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:11:25.286126|2017-10-11 05:11:25.286126
NCT00120263|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2006-05-08|||September 1998||1998-09-01|July 2005|2005-07-01|April 2004||2004-04-01|||||Interventional|||Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma|A Randomized Controlled Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma|Completed||N/A|92||London Health Sciences Centre|||||f||||||||||||||2017-10-11 05:11:25.54571|2017-10-11 05:11:25.54571
NCT00120276|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2009-05-05|||June 2004||2004-06-01|May 2008|2008-05-01||||||||Interventional|||RESTOR-MV: Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve|Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve (RESTOR-MV)|Completed||Phase 2|250|Anticipated|Myocor|||||f||||t||||||||||2017-10-11 05:11:25.62664|2017-10-11 05:11:25.62664
NCT00120289|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-06|2016-03-08|2015-06-01||September 2005||2005-09-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional||Intention-to-treat|Niacin Plus Statin to Prevent Vascular Events|AIM HIGH: Niacin Plus Statin to Prevent Vascular Events|Terminated||Phase 3|3414|Actual|Axio Research. LLC||2||"AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in   preventing primary outcome events."|f||||t||||||||||2017-10-11 05:11:25.805789|2017-10-11 05:11:25.805789
NCT00120302|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2008-01-15|||March 2005||2005-03-01|January 2008|2008-01-01|January 2006|Actual|2006-01-01|||||Interventional|||Quality of Life Study in Adults With Facial Eczema|Quality of Life Study in Adults With Facial Eczema|Completed||Phase 4|76|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:11:30.70717|2017-10-11 05:11:30.70717
NCT00120315|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2009-10-05|||December 2003||2003-12-01|October 2009|2009-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Proton Pump Inhibitor Treatment Stop|Proton Pump Inhibitor Treatment Stop: Discontinuation of Acid-suppressive Medication Among Long-term Users in a Primary Health Care Setting|Completed||Phase 4|171|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 05:11:30.813778|2017-10-11 05:11:30.813778
NCT00120523|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2016-04-26|2012-11-09|2011-08-23|April 2004||2004-04-01|April 2016|2016-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis|Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age With Mild to Moderate Atopic Dermatitis|Completed||Phase 3|2418|Actual|MEDA Pharma GmbH & Co. KG||2|||f||||f||||||||No||2017-10-11 05:11:33.35246|2017-10-11 05:11:33.35246
NCT00120328|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-10-04|||July 2005||2005-07-01|October 2007|2007-10-01|February 2007|Actual|2007-02-01|||||Interventional|||To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy|ASCEND - A Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Assess the Effect of the Endothelin Receptor Antagonist Avosentan on Time to Doubling of Serum Creatinine, End Stage Renal Disease or Death in Patients With Type 2 Diabetes Mellitus and Diabetic Nephropathy|Terminated||Phase 3|2364||Speedel Pharma Ltd.|||||||||t||||||||||2017-10-11 05:11:30.910495|2017-10-11 05:11:30.910495
NCT00120341|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-05-30|||April 2005||2005-04-01|May 2007|2007-05-01|June 2006||2006-06-01|||||Interventional|||Anodyne Therapy in Diabetic Sensory Neuropathy|A Randomized, Double Blind, Placebo Controlled Prospective Study to Evaluate the Effectiveness of Monochromatic Infrared Photo Energy to Improve Diabetic Sensory Neuropathy|Completed||Phase 4|60||Scott and White Hospital & Clinic|||||f||||||||||||||2017-10-11 05:11:31.003437|2017-10-11 05:11:31.003437
NCT00120354|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-15|2017-06-30|||July 11, 2005||2005-07-11|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Interventional|||Long-Term Lamivudine Therapy for Chronic Hepatitis B|Long-Term Lamivudine Therapy for Chronic Hepatitis B|Completed||Phase 4|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:11:31.070855|2017-10-11 05:11:31.070855
NCT00120367|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2011-12-21|||April 2005||2005-04-01|December 2011|2011-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)|Early Intensification of Combination Antiretroviral Therapy Including FUZEON® in the Treatment of Progressive Multifocal Leucoencephalopathy During HIV-1 Infection ANRS 125 Trial|Completed||Phase 2|30||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:11:31.158914|2017-10-11 05:11:31.158914
NCT00120380|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2012-08-20|||September 2004||2004-09-01|January 2006|2006-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)|Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension|Terminated||Phase 4|40|Actual|Hannover Medical School||2||Futility analysis|f||||||||||||||2017-10-11 05:11:31.243074|2017-10-11 05:11:31.243074
NCT00120393|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2010-02-03||2010-02-03|January 2004||2004-01-01|July 2009|2009-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir|A Phase IIIB, Open-label, Randomized, Multi-center Study Evaluating the Effect on Serum Lipids Following a Switch to ATV/r in HIV-1 Infected Subjects Who Have Achieved Virologic Suppression on a LPV/r Based Regimen.|Completed||Phase 3|192|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 05:11:31.331736|2017-10-11 05:11:31.331736
NCT00120406|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2014-07-21|2014-02-05|2011-04-25|March 2005||2005-03-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|October 2009|Actual|2009-10-01||Interventional|Zilver PTX||Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery|Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery|Completed||N/A|474|Actual|Cook Group Incorporated||2|||f||||t||||||||||2017-10-11 05:11:31.663308|2017-10-11 05:11:31.663308
NCT00120419|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2009-07-21|||April 2005||2005-04-01|January 2006|2006-01-01||||||||Interventional|||Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)||Unknown status|Recruiting|Phase 4|90|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||||f||||t||||||||||2017-10-11 05:11:32.38966|2017-10-11 05:11:32.38966
NCT00120432|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2012-03-07|||December 2004||2004-12-01|March 2012|2012-03-01|June 2005|Actual|2005-06-01|||||Interventional|||Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation|Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation|Completed||Phase 3|80|Actual|Khon Kaen University||1|||f||||t||||||||||2017-10-11 05:11:32.558923|2017-10-11 05:11:32.558923
NCT00120445|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2012-03-07|||July 2004||2004-07-01|March 2012|2012-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Comparison of Air and Expansile Gas in Pneumatic Retinopexy|Comparison of Air and Expansile Gas in Pneumatic Retinopexy|Completed||Phase 3|126|Actual|Khon Kaen University||1|||f||||t||||||||||2017-10-11 05:11:32.675237|2017-10-11 05:11:32.675237
NCT00120458|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2010-03-01|||July 2005||2005-07-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety|Black Cohosh Therapy for Menopause-Related Anxiety|Completed||Phase 4|50|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-10-11 05:11:32.772211|2017-10-11 05:11:32.772211
NCT00120471|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2013-09-12|||November 2006||2006-11-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies|A Phase I Open Label Trial of the Safety and Pharmacokinetics of Tenofovir Disoproxil Fumarate in HIV-1 Infected Pregnant Women and Their Infants|Completed||Phase 1|122|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 05:11:32.868142|2017-10-11 05:11:32.868142
NCT00120484|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2010-01-12|||April 2005||2005-04-01|January 2010|2010-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Vitamin B12 on the Body's Internal Clock|Effect of Vitamin B12 on the Human Circadian Pacemaker|Completed||N/A|10|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-10-11 05:11:32.98646|2017-10-11 05:11:32.98646
NCT00120497|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-13|2011-07-19|||July 2005||2005-07-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|July 2011|Anticipated|2011-07-01||Observational|||Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight|Growth Hormone and Insulin Resistance in Children With Intrauterine Growth Restriction|Unknown status|Recruiting|Phase 4|12|Anticipated|Massachusetts General Hospital|||1||f||||t||||||Samples Without DNA|"     Blood   "|||2017-10-11 05:11:33.057606|2017-10-11 05:11:33.057606
NCT00120510|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2014-10-13|||July 2007||2007-07-01|October 2014|2014-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti|A Randomized Clinical Trial to Determine the Efficacy of Early Versus Standard Antiretroviral Therapy in HIV Infected Adults With CD4+ T Cell Counts Between 200 and 350 Cells/mm3|Completed||N/A|816|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 05:11:33.16895|2017-10-11 05:11:33.16895
NCT00120536|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2017-05-16|||June 2005||2005-06-01|May 2017|2017-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|288|Actual|Novartis|||||f||||||||||||||2017-10-11 05:11:37.555228|2017-10-11 05:11:37.555228
NCT00120549|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2005-07-15|||August 2001||2001-08-01|July 2005|2005-07-01|March 2005||2005-03-01|||||Interventional|||Study of Assisted Hatching of Cleavage Stage Embryos|Prospective Randomized Trial of Assisted Hatching of Cleavage Stage Embryos|Completed||N/A|200||Shady Grove Fertility Reproductive Science Center|||||f||||||||||||||2017-10-11 05:11:37.632801|2017-10-11 05:11:37.632801
NCT00120562|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2009-08-27|||July 2007||2007-07-01|August 2009|2009-08-01||||||||Observational|||Studies of Biological Changes Related to Weight Loss After Gastric Bypass Surgery|A Gene Expression and Metabolic Profile of Weight Loss: Studies of Patients Following Gastric Bypass Surgery|Terminated||Phase 2|13|Anticipated|Rockefeller University|||1||f||||||||||||||2017-10-11 05:11:37.694274|2017-10-11 05:11:37.694274
NCT00120575|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2006-12-01|||January 2005||2005-01-01|December 2006|2006-12-01|September 2008||2008-09-01|||||Interventional|||Hemofiltration for Respiratory Failure After Bone Marrow Transplantation|Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2/Phase 3|112||Stanford University|||||f||||||||||||||2017-10-11 05:11:37.762379|2017-10-11 05:11:37.762379
NCT00120588|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2013-06-17|||July 1997||1997-07-01|June 2013|2013-06-01|July 2005|Actual|2005-07-01|||||Interventional|||Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth|Effect of Magnesium Sulfate on the Incidence of Periventricular Leukomalacia in the Very Preterm Neonate|Completed||Phase 4|700||University Hospital, Rouen|||||f||||f||||||||||2017-10-11 05:11:37.893491|2017-10-11 05:11:37.893491
NCT00120601|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2005-07-15|||March 2003||2003-03-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Trial for the Treatment of Alcohol Dependence|The Role of Pharmacotherapy in Prevention of Relapse in Alcohol Dependence|Unknown status|Active, not recruiting|Phase 4|200||University of Sydney|||||f||||||||||||||2017-10-11 05:11:37.986675|2017-10-11 05:11:37.986675
NCT00120614|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2009-04-07|||September 2001||2001-09-01|April 2009|2009-04-01|June 2007||2007-06-01|||||Interventional|||Educational/Behavioral Intervention Program for Parents of Premature Infants|Improving Outcomes of LBW Premature Infants and Parents|Completed||N/A|260||University of Rochester|||||f||||||||||||||2017-10-11 05:11:38.071963|2017-10-11 05:11:38.071963
NCT00120627|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2015-04-06|2014-09-23||November 2005||2005-11-01|August 2014|2014-08-01|September 2010|Actual|2010-09-01|February 2009|Actual|2009-02-01||Interventional|||Mantram Repetition to Manage PTSD in Veterans|Efficacy of Mantram Repetition on PTSD Symptoms in Veterans|Completed||N/A|146|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:11:38.223224|2017-10-11 05:11:38.223224
NCT00120640|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2012-09-18|||July 2005||2005-07-01|September 2012|2012-09-01||||||||Interventional|||Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate||Withdrawn||N/A|0|Actual|Yale University||||funding|f||||||||||||||2017-10-11 05:11:39.196808|2017-10-11 05:11:39.196808
NCT00120653|ClinicalTrials.gov processed this data on October 10, 2017|2006-06-19|2017-06-30|||July 14, 2005||2005-07-14|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Interventional|||Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)|Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:11:39.314885|2017-10-11 05:11:39.314885
NCT00120666|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-16|2017-06-30|||July 8, 2005||2005-07-08|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Observational|||Interhemispheric Plasticity in Humans|Interhemispheric Plasticity in Humans|Completed||N/A|108||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:11:39.421985|2017-10-11 05:11:39.421985
NCT00120679|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-20|||October 2002||2002-10-01|December 2007|2007-12-01|December 2003||2003-12-01|||||Interventional|||Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy|An Open-Label, Randomized Phase 2 Study to Validate a Patient Satisfaction Questionnaire for Anemia Treatment in Patient With Non-Small Cell Lung Cancer Treated With Darbepoetin Alfa or Recombinant Human Erythropoietin for Anemia Due to Chemotherapy|Completed||Phase 2|||Amgen|||||f||||||||||||||2017-10-11 05:11:39.510208|2017-10-11 05:11:39.510208
NCT00120692|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-20|||October 2002||2002-10-01|December 2007|2007-12-01|December 2003||2003-12-01|||||Interventional|||Treatment for Patients Suffering From Anemia Due to Chemotherapy|An Open-Label, Randomized Phase 2 Study to Validate a Patient Satisfaction Questionnaire for Anemia Treatment in Female Breast Cancer Patients Treated With Darbepoetin Alfa or Recombinant Human Erythropoietin for Anemia Due to Chemotherapy|Completed||Phase 2|||Amgen|||||f||||||||||||||2017-10-11 05:11:39.613372|2017-10-11 05:11:39.613372
NCT00120705|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2009-03-24|||November 2002||2002-11-01|March 2009|2009-03-01|September 2003||2003-09-01|||||Interventional|||Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy|A Randomized, Open-Label, Pilot Study to Evaluate Every Three Week Maintenance Dosing of Darbepoetin Alfa Therapy in Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy|Completed||Phase 2|204||Amgen|||||f||||||||||||||2017-10-11 05:11:39.708574|2017-10-11 05:11:39.708574
NCT00120718|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2008-09-26|||June 2002||2002-06-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||The Effect of Fasudil on Vascular Function in Humans|The Effect of Fasudil on Vascular Function in Humans|Completed||Phase 2|60|Anticipated|Brigham and Women's Hospital|||||f||||t||||||||||2017-10-11 05:11:39.795068|2017-10-11 05:11:39.795068
NCT00120731|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2007-06-14|||July 2005||2005-07-01|July 2005|2005-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Effects of Potassium Citrate in Urine of Children With Elevated Calcium in Urine and Kidney Stones|Urinary Chemistry and Acid-Base Effects of Potassium Citrate in Children With Idiopathic Hypercalciuria and Urolithiasis|Completed||N/A|23|Actual|Children's Mercy Hospital Kansas City|||||f||||f||||||||||2017-10-11 05:11:39.863762|2017-10-11 05:11:39.863762
NCT00120744|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2013-12-10|||January 2004||2004-01-01|December 2013|2013-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department|Randomized Trial of the Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Acute Gastroenteritis in a Pediatric Emergency Department|Completed||N/A|||The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:11:39.93883|2017-10-11 05:11:39.93883
NCT00120757|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2011-12-21|||October 2004||2004-10-01|December 2011|2011-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)|Efficacy of Alendronate Versus Placebo in the Treatment of HIV-1 Associated Osteoporosis, a Multicenter, Randomized, Controlled Trial. ANRS 120 Fosivir|Completed||Phase 3|140||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-10-11 05:11:40.028043|2017-10-11 05:11:40.028043
NCT00200408|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-07|||March 2004||2004-03-01|April 2015|2015-04-01||||January 2005|Actual|2005-01-01||Observational|||Assessment of Early Genetic Changes in Smokers|Assessment of Early Genetic Changes in Smokers|Terminated||N/A|10|Actual|Montefiore Medical Center|||2|unable to obtain funding|f||||||||||||||2017-10-11 05:32:19.354545|2017-10-11 05:32:19.354545
NCT00120770|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2007-02-27|||November 2004||2004-11-01|February 2007|2007-02-01|March 2007||2007-03-01|||||Interventional|||Cellulose Sulfate (CS) Gel and HIV in Nigeria|Randomized Controlled Trial of Cellulose Sulfate Gel and HIV in Nigeria|Terminated||Phase 3|2160||FHI 360||||The study was halted in January 2007 due to safety concerns.|||||||||||||||2017-10-11 05:11:40.123543|2017-10-11 05:11:40.123543
NCT00120783|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2007-01-17|||February 2002||2002-02-01|January 2007|2007-01-01|August 2003||2003-08-01|||||Interventional|||Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance|Efficacy and Tolerability of an Antiretroviral bi-Therapy in HIV-1 Infected Patients With Multidrug Resistant HIV ANRS 109 Vista Trial.|Terminated||Phase 2|40||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:11:40.230609|2017-10-11 05:11:40.230609
NCT00120796|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2016-07-20|||August 2005||2005-08-01|March 2008|2008-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)|Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection|Terminated||Phase 3|8|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2||poor patient recrutment|f||||t||||||||||2017-10-11 05:11:40.325203|2017-10-11 05:11:40.325203
NCT00120809|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2017-01-11|||July 2002||2002-07-01|January 2017|2017-01-01|September 2004||2004-09-01|||||Interventional|||Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae|A Randomised, Placebo Controlled Trial of Intermittent Preventative Treatment With Sulfadoxine-pyrimethamine in Gambian Multigravidae.|Completed||Phase 3|3000||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:11:40.453468|2017-10-11 05:11:40.453468
NCT00120822|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2017-01-11|||July 2002||2002-07-01|January 2017|2017-01-01|January 2004||2004-01-01|||||Interventional|||Folic Acid Supplementation in Gambian Primigravidae|A Study of the Effect of Folic Acid Supplementation on the Anti-malarial Action of Sulfadoxine-pyrimethamine When Used for Intermittent Preventive Treatment in Gambian Primigravidae.|Completed||Phase 3|1000||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:11:40.551693|2017-10-11 05:11:40.551693
NCT00120835|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2010-06-09|||July 2004||2004-07-01|June 2010|2010-06-01||||||||Interventional|||Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C|An Open-Label, Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and the Antiviral Activity of NM283 When Administered Alone and in Combination With Pegylated Interferon Alfa 2b to Treatment-Naive Adults With Genotype-1 Chronic Hepatitis C|Completed||Phase 1/Phase 2|||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:11:40.63739|2017-10-11 05:11:40.63739
NCT00120848|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2016-11-02|||November 2003||2003-11-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults|Study of the Efficacy of Candidate HPV 16/18 VLP Vaccine in the Prevention of HPV-16 and/or HPV-18 Cervical Infection in Adolescent & Young Adult Women in North America and Brazil Vaccinated in Primary Study 580299/001|Completed||Phase 2|776|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:11:40.739092|2017-10-11 05:11:40.739092
NCT00120861|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2010-06-09|||January 2005||2005-01-01|June 2010|2010-06-01||||||||Interventional|||Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy|A Randomized, Phase IIb Clinical Trial to Evaluate the Safety and Antiviral Activity of NM283 and the Combination of Pegylated Interferon Plus NM283, in Patients With Chronic Hepatitis C Who Have Previously Failed to Respond to Standard Therapy|Completed||Phase 2|||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:11:40.893244|2017-10-11 05:11:40.893244
NCT00120874|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2016-09-15|2016-04-28||August 2006||2006-08-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training|Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial|Completed||Phase 4|20|Actual|New York University School of Medicine|The original statistician who worked on this study left the institution prior to completing data analysis. A new statistician has been engaged. In the unlikely event that outcome measures data changes, it will be updated accordingly in this record.|2|||f||||t||||||||||2017-10-11 05:11:41.01531|2017-10-11 05:11:41.01531
NCT00120887|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2007-04-04|||April 2002||2002-04-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Lupus Atherosclerosis Prevention Study|Lupus Atherosclerosis Prevention Study|Completed||Phase 4|200||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:11:41.968034|2017-10-11 05:11:41.968034
NCT00120913|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2005-07-18||||||July 2005|2005-07-01|August 2004||2004-08-01|||||Interventional|||Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?||Completed||N/A|160||Oregon Health and Science University|||||f||||||||||||||2017-10-11 05:11:42.237737|2017-10-11 05:11:42.237737
NCT00120926|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2006-09-27|||August 2005||2005-08-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Dose Comparison of Amino Acids on Growth in Premature Neonates|Randomized Control Trial Evaluating the Effect of Two Different Doses of Amino Acids on Growth and Serum Amino Acids in Premature Neonates Admitted to the NICU|Completed||Phase 3|150||Mednax Center for Research, Education and Quality|||||f||||||||||||||2017-10-11 05:11:42.316444|2017-10-11 05:11:42.316444
NCT00120939|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2009-04-02||||||May 2007|2007-05-01||||||||Interventional|||Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer|Phase I Trial of Motexafin Gadolinium (MGd) and Docetaxel Chemotherapy in the Treatment of Advanced Solid Tumors|Completed||Phase 1|25||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 05:11:42.393425|2017-10-11 05:11:42.393425
NCT00120952|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-12|2006-08-04|||January 2003||2003-01-01|August 2006|2006-08-01|October 2009||2009-10-01|||||Interventional|||A Comparison Between Titanium Femoral Stem and Cobalt-Chromium Femoral Stem in Cemented Hip Arthroplasty|A Comparison Between Titanium Femoral Stem and Cobalt-Chromium Femoral Stem in Cemented Hip Arthroplasty. A Randomized Prospective Roentgen Stereogrammetric Analysis.|Unknown status|Active, not recruiting|N/A|40||University of Aarhus|||||f||||||||||||||2017-10-11 05:11:42.476665|2017-10-11 05:11:42.476665
NCT00120965|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2011-01-26|||June 2004||2004-06-01|January 2011|2011-01-01|March 2005|Actual|2005-03-01|||||Interventional|||AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)|AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)|Terminated||Phase 3|1837|Actual|University of Washington||2||"DSMB recommended termination due to lower survival to discharge in primary population and worse   discharge CPC scores in the treatment arm than control arm."|f||||t||||||||||2017-10-11 05:11:42.561807|2017-10-11 05:11:42.561807
NCT00120978|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2006-05-08|||December 2004||2004-12-01|April 2005|2005-04-01|August 2006||2006-08-01|||||Interventional|||Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial|Advair - CRP Study|Unknown status|Recruiting|Phase 4|250||University of British Columbia|||||f||||||||||||||2017-10-11 05:11:42.676595|2017-10-11 05:11:42.676595
NCT00120991|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-08|2008-02-29|||April 2002||2002-04-01|February 2008|2008-02-01|July 2008|Anticipated|2008-07-01|March 2006|Actual|2006-03-01||Interventional|||Best Bypass Surgery (BBS) Trial|Off-Pump Coronary Artery Bypass Grafting Versus Conventional Coronary Artery Bypass Grafting on Postoperative Mortality and Morbidity, A Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 3|341|Actual|Rigshospitalet, Denmark||1|||f||||||||||||||2017-10-11 05:11:42.85457|2017-10-11 05:11:42.85457
NCT00121004|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2013-09-04|||July 2005||2005-07-01|September 2013|2013-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||A Study to Tailor Advance Directives|A Study to Tailor Advance Directives|Completed||N/A|100||University of Chicago|||1||f||||f||||||||||2017-10-11 05:11:42.962108|2017-10-11 05:11:42.962108
NCT00121017|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-14|2006-07-26||||||July 2006|2006-07-01||||||||Interventional|||A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects|A Randomized, Open-Label Study Assessing Safety, Tolerability and Efficacy of an Induction-Maintenance Treatment Strategy Including Lopinavir/Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine Versus Efavirenz Plus Tenofovir Disoproxil Fumarate and Emtricitabine in Antiviral-naïve HIV-1/HCV Co-Infected Subjects|Withdrawn||Phase 2|200||Abbott|||||||||||||||||||2017-10-11 05:11:43.069137|2017-10-11 05:11:43.069137
NCT00121030|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-12-20|||October 2002||2002-10-01|December 2007|2007-12-01|December 2003||2003-12-01|||||Interventional|||Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy|An Open-Label, Randomized Phase 2 Study to Validate a Patient Satisfaction Questionnaire for Anemia Treatment in Patients With Gynecological Malignancies Treated With Darbepoetin Alfa or Recombinant Human Erythropoietin for Anemia Due to Chemotherapy|Completed||Phase 2|||Amgen|||||f||||||||||||||2017-10-11 05:11:43.17876|2017-10-11 05:11:43.17876
NCT00126776|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2009-07-14|2009-07-14||July 2004||2004-07-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Veterans Integrated Service Network (VISN) 23 Lung Disease Self Management/Case Management Program|VISN 23 Lung Disease Self Management/Case Management Program|Completed||N/A|743|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:11:43.306426|2017-10-11 05:11:43.306426
NCT00126789|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2012-06-04|||August 2005||2005-08-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain|An Open-Label, Long-Term Safety Study to Evaluate the Safety of the ZR-02-01 Matrix Transdermal Fentanyl Patch for the Treatment of Moderate to Severe Cancer Pain|Terminated||Phase 3|24|Actual|ZARS Pharma Inc.||1||Based on PK data, product did not meet requirement for further development.|f||||f||||||||||2017-10-11 05:11:43.748011|2017-10-11 05:11:43.748011
NCT00126802|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2016-07-04|||April 2005||2005-04-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer|The Role of Tomotherapy (Dynamic IMRT and Megavoltage CT Scanning) in Hypofractionated/Dose Escalated Conformal Radiation Treatment Using Magnetic Resonance Spectroscopy (MRS) Scans to Predict and Document the Pattern of Local Failure for High Risk Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|60|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 05:11:43.831638|2017-10-11 05:11:43.831638
NCT00126815|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2016-02-23|||February 2004||2004-02-01|December 2011|2011-12-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Observational|||Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy|Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy|Completed||N/A|1000|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-10-11 05:11:43.900315|2017-10-11 05:11:43.900315
NCT00126828|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2016-02-23|||January 2003||2003-01-01|October 2011|2011-10-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer|A Phase I/II Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer|Completed||Phase 1/Phase 2|18||AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:11:43.987229|2017-10-11 05:11:43.987229
NCT00126841|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2011-12-08|||November 2004||2004-11-01|December 2011|2011-12-01|November 2005||2005-11-01|||||Observational|||Computed Tomotherapy (CT) and Magnetic Resonance Imaging (MRI) Fusion on Radiation Treatment Planning for Patients With Cancer of the Cervix|To Assess the Feasibility and Impact of Computed Tomotherapy (CT) and Magnetic Resonance Imaging (MRI) Fusion on Radiation Treatment Planning for Ten Patients With Cancer of the Cervix|Completed||N/A|10||AHS Cancer Control Alberta|||1||f||||||||||||||2017-10-11 05:11:44.072808|2017-10-11 05:11:44.072808
NCT00126854|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2016-02-24|||October 2005||2005-10-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation|High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation|Completed||N/A|10|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 05:11:44.142793|2017-10-11 05:11:44.142793
NCT00127244|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2010-11-30|||June 2000||2000-06-01|November 2010|2010-11-01|October 2004||2004-10-01|||||Interventional|||Study Comparing Two Different Methods of Treating Periodontal Disease|Outcomes of Traditional and Medical Models of Periodontal Therapy|Completed||Phase 2|400||The Forsyth Institute|||||f||||||||||||||2017-10-11 05:11:50.91018|2017-10-11 05:11:50.91018
NCT00126867|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-01-12|||May 2005||2005-05-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment|Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Based Adjuvant Chemotherapy in Colon Cancer Treatment|Recruiting||N/A|104|Anticipated|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 05:11:44.214811|2017-10-11 05:11:44.214811
NCT00126880|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2011-06-22|||July 2005||2005-07-01|June 2011|2011-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV|A Phase II, Randomised, Double-blind, Dose-ranging Study of AVX754 Versus Lamivudine in Treatment-experienced HIV-1 Infected Patients With the M184V Mutation in Reverse Transcriptase|Completed||Phase 2|52|Actual|Avexa||3|||f||||t||||||||||2017-10-11 05:11:44.290422|2017-10-11 05:11:44.290422
NCT00126893|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2007-05-14|||October 2005||2005-10-01|December 2006|2006-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia|Phase 1 Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia|Terminated||Phase 1|36||Celgene|||||||||||||||||||2017-10-11 05:11:44.381839|2017-10-11 05:11:44.381839
NCT00126906|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2005-08-22|||October 2002||2002-10-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi|Intermittent Preventive Treatment With Sulfadoxine/Pyrimethamine During Pregnancy Among HIV-Positive and HIV-Negative Women: 2-Dose Versus Monthly – Malawi|Completed||N/A|700||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:11:44.441526|2017-10-11 05:11:44.441526
NCT00126919|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2012-02-08|||October 2004||2004-10-01|February 2012|2012-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Reduction of Topical Anesthetic Time for Subcutaneous Port Access Using Ultrasound|Randomized Crossover Trial of Sonication Followed by 5 Minute LMX4 Application Compared With 30 Minute LMX4 Application for Topical Anesthesia Prior to Subcutaneous Port Access in Children|Completed||Phase 4|40|Anticipated|Connecticut Children's Medical Center|||||f||||||||||||||2017-10-11 05:11:44.523885|2017-10-11 05:11:44.523885
NCT00126932|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2007-12-20|||October 2004||2004-10-01|December 2007|2007-12-01|December 2004||2004-12-01|||||Interventional|||Reduction of Topical Anesthetic Onset Time Using Ultrasound|Reduction of Topical Anesthetic Onset Time Using Ultrasound: A Randomized Controlled Trial Prior to Venipuncture in Young Children|Completed||Phase 4|70||Connecticut Children's Medical Center|||||f||||||||||||||2017-10-11 05:11:44.581766|2017-10-11 05:11:44.581766
NCT00126945|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2016-09-20|||August 2005||2005-08-01|September 2016|2016-09-01|October 2005|Actual|2005-10-01|||||Interventional|||Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs|A Primary Vaccination Study to Assess the Immunogenicity, Safety & Reactogenicity of 1 Dose of 4 Different Formulations of GSK Biologicals' Meningococcal Conjugate Vaccine (MenACWY) vs 1 Dose of MENCEVAX™ ACWY in Healthy Subjects Aged 15-19 Years|Completed||Phase 2|125|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:11:44.645604|2017-10-11 05:11:44.645604
NCT00126958|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2009-02-18|||July 2002||2002-07-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Observational|||Cost-Effectiveness in Bladder Cancer|Cost-Effectiveness of Follow-up of Patients With Superficial Bladder Cancer|Unknown status|Active, not recruiting|Phase 4|500||Erasmus Medical Center|||||f||||||||||||||2017-10-11 05:11:44.71704|2017-10-11 05:11:44.71704
NCT00126971|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2006-08-14|||July 2005||2005-07-01|August 2006|2006-08-01||||||||Interventional|||Chlorproguanil-Dapsone in Pregnant Women|Pharmacokinetics of Chlorproguanil-Dapsone in Pregnant Women With Plasmodium Falciparum Infection, and Reinfection With P. Falciparum During Pregnancy Following Treatment|Suspended||Phase 1|132||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:11:44.78658|2017-10-11 05:11:44.78658
NCT00126984|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2016-10-06||2009-09-03|July 2005||2005-07-01|October 2016|2016-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine|A Phase II, Open (Partially Double-blind), Randomized, Controlled Dose-range Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Investigational Vaccination Regimens Versus MENINGITEC™ or MENCEVAX™ ACWY When Given as One Dose to Children Aged 12 to 14 Months and 3 to 5 Years Old|Completed||Phase 2|508|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:11:44.916762|2017-10-11 05:11:44.916762
NCT00126997|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2016-09-20|||May 2005||2005-05-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases|Blinded, Randomised Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-mumps-rubella-varicella Candidate Vaccine When Given to Healthy Children in Their Second Year of Life|Completed||Phase 4|1439|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:11:45.233676|2017-10-11 05:11:45.233676
NCT00127010|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2016-09-23|||November 2005||2005-11-01|September 2016|2016-09-01|June 2006|Actual|2006-06-01|||||Interventional|||Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases|Blinded, Randomized Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Measles-mumps-rubella-varicella Candidate Vaccine Given to Healthy Children During the Second Year of Life|Completed||Phase 3|||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:11:45.53037|2017-10-11 05:11:45.53037
NCT00127023|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2016-09-20|||May 2005||2005-05-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases|Blinded, Randomised, Controlled Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Combined Measles-mumps-rubella-varicella Candidate Vaccine Given to Healthy Children in Their Second Year of Life|Completed||Phase 3|944||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:11:45.720306|2017-10-11 05:11:45.720306
NCT00127036|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-02-20|2012-01-05||October 2003||2003-10-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)|A Multicenter Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)|Terminated||Phase 2|65|Actual|H. Lee Moffitt Cancer Center and Research Institute|Study was Terminated early, not Completed. Study Drug now on the market. Due to slow accrual, too few patients who had both clinical and microarray data to perform the proposed analysis. 65 of 92 patients consented were assigned to treatment arms.|2||drug now on market|f||||t||||||||||2017-10-11 05:11:45.990369|2017-10-11 05:11:45.990369
NCT00127049|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2006-09-07|||December 2004||2004-12-01|September 2006|2006-09-01||||||||Interventional|||Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors|A Prospective Multicenter Phase II Trial of Gemcitabine, Cisplatin, and Ifosfamide (GIP) in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors (NSGCT) and a Predicted Favorable Prognosis|Unknown status|Recruiting|Phase 2|37||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:11:46.419052|2017-10-11 05:11:46.419052
NCT00127062|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2015-03-25|||May 2003||2003-05-01|August 2005|2005-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Health Effects of Diesel Exhaust in Asthmatic Patients: A Real-world Study in a London Street|Health Effects of Diesel Exhaust in Asthmatic Patients: A Real-world Study in a London Street|Completed||Phase 3|60||Imperial College London|||2||f||||t||||||Samples Without DNA|"     Exhaled breath condensate   "|||2017-10-11 05:11:46.505966|2017-10-11 05:11:46.505966
NCT00127075|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2011-12-28|||June 2005||2005-06-01|December 2011|2011-12-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis|POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-10-11 05:11:46.591199|2017-10-11 05:11:46.591199
NCT00127088|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2006-09-07|||October 2004||2004-10-01|September 2006|2006-09-01||||||||Interventional|||Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients|A Prospective Phase II of Peri-Operative Docetaxel + Laparoscopic Radical Prostatectomy in Patients With Localized Gleason 7 pT2a-pT2b Adenocarcinoma and a Risk of Relapse After Radical Prostatectomy|Suspended||Phase 2|37||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:11:46.69759|2017-10-11 05:11:46.69759
NCT00127101|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2015-04-02|2009-07-06||September 2005||2005-09-01|April 2015|2015-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)|A Phase I Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (Vorinostat; Zolinza) in Combination With Bexarotene in Patients With Advanced Cutaneous T-Cell Lymphoma|Terminated||Phase 1|23|Actual|Merck Sharp & Dohme Corp.|Study was discontinued due to low enrollment|6||The study was stopped due to low enrollment.|f||||||||||||||2017-10-11 05:11:46.819648|2017-10-11 05:11:46.819648
NCT00127127|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2015-02-02|||June 2005||2005-06-01|February 2015|2015-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Solid Tumors (0683-029)(COMPLETED)|A Phase I Clinical Study of MK0683 in Patients With Solid Tumors.|Completed||Phase 1|21|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-10-11 05:11:48.601772|2017-10-11 05:11:48.601772
NCT00127140|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2015-09-25|||June 2005||2005-06-01|September 2015|2015-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030)|A Phase I Clinical Study of MK0683 in Patients With Malignant Lymphoma|Completed||Phase 1|10|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-10-11 05:11:48.674983|2017-10-11 05:11:48.674983
NCT00127153|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2015-01-28|||March 2005||2005-03-01|January 2015|2015-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)|A Comparative Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of V110 Formulated With Either All New Process Polysaccharides or All Current Process Polysaccharides|Completed||Phase 3|130||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:11:48.751435|2017-10-11 05:11:48.751435
NCT00127166|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-03-10|2009-06-16||December 2005||2005-12-01|March 2017|2017-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)|A Multicenter, Double-Blind, Randomized, Crossover Design Study to Evaluate the Effect of Montelukast Vs. Salmeterol on the Inhibition of Exercise-Induced Bronchoconstriction in Asthmatic Patients Aged 6-14 Years|Completed||Phase 3|154|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:11:48.821005|2017-10-11 05:11:48.821005
NCT00127179|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-04-05|||January 1, 2004|Actual|2004-01-01|April 2017|2017-04-01|July 25, 2005|Actual|2005-07-25|July 1, 2005|Actual|2005-07-01||Interventional|||A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)|MK0906 Phase III Double-Blind Comparative Study - Benign Prostate Hyperplasia|Completed||Phase 3|600|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:11:49.440359|2017-10-11 05:11:49.440359
NCT00127192|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2015-05-20|2009-08-18||July 2005||2005-07-01|May 2015|2015-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)|Sitagliptin (MK0431) Late Phase II Double-Blind Dose-Response Study - Type 2 Diabetes Mellitus|Completed||Phase 2|363|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-10-11 05:11:49.544763|2017-10-11 05:11:49.544763
NCT00127205|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-07-13|||July 2005||2005-07-01|July 2017|2017-07-01|May 2020|Anticipated|2020-05-01|September 2017|Anticipated|2017-09-01||Interventional|||S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.|Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer|Active, not recruiting||Phase 3|5400|Anticipated|Southwest Oncology Group||3|||f||||t||||||||||2017-10-11 05:11:50.361199|2017-10-11 05:11:50.361199
NCT00127218|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2015-10-12|2015-09-01||September 2003||2003-09-01|October 2015|2015-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|NIA-Plaque||High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly|HDL Increased Plaque Stabilization in the Elderly|Completed||Phase 3|145|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 05:11:50.503677|2017-10-11 05:11:50.503677
NCT00127257|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2010-01-12|||September 1999||1999-09-01|January 2010|2010-01-01|June 2006||2006-06-01|||||Interventional|||Biofeedback for Dyssynergic Constipation|Biofeedback for Fecal Incontinence and Constipation|Completed||N/A|117||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:11:51.015189|2017-10-11 05:11:51.015189
NCT00127270|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-01-23|||May 2005||2005-05-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder|Using Behavioral Therapy in Combination With Drug-Darifenacin for Symptoms of Overactive Bladder|Completed||Phase 4|395|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:11:51.152274|2017-10-11 05:11:51.152274
NCT00127283|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-01-11|||May 2005||2005-05-01|January 2017|2017-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|FAST||Recombinant Factor VIIa in Acute Intracerebral Haemorrhage|Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral Haemorrhage|Completed||Phase 3|829|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:11:51.510446|2017-10-11 05:11:51.510446
NCT00127296|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-01-05|||July 2005||2005-07-01|January 2017|2017-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe|Comparison of the Accuracy and Precision of NovoLog® Mix 70/30 FlexPen® to Vial and Syringe in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|60|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:11:51.944482|2017-10-11 05:11:51.944482
NCT00127309|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2005-08-23|||June 2005||2005-06-01|July 2005|2005-07-01|August 2005||2005-08-01|||||Interventional|||Effect of Glutathione on Blood Alcohol and Hangover Symptoms||Completed||N/A|100||Piyavate Hospital|||||f||||||||||||||2017-10-11 05:11:52.017971|2017-10-11 05:11:52.017971
NCT00127322|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2006-02-09|||January 2004||2004-01-01|February 2006|2006-02-01|January 2006||2006-01-01|||||Observational|||The Early High Risk Period for Patients With Heart Failure|The Early High Risk Period for Patients With Incident Heart Failure: A Population Based Study|Unknown status|Active, not recruiting|N/A|450||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:11:52.07955|2017-10-11 05:11:52.07955
NCT00127335|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2011-07-26|||August 2005||2005-08-01|July 2011|2011-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Is Myopathy Part of Statin Therapy (IMPOSTER-16)|Double Blind, Prospective Randomized, Crossover Study of Patients With Muscle Complaints on Statin Therapy|Terminated||Phase 4|60|Anticipated|Scripps Health||2||Lack of funding|f||||f||||||||||2017-10-11 05:11:52.152771|2017-10-11 05:11:52.152771
NCT00127348|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2007-04-02|||May 2004||2004-05-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness|Effect of CPAP on Arterial Hypertension and Cardiovascular Morbi-Mortality in Patients With Sleep Apnea and Without Daytime Sleepiness|Completed||Phase 4|700||Sociedad Española de Neumología y Cirugía Torácica|||||f||||||||||||||2017-10-11 05:11:52.249127|2017-10-11 05:11:52.249127
NCT00127361|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2005-08-22|||January 1998||1998-01-01|April 2005|2005-04-01|February 2003||2003-02-01|||||Interventional|||Study of Having a Female Friend as Labor Support|Evaluation of Continuous Support in Labor|Completed||N/A|600||Saint Peters University Hospital|||||f||||||||||||||2017-10-11 05:11:52.325695|2017-10-11 05:11:52.325695
NCT00127374|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2016-11-07|||January 2005||2005-01-01|November 2016|2016-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||Mood and Behavior Changes Among Overweight Adolescent Females|Mood and Behavior Changes Among Overweight Adolescent Females|Withdrawn||N/A|0|Actual|University of Kentucky||||withdrawn due to non-response. PI left university|f||||||||||||||2017-10-11 05:11:52.397657|2017-10-11 05:11:52.397657
NCT00127387|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2012-06-22|||May 2001||2001-05-01|June 2012|2012-06-01|November 2005|Actual|2005-11-01|September 2005|Actual|2005-09-01||Interventional|||Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia|A Prospective, Randomized Pilot Study of Enbrel VS Placebo in Patients Receiving Radiation Therapy to Combat Fatigue and Cachexia|Terminated||Phase 2/Phase 3|54|Anticipated|The University of Texas Health Science Center at San Antonio||||PI moved to Oregon|f||||||||||||||2017-10-11 05:11:52.46238|2017-10-11 05:11:52.46238
NCT00127400|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2013-09-04|||February 2002||2002-02-01|September 2013|2013-09-01|July 2006||2006-07-01|||||Interventional|||A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED|A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With Intermittent Explosive Disorder|Completed||Phase 2|72||University of Chicago|||||f||||||||||||||2017-10-11 05:11:52.548331|2017-10-11 05:11:52.548331
NCT00127413|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2015-03-23|2014-11-17||September 2004||2004-09-01|March 2015|2015-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)|Integrated Treatment for Chronic Pain and PTSD|Completed||N/A|42|Actual|VA Office of Research and Development|Failure to engage in treatment, failure to complete treatment in a timely manner due to missed treatment sessions, and difficulty with compliance with treatment session recommendations led to lower completion rates|4|||f||||f||||||||||2017-10-11 05:11:52.636948|2017-10-11 05:11:52.636948
NCT00127452|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2010-07-06|||April 2002||2002-04-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality|Alpha Omega Trial: A Randomised, Placebo Controlled, Double Blind Intervention Study of the Effect of Low Doses of Omega-3 Fatty Acids on Cardiovascular Diseases in Patients With a History of Myocardial Infarction|Completed||N/A|4837|Actual|Wageningen University||4|||f||||t||||||||||2017-10-11 05:11:53.126304|2017-10-11 05:11:53.126304
NCT00127465|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2008-12-10|||November 2001||2001-11-01|August 2005|2005-08-01|July 2003||2003-07-01|||||Interventional|||Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants|Investigating the Impact of Tailored Reports on Anxiety|Completed||Phase 1/Phase 2|400||University of Plymouth|||||f||||||||||||||2017-10-11 05:11:54.647694|2017-10-11 05:11:54.647694
NCT00203346|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-22|||June 2005||2005-06-01|January 2009|2009-01-01||||||||Observational|||Research Study Examining Nerve Block for Migraine|Greater Occipital Nerve (GON) Block for Migraine|Completed||N/A|30||Thomas Jefferson University|||||f||||||||||||||2017-10-11 05:32:53.780255|2017-10-11 05:32:53.780255
NCT00127491|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2017-02-24|||May 2004||2004-05-01|February 2017|2017-02-01|May 2010|Actual|2010-05-01|August 2007|Actual|2007-08-01||Interventional|||Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury|A RCT of Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury|Completed||N/A|63|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||No||2017-10-11 05:11:54.867544|2017-10-11 05:11:54.867544
NCT00127504|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2005-08-23|||July 2003||2003-07-01|August 2005|2005-08-01|May 2004||2004-05-01|||||Interventional|||Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness|Trial of Rifampin and Azithromycin for Treatment of Endosymbiotic Bacteria (Wolbachia) in Onchocerca Volvulus in Guatemala|Completed||Phase 2|80||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:11:54.970414|2017-10-11 05:11:54.970414
NCT00127517|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2011-06-06|||March 2005||2005-03-01|June 2011|2011-06-01|August 2006|Actual|2006-08-01|||||Interventional|||Palliative Care Study in Patients With Advanced Cancer|A Phase II Double Blind, Placebo Controlled, Randomized, > Multicenter Study With AVR118 Solution in Patients With Advanced > Malignancies Who Are Not Candidates for Curative Chemotherapy.|Terminated||Phase 2|||Advanced Viral Research Corp||||Company shifted focus|||||||||||||||2017-10-11 05:11:55.061416|2017-10-11 05:11:55.061416
NCT00127530|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2016-01-04|2011-04-12||May 2005||2005-05-01|January 2016|2016-01-01|September 2006|Actual|2006-09-01|June 2006|Actual|2006-06-01||Interventional||Safety Population = Placebo (72), Fampridine-SR (228) Intent to Treat (ITT) Population = Placebo (72), Fampridine-SR (224). Four (4) randomized patients discontinued from the study prior to completing any of the scheduled double-blind assessments and therefore were excluded from the ITT population, which consisted of 296 patients.|Study of Oral Fampridine-SR in Multiple Sclerosis|Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis|Completed||Phase 3|301|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-10-11 05:11:55.171952|2017-10-11 05:11:55.171952
NCT00127543|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2006-02-06|||August 2005||2005-08-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Kid Cards: Teaching Kids About Medicines|Kid Cards: Teaching Kids About Medicines|Unknown status|Active, not recruiting|N/A|50||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:11:55.782042|2017-10-11 05:11:55.782042
NCT00127556|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2008-05-06|||April 2005||2005-04-01|May 2008|2008-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Transfusion Medicine - Prevention of Bedside Errors|Cluster-Randomised Controlled Trial of a Simple Intervention to Prevent Bedside Checking Errors in Blood Transfusion|Completed||N/A|300||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 05:11:55.868018|2017-10-11 05:11:55.868018
NCT00127569|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2007-01-11|||May 2003||2003-05-01|January 2007|2007-01-01|January 2006||2006-01-01|||||Interventional|||Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy|Multicenter, Phase II Trial Assessing the Efficacy of Rituximab in HIV Infected Patients With Multicentric Castleman Disease Dependent on Chemotherapy (ANRS 117 Study, CastlemaB)|Terminated||Phase 2|25||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:11:56.034922|2017-10-11 05:11:56.034922
NCT00127582|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2005-08-24|||January 2003||2003-01-01|May 2005|2005-05-01||||||||Interventional|||RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy|Evaluation of Arrhythmic Risk in Myotonic Dystrophy Type I (DM 1)|Unknown status|Recruiting|Phase 3|537||Catholic University of the Sacred Heart|||||f||||||||||||||2017-10-11 05:11:56.119336|2017-10-11 05:11:56.119336
NCT00127595|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2005-08-23|||January 2002||2002-01-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract|A Phase II Monocentric Study of Oxaliplatin in Combination With Gemcitabine in Patients With Advanced/Metastatic Transitional Cell Carcinoma of the Urothelial Tract|Terminated||Phase 2|28||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:11:56.206693|2017-10-11 05:11:56.206693
NCT00127621|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2005-08-24|||April 2002||2002-04-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||Early Tracheotomy Versus Prolonged Endotracheal Intubation in Intensive Care Unit (ICU) Patients|Early Tracheotomy Versus Prolonged Endotracheal Intubation in Intensive Care Unit Patients|Terminated||Phase 3|468||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:11:56.365469|2017-10-11 05:11:56.365469
NCT00127634|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2008-08-06|||July 2005||2005-07-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes|A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus|Completed||Phase 3|385|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-10-11 05:11:56.439427|2017-10-11 05:11:56.439427
NCT00127647|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2017-03-17|||November 2004||2004-11-01|March 2017|2017-03-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)|MK0476 Phase III Double-Blind Comparative Study - Allergic Rhinitis|Completed||Phase 3|1375|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-10-11 05:11:56.662766|2017-10-11 05:11:56.662766
NCT00127660|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2017-08-30|2014-12-01||September 2005||2005-09-01|August 2017|2017-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effect of Nutrition Labeling on Fast Food Choices|Effect of Nutrition Labeling on Fast Food Choices|Completed||N/A|605|Actual|University of Minnesota - Clinical and Translational Science Institute|Meal choices were tested on just one occasion.|4|||f||||f||||||||||2017-10-11 05:11:56.768391|2017-10-11 05:11:56.768391
NCT00127686|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2007-11-30|||September 2005||2005-09-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep|Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents|Completed||Phase 1|105|Actual|Penn State University||3|||f||||||||||||||2017-10-11 05:11:57.416078|2017-10-11 05:11:57.416078
NCT00127699|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2007-11-30|||August 2005||2005-08-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care|Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care|Completed||Phase 1|400||Penn State University|||||f||||||||||||||2017-10-11 05:11:57.5128|2017-10-11 05:11:57.5128
NCT00127712|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2013-09-06|2010-03-02||September 2004||2004-09-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery|Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery|Completed||Phase 4|130|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 05:11:57.64395|2017-10-11 05:11:57.64395
NCT00127725|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2005-11-14|||August 2005||2005-08-01|August 2005|2005-08-01|August 2009||2009-08-01|||||Interventional|||Pulsed Electromagnetic Field (PEMF) Stimulation for Tibia Fractures|A Double Blind Randomised Controlled Trial of Pulsed Electromagnetic Field (PEMF) Stimulation in Acute Tibial Shaft Fractures|Unknown status|Recruiting|Phase 2|340||Sydney South West Area Health Service|||||f||||||||||||||2017-10-11 05:11:58.114996|2017-10-11 05:11:58.114996
NCT00127738|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2007-01-08|||January 2005||2005-01-01|February 2006|2006-02-01|December 2006||2006-12-01|||||Interventional|||Renal Atherosclerotic Revascularization Evaluation: RAVE Study||Completed||N/A|240||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:11:58.274792|2017-10-11 05:11:58.274792
NCT00127751|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2005-08-24|||May 2000||2000-05-01|August 2005|2005-08-01|May 2003||2003-05-01|||||Interventional|||Heart Disease on the Mend|A Cardiovascular Disease Multifactor Risk Reduction Program for Medically Underserved High-Risk Patients|Completed||Phase 2|150||Stanford University|||||f||||||||||||||2017-10-11 05:11:58.374113|2017-10-11 05:11:58.374113
NCT00127764|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2007-08-29|||January 2001||2001-01-01|August 2004|2004-08-01|April 2005||2005-04-01|||||Interventional|||European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus|European Randomised Placebo-Controlled Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus (Pempuls Trial)|Completed||Phase 2/Phase 3|60||University Medical Center Groningen|||||f||||||||||||||2017-10-11 05:11:58.462849|2017-10-11 05:11:58.462849
NCT00127777|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2005-08-24|||July 2002||2002-07-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)|Randomized, Multi-Center, Partially Placebo-Controlled Phase IV-Study to Compare Efficacy and Tolerability of 48-Week Combined Therapy With Peginterferon Alfa-2a, Ribavirin and Amantadine Sulphate Versus Placebo in Untreated Patients With Chronic Hepatitis C Virus-Genotype-1-Infection|Unknown status|Active, not recruiting|Phase 4|700||University Hospital, Saarland|||||f||||||||||||||2017-10-11 05:11:58.549358|2017-10-11 05:11:58.549358
NCT00127790|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2012-09-14|2012-06-12||June 2005||2005-06-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Treatment of Insomnia Secondary to Chronic Pain|CBT for Co-Morbid Insomnia and Chronic Pain: Sleep, Pain and Immune Function Outcomes|Completed||N/A|28|Actual|University of Rochester|The foremost limitation of this pilot study is its small sample size, particularly for a four-arm design. Accordingly, a cautious approach to the interpretation of the findings is warranted.|4|||f||||f||||||||||2017-10-11 05:11:58.646054|2017-10-11 05:11:58.646054
NCT00127803|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2012-09-07|2012-03-13||July 2005||2005-07-01|September 2012|2012-09-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers|A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study of the Safety, Tolerability and Immunogenicity of a Clostridium Difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Adult Volunteers (18-55 Years)|Completed||Phase 1|50|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 05:11:59.206539|2017-10-11 05:11:59.206539
NCT00127816|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2016-03-14|||April 2005||2005-04-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy|Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy|Completed||N/A|40|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 05:12:00.198892|2017-10-11 05:12:00.198892
NCT00127829|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2009-04-22|||July 2005||2005-07-01|April 2009|2009-04-01|January 2008|Actual|2008-01-01|||||Interventional|AGUS||Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic|A Phase I, Open-Label, Dose Escalation Study Evaluating High-Dose Gefitinib (IRESSA®) on Weekly and Twice Weekly Schedules in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic|Completed||Phase 1|66|Anticipated|AstraZeneca||1|||f||||||||||||||2017-10-11 05:12:00.267259|2017-10-11 05:12:00.267259
NCT00127842|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2014-03-24|2010-11-04||August 2005||2005-08-01|March 2014|2014-03-01|September 2009|Actual|2009-09-01|August 2005|Actual|2005-08-01||Interventional|||REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)|Rating Evaluations in Psoriatic Arthritis (PsA) With Enbrel®|Completed||Phase 4|110|Actual|Amgen||1|||f||||||||||||||2017-10-11 05:12:00.499484|2017-10-11 05:12:00.499484
NCT00127855|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2016-10-21|2012-06-15||March 2003||2003-03-01|October 2016|2016-10-01|August 2004|Actual|2004-08-01|February 2004|Actual|2004-02-01||Interventional|||Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine|A Phase II, Open (Partially Double-blind), Randomised, Controlled, Multicentre, Primary Vaccination Study to Evaluate the Immunogenicity (Including Immune Memory), Reactogenicity and Safety of Three Different Formulations of the GSK Biologicals' Combined Haemophilus Influenzae Type B-meningococcal Serogroups CY Conjugate Vaccine Given Concomitantly With Infanrix® Penta and Prevenar®, Versus ActHIB® and Meningitec® Given Concomitantly With Infanrix® Penta and Versus ActHIB® Given Concomitantly With Infanrix® Penta and Prevenar® in Infants According to a 2-4-6 Month Schedule.|Completed||Phase 2|409|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:12:01.032125|2017-10-11 05:12:01.032125
NCT00127868|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2008-07-07|||March 2005||2005-03-01|May 2006|2006-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Selenium Sulfide, Ketoconazole and Ciclopirox Shampoo as Additional Treatments for Tinea Capitis (Scalp Ringworm)|A Randomized, Double-Blinded, Placebo-Controlled Study Observing the Efficacy of Selenium Sulfide 1% Shampoo, Ketoconazole 2% Shampoo, and Ciclopirox 1% Shampoo as Adjunctive Treatments for Tinea Capitis in Children|Completed||N/A|47|Actual|Chen, Catherine, M.D.||4|||f||||||||||||||2017-10-11 05:12:04.431213|2017-10-11 05:12:04.431213
NCT00203359|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-04-20|||September 2004||2004-09-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||TNF-Alpha Inhibition for Treatment of Alzheimer's Disease|Etanercept for Alzheimer's-Type Memory Loss Pilot Study|Completed||Phase 1|15||Tobinick, Edward Lewis, M.D.|||||f||||||||||||||2017-10-11 05:32:53.847659|2017-10-11 05:32:53.847659
NCT00127881|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-07-24|||July 2005||2005-07-01|July 2012|2012-07-01||||February 2014|Anticipated|2014-02-01||Interventional|||Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome|Open Label, Dose Escalation, Followed by Open Label,Single Arm Clinical Trial of HuMax-CD4 in Patients With Mycosis Fungoides Type CTCL (Stage IB-IVB) or Sezary Syndrome Who Are Refractory or Intolerant to Targretin® (Bexarotene) and One Other Standard Therapy|Terminated||Phase 3|76|Actual|Emergent Product Development Seattle LLC||1||New sponsor, other treatments available|f||||t||||||||||2017-10-11 05:12:04.525844|2017-10-11 05:12:04.525844
NCT00127907|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2007-10-16|||May 2004||2004-05-01|October 2007|2007-10-01||||||||Interventional|||Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest|Comparison of Epinephrine Associated With Vasopressin vs Epinephrine Alone in the Treatment of Out-of-Hospital Cardiac Arrests|Completed||Phase 4|2416||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:12:04.774083|2017-10-11 05:12:04.774083
NCT00127920|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2015-03-09|||August 2004||2004-08-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|August 2006|Actual|2006-08-01||Interventional|||Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients|A Phase II, Open-Label, Non-Randomized, Multi-Center Pilot Study of Intravenous Taxol, Carboplatin, Bevacizumab Given Every 21 Days in Patients With Newly Diagnosed Stage III/IV Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer|Completed||Phase 2|20|Actual|Gynecologic Oncology Associates||1|||f||||f||||||||||2017-10-11 05:12:04.885705|2017-10-11 05:12:04.885705
NCT00127933|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2011-07-13|2011-03-30||August 2005||2005-08-01|July 2011|2011-07-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer|An Open-label Study of Xeloda Plus Taxotere on Treatment Response in Patients With HER2-neu-negative, and the Addition of Herceptin for HER2-neu-positive Breast Cancer|Completed||Phase 4|157|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:12:05.07549|2017-10-11 05:12:05.07549
NCT00127946|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2011-08-08|||November 2005||2005-11-01|August 2005|2005-08-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|AMNIOECHANGE||Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses|Randomized Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses|Unknown status|Active, not recruiting|Phase 3|140|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 05:12:05.767468|2017-10-11 05:12:05.767468
NCT00127959|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2007-04-23|||March 2004||2004-03-01|April 2007|2007-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection|Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Antiretroviral Naïve Patients With HIV/HBV co-Infection|Completed||Phase 4|24||International Antiviral Therapy Evaluation Center|||||f||||f||||||||||2017-10-11 05:12:05.847851|2017-10-11 05:12:05.847851
NCT00127972|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2007-04-27|||February 2004||2004-02-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||2NN & CHARM Long-Term Follow-up Study|A Retrospective Study to Compare the 3-Year Antiviral Efficacy of Nevirapine and Efavirenz in Combination With D4t and 3tc in 2NN Patients and of Trizivir Versus Trizivir Plus Nevirapine in CHARM Patients|Completed||Phase 4|763|Actual|International Antiviral Therapy Evaluation Center|||||f||||f||||||||||2017-10-11 05:12:05.933843|2017-10-11 05:12:05.933843
NCT00127985|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2008-05-12|||August 2005||2005-08-01|May 2008|2008-05-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|NAIF||6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome|The Effect of 6-Methyl-Prednisolone on Organ Dysfunction and Mortality of Patients With Unresolving Multiple Organ Dysfunction Syndrome|Unknown status|Recruiting|Phase 4|240|Anticipated|Hospital Universitario Principe de Asturias||2|||f||||t||||||||||2017-10-11 05:12:06.021508|2017-10-11 05:12:06.021508
NCT00127998|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-07|2006-08-15|||July 2005||2005-07-01|August 2006|2006-08-01||||||||Interventional|||Antimalarial Drug Resistance in Mali|Characterization of Novel Molecular Tools for the Epidemiological Surveillance of Antimalarial Drug Resistance in Mali|Completed||N/A|1011||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:12:06.165867|2017-10-11 05:12:06.165867
NCT00128011|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2006-11-08|||May 2005||2005-05-01|November 2006|2006-11-01|June 2005||2005-06-01|||||Interventional|||Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine|A Safety and Immunogenicity Study of a New Formulation of the Locally-Produced Bivalent Killed, Whole-Cell Oral Cholera Vaccine in Vietnamese Subjects|Completed||Phase 2|150||International Vaccine Institute|||||f||||||||||||||2017-10-11 05:12:06.265552|2017-10-11 05:12:06.265552
NCT00128024|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2013-04-17|||February 2002||2002-02-01|April 2013|2013-04-01|February 2006|Actual|2006-02-01|February 2004|Actual|2004-02-01||Interventional|||Effects of Early Statin Treatment After Acute Myocardial Infarction (AMI) in Japanese Patients|Effects of Early Statin Treatment on Symptomatic Heart Failure and Ischemic Events After Acute Myocardial Infarction. The MUSASHI-AMI: A Multicenter Randomized Controlled Trial|Completed||Phase 4|460|Actual|Kumamoto University||2|||f||||||||||||||2017-10-11 05:12:06.340375|2017-10-11 05:12:06.340375
NCT00128037|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2016-09-20|||May 1999||1999-05-01|September 2016|2016-09-01|February 2006||2006-02-01|||||Interventional|||Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)|A Phase II Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors: Initial Report of Japan Clinical Oncology Group Trial (JCOG 9806)|Completed||Phase 2|75||Japan Clinical Oncology Group|||||f||||||||||||||2017-10-11 05:12:06.426913|2017-10-11 05:12:06.426913
NCT00128063|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2007-04-23|||August 2005||2005-08-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection|A Phase 1 & 2, Randomized Open-Label Study to Evaluate the Pharmacokinetics, Safety and Antiretroviral Activity of Succinylated Human Serum Albumin (Suc-HSA) in Treatment Naïve HIV-1 Infected Subjects|Completed||Phase 1/Phase 2|6||International Antiviral Therapy Evaluation Center|||||f||||t||||||||||2017-10-11 05:12:06.597384|2017-10-11 05:12:06.597384
NCT00128076|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2016-05-26|||August 2006||2006-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|August 2014|Actual|2014-08-01||Interventional|||All-Arthroscopic Versus Mini-Open Repair of Small or Moderate Rotator Cuff Tears|All-Arthroscopic Versus Mini-Open Repair of Small or Moderate Rotator Cuff Tears|Completed||Phase 3|275|Actual|McMaster University||2|||f||||t||||||||||2017-10-11 05:12:06.676537|2017-10-11 05:12:06.676537
NCT00128102|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2015-04-17|||June 2005||2005-06-01|April 2015|2015-04-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|||Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy|Completed||Phase 3|662|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:12:06.874248|2017-10-11 05:12:06.874248
NCT00128115|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2016-01-19|||September 2005||2005-09-01|January 2016|2016-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)|Proprietary Information - Exploratory (Non-Confirmatory) Trial|Terminated||Phase 2|83|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:12:06.971535|2017-10-11 05:12:06.971535
NCT00128128|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2015-05-14||2015-04-27|August 2005||2005-08-01|May 2015|2015-05-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections|Cranberry and Prevention of UTI A Comprehensive Approach|Completed||Phase 2|176|Actual|National Center for Complementary and Integrative Health (NCCIH)||4|||f||||f||||||||||2017-10-11 05:12:07.047919|2017-10-11 05:12:07.047919
NCT00128141|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2008-02-04|||August 2003||2003-08-01|February 2008|2008-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effect of Tactile and Kinesthetic Stimulation on Very Low Birth Weight Preterm Infants|Effect of Maternal Tactile and Kinesthetic Stimulation on Length of Hospital Stay of Very Low Birth Weight Infants|Completed||N/A|104|Actual|National Bioethics Commission of Brazil||2|||f||||f||||||||||2017-10-11 05:12:07.137488|2017-10-11 05:12:07.137488
NCT00128154|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2006-08-17|||January 2004||2004-01-01|August 2006|2006-08-01|December 2005||2005-12-01|||||Interventional|||Chromium Picolinate for the Treatment of Metabolic Syndrome|A Double-Blind Randomized Controlled Clinical Trial of Chromium Picolinate on Clinical and Biochemical Features of the Metabolic Syndrome|Completed||N/A|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:12:07.210163|2017-10-11 05:12:07.210163
NCT00128167|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2006-07-05|||October 2004||2004-10-01|July 2006|2006-07-01|December 2005||2005-12-01|||||Interventional|||Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6–59 Months of Age|A Randomized, Double-Blind Trial to Assess the Safety and Relative Efficacy of CAIV-T Against Inactivated Influenza Vaccine in Children 6–59 Months of Age|Completed||Phase 3|8500||MedImmune LLC|||||||||||||||||||2017-10-11 05:12:07.299712|2017-10-11 05:12:07.299712
NCT00128180|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2014-12-05|2011-12-05||January 2003||2003-01-01|December 2014|2014-12-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Interventional|||Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome|A Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Methylprednisolone as a Treatment for Presumed Hantavirus Cardiopulmonary Syndrome|Completed||Phase 2|66|Actual|University of New Mexico|While the study reached the target accrual of 60 confirmed cases, it was not powered to detect a difference in mortality. Higher disease severity in the placebo group at entry complicated both the efficacy and safety analyses.|2|||f||||t||||||||||2017-10-11 05:12:07.946981|2017-10-11 05:12:07.946981
NCT00128193|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2014-12-04|2010-09-30||April 2002||2002-04-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Leprosy Skin Test Antigens Trial|Two New Leprosy Skin Test Antigens: MLSA-LAM and MLCwA Phase II Study in a Leprosy-Endemic Region|Completed||Phase 2|260|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-10-11 05:12:08.648377|2017-10-11 05:12:08.648377
NCT00128206|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2013-05-09|2010-09-21||November 2004||2004-11-01|May 2013|2013-05-01|September 2009|Actual|2009-09-01|October 2008|Actual|2008-10-01||Interventional|||Treatment of Latent TB Infection for Jailed Persons|Clinical Trial of Short Course Rifampin Versus INH for LTBI in Jail|Completed||Phase 3|364|Actual|University of California, San Francisco|Initial enrollment estimates were not met, from lower TB rates, increased deportation rates and fewer Jail personnel for LTBI testing. The complexity of treatment in the jail led to technical problems in the analytic plan.|2|||f||||t||||||||||2017-10-11 05:12:12.314124|2017-10-11 05:12:12.314124
NCT00128219|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2015-01-15|2009-08-03||July 2003||2003-07-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Prevention of GBS Colonization Via Immunity|A Phase II Randomized, Double-Blinded, Comparative Clinical Trial for a Group B Streptococcus Serotype III-Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Acquisition of GBS Type III|Completed||Phase 2|667|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:12:12.776818|2017-10-11 05:12:12.776818
NCT00128232|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-04-27|||December 2002||2002-12-01|April 2012|2012-04-01||||August 2004|Actual|2004-08-01||Interventional|||Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients|Safety and Efficacy of Octreotide LAR in Treatment Naïve Acromegalic Patients|Completed||Phase 3|100||Novartis|||||f||||||||||||||2017-10-11 05:12:16.453787|2017-10-11 05:12:16.453787
NCT00128245|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2007-12-19|||September 2004||2004-09-01|December 2007|2007-12-01||||||||Interventional|||Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca|A 24-Week Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Evaluation of the Safety and Efficacy of 0.3% and 1% Pimecrolimus Ophthalmic Suspensions Used Twice Daily in Patients With Moderate to Severe Keratoconjunctivitis Sicca|Completed||N/A|440||Novartis|||||||||||||||||||2017-10-11 05:12:16.532091|2017-10-11 05:12:16.532091
NCT00128258|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2016-09-26|||May 2005||2005-05-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Autologous/Allogeneic Progenitor Stem Cell Therapy for Congestive Heart Failure|Phase 1 Study: Autologous/Allogeneic Bone Marrow Progenitor Cell Treatment for Heart Failure|Terminated||Phase 1|10|Actual|Amit, Patel N, M.D.||1||study no longer at pittsburgh|f||||t||||||||||2017-10-11 05:12:16.616334|2017-10-11 05:12:16.616334
NCT00128271|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2008-04-28|||August 2005||2005-08-01|August 2006|2006-08-01||||August 2006|Actual|2006-08-01||Interventional|||Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection|A Phase 1 Study of Chimeric Anti-Phosphatidylserine Monoclonal Antibody (Bavituximab) in Patients Chronically Infected With Hepatitis C Virus (HCV) Who Are Non-Responders or Relapsers After Treatment With Pegylated Interferon Plus Ribavirin|Completed||Phase 1|32||Peregrine Pharmaceuticals|||||f||||||||||||||2017-10-11 05:12:16.691251|2017-10-11 05:12:16.691251
NCT00204217|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-24|||September 2004||2004-09-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Monitoring of Intubation and Ventilation During Resuscitation|Monitoring of Intubation and Ventilation During Resuscitation|Completed||Phase 2|15||University of Oslo|||||f||||f||||||||||2017-10-11 05:33:02.22388|2017-10-11 05:33:02.22388
NCT00128284|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2008-05-21|||February 2005||2005-02-01|May 2008|2008-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time|A Comparison Trial of SmartPill Corporation GI Monitoring System With Scintigraphic Gastric Emptying Procedure for Determining Gastric Residence Time|Completed||N/A|148|Actual|The SmartPill Corporation|||2||f||||f||||||||||2017-10-11 05:12:16.777566|2017-10-11 05:12:16.777566
NCT00128297|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2009-09-25|||January 2001||2001-01-01|September 2009|2009-09-01|December 2002||2002-12-01|||||Interventional|||Pamidronate Administration in Breast Cancer Patients With Bone Metastases|Randomized, Multicentric Phase IV Clinical Trial for the Administration of Pamidronate in Breast Cancer Patients With Bone Metastases|Completed||Phase 4|120||Spanish Breast Cancer Research Group|||||f||||f||||||||||2017-10-11 05:12:16.889254|2017-10-11 05:12:16.889254
NCT00128310|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2007-02-06|||January 2001||2001-01-01|February 2007|2007-02-01|October 2005||2005-10-01|||||Interventional|||Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients|Randomized Phase III Trial Comparing Vinorelbine vs. Gemcitabine Plus Vinorelbine in Patients With Advanced Breast Cancer, Previously Treated With Anthracyclines and Taxanes|Completed||Phase 3|252||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:12:16.971825|2017-10-11 05:12:16.971825
NCT00128323|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-07|2008-02-07|||November 2002||2002-11-01|February 2008|2008-02-01|April 2005|Actual|2005-04-01|||||Interventional|||A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis|A Comparison of Gentian Violet Mouth Washes, Nystatin Drops and Ketoconazole Tabs in the Treatment of Oropharyngeal Candidiasis|Completed||Phase 3|558||University of Malawi College of Medicine|||||f||||||||||||||2017-10-11 05:12:17.050591|2017-10-11 05:12:17.050591
NCT00128336|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2016-05-12|||May 2004||2004-05-01|May 2016|2016-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management|The Heat Study: A 2-year Lifestyle Intervention in Overweight Women to Determine Optimal Approaches for Successful Maintenance of Weight Loss|Completed||Phase 3|200|Actual|University of Otago||4|||f||||f||||||||||2017-10-11 05:12:17.135342|2017-10-11 05:12:17.135342
NCT00128362|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2014-06-23|||September 2005||2005-09-01|June 2014|2014-06-01||||December 2011|Actual|2011-12-01||Interventional|||Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer|Clinical Trial of Sentinel Node Biopsy Versus Axillary Sampling in Women With Clinically Node Negative Operable Breast Cancer|Terminated||Phase 2|478|Actual|Tata Memorial Hospital||1||"After initiation of study many studies reported an equivalence of SNB and ALND which led to   widespread adoption of the former as standard procedure."|f||||||||||||||2017-10-11 05:12:17.237814|2017-10-11 05:12:17.237814
NCT00128375|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2007-12-12|||March 2005||2005-03-01|December 2007|2007-12-01|April 2008||2008-04-01|||||Interventional|||Financial Incentives for Smoking Cessation|Financial Incentives for Smoking Cessation|Completed||N/A|878||University of Pennsylvania|||||f||||||||||||||2017-10-11 05:12:17.338743|2017-10-11 05:12:17.338743
NCT00128388|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2013-06-26|||February 2000||2000-02-01|June 2013|2013-06-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||Psychodynamic Therapy for Treating Panic Disorder|Randomized Controlled Trial of Psychodynamic Psychotherapy vs. Applied Relaxation for Panic Disorder|Completed||Phase 2/Phase 3|49|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 05:12:17.429743|2017-10-11 05:12:17.429743
NCT00128401|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2014-04-17|2013-07-01||August 2005||2005-08-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional||The baseline mean and SD for CGI outcome measure was captured for 42 subjects only. The baseline mean and SD for LSAS outcome measure was captured for 40 subjects. Only 39 subjects were randomized.|Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia|Effect of D-Cycloserine on Treatment of Social Phobia|Completed||Phase 2|48|Actual|National Institutes of Health Clinical Center (CC)|The baseline mean and SD for CGI outcome measure was captured for 42 subjects only. The baseline mean and SD for LSAS outcome measure was captured for 40 subjects.|2|||f||||||||||||||2017-10-11 05:12:17.522721|2017-10-11 05:12:17.522721
NCT00128414|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2011-02-14|||August 2005||2005-08-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|April 2009|Actual|2009-04-01||Interventional|CORP||Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)|Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP Trial: COlchicine for Recurrent Pericarditis|Completed||Phase 3|120|Anticipated|Azienda Sanitaria Locale 3, Torino||2|||f||||t||||||||||2017-10-11 05:12:18.018065|2017-10-11 05:12:18.018065
NCT00128427|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2010-06-13|||June 2005||2005-06-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Colchicine to Prevent the Postpericardiotomy Syndrome|Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The COPPS Trial: COlchicine for the Prevention of Postpericardiotomy Syndrome|Completed||Phase 3|360|Anticipated|Azienda Sanitaria Locale 3, Torino||2|||f||||t||||||||||2017-10-11 05:12:18.115973|2017-10-11 05:12:18.115973
NCT00128440|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2013-10-28|||August 2005||2005-08-01|October 2013|2013-10-01||||September 2006|Actual|2006-09-01||Interventional|||High Dose Trial in COPD|A Randomized, Multiple-dose, Double-Blind, Crossover Study to Compare the Efficacy and Safety of 200 μg and 400 μg of BEA 2180 BR to Tiotropium 5 μg and Placebo When Each is Delivered by the Respimat® Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|78|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:12:18.225939|2017-10-11 05:12:18.225939
NCT00128453|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-06-06|||August 2005||2005-08-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences|Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The ICAP Trial: Investigation on Colchicine for Acute Pericarditis|Completed||Phase 3|240|Actual|Azienda Sanitaria Locale 3, Torino||2|||f||||||||||||||2017-10-11 05:12:18.330734|2017-10-11 05:12:18.330734
NCT00128466|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2009-02-24|||August 2004||2004-08-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Treatment and Diagnosis of Plague|Safety and Efficacy of Gentamicin Versus Streptomycin for the Treatment of Naturally Occurring Human Plague and Evaluation of Rapid Diagnostic Test Kits for Yersinia Pestis|Completed||Phase 2/Phase 3|114|Actual|Centers for Disease Control and Prevention|||||||||t||||||||||2017-10-11 05:12:18.426406|2017-10-11 05:12:18.426406
NCT00128687|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2014-02-07|||April 2003||2003-04-01|February 2014|2014-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Improving Coronary Prevention in a County Health System|Improving Coronary Prevention in a County Health System|Completed||N/A|419|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 05:12:24.776395|2017-10-11 05:12:24.776395
NCT00128479|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-02-14|||September 2004||2004-09-01|February 2012|2012-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Three Dose Levels of CORLUX™ (Mifepristone) Plus an Antidepressant vs. Placebo Plus an Antidepressant in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features (PMD)|Completed||Phase 3|443|Actual|Corcept Therapeutics||4|||f||||f||||||||||2017-10-11 05:12:18.629888|2017-10-11 05:12:18.629888
NCT00128492|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2011-05-17|2010-06-03||August 2005||2005-08-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|AIR-CF3||Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)|A Phase 3, Open-label, Follow-On Study of Multiple Courses of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients (AIR-CF3)|Completed||Phase 3|274|Actual|Gilead Sciences|Descriptive statistics for all participants receiving 1 or more doses of AZLI were summarized for the safety, microbiology, and efficacy endpoints. No formal hypothesis tests were planned. Rates of AEs and SAEs are not adjusted for time on study.||||f||||t||||||||||2017-10-11 05:12:18.909719|2017-10-11 05:12:18.909719
NCT00128505|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-02-14|||August 2005||2005-08-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression|An International, Open-Label Extension Study of the Safety and Tolerability of CORLUX™ (Mifepristone) for Recurrent Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features|Completed||Phase 3|104|Actual|Corcept Therapeutics||1|||f||||f||||||||||2017-10-11 05:12:21.225586|2017-10-11 05:12:21.225586
NCT00128518|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2011-12-29|||October 2004||2004-10-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs|IDEAL Study : Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs|Completed||Phase 4|139|Actual|Hospices Civils de Lyon||4|||f||||||||||||||2017-10-11 05:12:21.389083|2017-10-11 05:12:21.389083
NCT00128531|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2007-11-12|||September 2005||2005-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer|Efficacy and Safety of a New Leuprolide Acetate 3.75 mg Depot Formulation, GP-Pharm S.A., When Given as Palliative Treatment to Prostate Cancer Patients|Completed||Phase 3|120||GP-Pharm|||||f||||||||||||||2017-10-11 05:12:21.571762|2017-10-11 05:12:21.571762
NCT00128544|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2017-06-15|||May 2005||2005-05-01|June 2017|2017-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B|A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) Versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients With Chronic Hepatitis B|Completed||Phase 2|130||Novartis|||||||||||||||||||2017-10-11 05:12:21.843062|2017-10-11 05:12:21.843062
NCT00128557|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2007-04-09|||January 2004||2004-01-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh|A Randomized Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh|Terminated||Phase 3|25000||Johns Hopkins Bloomberg School of Public Health||||Study terminated based on DSMB recommendation in December 2006|f||||t||||||||||2017-10-11 05:12:21.914842|2017-10-11 05:12:21.914842
NCT00128570|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2013-09-16|||April 2006||2006-04-01|June 2009|2009-06-01|March 2011|Actual|2011-03-01|February 2010|Actual|2010-02-01||Interventional|||An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physical Activity and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index|Cancer Prevention Mastery Model Internet Intervention|Completed||N/A|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:12:22.030509|2017-10-11 05:12:22.030509
NCT00128583|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2013-12-18|||July 2005||2005-07-01|September 2005|2005-09-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Malignant Melanoma|Response of In-Transit Melanoma to Systemic Treatment With the Specific Active Immunotherapeutic Agent, Canvaxin™|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:12:22.098724|2017-10-11 05:12:22.098724
NCT00128596|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2017-04-25|||June 2004||2004-06-01|January 2006|2006-01-01||||December 2005|Actual|2005-12-01||Interventional|||Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery|A Phase II Study of Trisenox (Arsenic Trioxide) in the Treatment of Unresectable Liver Cancer|Completed||Phase 2|25|Anticipated|University of Pittsburgh||1|||f||||||||||||||2017-10-11 05:12:22.185229|2017-10-11 05:12:22.185229
NCT00128622|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-11-08|||September 2005||2005-09-01|November 2012|2012-11-01|May 2009|Actual|2009-05-01|March 2007|Actual|2007-03-01||Interventional|||Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer|A Phase I Study of Regulatory T Cell Depletion With Denileukin Diftitox Followed by Active Immunotherapy With Autologous Dendritic Cells Infected With CEA-6D Expressing Fowlpox-Tricom in Patients With Advanced or Metastatic Malignancies Expressing CEA|Completed||Phase 1|24|Actual|Duke University||1|||f||||||||||||||2017-10-11 05:12:22.267688|2017-10-11 05:12:22.267688
NCT00128635|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2016-02-17|||October 2005||2005-10-01|May 2007|2007-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme|An Open-Label, Dose Confirmation and Dosimetry Study of Interstitial 131 I-chTNT-1/B MAb (COTARA(TM)) For the Treatment of Glioblastoma Multiforme (GBM) at 1st or 2nd Relapse|Completed||Phase 1|22|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||||||||||||2017-10-11 05:12:22.382106|2017-10-11 05:12:22.382106
NCT00128661|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-05-24|2011-12-15||June 2004||2004-06-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants|A Double-Blind, Controlled, Randomized, Phase III Study of the Efficacy of an HPV16/18 VLP Vaccine in the Prevention of Advanced Cervical Intraepithelial Neoplasia (CIN2, CIN3, Adenocarcinoma In Situ [AIS] and Invasive Cervical Cancer) Associated With HPV 16 or HPV 18 Cervical Infection in Healthy Young Adult Women in Costa Rica.|Completed||Phase 3|7466|Actual|GlaxoSmithKline|"The following analysis occurence of histopathologically confirmed CIN2+ cases associated with HPV16 or HPV18 infection was not performed, in accordance with the Statistical Analysis Plan submitted to the FDA."|2|||f||||||||||||||2017-10-11 05:12:22.543898|2017-10-11 05:12:22.543898
NCT00128700|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-09-20|||June 2005||2005-06-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I/II Study on Concomitant and Adjuvant Temozolomide and Radiotherapy With or Without PTK787/ZK222584 in Newly Diagnosed GBM|Completed||Phase 1/Phase 2|20|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 05:12:24.84965|2017-10-11 05:12:24.84965
NCT00128713|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2015-10-05|2009-01-30||July 2004||2004-07-01|August 2013|2013-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|PLADO||Optimal Platelet Dose Strategy for Management of Thrombocytopenia|Determination of the Optimal Prophylactic Platelet Dose Strategy to Prevent Bleeding in Thrombocytopenic Patients (A TMH CTN Study)|Completed||Phase 3|1351|Actual|New England Research Institutes||3|||f||||t||||||||||2017-10-11 05:12:24.970892|2017-10-11 05:12:24.970892
NCT00128726|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-12-20|||June 2001||2001-06-01|December 2012|2012-12-01|August 2006|Actual|2006-08-01|||||Observational|||The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function|The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function|Completed||Phase 1|62|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||Samples With DNA|"     whole blood, urines, tissue   "|||2017-10-11 05:12:27.009017|2017-10-11 05:12:27.009017
NCT00128739|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2005-08-26|||January 2001||2001-01-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation|A Phase 3 Study to Evaluate the Place of Budesonide in the Treatment of GVHD|Completed||Phase 3|24||Rafa Laboratories|||||f||||||||||||||2017-10-11 05:12:27.126796|2017-10-11 05:12:27.126796
NCT00128752|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2005-08-26|||March 2003||2003-03-01|August 2005|2005-08-01|October 2003||2003-10-01|||||Interventional|||The CARO Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Healthy Subjects|Bioefficacy and Bioavailability of Beta-Carotene in Oil and in a Mixed Diet in Healthy Subjects Measured Using Specifically 13C-Labelled Beta-Carotene and Retinol|Completed||N/A|24||Radboud University|||||f||||||||||||||2017-10-11 05:12:27.229165|2017-10-11 05:12:27.229165
NCT00128765|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2011-11-21|||January 2005||2005-01-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice|Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease (COPD) in General Practice. A Randomized Controlled Trial Comparing Regular Practice Nurse Review, Self-management Education and Usual Care|Completed||N/A|165|Actual|Radboud University||3|||f||||t||||||||||2017-10-11 05:12:27.357549|2017-10-11 05:12:27.357549
NCT00128778|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2007-09-04|||October 2002||2002-10-01|September 2007|2007-09-01|December 2006||2006-12-01|||||Interventional|||Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients|Phase IV.III Clinical Trial to Evaluate Maintenance Treatment With Caelyx vs. Observation After Administration of Induction Chemotherapy in Metastatic Breast Cancer Patients|Completed||Phase 4|154|Anticipated|Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:12:27.535381|2017-10-11 05:12:27.535381
NCT00128791|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2007-05-24|||January 2003||2003-01-01|May 2007|2007-05-01|April 2005||2005-04-01|||||Interventional|||Nitroprusside for Prevention of no-Reflow in Primary Angioplasty|Intracoronary Nitroprusside for the Prevention of the No-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. A Randomized, Double Blind, Placebo-Controlled Clinical Trial|Terminated||Phase 4|100||Soroka University Medical Center|||||f||||||||||||||2017-10-11 05:12:27.672267|2017-10-11 05:12:27.672267
NCT00128804|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2005-08-26|||July 2004||2004-07-01|August 2005|2005-08-01|October 2004||2004-10-01|||||Interventional|||The STOVITA Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Ileostomy Patients|Bioefficacy and Bioavailability of Beta-Carotene in Oil and in a Mixed Diet in Ileostomy Patients Measuring Using Specifically 13C-Labelled Beta-Carotene and Retinol|Completed||N/A|18||Radboud University|||||f||||||||||||||2017-10-11 05:12:27.767433|2017-10-11 05:12:27.767433
NCT00128817|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2013-01-21|||May 2005||2005-05-01|January 2013|2013-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers|Phase III Randomized Clinical Trial to Compare Results of Concurrent Chemo-radiation With Surgery and Postoperative Radiotherapy/Chemoradiotherapy in Advanced Laryngeal and Hypopharyngeal Cancers|Terminated||Phase 3|900|Anticipated|Tata Memorial Hospital||2||Slow Accrual|f||||t||||||||||2017-10-11 05:12:27.863423|2017-10-11 05:12:27.863423
NCT00128830|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2013-06-10|2013-02-27||June 2005||2005-06-01|June 2013|2013-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study|An Open-Label Trial With TMC125 in HIV-1 Infected Subjects, Who Were Randomized to a TMC125 Treatment Arm in a Sponsor-Selected TMC125 Trial and Were Treated for at Least 48 Weeks|Completed||Phase 2|211|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||f||||||||||2017-10-11 05:12:28.020279|2017-10-11 05:12:28.020279
NCT00128843|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2008-09-23|||August 2001||2001-08-01|September 2008|2008-09-01|July 2005||2005-07-01|||||Interventional|||Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients|Phase II Randomized, Multicenter, Crossover Clinical Trial for Administration of Exemestane vs. Anastrozole as First Line Treatment for Postmenopausal Patients With Hormone Receptor Positive Advanced Breast Cancer|Completed||Phase 2|100||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:12:28.692898|2017-10-11 05:12:28.692898
NCT00128856|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2005-08-29|||December 2002||2002-12-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients|Phase II Pharmacogenomic and Clinical Trial for the Administration of Gemcitabine-Doxorubicin-Paclitaxel (GAT) as Neoadjuvant Treatment of Patients With Stage III Breast Cancer|Completed||Phase 2|43||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:12:28.806049|2017-10-11 05:12:28.806049
NCT00128869|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2008-05-08|||May 2005||2005-05-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of the Effectiveness of Mobilization and Manipulation of the Thoracic Spine in Patients With Mechanical Neck Pain|Comparison of the Effectiveness of Mobilization and Manipulation of the Thoracic Spine in Patients With Mechanical Neck Pain: A Randomized Clinical Trial|Completed||Phase 1|96|Anticipated|Newton-Wellesley Hospital|||||f||||||||||||||2017-10-11 05:12:28.888717|2017-10-11 05:12:28.888717
NCT00128882|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2009-02-02|||November 2004||2004-11-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|January 2008|Actual|2008-01-01||Interventional|||Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D|Treatment of Idiopathic Thrombocytopenic Purpura in Children With Subcutaneously Administered Anti-D|Completed||Phase 2|45|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 05:12:28.994272|2017-10-11 05:12:28.994272
NCT00128895|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2014-12-31|||June 2003||2003-06-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis|Prevention of Relapses in PR3-ANCA-associated Vasculitis, a Tailored Approach|Unknown status|Active, not recruiting|Phase 4|180|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-10-11 05:12:29.112407|2017-10-11 05:12:29.112407
NCT00128908|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2009-09-14|||September 2005||2005-09-01|September 2009|2009-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients|Sequential HAART in Treatment Resistant HIV-1 Infected Patients|Terminated||Phase 4|3|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2||Did not recruit|f||||f||||||||||2017-10-11 05:12:29.219466|2017-10-11 05:12:29.219466
NCT00128921|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2012-04-25|2011-04-15||April 2006||2006-04-01|April 2012|2012-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma|A Phase II Dose-Response Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma|Terminated||Phase 2|18|Actual|University of Arkansas|Early termination due to difficulty in accruing participants.|3||study terminated due to low accrual|f||||t||||||||||2017-10-11 05:12:29.313436|2017-10-11 05:12:29.313436
NCT00128934|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2007-12-18|||August 2005||2005-08-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder|Completed||Phase 3|744|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:12:29.696512|2017-10-11 05:12:29.696512
NCT00128947|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2008-03-03|||July 2005||2005-07-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers|Pharmacokinetics of Mycophenolic Acid and Mycophenolate 7-O-Phenolic Glucuronide in Healthy Subjects With or Without Two Common Genetic Polymorphisms in the Promoter Region of Uridine Diphosphate Glucuronosyltransferase 1A9|Completed||Phase 1|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:12:30.056335|2017-10-11 05:12:30.056335
NCT00128960|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2017-10-05|||August 5, 2005||2005-08-05|December 7, 2016|2016-12-07||||||||Observational|||Quality of Life in Patients Who Have Undergone Stem Cell Transplant|Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation|Completed||N/A|173|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:12:30.122471|2017-10-11 05:12:30.122471
NCT00128973|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2017-10-05|||August 3, 2005||2005-08-03|September 12, 2017|2017-09-12||||||||Observational|||Evaluation of Patients With Immune Function Abnormalities|Screening and Baseline Assessment of Patients With Abnormalities of Immune Function|Recruiting||N/A|2400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:12:30.183564|2017-10-11 05:12:30.183564
NCT00128986|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2016-04-05|||May 2005||2005-05-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Tomotherapy in Patients With Benign Brain Tumour|A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour|Completed||Phase 1|49|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 05:12:30.266845|2017-10-11 05:12:30.266845
NCT00128999|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2010-02-08|||September 2003||2003-09-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer|A Phase I/II Dose Escalation Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|5||AHS Cancer Control Alberta|||||f||||t||||||||||2017-10-11 05:12:30.335901|2017-10-11 05:12:30.335901
NCT00129012|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2016-02-24|||April 2005||2005-04-01|March 2012|2012-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer|Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer: A Feasibility Study|Completed||Phase 1|30|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 05:12:30.411977|2017-10-11 05:12:30.411977
NCT00129025|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2011-10-06|||October 2004||2004-10-01|October 2011|2011-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer|A Phase I/II Study of Escalated-Dose Short-Course Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer|Completed||Phase 1/Phase 2|35|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 05:12:30.493321|2017-10-11 05:12:30.493321
NCT00129038|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2013-10-28|||April 2004||2004-04-01|October 2013|2013-10-01||||January 2007|Actual|2007-01-01||Interventional|||Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients|A Randomised, Crossover Study Comparing the Biochemical and Platelet Effects of Modified-release Dipyridamole/Aspirin (200mg/25 mg bd; Asasantin Retard®) With Aspirin (75 mg qd) in Coronary Artery Disease Patients With Aspirin Resistance Manifesting as Persistent Thromboxane Formation.|Completed||Phase 4|11|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:12:30.647279|2017-10-11 05:12:30.647279
NCT00129051|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2010-02-08|||August 2001||2001-08-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases|Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases|Completed||Phase 1|20||AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:12:30.735992|2017-10-11 05:12:30.735992
NCT00129064|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2007-04-23|||November 2005||2005-11-01|April 2007|2007-04-01|March 2007||2007-03-01|||||Interventional|||Improving the Outpatient Referral Process With Electronic Communications|Improving the Outpatient Referral Process With Electronic Communications|Completed||N/A|200||Brigham and Women's Hospital|||||f||||t||||||||||2017-10-11 05:12:30.815946|2017-10-11 05:12:30.815946
NCT00129077|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2007-07-09|||March 2004||2004-03-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?|Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?|Completed||N/A|207|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-10-11 05:12:30.890368|2017-10-11 05:12:30.890368
NCT00129090|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2015-09-08|||March 2003||2003-03-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2014|Actual|2014-10-01||Interventional|||Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma|A Randomized Phase III Study to Compare Conventional Chemotherapy (CHOEP-14) + Rituximab vs High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation (Mega-CHOEP-21) + Rituximab in Younger Patients With Aggressive NHL|Unknown status|Active, not recruiting|Phase 3|450|Actual|German High-Grade Non-Hodgkin's Lymphoma Study Group||1|||f||||t||||||||||2017-10-11 05:12:30.968532|2017-10-11 05:12:30.968532
NCT00129116|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2016-10-21|2012-06-15||March 2003||2003-03-01|October 2016|2016-10-01|October 2004|Actual|2004-10-01|December 2003|Actual|2003-12-01||Interventional|||3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age|A Phase II, Open (Partially Double-blind), Randomised, Controlled, Multicentre, Primary Vaccination Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Three Different Formulations of GSK Biologicals' Combined Haemophilus Influenzae Type B-meningococcal Serogroups C and Y- Conjugate Vaccine and One Formulation of GSK Biologicals' Haemophilus Influenzae Type B-meningococcal Serogroup C Conjugate Vaccine Each Given Concomitantly With InfanrixTM Penta, Versus MeningitecTM, Given Concomitantly With InfanrixTM Hexa in Infants According to a 2-3-4 Month Schedule|Completed||Phase 2|388|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:12:31.116466|2017-10-11 05:12:31.116466
NCT00129129|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2016-09-22|2012-06-15||August 2004||2004-08-01|September 2016|2016-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine|Evaluate Immuno and Safety of GSKBiologicals' HibMenCYTT vs Licensed Hib Conjugate Vaccine, Each Coadministered With Pediarix® and Prevnar®, in Healthy Infants. An Exploratory Control Group Will Receive Licensed Menomune® at 3 to 5 Years|Completed||Phase 2|756|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:12:35.183782|2017-10-11 05:12:35.183782
NCT00129142|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2013-11-13|||October 2003||2003-10-01|November 2013|2013-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy|A Randomized, Double Blind, Placebo Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy|Completed||Phase 3|1200||GTx|||||f||||||||||||||2017-10-11 05:12:41.295121|2017-10-11 05:12:41.295121
NCT00129155|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2007-10-03|||February 2005||2005-02-01|October 2007|2007-10-01||||||||Interventional|||MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies|Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies|Unknown status|Recruiting|Phase 2|30|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:12:42.008784|2017-10-11 05:12:42.008784
NCT00129168|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2008-03-28|||August 2005||2005-08-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)|An Open-Label, Phase I/II, Multicenter Dose Escalation Study of Zosuquidar, Daunorubicin, and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|100|Anticipated|Kanisa Pharmaceuticals|||||||||||||||||||2017-10-11 05:12:42.133575|2017-10-11 05:12:42.133575
NCT00129181|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2009-08-27|||January 2005||2005-01-01|August 2009|2009-08-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease|A Single-blinded Assessment of the Short-term Effects of Cabergoline vs. Carbidopa/Levodopa on SPECT Dopamine Transporter Density in Out-patient Subjects With Parkinson's Disease|Completed||N/A|30|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-10-11 05:12:42.213778|2017-10-11 05:12:42.213778
NCT00129194|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2007-12-30|||August 2005||2005-08-01|December 2007|2007-12-01||||June 2007|Actual|2007-06-01||Interventional|||Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens|A Double-Blind, Placebo-Controlled, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of KP-1461 in HIV+ Adults Who Have Failed Two or More Highly Active Antiretroviral Regimens (HAART)|Completed||Phase 1|40|Anticipated|Koronis Pharmaceuticals.|||||f||||||||||||||2017-10-11 05:12:42.336296|2017-10-11 05:12:42.336296
NCT00129207|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2008-02-07||||||February 2008|2008-02-01||||September 2006|Actual|2006-09-01||Interventional|||Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade|Effect of Ketoconazole Administration on the Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Advanced Solid Tumors|Completed||Phase 1|||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-10-11 05:12:42.42064|2017-10-11 05:12:42.42064
NCT00129220|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2010-12-10|2010-01-21||July 2005||2005-07-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder|Placebo- and Haloperidol-Controlled Double-Blind Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder|Completed||Phase 3|224|Actual|Eli Lilly and Company|Identified errors were corrected.|3|||f||||||||||||||2017-10-11 05:12:42.700799|2017-10-11 05:12:42.700799
NCT00129233|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2013-04-29|||October 2004||2004-10-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|July 2010|Actual|2010-07-01||Interventional|||Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance|The Novel Antihypertensive Goal Of hYpertension With diAbetes ― Hypertensive Events and ARb Treatment (NAGOYA-HEART) Study|Completed||Phase 4|1150|Actual|Nagoya University||2|||f||||t||||||||||2017-10-11 05:12:43.842303|2017-10-11 05:12:43.842303
NCT00129246|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2013-01-02|2013-01-02||December 2004||2004-12-01|January 2013|2013-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain|Naltrexone & Bupropion to Stop Smoking With Less Weight Gain|Completed||Phase 1/Phase 2|40|Actual|Yale University||2|||f||||||||||||||2017-10-11 05:12:44.023118|2017-10-11 05:12:44.023118
NCT00129259|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2017-04-11|2013-06-21||September 2005||2005-09-01|April 2017|2017-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|AbATE|Intent-to-treat|Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes|Phase II Multiple-Dose Treatment of New Onset Type 1 Diabetes Mellitus With Anti-CD3 mAb|Completed||Phase 2|83|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in: 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from Division of Allergy, Immunology, and Transplantation (DAIT)-funded grants and contracts that also provides data analysis tools available to researchers; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal that makes data from the consortium's clinical trials publicly available.|2017-10-11 05:12:44.429274|2017-10-11 05:12:44.429274
NCT00129272|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2017-04-17|2017-01-16||May 2004||2004-05-01|April 2017|2017-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effectiveness of Bupropion for Treating Nicotine Dependence in Young People|Stress Response and Smoking Cessation in Depressed Youth|Completed||Phase 2|172|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||No||2017-10-11 05:12:45.256743|2017-10-11 05:12:45.256743
NCT00129298|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-04|2017-01-11|||December 2004||2004-12-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1|Tiagabine for the Treatment of Cocaine Dependence in Methadone-Maintained Individuals|Completed||Phase 2|80|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 05:12:45.695547|2017-10-11 05:12:45.695547
NCT00129311|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2015-03-11|2014-06-16||July 2004||2004-07-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Usefulness of Selegiline as an Aid to Quit Smoking - 1|Usefulness of Selegiline for Smoking Cessation|Completed||Phase 2|101|Actual|Yale University||2|||f||||t||||||||||2017-10-11 05:12:45.785921|2017-10-11 05:12:45.785921
NCT00129324|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2016-10-18|||March 2003||2003-03-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||HOME Study (Health Outcomes and Measures of the Environment Study)|Neurobehavioral Effects of Prevalent Neurotoxicants in Children: A Cohort Study of the Cincinnati Center for Children's Environmental Health|Enrolling by invitation||N/A|468|Actual|National Institute of Environmental Health Sciences (NIEHS)||2|||f||||f||||||||||2017-10-11 05:12:46.098044|2017-10-11 05:12:46.098044
NCT00129337|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2011-02-28|||June 2005||2005-06-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies|A Multicenter, Open-Label Safety and Pharmacokinetics Study of Chimeric Anti-Phosphatidylserine Monoclonal Antibody (Bavituximab) in Patients With Refractory Advanced Solid Tumor Malignancies|Completed||Phase 1|28|Anticipated|Peregrine Pharmaceuticals||4|||t||||f||||||||||2017-10-11 05:12:46.435732|2017-10-11 05:12:46.435732
NCT00129350|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2005-09-06|||September 2004||2004-09-01|August 2005|2005-08-01|February 2008||2008-02-01|||||Interventional|||Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation|An Assessment of Patient Outcomes Following a Rehabilitation Programme for Patients Who Have Received Lung or Heart-Lung Transplant - a Randomised Controlled Trial|Unknown status|Recruiting|Phase 1|60||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:12:46.542811|2017-10-11 05:12:46.542811
NCT00129363|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2008-12-24|||January 2002||2002-01-01|December 2008|2008-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study to Evaluate the Safety of Twice Daily Oral Carvedilol|A Multicenter, Open Label Extension Study to Evaluate the Safety of Twice Daily Oral Carvedilol in Pediatric Patients With Chronic Heart Failure|Completed||Phase 3|75|Actual|Shaddy, Robert, M.D.||1|||f||||||||||||||2017-10-11 05:12:46.646366|2017-10-11 05:12:46.646366
NCT00129376|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2005-09-07|||December 2002||2002-12-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients|Multicenter Phase II Trial of Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel (T) as Neoadjuvant Treatment for Operable Stage II and IIIA Breast Cancer Patients|Completed||Phase 2|63||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:12:46.776278|2017-10-11 05:12:46.776278
NCT00129389|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2012-11-21|||September 2003||2003-09-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients|Multicenter Randomized Phase III Clinical Trial to Compare 6 FAC Cycles(Fluorouracil, Doxorubicin, Cyclophosphamide) vs. 4 FAC Cycles Followed by 8 Weekly Paclitaxel Administrations, as Adjuvant Treatment for Node Negative Operable Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 3|1929|Actual|Spanish Breast Cancer Research Group||2|||f||||f||||||||||2017-10-11 05:12:46.859391|2017-10-11 05:12:46.859391
NCT00129402|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2015-09-02|2010-01-14||August 2005||2005-08-01|September 2015|2015-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)|Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|248|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:12:46.96642|2017-10-11 05:12:46.96642
NCT00129415|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2015-05-21|||August 2000||2000-08-01|May 2015|2015-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions|The Effectiveness of UVA1 and UVB Irradiation in the Treatment of Inflammatory Dermatoses: An Open Pilot Study|Terminated||Phase 1/Phase 2|28|Actual|University of Michigan||2||Slow enrollment|f||||f||||||||||2017-10-11 05:12:47.691831|2017-10-11 05:12:47.691831
NCT00129428|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2015-04-30|||August 2002||2002-08-01|April 2015|2015-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix|The Effectiveness of UVB Irradiation in the Treatment of Skin Conditions With Altered Dermal Matrix: An Open Pilot Study|Completed||Phase 1/Phase 2|33|Actual|University of Michigan||1|||f||||f||||||||||2017-10-11 05:12:47.795574|2017-10-11 05:12:47.795574
NCT00129441|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2011-10-14|2011-05-25||August 2005||2005-08-01|October 2011|2011-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study|Treatment of Cognitive Disability in Schizophrenia With a GABA-A Alpha2/3 Receptor Agonist|Completed||Phase 2|16|Actual|University of Pittsburgh|Small sample size; RBANS may lack appropriate sensitivity for short-term study; between-group differences in baseline clinical symptoms & neuropsychological function; excluding those with more modest cognitive impairments (RBANS standard score >90).|2|||f||||f||||||||||2017-10-11 05:12:47.91643|2017-10-11 05:12:47.91643
NCT00129454|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2017-06-02|||September 1, 2005|Actual|2005-09-01|June 2017|2017-06-01|March 1, 2008|Actual|2008-03-01|February 22, 2008|Actual|2008-02-22||Interventional|||Telemedicine Treatment for Veterans With Gulf War Illness|Telemedicine Treatment for Veterans With Gulf War Illness|Completed||N/A|128|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-10-11 05:12:48.525478|2017-10-11 05:12:48.525478
NCT00129467|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2015-04-06|2013-10-16||February 2005||2005-02-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|September 2009|Actual|2009-09-01||Interventional||The number of baseline participants is the number of subjects who received the intervention|Methylphenidate for Depressed Cancer Patients Receiving Palliative Care|Methylphenidate for Depressed Cancer Patients in Hospice|Completed||N/A|47|Actual|VA Office of Research and Development|Frequency threshold for reporting nonserious adverse events was not determined at the start of the study, but a % was required to be entered in order to complete the adverse event module|2|||f||||t||||||||||2017-10-11 05:12:48.616527|2017-10-11 05:12:48.616527
NCT00129480|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2015-04-06|2014-06-10||January 2006||2006-01-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|January 2009|Actual|2009-01-01||Interventional|SEACAP|Veterans receiving healthcare in VA primary care|Improving Chronic Pain Treatment in Primary Care|Improving the Treatment of Chronic Pain in Primary Care|Completed||N/A|401|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:12:49.211306|2017-10-11 05:12:49.211306
NCT00129493|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2015-04-06|||February 2004||2004-02-01|May 2009|2009-05-01|August 2007|Actual|2007-08-01|March 2006|Actual|2006-03-01||Interventional|||Group Visits to Improve Hypertension Management|Group Visits to Improve Hypertension Management|Completed||N/A|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:12:49.507419|2017-10-11 05:12:49.507419
NCT00129506|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-09|2007-04-18|||May 2005||2005-05-01|April 2007|2007-04-01|October 2005||2005-10-01|||||Interventional|||Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion|Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion|Completed||Phase 4|300||Wiebe, Ellen, M.D.|||||f||||||||||||||2017-10-11 05:12:49.6017|2017-10-11 05:12:49.6017
NCT00129519|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2010-07-14|||January 2004||2004-01-01|July 2010|2010-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence|Open-label Study to Evaluate the Use of Imiquimod 5% Cream for Reducing Postsurgical Recurrence or Persistence of Basal Cell Carcinoma Following Excision by Curettage|Completed||Phase 3|63|Actual|Graceway Pharmaceuticals, LLC||1|||f||||f||||||||||2017-10-11 05:12:49.674437|2017-10-11 05:12:49.674437
NCT00129532|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2005-09-07|||January 2004||2004-01-01|August 2005|2005-08-01||||||||Interventional|||Trial of SAVVY and HIV in Ghana|Randomized Controlled Trial of SAVVY and HIV in Ghana|Unknown status|Active, not recruiting|Phase 3|2142||Biosyn|||||||||||||||||||2017-10-11 05:12:49.744704|2017-10-11 05:12:49.744704
NCT00129545|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2015-04-29|2014-10-03||February 2005||2005-02-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional||2:1 randomazation, outcome analysis excludes the 93 subjects in the Roll-in arm|WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation|WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation (PROTECT AF)|Completed||Phase 2/Phase 3|800|Actual|Boston Scientific Corporation||3|||f||||t||||||||||2017-10-11 05:12:49.826086|2017-10-11 05:12:49.826086
NCT00129558|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2013-12-02|||July 2005||2005-07-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate PT-523 in Patients With Refractory Leukemia|A Phase I/II Study of PT-523 in Patients With Refractory Leukemia|Withdrawn||Phase 1/Phase 2|0|Actual|Spectrum Pharmaceuticals, Inc|||||f||||||||||||||2017-10-11 05:12:50.881962|2017-10-11 05:12:50.881962
NCT00129571|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2008-06-02|||August 2005||2005-08-01|June 2008|2008-06-01||||||||Interventional|||Study of XL820 in Adults With Solid Tumors|A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of XL820 Administered Orally to Subjects With Solid Tumors|Completed||Phase 1|||Exelixis|||||||||||||||||||2017-10-11 05:12:50.948979|2017-10-11 05:12:50.948979
NCT00129584|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2009-08-14|||January 2004||2004-01-01|August 2009|2009-08-01||||||||Interventional|||Endobronchial Valve for Emphysema Palliation Trial (VENT)|Endobronchial Valve for Emphysema Palliation Trial (VENT)|Completed||Phase 3|270||Emphasys Medical|||||||||||||||||||2017-10-11 05:12:51.003677|2017-10-11 05:12:51.003677
NCT00129597|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2007-03-09|||December 2004||2004-12-01|March 2007|2007-03-01||||||||Interventional|||Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy|Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy|Unknown status|Active, not recruiting|Phase 4|40||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:12:51.079595|2017-10-11 05:12:51.079595
NCT00129610|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2007-04-26|||January 2004||2004-01-01|April 2007|2007-04-01||||||||Interventional|||Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia|A Comparative Controlled Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia|Unknown status|Active, not recruiting|N/A|90||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:12:51.14034|2017-10-11 05:12:51.14034
NCT00129623|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-12-05|2015-12-05||December 2005||2005-12-01|December 2015|2015-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional||Baseline characteristics are presented for the safety population which included participants who had at least one dose of the trial medication documented in the case report form (CRF) whether withdrawn prematurely or not.|A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia|Double-blind, Placebo-controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of Oral Ibandronate Once Monthly in Postmenopausal Women With Osteopenia|Completed||Phase 4|160|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:12:51.240037|2017-10-11 05:12:51.240037
NCT00129636|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-10-21|||March 2004||2004-03-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||The Usefulness of Patients Receiving Their Own Letter After an Outpatient Attendance|A Study to Determine the Usefulness of Patients Receiving Their Own Letter After an Outpatient Attendance Compared to Receiving a Copy of the Letter Being Sent to Their General Practitioner|Completed||N/A|150||Imperial College London|||||f||||||||||||||2017-10-11 05:12:51.877379|2017-10-11 05:12:51.877379
NCT00129649|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-10-21|||May 2005||2005-05-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||Service Development: Assessing Non-attendance Rates in Outpatient Clinics|Service Development: Assessing Non-attendance Rates in Outpatient Clinics|Completed||N/A|500||Imperial College London|||||f||||||||||||||2017-10-11 05:12:51.946562|2017-10-11 05:12:51.946562
NCT00129662|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2017-03-08|||January 2005||2005-01-01|May 2010|2010-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Comprehension and Evaluation of a Pictorial Action Plan for Those With Asthma or COPD|Comprehension and Evaluation of a Pictorial Action Plan for Those With Asthma or Chronic Obstructive Pulmonary Disease|Completed||N/A|69|Actual|Imperial College London||1|||f||||||||||||||2017-10-11 05:12:52.013953|2017-10-11 05:12:52.013953
NCT00129675|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2014-07-14||2014-07-14|February 2003||2003-02-01|July 2014|2014-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty|Development of a Imaging Marker for Parkinson's Disease Through Use of Dynamic SPECT Imaging With [123I] Beta-CIT in Individuals With Parkinson's Symptoms|Completed||Phase 2|169|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-10-11 05:12:52.090804|2017-10-11 05:12:52.090804
NCT00123929|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2009-08-03|||January 2005||2005-01-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer|Patterns of Genetic Expression Associated to Sensibility to Doxorubicin Versus Docetaxel as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer|Completed||Phase 2|250|Anticipated|Hospital San Carlos, Madrid||2|||f||||f||||||||||2017-10-11 05:12:52.172869|2017-10-11 05:12:52.172869
NCT00123942|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2007-06-12|||April 2004||2004-04-01|June 2007|2007-06-01||||||||Interventional|||Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease|Phase I Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease|Terminated||Phase 1|31|Anticipated|MedImmune LLC||||"After review of safety events and have decided that further dose escalation of MEDI-507 as a   single agent is not feasible."|||||||||||||||2017-10-11 05:12:52.258037|2017-10-11 05:12:52.258037
NCT00123955|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2015-02-23|2015-02-06||April 2005||2005-04-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|June 2009|Actual|2009-06-01||Interventional|||PIE II: Pharmacological Intervention in the Elderly II|Exercise Intolerance in Elderly Diastolic Heart Failure|Completed||Phase 3|80|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-10-11 05:12:52.339046|2017-10-11 05:12:52.339046
NCT00123968|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2014-07-21||2013-07-18|May 2006||2006-05-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults|A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Boosted by a Multiclade HIV-1 Recombinant Adenovirus-5 Vector Vaccine, VRC-HIVADV014-00-VP, in HIV Uninfected Adult Volunteers in East Africa|Completed||Phase 1/Phase 2|326|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-10-11 05:12:52.688504|2017-10-11 05:12:52.688504
NCT00123981|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2013-11-05|||January 2005||2005-01-01|November 2013|2013-11-01|January 2011|Actual|2011-01-01|November 2008|Actual|2008-11-01||Interventional|||The Danish On-pump, Off-pump Randomization Study (DOORS)|The Impact of Avoiding Cardiopulmonary By-pass During Coronary Artery Bypass Surgery for Ischemic Heart Disease in Elderly Patients: The Danish On-pump, Off-pump Randomization Study (DOORS)|Completed||N/A|900|Actual|Odense University Hospital||2|||f||||t||||||||||2017-10-11 05:12:52.810712|2017-10-11 05:12:52.810712
NCT00123994|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2005-11-02|||February 2004||2004-02-01|July 2005|2005-07-01|October 2005||2005-10-01|||||Interventional|||Tai Chi or Hydrotherapy for People With Osteoarthritis of the Hip(s) or Knee(s)|Tai Chi or Hydrotherapy for People With Osteoarthritis of the Hip(s) or Knee(s)|Unknown status|Active, not recruiting|N/A|150||St George Hospital, Australia|||||f||||||||||||||2017-10-11 05:12:52.905239|2017-10-11 05:12:52.905239
NCT00124007|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2014-07-07|||November 2005||2005-11-01|July 2014|2014-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults|A Phase I, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine Followed by Recombinant, Multiclade HIV-1 Adenoviral Vector Vaccine or the Multiclade HIV-1 Adenoviral Vector Vaccine Alone in Healthy Adult Volunteers Not Infected With HIV|Completed||Phase 1|114|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:12:53.003144|2017-10-11 05:12:53.003144
NCT00124020|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2010-05-14|2009-11-03||January 2005||2005-01-01|May 2010|2010-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|ATTAIN2||Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus|A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia With a Focus on Patients With Infections Due to Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 3|771|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-10-11 05:12:53.124347|2017-10-11 05:12:53.124347
NCT00124033|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2006-09-07|||March 2004||2004-03-01|June 2005|2005-06-01|December 2015||2015-12-01|||||Interventional|||Management of Common Bile Duct (CBD) Stones at Laparoscopic Cholecystectomy|Management of CBD Stones at Laparoscopic Cholecystectomy: A NSW Collaborative Prospective Randomised Trial to Assess the Value of Transcystically Inserted CBD Stents to Facilitate Post-Operative ERCP|Terminated||N/A|340||South West Sydney Local Health District|||||f||||||||||||||2017-10-11 05:12:54.511304|2017-10-11 05:12:54.511304
NCT00124046|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2016-05-30|||September 2005||2005-09-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||Treatment of Persistent Urinary Incontinence in Children|Treatment of Persistent Urinary Incontinence in Children|Completed||N/A|14|Actual|University of British Columbia||2|||f||||f||||||||||2017-10-11 05:12:54.603151|2017-10-11 05:12:54.603151
NCT00131300|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2015-03-17|||April 2004||2004-04-01|March 2015|2015-03-01|February 2006||2006-02-01|||||Interventional|||A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis||Completed||Phase 3|||Sanofi|||||f||||||||||||||2017-10-11 05:13:22.723002|2017-10-11 05:13:22.723002
NCT00124059|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2015-10-02|||March 2003||2003-03-01|September 2013|2013-09-01|October 2005|Actual|2005-10-01|September 2005|Actual|2005-09-01||Interventional|||Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.|A Double-Blind Study of Quetiapine Fumarate (Seroquel) for the Treatment of Type A vs.Type B Alcoholics.|Completed||Phase 3|61|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 05:12:54.677677|2017-10-11 05:12:54.677677
NCT00124072|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2012-01-31|2010-03-29||July 1998||1998-07-01|January 2012|2012-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|SEARCH||Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine|SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine|Completed||Phase 3|12064|Actual|University of Oxford||4|||f||||t||||||||||2017-10-11 05:12:54.761803|2017-10-11 05:12:54.761803
NCT00124085|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-22|2012-08-07|||October 2003||2003-10-01|August 2012|2012-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Asthma in a Decentralized Patient Population: Is Traditional Disease Management Enough?|Asthma in a Decentralized Patient Population: Is Traditional Disease Management Enough? A Randomized, Controlled Trial Comparing Traditional Care to Two Systems of Disease Management for a Decentralized Population of Patients in South Texas|Completed||N/A|1053||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 05:12:55.096215|2017-10-11 05:12:55.096215
NCT00124098|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-06-13||||||June 2008|2008-06-01||||||||Interventional|||An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)|An Open-Label Study of Aranesp® (Darbepoetin Alfa) Administration Once Every Four Weeks in Anaemic Chronic Kidney Disease (CKD) Subjects|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-10-11 05:12:55.164775|2017-10-11 05:12:55.164775
NCT00124111|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2010-02-25||||||February 2010|2010-02-01||||||||Interventional|||A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer|A Single-arm Study Evaluating the Relative Dose Intensity of IV CMF Given on Day 1 and Day 8 With Pegfilgrastim Support in Subjects With Stage I-III Breast Cancer|Completed||Phase 2|||Amgen||1|||f||||||||||||||2017-10-11 05:12:55.231021|2017-10-11 05:12:55.231021
NCT00124124|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2015-02-11|||July 2005||2005-07-01|February 2015|2015-02-01|April 2009|Actual|2009-04-01|July 2008|Actual|2008-07-01||Interventional|||Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine|A Randomized, Controlled Trial of Melanoma Treatment: Comparison of Dendritic Cells Versus Montanide as Adjuvants to Stimulate Anti-tumor Immunity|Completed||Phase 1|50|Actual|Bhardwaj, Nina, M.D.||2|||f||||t||||||||||2017-10-11 05:12:55.483863|2017-10-11 05:12:55.483863
NCT00124137|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2007-03-14|||April 2004||2004-04-01|December 2005|2005-12-01|October 2005||2005-10-01|||||Interventional|||Ultrafiltration Versus Intravenous (IV) Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: (UNLOAD)|Ultrafiltration Versus IV Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Clinical Trial|Completed||N/A|200||CHF Solutions|||||f||||||||||||||2017-10-11 05:12:55.56099|2017-10-11 05:12:55.56099
NCT00124150|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2009-12-21|||June 2002||2002-06-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)|Phase 3 Study (Multi-center, Randomized Controlled Clinical Trial) of Intravenous Magnesium Sulfate to Improve Outcome After Aneurysmal Subarachnoid Haemorrhage|Completed||Phase 3|327|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 05:12:55.63285|2017-10-11 05:12:55.63285
NCT00124163|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2006-01-31|||July 2005||2005-07-01|January 2006|2006-01-01||||||||Observational|||Evaluation of Stool Tagging for Improved Patient Compliance|CT Colonography Ph. I CDI Trial: Evaluation of Stool Tagging for Improved Patient Compliance|Unknown status|Recruiting|Phase 1|60||Center for Diagnostic Imaging|||||f||||||||||||||2017-10-11 05:12:55.718342|2017-10-11 05:12:55.718342
NCT00124176|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2013-02-12|2010-07-14||April 2004||2004-04-01|December 2012|2012-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Continuous Levalbuterol for Treatment of Status Asthmaticus in Children|Continuous Levalbuterol for Treatment of Status Asthmaticus in Children|Completed||Phase 4|81|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-10-11 05:12:55.801261|2017-10-11 05:12:55.801261
NCT00124189|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2015-12-22|||July 2005||2005-07-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)|A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of GRN163L in Patients With Chronic Lymphoproliferative Disease|Completed||Phase 1|48|Anticipated|Geron Corporation||1|||f||||f||||||||||2017-10-11 05:12:56.100855|2017-10-11 05:12:56.100855
NCT00124202|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2013-07-29|||May 2003||2003-05-01|July 2013|2013-07-01|May 2007|Actual|2007-05-01|December 2004|Actual|2004-12-01||Interventional|||Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP)|Effect of a Fatty Meal on Cannulation at Endoscopic Retrograde Cholangiopancreatography|Completed||Phase 1/Phase 2|80|Actual|Emory University||1|||f||||f||||||||||2017-10-11 05:12:56.201995|2017-10-11 05:12:56.201995
NCT00124215|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-25|2010-05-03|||June 2005||2005-06-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection|A Phase 1 Double-Blind, Placebo Controlled, Dose-Escalation, Multi-center Therapeutic Trial of the Safety, Immunogenicity, and Efficacy of GI-5005; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing a Hepatitis C Virus NS3-Core Fusion Protein, in Patients With Chronic Hepatitis C Infection|Completed||Phase 1|48|Anticipated|GlobeImmune||1|||f||||||||||||||2017-10-11 05:12:56.282811|2017-10-11 05:12:56.282811
NCT00124228|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2010-05-26|||November 2004||2004-11-01|August 2009|2009-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|Infecir||Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis|Effects of Intravenous Albumin Administration on Renal Function and Survival in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. A Prospective, Stratified, Randomized and Controlled Study.|Completed||Phase 3|110|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-10-11 05:12:56.449346|2017-10-11 05:12:56.449346
NCT00129688|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2005-09-22|||April 2002||2002-04-01|February 2005|2005-02-01|June 2004||2004-06-01|||||Interventional|||Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children|Comparison of Efficacy, Safety and Economic Outcomes Between Once-Daily Versus Twice-Daily Amikacin in Combination With Cloxacillin in Febrile Neutropenic Children|Completed||N/A|166||Khon Kaen University|||||f||||||||||||||2017-10-11 05:12:56.543386|2017-10-11 05:12:56.543386
NCT00129701|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-05-27|||November 2003||2003-11-01|August 2005|2005-08-01|January 2006||2006-01-01|||||Interventional|||Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation|Proposal to Study Whether we Can Reduce Hospital Attendance by Those With Respiratory Conditions Without Compromising Care by the Use of Telephone Consultation|Completed||N/A|500||Imperial College London|||||f||||||||||||||2017-10-11 05:12:56.628859|2017-10-11 05:12:56.628859
NCT00129714|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2012-04-23|||August 2003||2003-08-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|April 2007|Actual|2007-04-01||Interventional|WEB||Westeinde Brachialgia Study|A Randomized Controlled Trial of Conservative Therapy in Cervical Radiculopathy|Completed||N/A|240||Medical Center Haaglanden||3|||f||||||||||||||2017-10-11 05:12:56.716741|2017-10-11 05:12:56.716741
NCT00129727|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2016-04-24|2011-07-20||June 2005||2005-06-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)|Phase II Evaluation of Carboplatin, Paclitaxel and Bevacizumab as First Line Chemotherapy and Consolidation for Advanced Ovarian Cancer|Completed||Phase 2|62|Actual|Massachusetts General Hospital|Phase II uncontrolled trial|1|||f||||t||||||||Yes|Manuscript was published in JCO|2017-10-11 05:12:56.834261|2017-10-11 05:12:56.834261
NCT00129740|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2017-07-03|||June 27, 2005|Actual|2005-06-27|July 2017|2017-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Oral Nilotinib|Active, not recruiting||Phase 2|149|Actual|M.D. Anderson Cancer Center||1|||f||||t|t|f||||||||2017-10-11 05:12:57.091538|2017-10-11 05:12:57.091538
NCT00129753|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2016-04-06|||June 2005||2005-06-01|October 2010|2010-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease|Phase II Study of Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Terminated due to slow accrual.|f||||f||||||||||2017-10-11 05:12:57.194927|2017-10-11 05:12:57.194927
NCT00129766|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2013-06-21|2013-06-21||November 2004||2004-11-01|June 2013|2013-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children|A Pivotal Phase 3 Study of MEDI-524 (Numax; Motavizumab), an Enhanced Potency Humanized RSV Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children|Completed||Phase 3|6635|Actual|MedImmune LLC||2|||f||||t||||||||||2017-10-11 05:12:57.427781|2017-10-11 05:12:57.427781
NCT00129779|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-06-04|||December 2003||2003-12-01|May 2008|2008-05-01|August 2006||2006-08-01|||||Interventional|||Assessment of the Effects of an Intermediate Care Package in Preventing Hospitalisation of Patients With COPD|A Randomised Control Trial Assessing the Effects of an Intermediate Care Package in Preventing Hospitalisation of Elderly Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|122||Imperial College London|||||f||||||||||||||2017-10-11 05:13:00.491733|2017-10-11 05:13:00.491733
NCT00129792|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2014-10-27|||January 2005||2005-01-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|June 2007|Actual|2007-06-01||Interventional|||Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome|Expectancy, Self-Efficacy and Outcomes in Metabolic Syndrome|Completed||N/A|79|Actual|Oregon Health and Science University||3|||f||||t||||||||||2017-10-11 05:13:00.569491|2017-10-11 05:13:00.569491
NCT00129805|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2008-08-18|||January 2001||2001-01-01|August 2008|2008-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)|Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial|Completed||Phase 3|1510|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 05:13:00.669816|2017-10-11 05:13:00.669816
NCT00129818|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2012-04-26|||July 2004||2004-07-01|April 2012|2012-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding|A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding|Completed||Phase 4|||Novartis|||||||||||||||||||2017-10-11 05:13:00.744385|2017-10-11 05:13:00.744385
NCT00129831|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2011-10-24|||September 2004||2004-09-01|October 2011|2011-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)|Dose Escalation Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|6|Actual|Novartis|||||||||||||||||||2017-10-11 05:13:00.827807|2017-10-11 05:13:00.827807
NCT00129844|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2008-08-19|||September 2005||2005-09-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer|Randomized Phase II Trial of Single Agent Motexafin Gadolinium for Second Line Treatment of Non-Small-Cell Lung Cancer|Completed||Phase 2|108|Anticipated|Pharmacyclics LLC.|||||||||||||||||||2017-10-11 05:13:02.339169|2017-10-11 05:13:02.339169
NCT00129857|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2006-05-04|||January 2001||2001-01-01|November 2004|2004-11-01|September 2004||2004-09-01|||||Interventional|||Dexanabinol in Severe Traumatic Brain Injury|Efficacy and Safety Evaluation of a Single Intravenous Dose of Dexanabinol in Patients Suffering From Severe Traumatic Brain Injury|Completed||Phase 3|860||Pharmos|||||||||||||||||||2017-10-11 05:13:02.526218|2017-10-11 05:13:02.526218
NCT00129870|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2009-02-12|||February 2005||2005-02-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|||||Interventional|||CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer|CONCEPT - Phase IV, Randomized, Prospective, Multicenter Comparison of Intermittent Schedule of Oxaliplatin Combined With FOLFOX/Bevacizumab vs Conventional Mode of Administration of FOLFOX/Bevacizumab + Neuroprophylaxis With Calcium/Magnesium for Optimization of First-Line Therapy of Metastatic Colorectal Cancer|Terminated||Phase 4|180|Actual|Sanofi||||"Unplanned interim analysis by DSMB indicated possible reduced response rate with the addition   of Ca/Mg in pooled population. Further analysis pending."|f||||t||||||||||2017-10-11 05:13:02.589801|2017-10-11 05:13:02.589801
NCT00129883|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2005-09-26|||September 2002||2002-09-01|August 2002|2002-08-01|April 2005||2005-04-01|||||Interventional|||Adherence to Guidelines for Antibiotic Use in Respiratory Infections at Hospitals|Prevention of Antimicrobial Resistance in Hospitals: Promoting Appropriate Use of Antibiotics in Hospital Departments of Internal and Pulmonary Medicine|Completed||N/A|2000||Radboud University|||||f||||||||||||||2017-10-11 05:13:02.662245|2017-10-11 05:13:02.662245
NCT00129896|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2009-04-27|||January 2004||2004-01-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|||||Interventional|||Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients|Open-Label Phase I-II Clinical Trial to Evaluate Treatment With Myocet/Taxotere/Herceptin as Primary Chemotherapy Treatment for HER2neu Positive Breast Cancer Patients|Completed||Phase 1/Phase 2|59|Anticipated|Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:13:02.749948|2017-10-11 05:13:02.749948
NCT00129909|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2012-06-13|||May 2005||2005-05-01|June 2012|2012-06-01|January 2007|Actual|2007-01-01|September 2006|Actual|2006-09-01||Interventional|||STITCH (Simplified Therapeutic Intervention To Control Hypertension)|Evaluation of a Primary Treatment Algorithm Using Fixed Dose Combination Therapy for the Management of Hypertension - Control and Intervention Arms|Completed||Phase 4|2081|Actual|University of Western Ontario, Canada||1|||f||||f||||||||||2017-10-11 05:13:02.835639|2017-10-11 05:13:02.835639
NCT00129922|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2005-09-26|||November 1999||1999-11-01|August 2005|2005-08-01|July 2007||2007-07-01|||||Interventional|||Fluorouracil, Epirubicin, and Cyclophosphamide (FEC) Versus FEC Plus Paclitaxel as Adjuvant Treatment for Node Positive Breast Cancer Patients|Multicenter Randomized Phase III Clinical Trial to Compare 6 Courses of FEC (Fluorouracil, Epirubicin and Cyclophosphamide) Vs. 4 Courses of FEC Followed by 8 Weekly Paclitaxel Administrations, as Adjuvant Treatment for Node Positive Operable Breast Cancer Patients|Completed||Phase 3|1250||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:13:02.911143|2017-10-11 05:13:02.911143
NCT00129935|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2007-02-06|||February 2004||2004-02-01|February 2007|2007-02-01|February 2012||2012-02-01|||||Interventional|||EC (Epirubicin, Cyclophosphamide) Followed by T (Docetaxel) Versus ET (Epirubicin, Docetaxel) Followed by X (Capecitabine) as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Patients|Multicenter, Randomized Phase III Trial to Compare Epirubicin and Cyclophosphamide (EC) Followed by Docetaxel (T) to Epirubicin and Docetaxel (ET) Followed by Capecitabine (X) as Adjuvant Treatment for Operable, Node Positive Breast Cancer Patients|Completed||Phase 3|1382||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:13:02.993252|2017-10-11 05:13:02.993252
NCT00129948|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2006-11-01|||July 2005||2005-07-01|November 2006|2006-11-01|October 2007||2007-10-01|||||Interventional|||Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)|An Open-Label, Single-Arm, Multi-Center, Phase II Study of Troxatyl™ (Troxacitabine) Administered by Continuous Infusion in Patients With Acute Myeloid Leukemia (AML) in Second Salvage|Terminated||Phase 2|211||SGX Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 05:13:03.077201|2017-10-11 05:13:03.077201
NCT00129961|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2012-04-09|2010-01-29||August 2005||2005-08-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients|A Randomized, Open-Label Study to Compare the Rate of New Non-Melanoma Skin Cancer in Maintenance Renal Allograft Recipients Converted to a Sirolimus-based Regimen Versus Continuation of a Calcineurin Inhibitor-based Regimen|Completed||Phase 4|86|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|A blinded review of data in May 2007 determined there was minimal added power in follow-up through 2 years vs. 1 year. The study was then amended to require at least 1 year of follow-up instead of 2 years.|2|||f||||f||||||||||2017-10-11 05:13:04.304852|2017-10-11 05:13:04.304852
NCT00129974|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2017-03-29|2017-02-01||August 2005||2005-08-01|March 2017|2017-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer|A Phase II Trial of Pemetrexed in Combination With Gemcitabine as First Line Treatment in Extensive-Stage Small Cell Lung Carcinoma|Terminated||Phase 2|1|Actual|Tufts Medical Center||||failure to accrue|f||||||||||||||2017-10-11 05:13:05.798801|2017-10-11 05:13:05.798801
NCT00129987|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-06-03|||November 2003||2003-11-01|May 2008|2008-05-01|August 2006||2006-08-01|||||Interventional|||Trial of Lay-led Individualised Self-management Education for Adults With Asthma|A Multi-centre Randomised Trial of Lay-led Individualised Self-management Education for Adults With Asthma|Completed||N/A|640||Imperial College London|||||f||||||||||||||2017-10-11 05:13:05.971984|2017-10-11 05:13:05.971984
NCT00130000|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2017-06-30|||August 9, 2005||2005-08-09|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Interventional|||Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria|SHEPHERD: Safety in Hemolytic PNH Patients Treated With Eculizumab: A Multi-Center Open-Label Research Design|Completed||Phase 3|87||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:13:06.06728|2017-10-11 05:13:06.06728
NCT00130013|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2005-09-22|||September 2003||2003-09-01|July 2004|2004-07-01|June 2004||2004-06-01|||||Interventional|||Efficacy of Single Versus Double Dose of Oral Amoxicillin for Non-Severe Pneumonia in Children|Comparison of Standard Versus Double Dose of Amoxicillin in the Treatment of Non-Severe Pneumonia in Children Aged 2-59 Months: A Multi-Centre Randomized Double Blind Controlled Trial in Pakistan|Completed||Phase 1/Phase 2|900||ARI Research Cell|||||f||||||||||||||2017-10-11 05:13:06.145025|2017-10-11 05:13:06.145025
NCT00130078|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2005-09-22|||September 2004||2004-09-01|August 2005|2005-08-01||||||||Interventional|||Trial of SAVVY Vaginal Gel and HIV in Nigeria|Randomized Controlled Trial of SAVVY and HIV in Nigeria|Unknown status|Recruiting|Phase 3|2142||Biosyn|||||||||||||||||||2017-10-11 05:13:06.219951|2017-10-11 05:13:06.219951
NCT00130091|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-02-18|||September 2009||2009-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children|The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children|Completed||Phase 2|120|Actual|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-11 05:13:06.299753|2017-10-11 05:13:06.299753
NCT00130104|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2007-10-03|||July 2005||2005-07-01|August 2005|2005-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Transthecal Metacarpal Block Versus Traditional Digital Block for Painful Finger Procedures in Children|Transthecal Metacarpal Block vs Traditional Digital Block for Painful Finger Procedures in Children|Completed||Phase 4|92|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-11 05:13:06.398937|2017-10-11 05:13:06.398937
NCT00130117|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2017-04-13|2015-12-24||April 2010||2010-04-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|August 2011|Actual|2011-08-01||Interventional|||Study of Leptin for the Treatment of Hypothalamic Amenorrhea|Randomized, Double-blind, Placebo-controlled Trial of Human Recombinant Leptin (r-metHuLeptin) for the Treatment of Hypothalamic (Exercise-Induced) Amenorrhea|Completed||Phase 2|20|Actual|Beth Israel Deaconess Medical Center|Number of participants was small and, therefore, our observations need to be validated in studies with larger sample sizes.|2|||f||||f||||||||No||2017-10-11 05:13:06.501264|2017-10-11 05:13:06.501264
NCT00130130|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2012-01-30|||August 2005||2005-08-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Observational|||Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes|Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes|Completed||Phase 1/Phase 2|20|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||||||||||||2017-10-11 05:13:07.087128|2017-10-11 05:13:07.087128
NCT00130143|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2005-09-26|||June 2003||2003-06-01|August 2005|2005-08-01|September 2004||2004-09-01|||||Interventional|||Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities|Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities|Completed||N/A|20||The Dale & Frances Hughes Cancer Center|||||f||||||||||||||2017-10-11 05:13:07.151676|2017-10-11 05:13:07.151676
NCT00130156|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2013-05-13|||October 2005||2005-10-01|February 2011|2011-02-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension|Effects of Combination Therapy With an α1-blocker (Sustained-release Preparation of Bunazosin or Doxazosin) in Inadequate Responders to an Angiotensin II Antagonist (Valsartan) in the Treatment of Patients With Mild to Moderate Essential Hypertension|Completed||Phase 4|93|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 05:13:07.232605|2017-10-11 05:13:07.232605
NCT00130169|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2015-06-29|||January 2006||2006-01-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies|A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies|Completed||Phase 1|30|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 05:13:07.365964|2017-10-11 05:13:07.365964
NCT00130182|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2013-05-21|||August 2005||2005-08-01|May 2013|2013-05-01||||September 2006|Actual|2006-09-01||Interventional|||A Study in Pediatric Patients With Cystic Fibrosis Lung Disease|A Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Pediatric Patients With Cystic Fibrosis Lung Disease|Completed||Phase 2|13|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:13:07.439222|2017-10-11 05:13:07.439222
NCT00130195|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2008-11-13|||September 2002||2002-09-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)|Phase 2 Study of Imatinib-Combined Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia|Completed||Phase 2|100|Actual|Japan Adult Leukemia Study Group||1|||f||||t||||||||||2017-10-11 05:13:07.511153|2017-10-11 05:13:07.511153
NCT00130208|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-04-13||2015-04-13|August 2005||2005-08-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Sulodexide in Early Diabetic Nephropathy|The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria|Completed||Phase 3|1000|Actual|Keryx Biopharmaceuticals||2|||f||||||||||||||2017-10-11 05:13:07.616985|2017-10-11 05:13:07.616985
NCT00130221|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2007-04-03|||June 2005||2005-06-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Interventional|||Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections|Skin Cleansing With Chlorhexidine to Improve Nosocomial Infection Risks. (SCCIN Project)|Completed||Phase 1|208||John H. Stroger Hospital|||||f||||f||||||||||2017-10-11 05:13:07.702321|2017-10-11 05:13:07.702321
NCT00130234|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2008-05-06|||November 2004||2004-11-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effect of Anti-IgE in Chronic Urticaria|Effect of Anti-IgE in Chronic Urticaria|Completed||Phase 2|20||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:13:07.779994|2017-10-11 05:13:07.779994
NCT00130247|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2013-01-31|2009-08-20||April 2002||2002-04-01|April 2010|2010-04-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Tuberculosis Treatment Shortening Trial|A Prospective Study of Shortening the Duration of Standard Short Course Chemotherapy From 6 Months to 4 Months in HIV-non-infected Patients With Fully Drug-Susceptible, Non-cavitary Pulmonary Tuberculosis With Negative Sputum Cultures After 2 Months of Anti-TB Treatment|Completed||Phase 3|394|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Enrollment was stopped early and the number of patients enrolled was 1/2 of the original sample size. The study was completed.|2|||f||||||||||||||2017-10-11 05:13:07.869806|2017-10-11 05:13:07.869806
NCT00130260|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2007-12-26|||August 2005||2005-08-01|December 2007|2007-12-01|April 2006|Actual|2006-04-01|December 2005|Actual|2005-12-01||Interventional|SHIELD-2||Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease|Phase 3b Multicenter, Randomized, Placebo-Controlled, Double-Blind Study Evaluating Immunogenicity and Safety of a 3rd and 4th Dose of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adults With End-Stage Renal Disease|Terminated||Phase 3|99|Actual|Nabi Biopharmaceuticals||4||unsatisfactory efficacy data from preceding trial|f||||f||||||||||2017-10-11 05:13:08.558795|2017-10-11 05:13:08.558795
NCT00130273|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2012-07-12|||July 2005||2005-07-01|July 2012|2012-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|MAPS||Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV|Managed Problem Solving: An HIV Adherence Trial|Completed||N/A|180|Actual|University of Pennsylvania||2|||f||||||||||||||2017-10-11 05:13:08.649294|2017-10-11 05:13:08.649294
NCT00130286|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2014-02-10|2013-12-16||March 2005||2005-03-01|February 2014|2014-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance|Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Recombinant Human Growth Hormone and/or Rosiglitazone in the Treatment of Human Immunodeficiency Virus-Associated Visceral Adiposity and Insulin Resistance|Completed||Phase 1/Phase 2|77|Actual|Weill Medical College of Cornell University||4|||f||||t||||||||||2017-10-11 05:13:08.749175|2017-10-11 05:13:08.749175
NCT00130299|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2010-08-27|||July 2004||2004-07-01|August 2010|2010-08-01|December 2006|Actual|2006-12-01|||||Interventional|||An 18-month Trial of a Low Glycemic Load Diet|An 18-month Randomized Controlled Trial of a Low Glycemic Load Diet|Completed||N/A|||Boston Children’s Hospital|||||f||||||||||||||2017-10-11 05:13:09.399245|2017-10-11 05:13:09.399245
NCT00130312|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-04-13||2015-04-13|August 2005||2005-08-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Sulodexide in Overt Diabetic Nephropathy|The Collaborative Study Group Trial: The Effect of Sulodexide in Overt Type 2 Diabetic Nephropathy|Terminated||Phase 4|1248|Actual|Keryx Biopharmaceuticals||2||No difference in protein excretion at 6&12 months. No safety issues.|f||||t||||||||||2017-10-11 05:13:09.460636|2017-10-11 05:13:09.460636
NCT00130325|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2010-01-12|||October 2004||2004-10-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Interventional|IRS||A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts|A Double Blind Placebo-controlled Randomized Trial of Isoniazid for the Reversion of a Positive IFNg ELISPOT in TB Case Contacts|Completed||N/A|214|Actual|Medical Research Council Unit, The Gambia||2|||f||||f||||||||||2017-10-11 05:13:09.654696|2017-10-11 05:13:09.654696
NCT00130338|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2017-03-24|||February 2002||2002-02-01|March 2017|2017-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Rivastigmine Capsules in Patients With Probable Vascular Dementia|An Open-label Extension to Evaluate the Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia|Completed||Phase 3|521|Actual|Novartis|||||f||||||||||||||2017-10-11 05:13:09.754956|2017-10-11 05:13:09.754956
NCT00130351|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2011-10-24|||July 2005||2005-07-01|October 2011|2011-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma|A 3-week Multicenter Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma|Completed||Phase 3|155|Actual|Novartis|||||||||||||||||||2017-10-11 05:13:09.827646|2017-10-11 05:13:09.827646
NCT00130364|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2008-01-10|||August 2005||2005-08-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis|Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis|Completed||Phase 4|200||Novartis||2|||f||||||||||||||2017-10-11 05:13:09.937562|2017-10-11 05:13:09.937562
NCT00130377|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2016-09-26|||August 2002||2002-08-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com|Biological Cell Therapy for the Treatment of Patients With Thoracic & Cardiovascular Disease|Recruiting||Phase 2/Phase 3|1000|Anticipated|Amit, Patel N, M.D.||2|||f||||t||||||||||2017-10-11 05:13:10.066686|2017-10-11 05:13:10.066686
NCT00130390|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2012-05-30|||August 2005||2005-08-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease|Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in Adults|Terminated||Phase 2|98|Actual|Romark Laboratories L.C.||2||terminated due to slow recruitment|f||||f||||||||||2017-10-11 05:13:10.178565|2017-10-11 05:13:10.178565
NCT00130403|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2011-01-10|||March 2004||2004-03-01|January 2011|2011-01-01|March 2007|Actual|2007-03-01|||||Interventional|||OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women|Open-Label Study to Determine How Prior Therapy With Alendronate or Risedronate in Postmenopausal Women With Osteoporosis Influences the Clinical Effectiveness of Teriparatide|Completed||Phase 4|290|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:13:10.306279|2017-10-11 05:13:10.306279
NCT00130416|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2008-07-03|||September 2004||2004-09-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|||||Interventional|||Improving Chronic Disease Care With PatientSite|Improving Chronic Disease Care With PatientSite|Completed||N/A|750||Robert Wood Johnson Foundation|||||f||||f||||||||||2017-10-11 05:13:10.408583|2017-10-11 05:13:10.408583
NCT00130429|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2009-08-20|||January 2004||2004-01-01|August 2009|2009-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease|Phase II Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Investigate the Safety, Effect on Cognition and Pharmacokinetic Profile of PYM50028 in Subjects With Mild Dementia of the Alzheimer's Type|Completed||Phase 2|250||Phytopharm|||||f||||||||||||||2017-10-11 05:13:10.493375|2017-10-11 05:13:10.493375
NCT00130442|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2016-03-30|||June 2005||2005-06-01|March 2016|2016-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma|A Phase II Study of PI-88 With Dacarbazine in Patients With Metastatic Melanoma|Completed||Phase 2|131|Actual|Medigen Biotechnology Corporation||2|||f||||t||||||||||2017-10-11 05:13:10.572193|2017-10-11 05:13:10.572193
NCT00130455|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2007-02-05|||April 2006||2006-04-01|February 2007|2007-02-01|January 2008||2008-01-01|||||Interventional|||Treatment of Depression in the Elderly|A 12 Week Multi-Centre, Randomized, Double-Blind, Placebo Controlled Evaluation of the Most Efficacious and Tolerable Dose of Escitalopram in the Treatment of Elderly Patients|Terminated||Phase 4|189||Psychiatric Hospital, Hillerod|||||f||||||||||||||2017-10-11 05:13:10.687597|2017-10-11 05:13:10.687597
NCT00130468|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2008-04-01|||November 2004||2004-11-01|April 2008|2008-04-01|May 2006||2006-05-01|||||Interventional|||TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis|A Double Blind, Randomized Trial of Intra-Articular Injections of 20 mg of Hyalgan® for the Treatment of Knee Pain Due to Osteoarthritis (Three Injection-Regimen for Efficacy And Duration-20 mg/2mL Dose: Tread-20)|Completed||Phase 4|150||Sanofi|||||f||||||||||||||2017-10-11 05:13:10.775045|2017-10-11 05:13:10.775045
NCT00130481|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2012-03-06|||April 2005||2005-04-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)|Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)|Completed||N/A|100||University of Florida|||||f||||||||||||||2017-10-11 05:13:10.841162|2017-10-11 05:13:10.841162
NCT00130494|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2007-02-06|||August 2002||2002-08-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-Symptomatic Bone Lesions|Multicenter, Open-Label, Randomized Phase III Trial for Administration of Zoledronate to Breast Cancer Metastatic Patients With Non-Symptomatic Bone Lesions|Terminated||Phase 3|224||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:13:10.930004|2017-10-11 05:13:10.930004
NCT00130507|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2011-10-25|||November 2005||2005-11-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab|Randomized Clinical Trial to Assess the Benefit of Adding Trastuzumab to Capecitabine and Vinorelbine as Second Line Treatment for HER2 Positive Breast Cancer Patients With Locally Advanced or Metastatic Disease, Progressing to a Previous Therapy Line With Trastuzumab and Taxanes|Terminated||Phase 2|14|Actual|Spanish Breast Cancer Research Group||2||"A new alternative treatment caused the decrease in the rhythm of recruitment and finally   termination of the trial."|f||||||||||||||2017-10-11 05:13:11.009362|2017-10-11 05:13:11.009362
NCT00130520|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2012-05-22|2010-12-13||June 2005||2005-06-01|December 2010|2010-12-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer|Phase II Open-Label Trial of Erlotinib (Tarceva) and Bevacizumab in Women With Advanced Ovarian Cancer|Completed||Phase 2|40|Actual|University of Arizona||1|||f||||t||||||||||2017-10-11 05:13:11.121442|2017-10-11 05:13:11.121442
NCT00130533|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2017-09-08|||January 2006||2006-01-01|September 2017|2017-09-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients|Multicenter, Open-label, Randomized Phase III Trial, to Evaluate Efficacy of Maintenance Treatment With Capecitabine (X) Following Standard Adjuvant Chemotherapy, in Operable Breast Cancer Patients With Negative Hormone Receptor, Negative HER2 Tumours|Completed||Phase 3|876|Actual|Spanish Breast Cancer Research Group||2|||f||||||||||||||2017-10-11 05:13:11.559244|2017-10-11 05:13:11.559244
NCT00130546|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2009-05-14|||November 2004||2004-11-01|May 2009|2009-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)|A Prospective, Randomized Intra-Individual Study With the Sirolimus Coated Cypher Select(TM) and the Paclitaxel(TM) Coated Express Balloon Expandable Stents for the Treatment of Patients With Two de Novo Native Coronary Artery Lesions.|Completed||Phase 3|112|Actual|University Hospital Freiburg||2|||f||||t||||||||||2017-10-11 05:13:11.66246|2017-10-11 05:13:11.66246
NCT00130559|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2011-10-18|||December 2003||2003-12-01|October 2011|2011-10-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||B-type Natriuretic Peptide (BNP)-Guided Diagnostic Strategy in Intensive Care Unit (ICU) Patients With Respiratory Failure|Does a Diagnostic Strategy Reduce Duration and Cost of Hospitalization in Patients With Acute Dyspnea? BASEL II Intensive Care Unit|Completed||Phase 4|286|Actual|University Hospital, Basel, Switzerland||1|||f||||||||||||||2017-10-11 05:13:11.781955|2017-10-11 05:13:11.781955
NCT00130572|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2008-05-21|||June 2004||2004-06-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Elidel Cream on Erosive Oral Lichen Planus|Randomized Placebo-Controlled Clinical Pilot Trial Regarding the Efficacy of Elidel Cream on Erosive Oral Lichen Planus|Completed||Phase 3|20|Actual|University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:13:11.914741|2017-10-11 05:13:11.914741
NCT00130585|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2005-10-03|||May 2005||2005-05-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Bioavailability of Folate From a Mixed Diet Using a Stable Isotope Method|The Relative Bioavailability of Folate From a Mixed Diet Compared to Synthetic Folic Acid Using a Stable Isotope Method|Completed||N/A|75||Wageningen University|||||f||||||||||||||2017-10-11 05:13:11.979389|2017-10-11 05:13:11.979389
NCT00130598|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2010-03-04|||June 2005||2005-06-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION|PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION|Completed||Phase 2/Phase 3|258|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-10-11 05:13:12.060204|2017-10-11 05:13:12.060204
NCT00130611|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2013-05-28|||January 2004||2004-01-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice|B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice|Completed||Phase 4|250|Actual|University Hospital, Basel, Switzerland||2|||f||||||||||||||2017-10-11 05:13:12.168089|2017-10-11 05:13:12.168089
NCT00130624|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2005-10-04|||June 2001||2001-06-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||The Winchester Falls Project|The Winchester Falls Project: A Cluster Randomised Community Intervention Trial of Secondary Prevention of Falls in Community-Dwelling Older People|Completed||Phase 3|516||Winchester and Eastleigh Healthcare NHS Trust|||||f||||||||||||||2017-10-11 05:13:12.27749|2017-10-11 05:13:12.27749
NCT00130637|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2017-01-27|2010-08-12||August 2005||2005-08-01|January 2017|2017-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis|Treatment of Active Anterior Uveitis Associated With JIA, Using Humanized Anti-Tac (HAT, Daclizumab)|Completed||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|The results of this trial need to be interpreted cautiously because of the small number of patients, the heterogeneity of the patient population (such as one participant with systemic JIA), and the nonrandomized and unmasked nature of the trial.|1|||f||||t||||||||No||2017-10-11 05:13:12.368226|2017-10-11 05:13:12.368226
NCT00130650|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2008-01-24|||May 2006||2006-05-01|January 2008|2008-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Pain Ease Spray in Reducing Needle Pain Associated With Intravenous Insertion in Children|Efficacy of Pain Ease Spray in Reducing Needle Pain Associated With Intravenous Insertion in Children|Completed||Phase 4|80|Actual|Children's Hospital of Eastern Ontario||1|||f||||t||||||||||2017-10-11 05:13:12.692225|2017-10-11 05:13:12.692225
NCT00130663|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2007-10-19|||January 2006||2006-01-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Recognition of Abnormal Pediatric Blood Pressures in Primary Care|Recognition of Abnormal Pediatric Blood Pressures in Primary Care|Completed||N/A|||Nationwide Children's Hospital|||||f||||||||||||||2017-10-11 05:13:12.891194|2017-10-11 05:13:12.891194
NCT00130676|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2012-02-14|||September 2004||2004-09-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression|A Randomized, Double-Blind, Placebo-Controlled Study of Safety and Efficacy of CORLUX™ (Mifepristone) in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features|Completed||Phase 3|257|Actual|Corcept Therapeutics||2|||f||||f||||||||||2017-10-11 05:13:12.951529|2017-10-11 05:13:12.951529
NCT00130689|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2015-05-12|2014-05-28||July 2005||2005-07-01|May 2015|2015-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||The analysis dataset is comprised of eligible and treated patients.|Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer|A Phase II Trial of Cetuximab in Unresectable or Metastatic Esophageal and Gastric Carcinoma|Completed||Phase 2|43|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:13:13.082726|2017-10-11 05:13:13.082726
NCT00130702|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2014-04-29|||August 2005||2005-08-01|April 2014|2014-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia|A Phase II Study of Iressa (Gefitinib), in Patients With Relapsed or Refractory Acute Myelogenous Leukemia and in Older Patients With Newly Diagnosed Acute Myelogenous Leukemia|Completed||Phase 2|18|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-11 05:13:13.357307|2017-10-11 05:13:13.357307
NCT00130715|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2015-03-11|||June 1998||1998-06-01|March 2015|2015-03-01|August 2003||2003-08-01|||||Interventional|||Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery|A Prospective, Randomized, Multicenter, Controlled Evaluation of the Efficacy and Safety of Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery|Completed||N/A|||Sanofi|||||||||||||||||||2017-10-11 05:13:13.441889|2017-10-11 05:13:13.441889
NCT00130741|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2007-04-10|||July 2005||2005-07-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)|A Phase I, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of a Combination Herbal Therapy (CHT), Versus Placebo in Improving the Overall Quality of Life and Symptoms in Patients With Irritable Bowel Syndrome (IBS)|Completed||Phase 1|100||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:13:14.949082|2017-10-11 05:13:14.949082
NCT00130754|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2011-02-22|||February 2005||2005-02-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation|A Prospective Randomized, Controlled Pilot Study in Order to Evaluate the Place of Thymoglobuline in Non-myeloablative Allogeneic Hemapoietic Stem-cell Transplantation (NST)|Completed||Phase 3|30|Actual|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 05:13:15.03905|2017-10-11 05:13:15.03905
NCT00130767|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2007-04-26|||December 2004||2004-12-01|April 2007|2007-04-01||||||||Interventional|||Kinetics of the Finasteride Prostate Induced Apoptosis|Kinetics of the Finasteride Prostate Induced Apoptosis|Unknown status|Active, not recruiting|Phase 4|90||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:13:15.122299|2017-10-11 05:13:15.122299
NCT00130780|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2015-12-18|2015-12-18||August 2005||2005-08-01|December 2015|2015-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC|Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) (BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC)|Completed||Phase 2|71|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:13:15.203714|2017-10-11 05:13:15.203714
NCT00130793|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2015-01-14|2009-05-11||August 2005||2005-08-01|January 2015|2015-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)|A Double-Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety, Tolerability and Immunogenicity of a Refrigerator-Stable Formulation of Zoster Vaccine Live (Oka/Merck)|Completed||Phase 3|368|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:13:15.588604|2017-10-11 05:13:15.588604
NCT00130806|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2016-09-06|||September 2005||2005-09-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)|A Study to Assess the Efficacy and Tolerability of MK0478 (Muraglitazar, Also, BMS 298585) Coadministered With Insulin in Patients With Type 2 Diabetes|Terminated||Phase 3|600||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:13:15.901602|2017-10-11 05:13:15.901602
NCT00130819|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2015-04-14|||November 2005||2005-11-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants|Buprenorphine Effectiveness Evaluation in HIV Enhancement (BEEHIVE): A Randomized Trial of HIV Clinic-based Buprenorphine/Naloxone vs. Case Management and Referral in Opioid-dependent Individuals|Completed||Phase 2|120|Anticipated|Johns Hopkins University||2|||f||||||||||||||2017-10-11 05:13:15.969413|2017-10-11 05:13:15.969413
NCT00130832|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2015-03-12|2009-08-07||October 2005||2005-10-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)|Safety and Immunogenicity of Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants|Completed||Phase 3|735|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:13:16.066298|2017-10-11 05:13:16.066298
NCT00130845|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2011-11-16|||February 2000||2000-02-01|November 2011|2011-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy|A Randomized, Controlled Study on the Efficacy and Safety of Octreotide Acetate in Microspheres in the Therapy of Patients With Moderately Severe or Severe Non-proliferate Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR)|Completed||Phase 3|312|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:13:16.533067|2017-10-11 05:13:16.533067
NCT00130858|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2009-04-01|||January 2005||2005-01-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|December 2007|Actual|2007-12-01||Interventional|||a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4|a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4|Completed||Phase 2|90|Anticipated|Cooperative Weichteilsarkom Study Group|||||f||||||||||||||2017-10-11 05:13:16.750953|2017-10-11 05:13:16.750953
NCT00130871|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2007-02-19|||January 2004||2004-01-01|February 2007|2007-02-01|January 2006||2006-01-01|||||Interventional|||Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass|Impact of Levosimendan Pretreatment on Weaning From Cardiopulmonary Bypass (CPB) in Patients With Diminished Left Ventricular Function Before Coronary Artery Bypass Grafting (CABG)|Completed||Phase 2|60||Orion Corporation, Orion Pharma|||||f||||||||||||||2017-10-11 05:13:16.889979|2017-10-11 05:13:16.889979
NCT00130884|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2007-02-19|||March 2005||2005-03-01|February 2007|2007-02-01|March 2006||2006-03-01|||||Interventional|||Peroral Levosimendan in Chronic Heart Failure|Effects of Peroral Levosimendan in the Prevention of Further Hospitalisations in Patients With Chronic Heart Failure. A Randomised, Phase II, Double-Blind, Placebo-Controlled, Multi-Centre, Parallel-Group Study|Completed||Phase 2|300||Orion Corporation, Orion Pharma|||||f||||||||||||||2017-10-11 05:13:16.962938|2017-10-11 05:13:16.962938
NCT00130897|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-14|2012-03-08|||July 2005||2005-07-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Expanded Access|||Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma|A SU011248 Expanded Access Protocol For Systemic Therapy Of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible For Participation In Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248|Approved for marketing||N/A|||Pfizer|||||||||f||||||||||2017-10-11 05:13:17.076819|2017-10-11 05:13:17.076819
NCT00130910|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2007-11-13|||March 2006||2006-03-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation|Randomized, Double Blind, Placebo Controlled Trial of Albendazole in Soil-Transmitted Helminth and HIV-1 co-Infected Kenyan Individuals to Determine the Effect of Such Treatment on HIV-1 Disease Progression and Genital Shedding.|Completed||N/A|234|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:13:17.69732|2017-10-11 05:13:17.69732
NCT00130923|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2015-08-03|2012-07-23||September 2005||2005-09-01|August 2015|2015-08-01|July 2010|Actual|2010-07-01|June 2009|Actual|2009-06-01||Interventional|||Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder|Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)|Completed||Phase 4|95|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 05:13:17.848663|2017-10-11 05:13:17.848663
NCT00130936|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2016-02-12|||October 2005||2005-10-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|||||Interventional|||Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates|Combined Phase I/II Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates|Terminated||Phase 1/Phase 2|50|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:13:18.341339|2017-10-11 05:13:18.341339
NCT00130949|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2006-12-18|||November 2004||2004-11-01|August 2005|2005-08-01|November 2005||2005-11-01|||||Interventional|||ALGRX 4975 in the Treatment of Tennis Elbow|A Randomized, Double-Blind, Placebo-Controlled, Phase II, Exploratory Evaluation of ALGRX 4975 in Subjects With Acute Lateral Epicondylitis|Completed||Phase 2|45||AlgoRx Pharmaceuticals|||||f||||||||||||||2017-10-11 05:13:18.703056|2017-10-11 05:13:18.703056
NCT00130962|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2005-09-30|||September 2004||2004-09-01|August 2005|2005-08-01|February 2006||2006-02-01|||||Interventional|||ALGRX 4975 in the Treatment of Patients With Morton's Neuroma|A Randomized, Double-Blind, Placebo-Controlled Trial of ALGRX 4975 in Subjects With Painful Intermetatarsal Neuroma|Completed||Phase 2|60||AlgoRx Pharmaceuticals|||||||||||||||||||2017-10-11 05:13:18.793943|2017-10-11 05:13:18.793943
NCT00130975|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2007-01-03|||April 2001||2001-04-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Candesartan in the Prevention of Relapsing Atrial Fibrillation||Completed||Phase 3|200||Asker & Baerum Hospital|||||f||||||||||||||2017-10-11 05:13:18.894998|2017-10-11 05:13:18.894998
NCT00130988|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2008-07-11|||January 2001||2001-01-01|July 2008|2008-07-01|March 2003|Actual|2003-03-01|February 2002|Actual|2002-02-01||Interventional|||DEPENAS: A Psychosocial Intervention for Patients With Medically Unexplained Symptoms|Efficacy of a Biopsychosocial Treatment for Somatizing Patients Carried Out by the General Practitioner|Completed||Phase 3|156||Basque Health Service|||||f||||f||||||||||2017-10-11 05:13:18.98602|2017-10-11 05:13:18.98602
NCT00131001|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2008-10-17|||April 2001||2001-04-01|April 2007|2007-04-01||||||||Interventional|||CARMEDAS: Cost-Effectiveness Analysis of Imaging Strategies in Symptomatic Carotid Stenosis|Cost-Effectiveness Analysis of Imaging Strategies in Symptomatic Carotid Stenosis|Unknown status|Active, not recruiting|N/A|300||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:13:19.069306|2017-10-11 05:13:19.069306
NCT00131014|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2016-11-16|||August 2004||2004-08-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies|Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies|Recruiting||N/A|1500|Anticipated|Dana-Farber Cancer Institute|||3||f||||||||||Samples With DNA|"     Whole blood Cheek cells Paraffin blocks of tumor tissue   "|||2017-10-11 05:13:19.145463|2017-10-11 05:13:19.145463
NCT00131027|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2008-11-13|||September 2002||2002-09-01|November 2008|2008-11-01|September 2011|Anticipated|2011-09-01|March 2011|Anticipated|2011-03-01||Interventional|||High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)|Randomized Controlled Trial to Test Efficacy of High-Dose Methotrexate Consolidation Therapy for BCR-ABL-Negative Acute Lymphoblastic Leukemia in Adults|Unknown status|Recruiting|Phase 3|240|Anticipated|Japan Adult Leukemia Study Group||2|||f||||t||||||||||2017-10-11 05:13:19.251398|2017-10-11 05:13:19.251398
NCT00131040|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2015-05-27|||January 2003||2003-01-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass|Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass|Completed||N/A|24||Imperial College London|||||f||||||||||||||2017-10-11 05:13:19.372106|2017-10-11 05:13:19.372106
NCT00131053|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2008-11-13|||September 2002||2002-09-01|November 2008|2008-11-01|September 2011|Anticipated|2011-09-01|May 2011|Anticipated|2011-05-01||Interventional|||Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)|Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients With BCR-ABL-Negative Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 2|120|Anticipated|Japan Adult Leukemia Study Group||1|||f||||t||||||||||2017-10-11 05:13:19.446718|2017-10-11 05:13:19.446718
NCT00131066|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2008-09-18|||August 2002||2002-08-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|October 2003|Actual|2003-10-01||Observational|||Long-Term Follow-Up Study of Psoriasis Patients|Long-Term Safety Follow-Up Study of Psoriasis Patients Who Have Received MEDI-507|Completed||N/A|200|Actual|MedImmune LLC|||1||f||||||||||||||2017-10-11 05:13:19.559434|2017-10-11 05:13:19.559434
NCT00131079|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2007-10-16|||October 2003||2003-10-01|October 2007|2007-10-01|March 2006|Actual|2006-03-01|||||Interventional|||PEPAF: Evaluation of Family Physician's Effectiveness for Physical Activity Promotion|Multi-Center Evaluation of the Experimental Program for Physical Activity Promotion (PEPAF), Carried Out by Family Physicians|Completed||Phase 3|4317|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 05:13:19.831913|2017-10-11 05:13:19.831913
NCT00207987|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-20|||October 2003||2003-10-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Observational|||Changes in Cerebral Oxygenation During Deliberate Hypotensive Anesthesia||Unknown status|Recruiting|N/A|40|Anticipated|China Medical University Hospital|||||f||||||||||||||2017-10-11 05:34:47.17898|2017-10-11 05:34:47.17898
NCT00131092|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2009-12-09|||June 1999||1999-06-01|December 2008|2008-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||The CHAT (Community Health Advice by Telephone) Study|Exercise Advice by Human or Computer: Testing 2 Theories|Completed||Phase 2|225||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:13:20.000071|2017-10-11 05:13:20.000071
NCT00131105|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2008-12-22|||July 2003||2003-07-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The TLC2 (Teaching Healthy Lifestyles to Caregivers 2)/CALM (Counseling Advice for Lifestyle Management) Study|Combining Exercise and Diet in Older Adults|Completed||Phase 2|200|Actual|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:13:20.11401|2017-10-11 05:13:20.11401
NCT00131118|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2017-05-31|||July 2004||2004-07-01|November 2016|2016-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta|Efficacy and Safety of Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta|Completed||Phase 2|127||Novartis|||||||||||||||||||2017-10-11 05:13:20.221099|2017-10-11 05:13:20.221099
NCT00131131|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2017-10-05|||May 2003||2003-05-01|October 2017|2017-10-01|December 2009|Actual|2009-12-01|November 2008|Actual|2008-11-01||Interventional|||Epidemiology of Gallbladder Sludge and Stones in Pregnancy|Epidemiology of Gallbladder Sludge & Stones in Pregnancy|Completed||N/A|1196|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f|f|f||||||||2017-10-11 05:13:20.359448|2017-10-11 05:13:20.359448
NCT00131144|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2011-11-16|||November 1999||1999-11-01|November 2011|2011-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy|A Randomized, Controlled Study on the Efficacy and Safety of Octreotide Acetate in Microspheres in the Therapy of Patients With Moderately Severe or Severe Non-proliferate Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR)|Completed||Phase 3|583|Actual|Novartis||3|||f||||||||||||||2017-10-11 05:13:20.513976|2017-10-11 05:13:20.513976
NCT00131157|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2007-02-28|||January 2003||2003-01-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||Evaluation of Spirometry Expert Support in General Practice|A Randomized-Controlled Evaluation of Spirometry Expert Support in General Practice|Unknown status|Active, not recruiting|N/A|39||Radboud University|||||f||||||||||||||2017-10-11 05:13:20.629285|2017-10-11 05:13:20.629285
NCT00131170|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2007-07-04|||September 2005||2005-09-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Paravertebral Block for Breast Surgery||Completed||Phase 4|90|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 05:13:20.762327|2017-10-11 05:13:20.762327
NCT00131183|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2006-09-11|||September 2005||2005-09-01|September 2006|2006-09-01||||||||Interventional|||Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina|The Effect of Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina|Unknown status|Recruiting|Phase 4|80||Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:13:20.871811|2017-10-11 05:13:20.871811
NCT00131196|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2016-05-13|||September 2005||2005-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|GAinS||Functional Genomic Influences on Disease Progression and Outcome in Sepsis|Functional Genomic Influences on Disease Progression and Outcome in Sepsis Due to Pneumonia or Peritonitis|Recruiting||N/A|4000|Anticipated|University of Oxford|||1||f||||t||||||Samples With DNA|"     whole blood, plasma and extracted DNA   "|||2017-10-11 05:13:21.046135|2017-10-11 05:13:21.046135
NCT00131209|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2008-07-03|||October 2004||2004-10-01|July 2008|2008-07-01|January 2008|Actual|2008-01-01|January 2006|Actual|2006-01-01||Interventional|||Trial to Test the Growth-Promoting Effect of Fortified Spreads When Used as Complementary Food for Infants|Lungwena Child Nutrition Intervention Study 3, LCNI-3. A Single-Centre Intervention Trial in Rural Malawi, Testing the Anthropometric and Health Benefits of Provision of Ready to - Use - Therapeutic Food RUTF as a Complementary Food|Completed||Phase 3|180||University of Tampere|||||f||||t||||||||||2017-10-11 05:13:21.440707|2017-10-11 05:13:21.440707
NCT00131222|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2014-05-19|||February 2005||2005-02-01|April 2007|2007-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Trial to Alleviate Malnutrition With Fortified Spread Given as a Food Supplement to Underweight Infants|Lungwena Child Nutrition Intervention Study-4, LCNI-4. A Single-centre Intervention Trial in Rural Malawi, Testing the Potency of RUTF Supplementation to Alleviate Moderate Malnutrition Among 6-17 Month Old Infants|Completed||Phase 3|176||University of Tampere|||||f||||t||||||||||2017-10-11 05:13:21.571604|2017-10-11 05:13:21.571604
NCT00131235|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2014-01-21|||December 2003||2003-12-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|May 2007|Actual|2007-05-01||Interventional|||Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth|Lungwena Antenatal Intervention Study. A Single-centre Intervention Trial in Rural Malawi, Testing Maternal and Infant Health Effects of Presumptive Intermittent Treatment of Pregnant Women With Sulfadoxine-pyrimethamine and Azithromycin|Completed||Phase 3|1320|Actual|University of Tampere||3|||f||||t||||||||||2017-10-11 05:13:21.680702|2017-10-11 05:13:21.680702
NCT00131248|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2013-12-12|2009-11-23||April 2004||2004-04-01|December 2013|2013-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||18 participants initially enrolled; 1 withdrew, leaving 17 participants analyzed.|Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants|Cross-over Trial of Medical Treatment for GERD in Preterm Infants|Completed||Phase 3|18|Actual|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-10-11 05:13:21.85898|2017-10-11 05:13:21.85898
NCT00131261|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2015-07-07|||January 2005||2005-01-01|July 2015|2015-07-01|June 2007|Actual|2007-06-01|January 2007|Actual|2007-01-01||Interventional|||Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma|A Phase II Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma|Completed||Phase 2|25|Actual|Onxeo||1|||||||||||||||||2017-10-11 05:13:22.152998|2017-10-11 05:13:22.152998
NCT00131274|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2005-10-04|||April 2003||2003-04-01|August 2005|2005-08-01|August 2007||2007-08-01|||||Interventional|||Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study|A Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy (Gleevec Imatinib Mesylate) in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 2/Phase 3|120||Daniels, Craig E., M.D.|||||||||||||||||||2017-10-11 05:13:22.49652|2017-10-11 05:13:22.49652
NCT00131287|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2010-01-04|||July 2005||2005-07-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)||Completed||Phase 3|108||ECbiotech Taiwan|||||f||||||||||||||2017-10-11 05:13:22.604462|2017-10-11 05:13:22.604462
NCT00131313|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2005-08-17|||January 2003||2003-01-01|August 2005|2005-08-01|April 2009||2009-04-01|||||Interventional|||Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.|A Multicenter, Open-Label Study of Nipent, Cytoxan and Rituxan in Patients With Previously Untreated or Treated Chronic Lymphocytic Leukemia.|Unknown status|Recruiting|Phase 4|180||East Valley Hematology and Oncology Medical Group|||||f||||||||||||||2017-10-11 05:13:22.858463|2017-10-11 05:13:22.858463
NCT00131326|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2017-07-27|||November 2003||2003-11-01|July 2017|2017-07-01|April 2006||2006-04-01|||||Interventional|||A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip||Completed||Phase 3|||Sanofi|||||||||||||||||||2017-10-11 05:13:23.23058|2017-10-11 05:13:23.23058
NCT00131339|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2009-08-25|||November 2004||2004-11-01|August 2009|2009-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder|Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Panic Disorder|Completed||N/A|40||Hartford Hospital|||||f||||||||||||||2017-10-11 05:13:23.370856|2017-10-11 05:13:23.370856
NCT00131352|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2015-03-17|2009-08-03||May 2005||2005-05-01|March 2015|2015-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee|A Multi-Centre, Parallel, Double-Blind, Blinded Evaluator, Randomised, Placebo-Controlled Evaluation of the Efficacy and Safety of a Single Dose of 6 mL of Synvisc in Patients With Symptomatic Osteoarthritis of the Knee|Completed||Phase 3|253|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 05:13:23.480141|2017-10-11 05:13:23.480141
NCT00131365|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2012-09-13|||January 2006||2006-01-01|September 2012|2012-09-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids|Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids|Completed||Phase 3|20|Actual|InSightec||1|||f||||||||||||||2017-10-11 05:13:26.270187|2017-10-11 05:13:26.270187
NCT00131378|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2016-03-09|2013-08-19||November 2004||2004-11-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|November 2012|Actual|2012-11-01||Interventional|||Growth Hormone, Cardiovascular Risk, and Visceral Adiposity|Growth Hormone, Cardiovascular Risk, and Visceral Adiposity|Completed||N/A|142|Actual|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-11 05:13:26.380126|2017-10-11 05:13:26.380126
NCT00131391|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2015-04-02|||July 2005||2005-07-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||A Study of MK0364 in Obese Patients (0364-014)|A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of Taranabant (MK0364) in Obese Patients Followed by a 1-Year Extension|Terminated||Phase 3|2400|Actual|Merck Sharp & Dohme Corp.||6||The overall profile does not support development for obesity|f||||||||||||||2017-10-11 05:13:27.439525|2017-10-11 05:13:27.439525
NCT00131404|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2015-02-04|||September 2005||2005-09-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|February 2007|Actual|2007-02-01||Interventional|||A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)|A 2-Year Study to Assess the Efficacy, Safety, and Tolerability of Taranabant in Obese Patients Followed by a 1-Year Extension|Terminated||Phase 3|2400|Actual|Merck Sharp & Dohme Corp.||5||The overall profile does not support development for obesity|f||||||||||||||2017-10-11 05:13:27.551477|2017-10-11 05:13:27.551477
NCT00131417|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2005-10-04|||October 2004||2004-10-01|August 2005|2005-08-01|February 2005||2005-02-01|||||Interventional|||Ready to Use Therapeutic Food in the Rehabilitation of Severely Malnourished Children|Comparison of the Efficacy of a Ready-to-Use Therapeutic Food With a Milk-Based Diet in the Rehabilitation of Severely Malnourished Ugandan Children|Unknown status|Active, not recruiting|Phase 3|128||Makerere University|||||f||||||||||||||2017-10-11 05:13:27.674927|2017-10-11 05:13:27.674927
NCT00131430|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2016-06-06|||August 2005||2005-08-01|March 2016|2016-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)|An 18-Month Study to Assess the Safety, Tolerability, and Efficacy of MK0364 in Obese Patients|Completed||Phase 2/Phase 3|500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:13:27.929556|2017-10-11 05:13:27.929556
NCT00131443|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2012-11-09|||February 2004||2004-02-01|November 2006|2006-11-01|August 2006||2006-08-01|||||Interventional|||Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine|A Double-Blind Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine|Completed||Phase 2/Phase 3|40||Monarch Medical Research|||||f||||||||||||||2017-10-11 05:13:28.004195|2017-10-11 05:13:28.004195
NCT00131456|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2016-04-06|2013-04-18||March 2004||2004-03-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|VEN||Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1|Marijuana Addiction and Depression: Venlafaxine Treatment|Completed||Phase 2|123|Actual|New York State Psychiatric Institute|This was an outpatient study and excluded patients with very severe depression. Thus we cannot generalize the findings to individuals with more severe depressive symptoms. The study length was relatively brief.|2|||f||||t||||||||||2017-10-11 05:13:28.102528|2017-10-11 05:13:28.102528
NCT00131469|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2013-10-30|||June 2005||2005-06-01|October 2013|2013-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|OI||Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta|A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)|Completed||Phase 4|79|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 05:13:28.49016|2017-10-11 05:13:28.49016
NCT00131482|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2010-08-23|||November 2004||2004-11-01|August 2010|2010-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist|A Double-blind, Randomized, Placebo-controlled Phase 2b Study to Establish the Effective Dose Range and to Evaluate the Safety of Chrysalin in Adult Subjects With a Fractured Distal Radius|Terminated||Phase 2|274|Actual|Capstone Therapeutics||5||Treatment with Chrysalin did not demonstrate benefit compared to placebo.|f||||f||||||||||2017-10-11 05:13:28.582325|2017-10-11 05:13:28.582325
NCT00131495|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2013-04-15|||July 2004||2004-07-01|April 2013|2013-04-01|February 2007|Actual|2007-02-01|February 2006|Actual|2006-02-01||Interventional|||Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido|A Randomized, Double-Blind, Placebo-controlled, Parallel-group, 52-week Study to Evaluate the Efficacy/Safety of Transdermal Patches Delivering Testosterone in Menopausal Women With Low Libido Not Receiving Estrogen Therapy|Completed||Phase 3|814|Actual|Warner Chilcott||2|||f||||f||||||||||2017-10-11 05:13:28.678724|2017-10-11 05:13:28.678724
NCT00131508|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2017-04-24|2010-02-19||May 2004||2004-05-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Trial of Oral Glutamine in Patients With Sickle Cell Anemia|A Randomized Controlled Trial of Oral Glutamine Supplementation Versus a Placebo Supplement in Children With Sickle Cell Anemia|Terminated||Phase 2|27|Actual|St. Jude Children's Research Hospital|The study was designed to enroll 46 participants (23 per arm). Due to slow accrual the study was terminated after enrolling 27 participants. Of the 27 participants enrolled, 2 dropped out of the study prior to randomization.|2||Due to slow participant accrual|f||||t||||||||||2017-10-11 05:13:28.796285|2017-10-11 05:13:28.796285
NCT00131521|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2009-06-20|||January 2005||2005-01-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Comparison of Different Mucoactive Agents for the Care of the Intubated Patient in a Surgical Trauma Intensive Care Unit|Comparison of Different Mucoactive Agents for the Care of the Intubated Patient in a Surgical Trauma Intensive Care Unit: A Randomized, Double Blind, Controlled Trial|Completed||N/A|260|Anticipated|The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 05:13:29.383015|2017-10-11 05:13:29.383015
NCT00131534|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2017-04-17|||August 1991||1991-08-01|April 2017|2017-04-01|January 2012|Actual|2012-01-01|February 2009|Actual|2009-02-01||Observational|||The Trauma Recovery and Resiliency Research Project|The Trauma Recovery and Resiliency Research Project|Completed||N/A|969|Actual|Cambridge Health Alliance|||1||f||||||||||||||2017-10-11 05:13:29.442988|2017-10-11 05:13:29.442988
NCT00131547|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2008-10-15|||September 2004||2004-09-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Randomized Study of a Simple Weight Loss Program for Obese Patients With Obstructive Sleep Apnea|A Randomized Controlled Pilot Study of a Simple Weight Loss Program for Obese Patients With Mild to Moderate Obstructive Sleep Apnea|Completed||N/A|56|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 05:13:29.53266|2017-10-11 05:13:29.53266
NCT00131560|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2011-06-07|||July 2005||2005-07-01|June 2011|2011-06-01|June 2023|Anticipated|2023-06-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of T Cell Genetic Immunotherapy for HIV|A Phase II, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Biological Activity of Single and Repeated Doses of Autologous T Cells Transduced With VRX496 in HIV-Positive Subjects|Active, not recruiting||Phase 2|60|Anticipated|VIRxSYS Corporation||1|||f||||t||||||||||2017-10-11 05:13:29.628094|2017-10-11 05:13:29.628094
NCT00131573|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2013-10-25|2013-04-11||May 2004||2004-05-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|March 2008|Actual|2008-03-01||Interventional|||An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome|Battery Powered Bion Clinical Investigation: Bion - An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urgency-Frequency Syndrome|Completed||Phase 3|118|Actual|Boston Scientific Corporation|This study was limited by poor adherence to the clinical protocol and by incomplete data recovery. Analysis of efficacy-related endpoints was not possible.|2|||f||||f||||||||||2017-10-11 05:13:29.737862|2017-10-11 05:13:29.737862
NCT00131586|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2016-02-24|||April 2003||2003-04-01|April 2012|2012-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins|Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins|Terminated||N/A|100|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 05:13:30.247098|2017-10-11 05:13:30.247098
NCT00131599|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2017-01-13|||August 2002||2002-08-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer|Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer|Active, not recruiting||N/A|104|Anticipated|AHS Cancer Control Alberta|||1||f||||||||||||||2017-10-11 05:13:30.319419|2017-10-11 05:13:30.319419
NCT00131612|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2016-02-24|||January 2002||2002-01-01|June 2012|2012-06-01|January 2013|Actual|2013-01-01|December 2005|Actual|2005-12-01||Observational|||An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment|An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 Using Epirubicin Clearance and the Ratios of Epirubicin and Epirubicinol Glucuronide to Epirubicin|Terminated||N/A|120|Actual|AHS Cancer Control Alberta|||1|did not apply for ethics renewal|f||||t||||||||||2017-10-11 05:13:30.40591|2017-10-11 05:13:30.40591
NCT00131625|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2005-10-07|||March 2000||2000-03-01|August 2005|2005-08-01|February 2002||2002-02-01|||||Interventional|||Impact of Exclusive Breast-Feeding in Guinea Bissau|Aspects of Exclusive Breast-Feeding in Guinea Bissau. Intervention Study to Clarify Recommendations for Breast-Feeding Policy in Developing Countries|Completed||Phase 4|1500||Bandim Health Project|||||f||||||||||||||2017-10-11 05:13:30.476204|2017-10-11 05:13:30.476204
NCT00131638|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2016-12-14|||January 2005||2005-01-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer|Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (rHuKGF) for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Receiving Adjuvant Radiotherapy and Chemotherapy(RT/CT)|Completed||Phase 3|241|Actual|Amgen||2|||f||||f||||||||||2017-10-11 05:13:30.553661|2017-10-11 05:13:30.553661
NCT00131651|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2007-12-04|||August 2005||2005-08-01|December 2007|2007-12-01||||||||Interventional|||ATN-161 in Advanced Renal Cell Cancer|A Dose-Ranging, Phase II, Open Label Study of ATN 161 in Advanced Renal Cell Cancer|Terminated||Phase 2|36||Attenuon|||||||||||||||||||2017-10-11 05:13:30.653174|2017-10-11 05:13:30.653174
NCT00131664|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2013-04-15|2012-01-28||September 2005||2005-09-01|April 2013|2013-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|AVALANCHE||Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)|Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin: A 48-week Randomized, Open-label, Multicentre Phase IIIB Study to Compare the Effectiveness of Combination Therapy to Monotherapy in Type 2 Diabetes Mellitus Patients|Completed||Phase 3|391|Actual|Canadian Heart Research Centre|The LOCF used in the ITT population for withdrawn subjects or missing values was analyzed as per protocol. The 3 treatment groups used throughout the results section were the numbers where the patients were originally randomized to.|3|||f||||t||||||||||2017-10-11 05:13:30.782496|2017-10-11 05:13:30.782496
NCT00131885|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2015-07-15|2010-03-21||August 2005||2005-08-01|July 2015|2015-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel|Effects of St. John's Wort on Levonorgestrel|Completed||Phase 4|36|Actual|University of Utah||4|||f||||t||||||||||2017-10-11 05:13:33.441774|2017-10-11 05:13:33.441774
NCT00131677|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2014-01-22|2013-08-08||February 2005||2005-02-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||400 participants enrolled (200 in San Francisco, 121 in Atlanta, and 79 in Boston). 201 were randomized to TDF and 199 to placebo. Participants were distributed similarly in terms of age, ethnicity, education, no. male partners in previous 3 mo., and no. of unprotected anal sexual contacts within the previous 3 mo.|Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men|Phase II Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men|Completed||Phase 2|400|Actual|Centers for Disease Control and Prevention||4|||f||||t||||||||||2017-10-11 05:13:31.635553|2017-10-11 05:13:31.635553
NCT00131690|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2005-10-07|||April 1996||1996-04-01|August 2005|2005-08-01|August 2002||2002-08-01|||||Interventional|||Effect of Caffeine on Fetal Growth|The Importance of Caffeine in Fetal Growth|Completed||Phase 4|1200||The Danish Epdiemiology Science Centre|||||f||||||||||||||2017-10-11 05:13:32.096578|2017-10-11 05:13:32.096578
NCT00131703|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-01-11|||March 2003||2003-03-01|January 2017|2017-01-01|March 2005||2005-03-01|||||Interventional|||Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women|A Randomised Double Blind Clinical Trial of Amodiaquine (AQ) and Sulphadoxine-pyrimethamine (SP) Used Singly and in Combination (AQ+SP) Compared With Chloroquine (CQ) in the Treatment of Falciparum Malaria Infection in Pregnancy|Completed||Phase 3|900||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:13:32.161174|2017-10-11 05:13:32.161174
NCT00131716|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-01-11|||May 2003||2003-05-01|January 2017|2017-01-01|May 2005||2005-05-01|||||Interventional|||Prevention of Severe Anaemia in Gambian Children|Chemoprophylaxis With Sulfadoxine-pyrimethamine to Prevent Recurrence of Severe Anaemia in Gambian Children Aged 3 Months to 9 Years|Completed||Phase 3|1200|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 05:13:32.248802|2017-10-11 05:13:32.248802
NCT00131729|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2006-03-17|||July 2001||2001-07-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Interventional|||Electronic Recording of Compliance With Occlusion Therapy for Amblyopia|Electronic Recording of Compliance With Occlusion Therapy for Amblyopia: 1 Effects of Patient Education on Compliance 2 Predictors for Non-Compliance|Completed||Phase 3|200||Erasmus Medical Center|||||f||||||||||||||2017-10-11 05:13:32.328364|2017-10-11 05:13:32.328364
NCT00131742|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2015-05-08|||July 2004||2004-07-01|May 2015|2015-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B|A Phase III Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B|Completed||Phase 3|||Novartis|||||||||||||||||||2017-10-11 05:13:32.398805|2017-10-11 05:13:32.398805
NCT00131755|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2011-07-15|||February 2005||2005-02-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy of Diazoxide in Type 1 Diabetes|Efficacy of 6 Months Treatment With Diazoxide at Bedtime in Preventing Beta-cell Demise in Newly Diagnosed Type 1 Diabetes|Completed||Phase 4|40|Actual|Grill, Valdemar, M.D.||1|||f||||f||||||||||2017-10-11 05:13:32.45369|2017-10-11 05:13:32.45369
NCT00131768|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2015-03-17|||November 2003||2003-11-01|March 2015|2015-03-01|February 2006||2006-02-01|||||Interventional|||A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis||Completed||Phase 3|||Sanofi|||||f||||||||||||||2017-10-11 05:13:32.515864|2017-10-11 05:13:32.515864
NCT00131781|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2007-04-26|||March 2001||2001-03-01|April 2007|2007-04-01||||||||Interventional|||Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder|Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder|Unknown status|Active, not recruiting|N/A|70||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:13:32.637455|2017-10-11 05:13:32.637455
NCT00131794|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2016-09-01|||January 2003||2003-01-01|August 2005|2005-08-01|December 2003||2003-12-01|||||Interventional|||Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria|The Effect of BCG Vaccine on Morbidity From Malaria|Completed||Phase 3|1200||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:13:32.793061|2017-10-11 05:13:32.793061
NCT00131807|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2015-05-27|||September 2005||2005-09-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Observational|||A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy|A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy|Completed||N/A|3000||Imperial College London|||||f||||||||||||||2017-10-11 05:13:32.855237|2017-10-11 05:13:32.855237
NCT00131820|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2008-03-10|||December 2001||2001-12-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam|Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam. An Evaluation of Feasibility, Public Acceptability, Effectiveness and Cost-Effectiveness in Students|Completed||Phase 4|100742||International Vaccine Institute|||||f||||||||||||||2017-10-11 05:13:32.923441|2017-10-11 05:13:32.923441
NCT00131833|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2008-03-10|||October 2001||2001-10-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China|Typhoid Vi Vaccine Effectiveness in a Population Older Than 5 Years of Age Living in an Endemic Area in Hechi, Guangxi, P.R. China: A Group-Randomized Controlled Demonstration Project|Completed||Phase 4|96468||International Vaccine Institute|||||f||||||||||||||2017-10-11 05:13:33.003281|2017-10-11 05:13:33.003281
NCT00131846|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2017-03-14|||April 2004|Actual|2004-04-01|March 2017|2017-03-01|November 2013|Actual|2013-11-01|August 2012|Actual|2012-08-01||Interventional|||Diuretics In the Management of Essential Hypertension (DIME) Study|Effect of Low Dose Thiazide Diuretics on New Onset Type 2 Diabetes in Patients With Essential Hypertension|Completed||Phase 4|1130|Actual|Kyoto University||2|||f||||t||||||||||2017-10-11 05:13:33.101525|2017-10-11 05:13:33.101525
NCT00131859|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2009-08-12|||October 2004||2004-10-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Diffusion-Tensor Magnetic Resonance Imaging (MRI) and the Evaluation of Perinatal Brain Injury|Diffusion-Tensor Magnetic Resonance Imaging and the Evaluation of Perinatal Brain Injury|Completed||N/A|5|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-10-11 05:13:33.224472|2017-10-11 05:13:33.224472
NCT00131872|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2008-01-24|||March 2004||2004-03-01|November 2006|2006-11-01|November 2006|Actual|2006-11-01|||||Interventional|||Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts|Clinical Study Comparing Expedial and ePTFE Vascular Access Grafts|Terminated||Phase 2|172||LeMaitre Vascular|||||||||||||||||||2017-10-11 05:13:33.312264|2017-10-11 05:13:33.312264
NCT00132275|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2008-05-19|||November 2003||2003-11-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Guidelines for Acute Sinusitis|Evaluation of National Guidelines for Acute Sinusitis|Completed||N/A|240|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:13:38.348993|2017-10-11 05:13:38.348993
NCT00131898|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2008-12-22|||May 2003||2003-05-01|December 2008|2008-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma|Phase III Prospective Randomized Trial of Pre-Operative Intensity Modulated Radiation Therapy (IMRT) Plus Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma|Completed||Phase 3|150||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 05:13:34.118262|2017-10-11 05:13:34.118262
NCT00131911|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2014-11-14|2014-06-19||June 2005||2005-06-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|October 2010|Actual|2010-10-01||Interventional|||Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors|A Phase II Trial of Bay 43-9006 in Progressive Metastatic Neuroendocrine Tumors|Completed||Phase 2|93|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:13:34.221535|2017-10-11 05:13:34.221535
NCT00131924|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2012-06-07||2011-02-18|March 2004||2004-03-01|June 2012|2012-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy|Phase II Study of High-Dose Estrogen in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapies|Terminated||Phase 2|1|Actual|Northwestern University||||Data Monitoring Committee recommended closure due to poor accrual.|f||||||||||||||2017-10-11 05:13:34.907402|2017-10-11 05:13:34.907402
NCT00131937|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2015-08-05|2015-06-10||October 2005||2005-10-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|September 2011|Actual|2011-09-01||Interventional|||Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma|A Phase II Study of Sorafenib (BAY 43-9006) in Recurrent Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|14|Actual|National Cancer Institute (NCI)|The study did not meet pre-specified criteria for continuing to second stage accrual (at least one response among the first 12 eligible patients), and was therefore closed per protocol without full accrual.|1|||f||||f||||||||||2017-10-11 05:13:35.00835|2017-10-11 05:13:35.00835
NCT00131950|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2013-07-09|||August 2003||2003-08-01|October 2005|2005-10-01|November 2005|Actual|2005-11-01|||||Interventional|||Effect of Lifestyle Factors and Hormone Function on Breast Density in Healthy Hispanic Women Who Are Undergoing Mammography for Breast Cancer Screening|Chicago Breast Health Project, Phase II|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:13:35.341855|2017-10-11 05:13:35.341855
NCT00131963|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2016-07-22|||October 2003||2003-10-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel|A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel|Completed||N/A|94|Actual|Duke University|||2||f||||f||||||Samples With DNA|"     DNA will be extracted from blood samples taken at the first cycle of Doxorubicin and/or     Paclitaxel to analyze certain genes that may predict the severity of side-effects that may be     experienced with chemotherapy.   "|||2017-10-11 05:13:35.416392|2017-10-11 05:13:35.416392
NCT00131989|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2013-01-08|||June 2005||2005-06-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia|Phase I Dose Escalation Trial of the Raf Kinase Inhibitor BAY 43-9006 (NSC #724772) as Single Agent for Adults With Relapsed and Refractory Acute Leukemias and Chronic Myeloid Leukemia in Blast Crisis|Completed||Phase 1|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:13:35.5162|2017-10-11 05:13:35.5162
NCT00132002|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2015-03-06|2015-03-06||June 2005||2005-06-01|February 2013|2013-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer|Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) (NSC 701852) as Salvage Therapy in Metastatic Breast Cancer|Terminated||Phase 2|14|Actual|National Cancer Institute (NCI)|Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results|1||Early termination for discouraging results|f||||||||||||||2017-10-11 05:13:35.62137|2017-10-11 05:13:35.62137
NCT00132015|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2012-03-14|||May 2006||2006-05-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis|A Phase II Clinical Trial of 17-(Allylamino)-17- Demethoxygeldanamycin (17-AAG, NSC 330507 and EPL Diluent, NSC 704057) in Adults With Systemic Mastocytosis|Completed||Phase 2|37|Anticipated|National Institutes of Health Clinical Center (CC)||1|||||||||||||||||2017-10-11 05:13:35.909454|2017-10-11 05:13:35.909454
NCT00132028|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2014-05-07|2012-02-28||September 2005||2005-09-01|January 2013|2013-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma|A Phase II Trial of Suberoylanilide Hydroxamic Acid (NSC-701852) for Recurrent or Primary Refractory Hodgkin's Lymphoma|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:13:36.000386|2017-10-11 05:13:36.000386
NCT00132041|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2009-02-06|||December 2005||2005-12-01|November 2007|2007-11-01||||||||Interventional|||Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis|Multicenter Feasibility Study of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:13:36.461264|2017-10-11 05:13:36.461264
NCT00132054|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2013-05-29|||May 2004||2004-05-01|December 2006|2006-12-01|November 2008|Actual|2008-11-01|December 2006|Actual|2006-12-01||Interventional|||Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer|Phase I Study of Weekly Irinotecan Combined With Amrubicin in Previously Treated Small-Cell Lung Cancer|Completed||Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:13:36.591054|2017-10-11 05:13:36.591054
NCT00132067|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2014-06-11|||October 2005||2005-10-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|August 2006|Actual|2006-08-01||Interventional|||Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer|A Phase II Evaluation of Vorinostat, (SAHA, NCI-Supplied Agent [NSC #701852]) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:13:36.687399|2017-10-11 05:13:36.687399
NCT00132080|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2014-03-03|||December 2002||2002-12-01|April 2012|2012-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network|Trial of Pulse Steroid Therapy in Kawasaki Disease (A Trial Conducted by the Pediatric Heart Network)|Completed||Phase 3|199|Actual|New England Research Institutes||1|||f||||t||||||||||2017-10-11 05:13:36.805434|2017-10-11 05:13:36.805434
NCT00132093|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2006-04-07|||April 2005||2005-04-01|November 2004|2004-11-01||||||||Interventional|||Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack|The Effects of Eplerenone on Left Ventricular Remodelling Post-Acute Myocardial Infarction: a Double-Blind Placebo-Controlled Cardiac MR-Based Study|Completed||Phase 4|100||NHS Greater Glasgow and Clyde|||||f||||||||||||||2017-10-11 05:13:36.888828|2017-10-11 05:13:36.888828
NCT00132106|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2007-08-30|||August 2005||2005-08-01|August 2007|2007-08-01||||||||Interventional|||The Effect of Alfa-Adrenergic Receptor Blockade on Insulin-Stimulated Forearm Glucose Uptake and Metabolism in Chronic Heart Failure|The Effect of a-Adrenergic Receptor Blockade on Insulin-Stimulated Forearm Glucose Uptake and Metabolism in Chronic Heart Failure|Unknown status|Recruiting|N/A|||Radboud University|||||f||||||||||||||2017-10-11 05:13:36.97879|2017-10-11 05:13:36.97879
NCT00132119|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2008-05-15|||August 2005||2005-08-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Nalmefene HCl in the Treatment of Pathological Gambling|Completed||Phase 2/Phase 3|233|Actual|Somaxon Pharmaceuticals||3|||f||||f||||||||||2017-10-11 05:13:37.06494|2017-10-11 05:13:37.06494
NCT00132132|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2015-05-04|2012-06-22||August 2005||2005-08-01|May 2015|2015-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Impact of Behavioral Intervention- Exercise, Nutrition, Education- on Body Mass Index (BMI)|Type 2 Diabetes and Obesity Pediatric Prevention Project|Completed||N/A|30|Actual|Steward St. Elizabeth's Medical Center of Boston, Inc.|A limitation of the study is the lost to follow up. However, our rate of lost to follow up is comparable to rates seen in similar studies in this field|2|||f||||t||||||||||2017-10-11 05:13:37.154689|2017-10-11 05:13:37.154689
NCT00132145|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2016-10-18|||April 2003||2003-04-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III)|A Randomized Trial of Electronic Integration of Care for Better Vascular Outcomes: The Compete III Study Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III)|Completed||N/A|1000|Actual|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||No||2017-10-11 05:13:37.486301|2017-10-11 05:13:37.486301
NCT00132158|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2012-04-16|||September 2005||2005-09-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors|A Dose Finding Study (Phase I) of the Combination of ZD1839 (Iressa®) and an Oral Formulation of Irinotecan (Camptosar™) in Children With Refractory Solid Tumors|Completed||Phase 1|19|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:13:37.573577|2017-10-11 05:13:37.573577
NCT00132171|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2005-10-19|||January 2001||2001-01-01|March 2002|2002-03-01|December 2001||2001-12-01|||||Interventional|||Helicobacter Pylori Eradication With a New Sequential Treatment|High Eradication Rates of Helicobacter Pylori With a New Sequential Treatment|Completed||Phase 3|1000||St. Orsola Hospital|||||f||||||||||||||2017-10-11 05:13:37.660847|2017-10-11 05:13:37.660847
NCT00132184|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2007-04-12|||September 2005||2005-09-01|April 2007|2007-04-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Vitamin D Treatment for Crohn´s Disease|Remission Keeping and Remission Inducing Effect by Vitamin-D in Crohns Disease, and in Vitro Vitamin-D Mediated T-Cell Immunomodulation|Unknown status|Active, not recruiting|Phase 2/Phase 3|110||University of Aarhus|||||f||||||||||||||2017-10-11 05:13:37.725178|2017-10-11 05:13:37.725178
NCT00132197|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-19|2011-11-11|||April 2005||2005-04-01|November 2011|2011-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Patients With Longstanding Unexplained Health Complaints|Treatment of Patients With Chronic Functional Disorders. A Randomized Controlled Trial of Specialized Treatment Compared to Usual Care.|Completed||Phase 2/Phase 3|120|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:13:37.798937|2017-10-11 05:13:37.798937
NCT00132210|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2010-10-20|||September 2002||2002-09-01|November 2009|2009-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients|Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients|Completed||Phase 4|200|Anticipated|University Hospital, Bonn||1|||f||||f||||||||||2017-10-11 05:13:37.88226|2017-10-11 05:13:37.88226
NCT00132223|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2006-04-11|||April 2005||2005-04-01|April 2006|2006-04-01|December 2005||2005-12-01|||||Interventional|||Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients|Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients With Headache and Dizziness or Epilepsy and Clinical Indication for an Angiography by Magnetic Imaging|Unknown status|Recruiting|Phase 4|10||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:13:37.989885|2017-10-11 05:13:37.989885
NCT00132236|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2005-10-20|||February 2002||2002-02-01|July 2005|2005-07-01|June 2004||2004-06-01|||||Interventional|||Nurse Smoking Cessation of Patients With Chronic Obstructive Pulmonary Disease (COPD) With Nicotine Replacement Therapy (NRT) and Behavioral Support|Smoking Cessation of Patients With COPD: A Multi-Center, Randomized, Placebo Controlled Nurse Conducted Smoking Cessation Trial|Terminated||Phase 3|300||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-10-11 05:13:38.086168|2017-10-11 05:13:38.086168
NCT00132249|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2015-06-08|||April 2004||2004-04-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Vietnam Head Injury Study - Phase III|A 40+ Year Post-Injury Follow-Up Study of Vietnam Veterans Who Sustained Traumatic Brain Injury While in Combat.|Completed||Phase 3|254|Actual|U.S. Army Medical Research and Materiel Command|||2||f||||f||||||||||2017-10-11 05:13:38.179449|2017-10-11 05:13:38.179449
NCT00132262|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-16|2013-01-29|||May 2003||2003-05-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2006|Actual|2006-08-01||Interventional|||Brief Intervention to Reduce Injury in Minorities|Brief Intervention to Reduce Injury in Minorities|Completed||N/A|1493|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 05:13:38.263089|2017-10-11 05:13:38.263089
NCT00132288|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2007-12-13|||May 2005||2005-05-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||MY PALS: A Community-Based Physical Activity Support Program for Older Adults|A Randomized Controlled Trial Linking Clinical Quality Improvement Programs for Older Diabetics to a Community Based Activity Support Center|Completed||N/A|305|Actual|University of Washington||1|||f||||t||||||||||2017-10-11 05:13:38.424724|2017-10-11 05:13:38.424724
NCT00132301|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2016-06-22|||June 2006||2006-06-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|October 2015|Actual|2015-10-01||Interventional|CAP||Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma|CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment (CAP)|Active, not recruiting||Phase 3|298|Actual|VA Office of Research and Development||2|||f||||t||||||||Undecided||2017-10-11 05:13:38.509128|2017-10-11 05:13:38.509128
NCT00132314|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2013-10-30|2013-05-29||September 2006||2006-09-01|October 2013|2013-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||We used the intention to treat (ITT) population as defined in Milestone 2.|Long-Acting Injectable Risperidone in the Treatment of Schizophrenia|CSP #555 - Long-Acting Injectable Risperidone in the Treatment of Schizophrenia|Completed||Phase 3|382|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:13:38.657807|2017-10-11 05:13:38.657807
NCT00132327|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-10-05|||August 16, 2005||2005-08-16|July 11, 2017|2017-07-11||||||||Observational|||Analysis of Lyme Disease Lesions|Analysis of Erythema Migrans Lesions|Recruiting||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:13:39.277973|2017-10-11 05:13:39.277973
NCT00132340|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2006-07-04|||August 2005||2005-08-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Deep Brain Stimulation to Treat Cervical Dystonia|Deep Brain Stimulation of the Globus Pallidus Interna or the Subthalamic Nucleus for Treatment of Primary Cervical Dystonia|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:13:39.351073|2017-10-11 05:13:39.351073
NCT00132353|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-10-05|||August 16, 2005||2005-08-16|July 26, 2017|2017-07-26||||||||Observational|||Training for Diagnosing Neurological Disorders|Clinical Neurophysiology: Training and Normative Values|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:13:39.409675|2017-10-11 05:13:39.409675
NCT00132366|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-06-30|||August 16, 2005||2005-08-16|June 25, 2009|2009-06-25|June 30, 2008|Actual|2008-06-30|June 30, 2008|Actual|2008-06-30||Observational|||Brain Excitability in Patients With Succinic Semialdehyde Dehydrogenase Deficiency|Cortical Excitability in Succinic Semialdehyde Dehydrogenase Deficiency|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:13:39.479569|2017-10-11 05:13:39.479569
NCT00132379|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2014-08-26|||November 2005||2005-11-01|August 2014|2014-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer|An Open-label, Phase I, Dose-escalation Study of ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1|13|Actual|Active Biotech AB||1|||f||||f||||||||||2017-10-11 05:13:39.538989|2017-10-11 05:13:39.538989
NCT00132392|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2006-12-18|||July 2005||2005-07-01|August 2005|2005-08-01|December 2005||2005-12-01|||||Interventional|||ALGRX 4975 After Total Knee Replacement|A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Total Knee Arthroplasty|Completed||Phase 2|40||AlgoRx Pharmaceuticals|||||||||||||||||||2017-10-11 05:13:39.628192|2017-10-11 05:13:39.628192
NCT00132405|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-15|2005-10-07|||May 2004||2004-05-01|August 2005|2005-08-01|September 2004||2004-09-01|||||Interventional|||Study of ALGRX 3268 for Needlestick Pain in Children|Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effectiveness and Safety of ALGRX 3268 0.5 Mg/20 Bar at the Back of the Hand in Pediatric Subjects|Completed||Phase 2|260||AlgoRx Pharmaceuticals|||||||||||||||||||2017-10-11 05:13:39.708014|2017-10-11 05:13:39.708014
NCT00132418|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2011-01-20|||April 2000||2000-04-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders|Double-blind, Randomized, Placebo-controlled Study of Enbrel (Etanercept) in the Treatment of Rheumatoid Arthritis Subjects With Comorbid Disorders|Completed||Phase 4|564|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:13:39.763926|2017-10-11 05:13:39.763926
NCT00132431|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2009-02-12|||July 2004||2004-07-01|February 2009|2009-02-01|July 2005||2005-07-01|||||Interventional|||START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism|Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism|Completed||Phase 4|300||Amgen|||||f||||||||||||||2017-10-11 05:13:39.831647|2017-10-11 05:13:39.831647
NCT00132444|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-11|2010-01-06|||October 2005||2005-10-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of UC-781 Vaginal Microbicide|Phase I Study of the Safety and Acceptability of UC-781 Topical Vaginal Microbicide in Heterosexual Women and Their Male Partners|Completed||Phase 1|90|Anticipated|Centers for Disease Control and Prevention||3|||f||||||||||||||2017-10-11 05:13:39.894882|2017-10-11 05:13:39.894882
NCT00132457|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2010-01-06|||October 2003||2003-10-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection|Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection|Completed||N/A|1830|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:13:39.971143|2017-10-11 05:13:39.971143
NCT00132470|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2007-07-23|||December 2004||2004-12-01|July 2007|2007-07-01|March 2007||2007-03-01|||||Interventional|||Treatment With AX200 for Acute Ischemic Stroke|AXIS IIa - Treatment With AX200 for Acute Ischemic Stroke|Completed||Phase 2|42||Axaron Bioscience AG|||||f||||||||||||||2017-10-11 05:13:40.043821|2017-10-11 05:13:40.043821
NCT00132483|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2007-10-19|||September 2003||2003-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||ExStroke Pilot Trial: Physical Exercise After Acute Ischaemic Stroke||Completed||Phase 3|314|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 05:13:40.169824|2017-10-11 05:13:40.169824
NCT00132496|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2009-11-02|2009-08-25||August 2005||2005-08-01|November 2009|2009-11-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole|Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients|Completed||Phase 2|111|Actual|Eisai Inc.|||||f||||f||||||||||2017-10-11 05:13:40.360044|2017-10-11 05:13:40.360044
NCT00132509|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2011-07-21|||September 2001||2001-09-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke|Comparison of the Classical Rt-PA Procedure (0.9mg/kg Over 60 Minutes) With a Longer Procedure With Lower Dose (0.8mg/kg Over 90 Minutes) in Acute Ischemic Stroke|Terminated||Phase 2|500|Anticipated|Hospices Civils de Lyon||2||End of promotion by the sponsor|f||||||||||||||2017-10-11 05:13:40.891493|2017-10-11 05:13:40.891493
NCT00132522|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2013-10-23|||May 2005||2005-05-01|October 2013|2013-10-01|April 2009|Actual|2009-04-01|June 2008|Actual|2008-06-01||Interventional|||EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide|A Study to Find the Highest Dose of Biological Study Drug (EMD 273066) That Can Be Given Safely to Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-Small Cell Lung Cancers When First Given a Low Dose of Cyclophosphamide|Completed||Phase 1|45|Actual|EMD Serono||1|||f||||f||||||||||2017-10-11 05:13:40.979237|2017-10-11 05:13:40.979237
NCT00132535|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2017-01-11|||August 2003||2003-08-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|||||Interventional|||Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda|Influence of HIV Infection on the Effectiveness of Malaria Prevention During Pregnancy, With Emphasis on the Effect of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda|Completed||N/A|2548||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:13:41.088357|2017-10-11 05:13:41.088357
NCT00132548|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-01-11|||June 2004||2004-06-01|January 2017|2017-01-01|December 2004||2004-12-01|||||Interventional|||A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children|A Randomised Trial of the Efficacy and Safety of Four Drug Regimens When Used for Intermittent Preventive Treatment of Malaria in Senegalese Children|Completed||Phase 3|2200||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:13:41.216184|2017-10-11 05:13:41.216184
NCT00127114|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-08-10|||September 2005|Actual|2005-09-01|August 2017|2017-08-01|July 26, 2007|Actual|2007-07-26|July 26, 2007|Actual|2007-07-26||Interventional|||Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)|Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)|Withdrawn||Phase 4|0|Actual|Johns Hopkins University||2||No funding and exclusion criteria were to stringent.|f||||||||||||||2017-10-11 05:13:41.318002|2017-10-11 05:13:41.318002
NCT00132561|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-01-11|||June 2002||2002-06-01|January 2017|2017-01-01|December 2003||2003-12-01|||||Interventional|||A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children|A Double-blind, Randomised, Placebo-controlled Trial to Measure the Potential of Intermittent Treatment With Artesunate Plus Sulphadoxine/Pyrimethamine (SP) to Reduce the Malaria Burden in Sub-Saharan Africa|Completed||Phase 2/Phase 3|1200||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:13:41.452249|2017-10-11 05:13:41.452249
NCT00132574|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2006-09-20|||August 2005||2005-08-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Pilot Study of a Dietary Intervention to Prevent Acne Recurrence|Milk Minimization and Acne Recurrence Trial (MMART)|Terminated||Phase 2|30||Harvard School of Public Health|||||f||||||||||||||2017-10-11 05:13:41.55952|2017-10-11 05:13:41.55952
NCT00132587|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2008-06-30|||March 2004||2004-03-01|June 2008|2008-06-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Total Knee Arthroplasty (TKA) Cemented Versus Cementless|Prospective Randomized Study of 130 Total Knee Arthroplasty With Cemented Femoral Implant Versus Cementless|Completed||N/A|130||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:13:41.655386|2017-10-11 05:13:41.655386
NCT00132600|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2005-10-18|||April 2005||2005-04-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Clinical Evaluation of Bacitracin|Clinical Evaluation of Bacitracin. A Phase II Dose-Response Study|Completed||Phase 2|20||Mekos Laboratories AS|||||||||||||||||||2017-10-11 05:13:41.74524|2017-10-11 05:13:41.74524
NCT00132613|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2016-09-20|||August 1999||1999-08-01|September 2016|2016-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion|A Randomized Controlled Trial to Evaluate the Efficacy of Intra-pericardial Instillation of a Sclerosing Agent After Pericardial Drainage in Patients With Malignant Pericardial Effusion Associated With Lung Cancer (JCOG9811)|Completed||Phase 3|80|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:13:41.885197|2017-10-11 05:13:41.885197
NCT00132626|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2007-02-20|||September 1992||1992-09-01|February 2007|2007-02-01|August 2005||2005-08-01|||||Interventional|||Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome|Dynamic SPECT Imaging With [123I]ß-CIT in Patients With Parkinsonism|Completed||Phase 2|500||Institute for Neurodegenerative Disorders|||||f||||||||||||||2017-10-11 05:13:42.080546|2017-10-11 05:13:42.080546
NCT00132639|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2016-09-20|||October 2002||2002-10-01|September 2016|2016-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)|Randomized Phase II Study of the Induction Chemotherapy With Docetaxel Alone vs CDDP + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)|Completed||Phase 2|80|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:13:42.158211|2017-10-11 05:13:42.158211
NCT00132652|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-02-21|||February 2005||2005-02-01|February 2017|2017-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B|A Randomized Trial of Switching Antiviral Therapy From Lamivudine to Telbivudine (LdT) vs. Continued Lamivudine Treatment in Adults With Chronic Hepatitis B|Completed||Phase 3|240||Novartis|||||||||||||||||||2017-10-11 05:13:42.273977|2017-10-11 05:13:42.273977
NCT00132665|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2012-12-06|||July 2003||2003-07-01|December 2012|2012-12-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)|Randomized Controlled Trial to Evaluate Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatine in Elderly Patients With Locally Advanced Non-small Cell Lung Cancer (JCOG0301, NCSLC-Elderly-CBDCA-RT Phase III)|Completed||Phase 3|200|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:13:42.390817|2017-10-11 05:13:42.390817
NCT00136786|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-12-07|||December 2006||2006-12-01|December 2015|2015-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3|Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals|Completed||Phase 1|25|Actual|New York State Psychiatric Institute||3|||f||||||||||||||2017-10-11 05:13:52.360214|2017-10-11 05:13:52.360214
NCT00132678|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-07-23|2008-10-24||February 2005||2005-02-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes|A Randomized, Double-blind, Placebo-controlled Study to Explore the Efficacy and Safety of Risperidone Long-acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar 1 Disorder, With Open-label Extension|Completed||Phase 3|559|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-10-11 05:13:42.6337|2017-10-11 05:13:42.6337
NCT00132691|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2016-10-13|2012-05-14||September 2005||2005-09-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|MUST||Multicenter Uveitis Steroid Treatment (MUST) Trial|Multicenter Uveitis Steroid Treatment (MUST) Trial|Completed||Phase 4|255|Actual|JHSPH Center for Clinical Trials||2|||f||||t||||||||||2017-10-11 05:13:43.417291|2017-10-11 05:13:43.417291
NCT00132704|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2014-07-23|||August 2004||2004-08-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation|An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation|Completed||Phase 3|149|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"     tissue   "|||2017-10-11 05:13:46.130786|2017-10-11 05:13:46.130786
NCT00132717|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2017-04-05|||January 1, 2005|Actual|2005-01-01|April 2017|2017-04-01|June 1, 2007|Actual|2007-06-01|June 1, 2007|Actual|2007-06-01||Interventional|||A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)|An Open-Label, Multicenter Study to Assess the Efficacy of Switching to a Combination Tablet Ezetimibe/Simvastatin 10mg/40mg, Compared to Doubling the Dose of Statin in Patients Hospitalized With a Coronary Event|Completed||Phase 3|450|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:13:46.216292|2017-10-11 05:13:46.216292
NCT00132730|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-03|2017-03-24|2014-03-17||June 1, 2004|Actual|2004-06-01|March 2017|2017-03-01|August 17, 2005|Actual|2005-08-17|August 17, 2005|Actual|2005-08-17||Interventional|||An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of MK-0873 in Patients With COPD|Terminated||Phase 2|604|Actual|Merck Sharp & Dohme Corp.|The extension studies were terminated based on data from the completed base study suggesting that MK-0873, at doses up to 2.5 mg per day, demonstrated no benefits versus placebo in lung function or symptoms in participants with COPD.|6|||f||||f||||||||||2017-10-11 05:13:46.310988|2017-10-11 05:13:46.310988
NCT00132743|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2013-04-24|||February 2007||2007-02-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|CLEVER||Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)|Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)|Unknown status|Active, not recruiting|Phase 3|119|Actual|Rhode Island Hospital||3|||f||||t||||||||||2017-10-11 05:13:47.659081|2017-10-11 05:13:47.659081
NCT00132756|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2006-11-06|||December 2003||2003-12-01|November 2006|2006-11-01||||||||Interventional|||Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer|Liposomal Doxorubicin and Estramustine Phosphate: A Phase II Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer|Terminated||Phase 1/Phase 2|30||Morton Plant Mease Health Care|||||f||||||||||||||2017-10-11 05:13:47.824093|2017-10-11 05:13:47.824093
NCT00132769|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-02|2015-07-29|2013-10-07||January 2005||2005-01-01|July 2015|2015-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)|A Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, Safety, and Tolerability of MK-0873 in Rheumatoid Arthritis|Completed||Phase 2|106|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:13:47.901957|2017-10-11 05:13:47.901957
NCT00132782|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2014-03-03|||March 2003||2003-03-01|February 2009|2009-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Observational|||Relationship Between Functional Health Status and Ventricular Performance After Fontan--Pediatric Heart Network|Relationship Between Functional Health Status and Ventricular Performance After Fontan (A Trial Conducted by the Pediatric Heart Network)|Completed||N/A|546|Actual|New England Research Institutes|||1||f||||t||||||||||2017-10-11 05:13:48.30431|2017-10-11 05:13:48.30431
NCT00132795|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2012-06-20|||May 2005||2005-05-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|ATIVR||Using Telephone Technology to Prevent Relapse After Alcoholism Treatment|Therapeutic IVR to Augment CBT in Alcohol Dependence|Completed||Phase 2|158|Actual|University of Vermont||2|||f||||f||||||||||2017-10-11 05:13:48.3585|2017-10-11 05:13:48.3585
NCT00132808|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2016-08-01|2010-12-10||July 2004||2004-07-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older|A 2-year Randomized, Multicenter, Double-blind, Placebo-controlled Study to Determine the Efficacy and Safety of Intravenous Zoledronic Acid 5 mg Administered Either Annually at Randomization and 12 Months, or Administered at Randomization Only in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia|Completed||Phase 3|581|Actual|Novartis||3|||f||||||||||||||2017-10-11 05:13:48.477403|2017-10-11 05:13:48.477403
NCT00132821|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2017-01-11|||August 2005||2005-08-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Impact of Smoking Cessation on Sleep - 5|Impact of Smoking Cessation on Sleep|Completed||Phase 4|59|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||t||||||||||2017-10-11 05:13:49.816803|2017-10-11 05:13:49.816803
NCT00132834|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2013-01-24|||November 2003||2003-11-01|January 2013|2013-01-01|March 2004|Actual|2004-03-01|||||Observational|||Methods of Determining Asthma Severity in Children|"Exhaled Breath Condensates (EBC) Study: Research Plan NIH/NIAID: Inner City Asthma Consortium (ICAC)"|Completed||N/A|80|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||||||||||||2017-10-11 05:13:49.929237|2017-10-11 05:13:49.929237
NCT00132847|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-08|2013-01-18|||April 2004||2004-04-01|January 2013|2013-01-01|October 2004||2004-10-01|||||Observational|||Comparing Allergenic Effects of 3 German Cockroach Extracts in Adults|German Cockroach Allergen Standardization Evaluation (CASE)|Terminated||N/A|4|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||||||2017-10-11 05:13:50.004208|2017-10-11 05:13:50.004208
NCT00136799|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2017-02-20|||June 2005||2005-06-01|February 2017|2017-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia|Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia|Completed||Phase 3|325|Actual|Novartis|||||f||||||||||||||2017-10-11 05:13:52.447998|2017-10-11 05:13:52.447998
NCT00132860|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2005-10-18|||May 2001||2001-05-01|August 2005|2005-08-01|December 2007||2007-12-01|||||Interventional|||Prophylactic ﻿Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)|﻿Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease: A Prospective, Randomized, Double-Blind Placebo-Controlled Study of Intermittent, Prophylactic Antibiotic Treatment With Azithromycin|Unknown status|Active, not recruiting|Phase 4|800||Odense University Hospital|||||f||||||||||||||2017-10-11 05:13:50.087045|2017-10-11 05:13:50.087045
NCT00132873|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2013-09-18|2013-09-18||October 2004||2004-10-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy|Long-Term, Open-Label, Multi-Center Extension Trial of Xyrem® (Sodium Oxybate) Oral Solution for the Treatment of Narcolepsy|Completed||Phase 3|59|Actual|Jazz Pharmaceuticals||1|||f||||||||||||||2017-10-11 05:13:50.175198|2017-10-11 05:13:50.175198
NCT00132886|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2012-05-02|||December 2004||2004-12-01|May 2012|2012-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure|Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Single Oral Tolvaptan Tablets on Hemodynamic Parameters in Subjects With Heart Failure|Completed||Phase 2|140|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 05:13:50.429652|2017-10-11 05:13:50.429652
NCT00136617|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-02-27|||August 2003||2003-08-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|July 2006|Actual|2006-07-01||Interventional|||Outpatient Treatment of Alcohol Withdrawal Syndrome|Comparison of a Fixed-Schedule Therapy Versus a Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome in Medical Out-Patients|Completed||Phase 3|165|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-10-11 05:13:50.575867|2017-10-11 05:13:50.575867
NCT00136630|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2012-01-27|||May 2005||2005-05-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|||||Observational|||Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations|Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations|Unknown status|Active, not recruiting|Phase 1|225|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||||||||||||2017-10-11 05:13:50.656021|2017-10-11 05:13:50.656021
NCT00136643|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-10-09|||June 2005||2005-06-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women|A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance and Acceptability of a Vaginal Gel Containing Sodium Lauryl Sulfate (Invisible Condom®) in Healthy Female Subjects|Completed||Phase 1/Phase 2|452||Laval University|||||||||||||||||||2017-10-11 05:13:50.752664|2017-10-11 05:13:50.752664
NCT00136656|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-02-11|||July 2005||2005-07-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|June 2008|Actual|2008-06-01||Interventional|||Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old|Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old. Cefixime PO 10d vs Ceftriaxone IV 4d Followed by Cefixime PO 6d. Multicenter, Randomised Trial of Equivalence.|Completed||Phase 4|700|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:13:50.828396|2017-10-11 05:13:50.828396
NCT00136669|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2006-09-07|||September 2003||2003-09-01|September 2006|2006-09-01|September 2005||2005-09-01|||||Interventional|||Acupuncture For Pancreatic Cancer Pain|Acupuncture For Pancreatic Cancer Pain: A Randomized Phase III Study|Completed||Phase 3|60||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 05:13:50.944456|2017-10-11 05:13:50.944456
NCT00136682|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2008-11-06|||August 2004||2004-08-01|November 2008|2008-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery|Postoperative Recovery in Patients Receiving Patient-Controlled Epidural Analgesia (PCEA) Compared to Patient-Controlled Intravenous Analgesia (PCA) After Major Open Gynecologic Surgery: A Randomized Controlled Trial|Completed||Phase 3|240|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:13:51.018097|2017-10-11 05:13:51.018097
NCT00136695|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-11-30|2016-11-30||October 2004||2004-10-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Anastrozole Administration in Elderly Hypogonadal Men|Anastrozole Administration in Elderly Hypogonadal Men|Completed||Phase 2|100|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 05:13:51.108752|2017-10-11 05:13:51.108752
NCT00136708|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2014-07-29|||March 2005||2005-03-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||First Breath: Neonatal Resuscitation in Developing Countries|FIRST BREATH: Neonatal Resuscitation in Developing Countries|Completed||N/A|120009|Actual|NICHD Global Network for Women's and Children's Health||2|||f||||t||||||||||2017-10-11 05:13:51.330558|2017-10-11 05:13:51.330558
NCT00136721|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-12-03|||June 2002||2002-06-01|December 2007|2007-12-01|May 2006||2006-05-01|||||Observational|||Parkin Mutations and Their Functional Consequences|Parkin Mutations and Their Functional Consequences|Unknown status|Active, not recruiting|Phase 1|2500||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||||||||||||2017-10-11 05:13:51.426043|2017-10-11 05:13:51.426043
NCT00136734|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-04-06|||April 1998||1998-04-01|April 2016|2016-04-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Methylphenidate Treatment for Cocaine Abuse and ADHD - 1|Methylphenidate Treatment for Cocaine Abuse and ADHD|Completed||Phase 1|124|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 05:13:51.504981|2017-10-11 05:13:51.504981
NCT00136747|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-12-03|||January 2004||2004-01-01|December 2015|2015-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1|Developing Medication For Tobacco Addiction: NMDA Agents|Completed||Phase 1|45|Actual|New York State Psychiatric Institute||3|||f||||||||||||||2017-10-11 05:13:51.616763|2017-10-11 05:13:51.616763
NCT00136760|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-10-05|2012-11-16||September 2003||2003-09-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia|Incentives Plus Bupropion for Smoking in Schizophrenics|Completed||Phase 2|57|Actual|Brown University||4|||f||||t||||||||||2017-10-11 05:13:51.734538|2017-10-11 05:13:51.734538
NCT00136773|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-03-08|||April 2003||2003-04-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|October 2005|Actual|2005-10-01||Interventional|||Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus|Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|332|Actual|Novartis|||||||||||||||||||2017-10-11 05:13:52.297675|2017-10-11 05:13:52.297675
NCT00136812|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-04-23|2016-02-22||July 2006||2006-07-01|April 2016|2016-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Treating Tobacco Dependence in Inpatient Psychiatry - 1|Treating Tobacco Dependence in Inpatient Psychiatry|Completed||Phase 2|224|Actual|Stanford University||2|||f||||t||||||||No|no plan to make individual participant data available|2017-10-11 05:13:52.535225|2017-10-11 05:13:52.535225
NCT00136825|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2017-01-11|||March 2003||2003-03-01|August 2007|2007-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1|N-acetylcysteine as Treatment in Cocaine Addiction|Completed||Phase 1|17|Actual|National Institute on Drug Abuse (NIDA)||2|||||||t||||||||||2017-10-11 05:13:52.819599|2017-10-11 05:13:52.819599
NCT00136838|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-04-06|2015-04-14||October 2001||2001-10-01|December 2015|2015-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2|Effect of Smoking Exposure on Tobacco Self-Administration Following Brief Abstinence|Completed||N/A|12|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 05:13:52.924778|2017-10-11 05:13:52.924778
NCT00136851|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2011-11-07|||December 2004||2004-12-01|June 2006|2006-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension|A 6-Week Multi-center, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension|Completed||Phase 4|259|Actual|Novartis|||||||||||||||||||2017-10-11 05:13:53.167822|2017-10-11 05:13:53.167822
NCT00136864|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-11-17|||August 2004||2004-08-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|November 2009|Actual|2009-11-01||Interventional|||Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)|The Impact of Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer: A Prospective Randomized Clinical Trial (PET START Trial)|Completed||Phase 3|310|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-10-11 05:13:53.242088|2017-10-11 05:13:53.242088
NCT00136877|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2006-12-27|||October 2001||2001-10-01|December 2006|2006-12-01|December 2005||2005-12-01|||||Interventional|||Tonsillectomy in Recurrent Tonsillitis|Effect of Tonsillectomy on Preventing Recurrent Streptococcal Throat Infections: A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|70||Oulu University Hospital|||||f||||||||||||||2017-10-11 05:13:53.352157|2017-10-11 05:13:53.352157
NCT00136890|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2013-01-14|||July 2004||2004-07-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|November 2008|Actual|2008-11-01||Interventional|ELPET||PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers|The Impact of Positron Emission Tomography (PET) Imaging in Staging Potentially Surgically Resectable Non-small Cell Lung Cancers: A Prospective Multicentre Randomized Clinical Trial|Completed||Phase 3|337|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-10-11 05:13:53.441377|2017-10-11 05:13:53.441377
NCT00136916|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2010-02-12|2009-12-10||June 2002||2002-06-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes|Efficacy and Safety of Exubera® (Inhaled Insulin) Compared With Subcutaneous Human Insulin Therapy in Adult Subjects With Type 2 Diabetes Mellitus: A Long-Term, Outpatient, Open-Label, Parallel-Group Comparative Trial|Terminated||Phase 3|635|Actual|Pfizer|Due to early termination of study, none of the subjects completed the study as planned. Subjects active at the time of study termination completed an end-of-study assessment and a 3-month follow-up visit.|2||See termination reason in detailed description.|f||||f||||||||||2017-10-11 05:13:54.033144|2017-10-11 05:13:54.033144
NCT00136929|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2005-12-12||||||August 2005|2005-08-01||||||||Interventional|||Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly|"A Prospective Randomized Trial of Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly Senior PAMI"|Unknown status|Active, not recruiting|N/A|530||PAMI Coordinating Center|||||f||||||||||||||2017-10-11 05:13:58.883519|2017-10-11 05:13:58.883519
NCT00136942|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2008-02-28|||April 2005||2005-04-01|April 2007|2007-04-01||||||||Interventional|ACTFAST SWISS||A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol|A Multicenter, 6-Week-Treatment, Open-Label Study Assessing The Percentage Of Hyperlipidemic Patients Achieving Low Density Lipoprotein Cholesterol Target With Atorvastatin|Completed||Phase 3|370||Pfizer|||||f||||||||||||||2017-10-11 05:13:58.942809|2017-10-11 05:13:58.942809
NCT00136955|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-05-22|2009-05-07||June 2004||2004-06-01|May 2015|2015-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Irinotecan Study For Cervical Cancer|An Open Labeled, Single-Arm, Multicentre Phase II Study To Evaluate The Efficacy And Safety Of Weekly Irinotecan Plus Cisplatin As First-Line Chemotherapy For Advanced Or Recurrent Squamous Cell Carcinoma Of The Uterine Cervix|Completed||Phase 2|41|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:13:59.161506|2017-10-11 05:13:59.161506
NCT00136968|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2009-03-10|||April 2005||2005-04-01|March 2009|2009-03-01|May 2005|Actual|2005-05-01|||||Interventional|||Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy|Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy|Completed||Phase 1|12|Actual|Pfizer|||||||||||||||||||2017-10-11 05:13:59.545205|2017-10-11 05:13:59.545205
NCT00136981|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-04-21|||December 2003||2003-12-01|April 2015|2015-04-01|November 2006|Actual|2006-11-01|||||Interventional|RADIANCE 1||Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.|Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-Mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Maximally Tolerated Atorvastatin Therapy Alone, in Subjects With Heterozygous Familial Hypercholesterolemia.|Completed||Phase 3|800||Pfizer|||||||||||||||||||2017-10-11 05:13:59.626845|2017-10-11 05:13:59.626845
NCT00136994|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-07-28|||March 2003||2003-03-01|July 2011|2011-07-01|November 2005|Actual|2005-11-01|||||Interventional|||IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)|An Open Trial to Evaluate the Efficacy and Tolerability of Ziprasidone IM and Oral in Patients With Psychosis and Acute Agitation.|Completed||Phase 3|160||Pfizer|||||f||||||||||||||2017-10-11 05:13:59.796544|2017-10-11 05:13:59.796544
NCT00137007|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-04-20|||November 2003||2003-11-01|April 2011|2011-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Zithromax EV in Community-Acquired Pneumonia (CAP)|A Multicenter, Open Label Trial Evaluating Intravenous Azithromycin Plus Intravenous Ampicillin/Sulbactam Followed by Oral Azithromycin Plus Intravenous Ampicillin/Sulbactam for the Treatment of Hospitalized Subjects With Community-Acquired Pneumonia (CAP)|Completed||Phase 4|151|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:13:59.922908|2017-10-11 05:13:59.922908
NCT00137020|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2006-08-11|||November 2004||2004-11-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder|A Multi-Center Study to Examine The Clinical Effects of Cross Titration of Antipsychotics With Ziprasidone in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|294||Pfizer|||||f||||||||||||||2017-10-11 05:13:59.988086|2017-10-11 05:13:59.988086
NCT00137033|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2008-07-14|||September 2004||2004-09-01|September 2007|2007-09-01|July 2005|Actual|2005-07-01|||||Interventional|||Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population|A Multicenter, Randomized, Active-Controlled Comparison Study of the Incidence of Gastroduodenal Ulcers Associated With Celecoxib and Low Dose ASA Versus Naproxen and Low Dose ASA in Healthy Subjects (50-75 Years of Age)|Completed||Phase 4|605||Pfizer|||||||||||||||||||2017-10-11 05:14:00.155373|2017-10-11 05:14:00.155373
NCT00137046|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-02-03|2009-12-07||May 2002||2002-05-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes|Efficacy and Safety of Exubera (Inhaled Insulin) Compared With Subcutaneous Human Insulin Therapy in Adult Subjects With Type 1 Diabetes Mellitus: A Long-Term, Outpatient, Open-Label, Parallel-Group Comparative Trial|Terminated||Phase 3|582|Actual|Pfizer|Due to early termination of study, none of the subjects completed the study as planned. Subjects active at the time of study termination completed an end-of-study assessment and a 3-month follow-up visit.|2||See termination reason in detailed description.|f||||f||||||||||2017-10-11 05:14:00.349752|2017-10-11 05:14:00.349752
NCT00137059|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2005-12-12|||November 2002||2002-11-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||Acetaminophen-Induced Hepatotoxicity in Chronic Alcohol Abusers||Completed||N/A|40||Queen's University|||||f||||||||||||||2017-10-11 05:14:04.418204|2017-10-11 05:14:04.418204
NCT00137072|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2011-09-03|||April 2005||2005-04-01|September 2011|2011-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Mild To Moderate Erectile Dysfunction Study|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study of Men With Mild to Moderate Erectile Dysfunction to Evaluate the Efficacy of Viagra 8 Hours Post-Dose|Completed||Phase 4|355|Actual|Pfizer|||||||||||||||||||2017-10-11 05:14:04.483895|2017-10-11 05:14:04.483895
NCT00137085|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-06-13|||September 2004||2004-09-01|April 2006|2006-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation|Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation|Completed||N/A|124||Queen's University|||||f||||||||||||||2017-10-11 05:14:04.617164|2017-10-11 05:14:04.617164
NCT00137098|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-10-02|||September 2003||2003-09-01|October 2009|2009-10-01|January 2006|Actual|2006-01-01|||||Observational|||Coronary Care Caffeine: Influence of Coffee on Heart Rate Post Myocardial Infarction|Influence of Coffee on Heart Rate Variability Post Myocardial Infarction|Completed||Phase 3|100|Actual|The Royal Bournemouth Hospital|||2||f||||t||||||||||2017-10-11 05:14:04.689857|2017-10-11 05:14:04.689857
NCT00137111|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2017-07-31|2011-02-28||July 8, 2000|Actual|2000-07-08|July 2017|2017-07-01|November 2020|Anticipated|2020-11-01|November 2010|Actual|2010-11-01||Interventional|||Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 3|501|Actual|St. Jude Children's Research Hospital||2|||f||||t|t|f||||||||2017-10-11 05:14:04.785427|2017-10-11 05:14:04.785427
NCT00137124|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2012-07-06|||May 2006||2006-05-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||L-Arginine Metabolism in Essential Hypertension|Transport and Metabolism of L-arginine: Role for Endothelial Dysfunction in Essential Hypertension|Completed||Phase 2/Phase 3|120|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-10-11 05:14:05.533982|2017-10-11 05:14:05.533982
NCT00137137|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-12-19|||June 2005||2005-06-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||The Mini-Screw as Orthodontic Anchoring: Survival, Clinical Efficiency and Experience of the Patient|The Mini-Screw as Orthodontic Anchoring: A Clinical Trial to Study Survival, Clinical Efficiency and Experience of the Patient|Completed||N/A|20||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:14:05.620888|2017-10-11 05:14:05.620888
NCT00137150|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-12-19|||January 2005||2005-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Comparison of Outcome and Complications Encountered in Flapless Surgery and Immediate Loading Versus the Classical Surgical Approach and Loading After 6-8 Weeks in the Posterior Maxilla|Comparison of Outcome and Complications Encountered in Flapless Surgery and Immediate Loading Versus the Classical Surgical Approach and Loading After 6-8 Weeks in the Posterior Maxilla|Completed||N/A|15||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:14:05.703917|2017-10-11 05:14:05.703917
NCT00137163|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2008-07-24|||March 2005||2005-03-01|July 2008|2008-07-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Evaluation of Dermafill Dressing for Donor Sites|Evaluation of Dermafill Dressing for Autogenous Skin Donor Sites|Completed||N/A|17||United States Army Institute of Surgical Research|||||f||||f||||||||||2017-10-11 05:14:05.775295|2017-10-11 05:14:05.775295
NCT00137176|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-06-22|||October 2004||2004-10-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2007|Actual|2007-10-01||Interventional|||EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis|EARLY IFNb-1a (Rebif) and Atorvastatin (Lipitor) Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis|Completed||N/A|30|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-10-11 05:14:05.851142|2017-10-11 05:14:05.851142
NCT00137189|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2017-05-12|||April 2005||2005-04-01|May 2017|2017-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation|Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation: A Randomised Controlled Trial|Completed||N/A|144|Actual|Uni Research||2|||f||||f||||||||No||2017-10-11 05:14:05.938345|2017-10-11 05:14:05.938345
NCT00137202|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2008-07-24|||June 2005||2005-06-01|July 2008|2008-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Post Burn Pruritus Study in Patients Undergoing Wound Healing|A Pilot Study to Determine the Pruritic Benefits of Ondansetron Versus Diphenhydramine in Burn Patients Undergoing Wound Healing|Completed||N/A|36|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-10-11 05:14:06.089081|2017-10-11 05:14:06.089081
NCT00137215|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2008-07-24|||January 2006||2006-01-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Evaluation of Silverlon Dressing for Autogenous Skin Donor Sites|Evaluation of Silverlon Dressing for Autogenous Skin Donor Sites|Completed||N/A|17|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-10-11 05:14:06.180994|2017-10-11 05:14:06.180994
NCT00137228|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-12-24|||January 2005||2005-01-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Measuring Hand Edema in Burn Patients|The Reliability and Concurrent Validity of the Figure-of-Eight Method of Measuring Hand Edema in Patients With Burn Injuries|Completed||N/A|20|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-10-11 05:14:06.262268|2017-10-11 05:14:06.262268
NCT00137241|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-04-06|||July 2004||2004-07-01|October 2006|2006-10-01|November 2005|Actual|2005-11-01|||||Observational|||Veterans as Leaders in Understanding and Education (VALUE)|Determining the Prevalence of Health Literacy Among Veterans|Completed||N/A|1850|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:14:06.342721|2017-10-11 05:14:06.342721
NCT00137254|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2012-04-10|||December 2005||2005-12-01|April 2012|2012-04-01|August 2008|Actual|2008-08-01|February 2007|Actual|2007-02-01||Interventional|||Insulin on Post Burn Hypermetabolism|Effects of Insulin on Post Burn Hypermetabolism|Completed||N/A|14|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-10-11 05:14:06.421427|2017-10-11 05:14:06.421427
NCT00137267|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-04-29|2014-08-25||June 2005||2005-06-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TLC||A Brief Community Linkage Intervention for Dually Diagnosed Individuals|A Brief Community Linkage Intervention for Dually Diagnosed Individuals|Completed||N/A|102|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:14:06.51038|2017-10-11 05:14:06.51038
NCT00137280|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-04-06|2014-10-03||June 2007||2007-06-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|March 2010|Actual|2010-03-01||Interventional|EQUIP-2|People with schizophrenia|Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)|Implementing Effective, Collaborative Care for Schizophrenia|Completed||N/A|1067|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:14:06.829183|2017-10-11 05:14:06.829183
NCT00137293|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-12-06|||November 2005||2005-11-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Study Evaluating GAP-486 in Heart Rhythm|A Study to Characterize the Acute Electrophysiologic Properties, Safety and Tolerability of GAP-486|Terminated||Phase 2|30||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:14:07.473988|2017-10-11 05:14:07.473988
NCT00137306|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-04-06|||January 2004||2004-01-01|February 2007|2007-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Facilitating the Adoption of Evidence-Based Depression Management in Substance Use Treatment Programs|Translating Depression Guidelines Into Substance Abuse Treatment|Completed||Phase 4|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:14:07.557704|2017-10-11 05:14:07.557704
NCT00137319|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-07-20|||October 2004||2004-10-01|July 2015|2015-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Impedance Threshold Device Tilt Study|An Evaluation of an Impedance Threshold Device (ITD) to Improve Hemodynamic Function During Orthostatic Challenge in Burn Patients|Terminated||N/A|2|Actual|United States Army Institute of Surgical Research||2||Aims of the study re-evaluated, did not justify allocation of resources.|f||||f||||||||||2017-10-11 05:14:07.633909|2017-10-11 05:14:07.633909
NCT00137332|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-12-06|||November 2005||2005-11-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery Disease|A Study of the Effects GAP-486 on Ventricular Tachyarrhythmia Induction|Terminated||Phase 2|90||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:14:07.704831|2017-10-11 05:14:07.704831
NCT00137345|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2013-02-07|||June 2005||2005-06-01|September 2006|2006-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients|A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients|Terminated||Phase 3|500||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:14:07.994165|2017-10-11 05:14:07.994165
NCT00137358|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2013-01-23||||||January 2013|2013-01-01||||||||Interventional|||Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer|Phase I Trial of Dose Escalated IMRT to the Para-aortic Nodes With Concurrent Cisplatin and Amifostine in Locally Advanced Cervical Cancer|Withdrawn||Phase 1|0|Actual|University of Alabama at Birmingham||1||unable to obtain funding to conduct study|f||||||||||||||2017-10-11 05:14:08.214923|2017-10-11 05:14:08.214923
NCT00137371|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-12-07|||August 2005||2005-08-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis|Efficacy and Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women With Atrophic Vaginitis|Completed||Phase 3|480||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:14:08.326318|2017-10-11 05:14:08.326318
NCT00137384|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2017-10-05|||August 25, 2005||2005-08-25|July 3, 2017|2017-07-03||||||||Observational|||Movement-Related Brain Networks Involved in Hand Dystonia|The Role of Cortical Coherence in Focal Hand Dystonia|Completed||N/A|60|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:14:08.481219|2017-10-11 05:14:08.481219
NCT00137592|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2012-09-06|||October 2005||2005-10-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Promoting Colorectal Cancer Screening in Rural Colorado|Promoting Colorectal Cancer Screening in Rural Colorado|Completed||N/A|480|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-10-11 05:14:15.842713|2017-10-11 05:14:15.842713
NCT00137397|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2006-10-05|||November 2004||2004-11-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder|A Multi-Centre, Randomised, Placebo Controlled, Double Blind, Parallel Group Study in Female Patients to Evaluate Whether Tolterodine ER Can Reverse the Increased Bladder Wall Thickness in Patients With Overactive Bladder.|Completed||Phase 4|80||Pfizer|||||f||||||||||||||2017-10-11 05:14:08.542037|2017-10-11 05:14:08.542037
NCT00137410|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2008-06-09|||November 2002||2002-11-01|July 2006|2006-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee|Protocol For A Multicentre, Double Blind, Parallel Group Pilot Study To Compare Celecoxib Long Term Vs Celecoxib Short Term Therapy In Treatment And Prevention Of New Flare In Patients With Osteoarthritis Of The Knee|Completed||Phase 3|200||Pfizer|||||f||||||||||||||2017-10-11 05:14:08.627675|2017-10-11 05:14:08.627675
NCT00137423|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-09-24|2009-05-14||May 2005||2005-05-01|September 2009|2009-09-01|May 2008|Actual|2008-05-01|September 2007|Actual|2007-09-01||Interventional|||Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer|A Phase 2 Efficacy And Safety Study Of SU011248 Administered In A Continuous Daily Regimen In Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma|Completed||Phase 2|107|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:14:08.734585|2017-10-11 05:14:08.734585
NCT00137436|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2011-08-25|2009-05-28||October 2005||2005-10-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|May 2008|Actual|2008-05-01||Interventional|||Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer|A Phase 1/2 Safety And Pharmacokinetic Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Metastatic Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 1/Phase 2|93|Actual|Pfizer|Per FDAAA, only the Phase 2 study results are posted.|1|||f||||f||||||||||2017-10-11 05:14:11.041073|2017-10-11 05:14:11.041073
NCT00137449|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-09-09|2009-04-10||September 2005||2005-09-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor|A Phase 2 Efficacy And Safety Study Of SU011248 Administered In A Continuous Daily Regimen In Patients With Advanced Gastrointestinal Stromal Tumor|Completed||Phase 2|60|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:14:13.34399|2017-10-11 05:14:13.34399
NCT00137462|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-11-15|||November 2004||2004-11-01|December 2006|2006-12-01|September 2006||2006-09-01|||||Interventional|||Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.|A Phase 3, Double-Blind, Randomized, Multisite Trial Of The Efficacy, Safety, And Tolerability Of The Fixed Combination Torcetrapib/Atorvastatin Administered Orally, Once Daily For 12 Months, Compared To Atorvastatin Alone, Titrated Based On NCEP ATP-III LDL-C Goals In Subjects With Fredrickson Types IIa And IIb Dyslipidemias|Completed||Phase 3|900||Pfizer|||||||||||||||||||2017-10-11 05:14:14.811468|2017-10-11 05:14:14.811468
NCT00137475|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2016-02-24|||February 2002||2002-02-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function|A Phase I/II Feasibility/Efficacy Study Using Intensity-Modulated Radiation Therapy in Head and Neck (H&N) Cancer Patients to Permit Sparing of Parotid Gland Function|Completed||Phase 1/Phase 2|130|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-10-11 05:14:15.116229|2017-10-11 05:14:15.116229
NCT00137488|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2016-02-24|||November 2005||2005-11-01|April 2012|2012-04-01||||December 2007|Actual|2007-12-01||Observational|||Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)|Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)|Completed||N/A|10|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-10-11 05:14:15.200738|2017-10-11 05:14:15.200738
NCT00137501|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-07-18|||May 2003||2003-05-01|July 2013|2013-07-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||Two Dose Regimens of Nifedipine for the Management of Preterm Labor|Study of Different Doses of Nifedipine to Treat Preterm Labor|Terminated||Phase 3|102|Actual|American University of Beirut Medical Center||2||The trial was terminated because of difficulties in recruitement.|f||||f||||||||||2017-10-11 05:14:15.263557|2017-10-11 05:14:15.263557
NCT00137514|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-28|2008-04-06|||March 2001||2001-03-01|April 2008|2008-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Chloroquine and Amodiaquine for Treatment of Malaria in Children|Chloroquine and Amodiaquine for Treatment of Symptomatic Children With Plasmodium Malaria in Guinea-Bissau|Completed||Phase 4|720||Bandim Health Project|||||f||||||||||||||2017-10-11 05:14:15.349644|2017-10-11 05:14:15.349644
NCT00137527|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2014-01-16|||February 2004||2004-02-01|January 2014|2014-01-01|February 2009|Actual|2009-02-01|||||Interventional|||Brain Oxygenation Monitoring in Patients Undergoing Coronary Artery Bypass Surgery|Prospective, Randomized Trial of Cerebral Oximetry Monitoring in Patients Undergoing Coronary Artery Bypass Surgery|Terminated||N/A|250||Atlantic Health System|||||f||||||||||||||2017-10-11 05:14:15.43034|2017-10-11 05:14:15.43034
NCT00137540|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2014-11-03|||September 2005||2005-09-01|November 2014|2014-11-01|July 2008|Actual|2008-07-01|April 2007|Actual|2007-04-01||Interventional|||FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)|First Line Radiofrequency Ablation vs. Antiarrhythmic Drugs for Atrial Fibrillation Treatment|Completed||Phase 3|40|Actual|Biosense Webster, Inc.|||||f||||||||||||||2017-10-11 05:14:15.508131|2017-10-11 05:14:15.508131
NCT00137553|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-28|2010-03-15|||May 2001||2001-05-01|March 2010|2010-03-01|March 2004||2004-03-01|||||Interventional|||The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children|The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children With Recrudescent Malaria in Guinea-Bissau|Completed||Phase 4|60||Bandim Health Project|||||f||||f||||||||||2017-10-11 05:14:15.58672|2017-10-11 05:14:15.58672
NCT00137579|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-12-12|||September 2003||2003-09-01|January 2003|2003-01-01|May 2004||2004-05-01|||||Interventional|||Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy|Phase IV, Simple Blind, 2-Parallel Groups Randomized Trial to Evaluate the Safety and Effectiveness of the Intramuscular Vs Subcutaneous Route for the Administration of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation|Completed||Phase 4|216||Catalan Institute of Health|||||f||||||||||||||2017-10-11 05:14:15.754673|2017-10-11 05:14:15.754673
NCT00137605|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2014-02-11|||September 2004||2004-09-01|February 2014|2014-02-01|October 2007|Actual|2007-10-01|||||Interventional|||Early Versus Delayed Pneumococcal Vaccination in HIV|A Pilot Study Assessing the Efficacy of Pneumococcal Vaccine in HIV Patients: Delayed Versus Immediate Immunization|Completed||Phase 1/Phase 2|79|Actual|CIHR Canadian HIV Trials Network||4|||f||||||||||||||2017-10-11 05:14:15.917363|2017-10-11 05:14:15.917363
NCT00137618|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-03-16|||November 2004||2004-11-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening|Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening - Univ of Texas - SIP 21-04|Completed||N/A|264|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:14:16.035957|2017-10-11 05:14:16.035957
NCT00137631|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-06-23|2010-03-10||August 2005||2005-08-01|April 2010|2010-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|3MV||Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM|Evaluation of Many Men, Many Voices, A Group Intervention for STD/HIV Prevention for Black Men Who Have Sex With Men (MSM) in the New York Metropolitan Area by People of Color in Crisis, Brooklyn, NY|Completed||Phase 1/Phase 2|341|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 05:14:16.118374|2017-10-11 05:14:16.118374
NCT00137644|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-01-06|||March 2005||2005-03-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|||||Interventional|||Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents|Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Innovative HIV Prevention Intervention for Minority Adolescents by the Philadelphia Health Management Corporation in Philadelphia, PA|Completed||Phase 1/Phase 2|264|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 05:14:16.465387|2017-10-11 05:14:16.465387
NCT00137657|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-12-12|||February 2002||2002-02-01|August 2005|2005-08-01|November 2003||2003-11-01|||||Interventional|||Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance|An Evaluation of the Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on the Development of Antifolate Resistance Among Plasmodium Falciparum, Streptococcus Pneumoniae, and Escherichia Coli|Completed||Phase 4|1478||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:14:16.542955|2017-10-11 05:14:16.542955
NCT00137670|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2012-09-26|||April 2002||2002-04-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2006|Actual|2006-03-01||Interventional|||Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients|Effectiveness of a Video-based Educational Intervention to Prevent Human Immunodeficiency Virus (HIV) and Sexually Transmitted Diseases (STDs) Among Patients Attending STD Clinics|Completed||N/A|45000||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:14:16.616965|2017-10-11 05:14:16.616965
NCT00137683|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2012-03-13|||September 2001||2001-09-01|March 2012|2012-03-01|March 2005||2005-03-01|||||Interventional|||Colorectal Cancer Control in Appalachian Churches|Colorectal Cancer Control in Appalachian Churches|Withdrawn||Phase 2/Phase 3|0|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:14:16.702744|2017-10-11 05:14:16.702744
NCT00137696|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2005-12-12|||September 2002||2002-09-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine|Immunogenicity of Inactivated Polio Vaccine in Puerto Rico; A Comparative Cohort Study of Two Vaccination Schedules|Completed||N/A|500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:14:16.775609|2017-10-11 05:14:16.775609
NCT00137709|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-10-30|||November 2004||2004-11-01|October 2007|2007-10-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Hormone Profiles in Adults With Newly Diagnosed Epilepsy|Hormone Profiles in Adults Treated With Valproate vs. Lamotrigine Monotherapy for Newly Diagnosed Epilepsy: A Prospective Randomised Study|Unknown status|Recruiting|Phase 4|80|Anticipated|Chinese University of Hong Kong||2|||f||||||||||||||2017-10-11 05:14:16.845122|2017-10-11 05:14:16.845122
NCT00137722|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2015-02-02|||January 2000||2000-01-01|December 2008|2008-12-01|August 2005||2005-08-01|||||Observational|||Outcomes From an Asthma Disease Management Program|Identification of Outcomes From an Asthma Disease Management Program|Completed||N/A|||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:14:16.941719|2017-10-11 05:14:16.941719
NCT00137735|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-10-30|||October 2003||2003-10-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Gabapentin for Carpal Tunnel Syndrome|Gabapentin for Carpal Tunnel Syndrome: A Randomised Controlled Trial|Completed||Phase 3|150|Actual|Chinese University of Hong Kong||2|||f||||||||||||||2017-10-11 05:14:17.012146|2017-10-11 05:14:17.012146
NCT00137748|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2010-06-08|||January 2001||2001-01-01|June 2010|2010-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients|Does Replacement With CMVIG in Hypogammaglobulinemic Patients Decrease the Rate of Opportunistic Infections and Chronic Rejection?|Completed||Phase 2/Phase 3|50|Anticipated|The Cleveland Clinic||1|||f||||||||||||||2017-10-11 05:14:17.110239|2017-10-11 05:14:17.110239
NCT00137761|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-10-30|||October 2004||2004-10-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|June 2007|Actual|2007-06-01||Interventional|||Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer|A Phase II Study of Docetaxel in Combination With ZD 1839 (IRESSA) in Previously Treated Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|32|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:14:17.181128|2017-10-11 05:14:17.181128
NCT00137774|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2013-04-07|||November 2004||2004-11-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|July 2005|Actual|2005-07-01||Interventional|||Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors|A Phase II Study of Bevacizumab in Combination With Temozolomide in Patients With Advanced Neuroendocrine Tumors|Completed||Phase 2|34|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:14:17.261248|2017-10-11 05:14:17.261248
NCT00137787|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-28|2008-11-11|||April 2005||2005-04-01|November 2008|2008-11-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|||Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases|Randomized Controlled Trial Comparing Ciprofloxacin With Cefepime in Febrile Neutropenic Patients With Hematologic Diseases|Unknown status|Recruiting|Phase 3|200|Anticipated|Center for Supporting Hematology-Oncology Trials||2|||f||||t||||||||||2017-10-11 05:14:17.34606|2017-10-11 05:14:17.34606
NCT00137800|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-08-02|||February 2003||2003-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|May 2005|Actual|2005-05-01||Interventional|||Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients|A Phase II Study of OSI-774 (Tarceva) in Elderly Subjects With Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|80|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:14:17.571782|2017-10-11 05:14:17.571782
NCT00137813|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-05-09|||August 2004||2004-08-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|September 2006|Actual|2006-09-01||Interventional|||Avastin and Taxotere for Esophagogastric Cancer|Phase II Study of Bevacizumab and Docetaxel (AvaTax) in Metastatic Esophagogastric Cancer|Active, not recruiting||Phase 2|42|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:14:17.660872|2017-10-11 05:14:17.660872
NCT00137826|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2011-12-23|||February 2004||2004-02-01|December 2011|2011-12-01|July 2009|Actual|2009-07-01|March 2007|Actual|2007-03-01||Interventional|||Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma|Phase II Study of Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Malignant Mesothelioma|Completed||Phase 2|37|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:14:17.753286|2017-10-11 05:14:17.753286
NCT00137839|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-08-02|||October 2004||2004-10-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung|A Phase II Study of Erlotinib (OSI-774); Tarceva in Women With Previously Untreated Advance Adenocarcinoma of the Lung|Active, not recruiting||Phase 2|75|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:14:17.853071|2017-10-11 05:14:17.853071
NCT00137852|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2017-09-18|||January 2002||2002-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|August 2004|Actual|2004-08-01||Interventional|||Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer|Phase II Trial of Cisplatin, CPT-11, Celecoxib (PCC), Concurrent Radiation Therapy, and Surgery for Resectable Esophageal Cancer|Completed||Phase 2|35|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:14:17.955062|2017-10-11 05:14:17.955062
NCT00137865|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2013-02-27|||August 2005||2005-08-01|February 2013|2013-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer|A Phase 1, Open Label, Dose Escalation Study of the Safety, Tolerability and Preliminary Efficacy of Intraperitoneal EGEN-001 in Patients With Recurrent Epithelial Ovarian Cancer|Terminated||Phase 1|18|Actual|EGEN, Inc.||1||"Sponsor decided to terminate the study early so they could begin a second dose-escalation study   of EGEN-001 in combination with standard chemotherapy."|f||||||||||||||2017-10-11 05:14:18.062742|2017-10-11 05:14:18.062742
NCT00137878|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2012-02-22||||||May 2011|2011-05-01||||||||Interventional|||TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer|A Phase II Randomized Trial Comparing TNFerade™ Biologic With Capecitabine and Radiation Therapy Followed by Surgical Resection Versus Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer|Completed||Phase 2|||GenVec|||||||||||||||||||2017-10-11 05:14:18.143981|2017-10-11 05:14:18.143981
NCT00137891|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2015-03-17|||June 2005||2005-06-01|March 2015|2015-03-01|August 2005||2005-08-01|||||Interventional|||Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone|Phase I Study Comparing Pharmacokinetics and Safety Profile of Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone|Completed||Phase 1|46||Sanofi|||||||||||||||||||2017-10-11 05:14:18.213459|2017-10-11 05:14:18.213459
NCT00137904|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2006-02-08||||||August 2005|2005-08-01||||||||Observational|||Sleep Disorders in Patients With Multiple Sclerosis|Study of Sleep Disorders and Fatigue in Patients With Multiple Sclerosis|Unknown status|Recruiting|N/A|51||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-10-11 05:14:18.280551|2017-10-11 05:14:18.280551
NCT00137917|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2016-09-15|||July 2002||2002-07-01|September 2016|2016-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs|A Primary Vaccination Study to Evaluate Immunogenicity, Safety and Reactogenicity of 3 Doses of GSK Biologicals/Finlay's Meningococcal B Candidate Vaccine Given Intramuscularly Using Either 0-2-4 Month or 0-1-6 Month Schedule to Healthy Subjects Aged 12-18 Years|Completed||Phase 2|478|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:14:18.349901|2017-10-11 05:14:18.349901
NCT00137930|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-09-20|||August 2005||2005-08-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis|Compare the Immunogenicity, Reactogenicity & Safety of 2 Different Formulations of GSK Biologicals' Live Attenuated Human Rotavirus (HRV) Vaccine Given as a Two-dose Primary Vaccination in Healthy Infants Previously Uninfected With HRV|Completed||Phase 2|250||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:14:18.419955|2017-10-11 05:14:18.419955
NCT00137943|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2012-09-26|||September 1999||1999-09-01|September 2012|2012-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Parents Matter!: Interventions to Promote Effective Parent-Child Communication|Parents Matter!: Interventions to Promote Effective Parent-Child Communication About Sex and Sexual Risk Among African American Families|Completed||Phase 1|2210||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:14:18.511444|2017-10-11 05:14:18.511444
NCT00137956|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-08-14|||December 2004||2004-12-01|August 2009|2009-08-01||||||||Interventional|||Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-Study|Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-Study|Terminated||Phase 3|270||Emphasys Medical|||||||||||||||||||2017-10-11 05:14:18.630859|2017-10-11 05:14:18.630859
NCT00137969|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2015-04-30|2009-06-05||May 2005||2005-05-01|April 2015|2015-04-01||||August 2008|Actual|2008-08-01||Interventional|EXPLORER|Intent-to-treat population: All randomized participants who received any amount of study drug.|A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus|Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With Moderate to Severe Systemic Lupus Erythematosus|Completed||Phase 2/Phase 3|262|Actual|Genentech, Inc.||2|||f||||f||||||||||2017-10-11 05:14:18.758224|2017-10-11 05:14:18.758224
NCT00137982|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2006-09-07|||August 2004||2004-08-01|August 2005|2005-08-01|July 2008||2008-07-01|||||Interventional|||Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility|Prospective Study, Randomized Controlled Trial Between Medical Treatment by Methotrexate Versus Conservative Surgical Treatment (Group 1) and Conservative Versus Radical Surgical Treatment (Group 2) to Evaluate Subsequent Fertility|Unknown status|Recruiting|Phase 4|600||Hopital Antoine Beclere|||||f||||||||||||||2017-10-11 05:14:20.077981|2017-10-11 05:14:20.077981
NCT00137995|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2017-03-09|||June 2003||2003-06-01|March 2017|2017-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma|Randomized Study of ICE Plus RITUXIMAB Versus DHAP Plus Rituximab in Previously Treated Patients With Diffuse Large B-cell Lymphoma, Followed by Randomized Maintenance With Rituximab|Completed||Phase 3|481|Actual|Lymphoma Study Association||2|||f||||t|f|f||||||No||2017-10-11 05:14:20.278128|2017-10-11 05:14:20.278128
NCT00138008|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-09-20|||May 2004||2004-05-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy|Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy (JCOG0401)|Completed||Phase 3|200|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:14:20.420021|2017-10-11 05:14:20.420021
NCT00138021|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-10-31|||July 2005||2005-07-01|October 2007|2007-10-01|May 2008|Anticipated|2008-05-01|||||Interventional|CT+SE||Cognitive Remediation in Supported Employment at Human Service Center (HSC)|Cognitive Remediation in Supported Employment at HSC|Unknown status|Active, not recruiting|N/A|50|Anticipated|Human Service Center, Illinois||1|||f||||f||||||||||2017-10-11 05:14:20.565287|2017-10-11 05:14:20.565287
NCT00138034|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2012-04-25|2012-02-20||January 2005||2005-01-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3|A Multicenter Randomized Trial in the Prevention of Reocclusion Following Successful Thrombolysis for Suspected Acute Myocardial Infarction: An Invasive Versus a Conservative Strategy|Completed||Phase 4|49|Actual|Heartcenter, University Medical Center St. Radboud||2|||f||||f||||||||||2017-10-11 05:14:20.730885|2017-10-11 05:14:20.730885
NCT00138047|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2005-12-02|||March 2003||2003-03-01|August 2005|2005-08-01|September 2004||2004-09-01|||||Interventional|||Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa|Randomized, Double-Blind, Placebo-Controlled Trial of Zinc Supplementation in HIV-1-Infected Children|Completed||Phase 2|100||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:14:21.127998|2017-10-11 05:14:21.127998
NCT00138060|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-07-19|||June 2005||2005-06-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants|Protocole Evaluant Chez Des Patients Porteurs de Cancers Colorectaux Metastatiques l'Interet Des Determinants Genotypiques Pour l'Optimisation de l'Efficacite et de la Tolerance de la Chimiotherapie Par Irinotecan et 5-fluorouracile|Completed||Phase 4|71|Actual|Institut de Recherche Clinique sur les Cancers et le Sang||1|||f||||f||||||||||2017-10-11 05:14:21.201874|2017-10-11 05:14:21.201874
NCT00138073|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2014-05-29|2014-03-24||December 2005||2005-12-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effectiveness of a Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation|Effectiveness of a Web-Based Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation Among Nurses and Physicians|Terminated||N/A|55|Actual|Massachusetts General Hospital|Study not completed.|1||The study was terminated because of lack of resources to complete it.|f||||t||||||||||2017-10-11 05:14:21.287597|2017-10-11 05:14:21.287597
NCT00138086|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2006-09-06|||March 2005||2005-03-01|September 2006|2006-09-01|March 2009||2009-03-01|||||Interventional|||Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma|Targeted Intensification by a New Preparative Regimen for Patients With Low-Grade B-Cell Lymphoma Utilizing Standard-Dose Yttrium-90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy (RIT) Combined With High-Dose Beam Followed by Autologous Stem Cell Transplantation (ASCT)|Completed||Phase 2|75||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:14:21.46297|2017-10-11 05:14:21.46297
NCT00138099|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-05-30|||July 2004||2004-07-01|November 2006|2006-11-01|June 2006|Actual|2006-06-01|||||Observational|||Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)|Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)|Completed||Phase 2/Phase 3|140|Actual|McMaster University|||||f||||t||||||||||2017-10-11 05:14:21.614601|2017-10-11 05:14:21.614601
NCT00138112|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2006-09-07|||November 2003||2003-11-01|September 2006|2006-09-01|November 2005||2005-11-01|||||Interventional|||Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation|Randomized Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Early Viridans Streptococcal Sepsis After Hematopoietic Cell Transplantation|Completed||Phase 3|126||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 05:14:21.753345|2017-10-11 05:14:21.753345
NCT00138125|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-01-28|2013-01-08||April 2005||2005-04-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer|Phase II Randomized Trial of Faslodex and Herceptin, Alone and Combined, in the First - Line Treatment of Hormone Receptor-Positive, HER-2/Neu-Overexpressing Metastatic Breast Cancer|Terminated||Phase 2|2|Actual|Translational Oncology Research International|Trial terminated due to slow patient accrual.Study closed with two subjects enrolled to treatment phase.Slow accrual was due to specific requirements of study population limiting enrollment and possibly due to availability of study drugs in clinic.|1||Due to low accrual|f||||t||||||||||2017-10-11 05:14:21.853954|2017-10-11 05:14:21.853954
NCT00138138|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-12-06|||October 2002||2002-10-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Psychostimulants for Fatigue in Prostate Cancer|Psychostimulants for Fatigue in Advanced Prostate Cancer|Completed||Phase 2|120||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 05:14:22.09159|2017-10-11 05:14:22.09159
NCT00138359|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26|||December 2004||2004-12-01|December 2006|2006-12-01|January 2005||2005-01-01|||||Interventional|||Mass Treatment T Solium Community Study|The Effect of a Single Control Intervention in the T Solium Life Cycle|Terminated||N/A|4200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:24.469875|2017-10-11 05:14:24.469875
NCT00138151|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-09-17|2013-09-17||March 2001||2001-03-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer|A Phase II Trial of Chemosensitization With Paclitaxel, 13-cis Retinoic Acid and Interferon Alpha-2b in Advanced Uterine Cervical Carcinoma|Terminated||Phase 2|33|Actual|Rutgers, The State University of New Jersey||1||Slow accrual and lack of study drug|f||||f||||||||||2017-10-11 05:14:22.1919|2017-10-11 05:14:22.1919
NCT00138164|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-05-29|||December 2004||2004-12-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|February 2006|Actual|2006-02-01||Interventional|||Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Multicenter Study of Ontak® (Denileukin Diftitox) in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:14:22.600727|2017-10-11 05:14:22.600727
NCT00138177|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-09-27|||July 2005||2005-07-01|September 2013|2013-09-01||||August 2011|Actual|2011-08-01||Interventional|||Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors|A Phase I Study of Suberoylanilide Hydroxamic Acid (Vorinostat) in Combination With 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX) in Patients With Colorectal Cancer and Other Solid Tumors|Completed||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:14:22.679456|2017-10-11 05:14:22.679456
NCT00138203|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2014-04-25|2013-02-13||June 2005||2005-06-01|December 2012|2012-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed Non-small Cell Lung Cancer|Completed||Phase 2|16|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:14:22.818099|2017-10-11 05:14:22.818099
NCT00138216|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2014-02-18|||October 2005||2005-10-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|June 2009|Actual|2009-06-01||Interventional|||Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors|A Phase I Study of Temozolomide, Oral Irinotecan, and Vincristine for Children With Refractory Solid Tumors|Completed||Phase 1|42|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 05:14:23.097418|2017-10-11 05:14:23.097418
NCT00138229|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2012-03-28|||July 2005||2005-07-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma|Phase II Trial Using Aldesleukin (IL-2) Following a Lymphodepleting Chemotherapy and Reinfusion of Autologous Lymphocytes Depleted of T Regulatory Lymphocytes in Metastatic Melanoma|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-10-11 05:14:23.305871|2017-10-11 05:14:23.305871
NCT00138242|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-06-25|||December 2004||2004-12-01|October 2006|2006-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer|Phase II Trial of Weekly Docetaxel (Taxotere®) and Carboplatin as Initial Chemotherapy for Women With Ovarian Cancer and Similar Malignancies|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:14:23.395704|2017-10-11 05:14:23.395704
NCT00138255|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26|||June 2004||2004-06-01|May 2005|2005-05-01|June 2005||2005-06-01|||||Observational|||Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines|MMR and Varicella Vaccine Responses in Extremely Premature Infants|Terminated||Phase 4|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:23.48348|2017-10-11 05:14:23.48348
NCT00138268|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26||||||October 2007|2007-10-01|February 2005||2005-02-01|||||Observational|||Pilot Study Freeze and Transport Immune Cells|Pilot Study to Optimize and Standardize Umbilical Cord Blood Collection and the Isolation, Freezing and Transportation of Cells for Studies of Cellular Immune Responses to Immunization|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:14:23.545818|2017-10-11 05:14:23.545818
NCT00138281|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26||||||March 2010|2010-03-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||Influenza Immunity Against Pandemic Respiratory Virus|Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus|Completed||Phase 4|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:23.605424|2017-10-11 05:14:23.605424
NCT00138294|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2017-05-16|2016-02-01||October 1998|Actual|1998-10-01|May 2017|2017-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|CEI||Control of Epidemic Influenza Through a School-based Influenza Vaccination Program|Phase 4, School-based, Open-labeled Research Trial for Control of Epidemic Influenza Through a School-based Influenza Vaccination Program in Central Texas.|Completed||Phase 4|29255|Actual|Baylor College of Medicine||2|||f||||t|t|f|||f|||No||2017-10-11 05:14:23.681277|2017-10-11 05:14:23.681277
NCT00138307|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26||||||March 2007|2007-03-01|March 2006||2006-03-01|||||Observational|||Correlates of Protection in Ghana|Immunological Correlates of Protection Against Clinical Malaria in a Cohort of Young Children in the Kassena Nankana District of Ghana|Completed||N/A|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:24.178634|2017-10-11 05:14:24.178634
NCT00138320|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2013-09-12|||August 2005||2005-08-01|August 2013|2013-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Herpevac Neonatal Substudy|Transfer of Herpes Simplex Virus Type 2 gD Subunit Vaccine-Induced Antibodies From Mothers to Neonates|Terminated||N/A|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||Samples Without DNA|"     Sera obtained from collected blood samples will be used. Ten mL of blood will be collected at     the maternal blood draw and from the umbilical vein. Three to 5 mL of blood will be collected     at each infant blood draw   "|||2017-10-11 05:14:24.253361|2017-10-11 05:14:24.253361
NCT00138333|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2011-11-10|||December 2005||2005-12-01|October 2007|2007-10-01|November 2006||2006-11-01|||||Observational|||Mercury Levels in Premature and LBW Infants Receiving Thimerosal-containing Vaccines|Assessment of Mercury Levels and Metabolism in Premature and Low Birth Weight (LBW) Infants Receiving Vaccines Containing Thimerosal|Completed||N/A|71|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:24.342372|2017-10-11 05:14:24.342372
NCT00138346|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26|||August 2004||2004-08-01|December 2006|2006-12-01|April 2007||2007-04-01|||||Observational|||Epi Cystic Hydatid Disease Peru|Epidemiology of Human Cystic Hydatid Disease|Completed||N/A|840||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:24.406206|2017-10-11 05:14:24.406206
NCT00138385|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26|||August 2005||2005-08-01|November 2007|2007-11-01|June 2007||2007-06-01|||||Interventional|||Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment|A Randomized Comparison of the Immune Response to Either Inactivated or Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age|Completed||Phase 4|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:24.630995|2017-10-11 05:14:24.630995
NCT00138398|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26|||October 2005||2005-10-01|October 2007|2007-10-01|October 2007||2007-10-01|||||Interventional|||T-cell Response-Flu Risk in Older Adults|T-cell Responses Predict Influenza Risk in Older Adults|Unknown status|Recruiting|N/A|850||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:24.718414|2017-10-11 05:14:24.718414
NCT00138411|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26|||October 2005||2005-10-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Monoclonal Antibody for Treatment of Inhalation Anthrax|Randomized, Placebo-Controlled, Double Blind, Dose-Escalation Phase I Study of the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of ETI-204 [Anthim(TM)] and Its Potential Interaction With Ciprofloxacin|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:14:24.803272|2017-10-11 05:14:24.803272
NCT00138437|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2014-11-05|||April 2006||2006-04-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Molecular and Immunological Tools for Detection of Strain Diversity, Drug Resistance and Immunological Responses|Molecular Epidemiology of Leprosy in Colombia|Completed||N/A|1554|Actual|Colorado State University|||3||f||||f||||||Samples With DNA|"     Blood, Nasal Swabs, Skin Biopsies and scrapings   "|||2017-10-11 05:14:27.674865|2017-10-11 05:14:27.674865
NCT00138450|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26||||||March 2007|2007-03-01|November 2004||2004-11-01|||||Observational|||Urinary Schistosomiasis Infection|Village Surveys of Morbidity Due to S. Haematobium for 1U01AI4547 Urinary Schistosomiasis-Determinants of Infection and Disease|Completed||N/A|4400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:27.786074|2017-10-11 05:14:27.786074
NCT00138463|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2011-11-03|||September 2003||2003-09-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||West Nile Virus Natural History|Investigation of the Natural History of West Nile Virus Infection in Patients With Recently Acquired West Nile Fever or Neuroinvasive Disease|Completed||N/A|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"     Cerebrospinal fluid, urine, serum.   "|||2017-10-11 05:14:29.574154|2017-10-11 05:14:29.574154
NCT00138476|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2014-05-08|||August 2004||2004-08-01|April 2012|2012-04-01|September 2012|Actual|2012-09-01|April 2012|Actual|2012-04-01||Interventional|||New Challenge Pool of Norwalk Virus Inoculum|Evaluation of a New Challenge Pool of Norwalk Virus Inoculum (Lot 42399) in Human Subjects|Completed||Phase 1|57|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-10-11 05:14:30.276188|2017-10-11 05:14:30.276188
NCT00138489|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26|||January 2004||2004-01-01|October 2007|2007-10-01||||||||Observational|||Papua New Guinean Duffy Negativity And Vivax Malar|Protocol 3B Susceptibility to Plasmodium Vivax Infection and Malaria During Early Childhood|Suspended||N/A|266||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:30.397733|2017-10-11 05:14:30.397733
NCT00138502|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-08-26|||September 2001||2001-09-01|October 2007|2007-10-01|April 2005||2005-04-01|||||Observational|||Funguria in Hospitalized Patients|The Significance of Funguria In Hospitalized Patients|Unknown status|Active, not recruiting|N/A|926||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:14:30.474282|2017-10-11 05:14:30.474282
NCT00138515|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2017-02-28|||November 2004||2004-11-01|February 2017|2017-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|418|Actual|Novartis|||||f||||||||||||||2017-10-11 05:14:30.546191|2017-10-11 05:14:30.546191
NCT00138528|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2017-02-20|||October 2004||2004-10-01|February 2017|2017-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome|Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome|Completed||Phase 4|55|Actual|Novartis|||||f||||||||||||||2017-10-11 05:14:30.667691|2017-10-11 05:14:30.667691
NCT00138541|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2017-02-28|||October 2004||2004-10-01|February 2017|2017-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes|Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes|Completed||Phase 3|440|Actual|Novartis|||||f||||||||||||||2017-10-11 05:14:30.805676|2017-10-11 05:14:30.805676
NCT00138554|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2017-02-21|||November 2004||2004-11-01|February 2017|2017-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes|Completed||Phase 3|318|Actual|Novartis||2|||||||||||||||||2017-10-11 05:14:30.975742|2017-10-11 05:14:30.975742
NCT00138567|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|530||Novartis|||||f||||||||||||||2017-10-11 05:14:31.088447|2017-10-11 05:14:31.088447
NCT00138580|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2017-02-28|||November 2004||2004-11-01|February 2017|2017-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes|Completed||Phase 3|345||Novartis|||||f||||||||||||||2017-10-11 05:14:31.165848|2017-10-11 05:14:31.165848
NCT00138593|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2017-02-28|||July 2004||2004-07-01|February 2017|2017-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%|Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%|Completed||Phase 3|180||Novartis|||||f||||||||||||||2017-10-11 05:14:31.250358|2017-10-11 05:14:31.250358
NCT00138606|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes|Completed||Phase 3|179|Actual|Novartis|||||f||||||||||||||2017-10-11 05:14:31.341932|2017-10-11 05:14:31.341932
NCT00138619|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-27|2012-05-04|||November 2004||2004-11-01|May 2012|2012-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|478|Actual|Novartis|||||f||||||||||||||2017-10-11 05:14:31.431488|2017-10-11 05:14:31.431488
NCT00138632|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-11-12|||September 2005||2005-09-01|November 2008|2008-11-01||||November 2007|Actual|2007-11-01||Interventional|ADVANCE||Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)|A Randomized, Double-Masked, Multicenter, Phase I/II Study of the Safety of PTK787 Administered to Patients With Predominantly Classic , Minimally Classic or Occult With no Classic Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|Completed||Phase 1/Phase 2|50|Actual|Novartis||3|||f||||||||||||||2017-10-11 05:14:31.518843|2017-10-11 05:14:31.518843
NCT00138645|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-01-15|2009-04-21||April 2005||2005-04-01|January 2016|2016-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|FORMULA||The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet|The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet|Completed||Phase 4|60|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-10-11 05:14:31.655999|2017-10-11 05:14:31.655999
NCT00138658|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2012-02-02|2011-10-06||November 2004||2004-11-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|A Phase 1-2 Study of Weekly OGX-011 Plus a Gemcitabine/Platinum-Based Regimen in Patients With Stage IIIB or IV Non Small Cell Lung Cancer|Completed||Phase 1/Phase 2|85|Actual|Achieve Life Sciences||1|||f||||f||||||||||2017-10-11 05:14:33.573454|2017-10-11 05:14:33.573454
NCT00138671|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-01-25|2009-09-02||January 2003||2003-01-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD|Efficacy and Safety of Inhaled Human Insulin (Exubera) Compared With Subcutaneous Human Insulin in the Therapy of Adult Subjects With Type 1 or Type 2 Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: A One-Year, Multicenter, Randomized, Outpatient, Open-Label, Parallel-Group Comparative Trial|Terminated||Phase 3|105|Actual|Pfizer|This study was terminated due to Pfizer's decision to stop marketing Exubera®. Due to inconsistency in concomitant medication data entry, interpretation of the event rates for non-severe exacerbations may be of limited clinical value.|2||See termination reason in detailed description.|f||||f||||||||||2017-10-11 05:14:34.340434|2017-10-11 05:14:34.340434
NCT00138684|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2012-05-18|||September 2003||2003-09-01|May 2012|2012-05-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Cytochrome P450 2E1 and Iron Overload|Cytochrome P450 2E1 and Iron Overload|Completed||Phase 2|50|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 05:14:36.520804|2017-10-11 05:14:36.520804
NCT00138697|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-04-18|||May 2001||2001-05-01|April 2007|2007-04-01|December 2004|Actual|2004-12-01|||||Interventional|||Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients|Kinetics, Efficacy and Safety of IVIG-L (Human Normal Intravenous Immunoglobulin for Intravenous Use) in Hypogammaglobulinemia Patients|Completed||Phase 2/Phase 3|15||Sanquin|||||f||||||||||||||2017-10-11 05:14:36.607764|2017-10-11 05:14:36.607764
NCT00138710|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2010-10-21|||August 2005||2005-08-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Short-term Effects of Aromatase Inhibition in Obese Men|Short-term Effects of Aromatase Inhibition in Obese Men|Completed||Phase 3|50|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-10-11 05:14:36.685806|2017-10-11 05:14:36.685806
NCT00138723|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2008-04-09|||October 2003||2003-10-01|March 2008|2008-03-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome|A Phase 3, Parallel Group, Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome|Completed||Phase 3|||Pfizer|||||||||||||||||||2017-10-11 05:14:36.768268|2017-10-11 05:14:36.768268
NCT00138736|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-08-29|||April 2004||2004-04-01|August 2007|2007-08-01|October 2006|Actual|2006-10-01|||||Interventional|||Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia|Phase II Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia|Completed||Phase 2|12|Actual|Sanquin||1|||f||||f||||||||||2017-10-11 05:14:36.823045|2017-10-11 05:14:36.823045
NCT00138749|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2011-04-06|||November 2004||2004-11-01|April 2011|2011-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.|An 8-Week, Multi-Centre,Randomised Double-Blind, Placebo Controlled, Parallel Group Study To Evaluate The Efficacy,Toleration And Safety Of (+)- [S,S]- Reboxetine In The Treatment Of Stress Urinary Incontinence (SUI) In Women.|Completed||Phase 2|402||Pfizer|||||f||||||||||||||2017-10-11 05:14:36.943482|2017-10-11 05:14:36.943482
NCT00138762|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2012-02-15||2012-02-15|July 2004||2004-07-01|February 2012|2012-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol|A Phase 3, Double Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety and Tolerability of Fixed Combination Torcetrapib/Atorvastatin Administered Orally Once Daily for 6 Months, Compared to Atorvastatin Alone or Placebo in Subjects With Mixed Dyslipidemia (Fredrickson Types IIa and IIb).|Completed||Phase 3|3800||Pfizer|||||f||||||||||||||2017-10-11 05:14:37.230602|2017-10-11 05:14:37.230602
NCT00138775|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-28|2006-12-24|||October 2004||2004-10-01|October 2006|2006-10-01|October 2007||2007-10-01|||||Interventional|||Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia|D-Serine Adjuvant Pharmacotherapy for the Treatment of Schizophrenia|Unknown status|Recruiting|Phase 2|200||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:14:37.64443|2017-10-11 05:14:37.64443
NCT00138788|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-11-19|||February 1996||1996-02-01|November 2008|2008-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases|To Determine Which of Two Radiotherapy Brain Fractionation Schemes is Superior in the Treatment of Brain Metastases|Completed||Phase 3|112|Anticipated|St George Hospital, Australia|||||f||||||||||||||2017-10-11 05:14:37.866636|2017-10-11 05:14:37.866636
NCT00138801|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2010-02-04|||March 2004||2004-03-01|March 2005|2005-03-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis|Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis. A Randomized Double-blind Comparison|Completed||Phase 3|||Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-11 05:14:37.956937|2017-10-11 05:14:37.956937
NCT00138814|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-12-14|||January 1997||1997-01-01|September 2005|2005-09-01|December 2015||2015-12-01|||||Interventional|||Boost Use in Breast Conservation Radiotherapy|A Randomised Comparison of Breast Conservation With or Without Lumpectomy Radiotherapy Boost|Unknown status|Recruiting|Phase 3|680||St George Hospital, Australia|||||f||||||||||||||2017-10-11 05:14:38.036721|2017-10-11 05:14:38.036721
NCT00138827|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-12-14|||November 1999||1999-11-01|May 1998|1998-05-01|March 2003||2003-03-01|||||Interventional|||Mouth Care Regimes During Radiotherapy|A Pilot Randomised Comparison of Bicarbonate Based Mouth Care Versus Biotene Based Mouth Care During Radiotherapy|Completed||Phase 4|50||St George Hospital, Australia|||||f||||||||||||||2017-10-11 05:14:38.155504|2017-10-11 05:14:38.155504
NCT00138840|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2008-12-03|||August 2005||2005-08-01|December 2008|2008-12-01||||||||Interventional|||Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease|A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, for the Induction of Clinical Response in Patients With Crohn's Disease|Completed||Phase 2|282||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-10-11 05:14:38.232985|2017-10-11 05:14:38.232985
NCT00138853|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2010-10-12|||November 2003||2003-11-01|October 2010|2010-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|Ti-Tan||A Roentgen Stereophotogrammetric Analysis on Migration of Knee Prostheses.|A Roentgen Stereophotogrammetric Analysis on Migration of Knee Prostheses. A Randomised Prospective Study of Tantalum Versus Titanium Implants.|Completed||N/A|50|Actual|University of Aarhus||2|||f||||t||||||||||2017-10-11 05:14:38.368846|2017-10-11 05:14:38.368846
NCT00138866|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2010-10-12|||November 2004||2004-11-01|July 2008|2008-07-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury|Risedronate for Treatment of Sublesional Osteoporosis After Spinal Cord Injury|Completed||Phase 3|46|Anticipated|Toronto Rehabilitation Institute||2|||f||||t||||||||||2017-10-11 05:14:38.483646|2017-10-11 05:14:38.483646
NCT00138879|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-12-14|||May 2003||2003-05-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Observational|||Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients|Plasma Citrulline Level: A Simple, Sensitive Method to Assess and Monitor Small Bowel Absorptive Function in Patients With Crohn's Disease?|Completed||N/A|54||St Mark's Hospital Foundation|||||f||||||||||||||2017-10-11 05:14:38.56816|2017-10-11 05:14:38.56816
NCT00138892|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2011-10-12|||August 2002||2002-08-01|October 2011|2011-10-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||A Randomized Controlled Trial of Long Versus Short Wait For Primary Total Hip and Knee Arthroplasty|A Randomized Controlled Trial of Long Versus Short Wait For Primary Total Hip and Knee Arthroplasty|Unknown status|Active, not recruiting|Phase 4|236|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:14:38.662158|2017-10-11 05:14:38.662158
NCT00138905|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-09-06|||February 2005||2005-02-01|September 2007|2007-09-01|April 2006|Actual|2006-04-01|||||Interventional|||Experimental Study of Mobile Base Station Related Radio-Frequency Electromagnetic Radiation|Experimental Study of Mobile Base Station Related Radio-Frequency Electromagnetic Radiation in Healthy Adults and Adolescents|Completed||Phase 4|80||University of Aarhus|||||f||||||||||||||2017-10-11 05:14:38.763341|2017-10-11 05:14:38.763341
NCT00138918|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2017-03-01|||June 2005||2005-06-01|March 2017|2017-03-01|May 13, 2008|Actual|2008-05-13|May 13, 2008|Actual|2008-05-13||Interventional|||Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer|A Phase II Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer|Completed||Phase 2|20|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:14:38.8488|2017-10-11 05:14:38.8488
NCT00138931|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-08-23|||September 1996||1996-09-01|August 2016|2016-08-01||||January 2025|Anticipated|2025-01-01||Observational|||Genetics of Cardiovascular and Neuromuscular Disease|Genetic Studies of Patients and Their Families With Inherited Cardiovascular and Neuromuscular Diseases.|Recruiting||N/A|2000|Anticipated|University of Chicago|||1||f||||f||||||||||2017-10-11 05:14:38.939045|2017-10-11 05:14:38.939045
NCT00138944|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-04-16|||January 2007||2007-01-01|April 2013|2013-04-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension|Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension|Completed||Phase 3|85|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-11 05:14:39.067708|2017-10-11 05:14:39.067708
NCT00138957|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-07-09|||September 2005||2005-09-01|July 2008|2008-07-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Study of a New Laparoscopic Technique for Parastomal Hernia Repair With Mesh|Laparoscopic Parastomal Hernia Repair Using an Innovative Composite Polypropylene Mesh - A Prospective Study|Withdrawn||N/A|20|Anticipated|University Hospital, Gentofte, Copenhagen||||too few patients included|f||||||||||||||2017-10-11 05:14:39.193573|2017-10-11 05:14:39.193573
NCT00138970|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-11-30|||January 2002||2002-01-01|August 2005|2005-08-01|February 2005||2005-02-01|||||Interventional|||Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk|Randomised, Double-Arm, Controlled, Open-Label Study Comparing Calcineurin Inhibitor-Free Immunosuppression (Zenapax®, CellCept® and Prednisolone) and Cyclosporine A Based Immunosuppression (Sandimmun Neoral®, CellCept® and Prednisolone) on the Outcome of Renal Function and Acute Rejection in 0 DR Mis-Matched Renal Allograft Recipients|Completed||Phase 4|70||University of Oslo School of Pharmacy|||||f||||||||||||||2017-10-11 05:14:39.277629|2017-10-11 05:14:39.277629
NCT00138983|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2006-11-28|||May 2000||2000-05-01|March 2000|2000-03-01|November 2003||2003-11-01|||||Interventional|||Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.|Prevention of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatic Diseases. The STOP-Study: a Randomized Placebo Controlled Trial With Alendronate Versus Alfacalcidol.|Completed||Phase 3|200||UMC Utrecht|||||f||||||||||||||2017-10-11 05:14:39.357882|2017-10-11 05:14:39.357882
NCT00138996|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-08-24|||March 2002||2002-03-01|August 2007|2007-08-01|June 2006|Actual|2006-06-01|||||Interventional|||Quality of Cardiopulmonary Resuscitation Without and With Defibrillator Feedback|Can the Quality of Cardiopulmonary Resuscitation Improve With Direct Online Feedback From the Defibrillator to the Rescuers on Their Resuscitation Efforts|Completed||Phase 2|300||University of Oslo|||||f||||f||||||||||2017-10-11 05:14:39.447426|2017-10-11 05:14:39.447426
NCT00139009|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-06-14|||June 2005||2005-06-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation||Completed||Phase 4|30||University of Oslo School of Pharmacy|||||f||||||||||||||2017-10-11 05:14:39.533646|2017-10-11 05:14:39.533646
NCT00139022|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-10-04|||November 2004||2004-11-01|February 2007|2007-02-01|June 2007|Actual|2007-06-01|||||Interventional|||Home Diagnosis and Treatment of Obstructive Sleep Apnea|Can Obstructive Sleep Apnea be Diagnosed at Home? A Randomised Trial of Home vs.in-Lab Diagnosis and Treatment of OSA.|Completed||N/A|50|Anticipated|University of Saskatchewan|||||f||||||||||||||2017-10-11 05:14:39.613308|2017-10-11 05:14:39.613308
NCT00139035|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2012-10-31|||April 2005||2005-04-01|October 2012|2012-10-01||||January 2006|Actual|2006-01-01||Interventional|||Effects of Cyclosporine A on Pancreatic Insulin Secretion|Effects of Cyclosporine A on Pancreatic Insulin Secretion|Completed||Phase 4|16||University of Oslo School of Pharmacy|||||f||||||||||||||2017-10-11 05:14:39.68883|2017-10-11 05:14:39.68883
NCT00139048|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-28|2017-05-02|||September 2005||2005-09-01|May 2017|2017-05-01|February 2007|Actual|2007-02-01|||||Interventional|||Australian Screening Mammography Decision Aid Trial: A Decision Aid for Women Aged 40 Thinking About Starting Mammography Screening|A Randomised Controlled Trial of an On-line Decision Aid for Women Aged 40 Considering Whether to Have Screening Mammograms to Evaluate the Change in Knowledge Regarding Mammography Screening.|Completed||N/A|200||University of Sydney|||||f||||||||||||||2017-10-11 05:14:39.772098|2017-10-11 05:14:39.772098
NCT00139061|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-10-30|||March 2005||2005-03-01|December 2006|2006-12-01|May 2006||2006-05-01|||||Interventional|||Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate|Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Forced Titration Study Of The Efficacy, Safety, And Tolerability Of Torcetrapib/Atorvastatin Compared To Fenofibrate In Subjects With Fredrickson Type IIB Dyslipidemia (Mixed Hyperlipidemia|Completed||Phase 3|128||Pfizer|||||||||||||||||||2017-10-11 05:14:39.86538|2017-10-11 05:14:39.86538
NCT00139074|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-01-25|||July 2005||2005-07-01|January 2013|2013-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients|Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients|Terminated||Phase 4|17|Actual|AstraZeneca||2||terminated due to very low recruitment rate (27 June 2006)|f||||f||||||||||2017-10-11 05:14:40.030021|2017-10-11 05:14:40.030021
NCT00139087|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-08-29|||January 2002||2002-01-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.|Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.|Completed||N/A|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:14:40.142461|2017-10-11 05:14:40.142461
NCT00130026|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2017-02-03|||March 2005||2005-03-01|February 2017|2017-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Caffeine in the Prevention of Post-operative Nausea and Vomiting|A Prospective, Randomized, Double-blind, Placebo-controlled Study of Caffeine in the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Ambulatory Surgery Under General Anesthesia|Completed||N/A|135|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-10-11 05:14:40.193372|2017-10-11 05:14:40.193372
NCT00130039|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-11|2010-01-04|2009-10-23||August 2005||2005-08-01|November 2009|2009-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|TOSS-2||Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II|Trial for Efficacy and Safety of Cilostazol on the Progression of Symptomatic Intracranial Stenosis Comparing Clopidogrel|Completed||Phase 4|457|Actual|Asan Medical Center||2|||f||||t||||||||||2017-10-11 05:14:40.2997|2017-10-11 05:14:40.2997
NCT00130065|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-12|2012-09-26|||November 2003||2003-11-01|September 2012|2012-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||The Effect of Folic Acid on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenya|The Effect of Folic Acid Supplementation on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenya|Completed||Phase 4|600||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:14:41.028845|2017-10-11 05:14:41.028845
NCT00139100|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-10-23|||February 2001||2001-02-01|August 2005|2005-08-01|March 2002||2002-03-01|||||Interventional|||Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area|Evaluation of Antibacterial Soap for Treatment of Lymphedema and Elephantiasis in an Area Endemic for Lymphatic Filariasis|Completed||N/A|200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:14:41.11849|2017-10-11 05:14:41.11849
NCT00139113|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2012-08-29|||September 1996||1996-09-01|August 2012|2012-08-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children|Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children|Completed||Phase 4|248|Actual|Centers for Disease Control and Prevention||6|||f||||t||||||||||2017-10-11 05:14:41.199354|2017-10-11 05:14:41.199354
NCT00139126|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2012-03-13|||August 2005||2005-08-01|March 2012|2012-03-01||||May 2008|Actual|2008-05-01||Interventional|||Research to Improve Smoke Alarm Functioning and Maintenance|Research to Improve Smoke Alarm Functioning and Maintenance|Completed||N/A|4500|Actual|Centers for Disease Control and Prevention||1|||f||||||||||||||2017-10-11 05:14:41.306477|2017-10-11 05:14:41.306477
NCT00139139|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-08-29|||September 2003||2003-09-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A|A Blinded Randomized Comparative Study of Hepatitis A Vaccine and Immune Globulin for Postexposure Prophylaxis for Hepatitis A Disease|Completed||N/A|1500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:14:41.376659|2017-10-11 05:14:41.376659
NCT00139152|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2014-01-06|||September 2005||2005-09-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair|Exhaled Breath Condensate and Nitric Oxide: Non-invasive Evaluation of Lung Disease After Treatment With Xolair|Completed||Phase 4|65|Actual|Creighton University||2|||f||||f||||||||||2017-10-11 05:14:41.453045|2017-10-11 05:14:41.453045
NCT00139165|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-03-03|||September 2004||2004-09-01|August 2005|2005-08-01|March 2006||2006-03-01|||||Interventional|||Long-Term Treatment of Collagenous Colitis With Budesonide|Long-Term Treatment of Collagenous Colitis With Budesonide. Prospective, Doubleblind Placebo-Controlled Trial.|Unknown status|Active, not recruiting|Phase 3|36||Bonderup, Ole K., M.D.|||||f||||t||||||||||2017-10-11 05:14:41.54488|2017-10-11 05:14:41.54488
NCT00139178|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2005-09-02|||March 2004||2004-03-01|August 2005|2005-08-01|April 2007||2007-04-01|||||Interventional|||Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.|Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. Influence on Metabolic Abnormalities|Completed||Phase 4|100||Danish HIV Research Group|||||f||||||||||||||2017-10-11 05:14:41.616636|2017-10-11 05:14:41.616636
NCT00139191|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2009-10-30|||July 2005||2005-07-01|October 2009|2009-10-01|May 2006|Actual|2006-05-01|||||Interventional|||Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer|A Pilot Study Evaluating the Correlation Between Carbon 11 Acetate (C-11 Acetate) Uptake and Retention as Measured by Positron Emission Tomography (PET) and Fatty Acid Synthase (FAS) Expression in Prostate Cancer|Completed||N/A|20||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:14:41.708427|2017-10-11 05:14:41.708427
NCT00139204|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2009-10-30|||April 2005||2005-04-01|October 2009|2009-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients|An Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine (C11 MET) in Prostate Cancer, as Assessed by Positron Emission Tomography (PET)|Completed||N/A|20||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:14:41.78032|2017-10-11 05:14:41.78032
NCT00139217|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2014-05-27|||August 2005||2005-08-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn|NO Need to Ventilate: A Trial of Non-invasive iNO in Persistent Pulmonary Hypertension of the Newborn|Completed||N/A|400|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 05:14:41.859702|2017-10-11 05:14:41.859702
NCT00139230|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-06-02|||January 1997||1997-01-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|TPLF-4, Compressed TPLF for Locally Advanced Squamous Cell Carcinoma|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:14:41.937753|2017-10-11 05:14:41.937753
NCT00139243|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-06-02|||October 1997||1997-10-01|June 2008|2008-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck|A Phase I/II Study of Taxotere, Cisplatin, 5-Fluorouracil and Leucovorin for Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|30||Dana-Farber Cancer Institute|||||||||||||||||||2017-10-11 05:14:42.02734|2017-10-11 05:14:42.02734
NCT00139256|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-11-25|||August 2005||2005-08-01|November 2013|2013-11-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|||Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section|Randomized Controlled Trial of Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section|Terminated||Phase 2/Phase 3|67|Actual|Emory University||2||Slow enrollment and lack of funds.|f||||f||||||||||2017-10-11 05:14:42.12063|2017-10-11 05:14:42.12063
NCT00139269|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-06-02|||February 1998||1998-02-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Phase I/II Pilot Study of Induction Chemotherapy With Docetaxel in Combination With Cisplatin and 5-Fluorouracil (5-FU) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 1/Phase 2|38||Dana-Farber Cancer Institute|||||||||||||||||||2017-10-11 05:14:42.221887|2017-10-11 05:14:42.221887
NCT00139282|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-11-27|||June 2005||2005-06-01|November 2007|2007-11-01||||||||Interventional|||"A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for Wet Age-Related Macular Degeneration"|A Phase 3, Multicenter, Randomized, Double-Masked, Controlled Study of Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration|Terminated||Phase 3|||Genaera Corporation|||||||||||||||||||2017-10-11 05:14:42.314528|2017-10-11 05:14:42.314528
NCT00139295|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2014-02-04|||October 2004||2004-10-01|February 2014|2014-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee|Comparison of the Efficacy and Safety of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee|Completed||Phase 3|||Sanofi|||||||||||||||||||2017-10-11 05:14:42.477331|2017-10-11 05:14:42.477331
NCT00139308|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2005-08-30||||||August 2005|2005-08-01||||||||Interventional|||High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome|Pilot Study of Internal Globus Pallidus or Median Centre of the Thalamus High Frequency Stimulation for the Treatment of Patients With Severe Tourette's Syndrome|Completed||Phase 1|||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-10-11 05:14:42.660005|2017-10-11 05:14:42.660005
NCT00139321|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2013-01-07|||June 2004||2004-06-01|January 2013|2013-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes|Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes|Terminated||N/A|110|Anticipated|Groupe Hospitalier Pitie-Salpetriere||1|||f||||||||||||||2017-10-11 05:14:42.734929|2017-10-11 05:14:42.734929
NCT00143039|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2014-12-17|||March 2006||2006-03-01|December 2014|2014-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|TandemMS||Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR|Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by Nonimmune Hydrops and Severe Symmetrical Intrauterine Growth Restriction-A Multicenter Prospective Pilot Cohort Study|Terminated||Phase 1|48|Actual|Mednax Center for Research, Education and Quality|||2|No metabolic disordered ID'd by TMS in either control/test group at >50%enrolled|f||||t||||||||||2017-10-11 05:14:44.226807|2017-10-11 05:14:44.226807
NCT00139334|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-09-20|||June 2005||2005-06-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|||||Interventional|||A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh|Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine (RIX4414 at 106.5 CCID50) When Given Concomitantly With OPV Versus Given Alone (HRV Vaccine Dose Given 15 Days After the OPV Dose) in Healthy Infants in Bangladesh|Completed||Phase 2|300||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:14:42.817848|2017-10-11 05:14:42.817848
NCT00139347|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-10-27|||December 2003||2003-12-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants|A Multi-country & Multi-center Study to Assess the Efficacy, Immunogenicity & Safety of Two Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants|Completed||Phase 3|6360||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:14:42.922704|2017-10-11 05:14:42.922704
NCT00139360|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-08-26|||May 2005||2005-05-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma|Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma and Predictive Value of Angiogenic Markers|Completed||Phase 2|35|Actual|Haukeland University Hospital||1|||f||||||||||||||2017-10-11 05:14:43.065162|2017-10-11 05:14:43.065162
NCT00139373|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-09-12||||||July 2005|2005-07-01||||||||Interventional|||Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy|Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy|Unknown status|Recruiting|Phase 2|16|Anticipated|Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-10-11 05:14:43.181911|2017-10-11 05:14:43.181911
NCT00139386|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-04-17|||October 2005||2005-10-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2009|Actual|2009-04-01||Interventional|||Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial|Effects of Candesartan Cilexetil on Cardiovascular Events in Japanese Patients With Hypertension After Sirolimus- or Paclitaxel-Eluting Stents Implantation|Completed||Phase 4|1119|Actual|Kumamoto University||2|||f||||t||||||||||2017-10-11 05:14:43.273769|2017-10-11 05:14:43.273769
NCT00139399|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2011-10-19|||May 1998||1998-05-01|October 2011|2011-10-01|November 2006|Actual|2006-11-01|July 2006|Actual|2006-07-01||Interventional|RSVP||Radial Artery Versus Saphenous Vein Patency (RSVP) Study|A Randomised Controlled Trial to Compare Angiographic Patency of Radial Artery Versus Saphenous Vein Used as Free Aorto-coronary Grafts in Coronary Revascularisation|Completed||Phase 3|142|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 05:14:43.400844|2017-10-11 05:14:43.400844
NCT00139425|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-04-21|||May 2003||2003-05-01|April 2016|2016-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Osteoporosis Disease Management Demonstration Project (0000-037)|Osteoporosis Prevention and Treatment Program: A Disease Management Demonstration Project|Completed||N/A|10000||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:14:43.50035|2017-10-11 05:14:43.50035
NCT00139438|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-04-21|||September 2004||2004-09-01|April 2016|2016-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)|Improving Management of Patients at High Risk for Osteoporotic Fractures|Completed||N/A|4266||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:14:43.563686|2017-10-11 05:14:43.563686
NCT00142974|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2012-04-19|||May 2004||2004-05-01|April 2012|2012-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy|Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy|Terminated||Phase 2|120||Novartis||||This study was terminated early in April 2005 due to low patient enrollment|||||||||||||||2017-10-11 05:14:43.623973|2017-10-11 05:14:43.623973
NCT00142987|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-01-24|||April 2004||2004-04-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|||||Interventional|||Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS|Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS|Completed||Phase 4|664||Novartis|||||||||||||||||||2017-10-11 05:14:43.698654|2017-10-11 05:14:43.698654
NCT00143000|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-04-04|||April 2004||2004-04-01|April 2008|2008-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3|A Multicenter Study Evaluating the Efficacy and Safety of 12 Weeks Versus 24 Weeks Peginterferon Alfa-2a 40KD Combination Therapy With Ribavirin in Interferon Naïve Patients With Chronic Hepatitis C Genotype 2 or 3 Infection|Completed||Phase 4|392|Actual|NORDynamIC Study Group||2|||f||||t||||||||||2017-10-11 05:14:43.783755|2017-10-11 05:14:43.783755
NCT00143013|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-06-11|||October 2004||2004-10-01|June 2008|2008-06-01|April 2007||2007-04-01|||||Observational|||Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes|Gene Expression Profiling by DNA Chips and Subsequent Bioinformatic Analysis for Identification of Genes and Biochemical Pathways Associated With Type 2 Diabetes|Unknown status|Recruiting|N/A|100|Anticipated|Odense University Hospital|||||f||||||||||||||2017-10-11 05:14:43.871506|2017-10-11 05:14:43.871506
NCT00143026|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-03-27|||July 2005||2005-07-01|March 2017|2017-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States|Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease.|Completed||Phase 4|184|Actual|Novartis|||||f||||||||||||||2017-10-11 05:14:44.084303|2017-10-11 05:14:44.084303
NCT00143052|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-06-23|||January 2002||2002-01-01|June 2008|2008-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Bone Status and Insulin Resistance in Hirsutism|Body Composition, Insulin Concentration, Androgens and Bone Status in Women Referred With Hirsutism|Completed||N/A|50|Actual|Odense University Hospital|||2||f||||||||||||||2017-10-11 05:14:44.446088|2017-10-11 05:14:44.446088
NCT00143065|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-02-06|||August 2005||2005-08-01|February 2017|2017-02-01|July 2009|Actual|2009-07-01|February 2007|Actual|2007-02-01||Interventional|||Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Feasibility/Phase II Trial of Fludarabine, Rituximab, and Alemtuzumab for Previously Treated B-Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)|Completed||Phase 2|8|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:14:44.531447|2017-10-11 05:14:44.531447
NCT00143078|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-11-13|||June 2005||2005-06-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|||Obesity and Weight Loss on Reproductive Function|The Effects of Morbid Obesity and Weight Loss on Reproductive Function: The Bariatric Surgery Model|Terminated||Phase 2|35|Actual|Milton S. Hershey Medical Center|||1|Close-out of the grant - study ceased on 1/1/2010|f||||f||||||Samples With DNA|"     whole blood & urine   "|||2017-10-11 05:14:44.630098|2017-10-11 05:14:44.630098
NCT00143091|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-03-19|||April 2005||2005-04-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|||||Interventional|||Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder|A Six-Week, Fixed Dose, Double-Blind, Double-Dummy, Placebo and Sertraline Controlled, Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Outpatients With Major Depressive Disorder|Terminated||Phase 2|200||Pfizer||||See Detailed Description for termination reason.|||||t||||||||||2017-10-11 05:14:44.712894|2017-10-11 05:14:44.712894
NCT00143104|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-03-09|||December 2004||2004-12-01|February 2007|2007-02-01|October 2006|Actual|2006-10-01|||||Interventional|||To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.|A Phase 2, Exploratory Study to Examine the Effects of Inhaled Insulin, Compared With Subcutaneously Administered Insulin, on Airway Lining Fluid Composition in Subjects With Type 1 Diabetes Mellitus.|Completed||Phase 2|20||Pfizer|||||||||||||||||||2017-10-11 05:14:44.853362|2017-10-11 05:14:44.853362
NCT00143117|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2012-11-05|||August 2004||2004-08-01|November 2012|2012-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation|A Phase 2b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Dose Response Study to Assess the Efficacy and Safety of Oral UK-390,957 in Men With Premature Ejaculation|Completed||Phase 2/Phase 3|460||Pfizer|||||||||||||||||||2017-10-11 05:14:44.948865|2017-10-11 05:14:44.948865
NCT00143130|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-03-04|||April 2005||2005-04-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|||||Interventional|PREPS EXT||Pregabalin In Partial Seizures Extension Study|Pregabalin in Partial Seizures (PREPS) Extension Study: An 18-month Follow-on Open-label, International, Multicenter Add-on Therapy Trial|Completed||Phase 3|227|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:14:45.208893|2017-10-11 05:14:45.208893
NCT00143143|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-07-21|||September 2001||2001-09-01|March 2006|2006-03-01|February 2006||2006-02-01|||||Interventional|||Pregabalin Open-Label Extension Trial in Patients With Partial Seizures|Pregabalin BID Open-Label Add-On Trial: A Follow-Up Study To Determine Long-Term Safety and Efficacy in Patients With Partial Seizures|Completed||Phase 3|300||Pfizer|||||f||||||||||||||2017-10-11 05:14:45.471673|2017-10-11 05:14:45.471673
NCT00143156|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-04-09|||March 2005||2005-03-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Pregabalin Versus Placebo in the Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|Completed||Phase 3|450||Pfizer|||||||||||||||||||2017-10-11 05:14:45.653715|2017-10-11 05:14:45.653715
NCT00143169|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-04-14|||September 2004||2004-09-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Of Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain Following Orthopedic Or Gynecological Surgery|Completed||Phase 3|220||Pfizer|||||f||||||||||||||2017-10-11 05:14:45.84685|2017-10-11 05:14:45.84685
NCT00143182|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-05-29|||January 7, 2005|Actual|2005-01-07|May 2017|2017-05-01|June 28, 2006|Actual|2006-06-28|June 28, 2006|Actual|2006-06-28||Interventional|||9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)|A Double-Blind, 9-Week Extension Study Evaluating the Safety and Maintenance of Effect of Asenapine vs. Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501006 (Secondary Title: ARES)|Completed||Phase 3|504|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:14:45.94925|2017-10-11 05:14:45.94925
NCT00143195|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-04-17|||April 2001||2001-04-01|April 2007|2007-04-01|January 2005||2005-01-01|||||Interventional|ANISSA||Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina|Open Label Study Comparing Amlodipine vs Long-Acting Nitrates in Patients With Chronic Stable Angina.|Completed||Phase 4|200||Pfizer|||||f||||||||||||||2017-10-11 05:14:46.06779|2017-10-11 05:14:46.06779
NCT00143208|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-01-18|||May 2003||2003-05-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.|Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom (Fixed Combination Of Latanoprost And Timolol) In Patients With Poag Or Oh. A 6-Month, Open, Multi-Center Trial In Italy|Completed||Phase 4|250||Pfizer|||||f||||||||||||||2017-10-11 05:14:46.174893|2017-10-11 05:14:46.174893
NCT00143221|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2006-12-07|||March 2004||2004-03-01|December 2006|2006-12-01|May 2005||2005-05-01|||||Interventional|||Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)|A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo-Controlled Flexible Dose Study With and Open-Label Extension to Assess the Efficacy and Safety of Viagra (Sildenafil Citrate) in the Treatment of Men With Erectile Dysfunction (ED) and Concomitant Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) in the United States|Completed||Phase 4|350||Pfizer|||||||||||||||||||2017-10-11 05:14:46.299027|2017-10-11 05:14:46.299027
NCT00143234|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-04-21|||May 2004||2004-05-01|April 2015|2015-04-01|July 2005||2005-07-01|||||Interventional|GEMINI-AALA||Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels|Clinical Utility of Amlodipine/Atorvastatin to Improve Concomitant Cardiovascular Risk Factors of Hypertension and Dyslipidemia|Completed||Phase 3|1825||Pfizer|||||f||||||||||||||2017-10-11 05:14:46.393888|2017-10-11 05:14:46.393888
NCT00134316|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2011-02-28|||August 2005||2005-08-01|February 2011|2011-02-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Cervical or Endometrial Cancer and Sexual Health Study|Cervical or Endometrial Cancer and Sexual Health Study|Completed||N/A|31|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:15:52.529453|2017-10-11 05:15:52.529453
NCT00143247|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2010-04-10|2009-01-16||March 2003||2003-03-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus|An Open-Label, Phase 2, Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus Participating in Extension Protocols 217-102, 103, or 104|Terminated||Phase 2|173|Actual|Pfizer|Study terminated early due to business and operational issues. All subjects who were treated with inhaled insulin in parent protocols(217-102,-103,or-104) or in extension protocols (217-102E,-103E,-104E,or A2171036)are included in safety evaluation.|1||See termination reason in detailed description.|f||||f||||||||||2017-10-11 05:14:46.771646|2017-10-11 05:14:46.771646
NCT00143260|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2012-06-07|||August 2005||2005-08-01|June 2012|2012-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose|Multicenter Randomized Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose - II|Completed||Phase 4|250||Pfizer|||||||||||||||||||2017-10-11 05:14:48.996692|2017-10-11 05:14:48.996692
NCT00143273|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2011-08-08|||June 2004||2004-06-01|August 2011|2011-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|JADE||Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation|Dose Response Study Of Lasofoxifene In Postmenopausal Women With Osteoporosis (Placebo-Controlled, Multicenter, Double-Blind, Comparative Study) - Japanese Asian Dose Evaluation: JADE|Completed||Phase 2|497|Actual|Ligand Pharmaceuticals||4|||f||||||||||||||2017-10-11 05:14:49.134057|2017-10-11 05:14:49.134057
NCT00143286|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-06-01|||April 2003||2003-04-01|June 2007|2007-06-01|March 2005|Actual|2005-03-01|||||Interventional|||A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation|A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline ( CP-526,555) for the Maintenance of Smoking Cessation|Completed||Phase 3|2000||Pfizer|||||||||||||||||||2017-10-11 05:14:49.267407|2017-10-11 05:14:49.267407
NCT00143299|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-06-01|||October 2003||2003-10-01|June 2007|2007-06-01|March 2005||2005-03-01|||||Interventional|||A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline|A 52-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety of Varenicline Tartrate ( CP-526,555) for Smoking Cessation|Completed||Phase 3|375||Pfizer|||||||||||||||||||2017-10-11 05:14:49.476387|2017-10-11 05:14:49.476387
NCT00143312|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-09-23|2009-04-02||February 2005||2005-02-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|VOSIFI||Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants|Prospective, Open-Label, Non-Comparative, Multicenter Study for the Secondary Prophylaxis of Invasive Fungal Infections (IFI) With Voriconazole in Patients With Allogeneic Stem Cell Transplants (SCT).|Completed||Phase 4|45|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 05:14:49.575841|2017-10-11 05:14:49.575841
NCT00143325|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-06-01|||January 2005||2005-01-01|June 2007|2007-06-01|June 2006|Actual|2006-06-01|||||Interventional|||An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation|An Open-Label, Multicenter Study With Follow-Up Evaluating the Safety and Efficacy of Varenicline Tartrate in Comparison to Transdermal Nicotine Patch for Smoking Cessation|Completed||Phase 3|730||Pfizer|||||||||||||||||||2017-10-11 05:14:50.094457|2017-10-11 05:14:50.094457
NCT00143338|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-02-11|||November 2004||2004-11-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|||||Interventional|||To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.|A Phase 2, Exploratory Study to Examine the Effects of Inhaled Insulin, Compared With Subcutaneously Administered Insulin, on Airway Lining Fluid Composition in Subjects With Type 2 Diabetes Mellitus.|Completed||Phase 2|20||Pfizer|||||||||||||||||||2017-10-11 05:14:50.230126|2017-10-11 05:14:50.230126
NCT00143351|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2006-12-28|||June 2003||2003-06-01|December 2006|2006-12-01|September 2005||2005-09-01|||||Interventional|||Mozart Relapse Study|Open Extension Study Evaluating the Long-Term Efficacy, Safety, and Tolerability of Oral Ziprasidone in the Treatment of Resistant/Intolerant Schizophrenic Patients Who Have Acutely Responded to Ziprasidone in the Mozart Study|Completed||Phase 3|75||Pfizer|||||f||||||||||||||2017-10-11 05:14:50.308731|2017-10-11 05:14:50.308731
NCT00143364|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-06-01|||June 2003||2003-06-01|June 2007|2007-06-01|March 2005|Actual|2005-03-01|||||Interventional|||A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation|A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation|Completed||Phase 3|1005||Pfizer|||||||||||||||||||2017-10-11 05:14:50.407749|2017-10-11 05:14:50.407749
NCT00143377|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-11-17|||September 2004||2004-09-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB|A Global Phase IV, Double-Blind, Placebo-Controlled, Randomized Trial To Evaluate The Effectiveness Of Detrusitol Sr 4mg On Patient's Perception Of Bladder Condition (PPBC).|Completed||Phase 4|600||Pfizer|||||f||||||||||||||2017-10-11 05:14:50.512845|2017-10-11 05:14:50.512845
NCT00143390|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-12-19|2011-10-12||April 2005||2005-04-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer|A Randomized, Double-Blind, Controlled Study Of Exemestane (Aromasin) Vs Anastrozole (Arimidex) As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer|Completed||Phase 3|298|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 05:14:50.587366|2017-10-11 05:14:50.587366
NCT00143403|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2010-09-24|2009-02-26||December 2001||2001-12-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|February 2008|Actual|2008-02-01||Interventional|||Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer|Multi-Centre Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone, As Adjuvant Treatment After Resection Of Liver Metastases For Colorectal Cancer.|Completed||Phase 3|321|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:14:52.997907|2017-10-11 05:14:52.997907
NCT00143416|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-07-24|||April 2004||2004-04-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Long Term Study With B2036-PEG|Long-Term Study of B2036-PEG in Acromegaly - Long Term Study With B2036-PEG -|Completed||Phase 3|16||Pfizer|||||f||||||||||||||2017-10-11 05:14:53.962181|2017-10-11 05:14:53.962181
NCT00143429|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-03-04||||||March 2015|2015-03-01||||||||Interventional|||Corneal Versus Conjunctival Delivery Using a Delivery Device|Effect Of Corneal Versus Conjunctival Delivery On The Corneal Safety, Tolerability, and Antihypertensive Efficacy Of The Xalatan Ophthalmic Delivery Device|Withdrawn||Phase 2|0|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:14:54.043391|2017-10-11 05:14:54.043391
NCT00143442|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-08-04|||December 2003||2003-12-01|August 2006|2006-08-01|October 2004||2004-10-01|||||Interventional|||Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures|A 5-Week, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN), Who Are Gabapentin Treatment Failures.|Completed||Phase 2|184||Pfizer|||||||||||||||||||2017-10-11 05:14:54.104338|2017-10-11 05:14:54.104338
NCT00143455|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2010-02-10|2009-12-11||June 2002||2002-06-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer|Open Label, Randomised Multicentre Phase III Study Of Irinotecan Hydrochloride (Campto (Registered)) And Cisplatin Versus Etoposide And Cisplatin In Chemotherapy Naive Patients With Extensive Disease - Small Cell Lung Cancer|Completed||Phase 3|485|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 05:14:54.213342|2017-10-11 05:14:54.213342
NCT00143468|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2011-11-30|||March 2005||2005-03-01|November 2011|2011-11-01|May 2008|Actual|2008-05-01|March 2007|Actual|2007-03-01||Interventional|||The Specific Elastance in Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) Patients|The Specific Elastance in Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) Patients: Barotrauma and Volutrauma|Completed||N/A|100|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-10-11 05:14:56.680066|2017-10-11 05:14:56.680066
NCT00143481|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-04-09|||March 2005||2005-03-01|April 2013|2013-04-01||||June 2006|Actual|2006-06-01||Interventional|||Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women|A Multi-Center, Double-Phase, Randomized, Double-Blind, Placebo Controlled (12-Week Double-Blind Followed by 12-Week Open-Label) Study Evaluating the Effect of Tolterodine ER on Urgency Urinary Incontinence (UUI), Urgency, Frequency, Sexual Quality of Life and Sexual Function in Women With Overactive Bladder|Completed||Phase 4|400||Pfizer|||||||||||||||||||2017-10-11 05:14:56.772517|2017-10-11 05:14:56.772517
NCT00143494|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-09-24|||July 2005||2005-07-01|September 2008|2008-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure|The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure|Completed||N/A|13|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-10-11 05:14:56.954594|2017-10-11 05:14:56.954594
NCT00143507|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-06-22|2015-05-13||December 2004||2004-12-01|June 2015|2015-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction|Effects of Ivabradine on Cardiovascular Events in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction. A Three-year Randomised Double-blind Placebo-controlled International Multicentre Study.|Completed||Phase 3|10917|Actual|Servier|The section Other Adverse Events (Not including serious) has been completed by the sponsor to include only the Non Serious Adverse Events emergent on treatment during the study.|2|||f||||||||||||||2017-10-11 05:14:57.12868|2017-10-11 05:14:57.12868
NCT00143520|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-04-08|||December 2004||2004-12-01|April 2011|2011-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes|A Randomized, Double-blind, Double-dummy, Placebo-controlled 26-week Dose-response Study of Rivoglitazone HCl (CS-011) With Active Comparator (Pioglitazone HCl) in Subjects With Type 2 Diabetes|Completed||Phase 2/Phase 3|441|Actual|Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:15:00.979361|2017-10-11 05:15:00.979361
NCT00143533|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-04-24|||September 2003||2003-09-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Interventional|||Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors|Phase I Study of Intravenous Irinotecan Using Selective Gastrointestinal Decontamination for Prevention of Diarrhea in Relapsed or Refractory Pediatric Solid Tumors|Completed||Phase 1|20|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:15:01.189154|2017-10-11 05:15:01.189154
NCT00143546|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-04-24|||November 2003||2003-11-01|April 2017|2017-04-01||||||||Expanded Access|||Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver|Compassionate Use of Defibrotide for Patients With Veno-Occlusive Disease|No longer available||N/A|||St. Jude Children's Research Hospital|||||||||||||||||||2017-10-11 05:15:01.289806|2017-10-11 05:15:01.289806
NCT00143559|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2009-01-28|||August 2005||2005-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|July 2006|Actual|2006-07-01||Interventional|||Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies|Haploidentical Hematopoietic Stem Cell Transplantation Utilizing Partial T-Cell Depletion as Immunotherapy for Hematologic Malignancies|Completed||Phase 2|17|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:15:01.396588|2017-10-11 05:15:01.396588
NCT00143572|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-04-24|||November 2004||2004-11-01|February 2010|2010-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease|Phase I Study of Combination Treatment With Hydroxyurea and Magnesium Pidolate in Patients With Sickle Cell Disease|Completed||Phase 1|16|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:15:01.5072|2017-10-11 05:15:01.5072
NCT00143780|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-04-15|||May 2002||2002-05-01|August 2005|2005-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination|Immunogenicity of Pneumococcal Conjugate Vaccine in Adult Allogeneic Bone Marrow Transplant Recipients - Randomized Controlled Trial of Pre-Transplant Donor Immunization|Completed||Phase 4|70||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:15:07.743939|2017-10-11 05:15:07.743939
NCT00143598|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-08-15|2014-06-03||June 2004||2004-06-01|August 2014|2014-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||806 patients were randomly assigned to an intervention. Three patients were identified as ineligible soon after randomization and were excluded from further analysis (ie, modified intention-to-treat). In the active ECS group, one patient had no DVT and in the placebo ECS group one patient had a previous DVT and another patient was moribund.|The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome|The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome After Symptomatic Proximal Deep Venous Thrombosis|Completed||Phase 3|806|Actual|Sir Mortimer B. Davis - Jewish General Hospital|While 14% withdrew or were lost to follow-up (F/U), the total rate of withdrawal, loss to F/U and death was less than what was projected. Adherence to study stockings tended to diminish over F/U; this occurred to a similar degree in both groups.|2|||f||||t||||||||||2017-10-11 05:15:01.695089|2017-10-11 05:15:01.695089
NCT00143611|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2012-01-31|||September 2005||2005-09-01|January 2012|2012-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy & Safety of Resatorvid in Adults With Severe Sepsis|A Pivotal, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety of TAK-242 in Adults With Severe Sepsis|Completed||Phase 3|277|Actual|Takeda||3|||f||||t||||||||||2017-10-11 05:15:02.549473|2017-10-11 05:15:02.549473
NCT00143624|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-12-08|||June 2003||2003-06-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels|Effect of Rosiglitazone Maleate (Avandia®) on Carotid Intima Media Thickness, Brachial Artery Reactivity, Glucose Metabolism, Blood Lipid Concentrations, Body Fat Distribution, and Biochemical Markers of Cardiovascular Risk in Patients With the HIV Metabolic Syndrome|Completed||N/A|50|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 05:15:03.072339|2017-10-11 05:15:03.072339
NCT00143637|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-03-26|||May 2005||2005-05-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Dose Response Relations for Health Effects Caused by Office Dust|Dose Response Relations for Health Effects Caused by Office Dust.|Completed||Phase 1/Phase 2|24|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 05:15:03.181337|2017-10-11 05:15:03.181337
NCT00143650|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-01-16|||January 2001||2001-01-01|January 2005|2005-01-01|September 2002||2002-09-01|||||Interventional|||SENOC-I Det Sunda Huset II - Sensitization of Occupants of Water Damaged Buildings.|Does House Dust From Water Damaged Buildings Cause Stronger Responses Among Occupants Than Dust From Buildings Without Water Damage? Can Occupants’ Sensitivity be Predicted by Biomarkers?|Completed||Phase 1/Phase 2|27||University of Aarhus|||||f||||||||||||||2017-10-11 05:15:05.953906|2017-10-11 05:15:05.953906
NCT00143663|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2012-05-23|||September 2005||2005-09-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol|A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 100 mg Versus Placebo in Subjects With Primary Hypercholesterolemia|Completed||Phase 3|361|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:15:06.096598|2017-10-11 05:15:06.096598
NCT00143676|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2012-05-23|||August 2005||2005-08-01|May 2012|2012-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia|A Double-blind, Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of TAK-475 50 mg, 100 mg, or Placebo When Co-administered With Atorvastatin (10 mg to 40 mg) in Subjects With Primary Hypercholesterolemia|Completed||Phase 3|448|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:15:06.459884|2017-10-11 05:15:06.459884
NCT00143689|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2014-09-25|||April 2002||2002-04-01|September 2014|2014-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||NRTI-Sparing Pilot Study|A Pilot Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor Sparing Regimen in Antiretroviral-Naïve, HIV-infected Patients|Completed||Phase 4|13|Actual|University of British Columbia||1|||f||||||||||||||2017-10-11 05:15:06.864739|2017-10-11 05:15:06.864739
NCT00143702|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-09-24|||August 2001||2001-08-01|September 2005|2005-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)|Randomized, Open-Label Study of Continued Stavudine Versus Abacavir Substitution With or Without Riboflavin and Thiamine Supplementation in HIV-Infected Patients Who Have Elevated Venous Lactic Acid While on Stavudine-Based Therapy (DAVE)|Completed||Phase 2/Phase 3|80|Anticipated|University of British Columbia|||||f||||||||||||||2017-10-11 05:15:06.989221|2017-10-11 05:15:06.989221
NCT00143715|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2011-07-19|||September 2004||2004-09-01|July 2011|2011-07-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Oral Vitamin K for Warfarin Associated Coagulopathy|A Multicentre, Multinational Study of Oral Vitamin K for the Treatment of Warfarin Associated Coagulopathy|Completed||Phase 3|690|Actual|St. Joseph's Healthcare Hamilton||2|||f||||t||||||||||2017-10-11 05:15:07.087898|2017-10-11 05:15:07.087898
NCT00143728|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-09-24|||January 2004||2004-01-01|September 2008|2008-09-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||3TC or No 3TC for HIV With 3TC Resistance|A Randomized Study to Evaluate Virologic Response Following Discontinuation vs. no Discontinuation of 3TC in Patients Who Are Infected With HIV With Previously Documented Reduced Susceptibility to 3TC and Who Have Adequate Virologic Suppression on Combination Antiretroviral Therapy|Suspended||Phase 4|152|Anticipated|University of British Columbia||||Enrollment.|f||||||||||||||2017-10-11 05:15:07.260203|2017-10-11 05:15:07.260203
NCT00143741|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-01-09|||May 2005||2005-05-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers|Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers|Completed||Phase 1|20|Actual|University of Chicago||1|||f||||||||||||||2017-10-11 05:15:07.373378|2017-10-11 05:15:07.373378
NCT00143754|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-08-31||||||August 2005|2005-08-01||||||||Interventional|||Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope|Benefit of Controlled Rehydration in Unexplained Syncope|Terminated||Phase 3|||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:15:07.513672|2017-10-11 05:15:07.513672
NCT00143767|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-03-18|||August 2005||2005-08-01|March 2007|2007-03-01||||||||Observational|||Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder|Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder|Unknown status|Recruiting|N/A|400||UMC Utrecht|||||f||||||||||||||2017-10-11 05:15:07.6271|2017-10-11 05:15:07.6271
NCT00143793|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2016-11-22|||June 2005||2005-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|||||Observational|MANPRO||NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema|Mannheim NT-proBNP Study (MANPRO) Evaluating NT-proBNP and New Biomarkers in Patients Suffering From Dyspnea and/or Peripheral Edema for the Differential Diagnosis of Congestive Heart Failure|Active, not recruiting||Phase 4|400|Anticipated|Universitätsmedizin Mannheim|||1||f||||f||||||Samples Without DNA|"     Peripheral blood samples   "|||2017-10-11 05:15:07.851979|2017-10-11 05:15:07.851979
NCT00143806|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-12-31|||October 2003||2003-10-01|December 2008|2008-12-01|May 2007||2007-05-01|||||Interventional|||Transitioning From Cyclosporine to Alefacept in Psoriasis|Investigator-Initiated, Use Study of Alefacept (Amevive) in Combination With Tapering Doses of Cyclosporine in Patients With Moderate to Severe Psoriasis|Completed||Phase 2|13||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-10-11 05:15:07.953177|2017-10-11 05:15:07.953177
NCT00143819|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-04-07|2017-01-04||September 2005||2005-09-01|April 2017|2017-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis|Double-Blind, Bilateral, Vehicle-Controlled, Randomized Trial of Neuroskin Forte to Relieve Symptoms of Dry Skin|Terminated||Phase 2|13|Actual|Rutgers, The State University of New Jersey|small sample size|2||Low enrollment|f||||f||||||||||2017-10-11 05:15:08.044354|2017-10-11 05:15:08.044354
NCT00143832|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-03-18|||September 2004||2004-09-01|March 2007|2007-03-01||||||||Observational|||Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning|Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning|Unknown status|Recruiting|N/A|90||UMC Utrecht|||||f||||||||||||||2017-10-11 05:15:08.413103|2017-10-11 05:15:08.413103
NCT00143845|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-01-18|2014-05-19||April 2003||2003-04-01|January 2017|2017-01-01|February 2013|Actual|2013-02-01|November 2010|Actual|2010-11-01||Interventional||54 patients were enrolled however 9 patients did not receive planned donor lymphocyte infusion. 45 patients were analyzed.|Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant|Phase II Trial of Adjuvant Cellular Immunotherapy for High-Risk Hematologic Malignancy After Reduced Intensity Allogeneic Stem Cell Transplantation|Completed||Phase 2|54|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:15:08.527785|2017-10-11 05:15:08.527785
NCT00143858|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-08-06|||September 2004||2004-09-01|August 2009|2009-08-01|October 2007|Actual|2007-10-01|||||Observational|||Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume|Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume|Completed||N/A|16|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-10-11 05:15:08.951894|2017-10-11 05:15:08.951894
NCT00143871|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2012-01-30|||April 2001||2001-04-01|January 2012|2012-01-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma|Rituximab Plus High-dose Chemotherapy With Autologous Stem Cell Support for Non-Hodgkin's Lymphoma|Completed||Phase 2|35||University of Michigan Cancer Center|||||f||||t||||||||||2017-10-11 05:15:09.024711|2017-10-11 05:15:09.024711
NCT00143884|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-04-20|||March 2000||2000-03-01|January 2007|2007-01-01||||||||Interventional|||Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood|Adjuvant Cellular Immunotherapy for High-Risk Hematologic Malignancy After Allogeneic Stem Cell Transplantation Using Low Intensity Conditioning|Terminated||Phase 2|30||University of Michigan Cancer Center|||||f||||||||||||||2017-10-11 05:15:09.107226|2017-10-11 05:15:09.107226
NCT00143910|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-12-05|||April 1993||1993-04-01|December 2013|2013-12-01|October 1999|Actual|1999-10-01|October 1999|Actual|1999-10-01||Observational|||Natural History Study of Azathioprine Adherence|Measurement of Compliance in Renal Transplant Recipients|Completed||N/A|180||University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 05:15:09.187396|2017-10-11 05:15:09.187396
NCT00143923|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-05-03|||March 2003||2003-03-01|May 2017|2017-05-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|HeartSCORE||Novel Strategies for Reducing Heart Disease Risk Disparities|Heart Strategies Concentrating On Risk Evaluation (Heart SCORE) Study|Active, not recruiting||N/A|2000|Actual|University of Pittsburgh||3|||f||||f|f|f||||||No||2017-10-11 05:15:09.296678|2017-10-11 05:15:09.296678
NCT00143936|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2010-01-14|||April 2003||2003-04-01|January 2008|2008-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||The Safety and Efficacy of Low and High Carbohydrate Diets|The Safety and Efficacy of Low and High Carbohydrate Diets|Completed||Phase 4|360|Actual|Temple University||2|||f||||t||||||||||2017-10-11 05:15:09.421637|2017-10-11 05:15:09.421637
NCT00143949|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-11-05|||March 1997||1997-03-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|March 2007|Actual|2007-03-01||Interventional|||Renin Angiotensin System Study (RASS/B-RASS)|Renin Angiotensin System Blockage-DN (RASS)|Completed||Phase 2|285|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-10-11 05:15:09.524214|2017-10-11 05:15:09.524214
NCT00143962|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-08-15|||July 2004||2004-07-01|August 2016|2016-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Comparison of Two Approaches to Weight Loss Follow-Up Study|Comparison of Two Approaches to Weight Loss Follow-Up Study|Completed||Phase 4|6|Actual|University of Pennsylvania||1|||f||||||||||||||2017-10-11 05:15:09.607748|2017-10-11 05:15:09.607748
NCT00143975|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2010-08-11|||June 2004||2004-06-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|July 2007|Actual|2007-07-01||Interventional|||Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)|Phase II Study on Gemtuzumab Ozogamicin in Combination With All-trans-Retinoic Acid, High-dose Cytarabine and Mitoxantrone in Patients With Primary Refractory Acute Myeloid Leukemia|Completed||Phase 2|95|Actual|University of Ulm||1|||f||||||||||||||2017-10-11 05:15:09.696058|2017-10-11 05:15:09.696058
NCT00143988|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2009-08-06|||May 2004||2004-05-01|August 2009|2009-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|SEXERRCISE||Heart Rate and Blood Pressure Response During Exercise and Sexual Activity in Normotensive and Hypertensive Volunteers|Heart Rate and Blood Pressure Response During Exercise and Sexual Activity in Normotensive and Hypertensive Volunteers|Completed||N/A|36|Actual|Rutgers, The State University of New Jersey|||4||f||||f||||||||||2017-10-11 05:15:10.044683|2017-10-11 05:15:10.044683
NCT00144001|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-04-06|||October 2000||2000-10-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2004|Actual|2004-09-01||Observational|TIGER||Factors Associated With in Suboptimal Prescribing for Older Patients With Epilepsy|Appropriateness of Antiepileptic Drug Use for Older Veterans|Completed||N/A|9682|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:15:10.19635|2017-10-11 05:15:10.19635
NCT00144014|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-05-04||2016-05-04|August 2005||2005-08-01|May 2016|2016-05-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|VASST||Safety and Efficacy Study in Acute Ischaemic Stroke|A Phase II, Multi-centre, Two-part Study to Evaluate the Safety and Efficacy of Study Drug in Acute Ischaemic Stroke.|Completed||Phase 2|49|Actual|Vernalis (R&D) Ltd||5|||f||||t||||||||Undecided||2017-10-11 05:15:10.325608|2017-10-11 05:15:10.325608
NCT00144027|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-04-06|2014-10-28||December 2004||2004-12-01|July 2014|2014-07-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|AMAIS||Patient-Centered Medication Adherence Intervention for Schizophrenia|Patient-Centered Medication Adherence Intervention for Schizophrenia|Completed||N/A|75|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:15:10.566588|2017-10-11 05:15:10.566588
NCT00144040|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-04-06|||February 2004||2004-02-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|||||Interventional|IMPAACT||Improving Antibiotic Use in Acute Care Treatment|Improving Antibiotic Use in Acute Care Setting|Completed||N/A|1000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:15:11.01384|2017-10-11 05:15:11.01384
NCT00144053|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2006-01-05|||April 2001||2001-04-01|August 2005|2005-08-01||||||||Interventional|||A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer|A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer|Completed||Phase 3|450||West Japan Thoracic Oncology Group|||||f||||||||||||||2017-10-11 05:15:11.136051|2017-10-11 05:15:11.136051
NCT00144066|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-09-01|||January 2003||2003-01-01|September 2005|2005-09-01||||||||Interventional|||A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer|A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 3|600||West Japan Thoracic Oncology Group|||||f||||||||||||||2017-10-11 05:15:11.313275|2017-10-11 05:15:11.313275
NCT00144079|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-05-08|||January 2000||2000-01-01|September 2005|2005-09-01|January 2010||2010-01-01|||||Interventional|||Multicenter Study Differentiated Thyroid Carcinoma|Phase 3 Trial of Adjuvant External Beam Radiotherapy for Locally Invasive Differentiated Thyroid Carcinoma|Completed||Phase 3|500||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:15:11.379338|2017-10-11 05:15:11.379338
NCT00144092|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-11-18|||May 2001||2001-05-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|||||Interventional|||HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma|High Dose Chemotherapy and Autologous or Allogeneic Blood Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma|Completed||Phase 2|60|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:15:11.58683|2017-10-11 05:15:11.58683
NCT00144105|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-10-31|||February 2004||2004-02-01|October 2013|2013-10-01||||November 2006|Actual|2006-11-01||Interventional|||A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.|A Randomised, Open Label, Active Controlled Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir Plus 100 mg or 200 mg Ritonavir p.o. BID in Combination With Standard Background Regimen in Comparison to 400 mg Lopinavir Plus 100 mg Ritonavir p.o. BID in Combination With Standard Background Regimen in Antiretroviral Therapy Naive Patients for 48 With Extension up to 156 Weeks|Terminated||Phase 2|562|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:15:11.674804|2017-10-11 05:15:11.674804
NCT00144118|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02|||January 2002||2002-01-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||The Effect of Isoflurane or Sevoflurane on Kidney Function|Post-Operative Creatinine Changes In Patients With Pre-Existing Renal Impairment After Low-Flow Isoflurane Or Sevoflurane: A Randomised Clinical Trial|Terminated||Phase 4|270||Austin Health|||||f||||||||||||||2017-10-11 05:15:11.941983|2017-10-11 05:15:11.941983
NCT00144131|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-05-22|||August 2005||2005-08-01|May 2013|2013-05-01||||||||Interventional|||Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy|Flexibility: A Study to Assess the Impact of Once Per Cycle Correction and Maintenance Dosing of Darbepoetin Alfa in Subjects With Non-Myeloid Malignancies With Anemia Due to Chemotherapy|Completed||Phase 2|750||Amgen||1|||||||||||||||||2017-10-11 05:15:12.01887|2017-10-11 05:15:12.01887
NCT00144144|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-07-13|||September 2004||2004-09-01|July 2006|2006-07-01|September 2008||2008-09-01|||||Interventional|||A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes|A Randomized, Controlled Study on Calcium Channel Blocker Versus Angiotensin II Antagonists in the Hypertensive Patients With Type 2 Diabetes Mellitus Under the Inadequately Controlled Blood Pressure With Angiotension II Antagonists|Unknown status|Active, not recruiting|Phase 4|300||Advanced-J|||||f||||||||||||||2017-10-11 05:15:12.144288|2017-10-11 05:15:12.144288
NCT00144157|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-11-13|||June 2003||2003-06-01|November 2013|2013-11-01|July 2006||2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV|An Open-Label Study of Nevirapine Plus Combivir® (ZDV+3TC) Treatment in Women Who Have Previously Received a Nevirapine Regimen for the Prevention of Mother to Child Transmission (pMTCT) of HIV-1.|Completed||Phase 4|53|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:12.242272|2017-10-11 05:15:12.242272
NCT00144170|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2014-06-23|2009-09-11||February 2003||2003-02-01|April 2014|2014-04-01||||October 2008|Actual|2008-10-01||Interventional|||Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)|Randomized, Open-label, Comparative Safety and Efficacy Study of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) Versus Genotypically-defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-experienced Patients (RESIST 2: Randomized Evaluation of Strategic Intervention in Multi-Drug Resistant Patients With Tipranavir)|Completed||Phase 3|882|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 05:15:12.546878|2017-10-11 05:15:12.546878
NCT00144183|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-11-01|||January 2003||2003-01-01|November 2013|2013-11-01|January 2007||2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)|An Open-label Study Evaluating the Resistance Profile of Single Dose Nevirapine(NVP) When Combined With a 4 or 7 Day Course of Combivir® (ZDV/3TC) Compared to Single Dose Nevirapine for the Prevention of Mother to Child Transmission (pMTCT) of HIV - Treatment Options Preservation Study (T.O.P.S.)|Completed||Phase 3|407||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:18.174103|2017-10-11 05:15:18.174103
NCT00144196|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2014-07-22|||March 2004||2004-03-01|July 2014|2014-07-01|July 2005||2005-07-01|July 2005|Actual|2005-07-01||Interventional|||12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)|A 12-week Double-blind, Randomised, Parallel-group, Multi-centre Study Evaluating the Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD, According to Swedish Guidelines (SPIRIMILD)|Completed||Phase 4|224||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:18.242957|2017-10-11 05:15:18.242957
NCT00144209|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-10-31|||February 2003||2003-02-01|October 2013|2013-10-01|February 2005||2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome|Swiss Restless Legs Syndrome Trial (SRLS) A Double-blind, Randomised, Crossover Trial Investigating the Efficacy and Safety of the Dopamine Agonist Pramipexole (Sifrol®, 0.25-0.75 mg Per Day) Versus Levodopa / Benserazide (Madopar® DR, 125-375 mg Per Day) in Patients With Restless Legs Syndrome|Completed||Phase 3|58|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:18.358555|2017-10-11 05:15:18.358555
NCT00144222|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-11-04|||January 2005||2005-01-01|November 2013|2013-11-01|August 2005||2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy|A Randomized, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 40 mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 40 mg|Completed||Phase 3|218|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:18.427584|2017-10-11 05:15:18.427584
NCT00144235|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-10-30|||March 2005||2005-03-01|October 2013|2013-10-01|July 2005||2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue|A 28 Day, Randomised, Double-blind, Placebo-controlled, Single-centre Trial to Evaluate the Efficacy and Safety of Pharmaton® PHL 00749 Film Coated Tablets (G115 40 mg, Multivitamin, Multimineral + Guarana 75 mg) 1/Day p.o. in Improving Mental Performance and to Decrease Fatigue in Healthy Male and Female Subjects in Regular Employment.|Completed||Phase 3|412||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:18.489571|2017-10-11 05:15:18.489571
NCT00144248|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-11-04|||May 2004||2004-05-01|November 2013|2013-11-01||||June 2006|Actual|2006-06-01||Interventional|||A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions|A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function|Completed||Phase 4|51|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:15:19.530052|2017-10-11 05:15:19.530052
NCT00144261|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-11-04|||November 2003||2003-11-01|November 2013|2013-11-01||||December 2006|Actual|2006-12-01||Interventional|||An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects|An Open-label, Non-randomized, Single-arm Study, to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma High Density Lipoproteins Concentration in HIV+ Subjects Treated With VIRAMUNE® Tablets|Completed||Phase 4|15|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:19.616949|2017-10-11 05:15:19.616949
NCT00144274|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-10-28|||April 2005||2005-04-01|October 2013|2013-10-01|November 2005||2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis|Efficacy and Tolerability of Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis - A Randomised, Double-blind, Placebo-controlled Parallel Group Study. AMBROSIA: Ambroxol Lozenges In Sore Throat In Adolescents|Completed||Phase 3|220||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:19.687915|2017-10-11 05:15:19.687915
NCT00144287|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-11-04|||May 2004||2004-05-01|November 2013|2013-11-01|April 2006||2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options|An Open Label Safety Study of Tipranavir Co-Administered With Low-Dose Ritonavir (TVP/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options|Completed||Phase 3|255|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:19.782299|2017-10-11 05:15:19.782299
NCT00144300|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2014-02-17|2011-09-16||January 2005||2005-01-01|February 2014|2014-02-01||||September 2010|Actual|2010-09-01||Interventional|||Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients|A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson's Disease Patients|Completed||Phase 4|246|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-10-11 05:15:19.955739|2017-10-11 05:15:19.955739
NCT00144313|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-09-20|||August 2005||2005-08-01|September 2007|2007-09-01|January 2006|Actual|2006-01-01|||||Interventional|||VaxTeen Hepatitis B Vaccine Booster Study|Persistence of Antibody and Response to Booster of a Recombinant Hepatitis B Vaccine in Children Who Responded to a Primary Course of 2.5µg Recombinant Hepatitis B Vaccine as Infants|Completed||Phase 4|60|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:15:21.691442|2017-10-11 05:15:21.691442
NCT00144326|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-10-31|||July 2003||2003-07-01|October 2013|2013-10-01|October 2005||2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect, of Tiotropium Inhalation Capsules on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|250|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:15:21.761137|2017-10-11 05:15:21.761137
NCT00144339|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2014-05-15|2009-02-21||December 2002||2002-12-01|April 2014|2014-04-01||||February 2008|Actual|2008-02-01||Interventional|||Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients|A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function With Tiotropium 18 mcg Inhalation Capsule Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|5993|Actual|Boehringer Ingelheim|Tio patients had significantly longer drug exposure,thus had increased chance of AE.Simple frequencies are biased for AE comparisons;exposure-adjusted incidence rates (IR) should be used. IR for serious AE(>1% patients) are in Outcome Measures.||||f||||||||||||||2017-10-11 05:15:22.46988|2017-10-11 05:15:22.46988
NCT00144352|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02|||September 2002||2002-09-01|September 2005|2005-09-01|July 2004||2004-07-01|||||Interventional|||In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults|The in-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Individuals-a 28 Day Efficacy Trial Involving HIV+ and HIV- Adults.|Completed||Phase 4|540||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:15:31.188979|2017-10-11 05:15:31.188979
NCT00144365|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-09-10|||February 2005||2005-02-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Facility and Home-based ART Delivery Systems in Uganda|Comparison of Facility and Home-based ART Delivery Systems in Uganda|Completed||Phase 3|1453|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:15:31.257728|2017-10-11 05:15:31.257728
NCT00144378|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-04-17|||October 2002||2002-10-01|April 2007|2007-04-01||||||||Interventional|||Irinotecan Versus Only Best Supportive Care for Gastric Cancer|Randomized Phase III Study With Irinotecan+Best Supportive Care Versus Only Best Supportive Care as Second Line Therapy for Metastatic Gastric Cancer|Completed||Phase 3|44||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:15:31.348297|2017-10-11 05:15:31.348297
NCT00144391|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-05-25|2017-04-14||July 2003||2003-07-01|April 2017|2017-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Testosterone Gel Applied to Women With Pituitary Gland Problems|Physiologic Testosterone Replacement in Women With Hypopituitarism|Completed||Phase 4|20|Actual|Charles Drew University of Medicine and Science|Small number of patients recruited.|2|||f||||t||||||||||2017-10-11 05:15:31.428748|2017-10-11 05:15:31.428748
NCT00144404|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-04-15|||August 2002||2002-08-01|April 2017|2017-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Observational|||Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism|Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism|Withdrawn||N/A|0|Actual|Charles Drew University of Medicine and Science||||this was not a clinical trial|f||||t||||||||||2017-10-11 05:15:31.754951|2017-10-11 05:15:31.754951
NCT00144417|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-08-02|||February 2006||2006-02-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment|TBTC Study 28: Evaluation of a Moxifloxacin-based, Isoniazid-sparing Regimen for Tuberculosis Treatment|Completed||Phase 2|433|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 05:15:31.82046|2017-10-11 05:15:31.82046
NCT00144430|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-02-02|||January 2004||2004-01-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children|A Phase II Study of Pentostatin For the Treatment of High Risk or Refractory Chronic GVHD in Children|Completed||Phase 2|60|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||t||||||||||2017-10-11 05:15:31.966704|2017-10-11 05:15:31.966704
NCT00144443|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-12-08|||March 2003||2003-03-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Kansas City Community Environmental Remediation And Training (KC CERT)|Kansas City Community Environmental Remediation And Training (KC CERT)|Unknown status|Active, not recruiting|N/A|200||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:15:32.08879|2017-10-11 05:15:32.08879
NCT00144456|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-08-06|||September 2004||2004-09-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||A New Active Vitamin D, ED-71 for Osteoporosis|A Prospective, Randomized, Double-blind Study to Compare the Effect of ED-71 With That of Alfacalcidol on Fracture Incidence in Osteoporotic Patients|Completed||Phase 3|1056|Actual|Chugai Pharmaceutical||2|||f||||||||||||||2017-10-11 05:15:32.236472|2017-10-11 05:15:32.236472
NCT00144469|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-01-29|||May 2002||2002-05-01|January 2009|2009-01-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C|A Phase III Study of Ro25-8310 (Peginterferon Alfa-2a) in Combination With Ro20-9963 (Ribavirin) in Patients With Chronic Hepatitis C|Completed||Phase 3|300|Actual|Chugai Pharmaceutical|||||f||||f||||||||||2017-10-11 05:15:32.324692|2017-10-11 05:15:32.324692
NCT00144482|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-01-29|||December 2003||2003-12-01|January 2009|2009-01-01|August 2005|Actual|2005-08-01|March 2005|Actual|2005-03-01||Interventional|||A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy|A Randomized, Double-Blind Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy|Completed||Phase 3|122|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-10-11 05:15:32.389702|2017-10-11 05:15:32.389702
NCT00144495|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-01-29|||February 2004||2004-02-01|January 2009|2009-01-01|May 2005|Actual|2005-05-01|November 2004|Actual|2004-11-01||Interventional|||A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy|A Multicenter, Open-Label Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy|Completed||Phase 3|104|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-10-11 05:15:32.449428|2017-10-11 05:15:32.449428
NCT00144508|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-01-30|||March 2003||2003-03-01|January 2009|2009-01-01|February 2006|Actual|2006-02-01|May 2004|Actual|2004-05-01||Interventional|||Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)|An Open-Label, Phase III Study to Evaluate the Efficacy and Safety of MRA in Patients With RA|Completed||Phase 3|306|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-10-11 05:15:32.520131|2017-10-11 05:15:32.520131
NCT00144521|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-01-30|||February 2004||2004-02-01|January 2009|2009-01-01|April 2006|Actual|2006-04-01|August 2004|Actual|2004-08-01||Interventional|||Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)|A Double-Blind, Phase III Study to Evaluate the Efficacy and Safety of MRA in Patients With RA|Completed||Phase 3|127|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-10-11 05:15:32.585988|2017-10-11 05:15:32.585988
NCT00144534|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-12-21|||June 2004||2004-06-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|August 2005|Actual|2005-08-01||Interventional|||Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Participated in Study MRA213JP|Completed||Phase 3|115|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-10-11 05:15:32.660023|2017-10-11 05:15:32.660023
NCT00144547|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-08-06|||April 2004||2004-04-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Participated in Study MRA012JP|Completed||Phase 3|241|Actual|Chugai Pharmaceutical||1|||f||||f||||||||||2017-10-11 05:15:32.717946|2017-10-11 05:15:32.717946
NCT00144560|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-12-11|||February 2005||2005-02-01|December 2008|2008-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)|An Open-Label, Clinical Pharmacology Study to Investigate Drug-Drug Interaction in Patients With RA|Completed||N/A|31|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-10-11 05:15:32.781042|2017-10-11 05:15:32.781042
NCT00144573|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-12-11|||January 2005||2005-01-01|December 2008|2008-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment|An Open-Label, Clinical Pharmacology Study to Evaluate the Safety and PK of MRA in Patients With RA With Renal Impairment|Completed||N/A|14|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-10-11 05:15:32.856418|2017-10-11 05:15:32.856418
NCT00144586|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-08-06|||March 2005||2005-03-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Participated in Study MRA220JP or MRA221JP|Completed||Phase 3|42|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-10-11 05:15:32.916458|2017-10-11 05:15:32.916458
NCT00144599|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-07-29|||May 2004||2004-05-01|July 2008|2008-07-01|October 2005|Actual|2005-10-01|||||Interventional|||Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)|A Double-Blind, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With sJIA|Completed||Phase 3|56|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-10-11 05:15:32.974286|2017-10-11 05:15:32.974286
NCT00144612|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-12-21|||July 2004||2004-07-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2005|Actual|2005-06-01||Interventional|||Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With sJIA Who Participated in Studies MRA011JP or MRA316JP|Completed||Phase 3|60|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-10-11 05:15:33.043602|2017-10-11 05:15:33.043602
NCT00144625|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-12-21|||February 2005||2005-02-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|July 2005|Actual|2005-07-01||Interventional|||Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety, Efficacy and PK of MRA in Patients With pJIA Who Participated in Study MRA318JP|Completed||Phase 3|19|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-10-11 05:15:33.108742|2017-10-11 05:15:33.108742
NCT00144638|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-09-01|||January 2002||2002-01-01|February 2005|2005-02-01|January 2003||2003-01-01|||||Observational|||Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality|Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality|Completed||N/A|450||Danish Procalcitonin Study Group|||||f||||||||||||||2017-10-11 05:15:33.175664|2017-10-11 05:15:33.175664
NCT00144651|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-08-06|||August 2001||2001-08-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of MRA in Patients With Rheumatoid Arthritis (RA)|An Open-label, Extension, Phase II Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Were Participated in Study MRA009JP|Completed||Phase 2|135|Actual|Chugai Pharmaceutical||1|||f||||f||||||||||2017-10-11 05:15:33.232928|2017-10-11 05:15:33.232928
NCT00144664|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-07-29|||November 2004||2004-11-01|July 2008|2008-07-01|October 2005|Actual|2005-10-01|April 2005|Actual|2005-04-01||Interventional|||Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)|An Open-Label, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With pJIA|Completed||Phase 3|19|Actual|Chugai Pharmaceutical||1|||f||||f||||||||||2017-10-11 05:15:33.307953|2017-10-11 05:15:33.307953
NCT00144677|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-01-24|||November 2003||2003-11-01|March 2009|2009-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation|Open Label Phase II Trial of Sirolimus in Combination With Tacrolimus for Graft-vs-Host Disease Prophylaxis After HLA-Matched, Unrelated, Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:15:33.379706|2017-10-11 05:15:33.379706
NCT00144690|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-11-02|||March 2005||2005-03-01|November 2015|2015-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures|A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures|Completed||Phase 2|||Eisai Inc.|||||f||||||||||||||2017-10-11 05:15:33.460087|2017-10-11 05:15:33.460087
NCT00144703|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-01-24|||July 2002||2002-07-01|January 2009|2009-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation|Open Label Phase II Trial of Sirolimus in Combination With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|55||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:15:33.534695|2017-10-11 05:15:33.534695
NCT00144716|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-01-11|||June 2003||2003-06-01|January 2017|2017-01-01|October 2003||2003-10-01|||||Interventional|||Evaluation of Combined Use of ITN's and Insect Repellents Against Malaria|Clinical Evaluation of Combined Use of ITN's and Plant-based Insect Repellent Against Malaria in the Amazon|Completed||Phase 3|4250||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:15:33.601553|2017-10-11 05:15:33.601553
NCT00144729|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-04-28|||May 1993||1993-05-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|||||Interventional|||Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor|Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor|Completed||Phase 1/Phase 2|85||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:15:33.666225|2017-10-11 05:15:33.666225
NCT00144755|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-09-01|||December 2003||2003-12-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma|Intensified CHOP Plus Rituximab (R-CHOP 14) Versus CHOP Plus Rituximab (R-CHOP 21) and Frontline/Prophylactic Darbepoetin Alfa Treatment Versus Usual Symptomatic Treatment of Anemia in Patients Aged 60 to 80 Years With Diffuse Large B-cell Lymphoma.|Completed||Phase 3|600|Actual|Lymphoma Study Association||4|||f||||t||||||||||2017-10-11 05:15:33.735833|2017-10-11 05:15:33.735833
NCT00144768|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2014-05-02|||July 2004||2004-07-01|April 2013|2013-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients|A Multicenter, Multinational, Open-Label Study of Anti-Laronidase Antibody Formation and Urinary GAG Levels in Patients With Mucopolysaccharidosis I (MPS I) Being Treated With Aldurazyme® (Laronidase).|Completed||Phase 4|25|Anticipated|Sanofi||1|||f||||f||||||||||2017-10-11 05:15:33.846702|2017-10-11 05:15:33.846702
NCT00144781|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-03-17|2009-03-27||December 2004||2004-12-01|March 2015|2015-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease|A Multicenter, Multinational, Randomized, Dose-Optimization Study of the Safety and Pharmacodynamic Response of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I|Completed||Phase 4|34|Actual|Sanofi|This study is limited by its small sample size and ability to detect small differences in urinary GAG levels between groups.|4|||f||||||||||||||2017-10-11 05:15:33.966964|2017-10-11 05:15:33.966964
NCT00144794|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-09-28|||November 20, 2003||2003-11-20|September 2017|2017-09-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2022|Anticipated|2022-09-30||Observational|||Mucopolysaccharidosis I (MPS I) Registry|Mucopolysaccharidosis I (MPS I) Registry|Recruiting||N/A|1500|Anticipated|Sanofi|||1||f||||f||||||||||2017-10-11 05:15:35.447052|2017-10-11 05:15:35.447052
NCT00144807|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-09-01|||December 2003||2003-12-01|September 2015|2015-09-01|April 2012|Actual|2012-04-01|September 2008|Actual|2008-09-01||Interventional|||ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma|Study of ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 59 Years With High Risk Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 2-3)|Completed||Phase 2|128|Actual|Lymphoma Study Association||1|||f||||t||||||||||2017-10-11 05:15:35.659414|2017-10-11 05:15:35.659414
NCT00144820|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02|||May 1999||1999-05-01|August 2005|2005-08-01|November 2001||2001-11-01|||||Interventional|||Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee Osteoarthritis|Intra-Articular Injections of Hyaluronan Versus 20 Ml NaCl Versus Placebo in Treatment of Knee Osteoarthritis: a Randomised, Double-Blind, Placebo Controlled Single Centre Trial.|Unknown status|Active, not recruiting|Phase 4|251||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-10-11 05:15:35.803536|2017-10-11 05:15:35.803536
NCT00144833|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-11-09|||March 2005||2005-03-01|November 2007|2007-11-01||||||||Interventional|||Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects|A Phase III, Randomized, Controlled, Open-Label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-Boosted HIV-1 Protease Inhibitor Regimen of Fosamprenavir/Lopinavir/Ritonavir 1400mg/533mg/133mg Twice Daily and an Increased Dosage Regimen of FPV/RTV 1400mg/100mg BID Versus the Standard Dosage Regimen of FPV/RTV 700mg/100mg BID for 24 Weeks in Multiple-PI Experienced, HIV-Infected Adults Experiencing Virological Failure|Terminated||Phase 3|150|Anticipated|GlaxoSmithKline||1||Incomplete data|f||||t||||||||||2017-10-11 05:15:35.877279|2017-10-11 05:15:35.877279
NCT00144859|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-05-31|||July 2005||2005-07-01|March 2011|2011-03-01||||||||Interventional|||Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)|A 28-day, Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Anti-inflammatory Effect and Steady-state Pharmacokinetics of SB-681323 7.5 mg Per Day in Patients With Chronic Obstructive Pulmonary Disease.|Completed||Phase 2|82||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:15:36.266633|2017-10-11 05:15:36.266633
NCT00144872|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-09-27|||November 1, 2004|Actual|2004-11-01|September 2017|2017-09-01|April 22, 2006|Actual|2006-04-22|April 22, 2006|Actual|2006-04-22||Interventional|||LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures|Evaluation of Lamotrigine in Subjects With Absence Seizures|Completed||Phase 1|54|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 05:15:36.382421|2017-10-11 05:15:36.382421
NCT00144885|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-02-11|||June 2005||2005-06-01|September 2005|2005-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|IMAGE||IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis|Resonance Magnetic Imaging at the Acute Phase of Endocarditis: Diagnostic and Therapeutic Impact|Completed||N/A|150|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 05:15:36.517285|2017-10-11 05:15:36.517285
NCT00144898|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-07-26|||July 2003||2003-07-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer|A Randomized, Phase III Clinical Trial GF-GS 01 to Compare Conventional Axillary Dissection Versus Sentinel Node Resection (GS) in Clinically Node-negative Operable Breast Cancer Unifocal N0 Patients|Completed||Phase 3|1627|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-10-11 05:15:36.602117|2017-10-11 05:15:36.602117
NCT00144911|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-10-26|||October 2004||2004-10-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.|A Randomized, Double-Blind, Parallel Group, 52-Week Study to Compare the Effect of Fluticasone Propionate/Salmeterol DISKUS® Inhaler Combination Product 250/50mcg Twice Daily With Salmeterol DISKUS® Inhaler 50mcg Twice Daily on the Annual Rate of Moderate/Severe Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|740|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:15:36.70453|2017-10-11 05:15:36.70453
NCT00134329|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2007-12-19|||May 2005||2005-05-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Observational|||Erectile Dysfunction and Diabetes Mellitus|Erectile Dysfunction and Diabetes Mellitus|Completed||N/A|300||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:15:52.647143|2017-10-11 05:15:52.647143
NCT00144937|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-09-01|||March 2003||2003-03-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease|A Randomized Controlled Trial Comparing Usual Care With a Multifactorial Intensified Intervention on Cardiovascular Risk Factors in Subjects With Arterial Peripheral Disease With and Without Diabetes. The Taulí Intervention Program (TIP).|Unknown status|Active, not recruiting|Phase 4|120||Hospital de Sabadell|||||f||||||||||||||2017-10-11 05:15:37.078249|2017-10-11 05:15:37.078249
NCT00144950|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02||||||September 2005|2005-09-01||||||||Interventional|||Urokinase Versus Primary Video-Assisted Thorascopic Surgery for Empyema||Completed||Phase 1|60||Institute of Child Health|||||f||||||||||||||2017-10-11 05:15:37.166117|2017-10-11 05:15:37.166117
NCT00144963|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-03-27|2012-05-11||July 2002||2002-07-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|Phase I-II Study of Liposomal Vincristine (VSLI) and Dexamethasone in Relapsed or Refractory Acute Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|36|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-11 05:15:37.245588|2017-10-11 05:15:37.245588
NCT00144976|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-03-26|||October 2003||2003-10-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma|Pilot Study, Without Direct Individual Benefice, of Biological Effect of Tarceva (OSI-774) at Posology of 150 mg by Day for Patients Stricken by ENT Epidermoid Carcinoma Waiting for First Surgical Picking up.|Completed||N/A|43|Actual|Institut Claudius Regaud||1|||f||||t||||||||||2017-10-11 05:15:37.596946|2017-10-11 05:15:37.596946
NCT00144989|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-09-20|||September 2002||2002-09-01|September 2016|2016-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC|A Phase III Study Comparing Etoposide and Cisplatin (EP) With Irinotecan and Cisplatin (IP) Following EP Plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for Limited-Stage Small-Cell Lung Cancer : JCOG0202-MF|Completed||Phase 3|281|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:15:37.671604|2017-10-11 05:15:37.671604
NCT00145002|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-09-20|||August 1998||1998-08-01|September 2016|2016-09-01|December 2004||2004-12-01|||||Interventional|||A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)|Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-cell Leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.|Completed||Phase 3|130||Japan Clinical Oncology Group|||||f||||||||||||||2017-10-11 05:15:37.816696|2017-10-11 05:15:37.816696
NCT00145015|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-07-29|||December 2004||2004-12-01|July 2008|2008-07-01|April 2008|Actual|2008-04-01|||||Interventional|||FishGastro Study: Fish Consumption and Gastro-Intestinal Health|Fish Consumption and Gastro-Intestinal Health With Special Emphasis on Reduction of Risk of Colon Cancer and Inflammatory Bowel Disease|Completed||N/A|270|Anticipated|Quadram Institute|||||f||||||||||||||2017-10-11 05:15:38.019993|2017-10-11 05:15:38.019993
NCT00145028|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-03-17|||May 2005||2005-05-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|December 2007|Actual|2007-12-01||Interventional|||Determination of Carboplatin's Optimal Plasmatic Exposure|Determination of Carboplatin's Optimal Plasmatic Exposure|Completed||N/A|400|Anticipated|Institut Claudius Regaud|||||f||||f||||||||||2017-10-11 05:15:38.098477|2017-10-11 05:15:38.098477
NCT00145041|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-03-27|2011-11-29||February 2005||2005-02-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction|An Evaluation of the Pharmacokinetic Profile of VSLI (Vincristine Sulfate Liposome Injection, 0.16 mg/mL) in Patients With Malignant Melanoma and Hepatic Dysfunction Secondary to Metastases|Completed||Phase 1|7|Actual|Spectrum Pharmaceuticals, Inc|The dose administered to subjects with impaired liver function was ~1 mg/m2 which is lower than is administered to subjects with normal liver function (2 mg/m2). The impact of liver impairment on that higher dose remains unknown.|1|||f||||f||||||||||2017-10-11 05:15:38.1942|2017-10-11 05:15:38.1942
NCT00145054|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-03-23||||||September 2005|2005-09-01||||||||Interventional|||Study of a Self-Help Depression Skills Program for College-Aged Youth|Randomized, Controlled Pilot Study of a Self-Help Depression Skills Program for College-Aged Youth|Completed||Phase 2/Phase 3|150||Kaiser Permanente|||||f||||||||||||||2017-10-11 05:15:38.439713|2017-10-11 05:15:38.439713
NCT00145067|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-11-02|||November 2003||2003-11-01|November 2015|2015-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Osteoporosis Disease Management Demonstration Project (0000-040)|Three Methods of Delivering Health Care for Secondary Prevention of Osteoporosis|Completed||N/A|230|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:15:38.494822|2017-10-11 05:15:38.494822
NCT00145080|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-10-30|||July 2004||2004-07-01|October 2015|2015-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Comparison of Osteoporosis Disease Management Strategies (0000-039)|Evaluation of Strategies for Increasing Osteoporosis Screening and Treatment in a Managed Care Organization|Completed||N/A|4685|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:15:38.546082|2017-10-11 05:15:38.546082
NCT00145093|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-11-21|||August 2004||2004-08-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus|The Effects of Organic Chromium Supplementation on Clinical Parameters of the Metabolic Syndrome, in Patients With Type 2 Diabetes Mellitus. A Randomised, Double-Blind, Placebo-Controlled Trial|Completed||Phase 3|60||Medical Research Foundation, The Netherlands|||||f||||||||||||||2017-10-11 05:15:38.592954|2017-10-11 05:15:38.592954
NCT00145106|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-12-14|||March 2002||2002-03-01|September 2005|2005-09-01|August 2002||2002-08-01|||||Interventional|||Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris|Regimen of Tazorac .1% Gel & Minocycline Cap in Tx of Individuals w/Acne Vulgaris: Effects of Maintenance Therapy on Duration of Improvement of Tazorac .1% Gel Used in Conjunction w/Placebo Cap Compared w/Minocycline Cap Used in Conjunction w/Either Tazorac .1% Gel or Vehicle Gel|Completed||Phase 4|189||KGL, Inc.|||||f||||||||||||||2017-10-11 05:15:38.659014|2017-10-11 05:15:38.659014
NCT00145119|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-11-04|2013-12-02||August 2001||2001-08-01|January 2014|2014-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational||Survivors of an acute Myocardial Infarction (AMI) with impaired left ventricular ejection fraction|CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction|Incidence and Prediction of Life-threatening Cardiac Arrhythmias in Patients With Depressed Left Ventricular Function After Acute Myocardial Infarction|Completed||N/A|312|Actual|Medtronic Bakken Research Center|||||f||||||||||||||2017-10-11 05:15:38.73774|2017-10-11 05:15:38.73774
NCT00145132|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2010-06-01|||June 2005||2005-06-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Beta-CIT-SPECT and Neurophysiology in Depression|Serotonin and Dopamine Transporter (SERT, DAT) Availabilities as Assessed by b-CIT and SPECT, and Neurophysiological Measures of Central Serotonergic Activity in Patients With Depression Under Treatment With Escitalopram|Completed||Phase 4|30|Actual|Ludwig-Maximilians - University of Munich||1|||f||||||||||||||2017-10-11 05:15:38.918861|2017-10-11 05:15:38.918861
NCT00145145|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-08-21|||January 2005||2005-01-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma|Phase I/II Study of Immunization With the MAGE-3.A1 Peptide Mixed With the Immunological Adjuvant CpG 7909 in Patients With Metastatic Melanoma|Terminated||Phase 1/Phase 2|14|Anticipated|Ludwig Institute for Cancer Research||||Poor Accrual|f||||||||||||||2017-10-11 05:15:39.008577|2017-10-11 05:15:39.008577
NCT00145158|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2009-06-19|||January 2005||2005-01-01|June 2009|2009-06-01|December 2009|Anticipated|2009-12-01|March 2009|Anticipated|2009-03-01||Interventional|||Immunization With 8 Peptides Mixed With Adjuvant Montanide ISA 51 in HLA-A2 Patients With Metastatic Cutaneous Melanoma|Phase I/II Study of Immunization With Multiple Peptides Mixed With the Immunological Montanide ISA 51 in HLA-A2 Patients With Metastatic Cutaneous Melanoma|Suspended||Phase 1/Phase 2|28|Anticipated|Ludwig Institute for Cancer Research||||Availability of Investigational agent|f||||||||||||||2017-10-11 05:15:39.100505|2017-10-11 05:15:39.100505
NCT00145171|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02|||February 2001||2001-02-01|November 2002|2002-11-01|August 2002||2002-08-01|||||Interventional|||A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.|Study of Orthostatic Changes Upon Apomorphine Dose Initiation in Late Stage Parkinson’s Disease Patients. A Dose Escalation Study With a Double-Blind Placebo-Controlled Efficacy Determination at 4 Mg.|Completed||Phase 3|56||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:15:39.193919|2017-10-11 05:15:39.193919
NCT00145184|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-03-28|||May 2005||2005-05-01|March 2015|2015-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis|Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis|Terminated||Phase 3|40|Actual|Harvard School of Public Health||2||Slow recruitment|f||||t||||||||||2017-10-11 05:15:39.264923|2017-10-11 05:15:39.264923
NCT00145197|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-12-02|||January 2004||2004-01-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities|Improving the Delivery of Effective Care to Minorities|Completed||N/A|1164|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-10-11 05:15:39.368766|2017-10-11 05:15:39.368766
NCT00145210|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-03-06|||April 2005||2005-04-01|September 2005|2005-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans|A Double-Blind, Randomized, Placebo- and Active-Controlled, Forced Titration Study Evaluating the Effects of Nebivolol on Blood Pressure and Heart Rate in African American Patients With Hypertension|Completed||Phase 3|630|Anticipated|Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:15:39.460396|2017-10-11 05:15:39.460396
NCT00145223|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2010-08-26|||August 2003||2003-08-01|March 2007|2007-03-01|July 2005||2005-07-01|||||Observational|||Research for Elim of Filariasis|Research for Elimination of Human Filariasis|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:15:39.539738|2017-10-11 05:15:39.539738
NCT00145236|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-09-12|||November 2001||2001-11-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension|A Double-Blind, Multicenter, Randomized, Placebo-Controlled, Parallel Group Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension.|Completed||Phase 3|300||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:15:39.604271|2017-10-11 05:15:39.604271
NCT00145249|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-05-10|2010-03-18||May 2005||2005-05-01|October 2009|2009-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis|A Phase II Randomized Trial of Amphotericin B Alone or Combined With Fluconazole in the Treatment of AIDS-Associated Cryptococcal Meningitis|Completed||Phase 2|143|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 05:15:41.528201|2017-10-11 05:15:41.528201
NCT00145262|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-12-29|||August 2003||2003-08-01|August 2003|2003-08-01||||||||Observational|||TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation|Therapeutic Angiogenesis Using Cell Transplantation (TACT) Study at Nagoya|Unknown status|Recruiting|Phase 2|||Nagoya University|||||f||||||||||||||2017-10-11 05:15:44.098964|2017-10-11 05:15:44.098964
NCT00145275|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-04-26|||December 2004||2004-12-01|April 2012|2012-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women|To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women|Completed||Phase 3|455||Novartis|||||||||||||||||||2017-10-11 05:15:44.17107|2017-10-11 05:15:44.17107
NCT00145288|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-03-23|||October 2003||2003-10-01|March 2007|2007-03-01|March 2005||2005-03-01|||||Observational|||Prospective Study of Patients With Hirsutism|Prospective Study of Patients Med Hirsutism as Primary Work Diagnose|Unknown status|Active, not recruiting|Phase 2/Phase 3|340||Odense University Hospital|||||f||||f||||||||||2017-10-11 05:15:44.256097|2017-10-11 05:15:44.256097
NCT00145301|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-05-18|||September 2004||2004-09-01|May 2012|2012-05-01||||November 2005|Actual|2005-11-01||Interventional|||52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine|A 52-week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability and Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid and Celecoxib 200 mg od in Patients With Primary Osteoarthritis of Hip, Knee, Hand or Spine|Completed||Phase 3|3036||Novartis|||||||||||||||||||2017-10-11 05:15:44.341825|2017-10-11 05:15:44.341825
NCT00225654|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-01-30|||January 2000||2000-01-01|January 2012|2012-01-01|November 2001||2001-11-01|||||Interventional|ELUTES I||The ELUTES Clinical Trial|The ELUTES Clinical Trial (European Evaluation of Paclitaxel Eluting Stent)|Completed||N/A|192||Cook Group Incorporated|||||f||||||||||||||2017-10-11 05:40:09.26992|2017-10-11 05:40:09.26992
NCT00145314|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2011-01-13|||May 2005||2005-05-01|January 2011|2011-01-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Interventional|||FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer|5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin) (FLOX Regimen), Given Continuously or Intermittently, in Combination With Cetuximab (Erbitux), in First-line Treatment of Metastatic Colorectal Cancer. A Phase III Multicenter Trial.|Completed||Phase 3|571|Actual|The Nordic Colorectal Cancer Biomodulation Group||3|||f||||||||||||||2017-10-11 05:15:44.416158|2017-10-11 05:15:44.416158
NCT00145327|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-06-24|2011-01-21||May 2005||2005-05-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)|A 3-year, Double-blind Extension to CZOL446H2301 to Evaluate the Long-term Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D|Completed||Phase 3|2456|Actual|Novartis||3|||f||||||||||||||2017-10-11 05:15:44.645922|2017-10-11 05:15:44.645922
NCT00145340|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-09-25|||September 2002||2002-09-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Pioglitazone Treatment in Polycystic Ovary Syndrome|The Effect of PPARgamma Stimulation on Glucose Metabolism, Insulin Resistance, Growth Hormone and Cortisol on Women Suffering From Polycystic Ovary Syndrome|Completed||Phase 4|30||Odense University Hospital|||||f||||t||||||||||2017-10-11 05:15:48.652369|2017-10-11 05:15:48.652369
NCT00145353|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-10-10|||November 2004||2004-11-01|October 2006|2006-10-01|June 2006||2006-06-01|||||Interventional|||Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose|Is Insulin NovoRapid Better Than Actrapid for Treating Type 1 Diabetic Patients When Simultaneously, Daily Adjusting the Insulin Dose?|Unknown status|Active, not recruiting|Phase 4|16||Odense University Hospital|||||f||||||||||||||2017-10-11 05:15:48.716576|2017-10-11 05:15:48.716576
NCT00145366|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2010-12-27|||April 2002||2002-04-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|||||Interventional|||rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter|Pretreatment With Recombinant Human Thyrotropin (rhTSH) for the Effect on Thyroid Size and Function, and for the Effect of Radioiodine Treatment in Patients With Nodular Goiter. Prospective, Randomized Double-blinded Trials.|Completed||Phase 2|110||Odense University Hospital|||||f||||||||||||||2017-10-11 05:15:48.78242|2017-10-11 05:15:48.78242
NCT00145379|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-05-17|||March 2003||2003-03-01|May 2013|2013-05-01|June 2006|Actual|2006-06-01|||||Interventional|||The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus|The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus|Completed||Phase 4|42|Actual|Odense University Hospital||2|||f||||||||||||||2017-10-11 05:15:48.855692|2017-10-11 05:15:48.855692
NCT00145392|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-06-23|||September 2002||2002-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|January 2007|Actual|2007-01-01||Observational|||Body Composition, Glucose Metabolism, Insulin Resistance and Gene Expression in Muscle Cells in Healthy Overweight Women|Body Composition, Glucose Metabolism, Insulin Resistance and Gene Expression in Muscle Cells in Healthy Overweight Women|Completed||Phase 4|10||Odense University Hospital|||||f||||f||||||||||2017-10-11 05:15:48.925886|2017-10-11 05:15:48.925886
NCT00145405|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-09-06|||September 2002||2002-09-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction|Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction - A Twelve Month Randomized Cross-Over Study in Patients With Acromegaly|Completed||Phase 4|12||Odense University Hospital|||||f||||||||||||||2017-10-11 05:15:48.988781|2017-10-11 05:15:48.988781
NCT00145418|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-06-19|2011-07-20||February 2005||2005-02-01|June 2014|2014-06-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer|Phase 2 Study Evaluating the Safety and Efficacy of Eloxatin (Oxaliplatin) and Docetaxel as First-line Therapy of Stage IV or IIIB Unresectable Non-Small Cell Lung Cancer|Terminated||Phase 2|15|Actual|Oncology Specialists, S.C.|Due to lack of recruitment, the study was closed early and conclusions should not necessarily be drawn from the data presented for duration of response|1||low enrollment|f||||f||||||||||2017-10-11 05:15:49.084718|2017-10-11 05:15:49.084718
NCT00145431|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2012-02-15||2012-02-15|March 2005||2005-03-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.|Phase 3, Multi-Center, Double-Blind, Randomized, Crossover Study Of The Efficacy, Safety, And Tolerability Of Fixed Combination Torcetrapib (Cp-529,414)/Atorvastatin, Compared With Atorvastatin Therapy Alone, And Fenofibrate Alone, In Subjects With Fredrickson Type III Hyperlipoproteinemia (Familial Dysbetalipoproteinemia).|Terminated||Phase 3|41|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:15:49.385584|2017-10-11 05:15:49.385584
NCT00145444|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-12-28|||March 2003||2003-03-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study|A Multicenter, Double-Blind, Randomized Trial Of Ziprasidone (80 - 160 Mg) Versus Olanzapine (10 - 20 Mg) In Patients With Recent-Onset Schizophrenia, Schizoaffective And Schizophreniform Disorder.|Completed||Phase 3|100||Pfizer|||||f||||||||||||||2017-10-11 05:15:49.617683|2017-10-11 05:15:49.617683
NCT00145457|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-06-05|||April 2001||2001-04-01|May 2007|2007-05-01|January 2005||2005-01-01|||||Interventional|CAREL||IGF1 Generation Test|A Multicentre Study on the Capacity of the IGF-1 Stimulation Test to Predict the Growth Promoting Effect of Standard and High Doses of Genotonorm® in Prepubertal Children With Growth Hormone Deficiency.|Completed||Phase 4|82||Pfizer|||||f||||||||||||||2017-10-11 05:15:49.70055|2017-10-11 05:15:49.70055
NCT00134108|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2005-10-25|||January 2003||2003-01-01|January 2003|2003-01-01|December 2005||2005-12-01|||||Interventional|||Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients|Randomised Controlled Clinical Effectiveness Trial of Cognitive Behaviour Therapy (CBT) Versus Treatment as Usual (TAU) for Insomnia in Cancer Patients|Unknown status|Active, not recruiting|N/A|||NHS Greater Clyde and Glasgow|||||f||||||||||||||2017-10-11 05:15:49.775888|2017-10-11 05:15:49.775888
NCT00134134|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2006-09-07|||February 2005||2005-02-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa|An Open-Label Assessment of the Efficacy & Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa|Completed||Phase 1|5||New York University School of Medicine|||||||||||||||||||2017-10-11 05:15:49.837549|2017-10-11 05:15:49.837549
NCT00134147|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2008-04-16|||April 2005||2005-04-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|||||Interventional|||A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control|A One Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera) on Glycemic Control in Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled on a Minimum of Two Oral Anti Diabetic Agents|Completed||Phase 3|1100||Pfizer|||||f||||||||||||||2017-10-11 05:15:49.944807|2017-10-11 05:15:49.944807
NCT00134160|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2010-10-03|||August 2005||2005-08-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study|The Study Comparing the Incidence of Cardiovascular Events Between High-dose ARB Monotherapy and Combination Therapy With ARB and Calcium Channel Blocker in Japanese Elderly Hypertensive Patients at High Cardiovascular Risk|Completed||Phase 4|1000|Anticipated|OSCAR Study||2|||f||||t||||||||||2017-10-11 05:15:50.317883|2017-10-11 05:15:50.317883
NCT00134173|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2007-12-06|||October 2003||2003-10-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|ILLUSTRATE||A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease|Phase 3, Multi-Center, Double-Blind, Randomized, Parallel Group, Coronary Artery Intravascular Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Atorvastatin Alone, in Subjects With Angiographically Documented Coronary Heart Disease.|Completed||Phase 3|1100||Pfizer|||||||||||||||||||2017-10-11 05:15:50.446229|2017-10-11 05:15:50.446229
NCT00134186|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2007-03-02||||||March 2007|2007-03-01||||||||Interventional|||Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer|Phase II Trial of Motexafin Gadolinium for Treatment of Metastatic Renal Cell Carcinoma|Completed||Phase 2|43||Pharmacyclics LLC.|||||||||||||||||||2017-10-11 05:15:50.984959|2017-10-11 05:15:50.984959
NCT00134199|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2009-08-11|||March 2005||2005-03-01|April 2006|2006-04-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects|A 6-Month, Randomized, Double-Blind, Placebo And Positive-Controlled Phase 2b Study To Evaluate The Effect Of Various Doses Of CP-945,598 On Weight Loss In Obese Subjects|Completed||Phase 2/Phase 3|282|Actual|Pfizer|||||||||||||||||||2017-10-11 05:15:51.053748|2017-10-11 05:15:51.053748
NCT00134212|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2005-12-30|||March 2002||2002-03-01|December 2005|2005-12-01|June 2004||2004-06-01|||||Interventional|||Dopexamine and Norepinephrine Compared With Epinephrine Alone in Septic Shock|Prospective, Randomized Study on Two Parallel Groups Comparing Dopexamine and Norepinephrine in Combination to Epinephrine Alone on Systemic and Pulmonary Hemodynamics, Gastric Mucosal Perfusion, and Oxidative Stress in Septic Shock|Completed||Phase 2|20||Rennes University Hospital|||||f||||||||||||||2017-10-11 05:15:51.210081|2017-10-11 05:15:51.210081
NCT00134225|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2005-10-25|||April 2005||2005-04-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain|Multi-Center, Multi-National Study to Demonstrate That Muscle Pattern Recognition is a Reliable and Valid Evaluation Tool for Patients Who Present With Acute, Sub-Acute, or Chronic Symptoms of Neck or Back Pain of a Musculoskeletal Origin|Unknown status|Recruiting|N/A|480||iTech Medical, Inc.|||||f||||||||||||||2017-10-11 05:15:51.306522|2017-10-11 05:15:51.306522
NCT00134238|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2012-02-15||2012-02-15|November 2003||2003-11-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|RADIANCE 2||Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.|Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Atorvastatin Alone, in Subjects With Mixed Hyperlipidemia|Terminated||Phase 3|755|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:15:51.43015|2017-10-11 05:15:51.43015
NCT00134251|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2009-01-29|||October 2005||2005-10-01|January 2009|2009-01-01||||||||Interventional|||Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Parallel Group Study Exploring Effects of SLV308 up to 42 mg/Day Administered as an Adjunctive Therapy to L-Dopa in Patients With Advanced Stage Parkinson's Disease|Completed||Phase 3|||Solvay Pharmaceuticals|||||f||||||||||||||2017-10-11 05:15:51.616083|2017-10-11 05:15:51.616083
NCT00134264|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2012-01-30||2012-01-30|July 2004||2004-07-01|January 2012|2012-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|ILLUMINATE||A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease|Phase 3 Multi Center, Double Blind, Randomized, Parallel Group Evaluation Of The Fixed Combination Torcetrapib/Atorvastatin, Administered Orally, Once Daily (Qd), Compared With Atorvastatin Alone, On The Occurrence Of Major Cardiovascular Events In Subjects With Coronary Heart Disease Or Risk Equivalents|Terminated||Phase 3|15067|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:15:51.727528|2017-10-11 05:15:51.727528
NCT00134277|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-09-08|||September 2004||2004-09-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|January 2009|Actual|2009-01-01||Interventional|||Trial Comparing Different Medical Devices for Infragenual Dilatation|Prospective Randomised Comparing Trial Between an Infragenual Dilatation (ID), an ID With Stenting, an ID With Cutting Balloon and Laser Therapy|Completed||N/A|35|Actual|University Hospital, Ghent||4|||f||||f||||||||||2017-10-11 05:15:52.296869|2017-10-11 05:15:52.296869
NCT00134290|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2007-12-19|||January 2002||2002-01-01|December 2007|2007-12-01|May 2004|Actual|2004-05-01|||||Interventional|||The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance|The Effects of Calorie Restriction - Whether or Not Calculated Based on BMR (Basic Metabolic Rate) - With or Without Metformin on Weight and Insulin Resistance of Obese Insulin Resistant Patients|Completed||Phase 4|48||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:15:52.371306|2017-10-11 05:15:52.371306
NCT00134303|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2014-12-04|||June 2005||2005-06-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity|Double Blinded Randomised Trial Comparing Metformin Versus Placebo in NASH Patients Receiving Bariatric Surgery for Obesity|Unknown status|Recruiting|Phase 4|200|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 05:15:52.441389|2017-10-11 05:15:52.441389
NCT00134342|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2010-12-22|||January 2005||2005-01-01|July 2005|2005-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Observational|||Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations|A Comparison of Traditional Tuberculosis Screening Methods With the T-SPOT TB Test for the Diagnosis of Latent Tuberculosis Infection in Immunocompromised Populations|Completed||Phase 3|203|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 05:15:52.72441|2017-10-11 05:15:52.72441
NCT00134355|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2015-01-15|||July 2005||2005-07-01|January 2015|2015-01-01|March 2007|Actual|2007-03-01|November 2006|Actual|2006-11-01||Interventional|||Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer|Phase II Evaluation of PTK787, an Oral Vascular Endothelial Growth Factor Inhibitor, in Patients With Non-Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|5|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:15:52.823342|2017-10-11 05:15:52.823342
NCT00134368|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2008-08-06|||November 2003||2003-11-01|August 2008|2008-08-01|December 2007||2007-12-01|||||Interventional|||Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo|Pilot, Investigator-Initiated, Proof-of-Concept, Study of the Efficacy and Safety of Etanercept (Enbrel) in Adults With Vitiligo|Completed||Phase 2|40||Rutgers, The State University of New Jersey|||||||||||||||||||2017-10-11 05:15:52.925843|2017-10-11 05:15:52.925843
NCT00134381|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2017-08-03|2017-04-11||May 2003||2003-05-01|August 2017|2017-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Green Tea and Ultraviolet Light-induced Skin Damage|The Effects of Topically Applied Constituents of Green Tea on UV Induced Increase in p53 and Apoptotic Markers in the Skin of Human Volunteers|Terminated||Phase 2|68|Actual|Rutgers, The State University of New Jersey|Early termination leading to small numbers of subjects analyzed|2||Principal Investigator left institution before study could complete.|f||||f||||||||||2017-10-11 05:15:52.996008|2017-10-11 05:15:52.996008
NCT00134394|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2008-08-06|||February 2005||2005-02-01|August 2008|2008-08-01|December 2007||2007-12-01|||||Interventional|||Etanercept With Tacrolimus for Psoriasis|Double-Blind, Placebo-Controlled, Bilateral Comparison of Topical Tacrolimus 0.1% vs. Placebo Ointment as Adjunctive Therapy for Patients With Moderate to Severe Psoriasis Who Are Candidates for or Poor Responders to Etanercept Therapy|Completed||Phase 2|20||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-10-11 05:15:53.64216|2017-10-11 05:15:53.64216
NCT00134407|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2011-09-02|||February 2001||2001-02-01|September 2011|2011-09-01|June 2006||2006-06-01|||||Interventional|||Postoperative Oral Intake Trial|Postoperative Enteral Feeding or Early Oral Intake at Will. Effects on Clinical Outcome|Completed||Phase 1|450||University Hospital of North Norway|||||f||||||||||||||2017-10-11 05:15:53.7334|2017-10-11 05:15:53.7334
NCT00134420|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2016-08-04|||February 2001||2001-02-01|August 2016|2016-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Growth Hormone and Chromosome 18q- and Abnormal Growth|Growth Hormone Trial for Children With 18q- and Abnormal Growth|Completed||Phase 3|20|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 05:15:53.810184|2017-10-11 05:15:53.810184
NCT00134433|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2012-06-20|||November 2004||2004-11-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|March 2007|Actual|2007-03-01||Interventional|||Endothelial Modulation for Angiogenic Therapy|Endothelial Modulation With L-Arginine in Patients Undergoing Angiogenic Therapy (EMAT): A 2x2 Factorial Trial|Completed||Phase 1/Phase 2|20|Actual|Ottawa Heart Institute Research Corporation|||||f||||t||||||||||2017-10-11 05:15:53.926784|2017-10-11 05:15:53.926784
NCT00134446|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2005-10-28|||March 2004||2004-03-01|March 2005|2005-03-01||||||||Interventional|||Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder|A Prospective Double Blind Randomized Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder|Unknown status|Recruiting|Phase 4|40||White River Junction Veterans Affairs Medical Center|||||f||||||||||||||2017-10-11 05:15:54.002596|2017-10-11 05:15:54.002596
NCT00134459|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2013-02-12|||June 2005||2005-06-01|July 2009|2009-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study Evaluating Bifeprunox in Bipolar Depression|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder|Completed||Phase 3|434|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:15:54.122229|2017-10-11 05:15:54.122229
NCT00134472|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2012-05-10|||December 2002||2002-12-01|May 2012|2012-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan|Therapeutic Strategy for Severe Head Trauma Patients With Mild Hypothermia and Estimation of Medical Expenses in Japan|Completed||Phase 3|150|Actual|Yamaguchi University Hospital||1|||f||||||||||||||2017-10-11 05:15:54.288478|2017-10-11 05:15:54.288478
NCT00134485|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2007-10-28|||March 2005||2005-03-01|December 2006|2006-12-01|March 2006||2006-03-01|||||Interventional|||Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia|Phase 3, Multi-Center, Double-Blind, Randomized, Parallel Group, Study of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib (CP-529,414) / Atorvastatin Administered Orally, Once Daily (QD) for Six Months, Compared With Maximally Tolerated Atorvastatin Therapy Alone, in Subjects With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|400||Pfizer|||||||||||||||||||2017-10-11 05:15:54.478514|2017-10-11 05:15:54.478514
NCT00134498|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2007-11-15|||February 2005||2005-02-01|March 2007|2007-03-01|November 2006||2006-11-01|||||Interventional|||A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides|Phase 3, Multi-Site, Double-Blind, Randomized, Forced Titration, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Fixed Combination Torcetrapib (CP 529,414)/Atorvastatin Administered Orally, Once Daily (Qd) For Eighteen Weeks, Compared With Atorvastatin Alone, In Subjects With Fredrickson Type IV Hypertriglyceridemia|Completed||Phase 3|160||Pfizer|||||||||||||||||||2017-10-11 05:15:54.626861|2017-10-11 05:15:54.626861
NCT00134511|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2007-11-05|||March 2005||2005-03-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder|Phase 3 Multi-Center, Open Label, Forced Titration Study To Evaluate The Efficacy, Safety, And Tolerability Of Torcetrapib/Atorvastatin Combination Administered Orally, Once Daily (Qd) In Patients With Homozygous Familial Hypercholesterolaemia|Completed||Phase 3|30||Pfizer|||||||||||||||||||2017-10-11 05:15:54.770659|2017-10-11 05:15:54.770659
NCT00135863|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-05-20|||May 2004||2004-05-01|January 2004|2004-01-01|May 2005||2005-05-01|||||Interventional|||MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis|Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis|Terminated||N/A|36||Ribe County Hospital|||||f||||||||||||||2017-10-11 05:16:17.750886|2017-10-11 05:16:17.750886
NCT00134524|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2007-07-08|||July 2005||2005-07-01|July 2007|2007-07-01|January 2008|Anticipated|2008-01-01|||||Interventional|||The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy|A Randomized, Sham-Controlled Clinical Study to Evaluate The Effect of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|Advanced Magnetic Research Institute International|||||f||||f||||||||||2017-10-11 05:15:54.844311|2017-10-11 05:15:54.844311
NCT00134537|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-10-03|||November 2004||2004-11-01|October 2011|2011-10-01|April 2012|Anticipated|2012-04-01|April 2011|Actual|2011-04-01||Interventional|||Wallis Mechanical Normalization System for Low Back Pain||Unknown status|Active, not recruiting|Phase 3|300|Anticipated|Zimmer Spine||2|||f||||t||||||||||2017-10-11 05:15:54.926289|2017-10-11 05:15:54.926289
NCT00134563|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2013-01-02|2012-10-03|2011-08-08|September 2004||2004-09-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|TEMSO||Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Design Study to Evaluate the Efficacy and Safety of Teriflunomide in Reducing the Frequency of Relapses and Delaying the Accumulation of Physical Disability in Subjects With Multiple Sclerosis With Relapses|Completed||Phase 3|1088|Actual|Sanofi||3|||f||||t||||||||||2017-10-11 05:15:55.262486|2017-10-11 05:15:55.262486
NCT00134576|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2010-06-01|||May 2007||2007-05-01|May 2010|2010-05-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Automated Assessment of Mental Health in the Workplace|Automated Assessment of Mental Health in the Workplace|Completed||N/A|150|Anticipated|Boston Medical Center||1|||f||||f||||||||||2017-10-11 05:15:56.827153|2017-10-11 05:15:56.827153
NCT00134589|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2009-08-03|||April 2005||2005-04-01|July 2007|2007-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||CHOICE: Communicating Health Options Through Information and Cancer Education|Increasing CRC Screening in Health Plan Members|Completed||Phase 4|450|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:15:56.916371|2017-10-11 05:15:56.916371
NCT00134602|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2012-09-26|||April 2003||2003-04-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|January 2007|Actual|2007-01-01||Interventional|||Pediatric Impact: Promoting Adherence to Medications Among HIV-infected Children|An Intervention to Promote Adherence to Antiretroviral Medications Among HIV-infected Children 5-12 Years of Age|Completed||N/A|180||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:15:57.028009|2017-10-11 05:15:57.028009
NCT00134615|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2016-06-02|||August 2004||2004-08-01|June 2016|2016-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|RQP||Testing the Right Question Project (RQP) Health Education Strategy in a Mental Health Setting|Testing the Right Question Project Health Education Strategy in a Mental Health Setting|Completed||N/A|231|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 05:15:57.15|2017-10-11 05:15:57.15
NCT00134628|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2016-01-11|||January 2001||2001-01-01|February 2012|2012-02-01|December 2015|Actual|2015-12-01|August 2011|Actual|2011-08-01||Interventional|||Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries|Hyperbaric Oxygen Radiation Tissue Injury Study - Project HORTIS|Terminated||Phase 3|248|Actual|Baromedical Research Foundation||2||"Discontinued cystitis study due to poor recruitment. To continue the trial under these   circumstances is considered non-viable."|f||||t||||||||||2017-10-11 05:15:57.28357|2017-10-11 05:15:57.28357
NCT00134641|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2007-12-20|||February 2003||2003-02-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas|A Phase II Study Evaluating Efficacy of the Combination of Gemcitabine and Vinorelbine in Advanced Soft Tissue Sarcoma|Completed||Phase 2|40||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:15:57.453061|2017-10-11 05:15:57.453061
NCT00134654|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2011-06-14|||March 2003||2003-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|July 2005|Actual|2005-07-01||Interventional|||Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer|A Phase II Trial of Two Doses of Conjugated Estrogens (Premarin) in Patients With Androgen-Independent Prostate Cancer|Completed||Phase 2|48|Actual|Dana-Farber Cancer Institute||2|||f||||||||||||||2017-10-11 05:15:57.538475|2017-10-11 05:15:57.538475
NCT00134667|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2007-01-12|||March 2005||2005-03-01|January 2007|2007-01-01|October 2008||2008-10-01|||||Interventional|||Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)|A Phase IIIb/IV Randomized, Double-Masked, Active Controlled, Dose-Ranging, Multi-Center Comparative Trial, in Parallel Groups, to Compare the Safety and Efficacy of Intravitreal Injections of Pegaptanib Sodium (Macugen) Given Every 6 Weeks for 102 Weeks, to Pegaptanib Sodium Plus Photodynamic Therapy (PDT) With Visudyne, in Patients With Exudative Age-Related Macular Degeneration (AMD)|Terminated||Phase 4|360||Eyetech Pharmaceuticals|||||||||||||||||||2017-10-11 05:15:57.672481|2017-10-11 05:15:57.672481
NCT00134680|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2014-09-12|||January 2000||2000-01-01|October 2012|2012-10-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC|Phase II Trial of the Combination of Letrozole 2.5 mg Daily and Trastuzumab 2 mg/kg Weekly in ErbB2 Positive and Estrogen Receptor and/or Progesterone Receptor Positive Metastatic Breast Cancer|Completed||Phase 2|33|Actual|Duke University||1|||f||||f||||||||||2017-10-11 05:15:57.760876|2017-10-11 05:15:57.760876
NCT00134706|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2009-12-07|||January 2004||2004-01-01|December 2009|2009-12-01|September 2009|Actual|2009-09-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer|A Phase II Study of Docetaxel Plus Carboplatin in Hormone Refractory Prostate Cancer Patients Refractory to Prior Docetaxel-based Chemotherapy|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:15:58.031474|2017-10-11 05:15:58.031474
NCT00134719|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-10|2016-09-23|2012-06-15||April 2005||2005-04-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines|A Multicentre Primary & Booster Vaccination Study of GSK Biologicals' Hib-MenCY-TT Conjugate Vaccine vs ActHIB® & MenC Conjugate Licensed Vaccine When Given According to the 2-4-6 Month Schedule to Healthy Infants With Booster Dose at 12 to 15 Months|Completed||Phase 2|1104|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:15:58.188521|2017-10-11 05:15:58.188521
NCT00134732|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2016-09-22|||July 2005||2005-07-01|September 2016|2016-09-01|May 2006|Actual|2006-05-01|||||Interventional|||Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis|Assess the Immunogenicity, Safety & Reactogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants (6-12 Weeks of Age at First Dose) Previously Uninfected With Human Rotavirus|Completed||Phase 3|150||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:16:00.525801|2017-10-11 05:16:00.525801
NCT00134745|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2013-06-13|||June 2005||2005-06-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome|The Growth of Genitalia Interna and the Bone Mineralization Under Hormonal Replacement Therapy and the Presence of Aortic Root Dilatation in Girls With Turner Syndrome|Completed||Phase 4|43|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-10-11 05:16:00.679737|2017-10-11 05:16:00.679737
NCT00134758|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2009-07-28|||October 2004||2004-10-01|July 2009|2009-07-01|October 2009|Anticipated|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients|Efficiency of Ursodesoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis Patients. URSOPAF|Unknown status|Active, not recruiting|Phase 2/Phase 3|90|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:16:00.763727|2017-10-11 05:16:00.763727
NCT00134771|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2005-11-04|||February 2001||2001-02-01|August 2005|2005-08-01|June 2003||2003-06-01|||||Interventional|||Trial of Nutritional Supplementation in Infants Born Small for Gestational Age||Completed||N/A|||Institute of Child Health|||||f||||||||||||||2017-10-11 05:16:00.873153|2017-10-11 05:16:00.873153
NCT00134784|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2014-07-15|2010-10-07||April 2000||2000-04-01|July 2014|2014-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|ELLDOPA||Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression|[123I]ß-CIT and SPECT in Vivo Three Year Imaging Assessment of Dopamine Transporter Density in Subjects With Early Parkinson's Disease Participating in Earlier vs. Later Levodopa in Parkinson's Disease|Completed||Phase 2|142|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-10-11 05:16:00.975238|2017-10-11 05:16:00.975238
NCT00134797|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2005-11-04|||February 2005||2005-02-01|August 2005|2005-08-01|February 2006||2006-02-01|||||Observational|||Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists|The Effect of MDRD GFR Reporting on Nephrology Referral Patterns by Internists|Unknown status|Recruiting|N/A|1500||United States Naval Medical Center, San Diego|||||f||||||||||||||2017-10-11 05:16:01.261903|2017-10-11 05:16:01.261903
NCT00134810|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2007-01-09|||March 2005||2005-03-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome|A Phase II Multicentre Multinational Prospective Randomised Double-Blind Placebo-Controlled Study Assessing the Efficacy and Safety of a Single Application of Three Doses of Dysport® in Patients With Upper Back Myofascial Pain Syndrome|Completed||Phase 2|340||Ipsen|||||f||||||||||||||2017-10-11 05:16:01.341368|2017-10-11 05:16:01.341368
NCT00134823|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-07-20|||March 2005||2005-03-01|July 2011|2011-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Improving Pediatric Safety and Quality With Health Care Information Technology|Improving Pediatric Safety and Quality With Health Care IT|Completed||N/A|5420|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 05:16:01.482514|2017-10-11 05:16:01.482514
NCT00134836|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2008-12-11|||April 2004||2004-04-01|December 2008|2008-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|PPCO||Preventive Primary Care Outreach for High Risk Older Persons|Preventive Primary Care Outreach for High Risk Older Persons|Completed||Phase 1|719|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 05:16:01.579562|2017-10-11 05:16:01.579562
NCT00134849|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2007-09-21|||September 2005||2005-09-01|September 2007|2007-09-01|March 2006|Actual|2006-03-01|||||Observational|||Hypertension in Management of Military Medicine|Hypertension in Management of Military Medicine|Terminated||N/A|1000|Anticipated|United States Naval Medical Center, San Diego||||Inadequate number of records screened; primary investigator left institution.|f||||f||||||||||2017-10-11 05:16:01.663514|2017-10-11 05:16:01.663514
NCT00134875|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-11|||December 2000||2000-12-01|October 2008|2008-10-01|December 2017|Anticipated|2017-12-01|December 2002|Actual|2002-12-01||Interventional|||Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers|Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers|Terminated||N/A|9|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-10-11 05:16:01.723862|2017-10-11 05:16:01.723862
NCT00134888|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-11|||December 2000||2000-12-01|July 2007|2007-07-01|November 2002|Actual|2002-11-01|||||Interventional|||Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence|The Acute and Protracted Blockade Efficacy of Buprenorphine/Naloxone|Completed||N/A|8|Actual|National Institute on Drug Abuse (NIDA)||4|||||||f||||||||||2017-10-11 05:16:01.823148|2017-10-11 05:16:01.823148
NCT00134901|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2016-04-06|2014-08-25||March 2003||2003-03-01|April 2016|2016-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2|A Double-Blind, Placebo-Controlled Trial of the Effectiveness of Memantine in Treating Cocaine Dependence|Completed||Phase 2|81|Actual|New York State Psychiatric Institute|participants who had achieved abstinence during the lead-in remained abstinent throughout the trial and there was little relapse-like behavior for a medication to address.|2|||f||||t||||||||||2017-10-11 05:16:01.902147|2017-10-11 05:16:01.902147
NCT00134914|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-11|||August 1996||1996-08-01|July 2008|2008-07-01|May 1998|Actual|1998-05-01|April 1998|Actual|1998-04-01||Interventional|||Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence|Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals|Completed||N/A|10|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-10-11 05:16:02.252916|2017-10-11 05:16:02.252916
NCT00134927|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-09|||September 2005||2005-09-01|October 2008|2008-10-01|November 2006|Actual|2006-11-01|May 2006|Actual|2006-05-01||Observational|||A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches|Usage Patterns of OTC Nicotine Patches: Consumer Survey|Completed||N/A|600|Actual|National Institute on Drug Abuse (NIDA)|||1||f||||t||||||||||2017-10-11 05:16:02.32076|2017-10-11 05:16:02.32076
NCT00134940|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-06-15|||January 2005||2005-01-01|June 2011|2011-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus|A Non-interventional Protocol to Collect Prospective and Retrospective Data in Patients Receiving Everolimus to Prevent Acute Rejection Following Cardiac Transplantation|Completed||Phase 4|100|Actual|Novartis|||1||f||||||||||||||2017-10-11 05:16:02.377285|2017-10-11 05:16:02.377285
NCT00134953|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2007-12-14|||January 2003||2003-01-01|December 2007|2007-12-01|May 2004|Actual|2004-05-01|||||Interventional|||Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment|Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment|Terminated||Phase 3|24||Novartis||||The Principal Investigator left the clinic and there was no one who could take over this study.|f||||||||||||||2017-10-11 05:16:02.442411|2017-10-11 05:16:02.442411
NCT00134966|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-05-15|||August 2005||2005-08-01|May 2017|2017-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa|A 39 Week Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Effect of Fixed Dose Carbidopa/Levodopa/Entacapone 100 mg t.i.d. vs. Immediate Release Carbidopa/Levodopa 25/100 mg (t.i.d.) in Parkinson's Disease Patients Requiring Levodopa|Completed||Phase 3|493|Actual|Novartis||2|||||||||||||||||2017-10-11 05:16:02.500437|2017-10-11 05:16:02.500437
NCT00134979|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-26|2011-10-24|||October 2004||2004-10-01|October 2011|2011-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease|Efficacy and Safety of Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease|Completed||Phase 4|847|Actual|Novartis|||||f||||||||||||||2017-10-11 05:16:02.665391|2017-10-11 05:16:02.665391
NCT00134992|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2006-06-07|||August 2004||2004-08-01|June 2006|2006-06-01||||||||Interventional|||A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers|Single-Center, Randomized, Double Masked, Two-Period Cross-Over, Three Days Per Period, Phase IV Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers|Completed||Phase 4|30||Novartis|||||f||||||||||||||2017-10-11 05:16:02.884|2017-10-11 05:16:02.884
NCT00135005|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2013-05-09|||August 2005||2005-08-01|May 2013|2013-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)|A Phase I Multicenter, Dose Escalation Study of AMN107 in Combination With Imatinib on a Continuous Daily Dosing Schedule in Adult Patients With Imatinib-resistant Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 1|59|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:16:02.950389|2017-10-11 05:16:02.950389
NCT00135018|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2012-05-22|||February 2006||2006-02-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer|Phase II Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer|Completed||Phase 2|||Organisation for Oncology and Translational Research||1|||f||||t||||||||||2017-10-11 05:16:03.023974|2017-10-11 05:16:03.023974
NCT00135031|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-06-14|||January 2004||2004-01-01|June 2011|2011-06-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Safety and Efficacy Evaluation of Bifidobacterium Infantis 35624 in Female Subjects With Irritable Bowel Syndrome|Completed||Phase 3|362||Procter and Gamble|||||f||||f||||||||||2017-10-11 05:16:03.081333|2017-10-11 05:16:03.081333
NCT00135044|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2007-09-21|||June 2005||2005-06-01|September 2007|2007-09-01||||||||Interventional|||A Trial of Taurine Supplementation in Parenteral Nutrition 1|A Randomised Double Blind Controlled Crossover Trial of Intravenous Taurine Supplementation in Parenteral Nutrition as an Effective Treatment for Reducing Hepatobiliary Complications in Chronic Intestinal Failure|Unknown status|Recruiting|N/A|24|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-10-11 05:16:03.231649|2017-10-11 05:16:03.231649
NCT00135057|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-01-10|||April 2004||2004-04-01|January 2011|2011-01-01|August 2005||2005-08-01|||||Interventional|||Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin|Insulin Glulisine Administered in a Fixed Bolus Regimen Versus Variable Bolus Regimen Based on Carbohydrate Counting in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin|Completed||Phase 3|281||Sanofi|||||||||||||||||||2017-10-11 05:16:03.302093|2017-10-11 05:16:03.302093
NCT00135070|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2007-04-27|||July 2005||2005-07-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Hospital In-Patient Insulin Study|A Randomised Study Comparing Continuous Intravenous Insulin Infusion With Subcutaneous Insulin Analogues in Hospitalised Patients With Type II Diabetes and Hyperglycaemia|Terminated||Phase 4|41|Actual|The Royal Bournemouth Hospital||2||No documentation with MHRA to support clinical trial of a medicinal product.|f||||t||||||||||2017-10-11 05:16:03.363794|2017-10-11 05:16:03.363794
NCT00135083|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-01-10|||August 2004||2004-08-01|January 2011|2011-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus|One Versus Two Versus Three Daily Rapid-acting Insulin Injections of APIDRA (Insulin Glulisine) as add-on to Lantus® and Oral Sensitizer Basal Therapy in Type 2 Diabetes: a Multicenter, Randomized, Parallel, Open-label Clinical Study|Completed||Phase 3|347|Actual|Sanofi||3|||||||f||||||||||2017-10-11 05:16:03.433883|2017-10-11 05:16:03.433883
NCT00135096|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-01-10|||August 2004||2004-08-01|January 2011|2011-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin|APIDRA® (Insulin Glulisine) Administered Premeal vs Postmeal in Adult Subjects With Type 2 Diabetes Mellitus Receiving LANTUS® (Insulin Glargine) as Basal Insulin: a Multicenter, Randomized, Parallel, Open Label Clinical Study|Completed||Phase 3|345|Actual|Sanofi||2|||||||||||||||||2017-10-11 05:16:03.502719|2017-10-11 05:16:03.502719
NCT00135109|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2014-09-19|||October 2004||2004-10-01|February 2010|2010-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy|Completed||Phase 3|654|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:16:03.571689|2017-10-11 05:16:03.571689
NCT00135122|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2008-09-11|||September 2003||2003-09-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache|Medication Overuse Headache: A Randomised Double Blind Study of Prednisolone or Placebo in Withdrawal Therapy (Phase 3), and a Randomised 1 Year Follow up by Neurologist or General Physician After Successful Withdrawal Therapy|Completed||Phase 3|100|Actual|Sorlandet Hospital HF||1|||f||||f||||||||||2017-10-11 05:16:03.641891|2017-10-11 05:16:03.641891
NCT00135135|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2008-06-02|||August 2005||2005-08-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Therapy for Children With Neuroblastoma|Neuroblastoma Protocol 2005: Therapy for Children With Advanced Stage High-Risk Neuroblastoma|Completed||Phase 2|23|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:16:03.732514|2017-10-11 05:16:03.732514
NCT00135148|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2007-12-19|||April 2004||2004-04-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Observational|||Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group|Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group|Completed||N/A|150||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:16:03.809409|2017-10-11 05:16:03.809409
NCT00135161|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2014-12-04|||September 2003||2003-09-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer|Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 05:16:03.862109|2017-10-11 05:16:03.862109
NCT00135174|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2008-06-12|||September 2003||2003-09-01|June 2008|2008-06-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Observational|||Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study|Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The FOLLOWPACE Study|Unknown status|Active, not recruiting|N/A|1526|Actual|UMC Utrecht|||1||f||||t||||||||||2017-10-11 05:16:03.932468|2017-10-11 05:16:03.932468
NCT00135187|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2012-02-05|||July 2004||2004-07-01|February 2012|2012-02-01|December 2007|Actual|2007-12-01|August 2006|Actual|2006-08-01||Interventional|||Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma|A Pilot Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma|Completed||N/A|30|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:16:03.994009|2017-10-11 05:16:03.994009
NCT00135200|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2017-05-03|2014-11-13||August 2005||2005-08-01|May 2017|2017-05-01|November 2017|Anticipated|2017-11-01|August 2013|Actual|2013-08-01||Interventional|||Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma|A Phase II Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma|Active, not recruiting||Phase 2|16|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:16:04.071021|2017-10-11 05:16:04.071021
NCT00135213|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2007-12-20|||October 2005||2005-10-01|September 2006|2006-09-01|July 2007|Actual|2007-07-01|||||Interventional|||PROS Brief Smoking Cessation Counseling in Pediatric Practice to Reduce Secondhand Smoke Exposure of Young Children|PROS Brief Smoking Cessation Counseling in Pediatric Practice to Reduce Secondhand Smoke Exposure of Young Children|Completed||Phase 1|1200|Anticipated|University of Rochester||1|||f||||||||||||||2017-10-11 05:16:04.259916|2017-10-11 05:16:04.259916
NCT00135226|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2015-12-02|||March 2005||2005-03-01|December 2015|2015-12-01||||September 2017|Anticipated|2017-09-01||Interventional|||ASCEND: A Study of Cardiovascular Events iN Diabetes|A Study of Cardiovascular Events iN Diabetes - A Randomized 2x2 Factorial Study of Aspirin Versus Placebo, and of Omega-3 Fatty Acid Supplementation Versus Placebo, for Primary Prevention of Cardiovascular Events in People With Diabetes|Active, not recruiting||Phase 4|15480|Actual|University of Oxford||4|||f||||||||||||||2017-10-11 05:16:04.318605|2017-10-11 05:16:04.318605
NCT00135239|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2008-06-16|||January 2006||2006-01-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Care Versus Usual Care for Acute Mechanical Lower Back Pain|Study Care Versus Usual Care for Acute Mechanical Lower Back Pain|Completed||N/A|88|Anticipated|University of British Columbia||1|||f||||||||||||||2017-10-11 05:16:05.725188|2017-10-11 05:16:05.725188
NCT00135252|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2007-12-23|||August 2005||2005-08-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2|Method of Oxygen Delivery (Comparison Nasal Cannula vs Oxygen Hood) and the Effect on Transcutaneous PaCO2|Terminated||Phase 2/Phase 3|44|Anticipated|The University of Texas Health Science Center, Houston||||Investigator left institution|f||||||||||||||2017-10-11 05:16:05.862272|2017-10-11 05:16:05.862272
NCT00135265|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2010-06-24|||October 2006||2006-10-01|June 2010|2010-06-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||PROS Smokebusters: Adolescent Smoking Cessation in Pediatric Primary Care|Adolescent Smoking Cessation in Pediatric Primary Care|Completed||Phase 1|4100|Anticipated|University of Rochester||1|||f||||||||||||||2017-10-11 05:16:05.936766|2017-10-11 05:16:05.936766
NCT00135278|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-04-08|||March 2008||2008-03-01|April 2011|2011-04-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Cerebrospinal Fluid (CSF) Drainage and Cytokine Profiling in the Treatment of Acute Spinal Cord Injury (SCI)|Cerebrospinal Fluid (CSF) Drainage and Cytokine Profiling in the Treatment of Acute Spinal Cord Injury (SCI) - A Pilot Study|Unknown status|Recruiting|N/A|30|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:16:06.03035|2017-10-11 05:16:06.03035
NCT00135291|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2008-01-02|||February 2003||2003-02-01|January 2008|2008-01-01|September 2004|Actual|2004-09-01|||||Interventional|||Effect of Leukoreduced Blood Transfusions on Infection Following Trauma|Effect of Leukoreduction in Infection Risk in Trauma|Completed||Phase 2/Phase 3|300||University of Washington|||||f||||||||||||||2017-10-11 05:16:06.131327|2017-10-11 05:16:06.131327
NCT00148967|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-11-20|||July 2003||2003-07-01|November 2006|2006-11-01|October 2005||2005-10-01|||||Interventional|||INTRINSIC RV - Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs|Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs|Completed||Phase 4|1535||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:17:25.168897|2017-10-11 05:17:25.168897
NCT00135304|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2014-02-07|||August 2005||2005-08-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism|ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism: A Comparison of Sensipar® and Low Dose Vitamin D vs. Escalating Doses of Vitamin D Alone|Completed||Phase 4|170|Actual|Amgen||2|||f||||||||||||||2017-10-11 05:16:06.24244|2017-10-11 05:16:06.24244
NCT00135317|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2013-05-21|||November 2004||2004-11-01|May 2013|2013-05-01||||||||Interventional|||AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies|A Randomized Open-Label Study of Darbepoetin Alfa Administered Every Three Weeks With or Without Parenteral Iron in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-10-11 05:16:06.372867|2017-10-11 05:16:06.372867
NCT00135330|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2015-03-19|2009-07-21||October 2005||2005-10-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus|An Evaluation of the Metabolic Effects of Exenatide, Rosiglitazone, and Exenatide Plus Rosiglitazone in Subjects With Type 2 Diabetes Mellitus Treated With Metformin|Completed||Phase 3|137|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 05:16:06.51857|2017-10-11 05:16:06.51857
NCT00135343|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-04-07||2010-01-27|April 2004||2004-04-01|July 2008|2008-07-01|October 2005||2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen|A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen|Completed||Phase 3|60||Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 05:16:08.305838|2017-10-11 05:16:08.305838
NCT00135356|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2010-04-20|2009-12-15||July 2005||2005-07-01|April 2010|2010-04-01|June 2008|Actual|2008-06-01|July 2007|Actual|2007-07-01||Interventional|||Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome|A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing a Reyataz-Based Substitution Approach in the Management of Lipodystrophy Syndrome. Research Into Atazanavir in Lipodystrophy (The REAL Study)|Completed||Phase 4|219|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-10-11 05:16:08.448911|2017-10-11 05:16:08.448911
NCT00135369|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-04-08||2010-01-28|September 2002||2002-09-01|April 2011|2011-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen|A Phase 3 Study Switching HIV-1 Infected Subjects With an Undetectable Viral Load From a HAART Regimen Dosed Twice Daily or More Frequently to a Once-Daily HAART Regimen|Completed||Phase 3|300||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:16:10.277166|2017-10-11 05:16:10.277166
NCT00135382|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2010-01-27||2010-01-27|June 2002||2002-06-01|January 2010|2010-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen|A Phase 3 Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen|Completed||Phase 3|254||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:16:10.552054|2017-10-11 05:16:10.552054
NCT00135395|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2010-02-03||2010-02-03|May 2004||2004-05-01|July 2008|2008-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen|A Phase IIIb, Open -Label, Randomized Multi-center Study Comparing the Antiviral Efficacy, Safety, and Effect on Serum Lipids of Atazanavir/Ritonavir Versus Lopinavir/Ritonavir, in Combination With Two Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIs) in HIV-1 Infected Subjects Experiencing Their First Virologic Failure While Receiving a NNRTI-containing HAART Regimen.|Completed||Phase 3|200|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 05:16:10.714116|2017-10-11 05:16:10.714116
NCT00135408|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-09-26|||December 2005||2005-12-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide|Randomized, Double-Blind, Placebo-Controlled Phase II Study Comparing the Safety of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide (Entocort EC) in Patients With Previously Treated Unresectable Stage III or IV Malignant Melanoma|Completed||Phase 2|115|Actual|Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 05:16:11.049365|2017-10-11 05:16:11.049365
NCT00135421|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2010-02-27||2010-02-27|November 2005||2005-11-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder|Completed||Phase 1/Phase 2|271|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 05:16:11.146593|2017-10-11 05:16:11.146593
NCT00135434|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-04-07|||September 2004||2004-09-01|November 2009|2009-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism|Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism|Completed||Phase 1|25||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 05:16:11.30425|2017-10-11 05:16:11.30425
NCT00135447|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-04-13|||September 2004||2004-09-01|April 2011|2011-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen|A Phase IV, Multicenter, Cross-sectional Study to Evaluate the I50L Substitution Among Subjects Experiencing Virologic Failure on a HAART Regimen Containing Atazanavir (ATV)|Completed||N/A|5000|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 05:16:11.405762|2017-10-11 05:16:11.405762
NCT00135460|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2006-03-13|||June 2003||2003-06-01|September 2005|2005-09-01|November 2007||2007-11-01|||||Interventional|||Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients|Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in Patients With HIV. Influence on Morphological and Metabolic Disorders. A Randomized, Open-Label Multicenter Trial.|Unknown status|Active, not recruiting|Phase 4|100||Danish HIV Research Group|||||f||||||||||||||2017-10-11 05:16:11.640667|2017-10-11 05:16:11.640667
NCT00135850|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-08-04|||March 2003||2003-03-01|October 2002|2002-10-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris|The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris|Completed||Phase 1/Phase 2|48||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:16:17.65928|2017-10-11 05:16:17.65928
NCT00135473|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2016-02-10|||April 2003||2003-04-01|February 2016|2016-02-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)|Prospective Randomized Multicenter Study on the Influence of Colloid vs Crystalloid Volume Resuscitation and of Intensive vs Conventional Insulin Therapy on Outcome in Patients With Severe Sepsis and Septic Shock|Completed||Phase 3|600||German Competence Network Sepsis|||||f||||||||||||||2017-10-11 05:16:11.736852|2017-10-11 05:16:11.736852
NCT00135486|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-09-15|||March 2002||2002-03-01|September 2016|2016-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants|Evaluate Immunogenicity, Reactogenicity, Safety of GSK Biologicals' MenC-TT Vaccine (2 Formulations) Given With Infanrix Hexa® + GSK Biologicals' Hib MenC-TT Vaccine (2 Formulations) Given With Infanrix Penta® to Infants in Mths 3,4,5 of Life|Completed||Phase 2|500|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:16:11.89345|2017-10-11 05:16:11.89345
NCT00135499|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2006-09-07|||January 2002||2002-01-01|September 2006|2006-09-01|January 2011||2011-01-01|||||Interventional|||R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-Cell Lymphoma|Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Non Previously Treated Patients Aged From 60 to 65 Years With Diffuse Large B-Cell Lymphoma|Terminated||Phase 3|560||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:16:11.984609|2017-10-11 05:16:11.984609
NCT00135525|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2011-01-27|||May 2003||2003-05-01|January 2011|2011-01-01|May 2006|Actual|2006-05-01|October 2005|Actual|2005-10-01||Interventional|||Study Of Generalized Anxiety Disorder|Clinical Evaluation of BRL29060 A in Generalized Anxiety Disorder|Completed||Phase 2|||GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 05:16:12.299532|2017-10-11 05:16:12.299532
NCT00135538|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-04-04|||November 2004||2004-11-01|April 2007|2007-04-01|April 2009|Anticipated|2009-04-01|||||Interventional|||The Additional Value of Noninvasive Ventilation Next to Rehabilitation in Hypercapnic COPD Patients|Does Chronic Ventilatory Support Improve the Outcomes of Rehabilitation in Hypercapnic COPD Patients?|Unknown status|Active, not recruiting|Phase 3|100||Groningen Research Institute for Asthma and COPD|||||f||||f||||||||||2017-10-11 05:16:12.374163|2017-10-11 05:16:12.374163
NCT00135551|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2012-02-19|||May 2003||2003-05-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Interventional|COPE||Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients|The Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial|Completed||Phase 4|3501|Actual|COPE Trial Group||3|||f||||t||||||||||2017-10-11 05:16:12.45423|2017-10-11 05:16:12.45423
NCT00135564|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-09-15|||January 2003||2003-01-01|September 2016|2016-09-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers|Evaluate the Persistence and Immune Memory Induced by a Primary Vaccination Course With GSK Biologicals' MenC-TT (1 Formulation) & GSK Biologicals' Hib-MenC-TT (2 Formulations) or Meningitec™ in Healthy Toddlers Aged 12-15 Months Primed in Study 711202/001|Completed||Phase 2|500|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:16:12.563004|2017-10-11 05:16:12.563004
NCT00135577|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2015-09-01|||September 2004||2004-09-01|September 2009|2009-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects|A Double-Blind, Placebo-Controlled, Multicenter Phase IIb Extension Study to Evaluate the Safety and Efficacy of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects|Completed||Phase 2|67|Actual|Cubist Pharmaceuticals LLC||4|||f||||||||||||||2017-10-11 05:16:12.643979|2017-10-11 05:16:12.643979
NCT00135590|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2007-11-20|||November 2004||2004-11-01|November 2004|2004-11-01|October 2007|Actual|2007-10-01|||||Interventional|PRO-PULSé||Evaluation of the Effectiveness of a Protein Pulse-Feeding Pattern in Elderly Patients|Evaluation of the Effectiveness of a Protein Pulse-Feeding Pattern in Elderly Patients|Completed||N/A|68|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:16:12.804046|2017-10-11 05:16:12.804046
NCT00135603|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2009-02-11|||February 2004||2004-02-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Antibiotic Therapy Versus Appendectomy for Acute Appendicitis|A Prospective Randomized Multicentric Trial Comparing Amoxicillin/Clavulanate Potassium Therapy to Appendectomy for Acute Non Complicated Appendicitis|Completed||N/A|243|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:16:12.942501|2017-10-11 05:16:12.942501
NCT00135616|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-04-27|||March 2005||2005-03-01|April 2007|2007-04-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Treatment of Female Stress Urinary Incontinence: Study Comparing Two Suburethral Slings, Retropubic Approach (TVT) and Trans-Obturator (TVT-O) Approach|Randomized Controlled Study Comparing Two Types of Suburethral Slings for the Surgical Treatment of Female Stress Incontinence : TVT and TVT-O.|Unknown status|Active, not recruiting|Phase 4|180|Anticipated|Hopital Antoine Beclere|||||f||||||||||||||2017-10-11 05:16:13.111832|2017-10-11 05:16:13.111832
NCT00135629|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2010-11-22|||October 2002||2002-10-01|November 2010|2010-11-01|February 2004||2004-02-01|||||Interventional|||Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever|Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: A Pilot Study. (Up-dosing Study)|Unknown status|Active, not recruiting|Phase 3|18||Imperial College London|||||f||||||||||||||2017-10-11 05:16:13.235185|2017-10-11 05:16:13.235185
NCT00135642|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-02-11|||February 1996||1996-02-01|August 2005|2005-08-01|October 1998||1998-10-01|||||Interventional|||Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma|Randomized Double Blind Placebo Controlled Trial of Grass Pollen Immunotherapy Using a Cluster Regime|Completed||Phase 3|44||Imperial College London|||||f||||||||||||||2017-10-11 05:16:13.33323|2017-10-11 05:16:13.33323
NCT00135655|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2013-05-20|||August 2005||2005-08-01|May 2013|2013-05-01||||||||Interventional|||A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema|A Randomized, Double-Masked, Parallel, Group, Multi-Center, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema|Withdrawn||Phase 2|0|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:16:13.436804|2017-10-11 05:16:13.436804
NCT00135681|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2016-01-14|||December 1996||1996-12-01|January 2016|2016-01-01|November 2001||2001-11-01|||||Interventional|||Immune Dysregulation in Children and Adults With Asthma||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-10-11 05:16:13.662393|2017-10-11 05:16:13.662393
NCT00135694|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-12-08|2016-10-13||October 2005||2005-10-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|A-WISH|Enrolled sample (subjects transplanted in the study)|Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant|A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients|Completed||Phase 2|275|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-10-11 05:16:13.789023|2017-10-11 05:16:13.789023
NCT00135720|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2015-06-02|||June 2004||2004-06-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris|A Double-Blinded, Placebo-Controlled Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris|Completed||Phase 2|12|Anticipated|Massachusetts General Hospital|||||f||||t||||||||||2017-10-11 05:16:16.287749|2017-10-11 05:16:16.287749
NCT00135733|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2009-02-10|||April 2004||2004-04-01|February 2009|2009-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus|A Randomized, Double-Blind, Placebo-Controlled Pilot Study of the Efficacy and Safety of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus|Terminated||Phase 2|13|Actual|Massachusetts General Hospital||2||Pharmaceutical sponsor withdrew financial support.|f||||f||||||||||2017-10-11 05:16:16.39747|2017-10-11 05:16:16.39747
NCT00135746|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-11|||May 2004||2004-05-01|October 2015|2015-10-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2|Effects of Transdermal Nicotine on Tobacco Withdrawal and the Effects of Smoking in Men and Women|Completed||N/A|128|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:16:16.522112|2017-10-11 05:16:16.522112
NCT00135759|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-11|||April 2005||2005-04-01|August 2008|2008-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Addition of Naltrexone to Methadone Taper|Place of Low-Dose Naltrexone in Opiate Detoxification|Completed||Phase 2|174|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 05:16:16.638037|2017-10-11 05:16:16.638037
NCT00135772|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-11|||October 2003||2003-10-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Observational|||Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2|Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder|Completed||N/A|100||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:16:16.743652|2017-10-11 05:16:16.743652
NCT00135785|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-11|||October 2005||2005-10-01|September 2009|2009-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2|A Randomized, Double-Blind, Placebo-Controlled Evaluation of Bupropion vs Placebo for the Treatment of Methamphetamine Dependence|Completed||Phase 2|73|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 05:16:16.810895|2017-10-11 05:16:16.810895
NCT00135798|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2013-04-11|2012-06-13||September 2005||2005-09-01|April 2013|2013-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|LADR||Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation|The Adult-to-adult Living Donor Liver Transplantation Cohort Study (A2ALL) Low Accelerated Dosing Regimen (LADR) Protocol: Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C Virus (HCV) After Liver Transplantation|Completed||Phase 2|79|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Failure to reach target of 84 transplanted patients (47 achieved); Inability to complete planned 12 weeks of treatment for some; Incomplete HCV RNA follow up; Inconsistent limits of detection of HCV RNA; Noncompliance with assigned treatment.|3|||f||||t||||||||||2017-10-11 05:16:16.893405|2017-10-11 05:16:16.893405
NCT00135811|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2012-05-21|||November 2004||2004-11-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)|Focal Segmental Glomerulosclerosis Clinical Trial|Completed||Phase 3|207|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 05:16:17.409019|2017-10-11 05:16:17.409019
NCT00135824|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-11-16|||March 2004||2004-03-01|November 2011|2011-11-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers|Local Tolerability and Safety of Povidone K25 (Artificial Tears Containing Povidone) vs. Placebo in Healthy Volunteers|Completed||Phase 4|30|Actual|Novartis|||||f||||||||||||||2017-10-11 05:16:17.491092|2017-10-11 05:16:17.491092
NCT00135837|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2006-06-20|||June 2003||2003-06-01|June 2006|2006-06-01||||||||Interventional|||Photodynamic Therapy in Occult-Only Lesions (POOL)|An Open-Label, Multicenter, Phase 4 Study of the Effect of Verteporfin for Injection Therapy in Subjects With Occult With No Classic Choroidal NeoVascularization Secondary to Age-Related Macular Degeneration|Completed||Phase 4|202||Novartis|||||f||||||||||||||2017-10-11 05:16:17.584947|2017-10-11 05:16:17.584947
NCT00135876|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2007-04-25|||October 2002||2002-10-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients|A Trial of Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients (PRODIGE)|Completed||Phase 3|512||Ontario Clinical Oncology Group (OCOG)|||||f||||f||||||||||2017-10-11 05:16:17.834781|2017-10-11 05:16:17.834781
NCT00135889|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2009-10-07|||January 2005||2005-01-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Continuous Femoral Nerve Block Following Total Knee Replacement|Improving Postoperative Rehabilitation Following Total Knee Arthroplasty With Perineural Local Anesthetic Infusion|Completed||N/A|50||National Institute of General Medical Sciences (NIGMS)|||||f||||t||||||||||2017-10-11 05:16:17.932297|2017-10-11 05:16:17.932297
NCT00135902|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-09-29|||February 2005||2005-02-01|September 2016|2016-09-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies|A Randomized Trial of Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in Pregnancies at High Risk|Completed||Phase 3|800|Actual|The George Washington University Biostatistics Center||1|||f||||t||||||||Yes|The data will be shared after completion and publication of the main analyses in accordance with NIH policy. The contact to obtain datasets is mfmudatasets@bsc.gwu.edu.|2017-10-11 05:16:18.039738|2017-10-11 05:16:18.039738
NCT00135915|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2009-10-30|||August 2005||2005-08-01|October 2009|2009-10-01|February 2007|Actual|2007-02-01|||||Observational|||Influence of Binge Drinking on Glucose Metabolism in Patients With Type 1 Diabetes - A Pilot Study|Influence of Binge Drinking on Glucose Metabolism in Patients With Type 1 Diabetes - A Pilot Study|Completed||Phase 2/Phase 3|10|Actual|The Royal Bournemouth Hospital|||2||f||||t||||||||||2017-10-11 05:16:18.219169|2017-10-11 05:16:18.219169
NCT00135928|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-08-04|||May 2003||2003-05-01|February 2005|2005-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Stem Cells in Myocardial Infarction|Bone Marrow Stimulation With G-CSF in Acute Myocardial Infarction,|Completed||Phase 2|78||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:16:18.283437|2017-10-11 05:16:18.283437
NCT00135941|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2009-06-02|||August 2005||2005-08-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)|Insulin Glargine Plus Insulin Glulisine MDI Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) Evaluating Differences in Patient Reported Outcomes|Completed||Phase 3|582|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:16:18.357155|2017-10-11 05:16:18.357155
NCT00135954|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2014-01-27|||July 1997||1997-07-01|February 2007|2007-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Treatment of Patients With Idiopathic Membranous Nephropathy|Treatment of Patients With Idiopathic Membranous Nephropathy at Risk for Renal Insufficiency: Comparison of Early Versus Late Start of Immunosuppressive Therapy|Completed||Phase 3|29|Actual|Radboud University||2|||f||||||||||||||2017-10-11 05:16:18.450549|2017-10-11 05:16:18.450549
NCT00135967|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2005-12-05|||May 2002||2002-05-01|August 2005|2005-08-01||||||||Interventional|||Mycophenolate Mofetil in Membranous Nephropathy|Treatment of Patients With Membranous Nephropathy and Renal Insufficiency With Mycophenolate Mofetil and Prednisone: a Pilot Study|Completed||Phase 2/Phase 3|30||Radboud University|||||f||||||||||||||2017-10-11 05:16:18.534372|2017-10-11 05:16:18.534372
NCT00135980|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-02-28|||August 2004||2004-08-01|February 2007|2007-02-01|July 2007||2007-07-01|||||Interventional|||Integrated Care for Cancer Patients; Developing, Implementing and Testing a Programme to Improve Integrated Care|Integrated Care for Cancer Patients|Unknown status|Recruiting|N/A|300||Radboud University|||||f||||||||||||||2017-10-11 05:16:18.612291|2017-10-11 05:16:18.612291
NCT00135993|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2014-09-24|||May 2005||2005-05-01|September 2009|2009-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Five-Arm Parallel-Group Trial to Investigate the Efficacy and Safety of Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|Completed||Phase 3|811|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:16:18.735723|2017-10-11 05:16:18.735723
NCT00136006|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2013-01-30|||August 2005||2005-08-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung Disease|The Burden of Chronic Obstructive Lung Disease (BOLD) Study|Unknown status|Active, not recruiting|N/A|1000|Anticipated|University of British Columbia|||1||f||||||||||||||2017-10-11 05:16:18.835047|2017-10-11 05:16:18.835047
NCT00136019|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2014-09-19|||March 2004||2004-03-01|July 2010|2010-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization|Completed||Phase 3|400|Anticipated|UCB Pharma|||||f||||||||||||||2017-10-11 05:16:18.916244|2017-10-11 05:16:18.916244
NCT00136032|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2008-02-12|||January 2002||2002-01-01|February 2008|2008-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women|Gender-Specific Effects of Physiologic GH Administration on Cardiovascular Risk Factors in Women With Growth Hormone Deficiency|Completed||N/A|63|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:16:18.976167|2017-10-11 05:16:18.976167
NCT00136045|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2014-09-24|||May 2005||2005-05-01|February 2010|2010-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome|A Multi-center, Randomized, Double-blind, Placebo-controlled, Four-arm Parallel-group Trial to Investigate the Efficacy and Safety of Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome|Completed||Phase 3|549|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:16:19.095348|2017-10-11 05:16:19.095348
NCT00136058|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-12-15|||January 2002||2002-01-01|December 2011|2011-12-01|April 2006||2006-04-01|||||Interventional|||Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients|Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients|Completed||Phase 3|250||University of Alberta|||||f||||||||||||||2017-10-11 05:16:19.162527|2017-10-11 05:16:19.162527
NCT00136071|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2005-12-19|||May 2005||2005-05-01|May 2005|2005-05-01|May 2010||2010-05-01|||||Interventional|||Transvaginal Tension Free Vaginal Tape-Obturator (TVT-O) Versus Transobturator Tape-Mentor (TOT) in the Management of Urodynamic Stress Urinary Incontinence|Randomised Prospective Blinded Trial Comparing Transvaginal Tension Free Vaginal Tape-Obturator (Outside-In) With Transobturator Tape-Mentor (Inside-Out) in Surgical Management of Urodynamic Stress Urinary Incontinence|Unknown status|Recruiting|N/A|230||South Glasgow University Hospitals NHS Trust|||||f||||||||||||||2017-10-11 05:16:19.226416|2017-10-11 05:16:19.226416
NCT00136084|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2012-11-02|2010-03-05||August 2002||2002-08-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|July 2008|Actual|2008-07-01||Interventional|||Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia|A Collaborative Trial for the Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia|Completed||Phase 3|238|Actual|St. Jude Children's Research Hospital||2|||f||||t||||||||||2017-10-11 05:16:19.552986|2017-10-11 05:16:19.552986
NCT00136097|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-12-19|||August 2005||2005-08-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Study on the Infection Risk of Long Dwell Period Catheters in High Risk Intensive Care Unit (ICU) Patients|Study on the Infection Risk of Long Dwell Period Catheters in High Risk ICU Patients|Terminated||N/A|142||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:16:20.165369|2017-10-11 05:16:20.165369
NCT00136110|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2007-04-30|||April 2005||2005-04-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis|A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS|Completed||Phase 3|165|Actual|UMC Utrecht|||||f||||||||||||||2017-10-11 05:16:20.234143|2017-10-11 05:16:20.234143
NCT00136123|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2014-12-04|||December 2005||2005-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Immediate Load of Dental Implants, Placed in Atrophic Upper and/or Lower Jaw of Partial or Complete Edentate Patients, According to Flapless Technique|Immediate Load of Dental Implants, Placed in Atrophic Upper and/or Lower Jaw of Partial or Complete Edentate Patients, According to Flapless Technique|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 05:16:20.30376|2017-10-11 05:16:20.30376
NCT00136136|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2014-12-04|||August 2003||2003-08-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Validation of Bispectral Index (BIS)-Monitor in 3 Groups of Newborn Children|Validation of BIS-monitor in 3 Groups of Newborn Children|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Ghent|||3||f||||f||||||||||2017-10-11 05:16:20.378703|2017-10-11 05:16:20.378703
NCT00136149|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2014-12-04|||January 2005||2005-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Study on Immediate Placement to Evaluate Astra Tech Osseospeed Implants in an Immediate Loading Protocol in Extraction Sockets and Healed Ridges|An Open, Prospective, Controlled Study on Immediate Placement to Evaluate Clinical Outcome of Astra Tech Implants, Fixture Microthread Osseospeed in an Immediate Loading Protocol in Extraction Sockets and Healed Ridges|Unknown status|Active, not recruiting|N/A|51|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 05:16:20.553121|2017-10-11 05:16:20.553121
NCT00136175|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-01-20|||November 1999||1999-11-01|January 2015|2015-01-01|October 2007|Actual|2007-10-01|December 2005|Actual|2005-12-01||Interventional|||Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder|Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Transitional Cell Carcinoma of the Bladder|Completed||Phase 2|68|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 05:16:20.628403|2017-10-11 05:16:20.628403
NCT00136188|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2012-06-18|||August 2009||2009-08-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Nitric Oxide (NO) Activity and Diabetic Nephropathy|Role of NO Activity for the Development of Diabetic Nephropathy|Completed||Phase 2/Phase 3|100|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||||||||||||2017-10-11 05:16:20.713536|2017-10-11 05:16:20.713536
NCT00136201|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2009-07-06|||November 2005||2005-11-01|July 2009|2009-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections|A Multicenter, Randomized, Open-Label Comparison of the Safety and Efficacy of Tigecycline> vs Imipenem/Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Chinese Subjects|Completed||Phase 3|200||Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-10-11 05:16:20.786875|2017-10-11 05:16:20.786875
NCT00136227|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2012-09-06|||October 2005||2005-10-01|September 2012|2012-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and Women|Trial of Interventions to Increase Utilization of Colorectal Cancer Screening and Promote Informed Decision Making About Colorectal Cancer Screening Among Hispanic Men and Women|Completed||N/A|521|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-10-11 05:16:20.94463|2017-10-11 05:16:20.94463
NCT00136240|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2013-07-24|||April 2003||2003-04-01|August 2008|2008-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Automated Telephone System to Improve Treatment Adherence in People With Depression|Telecom System to Improve Adherence to Antidepressants|Completed||N/A|144||Boston Medical Center|||||f||||||||||||||2017-10-11 05:16:21.037023|2017-10-11 05:16:21.037023
NCT00136253|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2005-12-12|||February 2002||2002-02-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Overcoming Nutritional Barriers in Hemodialysis Patients||Completed||N/A|||Case Western Reserve University|||||f||||||||||||||2017-10-11 05:16:21.121946|2017-10-11 05:16:21.121946
NCT00136266|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-02-02|||March 2005||2005-03-01|September 2007|2007-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Adherence With Iron Sprinkles Among High-Risk Infants|Adherence With Iron Sprinkles Among High-Risk Infants|Completed||Phase 3|128|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:16:21.183729|2017-10-11 05:16:21.183729
NCT00256620|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2008-03-31|||December 1996||1996-12-01|March 2008|2008-03-01|December 1999||1999-12-01|||||Interventional|||Improving Outcomes and Quality of Life After CABG|Improving Outcomes and Quality of Life After CABG|Completed||N/A|412||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:51:36.00188|2017-10-11 05:51:36.00188
NCT00136279|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2009-01-30|||January 2004||2004-01-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Linking Lives: Building Quality Parent Components for School-Based Health Programs in Middle Schools|RCT of Tobacco Use Prevention and Sexual Risk Reduction Interventions for Parents of African American and Latino Youth in Middle School|Completed||N/A|9510|Anticipated|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-11 05:16:21.271964|2017-10-11 05:16:21.271964
NCT00136292|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-01-16||||||January 2007|2007-01-01||||||||Interventional|||Study of Single Dose Daptomycin in Pediatric Patients With Gram-Positive Infection for Which They Are Receiving Standard Antibiotics|An Evaluation of the Pharmacokinetics of a Single Dose of Daptomycin (4 mg/kg) in Pediatric Patients Aged Two to Seventeen Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-Positive Infection|Completed||Phase 1|24||Cubist Pharmaceuticals LLC|||||||||||||||||||2017-10-11 05:16:21.360923|2017-10-11 05:16:21.360923
NCT00136305|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2015-02-03|||August 2005||2005-08-01|February 2015|2015-02-01||||May 2006|Actual|2006-05-01||Interventional|||Comparing Asthma Action Plans for Pediatric Asthma|Relative Effectiveness of Pictorial and Written Asthma Action Plans for Pediatric Asthma|Terminated||Phase 2|4|Actual|Children's Mercy Hospital Kansas City||2||PI moved to a different institution|f||||f||||||||||2017-10-11 05:16:21.424776|2017-10-11 05:16:21.424776
NCT00136318|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2013-03-20|2012-10-25||January 2004||2004-01-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|CIPPAD||Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients|Efficacy and Tolerability of Escitalopram for the Prevention of Pegylated Interferon Alfa Associated Depression in Patients With Chronic Hepatitis C Infection: a Randomized Controlled Trial.|Completed||Phase 3|208|Actual|Charite University, Berlin, Germany|Random assignment of patients before the preobservation period followed by patient withdrawal from the trial independent of antidepressant treatment weakens the strength of the randomization.|2|||f||||t||||||||||2017-10-11 05:16:21.509281|2017-10-11 05:16:21.509281
NCT00136331|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2016-07-17|||October 2005||2005-10-01|November 2008|2008-11-01|November 2006||2006-11-01|||||Interventional|||Study of a Pandemic Influenza Vaccine|Phase Ia Study of a Pandemic Influenza Vaccine|Completed||Phase 1|400||Seqirus|||||f||||||||||||||2017-10-11 05:16:21.914122|2017-10-11 05:16:21.914122
NCT00136344|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2016-02-11|||September 2003||2003-09-01|June 2007|2007-06-01|May 2006||2006-05-01|||||Interventional|||Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery|Antibiotic Prophylaxis for Cataract Surgery Version 7e January 22 2003|Completed||N/A|35000||City, University of London|||||f||||||||||||||2017-10-11 05:16:21.99651|2017-10-11 05:16:21.99651
NCT00136357|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2015-02-02|2014-01-27||August 2004||2004-08-01|February 2015|2015-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Treatment of Posttraumatic Stress Disorder in Kosovar High School Students Using Mind-Body Skills Groups|Treatment of Posttraumatic Stress Disorder in Kosovar High School Students Using Mind-Body Skills Groups: A Randomized Controlled Trial|Completed||N/A|82|Actual|The Center for Mind-Body Medicine||2|||f||||f||||||||||2017-10-11 05:16:22.118785|2017-10-11 05:16:22.118785
NCT00136370|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-09-21|||April 2004||2004-04-01|September 2007|2007-09-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn|Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa|Unknown status|Recruiting|Phase 3|8000|Anticipated|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 05:16:22.361027|2017-10-11 05:16:22.361027
NCT00136383|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2014-07-18|||March 2005||2005-03-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Comparing Paroxetine and Duloxetine on Cardiovascular Measures|A Study of the Effects of Paroxetine vs. Duloxetine on Heart Rate Variability and Autonomic Cardiovascular Control|Completed||Phase 2/Phase 3|40|Anticipated|Duke University|||||||||||||||||||2017-10-11 05:16:22.462393|2017-10-11 05:16:22.462393
NCT00136396|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2013-06-10|||January 2004||2004-01-01|June 2013|2013-06-01|November 2010|Actual|2010-11-01|November 2006|Actual|2006-11-01||Interventional|||Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease|An Open Label, Phase I/II Trial of Rituximab Therapy for Steroid-Refractory Chronic Graft vs. Host Disease|Completed||Phase 1/Phase 2|30|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:16:22.534281|2017-10-11 05:16:22.534281
NCT00136409|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2016-12-22|||May 2002||2002-05-01|December 2016|2016-12-01|December 2008|Actual|2008-12-01|August 2005|Actual|2005-08-01||Interventional|||A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)|A Phase II Study of Gleevec (Imatinib Mesylate) In Patients With BCR-Negative Myeloproliferative Disorders Including Patients With Idiopathic Myelofibrosis With Myeloid Dysplasia or Chronic Myelomonocytic Leukemia|Completed||Phase 2|34|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:16:22.596015|2017-10-11 05:16:22.596015
NCT00136422|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-03-09|||January 2000||2000-01-01|March 2011|2011-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia|A Phase I Study of Vaccination With Lethally Irradiated, Autologous Acute Myeloblastic Leukemia Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Colony Stimulating Factor in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia|Completed||Phase 1|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:16:22.668169|2017-10-11 05:16:22.668169
NCT00136435|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2017-06-15|||June 2002||2002-06-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Study in Adults With Untreated Acute Lymphoblastic Leukemia|A Multicenter Phase II Study in Adults With Untreated Acute Lymphoblastic Leukemia: Testing Pharmacokinetically Individualized Doses of L-Asparaginase Following the DFCI Pediatric Consortium Protocol|Active, not recruiting||Phase 2|100|Anticipated|Dana-Farber Cancer Institute||1|||f|||||t|f||||||||2017-10-11 05:16:22.734779|2017-10-11 05:16:22.734779
NCT00136448|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-03-09|||February 1993||1993-02-01|March 2011|2011-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML)|High-Dose Ara-C Followed by Continuous Infusion Interleukin-2 for Acute Myelogenous Leukemia in First Remission|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:16:22.855252|2017-10-11 05:16:22.855252
NCT00136461|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2011-03-09|||May 1997||1997-05-01|March 2011|2011-03-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|A Randomized Phase II Trial of All-Trans Retinoic Acid and One of Two Schedules of Bryostatin 1 in Patients With Refractory Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)|Completed||Phase 2|40||Dana-Farber Cancer Institute|||||||||||||||||||2017-10-11 05:16:22.937046|2017-10-11 05:16:22.937046
NCT00136474|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2009-10-30|||May 2003||2003-05-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|May 2005|Actual|2005-05-01||Interventional|||Amifostine for Head and Neck Irradiation in Lymphoma|A Randomized Phase II Trial of Amifostine for Head and Neck Irradiation in Lymphoma|Completed||Phase 2|75|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 05:16:23.034993|2017-10-11 05:16:23.034993
NCT00136487|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2009-12-07|||October 2002||2002-10-01|December 2009|2009-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer|A Randomized, Double Blind, Placebo-Controlled Trial of Celecoxib Versus Placebo in Men With Prostate Cancer With Rising PSA Following Prostatectomy or Radiation Therapy|Completed||Phase 2/Phase 3|85||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:16:23.167951|2017-10-11 05:16:23.167951
NCT00136500|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2017-06-08|||February 2005||2005-02-01|June 2017|2017-06-01|December 2027|Anticipated|2027-12-01|December 2027|Anticipated|2027-12-01||Observational|CRiALS||Clinical Research in ALS Study|Clinical Research in ALS|Recruiting||N/A|10000|Anticipated|University of Miami|||1||f||||f||||||Samples With DNA|"     DNA, blood, urine, CSF, skin biopsies   "|||2017-10-11 05:16:23.295934|2017-10-11 05:16:23.295934
NCT00136513|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2008-10-15|||April 2004||2004-04-01|October 2008|2008-10-01||||||||Interventional|||SB-743921 In Patients With Solid Tumors|A Phase I Study to Determine the Safety and Pharmacokinetics of Intravenous Administration of SB743921 on a Once Every 3 Week Schedule in Patients With Solid Tumors|Completed||Phase 1|30|Actual|GlaxoSmithKline|||||||||||||||||||2017-10-11 05:16:23.550304|2017-10-11 05:16:23.550304
NCT00136526|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2013-05-07|||December 2002||2002-12-01|May 2013|2013-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer|Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer: A Phase II Study|Completed||Phase 2|30|Actual|University of Washington||1|||f||||t||||||||||2017-10-11 05:16:23.618458|2017-10-11 05:16:23.618458
NCT00136539|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2013-02-15|||March 1999||1999-03-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|November 2006|Actual|2006-11-01||Interventional|||Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer|Neoadjuvant Therapy With Herceptin and Taxol for Stage II/III Breast Cancer|Completed||Phase 2|41|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:16:23.691351|2017-10-11 05:16:23.691351
NCT00136552|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2007-07-02|||May 2000||2000-05-01|July 2007|2007-07-01|December 2004||2004-12-01|||||Interventional|||Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden|FL-2000 Study for Newly Diagnosed Follicular Lymphoma Patients With a High Tumor Burden|Completed||Phase 3|360||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:16:23.776294|2017-10-11 05:16:23.776294
NCT00136565|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2007-11-06|||November 2005||2005-11-01|November 2007|2007-11-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Study of Bortezomib Combined With ACVBP in Peripheral T-Cell Lymphoma|A Phase II Study Evaluating the Efficacy and Safety of Bortezomib (Velcade™) Combined With ACVBP Regimen in Patients With Previously Untreated Peripheral T-Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Lymphoma Study Association||1|||f||||||||||||||2017-10-11 05:16:23.868953|2017-10-11 05:16:23.868953
NCT00136578|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2017-09-22|||October 20, 2004|Actual|2004-10-20|September 2017|2017-09-01|October 25, 2006|Actual|2006-10-25|October 25, 2006|Actual|2006-10-25||Interventional|||Ispinesib In Combination With Carboplatin In Patients With Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study of the Safety and Tolerability of Ispinesib in Combination With Carboplatin on an Every 21-Day Schedule in Subjects With Advanced Solid Tumors.|Completed||Phase 1|30|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 05:16:23.971382|2017-10-11 05:16:23.971382
NCT00136591|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2010-10-22|||September 2005||2005-09-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma|A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma|Terminated||Phase 2|87|Actual|Lymphoma Study Association||2||An arm closed due to lack of efficacy|f||||t||||||||||2017-10-11 05:16:24.080066|2017-10-11 05:16:24.080066
NCT00145470|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-04-21|||June 2005||2005-06-01|April 2015|2015-04-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008)(COMPLETED)(P05844)|A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode|Completed||Phase 3|324|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:16:24.346973|2017-10-11 05:16:24.346973
NCT00145483|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-01-30|||June 2002||2002-06-01|January 2008|2008-01-01||||||||Interventional|||Sildenafil For Meniere's Disease|A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study Of The Efficacy and Safety Of Sildenafil Given For The Acute Treatment Of Meniere's Disease|Completed||Phase 2|180||Pfizer|||||f||||||||||||||2017-10-11 05:16:24.46673|2017-10-11 05:16:24.46673
NCT00145496|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-09-24|2010-03-05|2009-04-17|December 2004||2004-12-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)|A Multicenter, Double-Blind, Flexible -Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine With Olanzapine in Stable Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia.|Completed||Phase 3|468|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:16:24.657775|2017-10-11 05:16:24.657775
NCT00145509|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-01-07|2010-03-26|2009-04-23|August 2005||2005-08-01|January 2015|2015-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)|A Phase 3, Placebo-Controlled, Double-Blinded Continuation Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Completing a 12-week Lead-in Trial and Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode|Completed||Phase 3|77|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:16:25.307739|2017-10-11 05:16:25.307739
NCT00145522|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-03-31|||November 2005||2005-11-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women|A Twelve 28-Day Cycles, Multicenter, Prospective, Randomized, Open, Blinded Endpoint, Parallel Group Study Comparing the Effect on Breast and Cardiovascular Metabolic Markers of Continuously Combined 17β-Estradiol/Dydrogesterone and Tibolone in Postmenopausal Women.|Completed||Phase 4|135|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:16:25.746407|2017-10-11 05:16:25.746407
NCT00145535|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2010-01-28|||May 2004||2004-05-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||SOLX Titanium Sapphire Laser for Trabeculoplasty|SOLX Titanium Sapphire Laser for Trabeculoplasty|Completed||Phase 3|120|Anticipated|SOLX, Inc.||2|||f||||f||||||||||2017-10-11 05:16:25.864791|2017-10-11 05:16:25.864791
NCT00145548|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-06-14|||December 2003||2003-12-01|May 2007|2007-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Pilot Study of the Spiration IBV™ System|Pilot Study of the Spiration IBV™ System|Completed||Phase 2|91|Actual|Spiration, Inc.||1|||f||||t||||||||||2017-10-11 05:16:26.027924|2017-10-11 05:16:26.027924
NCT00145561|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-10-21|||August 2005||2005-08-01|October 2008|2008-10-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-Infected Pregnant Women.|The Pharmacokinetics of SAquinavir (Invirase New Tablet Formulation) 1,000mg + Ritonavir (Norvir) 100mg q12h in HIV-Infected Pregnant Women (SARA)|Completed||Phase 1/Phase 2|40|Actual|Radboud University||1|||f||||f||||||||||2017-10-11 05:16:26.134449|2017-10-11 05:16:26.134449
NCT00145574|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2010-04-08|2009-11-06|2009-10-17|November 2005||2005-11-01|April 2010|2010-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol|Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients With Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naive to Lipid-lowering Therapy|Completed||Phase 4|194|Actual|Daiichi Sankyo, Inc.||3|||f||||||||||||||2017-10-11 05:16:26.299741|2017-10-11 05:16:26.299741
NCT00145587|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-04-24|2011-06-22||July 2004||2004-07-01|January 2011|2011-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Stem Cell Transplantation for Children Affected With Osteopetrosis|Allogeneic Hematopoietic Stem Cell Transplantation for Children Affected With Malignant Osteopetrosis: A Pilot Study|Terminated||N/A|15|Actual|St. Jude Children's Research Hospital|This study closed prior to completion of enrollment due to the principal investigator having left the institution.|1||Due to the principal investigator having left the institution.|f||||f||||||||||2017-10-11 05:16:27.708179|2017-10-11 05:16:27.708179
NCT00145600|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-03-31|2013-02-12||March 2000|Actual|2000-03-01|February 2017|2017-02-01|October 2021|Anticipated|2021-10-01|May 2012|Actual|2012-05-01||Interventional|||Therapy for Pediatric Hodgkin Lymphoma|Risk-Adapted Therapy for Pediatric Hodgkin's Disease|Active, not recruiting||Phase 2|296|Actual|St. Jude Children's Research Hospital||4|||f||||t|t|f||||||||2017-10-11 05:16:28.70585|2017-10-11 05:16:28.70585
NCT00145613|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2009-02-12|||June 2003||2003-06-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|July 2006|Actual|2006-07-01||Interventional|||Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies|Haploidentical Stem Cell Transplantation Utilizing T-Cell Depletion as Therapy for Patients With Refractory Hematological Malignancies|Completed||Phase 2|25|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:16:32.036456|2017-10-11 05:16:32.036456
NCT00145626|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-05-25|2015-06-08||May 2004||2004-05-01|May 2017|2017-05-01|July 2016|Actual|2016-07-01|March 2015|Actual|2015-03-01||Interventional||All evaluable participants are included.|HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies|HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies|Completed||Phase 2|40|Actual|St. Jude Children's Research Hospital|The study was limited due to the unavailability of the study drug OKT3 beginning in June 2011. The study was temporarily closed to accrual. Because OKT3 is still unavailable, the study was formally closed to accrual in March 2015.|1|||f||||f|f|t|f|||||||2017-10-11 05:16:32.199276|2017-10-11 05:16:32.199276
NCT00145639|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-06-08|||May 1999||1999-05-01|June 2011|2011-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma|Osteosarcoma 1999-A Study Of Intensive Chemotherapy Utilizing Ifosfamide, Carboplatin, and Doxorubicin for Adjuvant Chemotherapy for Treatment of Osteosarcoma|Completed||Phase 2|80|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:16:33.524052|2017-10-11 05:16:33.524052
NCT00145652|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-07-27|||December 2003||2003-12-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.|Phase 3 Study of Recombinant Erythropoetin and Adjuvant I.V. Iron Therapy of Anemic Patients With Lymphoproliferative Disorders|Completed||Phase 3|66||Sundsvall Hospital|||||f||||||||||||||2017-10-11 05:16:33.642473|2017-10-11 05:16:33.642473
NCT00145665|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-09-02|||January 2005||2005-01-01|February 2007|2007-02-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases|The Role of 3-Deoxy-3[18]Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases|Terminated||Phase 1/Phase 2|80|Anticipated|Radboud University||1||no accrual achieved|f||||||||||||||2017-10-11 05:16:33.756759|2017-10-11 05:16:33.756759
NCT00145678|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-01-05|||June 2004||2004-06-01|January 2015|2015-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder|Psychodynamic Therapy for Patients With Borderline Personality Disorder and Alcohol Abuse|Completed||Phase 2|30|Actual|State University of New York - Upstate Medical University||2|||f||||f||||||||||2017-10-11 05:16:33.877918|2017-10-11 05:16:33.877918
NCT00145691|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-03-20|||September 2005||2005-09-01|March 2007|2007-03-01|October 2006|Actual|2006-10-01|||||Interventional|||The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)|The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD) - An Eight Week Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi Center Trial. A Phase III Study|Completed||Phase 3|100||Sykehuset Innlandet HF|||||f||||t||||||||||2017-10-11 05:16:33.993656|2017-10-11 05:16:33.993656
NCT00145704|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-03-01|2010-10-26||June 2002||2002-06-01|March 2013|2013-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density|Treatment of Childhood Cancer Therapy-induced Osteopenia in Growth Hormone Deficient Adult Survivors: Does Bisphosphonate Treatment Improve Bone Mineral Density?|Terminated||N/A|6|Actual|State University of New York - Upstate Medical University|Early termination due to low enrollment, and lost to follow up of three subjects. Data was limited and therefore not reviewed/analyzed|2||due to low enrollment, participants are no longer being examined or treated|f||||f||||||||||2017-10-11 05:16:34.081834|2017-10-11 05:16:34.081834
NCT00145717|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02|||April 2005||2005-04-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||China Plant Sterol Trial|China Plant Sterol Trial – A Randomised Trial to Determine the Effects on Blood Cholesterol Levels of a Milk Tea Product Enriched With Plant Sterol Among 300 Chinese Living in Beijing|Completed||Phase 3|300||The George Institute|||||f||||||||||||||2017-10-11 05:16:34.314321|2017-10-11 05:16:34.314321
NCT00145730|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-11-28|||February 2002||2002-02-01|September 2005|2005-09-01|May 2004||2004-05-01|||||Interventional|||Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen|A Multicentre Randomised Placebo-Controlled Trail of Ibuprofen for the Prevention of Ectopic Bone-Related Pain and Disability After Elective Hip Replacement Surgery (HIPAID)|Completed||Phase 4|1000||The George Institute|||||f||||||||||||||2017-10-11 05:16:34.411807|2017-10-11 05:16:34.411807
NCT00145743|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-11-26|||November 2004||2004-11-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer|Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer: Protocol of a Randomized Clinical Trial at the Tumor Center Regensburg|Completed||Phase 1/Phase 2|200|Actual|Tumorzentrum Regensburg e.V.||2|||f||||t||||||||||2017-10-11 05:16:34.496831|2017-10-11 05:16:34.496831
NCT00145756|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02|||May 2004||2004-05-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||China Salt Substitute Study|China Salt Substitute Study-A Randomised Trial to Determine the Long-Term Effects of a Low Sodium, High Potassium Salt Substitute on Blood Pressure Among High-Risk Individuals in Northern China|Completed||N/A|600||The George Institute|||||f||||||||||||||2017-10-11 05:16:34.624478|2017-10-11 05:16:34.624478
NCT00145769|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-08-07|||July 2001||2001-07-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|June 2009|Actual|2009-06-01||Interventional|||A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum|A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum|Completed||Phase 3|326|Actual|Trans-Tasman Radiation Oncology Group (TROG)||3|||f||||t||||||||||2017-10-11 05:16:34.759552|2017-10-11 05:16:34.759552
NCT00145782|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-09-01|||September 1991||1991-09-01|September 2005|2005-09-01|December 1999||1999-12-01|||||Interventional|||The Ebeltoft Health Promotion Project|The Ebeltoft Health Promotion Project - A Randomized Controlled Trial With Multiphasic Preventive Health Screenings and Discussions in General Practice.|Completed||Phase 3|||University of Aarhus|||||f||||||||||||||2017-10-11 05:16:35.158885|2017-10-11 05:16:35.158885
NCT00145795|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-08-23|2012-10-24||April 2004||2004-04-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment|Randomized Trial of a Switch to a Kaletra + Current Dual Nucleoside Reverse Transcriptase Inhibitor (NRTI) Backbone Versus Continuation of the Current Regimen in Patients With Poor Immune Responses to Highly Active Antiretroviral Therapy (HAART) in Patients With Complete Viral Suppression: A Pilot Study|Completed||Phase 4|20|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 05:16:35.280844|2017-10-11 05:16:35.280844
NCT00146731|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2017-01-11|||January 2004||2004-01-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Trial of Antimalarial Drugs Used in Pregnancy in Tanzania|Treating Malaria During Pregnancy: A Randomized Trial of Potential Options for Treatment in an Area of High Drug Resistance in Tanzania|Completed||Phase 3|310|Actual|London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-10-11 05:16:35.943242|2017-10-11 05:16:35.943242
NCT00146744|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-05-24|||July 2005||2005-07-01|May 2017|2017-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults|Double-blind (Observer-blind), Randomised, Controlled, Phase I/II Study, to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Candidate Tuberculosis Vaccine, Mtb72F/AS02A Administered Intramuscularly at 0, 1, 2 Months to Healthy PPD-positive Volunteers Aged 18 to 50 Years|Completed||Phase 2|38||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:16:36.089775|2017-10-11 05:16:36.089775
NCT00146757|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-03-17|2008-11-20||October 2002||2002-10-01|March 2015|2015-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old|A Phase II Open-Label Clinical Trial of Recombinant Human Alpha-L-iduronidase (Aldurazyme®) to Evaluate the Safety and Pharmacokinetics in Mucopolysaccharidosis I (MPS I) Patients Less Than 5 Years Old|Completed||Phase 2|20|Actual|Sanofi|Due to the rarity of the disease, this study is limited by its small sample size and lack of a control group.|2|||f||||||||||||||2017-10-11 05:16:36.24415|2017-10-11 05:16:36.24415
NCT00146770|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-03-17|2009-01-07||May 2001||2001-05-01|March 2015|2015-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients|A Multicenter, Multinational, Open-Label Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I|Completed||Phase 3|45|Actual|Sanofi|Rare disease with limited sample size, lack of control group.FVC calculations less reliable for patients whose height is below the 3rdpercent of general population.Height term used to calculate FVC may be influenced by joint contractures and posture.|2|||f||||||||||||||2017-10-11 05:16:37.246929|2017-10-11 05:16:37.246929
NCT00146783|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2017-01-11|||June 2004||2004-06-01|January 2017|2017-01-01|February 2007|Actual|2007-02-01|||||Interventional|||Navrongo Drug Options for IPT in Pregnancy Trial|Efficacy of Sulphadoxine-pyrimethamine and Amodiaquine Alone or in Combination as Intermittent Preventive Treatment in Pregnancy in the Kassena-Nankana District of Ghana: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|3642|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-10-11 05:16:39.688485|2017-10-11 05:16:39.688485
NCT00146796|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2017-01-11|||January 2005||2005-01-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|||||Interventional|||A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Malaria in Tanzania|A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Non-Severe Malaria at Different Transmission Intensities of Plasmodium Falciparum in Tanzania|Completed||Phase 4|2400|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-10-11 05:16:39.766836|2017-10-11 05:16:39.766836
NCT00146809|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-03-03|||December 2003||2003-12-01|March 2007|2007-03-01|December 2005||2005-12-01|||||Interventional|||Study About Efficacy and Safety to Treat Multi-System-Atrophy|Double-Blind, Randomised, Two-Armed Study for the Evaluation of Efficacy and Safety of Minocycline for Treatment|Completed||Phase 3|60||German Parkinson Study Group (GPS)|||||f||||||||||||||2017-10-11 05:16:39.856632|2017-10-11 05:16:39.856632
NCT00146822|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-02-02|||February 2004||2004-02-01|February 2017|2017-02-01|March 2006||2006-03-01|||||Interventional|||REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance|ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance Study|Completed||Phase 4|1500||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:16:39.958677|2017-10-11 05:16:39.958677
NCT00146835|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-01-09|||April 2003||2003-04-01|January 2014|2014-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine|Phase IV, Prospective Study of the Safety of GSK Bios' Pediarix Administered to a Cohort of Infants in a US Health Maintenance Organization (HMO). (Post-Marketing PEDIARIX Safety Study)|Completed||N/A|120794|Actual|GlaxoSmithKline|||3||f||||||||||||||2017-10-11 05:16:40.019127|2017-10-11 05:16:40.019127
NCT00146848|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2011-12-20|2010-02-28||December 2004||2004-12-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|PEGASUS CRT||PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy|Pacing Evaluation - Atrial Support Study in Cardiac Resynchronization Therapy|Completed||Phase 4|1742|Actual|Boston Scientific Corporation|Lack of longer-term follow-up. Single blind design where investigator could be aware of treatment assignment. Two conservative atrial support pacing modes; results should not be extended to substantially more atrial pacing and higher heart rates.|3|||f||||t||||||||||2017-10-11 05:16:40.119245|2017-10-11 05:16:40.119245
NCT00146861|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-05-17|||July 2003|Actual|2003-07-01|May 2017|2017-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||LIFE Study - Limiting Chronotropic Incompetence for Pacemaker Recipients|Limiting Chronotropic Incompetence for Pacemaker Recipients|Completed||Phase 4|1500||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:16:40.459035|2017-10-11 05:16:40.459035
NCT00146874|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2010-08-17|||May 2004||2004-05-01|November 2006|2006-11-01||||March 2007|Actual|2007-03-01||Observational|||CRT RENEWAL Registry|Cardiac Resynchronization Therapy Registry Evaluating Patient Response With RENEWAL Family Devices|Completed||Phase 4|1000||Boston Scientific Corporation|||1||f||||||||||||||2017-10-11 05:16:40.509418|2017-10-11 05:16:40.509418
NCT00146887|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2006-11-06|||January 2005||2005-01-01|August 2005|2005-08-01|August 2005|Anticipated|2005-08-01|||||Interventional|||Comparison of Coronary CT Angiography to Invasive Coronary Angiography|A Trial Comparing the Sensitivity and Specificity of Coronary Angiography With Coronary CT Angiography|Unknown status|Recruiting|N/A|40|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:16:40.56856|2017-10-11 05:16:40.56856
NCT00146900|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2016-02-17|||August 2004||2004-08-01|February 2016|2016-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Prevention of Post Traumatic Stress Disorder by Early Treatment|Prevention of Post Traumatic Stress Disorder by Early Treatment|Completed||N/A|298|Actual|Hadassah Medical Organization||5|||f||||f||||||||||2017-10-11 05:16:40.637931|2017-10-11 05:16:40.637931
NCT00146913|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2007-04-26|||March 2004||2004-03-01|April 2007|2007-04-01||||||||Interventional|||AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year|A Phase II Study Evaluating the Efficacy and Tolerance of Combination Therapy of Imatinib Mesylate (IM) +-2A Interféron for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year|Unknown status|Active, not recruiting|Phase 2|30||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:16:40.728755|2017-10-11 05:16:40.728755
NCT00146926|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2007-04-26|||September 2005||2005-09-01|April 2007|2007-04-01||||||||Interventional|||Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion|Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion|Unknown status|Active, not recruiting|Phase 3|200||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:16:40.790241|2017-10-11 05:16:40.790241
NCT00146952|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2016-11-10|||January 2005||2005-01-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Interventional|||Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation|Evaluation of a Vibrotactile Sensory Aid Developed by the US Navy to Combat Pilot Disorientation as a Prosthesis in Patients With Postural Imbalance and Spatial Disorientation|Unknown status|Recruiting|Phase 1|30|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:16:40.857968|2017-10-11 05:16:40.857968
NCT00146978|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2006-11-06|||December 2000||2000-12-01|March 2006|2006-03-01|August 2005||2005-08-01|||||Interventional|||Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)|A Phase 1/2 Study to Evaluate Intra-Arterial Catheter Directed Therapy for Severe Gastro-Intestinal and/or Hepatic Graft vs. Host Disease (GVHD)|Completed||Phase 1/Phase 2|50||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:16:40.922794|2017-10-11 05:16:40.922794
NCT00147004|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-04-23|||March 2002||2002-03-01|April 2008|2008-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|Corticus||Corticosteroid Therapy of Septic Shock - Corticus|Corticosteroid Therapy of Septic Shock - Corticus. A Multi-National, Prospective, Double-Blind, Randomized, Placebo-Controlled Study|Completed||Phase 3|500|Actual|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 05:16:40.99625|2017-10-11 05:16:40.99625
NCT00141401|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-08-15|||September 1999||1999-09-01|August 2007|2007-08-01|July 2005|Actual|2005-07-01|||||Interventional|||Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.|An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.|Completed||Phase 3|240||Pfizer|||||f||||||||||||||2017-10-11 05:18:05.587049|2017-10-11 05:18:05.587049
NCT00147017|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2015-03-23|||June 2001||2001-06-01|September 2005|2005-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Regulation of the Release of Inflammatory Mediators From Lung Macrophages.|Regulation of the Release of Inflammatory Mediators From Lung Macrophages.|Completed||N/A|60|Actual|Imperial College London|||1||f||||||||||Samples Without DNA|"     protein samples have been retained   "|||2017-10-11 05:16:41.180312|2017-10-11 05:16:41.180312
NCT00147030|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2016-04-06|2016-03-08||December 2002||2002-12-01|November 2013|2013-11-01|August 2008|Actual|2008-08-01|November 2006|Actual|2006-11-01||Interventional||Infants who were less than 6 hours of age who had a gestational age of at least 36 weeks and perinatal asphyxial encephalopathy confirmed by 30 minutes’ amplitude-integrated electro-encephalography that showed abnormal background activity or seizures.|TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia|Whole Body Hypothermia for the Treatment of Perinatal Asphyxial Encephalopathy|Completed||N/A|325|Actual|Imperial College London||2|||f||||t||||||||No||2017-10-11 05:16:41.403443|2017-10-11 05:16:41.403443
NCT00147043|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2016-02-11|||January 2005||2005-01-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Adult Stem Cell Therapy in Liver Insufficiency|Adult Stem Therapy for Patients With Liver Insufficiency|Completed||Phase 1|5||Imperial College London|||||f||||||||||||||2017-10-11 05:16:42.094592|2017-10-11 05:16:42.094592
NCT00147056|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-05-17|||August 2012||2012-08-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors|A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors|Recruiting||Phase 1|10|Anticipated|InSightec||1|||f||||t||||||||||2017-10-11 05:16:42.157406|2017-10-11 05:16:42.157406
NCT00147069|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-05-27|||April 2004||2004-04-01|September 2005|2005-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Leukocyte Function in Asthma and COPD|Investigation Into Inflammatory Mechanisms in Airway Cells in Smokers and Non-smokers With Inflammatory Lung Disease.|Completed||N/A|90|Actual|Imperial College London|||1||f||||f||||||||||2017-10-11 05:16:42.225957|2017-10-11 05:16:42.225957
NCT00147082|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-08-24|||February 2001||2001-02-01|September 2006|2006-09-01|April 2007|Actual|2007-04-01|December 2004|Actual|2004-12-01||Observational|||Leukocyte Function in Chronic Obstructive Pulmonary Disease (COPD)|Leukocyte Migration and Differentiation in COPD Patients Compared to Healthy Smokers and Healthy Non-smoking Subjects.|Completed||N/A|90|Anticipated|Imperial College London|||3||f||||||||||||||2017-10-11 05:16:42.284485|2017-10-11 05:16:42.284485
NCT00147095|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-05-27|||February 2003||2003-02-01|September 2005|2005-09-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease|Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease|Completed||N/A|80|Actual|Imperial College London|||1||f||||||||||Samples Without DNA|"     RNA was isolated and sent to GeneLogic   "|||2017-10-11 05:16:42.341722|2017-10-11 05:16:42.341722
NCT00147108|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-09-13|||January 2003||2003-01-01|September 2012|2012-09-01|October 2005|Actual|2005-10-01|August 2005|Actual|2005-08-01||Interventional|||MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas|Phase 3 Study of MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas|Terminated||Phase 3|102|Actual|InSightec||1|||f||||||||||||||2017-10-11 05:16:42.4032|2017-10-11 05:16:42.4032
NCT00147121|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2016-09-20|||September 2002||2002-09-01|September 2016|2016-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)|Rituximab + Standard CHOP (R･S-CHOP) vs Rituximab+ Bi-weekly CHOP (R･Bi-CHOP) RCT(Phase II/III) for Stage III/IV Low-grade B-cell Lymphoma (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)|Completed||Phase 2/Phase 3|300|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:16:42.48628|2017-10-11 05:16:42.48628
NCT00147134|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2016-09-20|||November 2004||2004-11-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer|Randomized Controlled Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer（JCOG 0404,CRC Surg-LAP/OPEN)|Completed||Phase 3|1050|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:16:42.663671|2017-10-11 05:16:42.663671
NCT00147147|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2016-09-20|||January 1993||1993-01-01|September 2016|2016-09-01|March 2004||2004-03-01|||||Interventional|||Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)|Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by Oral Fluorouracil (UFT) in Serosa-positive Gastric Cancer (JCOG9206-2)|Completed||Phase 3|280||Japan Clinical Oncology Group|||||f||||||||||||||2017-10-11 05:16:43.081419|2017-10-11 05:16:43.081419
NCT00147160|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-04-10|||October 2003||2003-10-01|September 2006|2006-09-01|December 2007|Actual|2007-12-01|July 2006|Actual|2006-07-01||Interventional|||Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents|Phase II Study of the Combination of Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents at Diagnosis or in Relapse|Completed||Phase 2|87|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:16:43.151037|2017-10-11 05:16:43.151037
NCT00147186|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-01-12|||January 2000||2000-01-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Interventional|||The Effectiveness of Hylan GF-20 on Joint Reaction Forces and Kinematic Patterns During Gait in Patients With Knee Osteoarthritis||Unknown status|Active, not recruiting|N/A|||Kessler Foundation|||||f||||||||||||||2017-10-11 05:16:43.230036|2017-10-11 05:16:43.230036
NCT00147199|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-07-11|2012-12-03||June 2005||2005-06-01|July 2013|2013-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|TRIUMPH||Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)|TRIUMPH I: Double Blind Placebo Controlled Clinical Investigation Into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension|Completed||Phase 3|235|Actual|United Therapeutics||2|||f||||f||||||||||2017-10-11 05:16:43.324452|2017-10-11 05:16:43.324452
NCT00147212|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-12-11|2012-03-16||June 2002||2002-06-01|December 2012|2012-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||ET 743 (Yondelis) in Men With Advanced Prostate Cancer|A Phase II Study of Three Hour, Weekly Infusion of ET 743 (Yondelis) in Men With Advanced Prostate Cancer|Completed||Phase 2|50|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 05:16:44.177771|2017-10-11 05:16:44.177771
NCT00272324|ClinicalTrials.gov processed this data on October 10, 2017|2006-01-03|2006-01-03|||February 1992||1992-02-01|November 2005|2005-11-01|January 2007||2007-01-01|||||Interventional|||Aspirin/Folate Prevention of Large Bowel Polyps|Aspirin/Folate Prevention of Large Bowel Polyps|Completed||Phase 2/Phase 3|1121||Dartmouth-Hitchcock Medical Center|||||||||||||||||||2017-10-11 05:55:23.993394|2017-10-11 05:55:23.993394
NCT00147225|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-04-07|2014-04-07||August 2005||2005-08-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Cycle 1, Chemotherapy alone (Control Cycle); Beginning Cycle 2, Chemotherapy followed by AMG 531 subcutaneously of 21-28 day treatment cycle. There were 51 participants who received at least one dose of the study drug.|AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin|Phase I/II Study of AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin|Completed||Phase 1/Phase 2|55|Actual|M.D. Anderson Cancer Center||6|||f||||f||||||||||2017-10-11 05:16:44.39391|2017-10-11 05:16:44.39391
NCT00147238|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-07-31|2009-04-24||July 2005||2005-07-01|July 2012|2012-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast|A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast|Terminated||N/A|10|Actual|M.D. Anderson Cancer Center||2||Terminated at request of sponsor.|f||||f||||||||||2017-10-11 05:16:45.053763|2017-10-11 05:16:45.053763
NCT00147251|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-10-31|||May 2003||2003-05-01|September 2005|2005-09-01|May 2007||2007-05-01|||||Interventional|||Stop Atherosclerosis in Native Diabetics Study|Stop Atherosclerosis in Native Diabetics Study|Completed||Phase 4|548||Medstar Health Research Institute|||||f||||||||||||||2017-10-11 05:16:45.253882|2017-10-11 05:16:45.253882
NCT00147264|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2016-12-13|||April 2004||2004-04-01|December 2016|2016-12-01|November 2006|Actual|2006-11-01|January 2006|Actual|2006-01-01||Interventional|||Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial|A Randomized, Double Blind, 2X2 Factorial Design Study to Evaluate the Effects of Telmisartan vs Placebo, and of a Low-Glycemic Diet vs Control Diet, in Reducing Intra-Myocellular Lipids In Individuals With Abdominal Obesity|Completed||Phase 3|120||McMaster University|||||f||||||||||||||2017-10-11 05:16:45.343389|2017-10-11 05:16:45.343389
NCT00147277|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-08-12|2008-11-20||March 2004||2004-03-01|August 2015|2015-08-01|January 2008|Actual|2008-01-01|January 2006|Actual|2006-01-01||Interventional|ADVANCE_D||ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy|ADVANCE-D: ATP Delivery for Painless ICD Therapy|Completed||Phase 4|925|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-10-11 05:16:45.442872|2017-10-11 05:16:45.442872
NCT00147290|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-08-12|2008-11-20||February 2004||2004-02-01|August 2015|2015-08-01|January 2008|Actual|2008-01-01|April 2007|Actual|2007-04-01||Interventional|ADVANCE-CRTD||ADVANCE CRT - D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy|ADVANCE CRT - D: ATP Delivery for Painless ICD Therapy|Completed||Phase 4|526|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-10-11 05:16:45.731741|2017-10-11 05:16:45.731741
NCT00147303|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2015-04-08|||April 2004||2004-04-01|April 2015|2015-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-responsive Clinical Pharmacology Study|Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Clinical-pharmacological Dose-response Study.|Completed||Phase 3|46|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-10-11 05:16:46.046201|2017-10-11 05:16:46.046201
NCT00147316|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2012-02-29|2012-01-19||April 2002||2002-04-01|February 2012|2012-02-01|September 2003||2003-09-01|||||Interventional|||Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke|Japan Alteplase Clinical Trial (J-ACT): Phase 3 Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Acute Ischemic Stroke Within 3 Hours of Onset|Completed||Phase 3|103|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||||||||||||2017-10-11 05:16:46.118436|2017-10-11 05:16:46.118436
NCT00147329|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-02-21|||September 2005||2005-09-01|February 2007|2007-02-01|July 2006||2006-07-01|||||Interventional|||Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis|A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study To Evaluate the Tolerability, Pharmacokinetics, Pharmacodynamics, and Biologic Activity of MM-093 in Patients With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|30||Merrimack Pharmaceuticals|||||f||||||||||||||2017-10-11 05:16:46.542252|2017-10-11 05:16:46.542252
NCT00147342|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2016-09-02|||May 2005||2005-05-01|September 2016|2016-09-01|December 2005||2005-12-01|||||Observational|||The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes|The Effect of Basal Insulin During Exercise on the Development of Hypoglycemia in Children With Type 1 Diabetes|Completed||N/A|55||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 05:16:46.613452|2017-10-11 05:16:46.613452
NCT00147355|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2012-04-11|||November 2005||2005-11-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy|An Open-label, Randomised Study Comparing the Uptake of rIL-2 in HIV-1 Infected Individuals Receiving Different Combinations of Antiemetics and Analgesic Agents During rIL-2 Dosing in ESPRIT: Toxicity Substudy of ESPRIT: TOXIL-2 Substudy|Terminated||Phase 3|28|Actual|Kirby Institute||4||28 of 168 patients only were enrolled, numbers too low to be conclusive|f||||t||||||||||2017-10-11 05:16:46.716634|2017-10-11 05:16:46.716634
NCT00147368|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-05-30|||February 2005||2005-02-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|April 2006|Actual|2006-04-01||Interventional|||Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria|Pharmacokinetic-Pharmacodynamic Study of Adjunctive Arginine in Falciparum Malaria|Completed||Phase 1/Phase 2|50|Anticipated|Menzies School of Health Research|||||f||||t||||||||||2017-10-11 05:16:46.843994|2017-10-11 05:16:46.843994
NCT00147381|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-06-18|||January 2004||2004-01-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|August 2008|Actual|2008-08-01||Interventional|||Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection|Effectiveness and Safety of Campath-1H as an Induction Agent in Combination With Tacrolimus Monotherapy for Prevention of Graft Rejection Compared to Tacrolimus in Combination With MMF and Steroids in Cadaveric Kidney Transplantation|Completed||Phase 3|197|Actual|Medical University Innsbruck||3|||f||||f||||||||||2017-10-11 05:16:46.935715|2017-10-11 05:16:46.935715
NCT00147394|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-10-25|||December 2001||2001-12-01|October 2012|2012-10-01|June 2004|Actual|2004-06-01|||||Interventional|||Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)|Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder|Completed||Phase 1|100||Children's Hospital Medical Center, Cincinnati|||||f||||f||||||||||2017-10-11 05:16:47.047128|2017-10-11 05:16:47.047128
NCT00147420|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-12-16|||September 2005||2005-09-01|December 2013|2013-12-01|March 2007|Actual|2007-03-01|||||Interventional|||RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet|RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet|Completed||N/A|848||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-10-11 05:16:47.212872|2017-10-11 05:16:47.212872
NCT00147433|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-03-30|||February 2004||2004-02-01|September 2005|2005-09-01|November 2008||2008-11-01|||||Observational|||The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children|Are IQs Low in Offspring of Euthyroid Women With Low T4?|Unknown status|Recruiting|N/A|5000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:16:47.308588|2017-10-11 05:16:47.308588
NCT00147446|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-09-06|2012-10-26||May 2005||2005-05-01|September 2013|2013-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Stress Management for Patients With Multiple Sclerosis|Phase II Study of the Effects of Stress Management on Neuroimaging, Clinical, Immune and Psychosocial Outcomes|Completed||Phase 2|121|Actual|Northwestern University|we caution that it is premature to make specific clinical recommendations regarding the use of SMT-MS to manage MS disease-related activity. Future work should identify, refine, and optimize the active ingredients in this behavioral intervention.|2|||f||||t||||||||||2017-10-11 05:16:47.387157|2017-10-11 05:16:47.387157
NCT00147459|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2012-12-04|||September 2005||2005-09-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2006|Actual|2006-12-01||Interventional|||Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation|Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation|Unknown status|Recruiting|N/A|31|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 05:16:47.8232|2017-10-11 05:16:47.8232
NCT00147472|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-06-20|||May 2004||2004-05-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|August 2009|Actual|2009-08-01||Interventional|||Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)|A Prospective Cohort Study to Determine the Sensitivity of Positron Emission Tomography (PET) in Detecting Metastatic Cancer in Neck Lymph Nodes in Patients With Squamous Cell Head & Neck Cancer Managed With Primary Radiation Therapy|Completed||Phase 3|400|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-10-11 05:16:48.004374|2017-10-11 05:16:48.004374
NCT00147485|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-08-14|||December 2004||2004-12-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer|A Phase 1 Safety, Pharmacokinetic And Pharmacodynamic Study Of AG-024322, An Inhibitor Of Cyclin-Dependent Kinase 1, 2 And 4, Administered Intravenously Daily For 5 Days Every 3 Weeks To Patients With Advanced Cancer|Terminated||Phase 1|37|Actual|Pfizer||1||See Detailed Description|f||||||||||||||2017-10-11 05:16:48.241489|2017-10-11 05:16:48.241489
NCT00147498|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-12-20|2012-11-19|2012-11-07|January 2005||2005-01-01|December 2012|2012-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Compare 3 Dose Levels Of CP-690,550 Versus Placebo, Administered Orally Twice Daily (BID) For 6 Weeks, In The Treatment Of The Signs And Symptoms Of Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|264|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 05:16:48.422576|2017-10-11 05:16:48.422576
NCT00147511|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2011-05-09|||June 2003||2003-06-01|May 2011|2011-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Time To Efficacy and Onset Of Action Of Linezolid|Time To Efficacy and Onset Of Action Of Linezolid In Skin and Soft Tissue Infections|Completed||Phase 4|118|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:16:51.108717|2017-10-11 05:16:51.108717
NCT00147524|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-04-26|||October 2003||2003-10-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Interventional|||Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women|Multicenter, Open-Label (Non-Comparative) Study To Evaluate Changes In Flow Mediated Dilatation During And After A 6 Months Treatment Period With Step By Step Increased Doses With Quinapril Therapy In Post-Menopausal Women With Mild Or Moderate Hypertension|Completed||Phase 4|70||Pfizer|||||f||||||||||||||2017-10-11 05:16:51.163651|2017-10-11 05:16:51.163651
NCT00147537|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-10-01|2013-01-18|2012-05-08|February 2005||2005-02-01|October 2013|2013-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer|A Phase 1b Dose Escalation/Phase 2 Randomized, Non-Comparative, Multiple Center, Open Label Study Of CP 751,871 In Combination With Paclitaxel And Carboplatin And Of Paclitaxel And Carboplatin Alone As First Line Treatment For Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|282|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:16:51.796113|2017-10-11 05:16:51.796113
NCT00147550|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-09-11|||February 2004||2004-02-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|May 2007|Actual|2007-05-01||Interventional|||MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.|A Multicenter, Open-Label, Noncomparative Phase 1-2 Clinical And Pharmacokinetic Study Of Oral PD 0325901 In Patients With Advanced Cancer|Terminated||Phase 1/Phase 2|79|Actual|Pfizer||1||See termination reason in detailed description.|f||||f||||||||||2017-10-11 05:17:05.733465|2017-10-11 05:17:05.733465
NCT00147563|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-04-14|||October 2003||2003-10-01|May 2007|2007-05-01||||May 2006|Actual|2006-05-01||Interventional|||Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT|A Double-Blind, Parallel Design Study to Compare the Effectiveness of Eplerenone Versus Atenolol in Reversing the Remodeling of Resistance Arteries in Subjects With Mild to Moderate Primary Hypertension|Completed||Phase 4|34||Pfizer|||||||||||||||||||2017-10-11 05:17:05.965648|2017-10-11 05:17:05.965648
NCT00147576|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-10-01|||December 2003||2003-12-01|October 2012|2012-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.|Randomized, Placebo-Controlled Parallel Group Study Comparing Effect Of Three Doses Of CP-866,087 And Naltrexone On Acute Alcohol Consumption And Craving After Seven Days Of Treatment In Alcohol Dependent (DSM IV) Subjects Who Are Not Currently Seeking Treatment|Completed||Phase 2|88|Actual|Pfizer|||||||||||||||||||2017-10-11 05:17:06.037895|2017-10-11 05:17:06.037895
NCT00147589|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-01-23|||September 2004||2004-09-01|March 2007|2007-03-01|January 2007|Actual|2007-01-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.|Peds I (Pediatric Eplerenone Development Study I): A Randomized, Double-Blind, Placebo Withdrawal, Parallel Group, Dose-Response Study To Evaluate The Efficacy And Safety Of Eplerenone In The Treatment Of Hypertension In Children|Completed||Phase 3|320||Pfizer|||||||||||||||||||2017-10-11 05:17:06.139969|2017-10-11 05:17:06.139969
NCT00141414|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-12-28|||November 1997||1997-11-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.|Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.|Completed||Phase 2|82||Pfizer|||||||||||||||||||2017-10-11 05:18:05.668369|2017-10-11 05:18:05.668369
NCT00147602|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-04-21|||November 1998||1998-11-01|April 2015|2015-04-01|November 2005||2005-11-01|||||Interventional|SPARCL||Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke|A Double-Blind, Randomized, Placebo- Controlled Study Of Atorvastatin As Prevention Of Cerebrovascular Events In Patients With A Previous Transient Ischemic Attack (TIA) Or Stroke|Completed||Phase 4|4732||Pfizer|||||||||||||||||||2017-10-11 05:17:06.298473|2017-10-11 05:17:06.298473
NCT00147615|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-06-04|||October 2004||2004-10-01|June 2007|2007-06-01|June 2006||2006-06-01|||||Interventional|||The Long-Term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years|Peds II (Pediatric Eplerenone Development Study II)--An Open Label, Long-Term Study To Evaluate The Safety Of Eplerenone In The Treatment Of Hypertension In Children|Completed||Phase 3|140||Pfizer|||||||||||||||||||2017-10-11 05:17:06.733704|2017-10-11 05:17:06.733704
NCT00147628|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2011-06-07|||November 2005||2005-11-01|June 2011|2011-06-01|September 2006|Actual|2006-09-01|||||Interventional|||Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire|A Multi-Center, Double-Blind Placebo Controlled, Flexible-Dose Study With An Open-Label Phase To Assess The Efficacy Of Sildenafil Citrate On Erectile Function And Intercourse Satisfaction As Well As To Validate The Sexual Experience Questionnaire And Its Treatment Responsiveness In Men With Erectile Dysfunction|Completed||Phase 4|209|Actual|Pfizer|||||||||||||||||||2017-10-11 05:17:06.827913|2017-10-11 05:17:06.827913
NCT00147654|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2011-06-07|||November 2004||2004-11-01|June 2011|2011-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction|A Randomized, Double Blind, Placebo Controlled, Four Arm (Placebo, Tolterodine ER, Tamsulosin, and Tolterodine ER Plus Tamsulosin) Study To Evaluate The Clinical Efficacy And Safety Of Tolterodine ER 4 mg In Men Who Have Frequency and Urgency, With Or Without Urinary Urge Incontinence, With Or Without Bladder Outlet Obstruction|Completed||Phase 4|830||Pfizer|||||f||||||||||||||2017-10-11 05:17:06.927984|2017-10-11 05:17:06.927984
NCT00147667|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02|||April 2004||2004-04-01|March 2004|2004-03-01|March 2006||2006-03-01|||||Interventional|||Effects of Long Term Macrolide Antibiotic Therapy in Patients With COPD|Randomised Double Blind Placebo Controlled Trial of Effects of Long Term Low Dose Oral Erythromycin Therapy in Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Active, not recruiting|Phase 2/Phase 3|120||Royal Free and University College Medical School|||||f||||||||||||||2017-10-11 05:17:07.247776|2017-10-11 05:17:07.247776
NCT00147680|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-02-01|||September 2004||2004-09-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|June 2008|Actual|2008-06-01||Interventional|||Uterine Papillary Serous Cancer (UPSC) Trial|Prospective, Non-randomised Phase 2 Clinical Trial of Carboplatin Plus Paclitaxel With Sequential Radical Pelvic Radiotherapy for Uterine Serous Papillary Cancer|Completed||Phase 2|30|Anticipated|Queensland Centre for Gynaecological Cancer||1|||f||||f||||||||||2017-10-11 05:17:07.326288|2017-10-11 05:17:07.326288
NCT00147693|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-09-30|||June 2005||2005-06-01|September 2008|2008-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?|Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?|Completed||N/A|304|Actual|Radboud University||1|||f||||||||||||||2017-10-11 05:17:07.404006|2017-10-11 05:17:07.404006
NCT00147706|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2011-07-25|||September 2004||2004-09-01|July 2011|2011-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Does Access to an EHR Patient Portal Influence Chronic Disease Outcomes?|Does Access to an EHR Patient Portal Influence Chronic Disease Outcomes? A Randomised Trial Assessing Clinical and Behavioural Change Outcomes in Patients With CHF, Diabetes, or Secondary CVD|Completed||N/A|6000|Anticipated|Robert Wood Johnson Foundation|||||f||||||||||||||2017-10-11 05:17:07.488829|2017-10-11 05:17:07.488829
NCT00147719|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-01-16|||June 2004||2004-06-01|January 2012|2012-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||WelChol® With Metformin in Treating Patients With Type 2 Diabetes|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Monotherapy or Metformin Therapy in Combination With Other Oral Anti-Diabetic Agents|Completed||Phase 3|300||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:17:07.571041|2017-10-11 05:17:07.571041
NCT00147732|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-05-06|||April 2001||2001-04-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|February 2008|Actual|2008-02-01||Interventional|||Randomized Trial of ARCON in Larynx Cancer|A Multicentre, Randomised, Phase III Clinical Trial Comparing Accelerated Radiotherapy With Accelerated Radiotherapy Plus Carbogen and Nicotinamide (ARCON) in Clinical Stage T2-4 Laryngeal Carcinoma.|Completed||Phase 3|345|Actual|Radboud University||2|||f||||||||||||||2017-10-11 05:17:07.746952|2017-10-11 05:17:07.746952
NCT00147745|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2014-03-05|2009-07-15||June 2005||2005-06-01|March 2014|2014-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes|Effects of Colesevelam on Insulin Sensitivity in Type 2 Diabetes Mellitus|Completed||Phase 2|36|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||||2017-10-11 05:17:07.877932|2017-10-11 05:17:07.877932
NCT00147758|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-01-16|||June 2004||2004-06-01|January 2012|2012-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetics With Inadequate Glycemic Control on Sulfonylurea Monotherapy or Sulfonylurea Therapy in Combination With Other Oral Anti-Diabetic Agents|Completed||Phase 3|400||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:17:08.604096|2017-10-11 05:17:08.604096
NCT00147771|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-08-01|||September 2005||2005-09-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Imiquimod in Children With Plaque Morphea|Evaluation of the Efficacy and Safety of the Imiquimod 5% Topical Cream in Plaque Morphea: A Prospective, Multiple Baseline, Open Label Pilot Study|Completed||Phase 3|10|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||||2017-10-11 05:17:08.820633|2017-10-11 05:17:08.820633
NCT00147784|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-03-26|||March 2006||2006-03-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|June 2007|Actual|2007-06-01||Interventional|||HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.|HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a Methadone Maintenance Treated (MMT) Opioid Addicted Group.|Completed||Phase 3|10|Anticipated|Sorlandet Hospital HF||1|||f||||||||||||||2017-10-11 05:17:08.895003|2017-10-11 05:17:08.895003
NCT00147797|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2016-10-24|||May 2003||2003-05-01|April 2007|2007-04-01|June 2005||2005-06-01|||||Observational|||Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy|Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy|Completed||N/A|84||Saint Antoine University Hospital|||2||f||||||||||||||2017-10-11 05:17:08.975421|2017-10-11 05:17:08.975421
NCT00147810|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-03-23|||November 2001||2001-11-01|September 2005|2005-09-01|July 2004||2004-07-01|||||Interventional|||Adult Asthma Surveillance and Intervention in a Managed Care Setting|Adult Asthma Surveillance and Intervention in a Managed Care Setting|Completed||N/A|6948||Kaiser Permanente|||||f||||||||||||||2017-10-11 05:17:09.041464|2017-10-11 05:17:09.041464
NCT00147823|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-06-04|2013-12-17||December 2004||2004-12-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Subjects were randomized|Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions|A Prospective Randomized Study Comparing Vitoss Alone Versus Vitoss With Bone Marrow Aspirate in Benign Bone Lesions|Completed||N/A|63|Actual|State University of New York - Upstate Medical University|Limitation due to incomplete follow up by subjects or unavailability of radiographs. Also difficulties in assessing the outcomes of resorption if lesions were small or there was artifact from hardware in the area.|2|||f||||t||||||||||2017-10-11 05:17:09.130432|2017-10-11 05:17:09.130432
NCT00147836|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2008-03-31|||September 2004||2004-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients|Evaluation of the Effects of Oral Anti-Hyperglycemic Agents, Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion on Glycemic Control, B-Cell Function and the Remission Rate in Newly-Diagnosed Type 2 Diabetic Patients|Completed||N/A|436|Actual|Sun Yat-sen University||3|||f||||t||||||||||2017-10-11 05:17:09.736714|2017-10-11 05:17:09.736714
NCT00147849|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-11-28|||September 2000||2000-09-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Interventional|||A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice Guidelines for Children With Croup|A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice|Terminated||N/A|||University of Calgary|||||f||||||||||||||2017-10-11 05:17:09.83422|2017-10-11 05:17:09.83422
NCT00147862|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-02-06|||May 2005||2005-05-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Interventional|||Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?|Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?|Completed||Phase 3|240||Tata Memorial Hospital|||||f||||||||||||||2017-10-11 05:17:09.928375|2017-10-11 05:17:09.928375
NCT00147875|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-09-04|||March 2004||2004-03-01|September 2009|2009-09-01||||July 2007|Actual|2007-07-01||Interventional|||Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma|PVAG - Phase I/II Dose Finding Trial in Elderly Patients (> 60 Years) With Advanced Stages Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|60|Actual|University of Cologne|||||f||||||||||||||2017-10-11 05:17:10.002162|2017-10-11 05:17:10.002162
NCT00147888|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-09-04|||March 2004||2004-03-01|September 2013|2013-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Changes in Nasal Patency With Changes in Posture, Temperature, Humidity and Nasal Patency Seen by Acoustic Rhinometry|Physiological Changes in Nasal Patency in Response to Changes in Posture, Temperature, Humidity and Nasal Patency Measured by Acoustic Rhinometry|Completed||Phase 4|15|Actual|University of Chicago||1|||f||||t||||||||||2017-10-11 05:17:10.104715|2017-10-11 05:17:10.104715
NCT00147901|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2016-09-30|||January 2005||2005-01-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2008|Actual|2008-11-01||Interventional|||Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)|Multicenter Phase II Trial of Fludarabine and Cyclophosphamide in Combination With Alemtuzumab (FC-Cam) for Patients With Relapsed Chronic Lymphocytic Leukemia - CLL-2L Protocol of the German CLL-Study Group (GCLLSG)|Completed||Phase 2|61|Actual|German CLL Study Group||1|||f||||f||||||||No||2017-10-11 05:17:10.18397|2017-10-11 05:17:10.18397
NCT00147914|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-05-01|||February 2005||2005-02-01|May 2017|2017-05-01|February 18, 2017|Actual|2017-02-18|February 2007|Actual|2007-02-01||Interventional|||Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life|A Comparison Study Between Cefdinir and Amoxicilline/Clavulanate in Patients With Acute Sinusitis and Assessment of Quality of Life (QOL)|Completed||Phase 4|100|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 05:17:10.268193|2017-10-11 05:17:10.268193
NCT00147927|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-07-31|||December 2003||2003-12-01|July 2007|2007-07-01|December 2005||2005-12-01|||||Interventional|||Using Tailored Emails to Motivate Healthy Behavior Among Employees|Using Tailored Emails to Motivate Healthy Behavior, Improve Health Status, & Reduce Health Care Costs in Employee Populations: A Randomized Trial|Completed||N/A|2000||Robert Wood Johnson Foundation|||||f||||||||||||||2017-10-11 05:17:10.350548|2017-10-11 05:17:10.350548
NCT00147940|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-06-11|||April 2004||2004-04-01|June 2013|2013-06-01|August 2005||2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Correlation of Nasal Volume, Cross-Sectional Area With Nasalance Scores Measured by Acoustic Rhinometry and Nasometry|Correlation of Nasal Volume and Cross-Sectional Area With Nasalance Scores as Measured by Acoustic Rhinometry and Nasometry|Terminated||Phase 4|20||University of Chicago|||||f||||||||||||||2017-10-11 05:17:10.413358|2017-10-11 05:17:10.413358
NCT00147953|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2010-01-26|||June 2004||2004-06-01|January 2010|2010-01-01||||||||Interventional|||Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma|A Phase II Study of Rituximab Plus Low-Dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 2|30|Anticipated|University of Cologne|||||f||||||||||||||2017-10-11 05:17:10.48026|2017-10-11 05:17:10.48026
NCT00147966|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2010-03-22|2010-03-19||June 2008||2008-06-01|June 2008|2008-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)|Assessment of the Immunomodulatory Effects of Rituximab in Seropositive Rheumatoid Arthritis Using Arthroscopic Synovial Biopsies|Completed||Phase 2|24|Actual|University of California, San Diego||1|||f||||f||||||||||2017-10-11 05:17:10.553233|2017-10-11 05:17:10.553233
NCT00147979|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-12-04|||April 2004||2004-04-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|January 2009|Actual|2009-01-01||Interventional|||Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE|Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE|Completed||N/A|596|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 05:17:10.730102|2017-10-11 05:17:10.730102
NCT00147992|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-06-02|||June 2005||2005-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Immediate Loading of Implants in Totally Edentate Upper and Lower Jaw. Trial to Evaluate Survival of the Implants and Bridges, Quality of Prosthetic Work and Patient Satisfaction|Immediate Loading of Implants in Totally Edentate Upper and Lower Jaw. A Retrospective Trial to Evaluate Survival of the Implants and Bridges, Quality of Prosthetic Work and Patient Satisfaction|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 05:17:10.801122|2017-10-11 05:17:10.801122
NCT00148005|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-12-19|||September 2004||2004-09-01|December 2007|2007-12-01||||||||Interventional|||Prevalence, Etiology and Therapy of Micturition Disorders of Children With a Mental and/or Motoric Disability|Prevalence, Etiology and Therapy of Micturition Disorders of Children With a Mental and/or Motoric Disability|Completed||N/A|250||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:17:10.865272|2017-10-11 05:17:10.865272
NCT00148018|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-07-09|||March 2005||2005-03-01|September 2006|2006-09-01||||||||Interventional|||Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma|A Phase II Study of Bortezomib in Combination With Dexamethasone in Patients With Relapsed Hodgkin's Lymphoma|Terminated||Phase 2|37||University of Cologne|||||f||||||||||||||2017-10-11 05:17:10.923347|2017-10-11 05:17:10.923347
NCT00148031|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-04-23|||September 2003||2003-09-01|April 2013|2013-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Improving Hepatitis C Treatment in Injection Drug Users|Improving Hepatitis C Treatment in Injection Drug Users|Completed||Phase 4|111|Actual|State University of New York - Upstate Medical University||2|||f||||t||||||||||2017-10-11 05:17:10.986013|2017-10-11 05:17:10.986013
NCT00148044|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-12-19|||October 2003||2003-10-01|December 2007|2007-12-01|February 2004|Actual|2004-02-01|||||Observational|||Uremic Toxins of Patients With Acute Kidney Failure|Uremic Toxins of Patients With Acute Kidney Failure|Completed||N/A|30||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:17:11.073119|2017-10-11 05:17:11.073119
NCT00148057|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-02|||January 1988||1988-01-01|August 2005|2005-08-01|December 2005||2005-12-01|||||Interventional|||Diet and Breast Cancer Prevention Trial|An Explanatory Clinical Trial of Breast Cancer Prevention|Completed||Phase 3|4695||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:17:11.12841|2017-10-11 05:17:11.12841
NCT00148070|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-10-03|||March 1999||1999-03-01|October 2012|2012-10-01|February 2006|Actual|2006-02-01|September 2004|Actual|2004-09-01||Interventional|||Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer|Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer|Completed||Phase 2|45|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:17:11.185155|2017-10-11 05:17:11.185155
NCT00148083|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-02-27|||September 2005||2005-09-01|August 2005|2005-08-01|August 2007||2007-08-01|||||Interventional|||Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia|Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia|Unknown status|Recruiting|Phase 3|60||University of Illinois at Chicago|||||f||||||||||||||2017-10-11 05:17:11.385021|2017-10-11 05:17:11.385021
NCT00148096|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-12-23|||February 2003||2003-02-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Mechanical Heat Recovery Ventilation on House Dust Mite Sensitive Asthma|Randomised Controlled Trial of Mechanical Heat Recovery Ventilation on Asthma Control of Patients Allergic to the House Dust Mite|Completed||Phase 2|119|Actual|University of Glasgow||2|||f||||f||||||||||2017-10-11 05:17:11.478598|2017-10-11 05:17:11.478598
NCT00148109|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-01-15|2011-04-12||June 2005||2005-06-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|July 2008|Actual|2008-07-01||Interventional|||Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas|Phase II Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas|Completed||Phase 2|36|Actual|University of Michigan Cancer Center|accrual to EGFR + cohort suspended after first step for lack of efficacy of cetuximab.|2|||f||||t||||||||||2017-10-11 05:17:11.609737|2017-10-11 05:17:11.609737
NCT00148122|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2014-03-28|2014-02-13||November 2002||2002-11-01|March 2014|2014-03-01|July 2010|Actual|2010-07-01|August 2008|Actual|2008-08-01||Interventional||Although 40 patients were enrolled, 2 patients withdrew consent after treatment started, therefore only 38 were included in baseline analysis.|A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer|A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients With Metastatic or Advanced, Locally, Recurrent Head and Neck Cancer|Completed||Phase 2|40|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:17:12.106796|2017-10-11 05:17:12.106796
NCT00148135|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-12-28|||May 2001||2001-05-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|April 2006|Actual|2006-04-01||Interventional|||Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site|A Phase II Trial Evaluating the Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site|Terminated||Phase 2|||University of Michigan Cancer Center||||recruitment goals met|f||||||||||||||2017-10-11 05:17:12.62946|2017-10-11 05:17:12.62946
NCT00148148|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-01-09|||May 2004||2004-05-01|January 2007|2007-01-01|December 2007||2007-12-01|||||Interventional|||A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation|Phase II Randomised Study of the Safety, Efficacy and Pharmacokinetics of Caspofungin (CAS), Liposomal Amphotericin B (LAMB) or the Combination of Caspofungin With Liposomal Amphotericin B for Patients After Stem-Cell Transplantation|Completed||Phase 2|75|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-10-11 05:17:12.698664|2017-10-11 05:17:12.698664
NCT00148161|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-04-26|||November 2004||2004-11-01|September 2006|2006-09-01||||||||Observational|||Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering|Evoked and Induced Auditory Cortical Activity During Speech Perception and Speech Production in Stuttering|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-10-11 05:17:12.773564|2017-10-11 05:17:12.773564
NCT00148174|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-05-28|||August 1998||1998-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Predictors and Intervention for Noncompliance|Predictors and Intervention for Noncompliance|Completed||N/A|273|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-10-11 05:17:12.878431|2017-10-11 05:17:12.878431
NCT00148187|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-05-28|||January 2003||2003-01-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Prediction of Medication Compliance Following Renal Transplantation|Prediction of Medication Compliance Following Renal Transplantation|Completed||N/A|30|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-10-11 05:17:12.959837|2017-10-11 05:17:12.959837
NCT00148200|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-02-17|||February 2005||2005-02-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|November 2006|Actual|2006-11-01||Observational|||Female Sexual Dysfunction: Prevalence Among Italian Healthy Women|Prevalence of Female Sexual Dysfunctions Among Healthy Women Coming to the University of Bologna Gynecology Clinic as Outpatients.|Completed||N/A|500|Actual|Unita Complessa di Ostetricia e Ginecologia|||1||f||||||||||||||2017-10-11 05:17:13.065681|2017-10-11 05:17:13.065681
NCT00148213|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||September 2003||2003-09-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Observational|||Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma|Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma|Completed||N/A|100||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:17:13.147732|2017-10-11 05:17:13.147732
NCT00148226|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2006-01-03|||November 2003||2003-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial|Randomized Controlled Trial of Patient Decision Aids for Faecal Occult Blood Test Screening|Completed||Phase 2|||University of Sydney|||||f||||||||||||||2017-10-11 05:17:13.209195|2017-10-11 05:17:13.209195
NCT00148239|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-11-30|||September 2002||2002-09-01|November 2015|2015-11-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|SCI||Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury|Caregiver Intervention for Caregivers of SCI Patients|Completed||Phase 2/Phase 3|380|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 05:17:13.268661|2017-10-11 05:17:13.268661
NCT00148252|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-06-06|||February 2003||2003-02-01|June 2012|2012-06-01|February 2007|Actual|2007-02-01|November 2005|Actual|2005-11-01||Interventional|||Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant|Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant - Randomised Withdrawal of Mycophenolate Mofetil (CellCept®) or Cyclosporine A (Sandimmun Neoral®)|Terminated||Phase 4|298||University of Oslo School of Pharmacy||||To high rejection rate in CsA withdrawal arm|f||||||||||||||2017-10-11 05:17:13.362596|2017-10-11 05:17:13.362596
NCT00148265|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-06-21|||April 2005||2005-04-01|November 2005|2005-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema|Phase II/III Multicentre Randomised Clinical Trial of Laser Treatment Plus 4 mg Intravitreal Triamcinolone Injection to Reduce Diabetic Macular Oedema|Completed||Phase 2/Phase 3|54|Actual|University of Sydney||1|||f||||t||||||||||2017-10-11 05:17:13.469663|2017-10-11 05:17:13.469663
NCT00148278|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2010-07-21|||October 1999||1999-10-01|July 2010|2010-07-01|December 2005|Actual|2005-12-01|December 2004|Actual|2004-12-01||Interventional|CATS||Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock|Prospective, Multicenter, Randomized, Double-Blind Study Comparing Safety and Efficacy of Norepinephrine Plus Dobutamine Versus Epinephrine Alone in Septic Shock.|Completed||Phase 2/Phase 3|330|Actual|University of Versailles||2|||f||||t||||||||||2017-10-11 05:17:13.558154|2017-10-11 05:17:13.558154
NCT00148291|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-01-05|||June 1999||1999-06-01|September 2005|2005-09-01||||||||Interventional|||Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer|Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|180||West Japan Thoracic Oncology Group|||||f||||||||||||||2017-10-11 05:17:13.690456|2017-10-11 05:17:13.690456
NCT00148304|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2016-06-03|||September 2005||2005-09-01|June 2016|2016-06-01|June 2008|Actual|2008-06-01|August 2007|Actual|2007-08-01||Observational|||Insulin Treatment Variation in Southwestern Diabetics|Insulin Treatment Variation in Southwestern Diabetics - Therapeutic Decision-making|Completed||N/A|1248|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:17:13.744392|2017-10-11 05:17:13.744392
NCT00148317|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-06-19|2017-02-24||June 2005||2005-06-01|June 2017|2017-06-01|November 2012|Actual|2012-11-01|February 2011|Actual|2011-02-01||Interventional|||Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma|A Sequential Phase II Trial of the Combination of Bortezomib (VELCADE), Dexamethasone (DECADRON) and Pegylated Liposomal Doxorubicin (DOXIL) Followed by High Dose Cyclophosphamide in Multiple Myeloma Patients|Completed||Phase 2|38|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-10-11 05:17:13.826279|2017-10-11 05:17:13.826279
NCT00148330|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-06-29|||May 2005||2005-05-01|May 2005|2005-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study|An Open Label Extension of the Phase II/III Clinical Trial of Intravitreal Triamcinolone on the Effects and Safety of Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment|Completed||Phase 2/Phase 3|64|Actual|University of Sydney||1|||f||||t||||||||||2017-10-11 05:17:14.27311|2017-10-11 05:17:14.27311
NCT00148343|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2011-12-22|||July 2005||2005-07-01|December 2011|2011-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Functional Electrical Stimulation for Footdrop in Hemiparesis|Functional Electrical Stimulation for Footdrop in Hemiparesis|Completed||Phase 2|110|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-10-11 05:17:14.35668|2017-10-11 05:17:14.35668
NCT00148356|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-03-31|||September 2004||2004-09-01|March 2011|2011-03-01|October 2010|Actual|2010-10-01|May 2006|Actual|2006-05-01||Interventional|ZoMaxx™ I||Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries|A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System Compared to the TAXUS™ Express2 Paclitaxel-Eluting Coronary Stent System in de Novo Coronary Artery Lesions|Completed||Phase 2/Phase 3|401|Actual|Abbott Vascular||2|||f||||t||||||||||2017-10-11 05:17:14.460141|2017-10-11 05:17:14.460141
NCT00148369|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-02-18|||June 2005||2005-06-01|February 2010|2010-02-01|September 2007|Actual|2007-09-01|November 2006|Actual|2006-11-01||Observational|||A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin|A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin|Completed||N/A|31|Actual|Amgen|||1||f||||||||||None Retained|"     none collected.   "|||2017-10-11 05:17:14.586311|2017-10-11 05:17:14.586311
NCT00148382|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-04-10|||April 2005||2005-04-01|April 2007|2007-04-01|July 2005||2005-07-01|||||Interventional|||Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects|Randomized, Double Blind, Parallel Group, Repeat Dose Pharmacokinetic and Pharmacodynamic Study of Four Doses of ATL-962 (40mg, 80mg, 120mg 240mg) in Otherwise-Healthy Obese Volunteers|Completed||Phase 1|80||Alizyme|||||f||||||||||||||2017-10-11 05:17:14.648325|2017-10-11 05:17:14.648325
NCT00148395|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-04-21|||June 2002||2002-06-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|||||Interventional|||Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.|Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.|Completed||Phase 3|280||Aktion Bronchialkarzinom e.V.|||||f||||||||||||||2017-10-11 05:17:14.702405|2017-10-11 05:17:14.702405
NCT00148408|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-04-28|||December 2003||2003-12-01|September 2006|2006-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Trial of Asthma Patient Education (TAPE)|Trial of Asthma Patient Education (TAPE)|Completed||Phase 4|600||American Lung Association Asthma Clinical Research Centers|||||f||||||||||||||2017-10-11 05:17:14.774242|2017-10-11 05:17:14.774242
NCT00148421|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2013-05-13||||||May 2013|2013-05-01||||||||Interventional|||Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.|A Study of Darbepoetin Alfa Administered Once Every 2 Weeks (Q2W) Compared With Epoetin Alfa Administered Once Every Week (QW) for the Treatment of Anemia in Subjects With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-10-11 05:17:14.870151|2017-10-11 05:17:14.870151
NCT00148434|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-26|||January 2002||2002-01-01|September 2005|2005-09-01|March 2003||2003-03-01|||||Interventional|||Study on Impact of Patient-Held Guidelines on Blood Pressure|A Pilot Randomised Controlled Trial to Assess the Impact on Blood Pressure Control of Empowering Patients to Become Involved in Their Own Blood Pressure Management.|Completed||Phase 2|300||Ashgrove Research Practice|||||f||||||||||||||2017-10-11 05:17:15.079102|2017-10-11 05:17:15.079102
NCT00148447|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-05-02|||November 2004||2004-11-01|February 2007|2007-02-01|September 2005||2005-09-01|||||Interventional|||The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia|Placebo-Controlled Trial of Cipralex in the Treatment of Negative Symptoms in Schizophrenia|Completed||Phase 3|40||BeerYaakov Mental Health Center|||||f||||f||||||||||2017-10-11 05:17:15.147713|2017-10-11 05:17:15.147713
NCT00148460|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-10-28|||March 2001||2001-03-01|October 2013|2013-10-01|February 2006||2006-02-01|||||Interventional|||Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction|A Randomised, Open-label, Multi-center, Angiographic Trial to Compare the Efficacy and Safety of Single Bolus of Tenecteplase (Metalyse®) With Accelerated Infusion of Alteplase in Asian Patients With Acute Myocardial Infarction|Completed||Phase 3|270||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:17:15.213694|2017-10-11 05:17:15.213694
NCT00148473|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||March 2000||2000-03-01|September 2005|2005-09-01|October 2001||2001-10-01|||||Interventional|||Oral Versus Vaginal Misoprostol for Induction of Labor|A Single Dose of Oral Versus Vaginal Misoprostol for Induction of Labor: A Randomized Controlled Trial|Completed||Phase 2/Phase 3|180||Bangkok Metropolitan Administration Medical College and Vajira Hospital|||||f||||||||||||||2017-10-11 05:17:15.310522|2017-10-11 05:17:15.310522
NCT00148486|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-10-28|||June 2003||2003-06-01|October 2013|2013-10-01||||March 2005|Actual|2005-03-01||Interventional|||A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)|A Fourteen-week Placebo-controlled Dose-response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)|Completed||Phase 2|261||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:17:15.380948|2017-10-11 05:17:15.380948
NCT00148499|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-10-30|||October 2005||2005-10-01|October 2013|2013-10-01|June 2006||2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis|Efficacy and Tolerability of Ambroxol Lozenge 20 mg in Relieving Pain of Sore Throat in Patients With Acute Viral Pharyngitis-A Randomised, Double-blind,Placebo- and Active-controlled Parallel Group Study|Completed||Phase 3|751||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:17:15.617252|2017-10-11 05:17:15.617252
NCT00148512|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-10-28|||March 2003||2003-03-01|October 2013|2013-10-01|February 2005||2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations|A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Exploratory Study of NS 2330 (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations (Study for Proof of Concept in ADVAnced Parkinson Disease of NS 2330 / ADVANS)|Completed||Phase 2|254|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:17:15.716786|2017-10-11 05:17:15.716786
NCT00148525|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-07-01|||July 2006||2006-07-01|June 2011|2011-06-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|||The Study of Automated Telephone Programs for the Maintenance of Dietary Change|Trial of 2 TeleComputer Diet Change Maintenance Programs|Completed||Phase 1|1049|Actual|Boston Medical Center||3|||f||||t||||||||||2017-10-11 05:17:15.901033|2017-10-11 05:17:15.901033
NCT00148538|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-02-25|||July 2005||2005-07-01|February 2013|2013-02-01|April 2012|Actual|2012-04-01|December 2010|Actual|2010-12-01||Interventional|||Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)|Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)|Completed||Phase 2/Phase 3|66|Actual|Ottawa Hospital Research Institute||1|||f||||||||||||||2017-10-11 05:17:15.994574|2017-10-11 05:17:15.994574
NCT00148551|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-07-26|||January 2004||2004-01-01|July 2007|2007-07-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.|Triamcinolone Acetonide as an Adjunctive Treatment to Verteporfin Therapy in Neovascular Age-Related Macular Degeneration: Randomized Placebo-Controlled Clinical Trial.|Unknown status|Active, not recruiting|Phase 2/Phase 3|120|Anticipated|Canadian Retinal Trials Group|||||f||||||||||||||2017-10-11 05:17:16.116724|2017-10-11 05:17:16.116724
NCT00148564|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-09-26|||March 2004||2004-03-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Energy Homeostasis Under Treatment With Atypical Antipsychotics|Energy Homeostasis and Metabolism in Patients With Schizophrenic Disorders Under Treatment With Atypical Antipsychotics|Completed||Phase 4|40|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 05:17:16.235287|2017-10-11 05:17:16.235287
NCT00288769|ClinicalTrials.gov processed this data on October 10, 2017|2006-02-07|2009-01-22|||March 2006||2006-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Oral Vitamin B12 as Potential Treatment of Recurrent Aphthous Stomatitis||Completed||N/A|||Soroka University Medical Center||1|||f||||||||||||||2017-10-11 06:00:52.256693|2017-10-11 06:00:52.256693
NCT00148577|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||August 2002||2002-08-01|September 2005|2005-09-01|December 2003||2003-12-01|||||Observational|||Pain Relief by Applying TENS on Acupuncture Points During the First Stage of Labour|Pain Relief by Applying Transcutaneous Electrical Nerve Stimulation (TENS) on Acupuncture Points During the First Stage of Labour: a Randomised Controlled Trial|Unknown status|Active, not recruiting|Phase 3|100||Chang Gung Memorial Hospital|||||f||||||||||||||2017-10-11 05:17:16.341829|2017-10-11 05:17:16.341829
NCT00148590|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-10-17|||November 2005||2005-11-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Memantine for the Prevention of Negative Symptomatology|Memantine for the Prevention of Negative Symptomatology and Cognitive Impairment in Schizophrenia|Terminated||Phase 3|40|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 05:17:16.415289|2017-10-11 05:17:16.415289
NCT00148603|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-12-26|||September 2005||2005-09-01|December 2011|2011-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Montelukast in the Treatment of Duodenal Eosinophilia|Montelukast in the Treatment of Duodenal Eosinophilia in Children With Dyspepsia: Effect on Eosinophil Density and Activation in Relation to Pharmacokinetics|Completed||N/A|24|Anticipated|Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:17:16.504091|2017-10-11 05:17:16.504091
NCT00148616|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-10-17|||April 2004||2004-04-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Memantine for the Treatment of Negative Symptomatology|Memantine for the Treatment of Negative Symptomatology and Cognitive Impairment in Schizophrenia|Terminated||Phase 3|40|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 05:17:16.582832|2017-10-11 05:17:16.582832
NCT00148629|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-11-16|||April 2004||2004-04-01|September 2005|2005-09-01||||||||Interventional|||Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women|Preventing Unnecessary Blood Transfusions in Pregnant Women in Africa Through Effective Primary Health Care|Unknown status|Active, not recruiting|Phase 3|2500||Cornell University|||||f||||||||||||||2017-10-11 05:17:16.685747|2017-10-11 05:17:16.685747
NCT00148642|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-01-14|||November 2002||2002-11-01|January 2017|2017-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|NASCENT||Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)|Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)|Completed||Phase 3|2003|Actual|C. R. Bard||2|||f||||t||||||||||2017-10-11 05:17:16.782429|2017-10-11 05:17:16.782429
NCT00148655|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-12-22|||May 2003||2003-05-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Educational Interventions for Patients With DCIS|A Randomized Trial for Educational Interventions for Patients With DCIS Actually Making Treatment Decisions|Completed||N/A|120|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:17:16.90029|2017-10-11 05:17:16.90029
NCT00148668|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-03-29|2012-12-19||December 2003||2003-12-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|January 2009|Actual|2009-01-01||Interventional|||Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer|A Randomized Phase II Study of Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in Early Stage, HER-2 Positive Breast Cancer|Completed||Phase 2|81|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 05:17:17.024311|2017-10-11 05:17:17.024311
NCT00148681|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-10-30|||May 2001||2001-05-01|October 2009|2009-10-01|April 2010|Anticipated|2010-04-01|May 2003|Actual|2003-05-01||Interventional|||Preoperative Herceptin and Navelbine for Breast Cancer|Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer|Unknown status|Active, not recruiting|Phase 2|49|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 05:17:17.35756|2017-10-11 05:17:17.35756
NCT00148694|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-08-29|||July 2004||2004-07-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|May 2006|Actual|2006-05-01||Interventional|||Preoperative Cisplatin in Early Stage Breast Cancer|A Phase II Trial of Cisplatin in Early Stage ER-, PR-, HER-2 Negative Breast Cancer|Completed||Phase 2|27|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 05:17:17.478682|2017-10-11 05:17:17.478682
NCT00148707|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-12-19|||October 2004||2004-10-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer|Phase II Study of CT-2103 in Patients With Metastatic Breast Cancer|Completed||Phase 2|45||Dana-Farber Cancer Institute|||||||||||||||||||2017-10-11 05:17:17.569589|2017-10-11 05:17:17.569589
NCT00148720|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-11-09|||September 2004||2004-09-01|November 2015|2015-11-01||||September 2007|Actual|2007-09-01||Interventional|||Capecitabine in Women With Operable Breast Cancer|A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer|Terminated||Phase 2|80|Anticipated|Dana-Farber Cancer Institute||1||Slow accrual|f||||||||||||||2017-10-11 05:17:17.671173|2017-10-11 05:17:17.671173
NCT00148733|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-01-30|2015-02-02||January 2004||2004-01-01|January 2017|2017-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia|Community- and Health Facility-based Intervention With Zinc as Adjuvant Therapy for Pneumonia to Enhance Child Health and Nutrition|Completed||Phase 2/Phase 3|2628|Actual|Centre For International Health||2|||f||||t||||||||No||2017-10-11 05:17:17.787467|2017-10-11 05:17:17.787467
NCT00148746|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-06-08|||May 2004||2004-05-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|September 2006|Actual|2006-09-01||Interventional|||Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis|Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis|Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:17:18.030891|2017-10-11 05:17:18.030891
NCT00148759|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-11-08|2009-11-24||June 2005||2005-06-01|November 2013|2013-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|LPVGenderPK||Kaletra Sex/Gender Pharmacokinetics (PK) Study|A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir: A 24-hour Pharmacokinetic Profile to Evaluate Sex Differences|Completed||Phase 4|23|Actual|Emory University||2|||f||||f||||||||||2017-10-11 05:17:18.101989|2017-10-11 05:17:18.101989
NCT00148772|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-06-24|||August 2005||2005-08-01|August 2005|2005-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy|Phase II Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising PSA on Hormone Therapy|Completed||Phase 2|29|Anticipated|NorthShore University HealthSystem Research Institute|||||f||||||||||||||2017-10-11 05:17:18.550951|2017-10-11 05:17:18.550951
NCT00148785|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-11-08|||July 2005||2005-07-01|November 2013|2013-11-01|January 2007|Actual|2007-01-01|||||Interventional|||A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir|Pharmacokinetics of an Indinavir, Ritonavir and Amprenavir Regimen in HIV-Infected Individuals: A Pilot Study|Completed||Phase 4|15|Anticipated|Emory University|||||f||||||||||||||2017-10-11 05:17:18.649251|2017-10-11 05:17:18.649251
NCT00148798|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-06-13|2011-08-24||October 2004||2004-10-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|July 2007|Actual|2007-07-01||Interventional|FLEX||Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)|Open, Randomized, Controlled, Multicenter Phase III Study Comparing Cisplatin/Vinorelbine Plus Cetuximab Versus Cisplatin/Vinorelbine as First-line Treatment for Patients With Epidermal Growth Factor Receptor Expressing (EGFR-expressing) Advanced NSCLC.|Completed||Phase 3|1861|Actual|Merck KGaA||2|||f||||t||||||||||2017-10-11 05:17:18.788817|2017-10-11 05:17:18.788817
NCT00148824|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-03-20|||February 2003||2003-02-01|March 2008|2008-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.|Immunological Efficacy of a Prime-Boost Strategy Combining a 7-Valent Pneumococcal Conjugate Vaccine (PCV) Followed by a 23-Valent Pneumococcal Polysaccharide Vaccine (PPV) Versus PPV Alone in HIV-Infected Adults. ANRS 114 PNEUMOVAC.|Completed||Phase 2|212||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:17:22.619957|2017-10-11 05:17:22.619957
NCT00148837|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-02-06|||September 2004||2004-09-01|February 2008|2008-02-01||||||||Interventional|||Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis|Randomized Double Blind Trial Comparing the Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin for Initial Treatment of Patients With Hepatitis C With Genotype 1 or 4 and Severe Fibrosis|Unknown status|Active, not recruiting|Phase 2|112|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||f||||||||||2017-10-11 05:17:22.716802|2017-10-11 05:17:22.716802
NCT00148850|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-10-19|||February 2003||2003-02-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients|A Randomized, Phase 3, Double Blind, Multicentre Trial, Evaluating the Effect of Pioglitazone Versus Placebo on Change in Lipoatrophy in HIV- 1 Infected Patients Treated With Stable Antiretroviral Therapy for at Least 6 Months.ANRS 113 LIPIOT Study|Terminated||Phase 3|130||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:17:22.799731|2017-10-11 05:17:22.799731
NCT00148863|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-08-29|||June 2004||2004-06-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C|Pilot Study on Interferon Gamma in Association With Peg-Interferon Alpha 2a and Ribavirin Among Patients With a Chronic Hepatitis C and Non Responders to the Association of Peg-Interferon Alpha 2b or 2a and Ribavirin ANRS HC16 Gammatri|Completed||Phase 2|65||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:17:24.060958|2017-10-11 05:17:24.060958
NCT00148876|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-02-22|||September 2003||2003-09-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||TBP Study With Capecitabine Plus Minus Trastuzumab|A Multicenter Randomized Phase III Study to Compare Capecitabine Alone or in Combination With Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer and Progression After Previous Treatment With Trastuzumab|Completed||Phase 3|482|Anticipated|German Breast Group||2|||f||||t||||||||||2017-10-11 05:17:24.147374|2017-10-11 05:17:24.147374
NCT00148889|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-02-10|||July 2005||2005-07-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Double-Blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical Dystonia|Prospective,Randomised, Double-Blind, Multicenter Study to Assess the Efficacy and Safety of Bilateral Globus Pallidus Internus - in Patients With Medically Refractory Primary Cervical Dystonia|Completed||Phase 3|63|Actual|German Parkinson Study Group (GPS)||2|||f||||f||||||||||2017-10-11 05:17:24.221462|2017-10-11 05:17:24.221462
NCT00148902|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-10-06|||April 2003||2003-04-01|October 2008|2008-10-01||||||||Interventional|||Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)|A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Docetaxel (TAXOTERE)|Completed||Phase 1|50||GlaxoSmithKline|||||||||||||||||||2017-10-11 05:17:24.323367|2017-10-11 05:17:24.323367
NCT00148915|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-11-04|||August 2005||2005-08-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo|A One Year, Parallel, Placebo-controlled, Double-blind, Randomized Study to Assess the Effect of Monthly 150 mg Oral Ibandronate Dosing Versus Placebo on Bone Quality and Strength at the Proximal Femur in Women With Osteoporosis|Completed||Phase 4|98|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-10-11 05:17:24.386812|2017-10-11 05:17:24.386812
NCT00148928|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-06-01|||March 1, 2005|Actual|2005-03-01|June 2017|2017-06-01|November 7, 2006|Actual|2006-11-07|November 7, 2006|Actual|2006-11-07||Interventional|||Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA|A Multicenter, Open-label Phase I/II Trial to Evaluate the Safety and Activity of CPC-P501 Protein Formulated With the Adjuvant AS15 as First-line Treatment in Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA|Completed||Phase 1|25|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:17:24.495769|2017-10-11 05:17:24.495769
NCT00148954|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-01-10|2011-10-07||July 2005||2005-07-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|March 2009|Actual|2009-03-01||Interventional|||RIGHT: Rhythm ID Going Head-to-Head Trial|Rhythm ID Going Head-to-head Trial|Completed||Phase 4|1962|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-11 05:17:24.836121|2017-10-11 05:17:24.836121
NCT00148980|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-04-27|||April 2003||2003-04-01|February 2006|2006-02-01||||||||Interventional|||Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation|Creation of Bone Marrow Microenvironment for Treatment of MDS in Conjunction With Allogeneic Stem Cell Transplantation|Withdrawn||Phase 2|24|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-10-11 05:17:25.226912|2017-10-11 05:17:25.226912
NCT00148993|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-04-07|||July 1998||1998-07-01|July 2005|2005-07-01|July 2005|Anticipated|2005-07-01|||||Interventional|||Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors|Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors|Withdrawn||Phase 1/Phase 2|100|Anticipated|Hadassah Medical Organization||||PI (Prof. Slavin) not longer work at Hadassah|f||||||||||||||2017-10-11 05:17:25.295299|2017-10-11 05:17:25.295299
NCT00149006|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-03-13|||December 1996||1996-12-01|September 2005|2005-09-01||||||||Interventional|||Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors|Tumor-Selective and Systemic Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With rIL-2 and Non-Myeloablative Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|100|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:17:25.36109|2017-10-11 05:17:25.36109
NCT00149019|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-04-07|||May 2002||2002-05-01|September 2005|2005-09-01|September 2005|Anticipated|2005-09-01|||||Interventional|||Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.|Innovative Approaches for Targeted Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.|Withdrawn||Phase 2|12|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-10-11 05:17:25.430953|2017-10-11 05:17:25.430953
NCT00149032|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-04-07|||August 2001||2001-08-01|September 2005|2005-09-01||||||||Interventional|||Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host|Treatment of Patients With Resistant Cancer/ Post Allogeneic Stem Cell Transplantation With Donor Lymphocytes Sensitized by Antigens Expressed by the Host|Withdrawn||Phase 2|50|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:17:25.494699|2017-10-11 05:17:25.494699
NCT00149045|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-11-06|||November 2001||2001-11-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Follow up and Observation of Charcot Marie Tooth Disease in Families|Clinical and Genetic Features of Familial Neuropathy|Completed||N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:17:25.55329|2017-10-11 05:17:25.55329
NCT00149058|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||October 2005||2005-10-01|September 2005|2005-09-01|January 2008||2008-01-01|||||Interventional|||Erythropoietin in Acute Myocardial Infarction|A Phase II Randomised Trial to Investigate the Safety and Efficacy of Recombinant Human Erythropoietin on Infarct Size in Patients Undergoing Primary Percutaneous Coronary Angioplasty for ST-Segment Elevation Myocardial Infarction|Unknown status|Not yet recruiting|Phase 2|124||Hammersmith Hospitals NHS Trust|||||f||||||||||||||2017-10-11 05:17:25.600931|2017-10-11 05:17:25.600931
NCT00149071|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-11-02|||March 2004||2004-03-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Transcranial Magnetic Stimulation (rTMS) Accelerates the Response to Escitalopram in Major Depression|Treatment of Therapy-Resistant Major Depression With Transcranial Stimulation rTMS in Combination With Escitalopram|Completed||N/A|61|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-10-11 05:17:25.671232|2017-10-11 05:17:25.671232
NCT00149084|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-09-08|||April 2003||2003-04-01|September 2005|2005-09-01||||||||Interventional|||Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori|Pharmacogenomics-Based Tailor-Made Strategy for Eradication of Helicobacter Pylori|Unknown status|Recruiting|Phase 3|296||Hamamatsu University|||||f||||||||||||||2017-10-11 05:17:25.746469|2017-10-11 05:17:25.746469
NCT00149097|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-05-06|||March 2005||2005-03-01|May 2008|2008-05-01|January 2007|Actual|2007-01-01|||||Observational|||Role of the Autonomic Nervous System in HIV-Lipodystrophy|Autonomic Nervous System Activity in the Pathogenesis of the Lipodystrophy Syndrome in HIV-Infected Patients.|Completed||N/A|54|Actual|Hannover Medical School|||2||f||||f||||||Samples Without DNA|"     Serum and Plasma   "|||2017-10-11 05:17:25.828571|2017-10-11 05:17:25.828571
NCT00149110|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-08-04|||September 2005||2005-09-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Chronos: the Use of Chronobiological Treatment in Depression|"The CHRONOS Study: Can the Sleep-deprivation Induced Antidepressive Effect in Patients With Major Depression be Sustained by Correction of Diurnal Rhythms, Long Term Light Treatment and Duloxetine Treatment?"|Completed||N/A|75|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-10-11 05:17:25.883825|2017-10-11 05:17:25.883825
NCT00149123|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-02-11|||April 2005||2005-04-01|October 2007|2007-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Low-dose Hydrocortisone in Acutely Burned Patients|Low-dose Hydrocortisone in the Treatment of the Shock of Burned Patients|Completed||Phase 4|40|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:17:25.969558|2017-10-11 05:17:25.969558
NCT00149136|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-04-26|||August 2002||2002-08-01|April 2007|2007-04-01||||||||Interventional|||Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.|Evaluation of Imatinib (GLIVEC) After Induction Therapy in Patients Aged More Than 55 Years With Philadelphia Positive Acute Lymphoblastic Leukaemia (Ph+ ALL) : a Non Randomised, Controlled, Open, Multicentric, International Phase II Clinical Study (CSTI 571 AFR09 Trial)|Unknown status|Active, not recruiting|Phase 2|30||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:17:26.027143|2017-10-11 05:17:26.027143
NCT00149149|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-07-16|||May 2005||2005-05-01|September 2005|2005-09-01||||||||Interventional|||Effect of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers|Use of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers Taking Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)|Unknown status|Recruiting|Phase 1|12|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:17:26.093682|2017-10-11 05:17:26.093682
NCT00149162|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-02-11|||March 2005||2005-03-01|February 2009|2009-02-01|March 2012|Anticipated|2012-03-01|December 2010|Anticipated|2010-12-01||Interventional|Elam02||Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2|Multicenter Protocol in Treating Patients With Childhood Acute Myeloid Leukemia. Randomized Study of Maintenance Treatment With Interleukin-2|Unknown status|Recruiting|Phase 3|580|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:17:26.186043|2017-10-11 05:17:26.186043
NCT00141622|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-05-14|||April 2005||2005-04-01|August 2005|2005-08-01|October 2006||2006-10-01|||||Interventional|||Sodium-Endothelial Function-CKD Study|Does Sodium Affect Endothelial Function in Individuals With Chronic Kidney Disease?|Completed||N/A|50|Anticipated|St George's, University of London|||||f||||||||||||||2017-10-11 05:18:17.095488|2017-10-11 05:18:17.095488
NCT00149175|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-03-12|||December 2002||2002-12-01|March 2010|2010-03-01|October 2007|Anticipated|2007-10-01|||||Observational|||Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment|Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment|Unknown status|Recruiting|Phase 1|4000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||3||f||||||||||||||2017-10-11 05:17:26.324118|2017-10-11 05:17:26.324118
NCT00149188|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-06-18|||February 2004||2004-02-01|June 2012|2012-06-01||||||||Interventional|||Somatuline Autogel: Acromegaly Self/Partner Injection Study|A Phase IV, Multicentre, Open Label, Controlled Study to Assess the Ability of Patients With Acromegaly, or Their Partners, to Administer Somatuline Autogel.|Completed||Phase 4|30||Ipsen|||||f||||||||||||||2017-10-11 05:17:26.642096|2017-10-11 05:17:26.642096
NCT00149201|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-02-02|||November 2002||2002-11-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis|Randomized Phase III Study of 5-FU Continuous Infusion (5FUci) Versus MTX+5-FU Sequential Therapy (MF) in Gastric Cancer With Peritoneal Metastasis (JCOG0106-MF, MF/5FU)|Completed||Phase 3|160||Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:17:26.790929|2017-10-11 05:17:26.790929
NCT00149214|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-03-15|2009-02-11||September 2005||2005-09-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|February 2008|Actual|2008-02-01||Interventional|||Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens|A Randomized Phase 2 Trial of Doxorubicin Plus Pemetrexed Followed by Docetaxel, Versus Doxorubicin Plus Cyclophosphamide Followed by Docetaxel, as Neoadjuvant Treatment for Early Breast Cancer|Completed||Phase 2|257|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:17:26.980969|2017-10-11 05:17:26.980969
NCT00149227|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-12-09|2011-07-05||January 2004||2004-01-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)|Add-on Effects of Valsartan on Morbi- Mortality in High Risk Hypertension|Completed||Phase 4|3031|Actual|Kyoto Prefectural University of Medicine|The study was performed using PROBE design, which does not exclude possible bias for softer endpoints such as angina and TIA. However, all softer endpoints were diagnosed by CAG and CT/MRI. We believe that under reporting would be unlikely.|2|||f||||t||||||||||2017-10-11 05:17:28.425563|2017-10-11 05:17:28.425563
NCT00149240|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-09-29|||January 2005||2005-01-01|July 2007|2007-07-01|September 2005||2005-09-01|||||Interventional|||Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome|A Phase II, Multicentre, Randomised, Double-blind, Parallel and Controlled With Placebo Pilot Study to Evaluate the Efficacy and Safety of a Single Dose of Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment, in Patients With Primary Myofascial Syndrome of Cervical and Dorsal Localisation|Completed||Phase 2|24||Ipsen|||||f||||||||||||||2017-10-11 05:17:28.910148|2017-10-11 05:17:28.910148
NCT00149253|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||December 2004||2004-12-01|October 2004|2004-10-01|May 2005||2005-05-01|||||Interventional|||Pre-Emptive Analgesia Efficacy of Etoricoxib for Postoperative Pain|A Randomized, Double-Blind, Controlled Trial of Etoricoxib as a Pre-Emptive Analgesic for Abdominal Hysterectomy|Completed||Phase 3|50||Khon Kaen University|||||f||||||||||||||2017-10-11 05:17:29.017854|2017-10-11 05:17:29.017854
NCT00149266|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-02-02|||July 1995||1995-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)|Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)|Terminated||Phase 3|167|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:17:29.086658|2017-10-11 05:17:29.086658
NCT00149279|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-09-20|||July 1995||1995-07-01|September 2016|2016-09-01|April 2006||2006-04-01|||||Interventional|||A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer|Randomized Controlled Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer (JCOG9501)|Completed||Phase 3|520||Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:17:29.161308|2017-10-11 05:17:29.161308
NCT00132899|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2013-12-10|||December 2005||2005-12-01|December 2005|2005-12-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|||COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)|A Phase III Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Multi-Centre Study to Evaluate the Safety and Efficacy of Infliximab in Combination With Methotrexate for the Long-term Treatment of Crohn's Disease (CD)|Completed||Phase 3|128|Actual|University of Western Ontario, Canada||2|||f||||t||||||||||2017-10-11 05:17:29.251823|2017-10-11 05:17:29.251823
NCT00132912|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2017-05-23|||August 30, 2005|Actual|2005-08-30|May 2017|2017-05-01|January 28, 2007|Actual|2007-01-28|January 28, 2007|Actual|2007-01-28||Interventional|||Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention|Completed||Phase 2|1030|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:17:29.345551|2017-10-11 05:17:29.345551
NCT00132925|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2011-01-10|||November 2003||2003-11-01|January 2011|2011-01-01|February 2006||2006-02-01|||||Interventional|||An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis|An Efficacy and Safety Evaluation of Nasacort AQ 110 µg QD Children Ages 2-5 Years With Perennial Allergic Rhinitis|Completed||Phase 3|460||Sanofi|||||f||||||||||||||2017-10-11 05:17:29.499055|2017-10-11 05:17:29.499055
NCT00132938|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2011-06-07|||January 2004||2004-01-01|June 2011|2011-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis|An Open-label, Randomized, Multicenter, Clinical Study to Compare the Effects of Telithromycin, Azithromycin and Cefuroxime Axetil on the Penicillin or Macrolide Resistance of Streptococcus Pneumoniae in Patients With Acute Exacerbation of Chronic Bronchitis|Completed||Phase 4|5660||Sanofi|||||f||||||||||||||2017-10-11 05:17:29.662674|2017-10-11 05:17:29.662674
NCT00132951|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2009-08-26|||October 2004||2004-10-01|August 2009|2009-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|KEYS||KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections|A Randomized, Investigator Blinded, Multi-Center Clinical Study To Compare Patient Outcomes and Clinical Effectiveness of Telithromycin Versus Azithromycin in Outpatients With Lower Respiratory Tract Infections|Terminated||Phase 4|2051|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:17:29.760643|2017-10-11 05:17:29.760643
NCT00132977|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2015-04-13|||July 2005||2005-07-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|RethinQ||RethinQ Study - Evaluating Pacing in Heart Failure Patients|Resynchronization Therapy in Normal QRS (RethinQ) Clinical Investigation|Completed||Phase 3|250|Actual|St. Jude Medical||2|||f||||t||||||||||2017-10-11 05:17:30.027802|2017-10-11 05:17:30.027802
NCT00132990|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2007-01-11|||February 2003||2003-02-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||A Multicenter Pilot Study of Pallidal Deep Brain Stimulation for Cervical Dystonia|A Multicenter Pilot Study of Pallidal Deep Brain Stimulation of Cervical Dystonia|Unknown status|Active, not recruiting|N/A|10||University of Calgary|||||f||||||||||||||2017-10-11 05:17:30.268711|2017-10-11 05:17:30.268711
NCT00133003|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2008-04-12|||March 2003||2003-03-01|April 2008|2008-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)|Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of the Glycoprotein IIb/IIIa Inhibition With Abciximab in Patients With ACS Undergoing Coronary Stenting After Pretreatment With a High Loading Dose of Clopidogrel (ISAR-REACT-2)|Completed||Phase 4|2022|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:17:30.356218|2017-10-11 05:17:30.356218
NCT00133016|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2015-12-01|||August 2006||2006-08-01|December 2015|2015-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Efficacy of Early Amniotomy for Induction of Labor|The Efficacy of Early Amniotomy for Induction of Labor|Withdrawn||N/A|0|Actual|University of Pennsylvania||||no funding|f||||||||||||||2017-10-11 05:17:30.448498|2017-10-11 05:17:30.448498
NCT00133029|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2016-08-12|||July 2004||2004-07-01|August 2016|2016-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity||Terminated||Phase 4|||University of Pennsylvania|||||f||||||||||||||2017-10-11 05:17:30.505648|2017-10-11 05:17:30.505648
NCT00133042|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2011-09-16|||December 2004||2004-12-01|February 2009|2009-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma||Completed||Phase 4|16||University of Florida|||||||||||||||||||2017-10-11 05:17:30.557658|2017-10-11 05:17:30.557658
NCT00133055|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2011-08-15|||July 2005||2005-07-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Parenting Matters: Helping Parents With Young Children|Parenting Matters: Helping Parents With Young Children|Completed||Phase 2|548|Actual|University of Western Ontario, Canada||2|||f||||||||||||||2017-10-11 05:17:30.627305|2017-10-11 05:17:30.627305
NCT00133068|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2016-05-10|||March 2005||2005-03-01|May 2016|2016-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Collaboration to Reduce Disparities in Hypertension|Collaboration to Reduce Disparities in Hypertension|Completed||Phase 4|802|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 05:17:30.708596|2017-10-11 05:17:30.708596
NCT00133081|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-17|2005-10-20|||October 2002||2002-10-01|March 2004|2004-03-01|August 2006||2006-08-01|||||Interventional|||Study to Improve the Treatment of Epilepsy (SITE)|Study to Improve the Treatment of Epilepsy (SITE). A Randomized Study Comparing Adjustment of Treatment to Reduce Side Effects of Antiepileptic Drugs With Continuing Treatment Unchanged|Unknown status|Active, not recruiting|Phase 4|255||UMC Utrecht|||||f||||||||||||||2017-10-11 05:17:30.79731|2017-10-11 05:17:30.79731
NCT00133094|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2015-04-06|||June 2006||2006-06-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Systematic Management of High Cholesterol Utilizing Computer Monitoring|Management of Hypercholesterolemia Utilizing a Case Management System, Incorporating Computer-Based Decision Support Technology|Completed||N/A|220|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:17:30.873193|2017-10-11 05:17:30.873193
NCT00133107|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2011-08-18|||January 2005||2005-01-01|August 2011|2011-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus|A Single Center, Open-label, Pilot Study Evaluating the Safety and Effectiveness of Subcutaneous Efalizumab in the Treatment of Oral Lichen Planus|Completed||N/A|4|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-10-11 05:17:30.950501|2017-10-11 05:17:30.950501
NCT00133133|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2006-12-18|||July 2005||2005-07-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Efficacy and Safety of ALGRX 4975 in the Treatment of Postoperative Pain After Gall Bladder Removal|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Open Cholecystectomy|Completed||Phase 2|40||AlgoRx Pharmaceuticals|||||f||||||||||||||2017-10-11 05:17:31.028723|2017-10-11 05:17:31.028723
NCT00133146|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2010-06-16|||September 2005||2005-09-01|September 2009|2009-09-01||||||||Interventional|||Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine|A Double-Blind Phase IIa Study to Demonstrate the Contribution of MPL to Tyrosine Adsorbed Grass/Rye Pollen Allergoid (Grass MATA) With a Single-Blind Portion to Evaluate the Residual Allergenicity in Skin Test in Volunteers Allergic to Grass and Rye Pollen|Completed||Phase 2|40||Allergy Therapeutics|||||||||||||||||||2017-10-11 05:17:31.094339|2017-10-11 05:17:31.094339
NCT00133159|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2010-06-16|||September 2005||2005-09-01|June 2010|2010-06-01||||||||Interventional|||Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen|A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Grass/Rye Pollen Allergoid With MPL in Patients Sensitized to Grass and Rye Pollen|Completed||Phase 2|68||Allergy Therapeutics|||||||||||||||||||2017-10-11 05:17:31.167041|2017-10-11 05:17:31.167041
NCT00133172|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-09-05|||July 2005||2005-07-01|September 2014|2014-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection|Evaluation of the Long-term Safety and Efficacy of a Tacrolimus-based 5-day Steroid Rapid Withdrawal Immunoprophylactic Regimen in de Novo Renal Transplantation|Terminated||Phase 4|85|Actual|Astellas Pharma Inc||2||Varience of supply chain from that required by protocol|f||||t||||||||||2017-10-11 05:17:31.238722|2017-10-11 05:17:31.238722
NCT00133185|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2013-11-18|||March 2004||2004-03-01|November 2013|2013-11-01|March 2005||2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension|A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5 mg in Comparison With Losartan 50 mg Plus Hydrochlorothiazide 12.5 mg in Taiwanese Patients With Mild to Moderate Hypertension|Completed||Phase 3|31||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:17:31.358373|2017-10-11 05:17:31.358373
NCT00133198|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2013-11-07|||April 2004||2004-04-01|November 2013|2013-11-01|February 2005||2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)|A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Trial Comparing Fixed Doses of 0.25 mg, 0.50 mg and 0.75 mg Pramipexole (Mirapex®) Administered Orally to Investigate the Safety and Efficacy in Patients With Idiopathic Restless Legs Syndrome for 12 Weeks|Completed||Phase 3|345|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:17:31.424463|2017-10-11 05:17:31.424463
NCT00133211|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2015-03-05|||September 2005||2005-09-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MANTRA-PAF||Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation|Medical Antiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: A Randomized Prospective Multicentre Study (MANTRA-PAF)|Completed||Phase 3|294|Actual|Danish Heart Foundation||2|||f||||t||||||||||2017-10-11 05:17:31.569288|2017-10-11 05:17:31.569288
NCT00133224|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2008-09-19|||July 2005||2005-07-01|September 2008|2008-09-01|June 2009|Anticipated|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients|A Phase III Randomized, Open-Label Study of Docetaxel in Combination With CG1940 and CG8711 Versus Docetaxel and Prednisone in Taxane-Naïve Patients With Metastatic Hormone-Refractory Prostate Cancer With Pain|Terminated||Phase 3|408|Actual|Cell Genesys||2||Accrual and treatment with CG1940/CG8711 stopped due to IDMC recommendation.|f||||||||||||||2017-10-11 05:17:31.655767|2017-10-11 05:17:31.655767
NCT00133237|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2010-03-12|||July 2005||2005-07-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)|Prospective, Randomized Trial of the Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent for the Treatment of Unprotected Left Main Coronary Artery Disease(ISAR-LEFT-MAIN)|Completed||Phase 4|607|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:17:32.104164|2017-10-11 05:17:32.104164
NCT00133250|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-20|2010-03-15|||June 2003||2003-06-01|March 2010|2010-03-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)|Value of Abciximab in Patients With AMI Undergoing PCI After High Dose Clopidogrel Pretreatment (BRAVE 3)|Completed||Phase 4|800|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:17:32.212441|2017-10-11 05:17:32.212441
NCT00133263|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-07-09|||January 2001||2001-01-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|April 2005|Actual|2005-04-01||Interventional|||Effectiveness of a Standardized Bereavement Intervention in Primary Care|"Effectiveness of Primary Bereavement Care (PBC) in Widows: A Cluster Randomized Controlled Trial"|Completed||Phase 3|87|Actual|Carlos III Health Institute||2|||f||||f||||||||||2017-10-11 05:17:32.320773|2017-10-11 05:17:32.320773
NCT00133276|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2010-02-18|||August 2005||2005-08-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment|Prophylactic Treatment of Peginterferon-associated Psychopathology. A Double-blind Placebo-controlled Trial on the Effects of Escitalopram (Lexapro®) in Patients Treated With Peginterferon and Ribavirin (POPS Study)|Completed||Phase 2/Phase 3|80|Anticipated|Foundation for Liver Research||2|||f||||f||||||||||2017-10-11 05:17:32.409775|2017-10-11 05:17:32.409775
NCT00133289|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2007-07-09|||July 2005||2005-07-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Interventional|||ULTRA Study for Pacemaker Patients|Ventricular Automatic Capture Assessment Study|Completed||Phase 4|950||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:17:32.503666|2017-10-11 05:17:32.503666
NCT00133302|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2007-01-17|||February 1999||1999-02-01|August 2006|2006-08-01|February 2005||2005-02-01|||||Interventional|||Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)|Randomized Phase III Study of Standard CHOP (S-CHOP) Versus Biweekly CHOP (Bi-CHOP) in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)|Terminated||Phase 3|450||Japan Clinical Oncology Group|||||f||||||||||||||2017-10-11 05:17:32.562719|2017-10-11 05:17:32.562719
NCT00133315|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2007-04-09|||September 2004||2004-09-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||TNFalfa Blocking Treatment of Spondylarthropathies|TNFalfa Blocking Treatment of Spondylarthropathies - A Danish Multicenter Study of New Methods for Better Monitoring and Prognostifying Patients With Spondylarthropathies|Completed||Phase 4|50||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:17:32.631121|2017-10-11 05:17:32.631121
NCT00133328|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2005-10-27|||January 2002||2002-01-01|January 2002|2002-01-01|November 2005||2005-11-01|||||Interventional|||A Morbidity-Mortality and Remodeling Study With Valsartan|A Morbi-Mortality and Remodeling Study With Valsartan in Patients With Hypertension and Cardiovascular Disease|Unknown status|Active, not recruiting|Phase 4|3000||Jikei University School of Medicine|||||f||||||||||||||2017-10-11 05:17:32.706851|2017-10-11 05:17:32.706851
NCT00133341|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2006-02-24|||April 2005||2005-04-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate|Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate for ”TRUE Test® Panel 3” – a Phase II, Dose-Response Study.|Completed||Phase 2|60||Mekos Laboratories AS|||||f||||||||||||||2017-10-11 05:17:32.790463|2017-10-11 05:17:32.790463
NCT00133354|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2011-10-11|||November 2001||2001-11-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2006|Actual|2006-08-01||Interventional|||Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys|Double-blind Trial Investigating the Safety and Efficacy of the Inhibitor Anastrozole (ARIMIDEX) in Delaying Epiphyseal Fusion and Increasing Height Potential of Adolescent Males With Growth Hormone (GH) Deficiency|Completed||Phase 2/Phase 3|53|Actual|Nemours Children's Clinic||2|||f||||t||||||||||2017-10-11 05:17:32.856822|2017-10-11 05:17:32.856822
NCT00133367|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2016-07-22|||August 2005||2005-08-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus|Phase II Study of Sequential Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis|Completed||Phase 2|32|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 05:17:32.942696|2017-10-11 05:17:32.942696
NCT00133380|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2007-04-04|||July 2005||2005-07-01|April 2007|2007-04-01|September 2006||2006-09-01|||||Interventional|||A Study in People With High Cholesterol|PPAR Alpha (LY518674): A Phase 2 Study of the Combinatorial Effect of LY518674 and Atorvastatin in Subjects With Hypercholesterolemia|Completed||Phase 2|300||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:17:33.029366|2017-10-11 05:17:33.029366
NCT00133393|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26|||January 2002||2002-01-01|October 2005|2005-10-01|July 2005||2005-07-01|||||Interventional|||Pentoxifylline in Children With Malaria|Dose Finding Study of Pentoxifylline in Children With Cerebral Malaria|Terminated||Phase 2|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:17:33.14353|2017-10-11 05:17:33.14353
NCT00133406|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2011-03-04|||June 2006||2006-06-01|March 2011|2011-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Long-term Impact and Intervention for Diarrhea in Brazil|Long-term Impact and Intervention for Diarrhea in Brazil|Unknown status|Recruiting|Phase 3|321|Anticipated|University of Virginia||6|||f||||f||||||||||2017-10-11 05:17:33.197518|2017-10-11 05:17:33.197518
NCT00133419|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26||||||March 2007|2007-03-01|January 2006||2006-01-01|||||Interventional|||Micronutrients and Enteric Infections in African Children|The Effect of Prophylactic Micronutrient Supplementation of Morbidity and Growth in HIV-infected and HIV-uninfected Children in South Africa|Completed||Phase 2|516||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:17:33.299013|2017-10-11 05:17:33.299013
NCT00133432|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26|||September 2005||2005-09-01|March 2010|2010-03-01|July 2007|Anticipated|2007-07-01|July 2007|Anticipated|2007-07-01||Interventional|||Zinc and Pneumonia Protocol|The Effect of Zinc Supplementation on Duration of Hospitalization in Tanzanian Children Presenting With Acute Pneumonia|Terminated||Phase 3|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:17:33.361318|2017-10-11 05:17:33.361318
NCT00133445|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2011-11-03|||December 2005||2005-12-01|October 2009|2009-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Pentavalent DTaP-Hep B-IPV|Randomized, Single Blinded Study of the Safety and Immunogenicity of Pentavalent DTaP-Hep B-IPV Combination Vaccine (Pediarix™; GlaxoSmithKline (GSK) Biologicals) Administered to Healthy Neonates and Infants at Birth, 2, and 6 Months of Age Compared to a Routine Infant Schedule at 2, 4, and 6 Months of Age|Completed||Phase 2|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:17:33.424155|2017-10-11 05:17:33.424155
NCT00133458|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26||||||October 2005|2005-10-01|June 2007||2007-06-01|||||Interventional|||RCT ALB for SA Cysticercosis|Randomized, Double Blind Comparison of Two Lenghts of Albendazole Therapy for Subarachnoid Cysticercosis|Withdrawn||Phase 3|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:17:33.495183|2017-10-11 05:17:33.495183
NCT00133471|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26|||March 2005||2005-03-01|January 2009|2009-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults|Evaluation of the Reactogenicity and Immunogenicity of Four Dosage Levels of Intramuscular Monovalent Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults|Completed||Phase 1/Phase 2|96|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||||||||||||2017-10-11 05:17:33.577267|2017-10-11 05:17:33.577267
NCT00133484|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26||||||December 2005|2005-12-01|May 2007||2007-05-01|||||Interventional|||UMD rPA Regimen Trial in Adults|A Phase II Study to Assess the Safety, Tolerability, Immunogenicity, and Optimal Primary Schedule of 3 Recombinant Protective Antigen (rPA) Anthrax Vaccines Administered in Two Intramuscular Doses to Healthy Adults|Terminated||Phase 2|270||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:17:33.674478|2017-10-11 05:17:33.674478
NCT00133497|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2017-07-03||2017-07-03|June 2006||2006-06-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females|A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Safety and Efficacy of the Cytomegalovirus gB/MF59 Vaccine in Preventing Systemic Cytomegalovirus Infection in Healthy Adolescent Females|Completed||Phase 2|409|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:17:33.736183|2017-10-11 05:17:33.736183
NCT00133510|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26|||November 2004||2004-11-01|March 2008|2008-03-01|September 2006||2006-09-01|||||Interventional|||Influenza Vaccine in Pediatric Transplant Subjects|Prospective Comparative Study of the Humoral and Cell-Mediated Immune Responses to the Trivalent Subviron Influenza Vaccine in Pediatric Liver Transplant Recipients as an Indicator for Response of Immunocompromised Subjects to Vaccination Against Agents of Bioterrorism|Completed||Phase 4|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:17:33.822691|2017-10-11 05:17:33.822691
NCT00133523|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2014-12-04|||October 2004||2004-10-01|October 2009|2009-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||FLU-VACS Comparative Study in Adults|Comparative Study of Influenza Vaccines in Adults - FLU-VACS|Completed||Phase 4|2349|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 05:17:33.876067|2017-10-11 05:17:33.876067
NCT00133536|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26|||January 2006||2006-01-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A/H5N1 Vaccine in Healthy Children Aged 2-9 Years|A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II, Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Children Aged 2 Years Through 9 Years|Completed||Phase 1/Phase 2|157|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:17:33.974335|2017-10-11 05:17:33.974335
NCT00133549|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2014-10-16|||November 2000||2000-11-01|May 2011|2011-05-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||9-valent CRM 197 Pneumococcal|Evaluation of a 9-valent CRM 197- Conjugated Pneumococcal Polysaccharide Vaccine in Elderly Adults|Completed||Phase 2|180|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 05:17:34.071307|2017-10-11 05:17:34.071307
NCT00133562|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2008-10-27|||August 2004||2004-08-01|October 2008|2008-10-01|May 2006||2006-05-01|||||Interventional|||HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition|Prospective Double Blind Randomized Clinical Trial of Alanyl-Glutamine or Glycine in Hospitalized Children With Persistent Diarrhea or Malnutrition.|Withdrawn||Phase 3|108||University of Virginia|||||f||||f||||||||||2017-10-11 05:17:34.148516|2017-10-11 05:17:34.148516
NCT00133575|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2014-12-11|2009-03-26||October 2005||2005-10-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||ACAM 3000 MVA at Harvard Medical School|ACAM 3000 MVA (Acambis Modified Vaccinia Ankara) Immunization Followed by Dryvax® Vaccination of Healthy Vaccinia-Naïve Adults: A Phase I/II, Placebo-Controlled Study of the Effects of Dose and Route of Administration of MVA on Safety, Reactogenicity and Immunogenicity, Followed by Dryvax® Immunization to Assess Effects of MVA Vaccination on Dryvax® Takes|Completed||Phase 1/Phase 2|72|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The Dryvax challenge was optional and administered to only a subset of participants before being discontinued prior to being offered to the subjects in the last cohort.|6|||f||||||||||||||2017-10-11 05:17:34.809568|2017-10-11 05:17:34.809568
NCT00133588|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2010-08-26|||November 2006||2006-11-01|May 2007|2007-05-01|January 2007||2007-01-01|||||Interventional|||Proteomic Profiling for Influenza|Proteomic Profiling for Influenza Vaccination|Completed||Phase 4|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:17:37.951999|2017-10-11 05:17:37.951999
NCT00133601|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2009-01-15|||October 2004||2004-10-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|July 2007|Actual|2007-07-01||Interventional|||Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients|Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients|Completed||Phase 1|28|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-10-11 05:17:38.00243|2017-10-11 05:17:38.00243
NCT00133614|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2005-10-28|||August 2001||2001-08-01|August 2005|2005-08-01|April 2004||2004-04-01|||||Interventional|||Prone Positioning in Pediatric Acute Lung Injury|Prone Positioning in Pediatric Acute Lung Injury|Completed||Phase 3|102||National Institute of Nursing Research (NINR)|||||f||||||||||||||2017-10-11 05:17:38.092515|2017-10-11 05:17:38.092515
NCT00133627|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2011-11-16|||April 2005||2005-04-01|November 2011|2011-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis|Safety and Efficacy Comparison Ketotifen Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis|Completed||Phase 4|229|Actual|Novartis|||||f||||||||||||||2017-10-11 05:17:38.164856|2017-10-11 05:17:38.164856
NCT00133640|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2006-09-07|||January 2005||2005-01-01|August 2006|2006-08-01|December 2008||2008-12-01|||||Interventional|||Early Rehabilitation After Hip Fracture|Early Rehabilitation After Hip Fracture: A Randomized Controlled Trial Comparing Different Vitamin D and Rehabilitation Programs|Unknown status|Recruiting|Phase 3|204||Swiss National Science Foundation|||||f||||||||||||||2017-10-11 05:17:38.227884|2017-10-11 05:17:38.227884
NCT00133653|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2005-10-28|||August 2001||2001-08-01|August 2004|2004-08-01|July 2004||2004-07-01|||||Observational|||The Double Exposure Study: The Impact of Job Strain and Marital Cohesion on Blood Pressure|The Impact of Job Strain and Marital Cohesion on Ambulatory Blood Pressure Over One Year: The Double Exposure Study|Completed||N/A|250||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:17:38.320088|2017-10-11 05:17:38.320088
NCT00133666|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-19|2008-07-16|||September 2004||2004-09-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Improving Asthma Communication in Minority Families|Improving Asthma Communication in Minority Families|Completed||Phase 2|231|Actual|National Institute of Nursing Research (NINR)||2|||f||||||||||||||2017-10-11 05:17:38.387644|2017-10-11 05:17:38.387644
NCT00133679|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-08-11|||February 2006||2006-02-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Chronic Sildenafil for Severe Diaphragmatic Hernia|Chronic Sildenafil for Severe Diaphragmatic Hernia|Terminated||Phase 4|9|Actual|University of California, San Francisco||2||"Change in clinical practice allowing chronic therapy at 6 weeks of age, incompatible with   possibility of placebo beyond 6 weeks of age on study protocol"|f||||t||||||||||2017-10-11 05:17:38.474014|2017-10-11 05:17:38.474014
NCT00133692|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2011-09-16|||September 1997||1997-09-01|August 2010|2010-08-01|February 2003||2003-02-01|||||Interventional|||INVEST: INternational VErapamil SR Trandolapril STudy|INternational VErapamil SR Trandolapril STudy|Completed||Phase 4|22000||University of Florida|||||f||||||||||||||2017-10-11 05:17:38.574519|2017-10-11 05:17:38.574519
NCT00133705|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-02-13|2012-11-01||July 2003||2003-07-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Trial of Mifepristone for Fibroids|Randomized Control Trial Of Mifepristone for Fibroids|Completed||Phase 3|70|Actual|University of Rochester|There were no adverse events in this clinical trial.|2|||f||||t||||||||||2017-10-11 05:17:38.785785|2017-10-11 05:17:38.785785
NCT00133718|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2017-01-23|||January 2002||2002-01-01|January 2017|2017-01-01|May 29, 2012|Actual|2012-05-29|April 2006|Actual|2006-04-01||Interventional|||A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control|Asker and Baerum Cardiovascular Diabetes Study|Completed||Phase 4|120|Actual|Asker & Baerum Hospital||2|||f||||t|t|f|||f|||No||2017-10-11 05:17:39.038537|2017-10-11 05:17:39.038537
NCT00133731|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2008-07-01|||September 2004||2004-09-01|June 2008|2008-06-01|October 2005|Actual|2005-10-01|||||Interventional|SEPIA-PCI||The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention|A Multinational, Randomized, Double-Blind, Double-Dummy, Exploratory, Parallel Group, Dose-Ranging Phase II Study to Evaluate Pharmacodynamics, Safety and Tolerability, and Pharmacokinetics of Several Intravenous Regimens of Factor Xa Inhibitor Otamixaban (XRP0673), in Comparison to Intravenous Unfractionated Heparin, in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention|Completed||Phase 2|947|Actual|Sanofi|||||||||||||||||||2017-10-11 05:17:39.166222|2017-10-11 05:17:39.166222
NCT00133744|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2011-03-18|||May 2006||2006-05-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality|Impact of Iron/Folic Acid Versus Multimicronutrient Versus Folic Acid Supplements During Pregnancy on Mortality, Morbidity, and Complications During Pregnancy, Labor, and Delivery: A Randomized Controlled Trial in China|Completed||Phase 3|18962|Actual|Centers for Disease Control and Prevention||3|||f||||t||||||||||2017-10-11 05:17:39.533995|2017-10-11 05:17:39.533995
NCT00139529|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2015-12-21|||March 2006||2006-03-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Education and Counseling for Abstinence From Tobacco After Pregnancy|Postpartum Maintenance of Abstinence From Tobacco|Completed||N/A|757|Actual|Brown University||2|||f||||f||||||||||2017-10-11 05:19:37.003145|2017-10-11 05:19:37.003145
NCT00140465|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-11-13|||October 2004||2004-10-01|November 2007|2007-11-01|July 2005|Actual|2005-07-01|||||Interventional|||75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)|A Double-Blind, Randomized Comparison Between Two Different Clopidogrel Maintenance Doses After Percutaneous Coronary Intervention (ISAR-CHOICE-2)|Completed||Phase 4|60|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:17:39.655898|2017-10-11 05:17:39.655898
NCT00140478|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-12-07|||February 2005||2005-02-01|December 2009|2009-12-01|January 2008|Actual|2008-01-01|June 2006|Actual|2006-06-01||Interventional|||Mifepristone (RU-486) in Androgen Independent Prostate Cancer|A Phase II Study of Mifepristone (RU-486) in Androgen Independent Prostate Cancer With Correlative Assessment of Androgen Receptor Co-Repressor Proteins|Completed||Phase 2|48|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:17:39.779371|2017-10-11 05:17:39.779371
NCT00140491|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2013-10-22|||August 2005||2005-08-01|October 2013|2013-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy|Visual Field Defects in Non-Arteritic Anterior Ischemic Optic Neuropathy: Effect of Vision Restoration Therapy (VRT)|Completed||N/A|20||Emory University|||||f||||||||||||||2017-10-11 05:17:39.883323|2017-10-11 05:17:39.883323
NCT00140504|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2013-02-24|||April 2003||2003-04-01|February 2013|2013-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Preventing Adverse Drug Events With PatientSite|Preventing Adverse Drug Events With PatientSite|Completed||N/A|800|Anticipated|Dana-Farber Cancer Institute||2|||f||||f||||||||||2017-10-11 05:17:39.947286|2017-10-11 05:17:39.947286
NCT00140517|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-01-11|||October 2002||2002-10-01|January 2017|2017-01-01|March 2008|Actual|2008-03-01|June 2007|Actual|2007-06-01||Interventional|||Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance|Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance|Completed||N/A|700||London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-10-11 05:17:41.666266|2017-10-11 05:17:41.666266
NCT00140530|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-01-10|||March 2004||2004-03-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|||||Interventional|||Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)|A Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Prevention of Restenosis (ISAR-TEST-1)|Completed||Phase 4|450|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:17:41.734755|2017-10-11 05:17:41.734755
NCT00140543|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-11-17|||February 2002||2002-02-01|August 2005|2005-08-01|April 2008||2008-04-01|||||Interventional|||European Trial of Immunosuppression in SPK Tx|A European Multicenter Open-Label Randomised Trial to Evaluate the Efficacy and Safety of Sirolimus and Tacrolimus Compared to MMF and Tacrolimus With Short-Course Induction Therapy, Short-Term Steroids Application in De Novo SPK Transplanted Diabetic Patients|Unknown status|Active, not recruiting|Phase 3|228||EUROSPK Study Group|||||f||||||||||||||2017-10-11 05:17:41.823238|2017-10-11 05:17:41.823238
NCT00140556|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-01-14|2010-08-19||August 2005||2005-08-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|May 2009|Actual|2009-05-01||Interventional|||Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer|Concurrent Angiogenic and EGFR Blockade in Conjunction With Curative Intent Chemoradiation for Locally Advanced Head and Neck Cancer|Completed||Early Phase 1|28|Actual|Duke University||1|||f||||f||||||||||2017-10-11 05:17:41.943157|2017-10-11 05:17:41.943157
NCT00140569|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-08-31|||January 1994||1994-01-01|August 2005|2005-08-01|January 2004||2004-01-01|||||Interventional|||Randomized Study for Patients With Follicular Lymphoma Needing Treatment|Randomized Study for Patients With Follicular Lymphoma Needing Treatment|Completed||Phase 3|400||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:17:42.209795|2017-10-11 05:17:42.209795
NCT00140582|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2017-03-09|||December 2004|Actual|2004-12-01|March 2017|2017-03-01|December 2016|Actual|2016-12-01|May 2007|Actual|2007-05-01||Interventional|||Primary Rituximab and Maintenance|Advanced Follicular Lymphoma Evaluating the Benefit of Maintenance Therapy With Rituximab (MabThera®) After Induction of Response With Chemotherapy Plus Rituximab in Comparison With no Maintenance Therapy|Completed||Phase 3|1217|Actual|Lymphoma Study Association||2|||f||||t||||||||No||2017-10-11 05:17:42.300712|2017-10-11 05:17:42.300712
NCT00140595|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2011-03-03|||December 2003||2003-12-01|March 2011|2011-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1|Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients Aged From 18 to 59 Years With Diffuse Large B-cell Lymphoma and a Age-adjusted IPI of 1.|Completed||Phase 3|380|Anticipated|Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:17:42.53033|2017-10-11 05:17:42.53033
NCT00140608|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2015-03-17|||June 2003||2003-06-01|March 2015|2015-03-01|May 2005||2005-05-01|||||Interventional|||Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery||Terminated||N/A|||Sanofi|||||f||||||||||||||2017-10-11 05:17:42.643796|2017-10-11 05:17:42.643796
NCT00140621|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-04-16|2015-04-01||July 2005||2005-07-01|April 2015|2015-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Efficacy evaluable population (EEP) included all registered participants except those who had serious deviations from protocol compliance requirements, did not receive study drug, had no data available at baseline or after study drug administration, and who were found to have no condition in cardiac Fabry disease.|A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease|A Multicenter Open-label Study of the Safety and Efficacy of α-galactosidase A (R-h α-GAL) Replacement Therapy in Patients With Cardiac Fabry Disease|Completed||Phase 4|6|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 05:17:42.740739|2017-10-11 05:17:42.740739
NCT00140634|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-06-01|||March 1995||1995-03-01|June 2017|2017-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||The Objectives of the Cartilage Repair Registry is to Report Long Term Efficacy and Safety of Cartilage Repair Procedures in Registry Patients|Cartilage Repair Registry|Completed||N/A|2233|Actual|Vericel Corporation|||1||f||||f||||||||||2017-10-11 05:17:43.234014|2017-10-11 05:17:43.234014
NCT00140647|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-08-21|||July 2001||2001-07-01|August 2008|2008-08-01|July 2006|Actual|2006-07-01|||||Interventional|||The Study of Atherosclerosis With Ramipril and Rosiglitazone|The Study of Atherosclerosis With Ramipril and Rosiglitazone|Completed||Phase 3|1200||Gerstein, Hertzel, MD|||||||||||||||||||2017-10-11 05:17:43.324399|2017-10-11 05:17:43.324399
NCT00140855|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-04-04|||July 2005||2005-07-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma|A Phase II Study of Anti-CTLA4 Antibody in Advanced Synovial Sarcoma Patients|Terminated||Phase 2|17||Ludwig Institute for Cancer Research||||Study discontinued due to poor accrual.|f||||t||||||||||2017-10-11 05:17:45.862041|2017-10-11 05:17:45.862041
NCT00140660|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-03-09|||December 2003|Actual|2003-12-01|March 2017|2017-03-01|April 2012|Actual|2012-04-01|July 2008|Actual|2008-07-01||Interventional|||ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma|Randomized Study of ACVBP Versus ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 65 Years With Low-risk Localized Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 0)|Terminated||Phase 3|223|Actual|Lymphoma Study Association||2||Low acrual|f||||t|f|f||||||No||2017-10-11 05:17:43.422415|2017-10-11 05:17:43.422415
NCT00140673|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2016-09-20|||August 2003||2003-08-01|September 2016|2016-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.|A Placebo-controlled, Multi-country & Multi-center Study to Assess the Efficacy, Safety & Immunogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants|Completed||Phase 3|63227|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:17:43.554156|2017-10-11 05:17:43.554156
NCT00140686|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-03-21|||September 2004||2004-09-01|March 2017|2017-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines|A Multi-country & Multi-center Study to Assess the Efficacy, Safety & Immunogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines|Completed||Phase 3|3994|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:17:43.71507|2017-10-11 05:17:43.71507
NCT00140699|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-04-26||||||April 2007|2007-04-01||||||||Observational|||Balance Control and Maturation in Normal and Deaf Children Aged From 6 to 14 Years Old|Balance Control and Maturation in Normal and Deaf Children Aged From 6 to 14 Years Old|Unknown status|Active, not recruiting|N/A|240||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:17:44.091388|2017-10-11 05:17:44.091388
NCT00140712|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-09-08|||June 10, 2005|Actual|2005-06-10|September 2017|2017-09-01|February 28, 2008|Actual|2008-02-28|February 28, 2008|Actual|2008-02-28||Interventional|||Ropinirole Tablets In Young Patients With Restless Legs Syndrome|A Study to Determine the Tolerability and Pharmacokinetics for Ropinirole in Paediatric / Adolescent Patients With RLS (Type 2)|Completed||Phase 1|9|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 05:17:44.154165|2017-10-11 05:17:44.154165
NCT00140725|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-10-15|||April 2000||2000-04-01|October 2008|2008-10-01||||||||Interventional|||Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)|A Randomised Trial of Lamivudine Plus Interferon Versus Lamivudine for the Treatment of HBeAg Positive Chronic Hepatitis B Virus (HBV)|Completed||Phase 3|160||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:17:44.282547|2017-10-11 05:17:44.282547
NCT00140738|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-06-12|||March 10, 2005|Actual|2005-03-10|May 2017|2017-05-01|September 29, 2009|Actual|2009-09-29|September 29, 2008|Actual|2008-09-29||Interventional|||Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer|A Multicenter, Open-label Phase I/II Trial of the Safety and Efficacy of the dHER2 Recombinant Protein Combined With Immunological Adjuvant AS15 in Patients With Metastatic Breast Cancer Overexpressing HER2/Neu|Completed||Phase 1|3|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 05:17:44.387748|2017-10-11 05:17:44.387748
NCT00140751|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2013-09-18|||October 2005||2005-10-01|September 2013|2013-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|KALESOLO||Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients|A 48-Weeks National Multicenter Randomized Open Clinical Trial Evaluating Tolerance and Efficacy of a Treatment Simplification by Lopinavir/Ritonavir Versus Continuation of Current Treatment in HIV-Infected Patients With a Viral Load Inferior to 50 Copies/mL Since 6 Months At Least|Completed||Phase 3|186|Actual|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba||2|||f||||||||||||||2017-10-11 05:17:44.545814|2017-10-11 05:17:44.545814
NCT00140764|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2011-08-09|||January 2003||2003-01-01|August 2011|2011-08-01|March 2005||2005-03-01|||||Interventional|||Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi||Completed||Phase 3|||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:17:44.719558|2017-10-11 05:17:44.719558
NCT00140790|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2016-02-25|||August 2006||2006-08-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study|Effects of Valsartan on Cardiovascular Events in Patients With Renal Dysfunction|Terminated||Phase 4|1000|Actual|Kumamoto University||2||"The number of actual events was extremely low. We extended the study period, but it was still   not enough. Also, many patients were loss of follow up."|f||||t||||||||||2017-10-11 05:17:44.813152|2017-10-11 05:17:44.813152
NCT00140803|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-07-11|||October 2003||2003-10-01|July 2007|2007-07-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration|A Randomized, Single-Masked, Multi-Center, Phase 2 Evaluation Of The Effect Of PDT Using Visudyne In Combination With Intravitreal Injection Of Either 0 mg, 1mg or 4mg of Kenalog In Subfoveal Occult & Minimally Classic CNV Secondary To ARMD|Completed||Phase 2|106|Actual|Manhattan Eye, Ear & Throat Hospital||3|||t||||t||||||||||2017-10-11 05:17:44.947984|2017-10-11 05:17:44.947984
NCT00140816|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2011-07-03|||September 2005||2005-09-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Dairy Products and Metabolic Effects (Norwegian Part)|Dairy Products and Metabolic Effects - A Multicentre Nordic Study|Completed||N/A|40|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-10-11 05:17:45.059642|2017-10-11 05:17:45.059642
NCT00140829|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2012-03-26|||July 2003||2003-07-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|||||Observational|Spatax||SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias|Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias|Unknown status|Recruiting|Phase 1|6000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-10-11 05:17:45.194212|2017-10-11 05:17:45.194212
NCT00140842|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2011-10-03|2011-03-03||May 2005||2005-05-01|September 2011|2011-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents|Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents|Completed||N/A|47|Actual|Massachusetts General Hospital|Limited number of participants-pilot study||2||f||||f||||||Samples Without DNA|"     Serum and urine collected   "|||2017-10-11 05:17:45.534144|2017-10-11 05:17:45.534144
NCT00140868|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-12-06|||December 2002||2002-12-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery|Outcome of Palliative Management of Malignant Large Bowel Obstruction With Colorectal Stents or Surgery|Completed||Phase 3|180||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 05:17:45.964293|2017-10-11 05:17:45.964293
NCT00140881|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2017-03-24|||June 1, 2000|Actual|2000-06-01|March 2017|2017-03-01|February 14, 2003|Actual|2003-02-14|February 14, 2003|Actual|2003-02-14||Interventional|||A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children|Completed||Phase 4|220|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:17:46.041214|2017-10-11 05:17:46.041214
NCT00140894|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2017-09-27|||March 1, 2003|Actual|2003-03-01|September 2017|2017-09-01||||||||Interventional|||A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Rofecoxib in Familial Adenomatous Polyposis (FAP)|Terminated||Phase 4|62||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:17:46.120696|2017-10-11 05:17:46.120696
NCT00140907|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2017-09-15|||March 14, 2000|Actual|2000-03-14|September 2017|2017-09-01|January 1, 2005|Actual|2005-01-01|January 1, 2005|Actual|2005-01-01||Interventional|||ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)|A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Renal Transplant|Completed||Phase 4|367|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:17:46.203397|2017-10-11 05:17:46.203397
NCT00140920|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2017-05-05|||May 25, 2004|Actual|2004-05-25|May 2017|2017-05-01|September 27, 2004|Actual|2004-09-27|September 27, 2004|Actual|2004-09-27||Interventional|||A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)|A Study to Compare Pre-Operative Administration of Rofecoxib Vs Post-Operative Administration of Diclofenac or Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement in Patients With Osteoarthritis of the Knee.|Terminated||Phase 4|11|Actual|Merck Sharp & Dohme Corp.||||Recruitment/study discontinued after withdrawal of marketing authorisation. No data entered.|f||||||||||||||2017-10-11 05:17:46.317941|2017-10-11 05:17:46.317941
NCT00140933|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-12-01|||April 2003||2003-04-01|December 2006|2006-12-01||||||||Interventional|||A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome|A Randomized, Double-Blind, 7-Day Study of the Efficacy and Safety of Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome|Terminated||Phase 3|274||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:17:46.400781|2017-10-11 05:17:46.400781
NCT00140946|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-01-21|||March 1998||1998-03-01|January 2016|2016-01-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|||A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)|A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Two-Period, Parallel-group Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients.|Completed||Phase 4|546|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:17:46.47246|2017-10-11 05:17:46.47246
NCT00140959|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-04-12|||February 1, 2003|Actual|2003-02-01|April 2017|2017-04-01|June 30, 2004|Actual|2004-06-30|June 30, 2004|Actual|2004-06-30||Interventional|||Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)|Antihypertensive Effects of a Fixed-dose Combination of Losartan and Hydrochlorothiazide Plus Amlodipine Versus a Hydrochlorothiazide and Atenolol Combination Plus Amlodipine in Subjects With Ambulatory Systolic Hypertension.|Completed||Phase 4|120||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:17:46.71233|2017-10-11 05:17:46.71233
NCT00140972|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2017-04-06|||December 3, 2004|Actual|2004-12-03|April 2017|2017-04-01|June 27, 2005|Actual|2005-06-27|June 27, 2005|Actual|2005-06-27||Interventional|||A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)|A Multicenter, Randomized, Parallel-group, 4-Week, Double-Blind and Active Comparator-Controlled Study to Assess Efficacy, Safety, and Tolerability of Etoricoxib 60 mg Once Daily Versus Diclofenac Sodium 75 mg Twice Daily in the Treatment of Chinese Patients With Osteoarthritis of the Knee or Hip|Completed||Phase 4|160|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:17:46.802257|2017-10-11 05:17:46.802257
NCT00140985|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-01-09|||February 2000||2000-02-01|January 2015|2015-01-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)|A Randomized, Parallel, Double Blind Study of Losartan Versus Amlodipine in Patients With Mild to Moderate Hypertension and Chronic Nondiabetic Proteinuric Nephropathy: Evaluation of the Effect on Proteinuria and on the Plasmatic Levels of Growth Factors (TGFß and VEGF)|Completed||Phase 4|97|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:17:46.886639|2017-10-11 05:17:46.886639
NCT00140998|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2010-08-12|||January 2001||2001-01-01|August 2010|2010-08-01|June 2004||2004-06-01|||||Interventional|||Estrogen Treatment (Oral vs. Patches) in Turner Syndrome|Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery|Completed||Phase 3|16||Nemours Children's Clinic|||||f||||||||||||||2017-10-11 05:17:47.006893|2017-10-11 05:17:47.006893
NCT00141024|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-06-28|||January 2006||2006-01-01|June 2016|2016-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the Recombinant Protein Vaccine EP-1043 and the DNA Vaccine EP HIV-1090 Given Alone or in Combination in Healthy, HIV-1-Uninfected Adult Participants|Completed||Phase 1|84|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-10-11 05:17:47.54401|2017-10-11 05:17:47.54401
NCT00141037|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-01|2016-10-19|2013-05-21||March 2004||2004-03-01|October 2016|2016-10-01|November 2010|Actual|2010-11-01|September 2006|Actual|2006-09-01||Interventional|||Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation|Randomized, Multi-Center Comparative Trial of Tacrolimus w/Steroids and Standard Daclizumab Induction vs a Novel Steroid-Free Tacrolimus Based Immunosuppression Protocol w/ Extended Daclizumab Induction in Pediatric Renal Transplantation|Completed||Phase 1/Phase 2|130|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|"The results cannot be generalized and daclizumab has since been withdrawn from the United States market (business-related, not due to any safety issues).
The study was not powered to definitively evaluate small differences in rejection rate."|2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 05:17:47.682791|2017-10-11 05:17:47.682791
NCT00141050|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-12-17|||May 2005||2005-05-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|||||Interventional|||Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD|Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD|Completed||Phase 3|90||Novartis|||||||||||||||||||2017-10-11 05:17:48.675573|2017-10-11 05:17:48.675573
NCT00141063|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-12-17|||June 2005||2005-06-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Interventional|||Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD|Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD|Completed||Phase 3|90||Novartis|||||||||||||||||||2017-10-11 05:17:48.744585|2017-10-11 05:17:48.744585
NCT00141076|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2010-08-27|||October 2003||2003-10-01|August 2010|2010-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Glycemic Index and CVD: a Crossover Feeding Study|Glycemic Index, Obesity, Insulin Resistance and CVD Risk, Part 2|Completed||N/A|24||Boston Children’s Hospital|||||f||||||||||||||2017-10-11 05:17:48.827435|2017-10-11 05:17:48.827435
NCT00141089|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-01-31|||March 2004||2004-03-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.|Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.|Completed||Phase 3|1026||Novartis|||||f||||||||||||||2017-10-11 05:17:48.908236|2017-10-11 05:17:48.908236
NCT00141102|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2011-04-18|2010-05-11||October 2005||2005-10-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|CONDOR||Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis|Double-Blind, Triple Dummy, Parallel-Group, Randomized, Six-Month Study To Compare Celecoxib (200 Mg BID) With Diclofenac Sr (75 Mg BID) Plus Omeprazole (20 Mg QD) For Gastrointestinal Events In Subjects With Osteoarthritis And Rheumatoid Arthritis At High-Risk Of Gastrointestinal Adverse Events|Completed||Phase 4|4484|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 05:17:49.036716|2017-10-11 05:17:49.036716
NCT00141115|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-08-17|2012-11-26||March 2004||2004-03-01|August 2017|2017-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Levetiracetam for the Treatment of Alcohol Dependence and Anxiety|Pilot Trial of Levetiracetam in the Treatment of Alcohol Dependence With Comorbid Anxiety|Completed||Phase 2|3|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-10-11 05:17:50.970106|2017-10-11 05:17:50.970106
NCT00141128|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2011-05-31|||December 2005||2005-12-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.|Measurement Of Urethral Function In Women With Stress Urinary Incontinence - Evaluation Of The Sensitivity Of Urethral Reflectometry Compared To Urethral Pressure Profilometry, Using [S,S]-Reboxetine To Detect Pharmacological Augmentation Of Urethral Pressure.|Completed||Phase 2|18|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:17:51.141176|2017-10-11 05:17:51.141176
NCT00141141|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-10-28|||January 2004||2004-01-01|October 2008|2008-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia|A Phase IV, Multicenter, Randomized, Open Label Study To Evaluate The Efficacy And Safety Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia|Completed||Phase 4|383|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:17:51.211076|2017-10-11 05:17:51.211076
NCT00141154|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2011-05-27|||October 2004||2004-10-01|May 2011|2011-05-01||||||||Interventional|||Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan|A Randomized, Multicenter, Active And Placebo Controlled Parallel Group Study To Evaluate The Efficacy And Safety Of Celecoxib (Ym177) 200 Bid Compared To Loxoprofen 60 Mg Tid In Patients With Low Back Pain|Completed||Phase 3|1234|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:17:51.371325|2017-10-11 05:17:51.371325
NCT00141167|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2010-09-03|||February 2005||2005-02-01|September 2010|2010-09-01|January 2006|Actual|2006-01-01|||||Interventional|||A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation|A Twelve-Week, Double-Blind, Placebo-Controlled, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate 1 MG BID for Smoking Cessation|Completed||Phase 3|250|Actual|Pfizer|||||||||||||||||||2017-10-11 05:17:51.512471|2017-10-11 05:17:51.512471
NCT00141180|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-07-23|||September 2003||2003-09-01|November 2005|2005-11-01|October 2005||2005-10-01|||||Interventional|||CP-481,715 Nickel Allergy Study.|Placebo-Controlled, Randomized, Parallel Group, Multiple-Dose Study to Evaluate the Effects of CP-481,715 on Clinical Response and Cellular Infiltration Following Contact Allergen Challenge to the Skin of Nickel Allergic Subjects.|Completed||Phase 1|48||Pfizer|||||||||||||||||||2017-10-11 05:17:51.584075|2017-10-11 05:17:51.584075
NCT00141193|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-08-05|||February 2001||2001-02-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|PRESAP||Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)|Clinical Protocol For a Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Celecoxib (SC-58635) In The Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)|Completed||Phase 3|1561|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 05:17:51.662884|2017-10-11 05:17:51.662884
NCT00141206|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-06-01|||May 2003||2003-05-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation|A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation|Completed||Phase 3|1005||Pfizer|||||||||||||||||||2017-10-11 05:17:51.950988|2017-10-11 05:17:51.950988
NCT00141219|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-09-23|2008-12-19||December 2005||2005-12-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pregabalin Peripheral Neuropathic Pain Study|A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pregabalin (150 mg - 600 mg/Day) Using a Flexible, Optimized Dose Schedule in Subjects With Peripheral Neuropathic Pain|Completed||Phase 3|241|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:17:52.192844|2017-10-11 05:17:52.192844
NCT00141232|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-11-21|||November 2004||2004-11-01|November 2008|2008-11-01|July 2006|Actual|2006-07-01|||||Interventional|AFORRD||Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes|A Multicentre, Randomised, Double Blind Placebo Controlled Trial Evaluating Atorvastatin in Factorial With Omega-3 Fatty Acids Cardiovascular Risk Reduction in Patients With Type 2 Diabetes|Completed||Phase 4|810|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:17:53.1559|2017-10-11 05:17:53.1559
NCT00141245|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-12-28|||October 1998||1998-10-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.|Pregabalin Open-Label, Multicenter Add-On Trial Following a 4-Day Double-Blind Transition Period to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.|Completed||Phase 3|325||Pfizer|||||f||||||||||||||2017-10-11 05:17:53.336794|2017-10-11 05:17:53.336794
NCT00141258|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-04-28|||October 2005||2005-10-01|April 2009|2009-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Pregabalin Epilepsy Add-On Trial|Pregabalin Add-On Titration Trial: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Pregabalin (150 mg - 600 mg/Day) Using a Flexible, Optimized Dose Schedule in Subjects With Partial Seizures|Completed||Phase 3|178|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:17:53.468467|2017-10-11 05:17:53.468467
NCT00141271|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-04-03|2009-02-24||July 2005||2005-07-01|April 2009|2009-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression|A Six-Week, Randomized, Double-Blind, Multicenter, Fixed-Flexible Dose, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral Ziprasidone in Outpatients With Bipolar I Depression|Completed||Phase 3|536|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 05:17:53.599536|2017-10-11 05:17:53.599536
NCT00141284|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2011-05-09||2011-01-03|October 2005||2005-10-01|May 2011|2011-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C|A Phase Iv Single-Arm Open-Label Non-Randomized Study To Evaluate The Safety And Pharmacokinetics Of Nelfinavir (Viracept, A430) 1250mg Twice Daily (250mg Or 625mg Forms) With Lamivudine/Zidovudine (Combivir) Background Therapy In Hiv/Hepatitis C Virus (Hcv) Co-Infected Subjects With Hepatic Dysfunction.|Completed||Phase 4|12|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:17:56.828367|2017-10-11 05:17:56.828367
NCT00141297|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-12-03|2015-03-04||September 2004||2004-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|July 2008|Actual|2008-07-01||Interventional||Full Analysis Set (FAS) included all enrolled participants who received at least one dose of study medication.|A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer|A Phase I Clinical, Pharmacokinetic, And Pharmacodynamic Evaluation Of 2 Schedules Of Oral PD 0332991, A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer|Completed||Phase 1|74|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:17:56.997192|2017-10-11 05:17:56.997192
NCT00141310|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-07-23|||September 2004||2004-09-01|July 2007|2007-07-01|April 2006|Actual|2006-04-01|||||Interventional|||Sildenafil Citrate for the Treatment of Established Pre-Eclampsia|A Randomised, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study to Evaluate the Efficacy, Safety and Toleration of Oral Sildenafil Citrate Administered in the Dose Range of 20 - 80 Mg TID for the Treatment of Pre-Eclampsia. (PET)|Terminated||Phase 2|76||Pfizer||||"Study prematurely discont’d 20-Apr-2006 after interim analysis suggested sample size could be   reduced without losing power. No safety concerns led to decision."|f||||||||||||||2017-10-11 05:18:02.928992|2017-10-11 05:18:02.928992
NCT00141323|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2011-08-08||2009-03-26|November 2001||2001-11-01|August 2011|2011-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|PEARL||Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)|PEARL: Postmenopausal Evaluation And Risk-Reduction With Lasofoxifene|Completed||Phase 3|8556|Anticipated|Ligand Pharmaceuticals||3|||f||||t||||||||||2017-10-11 05:18:03.032858|2017-10-11 05:18:03.032858
NCT00141336|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-12-28|||November 1999||1999-11-01|December 2006|2006-12-01|July 2005||2005-07-01|||||Interventional|||To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.|Pregabalin BID Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.|Completed||Phase 3|750||Pfizer|||||||||||||||||||2017-10-11 05:18:03.423309|2017-10-11 05:18:03.423309
NCT00141349|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-07-23|||February 2005||2005-02-01|January 2006|2006-01-01|August 2005||2005-08-01|||||Interventional|||Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction|A Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study to Assess the Time to Onset, Safety, and Toleration of Differing Doses and Combinations of Immediate Release and Modified Release Formulations of UK369,003 in Adult Male Subject With Erectile Dysfunction|Completed||Phase 2|300||Pfizer|||||||||||||||||||2017-10-11 05:18:05.036241|2017-10-11 05:18:05.036241
NCT00141362|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-12-29|||October 2001||2001-10-01|December 2006|2006-12-01|August 2005||2005-08-01|||||Interventional|||Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.|An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Chronic Neuropathic Pain.|Completed||Phase 3|325||Pfizer|||||f||||||||||||||2017-10-11 05:18:05.169015|2017-10-11 05:18:05.169015
NCT00141375|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-01-09|||August 2002||2002-08-01|January 2008|2008-01-01|January 2006|Actual|2006-01-01|||||Interventional|||To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.|An Open-Label Extension to Evaluate the Safety and Efficacy of Pregabalin for Treatment of Chronic Central Neuropathic Pain After Spinal Cord Injury.|Completed||Phase 3|132||Pfizer|||||f||||||||||||||2017-10-11 05:18:05.215044|2017-10-11 05:18:05.215044
NCT00141388|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-11-05|||July 1998||1998-07-01|November 2009|2009-11-01|October 2005|Actual|2005-10-01|||||Interventional|||To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures|Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.|Completed||Phase 3|455|Actual|Pfizer|||||||||||||||||||2017-10-11 05:18:05.420263|2017-10-11 05:18:05.420263
NCT00141427|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-03-21|||November 2004||2004-11-01|June 2006|2006-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.|Pregabalin In Partial Seizures (Preps) : An Open-Label, International, Multicenter Add-On Therapy Trial|Completed||Phase 4|540||Pfizer|||||f||||||||||||||2017-10-11 05:18:05.798274|2017-10-11 05:18:05.798274
NCT00141440|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-12-29|||July 2005||2005-07-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Effect of Cycling Off Criteria During Pressure Support Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients|The Effect of Cycling Off Criteria During Pressure Support Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients|Completed||N/A|13|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-10-11 05:18:05.964938|2017-10-11 05:18:05.964938
NCT00141453|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2011-05-09|2009-08-31||April 2003||2003-04-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial|CS-866DM Phase 3 Clinical Study: A Double-Blind Controlled Trial in Patients With Diabetic Nephropathy and Overt Proteinuria Secondary to Type 2 Diabetes Mellitus|Completed||Phase 3|577|Actual|Daiichi Sankyo, Inc.||2|||f||||||||||||||2017-10-11 05:18:06.069848|2017-10-11 05:18:06.069848
NCT00141466|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-04-22|||September 2005||2005-09-01|February 2007|2007-02-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Implementation of a New Strategy to Identify HNPCC Patients|Cost Effectiveness of Two Different Implementation Procedures to Change Clinicians Practice Roles in the Detection of Hereditary Colorectal Cancer|Unknown status|Recruiting|N/A|360|Anticipated|Radboud University|||||f||||||||||||||2017-10-11 05:18:07.913822|2017-10-11 05:18:07.913822
NCT00141479|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-01-15|||May 2005||2005-05-01|May 2006|2006-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox|A Single-center Safety and Tolerability Study to Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:18:08.02179|2017-10-11 05:18:08.02179
NCT00141492|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-01-19|||October 2004||2004-10-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes|A Double Blind, Randomized, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of Androgel, as an Adjunct to Hypoglycemic Therapy, in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:18:08.093501|2017-10-11 05:18:08.093501
NCT00141505|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-01-15|||February 2005||2005-02-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||PK Effects of Bifeprunox & Valproate in Bipolar I|Placebo-controlled Study on the Pharmacokinetics,Pharmacodynamics, Safety and Tolerability of Concurrent Valproate and Bifeprunox Administration in Subjects With Bipolar I Disorder|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:18:08.268318|2017-10-11 05:18:08.268318
NCT00141518|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-06-06|2016-04-11||March 2006||2006-03-01|June 2016|2016-06-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|DAPHNE||Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact|A Long-term Health Economics Study of Intraduodenal Levodopa (Duodopa®) in Routine Care for Patients With Advanced Idiopathic Parkinson's Disease With Severe Motor Fluctuations and Hyper-/Dyskinesia|Completed||Phase 4|77|Actual|AbbVie||3|||f||||||||||||||2017-10-11 05:18:08.752171|2017-10-11 05:18:08.752171
NCT00141531|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2012-06-13|||July 2005||2005-07-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase II Trial of EOquin in High-risk Superficial Bladder Cancer|Phase II Study of Intravesical Instillation of EOQUIN™ in High Risk Superficial Bladder Cancer|Completed||Phase 2|53|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-10-11 05:18:16.026504|2017-10-11 05:18:16.026504
NCT00141544|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-04-10|||July 2004||2004-07-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|||The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women|A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women|Terminated||Phase 2|28|Actual|Solvay Pharmaceuticals||2||Lack of enrollment|f||||f||||||||||2017-10-11 05:18:16.149287|2017-10-11 05:18:16.149287
NCT00141557|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-04-10|||July 2004||2004-07-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|||The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women|A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women|Terminated||Phase 2|133|Actual|Solvay Pharmaceuticals||2||Lack of enrollment|f||||f||||||||||2017-10-11 05:18:16.385103|2017-10-11 05:18:16.385103
NCT00141570|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-01-15|||June 2004||2004-06-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women|A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women|Completed||Phase 2|350||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:18:16.589809|2017-10-11 05:18:16.589809
NCT00141583|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-06-05|||April 2004||2004-04-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Interventional|||The Renin-Angiotensin System in Essential Hypertension|The Renin-Angiotensin System in Essential Hypertension|Terminated||N/A|11|Anticipated|St George's, University of London||||Insufficient accrual rate|f||||||||||||||2017-10-11 05:18:16.904786|2017-10-11 05:18:16.904786
NCT00141596|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-06-05|||July 2003||2003-07-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Interventional|||Extracellular Fluid in Resistant Hypertension|A Study to Investigate the Contribution of Extracellular Fluid Volume Expansion to Drug Resistant Hypertension|Terminated||N/A|32|Anticipated|St George's, University of London||||Insufficient accrual rate|f||||||||||||||2017-10-11 05:18:16.970368|2017-10-11 05:18:16.970368
NCT00141609|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-05-10|||April 2004||2004-04-01|May 2007|2007-05-01|October 2006||2006-10-01|||||Interventional|||Haemodialysis Salt Reduction Study|A Study Looking at the Effects of a Modest Reduction in Dietary Salt Intake on Blood Pressure Control in Haemodialysis Patients|Completed||N/A|20|Anticipated|St George's, University of London|||||f||||||||||||||2017-10-11 05:18:17.028596|2017-10-11 05:18:17.028596
NCT00141635|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-08-31|||December 2002||2002-12-01|August 2005|2005-08-01|June 2004||2004-06-01|||||Observational|||Implementation of Quality of Life Diagnostics and Therapy|Enhancing the Status of Quality of Life Diagnostics in Caring for Breast Cancer Patients: Results From a Multilevel Implementation Study in a Regional Tumor Centre|Completed||Phase 1|190||Tumorzentrum Regensburg e.V.|||||f||||||||||||||2017-10-11 05:18:17.159799|2017-10-11 05:18:17.159799
NCT00141648|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-09-29|||September 2000||2000-09-01|September 2009|2009-09-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Chemotherapy and Radiotherapy for Osteolymphoma|A Prospective Non-randomised Trial of Chemotherapy and Radiotherapy for Osteolymphoma|Completed||N/A|70|Actual|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||f||||||||||2017-10-11 05:18:17.234524|2017-10-11 05:18:17.234524
NCT00141661|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-08-19|||October 2005||2005-10-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients|A Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multiple Dose, Multicenter Study in Subjects With Mild to Moderate Dementia of the Alzheimer's Type to Evaluate the Safety and Tolerability of Two 10-Week Dose Regimens of Orally-Administered PF-04494700|Completed||Phase 2|67|Actual|Pfizer||3|||f||||f||||||||||2017-10-11 05:18:17.358777|2017-10-11 05:18:17.358777
NCT00141674|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-09-02|||March 2005||2005-03-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Age of Blood in Brain Injury|A Prospective Randomized Controlled Trial Comparing the Effects of Fresh vs. Old Blood on Cerebral Oxygen Extraction in Patients With Traumatic Brain Injuries|Completed||N/A|60|Anticipated|University of British Columbia|||||f||||||||||||||2017-10-11 05:18:17.462507|2017-10-11 05:18:17.462507
NCT00141687|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-09-14|||December 2004||2004-12-01|September 2016|2016-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Early External Cephalic Version (ECV) 2 Trial|Early External Cephalic Version 2 Trial|Completed||N/A|1543|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 05:18:17.526439|2017-10-11 05:18:17.526439
NCT00141700|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-12-28|||March 2003||2003-03-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|March 2005|Actual|2005-03-01||Interventional|||Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma|Rituximab Plus High-Dose Chemotherapy With Autologous Stem Cell Support for Poor-Prognosis Non-Hodgkin's Lymphoma|Terminated||Phase 2|30||University of Michigan Cancer Center||||enrollment completed|f||||||||||||||2017-10-11 05:18:17.622305|2017-10-11 05:18:17.622305
NCT00141713|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2013-03-12|||October 2003||2003-10-01|March 2013|2013-03-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease|The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease|Completed||Phase 2|40|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-10-11 05:18:17.691073|2017-10-11 05:18:17.691073
NCT00141726|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-11-04|2014-03-12||October 2003||2003-10-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional||All patients enrolled that received at least one scheduled dose.|Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant|Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Sub-Acute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation. A Phase II Study|Completed||Phase 2|34|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:18:17.771946|2017-10-11 05:18:17.771946
NCT00141739|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-12-01|2014-01-21||August 2004||2004-08-01|December 2016|2016-12-01|September 2012|Actual|2012-09-01|August 2011|Actual|2011-08-01||Interventional|||Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)|The Addition of Etanercept to Standard GVHD Prophylaxis in Patients Undergoing a Full Intensity Allogeneic Hematopoietic Stem Cell Transplant for the Prevention of Transplant Related Complications|Completed||Phase 2|100|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:18:18.120771|2017-10-11 05:18:18.120771
NCT00141752|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-10-31|||October 2002||2002-10-01|January 2012|2012-01-01||||December 2006|Actual|2006-12-01||Observational|||Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke Patients|Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke Patients|Completed||N/A|311|Actual|University Health Network, Toronto|||1||f||||||||||||||2017-10-11 05:18:18.770495|2017-10-11 05:18:18.770495
NCT00141765|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2014-05-19|2014-05-19||January 1997||1997-01-01|May 2014|2014-05-01|February 2010|Actual|2010-02-01|December 2008|Actual|2008-12-01||Interventional|||Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers|Myeloablative Chemotherapy With Stem Cell Rescue for Rare Poor-Prognosis Cancers|Completed||Phase 2|25|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:18:18.857325|2017-10-11 05:18:18.857325
NCT00141778|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2013-02-19|2012-08-03||April 2005||2005-04-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)|RAAS, Inflammation, and Post-operative AF|Completed||Phase 2/Phase 3|455|Actual|Vanderbilt University|We excluded patients with an ejection fraction less than 30% or a creatinine above 1.6 and therefore the results are not applicable to patients with left ventricular dysfunction or more severe chronic kidney disease.|3|||f||||t||||||||||2017-10-11 05:18:19.091863|2017-10-11 05:18:19.091863
NCT00141791|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-08-06|||May 2005||2005-05-01|August 2009|2009-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study Evaluating Etanercept in Moderate to Severe Asthma|A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Safety and Efficacy of Etanercept 25mg Twice Weekly in Subjects With Moderate to Severe Persistent Asthma|Completed||Phase 2|120||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:18:19.954472|2017-10-11 05:18:19.954472
NCT00141804|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-11-30|||January 2002||2002-01-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Efficacy and Safety of Sirolimus in Combination With Tacrolimus|A Randomized Multicenter Study to Compare Tacrolimus and MMF With Tacrolimus and Rapamycin in Patients After Renal Transplantation|Unknown status|Active, not recruiting|Phase 3|190||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:18:20.069305|2017-10-11 05:18:20.069305
NCT00141817|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2011-11-23|2011-11-23||August 2005||2005-08-01|November 2011|2011-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study Evaluating Pantoprazole in Children With GERD|A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of Pantoprazole Sodium in Children Aged 1 Through 11 Years With Endoscopically Proven GERD|Completed||Phase 3|41|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:18:20.18578|2017-10-11 05:18:20.18578
NCT00141830|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2009-09-15|||August 2005||2005-08-01|September 2009|2009-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis|A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 3 Oral Doses of ERB-041 in Subjects With Rheumatoid Arthritis on a Background of Methotrexate Therapy|Completed||Phase 2|159|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:18:20.94624|2017-10-11 05:18:20.94624
NCT00141843|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-04-21|||July 2005||2005-07-01|April 2008|2008-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A|A Randomized Two-Way Blinded Crossover-Design Study to Establish the Bioequivalence of B-Domain Deleted Recombinant Factor VIII (BDDrFVIII,Refacto AF) With a Full Length Recombinant Factor VIII Preparation (FLrFVIII,Advate), Followed by an Open-Label Trial of the Safety and Efficacy of ReFacto AF in Previously Treated Patients With Hemophilia A.|Completed||Phase 3|100||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:18:21.111202|2017-10-11 05:18:21.111202
NCT00141856|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-06-19|||June 2005||2005-06-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study)|Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study)|Completed||Phase 4|420|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 05:18:21.251605|2017-10-11 05:18:21.251605
NCT00141869|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-06-30|||August 30, 2005||2005-08-30|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Observational|||Brain Activity Associated With Tics in Patients With Tourette Syndrome|MEG Study of Altered Sensory Processing in Tourette Syndrome: An Exploration of Sensory Tics|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:18:21.317064|2017-10-11 05:18:21.317064
NCT00141882|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2010-11-03|||March 1999||1999-03-01|November 2010|2010-11-01|August 2006|Actual|2006-08-01|January 2006|Actual|2006-01-01||Interventional|||Memantine in Patients With Chronic Glaucoma||Completed||Phase 3|1119|Actual|Allergan||3|||f||||f||||||||||2017-10-11 05:18:21.366319|2017-10-11 05:18:21.366319
NCT00141895|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-07-18|||September 2004||2004-09-01|July 2013|2013-07-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Termination for Intrauterine Fetal Death|A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Intrauterine Fetal Death|Terminated||Phase 3|73|Actual|American University of Beirut Medical Center||2||Difficulty recruiting|f||||f||||||||||2017-10-11 05:18:21.410867|2017-10-11 05:18:21.410867
NCT00141908|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-07-18|||October 2006||2006-10-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate|Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate|Completed||Phase 2|290|Anticipated|American University of Beirut Medical Center||2|||f||||f||||||||||2017-10-11 05:18:21.486649|2017-10-11 05:18:21.486649
NCT00141921|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-09-07|2016-11-29||August 11, 2005|Actual|2005-08-11|September 2017|2017-09-01|August 16, 2017|Actual|2017-08-16|December 19, 2011|Actual|2011-12-19||Interventional|||Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis|An Open-Label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects With Plaque Psoriasis|Completed||Phase 3|182|Actual|Amgen||1|||f||||t||||||||||2017-10-11 05:18:21.591963|2017-10-11 05:18:21.591963
NCT00141934|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-04-04|||August 2005||2005-08-01|April 2007|2007-04-01||||||||Interventional|||A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.|Phase II Randomised, Double-Blind, Multicentre, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Compare the Efficacy, Safety and Tolerability of 3 Strengths of AD 452 in Adults With Active RA Who Are Currently Taking Methotrexate.|Completed||Phase 2|232||Sosei|||||||||||||||||||2017-10-11 05:18:22.516131|2017-10-11 05:18:22.516131
NCT00141947|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-07-23|||September 2005||2005-09-01|October 2005|2005-10-01|September 2006||2006-09-01|||||Interventional|||Bexarotene Treatment in Schizophrenia|Safety and Efficacy of Add-On Oral Bexarotene to Antipsychotic Treatment in Schizophrenia Patients: An Open Label Trial|Unknown status|Recruiting|Phase 3|15|Anticipated|Beersheva Mental Health Center|||||f||||t||||||||||2017-10-11 05:18:22.592653|2017-10-11 05:18:22.592653
NCT00141960|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-11-18|||September 2005||2005-09-01|June 2010|2010-06-01||||||||Interventional|||Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease|YM1170 Phase 2/3 Study: A Double Blind, Placebo Controlled, Group-comparison Study in Patients With Non-erosive Gastroesophageal Reflux Disease|Completed||Phase 2/Phase 3|480||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:18:22.687188|2017-10-11 05:18:22.687188
NCT00141973|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-05-13|||November 2004||2004-11-01|May 2008|2008-05-01|December 2005||2005-12-01|||||Observational|||Time Course of Procalcitonin and C Reactive Protein in Septic Patients Under Treatment With Corticosteroids||Completed||N/A|||Ospedale Regionale Bellinzona e Valli|||||f||||||||||||||2017-10-11 05:18:22.775001|2017-10-11 05:18:22.775001
NCT00141986|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-04-25|||November 2003||2003-11-01|September 2005|2005-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 Diabetes|Pilot Trial of Vitamin D for the Prevention of Type 1 Diabetes|Completed||Phase 1|9|Actual|Canadian Diabetes Association||2|||f||||f||||||||||2017-10-11 05:18:22.856478|2017-10-11 05:18:22.856478
NCT00141999|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-09-26|||May 2001||2001-05-01|September 2012|2012-09-01|March 2008|Actual|2008-03-01|March 2005|Actual|2005-03-01||Observational|||Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents|An Evaluation of Long-Term Protection Against Hepatitis B Virus Infection: Response of Alaska Native Children and Adolescents Who Received the Primary Recombinant Hepatitis B Vaccine Series Beginning at Birth to an Additional Dose of Vaccine|Completed||Phase 4|400||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:18:22.968333|2017-10-11 05:18:22.968333
NCT00142012|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-11-16|||October 2002||2002-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||School-Based Obesity Prevention Program|School-Based Obesity Prevention Program|Completed||N/A|1500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:18:23.039526|2017-10-11 05:18:23.039526
NCT00142025|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2009-02-18|||September 2001||2001-09-01|February 2009|2009-02-01|March 2002||2002-03-01|||||Interventional|||Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Oxcarbazepine Efficacy in Asthma Therapy|Completed||Phase 4|55||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-10-11 05:18:23.100331|2017-10-11 05:18:23.100331
NCT00142038|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-04-17|||March 2004||2004-03-01|April 2007|2007-04-01|December 2007||2007-12-01|||||Interventional|||Docetaxel and Capecitabine in Advanced Gastric Cancer|Phase II Study of Docetaxel and Capecitabine as 1st Line Therapy for Patients With Locally Advanced or Metastatic Gastric Cancer|Completed||Phase 2|80||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:18:23.186988|2017-10-11 05:18:23.186988
NCT00142051|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-07-15|||April 2005||2005-04-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis|Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis|Terminated||Phase 2|18|Actual|Boston Children’s Hospital||2||18 or 20 enrolled, stopped due to paucity of available participants|f||||t||||||||||2017-10-11 05:18:23.266098|2017-10-11 05:18:23.266098
NCT00142064|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-04-16|||August 2005||2005-08-01|September 2006|2006-09-01|April 2007|Actual|2007-04-01|||||Interventional|||A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures|A Randomized Control Trial Comparing Single to Multiple Application Lidocaine Analgesia Prior to Urethral Catheterization Procedures|Completed||Phase 2|200||Children's Mercy Hospital Kansas City|||||f||||t||||||||||2017-10-11 05:18:23.361795|2017-10-11 05:18:23.361795
NCT00142077|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-04-04|||October 2005||2005-10-01|January 2006|2006-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Electronic Health Records for Health Promotion|Health Promotion in the Workplace Using Personally Controlled Health Records|Completed||N/A|700||Boston Children’s Hospital|||||f||||||||||||||2017-10-11 05:18:23.447811|2017-10-11 05:18:23.447811
NCT00142090|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2009-02-02|||November 2004||2004-11-01|January 2009|2009-01-01|July 2007|Actual|2007-07-01|December 2005|Actual|2005-12-01||Interventional|||Use of Salt-Water Solution to Improve Symptoms in Concussion|Use of 3% Hypertonic Saline to Improve Clinical Symptoms in Concussed Patients|Completed||N/A|8|Actual|Rady Children's Hospital, San Diego||2|||f||||f||||||||||2017-10-11 05:18:23.524483|2017-10-11 05:18:23.524483
NCT00142103|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2011-05-13|||September 2005||2005-09-01|May 2011|2011-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects|CPG10101 Combination Therapy For The Treatment Of Hepatitis C: A Phase 1b Open Label Randomized Trial Of CPG10101 Alone, With Interferon, Ribavirin, Or Interferon And Ribavirin In The Treatment Of Relapsed Hepatitis C Virus (HCV) Subjects|Completed||Phase 1|91|Actual|Pfizer||6|||f||||t||||||||||2017-10-11 05:18:23.603277|2017-10-11 05:18:23.603277
NCT00142116|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-05-08|2013-06-13||May 2003||2003-05-01|May 2014|2014-05-01|February 2008|Actual|2008-02-01|February 2004|Actual|2004-02-01||Interventional|||Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia|Phase II Study of Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia|Completed||Phase 2|25|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:18:23.720374|2017-10-11 05:18:23.720374
NCT00142129|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-06-23|||December 2003||2003-12-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia|Phase II Study of Velcade in Waldenstrom's Macroglobulinemia|Completed||Phase 2|27||Dana-Farber Cancer Institute|||||||||||||||||||2017-10-11 05:18:23.926197|2017-10-11 05:18:23.926197
NCT00142155|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-06-23|||January 2002||2002-01-01|June 2011|2011-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia|Correlation of Fc Gamma RIIIA Receptor Expression and Response to Rituximab and Other Monoclonal Antibodies in Patients With Waldenstrom's Macroglobulinemia|Completed||N/A|300|Anticipated|Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:18:24.003703|2017-10-11 05:18:24.003703
NCT00142168|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-03-23|2012-12-19||September 2004||2004-09-01|March 2016|2016-03-01|April 2008|Actual|2008-04-01|May 2006|Actual|2006-05-01||Interventional|||CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia|Phase II Study of CC-5103 and Rituximab in Waldenstrom's Macroglobulinemia|Terminated||Phase 2|16|Actual|Dana-Farber Cancer Institute|Due to toxicity, study was terminated.|1||Toxicity|f||||t||||||||||2017-10-11 05:18:24.075629|2017-10-11 05:18:24.075629
NCT00142181|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-12-19|||March 2003||2003-03-01|December 2012|2012-12-01|June 2008|Actual|2008-06-01|October 2005|Actual|2005-10-01||Interventional|||Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia|Phase II Study of Campath-1H in Patients With Lymphoplasmacytic Lymphoma (Waldenstrom's Macroglobulinemia)|Completed||Phase 2|27|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:18:24.301092|2017-10-11 05:18:24.301092
NCT00142194|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2013-09-26|||June 2005||2005-06-01|September 2013|2013-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation|Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation|Completed||Phase 1|47|Actual|Emory University|||1||f||||f||||||||||2017-10-11 05:18:24.382754|2017-10-11 05:18:24.382754
NCT00142207|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-01-11|||January 2004||2004-01-01|January 2017|2017-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Preventing Malaria During Pregnancy in Epidemic-prone Areas.|The Efficacy and Cost-effectiveness of Malaria Prevention in Pregnancy in an Area of Low and Unstable Transmission in Kabale, Uganda: Use of Intermittent Preventive Treatment and Insecticide-treated Nets.|Completed||Phase 3|4775|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-10-11 05:18:24.449874|2017-10-11 05:18:24.449874
NCT00142220|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2006-09-08|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Interventional|||The Benefit of Adding Fish Oil to the Nutrition of Critically Ill Patients|Comparison Between Two Different Proportions of Omega-3- and Omega-6-Fatty Acids in the Parenteral Nutrition of Critically Ill Patients|Completed||Phase 4|160||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:18:24.53105|2017-10-11 05:18:24.53105
NCT00142233|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-09-11|||June 2004||2004-06-01|August 2005|2005-08-01|December 2008|Anticipated|2008-12-01|||||Interventional|||EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis|Double Blind Randomised Controlled Trial to Investigate the Efficacy of ANTOX (Vers) 1.2 and MGCT (Magnesiocard) for the Treatment of Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis|Unknown status|Recruiting|Phase 2/Phase 3|240|Anticipated|University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:18:24.592428|2017-10-11 05:18:24.592428
NCT00142246|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-01-25|||January 2005||2005-01-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.|Intermittent Preventive Treatment in Schools: a Randomised Controlled Trial of the Impact of IPT on Malaria, Anaemia and Education Amongst Schoolchildren in Western Kenya|Completed||Phase 3|6758|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-10-11 05:18:24.676748|2017-10-11 05:18:24.676748
NCT00142259|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-12-05|||October 2002||2002-10-01|September 2005|2005-09-01|August 2009||2009-08-01|||||Interventional|||Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia|Randomisierte, Doppelblinde Langzeitstudie Zur Klinischen Wirksamkeit Der Bilateralen Globus Pallidus Internus-Stimulation Bei Idiopathischer Generalisierter Oder Segmentaler Dystonie|Unknown status|Active, not recruiting|Phase 4|40||German Parkinson Study Group (GPS)|||||f||||||||||||||2017-10-11 05:18:24.750498|2017-10-11 05:18:24.750498
NCT00142272|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-11-18|||May 2001||2001-05-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Interventional|||Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial|Randomised, Open, Parallel Group Clinical Trial to Compare the Efficacy and Safety of a Single Dose of Ciprofloxacin Oral Suspension 20 Mg/Kg With a 3-Day Course of Erythromycin Oral Suspension Administered in a Dose of 12.5 Mg/Kg Every 6 Hours (12 Doses) in the Treatment of Children,With Clinically Severe Cholera Due to V. Cholerae O1 or O139.|Completed||Phase 3|180||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-10-11 05:18:24.816598|2017-10-11 05:18:24.816598
NCT00142285|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-01-06|||November 2004||2004-11-01|July 2006|2006-07-01|May 2008|Actual|2008-05-01|May 2006|Actual|2006-05-01||Interventional|||Zinc Pneumonia Outpatient Trial in Children < 2 Years|Efficacy of Zinc in the Treatment of Outpatient Pneumonia in an Urban Slum Among Children Less Than 2 Years Old|Completed||Phase 3|2260|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-10-11 05:18:24.886256|2017-10-11 05:18:24.886256
NCT00142298|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-03-24|2011-01-12||March 2005||2005-03-01|March 2015|2015-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies|An Open Label Trial of Telbivudine (LdT) in Adults With Chronic Hepatitis B Previously Treated in Idenix-Sponsored Telbivudine Studies|Completed||Phase 3|1869|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:18:25.008803|2017-10-11 05:18:25.008803
NCT00142311|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-04-18|||November 2003||2003-11-01|April 2007|2007-04-01|September 2006||2006-09-01|||||Observational|||Functional Characterization of Parkin + Patients|Clinical, Molecular and Metabolic Comparison Between Early Onset Parkinsonian, With or Without Parkin Mutation: Physiopathological Perspectives|Terminated||Phase 1|97||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||||||||||||2017-10-11 05:18:29.748038|2017-10-11 05:18:29.748038
NCT00142324|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-12-13|||November 2003||2003-11-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Interventional|||CALM-AD|A Randomised Placebo Controlled Trial of a Cholinesterase Inhibitor in the Management of Agitation in Dementia That is Unresponsive to a Psychological Intervention|Unknown status|Active, not recruiting|Phase 4|190||Institute of Psychiatry, London|||||f||||||||||||||2017-10-11 05:18:29.850371|2017-10-11 05:18:29.850371
NCT00142337|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-01-04|||December 2004||2004-12-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|May 2006|Actual|2006-05-01||Interventional|||One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine|A Phase 2, One Arm, Open Label, Feasibility Study Assessing One Month Zidovudine/Didanosine Postpartum Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine to Prevent Mother to Child Transmission of HIV|Completed||Phase 2|244|Actual|Institut de Recherche pour le Developpement||1|||f||||||||||||||2017-10-11 05:18:29.939321|2017-10-11 05:18:29.939321
NCT00142350|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-09-08|||November 2000||2000-11-01|September 2016|2016-09-01|January 2007||2007-01-01|||||Interventional|||A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer|Randomized Phase III Study of 5-FU Continuous Infusion (5-FUci) Versus CPT-11 Plus CDDP (CP) Versus S-1 Alone (S-1) in Advanced Gastric Cancer (JCOG9912)|Completed||Phase 3|690||Japan Clinical Oncology Group||3|||f||||t||||||||||2017-10-11 05:18:30.203055|2017-10-11 05:18:30.203055
NCT00142363|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-02-28|||May 2004||2004-05-01|February 2006|2006-02-01|December 2006||2006-12-01|||||Observational|||Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies|The DNA and Cell Bank of IFR of Neurosciences: Clinical and Genetic Study of Parkinson's Disease and Epilepsies|Terminated||Phase 1|1700||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||||||||||||2017-10-11 05:18:30.333504|2017-10-11 05:18:30.333504
NCT00142376|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-09-01|||September 2004||2004-09-01|September 2004|2004-09-01|August 2005||2005-08-01|||||Observational|||Short Term Outcomes of Children With Acute Respiratory Distress Syndrome||Completed||N/A|||Nationwide Children's Hospital|||||f||||||||||||||2017-10-11 05:18:30.415816|2017-10-11 05:18:30.415816
NCT00142389|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2011-06-21|||August 2004||2004-08-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Mother's Gift Project|Comparison of Maternal and Infant Immunization Strategies to Prevent Pneumococcal Disease|Completed||Phase 1/Phase 2|680||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:18:30.469258|2017-10-11 05:18:30.469258
NCT00142402|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-09-25|||June 2003||2003-06-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Modafinil in Multiple Sclerosis|Modafinil for Improving New Learning and Memory in Multiple Sclerosis|Completed||N/A|20||Kessler Foundation|||||f||||||||||||||2017-10-11 05:18:30.530799|2017-10-11 05:18:30.530799
NCT00142415|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-02-01|2016-11-30||February 2005||2005-02-01|February 2017|2017-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||The Safety Analysis Set comprises all subjects who received at least 1 dose of 111-In-DOTA-cG250 or 177-Lu-DOTA-cG250.|Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer|Phase I/II Study of Increasing Doses of Lutetium-177 Labeled Chimeric Monoclonal Antibody cG250 (177^Lu-DOTA-cG250) in Patients With Advanced Renal Cancer|Completed||Phase 1/Phase 2|26|Actual|Ludwig Institute for Cancer Research||6|||f||||f||||||||Yes|Data have been published|2017-10-11 05:18:30.623084|2017-10-11 05:18:30.623084
NCT00142428|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2014-03-16|||January 2005||2005-01-01|March 2014|2014-03-01|October 2008|Actual|2008-10-01|October 2005|Actual|2005-10-01||Interventional|||Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma|A Phase II Study of Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|30|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 05:18:31.961918|2017-10-11 05:18:31.961918
NCT00142441|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-06-01|||June 2003||2003-06-01|June 2016|2016-06-01|December 2004||2004-12-01|||||Interventional|||Effect of Pulse Width on Scar Treatment Using a 595-nm Pulsed Dye Laser|Effect of Pulse Width of a 595-nm Flashlamp-pumped Pulsed-dye Laser on the Treatment Response of Keloidal and Hypertrophic Sternotomy Scars|Completed||N/A|19||Mahidol University|||||f||||||||||||||2017-10-11 05:18:32.038348|2017-10-11 05:18:32.038348
NCT00142454|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-09-20|||August 2005||2005-08-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)|NY-ESO-1 Protein Vaccination in Malignant Melanoma Administered With Imiquimod as Adjuvant|Completed||Phase 1|9||Ludwig Institute for Cancer Research|||||||||||||||||||2017-10-11 05:18:32.103325|2017-10-11 05:18:32.103325
NCT00142467|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2014-03-15|||April 2004||2004-04-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|August 2006|Actual|2006-08-01||Interventional|||Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma|Phase II Study of Gemcitabine, Oxaliplatin in Combination With Bevacizumab (Avastin) in Patients With Hepatocellular Carcinoma|Completed||Phase 2|33|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 05:18:33.866247|2017-10-11 05:18:33.866247
NCT00142480|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-12-28|||December 2004||2004-12-01|December 2007|2007-12-01||||July 2007|Actual|2007-07-01||Interventional|||Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer|Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Biliary Tract and Gallbladder Cancer|Unknown status|Active, not recruiting|Phase 2|26|Anticipated|Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 05:18:34.002106|2017-10-11 05:18:34.002106
NCT00142493|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-12-23|||September 2004||2004-09-01|December 2015|2015-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Affective Content on Drug Induced Amnesia of Episodic Memory|Effect of Affective Content on Drug Induced Amnesia of Episodic Memory|Completed||Phase 1|79|Actual|Memorial Sloan Kettering Cancer Center||5|||f||||||||||||||2017-10-11 05:18:34.081826|2017-10-11 05:18:34.081826
NCT00142519|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-04-03|||March 2005|Actual|2005-03-01|April 2017|2017-04-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain|Translational Studies in Analgesic Pharmacology: Analgesic Synergy in Clinical Pain. A Phase 2 Study Comparing a Single Dose of a 1:1 Combination of Methadone and Morphine With Morphine Alone in Patients With Post-operative Pain.|Active, not recruiting||Phase 2|70|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:18:34.257275|2017-10-11 05:18:34.257275
NCT00142532|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-01-13|||June 2005||2005-06-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Acupuncture for Post-Thoracotomy Pain|Acupuncture for Post-Thoracotomy Pain: A Randomized Controlled Trial|Completed||Phase 3|162|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:18:34.333345|2017-10-11 05:18:34.333345
NCT00142545|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-08-31|||July 1999||1999-07-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||"Long Term Safety and Efficacy of SC Apomorphine in Treatment of Off Episodes in Late-Stage Parkinson's Disease"|Long-Term Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of “Off” Episodes in Patients With “On-Off” or “Wearing-Off” Effects Associated With Late-Stage Parkinson’s Disease|Completed||Phase 3|800||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:18:34.404879|2017-10-11 05:18:34.404879
NCT00142558|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-04-07|||January 1, 2005|Actual|2005-01-01|April 2017|2017-04-01|May 1, 2005|Actual|2005-05-01|May 1, 2005|Actual|2005-05-01||Interventional|||A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)|A Randomized, Double-Blind, Active-Comparator-Controlled 5-Day Trial of the Effect of Etoricoxib 120 mg Versus Indomethacin 150 mg in the Treatment of Acute Gout|Completed||Phase 4|180|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:18:34.478438|2017-10-11 05:18:34.478438
NCT00142571|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-10-01|||January 2003||2003-01-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma|Ph III Random Trial of 120-Min Infusion Gemcitabine v. 90-Min Infusion Gemcitabine + Docetaxel in Unresectable Soft Tissue Sarcoma: A Multi-Disciplinary Trial of the North Amer. Sarcoma Study Group of the Connective Tissue Oncology Society|Completed||Phase 3|120||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 05:18:34.555042|2017-10-11 05:18:34.555042
NCT00142584|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2008-03-06|||August 2005||2005-08-01|August 2005|2005-08-01|March 2008|Actual|2008-03-01|March 2008|Anticipated|2008-03-01||Interventional|||Evaluation of the Long-Term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension|An Open-Label, Randomized Study Evaluating the Long-Term Effects of Metoprolol Versus Nebivolol as Monotherapy or in Combination With Amlodipine or Hydrochlorothiazide for the Treatment of Patients With Hypertension|Completed||Phase 3|1000|Anticipated|Mylan Bertek Pharmaceuticals||2|||f||||||||||||||2017-10-11 05:18:34.629894|2017-10-11 05:18:34.629894
NCT00142597|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-04-09|2014-12-04||May 2005||2005-05-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia|Mechanisms of Acupuncture Analgesia|Completed||Phase 1/Phase 2|46|Actual|University of Michigan||2|||f||||||||||||||2017-10-11 05:18:34.864192|2017-10-11 05:18:34.864192
NCT00142610|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-03-01|||August 2005||2005-08-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|VITAS||The Role of Vitamins E and C in Maintaining Lung Health in People With Asthma|Effect of Alpha Tocopherol and Ascorbate Supplementation on Airway Antioxidant Levels in Allergic Asthmatics|Completed||Phase 1|16|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 05:18:35.078869|2017-10-11 05:18:35.078869
NCT00142623|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-07-29|||February 2006||2006-02-01|July 2008|2008-07-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|ETS||Tailored Videos to Reduce Tobacco Smoke Exposure Among Pregnant Women and Newborns|Reducing ETS Exposure of Pregnant Women and Newborns|Unknown status|Recruiting|N/A|650|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-10-11 05:18:35.169886|2017-10-11 05:18:35.169886
NCT00142636|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-11-21|||February 2004||2004-02-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Observational|||CRICKET Study, Coronary Calcium Scores in Patients With Chronic Kidney Disease|Coronary Artery Calcification in Chronic Kidney Disease Using Multidetector Row Spiral Computed Tomography|Unknown status|Active, not recruiting|N/A|200||United States Naval Medical Center, San Diego|||||f||||||||||||||2017-10-11 05:18:35.25819|2017-10-11 05:18:35.25819
NCT00142649|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-01-18|||September 2002||2002-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Adherence to Weight Loss for Hypertension in African American Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:18:35.321168|2017-10-11 05:18:35.321168
NCT00142662|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-03-26|||September 2002||2002-09-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Cafeteria-Based Study of Weight Gain Prevention||Completed||N/A|||Drexel University|||||f||||||||||||||2017-10-11 05:18:35.381731|2017-10-11 05:18:35.381731
NCT00142675|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-03-04|||February 2003||2003-02-01|March 2014|2014-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Using Peers to Promote Exercise in Older Adults||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 05:18:35.451056|2017-10-11 05:18:35.451056
NCT00142688|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-10-28|||August 2004||2004-08-01|October 2015|2015-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Examining Psychosocial Mediators of Exercise Behavior|Examining Psychosocial Mediators of Exercise Behavior|Completed||Phase 1|448|Actual|HealthPartners Institute||2|||f||||||||||||||2017-10-11 05:18:35.514904|2017-10-11 05:18:35.514904
NCT00142701|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-02-04|||April 1999||1999-04-01|February 2016|2016-02-01|March 2005|Actual|2005-03-01|September 2004|Actual|2004-09-01||Interventional|||Enhancing Support for Women at Risk for Heart Disease||Completed||N/A|||Oregon Research Institute|||||f||||f||||||||Undecided||2017-10-11 05:18:35.595667|2017-10-11 05:18:35.595667
NCT00142714|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-10-13|||August 2003||2003-08-01|October 2006|2006-10-01|June 2005||2005-06-01|||||Interventional|||Effects of Spinal Cord Injury on Female Sexual Response|Effects of SCI on Female Sexual Response|Unknown status|Recruiting|N/A|70||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:18:35.66892|2017-10-11 05:18:35.66892
NCT00142727|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-01-11|||January 2004||2004-01-01|July 2007|2007-07-01|February 2006||2006-02-01|||||Interventional|||Opioid Agonist and Antagonist Effects on Opioid Dependence|The Variability of Agonist and Antagonist Effects as a Function of Level of Physical Dependence|Terminated||Phase 2|16|Anticipated|National Institute on Drug Abuse (NIDA)||1||Study terminated due to halt in funding; may resume recruiting in future|f||||f||||||||||2017-10-11 05:18:35.735572|2017-10-11 05:18:35.735572
NCT00142740|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-02-27|||October 2005||2005-10-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025|Population Genetics and Immune Response to Hepatitis B Vaccination in Adolescents: A Substudy of ATN 024 and ATN 025|Completed||N/A|337|Actual|University of North Carolina, Chapel Hill|||2||f||||t||||||Samples With DNA|"     Approximately 5 ml whole blood or 5 x 106 peripheral blood mononuclear cells.   "|||2017-10-11 05:18:35.813047|2017-10-11 05:18:35.813047
NCT00142753|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2017-02-27|||August 2005||2005-08-01|February 2016|2016-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Immunologic Memory (Supp. of ATN 024)|Correlates of HBV-Specific B Cell Memory Following Vaccination in HIV-Infected Adolescents and HIV-Uninfected Adolescents: A Substudy of ATN 024 and ATN 025|Completed||Phase 4|95|Actual|University of North Carolina, Chapel Hill||5|||f||||||||||||||2017-10-11 05:18:35.899096|2017-10-11 05:18:35.899096
NCT00142766|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-10-05|||February 2004||2004-02-01|October 2015|2015-10-01|March 2007|Actual|2007-03-01|July 2006|Actual|2006-07-01||Interventional|||Sedation Management in Pediatric Patients Supported on Mechanical Ventilation|Sedation Management in Pediatric Patients Supported on Mechanical Ventilation|Completed||Phase 2|245|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-10-11 05:18:35.993522|2017-10-11 05:18:35.993522
NCT00142779|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-01-11|||April 2001||2001-04-01|May 2009|2009-05-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts|Serotonin Treatment of Cocaine Dependence|Completed||N/A|220||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:18:36.069676|2017-10-11 05:18:36.069676
NCT00142805|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-12-30|||October 2004||2004-10-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Ketasyn in Mild to Moderate Alzheimer's Disease|Safety, Tolerability and Efficacy Study of Ketasyn™ (AC-1202) Administered for Ninety Days in Subjects With Probable Alzheimer's Disease of Mild to Moderate Severity|Completed||Phase 2|100||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:18:36.231795|2017-10-11 05:18:36.231795
NCT00142818|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-08-27|2014-08-12||February 2006||2006-02-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|Mod-Nal||Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence|A Phase II, Double-blind, Placebo-Controlled, Pilot Trial of the Combination of Modafinil and Naltrexone for the Treatment of Cocaine and Alcohol Dependence|Completed||Phase 2|164|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-10-11 05:18:36.483702|2017-10-11 05:18:36.483702
NCT00142831|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-01-11|||April 1999||1999-04-01|August 2008|2008-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Bupropion as an Adjunct to the Nicotine Patch Plus CBT|Effectiveness of Bupropion Used in Combination With the Nicotine Replacement Patch and Cognitive Behavioral Therapy for Treating Nicotine Dependent Individuals - 1|Completed||Phase 4|293|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 05:18:36.880631|2017-10-11 05:18:36.880631
NCT00142844|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-01-11|||September 1999||1999-09-01|October 2016|2016-10-01|January 2008|Actual|2008-01-01|March 2005|Actual|2005-03-01||Interventional|||Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1|Two Medications, Disulfiram and Naltrexone, in the Treatment of Patients With Both Cocaine and Alcohol Dependence|Completed||Phase 2|208|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||f||||||||||2017-10-11 05:18:36.965241|2017-10-11 05:18:36.965241
NCT00142870|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-01-11|||March 2005||2005-03-01|October 2016|2016-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effectiveness of Bupropion in Treating Marijuana Dependent Individuals|Effects of Bupropion on Marijuana Withdrawal Symptoms|Completed||Phase 2|30|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-10-11 05:18:37.072591|2017-10-11 05:18:37.072591
NCT00142883|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-07-07|||September 2004||2004-09-01|July 2015|2015-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3|The Effects of GABA Medications on Cocaine Responses in Humans|Terminated||N/A|72|Actual|Yale University||2||Study has been completed|f||||t||||||||||2017-10-11 05:18:37.178396|2017-10-11 05:18:37.178396
NCT00142896|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-01-11|||February 2005||2005-02-01|August 2008|2008-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Tramadol to Reduce Opioid Withdrawal Symptoms|Withdrawal Suppression Efficacy of Tramadol|Completed||Phase 2|16|Actual|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:18:37.27117|2017-10-11 05:18:37.27117
NCT00142909|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-07-28|2012-11-01||February 2005||2005-02-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1|Lofexidine: Enhancing Naltrexone Treatment for Opiate Addiction|Completed||Phase 2|86|Actual|Yale University||2|||f||||t||||||||||2017-10-11 05:18:37.36438|2017-10-11 05:18:37.36438
NCT00142922|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2010-03-01|||October 2002||2002-10-01|March 2010|2010-03-01|October 2007||2007-10-01|||||Interventional|||Breaking Down Barriers to Diabetes Self-Care|Breaking Down Barriers to Diabetes Self-Care|Completed||N/A|222||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-10-11 05:18:37.775974|2017-10-11 05:18:37.775974
NCT00142935|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-05-08|2013-12-05||September 2006||2006-09-01|May 2009|2009-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1|Opiate Replacement Therapy at Release From Incarceration|Completed||N/A|87|Actual|The Miriam Hospital||3|||f||||t||||||||||2017-10-11 05:18:37.868426|2017-10-11 05:18:37.868426
NCT00142948|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-10-22|||February 2006||2006-02-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts|Heroin Addiction Treatment: Naltrexone and Adrenergic Agents|Completed||Phase 2|301|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 05:18:38.362659|2017-10-11 05:18:38.362659
NCT00142961|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-04-06|||October 2005||2005-10-01|March 2016|2016-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder|Marijuana-Abusing Attention Deficit Hyperactivity Disorder (ADHD) Teens: Atomoxetine Treatment|Completed||Phase 2|2|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 05:18:38.459326|2017-10-11 05:18:38.459326
NCT00149292|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-07-31|||August 2005||2005-08-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Study of LY2140023 in Schizophrenia|A Randomized, Double-Blind Comparison of LY2140023, Olanzapine, and Placebo in the Treatment of Patients With Schizophrenia|Completed||Phase 2|250||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:18:38.550336|2017-10-11 05:18:38.550336
NCT00149305|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-04-08|||May 2005||2005-05-01|October 2009|2009-10-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Observational|||Genetic Study of Nephrolithiasis in Gouty Diathesis|Genetic Study of Nephrolithiasis in Gouty Diathesis|Terminated||N/A|37|Actual|Mario Negri Institute for Pharmacological Research|||2|Non significative preliminary data|f||||f||||||Samples With DNA|"     Whole blood on EDTA   "|||2017-10-11 05:18:38.634872|2017-10-11 05:18:38.634872
NCT00149318|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-11-07|||December 2002||2002-12-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2008|Actual|2008-10-01||Observational|||Enzyme Replacement Therapy in Fabry Disease|Evaluation of the Long Term Efficacy of Enzyme Replacement Therapy in Fabry Disease|Terminated||N/A|2|Actual|Mario Negri Institute for Pharmacological Research|||1|Difficulties in the patient's enrolment|f||||f||||||Samples With DNA|"     Whole blood on EDTA. Serum. Urine samples.   "|||2017-10-11 05:18:38.711436|2017-10-11 05:18:38.711436
NCT00149331|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-09-07|||July 2005||2005-07-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||The Effects of Two Education Strategies About Insulin on Patient Preferences and Perceptions About Insulin Therapy|A Randomized Controlled Trial Comparing the Effects of Two Education Strategies About Insulin on Preferences and Perceptions About Insulin Therapy|Completed||Phase 4|86||McMaster University|||||f||||||||||||||2017-10-11 05:18:38.782403|2017-10-11 05:18:38.782403
NCT00149344|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-07-27|||September 2005||2005-09-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Vertical Scar Versus Inferior Pedicle Reduction Mammoplasty|Vertical Scar Versus Inferior Pedicle Reduction Mammoplasty: A Randomized Controlled Trial and Cost-Utility Analysis|Completed||N/A|254|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 05:18:38.854483|2017-10-11 05:18:38.854483
NCT00149357|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-03-21|||July 2005||2005-07-01|March 2017|2017-03-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Observational|||Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)|Determining the Risk of Fetal Loss in Women With Unprovoked Venous Thromboembolism (VTE) Who Do NOT Have Identifiable Inherited Thrombophilia Compared With Women Who Have the Diagnosis of VTE Excluded|Terminated||N/A|239|Actual|McMaster University|||1|Funding withdrawn due to low enrollment|f||||t||||||||||2017-10-11 05:18:38.952403|2017-10-11 05:18:38.952403
NCT00149370|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||January 2001||2001-01-01|August 2005|2005-08-01|August 2003||2003-08-01|||||Observational|||Quality of Life Among Breast Reduction Patients|A Prospective Study of Patients Undergoing Breast Reduction Surgery: Health-Related Quality of Life and Clinical Outcomes|Completed||N/A|52||McMaster University|||||f||||||||||||||2017-10-11 05:18:39.162855|2017-10-11 05:18:39.162855
NCT00149383|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-04-10|||December 2004||2004-12-01|April 2015|2015-04-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria|A Randomized, Double-blind, Placebo-controlled Trial of Rosiglitazone as Adjunctive Therapy for P.Falciparum Infection|Completed||Phase 1/Phase 2|140|Actual|Mahidol University||2|||f||||||||||||||2017-10-11 05:18:39.253505|2017-10-11 05:18:39.253505
NCT00149617|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-10-08|||April 2004||2004-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1|Career Training in Marijuana Dependence|Completed||Phase 2|81|Actual|Medical University of South Carolina|||||f||||||||||||||2017-10-11 05:18:41.030282|2017-10-11 05:18:41.030282
NCT00149409|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-07-12|||September 2005||2005-09-01|September 2005|2005-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure|Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure:Effects On Endothelial Function, Left Ventricular Remodelling, Natriuretic Peptide Levels, And Exercise Capacity|Completed||Phase 2/Phase 3|||Medical University of Vienna||3|||f||||||||||||||2017-10-11 05:18:39.494246|2017-10-11 05:18:39.494246
NCT00149422|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-02-08|||June 2004||2004-06-01|August 2008|2008-08-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Effect of NT-proBNP Guided Treatment of Chronic Heart Failure|Can Pro-brain-natriuretic Peptide Guided Therapy of Chronic Heart Failure Improve Heart Failure Morbidity and Mortality?|Completed||N/A|||Netherlands Heart Foundation||2|||f||||t||||||||||2017-10-11 05:18:39.58428|2017-10-11 05:18:39.58428
NCT00149435|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-12-18|||September 2005||2005-09-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Cardiovascular Health Study (CHS) Events Follow-up Study||Completed||N/A|5888|Actual|University of Washington|||1||f||||||||||||||2017-10-11 05:18:39.686973|2017-10-11 05:18:39.686973
NCT00149448|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-04-13|||May 2004||2004-05-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Effectiveness of the TB Contact Priority Model||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:18:39.765884|2017-10-11 05:18:39.765884
NCT00149461|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-01-16|||September 2006||2006-09-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|April 2008|Actual|2008-04-01||Interventional|||Written Asthma Actions Plans Versus No Written Instructions In Specialty Care|The Efficacy of Written Treatment Plans in Asthma|Completed||N/A|407|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 05:18:39.82425|2017-10-11 05:18:39.82425
NCT00149474|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-02-17|||August 1994||1994-08-01|September 2005|2005-09-01|July 1999|Actual|1999-07-01|||||Interventional|||Peak Flow Monitoring in Older Adults With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:18:39.944446|2017-10-11 05:18:39.944446
NCT00149487|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-11-06|||January 2001||2001-01-01|November 2006|2006-11-01||||||||Interventional|||Enhancing Treatment Adherence in Pediatric Asthma With a Problem Solving Intervention|Randomized Controlled Trial of Problem Solving Intervention to Enhance Treatment Adherence in Pediatric Asthma|Unknown status|Active, not recruiting|N/A|120||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:18:40.012422|2017-10-11 05:18:40.012422
NCT00149513|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-12-18|||September 2003||2003-09-01|December 2012|2012-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Post-Hospital Case Management to Improve Clinical Outcomes in Individuals Requiring Mechanical Ventilation|King County Lung Injury Project: Survivor Outcome Study (KCLIP:SOS)|Completed||N/A|600|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:18:40.222911|2017-10-11 05:18:40.222911
NCT00149526|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-02-17|||June 2001||2001-06-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Does Shared Decision-Making Improve Asthma Outcomes?||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:18:40.317933|2017-10-11 05:18:40.317933
NCT00149539|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-01-11|||June 2004||2004-06-01|July 2007|2007-07-01|January 2006|Actual|2006-01-01|||||Interventional|||Abuse Potential of Buprenorphine/Naloxone|Abuse Potential of Buprenorphine/Naloxone as a Function of Maintenance Dose of Buprenorphine/Naloxone|Terminated||Phase 2|12|Actual|National Institute on Drug Abuse (NIDA)||1||Funding ended for the study|f||||f||||||||||2017-10-11 05:18:40.388169|2017-10-11 05:18:40.388169
NCT00149552|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-03-01|||June 2001||2001-06-01|March 2012|2012-03-01|January 2007|Actual|2007-01-01|||||Interventional|||Zinc Therapy in HIV Infected Individuals Who Abuse Drugs|Zinc Therapy in Zinc Deficient HIV Positive Drug Users|Completed||N/A|231|Actual|Florida International University||2|||f||||t||||||||||2017-10-11 05:18:40.467775|2017-10-11 05:18:40.467775
NCT00149565|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-12-15|||October 1997||1997-10-01|December 2004|2004-12-01|July 2005||2005-07-01|||||Interventional|||Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma|Hepatocellular Carcinoma Postoperative Adjuvant Therapy Disease Committee of Taiwan Cooperative Oncology Group|Completed||Phase 3|268||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-10-11 05:18:40.557019|2017-10-11 05:18:40.557019
NCT00149578|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-05-16|||October 2004||2004-10-01|May 2007|2007-05-01|October 2008|Anticipated|2008-10-01|||||Interventional|||A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer|A Phase II Study of Induction Chemotherapy Followed by Concurrent Chemotherapy With Radiotherapy in Locally Advanced Pancreatic Cancer|Unknown status|Recruiting|Phase 2|45|Anticipated|National Health Research Institutes, Taiwan|||||f||||t||||||||||2017-10-11 05:18:40.651344|2017-10-11 05:18:40.651344
NCT00149591|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-09-04|||April 2001||2001-04-01|September 2006|2006-09-01|January 2007||2007-01-01|||||Interventional|||The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)|Early and Long-Term Outcome of Elective Stenting of the Infarct-Related Artery in Patients With Viability in the Infarct-Area Early After Acute Myocardial Infarction. The VIAMI-Trial.|Unknown status|Active, not recruiting|N/A|300||Netherlands Heart Foundation|||||f||||||||||||||2017-10-11 05:18:40.778056|2017-10-11 05:18:40.778056
NCT00149604|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-12-01|||March 2000||2000-03-01|December 2009|2009-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||AFTER: Altering Fat Through Estrogen and Raloxifene|Modulation of Visceral Fat by Estrogens After Menopause|Completed||Phase 2|108||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:18:40.938278|2017-10-11 05:18:40.938278
NCT00288782|ClinicalTrials.gov processed this data on October 10, 2017|2006-02-07|2007-04-18|||February 2006||2006-02-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||PET Neuroimaging of [11C]Mirtazapine|Receptor Occupancy Determined by PET Neuroimaging of [11C]Mirtazapine in Healthy Humans|Completed||Phase 4|24||University of Aarhus|||||f||||f||||||||||2017-10-11 06:00:52.344252|2017-10-11 06:00:52.344252
NCT00149903|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01||||June 2006|Actual|2006-06-01||Interventional|||Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients|Multicenter, Double-blind, Randomized, Parallel Group Study on Efficacy and Safety of Enteric-coated Mycophenolate Sodium vs. Mycophenolate Mofetil in de Novo Chinese Renal Transplant Recipients|Completed||Phase 3|300||Novartis|||||f||||||||||||||2017-10-11 05:18:41.110383|2017-10-11 05:18:41.110383
NCT00149916|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-11-01|||April 2000||2000-04-01|November 2011|2011-11-01||||April 2004|Actual|2004-04-01||Interventional|||Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107|Multicenter, Open-label Follow-up Study on the Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Patients.|Completed||Phase 3|139|Actual|Novartis||1|||||||||||||||||2017-10-11 05:18:41.191662|2017-10-11 05:18:41.191662
NCT00149929|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-02-01|||December 1999||1999-12-01|February 2011|2011-02-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301|Multicenter, Open-label Follow-up Study on the Safety of Enteric-coated Mycophenolate Sodium in de Novo Renal Transplant Patients|Completed||Phase 3|246|Actual|Novartis|||||||||||||||||||2017-10-11 05:18:41.264657|2017-10-11 05:18:41.264657
NCT00149942|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-11-16|||October 2004||2004-10-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy|Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From GI Adverse Events While on Mycophenolate Mofetil Therapy|Completed||Phase 4|23|Actual|Novartis|||||f||||||||||||||2017-10-11 05:18:41.347649|2017-10-11 05:18:41.347649
NCT00149968|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-10-14|||April 2005||2005-04-01|October 2009|2009-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife)|Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife)|Completed||Phase 4|196|Actual|Novartis||1|||f||||f||||||||||2017-10-11 05:18:41.425367|2017-10-11 05:18:41.425367
NCT00149981|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-12-10|||August 2003||2003-08-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|Umbrella||A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation|A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation|Completed||Phase 4|1025|Actual|Novartis||1|||f||||f||||||||||2017-10-11 05:18:41.565974|2017-10-11 05:18:41.565974
NCT00149994|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-04-07|2011-01-25||December 2002||2002-12-01|April 2011|2011-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients|DELTA Study Dutch Evaluation in Liver Transplantation To Assess the Efficacy of Cyclosporine A Microemulsion With C-2h Monitoring Versus Tacrolimus With Trough Monitoring in de Novo Liver Transplant Recipients|Completed||Phase 4|171|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:18:42.185102|2017-10-11 05:18:42.185102
NCT00150007|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2017-09-12|||June 2004||2004-06-01|November 2011|2011-11-01||||June 2005|Actual|2005-06-01||Interventional|||Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)|Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)|Completed||Phase 4|335||Novartis|||||f||||||||||||||2017-10-11 05:18:43.016932|2017-10-11 05:18:43.016932
NCT00150020|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-01-21|||October 2004||2004-10-01|January 2008|2008-01-01||||February 2006|Actual|2006-02-01||Interventional|||Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance|Safety and Tolerability of Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients With GI Intolerance|Completed||Phase 4|728|Anticipated|Novartis|||||||||||||||||||2017-10-11 05:18:43.085228|2017-10-11 05:18:43.085228
NCT00150033|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-05-21|||May 2005||2005-05-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|||||Observational|||Health-Related Quality of Life for Thyroid Patients|Development and Validation of a Thyroid-Specific Quality of Life Measure|Completed||Phase 2|1200|Anticipated|Odense University Hospital|||||f||||||||||||||2017-10-11 05:18:43.173243|2017-10-11 05:18:43.173243
NCT00150046|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2011-11-01|||December 2004||2004-12-01|November 2011|2011-11-01||||May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients|A 12-month, Multicenter, Randomized, Open-label Non-inferiority Study of Renal Function and Efficacy Comparing Concentration-controlled Certican (1.5 mg/Day Starting Dose) With Reduced Neoral Dose Versus MMF With Standard Neoral Dose in de Novo Heart Transplant Recipients|Completed||Phase 3|176|Anticipated|Novartis|||||f||||||||||||||2017-10-11 05:18:43.242064|2017-10-11 05:18:43.242064
NCT00150059|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-02-14|||December 2004||2004-12-01|February 2008|2008-02-01|December 2005|Actual|2005-12-01|||||Interventional|||Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis||Completed||Phase 4|||Novartis|||||f||||||||||||||2017-10-11 05:18:43.340022|2017-10-11 05:18:43.340022
NCT00150072|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-02-21|||October 2004||2004-10-01|February 2017|2017-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of Imatinib in Chordoma|Phase II Study of Imatinib Mesylate in Chordoma|Completed||Phase 2|55|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:18:43.425363|2017-10-11 05:18:43.425363
NCT00150085|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-02-17|||February 2004||2004-02-01|February 2011|2011-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion|A Prospective, Randomized, Open-label, Twenty-six Week Study of the Efficacy and Safety of Converting Kidney and Liver Transplant Recipients With Tacrolimus-associated Abnormal Glucose Metabolism to Cyclosporine Micro-emulsion With C2 Monitoring|Terminated||Phase 4|50|Actual|Novartis|||||f||||||||||||||2017-10-11 05:18:43.56924|2017-10-11 05:18:43.56924
NCT00150306|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-08-16|||November 2002||2002-11-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD|A Multicenter, 10-Week, Randomized, Double-Blind Study Of Sertraline And Placebo In Children And Adolescents With Posttraumatic Stress Disorder (PTSD)|Terminated||Phase 3|160||Pfizer||||Please see Detailed Description below for termination reason.|||||f||||||||||2017-10-11 05:18:46.348329|2017-10-11 05:18:46.348329
NCT00150098|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-04-07|||February 2005||2005-02-01|April 2014|2014-04-01|October 2010|Actual|2010-10-01|November 2009|Actual|2009-11-01||Interventional|||Project UNITY - HIV Risk Reduction and Vaccine Education Interventions|Project UNITY - A Randomized Trial of Enhanced HIV Risk Reduction and Vaccine Education Interventions in Reducing Sexual Risk and Increasing Vaccine Trial Knowledge Among HIV-negative, High-risk Women Who Use Non-injection Drugs|Completed||N/A|400|Actual|New York Blood Center||1|||f||||f||||||||||2017-10-11 05:18:43.671403|2017-10-11 05:18:43.671403
NCT00150111|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-10-05|||June 2003||2003-06-01|October 2006|2006-10-01|October 2006||2006-10-01|||||Interventional|||Rituximab in the Treatment of Graves' Disease|B Cell Depletion With the Anti-CD20 Monoclonal Antibody Rituximab in the Treatment of Graves' Disease|Completed||Phase 1/Phase 2|20||Odense University Hospital|||||f||||||||||||||2017-10-11 05:18:43.772225|2017-10-11 05:18:43.772225
NCT00150124|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-12-03|||January 2003||2003-01-01|December 2013|2013-12-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Block-replacement Therapy During Radioiodine Therapy|The Influence of Continuous Block-replacement Therapy on the Effect of Radioiodine in Patients With Hyperthyroidism|Completed||Phase 4|100|Actual|Odense University Hospital||2|||f||||f||||||||||2017-10-11 05:18:43.88013|2017-10-11 05:18:43.88013
NCT00150137|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-02-02|||January 2003||2003-01-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Antithyroid Drugs During Radioiodine Therapy|The Influence of Continuous Treatment With Antithyroid Drugs on the Effect of Radioiodine in Patients With Hyperthyroidism|Completed||Phase 4|80||Odense University Hospital|||||f||||||||||||||2017-10-11 05:18:43.974453|2017-10-11 05:18:43.974453
NCT00150150|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-03-26|||January 2001||2001-01-01|March 2007|2007-03-01|March 2006||2006-03-01|||||Interventional|||Laser Therapy of Benign Thyroid Nodules|Ultrasound Guided Interstitial Laser Photocoagulation on Benign Thyroid Nodules|Unknown status|Active, not recruiting|Phase 3|70||Odense University Hospital|||||f||||||||||||||2017-10-11 05:18:44.061845|2017-10-11 05:18:44.061845
NCT00150163|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-03-28|||March 2002||2002-03-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Observational|||Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men|Odense Androgen Study – A Population-Based Study of Androgens, Body Composition, and Muscle Function in 20-29 Year-Old Danish Men|Unknown status|Active, not recruiting|N/A|800||Odense University Hospital|||||f||||||||||||||2017-10-11 05:18:44.136828|2017-10-11 05:18:44.136828
NCT00150176|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-10-29|2010-04-28|2009-04-29|April 2005||2005-04-01|October 2015|2015-10-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)|A Randomized, Placebo-Controlled, Double-Blind Trial of Asenapine in the Prevention of Relapse After Long-Term Treatment of Schizophrenia|Completed||Phase 3|831|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:18:44.220901|2017-10-11 05:18:44.220901
NCT00150189|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-12-22|||November 2003||2003-11-01|December 2006|2006-12-01||||||||Interventional|||Utilization of Oral Sucrose to Decrease Pain in Infants During Immunizations|Efficacy of Oral Sucrose Analgesia During Routine Immunizations at 6 Weeks and 4 Months of Age|Completed||N/A|140||Penn State University|||||f||||||||||||||2017-10-11 05:18:45.007353|2017-10-11 05:18:45.007353
NCT00150202|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-05-04|||July 2004||2004-07-01|November 2006|2006-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)|Clinical Study Of EYE001 In Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|Completed||Phase 3|90||Pfizer|||||f||||||||||||||2017-10-11 05:18:45.226484|2017-10-11 05:18:45.226484
NCT00150215|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-07-24|||July 2005||2005-07-01|April 2006|2006-04-01|October 2005||2005-10-01|||||Interventional|||A First In Human Study Of PF-00184562 In Healthy Volunteers|An Oral, Rising Single-Dose Tolerance, Pharmacokinetic, and Pharmacodynamic Study of Pf-00184562 Capsules In Healthy Volunteers|Completed||Phase 1|18||Pfizer|||||||||||||||||||2017-10-11 05:18:45.398373|2017-10-11 05:18:45.398373
NCT00150228|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-05-31|||December 2001||2001-12-01|May 2007|2007-05-01|September 2002|Actual|2002-09-01|||||Interventional|||12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation|A Twelve-Week Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety and Efficacy of a Flexible-Dosing Strategy for CP-526,555 ( 0.5 mg to 2.0 mg Total Daily Dose ) in Smoking Cessation|Completed||Phase 2|300||Pfizer|||||||||||||||||||2017-10-11 05:18:45.463938|2017-10-11 05:18:45.463938
NCT00150241|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-10-16|||February 2000||2000-02-01|October 2015|2015-10-01|January 2002|Actual|2002-01-01|||||Interventional|||A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation|A Seven-Week Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Three Doses of CP-526,555 ( 0.3 mg QD, 1 mg QD, and 1 mg BID ) in Comparison With Zyban in Smoking Cessation|Completed||Phase 2|625||Pfizer|||||||||||||||||||2017-10-11 05:18:45.539844|2017-10-11 05:18:45.539844
NCT00150254|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-06-01|||September 2001||2001-09-01|June 2007|2007-06-01|October 2002|Actual|2002-10-01|||||Interventional|||12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.|A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Four Dosing Strategies for CP-526,555 ( 0.5 mg BID Titrated, 0.5 mg BID, 1 mg BID, and Titrated 1 mg BID ) in Smoking Cessation|Completed||Phase 2|625||Pfizer|||||||||||||||||||2017-10-11 05:18:45.678874|2017-10-11 05:18:45.678874
NCT00150267|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-11-04|||February 2002||2002-02-01|November 2008|2008-11-01||||||||Interventional|||A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension|A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension|Completed||Phase 3|976|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:18:45.782523|2017-10-11 05:18:45.782523
NCT00150280|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-07-23|||October 2004||2004-10-01|November 2005|2005-11-01|July 2005||2005-07-01|||||Interventional|||Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery|A Prospective, Randomized, Double-Blind, Double-Dummy, Multi-Center Study Comparing Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery|Completed||Phase 3|132||Pfizer|||||f||||||||||||||2017-10-11 05:18:46.028582|2017-10-11 05:18:46.028582
NCT00150293|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-03-04|||March 2002||2002-03-01|March 2015|2015-03-01|November 2005||2005-11-01|||||Interventional|||Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.|Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.|Completed||Phase 3|337||Pfizer|||||f||||||||||||||2017-10-11 05:18:46.105759|2017-10-11 05:18:46.105759
NCT00150319|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-09-25|||June 2005||2005-06-01|September 2008|2008-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend|An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Iv Containing Sbecd As An Excipient Following Multiple Dosing With Vfend®; I.V. In Subjects With Moderately Impaired Renal Function|Terminated||Phase 1/Phase 2|1|Actual|Pfizer||||See Detailed Description|f||||||||||||||2017-10-11 05:18:46.449881|2017-10-11 05:18:46.449881
NCT00150332|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-05-09|||January 2003||2003-01-01|May 2011|2011-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan|Linezolid (PNU-10766/PNU10766SS) in the Treatment of MRSA Infections in Patients Whose Conventional Therapy Has Failed, or Who Are Intolerant to Conventional Therapy; an Open-label, Multi-center Trial|Completed||Phase 3|24|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:18:46.780888|2017-10-11 05:18:46.780888
NCT00150345|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-01-17|2010-04-05||January 2005||2005-01-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|IDEA||Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients|Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In High-Risk Neutropenic Patients With Fever And A Positive Panfungal Polymerase Chain Reaction Assay (IDEA Study)|Completed||Phase 3|147|Actual|Pfizer|One participant in the Immediate Voriconazole treatment group was incorrectly included in the original Primary efficacy analysis and has now been excluded; IFI was identified on the day study treatment started (not prior to study treatment).|2|||f||||f||||||||||2017-10-11 05:18:46.909212|2017-10-11 05:18:46.909212
NCT00150358|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-12-07|||March 2005||2005-03-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .|Open Label, Multicenter, Non Comparative Study, To Confirm The Efficacy And Tolerability Of Viagra In Subjects With Erectile Dysfunction And Arterial Hypertension Who Are Taking Antihypertensive Treatment.|Completed||Phase 4|253||Pfizer|||||f||||||||||||||2017-10-11 05:18:48.042922|2017-10-11 05:18:48.042922
NCT00150371|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-07-01|||June 2004||2004-06-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Interventional|CANACTFAST||Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration|A Multicenter, 12 Week Treatment Single Step Titration Open-Label Study Assessing The % Of Patients Achieving Ldl-C Target With Atorvastatin Starting Doses Of 10mg, 20mg, 40mg and 80mg.|Completed||Phase 3|1100||Pfizer|||||f||||||||||||||2017-10-11 05:18:48.147993|2017-10-11 05:18:48.147993
NCT00150384|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-04-21|||July 2004||2004-07-01|April 2015|2015-04-01|August 2005|Actual|2005-08-01|||||Interventional|CAPABLE||Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population|Clinical Utility Of Caduet In Simultaneously Achieving Blood Pressure And Lipid Endpoints In A Specific Patient Population (CAPABLE)|Completed||Phase 4|500||Pfizer|||||||||||||||||||2017-10-11 05:18:48.384568|2017-10-11 05:18:48.384568
NCT00150397|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-06-07|||March 2005||2005-03-01|June 2012|2012-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Six-Week Study Of The Efficacy And Safety Of Tofimilast Dry Powder For Inhalation In Adults With Persistent Asthma|Completed||Phase 2|112||Pfizer|||||f||||||||||||||2017-10-11 05:18:48.77181|2017-10-11 05:18:48.77181
NCT00150410|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-10-28|||January 2003||2003-01-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose|A One-Year, Open, Randomized, Parallel, Three-Arm Study Comparing Exubera® (Insulin Dry Powder Pulmonary Inhaler) vs. Avandia® (Rosiglitazone Maleate) as Add-On Therapy vs. Exubera® Substitution of Sulfonylurea in Patients With Type 2 Diabetes, Poorly Controlled on Combination Sulfonylurea and Metformin Treatment|Completed||Phase 3|626|Actual|Pfizer|||||||||||||||||||2017-10-11 05:18:48.881005|2017-10-11 05:18:48.881005
NCT00150423|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-12-28|||January 2001||2001-01-01|December 2006|2006-12-01|July 2005||2005-07-01|||||Interventional|||To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.|An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.|Completed||Phase 3|384||Pfizer|||||f||||||||||||||2017-10-11 05:18:49.198118|2017-10-11 05:18:49.198118
NCT00150436|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-12-20|||February 2002||2002-02-01|December 2006|2006-12-01|July 2005||2005-07-01|||||Interventional|||To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.|An Open-Label Extension Safety and Efficacy Study of Pregabalin in Patients With Postherpetic Neuralgia|Completed||Phase 3|276||Pfizer|||||f||||||||||||||2017-10-11 05:18:49.248478|2017-10-11 05:18:49.248478
NCT00150449|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-07-13|||January 2001||2001-01-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.|A 1-Year Open-Label Safety Extension Study of Pregabalin in Patients With Anxiety Disorders|Completed||Phase 3|511||Pfizer|||||f||||||||||||||2017-10-11 05:18:49.316057|2017-10-11 05:18:49.316057
NCT00150462|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-04-28|2015-10-29||September 2005||2005-09-01|April 2017|2017-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies|A Phase I Study of the Safety and Pharmacokinetics of Escalating Intravenous Doses of the Proteasome Inhibitor PR-171 in Patients With Hematological Malignancies|Completed||Phase 1|48|Actual|Amgen||11|||f||||f||||||||||2017-10-11 05:18:49.734306|2017-10-11 05:18:49.734306
NCT00150475|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||January 2005||2005-01-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Contamination During Removal of Two Different Personal Protective Systems|Contamination During Removal of Two Different Personal Protective Systems When Working Under Conditions Requiring Enhanced Respiratory and Contact Precautions|Completed||N/A|50||Queen's University|||||f||||||||||||||2017-10-11 05:18:54.815983|2017-10-11 05:18:54.815983
NCT00150488|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-09-17|||September 2005||2005-09-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||URACYST® For the Treatment of GAG Deficient Interstitial Cystitis|URACYST® For the Treatment of GAG Deficient Interstitial Cystitis|Completed||Phase 2/Phase 3|53|Actual|Queen's University||1|||f||||f||||||||||2017-10-11 05:18:54.87781|2017-10-11 05:18:54.87781
NCT00151463|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-08-15|||January 2005||2005-01-01|August 2007|2007-08-01||||||||Interventional|||QEQ Treatment Responsiveness Evaluation Study|An Open-Label, Non-Comparative Study To Evaluate Treatment Responsiveness To The Quality Of Erection Questionnaire (QEQ) In Men With Erectile Dysfunction Treated With Viagra (Sildenafil Citrate)|Completed||Phase 4|100||Pfizer|||||f||||||||||||||2017-10-11 05:19:07.889696|2017-10-11 05:19:07.889696
NCT00150514|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||January 2002||2002-01-01|November 2003|2003-11-01|December 2006||2006-12-01|||||Interventional|||Effects of Sublingual Immunotherapy on Grasspollen Allergy|A Placebo Controlled, Double-Blind, Randomised Study to Assess Efficacy of Sublingual Immunotherapy in Patients With Grass Pollen Allergy Through Assessment of Its Immunological Effects on the Mucosal Tissue of the Nose.|Completed||Phase 4|38||Radboud University|||||f||||||||||||||2017-10-11 05:18:54.965027|2017-10-11 05:18:54.965027
NCT00150540|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-09-13|||October 2002||2002-10-01|September 2007|2007-09-01|January 2006|Actual|2006-01-01|||||Interventional|||A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.|A Long Term, Open Label Extension Study of Protocols LAM-IV-301, LAM-IV 303, LAM-IV 307 AND LAM-IV 308.|Completed||Phase 3|93||Shire|||||||||||||||||||2017-10-11 05:18:55.185813|2017-10-11 05:18:55.185813
NCT00150553|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-11-01|||January 2005||2005-01-01|May 2006|2006-05-01|October 2005||2005-10-01|||||Interventional|||Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder|A Phase IIIb, Randomized, Double-Blind, Parallel Group Study in Bipolar I Patients to Assess the Efficacy and Safety of SPD417 Administered Once Daily vs Twice Daily in the Treatment of Manic Symptoms|Completed||Phase 3|102||Validus Pharmaceuticals|||||||||||||||||||2017-10-11 05:18:55.253545|2017-10-11 05:18:55.253545
NCT00150566|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-04-29|||February 2004||2004-02-01|April 2010|2010-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood|A Phase IIIb, Multi-center, Two-Cohort, Randomized Study, With an Open-Label Run-In and a Long-Term Extensions Phase, Assessing an Extended Dose Range of Lanthanum Carbonate in End Stage Renal Disease Subjects Receiving Hemodialysis|Completed||Phase 3|460||Shire|||||f||||||||||||||2017-10-11 05:18:55.321059|2017-10-11 05:18:55.321059
NCT00150579|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-11-02|||January 2005||2005-01-01|November 2007|2007-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Efficacy and Safety of SPD465 in Adults With ADHD|A Phase III, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).|Completed||Phase 3|240||Shire|||||||||||||||||||2017-10-11 05:18:55.384297|2017-10-11 05:18:55.384297
NCT00150592|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-05-06|2009-09-10||May 2005||2005-05-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|||||Interventional|||Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17|A Phase II Study to Assess the Safety, Tolerability and Efficacy of SPD503 Administered to Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|182|Actual|Shire||2|||||||||||||||||2017-10-11 05:18:55.457318|2017-10-11 05:18:55.457318
NCT00150605|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-11-01|||February 2005||2005-02-01|June 2006|2006-06-01|October 2005||2005-10-01|||||Interventional|||Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder|A Phase IIIb, Open Label Observational Study of SPD417 Used in Combination With Other Psychotropic Medications for the Treatment of Bipolar I Disorder|Completed||Phase 3|50||Validus Pharmaceuticals|||||||||||||||||||2017-10-11 05:18:55.982844|2017-10-11 05:18:55.982844
NCT00150618|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-11-25|2009-09-10||April 2004||2004-04-01|November 2009|2009-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17|A Phase III, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled Safety and Efficacy Study of SPD503 in Children and Adolescents Aged 6-17 With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|324|Actual|Shire||5|||||||||||||||||2017-10-11 05:18:56.05685|2017-10-11 05:18:56.05685
NCT00150631|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-11-25|||November 2000||2000-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|January 2004|Actual|2004-01-01||Interventional|||Danish Hypertension Prevention Project - DHYPP|Danish Hypertension Prevention Project|Unknown status|Active, not recruiting|Phase 3|100|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-10-11 05:18:56.788892|2017-10-11 05:18:56.788892
NCT00150644|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-05-27|||July 2003||2003-07-01|May 2008|2008-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy|A Phase 2, 12-Week, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of J867 on Uterine Artery Blood Flow and the Morphology of the Endometrium, Myometrium, and Uterine Leiomyomata in Subjects With Uterine Leiomyomata Scheduled for Hysterectomy.|Completed||Phase 2|33|Actual|Abbott||3|||f||||f||||||||||2017-10-11 05:18:56.862441|2017-10-11 05:18:56.862441
NCT00150657|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-11-28|||November 2004||2004-11-01|September 2005|2005-09-01||||||||Interventional|||Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer|Phase II Trial of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|45||St. John Providence Health System|||||||||||||||||||2017-10-11 05:18:56.946507|2017-10-11 05:18:56.946507
NCT00150670|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-07-06|||March 2002||2002-03-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer|Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer|Completed||Phase 3|300||Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 05:18:57.045024|2017-10-11 05:18:57.045024
NCT00150683|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||March 1999||1999-03-01|September 2005|2005-09-01|July 2001||2001-07-01|||||Interventional|||Effectiveness of Vibration and Standing Versus Standing Alone for the Treatment of Osteoporosis for People With Spinal Cord Injury.|Evaluation of Conventional and Innovative Standing Frame for the Treatment of Osteoporosis After Spinal Cord Injury|Completed||N/A|60||Toronto Rehabilitation Institute|||||f||||||||||||||2017-10-11 05:18:57.141999|2017-10-11 05:18:57.141999
NCT00150696|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-11-20|||February 2000||2000-02-01|November 2007|2007-11-01|November 2005||2005-11-01|||||Interventional|||Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.|Risedronate for Prevention of Osteoporosis After Spinal Cord Injury|Completed||Phase 3|38||Toronto Rehabilitation Institute|||||f||||||||||||||2017-10-11 05:18:57.21122|2017-10-11 05:18:57.21122
NCT00133965|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2011-04-19|||May 2005||2005-05-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Psychosocial Support for Cancer Patients|Psychosocial Support for Cancer Patients|Completed||N/A|281|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-10-11 05:19:26.717464|2017-10-11 05:19:26.717464
NCT00150709|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-02-14|||February 1998||1998-02-01|February 2017|2017-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy|A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of The Safety And Efficacy Of Levetiracetam (Ucb L059) In Children With Epilepsy|Completed||Phase 3|238||UCB Pharma|||||f||||||||||||||2017-10-11 05:18:57.299797|2017-10-11 05:18:57.299797
NCT00150722|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-11-07|||September 2005||2005-09-01|November 2008|2008-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||High-Density Lipoprotein (HDL) Modulation and Endothelial Function|HDL Modulation and Endothelial Function|Completed||Phase 3|75|Actual|University of Calgary||1|||f||||||||||||||2017-10-11 05:18:57.618775|2017-10-11 05:18:57.618775
NCT00150735|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-11-25|||June 2002||2002-06-01|July 2010|2010-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy|A Multicenter, Double-blind, Randomized, Parallel Group, Positive-controlled Trial Comparing the Efficacy and Safety of Levetiracetam (1000 to 3000 mg/Day Oral b.i.d.) to Carbamazepine (400 to 1200 mg/Day Oral b.i.d.), Used as Monotherapy for up to a Maximum of 121 Weeks in Subjects (≥ 16 Years) Newly or Recently Diagnosed as Suffering From Epilepsy, and Experiencing Partial or Generalized Tonic-clonic Seizures|Completed||Phase 3|580||UCB Pharma|||||f||||||||||||||2017-10-11 05:18:57.725218|2017-10-11 05:18:57.725218
NCT00150748|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-03-24|||November 2001||2001-11-01|March 2015|2015-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy|An Open-label, Multicenter, Follow-up Study to Evaluate the Safety and Efficacy of Levetiracetam (LEV) (Oral Tablets of 166, 250 or 500 mg b.i.d.), at Individualized Doses up to a Maximum of 4000 mg/Day (or 80 mg/kg/Day for Children and Adolescents Less Than 50 kg), in Children (≥ 4 Years Old), Adolescents and Adults Suffering From Primary Generalized Seizures|Completed||Phase 3|217|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:18:57.816062|2017-10-11 05:18:57.816062
NCT00150761|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-08-25|||July 2004||2004-07-01|September 2009|2009-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Facial Thermography Study of Levocetirizine Versus Cetirizine|A Randomized, Double-blind, Double Dummy, Placebo Controlled, Cross-over Exploratory Trial in Healthy Male Adult Subjects: Comparison by Means of Infrared Thermography of the Anti-H1 Potency of Levocetirizine 5 mg and Cetirizine 10 mg Tablet Single Oral Dose After Nasal Histamine Provocation.|Completed||Phase 4|60||UCB Pharma|||||f||||||||||||||2017-10-11 05:18:57.935286|2017-10-11 05:18:57.935286
NCT00150774|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-09-16|||November 2001||2001-11-01|February 2010|2010-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults|A Double-blind, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Levetiracetam (LEV) (Oral Tablets of 500 mg b.i.d.) at a Dose of 3000 mg/Day as Adjunctive Treatment in Adolescents (≥ 12 Years) and Adults (≤ 65 Years) Suffering From Idiopathic Generalized Epilepsy With Myoclonic Seizures.|Completed||Phase 3|116||UCB Pharma|||||f||||||||||||||2017-10-11 05:18:58.024055|2017-10-11 05:18:58.024055
NCT00150787|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-11-25|||July 2003||2003-07-01|September 2009|2009-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.|A Multicenter, Double-blind, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam (1000 to 3000 mg/Day Oral b.i.d.) and Carbamazepine (400 to 1200 mg/Day Oral b.i.d.), Used as Monotherapy in Subjects (≥ 16 Years) Coming From the N01061 Trial.|Completed||Phase 3|250||UCB Pharma|||||f||||||||||||||2017-10-11 05:18:58.119923|2017-10-11 05:18:58.119923
NCT00150800|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-09-29|||January 2006|Actual|2006-01-01|September 2017|2017-09-01|September 2017|Actual|2017-09-01|September 2017|Actual|2017-09-01||Interventional|||This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment|An Open-label, Multi-center, Follow-up Trial to Evaluate Long Term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment at a Flexible Dose up to a Maximum of 200 mg/Day in Subjects Aged 16 Years or Older Suffering From Epilepsy|Completed||Phase 3|668|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:18:58.195487|2017-10-11 05:18:58.195487
NCT00150813|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-12-05|||August 2005||2005-08-01|September 2009|2009-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.|A Multicenter, Open-label, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam Individualized Dose From 1000 to 3000 mg/Day (Oral Tablets of 500 mg b.i.d.), Used as Monotherapy in Subjects (≥ 16 Years) Suffering From Epilepsy and Coming From the N01061 or the N01093 Trials.|Completed||Phase 3|70||UCB Pharma|||||f||||||||||||||2017-10-11 05:18:58.622517|2017-10-11 05:18:58.622517
NCT00150826|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-04-12|||May 2000||2000-05-01|April 2012|2012-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia|A Double-Blind, Multicenter, Placebo Controlled Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease.|Completed||Phase 4|78|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 05:18:58.773063|2017-10-11 05:18:58.773063
NCT00150839|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-11-20|||March 2006||2006-03-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|COATS||Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy|Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy - a Monocentric, Double-Blind, Placebo-Controlled Trial|Unknown status|Recruiting|Phase 4|80|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-10-11 05:18:58.889389|2017-10-11 05:18:58.889389
NCT00150852|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-12-28|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.|Vancomycin for Prophylaxis of PEG-Related Wound Infection in MRSA-Positive Patients: a Double-Blind, Randomized, Placebo-Controlled Study|Unknown status|Recruiting|Phase 2|96||University Hospital, Geneva|||||f||||||||||||||2017-10-11 05:18:59.04888|2017-10-11 05:18:59.04888
NCT00150865|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||September 2001||2001-09-01|September 2005|2005-09-01|March 2002||2002-03-01|||||Interventional|||Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery|Study of Posterior Lumbar Plexus Block for Pain Relief After Hip Surgery|Completed||N/A|60||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:18:59.165327|2017-10-11 05:18:59.165327
NCT00150878|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-06-19|||December 2003||2003-12-01|June 2013|2013-06-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission|Randomized Phase III Comparison of 12 Gy TBI and Cyclophosphamide 120 mg/kg With Fludarabine 120 mg/Sqm and 8 Gy TBI Before Allogeneic Transplantation in Patients With Acute Myeloid Leukemia in First Remission|Terminated||Phase 3|198|Actual|University Hospital Carl Gustav Carus||2||Insurance coverage reached|f||||t||||||||||2017-10-11 05:18:59.249328|2017-10-11 05:18:59.249328
NCT00150891|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-05-08|||January 1998||1998-01-01|May 2007|2007-05-01|January 2006|Actual|2006-01-01|||||Observational|||Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection|Role of Th1, Th2 and Monokine Responses as Risk Factors of Acute and Chronic Renal Transplant Rejection – Impact of Different Immunosuppressive Protocols|Completed||N/A|84|Actual|University of Giessen|||||f||||f||||||||||2017-10-11 05:18:59.344155|2017-10-11 05:18:59.344155
NCT00150904|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-02-13|||August 2005||2005-08-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Observational|||Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)|Request for Blood Samples to Examine the Effect of Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Patients With Hepatitis C and in Patients Coinfected With Hepatitis C and HIV|Completed||N/A|28|Actual|UMC Utrecht|||||f||||||||||||||2017-10-11 05:18:59.438636|2017-10-11 05:18:59.438636
NCT00150917|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-06-12|||July 2001||2001-07-01|December 2006|2006-12-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||RCT of a Group Intervention for Women With a Family History of Breast Cancer|A Randomized Controlled Trial of a Group Intervention for Women With a Family History of Breast Cancer|Completed||Phase 3|150|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 05:18:59.517916|2017-10-11 05:18:59.517916
NCT00150930|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-11-27|||October 2002||2002-10-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness|Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness|Unknown status|Active, not recruiting|Phase 4|200||UMC Utrecht|||||f||||||||||||||2017-10-11 05:18:59.61852|2017-10-11 05:18:59.61852
NCT00150943|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-04-26|||June 2000||2000-06-01|April 2006|2006-04-01||||||||Interventional|||Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis|The Benefit of STent Placement and Blood Pressure and Lipid-Lowering for the Prevention of Progression of Renal Dysfunction Caused by Atherosclerotic Ostial Stenosis of the Renal Artery (STAR)|Completed||Phase 3|140||UMC Utrecht|||||f||||||||||||||2017-10-11 05:18:59.725751|2017-10-11 05:18:59.725751
NCT00150956|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||April 1999||1999-04-01|October 2000|2000-10-01|January 2002||2002-01-01|||||Interventional|||Effects of Daily Home Hemodialysis on Circulation, Mental Functions, and Quality of Life|Study Into the Effects of Daily Home Hemodialysis on Hemodynamics, Neurocognitive Functions, and Quality of Life|Completed||Phase 3|12||UMC Utrecht|||||f||||||||||||||2017-10-11 05:18:59.824046|2017-10-11 05:18:59.824046
NCT00150969|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-11-19|2012-01-10||January 2002||2002-01-01|November 2012|2012-11-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||Vitamin K Supplementation in Post-Menopausal Osteopenia|Evaluation of the Clinical Use of Vitamin K Supplementation in Post-Menopausal Women With Osteopenia (ECKO Trial)|Completed||Phase 3|440|Actual|University Health Network, Toronto|Originally designed as a 2-year study with BMD as primary outcome. Thus, the number of women followed to 3 and 4 years was small, and the study was not powered to examine fracture outcomes.|2|||f||||t||||||||||2017-10-11 05:18:59.922653|2017-10-11 05:18:59.922653
NCT00150982|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-08-06|||September 2003||2003-09-01|August 2008|2008-08-01|February 2005||2005-02-01|||||Interventional|||Alefacept Mechanism of Action in Psoriasis|In Vivo Induction of T Cell Apoptosis by Alefacept (LFA-3/IgG1 Fusion Protein, Amevive) in Patients With Psoriasis: An Investigator-Initiated, Open-Label, Mechanism of Action Study|Completed||Phase 2|9||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-10-11 05:19:00.432379|2017-10-11 05:19:00.432379
NCT00150995|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-01-20|||May 2001||2001-05-01|January 2015|2015-01-01|April 2006|Actual|2006-04-01|October 2003|Actual|2003-10-01||Interventional|||Tetrathiomolybdate in Hormone Refractory Prostate Cancer|A Phase II Trail of Tetrathiomolybdate in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|19|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:19:00.495105|2017-10-11 05:19:00.495105
NCT00151008|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-08-06|||November 2003||2003-11-01|August 2008|2008-08-01|August 2005||2005-08-01|||||Interventional|||Bexarotene With Narrow-Band UVB for Psoriasis|Investigator-Initiated, Double Blind, Vehicle-Controlled, Bilateral Comparison Trial of Bexarotene (Targretin) Gel 1% vs. Vehicle Gel in Combination With Narrow Band UVB Phototherapy for Moderate to Severe Psoriasis Vulgaris|Completed||Phase 2|35||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-10-11 05:19:00.568011|2017-10-11 05:19:00.568011
NCT00151021|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-12-08|||June 2005||2005-06-01|December 2009|2009-12-01|January 2006||2006-01-01|||||Interventional|||Stepping Up to Health: Feedback to Promote Physical Activity in Diabetes|Automated Step-count Feedback to Promote Physical Activity in Diabetes|Completed||N/A|40|Anticipated|University of Michigan|||||f||||||||||||||2017-10-11 05:19:00.628795|2017-10-11 05:19:00.628795
NCT00151034|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-01-20|||September 2000||2000-09-01|January 2015|2015-01-01|October 2007|Actual|2007-10-01|August 2004|Actual|2004-08-01||Interventional|||Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer|Phase II Evaluation of Trastuzumab (Herceptin), Paclitaxel, Carboplatin, and Gemcitabine in the Treatment of Advanced Urothelial Cancer|Completed||Phase 2|33|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:19:00.687166|2017-10-11 05:19:00.687166
NCT00151047|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-01-19|||March 2003||2003-03-01|January 2015|2015-01-01|October 2007|Actual|2007-10-01|January 2005|Actual|2005-01-01||Interventional|||Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer|Evaluation of Primary Chemotherapy With Docetaxel Plus Capecitabine in Selected Patients With Newly Diagnosed Localized or Locally Advanced Prostate Cancer|Completed||Phase 2|15|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:19:00.789182|2017-10-11 05:19:00.789182
NCT00151060|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-01-19|||December 1998||1998-12-01|January 2015|2015-01-01|June 2006|Actual|2006-06-01|November 2004|Actual|2004-11-01||Interventional|||Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate|Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Patients With Hormonally Responsive Adenocarcinoma of the Prostate|Completed||Phase 2|28|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:19:00.854412|2017-10-11 05:19:00.854412
NCT00151073|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-01-21|||April 2002||2002-04-01|January 2015|2015-01-01|September 2007|Actual|2007-09-01|September 2005|Actual|2005-09-01||Interventional|||Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate|An Evaluation of Estramustine, Docetaxel and Zoledronate in Patients With Hormone-Refractory Adenocarcinoma of the Prostate|Completed||Phase 2|28|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 05:19:00.923301|2017-10-11 05:19:00.923301
NCT00151086|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-01-20|||December 2001||2001-12-01|January 2015|2015-01-01|August 2006|Actual|2006-08-01|March 2004|Actual|2004-03-01||Interventional|||Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer|Phase I/II Evaluation of Oral Estramustine and Oral Vinorelbine on an Intermittent Schedule in Patients With Hormone-Refractory Adenocarcinoma of the Prostate|Completed||Phase 1/Phase 2|33|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:19:01.218908|2017-10-11 05:19:01.218908
NCT00151099|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-12-17|||September 2005||2005-09-01|August 2007|2007-08-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Safety of Preoperative Oral Administration of a High Caloric Drink With Protein|Safety of Preoperative Oral Administration of a High Caloric Drink With Protein in Patients With Dysgnathia|Withdrawn||Phase 4|0|Actual|University Hospital Muenster||||There is no possibility to reach the target patient number within the set time frame|f||||||||||||||2017-10-11 05:19:01.301328|2017-10-11 05:19:01.301328
NCT00151112|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-09-10|||September 2005||2005-09-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Two Different Procedures for Plexus Anesthesia|Comparison of Two Different Procedures for Plexus Anesthesia: Standard Position Versus Combination of Lateral Position and 20° Trendelenburg Position|Completed||N/A|100|Actual|University Hospital Muenster||2|||f||||f||||||||||2017-10-11 05:19:01.37486|2017-10-11 05:19:01.37486
NCT00151125|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-05-16|||July 2004||2004-07-01|May 2016|2016-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Phase II Study of IL-11 (Neumega) in Von Willebrand Disease|Phase II Comparison Study of Hemostatic Efficacy of Escalating Doses of Interleukin-11 (rhIL-11, Neumega) in Subjects With Type 1 Von Willebrand Disease|Completed||Phase 2|12|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-10-11 05:19:01.470922|2017-10-11 05:19:01.470922
NCT00151138|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-12-13|||September 2002||2002-09-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Cognitive/Cerebrovascular Consequences of HTN Treatment|Cognitive and Cerebrovascular Sequelae of Hypertension|Completed||N/A|50||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:19:01.570282|2017-10-11 05:19:01.570282
NCT00151151|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-09-12|||February 2003||2003-02-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The S.A.F.E. Study : Computer-Aided Counseling to Prevent Teen Pregnancy/Sexually Transmitted Diseases (STDs)|The S.A.F.E. Study: Computer-Aided Counseling to Prevent Teen Pregnancy/STDs - Validity and Reliability Testing of Computer Measures, Pilot-testing of Timeline Followback Calendar Protocol, and Randomized Efficacy Study|Completed||N/A|660|Anticipated|University of Pittsburgh|||||f||||f||||||||||2017-10-11 05:19:01.671922|2017-10-11 05:19:01.671922
NCT00151164|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-07-11|||April 2004||2004-04-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Thymic Tolerance in Pediatric Heart Transplantation|Thymic Tolerance in Pediatric Heart Transplantation|Terminated||Phase 2|48|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||||"Due to failure to control sufficient patients in the active arm, this study has now been   closed."|f||||||||||||||2017-10-11 05:19:01.771982|2017-10-11 05:19:01.771982
NCT00151177|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-11-23|||April 2005||2005-04-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Continuous Positive Airway Pressure Ventilation After Acute Ischemic Stroke|Feasibility and Efficacy Study of Early Continuous Positive Airway Pressure Ventilation in Patients With Acute Ischemic Stroke|Completed||Phase 1/Phase 2|100|Anticipated|University Hospital Muenster||2|||f||||f||||||||||2017-10-11 05:19:01.87495|2017-10-11 05:19:01.87495
NCT00151190|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-01-07|||April 2005||2005-04-01|January 2010|2010-01-01|August 2006||2006-08-01|||||Interventional|||"Community Diabetes Education Program Evaluation Code Evaluation"|Community Diabetes Education Program Evaluation|Completed||Phase 3|180||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 05:19:02.0048|2017-10-11 05:19:02.0048
NCT00151203|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-02-13|||December 2004|Actual|2004-12-01|February 2017|2017-02-01|August 2022|Anticipated|2022-08-01|April 2007|Actual|2007-04-01||Interventional|||Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma|A Phase II Study of Clarithromycin (Biaxin), Lenalidomide (Revlimid), and Dexamethasone (Decadron) for Newly Diagnosed Subjects With Multiple Myeloma|Active, not recruiting||Phase 2|50|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-10-11 05:19:02.105838|2017-10-11 05:19:02.105838
NCT00151216|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-05-23|||June 2004||2004-06-01|May 2017|2017-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis|Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Expressing the Human CLN2 cDNA to the Brain of Children With Late Infantile Neuronal Ceroid Lipofuscinosis|Active, not recruiting||Phase 1|10|Actual|Weill Medical College of Cornell University||2|||f||||t|t|f||||||Undecided||2017-10-11 05:19:02.178997|2017-10-11 05:19:02.178997
NCT00151229|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-06-03|||October 2003||2003-10-01|June 2015|2015-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|VALISH||Valsartan in Elderly Isolated Systolic Hypertension Study|Valsartan in Elderly Isolated Systolic Hypertension|Completed||Phase 4|3079|Actual|VALISH study||2|||f||||t||||||||||2017-10-11 05:19:02.267147|2017-10-11 05:19:02.267147
NCT00151242|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-09-19|||July 2004||2004-07-01|September 2017|2017-09-01|August 2013|Actual|2013-08-01|August 2011|Actual|2011-08-01||Interventional|||Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia|Randomized Phase II/III-Study on All-Trans Retinoic Acid in Combination With Induction and Consolidation Therapy as Well as Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 2/Phase 3|920|Actual|University of Ulm||2|||f||||||||||||||2017-10-11 05:19:02.346455|2017-10-11 05:19:02.346455
NCT00151450|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-03-19|||March 2005||2005-03-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|||||Interventional|||Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder|An 8-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study Of Pregabalin (300-600 Mg/Day) And Venlafaxine XR (75-225 Mg/Day) For The Acute Treatment Of DSM-IV Generalized Anxiety Disorder In Outpatients|Completed||Phase 3|390||Pfizer|||||f||||||||||||||2017-10-11 05:19:07.694452|2017-10-11 05:19:07.694452
NCT00151255|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-04-18|||June 2004||2004-06-01|April 2017|2017-04-01|January 2011|Actual|2011-01-01|June 2009|Actual|2009-06-01||Interventional|||All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia|Phase III - Study on All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 3|500|Anticipated|University of Ulm||1|||f||||||||||||||2017-10-11 05:19:02.495316|2017-10-11 05:19:02.495316
NCT00151268|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-07-28|||March 2004||2004-03-01|July 2016|2016-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Genotype - Phenotype Correlations of LINCL|Genotype - Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis|Completed||N/A|18|Actual|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"     whole blood, serum   "|No||2017-10-11 05:19:02.633684|2017-10-11 05:19:02.633684
NCT00151281|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-08-10|2017-02-23||November 2004||2004-11-01|August 2017|2017-08-01|April 7, 2011|Actual|2011-04-07|December 2009|Actual|2009-12-01||Interventional|||Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma|Phase II Trial of Anti-Angiogenic Therapy With RT-PEPC in Patients With Relapsed Mantle Cell Lymphoma|Completed||Phase 2|25|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-10-11 05:19:02.702116|2017-10-11 05:19:02.702116
NCT00151294|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-09-12|||November 2004||2004-11-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Interventional|||The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis|A Double-Blind, Placebo-Controlled Investigation Into the Safety and Efficacy of Escitalopram for Depression in Multiple Sclerosis|Terminated||Phase 4|20||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:19:04.462672|2017-10-11 05:19:04.462672
NCT00151307|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-06-05|||February 2001||2001-02-01|June 2008|2008-06-01|April 2007||2007-04-01|||||Interventional|||Effects of Cerebral Oxygen Saturation on Neuropsychological Outcomes|The Effects of Monitoring and Maintaining Cerebral Oxygen Saturation on Neuropsychological Outcomes in Patients Undergoing Cardiac Surgery|Terminated||Phase 2/Phase 3|200|Anticipated|Weill Medical College of Cornell University||||Could not recruit any more people.|f||||||||||||||2017-10-11 05:19:04.540712|2017-10-11 05:19:04.540712
NCT00151320|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-02-23|2017-02-23||January 2004|Actual|2004-01-01|February 2017|2017-02-01|April 24, 2013|Actual|2013-04-24|April 2010|Actual|2010-04-01||Interventional|||Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL|Phase I/II Trial of VELCADE+ CHOP-Rituximab in Patients With Previously Untreated Diffuse Large B Cell or Mantle Cell Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|76|Actual|Weill Medical College of Cornell University||1|||f|||||t|f||||||Undecided||2017-10-11 05:19:04.606709|2017-10-11 05:19:04.606709
NCT00151333|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-09-03|||February 2005||2005-02-01|September 2009|2009-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)|A Randomized, Double-blind, Placebo-controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics Trial of Multiple Ascending Fixed Doses of SRA-333 in Subjects With Mild to Moderate Alzheimer's Disease.|Completed||Phase 2|16||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:19:04.804186|2017-10-11 05:19:04.804186
NCT00151346|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-03-17|||October 2003||2003-10-01|March 2008|2008-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Combined Spinal-Epidural Versus Traditional Labor Epidural|Combined Spinal-Epidural Versus Traditional Labor Epidural: A Randomized, Controlled Trial Comparing Maternal and Fetal Effects|Completed||Phase 4|127|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 05:19:04.863599|2017-10-11 05:19:04.863599
NCT00151359|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||February 2002||2002-02-01|September 2005|2005-09-01||||||||Observational|||Clinical Trials Stage of 'SoleSensor': A Balance-Enhancing Shoe Insert.|Clinical Trials Stage of 'SoleSensor': A Balance-Enhancing Shoe Insert.|Completed||N/A|||Wilfrid Laurier University|||||f||||||||||||||2017-10-11 05:19:04.946646|2017-10-11 05:19:04.946646
NCT00151372|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-12-07|2009-07-07||March 2002||2002-03-01|December 2009|2009-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients|Treatment Effectiveness in Depressed Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|141|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 05:19:05.015865|2017-10-11 05:19:05.015865
NCT00151385|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-06-26|||November 2005||2005-11-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Evaluating Inhibitor Specificity in Hemophilia A|A Multicenter Study to Describe the Immunogenic Epitope(s) of Factor VIII in Previously Treated Patients With Congenital Hemophilia A Who Develop De Novo Factor VIII Inhibitors While Receiving Factor VIII Infusion Therapy.|Withdrawn||Phase 4|0|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:19:06.514334|2017-10-11 05:19:06.514334
NCT00151398|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-02-07||2013-02-07|September 2005||2005-09-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)|A 3-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability, and Efficacy Study Of 3 Doses Of Lecozotan (SRA-333) SR In Outpatients With Mild To Moderate Alzheimer's Disease With Donepezil As Active Control.|Completed||Phase 2|229|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||t||||||||||2017-10-11 05:19:06.630046|2017-10-11 05:19:06.630046
NCT00151424|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-08-18|||February 15, 2005|Actual|2005-02-15|August 2017|2017-08-01|February 6, 2006|Actual|2006-02-06|January 6, 2006|Actual|2006-01-06||Interventional|||Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)|A Multicenter, Randomized, Double-Blind, Flexible-Dose, 6-Week Trial of the Efficacy and Safety of Asenapine Compared With Placebo Using Olanzapine Positive Control in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 3|277|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 05:19:07.460338|2017-10-11 05:19:07.460338
NCT00151437|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-04-22|||November 2004||2004-11-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Canadian Pegvisomant Compassionate Study In Acromegalic Patients|A Multi-Center, Open-Label Study For The Compassionate Use Of Pegvisomant In Acromegalic Patients Refractory To Conventional Therapy and For Patients Who Received The Product During The Clinical Development Program.|Completed||Phase 4|30||Pfizer|||||f||||||||||||||2017-10-11 05:19:07.574833|2017-10-11 05:19:07.574833
NCT00151476|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-03-04|2009-11-19||November 2004||2004-11-01|March 2010|2010-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients|A Registry-Based Observational Study Assessing Clinical Outcomes In Familial Adenomatous Polyposis In Patients Receiving Celecoxib (Celebrex(Registered), Onsenal(Registered)) Compared With Control Patients|Terminated||Phase 4|68|Actual|Pfizer|Study prematurely discontinued May 2008 prior to reaching enrollment target; due to limited number of matched pairs, results do not provide sufficient data to evaluate effectiveness of celecoxib. Last subject last visit was November 2008.||2|See Detailed Description|f||||f||||||||||2017-10-11 05:19:08.001919|2017-10-11 05:19:08.001919
NCT00151489|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-03-14|||April 2005||2005-04-01|September 2006|2006-09-01|June 2006|Actual|2006-06-01|||||Interventional|||Safety and Efficacy Study of Pregabalin in Fibromyalgia|A Six-Month, Double-Blind, Placebo Controlled, Durability of Effect Study of Pregabalin for Pain Associated With Fibromyalgia|Completed||Phase 3|1020||Pfizer|||||||||||||||||||2017-10-11 05:19:09.153233|2017-10-11 05:19:09.153233
NCT00151502|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-07-09|||November 2002||2002-11-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|||||Interventional|||To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.|An 80-Week, Randomized, Multi-Center, Parallel-Group, Double-Blind Study of the Efficacy and Safety of Atorvastatin 80 MG Plus an Acetylcholinesterase Inhibitor Versus an Acetylcholinesterase Inhibitor Alone in the Treatment of Mild to Moderate Alzheimer's Disease.|Completed||Phase 3|600||Pfizer|||||||||||||||||||2017-10-11 05:19:09.593375|2017-10-11 05:19:09.593375
NCT00151515|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-09-28|||October 2003||2003-10-01|September 2016|2016-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss|A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of 5 Percent Minoxidil Foam in the Treatment of Androgenetic Alopecia in Males|Completed||Phase 3|352|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||f||||||||||2017-10-11 05:19:09.894435|2017-10-11 05:19:09.894435
NCT00151528|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-03-07|||January 2005||2005-01-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||An Open-Label Trial of Pregabalin in Patients With Fibromyalgia|A Long-Term, Open-Label, Safety Trial of Pregabalin in Patients With Fibromyalgia|Completed||Phase 3|428||Pfizer|||||||||||||||||||2017-10-11 05:19:10.045281|2017-10-11 05:19:10.045281
NCT00151541|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-05-27|||February 2005||2005-02-01|May 2011|2011-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%|A Phase 3, Randomized, Double-blind, Multi-dose Study to Evaluate the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG 5%) When Co-administered With Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% in the Treatment of Acne Vulgaris.|Completed||Phase 3|301|Actual|Allergan|||||||||||||||||||2017-10-11 05:19:10.35399|2017-10-11 05:19:10.35399
NCT00151554|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-07-28|||February 2005||2005-02-01|July 2010|2010-07-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Reducing Intensive Care Unit (ICU) Related Anxiety Through a Structured Information Program|Reducing ICU Related Anxiety Through a Structured Information Program. A Randomized Controlled Clinical Trial|Completed||N/A|140|Actual|Philipps University Marburg Medical Center||2|||f||||||||||||||2017-10-11 05:19:10.435086|2017-10-11 05:19:10.435086
NCT00151567|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-12-03|||February 2002||2002-02-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|TAMSULOSINE||Evaluation of Tamsulosin in the Treatment of Ureteral Stones|Interest of a Treatment With the alpha1-blocker Tamsulosin in the Elimination of Pelvis Ureteral Stones|Completed||Phase 3|129|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-10-11 05:19:10.540091|2017-10-11 05:19:10.540091
NCT00151580|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-05-18|||February 2002||2002-02-01|November 2007|2007-11-01|July 2006|Actual|2006-07-01|||||Interventional|TRANSPEG||Treatment of Recurrent Hepatitis C After Liver Transplantation|Comparison of Maintenance Treatment by Ribavirin to a Placebo, After an Initial One-year Treatment With Pegylated Interferon-α2a - Ribavirin Association in Hepatitis C Viral Recurrence After Liver Transplantation|Completed||Phase 3|200|Actual|Rennes University Hospital||2|||f||||||||||||||2017-10-11 05:19:10.761255|2017-10-11 05:19:10.761255
NCT00151593|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-11-22|||February 2002||2002-02-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Evaluation of Celsior® in Liver Transplant Preservation.|Celsior®: Evaluation of an Organ Preservation Solution in Liver Transplantation.|Completed||Phase 2|140|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-10-11 05:19:10.90427|2017-10-11 05:19:10.90427
NCT00151606|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-01-09|||December 2002||2002-12-01|January 2006|2006-01-01|February 2004||2004-02-01|||||Interventional|||Comparison of Two Protocols to Prevent the Acquisition of Methicillin-Resistant Staphylococcus Aureus.|Evaluation of Two Protocols to Prevent the Acquisition of Methicillin-Resistant Staphylococcus Aureus in Intensive Care Units.|Completed||N/A|500||Rennes University Hospital|||||f||||||||||||||2017-10-11 05:19:11.126737|2017-10-11 05:19:11.126737
NCT00151619|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-12-30|||February 1999||1999-02-01|December 2005|2005-12-01||||||||Interventional|||Effects of Amlodipine in the Management of Chronic Heart Failure|Regional and Systemic Hemodynamic Effects of a Long-Term Administration of Amlodipine in Patients With Chronic Heart Failure Treated With a Combination of Enalapril, Furosemide and Digoxin|Suspended||Phase 2|24||Rennes University Hospital|||||f||||||||||||||2017-10-11 05:19:11.260717|2017-10-11 05:19:11.260717
NCT00151632|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-07-03|||May 2003||2003-05-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|MMF-FK||Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation|Evaluation of the Benefit/Risk Ratio of a Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil on the Prevention of Complications in Adult Liver Transplantation|Terminated||Phase 3|195|Actual|Rennes University Hospital||2||insufficient enrollment|f||||t||||||||||2017-10-11 05:19:11.388743|2017-10-11 05:19:11.388743
NCT00151645|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-12-30|||December 2003||2003-12-01|December 2005|2005-12-01|July 2005||2005-07-01|||||Interventional|||Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.|Renal Cell Carcinoma Treatment With Activated Tumor- Infiltrated Lymphocytes. A Non-Randomized Phase II Trial.|Terminated||Phase 2|36||Rennes University Hospital|||||f||||||||||||||2017-10-11 05:19:11.524855|2017-10-11 05:19:11.524855
NCT00139516|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2014-03-11|||September 2001||2001-09-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Chinese Community Smoking Cessation Project||Completed||N/A|||University of California, San Francisco|||||f||||||||||||||2017-10-11 05:19:36.941465|2017-10-11 05:19:36.941465
NCT00151658|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-12|||October 2002||2002-10-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)|Randomized Multicenter Comparison of Sirolimus Versus Bare Metal Stent Implantation in Complex Coronary Lesions. Acronym: Scand Stent|Completed||N/A|322||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:19:11.65709|2017-10-11 05:19:11.65709
NCT00151671|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-02-24|||April 2003||2003-04-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|IMPACT||Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer|Prospective, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Effect of Oral Immune-Enhancing Nutritional Supplement on Hepatic Function After Liver Resection for Primary or Secondary Cancer on Cirrhosis or Liver Fibrosis|Terminated||Phase 2/Phase 3|35|Actual|Rennes University Hospital||2||insufficient enrollment rate|f||||f||||||||||2017-10-11 05:19:11.79858|2017-10-11 05:19:11.79858
NCT00151684|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-02-27|||November 2004||2004-11-01|February 2008|2008-02-01||||||||Interventional|||Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men|Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men: a Dose Response Study, Part II|Completed||Phase 2|25|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-10-11 05:19:11.923551|2017-10-11 05:19:11.923551
NCT00151697|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-08-08|||May 2005||2005-05-01|August 2011|2011-08-01||||||||Interventional|||LANN-study: Lantus, Amaryl, Novorapid, Novomix Study|New Approach to Treat Type II Diabetes Failing on Maximal Oral Treatment|Completed||Phase 3|150|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-10-11 05:19:12.020551|2017-10-11 05:19:12.020551
NCT00151710|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-02-28||||||February 2007|2007-02-01||||||||Interventional|||Effects of Pioglitazone in Congenital Adrenal Hyperplasia|Effects of Pioglitazone in Glucocorticoid-Induced Insulin Resistance. Studies in Congenital Adrenal Hyperplasia.|Completed||N/A|||Radboud University|||||f||||||||||||||2017-10-11 05:19:12.115466|2017-10-11 05:19:12.115466
NCT00151723|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-17|||April 2004||2004-04-01|September 2005|2005-09-01||||||||Interventional|||Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?|Subclinical Hyperthyroidism ”To Treat or Not to Treat?” A Dutch Multicenter Trial|Unknown status|Recruiting|N/A|200|Anticipated|Radboud University|||||f||||||||||||||2017-10-11 05:19:12.189715|2017-10-11 05:19:12.189715
NCT00151736|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-06-08|||September 2004||2004-09-01|June 2012|2012-06-01|February 2008|Actual|2008-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)|A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 2|88|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-10-11 05:19:12.302975|2017-10-11 05:19:12.302975
NCT00151749|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-01-16|||June 2004||2004-06-01|January 2012|2012-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||WelChol® and Insulin in Treating Patients With Type 2 Diabetes|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetes With Inadequate Glycemic Control on Insulin Therapy Alone or Insulin Therapy Combination With Other Oral Anti-diabetic Agents|Completed||Phase 3|260||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:19:12.440587|2017-10-11 05:19:12.440587
NCT00151762|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-12-26|||December 2004||2004-12-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes|A Multi-Center, 52-Week, Open-Label Extension Study (From Studies WEL-301, WEL-302, and WEL-303) to Evaluate the Long-Term Safety and Tolerability of WelChol® in Type 2 Diabetic Patients|Completed||Phase 3|780||Daiichi Sankyo, Inc.|||||f||||f||||||||||2017-10-11 05:19:12.633993|2017-10-11 05:19:12.633993
NCT00151775|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-05-26|2010-03-08|2009-08-19|May 2005||2005-05-01|May 2016|2016-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure|Dose-ranging Study to Evaluate the Safety and Efficacy of Olmesartan Medoxomil in Children and Adolescents With Hypertension|Completed||Phase 2/Phase 3|362|Actual|Daiichi Sankyo, Inc.||3|||f||||||||||||||2017-10-11 05:19:12.8569|2017-10-11 05:19:12.8569
NCT00151788|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-01-16|||February 2004||2004-02-01|January 2012|2012-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.|A Randomized, Double-blind, Stratified, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of the ACAT Inhibitor CS-505 for Reducing the Progression of Atherosclerosis in Subjects With Heterozygous Familial Hypercholesterolemia and Carotid Atherosclerosis Using Carotid Ultrasound (CUS)|Terminated||Phase 2/Phase 3|796||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:19:15.790677|2017-10-11 05:19:15.790677
NCT00151801|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||May 2002||2002-05-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Interventional|||Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients|Safety and Tolerability of Oral Two-Doses Estroprogestins Associated With Interferon-Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis|Unknown status|Recruiting|Phase 2|200||S. Andrea Hospital|||||f||||||||||||||2017-10-11 05:19:15.984122|2017-10-11 05:19:15.984122
NCT00151814|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-04-12|2010-03-19|2008-12-05|September 2005||2005-09-01|April 2010|2010-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Olmesartan Pediatric Pharmacokinetic (PK) Study|An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension|Completed||Phase 1|24|Actual|Daiichi Sankyo, Inc.||1|||f||||||||||||||2017-10-11 05:19:16.162043|2017-10-11 05:19:16.162043
NCT00151827|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-10-13|||August 2003||2003-08-01|October 2010|2010-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Olmesartan Medoxomil in Hypertension and Renal Impairment|Efficacy and Safety of Olmesartan Medoxomil Compared With Losartan in Patients With Hypertension and Mild to Moderate Renal Impairment|Completed||Phase 3|393|Actual|Daiichi Sankyo, Inc.||2|||f||||f||||||||||2017-10-11 05:19:17.124382|2017-10-11 05:19:17.124382
NCT00151840|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-01-30|||October 2001||2001-10-01|January 2006|2006-01-01|March 2002||2002-03-01|||||Interventional|||Efficacy and Safety of IVIG-L in ITP Patients|Efficacy and Safety of IVIG-L (Human Normal Immunoglobulin for Intravenous Use)in Idiopathic Thrombocytopenic Purpura (ITP)Patients|Completed||Phase 3|20||Sanquin|||||f||||||||||||||2017-10-11 05:19:17.230382|2017-10-11 05:19:17.230382
NCT00151853|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-01-30|||March 2002||2002-03-01|January 2006|2006-01-01|September 2004||2004-09-01|||||Interventional|||Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery|Phase IV Study on the Efficacy of PPSB-SD and VP-VI in Patients Using Oral Anticoagulant Therapy and Undergoing Acute Cardiac Surgery With a Cardiopulmonary Bypass|Completed||Phase 4|40||Sanquin|||||f||||||||||||||2017-10-11 05:19:17.386036|2017-10-11 05:19:17.386036
NCT00151866|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-02-26|||October 2003||2003-10-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma|A Multicentre Randomised Study of the Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma|Completed||Phase 3|180||Sanquin Research & Blood Bank Divisions|||||f||||||||||||||2017-10-11 05:19:17.496426|2017-10-11 05:19:17.496426
NCT00151879|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-09-19|||February 2005||2005-02-01|July 2010|2010-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures|A Multicenter, Open-label Trial to Investigate the Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures With or Without Secondary Generalization.|Completed||Phase 2/Phase 3|160|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:19:17.604785|2017-10-11 05:19:17.604785
NCT00151892|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-02-13|2010-08-26||April 2005||2005-04-01|February 2017|2017-02-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis|A Phase III, Randomized Multi-centre, Double-blind, Parallel Group, Active Comparator Study to Compare the Efficacy and Safety of SPD476 (Mesalazine)2.4g/Day Once Daily With Asacol 1.6g/Day Twice Daily in the Maintenance of Remission in Patients With Ulcerative Colitis|Completed||Phase 3|829|Actual|Shire||2|||f||||||||||||||2017-10-11 05:19:17.732309|2017-10-11 05:19:17.732309
NCT00151905|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-05-04|||November 2003||2003-11-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||The Use of an Inhaled Salt Solution to Treat Viral Lung Infections in Infants.|Nebulized Hypertonic Saline in the Treatment of Bronchiolitis in Infants|Completed||Phase 2/Phase 3|||Sheikh Khalifa Medical City|||||f||||||||||||||2017-10-11 05:19:19.093498|2017-10-11 05:19:19.093498
NCT00151918|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-06-06|||January 2005||2005-01-01|September 2007|2007-09-01|August 2006|Actual|2006-08-01|||||Interventional|||Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease|A Multi-Centre, Open Label, Randomized, Parallel Group Pilot Study to Assess the Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease|Completed||Phase 3|48||Shire|||||||||||||||||||2017-10-11 05:19:19.179542|2017-10-11 05:19:19.179542
NCT00151931|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-08-31|||May 2004||2004-05-01|August 2011|2011-08-01|January 2006|Actual|2006-01-01|||||Interventional|||Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis|A Multi-Centre, Open-Label Study Assessing the Efficacy and Tolerability of Lanthanum Carbonate in the Reduction of Serum Phosphate Levels in End Stage Renal Disease Patients Receiving Dialysis|Completed||Phase 3|456||Shire|||||f||||||||||||||2017-10-11 05:19:19.239461|2017-10-11 05:19:19.239461
NCT00151944|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-06-06|||November 2003||2003-11-01|December 2008|2008-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.|A Phase III, Randomized, Multi-center, Open-label, 12 to 14 Month Extension Study to Evaluate the Safety and Tolerability of SPD476 (Mesalazine) Given Once Daily vs. Twice Daily for the Maintenance of Ulcerative Colitis in Remission.|Completed||Phase 3|400||Shire|||||f||||||||||||||2017-10-11 05:19:19.308339|2017-10-11 05:19:19.308339
NCT00151957|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-03-27|||October 2004||2004-10-01|March 2017|2017-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials|A Phase III, Multi-center, Open-label Study of Methylphenidate Transdermal System (MTS) in Pediatric Patients Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|450|Actual|Noven Therapeutics||1|||f||||f||||||||No||2017-10-11 05:19:19.386233|2017-10-11 05:19:19.386233
NCT00151970|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-07-08|||June 2005||2005-06-01|July 2015|2015-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD|A Phase IIB, Randomized, Double-blind, Multi-Center, Placebo-Controlled, Dose-Optimization, 3-way Cross-Over, Analog Classroom Study to Assess the Efficacy, Duration of Effect, Tolerability and Safety of 4- and 6- Hour Wear Times of Methylphenidate Transdermal System (MTS) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|128|Actual|Noven Therapeutics||3|||f||||f||||||||||2017-10-11 05:19:19.461252|2017-10-11 05:19:19.461252
NCT00151983|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-07-08|||June 2005||2005-06-01|July 2015|2015-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy|A Prospective, Open-Label, Multi-Center Study Evaluating the Safety and Tolerability of Methylphenidate Transdermal System (MTS) in Children Aged 6-12 Previously Treated With Extended-Release Methylphenidate Product.|Completed||Phase 3|175|Actual|Noven Therapeutics||2|||f||||f||||||||||2017-10-11 05:19:19.55128|2017-10-11 05:19:19.55128
NCT00151996|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-11-25|2009-09-10||August 2004||2004-08-01|November 2009|2009-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Phase II, Open-Label Co-Administration Study of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|75|Actual|Shire||2|||||||||||||||||2017-10-11 05:19:19.734256|2017-10-11 05:19:19.734256
NCT00152009|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-11-25|2009-09-10||January 2003||2003-01-01|November 2009|2009-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17|A Phase III, Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Safety and Efficacy Study of SPD503 in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|345|Actual|Shire||4|||||||||||||||||2017-10-11 05:19:20.202607|2017-10-11 05:19:20.202607
NCT00152022|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-01-12|||April 2005||2005-04-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.|A Phase III, Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).|Completed||Phase 3|412||Shire|||||||||||||||||||2017-10-11 05:19:20.894635|2017-10-11 05:19:20.894635
NCT00152035|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-01-12|||March 2005||2005-03-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety of SPD465 in Treating Adults With ADHD.|A Phase III, Multi-center, 12-month, Open-label Safety Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).|Completed||Phase 3|1040||Shire|||||f||||||||||||||2017-10-11 05:19:20.953596|2017-10-11 05:19:20.953596
NCT00152048|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-06-06|||November 2004||2004-11-01|September 2007|2007-09-01|October 2005|Actual|2005-10-01|||||Interventional|||Evaluation of Eflornithine on Facial and Forearm Skin|A 24 Week Randomised Double Blind Placebo Controlled Study to Evaluate the Atrophogenic Potential of Eflornithine in the Treatment of Women With Excessive Facial Hair|Completed||Phase 4|78||Shire|||||f||||||||||||||2017-10-11 05:19:21.008332|2017-10-11 05:19:21.008332
NCT00152061|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-06-18|||January 2005||2005-01-01|June 2013|2013-06-01|August 2005|Actual|2005-08-01|||||Interventional|||The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens|The Role of 3TC/FTC in Partially Suppressive Antiretroviral Regimens: The Switch Study|Completed||N/A|40||Stanford University|||||f||||f||||||||||2017-10-11 05:19:21.067186|2017-10-11 05:19:21.067186
NCT00152074|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-08|||April 2004||2004-04-01|September 2006|2006-09-01|December 2007|Actual|2007-12-01|||||Interventional|||Salt Reduction on Blood Pressure and Cardiovascular Organ Damage|Effects of Modest Salt Reduction on Blood Pressure and Markers of Target Organ Damage in Patients With Untreated Essential Hypertension or Prehypertension|Completed||Phase 3|210|Anticipated|St George's, University of London|||||f||||||||||||||2017-10-11 05:19:21.162067|2017-10-11 05:19:21.162067
NCT00152087|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||October 2002||2002-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.|Treatment of Unresectable Hepatocellular Carcinoma With Therasphere. A Human Device Evaluation Protocol.|Unknown status|Recruiting|Phase 2|25||St. Joseph's Hospital, Florida|||||||||||||||||||2017-10-11 05:19:21.23359|2017-10-11 05:19:21.23359
NCT00152100|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-05-19|||February 2004||2004-02-01|May 2009|2009-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome|Transplantation of Highly Purified Haploidentical CD133 Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome|Completed||Phase 1|4|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:19:21.329084|2017-10-11 05:19:21.329084
NCT00152113|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-04-24|||April 2005||2005-04-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound|Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Doppler Ultrasound Using Reduced-Intensity Conditioning and T-Cell Depleted HSC From Partially Matched Family Donors|Completed||Phase 1|5|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:19:21.401397|2017-10-11 05:19:21.401397
NCT00152126|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-02-12|||August 2003||2003-08-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|August 2005|Actual|2005-08-01||Interventional|||Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas|Busulfan and Melphalan With Autologous Hematopoietic Stem Cell Support With Positively-Selected CD133+ Hematopoietic Cells for Children With High Risk Solid Tumors and Lymphomas|Completed||N/A|26|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:19:21.47859|2017-10-11 05:19:21.47859
NCT00152139|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-01-28|||May 2002||2002-05-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|June 2005|Actual|2005-06-01||Interventional|||Stem Cell Transplantation for Patients With Hematologic Malignancies|Hematopoietic Stem Cell Transplantation Using Matched Unrelated Donor Peripheral Blood or Bone Marrow for Patients With Hematologic Malignancies|Completed||Phase 3|33|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:19:21.579083|2017-10-11 05:19:21.579083
NCT00152152|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-22|||October 2002||2002-10-01|May 2008|2008-05-01||||September 2007|Actual|2007-09-01||Observational|||Use of Radiostereometric Analysis Beads (RSA) to Measure Motion in the Spine, Following Lumbar Spinal Surgery|Use of Radiostereometric Analysis (RSA) for Measuring Spinal Motion Following Lumbar Spinal Surgery|Completed||N/A|75|Anticipated|State University of New York - Upstate Medical University|||||f||||||||||||||2017-10-11 05:19:21.668515|2017-10-11 05:19:21.668515
NCT00152165|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-12-01|||November 2003||2003-11-01|December 2008|2008-12-01||||||||Observational|||Use of Radiostereometric Analysis (RSA) Following Spinal Fusion Versus the DYNESYS Stabilization System|A Biomechanical Assessment of the DYNESYS Stabilization System Using Radiostereometric Analysis|Completed||N/A|12||State University of New York - Upstate Medical University|||||f||||||||||||||2017-10-11 05:19:21.721332|2017-10-11 05:19:21.721332
NCT00152178|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-07-06|||July 1996||1996-07-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)|The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)|Completed||Phase 3|680|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 05:19:21.773288|2017-10-11 05:19:21.773288
NCT00152191|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-07-06|||October 1996||1996-10-01|July 2011|2011-07-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)|A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared With CMF in High-risk Women With Axillary Node-negative Breast Cancer (NSAS-BC)|Completed||Phase 3|1300|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 05:19:21.849474|2017-10-11 05:19:21.849474
NCT00152217|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-07-06|||September 2001||2001-09-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|May 2007|Actual|2007-05-01||Interventional|||Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)|Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)|Completed||Phase 3|1000|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 05:19:22.232013|2017-10-11 05:19:22.232013
NCT00152230|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-07-06|||October 1996||1996-10-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|March 2006|Actual|2006-03-01||Interventional|||A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)|A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of UFT Compared With Surgery Alone in Patients With Dukes C Colorectal Cancer (NSAS-CC)|Completed||Phase 3|900|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 05:19:22.299101|2017-10-11 05:19:22.299101
NCT00152243|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-07-06|||June 1997||1997-06-01|July 2011|2011-07-01|August 2007|Actual|2007-08-01|March 2006|Actual|2006-03-01||Interventional|||A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)|A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of UFT Compared With Surgery Alone for Serosa-negative Advanced Gastric Cancer (NSAS-GC)|Completed||Phase 3|500|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-10-11 05:19:22.367403|2017-10-11 05:19:22.367403
NCT00152256|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-05-27|||September 2003||2003-09-01|May 2008|2008-05-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids|A Phase 3,6-Month, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Two Doses of Asoprisnil Versus Placebo in Subjects With Uterine Leiomyomata|Completed||Phase 3|239|Actual|Abbott||3|||f||||t||||||||||2017-10-11 05:19:22.43198|2017-10-11 05:19:22.43198
NCT00152269|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-05-27|||July 2002||2002-07-01|May 2008|2008-05-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Treatment of Uterine Fibroids With Asoprisnil(J867)|A Phase III, 12-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety (Including Bone Density Assessment) of Two Doses of J867 Versus Placebo in Subjects With Uterine Leiomyomata|Completed||Phase 3|475|Actual|Abbott||3|||f||||t||||||||||2017-10-11 05:19:22.506889|2017-10-11 05:19:22.506889
NCT00152282|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-05-27|||September 2000||2000-09-01|May 2008|2008-05-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women|A Phase II Pilot Study to Evaluate the Safety and Efficacy of J867 Administered With Estrogen to Postmenopausal Women|Completed||Phase 2|105|Actual|Abbott||4|||f||||f||||||||||2017-10-11 05:19:22.578409|2017-10-11 05:19:22.578409
NCT00152295|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-05-27|||April 2001||2001-04-01|May 2008|2008-05-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women|A Phase II Long-Term Extension Safety Study of J867 Administered With Estrogen to Postmenopausal Women|Completed||Phase 2|18|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:19:22.651098|2017-10-11 05:19:22.651098
NCT00152308|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||December 2004||2004-12-01|September 2005|2005-09-01|February 2007||2007-02-01|||||Interventional|||Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis|A Prospective, Placebo-Controlled, Double-Blind, Randomized Study Evaluating the Efficacy of Non-Polymer-Based Coating With Two Different Rapamycin-Dosages for the Prevention of Restenosis After Percutaneous Coronary Interventions|Unknown status|Recruiting|Phase 4|333||Translumina GmbH|||||f||||||||||||||2017-10-11 05:19:22.730672|2017-10-11 05:19:22.730672
NCT00152321|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-07-25|||September 2003||2003-09-01|July 2015|2015-07-01|March 2010|Actual|2010-03-01|March 2006|Actual|2006-03-01||Interventional|||Strategies Targeting Osteoporosis to Prevent Recurrent Fractures|Strategies Targeting Osteoporosis to Prevent Recurrent Fractures (STOP# Study)|Completed||N/A|242|Actual|University of Alberta||2|||f||||f||||||||||2017-10-11 05:19:22.858|2017-10-11 05:19:22.858
NCT00152334|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-05-30|||September 2005||2005-09-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy of Botox in Patients With Idiopathic Clubfoot|Treatment of Idiopathic Clubfoot Utilizing Botulinum Toxin A: A New Treatment for Correction|Active, not recruiting||N/A|50|Anticipated|University of British Columbia||1|||f||||||||||||||2017-10-11 05:19:23.045277|2017-10-11 05:19:23.045277
NCT00152347|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-07-30|||September 2005||2005-09-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|December 2012|Actual|2012-12-01||Interventional|||A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot|A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot|Unknown status|Active, not recruiting|N/A|36|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:19:23.130429|2017-10-11 05:19:23.130429
NCT00152360|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-03-28|||June 2005||2005-06-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Xenical on Weight and Risk Factors|The Effect of Xenical on Weight, Risk Factors and Burden of Medication|Completed||Phase 4|25|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:19:23.207851|2017-10-11 05:19:23.207851
NCT00152373|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-12-02|||July 2004||2004-07-01|September 2009|2009-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS|A Double-blind, Placebo-controlled, Randomized Study: 16-week Evaluation of the Efficacy and Safety of Levetiracetam (LEV) as add-on Therapy in Adults and Adolescents Older Than 16 Years Suffering From Partial Seizures.|Completed||Phase 3|192||UCB Pharma|||||f||||||||||||||2017-10-11 05:19:23.289712|2017-10-11 05:19:23.289712
NCT00152386|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-08-26|||February 2005||2005-02-01|July 2010|2010-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis|A Phase III Multicentre, Double Blind, Placebo-controlled, Parallel Group 52-week Study to Assess the Efficacy and Safety of 2 Dose Regimens of Lyophilised CDP870 as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms and Preventing Structural Damage in Patients With Active Rheumatoid Arthritis Who Have an Incomplete Response to Methotrexate|Completed||Phase 3|950||UCB Pharma|||||f||||||||||||||2017-10-11 05:19:23.358661|2017-10-11 05:19:23.358661
NCT00133757|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2013-02-13|||June 2005||2005-06-01|February 2013|2013-02-01|May 2006||2006-05-01|||||Interventional|||Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers|Pharmacotherapy-assisted Extinction (Pharmacoextinction): A Novel Approach to the Treatment of Nicotine Dependence in Humans|Completed||Phase 1|50||Centre for Addiction and Mental Health|||||f||||||||||||||2017-10-11 05:19:23.588067|2017-10-11 05:19:23.588067
NCT00133770|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2013-07-29|||July 2004||2004-07-01|July 2013|2013-07-01|March 2007|Actual|2007-03-01|July 2006|Actual|2006-07-01||Interventional|||Intravenous (IV) Pantoprazole in Erosive Esophagitis|A Pilot Study of Efficacy and Safety of Continuous Intravenous Infusion of Pantoprazole in the Treatment of Severe Erosive Esophagitis|Completed||Phase 4|20|Actual|Emory University||1|||f||||f||||||||||2017-10-11 05:19:23.664|2017-10-11 05:19:23.664
NCT00133783|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2005-10-25|||May 2005||2005-05-01|May 2005|2005-05-01|May 2007||2007-05-01|||||Observational|||Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure|Intermedin is an Estrogen- Modulated Factor for Reducing Blood Pressure|Unknown status|Recruiting|N/A|500||Chang Gung Memorial Hospital|||||f||||||||||||||2017-10-11 05:19:23.740428|2017-10-11 05:19:23.740428
NCT00133796|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2017-02-03|||October 2001||2001-10-01|February 2017|2017-02-01|April 2007|Actual|2007-04-01|September 2005|Actual|2005-09-01||Interventional|||Neoadjuvant Herceptin in Patients With Breast Cancer|A Phase II Study of the Effects of Herceptin in Patients With Locally Advanced HER-2/NEU Overexpressing Breast Cancer|Terminated||Phase 2|40|Actual|Baylor Breast Care Center||1||Closed to accrual 4/19/2006 / Study doesn't qualify for reporting.|f||||t||||||||No||2017-10-11 05:19:23.815437|2017-10-11 05:19:23.815437
NCT00133809|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2016-06-16|2016-04-25||July 2002||2002-07-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Eligible participants who received islet transplantation|Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression|Islet Transplantation in Type 1 Diabetes Using the Edmonton Protocol of Steroid Free Immunosuppression|Completed||Phase 2|8|Actual|Emory University||1|||f||||t||||||||||2017-10-11 05:19:23.902444|2017-10-11 05:19:23.902444
NCT00133822|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2015-08-18|||April 2004||2004-04-01|August 2015|2015-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial|Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD|Completed||Phase 1/Phase 2|65||Emory University|||||f||||||||||||||2017-10-11 05:19:24.212211|2017-10-11 05:19:24.212211
NCT00133835|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2005-10-24|||March 1998||1998-03-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Comparison of Extracorporeal Shock Wave Lithotripsy (ESWL) Alone and ESWL Plus Endoscopy for Painful Chronic Pancreatitis|Comparison of ESWL Alone and ESWL Combined With Endoscopic Drainage of the Main Pancreatic Duct for Painful Chronic Pancreatitis|Completed||Phase 1/Phase 2|50||Erasme University Hospital|||||f||||||||||||||2017-10-11 05:19:24.288863|2017-10-11 05:19:24.288863
NCT00133848|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2016-09-22|||April 2005||2005-04-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment|A Randomised, Double-blind, Multicentre, Superiority Placebo-controlled, Phase III Study to Assess the Efficacy and Safety of Topical 1% SB-275833 Ointment Versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adults and Paediatric Subjects With Impetigo.|Completed||Phase 3|210||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:19:24.37422|2017-10-11 05:19:24.37422
NCT00133861|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2008-06-30|||April 2005||2005-04-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles|Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles. Assessment of Efficiency of Botulinum Toxin on Spasticity in Agonist and Antagonist Muscles Using Clinical Assessment and Gait Analysis in Cerebral Palsy Children: Rectus Femoris and Semitendinosus|Completed||Phase 2/Phase 3|23|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:19:24.497575|2017-10-11 05:19:24.497575
NCT00133874|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2017-01-20|||April 2005||2005-04-01|January 2017|2017-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo|An Observer-blind, Multicenter, Non-inferiority, Comparative Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, Versus Topical 2% Fusidic Acid Cream Applied Three Times Daily for 7 Days in the Treatment Adult and Paediatric Subjects With Impetigo|Completed||Phase 3|520|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:19:24.595918|2017-10-11 05:19:24.595918
NCT00133887|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2014-07-01|||April 2004||2004-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|March 2011|Actual|2011-03-01||Interventional|||TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients|Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients - Multicentric Randomized, Open-label Study of Rapamycin vs Calcineurin Inhibitors|Completed||Phase 3|77|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-10-11 05:19:24.798062|2017-10-11 05:19:24.798062
NCT00133900|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2009-07-27|||December 2004||2004-12-01|March 2008|2008-03-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Observational|IMMC-38||Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy|Circulating Tumor Cells and the Prediction of Overall Survival in Patients With Androgen Independent Prostate Cancer Entering Onto Chemotherapy|Unknown status|Active, not recruiting|N/A|276|Actual|Immunicon|||1||f||||f||||||Samples With DNA|"     Serum Samples and RNA samples have been retained.   "|||2017-10-11 05:19:24.880551|2017-10-11 05:19:24.880551
NCT00133913|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2008-03-17|||March 2004||2004-03-01|March 2008|2008-03-01|January 2009|Anticipated|2009-01-01|January 2007|Actual|2007-01-01||Observational|IMMC-06||Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer|Longitudinal Enumeration of Circulating Tumor Cells in Patients With Metastatic Colorectal Carcinomas|Unknown status|Active, not recruiting|N/A|486|Actual|Immunicon|||1||f||||f||||||||||2017-10-11 05:19:24.962506|2017-10-11 05:19:24.962506
NCT00133939|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-23|2007-04-26||||||April 2007|2007-04-01||||||||Interventional|||Proportional Ventilation and Ventilatory Synchronism|Proportional Ventilation and Ventilatory Synchronism|Unknown status|Recruiting|N/A|10||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:19:25.329808|2017-10-11 05:19:25.329808
NCT00133952|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2016-08-25|2015-12-22|2011-09-20|August 2005||2005-08-01|August 2016|2016-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Ruboxistaurin on Clinically Significant Macular Edema|The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema|Completed||Phase 3|309|Actual|Chromaderm, Inc.||2|||f||||||||||||||2017-10-11 05:19:25.445221|2017-10-11 05:19:25.445221
NCT00133978|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-08-26|2013-04-29||April 2005||2005-04-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|REDOXS|Five randomized patients were not evaluable because we could not ascertain their 28-day vital status leaving 1218 patients in the final intention-to-treat analysis.|Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients|REducing Deaths Due to OXidative Stress The REDOXS© Study|Completed||Phase 3|1223|Actual|Clinical Evaluation Research Unit at Kingston General Hospital||4|||f||||t||||||||||2017-10-11 05:19:26.846435|2017-10-11 05:19:26.846435
NCT00133991|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-04-16|||March 2005||2005-03-01|April 2014|2014-04-01|July 2012|Actual|2012-07-01|July 2010|Actual|2010-07-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia|Phase II Study of Intensified CVP, Rituximab, and High Dose Cyclophosphamide for Adult Burkitt or Burkitt-Like Lymphoma|Completed||Phase 2|21|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 05:19:28.150843|2017-10-11 05:19:28.150843
NCT00134004|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2015-09-02|2015-06-26||October 2004||2004-10-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer|A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies|Completed||Phase 2|210|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 05:19:28.882281|2017-10-11 05:19:28.882281
NCT00134017|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2016-10-17|||May 2004||2004-05-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|||Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer|HLA Matched Related and Unrelated Bone Marrow Transplantation With Busulfan/Cyclophosphamide and Post Transplantation Cyclophosphamide for Hematological Malignancies|Active, not recruiting||Phase 2|92|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 05:19:29.238071|2017-10-11 05:19:29.238071
NCT00134030|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2017-05-02|||November 2005||2005-11-01|May 2017|2017-05-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma|A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy (IND# 12697)|Active, not recruiting||Phase 3|1164|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-10-11 05:19:29.581004|2017-10-11 05:19:29.581004
NCT00134043|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-07-23|2014-04-18||December 2005||2005-12-01|July 2014|2014-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer|Phase II Study of Histone Deacetylase Inhibitor SAHA (Vorinostat) in Patients With Metastatic Thyroid Carcinoma|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:19:30.089925|2017-10-11 05:19:30.089925
NCT00134056|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2017-05-04|2017-01-04||August 2006||2006-08-01|May 2017|2017-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional||A total of 1038 patients were randomized to this study, 42 of which were ineligible. Baseline analysis population includes 994 patients (excluding the 42 ineligible patients and 2 additional patients who withdrew all consent prior to receiving protocol treatment).|S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy|Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer|Completed||Phase 3|1038|Actual|Southwest Oncology Group||2|||f||||t||||||||Yes|http://swog.org/Visitors/Download/Policies/Policy43.pdf|2017-10-11 05:19:30.889044|2017-10-11 05:19:30.889044
NCT00134069|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-04-15|||June 2005||2005-06-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer|Phase I/II Clinical, Pharmacological, and Biological Study of BAY 43-9006 in Combination With Cetuximab and Irinotecan in Patients With Advanced Colorectal Cancer|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:19:36.098923|2017-10-11 05:19:36.098923
NCT00134082|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2015-10-30|||July 2005||2005-07-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma|Pilot Study of Rituximab, High Dose Cyclophosphamide, and GM-CSF Based Immunotherapy for Relapsed Hodgkin's Lymphoma|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 05:19:36.215088|2017-10-11 05:19:36.215088
NCT00134095|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2013-09-16|||September 2004||2004-09-01|January 2010|2010-01-01||||August 2008|Actual|2008-08-01||Interventional|||S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer|Phase II Clinical Study of Preoperative S-1/CPT-11 Combination Chemotherapy in Patients With Locally Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|70|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:19:36.296317|2017-10-11 05:19:36.296317
NCT00139451|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2011-10-11|||May 2004||2004-05-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|December 2007|Actual|2007-12-01||Interventional|||Nutrients and Hormones: Effects in Boys With Disordered Growth|Nutrients and Hormones: Effects in Boys With Disordered Growth|Completed||Phase 2|20|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-10-11 05:19:36.389734|2017-10-11 05:19:36.389734
NCT00139477|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2012-10-21|2012-06-25||November 2003||2003-11-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|May 2009|Actual|2009-05-01||Interventional|||Study of Serum Markers for Cardiovascular Risk in Obese Youth and Impact of Lifestyle and Medication Intervention|Understanding the Effects of Therapeutic Intervention on Cardiovascular Risk Markers, Insulin Resistance, and Intra-Hepatic Fat Contents in Obese Children at High Risk for the Metabolic Syndrome.|Completed||N/A|66|Actual|Nemours Children's Clinic|Protocol #2 attrition was high, such that, we could not derive conclusions beyond the 6 month time period. Therefore, conclusions were based on participants after completing the first intervention without crossover to the second intervention.|2|||f||||t||||||||||2017-10-11 05:19:36.495585|2017-10-11 05:19:36.495585
NCT00139490|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2012-12-19|||February 2006||2006-02-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|||Home-Based Program to Treat High Blood Pressure in African Americans|Home-Based Blood Pressure Interventions for African Americans|Completed||N/A|846|Actual|Visiting Nurse Service of New York||3|||f||||t||||||||||2017-10-11 05:19:36.864861|2017-10-11 05:19:36.864861
NCT00139542|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2009-05-08|||September 2005||2005-09-01|May 2009|2009-05-01|June 2008|Actual|2008-06-01|March 2007|Actual|2007-03-01||Interventional|DEFI2005||"AED Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named One Shock Per Minute"|"Automated External Defibrillator (AED) Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named One Shock Per Minute"|Completed||Phase 3|5107|Actual|Fire Brigade Of Paris Emergency Medicine Dept||2|||f||||t||||||||||2017-10-11 05:19:37.087382|2017-10-11 05:19:37.087382
NCT00139555|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2017-02-21|||July 2004||2004-07-01|February 2017|2017-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension|Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension|Completed||Phase 4|125|Actual|Novartis|||||||||||||||||||2017-10-11 05:19:37.186051|2017-10-11 05:19:37.186051
NCT00139568|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-01-31|||February 2005||2005-02-01|January 2008|2008-01-01|October 2005|Actual|2005-10-01|||||Interventional|||An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation|An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation|Completed||Phase 3|600||Novartis|||||f||||||||||||||2017-10-11 05:19:37.257879|2017-10-11 05:19:37.257879
NCT00139581|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-04-22|||September 2004||2004-09-01|April 2008|2008-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects|Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects|Completed||Phase 4|||Novartis||2|||f||||||||||||||2017-10-11 05:19:37.323562|2017-10-11 05:19:37.323562
NCT00139594|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2017-03-24|||December 2004||2004-12-01|March 2017|2017-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder|A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder|Completed||Phase 4|181|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:19:37.401821|2017-10-11 05:19:37.401821
NCT00139607|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2009-08-13|||September 2002||2002-09-01|August 2009|2009-08-01|January 2005||2005-01-01|||||Interventional|||Parecoxib In Post Surgery (Hemicolectomy) Pain|A Multicenter, Open Label, Pilot Study To Evaluate Analgesic Activity And Safety Of Parecoxib 40 Mg IV In Patients Undergoing Hemicolectomy, In The Optimal Management Of Acute Post-Operative Pain Of Surgical Patients|Terminated||Phase 3|60||Pfizer||||Please see detailed description for termination reason.|f||||||||||||||2017-10-11 05:19:37.665692|2017-10-11 05:19:37.665692
NCT00139620|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-06-12|||May 2005||2005-05-01|June 2015|2015-06-01|September 2007|Actual|2007-09-01|||||Interventional|||A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function|An Open-Label Study to Characterize the Pharmacokinetic Parameters of Erlotinib (Tarceva®, OSI-774) in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function|Completed||Phase 1|39|Actual|Astellas Pharma Inc|||||||||||||||||||2017-10-11 05:19:37.730741|2017-10-11 05:19:37.730741
NCT00139633|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2005-08-29|||July 2000||2000-07-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Selective Dose Escalation for Esophageal Cancer|Phase II Selective Dose Escalation of Chemoradiotherapy for Esophageal Cancer|Unknown status|Active, not recruiting|Phase 2|25||The Oregon Clinic|||||f||||||||||||||2017-10-11 05:19:37.832392|2017-10-11 05:19:37.832392
NCT00139646|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-05-02|||April 2002||2002-04-01|May 2008|2008-05-01|April 2004||2004-04-01|||||Interventional|||Parecoxib in Renal Colic|A Multicenter Single-Blind, Single Dose Efficacy and Safety Pilot Study Comparing Intramuscular Parecoxib and Diclofenac in Renal Colic|Terminated||Phase 3|50||Pfizer||||See Detailed Description|f||||||||||||||2017-10-11 05:19:37.936163|2017-10-11 05:19:37.936163
NCT00139659|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2010-05-26|2009-10-21||January 2003||2003-01-01|October 2009|2009-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma|Efficacy and Safety of Inhaled Human Insulin (Exubera) Compared With Subcutaneous Human Insulin in the Therapy of Adult Subjects With Type 1 or Type 2 Diabetes Mellitus and Chronic Asthma: A One-Year, Multicenter, Randomized, Outpatient, Open-Label, Parallel-Group Comparative Trial|Completed||Phase 3|288|Actual|Pfizer|Data for some secondary endpoints were not tabulated or analyzed for this study and some concomitant medication data were not accurately recorded and tabulated due to lack of resources resulting from scaling down of Exubera® development.|2|||f||||f||||||||||2017-10-11 05:19:38.29779|2017-10-11 05:19:38.29779
NCT00139672|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-06-12|||January 2004||2004-01-01|June 2008|2008-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study To Investigate The Effect Of Pd-217,014 In Patients With Irritable Bowel Syndrome (IBS)|Completed||Phase 2|330||Pfizer|||||f||||||||||||||2017-10-11 05:19:42.253235|2017-10-11 05:19:42.253235
NCT00139685|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-09-23|||April 1998||1998-04-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|August 2006|Actual|2006-08-01||Interventional|||Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception|Depo-Provera: Evaluation of Bone Mineral Density and Total Body Calcium in Adolescent DP 150 CI Users and Matched Controls|Completed||Phase 4|350||Pfizer|||||f||||||||||||||2017-10-11 05:19:42.316773|2017-10-11 05:19:42.316773
NCT00139698|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-07-30|||September 2005||2005-09-01|April 2007|2007-04-01|July 2006||2006-07-01|||||Interventional|OSCAR||Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension|A Phase III, Multicenter, Open-Label, Dose-Titrating, 16-Week Study Evaluating The Efficacy, Tolerability and Safety of Olmesartan Medoxomil 20 Mg and 40 Mg Alone or in Combination With 12.5 Mg to 25 Mg of Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension|Completed||Phase 3|410||Pfizer|||||f||||||||||||||2017-10-11 05:19:42.43724|2017-10-11 05:19:42.43724
NCT00139711|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-03-27|||March 2003||2003-03-01|October 2006|2006-10-01|June 2006||2006-06-01|||||Interventional|||Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer|A Multicenter Randomized Phase II Study Evaluating The Activity And Tolerability Of Three Different Combinations Of Docetaxel (Taxotere) And Irinotecan (Campto) As Second Line Therapy For Recurrent Or Metastatic Non Small Cell Lung Cancer (NSCLS)|Completed||Phase 2|138||Pfizer|||||f||||||||||||||2017-10-11 05:19:42.736428|2017-10-11 05:19:42.736428
NCT00139724|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2009-12-18|||May 2005||2005-05-01|December 2009|2009-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet|A Phase III Randomized, Double-Blind, Double Dummy, Multi-Center Study To Compare The Efficacy, Safety And Tolerability Of Tolterodine Extended Release Capsule With Tolterodine Immediate Release Tablet In Subjects With Symptoms Of Overactive Bladder|Completed||Phase 3|260|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:19:42.848644|2017-10-11 05:19:42.848644
NCT00139737|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2010-08-02|2010-06-15||March 2002||2002-03-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia|Open Extension Study Evaluating the Safety and Tolerability of Oral Ziprasidone in the Treatment of Subjects Who Have Successfully Completed a Previous Ziprasidone Study|Completed||Phase 3|344|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:19:42.966052|2017-10-11 05:19:42.966052
NCT00139750|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-06-01|||December 2004||2004-12-01|June 2007|2007-06-01|February 2006|Actual|2006-02-01|||||Interventional|||12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation|A Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating The Efficacy And Safety Of CP-526,555 In Smokers Motivated To Stop Smoking|Completed||Phase 2|600||Pfizer|||||f||||||||||||||2017-10-11 05:19:43.666363|2017-10-11 05:19:43.666363
NCT00139763|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-03-15|||July 2005||2005-07-01|March 2007|2007-03-01|March 2006||2006-03-01|||||Interventional|||US Inhaled Insulin Therapeutic Choice Questionnaire Study|A US Randomized Questionnaire-Based Trial Assessing The Impact Of The Availability Of Inhaled Insulin On Therapeutic Choice In Patients With Suboptimally Controlled Type 2 Diabetes|Completed||Phase 3|740||Pfizer|||||f||||||||||||||2017-10-11 05:19:43.763512|2017-10-11 05:19:43.763512
NCT00139776|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2009-06-24|2009-02-20||July 2005||2005-07-01|June 2009|2009-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||"Study Of Continuous Use Of Celecoxib Vs. Usual or Intermittent Use"|"Double-Blind Parallel-Group Randomized Study Of Efficacy And Safety Of Continuous Use Of Celecoxib Vs. The Usual Use Of Celecoxib In The Treatment Of Subjects With Chronic Osteoarthritis Of The Hip Or Knee Who Require an Anti-Inflammatory Medication for Control Of Their Pain"|Completed||Phase 4|875|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 05:19:43.968745|2017-10-11 05:19:43.968745
NCT00139789|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-08-29|||January 2005||2005-01-01|September 2009|2009-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis|A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis|Completed||Phase 3|60|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:19:46.382423|2017-10-11 05:19:46.382423
NCT00139802|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2005-08-30|||April 1997||1997-04-01|January 1997|1997-01-01|June 2001||2001-06-01|||||Interventional|||DANish Multicenter STENT Trial|Low Restenosis Rate of the NIR Coronary Stent: Results of the Danish Multicenter Stent Study (DANSTENT) – a Randomized Study Comparing a First-Generation With a Second-Generation Stent.|Completed||Phase 4|400||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:19:46.439536|2017-10-11 05:19:46.439536
NCT00139815|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2016-09-13|||April 2003||2003-04-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Michelangelo - Oasis 5|An International, Randomized, Double-blind Study Evaluating the Efficacy and Safety of Fondaparinux Versus Enoxaparin in the Acute Treatment of Unstable Angina/Non ST-segment Elevation MI Acute Coronary Syndromes|Completed||Phase 3|20078|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:19:46.506277|2017-10-11 05:19:46.506277
NCT00139828|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-08-29|||May 2003||2003-05-01|August 2007|2007-08-01|February 2007|Actual|2007-02-01|||||Interventional|||Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)|Post Marketing Study in Haemophilia B Patients Using Nonafact® 100 IU/ml Powder and Solvent for Solution for Injection(Human Coagulation Factor IX)(Human Plasma Derived Factor IX Product, Freeze Dried)|Completed||Phase 4|12|Actual|Sanquin||1|||f||||f||||||||||2017-10-11 05:19:46.606207|2017-10-11 05:19:46.606207
NCT00139841|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2014-05-08|||October 2005||2005-10-01|May 2014|2014-05-01|October 2009|Actual|2009-10-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab|A Multi-Center Phase III Study to Investigate the Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab|Completed||Phase 3|103|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 05:19:46.692421|2017-10-11 05:19:46.692421
NCT00139854|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-08-29|||August 2004||2004-08-01|September 2009|2009-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety|A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-10-11 05:19:46.884143|2017-10-11 05:19:46.884143
NCT00139867|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2014-10-17|||January 2004||2004-01-01|September 2009|2009-09-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease|A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-10-11 05:19:46.973765|2017-10-11 05:19:46.973765
NCT00139880|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-09-03|||June 2005||2005-06-01|September 2009|2009-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease|A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-10-11 05:19:47.057729|2017-10-11 05:19:47.057729
NCT00139893|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-03-25|||June 2005||2005-06-01|May 2008|2008-05-01||||October 2005|Actual|2005-10-01||Interventional|||A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis|A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis|Completed||N/A|||UCB Pharma|||||f||||||||||||||2017-10-11 05:19:47.299293|2017-10-11 05:19:47.299293
NCT00139906|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-01-15|||August 2005||2005-08-01|March 2006|2006-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Twice Daily Titration Study of the Safety and Tolerability of Bifeprunox in Subjects With Schizophrenia|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:19:47.388048|2017-10-11 05:19:47.388048
NCT00139919|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2015-01-15|||January 2006||2006-01-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder|A Randomized, Double-Blind, Placebo-Controlled, Sequential Panel Study of the Safety and Tolerability of Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Either Schizophrenia or Bipolar Disorder With an Optional Open-Label 26-Week Extension Study|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:19:47.472267|2017-10-11 05:19:47.472267
NCT00139932|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2017-03-22|||September 1, 2005|Actual|2005-09-01|March 2017|2017-03-01|November 21, 2006|Actual|2006-11-21|November 21, 2006|Actual|2006-11-21||Interventional|||Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)|A Double-Blind Randomized, Parallel-Group, Multicenter Clinical Study to Compare the Efficacy and Tolerability of Tiotropium Bromide Alone vs. the Co-Administration of Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD|Completed||Phase 4|255|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:19:47.56077|2017-10-11 05:19:47.56077
NCT00139945|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2010-01-19|||October 2005||2005-10-01|January 2010|2010-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients|Effects of Acute Ghrelin Infusion to Growth Hormone Deficient Adults: Growth Hormone and Cortisol Interaction|Completed||N/A|8|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:19:47.652656|2017-10-11 05:19:47.652656
NCT00139958|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2010-07-26|||November 2003||2003-11-01|May 2010|2010-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Prognosis of Acute Coronary Syndrome in HIV-infected Patients|Prognosis After Acute Coronary Syndrome in HIV-infected Patients|Completed||Phase 4|300|Actual|Saint Antoine University Hospital|||2||f||||t||||||Samples Without DNA|"     Lipids, CRP, glycemia, insulinemia   "|||2017-10-11 05:19:47.744873|2017-10-11 05:19:47.744873
NCT00139971|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2006-01-05|||December 2001||2001-12-01|August 2005|2005-08-01||||||||Interventional|||Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer||Unknown status|Recruiting|Phase 3|600||West Japan Thoracic Oncology Group|||||f||||||||||||||2017-10-11 05:19:47.850045|2017-10-11 05:19:47.850045
NCT00139984|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2017-02-01|||October 2003||2003-10-01|February 2017|2017-02-01|May 2007|Actual|2007-05-01|||||Interventional|||Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance|Impact of Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance in Medical Outpatients: The Hyper-ABC Study|Completed||Phase 4|170|Anticipated|University Hospital, Basel, Switzerland|||||f||||f||||||||||2017-10-11 05:19:47.946737|2017-10-11 05:19:47.946737
NCT00139997|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2013-01-29|2012-09-07||January 2002||2002-01-01|January 2013|2013-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Environmental Treatment for Seasonal Affective Disorder (SAD)|A Multicenter, Randomized Controlled Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy For Seasonal Affective Disorder|Completed||N/A|26|Actual|Yale University||2|||f||||f||||||||||2017-10-11 05:19:48.055732|2017-10-11 05:19:48.055732
NCT00140010|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2009-05-19|||April 2005||2005-04-01|May 2009|2009-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Erythropoietin Therapy for Subarachnoid Hemorrhage|Effects of Systemic Erythropoietin Therapy on Cerebral Autoregulation and Incidence of Delayed Ischemic Deficits in Patients With Aneurysmal Subarachnoid Hemorrhage|Completed||Phase 2|80|Actual|University of Cambridge||1|||f||||t||||||||||2017-10-11 05:19:48.551572|2017-10-11 05:19:48.551572
NCT00140023|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2011-05-09|||September 2005||2005-09-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia|A Multi-center, Open Label Study to Evaluate the Efficacy and Safety of Azithromycin Microspheres in Subjects Identified as Having Low Risk Community Acquired Pneumonia (CAP)|Completed||Phase 3|47|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:19:48.645186|2017-10-11 05:19:48.645186
NCT00140036|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-02-28|||September 2002||2002-09-01|February 2008|2008-02-01|August 2005||2005-08-01|||||Interventional|||Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).|Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).|Completed||Phase 4|137||Pfizer|||||f||||||||||||||2017-10-11 05:19:48.717739|2017-10-11 05:19:48.717739
NCT00140049|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2007-11-29|||July 2005||2005-07-01|November 2007|2007-11-01|July 2006|Actual|2006-07-01|||||Interventional|||A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma|A 12-Week Randomized, Evaluator-Masked, Parallel-Group, Multinational, Multi-Center Study Comparing The Efficacy And Safety Of The Fixed Combination Of Latanoprost And Timolol (Xalacom) With The Fixed Combination Of Dorzolamide And Timolol (Cosopt) In Patients With Open-Angle Glaucoma Or Ocular Hypertension.|Completed||Phase 4|238||Pfizer|||||f||||||||||||||2017-10-11 05:19:48.835689|2017-10-11 05:19:48.835689
NCT00140062|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2008-04-04|||February 2002||2002-02-01|April 2008|2008-04-01|April 2006||2006-04-01|||||Interventional|||Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.|"A Randomized Post-Marketing Efficacy And Safety Study Of Xalatan Compared With Usual Care Over 36 Months In Patients With Primary Open-Angle Glaucoma, Exfoliative Glaucoma Or Ocular Hypertension"|Completed||Phase 4|329||Pfizer|||||f||||||||||||||2017-10-11 05:19:48.940374|2017-10-11 05:19:48.940374
NCT00145834|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-09-01|||February 2004||2004-02-01|September 2005|2005-09-01|April 2005||2005-04-01|||||Interventional|||Early Breastfeeding Cessation - is It Possible to Prevent?|A Randomised Community Based Experimental Trial in the Health Visitor's Practice Field|Completed||Phase 1|1456||University of Aarhus|||||f||||||||||||||2017-10-11 05:19:54.695175|2017-10-11 05:19:54.695175
NCT00140075|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2011-05-24|||November 2000||2000-11-01|May 2011|2011-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer|Phase III, Randomized Study Of Epirubicin/Cyclophosphamide Followed By Taxane (Sequential Chemotherapy) Versus Epirubicin/Taxane (Concurrent Chemotherapy) As Adjuvant Treatment For Operable, Node-Positive Breast Cancer|Completed||Phase 3|606|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:19:49.058174|2017-10-11 05:19:49.058174
NCT00140088|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-08-31|||December 2004||2004-12-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Effectiveness and Safety of ALGRX 3268 in Pediatric Subjects.|Completed||Phase 3|504||AlgoRx Pharmaceuticals|||||||||||||||||||2017-10-11 05:19:49.234883|2017-10-11 05:19:49.234883
NCT00140101|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2012-01-06|||May 2005||2005-05-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|September 2007|Actual|2007-09-01||Interventional|ZoMaxx™ II||Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries|A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System as Compared to the TAXUS™ Express2™ Paclitaxel-Eluting Stent in de Novo Coronary Artery Lesions|Completed||Phase 2|1099|Actual|Abbott Vascular||2|||f||||t||||||||||2017-10-11 05:19:49.322065|2017-10-11 05:19:49.322065
NCT00140114|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2012-07-12|||January 2004||2004-01-01|August 2008|2008-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Sublingual Versus Vaginal Misoprostol for Labor Induction at Term||Completed||Phase 3|170|Actual|American University of Beirut Medical Center||2|||f||||t||||||||||2017-10-11 05:19:49.783738|2017-10-11 05:19:49.783738
NCT00140140|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2013-08-20|2013-08-20||August 2005||2005-08-01|August 2013|2013-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer|An Open-Label Phase I/II Study of Weekly ABI-007 and Vinorelbine With or Without G-CSF in Patients With Stage IV (Metastatic) Breast Cancer|Terminated||Phase 1/Phase 2|16|Actual|Celgene||3||Unable to determine the optimum tolerated dose|f||||f||||||||||2017-10-11 05:19:49.879849|2017-10-11 05:19:49.879849
NCT00140153|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-11-23|||April 2005||2005-04-01|November 2009|2009-11-01|April 2006||2006-04-01|||||Interventional|||Testosterone in Female Hypoactive Sexual Desire Disorder|Transdermal Testosterone Gel Prn Application for Hypoactive Sexual Desire Disorder in Women: A Controlled Study|Completed||Phase 3|20||Beersheva Mental Health Center|||||f||||||||||||||2017-10-11 05:19:51.29958|2017-10-11 05:19:51.29958
NCT00140166|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-11-23|||July 2005||2005-07-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|||||Interventional|||Treatment of Acute Schizophrenia With Vitamin Therapy|The Treatment of Acute Schizophrenia With High Dose Niacinmide Plus Ascorbate Plus Pyridoxine Plus Centrum Forte vs. Centrum Forte Only as an Add-On to Risperidone and Dietary Counseling|Completed||Phase 4|55|Anticipated|Beersheva Mental Health Center|||||f||||t||||||||||2017-10-11 05:19:51.364983|2017-10-11 05:19:51.364983
NCT00140179|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-11-23|||September 2004||2004-09-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|||||Interventional|||Valnoctamide in Mania|Valnoctamide as a Valproate Substitute With Low Teratogenic Potential: Double-Blind Controlled Clinical Trial|Completed||Phase 3|80|Anticipated|Beersheva Mental Health Center|||||f||||t||||||||||2017-10-11 05:19:51.43469|2017-10-11 05:19:51.43469
NCT00140192|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2009-07-28|||September 2004||2004-09-01|October 2005|2005-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Creatine Treatment in Psychiatric Disorders|Creatine as a New Treatment for Schizophrenia:A Double-Blind Trial|Completed||Phase 3|12|Actual|Beersheva Mental Health Center|||||f||||||||||||||2017-10-11 05:19:51.511683|2017-10-11 05:19:51.511683
NCT00140218|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-01-05|||August 2005||2005-08-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|January 2007|Actual|2007-01-01||Interventional|||R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis|Futility Study of R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis|Completed||Phase 1/Phase 2|30|Actual|Bennett, James P., Jr., M.D., Ph.D.||1|||t||||t||||||||||2017-10-11 05:19:51.654759|2017-10-11 05:19:51.654759
NCT00140231|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2017-05-05|2015-12-29||October 2002||2002-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|March 2011|Actual|2011-03-01||Interventional|||Role of Leptin in the Neuroendocrine and Immune Response to Fasting|Role of Leptin in the Neuroendocrine and Immune Response to Fasting in Humans|Completed||Phase 1/Phase 2|13|Actual|Beth Israel Deaconess Medical Center|Our study is confined to lean, healthy female subjects; therefore, our results should not be generalized to male, obese,or diabetic subjects|2|||f||||f||||||||Undecided||2017-10-11 05:19:51.733354|2017-10-11 05:19:51.733354
NCT00140244|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2017-04-06|2015-12-22||December 2001||2001-12-01|April 2017|2017-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome|Role of Leptin in Highly Active Antiretroviral Therapy (HAART)-Induced Lipodystrophy and Metabolic Syndrome in HAART-Treated HIV Patients|Completed||Phase 2|7|Actual|Beth Israel Deaconess Medical Center||2|||f||||||||||||||2017-10-11 05:19:52.062904|2017-10-11 05:19:52.062904
NCT00140257|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-12-30|||November 2004||2004-11-01|December 2008|2008-12-01||||December 2008|Anticipated|2008-12-01||Interventional|||DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome|A Double-Blind, Placebo-Controlled Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome|Unknown status|Active, not recruiting|Phase 4|240|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-10-11 05:19:52.593291|2017-10-11 05:19:52.593291
NCT00140270|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2005-08-30|||August 2002||2002-08-01|August 2005|2005-08-01|December 2002||2002-12-01|||||Interventional|||RCT of PEP Program to Reduce ACL Injuries in Female Collegiate Soccer Players|Evaluating the Effectiveness of a Neuromuscular and Proprioceptive Training Program to Reduce Ligamentous Knee Injuries Among Female Collegiate Soccer Players.|Completed||Phase 2|4000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:19:52.654256|2017-10-11 05:19:52.654256
NCT00145847|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-01-07|||April 2003||2003-04-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Naltrexone Treatment of Alcohol Abuse in Schizophrenia|Naltrexone Treatment of Alcohol Abuse in Schizophrenia|Completed||Phase 4|90|Actual|State University of New York - Upstate Medical University||2|||f||||t||||||||||2017-10-11 05:19:54.788275|2017-10-11 05:19:54.788275
NCT00140283|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2005-08-31|||July 2004||2004-07-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||Effectiveness of a Educational Intervention to Improve the Resolution Capacity of Primary Health Care Teams.|Phase IV Cluster Randomised Controlled Trial With 2 Parallel Groups, to Evaluate the Effectiveness of a Educational Intervention to Improve the Resolution Capacity.|Unknown status|Active, not recruiting|Phase 4|48||Catalan Institute of Health|||||f||||||||||||||2017-10-11 05:19:52.70643|2017-10-11 05:19:52.70643
NCT00140296|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2005-08-30|||March 2003||2003-03-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Interventional|||Using the Healthcare Visit to Improve Contraceptive Use|Using the Healthcare Visit to Improve Contraceptive Use|Completed||N/A|747||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:19:52.761402|2017-10-11 05:19:52.761402
NCT00140309|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-03-16|||July 2003||2003-07-01|March 2007|2007-03-01|December 2005|Actual|2005-12-01|||||Interventional|||TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment|TBTC Study 27: An Evaluation of the Activity and Tolerability of Moxifloxacin During the First Two Months of Treatment for Pulmonary Tuberculosis--A Double-Blind, Randomized, Multicenter Study by the Tuberculosis Trials Consortium|Completed||Phase 2|350||Centers for Disease Control and Prevention|||||f||||t||||||||||2017-10-11 05:19:52.827178|2017-10-11 05:19:52.827178
NCT00140322|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2016-02-02|||October 2002||2002-10-01|February 2016|2016-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Dane County Safety Assessment (SAFE) Research Study|Dane County Safety Assessment for Elders (SAFE) Research Study|Completed||N/A|455||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:19:53.019669|2017-10-11 05:19:53.019669
NCT00140335|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2010-03-08|||December 2004||2004-12-01|March 2010|2010-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Evaluation of a Handwashing Promotion Program in Chinese Elementary Schools|Evaluation of a Handwashing Promotion Program in Chinese Elementary Schools|Completed||Phase 4|5000||Centers for Disease Control and Prevention|||||f||||t||||||||||2017-10-11 05:19:53.085665|2017-10-11 05:19:53.085665
NCT00140348|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2007-12-18|||December 2001||2001-12-01|December 2007|2007-12-01|April 2005|Actual|2005-04-01|||||Interventional|||Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine|A Phase I/II Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine in Patients With Metastatic Hormone-Refractory Prostate Cancer|Completed||Phase 1/Phase 2|80||Cell Genesys|||||||||||||||||||2017-10-11 05:19:53.179192|2017-10-11 05:19:53.179192
NCT00140361|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2012-09-10|||January 2000||2000-01-01|September 2012|2012-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria|Assessing and Monitoring the Efficacy of Sulfadoxine/ Pyrimethamine (SP) and the Combination of SP Plus Artesunate for Uncomplicated Malaria Infections Among Children|Completed||Phase 4|390|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:19:53.259999|2017-10-11 05:19:53.259999
NCT00140374|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2005-08-30|||December 1998||1998-12-01|August 2005|2005-08-01|February 2001||2001-02-01|||||Interventional|||Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)|Phase I/II Study of Vaccination Priming and Vaccine Boosting With Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines in Patients With Prostate Cancer|Completed||Phase 1/Phase 2|36||Cell Genesys|||||||||||||||||||2017-10-11 05:19:53.340752|2017-10-11 05:19:53.340752
NCT00140387|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2005-08-30|||May 1999||1999-05-01|August 2005|2005-08-01|March 2001||2001-03-01|||||Interventional|||Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)|Phase I/II Study of a Prime-Boost Schedule of Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) in Hormone-naïve Prostate Cancer Patients|Completed||Phase 1/Phase 2|20||Cell Genesys|||||||||||||||||||2017-10-11 05:19:53.388264|2017-10-11 05:19:53.388264
NCT00140400|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2005-08-30|||May 1999||1999-05-01|August 2005|2005-08-01|January 2001||2001-01-01|||||Interventional|||Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer|Phase I/II Study of a Prime-Boost Schedule of Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Hormone-Refractory Prostate Cancer|Completed||Phase 1/Phase 2|50||Cell Genesys|||||||||||||||||||2017-10-11 05:19:53.43594|2017-10-11 05:19:53.43594
NCT00140413|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-03-27|2015-02-17||December 2004||2004-12-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Please note, 3 children were unenrolled from the study and were therefore excluded from our analysis of results. Therefore, while the participant flow section lists 20 participants, the baseline analysis and results are based on 17 participants.|Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia|Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia|Completed||Phase 4|20|Actual|Children's Hospital Los Angeles||2|||f||||f||||||||||2017-10-11 05:19:53.49609|2017-10-11 05:19:53.49609
NCT00140426|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-12-29|2015-06-08||August 2004||2004-08-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||Females age 12 - 21|A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa|A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa|Completed||Phase 4|41|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-10-11 05:19:53.870128|2017-10-11 05:19:53.870128
NCT00140439|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-08-21|||April 2002||2002-04-01|August 2015|2015-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Improving Asthma Outcomes in an Urban Pediatric Population|Improving Asthma Outcomes in a High Morbidity Urban Pediatric Population: an Emergency Department-based Randomized Clinical Trial|Completed||N/A|488|Actual|Children's Research Institute||1|||f||||f||||||||||2017-10-11 05:19:54.460413|2017-10-11 05:19:54.460413
NCT00140452|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2007-11-20|||February 2005||2005-02-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Phase II Study Using Thalidomide for the Treatment of ALS|Phase II Study Using Thalidomide for the Treatment of Amyotrophic Lateral Sclerosis|Completed||Phase 2|24|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-10-11 05:19:54.556464|2017-10-11 05:19:54.556464
NCT00145808|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-09-04|||June 2005||2005-06-01|September 2013|2013-09-01|November 2008|Actual|2008-11-01|June 2007|Actual|2007-06-01||Interventional|||Wireless Capsule Endoscopy in Ulcerative Colitis|Prospective Controlled Assessment of Wireless Capsule Endoscopy (WCE) in Ulcerative Colitis (UC)|Completed||Phase 3|116|Anticipated|University of Chicago||1|||f||||||||||||||2017-10-11 05:19:54.627033|2017-10-11 05:19:54.627033
NCT00145860|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-09-04|||April 2002||2002-04-01|September 2013|2013-09-01|August 2005||2005-08-01|||||Observational|||Do Patients With Colorectal Cancer Understand That Their Family is at Risk?|Do Patients With Colorectal Cancer Understand That Their Family is at Increased Risk?|Terminated||N/A|650||University of Chicago|||||f||||||||||||||2017-10-11 05:19:54.899538|2017-10-11 05:19:54.899538
NCT00145873|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-10-07|||August 2003||2003-08-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Nesiritide in Chronic Heart Failure|Continuous Infusion Nesiritide in Chronic Heart Failure-University of Chicago (CINCH-UC)|Terminated||Phase 2|20||University of Chicago||||Unable to complete study|f||||||||||||||2017-10-11 05:19:54.972915|2017-10-11 05:19:54.972915
NCT00145886|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2016-01-08|||February 2003||2003-02-01|January 2016|2016-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||rhPTH Therapy for Low Turnover Bone Fragility|Effect of 12 Months Treatment With rhPTH on Calcium Balance, Bone Turnover, Bone Mineral Density, and Bone Micro-architecture in Patients With Fractures Associated With Low Bone Turnover and Sclerosing Bone Disorders|Terminated||Phase 1|2|Actual|University of Chicago||1||Slow enrollment|f||||f||||||||||2017-10-11 05:19:55.076325|2017-10-11 05:19:55.076325
NCT00145912|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-09-04|||February 2007||2007-02-01|September 2013|2013-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|CATCH-IT||Primary Care Based Depression Prevention for Adolescents/Young Adults/Young Adults and Young Adults|Primary Care Based Depression Prevention for Adolescents/Young Adults/Young Adults and Young Adults|Completed||N/A|49|Actual|University of Chicago||2|||f||||f||||||||||2017-10-11 05:19:55.154537|2017-10-11 05:19:55.154537
NCT00145925|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2008-09-16|||June 2001||2001-06-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes|ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation|Completed||Phase 3|11140|Actual|The George Institute||2|||f||||t||||||||||2017-10-11 05:19:55.232588|2017-10-11 05:19:55.232588
NCT00145938|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-10-07|||September 2003||2003-09-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Sildenafil and Pulmonary Artery Pressure|A Pilot Study of the Effect of Chronic Administration of Sildenafil on Pulmonary Artery Pressure in Patients With Portopulmonary Hypertension|Terminated||Phase 2|10||University of Chicago||||Unable to complete study|f||||||||||||||2017-10-11 05:19:55.327491|2017-10-11 05:19:55.327491
NCT00145951|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-03-27|||May 2006||2006-05-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|September 2007|Actual|2007-09-01||Observational|||Reducing the Risk of Developing Major Depression in Adolescents/Young Adults With Minor Depression/Depression Symptoms|Randomized Trial of a Motivational Interview Versus Brief Advice in Primary Care to Engage Mid-Late Adolescents With a Web-based Depression Prevention Intervention|Terminated||N/A|93|Actual|University of Chicago|||3|Lost funding|f||||||||||||||2017-10-11 05:19:55.410963|2017-10-11 05:19:55.410963
NCT00145964|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-11-28|||August 2004||2004-08-01|August 2005|2005-08-01||||||||Observational|||Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)|Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)|Unknown status|Recruiting|N/A|500||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:19:55.485787|2017-10-11 05:19:55.485787
NCT00145990|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-03-01|||September 2005||2005-09-01|March 2012|2012-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine||Completed||N/A|12||University of Florida|||||f||||||||||||||2017-10-11 05:19:55.922047|2017-10-11 05:19:55.922047
NCT00146003|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-08-06|||March 2005||2005-03-01|August 2008|2008-08-01|December 2007||2007-12-01|||||Interventional|||Efalizumab for Eczema|Investigator-Initiated Trial of Efalizumab for Atopic Dermatitis: A Proof of Concept Study in Adults|Completed||Phase 2|10||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-10-11 05:19:56.022514|2017-10-11 05:19:56.022514
NCT00146016|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2005-09-01|||February 2000||2000-02-01|September 2005|2005-09-01|January 2007||2007-01-01|||||Interventional|||Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients|Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients|Completed||Phase 3|390||UMC Utrecht|||||f||||||||||||||2017-10-11 05:19:56.123744|2017-10-11 05:19:56.123744
NCT00146029|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-03-24||||||March 2008|2008-03-01||||||||Observational|||Companion Pharmacogenetic Study to UMCC 9900/9901||Terminated||N/A|||University of Michigan Cancer Center|||||f||||||||||||||2017-10-11 05:19:56.21041|2017-10-11 05:19:56.21041
NCT00146042|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-10-03|||March 1999||1999-03-01|October 2012|2012-10-01|March 2005|Actual|2005-03-01|March 2004|Actual|2004-03-01||Interventional|||UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer|Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer|Completed||Phase 2|22|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:19:56.272685|2017-10-11 05:19:56.272685
NCT00146055|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2012-08-07|||March 2000||2000-03-01|August 2012|2012-08-01|October 2007|Actual|2007-10-01|November 2004|Actual|2004-11-01||Interventional|||Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood|Low-Intensity Preparative Regimen and Allogeneic Peripheral Blood Stem Cell Transplantation From Unrelated Donor in Patients With Hematologic Malignancy|Completed||Phase 2|60||University of Michigan Cancer Center|||||f||||||||||||||2017-10-11 05:19:56.370887|2017-10-11 05:19:56.370887
NCT00146068|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-02-28|||September 2004||2004-09-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis|Phase IV Double-Blind Randomized Study to Evaluate Safety and Efficacy of Interferon Beta-1a (Avonex) Plus Simvastatin (Zocor) Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis Over a One Year Period|Completed||Phase 4|30||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-10-11 05:19:56.441853|2017-10-11 05:19:56.441853
NCT00146081|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2008-03-26|||August 2002||2002-08-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|SHARE||Weight Management Skills in African American Outpatients|Weight Management Skills in African American Outpatients|Completed||N/A|344||University of Pennsylvania||4|||f||||||||||||||2017-10-11 05:19:56.527043|2017-10-11 05:19:56.527043
NCT00146094|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2011-08-29|||March 2003||2003-03-01|August 2011|2011-08-01||||||||Interventional|||Bone Mineral Density (BMD) in HIV Infection|Osteopenia and Osteoporosis in HIV Infection. Prospective BMD Measurement in Antiretroviral (ARV) Treated and Untreated HIV-1 Infected Patients|Completed||N/A|||University Hospital, Strasbourg, France|||||f||||||||||||||2017-10-11 05:19:56.599148|2017-10-11 05:19:56.599148
NCT00146107|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2013-04-22|||January 2005||2005-01-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Weight Loss and Exercise in Obese, Physically Limited, Older Women and Men|Weight Loss and Exercise in Frail Obese Elderly Subjects|Completed||Phase 3|107|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-10-11 05:19:56.765755|2017-10-11 05:19:56.765755
NCT00146120|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2009-02-05|||May 1998||1998-05-01|December 2008|2008-12-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result|Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result|Completed||Phase 3|400||University of Ulm|||||f||||||||||||||2017-10-11 05:19:56.860163|2017-10-11 05:19:56.860163
NCT00146133|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2006-05-02|||January 2003||2003-01-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Weight Loss and Exercise in Physically Limited Obese Elderly Subjects|Effect of Weight Loss and Physical Training on Musculoskeletal Status, Physical Function, and Quality-of-Life in Physically Limited, Obese, Elderly Subjects|Completed||Phase 3|28||Washington University School of Medicine|||||f||||||||||||||2017-10-11 05:19:56.966857|2017-10-11 05:19:56.966857
NCT00146146|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2009-02-17|||May 2005||2005-05-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|May 2006|Actual|2006-05-01||Interventional|||Testosterone and Its Metabolites in GID|Role of Testosterone and Its Metabolites Regarding Different Physiological Functions in Subjects Affected by Gender Identity Disorder (FtM Transsexuals)|Completed||Phase 3|15|Actual|Unita Complessa di Ostetricia e Ginecologia||1|||f||||f||||||||||2017-10-11 05:19:57.037636|2017-10-11 05:19:57.037636
NCT00146159|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-12-21|||March 2005||2005-03-01|December 2007|2007-12-01||||September 2007|Actual|2007-09-01||Interventional|||Study Evaluating Mitoxantrone in Multiple Sclerosis|A Double-Blind, Three-Armed, Randomized Phase-III-Study, to Compare the Efficacy, Tolerability and Safety of Three Doses of Mitoxantrone in the Treatment of Patients With Secondary Progressive Multiple Sclerosis|Terminated||Phase 3|336|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||||||||||||2017-10-11 05:19:57.139943|2017-10-11 05:19:57.139943
NCT00146185|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2005-11-15|||February 2005||2005-02-01|April 2005|2005-04-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety of ALGRX 3268 in Children Undergoing Minor Needle-Stick Procedures.|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Effectiveness and Safety of ALGRX 3268 in Pediatric Subjects.|Completed||Phase 3|504||AlgoRx Pharmaceuticals|||||||||||||||||||2017-10-11 05:19:57.320409|2017-10-11 05:19:57.320409
NCT00146198|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2006-12-18|||September 2005||2005-09-01|December 2006|2006-12-01|February 2006||2006-02-01|||||Interventional|||Efficacy and Safety of ALGRX 4975 in Treatment of Postoperative Pain After Hernia Repair|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Inguinal Hernia Repair|Completed||Phase 2|40||AlgoRx Pharmaceuticals|||||f||||||||||||||2017-10-11 05:19:57.379245|2017-10-11 05:19:57.379245
NCT00146211|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-12-24|||September 2005||2005-09-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|August 2007|Actual|2007-08-01||Interventional|||TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease|A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-Controlled Trial of Ethyl-EPA (Miraxion™) in Subjects With Mild to Moderate Huntington's Disease|Completed||Phase 3|300|Actual|Amarin Neuroscience Ltd|||||f||||||||||||||2017-10-11 05:19:57.44211|2017-10-11 05:19:57.44211
NCT00146224|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-02-25|||September 2005||2005-09-01|February 2010|2010-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis|A Randomized, Double-Blind, Equivalence Study of the Efficacy of Epoetin Alfa Manufactured by Deep Tank Bioreactor Technology and Epoetin Alfa Manufactured by Roller-Bottle Technology for the Treatment of Anemia in Patients With Chronic Kidney Disease (CKD) Receiving Hemodialysis|Completed||Phase 3|420|Anticipated|Amgen||2|||f||||||||||||||2017-10-11 05:19:57.590955|2017-10-11 05:19:57.590955
NCT00146237|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-11-23|||November 2003||2003-11-01|November 2009|2009-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Phenytoin as an Augmentation for SSRI Failures|Phenytoin as an Augmentation for SSRI Failures: A Controlled Study|Completed||Phase 4|40|Anticipated|Beersheva Mental Health Center|||||f||||||||||||||2017-10-11 05:19:57.667126|2017-10-11 05:19:57.667126
NCT00146250|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||January 2005||2005-01-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||The Effect of N2O Administration on Arterial Oxygenation|Relationship of Oxygenation During Anaesthesia in the Presence of N2O or N2 to Mode of Ventilation|Completed||Phase 4|20||Austin Health|||||f||||||||||||||2017-10-11 05:19:57.730322|2017-10-11 05:19:57.730322
NCT00146263|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-04|2010-09-05|||September 2005||2005-09-01|September 2005|2005-09-01|June 2007||2007-06-01|||||Interventional|||Cognitive Training in the Elderly|The Effect of Computerized Cognitive Training on Neuropsychological Measures of Cognitive Function in the Elderly|Unknown status|Recruiting|N/A|300|Anticipated|Beersheva Mental Health Center|||||f||||||||||||||2017-10-11 05:19:57.792843|2017-10-11 05:19:57.792843
NCT00146276|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-09-26|||July 2000||2000-07-01|September 2005|2005-09-01||||||||Interventional|||Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer|Adjuvant vs. Progression-Triggered Treatment With Gemcitabine After Radical Cystectomy for Locally Advanced Transitional Cell Carcinoma of the Bladder in Patients Not Suitable for Cisplatin-Based Chemotherapy - A Phase 3 Study|Unknown status|Recruiting|Phase 3|178||Association of Urogenital Oncology (AUO)|||||f||||||||||||||2017-10-11 05:19:57.886539|2017-10-11 05:19:57.886539
NCT00146484|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2005-09-06|||April 1996||1996-04-01|September 2005|2005-09-01|January 2001||2001-01-01|||||Interventional|||A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes|A Randomized Controlled Trial of Two Versus Three Daily Insulin Injections in Children and Adolescents With New Onset Type 1 Diabetes Mellitus|Completed||Phase 2|100||Children's Hospital of Eastern Ontario|||||f||||||||||||||2017-10-11 05:20:03.868531|2017-10-11 05:20:03.868531
NCT00146289|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-10-31|||February 2005||2005-02-01|October 2013|2013-10-01||||October 2005|Actual|2005-10-01||Interventional|||The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects|A Randomised, DB, Placebo-controlled, Parallel Group, 16-wk MICARDIS (160mg) Tab, Proof-of-concept, Evaluating Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive, Using the OGTT, With a Clamp Sub-group|Completed||Phase 2|138||Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:19:57.979051|2017-10-11 05:19:57.979051
NCT00146302|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2012-03-16|||November 2002||2002-11-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?|BCG Vaccination and Childhood Morbidity and Mortality: Interventions With Possible Implications for the Immunisation Policy in Developing Countries. Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth?|Completed||Phase 4|2320|Actual|Bandim Health Project||1|||f||||||||||||||2017-10-11 05:19:58.078332|2017-10-11 05:19:58.078332
NCT00146315|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-05-31|||January 2005||2005-01-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||ESCAP: Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting|Effectiveness of the Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting (ESCAP): a Randomized Clinical Trial|Completed||Phase 3|97|Actual|Basque Health Service||2|||f||||f||||||||||2017-10-11 05:19:58.157805|2017-10-11 05:19:58.157805
NCT00146328|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2014-01-31|2009-05-26||April 2001||2001-04-01|January 2014|2014-01-01||||May 2008|Actual|2008-05-01||Interventional|||Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects|A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects|Completed||Phase 2/Phase 3|997|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 05:19:58.304399|2017-10-11 05:19:58.304399
NCT00146341|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2013-11-18|||April 2005||2005-04-01|November 2013|2013-11-01|September 2006||2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg|An Eight Week Randomized, Double-Blind, Double-Dummy Study Comparing a Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlorothiazide 12.5mg to Telmisartan 80mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 80mg.|Completed||Phase 3|345|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:20:02.512101|2017-10-11 05:20:02.512101
NCT00146354|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2007-03-01||||||August 2005|2005-08-01||||||||Interventional|||The Effects of a Results Management System on Physician Awareness of Post-Discharge Test Results|The Effects of a Results Management System on Physician Awareness of Post-Discharge Laboratory and Radiology Results|Completed||Phase 3|||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 05:20:02.600812|2017-10-11 05:20:02.600812
NCT00146367|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-09-12|||January 2004||2004-01-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Evaluation of the Active Living Every Day Exercise Program for People With Arthritis|Evaluation of the Health Benefits of the Active Living Every Day Physical Activity Program Among Persons With Arthritis|Completed||Phase 2/Phase 3|355||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:02.664239|2017-10-11 05:20:02.664239
NCT00146380|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-09-26|||July 2003||2003-07-01|September 2012|2012-09-01|January 2013|Anticipated|2013-01-01|January 2009|Actual|2009-01-01||Interventional|KiBS||A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding|A Phase II Open Label Clinical Trial of Maternal Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Maximal Reduction of Mother-to-child HIV Transmission in Resource-limited Settings Among Breastfeeding Populations|Unknown status|Active, not recruiting|Phase 2|520|Anticipated|Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-10-11 05:20:02.741509|2017-10-11 05:20:02.741509
NCT00146393|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2005-12-08|||July 2003||2003-07-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Interventional|||Health Benefits of an Exercise Program for Adults With Arthritis|Evaluation of People With Arthritis Can Exercise|Completed||Phase 2/Phase 3|347||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:02.817062|2017-10-11 05:20:02.817062
NCT00146406|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-09-10|||January 2005||2005-01-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Multi-level Interventions for STD Prevention Among Adolescents|Integrated Multi-level Interventions to Improve Adolescent Health Through the Prevention of STD, Including HIV, and Teen Pregnancy|Terminated||N/A|36502|Actual|Centers for Disease Control and Prevention||||IRB terminated due to no continuation request.|f||||||||||||||2017-10-11 05:20:02.908302|2017-10-11 05:20:02.908302
NCT00146419|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2015-07-28|||March 2004||2004-03-01|September 2012|2012-09-01|June 2013|Actual|2013-06-01|August 2006|Actual|2006-08-01||Observational|||Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)|Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)|Completed||N/A|699|Actual|Centers for Disease Control and Prevention|||1||f||||f||||||||||2017-10-11 05:20:02.988174|2017-10-11 05:20:02.988174
NCT00146432|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-08-21||||||August 2009|2009-08-01||||||||Interventional|||Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)|Prospective, Controlled Pilot Trial: Treatment of Patients in Severe Sepsis and Septic Shock With Immunoadsorption of LPS, IL-6, C5a|Completed||Phase 2/Phase 3|||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:20:03.093812|2017-10-11 05:20:03.093812
NCT00146445|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-09-26|||August 2001||2001-08-01|September 2012|2012-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Behavioral Intervention Trial for HIV-infected Injection Drug Users|Intervention for Seropositive Injection Drug Users - Research and Evaluation (INSPIRE)|Completed||Phase 2/Phase 3|1000||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:20:03.164679|2017-10-11 05:20:03.164679
NCT00146458|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-09-19|||January 2002||2002-01-01|September 2006|2006-09-01|December 2007||2007-12-01|||||Interventional|||Usefulness of FDG-PET for Advanced Cervical Cancer|A Phase III Randomized Trial of FDG-PET in the Management of Advanced Cervical Cancer With Enlarged Pelvic Lymph Node on MRI Image|Unknown status|Active, not recruiting|Phase 3|200||Chang Gung Memorial Hospital|||||f||||||||||||||2017-10-11 05:20:03.689527|2017-10-11 05:20:03.689527
NCT00146471|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2009-12-29|||January 2006||2006-01-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome|Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome [Sicherheit Und Wirksamkeit Von Levetiracetam (Keppra) für Die Behandlung Des stationären Alkoholentzugsyndroms]|Completed||Phase 3|120|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 05:20:03.770183|2017-10-11 05:20:03.770183
NCT00146523|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2012-02-14|||May 2005||2005-05-01|February 2012|2012-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression|An International, Double-Blind, Placebo-Controlled, Study of the Efficacy and Safety of CORLUX™ (Mifepristone) vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Psychotic Major Depression (PMD)|Completed||Phase 3|247|Actual|Corcept Therapeutics||2|||f||||f||||||||||2017-10-11 05:20:04.107633|2017-10-11 05:20:04.107633
NCT00146536|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2017-03-30|||November 2004||2004-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy|The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS, or Atypical Ductal Hyperplasia (ADH) in Patients Diagnosed With Lobular Neoplasia of the Breast by Core Needle Biopsy|Completed||N/A|78|Anticipated|Dana-Farber Cancer Institute|||1||f||||f||||||Samples With DNA|"     Option of keeping tissue sample for further research   "|||2017-10-11 05:20:05.966026|2017-10-11 05:20:05.966026
NCT00146549|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2009-10-30|||August 2001||2001-08-01|October 2009|2009-10-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer|A Randomized Phase III Study of Trastuzumab (Herceptin) in Combination With Either Vinorelbine (Navelbine), or Taxane-based Chemotherapy in Patients With HER2 Overexpressing Metastatic Breast Cancer|Completed||Phase 3|250||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:20:06.033014|2017-10-11 05:20:06.033014
NCT00146562|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-02-15|||July 2003||2003-07-01|February 2013|2013-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer|A Phase II Study of Pegfilgrastim (Neulasta) and Darbepoetin Alfa (Aranesp) in Support of Dose-Dense Adjuvant Chemotherapy for Breast Cancer|Completed||Phase 2|109|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:20:06.110194|2017-10-11 05:20:06.110194
NCT00146575|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-01-10|||June 2003||2003-06-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)|Randomized Trial of Paclitaxel-Eluting Stent and Sirolimus-Eluting Stent for Restenosis Reduction in Small Coronary Vessels (ISAR-SMART-3)|Completed||Phase 4|360|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:20:06.229312|2017-10-11 05:20:06.229312
NCT00146588|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-03-23|||April 2002||2002-04-01|October 2014|2014-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer|A Pilot Study of Cytoxan, Epirubicin, and Capecitabine in Women With Stage I/II/IIIA Breast Cancer|Completed||N/A|55|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:20:06.330747|2017-10-11 05:20:06.330747
NCT00146601|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2007-12-20|||June 2004||2004-06-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer|A Phase II Study of Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer|Completed||Phase 2|35|Anticipated|Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:20:06.432835|2017-10-11 05:20:06.432835
NCT00146614|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-03-06|||July 2002||2002-07-01|March 2012|2012-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation|Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Allogeneic Non-Myeloablative Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|105||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:20:06.524521|2017-10-11 05:20:06.524521
NCT00146627|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-09-28||||||September 2009|2009-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis|Clinical Study Comparing the Nifurtimox-Eflornithine Combination With the Standard Eflornithine Regimen for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis in the Meningoencephalitic Phase|Completed||Phase 3|280|Anticipated|Drugs for Neglected Diseases|||||f||||||||||||||2017-10-11 05:20:06.640319|2017-10-11 05:20:06.640319
NCT00146653|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-11-19|||December 2005||2005-12-01|November 2013|2013-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Heparin Management During Cardiopulmonary Bypass in Children|A Comparison of Heparin Management Strategies in Children Undergoing Cardiopulmonary Bypass.|Completed||N/A|20|Actual|Emory University|||1||f||||f||||||Samples With DNA|"     Blood is being collected to obtain Xa results.   "|||2017-10-11 05:20:07.013296|2017-10-11 05:20:07.013296
NCT00146666|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-03|2009-12-16|||September 2005||2005-09-01|August 2009|2009-08-01|September 2006|Anticipated|2006-09-01|||||Interventional|||Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)|Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)|Unknown status|Recruiting|Phase 2|90|Anticipated|FlowMedic|||||f||||||||||||||2017-10-11 05:20:07.095414|2017-10-11 05:20:07.095414
NCT00146679|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2013-09-06|||March 2001||2001-03-01|September 2013|2013-09-01|February 2006|Actual|2006-02-01|June 2005|Actual|2005-06-01||Interventional|||Psychoeducational Intervention for ICD Patients (PEACE)|Psychoeducational Intervention for ICD Patients (PEACE)|Completed||N/A|246|Actual|Emory University||3|||f||||t||||||||||2017-10-11 05:20:07.190507|2017-10-11 05:20:07.190507
NCT00146692|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2017-01-11|||April 2004||2004-04-01|January 2017|2017-01-01|February 2005|Actual|2005-02-01|||||Interventional|||A Trial of Improved Financial Access to Healthcare in Ghana|Impact of Improved Financial Access to Health Care on Morbidity Due to Severe Malaria and Healthcare Utilization Among Children 6 Months to Five Years of Age in a Hyper Endemic Area in Ghana: a Randomized Controlled Trial|Completed||Phase 4|2000||London School of Hygiene and Tropical Medicine|||||f||||f||||||||||2017-10-11 05:20:07.307347|2017-10-11 05:20:07.307347
NCT00146705|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2007-07-31|||May 2005||2005-05-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Observational|||Long Term Follow-up of Pegylated-Interferon Alpha-2b|Long Term Follow-up of Pegylated-Interferon Alpha-2b and Lamivudine Combination Therapy in Patients With Chronic HBV Infection|Completed||N/A|266|Actual|Foundation for Liver Research|||||f||||f||||||||||2017-10-11 05:20:07.391154|2017-10-11 05:20:07.391154
NCT00146718|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2017-01-11|||August 2003||2003-08-01|January 2017|2017-01-01|May 2005||2005-05-01|||||Interventional|||Anti-Malarial Drug Resistance in Cameroon|Anti-malarial Drug Resistance in Cameroon: Therapeutic Efficacy and Biological Markers of Resistance|Completed||Phase 2/Phase 3|755||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:20:07.46023|2017-10-11 05:20:07.46023
NCT00152399|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-09-17|||September 2000||2000-09-01|September 2012|2012-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding|A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial To Study The Efficacy And The Safety Of The Early Administration Of Somatostatin (Ucb) 12 Mg/24 H IV Infusion And Two IV Boluses Of 250 Mcg During 72 Hours In The Treatment Of Subjects With Acute Severe Upper Gastrointestinal Bleeding (UGIB) With Suspicion Of Peptic Ulcer Bleeding [The PUB Study]|Completed||Phase 2|370||UCB Pharma|||||f||||||||||||||2017-10-11 05:20:07.540508|2017-10-11 05:20:07.540508
NCT00152412|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-08-25|||June 2004||2004-06-01|September 2009|2009-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis|A 4 Week Open, Multi-center Study Evaluating the Safety of Levocetirizine 1.25 mg b.i.d. Given as 0.5 mg/mL Oral Solution in 2 to 6 Year-old Children Suffering From Allergic Rhinitis.|Completed||Phase 2|30||UCB Pharma|||||f||||||||||||||2017-10-11 05:20:07.655883|2017-10-11 05:20:07.655883
NCT00152425|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-09-06|||February 2004||2004-02-01|July 2010|2010-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).|A Phase III Multi-national, Multi-centre, Double-blind Placebo-controlled Parallel Group, 26 Week Study to Assess the Maintenance of Clinical Response to Humanised Anti-TNF PEG Conjugate, CDP870 400 mg sc, (Dosed 4-weekly From Weeks 8 to 24), in the Treatment of Patients With Active Crohn's Disease Who Have Responded to Open Induction Therapy (Dosed at Weeks 0, 2 and 4) With CDP870|Completed||Phase 3|392||UCB Pharma|||||f||||||||||||||2017-10-11 05:20:07.726193|2017-10-11 05:20:07.726193
NCT00152438|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-09-20|||September 2005||2005-09-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|October 2009|Actual|2009-10-01||Interventional|||Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized Progesterone|Vasomotor Symptoms and Endothelial Function—A Randomized Placebo-controlled Trial of Oral Micronized Progesterone (Prometrium®)|Unknown status|Active, not recruiting|Phase 2|125|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 05:20:07.794509|2017-10-11 05:20:07.794509
NCT00152451|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-02-09|||May 2005||2005-05-01|February 2017|2017-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures|An Open-label, Exploratory, Multicenter, Dose-escalation Study Examining the Efficacy, Safety and Tolerability of Ucb 44212 Used at Doses of 10 mg, 20 mg, 40 mg and 80 mg b.i.d. (Total Daily Dose of 20 to 160 mg) in Adult Subjects (18-65 Years) With Refractory Epilepsy Suffering From Partial Onset Seizures (Whether or Not Secondarily Generalized) and Treated With 1, 2 or 3 Approved Antiepileptic Drugs|Completed||Phase 2|30||UCB Pharma|||||f||||||||||||||2017-10-11 05:20:07.880452|2017-10-11 05:20:07.880452
NCT00152477|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-02-22|||August 2005||2005-08-01|February 2017|2017-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer|A Two-Part, Open Label Phase II Trial: Part One, Dose Escalation Safety; Part Two, Randomized/Comparing CDP791 Plus Carboplatin/Paclitaxel With Carboplatin/Paclitaxel Alone in Subjects With Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer|Completed||Phase 2|165|Actual|UCB Pharma||3|||f||||||||||||||2017-10-11 05:20:08.002891|2017-10-11 05:20:08.002891
NCT00152490|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-09-06|||December 2003||2003-12-01|February 2010|2010-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)|A Phase III Multi-national, Multi-centre, Double-blind Placebo-controlled Parallel Group, 26 Week Study to Assess the Safety and Efficacy of the Humanised Anti-TNF PEG Conjugate, CDP870 400 mg sc, (Dosed at Weeks 0, 2, 4 Then 4-weekly to Week 24), in the Treatment of Patients With Active Crohn's Disease|Completed||Phase 3|604||UCB Pharma|||||f||||||||||||||2017-10-11 05:20:08.137994|2017-10-11 05:20:08.137994
NCT00152503|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-09-30|||August 2005||2005-08-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam|An Open Label, Exploratory, Dose-Escalation, Multicenter Study Examining the Safety, Tolerability and Efficacy of Ucb 44212 (Seletracetam) Used at Doses of 10, 20, 40, and 80 mg b.i.d. (Total Daily Doses of 20 - 160 mg) Administration (Oral Capsules) in Adult Subjects (18 - 65 Years) With Refractory Epilepsy Suffering From Partial Onset Seizures Who Are Currently Receiving Levetiracetam (LEV) But Still Experiencing Seizures|Completed||Phase 2|60||UCB Pharma|||||f||||||||||||||2017-10-11 05:20:08.213119|2017-10-11 05:20:08.213119
NCT00152516|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-02-08|2009-08-27||October 2004||2004-10-01|April 2010|2010-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures|A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures.|Completed||Phase 3|255|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:20:08.468569|2017-10-11 05:20:08.468569
NCT00152529|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-09-04|||October 2003||2003-10-01|September 2013|2013-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Observational|||C.A.T.C.H.-I.T.Competent Adulthood Transition With Cognitive, Humanistic and Interpersonal Teaching|"C.A.T.C.H.-I.T. Competent Adulthood Transition With Cognitive, Humanistic and Interpersonal Teaching"|Terminated||N/A|8||University of Chicago||||Study completed|f||||||||||||||2017-10-11 05:20:09.411238|2017-10-11 05:20:09.411238
NCT00152542|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-06-11|||May 2005||2005-05-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants|Follow up at School-age of Children Participating in the Nitric Oxide Ventilatory Approach (NOVA) Study|Completed||Phase 3|160|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 05:20:09.480769|2017-10-11 05:20:09.480769
NCT00152555|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-06-11|||March 2003||2003-03-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Physical Therapy for Systemic Lupus Erythematosus (SLE)|Physical Therapy for Improvement of Quality of Life in Patients With Systemic Lupus Erythematosus (SLE)|Terminated||N/A|100||University of Chicago||||study completed|f||||||||||||||2017-10-11 05:20:09.569538|2017-10-11 05:20:09.569538
NCT00152568|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-09-04|||June 2001||2001-06-01|September 2013|2013-09-01|December 2003|Actual|2003-12-01|September 2003|Actual|2003-09-01||Interventional|||The Effectiveness of Car Seat Checks at Routine Pediatric Visits|The Effectiveness of Car Seat Checks at Routine Pediatric Visits|Completed||N/A|364|Actual|University of Chicago||1|||f||||f||||||||||2017-10-11 05:20:09.650041|2017-10-11 05:20:09.650041
NCT00152581|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-11-29|||April 2002||2002-04-01|September 2005|2005-09-01||||||||Interventional|||Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication|Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication|Completed||Phase 4|40||University College London Hospitals|||||f||||||||||||||2017-10-11 05:20:09.718442|2017-10-11 05:20:09.718442
NCT00152594|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-11-13|||October 2004||2004-10-01|November 2006|2006-11-01|January 2006||2006-01-01|||||Interventional|||Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia|Phase III Study of Safety, Tolerance, Efficacy, Pharmacokinetics, and Costs of Therapy With Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia|Terminated||Phase 3|150||University of Cologne|||||f||||||||||||||2017-10-11 05:20:09.787257|2017-10-11 05:20:09.787257
NCT00152607|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-09-26|||April 2000||2000-04-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Orthotopic Liver Transplantation Using a Living Donor|Orthotopic Liver Transplantation Using a Living Donor Into An Adult Recipient|Terminated||Phase 4|20|Actual|University of Chicago||1||Poor accrual|f||||||||||||||2017-10-11 05:20:09.854571|2017-10-11 05:20:09.854571
NCT00152620|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-09-04|||June 2004||2004-06-01|September 2013|2013-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease|Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease|Terminated||N/A|40||University of Chicago||||study completed|f||||||||||||||2017-10-11 05:20:09.913666|2017-10-11 05:20:09.913666
NCT00152633|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-07-04|||September 2005||2005-09-01|July 2012|2012-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension|Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension|Withdrawn||Phase 2/Phase 3|0|Actual|University of Erlangen-Nürnberg Medical School||2||No patient could be recruited.|f||||f||||||||||2017-10-11 05:20:09.981951|2017-10-11 05:20:09.981951
NCT00152646|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-02-03|||March 2005||2005-03-01|September 2005|2005-09-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Platelets Induced Vasodilation, in Vitro and in Vivo Study|Platelets Induced Vasodilation, in Vitro and in Vivo Study in Patients With Arteriopathy and Healthy Subjects.|Unknown status|Recruiting|Phase 4|36|Anticipated|University Hospital, Angers|||||f||||t||||||||||2017-10-11 05:20:10.076678|2017-10-11 05:20:10.076678
NCT00152659|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-05-16|||September 1998||1998-09-01|May 2016|2016-05-01||||December 2030|Anticipated|2030-12-01||Observational|||Developing Criteria for Cortical Resections|Developing Functional and Structural Criteria for Cortical Resections|Recruiting||N/A|1000|Anticipated|University of Chicago|||1||f||||f||||||||||2017-10-11 05:20:10.133571|2017-10-11 05:20:10.133571
NCT00152672|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-10-27|||June 2005||2005-06-01|February 2005|2005-02-01||||||||Interventional|||Treatment of Sleep Apnea Syndrome With nCPAP Versus Oral Appliance|Treatment of Sleep Apnea Syndrome With nCPAP Versus Oral Appliance: a Multicentre Prospective Randomized Crossover Trial|Unknown status|Recruiting|N/A|60||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:20:10.208904|2017-10-11 05:20:10.208904
NCT00152685|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-11-29||||||September 2005|2005-09-01||||||||Interventional|||High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury||Unknown status|Recruiting|Phase 2/Phase 3|40||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:20:10.272047|2017-10-11 05:20:10.272047
NCT00152698|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-01-18|||November 2009||2009-11-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia|A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Study the Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia|Completed||Phase 3|80||University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-10-11 05:20:10.386904|2017-10-11 05:20:10.386904
NCT00152711|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-02-12|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis|Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis: A Prospective Cross Over Trial|Unknown status|Recruiting|N/A|40||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:20:10.454141|2017-10-11 05:20:10.454141
NCT00152724|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-03-16|||January 1996||1996-01-01|March 2007|2007-03-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Mechanisms of Human Cutaneous Microcirculation in Healthy Volunteers|Etude de la Reserve Vasomotrice Microcirculatoire cutanée|Unknown status|Recruiting|Phase 4|85||University Hospital, Angers|||||f||||f||||||||||2017-10-11 05:20:10.523971|2017-10-11 05:20:10.523971
NCT00153283|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-02-18|||September 2003||2003-09-01|February 2009|2009-02-01|April 2004||2004-04-01|||||Interventional|||Study of Efficacy of Gabapentin in Therapy of Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Gabapentin Efficacy in Asthma Therapy|Completed||Phase 4|68||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-10-11 05:20:10.730211|2017-10-11 05:20:10.730211
NCT00153296|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-02-18|||August 2004||2004-08-01|February 2009|2009-02-01|April 2005||2005-04-01|||||Interventional|||Study of Efficacy of Carbamazepine in Therapy of Patients With Moderate Persistent and Severe Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Carbamazepine Efficacy in Moderate Persistent and Severe Asthma Therapy|Completed||Phase 4|68||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-10-11 05:20:10.788726|2017-10-11 05:20:10.788726
NCT00153309|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-11-16|||June 2003||2003-06-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Program Evaluation of People With Arthritis Can Exercise|Evaluation of the Health Benefits of the People With Arthritis Can Exercise Program|Completed||Phase 2/Phase 3|320||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:10.871727|2017-10-11 05:20:10.871727
NCT00153322|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||November 2002||2002-11-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Shape Up Somerville: Eat Smart Play Hard|Shape Up Somerville: Eat Smart Play Hard|Completed||N/A|3000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:10.958025|2017-10-11 05:20:10.958025
NCT00153335|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-02-24|||June 2005||2005-06-01|February 2010|2010-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Computerized Risk Assessment in an Employee Population|Computerized Risk Assessment in an Employee Population|Completed||N/A|300|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:11.058358|2017-10-11 05:20:11.058358
NCT00153348|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-03-13|||January 2001||2001-01-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||South Central Foundation - WISEWOMAN Project|South Central Foundation - WISEWOMAN Project|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:11.159478|2017-10-11 05:20:11.159478
NCT00153361|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-01-06|||October 2002||2002-10-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Project MIX: Behavioral Intervention to Reduce Risk Among Substance-Using MSM|Project Mix: Behavioral Intervention to Reduce Sexual Risk Behavior of Substance-Using (Non-Injection) Men Who Have Sex With Men|Completed||N/A|1750|Anticipated|Centers for Disease Control and Prevention||3|||f||||||||||||||2017-10-11 05:20:11.234931|2017-10-11 05:20:11.234931
NCT00153374|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-03-13||||||March 2012|2012-03-01||||||||Interventional|||Iowa WISEWOMAN Project|Iowa WISEWOMAN Project|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:11.335334|2017-10-11 05:20:11.335334
NCT00153387|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08||||||September 2005|2005-09-01||||||||Interventional|||Illinois WISEWOMAN Project|Illinois WISEWOMAN Project|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:11.379865|2017-10-11 05:20:11.379865
NCT00153426|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-06-27|||July 2003||2003-07-01|June 2012|2012-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||West Virginia WISEWOMAN Project|West Virginia WISEWOMAN Project|Completed||N/A|733|Actual|West Virginia University||1|||f||||f||||||||||2017-10-11 05:20:11.541936|2017-10-11 05:20:11.541936
NCT00153439|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-09-06|||July 2003||2003-07-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Purdue University Parenting Program Attrition|Purdue University Parenting Program Attrition and Compliance Efficacy Trial|Completed||Phase 1|560||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:20:11.623893|2017-10-11 05:20:11.623893
NCT00153452|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||November 2004||2004-11-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Observational|||Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners|Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners|Completed||N/A|630||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:11.699791|2017-10-11 05:20:11.699791
NCT00153465|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-09-06|||January 2004||2004-01-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||University of Oklahoma Parenting Program Attrition|University of Oklahoma Health Sciences Center Parenting Program Attrition and Compliance Efficacy Trial|Completed||Phase 1|450||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:20:11.76666|2017-10-11 05:20:11.76666
NCT00153478|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||July 2002||2002-07-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Project CHOICES Efficacy Study|Project CHOICES Efficacy Study for Preventing Alcohol-Exposed Pregnancies|Completed||Phase 2|1200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:11.866804|2017-10-11 05:20:11.866804
NCT00153491|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||August 2002||2002-08-01|September 2005|2005-09-01|August 2006||2006-08-01|||||Observational|||Adherence to Lumefantrine-Artemether|Assessment of Adherence to a 6-Dose Regimen of Coartem for Treatment of Uncomplicated Malaria in Children Under 5 Years in Tanzania|Completed||Phase 4|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:11.971264|2017-10-11 05:20:11.971264
NCT00153504|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-04-04|||July 2004||2004-07-01|April 2012|2012-04-01|January 2007|Actual|2007-01-01|||||Interventional|H&H||Housing and Health Study|Housing and Health Study|Completed||N/A|630|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 05:20:12.054434|2017-10-11 05:20:12.054434
NCT00153517|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||October 1999||1999-10-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy|Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy (Randomized Trial of BV Treatment in Pregnancy)|Completed||Phase 2|126||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:20:12.138484|2017-10-11 05:20:12.138484
NCT00153530|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-12-23|||May 2000||2000-05-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|||||Interventional|||Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)|Phase IV Study on the Role of Whole Brain Irradiation in Primary CNS Lymphoma (PCNSL) After High-dose Methotrexate|Completed||Phase 4|604|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-10-11 05:20:12.226241|2017-10-11 05:20:12.226241
NCT00153543|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-03-19|||May 2002||2002-05-01|September 2005|2005-09-01|June 2003||2003-06-01|||||Interventional|||Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders|Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders|Completed||Phase 1|90||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 05:20:12.326109|2017-10-11 05:20:12.326109
NCT00153556|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||September 2001||2001-09-01|September 2005|2005-09-01|November 2003||2003-11-01|||||Interventional|||Study to Eliminate Hib Carriage in Rural Alaska Native Villages|A Demonstration Project for the Elimination of Haemophilus Influenzae Type B in Three Rural Alaska Native Villages|Completed||Phase 4|3200||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 05:20:12.394328|2017-10-11 05:20:12.394328
NCT00153569|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-05-25|||March 2003||2003-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Multiepitope Peptide Vaccination in Melanoma|Phase II Study of Multiepitope Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in Metastatic Melanoma|Unknown status|Active, not recruiting|Phase 2|25||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:20:12.497986|2017-10-11 05:20:12.497986
NCT00153582|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-02-21|||April 2002||2002-04-01|September 2005|2005-09-01||||||||Interventional|||WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)|Phase II Study of WT1 126-134 Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in AML|Unknown status|Recruiting|Phase 2|25||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:20:12.568982|2017-10-11 05:20:12.568982
NCT00153595|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-23|||November 2004||2004-11-01|September 2005|2005-09-01||||||||Interventional|||EWO1 in Persistent Allergic Rhinitis Patients|A Double-Blind, Randomized Parallel Group, Placebo-Control Study of EW01 in Persistent Allergic Rhinitis (PAR) Patients|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|China Medical University Hospital|||||f||||||||||||||2017-10-11 05:20:12.646278|2017-10-11 05:20:12.646278
NCT00153608|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-02-13|||April 2004||2004-04-01|September 2005|2005-09-01||||||||Interventional|||WT1 Peptid Vaccination in Carcinomas|Phase II Study of WT1 126-134 Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in Carcinomas|Unknown status|Recruiting|Phase 2|25||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:20:12.739951|2017-10-11 05:20:12.739951
NCT00153621|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-02|||September 2004||2004-09-01|September 2005|2005-09-01|September 2007|Actual|2007-09-01|||||Observational|||Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients|Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric Patients in the Special Immunology, Burgess, and Nephrology Clinics|Completed||N/A|320|Anticipated|Children's Research Institute|||||f||||||||||||||2017-10-11 05:20:12.822427|2017-10-11 05:20:12.822427
NCT00153634|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-03-12|||March 2004||2004-03-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)|Standard vs. Biofilm Susceptibility Testing in CF|Completed||N/A|75|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-10-11 05:20:12.898924|2017-10-11 05:20:12.898924
NCT00153647|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-03-14|||May 2005||2005-05-01|August 2007|2007-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|CAC||A Study to Assess Cap-Assisted Colonoscopy Versus Regular Colonoscopy for the First or Repeated Colonoscopy|A Study to Assess the Success Rate of Cap-Assisted Colonoscopy Versus Regular Colonoscopy for the First or Repeated Colonoscopy (CAC Study)|Completed||N/A|1000|Actual|Chinese University of Hong Kong||2|||f||||||||||||||2017-10-11 05:20:13.025303|2017-10-11 05:20:13.025303
NCT00153660|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-12-30|||June 2005||2005-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2014|Actual|2014-11-01||Interventional|||Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients|A Double-blind Randomized Comparison of Celecoxib Plus Esomeprazole Versus Naproxen Plus Esomeprazole for Prevention of Recurrent Ulcer Bleeding in Patients With Arthritis and Cardiothrombotic Diseases (NSAID#8 Study)|Completed||Phase 3|514|Actual|Chinese University of Hong Kong||2|||f||||t||||||||No||2017-10-11 05:20:13.132483|2017-10-11 05:20:13.132483
NCT00153673|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-04-20|||February 2001||2001-02-01|April 2017|2017-04-01|April 12, 2017|Actual|2017-04-12|December 28, 2016|Actual|2016-12-28||Interventional|||Effect of Selective COX-2 Inhibition on Ulcer Healing|Phase III Study of a Double-Blind Randomized Comparison of Famotidine Plus Celecoxib Versus Dologesics for Gastric Ulcer Healing in Arthritis Patients (NSAID#5A Study)|Completed||Phase 3|200|Actual|Chinese University of Hong Kong||2|||f||||||||||||||2017-10-11 05:20:13.213558|2017-10-11 05:20:13.213558
NCT00153686|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-09|||June 2005||2005-06-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Interventional|||Capsule Endoscopy or Mesenteric Angiogram in Patients With Overt Gastrointestinal Bleeding (GIB) of Obscure Origin|Capsule Endoscopy or Mesenteric Angiogram in Patients With Overt Gastrointestinal Bleeding of Obscure Origin: A Randomized Study|Completed||N/A|58|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-10-11 05:20:13.28384|2017-10-11 05:20:13.28384
NCT00153699|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-10-30|||September 2004||2004-09-01|October 2007|2007-10-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Relationship Between Topiramate Use and Ocular Angle Status|Relationship Between Topiramate Use and Ocular Angle Status: A Prospective Pilot Study|Unknown status|Active, not recruiting|Phase 4|15|Anticipated|Chinese University of Hong Kong||1|||f||||||||||||||2017-10-11 05:20:13.363663|2017-10-11 05:20:13.363663
NCT00153712|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-08-15|||August 2002||2002-08-01|August 2017|2017-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers|A Prospective Cohort Study to Study the Natural History and Ulcer Recurrence Without Acid Suppression of Non-NSAID, Non-HP Bleeding Peptic Ulcer Patients|Completed||N/A|391|Actual|Chinese University of Hong Kong|||2||f||||f||||||||||2017-10-11 05:20:13.436577|2017-10-11 05:20:13.436577
NCT00153725|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-26|||February 2003||2003-02-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||Intravenous Pantoloc In Aspirin-Induced Ulcer Bleeding||Completed||N/A|156||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:20:13.500763|2017-10-11 05:20:13.500763
NCT00153738|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-03-12|||March 2004||2004-03-01|March 2014|2014-03-01|August 2005||2005-08-01|||||Interventional|||Phytosterol Supplementation and Cardiovascular Risk|Effectiveness of Phytosterol Supplementation on Select Indices of Cardiovascular Risk|Completed||N/A|72||The Cooper Institute|||||f||||||||||||||2017-10-11 05:20:13.559751|2017-10-11 05:20:13.559751
NCT00153751|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-09|||September 2005||2005-09-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS)|Clinical Study to Test the Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With IBS|Completed||Phase 2|84|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-11 05:20:13.613025|2017-10-11 05:20:13.613025
NCT00153764|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-08-01|||September 2004||2004-09-01|August 2012|2012-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|Omega-3||Effectiveness of a Vitamin Mineral Supplement|Effectiveness of a One-a-Day Cooper Complete Vitamin / Mineral Supplement With or Without Omega-3 Fatty Acid Ingestion|Completed||Phase 1|75|Actual|The Cooper Institute||1|||f||||f||||||||||2017-10-11 05:20:13.699458|2017-10-11 05:20:13.699458
NCT00153777|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-08-27|||July 2005||2005-07-01|August 2015|2015-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Cellulose Sulfate and HIV Transmission Among Women|Randomized Controlled Trial of 6% Cellulose Sulfate Gel and the Effect on Vaginal HIV Transmission|Terminated||Phase 3|1428|Actual|CONRAD||2||IDMC recommendation|f||||t||||||||||2017-10-11 05:20:13.768703|2017-10-11 05:20:13.768703
NCT00153790|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-03-12|||April 2005||2005-04-01|March 2014|2014-03-01|May 2006||2006-05-01|||||Interventional|||LEAN Project: Weight Loss and Appetite Suppression|The Effect of Soy Lecithin-derived N-oleoyl-phosphatidyl-ethanolamine (NOPE) and Green Tea-derived Epigallocatechin Gallate (EGCG) on Indices of Weight Loss and Appetite Suppression|Completed||Phase 1|60||The Cooper Institute|||||f||||||||||||||2017-10-11 05:20:13.98487|2017-10-11 05:20:13.98487
NCT00153803|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-11-11|||May 2005||2005-05-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)|A National Web-Based Randomized Phase III Study of Erlotinib or Placebo Following Concurrent Docetaxel, Carboplatin, and Thoracic Radiotherapy in Patients With Inoperable Stage III Non-Small Cell Lung Cancer (D0410).|Completed||Phase 3|30|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 05:20:14.084932|2017-10-11 05:20:14.084932
NCT00153829|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-02-20|||December 2004||2004-12-01|February 2015|2015-02-01|February 2006||2006-02-01|||||Interventional|||Chronic Illness Care Management (CICM) Study In Primary Care||Completed||Phase 1|200||Bruyere Research Institute|||||f||||||||||||||2017-10-11 05:20:17.372184|2017-10-11 05:20:17.372184
NCT00153855|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-06|||January 2005||2005-01-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Observational|||Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates|Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates|Terminated||Phase 3|50||Children's Hospital of Philadelphia|||||f||||||||||||||2017-10-11 05:20:17.540465|2017-10-11 05:20:17.540465
NCT00153868|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-06-27|||October 2003||2003-10-01|June 2016|2016-06-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer|Pilot Web-based Study of Functional Status, Symptom Palliation and Quality of Life Benefits Associated With Darbepoetin Alfa (Aranesp®) Administration in Anemic Patients With Cancer.|Active, not recruiting||N/A|43|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 05:20:17.613117|2017-10-11 05:20:17.613117
NCT00153881|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-11-11|||February 2000||2000-02-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer|Docetaxel and Carboplatin Followed by a Dose-Ranging Study of Oral Capecitabine, Weekly Docetaxel, and Concomitant External Beam Radiotherapy for the Treatment of Patients With Stage II-III Carcinoma of the Esophagus and Gastro-Esophageal Junction|Completed||Phase 1|44|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 05:20:17.689083|2017-10-11 05:20:17.689083
NCT00153894|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-06-24|||December 2003||2003-12-01|June 2016|2016-06-01|February 2008|Actual|2008-02-01|June 2006|Actual|2006-06-01||Interventional|||Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors|Pilot Study of the Effects of an Exercise Intervention on Insulin Levels in Breast Cancer Survivors|Completed||N/A|100|Actual|Dana-Farber Cancer Institute||2|||f||||f||||||||No||2017-10-11 05:20:17.776475|2017-10-11 05:20:17.776475
NCT00153907|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-02-05|||March 2002||2002-03-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer|A Phase I Study of Oral Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer|Completed||Phase 1|40|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:20:17.860119|2017-10-11 05:20:17.860119
NCT00153920|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-01-21|2016-01-21||December 2003||2003-12-01|January 2016|2016-01-01|September 2008|Actual|2008-09-01|July 2007|Actual|2007-07-01||Interventional||The analysis population is comprised of eligible and treated participants.|Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma|Phase II Trial of Velcade (Bortezomib) in Patients With Previously Untreated Multiple Myeloma|Completed||Phase 2|66|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-10-11 05:20:18.067309|2017-10-11 05:20:18.067309
NCT00153933|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-01-21|||August 2004||2004-08-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma|An Open-Label Phase I Study of the Safety and Efficacy of Bortezomib in Combination With CC-5013 in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma|Completed||Phase 1|58|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:20:18.604285|2017-10-11 05:20:18.604285
NCT00153946|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-12|||August 2004||2004-08-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|EAST||Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke|Multicenter Randomized Open-Label Comparison Study on the Efficacy and Safety of Argatroban Monotherapy With Argatroban-Edaravone Combination Therapy|Completed||Phase 4|814|Actual|Combination Therapy for Acute Ischemic Stroke Study Group||2|||f||||t||||||||||2017-10-11 05:20:18.72358|2017-10-11 05:20:18.72358
NCT00153959|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07||||||September 2005|2005-09-01||||||||Interventional|||Psychiatric Day Hospital Treatment||Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:20:18.827579|2017-10-11 05:20:18.827579
NCT00153972|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-12-17|||February 2005||2005-02-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease|Dopamine Turnover Rate Measured With F-Dopa-PET as Surrogate Parameter for Diagnosis and Progression Analysis of Early Parkinson's Disease|Completed||Phase 4|39|Actual|Technische Universität Dresden||2|||f||||t||||||||||2017-10-11 05:20:18.918498|2017-10-11 05:20:18.918498
NCT00153985|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-07-24|2012-12-05||March 2004||2004-03-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|March 2008|Actual|2008-03-01||Interventional|||Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies|Multi-Center Study Using Allogeneic Stem Cell Transplantation Following Reduced Intensity Chemotherapy in Patients With Hemoglobinopathies|Completed||Phase 2|2|Actual|Dana-Farber Cancer Institute|Early termination leading to small numbers of subjects analyzed.|1|||f||||t||||||||||2017-10-11 05:20:19.015595|2017-10-11 05:20:19.015595
NCT00153998|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-02-26|||November 2004||2004-11-01|April 2007|2007-04-01||||March 2008|Actual|2008-03-01||Interventional|||Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)|Open, Randomized, Multicenter, Randomized Phase II Trial Comparing the Combination of Cetuximab With Oxaliplatin/5-FU/FA Versus the Combination of Cetuximab With Irinotecan/5-FU/FA as Neoadjuvant Treatment in Patients With Non-Resectable Colorectal Liver Metastases|Completed||Phase 2|135|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-10-11 05:20:19.268639|2017-10-11 05:20:19.268639
NCT00154011|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-11|||September 2005||2005-09-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.|Characterization of Vascular Effects of Rosiglitazone.|Completed||N/A|24||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:20:19.477679|2017-10-11 05:20:19.477679
NCT00154024|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-27|||March 2003||2003-03-01|July 2006|2006-07-01|October 2006||2006-10-01|||||Interventional|||Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.|Characterization of Local Vascular Effects of Angiotensin II and Histamine After Treatment With Irbesartan and Atorvastatin.|Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:20:19.546069|2017-10-11 05:20:19.546069
NCT00154037|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-12|||October 2005||2005-10-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.|Characterization of Vascular Effects of Candesartan and Pioglitazone.|Completed||N/A|40||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:20:19.641404|2017-10-11 05:20:19.641404
NCT00154050|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-11|||May 2004||2004-05-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty||Completed||N/A|22||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:20:19.726214|2017-10-11 05:20:19.726214
NCT00154063|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-05-21|2015-05-21||January 2005||2005-01-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy and Safety Study of E2007 in Migraine Prophylaxis|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 in Migraine Prophylaxis|Completed||Phase 2|206|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 05:20:19.863814|2017-10-11 05:20:19.863814
NCT00154089|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-02-20|||November 2004||2004-11-01|August 2006|2006-08-01|December 2006|Actual|2006-12-01|April 2006|Actual|2006-04-01||Interventional|||A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia|A Pilot Translational Study of Tetra-O-Methyl Nordihydroguaiaretic Acid (EM-1421) for the Treatment of Cervical Intraepithelial Neoplasia Induced by Human Papilloma Virus|Completed||Phase 1/Phase 2|8|Actual|Erimos Pharmaceuticals||1|||f||||f||||||||No||2017-10-11 05:20:21.592755|2017-10-11 05:20:21.592755
NCT00154102|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-12|2010-11-30||May 2004||2004-05-01|January 2017|2017-01-01|March 2011|Actual|2011-03-01|December 2006|Actual|2006-12-01||Interventional|CRYSTAL||Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)|Open, Randomized, Controlled, Multicenter Phase III Study Comparing 5FU/ FA Plus Irinotecan Plus Cetuximab Versus 5FU/FA Plus Irinotecan as First-line Treatment for Epidermal Growth Factor Receptor-expressing Metastatic Colorectal Cancer|Completed||Phase 3|1221|Actual|Merck KGaA|A non-specific outcome measure 'Safety' was deleted from the entry in error. A replacement outcome was created. The outcome refers to adverse events.|2|||f||||t||||||||||2017-10-11 05:20:21.793244|2017-10-11 05:20:21.793244
NCT00154115|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-01-20|||March 2005||2005-03-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Levosimendan in High Risk Heart Valve Surgery|Efficacy of Levosimendan in Cardiac Failure After Heart Valve Surgery|Completed||Phase 4|200|Anticipated|Kuopio University Hospital||2|||f||||t||||||||||2017-10-11 05:20:25.646181|2017-10-11 05:20:25.646181
NCT00154128|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-17|||April 2005||2005-04-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||The Influence of a Stabilization Splint on the Body Posture|The Influence of of a Stabilization Splint on the Body Posture in TMD Cases and Controls|Completed||Phase 1|40||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:20:25.732694|2017-10-11 05:20:25.732694
NCT00154141|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-07-11|||June 2005||2005-06-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures|A Prospective, Randomized Controlled Study to Compare the Effects of a Fibrin Sealant (FS2) Versus Manual Compression on Haemostatic Efficacy During Vascular Surgical Procedures Utilising Polytetrafluorethylene Graft Material on an End-to-Side Femoral or Upper Extremity Vascular Access Arterial Anastomosis|Completed||Phase 3|150||Ethicon, Inc.|||||||||||||||||||2017-10-11 05:20:25.810219|2017-10-11 05:20:25.810219
NCT00154154|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-12-11|||October 2002||2002-10-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|June 2007|Actual|2007-06-01||Interventional|||Hope for the Chronically Suicidal Patient|Hope for the Chronically Suicidal Patient: Evaluating the Clinical and Health Services Impact of Dialectical Behaviour Therapy in Individuals With Borderline Personality Disorder|Completed||N/A|180|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 05:20:25.906143|2017-10-11 05:20:25.906143
NCT00154167|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-12|||February 2003||2003-02-01|September 2005|2005-09-01|June 2003||2003-06-01|||||Interventional|||Safety and Efficacy Study of NV-101 in Dental Patients|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of NV-101 in Dental Patients|Completed||Phase 2|122||Novalar Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 05:20:26.043156|2017-10-11 05:20:26.043156
NCT00154180|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-09-10|||September 2005||2005-09-01|September 2009|2009-09-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|||Kronos Early Estrogen Prevention Study (KEEPS)|Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women|Unknown status|Active, not recruiting|Phase 4|728|Anticipated|Kronos Longevity Research Institute||2|||f||||t||||||||||2017-10-11 05:20:26.112163|2017-10-11 05:20:26.112163
NCT00154193|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-04-20|||June 2004||2004-06-01|April 2016|2016-04-01||||November 2007|Actual|2007-11-01||Interventional|||Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels|A 12-month Study to Investigate the Correlations Between Cyclosporine Microemulsion C2 Levels (High, Medium and Low) and AUC0-4 With Regard to Outcome in de Novo Heart and Lung Transplantation - Identification of Target Cyclosporine Microemulsion C2 Levels.|Completed||Phase 4|190|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:20:26.325207|2017-10-11 05:20:26.325207
NCT00154206|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-02-22|||September 2004||2004-09-01|February 2017|2017-02-01||||January 2007|Actual|2007-01-01||Interventional|||Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients|A Multicenter, Open, Single Arm, Pilot Study to Evaluate Efficacy, Tolerability and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients|Completed||Phase 4|15||Novartis|||||f||||||||||||||2017-10-11 05:20:26.408035|2017-10-11 05:20:26.408035
NCT00154219|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-05-18|||November 2004||2004-11-01|May 2012|2012-05-01||||October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis|A 13-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Group Trial of Lumiracoxib (COX189) 100 mg o.d. in Patients With Primary Hip Osteoarthritis Using Celecoxib (200 mg o.d.) as a Positive Control|Completed||Phase 3|1200||Novartis|||||||||||||||||||2017-10-11 05:20:26.495105|2017-10-11 05:20:26.495105
NCT00154232|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-11-01|||June 2004||2004-06-01|November 2011|2011-11-01||||March 2005|Actual|2005-03-01||Interventional|||Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)|A 3 Month, Multicenter, Open-label Study to Evaluate the Impact of the Immunosuppressive Combination of Enteric-Coated Mycophenolate Sodium (EC- MPS), Basiliximab and Cyclosporine for Microemulsion With C2 Monitoring, on Efficacy and Safety Outcomes in de Novo Kidney Transplant Recipients at Potential High Risk of DGF.|Completed||Phase 4|46||Novartis|||||f||||||||||||||2017-10-11 05:20:26.646936|2017-10-11 05:20:26.646936
NCT00154245|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-02-21|||January 2004||2004-01-01|February 2017|2017-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.||Completed||Phase 4|20||Novartis|||||f||||||||||||||2017-10-11 05:20:26.741217|2017-10-11 05:20:26.741217
NCT00154258|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-03-17|||April 2001||2001-04-01|March 2017|2017-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia|An Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia|Completed||Phase 2|19|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:20:26.830748|2017-10-11 05:20:26.830748
NCT00154271|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-11-07|||January 2004||2004-01-01|August 2006|2006-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)|Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)|Completed||Phase 4|1677|Actual|Novartis|||||||||||||||||||2017-10-11 05:20:26.947814|2017-10-11 05:20:26.947814
NCT00154284|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-02-28|2011-01-04||July 2005||2005-07-01|February 2017|2017-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|CERTES02||Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients|A 12 Month, Multicenter, Randomized, Parallel, Open-label Study, to Evaluate Renal Function and Efficacy of Everolimus With Basiliximab and Cyclosporine Microemulsion Discontinuation at 3 Month Post-transplant Versus Minimization, in de Novo Kidney Transplant Recipients|Completed||Phase 3|114|Actual|Novartis|This is a combined analysis using 81 patients randomized and treated in CRAD001A2419 with 33 randomized and treated in CRAD001A2423. This approach is reflected in the protocol amendments for each study, and the one clinical study report for both.|2|||f||||||||||||||2017-10-11 05:20:27.071744|2017-10-11 05:20:27.071744
NCT00154297|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-03-30|2011-01-04||June 2005||2005-06-01|March 2011|2011-03-01||||June 2008|Actual|2008-06-01||Interventional|||Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients|A National Multicentre Randomized Study Comparing the Early Versus Delayed Administration of Everolimus in de Novo Kidney Transplant Recipients at Risk of Delayed Graft Function|Completed||Phase 4|139|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:20:27.715003|2017-10-11 05:20:27.715003
NCT00154310|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-10-21|2011-01-11||June 2005||2005-06-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients|Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a CNI-free Regimen With Enteric-Coated Mycophenolate Sodium (EC-MPS) and Everolimus in Comparison to Standard Therapy With Enteric-Coated Mycophenolate Sodium (EC-MPS) and Cyclosporine Microemulsion in de Novo Renal Transplant Patients|Completed||Phase 4|300|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:20:29.23856|2017-10-11 05:20:29.23856
NCT00154323|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-02-21|||January 2003||2003-01-01|February 2017|2017-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.|A Multi-center, Randomized, Double-blind, Parallel Group, Placebo-controlled 52 Weeks Clinical Trial to Evaluate Efficacy and Safety of Oxcarbazepine p.o.(300-1200 mg/Day) as Adjuvant Therapy in the Bipolar Disorder I or II Treatment|Completed||Phase 4|55|Actual|Novartis|||||f||||||||||||||2017-10-11 05:20:30.814065|2017-10-11 05:20:30.814065
NCT00154336|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-04-24|||July 2004|Actual|2004-07-01|April 2017|2017-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.|3-Month, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety & Tolerability of Imatinib 400 mg Daily in Combination With Methotrexate (MTX)Compared to MTX Alone in the Treatment of Rheumatoid Arthritis (RA).|Completed||Phase 2|50|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:20:30.887286|2017-10-11 05:20:30.887286
NCT00154349|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-21|||October 2003||2003-10-01|February 2017|2017-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia|Phase II Study of Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia|Completed||Phase 2|8|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:20:31.003659|2017-10-11 05:20:31.003659
NCT00154362|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-11-22|||April 2003||2003-04-01|November 2011|2011-11-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.|A Multi-center, Randomized, Double-blind, Cross-over, Placebo-controlled Clinical Trial to Evaluate Efficacy and Safety of Oxcarbazepine p.o. (300-1200 mg/Day) as Adjuvant Therapy for Impulsivity and Aggressive Behavior in Conduct Disorders in Adolescents|Completed||Phase 4|50|Actual|Novartis|||||f||||||||||||||2017-10-11 05:20:31.075961|2017-10-11 05:20:31.075961
NCT00154375|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-19|2011-01-13||October 2004||2004-10-01|April 2011|2011-04-01||||August 2008|Actual|2008-08-01||Interventional|||Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma|Phase III Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma|Completed||Phase 3|240|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:20:31.155399|2017-10-11 05:20:31.155399
NCT00154388|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-11-16|||February 2001||2001-02-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases|Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases|Completed||Phase 2|185|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:20:33.950177|2017-10-11 05:20:33.950177
NCT00154401|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-24|||January 2005||2005-01-01|January 2017|2017-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.|Completed||Phase 2|177|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:20:34.037555|2017-10-11 05:20:34.037555
NCT00154414|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-24|||January 2005||2005-01-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes|Effect of Liraglutide on Glycaemic Control in Japanese Subjects With Type 2 Diabetes.|Completed||Phase 2|226|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:20:34.236561|2017-10-11 05:20:34.236561
NCT00154427|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-11|||August 2004||2004-08-01|January 2017|2017-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Use of Activated Recombinant Human Factor VII in Cardiac Surgery|A Multi-centre, Randomised, Double-blind, Placebocontrolled, Dose Escalation Trial on Safety and Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in the Treatment of Post-operative Bleeding in Patients Following Cardiac Surgery Requiring Cardiopulmonary Bypass|Terminated||Phase 2|172|Actual|Novo Nordisk A/S||||"Trial terminated after recruiting 172 patients but without proceeding to the highest dosing   cohort as this no longer reflects common clinical practice"|f||||f||||||||||2017-10-11 05:20:34.313561|2017-10-11 05:20:34.313561
NCT00154440|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-03-23|||November 2001||2001-11-01|March 2007|2007-03-01|October 2013|Anticipated|2013-10-01|||||Interventional|||Helicobacter – Lymphoma – Radiation Part I: Eradication, Part II: Radiation|Treatment of Low-Grade Gastric Non-Hodgkin‘s Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type Stages IE & II1E (HELYX-Study)|Unknown status|Recruiting|Phase 3|200||Technische Universität Dresden|||||f||||t||||||||||2017-10-11 05:20:34.640641|2017-10-11 05:20:34.640641
NCT00154453|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 2004||2004-01-01|October 2003|2003-10-01|August 2004||2004-08-01|||||Interventional|||Age-Related Changes in Myosin Heavy Chain Composition in Human Orbicularis Oculi Muscle||Completed||Phase 1|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:34.767569|2017-10-11 05:20:34.767569
NCT00154466|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-25|2012-12-06||July 2004||2004-07-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|July 2010|Actual|2010-07-01||Interventional|||Study on the Efficacy and Mechanism of Cardiac Rehabilitation for Stem Cell Mobilization and Heart Failure Improvement|An Association Study Between Cardiac Rehabilitation and Stem Cell Mobilization in Patients With Myocardial Infarction|Completed||N/A|58|Actual|National Taiwan University Hospital|First, our trial is small size. Second, these results are applicable only for male patients less than 65 years old with ST-segment elevation MI after successful PCI. Third, the source of angiogenic cytokines cannot be elucidated.|3|||f||||t||||||||||2017-10-11 05:20:34.845146|2017-10-11 05:20:34.845146
NCT00154479|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-12-13|||October 2003||2003-10-01|October 2003|2003-10-01|December 2008||2008-12-01|||||Observational|||The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human Papillomavirus||Unknown status|Recruiting|N/A|700||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:35.259286|2017-10-11 05:20:35.259286
NCT00154492|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-12|||April 2004||2004-04-01|January 2017|2017-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Use of NovoSeven® in Active Variceal Bleeding|Effectiveness and Safety of Use of NovoSeven® in the Treatment of Active Variceal Bleeding in Patients With Advanced Cirrhosis|Completed||Phase 2|265|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:20:35.35221|2017-10-11 05:20:35.35221
NCT00154505|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||September 2002||2002-09-01|August 2002|2002-08-01|November 2004||2004-11-01|||||Interventional|||Effects of Lateral Trunk Support on Spinal Alignment in Spinal Cord Injured Persons|Effects of Lateral Trunk Support on Spinal Alignment in Spinal Cord Injured Persons|Completed||Phase 1|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:35.541001|2017-10-11 05:20:35.541001
NCT00154518|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-02-20|||January 2004||2004-01-01|February 2013|2013-02-01|December 2005||2005-12-01|||||Interventional|||The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement|The Role of Matrix Metalloproteinases in Orthodontic Treatment|Completed||Phase 1|12|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:35.603355|2017-10-11 05:20:35.603355
NCT00154531|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||August 2004||2004-08-01|December 2003|2003-12-01|May 2005||2005-05-01|||||Observational|||Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI|Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by Surface-Enhanced Laser Desorption/Ionization (SELDI)|Unknown status|Recruiting|N/A|230||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:35.681819|2017-10-11 05:20:35.681819
NCT00154544|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||August 2004||2004-08-01|December 2003|2003-12-01||||||||Observational|||Searching for the Liver Cancer-Related Biomarkers|Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by PROTEOMEX|Unknown status|Recruiting|Phase 1|50||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:35.7552|2017-10-11 05:20:35.7552
NCT00154557|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||August 2004||2004-08-01|August 2004|2004-08-01|July 2006||2006-07-01|||||Observational|||Influence of the Psychophysiological Status of Elite Judo Athletes on Their Performance and Injury||Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:35.817974|2017-10-11 05:20:35.817974
NCT00154570|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-21|||February 2004||2004-02-01|February 2004|2004-02-01|August 2005||2005-08-01|||||Observational|||24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis|Integrating Simultaneous Recording of 24 Hour Esophageal pH and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:35.886283|2017-10-11 05:20:35.886283
NCT00154583|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-12-20|||January 2003||2003-01-01|January 2003|2003-01-01|December 2008||2008-12-01|||||Observational|||Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions||Unknown status|Recruiting|N/A|500||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:35.966776|2017-10-11 05:20:35.966776
NCT00154596|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-03-15|||February 2004||2004-02-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Etiology Study of Kawasaki Disease|Etiology Study of Kawasaki Disease--A Prospective Household and Case Control Study|Recruiting||N/A|700|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     Blood, throat swab, nasopharyngeal aspiration, and rectal swab will be obtained during acute     illness and at convalescence (about 2 weeks after discharge). These specimens will be     processed for viral isolation, bacterial culture and toxin detection, PCR, subtractive     cloning, VIDISCA, gene chips, peptide library, cytokine/chemokine measurement, antibody     detection for specific pathogens, etc. Questionnaire for contact history and clinical     symptoms will be performed.   "|||2017-10-11 05:20:36.028316|2017-10-11 05:20:36.028316
NCT00154609|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-01-20|||January 2002||2002-01-01|January 2002|2002-01-01||||||||Interventional|||Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis|The Use Tradition Chinese Native Medicine Treats the Osteoporosis Research|Unknown status|Recruiting|Phase 1|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.115477|2017-10-11 05:20:36.115477
NCT00154622|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-12-05|||January 2004||2004-01-01|December 2012|2012-12-01|December 2008|Actual|2008-12-01|December 2006|Actual|2006-12-01||Interventional|||Management and Outcome of Work-Related Musculoskeletal Disorders|National Taiwan University Hospital|Completed||N/A|160|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 05:20:36.18002|2017-10-11 05:20:36.18002
NCT00154635|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease|A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease|Unknown status|Not yet recruiting|Phase 2|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.249188|2017-10-11 05:20:36.249188
NCT00154648|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-06-04|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Interventional|||CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist|An Open, Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA) Study of Arteries Using Gadovist 1.0 in Comparison to Intra-Arterial Digital Subtraction Angiography (IA DSA) Using Ultravist|Unknown status|Recruiting|Phase 4|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.393391|2017-10-11 05:20:36.393391
NCT00154661|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||January 2000||2000-01-01|June 2001|2001-06-01|June 2001||2001-06-01|||||Interventional|||Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis|Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis|Completed||N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.546242|2017-10-11 05:20:36.546242
NCT00154674|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-21|||April 2005||2005-04-01|January 2004|2004-01-01|October 2005||2005-10-01|||||Interventional|||Safety and Feasibility of Endovascular Cooling Device in Patients With Hypothermic Cardiopulmonary Resuscitation||Unknown status|Recruiting|N/A|15||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.62945|2017-10-11 05:20:36.62945
NCT00154687|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-30|||October 2000||2000-10-01|July 2005|2005-07-01|December 2004|Actual|2004-12-01|||||Interventional|||Weekly TP-HDFL in the Treatment of Advanced TCC|A Phase II Study of Weekly Paclitaxel, Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin(Weekly TP-HDFL) in the Treatment of Advanced Transitional Cell Carcinoma(TCC)|Completed||Phase 2|40|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:20:36.69755|2017-10-11 05:20:36.69755
NCT00154700|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-12-19|||January 2001||2001-01-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer|A Phase II Study of Twice Weekly Paclitaxel, Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid in the Treatment of Recurrent or Metastatic Esophageal Cancer|Completed||Phase 2|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.775101|2017-10-11 05:20:36.775101
NCT00154713|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||July 2005||2005-07-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment|A Phase I/II Clinical Study of Immunotherapy for Advanced Colorectal Cancers Using CEA-Pulsed Dendritic Cells Mixed With Tetanus Toxoid and Subsequent IL-2 Treatment|Unknown status|Recruiting|Phase 1/Phase 2|37||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.852539|2017-10-11 05:20:36.852539
NCT00154726|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-21|||April 1997||1997-04-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers|A Phase II Study of Weekly Paclitaxel(Taxol)and 24-Hour Infusion High-Dose 5-Fluorouracil and Leucovorin(HDFL)in the Treatment Locally Advanced and Recurrent/Metastatic Gastric Cancers|Completed||Phase 2|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.925718|2017-10-11 05:20:36.925718
NCT00154739|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-08-01|||October 1998||1998-10-01|July 2005|2005-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)|A Phase II Randomized Trial of Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin in Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|86|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:36.995888|2017-10-11 05:20:36.995888
NCT00154752|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-21|||January 1999||1999-01-01|January 1999|1999-01-01|June 2005||2005-06-01|||||Interventional|||Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer|A Randomized Trial Comparing Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer|Unknown status|Recruiting|Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:37.07613|2017-10-11 05:20:37.07613
NCT00154765|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-21|||March 2003||2003-03-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Interventional|||Effect of Sling Suspension Exercises in Proprioception of Patients With Knee Osteoarthritis|Graduate School of Physical Therapy, College of Medicine, NTU, Taiwan|Completed||N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:37.151827|2017-10-11 05:20:37.151827
NCT00154778|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-30|||March 2003||2003-03-01|July 2005|2005-07-01|June 2005|Actual|2005-06-01|||||Interventional|||Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer|An Open,Multi-Center,Phase II Clinical Trial tO Evaluate Efficacy and Safety oF TAXOL(PACLITAXEL),UFT,and LEUCOVORIN in Patients With Advanced Gastric Cancer|Completed||Phase 2|55|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 05:20:37.241251|2017-10-11 05:20:37.241251
NCT00154791|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||March 2003||2003-03-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma|Phase I/II Trial of Biweekly Gemcitabine, Oxaliplatin, and 48-Hour Infusion of High-Dose 5-FU/Leucovorin (GOFL) in Advanced Pancreatic Adenocarcinoma|Completed||Phase 1/Phase 2|45||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:37.337564|2017-10-11 05:20:37.337564
NCT00154804|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-08-22|||August 2001||2001-08-01|April 2004|2004-04-01|April 2004|Actual|2004-04-01|||||Interventional|||CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer|A Phase II Study of Concurrent Chemoradiotherapy With Twice Weekly Paclitaxel and Cisplatin (Twice Weekly TP) Followed by Surgery for Locally Advanced Esophageal Cancer|Completed||Phase 2|40|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:20:37.425998|2017-10-11 05:20:37.425998
NCT00154817|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-21|||January 2002||2002-01-01|January 2002|2002-01-01|May 2005||2005-05-01|||||Interventional|||A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)|A Phase II Clinical and Mechanistic Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma|Completed||Phase 2|12||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:37.530506|2017-10-11 05:20:37.530506
NCT00154830|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-22|||August 2004||2004-08-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Alterations of Functional Activities and Leg Stiffness After Hamstring Lengthening in Cerebral Palsy Children|Alterations of Functional Activities and Leg Stiffness After Hamstring Lengthening in Cerebral Palsy Children|Completed||Phase 4|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:37.596147|2017-10-11 05:20:37.596147
NCT00154843|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-01-08|||March 2004||2004-03-01|August 2006|2006-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation|A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation|Completed||Phase 2|74|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 05:20:37.661827|2017-10-11 05:20:37.661827
NCT00154856|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||August 2004||2004-08-01|February 2003|2003-02-01|July 2005||2005-07-01|||||Interventional|||Influence of Mechanical Stimulus on Distraction Osteogenesis|Influence of Mechanical Stimulus on Distraction Osteogenesis|Completed||Phase 4|10||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:37.753785|2017-10-11 05:20:37.753785
NCT00154869|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-08-10|||June 2004||2004-06-01|August 2005|2005-08-01|August 2007||2007-08-01|||||Interventional|||Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C|An Open Label, Comparative, Multi-Center Study, to Evaluate the Efficacy and Safety of Peginterferon Alfa-2a Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C|Unknown status|Recruiting|Phase 3|320|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:37.840873|2017-10-11 05:20:37.840873
NCT00154882|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-01-20|||September 2003||2003-09-01|July 2005|2005-07-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer|Weekly Low-dose Paclitaxel (Phyxol) Plus 24-Hour Infusion of Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|43|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:20:37.949704|2017-10-11 05:20:37.949704
NCT00154895|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-10-19|||June 2001||2001-06-01|June 2001|2001-06-01|March 2005||2005-03-01|||||Interventional|||Additional Minocycline Pleurodesis After Thoracoscopic Procedures for Primary Spontaneous Pneumothorax|Phase III Study of Additional Minocycline Pleurodesis After Video-Assisted Thoracoscopic Surgery for Primary Spontaneous Pneumothorax|Unknown status|Recruiting|Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.048691|2017-10-11 05:20:38.048691
NCT00154921|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-22|||January 2004||2004-01-01|January 2004|2004-01-01|December 2007||2007-12-01|||||Observational|||Clinical Usefulness of Optical Skin Biopsy|Clinical Usefulness of Optical Skin Biopsy|Unknown status|Recruiting|Phase 1|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.140995|2017-10-11 05:20:38.140995
NCT00154934|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-02-02|||January 2004||2004-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|||||Observational|||the Implications of Pathogenesis of Pre-Eclampsia|The Impact of Interleukin-10 in the Invasion Capacity and Immunoregulation During Pregnancy: the Implications of Pathogenesis of Pre-Eclampsia.|Terminated||N/A|0|Actual|National Taiwan University Hospital|||1|difficult to enroll subjects|f||||t||||||Samples Without DNA|"     placenta biopsy   "|||2017-10-11 05:20:38.211233|2017-10-11 05:20:38.211233
NCT00154947|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-07-18|||May 2004||2004-05-01|July 2006|2006-07-01|May 2006||2006-05-01|||||Observational|||Develop Biomarkers for Assessing RA Joint Erosion|Develop Biomarkers for Assessing RA Joint Erosion|Unknown status|Active, not recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.278185|2017-10-11 05:20:38.278185
NCT00154960|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||June 2004||2004-06-01|June 2004|2004-06-01||||||||Observational|||Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.|Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.|Unknown status|Recruiting|N/A|1000||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.351207|2017-10-11 05:20:38.351207
NCT00154973|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||August 2004||2004-08-01|August 2004|2004-08-01|June 2005||2005-06-01|||||Observational|||Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers||Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.443904|2017-10-11 05:20:38.443904
NCT00155012|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||August 2004||2004-08-01|April 2004|2004-04-01|August 2006||2006-08-01|||||Observational|||Clinical Application of MDCT in Coronary Artery Disease|Clinical Application of 16-Detector Row Computed Tomography in Coronary Artery Disease|Unknown status|Recruiting|Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.657134|2017-10-11 05:20:38.657134
NCT00155025|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||May 2004||2004-05-01|April 2004|2004-04-01||||||||Observational|||Family History in Prostate Cancer Patients in Taiwan||Unknown status|Recruiting|N/A|1500||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.735314|2017-10-11 05:20:38.735314
NCT00155038|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 1998||1998-01-01|May 2004|2004-05-01|December 2005||2005-12-01|||||Observational|||Imaging Characteristics of Breast Cancer in Women Under 40 Years of Age||Unknown status|Recruiting|N/A|75||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.807659|2017-10-11 05:20:38.807659
NCT00155051|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||July 2004||2004-07-01|June 2004|2004-06-01|April 2005||2005-04-01|||||Observational|||Progestin Treatment for Endometrial Stromal Cells in Adenomyosis||Unknown status|Recruiting|N/A|45||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.883507|2017-10-11 05:20:38.883507
NCT00155064|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-12-15|||July 2002||2002-07-01|December 2014|2014-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism||Completed||Phase 4|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:38.952279|2017-10-11 05:20:38.952279
NCT00155077|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-10-19|||June 2004||2004-06-01|June 2004|2004-06-01|June 2009||2009-06-01|||||Observational|||The Correlation Between Tumor Angiogenesis and the Effect of Radiation Therapy in Cervical Cancer Patients|The Correlation Between Tumor Angiogenesis and the Effect of Radiation Therapy in Cervical Cancer Patients|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.029473|2017-10-11 05:20:39.029473
NCT00155090|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 2005||2005-01-01|January 2005|2005-01-01|December 2005||2005-12-01|||||Observational|||Proton Magnetic Resonance Spectroscopy of Normal Breast Tissues in Women Volunteers||Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.097112|2017-10-11 05:20:39.097112
NCT00155103|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-03-20|||August 2004||2004-08-01|July 2005|2005-07-01||||||||Observational|||Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma|Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|1600||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.183391|2017-10-11 05:20:39.183391
NCT00155116|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-22|||October 2004||2004-10-01|October 2004|2004-10-01|December 2006||2006-12-01|||||Observational|||SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.26455|2017-10-11 05:20:39.26455
NCT00155129|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 2005||2005-01-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||The Role of CGRPand Nociceptin in Migraine|The Role of Calcitonin Gene-Related Peptide(CGRP)and Nociceptin in the Pathogenesis of Migraine|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.400275|2017-10-11 05:20:39.400275
NCT00155142|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||September 2004||2004-09-01|September 2004|2004-09-01||||||||Observational|||Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.|Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.547629|2017-10-11 05:20:39.547629
NCT00155155|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-12-01|||May 2005||2005-05-01|November 2008|2008-11-01||||April 2008|Actual|2008-04-01||Observational|||Studies of Immune Responses in Patients With Chronic Hepatitis B|Analysis of HBV-Specific T Cell Responses and Regulatory T Cells in Patients With Chronic Hepatitis B Virus Infection|Completed||Phase 1|100|Anticipated|National Taiwan University Hospital|||||f||||f||||||||||2017-10-11 05:20:39.611995|2017-10-11 05:20:39.611995
NCT00155168|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||April 2004||2004-04-01|April 2004|2004-04-01||||||||Observational|||Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System|Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System: Establishing a Novel Highly Efficient and Reliable SMA Carrier Screening Test|Unknown status|Recruiting|N/A|500||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.68275|2017-10-11 05:20:39.68275
NCT00155181|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 2005||2005-01-01|January 2005|2005-01-01|August 2005||2005-08-01|||||Observational|||Molecular Mechanism of Nasopharyngeal Carcinoma|the Garduate Institute of Microbiology in National Taiwan University|Unknown status|Recruiting|N/A|25||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.77187|2017-10-11 05:20:39.77187
NCT00155194|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||April 2004||2004-04-01|June 2005|2005-06-01||||||||Observational|||Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice|Impaired T-Lymphocyte Proliferative Function in Biliary Atresia Children With Prolonged Jaundice|Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.861487|2017-10-11 05:20:39.861487
NCT00155207|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||May 2005||2005-05-01|May 2005|2005-05-01|April 2008||2008-04-01|||||Observational|||A Study on Risk Mutations of Vulnerability Genes of Schizophrenia|A Study on Risk Mutations of Vulnerability Genes of Schizophrenia|Unknown status|Recruiting|N/A|1065||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:39.946111|2017-10-11 05:20:39.946111
NCT00155220|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-01-25|||August 2004||2004-08-01|August 2004|2004-08-01|March 2006||2006-03-01|||||Interventional|||Treatment of Lymphedema: Application of the Kinesio Taping|Treatment of Lymphedema- Application of the Kinesio Taping|Unknown status|Recruiting|Phase 2|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:40.067306|2017-10-11 05:20:40.067306
NCT00155233|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-22|||January 2005||2005-01-01|June 2005|2005-06-01||||||||Interventional|||Interaction Between Nalbuphine and Morphine in PCA|Interaction Between Nalbuphine and Morphine in Postoperative PCA for Gynecologic Patients|Unknown status|Recruiting|Phase 4|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:40.218004|2017-10-11 05:20:40.218004
NCT00155246|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-01-27|||July 2004||2004-07-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy of Pentoxifylline on Chronic Kidney Disease|Phase 4 Study of the Efficacy of Pentoxifylline in Patients With Chronic Kidney Disease Receiving Angiotensin Receptor Blockade|Completed||Phase 4|60|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 05:20:40.323563|2017-10-11 05:20:40.323563
NCT00155259|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-23|||October 2004||2004-10-01|July 2005|2005-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer|Docetaxel by 1 Hour Infusion Followed by 24 Hour Infusion of Cisplatin Plus Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer|Completed||Phase 2|47|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:20:40.407815|2017-10-11 05:20:40.407815
NCT00155272|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||March 2005||2005-03-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma|A Pilot Clinical and Mechanistic Study of Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|19||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:40.507873|2017-10-11 05:20:40.507873
NCT00155285|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-10-19|||January 2000||2000-01-01|April 2003|2003-04-01|December 2006||2006-12-01|||||Interventional|||Evaluating the Infant Complex Congenital Heart Disease by Multidetector Computed Tomography|Integrated Evaluating the Infant Complex Congenital Heart Disease by Multidetector(16)Spiral Computed Tomography|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:40.600222|2017-10-11 05:20:40.600222
NCT00155311|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-03-14|||January 2005||2005-01-01|March 2013|2013-03-01||||December 2008|Actual|2008-12-01||Interventional|||The Regulation of Osteoprotegerin by Mechanical Stimulation||Completed||Phase 1|10|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 05:20:40.691171|2017-10-11 05:20:40.691171
NCT00155324|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-11-30|||October 2004||2004-10-01|November 2012|2012-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Change and Clinical Significance of Plantar Fascia Thickness After ESWT|Change and Clinical Significance of Plantar Fascia Thickness After Extracorporeal Shock Wave Therapy|Completed||N/A|60|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:40.773746|2017-10-11 05:20:40.773746
NCT00155337|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-12-20|||August 2004||2004-08-01|December 2012|2012-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia|Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia|Completed||Phase 4|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:40.840957|2017-10-11 05:20:40.840957
NCT00155350|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-02-24|||November 2004||2004-11-01|August 2005|2005-08-01|December 2007||2007-12-01|||||Interventional|||Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients|Treatment of Coronary Atherosclerosis and Calcification by Insulin Sensitizers in Insulin-Resistant Patients: Evaluated by EBCT, 16-Slice MDCT Coronary Angiography/Scanning, and Intravascular Ultrasound|Unknown status|Recruiting|Phase 4|120||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:40.912173|2017-10-11 05:20:40.912173
NCT00155363|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-12-19|||September 2004||2004-09-01|June 2005|2005-06-01||||||||Interventional|||Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis|The Impact of Conventional Hemodialysis, High Flux Hemodialysis and Hemodiafiltration on Adiponectin, Vascular Function and Clinical Prognosis|Unknown status|Recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:41.006496|2017-10-11 05:20:41.006496
NCT00155376|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-25|||September 2005||2005-09-01|April 2005|2005-04-01|September 2005||2005-09-01|||||Interventional|||Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography||Unknown status|Recruiting|Phase 4|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:41.111312|2017-10-11 05:20:41.111312
NCT00155389|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-11-12|||January 2004||2004-01-01|July 2012|2012-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Community-based Helicobacter Pylori Eradication|Community-based Helicobacter Pylori Eradication With Two Sequential Antibiotic Regimens for the Residents and Migrants From a High-risk Area for Gastric Cancer|Unknown status|Recruiting|Phase 4|5000|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 05:20:41.190509|2017-10-11 05:20:41.190509
NCT00155402|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-28|||April 2005||2005-04-01|March 2005|2005-03-01|March 2008||2008-03-01|||||Interventional|||The Application of Fibrin Glue in Ocular Surface Diseases|Phase 1 Study of Applying Fibrin Glue in Patients With Corneal Ulcer or Patients Requiring Wound Closure by Suture|Withdrawn||Phase 1|30|Anticipated|National Taiwan University Hospital||1||Short of supply of fibrin glue|f||||f||||||||||2017-10-11 05:20:41.308249|2017-10-11 05:20:41.308249
NCT00155415|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-12-01|||April 2005||2005-04-01|September 2005|2005-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Prospective Single-Blinded Randomized Trial Comparing Colonoscopic Preparation at Different Time||Completed||N/A|120||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:41.407072|2017-10-11 05:20:41.407072
NCT00155428|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-12-19|||May 2005||2005-05-01|May 2005|2005-05-01|December 2008||2008-12-01|||||Interventional|||Biomodel in Tetralogy of Fallot|Application of Biocardiac Model in Total Correction of Tetralogy of Fallot|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:41.49564|2017-10-11 05:20:41.49564
NCT00155454|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-12-26|||September 2004||2004-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy|Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy|Completed||N/A|61|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 05:20:41.692542|2017-10-11 05:20:41.692542
NCT00155467|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-10-19|||January 1995||1995-01-01|January 1995|1995-01-01|December 2010||2010-12-01|||||Interventional|||Establish a CT Images Database of Patients With Congenital Heart Disease|Establish a CT Images Database of Patients With Congenital Heart Disease|Unknown status|Recruiting|N/A|5000||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:41.777289|2017-10-11 05:20:41.777289
NCT00155480|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-12-05|||January 2000||2000-01-01|November 2012|2012-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Establish Finite Element Mesh of the Numerical Models of the Thoracic Aorta|Establish Finite Element Mesh of the Numerical Models of the Thoracic Aorta|Completed||N/A|80|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:41.860594|2017-10-11 05:20:41.860594
NCT00155493|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 2006||2006-01-01|June 2005|2005-06-01|August 2006||2006-08-01|||||Interventional|||Age-Related Changes in Proliferation and Differentiation Capacity of Human Preadipocytes From Periorbital Fat.||Unknown status|Not yet recruiting|Phase 1|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:41.925869|2017-10-11 05:20:41.925869
NCT00155506|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||November 2002||2002-11-01|November 2002|2002-11-01|December 2004||2004-12-01|||||Observational|||Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios|Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios|Completed||N/A|600||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:41.998592|2017-10-11 05:20:41.998592
NCT00155519|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||July 2002||2002-07-01|August 2000|2000-08-01|July 2002||2002-07-01|||||Observational|||A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions|A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions|Completed||N/A|130||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.063197|2017-10-11 05:20:42.063197
NCT00155532|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||April 2002||2002-04-01|June 2005|2005-06-01|March 2004||2004-03-01|||||Interventional|||Skin Denervation in Systemic Lupus Erythematosus||Completed||Phase 1|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.11939|2017-10-11 05:20:42.11939
NCT00155545|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-12-06|||September 2005||2005-09-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Influence of Leg Length Discrepancy on the Spinal Shape and Biomechanics in Functional and Idiopathic Scoliosis Patients|Influence of Leg Length Discrepancy on the Spinal Shape and Biomechanics During Static and Dynamic Activities in Functional and Idiopathic Scoliosis Patients|Completed||Phase 1|30|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 05:20:42.191998|2017-10-11 05:20:42.191998
NCT00155558|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-07-23|||March 2001||2001-03-01|November 2000|2000-11-01|December 2005|Actual|2005-12-01|||||Interventional|||A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers|A Phase I Trial of HDFL48(Weekly 48-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin) in Recurrent or Metastatic Colorectal Cancers|Completed||Phase 1|16|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:20:42.272049|2017-10-11 05:20:42.272049
NCT00155571|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||August 2001||2001-08-01|January 2001|2001-01-01||||||||Observational|||The Occurrence of Periopathogens in Betel-Nut Chewers and the Effects of Areca-Nut on Periopathogens|The Occurrence of Periopathogens in Betel-Nut Chewers and the Effects of Areca-Nut on Periopathogens|Completed||N/A|186||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.342069|2017-10-11 05:20:42.342069
NCT00155584|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||December 1994||1994-12-01|December 1994|1994-12-01|December 1996||1996-12-01|||||Observational|||Topical 5-ALA Photodynamic Therapy for the Treatment of Verruca Vulgaris|Topical 5-Aminolevulinic Acid Photodynamic Therapy for the Treatment of Verruca Vulgaris: Comparison of Red and Green Light-Emitting Diode Array|Unknown status|Recruiting|Phase 3|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.402414|2017-10-11 05:20:42.402414
NCT00155597|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-01-11|||August 1999||1999-08-01|December 2009|2009-12-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||The Outcome and Cost Analysis of Home-care Physical Therapy for Postoperative Hip Fracture Patients||Completed||N/A|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.468676|2017-10-11 05:20:42.468676
NCT00155610|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-01-28||||||September 2005|2005-09-01|December 2006||2006-12-01|||||Observational|||The Relationship Between Voiding Dysfunction and Intravesical Sensory Threshold in Diabetes Women|A Cross-Sectional Study of the Relationship Between Voiding Dysfunction and Intravesical Sensory Threshold in Diabetes Women|Terminated||Phase 1/Phase 2|120|Anticipated|National Taiwan University Hospital||||No clinical significant|f||||||||||||||2017-10-11 05:20:42.523651|2017-10-11 05:20:42.523651
NCT00155623|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-10-19|||February 2001||2001-02-01|January 2001|2001-01-01|July 2003||2003-07-01|||||Observational|||Establish Epidemiologic Data of H. Pylori Infection in Children and Adolescents-Using C13-UBT|Establish the Precise Epidemiologic Data of Helicobacter Pylori Infection in Children and Adolescents – Using the 13C-Urea Breath Test|Completed||N/A|3000||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.59239|2017-10-11 05:20:42.59239
NCT00155636|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||January 2002||2002-01-01|January 2002|2002-01-01|December 2005||2005-12-01|||||Observational|||A Study on Etiological Factors of Schizophrenia|A Study on Etiological Factors of Schizophrenia|Terminated||N/A|1056||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.66808|2017-10-11 05:20:42.66808
NCT00155649|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||April 2002||2002-04-01|October 2001|2001-10-01|April 2005||2005-04-01|||||Observational|||A Positional Cloning Study on Schizophrenia||Completed||N/A|320||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.717839|2017-10-11 05:20:42.717839
NCT00155662|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-12-05|||August 2002||2002-08-01|December 2012|2012-12-01|September 2007|Actual|2007-09-01|December 2004|Actual|2004-12-01||Interventional|||The Effect of a Work-hardening Program for Return-to-work for Workers With Low Back Pain||Completed||N/A|60|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.768026|2017-10-11 05:20:42.768026
NCT00155675|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-01-11|||January 2000||2000-01-01|December 2009|2009-12-01|January 2001|Actual|2001-01-01|||||Interventional|||Pseudodrynaria Coronana (Wall) Ching|"Clinical Effect of Traditional Chinese Medicine - Gusuibu"|Completed||Phase 1|120|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.840808|2017-10-11 05:20:42.840808
NCT00155688|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||December 1998||1998-12-01|December 1998|1998-12-01|December 2002||2002-12-01|||||Observational|||A Genetic Linkage Study of Schizophrenia|A Genetic Linkage Study of Schizophrenia|Completed||N/A|2400||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.897867|2017-10-11 05:20:42.897867
NCT00155701|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||August 2002||2002-08-01|August 2002|2002-08-01|July 2003||2003-07-01|||||Observational|||Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia|Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia|Completed||N/A|500||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:42.940727|2017-10-11 05:20:42.940727
NCT00155714|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-03-15|||November 2002||2002-11-01|January 2010|2010-01-01|May 2005|Anticipated|2005-05-01|||||Interventional|||Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension|Clinical Efficacy of Type-5 Phosphodiesterase Inhibitors (Sildenafil and Vadenafil) in Primary and Secondary Pulmonary Hypertension|Withdrawn||N/A|20|Anticipated|National Taiwan University Hospital||||"We can't obtained the test drug (Vadenafil) from Bayer. They decided not to carry out this   trail in Taiwan. Therefore this trail has never been started."|f||||||||||||||2017-10-11 05:20:43.000739|2017-10-11 05:20:43.000739
NCT00155727|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||January 2000||2000-01-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Comparison of Laparoscopic Colectomy Versus Open Colectomy for Colorectal Cancer: … A Prospective Randomized Trial|Comparison of Treatment Outcome for Laparoscopic Colectomy Versus Traditional Open Colectomy for the Treatment of Colorectal Cancer: … A Prospective Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|600||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:43.068363|2017-10-11 05:20:43.068363
NCT00155740|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||January 2002||2002-01-01|October 2001|2001-10-01|December 2006||2006-12-01|||||Observational|||Mesothelin as a New Tumor Marker for Ovarian Cancer||Unknown status|Recruiting|N/A|250||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:43.133258|2017-10-11 05:20:43.133258
NCT00155753|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-06-08|||August 2002||2002-08-01|April 2010|2010-04-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Observational|||Genomewide Screening of Pathological Myopia|Genomewide Screening of Pathological Myopia|Unknown status|Recruiting|N/A|600|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"     DNA extracted from blood   "|||2017-10-11 05:20:43.206324|2017-10-11 05:20:43.206324
NCT00155766|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||January 2003||2003-01-01|June 2002|2002-06-01|March 2006||2006-03-01|||||Interventional|||Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)|A Pilot Study for the Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs) Pulsed With Human Papillomavirus Type 16 E7 Antigen|Unknown status|Recruiting|Phase 1|12||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:43.362302|2017-10-11 05:20:43.362302
NCT00149630|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-02-04|2012-10-22||January 2005||2005-01-01|February 2017|2017-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|Disulfiram||Pharmacogenetics of Disulfiram for Cocaine|Effectiveness of Disulfiram for Treating Cocaine Dependence in Individuals With Different Dopamine Beta Hydroxylase (DBH) Genes|Completed||Phase 2|93|Actual|Baylor College of Medicine|The sample size is small for this genetic association study, and larger replications of this preliminary study are needed. Most cocaine abusers are not also opioid dependent, which limits generalization of findings.|2|||f||||t||||||||No||2017-10-11 05:20:43.530869|2017-10-11 05:20:43.530869
NCT00149643|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-06-17|2012-02-08||September 2004||2004-09-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|August 2009|Actual|2009-08-01||Interventional|CADY||Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence|Fluoxetine for Major Depressive Disorder/Cannabis Disorder in Young People|Completed||Phase 2|70|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 05:20:43.872131|2017-10-11 05:20:43.872131
NCT00149656|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-04-26|||June 2003||2003-06-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|July 2010|Actual|2010-07-01||Interventional|||The Effects of Nutritional Supplementation and Drug Abuse on HIV|HIV Disease, Drug Abuse, and Nutrient Therapy in Botswana|Completed||N/A|878|Actual|Florida International University||4|||f||||t||||||||||2017-10-11 05:20:44.191703|2017-10-11 05:20:44.191703
NCT00149669|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-08-15|2016-09-02||December 2005||2005-12-01|August 2017|2017-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Employment-based Reinforcement of Naltrexone Ingestion and Abstinence|Employment-Based Addiction Pharmacotherapy|Completed||N/A|67|Actual|Johns Hopkins University||2|||f||||f|f|f|||f|||||2017-10-11 05:20:44.294863|2017-10-11 05:20:44.294863
NCT00149682|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-01-12|||July 2005||2005-07-01|January 2010|2010-01-01|December 2007||2007-12-01|||||Interventional|||Obesity Assessment and Education Through the Internet|Obesity Assessment and Education Through the Internet|Completed||Phase 2|100||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:20:44.717455|2017-10-11 05:20:44.717455
NCT00149695|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2010-08-20|||July 2004||2004-07-01|August 2010|2010-08-01|December 2005|Actual|2005-12-01|||||Interventional|||Soft Drink, Milk and Obesity in Chilean Children|Soft Drink, Milk and Obesity in Chilean Children|Completed||N/A|96||Boston Children’s Hospital|||||f||||||||||||||2017-10-11 05:20:44.794036|2017-10-11 05:20:44.794036
NCT00149708|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-06-13|||September 2005||2005-09-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Consequence of Lifetime Isolated Growth Hormone Deficiency|Consequence of Lifetime Isolated Growth Hormone Deficiency|Completed||N/A|400|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||||||||||||2017-10-11 05:20:44.872144|2017-10-11 05:20:44.872144
NCT00149721|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-03-01|||September 2005||2005-09-01|March 2010|2010-03-01|December 2007||2007-12-01|||||Interventional|||Anterior Pituitary Function in Patients With Hydrocephalus|Anterior Pituitary Function in Patients With Hydrocephalus|Terminated||N/A|30||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:20:44.957433|2017-10-11 05:20:44.957433
NCT00149734|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2017-05-12|||January 2005||2005-01-01|May 2017|2017-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia|Atypical Antipsychotics and P50 Sensory Gating|Completed||N/A|85|Actual|University of Colorado, Denver||2|||f||||f|t|f|||f|||No||2017-10-11 05:20:45.068973|2017-10-11 05:20:45.068973
NCT00149747|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-04-25|2013-06-18||August 1999||1999-08-01|April 2016|2016-04-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|RTC||The Effectiveness of Regular Exercise on Improving Sleep in Older Adults|Promoting Exercise, Sleep and Well-Being in Older Adults|Completed||Phase 2/Phase 3|66|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 05:20:45.171842|2017-10-11 05:20:45.171842
NCT00149760|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-02-19|||August 2003||2003-08-01|February 2014|2014-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder|Cognitive Affective Behavior Therapy for Somatization|Completed||Phase 2|88|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 05:20:45.437544|2017-10-11 05:20:45.437544
NCT00149773|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2015-04-06|||May 2005||2005-05-01|June 2006|2006-06-01|February 2011|Actual|2011-02-01|December 2008|Actual|2008-12-01||Interventional|||Cognitive Therapy for Suicidal Older Men in Primary Care Settings|Cognitive Therapy for Suicidal Older Men in Primary Care Settings|Completed||Phase 1|34|Actual|University of Pennsylvania||2|||f||||||||||||||2017-10-11 05:20:45.526698|2017-10-11 05:20:45.526698
NCT00149786|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-04-09|||October 2004||2004-10-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Effectiveness of Family-Based Versus Individual Psychotherapy in Treating Adolescents With Anorexia Nervosa|Treatment of Adolescents With Anorexia Nervosa|Completed||Phase 1|120|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 05:20:45.613054|2017-10-11 05:20:45.613054
NCT00149799|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-11-14|2014-10-17||May 2005||2005-05-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||As the primary endpoint is based on participants randomized to Phase II (i.e. those who completed Phase I, met criteria for response, and were willing to continue on in the study), baseline characteristics are provided for the 58 Phase II participants.|Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder|Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder|Completed||Phase 3|100|Actual|Massachusetts General Hospital|Our findings may not be fully generalizable - for example, we excluded those with a co-occurring substance use disorder, higher levels of suicidality, and more severely ill patients who required concomitant therapy or a higher level of care.|2|||f||||t||||||||||2017-10-11 05:20:45.71403|2017-10-11 05:20:45.71403
NCT00149812|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2016-08-03|||January 2005||2005-01-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||A Clinic-based Prevention Program for Families of Depressed Mothers|A Clinic-based Program for Families of Depressed Mothers|Completed||Phase 1|26|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||No||2017-10-11 05:20:46.264878|2017-10-11 05:20:46.264878
NCT00149825|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-05-12|2009-07-30||June 2004||2004-06-01|May 2014|2014-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome||Completed||Phase 2|30|Actual|Stanford University|Limitations of the current pilot study include a small sample size, relative racial homogeneity, and exclusion of patients with comorbidity.|2|||f||||||||||||||2017-10-11 05:20:46.370725|2017-10-11 05:20:46.370725
NCT00149851|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-08-31|||January 2004||2004-01-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)|A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)|Completed||Phase 2|832||Novartis|||||||||||||||||||2017-10-11 05:20:46.844467|2017-10-11 05:20:46.844467
NCT00149864|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-02-01|||February 2000||2000-02-01|February 2011|2011-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302|Multicenter, Open-label Follow-up Study on the Safety of Enteric-coated Mycophenolate Sodium in Maintenance Renal Transplant Patients|Completed||Phase 3|264|Actual|Novartis|||||||||||||||||||2017-10-11 05:20:46.91035|2017-10-11 05:20:46.91035
NCT00149877|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2008-01-31|||April 2004||2004-04-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation|Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation|Completed||Phase 4|250||Novartis|||||f||||||||||||||2017-10-11 05:20:46.963255|2017-10-11 05:20:46.963255
NCT00149890|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2011-08-17|2011-01-20||March 2004||2004-03-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids|A Multicenter, Open-label, Randomized, Two Arm Study to Investigate the Efficacy and Safety of a Therapy Avoiding Intraoperative Steroids in Combination With Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients|Completed||Phase 3|77|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:20:47.055337|2017-10-11 05:20:47.055337
NCT00155779|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||December 2003||2003-12-01|December 2003|2003-12-01|December 2004||2004-12-01|||||Observational|||ACE Gene Polymorphism and ARDS Outcome|Polymorphism of the Angiotensin-Converting Enzyme Gene and the Outcome of Acute Respiratory Distress Syndrome|Completed||N/A|250||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:48.435966|2017-10-11 05:20:48.435966
NCT00155792|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||January 2002||2002-01-01|December 2001|2001-12-01|December 2006||2006-12-01|||||Observational|||The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being||Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:48.50804|2017-10-11 05:20:48.50804
NCT00155805|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-25|||February 2004||2004-02-01|February 2004|2004-02-01|December 2006||2006-12-01|||||Observational|||Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus|Immunologic Factors Correlating With Cyclooxygenase and Nitric Oxide Synthase in Reflux Esophagitis and Barrett’s Esophagus|Unknown status|Recruiting|N/A|90||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:48.598247|2017-10-11 05:20:48.598247
NCT00155818|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||August 2003||2003-08-01|August 2003|2003-08-01|July 2004||2004-07-01|||||Observational|||Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia|Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia|Completed||N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:48.687606|2017-10-11 05:20:48.687606
NCT00155831|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-03-29|||August 2003||2003-08-01|March 2010|2010-03-01|March 2007|Actual|2007-03-01|March 2005|Actual|2005-03-01||Observational|||Neural Development and Its Influencing Factors in Premature Infants With Chronic Lung Disease||Completed||N/A|120|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-10-11 05:20:48.752511|2017-10-11 05:20:48.752511
NCT00155844|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||February 2003||2003-02-01|January 2003|2003-01-01|July 2004||2004-07-01|||||Observational|||"Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing ThroughMarrow-Blood Barrier"||Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:48.838216|2017-10-11 05:20:48.838216
NCT00155857|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-22|||July 2003||2003-07-01|June 2005|2005-06-01|July 2007||2007-07-01|||||Observational|||The Genetic Study of Primary Angle-Closure Glaucoma|National Taiwan University Hospital|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:48.910404|2017-10-11 05:20:48.910404
NCT00155870|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||June 2005||2005-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Health-Related QoL Among Women Receiving Hysterectomy in NTUH|Health-Related Quality of Life Among Women Receiving Hysterectomy in National Taiwan University Hospital|Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:48.991782|2017-10-11 05:20:48.991782
NCT00155883|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-08-14|||June 2004||2004-06-01|July 2005|2005-07-01|July 2005|Anticipated|2005-07-01|||||Interventional|||Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer|Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer|Terminated||Phase 2|54|Anticipated|National Taiwan University Hospital||||slow a accrul due to many competitive trials.|f||||||||||||||2017-10-11 05:20:49.091553|2017-10-11 05:20:49.091553
NCT00155896|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 2003||2003-01-01|September 2002|2002-09-01|December 2008||2008-12-01|||||Observational|||Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:49.169964|2017-10-11 05:20:49.169964
NCT00155909|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-22|||July 2003||2003-07-01|June 2005|2005-06-01|June 2006||2006-06-01|||||Observational|||Risk Factors of Radiation Pneumonitis|To Investigate Risk Factors of Radiation Pneumonitis, Fibrosis, and Impairment of Quality of Life by Radiotherapeutic Dosimetric and Biological Parameters for Lung Cancer Patients Receiving Thoracic Radiotherapy|Unknown status|Recruiting|N/A|53||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:49.249603|2017-10-11 05:20:49.249603
NCT00155922|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-12-13|||November 2003||2003-11-01|September 2005|2005-09-01||||||||Observational|||The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients|The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients, Special Relevance to Atherosclerosis|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:49.334819|2017-10-11 05:20:49.334819
NCT00155935|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-08-10|||January 2004||2004-01-01|January 2004|2004-01-01|December 2008||2008-12-01|||||Interventional|||The Development of Human Immunologic Assays Specific to Folate Receptor Antigen|The Development of Human Immunologic Assays Specific to Folate Receptor Antigen|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:49.416504|2017-10-11 05:20:49.416504
NCT00155948|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-19|||September 2003||2003-09-01|April 2004|2004-04-01|May 2004||2004-05-01|||||Observational|||Estimation of Muscle Area and Thickness of Deep Cervical Muscle Contraction During Cervical and Limb Movements|Estimation of Muscle Area and Thickness of Deep Cervical Muscle Contraction During Cervical and Limb Movements|Completed||N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:20:49.504699|2017-10-11 05:20:49.504699
NCT00155961|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2006-02-02|||March 2002||2002-03-01|September 2005|2005-09-01||||||||Observational|||Odense Androgen Study in the Elderly|Odense Androgen Study in the Elderly|Completed||Phase 1|600||Odense University Hospital|||||f||||||||||||||2017-10-11 05:20:49.569118|2017-10-11 05:20:49.569118
NCT00155974|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-21|||February 2004||2004-02-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Rapid Vaccination of Hard-To-Reach Populations|Rapid Vaccination of Hard-to-Reach Populations|Unknown status|Recruiting|N/A|4000||The New York Academy of Medicine|||||f||||||||||||||2017-10-11 05:20:49.642193|2017-10-11 05:20:49.642193
NCT00155987|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-07-22|||August 2003||2003-08-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Interventional|||The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury|Multi-centre Prospective Randomised Trial of Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury|Unknown status|Active, not recruiting|Phase 3|165|Anticipated|National Trauma Research Institute||1|||f||||t||||||||||2017-10-11 05:20:49.729533|2017-10-11 05:20:49.729533
NCT00156000|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-12-17|||August 2005||2005-08-01|December 2014|2014-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo|Fetal Fibronectin (fFN) and Salivary Estriol (E3) in the Prediction of Preterm Birth in Women With Twin Pregnancies Receiving 17-Alpha-Hydroxyprogesterone Caproate or Placebo|Withdrawn||Phase 1|0|Actual|Mednax Center for Research, Education and Quality|||1|This study was stopped because of insufficient enrollment.|f||||f||||||||||2017-10-11 05:20:49.830863|2017-10-11 05:20:49.830863
NCT00156013|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-04-20|2011-10-06||September 2005||2005-09-01|April 2015|2015-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)|A Phase I/II Open-label Study of Clofarabine in Patients With Relapsed or Refractory Diffuse Large Cell B-Cell NHL|Completed||Phase 1/Phase 2|33|Actual|Oncology Specialists, S.C.||1|||f||||f||||||||||2017-10-11 05:20:49.929565|2017-10-11 05:20:49.929565
NCT00156026|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-01-28|||November 2000||2000-11-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1|Randomized Trial of Immediate Treatment vs. Colposcopic Follow-up for Biopsy-Proven CIN 1|Completed||Phase 3|415|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-10-11 05:20:50.382139|2017-10-11 05:20:50.382139
NCT00156039|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-07-24|||January 1997||1997-01-01|July 2009|2009-07-01|June 2003|Actual|2003-06-01|||||Interventional|||Randomized Trial of Follow-up Strategies in Breast Cancer|A Randomized Trial of Follow-up Strategies in Breast Cancer|Completed||Phase 4|968|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-10-11 05:20:50.495754|2017-10-11 05:20:50.495754
NCT00156052|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-03|||April 1993||1993-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer|A Randomized Trial of Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer|Completed||N/A|1234|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-10-11 05:20:50.604264|2017-10-11 05:20:50.604264
NCT00156065|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-10-12|2010-02-24||September 2005||2005-09-01|October 2015|2015-10-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)|A Multicenter, Randomized, Double-Blind, Flexible-Dose, Long-Term Extension Trial of the Safety and Maintenance of Effect of Asenapine Using Haloperidol Positive Control in Subjects Who Complete Protocol 041023 [NCT00156104]|Completed||Phase 3|187|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 05:20:50.72873|2017-10-11 05:20:50.72873
NCT00156078|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-03-28|||January 2005||2005-01-01|March 2008|2008-03-01|May 2007||2007-05-01|||||Interventional|||A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)|A 14-Week, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study To Evaluate The Safety And Efficacy Of Pregabalin (150mg-600mg/Day) Using A Flexible Optimal Dose Schedule In Patients With Painful Diabetic Peripheral Neuropathy (DPN).|Completed||Phase 4|450||Pfizer|||||f||||||||||||||2017-10-11 05:20:51.324425|2017-10-11 05:20:51.324425
NCT00156091|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-08-10|||April 2005||2005-04-01|August 2015|2015-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)|A Multicenter, Randomized, Double-Blind, Flexible-Dose, Long-Term Extension Trial of the Safety and Maintenance of Effect of Asenapine Using Olanzapine Positive Control in Subjects Who Complete Protocols 041021 or 041022.|Completed||Phase 3|260|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 05:20:51.477226|2017-10-11 05:20:51.477226
NCT00156104|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-08-18|||July 1, 2005|Actual|2005-07-01|August 2017|2017-08-01|September 16, 2006|Actual|2006-09-16|August 18, 2006|Actual|2006-08-18||Interventional|||Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-Week Trial of the Efficacy and Safety of Asenapine Compared With Placebo Using Haloperidol Positive Control in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 3|460|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 05:20:51.559261|2017-10-11 05:20:51.559261
NCT00156910|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-10-24|2010-11-05|2009-06-17|February 2006||2006-02-01|October 2013|2013-10-01|July 2008|Actual|2008-07-01|November 2007|Actual|2007-11-01||Interventional|||A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches||Completed||Phase 3|679|Actual|Allergan||2|||f||||||||||||||2017-10-11 05:20:51.667704|2017-10-11 05:20:51.667704
NCT00156923|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-06-08|2010-10-08||October 2003||2003-10-01|June 2017|2017-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults|A Multi-Center Extension of Alkermes' Study ALK21-003-EXT (NCT01218971) to Evaluate the Long-Term Safety of Medisorb® Naltrexone|Completed||Phase 3|108|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-10-11 05:20:52.246194|2017-10-11 05:20:52.246194
NCT00156936|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-11-05|2010-10-08||August 2004||2004-08-01|November 2010|2010-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])|An Open-Label, Multi-Center Study to Evaluate the Long-Term Safety of Medisorb® Naltrexone|Terminated||Phase 3|108|Actual|Alkermes, Inc.||2||Business decision|f||||f||||||||||2017-10-11 05:20:52.829076|2017-10-11 05:20:52.829076
NCT00156949|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-02-18|||April 2005||2005-04-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||EPO Deep Tank in Dialysis Subjects|An Open-Label, Single-Arm Study to Assess the Safety of Epoetin Alfa Manufactured by a Deep Tank Technology in Subjects With Chronic Kidney Disease Receiving Dialysis|Completed||Phase 3|580|Actual|Amgen||1|||f||||||||||||||2017-10-11 05:20:53.412076|2017-10-11 05:20:53.412076
NCT00156962|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-07-17|||April 2005||2005-04-01|July 2008|2008-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)|A Randomized, Open-Label Study to Assess the Safety of Epoetin Alfa Manufactured by Deep Tank Technology and Epoetin Alfa Manufactured by Roller Bottle Technology in Subjects With Chronic Kidney Disease Not on Dialysis|Terminated||Phase 3|850|Anticipated|Amgen||2||Regulatory decision not to proceed|f||||||||||||||2017-10-11 05:20:53.507388|2017-10-11 05:20:53.507388
NCT00156975|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-12-24|||November 2004||2004-11-01|April 2007|2007-04-01||||||||Interventional|||Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases|Adjuvant Chemotherapy With Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases- Randomized Phase III Study|Unknown status|Active, not recruiting|Phase 3|384||Arbeitsgruppe Lebermetastasen und Tumoren|||||f||||||||||||||2017-10-11 05:20:53.624989|2017-10-11 05:20:53.624989
NCT00156988|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-08-07|||March 2004||2004-03-01|August 2009|2009-08-01|December 2005||2005-12-01|||||Interventional|||The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns|The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns|Completed||Phase 4|||Association of Dutch Burn Centres|||||f||||||||||||||2017-10-11 05:20:53.724985|2017-10-11 05:20:53.724985
NCT00157001|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-01-15|||August 2000||2000-08-01|January 2014|2014-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Feasibility Study of Photopheresis Post Angioplasty|Feasibility Study of Photopheresis Post Angioplasty|Terminated||Phase 2|120||Atlantic Health System|||||f||||t||||||||||2017-10-11 05:20:53.811034|2017-10-11 05:20:53.811034
NCT00157027|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-01-15|||December 2003||2003-12-01|January 2014|2014-01-01|April 2010|Anticipated|2010-04-01|||||Interventional|HIV-HAART||RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)|The Use of Extracorporeal Photochemotherapy With UVADEX in Patients With HIV Who Are Refractory or Intolerant to HAART|Withdrawn||Phase 1|0|Actual|Atlantic Health System||1|||f||||t||||||||||2017-10-11 05:20:57.197944|2017-10-11 05:20:57.197944
NCT00157040|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||June 2002||2002-06-01|September 2011|2011-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A|Recombinant Antihemophilic Factor (rAHF-PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Pharmacokinetics, Immunogenicity, Efficacy and Safety in Previously Treated Pediatric Patients With Hemophilia A|Completed||Phase 2/Phase 3|50||Baxalta US Inc.|||||f||||||||||||||2017-10-11 05:20:57.269266|2017-10-11 05:20:57.269266
NCT00157053|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||November 2001||2001-11-01|February 2011|2011-02-01|August 2004|Actual|2004-08-01|||||Interventional|||Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901|Evaluation of Pharmacokinetics, Safety, Efficacy and Immunogenicity of rAHF-PFM in Previously Treated Hemophilia A Patients - A Continuation Study|Completed||Phase 2/Phase 3|||Baxalta US Inc.|||||||||||||||||||2017-10-11 05:20:57.359106|2017-10-11 05:20:57.359106
NCT00157066|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-01-05|||December 2002||2002-12-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||Effects of Vitamin D Supplementation on Antimycobacterial Immunity|Effects of Vitamin D Supplementation on Antimycobacterial Immunity: A Randomised Trial|Completed||N/A|230||Barts & The London NHS Trust|||||f||||||||||||||2017-10-11 05:20:57.454335|2017-10-11 05:20:57.454335
NCT00157079|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||June 2002||2002-06-01|October 2006|2006-10-01|December 2003||2003-12-01|||||Interventional|||Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders|A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders|Completed||Phase 3|||Baxalta US Inc.|||||||||||||||||||2017-10-11 05:20:57.515173|2017-10-11 05:20:57.515173
NCT00157092|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||March 2004||2004-03-01|October 2006|2006-10-01|October 2004||2004-10-01|||||Interventional|||Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency|A Phase 1B/2A Study to Evaluate the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency|Completed||Phase 1/Phase 2|15||Baxalta US Inc.|||||||||||||||||||2017-10-11 05:20:57.602448|2017-10-11 05:20:57.602448
NCT00157105|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||February 2001||2001-02-01|October 2006|2006-10-01|August 2004||2004-08-01|||||Interventional|||Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery|Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures|Completed||N/A|||Baxalta US Inc.|||||||||||||||||||2017-10-11 05:20:57.670808|2017-10-11 05:20:57.670808
NCT00157118|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||August 2003||2003-08-01|July 2013|2013-07-01|March 2005|Actual|2005-03-01|||||Interventional|||Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency|A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency|Completed||Phase 2/Phase 3|18|Actual|Baxalta US Inc.|||||||||||||||||||2017-10-11 05:20:57.752116|2017-10-11 05:20:57.752116
NCT00157131|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-04-19|||June 2004||2004-06-01|April 2017|2017-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients|A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing|Completed||Phase 3|150|Actual|Baxter Healthcare Corporation||2|||||||||||||||||2017-10-11 05:20:59.511146|2017-10-11 05:20:59.511146
NCT00157144|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-03-06|||October 2004||2004-10-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005||Completed||N/A|||Bayside Health|||||f||||||||||||||2017-10-11 05:20:59.711534|2017-10-11 05:20:59.711534
NCT00157157|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-06-26|2011-02-15||April 2004||2004-04-01|June 2014|2014-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients|Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A|Completed||Phase 3|66|Actual|Baxalta US Inc.||1|||f||||t||||||||||2017-10-11 05:20:59.838652|2017-10-11 05:20:59.838652
NCT00157170|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-10-19|||September 2002||2002-09-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||The Effects of a Supervised Exercise Program on Self Efficacy of People Living With HIV/AIDS.|The Effects of a Supervised Exercise Program on Self Efficacy, Quality of Life Status, Cardiovascular Fitness and Hospital Readmission Rates of People Living With HIV/AIDS.|Completed||N/A|40||Bayside Health|||||f||||||||||||||2017-10-11 05:21:00.659276|2017-10-11 05:21:00.659276
NCT00157183|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-12-04|||March 2003||2003-03-01|September 2005|2005-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation|Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation|Completed||Phase 1/Phase 2|59|Actual|Bayside Health|||||f||||||||||||||2017-10-11 05:21:00.737919|2017-10-11 05:21:00.737919
NCT00157196|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-07-23|2015-07-23||April 2005||2005-04-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|September 2007|Actual|2007-09-01||Interventional||The intention-to-treat (ITT) analysis set included all the enrolled participants who received at least 1 dose of trial treatment.|Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease|A Multi-center, Non-randomized, Open Label Safety Study of BLP25 Liposome Vaccine (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Patients With Unresectable Stage III Disease|Completed||Phase 2|22|Actual|Merck KGaA||1|||f||||||||||||||2017-10-11 05:21:00.841153|2017-10-11 05:21:00.841153
NCT00157209|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-10-19|2015-07-23||August 2000||2000-08-01|October 2015|2015-10-01|July 2012|Actual|2012-07-01|March 2006|Actual|2006-03-01||Interventional||Baseline analysis population included all randomized participants.|Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)|A Multicenter Phase IIb Randomised, Controlled Study of BLP25 Liposome Vaccine for Active Specific Immunotherapy of Non-Small Cell Lung Cancer|Completed||Phase 2|171|Actual|Merck KGaA||2|||f||||||||||||||2017-10-11 05:21:01.175462|2017-10-11 05:21:01.175462
NCT00157222|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-12-07|||May 2005||2005-05-01|September 2005|2005-09-01|April 2008||2008-04-01|||||Observational|||Characterizing and Diagnosis’s of the Charcot Foot (Charcot Osteoarthropathy) in Diabetic Patients|Characterizing and Diagnosis’s of the Charcot Foot (Charcot Osteoarthropathy) in Diabetic Patients|Unknown status|Recruiting|N/A|50||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:21:02.025734|2017-10-11 05:21:02.025734
NCT00157235|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-10-31|||September 2002||2002-09-01|October 2013|2013-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients|A Randomized, Double Blind , Placebo Controlled Trial to Compare the Effect of Tiotropium Inhalation Capsules on Exercise Tolerance in Patients With COPD Participating in 8 Weeks of Pulmonary Rehabilitation|Completed||Phase 3|234||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:21:02.126996|2017-10-11 05:21:02.126996
NCT00157248|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-05-08|2010-11-18||December 2003||2003-12-01|February 2014|2014-02-01||||January 2009|Actual|2009-01-01||Interventional||All patients in follow-up study.|Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048|Long-term, Open-label Follow-up Treatment of Patients With Atrial Fibrillation Who Have Been Previously Treated With BIBR 1048 in the PETRO Trial (Trial 1160.20 - NCT01227629). (PETRO Extension Trial: PETRO-Ex)|Terminated||Phase 2|361|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 05:21:02.45684|2017-10-11 05:21:02.45684
NCT00157261|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-10-28|||January 2004||2004-01-01|October 2013|2013-10-01|June 2006||2006-06-01|June 2006||2006-06-01||Interventional|||Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial|A Prospective, Randomised, Double-blind, Placebo-controlled, International, Multicentre, Parallel-group Comparison Trial Evaluating the Efficacy and Safety of Tenecteplase During Cardiopulmonary Resuscitation as Compared With Standard Treatment in Patients Suffering From Out-of-hospital Cardiac Arrest of Presumed Cardiac Origin Thrombolysis in Cardiac Arrest (TROICA) Trial|Terminated||Phase 3|1050||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:21:08.203219|2017-10-11 05:21:08.203219
NCT00157274|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-04-02|||July 2005||2005-07-01|September 2005|2005-09-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome|Phase II Study of Alemtuzumab in Patients With Advanced Mycosis Fungoides/Sezary Syndrome|Unknown status|Recruiting|Phase 2|20||Latin American Cooperative Onco-Haematology Group - Peru|||||f||||||||||||||2017-10-11 05:21:08.417767|2017-10-11 05:21:08.417767
NCT00157287|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-08-24|||June 2003||2003-06-01|August 2017|2017-08-01|April 2006|Actual|2006-04-01|June 2005|Actual|2005-06-01||Interventional|||A Cluster Randomized Trial to Improve Weaning and Extubation From Mechanical Ventilation in Community Hospitals|A Cluster Randomized Trial to Improve Weaning and Extubation From Mechanical Ventilation in Community Hospitals|Completed||Phase 3|||Lawson Health Research Institute|||||f||||f|f|f||||||||2017-10-11 05:21:08.517061|2017-10-11 05:21:08.517061
NCT00157300|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-07-30|||July 2005||2005-07-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation|PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation|Completed||Phase 4|92|Actual|Leiden University Medical Center||1|||f||||t||||||||||2017-10-11 05:21:08.614068|2017-10-11 05:21:08.614068
NCT00157313|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-01-27|||January 1998||1998-01-01|September 2005|2005-09-01|December 2022|Anticipated|2022-12-01|||||Interventional|||Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis|Randomised Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis|Active, not recruiting||N/A|600||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:21:08.711791|2017-10-11 05:21:08.711791
NCT00157326|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-10-23|||September 2005||2005-09-01|October 2007|2007-10-01|June 2006|Actual|2006-06-01|||||Interventional|||Tadalafil in Subjects With Mild to Moderate Hypertension|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Tadalafil (5mg and 20mg) Administered Once Daily to Subjects With Mild to Moderate Hypertension|Completed||Phase 2|180|Actual|Eli Lilly and Company|||||||||||||||||||2017-10-11 05:21:08.80317|2017-10-11 05:21:08.80317
NCT00157339|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-11-21|||August 2005||2005-08-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD|A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma|Completed||Phase 3|299|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 05:21:08.899455|2017-10-11 05:21:08.899455
NCT00157378|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||November 2000||2000-11-01|January 2000|2000-01-01|December 2004||2004-12-01|||||Interventional|||Optimization of Acute Treatment in First Episode Schizophrenia|Optimization of Acute Treatment in First Episode Schizophrenic Patients by New Pharmacological Treatments|Unknown status|Active, not recruiting|Phase 4|300||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-10-11 05:21:09.448332|2017-10-11 05:21:09.448332
NCT00157482|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-02-12|||January 2005||2005-01-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Ezetimibe and Simvastatin in Dyslipidemia of Diabetes|A Randomized, Prospective, Double-Blind Study to Evaluate the Effects on Lipid Profile of Combined Ezetimibe and Simvastatin Therapy as Compared to Simvastatin Alone in People With Type 2 Diabetes|Completed||Phase 2|108||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-10-11 05:21:09.550908|2017-10-11 05:21:09.550908
NCT00157508|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-04-08|||March 2003||2003-03-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy|A Pilot, Randomised, Double-blind, Cross-over Study to Assess the Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy|Terminated||Phase 2|13||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-10-11 05:21:09.64224|2017-10-11 05:21:09.64224
NCT00157521|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-12-21|||September 2002||2002-09-01|December 2006|2006-12-01|May 2006||2006-05-01|||||Interventional|||L-Arginine in Pre-Eclampsia|A Double-Blind, Randomized, Pilot Study to Explore Whether Enhancing L-Arginine Bioavailability by Oral Supplementation Increases NO Production and Prevents Peroxynitrite Generation in the Pre-Eclamptic Placenta|Completed||Phase 3|30||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-10-11 05:21:09.716535|2017-10-11 05:21:09.716535
NCT00157534|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||October 2004||2004-10-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection|A Phase II, Randomised, Dose-Ranging, Open-Label, Multi-Centre Study to Evaluate the Safety and Efficacy of Celgosivir for 12 Weeks in Patients With Chronic Hepatitis C Infection|Completed||Phase 2|43||BioWest Therapeutics Inc|||||f||||||||||||||2017-10-11 05:21:09.780944|2017-10-11 05:21:09.780944
NCT00157547|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-23|||April 2003||2003-04-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression|The Use of Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Major Depressive Disorder|Completed||Phase 4|95|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 05:21:09.835879|2017-10-11 05:21:09.835879
NCT00157560|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-12-28|||December 2000||2000-12-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|November 2006|Actual|2006-11-01||Interventional|||Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma|A Phase II Trial of ModifiedTriple Doublet Therapy in the Treatment of Women With Newly Diagnosed Carcinoma of Müllerian Origin|Completed||Phase 2|83||Massachusetts General Hospital|||||f||||f||||||||||2017-10-11 05:21:09.915836|2017-10-11 05:21:09.915836
NCT00157573|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-03-27|2013-04-23||December 2004||2004-12-01|March 2017|2017-03-01|April 2010|Actual|2010-04-01|October 2008|Actual|2008-10-01||Interventional||72 ovarian cancer patients with evaluable or measurable disease.|GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer|Phase II Trial of GM-CSF in Women With Asymptomatic Ovarian, Primary Peritoneal, or Tubal Carcinoma|Completed||Phase 2|72|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 05:21:10.035942|2017-10-11 05:21:10.035942
NCT00157586|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-04-08|||February 2002||2002-02-01|March 2006|2006-03-01|June 2008||2008-06-01|||||Interventional|||Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)|A Multicenter, Randomized, Prospective, Double-blind Study to Evaluate the Nephroprotective Effect of Delapril Alone or Combined With Manidipine in Patients With Type 2 Diabetes|Completed||Phase 3|342||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-10-11 05:21:10.816255|2017-10-11 05:21:10.816255
NCT00157599|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-07-25|||January 2002||2002-01-01|October 2007|2007-10-01|March 2007||2007-03-01|||||Interventional|||MDA D-Dimer / Recurrent DVT Study|A Cohort Study Evaluating the Safety of a Diagnostic Strategy Involving D-Dimer and Compression Ultrasonography in Patients With Suspected Recurrent Deep Vein Thrombosis|Completed||N/A|500||McMaster University|||||f||||||||||||||2017-10-11 05:21:10.899303|2017-10-11 05:21:10.899303
NCT00157612|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-07-19|||January 2001||2001-01-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||A Clinical Pathway for Nursing Home Acquired Pneumonia|A Randomized Control Trial of a Clinical Pathway for Nursing Home Pneumonia.|Completed||N/A|680||McMaster University|||||f||||||||||||||2017-10-11 05:21:10.988469|2017-10-11 05:21:10.988469
NCT00157625|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-09-11|||April 2003||2003-04-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Automatic Stop Orders for Urinary Catheters|A Randomized Controlled Trial of Automatic Stop Orders for Urinary Catheterization in Hospitalized Patients|Completed||N/A|630||McMaster University|||||f||||||||||||||2017-10-11 05:21:11.059429|2017-10-11 05:21:11.059429
NCT00157638|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-08|||February 2004||2004-02-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics|Optimizing Drug Therapy in Primary Care: Integrating Pharmacists With Ontario Family Physician Group Practices.|Completed||Phase 4|1400||McMaster University|||||f||||||||||||||2017-10-11 05:21:11.138022|2017-10-11 05:21:11.138022
NCT00157664|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-06-16|||July 2004||2004-07-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|May 2008|Anticipated|2008-05-01||Observational|||Long Study - Longitudinal Thrombosis in End Stage Renal Disease|Canadian Longitudinal Thrombosis in End Stage Renal Disease Pilot Study|Unknown status|Active, not recruiting|N/A|400|Anticipated|McMaster University|||1||f||||t||||||Samples Without DNA|"     serum and plasma   "|||2017-10-11 05:21:11.314539|2017-10-11 05:21:11.314539
NCT00157677|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-10-25|||October 2004||2004-10-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|SELECT||Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)|Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis: A Randomized Trial|Completed||Phase 3|1727|Actual|McMaster University||2|||f||||t||||||||||2017-10-11 05:21:11.376927|2017-10-11 05:21:11.376927
NCT00157690|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-10-22|||December 2003||2003-12-01|October 2008|2008-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients|A Multicentre, Double-Blind, Randomized Placebo-Controlled Study of 70mg Alendronate Once Weekly for the Prevention and Treatment of Osteoporosis in Canadian Adult Cystic Fibrosis Patients|Completed||Phase 4|56|Actual|McMaster University||2|||f||||t||||||||||2017-10-11 05:21:11.473754|2017-10-11 05:21:11.473754
NCT00157703|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-12-12|||May 2005||2005-05-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||G207 Followed by Radiation Therapy in Malignant Glioma|A Staged Phase 1 Study of the Treatment of Malignant Glioma With G207, a Genetically Engineered HSV-1, Followed by Radiation Therapy|Completed||Phase 1|9|Actual|MediGene||1|||f||||t||||||||||2017-10-11 05:21:11.686193|2017-10-11 05:21:11.686193
NCT00157716|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-30|||April 2004||2004-04-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multi-Center Study to Evaluate the Cardiovascular and Cerebrovascular Effects of MC-1 in Patients Undergoing High-Risk Coronary Artery Bypass Graft (CABG) Surgery|Completed||Phase 2|900||Medicure|||||f||||||||||||||2017-10-11 05:21:11.765035|2017-10-11 05:21:11.765035
NCT00157729|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-30|||August 2004||2004-08-01|October 2006|2006-10-01|July 2005||2005-07-01|||||Interventional|||MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)|Evaluation of the Effects of MC-1 Alone and in Combination With an ACE Inhibitor on Ambulatory Blood Pressure and Metabolic Function in Hypertensive Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|160||Medicure|||||f||||||||||||||2017-10-11 05:21:11.871676|2017-10-11 05:21:11.871676
NCT00157742|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-15|||September 2000||2000-09-01|September 2005|2005-09-01|January 2007||2007-01-01|||||Interventional|||Comparison of SCS and PMR in Patients With Refractory Angina Pectoris|An Open Single-Centre Parallel Randomised Trial of Spinal Cord Stimulation (SCS) and Percutaneous Myocardial Revascularisation (PMR) in Patients With Refractory Angina Pectoris|Terminated||Phase 4|66||Medtronic|||||f||||||||||||||2017-10-11 05:21:11.97911|2017-10-11 05:21:11.97911
NCT00158106|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||February 2005||2005-02-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Assessing the Effectiveness of Communication Therapy in the North West (The ACT NoW Pilot Study)|Assessing the Effectiveness of Communication Therapy in the North West (The ACT NoW Pilot Study)|Completed||N/A|60||NHS Health Technology Assessment Programme|||||f||||||||||||||2017-10-11 05:21:16.915054|2017-10-11 05:21:16.915054
NCT00157755|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-02-23|2009-12-18||June 2002||2002-06-01|December 2009|2009-12-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis)|Gastric Stimulation for Vomiting, Nausea and Related Symptoms Associated With Gastroparesis Using Enterra® Gastric Stimulation System|Terminated||N/A|87|Actual|MedtronicNeuro|Early termination of the study impacted the ability to analyze the primary endpoint and secondary endpoint 1 for the idiopathic arm of the study. The minimum sample size for analysis of these endpoints was 32 subjects.|1|||f||||||||||||||2017-10-11 05:21:12.087406|2017-10-11 05:21:12.087406
NCT00157768|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-08-04|||June 1999||1999-06-01|August 2008|2008-08-01|April 2008|Anticipated|2008-04-01|||||Interventional|||IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction|IRIS - Immediate Risk-Stratification Improves Survival - Joint Study of the German University Hospitals and German Society of Leading Cardiological Hospital Physicians (ALKK)|Unknown status|Active, not recruiting|Phase 4|900|Anticipated|Medtronic Bakken Research Center|||||f||||||||||||||2017-10-11 05:21:12.797372|2017-10-11 05:21:12.797372
NCT00157781|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-13|||August 2000||2000-08-01|September 2005|2005-09-01|November 2003||2003-11-01|||||Interventional|||LEAF - Low Energy In Atrial Fibrillation|Low Energy in Atrial Fibrillation AF Phase IV Study in AT/AF Population Atrial Arrhythmias Prevention and Reduction With Low Energy Atrial Antitachycardia Pacemaker|Terminated||Phase 4|237||Medtronic Bakken Research Center|||||f||||||||||||||2017-10-11 05:21:12.870914|2017-10-11 05:21:12.870914
NCT00157794|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-14|||February 2004||2004-02-01|February 2017|2017-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||EnTRINSIC - EnPulse Trial on Search AV+ Influence|EnPulse Trial on Search AV+ Influence|Terminated||Phase 4|135|Actual|Medtronic Bakken Research Center||2||"Protocol pre-specified interim analysis showed that difference between groups was too small to   reach significance."|f||||f||||||||||2017-10-11 05:21:12.950164|2017-10-11 05:21:12.950164
NCT00157807|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-02-14|||September 2005||2005-09-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|June 2008|Actual|2008-06-01||Interventional|||Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac Surgery|Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac Surgery. A Prospective Randomized Multi Center Trial|Terminated||N/A|24|Actual|Medtronic Bakken Research Center||2||no eligible patients can be found|f||||||||||||||2017-10-11 05:21:13.059955|2017-10-11 05:21:13.059955
NCT00157820|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-03-09|2011-03-10||November 2000||2000-11-01|March 2017|2017-03-01|October 2005|Actual|2005-10-01|May 2005|Actual|2005-05-01||Interventional|DATAS||DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study|DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study|Completed||N/A|354|Actual|Medtronic Bakken Research Center|"The follow-up might have been too short to reveal differences in heart failure-related hospitalizations and related mortality.
Premature crossovers are a limitation of RCT. However, our scoring system severely penalized this cross-overs."|3|||f||||t||||||||No||2017-10-11 05:21:13.184084|2017-10-11 05:21:13.184084
NCT00157833|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-06-23|||July 2004||2004-07-01|June 2006|2006-06-01|August 2005||2005-08-01|||||Interventional|||A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.|A Randomized Trial to Determine the Efficacy and Safety of Coartemether and Artekin for the Treatment of Acute Falciparum and Vivax Malaria in Timika, Papua|Completed||N/A|750||Menzies School of Health Research|||||f||||||||||||||2017-10-11 05:21:13.873176|2017-10-11 05:21:13.873176
NCT00157846|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-14|||October 2003||2003-10-01|February 2017|2017-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||X-Change HF - Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure|Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure to Investigate the Effect of Preventive Stimulation|Terminated||Phase 4|36|Actual|Medtronic Bakken Research Center||2||Due to existing evidence eligible patients receive CRT treatment in first place|f||||f||||||||No||2017-10-11 05:21:14.168225|2017-10-11 05:21:14.168225
NCT00157859|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||April 2004||2004-04-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, Indonesia|To Evaluate the Efficacy of Chloroquine and SP for Acute Uncomplicated P. Falciparum and the Efficacy of Chloroquine for Acute Uncomplicated P. Vivax in the Timika Region of Papua, Indonesia.|Completed||N/A|150||Menzies School of Health Research|||||f||||||||||||||2017-10-11 05:21:14.261768|2017-10-11 05:21:14.261768
NCT00157872|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-05-23|||January 7, 2004|Actual|2004-01-07|May 2017|2017-05-01|September 19, 2004|Actual|2004-09-19|July 5, 2004|Actual|2004-07-05||Interventional|||A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)|A Multicenter, Randomized, Parallel-Group, 8-Week, Double-Blind, and Active Comparator-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Rofecoxib Tablet 25 mg Once Daily Versus Naproxen Table 500 mg Twice Daily in the Treatment of Chinese Patient With Rheumatoid Arthritis|Completed||Phase 4|150||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:21:14.333984|2017-10-11 05:21:14.333984
NCT00157885|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-06-23|||July 2005||2005-07-01|June 2006|2006-06-01|December 2005||2005-12-01|||||Interventional|||A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.|A Randomized Trial to Compare the Efficacy of Artekin and Amodiaquine Plus Artesunate for the Treatment of Acute Falciparum and Vivax Malaria in Timika, Papua|Completed||N/A|400||Menzies School of Health Research|||||f||||||||||||||2017-10-11 05:21:14.405373|2017-10-11 05:21:14.405373
NCT00157898|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-02-17|||January 2004||2004-01-01|February 2017|2017-02-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)|A Prospective, Multicenter, Open, Randomized, Comparative Study to Evaluate the Safety and Efficacy of Ertapenem Versus it's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults|Completed||Phase 4|134|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:21:14.48952|2017-10-11 05:21:14.48952
NCT00157911|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-03-07|||December 2002||2002-12-01|March 2017|2017-03-01|December 2003|Actual|2003-12-01|October 2003|Actual|2003-10-01||Interventional|||A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)|A Double-Blind, Randomized, Multicenter, Active-Comparative, 12-Week Study to Assess the Efficacy and Safety of the Drug in Conjunction With Another Drug in Korean Patients With Primary Hypercholesterolemia|Completed||Phase 3|136|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:21:14.567858|2017-10-11 05:21:14.567858
NCT00157924|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-03-14|||November 2005||2005-11-01|March 2017|2017-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)|A Multicenter, Randomized, Open-label Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe (+) Simvastatin Versus Atorvastatin in Hypercholesterolemic Patients With Diabetes Mellitus or Metabolic Syndrome|Completed||Phase 4|190|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:21:14.644339|2017-10-11 05:21:14.644339
NCT00157937|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-03-03|||February 2003||2003-02-01|March 2017|2017-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)|A Randomized, Open Label, Cross-Over Study Comparing Effectiveness for the Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics|Completed||Phase 4|31|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:21:14.723247|2017-10-11 05:21:14.723247
NCT00157950|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-01-07|2010-08-17||October 2005||2005-10-01|January 2016|2016-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)|An Immunogenicity and Safety Study of Gardasil (V501 (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine)) in Females 9 to 23 Years of Age in Korea|Completed||Phase 3|176|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:21:14.812849|2017-10-11 05:21:14.812849
NCT00157963|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-04-12|||February 5, 2005|Actual|2005-02-05|April 2017|2017-04-01|February 8, 2006|Actual|2006-02-08|February 8, 2006|Actual|2006-02-08||Interventional|||Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)|A 12 Week, Open, Randomized, Parallel, Multicenter Study of Efficacy, Tolerability & Safety of Hydrochlorothiazide (+) Losartan Potassium Versus Amlodipine in Essential Hypertensive Patients.|Completed||Phase 4|174|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:21:15.325044|2017-10-11 05:21:15.325044
NCT00157976|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-29|||September 2005||2005-09-01|November 2005|2005-11-01||||||||Interventional|||Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration|A Phase III Randomized, Multicenter, Multinational, Double-Masked, Placebo-Controlled Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Classic and Occult Subfoveal Choroidal Neovascularization Associated With AMD|Unknown status|Recruiting|Phase 3|660||Miravant Pharmaceuticals|||||||||||||||||||2017-10-11 05:21:15.410683|2017-10-11 05:21:15.410683
NCT00157989|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-08|||October 2004||2004-10-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Pilot Study to Assess Safety and Feasibility of Resuscitation of Preterm Infants With Controlled Volume of Air/Oxygen|Safety and Feasibility of Controlled Tidal Volume Resuscitation of Preterm Infants ≤ 28 Weeks’ Gestation: A Randomized Controlled Pilot Study|Terminated||Phase 3|40||Mount Sinai Hospital, Canada|||||f||||||||||||||2017-10-11 05:21:15.500548|2017-10-11 05:21:15.500548
NCT00158002|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-04-04|||February 2004||2004-02-01|April 2007|2007-04-01|August 2006||2006-08-01|||||Interventional|||A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine|An Open-Label Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine|Completed||Phase 2|40||Monarch Medical Research|||||f||||||||||||||2017-10-11 05:21:15.569884|2017-10-11 05:21:15.569884
NCT00158015|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-10-03|||October 2004||2004-10-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy|Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy|Completed||N/A|70|Actual|Minneapolis Medical Research Foundation|||1||f||||f||||||||||2017-10-11 05:21:15.660571|2017-10-11 05:21:15.660571
NCT00158028|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-08-02|||November 1995||1995-11-01|August 2016|2016-08-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder|Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder|Completed||N/A|25|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 05:21:15.733629|2017-10-11 05:21:15.733629
NCT00158041|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||January 2002||2002-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Subcutaneous Amifostine Safety Study|Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities|Completed||Phase 4|452||Mt. Sinai Medical Center, Miami|||||f||||||||||||||2017-10-11 05:21:15.829948|2017-10-11 05:21:15.829948
NCT00158054|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-08-15|2015-03-04||January 2005||2005-01-01|August 2017|2017-08-01|April 2015|Actual|2015-04-01|February 2008|Actual|2008-02-01||Interventional|||COPES Phase I Randomized Controlled Trial of Treatment For Distress in Heart Disease Patients|Consortium for Translation of Psychosocial Depression Theories to Interventions and Dissemination - Project 2: Phase I Randomized Controlled Trial of Patient Preference, Stepped-Care Treatment For Distress in Heart Disease Patients|Completed||N/A|157|Actual|Columbia University||2|||f||||t||||||||||2017-10-11 05:21:15.922375|2017-10-11 05:21:15.922375
NCT00158067|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-08-24|||March 2002||2002-03-01|August 2010|2010-08-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|||Study of an External Responsive Neurostimulator System on Epileptiform Activity|Automated Response to Spontaneous Epileptiform Activity Using the External Responsive Neurostimulator (eRNS) System Clinical Investigation|Completed||Phase 2|150|Anticipated|NeuroPace|||||||||||||||||||2017-10-11 05:21:16.575575|2017-10-11 05:21:16.575575
NCT00158080|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07||||||September 2005|2005-09-01||||||||Interventional|||Hemofiltration for Contrast-Induced Nephropathy|Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration|Unknown status|Recruiting|N/A|100||Nara Medical University|||||f||||||||||||||2017-10-11 05:21:16.672274|2017-10-11 05:21:16.672274
NCT00158093|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-07|||June 2003||2003-06-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Interventional|||A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo|A Randomized, Parallel Group Safety Evaluation of Electrocardiographic Intervals and Blood Pressure in Normal Healthy Volunteers After Nebivolol, Atenolol, Moxifloxacin, or Placebo Administration After Single and Repeated Doses|Completed||Phase 1|260||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:21:16.809161|2017-10-11 05:21:16.809161
NCT00158340|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-11-04|||August 2004||2004-08-01|November 2011|2011-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|BEST||Guided Self-Help Treatment for Binge Eating Disorder|Binge Eating Self-Guided Treatment (BEST)|Completed||N/A|284|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-11 05:21:20.310667|2017-10-11 05:21:20.310667
NCT00158119|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-07-23|||July 2001||2001-07-01|July 2010|2010-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Comparison of Weighted Vest Exercise and Strength Training|Ameliorating Disability Through Power Training|Completed||Phase 3|160||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:21:17.005231|2017-10-11 05:21:17.005231
NCT00158132|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-11|||September 1999||1999-09-01|October 2016|2016-10-01|February 2006|Actual|2006-02-01|March 2005|Actual|2005-03-01||Interventional|||Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2|A Double-Blind, Placebo Controlled Trial of Propranolol and Amantadine for the Treatment of Cocaine Dependent Subjects With Severe Cocaine Withdrawal Symptoms|Completed||Phase 2|199|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||f||||||||||2017-10-11 05:21:17.093699|2017-10-11 05:21:17.093699
NCT00158145|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-09|||September 2005||2005-09-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2|Longitudinal Study of Prostate, Lung, Colon, and Ovarian Cancer (PLCO) Screen Trial|Completed||Phase 2|72|Actual|National Institute on Drug Abuse (NIDA)|||1||f||||||||||Samples Without DNA|"     Urine and blood samples.   "|||2017-10-11 05:21:17.18837|2017-10-11 05:21:17.18837
NCT00158158|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-09|||September 2005||2005-09-01|October 2016|2016-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2|Interventions for Tobacco Dependent Adolescents|Completed||Phase 2/Phase 3|200|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 05:21:17.244598|2017-10-11 05:21:17.244598
NCT00158171|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-09|||April 2002||2002-04-01|October 2016|2016-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1|Interventions for Tobacco Dependent Adolescents|Completed||Phase 2|128|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 05:21:17.326421|2017-10-11 05:21:17.326421
NCT00158184|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-06-08|2013-04-10||June 2004||2004-06-01|June 2017|2017-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Prescription Opioid Effects in Abusers Versus Non-Abusers|Prescription Opioid Effects in Drug and Non-drug Abusers - 1|Completed||Phase 2|27|Actual|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-10-11 05:21:17.436342|2017-10-11 05:21:17.436342
NCT00158197|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-08-11|2013-05-30||December 2004||2004-12-01|August 2015|2015-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long-term Behavior Change - 1|Behavior Change: Reinforcement Schedule Effects|Completed||N/A|119|Actual|Friends Research Institute, Inc.||4|||f||||t||||||||||2017-10-11 05:21:17.751403|2017-10-11 05:21:17.751403
NCT00158210|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-11|||May 2006||2006-05-01|September 2009|2009-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Rivastigmine For Methamphetamine Dependent Individuals|Double-Blind Randomized Placebo Controlled Trial of Rivastigmine (Excelon) as a Potential Medication for Methamphetamine Abuse|Completed||Phase 1|18|Actual|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:21:18.359365|2017-10-11 05:21:18.359365
NCT00158223|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-04-07|2013-09-03||October 2004||2004-10-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia|Pimozide Augmentation of Clozapine in Schizophrenia|Completed||Phase 4|76|Actual|Icahn School of Medicine at Mount Sinai|Neither baseline nor follow-up clozapine plasma concentrations were reported. Possible that one or both groups did not have therapeutic baseline clozapine levels and/or had pharmacokinetic interactions with the study drug changing concentrations.|2|||f||||t||||||||||2017-10-11 05:21:18.612819|2017-10-11 05:21:18.612819
NCT00158236|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-11|||January 1997||1997-01-01|January 2006|2006-01-01|March 1998||1998-03-01|||||Interventional|||Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users|Effects of Buprenorphine/Naloxone in Non-Dependent Opioid Abusers|Completed||N/A|7||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-10-11 05:21:18.900775|2017-10-11 05:21:18.900775
NCT00158249|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-10-15|2014-10-15||September 2009||2009-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals|Cannabis Dependence: Imaging and Medication Development - 1|Completed||Phase 2|21|Actual|Mclean Hospital||2|||f||||f||||||||||2017-10-11 05:21:18.978638|2017-10-11 05:21:18.978638
NCT00158262|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-04-06|2013-05-07||September 2004|Actual|2004-09-01|April 2017|2017-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||All randomized participants with data available for analysis. 1 participant in each arm dropped out prior to analysis and are excluded.|Effect of Propranolol on Preventing Posttraumatic Stress Disorder|Prophylaxis of Posttraumatic Stress Disorder With Post-Trauma Propranolol|Completed||Phase 4|43|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:21:19.3419|2017-10-11 05:21:19.3419
NCT00158288|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-11|||March 1997||1997-03-01|September 2005|2005-09-01|August 2001||2001-08-01|||||Interventional|||The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1|LAAM With Behavioral Treatment for Opioid/Cocaine Abuse|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:21:19.854832|2017-10-11 05:21:19.854832
NCT00158301|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-11-07|||September 2004||2004-09-01|November 2013|2013-11-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|||Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents|Continuation Phase CBT for Youth With MDD|Completed||N/A|72|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 05:21:19.947066|2017-10-11 05:21:19.947066
NCT00158314|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-06-28|||March 1998||1998-03-01|June 2013|2013-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Cognitive Behavioral Therapy for Treatment of Pathological Gambling|Cognitive Behavioral Treatment for Pathological Gambling|Completed||Phase 1|231||UConn Health|||||f||||t||||||||||2017-10-11 05:21:20.077161|2017-10-11 05:21:20.077161
NCT00158327|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-01-21|||March 2004||2004-03-01|January 2014|2014-01-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||Telephone-Based Care Management Program for Individuals With Anxiety Disorders|The RELAX Trial: Reducing Limitations From Anxiety in Primary Care|Completed||Phase 3|360|Anticipated|University of Pittsburgh||2|||f||||||||||||||2017-10-11 05:21:20.191161|2017-10-11 05:21:20.191161
NCT00158353|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-06-18|||May 2005||2005-05-01|June 2013|2013-06-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Evaluation of a Youth Mentoring Program|Development and Evaluation of a Youth Mentoring Program|Unknown status|Active, not recruiting|Phase 1/Phase 2|40|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-10-11 05:21:20.408671|2017-10-11 05:21:20.408671
NCT00158366|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-07-19|||May 2004||2004-05-01|July 2017|2017-07-01|July 1, 2018|Anticipated|2018-07-01|May 2010|Actual|2010-05-01||Interventional|||Reducing the Weight of Overweight Schizophrenia Patients|A Clinical Trial Of Weight Reduction in Schizophrenia|Active, not recruiting||N/A|300|Anticipated|University of Pittsburgh||4|||f||||t||||||||||2017-10-11 05:21:20.509461|2017-10-11 05:21:20.509461
NCT00158379|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-12-12|2016-10-04||July 2003||2003-07-01|December 2016|2016-12-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Taxol Carboplatin and Erythropoetin|Carboplatin With Following Taxol® Therapy Under Additional Application of Epoetin Alfa (ERYPO ®) With Female Patients With Advanced Ovarian Cancer FIGO IA/G3 - IV|Completed||Phase 2|105|Actual|North Eastern Germany Society of Gynaecologic Oncology||1|||f||||f||||||||No||2017-10-11 05:21:20.625049|2017-10-11 05:21:20.625049
NCT00158405|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-12-29|||December 2002||2002-12-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)|Multicentric Randomised Controlled Trial Assessing the Efficacy of Two Strategies of Structured Treatment Interruption of Highly Active Antiretroviral Therapy (HAART) Compared With a Continuous HAART in HIV- Infected Adults in Abidjan|Completed||Phase 3|840|Actual|French National Agency for Research on AIDS and Viral Hepatitis||3|||f||||t||||||||||2017-10-11 05:21:20.8883|2017-10-11 05:21:20.8883
NCT00158418|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-01-28|||August 2002||2002-08-01|September 2005|2005-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Cemented vs. Non-Cemented TSA for OA of the Shoulder|Cemented Versus Uncemented Fixation of Humeral Components in Total Shoulder Arthroplasty for Osteoarthritis of the Shoulder|Completed||Phase 3|160||Fowler Kennedy Sport Medicine Clinic|||||f||||||||||||||2017-10-11 05:21:20.997282|2017-10-11 05:21:20.997282
NCT00158431|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-11-26|||January 1999||1999-01-01|November 2015|2015-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Surgery Versus no Surgery for OA of the Knee|Arthroscopic Surgery Versus Non-surgical Treatment of Osteoarthritis of the Knee|Completed||Phase 3|186|Actual|Fowler Kennedy Sport Medicine Clinic||2|||f||||t||||||||||2017-10-11 05:21:21.161133|2017-10-11 05:21:21.161133
NCT00158444|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-07-20|||August 2005||2005-08-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|January 2009|Actual|2009-01-01||Interventional|||"Study of the HemiCAP™ Unicondylar Femoral Resurfacing Prosthesis."|"A Prospective, Non-Randomized, Non-Comparative, Open Label Multi-Center, Feasibility Study to Examine the Safety and Effectiveness of the HemiCAP™ Unicondylar Femoral Resurfacing Prosthesis."|Completed||N/A|1|Actual|Arthrosurface, Inc.||1|||f||||t||||||||Undecided||2017-10-11 05:21:21.353016|2017-10-11 05:21:21.353016
NCT00158457|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-02|||June 2004||2004-06-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)|Pilot Trial to Evaluate the Efficacy and Tolerance of a Simple Once Daily Combined Regimen Including Tenofovir (TDF), Emtricitabine (FTC) and Efavirenz (EFV) in HIV-1 Infected Patients Naive to Prior Antiretroviral Treatment in Senegal|Completed||Phase 3|40|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||||||||||||2017-10-11 05:21:21.470802|2017-10-11 05:21:21.470802
NCT00158470|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-07-02|||September 2003||2003-09-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)|Feasibility Study of a Once Daily Antiretroviral Regimen for HIV-Infected Patients With CD4 Below 200/mm3, in Hô Chi Minh City, Vietnam|Completed||Phase 3|100|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||f||||||||||2017-10-11 05:21:21.569415|2017-10-11 05:21:21.569415
NCT00158483|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-12-29|||May 2003||2003-05-01|December 2008|2008-12-01|October 2005|Actual|2005-10-01|||||Interventional|||Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)|Anti-Herpetic Treatment Associated With Syndromic Management of Genital Ulcer in Africa: Clinical and Biological Evaluation on HIV-1 and HSV-2 Shedding (ANRS 1212)|Completed||Phase 2|449|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||f||||||||||2017-10-11 05:21:21.663269|2017-10-11 05:21:21.663269
NCT00158496|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-04-23|||August 2002||2002-08-01|April 2007|2007-04-01|January 2005|Actual|2005-01-01|||||Interventional|||Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)|Clinical Trial of the Efficacy of the Combination of Pegylated Interferon (PEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C|Completed||Phase 3|100||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-10-11 05:21:21.759729|2017-10-11 05:21:21.759729
NCT00158509|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-06-06|||August 2004||2004-08-01|June 2006|2006-06-01|July 2005||2005-07-01|||||Interventional|||Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding|Efficacy of an HSV2 Genital Herpes Suppressive Treatment on HIV and HSV2 Genital Shedding Among Co-Infected Patients Receiving or Not Antiretroviral Drugs|Completed||Phase 2|215||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:21:21.851466|2017-10-11 05:21:21.851466
NCT00158522|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-02-06|||February 2003||2003-02-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)|Clinical Trial of the Efficacy of Pegylated Interferon (PEG-IFNα-2a) Alone in Egyptian Patients With Acute Hepatitis C|Completed||Phase 3|31|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-10-11 05:21:21.929104|2017-10-11 05:21:21.929104
NCT00158535|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||June 2002||2002-06-01|September 2005|2005-09-01||||||||Interventional|||Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection|Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection ANRS HC08 Thevic|Terminated||Phase 2|15||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:21:22.03863|2017-10-11 05:21:22.03863
NCT00158548|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-11|||June 2001||2001-06-01|January 2017|2017-01-01|December 2004|Actual|2004-12-01|||||Interventional|||ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan|Studies on Adding Artesunate to Existing Antimalarial Therapies With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan|Completed||Phase 3|650|Actual|London School of Hygiene and Tropical Medicine||9|||f||||t||||||||||2017-10-11 05:21:22.12603|2017-10-11 05:21:22.12603
NCT00158561|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-11|||February 2004||2004-02-01|January 2017|2017-01-01|March 2006|Actual|2006-03-01|||||Interventional|||Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria|An Open-label Three Arm Trial of the Efficacy and Safety of Chlorproguanil / Dapsone (Lapdap) Compared With Chloroquine and Sulfadoxine / Pyrimethamine for the Treatment of Vivax Malaria in Pakistan and Afghanistan|Completed||Phase 3|750||London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-10-11 05:21:22.21799|2017-10-11 05:21:22.21799
NCT00158574|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-11|||January 2005||2005-01-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Kilimanjaro IPTi Drug Options Trial|Drug Options for Intermittent Preventive Treatment for Malaria in Infants in an Area With High Resistance to Sulfadoxine/Pyrimethamine: an Evaluation of Short and Long-acting Antimalarial Drugs|Completed||Phase 2/Phase 3|2419|Actual|London School of Hygiene and Tropical Medicine||4|||f||||t||||||||||2017-10-11 05:21:22.305558|2017-10-11 05:21:22.305558
NCT00158587|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-11|||April 2004||2004-04-01|January 2017|2017-01-01|March 2007|Actual|2007-03-01|||||Interventional|||Eight Week Primaquine Regimen for the Treatment of Vivax Malaria|A Placebo Controlled, Randomised Evaluation of an Eight Week Primaquine Regimen for the Treatment of Vivax Malaria.|Completed||Phase 3|150|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-10-11 05:21:22.421262|2017-10-11 05:21:22.421262
NCT00158600|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-04-06|2010-06-24||September 2005||2005-09-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease|Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy and Pharmacokinetics of Myozyme in Patients With Late-Onset Pompe Disease.|Completed||Phase 3|90|Actual|Sanofi||2|||t||||t||||||||||2017-10-11 05:21:22.524497|2017-10-11 05:21:22.524497
NCT00158613|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-06-01|||March 2000||2000-03-01|June 2017|2017-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study of the Treatment of Articular Repair (STAR)|A Prospective, Longitudinal Within-Patient Evaluation of the Effectiveness (Durability) of Carticel® (Autologous Cultured Chondrocytes) Compared to Non-Carticel Surgical Treatment for Articular Cartilage Defects of the Knee.|Completed||Phase 4|126|Actual|Vericel Corporation||1|||f||||f||||||||||2017-10-11 05:21:24.837082|2017-10-11 05:21:24.837082
NCT00158626|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-03-18|||September 2003||2003-09-01|March 2015|2015-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Does Doing Pelvic Floor Exercise Ease Symptoms for Women Living With Prolapse?|A Feasibility Study for an RCT of a Pelvic Floor Muscle Training Intervention for Pelvic Organ Prolapse|Completed||Phase 1/Phase 2|50||Glasgow Caledonian University|||||f||||||||||||||2017-10-11 05:21:24.987112|2017-10-11 05:21:24.987112
NCT00158652|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-11-07|||March 2000||2000-03-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC|Phase III Trial Comparing Conventional RT With Concomitant CT Versus Accelerated RT With Concomitant CT Versus Very Accelerated RT Alone in Patients With Head and Neck Squamous Cell Carcinoma|Completed||Phase 3|840|Actual|Groupe Oncologie Radiotherapie Tete et Cou||3|||f||||||||||||||2017-10-11 05:21:25.358118|2017-10-11 05:21:25.358118
NCT00158678|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-03-23|||September 2005||2005-09-01|March 2015|2015-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC|Phase III Trial of Intensity-modulated Radiotherapy Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma|Active, not recruiting||Phase 3|310|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||2|||f||||||||||||||2017-10-11 05:21:25.740007|2017-10-11 05:21:25.740007
NCT00158691|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||March 2001||2001-03-01|September 2005|2005-09-01||||||||Interventional|||Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas|A Randomized Phase III Study Comparing Intravenous Versus Subcutaneous Administration of Amifostine in Prevention of Xerostomia for Patients Receiving Radiotherapy for Head and Neck Carcinomas|Completed||Phase 3|296||Groupe Oncologie Radiotherapie Tete et Cou|||||f||||||||||||||2017-10-11 05:21:25.873775|2017-10-11 05:21:25.873775
NCT00158704|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-03-07|||January 2002||2002-01-01|April 2006|2006-04-01|January 2005||2005-01-01|||||Interventional|||Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.|An Open-Label, Continued Access Study of Adefovir Dipivoxil for Patients With Chronic HBV Infection Who Have Completed a Gilead-Sponsored Study of Adefovir Dipivoxil.|Terminated||N/A|400||Gilead Sciences||||The study stopped due to marketing approval by the FDA.|||||||||||||||2017-10-11 05:21:25.967651|2017-10-11 05:21:25.967651
NCT00158717|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-01-06|||April 2003||2003-04-01|January 2014|2014-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.|A Phase 3b, Long-Term, Observational Study of the Durability of Seroconversion in Patients With Chronic Hepatitis B Virus Infection Who Have Seroconverted While Participating in a Previous Gilead-Sponsored Study of Adefovir Dipivoxil.|Completed||N/A|107|Actual|Gilead Sciences|||||||||||||||||||2017-10-11 05:21:26.039691|2017-10-11 05:21:26.039691
NCT00158730|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-11-17|||April 2003||2003-04-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment|Study of the Safety and Efficacy of AmBisome Loading Dose Regimen Vs. a Standard AmBisome Regimen for Initial Treatment of Invasive Aspergillosis and Other Filamentous Fungal Infections in Immunocompromised Patients|Completed||Phase 3|800||Gilead Sciences|||||||||||||||||||2017-10-11 05:21:26.134731|2017-10-11 05:21:26.134731
NCT00158743|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-07-17|2014-07-17||February 2004||2004-02-01|July 2014|2014-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy Study of Digibind for Treatment of Severe Preeclampsia|A Parallel, Double-blind, Placebo Controlled, Randomized Comparison of an Anti-digoxin Antibody (Digibind) Versus Placebo for the Treatment of Antepartum Patients With Severe Preeclampsia|Completed||Phase 2|51|Actual|BTG International Inc.||2|||f||||t||||||||||2017-10-11 05:21:26.240913|2017-10-11 05:21:26.240913
NCT00158756|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-04-14|2016-12-20||September 12, 2005|Actual|2005-09-12|April 2017|2017-04-01|November 23, 2006|Actual|2006-11-23|November 1, 2006|Actual|2006-11-01||Interventional|||Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants|A Phase III, Partially Blind, Randomized Study to Evaluate the Immunogenicity, Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Tritanrix™-HepB and GSK Biologicals Kft's DTPw-HBV Vaccines as Compared to Concomitant Administration of Commonwealth Serum Laboratory's (CSL's) DTPw (Triple Antigen™) and GSK Biologicals' HBV (Engerix™-B), When Co-administered With GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine, to Healthy Infants at 3, 4½ and 6 Months of Age, After a Birth Dose of Hepatitis B Vaccine.|Completed||Phase 3|308|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:21:26.796654|2017-10-11 05:21:26.796654
NCT00158769|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-09-20|||March 31, 2005|Actual|2005-03-31|September 2017|2017-09-01|October 26, 2005|Actual|2005-10-26|October 26, 2005|Actual|2005-10-26||Interventional|||A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers|An Open-Label, Non-Randomised, Pharmacokinetic, Metabolic Disposition and Safety Study of a 3 Day Continuous Infusion of GR270773 in Healthy Subjects and Subjects With Hepatic Impairment.|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-10-11 05:21:29.596679|2017-10-11 05:21:29.596679
NCT00158782|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-03-17|||September 2004||2004-09-01|March 2011|2011-03-01||||||||Interventional|||Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients|An Open-Label, Safety, Pharmacokinetic and Pharmacodynamic Study of Multiple Doses of GW786034 and Lapatinib Concomitantly Administered in Cancer Patients.|Completed||Phase 1|65||GlaxoSmithKline|||||||||f||||||||||2017-10-11 05:21:29.69674|2017-10-11 05:21:29.69674
NCT00158795|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-05-24|||January 2005||2005-01-01|May 2017|2017-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine|Assess the Safety & Reactogenicity of GSK Biologicals Hib Vaccine Co-administered With Chinese Local DTPw Vaccine When Compared to Chinese Local DTPw Vaccine Administered Alone, in Healthy Infants at 3,4 & 5 Mths of Age|Completed||Phase 4|454|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:21:29.841476|2017-10-11 05:21:29.841476
NCT00158808|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-05-24|||January 2005||2005-01-01|May 2017|2017-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths|Assess the Immunogenicity &d Reactogenicity of a Booster Dose of a Formulation of GSK Biologicals' DTPw-HBV/Hib Vaccine at 15-18 Mths of Age in Infants Previously Primed With the Same Vaccine|Completed||Phase 2|175|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:21:30.155384|2017-10-11 05:21:30.155384
NCT00158821|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-06-21|||March 2000||2000-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|December 2001|Actual|2001-12-01||Interventional|||Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.|A Phase 3, Randomized, Double-Blind, Multicenter Study of the Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.(Extension)|Completed||Phase 3|180|Anticipated|Gilead Sciences||1|||f||||||||||||||2017-10-11 05:21:30.2485|2017-10-11 05:21:30.2485
NCT00158834|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-10-09|||November 1999||1999-11-01|October 2008|2008-10-01||||||||Interventional|||Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications|Comparison of Stepwise Treatment of Asthmatic Children With Salmeterol/Fluticasone Propionate Combination Product (Seretide®) and/or Fluticasone Propionate (Flixotide®) Based on PD20 Methacholine and Symptoms or Based on Symptoms Only (Children Asthma Therapy Optimal)|Completed||Phase 3|200||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:21:30.373919|2017-10-11 05:21:30.373919
NCT00158847|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-01-10|||April 2000||2000-04-01|January 2005|2005-01-01|May 2005||2005-05-01|||||Interventional|||Modification Of Disease Outcome In COPD|Modification of Disease Outcome in COPD. Shortterm Versus Longterm Treatment With Inhaled Corticosteroids, Either or Not Combined With a Long-Acting Beta2-Agonist.|Terminated||Phase 4|200||Leiden University Medical Center|||||f||||||||||||||2017-10-11 05:21:30.492996|2017-10-11 05:21:30.492996
NCT00158873|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-10-15|||September 2004||2004-09-01|October 2008|2008-10-01||||||||Interventional|||Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects|A Centre-Randomized, Open-Label, Cross-Over Study to Compare the Pharmaco-Economic Consequences of an Ultiva (Remifentanil Hydrochloride) Based Regimen With Conventional Sedative Based Regimens in ICU Subjects Requiring Short-Term Mechanical Ventilation With Analgesia and Sedation|Completed||Phase 4|224||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:21:30.895542|2017-10-11 05:21:30.895542
NCT00158886|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-05-21|||November 2001||2001-11-01|May 2009|2009-05-01||||||||Interventional|||Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer|A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Cancer|Terminated||Phase 1|36||GlaxoSmithKline||1|||||||||||||||||2017-10-11 05:21:31.035815|2017-10-11 05:21:31.035815
NCT00158899|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-05-24|||August 2004||2004-08-01|May 2017|2017-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol|A Multi-center, Three-staged With Interim Analyses, Parallel, Randomized, Double-blind, fenofibrate-and Placebo-controlled Proof of Concept and Dose-response Evaluation of the Safety, Tolerability, and Effects on Plasma High-density Lipoprotein Cholesterol (HDLc) and Triglycerides of Eight Weeks Treatment With GW501516 in Otherwise Healthy Patients With Low HDLc, Mildly to Moderately Elevated Triglycerides, and Normal Low-density Lipoprotein Cholesterol (LDLc)|Completed||Phase 2|424|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-10-11 05:21:31.125814|2017-10-11 05:21:31.125814
NCT00158912|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-11-20|||August 2003||2003-08-01|November 2006|2006-11-01|May 2005||2005-05-01|||||Interventional|||VAST - Ventricular Arrhythmia Suppression Trial|Ventricular Arrhythmia Suppression Trial|Completed||Phase 4|550||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:21:31.310033|2017-10-11 05:21:31.310033
NCT00158925|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-05-02|2017-03-17||September 2004||2004-09-01|May 2017|2017-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|EASYTRAK EPI||The EASYTRAK EPI Clinical Investigation|The EASYTRAK EPI Clinical Investigation|Completed||N/A|100|Actual|Boston Scientific Corporation||1|||f||||||||||||No||2017-10-11 05:21:31.374301|2017-10-11 05:21:31.374301
NCT00158938|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-06-22|||May 2003||2003-05-01|June 2007|2007-06-01|November 2004|Actual|2004-11-01|||||Interventional|||Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead|Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead|Completed||Phase 2/Phase 3|115||Boston Scientific Corporation|||||||||||||||||||2017-10-11 05:21:33.379753|2017-10-11 05:21:33.379753
NCT00158951|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-06-22|||March 2003||2003-03-01|June 2007|2007-06-01|October 2004||2004-10-01|||||Interventional|||Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF|Device Evaluation of CONTAK(R) RENEWAL 2/4/4HE and EASYTRAK(R) 2: Assessment of Safety and Effectiveness in Heart Failure (DECREASE-HF)|Completed||Phase 2/Phase 3|360||Boston Scientific Corporation|||||||||||||||||||2017-10-11 05:21:33.445934|2017-10-11 05:21:33.445934
NCT00158964|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-06-22|||March 2005||2005-03-01|June 2007|2007-06-01|April 2007|Actual|2007-04-01|||||Interventional|||EASYTRAK 4 Steerable LV Lead|EASYTRAK® 4 STEERABLE LV Lead Clinical Investigation|Completed||Phase 2/Phase 3|110||Boston Scientific Corporation|||||||||||||||||||2017-10-11 05:21:33.537263|2017-10-11 05:21:33.537263
NCT00158977|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-09-28|||November 2003||2003-11-01|September 2011|2011-09-01|February 2008|Actual|2008-02-01|October 2004|Actual|2004-10-01||Interventional|||CONTAK RENEWAL 3 AVT|CONTAK RENEWAL 3 AVT Study|Completed||Phase 3|73|Actual|Boston Scientific Corporation||1|||f||||||||||||||2017-10-11 05:21:33.639815|2017-10-11 05:21:33.639815
NCT00158990|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-01-02|||October 2002||2002-10-01|August 2005|2005-08-01|July 2007||2007-07-01|||||Interventional|||Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.|Triiodothyronine (T3) Supplementation in Bipolar and Unipolar Depression: A Random Assignment, Double Blind, Placebo-Controlled Study.|Completed||Phase 3|220||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:21:33.736224|2017-10-11 05:21:33.736224
NCT00159003|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-08-09|||January 1, 1998|Actual|1998-01-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|||Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel|Molecular Analysis of Genetic Elements Which May Influence Predisposition and Prognosis of Hematological Malignancies in Different Ethnic Groups in Israel|Completed||N/A|100|Actual|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"     DNA only   "|||2017-10-11 05:21:33.822774|2017-10-11 05:21:33.822774
NCT00159016|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-04-27|||August 2002||2002-08-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study.|The Possible Role of Glivec in Patients With Tumor Cells Positive for C-kit or Platelet Derived Growth Factor Receptor (PDGFR); a Multi Center Study.|Withdrawn||Phase 2|100||Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-10-11 05:21:33.900988|2017-10-11 05:21:33.900988
NCT00159029|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-08-09|||April 1, 2004|Actual|2004-04-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|||Genetics of Alpha Thalassemia in Israeli Ethnic Groups|Haplotype Analysis of Alpha Globin Genes in Israeli Ethnic Groups|Completed||N/A|100|Actual|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"     DNA isolated from peripheral blood.   "|||2017-10-11 05:21:34.091394|2017-10-11 05:21:34.091394
NCT00159042|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-08-09|||July 2004|Actual|2004-07-01|August 2017|2017-08-01|July 1, 2017|Actual|2017-07-01|July 1, 2017|Actual|2017-07-01||Observational|||Genetic Factors Affecting the Severity of Beta Thalassemia|Identification of Novel Genetic Modifiers in Beta-thalassemia|Completed||N/A|50|Actual|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"     DNA isolated from peripheral blood   "|||2017-10-11 05:21:34.175473|2017-10-11 05:21:34.175473
NCT00159055|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-07|||February 2004||2004-02-01|September 2005|2005-09-01||||||||Interventional|||Adoptive Immunotherapy for CMV Disease|Prevention and Treatment of CMV Disease by Adoptive Immunotherapy With Immune Donor Lymphocytes in Conjunction With Non-myeloablative Stem Cell Transplantation (NST)|Withdrawn||Phase 1/Phase 2|20|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-10-11 05:21:34.255344|2017-10-11 05:21:34.255344
NCT00159068|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-08-09|||February 2004||2004-02-01|August 2017|2017-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Analysis of Genetic Factors Which May Influence the Course of HIV Infection|Genetic Influences on the Course and Response to Treatment of HIV: Contribution of Polymorphisms in Drug Metabolism and Disposition Genes and Haptoglobin Polymorphisms|Completed||N/A|100|Actual|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"     DNA isolated from peripheral blood.   "|||2017-10-11 05:21:34.335244|2017-10-11 05:21:34.335244
NCT00159081|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-02-06|||November 2000||2000-11-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||One Year Drug Treatment in First-Episode Schizophrenia|One Year Maintenance Treatment With Low Dose Haloperidol vs. Risperidone in First-Episode Schizophrenia|Completed||Phase 4|159|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-10-11 05:21:34.402419|2017-10-11 05:21:34.402419
NCT00159094|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-05-30|||October 2003||2003-10-01|September 2005|2005-09-01||||||||Interventional|||A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer|A Phase II Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|Hematology Oncology Consultants|||||f||||||||||||||2017-10-11 05:21:34.511743|2017-10-11 05:21:34.511743
NCT00159107|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-01-29|||May 2003||2003-05-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Integrative Therapy in Alcoholism|Acamprosate and Integrative Behavior Therapy in the Outpatient Treatment of Alcohol Dependents|Completed||Phase 4|371|Actual|Heinrich-Heine University, Duesseldorf||3|||f||||t||||||||||2017-10-11 05:21:34.609637|2017-10-11 05:21:34.609637
NCT00159120|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-01-28|||November 2001||2001-11-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia|Maintenance Treatment vs. Stepwise Drug Discontinuation After One Year of Maintenance Treatment in First-Episode Schizophrenia|Completed||Phase 4|71|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-10-11 05:21:34.721267|2017-10-11 05:21:34.721267
NCT00159133|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-01-28|||November 2001||2001-11-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia|Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepine in Patients With First-Episode Schizophrenia After One Year Maintenance Treatment Under Further Maintenance Treatment vs. Stepwise Discontinued Drugs|Completed||Phase 4|71|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-10-11 05:21:34.833322|2017-10-11 05:21:34.833322
NCT00159146|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-12-20|||August 2002||2002-08-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression|A Short Term Double Blind Randomised Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression|Terminated||N/A|31|Actual|Hillerod Hospital, Denmark||2||lack of participants fulfilling inclusion criteria|f||||f||||||||||2017-10-11 05:21:34.94097|2017-10-11 05:21:34.94097
NCT00159159|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-04-26|||March 2004||2004-03-01|April 2007|2007-04-01||||||||Interventional|||LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant|LOW CYCLO: A Multicenter, Prospective, Randomized Study Evaluating the Benefit, on Renal Function, of Two Doses of Ciclosporine: Low Dose Versus Usual Dose, in Association With Mycophenolate and Corticoïds, in de Novo Cardiac Transplant|Unknown status|Active, not recruiting|Phase 4|106||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:21:35.038376|2017-10-11 05:21:35.038376
NCT00159172|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-03-05|||September 2005||2005-09-01|September 2005|2005-09-01|May 2008||2008-05-01|||||Interventional|||Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease|Phase 1 Study of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease|Unknown status|Recruiting|Phase 1/Phase 2|10||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:21:35.120192|2017-10-11 05:21:35.120192
NCT00159185|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-07-20|||January 2004||2004-01-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Observational|||Epidemiology Study in Major Orthopaedic Surgery|Epidemiology Study in Major Orthopaedic Surgery|Completed||N/A|500||Hoersholm Hospital|||||f||||||||||||||2017-10-11 05:21:35.233513|2017-10-11 05:21:35.233513
NCT00159198|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-09-05|||September 2002||2002-09-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|||||Observational|||Amyotrophic Lateral Sclerosis and Frontotemporal Dementia|Genetic Linkage in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia|Terminated||Phase 1|400|Actual|Assistance Publique - Hôpitaux de Paris|||2|Completed|f||||t||||||Samples With DNA|"     Whole blood   "|||2017-10-11 05:21:35.294364|2017-10-11 05:21:35.294364
NCT00159211|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-11-06|||May 2005||2005-05-01|April 2007|2007-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin|Evolution of Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin, in Association With Metformin or Sulfonylurea.|Terminated||N/A|28|Actual|Assistance Publique - Hôpitaux de Paris||2||inclusion was finished|f||||f||||||||||2017-10-11 05:21:35.418747|2017-10-11 05:21:35.418747
NCT00159224|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-09-04|||April 2005||2005-04-01|September 2015|2015-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Induction-maintenance of Lopinavir/r in HIV-infected Subjects|"Study ACA-ARGE-04-001 A Pilot, Open-Label Study Assessing Safety, Tolerability, Efficacy of a Simplified Lopinavir/Ritonavir Induction/Maintenance Therapy in HIV-Infected Subjects on Their First Protease Inhibitor-Based Regimen."|Completed||Phase 4|100|Actual|The Huesped Foundation||2|||f||||f||||||||||2017-10-11 05:21:35.511521|2017-10-11 05:21:35.511521
NCT00159237|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-08-12|||February 2005||2005-02-01|August 2008|2008-08-01|December 2008||2008-12-01|||||Observational|||GR Defect in Peripheral Blood Mononuclear Cells in COPD|GR Defect in Peripheral Blood Mononuclear Cells in COPD|Completed||N/A|30|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:21:35.603982|2017-10-11 05:21:35.603982
NCT00159250|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-02-22|||October 2007||2007-10-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy|Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: A Phase I/II Clinical Trial Using AVI-4658|Completed||Phase 1/Phase 2|7|Actual|Imperial College London||1|||f||||t||||||||||2017-10-11 05:21:35.665879|2017-10-11 05:21:35.665879
NCT00159263|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||November 2004||2004-11-01|September 2005|2005-09-01||||||||Interventional|||Effect of Symbicort on GR Localisation in Asthma|Effect of Symbicort on GR (Glucocorticoid Receptor) Translocation in Induced Sputum in Comparison With Budesonide, Formoterol and Placebo. A Single Dose Exploratory Study in Patients With Mild Asthma|Completed||N/A|10||Imperial College London|||||f||||||||||||||2017-10-11 05:21:35.756864|2017-10-11 05:21:35.756864
NCT00159276|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-08-12|||December 2005||2005-12-01|August 2008|2008-08-01|December 2008||2008-12-01|||||Observational|||GR Defect in Sputum Cells in COPD|GR Defect in Sputum Cells in COPD|Completed||N/A|30|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:21:35.830331|2017-10-11 05:21:35.830331
NCT00159289|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-03|||June 2003||2003-06-01|August 2008|2008-08-01||||||||Interventional|||Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)|Effect of Endotoxin on Inflammatory Markers in Exhaled Breath, Sputum, Saliva and Nasal Lavage in Healthy Non-Smokers and Current Smokers Including Patients With COPD|Withdrawn||N/A|0|Actual|Imperial College London||2||No resources available|f||||||||||||||2017-10-11 05:21:36.011125|2017-10-11 05:21:36.011125
NCT00159302|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||September 2003||2003-09-01|September 2005|2005-09-01||||||||Observational|||Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control|A Pilot Study to Evaluate and Develop Biomarkers of iNOS Activity in Patients With COPD or Asthma and Healthy Volunteers|Completed||N/A|36||Imperial College London|||||f||||||||||||||2017-10-11 05:21:36.090435|2017-10-11 05:21:36.090435
NCT00159315|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-03|||October 2002||2002-10-01|August 2008|2008-08-01||||||||Interventional|||ATP/AMP Challenge in Healthy Non-smokers, Smokers, Patients With Asthma, and Patients With Chronic Obstructive Pulmonary Disease (COPD)|Adenosine 5`-Triphosphate (ATP) Challenge in Healthy Non-smokers, Current Smokers and Patients With Mild Asthma and Chronic Obstructive Pulmonary Disease (COPD)|Withdrawn||N/A|0|Actual|Imperial College London||||no resources available|f||||||||||||||2017-10-11 05:21:36.171287|2017-10-11 05:21:36.171287
NCT00159328|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-08-12|||March 2003||2003-03-01|August 2008|2008-08-01|December 2006||2006-12-01|||||Interventional|||Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids|Phase 4 Study of Magnetic Resonance Guided Focused Ultrasound Surgery Following Gonadotrophin Releasing Hormone Agonist Treatment for Symptomatic Uterine Fibroids|Completed||Phase 4|50||Imperial College London|||||f||||||||||||||2017-10-11 05:21:36.245485|2017-10-11 05:21:36.245485
NCT00159341|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-08-12|||September 2005||2005-09-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Cigarette Smoke Nasal and Whole Blood Challenge in Patients With COPD|Completed||Phase 1|16|Actual|Imperial College London||1|||f||||f||||||||||2017-10-11 05:21:36.327455|2017-10-11 05:21:36.327455
NCT00159354|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-28|||June 2005||2005-06-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Measurement of Smoking−Induced Neutrophil Activation|Evaluation of Smoking−Induced Neutrophil Activation as a Potential Biomarker of Response to Therapeutic Interventions in COPD: Proof of Concept Study|Completed||N/A|16|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:21:36.42168|2017-10-11 05:21:36.42168
NCT00159367|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-02-16|||January 2005||2005-01-01|August 2008|2008-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps Muscle|The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps Muscle in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|20|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:21:36.507174|2017-10-11 05:21:36.507174
NCT00159380|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-06-03|||September 2003||2003-09-01|April 2008|2008-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects|A Double Blind, Crossover Placebo-controlled Study to Evaluate the Effect of L-arginine and Aminoguanidine on Bronchial, Alveolar and Nasal NO and NO Metabolites in Exhaled Air, Breath Condensate, Saliva, Nasal Lavage Fluid and Induced Sputum in 10 Normal and 15 Asthmatic Subjects|Completed||N/A|25|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:21:36.578669|2017-10-11 05:21:36.578669
NCT00159393|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-08-29|||October 2003||2003-10-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Percutaneous Nephrolithotomy: A Registry and Database|Percutaneous Nephrolithotomy: A Registry and Database|Recruiting||N/A|3000|Anticipated|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-10-11 05:21:36.662698|2017-10-11 05:21:36.662698
NCT00159406|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-08-29|||October 2003||2003-10-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Laser Prostatectomy Database and Registry|Laser Prostatectomy for Benign Prostatic Hyperplasia: A Registry and Database|Recruiting||N/A|3000|Anticipated|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-10-11 05:21:36.762302|2017-10-11 05:21:36.762302
NCT00159419|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-05-17|2013-11-12||August 1999||1999-08-01|May 2017|2017-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Bisphosphonate Therapy for Osteogenesis Imperfecta|Bisphosphonate Therapy for Osteogenesis Imperfecta|Completed||Phase 4|18|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 05:21:36.884836|2017-10-11 05:21:36.884836
NCT00159432|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-07-22|2013-11-27||February 2005||2005-02-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|June 2009|Actual|2009-06-01||Interventional||All the participants who were enrolled are included in the analysis as per protocol.|Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer|Phase II Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer|Completed||Phase 2|63|Actual|University of Southern California||1|||f||||||||||||||2017-10-11 05:21:37.211984|2017-10-11 05:21:37.211984
NCT00159445|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-05-20|||March 2004||2004-03-01|May 2014|2014-05-01|November 2007|Actual|2007-11-01|March 2007|Actual|2007-03-01||Interventional|||Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer|Phase II Study of Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|53|Anticipated|University of Southern California|||||f||||||||||||||2017-10-11 05:21:37.634174|2017-10-11 05:21:37.634174
NCT00159458|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-05-20|||July 2003||2003-07-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer|Phase II Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer|Terminated||Phase 2|7|Actual|University of Southern California||1||Insufficient Accrual|||||||||||||||2017-10-11 05:21:37.703862|2017-10-11 05:21:37.703862
NCT00159471|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||February 2005||2005-02-01|May 2014|2014-05-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.|A Pilot Trial of Germline Polymorphisms as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.|Terminated||N/A|1|Actual|University of Southern California||1||Insufficient Accrual|f||||t||||||||||2017-10-11 05:21:37.799756|2017-10-11 05:21:37.799756
NCT00159484|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-06-23|||October 2004||2004-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer|Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer (CEPO906AUS10)|Active, not recruiting||Phase 1/Phase 2|75|Actual|University of Southern California||1|||f||||t||||||||||2017-10-11 05:21:37.891739|2017-10-11 05:21:37.891739
NCT00159497|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-03-28|||October 1998||1998-10-01|March 2014|2014-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Bone Remodeling Around HA-coated Acetabular Cups.|Bone Remodeling Around HA-coated Acetabular Cups.|Completed||Phase 4|100|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-10-11 05:21:37.976165|2017-10-11 05:21:37.976165
NCT00159510|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-10-05|||April 2004||2004-04-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MB-NO||Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome|A Controlled Prospective Randomized Open-Label Study of Methylene Blue and Inhaled Nitric Oxide in Patients With Septic Shock and Acute Lung Injury|Terminated||Phase 1|28|Actual|Northern State Medical University||4||Inability to recruit the patients due to the short supply and changed local hospital protocol|f||||f||||||||||2017-10-11 05:21:38.070096|2017-10-11 05:21:38.070096
NCT00152737|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-07-16|||March 2004||2004-03-01|July 2015|2015-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Objective Evaluation of Proximal Ischemia|Effet Des Gestes de Revascularisation à l'étage Proximal|Completed||N/A|165|Actual|University Hospital, Angers|||1||f||||t||||||||||2017-10-11 05:21:38.169581|2017-10-11 05:21:38.169581
NCT00152750|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-02-27|||September 2006||2006-09-01|October 2006|2006-10-01|October 2008||2008-10-01|||||Interventional|||Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD|Aggressive Behaviour in Children With Tourette's Syndrome (TS) and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)|Unknown status|Recruiting|Phase 4|32||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:21:38.262004|2017-10-11 05:21:38.262004
NCT00152763|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-01-05|2010-10-27||October 2003||2003-10-01|January 2011|2011-01-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Psychological Support for Patients With an Implantable Cardioverter Defibrillator|Psychological Support for Patients With an Implantable Cardioverter Defibrillator|Completed||Phase 3|193|Actual|University Health Network, Toronto||4|||f||||||||||||||2017-10-11 05:21:38.4103|2017-10-11 05:21:38.4103
NCT00152776|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-04-18|||February 2005||2005-02-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Treating Climacteric Symptoms With a Complex Homeopathic Remedy|Treatment of Climacteric Symptoms With Ovaria Comp - A Prospective Randomized Placebo Controlled Doubleblind Study|Completed||Phase 4|102||Heidelberg University|||||f||||f||||||||||2017-10-11 05:21:39.783908|2017-10-11 05:21:39.783908
NCT00152789|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-08-07|||April 2001||2001-04-01|January 2008|2008-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy|Oxygenation of the Prostate Gland: a Polarographic Electrode Study in Men Undergoing Prostate Biopsy.|Completed||Phase 2|40|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:21:39.89981|2017-10-11 05:21:39.89981
NCT00152802|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-02-16|||January 2005||2005-01-01|September 2005|2005-09-01|January 2009||2009-01-01|||||Interventional|||Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine|Immunogenicity of Pneumococcal Vaccine in Liver Transplant Recipients Using a Conjugate-Polysaccharide Priming-Booster Strategy|Unknown status|Active, not recruiting|Phase 4|130||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:21:39.992077|2017-10-11 05:21:39.992077
NCT00152815|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-07-17|||October 2003||2003-10-01|July 2013|2013-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions|Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions|Terminated||Phase 2|30|Actual|University Health Network, Toronto||1||Not enough eligible patients available|f||||f||||||||||2017-10-11 05:21:40.080316|2017-10-11 05:21:40.080316
NCT00152828|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2016-02-08|||February 2001||2001-02-01|February 2016|2016-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix|A Phase I/II Trial of the Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix|Completed||Phase 1/Phase 2|31|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 05:21:40.182123|2017-10-11 05:21:40.182123
NCT00152841|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-03-16|||June 2002||2002-06-01|March 2009|2009-03-01||||February 2009|Actual|2009-02-01||Interventional|||Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis|Effect of Iron and Antioxidant Vitamins on Disease Activity and Oxidative Stress in Inflammatory Bowel Disease (IBD)|Terminated||Phase 2|30|Anticipated|University Health Network, Toronto||||Lack of patients|f||||f||||||||||2017-10-11 05:21:40.263437|2017-10-11 05:21:40.263437
NCT00152854|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-03-04|||July 2005||2005-07-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Acetaminophen for Cancer Pain|A Randomised, Placebo-controlled, Crossover Trial of Acetaminophen in Cancer Patients on Strong Opioids|Completed||Phase 3|12|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-10-11 05:21:40.348684|2017-10-11 05:21:40.348684
NCT00152867|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-06-26|||January 2005||2005-01-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy|A Randomised Double-Blind Placebo Controlled Cross Over Trial of the Impact on Quality of Life of Continuing Dexamethasone Beyond 24 Hours Following Moderately Emetogenic Chemotherapy|Completed||Phase 3|86|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-10-11 05:21:40.473319|2017-10-11 05:21:40.473319
NCT00152880|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-29|||July 2005||2005-07-01|September 2005|2005-09-01||||||||Observational|||Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative|Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative, Have Normal ALT, and HBV DNA ≥10,000 Copies/mL|Unknown status|Recruiting|N/A|30||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:21:40.566417|2017-10-11 05:21:40.566417
NCT00152893|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-07-17|||August 2002||2002-08-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities|The Effects of Chromium Supplementation on Glucose and Lipid Metabolism in Patients With HIV Infection|Completed||Phase 2|52|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-10-11 05:21:40.639646|2017-10-11 05:21:40.639646
NCT00152906|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-09-19|||July 2003||2003-07-01|September 2017|2017-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Stereotactic Radiotherapy (SRT) Liver (COLD 1)|Phase I/II Trial of Highly Conformal Radiotherapy for Unresectable Liver Metastases and Hepatobiliary Carcinoma|Active, not recruiting||Phase 1/Phase 2|140|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:21:40.740408|2017-10-11 05:21:40.740408
NCT00152919|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-08-12|||February 2004||2004-02-01|August 2010|2010-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy|A Comparison of 2 Schedules of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy - A Randomized Phase III Trial|Completed||Phase 3|100|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:21:40.828233|2017-10-11 05:21:40.828233
NCT00152932|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-23|||May 2005||2005-05-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide|Ocular Blood Flow Measured by HRF and CLBF in Newly Diagnosed and Early Glaucoma Patients Before and After Instillation of Dorzolamide 2%|Unknown status|Recruiting|N/A|17|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:21:40.906704|2017-10-11 05:21:40.906704
NCT00152945|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-09-28|||April 2005||2005-04-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Determining the Responsiveness of Intestinal Lipoprotein Production to an Elevation of Plasma Free Fatty Acids||Completed||N/A|10|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 05:21:41.001389|2017-10-11 05:21:41.001389
NCT00152958|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-11-18|||January 2004||2004-01-01|November 2013|2013-11-01||||February 2005|Actual|2005-02-01||Interventional|||A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)|A Double-blind, Placebo-controlled, Randomised Withdrawal Study of 3 Month Duration in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)|Completed||Phase 3|224||Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:21:41.102688|2017-10-11 05:21:41.102688
NCT00152971|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-04-22|2010-11-18||November 2004||2004-11-01|April 2014|2014-04-01||||June 2006|Actual|2006-06-01||Interventional|||Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement|A Phase III, Randomized, Parallel-group, Double-blind, Active Controlled Study to Investigate the Efficacy and Safety of Two Different Dose Regimens (75mg Day 1 Followed by 150 mg Day 2-completion, and 110 mg Day 1 Followed by 220 mg Day 2-completion) of Dabigatran Etexilate Administered Orally (Capsules), Compared to Enoxaparin 30 mg Twice a Day Subcutaneous for 12 - 15 Days in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Knee Replacement Surgery|Completed||Phase 3|2615|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 05:21:41.258224|2017-10-11 05:21:41.258224
NCT00152984|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-10-31|||December 2004||2004-12-01|October 2013|2013-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma|A 12-week Randomised, Double Blind, Placebo Controlled, Parallel Group Trial Evaluating the Efficacy and Safety of Inhaled Tiotropium 18μg q.d. in Patients With COPD and a Concomitant Diagnosis of Asthma|Completed||Phase 4|472||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:21:42.988392|2017-10-11 05:21:42.988392
NCT00152997|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-10-30|||August 2004||2004-08-01|October 2013|2013-10-01||||December 2005|Actual|2005-12-01||Interventional|||Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome|A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pramipexole With the Dose Range From 0.125 mg to 0.75 mg Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome.|Completed||Phase 2|41|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:21:43.211595|2017-10-11 05:21:43.211595
NCT00153010|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-10-28|||February 2003||2003-02-01|October 2013|2013-10-01||||March 2005|Actual|2005-03-01||Interventional|||An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type|A Phase II Double-Blind, Randomized, Dose-Ranging, Placebo-Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type|Completed||Phase 2|430|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:21:43.304016|2017-10-11 05:21:43.304016
NCT00153023|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-12|||April 2003||2003-04-01|November 2013|2013-11-01|December 2005||2005-12-01|December 2005|Actual|2005-12-01||Interventional|||1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy|A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Investigate the Efficacy of Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy VIVALDI-Study|Completed||Phase 4|885||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:21:43.575465|2017-10-11 05:21:43.575465
NCT00153036|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-04-30||2014-04-30|April 2003||2003-04-01|April 2014|2014-04-01||||February 2008|Actual|2008-02-01||Interventional|||Rt-PA in the Treatment of Acute Ischemic Stroke|ECASS III - European Cooperative Acute Stroke Study III: A Placebo Controlled Trial of Alteplase (Rt-PA) in Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4 Hours 30 Minutes After Stroke Onset|Completed||Phase 3|821|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:21:43.893864|2017-10-11 05:21:43.893864
NCT00153049|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-07|||June 2004||2004-06-01|November 2013|2013-11-01|June 2005||2005-06-01|June 2005|Actual|2005-06-01||Interventional|||3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension|A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension|Completed||Phase 2|583|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:21:44.290801|2017-10-11 05:21:44.290801
NCT00153062|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-04-22|2009-02-06||August 2003||2003-08-01|April 2014|2014-04-01||||April 2008|Actual|2008-04-01||Interventional|||PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes|PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis|Completed||Phase 4|20332|Actual|Boehringer Ingelheim|All SAEs and AEs that led to temporary or permanent trial drug discontinuation were reported, except in Japan, where all AEs were collected. Protocol-defined outcome events were not reported as AEs, but were recorded on the appropriate form|4|||f||||||||||||||2017-10-11 05:21:44.905794|2017-10-11 05:21:44.905794
NCT00153075|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-10-28|||September 2005||2005-09-01|October 2013|2013-10-01|December 2005||2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised Open Label, Six Way, Cross-over Scintigraphic Evaluation of the Effect of Inspiratory Flow Rate on Lung and Oropharyngeal Deposition With the Respimat Inhaler vs. a Metered Dose Inhaler (HFA-MDI) Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 4|19||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:22:01.344107|2017-10-11 05:22:01.344107
NCT00153088|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-10-31|||January 2003||2003-01-01|October 2013|2013-10-01|November 2005||2005-11-01|November 2005|Actual|2005-11-01||Interventional|||INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy|A Randomised, Double-blind, Placebo-controlled, Multicenter Trial to Investigate the Preventive Effect of BIBR277 (Telmisartan) in Diabetic Nephropathy on Transition From Incipient to Overt Nephropathy - Incipient to Overt : Angiotensin 2 Receptor Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION Study -|Completed||Phase 4|527|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:22:01.647765|2017-10-11 05:22:01.647765
NCT00153101|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-13|2009-06-15||November 2001||2001-11-01|May 2014|2014-05-01||||June 2008|Actual|2008-06-01||Interventional||The Full Analysis Set (FAS) followed the intent-to-treat principle; it included all patients who were randomised and had any follow-up information available (i.e. 'date last seen' was available for these patients).|Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.|ONTARGET ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial A Large, Simple Randomized Trial of an Angiotensin II Receptor Antagonist (Telmisartan) and an ACE-Inhibitor (Ramipril) in Patients at High Risk for Cardiovascular Events and TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects With Cardiovascular Disease. A Parallel Study Comparing the Effects of Telmisartan With Placebo and Outcomes in Patients at High Risk for Cardiovascular Events and Intolerant to ACE-I.|Completed||Phase 4|31546|Actual|Boehringer Ingelheim|Only non-serious Adverse Events (AE) which lead to discontinuation of study medication were assessed and collected; the frequency was under 5%. Non-serious AEs per se were not assessed or collected.||||f||||||||||||||2017-10-11 05:22:02.802095|2017-10-11 05:22:02.802095
NCT00153114|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-02-06|||January 2003||2003-01-01|February 2013|2013-02-01||||September 2004|Actual|2004-09-01||Interventional|||PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children|PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children|Completed||Phase 4|100||Braintree Laboratories|||||||||||||||||||2017-10-11 05:22:33.176285|2017-10-11 05:22:33.176285
NCT00153127|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-02-06|||November 2001||2001-11-01|February 2013|2013-02-01||||September 2004|Actual|2004-09-01||Interventional|||Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications|Comparison of Braintree PolyethyleneGlycol(PEG) Laxative and Placebo for Relief of Constipation From Constipating Medications|Completed||Phase 4|100||Braintree Laboratories|||||||||||||||||||2017-10-11 05:22:33.267517|2017-10-11 05:22:33.267517
NCT00153140|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-02-06|||July 2004||2004-07-01|February 2013|2013-02-01||||October 2004|Actual|2004-10-01||Interventional|||Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation|Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation|Completed||Phase 4|239||Braintree Laboratories|||||||||||||||||||2017-10-11 05:22:33.376781|2017-10-11 05:22:33.376781
NCT00153153|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-02-06|||August 2003||2003-08-01|February 2013|2013-02-01||||December 2004|Actual|2004-12-01||Interventional|||Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients|Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients|Completed||Phase 4|300||Braintree Laboratories|||||||||||||||||||2017-10-11 05:22:33.508424|2017-10-11 05:22:33.508424
NCT00153166|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-09-22|2013-04-24||January 2004||2004-01-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|November 2010|Actual|2010-11-01||Interventional||Baseline Characteristics were collected according to the clinical diagnosis of the patients and not according to randomization. Participants are grouped at Baseline regardless of randomization because we are measuring baseline characteristics that do not depend on which intervention they received.|ARREST PAD (Peripheral Arterial Disease)|The Contribution of Inflammation and Insulin Resistance to Intermittent Claudication|Completed||Phase 2/Phase 3|76|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-11 05:22:33.676766|2017-10-11 05:22:33.676766
NCT00153179|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-05-30|2013-03-19||September 2005||2005-09-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|December 2011|Actual|2011-12-01||Interventional|||Free Fatty Acids and Vascular Function in Subjects With Diabetes|The Impact of Free Fatty Acid Reduction on Vascular Function and Skeletal Muscle Glucose Utilization in Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|110|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 05:22:34.062608|2017-10-11 05:22:34.062608
NCT00153192|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-04-25|||April 2001||2001-04-01|April 2013|2013-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain|A Randomized Controlled Clinical Trial of Dronabinol (Marinol) vs Placebo as Add-on Therapy For Patients on Opioids for Chronic Pain|Completed||Phase 2/Phase 3|30||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 05:22:35.056382|2017-10-11 05:22:35.056382
NCT00153205|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-02-14|||February 2000||2000-02-01|February 2017|2017-02-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||Serious Medication Errors in Pediatrics: Evaluation of Prevention Strategies|Serious Medication Errors in Pediatrics: Evaluation of Prevention Strategies|Withdrawn||N/A|0|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-10-11 05:22:35.154333|2017-10-11 05:22:35.154333
NCT00153218|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-02-13|||June 2004||2004-06-01|February 2012|2012-02-01||||||||Observational|||An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu|An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu|Completed||N/A|94|Actual|Cancer Research Network|||1||f||||||||||||||2017-10-11 05:22:35.469129|2017-10-11 05:22:35.469129
NCT00153231|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-03-26|||March 2003||2003-03-01|March 2015|2015-03-01|May 2007|Actual|2007-05-01|December 2005|Actual|2005-12-01||Interventional|||Posterior IVS Versus Sacrospinous Suspension in Vaginal Vault Prolapse Repair|Clinical Evaluation of Morbidity and Efficacy of Posterior IVS (Infracoccygeal Sacropexy), in Comparison to the Standard Sacrospinous Suspension in the Surgical Treatment of Vaginal Vault Prolapse by the Vaginal Route.|Completed||Phase 4|49|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-10-11 05:22:35.54839|2017-10-11 05:22:35.54839
NCT00153244|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-02-18|||August 2002||2002-08-01|February 2009|2009-02-01|May 2003||2003-05-01|||||Interventional|||Study of Efficacy of Lamotrigine in Therapy of Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Lamotrigine Efficacy in Asthma Therapy|Completed||Phase 4|76||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-10-11 05:22:35.625801|2017-10-11 05:22:35.625801
NCT00153257|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||June 2005||2005-06-01|September 2005|2005-09-01|June 2011||2011-06-01|||||Interventional|||Comparative Study of Mesh Versus No Mesh in Prolapse Surgery|Comparison of the Prosthesis Ugytex by the Trans-Obturator Approach and Anterior Colporrhaphy for the Surgical Treatment of Anterior Vaginal Wall Prolapse.|Unknown status|Recruiting|Phase 4|194||Centre Hospitalier Universitaire de Nīmes|||||f||||||||||||||2017-10-11 05:22:35.712865|2017-10-11 05:22:35.712865
NCT00153270|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-02-18|||September 2000||2000-09-01|February 2009|2009-02-01|April 2001||2001-04-01|||||Interventional|||Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Sodium Valproate Efficacy in Asthma Therapy|Completed||Phase 4|46||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-10-11 05:22:35.829509|2017-10-11 05:22:35.829509
NCT00159523|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-02-04|||December 2003||2003-12-01|August 2015|2015-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic|The Impact of Perinatal Daily Supplement of a Probiotic (Lactobacillus Rhamnosus GG), Given to Mothers, on Immunological Development, Atopic Sensitisation and Allergic Disease in Their Off-spring|Completed||N/A|416|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:22:35.908639|2017-10-11 05:22:35.908639
NCT00159536|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-06-08|||February 2005||2005-02-01|June 2017|2017-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|PregMet||Metformin in Pregnant PCOS Women|Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome (PCOS)|Completed||Phase 3|257|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 05:22:36.111395|2017-10-11 05:22:36.111395
NCT00159549|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-16|||January 2000||2000-01-01|January 2017|2017-01-01|December 2005||2005-12-01|||||Interventional|||Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease|Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|60|Actual|Norwegian University of Science and Technology||2|||f||||||||||||||2017-10-11 05:22:36.281352|2017-10-11 05:22:36.281352
NCT00159562|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-06-04|||September 2005||2005-09-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Psycho-education of Patients With Bipolar Disorder|Effects of Psycho-education of Patients With Bipolar Disorder|Completed||N/A|85|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:22:36.91981|2017-10-11 05:22:36.91981
NCT00159575|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-01-02|||March 2005||2005-03-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|August 2009|Actual|2009-08-01||Interventional|||Metformin in Assisted Reproduction-MET-AR-study|Metformin Treatment Before IVF / ICSI in Non-obese Women With Polycystic Ovarian Syndrome|Terminated||Phase 4|150|Actual|Norwegian University of Science and Technology||1||Slow patient recruitment and expiry of study medication(aug2009)|f||||f||||||||||2017-10-11 05:22:37.033786|2017-10-11 05:22:37.033786
NCT00159588|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-07-18|||January 2004||2004-01-01|July 2016|2016-07-01|December 2007|Actual|2007-12-01|November 2006|Actual|2006-11-01||Interventional|||Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?|Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly? A Randomized Multi-centre Follow-up.|Completed||N/A|64|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 05:22:37.479159|2017-10-11 05:22:37.479159
NCT00159601|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-03-31|||June 2003|Actual|2003-06-01|March 2017|2017-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Quality of Life and Mental Health in Children and Adolescents|Quality of Life and Mental Health in Children and Adolescents in a Child and Adolescent Psychiatric Outpatient Clinic and in the Normal Population|Completed||N/A|2342|Actual|Norwegian University of Science and Technology|||2||f||||f|f|f||||||No||2017-10-11 05:22:37.587202|2017-10-11 05:22:37.587202
NCT00159614|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-01-28|||September 2005||2005-09-01|January 2008|2008-01-01||||||||Interventional|||Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment|Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With Congestive Heart Failure (CHF) and Renal Impairment|Completed||Phase 2|30||NovaCardia, Inc.|||||f||||||||||||||2017-10-11 05:22:37.69131|2017-10-11 05:22:37.69131
NCT00159627|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-01-28|||August 2004||2004-08-01|January 2008|2008-01-01||||||||Interventional|||Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).|A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study of the Effects of KW-3902 on Diuresis in Patients With Congestive Heart Failure (CHF) Refractory to High Dose Diuretic Therapy|Completed||Phase 2|52||NovaCardia, Inc.|||||f||||||||||||||2017-10-11 05:22:37.808648|2017-10-11 05:22:37.808648
NCT00159640|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-03-27|||February 2004||2004-02-01|March 2007|2007-03-01||||||||Interventional|||Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia|A Multi-Center, Randomized, Double Blind, Dose-Response, Placebo And Gabapentin Controlled Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia|Terminated||Phase 2|315||Pfizer|||||f||||||||||||||2017-10-11 05:22:37.960058|2017-10-11 05:22:37.960058
NCT00159653|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-10-08|||July 2005||2005-07-01|October 2012|2012-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma|A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Xalacom Given In The Evening, Xalatan Given In The Evening, And Timolol Given In The Morning In Patients With Open Angle Glaucoma Or Ocular Hypertension.|Completed||Phase 3|500|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:22:38.219194|2017-10-11 05:22:38.219194
NCT00159666|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-03-07|||October 2004||2004-10-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia|A Double-Blind Randomized Placebo-Controlled Trial of the Time to Onset of Pain Relief in Subjects With Post Therapeutic Neuralgia (PHN) Treated With Pregabalin (150 - 600 Mg/Day Flexible Optimized Dose or 300 Mg/Day Fixed Dose) or Placebo|Completed||Phase 4|255||Pfizer|||||||||||||||||||2017-10-11 05:22:38.46933|2017-10-11 05:22:38.46933
NCT00159679|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-04-28|||September 2004||2004-09-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy|A 13 Week, Double-Blind, Placebo-Controlled Phase 4 Trial of Pregabalin (CI-1008, 600 mg/Day) for Relief of Pain in Subjects With Painful Diabetic Peripheral Neuropathy|Completed||Phase 4|167|Actual|Pfizer|||||||||||||||||||2017-10-11 05:22:38.656436|2017-10-11 05:22:38.656436
NCT00159692|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-02-06|||March 2003||2003-03-01|February 2009|2009-02-01|August 2005|Actual|2005-08-01|||||Interventional|ADHERE||Amlodipine Diabetic Hypertension Efficacy Response Trial|A Multi-Center, Randomized, Double-Blind, Double-Dummy Study Evaluating The Safety and Efficacy Of The Addition Of Amlodipine To Quinapril Or Losartan In The Treatment Of Diabetic Hypertensive Subjects|Completed||Phase 4|739|Actual|Pfizer|||||||||||||||||||2017-10-11 05:22:38.821416|2017-10-11 05:22:38.821416
NCT00159705|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-10-09|||April 2005||2005-04-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy|A Randomized Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy|Completed||Phase 3|276|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:22:38.890753|2017-10-11 05:22:38.890753
NCT00159718|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-01-29|||July 2001||2001-07-01|January 2008|2008-01-01|January 2007||2007-01-01|||||Interventional|DUAAL||Double Blind Atorvastatin Amlodipine Study|Double Blind Atorvastatin Amlodipine Study (DUAAL) Effect Of Amlodipine, Atorvastatin And The Combination On Transient Myocardia Ischemia In Coronary Artery Disease.|Completed||Phase 4|360||Pfizer|||||f||||||||||||||2017-10-11 05:22:39.075632|2017-10-11 05:22:39.075632
NCT00159731|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-03-14|||January 2005||2005-01-01|July 2006|2006-07-01|May 2006||2006-05-01|||||Interventional|||Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy|An Open Label Extension Safety Trial of Pregabalin (CI-1008) in Subjects With Diabetic Peripheral Neuropathy|Completed||Phase 4|160||Pfizer|||||||||||||||||||2017-10-11 05:22:39.399866|2017-10-11 05:22:39.399866
NCT00159744|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-05-29|||November 30, 2004|Actual|2004-11-30|May 2017|2017-05-01|April 29, 2006|Actual|2006-04-29|April 29, 2006|Actual|2006-04-29||Interventional|||3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)|A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501004 (Secondary Title: ARES)|Completed||Phase 3|488|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 05:22:39.522429|2017-10-11 05:22:39.522429
NCT00159757|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-08-01|||November 2003||2003-11-01|August 2007|2007-08-01|February 2005||2005-02-01|||||Interventional|||12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients|12 Week Open Label, Multicenter, Non-Comparative Switch Study Evaluating Efficacy, Tolerability And Safety Of Oral Ziprasidone In Treatment Of Patients Suffering From Schizophrenia Who Have Already Been Treated With An Other Antipsychotic.|Terminated||Phase 4|150||Pfizer||||See Detailed Description for Termination Reason|f||||||||||||||2017-10-11 05:22:39.618342|2017-10-11 05:22:39.618342
NCT00159770|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-12-28|||November 2001||2001-11-01|December 2006|2006-12-01|September 2004||2004-09-01|||||Interventional|||Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients|Tolerability, Safety, And Efficacy Of Ziprasidone (80 - 160 Mg/D) Versus Olanzapine (10 - 20 Mg/D), Risperidone (4 - 8 Mg/D) Or Quetiapine (300 - 750 Mg/D) In Pretreated Patients With Schizophrenia, Schizoaffective Disorder Or Schizophreniform Disorders - A 12-Week Open-Label, Multicenter Clinical Trial.|Completed||Phase 3|290||Pfizer|||||f||||||||||||||2017-10-11 05:22:39.712687|2017-10-11 05:22:39.712687
NCT00159783|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-02-06|2010-04-15||July 2005||2005-07-01|February 2015|2015-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)|A Double-Blind, 40-Week Continuation Study Evaluating the Safety of Asenapine and Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501007 (Secondary Title: ARES)|Completed||Phase 3|218|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:22:39.905391|2017-10-11 05:22:39.905391
NCT00159796|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-05-29|||December 14, 2004|Actual|2004-12-14|May 2017|2017-05-01|April 28, 2006|Actual|2006-04-28|March 28, 2006|Actual|2006-03-28||Interventional|||3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)|A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501005 (Secondary Title: ARES)|Completed||Phase 3|489|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 05:22:40.668142|2017-10-11 05:22:40.668142
NCT00159809|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-01-18|||March 2004||2004-03-01|January 2008|2008-01-01|August 2004||2004-08-01|||||Interventional|||Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction|A Multi-Center, Flexible Dose Study With A Double-Blind, Randomized, Placebo-Controlled Phase Followed By An Open-Label Phase To Evaluate The Impact Of Treatment With Sildenafil Citrate On The Symptoms Of Depression And Quality Of Life (Qol) Of Male Patients With Erectile Dysfunction (ED)|Completed||Phase 4|140||Pfizer|||||f||||||||||||||2017-10-11 05:22:40.756528|2017-10-11 05:22:40.756528
NCT00159822|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-01-13|2009-12-02||July 2005||2005-07-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Voriconazole For Chronic Bronchopulmonary Aspergillosis|Voriconazole For Primary Therapy Of Proven, Chronic Bronchopulmonary Aspergillosis, In Minimally Immunocompromised Or, Non-Immunocompromised Hosts|Completed||Phase 2/Phase 3|48|Actual|Pfizer|Study treatment duration is at least 6 months for subjects with best achievable response after 3 months of treatment, of 9 months for subjects with best achievable response after 6 months of treatment and of 12 months in other cases.|1|||f||||f||||||||||2017-10-11 05:22:40.831833|2017-10-11 05:22:40.831833
NCT00159835|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-04-21|||February 1999||1999-02-01|April 2015|2015-04-01|March 2005||2005-03-01|||||Interventional|IDEAL||Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD|Atorvastatin Compared With Simvastatin In The Prevention of CHD Morbidity And Mortality In Patients With CHD|Completed||Phase 4|8600||Pfizer|||||f||||||||||||||2017-10-11 05:22:43.704721|2017-10-11 05:22:43.704721
NCT00159848|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-05-02|||September 2003||2003-09-01|May 2013|2013-05-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra|Effectiveness Of An Educational Program To Improve Patients' Satisfaction Regarding Their Management Of Erectile Dysfunction With Sildenafil|Completed||Phase 4|8000||Pfizer|||||f||||||||||||||2017-10-11 05:22:45.289208|2017-10-11 05:22:45.289208
NCT00160654|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-11-14|||November 2003||2003-11-01|July 2010|2010-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy|A Phase IV, Open-label, Multi-center, Community-based Trial Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.|Completed||Phase 4|345||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:51.690365|2017-10-11 05:22:51.690365
NCT00160342|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-08-14|||June 2005||2005-06-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes|A Multi-Center, Double-Blind, Placebo-Controlled Comparison of Multiple Doses of Esterified Estrogens and Methyltestosterone, in Combination and Alone, in Relieving Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 2|1251|Anticipated|Solvay Pharmaceuticals||9|||f||||f||||||||||2017-10-11 05:22:45.468304|2017-10-11 05:22:45.468304
NCT00160355|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-04-24|||May 2005||2005-05-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|||Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome|Haploidentical Hematopoietic Stem Cell Transplantation for Pediatric Patients With Wiskott-Aldrich Syndrome: A Pilot Study|Completed||Phase 1|4|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:22:45.86707|2017-10-11 05:22:45.86707
NCT00160368|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-04-24|||January 2005||2005-01-01|April 2007|2007-04-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Effects of Potassium Salts on Blood Pressure and Target Organ Damage|Effect of Potassium Bicarbonate and Potassium Chloride on Blood Pressure and Markers of Target Organ Damage in Hypertensives|Unknown status|Recruiting|Phase 3|45||St George's, University of London|||||f||||||||||||||2017-10-11 05:22:45.961175|2017-10-11 05:22:45.961175
NCT00160381|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-27|||September 2002||2002-09-01|May 2008|2008-05-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids|A Phase III, 12-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Doses of J867 Versus Placebo in Subjects With Uterine Leiomyomata.|Completed||Phase 3|432|Actual|Abbott||3|||f||||t||||||||||2017-10-11 05:22:46.045589|2017-10-11 05:22:46.045589
NCT00160394|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-05-24|||December 2004||2004-12-01|May 2017|2017-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris|Multi-Centre, Single-Blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Duac® Gel And Differin® Gel in the Topical Treatment of Mild to Moderate Acne Vulgaris|Completed||Phase 4|130|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:22:46.133292|2017-10-11 05:22:46.133292
NCT00160407|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-11-19|||October 2003||2003-10-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)|Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)|Completed||Phase 4|50||St. Louis University|||||f||||||||||||||2017-10-11 05:22:46.215054|2017-10-11 05:22:46.215054
NCT00160420|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-27|||December 2002||2002-12-01|May 2008|2008-05-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398|A Phase 2, 12-Month, Open Label Extension Study to Evaluate the Safety of J867(5 mg QD) in Subjects With Endometriosis|Completed||Phase 2|73|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:22:46.291729|2017-10-11 05:22:46.291729
NCT00160433|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-27|||August 2002||2002-08-01|May 2008|2008-05-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.|A Phase II, 3-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Doses of J867 (0.5, 1.5 and 5 mg QD) Versus Placebo in Subjects With Endometriosis|Completed||Phase 2|131|Actual|Abbott||4|||f||||f||||||||||2017-10-11 05:22:46.362814|2017-10-11 05:22:46.362814
NCT00160446|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-27|||May 2000||2000-05-01|May 2008|2008-05-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis|A Phase II Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of J867 Administered in Patients With Endometriosis|Completed||Phase 2|130|Actual|Abbott||4|||f||||f||||||||||2017-10-11 05:22:46.46465|2017-10-11 05:22:46.46465
NCT00160459|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-27|||May 2000||2000-05-01|May 2008|2008-05-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids|A Phase 2, Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Asoprisnil (J867) in Patients With Uterine Leiomyomata.|Completed||Phase 2|129|Actual|Abbott||4|||f||||f||||||||||2017-10-11 05:22:46.546176|2017-10-11 05:22:46.546176
NCT00160472|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-02-25|||March 2004||2004-03-01|March 2004|2004-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms|Evaluation of Vasopressin and Vasopressin Receptor Expression in the Arteries and Veins of Ovarian Neoplasms|Completed||N/A|110|Anticipated|Tripler Army Medical Center|||||f||||||||||||||2017-10-11 05:22:46.752765|2017-10-11 05:22:46.752765
NCT00160485|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-02-10|||June 2004||2004-06-01|July 2011|2011-07-01|June 2010|Anticipated|2010-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes|Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes|Withdrawn||Phase 4|0|Actual|Tripler Army Medical Center||2||Active Duty principle investigator currently deployed|f||||t||||||||||2017-10-11 05:22:46.858113|2017-10-11 05:22:46.858113
NCT00160498|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-03-07|||May 2004||2004-05-01|March 2008|2008-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Dose-Titration Study to Assess the Efficacy of Lercanidipine 10 mg and 20 mg Once Daily p. o. in Hypertensive Subjects (I or II WHO) With Elevated Body Weight.|Completed||N/A|180||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:46.977946|2017-10-11 05:22:46.977946
NCT00160511|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-11-25|||April 2004||2004-04-01|September 2009|2009-09-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)|A Double-blind, Randomized, Placebo-controlled, Parallel-group, 16 Week, Multicenter Trial Evaluating the Efficacy and Safety of Levetiracetam 500 mg Tablets in Bid Administration (Daily Dose Ranging From 1000 mg to 3000 mg), in Adults (≥ 18 Years of Age) Suffering From Postherpetic Neuralgia|Completed||Phase 2|170||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:47.066048|2017-10-11 05:22:47.066048
NCT00161057|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-04-22|||December 2001||2001-12-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|||||Observational|||Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment|Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment|Completed||N/A|78|Actual|UMC Utrecht|||1||f||||||||||||||2017-10-11 05:22:57.03677|2017-10-11 05:22:57.03677
NCT00160524|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-08-02|2013-08-02||July 2004||2004-07-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PRECiSE 3|Baseline Characteristics refer to the Safety Population, including all enrolled subjects who received at least one injection of study treatment in feeder study C87031 [NCT00152490] or C87032 [NCT00152425].|A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]|A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032|Completed||Phase 3|596|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:22:47.199631|2017-10-11 05:22:47.199631
NCT00160537|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-12-13|||May 2005||2005-05-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)|A Monocenter, Double-blind, Randomized Trial, With Two Parallel Groups Comparing the Clinical Efficacy of Levocetirizine 5 mg Capsules and Desloratadine 5 mg Capsules Taken Once a Day Over 3 Weeks of Treatment in Adult Subjects Suffering From Seasonal Allergic Rhinitis (SAR) Due to Grass Pollen|Completed||Phase 4|200||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:48.671885|2017-10-11 05:22:48.671885
NCT00160550|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-11-25|||September 2001||2001-09-01|September 2009|2009-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures|A Double-blind, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adjunctive Treatment With 3000 mg/Day (Pediatric Target Dose of 60 mg/kg/Day) Oral Levetiracetam (LEV) (166, 250, and 500mg Tablets), in Adult and Pediatric Subjects (4-65 Years) Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic (PGTC) Seizures.|Completed||Phase 3|154||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:48.750685|2017-10-11 05:22:48.750685
NCT00160563|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-02-12|2009-06-17||June 2004||2004-06-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)|The Prolongation of the EPAAC™ Trial - NCT00152464 (The Early Prevention of Asthma in Atopic Children). A Multi-country, Double Blind, Placebo (PLC) Controlled, Follow-up Trial With 3 Parallel Groups (LCTZ-LCTZ, LCTZ-PLC and PLC-PLC) : Evaluation of the Long Term Efficacy and Safety of Levocetirizine (LCTZ) (5 mg/ml Oral Drops -0.125 mg/kg b.w. b.i.d.) Administered for an Additional 18 Months Period in Preventing the Onset of Asthma in Children Coming From the EPAAC Trial.|Terminated||Phase 3|207|Actual|UCB Pharma||3||"The predecessor study A00309 (NCT00152464) did not show statistical significance in time to   onset of asthma between the levocetirizine and placebo groups."|f||||f||||||||||2017-10-11 05:22:48.839376|2017-10-11 05:22:48.839376
NCT00160576|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-12-05|||July 2003||2003-07-01|September 2009|2009-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias|A Therapeutic Exploratory, Single Arm, Multicenter Trial to Evaluate the Efficacy and Safety of Levetiracetam up to 4000 mg/Day (500mg Oral Tablets) on Levodopa Induced Dyskinesias in Adults With Idiopathic Parkinson's Disease|Completed||Phase 2|30||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:49.660921|2017-10-11 05:22:49.660921
NCT00160589|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-12-13|||April 2005||2005-04-01|September 2009|2009-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)|A Multicentre, Double-blind, Parallel, Randomized, Placebo-controlled Study : Evaluation of the Efficacy and Safety of Levocetirizine 5 mg and Desloratadine 5 mg Administered Orally as Capsules Once Daily, in the Morning, Over 2 Weeks in Patients Suffering From Allergic Rhinitis (AR)|Completed||Phase 4|729||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:49.737328|2017-10-11 05:22:49.737328
NCT00160602|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-09-06|||June 2005||2005-06-01|February 2010|2010-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis|A Phase III Multi-center, Double-blind, Placebo-controlled, Parallel Group 24-Week Study to Assess the Efficacy and Safety of Two Dose Regimens of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis Who Have an Incomplete Response to Methotrexate.|Completed||Phase 3|590||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:49.821997|2017-10-11 05:22:49.821997
NCT00160615|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-03-03|||September 2001||2001-09-01|September 2009|2009-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method|Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method|Completed||Phase 3|97||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:50.04513|2017-10-11 05:22:50.04513
NCT00160628|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-11-25|||March 2004||2004-03-01|February 2010|2010-02-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy|A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Levetiracetam as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy for Bridging Purpose With a Similar Study on Caucasian Epileptic Subjects|Completed||Phase 3|100||UCB Pharma|||||f||||||||||||||2017-10-11 05:22:50.124393|2017-10-11 05:22:50.124393
NCT00160641|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-04-10|2013-01-31||November 2005||2005-11-01|April 2013|2013-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Baseline Characteristics refer to the Safety Set (SS). SS consists of all enrolled subjects who received at least 1 dose of study medication.|A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis|A Phase III Multi-center, Open-label, Follow-up Study, to Assess the Safety and Efficacy of Liquid Certolizumab Pegol as Additional Medication to Methotrexate, in the Treatment of Signs and Symptoms and in the Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis Who Participated in Study CDP870-050|Completed||Phase 3|567|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:22:50.250899|2017-10-11 05:22:50.250899
NCT00160667|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-10-15|||October 2004||2004-10-01|October 2010|2010-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)|A Double Blind, Randomized, Placebo-controlled, Parallel Group Study, for the Assessment of Efficacy, Safety and Tolerability of Brivaracetam at the Doses of 200 mg/Day and 400 mg/Day, in Subjects (at Least 18 Years Old) Suffering From Post-herpetic Neuralgia (PHN)|Completed||Phase 2|152|Actual|UCB Pharma||3|||f||||f||||||||||2017-10-11 05:22:51.809595|2017-10-11 05:22:51.809595
NCT00160693|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-06-04|2012-02-15||March 2003||2003-03-01|June 2012|2012-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis|A Phase III, Multicenter, Open-Label Long-Term Study to Assess the Safety and Tolerability of CDP870 400 mg Subcutaneously Every 4 Weeks, in Subjects With Rheumatoid Arthritis|Completed||Phase 3|402|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:22:52.1272|2017-10-11 05:22:52.1272
NCT00160706|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-05-16|2013-05-16||February 2004||2004-02-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PRECiSE 4|Baseline Characteristics refer to the Safety Population, including all enrolled subjects who received at least one injection of study treatment in feeder study C87031 [NCT00152490] or C87032 [NCT00152425].|A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease|A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Re-exposure After a Variable Interval and Subsequent Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed at Weeks 0, 2 and 4 Then Every 4 Weeks), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Been Withdrawn From Studies CDP870-031 or CDP870-032 Due to an Exacerbation of Crohn's Disease.|Completed||Phase 3|310|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:22:53.523733|2017-10-11 05:22:53.523733
NCT00160719|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-10-26|||September 1999||1999-09-01|October 2012|2012-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||HLA Sensitization Following Major Cortical Allograft Bone Procedures|HLA Sensitization Following Major Cortical Allograft Bone Procedures|Completed||Phase 4|10|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 05:22:54.539721|2017-10-11 05:22:54.539721
NCT00160732|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-19|||October 2003||2003-10-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Allogenic Islet Cell Transplantation|Allogenic Islet Cells (Human, U. of Chicago) Administered Via Intraportal Infusion; and Immunosuppressive Therapy|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|University of Chicago||1|||f||||f||||||||||2017-10-11 05:22:54.616951|2017-10-11 05:22:54.616951
NCT00160745|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2013-01-18||||||January 2013|2013-01-01|September 2006||2006-09-01|||||Interventional|||Rosuvastatin and Renal Endothelial Function|A Randomised, Double-blind, Placebo-controlled, Mono-centre, Explorative Phase II Trial to Study the Effects of Rosuvastatin on Basal Production and Release of Nitric Oxide From the Renal Vasculature in Patients With Hypercholesterolemia.|Completed||Phase 2|46||University of Erlangen-Nürnberg Medical School|||||f||||||||||||||2017-10-11 05:22:54.728484|2017-10-11 05:22:54.728484
NCT00160758|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-10-26|||December 1999||1999-12-01|October 2012|2012-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Physical Characteristics of Retrieved Massive Allografts|Physical Characteristics of Retrieved Massive Allografts|Completed||Phase 4|18|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 05:22:54.827277|2017-10-11 05:22:54.827277
NCT00160771|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-08-15|||January 2005||2005-01-01|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Biomechanics/Motion Analysis Laboratory Data Bank|University of Florida Biomechanics/Motion Analysis Laboratory Data Bank|Recruiting||N/A|10000|Anticipated|University of Florida|||1||f||||f||||||||||2017-10-11 05:22:54.903534|2017-10-11 05:22:54.903534
NCT00160784|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-12-04|||March 1997||1997-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Arthroscopy and Manipulation vs a Home Therapy Program in the Treatment of Adhesive Capsulitis|Arthroscopy and Manipulation vs a Home Therapy Program in the Treatment of Adhesive Capsulitis of the Shoulder - A Prospective Randomized Study|Completed||Phase 4|58|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 05:22:54.994167|2017-10-11 05:22:54.994167
NCT00160797|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-04-30|||August 2005||2005-08-01|April 2012|2012-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Total Knee Arthroplasty Outcome Study|MIS™ Minimally Invasive Solutions™ Total Knee Arthroplasty Outcome Study #02-800|Withdrawn||Phase 4|0|Actual|University of Florida||||10/2005 PI assigned duties as trauma physician in addition other duties|f||||||||||||||2017-10-11 05:22:55.121014|2017-10-11 05:22:55.121014
NCT00160810|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-05-17|||April 2001||2001-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|October 2010|Actual|2010-10-01||Observational|||Outcome Study of Complex Distal Radius Fractures|Outcome Study of Complex Distal Radius Fractures: Open Reduction Internal Fixation (ORIF) With A Volar Fixed Angled Plate Versus A Distal Radius Volar (DRV) Plate Versus External Fixation|Completed||Phase 4|74|Actual|University of Florida|||1||f||||f||||||||||2017-10-11 05:22:55.189071|2017-10-11 05:22:55.189071
NCT00160823|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-11|||September 2005||2005-09-01|September 2006|2006-09-01||||||||Interventional|||Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients|Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital|Unknown status|Recruiting|Phase 3|102||University Hospital, Geneva|||||f||||||||||||||2017-10-11 05:22:55.260064|2017-10-11 05:22:55.260064
NCT00160836|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-04-18|||October 2004||2004-10-01|April 2007|2007-04-01||||||||Interventional|||Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter|Biliary Tissue Sampling Using a Cytology Brush or the G.I.U.M. Catheter: a Prospective Randomized Controlled Study.|Unknown status|Recruiting|Phase 1|68||University Hospital, Geneva|||||f||||||||||||||2017-10-11 05:22:55.355907|2017-10-11 05:22:55.355907
NCT00160849|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-10-19|||August 2004||2004-08-01|July 2005|2005-07-01|March 2007||2007-03-01|||||Interventional|||Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression|Study on the Feasibility of Antiretroviral Therapy With a Single Agent - Lopinavir/r - in Patients Treated With HAART and With Viral Load Below 80 Copies/Ml|Completed||Phase 4|60||Universidade Federal do Rio de Janeiro|||||f||||||||||||||2017-10-11 05:22:55.452473|2017-10-11 05:22:55.452473
NCT00160862|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-09|||May 2003||2003-05-01|September 2005|2005-09-01|November 2003||2003-11-01|||||Interventional|||NK-1 Antagonism of SLV317 in Humans|A Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Effect of a Single Oral Dose of SLV 317 on Substance P-Induced Venodilation in the Hand Vein of Healthy Male Volunteers|Completed||Phase 1|18||Heidelberg University|||||f||||||||||||||2017-10-11 05:22:55.52612|2017-10-11 05:22:55.52612
NCT00160875|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-05-03|||April 2009||2009-04-01|May 2017|2017-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer|A Phase II Study to Assess the Efficacy of Combined Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy (External Beam, Brachytherapy), Plus Surgery for Potentially Resectable Thoracic Esophageal Cancer|Completed||Phase 2/Phase 3|54|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 05:22:55.604319|2017-10-11 05:22:55.604319
NCT00160888|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-09|||November 1999||1999-11-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Vasoreactivity in Carriers of Genetic Polymorphisms|Endothelium-Dependent Vasoreactivity in Nitric Oxide Synthase Gene (Glu298Asp) Polymorphism: Studies in Healthy Volunteers|Unknown status|Recruiting|Phase 1|100||Heidelberg University|||||f||||||||||||||2017-10-11 05:22:55.714363|2017-10-11 05:22:55.714363
NCT00160901|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-04-18|||August 2003||2003-08-01|March 2007|2007-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer|Prospective Randomized Trial With Complementary Therapies During Chemotherapy at the Women's Hospital of the University of Heidelberg|Completed||Phase 4|150||Heidelberg University|||||f||||f||||||||||2017-10-11 05:22:55.803445|2017-10-11 05:22:55.803445
NCT00160914|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-04-06|||December 2001||2001-12-01|April 2016|2016-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Childhood Obesity: Variations in Management|Childhood Obesity: Variations in Management|Completed||N/A|500|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 05:22:55.901877|2017-10-11 05:22:55.901877
NCT00160927|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-03-16|||January 2003||2003-01-01|March 2007|2007-03-01|January 2008|Anticipated|2008-01-01|||||Observational|||Microvascular Response in Diabetes Mellitus|Microcirculation cutanée et Vasodilatation Induite Par la Pression Non-Nociceptive Chez Les diabètiques|Unknown status|Recruiting|N/A|90||University Hospital, Angers|||||f||||f||||||||||2017-10-11 05:22:55.980382|2017-10-11 05:22:55.980382
NCT00160940|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-11-29|||February 2002||2002-02-01|September 2005|2005-09-01||||||||Observational|||Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis|Differential Gene Expression in Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis With or Without a Complicating Hepatoma or Autoimmune Liver Disease|Unknown status|Recruiting|N/A|200||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:22:56.088683|2017-10-11 05:22:56.088683
NCT00160953|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-08-10|||February 2005||2005-02-01|August 2010|2010-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Endorectal Coil Magnetic Resonance Images (ERC-MRI)|Development of a Prostate Deformation Model to Enable Accurate Registration of Endorectal Coil Magnetic Resonance Images (ERC-MRI) to Reference Treatment Planning CT Images|Completed||Phase 2|20||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:22:56.201762|2017-10-11 05:22:56.201762
NCT00160966|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-03-27|||September 2004||2004-09-01|January 2017|2017-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy|Prospective Randomized Study to Characterize Risk Factors of Polyomavirus-related Transplant Nephropathy and the Impact of Three Immunosuppressive Regimens on Nephropathy Incidence|Completed||Phase 4|108|Actual|University of Giessen||3|||f||||t||||||||Yes|De-identified data of all participants will be made available within 1 year of study completion.|2017-10-11 05:22:56.268905|2017-10-11 05:22:56.268905
NCT00160979|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-09-21|||January 2001||2001-01-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Transrectal Tumour Oxygen - US Army|A Study of Transrectal Tumour Oxygen Measurements in Patients With Clinically Localized Prostate Cancer|Active, not recruiting||Phase 2|195|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:22:56.382909|2017-10-11 05:22:56.382909
NCT00160992|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||July 2004||2004-07-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients|Phase I Study of in Vivo Expansion of Melan-A/MART-1 Antigen-Specific CD8 T Lymphocytes Following Transient Immunosuppression in Patients With Advanced Melanoma|Suspended||Phase 1|6||University of Lausanne Hospitals|||||f||||||||||||||2017-10-11 05:22:56.468802|2017-10-11 05:22:56.468802
NCT00161018|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-03-04|||November 2003||2003-11-01|March 2015|2015-03-01|November 2004|Actual|2004-11-01|||||Interventional|||New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia||Completed||Phase 3|150||University of Maryland|||||f||||||||||||||2017-10-11 05:22:56.789152|2017-10-11 05:22:56.789152
NCT00161031|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-03-04|||April 2004||2004-04-01|March 2015|2015-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia|Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia|Completed||N/A|30|Anticipated|University of Maryland|||||f||||||||||||||2017-10-11 05:22:56.871469|2017-10-11 05:22:56.871469
NCT00161044|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-03-04|||September 2004||2004-09-01|March 2015|2015-03-01|September 2005||2005-09-01|||||Interventional|||An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms|An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms|Completed||N/A|20||University of Maryland|||||f||||||||||||||2017-10-11 05:22:56.958729|2017-10-11 05:22:56.958729
NCT00161070|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-03-21|||July 1997||1997-07-01|March 2007|2007-03-01|December 2006|Actual|2006-12-01|||||Interventional|||ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial|ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial|Completed||Phase 4|4500||UMC Utrecht|||||f||||||||||||||2017-10-11 05:22:57.154888|2017-10-11 05:22:57.154888
NCT00161083|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-07-26|||November 2001||2001-11-01|September 2005|2005-09-01|November 2004||2004-11-01|||||Interventional|||UDCA for Symptomatic Gallstone Disease|Studie Naar De Effectiviteit Van Ursodeoxycholzuur Ter Preventie Van Galsteen-Gerelateerde Klachten Bij patiënten in Afwachting Van Een Cholecystectomie|Completed||Phase 4|180||UMC Utrecht|||||f||||||||||||||2017-10-11 05:22:57.318465|2017-10-11 05:22:57.318465
NCT00161096|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-02-01|||March 2004||2004-03-01|November 2004|2004-11-01|September 2005||2005-09-01|||||Interventional|||On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication|Comparison of the Percentage Chronic on-Demand Users Treated With 20 Mg Pantoprazole on-Demand and Placebo o.d Versus Placebo on-Demand and 20 Mg Pantoprazole o.d. After Symptom Relief With 20 Mg Pantoprazole o.d.|Unknown status|Active, not recruiting|Phase 3|276||UMC Utrecht|||||f||||||||||||||2017-10-11 05:22:57.438918|2017-10-11 05:22:57.438918
NCT00161109|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-12|||October 2002||2002-10-01|October 2004|2004-10-01|October 2012||2012-10-01|||||Observational|||Genetics and Psychopathology in the 22q11 Deletion Syndrome|Genetics and Psychopathology in the 22q11 Deletion Syndrome|Unknown status|Recruiting|N/A|175||UMC Utrecht|||||f||||||||||||||2017-10-11 05:22:57.544177|2017-10-11 05:22:57.544177
NCT00161122|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-02-13|||September 2003||2003-09-01|July 2005|2005-07-01|June 2006||2006-06-01|||||Interventional|||Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)|Effectiveness and Costs of Combined Influenza and Pneumococcal Vaccination in Pre-School Children With Recurrent Respiratory Tract Infections (RTI): a General Practice-Based Randomized Controlled Trial|Completed||Phase 4|660||UMC Utrecht|||||f||||||||||||||2017-10-11 05:22:57.657904|2017-10-11 05:22:57.657904
NCT00161135|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-04-19|||January 1999||1999-01-01|April 2007|2007-04-01||||||||Observational|||Magnetic Resonance Imaging in Children and Adolescents With Autism and Multiple Complex Developmental Disorders|Magnetic Resonance Imaging in Children and Adolescents With Autism and Multiple Complex Developmental Disorders|Completed||N/A|150||UMC Utrecht|||||f||||f||||||||||2017-10-11 05:22:57.757371|2017-10-11 05:22:57.757371
NCT00161148|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-01-08|||January 2005||2005-01-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Probiotics in Patients With Primary Sclerosing Cholangitis|Probiotics in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease- a Randomized Placebo-Controlled Cross-Over Trial|Unknown status|Recruiting|Phase 3|12||UMC Utrecht|||||f||||||||||||||2017-10-11 05:22:57.836461|2017-10-11 05:22:57.836461
NCT00161161|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-12-29|||October 1999||1999-10-01|September 2005|2005-09-01|December 2002||2002-12-01|||||Observational|||Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder|Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder|Completed||N/A|90||UMC Utrecht|||||f||||||||||||||2017-10-11 05:22:57.948194|2017-10-11 05:22:57.948194
NCT00161174|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-04-28|||July 2005||2005-07-01|April 2015|2015-04-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Observational|||Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity|Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity. (KWF RUG 2004-3157)|Completed||N/A|173|Actual|University Medical Center Groningen|||1||f||||||||||Samples With DNA|"     For cured patients with complete data on cardiovascular risk factors and presence of     subclinical cardiovascular damage only DNA will be collected.   "|||2017-10-11 05:22:58.025527|2017-10-11 05:22:58.025527
NCT00161187|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-11-05|||May 2001||2001-05-01|September 2013|2013-09-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor|A Pilot Study of Irradiated HLA-Partially Matched Allogeneic Related Donor Lymphocytes for Patients With Selected Malignancies|Completed||Phase 1|37|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-11 05:22:58.152882|2017-10-11 05:22:58.152882
NCT00161200|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-12-10|||December 2002||2002-12-01|December 2009|2009-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor|Studies of Esophageal Metaplasia Using a Novel Antibody: Reversibility of Columnar Metaplasia by Proton Pump Inhibitor|Terminated||Phase 3|60||Rutgers, The State University of New Jersey||||slow accrual|||||||||||||||2017-10-11 05:22:58.344863|2017-10-11 05:22:58.344863
NCT00161213|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-11-21|2012-11-21||September 2005||2005-09-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer|Phase II Study of Imatinib Mesylate and Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer|Completed||Phase 2|44|Actual|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-10-11 05:22:58.440239|2017-10-11 05:22:58.440239
NCT00161226|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-12-10|||February 2004||2004-02-01|December 2009|2009-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35|A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35|Terminated||Phase 2|44|Anticipated|Rutgers, The State University of New Jersey|||1|Principal investigator left institution|f||||||||||||||2017-10-11 05:22:58.791052|2017-10-11 05:22:58.791052
NCT00161239|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-12-10|||February 2005||2005-02-01|December 2009|2009-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma|LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma|Terminated||N/A|64|Anticipated|Rutgers, The State University of New Jersey||||toxicity|f||||||||||||||2017-10-11 05:22:58.857462|2017-10-11 05:22:58.857462
NCT00161252|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-27|||March 2005||2005-03-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Observational|||Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly|Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly Men|Withdrawn||N/A|0|Actual|Rutgers, The State University of New Jersey|||1||f||||||||||||||2017-10-11 05:22:58.932305|2017-10-11 05:22:58.932305
NCT00161265|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-07-28|||May 2005||2005-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|August 2012|Actual|2012-08-01||Observational|||Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer|UMCC 2004.064: Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer|Completed||N/A|68|Actual|University of Michigan Cancer Center|||1||f||||t||||||Samples Without DNA|"     tissue   "|Undecided||2017-10-11 05:22:58.988462|2017-10-11 05:22:58.988462
NCT00161278|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-07-28|||December 2004||2004-12-01|July 2008|2008-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling|Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer Through Gene Expression Profiling.|Terminated||Phase 2|1|Actual|University of Michigan Cancer Center||||recruitment has ended|f||||t||||||||||2017-10-11 05:22:59.055802|2017-10-11 05:22:59.055802
NCT00161291|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-12-30|||June 2005||2005-06-01|December 2010|2010-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer|A Phase II Open Label Trial of Pre-Operative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer|Completed||Phase 2|28|Actual|University of Alabama at Birmingham|||||f||||t||||||||||2017-10-11 05:22:59.135129|2017-10-11 05:22:59.135129
NCT00161304|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-11|||April 2003||2003-04-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Interventional|||Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency|Effects of Testosterone Administration on Tissues of Men With A.D.A.M. (Androgen Deficiency of Aging Men)|Completed||Phase 2/Phase 3|44||Urological Sciences Research Foundation|||||f||||||||||||||2017-10-11 05:22:59.205835|2017-10-11 05:22:59.205835
NCT00161317|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-01-05|||December 2003||2003-12-01|January 2016|2016-01-01|February 2006||2006-02-01|||||Interventional|||Evaluation of a Living With Hope Program|Development, Implementation and Evaluation of a Psychosocial Supportive Hope Focused Program for Patients With Advanced Cancer|Completed||N/A|60||University of Saskatchewan|||||f||||||||||||||2017-10-11 05:22:59.258282|2017-10-11 05:22:59.258282
NCT00161330|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||June 2000||2000-06-01|July 2004|2004-07-01|July 2005||2005-07-01|||||Interventional|||Oral Vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT|A Multicenter Randomized Controlled Trial of Antibiotic Treatment in Children With Urinary Tract Infections: Oral Amoxicillin/Clavulanic Acid Vs Initial Iv Ceftriaxone.|Terminated||Phase 3|440||University of Padova|||||f||||||||||||||2017-10-11 05:22:59.309347|2017-10-11 05:22:59.309347
NCT00161343|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-09-04|||December 2004||2004-12-01|April 2009|2009-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Maintaining HIV Prevention Gains in Female Adolescents|Randomized Controlled Trial of an Group Intervention to Maintain HIV Prevention Gains in Female Adolescents|Completed||Phase 2|640|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 05:22:59.39155|2017-10-11 05:22:59.39155
NCT00161356|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-06-20|||September 2005||2005-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Ambisome in Liver Transplant Patients|Blood, Bile and Tissue Pharmacokinetics of Single Dose Liposomal Amphotericin B (AmBisome ®) in Liver Transplant Patients.|Terminated||Phase 4|10|Actual|The University of Texas Health Science Center, Houston||1||Budget issues|f||||f||||||||||2017-10-11 05:22:59.490401|2017-10-11 05:22:59.490401
NCT00161369|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-10-19|||April 2000||2000-04-01|October 2005|2005-10-01|March 2005||2005-03-01|||||Observational|||Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients|Contribution of Homocysteine and Asymmetric Dimethylarginine to Atherosclerosis and Cardiovascular Events in Maintenance Hemodialysis Patients|Completed||N/A|200||University of Shizuoka|||||f||||||||||||||2017-10-11 05:22:59.553552|2017-10-11 05:22:59.553552
NCT00161382|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-06-23|2014-05-21||September 2002||2002-09-01|June 2014|2014-06-01|July 2008|Actual|2008-07-01|March 2007|Actual|2007-03-01||Interventional|||Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students|HIV Prevention Programs for Middle School Students|Completed||N/A|3007|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 05:22:59.624185|2017-10-11 05:22:59.624185
NCT00161395|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-14|||January 2003||2003-01-01|September 2005|2005-09-01|March 2007|Actual|2007-03-01|August 2006|Actual|2006-08-01||Interventional|||Study of Time to Pregnancy in Normal Fertility|Randomized Trial of Fertility Awareness and Time to Pregnancy in Couples of Normal Fertility|Completed||Phase 2|143|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 05:22:59.902218|2017-10-11 05:22:59.902218
NCT00161408|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||December 2000||2000-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Psychological Intervention for Relapse Prevention in First Episode Schizophrenia|Psychological Intervention for Relapse Prevention in First Episode Schizophrenia|Unknown status|Active, not recruiting|N/A|106||University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:22:59.982635|2017-10-11 05:22:59.982635
NCT00161421|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-09-18|||March 2005||2005-03-01|September 2008|2008-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone|Oral Androgens in Man-3: Pharmacokinetics of Oral Testosterone With Concomitant Inhibition of 5α-Reductase by Dutasteride Short Title: ORAL T-3|Completed||Phase 2|18|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 05:23:00.077493|2017-10-11 05:23:00.077493
NCT00161434|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-12-29|||March 2003||2003-03-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons|A Randomized, Double-Blind, Placebo Controlled Crossover Trial Using Valacyclovir to Suppress HSV and HIV Shedding in HIV-1, HSV-2 Coinfected Persons|Completed||Phase 4|60|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:23:00.210858|2017-10-11 05:23:00.210858
NCT00161447|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-09-18|||May 2004||2004-05-01|September 2008|2008-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|ACY-5||Male Hormonal Contraceptive Development-ACY-5|Male Hormonal Contraceptive Development: Suppression of Spermatogenesis With the Addition of a Potent Antagonist (Acyline) to Testosterone and DMPA (ACY-5)|Completed||Phase 1/Phase 2|43|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:23:00.30865|2017-10-11 05:23:00.30865
NCT00161460|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-05-11|||June 2005||2005-06-01|May 2016|2016-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Colorectal Cancer Screening Intervention in UWPN Clinics|Colorectal Cancer Screening Intervention in UWPN Clinics|Completed||N/A|80|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:23:00.444566|2017-10-11 05:23:00.444566
NCT00161473|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-06-26|2012-02-24||January 2001||2001-01-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Alzheimer's in Long-Term Care--Treatment for Agitation|Alzheimer's in Long-Term Care--Treatment for Agitation|Completed||N/A|24|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 05:23:00.551409|2017-10-11 05:23:00.551409
NCT00161486|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-09-18|||July 2004||2004-07-01|September 2008|2008-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|ACYP-1||The Effects of Testosterone on Prostate Tissue (ACYP-1)|The Effects of Testosterone on Prostate Tissue in Normal Men (ACYP-1)|Completed||Phase 1|13|Actual|University of Washington||3|||f||||f||||||||||2017-10-11 05:23:02.679871|2017-10-11 05:23:02.679871
NCT00161525|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-01-03|||October 2003||2003-10-01|January 2011|2011-01-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon Gases|Perfluorocarbon Gases for the Repair of Retinal Detachments.|Unknown status|Recruiting|Phase 2|25|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 05:23:02.783894|2017-10-11 05:23:02.783894
NCT00161538|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-10-19|||July 2000||2000-07-01|October 2006|2006-10-01|June 2006||2006-06-01|||||Interventional|||Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation|A Randomized, Prospective Multicenter Study to Examine the Optimal Position of the Atrial Leads for Therapy of the Sinus Node Syndrome|Completed||Phase 4|456||Medtronic BRC|||||f||||||||||||||2017-10-11 05:23:02.882528|2017-10-11 05:23:02.882528
NCT00161551|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-01|||November 2004||2004-11-01|October 2006|2006-10-01|December 2010||2010-12-01|||||Interventional|||Mode Evaluation in Sick Sinus Syndrome Trial (MODEST)|A Randomized, Prospective Multicenter Study to Determine the Incidence of Atrial Fibrillation and Heart Failure in Correlation to Stimulation Modes of Pacemakers|Unknown status|Recruiting|Phase 4|402|Anticipated|Medtronic BRC|||||f||||||||||||||2017-10-11 05:23:03.004974|2017-10-11 05:23:03.004974
NCT00161564|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-05-15|||February 2004||2004-02-01|May 2008|2008-05-01||||||||Interventional|||A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone|A Randomized Trial Comparing Higher Doses of Rituximab (Rituxan) With Standard Doses of Rituxan in Combination With CVP (Cyclophosphamide, Vincristine,and Prednisone) in Subjects With Chronic ITP Who Have Failed/Relapsed After Rituxan Treatment|Withdrawn||Phase 2|||Weill Medical College of Cornell University|||||||||||||||||||2017-10-11 05:23:03.169409|2017-10-11 05:23:03.169409
NCT00161577|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-05-12|||January 2004||2004-01-01|May 2009|2009-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery|Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Ketorolac in the Management of Post-Operative Pain After Heart Surgery|Completed||Phase 4|25|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 05:23:03.267771|2017-10-11 05:23:03.267771
NCT00161590|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-10-21|||July 2004||2004-07-01|October 2008|2008-10-01||||||||Interventional|||Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma|Phase I Study of CHOP Plus Campath (C-CHOP) for the Treatment of T-Cell, Null-Cell, and NK-Cell Lymphomas|Completed||Phase 1|||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:23:03.361979|2017-10-11 05:23:03.361979
NCT00161603|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-04-01|||April 2003||2003-04-01|April 2008|2008-04-01|September 2003||2003-09-01|||||Observational|||Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study|Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study|Completed||N/A|18||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:23:03.424577|2017-10-11 05:23:03.424577
NCT00161616|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-07-31|2009-07-31||September 2003||2003-09-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating InductOs in Diaphyseal Tibia Fractures|A Prospective, Randomized, Controlled, Stratified Study of InductOs in Subjects With Open Diaphyseal Tibia Fractures Treated With Reamed Locked Intramedullary Nail Fixation|Completed||Phase 4|277|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-10-11 05:23:03.51215|2017-10-11 05:23:03.51215
NCT00161629|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2007-12-03|||September 2005||2005-09-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures|A Phase 1 Dose-Escalating, Double-Blind, Placebo-Controlled, Multicenter, Safety and Feasibility Study of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)/Calcium Phosphate Matrix (CPM) as an Adjuvant Therapy for Closed Distal Radius Fractures|Completed||Phase 1|40|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:23:04.698445|2017-10-11 05:23:04.698445
NCT00161642|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-09-09|||November 2004||2004-11-01|September 2009|2009-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study Evaluating CMD-193 in Advanced Malignant Solid Tumors|A Phase 1 Dose Escalation Study of CMD-193 in Subjects With Advanced Malignant Tumors.|Completed||Phase 1|54|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:23:04.838852|2017-10-11 05:23:04.838852
NCT00161655|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-09-25|||April 2005||2005-04-01|September 2009|2009-09-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis|A Multicenter, Open-label, Randomized, Pilot-study to Evaluate the Efficacy and Safety of the Combination of Etanercept (ETN) and Methotrexate and of Etanercept (ETN) Alone in Patients With Plaque Psoriasis Despite Methotrexate Therapy|Completed||Phase 4|60||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:23:04.926342|2017-10-11 05:23:04.926342
NCT00161668|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-03-14|||October 2001||2001-10-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care|Prospective Observational Study of Mylotarg (Gemtuzumab Ozogamicin) in Usual Care|Completed||Phase 4|500||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:23:05.054848|2017-10-11 05:23:05.054848
NCT00161681|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-02-07|||July 2005||2005-07-01|May 2007|2007-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Levonorgestrel 90 Mcg and Ethinyl Estradiol 20 Mcg in a Continuous Daily Regimen on Menstrual Cycle-Related Symptoms|Completed||Phase 3|200||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:23:05.28381|2017-10-11 05:23:05.28381
NCT00161694|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-06-02|||July 2005||2005-07-01|June 2008|2008-06-01||||||||Interventional|||Use of Sucrose to Relieve Pain During Eye Exams in Infants|Effectiveness of an Oral Sucrose Solution in Reducing Pain and Anxiety Associated With Neonatal Ophthalmologic Examination|Terminated||N/A|300|Anticipated|Weill Medical College of Cornell University||||results did not show intervention was beneficial|f||||||||||||||2017-10-11 05:23:05.785451|2017-10-11 05:23:05.785451
NCT00161707|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||January 2003||2003-01-01|October 2006|2006-10-01|October 2003||2003-10-01|||||Interventional|||Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency|Phase I Safety Investigation of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency|Completed||Phase 1/Phase 2|||Baxalta US Inc.|||||||||||||||||||2017-10-11 05:23:05.882693|2017-10-11 05:23:05.882693
NCT00161720|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||June 2005||2005-06-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Observational|||Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND|A Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND|Completed||Phase 4|||Baxalta US Inc.|||||||||||||||||||2017-10-11 05:23:05.972907|2017-10-11 05:23:05.972907
NCT00161733|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-04-04|||September 2002||2002-09-01|April 2017|2017-04-01|November 2004||2004-11-01|||||Interventional|||Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery|Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery|Completed||Phase 3|||Baxter Healthcare Corporation|||||||||||||||||||2017-10-11 05:23:06.083557|2017-10-11 05:23:06.083557
NCT00161746|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||April 1998||1998-04-01|May 2015|2015-05-01|June 1999||1999-06-01|||||Interventional|||Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years|Multicentre Randomized Double-Blind Phase II/III Study on the Safety and Immunogenicity of Three Vaccinations With TICOVAC in Two Dosages in Healthy Children Aged Between Six Months and Three Years|Completed||Phase 2/Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 05:23:06.218608|2017-10-11 05:23:06.218608
NCT00161759|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-19|||March 2002||2002-03-01|October 2006|2006-10-01|January 2004||2004-01-01|||||Interventional|||Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds|A Study to Assess the Safety and Efficacy of Fibrin Sealant (FS 4IU) for Wound Healing in Subjects With Burn Wounds Requiring Skin Grafting Procedures|Completed||Phase 1/Phase 2|40||Baxter Healthcare Corporation|||||||||||||||||||2017-10-11 05:23:06.349431|2017-10-11 05:23:06.349431
NCT00161772|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||March 2002||2002-03-01|May 2015|2015-05-01|August 2002||2002-08-01|||||Interventional|||Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.|Double-blind, Randomized, Multicenter Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.|Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-10-11 05:23:06.469991|2017-10-11 05:23:06.469991
NCT00161785|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||June 2004||2004-06-01|May 2015|2015-05-01|July 2005||2005-07-01|||||Interventional|||Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years||Completed||Phase 4|340||Pfizer|||||f||||||||||||||2017-10-11 05:23:06.618734|2017-10-11 05:23:06.618734
NCT00161798|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||September 2001||2001-09-01|May 2015|2015-05-01|March 2002||2002-03-01|||||Interventional|||Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.|Double-blind, Randomized, Multicenter Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.|Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-10-11 05:23:06.688092|2017-10-11 05:23:06.688092
NCT00161811|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-10-07|||November 2004||2004-11-01|October 2006|2006-10-01|July 2005||2005-07-01|||||Interventional|||Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005|Single-blind Randomized Controlled Phase II/III Study to Investigate the Immunogenicity and Safety After a Single Vaccination With Three Different Lots of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell-derived) in Comparison to a Licensed Egg Derived Influenza Vaccine for Season 2004/2005.|Completed||Phase 2/Phase 3|1400||Nanotherapeutics, Inc.|||||f||||||||||||||2017-10-11 05:23:06.794732|2017-10-11 05:23:06.794732
NCT00161824|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||October 2001||2001-10-01|May 2015|2015-05-01|January 2002||2002-01-01|||||Interventional|||Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR|Single-blind, Randomized, Multicenter Comparison of FSME IMMUN NEW and ENCEPUR: Safety and Tolerability of Two Vaccinations in Healthy Volunteers Aged 16 to 65 Years.|Completed||Phase 3|3800||Pfizer|||||f||||||||||||||2017-10-11 05:23:06.914697|2017-10-11 05:23:06.914697
NCT00161837|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-10-07|||December 2003||2003-12-01|October 2006|2006-10-01|July 2004||2004-07-01|||||Interventional|||Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004|Single-blind Randomized Controlled Phase II/III Study to Investigate the Immunogenicity and Safety of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived) in Comparison to a Licensed Egg-derived Influenza Vaccine for Season 2003/2004|Completed||Phase 2/Phase 3|||Nanotherapeutics, Inc.|||||f||||||||||||||2017-10-11 05:23:07.015695|2017-10-11 05:23:07.015695
NCT00161850|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||February 2002||2002-02-01|May 2015|2015-05-01|August 2002||2002-08-01|||||Interventional|||FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years|Follow-up Study to Investigate the Safety and Immunogenicity of a Third Vaccination With Three Different Antigen Concentrations of FSME IMMUN NEW in Children Aged 1 to 6 Years|Completed||Phase 2|615||Pfizer|||||f||||||||||||||2017-10-11 05:23:07.085463|2017-10-11 05:23:07.085463
NCT00161863|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||September 2002||2002-09-01|May 2015|2015-05-01|January 2003||2003-01-01|||||Interventional|||Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years|Open-label Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 05:23:07.205835|2017-10-11 05:23:07.205835
NCT00161876|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||May 2002||2002-05-01|May 2015|2015-05-01|August 2002||2002-08-01|||||Interventional|||FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years|Open-label, Multicenter, Follow-up Phase III Study to Investigate the Safety of the Third Vaccination of FSME-IMMUN NEW in Volunteers Aged 16 to 66 Years|Completed||Phase 3|3973||Pfizer|||||f||||||||||||||2017-10-11 05:23:07.277368|2017-10-11 05:23:07.277368
NCT00161889|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||February 2002||2002-02-01|May 2015|2015-05-01|August 2002||2002-08-01|||||Interventional|||FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years|Follow-up Study to Investigate the Safety and Immunogenicity of a Third Vaccination With Three Different Antigen Concentrations of FSME IMMUN NEW in Children Aged 6 to 16 Years|Completed||Phase 2|615||Pfizer|||||f||||||||||||||2017-10-11 05:23:07.359838|2017-10-11 05:23:07.359838
NCT00161902|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-20|||August 2001||2001-08-01|October 2006|2006-10-01|March 2003||2003-03-01|||||Interventional|||Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement|A Randomized, Controlled, Multicenter Study to Evaluate Efficacy and Safety of Fibrin Sealant VH S/D for Hemostasis in Subjects Undergoing Total Hip Replacement|Completed||Phase 3|||Baxter Healthcare Corporation|||||f||||||||||||||2017-10-11 05:23:07.47931|2017-10-11 05:23:07.47931
NCT00161915|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-20|||December 2000||2000-12-01|October 2006|2006-10-01|January 2004||2004-01-01|||||Interventional|||Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal Varices|Prospective Randomized Study on the Efficacy of Endoscopic Injection Therapy With Fibrin Sealant Versus Endoscopic Ligature for Acute Hemostasis and the Prophylaxis of Recurrent Bleeding From Esophageal Varices|Completed||Phase 3|||Baxter Healthcare Corporation|||||f||||||||||||||2017-10-11 05:23:07.569516|2017-10-11 05:23:07.569516
NCT00161928|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||April 2002||2002-04-01|May 2015|2015-05-01|January 2003||2003-01-01|||||Interventional|||Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants|A Randomized, Open-Label Trial of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants|Completed||Phase 3|330||Pfizer|||||f||||||||||||||2017-10-11 05:23:07.769709|2017-10-11 05:23:07.769709
NCT00161941|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||June 2003||2003-06-01|May 2015|2015-05-01|December 2003||2003-12-01|||||Observational|||Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216|Open-label Multicenter Phase 3B Follow-up Study to Investigate the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens One Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in the NeisVac-C Non-interference Study 216|Completed||N/A|321||Pfizer|||||f||||||||||||||2017-10-11 05:23:07.857285|2017-10-11 05:23:07.857285
NCT00161954|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||March 2004||2004-03-01|May 2015|2015-05-01|May 2004||2004-05-01|||||Interventional|||Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years|Open Phase IV Clinical Study to Evaluate the Immunogenicity and Safety of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years|Completed||Phase 4|||Pfizer|||||f||||||||||||||2017-10-11 05:23:07.932719|2017-10-11 05:23:07.932719
NCT00161967|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||May 2005||2005-05-01|May 2015|2015-05-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|||TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)|Open-label Follow-up Study to Investigate the Seropersistence of TBE Antibodies and the Booster Response to a Tick-borne Encephalitis Vaccine in Children and Adolescents Aged 3 - 18 Years|Completed||Phase 4|375|Anticipated|Pfizer||1|||f||||t||||||||||2017-10-11 05:23:07.997704|2017-10-11 05:23:07.997704
NCT00161980|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-20|||June 2001||2001-06-01|October 2006|2006-10-01|December 2002||2002-12-01|||||Interventional|||Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites|A Randomized and Controlled Clinical Study to Evaluate the Efficacy and Safety of Fibrin Sealant VH S/D (FS VH S/D) in Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites|Completed||Phase 3|||Baxter Healthcare Corporation|||||f||||||||||||||2017-10-11 05:23:08.092127|2017-10-11 05:23:08.092127
NCT00161993|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||June 2002||2002-06-01|October 2006|2006-10-01|September 2003||2003-09-01|||||Interventional|||Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)|Prospective Open-Label Study of Pharmacokinetics, Efficacy and Safety of Immune Globulin Intravenous (Human), 10% TVR Solution in Patients With Hypo- or Agammaglobulinemia|Completed||Phase 2|||Baxalta US Inc.|||||f||||||||||||||2017-10-11 05:23:08.181406|2017-10-11 05:23:08.181406
NCT00162006|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||January 2003||2003-01-01|October 2006|2006-10-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura|Prospective Open-Label Study of the Efficacy and Safety of Immune Globulin Intravenous (Human), 10% TVR Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura|Completed||Phase 2|28|Actual|Baxalta US Inc.|||||f||||||||||||||2017-10-11 05:23:08.27208|2017-10-11 05:23:08.27208
NCT00162019|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||March 2003||2003-03-01|April 2008|2008-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients|Phase 3, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of IMMUNATE Solvent Detergent (IMMUNATE SD) in Previously Treated Patients With Severe or Moderately Severe Hemophilia A|Completed||Phase 3|56|Actual|Baxalta US Inc.|||||f||||t||||||||||2017-10-11 05:23:08.373249|2017-10-11 05:23:08.373249
NCT00162032|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-10-08|2013-04-30||August 2005||2005-08-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease|A Phase III, Open-Label, Non-Randomized, International, Multicenter Trial to Evaluate the Efficacy and Safety of CARDIOLITE® Myocardial Perfusion Imaging in Pediatric Subjects With Kawasaki Disease|Completed||Phase 3|445|Actual|Lantheus Medical Imaging||2|||f||||f||||||||||2017-10-11 05:23:08.476101|2017-10-11 05:23:08.476101
NCT00162045|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-06-01|||January 2005||2005-01-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects|A Phase I-II, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of Technetium Tc99m Sestamibi in Pediatric Subjects|Completed||Phase 1/Phase 2|79|Actual|Lantheus Medical Imaging||1|||f||||f||||||||||2017-10-11 05:23:08.96055|2017-10-11 05:23:08.96055
NCT00162058|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-17|||March 2004||2004-03-01|August 2011|2011-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Phase II Study of DMP 115 to Assess Focal Liver Lesions|An Open-Label, Non-Randomized, Phase II Trial To Assess Focal Liver Lesion Detection Using Definity-Enhanced Ultrasound Imaging|Completed||Phase 2|80||Lantheus Medical Imaging|||||f||||||||||||||2017-10-11 05:23:09.055064|2017-10-11 05:23:09.055064
NCT00162071|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-31|||July 2005||2005-07-01|January 2017|2017-01-01||||March 2006|Actual|2006-03-01||Interventional|||A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging|"A Phase II Open-Label, Non-Randomized, Single-Center Trial to Determine the Optimal Myocardial Perfusion Image Acquisition Time Following BMS068645 Administration"|Terminated||Phase 2|20||Forest Laboratories||||Sponsor decided not to continue with the development program|f||||||||||||||2017-10-11 05:23:09.125111|2017-10-11 05:23:09.125111
NCT00162084|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-31|||April 2005||2005-04-01|January 2017|2017-01-01||||March 2006|Actual|2006-03-01||Interventional|||A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography|A Phase 3, Parallel, Double Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection With BMS068645 and Adenosine Stress SPECT Compared to Coronary Angiography|Terminated||Phase 3|2000||Forest Laboratories||||Business decision to stop the program|f||||||||||||||2017-10-11 05:23:09.211398|2017-10-11 05:23:09.211398
NCT00162097|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-09-07|2010-07-28||November 2004||2004-11-01|September 2010|2010-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment|Pharmacokinetics of Efavirenz During Treatment of HIV-1 Infected Subjects With Hepatic Impairment.|Completed||Phase 1|21|Actual|Bristol-Myers Squibb|The study was terminated early leading to a small number of participants treated and analyzed. Due to the small sample size, no conclusion could be made for participants with Child-Pugh scores B and C (moderate and severe hepatic impairment).|4|||f||||f||||||||||2017-10-11 05:23:09.460896|2017-10-11 05:23:09.460896
NCT00162110|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-10-26|||November 2004||2004-11-01|October 2015|2015-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces|A Phase II Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces|Completed||Phase 2|40||Eli Lilly and Company||1|||f||||||||||||||2017-10-11 05:23:10.486911|2017-10-11 05:23:10.486911
NCT00162136|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-02-09|2009-07-03||September 2005||2005-09-01|February 2016|2016-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.|Phase I Study of Ixabepilone Administered as a 24-Hour Infusion in Patients With Advanced Solid Malignancies|Completed||Phase 1|35|Actual|R-Pharm||1|||f||||f||||||||||2017-10-11 05:23:15.130028|2017-10-11 05:23:15.130028
NCT00162149|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-07|||October 2005||2005-10-01|June 2008|2008-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||ATV/Ritonavir Nevirapine Interaction (USPAC)|Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Nevirapine on the Pharmacokinetics of Atazanavir in HIV-Infected Individuals|Completed||Phase 1|46||Bristol-Myers Squibb||4|||f||||||||||||||2017-10-11 05:23:17.588486|2017-10-11 05:23:17.588486
NCT00162175|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-09-10||2010-09-10|July 2003||2003-07-01|September 2007|2007-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||PPAR-COMBO With Sulfonylurea|A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Glyburide Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone|Completed||Phase 3|534||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:23:17.708858|2017-10-11 05:23:17.708858
NCT00162188|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-01-08|||May 2001||2001-05-01|January 2014|2014-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Expanded Access|||An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada|Canadian Sustiva Oral Liquid Expanded Access Program: An Open-Label, Multicenter Expanded Access Study of the Liquid Formulation of Sustiva (Efavirenz, DMP266)|No longer available||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 05:23:18.057897|2017-10-11 05:23:18.057897
NCT00162201|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-11|||October 2003||2003-10-01|April 2011|2011-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy|An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy|Completed||Phase 1|16|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-10-11 05:23:18.136357|2017-10-11 05:23:18.136357
NCT00162214|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-13|||August 2005||2005-08-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Dasatinib in Patients With Advanced Solid Tumors|Phase I Study to Evaluate the Effect of Ketoconazole on the Pharmacokinetics of Dasatinib and the Effect of Dasatinib on Pharmacodynamic Markers in Patients With Advanced Solid Tumors|Terminated||Phase 1|60||Bristol-Myers Squibb||1|||f||||||||||||||2017-10-11 05:23:18.346437|2017-10-11 05:23:18.346437
NCT00162227|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-01-08|||September 2000||2000-09-01|January 2014|2014-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Expanded Access|||An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection|US Sustiva Oral Liquid Expanded Access Program: an Open-label, Multicenter Expanded Access Study of the Liquid Formulation of Sustiva (Efavirenz, DMP 266)|No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:23:18.477101|2017-10-11 05:23:18.477101
NCT00162656|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-03-27|||May 1996||1996-05-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|May 2004|Actual|2004-05-01||Interventional|||Treatment of Mature B-cell Lymphoma/Leukaemia|Treatment of Mature B-cell Lymphoma/Leukaemia A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study|Completed||Phase 3|848|Actual|Gustave Roussy, Cancer Campus, Grand Paris||6|||f||||t||||||||||2017-10-11 05:23:32.848384|2017-10-11 05:23:32.848384
NCT00162240|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-04-26|||June 2003||2003-06-01|April 2012|2012-04-01|May 2004|Actual|2004-05-01|||||Interventional|||PPAR - Combination With Metformin|A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Metformin Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone|Completed||Phase 3|534||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:23:18.696761|2017-10-11 05:23:18.696761
NCT00162253|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-02-27||2010-02-27|April 2005||2005-04-01|September 2007|2007-09-01||||June 2006|Actual|2006-06-01||Interventional|||Study of BMS-587101 in Patients With Moderate to Severe Psoriasis|Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of BMS-587101 in Patients With Moderate to Severe Psoriasis|Terminated||Phase 2|120||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:23:19.576194|2017-10-11 05:23:19.576194
NCT00162266|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-05-30|2012-02-21||October 2000||2000-10-01|May 2012|2012-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Abatacept With Methotrexate- Phase IIB|A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Clinical Efficacy of Two Different Doses of BMS-188667 Administered Intravenously to Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate|Completed||Phase 2|524|Actual|Bristol-Myers Squibb||4|||f||||||||||||||2017-10-11 05:23:20.455811|2017-10-11 05:23:20.455811
NCT00162279|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-12-02||2010-09-10|October 2000||2000-10-01|December 2010|2010-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||The Study of Abatacept in Combination With Etanercept|A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Clinical Efficacy of Intravenous Infusions of BMS-188667 (10 mg/kg) Given Monthly in Combination With Subcutaneous Injections of Etanercept (25mg)Given Twice Weekly to Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|141||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:23:28.556826|2017-10-11 05:23:28.556826
NCT00162292|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-02-27||2010-02-27|November 2005||2005-11-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background|Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background|Completed||Phase 1|33|Anticipated|Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 05:23:28.693271|2017-10-11 05:23:28.693271
NCT00162305|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-10-26|||April 2005||2005-04-01|October 2016|2016-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects|A Double-blind, Placebo-controlled, Randomized, Multiple-dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Bms-512148 in Diabetic Subjects|Completed||Phase 2|47|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 05:23:28.79711|2017-10-11 05:23:28.79711
NCT00162318|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-10-26|||March 2005||2005-03-01|October 2015|2015-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1|30||Eli Lilly and Company||1|||f||||||||||||||2017-10-11 05:23:28.92589|2017-10-11 05:23:28.92589
NCT00162331|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-14|||January 2005||2005-01-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI|AIR-MI: Assessment of Ischemia and Remodeling Following Acute Myocardial Infarction|Completed||Phase 4|74|Actual|Lantheus Medical Imaging|||||f||||f||||||||||2017-10-11 05:23:29.011016|2017-10-11 05:23:29.011016
NCT00162344|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-14|||December 2003||2003-12-01|April 2011|2011-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.|AceP-D: Non-invasive Assessment of Atypical Chest Pain in Patients With Diabetes|Completed||Phase 4|205|Actual|Lantheus Medical Imaging||1|||f||||||||||||||2017-10-11 05:23:29.107735|2017-10-11 05:23:29.107735
NCT00162357|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-14|||April 2004||2004-04-01|April 2011|2011-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty|Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention|Completed||Phase 4|106|Actual|Lantheus Medical Imaging|||||f||||f||||||||||2017-10-11 05:23:29.20388|2017-10-11 05:23:29.20388
NCT00162370|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-10-14|2016-04-17||April 2004||2004-04-01|September 2014|2014-09-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional||Peri- or post-menopausal female subjects between 40 and 65 years of age with an intermediate likelihood of CAD who are scheduled to undergo stress echocardiography|A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease|SMART: Stress Echocardiography in Menopausal Women at Risk for Coronary Artery Disease Trial|Completed||Phase 4|400|Actual|Lantheus Medical Imaging||1|||f||||f||||||||No||2017-10-11 05:23:29.299374|2017-10-11 05:23:29.299374
NCT00162383|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2017-03-03|||July 1995||1995-07-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Metabolic Capacity of Israeli Populations|Phenotypic and Genotypic Evaluation of Cytochrome P450 Isoforms in Populations of Different Ethnic Composition|Recruiting||N/A|1200|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-10-11 05:23:30.19686|2017-10-11 05:23:30.19686
NCT00162396|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2008-10-28|||August 1999||1999-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of the Response to Salbutamol Among Asthma Patients|Evaluation of Genetic Factors That May Account for Variability in the Response to Salbutamol Among Patients Suffering From Asthma|Unknown status|Recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:23:30.301406|2017-10-11 05:23:30.301406
NCT00162409|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2008-10-28|||August 2001||2001-08-01|October 2008|2008-10-01||||||||Interventional|||Relationship Between Folic Acid and Warfarin Metabolism and Effect|The Effect of Folic Acid Concentration and Folic Acid Supplementation on Warfarin Pharmacokinetic and Warfarin Dose Requirement at Steady State.|Unknown status|Recruiting|N/A|400|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:23:30.411934|2017-10-11 05:23:30.411934
NCT00162422|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2008-10-28|||August 2003||2003-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of the Bronchodilatation Effect of Albuterol ex-Vivo|The Effect of β2 Genetic Polymorphisms on the Brochodilatation Effect of Albuterol ex-Vivo|Unknown status|Recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:23:30.510804|2017-10-11 05:23:30.510804
NCT00162435|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2017-03-03|||August 2002||2002-08-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Genetic Determinants of Warfarin Anticoagulation Effect|Warfarin Induction Regimen Based Upon CYP2C9, VKORC1 Factor VII Genotyping, PMR and INR Monitoring, as Compared to the Conventional Regimen: a Prospective Controlled Study|Recruiting||N/A|500|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 05:23:30.631166|2017-10-11 05:23:30.631166
NCT00162448|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-08-18|||January 2005||2005-01-01|August 2008|2008-08-01||||||||Interventional|||A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators|Double-Blind, Randomized, Single-Dose Study to Evaluate the Atrial Selectivity and Safety of BMS-394136 in Patients With Implanted Dual-Chamber Pacemakers or Defibrillators|Completed||Phase 1|36||Bristol-Myers Squibb||2|||f||||||||||||||2017-10-11 05:23:30.789606|2017-10-11 05:23:30.789606
NCT00162461|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2017-03-03|||August 1998||1998-08-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evaluation of CYP2C9 Activity|The Use of Phenytoin Metabolic Ratio as a Putative Marker of CYP2C9 Activity In-vivo|Recruiting||N/A|1200|Anticipated|Hadassah Medical Organization||1|||f||||||||||||Undecided||2017-10-11 05:23:30.907944|2017-10-11 05:23:30.907944
NCT00162474|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2017-03-03|||September 2003||2003-09-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Determinants of Warfarin Metabolism|Correlation Between Phenotypic Activity of CYP2C9 and Genetic Polymorphism in CYP2C9 and Warfarin Metabolism.|Recruiting||N/A|600|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-10-11 05:23:31.055856|2017-10-11 05:23:31.055856
NCT00162487|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2008-10-28|||August 2002||2002-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation|Evaluation of β2 Genetic Polymorphisms and the Effect of Albuterol Inhalation on Potassium and Glucose Plasma Concentration|Unknown status|Recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:23:31.202864|2017-10-11 05:23:31.202864
NCT00162500|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2010-11-09||||||September 2005|2005-09-01||||||||Interventional|||A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies|A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies|Withdrawn||Phase 2|15|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:23:31.320189|2017-10-11 05:23:31.320189
NCT00162513|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-04-27|||December 2006||2006-12-01|September 2006|2006-09-01||||||||Interventional|||Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia|Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia|Withdrawn||Phase 1/Phase 2|||Hadassah Medical Organization||||PI is no longer work at Hadassah|f||||||||||||||2017-10-11 05:23:31.427178|2017-10-11 05:23:31.427178
NCT00162526|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-04-07|||December 2005||2005-12-01|September 2005|2005-09-01||||||||Interventional|||Tocopherol is a Novel Treatment for Cancer Related Mucositis|A Randomized Double Blind Placebo Controlled Clinical Trial Aim to Assess the Efficacy of Vitamin E Formulation (Tocopherol) in the Treatment of Chemotherapy Induced Stomatitis in Patients Undergoing Stem Cell Transplantation|Withdrawn||Phase 2|30|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-10-11 05:23:31.612181|2017-10-11 05:23:31.612181
NCT00162539|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2012-07-25|||October 2005||2005-10-01|May 2005|2005-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid Dimension|Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid Dimension|Completed||N/A|130|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 05:23:31.692764|2017-10-11 05:23:31.692764
NCT00162552|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-01-16|||August 2004||2004-08-01|August 2005|2005-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|PENTOCIR||Clinical Trial of Pentoxifylline in Patient With Cirrhosis|Clinical Trial of Pentoxifylline Administration Versus Placebo on Survival in Patients With Cirrhosis and Severe Liver Failure|Completed||Phase 3|342|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 05:23:31.764646|2017-10-11 05:23:31.764646
NCT00162565|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-05-22|||November 2004||2004-11-01|August 2005|2005-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|BConvinced||Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening|Beta-Blocker Continuation Versus Interruption in Patients With Congestive Heart Failure Hospitalized for Heart Failure Worsening (B-CONVINCED)|Completed||Phase 4|180|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:23:31.854367|2017-10-11 05:23:31.854367
NCT00162578|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-07-20|||December 2002||2002-12-01|July 2007|2007-07-01|November 2005|Actual|2005-11-01|||||Observational|||Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis|Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis Treated With Dexamethasone|Completed||N/A|14|Actual|Assistance Publique - Hôpitaux de Paris|||||f||||f||||||||||2017-10-11 05:23:31.985972|2017-10-11 05:23:31.985972
NCT00162591|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-11-21|||October 2004||2004-10-01|October 2004|2004-10-01||||||||Interventional|||Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl|Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl|Unknown status|Recruiting|N/A|40||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:23:32.057871|2017-10-11 05:23:32.057871
NCT00162604|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-08|||May 2005||2005-05-01|February 2005|2005-02-01||||||||Interventional|||Prophylactic Antibiotic Treatment During Vaginal Repair|Antibiotikaprofylakse Ved Vaginalplastik|Unknown status|Recruiting|N/A|200||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:23:32.130357|2017-10-11 05:23:32.130357
NCT00162617|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-08-29|||January 2004||2004-01-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||The Effect of Liberal vs. Restrictive Transfusion Strategies on Rehabilitation After Hip Fracture Surgery|The Effect of Liberal vs. Restrictive Transfusion Strategies on Rehabilitation After Hip Fracture Surgery|Unknown status|Active, not recruiting|Phase 4|120||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:23:32.216119|2017-10-11 05:23:32.216119
NCT00162630|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-13|||May 2003||2003-05-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase|Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase|Completed||Phase 4|48||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:23:32.286885|2017-10-11 05:23:32.286885
NCT00162643|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-09-13|||December 2004||2004-12-01|September 2006|2006-09-01|December 2007||2007-12-01|||||Interventional|||PI Vs. NNRTI Based Therapy for HIV Advanced Disease|Boosted PI VS. NNRTI Based Therapy as Initial Treatment for HIV-1 Infected Patients With Advanced Disease|Unknown status|Recruiting|Phase 4|300||Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||||f||||||||||||||2017-10-11 05:23:32.355953|2017-10-11 05:23:32.355953
NCT00162669|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-07|||May 2005||2005-05-01|September 2006|2006-09-01||||||||Interventional|||Bevacizumab in Advanced Hepatocellular Carcinoma|Phase II Study Evaluating the Efficacy of Bevacizumab (Avastin@) in Hepatocellular Carcinoma Not Amenable to Curative Treatment|Unknown status|Recruiting|Phase 2|50||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:23:32.95339|2017-10-11 05:23:32.95339
NCT00162682|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-01-04|||May 2005||2005-05-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|April 2010|Actual|2010-04-01||Interventional|||Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand|A Phase III, Randomized, Non-inferiority Trial Comparing the Standard Viral Load Based Antiretroviral Monitoring Strategy With a CD4 Based Monitoring Strategy Among Antiretroviral Naive Immunocompromised Adults in Thailand|Completed||Phase 3|716|Actual|Institut de Recherche pour le Developpement||2|||f||||t||||||||||2017-10-11 05:23:33.031362|2017-10-11 05:23:33.031362
NCT00162695|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||July 1995||1995-07-01|September 2005|2005-09-01||||||||Interventional|||Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood||Terminated||Phase 3|400||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:23:33.156307|2017-10-11 05:23:33.156307
NCT00162708|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||July 1996||1996-07-01|September 2005|2005-09-01||||||||Interventional|||Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC|A Randomized Trial Evaluating a Very Intense Radiotherapy-Chemotherapy Regimen Versus a Very Accelerated Radiotherapy in Advanced Head and Neck Squamous Cell Carcinoma|Completed||Phase 2/Phase 3|120||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:23:33.217436|2017-10-11 05:23:33.217436
NCT00162721|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-08-09|||September 2001||2001-09-01|August 2007|2007-08-01||||||||Interventional|||The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas|Phase III Study About the Effects of the Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas|Unknown status|Recruiting|Phase 3|270|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-10-11 05:23:33.293999|2017-10-11 05:23:33.293999
NCT00162734|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-06-21|||February 2005||2005-02-01|June 2012|2012-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy|A Phase 3, Randomized, Open-Label Study of the Safety and Efficacy of Two Dose Levels of Interferon Alfacon-1 (Infergen, CIFN) Plus Ribavirin Administered Daily for 48 Weeks Versus No Treatment in Hepatitis C Infected Patients Who Are Nonresponders to Previous Pegylated Interferon Alfa Plus Ribavirin Therapy and During at Least 24 Weeks of No Treatment in IRHC-001|Completed||Phase 3|144|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||||||||||||2017-10-11 05:23:33.386153|2017-10-11 05:23:33.386153
NCT00162747|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-09-11|||December 2001||2001-12-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Topical Therapy for Prevention of Infections in Preterm Infants|Topical Emollient Therapy for Prevention of Infections in Preterm Infants|Completed||Phase 4|600||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:23:33.459128|2017-10-11 05:23:33.459128
NCT00162760|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-06-18|||October 2003||2003-10-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide|Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide|Completed||Phase 2|19||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:23:33.544728|2017-10-11 05:23:33.544728
NCT00162773|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-07-27|2017-06-29||April 2005|Actual|2005-04-01|July 2017|2017-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effect of Anti-IgE in Non-Allergic Asthma|Effect of Anti-IgE in Non-Allergic Asthma|Terminated||Phase 2|29|Actual|Johns Hopkins University||2||PI left institution|f||||f||||||||||2017-10-11 05:23:33.713559|2017-10-11 05:23:33.713559
NCT00162786|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-10-19|||May 2005||2005-05-01|December 2005|2005-12-01|November 2005||2005-11-01|||||Interventional|||Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance|Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance|Terminated||Phase 4|20||J. Uriach and Company|||||f||||||||||||||2017-10-11 05:23:33.91506|2017-10-11 05:23:33.91506
NCT00162799|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-06-22|||July 2002||2002-07-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in Human Obesity|Phase IIa Study of Triflusal in the Attenuation of Insulin Resistance in Men and Woman With Obesity|Completed||Phase 2|30||J. Uriach and Company|||||f||||||||||||||2017-10-11 05:23:33.998242|2017-10-11 05:23:33.998242
NCT00162812|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-07-16|||January 2003||2003-01-01|July 2008|2008-07-01|April 2009|Anticipated|2009-04-01|December 2008|Anticipated|2008-12-01||Interventional|TOP||Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin|Prospective Evaluation of Topoisomerase II Alpha Gene Amplification and Protein Overexpression as Markers Predicting the Efficacy of Epirubicin in the Primary Treatment of Breast Cancer Patients|Terminated||Phase 2|338|Anticipated|Jules Bordet Institute||1||Low accrual rate|f||||f||||||||||2017-10-11 05:23:34.089015|2017-10-11 05:23:34.089015
NCT00162825|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-07-09|||January 2004||2004-01-01|June 2003|2003-06-01|December 2006|Actual|2006-12-01|||||Observational|||Role of CD7 in Skin Inflammation and Psoriasis||Completed||N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:23:34.177521|2017-10-11 05:23:34.177521
NCT00162838|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-22|||October 2003||2003-10-01|May 2003|2003-05-01||||||||Observational|||Effects of Periodontal Pathogens, Porphyromonas Gingivalis and Tannerella Forsythensis, on Cytokine Production From Human Monocyte-Derived Dendritic Cells|Effects of Periodontal Pathogens, Porphyromonas Gingivalis and Tannerella Forsythensis, on Cytokine Production From Human Monocyte-Derived Dendritic Cells.|Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:23:34.266418|2017-10-11 05:23:34.266418
NCT00156117|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-08-18|||May 12, 2005|Actual|2005-05-12|August 2017|2017-08-01|May 30, 2006|Actual|2006-05-30|April 28, 2006|Actual|2006-04-28||Interventional|||Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)|A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-Week Trial of the Efficacy and Safety of Asenapine Compared With Placebo Using Olanzapine Positive Control in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 3|417|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 05:23:34.367375|2017-10-11 05:23:34.367375
NCT00156130|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-05-06|||October 2003||2003-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Accelerated Radiotherapy Outcomes in Women|Accelerated Radiotherapy Outcomes in Women (Long Term Outcomes of a Randomized Trial of Breast Irradiation Schedules After Lumpectomy in Women With Node-Negative Breast Cancer)(AROW)|Completed||Phase 4|1234|Actual|Ontario Clinical Oncology Group (OCOG)|||2||f||||f||||||||||2017-10-11 05:23:34.480565|2017-10-11 05:23:34.480565
NCT00156143|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-07-27|||April 2002||2002-04-01|July 2007|2007-07-01|April 2005||2005-04-01|||||Interventional|TAUBER||Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents|GH Therapy in Partial GHD Adolescents : Evaluation of Efficacy Based on Body Composition and Comparison of 2 Different Doses of Genotonorm®. Open-Label, Randomised, Comparative, Controlled, Parallel-Group, Multi-Center Phase IIIB Clinical Trial.|Completed||Phase 3|90||Pfizer|||||f||||||||||||||2017-10-11 05:23:34.586826|2017-10-11 05:23:34.586826
NCT00156156|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-05-27|||November 2004||2004-11-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of Asoprisnil in the Treatment of Uterine Fibroids.|A Phase 3, Continuation Study to Evaluate the Long-Term Safety of Asoprisnil in Subjects With Uterine Leiomyomata|Completed||Phase 3|149|Actual|Abbott||2|||f||||f||||||||||2017-10-11 05:23:34.650294|2017-10-11 05:23:34.650294
NCT00156169|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-08-10|||May 2001||2001-05-01|August 2009|2009-08-01|December 2006|Actual|2006-12-01|||||Interventional|||The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.|The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid|Completed||Phase 3|50|Anticipated|Sheba Medical Center|||||f||||f||||||||||2017-10-11 05:23:34.742974|2017-10-11 05:23:34.742974
NCT00156182|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-03-03|||April 2001||2001-04-01|May 2008|2008-05-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.|A Phase 2, Long-Term, Open-Label, Safety Extension Study of Asoprisnil (J867) in Patients With Uterine Leiomyomata|Completed||Phase 2|38|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:23:34.794914|2017-10-11 05:23:34.794914
NCT00156195|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-05-27|||September 2003||2003-09-01|May 2008|2008-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids|A Phase 3, 12-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata|Completed||Phase 3|523|Actual|Abbott||2|||f||||t||||||||||2017-10-11 05:23:34.868203|2017-10-11 05:23:34.868203
NCT00156208|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-05-27|||April 2004||2004-04-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety of Treatment of Uterine Fibroids With Asoprisnil|A Phase III, 18-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata|Completed||Phase 3|166|Actual|Abbott||2|||f||||f||||||||||2017-10-11 05:23:34.942498|2017-10-11 05:23:34.942498
NCT00156221|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||September 2000||2000-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||MR Scanning of Very Young Children With Severe Developmental Disorders|MR Scanning of Very Young Children With Severe Developmental Disorders (Autistic Spectrum Disorders and/or Mental Retardation and/or Language Disorders)|Completed||N/A|||UMC Utrecht|||||f||||||||||||||2017-10-11 05:23:35.067429|2017-10-11 05:23:35.067429
NCT00156234|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-09-08|||March 2005||2005-03-01|September 2005|2005-09-01||||||||Interventional|||Skeletal Muscle Dysfunction in Heart Failure|Training and Congestive Heart Failure|Unknown status|Recruiting|N/A|45||Ullevaal University Hospital|||||f||||||||||||||2017-10-11 05:23:35.133687|2017-10-11 05:23:35.133687
NCT00156247|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-02-13|2011-07-11||September 2005||2005-09-01|February 2015|2015-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Acitretin and Etanercept in Psoriasis|Pilot, Single-Arm Study of the Effect of Adding Acitretin to Etanercept Therapy in Patients With Moderate to Severe Psoriasis Who Fail to Respond to Etanercept Monotherapy|Completed||Phase 2|10|Actual|Rutgers, The State University of New Jersey|small sample size; lack of control group|1|||f||||f||||||||||2017-10-11 05:23:35.213906|2017-10-11 05:23:35.213906
NCT00156260|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-10-04|||January 2003||2003-01-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage|UMCC 2-48 Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage|Terminated||N/A|88|Anticipated|University of Michigan Cancer Center|||||f||||||||||||||2017-10-11 05:23:35.403491|2017-10-11 05:23:35.403491
NCT00156273|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-07-03|||April 2005||2005-04-01|July 2017|2017-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer|A Pilot Study to Determine the Feasibility of Quantifying Apoptosis and Bcl-2 Expression in Circulating Tumor Cells (CTCs) in Women Undergoing Treatment for Metastatic Breast Cancer|Completed||N/A|69|Actual|University of Michigan Cancer Center|||1||f||||t||||||||||2017-10-11 05:23:35.458084|2017-10-11 05:23:35.458084
NCT00156286|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2010-11-12|||March 2002||2002-03-01|November 2010|2010-11-01|April 2006|Actual|2006-04-01|January 2006|Actual|2006-01-01||Interventional|||Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC|Phase II Trial of Gleevec (Imatinib Mesylate, STI571) Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive, Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|20||University of Michigan Cancer Center|||||f||||t||||||||||2017-10-11 05:23:35.511461|2017-10-11 05:23:35.511461
NCT00156299|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-11-18|||March 2003||2003-03-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate|A Pilot Study of Nuclear Factor-kappa B (NFkB) Inhibition During Induction Chemotherapy for Patients With Acute Myelogenous Leukemia (AML)|Terminated||Phase 1|15|Actual|Rutgers, The State University of New Jersey||2||Replaced by another study|f||||f||||||||||2017-10-11 05:23:35.763242|2017-10-11 05:23:35.763242
NCT00156312|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-02-05|||July 2003||2003-07-01|February 2012|2012-02-01|February 2007|Actual|2007-02-01|May 2005|Actual|2005-05-01||Interventional|||Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine|Evaluation of Thymidine Phosphorylase and Other Predictive/Prognostic Factors in Primary Breast Cancer Treated With Docetaxel and Capecitabine (DC)|Completed||N/A|25|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:23:35.861667|2017-10-11 05:23:35.861667
NCT00156325|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2005-12-30|||February 2004||2004-02-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Escitalopram as a Mood Stabilizer for Bipolar II Disorder|A Double-Blind, Placebo-Controlled Trial of Escitalopram as a Mood Stabilizer for Bipolar II Disorder|Completed||Phase 2|10||The University of New South Wales|||||f||||||||||||||2017-10-11 05:23:35.938789|2017-10-11 05:23:35.938789
NCT00156338|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-01-16|||July 2005||2005-07-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Intraoperative Fluid Management on Morbidity|Effect of Intraoperative Fluid Management on Morbidity in Patients Undergoing Colorectal Surgery|Completed||N/A|108|Actual|University Hospital Muenster||3|||f||||f||||||||||2017-10-11 05:23:36.005001|2017-10-11 05:23:36.005001
NCT00156351|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-03-26|||January 2003||2003-01-01|March 2008|2008-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Walking For Wellness Program Evaluation|Evaluation of the National Black Women's Health Project Walking for Wellness Program|Completed||N/A|186||University of Pennsylvania|||||f||||||||||||||2017-10-11 05:23:36.088657|2017-10-11 05:23:36.088657
NCT00156364|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-12-10|||January 1981||1981-01-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Studies of Organ Transplantation in Animals and Man|"Ii-Pancreas Transplantation in Man, Long Term Effects of Cyclosporine (CSA) and Tacrolimus (FK506) on Renal Structure and Function, Studies of the Renal Interstitium Type I Diabetic Patients,"|Completed||N/A|655|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||Samples With DNA|"     Skin Fibroblasts, Plasma and Serum samples, Urine samples, kidney biopsy culture samples.   "|||2017-10-11 05:23:36.163311|2017-10-11 05:23:36.163311
NCT00156377|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-05-24|||November 2002||2002-11-01|September 2005|2005-09-01||||||||Interventional|||Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections|Investigation of the Influence of Intranasal Mupirocin on the Prevalence of S. Aureus Nosocomial Infections by Eradication of Intranasal S. Aureus|Completed||Phase 4|1200||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:23:36.254894|2017-10-11 05:23:36.254894
NCT00156390|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-11-21|2014-05-21||June 2005||2005-06-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Predictors of Response to Biventricular Pacing in Heart Failure|Predictors of Response to Biventricular Pacing in Heart Failure|Completed||N/A|187|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 05:23:36.335007|2017-10-11 05:23:36.335007
NCT00156403|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-12-13|||August 2005||2005-08-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|||||Interventional|||A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis|Hereditary Pancreatitis Amlodipine Trial(H-PAT): A Pilot Study|Completed||Phase 1/Phase 2|8||University of Pittsburgh|||||||||||||||||||2017-10-11 05:23:36.575546|2017-10-11 05:23:36.575546
NCT00156416|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2014-12-02|||February 2005||2005-02-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Menopause and Meditation for Breast Cancer Survivors|Menopause and Meditation for Breast Cancer Survivors|Completed||Phase 1/Phase 2|51|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 05:23:36.645994|2017-10-11 05:23:36.645994
NCT00156429|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-10-24|||July 2005||2005-07-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Genetic Predictors of Outcome in HCM Patients|Genetic Predictors of Outcome in HCM Patients|Active, not recruiting||N/A|540|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"     Blood sample for DNA analysis   "|||2017-10-11 05:23:36.819552|2017-10-11 05:23:36.819552
NCT00156442|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-01-11|||September 2005||2005-09-01|September 2006|2006-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||A Study to Examine the Relationship Between Sleep Apnea and Cleft Lip/Palate|OSAS in Children With Cleft Lip/Palate|Completed||N/A|100|Anticipated|University of Rochester|||1||f||||f||||||||||2017-10-11 05:23:36.885862|2017-10-11 05:23:36.885862
NCT00156455|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-04-29|||September 2004||2004-09-01|April 2015|2015-04-01||||March 2008|Actual|2008-03-01||Observational|||Sleep Disordered Breathing in Children With Single Ventricle Physiology|Sleep Disordered Breathing in Children With Single Ventricle Physiology|Withdrawn||N/A|0|Actual|University of Rochester|||1|lack of study personel|f||||f||||||||||2017-10-11 05:23:36.954763|2017-10-11 05:23:36.954763
NCT00156468|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-05-11|||October 2003||2003-10-01|May 2011|2011-05-01|September 2005||2005-09-01|||||Interventional|||Office-Based Asthma Screening Intervention|Office-Based Asthma Screening Intervention|Completed||N/A|365||University of Rochester|||||f||||||||||||||2017-10-11 05:23:37.022759|2017-10-11 05:23:37.022759
NCT00156481|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-05-11|||December 2004||2004-12-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||A Qualitative Study About Smoking Practices|Smoking Practices Among Parents of Urban Children With Asthma: A Qualitative Study|Completed||N/A|35|Actual|University of Rochester|||1||f||||||||||||||2017-10-11 05:23:37.0975|2017-10-11 05:23:37.0975
NCT00156494|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-05-11|||June 2004||2004-06-01|May 2011|2011-05-01||||||||Observational|||Attitudes About Smoking: A Telephone Survey|"Attitudes About Smoking A Telephone Survey of Parents of Young Urban Children"|Completed||N/A|371|Actual|University of Rochester|||1||f||||f||||||||||2017-10-11 05:23:37.213449|2017-10-11 05:23:37.213449
NCT00156507|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-05-11|||January 2003||2003-01-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Improving Asthma Care for Very Low Birth Weight Infants|Improving Asthma Care for Very Low Birth Weight Infants|Completed||N/A|192|Actual|University of Rochester||1|||f||||f||||||||||2017-10-11 05:23:37.298349|2017-10-11 05:23:37.298349
NCT00156520|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-04-09|||March 2005||2005-03-01|April 2010|2010-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis|Jeanne Grace; Head Research Subjects Review Board|Completed||Phase 4|40|Anticipated|University of Rochester|||||f||||||||||||||2017-10-11 05:23:37.402001|2017-10-11 05:23:37.402001
NCT00156533|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-10-21|2011-10-10||March 2005||2005-03-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing|Long Term Treatment With Zolpidem: The Relative Efficacy of Nightly (Quaque Hora Somni [QHS]) & Intermittent Dosing and the Potential for Long Term Clinical Gains After Treatment Discontinuation.|Completed||Phase 4|20|Actual|University of Rochester|About 25% of the target sample was obtained. As a result our capacity to detect trends and to calculate effect sizes was greatly diminished. Accordingly, our observations must be very limited in scope.|4|||f||||t||||||||||2017-10-11 05:23:37.510451|2017-10-11 05:23:37.510451
NCT00156546|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2005-11-30|||May 2000||2000-05-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Interventional|||Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection|Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a History of Upper Urinary Tract Infections:a Multicentre Randomised Study|Unknown status|Active, not recruiting|Phase 4|660||University of Padova|||||f||||||||||||||2017-10-11 05:23:38.084253|2017-10-11 05:23:38.084253
NCT00156559|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-09-15|||January 2004||2004-01-01|September 2015|2015-09-01|May 2005|Actual|2005-05-01|||||Observational|||MMR and Varicella Vaccine in Premature Infants|MMR and Varicella Vaccine Responses in Extremely Premature Infants|Completed||Phase 4|32||University of Rochester|||||f||||||||||||||2017-10-11 05:23:38.240989|2017-10-11 05:23:38.240989
NCT00156572|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2007-12-26|||April 2005||2005-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Management of Hyponatremia in Preterm Infants on Diuretics|Management of Hyponatremia in Preterm Infants on Diuretics|Terminated||Phase 3|58|Anticipated|The University of Texas Health Science Center, Houston||||decreasing rate of enrollment|f||||||||||||||2017-10-11 05:23:38.343127|2017-10-11 05:23:38.343127
NCT00156585|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-01-13|||August 2005||2005-08-01|January 2015|2015-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Predictive Value of Dynamic Contrast Enhancement MRI on a Cerebral Tumor Response to Gamma Knife Treatment|Prospective Study of Predictive Value of Dynamic Contrast Enhancement Magnetic Resonance Imaging With Gadolinium on the Response of a Cerebral Tumor to a Treatment With Gamma Knife|Completed||N/A|31|Actual|Université de Sherbrooke|||1||f||||f||||||||||2017-10-11 05:23:38.462341|2017-10-11 05:23:38.462341
NCT00156598|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-06-28|||August 2004||2004-08-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Metal Ion Serum Concentrations in Patients With Total Hip Replacements|Cobalt, Chromium and Titanium Serum Concentrations in Patients With Metal-on-Metal vs. Metal on Polyethylene Total Hip Replacements|Terminated||N/A|5|Actual|The University of Texas Health Science Center at San Antonio|||1|Resident graduated; faculty mentor retired|f||||||||||||||2017-10-11 05:23:38.577906|2017-10-11 05:23:38.577906
NCT00156611|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-09-11|||January 2002||2002-01-01|September 2006|2006-09-01|December 2009||2009-12-01|||||Interventional|||Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease|ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease – A Randomized Prospective Trial (RIO-Trial)|Unknown status|Active, not recruiting|Phase 2/Phase 3|420||University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:23:38.659035|2017-10-11 05:23:38.659035
NCT00156624|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2006-04-24|||July 2004||2004-07-01|September 2005|2005-09-01|October 2007||2007-10-01|||||Interventional|||Thunder Trial - Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries|Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries (Thunder – Trial)|Unknown status|Active, not recruiting|Phase 2/Phase 3|135||University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:23:38.762605|2017-10-11 05:23:38.762605
NCT00156637|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-04-06|||June 2005||2005-06-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Strategies to Improve Schizophrenia Treatment|A Study of Strategies to Improve Schizophrenia Treatment|Completed||N/A|106|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:23:38.866491|2017-10-11 05:23:38.866491
NCT00156650|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-09-18|||December 2004||2004-12-01|September 2008|2008-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|IHOP-5||Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum|Male Hormonal Contraception Development: Suppression of Spermatogenesis With the Addition of a Potent GnRH Antagonist (Acyline) to Testosterone and DMPA (ACY-5) -Sub-Study (HOP 5)|Completed||Phase 1/Phase 2|23|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:23:39.004961|2017-10-11 05:23:39.004961
NCT00156663|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-25|2015-04-06|||May 2004||2004-05-01|February 2007|2007-02-01|September 2005|Actual|2005-09-01|||||Interventional|||Toward Gender Aware VA Healthcare: Development and Evaluation of an Intervention|Toward Gender Aware VA Health Care: Development and Evaluation of an Intervention|Completed||N/A|250|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:23:39.118926|2017-10-11 05:23:39.118926
NCT00156676|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-09-18|||September 2004||2004-09-01|September 2013|2013-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Restoration of Walking in Multiple Sclerosis Using Treadmill Training.|Pilot Study on Gait & Motor Function in MS Using BWS Treadmill Training|Completed||N/A|30|Anticipated|VA Office of Research and Development||2|||f||||||||||||||2017-10-11 05:23:39.226996|2017-10-11 05:23:39.226996
NCT00156689|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-01-02|||August 2005||2005-08-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy.|A Pilot Study in a Double Blind, Randomized, Placebo-Controlled, Parallel-Group, 16 Week, Trial Design Evaluating the Efficacy and Safety of Levetiracetam 500 mg Tablets in Bid Administration (Daily Dose Ranging From 1000 mg to 3000 mg), in Adults (>18 Years of Ages) Suffering From Chronic Idiopathic Axonal Polyneuropathy|Completed||Phase 2|30|Actual|Vanderbilt University|||||f||||f||||||||||2017-10-11 05:23:39.358787|2017-10-11 05:23:39.358787
NCT00156702|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-01-07|||January 2001||2001-01-01|January 2013|2013-01-01|October 2006|Actual|2006-10-01|||||Interventional|||Researching the Youth Smoking Experience|Researching the Youth Smoking Experience|Completed||Phase 1|40|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 05:23:39.457653|2017-10-11 05:23:39.457653
NCT00156715|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2012-02-16|2010-11-19||March 2004||2004-03-01|February 2012|2012-02-01|October 2008|Actual|2008-10-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder|Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia|Completed||Phase 4|23|Actual|Dartmouth-Hitchcock Medical Center|Lack of a control group; Small study group size, and the consequent lack of power to detect a significant change; Differences between the populations at the two sites.|1|||f||||t||||||||||2017-10-11 05:23:39.587847|2017-10-11 05:23:39.587847
NCT00156728|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-11-03|||October 2003||2003-10-01|November 2008|2008-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT|Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)|Completed||Phase 4|172||Medtronic BRC||1|||f||||||||||||||2017-10-11 05:23:39.969384|2017-10-11 05:23:39.969384
NCT00156741|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2011-08-01|||April 2004||2004-04-01|September 2005|2005-09-01|April 2006||2006-04-01|||||Interventional|||Efficacy of a Pacemaker Algorithm in Promotion of the Intrinsic Heart Activity.|IntAct, Study on Promotion of Intrinsic Activity.|Unknown status|Active, not recruiting|Phase 4|150||Medtronic BRC|||||f||||||||||||||2017-10-11 05:23:40.554785|2017-10-11 05:23:40.554785
NCT00156767|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-10-05|||October 20, 2004||2004-10-20|January 26, 2017|2017-01-26||||||||Observational|||Adrenal Function in Critical Illness|Adrenal Function in Critical Illness|Completed||N/A|225|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:23:40.799436|2017-10-11 05:23:40.799436
NCT00163124|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-12|||March 2005||2005-03-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||A Randomized Controlled Trial of Best Approach to Care Compared to Diversified Chiropractic Adjustive Technique|A Randomized Controlled Trial of Best Approach to Care Compared to Diversified Adjustive Technique|Completed||N/A|155||Parker College of Chiropractic|||||f||||||||||||||2017-10-11 05:23:48.223129|2017-10-11 05:23:48.223129
NCT00156780|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-19|||August 2004||2004-08-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF|A Phase 1, Double Blind, Crossover, Placebo-Controlled, Dual-Injection, Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and Chronic Obstructive Pulmonary Disease (COPD) and/or Congestive Heart Failure (CHF)|Completed||Phase 1|||Acusphere|||||||||||||||||||2017-10-11 05:23:40.901557|2017-10-11 05:23:40.901557
NCT00156793|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-07-13|||December 2003||2003-12-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging|A Phase 3, International, Multicenter, Open Label, Dual-Injection, Echocardiographic Imaging and Safety Study of AI-700 in Patients With Suspected Ischemic Heart Disease Undergoing Single-Photon Emission Computed Tomography (Real-Time Assessment of Myocardial Perfusion With Echocardiography: RAMP 1)|Completed||Phase 3|400||Acusphere|||||||||||||||||||2017-10-11 05:23:40.974801|2017-10-11 05:23:40.974801
NCT00156806|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2017-01-23|||March 2002||2002-03-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|May 2005|Actual|2005-05-01||Interventional|||Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.|Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.|Completed||Phase 3|231||AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:23:41.048574|2017-10-11 05:23:41.048574
NCT00156819|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-11-04|2015-11-04||June 2003||2003-06-01|November 2015|2015-11-01|August 2006|Actual|2006-08-01|August 2005|Actual|2005-08-01||Interventional|||The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial|The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial|Completed||Phase 4|500|Actual|JHSPH Center for Clinical Trials||3|||f||||||||||||||2017-10-11 05:23:41.148339|2017-10-11 05:23:41.148339
NCT00156845|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-07-13|||December 2003||2003-12-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography|A Phase 3, International, Multicenter, Open-Label, Dual-Injection, Echocardiographic Imaging and Safety Study in Patients With Suspected Ischemic Heart Disease Undergoing Diagnostic Coronary Angiography (Real-Time Assessment of Myocardial Perfusion With Echocardiography: RAMP 2)|Completed||Phase 3|450||Acusphere|||||||||||||||||||2017-10-11 05:23:41.846806|2017-10-11 05:23:41.846806
NCT00156858|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-01-18|||January 1998||1998-01-01|September 2011|2011-09-01|December 2010||2010-12-01|||||Interventional|||Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study|Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell|Unknown status|Recruiting|N/A|200|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:23:41.979214|2017-10-11 05:23:41.979214
NCT00156871|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-01-18|||April 2003||2003-04-01|August 2011|2011-08-01|December 2005|Actual|2005-12-01|||||Interventional|||Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)|Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant|Completed||N/A|24|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:23:42.090783|2017-10-11 05:23:42.090783
NCT00156884|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-01-18|||August 2003||2003-08-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer|A Randomized Phase II Trial of Strontium-89 With or Without Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer|Completed||Phase 2|58|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:23:42.177677|2017-10-11 05:23:42.177677
NCT00156897|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-08-25|||December 2004||2004-12-01|August 2006|2006-08-01|October 2005||2005-10-01|||||Interventional|||Efficacy and Safety of ATL-962 in Obese Diabetics|Multicentre Double Blind Placebo Controlled Parallel Group Dose Ranging Study of ATL-962 to Assess Weight Loss, Safety and Tolerability in Obese Patients With Type II Diabetes Being Treated With Metformin, in Comparison With Orlistat|Completed||Phase 2|600||Alizyme|||||f||||||||||||||2017-10-11 05:23:42.299216|2017-10-11 05:23:42.299216
NCT00162851|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-23|||April 2003||2003-04-01|August 2005|2005-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia|A Pilot Study to Evaluate the Safety of Subcutaneous Alemtuzumab (MabCampath, Campath) in Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|20|Anticipated|Karolinska University Hospital|||||f||||||||||||||2017-10-11 05:23:42.498858|2017-10-11 05:23:42.498858
NCT00162864|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-03-23|||December 1999||1999-12-01|September 2005|2005-09-01|April 2002||2002-04-01|||||Interventional|||A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary Disease|A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary Disease|Completed||Phase 3|200||Kaiser Permanente|||||f||||||||||||||2017-10-11 05:23:42.564889|2017-10-11 05:23:42.564889
NCT00162877|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-22|||June 2004||2004-06-01|January 2004|2004-01-01|April 2005||2005-04-01|||||Interventional|||The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships|The Role of CYP2C19 Poor Metabolizers and Extensive Metabolizers of PPI in Short-Term Triple Therapy on the Eradication of H. Pylori Infection: Implication of PK/PD Relationships|Unknown status|Active, not recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:23:42.647558|2017-10-11 05:23:42.647558
NCT00162890|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-03-15|||February 2002||2002-02-01|December 2009|2009-12-01|July 2003|Actual|2003-07-01|July 2002|Actual|2002-07-01||Observational|||Evaluation and Physical Therapy for Patients With Degenerated Cervical Spine|Evaluation and Physical Therapy for Patients With Degenerated Cervical Spine|Completed||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 05:23:42.737208|2017-10-11 05:23:42.737208
NCT00162903|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-22|||January 2002||2002-01-01|October 2001|2001-10-01|December 2002||2002-12-01|||||Observational|||Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants|The Role of Nitric Oxide, Endothelin-1, and Inflammatory Mediators in the Patency of Ductus Arteriosus in Preterm Infants|Completed||N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:23:42.816683|2017-10-11 05:23:42.816683
NCT00162916|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-06-03|||May 2005||2005-05-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||Antidepressant Maintenance in Traumatic Brain Injury|A Randomized Controlled Trial of Antidepressant Maintenance for Major Depression Following Mild Traumatic Brain Injury|Unknown status|Active, not recruiting|Phase 4|21|Actual|Ontario Neurotrauma Foundation||2|||f||||f||||||||||2017-10-11 05:23:42.867245|2017-10-11 05:23:42.867245
NCT00162929|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2012-05-31|||January 2005||2005-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|July 2009|Actual|2009-07-01||Interventional|AdHERe||Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)|A Phase I Study Investigating Multiple Injections of Autologous CD34+ Derived Dendritic Cells Transduced With an Adenovirus Expressing Rat Her-2/Neu in Patients With Metastatic or Locally Recurrent Breast Cancer|Completed||Phase 1|5|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-10-11 05:23:42.963423|2017-10-11 05:23:42.963423
NCT00162942|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-03-05|2009-01-15||January 2005||2005-01-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study for the Treatment of Crohn's Disease With Adacolumn|A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Crohn's Disease|Completed||Phase 3|235|Actual|Otsuka America Pharmaceutical||2|||f||||||||||||||2017-10-11 05:23:43.068571|2017-10-11 05:23:43.068571
NCT00162955|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-05-07|||May 2004||2004-05-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Prevention of CHOP-induced Chronic Cardiotoxicity|The Multi-centers Trial for Patients With Non-Hodgkin's Lymphoma to Assess the Protective Effect of Valsartan on Chronic Cardiotoxicity Induced by CHOP|Completed||Phase 4|150|Actual|Osaka City University||2|||f||||t||||||||||2017-10-11 05:23:44.190929|2017-10-11 05:23:44.190929
NCT00162968|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-23|||December 2004||2004-12-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Escitalopram as a Treatment for Pain in Polyneuropathy|Escitalopram as a Treatment for Pain in Polyneuropathy. A Double-Blind, Randomized, Placebo Controlled Trial.|Completed||Phase 4|50||Odense University Hospital|||||f||||||||||||||2017-10-11 05:23:44.291822|2017-10-11 05:23:44.291822
NCT00162981|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-01-06|2011-11-07||October 2005||2005-10-01|January 2012|2012-01-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Clobazam in Subjects With Lennox-Gastaut Syndrome|Safety and Efficacy of Clobazam in Subjects With Lennox-Gastaut Syndrome|Completed||Phase 2|68|Actual|Lundbeck LLC||2|||f||||t||||||||||2017-10-11 05:23:44.390777|2017-10-11 05:23:44.390777
NCT00162994|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-12-20|||February 2002||2002-02-01|February 2002|2002-02-01|August 2005||2005-08-01|||||Interventional|||Prevention Recurrent Otitis Media in the Young Children|Effect of Adenotomy and Tympanostomy on Preventing Recurrent Otitis Media in the Young Children|Unknown status|Active, not recruiting|N/A|300||Oulu University Hospital|||||f||||||||||||||2017-10-11 05:23:44.937792|2017-10-11 05:23:44.937792
NCT00163007|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-05-08|||May 2005||2005-05-01|May 2009|2009-05-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Nutritional Therapy for Stroke Patients|Nutritional Therapy for Patients With Acute Stroke and With Poor Nutritional Status or at Risk of Poor Nutritional Status|Completed||Phase 2/Phase 3|125|Anticipated|Ostfold Hospital Trust|||||f||||||||||||||2017-10-11 05:23:45.049023|2017-10-11 05:23:45.049023
NCT00163020|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-03-11|2012-06-05||November 2004||2004-11-01|March 2016|2016-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|170HP||17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies|17-Alpha-Hydroxyprogesterone Caproate for Reduction of Neonatal Morbidity Due to Preterm Birth in Twin and Triplet Pregnancies - A Concurrent Randomized Double-blinded Clinical Trial|Completed||Phase 2/Phase 3|321|Actual|Mednax Center for Research, Education and Quality||2|||f||||t||||||||Undecided||2017-10-11 05:23:45.150877|2017-10-11 05:23:45.150877
NCT00163033|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-05-18|||June 2005||2005-06-01|May 2012|2012-05-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women|Phase I Study to Evaluate the Safety, Tolerability, PK and Pharmacodynamics of 3 Dosages of Estetrol, the Lowest Dose of 2 mg Estetrol Compared With 2 mg of E2, After Daily Oral Administration for 28 Days in Healthy Postmenopausal Women|Completed||Phase 1|49|Actual|Pantarhei Bioscience|||||f||||f||||||||||2017-10-11 05:23:47.715723|2017-10-11 05:23:47.715723
NCT00163046|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-04-23|||October 2005||2005-10-01|April 2008|2008-04-01|April 2006|Actual|2006-04-01|||||Interventional|||A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 28-Day, Polysomnographic Study of Gabapentin 250 mg in Transient Insomnia Induced by a Sleep Phase Advance|Completed||Phase 3|256|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:23:47.778871|2017-10-11 05:23:47.778871
NCT00163059|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-21|||May 2004||2004-05-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD|A Randomized, Double-Blinded, Placebo-Controlled Trial To Assess The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With Treatment Refractory Major Depressive Disorder|Completed||Phase 2|30||Pfizer|||||||||||||||||||2017-10-11 05:23:47.869755|2017-10-11 05:23:47.869755
NCT00163072|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-10-24|||October 2005||2005-10-01|April 2007|2007-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Pharmacokinetics and Safety of Transdermal Megestrol Acetate|Pharmacokinetics and Safety of Transdermal Megestrol Acetate|Withdrawn||Phase 4|0|Actual|Milton S. Hershey Medical Center||1|||f||||f||||||||||2017-10-11 05:23:47.934471|2017-10-11 05:23:47.934471
NCT00163085|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-21|||May 2005||2005-05-01|September 2006|2006-09-01|January 2006||2006-01-01|||||Interventional|||The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Explore The Efficacy And Safety Of The NR2B NMDA Antagonist CP-101,606 In Patients With Idiopathic Parkinson's Disease|Completed||Phase 2|12||Pfizer|||||||||||||||||||2017-10-11 05:23:48.001712|2017-10-11 05:23:48.001712
NCT00163098|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-12|||December 2004||2004-12-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD|A Multi-Centre, Multinational, Randomized, Double-Blind, Placebo Controlled, Proof Of Concept Trial To Assess The Effects Of A Subject-Optimized Dose Of UK-369,003 On Exercise Capacity In Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 1/Phase 2|136||Pfizer|||||f||||||||||||||2017-10-11 05:23:48.060395|2017-10-11 05:23:48.060395
NCT00163111|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-25|||September 1998||1998-09-01|April 2011|2011-04-01|May 2003|Actual|2003-05-01|||||Interventional|||A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.|A Randomized, Open Label, Comparative Multicenter Study Of Voriconazole Versus Conventional Amphotericin B Followed By Fluconazole In The Treatment Of Candidaemia In Non Neutropenic Subjects.|Completed||Phase 3|412|Actual|Pfizer|||||||||||||||||||2017-10-11 05:23:48.170356|2017-10-11 05:23:48.170356
NCT00163137|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-10|||May 2003||2003-05-01|August 2011|2011-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|CORAL||Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss|Double-Blind Placebo-Controlled Trial Of The Safety, Toleration and Efficacy Of Lasofoxifene 0.25 Mg/D and Raloxifene 60Mg/D For The Prevention Of Bone Loss In Postmenopausal Women|Completed||Phase 3|540|Actual|Ligand Pharmaceuticals||3|||f||||||||||||||2017-10-11 05:23:48.290955|2017-10-11 05:23:48.290955
NCT00163150|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-03-13|||June 2003||2003-06-01|April 2007|2007-04-01|February 2006|Actual|2006-02-01|||||Interventional|LA BICHAT||Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke|Lacunar-Brain Infarction Cerebral Hyperactivity And Atorvastatin Trial. A Placebo-Controlled Trial Of High-Dose Atorvastatin In Patients With Cerebral Small Vessel Disease.|Completed||Phase 4|128||Pfizer|||||f||||||||||||||2017-10-11 05:23:48.628463|2017-10-11 05:23:48.628463
NCT00163163|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-03-17|||January 2003||2003-01-01|March 2008|2008-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women|Carotid Atorvastatin Study In Hyperlipidemic Post-Menopausal Women: A Randomized Evaluation of Atorvastatin, Versus Placebo (CASHMERE)|Completed||Phase 3|400||Pfizer|||||f||||||||||||||2017-10-11 05:23:48.704859|2017-10-11 05:23:48.704859
NCT00163176|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-12-15|||July 2005||2005-07-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Observational|||Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors|Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors|Completed||Phase 1|50|Actual|Radboud University|||1||f||||f||||||||||2017-10-11 05:23:48.923511|2017-10-11 05:23:48.923511
NCT00163462|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-02|||October 2004||2004-10-01|October 2016|2016-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)|Comparison of Ciclesonide (80 mcg or 160 mcg Once Daily in the Evening) and Fluticasone Propionate (100 mcg Twice Daily in the Morning and Evening) in Pediatric Asthma Patients|Completed||Phase 3|750||AstraZeneca|||||f||||||||||||||2017-10-11 05:23:49.006206|2017-10-11 05:23:49.006206
NCT00163475|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-10-24|||May 2004||2004-05-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)|The MOVE-study: Morning Versus Evening Administration of 500 mcg Roflumilast Once Daily for 6 Weeks in Patients With Asthma|Completed||Phase 3|511||AstraZeneca|||||f||||||||||||||2017-10-11 05:23:49.191368|2017-10-11 05:23:49.191368
NCT00163488|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-02|||January 2005||2005-01-01|October 2016|2016-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)|Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Fluticasone Propionate/Salmeterol (FP/SAL) in Patients (18-60 Years) With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|106||AstraZeneca|||||f||||||||||||||2017-10-11 05:23:49.268255|2017-10-11 05:23:49.268255
NCT00163501|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-29|||December 2003||2003-12-01|October 2016|2016-10-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial to Assess the Long Term Safety of Ciclesonide, Applied as a Nasal Spray (200 Mcg, Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 12 Years and Older|Completed||Phase 3|600||AstraZeneca|||||f||||||||||||||2017-10-11 05:23:49.339031|2017-10-11 05:23:49.339031
NCT00163514|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-01|||May 2004||2004-05-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial Designed to Assess the Efficacy and Safety of Ciclesonide Applied as a Nasal Spray at Three Dose Levels (200 Mcg, 100 Mcg, or 25 Mcg, Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 6-11 Years of Age|Completed||Phase 3|636||AstraZeneca|||||f||||||||||||||2017-10-11 05:23:49.628233|2017-10-11 05:23:49.628233
NCT00163527|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-01|||April 2003||2003-04-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)|A 24-Week, Double-Blind, Parallel Group, Placebo and Active Controlled Study to Investigate the Efficacy and Safety of Daily Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Chronic Asthma|Completed||Phase 3|2054||AstraZeneca|||||f||||||||||||||2017-10-11 05:23:49.889585|2017-10-11 05:23:49.889585
NCT00163540|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||May 2005||2005-05-01|May 2015|2015-05-01|June 2005||2005-06-01|||||Interventional|||Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)|Open-Label, Follow-up, Phase IV Clinical Study to Evaluate the Immunogenicity and Safety of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated Using a Rapid Immunization Schedule (Follow-up to Study 225)|Completed||Phase 4|||Pfizer|||||f||||||||||||||2017-10-11 05:23:50.074383|2017-10-11 05:23:50.074383
NCT00163553|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-29|||December 2004||2004-12-01|January 2009|2009-01-01||||||||Interventional|||Neuraxial Pethidine After Lumbar Surgery Trial|Neuraxial Pethidine After Lumbar Surgery Trial|Unknown status|Recruiting|Phase 3|60|Anticipated|Austin Health||2|||f||||||||||||||2017-10-11 05:23:50.171944|2017-10-11 05:23:50.171944
NCT00163566|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-07-10|||October 2004||2004-10-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|October 2006|Actual|2006-10-01||Interventional|||Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80|A Phase II, Placebo-Controlled, Double-Blind, Dose-Ranging (35mg/Day or 70 mg/Day), Randomized, Study of Cutaneous Dihydrotestosterone (DHT)-Gel (0.7% Hydroalcoholic Gel) in Older Hypogonadal Males Ages 55-80 Years: Effect on Body Composition, Libido, and Physical and Sexual Functioning|Unknown status|Active, not recruiting|Phase 2|128|Actual|ASCEND Therapeutics||3|||f||||||||||||||2017-10-11 05:23:50.304858|2017-10-11 05:23:50.304858
NCT00163579|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-04-14|||July 2004||2004-07-01|September 2005|2005-09-01|March 2007|Anticipated|2007-03-01|||||Interventional|||The Impact of Bryophyllum on Preterm Delivery|The Impact of the Prophylactic or Therapeutic Application of Bryophyllum on Preterm Delivery - a Prospective Study|Unknown status|Recruiting|Phase 4|180|Anticipated|Basel Women’s University Hospital|||||f||||f||||||||||2017-10-11 05:23:50.438824|2017-10-11 05:23:50.438824
NCT00163592|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-10-20|||September 2003||2003-09-01|October 2006|2006-10-01|February 2004||2004-02-01|||||Observational|||Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis|Non- Interventional Study of Tissucol® for Hemostasis in Subjects With Femoral Vascular Anastomosis Undergoing Vascular Reconstruction With PTFE Prosthesis|Completed||Phase 4|60||Baxter Healthcare Corporation|||||f||||||||||||||2017-10-11 05:23:50.537923|2017-10-11 05:23:50.537923
NCT00163605|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-11-14|||September 2004||2004-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures|A Prospective Clinical Study to Evaluate the Performance and Safety of the Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures|Completed||Phase 2/Phase 3|86||Baxter Healthcare Corporation|||||f||||||||||||||2017-10-11 05:23:50.616786|2017-10-11 05:23:50.616786
NCT00163618|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-05-20|||June 2005||2005-06-01|May 2015|2015-05-01|July 2006|Actual|2006-07-01|||||Observational|||Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children|Multicenter Phase IV Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children|Completed||Phase 4|||Pfizer|||||f||||f||||||||||2017-10-11 05:23:50.693425|2017-10-11 05:23:50.693425
NCT00163631|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2006-10-03||||||September 2005|2005-09-01||||||||Observational|||Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis|Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis|Completed||N/A|||Bayside Health|||||f||||||||||||||2017-10-11 05:23:50.763745|2017-10-11 05:23:50.763745
NCT00163644|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2016-01-06|||November 2003||2003-11-01|January 2016|2016-01-01||||December 2009|Actual|2009-12-01||Interventional|||RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT|Randomised Controlled Trial to Investigate the Effects of an Exercise Programme on Physical Performance and Quality of Life After a Bone Marrow Transplant|Active, not recruiting||N/A|66|Anticipated|Bayside Health||3|||f||||||||||||||2017-10-11 05:23:50.829012|2017-10-11 05:23:50.829012
NCT00163657|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-11-15|2012-02-23||July 2002||2002-07-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|April 2006|Actual|2006-04-01||Interventional|||Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection|An Open-Label, Randomized, Prospective Multicenter Study To Compare The Efficacy And Safety Among 3 Immunosuppressant Treatment Regimens In Patients Receiving A Liver Transplant For ESLD Caused By Chronic Hepatitis C|Completed||Phase 4|312|Actual|Baylor Research Institute||3|||f||||t||||||||No|No their is not a plan to make individual Participant data available|2017-10-11 05:23:50.935837|2017-10-11 05:23:50.935837
NCT00163670|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2013-12-04|||September 2005||2005-09-01|September 2005|2005-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||The Impact of Sleep Disorders on Motor Vehicle Accidents|The Impact of Sleep Disorders on Motor Vehicle Accidents|Completed||N/A|40|Actual|Bayside Health|||2||f||||f||||||||||2017-10-11 05:23:51.333865|2017-10-11 05:23:51.333865
NCT00163683|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2013-12-03|||January 2003||2003-01-01|September 2005|2005-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effects of a Mediterranean Style Diet on Vascular Health in Type 2 Diabetes|The Effect of a Mediterranean Style Diet Versus a Conventional High Carbohydrate, Low Fat Diet on Glycaemic and Lipid Control and on Vascular Inflammatory Markers in People With Newly Diagnosed Type 2 Diabetes|Completed||N/A|24|Actual|Bayside Health|||||f||||f||||||||||2017-10-11 05:23:51.390425|2017-10-11 05:23:51.390425
NCT00163696|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-07-25|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Observational|||Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease|Measurements of Inhomogeneity of the Small Airway With Patients With Cystic Fibrosis, Asthma and Bronchiolitis Obliterans Syndrome (Post Transplant) Using the Multi Breath Nitrogen Washout Technique|Unknown status|Recruiting|N/A|90|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:23:51.467631|2017-10-11 05:23:51.467631
NCT00163709|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2006-10-03|||August 2005||2005-08-01|May 2005|2005-05-01||||||||Interventional|||BNP Testing in Patients With SOB on Presentation to ED|A Randomised Trial of BNP Testing in Patients With Shortness of Breath in the Emergency Department to Improve Patient Outcome|Unknown status|Recruiting|Phase 1|600||Bayside Health|||||f||||||||||||||2017-10-11 05:23:51.554681|2017-10-11 05:23:51.554681
NCT00163722|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2013-02-17|||September 2005||2005-09-01|September 2005|2005-09-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients|A Multicentre Randomised Controlled Trial Comparing the Current Standard Diagnostic Strategy for Invasive Aspergillosis to the New Diagnostic Strategy for Invasive Aspergillosis in High-Risk Haematology Patients in Order to Determine Which Strategy Results in the Lower Rates of Use of Empiric Antifungal Therapy|Completed||Phase 3|240|Actual|Bayside Health||2|||f||||t||||||||||2017-10-11 05:23:51.65007|2017-10-11 05:23:51.65007
NCT00163735|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-12-03|||August 2002||2002-08-01|September 2005|2005-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Potential Allergens in Wine: Double-blind Placebo-controlled Trial|Potential Allergens in Wine: Double Blind Placebo-controlled Trial and Basophil Activation Analysis|Completed||N/A|48|Actual|Bayside Health|||||f||||||||||||||2017-10-11 05:23:51.820777|2017-10-11 05:23:51.820777
NCT00163748|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-06|||February 2001||2001-02-01|January 2016|2016-01-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma|A Pilot Study of Outpatient Vinorelbine and Gemcitabine With Filgrastim Support for Patients With Relapsed or Refractory Lymphoma.|Completed||Phase 2|40||Bayside Health|||||f||||||||||||||2017-10-11 05:23:51.977855|2017-10-11 05:23:51.977855
NCT00163761|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2016-01-06|||December 2002||2002-12-01|January 2016|2016-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy Study of Outpatient Therapy for Lymphoma|A Multicentre Phase II Study of Risk-adjusted Outpatient-based Salvage Therapy for Patients With Relapsed and Refractory Lymphoma|Completed||Phase 2|90|Actual|Bayside Health||2|||f||||f||||||||||2017-10-11 05:23:52.058192|2017-10-11 05:23:52.058192
NCT00163774|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-16|||November 2002||2002-11-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Interventional|||Intensive Monitoring of Brain Injured Patients|Intensive Monitoring of Brain Injured Patients; Icp Monitoring, Transcranial Doppler, Jugular Bulb Oximetry, Brain Oxygenation, Brain Temperature and Microdialysis.|Completed||N/A|20|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:23:52.199364|2017-10-11 05:23:52.199364
NCT00163787|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-10-24|||June 2003||2003-06-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Clinical Identification of Fall Risk Early After Unilateral Transtibial Amputation|Clinical Identification of Increased Fall Risk Early After Unilateral Transtibial Amputation|Completed||N/A|50||Bayside Health|||||f||||||||||||||2017-10-11 05:23:52.267359|2017-10-11 05:23:52.267359
NCT00163800|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-07|||July 2003||2003-07-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Observational|||Outcome Predictors in Acute Brain Injury|Outcome Predictors in Acute Brain Injury, A Pilot Study|Completed||N/A|60||Bayside Health|||||f||||||||||||||2017-10-11 05:23:52.329|2017-10-11 05:23:52.329
NCT00163813|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-02-23||||||August 2005|2005-08-01||||||||Interventional|ENTERIC||The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study|The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care Study|Unknown status|Not yet recruiting|N/A|180||Bayside Health|||||f||||||||||||||2017-10-11 05:23:52.378719|2017-10-11 05:23:52.378719
NCT00163826|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-06|||March 2004||2004-03-01|January 2016|2016-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Spinal Clearance Study: Expediting the Spinal Clearance Process in the Major Trauma Patient|Optimisation of Patient Management Through Expediting the Spinal Clearance Process in the Major Trauma Patient|Completed||Phase 4|299|Actual|Bayside Health|||1||f||||f||||||||||2017-10-11 05:23:52.475071|2017-10-11 05:23:52.475071
NCT00163839|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-02-14|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema|The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria or Angioedema: A Randomised Controlled Study|Unknown status|Not yet recruiting|N/A|50|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:23:52.547962|2017-10-11 05:23:52.547962
NCT00163852|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||February 2004||2004-02-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis|Salt Replacement for Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis|Unknown status|Recruiting|Phase 2/Phase 3|40||Bayside Health|||||f||||||||||||||2017-10-11 05:23:52.648544|2017-10-11 05:23:52.648544
NCT00163865|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-25|||May 2005||2005-05-01|September 2005|2005-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents|A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents|Completed||N/A|71|Actual|Bayside Health|||2||f||||f||||||||||2017-10-11 05:23:52.762143|2017-10-11 05:23:52.762143
NCT00163878|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-03|||November 2004||2004-11-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Is Sensory Stimulation Effective in Reducing Time Spent in a Coma or Vegetative State|A Randomised Control Trial to Determine the Effectiveness of Sensory Stimulation Program in Reducing the Length of Time Spent by Severely Brain Injured Patients in a Vegetative State in the Acute Hospital Environment|Unknown status|Recruiting|Phase 4|||Bayside Health|||||f||||||||||||||2017-10-11 05:23:52.874083|2017-10-11 05:23:52.874083
NCT00163891|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-03|||September 2003||2003-09-01|September 2005|2005-09-01||||||||Interventional|||Comparison of Two Chest Physiotherapy Protocols in Lung Transplant Recipients|A Prospective Randomised Two Month Trial Comparing Twho Chest Physiotherapy Protocols in Lung Transplant Recipients|Completed||N/A|40||Bayside Health|||||f||||||||||||||2017-10-11 05:23:52.966195|2017-10-11 05:23:52.966195
NCT00163904|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-31|||January 2005||2005-01-01|September 2005|2005-09-01||||||||Interventional|||Can a Modified Fat Diet With Low Glycaemic Load Improve Insulin Sensitivity and Inflammatory Mediators in Overweight People With Chronic Heart Failure?|Can a Modified Fat Diet With Low Glycaemic Load Improve Insulin Sensitivity and Inflammatory Mediators in Overweight People With Chronic Heart Failure?|Unknown status|Recruiting|Phase 1|50|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.044876|2017-10-11 05:23:53.044876
NCT00163917|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-03-14|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||A Study of the Effectiveness of Virtual Reality Relaxation Combined With Patient-Controlled Analgesia (PCA) Morphine for Those Undergoing Burn Dressing Changes|Predicting the Effectiveness of Virtual Reality Relaxation on Pain and Anxiety When Added to PCA Morphine in a Population of Burn Patients Having Dressing Changes|Unknown status|Recruiting|N/A|90||Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.153537|2017-10-11 05:23:53.153537
NCT00163930|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-02|||January 2005||2005-01-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Observational|||Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata|Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata|Unknown status|Recruiting|N/A|||Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.278127|2017-10-11 05:23:53.278127
NCT00163943|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-07-31|||April 2005||2005-04-01|September 2005|2005-09-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions|Neural Mechanisms Predisposing to Cardiovascular Risk in Individuals With the Metabolic Syndrome: Benefits of Dietary Weight Loss, Weight Loss Maintenance and Aerobic Exercise|Unknown status|Recruiting|N/A|66|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.400185|2017-10-11 05:23:53.400185
NCT00163956|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-03|||August 2005||2005-08-01|September 2005|2005-09-01|December 2010||2010-12-01|||||Observational|||Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes|Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes|Unknown status|Recruiting|N/A|20||Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.509064|2017-10-11 05:23:53.509064
NCT00163969|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-13|||April 2002||2002-04-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||The Use of Ketamine as Rescue Analgesia in the Recovery Room Following Opioid Administration. A Double-blind Randomised Trial in Postoperative Patients|The Use of Ketamine as Rescue Analgesia in the Recovery Room Following Opioid Administration. A Double-blind Randomised Trial in Postoperative Patients.|Completed||Phase 4|40||Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.614041|2017-10-11 05:23:53.614041
NCT00163982|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-25||||||September 2005|2005-09-01||||||||Interventional|||Vasoactive Peptides in Portal Pressure||Unknown status|Recruiting|N/A|||Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.712326|2017-10-11 05:23:53.712326
NCT00163995|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-25||||||September 2005|2005-09-01||||||||Observational|||Urotensin II and Vascular Tone in Cirrhosis||Unknown status|Recruiting|N/A|40|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.778985|2017-10-11 05:23:53.778985
NCT00164437|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2002||2002-09-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||CD-ROM Intervention for Prostate Cancer Screening|CD-ROM Intervention for Prostate Cancer Screening|Completed||Phase 2/Phase 3|554||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:56.825221|2017-10-11 05:23:56.825221
NCT00164008|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-03|||October 2002||2002-10-01|September 2005|2005-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention|Comparison Between Pamidronate and Zoledronic Acid for the Treatment of Heart and Lung Transplant Related Osteopaenia and Osteoporosis|Completed||Phase 4|56|Actual|Bayside Health|||||f||||||||||||||2017-10-11 05:23:53.857088|2017-10-11 05:23:53.857088
NCT00164021|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-13|||February 2001||2001-02-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Observational|||The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation|The Prevalence and Significance of Gastro-oesophageal Reflux in Adults With Cystic Fibrosis Before and After Lung Transplantation, Together With the Effects of Physiotherapy Airway Clearance Techniques on Gastro-oesophageal Function|Recruiting||N/A|180|Anticipated|Bayside Health|||2||f||||f||||||||||2017-10-11 05:23:53.917196|2017-10-11 05:23:53.917196
NCT00164034|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-02-10|||November 2005||2005-11-01|September 2005|2005-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Trauma Reception and Resuscitation Project|Trauma Reception and Resuscitation Project - 'Time for a New Approach'|Completed||N/A|1171|Actual|Bayside Health|||||f||||||||||||||2017-10-11 05:23:54.044184|2017-10-11 05:23:54.044184
NCT00164047|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-07-29|||April 2003||2003-04-01|July 2009|2009-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||ENIGMA - Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: a Randomised Controlled Trial|Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: a Randomised Controlled Trial|Completed||Phase 4|2070|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:23:54.128062|2017-10-11 05:23:54.128062
NCT00164060|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-03|||February 2004||2004-02-01|September 2005|2005-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection|Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection|Terminated||N/A|158|Actual|Bayside Health|||||f||||||||||||||2017-10-11 05:23:54.215353|2017-10-11 05:23:54.215353
NCT00164073|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-31|||February 2004||2004-02-01|September 2005|2005-09-01|February 2007||2007-02-01|||||Observational|||Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection|Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection|Unknown status|Recruiting|N/A|60|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:23:54.285999|2017-10-11 05:23:54.285999
NCT00164086|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-10||||||September 2005|2005-09-01||||||||Interventional|||Atorvastatin in Myeloma||Unknown status|Not yet recruiting|Phase 1|||Bayside Health|||||f||||||||||||||2017-10-11 05:23:54.363393|2017-10-11 05:23:54.363393
NCT00164099|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-10-30|||November 2005||2005-11-01|September 2006|2006-09-01|June 2007|Actual|2007-06-01|||||Interventional|||The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study|The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study|Terminated||Phase 4|40|Actual|Beth Israel Medical Center||1||Patients would not take product|f||||f||||||||||2017-10-11 05:23:54.429388|2017-10-11 05:23:54.429388
NCT00164112|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-13|||November 2004||2004-11-01|March 2005|2005-03-01|June 2005||2005-06-01|||||Interventional|||Comparative Effects of Azithromycin, Telithromycin and Levofloxacin on Drug Metabolizing Enzymes|Comparison of the Effect of Azithromycin, Telithromycin and Levofloxacin on Drug Metabolizing Enzymes Using the Validated Cooperstown 5+1 Cocktail|Completed||Phase 4|16||Bassett Healthcare|||||f||||||||||||||2017-10-11 05:23:54.510449|2017-10-11 05:23:54.510449
NCT00164125|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-02-06|||July 2003||2003-07-01|February 2013|2013-02-01||||November 2004|Actual|2004-11-01||Interventional|||An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients|An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients|Completed||Phase 4|300||Braintree Laboratories|||||||||||||||||||2017-10-11 05:23:54.581316|2017-10-11 05:23:54.581316
NCT00164138|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-26|||December 2001||2001-12-01|September 2005|2005-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease|Development of an Intervention and and Education Program for Adult Women With Urinary Incontinence and Chronic Lung Disease Including Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|99|Actual|Bayside Health||1|||f||||f||||||||||2017-10-11 05:23:54.751425|2017-10-11 05:23:54.751425
NCT00164151|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-02-06|||June 2001||2001-06-01|February 2013|2013-02-01||||May 2002|Actual|2002-05-01||Interventional|||A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.|A Comparison of the Efficacy and Safety of Two Bowel Preparations: HalfLytely® (2L NuLYTELY and 20 mg Bisacodyl), and Visicol™ Prior To Colonoscopy.|Completed||Phase 3|60||Braintree Laboratories|||||||||||||||||||2017-10-11 05:23:54.832309|2017-10-11 05:23:54.832309
NCT00164164|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-02-06|||August 1999||1999-08-01|February 2013|2013-02-01||||June 2000|Actual|2000-06-01||Interventional|||HalfLytely Bowel Prep System for Colonoscopy|HalfLytely Bowel Prep System for Colonoscopy|Completed||Phase 3|200||Braintree Laboratories|||||||||||||||||||2017-10-11 05:23:54.892311|2017-10-11 05:23:54.892311
NCT00164177|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-02-06|||October 2004||2004-10-01|February 2013|2013-02-01||||December 2004|Actual|2004-12-01||Interventional|||Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.|A Preliminary Evaluation Of The Efficacy Of HalfLYTELY® For Bowel Cleansing Before Virtual Colonoscopy (VC) and Conventional Colonoscopy (CC).|Completed||Phase 4|20||Braintree Laboratories|||||||||||||||||||2017-10-11 05:23:54.952658|2017-10-11 05:23:54.952658
NCT00164190|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-10-14|||July 2004||2004-07-01|October 2010|2010-10-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarction|Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction- The TRANSFER-AMI Trial|Completed||N/A|1200|Anticipated|Canadian Heart Research Centre||1|||f||||t||||||||||2017-10-11 05:23:55.215094|2017-10-11 05:23:55.215094
NCT00164203|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-04|||April 2005||2005-04-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|December 2007|Actual|2007-12-01||Interventional|||The Feelings Club: Evaluating a School-based Intervention for Children at Risk for Depression and Anxiety Disorders|The Feelings Club: Evaluating a School-based Intervention for Children at Risk for Depression and Anxiety Disorders|Completed||N/A|150|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-10-11 05:23:55.300992|2017-10-11 05:23:55.300992
NCT00164216|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-10|||March 2005||2005-03-01|September 2012|2012-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in Peru|Evaluation of the Efficacy and Effectiveness of Combined Therapy With Mefloquine and Artesunate for Uncomplicated Malaria Treatment in the Loreto Region (Amazon Basin), Peru|Completed||Phase 4|208|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:55.396798|2017-10-11 05:23:55.396798
NCT00164229|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-04-25|||October 2001||2001-10-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Fetal Alcohol Syndrome: Socio-Cognitive Habilitation|Study to Investigate the Effectiveness of a Math Intervention for Children With Fetal Alcohol Syndrome or Related Condition|Completed||Phase 1/Phase 2|100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:55.472138|2017-10-11 05:23:55.472138
NCT00164242|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 2002||2002-01-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Treatment of Tardive Dyskinesia With Galantamine|Treatment of Tardive Dyskinesia With Galantamine|Completed||Phase 4|36||Caroff, Stanley N., M.D.|||||f||||||||||||||2017-10-11 05:23:55.547144|2017-10-11 05:23:55.547144
NCT00164255|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-10|||January 2003||2003-01-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy|Efficacy of Intermittent Sulfadoxine-Pyrimethamine and Sulfadoxine-Pyrimethamine + Artesunate Treatment in the Prevention of Malaria in Pregnancy in an Area With Chloroquine-Resistant Plasmodium Falciparum|Completed||Phase 4|1614|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:55.630445|2017-10-11 05:23:55.630445
NCT00164268|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-09-06|||October 2002||2002-10-01|September 2007|2007-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Ke Ala Lokahi Demonstration Project for Sexual and Domestic Violence Prevention|Ke Ala Lokahi Demonstration Project for the Early Intervention and Prevention of Sexual and Domestic Violence Among Racial and Ethnic Populations|Completed||Phase 1|300||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:55.72523|2017-10-11 05:23:55.72523
NCT00164281|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-02-05|||November 2004||2004-11-01|February 2014|2014-02-01|May 2011|Actual|2011-05-01|July 2009|Actual|2009-07-01||Interventional|||Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana|A Randomized, Placebo-Controlled Study of Limited vs. Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana|Completed||Phase 4|2000|Actual|Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-10-11 05:23:55.802101|2017-10-11 05:23:55.802101
NCT00164294|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09||||||September 2005|2005-09-01||||||||Interventional|||ED Intervention to Reduce Risky Behaviors in Drivers|ED Intervention to Reduce Risky Behaviors in Drivers|Completed||Phase 2|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:55.92159|2017-10-11 05:23:55.92159
NCT00164307|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-07|||October 2001||2001-10-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships|Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships|Completed||Phase 1/Phase 2|100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:55.998238|2017-10-11 05:23:55.998238
NCT00164320|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||May 2004||2004-05-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Interventional|||Project TEAM: Teaching HIV Prevention in the HIV Clinic|Project TEAM: Teaching HIV Prevention in the HIV Clinic|Completed||Phase 2|600||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:56.078001|2017-10-11 05:23:56.078001
NCT00164333|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-26|||September 2004||2004-09-01|September 2012|2012-09-01|April 2008|Actual|2008-04-01|May 2007|Actual|2007-05-01||Interventional|||The Treatment Advocacy Program|The Treatment Advocacy Program|Completed||Phase 2|300||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:56.147738|2017-10-11 05:23:56.147738
NCT00164346|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-03-23|||January 2002||2002-01-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)|Neurocognitive Habilitation for Children With FAS/ARND|Completed||Phase 1/Phase 2|100|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:56.21596|2017-10-11 05:23:56.21596
NCT00164359|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-26|||April 2005||2005-04-01|September 2012|2012-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi|A Double-blind Randomised Trial to Assess the Tolerability of Amodiaquine Plus Artesunate (AQ-Art) Versus Chlorproguanil Plus Dapsone Plus Artesunate (CDA) in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi|Completed||Phase 4|212||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:56.316321|2017-10-11 05:23:56.316321
NCT00164372|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-26|||May 2002||2002-05-01|September 2012|2012-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users|Collaborative Injection Drug Users Study III/Drug Users Intervention Trial (CIDUS III/DUIT)|Completed||Phase 2/Phase 3|1400||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:56.422772|2017-10-11 05:23:56.422772
NCT00164385|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-10-20||||||September 2005|2005-09-01||||||||Interventional|||Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS|Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:56.518335|2017-10-11 05:23:56.518335
NCT00164398|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-10|||June 2004||2004-06-01|September 2012|2012-09-01|September 2008|Actual|2008-09-01|October 2006|Actual|2006-10-01||Interventional|||HIP: HIV Intervention for Providers|HIP: HIV Intervention for Providers|Completed||Phase 2|50|Anticipated|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:56.579975|2017-10-11 05:23:56.579975
NCT00164411|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-03-13|||January 2004||2004-01-01|March 2012|2012-03-01|March 2005||2005-03-01|||||Interventional|||Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine|Pneumococcal Conjugate Vaccine (Prevnar; Wyeth) With Pneumococcal Polysaccharide Vaccine (23-valent) and Tetanus/Diphtheria Vaccine|Completed||Phase 1|30||Centers for Disease Control and Prevention|||||||||||||||||||2017-10-11 05:23:56.657085|2017-10-11 05:23:56.657085
NCT00164424|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-10|||March 2005||2005-03-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|March 2009|Actual|2009-03-01||Interventional|||Episodic Acyclovir Therapy for Genital Ulcers|Impact of Episodic Acyclovir Therapy on Ulcer Duration and HIV Shedding From Genital Ulcers Among Men in South Africa|Completed||Phase 2/Phase 3|613|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:56.739935|2017-10-11 05:23:56.739935
NCT00164450|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-08-22|||September 2005||2005-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection|TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children Receiving Once Weekly Rifapentine and Isoniazid for the Treatment of Latent Tuberculosis Infection|Completed||N/A|230|Anticipated|Centers for Disease Control and Prevention|||||f||||t||||||||||2017-10-11 05:23:56.916774|2017-10-11 05:23:56.916774
NCT00164463|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-06-07|||July 2004||2004-07-01|June 2011|2011-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment|TBTC Study 27/28 PK: Pharmacokinetic Issues in the Use of Moxifloxacin for Treatment of Tuberculosis|Completed||Phase 2|72|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-10-11 05:23:57.065124|2017-10-11 05:23:57.065124
NCT00164476|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2003||2003-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Promoting Clinical Preventive Services Among Adults With Disabilities|Promoting Prevention Among Adults With Disabilities|Completed||Phase 1|200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:57.186651|2017-10-11 05:23:57.186651
NCT00164489|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2003||2003-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Health Promotion of People With Disabilities|Intervention Research Grants to Promote the Health of People With Disabilities|Completed||Phase 2/Phase 3|400||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:57.270529|2017-10-11 05:23:57.270529
NCT00164502|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2003||2003-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Limb Loss Self-Management Program|"Limb Loss Self-Management Program: Promoting Amputee Life Skills"|Completed||Phase 2|500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:57.341275|2017-10-11 05:23:57.341275
NCT00164515|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-07-27|||October 2004||2004-10-01|July 2011|2011-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|PEP||Increasing Physical Activity Among Overweight Women With Mobility Disabilities.|Personalized Exercise Programme (PEP) I: Physician Referral Approach to Increasing Awareness and Sustainability of Physical Activity for Overweight Adults With Mobility Limitations.|Completed||Phase 2|96|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-11 05:23:57.41732|2017-10-11 05:23:57.41732
NCT00164528|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2001||2001-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Intervening With Children/Adolescents With FAS/ARND|Intervening With Children/Adolescents With FAS/ARND|Completed||Phase 1/Phase 2|52||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:57.506526|2017-10-11 05:23:57.506526
NCT00164541|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-20|||September 2004||2004-09-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||An Arts-Based Initiative for the Prevention of Violence Against Women and Girls|An Arts-Based Initiative for the Prevention of Violence Against Women and Girls|Completed||Phase 1|1440|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:57.570672|2017-10-11 05:23:57.570672
NCT00164554|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-25|||October 2001||2001-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Fetal Alcohol Syndrome/ARND Research Consortion|Fetal Alcohol Syndrome/ARND Research Consortion-Oklahoma|Completed||Phase 1/Phase 2|100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:57.642328|2017-10-11 05:23:57.642328
NCT00164567|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-10-22||||||October 2009|2009-10-01||||||||Interventional|||Intimate Partner Violence (IPV)Screening in Health Care Clinics in Rural South Carolina|IPV Screening in Health Care Clinics in Rural South Carolina|Completed||Phase 2|1200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:57.721593|2017-10-11 05:23:57.721593
NCT00164580|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-26|||October 1996||1996-10-01|September 2012|2012-09-01|August 2004|Actual|2004-08-01|August 2002|Actual|2002-08-01||Interventional|||Community Intervention Trial for Youth (CITY) Study|Prevention of HIV Infection in Youth at Risk: Developing Community-Level Intervention Strategies That Work (Community Intervention Trial for Youth (CITY) Study)|Completed||Phase 2/Phase 3|12000||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:57.793017|2017-10-11 05:23:57.793017
NCT00164593|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-04-04|||April 2005||2005-04-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|||Youth Empowerment Solutions for Peaceful Communities|Youth Empowerment Solutions for Peaceful Communities|Completed||Phase 1|1142|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-10-11 05:23:57.936029|2017-10-11 05:23:57.936029
NCT00164606|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-20|||May 2003||2003-05-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||A Dissemination Trial of the Positive Parenting Program to Reduce Child Maltreatment in South Carolina|A Dissemination Trial of the Positive Parenting Program to Reduce Child Maltreatment in South Carolina|Completed||Phase 2|14690|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:58.022823|2017-10-11 05:23:58.022823
NCT00164619|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-04|||July 2001||2001-07-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|November 2006|Actual|2006-11-01||Interventional|||Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR|Testing the Effectiveness of the VOICES/VOCES Intervention Package as Implemented by STD and HIV Prevention Agencies That Target Hispanics and African Americans in the U.S. and Puerto Rico|Completed||Phase 2/Phase 3|3660|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 05:23:58.097637|2017-10-11 05:23:58.097637
NCT00164632|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2001||2001-10-01|September 2005|2005-09-01||||||||Interventional|||No More Falls Injury Prevention Study|California No More Falls! Senior Injury Prevention Program|Completed||N/A|552||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:58.192888|2017-10-11 05:23:58.192888
NCT00164645|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-04-26||||||September 2005|2005-09-01||||||||Interventional|||Problem Solving for Caregivers of Persons With Brain Injury|Problem Solving for Caregivers of Patients With Traumatic Brain Injury|Unknown status|Recruiting|Phase 3|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:58.244246|2017-10-11 05:23:58.244246
NCT00164658|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-06|||September 2005||2005-09-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Evaluating Tools for Health Promotion and Disease Prevention|Evaluating Tools for Health Promotion and Disease Prevention|Completed||Phase 1|8400|Anticipated|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-10-11 05:23:58.305335|2017-10-11 05:23:58.305335
NCT00164671|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||November 2003||2003-11-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Testing the POWER Project: A Neighborhood Intervention Trial|Testing the POWER Project: A Neighborhood Intervention Trial|Completed||N/A|5000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:58.401204|2017-10-11 05:23:58.401204
NCT00164684|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-02-08|||September 2001||2001-09-01|February 2012|2012-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Men of Color Fatherhood Education and Violence Prevention Project|Men of Color Fatherhood Education and Violence Prevention Project|Completed||Phase 1|||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:58.484209|2017-10-11 05:23:58.484209
NCT00164697|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-02-02|||October 1999||1999-10-01|September 2012|2012-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|Legacy||Legacy for Children, an Early Intervention Study to Promote Optimal Child Development in Low-income Families|Legacy for Children, The CDC Parenting Research Projects|Completed||N/A|547|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||No||2017-10-11 05:23:58.547208|2017-10-11 05:23:58.547208
NCT00164710|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-26|||April 2005||2005-04-01|September 2012|2012-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi|An Open Randomised Trial of the Efficacy of Sulfadoxine-Pyrimethamine (SP), Amodiaquine + SP (AQ-SP), AQ + Artesunate (AQ-Art), Chlorproguanil-Dapsone + Art (CD-Art), and Lumefantrine-Artemether (LA) for Uncomplicated Malaria in Malawi|Completed||Phase 4|365||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:23:58.661641|2017-10-11 05:23:58.661641
NCT00164723|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-08-10|||February 2005||2005-02-01|January 2011|2011-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Endoscopic Evaluation of Lower Gastrointestinal Bleeding (GIB) in Patients Presenting With Melena|Endoscopic Evaluation of the Incidence and Etiology of Lower Gastrointestinal Bleeding in Patients Presenting With Melena|Completed||N/A|165|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-10-11 05:23:58.761135|2017-10-11 05:23:58.761135
NCT00164736|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-22|||March 2004||2004-03-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Breastfeeding, Antiretroviral, and Nutrition Study|HIV Infection and Breastfeeding: Interventions for Maternal and Infant Health|Completed||Phase 3|2369|Actual|Centers for Disease Control and Prevention||6|||f||||t||||||||||2017-10-11 05:23:58.841527|2017-10-11 05:23:58.841527
NCT00164749|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-04-25|||October 2004||2004-10-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease|A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease|Completed||Phase 1/Phase 2|36|Actual|Chinese University of Hong Kong||3|||f||||||||||||||2017-10-11 05:23:58.957741|2017-10-11 05:23:58.957741
NCT00164762|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-27|||June 2005||2005-06-01|September 2007|2007-09-01|November 2006|Actual|2006-11-01|||||Observational|||Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers|Nevirapine Pharmacodynamics and Resistance Among HIV-Infected Mothers in Lilongwe, Malawi|Completed||N/A|126|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:23:59.045543|2017-10-11 05:23:59.045543
NCT00164775|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-09-14|||June 2005||2005-06-01|September 2016|2016-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia|The Efficacy of Imipramine in Treatment of Functional Dyspepsia: A Double Blind Randomized Placebo Controlled Trial|Completed||Phase 3|107|Actual|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-10-11 05:23:59.278035|2017-10-11 05:23:59.278035
NCT00164788|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-08-27|||July 2004||2004-07-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole|A Randomized Comparison of High Dose Oral to Intravenous Esomeprazole in Patients After Endoscopic Control to Their Bleeding Peptic Ulcers: an Intra-gastric pH Study.|Terminated||Phase 2|7|Actual|Chinese University of Hong Kong||2||No suitable patients and many patients refused the study|f||||f||||||||||2017-10-11 05:23:59.402206|2017-10-11 05:23:59.402206
NCT00164801|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-03-25|||November 2004||2004-11-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|||||Interventional|||Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese?|Is Visceral Hyperalgesia the Culprit of Noncardiac Chest Pain in Chinese? Part 2: Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP Patients|Terminated||N/A|60|Actual|Chinese University of Hong Kong||||Funding ended|f||||||||||||||2017-10-11 05:23:59.533418|2017-10-11 05:23:59.533418
NCT00164814|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-03-25||||||March 2008|2008-03-01||||||||Observational|||The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients|Is Visceral Hyperalgesia the Culprit of Noncardiac Chest Pian in Chinese? Part I: The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients|Terminated||N/A|100|Actual|Chinese University of Hong Kong||||Funding ended|f||||||||||||||2017-10-11 05:23:59.614752|2017-10-11 05:23:59.614752
NCT00164827|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-11|||January 2003||2003-01-01|September 2005|2005-09-01||||||||Observational|||Surveillance of Bleeding Peptic Ulcer Using Wireless Capsule Endoscopy|Phase 3 Study on the Use of Capsule Endoscope for Surveillance and Detection of Peptic Ulcer Rebleeding After Therapeutic Endoscopy|Unknown status|Recruiting|Phase 3|50||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:23:59.685984|2017-10-11 05:23:59.685984
NCT00164840|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-03-29|||May 2003||2003-05-01|March 2010|2010-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy|Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy|Completed||Phase 3|244|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:23:59.800251|2017-10-11 05:23:59.800251
NCT00164853|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2012-02-16|||September 2005||2005-09-01|September 2010|2010-09-01||||September 2011|Actual|2011-09-01||Interventional|||Compare Combined Sphincterotomy and Balloon Dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones|Combined Sphincterotomy and Balloon Dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones—a Randomized Controlled Trial|Completed||Phase 3|180|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-10-11 05:23:59.89713|2017-10-11 05:23:59.89713
NCT00164866|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-06-05|||February 2004||2004-02-01|June 2007|2007-06-01|September 2005||2005-09-01|||||Interventional|||Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy|Administration of Intravenous Proton Pump Inhibitor Prior to Endoscopy [APPE] in Patients With Upper Gastrointestinal Bleeding; a Double-Blind Placebo-Controlled Randomised Study.|Completed||Phase 4|638||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:00.01399|2017-10-11 05:24:00.01399
NCT00164879|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-06|||January 2000||2000-01-01|September 2005|2005-09-01||||||||Interventional|||Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers|Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers: A Randomised Trial|Unknown status|Recruiting|Phase 3|70|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:00.098389|2017-10-11 05:24:00.098389
NCT00164892|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-16|||October 2004||2004-10-01|September 2005|2005-09-01||||||||Interventional|||Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial|Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial|Unknown status|Active, not recruiting|Phase 3|214||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:00.221299|2017-10-11 05:24:00.221299
NCT00164905|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-08-27|||September 2004||2004-09-01|August 2012|2012-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage|Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage: Can it Guide the Use of and Predict Failure of Endoscopic Treatment? A Prospective, Multicenter, Randomized, Controlled Study|Terminated||N/A|121|Actual|Chinese University of Hong Kong||2||Slow recruitment|f||||f||||||||||2017-10-11 05:24:00.308368|2017-10-11 05:24:00.308368
NCT00164918|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||Role of Routine Nasogastric Decompression After Subtotal Gastrectomy|Role of Routine Nasogastric Decompression After Subtotal Gastrectomy|Unknown status|Recruiting|Phase 3|90||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:00.407186|2017-10-11 05:24:00.407186
NCT00164931|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-06-09|||October 2003||2003-10-01|September 2005|2005-09-01||||||||Interventional|||A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer|Phase 3 Study of Prospective Randomized Trial Comparing Adjunctive High Dose Omeprazole Infusion Against Scheduled Second Endoscopy in the Prevention of Peptic Ulcer Rebleeding After Therapeutic Endoscopy|Completed||Phase 3|240|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:00.51923|2017-10-11 05:24:00.51923
NCT00164944|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-04-20|||April 2004||2004-04-01|April 2017|2017-04-01|April 6, 2017|Actual|2017-04-06|August 2016|Actual|2016-08-01||Observational|||Screening for Colorectal Neoplasm in First Degree Relatives of the Affected|Colonoscopic Screening in First-degree Relatives of Hong Kong Chinese Patients With Sporadic Colorectal Cancer: a Cohort Study With Case Control Analysis|Completed||N/A|748|Actual|Chinese University of Hong Kong|||2||f||||f||||||||||2017-10-11 05:24:00.625453|2017-10-11 05:24:00.625453
NCT00164957|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-02-02|||September 2002||2002-09-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effect of Continuous Versus Enteral Pump Feeding in Aspiration in Tube Fed Patients|The Effect of Continuous vs Enteral Pump Feeding in Aspiration in Tube Fed Patients|Completed||N/A|222|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:00.712782|2017-10-11 05:24:00.712782
NCT00164970|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-02-02|||October 2004||2004-10-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?|Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?|Completed||Phase 4|166|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:00.787525|2017-10-11 05:24:00.787525
NCT00164996|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2012-02-16|||September 2004||2004-09-01|September 2005|2005-09-01||||September 2010|Actual|2010-09-01||Interventional|||Ultrathin Versus Conventional Esophagogastroduodenoscopy in Unsedated Patient With or Without Local Pharyngeal Anaesthesia|Comparison of Ultrathin Versus Conventional Esophagogastroduodenoscopy in Unsedated Patients With or Without Local Pharyngeal Anaesthesia: A Randomized Controlled Trial|Completed||Phase 3|400|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:00.877595|2017-10-11 05:24:00.877595
NCT00165009|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-10|||June 2005||2005-06-01|May 2013|2013-05-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|||Resolution Endoclips Vs Epinephrine Injection and Heater Probe|A Prospective Randomized Comparison of a Novel Hemostatic Clip (Resolution Clip™) to Combined Epinephrine Injection and Heater Probe Thermocoagulation in the Endoscopic Control of Ulcer Bleeding|Terminated||Phase 3|103|Actual|Chinese University of Hong Kong||2||Slow recruitment|f||||f||||||||||2017-10-11 05:24:00.950651|2017-10-11 05:24:00.950651
NCT00165022|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-27|||September 2003||2003-09-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|||||Observational|||Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population|Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population|Completed||N/A|330|Actual|Chinese University of Hong Kong|||1||f||||||||||||||2017-10-11 05:24:01.044913|2017-10-11 05:24:01.044913
NCT00165035|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-03|||May 2005||2005-05-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|January 2007|Actual|2007-01-01||Interventional|||Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)|Multi-Center, Single-Blind, Two-Arm, Randomized, Controlled, Non Inferiority Trial of the Conor CoStar Paclitaxel-Eluting Coronary Stent System vs the TAXUS DES in Patients With De Novo Lesions of the Native Coronary Arteries|Completed||Phase 3|1701|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:24:01.110327|2017-10-11 05:24:01.110327
NCT00165048|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-08|||October 2004||2004-10-01|September 2005|2005-09-01||||||||Interventional|||Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial|Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 3|206||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:01.222574|2017-10-11 05:24:01.222574
NCT00165061|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||July 2000||2000-07-01|September 2005|2005-09-01||||||||Interventional|||Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer – Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)|Phase 3 Multicenter Randomized Study Comparing Esophagectomy Against Definitive Chemoradiation for Treatment of Squamous Esophageal Cancer|Completed||Phase 3|80||Chinese University of Hong Kong|||||f||||||||||||||2017-10-11 05:24:01.297368|2017-10-11 05:24:01.297368
NCT00165074|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-11-19|||June 2003||2003-06-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation|Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With|Completed||N/A|11|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-11 05:24:01.385252|2017-10-11 05:24:01.385252
NCT00165087|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-20|||January 1996||1996-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment of Childhood Acute Lymphoblastic Leukemia|Treatment of Childhood Acute Lymphoblastic Leukemia|Terminated||Phase 3|491||Dana-Farber Cancer Institute||||Terminated by IRB for continuing review|||||||||||||||2017-10-11 05:24:01.470359|2017-10-11 05:24:01.470359
NCT00165100|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-20|||January 2000||2000-01-01|December 2007|2007-12-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer|Dynamic Area Telethermometry (DAT) as an Auxiliary Imaging Modality in Assessment of Patients With Cancer|Completed||N/A|50||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:01.585927|2017-10-11 05:24:01.585927
NCT00165126|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-10-30|||January 2004||2004-01-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|January 2006|Actual|2006-01-01||Observational|||Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma|Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma|Completed||N/A|40|Actual|Dana-Farber Cancer Institute|||1||f||||t||||||||||2017-10-11 05:24:01.647859|2017-10-11 05:24:01.647859
NCT00165139|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-10-30|||January 1996||1996-01-01|October 2009|2009-10-01|February 2009|Actual|2009-02-01|November 2000|Actual|2000-11-01||Interventional|||Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas|Double Dose Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Stage Neuroblastoma and Sarcomas|Completed||Phase 2|20|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:24:01.712374|2017-10-11 05:24:01.712374
NCT00165152|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-08-07|||July 1998||1998-07-01|August 2012|2012-08-01|June 2005|Actual|2005-06-01|September 2001|Actual|2001-09-01||Interventional|||Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing|A Randomized Study of Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing|Completed||N/A|150|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 05:24:01.795411|2017-10-11 05:24:01.795411
NCT00165178|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-04-23|||September 2000||2000-09-01|April 2013|2013-04-01|May 2011|Actual|2011-05-01|December 2004|Actual|2004-12-01||Interventional|||Treatment of Acute Lymphoblastic Leukemia in Children|Treatment of Acute Lymphoblastic Leukemia in Children|Completed||Phase 3|498|Actual|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-10-11 05:24:01.918777|2017-10-11 05:24:01.918777
NCT00165191|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-04-27|||August 1998||1998-08-01|April 2009|2009-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus|A Phase II Study of Doxorubicin, Cisplatin, and 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus|Completed||Phase 2|32||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:02.097487|2017-10-11 05:24:02.097487
NCT00165204|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-20|||April 2004||2004-04-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy|A Randomized Study of the Effects of Tibolone on Bone Density, Menopause Symptoms and Breast Density in High Risk Women After Prophylactic Oophorectomy|Completed||Phase 2|50||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:02.21449|2017-10-11 05:24:02.21449
NCT00165217|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-20|||November 2001||2001-11-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma|A Phase II Trial of Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma|Completed||Phase 2|37||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:02.295708|2017-10-11 05:24:02.295708
NCT00165230|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-04-27|||May 2002||2002-05-01|April 2009|2009-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors|A Phase II Study of Thalidomide in Combination With Temodar in Patients With Metastatic Neuroendocrine Tumors|Completed||Phase 2|32||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:02.439322|2017-10-11 05:24:02.439322
NCT00165243|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-06-06|||September 1998||1998-09-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|January 2004|Actual|2004-01-01||Interventional|||Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer|Tangential Radiation Therapy Without Axillary Dissection in Early-Stage Breast Cancer|Completed||Phase 2|100|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-11 05:24:02.524242|2017-10-11 05:24:02.524242
NCT00165256|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-07-05|||May 1995||1995-05-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|July 2002|Actual|2002-07-01||Observational|||Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast|Wide Excision Alone for DCIS-Grades 1 and 2|Terminated||Phase 2|158|Actual|Dana-Farber Cancer Institute|||1|The pre-specified stopping boundary was reached.|f||||f||||||||No||2017-10-11 05:24:02.591308|2017-10-11 05:24:02.591308
NCT00165269|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-10-30|||May 1992||1992-05-01|October 2009|2009-10-01|February 2008|Actual|2008-02-01|June 2000|Actual|2000-06-01||Interventional|||Mantle Irradiation for Hodgkin's Disease|Mantle Irradiation for Selected Hodgkin's Disease Patients With Stage IA-IIA Disease|Completed||Phase 2|100|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:24:02.673375|2017-10-11 05:24:02.673375
NCT00165282|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-26|||April 2005||2005-04-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|January 2010|Actual|2010-01-01||Interventional|||Mindfulness Meditation in Bone Marrow Transplantation|Mindfulness Meditation in Bone Marrow Transplantation|Completed||Phase 2/Phase 3|241|Actual|Emory University||3|||f||||t||||||||||2017-10-11 05:24:02.760186|2017-10-11 05:24:02.760186
NCT00165295|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-06-23|||September 2005||2005-09-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Sildenafil Citrate in Waldenstrom's Macroglobulinemia|Phase II Study of Sildenafil Citrate in Waldenstrom's Macroglobulinemia|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:02.84781|2017-10-11 05:24:02.84781
NCT00165308|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-07-08|||April 2001||2001-04-01|July 2014|2014-07-01|June 2009|Actual|2009-06-01|March 2004|Actual|2004-03-01||Interventional|||Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors|A Feasibility Study of Tamoxifen Prevention of Breast Cancer in Hodgkin's Disease Survivors|Completed||N/A|29|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:24:02.915648|2017-10-11 05:24:02.915648
NCT00165334|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-07-21|||June 2005||2005-06-01|July 2009|2009-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer|Phase II Trial of Cetuximab Plus Vinorelbine in Previously Untreated Patients > 70 With Advanced NSCLC|Completed||Phase 2|53||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:03.002459|2017-10-11 05:24:03.002459
NCT00165347|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-20|||December 2003||2003-12-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Protein Tyrosine Kinases (PTK) in Multiple Myeloma|Phase II Study of PTK787/ZK222584 in Multiple Myeloma|Completed||Phase 2|10||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:03.084113|2017-10-11 05:24:03.084113
NCT00165360|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-10-30|||September 2001||2001-09-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|December 2006|Actual|2006-12-01||Interventional|||Prolonged Daily Temozolomide for Low-Grade Glioma|A Phase II Study of Prolonged Daily Temozolomide for Low-Grade Glioma|Completed||Phase 2|46|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:24:03.168083|2017-10-11 05:24:03.168083
NCT00165373|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-21|||January 2003||2003-01-01|December 2007|2007-12-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||rhEndostatin Protein Involving Pediatric Patients With Cancer|A Phase I, Safety, Pharmacokinetic and Pharmacodynamic Study of rhEndostatin Protein Administered by Continuous Intravenous Infusion to Pediatric Patients With Cancer|Terminated||Phase 1|21|Actual|Dana-Farber Cancer Institute||1||Lack of drug supply|f||||f||||||||||2017-10-11 05:24:03.260702|2017-10-11 05:24:03.260702
NCT00165386|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-12-07|||July 2001||2001-07-01|December 2009|2009-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients|MRI-guided Bone Marrow Biopsies of Advanced CaP Patients|Completed||N/A|20||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:04.825556|2017-10-11 05:24:04.825556
NCT00165399|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-07-02|||March 2004||2004-03-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|April 2005|Actual|2005-04-01||Interventional|||Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment|Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment|Completed||Phase 2|61|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:24:04.898787|2017-10-11 05:24:04.898787
NCT00165412|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-08-13|||July 2005||2005-07-01|August 2012|2012-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease|Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease|Completed||N/A|168|Anticipated|Dana-Farber Cancer Institute|||1||f||||f||||||||||2017-10-11 05:24:04.981551|2017-10-11 05:24:04.981551
NCT00165425|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-07-26|||February 2004||2004-02-01|July 2017|2017-07-01|April 2018|Anticipated|2018-04-01|October 2007|Actual|2007-10-01||Interventional|||Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation|Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation|Active, not recruiting||N/A|210|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-11 05:24:05.154446|2017-10-11 05:24:05.154446
NCT00165438|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-12-19|||October 2001||2001-10-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|November 2005|Actual|2005-11-01||Observational|||Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy|A Prospective Study of Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy With or Without Mediastinal Irradiation|Completed||N/A|60|Actual|Dana-Farber Cancer Institute|||1||f||||t||||||||||2017-10-11 05:24:05.243603|2017-10-11 05:24:05.243603
NCT00165451|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-07-06|||June 2001||2001-06-01|July 2011|2011-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer|Anti-Angiogenic Chemotherapy: A Phase II Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer|Completed||Phase 2|20|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-10-11 05:24:05.316148|2017-10-11 05:24:05.316148
NCT00165464|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-04-24|||August 2001||2001-08-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|March 2005|Actual|2005-03-01||Interventional|||Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer|A Phase II Trial of Taxotere, Cisplatin, and Irinotecan in Advanced Esophageal and Gastric Cancer|Completed||Phase 2|54|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:24:05.410234|2017-10-11 05:24:05.410234
NCT00165477|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-03-08|||September 2005||2005-09-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|November 2007|Actual|2007-11-01||Interventional|||Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study of Lenalidomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme.|Completed||Phase 2|23|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:24:05.507258|2017-10-11 05:24:05.507258
NCT00165490|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-11-07|||August 2004||2004-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2007|Actual|2007-11-01||Interventional|||Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer|Phase II Trial of Cetuximab, Irinotecan, Cisplatin (CPC), Concurrent Radiation Therapy, and Surgery for Resectable Esophageal Cancer|Completed||Phase 2|19|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:24:05.597144|2017-10-11 05:24:05.597144
NCT00165503|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-25|2014-04-23||April 2004||2004-04-01|July 2016|2016-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate|A Phase II Feasibility Study of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate Followed ny Adjuvant ALIMTA/Cisplatin|Terminated||Phase 2|16|Actual|Dana-Farber Cancer Institute|This trial was terminated due to low accrual and feasibility.|1||lack of acurral|f||||t||||||||No||2017-10-11 05:24:05.677128|2017-10-11 05:24:05.677128
NCT00165516|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-03-26|||January 2004||2004-01-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|July 2006|Actual|2006-07-01||Interventional|||Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate|A Phase II Feasibility Study of Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate|Completed||Phase 2|85|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:24:06.041134|2017-10-11 05:24:06.041134
NCT00170378|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-06-26|||December 2002||2002-12-01|October 2012|2012-10-01|August 2005|Actual|2005-08-01|||||Interventional|||The Use of Low Molecular Weight Heparin in Traumatic Brain Injury|The Use of Low Molecular Weight Heparin in Traumatic Brain Injury|Completed||Phase 4|300||Minneapolis Medical Research Foundation|||||f||||||||||||No||2017-10-11 05:25:41.012507|2017-10-11 05:25:41.012507
NCT00165542|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-21|||June 1998||1998-06-01|November 2016|2016-11-01|August 2009|Actual|2009-08-01|February 2004|Actual|2004-02-01||Observational|||A-protein Levels in Adult and Pediatric Brain Tumor Patients|Determination of A-Protein Levels in Adult and Pediatric Brain Tumor Patients|Completed||N/A|54|Actual|Dana-Farber Cancer Institute|||1||f||||f||||||Samples With DNA|"     whole blood cerebrospinal fluid   "|No||2017-10-11 05:24:06.127657|2017-10-11 05:24:06.127657
NCT00165555|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-03-26|||August 1999||1999-08-01|March 2014|2014-03-01|November 2009|Actual|2009-11-01|April 2002|Actual|2002-04-01||Interventional|||Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma|Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin and Intravenous Sodium Thiosulfate in the Multimodality Treatment of Malignant Pleural Mesothelioma|Completed||Phase 1|70|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:24:06.206445|2017-10-11 05:24:06.206445
NCT00165568|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-10-30|||July 2005||2005-07-01|October 2009|2009-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer|Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer|Completed||Phase 2|20||Dana-Farber Cancer Institute|||||f||||||||||||||2017-10-11 05:24:06.295782|2017-10-11 05:24:06.295782
NCT00165581|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-20|||December 2002||2002-12-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma|A Pilot Clinical Trial to Evaluate High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Favorable Stage I and II Breast Cancer|Terminated||N/A|15||Dana-Farber Cancer Institute||||Due to continuing review|f||||||||||||||2017-10-11 05:24:06.377394|2017-10-11 05:24:06.377394
NCT00165594|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-01-22|||February 2005||2005-02-01|January 2014|2014-01-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||A Study of E7070 in Patients With Gastric Cancer|Non-Randomized, Open, Uncontrolled, Dose Comparison Study of E7070 in Patients With Gastric Cancer|Terminated||Phase 1/Phase 2|50||Eisai Inc.||||Study was completed.|f||||||||||||||2017-10-11 05:24:06.456421|2017-10-11 05:24:06.456421
NCT00165607|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-28|||April 1996||1996-04-01|January 2010|2010-01-01||||June 2005|Actual|2005-06-01||Interventional|||Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)||Completed||Phase 4|||Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:06.548647|2017-10-11 05:24:06.548647
NCT00165620|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-28|||November 2004||2004-11-01|January 2010|2010-01-01||||April 2005|Actual|2005-04-01||Interventional|||A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease||Completed||Phase 2|||Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:06.616781|2017-10-11 05:24:06.616781
NCT00165633|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-12-05|||March 2004||2004-03-01|December 2008|2008-12-01|March 2007|Actual|2007-03-01|||||Interventional|||A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma|A Randomized, Placebo-Controlled, Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma|Terminated||Phase 2/Phase 3|540|Anticipated|Eisai Inc.||3|||f||||||||||||||2017-10-11 05:24:06.693721|2017-10-11 05:24:06.693721
NCT00165646|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-07-14|2011-05-23||September 2004||2004-09-01|August 2010|2010-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease|A Double-Blind, Placebo-Controlled, Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease|Completed||Phase 3|288|Actual|Eisai Inc.||3|||f||||||||||||||2017-10-11 05:24:06.855749|2017-10-11 05:24:06.855749
NCT00165659|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-28|||November 2002||2002-11-01|January 2010|2010-01-01||||May 2005|Actual|2005-05-01||Interventional|||A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020||Completed||Phase 2|||Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:07.514032|2017-10-11 05:24:07.514032
NCT00165672|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-06|2011-07-19||May 2005||2005-05-01|August 2010|2010-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease|A Clinical Pharmacology Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease|Completed||Phase 3|26|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 05:24:07.82803|2017-10-11 05:24:07.82803
NCT00165685|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-28|||July 2004||2004-07-01|January 2010|2010-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Comparative Study of KES524 in Patients With Obesity Disease|A Double-Blind, Placebo-Controlled, Comparative Study of KES524 in Patients With Obesity Disease|Completed||Phase 3|||Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:08.156275|2017-10-11 05:24:08.156275
NCT00165698|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-11|2010-12-02||May 2005||2005-05-01|July 2014|2014-07-01|July 2007|Actual|2007-07-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women|Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women|Completed||Phase 3|240|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 05:24:08.301041|2017-10-11 05:24:08.301041
NCT00165711|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-08|||March 2003||2003-03-01|December 2005|2005-12-01||||||||Interventional|||The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.||Completed||Phase 4|||Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:08.93374|2017-10-11 05:24:08.93374
NCT00165724|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-05-02|||June 2004||2004-06-01|July 2010|2010-07-01|December 2006|Actual|2006-12-01|July 2006|Actual|2006-07-01||Interventional|||Alzheimer's Disease Long-term Follow-up Study (ALF Study)|Alzheimer's Disease Long-term Follow-up Study (ALF Study)|Completed||Phase 4|114|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:08.996782|2017-10-11 05:24:08.996782
NCT00165737|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-03-31|||March 2003||2003-03-01|March 2011|2011-03-01|June 2006|Actual|2006-06-01|August 2005|Actual|2005-08-01||Interventional|||Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease|A 24-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy, Safety and Tolerability of Donepezil Hydrochloride (E2020) in Patients With Dementia Associated With Cerebrovascular Disease|Completed||Phase 3|974|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:09.065495|2017-10-11 05:24:09.065495
NCT00171626|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-20|||August 2004||2004-08-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Completed||Phase 3|480||Novartis|||||f||||||||||||||2017-10-11 05:25:42.547305|2017-10-11 05:25:42.547305
NCT00165750|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-19|||March 2005||2005-03-01|November 2013|2013-11-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients|Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients|Terminated||Phase 4|40|Actual|Eisai Inc.||1||Lack of patients to enroll.|f||||||||||||||2017-10-11 05:24:09.136452|2017-10-11 05:24:09.136452
NCT00165763|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-05-02|||September 2005||2005-09-01|September 2009|2009-09-01||||September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia|An Open Label Study on the Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia|Completed||Phase 4|36|Actual|Eisai Inc.||1|||f||||t||||||||||2017-10-11 05:24:09.208221|2017-10-11 05:24:09.208221
NCT00165776|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-02-06|2013-07-12||June 2004||2004-06-01|February 2014|2014-02-01|November 2006|Actual|2006-11-01|May 2006|Actual|2006-05-01||Interventional||After randomized to the treatment groups, 3 patients (2 of the placebo group and 1 of the 5000U group) had no treatment. The reason was that 2 of them requested withdrawal from the study and 1 ceased to return for visits.|Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis|Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis|Completed||Phase 2|133|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:09.32204|2017-10-11 05:24:09.32204
NCT00165789|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-05-28|2015-04-15||September 2005||2005-09-01|April 2015|2015-04-01|September 2006|Actual|2006-09-01|February 2006|Actual|2006-02-01||Interventional|||A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations|A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations|Completed||Phase 2|75|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:10.005207|2017-10-11 05:24:10.005207
NCT00165802|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-20|||May 2006||2006-05-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors|A Phase I Open Label Study of E7974 Administered on Day 1 of a 21-Day Cycle In Patients With Advanced Solid Tumors|Completed||Phase 1|40|Anticipated|Eisai Inc.||1|||f||||||||||||||2017-10-11 05:24:11.732423|2017-10-11 05:24:11.732423
NCT00165815|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-05-08|||August 2002||2002-08-01|November 2005|2005-11-01|July 2005||2005-07-01|||||Interventional|||The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia||Completed||Phase 3|||Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:11.836879|2017-10-11 05:24:11.836879
NCT00165828|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-06-26|||May 2005||2005-05-01|November 2013|2013-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization|Randomized Trial to Assess Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization|Terminated||Phase 4|157|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 05:24:11.933342|2017-10-11 05:24:11.933342
NCT00165841|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-05-13|2009-08-18||October 2004||2004-10-01|December 2009|2009-12-01|June 2008|Actual|2008-06-01|December 2005|Actual|2005-12-01||Interventional|||Maintenance Intermittent Therapy for Symptomatic GERD Patients|A Double-Blind, Placebo-Controlled Study of Rabeprazole 20 mg Maintenance Intermittent Therapy Following Acute Treatment in Patients Wth Symptomatic Gastroesophageal Reflux Disease|Completed||Phase 2|200|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 05:24:12.130143|2017-10-11 05:24:12.130143
NCT00165854|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-06-26|||March 2003||2003-03-01|October 2006|2006-10-01||||||||Interventional|||Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer||Completed||Phase 2|46||Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:12.615726|2017-10-11 05:24:12.615726
NCT00165867|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-06|||April 2005||2005-04-01|October 2006|2006-10-01||||||||Interventional|||An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin||Completed||Phase 2|40||Eisai Inc.|||||f||||||||||||||2017-10-11 05:24:12.725743|2017-10-11 05:24:12.725743
NCT00165880|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-06-30|||December 2004||2004-12-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|||||Interventional|||An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine|An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Metastatic Breast Cancer Patients Following Prior Anthracycline and Taxane Therapy|Terminated||Phase 2|62|Actual|Eisai Inc.||||This study was stopped prematurely due to lack of efficacy.|f||||||||||||||2017-10-11 05:24:12.81792|2017-10-11 05:24:12.81792
NCT00165893|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-12-23|||September 2004||2004-09-01|December 2013|2013-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease|Comparison of Internal Disc Decompression (IDD) vs. a Standardized Non-surgical Treatment Program for Chronic Low Back Pain Secondary to Mild to Moderate Degenerative Disc Disease (DDD)|Completed||Phase 4|50||Emory University|||||f||||||||||||||2017-10-11 05:24:12.995838|2017-10-11 05:24:12.995838
NCT00165906|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-19|||January 2005||2005-01-01|November 2013|2013-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Thrombin Generation in Neonates|A Pilot Study Examining Thrombin Generation in the Neonatal Population|Completed||N/A|20|Actual|Emory University|||1||f||||f||||||Samples With DNA|"     A blood sample is obtained to measure the thrombin level.   "|||2017-10-11 05:24:13.071099|2017-10-11 05:24:13.071099
NCT00165919|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-12|||September 2005||2005-09-01|November 2013|2013-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Immune Response to Hepatitis C Virus|Immunologic Determinants of Hepatitis C Virus Infection Resolution or Persistence|Withdrawn||Phase 1|0|Actual|Emory University|||1|Not a clinical trial; human specimens from treatment site for basic research.|f||||f||||||||||2017-10-11 05:24:13.155126|2017-10-11 05:24:13.155126
NCT00165932|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-05-30|||June 2004||2004-06-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Ventricular Synchrony in Pediatric Patients|A Single Center Prospective, Pilot Study Examining the Non-invasive Evaluation of Ventricular Synchrony in Pediatric Patients|Completed||N/A|145|Actual|Emory University|||1||f||||f||||||||||2017-10-11 05:24:13.253134|2017-10-11 05:24:13.253134
NCT00165945|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-30|||June 2004||2004-06-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Observational|||4-D Visualization Using Magnetic Resonance Imaging (MRI) in the Congenital Heart Disease Population|Using 4-D Visualization Software With Magnetic Resonance Images in the Congenital Heart Disease Population|Completed||N/A|500|Actual|Emory University|||1||f||||f||||||||||2017-10-11 05:24:13.328209|2017-10-11 05:24:13.328209
NCT00165958|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-11|2013-07-17||January 2005||2005-01-01|July 2014|2014-07-01|July 2011|Actual|2011-07-01|July 2008|Actual|2008-07-01||Interventional|||Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts|Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts|Completed||Phase 4|40|Actual|Emory University|The limitations of this study include the small, predominately male patient population, lack of complete follow-up of secondary endpoint measurements at every time point.|2|||f||||f||||||||||2017-10-11 05:24:13.398695|2017-10-11 05:24:13.398695
NCT00165971|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-16|||December 2003||2003-12-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Recovery From General Anesthesia|Recovery From General Anesthesia|Completed||N/A|100||Emory University|||||f||||||||||||||2017-10-11 05:24:13.76169|2017-10-11 05:24:13.76169
NCT00165984|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-04-04|2011-11-11||January 2004||2004-01-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy|Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy|Completed||N/A|224|Actual|Emory University|Relatively small number of patients given the low incidence of this mutation||1||f||||f||||||Samples With DNA|"     Whole blood and serum.   "|||2017-10-11 05:24:13.847455|2017-10-11 05:24:13.847455
NCT00159861|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-12-20|2010-04-02||July 2003||2003-07-01|December 2013|2013-12-01|January 2006|Actual|2006-01-01|||||Interventional|||The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH|A Multinational, Multi-Center, Randomised, Double-Bind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Efficacy of a Subject Optimised Dose of Sildenafil Citrate (20, 40, or 80 mg. Sildenafil Citrate TID) Based on the Toleration, When Used in Combination With Intravenous Prostacyclin( Epoprostenol) in the Treatment of Pulmonary Arterial Hypertension.|Completed||Phase 3|267|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:24:14.262826|2017-10-11 05:24:14.262826
NCT00159874|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-07-17|2013-12-19||January 2004||2004-01-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children|A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131|Completed||Phase 3|234|Actual|Pfizer||3|||f||||t||||||||||2017-10-11 05:24:22.660569|2017-10-11 05:24:22.660569
NCT00159887|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-06-07|||December 2002||2002-12-01|June 2011|2011-06-01|February 2007|Actual|2007-02-01|||||Interventional|||Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension|A Multi-Centre, Multinational, Long-Term Extension Study, to Assess the Safety and Toleration of Subject Optimised Treatment Regimens of Oral Sildenafil Citrate for Pulmonary Arterial Hypertension in Subjects Who Have Completed Study A1481140.|Completed||Phase 3|260|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:24:25.795321|2017-10-11 05:24:25.795321
NCT00159900|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-04-04|||May 2005||2005-05-01|April 2008|2008-04-01|January 2006||2006-01-01|||||Interventional|||Quality of Erection Study|A Multicenter, Parallel Group Flexible Dose Study With A Double Blind, Randomized, Placebo Controlled Phase And An Open-Label Phase To Evaluate The Quality Of Erections In Men With Erectile Dysfunction Treated With Sildenafil Citrate|Completed||Phase 4|300||Pfizer|||||f||||||||||||||2017-10-11 05:24:26.163002|2017-10-11 05:24:26.163002
NCT00159913|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-01-23|2009-06-02||August 2003||2003-08-01|January 2014|2014-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.|A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.|Completed||Phase 3|235|Actual|Pfizer||4|||f||||t||||||||||2017-10-11 05:24:26.332728|2017-10-11 05:24:26.332728
NCT00159926|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-01-04|||January 2003||2003-01-01|November 2007|2007-11-01|February 2004|Actual|2004-02-01|||||Interventional|||Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response|Does Cleansing of Suction Blood During Cardiac Surgery With Heart and Lung Machine Reduce the Postoperative Inflammatory Response ?|Terminated||Phase 3|30|Actual|Rigshospitalet, Denmark||2||For financial and logistical reasons|f||||f||||||||||2017-10-11 05:24:28.544633|2017-10-11 05:24:28.544633
NCT00159939|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-06-09|||February 2004||2004-02-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Prone-Supine Study II: The Effect of Prone Positioning for Patients Affected by Acute Respiratory Distress Syndrome|Prone-Supine Study II: The Effect of Prone Positioning for Patients Affected by Acute Respiratory Distress Syndrome|Completed||Phase 3|344|Actual|Policlinico Hospital||2|||f||||t||||||||||2017-10-11 05:24:28.677094|2017-10-11 05:24:28.677094
NCT00159952|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2013-11-26|||November 2004||2004-11-01|February 2009|2009-02-01|November 2007|Actual|2007-11-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock|Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock|Completed||Phase 2/Phase 3|90|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-10-11 05:24:28.841848|2017-10-11 05:24:28.841848
NCT00159965|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-11-07|2010-08-11||December 2003||2003-12-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|NES||Treatments for Psychogenic Nonepileptic Seizures (NES)|Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES|Completed||Phase 4|38|Actual|Rhode Island Hospital|pilot sample size; drop-outs because of some patient’s concern that they would receive the placebo, despite the equipoise that exists for NES treatment(s). Excluding patients who did not have vEEG may present a potential sampling bias.|2|||f||||t||||||||||2017-10-11 05:24:28.974315|2017-10-11 05:24:28.974315
NCT00159978|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-05-06|||July 2005||2005-07-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Validation of 18F-MISO-PET and 18F-FLT-PET|Validation of 18F-MISO-PET and 18F-FLT-PET by Immunohistochemical Assessment of Head and Neck Cancer Resection Specimen|Terminated||Phase 1|21|Actual|Radboud University|||1|Problems with FMISO supply|f||||f||||||Samples With DNA|"     Tumor resection specimen   "|||2017-10-11 05:24:29.800388|2017-10-11 05:24:29.800388
NCT00159991|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-02-12|||February 2002||2002-02-01|January 2008|2008-01-01|February 2015|Anticipated|2015-02-01|February 2011|Anticipated|2011-02-01||Interventional|CARRPO||Copenhagen Arterial Revascularization Randomized Patency and Outcome Trial|Arterial Revascularization for Coronary Bypass Surgery: A Randomized Trial Comparing the Outcome After Using LIMA + Vein Grafts Versus Total Arterial Revascularization With LIMA + RIMA + Radial Artery Grafts|Unknown status|Active, not recruiting|Phase 3|331|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-10-11 05:24:29.88052|2017-10-11 05:24:29.88052
NCT00160004|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-06-05|||March 2006||2006-03-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|||||Interventional|||The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis|The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis|Terminated||Phase 1/Phase 2|20|Anticipated|Radboud University||||problems with including patients and a large multicenter Trial is now starting as follow-up|f||||||||||||||2017-10-11 05:24:29.992111|2017-10-11 05:24:29.992111
NCT00160017|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-11-27|||January 2005||2005-01-01|November 2015|2015-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative|Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative to Improve Diabetes Care, Its Health Outcomes and Economic Costs|Completed||N/A|1861|Actual|Radboud University|||2||f||||||||||||||2017-10-11 05:24:31.067474|2017-10-11 05:24:31.067474
NCT00160030|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-12-04|||September 2004||2004-09-01|December 2009|2009-12-01||||October 2007|Actual|2007-10-01||Interventional|||Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer|Phase II Study Comparing Radiochemotherapy With the Folfox 4 Regimen Versus Radiochemotherapy With 5FU-Cisplatin (Herskovic Regimen) in First Line Treatment of Patients With Inoperable Esophageal Cancer|Completed||Phase 2|97|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 05:24:31.267627|2017-10-11 05:24:31.267627
NCT00160043|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-12-14|||March 2005||2005-03-01|December 2014|2014-12-01|November 2008|Actual|2008-11-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.|Phase II Open-label Study to Investigate the Efficacy and Safety of PTK787/ZK 222584 Orally Administered Once Daily or Twice Daily at 1250 mg as Second-line Monotherapy in Patients With Stage IIIB or Stage IV Non-small-cell Lung Cancer (NSCLC)|Completed||Phase 2|112|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:24:31.371237|2017-10-11 05:24:31.371237
NCT00160056|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-05-08|||April 2005||2005-04-01|May 2015|2015-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity|The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity in Subjects With Homozygous Arg16 and gly16 Polymorphism of the β2-adrenergic Receptor|Completed||N/A|16|Actual|Radboud University||1|||f||||||||||||||2017-10-11 05:24:31.479325|2017-10-11 05:24:31.479325
NCT00160069|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-12-02|||August 2005||2005-08-01|December 2014|2014-12-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer|Phase II Study to Investigate the Efficacy and Safety of ZK 219477 as Second Line Therapy in Patients With Stage IIIB or Stage IV Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|128|Actual|Bayer||3|||f||||f||||||||||2017-10-11 05:24:31.560904|2017-10-11 05:24:31.560904
NCT00160082|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-02|||January 2001||2001-01-01|September 2005|2005-09-01|May 2003||2003-05-01|||||Interventional|||Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)|Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS): A Randomized, Two-Arm, Parallel, Double-Blind, Multi-Centre, Placebo Controlled Study|Completed||N/A|124||Pharmalink AB|||||f||||||||||||||2017-10-11 05:24:31.702177|2017-10-11 05:24:31.702177
NCT00160095|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-05-06|||July 2001||2001-07-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2010|Actual|2010-03-01||Observational|||Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas|Patient Selection for Hypoxia Modifying Treatments Based on Functional Microregional Imaging of Tumor Vasculature, Oxygenation and Proliferation in Squamous Cell Carcinoma of the Larynx|Completed||Phase 3|79|Actual|Radboud University|||1||f||||||||||Samples With DNA|"     Tumor biopsies   "|||2017-10-11 05:24:31.974108|2017-10-11 05:24:31.974108
NCT00160108|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-11|||July 2005||2005-07-01|September 2006|2006-09-01|July 2007||2007-07-01|||||Interventional|||A Dietary Intervention- Randomized Controlled Trial (DIRECT) Study; BGU-Harvard–Robarts Collaboration||Unknown status|Active, not recruiting|Phase 1|300||The S. Daniel Abraham International Center for Health and Nutrition|||||f||||||||||||||2017-10-11 05:24:32.054225|2017-10-11 05:24:32.054225
NCT00160121|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-09-03|||January 2005||2005-01-01|December 2013|2013-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease|A Phase IV, Open-Label, Multi-Center Trial Evaluating the Efficacy of Fosrenol Compared to Existing Therapy in Adults With End Stage Renal Disease Treated for Hyperphosphatemia|Completed||Phase 4|2500||Shire|||||f||||||||||||||2017-10-11 05:24:32.150042|2017-10-11 05:24:32.150042
NCT00160134|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-01-29|||January 2005||2005-01-01|January 2009|2009-01-01||||||||Interventional|||Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure|A Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Parallel Group, Single Dose Study to Evaluate Cardiac Hemodynamics and Safety During Right Heart Catheterization of Three IV Doses of SLV320 in Subjects With Congestive Heart Failure Requiring Diuretic Treatment|Completed||Phase 2|||Solvay Pharmaceuticals|||||f||||||||||||||2017-10-11 05:24:32.223496|2017-10-11 05:24:32.223496
NCT00160147|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-01-29||2015-01-29|December 2005||2005-12-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type|A Randomized, Double-Blind, Placebo-controlled, Efficacy, Safety, and Tolerability Study of Bifeprunox in the Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type|Terminated||Phase 3|60|Actual|Solvay Pharmaceuticals||2||The study was discontinued prematurely on 25 February 2008 due to slow enrollment|f||||||||||||||2017-10-11 05:24:32.295731|2017-10-11 05:24:32.295731
NCT00160160|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2009-01-29|||October 2004||2004-10-01|January 2009|2009-01-01||||||||Interventional|||Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes|A Multi-Center, Double-Blind, Randomized Study Comparing the Efficacy of Combination Therapy of Eprosartan Respectively Ramipril With Low-Dose Hydrochlorothiazide and Moxonidine on Blood Pressure Levels in Patients With Hypertension and Associated Diabetes Mellitus Type 2|Completed||N/A|440||Solvay Pharmaceuticals|||||f||||||||||||||2017-10-11 05:24:32.517075|2017-10-11 05:24:32.517075
NCT00160173|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2013-07-11||||||July 2013|2013-07-01||||||||Interventional|||Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy|Efficacy Study Comparing 0.9 g and 1.25 g EstroGelÂ® 0.03% Doses With Placebo in the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated With Menopause|Completed||Phase 4|||ASCEND Therapeutics|||||f||||||||||||||2017-10-11 05:24:32.743749|2017-10-11 05:24:32.743749
NCT00160186|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-03-28|||December 2003||2003-12-01|March 2008|2008-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy|Double-Blind, Multicenter, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy|Completed||Phase 4|40||Solvay Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:24:33.067156|2017-10-11 05:24:33.067156
NCT00160199|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-06-30|2010-02-11||November 2004||2004-11-01|June 2010|2010-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion|Evaluation of Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding in Subjects With Secondary Amenorrhea|Completed||Phase 4|240|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:24:33.19546|2017-10-11 05:24:33.19546
NCT00160212|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-29|||December 2004||2004-12-01|January 2009|2009-01-01||||||||Interventional|||Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension|A Randomized, Placebo-Controlled, Double-Blind, Six-Arm, Dose Escalation, Multi-Center Study to Evaluate the Efficacy and Safety of SLV306: 150, 300, 600 mg Once Daily, 150-300 mg Twice Daily and Amlodipine 5-10 mg Once Daily in Subjects With Hypertension|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:24:33.728887|2017-10-11 05:24:33.728887
NCT00160225|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-11-09|||July 2005||2005-07-01|November 2007|2007-11-01||||||||Interventional|||Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension|A Randomized, Double-Blind, Placebo Controlled, Two-Treatment and Two-Period Cross-Over, Mono-Center Study to Evaluate the Efficacy and Safety of Daglutril 300 mg Once Daily Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:24:34.187643|2017-10-11 05:24:34.187643
NCT00160238|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-12-21|||January 2003||2003-01-01|December 2006|2006-12-01||||||||Interventional|||Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy|A Double-Blind, Placebo-Controlled, Randomized, Clinical Study of the Effects of Betaserc® 24 mg (1 Tablet b.i.d Over 3 Months) on Vestibular Compensation Following Vestibular Neurotomy in Patients With Disabling Menière's Disease|Completed||Phase 4|20||Solvay Pharmaceuticals|||||f||||||||||||||2017-10-11 05:24:34.244224|2017-10-11 05:24:34.244224
NCT00160251|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-10-13|2011-05-13||September 2005||2005-09-01|October 2015|2015-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)|PEG-Intron/REBETOL vs PEG-Intron/ SCH 503034 With and Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 (HCV-1) Peginterferon Alfa/Ribavirin Nonresponders: A SCH 503034 Dose-Finding Phase 2 Study|Completed||Phase 2|357|Actual|Merck Sharp & Dohme Corp.|The implementation of amendment 2 led to changes in boceprevir dose in all treatment arms and different overall lengths of therapy within the same treatment arm, making the SVR endpoint uninterpretable.|9|||f||||t||||||||||2017-10-11 05:24:34.364827|2017-10-11 05:24:34.364827
NCT00160264|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-29|||January 2003||2003-01-01|January 2009|2009-01-01||||||||Interventional|||Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women|A Randomized, Double-Blind, Multicenter, Parallel Pilot Clinical Trial to Study the Efficay of a Treatment of Lactulose + Vitamin D + Calcium 0.5 g Concurrently Controlled With a Standard Treatment (Vit D + Calcium) in Bone Mass Preservation Among Postmenopausal Women|Completed||Phase 4|40||Solvay Pharmaceuticals|||||f||||||||||||||2017-10-11 05:24:39.285847|2017-10-11 05:24:39.285847
NCT00160277|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-29|||July 2005||2005-07-01|January 2009|2009-01-01||||||||Interventional|||Efficacy and Safety of Moxonidine in Indian Patients|Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension|Completed||Phase 3|100||Solvay Pharmaceuticals|||||f||||||||||||||2017-10-11 05:24:39.353566|2017-10-11 05:24:39.353566
NCT00160290|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-04-29|||March 2002||2002-03-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures|An Open, Randomized, Parallel Group, Single Center Study to Investigate the Effect of Lactulose Versus Plantago Ovate on the Quality of Life of Patients With Hard Stools and Hemorrhoids or Anal Fissure|Terminated||Phase 4|97|Actual|Solvay Pharmaceuticals||2||This trial discontinued on 30 JUN 2006 due to a lack of enrolment|f||||f||||||||||2017-10-11 05:24:39.439432|2017-10-11 05:24:39.439432
NCT00160303|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-07-22|||January 2005||2005-01-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow|Prolotherapy vs. Corticosteroid Therapy for the Treatment of Lateral Epicondylitis of the Elbow, A Randomized Controlled Trial.|Completed||Phase 3|56|Anticipated|Spaulding Rehabilitation Hospital|||||f||||||||||||||2017-10-11 05:24:39.541206|2017-10-11 05:24:39.541206
NCT00160316|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-03-11|||April 2005||2005-04-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination|Endometrial Safety of a Low Dose Continuous Combined 17 -Estradiol/Dydrogesterone Hormone Replacement Regimen (E2 0.5 mg/ D 2.5 mg) in Postmenopausal Women - A One-Year, Open Label, Multi-Center Study|Completed||Phase 3|454|Actual|Solvay Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:24:39.620843|2017-10-11 05:24:39.620843
NCT00160329|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-07-19|||January 2004||2004-01-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|April 2007|Actual|2007-04-01||Interventional|||Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia|The De-Escalate Trial: Atazanavir or Atazanavir/Ritonavir Substitution for Ritonavir Boosted PI Therapy in HIV-Infected Individuals Experiencing Ongoing HIV Viremia and Hyperlipidemia: A Randomized Controlled Pilot Study|Completed||Phase 3|60|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 05:24:39.73806|2017-10-11 05:24:39.73806
NCT00165997|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-12-09|||February 2004||2004-02-01|December 2013|2013-12-01|October 2007|Actual|2007-10-01|||||Observational|||Quality of Life in Patients Post Radiofrequency Ablation|The Effects of Radiofrequency Ablation Procedures on Quality of Life in the Pediatric Cohort|Terminated||N/A|50|Anticipated|Emory University||||sufficient data collected for significant conclusive results|f||||||||||||||2017-10-11 05:24:39.835701|2017-10-11 05:24:39.835701
NCT00166010|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-06-03|||October 2004||2004-10-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effects of Nesiritide in Pediatric Patients With Heart Failure|A Single-center, Pharmacokinetic Evaluation of Nesiritide in the Pediatric Population With Heart Failure|Withdrawn||N/A|0|Actual|Emory University||1||"Observational study that DSMB placed on hold (withdrew 4 subjects). Protocol revised and   received IND to become interventional PK study (no subjects enrolled)."|f||||t||||||||||2017-10-11 05:24:39.914071|2017-10-11 05:24:39.914071
NCT00166023|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-25|||August 2005||2005-08-01|November 2013|2013-11-01|December 2006||2006-12-01|||||Observational|||Outcomes Following Medical or Surgical Management of Endocarditis|A Review of Outcomes Following Medical or Surgical Management of Endocarditis|Completed||N/A|100||Emory University|||||f||||||||||||||2017-10-11 05:24:41.252363|2017-10-11 05:24:41.252363
NCT00166036|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-08-28|2012-06-08||September 2004||2004-09-01|August 2014|2014-08-01|April 2009|Actual|2009-04-01|March 2008|Actual|2008-03-01||Interventional|STOPCAP||Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells|Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells: Comparison of Atorvastatin With Pravastatin|Completed||Phase 2|36|Actual|Emory University|Detection of changes in Oxidative stress with significance requires a much larger cohort study.|2|||f||||f||||||||||2017-10-11 05:24:41.348967|2017-10-11 05:24:41.348967
NCT00166049|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-11-09|||April 2005||2005-04-01|September 2013|2013-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Education and Supportive Partners Improving Self-Care (ENSPIRE)|A Family Partnership Intervention in Heart Failure|Completed||N/A|170|Actual|Emory University||3|||f||||t||||||||||2017-10-11 05:24:41.633105|2017-10-11 05:24:41.633105
NCT00166062|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-19|||January 2004||2004-01-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Effectiveness of Computer Screening for Intimate Partner Violence||Completed||N/A|||Emory University|||||f||||||||||||||2017-10-11 05:24:41.748688|2017-10-11 05:24:41.748688
NCT00166075|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-12-12|||January 2004||2004-01-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Observational|||Mental Health Symptoms and Intimate Partner Violence|Mental Health Symptoms and Intimate Partner Violence|Completed||N/A|569|Actual|Emory University|||1||f||||f||||||||||2017-10-11 05:24:41.838699|2017-10-11 05:24:41.838699
NCT00166088|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-15|||December 2004||2004-12-01|November 2013|2013-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)|Effects of Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and EPC's|Completed||Phase 2|30|Actual|Emory University||3|||f||||f||||||||||2017-10-11 05:24:41.920954|2017-10-11 05:24:41.920954
NCT00166101|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-09|||August 2002||2002-08-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||NIRS in Neonatal Cardiac Surgery|Near Infrared Spectroscopy Monitoring of Cerebral Oxygen Saturation in Neonatal Cardiac Surgery - Comparison With Common Methods of Estimating Adequate Systemic Perfusion|Completed||N/A|25|Actual|Emory University|||1||f||||f||||||||||2017-10-11 05:24:42.005732|2017-10-11 05:24:42.005732
NCT00166114|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-15|2013-12-09||February 2002||2002-02-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Depression, Epinephrine, and Platelet Function|Do Antidepressants Reverse the Effects of Early Life Stress on the Brain and Thrombovascular System and Improve Psychological, Neuroendocrine, and Platelet Function: A Study of Men and Women With Childhood Abuse.|Completed||Phase 4|40|Actual|Emory University||2|||f||||t||||||||||2017-10-11 05:24:42.091957|2017-10-11 05:24:42.091957
NCT00166127|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-13|||May 2005||2005-05-01|November 2013|2013-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Study of Blood Concentrations and Physiologic Effects of Levosimendan Given During Heart Surgery|Pharmacokinetics and Pharmacodynamics of Levosimendan During Cardiac Surgery|Terminated||Phase 3|1|Actual|Emory University||1||Unable to renegotiate an expired contract w/sponsor providing study med|f||||f||||||||||2017-10-11 05:24:42.489101|2017-10-11 05:24:42.489101
NCT00166140|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-19|||December 2002||2002-12-01|November 2013|2013-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.|Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.|Completed||N/A|125||Emory University|||1||f||||||||||||||2017-10-11 05:24:42.643392|2017-10-11 05:24:42.643392
NCT00166153|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-19|||January 2003||2003-01-01|November 2013|2013-11-01|May 2005||2005-05-01|||||Interventional|||Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept|The Relationships Between Mycophenolic Acid Levels, T-Cell Subsets and Outcomes in Pediatric Heat Transplant Recipients Receiving Mycophenolate Mofetil (Cellcept)|Terminated||N/A|30||Emory University|||||f||||||||||||||2017-10-11 05:24:42.721675|2017-10-11 05:24:42.721675
NCT00166166|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-12|2015-05-08||July 2002||2002-07-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Baseline characteristics represent subjects that completed the study.|Endothelial Hyperpolarization in Humans|Physiology and Pathologic Role of Endothelium-Derived Hyperpolarizing Factor in Humans|Terminated||Phase 2|174|Actual|Emory University|Findings are limited to the forearm microcirculations, thus other vascular beds including conductance arteries warrant further investigation. Nevertheless, it is known that the contribution of EDHF is less in conductance vessels than in microvessels.|2||Limited clinical staff|f||||f||||||||||2017-10-11 05:24:42.822239|2017-10-11 05:24:42.822239
NCT00166179|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-09-25|||November 2003||2003-11-01|September 2014|2014-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI|Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI|Completed||N/A|57|Actual|Emory University|||1||f||||f||||||||||2017-10-11 05:24:43.319011|2017-10-11 05:24:43.319011
NCT00166192|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-12|||January 2008||2008-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|January 2010|Actual|2010-01-01||Interventional|||Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid|Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid: A Comparison of Clinical Efficacy|Completed||Phase 4|19|Actual|Emory University||1|||f||||t||||||||||2017-10-11 05:24:43.392811|2017-10-11 05:24:43.392811
NCT00166205|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-08-03|2008-10-21||June 2003||2003-06-01|August 2015|2015-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity|A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity|Completed||Phase 3|276|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-10-11 05:24:43.513396|2017-10-11 05:24:43.513396
NCT00166218|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-26|||February 2004||2004-02-01|November 2013|2013-11-01|February 2005||2005-02-01|||||Observational|||NIRS Monitoring in the Ambulatory Single Ventricle Patient|Evaluation of Near-infrared Spectroscopy for Non-invasive Monitoring of the Ambulatory Single Ventricle Patient|Terminated||N/A|30||Emory University|||||f||||||||||||||2017-10-11 05:24:44.091662|2017-10-11 05:24:44.091662
NCT00166231|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-02-24|||March 2004||2004-03-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Understanding Pediatric Chest Pain and Other Symptoms|Understanding Pediatric Symptoms and Other Symptoms|Completed||N/A|156|Actual|Emory University|||2||f||||f||||||||||2017-10-11 05:24:44.172276|2017-10-11 05:24:44.172276
NCT00166244|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-02-11|||May 2003||2003-05-01|February 2009|2009-02-01|April 2006|Actual|2006-04-01|March 2005|Actual|2005-03-01||Interventional|||Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation|An Open, Prospective, Randomised, Controlled, Multi-Center Study Comparing Fixed Dose vs Concentration Controlled Mycophenolate Mofetil Regimens for de Novo Patients Following Transplantation|Completed||Phase 4|901|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-10-11 05:24:44.28359|2017-10-11 05:24:44.28359
NCT00166257|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-05-26|||February 2000||2000-02-01|May 2009|2009-05-01|May 2011|Anticipated|2011-05-01|February 2011|Anticipated|2011-02-01||Interventional|||PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism|Randomized Clinical Trial Comparing the Efficacy of Percutaneous Closure of Patent Foramen Ovale (PFO) With Medical Treatment in Patients With Cryptogenic Embolism|Unknown status|Active, not recruiting|Phase 4|414|Actual|Foundation for Cardiovascular Research, Zurich||2|||f||||t||||||||||2017-10-11 05:24:44.670627|2017-10-11 05:24:44.670627
NCT00166270|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-09-13|||January 2005||2005-01-01|September 2012|2012-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids|Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids|Completed||Phase 4|70|Actual|InSightec||1|||f||||||||||||||2017-10-11 05:24:44.806581|2017-10-11 05:24:44.806581
NCT00166283|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-06-08|||February 2005||2005-02-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Improving New Learning and Memory in Multiple Sclerosis|Improving New Learning in Multiple Sclerosis: A Randomized Clinical Trial|Completed||N/A|88|Actual|Kessler Foundation||2|||f||||t||||||||||2017-10-11 05:24:44.90243|2017-10-11 05:24:44.90243
NCT00166296|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-03-04|2011-02-08||March 2005||2005-03-01|March 2011|2011-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients|Study of the Efficacy and Safety of Escitalopram for the Prevention of Depressive Episodes Induced by Peg-Interferon Alpha2a and Ribavirin in Chronic Hepatitis C Patients. Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 2|133|Actual|Germans Trias i Pujol Hospital|The low depression rate found may have underpowered the study. Selection of a much less depressive sample than in other studies. Limitation to the first 12 weeks of antiviral treatment.|2|||f||||f||||||||||2017-10-11 05:24:44.999056|2017-10-11 05:24:44.999056
NCT00166309|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-18|||July 2000||2000-07-01|April 2007|2007-04-01|June 2005|Actual|2005-06-01|||||Interventional|||The FEIBA NovoSeven Comparative Study|FENOC: The FEIBA NovoSeven Comparative Study|Completed||N/A|60||Skane University Hospital|||||f||||t||||||||||2017-10-11 05:24:45.496292|2017-10-11 05:24:45.496292
NCT00166322|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-05-06|||January 2004||2004-01-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects||Completed||N/A|35|Actual|Ludwig-Maximilians - University of Munich||1|||f||||||||||||||2017-10-11 05:24:45.585643|2017-10-11 05:24:45.585643
NCT00167648|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-15|||March 2005||2005-03-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|NE2||Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer|Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer|Completed||Phase 2|17|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 05:24:45.780115|2017-10-11 05:24:45.780115
NCT00167661|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-10-09|||June 2004||2004-06-01|October 2015|2015-10-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation|Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation|Terminated||Phase 1/Phase 2|50|Anticipated|University of Wisconsin, Madison||1||Enrollment suspended pending protocol revision to change study to observational|f||||t||||||||||2017-10-11 05:24:45.88187|2017-10-11 05:24:45.88187
NCT00167674|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-06-14|||May 2003||2003-05-01|June 2012|2012-06-01|April 2006|Actual|2006-04-01|March 2005|Actual|2005-03-01||Interventional|||ARVs to Prevent Breastmilk HIV:Viral and Immune Responses|ARVs to Prevent Breastmilk HIV:Viral and Immune Responses|Completed||Phase 2|58|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:24:45.977056|2017-10-11 05:24:45.977056
NCT00167687|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-02-13|||September 2005||2005-09-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Prazosin Alcohol Dependence IVR Study|A Double-Blind Placebo-Controlled Trial of Prazosin for the Treatment of Alcohol Dependence|Completed||Phase 4|23|Actual|University of Washington||1|||f||||t||||||||||2017-10-11 05:24:46.08879|2017-10-11 05:24:46.08879
NCT00167700|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2012-10-03|||February 1997||1997-02-01|September 2012|2012-09-01|December 2015|Anticipated|2015-12-01|||||Interventional|NAMI||Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight|Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI): Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight|Unknown status|Recruiting|N/A|800|Anticipated|University of Turku||6|||f||||f||||||||||2017-10-11 05:24:46.21472|2017-10-11 05:24:46.21472
NCT00167713|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-19|||April 2003||2003-04-01|September 2005|2005-09-01|January 2004||2004-01-01|||||Interventional|||Treatment of Fever Due to Malaria With Ibuprofen|Randomised, Double-Blind, Placebo Controlled Study of the Antipyretic Effect of Ibuprofen in Children With Uncomplicated Malaria|Completed||Phase 4|50||Albert Schweitzer Hospital|||||f||||||||||||||2017-10-11 05:24:46.367437|2017-10-11 05:24:46.367437
NCT00167726|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-12-05|||January 2005||2005-01-01|December 2014|2014-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Neuraxial and Neurolytic Analgesia for Intractable Pain|Neuraxial and Neurolytic Analgesia for Intractable Pain|Completed||N/A|19|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-10-11 05:24:46.448866|2017-10-11 05:24:46.448866
NCT00167739|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-19|||April 2003||2003-04-01|September 2005|2005-09-01|February 2004||2004-02-01|||||Interventional|||Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine|Short Course of Quinine Plus a Single Dose of Sulphadoxine-Pyrimethamine for Plasmodium Falciparum Malaria|Completed||Phase 4|50||Albert Schweitzer Hospital|||||f||||||||||||||2017-10-11 05:24:46.508707|2017-10-11 05:24:46.508707
NCT00167752|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2016-10-24|||December 2002||2002-12-01|October 2016|2016-10-01||||February 2006|Actual|2006-02-01||Observational|||Psychiatric Problems in Chronic Skin Diseases|Quality of Life, Emotional and Sleep Problems in Chronic Skin Diseases|Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:24:46.591671|2017-10-11 05:24:46.591671
NCT00167765|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-05-01|||March 2005||2005-03-01|May 2007|2007-05-01|May 2005|Actual|2005-05-01|||||Interventional|||Abciximab in Wake-up Stroke|Does Abciximab Save Hypoperfused Ischemic Brain Tissue in Wake-Up Stroke: A Placebo-Controlled, Randomized, MR Imaging Study|Terminated||Phase 3|50||University of Zurich||||Higher hemorrhage rates of Abciximab in ABESST II trial|f||||t||||||||||2017-10-11 05:24:46.648503|2017-10-11 05:24:46.648503
NCT00167778|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-01|2014-07-28|2013-10-25||January 2005||2005-01-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Prosthetic Components and Stability in Amputee Gait|Turning Corners: Prosthetic Components and Stability in Amputee Gait|Completed||N/A|12|Actual|VA Office of Research and Development|Our sample population consisted of community ambulators whose results may not generalize to all lower limb amputees.|2|||f||||f||||||||||2017-10-11 05:24:46.757471|2017-10-11 05:24:46.757471
NCT00167791|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-10-13|||July 2005||2005-07-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant|Multicenter Trial Using Multi-dose Rituximab as Induction and Desensitization Therapy for Patients on the Waiting List for Kidney Transplant With a Positive Donor Specific Crossmatch to a Living Donor|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison||1||lack of enrollment|f||||t||||||||||2017-10-11 05:24:47.819713|2017-10-11 05:24:47.819713
NCT00167804|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-12-02|||September 2004||2004-09-01|December 2011|2011-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Comparing Virtual Reality Therapy to Usual Treatment for PTSD|Comparing Virtual Reality Therapy to Usual Treatment for PTSD|Completed||N/A|20|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 05:24:47.908535|2017-10-11 05:24:47.908535
NCT00167817|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2007-04-18|||July 2003||2003-07-01|April 2007|2007-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study|Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study|Completed||Phase 4|15||Veterans Medical Research Foundation|||||f||||f||||||||||2017-10-11 05:24:48.003853|2017-10-11 05:24:48.003853
NCT00167830|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-01-16|||November 2003||2003-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Barriers to Treatment in Obese Adolescents|Understanding The Barriers in Treatment of Obesity in Adolescents 11-18 in Central Virginia|Completed||Phase 1/Phase 2|292|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 05:24:48.073702|2017-10-11 05:24:48.073702
NCT00167843|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2013-01-23|||December 2002||2002-12-01|January 2013|2013-01-01|March 2007||2007-03-01|||||Interventional|||Reducing the Effects of Malaria in Children by Administering Repeated Preventive Doses|A Longitudinal Study Assessing the Infectious Status and Immunity of Mothers and Their Children in Lambaréné, Including Intermittent Treatment of Children With Sulfadoxine-pyrimethamine for Malaria Control and Its Impact on Long-term Health|Completed||Phase 4|1189||Albert Schweitzer Hospital|||||f||||||||||||||2017-10-11 05:24:48.173777|2017-10-11 05:24:48.173777
NCT00167856|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-03-26|||June 2005||2005-06-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury|Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury|Completed||N/A|16|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:24:48.274703|2017-10-11 05:24:48.274703
NCT00167869|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-23|||June 2004||2004-06-01|May 2008|2008-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.|LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.|Completed||Phase 2|135||Wageningen University|||||f||||||||||||||2017-10-11 05:24:48.368804|2017-10-11 05:24:48.368804
NCT00167882|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-08|||July 2005||2005-07-01|August 2006|2006-08-01|August 2006||2006-08-01|||||Interventional|||The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels||Completed||Phase 4|24||VU University Medical Center|||||f||||||||||||||2017-10-11 05:24:48.457439|2017-10-11 05:24:48.457439
NCT00167895|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2007-04-24|||October 2004||2004-10-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||The Use of Platelet Derived Growth Factors in Total Knee Arthroplasty, a Randomized Trial|The Use of Platelet Derived Growth Factors in Total Knee Arthroplasty, a Randomized Trial|Completed||Phase 3|100||Westfries Hospital|||||f||||t||||||||||2017-10-11 05:24:48.550221|2017-10-11 05:24:48.550221
NCT00167908|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-02-03|||October 2001||2001-10-01|February 2009|2009-02-01|May 2007|Actual|2007-05-01|||||Interventional|||Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer|Pilot Study to Test Whether Amifostine Can Further Protect Salivary Function in Head and Neck Cancer Patients Treated With IMRT|Completed||Phase 2|27||Washington University School of Medicine|||||f||||||||||||||2017-10-11 05:24:48.655219|2017-10-11 05:24:48.655219
NCT00167921|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-05-25|||October 2005||2005-10-01|May 2007|2007-05-01||||||||Interventional|||Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis|A Multiple-Dose, Comparative Bioavailability Study of Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Postmenopausal Women With Atrophic Vaginitis.|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:24:48.729898|2017-10-11 05:24:48.729898
NCT00167947|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-03-13|||January 2005||2005-01-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study Evaluating Sirolimus in Kidney Transplant Recipients.|A Randomized, Open Label Study to Evaluate the Effects of a Regimen With Sirolimus,Low Doses Cyclosporine and Steroids vs a Regimen With Sirolimus and Steroids, After an Induction Period With Basiliximab, Sirolimus,Cyclosporine and Steroids in de Novo Renal Transplant Patients.|Completed||Phase 3|150|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-10-11 05:24:48.926688|2017-10-11 05:24:48.926688
NCT00167960|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-03-14|||January 2005||2005-01-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit|Effects on the Emergence and Transmission of Vancomycin-Resistant Enterococci After Changes in Antibiotic Use in a Hematology Unit.|Completed||Phase 4|1500||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:24:49.050179|2017-10-11 05:24:49.050179
NCT00167973|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2010-05-25|||January 2002||2002-01-01|May 2010|2010-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use|A Prospective Registry of European Hemophilia B Patients Receiving BeneFIX®(Nonacog Alfa, Recombinant Human Factor IX) for Usual Use|Completed||Phase 4|218|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-10-11 05:24:49.140009|2017-10-11 05:24:49.140009
NCT00167986|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-03-14|||January 2005||2005-01-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care|Antibiotic Intervention Trial in a Medical Intensive Care Unit to Reduce the Acquisition of Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae.|Completed||Phase 4|480||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:24:49.391954|2017-10-11 05:24:49.391954
NCT00167999|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-03-14|||February 2005||2005-02-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units|Effects of Piperacillin-Tazobactam Use on the Prevalence Rate of Extended-Spectrum Beta-Lactamase (ESBL) Producing Escherichia Coli and Klebsiella Pneumoniae in Hematology and Oncology Units.|Completed||Phase 4|200||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:24:49.46695|2017-10-11 05:24:49.46695
NCT00168012|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-10|||September 2004||2004-09-01|February 2011|2011-02-01|September 2005|Actual|2005-09-01|||||Interventional|||Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)|An Open Study to Evaluate the Safety and Efficacy of IVIG-F10 in Patients With Primary Immunodeficiency Diseases (PID)|Completed||Phase 3|42||CSL Behring|||||||||||||||||||2017-10-11 05:24:49.535792|2017-10-11 05:24:49.535792
NCT00168025|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-06-05|||September 2004||2004-09-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)|A Multicenter Study on the Efficacy, Safety and Pharmacokinetics of IgPro10 in Patients With Primary Immunodeficiency (PID)|Completed||Phase 3|89|Actual|CSL Behring||1|||f||||||||||||||2017-10-11 05:24:49.610779|2017-10-11 05:24:49.610779
NCT00168038|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-10-18|2011-08-22||December 2004||2004-12-01|October 2011|2011-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10|An Open-label, Multicenter Study on the Efficacy and Safety of IgPro10 in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)|Completed||Phase 3|58|Actual|CSL Behring||1|||f||||||||||||||2017-10-11 05:24:49.708485|2017-10-11 05:24:49.708485
NCT00168051|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2013-02-07|||April 2005||2005-04-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A|A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)|Completed||Phase 4|21|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:24:50.111037|2017-10-11 05:24:50.111037
NCT00168064|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2012-10-02|2011-07-12||May 2006||2006-05-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides|A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients With Stage I or IIA Mycosis Fungoides (MF)|Completed||Phase 2|260|Actual|Yaupon Therapeutics||2|||f||||f||||||||||2017-10-11 05:24:50.222028|2017-10-11 05:24:50.222028
NCT00168077|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-10|||September 2005||2005-09-01|February 2011|2011-02-01|November 2006|Actual|2006-11-01|||||Interventional|||Prothrombin Complex Concentrate for Anticoagulant Reversal|Efficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral Anticoagulation|Completed||Phase 3|40||CSL Behring|||||f||||||||||||||2017-10-11 05:24:50.623922|2017-10-11 05:24:50.623922
NCT00168090|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-10|||October 2001||2001-10-01|February 2011|2011-02-01|May 2006||2006-05-01|||||Interventional|||Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)|Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrand's Disease.|Completed||Phase 4|30||CSL Behring|||||f||||||||||||||2017-10-11 05:24:50.811813|2017-10-11 05:24:50.811813
NCT00168103|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-11|2010-04-21||June 2005||2005-06-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks|Human Pasteurized C1 Esterase Inhibitor Concentrate (CE1145) in Subjects With Congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks|Completed||Phase 2/Phase 3|126|Actual|CSL Behring|A test for futility of the C1-INH 10 U/kg bw group conducted during a planned interim analysis led to ceasing recruitment for the C1-INH 10 U/kg bw group.|3|||f||||t||||||||||2017-10-11 05:24:50.906419|2017-10-11 05:24:50.906419
NCT00168116|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-02-23|||July 2000||2000-07-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure|To Evaluate the Effects of Transfer of Submandibular Salivary Gland to the Submental Region (Outside the Radiation Field) on Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure|Completed||Phase 2|42|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 05:24:51.670342|2017-10-11 05:24:51.670342
NCT00168129|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-12-08|||June 2001||2001-06-01|December 2011|2011-12-01|July 2005||2005-07-01|||||Interventional|||Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases|Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases|Completed||Phase 1|10||AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:24:51.747148|2017-10-11 05:24:51.747148
NCT00168142|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-02-23|||October 2003||2003-10-01|December 2011|2011-12-01|August 2009|Actual|2009-08-01|July 2008|Actual|2008-07-01||Observational|||MVCT Imaging Pilot Study Using Helical Tomotherapy|MVCT Imaging Pilot Study Using Helical Tomotherapy|Completed||N/A|16|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-10-11 05:24:51.81926|2017-10-11 05:24:51.81926
NCT00168155|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-01-18|||January 2002||2002-01-01|September 2011|2011-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma|Phase 2 Study of Neoadjuvant 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma|Completed||Phase 2|70||AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:24:51.887311|2017-10-11 05:24:51.887311
NCT00168168|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-02-08|||July 2003||2003-07-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159|ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159|Completed||N/A|60||AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:24:51.962211|2017-10-11 05:24:51.962211
NCT00168181|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-15|||April 2002||2002-04-01|April 2011|2011-04-01|April 2008||2008-04-01|||||Interventional|||Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients|A Phase III Randomized Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients|Completed||Phase 3|220|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-10-11 05:24:52.038134|2017-10-11 05:24:52.038134
NCT00168194|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-01-19|||December 2004||2004-12-01|January 2012|2012-01-01|December 2009|Actual|2009-12-01|||||Observational|||Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History|Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History|Completed||N/A|104|Actual|The Alfred|||1||f||||f||||||Samples Without DNA|"     plasma   "|||2017-10-11 05:24:52.156313|2017-10-11 05:24:52.156313
NCT00168207|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-01-19|||May 2005||2005-05-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|||||Observational|||IL-7 Receptor Polymorphisms and Immune Recovery With HAART|The Relationship of Single Nucleotide Polymorphisms in the Interleukin-7 Receptor-α Gene to CD4+ Immune Recovery in HIV Infected Patients Who Begin Antiretroviral Treatment With HAART|Completed||N/A|106|Actual|The Alfred|||1||f||||f||||||Samples With DNA|"     Plasma, PBMC and DNA   "|||2017-10-11 05:24:52.259126|2017-10-11 05:24:52.259126
NCT00168220|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-01-19|||August 2005||2005-08-01|January 2012|2012-01-01||||||||Observational|||Predictors of Drug Hypersensitivity in HIV Infected Subjects|Predictors of Drug Hypersensitivity in HIV Infected Subjects|Withdrawn||N/A|0|Actual|The Alfred|||2|Insufficient recruitment|f||||f||||||Samples With DNA|"     plasma, DNA   "|||2017-10-11 05:24:52.361907|2017-10-11 05:24:52.361907
NCT00168233|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-01-19|||June 2005||2005-06-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Observational|||Impact of HIV and Its Treatment on Reverse Cholesterol Transport|Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport|Completed||N/A|44|Actual|The Alfred|||3||f||||f||||||||||2017-10-11 05:24:52.470956|2017-10-11 05:24:52.470956
NCT00168246|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-02-26|||June 2005||2005-06-01|February 2007|2007-02-01||||||||Observational|||Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific|A Cross-Sectional Study of HIV-Related Neurological Disorders in Ten Countries of the Asia Pacific Region|Unknown status|Active, not recruiting|N/A|600||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 05:24:52.563127|2017-10-11 05:24:52.563127
NCT00168259|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-01-19|||December 2004||2004-12-01|January 2012|2012-01-01|December 2009|Actual|2009-12-01|||||Observational|||Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals|Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals|Completed||N/A|20|Actual|The Alfred|||1||f||||f||||||Samples With DNA|"     Plasma, and DNA   "|||2017-10-11 05:24:52.623475|2017-10-11 05:24:52.623475
NCT00168272|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-04-13|||June 2004||2004-06-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Priming rTMS In Major Depression|A Randomised Double-Blind Trial of Low and High Frequency Stimulation rTMS (Repetitive Transcranial Magnetic Stimulation) In Major Depression|Completed||N/A|100||The Alfred|||||f||||||||||||||2017-10-11 05:24:52.701489|2017-10-11 05:24:52.701489
NCT00168285|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-04|||March 2005||2005-03-01|April 2007|2007-04-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Pulmonary Rehabilitation in Interstitial Lung Disease|Pulmonary Rehabilitation in Interstitial Lung Disease - a Multi-Centre, Single-Blinded Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|56||The Alfred|||||f||||f||||||||||2017-10-11 05:24:52.763534|2017-10-11 05:24:52.763534
NCT00168298|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-15|2009-07-15||November 2004||2004-11-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion||Completed||Phase 3|668|Actual|Allergan||3|||f||||f||||||||||2017-10-11 05:24:52.879228|2017-10-11 05:24:52.879228
NCT00168558|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-03-04|||July 2003||2003-07-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Early Two-dose Measles Vaccination Trial|Measles Vaccination in Guinea-Bissau. Strategies to Reduce Disease Burden and Improve Child Survival|Completed||Phase 4|5879|Actual|Bandim Health Project||3|||f||||t||||||||||2017-10-11 05:25:01.245484|2017-10-11 05:25:01.245484
NCT00168311|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-04-15|2010-06-15||August 2002||2002-08-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|rTMS||A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia|A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magentic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia and Related Disorders|Completed||N/A|22|Actual|The Alfred|Insufficient time period used to be able to establish a substantive therapeutic effect of rTMS; standard dosing method may be inadequate due to volumetric changes in brain regions in schizophrenia; concurrent antipsychotic medication.|2|||f||||f||||||||||2017-10-11 05:24:53.647137|2017-10-11 05:24:53.647137
NCT00168324|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-15|2009-07-15||October 2004||2004-10-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|March 2008|Actual|2008-03-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion||Completed||Phase 3|599|Actual|Allergan||3|||f||||f||||||||||2017-10-11 05:24:53.915227|2017-10-11 05:24:53.915227
NCT00168337|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-10|2014-07-10|2013-05-30|May 2005||2005-05-01|July 2014|2014-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema||Completed||Phase 3|554|Actual|Allergan||3|||f||||f||||||||||2017-10-11 05:24:54.622361|2017-10-11 05:24:54.622361
NCT00168350|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-11-03|||March 2000||2000-03-01|November 2010|2010-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Memantine in Patients With Chronic Glaucoma||Completed||Phase 3|1179|Actual|Allergan||3|||f||||f||||||||||2017-10-11 05:24:56.523568|2017-10-11 05:24:56.523568
NCT00168363|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-27|||January 2005||2005-01-01|May 2011|2011-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|207|Actual|Allergan|||||f||||||||||||||2017-10-11 05:24:56.582666|2017-10-11 05:24:56.582666
NCT00168376|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-04-13|||July 2004||2004-07-01|April 2007|2007-04-01|April 2006|Actual|2006-04-01|||||Interventional|||A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder|A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder|Completed||N/A|60||The Alfred|||||f||||||||||||||2017-10-11 05:24:56.651857|2017-10-11 05:24:56.651857
NCT00168389|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-10|2014-07-10|2013-06-21|February 2005||2005-02-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema||Completed||Phase 3|494|Actual|Allergan||3|||f||||f||||||||||2017-10-11 05:24:56.747833|2017-10-11 05:24:56.747833
NCT00168402|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-27|||February 2002||2002-02-01|May 2011|2011-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis||Completed||Phase 3|193|Actual|Allergan|||||f||||||||||||||2017-10-11 05:24:58.278018|2017-10-11 05:24:58.278018
NCT00168415|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-26|||August 2005||2005-08-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis||Completed||Phase 4|144|Actual|Allergan||1|||f||||||||||||||2017-10-11 05:24:58.348103|2017-10-11 05:24:58.348103
NCT00168428|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-10-24|2010-11-05|2009-06-17|March 2006||2006-03-01|October 2013|2013-10-01|August 2008|Actual|2008-08-01|December 2007|Actual|2007-12-01||Interventional|||A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches||Completed||Phase 3|705|Actual|Allergan||2|||f||||||||||||||2017-10-11 05:24:58.449236|2017-10-11 05:24:58.449236
NCT00168441|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-27|||June 2004||2004-06-01|May 2011|2011-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia||Completed||Phase 2|117|Actual|Allergan|||||f||||||||||||||2017-10-11 05:24:58.915334|2017-10-11 05:24:58.915334
NCT00168454|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-10-11|2009-09-02||July 2005||2005-07-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||A Research Study for Patients With Overactive Bladder||Completed||Phase 2|313|Actual|Allergan||6|||f||||t||||||||||2017-10-11 05:24:59.013449|2017-10-11 05:24:59.013449
NCT00168467|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-28||||||January 2009|2009-01-01||||||||Interventional|||The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease|The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease|Completed||Phase 4|40||Baker Heart Research Institute|||||f||||||||||||||2017-10-11 05:25:00.633043|2017-10-11 05:25:00.633043
NCT00168480|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-26|||November 2003||2003-11-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis||Completed||Phase 4|424|Actual|Allergan||1|||f||||||||||||||2017-10-11 05:25:00.703076|2017-10-11 05:25:00.703076
NCT00168493|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-05-19|||June 2000||2000-06-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||The Neurobiology of Depressive Illness|The Neurobiology of Depressive Illness: Causes and Consequences of Altered Brain Monoaminergic Function|Unknown status|Recruiting|N/A|40|Anticipated|Baker Heart Research Institute||1|||f||||f||||||||||2017-10-11 05:25:00.80392|2017-10-11 05:25:00.80392
NCT00168506|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2007-04-04|||June 2002||2002-06-01|April 2007|2007-04-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Panic Disorder and Cardiac Risk|Panic Disorder and Cardiac Risk: Evaluation of a Psychological Treatment Which Addresses Biology, Psychology and Behaviour|Unknown status|Recruiting|N/A|50||Baker Heart Research Institute|||||f||||||||||||||2017-10-11 05:25:00.883973|2017-10-11 05:25:00.883973
NCT00168519|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-12-14|||October 2002||2002-10-01|December 2009|2009-12-01|April 2009|Actual|2009-04-01|||||Interventional|||Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes|Contraction Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes|Completed||N/A|40|Anticipated|Baker Heart Research Institute||1|||f||||||||||||||2017-10-11 05:25:00.955196|2017-10-11 05:25:00.955196
NCT00168532|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-02-25|||January 1998||1998-01-01|February 2008|2008-02-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Prophylactic Antibiotics in Measles|Prophylactic Antibiotics in Measles Infection. A Community-Based Randomised Double-Blind Placebo-Controlled Trial in Guinea-Bissau|Completed||Phase 3|218||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.045421|2017-10-11 05:25:01.045421
NCT00168545|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-09-21|||January 2006||2006-01-01|September 2006|2006-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Immunology of Non-specific Effects of Vaccine|Non-specific Effects of Vaccines - In Search of the Immunological Background|Completed||Phase 4|400||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.148782|2017-10-11 05:25:01.148782
NCT00168571|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-09-21|||March 2002||2002-03-01|September 2006|2006-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Long-term Follow-up of Measles Antibodies|Long-term Follow-up of Protective Measles Antibodies in the Two-dose Study of Standard-titre Measles Vaccine in Guinea-Bissau|Completed||Phase 4|1960||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.355537|2017-10-11 05:25:01.355537
NCT00168584|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||November 2002||2002-11-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||Different Doses of Vitamin A and Childhood Morbidity and Mortality|Randomised Study of the Impact of Different Doses of Vitamin A on Childhood Morbidity and Mortality|Completed||Phase 4|5400||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.439738|2017-10-11 05:25:01.439738
NCT00168597|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-14|||August 2002||2002-08-01|November 2013|2013-11-01||||November 2013|Actual|2013-11-01||Interventional|||Vitamin A With BCG Vaccine|Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries?|Completed||Phase 4|4800||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.561081|2017-10-11 05:25:01.561081
NCT00168610|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-14|||November 2004||2004-11-01|November 2013|2013-11-01||||||||Interventional|||Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine|Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries? Randomized Prospective Studies in Guinea-Bissau|Unknown status|Active, not recruiting|Phase 4|7600|Actual|Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.646714|2017-10-11 05:25:01.646714
NCT00168623|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-14|||November 2003||2003-11-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|||||Interventional|||Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity|Randomised Trial of Vitamin A Supplementation Given With Routine Childhood Vaccines at National Immunisation Days|Unknown status|Active, not recruiting|Phase 4|6200||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.762435|2017-10-11 05:25:01.762435
NCT00168636|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-14|||November 2004||2004-11-01|November 2013|2013-11-01||||November 2013|Actual|2013-11-01||Interventional|||Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality|The Impact of Different Doses of Vitamin A Supplementation on Male and Female Childhood Morbidity and Mortality|Completed||Phase 4|11000||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.873404|2017-10-11 05:25:01.873404
NCT00168649|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-14|||June 2005||2005-06-01|November 2013|2013-11-01|June 2014||2014-06-01|||||Interventional|||Vitamin A and Response to Endotoxin|The Effect of Vitamin A on the Response to Endotoxin|Unknown status|Active, not recruiting|N/A|40||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:01.96427|2017-10-11 05:25:01.96427
NCT00168662|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-02-25|||March 1995||1995-03-01|February 2008|2008-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Non-Specific Effects of Standard Titre Measles Vaccination|Trial of Two-Dose Standard Measles Vaccination Schedule: Long-Term Impact on Morbidity and Mortality of a Two-Dose Vaccination Schedule at 6 and 9 Months of Age Compared With a Standard Regimen of One Dose at 9 Months of Age|Completed||Phase 4|7800||Bandim Health Project|||||f||||||||||||||2017-10-11 05:25:02.053827|2017-10-11 05:25:02.053827
NCT00168688|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-15|||January 2001||2001-01-01|November 2013|2013-11-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Prenatal Multi-micronutrient Supplementation and Pregnancy Outcome|The Effects of Prenatal Multi-micronutrient Supplements on Pregnancy Outcome, Peri- and Neonatal Mortality on Maternal and Infant Nutritional Status: A Randomised, Controlled Trial Among Women in Guinea-Bissau|Completed||Phase 1|2100|Actual|Bandim Health Project||3|||f||||||||||||||2017-10-11 05:25:02.186748|2017-10-11 05:25:02.186748
NCT00168701|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-11-14|||October 2004||2004-10-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy and Safety of BG00012 in MS|Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy and Safety of BG00012 in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|260||Biogen|||||f||||||||||||||2017-10-11 05:25:02.298779|2017-10-11 05:25:02.298779
NCT00168714|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-06-06|||February 2004||2004-02-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)|Avonex Pregnancy Exposure Registry|Completed||N/A|329|Actual|Biogen|||1||f||||t||||||||||2017-10-11 05:25:02.721717|2017-10-11 05:25:02.721717
NCT00168727|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-18|||June 2003||2003-06-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma|Zevalin® (Ibritumomab Tiuxetan) Followed by Rituxan® (Rituximab) Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma|Completed||Phase 4|12||Biogen|||||f||||||||||||||2017-10-11 05:25:02.81508|2017-10-11 05:25:02.81508
NCT00168740|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||April 1995||1995-04-01|September 2005|2005-09-01||||||||Interventional|||Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)|Pivotal Phase III Multi-Center Study to Evaluate the Safety and Efficacy of Once Weekly Times Four Dosing of IDEC-C2B8 (IDEC-102) in Patients With Relapsed Low-Grade or Follicular B-Cell Lymphoma|Completed||Phase 3|150||Biogen|||||||||||||||||||2017-10-11 05:25:02.925592|2017-10-11 05:25:02.925592
NCT00168753|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-09-05|||July 2004||2004-07-01|September 2014|2014-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Community Based Trial for AMEVIVE®|An Open-Label Community-Based Study to Determine the Safety and Efficacy of an Extended Course of Alefacept, Following a Standard 12-Week Course of Amevive®, With Commonly Used Clinical Assessment Tools|Completed||Phase 4|114|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-10-11 05:25:03.08681|2017-10-11 05:25:03.08681
NCT00168766|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-09-12|||January 2003||2003-01-01|April 2011|2011-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS|A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Investigating Methylprednisolone in Combination With Interferon-beta-1a for the Treatment of Patients With Relapsing-remitting Multiple Sclerosis|Completed||Phase 4|345|Actual|Biogen||2|||f||||f||||||||||2017-10-11 05:25:03.749787|2017-10-11 05:25:03.749787
NCT00168779|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-10-31|||September 2005||2005-09-01|October 2013|2013-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension|A Randomized, Double-blind, Placebo-controlled, Forced-titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg Taken Orally for Eight Weeks in Patients With Stage 1 or Stage 2 Hypertension.|Completed||Phase 4|1185||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:25:03.983225|2017-10-11 05:25:03.983225
NCT00168792|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-10-28|||November 2003||2003-11-01|October 2013|2013-10-01||||July 2006||2006-07-01||Interventional|||A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)|A Phase IIIb - IV, Randomised, Open Label Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early PCI as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction. ASSENT 4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction.)|Terminated||Phase 4|1671||Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:25:04.299824|2017-10-11 05:25:04.299824
NCT00168805|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-08|2010-11-18||November 2004||2004-11-01|February 2014|2014-02-01||||May 2006|Actual|2006-05-01||Interventional|||RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery|RE-MODEL (Thromboembolism Prevention After Knee Surgery). Two Different Dose Regimens of Orally Administered Dabigatran Etexilate Capsules [150 or 220 mg Once Daily Starting With a Half Dose (i.e.75 or 110 mg) on the Day of Surgery] Compared to Subcutaneous Enoxaparin 40 mg Once Daily for 6-10 Days|Completed||Phase 3|2101|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 05:25:05.220046|2017-10-11 05:25:05.220046
NCT00168818|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-08|2010-11-18||November 2004||2004-11-01|February 2014|2014-02-01||||July 2006|Actual|2006-07-01||Interventional|||Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery|A Phase III Randomised, Parallel Group, Double-blind, Active Controlled Study to Investigate the Efficacy and Safety of Two Different Dose Regimens of Orally Administered Dabigatran Etexilate Capsules [150 or 220 mg Once Daily Starting With Half Dose (75 or 110 mg) on the Day of Surgery] Compared to Subcutaneous Enoxaparin 40 mg Once Daily for 28-35 Days, in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip Replacement Surgery. RE-NOVATE (Extended Thromboembolism Prevention After Hip Surgery)|Completed||Phase 3|3494|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 05:25:06.849499|2017-10-11 05:25:06.849499
NCT00168831|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-15|2009-01-30||February 2003||2003-02-01|September 2013|2013-09-01||||June 2005|Actual|2005-06-01||Interventional|||Tiotropium / Respimat One-Year Study|A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Comparison of One-Year Treatment of Two Doses (5mg and 10mg) of Tiotropium Inhalation Solution Delivered by the Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|1007|Actual|Boehringer Ingelheim||3|||||||||||||||||2017-10-11 05:25:08.911948|2017-10-11 05:25:08.911948
NCT00168844|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-15|2009-01-30||January 2003||2003-01-01|September 2013|2013-09-01||||June 2005|Actual|2005-06-01||Interventional|||Tiotropium / Respimat One-Year Study|A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Comparison of One-Year Treatment of Two Doses (5mg and 10mg) of Tiotropium Inhalation Solution Delivered by the Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|983|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-10-11 05:25:12.185272|2017-10-11 05:25:12.185272
NCT00168857|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-04|||July 2003||2003-07-01|November 2013|2013-11-01||||June 2006|Actual|2006-06-01||Interventional|||A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)|A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare MICARDIS® (Telmisartan) 80 mg Versus COZAAR® (Losartan) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)|Completed||Phase 4|860|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:25:14.988821|2017-10-11 05:25:14.988821
NCT00168870|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-08-30|||February 2003||2003-02-01|September 2006|2006-09-01||||||||Interventional|||Study of Metastatic Ocular Melanoma|Randomized Phase II Study to Compare a Combination Therapy With Gemcitabine and Treosulfan Versus a Monotherapy as First-Line Chemotherapy for Patients With Metastatic Ocular Melanoma|Unknown status|Recruiting|Phase 2|48|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:25:15.441185|2017-10-11 05:25:15.441185
NCT00168883|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-10-31|||October 2002||2002-10-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Study for Patients With Non Small Cell Lung Cancer (NSCLC)|Randomized Phase II Study to Determine the Efficacy of a Three Weekly vs. Weekly Therapy With Paclitaxel Plus Carboplatin vs. Paclitaxel Plus Vinorelbine for Patients With Non Small Cell Lung Cancer According to UICC Stage IIIB and IV|Unknown status|Recruiting|Phase 2|80||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:25:15.543905|2017-10-11 05:25:15.543905
NCT00168896|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-02-13|||October 2001||2001-10-01|September 2001|2001-09-01|December 2006||2006-12-01|||||Interventional|||A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage|A Randomised Phase II/III Study to Compare the Combination of Carboplatin Plus Irinotecan Vs. the Combination of Carboplatin Plus Etoposide for SCLC in Extensive Disease Stage|Unknown status|Recruiting|Phase 2/Phase 3|286||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:25:15.634471|2017-10-11 05:25:15.634471
NCT00168909|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-05-08|||June 2003||2003-06-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|July 2007|Actual|2007-07-01||Interventional|||Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)|Influence of Alfacalcidol on Falls in Elderly Postmenopausal, Alendronate-Treated, Osteopenic/Osteoporotic Women With High Risk of Falls|Completed||Phase 4|282|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-10-11 05:25:15.733394|2017-10-11 05:25:15.733394
NCT00168922|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-04-27|||February 2001||2001-02-01|January 2001|2001-01-01|December 2006||2006-12-01|||||Interventional|||Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)|Phase II Study to Determine the Efficacy of Bendamustin (Ribomustin) in Patients With Recurrent Small Cell Bronchial Carcinoma After Cytostatic Polychemotherapy|Unknown status|Recruiting|Phase 2|50||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:25:15.826771|2017-10-11 05:25:15.826771
NCT00168935|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-06|||March 2004||2004-03-01|September 2005|2005-09-01|December 2008|Actual|2008-12-01|August 2007|Actual|2007-08-01||Interventional|||Malnutrition in Gastroenterology Patients||Completed||Phase 4|||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:25:15.9267|2017-10-11 05:25:15.9267
NCT00168948|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-11-01|||March 2003||2003-03-01|February 2003|2003-02-01|August 2005||2005-08-01|||||Interventional|||Intermittent Antimalaria Treatment With SP in African Children|Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children: A Randomised, Double Blind, and Placebo-Controlled Clinical Trial|Unknown status|Active, not recruiting|Phase 4|1200||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:25:16.009694|2017-10-11 05:25:16.009694
NCT00168987|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-05-05|||January 2005||2005-01-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|November 2006|Actual|2006-11-01||Interventional|||Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors|Pilot Study: Randomized Controlled Trial on the Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors|Completed||Phase 4|30|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:25:16.238712|2017-10-11 05:25:16.238712
NCT00169000|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-08-04|||January 2003||2003-01-01|August 2009|2009-08-01|March 2006|Actual|2006-03-01|September 2005|Actual|2005-09-01||Interventional|||Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers|Phase I Study of a Novel Schedule of Capecitabine and Docetaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|12|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-10-11 05:25:16.321074|2017-10-11 05:25:16.321074
NCT00169013|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-11|||May 2002||2002-05-01|April 2007|2007-04-01|June 2006||2006-06-01|||||Interventional|||Gabapentin in Phantom and Stump Pain|Gabapentin in the Prevention of Phantom Limb Pain|Completed||Phase 4|||Danish Pain Research Center|||||f||||t||||||||||2017-10-11 05:25:16.411737|2017-10-11 05:25:16.411737
NCT00169026|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-09-10|||May 1999||1999-05-01|September 2005|2005-09-01|January 2004||2004-01-01|||||Interventional|||Alcoholism and Schizophrenia: Effects of Clozapine|Alcoholism and Schizophrenia: Effects of Clozapine|Terminated||Phase 4|64||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 05:25:16.486881|2017-10-11 05:25:16.486881
NCT00169039|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2015-04-06|||December 1994||1994-12-01|April 2015|2015-04-01|February 2002||2002-02-01|||||Interventional|||Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia|Clozapine Response and Biogenic Amines in Schizophrenia|Terminated||Phase 4|66||Harvard Medical School|||||f||||||||||||||2017-10-11 05:25:16.57319|2017-10-11 05:25:16.57319
NCT00169052|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2013-09-06|||September 2001||2001-09-01|September 2001|2001-09-01|August 2006||2006-08-01|||||Interventional|||Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People|Rehabilitation and Health Care for Elderly With SMI|Completed||N/A|180||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 05:25:16.661702|2017-10-11 05:25:16.661702
NCT00169065|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2015-04-06|||August 1998||1998-08-01|April 2015|2015-04-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|COES||Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia|Clozapine vs. Olanzapine: An Effectiveness Study|Completed||Phase 4|38|Actual|Harvard Medical School||2|||f||||t||||||||||2017-10-11 05:25:16.746575|2017-10-11 05:25:16.746575
NCT00169078|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-11|||July 2002||2002-07-01|January 2017|2017-01-01|December 2002||2002-12-01|||||Interventional|||Impact of Insecticide-treated Curtains on Antimalarial Drug Resistance|A Study of the Impact of Insecticide-treated Curtains on the Prevalence of Antimalarial Drug Resistance in Children With Uncomplicated Malaria in Burkina Faso|Completed||N/A|1035||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:25:16.856974|2017-10-11 05:25:16.856974
NCT00169091|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2015-04-06|||March 1996||1996-03-01|April 2015|2015-04-01|October 2003||2003-10-01|September 2003|Actual|2003-09-01||Interventional|||Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia|Clozapine or Haloperidol in First Episode Schizophrenia|Terminated||Phase 4|32|Actual|Harvard Medical School||2|||f||||||||||||||2017-10-11 05:25:16.982033|2017-10-11 05:25:16.982033
NCT00169104|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-10-19|||July 2002||2002-07-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function|A Phase II Trial of Trastuzumab, Neupogen, and Vinorelbine Investigating the Effects on Immune Function and Clinical Outcomes in Patients With Metastatic Breast Cancer Overexpressing Her-2/Neu|Terminated||Phase 2/Phase 3|23|Actual|Dartmouth-Hitchcock Medical Center||2||Closed due to achievement of primary study endpoint|f||||t||||||||||2017-10-11 05:25:17.133405|2017-10-11 05:25:17.133405
NCT00169117|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-11|||June 2002||2002-06-01|January 2017|2017-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Stitch in Time May Save Lives: Turning Poor Bednets Into Good Ones|A Stitch in Time May Save Lives: Turning Poor Bednets Into Good Ones|Completed||N/A|772|Actual|London School of Hygiene and Tropical Medicine||1|||f||||f||||||||||2017-10-11 05:25:17.289573|2017-10-11 05:25:17.289573
NCT00169130|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-07-12|||October 1999||1999-10-01|July 2007|2007-07-01||||||||Interventional|||ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma|Prospective Study of ACVBP Followed by Autologous Stem Cell Transplantation in Case of BCL-2 Overexpression in Non Previously Treated Patients Aged 60 Years or Less With Low-Intermediate Risk Diffuse Large B-Cell Lymphoma|Completed||Phase 2/Phase 3|300||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:25:17.413239|2017-10-11 05:25:17.413239
NCT00169143|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-06|||May 2004||2004-05-01|September 2006|2006-09-01|January 2007||2007-01-01|||||Interventional|||Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma|Study of R-ACVBP Regimen Supported by Pegfilgrastim in Previously Untreated Patients Aged From 18 to 60 Years With High-Risk Diffuse Large B-Cell Lymphoma (Age-Adjusted Ipi >or= 2)|Completed||Phase 2|60||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:25:17.563423|2017-10-11 05:25:17.563423
NCT00169156|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-09|||December 2005|Actual|2005-12-01|March 2017|2017-03-01|November 2012|Actual|2012-11-01|December 2008|Actual|2008-12-01||Interventional|||A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma|Study of the Efficacy and the Safety of First Line Treatment With CHOP Plus Rituximab (R-CHOP) in Patients Aged 60 to 80 Years With Previously Untreated T-cell Angioimmunoblastic Lymphoma (AIL).|Completed||Phase 2|27|Actual|Lymphoma Study Association||1|||f||||t||||||||No||2017-10-11 05:25:17.701928|2017-10-11 05:25:17.701928
NCT00169169|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 1999||1999-10-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma|Randomised Phase 3 Study of Rituximab in High-Risk Patients With Diffuse Large B-Cell Lymphoma Who Received a First-Line Consolidative Chemotherapy With Autologous Stem Cell Transplant (ASCT).|Terminated||Phase 3|430||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:25:17.805186|2017-10-11 05:25:17.805186
NCT00169182|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||December 2000||2000-12-01|September 2005|2005-09-01||||||||Interventional|||Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma|Randomized Study Comparing Induction Chemotherapy With Docetaxel, Cisplatin, 5FU Versus Cisplatin, 5 FU in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma|Completed||Phase 3|220||Groupe Oncologie Radiotherapie Tete et Cou|||||f||||||||||||||2017-10-11 05:25:17.890087|2017-10-11 05:25:17.890087
NCT00169195|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-09-01|||April 2003||2003-04-01|September 2015|2015-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma|Gemcitabine-oxaliplatin Plus Rituximab (R-GEMOX) in Refractory/Relapsed Patients With CD 20 Positive Diffuse Large B-cell Lymphoma, Non Eligible for High-dose Chemotherapy Followed by Autotransplantation|Completed||Phase 2|49|Actual|Lymphoma Study Association||1|||f||||||||||||||2017-10-11 05:25:17.964415|2017-10-11 05:25:17.964415
NCT00169208|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-09|||April 2001||2001-04-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma|An Open Label, Multicenter, Non Randomized Phase II Study to Evaluate Anti-Tumor Activity and Safety of a Combination of Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma.|Completed||Phase 2|50||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:25:18.05463|2017-10-11 05:25:18.05463
NCT00169221|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-14|||September 2005||2005-09-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2009|Actual|2009-07-01||Interventional|||Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas|CARISSA Trial - Multicenter Randomized Phase II Trial Comparing Post-operative Radiotherapy and Cisplatin Alone or in Combination With the EGFR Inhibitor ZD 1839 (Iressa) in Upper Aerodigestive Tract Carcinomas|Terminated||Phase 2|54|Actual|Groupe Oncologie Radiotherapie Tete et Cou||2||"Toxicity in an independent study IMEX. The trial was subsequently terminated (54 pts instead of   140) despite safety analyses showing no excess of toxicity"|f||||||||||||||2017-10-11 05:25:18.155055|2017-10-11 05:25:18.155055
NCT00169247|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-23|||October 2005||2005-10-01|June 2011|2011-06-01||||April 2011|Actual|2011-04-01||Interventional|||Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation|Larynx Preservation With Induction Chemotherapy (Cisplatin, 5FU, Docetaxel) Followed by Radiotherapy Combined With Either Cisplatin or Cetuximab in Laryngopharyngeal Squamous Cell Carcinoma - A Randomised Phase II Study|Completed||Phase 2|156|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou|||||f||||||||||||||2017-10-11 05:25:18.535231|2017-10-11 05:25:18.535231
NCT00169260|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-12-27|||February 2005||2005-02-01|December 2010|2010-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Proactive Health Intervention for Tobacco Users (Get PHIT)|Proactive Cessation Intervention With Biomarker Feedback|Completed||Phase 2/Phase 3|536|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 05:25:18.630412|2017-10-11 05:25:18.630412
NCT00169299|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2001||2001-06-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||Herbal Alternatives for Menopause Symptoms (HALT Study)|Herbal Alternatives for Menopause Symptoms: A Randomized Trial|Unknown status|Active, not recruiting|Phase 4|351||Kaiser Permanente|||||f||||||||||||||2017-10-11 05:25:18.927304|2017-10-11 05:25:18.927304
NCT00169312|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-09-19|||August 2005||2005-08-01|September 2009|2009-09-01|June 2007||2007-06-01|||||Interventional|||Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations|The HMO Cancer Research Network (CRN) - Making Effective Nutritional Choices for Cancer Prevention: The MENU Study|Unknown status|Active, not recruiting|N/A|2619|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:25:19.028107|2017-10-11 05:25:19.028107
NCT00169325|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-09-11|||September 2005||2005-09-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions||Completed||N/A|11|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||||||||||||2017-10-11 05:25:19.112505|2017-10-11 05:25:19.112505
NCT00169338|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-09-14|||September 2005||2005-09-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia||Completed||Phase 2|13|Actual|Groupe Hospitalier Pitie-Salpetriere||2|||f||||||||||||||2017-10-11 05:25:19.176402|2017-10-11 05:25:19.176402
NCT00169351|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Observational|||National Gilles De La Tourette Study Group||Unknown status|Recruiting|N/A|||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-10-11 05:25:19.239492|2017-10-11 05:25:19.239492
NCT00169364|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-28|||May 2002||2002-05-01|September 2005|2005-09-01||||||||Interventional|||Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin Mutation|Comparison of Clinical, Molecular and Metabolic Characteristics of PD Patients With and Without Parkin Mutation|Unknown status|Recruiting|N/A|50|Anticipated|Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-10-11 05:25:19.301376|2017-10-11 05:25:19.301376
NCT00169377|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-07-22|||October 2005||2005-10-01|July 2008|2008-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD)|Study of the Effects of High Frequency Stimulation of the Subthalamic Stimulation in the Treatment of Severe Obsessive-Compulsive Disorders|Completed||Phase 1/Phase 2|16|Actual|Groupe Hospitalier Pitie-Salpetriere||2|||f||||t||||||||||2017-10-11 05:25:19.365438|2017-10-11 05:25:19.365438
NCT00169390|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-03-17|||March 2004||2004-03-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Monoamine Oxidases in Smoking Pregnant Women and Newborns|Comparison of Monoamines Oxidases A and B Activities and the Metabolism of Nicotine in Smoking and Nonsmoking Pregnant Women and in Their Newborns. Evaluation of Their Effects on the Newborns' Behavior|Completed||N/A|59|Actual|Groupe Hospitalier Pitie-Salpetriere|||2||f||||f||||||Samples Without DNA|"     plasma DHPG, HVA, 5HIAA, 5HT, cotinine   "|||2017-10-11 05:25:19.447953|2017-10-11 05:25:19.447953
NCT00169416|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-04-14|||March 2005||2005-03-01|April 2015|2015-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Evaluation Of Valaciclovir In Patients With Chickenpox|Clinical Evaluation of Valaciclovir Hydrochloride: 256U87 in Patients With Chickenpox - Open Uncontrolled Study.|Completed||Phase 3|43|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-10-11 05:25:19.578558|2017-10-11 05:25:19.578558
NCT00169442|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-08|2017-01-10||February 10, 2005|Actual|2005-02-10|May 2017|2017-05-01|March 10, 2006|Actual|2006-03-10|March 1, 2006|Actual|2006-03-01||Interventional|||Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants|Immune Memory of GSK's DTPw-HBV/Hib Vaccine by Giving Plain PRP Polysaccharide at 10 Mths. Immuno & Reacto of a Booster Dose of DTPw-HBV/Hib or DTPw-HBV or DTPw-HBV+Hib at 15-18 Mths in Infants Previously Primed With DTPw-HBV/Hib|Completed||Phase 3|745|Actual|GlaxoSmithKline|None reported.|6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:25:19.666978|2017-10-11 05:25:19.666978
NCT00169455|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-13|||March 2005||2005-03-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants|A Phase IIIb, Partially Blind, Randomized, Placebo-controlled Study to Asses the Effect on Immunogenicity of Administration of Vaccine Without Buffering Agent and to Assess Heat Stability in Terms of Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Following a 0, 2 Month Schedule, in Healthy Infants Previously Uninfected With Human Rotavirus|Completed||Phase 3|450|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:25:22.533068|2017-10-11 05:25:22.533068
NCT00169468|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-05-26|||January 2005||2005-01-01|May 2009|2009-05-01|August 2011|Anticipated|2011-08-01|||||Interventional|||Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma|Phase II Study of the Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|48||Lymphoma Study Association|||||f||||||||||||||2017-10-11 05:25:22.626758|2017-10-11 05:25:22.626758
NCT00169481|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-01-09|||October 2004||2004-10-01|January 2017|2017-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine|A Randomized, Controlled, Phase II Study to Evaluate the Safety and Immunogenicity of Different Formulations of GlaxoSmithKline Biologicals' 11-valent Pneumococcal Conjugate Vaccine, When Administered Intramuscularly as a 3-dose Primary Immunization (2-3-4 Month Schedule) Before 6 Months of Age|Completed||Phase 2|689|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:25:22.727297|2017-10-11 05:25:22.727297
NCT00169494|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-09-09|||September 2004||2004-09-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18|Immunogenicity: 3 Consecutive Lots of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly at 0,1,6 Month Schedule in Healthy Females Aged 10-25 Years and Demonstrate Non-inferiority of Candidate HPV Vaccine Manufactured by Modified Production Process|Completed||Phase 3|770|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:25:24.259299|2017-10-11 05:25:24.259299
NCT00169507|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-24|||March 2005||2005-03-01|May 2017|2017-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23)|Phase III Multicentric Open Study to Evaluate Immunological Memory Induced by 3-dose Primary Vaccination Followed by Booster Dose of GSK Biologicals' 11-valent Conjugate Pneumococcal Vaccine Compared to Unprimed Subjects by Giving 1 Dose of Aventis Pasteur's Pneumo 23|Completed||Phase 3|100||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:25:24.362419|2017-10-11 05:25:24.362419
NCT00169520|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-15|||June 2004||2004-06-01|October 2008|2008-10-01||||||||Interventional|||SB-715992 In Combination With Docetaxel In Patients With Solid Tumors|A Phase I, Open-Label Study of SB-715992 in Combination With Docetaxel in Patients With Advanced Solid Tumors.|Completed||Phase 1|30|Actual|GlaxoSmithKline|||||||||||||||||||2017-10-11 05:25:24.439311|2017-10-11 05:25:24.439311
NCT00169533|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-21|||August 2004||2004-08-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Rollover Study Of Lapatinib In Cancer Patients|An Open Label, Phase 1b Rollover Study to Assess the Long-Term Safety Profile of Lapatinib (GW572016) in Cancer Patients.|Completed||Phase 1|31|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-10-11 05:25:24.514435|2017-10-11 05:25:24.514435
NCT00169546|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-09-13|||January 2003||2003-01-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.|Randomised, Double-blind Parallel Group Study to Assess the Bronchodilative and Bronchoprotective Properties of SERETIDE DISKUS ® Inhlaer 50/100mcg Twice Daily vs. FLIXOTIDE® Inhaler 200mcg Twice Daily.|Completed||Phase 4|64|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:25:24.615836|2017-10-11 05:25:24.615836
NCT00169559|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-10-18|||November 2003||2003-11-01|October 2012|2012-10-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||"Dyslipidemia Study Investigating The Increase In Good Cholesterol"|A Multi-center, Three-staged, Randomized, Parallel Group, Sequential, Double-blind, fenofibrate-and Placebo-controlled Dose-response Evaluation of the Safety, Tolerability, and Effects on Plasma HDLc and TG of Eight Weeks Treatment With 1µg to 20µg Daily Doses of GW590735 in Otherwise Healthy Subjects With Low HDLc, Mildly to Moderately Elevated TG, and Normal LDLc|Completed||Phase 2|250|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 05:25:24.862957|2017-10-11 05:25:24.862957
NCT00169572|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-05-06|||February 2005||2005-02-01|May 2010|2010-05-01||||||||Interventional|||Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy|See Detailed Description|Completed||Phase 2|492||GlaxoSmithKline||1|||f||||||||||||||2017-10-11 05:25:25.106823|2017-10-11 05:25:25.106823
NCT00169585|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-24|||March 2005||2005-03-01|May 2017|2017-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)|A National, Multicentric, Randomised, Controlled Trial. Applications of a Critical Pathway Using Levofloxacin for the Management of Patients With Abnormal PSA.|Completed||Phase 3|240|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:25:25.327434|2017-10-11 05:25:25.327434
NCT00169598|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-26|||February 2002||2002-02-01|April 2007|2007-04-01||||||||Interventional|TEPELY||Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study|Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study|Unknown status|Active, not recruiting|N/A|80||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:25:25.441054|2017-10-11 05:25:25.441054
NCT00169611|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-01-26|||January 2004||2004-01-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate|Comportemental and Neuropsychologic Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate. A Double-blind Randomised Study Methylphenidate Versus Placebo|Completed||Phase 4|80|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:25:25.527136|2017-10-11 05:25:25.527136
NCT00169624|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-10-04|||October 2005||2005-10-01|October 2007|2007-10-01||||||||Interventional|||Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin|The DIAMET Study: Peripheral and Coronary Endothelial Dysfunction in Type 2diabetic Patients- Evaluation of Reversibility Following 3 Months of Metformin Treatment|Terminated||Phase 3|30||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:25:25.612373|2017-10-11 05:25:25.612373
NCT00169637|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-30|||June 2006||2006-06-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|||||Interventional|||Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome|Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome|Completed||Phase 3|14|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-10-11 05:25:25.679536|2017-10-11 05:25:25.679536
NCT00169650|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-14|||July 2003||2003-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Laparoscopic Pyeloplasty Registry and Database|Laparoscopic Pyeloplasty: A Registry and Database|Completed||N/A|64|Actual|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-10-11 05:25:25.777233|2017-10-11 05:25:25.777233
NCT00169663|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-04-23|||July 2003||2003-07-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings|Brushite Stones: A Registry and Database of Clinical and Laboratory Findings|Completed||N/A|90|Actual|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-10-11 05:25:25.866228|2017-10-11 05:25:25.866228
NCT00169676|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-06-28|||June 2003||2003-06-01|September 2008|2008-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Registry and Database Lap Prostatectomy|Laparoscopic Radical Prostatectomy: A Registry and Database|Completed||N/A|9|Actual|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-10-11 05:25:25.942354|2017-10-11 05:25:25.942354
NCT00169689|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-01-28|||June 2003||2003-06-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|||||Interventional|||Repetitive Transcranial Magnetic Stimulation|Therapeutic and Biological Effects of High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia|Completed||N/A|40|Actual|Heinrich-Heine University, Duesseldorf||1|||f||||f||||||||||2017-10-11 05:25:26.053337|2017-10-11 05:25:26.053337
NCT00169702|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-01-28|||June 2003||2003-06-01|April 2007|2007-04-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effect of a Weight Management Program During Treatment With Olanzapine|The Effect of a Weight Management Program to Prevent Weight Gain and Metabolic Abnormalities During Treatment With the Atypical Neuroleptic Olanzapine: A Randomised Study|Completed||N/A|100|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-10-11 05:25:26.158955|2017-10-11 05:25:26.158955
NCT00169715|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-09-16|||February 2003||2003-02-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Database and Registry for Renal Diverticulum|Percutaneous Surgical Outcomes and Metabolic Findings in Patients With Stone-Bearing Calicial Diverticula|Completed||N/A|86|Actual|Indiana Kidney Stone Institute||1|||f||||f||||||||||2017-10-11 05:25:26.439149|2017-10-11 05:25:26.439149
NCT00169728|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-06|||September 2003||2003-09-01|June 2012|2012-06-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Interventional|||Vaccination of Children Following Allogeneic Stem Cell Transplantation|Immunogenicity of the DTaP-IPV-HBV/Hib Combination Vaccine Infanrix Hexa and the Heptavalent Pneumococcal Conjugate Vaccine Prevenar in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplantation|Completed||Phase 3|53|Actual|Heinrich-Heine University, Duesseldorf||1|||f||||||||||||||2017-10-11 05:25:26.562154|2017-10-11 05:25:26.562154
NCT00169741|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-02-22|||May 2005||2005-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC|Alterations in Renal Blood Flow as a Consequence of Percutaneous Nephrolithotomy (PERC)|Completed||N/A|4|Actual|Indiana Kidney Stone Institute||1|||f||||f||||||||||2017-10-11 05:25:26.693898|2017-10-11 05:25:26.693898
NCT00169754|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-09-16|||April 2005||2005-04-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Attached Stone Project: Do Calcium Oxalate Renal Calculi Originate From Randall's Plaque?|Do Calcium Oxalate Renal Calculi Originate From Randall's Plaque?|Completed||N/A|32|Actual|Indiana Kidney Stone Institute||1|||f||||f||||||||||2017-10-11 05:25:26.792066|2017-10-11 05:25:26.792066
NCT00169767|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-04-23|||May 2005||2005-05-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate|Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate: A Randomized Comparison Study|Terminated||N/A|18|Actual|Indiana Kidney Stone Institute|||1|Poor enrollment|f||||f||||||||||2017-10-11 05:25:26.898987|2017-10-11 05:25:26.898987
NCT00169780|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-12-05|||July 2002||2002-07-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Kidney Stone Structural Analysis By Helical Computed Tomography (CT)|Kidney Stone Structural Analysis by Helical Computed Tomography (A Pilot Study)|Completed||N/A|7|Actual|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-10-11 05:25:27.047872|2017-10-11 05:25:27.047872
NCT00169806|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-14|||November 1998||1998-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis|Randall's Plaques: Pathogenesis and Relationship to Nephrolithiasis|Recruiting||N/A|400|Anticipated|Indiana Kidney Stone Institute||1|||f||||t||||||||||2017-10-11 05:25:27.273666|2017-10-11 05:25:27.273666
NCT00169819|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-02-23|||October 2003||2003-10-01|February 2007|2007-02-01|April 2006||2006-04-01|||||Interventional|||EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study|A Randomized Trial Comparing Same Day Discharge and a Single Bolus of Abciximab to Overnight Hospitalization and Bolus + Perfusion Abciximab After Uncomplicated Trans-Radial Coronary Artery Stenting|Completed||Phase 4|1000||Laval University|||||f||||t||||||||||2017-10-11 05:25:27.385037|2017-10-11 05:25:27.385037
NCT00169832|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-09|||June 2003||2003-06-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|VICTORY||Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial|A Multicenter Randomized Double-Blind Trial Comparing Rosiglitazone to Placebo for the Prevention of Atherosclerosis Progression After Coronary Bypass Surgery in Diabetic Patients|Completed||Phase 3|193|Actual|Laval University||2|||f||||t||||||||||2017-10-11 05:25:27.471922|2017-10-11 05:25:27.471922
NCT00169845|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-10-17|||October 1994||1994-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|June 2003|Actual|2003-06-01||Interventional|||Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients|Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients|Active, not recruiting||Phase 3|540|Actual|Laval University||2|||f||||t||||||||Yes|A letter was sent to each participant.|2017-10-11 05:25:27.607335|2017-10-11 05:25:27.607335
NCT00169858|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-05-24|||September 1995||1995-09-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Interventional|||Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections|Open Randomised Clinical Study of the Long Term Immunogenicity of Engerix-B in 10 Year Old Children and of the Effect of Booster Injections Given 5, 10 or 15 Years After Primary Vaccination|Completed||Phase 4|1129|Actual|Laval University||1|||f||||f||||||||||2017-10-11 05:25:27.713954|2017-10-11 05:25:27.713954
NCT00169871|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-20|||March 2005||2005-03-01|May 2006|2006-05-01|December 2006|Actual|2006-12-01|||||Observational|||Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia|Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia|Completed||Phase 4|1000||CHU de Quebec-Universite Laval|||||f||||||||||||||2017-10-11 05:25:27.795794|2017-10-11 05:25:27.795794
NCT00169884|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-01-31|||March 2002||2002-03-01|January 2005|2005-01-01|March 2007||2007-03-01|||||Interventional|||The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients|The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients: A Randomized Controlled Trial Among Adolescents and Young Adults|Unknown status|Recruiting|Phase 2|120||Leiden University Medical Center|||||f||||||||||||||2017-10-11 05:25:27.851637|2017-10-11 05:25:27.851637
NCT00169897|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-11|||January 2004||2004-01-01|August 2005|2005-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Pulmonary Rehabilitation at Home Versus at the Gymnasium|Effects of a Home-based Versus a Hospital-based Outpatient Pulmonary Rehabilitation Program in Patients With COPD: a Multicenter, Randomized Trial|Completed||N/A|252|Actual|Laval University||2|||f||||f||||||||||2017-10-11 05:25:27.934898|2017-10-11 05:25:27.934898
NCT00169910|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-12-13|||December 2005||2005-12-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients|VIP: Vascular Imaging Project. Prospective Randomized Study on the Effect of AUC-monitored Treatment With Steroids Combined With Either a Calcineurin Inhibitor or Mycophenolate Mofetil on the Progression of Subclinical Cardiovascular Disease in Renal Transplant Recipients.|Completed||Phase 4|119|Actual|Leiden University Medical Center||2|||f||||||||||||||2017-10-11 05:25:28.036773|2017-10-11 05:25:28.036773
NCT00169923|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-30|||April 2007||2007-04-01|September 2008|2008-09-01|May 2009|Anticipated|2009-05-01|||||Interventional|Hercules||Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease|Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease|Withdrawn||Phase 2/Phase 3|200|Anticipated|Leiden University Medical Center||2||it was not possible to recruit any patient in the study|f||||t||||||||||2017-10-11 05:25:28.11397|2017-10-11 05:25:28.11397
NCT00169936|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-26|||December 2004||2004-12-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients|Evaluation of Magnetocardiography as a Tool for Non-invasive Detection of Tissue Rejection in Cardiac Transplant Recipients|Completed||Phase 3|6|Actual|Mayo Clinic|||||||||||||||||||2017-10-11 05:25:28.175876|2017-10-11 05:25:28.175876
NCT00169949|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-09-24|||January 2004||2004-01-01|April 2007|2007-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Aripiprazole Treatment of the Prodrome|Open-Label Study of Aripiprazole in Individuals at Risk for Chronic Mental Illness|Terminated||N/A|30||Northwell Health||||The study was terminated due to low enrollment.|f||||t||||||||||2017-10-11 05:25:28.226953|2017-10-11 05:25:28.226953
NCT00169962|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-09|||January 2004||2004-01-01|October 2015|2015-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study of Pulmozyme to Treat Severe Asthma Episodes|Use of Aerosolized rhDNase (Pulmozyme®) in Emergency Department Adults With Refractory Acute Asthma: A Pilot Study|Completed||Phase 2|51|Anticipated|Northwell Health|||||f||||||||||||||2017-10-11 05:25:28.29685|2017-10-11 05:25:28.29685
NCT00169975|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-07-15|||August 2004||2004-08-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.|Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina as Defined by ACC/AHA Guidelines|Completed||Phase 3|137|Actual|Mayo Clinic|||1||f||||f||||||||||2017-10-11 05:25:28.362217|2017-10-11 05:25:28.362217
NCT00169988|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-12-16|||March 2004||2004-03-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms|Sertraline Alone vs. in Combination With Risperidone in the Treatment of Attenuated Positive and Negative Symptoms|Completed||N/A|8|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 05:25:28.419364|2017-10-11 05:25:28.419364
NCT00170001|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-12-13|||April 2005||2005-04-01|December 2011|2011-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy|Which Supraesophageal Reflux Symptoms Reliably Respond to PPI Therapy: A Large Simple Trial|Completed||N/A|500|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 05:25:28.496302|2017-10-11 05:25:28.496302
NCT00170014|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-14|||October 2004||2004-10-01|February 2011|2011-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Precision of the Magnetocardiographer for Data Aquision and Analysis.|Reproducibility of Magnetocardiography Measurements Using the Cardiomag Magnetocardiograph System Model 2409 and Its Software for Data Acquisition and Analysis|Completed||Phase 3|12|Actual|Mayo Clinic|||||f||||||||||||||2017-10-11 05:25:28.579878|2017-10-11 05:25:28.579878
NCT00170027|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-14|||July 2003||2003-07-01|February 2011|2011-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease|Safety and Efficacy of the CMI Magnetocardiograph Model 2409 for Diagnosing Coronary Heart Disease|Completed||Phase 3|250|Actual|Mayo Clinic|||||||||||||||||||2017-10-11 05:25:28.647559|2017-10-11 05:25:28.647559
NCT00170053|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-07-27|||June 2005||2005-06-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids|Randomized Trial of Thymoglobulin Induction, Initial Tacrolimus, and Mycophenolate Mofetil Therapy With Steroid Avoidance in Primary Kidney Transplant Recipients Followed by Continued Tacrolimus/Mycophenolate Mofetil Therapy vs. Sirolimus/ Mycophenolate Mofetil Therapy|Completed||Phase 1|177|Actual|Mayo Clinic||1|||f||||||||||||||2017-10-11 05:25:28.853678|2017-10-11 05:25:28.853678
NCT00170079|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-12-01|||April 2005||2005-04-01|December 2014|2014-12-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Prolonged Smoking Cessation Using Prescription Step Care|Prolonged Smoking Cessation Using Prescription Step Care|Completed||N/A|270|Actual|University of Tennessee||1|||f||||t||||||||||2017-10-11 05:25:28.947733|2017-10-11 05:25:28.947733
NCT00170105|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-02-01|||August 2005||2005-08-01|February 2010|2010-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Posturing Effects on Perception of Time and Perceptions of the Provider-Patient Interaction in the Emergency Department|Posturing Effects on Perception of Time and Perceptions of the Provider-Patient Interaction in the Emergency Department|Completed||Phase 2|244|Actual|Mayo Clinic|||1||f||||t||||||||||2017-10-11 05:25:29.030762|2017-10-11 05:25:29.030762
NCT00170118|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-01-27|||June 2005||2005-06-01|January 2010|2010-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||"Effects of Motivational Interviewing on Self-Efficacy and Standardized Low Back Pain Outcomes in Patients With Chronic Back Pain"|Effects of Motivational Interviewing on Self-Efficacy and Standardized Low Back Pain Outcomes in Patients With Chronic Back Pain|Completed||N/A|6|Actual|Mayo Clinic|||||f||||||||||||||2017-10-11 05:25:29.095466|2017-10-11 05:25:29.095466
NCT00170131|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-20|||September 2002||2002-09-01|May 2011|2011-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||MMF Influence on HCV Viral Evolution After Liver Transplantation|The Influence MMF on 5UTR HCV Quasispecies Variation: A Potential Factor in the Natural History of Post-OLT x HCV Infection|Completed||Phase 4|17|Actual|Mayo Clinic|||1||f||||||||||||||2017-10-11 05:25:29.16288|2017-10-11 05:25:29.16288
NCT00170144|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-03-14|||September 2005||2005-09-01|March 2011|2011-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Branched Chain Amino Acids on Muscle|Branched Chain Amino Acids as Stimulant of Muscle Mitochondrial Function in Elderly People|Completed||N/A|40|Anticipated|Mayo Clinic|||||f||||||||||||||2017-10-11 05:25:29.214417|2017-10-11 05:25:29.214417
NCT00170157|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-06|2013-05-03||June 2004||2004-06-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|April 2011|Actual|2011-04-01||Interventional|||Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer|A Phase II Immunotherapeutic Trial: Combination Androgen Ablative Therapy and CTLA-4 Blockade as a Treatment for Advanced Prostate Cancer|Completed||Phase 2|112|Actual|Mayo Clinic||2|||f||||f||||||||||2017-10-11 05:25:29.295787|2017-10-11 05:25:29.295787
NCT00163189|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-06-22|2015-06-01||January 2005||2005-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Safety analysis set included all participants (including a site with GCP issues) who had received at least 1 study dose of growth hormone (GH).|Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm|Evolution Of Growth Rate In Children With Growth Retardation Related To Long-term Corticotherapy And Treated By Genotonorm|Completed||Phase 3|98|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:25:29.853998|2017-10-11 05:25:29.853998
NCT00163202|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-03-14|||June 2002||2002-06-01|April 2007|2007-04-01|August 2005|Actual|2005-08-01|||||Interventional|CAP||Comparative Atorvastatin Pleiotropic Effects|A Multicenter, Randomized Double-Blind Study Comparing The Pleiotropic Effects Of Atorvastatin 10 Mg And 80 Mg Over A 26-Week Period In Subjects With Coronary Atherosclerosis|Completed||Phase 4|330||Pfizer|||||f||||||||||||||2017-10-11 05:25:31.455349|2017-10-11 05:25:31.455349
NCT00163215|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-11-19|2012-10-02||January 2005||2005-01-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Growth Retardation In Children With Special Pathological Conditions Or Disease|Evolution Of Growth Rate In Children Suffering From A Disease Associated With Growth Retardation and Treated By Genotonorm. A Pilot Study.|Completed||Phase 3|46|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 05:25:31.703118|2017-10-11 05:25:31.703118
NCT00163228|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-10-15|||January 2001||2001-01-01|October 2008|2008-10-01|May 2007|Anticipated|2007-05-01|||||Observational|||Functional Evaluation of the Total Knee Prostheses:Rising From a Chair|Functional Evaluation of Total Knee Arthroplasties,Protocol for Rising From a Chair.|Withdrawn||N/A|100|Anticipated|Radboud University|||2||f||||||||||||||2017-10-11 05:25:32.484363|2017-10-11 05:25:32.484363
NCT00163241|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-07-17|||June 2004||2004-06-01|July 2007|2007-07-01|January 2006||2006-01-01|||||Interventional|||Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression|A Double-Blind, Placebo-Controlled, Randomized 24-Month Study, Assessing The Effect Of Celecoxib (Celebrex) Long Term Treatment On Hip Osteoarthritis (OA) Progression OSCARE|Terminated||Phase 3|666||Pfizer||||Please see detailed description for termination reason.|f||||||||||||||2017-10-11 05:25:32.594834|2017-10-11 05:25:32.594834
NCT00163254|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-09-11|||September 2003||2003-09-01|September 2006|2006-09-01|November 2006||2006-11-01|||||Interventional|||Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee|Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee|Unknown status|Active, not recruiting|Phase 2|||University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:25:32.962873|2017-10-11 05:25:32.962873
NCT00163267|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2011-08-05|||September 2005||2005-09-01|April 2007|2007-04-01|April 2011|Actual|2011-04-01|December 2009|Actual|2009-12-01||Interventional|||Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel|Follow-up Management of Peripheral Arterial Intervention With Clopidogrel MIRROR-Study|Completed||Phase 2/Phase 3|80|Actual|University Hospital Tuebingen||2|||f||||||||||||||2017-10-11 05:25:33.060075|2017-10-11 05:25:33.060075
NCT00163280|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-02-11|||July 2004||2004-07-01|February 2008|2008-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis|Randomised Double-Blind Placebo-Controlled Study of Orally Administered ATL-104 to Assess Safety, Tolerance and Effect on Oral Mucositis in Patients Following Treatment With Chemotherapy and Peripheral Blood Stem Cell Transplant (PBSCT)|Completed||Phase 2|63|Actual|Alizyme||4|||f||||t||||||||||2017-10-11 05:25:33.17866|2017-10-11 05:25:33.17866
NCT00163306|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-05-04|||May 2005||2005-05-01|May 2007|2007-05-01||||||||Interventional|||Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)|Complete Remission: Evaluation of the Complete Remission Rates in Patients With Symptomatic Non-erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (GERD) Treated With Pantoprazole 40 Milligram o.d. Over 4 or 8 or 12 Weeks|Completed||Phase 3|1200||Takeda|||||f||||||||||||||2017-10-11 05:25:35.019608|2017-10-11 05:25:35.019608
NCT00163319|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-01|||November 2004||2004-11-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)|Comparison of Inhaled Ciclesonide (640 mcg/Day) and Fluticasone Propionate (1000 mcg/Day) in Patients With Moderate and Severe Persistent Asthma|Completed||Phase 3|500||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:35.235084|2017-10-11 05:25:35.235084
NCT00163332|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-02|||March 2003||2003-03-01|September 2016|2016-09-01||||||||Interventional|||Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)|Comparison of Inhaled Ciclesonide (160 mcg b.i.d. or 320 mcg b.i.d.) and Fluticasone Propionate (250 mcg b.i.d. or 500 mcg b.i.d.) in Pretreated Patients With Mild to Moderate Asthma|Completed||Phase 3|30||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:35.666529|2017-10-11 05:25:35.666529
NCT00163345|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-07|||September 2003||2003-09-01|December 2016|2016-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)|Evaluation of Parameters of the Small Airways and Their Changes Under Treatment With Ciclesonide (320 mcg Once Daily) Versus Placebo in Patients With Asthma|Completed||Phase 3|20||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:35.831995|2017-10-11 05:25:35.831995
NCT00163358|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-29|||September 2003||2003-09-01|October 2016|2016-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)|Efficacy of Ciclesonide and of a Fixed Combination With Fluticasone Propionate and Salmeterol Versus Placebo on Long-term Asthma Control|Completed||Phase 3|630||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:35.97865|2017-10-11 05:25:35.97865
NCT00163371|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-30|||September 2005||2005-09-01|October 2016|2016-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)|Effect of Ciclesonide (320 mcg/Day) vs Fluticasone Propionate (375 mcg/Day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children With Mild Asthma|Completed||Phase 3|28||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:36.378423|2017-10-11 05:25:36.378423
NCT00163384|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-29|||January 2004||2004-01-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)|A Comparative Study of Inhaled Ciclesonide 160 mcg/Day vs Budesonide 400 mcg/Day in Patients With Asthma|Completed||Phase 3|240||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:36.494013|2017-10-11 05:25:36.494013
NCT00163397|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-29|||January 2004||2004-01-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)|A Comparative Study of Inhaled Ciclesonide 160 mcg/Day vs Budesonide 400 mcg/Day in Patients With Asthma|Completed||Phase 3|120||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:36.655602|2017-10-11 05:25:36.655602
NCT00163410|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-01|||April 2003||2003-04-01|December 2016|2016-12-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)|A Comparative Study of Inhaled Ciclesonide 200 mcg/Day vs Fluticasone Propionate 200 mcg/Day in Children With Asthma|Completed||Phase 3|500||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:36.775571|2017-10-11 05:25:36.775571
NCT00163423|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-07|||November 2004||2004-11-01|December 2016|2016-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)|Comparison of Ciclesonide (80 mcg Once Daily in the Evening) and Fluticasone Propionate (100 mcg Twice Daily) in Patients With Mild to Moderate Asthma|Completed||Phase 3|480||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:36.93945|2017-10-11 05:25:36.93945
NCT00163436|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-29|||September 2005||2005-09-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)|Comparison of the Efficacy and Safety of 160 mcg Ciclesonide Administered Once Daily in the Evening With or Without Different Spacer Types in Patients With Asthma|Completed||Phase 3|450||AstraZeneca|||||f||||||||||||||2017-10-11 05:25:37.167043|2017-10-11 05:25:37.167043
NCT00163449|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-07|||November 2005||2005-11-01|December 2016|2016-12-01|May 2007|Actual|2007-05-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)|BALLOON: Efficacy and Safety - Study by ALTANA on Ciclesonide in Pre-school Asthma Patients|Completed||Phase 3|1000|Anticipated|AstraZeneca||4|||f||||||||||||||2017-10-11 05:25:37.436914|2017-10-11 05:25:37.436914
NCT00170170|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-02-01|||November 2004||2004-11-01|February 2010|2010-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation|Clinical Predictors of Late-onset CMV Disease in Solid Organ Transplant Recipients: A Strategy to Improve the Benefits and Reduce the Risks of Anti-CMV Prophylaxis|Completed||N/A|500|Actual|Mayo Clinic|||1||f||||||||||||||2017-10-11 05:25:37.788131|2017-10-11 05:25:37.788131
NCT00170183|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-11-13|||March 2003||2003-03-01|November 2009|2009-11-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure|BNP as Adjuvant Therapy to Preserve Renal Function and Facilitate Diuresis in Hospitalized Patients With Heart Failure|Completed||Phase 3|104|Anticipated|Mayo Clinic|||||f||||||||||||||2017-10-11 05:25:37.879945|2017-10-11 05:25:37.879945
NCT00170196|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-26|||August 2005||2005-08-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy Studies of Corticosteroid Therapy in Community-Acquired Pneumonia|The CAPISCE-Trial: Community-Acquired Pneumonia; an Intervention Study With Corticosteroids|Completed||Phase 3|216|Actual|Medical Center Alkmaar||2|||f||||||||||||||2017-10-11 05:25:37.969307|2017-10-11 05:25:37.969307
NCT00170209|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-06-06|||August 2011||2011-08-01|June 2017|2017-06-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)|A Randomized Trial to Compare Effectiveness of 4 Months Rifampin (4 RIF) With 9 Months Isoniazid (9 INH) in the Prevention of Active TB in Children: The P4v9 Trial|Completed||Phase 3|844|Actual|McGill University||2|||f||||t||||||||Undecided||2017-10-11 05:25:38.052035|2017-10-11 05:25:38.052035
NCT00170222|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-09-26|||July 2002||2002-07-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)|The Value of Antibiotic Treatment of Exacerbations of Hospitalised COPD Patients|Completed||Phase 4|258|Anticipated|Medical Center Alkmaar|||||f||||||||||||||2017-10-11 05:25:38.167999|2017-10-11 05:25:38.167999
NCT00170235|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-09-03|||August 2004||2004-08-01|May 2008|2008-05-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Reducing Arm Morbidity in Pre- and Post-breast Cancer Surgery|Reducing Arm Morbidity Through Physical Therapy Provided Pre- and Post-breast Cancer Surgery|Completed||N/A|50|Actual|McGill University||2|||f||||f||||||||||2017-10-11 05:25:38.238182|2017-10-11 05:25:38.238182
NCT00170248|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-07|||October 2006||2006-10-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Computer-Based Decision Support in Managing Asthma in Primary Care|Evaluating the Impact of Computer-Based Decision Support for the Management of Asthma in Primary Care|Completed||N/A|4447|Actual|McGill University||2|||f||||||||||||||2017-10-11 05:25:38.314606|2017-10-11 05:25:38.314606
NCT00170261|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-08|||April 2002||2002-04-01|October 2008|2008-10-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope|Early Loop-Recorder in Suspected Arrhythmogenic Syncope|Completed||Phase 4|100|Anticipated|Medtronic Bakken Research Center|||||f||||||||||||||2017-10-11 05:25:38.396125|2017-10-11 05:25:38.396125
NCT00170274|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-11|||August 2000||2000-08-01|September 2017|2017-09-01|October 2014|Actual|2014-10-01|June 2011|Actual|2011-06-01||Interventional|||APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias|Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias Who Need Cardiac Pacing|Completed||Phase 4|156|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-10-11 05:25:38.464432|2017-10-11 05:25:38.464432
NCT00170287|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-09-05|||May 2002||2002-05-01|September 2017|2017-09-01|August 2011|Actual|2011-08-01|April 2010|Actual|2010-04-01||Interventional|SMS||SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)|Substrate Modification Study in Patients Getting an ICD|Completed||Phase 4|116|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-10-11 05:25:38.563391|2017-10-11 05:25:38.563391
NCT00170300|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-12-29|||January 2001||2001-01-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Care-HF CArdiac Resynchronization in Heart Failure|Outcome Trial (Long Term)to Evaluate the Effects of Cardiac Resynchronization Therapy on the Mortality and Morbidity of Patients With Heart Failure|Completed||N/A|813||Medtronic Bakken Research Center|||||f||||||||||||||2017-10-11 05:25:40.519525|2017-10-11 05:25:40.519525
NCT00170313|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-14|||December 2003||2003-12-01|January 2017|2017-01-01|January 2007|Actual|2007-01-01|||||Interventional|||CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation|Conducted AF-Response Study (Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation Treated With InSync III Marquis)|Terminated||Phase 4|100|Anticipated|Medtronic Bakken Research Center||2||Ventricular rate during AF in CRT-patients much lower than expected|f||||f||||||||No||2017-10-11 05:25:40.616873|2017-10-11 05:25:40.616873
NCT00170326|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-18|||January 2002||2002-01-01|April 2017|2017-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|Prevent-HF||Progressive Ventricular Dysfunction Prevention in Pacemaker Patients|Progressive Ventricular Dysfunction Prevention in Pacemaker Patients|Completed||N/A|108|Actual|Medtronic Bakken Research Center||2|||f||||t||||||||No||2017-10-11 05:25:40.717324|2017-10-11 05:25:40.717324
NCT00170339|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-09-12|||April 2005||2005-04-01|September 2016|2016-09-01|April 2007|Actual|2007-04-01|||||Observational|||Bone Density and Serum Testosterone in Male Methadone Maintained Patients|Bone Density and Serum Testosterone in Male Methadone Maintained Patients|Completed||N/A|60||Minneapolis Medical Research Foundation|||||f||||||||||||||2017-10-11 05:25:40.807534|2017-10-11 05:25:40.807534
NCT00170352|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-27|||November 2002||2002-11-01|August 2015|2015-08-01|November 2008|Actual|2008-11-01|November 2007|Actual|2007-11-01||Interventional|||Comparison Between Different Types of Oxygen Treatment Following Traumatic Brain Injury|Hyperbaric and Normobaric Oxygen in Severe Brain Injury|Completed||Phase 2|80|Actual|Minneapolis Medical Research Foundation||4|||f||||t||||||||||2017-10-11 05:25:40.878917|2017-10-11 05:25:40.878917
NCT00170391|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-09-10|||October 2002||2002-10-01|October 2002|2002-10-01|December 2005||2005-12-01|||||Interventional|||Do People With Insomnia Sleep Better After Psychological Treatment?|Does CBT for Insomnia Improve the PSG Sleep of Patients Treated in Primary Care?|Unknown status|Active, not recruiting|N/A|||NHS Greater Clyde and Glasgow|||||f||||||||||||||2017-10-11 05:25:41.095495|2017-10-11 05:25:41.095495
NCT00170404|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-08-26|||June 2000||2000-06-01|February 2007|2007-02-01|October 2005||2005-10-01|||||Interventional|||TB Nutrition, Immunology and Epidemiology|Nutrition, Immunology, and Epidemiology of Tuberculosis|Completed||Phase 3|887||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:25:41.153343|2017-10-11 05:25:41.153343
NCT00170417|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||December 2000||2000-12-01|December 2000|2000-12-01|May 2003||2003-05-01|||||Interventional|||Clinical Benefit of CBT for Insomnia in Primary Care|Clinical and Health Economic Benefit of Non-Pharmacological Treatment of Chronic Insomnia in Primary Care|Completed||N/A|||NHS Greater Clyde and Glasgow|||||f||||||||||||||2017-10-11 05:25:41.38922|2017-10-11 05:25:41.38922
NCT00170430|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-03-16|||May 2003||2003-05-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Reducing Vaginal Infections in Women|Reducing Vaginal Infections in Women at Risk for HIV-1|Completed||Phase 3|400||University of Washington|||||f||||||||||||||2017-10-11 05:25:41.458688|2017-10-11 05:25:41.458688
NCT00170443|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-11||||||April 2006|2006-04-01|June 2004||2004-06-01|||||Interventional|||Trivalent rHA Dose Escalation Study in Elderly Subjects|A Phase II Evaluation of the Reactogenicity and Immunogenicity of Different Doses of Intramuscular Trivalent Baculovirus-expressed Influenza HA Vaccine in Healthy Elderly Adults|Completed||Phase 2|399|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:25:41.547408|2017-10-11 05:25:41.547408
NCT00170456|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-09-12|||March 2005||2005-03-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Phase II Study of Range and Schedule of rPA Doses|A Double-Blind, Parallel-Group Study of the Safety, Tolerability and Immunogenicity of a Range of Doses and Dosing Schedules of Recombinant (rPA Based) Anthrax Vaccine in Healthy Subjects|Completed||Phase 2|415|Actual|PharmAthene UK Limited||4|||f||||t||||||||||2017-10-11 05:25:41.639846|2017-10-11 05:25:41.639846
NCT00170469|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-09-12|||March 2005||2005-03-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed|A Phase II, Dose Ranging Multi-Centre, Single Blind, Parallel-Group, Controlled Study of the Safety, Tolerability and Immunogenicity of Recombinant (rPA Based) Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed in a Healthy Population|Completed||Phase 2|226|Actual|PharmAthene UK Limited||3|||f||||t||||||||||2017-10-11 05:25:41.749771|2017-10-11 05:25:41.749771
NCT00170482|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-11|||April 2005||2005-04-01|April 2011|2011-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||Elderly Influenza Vaccine Immunogenicity Substudy|In Depth Immunologic Studies in Elderly Subjects Receiving Either Standard-Dose Fluzone (15mcg HA/Virus Strain) or High-Dose (60 Mcg HA/Virus Strain) Trivalent Inactivated Influenza Virus Vaccine|Completed||N/A|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:25:41.921526|2017-10-11 05:25:41.921526
NCT00170495|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-26|||September 2004||2004-09-01|September 2008|2008-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Acute Viral Respiratory Infections in Elderly|Etiology and Impact of Acute Viral Respiratory Infections in Ambulatory Elderly Populations|Terminated||N/A|3000|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples Without DNA|"     blood, sputum, nasal and throat swabs   "|||2017-10-11 05:25:42.009449|2017-10-11 05:25:42.009449
NCT00171548|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-19|||October 2004||2004-10-01|September 2008|2008-09-01||||July 2007|Actual|2007-07-01||Observational|||Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients|Project to Promote the Evaluation of Cardiovascular Risk in Clinical Practice, and Assess Its Evolution After the Implementation of Multifactorial Preventive Strategy Aimed at Reducing the Level of Global Risk (SCORE Algorithm) in Subjects With Metabolic Syndrome and a Risk Level of 5%|Completed||Phase 4|600|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:42.100705|2017-10-11 05:25:42.100705
NCT00171561|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||March 2003||2003-03-01|November 2011|2011-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.|A 24-week Study to Evaluate the Effectiveness of Valsartan in Combination With Hydrochlorothiazide Versus Amlodipine on Arterial Compliance in Patients With Hypertension, Type 2 Diabetes and Albuminuria|Completed||Phase 4|144|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:42.176604|2017-10-11 05:25:42.176604
NCT00171574|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-22|||November 2004||2004-11-01|February 2017|2017-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Antiproteinuric Effect of Valsartan and Lisinopril|Antiproteinuric Effect of Valsartan, Lisinopril and Valsartan Plus Lisinopril in Non-diabetic and Diabetic Renal Disease: a Randomized, Double Blind, Parallel Group, Controlled Trial With 5 Months Follow-up|Completed||Phase 4|124|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:42.265802|2017-10-11 05:25:42.265802
NCT00171587|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-18|||May 2002||2002-05-01|November 2009|2009-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer|A Phase IB, Open-label, Dose-escalating Study of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer|Completed||Phase 1/Phase 2|22|Anticipated|Novartis|||||f||||||||||||||2017-10-11 05:25:42.352554|2017-10-11 05:25:42.352554
NCT00171600|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||July 2005||2005-07-01|November 2011|2011-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Antialbuminuric Effects of Valsartan and Lisinopril|Comparative, Open Multicenter Trial Assessing the Effect on Albumin Excretion Rate of 320mg Valsartan (With or Without HCTZ) vs 40mg Lisinopril (With or Without HCTZ) on Hypertensive Patients With Diabetic and Non-diabetic Nephropathy and Albuminuria|Terminated||Phase 4|54|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:42.425551|2017-10-11 05:25:42.425551
NCT00171613|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-27|||February 2005||2005-02-01|April 2012|2012-04-01||||October 2005|Actual|2005-10-01||Interventional|||A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients|A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients|Completed||Phase 4|32||Novartis|||||f||||||||||||||2017-10-11 05:25:42.492576|2017-10-11 05:25:42.492576
NCT00171639|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-21|||June 2004||2004-06-01|February 2017|2017-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis|The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis|Completed||Phase 3|28|Actual|Novartis|||||f||||f||||||||||2017-10-11 05:25:42.631499|2017-10-11 05:25:42.631499
NCT00171652|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-09|||May 2005||2005-05-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis|Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis|Completed||Phase 3|360||Novartis|||||||||||||||||||2017-10-11 05:25:42.717173|2017-10-11 05:25:42.717173
NCT00171665|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-13|||May 2005||2005-05-01|April 2015|2015-04-01|December 2005||2005-12-01|||||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis|Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis|Completed||Phase 3|360||Novartis|||||||||||||||||||2017-10-11 05:25:42.884684|2017-10-11 05:25:42.884684
NCT00171678|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-20|||October 2004||2004-10-01|April 2012|2012-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Completed||Phase 3|480||Novartis|||||f||||||||||||||2017-10-11 05:25:43.285317|2017-10-11 05:25:43.285317
NCT00171691|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-20|||October 2004||2004-10-01|April 2012|2012-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Completed||Phase 3|450||Novartis|||||f||||||||||||||2017-10-11 05:25:43.360866|2017-10-11 05:25:43.360866
NCT00171704|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-01|2012-02-27||April 2005||2005-04-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer|A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer|Completed||Phase 3|263|Actual|Novartis|The study was designed to investigate the effects of letrozole compared with tamoxifen for 2 years on BMD spine (L2-L4). The study was too small to investigate the comparative efficacy of treatments on disease-free survival or on overall survival.|2|||f||||||||||||||2017-10-11 05:25:43.474159|2017-10-11 05:25:43.474159
NCT00171717|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-31|||February 2004||2004-02-01|January 2011|2011-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant|Pilot Study of the Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients Presenting With New Onset Diabetes After the 3rd Month Post-transplant.|Completed||Phase 4|39|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:44.448183|2017-10-11 05:25:44.448183
NCT00171730|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-15|||August 2004||2004-08-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly|Extension to a Multi-center, Randomized, Crossover, Open Label, Dose Finding Study to Compare the Safety, Efficacy, and Pharmacokinetics/Pharmacodynamics (PK/PD) Relationship of Multiple Doses of Pasireotide (SOM230) (200, 400, and 600 μg Bid) and Doses of Open Label Sandostatin® (SMS) (100 μg Tid) in Acromegalic Patients|Completed||Phase 2|30|Actual|Novartis||1|||f||||f||||||||||2017-10-11 05:25:44.512178|2017-10-11 05:25:44.512178
NCT00171743|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-05|||April 2004||2004-04-01|June 2017|2017-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients|Switch From Tacrolimus to Cyclosporine Microemulsion: Immunosuppressive Agents and Diabetes Management in Liver Transplant Recipients in Maintenance (DIALIVER)|Completed||Phase 4|47|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:44.611943|2017-10-11 05:25:44.611943
NCT00171756|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-20|||June 2004||2004-06-01|February 2017|2017-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.|A Double-blind, Double-dummy, Multi-centre, Randomized, Active Controlled, Parallel Group Pilot Trial to Compare the Effects of Valsartan and Atenolol on the Pro-thrombotic State in Patients With Mild to Moderate Hypertension.|Completed||Phase 4|92|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:44.670925|2017-10-11 05:25:44.670925
NCT00171769|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-21|||April 2005||2005-04-01|February 2017|2017-02-01||||August 2006|Actual|2006-08-01||Interventional|||Atrial Fibrillation Feasibility Certoparin Trial - AFFECT|An Open Label, Multi-center Trial to Evaluate the Feasibility and Safety of Short-term Treatment With Subcutaneously Injected Certoparin (8000 U Anti-Xa Twice Daily) in Patients With Persistent Nonvalvular Atrial Fibrillation|Completed||Phase 3|200||Novartis|||||f||||||||||||||2017-10-11 05:25:44.742563|2017-10-11 05:25:44.742563
NCT00171782|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-07|||February 2004||2004-02-01|June 2006|2006-06-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Hypertension and Cardiovascular Risk Factors|Valsartan Plus Hydrochlorothiazide in Patients With Hypertension and Cardiovascular Risk Factors|Completed||Phase 4|76|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:44.812855|2017-10-11 05:25:44.812855
NCT00171795|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-22|||November 2002||2002-11-01|November 2011|2011-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment|Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment|Completed||Phase 3|67|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:44.87969|2017-10-11 05:25:44.87969
NCT00171808|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-16|||April 2005||2005-04-01|November 2016|2016-11-01||||May 2010|Actual|2010-05-01||Interventional|deFEND||Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer|Phase II Study on Letrozole in Patients With Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer|Completed||Phase 2|26|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:44.943188|2017-10-11 05:25:44.943188
NCT00171821|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-05|||April 2005||2005-04-01|June 2013|2013-06-01|July 2010|Actual|2010-07-01|May 2009|Actual|2009-05-01||Interventional|||A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload|A One Year, Open-label, Single-arm, Multi-center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20 mg/kg/Day) in Patients Diagnosed With Transfusion-dependent Iron Overload|Completed||Phase 3|1784|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:45.075281|2017-10-11 05:25:45.075281
NCT00171834|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-01-06|2011-01-11||August 2003||2003-08-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer|An Open Label, Phase I/II Dose Escalating Study Evaluating the Safety and Efficacy of EPO906, qw3, in Patients With Non-small Cell Lung Cancer.|Completed||Phase 1/Phase 2|89|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:45.584383|2017-10-11 05:25:45.584383
NCT00171847|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-30|||March 2003||2003-03-01|March 2010|2010-03-01||||October 2008|Actual|2008-10-01||Interventional|eLEcTRA||Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer|An Open Label, Randomized Comparison of Femara® 2.5mg Once Daily With or Without Weekly Herceptin® Until Disease Progression as First-line Treatment in Postmenopausal Women With Advanced Breast Cancer.|Terminated||Phase 4|93|Actual|Novartis||3|||f||||||||||||||2017-10-11 05:25:47.601215|2017-10-11 05:25:47.601215
NCT00171860|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-29|||September 2002||2002-09-01|April 2012|2012-04-01||||July 2007|Actual|2007-07-01||Interventional|||A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome|A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome|Terminated||Phase 2|24|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:47.682764|2017-10-11 05:25:47.682764
NCT00171873|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-08|2011-02-28||September 2001||2001-09-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|June 2008|Actual|2008-06-01||Interventional|||Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut|Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut|Unknown status|Active, not recruiting|Phase 3|85|Actual|Philipps University Marburg Medical Center||2|||f||||||||||||||2017-10-11 05:25:47.778541|2017-10-11 05:25:47.778541
NCT00171886|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-23|||July 2002||2002-07-01|March 2011|2011-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Octreotide Efficacy and Safety in First-line Acromegalic Patients|Octreotide Efficacy and Safety in First-line Acromegalic Patients|Completed||Phase 4|20|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:48.030023|2017-10-11 05:25:48.030023
NCT00171899|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-21|||April 2005||2005-04-01|February 2017|2017-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)|Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Ph+ CML|Completed||Phase 4|80|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:48.116661|2017-10-11 05:25:48.116661
NCT00171912|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-21|||September 2004||2004-09-01|February 2017|2017-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes|Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes|Completed||Phase 2|38|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:48.19499|2017-10-11 05:25:48.19499
NCT00171925|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-05|2011-01-20||August 2000||2000-08-01|April 2012|2012-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I|Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I|Terminated||Phase 3|143|Actual|Novartis|Only exploratory analyses were performed as the trial was terminated early due to lack of obtaining the required sample size. Secondary Outcomes for Quality of Life and Bone Markers not posted due to sparse data.|2||Recruitment in study could not be reached after 8 yrs of recruiting|f||||||||||||||2017-10-11 05:25:48.301268|2017-10-11 05:25:48.301268
NCT00171938|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-23|||April 2004|Actual|2004-04-01|November 2009|2009-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)|Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)|Terminated||Phase 2|30|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:49.142328|2017-10-11 05:25:49.142328
NCT00171951|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-15|||August 2004||2004-08-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease|Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease|Completed||Phase 2|19|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:49.238496|2017-10-11 05:25:49.238496
NCT00171964|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-05-31|||May 2002||2002-05-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions|Evaluation of the Efficacy and Tolerability of Zoledronic Acid in Combination With Radiotherapy in Patients With Advanced Osteolytic Bone Lesions|Completed||Phase 4|75|Actual|Novartis||1|||f||||t||||||||||2017-10-11 05:25:49.330844|2017-10-11 05:25:49.330844
NCT00171977|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-06|||July 2004||2004-07-01|August 2012|2012-08-01||||April 2009|Actual|2009-04-01||Interventional|||Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)|Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 4|64|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:49.421941|2017-10-11 05:25:49.421941
NCT00171990|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-14|||January 2003||2003-01-01|August 2013|2013-08-01|February 2006|Actual|2006-02-01|||||Interventional|||Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes|Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes|Completed||Phase 3|1461|Actual|Novartis|||||f||||||||||||||2017-10-11 05:25:49.501377|2017-10-11 05:25:49.501377
NCT00172003|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-16|||September 2004||2004-09-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis|Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis|Completed||Phase 4|50|Actual|Novartis||1|||f||||t||||||||||2017-10-11 05:25:49.56492|2017-10-11 05:25:49.56492
NCT00172198|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||March 2005||2005-03-01|January 2005|2005-01-01|March 2007||2007-03-01|||||Interventional|||Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.|A Prospective, Controlled, Randomized, Study Evaluating the Clinical Efficacy, Including Nutritional Status, Immune Function and Safety of Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.|Unknown status|Recruiting|Phase 4|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:54.456126|2017-10-11 05:25:54.456126
NCT00172016|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-27|||January 2004||2004-01-01|April 2012|2012-04-01||||April 2005|Actual|2005-04-01||Interventional|||A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates|A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates|Completed||Phase 4|43|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:49.643975|2017-10-11 05:25:49.643975
NCT00172029|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-26|||April 2003||2003-04-01|March 2010|2010-03-01||||September 2005|Actual|2005-09-01||Interventional|||Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid|Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid|Completed||Phase 4|116|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:25:49.711802|2017-10-11 05:25:49.711802
NCT00172042|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-13|2011-06-16||March 2005||2005-03-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)|A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer|Completed||Phase 3|437|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:25:49.832179|2017-10-11 05:25:49.832179
NCT00172055|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-02|||December 2004||2004-12-01|March 2017|2017-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy|Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy|Completed||Phase 3|218|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:25:51.151788|2017-10-11 05:25:51.151788
NCT00172068|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-12-21|||January 2002||2002-01-01|December 2009|2009-12-01||||November 2008|Actual|2008-11-01||Interventional|MRD-1||Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow|Efficacy and Tolerability of Intravenous Zometa® (Zoledronic Acid) 4 mg in Primary Breast Cancer Patients With Disseminated Tumor Cells in Bone Marrow. A Prospective, Randomized, Parallel Group, Open-label, Clinical Pilot Study.|Terminated||Phase 2|96|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:25:51.277771|2017-10-11 05:25:51.277771
NCT00172081|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-11-10|||April 2000||2000-04-01|September 2005|2005-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis|An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis|Completed||Phase 3|2532|Actual|Shire||2|||f||||t||||||||||2017-10-11 05:25:51.503958|2017-10-11 05:25:51.503958
NCT00172094|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-11-11|||December 2003||2003-12-01|September 2005|2005-09-01|July 2004|Actual|2004-07-01|June 2004|Actual|2004-06-01||Interventional|||Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches|A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches|Completed||Phase 2|189|Actual|Shire||3|||f||||f||||||||||2017-10-11 05:25:51.913291|2017-10-11 05:25:51.913291
NCT00172107|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-11-11|||May 1995||1995-05-01|September 2005|2005-09-01|March 1997|Actual|1997-03-01|March 1997|Actual|1997-03-01||Interventional|||A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis|A Double Blind, Placebo Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis|Completed||Phase 2|217|Actual|Shire||4|||f||||f||||||||||2017-10-11 05:25:52.074578|2017-10-11 05:25:52.074578
NCT00172120|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-11-11|||January 2005||2005-01-01|September 2005|2005-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|TRES||Open Label Extension|An 18-month, Open-label Extension Study of Once-daily ALX1-11 for the Treatment of Postmenopausal Women With Osteoporosis (TRES)|Completed||Phase 3|91|Actual|Shire||1|||f||||f||||||||||2017-10-11 05:25:52.257585|2017-10-11 05:25:52.257585
NCT00172133|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-11-11|||October 2001||2001-10-01|August 2008|2008-08-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|OLES||Open Label Extension Study of PREOS|An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)|Completed||Phase 3|1683|Actual|Shire||1|||t||||t||||||||||2017-10-11 05:25:52.388408|2017-10-11 05:25:52.388408
NCT00172146|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2002||2002-08-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Observational|||Influences of Cane Use on Voluntary Forward Stepping Movement and Associated Attentional Demands in Hemiplegic Patients|Influences of Cane Use on Voluntary Forward Stepping Movement and Associated Attentional Demands in Hemiplegic Patients|Unknown status|Active, not recruiting|N/A|22||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:52.961639|2017-10-11 05:25:52.961639
NCT00172159|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-22|||January 2000||2000-01-01|January 2000|2000-01-01|June 2005|Anticipated|2005-06-01|||||Interventional|||Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers|Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers|Unknown status|Recruiting|Phase 2|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:53.014798|2017-10-11 05:25:53.014798
NCT00172172|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-11-11|||February 2004||2004-02-01|August 2008|2008-08-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|CAP||Calcium Supplementation in Postmenopausal Women|A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)|Completed||Phase 3|374|Actual|Shire||3|||t||||f||||||||||2017-10-11 05:25:53.095736|2017-10-11 05:25:53.095736
NCT00172185|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-11-10|2013-03-12||January 2005||2005-01-01|September 2014|2014-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)|A Study of the Safety and Efficacy of Teduglutide in Subjects With Parenteral Nutrition-Dependent Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)|Completed||Phase 3|65|Actual|Shire||2|||f||||t||||||||||2017-10-11 05:25:53.340178|2017-10-11 05:25:53.340178
NCT00172211|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-04|||September 2005||2005-09-01|January 2007|2007-01-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients|Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients|Completed||N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:54.535806|2017-10-11 05:25:54.535806
NCT00172224|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-13|||August 2002||2002-08-01|November 2012|2012-11-01||||||||Observational|||Dynamic Magnetic Resonance (MR) Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related Research|Dynamic MR Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related Research|Completed||Phase 3|100|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 05:25:54.604298|2017-10-11 05:25:54.604298
NCT00172237|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-28|||December 2009||2009-12-01|January 2010|2010-01-01|July 2010|Anticipated|2010-07-01|||||Observational|||Proprioception and Eye-head Coordination for the Cervical Spine|Proprioception and Eye-head Coordination for the Cervical Spine|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-10-11 05:25:54.66358|2017-10-11 05:25:54.66358
NCT00172250|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||September 2003||2003-09-01|August 2005|2005-08-01||||||||Observational|||The Study of Relationship of Plasma Concentrations of Folic Acid, Vitamin B and Homocysteine With Carotid Atherosclerosis and Endothelium-Dependent Vasodilatation of Geriatric and Young Patients in the Ambulatory Care Department of NTUH||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:54.72406|2017-10-11 05:25:54.72406
NCT00172263|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-06||||||December 2012|2012-12-01||||||||Interventional|||The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes||Withdrawn||N/A|0|Actual|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:54.769633|2017-10-11 05:25:54.769633
NCT00172276|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-14||||||June 2005|2005-06-01||||||||Observational|||Angiotensin Converting Enzyme Gene Polymorphism in Children With Idiopathic Nephrotic Syndrome||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:54.826887|2017-10-11 05:25:54.826887
NCT00172289|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-01-06|||August 2004||2004-08-01|December 2004|2004-12-01|December 2006||2006-12-01|||||Observational|||Measurement of Pulse Wave Velocity in Spinal Cord Injury and Stroke Patients|Measurement of Pulse Wave Velocity in Spinal Cord Injury and Stroke Patients|Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:54.870872|2017-10-11 05:25:54.870872
NCT00172302|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||November 2005||2005-11-01|May 2005|2005-05-01||||||||Interventional|||Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?|Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?|Unknown status|Not yet recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:54.937188|2017-10-11 05:25:54.937188
NCT00172315|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-28|||December 2003||2003-12-01|August 2005|2005-08-01||||||||Observational|||Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects|Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects, With Serial Follow-Up|Unknown status|Recruiting|Phase 3|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.030577|2017-10-11 05:25:55.030577
NCT00172328|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||September 2004|2004-09-01||||||||Interventional|||Antibody Response and Immune Memory 15-18 Years After HBV Vaccination||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.097521|2017-10-11 05:25:55.097521
NCT00172341|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-02||||||July 2004|2004-07-01||||||||Interventional|||Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children|Efficacy and Safety of Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children: A Double-Blind, Randomized, and Placebo-Controlled Study|Unknown status|Not yet recruiting|Phase 4|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.166534|2017-10-11 05:25:55.166534
NCT00172354|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-30|||October 2004||2004-10-01|November 2012|2012-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest|Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest|Completed||N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.358526|2017-10-11 05:25:55.358526
NCT00172367|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-25|||January 2006||2006-01-01|November 2004|2004-11-01||||||||Interventional|||Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma||Withdrawn||Phase 2|80|Anticipated|National Taiwan University Hospital||||"This study was for National Science Council project. The study was not funded, so the study was   withdrawn."|f||||||||||||||2017-10-11 05:25:55.426808|2017-10-11 05:25:55.426808
NCT00172380|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-19|||February 2005||2005-02-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III|Phase II Study Evaluating Docetaxel and CDDP as Neoadjuvant Chemotherapy Prior to Surgery, Followed by Adjuvant Docetaxel Plus CDDP in Chemonaive Patients With NSCLC Stage III|Completed||Phase 2|41|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:25:55.494983|2017-10-11 05:25:55.494983
NCT00172393|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-03|||January 2003||2003-01-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Observational|||Long Term Outcomes of EV71 CNS Infection|Long Term Outcomes of EV71 Central Nervous System Infection|Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.569376|2017-10-11 05:25:55.569376
NCT00172406|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||August 2005|2005-08-01||||||||Observational|||The Relation Between Serum Level of Amioterminal Propeptide of Type I Procollagen and Diastolic Dysfunction in Hypertensive Patients Without Diabetes Mellitus||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.6725|2017-10-11 05:25:55.6725
NCT00172419|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-01-02|||March 2007||2007-03-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.|Statin-Induced Vulnerable Plaque Regression After Atorvastatin Treatment: Serial Evaluation by 18F-Fluorodeoxyglucose Positron Emission Tomography Study|Completed||N/A|43|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:25:55.718946|2017-10-11 05:25:55.718946
NCT00172432|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||August 2005|2005-08-01||||||||Observational|||Aminoterminal Propeptide of Type III Procollagen and Severity of Coronary Artery Disease in Patients Without Myocardial Infarction||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.803864|2017-10-11 05:25:55.803864
NCT00172458|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-14||||||August 2005|2005-08-01||||||||Observational|||Clinical Results and Restenosis Analysis of Symptomatic Ostial Vertebral Artery Stenosis Treated With Tubular Coronary Stents|Clinical Results and Restenosis Analysis of Symptomatic Ostial Vertebral Artery Stenosis Treated With Tubular Coronary Stents|Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.9235|2017-10-11 05:25:55.9235
NCT00172471|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20||||||December 2004|2004-12-01||||||||Observational|||The Relationship Between Sleep Disorders and Cytokine Levels Among Hemodialysis and Peritoneal Dialysis Patients||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:55.987516|2017-10-11 05:25:55.987516
NCT00172484|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-15|||January 2005||2005-01-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||North Taiwan Stroke Center for Prevention and Treatment|North Taiwan Stroke Center for Prevention and Treatment|Completed||Phase 3|250|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 05:25:56.042263|2017-10-11 05:25:56.042263
NCT00172497|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2001||2001-08-01|August 2001|2001-08-01|October 2005||2005-10-01|||||Observational|||Aggressive Acts Among Patients With Schizophrenia|A Study of the Aggressive Acts Among Patients With Schizophrenia|Suspended||N/A|450||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.106924|2017-10-11 05:25:56.106924
NCT00172510|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|August 2004|2004-08-01|August 2005||2005-08-01|||||Observational|||Mutation Analysis of 17α-Hydroxylase||Unknown status|Recruiting|N/A|25||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.176491|2017-10-11 05:25:56.176491
NCT00172523|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2004||2004-10-01|October 2004|2004-10-01|August 2005||2005-08-01|||||Observational|||Metabolic Disorders in Polycystic Ovarian Syndrome||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.361753|2017-10-11 05:25:56.361753
NCT00172536|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-21|||October 2004||2004-10-01|March 2011|2011-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft|Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft|Completed||N/A|65|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 05:25:56.436672|2017-10-11 05:25:56.436672
NCT00172549|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||March 2004||2004-03-01|July 2005|2005-07-01|October 2004||2004-10-01|||||Observational|||Quality of Life and Its Related Factors of Patients With Major Depressive Disorder||Completed||Phase 1|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.535029|2017-10-11 05:25:56.535029
NCT00172562|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-02-28||||||August 2005|2005-08-01||||||||Observational|||Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image||Unknown status|Recruiting|Phase 3|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.579469|2017-10-11 05:25:56.579469
NCT00172575|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||December 2004||2004-12-01|December 2004|2004-12-01|December 2006||2006-12-01|||||Observational|||Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI||Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.656388|2017-10-11 05:25:56.656388
NCT00172588|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-25|||January 2005||2005-01-01|December 2004|2004-12-01|October 2005||2005-10-01|||||Observational|||Evaluation of Endometrial Stromal Cell Apoptosis in Adenomyosis||Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.728479|2017-10-11 05:25:56.728479
NCT00172601|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||August 2005||2005-08-01|December 2004|2004-12-01||||||||Interventional|||Mobilization Techniques in Patients With Frozen Shoulder: a Randomized Multiple-Treatment Trial||Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.79444|2017-10-11 05:25:56.79444
NCT00172614|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-28|||December 2004||2004-12-01|December 2004|2004-12-01||||||||Observational|||The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance||Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.887415|2017-10-11 05:25:56.887415
NCT00172627|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|December 2004|2004-12-01||||||||Observational|||Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer|Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer|Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:56.948592|2017-10-11 05:25:56.948592
NCT00172640|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|December 2004|2004-12-01||||||||Observational|||Genetic Studies in Liver Cancer Patients|Identification of Differentially Expressed Genes in Hepatocellular Carcinoma With DNA Microarrays|Unknown status|Recruiting|Phase 1|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.022523|2017-10-11 05:25:57.022523
NCT00172653|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-15|||August 2005||2005-08-01|August 2005|2005-08-01|July 2006||2006-07-01|||||Observational|||Function-Related Tests for Subjects With Stiff Shoulders: Reliability and Validity|Assessment of Function-Related Tests for Subjects With Stiff Shoulders: Reliability, Validity, Clinical Usefulness, and Biomechanical Analysis|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.091602|2017-10-11 05:25:57.091602
NCT00172666|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-29|||August 2005||2005-08-01|December 2004|2004-12-01|July 2006||2006-07-01|||||Observational|||Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)|Investigating Genetic Polymorphism of Decoy Receptor 3 (DcR3) Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|450||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.158634|2017-10-11 05:25:57.158634
NCT00172679|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-26|||July 2005||2005-07-01|December 2004|2004-12-01|June 2006||2006-06-01|||||Observational|||Effects of Tai Chi Exercise on Innate and Adaptive Immune Function||Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.22956|2017-10-11 05:25:57.22956
NCT00172692|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-12-14|||July 2004||2004-07-01|June 2005|2005-06-01|August 2004||2004-08-01|||||Observational|||Observation and Evaluation of Chewing Velocity Changes on Soft Food Chewing Efficiency||Completed||Phase 2|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.292514|2017-10-11 05:25:57.292514
NCT00172705|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2004||2004-09-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Observational|||Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique|Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.349324|2017-10-11 05:25:57.349324
NCT00172718|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-05|||March 2005||2005-03-01|February 2005|2005-02-01||||||||Observational|||Using 3.3mm Screw Tap and Cutting Resistance to Evaluate Bone Quality Around Dental Implant|Using 3.3mm Screw Tap to Modify the Standard Implantation Procedure and to Measure the Cutting Resistance for Establishing a More Objective Method to Evaluate the Peri-Implant Bone Quality|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.412715|2017-10-11 05:25:57.412715
NCT00172731|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||March 2005||2005-03-01|February 2005|2005-02-01|June 2005||2005-06-01|||||Observational|||Measurement of Activity Participation for Persons With Schizophrenia Living in the Community||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.478573|2017-10-11 05:25:57.478573
NCT00172744|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-10|||April 2005||2005-04-01|March 2005|2005-03-01|July 2006||2006-07-01|||||Observational|||Effect of Cyclic Tensional Force on Osteogenic Differentiation of Human Periodontal Ligament Stem Cells||Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.541461|2017-10-11 05:25:57.541461
NCT00172757|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-25|||January 2002||2002-01-01|January 2003|2003-01-01|June 2005||2005-06-01|||||Observational|||Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in Taiwan|Risk Factors of Colorectal Cancer in Taiwan-With Special Reference to the Association With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations|Unknown status|Recruiting|Phase 2|1000||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.619887|2017-10-11 05:25:57.619887
NCT00172770|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||August 2004||2004-08-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Observational|||The Establishment of the Early Intervention Program for Patients With Schizophrenia||Unknown status|Recruiting|Phase 1/Phase 2|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.680986|2017-10-11 05:25:57.680986
NCT00172783|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01|December 2005||2005-12-01|||||Observational|||PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period|PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period|Unknown status|Recruiting|N/A|460||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.75689|2017-10-11 05:25:57.75689
NCT00172796|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-29|||April 2005||2005-04-01|April 2005|2005-04-01||||||||Observational|||Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-Diabetes||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:57.843436|2017-10-11 05:25:57.843436
NCT00172809|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-05|||July 2005||2005-07-01|June 2007|2007-06-01|January 2007|Actual|2007-01-01|June 2006|Actual|2006-06-01||Interventional|||Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease|A Pilot Study in Comparing the Efficacy and Safety of Peginterferon Alfa-2a and Interferon Alfa-2a in Treating Patients With End Stage Renal Disease and Chronic Hepatitis C|Completed||Phase 4|50|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-10-11 05:25:57.92057|2017-10-11 05:25:57.92057
NCT00172822|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2003||2003-01-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Appendicitis With Medical Treatment||Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.046605|2017-10-11 05:25:58.046605
NCT00172835|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||March 2005||2005-03-01|March 2005|2005-03-01||||||||Observational|||Use of Procalcitonin in the Diagnosis of Pleural Effusion|Evaluation of Procalcitonin as a Diagnostic Tool for Patients With Pleural Effusion|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.104607|2017-10-11 05:25:58.104607
NCT00172848|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||October 2004||2004-10-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Observational|||Mastery, Social Support and Depression of Patients With Major Depression||Completed||Phase 1|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.166259|2017-10-11 05:25:58.166259
NCT00172861|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|March 2005|2005-03-01||||||||Observational|||Cyclooxygenase-2-Associated Factors and Gastric Carcinogenesis Mechanisms-Clinical Association and Genomic Investigation||Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.21743|2017-10-11 05:25:58.21743
NCT00172874|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-12-29|||January 1998||1998-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Observational|||Cross-Cultural Validity of EDI-1 Among Clinical and Non-Clinical Taiwanese Population|Cross-Cultural Validity of EDI-1 Among Clinical and Non-Clinical Taiwanese Population|Completed||N/A|1500|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-10-11 05:25:58.281901|2017-10-11 05:25:58.281901
NCT00172887|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-22|||March 2005||2005-03-01|March 2005|2005-03-01|July 2005||2005-07-01|||||Observational|||Needs Assessment of Long-Term Care for Psychiatric Patients||Unknown status|Recruiting|N/A|1150|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.345157|2017-10-11 05:25:58.345157
NCT00172900|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||MRS and DTI of White Matter in Alzheimer's Disease|MR Spectroscopy and Diffusion Tensor Imaging of White Matter in Alzheimer's Disease|Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.413557|2017-10-11 05:25:58.413557
NCT00172913|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01|July 2008||2008-07-01|||||Observational|||Aberration-Free Refraction Correction|National Taiwan University Hospital|Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.492174|2017-10-11 05:25:58.492174
NCT00172926|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||May 2005||2005-05-01|June 2005|2005-06-01|April 2007||2007-04-01|||||Observational|||Study on the Relationship Between Physical Constitution and Diseases|Cross Sectional Study on Relationship Between Physical Constitution and Diseases in the Integrative Chinese Medicine and Western Medicine|Unknown status|Recruiting|N/A|1000||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.560254|2017-10-11 05:25:58.560254
NCT00172939|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-14|||June 2005||2005-06-01|March 2005|2005-03-01|January 2008||2008-01-01|||||Interventional|||Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model|Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model|Unknown status|Recruiting|Phase 1|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.629738|2017-10-11 05:25:58.629738
NCT00172952|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01|January 2006||2006-01-01|||||Observational|||The Role of SNP of ECM and MMP on the Development of Pathological High Myopia|National Taiwan University Hospital|Unknown status|Recruiting|N/A|600||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.707479|2017-10-11 05:25:58.707479
NCT00172965|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|August 2004|2004-08-01|June 2005||2005-06-01|||||Observational|||Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography|Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography|Unknown status|Recruiting|Phase 4|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.931188|2017-10-11 05:25:58.931188
NCT00172978|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-10-26||||||April 2005|2005-04-01||||||||Observational|||Indications and Related Factors for Caesarean Delivery, 1996 to 2002.||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:58.993113|2017-10-11 05:25:58.993113
NCT00172991|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||January 2003|2003-01-01||||||||Observational|||Adiponectin Gene and Coronary Artery Disease||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.049457|2017-10-11 05:25:59.049457
NCT00173004|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||February 2003|2003-02-01||||||||Observational|||Angiotensinogen Gene and Hypertension||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.107067|2017-10-11 05:25:59.107067
NCT00173017|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2003||2003-08-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||The Physiological Impact of N95 Masks on Medical Staff|The Physiological Impact of N95 Masks on Medical Staff|Completed||N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.181291|2017-10-11 05:25:59.181291
NCT00173030|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||April 2004|2004-04-01||||||||Observational|||Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein Genes||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.261565|2017-10-11 05:25:59.261565
NCT00173043|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||October 2004||2004-10-01|October 2004|2004-10-01|August 2005||2005-08-01|||||Observational|||The Role of Insulin Resistance in PCOS|The Role of Insulin Resistance and Adiponectin in the Pathogenesis of Polycystic Ovary Syndrome|Unknown status|Recruiting|N/A|500||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.345704|2017-10-11 05:25:59.345704
NCT00173056|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-23||||||December 2004|2004-12-01||||||||Observational|||The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.413651|2017-10-11 05:25:59.413651
NCT00173069|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||January 2006||2006-01-01|July 2005|2005-07-01|December 2010||2010-12-01|||||Observational|||A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)|A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)|Unknown status|Not yet recruiting|N/A|324||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.4876|2017-10-11 05:25:59.4876
NCT00173082|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-28|||June 2005||2005-06-01|November 2007|2007-11-01|July 2008|Anticipated|2008-07-01|||||Observational|||Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism|Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.553668|2017-10-11 05:25:59.553668
NCT00173095|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|January 2005|2005-01-01|January 2008||2008-01-01|||||Observational|||The Bilirubin Levels in Cerebrospinal Fluid of Spontaneous Subarachnoid Hemorrhage Patients|The Bilirubin Levels in Cerebrospinal Fluid of Spontaneous Subarachnoid Hemorrhage Patients|Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.645362|2017-10-11 05:25:59.645362
NCT00173108|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-21|||January 2006||2006-01-01|March 2011|2011-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Early Intervention for Preterm Infants|Early Intervention for Preterm Infants|Completed||N/A|240|Actual|National Taiwan University Hospital||4|||f||||f||||||||||2017-10-11 05:25:59.722955|2017-10-11 05:25:59.722955
NCT00173121|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||May 2005||2005-05-01|April 2005|2005-04-01|June 2005||2005-06-01|||||Observational|||Environmental Enterovirus Monitoring|Environmental Enterovirus Monitoring|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.797051|2017-10-11 05:25:59.797051
NCT00173134|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||May 2005||2005-05-01|June 2005|2005-06-01|March 2006||2006-03-01|||||Observational|||The Prevalence of Erectile Dysfunction (ED) and ED Related Quality of Life of Diabetic Men|Investigating the Prevalence of Erectile Dysfunction and Erectile Dysfunction Related Quality of Life of Diabetic Men in Taiwan|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:25:59.994998|2017-10-11 05:25:59.994998
NCT00173147|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-24|||May 2005||2005-05-01|April 2005|2005-04-01||||||||Observational|||Morphology of the VMO in Patients With PFPS and Healthy Young Adults--A Sonographic Study|Morphology of the Vastus Medialis Obliquus in Patients With Patellofemoral Pain Syndrome and Healthy Young Adults --A Sonographic Study|Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.092715|2017-10-11 05:26:00.092715
NCT00173160|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|August 2004|2004-08-01|July 2005||2005-07-01|||||Observational|||Epidemiological Studies of Eating Disorders in Gifted Dance Students (2nd Year).|Epidemiological Studies of Eating Disorders in Gifted Dance Students: Prevalence Rate, Risk Factors and 1-Year Outcome (2nd Year).|Completed||N/A|700||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.170182|2017-10-11 05:26:00.170182
NCT00173173|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2003||2003-08-01|August 2003|2003-08-01|July 2004||2004-07-01|||||Observational|||Epidemiological Studies of Eating Disorders in Gifted Dance Students(1st Year)|Epidemiological Studies of Eating Disorders in Gifted Dance Students and Ordinary High School Students:Prevalence Rate, Risk Factors and 1-Year Outcome (1st Year).|Completed||N/A|2200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.241434|2017-10-11 05:26:00.241434
NCT00173186|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 1987||1987-01-01|June 2005|2005-06-01|February 2005||2005-02-01|||||Observational|||Aortic Regurgitation After Surgical Repair of Outlet-Type Ventricular Septal Defect|Aortic Regurgitation After Surgical Repair of Outlet-Type Ventricular Septal Defect|Unknown status|Recruiting|N/A|411||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.320968|2017-10-11 05:26:00.320968
NCT00173199|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-29|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation|The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation|Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.406445|2017-10-11 05:26:00.406445
NCT00173212|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2005||2005-09-01|May 2005|2005-05-01|March 2006||2006-03-01|||||Observational|||Proliferation of Endometrial Stromal Cells in Adenomyosis||Unknown status|Active, not recruiting|N/A|45||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.487294|2017-10-11 05:26:00.487294
NCT00173225|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Sputum and Plasma Levels of Nociceptin and Substance P in Patients With Asthma, COPD and Chronic Cough|Association Between Sputum and Plasma Levels of Nociceptin and Substance P With Cough Severity and Airway Hyperreactivity in Patients With Asthma, COPD and Chronic Cough|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.585647|2017-10-11 05:26:00.585647
NCT00173238|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||June 2005||2005-06-01|June 2005|2005-06-01|June 2008||2008-06-01|||||Observational|||The Study of Human Atherosclerosis by Polarization-Sensitive Optical Coherence Tomography||Unknown status|Recruiting|N/A|5||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.680571|2017-10-11 05:26:00.680571
NCT00173251|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2006||2006-01-01|June 2005|2005-06-01|August 2006||2006-08-01|||||Interventional|||The Difference in Presentation Level of Variant Receptors in Female Breast Tissue in Macromastia and Micromastia||Unknown status|Not yet recruiting|Phase 1|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.797181|2017-10-11 05:26:00.797181
NCT00173264|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|May 2005|2005-05-01|June 2005||2005-06-01|||||Observational|||Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis||Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.865167|2017-10-11 05:26:00.865167
NCT00173277|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2003||2003-06-01|June 2005|2005-06-01|July 2004||2004-07-01|||||Observational|||Screening for CRC Using a Mixed Strategy of Sigmoidoscopy and Colonoscopy in Average-Risk Population According to Age|Screening for CRC Using a Mixed Strategy of Sigmoidoscopy and Colonoscopy in Average-Risk Population According to Age|Unknown status|Recruiting|N/A|2500||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:00.946708|2017-10-11 05:26:00.946708
NCT00173290|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-02|||July 2004||2004-07-01|June 2005|2005-06-01|December 2006|Anticipated|2006-12-01|||||Observational|||Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function||Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.069716|2017-10-11 05:26:01.069716
NCT00173303|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2006||2006-01-01|June 2005|2005-06-01|January 2008||2008-01-01|||||Observational|||The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective Study||Unknown status|Not yet recruiting|N/A|3000||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.199804|2017-10-11 05:26:01.199804
NCT00173316|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|August 2004|2004-08-01|June 2005||2005-06-01|||||Observational|||Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions|The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions|Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.325304|2017-10-11 05:26:01.325304
NCT00173329|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-10-20|||August 2005||2005-08-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Observational|||The Quality of Life of Patients With Severe Illnesses||Unknown status|Recruiting|Phase 2|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.452697|2017-10-11 05:26:01.452697
NCT00173342|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||Congenital or Idiopathic Complete Right Bundle Branch Block: Physiological Significance and Molecular Characterization|Congenital or Idiopathic Complete Right Bundle Branch Block: Physiological Significance and Molecular Characterization|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.544644|2017-10-11 05:26:01.544644
NCT00173355|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||June 2005||2005-06-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans|Retrospective Clinical Outcome Study of Pediatric Dermatofibrosarcoma Protuberans: Single Institutional Experience of Twelve Cases From 1977-2002|Unknown status|Recruiting|N/A|12||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.631222|2017-10-11 05:26:01.631222
NCT00173368|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2003||2003-01-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Observational|||Study of Endoscopic Sphincterotomy With Needle Knife Papillotome in Patients of Ampullary Impacted Stone||Completed||N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.739372|2017-10-11 05:26:01.739372
NCT00173381|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-29|||August 2004||2004-08-01|June 2005|2005-06-01||||||||Observational|||The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.832594|2017-10-11 05:26:01.832594
NCT00173394|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-12-18|||August 2005||2005-08-01|July 2005|2005-07-01|December 2008||2008-12-01|||||Observational|||The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients||Unknown status|Recruiting|N/A|250||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:01.964792|2017-10-11 05:26:01.964792
NCT00173407|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-26|||January 2006||2006-01-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion|Correlation of PTEN and IGFBP-3 in the Invasion of Ovarian Endometrioid Carcinoma|Withdrawn||N/A|0|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:26:02.070734|2017-10-11 05:26:02.070734
NCT00173420|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-22|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||Mechanisms of Neuropathic Pain: Investigation by Contact Heat Evoked Potential|Mechanisms of Neuropathic Pain: Investigation by Contact Heat Evoked Potential|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:02.178152|2017-10-11 05:26:02.178152
NCT00173433|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-12-08|||August 2005||2005-08-01|December 2014|2014-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Exogenous Reinfection of Tuberculosis in Taiwan|The Importance of Exogenous Reinfection in the Tuberculosis Endemic of Taiwan|Completed||N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 05:26:02.266206|2017-10-11 05:26:02.266206
NCT00173446|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-06-07|||January 2002||2002-01-01|August 2005|2005-08-01||||||||Observational|||D2 Dopamine Receptor on Human Aldosterone-Producing Adenoma and Its Role in Aldosterone Secretion and Cell Proliferation|Expression of D2-Like Dopamine Receptor of Human Aldosterone-Producing Adenoma and Its Role in Regulation of Aldosterone Secretion and Cell Proliferation|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:02.405059|2017-10-11 05:26:02.405059
NCT00173459|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||July 2004|2004-07-01||||||||Observational|||Dynamic Profiles of Cytokine/Chemokine in Severe Acute Respiratory Syndrome||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:02.498823|2017-10-11 05:26:02.498823
NCT00173472|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||July 2002||2002-07-01|July 2002|2002-07-01|July 2005||2005-07-01|||||Observational|||Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer|Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:02.550945|2017-10-11 05:26:02.550945
NCT00173485|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||June 2005||2005-06-01|June 2005|2005-06-01|June 2009||2009-06-01|||||Observational|||The Study of Infection and Cell Inflammation in Peritoneal Dialysate||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:02.621712|2017-10-11 05:26:02.621712
NCT00173498|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||July 2005||2005-07-01|July 2005|2005-07-01|October 2005||2005-10-01|||||Observational|||Common Allergens in Skin Tests for Adult Atopic Dermatitis|Common Allergens in Skin Tests for Adult Atopic Dermatitis|Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:02.705285|2017-10-11 05:26:02.705285
NCT00173511|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||July 2005||2005-07-01|July 2005|2005-07-01|February 2006||2006-02-01|||||Observational|||Cardiovascular Events in Patients With CAD During Emergent Endoscopy for Upper Gastrointestinal Bleeding||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:02.786974|2017-10-11 05:26:02.786974
NCT00173524|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-05-18|||September 2005||2005-09-01|April 2009|2009-04-01|September 2005|Anticipated|2005-09-01|||||Observational|||PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)|PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) : A Cost-Effectiveness Analysis and Cost-Utility Analysis|Unknown status|Active, not recruiting|Phase 4|200|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 05:26:02.859569|2017-10-11 05:26:02.859569
NCT00173537|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-26|||July 2005||2005-07-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|November 2009|Actual|2009-11-01||Interventional|||Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension|Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension|Unknown status|Recruiting|N/A|1|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-10-11 05:26:02.930199|2017-10-11 05:26:02.930199
NCT00173550|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-22|||August 2004||2004-08-01|July 2005|2005-07-01||||||||Observational|||Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women|Perception and Attitude Toward Estrogen Therapy Among Operated Women With Premature or Immature Menopause|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.020532|2017-10-11 05:26:03.020532
NCT00173563|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-30|||January 2005||2005-01-01|August 2005|2005-08-01|September 2005|Anticipated|2005-09-01|||||Observational|||Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children|Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children|Unknown status|Recruiting|N/A|10|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.099461|2017-10-11 05:26:03.099461
NCT00173576|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-10-26|||April 2003||2003-04-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Observational|||Clinical Study of SARS in Children|Clinical Study of SARS in Children|Completed||N/A|800||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.151408|2017-10-11 05:26:03.151408
NCT00173589|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||August 2005|2005-08-01||||||||Observational|||Inflammatory and Fibrotic Markers and Atrial Fibrillation||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.199306|2017-10-11 05:26:03.199306
NCT00173602|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-30|||September 2005||2005-09-01|August 2005|2005-08-01|August 2007|Anticipated|2007-08-01|||||Observational|||The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis Patients|The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis Patients|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.256142|2017-10-11 05:26:03.256142
NCT00173615|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-01-16|||April 1996||1996-04-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|||||Observational|||Extracorporeal Membrane Oxygenation Effect in Prolonged Cardiopulmonary Resuscitation||Completed||N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.31444|2017-10-11 05:26:03.31444
NCT00173628|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||January 1990||1990-01-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Observational|||Autoantibodies in Patients With Type 1 Diabetes Mellitus||Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.407074|2017-10-11 05:26:03.407074
NCT00173641|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||September 2005||2005-09-01|September 2005|2005-09-01|August 2006||2006-08-01|||||Observational|||The Role of Regulatory T Cell in Patients With Type 1 Diabetes Mellitus||Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.466008|2017-10-11 05:26:03.466008
NCT00173654|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||August 2005||2005-08-01|August 2005|2005-08-01|August 2006||2006-08-01|||||Observational|||Mutation Analysis of 17βhydroxysteroid Dehydrogenase 3 Deficiency||Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.53274|2017-10-11 05:26:03.53274
NCT00173667|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20||||||July 2005|2005-07-01||||||||Interventional|||A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension|A Randomized Controlled Study of Nifecardia SRFC (Nifedipine) and Adalat OROS (Nifedipine) in the Treatment of Patients With Essential Hypertension|Unknown status|Not yet recruiting|Phase 4|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.599448|2017-10-11 05:26:03.599448
NCT00173680|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||August 2005||2005-08-01|August 2005|2005-08-01||||||||Observational|||Methylation Status of CD44 Promoter Region in Primary Lung Cancer||Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.671053|2017-10-11 05:26:03.671053
NCT00173693|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-06|||January 2006||2006-01-01|November 2012|2012-11-01|December 2010|Anticipated|2010-12-01|||||Interventional|||What is the Best Policy to Prevent Osteoporotic Fracture?||Withdrawn||N/A|0|Actual|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.736373|2017-10-11 05:26:03.736373
NCT00173706|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-02-28|||October 2004||2004-10-01|August 2005|2005-08-01||||||||Interventional|||Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis|Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis|Unknown status|Recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:03.819067|2017-10-11 05:26:03.819067
NCT00173719|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-08-26|||September 2003||2003-09-01|January 2013|2013-01-01|July 2004|Actual|2004-07-01|January 2004|Actual|2004-01-01||Interventional|||Influence of Assistive Device Use While Performing Dual Task in Patients With Stroke|Influence of Assistive Device Use on Dynamic Balance and the Associated Attentional Demands During Standing and Walking in Patients With Stroke|Completed||N/A|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.137075|2017-10-11 05:26:04.137075
NCT00173732|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 2005||2005-09-01|June 2005|2005-06-01||||||||Observational|||Establishment of Comprehensive Genetic Analysis From a Single Cell|Establishment of Comprehensive Genetic Analysis From a Single Cell|Unknown status|Not yet recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.208522|2017-10-11 05:26:04.208522
NCT00173745|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||June 2003||2003-06-01|July 2002|2002-07-01|September 2005||2005-09-01|||||Interventional|||Treatment of Drooling With Type A Botulinum Toxin in Children With Cerebral Palsy|Treatment of Drooling With Type A Botulinum Toxin A in Children With Cerebral Palsy|Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.274323|2017-10-11 05:26:04.274323
NCT00173758|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-20|||September 2005||2005-09-01|June 2005|2005-06-01||||||||Interventional|||The Expression of IL-15 and Its Receptor in Decidua|The Expression of IL-15 and Its Receptor in Uterine NK Cells and Clinical Applications|Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.360731|2017-10-11 05:26:04.360731
NCT00173771|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2004||2004-08-01|August 2005|2005-08-01|May 2007||2007-05-01|||||Observational|||Development of a Comprehensive ADL Scale for Stroke Patients|Development of a Comprehensive ADL Scale for Stroke Patients|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.438629|2017-10-11 05:26:04.438629
NCT00173784|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|April 2008||2008-04-01|||||Observational|||Development of an Instrumental Activities of Daily Living Scale|Development of an Instrumental Activities of Daily Living Scale for Patients|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.516994|2017-10-11 05:26:04.516994
NCT00173797|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|April 2008||2008-04-01|||||Observational|||Comparison of Psychometric Properties of Three Depression Measures in Patients With Stroke|Comparison of Psychometric Properties of Three Depression Measures in Patients With Stroke|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.589965|2017-10-11 05:26:04.589965
NCT00173810|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|April 2007||2007-04-01|||||Observational|||Development of a Refined Version of the Stroke Rehabilitation Assessment of Movement Scale for Stroke Patients|Development of a Refined Version of the Stroke Rehabilitation Assessment of Movement Scale for Stroke Patients|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.659214|2017-10-11 05:26:04.659214
NCT00173823|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-03-10|||June 2004||2004-06-01|August 2005|2005-08-01||||||||Observational|||Malnutrition and Inflammation in Dialysis Patients in Taiwan|Malnutrition and Inflammation in Taiwan: Prospective Outcome Evaluation Method (MIT-POEM) in Dialysis Patients|Unknown status|Recruiting|N/A|1500||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.725018|2017-10-11 05:26:04.725018
NCT00173836|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-09-04|||August 2003||2003-08-01|August 2009|2009-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount|Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount|Completed||N/A|122|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-10-11 05:26:04.785536|2017-10-11 05:26:04.785536
NCT00173849|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2006||2006-01-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Observational|||The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma||Unknown status|Not yet recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:04.859802|2017-10-11 05:26:04.859802
NCT00173862|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2007-07-23|||May 2000||2000-05-01|June 2005|2005-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC|A Phase II Study of Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced Transitional Cell Carcinoma|Completed||Phase 2|18|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:26:04.93359|2017-10-11 05:26:04.93359
NCT00173875|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-07-27|||March 2005||2005-03-01|July 2005|2005-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer|A Phase II Study to Evaluate the Efficacy and Safety of Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|108|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:26:05.200566|2017-10-11 05:26:05.200566
NCT00173888|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2012-12-04|||July 2003||2003-07-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)|A Randomized Phase II Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer|Completed||Phase 2|15|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-10-11 05:26:05.337404|2017-10-11 05:26:05.337404
NCT00173901|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-13|||March 2001||2001-03-01|January 2001|2001-01-01|April 2002||2002-04-01|||||Interventional|||Adverse Drug Reactions of Different Brands of Ceftazidime Injection|Adverse Drug Reactions of Different Brands of Ceftazidime Injection|Unknown status|Active, not recruiting|Phase 4|536||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:05.445903|2017-10-11 05:26:05.445903
NCT00173914|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-13|||March 2003||2003-03-01|September 2005|2005-09-01||||||||Observational|||The Association of Endothelial Dysfunction and Cardiac Allograft Vasculopathy||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:05.538712|2017-10-11 05:26:05.538712
NCT00173927|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-29|||March 2004||2004-03-01|September 2005|2005-09-01||||||||Observational|||Images in Extracranial Artery Stenosis|The Differences in Images of Vertebral Artery Stenosis and Carotid Artery Stenosis Pre- and Post-Percutaneous Transluminal Angioplasty and the Gene Expression Patterns in Peripheral White Blood Cells|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:05.618104|2017-10-11 05:26:05.618104
NCT00173953|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-13|||January 2001||2001-01-01|December 2000|2000-12-01|October 2001||2001-10-01|||||Interventional|||Lymphocytic Subsets and Cytokine Production With H. Pylori Infection|Lymphocytic Subsets and Cytokine Production in the Gastric Samples of Patients With Helicobacter Pylori Infection|Completed||N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:05.772638|2017-10-11 05:26:05.772638
NCT00173966|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-13|||January 2005||2005-01-01|December 2004|2004-12-01||||||||Observational|||A Case Control Study to Investigate the Possible Association Between Atrial Fibrillation and Endothelium Dysfunction by Using Flow-Mediated Vasodilation Method||Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:05.866648|2017-10-11 05:26:05.866648
NCT00173979|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-05|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||Tendon Mechanical Properties and Morphological Characteristics of Human Bicep and Tricep Muscles: An In Vivo Ultrasonographical Study|Tendon Mechanical Properties and Morphological Characteristics of Human Muscle|Unknown status|Recruiting|Phase 1|15|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:05.95044|2017-10-11 05:26:05.95044
NCT00173992|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2005-09-13|||September 2005||2005-09-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||Balance Recovery and Training on Fall Prevention in Stroke|Balance Recovery and Training on Fall Prevention in Stroke|Unknown status|Not yet recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:06.050572|2017-10-11 05:26:06.050572
NCT00174005|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-05|||December 1994||1994-12-01|December 1994|1994-12-01||||||||Observational|||Validity and Reliability in Measuring Biceps and Triceps by Using Ultrasound|Validity and Reliability in Measuring Tendon and Muscular Morphologic Characteristics of Biceps and Triceps by Using Ultrasound|Unknown status|Recruiting|Phase 1|20|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:06.148428|2017-10-11 05:26:06.148428
NCT00166348|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-19|||March 2003||2003-03-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|February 2007|Actual|2007-02-01||Interventional|||Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?|Efficacy of Group Based Cognitive Rehabilitation Following Acquired Brain Injury|Completed||N/A|20|Actual|Mayo Clinic|||||f||||||||||||||2017-10-11 05:26:06.232732|2017-10-11 05:26:06.232732
NCT00166361|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-06-19|2014-06-19||February 2004||2004-02-01|June 2014|2014-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent|Long-Term Temporary Drainage of Malignant Extrinsic Ureteral Obstruction Secondary to Inoperable Pelvic or Abdominal Malignancies Using the Memokath 051 Ureteral Stent|Completed||N/A|29|Actual|Mayo Clinic|Low number of subjects in each cohort.|2|||f||||t||||||||||2017-10-11 05:26:06.350743|2017-10-11 05:26:06.350743
NCT00166374|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-19||||||January 2010|2010-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||To Evaluate Success of Cement Treatment of Spinal Compression Fractures|Outcomes Following Balloon Kyphoplasty for Vertebral Compression Fracture|Completed||N/A|200|Actual|Mayo Clinic|||||f||||||||||||||2017-10-11 05:26:06.879036|2017-10-11 05:26:06.879036
NCT00166387|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-03-24|||April 2003||2003-04-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Hemophilia Inhibitor Genetics Study (HIGS)|Hemophilia Inhibitor Genetics Study (HIGS)|Completed||N/A|1137|Actual|Skane University Hospital|||1||f||||t||||||Samples With DNA|"     Plasma, cells, DNA   "|||2017-10-11 05:26:06.947949|2017-10-11 05:26:06.947949
NCT00166400|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-07-23|||July 2004||2004-07-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.|Beta Blockade in Mitral Regurgitation|Completed||Phase 4|60|Anticipated|Mayo Clinic||1|||f||||||||||||||2017-10-11 05:26:07.037759|2017-10-11 05:26:07.037759
NCT00166413|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-05|||April 2005||2005-04-01|May 2011|2011-05-01||||December 2006|Actual|2006-12-01||Interventional|||Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis|A Phase II Trial of CC-5013 in Patients With Primary Systemic Amyloidosis|Completed||Phase 2|38|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-10-11 05:26:07.107791|2017-10-11 05:26:07.107791
NCT00166426|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-13|||February 2003||2003-02-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|May 2007|Actual|2007-05-01||Interventional|||Exisulind Versus Placebo After Surgical Removal of the Prostate|Prospective, Randomized, Double-Blind Trial of Adjuvant Exisulind Versus Placebo for Patients at Risk for Prostate Cancer Recurrence After Radical Prostatectomy|Completed||Phase 2|240|Anticipated|Mayo Clinic|||||||||||||||||||2017-10-11 05:26:07.178479|2017-10-11 05:26:07.178479
NCT00166439|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-21|||March 2005|Actual|2005-03-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma|A Phase II Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma|Completed||Phase 2|50|Actual|Mayo Clinic||1|||f||||t||||||||||2017-10-11 05:26:07.241449|2017-10-11 05:26:07.241449
NCT00166452|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-03-22|||July 2005||2005-07-01|March 2011|2011-03-01|February 2009|Actual|2009-02-01|April 2007|Actual|2007-04-01||Interventional|||A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1|Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidamide in the Treatment of Complex Regional Pain Syndrome Type1|Completed||Phase 3|7|Actual|Mayo Clinic|||||||||||||||||||2017-10-11 05:26:07.336319|2017-10-11 05:26:07.336319
NCT00166465|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-03-11|||August 2003||2003-08-01|March 2011|2011-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Stage IV Colorectal CA ALIMTA|A Phase I Dose-Finding Study and a Randomized Phase II Study of ALIMTA Plus Oxaliplatin Versus Oxaliplatin Plus 5-Fluorouracil and Leucovorin (FOLFOX 4 Regimen) in the First-Line Treatment of Patients With Locally Advanced Unresectable or Stage IV Colorectal Cancer|Completed||Phase 1/Phase 2|200||Mayo Clinic|||||f||||t||||||||||2017-10-11 05:26:07.403975|2017-10-11 05:26:07.403975
NCT00166478|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-26|||April 2002||2002-04-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Exisulind Prior to Radical Prostatectomy|A Prospective Controlled Phase II Study of Preoperative Exisulind Therapy Initiated Prior to Radical Prostatectomy: Effect on Apoptosis|Completed||Phase 2|130|Actual|Mayo Clinic|||||||||||||||||||2017-10-11 05:26:07.470655|2017-10-11 05:26:07.470655
NCT00167349|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-14|||December 2003||2003-12-01|April 2011|2011-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|CPB-I||Cardiopulmonary Bypass and Inflammatory Response|Cardiopulmonary Bypass and Inflammatory Response|Completed||N/A|37|Actual|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"     plasma and serum   "|||2017-10-11 05:26:17.360092|2017-10-11 05:26:17.360092
NCT00166491|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-15|||July 2005||2005-07-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care Unit|Comparison of Two Approved Insulin Infusion Protocols for Glycemic Control in Critically Ill Patients|Completed||N/A|238|Actual|Mayo Clinic|||||f||||||||||||||2017-10-11 05:26:07.532226|2017-10-11 05:26:07.532226
NCT00166504|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-03-13|2008-10-13||October 2005||2005-10-01|March 2017|2017-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)|A Multicenter, Randomized, Open-label Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe (+) Simvastatin Versus Atorvastatin in Patients With Primary Hypercholesterolemia|Completed||Phase 4|203|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:26:07.607361|2017-10-11 05:26:07.607361
NCT00166517|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-03-12|2009-07-06||August 2005||2005-08-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||V260 Registration Study (V260-013)(COMPLETED)|Immunogenicity and Safety of V260 in Healthy Infants in Korea|Completed||Phase 3|178|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:26:07.916201|2017-10-11 05:26:07.916201
NCT00166530|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-03-13|||November 2005||2005-11-01|March 2017|2017-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)|A Prospective Randomized Open Label Blinded Endpoint Multicenter Study in Patients With Coronary Artery Disease to Assess the LDL Lowering Effect of Switching to Ezetimibe (+) Simvastatin for Cholesterol Lowering, Compared the Dose of the Statin Used.|Completed||Phase 4|367|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:26:08.634473|2017-10-11 05:26:08.634473
NCT00166543|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-07-28||2015-06-26|May 2004||2004-05-01|June 2015|2015-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer|A Phase II, Randomized, Double-Blinded Efficacy and Safety Study of Three Doses of TAS-108 Administered Orally in Postmenopausal Patients With Locally Advanced or Locally Recurrent Inoperable or Progressive Metastatic Breast Cancer Following Standard First-Line Endocrine Therapy|Completed||Phase 2|146|Actual|SRI International||3|||f||||||||||||||2017-10-11 05:26:08.743035|2017-10-11 05:26:08.743035
NCT00166556|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-20|||January 2005||2005-01-01|May 2011|2011-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation|Thistlethwaite Protocol # ITN025ST - Immunosuppression With Campath-1H and Tacrolimus in Liver Transplantation|Completed||Phase 2|10|Anticipated|Mayo Clinic|||||||||||||||||||2017-10-11 05:26:08.826743|2017-10-11 05:26:08.826743
NCT00166569|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-03-27|||January 2003||2003-01-01|March 2017|2017-03-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||The Genetics of Polycystic Ovarian Syndrome|The Genetics of Polycystic Ovarian Syndrome|Recruiting||N/A|2700|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||||||2017-10-11 05:26:08.896844|2017-10-11 05:26:08.896844
NCT00166582|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-06-28|||April 2002||2002-04-01|November 2005|2005-11-01|September 2005||2005-09-01|||||Interventional|||Parent-Youth Teamwork in Pediatric Asthma Management|Parent-Youth Teamwork in Pediatric Asthma Management|Completed||Phase 2|60||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:26:08.964738|2017-10-11 05:26:08.964738
NCT00166595|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-01-27|||February 2003||2003-02-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|||||Interventional|||Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)|Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)|Completed||Phase 1/Phase 2|100||Children's Hospital Medical Center, Cincinnati|||||f||||f||||||||||2017-10-11 05:26:09.032843|2017-10-11 05:26:09.032843
NCT00166608|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-04-10|||December 2002||2002-12-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|May 2007|Actual|2007-05-01||Observational|||Cytokines Polymorphisms and Acetaminophen Toxicity|Measurement of Nitrotyrosine Adducts and Cytokines in Acetaminophen Overdose Patients|Completed||N/A|111|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-10-11 05:26:09.104808|2017-10-11 05:26:09.104808
NCT00166621|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-07-19|||March 2004||2004-03-01|July 2011|2011-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy|Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy|Completed||Phase 1/Phase 2|20||Chugani, Diane C.|||||f||||t||||||||||2017-10-11 05:26:09.193235|2017-10-11 05:26:09.193235
NCT00166634|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-01-10|||July 2003||2003-07-01|January 2011|2011-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Ambulatory Blood Pressure Monitoring in Hypertension|The Role of Ambulatory Blood Pressure Monitoring (ABPM) in Interventional Trials Conducted in Children With Hypertension|Completed||N/A|126|Anticipated|Arkansas Children's Hospital Research Institute|||||f||||f||||||||||2017-10-11 05:26:09.27985|2017-10-11 05:26:09.27985
NCT00166647|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-01-10|||February 2004||2004-02-01|January 2013|2013-01-01||||||||Observational|||Thiopurine Methyltransferase Polymorphisms Evaluation|Evaluation of Thiopurine Methyltransferase Polymorphisms in the Hispanic Population|Withdrawn||Phase 4|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Observational Study should not be in CT.gov|f||||||||||||||2017-10-11 05:26:09.349451|2017-10-11 05:26:09.349451
NCT00166673|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-09-02|||August 2005||2005-08-01|September 2016|2016-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Pilot Study of the Navigator Continuous Glucose Monitor|A Pilot Study to Evaluate the Navigator Continuous Glucose Sensor in the Management of Type 1 Diabetes in Children|Completed||Phase 2/Phase 3|60||Jaeb Center for Health Research|||||f||||||||||||||2017-10-11 05:26:09.507713|2017-10-11 05:26:09.507713
NCT00170664|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-03-24|||January 1999||1999-01-01|March 2016|2016-03-01|September 2004|Actual|2004-09-01|March 2003|Actual|2003-03-01||Interventional|||Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer||Completed||Phase 2|129|Actual|North Eastern Germany Society of Gynaecologic Oncology||1|||f||||||||||||||2017-10-11 05:27:03.24243|2017-10-11 05:27:03.24243
NCT00166686|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-01-10||||||January 2013|2013-01-01||||||||Interventional|||Clonidine for Neurocognitive Sequelae|Clonidine for the Treatment of Neurocognitive Sequelae Following Cancer Treatment in Children|Withdrawn||Phase 1/Phase 2|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Study was never initiated|f||||||||||||||2017-10-11 05:26:09.601556|2017-10-11 05:26:09.601556
NCT00166699|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-06-10|||September 2005||2005-09-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Trial of the Use of Ultrasound to Aid the Insertion of Combined Spinal Epidural Anaesthesia|The Clinical Evaluation of a Novel Ultrasound Probe to Guide the Insertion of Central Regional Anaesthesia Using a Regional Anaesthetic Needle Modified to Aid Insertion Under Ultrasound Guidance in Morbidly Obese Women Undergoing Elective Caesarean Section|Completed||Phase 3|42|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-10-11 05:26:09.670237|2017-10-11 05:26:09.670237
NCT00166712|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-10-20|2012-11-29||April 2005||2005-04-01|October 2015|2015-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|Cell220||A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression|A Phase IV, Single Center Pilot Study Using Alemtuzumab (Campath-1H) Induction Combined With Prednisone-Free, Calcineurin-Inhibitor-Free Immunosuppression in Kidney Transplantation|Terminated||Phase 4|40|Actual|Northwestern University||2||Study stopped due to lack of efficacy & funding.|f||||t||||||||||2017-10-11 05:26:09.773548|2017-10-11 05:26:09.773548
NCT00166725|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2009-11-18|||February 2004||2004-02-01|November 2009|2009-11-01||||||||Interventional|||Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients|A Randomized, Open Label, Multicenter Study Evaluating the Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients|Completed||Phase 2|40|Anticipated|Novartis|||||f||||||||||||||2017-10-11 05:26:11.832566|2017-10-11 05:26:11.832566
NCT00166738|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-08-23|||September 2005||2005-09-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Observational|||Analysis of Genomic DNA Alterations in Familial Schizophrenia|Analysis of Genomic DNA Alterations in Familial Schizophrenia|Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:11.915878|2017-10-11 05:26:11.915878
NCT00166751|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-10-26|||September 2005||2005-09-01|December 2004|2004-12-01|November 2006||2006-11-01|||||Observational|||Sonographic Assessment of Laryngeal Elevation|Sonographic Assessment of Laryngeal Elevation in Cerebrovascular Accident Patients With Dysphagia|Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:11.979501|2017-10-11 05:26:11.979501
NCT00166764|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-10-26|||September 2005||2005-09-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Observational|||A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders|A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:12.052753|2017-10-11 05:26:12.052753
NCT00166777|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2006-09-07|||September 2005||2005-09-01|August 2005|2005-08-01|June 2006||2006-06-01|||||Interventional|||Effect of Hip Adduction Combination With Knee Extension Exercise on Morphology of Quadriceps Muscles, Pain and Functional Outcomes in Patients With PFPS||Unknown status|Recruiting|Phase 1|90||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:12.109576|2017-10-11 05:26:12.109576
NCT00166790|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2014-12-05|||September 2005||2005-09-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease|Detection of Minimal Amount of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-10-11 05:26:12.173875|2017-10-11 05:26:12.173875
NCT00166803|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2009-01-02|||June 2005||2005-06-01|December 2008|2008-12-01||||November 2008|Anticipated|2008-11-01||Interventional|||The Impact of Rosiglitazone on Regression of Atherosclerosis|The Impact of Rosiglitazone on Regression of Atherosclerosis: A Serial 18F-Fluorodeoxyglucose Positron Emission Tomography Study|Suspended||N/A|60|Anticipated|National Taiwan University Hospital||1||no fund|f||||||||||||||2017-10-11 05:26:12.248158|2017-10-11 05:26:12.248158
NCT00166816|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||March 2002||2002-03-01|July 2001|2001-07-01|June 2003||2003-06-01|||||Interventional|||The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients|The Pharmacokinetics and Dosage Regimen of Sirolimus in a Cyclosporine or Tacrolimus-Based Immunosuppression in Renal Transplant Patients|Unknown status|Active, not recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:12.313166|2017-10-11 05:26:12.313166
NCT00166829|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-03-07|||May 2004||2004-05-01|August 2003|2003-08-01||||||||Interventional|||The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus|The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus|Unknown status|Recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:12.389053|2017-10-11 05:26:12.389053
NCT00166842|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2002||2002-09-01|July 2002|2002-07-01||||||||Interventional|||Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets|Effects of Conversion From Sirolimus Oral Solution to Tablets in Renal Transplant Recipients.|Unknown status|Active, not recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:12.465718|2017-10-11 05:26:12.465718
NCT00166855|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||July 2005||2005-07-01|May 2005|2005-05-01|July 2009||2009-07-01|||||Interventional|||Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma||Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:12.718065|2017-10-11 05:26:12.718065
NCT00166868|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-08-19|||December 2003||2003-12-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|||Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy|Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia|Completed||N/A|30|Actual|National Taiwan University Hospital||3|||f||||||||||||||2017-10-11 05:26:12.835021|2017-10-11 05:26:12.835021
NCT00166881|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-04|||June 2000||2000-06-01|November 2012|2012-11-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|P-HDFL-DI||Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin|Phase II Trial of Consolidation or Salvage Chemotherapy by Using Weekly Docetaxel/Irinotecan After Cisplatin Plus Weekly 24-Hour Infusion of High-dose 5-Fluorouracil/Leucovorin for Non-resectable Gastric Cancers|Completed||Phase 2|29|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 05:26:12.959731|2017-10-11 05:26:12.959731
NCT00166894|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-23|||May 2005||2005-05-01|May 2005|2005-05-01||||||||Observational|||Use of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in the Diagnosis of Pleural Effusion|Evaluation of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) as a Diagnostic Tool for Patients With Pleural Effusion|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.066119|2017-10-11 05:26:13.066119
NCT00166907|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-13|||January 2002||2002-01-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||Balance Recovery and Training on Fall Prevention in Stroke|Balance Recovery and Training on Fall Prevention in Stroke|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.14751|2017-10-11 05:26:13.14751
NCT00166920|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||July 2004||2004-07-01|February 2005|2005-02-01|July 2004||2004-07-01|||||Observational|||Measurement of Cerebral Oxygen Extraction Fraction Using MRI Technique||Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.220899|2017-10-11 05:26:13.220899
NCT00166933|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||June 2005||2005-06-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Minimal Erythema Dose of UV-B in Normal Population of Taiwan|Minimal Erythema Dose of UV-B in Normal Population of Taiwan|Completed||N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.285941|2017-10-11 05:26:13.285941
NCT00166946|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-20|||June 2005||2005-06-01|November 2004|2004-11-01|January 2008||2008-01-01|||||Interventional|||Effects of Arsenic on Keratinocytes in a Skin Equivalent Model|Effects of Arsenic on Keratinocytes in a Skin Equivalent Model|Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.359269|2017-10-11 05:26:13.359269
NCT00166959|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|June 2005|2005-06-01|December 2005||2005-12-01|||||Observational|||Reliability and Validity of Modified Postural Assessment Scale for Stroke Patients and the Application of This Scale on Early Detection of Patients With Stroke at High Risk of Falls|Reliability and Validity of Modified Postural Assessment Scale for Stroke Patients and the Application of This Scale on Early Detection of Patients With Stroke at High Risk of Falls|Unknown status|Recruiting|N/A|90||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.440133|2017-10-11 05:26:13.440133
NCT00166972|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Observational|||Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis|Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis|Completed||N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.520679|2017-10-11 05:26:13.520679
NCT00166985|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-12-26|||September 2004||2004-09-01|August 2004|2004-08-01|December 2008||2008-12-01|||||Observational|||The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients|The Role of Functional MRI and Doppler Sonography in Assessing Intratumoral Angiogenesis of Endometrial Cancer Patients|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.586584|2017-10-11 05:26:13.586584
NCT00166998|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||March 2005||2005-03-01|February 2005|2005-02-01|July 2006||2006-07-01|||||Observational|||The Study of Infrared Imaging on Breast Cancer||Unknown status|Recruiting|N/A|600||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.664785|2017-10-11 05:26:13.664785
NCT00167011|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-05|||July 1995||1995-07-01|November 2012|2012-11-01|January 2002|Actual|2002-01-01|||||Interventional|||Patterns of Coronary Artery Anatomy in Children With Congenital Heart Disease by Computed Tomography|Patterns of Coronary Artery Anatomy in Children With Congenital Heart Disease by Computed Tomography|Completed||N/A|200|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.743454|2017-10-11 05:26:13.743454
NCT00167024|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-25|||March 2005||2005-03-01|March 2005|2005-03-01||||||||Observational|||Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical Outcome||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.812571|2017-10-11 05:26:13.812571
NCT00167037|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 1999||1999-08-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Observational|||Fast Stepping in Stroke Patients for Fall Prediction and Prevention:Control Mechanisms and Clinical Implications|Fast Stepping in Stroke Patients for Fall Prediction and Prevention:Control Mechanisms and Clinical Implications|Unknown status|Active, not recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.877683|2017-10-11 05:26:13.877683
NCT00167050|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-25|||July 2005||2005-07-01|June 2005|2005-06-01|June 2006||2006-06-01|||||Observational|||The Pathogenesis of Superior Limbic Keratoconjunctivitis||Unknown status|Recruiting|N/A|10||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.929188|2017-10-11 05:26:13.929188
NCT00167063|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 1999||1999-08-01|September 2005|2005-09-01|December 2000||2000-12-01|||||Observational|||Falls in Stroke Patients After Hospital Discharge: Prevalence and Risk Factors|Falls in Stroke Patients After Hospital Discharge: Prevalence and Risk Factors|Unknown status|Active, not recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:13.998319|2017-10-11 05:26:13.998319
NCT00167076|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 1999||1999-08-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Observational|||Clinical Applications and Evaluations of A Portable In-Shoe Plantar Pressure Monitoring and Biofeedback Gait System for Ambulation Training in Stroke Rehabilitation|Clinical Applications and Evaluations of A Portable In-Shoe Plantar Pressure Monitoring and Biofeedback Gait System for Ambulation Training in Stroke Rehabilitation|Unknown status|Active, not recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:14.07542|2017-10-11 05:26:14.07542
NCT00167089|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-10-05|||August 1998||1998-08-01|September 2009|2009-09-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Effects of Early Treadmill Training on Ambulatory Ability in Stroke Patients: Electromyographic and Kinematic Analyses|Effects of Early Treadmill Training on Ambulatory Ability in Stroke Patients: Electromyographic and Kinematic Analyses|Completed||N/A|40|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-10-11 05:26:14.138436|2017-10-11 05:26:14.138436
NCT00167102|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-06-16|2013-02-27||July 2005||2005-07-01|June 2017|2017-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||23 participants were allocated to alefacept 22 participants were allocated to placebo|Alefacept in Patients With Severe Scalp Alopecia Areata|A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate The Safety and Therapeutic Efficacy of Intramuscular Administration of Alefacept in Patients With Chronic, Severe Scalp Alopecia Areata|Completed||N/A|45|Actual|University of Minnesota - Clinical and Translational Science Institute|This study was limited by the number of patients randomized to receive treatment.|2|||f||||f||||||||||2017-10-11 05:26:14.234108|2017-10-11 05:26:14.234108
NCT00167115|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-07-09|||December 2004||2004-12-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Metabolic Effects of Alcohol|Metabolic Effects of Alcohol in the Form of Wine in Persons With Type 2 Diabetes Mellitus|Completed||N/A|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-10-11 05:26:14.527414|2017-10-11 05:26:14.527414
NCT00167128|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-14|||March 2005||2005-03-01|May 2006|2006-05-01||||||||Interventional|||The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility|The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-10-11 05:26:14.599571|2017-10-11 05:26:14.599571
NCT00167141|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2010-02-01|||February 2005||2005-02-01|March 2007|2007-03-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Contraception in Normal and Subnormal Men|Hormonal Male Contraception in Men With Normal and Subnormal Semen Parameters|Terminated||Phase 2|41|Actual|University Hospital Muenster||1|||f||||||||||||||2017-10-11 05:26:14.840096|2017-10-11 05:26:14.840096
NCT00167154|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2012-03-15|||June 2004||2004-06-01|March 2012|2012-03-01|August 2008|Actual|2008-08-01|April 2007|Actual|2007-04-01||Interventional|||Risperidone and Suicidality in Major Depressive Disorder|Efficacy of Risperidone in the Management of Suicidality in Major Depressive Disorder|Completed||Phase 3|30|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-10-11 05:26:14.922465|2017-10-11 05:26:14.922465
NCT00167167|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-07-07|||December 1995||1995-12-01|July 2009|2009-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia|Treatment of Relapsed Leukemia After Allogeneic Bone Marrow Transplantation Using Donor-Derived Lymphocytes|Completed||N/A|40|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-10-11 05:26:15.050242|2017-10-11 05:26:15.050242
NCT00167180|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-06-09|2017-04-28||January 2004||2004-01-01|February 2016|2016-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Post Transplant Donor Lymphocyte Infusion|Use of Cyclophosphamide/Fludarabine to Promote in Vivo Expansion of Donor Lymphocyte Infusions (DLI) to Enhance Efficacy After Allogeneic Transplant|Completed||Phase 2|57|Actual|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-10-11 05:26:15.162559|2017-10-11 05:26:15.162559
NCT00167206|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-11-30|2009-07-07||March 2004||2004-03-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Stem Cell Transplantation for Fanconi Anemia|A Study of Thymic Shielding in Recipients of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Stem Cell Transplantation in Patients With Fanconi Anemia|Terminated||Phase 1/Phase 2|16|Actual|Masonic Cancer Center, University of Minnesota|Study ended early as thymic shielding was found to be safe. Therefore, a new study was designed using thymic shielding.|1||Treatment with thymic shielding found safe, another study started.|f||||t||||||||||2017-10-11 05:26:15.703361|2017-10-11 05:26:15.703361
NCT00167219|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-10-04|||November 18, 1999|Actual|1999-11-18|September 2017|2017-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)|Hematopoietic Cell Transplantation in Children With Juvenile Myelomonocytic Leukemia|Recruiting||Phase 1/Phase 2|20|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|t|f|||f|||||2017-10-11 05:26:16.021664|2017-10-11 05:26:16.021664
NCT00167232|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-10-05|||January 1998||1998-01-01|September 2013|2013-09-01|July 2003|Actual|2003-07-01|February 2003|Actual|2003-02-01||Interventional|||Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence|Naltrexone and Psychosocial Treatments for the Treatment of Cocaine Dependence Complicated by Alcohol Dependence|Completed||Phase 3|164|Actual|University of Pennsylvania||2|||f||||||||||||||2017-10-11 05:26:16.12253|2017-10-11 05:26:16.12253
NCT00167245|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-08-21|2013-04-24||September 2004||2004-09-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|TOP2||Topiramate for Alcohol and Cocaine Dependence|A Phase II, Randomized, Double-blind, Placebo-Controlled, Pilot Trial of Topiramate for Alcohol and Comorbid Cocaine Dependence|Completed||Phase 2|170|Actual|University of Pennsylvania|The total number of subjects was relatively small and thus the results should be considered preliminary. The study drop-out rate was formidable, though it was comparable with most trials involving cocaine-dependent patients.|2|||f||||t||||||||||2017-10-11 05:26:16.225409|2017-10-11 05:26:16.225409
NCT00167258|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-12-14||||||December 2009|2009-12-01|February 2007||2007-02-01|||||Interventional|||Effectiveness and Costs of Enhanced Cocaine Treatments||Completed||Phase 2|||University of Pennsylvania|||||f||||||||||||||2017-10-11 05:26:16.573455|2017-10-11 05:26:16.573455
NCT00167271|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-02-18|||October 2002||2002-10-01|February 2011|2011-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Promoting Health in People With Fibromyalgia|Efficacy of Computer and SenseWear Technologies for Promoting Health in People With Fibromyalgia: A Randomized Clinical Trial|Completed||N/A|72|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 05:26:16.636443|2017-10-11 05:26:16.636443
NCT00167284|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||October 2001||2001-10-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Patient Provider Partnership: Improving Diabetes Care in the Community|Patient Provider Partnership: Improving Diabetes Care in the Community|Completed||N/A|270||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:16.719816|2017-10-11 05:26:16.719816
NCT00167297|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-10|||November 2004||2004-11-01|June 2010|2010-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Atomoxetine for the Treatment of Cannabis Dependence|A Pilot Trial of Atomoxetine to Enhance Motivational Interviewing Therapy for the Treatment of Cannabis Dependence|Completed||Phase 2|16|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-10-11 05:26:16.782276|2017-10-11 05:26:16.782276
NCT00167310|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-24|2017-01-06||September 2005||2005-09-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CAD|The participants withdraw voluntarily after signing the consent form.|Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation|CAD Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation|Completed||Phase 2|57|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 05:26:16.89077|2017-10-11 05:26:16.89077
NCT00167323|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-05-16|||July 2003||2003-07-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Early Recovery Adherence Therapy for Bipolar Alcoholics|Early Recovery Adherence Therapy for Bipolar Alcoholics|Completed||N/A|48||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:17.207443|2017-10-11 05:26:17.207443
NCT00167362|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-06|||August 2001||2001-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2009|Actual|2009-08-01||Interventional|||Cognitive Enhancement Therapy for Early-Stage Schizophrenia|Rehabilitation, Brain Function and Early Schizophrenia|Completed||Phase 3|67|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 05:26:17.439165|2017-10-11 05:26:17.439165
NCT00167375|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-02-13|||January 2005||2005-01-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|||||Observational|||Testing the Nocturnal Sleep Latency Profile in Primary Insomnia|Testing the Nocturnal Sleep Latency Profile in Primary Insomnia|Completed||Phase 1|24|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:17.532868|2017-10-11 05:26:17.532868
NCT00167388|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-04-19|2016-01-06||September 2005||2005-09-01|April 2017|2017-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants|The Effect of Packed Red Blood Cell Transfusion on Superior Mesenteric Artery Blood Flow Velocity in Premature Infants After Feeding|Completed||Phase 1|22|Actual|University of Pittsburgh||4|||f||||t||||||||No||2017-10-11 05:26:17.75127|2017-10-11 05:26:17.75127
NCT00167401|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-05-15|||February 2002||2002-02-01|May 2009|2009-05-01||||June 2007|Actual|2007-06-01||Interventional|||Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer|A Phase II Trial of One-Cycle Induction Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer|Completed||Phase 2|||University of Rochester|||||f||||t||||||||||2017-10-11 05:26:18.221662|2017-10-11 05:26:18.221662
NCT00167427|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-09-22|||April 2006||2006-04-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Genotoxicity Assessment for Patients Undergoing Radiation Treatment|Genotoxicity Assessment for Patients Receiving Large Field Irradiation|Recruiting||N/A|120|Anticipated|University of Rochester|||1||f||||f||||||||||2017-10-11 05:26:18.383227|2017-10-11 05:26:18.383227
NCT00167440|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-11-25|||August 2004||2004-08-01|November 2015|2015-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients|Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Patients|Withdrawn||Phase 3|0|Actual|University of Rochester|||1|Personelle changes mandated suspension.|f||||f||||||||||2017-10-11 05:26:18.46273|2017-10-11 05:26:18.46273
NCT00167453|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-10-04|||September 2005||2005-09-01|September 2006|2006-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Benefits of Exercise and Education for Individuals With Parkinson's Disease (BEEP)|Evaluation of the Benefits of a Group Exercise Program and a Group Exercise and Education Program for Individuals With Parkinson's Disease (BEEP)|Completed||Phase 1|45|Anticipated|University of Saskatchewan|||||f||||||||||||||2017-10-11 05:26:18.556405|2017-10-11 05:26:18.556405
NCT00167466|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-10-26|||October 2005||2005-10-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Placebo Controlled Trial of a Titanium Dioxide Semiconductor Toothbrush on Mild-to-moderate Gum Disease|Randomized, Double-blind, Placebo-controlled Crossover Trial of the Soladey-3 Toothbrush on Periodontal Disease Indices in Patients With Mild-to-moderate Periodontal Disease|Completed||N/A|120|Anticipated|University of Saskatchewan||2|||f||||t||||||||||2017-10-11 05:26:18.641828|2017-10-11 05:26:18.641828
NCT00167479|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2006-09-08|||September 2003||2003-09-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||A Study of Risperidone Monotherapy in Bipolar Anxiety|A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Current at Least Moderately Severe Anxiety and Lifetime Panic Disorder or Generalized Anxiety Disorder|Completed||Phase 4|60||University of South Florida|||||f||||||||||||||2017-10-11 05:26:18.728304|2017-10-11 05:26:18.728304
NCT00167492|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-12-05|||September 2005||2005-09-01|December 2013|2013-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Enteric Coated Myfortic for Liver Transplant Recipients|Enteric Coated Mycophenolic Acid (Myfortic) in Liver Transplant Recipients- Effect on Compliance and Calcineurin Inhibitor and Corticosteroid Sparing|Withdrawn||Phase 4|0|Actual|The University of Texas Health Science Center, Houston||1|||f||||||||||||||2017-10-11 05:26:18.873217|2017-10-11 05:26:18.873217
NCT00167505|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-10-25|||September 2006||2006-09-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School Students|SIP 4-04 Evaluation of Abstinence-Only and Abstinence-Plus Program to Prevent HIV, STD, and Pregnancy Among Middle School Students|Completed||N/A|1742|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-10-11 05:26:18.984263|2017-10-11 05:26:18.984263
NCT00167518|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-05|2005-09-11|||March 2002||2002-03-01|January 2005|2005-01-01|April 2005||2005-04-01|||||Interventional|||Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)|Phase II/III Intravitreal Triamcinolone for Treatment of Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment|Completed||Phase 2/Phase 3|70||University of Sydney|||||f||||||||||||||2017-10-11 05:26:19.101321|2017-10-11 05:26:19.101321
NCT00167531|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-10-01|||August 2002||2002-08-01|September 2006|2006-09-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||The Efficacy of Treadmill Training in Establishing Walking After Stroke|The Efficacy of Treadmill Training in Establishing Walking After Stroke|Completed||Phase 2|126|Actual|University of Sydney||2|||f||||f||||||||||2017-10-11 05:26:19.199419|2017-10-11 05:26:19.199419
NCT00167544|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-07-29|2013-03-25||November 2005||2005-11-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|January 2009|Actual|2009-01-01||Interventional|||Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants|A Randomized Trial of Hydrocortisone in Very Preterm Infants at High Risk for Neurologic and Pulmonary Impairments|Completed||Phase 2|64|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-10-11 05:26:19.306846|2017-10-11 05:26:19.306846
NCT00167557|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-11-18|||January 2005||2005-01-01|November 2013|2013-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment|Tacrolimus Monotherapy in OLT Recipients With HCV Under Preemptive Treatment With Interferon and Ribavirin|Withdrawn||Phase 4|0|Actual|The University of Texas Health Science Center, Houston||1||The PI left the institution.|f||||f||||||||||2017-10-11 05:26:19.747473|2017-10-11 05:26:19.747473
NCT00167570|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-04-24|||April 2003||2003-04-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Long Term Clinical Evaluation of SLS Transtibial Sockets|Long Term Clinical Evaluation of SLS Transtibial Sockets|Completed||N/A|11|Actual|The University of Texas Health Science Center at San Antonio|||||f||||f||||||||||2017-10-11 05:26:19.840561|2017-10-11 05:26:19.840561
NCT00167583|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-07-26|||November 2004||2004-11-01|March 2009|2009-03-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|INCYTOB||Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)|Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet`s Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB)|Unknown status|Recruiting|Phase 3|100|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-10-11 05:26:19.923291|2017-10-11 05:26:19.923291
NCT00167596|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-07-19|||July 2005||2005-07-01|July 2016|2016-07-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|OTO-STS||Near Infrared Spectroscopy (NIRS) in Severe Sepsis|Phase III Study of Usefulness of Near Infrared Spectroscopy to Optimize Tissues Perfusion and Oxygenation in Severe Sepsis|Terminated||Phase 2/Phase 3|103|Actual|University of Versailles||2||recruitment was stopped as consequence of cessation of funding (economic crisis)|f||||t||||||||||2017-10-11 05:26:20.084036|2017-10-11 05:26:20.084036
NCT00167609|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2010-04-05|||November 2004||2004-11-01|April 2010|2010-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy and Safety of DHEA for Myotonic Dystrophy|Phase 3 Study of Oral Dehydroepiandrosterone (DHEA) in Adults With Myotonic Dystrophy|Completed||Phase 2/Phase 3|75|Actual|University of Versailles||3|||f||||t||||||||||2017-10-11 05:26:20.17788|2017-10-11 05:26:20.17788
NCT00167622|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2016-07-19|||April 2005||2005-04-01|July 2016|2016-07-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Early Mechanical Ventilation for Guillain Barré Syndrome|Efficacy and Safety of Preventive Mechanical Ventilation in Adults With Guillain Barré Syndrome|Completed||Phase 2|50|Actual|University of Versailles||2|||f||||f||||||||||2017-10-11 05:26:20.265631|2017-10-11 05:26:20.265631
NCT00174018|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-06|||September 1993||1993-09-01|August 1993|1993-08-01||||||||Observational|||Validity and Reliability in Measuring the Subacromial Space by Using Ultrasound|Validity and Reliability in Measuring the Subacromial Space by Using Ultrasound|Completed||Phase 1|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.349245|2017-10-11 05:26:20.349245
NCT00174031|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-11-25|||December 1993||1993-12-01|September 1993|1993-09-01||||||||Observational|||Prevalence and Profiles of Sports Injury in Taiwanese Adolescent Baseball Players|Prevalence and Profiles of Sports Injury in Taiwanese Adolescent Baseball Players|Unknown status|Recruiting|Phase 1/Phase 2|800||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.41119|2017-10-11 05:26:20.41119
NCT00174044|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-20|||August 2005||2005-08-01|August 2005|2005-08-01|July 2006||2006-07-01|||||Observational|||Control Strategies of the Locomotor System During Obstacle-Crossing in Stroke Patients|Control Strategies of the Locomotor System During Obstacle-Crossing in Stroke Patients|Unknown status|Recruiting|N/A|120||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.472929|2017-10-11 05:26:20.472929
NCT00174057|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Observational|||The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy||Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.539798|2017-10-11 05:26:20.539798
NCT00174070|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-11-02|||August 2005||2005-08-01|July 2005|2005-07-01|February 2006||2006-02-01|||||Observational|||Etiologies and Outcomes of Acute Respiratory Failure in Community|Etiologies and Outcomes Analysis of Acute Respiratory Failure in Community|Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.609809|2017-10-11 05:26:20.609809
NCT00174083|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|December 2006||2006-12-01|||||Observational|||Diagnosis of Active Tuberculosis by ELISPOT|Diagnosis of Active Tuberculosis in Endemic Area by Using Enzyme-Linked Immunospot Assay for Gamma-Interferon|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.687547|2017-10-11 05:26:20.687547
NCT00174096|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-03-30|||August 2005||2005-08-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Observational|||The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.760065|2017-10-11 05:26:20.760065
NCT00174109|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Observational|||The Relation of Microtubule-Associated Protein 2 and Cell Migration||Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.828069|2017-10-11 05:26:20.828069
NCT00174122|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-02-28|||July 2005||2005-07-01|September 2004|2004-09-01|June 2006||2006-06-01|||||Observational|||Procalcitonin in Diagnosing Bacteremia in the Emergency Department||Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.899065|2017-10-11 05:26:20.899065
NCT00174135|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-29|||August 2005||2005-08-01|December 2004|2004-12-01||||||||Observational|||Sarcopenia Studies for the Elderly Population in Taiwan|Sarcopenia Studies for the Elderly Population in Taiwan|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:20.955694|2017-10-11 05:26:20.955694
NCT00174148|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-20|||July 2005||2005-07-01|December 2004|2004-12-01|July 2006||2006-07-01|||||Observational|||Sensorimotor Dysfunction of Individuals With Neck Pain|Sensorimotor Dysfunction of Individuals With Neck Pain|Unknown status|Recruiting|Phase 1|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:21.010115|2017-10-11 05:26:21.010115
NCT00174161|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|December 2005||2005-12-01|||||Observational|||The Symptom Experience of Women With Perimenstrual Syndrome;Women's Health Related Quality of Life.||Unknown status|Recruiting|N/A|1000||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:21.061137|2017-10-11 05:26:21.061137
NCT00174174|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||September 2003||2003-09-01|October 2004|2004-10-01||||||||Interventional|||Provigil (Modafinil) Study by Taiwan Biotech Co.|A Placebo Control, Double Blind, Cross Over Study of Modafinil in Patients With Narcolepsy|Completed||N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:21.121395|2017-10-11 05:26:21.121395
NCT00175708|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-30|||September 2005||2005-09-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Pedobarographic Assessments of Clubfoot Treated Patients|Pedobarographic Assessments of Clubfoot Treated Patients|Recruiting||N/A|100|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 05:26:27.380527|2017-10-11 05:26:27.380527
NCT00174187|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-11-05|2012-09-11||September 2000||2000-09-01|November 2012|2012-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy|Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) in Children With Short Stature Secondary to a Long Term Corticoid Therapy. A Study of Efficacy and Safety.|Terminated||Phase 3|30|Actual|Pfizer|Results for secondary and other pre-specified endpoints (except IGF-1) are reported for only up to 3 years because data beyond Year 3 was not summarized as the study was terminated due to Good Clinical Practice (GCP) non-compliance issues.|1||See termination reason in detailed description.|f||||f||||||||||2017-10-11 05:26:21.336452|2017-10-11 05:26:21.336452
NCT00174200|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-07-11|||December 2004||2004-12-01|July 2008|2008-07-01|May 2006|Actual|2006-05-01|||||Interventional|||Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone|A Randomized, Double-Blind, Crossover Add-On Study To Assess The Differential Sensitivity Of 2 Spatial Working Memory Tests (The Groton Maze Learning Test [GMLT] And The Motor Delayed Response Test [MDR]) In Non-Agitated, Antipsychotic Drug-Naive First-Episode Schizophrenic Or Schizophreniform Patients Treated With Risperidone 2 Mg Daily Or Placebo|Completed||N/A|20||Pfizer|||||f||||||||||||||2017-10-11 05:26:23.396568|2017-10-11 05:26:23.396568
NCT00174213|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-08-29|||September 1994||1994-09-01|August 1994|1994-08-01||||||||Observational|||Validity and Reliability in Measuring Iliotibial Tract by Using Ultrasound|Validity and Reliability in Measuring Iliotibial Tract by Using Ultrasound|Unknown status|Recruiting|Phase 1|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:26:23.469654|2017-10-11 05:26:23.469654
NCT00174226|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-07-10|||November 2004||2004-11-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|||||Interventional|||Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar|Eight-Week, Double-Blind, 3-Arm Parallel, Placebo-Controlled, Randomized Efficacy And Safety Trial Of Atomoxetine, Atomoxetine Plus Buspirone, And Placebo In Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 2|241|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:26:23.530054|2017-10-11 05:26:23.530054
NCT00174239|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-05-24|||July 2004||2004-07-01|May 2007|2007-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.|A Double-Blind, Randomized, Comparative Study of Cabaser and Sinemet CR For The Treatment Of Nocturnal Disability In Levodopa -Treated Parkinson's Disease Patients.|Terminated||Phase 4|220||Pfizer||||See Detailed Description for termination reason.|f||||f||||||||||2017-10-11 05:26:23.61937|2017-10-11 05:26:23.61937
NCT00174252|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-06-10|2010-04-02||February 2005||2005-02-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age|Evolution of IGF-1 in Children Born Small for Gestational Age and With Growth Retardation, Treated by Genotonorm Especially Evolution After Dose Adaptation.|Completed||Phase 3|57|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:26:23.750179|2017-10-11 05:26:23.750179
NCT00174265|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-06-08|2010-05-27|2009-06-09|July 2005||2005-07-01|June 2015|2015-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)|A Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the Safety and Efficacy of Asenapine With Olanzapine in Subjects Who Completed Protocol A7501013|Completed||Phase 3|196|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:26:24.465323|2017-10-11 05:26:24.465323
NCT00174278|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-08-04|||February 1997||1997-02-01|August 2008|2008-08-01|October 2006|Actual|2006-10-01|||||Interventional|||Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary|Treatment With Recombinant Human Growth Hormone (Genotonorm®) In Children With Short Stature Secondary To A Long Term Corticoid Therapy. A Study of Efficacy and Safety.|Completed||Phase 3|14||Pfizer|||||f||||||||||||||2017-10-11 05:26:24.820628|2017-10-11 05:26:24.820628
NCT00174291|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-10-26|2012-10-26||March 2002||2002-03-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy|Prevention of Retarded Growth by Early Treatment With Recombinant Human Growth Factor Genotonorm (Registered) in Children With Systemic Forms of Chronic Juvenile Arthritis Receiving Long-term Corticosteroid Therapy. Extension of the Study Beyond Three Years|Terminated||Phase 3|21|Actual|Pfizer|Data for bone mineral density (BMD), bone mineral content (BMC) and IGFBP3 were not analyzed because of change in planned analysis after the study was prematurely terminated due to Good Clinical Practice (GCP) non-compliance issues.|1||See termination reason in detailed description.|f||||f||||||||||2017-10-11 05:26:24.913595|2017-10-11 05:26:24.913595
NCT00174304|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-01-06|||October 2004||2004-10-01|April 2007|2007-04-01|September 2006||2006-09-01|||||Interventional|JEWEL II||Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.|An International, Multicentre, Open Label Study To Assess The Effectiveness Of Amlodipine/Atorvastatin Combination In Subjects With Hypertension And Dyslipidaemia. (The JEWEL II Study)|Completed||Phase 4|1120||Pfizer|||||f||||||||||||||2017-10-11 05:26:26.313934|2017-10-11 05:26:26.313934
NCT00174317|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-11-30|||August 2003||2003-08-01|December 2005|2005-12-01|February 2005||2005-02-01|||||Interventional|||Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip|Clinical Protocol For A Multicentre, Double-Blind, Randomised, Parallel Group Study To Compare The Efficacy and Tolerability Of Celecoxib Vs. Diclofenac In The Treatment Of Subjects With Osteoarthritis Of The Hip Requiring Joint Replacement Therapy|Completed||Phase 4|250||Pfizer|||||f||||||||||||||2017-10-11 05:26:26.626513|2017-10-11 05:26:26.626513
NCT00174330|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-02-20|||May 2005||2005-05-01|February 2007|2007-02-01|February 2006||2006-02-01|||||Interventional|||Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia|A Multi-Center, Randomized, Open-Label Study To Evaluate Efficacy And Safety Of Dual Therapy With Atorvastatin Plus Amlodipine When Compared Amlodipine Therapy Alone In The Treatment Of Subjects With Concurrent Hyperlipidemia And Hypertension.|Completed||Phase 4|330||Pfizer|||||f||||||||||||||2017-10-11 05:26:26.868465|2017-10-11 05:26:26.868465
NCT00174343|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-21|||November 2001||2001-11-01|April 2011|2011-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients|Phase II Study Evaluating The Role Of Exemestane On Clinical And Pathologic Response Rates, And Its Aromatase Activity As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients.|Completed||Phase 2|46||Pfizer|||||f||||||||||||||2017-10-11 05:26:27.013593|2017-10-11 05:26:27.013593
NCT00175721|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-03-14|||December 2005||2005-12-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Trial Comparing Care in Multiple Clinics Versus Care in a Cardiac, Diabetes and Kidney Care Clinic|Randomized Controlled Trial Comparing Current Care in Multiple Clinics Vs Care in a Novel Cardiac, Diabetes & Kidney Care Clinic|Completed||N/A|150|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:26:27.476524|2017-10-11 05:26:27.476524
NCT00175734|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-30|||August 2005||2005-08-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2007|Actual|2007-12-01||Interventional|||Interactive Studies of Endstage Diabetic Dialysis Patients|Integrated Studies in Vascular Reactivity and Anemia Correction Therapy in Endstage Kidney Disease Patients|Unknown status|Active, not recruiting|N/A|80|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:26:27.565444|2017-10-11 05:26:27.565444
NCT00175747|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2000||2000-01-01|September 2005|2005-09-01|December 2002||2002-12-01|||||Interventional|||A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)|A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People With Dysplasia of the Bronchial Epithelium|Completed||Phase 2/Phase 3|120||University of British Columbia|||||f||||||||||||||2017-10-11 05:26:27.640073|2017-10-11 05:26:27.640073
NCT00175760|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-11|||December 2004||2004-12-01|April 2011|2011-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?|Prospective Assessment of High Titre TTG to Diagnose Celiac Disease in Select Paediatric Patients.|Completed||N/A|100|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 05:26:27.720157|2017-10-11 05:26:27.720157
NCT00175773|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-10|||November 2004||2004-11-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Mechanisms of Orthostatic Intolerance in Spinal Cord Injured Individuals and Following Bed Rest|Mechanisms of Orthostatic Intolerance in Spinal Cord Injured Individuals and Following Bed Rest|Completed||N/A|51|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 05:26:27.793257|2017-10-11 05:26:27.793257
NCT00175786|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-24|||July 2005||2005-07-01|September 2008|2008-09-01||||||||Observational|||Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma|Neuroradiologic Screening of Patients With Normal Tension Glaucoma|Completed||N/A|50|Anticipated|University of British Columbia|||||f||||||||||||||2017-10-11 05:26:27.864583|2017-10-11 05:26:27.864583
NCT00175799|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-05|||September 2007||2007-09-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|September 2011|Actual|2011-09-01||Observational|||Validation of Severity of Illness Scoring Systems in Paediatric Intensive Care Units in Canada|Validation of Severity of Illness Scoring Systems in Paediatric Intensive Care Units in Canada Outcome: Validation and Comparison of 2 Severity of Illness Scores in Canadian PICU Population|Completed||N/A|10000|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 05:26:27.942431|2017-10-11 05:26:27.942431
NCT00175812|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-06-23|||November 2004||2004-11-01|June 2015|2015-06-01|November 2009|Actual|2009-11-01|May 2008|Actual|2008-05-01||Interventional|||Differentiation Induction in Acute Myelogenous Leukemia|Differentiation Induction Therapy for Acute Myelogenous Leukemia|Completed||Phase 1/Phase 2|24|Actual|University of Bergen||1|||f||||f||||||||||2017-10-11 05:26:28.020484|2017-10-11 05:26:28.020484
NCT00175825|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-08-28|||November 2005||2005-11-01|August 2012|2012-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.|A Double-blind, Randomized, Placebo-controlled, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures.|Completed||Phase 2|210|Actual|UCB Pharma||4|||f||||f||||||||||2017-10-11 05:26:28.173531|2017-10-11 05:26:28.173531
NCT00175838|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-01-17|||July 1997||1997-07-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|PT-1||Primary Thrombocythaemia 1 Trial|A Randomised Trial to Compare Aspirin vs Hydroxyurea/Aspirin in 'Intermediate Risk' Primary Thrombocythaemia and Aspirin Only With Observation in 'Low Risk'Primary Thrombocythaemia|Completed||N/A|1398|Actual|University of Cambridge||2|||f||||t||||||||||2017-10-11 05:26:28.565733|2017-10-11 05:26:28.565733
NCT00175851|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-05-25|||May 2008||2008-05-01|May 2012|2012-05-01||||||||Interventional|||Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy|An Open-label, Multicenter, Follow-up Trial to Evaluate the Long-term Safety and Efficacy of Seletracetam Used as Adjunctive Treatment Using a Flexible Dosing Scheme of 4 to 80 mg b.i.d. in Subjects Aged 16 Years or Older Suffering From Epilepsy|Withdrawn||Phase 3|0|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:26:28.709858|2017-10-11 05:26:28.709858
NCT00175864|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-03-19|||February 2006||2006-02-01|March 2012|2012-03-01||||||||Interventional|||Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.|Open Label, Multicenter Study of the Safety and Efficacy of Oral Treatment With Immediate Release Seletracetam (Ucb 44212) at Individualized Doses up to a Maximum of 160mg/Day in Refractory Epileptic Patients.|Withdrawn||Phase 3|0|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:26:28.78848|2017-10-11 05:26:28.78848
NCT00175877|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-03-22|2013-02-04||June 2005||2005-06-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Baseline Characteristics refer to the Safety Set (SS). SS consists of all enrolled subjects who received at least 1 dose of study medication.|A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis|A Phase III Multi-centre, Open-label, follow-on Study to CDP870-027, to Assess the Efficacy and Safety of Lyophilized CDP870 an Engineered Human Anti-TNF PEG Conjugate, as Additional Medication to Methotrexate, in the Treatment of Signs and Symptoms and Preventing Structural Damage in Patients With Active Rheumatoid Arthritis|Completed||Phase 3|857|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:26:28.913656|2017-10-11 05:26:28.913656
NCT00175890|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-07-06|||October 2004||2004-10-01|July 2015|2015-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.|A Double-Blind, Randomized, Multicenter, Placebo-controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/Day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age From 1 Month to Less Than 4 Years of Age. N01009|Completed||Phase 3|116|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 05:26:31.592899|2017-10-11 05:26:31.592899
NCT00175903|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-03-12|||February 2005||2005-02-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy|A Therapeutic Confirmatory, Open-label, Multi-center, Randomized 2 Parallel Groups, Community-based Trial Studying the Efficacy and Safety of Levetiracetam (1000 to 3000 mg/Day Oral Tablets 250-500 mg b.i.d.) Compared to Sodium Valproate (1000 to 2000 mg/Day Oral ER Tablets 300-500 mg b.i.d.) and Carbamazepine (600 to 1600 mg/Day Oral CR Tablets 200-400 mg b.i.d.) as Monotherapy in Subjects With Newly Diagnosed Epilepsy.|Completed||Phase 3|1701|Actual|UCB Pharma||2|||f||||f||||||||||2017-10-11 05:26:32.149556|2017-10-11 05:26:32.149556
NCT00175916|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-08-31|||September 2005||2005-09-01|August 2017|2017-08-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy|An Open-label, Multicenter, Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment at a Flexible Dose up to a Maximum of 200 mg/Day in Subjects Aged 16 Years or Older Suffering From Epilepsy|Active, not recruiting||Phase 3|853|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:26:32.894075|2017-10-11 05:26:32.894075
NCT00175929|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-04-10|||May 2005||2005-05-01|April 2015|2015-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of Brivaracetam in Subjects With Partial Onset Seizures|A Multicenter, Double-blind, Randomized, Placebo-controlled, 3 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Ucb 34714 Used as Adjunctive Treatment at Doses of 50 and 150 mg/Day in b.i.d. Administration (Oral Capsules of 25 mg) for a Maximum of 12 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized|Completed||Phase 2|157|Actual|UCB Pharma||3|||f||||t||||||||||2017-10-11 05:26:33.325594|2017-10-11 05:26:33.325594
NCT00175942|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-09-10|||February 2003||2003-02-01|May 2005|2005-05-01||||||||Observational|||Risk Indicators in Patients With Ventricular Fibrillation During Acute Myocardial Infarction|Indicators of Coagulation Activation and Inflammation Contributing to Ventricular Fibrillation Complicating Acute Myocardial Infarction|Unknown status|Recruiting|N/A|300||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:33.534435|2017-10-11 05:26:33.534435
NCT00175955|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-12-05|||May 2005||2005-05-01|September 2009|2009-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia|An 8-week Exploratory, Double-blind, Placebo Controlled, Randomized Trial: Evaluation of the Efficacy and Safety of Levetiracetam up to 3000 mg/Day (250-500 mg Oral Tablets in b.i.d. Administration) on Neuroleptic-induced Tardive Dyskinesia in Subjects With Stable Axis I Psychiatric Disorder, Aged From at Least 18 Years to 80 Years.|Completed||Phase 2|70||UCB Pharma|||||f||||||||||||||2017-10-11 05:26:33.608488|2017-10-11 05:26:33.608488
NCT00175968|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||March 2001||2001-03-01|September 2005|2005-09-01|April 2003||2003-04-01|||||Interventional|||Influence of Bedrest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity|Influence of Bed-Rest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity|Completed||Phase 1|10||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:33.706587|2017-10-11 05:26:33.706587
NCT00175981|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||February 2003||2003-02-01|September 2005|2005-09-01|November 2004||2004-11-01|||||Interventional|||Interaction Between Fluvoxamine and Sildenafil|Pharmacokinetic and Pharmacodynamic Evaluation of the Interaction Between Fluvoxamine and Sildenafil in Healthy Males|Completed||Phase 1|12||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:33.768387|2017-10-11 05:26:33.768387
NCT00175994|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-16|||July 2005||2005-07-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Observational|||Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism|Bioavailability and Metabolism of Voriconazole as a Function of the CYP2C19 Genotype|Completed||Phase 1|24||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:33.87426|2017-10-11 05:26:33.87426
NCT00176007|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-09-10||||||June 2005|2005-06-01||||||||Interventional|||Hypoxia Impairs Endothelial Function in HAPEs|Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema.|Completed||Phase 1|||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:33.961552|2017-10-11 05:26:33.961552
NCT00176020|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-14||||||August 2005|2005-08-01||||||||Interventional|||Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression|Double-Blind, Randomized, Placebo-Controlled, Single-Center, 2 Treatment, 3-Way Crossover Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of a Single Oral Repeated Dose of 500 Mg Nicotinic Acid as Tablets in Healthy Subjects|Unknown status|Not yet recruiting|Phase 1|18||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:34.029117|2017-10-11 05:26:34.029117
NCT00176033|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-02-12|||January 2005||2005-01-01|February 2009|2009-02-01||||||||Observational|||Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra|Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra (Lopinavir/Ritonavir) and on the Concentration Relations Between Plasma, Blood Cells, Saliva and Urine|Completed||Phase 1|12|Anticipated|Heidelberg University|||||f||||||||||||||2017-10-11 05:26:34.089003|2017-10-11 05:26:34.089003
NCT00176046|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-05-03|||May 1999|Actual|1999-05-01|June 2009|2009-06-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study|Prospective Controlled Randomized Feasibility Study on a Treatment With Viscum Album in Patients With Breast Cancer to Identify Appropriate Surrogate Parameters for a Randomized Study of the Efficacy of Treatment With Mistletoe Extracts|Completed||Phase 4|114|Actual|Heidelberg University||2|||f||||f||||||||||2017-10-11 05:26:34.284404|2017-10-11 05:26:34.284404
NCT00176059|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-05-08|||October 2001||2001-10-01|May 2007|2007-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients|Immunoglobulin Induction Therapy in Renal Transplant Recipients on Tacrolimus/Azathioprine or Tacrolimus/MMF: Effects on Th1, Th2, B Cell-/Monokine Responses and Immunoregulatory Autoantibody Levels|Completed||Early Phase 1|50|Actual|University of Giessen||2|||f||||f||||||||||2017-10-11 05:26:34.408386|2017-10-11 05:26:34.408386
NCT00176072|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|July 2004|2004-07-01|November 2004||2004-11-01|||||Observational|||BlueCQ Bioavailability|B l u e C Q - P r o j e c t: Bioavailability of Methylene Blue (MB) - Comparison of an Intravenous and Two Oral Formulations - and Influence of Sustained Release MB on Chloroquine (CQ) Concentrations|Completed||Phase 1|18||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:34.5343|2017-10-11 05:26:34.5343
NCT00176085|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-05-27|||October 2004||2004-10-01|May 2015|2015-05-01|March 2005|Actual|2005-03-01|||||Observational|||Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH|Pharmacokinetics of 11-Nor-9-carboxy-D9-tetrahydrocannabinol (THCCOOH) and Its Acyl-glucuronide (THCCOOH-GLu) After Intravenous Administration of THCCOOH in Healthy Human Subjects|Completed||Phase 1|10||Heidelberg University|||1||f||||||||||||||2017-10-11 05:26:34.582872|2017-10-11 05:26:34.582872
NCT00176098|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-02-06|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||Hypnosis for Eye Surgery|Correlation of Stress, Patient Comfort and Safety to Bispectral Index in Patients Under Hypnosis for Cataract Surgery|Unknown status|Recruiting|Phase 1/Phase 2|70||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:34.64158|2017-10-11 05:26:34.64158
NCT00176111|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-15|||January 2004||2004-01-01|January 2004|2004-01-01|January 2005||2005-01-01|||||Interventional|||Effects of Local Anesthetic or Saline Solution on Peripheral Nerve Stimulation – a Randomised Study|Effects of Local Anesthetic or Saline Solution on Peripheral Nerve Stimulation – a Randomised, Double-Blind, Multicenter Study About the Stimulability of Anesthetized Nerves|Terminated||Phase 4|40||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:34.727774|2017-10-11 05:26:34.727774
NCT00176124|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2008-06-09|||April 2001||2001-04-01|June 2008|2008-06-01|September 2005|Actual|2005-09-01|April 2005|Actual|2005-04-01||Interventional|LDAWB-2001||Leukocyte Depletion of Autologous Whole Blood|Leukocyte Depletion of Autologous Whole Blood: Impact on Perioperative Infection Rate and Length of Hospital Stay for Hip Arthroplasty Patients|Completed||Phase 4|1089|Actual|Heidelberg University||2|||f||||t||||||||||2017-10-11 05:26:34.811547|2017-10-11 05:26:34.811547
NCT00176137|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-04-21|||October 1995||1995-10-01|April 2008|2008-04-01|September 2005||2005-09-01|||||Interventional|||Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)|Cisplatin/Etoposide Followed by Twice-Daily Chemoradiation (hfRT/CT) Versus Cisplatin/Etoposide Alone Before Surgery in Stage III Non-Small Cell Lung Cancer. A Phase III Trial of the German Lung Cancer Cooperative Group (GLCCG)|Completed||Phase 3|500||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:34.955009|2017-10-11 05:26:34.955009
NCT00176150|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13||||||April 2003|2003-04-01||||||||Observational|||Drug Transport in Patients With Anorexia Nervosa|Influence of Cholesterol Plasma Levels on Drug Transport in Patients With Anorexia Nervosa|Unknown status|Recruiting|N/A|||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:35.065664|2017-10-11 05:26:35.065664
NCT00176163|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-02-01|||August 2005||2005-08-01|September 2005|2005-09-01|May 2009||2009-05-01|||||Interventional|||Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain|Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain|Completed||Phase 2|240|Anticipated|Heidelberg University|||||f||||||||||||||2017-10-11 05:26:35.147327|2017-10-11 05:26:35.147327
NCT00176176|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-11||||||November 2004|2004-11-01||||||||Interventional|||Investigation of Cognitive Function Before and After Induced Ventricular Fibrillation in Electrophysiological (EP) Study|Change of EEG Activity and Cerebral Circulation During Induced Ventricular Fibrillation and Investigation of Cognitive Function Before and After Induced Ventricular Fibrillation in EP Study|Unknown status|Recruiting|N/A|30||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:35.235298|2017-10-11 05:26:35.235298
NCT00176189|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-25|||February 2005||2005-02-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Clinical Performance of Extended All-Ceramic Fixed Partial Dentures Based on Zircon-Oxide Ceramics.|Clinical Performance of Extended All-Ceramic Fixed Partial Dentures Based on Zircon-Oxide Ceramics|Completed||N/A|30||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:35.352389|2017-10-11 05:26:35.352389
NCT00176202|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-11-04|2015-06-02||April 2003||2003-04-01|November 2015|2015-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||AGE 10 TO 20 YRS GENDER :BOTH|Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar|Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar|Completed||Phase 3|65|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-10-11 05:26:35.433566|2017-10-11 05:26:35.433566
NCT00176215|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 2003||2003-05-01|July 2005|2005-07-01||||||||Interventional|||Clinical Comparison of RPDs Retained by Conical and Galvanoformed Double Crowns.||Unknown status|Active, not recruiting|Phase 4|||Heidelberg University|||||f||||||||||||||2017-10-11 05:26:35.793043|2017-10-11 05:26:35.793043
NCT00176228|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-28|2013-06-20||February 2004||2004-02-01|June 2015|2015-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Lamotrigine Monotherapy in Pediatric Bipolar Disorder|Open Trial of Lamotrigine Monotherapy in Pediatric Bipolar Disorder|Completed||Phase 2|48|Actual|University of Illinois at Chicago||1|||f||||t||||||||||2017-10-11 05:26:35.860269|2017-10-11 05:26:35.860269
NCT00176241|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-03|||December 2005||2005-12-01|June 2015|2015-06-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer|A Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent Head & Neck Cancer|Terminated||Phase 1|7|Actual|University of Kentucky||1||Slow accrual|f||||f||||||||||2017-10-11 05:26:36.050093|2017-10-11 05:26:36.050093
NCT00176254|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-01-24|2013-12-08||May 2000||2000-05-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer|Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer|Completed||Phase 2|40|Actual|University of Kentucky|Heterogeneity of post-induction treatment given. While definitive therapy did differ, it was stratified by response to induction therapy, an accepted practice. Conclusions remain exploratory, because of the small sample size and heterogeneity.|1|||f||||f||||||||||2017-10-11 05:26:36.16438|2017-10-11 05:26:36.16438
NCT00176267|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-04-18|||September 2002||2002-09-01|April 2017|2017-04-01|January 31, 2017|Actual|2017-01-31|January 2005|Actual|2005-01-01||Interventional|||Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer|Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer|Completed||Phase 2|26|Actual|University of Kentucky||1|||f||||f||||||||||2017-10-11 05:26:38.226121|2017-10-11 05:26:38.226121
NCT00177281|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-12-18|||September 2003||2003-09-01|December 2013|2013-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of S-CKD602 in Patients With Advanced Malignancies|A Phase I Study to Evaluate the Safety and Pharmacokinetics of S-CKD602 in Patients With Advanced Malignancies|Completed||Phase 1|45|Actual|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:52.92619|2017-10-11 05:26:52.92619
NCT00176280|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-06-16|||September 2005||2005-09-01|June 2015|2015-06-01||||||||Interventional|||Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma|A Randomized Phase II Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemcitabine and 5-Fluorouracil (5-FU) in Patients With Metastatic Renal Cell Carcinoma (RCC)|Withdrawn||Phase 2|0|Actual|University of Kentucky||||Slow accrual|f||||||||||||||2017-10-11 05:26:38.317886|2017-10-11 05:26:38.317886
NCT00176293|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-20|||October 2005||2005-10-01|April 2015|2015-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer|A Randomized Phase II Trial of Doxil With or Without Dexamethasone in Treatment of Patients With Metastatic Hormone Refractory Prostate Cancer|Terminated||Phase 2|2|Actual|University of Kentucky||2||Slow accrual|f||||||||||||||2017-10-11 05:26:38.394099|2017-10-11 05:26:38.394099
NCT00176306|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-09-12|2011-08-02||January 2005||2005-01-01|September 2012|2012-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Levofloxacin Pharmacokinetics (PK) in the Severely Obese|Levofloxacin Pharmacokinetics in the Severely Obese|Completed||Phase 4|15|Actual|University of Kentucky|The number of ambulatory volunteers was low The acutely ill cohort was a heterogeneous population We remain unable to predict the precise effect of all of these different physiologic processes on drug pharmacokinetics|1|||f||||f||||||||||2017-10-11 05:26:38.496692|2017-10-11 05:26:38.496692
NCT00176319|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-07-14|||May 2005||2005-05-01|July 2009|2009-07-01||||December 2008|Actual|2008-12-01||Interventional|LEICA||Leipzig Exercise Intervention in Chronic Heart Failure and Aging|Age-related Functional and Molecular Effects of Short-term Aerobic Endurance Training in Patients With Stable Chronic Heart Failure and Age-matched Healthy Controls.|Completed||Phase 2|120|Actual|University of Leipzig||8|||f||||||||||||||2017-10-11 05:26:38.673802|2017-10-11 05:26:38.673802
NCT00176332|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2007-07-31|||March 2004||2004-03-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure|Impact of Three Months of Rosuvastatin Treatment on Peripheral Endothelial Function, Inflammatory Markers in the Blood and the Skeletal Muscle and on Postnatal Vasculogenesis in Patients With Severe Chronic Heart Failure|Completed||Phase 2|40||University of Leipzig|||||f||||||||||||||2017-10-11 05:26:38.745801|2017-10-11 05:26:38.745801
NCT00176345|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-11|||January 2001||2001-01-01|September 2005|2005-09-01||||||||Interventional|||Impact of Exercise Training on Endothelial Function in CAD|Impact of Exercise Training on Bradykinin-Mediated Endothelial Function in Patients With Coronary Artery Disease|Unknown status|Recruiting|Phase 2|20||University of Leipzig|||||f||||||||||||||2017-10-11 05:26:38.820281|2017-10-11 05:26:38.820281
NCT00176358|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-09-07||||||September 2005|2005-09-01||||||||Interventional|||Percutaneous Coronary Angioplasty Compared With Exercise Training in Symptomatic Coronary Artery Disease||Unknown status|Recruiting|Phase 2/Phase 3|400|Anticipated|University of Leipzig|||||f||||||||||||||2017-10-11 05:26:38.90593|2017-10-11 05:26:38.90593
NCT00176371|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-07|||July 2005||2005-07-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Improvement of Physical Activity and Correction of Body Mass Index in School Children||Unknown status|Recruiting|N/A|500|Anticipated|University of Leipzig|||||f||||||||||||||2017-10-11 05:26:40.144216|2017-10-11 05:26:40.144216
NCT00176384|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2007-07-31|||March 2003||2003-03-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Impact of Exercise Training on Exercise Capacity in Patients With Severe Chronic Heart Failure|Impact of Three Months of Aerobic Exercise Training on Exercise Capacity and Peripheral Maladaptations in Patients With Severe Chronic Heart Failure (NYHA III b)|Completed||Phase 2|36||University of Leipzig|||||f||||||||||||||2017-10-11 05:26:40.221691|2017-10-11 05:26:40.221691
NCT00176397|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-06|||August 2003||2003-08-01|September 2005|2005-09-01||||||||Interventional|||Percutaneous Coronary Intervention (PCI) With Drug-Eluting Stents (DES) Versus Coronary Artery Bypass Graft (CABG) for Patients With Significant Left Main Stenosis|PCI With DES Versus CABG for Patients With Significant Left Main Stenosis|Unknown status|Recruiting|Phase 2|200|Anticipated|University of Leipzig|||||f||||||||||||||2017-10-11 05:26:40.310073|2017-10-11 05:26:40.310073
NCT00176410|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-01-13|||January 2003||2003-01-01|September 2006|2006-09-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Statin Therapy in Asymptomatic Aortic Stenosis||Unknown status|Recruiting|Phase 2|100|Anticipated|University of Leipzig||1|||f||||||||||||||2017-10-11 05:26:40.416238|2017-10-11 05:26:40.416238
NCT00176423|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-06-26|||May 2002||2002-05-01|June 2007|2007-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia|Adjunctive Galantamine for Treatment of Cognitive Impairments in Patients With Schizophrenia|Completed||Phase 4|120||University of Maryland|||||f||||t||||||||||2017-10-11 05:26:40.524347|2017-10-11 05:26:40.524347
NCT00176436|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-07|2013-01-18||February 2004||2004-02-01|May 2013|2013-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients|Double-Blind Study of Atomoxetine for Weight Management in Patients Taking Olanzapine or Clozapine|Completed||Phase 4|40|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 05:26:40.642851|2017-10-11 05:26:40.642851
NCT00176449|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-30|||April 2001||2001-04-01|March 2017|2017-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Comparison of Bupropion SR and Placebo for Smoking Cessation|A Comparison of Bupropion SR and Placebo for Smoking Cessation|Completed||Phase 4|52|Actual|University of Maryland||2|||f||||t||||||||||2017-10-11 05:26:40.946292|2017-10-11 05:26:40.946292
NCT00176462|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-12|2013-11-15||February 2001||2001-02-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||CINJALL: Treatment for Children With Acute Lymphocytic Leukemia|CINJALL: Treatment for Children With Acute Lymphocytic Leukemia|Completed||Phase 2|60|Actual|Rutgers, The State University of New Jersey|Antifolate therapy was non-randomly assigned, therefore, we do not have a statistical basis to compare the toxicity observed among patients on the standard risk and high risk treatment arms.|2|||f||||f||||||||||2017-10-11 05:26:41.061633|2017-10-11 05:26:41.061633
NCT00176475|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-13|||January 2005||2005-01-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease|A Pilot Study of Irradiated HLA-Partially Matched Allogeneic Related Donor Lymphocytes in Conjunction With Rituximab for Selected Patients With CD20 + Malignancies|Terminated||Phase 1|2|Actual|Rutgers, The State University of New Jersey||1||slow accrual|f||||t||||||||||2017-10-11 05:26:41.979337|2017-10-11 05:26:41.979337
NCT00176488|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-20|2013-09-18||June 2003||2003-06-01|February 2017|2017-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer|A Phase II Trial of Sequential Epirubicin/Vinorelbine in Patients With Advanced Breast Cancer|Terminated||Phase 2|31|Actual|Rutgers, The State University of New Jersey||1||Competing studies|f||||f||||||||||2017-10-11 05:26:42.118024|2017-10-11 05:26:42.118024
NCT00176501|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-18|2013-11-18||August 2004||2004-08-01|November 2013|2013-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer|Immunotherapy for Patients With Renal Cell Carcinoma|Terminated||Phase 2|3|Actual|Rutgers, The State University of New Jersey||1||Slow accrual|f||||f||||||||||2017-10-11 05:26:42.433113|2017-10-11 05:26:42.433113
NCT00176514|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-10|||July 2000||2000-07-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Pilot Trial to Assess the Effects of Green Tea in the Prevention of Therapy-Induced Mucositis|A Pilot Trial to Assess the Effects of Green Tea in the Prevention of Therapy-Induced Mucositis|Terminated||N/A|37||Rutgers, The State University of New Jersey||||slow accrual|f||||f||||||||||2017-10-11 05:26:42.651914|2017-10-11 05:26:42.651914
NCT00176527|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-10|||November 2002||2002-11-01|December 2009|2009-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Trial of 13-Cis Retinoic Acid, Alpha Interferon, Taxotere, and Estramustine (R.I.T.E.) for the Treatment of Hormone Refractory Prostate Cancer|Terminated||Phase 2|40|Anticipated|Rutgers, The State University of New Jersey||||accrual goal met|f||||t||||||||||2017-10-11 05:26:42.742663|2017-10-11 05:26:42.742663
NCT00176540|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-16|||October 2003||2003-10-01|May 2011|2011-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Dextromethorphan in Treating Patients With Fatigue Caused by Cancer|A Pilot Trial to Evaluate the Effects of Dextromethorphan in Patients Suffering From Cancer-Related Fatigue|Terminated||N/A|30|Anticipated|Rutgers, The State University of New Jersey||||slow accrual|f||||t||||||||||2017-10-11 05:26:42.835953|2017-10-11 05:26:42.835953
NCT00176553|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-10|||March 2003||2003-03-01|December 2009|2009-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity|A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity|Terminated||N/A|20|Anticipated|Rutgers, The State University of New Jersey||1||slow accrual|f||||t||||||||||2017-10-11 05:26:42.931341|2017-10-11 05:26:42.931341
NCT00176566|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-10|||September 2003||2003-09-01|December 2009|2009-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia|A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia|Terminated||Phase 2|8|Actual|Rutgers, The State University of New Jersey||1||Transitioned into a national study through ECOG|f||||||||||||||2017-10-11 05:26:43.050115|2017-10-11 05:26:43.050115
NCT00176579|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-11|||June 2003||2003-06-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer|Assessing Bone Mineral Density as a Risk Factor for Early Clinically Significant Prostate Cancer|Completed||N/A|27|Actual|Rutgers, The State University of New Jersey|||1||f||||t||||||||||2017-10-11 05:26:43.268669|2017-10-11 05:26:43.268669
NCT00176592|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-11-07|||January 2003||2003-01-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|January 2007|Actual|2007-01-01||Interventional|BECOME||Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI|Phase IV, Rater-blinded, Randomized Study, Comparing 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting(RR) or CIS Forms of ms Using 3 Tesla(3T) Magnetic Resonance Imaging (MRI) With Triple-dose Gadolinium|Unknown status|Active, not recruiting|Phase 4|93|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-11 05:26:43.365057|2017-10-11 05:26:43.365057
NCT00176605|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-18|2013-09-17||May 2005||2005-05-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer|A Phase II Trial of Metronomic Dosing of Etoposide and Cyclophosphamide in Patients With Stage D0 Prostate Cancer.|Completed||Phase 2|15|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-10-11 05:26:43.487017|2017-10-11 05:26:43.487017
NCT00176618|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-12-10|||April 2004||2004-04-01|December 2009|2009-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon|The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon|Terminated||N/A|60|Anticipated|Rutgers, The State University of New Jersey||1||principal Investigator left institution|f||||||||||||||2017-10-11 05:26:43.787172|2017-10-11 05:26:43.787172
NCT00176631|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-15|2013-11-15||September 2007||2007-09-01|November 2013|2013-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Trial of Licorice Root and Docetaxel in Patients With Hormone Refractory Prostate Cancer|Terminated||Phase 2|10|Actual|Rutgers, The State University of New Jersey||1||slow accrual|f||||f||||||||||2017-10-11 05:26:43.901268|2017-10-11 05:26:43.901268
NCT00176644|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-05|2013-11-05||May 2005||2005-05-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer|Phase II Trial of Transdermal Estradiol in Patients With Hormone Refractory Prostate Cancer|Terminated||Phase 2|23|Actual|Rutgers, The State University of New Jersey||1||Treatment ineffective|f||||f||||||||||2017-10-11 05:26:44.221937|2017-10-11 05:26:44.221937
NCT00176657|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-27|||September 2004||2004-09-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||The Use of HEMOBAG to Salvage Blood After Cardiac Surgery|Comparison of Whole Blood Return and Normal Practice Red Blood Cell Salvage Return Following Cardiopulmonary Bypass|Terminated||Phase 2|50||Rutgers, The State University of New Jersey||||Inability to attain sufficient numbers of subjects|f||||||||||||||2017-10-11 05:26:44.565582|2017-10-11 05:26:44.565582
NCT00176670|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-04|||January 2004||2004-01-01|June 2008|2008-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A GameBoy as a Distraction Before Surgery in Children|Is Preoperative Distraction With a Hand Held Game Boy as Effective as Midazolam in Reducing Preoperative Anxiety Levels in Children?|Completed||Phase 2|158||Rutgers, The State University of New Jersey|||||f||||f||||||||No||2017-10-11 05:26:44.647309|2017-10-11 05:26:44.647309
NCT00176683|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-26|||July 2005||2005-07-01|January 2017|2017-01-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Observational|||The Use of Capnography as a Guide for Oral Intubation|Assessing the Use of Capnography as a Guide for Endotracheal Intubation|Terminated||N/A|20|Actual|Rutgers, The State University of New Jersey|||1|study was suspended because of difficluty maintaining equipment|f||||f||||||||||2017-10-11 05:26:44.75073|2017-10-11 05:26:44.75073
NCT00176696|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-04|||August 2005||2005-08-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Biobehavioral Recovery From Surgery and Anesthesia|"Detection of Nociception (Pain) During General Anesthesia"|Terminated||Phase 2|20|Actual|Rutgers, The State University of New Jersey|||1|Principal Investigator has left the UMDNJ|f||||f||||||||No||2017-10-11 05:26:44.831143|2017-10-11 05:26:44.831143
NCT00176722|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-23|||June 2006||2006-06-01|April 2015|2015-04-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Observational|||Intraocular Pressure During Prone Spinal Surgery|The Effect of Table Position on Intraocular Pressure (IOP) and Ocular Perfusion Pressure (OPP) During Prone Spine Surgery|Terminated||Phase 2|7|Actual|Rutgers, The State University of New Jersey|||1|Principal Investigator is leaving the UMDNJ|f||||f||||||||||2017-10-11 05:26:44.917126|2017-10-11 05:26:44.917126
NCT00176735|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-05-18|||December 2001||2001-12-01|May 2015|2015-05-01|August 2005||2005-08-01|||||Interventional|||Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer|Pilot Trial of Capecitabine and Radiation Therapy With Pre and Post Combination Chemotherapy in Advanced Pancreatic Cancer|Terminated||N/A|||University of Michigan Cancer Center|||||f||||||||||||||2017-10-11 05:26:45.004281|2017-10-11 05:26:45.004281
NCT00176748|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-01-14|||July 2005||2005-07-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|August 2006|Actual|2006-08-01||Interventional|||Treatment for Patients With Metastatic Thyroid Cancer|Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer Who Are Refractory to or Not Suitable Candidates for 131I Treatment|Completed||Phase 2|3|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-10-11 05:26:45.080338|2017-10-11 05:26:45.080338
NCT00176761|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-06|||March 2000||2000-03-01|September 2006|2006-09-01|May 2006||2006-05-01|||||Interventional|||Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine|A Phase II Trial Assessing Autologous, Tumor-Pulsed Dendritic Cells as a Tumor Vaccine Administered With IL-2 in Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|27||University of Michigan Cancer Center|||||||||||||||||||2017-10-11 05:26:45.187405|2017-10-11 05:26:45.187405
NCT00176774|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-02-05|||February 2001||2001-02-01|February 2012|2012-02-01|April 2004|Actual|2004-04-01|February 2004|Actual|2004-02-01||Interventional|||Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma|A Pilot Trial of Irinotecan, 5-Fluorouracil, and Leucovorin Combined With the Anti-Angiogenesis Agent Tetrathiomolybdate in Metastatic Colorectal Carcinoma (UMCC 0075)|Completed||Phase 2|24|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-10-11 05:26:45.282596|2017-10-11 05:26:45.282596
NCT00176787|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-28|||October 2000||2000-10-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|May 2005|Actual|2005-05-01||Interventional|||Radiation Therapy With Capecitabine in Rectal Cancer|Phase II Trial of Preoperative Radiation Therapy With Capecitabine in Rectal Cancer (UMCC 0046)|Terminated||Phase 2|30||University of Michigan Cancer Center||||recruitment goals met|f||||||||||||||2017-10-11 05:26:45.372896|2017-10-11 05:26:45.372896
NCT00176800|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|2016-04-14||November 2001||2001-11-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|February 2006|Actual|2006-02-01||Interventional|||Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma|Pre-Operative Chemoradiation Followed by Post-Operative Tetrathiomolybdate (TM) in Patients With Loco-Regional Esophageal Carcinoma (UMCC 2001-007)|Completed||Phase 2|69|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-10-11 05:26:45.455708|2017-10-11 05:26:45.455708
NCT00176813|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-04-29|||March 2003||2003-03-01|April 2008|2008-04-01|November 2006|Actual|2006-11-01|November 2003|Actual|2003-11-01||Interventional|||Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer|Phase II Study of Gemcitabine, Cisplatin, and Celecoxib in the Treatment of Metastatic Pancreatic Cancer|Completed||Phase 2|5|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-10-11 05:26:45.718192|2017-10-11 05:26:45.718192
NCT00176826|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-04-22|2014-03-27||September 2000||2000-09-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|August 2012|Actual|2012-08-01||Interventional|||T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders|In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders|Unknown status|Active, not recruiting|Phase 2/Phase 3|22|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 05:26:45.814164|2017-10-11 05:26:45.814164
NCT00176839|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-17|2013-01-11||June 7, 2000|Actual|2000-06-07|February 2017|2017-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Stem Cell Transplantation for Hematological Malignancies|Busulfan, Cyclophosphamide, and Melphalan Followed by Allogeneic Hematopoietic Cell Transplantation in Patients With Hematological Malignancies|Terminated||Phase 2/Phase 3|11|Actual|Masonic Cancer Center, University of Minnesota||1||Replaced by a different study|f||||t||||||||||2017-10-11 05:26:46.27983|2017-10-11 05:26:46.27983
NCT00176852|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-10-03|2017-03-28||June 2002||2002-06-01|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|March 2014|Actual|2014-03-01||Interventional|||Stem Cell Transplant for Hemoglobinopathy|Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathy Using a Preparative Regimen to Achieve Stable Mixed Chimerism|Active, not recruiting||Phase 2/Phase 3|22|Actual|Masonic Cancer Center, University of Minnesota||3|||f||||t||||||||||2017-10-11 05:26:46.651778|2017-10-11 05:26:46.651778
NCT00176865|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-03|2015-05-06||August 2002||2002-08-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2012|Actual|2012-08-01||Interventional|||Stem Cell Transplant for Immunologic or Histiocytic Disorders|Allogeneic Hematopoietic Stem Cell Transplant for Patients With Immunologic or Histiocytic Disorders Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism|Completed||Phase 2|19|Actual|Masonic Cancer Center, University of Minnesota||3|||f||||t||||||||||2017-10-11 05:26:47.699592|2017-10-11 05:26:47.699592
NCT00176878|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-06|2009-06-18||June 2000||2000-06-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Stem Cell Transplant for Bone Marrow Failure Syndromes|Bone Marrow Transplantation for Non-Malignant Congenital Bone Marrow Failure Disorders|Completed||Phase 2/Phase 3|10|Actual|Masonic Cancer Center, University of Minnesota|Pharmacokinetic parameters in patients receiving 2 mg/kg/dose of busulfan twice daily was not performed. No data is available.|1|||f||||t||||||||||2017-10-11 05:26:48.546714|2017-10-11 05:26:48.546714
NCT00176904|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-06|2011-05-17||January 1995||1995-01-01|November 2012|2012-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Stem Cell Transplant for Inborn Errors of Metabolism|Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation|Completed||Phase 2/Phase 3|135|Actual|Masonic Cancer Center, University of Minnesota|Change in Neuropsychometric function data is not available. Data would have been noted as descriptive and patient specific, as well as disease specific; not table format. No formal analysis was intended.|1|||f||||f||||||||||2017-10-11 05:26:48.924269|2017-10-11 05:26:48.924269
NCT00176917|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-06|2009-07-28||May 1999||1999-05-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|May 2008|Actual|2008-05-01||Interventional|||Stem Cell Transplantation for Hurler|Hematopoietic Stem Cell Transplantation for Hurler Syndrome, Maroteaux Lamy Syndrome (MPS VI), and Alpha Mannosidase Deficiency (Mannosidosis)|Completed||Phase 2|41|Actual|Masonic Cancer Center, University of Minnesota|"Based on variability in age, diagnosis and condition of these patients, the data on enzyme levels and neuropsych testing is extremely difficult to report.
See Secondary Outcome Measures #3 and #4; no other adverse events were collected."|1|||f||||f||||||||||2017-10-11 05:26:49.167019|2017-10-11 05:26:49.167019
NCT00176930|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-10-04|||October 2001||2001-10-01|September 2017|2017-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stem Cell Transplant for Hematological Malignancy|Allogeneic Transplant for Hematological Malignancy|Recruiting||N/A|350|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 05:26:49.525702|2017-10-11 05:26:49.525702
NCT00176943|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-02-13|||October 2000||2000-10-01|February 2014|2014-02-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%|Phenotype and Cytokine Production Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Aldara 5% Cream Using Flow Cytometry|Completed||Phase 4|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-10-11 05:26:49.669479|2017-10-11 05:26:49.669479
NCT00176956|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-01|||November 2002||2002-11-01|February 2013|2013-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients|Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients|Terminated||Phase 3|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute||||IRB approval has lapsed.|f||||f||||||||||2017-10-11 05:26:49.757692|2017-10-11 05:26:49.757692
NCT00176969|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-30|||August 1997||1997-08-01|May 2014|2014-05-01|June 2000||2000-06-01|||||Interventional|||Response of Topical Capsaicin in Alopecia Areata|Perifollicular Nerves in Alopecia Areata: Response to Topical Capsaicin|Completed||Phase 4|24||University of Minnesota - Clinical and Translational Science Institute|||||f||||t||||||||||2017-10-11 05:26:49.826186|2017-10-11 05:26:49.826186
NCT00176982|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-08-12|||April 2002||2002-04-01|August 2009|2009-08-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Plaquenil for Alopecia Areata, Alopecia Totalis|Open Label Study of Hydroxychloroquine for Alopecia Areata, Alopecia Totalis|Completed||Phase 4|16||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 05:26:49.929298|2017-10-11 05:26:49.929298
NCT00176995|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-08|||March 1999||1999-03-01|November 2006|2006-11-01|October 2000||2000-10-01|||||Interventional|||Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae|Phase II, Open-Label Study of the Effect of 15% Eflornithine Hydrochloride Cream on Facial Hair of Men of African-American Descent With Pseudofolliculitis Barbae: A Laser Scanning Confocal Microscopy and Video Imaging Study|Completed||Phase 2|15||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 05:26:50.01157|2017-10-11 05:26:50.01157
NCT00177008|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-01-25|||March 2004||2004-03-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety|Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety|Completed||Phase 4|18||Rutgers, The State University of New Jersey|||||||||||||||||||2017-10-11 05:26:50.127508|2017-10-11 05:26:50.127508
NCT00177021|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-11-08|||October 2000||2000-10-01|November 2006|2006-11-01|August 2002||2002-08-01|||||Interventional|||Aldara for the Treatment of Extensive Alopecia Areata|Aldara for the Treatment of Extensive Alopecia Areata|Completed||Phase 4|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 05:26:50.243967|2017-10-11 05:26:50.243967
NCT00177034|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-07-09|||November 2004||2004-11-01|July 2012|2012-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Examination Of Vitiligo Skin Samples Before and After UVB Treatment|Characterization of Keratinocyte Populations From Normal, Perilesional and Lesional Skin in Vitiligo Patients by Laser Capture Microdissection and Gene Array Analysis Before and After Narrow Band UVB Treatment|Terminated||N/A|12||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 05:26:50.316082|2017-10-11 05:26:50.316082
NCT00177047|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-10-04|||April 20, 2004|Actual|2004-04-20|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Autologous Transplant for Multiple Myeloma|Autologous Transplantation for Multiple Myeloma|Recruiting||Phase 2/Phase 3|150|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 05:26:50.384491|2017-10-11 05:26:50.384491
NCT00177060|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-02-26|||October 2003||2003-10-01|February 2010|2010-02-01|May 2007|Actual|2007-05-01|||||Interventional|||Topical Hydromorphone for Wound Healing|Topical Hydromorphone for Wound Healing|Terminated||Phase 1/Phase 2|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||||No funding available.|f||||f||||||||||2017-10-11 05:26:50.509984|2017-10-11 05:26:50.509984
NCT00177086|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-15|||September 2005||2005-09-01|March 2013|2013-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi|Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi|Completed||Phase 3|76|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-10-11 05:26:50.599526|2017-10-11 05:26:50.599526
NCT00177099|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-08|||July 2003||2003-07-01|November 2006|2006-11-01|September 2004||2004-09-01|||||Interventional|||Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice|Neurotrophic Effects of Immunophilin Ligands on Human Hair Follicles Grafted Onto Service Combined Immunodeficient (SCID) Mice|Completed||Phase 1|35||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 05:26:50.696697|2017-10-11 05:26:50.696697
NCT00177112|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-01-31|||June 2005||2005-06-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy|Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy|Completed||Phase 3|275|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 05:26:50.768154|2017-10-11 05:26:50.768154
NCT00177125|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-03|||January 2004||2004-01-01|February 2012|2012-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP|Evaluating the Effect of the Vacuum Constriction Device on Erectile Function and Penile Length Post Radical Retropubic Prostatectomy|Completed||Phase 3|220||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-10-11 05:26:50.842639|2017-10-11 05:26:50.842639
NCT00177138|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-02-05|||July 2004||2004-07-01|February 2013|2013-02-01|November 2006|Actual|2006-11-01|||||Interventional|||Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation|Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation|Terminated||Phase 4|9|Actual|University of Minnesota - Clinical and Translational Science Institute||2||The clinical use of Campath for transplant patients was temporarily suspended.|f||||f||||||||||2017-10-11 05:26:50.90743|2017-10-11 05:26:50.90743
NCT00177164|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-03-17|2016-01-07||November 2003||2003-11-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Interventional||Two patients in the Risperidone LAI group were not included in the analysis as they did not receive any assessment after the baseline assessment|Risperdal Consta for Bipolar Disorder|A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study|Completed||Phase 3|50|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 05:26:51.03085|2017-10-11 05:26:51.03085
NCT00177177|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-01-15|||March 2004||2004-03-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||L-carnosine for Schizophrenia|L-Carnosine, an Antioxidant and AGE Inhibitor (Advanced Glycation End Products) for Cognitive Enhancement Among Persons With Schizophrenia: A Randomized, Add-on Double-Blind, Placebo Controlled, Clinical Trial|Completed||N/A|84|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 05:26:51.541943|2017-10-11 05:26:51.541943
NCT00177190|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-27|||June 2002||2002-06-01|June 2013|2013-06-01|January 2006|Actual|2006-01-01|January 2005|Actual|2005-01-01||Observational|||In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)|In Vitro Evaluation of Immune Responses in CTCL|Completed||N/A|8|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"     White cells   "|||2017-10-11 05:26:51.655262|2017-10-11 05:26:51.655262
NCT00177203|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-05-27|||June 2003||2003-06-01|May 2015|2015-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|AW3||Agewise Project 3: Brief Behavioral Treatment of Insomnia in Primary Care|Agewise Project 3: Brief Behavioral Treatment of Insomnia in Primary Care|Completed||N/A|140|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:26:51.741279|2017-10-11 05:26:51.741279
NCT00177216|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-02-29|2009-05-26||February 2002||2002-02-01|February 2016|2016-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Characteristics of Sleep Patterns in Young Adults With and Without Insomnia|Psychobiology and Treatment Response in Primary Insomnia|Completed||Phase 4|69|Actual|University of Pittsburgh||3|||f||||t||||||||Yes|To gain access to data, researchers must submit a description of their project to the Principal Investigator, including the investigator's personal identification and institutional affiliation, a current CV, qualifications, duration of the proposed research, source of funding, and a conflict of interest statement. The protocol must include study aims, background and significance, methods and types of analysis, and a description of the data requested. Once approved, the investigator must complete a University of Pittsburgh IRB exempt research application form and document completion of a responsible conduct of research program. Data will be prepared by an 'honest broker' from the data management staff of the project. This person will complete the honest broker certification form required by our IRB. Data will be provided as a SAS data set, and will not include information that could identify individual research participants or that the original consent form expressly forbade.|2017-10-11 05:26:51.832074|2017-10-11 05:26:51.832074
NCT00177229|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-02-15|||July 2001||2001-07-01|February 2008|2008-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||KidQuest Family-Based Weight Control|Family-Based Treatment of Severe Pediatric Obesity|Completed||N/A|192|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 05:26:52.282129|2017-10-11 05:26:52.282129
NCT00177242|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-15|||September 2004||2004-09-01|January 2016|2016-01-01|December 2006|Actual|2006-12-01|||||Interventional|||Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma|Phase II Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma|Completed||Phase 2|45||University of Pittsburgh|||||f||||t||||||||||2017-10-11 05:26:52.359498|2017-10-11 05:26:52.359498
NCT00177255|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-10|2016-01-10||April 2005||2005-04-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers|A Phase II Study of Weekly Docetaxel (Taxotere®) in Combination With Capecitabine (Xeloda) in Advanced Gastric and Gastro-Esophageal Adenocarcinomas.|Terminated||Phase 2|40|Actual|University of Pittsburgh||1||Roche has withdrawn support|f||||t||||||||||2017-10-11 05:26:52.454166|2017-10-11 05:26:52.454166
NCT00177268|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-09-23|||October 2004||2004-10-01|September 2016|2016-09-01|January 2024|Anticipated|2024-01-01|January 2023|Anticipated|2023-01-01||Observational|||Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research|Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research|Recruiting||N/A|200|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"     White blood cells and/or skin biopsy tissue are retained.   "|Undecided||2017-10-11 05:26:52.826905|2017-10-11 05:26:52.826905
NCT00177294|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-01-10|2010-12-22||April 2004||2004-04-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression|Geriatric Depression: Getting Better, Getting Well|Completed||Phase 4|319|Actual|University of Pittsburgh|The study design does not allow an inference about which specific intervention led to further improvement. Was it simply a dose increase of escitalopram from 10mg to 20mg? Is this intensive contact necessary for improvement?|2|||f||||t||||||||||2017-10-11 05:26:53.01239|2017-10-11 05:26:53.01239
NCT00177307|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-06-01|2016-01-12||January 2005||2005-01-01|June 2016|2016-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer|Phase II Study of the A-ICOX Regimen Consisting of Bevacizumab (Avastinâ), Intermittent Dose Capecitabine (Xelodaâ) and Oxaliplatin (Eloxatinâ) in Patients With Untreated Advanced Colorectal Cancer|Completed||Phase 2|40|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:26:53.278015|2017-10-11 05:26:53.278015
NCT00177320|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-21|||March 2005||2005-03-01|January 2016|2016-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||Rheumatic Diseases and Computer Use|Rheumatic Diseases and Computer Use: A Needs Assessment|Completed||N/A|359|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-10-11 05:26:53.877866|2017-10-11 05:26:53.877866
NCT00177333|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-28|||September 2005||2005-09-01|January 2016|2016-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens|Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens|Completed||Phase 4|40|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 05:26:53.965354|2017-10-11 05:26:53.965354
NCT00177346|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-05|||October 2003||2003-10-01|January 2016|2016-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection|A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection|Completed||N/A|52|Actual|University of Pittsburgh||2|||f||||||||||||||2017-10-11 05:26:54.056387|2017-10-11 05:26:54.056387
NCT00177359|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-12|||November 2005||2005-11-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Restoring Skill in Walking|Restoring Skill in Walking|Completed||Phase 2|48|Anticipated|University of Pittsburgh|||||f||||t||||||||||2017-10-11 05:26:54.161327|2017-10-11 05:26:54.161327
NCT00177372|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-28|||January 2005||2005-01-01|January 2016|2016-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|MIMID||Mifepristone and Misoprostol for Fetal Demise|Mifepristone and Misoprostol for the Treatment of Early Pregnancy Failure: a Pilot Clinical Trial|Completed||Phase 4|30|Actual|University of Pittsburgh||1|||f||||f||||||||No||2017-10-11 05:26:54.244005|2017-10-11 05:26:54.244005
NCT00177385|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-05-27|||June 2003||2003-06-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|June 2009|Actual|2009-06-01||Interventional|AgeWise||Aging Well, Sleeping Efficiently: Protecting Health In Later Life|AGEWISE Project 4: PROTECTING HEALTH IN LATER LIFE|Completed||N/A|66||University of Pittsburgh|||||f||||t||||||||||2017-10-11 05:26:54.347684|2017-10-11 05:26:54.347684
NCT00177398|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-13|||February 2005||2005-02-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings|The Effect of Insulin Glargine on Glycemic Control, Morbidity, and Length of Stay in Hospitalized Subjects With Diabetes Receiving Enteral Nutrition|Completed||Phase 4|50||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:54.433121|2017-10-11 05:26:54.433121
NCT00177411|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-09-03|||July 2005||2005-07-01|September 2014|2014-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||"PTHrP(1-36) IV Dose Escalation Study"|"Determining the Maximum Tolerable Dose and Pharmacokinetic Parameters of Intravenous PTHrP(1-36)"|Withdrawn||Phase 1|0|Actual|University of Pittsburgh||1||Protocol design was changed so it no longer fit the description of this study.|f||||t||||||||||2017-10-11 05:26:54.563168|2017-10-11 05:26:54.563168
NCT00177424|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-06-26|||July 2004||2004-07-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes|Intervention to Prevent Post-Stroke Major Depression.|Terminated||Phase 4|154|Anticipated|University of Pittsburgh||2||Recruitment goals could not be met.|f||||||||||||||2017-10-11 05:26:54.674785|2017-10-11 05:26:54.674785
NCT00177437|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-12|||June 1999||1999-06-01|December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Home Screening for Chlamydia Surveillance|Home Screening for Chlamydia Surveillance|Completed||Phase 3|403||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:54.773419|2017-10-11 05:26:54.773419
NCT00177463|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-07|||September 2004||2004-09-01|January 2016|2016-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||L-Carnosine for Bipolar I Disorder|A Pilot Add-on Randomized, Placebo Controlled Intervention Trial of Cognitive Enhancement in Persons With Bipolar Disorder Using an Antioxidant and Advanced Glycation End (AGE) Product Inhibitor: L-Carnosine|Completed||N/A|47|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 05:26:54.850301|2017-10-11 05:26:54.850301
NCT00177476|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2003||2003-09-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Interventional|||Enhancing Exercise Participation in Overweight Adults|Enhancing Exercise Participation in Overweight Adults|Completed||Phase 1/Phase 2|225||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:54.955784|2017-10-11 05:26:54.955784
NCT00177489|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-04|||June 2002||2002-06-01|January 2016|2016-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|REACH||Coordinating Center for Caregiver Intervention Trial|Coordinating Center for Multisite Intervention Trial for Diverse Caregivers|Completed||N/A|613|Actual|University of Pittsburgh||2|||f||||t||||||||Yes|There is no plan to make individual participant data available.|2017-10-11 05:26:55.077308|2017-10-11 05:26:55.077308
NCT00177502|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2003||2003-01-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Effect of Exercise on Prevention of Weight Gain|Effect of Exercise on Prevention of Weight Gain|Completed||Phase 1/Phase 2|294||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:55.230492|2017-10-11 05:26:55.230492
NCT00177515|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-04|||March 2005||2005-03-01|May 2010|2010-05-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Computer-assisted Preventive Health Education for Women of Reproductive Age in Urgent Care Settings|Preventive Health Education for Women of Reproductive Age|Completed||Phase 3|446|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 05:26:55.300063|2017-10-11 05:26:55.300063
NCT00177528|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-08|||October 2000||2000-10-01|October 2008|2008-10-01||||November 2004|Actual|2004-11-01||Interventional|||Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression|Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression|Completed||Phase 4|70||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:55.396049|2017-10-11 05:26:55.396049
NCT00177541|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-04|||February 2004||2004-02-01|August 2017|2017-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Further Enhancing Non-pharmacologic Therapy for Incontinence|Further Enhancing Non-pharmacologic Therapy for Incontinence|Completed||N/A|123|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:26:55.511829|2017-10-11 05:26:55.511829
NCT00177554|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-05-27|||November 2003||2003-11-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma|Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma|Completed||Phase 2|60|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:26:55.6502|2017-10-11 05:26:55.6502
NCT00177567|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||July 2001||2001-07-01|September 2005|2005-09-01|January 2004||2004-01-01|||||Interventional|||Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study|Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study|Completed||Phase 4|60||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:55.7461|2017-10-11 05:26:55.7461
NCT00177580|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-01-08|||July 2003||2003-07-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|January 2007|Actual|2007-01-01||Interventional|||Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin|A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Adjunctive Treatment With Pravastatin in Partially Remitted Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|72|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:55.85389|2017-10-11 05:26:55.85389
NCT00177593|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2005||2005-06-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||The Effect of HealthWear on Short-Term Weight Loss|The Effect of HealthWear on Short-Term Weight Loss|Completed||Phase 1/Phase 2|75||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:55.949927|2017-10-11 05:26:55.949927
NCT00177606|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-05-26|||July 2003||2003-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|||||Observational|||Donors After Cardiac Death: Validating Identification Criteria|Donors After Cardiac Death: Validating Identification Criteria|Completed||N/A|600||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:56.053181|2017-10-11 05:26:56.053181
NCT00177619|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-02-10|||May 2002||2002-05-01|February 2014|2014-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)|Prevention of Osteoporosis in Men With Prostate Cancer|Completed||Phase 3|120||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:56.140522|2017-10-11 05:26:56.140522
NCT00177632|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||July 2003||2003-07-01|September 2005|2005-09-01|July 2004||2004-07-01|||||Interventional|||Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.|Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.|Completed||Phase 1/Phase 2|66||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:56.224095|2017-10-11 05:26:56.224095
NCT00177645|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-02-12|||March 2002||2002-03-01|January 2016|2016-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Inhaled Bicarbonate Therapy in Cystic Fibrosis|Inhaled Bicarbonate Therapy in Cystic Fibrosis|Completed||Phase 1|16|Actual|University of Pittsburgh||1|||f||||f||||||||No||2017-10-11 05:26:56.292587|2017-10-11 05:26:56.292587
NCT00177658|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-23|||March 2006|Actual|2006-03-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||NCCLS Interpretive Criteria for Salmonella|NCCLS Interpretive Criteria for Salmonella|Completed||N/A|50|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 05:26:56.371976|2017-10-11 05:26:56.371976
NCT00177671|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-31|2011-02-18||December 2003||2003-12-01|January 2013|2013-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Antidepressant Medication Plus Donepezil for Treating Late-life Depression|Maintenance Therapies in Late-Life Depression: MTLD III|Completed||Phase 4|220|Actual|University of Pittsburgh|Observations about dementia conversion rates were obtained from post hoc subgroup analyses of participants with mild cognitive impairment (N=57) and participants with normal cognition at time of randomization (N=63).|2|||f||||t||||||||||2017-10-11 05:26:56.449145|2017-10-11 05:26:56.449145
NCT00177684|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-16|||September 2004||2004-09-01|December 2008|2008-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)|Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)|Completed||Phase 3|48||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:56.882791|2017-10-11 05:26:56.882791
NCT00177697|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 1999||1999-09-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Interventional|||A Mentor-Based Approach to Long-Term Weight Loss|A Mentor-Based Approach to Long-Term Weight Loss|Completed||Phase 1/Phase 2|174||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:56.952564|2017-10-11 05:26:56.952564
NCT00177710|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-16|||January 2006||2006-01-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study|Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study|Completed||Phase 3|48|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:57.016919|2017-10-11 05:26:57.016919
NCT00177723|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-16|||August 2005||2005-08-01|December 2008|2008-12-01|February 2007|Actual|2007-02-01|||||Observational|||Towards Reducing Resistance and Hematological Toxicity of Linezolid|Towards Reducing Resistance and Hematological Toxicity of Linezolid|Completed||Phase 4|50||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:57.082526|2017-10-11 05:26:57.082526
NCT00177736|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-11|||September 2005||2005-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Observational|||Pharmacodynamic Parameters of Two Different Doses of Cefepime|Pharmacodynamic Parameters of Two Different Doses of Cefepime|Completed||Phase 4|180|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:57.144689|2017-10-11 05:26:57.144689
NCT00177749|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-16|||August 2004||2004-08-01|December 2008|2008-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095|Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095|Terminated||Phase 4|10||University of Pittsburgh||||Study is complete Analysis is complete|||||||||||||||2017-10-11 05:26:57.209757|2017-10-11 05:26:57.209757
NCT00177775|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-16|||April 2005||2005-04-01|December 2008|2008-12-01|August 2005||2005-08-01|||||Interventional|||Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea|Whey Protein Concentrate 40% (WPC-40) Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea: A Prospective, Randomized, Controlled Phase II Study - Version 5.1.B|Terminated||Phase 2/Phase 3|60||University of Pittsburgh||||Study is completed and analysis completed|f||||||||||||||2017-10-11 05:26:57.349494|2017-10-11 05:26:57.349494
NCT00177788|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-14|||September 2005||2005-09-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Voriconazole as Prophylaxis for Liver Transplant Recipients|Voriconazole as Prophylaxis for Liver Transplant Recipients|Completed||N/A|800|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 05:26:57.409041|2017-10-11 05:26:57.409041
NCT00177801|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-14|||May 2006||2006-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Organ Transplant Infection Prevention and Detection Project|"Organ Transplant Infection Prevention and Detection Project 1.0; Cohort Study of Transplant Recipients at Ultra-High Risk for Invasive Fungal Infections"|Completed||Phase 4|200|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"     No genetic testing will be performed on any of the samples being obtained. The biologic     samples will be under the control of the principal investigator of this research project. To     protect confidentiality, all personal identifiers (i.e., name, social security number, and     birth date) will be removed (de-identified) and replaced with a specific code number. The     information linking these code numbers to the corresponding subjects' identities will be kept     in a separate, secure location. The investigators on this study will keep the samples     indefinitely. The biologic samples may be given to the Centers for Disease Control and     Prevention. If a subject withdraws and provides the request in writing, samples collected and     not already processed will be destroyed. All samples will be kept in the investigator's     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.   "|||2017-10-11 05:26:57.481151|2017-10-11 05:26:57.481151
NCT00177814|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-23|||September 2005|Actual|2005-09-01|June 2017|2017-06-01|June 2017|Actual|2017-06-01|June 2017|Actual|2017-06-01||Observational|||Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit|Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit|Completed||N/A|1000|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 05:26:57.541836|2017-10-11 05:26:57.541836
NCT00177827|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-12-02|||March 2004||2004-03-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|||||Observational|||Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients|Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients: Pharmacokinetics and Correlation Between Plasma and Lung Concentrations With Toxicity/Efficacy|Completed||Phase 4|104||University of Pittsburgh|||1||f||||t||||||||||2017-10-11 05:26:57.623482|2017-10-11 05:26:57.623482
NCT00177840|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-03-27|||September 2005||2005-09-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients|Acupuncture for Cancer-Related Fatigue in Breast Cancer Patients|Completed||Phase 1|54|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 05:26:57.687779|2017-10-11 05:26:57.687779
NCT00177853|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-07-01|||December 2006||2006-12-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|December 2006|Actual|2006-12-01||Interventional|||Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer|A Phase I Study of Celecoxib, Irinotecan and Concurrent Radiotherapy in the Preoperative Treatment of Pancreatic Cancer|Terminated||Phase 1|23|Anticipated|University of Pittsburgh||1||terminated|f||||t||||||||||2017-10-11 05:26:57.768851|2017-10-11 05:26:57.768851
NCT00177866|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-07-28|2016-06-15||December 2003||2003-12-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||No results or publication, data destroyed due to age of study.|Safety of Celecoxib in Patients With Crohn's Disease|The Safety of Celecoxib (Celebrex) in Patients With Crohn's Disease|Terminated||Phase 4|28|Actual|University of Pittsburgh||2||We were unable to get additional funding to complete study.|f||||t||||||||||2017-10-11 05:26:57.862953|2017-10-11 05:26:57.862953
NCT00177879|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-06|||August 2005||2005-08-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Usability of a Website for People With Schizophrenia|Schizophrenia Website Usability|Withdrawn||N/A|0|Actual|National Institute of Mental Health (NIMH)||||Funding was never granted for this study. No participants were ever enrolled.|f||||||||||||||2017-10-11 05:26:58.031731|2017-10-11 05:26:58.031731
NCT00177892|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-28|||September 2003||2003-09-01|February 2008|2008-02-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress|OSA and Metabolic Syndrome: Role of Oxidative Stress|Unknown status|Recruiting|N/A|76|Anticipated|National Institute on Aging (NIA)||5|||f||||t||||||||||2017-10-11 05:26:58.11639|2017-10-11 05:26:58.11639
NCT00177918|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-08|||August 2006||2006-08-01|June 2017|2017-06-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||Prospective Evaluations of Infectious Complication in Lung Transplant Recipients|Prospective Evaluations of Infectious Complications in Lung Transplant Recipients|Recruiting||N/A|600|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"     All biologic samples will be under the control of the principal investigator of this research     project. To protect confidentiality, all personal identifiers will be removed and replaced     with a specific code number. The information linking these code numbers to the corresponding     subjects' identities will be kept in a separate, secure location. The investigators on this     study will keep the samples indefinitely. All samples that are provided to outside facilities     will be sent with a code number. Samples may be sent to other investigators not associated     with this study to perform diagnostic testing (e.g., viral, fungal, bacterial and     immunological). All samples will be provided to investigators not associated with the study     without any identifiers and only contain a code number. If a subject withdraws and provides     the request in writing, samples collected and not already processed will be destroyed.   "|||2017-10-11 05:26:58.249373|2017-10-11 05:26:58.249373
NCT00178139|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-26|||April 2004||2004-04-01|August 2015|2015-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Music Therapy for Patients Being Weaned From Mechanical Ventilation|Music Therapy as an Adjunctive Treatment in the Management of Stress for Patients Being Weaned From Mechanical Ventilation|Completed||Phase 1|77|Actual|University of Rochester||1|||f||||f||||||||||2017-10-11 05:27:00.680797|2017-10-11 05:27:00.680797
NCT00177931|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-16|||March 2005||2005-03-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit|Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit|Completed||N/A|25|Actual|University of Pittsburgh|||1||f||||||||||Samples Without DNA|"     All biologic samples will be under the control of the principal investigator of this research     project. To protect confidentiality, all personal identifiers will be removed and replaced     with a specific code number. The information linking these code numbers to the corresponding     subjects' identities will be kept in a separate, secure location. The investigators on this     study will keep the samples indefinitely. All samples will be provided to investigators not     associated with the study without any identifiers and only contain a code number. If a     subject withdraws samples collected and not already processed will be destroyed.   "|||2017-10-11 05:26:58.535184|2017-10-11 05:26:58.535184
NCT00177944|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-15|||August 2005||2005-08-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Invasive Fungal Infections Surveillance Initiative|Invasive Fungal Infections Surveillance Initiative|Completed||N/A|172|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 05:26:58.625303|2017-10-11 05:26:58.625303
NCT00177957|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-08|||April 2005||2005-04-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Gram Negative Bacteremia, Risk Factors for Failure of Therapy|Gram Negative Bacteremia, Risk Factors for Failure of Therapy|Completed||N/A|600|Anticipated|University of Pittsburgh|||1||f||||t|f|f||||||No|not sharing|2017-10-11 05:26:58.735292|2017-10-11 05:26:58.735292
NCT00177970|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-14|2016-06-15||October 2003||2003-10-01|September 2016|2016-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||No results available record destroyed due to age of study. no publications|IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff|Intravenous Immunoglobulin G Versus Placebo for the Treatment of Patients With Severe Clostridium Difficile-Associated Diarrhea and Colitis|Terminated||Phase 4|14|Actual|University of Pittsburgh||2||We were unable to receive IVIG free from phamaceutical company.|f||||t||||||||No|records not available|2017-10-11 05:26:58.830242|2017-10-11 05:26:58.830242
NCT00177983|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-06-26|||January 2003||2003-01-01|June 2014|2014-06-01|January 2005||2005-01-01|||||Interventional|||Web-based Support for People With Schizophrenia and Their Families|Support to Patients and Families|Completed||N/A|80||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:59.179449|2017-10-11 05:26:59.179449
NCT00177996|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-14|||October 2001||2001-10-01|January 2016|2016-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Pharmacotherapy in Depression With Panic Spectrum|Pharmacotherapy in Depression With Panic Spectrum|Completed||Phase 4|30|Actual|University of Pittsburgh||2|||f||||f||||||||Undecided||2017-10-11 05:26:59.259601|2017-10-11 05:26:59.259601
NCT00178009|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-18|||January 2006||2006-01-01|February 2011|2011-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Developing and Assessing Competencies for Caregivers and Patients With Ventricular Assist Devices|Developing and Assessing Competencies for Patients, Caregivers and Health Professionals for the Care of Patients Implanted With Ventricular Assist Devices|Completed||N/A|8|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-10-11 05:26:59.365658|2017-10-11 05:26:59.365658
NCT00178022|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-05-27|||February 2005||2005-02-01|May 2008|2008-05-01|September 2006|Actual|2006-09-01|||||Interventional|||A Trial of Two On-Line Interventions for Child Brain Injury|A Trial of Two On-Line Interventions for Child Brain Injury|Completed||N/A|120||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:59.447644|2017-10-11 05:26:59.447644
NCT00178035|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-31|||December 1999||1999-12-01|July 2013|2013-07-01|August 2003||2003-08-01|||||Interventional|||Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals|Geriatric Depression: Neurobiology of Treatment|Completed||Phase 4|158||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:59.527662|2017-10-11 05:26:59.527662
NCT00178048|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 1998||1998-09-01|September 2005|2005-09-01|December 2003||2003-12-01|||||Interventional|||Paroxetine in the Treatment of Chronic Primary Insomnia|Paroxetine in the Treatment of Chronic Primary Insomnia: A Double-Blind, Randomized, Placebo-Controlled Study of Efficacy Over Six Weeks|Completed||Phase 4|66||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:59.629596|2017-10-11 05:26:59.629596
NCT00178061|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-21|||August 1997||1997-08-01|June 2013|2013-06-01|August 2002||2002-08-01|||||Interventional|||Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder|Treatment of Primary Mood Disorders in the Comorbidly Ill|Completed||Phase 4|13||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:59.740668|2017-10-11 05:26:59.740668
NCT00178074|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-31|||February 1999||1999-02-01|July 2013|2013-07-01|April 2003||2003-04-01|||||Interventional|||The Effects of Sleep Deprivation on Antidepressant Response|The Effects of Sleep Deprivation on Antidepressant Response in Geriatric Depression: Neurometabolic Substrates Studied With PET|Completed||Phase 4|80||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:26:59.841166|2017-10-11 05:26:59.841166
NCT00178087|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-06|||August 2005||2005-08-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression|Pathways Linking Late-Life Depression to MCI & Dementia|Completed||N/A|331|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 05:26:59.937419|2017-10-11 05:26:59.937419
NCT00178100|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-31|||March 1999||1999-03-01|July 2013|2013-07-01|August 2005||2005-08-01|||||Interventional|||Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression|Maintenance Therapies in Late-Life Depression 2 (MTLD-2)|Completed||Phase 4|225||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:27:00.051119|2017-10-11 05:27:00.051119
NCT00178113|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-26|||July 2003||2003-07-01|May 2015|2015-05-01|July 2004||2004-07-01|||||Interventional|||A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia|Phase I Clinical Trial: Randomized Lycopene Supplementation in Tobago Men With High-Grade Prostatic-Intraepithelial Neoplasia|Completed||Phase 1|80||University of Pittsburgh|||||||||||||||||||2017-10-11 05:27:00.151198|2017-10-11 05:27:00.151198
NCT00178126|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-28|2016-10-11||March 2004||2004-03-01|April 2017|2017-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||An RCT on Preventing Pressure Ulcers With Wheelchair Seat Cushions|An RCT on Preventing Pressure Ulcers With Seat Cushions|Completed||N/A|232|Actual|University of Pittsburgh||2|||f||||f||||||||No||2017-10-11 05:27:00.257293|2017-10-11 05:27:00.257293
NCT00178152|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-11|||May 2005||2005-05-01|May 2011|2011-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Erythema Toxicum Neonatorum in Newborns and the Development of Asthma|The Implication of Erythema Toxicum Neonatorum in Newborns on the Development of Future Asthma|Completed||N/A|334|Actual|University of Rochester|||1||f||||||||||||||2017-10-11 05:27:00.780722|2017-10-11 05:27:00.780722
NCT00178165|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 1996||1996-09-01|September 2005|2005-09-01|November 2001||2001-11-01|||||Interventional|||Coordinating Center for Enhancing ADRD Caregiving|Coordinating Center for Enhancing Alzheimer Disease and Related Disorder Caregiving|Completed||N/A|1200||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:27:00.876829|2017-10-11 05:27:00.876829
NCT00178178|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-27|2015-04-09||March 2005||2005-03-01|August 2015|2015-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Arthroscopic Anterior Cruciate Ligament Reconstruction: A Comparison of Three Catheter Placement Positions|A Placebo Controlled, Prospective, Randomized Clinical Investigation of the Efficacy of Continuous Infusion Regional Anesthetic on Postoperative Pain Following Arthroscopic Anterior Cruciate Ligament Reconstruction: A Comparison of Three Catheter Placement Positions|Completed||N/A|96|Actual|University of Rochester||4|||f||||f||||||||||2017-10-11 05:27:01.05077|2017-10-11 05:27:01.05077
NCT00178191|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-27|2009-06-12||June 2005||2005-06-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Randomized Trial for Botox Urinary Incontinence|A Randomized Trial of Botox for Severe Urge Incontinence|Completed||N/A|28|Actual|University of Rochester|Please see published manuscripts for additional details|3|||f||||t||||||||||2017-10-11 05:27:01.737206|2017-10-11 05:27:01.737206
NCT00178204|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-12-03|||November 2004||2004-11-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|May 2009|Actual|2009-05-01||Observational|||Sleep Architecture and Chemotherapy-Related Fatigue|Sleep Architecture and Chemotherapy-Related Fatigue|Completed||N/A|26|Actual|University of Rochester|||1||f||||f||||||||||2017-10-11 05:27:02.151805|2017-10-11 05:27:02.151805
NCT00178217|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-22|||July 2002||2002-07-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Interventional|||Music Therapy During Botulinum Injections|Music Therapy as Procedural Support During Botulinum Injections for Pediatric Patients|Completed||Phase 1/Phase 2|101|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 05:27:02.231662|2017-10-11 05:27:02.231662
NCT00178230|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-06-09|||March 15, 1996|Actual|1996-03-15|June 2017|2017-06-01|November 25, 2013|Actual|2013-11-25|November 25, 2013|Actual|2013-11-25||Observational|||Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity|Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity in Thoracic Malignancies|Completed||N/A|82|Actual|University of Rochester|||1||f|||||f|f||||||||2017-10-11 05:27:02.312395|2017-10-11 05:27:02.312395
NCT00170508|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-08-22|||June 2005||2005-06-01|July 2011|2011-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Young Adult Influenza Vaccine Immunogenicity Substudy|In Depth Immunologic Studies in Healthy Young Adults Who Receive The Standard Dose Fluzone® (15mcgHA/Virus Strain) Trivalent Inactivated Influenza Virus Vaccine|Completed||N/A|15|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-10-11 05:27:02.368664|2017-10-11 05:27:02.368664
NCT00170521|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-26|||August 2006||2006-08-01|December 2006|2006-12-01|August 2008||2008-08-01|||||Observational|||Mol Epi GrAS in Nicaragua|The Molecular Epidemiology of Streptococcus Pyogenes Among Children in Leon, Nicaragua|Terminated||N/A|13000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:27:02.435227|2017-10-11 05:27:02.435227
NCT00170534|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-26|||October 2004||2004-10-01|April 2009|2009-04-01|April 2007||2007-04-01|||||Interventional|||Intervention for Male STDs in India|An Intervention for Male STD Patients in India|Terminated||N/A|1892||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:27:02.486484|2017-10-11 05:27:02.486484
NCT00170547|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-12-04|||September 2005||2005-09-01|July 2006|2006-07-01|February 2006||2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Comparison of Delivery Routes of Flu Vaccine in Adults|Immunogenicity and Safety of a Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route Compared to an Intramuscular Vaccination With Fluzone(R) in Healthy Adults|Completed||Phase 2|1597|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 05:27:02.54324|2017-10-11 05:27:02.54324
NCT00170560|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-08-26|||October 2001||2001-10-01|October 2007|2007-10-01|February 2007||2007-02-01|||||Observational|||Impact of Gender on Patients|Impact of Gender on Infected Hospitalized Patients|Unknown status|Recruiting|N/A|570||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:27:02.690346|2017-10-11 05:27:02.690346
NCT00170586|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-08-26|||September 2003||2003-09-01|March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||Novel Protective Underglove|Novel Protective Underglove|Completed||Phase 2|325||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:27:02.820579|2017-10-11 05:27:02.820579
NCT00170612|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-20|||November 2005||2005-11-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|January 2008|Actual|2008-01-01||Interventional|||Pneumococcal Vaccination of Fiji Infants|A Single-Blind Open-Label Randomized Phase II Study of the Safety, Immunogenicity and Impact on Pneumococcus (Pnc) Carriage of the Pnc Vaccination Regimens Combining 1, 2, or 3 Doses of 7-Valent Pneumococcal Conjugate Vaccine (PCV) in the First 4 Months of Life Followed by a Single Dose of 23-Valent Pneumococcal Polysaccharide Vaccine (PPS) at 12 Months of Age|Completed||Phase 2|552|Actual|University of Melbourne||8|||f||||t||||||||||2017-10-11 05:27:02.88768|2017-10-11 05:27:02.88768
NCT00170625|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-12-13|2016-10-04||June 2004||2004-06-01|December 2016|2016-12-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer|Multicenter, Prospective Phase-I/II-study: Topotecan and Carboplatin in the Therapy of Patients With Relapsed Ovarian Cancer|Completed||Phase 1/Phase 2|28|Actual|North Eastern Germany Society of Gynaecologic Oncology||1|||f||||f||||||||No||2017-10-11 05:27:02.993178|2017-10-11 05:27:02.993178
NCT00170638|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-04-24|||April 2005||2005-04-01|January 2008|2008-01-01|April 2010||2010-04-01|||||Observational|||Tuberculosis Immunity in Children|Tuberculosis Immunity in Children|Completed||N/A|260||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:27:03.185682|2017-10-11 05:27:03.185682
NCT00170677|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-13|||September 2005||2005-09-01|July 2010|2010-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer|Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer|Completed||Phase 2|194|Actual|North Eastern Germany Society of Gynaecologic Oncology||2|||f||||f||||||||||2017-10-11 05:27:03.308547|2017-10-11 05:27:03.308547
NCT00170690|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-31|||August 2004||2004-08-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Preference Study With Elderly Patients Recurrent Ovarian Cancer|Präferenz-Studie Bei älteren Patientinnen Mit Ovarialkarzinomrezidiv: Treosulfan Oral vs. intravenös|Completed||Phase 3|123|Actual|North Eastern Germany Society of Gynaecologic Oncology||2|||f||||f||||||||||2017-10-11 05:27:03.395688|2017-10-11 05:27:03.395688
NCT00170703|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-19|||December 2004||2004-12-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.|Assessment of the Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Speech-Language Rehabilitation to Enhance Recovery in Patients Suffering From Broca's Aphasia, Following a Stroke.|Completed||Phase 1|8||Northstar Neuroscience|||||f||||f||||||||||2017-10-11 05:27:05.131515|2017-10-11 05:27:05.131515
NCT00170716|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-18|||September 2004||2004-09-01|December 2007|2007-12-01|March 2008|Anticipated|2008-03-01|||||Interventional|EVEREST||Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis|Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Rehabilitation Activities to Enhance Motor Recovery in Patients Suffering From Upper Extremity Hemiparesis Following a Stroke|Unknown status|Active, not recruiting|Phase 3|174|Anticipated|Northstar Neuroscience||2|||f||||t||||||||||2017-10-11 05:27:05.270561|2017-10-11 05:27:05.270561
NCT00170729|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-28|||August 17, 2004|Actual|2004-08-17|February 2017|2017-02-01|February 28, 2005|Actual|2005-02-28|February 28, 2005|Actual|2005-02-28||Interventional|||A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery|Multi-center, Randomized, Double Masked, Vehicle Controlled Phase IV Study to Compare the Efficacy, Ocular Safety and Tolerability of a Two Day Treatment With Eye Drops (0.5% Prednisolone Acetate, One Drop Four Times Per Day) in Patients With Intraocular Inflammation After Cataract Surgery, Followed by an Open Label Observational Period of 12 Days|Completed||Phase 4|62|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:05.42377|2017-10-11 05:27:05.42377
NCT00170742|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-08-08|||December 2003||2003-12-01|August 2008|2008-08-01||||May 2006|Actual|2006-05-01||Interventional|||Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.|A Randomized, Open Label, Controlled Study on the Efficacy and Safety of Octreotide i.m. in Patients With Proliferative Diabetic Retinopathy (PDR) After Start of Laser Coagulation|Terminated||Phase 3|17||Novartis||||trial stopped on Sept 24, 2007|f||||||||||||||2017-10-11 05:27:05.508965|2017-10-11 05:27:05.508965
NCT00170755|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-01-15|||April 2002||2002-04-01|January 2008|2008-01-01|January 2005|Actual|2005-01-01|||||Interventional|||A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder|A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder|Completed||Phase 3|718|Actual|Novartis||1|||||||||||||||||2017-10-11 05:27:05.585215|2017-10-11 05:27:05.585215
NCT00170768|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-01-18|||February 2005||2005-02-01|January 2008|2008-01-01|May 2005|Actual|2005-05-01|||||Interventional|||Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over|Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over|Completed||Phase 2|150|Actual|Novartis||3|||||||||||||||||2017-10-11 05:27:05.669069|2017-10-11 05:27:05.669069
NCT00170781|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-11-29|||June 2005||2005-06-01|June 2006|2006-06-01||||||||Interventional|||Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout|A 1-Week, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel Trial Comparing Lumiracoxib (400 mg Once Daily) in Patients With Acute Flares of Gout, Using Indomethacin (50 mg Three Times a Day)|Completed||Phase 4|234||Novartis|||||f||||||||||||||2017-10-11 05:27:05.762665|2017-10-11 05:27:05.762665
NCT00170794|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-11-16|||September 2004||2004-09-01|November 2016|2016-11-01||||July 2006|Actual|2006-07-01||Interventional|||Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.|A One Year, Multicenter, Open-Label, Single Arm, Pilot Study of the Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-10-11 05:27:05.855967|2017-10-11 05:27:05.855967
NCT00170820|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-23|||February 2005||2005-02-01|February 2017|2017-02-01||||March 2006|Actual|2006-03-01||Interventional|||Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen|A Single Arm, Prospective, Open-label, Pilot Study to Assess Effects of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen|Completed||Phase 4|20||Novartis|||||f||||||||||||||2017-10-11 05:27:05.938855|2017-10-11 05:27:05.938855
NCT00170833|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-11-01|||November 2003||2003-11-01|November 2011|2011-11-01||||November 2005|Actual|2005-11-01||Interventional|||Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients|A Prospective, Multicenter, Open Label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus (RAD001) With Basiliximab, Corticosteroids and Lower Levels Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Recipients|Completed||Phase 3|80||Novartis|||||||||||||||||||2017-10-11 05:27:06.038971|2017-10-11 05:27:06.038971
NCT00170846|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-01-15|2010-12-17||February 2005||2005-02-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients|Assessment of Everolimus in Addition to Calcineurin Inhibitors Reduction in Maintenance Renal Transplant Recipients|Completed||Phase 4|394|Actual|Novartis||3|||f||||t||||||||||2017-10-11 05:27:06.318188|2017-10-11 05:27:06.318188
NCT00171184|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-16|||April 2005||2005-04-01|May 2017|2017-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder|Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder|Completed||Phase 4|400|Actual|Novartis||2|||||||||||||||||2017-10-11 05:27:15.952352|2017-10-11 05:27:15.952352
NCT00170859|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-11-16|||August 2004||2004-08-01|November 2016|2016-11-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients|A One-year Multicenter, Randomized, Open-label Study of the Safety and Efficacy of Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-10-11 05:27:08.342346|2017-10-11 05:27:08.342346
NCT00170872|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-05-18|||November 2004||2004-11-01|May 2012|2012-05-01||||July 2005|Actual|2005-07-01||Interventional|||6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis|A 6 Week, Multicenter, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of Lumiracoxib 200mg o.d. in Patients With Primary Knee Osteoarthritis or Rheumatoid Arthritis|Completed||Phase 3|135||Novartis|||||f||||||||||||||2017-10-11 05:27:08.414491|2017-10-11 05:27:08.414491
NCT00170885|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-11-15|||May 2005||2005-05-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients|Multicenter, Randomized, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of Two Regimens of Everolimus Plus Cyclosporine Microemulsion, Given According to Different Blood Target Levels, in de Novo Renal Transplant Recipients|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-10-11 05:27:08.648499|2017-10-11 05:27:08.648499
NCT00170898|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-10-12|||November 2004||2004-11-01|June 2006|2006-06-01||||||||Interventional|||Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain|A 7-Day Multicenter Randomized Double-Blind, Double-Dummy Parallel Group Trial to Assess the Safety and Efficacy of 400 mg Lumiracoxib Once Daily Versus 500 mg Naproxen Twice Daily in Patients With Acute Musculoskeletal Pain Due to Uncomplicated Soft Tissue Injury|Completed||Phase 4|419||Novartis|||||f||||||||||||||2017-10-11 05:27:08.732215|2017-10-11 05:27:08.732215
NCT00170911|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-11-01|||March 2005||2005-03-01|November 2011|2011-11-01||||December 2005|Actual|2005-12-01||Interventional|||Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.|Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.|Completed||Phase 2|160||Novartis|||||f||||||||||||||2017-10-11 05:27:08.80217|2017-10-11 05:27:08.80217
NCT00170924|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-11-07|||August 2004||2004-08-01|November 2011|2011-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.|A Multi-center, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Effect of the Angiotensin II Antagonist Valsartan on Diastolic Function in Patients With Hypertension and Diastolic Dysfunction|Completed||Phase 4|317|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:08.866111|2017-10-11 05:27:08.866111
NCT00170937|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2016-11-16|||November 2004||2004-11-01|November 2016|2016-11-01||||March 2006|Actual|2006-03-01||Interventional|||A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome|A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan and Hydrochlorothiazide Combined and Alone, in Patients With Metabolic Syndrome|Completed||Phase 4|507||Novartis|||||f||||||||||||||2017-10-11 05:27:08.950979|2017-10-11 05:27:08.950979
NCT00170950|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-04-19|2011-01-13||October 2003||2003-10-01|April 2011|2011-04-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|ACCOMPLISH||Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension|A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients With High Risk Hypertension|Terminated||Phase 3|11506|Actual|Novartis|Study was stopped early, as recommended by the Data Monitoring Committee, due to positive efficacy results.|2||"The study was terminated early because of significant efficacy results for the primary endpoint   in favor of benazepril/amlodipine treatment."|f||||||||||||||2017-10-11 05:27:09.121705|2017-10-11 05:27:09.121705
NCT00170963|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-05-15|||October 2004||2004-10-01|May 2017|2017-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone|Valsartan/Amlodipine 160/5 mg or 160/10 mg Versus Valsartan 160 mg Alone for 8 Weeks in Hypertensive Patients Who Are Not Adequately Controlled on Valsartan 160 mg Monotherapy|Completed||Phase 3|1018|Actual|Novartis|||||||||||||||||||2017-10-11 05:27:14.030587|2017-10-11 05:27:14.030587
NCT00170976|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-11-07|||April 2004||2004-04-01|November 2011|2011-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension|A 54 Week, Extension to the Double-blind, Multicenter, Multifactorial, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Valsartan (160 mg and 320 mg) and Amlodipine (10 mg) Combined and Alone in Hypertensive Patients|Completed||Phase 3|403|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:14.105008|2017-10-11 05:27:14.105008
NCT00170989|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-11-07|||September 2004||2004-09-01|June 2006|2006-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone|Comparison of the Combination of Valsartan 320 mg Plus Hydrochlorothiazide 12.5 mg and Valsartan 320 mg Plus Hydrochlorothiazide 25 mg to Valsartan 320 mg in Mild to Moderate Hypertensive Patients Not Adequately Controlled With Valsartan 320 mg|Completed||Phase 3|2714|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:14.180575|2017-10-11 05:27:14.180575
NCT00171002|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-05-15|||November 2004||2004-11-01|May 2017|2017-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone|A Multicenter Trial to Evaluate the Safety and Efficacy of the Combination of Valsartan/Amlodipine 160/10 mg Versus Amlodipine 10 mg Alone for 8 Weeks in Hypertensive Patients Who Are Not Adequately Controlled on Amlodipine 10 mg Monotherapy|Completed||Phase 3|936|Actual|Novartis|||||||||||||||||||2017-10-11 05:27:14.247735|2017-10-11 05:27:14.247735
NCT00171210|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-24|2010-12-14||October 2004||2004-10-01|May 2011|2011-05-01||||April 2008|Actual|2008-04-01||Interventional|||An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload|An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670)in β-thalassemia Patients With Transfusional Iron Overload|Completed||Phase 3|506|Actual|Novartis||1|||f||||f||||||||||2017-10-11 05:27:16.067944|2017-10-11 05:27:16.067944
NCT00171015|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-11-07|||December 2004||2004-12-01|November 2011|2011-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil|An Open,Multicenter Study to Evaluate the Efficacy and Safety of a 4 Week Therapy With Valsartan/Hydrochlorothiazide 160/25 (Fixed Dose Combination of Valsartan 160 mg Plus HCTZ 25 mg) in Patients Not Adequately Responding to a 4 Week Monotherapy With Olmesartan Medoxomil 40 mg or Combination Therapy With Olmesartan Medoxomil 20 mg Plus HCTZ 12.5 mg|Completed||Phase 3|212|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:14.311888|2017-10-11 05:27:14.311888
NCT00171028|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-11-07|||December 2003||2003-12-01|June 2006|2006-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension|A Double-Blind, Randomized, Multi-Center Study Followed By 12 Months Open-Label Treatment To Evaluate The Dose Response And Safety Of Valsartan In Pediatric Hypertension Patients 1 - 5 Years Of Age|Completed||Phase 3|90|Actual|Novartis|||||||||||||||||||2017-10-11 05:27:14.386423|2017-10-11 05:27:14.386423
NCT00171041|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2016-11-16|||December 2002||2002-12-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age|A Double-Blind, Randomized, Multi-Center Study Followed By 12 Months Open-Label Treatment To Evaluate The Dose Response And Safety Of Valsartan In Pediatric Hypertensive Patients|Completed||Phase 3|265|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:14.46513|2017-10-11 05:27:14.46513
NCT00171054|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-06-02|2010-12-21||September 2003||2003-09-01|June 2011|2011-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension|A Randomized, Double-blind, Parallel Group, Active-controlled, 38-week Study to Evaluate the Efficacy of Valsartan Versus Amlodipine on the Arterial Properties of Postmenopausal Women With Mild to Moderate Hypertension|Completed||Phase 4|125|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:27:14.657861|2017-10-11 05:27:14.657861
NCT00171067|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-05-15|||July 2004||2004-07-01|May 2017|2017-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria|A Study to Evaluate the Effectiveness of Valsartan 320 mg in Combination With Lisinopril 20 mg Versus Monotherapy With Lisinopril 40 mg or Valsartan 320 mg in Hypertensive Patients With Microalbuminuria on the Reduction of Urinary Albumin Creatinine Ratio|Completed||Phase 3|134|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:15.160713|2017-10-11 05:27:15.160713
NCT00171080|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-05-16|||April 2004||2004-04-01|May 2017|2017-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis|A 2 x 5-week Multicenter, Cross-over Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan 80 mg Compared to Irbesartan 150 mg in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis|Completed||Phase 3|86|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:15.24398|2017-10-11 05:27:15.24398
NCT00171093|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-02-20|||September 2004||2004-09-01|February 2017|2017-02-01||||January 2006|Actual|2006-01-01||Interventional|||A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia|A 10-12 Week Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of the Combination of Valsartan (320 mg) and Simvastatin (80 mg) Compared to Valsartan (320 mg) and Simvastatin (80 mg) Monotherapies in Essential Hypertension and Hypercholesterolemia|Completed||Phase 3|369||Novartis|||||||||||||||||||2017-10-11 05:27:15.329426|2017-10-11 05:27:15.329426
NCT00171106|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2016-11-16|||December 2002||2002-12-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure|A Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Determine the Effects of Valsartan on Exercise Time in Subjects With Symptomatic Diastolic Heart Failure|Completed||Phase 4|150||Novartis|||||f||||||||||||||2017-10-11 05:27:15.413213|2017-10-11 05:27:15.413213
NCT00171119|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-12-16|||January 2004||2004-01-01|December 2008|2008-12-01||||March 2005|Actual|2005-03-01||Interventional|||A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril|A 24-Week Study to Assess Blood Pressure Independent Effects of Valsartan Treatment, Benazepril Treatment and Combination of Both Valsartan and Benazepril Treatment on Urinary Albumin Excretion Rate With Type II Diabetes Mellitus and Microalbuminuria|Terminated||Phase 4|81|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:15.498493|2017-10-11 05:27:15.498493
NCT00171132|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-02-21|||August 2004||2004-08-01|February 2017|2017-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women|A 26-week Double-blind, Randomized, Multicenter Parallel-group Trial to Compare the Effects of Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women With Impaired Exercise Tolerance|Completed||Phase 4|64|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:15.574577|2017-10-11 05:27:15.574577
NCT00171145|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-18|||April 2004||2004-04-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|||||Interventional|||A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.|A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.|Completed||Phase 3|445|Actual|Novartis||2|||||||||||||||||2017-10-11 05:27:15.661156|2017-10-11 05:27:15.661156
NCT00171158|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-21|||August 2004||2004-08-01|February 2017|2017-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis|An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis|Completed||Phase 2|20|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:27:15.751388|2017-10-11 05:27:15.751388
NCT00171171|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-28|||May 2004||2004-05-01|November 2016|2016-11-01||||November 2006|Actual|2006-11-01||Interventional|||A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis|A Study of Efficacy and Safety of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis|Completed||Phase 3|252|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:27:15.852766|2017-10-11 05:27:15.852766
NCT00171223|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-21|||August 2004||2004-08-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia|An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia|Completed||Phase 2|356|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:27:17.725481|2017-10-11 05:27:17.725481
NCT00171236|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||October 2001||2001-10-01|September 2005|2005-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia|Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|84|Actual|Novartis|||||||||||||||||||2017-10-11 05:27:17.853913|2017-10-11 05:27:17.853913
NCT00171249|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-21|||August 2004||2004-08-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia|An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia|Completed||Phase 2|57|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:27:17.926519|2017-10-11 05:27:17.926519
NCT00171262|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-20|||August 2004||2004-08-01|February 2017|2017-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers|Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers|Completed||Phase 4|120|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:18.042255|2017-10-11 05:27:18.042255
NCT00171275|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-15|||November 2003||2003-11-01|July 2010|2010-07-01||||February 2007|Actual|2007-02-01||Interventional|||Fluvastatin in the Therapy of Acute Coronary Syndrome|Fluvastatin in the Therapy of Acute Coronary Syndrome|Completed||Phase 4|1000||Novartis|||||f||||||||||||||2017-10-11 05:27:18.252985|2017-10-11 05:27:18.252985
NCT00171288|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||August 2003||2003-08-01|November 2011|2011-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone|Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone|Completed||Phase 3|83|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:18.342351|2017-10-11 05:27:18.342351
NCT00171301|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-08-28|2011-01-12||June 2005||2005-06-01|August 2011|2011-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|ESCALATOR||Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)|1-year Extension to CICL670A2402 an Open-label, Multi-center Trial of the Efficacy and Safety of Long-term Treatment With Deferasirox (10 to 20 mg/kg/Day) in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2- Year Duration)|Completed||Phase 4|233|Actual|Novartis|An internal review revealed major Good Clinical Practice violations at 2 sites in Saudi Arabia: 602 for core + extension, 601 for 2-yr extension. Therefore data was excluded (completely for 602 + partly for 601) from analyses.|1|||f||||t||||||||||2017-10-11 05:27:18.468876|2017-10-11 05:27:18.468876
NCT00171314|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-19|2011-12-15||March 2004||2004-03-01|March 2012|2012-03-01||||November 2010|Actual|2010-11-01||Interventional|||The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer|The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer|Completed||Phase 3|527|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:27:19.361549|2017-10-11 05:27:19.361549
NCT00171327|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||July 2004||2004-07-01|November 2011|2011-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction|Efficacy and Safety of Fluvastatin 80 mg or Valsartan 160 mg and Their Combination in Dyslipidemic Patients With Arterial Hypertension and Endothelial Dysfunction|Completed||Phase 4|213|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:20.721291|2017-10-11 05:27:20.721291
NCT00171340|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-04-10|2011-03-22||May 2003||2003-05-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.|An Open-Label, Randomized, MultiCenter Study to Evaluate the Use of Zolendronic Acid in the Prevention of Cancer Treatment-Related Bone Loss in Postmenopausal Women With Estrogen Positive and/or Progesterone Positive Breast Cancer Receiving Letrozole as Adjuvant Therapy|Completed||Phase 3|1065|Actual|Novartis||2|||f||||t||||||||||2017-10-11 05:27:20.850502|2017-10-11 05:27:20.850502
NCT00171353|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||July 2004||2004-07-01|November 2011|2011-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure|A Study to Describe Vascular and Renal Effects and Safety of Valsartan 80 and 160 mg in Arterial Hypertension Patients|Completed||Phase 4|109|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:22.612598|2017-10-11 05:27:22.612598
NCT00171366|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-04-05|||July 2004||2004-07-01|April 2016|2016-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.|A Multicenter, Group Study to Evaluate the Safety and Efficacy of Amlodipine and Benazepril Administered in Combination Compared to Amlodipine Monotherapy in Hypertensive Patients Not Adequately Controlled With Amlodipine Alone|Completed||Phase 3|1422|Actual|Novartis|||||||||||||||||||2017-10-11 05:27:22.677723|2017-10-11 05:27:22.677723
NCT00171379|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-01|||March 2004||2004-03-01|February 2011|2011-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant|Open-label Study to Evaluate the Tolerability, Safety and Efficacy of the Equimolar Conversion From Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) in Patients With Renal Transplant|Completed||Phase 3|162|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:22.835747|2017-10-11 05:27:22.835747
NCT00171392|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-01|||March 2004||2004-03-01|February 2011|2011-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus|Open-label Study to Evaluate the Tolerability, Safety and Efficacy of the Equimolar Conversion From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium in Patients With Stable Renal Transplant Receiving Tacrolimus|Completed||Phase 3|132|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:22.91074|2017-10-11 05:27:22.91074
NCT00171405|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2016-11-16|||June 2005||2005-06-01|November 2016|2016-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg|A 4 Month Extension to a 12 Month, Randomized, Open-label, Multicenter, Study to Assess the Long-term Safety of Aliskiren 150 mg Alone and 300 mg Alone or With the Optional Addition of Hydrochlorothiazide (12.5 mg or 25 mg) in Patients With Essential Hypertension|Completed||Phase 3|250||Novartis|||||||||||||||||||2017-10-11 05:27:22.981276|2017-10-11 05:27:22.981276
NCT00171418|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-24|||June 2003||2003-06-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).|Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).|Completed||Phase 3|54||Novartis|||||||||||||||||||2017-10-11 05:27:23.087071|2017-10-11 05:27:23.087071
NCT00171431|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-04-19|||November 2004||2004-11-01|April 2012|2012-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)|The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)|Terminated||Phase 3|20||Novartis||||This study was terminated early in May 2006 due to low patient enrollment|f||||||||||||||2017-10-11 05:27:23.160265|2017-10-11 05:27:23.160265
NCT00171444|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||June 2004||2004-06-01|September 2005|2005-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Comparison of Two Treatment Strategies in Hypertensive Patients|A 8-week Comparison, in a General Practice Setting, Between Two Treatment Strategies With Valsartan and Valsartan/HCTZ Aiming at Normalizing de Novo Hypertensive Patients Who Are Not Adequately Controlled With Their Monotherapy or Biotherapy Treatment or Experiencing Unacceptable Side-effects, According to Their Baseline Blood Pressure|Completed||Phase 4|4445|Actual|Novartis|||||f||||||||||||||2017-10-11 05:27:23.249458|2017-10-11 05:27:23.249458
NCT00171457|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-09|||April 2005||2005-04-01|October 2007|2007-10-01|September 2006|Actual|2006-09-01|||||Interventional|||The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.|The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.|Completed||Phase 3|24||Novartis|||||||||||||||||||2017-10-11 05:27:23.344583|2017-10-11 05:27:23.344583
NCT00171470|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-31|||April 2005||2005-04-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.|The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.|Completed||Phase 3|60||Novartis|||||||||||||||||||2017-10-11 05:27:23.433082|2017-10-11 05:27:23.433082
NCT00171483|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-24|||January 2004||2004-01-01|January 2008|2008-01-01|April 2005|Actual|2005-04-01|||||Interventional|||Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).|Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).|Completed||Phase 3|30||Novartis|||||||||||||||||||2017-10-11 05:27:23.529539|2017-10-11 05:27:23.529539
NCT00171496|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-16|||October 2003||2003-10-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients|A Six-month Open Label, Multicenter, Randomized Study to Evaluate the Incidence of New Onset Diabetes Mellitus and Glucose Metabolism in Patients Receiving Cyclosporine Microemulsion With C-2 Monitoring Versus Tacrolimus After de Novo Kidney Transplantation|Completed||Phase 4|693|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:27:23.629844|2017-10-11 05:27:23.629844
NCT00171509|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-01-31|||May 2004||2004-05-01|January 2011|2011-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients|A Multicenter, Randomized Open-label Pilot Study to Explore the Benefit of a Conversion From a Twice a Day Administration of Cyclosporine Microemulsion to a Once a Day Administration and to Identify the C2 Ranges to Target After Conversion in Stable Liver Transplant Recipients|Completed||Phase 4|61|Actual|Novartis||3|||f||||||||||||||2017-10-11 05:27:23.733717|2017-10-11 05:27:23.733717
NCT00171522|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-03-02|||May 2005||2005-05-01|March 2016|2016-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Preference of Tegaserod vs. PEG 3350 in Patients With Constipation|A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation|Completed||Phase 4|52||Novartis|||||||||||||||||||2017-10-11 05:27:23.82235|2017-10-11 05:27:23.82235
NCT00171535|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||October 2004||2004-10-01|June 2006|2006-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension|A Study to Evaluate the Safety and Efficacy of Valsartan/Amlodipine Compared to Lisinopril/Hydrochlorothiazide Given Once Daily for 6 Weeks is Patients With Severe Hypertension|Completed||Phase 3|130|Actual|Novartis|||||||||||||||||||2017-10-11 05:27:23.920503|2017-10-11 05:27:23.920503
NCT00178243|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-06||||||September 2006|2006-09-01||||||||Interventional|||Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation|A Phase I/II Trial Of the Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation Delivered by 3D Conformal Radiation Therapy and Radiosurgery|Completed||Phase 1/Phase 2|||University of Rochester|||||f||||||||||||||2017-10-11 05:27:24.001269|2017-10-11 05:27:24.001269
NCT00178256|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-03|2013-12-11||June 1998||1998-06-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer|A Phase I/II Clinical Trial Of Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable (Stage III) Lung Cancers|Completed||Phase 1/Phase 2|41|Actual|University of Rochester||4|||f||||||||||||||2017-10-11 05:27:24.075726|2017-10-11 05:27:24.075726
NCT00180193|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-08-25|||December 2003||2003-12-01|August 2009|2009-08-01||||||||Observational|||F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response|F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response|Terminated||Phase 2|40|Anticipated|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 05:27:29.680641|2017-10-11 05:27:29.680641
NCT00178269|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-05-15|||January 2005||2005-01-01|May 2009|2009-05-01||||June 2006|Actual|2006-06-01||Interventional|||Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix|A Phase Ii Clinical Study Using Weekly Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix|Completed||Phase 2|||University of Rochester|||||f||||||||||||||2017-10-11 05:27:24.391765|2017-10-11 05:27:24.391765
NCT00178282|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-02|||June 2005||2005-06-01|November 2011|2011-11-01|October 2007|Actual|2007-10-01|January 2007|Actual|2007-01-01||Interventional|||Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence|Pilot Study: Low Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence|Terminated||N/A|23|Actual|University of Rochester||1||The study was terminated early due to poor subject enrollment.|f||||f||||||||||2017-10-11 05:27:24.468302|2017-10-11 05:27:24.468302
NCT00178295|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-03|||November 1999||1999-11-01|August 2015|2015-08-01||||December 2013|Actual|2013-12-01||Observational|||Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury|Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury|Completed||N/A|44|Actual|University of Rochester|||1||f||||f||||||Samples Without DNA|"     Blood plasma   "|||2017-10-11 05:27:24.558908|2017-10-11 05:27:24.558908
NCT00178308|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-06||||||September 2006|2006-09-01||||||||Observational|||Measuring Alterations of DNA in Human Blood||Completed||N/A|24||University of Rochester|||||f||||||||||||||2017-10-11 05:27:24.624281|2017-10-11 05:27:24.624281
NCT00178321|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-04-29|||September 2005||2005-09-01|April 2015|2015-04-01|August 2006||2006-08-01|||||Interventional|||Improving Sleep in the Pediatric Intensive Care Unit|Improving Sleep and Outcomes in Critically Ill Children|Withdrawn||N/A|0|Actual|University of Rochester|||||f||||||||||||||2017-10-11 05:27:24.682028|2017-10-11 05:27:24.682028
NCT00178334|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-01-28|||March 2006||2006-03-01|January 2013|2013-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Screening for Urinary Incontinence by Primary Care Providers|Screening for Urinary Incontinence by Primary Care Providers|Completed||N/A|554|Actual|University of Rochester|||1||f||||f||||||||||2017-10-11 05:27:24.761175|2017-10-11 05:27:24.761175
NCT00178347|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-05-15|||December 2004||2004-12-01|May 2009|2009-05-01||||||||Observational|||Radiation Dosimetry in Teeth|Radiation Dosimetry in Teeth|Terminated||N/A|10|Anticipated|University of Rochester|||1||f||||f||||||||||2017-10-11 05:27:24.819862|2017-10-11 05:27:24.819862
NCT00178360|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-08-19|||July 2004||2004-07-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Music Therapy on Huntington's Disease|The Effects of Music Therapy on Depression, Chorea and Other Symptoms of Huntington's Disease|Completed||Phase 1|11|Actual|University of Rochester||2|||f||||f||||||||||2017-10-11 05:27:24.88908|2017-10-11 05:27:24.88908
NCT00178373|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-21|||May 2004||2004-05-01|December 2015|2015-12-01|March 2006|Actual|2006-03-01|December 2005|Actual|2005-12-01||Interventional|||Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer|Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer|Completed||Phase 2|96|Anticipated|University of Rochester||2|||f||||t||||||||||2017-10-11 05:27:24.982538|2017-10-11 05:27:24.982538
NCT00178386|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-11|||September 2004||2004-09-01|June 2015|2015-06-01|April 2008|Actual|2008-04-01|September 2005|Actual|2005-09-01||Observational|||Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer|Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer and Brain Tumor in Facilities With and Without Educational Liaison Services.|Completed||Phase 1|220|Actual|University of Rochester|||2||f||||f||||||||||2017-10-11 05:27:25.12178|2017-10-11 05:27:25.12178
NCT00178399|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-01|||April 2001||2001-04-01|May 2017|2017-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study For Using Radiosurgery On Limited Metastases|A Pilot Study For Using Radiosurgery On Limited Metastases|Suspended||N/A|138|Actual|University of Rochester||1||to analyze data of subjects already enrolled.|f||||t||||||||||2017-10-11 05:27:25.213557|2017-10-11 05:27:25.213557
NCT00178412|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-06-13|||April 2003||2003-04-01|June 2012|2012-06-01|March 2009|Actual|2009-03-01|April 2006|Actual|2006-04-01||Interventional|||Improving Outcomes of Hospitalized Elders and Caregivers|Improving Outcomes of Hospitalized Elders and Caregivers|Completed||Phase 2|421|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 05:27:25.293014|2017-10-11 05:27:25.293014
NCT00178425|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-18|||January 2005||2005-01-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|||PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients|Pharmacokinetics of Intravenous / Oral MMF and Oral Tacrolimus in Live Donor and Deceased Donor Liver Transplant Patients|Completed||Phase 4|24||University of Rochester|||||f||||f||||||||||2017-10-11 05:27:25.382217|2017-10-11 05:27:25.382217
NCT00178438|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-16|||June 2005||2005-06-01|September 2015|2015-09-01|June 2006||2006-06-01|||||Interventional|||Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease|A Prospective Trial of Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease|Withdrawn||Phase 1/Phase 2|0|Actual|University of Rochester|||||f||||||||||||||2017-10-11 05:27:25.448347|2017-10-11 05:27:25.448347
NCT00178451|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-17||||||December 2015|2015-12-01||||||||Interventional|||Stroke Prevention With Abciximab in Carotid Endarterectomy|Stroke Prevention With Abciximab in Carotid Endarterectomy|Withdrawn||Phase 1/Phase 2|0|Actual|University of Rochester|||||||||||||||||||2017-10-11 05:27:25.522732|2017-10-11 05:27:25.522732
NCT00178464|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-29|2011-08-09||March 2005||2005-03-01|September 2011|2011-09-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|START||Aspirin Prophylaxis in Sickle Cell Disease|Aspirin Prophylaxis in Sickle Cell Disease|Completed||Phase 1/Phase 2|11|Actual|University of Rochester||1|||f||||t||||||||||2017-10-11 05:27:25.6165|2017-10-11 05:27:25.6165
NCT00178477|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-04-18|2011-08-12||January 2002||2002-01-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study of Breath-holding as a Means to Reduce Tumor Motion From Breathing|Feasibility Study for Gated External-Beam Radiotherapy for Patients With Internal, Extra-cranial Tumors|Terminated||N/A|10|Actual|University of Rochester||1||Drs Okunieff and ODell have left the University of Rochester|f||||f||||||||||2017-10-11 05:27:26.166196|2017-10-11 05:27:26.166196
NCT00178490|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-06-02|||January 2005||2005-01-01|June 2014|2014-06-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||Effect of High Blood Pressure and Antihypertensive Treatment on Brain Functioning in Children|Neurocognitive Function in Children With Hypertension|Completed||Phase 1|100|Anticipated|University of Rochester||2|||f||||f||||||||||2017-10-11 05:27:26.328426|2017-10-11 05:27:26.328426
NCT00178503|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-06|2013-01-14||September 2005||2005-09-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children|ADHD Symptoms in Autism: Cognition, Behavior, Treatment|Completed||Phase 2/Phase 3|24|Actual|The University of Texas Health Science Center, Houston|We did not have teacher behavioral data for all of the children because some of them were seen during the summer, when teacher input was not available.|4|||f||||t||||||||||2017-10-11 05:27:26.427417|2017-10-11 05:27:26.427417
NCT00178516|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-07-29|||June 2004||2004-06-01|July 2009|2009-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Vitamin E and Male Infertility|Vitamin E and Male Infertility|Completed||N/A|58|Actual|University of Rochester|||2||f||||f||||||Samples With DNA|"     whole blood, serum, semen   "|||2017-10-11 05:27:26.849427|2017-10-11 05:27:26.849427
NCT00178529|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-03-02|||July 2001||2001-07-01|March 2007|2007-03-01|September 2005||2005-09-01|||||Interventional|||Intervention for Stroke Survivors and Their Spousal Caregivers|Intervention for Stroke Survivors and Their Spousal Caregivers|Completed||N/A|160||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 05:27:26.920197|2017-10-11 05:27:26.920197
NCT00178542|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-03|||September 2005||2005-09-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle|Changes in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle|Terminated||N/A|20|Actual|The University of Texas Health Science Center, Houston|||1|Insufficient enrollment|f||||f||||||||||2017-10-11 05:27:27.00915|2017-10-11 05:27:27.00915
NCT00178555|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-03-22|||August 2003||2003-08-01|March 2016|2016-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Comparison of the Video and Macintosh Laryngoscope in Patients Who May be Difficult to Intubate|A Comparison of Laryngoscopy Techniques Using the Video Laryngoscope and the Traditional Macintosh Laryngoscope in Patients Who May be Difficult to Intubate|Completed||Phase 4|200||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 05:27:27.085127|2017-10-11 05:27:27.085127
NCT00178568|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-26|||February 2003||2003-02-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Observational|||Reducing Caregiver Stress and Sleep Disturbances in Patients With Progressive Dementia|AgeWise Project 2: Reducing Stress and Sleep Disturbances in Caregivers of Patients With Progressive Dementia|Completed||Phase 1|60|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"     Saliva collected on cotton rolls and frozen by participant. Kept frozen until shipped for     assay.   "|||2017-10-11 05:27:27.164827|2017-10-11 05:27:27.164827
NCT00180076|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-03-29|||July 2004||2004-07-01|March 2010|2010-03-01|March 2008||2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Budesonide for Maintenance Treatment of Collagenous Colitis|Efficacy and Safety of Budesonide in Maintenance Treatment of Collagenous Colitis|Completed||Phase 3|75|Anticipated|Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:27:27.305125|2017-10-11 05:27:27.305125
NCT00180089|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-03-29|||January 2004||2004-01-01|March 2010|2010-03-01|January 2010||2010-01-01|March 2009|Actual|2009-03-01||Interventional|||Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation|Efficacy and Safety of Orale Budesonide in the Prevention of Acute Gastrointestinal Graft-versus-host Disease Following Allogenic Stem Cell Transplantation|Completed||Phase 3|242|Anticipated|Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:27:27.385208|2017-10-11 05:27:27.385208
NCT00180102|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-23|||December 2003||2003-12-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years|AML2003 - Randomized Comparison Between Standard-Therapy and Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years. A Prospective, Randomized, Multi-center Therapy-Optimizing-Study.|Completed||Phase 4|600|Anticipated|Technische Universität Dresden||4|||f||||||||||||||2017-10-11 05:27:27.467351|2017-10-11 05:27:27.467351
NCT00180115|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-07-16|||February 1996||1996-02-01|July 2007|2007-07-01|November 2008||2008-11-01|||||Interventional|||AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients|AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients. A Cooperative AML-Study of the German SHG-Study Group.|Completed||Phase 4|400||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:27:27.550698|2017-10-11 05:27:27.550698
NCT00180128|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-07-08|||January 2000||2000-01-01|July 2011|2011-07-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia|AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia(APL)|Unknown status|Recruiting|Phase 4|80|Anticipated|Technische Universität Dresden||1|||f||||||||||||||2017-10-11 05:27:27.628525|2017-10-11 05:27:27.628525
NCT00180141|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-06|||April 2005||2005-04-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Elidel-Study: Elidel in Patients With Atopic Dermatitis|Control of Therapy With Elidel vs Placebo in Patients With Atopic Dermatitis Using Bioengineering Methods|Completed||Phase 4|24|Anticipated|Technische Universität Dresden|||||f||||f||||||||||2017-10-11 05:27:27.721243|2017-10-11 05:27:27.721243
NCT00180154|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-23|||July 2005||2005-07-01|August 2011|2011-08-01||||||||Observational|||Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET|Tumor Metabolism of Lung Cancer Underwent Percutaneous Radiation Measured With F-18-FDG-PET|Completed||N/A|50|Anticipated|Technische Universität Dresden|||1||f||||||||||||||2017-10-11 05:27:27.786041|2017-10-11 05:27:27.786041
NCT00180167|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-08-19|||January 2005||2005-01-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC|Therapy of AML in Patients Older Than 60 Years: Randomized Comparison of a Double Induction With Daunorubicin and AraC (as Continuous Infusion) With a Double Induction With Mitoxantrone and Intermittent, Medium High Dose AraC|Completed||Phase 4|492|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-10-11 05:27:29.523344|2017-10-11 05:27:29.523344
NCT00180180|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-15|||July 2006||2006-07-01|March 2016|2016-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO|Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO|Active, not recruiting||Phase 2|60|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 05:27:29.60845|2017-10-11 05:27:29.60845
NCT00180206|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-01-13|||January 2005||2005-01-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Interventional|||Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing Endoprosthesis|Prospective, Non-Randomised, Non-Comparative Multicentric Investigation of the Functional and Radiological Result and Subjective Patient Outcome After Implantation of a Hip Resurfacing Endoprosthesis (Birmingham Hip Resurfacing)|Unknown status|Recruiting|Phase 4|300||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:27:29.736201|2017-10-11 05:27:29.736201
NCT00180219|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-08-24|||January 2006||2006-01-01|August 2016|2016-08-01|June 2006|Actual|2006-06-01|||||Observational|||Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the Mother|An Open Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the Mother (Hormonal and Age Related Changes of the Aortal Elasticity)|Withdrawn||Phase 1|0|Actual|Technische Universität Dresden|||3|recruitment failure|f||||f||||||||||2017-10-11 05:27:29.815975|2017-10-11 05:27:29.815975
NCT00180232|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-02-02|||April 2006||2006-04-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|||||Observational|||An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness|An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness (Changes of the Aortal Elasticity Due to a Newly Established Aminobiphosphinate Therapy for the Treatment of Osteoporosis)|Withdrawn||N/A|0|Actual|Technische Universität Dresden|||1|Clinical partner left University,|f||||f||||||||||2017-10-11 05:27:29.893016|2017-10-11 05:27:29.893016
NCT00180245|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-15|||July 2005||2005-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET||Completed||N/A|44|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-10-11 05:27:29.957684|2017-10-11 05:27:29.957684
NCT00180258|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-01-23|||January 2000||2000-01-01|January 2007|2007-01-01|December 2002||2002-12-01|||||Interventional|||Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure|Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure|Completed||Phase 2/Phase 3|2200||Boston Scientific Corporation|||||||||||||||||||2017-10-11 05:27:30.049798|2017-10-11 05:27:30.049798
NCT00180271|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-01-24|2011-02-23|2010-07-09|December 2004||2004-12-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|MADIT-CRT||MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy|Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy|Completed||Phase 2/Phase 3|1820|Actual|Boston Scientific Corporation|The FDA Circulatory Devices advisory panel recommended approval for the patient subpopulation with left bundle branch block (LBBB) only. Consequently, FDA has restricted indications for use to LBBB.|2|||f||||t||||||||||2017-10-11 05:27:30.131889|2017-10-11 05:27:30.131889
NCT00180284|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-09-28|||November 2004||2004-11-01|September 2011|2011-09-01|February 2008|Actual|2008-02-01|May 2005|Actual|2005-05-01||Interventional|||SITELINE 2 Polyurethane|SITELINE 2 Polyurethane Clinical Investigation|Completed||Phase 3|200|Actual|Boston Scientific Corporation||1|||f||||||||||||||2017-10-11 05:27:32.137158|2017-10-11 05:27:32.137158
NCT00180297|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-24|||April 2005||2005-04-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead|Evaluation of the Success Rate and the Clinical Evolution of a Ventricular Lead Implanted in the Septum Versus the Right Ventricular Apex.|Completed||N/A|208|Actual|Boston Scientific Corporation||2|||f||||||||||||||2017-10-11 05:27:32.220973|2017-10-11 05:27:32.220973
NCT00180310|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-07-18|||July 2005||2005-07-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|July 2007|Actual|2007-07-01||Interventional|SPIRIT II||SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System|A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 3|300|Actual|Abbott Vascular||2|||f||||t||||||||||2017-10-11 05:27:32.339237|2017-10-11 05:27:32.339237
NCT00180323|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-05|2012-03-09||November 2004||2004-11-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||ACC - Atrial Contribution to CRT|ACC - Atrial Contribution to CRT|Completed||Phase 4|43|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 05:27:32.532323|2017-10-11 05:27:32.532323
NCT00180336|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-06-22|||July 2004||2004-07-01|June 2007|2007-06-01||||||||Interventional|||Safety and Efficacy Study of RENEWAL 4 AVT|CONTAK RENEWAL 4 AVT Field Following|Completed||Phase 2/Phase 3|170||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:27:32.91955|2017-10-11 05:27:32.91955
NCT00180349|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-12|||December 2004||2004-12-01|April 2017|2017-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Leader - Evaluation of Endotak Reliance|Short and Long Term Evaluation of Electrical Measurements and Defibrillation Energies, Results of ATP and Diagnostic Functions of Devices Connected to Endotak RELIANCE® Defibrillation Leads|Completed||N/A|904|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-10-11 05:27:32.997018|2017-10-11 05:27:32.997018
NCT00180362|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-17|||May 2004||2004-05-01|February 2017|2017-02-01|September 2004||2004-09-01|||||Interventional|Quick ICD||Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ?|Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary in Patients After Survived Cardiac Arrest? A Prospective Randomised Multi-centre Trial.|Completed||Phase 4|200||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:27:33.14056|2017-10-11 05:27:33.14056
NCT00180375|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-17|||May 2002||2002-05-01|February 2017|2017-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator|OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator|Completed||N/A|636|Actual|Boston Scientific Corporation|||1||f||||f||||||||No||2017-10-11 05:27:33.249447|2017-10-11 05:27:33.249447
NCT00180388|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-31|||May 2004||2004-05-01|March 2007|2007-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||VENEK: Healing in Different Vein Harvesting Methods During Aortocoronary Coronary Artery Bypass Graft Surgery (CABG)|Comparison of Clinical and Economical Parameters of Healing in Different Vein Harvesting Methods During Aortocoronary CABG|Terminated||Phase 4|300|Anticipated|Boston Scientific Corporation||2||terminated for logistical reasons|f||||||||||||||2017-10-11 05:27:33.42612|2017-10-11 05:27:33.42612
NCT00180401|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-17|||June 2002||2002-06-01|February 2017|2017-02-01|October 2007|Actual|2007-10-01|||||Observational|||MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms|MODULA-Study: Modul 10: Benefit of CRT-therapy in CRT-Patients With QRS-complex of 120 - 150 ms|Terminated||N/A|100|Anticipated|Boston Scientific Corporation|||2|no longer interest from medical community|f||||||||||||||2017-10-11 05:27:33.552406|2017-10-11 05:27:33.552406
NCT00180414|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-17|||August 2003||2003-08-01|February 2017|2017-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||MODULA Modul 7 VRR: Correlation Between Ventricular Rate Regulation (VRR) and the Percentage of Biventricular Pacing in Cardiac Resynchronization Therapy (CRT) Patients With Atrial Fibrillation|MODULA-Study: Modul 7 VRR: Correlation Between Ventricular Rate Regulation (VRR) and the Percentage of Biventricular Pacing as Well as Subjective Quality of Life and Level of Physical Ability in CRT Patients With Atrial Fibrillation|Terminated||Phase 4|40|Anticipated|Boston Scientific Corporation||||low enrolment rate|f||||||||||||||2017-10-11 05:27:33.652233|2017-10-11 05:27:33.652233
NCT00180427|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-22|||June 2001||2001-06-01|April 2008|2008-04-01|November 2004|Actual|2004-11-01|||||Interventional|||"VERRARI - Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"|"VERRARI - Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"|Completed||Phase 4|75||Guidant Corporation|||||f||||||||||||||2017-10-11 05:27:33.735986|2017-10-11 05:27:33.735986
NCT00180440|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-03-25|||July 2002||2002-07-01|March 2009|2009-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||INSURE: INcidence Free SUrvival Before and After Implantable Cardioverter Defibrillator (ICD) Replacement|INcidence Free SUrvival Before and After ICD Replacement|Completed||Phase 4|528|Anticipated|Guidant Corporation|||1||f||||||||||||||2017-10-11 05:27:33.811144|2017-10-11 05:27:33.811144
NCT00180453|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-01-05|||December 2003||2003-12-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|April 2005|Actual|2005-04-01||Interventional|||SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System|SPIRIT First: A Clinical Evaluation of an Investigational Device. The Abbott XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 3|60|Actual|Abbott Vascular||2|||f||||t||||||||||2017-10-11 05:27:33.900609|2017-10-11 05:27:33.900609
NCT00180466|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-24|||October 2004||2004-10-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions|Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) An Imaging Study in Patients With Unstable Atherosclerotic Lesions|Completed||N/A|697|Actual|Abbott Vascular|||1||f||||t||||||Samples With DNA|"     Aproximately 1 ML blood   "|||2017-10-11 05:27:34.039669|2017-10-11 05:27:34.039669
NCT00180479|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-16|2008-10-15||June 2005||2005-06-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|December 2006|Actual|2006-12-01||Interventional|||SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)|SPIRIT III: A Clinical Evaluation of the Investigational Device XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) in the Treatment of Subjects With de Novo Native Coronary Artery Lesions|Completed||Phase 3|1002|Actual|Abbott Vascular||2|||f||||t||||||||||2017-10-11 05:27:34.82679|2017-10-11 05:27:34.82679
NCT00180492|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-27|||October 2004||2004-10-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|December 2006|Actual|2006-12-01||Interventional|||Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE|Carotid RX ACCULINK(TM)/ACCUNET(TM) Post-Approval Trial to Uncover Unanticipated or Rare Events - CAPTURE|Completed||N/A|1500||Abbott Vascular|||||f||||||||||||||2017-10-11 05:27:37.38789|2017-10-11 05:27:37.38789
NCT00180505|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-02-23|||March 2005||2005-03-01|February 2010|2010-02-01|October 2009|Actual|2009-10-01|March 2006|Actual|2006-03-01||Interventional|||ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries|Non-Randomized, Prospective, Multi-center Evaluation of the ABSOLUTE™ .035 Peripheral Self-Expanding Stent System for Occluded or Stenotic Superficial Femoral or Proximal Popliteal Arteries|Completed||Phase 4|120|Anticipated|Abbott Vascular||1|||f||||f||||||||||2017-10-11 05:27:37.468226|2017-10-11 05:27:37.468226
NCT00180518|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-10|||May 2000||2000-05-01|September 2008|2008-09-01|November 2003|Actual|2003-11-01|October 2003|Actual|2003-10-01||Interventional|||"ACCULINK for Revascularization of Carotids in High Risk Patients The ARCHeR Trial"|Prospective, Non-Randomized, Multi-Center, Single-Arm Trial to Assess Safety & Efficacy of the Acculink Carotid Stent System With the Accunet Embolic Protection System in High-Risk Patients With Carotid Artery Lesions.|Completed||Phase 2/Phase 3|581||Abbott Vascular||1|||f||||t||||||||||2017-10-11 05:27:37.577297|2017-10-11 05:27:37.577297
NCT00180531|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-12-12|||February 2004||2004-02-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2|Monitoring of Arrhythmias and Heart Rate Variability in Patients With Congestive Heart Failure Treated With the Cardiac Resynchronisation Pacemaker Renewal TR2|Completed||Phase 4|500||Guidant Corporation|||||f||||||||||||||2017-10-11 05:27:37.674834|2017-10-11 05:27:37.674834
NCT00180544|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-24|||July 2000||2000-07-01|July 2008|2008-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|HERCULINK 14||Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease|A Prospective, Non-Randomized, Multicenter, Single-Arm, Clinical Trial to Assess the Safety and Efficacy of the RX HERCULINK 14 Peripheral Stent System for Treatment in de Novo or Restenotic Renal Artery Stenosis|Terminated||Phase 3|167|Actual|Abbott Vascular||1||"Device superceded by next generation device. Enrollment stopped, long term follow up was   completed in August of 2004."|f||||t||||||||||2017-10-11 05:27:37.884264|2017-10-11 05:27:37.884264
NCT00180557|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-03-10|||September 2003||2003-09-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Austria Study - Analysis of Difference Between Active and Passive Fixation Leads|Analyse Der Unterschiede Zwischen Aktiv-fixierenden Und Passiv-fixierenden Stimulations-Elektroden Hinsichtlich Implantationsdauer Und Elektrischer Parameter|Completed||Phase 4|120|Actual|Guidant Corporation||2|||f||||f||||||||||2017-10-11 05:27:37.97526|2017-10-11 05:27:37.97526
NCT00180570|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-03-10|||January 1997||1997-01-01|September 2005|2005-09-01|January 2006||2006-01-01|||||Interventional|SALT||SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing Electrodes|Scandinavian Atrial Lead Trial|Suspended||Phase 4|385||Guidant Corporation|||||f||||||||||||||2017-10-11 05:27:38.063734|2017-10-11 05:27:38.063734
NCT00182195|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-19|||August 2000||2000-08-01|April 2007|2007-04-01|March 2006|Actual|2006-03-01|||||Interventional|LOVS||Lung Open Ventilation to Decrease Mortality in the Acute Respiratory Distress Syndrome|A Randomized Trial of a Lung-Open Ventilation Strategy in Acute Lung Injury|Completed||Phase 3|980||McMaster University|||||f||||t||||||||||2017-10-11 05:27:52.137777|2017-10-11 05:27:52.137777
NCT00180583|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-07-31|||February 2002||2002-02-01|July 2008|2008-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Vision II: Evaluation of GALILEO Intravascular Radiotherapy System|Vision II: Non Randomized French Evaluation of GALILEO Intravascular Radiotherapy System in Patients With de Novo Coronary Arteries Lesions by Restenosis on Angioplasty or Restenosis on Endoprosthesis|Completed||Phase 4|268|Actual|Abbott Vascular||1|||f||||||||||||||2017-10-11 05:27:38.142315|2017-10-11 05:27:38.142315
NCT00180596|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-01-05|||January 2000||2000-01-01|June 2005|2005-06-01|September 2005||2005-09-01|||||Interventional|||PACMAN - PAcing for CardioMyopathies, a EuropeAN Study|Pacing for Cardiomyopathies, a European Study- A Therapy Acceptance Study|Completed||Phase 4|262||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:27:38.226504|2017-10-11 05:27:38.226504
NCT00180609|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-04-22|||December 2003||2003-12-01|April 2009|2009-04-01|July 2006||2006-07-01|||||Observational|||SCANCAP Scandinavian Automatic Capture Study|Scandinavian Automatic Capture Study|Completed||Phase 4|203||Guidant Corporation|||1||f||||||||||||||2017-10-11 05:27:38.305048|2017-10-11 05:27:38.305048
NCT00180622|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||July 2001||2001-07-01|September 2005|2005-09-01||||||||Observational|||Markers for COPD|Non-Invasive Markers for COPD|Completed||N/A|52||Imperial College London|||||f||||||||||||||2017-10-11 05:27:38.369721|2017-10-11 05:27:38.369721
NCT00180635|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-06-03|||October 2003||2003-10-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD|A Double Blind, Crossover Placebo-controlled Study to Evaluate the Effect of L-arginine and Aminoguanidine on Bronchial and Alveolar Nitric Oxide and Nitric Oxide Metabolites in Exhaled Air, Breath Condensate, Nasal Lavage, Mouth Wash Fluid, and Induced Sputum in 7 Healthy Non-smokers, 10 Smokers and 12 COPD Patients|Completed||N/A|29|Anticipated|Imperial College London||2|||f||||||||||||||2017-10-11 05:27:38.457794|2017-10-11 05:27:38.457794
NCT00180648|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-02-19|||February 2005||2005-02-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure|Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure|Completed||N/A|30|Actual|Imperial College London|||1||f||||t||||||Samples Without DNA|"     Plasma   "|||2017-10-11 05:27:38.536397|2017-10-11 05:27:38.536397
NCT00180661|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-27|||August 2003||2003-08-01|October 2015|2015-10-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Observational|SARP||Inflammation and Corticosteroid Responsiveness in Severe Asthma|Inflammation and Corticosteroid Responsiveness in Severe Asthma|Completed||Phase 2/Phase 3|95|Actual|Imperial College London|||3||f||||t||||||Samples With DNA|"     endobronchial biopsies and blood specimens.   "|||2017-10-11 05:27:38.609868|2017-10-11 05:27:38.609868
NCT00180674|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-10|||August 2005||2005-08-01|September 2005|2005-09-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||Anticoagulation in Liver Fibrosis|Anticoagulation for Liver Fibrosis in Patients With Hepatitis C Virus Infection: Pilot Study|Completed||Phase 2|12|Actual|Imperial College London||1|||f||||||||||||||2017-10-11 05:27:38.700781|2017-10-11 05:27:38.700781
NCT00180687|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-12|2015-06-09||October 2004||2004-10-01|August 2015|2015-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Clinical Trial of the Use of Intraperitoneal Local Anaesthetic|Prospective Double Blind Randomized Controlled Trial of the Use of Intraperitoneal Nebulised Local Anaesthetic|Completed||Phase 3|80|Actual|Imperial College London||4|||f||||t||||||||||2017-10-11 05:27:38.790799|2017-10-11 05:27:38.790799
NCT00180700|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-02-11|||June 2003||2003-06-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||The Influence of Psychological Interventions Upon Disease Progression in HIV-infected Patients Receiving no Medication|The Effects of Two Psychological Intervention Techniques, Self-hypnosis and Johrei Healing Method, on Quality of Life, Psychological Well-being, EEG Measures and Various Immunological Measures Including CD4+ Counts in Early HIV: a Randomly Controlled Pilot Study|Completed||N/A|100||Imperial College London|||||f||||||||||||||2017-10-11 05:27:39.324656|2017-10-11 05:27:39.324656
NCT00180713|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-03|||October 2005||2005-10-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|||Simvastatin as a Treatment for Pulmonary Hypertension|Simvastatin as a Treatment for Pulmonary Hypertension|Completed||Phase 1/Phase 2|42|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 05:27:39.404285|2017-10-11 05:27:39.404285
NCT00180726|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-08-12|||December 2003||2003-12-01|August 2008|2008-08-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Molecular Mechanism of Asthma|Regulation of Inflammatory Mediators in Asthma|Withdrawn||N/A|30|Anticipated|Imperial College London|||||f||||t||||||||||2017-10-11 05:27:39.527482|2017-10-11 05:27:39.527482
NCT00180739|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-08-12|||April 2004||2004-04-01|August 2008|2008-08-01||||||||Interventional|||Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future|Magnetic Resonance Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids in Women Desiring Future Pregnancies|Completed||Phase 4|60|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:27:39.602287|2017-10-11 05:27:39.602287
NCT00180752|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-02-17|||September 2005||2005-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||HDAC Activity in Peripheral Skeletal Muscle in COPD|The Investigation of HDAC and NF Kappa B Activity in Peripheral Skeletal Muscle in COPD|Completed||N/A|31|Actual|Imperial College London|||1||f||||f||||||Samples With DNA|"     Plasma and serum samples, quadriceps muscle specimens   "|No||2017-10-11 05:27:39.680033|2017-10-11 05:27:39.680033
NCT00180765|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-08-24|||October 2001||2001-10-01|September 2005|2005-09-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Observational|||Regulation of the Release of Inflammatory Mediators From Blood Leukocytes|Regulation of the Release of Inflammatory Mediators From Blood Leukocytes: A Comparison of Healthy Subjects, Healthy Smokers and Patients With COPD.|Completed||N/A|30||Imperial College London|||||f||||||||||||||2017-10-11 05:27:39.753288|2017-10-11 05:27:39.753288
NCT00180778|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss|Randomised Controlled Trial of Low Dose Steroid +Aspirin +Heparin Versus Aspirin+Heparin Amongst Pregnant Women With APS|Unknown status|Not yet recruiting|Phase 1/Phase 2|90||Imperial College London|||||f||||||||||||||2017-10-11 05:27:39.838014|2017-10-11 05:27:39.838014
NCT00179036|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-05|||January 2000||2000-01-01|April 2017|2017-04-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|SQUID||Biomagnetic Signals of Intestinal Ischemia II|Biomagnetic Signals of Intestinal Ischemia II|Completed||N/A|17|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||||2017-10-11 05:29:10.938301|2017-10-11 05:29:10.938301
NCT00180791|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-09-17|||July 2002||2002-07-01|September 2006|2006-09-01||||||||Interventional|||High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood|Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy|Unknown status|Recruiting|Phase 2|71|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:39.943824|2017-10-11 05:27:39.943824
NCT00180804|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-13|||April 2005||2005-04-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages|Combination of Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages|Unknown status|Recruiting|N/A|400||Imperial College London|||||f||||||||||||||2017-10-11 05:27:40.02843|2017-10-11 05:27:40.02843
NCT00180817|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 1998||1998-09-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.|Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies in Women Presenting as Recurrent Miscarriages.|Unknown status|Recruiting|N/A|250||Imperial College London|||||f||||||||||||||2017-10-11 05:27:40.115065|2017-10-11 05:27:40.115065
NCT00180830|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-07|||December 2003||2003-12-01|September 2006|2006-09-01||||||||Interventional|||Glivec Phase II Pediatric Study|Open Label, Pilot Phase II Study of Glivec in Children and Adolescents With Life Threatening Diseases Known to Be Associated With One or More Glivec-Sensitive Tyrosine Kinases|Terminated||Phase 2|36||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.199024|2017-10-11 05:27:40.199024
NCT00180843|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-09-21|||September 2005||2005-09-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease|Assessment of Ventilation-perfusion Abnormalities in Patients With Smoking-related Airways Disease in Stable Condition and the Effect of Bronchodilator Therapy|Terminated||N/A|2|Actual|Imperial College London||2||lack of resources research fellow left|f||||f||||||||||2017-10-11 05:27:40.273134|2017-10-11 05:27:40.273134
NCT00180856|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-11|||January 2002||2002-01-01|September 2005|2005-09-01||||||||Interventional|||Radiofrequency Ablation of Lung Tumors|A Phase II Study of Radiofrequency Ablation of Lung Tumors|Completed||Phase 2|60||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.360865|2017-10-11 05:27:40.360865
NCT00180869|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 1997||1997-09-01|September 2005|2005-09-01||||||||Interventional|||Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients|A Randomized Study of Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion During Surgery in Cancer Patients|Completed||Phase 3|150||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.432107|2017-10-11 05:27:40.432107
NCT00180882|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-07|||October 2004||2004-10-01|September 2006|2006-09-01||||||||Interventional|||LMBA02 Protocol for Patients With a Burkitt Lymphoma||Unknown status|Recruiting|Phase 3|260||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.50801|2017-10-11 05:27:40.50801
NCT00180895|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-07|||June 2004||2004-06-01|September 2006|2006-09-01||||||||Interventional|||Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL|A Phase II Study of Mabthera (Rituximab) in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL|Terminated||Phase 2|40||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.59123|2017-10-11 05:27:40.59123
NCT00180908|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 1994||1994-06-01|September 2005|2005-09-01||||||||Interventional|||Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children|SFOP-OS94: Multicentric Randomised Phase III Trial Comparing Efficacy of Preoperative High-Dose Methotrexate Plus Doxorubicin to Efficacy of High-Dose Methotrexate Plus Etoposide and Ifosfamide, in Children and Adolescents Osteosarcoma|Completed||Phase 3|226||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.679215|2017-10-11 05:27:40.679215
NCT00180921|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-24|||July 2004||2004-07-01|September 2006|2006-09-01||||||||Interventional|||Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck|Phase II Study of Imatinib (Glivec) Administered as a Daily Oral Treatment in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck Overexpressing KIT|Unknown status|Recruiting|Phase 2|30|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.75602|2017-10-11 05:27:40.75602
NCT00180934|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-22|||July 1999||1999-07-01|September 2005|2005-09-01||||||||Interventional|||Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area|Interest of a Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area: a Multicentric Phase III Randomized Trial|Unknown status|Active, not recruiting|Phase 3|280||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.835417|2017-10-11 05:27:40.835417
NCT00180947|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-07|||June 2003||2003-06-01|September 2006|2006-09-01||||||||Interventional|||Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse|Phase II Study of Vinorelbine + Cyclofosfamide Association Among Patients Reached of Refractory Tumours or in Relapse|Unknown status|Recruiting|Phase 2|210||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.901007|2017-10-11 05:27:40.901007
NCT00180960|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-07|||June 2003||2003-06-01|September 2006|2006-09-01||||||||Interventional|||Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia|Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery With Intraperitoneal Chemohyperthermia Using Oxaliplatin Plus Irinotecan|Terminated||Phase 2|100||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:40.97455|2017-10-11 05:27:40.97455
NCT00180973|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||February 1995||1995-02-01|September 2005|2005-09-01||||||||Interventional|||PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.|MULTICENTRIC INTERNATIONAL RANDOMIZED PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.|Unknown status|Active, not recruiting|Phase 3|520||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:41.043634|2017-10-11 05:27:41.043634
NCT00180986|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-13|||October 1995||1995-10-01|September 2005|2005-09-01||||||||Interventional|||Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child|Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child|Unknown status|Active, not recruiting|Phase 3|120||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:41.317485|2017-10-11 05:27:41.317485
NCT00180999|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-07|||February 2002||2002-02-01|September 2006|2006-09-01||||||||Interventional|||Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course|Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course|Terminated||Phase 3|420||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:41.379066|2017-10-11 05:27:41.379066
NCT00181012|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-18|||May 2005||2005-05-01|September 2006|2006-09-01||||||||Interventional|||Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics|Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics: Efficacy Study in Adults and Children. Randomized Prospective Study With Direct Individual Benefit|Unknown status|Recruiting|Phase 3|100|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:41.440164|2017-10-11 05:27:41.440164
NCT00181025|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-11|||May 2004||2004-05-01|September 2006|2006-09-01||||||||Interventional|||Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs’ Girdle|Isolated Pelvic and Limb Perfusion With 1mg TNFa in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs’ Girdle|Unknown status|Recruiting|Phase 2|33|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:41.523456|2017-10-11 05:27:41.523456
NCT00181038|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-27|||June 2004||2004-06-01|September 2006|2006-09-01||||||||Interventional|||Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery|Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery: Comparing Continuous Infusion of Local Anesthetic With Systemic Multimodal Analgesia|Unknown status|Recruiting|Phase 3|40|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:41.598985|2017-10-11 05:27:41.598985
NCT00181051|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||February 2003||2003-02-01|September 2005|2005-09-01||||||||Interventional|||Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia|Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia|Suspended||Phase 3|128||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-10-11 05:27:41.673213|2017-10-11 05:27:41.673213
NCT00181064|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-07-01|||September 2005||2005-09-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Atkins Diet for Difficult-to-Control Headaches in Teenagers|Use of the Atkins Diet for Adolescents With Chronic Daily Headache.|Completed||Phase 1|10|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-10-11 05:27:41.75519|2017-10-11 05:27:41.75519
NCT00181077|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2012-09-21|||June 2003||2003-06-01|September 2012|2012-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Hypertonic Saline Use in Preeclampsia|Hypertonic Saline Use for Volume Expansion in Postpartum Preeclampsia|Completed||Phase 1|20||Johns Hopkins University|||||f||||f||||||||||2017-10-11 05:27:41.831559|2017-10-11 05:27:41.831559
NCT00181090|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2009-03-26|||February 2005||2005-02-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Use of the Atkins Diet for Children With Intractable Epilepsy: A Comparison of Daily Carbohydrate Limits||Completed||Phase 1|30||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:27:41.910504|2017-10-11 05:27:41.910504
NCT00181116|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2009-03-26|||March 2005||2005-03-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Levetiracetam for Benign Rolandic Epilepsy|Efficacy of Levetiracetam for Language Dysfunction Associated With Benign Epilepsy With Centrotemporal Spikes|Completed||Phase 4|6||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:27:41.98753|2017-10-11 05:27:41.98753
NCT00181129|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-29|||September 2002||2002-09-01|September 2008|2008-09-01||||||||Interventional|||Fatigue and Cancer Treatment(FACT)- an Exercise Intervention|Mitigating Cancer Treatment-Related Fatigue by Exercise|Completed||N/A|140|Anticipated|Johns Hopkins University|||||f||||||||||||||2017-10-11 05:27:42.063582|2017-10-11 05:27:42.063582
NCT00181142|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-09-10|||October 1999||1999-10-01|August 2004|2004-08-01|December 2004||2004-12-01|||||Interventional|||The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation|A Phase 3 Study Comparing the Use of Daclizumab Vs Thymoglobulin as Induction Therapy in Lung Transplantation|Completed||Phase 2/Phase 3|60||Johns Hopkins University|||||||||||||||||||2017-10-11 05:27:42.125851|2017-10-11 05:27:42.125851
NCT00181155|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-28|2015-11-11||November 2004||2004-11-01|April 2017|2017-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Intravenous Allopurinol in Heart Failure|Effects of Xanthine Oxidase Inhibition on Mechano-Energetic Coupling in Heart Failure|Completed||Phase 2|18|Actual|Johns Hopkins University|The limitations of the current study include the small placebo group sample size and the etiologic heterogeneity of the nonischemic cardiomyopathy group.|2|||f||||f||||||||No||2017-10-11 05:27:42.212516|2017-10-11 05:27:42.212516
NCT00181181|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-27|||May 2003||2003-05-01|September 2006|2006-09-01|April 2007|Actual|2007-04-01|June 2006|Actual|2006-06-01||Interventional|||The Effect of Statin Use on Vascular Function in Hypertensive Subjects|The Effect of Statin Use on Vascular Function in Hypertensive Subjects|Terminated||Phase 4|24|Actual|Johns Hopkins University||2||"Coronary flow by echo Doppler was obtainable in about 50% of subjects. The study was stopped   early because of insufficient sample size to achieve adequate power"|f||||||||||||||2017-10-11 05:27:42.549884|2017-10-11 05:27:42.549884
NCT00179049|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-12|||April 2003||2003-04-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|||||Observational|||Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant|Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant (HSCT)|Completed||N/A|100|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-10-11 05:29:11.012746|2017-10-11 05:29:11.012746
NCT00181194|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 2005||2005-05-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Reducing Asthma Disparities by Improving Provider-Patient Communication|Reducing Asthma Disparities by Improving Provider-Patient Communication About Asthma Severity and Adherence With Therapy|Unknown status|Recruiting|N/A|350||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:27:42.646335|2017-10-11 05:27:42.646335
NCT00181220|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-08-21|||April 2004||2004-04-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma|Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 1|20||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:27:42.819819|2017-10-11 05:27:42.819819
NCT00181233|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-27|||October 2003||2003-10-01|June 2017|2017-06-01|July 2020|Anticipated|2020-07-01|June 2019|Anticipated|2019-06-01||Observational|||Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk|Functional Energetics and Imaging for Phenotypic Characterization of Patients at Risk for Sudden Cardiac Death|Recruiting||N/A|400|Anticipated|Johns Hopkins University|||1||f||||f||||||||No||2017-10-11 05:27:42.905364|2017-10-11 05:27:42.905364
NCT00181246|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-08-23|||October 2003||2003-10-01|August 2017|2017-08-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain||Completed||N/A|53||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:27:42.999419|2017-10-11 05:27:42.999419
NCT00181259|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-28|||January 1988||1988-01-01|April 2017|2017-04-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|||Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism|In Vivo Cardiac Metabolism in Normal, Ischemic, and Cardiomyopathic Patients During Rest and Stress|Recruiting||N/A|500|Anticipated|Johns Hopkins University|||1||f||||f||||||||No||2017-10-11 05:27:43.076699|2017-10-11 05:27:43.076699
NCT00181272|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2013-05-09|||September 2005||2005-09-01|May 2013|2013-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease|Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease|Terminated||Phase 2|18||Johns Hopkins University||||Principal Investigator moved institutions|f||||||||||||||2017-10-11 05:27:43.174434|2017-10-11 05:27:43.174434
NCT00181298|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-03-05|||March 2006||2006-03-01|March 2008|2008-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Memantine in Systemic Lupus Erythematosus|Memantine in Systemic Lupus Erythematosus|Completed||N/A|61|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 05:27:43.375858|2017-10-11 05:27:43.375858
NCT00181311|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2006-10-25|||August 2005||2005-08-01|August 2005|2005-08-01|October 2006||2006-10-01|||||Observational|||Investigation of the Incidence of Complications After Vaginal and Abdominal Hysterectomy|Prospective Investigation of the Incidence of Complications After Vaginal and Abdominal Hysterectomy|Unknown status|Recruiting|N/A|200||Maasland Hospital|||||f||||||||||||||2017-10-11 05:27:43.481749|2017-10-11 05:27:43.481749
NCT00181350|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-06-29|||November 2003||2003-11-01|June 2009|2009-06-01|July 2007|Actual|2007-07-01|||||Interventional|||Serial CT Scans in Fractionated Stereotactic Radiotherapy|Serial CT Scans for the Evaluation of Two Different Relocatable Fixation Systems in Fractionated Stereotactic Radiotherapy|Completed||Phase 3|20||Maastricht Radiation Oncology|||||f||||t||||||||||2017-10-11 05:27:43.562911|2017-10-11 05:27:43.562911
NCT00181506|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-29|||December 2001||2001-12-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy|HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Accelerated Conformal Radiotherapy in Patients With Inoperable Non-Small Cell Lung Cancer.|Completed||Phase 1/Phase 2|180||Maastricht Radiation Oncology|||||f||||||||||||||2017-10-11 05:27:43.716038|2017-10-11 05:27:43.716038
NCT00181532|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-29|||May 2003||2003-05-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|||||Interventional|||Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC|A Multicentre Randomised Double Blind Placebo-Controlled Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC. An Evaluation of Both Tumor Radiosensitization and Normal Tissue Protection|Completed||Phase 2|102||Maastricht Radiation Oncology|||||f||||t||||||||||2017-10-11 05:27:43.799205|2017-10-11 05:27:43.799205
NCT00181545|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-29|||December 2004||2004-12-01|June 2009|2009-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.|Individualised Radiation Dose Determination on Basis of Normal Tissue Dose Constraints in Patients With Non-Small-Cell Lung Cancer: A Phase I Study|Completed||Phase 1|30|Anticipated|Maastricht Radiation Oncology|||||f||||t||||||||||2017-10-11 05:27:43.882162|2017-10-11 05:27:43.882162
NCT00181558|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-05-07|||December 2001||2001-12-01|May 2010|2010-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone|Atrasentan and Zometa for Men With Androgen Independent Prostate Cancer Metastatic to Bone: A Randomized Pilot Study|Completed||Phase 2|44||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:43.964393|2017-10-11 05:27:43.964393
NCT00181571|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-26|||June 2003||2003-06-01|June 2013|2013-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder|A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 4|297|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:27:44.053598|2017-10-11 05:27:44.053598
NCT00181584|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-07-09|||September 2003||2003-09-01|July 2013|2013-07-01||||February 2006|Actual|2006-02-01||Interventional|||Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer|Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer|Completed||Phase 2|60|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-10-11 05:27:44.144268|2017-10-11 05:27:44.144268
NCT00181597|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-12-02|||March 2004||2004-03-01|December 2013|2013-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Trilostane for Androgen-Independent Prostate Cancer|A Phase II Study of Trilostane for Androgen-Independent Prostate Cancer|Completed||Phase 2|24|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:27:44.241067|2017-10-11 05:27:44.241067
NCT00181610|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-05-08|2013-02-05||September 2004||2004-09-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||One subject did not complete the study and data was not analyzed for that subject.|Recombinant Human Prolactin for Lactation Induction|Recombinant Human Prolactin for Lactation Induction in Mothers of Premature Infants|Completed||Phase 2|11|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-10-11 05:27:44.323679|2017-10-11 05:27:44.323679
NCT00181623|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-05-07|2013-02-05||January 2005||2005-01-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Recombinant Human Prolactin for Lactation Induction|Recombinant Human Prolactin for Lactation Induction in Prolactin Deficient Mothers|Completed||Phase 2|6|Actual|Massachusetts General Hospital|Small numbers as this was an orphan disease trial.|1|||f||||||||||||||2017-10-11 05:27:44.641718|2017-10-11 05:27:44.641718
NCT00181636|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-23||||||April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder||Completed||N/A|25||Massachusetts General Hospital|||||f||||f||||||||||2017-10-11 05:27:44.807263|2017-10-11 05:27:44.807263
NCT00181649|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-05-08|||September 2006||2006-09-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Recombinant Human Prolactin for Lactation Induction|Recombinant Human Prolactin for Lactation Induction in Adoptive Mothers|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||1||Not able to recruit any subjects.|f||||||||||||||2017-10-11 05:27:44.879206|2017-10-11 05:27:44.879206
NCT00181662|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-02|||August 2005||2005-08-01|April 2007|2007-04-01||||||||Interventional|||Pharmacokinetics of Curcumin in Healthy Volunteers|Evaluation of Naturally Occurring Inhibitors of UDP-Glucuronyltransferase on the Oral Bioavailability of Curcumin in Normal Healthy Volunteers|Completed||N/A|6||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:44.949207|2017-10-11 05:27:44.949207
NCT00181675|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-22|||December 2002||2002-12-01|July 2010|2010-07-01|September 2003||2003-09-01|||||Interventional|||A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder|A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 4|40||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:45.021508|2017-10-11 05:27:45.021508
NCT00181688|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-04|||October 2003||2003-10-01|December 2012|2012-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer|A Phase II Study of ZD1839 (Iressa) Plus Anastrozole (Arimidex) in Patients With Relapsed Ovarian Cancer|Completed||Phase 2|35||Massachusetts General Hospital|||||f||||t||||||||||2017-10-11 05:27:45.11838|2017-10-11 05:27:45.11838
NCT00181701|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-04|||October 2004||2004-10-01|December 2012|2012-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin|A Phase II Trial of Intraperitoneal Paclitaxel and Carboplatin Therapy in the Treatment of Women With Newly Diagnosed, Optimally Cytoreduced Carcinoma of Mullerian Origin|Completed||Phase 2|46|Anticipated|Massachusetts General Hospital|||||f||||t||||||||||2017-10-11 05:27:45.194183|2017-10-11 05:27:45.194183
NCT00181714|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-05-02|2012-01-05||November 2003||2003-11-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta|Prevention of Cigarette Smoking in ADHD Youth With Concerta|Completed||Phase 4|203|Actual|Massachusetts General Hospital|The main limitation of this report stems from its uncontrolled, open-label design. Thus, we cannot assert a causal relationship between lower smoking rates and OROS MPH prescription.|1|||f||||t||||||||||2017-10-11 05:27:45.432475|2017-10-11 05:27:45.432475
NCT00181727|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-21|||January 2004||2004-01-01|October 2013|2013-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder|Open-Label Study of Divalproex Sodium Extended Release for the Treatment of Mania in Children Ages 6-12 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Completed||Phase 4|14||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:45.769813|2017-10-11 05:27:45.769813
NCT00181740|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-07-22|||December 2003||2003-12-01|July 2010|2010-07-01|July 2005|Actual|2005-07-01|||||Interventional|||Concerta Treatment in Adults With ADHD NOS|A Pilot Study of Concerta Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified|Completed||Phase 4|30||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:45.87742|2017-10-11 05:27:45.87742
NCT00181753|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-12|||November 2009||2009-11-01|January 2017|2017-01-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|||Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition|Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition|Withdrawn||N/A|0|Actual|National Institute of General Medical Sciences (NIGMS)||4||"State of Mass. tightened regulations for making intravenous solutions for research subjects.   Study was withdrawn and no participants were enrolled."|f||||t||||||||||2017-10-11 05:27:45.975239|2017-10-11 05:27:45.975239
NCT00181766|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-02|2010-02-26||December 2003||2003-12-01|December 2013|2013-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)|A Pilot Study of Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified|Completed||Phase 4|45|Actual|Massachusetts General Hospital|"small, open label study
short exposure to medication"|1|||f||||t||||||||||2017-10-11 05:27:46.115819|2017-10-11 05:27:46.115819
NCT00181779|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-21|||February 2003||2003-02-01|October 2013|2013-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder|Open-Label Pilot Study of Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Completed||Phase 4|20||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:46.42379|2017-10-11 05:27:46.42379
NCT00181792|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-02|||May 2005||2005-05-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta|Family Risk Analysis of Substance Use in ADHD Youth Treated With Concerta|Completed||Phase 4|70|Actual|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-11 05:27:46.524473|2017-10-11 05:27:46.524473
NCT00181805|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-23|||September 2004||2004-09-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|June 2010|Actual|2010-06-01||Observational|||Natural History of Gastroesophageal Reflux (GER) in Children and Adolescents|The Natural History of Children With Persistent Gastroesophageal Reflux Disease (Ages 12 to 17 Years)|Unknown status|Active, not recruiting|N/A|25|Anticipated|Massachusetts General Hospital|||2||f||||f||||||||||2017-10-11 05:27:46.592155|2017-10-11 05:27:46.592155
NCT00181818|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 1999||1999-10-01|September 2005|2005-09-01|December 2003||2003-12-01|||||Interventional|||Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease|Safety and Efficacy of Sustained-Release (SR) Bupropion for Smokers Hospitalized Smokers With Acute Coronary Heart Disease|Completed||Phase 4|248||Massachusetts General Hospital|||||||||||||||||||2017-10-11 05:27:46.679883|2017-10-11 05:27:46.679883
NCT00181831|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-12|||December 2002||2002-12-01|June 2013|2013-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Spectroscopy in Children and Adolescents With Bipolar Disorder|Proton Magnetic Resonance Spectroscopy in Children and Adolescents With Bipolar Disorder|Completed||N/A|80||Massachusetts General Hospital|||1||f||||||||||||||2017-10-11 05:27:46.791325|2017-10-11 05:27:46.791325
NCT00181844|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-09|2011-07-27||January 2005||2005-01-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder|A Pilot Open Study of the Safety and Effectiveness of Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorders|Completed||Phase 4|51|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 05:27:46.899717|2017-10-11 05:27:46.899717
NCT00181857|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-30|||February 2005||2005-02-01|October 2013|2013-10-01|February 2008|Actual|2008-02-01|February 2006|Actual|2006-02-01||Observational|||Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)|Risk of Attention Deficit Hyperactivity Disorder in the Children of Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified: A Pilot Study|Completed||N/A|58|Actual|Massachusetts General Hospital|||1||f||||t||||||||||2017-10-11 05:27:47.207411|2017-10-11 05:27:47.207411
NCT00181870|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-18|||July 2005||2005-07-01|June 2010|2010-06-01||||August 2007|Actual|2007-08-01||Interventional|||Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder|Open-Label Study of Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Completed||Phase 4|33|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 05:27:47.293098|2017-10-11 05:27:47.293098
NCT00181883|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-09|2011-07-19||February 2005||2005-02-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder|Open-Label Study of Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar and Bipolar Spectrum Disorder|Completed||Phase 4|30|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 05:27:47.404476|2017-10-11 05:27:47.404476
NCT00181896|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-14|||January 2005||2005-01-01|July 2011|2011-07-01||||February 2007|Actual|2007-02-01||Interventional|||Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder|Open-Label Study of Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar and Bipolar Spectrum Disorder|Terminated||Phase 4|1|Actual|Massachusetts General Hospital||1||Study was terminated due to lack of recruitment|f||||t||||||||||2017-10-11 05:27:47.671819|2017-10-11 05:27:47.671819
NCT00181909|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-27|||September 2001||2001-09-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Efficacy of Proactive Telephone Counseling for Pregnant Smokers Enrolled in a Managed Care Organization||Completed||Phase 3|434||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:47.740973|2017-10-11 05:27:47.740973
NCT00181922|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-21|||March 2002||2002-03-01|October 2013|2013-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder|Open-Label Study of Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Spectrum Disorder|Completed||Phase 4|20||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:47.812539|2017-10-11 05:27:47.812539
NCT00181935|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-05-03|||March 2001||2001-03-01|May 2013|2013-05-01|July 2004|Actual|2004-07-01|||||Interventional|||Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder|Open-Label Comparative Study of Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Spectrum Disorder|Completed||Phase 4|40||Massachusetts General Hospital|||||f||||f||||||||||2017-10-11 05:27:47.885239|2017-10-11 05:27:47.885239
NCT00181948|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-18|||September 2004||2004-09-01|June 2010|2010-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy|A Pilot Study of Strattera Treatment in Children With Attention-Deficit/Hyperactivity Disorder Who Have Poor Response to Stimulant Therapy|Completed||Phase 4|30|Anticipated|Massachusetts General Hospital|||||f||||f||||||||||2017-10-11 05:27:47.954118|2017-10-11 05:27:47.954118
NCT00181961|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-02-09|||April 2005||2005-04-01|February 2006|2006-02-01||||||||Interventional|||Safety and Effectiveness Study of Maca Root to Treat Antidepressant-Induced Sexual Dysfunction|A Dose-Finding Study of the Tolerability and Efficacy of Maca Root in Patients With Antidepressant-Induced Sexual Dysfunction|Unknown status|Active, not recruiting|Phase 3|20||Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:48.02717|2017-10-11 05:27:48.02717
NCT00181974|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-10-22|||March 2000||2000-03-01|October 2012|2012-10-01|November 2007|Actual|2007-11-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy of a Fibrin Sealant in Burn Surgery|Efficacy of a Fibrin Sealant in Burn Surgery|Completed||N/A|25|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:27:48.081079|2017-10-11 05:27:48.081079
NCT00181987|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-21|||August 2002||2002-08-01|October 2013|2013-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder|Open-Label Study of Concerta in the Treatment of ADHD in Youth and Adults With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Completed||Phase 4|29|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 05:27:48.149824|2017-10-11 05:27:48.149824
NCT00182000|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-10|2012-05-01||November 2003||2003-11-01|July 2012|2012-07-01||||January 2008|Actual|2008-01-01||Interventional|||Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy|A Randomized, Double-Blind, Placebo-Controlled Medication Trial With D-Cycloserine for Individuals With OCD Currently Receiving Behavior Therapy|Completed||Phase 3|33|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-10-11 05:27:48.222681|2017-10-11 05:27:48.222681
NCT00182013|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-06-12|||June 2001||2001-06-01|June 2013|2013-06-01||||February 2004|Actual|2004-02-01||Interventional|||Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder||Completed||Phase 4|106|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 05:27:48.571159|2017-10-11 05:27:48.571159
NCT00182026|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-10-07|||June 2005||2005-06-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation|A Randomized Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation: Diabetes IN-CHARGE|Unknown status|Active, not recruiting|N/A|500|Anticipated|McMaster University||1|||f||||f||||||||||2017-10-11 05:27:48.63908|2017-10-11 05:27:48.63908
NCT00182039|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-04-10|||October 2002||2002-10-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|POISE||POISE Trial: Perioperative Ischemic Evaluation Study|Perioperative Ischemic Evaluation Study (POISE) Trial|Terminated||Phase 3|8351|Actual|McMaster University||2||Please see detailed description for reason why study was terminated.|f||||t||||||||||2017-10-11 05:27:48.735366|2017-10-11 05:27:48.735366
NCT00182052|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-05-22|||September 2000||2000-09-01|May 2013|2013-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer|Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer: A Randomized Double-Blind, Placebo Controlled Phase III Study|Completed||Phase 3|100|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:27:48.848592|2017-10-11 05:27:48.848592
NCT00182065|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-07|||March 2004||2004-03-01|August 2005|2005-08-01|October 2006||2006-10-01|||||Observational|||Heart Failure, Functional and Cognitive Decline, and Psychiatric Symptoms in Nursing Home Patients|The Effect of Congestive Heart Failure on Functional and Cognitive Decline and Neuropsychiatric Symptoms in Residents of Long-Term Care Facilities|Unknown status|Active, not recruiting|N/A|586||McMaster University|||||f||||||||||||||2017-10-11 05:27:48.948593|2017-10-11 05:27:48.948593
NCT00182078|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-07-08|2012-06-12||November 2002||2002-11-01|July 2014|2014-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional||Analysis was conducted with participants using available data. The different number participants who completed measures at the final time point is as follows: DICA-Parent (6 placebo, 15 sertraline); DICA-Child (6 placebo, 16 sertraline); and CDI (4 placebo, 16 sertraline).|A Study of Sertraline to Prevent PTSD|A Study of Sertraline to Prevent PTSD|Completed||Phase 4|26|Actual|Massachusetts General Hospital|One limitation of this study was the small sample size, due to the challenge of recruiting traumatized children and their parents for participation in a randomized controlled trial of a medication.|2|||f||||t||||||||||2017-10-11 05:27:49.039126|2017-10-11 05:27:49.039126
NCT00182091|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-04-26|2012-02-07||August 2004||2004-08-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency|Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly|Completed||N/A|75|Actual|Massachusetts General Hospital||4|||f||||t||||||||||2017-10-11 05:27:49.401123|2017-10-11 05:27:49.401123
NCT00182104|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-19|||August 1998||1998-08-01|April 2007|2007-04-01|July 2005|Actual|2005-07-01|||||Interventional|||International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures|An International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures|Completed||Phase 4|111||McMaster University|||||f||||||||||||||2017-10-11 05:27:51.347809|2017-10-11 05:27:51.347809
NCT00182117|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-01-23|||October 2003||2003-10-01|September 2005|2005-09-01|April 2006||2006-04-01|||||Observational|||Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population|Pilot Bleeding Study|Unknown status|Recruiting|N/A|490||McMaster University|||||f||||||||||||||2017-10-11 05:27:51.438031|2017-10-11 05:27:51.438031
NCT00182130|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-09-10|||May 2002||2002-05-01|July 2005|2005-07-01|June 2007||2007-06-01|||||Interventional|||Quality Initiative in Rectal Cancer (QIRC) Trial|Quality Initiative in Rectal Cancer (QIRC) Trial|Unknown status|Active, not recruiting|N/A|691||McMaster University|||||f||||||||||||||2017-10-11 05:27:51.507653|2017-10-11 05:27:51.507653
NCT00182156|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-06-16|||October 2004||2004-10-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Cohort Study Comparing Short Daily Hemodialysis (HD) With Conventional HD|Cohort Study Examining the Effects of Short Daily Hemodialysis As Compared to Conventional Hemodialysis in Outpatients Treated at St Joseph's Healthcare, Hamilton|Unknown status|Active, not recruiting|N/A|40|Anticipated|McMaster University|||3||f||||f||||||||||2017-10-11 05:27:51.815495|2017-10-11 05:27:51.815495
NCT00182169|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||July 1997||1997-07-01|March 2003|2003-03-01|June 2005||2005-06-01|||||Interventional|||Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure|Randomized, Placebo Control, Clinical Trial Evaluating the Effect of Human Recombinant Growth Hormone in Patients With Severe Congestive Heart Failure. The Growth Hormone In Heart Failure Trial (GIFT)|Completed||Phase 2|80||McMaster University|||||f||||||||||||||2017-10-11 05:27:51.993643|2017-10-11 05:27:51.993643
NCT00182182|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-08|||July 2003||2003-07-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Interventional|||Evaluation of a Primary Care Based Heart Failure Management Program|Congestive Heart Failure Assessment and Management in Primary Care: CHAMP|Unknown status|Active, not recruiting|Phase 2/Phase 3|170||McMaster University|||||f||||||||||||||2017-10-11 05:27:52.058572|2017-10-11 05:27:52.058572
NCT00182208|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-07-21|||May 2004||2004-05-01|July 2008|2008-07-01|December 2005|Actual|2005-12-01|June 2005|Actual|2005-06-01||Interventional|||Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial|Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial|Completed||Phase 3|32||McMaster University|||||f||||t||||||||||2017-10-11 05:27:52.209695|2017-10-11 05:27:52.209695
NCT00182221|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-28|||August 2003||2003-08-01|March 2017|2017-03-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Safety of a Diagnostic Strategy With D-Dimer Testing for PE|A Cohort Study Evaluating the Safety of a Diagnostic Strategy Involving D-Dimer Testing in Patients With Suspected Pulmonary Embolism|Completed||Phase 3|1000|Anticipated|McMaster University|||||f||||t||||||||||2017-10-11 05:27:52.30808|2017-10-11 05:27:52.30808
NCT00182234|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-17|||December 2005||2005-12-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||SONICS - Effectiveness of Specialist Oncology Nursing|A Study of the Effectiveness of Specialist Oncology Nursing Case Management in Improving Continuity of Supportive Cancer Care in the Community (SONICS)|Completed||Phase 3|183|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 05:27:52.393458|2017-10-11 05:27:52.393458
NCT00182247|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||December 1998||1998-12-01|September 2005|2005-09-01|January 2001||2001-01-01|||||Interventional|||D-Dimer and IPG for Recurrent Thrombosis (DIRECT)|D-Dimer and IPG for Recurrent Thrombosis (DIRECT) Study|Terminated||Phase 3|600||McMaster University|||||f||||||||||||||2017-10-11 05:27:52.47364|2017-10-11 05:27:52.47364
NCT00182260|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-14|||January 2000||2000-01-01|November 2012|2012-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD|ELVIS (Esophagitis-Laparoscopy Versus Inhibitors of Secretion) A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication (LNF) Versus Omeprazole for Treatment of Patients With Chronic Gastro-Esophageal Reflux Disease (GERD)|Completed||N/A|216|Actual|McMaster University||2|||f||||||||||||||2017-10-11 05:27:52.57607|2017-10-11 05:27:52.57607
NCT00182273|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2002||2002-01-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Canalith Repositioning Procedure for BPPV in Primary Care|Treatment of Benign Paroxysmal Positional Vertigo With the Canalith Repositioning Procedure in Family Practice: A Randomized Controlled Trial|Completed||Phase 3|56||McMaster University|||||f||||||||||||||2017-10-11 05:27:52.666993|2017-10-11 05:27:52.666993
NCT00182286|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 1999||1999-09-01|August 2005|2005-08-01|July 2001||2001-07-01|||||Observational|||Evaluation of Continuity of Care at a Health Service Organization|The Evaluation of the Continuity of Care at the Group Health Centre, A Unique Multi-Specialty, Multi-Disciplinary Health Service Organization|Completed||N/A|342||McMaster University|||||f||||||||||||||2017-10-11 05:27:52.740114|2017-10-11 05:27:52.740114
NCT00182299|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-19|||September 2003||2003-09-01|April 2007|2007-04-01|April 2008|Anticipated|2008-04-01|||||Interventional|||An RCT to Compare the Outcomes of Patients With Large Rotator Cuff Repair That Undergo Repair With or Without SIS|A Randomized Clinical Trial Comparing the Effectiveness of Rotator Cuff Repair With or Without Augmentation With Porcine Small Intestine Submucosa (SIS) for Large Rotator Cuff Tears: Pilot Study Phase|Unknown status|Active, not recruiting|Phase 4|60||McMaster University|||||f||||t||||||||||2017-10-11 05:27:52.809776|2017-10-11 05:27:52.809776
NCT00182312|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-26|||October 1999||1999-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|March 2007|Actual|2007-03-01||Interventional|||Caffeine for Apnea of Prematurity (CAP)|Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants|Completed||Phase 3|2000|Anticipated|McMaster University||1|||f||||t||||||||||2017-10-11 05:27:52.870838|2017-10-11 05:27:52.870838
NCT00182325|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-18|||February 2004||2004-02-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Effects of a Personalized Web-Based Antenatal Care Planner|Women's Web Access to Their Own Antenatal Health Record and Personalized Health Information: Effect on Pregnancy Health Outcomes and Patient Satisfaction|Completed||Phase 3|210||McMaster University|||||f||||f||||||||||2017-10-11 05:27:53.03319|2017-10-11 05:27:53.03319
NCT00182338|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-19|||January 2005||2005-01-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Evaluation of Volume Status in Peritoneal Dialysis Patients|Evaluation of Volume Status in Peritoneal Dialysis Patients|Completed||N/A|22|Actual|McMaster University|||1||f||||f||||||||||2017-10-11 05:27:53.106068|2017-10-11 05:27:53.106068
NCT00182351|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-07|||April 1996||1996-04-01|September 2006|2006-09-01|July 1999||1999-07-01|||||Interventional|||D-Dimer Vs Serial Compression Ultrasound Study|Evaluation of the Safety, Efficacy and Cost-Effectiveness of Two Strategies for the Diagnosis of Deep Vein Thrombosis|Completed||Phase 3|810||McMaster University|||||f||||||||||||||2017-10-11 05:27:53.188294|2017-10-11 05:27:53.188294
NCT00182364|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2006-11-16|||February 2003||2003-02-01|November 2006|2006-11-01|February 2004||2004-02-01|||||Interventional|||PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)|PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)|Completed||Phase 3|120||McMaster University|||||f||||||||||||||2017-10-11 05:27:53.272747|2017-10-11 05:27:53.272747
NCT00182377|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-19||||||September 2004|2004-09-01||||||||Interventional|||Pentastarch Use in Cardiac Surgery|A Randomized, Prospective, Blinded Clinical Trial to Evaluate the Efficacy and Safety of Pentastarch Use in Patients Undergoing Coronary Artery Bypass Surgery or Valve Replacement Surgery Using Cardiopulmonary Bypass Circuits|Unknown status|Recruiting|N/A|||McMaster University|||||f||||||||||||||2017-10-11 05:27:53.520946|2017-10-11 05:27:53.520946
NCT00182390|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-22|||February 2001||2001-02-01|September 2015|2015-09-01|November 2005|Actual|2005-11-01|February 2003|Actual|2003-02-01||Interventional|||Premature Infants in Need of Transfusion (PINT)|A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns <1000g Birth Weight|Completed||Phase 3|424||McMaster University|||||f||||||||||||||2017-10-11 05:27:53.638899|2017-10-11 05:27:53.638899
NCT00182403|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-06|||September 1998||1998-09-01|June 2017|2017-06-01|May 2004||2004-05-01|||||Interventional|||Fixed Dose Heparin Study|Fixed Dose Unfractionated Heparin for Initial Treatment of Venous Thromboembolism|Completed||Phase 3|866||McMaster University|||||f||||||||||||||2017-10-11 05:27:53.781523|2017-10-11 05:27:53.781523
NCT00182416|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-18|||May 2004||2004-05-01|October 2007|2007-10-01|January 2006|Actual|2006-01-01|||||Interventional|||Second Canadian Trial of Physiologic Pacing (CTOPP II): Pilot Trial|Second Canadian Trial of Physiologic Pacing (CTOPP II): Pilot Trial|Completed||Phase 3|300||McMaster University|||||f||||||||||||||2017-10-11 05:27:53.899453|2017-10-11 05:27:53.899453
NCT00182429|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-04-12|||February 2004||2004-02-01|April 2016|2016-04-01|April 2005||2005-04-01|||||Interventional|||Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment|Prospective, Randomized Study of Oral Metronidazole vs. Oral Metronidazole and Rifampin for Treatment of Clostridium Difficile-associated Diarrhea (CDAD)|Completed||Phase 3|100||McMaster University|||||f||||||||||||||2017-10-11 05:27:54.000878|2017-10-11 05:27:54.000878
NCT00182442|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-10-10|||October 2003||2003-10-01|March 2005|2005-03-01|March 2006||2006-03-01|||||Interventional|||Cognition, Functioning and Quality of Life|A One-Year Multi-Centre Randomized, Double Blind, Controlled Effectiveness Study of Quetiapine and Olanzapine, Comparing Their Relative Potential in Improving Neuro-Cognitive Deficits, Functional Outcomes and Quality of Life in Schizophrenia|Completed||Phase 4|80||McMaster University|||||f||||||||||||||2017-10-11 05:27:54.114027|2017-10-11 05:27:54.114027
NCT00182455|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-12-12|||March 2004||2004-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)|Topiramate Augmentation to a Selective Serotonin Re-uptake Inhibitor (SSRI) in Treatment-Resistant Generalized Social Phobia: A Double-Blind Placebo -Controlled Trial.|Recruiting||Phase 4|48|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 05:27:54.228297|2017-10-11 05:27:54.228297
NCT00182468|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-09-08|||April 2005||2005-04-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Does Routine Screening for Intimate Partner Violence Against Women in Health Care Settings do More Good Than Harm?|If, When and How to Ask the Question(s): Assessing Screening Approaches to Identifying Woman Abuse in Health Care Settings|Completed||N/A|5681|Actual|McMaster University||2|||f||||t||||||||||2017-10-11 05:27:54.394742|2017-10-11 05:27:54.394742
NCT00182481|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-15|||September 1999||1999-09-01|October 2003|2003-10-01|September 2001||2001-09-01|||||Interventional|||LOMA: Long-Term Management of Asthma|Long Term Management of Asthma (LOMA) Study- How Useful is the Sputum Count Compared With the Usual Clincal Variables?|Completed||N/A|112||McMaster University|||||f||||||||||||||2017-10-11 05:27:54.56055|2017-10-11 05:27:54.56055
NCT00182494|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||February 2005||2005-02-01|July 2005|2005-07-01|January 2009||2009-01-01|||||Interventional|||Diabetes Prevention Program in Schizophrenia [DPPS]|A Five Year, Prospective, Randomized, Blinded, Controlled Trial Comparing the Efficacy of a Modified Diabetes Prevention Protocol and the Standard Comprehensive Outpatient Care in Lowering the Incidence of New Onset Diabetes Among People Treated for Schizophrenia and Are at Risk to Develop Type II Diabetes Mellitus.|Unknown status|Recruiting|Phase 4|200||McMaster University|||||f||||||||||||||2017-10-11 05:27:54.665645|2017-10-11 05:27:54.665645
NCT00182507|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-09-08|||June 2000||2000-06-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Olanzapine in the Treatment of Hair Pulling (Trichotillomania)|A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania|Completed||Phase 4|34||McMaster University|||||f||||||||||||||2017-10-11 05:27:54.764318|2017-10-11 05:27:54.764318
NCT00182520|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-03-21|||January 2002||2002-01-01|March 2017|2017-03-01|April 2019|Anticipated|2019-04-01|February 2019|Anticipated|2019-02-01||Interventional|||Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)|A Study of Topiramate Augmentation in Serotonin Reuptake Inhibitor (SRI) -Refractory Obsessive Compulsive Disorder|Recruiting||Phase 4|48|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 05:27:54.838877|2017-10-11 05:27:54.838877
NCT00182533|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-03-21|||July 2002||2002-07-01|March 2017|2017-03-01|March 2018|Anticipated|2018-03-01|January 2018|Anticipated|2018-01-01||Interventional|||Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders|Sertraline in the Treatment of Generalized Social Phobia With Comorbidity|Active, not recruiting||Phase 4|170|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 05:27:54.954934|2017-10-11 05:27:54.954934
NCT00182546|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-04-27|||August 1998||1998-08-01|August 2005|2005-08-01|January 2001||2001-01-01|||||Interventional|||Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)|Canadian Pulmonary Embolism Diagnosis Study|Terminated||Phase 3|1126||McMaster University|||||f||||||||||||||2017-10-11 05:27:55.074439|2017-10-11 05:27:55.074439
NCT00182559|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2014-02-04|||April 2004||2004-04-01|February 2014|2014-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Vienna Prograf and Endothelial Progenitor Cell Study|The Vienna Prograf and Endothelial Progenitor Cell Study|Completed||Phase 4|148|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-10-11 05:27:55.203414|2017-10-11 05:27:55.203414
NCT00182572|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-08-11|||July 2005||2005-07-01|August 2008|2008-08-01||||||||Interventional|||Science-Based Treatment for Opioid-Dependent Adolescents|Science-Based Treatment for Opioid-Dependent Adolescents|Unknown status|Recruiting|Phase 2|80|Anticipated|National Development and Research Institutes, Inc.|||||||||||||||||||2017-10-11 05:27:55.332693|2017-10-11 05:27:55.332693
NCT00182585|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-08-11|||August 2004||2004-08-01|August 2008|2008-08-01||||||||Interventional|||Computer-Assisted HIV Prevention for Young Drug Users|Computer-Assisted HIV Prevention for Young Drug Users|Unknown status|Active, not recruiting|N/A|56|Anticipated|National Development and Research Institutes, Inc.|||||f||||||||||||||2017-10-11 05:27:55.464824|2017-10-11 05:27:55.464824
NCT00182598|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-08-11|||December 2004||2004-12-01|August 2008|2008-08-01||||||||Interventional|||Applying Web Technology to Buprenorphine Treatment|Applying Web Technology to Buprenorphine Treatment|Unknown status|Recruiting|N/A|90|Anticipated|National Development and Research Institutes, Inc.|||||f||||||||||||||2017-10-11 05:27:55.577178|2017-10-11 05:27:55.577178
NCT00182611|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2013-06-25|||April 2004||2004-04-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer|Phase III Clinical Study of Preoperative S-1/CDDP Combination Chemotherapy in Patients With Potentially Resectable Stage III Advanced Gastric Cancer|Completed||Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:27:55.715527|2017-10-11 05:27:55.715527
NCT00182624|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-06-30|||February 2, 2004||2004-02-02|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Observational|||Magnetic Resonance Imaging to Evaluate Prostate Cancer|Comprehensive Prostate MRI for the Evaluation of Prostate Cancer at 3.0T: A Pilot Study|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:27:55.854336|2017-10-11 05:27:55.854336
NCT00182637|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-01-19|2016-01-19||July 2004||2004-07-01|January 2016|2016-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma|A Phase II Study of Bortezomib (VELCADE®) in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL)|Completed||Phase 2|5|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:27:55.946978|2017-10-11 05:27:55.946978
NCT00182650|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-12-23|||June 2004||2004-06-01|December 2009|2009-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma|Pilot/Feasibility Study To Evaluate The Safety Of Cellular Immunotherapy For CD19+ Follicular Lymphoma Using Autologous Cytolytic T Cells Genetically-Modified To Be CD19-Specific And Co-Express HyTK|Completed||Phase 1|5|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-10-11 05:27:56.206977|2017-10-11 05:27:56.206977
NCT00182663|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-06-22|||June 2003||2003-06-01|April 2017|2017-04-01||||April 2007|Actual|2007-04-01||Interventional|||Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant|Maintenance Therapy With Thalidomide, Dexamethasone and Clarithromycin (Biaxin) Following Autologous/Syngeneic Transplant for Multiple Myeloma|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-10-11 05:27:56.361474|2017-10-11 05:27:56.361474
NCT00182689|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-05-06|2012-08-20||July 2005||2005-07-01|December 2012|2012-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer|A Phase II Trial of BAY 43-9006 (NSC-724772) in Patients With Platinum-Treated Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|89|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:27:56.579404|2017-10-11 05:27:56.579404
NCT00182702|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2013-03-22|||July 2005||2005-07-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer|A Phase II Trial of BMS 247550 (Ixabepilone) in Advanced Renal Cell Carcinoma|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:27:57.539107|2017-10-11 05:27:57.539107
NCT00182715|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2013-09-16|||March 2005||2005-03-01|December 2007|2007-12-01||||May 2009|Anticipated|2009-05-01||Interventional|||Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer|A Three-Arm Randomised Controlled Trial Comparing Either Continuous Chemotherapy Plus Cetuximab or Intermittent Chemotherapy With Standard Continuous Palliative Combination Chemotherapy With Oxaliplatin and a Fluoropyrimidine in First Line Treatment of Metastatic Colorectal Cancer (COIN)|Unknown status|Active, not recruiting|Phase 3|2421|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:27:57.649564|2017-10-11 05:27:57.649564
NCT00182728|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-06-14|2017-03-20||March 18, 2003|Actual|2003-03-18|June 2017|2017-06-01|July 2, 2027|Anticipated|2027-07-02|September 2011|Actual|2011-09-01||Interventional|NRR||Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer|Partial Breast Treatment Using Single Dose Intraoperative Radiotherapy for Patients With Early Stage Breast Cancer - A Feasibility Study With Molecular Analysis of Tumors and Normal Breast Epithelial Tissue|Active, not recruiting||N/A|89|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 05:27:57.947167|2017-10-11 05:27:57.947167
NCT00174356|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-11-06|||December 2002||2002-12-01|January 2006|2006-01-01|October 2005||2005-10-01|||||Interventional|||PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients|A Phase 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel And Carboplatin As First-Line Chemotherapy In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|39||Pfizer|||||f||||||||||||||2017-10-11 05:27:58.294947|2017-10-11 05:27:58.294947
NCT00174369|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-03-16|||November 2005||2005-11-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer|Phase 2 Study Of The MEK Inhibitor PD-0325901 In Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|34|Actual|Pfizer||1||Terminated [See Detailed Description for Termination Reason.]|f||||f||||||||||2017-10-11 05:27:58.371675|2017-10-11 05:27:58.371675
NCT00174382|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-03-04|2009-04-24||June 2005||2005-06-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia|An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia|Terminated||Phase 3|149|Actual|Pfizer||1||See Detailed Description|f||||f||||||||||2017-10-11 05:27:58.507597|2017-10-11 05:27:58.507597
NCT00174395|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-10-31|||March 2005||2005-03-01|October 2007|2007-10-01|October 2006|Actual|2006-10-01|||||Interventional|||A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine|A Multi-Center, Open-Label, Randomized, Parallel-Group Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine in Early Intervention.|Completed||Phase 4|220||Pfizer|||||f||||||||||||||2017-10-11 05:27:59.372541|2017-10-11 05:27:59.372541
NCT00174408|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-01|||March 1990||1990-03-01|May 2007|2007-05-01|February 2005||2005-02-01|||||Interventional|||Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age|Growth Hormone Treatment in Short Children Born Small for Date (Genotonorm)|Completed||Phase 3|110||Pfizer|||||f||||||||||||||2017-10-11 05:27:59.504009|2017-10-11 05:27:59.504009
NCT00174421|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-01|||April 2001||2001-04-01|May 2007|2007-05-01|August 2005||2005-08-01|||||Interventional|||Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height|Genotropin in Short Children Born Small for Gestational Ag - A Long-Term Study in Belgium|Completed||Phase 3|36||Pfizer|||||f||||||||||||||2017-10-11 05:27:59.561203|2017-10-11 05:27:59.561203
NCT00174434|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-01-26|||September 2005||2005-09-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer|A Phase 1 Study Of Paclitaxel In Combination With SU011248 For Patients With Breast Cancer As First-Line Treatment In The Advanced Disease Setting|Completed||Phase 1|22|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:27:59.640489|2017-10-11 05:27:59.640489
NCT00174447|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-20|2009-10-15||October 2001||2001-10-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031|Open Extension Study Evaluating The Long Term Efficacy , Safety And Tolerability Of Oral Ziprasidone In The Treatment Of Patients Who Have Successfully Completed The Previous Ziprasidone Study A1281031|Completed||Phase 3|43|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:27:59.770947|2017-10-11 05:27:59.770947
NCT00174642|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-09-14|||December 2004||2004-12-01|September 2009|2009-09-01||||December 2008|Actual|2008-12-01||Interventional|OSIRIS||Opposing Step-by-step Insulin Reinforcement to Intensified Strategy|Comparison of Three Therapeutic Strategies for Treating Type 2 Diabetes Mellitus Patients Poorly Controlled With Basal Insulin Associated With Oral Antidiabetic Drugs|Completed||Phase 3|811|Actual|Sanofi||3|||f||||||||||||||2017-10-11 05:28:02.51632|2017-10-11 05:28:02.51632
NCT00174460|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-07|2009-03-16||August 2005||2005-08-01|March 2017|2017-03-01|March 2010|Actual|2010-03-01|March 2008|Actual|2008-03-01||Interventional|AGA||Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age|Somatropin Therapy For Short Children Born Of Premature Gestation, A Controlled, Prospective Randomized, Multicenter Study With An Untreated Control Group.|Completed||Phase 2|33|Actual|Pfizer|Result values for the primary outcome measures were revised at the final analysis due to programmatic corrections: age rounded up if >6 months past last birthday. Height and height SDS not rounded for final analysis; rounded only for the reports.|2|||f||||f||||||||||2017-10-11 05:28:00.41736|2017-10-11 05:28:00.41736
NCT00174473|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-09|||June 2003||2003-06-01|May 2011|2011-05-01|August 2005|Actual|2005-08-01|||||Interventional|||A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children|An Open-label, Intravenous to Oral Switch, Multiple Dose Multi-Centre Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Hospitalized Children Aged 2 to 12 Years Who Require Treatment for the Prevention of Systemic Fungal Infections.|Completed||Phase 1/Phase 2|49|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:28:01.436839|2017-10-11 05:28:01.436839
NCT00174486|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-23|||February 2005||2005-02-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction|A Double Blind, Placebo Controlled, Parallel Group, Multicenter Study To Assess The Duration Of Action, Safety And Toleration Of Differing Doses and Combinations Of Immediate and Modified Release Formulations Of UK-369,003 and Cialis Compared To Placebo In Adult Male Subjects With Erectile Dysfunction|Completed||Phase 2|300||Pfizer|||||f||||||||||||||2017-10-11 05:28:01.487|2017-10-11 05:28:01.487
NCT00174499|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-07-06|||July 2005||2005-07-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum|An Open-label Study on Nicorette Freshmint Gum, 2 MG AND 4 MG in Smokers With Visible Teeth Staining Motivated to Quit|Completed||Phase 4|78|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 05:28:01.551419|2017-10-11 05:28:01.551419
NCT00174512|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-07|||March 2005||2005-03-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade|A Methodological Open-Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarisation and QT Interval At Fixed Heart Rate Under Autonomic Blockade|Completed||Phase 1|36||Pfizer|||||f||||||||||||||2017-10-11 05:28:01.63781|2017-10-11 05:28:01.63781
NCT00174525|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-05-08|||April 2005||2005-04-01|May 2012|2012-05-01|April 2008||2008-04-01|||||Interventional|||Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease|A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD|Unknown status|Active, not recruiting|Phase 2|||Pharmacology Research Institute|||||||||||||||||||2017-10-11 05:28:01.704594|2017-10-11 05:28:01.704594
NCT00174538|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-06-29|||March 2005||2005-03-01|July 2005|2005-07-01|December 2005||2005-12-01|||||Interventional|||Codeine in Sickle Cell Disease|The Effects of Cytochrome P450 2D6 Genotype on Pain Management With Codeine in Sickle Cell Disease|Completed||Phase 1/Phase 2|60|Anticipated|PriCara, Unit of Ortho-McNeil, Inc.|||||f||||||||||||||2017-10-11 05:28:01.763134|2017-10-11 05:28:01.763134
NCT00174551|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-07|||November 2003||2003-11-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||Feasibility Study: The Effect of Prazosin for Nighttime Symptoms of Civilian PTSD|The Effect of Prazosin for Nighttime Symptoms of Civilian PTSD|Unknown status|Active, not recruiting|N/A|20||Rainier Associates|||||f||||||||||||||2017-10-11 05:28:01.841582|2017-10-11 05:28:01.841582
NCT00174564|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-02-15|||April 2003||2003-04-01|February 2012|2012-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||EXIBIT: Oxaliplatin in Biliary Tract Cancer|A Multicentre Phase II Trial of Gemcitabine and Oxaliplatin (GEMOX) in Patients With Biliary Tract Cancer|Completed||Phase 2|67|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:28:01.905852|2017-10-11 05:28:01.905852
NCT00174577|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||February 2003||2003-02-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant|Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to an Adequate Trial of Antidepressant|Unknown status|Active, not recruiting|Phase 3|84||Rhode Island Hospital|||||f||||||||||||||2017-10-11 05:28:01.959013|2017-10-11 05:28:01.959013
NCT00174590|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-28|||September 2001||2001-09-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Treatment of Major Depressive Disorder With Psychotic Features.|Treatment of Major Depressive Disorder With Psychotic Features With Risperidone Monotherapy; Risperidone and Sertraline; or Haloperidol and Sertraline|Terminated||Phase 3|30||Rush University Medical Center|||||f||||||||||||||2017-10-11 05:28:02.029346|2017-10-11 05:28:02.029346
NCT00174603|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-28|||August 2005||2005-08-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Treatment of Depression With Quetiapine|Treatment of Major Depressive Disorder With Psychotic Features With Quetiapine Monotherapy; Quetiapine and Citalopram; or Haloperidol and Citalopram|Terminated||Phase 3|60||Rush University Medical Center||||Unable to recruit subjects|f||||f||||||||||2017-10-11 05:28:02.089733|2017-10-11 05:28:02.089733
NCT00174616|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-12-04|||July 2003||2003-07-01|December 2009|2009-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision|Phase 2 Study of Weekly Oxaliplatin and Capecitabine (XELOX) in Combination With Preoperative Radiotherapy in Patients With MRI Defined Locally Advanced Rectal Cancer|Completed||Phase 2|87|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:28:02.300374|2017-10-11 05:28:02.300374
NCT00174629|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-12-04|||June 2001||2001-06-01|December 2009|2009-12-01||||January 2007|Actual|2007-01-01||Interventional|||GILT Docetaxel - Non-Small Cell Lung Cancer|Open-Label, Cooperative, Randomized, Multicenter Phase III Study on the Use of Cisplatin Resistant Genotype (ERCC1 Over-Expression) in Tumor RNA to Customize Chemotherapy in Stage IV-IIIB (Malignant Pleural Effusion) Non-Small-Cell Lung Cancer Patients|Completed||Phase 3|449|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:28:02.41371|2017-10-11 05:28:02.41371
NCT00178984|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-05|||June 2000||2000-06-01|April 2017|2017-04-01|August 10, 2012|Actual|2012-08-10|August 10, 2012|Actual|2012-08-10||Observational|SQUID||Biomagnetic Characterization of Gastric Dysrhythmias:Study 2|Biomagnetic Characterization of Gastric Dysrhythmias:Study 2|Completed||N/A|78|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||||2017-10-11 05:29:10.59218|2017-10-11 05:29:10.59218
NCT00174655|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-11-09|||June 1998||1998-06-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||BIG 02/98 Docetaxel - Breast Cancer|An Intergroup Phase III Trial to Evaluate the Activity of Docetaxel, Given Either Sequentially or in Combination With Doxorubicin, Followed by CMF, in Comparison to Doxorubicin Alone or in Combination With Cyclophosphamide, Followed by CMF, in the Adjuvant Treatment of Node-positive Breast Cancer Patients.|Completed||Phase 3|2887|Actual|Sanofi||4|||f||||||||||||||2017-10-11 05:28:02.688943|2017-10-11 05:28:02.688943
NCT00174668|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-09-14|||November 2004||2004-11-01|September 2009|2009-09-01||||November 2007|Actual|2007-11-01||Interventional|GINGER||Insulin Glulisine in Diabetes Mellitus, Type 2|52-week, Open, Randomized, Multinational, Multicenter Clinical Trial Comparing Insulin Glulisine in Combination With Insulin Glargine in an Intensified Insulin Regimen to a Two-injection Conventional Insulin Regimen in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control Pretreated With a Two-injection Conventional Insulin Therapy|Completed||Phase 3|311|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:28:02.847206|2017-10-11 05:28:02.847206
NCT00174681|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-01-10|||April 2003||2003-04-01|January 2011|2011-01-01||||||||Interventional|||Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes|Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes|Completed||Phase 4|390||Sanofi|||||f||||||||||||||2017-10-11 05:28:02.99823|2017-10-11 05:28:02.99823
NCT00174694|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-09-24|||November 2004||2004-11-01|September 2009|2009-09-01||||December 2005|Actual|2005-12-01||Interventional|||CHOOSE : Telithromycin, Acute Bacterial Sinusitis|A Prospective, Randomized, Open-label, Active-controlled Study in Adult Subjects With Acute Bacterial Sinusitis Comparing the Clinical Efficacy of Telithromycin (KETEK®) 800 mg Once a Day for 5 Days Versus Amoxicillin-clavulanic Acid (AUGMENTIN®) 875/125 mg Twice a Day for 10 Days|Completed||Phase 4|298|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:28:03.088602|2017-10-11 05:28:03.088602
NCT00174707|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-04|||December 1997||1997-12-01|December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Docetaxel in Breast Cancer Patients|A Phase III Randomized Study of Sequential Epidoxorubicin Followed By CMF: Cyclophosphamide+Methotrexate+Fluorouracil (Arm A) Versus Sequential Epidoxorubicin Followed By Docetaxel Followed By CMF (Arm B) Versus Sequential Intensified Epidoxorubicin Followed By Docetaxel Followed By High-Dose Cyclophosphamide (Arm C) in Early Breast Cancer Patients With Positive Axillary Lymph Nodes|Completed||Phase 3|998|Actual|Sanofi||3|||f||||||||||||||2017-10-11 05:28:03.170561|2017-10-11 05:28:03.170561
NCT00174720|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-07|||September 2005||2005-09-01|April 2009|2009-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.|A Multinational,Multicenter,Randomized,Double-Blind,Placebo-Controlled,Parallel-Group Study to Assess the Efficacy of Ciclesonide Metered-Dose Inhaler at a Daily Dose of 160 μg Administered Either in a Once-Daily in the Morning Regimen (160 μg qd AM) for 16 Weeks or in a 160 μg qd AM Regimen for 12 Weeks Preceded by a Twice-Daily Regimen (80 μg Bid) for 4 Weeks,or in an 80 μg Bid Regimen for 16 Weeks,in Adults and Adolescents With Mild to Moderate Persistent Asthma Not Treated With Steroids|Completed||Phase 3|708|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:28:03.294267|2017-10-11 05:28:03.294267
NCT00174733|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-07|||July 2005||2005-07-01|April 2009|2009-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy of Ciclesonide Metered-Dose Inhaler at a Daily Dose of 160 μg Administered for Twelve Weeks Either in a Once-Daily Regimen in the Morning (160 μg qd AM) or in a Twice Daily Regimen (80 μg Bid) in Adults and Adolescents With Mild to Moderate Persistent Asthma Treated Previously With Inhaled Corticosteroids|Completed||Phase 3|456|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:28:03.406673|2017-10-11 05:28:03.406673
NCT00174746|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-07|||March 2005||2005-03-01|April 2009|2009-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma|A Placebo- and Active-Controlled (Ciclesonide Metered-Dose Inhaler), Randomized, Parallel-Group, Dose-Range Finding Study of Ciclesonide Administered by Dry Powder Inhaler (Ultrahaler) in Adult and Adolescent Patients With Persistent Asthma|Completed||Phase 2|1145|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:28:03.50255|2017-10-11 05:28:03.50255
NCT00174759|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-01-10|||September 2004||2004-09-01|January 2011|2011-01-01||||||||Interventional|||CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease|A Double-blind, Randomized Study of Clopidogrel 75 mg/d vs Placebo, on a Background of ASA 75-100 mg/d,in Peripheral Arterial Disease (PAD) Patients Receiving a Unilateral Below Knee Bypass Graft.|Completed||Phase 3|1460|Anticipated|Sanofi|||||f||||||||||||||2017-10-11 05:28:03.587103|2017-10-11 05:28:03.587103
NCT00174772|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-02-15|||March 2004||2004-03-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)|A Two Arm Phase II Study Comparing Docetaxel/Cisplatin Induction Therapy Followed By Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Followed By Consolidation Docetaxel/Cisplatin in Patients With Locally Advanced Unresectable NSCLC (Stage IIIA-Multiple cN2 or IIIB)|Completed||Phase 2|72|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:28:03.709132|2017-10-11 05:28:03.709132
NCT00174785|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-01-05|2009-07-24||June 2005||2005-06-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|ATHENA||A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation|A Placebo-controlled,Double-blind,Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (AF/AFL)|Completed||Phase 3|4628|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 05:28:03.897119|2017-10-11 05:28:03.897119
NCT00174798|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-01|||May 2005||2005-05-01|February 2012|2012-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.|A Randomized, Double-blind, Placebo and Active-controlled Efficacy and Safety Study of SSR240600C in Patients With Overactive Bladder (OAB) or Urge Urinary Incontinence (UUI)|Completed||Phase 2|118|Actual|Sanofi||3|||f||||||||||||||2017-10-11 05:28:06.904094|2017-10-11 05:28:06.904094
NCT00174811|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-02|||June 2005||2005-06-01|April 2009|2009-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections|Multinational, Randomized, Double-Blind, Double-Dummy, Comparative Study to Evaluate the Efficacy and Safety of Telithromycin 25 mg/kg Given Once Daily for 5 or 10 Days Depending on Age and Previous Treatment History Versus Cefuroxime Axetil 15 mg/kg, Given Twice Daily for 10 Days, in Children With Acute Otitis Media|Terminated||Phase 3|639|Actual|Sanofi||||Pediatric development program terminated by sponsor|f||||||||||||||2017-10-11 05:28:07.216682|2017-10-11 05:28:07.216682
NCT00174824|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-26|||June 2001||2001-06-01|March 2009|2009-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients|Evaluation of Diabetic Retinopathy Progression in Subjects With Type 2 Diabetes Mellitus Treated With Insulin|Completed||Phase 4|1024|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:28:07.360064|2017-10-11 05:28:07.360064
NCT00174837|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-04-27||2016-04-27|April 2005||2005-04-01|April 2016|2016-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|TRACE||TRACE: Tirapazamine-Radiation And Cisplatin Evaluation|Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer|Completed||Phase 3|317|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 05:28:07.454912|2017-10-11 05:28:07.454912
NCT00174850|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-09-17|||July 2004||2004-07-01|September 2008|2008-09-01|May 2005||2005-05-01|||||Interventional|||Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction|A 14 Week Open-Label Study to Evaluate the Tolerability of Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction in Generalized Anxiety Disorder Patients|Completed||Phase 4|30||State University of New York - Upstate Medical University|||||f||||||||||||||2017-10-11 05:28:07.610447|2017-10-11 05:28:07.610447
NCT00174863|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-22|||October 2003||2003-10-01|December 2008|2008-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|ODYSSEY||Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer|Evaluation of Two Doses of SR31747A (75 mg and 125 mg) in Non-Metastatic Androgen-Independent Prostate Cancer. Randomized, Double-Blind, Placebo Controlled Phase II Study|Completed||Phase 2|232|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:28:07.706779|2017-10-11 05:28:07.706779
NCT00174876|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-09-17|||July 2004||2004-07-01|September 2008|2008-09-01|May 2005||2005-05-01|||||Interventional|||Aripiprazole as Augmentation for TRD|An Open-Label Study of Aripiprazole (Abilify) as an Augmentation Agent in Patients With Treatment-Resistant Depression|Completed||Phase 2|20||State University of New York - Upstate Medical University|||||f||||||||||||||2017-10-11 05:28:07.83745|2017-10-11 05:28:07.83745
NCT00174889|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-05-20|||January 2005||2005-01-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Pregnenolone in the Management of Schizophrenia Patients|Efficacy and Safety of Pregnenolone Augmentation in the Management of Schizophrenia Patients: a Randomised Double-Blind Placebo-Controlled Trial|Completed||Phase 1|60||Sha’ar Menashe Mental Health Center|||||f||||||||||||||2017-10-11 05:28:07.941298|2017-10-11 05:28:07.941298
NCT00174902|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-10-24|||October 2003||2003-10-01|October 2003|2003-10-01|August 2004||2004-08-01|||||Interventional|||The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress|The Effect of Beta-Blockers, Aspirin, and Natural Habituation on Procoagulant Activity, Expression of Cellular Adhesion Molecules, and Endothelial Activation in Response to Acute Mental Stress: a Randomized Controlled Trial.|Unknown status|Active, not recruiting|Phase 1/Phase 2|80||Swiss Federal Institute of Technology|||||f||||||||||||||2017-10-11 05:28:08.051406|2017-10-11 05:28:08.051406
NCT00174915|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-01-31|2009-03-12||February 2003||2003-02-01|January 2012|2012-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|APEX||Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.|A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.|Completed||Phase 3|1072|Actual|Takeda||5|||f||||f||||||||||2017-10-11 05:28:08.234963|2017-10-11 05:28:08.234963
NCT00174928|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-07-20|||May 2005||2005-05-01|July 2010|2010-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease|A Phase 1, Single- and Repeated-Dose, Randomized, Open-Label, Multi-center Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Lansoprazole in Neonates With Clinically-Evident Gastroesophageal Reflux Disease.|Completed||Phase 1|24|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:28:10.863929|2017-10-11 05:28:10.863929
NCT00174941|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-01-25|2009-03-12||March 2001||2001-03-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|FOCUS||Long-Term Safety of Febuxostat in Subjects With Gout.|Phase II, Open-Label Study, to Assess the Long-Term Safety of Oral TMX-67 in Subjects With Gout|Completed||Phase 2|116|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:28:10.968297|2017-10-11 05:28:10.968297
NCT00174954|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-22|2009-03-12||March 2002||2002-03-01|July 2010|2010-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|||Magnetic Resonance Imaging in Subjects With Gouty Tophi|A Study to Validate Magnetic Resonance Imaging (MRI) in the Quantitative Assessment of Gouty Tophi.|Completed||Phase 2|32|Actual|Takeda|||1||f||||f||||||None Retained|"     None taken or retained.   "|||2017-10-11 05:28:12.244225|2017-10-11 05:28:12.244225
NCT00174967|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-07-27|2009-03-12||January 2001||2001-01-01|July 2011|2011-07-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout|Phase II, Dose-Response, Safety and Efficacy Study of Oral TMX-67 in Subjects With Gout.|Completed||Phase 2|153|Actual|Takeda||4|||f||||f||||||||||2017-10-11 05:28:12.452408|2017-10-11 05:28:12.452408
NCT00178997|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-05|||February 2004||2004-02-01|April 2017|2017-04-01|September 1, 2010|Actual|2010-09-01|September 1, 2010|Actual|2010-09-01||Observational|SQUID||Realistic Models of Gastrointestinal Bioelectromagnetism|Realistic Models of Gastrointestinal Bioelectromagnetism|Completed||N/A|20|Actual|Vanderbilt University Medical Center|||2||f||||f||||||||||2017-10-11 05:29:10.668363|2017-10-11 05:29:10.668363
NCT00174993|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-02-27|||May 2001||2001-05-01|February 2012|2012-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|PROactive||Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes|PROspective PioglitAzone Clinical Trial In MacroVascular Events: A Macrovascular Outcome Study in Type 2 Diabetic Patients Comparing Pioglitazone With Placebo in Addition to Existing Therapy|Completed||Phase 3|4373|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:28:15.498079|2017-10-11 05:28:15.498079
NCT00175006|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-22|2009-03-12||November 2002||2002-11-01|July 2010|2010-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|||Validation Study of Physical Measurement of Tophi|A Study to Assess a Direct Physical Measurement Method for Evaluation of Tophus Nodules in Subjects With Gout.|Completed||Phase 2|13|Actual|Takeda|||1||f||||f||||||None Retained|"     None taken or retained   "|||2017-10-11 05:28:15.744915|2017-10-11 05:28:15.744915
NCT00175019|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-22|2009-03-12||July 2003||2003-07-01|July 2010|2010-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|EXCEL||Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010|A Phase 3, Open-Label, Randomized, Allopurinol-Controlled Study to Assess the Long-Term Safety of Oral Febuxostat in Subjects With Gout|Completed||Phase 3|1086|Actual|Takeda|Subjects may receive >1 treatment. Adverse events are summarized by treatment at time of observation and subjects who receive >1 treatment are summarized for each treatment they receive, so subjects at risk will not match number of participants.|3|||f||||f||||||||||2017-10-11 05:28:16.072499|2017-10-11 05:28:16.072499
NCT00175032|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-20|||July 2003||2003-07-01|July 2010|2010-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin|A Randomized, Double-Blind, Phase 3 Study to Compare the Efficacy and Safety of Lansoprazole 30 mg QD and Naproxen 500 mg BID Versus Celecoxib 200 mg QD in Risk Reduction of Non Steroidal Anti-Inflammatory-Associated Ulcers in Osteoarthritis Subjects Taking Low Dose Aspirin|Completed||Phase 3|1045|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:28:17.402646|2017-10-11 05:28:17.402646
NCT00175045|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-20|||June 2003||2003-06-01|July 2010|2010-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis|A Phase 2, Open-Label Multicenter Study to Evaluate the Pharmacodynamics of Intravenous Lansoprazole to That of Oral Lansoprazole in Subjects With Erosive Esophagitis|Completed||Phase 2|68|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:28:17.491524|2017-10-11 05:28:17.491524
NCT00175058|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-06-15|||August 2005||2005-08-01|June 2012|2012-06-01|May 2008|Actual|2008-05-01|June 2007|Actual|2007-06-01||Interventional|AMIHOT II||Acute Myocardial Infarction With HyperOxemic Therapy II (AMIHOT II)|Acute Myocardial Infarction With HyperOxemic Therapy II|Completed||Phase 3|317|Actual|TherOx||2|||f||||t||||||||||2017-10-11 05:28:17.569989|2017-10-11 05:28:17.569989
NCT00175071|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-04-24|||March 2004||2004-03-01|April 2017|2017-04-01|December 2017|Anticipated|2017-12-01|April 2007|Actual|2007-04-01||Interventional|||Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers|Effect of Conventional and Reformulated Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers|Active, not recruiting||N/A|30|Anticipated|Tufts University||1|||f||||f||||||||||2017-10-11 05:28:17.649507|2017-10-11 05:28:17.649507
NCT00175084|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-05-21|||October 2004||2004-10-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers|Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers|Completed||N/A|30|Anticipated|Tufts University||1|||f||||f||||||||||2017-10-11 05:28:17.720059|2017-10-11 05:28:17.720059
NCT00175097|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-11-26|||June 2001||2001-06-01|November 2014|2014-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Soybean Based Diets and CVD Risk Factors|Impact of Different Forms of Soybean Based Foods on Cardiovascular Disease Risk Factors in Hypercholesterolemic Subjects.|Completed||N/A|30|Actual|Tufts University||4|||f||||f||||||||||2017-10-11 05:28:17.808164|2017-10-11 05:28:17.808164
NCT00175110|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-02||||||December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure|The Effect of Hibiscus Sabdariffa L. Tisane on Blood Pressure in Prehypertensive and Mildly Hypertensive Men and Women|Completed||Phase 1/Phase 2|66|Actual|Tufts University||2|||f||||f||||||||||2017-10-11 05:28:17.915041|2017-10-11 05:28:17.915041
NCT00175123|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-02-19|||May 2005||2005-05-01|February 2009|2009-02-01|June 2008|Anticipated|2008-06-01|March 2008|Anticipated|2008-03-01||Interventional|||Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele|Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Children Born With Myelomeningocele|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:28:18.142961|2017-10-11 05:28:18.142961
NCT00175136|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2010-10-12|||January 2005||2005-01-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Comparison of the Design of Tibia Stems in Cemented Total Knee Arthroplasty - Wedge Stem Versus I-beam Stem.|A Comparison of the Design of Tibia Stems - Wedge Stem Versus I-beam Stem. A Prospective Randomized Migration- and Bone Density Study on Primary Cemented Knee Implants.|Completed||N/A|54|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 05:28:18.234978|2017-10-11 05:28:18.234978
NCT00175149|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-12-06|||January 2002||2002-01-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Active Vitamin D Effect on Left Ventricular Hypertrophy|The Efficacy of 1,25 Dihydroxycholecalciferol on the Cardiovascular System in Patients With Renal Dysfunction|Terminated||Phase 4|24|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 05:28:18.371605|2017-10-11 05:28:18.371605
NCT00175162|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2010-10-13|||June 2007||2007-06-01|October 2010|2010-10-01|December 2010||2010-12-01|||||Interventional|||A Comparison of Fixation Method in Total Knee Arthroplasty - Low Viscosity Versus High Viscosity Bone Cement|A Comparison of Fixation Method in Total Knee Arthroplasty - Low Viscosity Versus High Viscosity Bone Cement. A Prospective Randomized Migration- and Bone Density Study on Primary Cemented Knee Implants.|Withdrawn||N/A|50|Anticipated|University of Aarhus||2||No financing possible|f||||f||||||||||2017-10-11 05:28:18.464851|2017-10-11 05:28:18.464851
NCT00175175|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-13|||March 2002||2002-03-01|September 2006|2006-09-01||||||||Interventional|||Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients|Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients|Completed||N/A|220||University of Alberta|||||f||||||||||||||2017-10-11 05:28:18.555074|2017-10-11 05:28:18.555074
NCT00175188|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2010-10-12|||June 2004||2004-06-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||An RSA and DEXA Study on Migration of Proximal Interphalangeal (PIP) Joint Prostheses of the Hand|A Roentgen Stereophotogrammetric Analysis and DEXA Study on Migration of Proximal Interphalangeal Joint Prostheses of the Hand. A Randomised Prospective Study of Cemented Versus Non-cemented Implants|Completed||N/A|30|Actual|University of Aarhus||2|||f||||f||||||||||2017-10-11 05:28:18.63201|2017-10-11 05:28:18.63201
NCT00175201|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2006-05-04|||May 2005||2005-05-01|May 2006|2006-05-01|March 2008||2008-03-01|||||Interventional|||Cost Efficacy of a Clinical Pathway to Patients Undergoing Hip and Knee Replacement Surgery|From Efficacy to Effectiveness of a Proactive Perioperative Care and Rehabilitation in Patients Undergoing Primary Total Hip or Knee Replacement|Unknown status|Recruiting|N/A|80||University of Aarhus|||||f||||||||||||||2017-10-11 05:28:18.72134|2017-10-11 05:28:18.72134
NCT00175214|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-09-10|||January 2001||2001-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Controlled Trial to Increase Detection and Treatment of Osteoporosis in Older Patients With a Wrist Fracture|Controlled Trial to Increase Detection and Treatment of Osteoporosis in Older Patients With a Wrist Fracture|Completed||N/A|160||University of Alberta|||||f||||||||||||||2017-10-11 05:28:18.807411|2017-10-11 05:28:18.807411
NCT00175227|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-05-09|||May 1996||1996-05-01|May 2011|2011-05-01||||October 2000|Actual|2000-10-01||Interventional|||Prevention of Contrast-Induced Nephropathy|Prevention of Contrast-Induced Nephropathy: a Randomized Controlled Trial of Saline + Furosemide + Mannitol in High Risk Patients Undergoing Cardiac Angiography|Completed||N/A|200|Anticipated|University of Alberta||2|||f||||f||||||||||2017-10-11 05:28:18.896175|2017-10-11 05:28:18.896175
NCT00175240|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-07-25|||March 2005||2005-03-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|August 2011|Actual|2011-08-01||Interventional|||Enhancing the Secondary Prevention of Coronary Artery Disease|Enhancing the Use of Secondary Prevention Strategies in Patients With Coronary Artery Disease (The ESP-CAD Study)|Completed||Phase 4|480|Anticipated|University of Alberta|||||f||||||||||||||2017-10-11 05:28:18.985026|2017-10-11 05:28:18.985026
NCT00175253|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-11|||November 2005||2005-11-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|||||Interventional|||Alemtuzumab Induction in Islet Transplantation|Alemtuzumab Induction With Tacrolimus and MMF Maintenance Immunosuppression in Islet Transplantation|Completed||Phase 2|12|Anticipated|University of Alberta|||||f||||||||||||||2017-10-11 05:28:19.073056|2017-10-11 05:28:19.073056
NCT00175266|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-10-01||||||October 2009|2009-10-01||||||||Interventional|||Islet Transplantation Using Campath-1H and Infliximab Induction|Islet Transplantation in Type 1 Diabetic Patients Using Campath-1H and Infliximab Induction|Completed||Phase 2|12||University of Alberta|||||f||||||||||||||2017-10-11 05:28:19.150004|2017-10-11 05:28:19.150004
NCT00175279|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-05-09|||January 2002||2002-01-01|May 2011|2011-05-01|April 2005||2005-04-01|||||Interventional|||A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease|A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease|Completed||N/A|160||University of Alberta|||||f||||||||||||||2017-10-11 05:28:19.215699|2017-10-11 05:28:19.215699
NCT00175292|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-05-12|||December 2003||2003-12-01|May 2008|2008-05-01||||||||Interventional|||A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.|A Randomized and Placebo-Controlled Double-Blind Multicentre Study to Determine the Efficacy and Safety of VSL#3 Probiotic Food Supplement Mixture in Prevention of Endoscopic Recurrence in Crohn's Disease Patients With Ileocolonic Surgical Resection and Small Intestine to Colon Anastomosis.|Completed||Phase 3|120|Anticipated|University of Alberta|||||f||||||||||||||2017-10-11 05:28:19.296355|2017-10-11 05:28:19.296355
NCT00175305|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-10-29|||August 2004||2004-08-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Prader-Willi Syndrome and Appetite|Effect of Somatostatin on Ghrelin Concentrations, Food Seeking Behaviour and Weight in Patients With Prader-Willi Syndrome|Terminated||Phase 3|10|Anticipated|University of British Columbia|||||f||||||||||||||2017-10-11 05:28:19.390333|2017-10-11 05:28:19.390333
NCT00175318|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-02-09|||April 2005||2005-04-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Testing a Tooth Decay Prevention Program With Cree Mothers and Infants|A Clinical Trial of the Effectiveness of Motivational Interviewing as a Preventive Strategy for Dental Caries in Cree Infants|Completed||N/A|309|Anticipated|University of British Columbia||1|||f||||||||||||||2017-10-11 05:28:19.478946|2017-10-11 05:28:19.478946
NCT00175344|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2014-02-18|||February 2004||2004-02-01|February 2014|2014-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Does Scar Massage Improve Postoperative Pain and Function in Women With Breast Cancer?|Does Scar Tissue Massage Improve Postoperative Pain and Function in Women With Breast Cancer? A Randomized Controlled Study.|Completed||Phase 3|96|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:19.558299|2017-10-11 05:28:19.558299
NCT00175357|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-09-25|||March 2005||2005-03-01|September 2014|2014-09-01|April 2009|Actual|2009-04-01|April 2007|Actual|2007-04-01||Interventional|||NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction|North American Opiate Medication Initiative (NAOMI): Multi-Centre, Randomized Controlled Trial of Heroin-Assisted Therapy for Treatment-Refractory Injection Opiate Users|Completed||Phase 3|192|Actual|University of British Columbia||2|||f||||t||||||||||2017-10-11 05:28:19.636248|2017-10-11 05:28:19.636248
NCT00175370|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-06-18|||September 2000||2000-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus|Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus; Removal of Catheter Followed by 2 Days Compared With 7 Days Intravenous Vancomycin|Completed||N/A|60|Anticipated|University of British Columbia|||||f||||f||||||||||2017-10-11 05:28:19.727425|2017-10-11 05:28:19.727425
NCT00175383|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2013-04-09|||June 2004||2004-06-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer|A Randomized Trial of Short Versus Long Acting LHRH Agonist Preparation Prior to Transperineal Implantation of the Prostate|Unknown status|Recruiting|Phase 3|100|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:19.811735|2017-10-11 05:28:19.811735
NCT00175396|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2014-03-14|||May 2004||2004-05-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|December 2011|Actual|2011-12-01||Interventional|||Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy|A Randomized Phase III Study Comparing Androgen Suppression and Elective Pelvic Nodal Irradiation Followed by High Dose 3-D Conformal Boost Versus Androgen Suppression and Elective Pelvic Nodal Irradiation Followed by 125-Iodine Brachytherapy Implant Boost for Patients With Intermediate and High Risk Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 05:28:19.900397|2017-10-11 05:28:19.900397
NCT00175409|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-04-11|||January 2008||2008-01-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Breast Feeding Analgesia in Preterm Infants|Breast Feeding Analgesia in Preterm Infants|Completed||Phase 1|50|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-10-11 05:28:19.988678|2017-10-11 05:28:19.988678
NCT00175422|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2010-12-15|||May 2005||2005-05-01|December 2010|2010-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Parents Helping Infants Study: Educational Intervention to Change the Knowledge, Attitudes and Behaviour of New Parents About Early Infant Crying|The Period of PURPLE Crying: An Educational Intervention to Change the Knowledge, Attitudes and Behaviour of New Parents About Early Infant Crying|Completed||Phase 1/Phase 2|1833|Actual|University of British Columbia||1|||f||||||||||||||2017-10-11 05:28:20.249877|2017-10-11 05:28:20.249877
NCT00175435|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2010-10-29|||August 2005||2005-08-01|October 2010|2010-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator|Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator|Completed||Phase 1/Phase 2|39|Actual|University of British Columbia||3|||f||||f||||||||||2017-10-11 05:28:20.335899|2017-10-11 05:28:20.335899
NCT00175448|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2008-09-24|||September 2005||2005-09-01|September 2005|2005-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Physiotherapy Versus Home Exercise Following Hip Replacement Surgery|A Randomized Controlled Trial of Outpatient Physiotherapy Versus a Self-Administered Home Exercise Program Following Discharge Home From Total Hip Arthroplasty|Completed||N/A|144|Anticipated|University of British Columbia|||||f||||||||||||||2017-10-11 05:28:20.42605|2017-10-11 05:28:20.42605
NCT00175461|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2017-03-01|||September 2005||2005-09-01|March 2017|2017-03-01|August 31, 2011|Actual|2011-08-31|April 2009|Actual|2009-04-01||Interventional|||Comparison of Two Minimally Invasive Surgical Techniques for Hip Replacement|Comparison of the Clinical Effectiveness and Cost-effectiveness of the MIS Anterolateral Approach (MIS Watson Jones, G3) Versus Anterolateral Mini or Posterolateral Mini Approaches in Primary Total Hip Arthroplasty|Completed||Phase 1|156|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:20.485865|2017-10-11 05:28:20.485865
NCT00175474|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-10-12|||September 2005||2005-09-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of a Minimally Invasive Technique for Total Knee Replacement to a Standard Technique|Minimally Invasive Total Knee Arthroplasty Versus a Standard Surgical Technique: a Single-blinded Single-centre Randomized Controlled Trial|Completed||Phase 1|102|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:20.542746|2017-10-11 05:28:20.542746
NCT00175487|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2014-03-17|||September 2007||2007-09-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Hip Resurfacing to Large Femoral Head Total Hip Arthroplasty|Femoral Head Resurfacing Versus a Large Femoral Head (Durom®) Total Hip System: A Prospective Randomized Trial|Unknown status|Active, not recruiting|N/A|56|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:20.605303|2017-10-11 05:28:20.605303
NCT00175500|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-09-20|||September 2007||2007-09-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of Conventional and Large Diameter Femoral Heads for the Prevention of Hip Dislocation|A Randomized Multi-Centre Controlled Trial of Large Diameter (36/40 mm) Versus Conventional Diameter (32 mm) Femoral Heads for the Prevention of Post Revision Arthroplasty Dislocation|Unknown status|Active, not recruiting|N/A|400|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:20.672142|2017-10-11 05:28:20.672142
NCT00175513|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-04-12|||September 2005||2005-09-01|April 2011|2011-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis|V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis|Completed||Phase 2|100|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:20.813982|2017-10-11 05:28:20.813982
NCT00175526|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-30|||September 2005||2005-09-01|May 2016|2016-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Predicting Complications in Women With Toxaemia|PIERS (Pre-eclampsia Integrated Estimate of RiSk) Model: Predicting Adverse Maternal Outcomes in Pre-eclampsia|Completed||N/A|650|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 05:28:20.890043|2017-10-11 05:28:20.890043
NCT00175539|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-30|||November 2005||2005-11-01|May 2017|2017-05-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties|Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties|Completed||N/A|25|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:20.974887|2017-10-11 05:28:20.974887
NCT00175552|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-16||||||July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Ministry of Child and Family Development (MCFD) Interpersonal Psychotherapy for Adolescents (IPT-A) Training Project|Evaluating the Effectiveness of Different Interpersonal Psychotherapy for Adolescents (IPT-A) Therapist Training Models|Completed||N/A|24|Anticipated|University of British Columbia|||||f||||||||||||||2017-10-11 05:28:21.041609|2017-10-11 05:28:21.041609
NCT00175565|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2010-07-26|||January 2002||2002-01-01|July 2010|2010-07-01|July 2003||2003-07-01|||||Interventional|||Inhaled Steroid Reduces Systemic Inflammation in COPD|Effects of Fluticasone On Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease|Completed||Phase 4|50||University of British Columbia|||||f||||||||||||||2017-10-11 05:28:21.115668|2017-10-11 05:28:21.115668
NCT00175578|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-15|||May 2005||2005-05-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|||||Observational|||Detection of Early Lung Cancer by Serum Protein Expression Profiling|Differences in SELDI Produced Serum Protein Profiles of Non-small Cell Lung Cancer Patients Compared to Healthy Heavy Smoking Adults|Unknown status|Recruiting|N/A|220|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-10-11 05:28:21.209636|2017-10-11 05:28:21.209636
NCT00175591|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||August 2007||2007-08-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Effect of Femoral Nerve Block on Opioid Requirements After Surgery for a Femur Fracture in Children|The Effect of Femoral Nerve Block on Opioid Requirements Following Femoral Fracture Fixation With Flexible Nails in the Paediatric Population: A Double Blind, Prospective Randomized Clinical Trial|Terminated||Phase 1|25|Actual|University of British Columbia||1||It has become a standard of care to give Femoral nerve blocks and have discontinued this study|f||||f||||||||||2017-10-11 05:28:21.291833|2017-10-11 05:28:21.291833
NCT00175604|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-05|||August 2004||2004-08-01|February 2011|2011-02-01|February 2008|Anticipated|2008-02-01|February 2008|Anticipated|2008-02-01||Interventional|||Comparative Trial of Botox in the Management of Children With Congenital Muscular Torticollis|Comparative Trial of Botox Versus Conventional Treatment Used in the Management of Children With Congenital Muscular Torticollis (CMT)|Withdrawn||Phase 1|0|Actual|University of British Columbia||1||Not able to recruit any subjects for the study and was closed in February 2008|f||||f||||||||||2017-10-11 05:28:21.381299|2017-10-11 05:28:21.381299
NCT00175617|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-01|||September 2005||2005-09-01|March 2017|2017-03-01|March 9, 2009|Actual|2009-03-09|March 9, 2009|Actual|2009-03-09||Interventional|||Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss|Efficacy of Therapy With the Anti-androgen Spironolactone Compared to Topical Minoxidil in Female Pattern Hair Loss|Completed||Phase 2|40|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:21.464876|2017-10-11 05:28:21.464876
NCT00175630|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-30|||December 2010||2010-12-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2011|Actual|2011-09-01||Interventional|||The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction|Effect of Femoral Nerve Block on Opioid Requirements Following Anterior Cruciate Ligament Reconstruction: A Double Blind, Prospective Randomized Controlled Trial|Active, not recruiting||Phase 1|30|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:21.54743|2017-10-11 05:28:21.54743
NCT00175643|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2006-05-08|||February 2005||2005-02-01|May 2006|2006-05-01|November 2005||2005-11-01|||||Interventional|||Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses|Open-Label Study to Assess Safety and Efficacy of Imiquimod 5% Cream Applied 3 Days Per Week in 1 or 2 Cycles for Treatment of Actinic Keratoses on the Head|Completed||Phase 3|20||University of British Columbia|||||f||||||||||||||2017-10-11 05:28:21.632957|2017-10-11 05:28:21.632957
NCT00175656|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-12|||January 2007||2007-01-01|April 2011|2011-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Titanium Elastic Nails in the Treatment of Pediatric Femur Fractures|Titanium Elastic Nails in the Treatment of Paediatric Femoral Fractures: A Prospective Randomized Clinical Trial of Eliminating Nail Protrusion to Decrease Soft Tissue Complications|Completed||Phase 1|80|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:21.704457|2017-10-11 05:28:21.704457
NCT00175669|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-11|||August 2007||2007-08-01|April 2011|2011-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Trial of a Botulinum A Toxin (Botox) Injection in the Gastrocnemius Muscle in Children With Idiopathic Toe Walking|Randomized Controlled Trial of a Botulinum A Toxin (Botox) Injection in the Gastrocnemius Muscle in Children With Idiopathic Toe Walking|Completed||Phase 2|32|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:21.800168|2017-10-11 05:28:21.800168
NCT00175682|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-01|||December 2004||2004-12-01|March 2017|2017-03-01|July 28, 2011|Actual|2011-07-28|July 28, 2011|Actual|2011-07-28||Interventional|||Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study|Prophylactic Value of Prazosin in Reducing the Objective and Subjective Measures of Autonomic Dysreflexia Provoked by Ejaculation in Men With Spinal Cord Injury|Completed||N/A|7|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:28:21.875414|2017-10-11 05:28:21.875414
NCT00175695|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-03|||December 2004||2004-12-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Disease Modification in Toxaemia of Pregnancy|A Safety and Efficacy Trial of Recombinant Human Activated Protein C in Both Early-onset Pre-eclampsia and Severe Postpartum Pre-eclampsia.|Completed||Phase 2|30|Actual|University of British Columbia|||1||f||||f||||||||||2017-10-11 05:28:21.963187|2017-10-11 05:28:21.963187
NCT00182741|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-05-01|||September 2004||2004-09-01|May 2017|2017-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer|Phase II Study of DN-101 (High Dose Pulse Calcitriol), Mitoxantrone, Prednisone in Androgen-Independent Prostate Cancer (AIPC)|Completed||Phase 2|19|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 05:28:22.050521|2017-10-11 05:28:22.050521
NCT00182754|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-02-28|2017-02-28||October 2005||2005-10-01|February 2017|2017-02-01|March 2013|Actual|2013-03-01|September 2009|Actual|2009-09-01||Interventional|||Octreotide in Treating Patients With Cancer-Related Malignant Ascites|An Exploratory, Randomized, Placebo-Controlled Trial of Depot Octreotide (Sandostatin LARDepot) for Symptomatic Ascites in Cancer Patients|Completed||Phase 3|33|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-10-11 05:28:22.164524|2017-10-11 05:28:22.164524
NCT00182767|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-02-11|2015-06-17||January 2006||2006-01-01|February 2014|2014-02-01|May 2014|Actual|2014-05-01|April 2012|Actual|2012-04-01||Interventional|||Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer|A Phase I/II Study of BMS-247550 and Pegylated Liposomal Doxorubicin (Doxil®) in Patients With Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Who Have Been Previously Treated With a Platinum and a Taxane|Completed||Phase 1/Phase 2|45|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:28:22.882637|2017-10-11 05:28:22.882637
NCT00182780|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-07-12|||October 2005||2005-10-01|July 2016|2016-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||American Ginseng in Treating Patients With Cancer-Related Fatigue|The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Dose-Finding, Placebo-Controlled Study|Completed||N/A|290|Actual|Alliance for Clinical Trials in Oncology||4|||f||||f||||||||||2017-10-11 05:28:24.109528|2017-10-11 05:28:24.109528
NCT00182793|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-01-31|2017-01-31||July 2005||2005-07-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer|Phase II Study of Tandem Cycle Dose-Intense Chemotherapy of Melphalan and Carboplatin, Thiotepa and Cyclophosphamide (STMP V) ± Trastuzumab Followed by Helical Tomotherapy or Local Regional Radiation Therapy for Stage IV Metastatic and Stage IIIB/C Breast Cancer|Completed||Phase 2|32|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-10-11 05:28:24.209438|2017-10-11 05:28:24.209438
NCT00182806|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2012-03-05|||September 2004||2004-09-01|March 2012|2012-03-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Irinotecan Followed by Gemcitabine in NSCLC Following Failure of Platinum Based Therapy|Completed||Phase 2|38|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 05:28:24.775996|2017-10-11 05:28:24.775996
NCT00182819|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-10-11|||July 2005||2005-07-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional|||Radiation Therapy or Temozolomide in Treating Patients With Gliomas|Primary Chemotherapy With Temozolomide Versus Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study|Completed||Phase 3|709|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-10-11 05:28:24.879432|2017-10-11 05:28:24.879432
NCT00182832|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-04-11|||June 2006||2006-06-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||e-CHAMP: Enhancing Care for Hospitalized Older Adults With Memory Problems|Enhancing Care for Hospitalized Older Adults With Cognitive Impairment|Completed||N/A|424|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 05:28:25.180936|2017-10-11 05:28:25.180936
NCT00182845|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-02-28|||February 2005||2005-02-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Donepezil in the Prevention of Post-Operative Cognitive Decline|Preventing Post-Operative Cognitive Decline|Completed||Phase 4|30||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:25.285846|2017-10-11 05:28:25.285846
NCT00182858|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-06-30|||February 10, 2003||2003-02-10|March 8, 2017|2017-03-08|December 31, 2018||2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Gerontology Research Center Tissue Procurement for Biomedical Research|Tissue Procurement for Biomedical Research|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:28:25.379827|2017-10-11 05:28:25.379827
NCT00182871|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-10-29|||November 2001||2001-11-01|October 2009|2009-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Testosterone Effects on Bone and Frailty|Testosterone Effects on Bone and Frailty in Men With Osteoporosis|Completed||Phase 4|140||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:25.452056|2017-10-11 05:28:25.452056
NCT00182884|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-02-28|||July 2004||2004-07-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Donepezil in Preventing Delirium in Hospitalized Elderly|Preventing Delirium in Hospitalized Elderly|Completed||Phase 4|30||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:25.543736|2017-10-11 05:28:25.543736
NCT00182897|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-09|||October 2000||2000-10-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||PACT: Providers and Alzheimer's Caregivers Together|Providers and Alzheimer's Caregivers Together|Completed||N/A|120||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:25.624265|2017-10-11 05:28:25.624265
NCT00182923|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-08-28|||May 2003||2003-05-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Forearm Vascular Relaxation|Determinants of Forearm Vascular Relaxation: Role of Genetic Polymorphisms|Completed||N/A|400||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:25.698096|2017-10-11 05:28:25.698096
NCT00182936|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-16|||May 2000||2000-05-01|November 2006|2006-11-01|June 2004||2004-06-01|||||Interventional|||A Trial to Reduce Delirium in Aged Post Acute Patients|A Trial to Reduce Delirium in Aged Post Acute Patients|Completed||Phase 3|500||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:25.765724|2017-10-11 05:28:25.765724
NCT00182949|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-30|||November 19, 2003||2003-11-19|January 2, 2015|2015-01-02|January 2, 2015||2015-01-02|||||Observational|||Genetics and Epidemiology of Aging Associated Conditions in the Sardinian Population|Genetics and Epidemiology of Aging Associated Conditions in the Sardinian Population (SARDINIA)|Completed||N/A|15000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:28:25.845323|2017-10-11 05:28:25.845323
NCT00182962|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-16|||March 2002||2002-03-01|November 2006|2006-11-01|October 2006||2006-10-01|||||Interventional|||GRACE: Geriatric Resources for Assessment and Care of Elders|Geriatric Resources for Assessment and Care of Elders|Completed||N/A|1270||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:25.9161|2017-10-11 05:28:25.9161
NCT00182975|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-08-21|||September 2002||2002-09-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Dehydroepiandrosterone (DHEA) in Humans|Is DHEA Replacement Beneficial?|Completed||Phase 3|142|Actual|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:25.981313|2017-10-11 05:28:25.981313
NCT00182988|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-11-24|||October 2004||2004-10-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|||||Observational|||Alzheimer's Caregiver Communication Study|Alzheimer's Caregiver Ratings of Communication & Coping Behavior|Completed||N/A|140|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:26.050373|2017-10-11 05:28:26.050373
NCT00183001|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-13|||October 2001||2001-10-01|February 2009|2009-02-01|October 2006||2006-10-01|||||Interventional|||Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification|Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification|Completed||Phase 3|452||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:26.113345|2017-10-11 05:28:26.113345
NCT00183014|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-16|||September 2005||2005-09-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Caminemos! Trial to Increase Walking Among Sedentary Older Latinos|Trial to Increase Walking Among Sedentary Older Latinos|Completed||N/A|600|Anticipated|National Institute on Aging (NIA)||2|||f||||||||||||||2017-10-11 05:28:26.189015|2017-10-11 05:28:26.189015
NCT00183027|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-08|||November 2002||2002-11-01|November 2006|2006-11-01|December 2004||2004-12-01|||||Interventional|||Dietary Energy Restriction and Metabolic Aging in Humans|Dietary Energy Restriction and Metabolic Aging in Humans|Completed||N/A|44||National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:26.270966|2017-10-11 05:28:26.270966
NCT00183040|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-05-28|||September 2002||2002-09-01|May 2009|2009-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||HORMA: Hormonal Regulators of Muscle and Metabolism in Aging|Hormonal Regulators of Muscle and Metabolism in Aging|Completed||Phase 2|108|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:26.337924|2017-10-11 05:28:26.337924
NCT00183053|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-10-29|||May 2006||2006-05-01|October 2009|2009-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Proximity Alarms to Reduce Patient Falls|Trial of Proximity Alarms to Reduce Patient Falls|Completed||N/A|10000|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:28:26.431443|2017-10-11 05:28:26.431443
NCT00183066|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-03|||July 2002||2002-07-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Collection of Bone Marrow Aspirate From Volunteer Donors|Collection of Bone Marrow Aspirate From Volunteer Donors for In Vitro Hematopoietic Research|Completed||N/A|63|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||||||||Samples With DNA|"     Bone marrow aspirates Whole blood   "|||2017-10-11 05:28:26.492209|2017-10-11 05:28:26.492209
NCT00183079|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-11-05|||March 2004||2004-03-01|October 2008|2008-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Reducing Alcohol Use in Depressed Patients|Brief Alcohol Intervention With Depressed Patients|Completed||Phase 2|200|Actual|Rhode Island Hospital||1|||f||||||||||||||2017-10-11 05:28:26.549694|2017-10-11 05:28:26.549694
NCT00183807|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||October 2003||2003-10-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|February 2006|Actual|2006-02-01||Interventional|||A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer|A Phase II Study of Irinotecan (Camptosar), Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer|Terminated||Phase 2|6|Actual|University of Southern California||1||Insufficient Accrual|f||||t||||||||||2017-10-11 05:28:26.624925|2017-10-11 05:28:26.624925
NCT00183820|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-07-05|||November 2004||2004-11-01|July 2017|2017-07-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|||Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma|A Phase II Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma|Completed||Phase 2|30|Actual|University of Southern California||1|||f||||||||||||||2017-10-11 05:28:26.691323|2017-10-11 05:28:26.691323
NCT00183833|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||December 2002||2002-12-01|May 2014|2014-05-01|August 2010|Actual|2010-08-01|July 2009|Actual|2009-07-01||Interventional|||Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors|Phase I/II Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors|Completed||Phase 1|40|Actual|University of Southern California||1|||f||||||||||||||2017-10-11 05:28:26.773961|2017-10-11 05:28:26.773961
NCT00183846|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||December 2000||2000-12-01|May 2014|2014-05-01|July 2009|Actual|2009-07-01|October 2007|Actual|2007-10-01||Interventional|||Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers|Phase I Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers|Completed||Phase 1|22|Actual|University of Southern California||1|||f||||||||||||||2017-10-11 05:28:26.848371|2017-10-11 05:28:26.848371
NCT00183859|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||September 1999||1999-09-01|May 2014|2014-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan|Phase I Clinical and Pharmacokinetic Trial of Intra-Peritoneal Irinotecan|Completed||Phase 1|42|Actual|University of Southern California||1|||f||||||||||||||2017-10-11 05:28:26.921714|2017-10-11 05:28:26.921714
NCT00183872|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-04-08|||April 14, 2005|Actual|2005-04-14|April 2017|2017-04-01|October 20, 2015|Actual|2015-10-20|October 20, 2014|Actual|2014-10-20||Interventional|||Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma|Phase II Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma|Completed||Phase 2|40|Actual|University of Southern California||1|||f||||t|t|f|||f|||||2017-10-11 05:28:26.987772|2017-10-11 05:28:26.987772
NCT00183885|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-06-22|||October 2004||2004-10-01|June 2017|2017-06-01|October 2017|Anticipated|2017-10-01|February 2013|Actual|2013-02-01||Interventional|||A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma|A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C|Active, not recruiting||Phase 2|76|Actual|University of Southern California||1|||f||||||||||||||2017-10-11 05:28:27.065427|2017-10-11 05:28:27.065427
NCT00183898|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-04-08|||December 28, 2004|Actual|2004-12-28|April 2017|2017-04-01|June 28, 2018|Anticipated|2018-06-28|December 28, 2017|Anticipated|2017-12-28||Interventional|||Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer|Phase II Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer|Active, not recruiting||Phase 2|75|Actual|University of Southern California||1|||f||||t|t|f|||f|||||2017-10-11 05:28:27.130703|2017-10-11 05:28:27.130703
NCT00183911|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||November 2003||2003-11-01|May 2014|2014-05-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma|Phase II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-Fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma|Completed||Phase 2|25|Anticipated|University of Southern California|||||f||||t||||||||||2017-10-11 05:28:27.194313|2017-10-11 05:28:27.194313
NCT00183924|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||March 2001||2001-03-01|May 2014|2014-05-01|December 2008|Actual|2008-12-01|July 2006|Actual|2006-07-01||Interventional|||Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.|A Phase II Pilot Study of Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.|Completed||Phase 2|20|Actual|University of Southern California||1|||f||||t||||||||||2017-10-11 05:28:27.383142|2017-10-11 05:28:27.383142
NCT00183937|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||April 2005||2005-04-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|October 2010|Actual|2010-10-01||Interventional|||Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer|A Phase II Study of Bortezomib (Velcade®, PS-341) and Docetaxel for Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|15|Actual|University of Southern California||1|||f||||t||||||||||2017-10-11 05:28:27.456586|2017-10-11 05:28:27.456586
NCT00183950|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||March 2000||2000-03-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy|Phase I/II Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy|Terminated||Phase 1/Phase 2|12|Actual|University of Southern California||1||No funding|||||t||||||||||2017-10-11 05:28:27.527699|2017-10-11 05:28:27.527699
NCT00179491|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-02|||April 1998||1998-04-01|November 2007|2007-11-01|November 2001|Actual|2001-11-01|||||Interventional|||Study of the Therapeutic Effects of Intercessory Prayer (STEP)|Study of the Therapeutic Effects of Intercessory Prayer (STEP)|Completed||Phase 3|1802|Actual|Beth Israel Deaconess Medical Center||3|||f||||||||||||||2017-10-11 05:29:16.243606|2017-10-11 05:29:16.243606
NCT00183963|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-20|2012-11-09||August 2006||2006-08-01|May 2014|2014-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)|A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)|Terminated||Phase 2|4|Actual|University of Southern California|Due to insufficient accrual, analysis was not conducted.|4||Insufficient accrual|f||||||||||||||2017-10-11 05:28:27.593272|2017-10-11 05:28:27.593272
NCT00183976|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-20|||April 2005||2005-04-01|May 2006|2006-05-01|January 2006|Actual|2006-01-01|September 2005|Actual|2005-09-01||Interventional|||Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas|A Pilot Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas|Terminated||Phase 2|15||University of Southern California||||Insufficient Accrual|f||||t||||||||||2017-10-11 05:28:28.154601|2017-10-11 05:28:28.154601
NCT00183989|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-20|||August 2000||2000-08-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma|A Pilot Phase II Trial of Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma|Terminated||Phase 2|30|Anticipated|University of Southern California||||Insufficient accrual|f||||||||||||||2017-10-11 05:28:28.317572|2017-10-11 05:28:28.317572
NCT00184002|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-07-13|2017-07-13||January 10, 2003|Actual|2003-01-10|July 2017|2017-07-01|May 7, 2013|Actual|2013-05-07|December 19, 2012|Actual|2012-12-19||Interventional|||Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas|A Phase II Study Of Pegylated Liposomal Doxorubicin (Doxil) In Combination With Rituxan, Cyclophosphamide, Vincristine and Prednisone (DR-COP) In Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas|Completed||Phase 2|68|Actual|University of Southern California||1|||f||||t|t|f|||f|||||2017-10-11 05:28:28.410847|2017-10-11 05:28:28.410847
NCT00184015|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-08|||August 18, 2005|Actual|2005-08-18|April 2017|2017-04-01|August 21, 2018|Anticipated|2018-08-21|August 21, 2016|Actual|2016-08-21||Interventional|||"Bortezomib and Bevacizumab (BB-mib-mab) in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)"||Active, not recruiting||Phase 1/Phase 2|50|Actual|University of Southern California||2|||f||||||||||||||2017-10-11 05:28:28.958852|2017-10-11 05:28:28.958852
NCT00184028|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-20|2013-03-21||September 2004||2004-09-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck|Phase II Trial of Taxotere and Oxaliplatin Combination Chemotherapy in Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 2|12|Actual|University of Southern California||1||Insufficient Accrual|f||||||||||||||2017-10-11 05:28:29.049685|2017-10-11 05:28:29.049685
NCT00184041|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-20|||July 2004||2004-07-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Intensified Post Remission Therapy Containing PEG-Asparaginase|Treatment Of Newly Diagnosed Adult Acute Lymphoblastic Leukemia With Intensified Post Remission Therapy Containing PEG-Asparaginase.|Completed||Phase 2|47|Actual|University of Southern California||1|||f||||t||||||||||2017-10-11 05:28:29.447507|2017-10-11 05:28:29.447507
NCT00184054|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-16|2014-06-13||April 2002||2002-04-01|July 2014|2014-07-01|August 2011|Actual|2011-08-01|June 2009|Actual|2009-06-01||Interventional||All participants were included in the analysis.|Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia|Phase II Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-APL Acute Myelogenous Leukemia|Terminated||Phase 2|11|Actual|University of Southern California||1||Competing studies|f||||||||||||||2017-10-11 05:28:29.532681|2017-10-11 05:28:29.532681
NCT00184067|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-20|||May 2004||2004-05-01|January 2014|2014-01-01|September 2009|Actual|2009-09-01|April 2007|Actual|2007-04-01||Interventional|||Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma|A Randomized Phase II Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Resected Stages IIB/C, III, and IV Melanoma|Terminated||Phase 2|23|Actual|University of Southern California||2||Primary PI left institution|f||||||||||||||2017-10-11 05:28:29.806297|2017-10-11 05:28:29.806297
NCT00184080|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-20|||May 2004||2004-05-01|May 2014|2014-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Multicenter Open-Label Non-Randomized Phase II Study of Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|7|Actual|University of Southern California|||||f||||||||||||||2017-10-11 05:28:29.880065|2017-10-11 05:28:29.880065
NCT00184093|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-07-14|2017-07-14||June 1999||1999-06-01|July 2017|2017-07-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma|Phase I/II Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma: Analysis of Prognostic Factors and Determinants of Response: A Pilot Study|Completed||Phase 1/Phase 2|35|Actual|University of Southern California||1|||f||||||||||||||2017-10-11 05:28:29.949997|2017-10-11 05:28:29.949997
NCT00184106|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-23|||October 2004|Actual|2004-10-01|February 2017|2017-02-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo|A Randomised, Triple Blind, Placebo-controlled Trial Comparing the Effects of Cognitive Therapy, Paroxetine and Both Cognitive Therapy and Paroxetine in the Treatment of Patients With Primary Social Phobia|Completed||Phase 4|86|Actual|Norwegian University of Science and Technology||4|||f||||f|f|f||||||||2017-10-11 05:28:30.320844|2017-10-11 05:28:30.320844
NCT00184119|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-03-10|||October 2001||2001-10-01|March 2017|2017-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effects of a Psychiatric Intensive Care Unit|Effects of a Psychiatric Intensive Care Unit in an Acute Psychiatric Department.|Completed||N/A|118|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||No||2017-10-11 05:28:30.401886|2017-10-11 05:28:30.401886
NCT00184132|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-03-10|||November 2000|Actual|2000-11-01|March 2017|2017-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||The Effects of Different Interior Decorations in a Psychiatric Intensive Care Unit.|The Effects of Different Interior Decorations in a Psychiatric Intensive Care Unit.|Completed||N/A|54|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||No||2017-10-11 05:28:30.478075|2017-10-11 05:28:30.478075
NCT00184145|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-02-24|||June 2004|Actual|2004-06-01|February 2017|2017-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||EMDR in the Treatment of Specific Phobia.|EMDR (Eye Movement Desensitization and Reprocessing) in the Treatment of Specific Phobia. A Randomised Controlled Trial.|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||1||approval of ethical committee was denied|f||||t|f|f||||||||2017-10-11 05:28:30.559034|2017-10-11 05:28:30.559034
NCT00184158|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-17|||January 2005|Actual|2005-01-01|August 2017|2017-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Treatment for Cubital Tunnel Syndrome|Cubital Tunnel Treatment, Evaluation of Conservative and Operative Alternatives|Completed||N/A|81|Actual|Norwegian University of Science and Technology||1|||f||||f|f|f||||||||2017-10-11 05:28:30.628016|2017-10-11 05:28:30.628016
NCT00184171|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2015-01-20|||November 2001||2001-11-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|September 2010|Actual|2010-09-01||Interventional|||Treatment of Microscopic Colitis|Treatment of Microscopic Colitis (Collagenous Colitis and Lymphocytic Colitis) With Budesonide, Bismuth or Fiber|Terminated||N/A|105|Actual|Norwegian University of Science and Technology||3||insufficient data quality|f||||f||||||||||2017-10-11 05:28:30.861782|2017-10-11 05:28:30.861782
NCT00184184|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-10|||October 2004|Actual|2004-10-01|March 2017|2017-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Observational|||Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients|Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients|Completed||N/A|262|Actual|Norwegian University of Science and Technology|||1||f||||||||||||||2017-10-11 05:28:30.973448|2017-10-11 05:28:30.973448
NCT00184197|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-10|||May 2005|Actual|2005-05-01|March 2017|2017-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Botulinum Toxin Injection in Neck Muscles in Cervicogenic Headache|Botulinum Toxin Injection in Neck Muscles in Cervicogenic Headache: A Prospective, Randomized, Double-blind, Cross-over Study|Completed||Phase 2|28|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 05:28:31.04048|2017-10-11 05:28:31.04048
NCT00184210|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-17|||January 2000|Actual|2000-01-01|August 2017|2017-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue|HR MAS MR Spectroscopy of Breast Cancer Tissue|Recruiting||N/A|1000|Anticipated|Norwegian University of Science and Technology|||1||f||||f|f|f||||Samples With DNA|"     tissue   "|||2017-10-11 05:28:31.125272|2017-10-11 05:28:31.125272
NCT00184223|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-06-03|||October 2004||2004-10-01|May 2016|2016-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use|Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use|Completed||N/A|135|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||No||2017-10-11 05:28:31.210193|2017-10-11 05:28:31.210193
NCT00184236|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-29|||February 2005|Actual|2005-02-01|March 2017|2017-03-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Cardiovascular Risk Factors in Overweight Adolescents|Aerobic Interval Training Reduces Cardiovascular Risk Factors More Than a Multitreatment Approach in Overweight Adolescents|Completed||N/A|54|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||No||2017-10-11 05:28:31.298865|2017-10-11 05:28:31.298865
NCT00184249|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-18|||June 2005||2005-06-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|June 2010|Actual|2010-06-01||Interventional|||A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation|A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||1||Collaborators did not enter patients into the study|f||||f||||||||||2017-10-11 05:28:31.38602|2017-10-11 05:28:31.38602
NCT00184262|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-20|||January 2003||2003-01-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Exposure and Response Prevention With Behavioral- Versus Cognitive Therapy Rationale in Obsessive Compulsive Disorder|Exposure and Response Prevention (ERP) With Behavioral- Versus Cognitive Therapy Rationale in the Treatment of OCD|Completed||N/A|35|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:28:31.480788|2017-10-11 05:28:31.480788
NCT00184275|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-03-06|||May 2005||2005-05-01|March 2014|2014-03-01|December 2010|Actual|2010-12-01|May 2007|Actual|2007-05-01||Observational|||Characterization of Brain Metastases|Brain Metastases Tissue Characterized by High-resolution Magic Angle Spinning MR and Micro Array|Completed||N/A|26|Actual|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"     frozen tumor tissue samples   "|||2017-10-11 05:28:31.588891|2017-10-11 05:28:31.588891
NCT00184288|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-01|||November 2004||2004-11-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|June 2006|Actual|2006-06-01||Observational|||Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.|Single Volume 1H MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology|||1|no patients recruited|f||||f||||||||||2017-10-11 05:28:32.171558|2017-10-11 05:28:32.171558
NCT00184301|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-28|||September 2005|Actual|2005-09-01|March 2017|2017-03-01|October 2013|Actual|2013-10-01|December 2011|Actual|2011-12-01||Interventional|||A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.|Treatment of Patients With Concurrent Eating Disorder and Personality Disorder: A Controlled Randomized Comparison Study, of Treatments Given to In-patients and Out-patients.|Completed||N/A|43|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||No||2017-10-11 05:28:32.23327|2017-10-11 05:28:32.23327
NCT00184314|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-08|||March 2004|Actual|2004-03-01|February 2017|2017-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Observational|||Follow-up of Eating Disorder Patients From a 15-year Period.|Follow-up Eating Disorder Patients and Their Parents Leaving Treatment From 1988 to 2002 at Child and Adolescent Department at Levanger Hospital.|Completed||N/A|40|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 05:28:32.324087|2017-10-11 05:28:32.324087
NCT00184327|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-16|||January 2002||2002-01-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|December 2006|Actual|2006-12-01||Observational|||Changes Following Inpatient Child-oriented Family Treatment|Change Across Intensive Inpatient Family Treatment in Child and Adolescent Psychiatry. A Multi-site Study of Parents and Children in Inpatient Family Treatment|Completed||Phase 1|150|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 05:28:32.403126|2017-10-11 05:28:32.403126
NCT00184340|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-08|||January 2004|Actual|2004-01-01|February 2017|2017-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Secured Internet-mediated Psychotherapy With Psychiatry Patients|Secured Internet-mediated Psychotherapy With Psychiatry Patients. Software Improvement, Clinical Trials and Development of Clinical Precautions|Completed||N/A|6|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 05:28:32.495678|2017-10-11 05:28:32.495678
NCT00184353|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-10-20|||November 2003||2003-11-01|October 2011|2011-10-01|June 2005|Actual|2005-06-01|December 2004|Actual|2004-12-01||Observational|||Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.|In Vivo Proton MR Spectroscopy of Brain Metastases Obtained at 1,5T and 3T.|Completed||N/A|19|Actual|Norwegian University of Science and Technology|||2||f||||f||||||||||2017-10-11 05:28:32.57593|2017-10-11 05:28:32.57593
NCT00184366|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-01-18|||May 2005||2005-05-01|January 2012|2012-01-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Observational|||Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis|Classification and Characterization of Patients Suffering From Moderate to Severe Plaque Psoriasis Responding to Subcutaneous Administered Efalizumab|Terminated||Phase 4|96|Actual|Norwegian University of Science and Technology|||1|efalizumab was withdrawn from market; full 2 years follow-up only 14 patients|f||||f||||||||||2017-10-11 05:28:32.639533|2017-10-11 05:28:32.639533
NCT00184379|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-24|||April 2005||2005-04-01|August 2017|2017-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effects of Psychoeducation of Relatives to Patients With Serious Mental Illness|Effects of Psychoeducation of Relatives to Patients With Serious Mental Illness|Completed||N/A|50|Actual|Norwegian University of Science and Technology||4|||f||||f|f|f||||||||2017-10-11 05:28:32.708429|2017-10-11 05:28:32.708429
NCT00184392|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-02-27|||January 2005||2005-01-01|February 2014|2014-02-01|September 2007|Actual|2007-09-01|December 2005|Actual|2005-12-01||Interventional|||Cleaning of the Nose After Sinus Surgery: Necessary or Only Bothersome?|Debridement After Functional Endoscopic Sinus Surgery|Completed||N/A|60|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-10-11 05:28:32.793881|2017-10-11 05:28:32.793881
NCT00184405|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-01-05|||March 2005||2005-03-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Child Results Following Preventive Children of Parents With Psychiatric and Addictive Problems (COPP) Groups|Preventive Peer Groups for Children of Parents With Psychiatric and Addictive Problems (COPP). Child Experiences and Observed Child Changes Following the Intervention|Terminated||Phase 1|6|Actual|Norwegian University of Science and Technology|||1|Terminated to financial cut|f||||t||||||||||2017-10-11 05:28:34.550336|2017-10-11 05:28:34.550336
NCT00184418|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-03-09|||January 2005|Actual|2005-01-01|March 2017|2017-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||The Immune System and Psychiatric Disorders|The Immune System and Psychiatric Disorders|Completed||N/A|1400|Actual|Norwegian University of Science and Technology|||1||f||||f|f|f||||Samples Without DNA|"     Serum, frozen   "|No||2017-10-11 05:28:34.614232|2017-10-11 05:28:34.614232
NCT00184431|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-10-17|||April 2004||2004-04-01|October 2011|2011-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Does Intensive Task Specific Training Improve Balance After Acute Stroke?|A Randomized Controlled Trial Comparing Intensive Task Specific Training With Traditional Follow up Care After Discharge From a Stroke Unit.|Completed||N/A|62|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:28:34.69717|2017-10-11 05:28:34.69717
NCT00184444|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-07-19|||September 2004||2004-09-01|July 2016|2016-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients|Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients|Completed||N/A|25|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:28:34.782097|2017-10-11 05:28:34.782097
NCT00184457|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-01-16|||September 2005||2005-09-01|November 2011|2011-11-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|||Maximal Leg Press Strength Training Study for Coronary Artery Disease Patients|Maximal Leg Press Strength Training for Coronary Artery Disease Patients. Training Effect on Serum Testosterone and Work Economy|Completed||N/A|12|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-10-11 05:28:34.862849|2017-10-11 05:28:34.862849
NCT00184470|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-04-18|||December 2004||2004-12-01|April 2008|2008-04-01|January 2007||2007-01-01|June 2006|Actual|2006-06-01||Observational|||Trauma Registration at St. Olavs Hospital 2000-2003|Mapping of Traumatized Patients Referred to St. Olavs Hospital in the Period 2000-2003-Norwegian University of Science and Technology|Terminated||Phase 3|1000||Norwegian University of Science and Technology|||||f||||||||||||||2017-10-11 05:28:34.941585|2017-10-11 05:28:34.941585
NCT00184483|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-02-04|||October 2001||2001-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Multi-site Trial Comparing Lichtensteins Operation and Prolene Hernia System in Inguinal HErnia Repair|Randomized Multi Site Trial Comparing Lichtensteins Operation and Prolene Hernia System in Inguinal HErnia Repair.|Completed||N/A|405|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:28:34.999439|2017-10-11 05:28:34.999439
NCT00184496|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-02-27|||August 2004||2004-08-01|February 2014|2014-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study|Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study|Completed||Phase 3|42|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:28:35.104849|2017-10-11 05:28:35.104849
NCT00184509|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-01-25|||February 1993||1993-02-01|January 2017|2017-01-01|May 1998||1998-05-01|||||Interventional|||Continued Early Intervention for Recent-onset Schizophrenia|Continued Early Intervention for Recent-onset Schizophrenia. A Randomized Controlled Study.|Terminated||Phase 3|50||Norwegian University of Science and Technology|||||f||||||||||||||2017-10-11 05:28:35.19525|2017-10-11 05:28:35.19525
NCT00184522|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-08-08|||August 2002||2002-08-01|September 2005|2005-09-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||On Demand Treatment of Reflux Disease|Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.|Completed||Phase 4|82|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:28:35.270168|2017-10-11 05:28:35.270168
NCT00183118|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-07-19|||October 2004||2004-10-01|July 2017|2017-07-01|December 2005|Actual|2005-12-01|||||Interventional|||Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)|HIV Prevention Partnership in Russian Alcohol Treatment|Completed||Phase 1/Phase 2|180|Actual|Boston Medical Center||1|||f||||f|f|f||||||||2017-10-11 05:30:35.080052|2017-10-11 05:30:35.080052
NCT00184535|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-09-20|||July 2005|Actual|2005-07-01|September 2017|2017-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||"Recording Methods of Muscle Activity Onset."|"Muscle Activity Onset in the Transversus Abdominis - Simultaneous Recordings by Intramuscular Electromyography and High Frame Rate Ultrasound Imaging."|Completed||N/A|10|Actual|Norwegian University of Science and Technology|||1||f||||f|f|f||||||||2017-10-11 05:28:35.379359|2017-10-11 05:28:35.379359
NCT00184548|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-06-13|2009-09-04||October 2005||2005-10-01|June 2014|2014-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|CONTROL||Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding|A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven®/NiaStase®) in Severely Injured Trauma Patients With Bleeding Refractory to Standard Treatment|Terminated||Phase 3|554|Actual|Novo Nordisk A/S|Trial was terminated after planned interim analysis for futility showed a lower than expected conditional power for showing superiority (11.2% [actual] vs. 50% [required]). 554 of 1502 planned patients were included in the intent-to-treat population.|4||See termination reason in detailed description|f||||f||||||||||2017-10-11 05:28:35.630065|2017-10-11 05:28:35.630065
NCT00184561|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2017-01-05|||July 2005||2005-07-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes|Change in HbA1c With Biphasic Insulin Aspart 70/30 in Two Different Treatment Regiments in Subjects With Type 2 Diabetes Inadequately Controlled With Oral Anti-diabetic Drug Therapy.|Completed||Phase 4|321|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:38.637782|2017-10-11 05:28:38.637782
NCT00184574|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-01-04|||April 2005||2005-04-01|January 2017|2017-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes|Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30, Biphasic Insulin Aspart 50/50, and Biphasic Insulin Aspart 30/70 All in Combination With Metformin in Subjects With Type 2 Diabetes (the INTENSIMIX Trial).|Completed||Phase 3|603|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:38.75567|2017-10-11 05:28:38.75567
NCT00184587|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-04-22|||March 2005||2005-03-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Prophylactic Treatment of Episodic Cluster Headache|Prophylactic Treatment of Episodic Cluster Headache With an Angiotensin II Receptor Blocker (Candesartan Cilexetil); a Randomized, Placebo Controlled Parallel Study|Completed||Phase 2|40|Actual|Norwegian University of Science and Technology||2|||f||||||||||||||2017-10-11 05:28:39.074477|2017-10-11 05:28:39.074477
NCT00184600|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-26|2011-05-10||November 2004||2004-11-01|January 2017|2017-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|4T||Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes|A 36-month, Multi-centre, Open-label, Randomised, Parallel-group Trial Comparing the Safety, Efficacy and Durability of Adding a Basal Insulin Versus a Twice Daily Insulin Mixture Versus a Meal-time Rapid-Acting Insulin in Subjects With Type 2 Diabetes Inadequately Controlled on Therapy With Oral Agents, and Assessing the Requirement for More Complex Insulin Regimens to Achieve and Maintain Glycaemic Control, Their Efficacy and Durability|Completed||Phase 3|708|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 05:28:39.27784|2017-10-11 05:28:39.27784
NCT00184613|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-10-14|||May 2005||2005-05-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes|An Open-label, Randomised, In-patient, Cross Over PK/PD Trial Investigating the Pharmackinectic and Pharmacodynamic Profiles Following Continuous Subcutaneous Infusion of Insulin Aspart or Injection of Insulin Glargine in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|22|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:43.271657|2017-10-11 05:28:43.271657
NCT00184626|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-22|||September 10, 2004|Actual|2004-09-10|February 2017|2017-02-01|October 24, 2005|Actual|2005-10-24|October 24, 2005|Actual|2005-10-24||Interventional|||Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.|Safety and Efficacy of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.|Completed||Phase 4|97|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:43.340122|2017-10-11 05:28:43.340122
NCT00184639|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-22|||August 16, 2004|Actual|2004-08-16|February 2017|2017-02-01|November 22, 2005|Actual|2005-11-22|November 22, 2005|Actual|2005-11-22||Interventional|||Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes|Comparison of Efficacy and Safety of Insulin Detemir and Insulin Semilente®MC in Children, Adolescents and Young Adults With Type 1 Diabetes on Basal-Bolus Regimen.|Completed||Phase 3|71|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:43.433162|2017-10-11 05:28:43.433162
NCT00184652|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-23|||April 2003||2003-04-01|January 2017|2017-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease|The Effect of Norditropin® on Nutritional Status in Adult Patients in Chronic Haemodialysis|Completed||Phase 2|140|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:43.513099|2017-10-11 05:28:43.513099
NCT00184665|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-26|||June 2004||2004-06-01|January 2017|2017-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes|2 Year Efficiency and Safety Comparison of Insulin Detemir and NPH Insulin in Type 1 Diabetes.|Completed||Phase 3|501|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:43.65172|2017-10-11 05:28:43.65172
NCT00184678|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-12|||February 2002||2002-02-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency|Effect of Two Years of Treatment With Norditropin® SimpleXx® on Bone Mineral Density in Young Adults With Childhood-Onset Growth Hormone Deficiency|Completed||Phase 3|161|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:43.935664|2017-10-11 05:28:43.935664
NCT00184691|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-17|||April 1999||1999-04-01|January 2017|2017-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years|Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone Which Will be Started Randomly at the Ages of 2 to 5, in Children Diagnosed of IUGR|Completed||Phase 3|78|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:44.112798|2017-10-11 05:28:44.112798
NCT00184717|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-06|2010-12-22||August 18, 2004|Actual|2004-08-18|June 2017|2017-06-01|December 28, 2009|Actual|2009-12-28|March 29, 2006|Actual|2006-03-29||Interventional|||Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)|GHLIQUID-1516: A 104-week, Multi-centre, Randomised, Double-blind, Parallel-group, no Treatment Controlled (Open-label) Trial Investigating the Efficacy and Safety of Two Doses of NN-220 in Subjects With Short Stature Born Small for Gestational Age / GHLIQUID-1517: A Long-term, Multi-centre, Randomised, Controlled, Double-blind, Parallel-group Trial, Investigating the Efficacy and Safety of Two Doses of NN-220 in Subjects With Short Stature Born Small for Gestational Age|Completed||Phase 3|98|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-10-11 05:28:44.229727|2017-10-11 05:28:44.229727
NCT00184730|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-16|||November 2004||2004-11-01|November 2016|2016-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)|Investigation of the Efficacy and Safety of hGH in Long Term (More Than 48 Weeks) in GHDA.|Completed||Phase 3|86|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:45.79391|2017-10-11 05:28:45.79391
NCT00184743|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-27|||December 6, 2003|Actual|2003-12-06|February 2017|2017-02-01|December 28, 2005|Actual|2005-12-28|December 28, 2005|Actual|2005-12-28||Interventional|||Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)|Investigation of the Efficacy and Safety of NN-220 for 48 Weeks in Adults With Growth Hormone Deficiency|Completed||Phase 3|112|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:45.862653|2017-10-11 05:28:45.862653
NCT00184756|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-12|||November 2002||2002-11-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy on Height in SGA Children Treated With Growth Hormone|Effect of Two Years Treatment With Growth Hormone on Height in SGA Children.|Completed||Phase 3|151|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:45.936886|2017-10-11 05:28:45.936886
NCT00184769|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-23|||January 29, 1998|Actual|1998-01-29|February 2017|2017-02-01|December 21, 2005|Actual|2005-12-21|December 21, 2005|Actual|2005-12-21||Interventional|||Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.|Open Randomized Trial Examining the Growth and Safety Effects of Treatment With Recombinant Growth Hormone on Infants Aged 1 to 2 Years With Growth Retardation Secondary to Chronic Renal Insufficiency|Completed||Phase 4|16|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:28:46.081054|2017-10-11 05:28:46.081054
NCT00184782|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-20|||September 2003||2003-09-01|September 2005|2005-09-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning|Exploratory Study on FDG-PET Scanning in Evaluating the Metabolic Activity of Liver Metastases Before and After Resection of the Primary Tumor in Patients With a Colorectal Malignancy|Unknown status|Recruiting|N/A|30|Anticipated|Radboud University|||||f||||||||||||||2017-10-11 05:28:46.1926|2017-10-11 05:28:46.1926
NCT00184795|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-22|||May 28, 2004|Actual|2004-05-28|February 2017|2017-02-01|May 4, 2005|Actual|2005-05-04|May 4, 2005|Actual|2005-05-04||Interventional|CHOICE||Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations|A Six Month Double-blind, Randomised, Parallel-group, Placebo-controlled, Multi-centre Trial to Investigate the Efficacy and Safety of Two Ultra-low Dose Combinations With 0.5 mg Estradiol and 0.1 mg or 0.25 mg Norethisterone Acetate (Activelle Low Dose 0.1/Activelle Low Dose 0.25) for Treatment of Menopausal Symptoms|Completed||Phase 3|576|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-10-11 05:28:46.276949|2017-10-11 05:28:46.276949
NCT00184808|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Observational|||Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily Life||Unknown status|Recruiting|N/A|15||Radboud University|||||f||||||||||||||2017-10-11 05:28:46.731661|2017-10-11 05:28:46.731661
NCT00184821|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-04|||June 2004||2004-06-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Observational|||Ischemic Injury and Ischemic Preconditioning in Diabetes|Acute Local Ischemic Preconditioning in Patients With Type 1 Diabetes in Vivo|Completed||N/A|20||Radboud University|||||f||||f||||||||||2017-10-11 05:28:46.794658|2017-10-11 05:28:46.794658
NCT00184834|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 1999||1999-06-01|September 2005|2005-09-01|November 2002||2002-11-01|||||Observational|||Quality of Life and Liver Metastases|Quality of Life After Surgical Treatment of Colorectal Liver Metastases|Completed||N/A|100||Radboud University|||||f||||||||||||||2017-10-11 05:28:46.874496|2017-10-11 05:28:46.874496
NCT00184847|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-27|||March 2005||2005-03-01|March 2008|2008-03-01||||||||Interventional|||Adenosine Receptors Influence Ischemia-Reperfusion Injury|Adenosine Receptor Involvement in Acute Ischemic Preconditioning of the Vascular Endothelium|Suspended||N/A|8|Anticipated|Radboud University|||||f||||||||||||||2017-10-11 05:28:46.944583|2017-10-11 05:28:46.944583
NCT00184860|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-26|||June 2003||2003-06-01|April 2007|2007-04-01||||||||Interventional|||The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients|The Value of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes in Patients With a Squamous Cell Carcinoma of the Head-and-Neck Region, Who Are to be Treated With Definitive Radiotherapy|Completed||N/A|80||Radboud University|||||f||||||||||||||2017-10-11 05:28:47.01184|2017-10-11 05:28:47.01184
NCT00184873|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-02-08|||January 2005||2005-01-01|August 2007|2007-08-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance in Leg Ulcer Patients|Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance With Compression Therapy and Prescribed Exercise in Leg Ulcer Patients|Completed||N/A|180|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 05:28:47.06222|2017-10-11 05:28:47.06222
NCT00184886|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-02-13|||November 2003||2003-11-01|February 2006|2006-02-01|January 2005||2005-01-01|||||Interventional|||The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans|The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans|Completed||N/A|10||Radboud University|||||f||||||||||||||2017-10-11 05:28:47.16525|2017-10-11 05:28:47.16525
NCT00184899|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-02-28|||August 2005||2005-08-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids|The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids|Completed||N/A|20||Radboud University|||||f||||||||||||||2017-10-11 05:28:47.32726|2017-10-11 05:28:47.32726
NCT00184912|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-28|||September 2003||2003-09-01|February 2006|2006-02-01|January 2006||2006-01-01|||||Interventional|||The Effect of Caffeine on Ischemic Preconditioning|Caffeine Reduces Acute Ischemic Preconditioning|Completed||N/A|24||Radboud University|||||f||||||||||||||2017-10-11 05:28:47.405966|2017-10-11 05:28:47.405966
NCT00184925|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-11-05|||October 2003||2003-10-01|November 2014|2014-11-01|August 2005|Actual|2005-08-01|April 2005|Actual|2005-04-01||Interventional|||Ventilator Associated Pneumonia and Late Complications of Percutaneous Tracheostomy|The Development of Ventilator Associated Pneumonia and Late Complications of Two Different Percutaneous Tracheostomy Techniques|Terminated||N/A|120|Actual|Radboud University||1||Analysis was frustrated by inadequate PhD's....|f||||t||||||||||2017-10-11 05:28:47.485634|2017-10-11 05:28:47.485634
NCT00184938|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-27|||January 2005||2005-01-01|March 2008|2008-03-01||||||||Interventional|||Opioid Receptors Influence Ischemia-Reperfusion Injury|Opioid Induced Acute Preconditioning|Suspended||N/A|40|Anticipated|Radboud University|||||f||||||||||||||2017-10-11 05:28:47.570915|2017-10-11 05:28:47.570915
NCT00184951|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-21|||April 2004||2004-04-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients|Pharmacodynamics and Pharmacokinetics of Combined Use of Rosuvastatin (Crestor) and Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients With Hyperlipidemia (ROSALKA)|Completed||Phase 2|30||Radboud University|||||f||||||||||||||2017-10-11 05:28:47.652942|2017-10-11 05:28:47.652942
NCT00184964|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-03|||June 2004||2004-06-01|June 2008|2008-06-01||||||||Interventional|||Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis|The Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis With Histological Examination of the Resected Specimen|Unknown status|Recruiting|N/A|15|Anticipated|Radboud University|||||f||||||||||||||2017-10-11 05:28:47.736916|2017-10-11 05:28:47.736916
NCT00184977|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-03-11|||December 1998||1998-12-01|August 2006|2006-08-01|January 2003||2003-01-01|||||Interventional|||COPD on Primary Care Treatment (COOPT)|A Double-blind Placebo-controlled Trial Comparing the Efficacy and Cost-effectiveness of Inhaled Fluticason Propionate Versus Oral N-acetylcysteine in the Treatment of Patients With COPD in General Practice|Completed||Phase 4|270||Radboud University|||||f||||||||||||||2017-10-11 05:28:47.80661|2017-10-11 05:28:47.80661
NCT00184990|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-14|||January 2005||2005-01-01|April 2008|2008-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Effect of Selective iNOS Inhibition During Human Endotoxemia|Effect of Selective iNOS Inhibition During Human Endotoxemia|Completed||Phase 1|7|Actual|Radboud University||1|||f||||f||||||||||2017-10-11 05:28:47.897305|2017-10-11 05:28:47.897305
NCT00185003|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-16|||January 2003||2003-01-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Blockade of Vascular Potassium Channels During Human Endotoxemia|Blockade of Vascular Potassium Channels During Human Endotoxemia|Completed||Phase 1|36|Actual|Radboud University||6|||f||||f||||||||||2017-10-11 05:28:47.970998|2017-10-11 05:28:47.970998
NCT00185016|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2005-09-15|||March 2003||2003-03-01|September 2005|2005-09-01|November 2004||2004-11-01|||||Interventional|||Women Abuse and the Role of the Family Doctor.|Women Abuse and the Role of the Family Doctor. Testing an Intervention in a Randomised Controlled Trial.|Terminated||N/A|||Radboud University|||||f||||||||||||||2017-10-11 05:28:48.040511|2017-10-11 05:28:48.040511
NCT00185029|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-14|||April 2002||2002-04-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||MR-Lymphography and Lymph Node Staging in Prostate Cancer|MRI With a Lymph Node Specific Contrast Agent: an Alternative for CT-Scanning and Lymph Node Dissection in Patients With Prostate Cancer?|Unknown status|Active, not recruiting|Phase 4|396||Radboud University|||||f||||||||||||||2017-10-11 05:28:48.108515|2017-10-11 05:28:48.108515
NCT00185042|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-09-10|||November 2002||2002-11-01|September 2007|2007-09-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of the ACAT Inhibitor CS-505 for Reducing the Progression of Atherosclerosis in Subjects With Coronary Artery Disease Using Intravascular Ultrasound (IVUS)|Completed||Phase 2|534|Actual|Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:28:48.188768|2017-10-11 05:28:48.188768
NCT00185055|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-15|||November 2004||2004-11-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects|The Relative Effects of Single Doses of Olmesartan Medoxomil, Irbesartan and Valsartan at High Dosage Levels on the Renin-Angiotensin-Aldosterone System in Healthy Normal Subjects|Completed||Phase 4|20||Daiichi Sankyo, Inc.|||||||||||||||||||2017-10-11 05:28:48.335675|2017-10-11 05:28:48.335675
NCT00185068|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||March 2004||2004-03-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension|A Prospective, Open Label, Titration Study to Assess the Efficacy and Safety of Benicar® and Benicar ®HCT in Patients With Stage II Systolic Hypertension|Completed||Phase 4|110||Daiichi Sankyo, Inc.|||||||||||||||||||2017-10-11 05:28:48.397422|2017-10-11 05:28:48.397422
NCT00185081|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-04-06|||July 2005||2005-07-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging|Radioimmunodetection of CEA-Producing Tumors Using a Bispecific Antibody Pre-targeting Method and an In-Labeled Peptide|Completed||Phase 1|42|Anticipated|Radboud University|||||f||||||||||||||2017-10-11 05:28:48.498158|2017-10-11 05:28:48.498158
NCT00185094|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-22|||February 2004||2004-02-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin|The Effects of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on Insulin Sensitivity in Overweight and Obese Subjects With Hypertension|Completed||Phase 4|60||Daiichi Sankyo, Inc.|||||||||||||||||||2017-10-11 05:28:48.579986|2017-10-11 05:28:48.579986
NCT00185107|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-09-10|||March 2005||2005-03-01|September 2007|2007-09-01|October 2005||2005-10-01|||||Interventional|||Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Combination With Zetia® Compared to Zetia® Alone in Patients With Primary Hypercholesterolemia|Completed||Phase 4|45||Daiichi Sankyo, Inc.|||||f||||f||||||||||2017-10-11 05:28:48.670988|2017-10-11 05:28:48.670988
NCT00183131|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-05-05|||October 2004||2004-10-01|December 2007|2007-12-01|November 2004|Actual|2004-11-01|||||Interventional|||The iHealth Study in College Students|Internet Screening and Brief Intervention for Hazardous Drinking in College Students: A Pilot Study|Completed||Phase 2|4300||Boston Medical Center|||||f||||||||||||||2017-10-11 05:30:35.171335|2017-10-11 05:30:35.171335
NCT00185120|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-01-16|||September 2005||2005-09-01|January 2012|2012-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker|A Study on the Efficacy and Safety of Olmesartan Medoxomil and Its Combination With Hydrochlorothiazide Compared With an ACE Inhibitor and Its Combination With a Calcium Channel Blocker in Patients With Stage 2 Hypertension|Completed||Phase 4|152||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:28:49.053745|2017-10-11 05:28:49.053745
NCT00185133|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-12|||May 2005||2005-05-01|December 2007|2007-12-01|January 2007||2007-01-01|||||Interventional|||Study of co-Administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension|A Randomized, Double-Blind, Placebo-Controlled Factorial Study Evaluating the Efficacy and Safety of co-Administration of Olmesartan Medoxomil Plus Amlodipine Compared to Monotherapy in Patients With Mild to Severe Hypertension|Completed||Phase 3|1900||Daiichi Sankyo, Inc.|||||f||||f||||||||||2017-10-11 05:28:49.172957|2017-10-11 05:28:49.172957
NCT00185146|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-03-27|||September 2002||2002-09-01|March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety of Pactimibe in Patients With Atherosclerosis|Effect of Pactimibe on the Progression of Atherosclerosis as Measured by 2-D and 3-D Carotid Ultrasound|Completed||Phase 2|200||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:28:49.580337|2017-10-11 05:28:49.580337
NCT00185159|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-19|||October 2004||2004-10-01|January 2010|2010-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Olmesartan Medoxomil in Diabetes Mellitus|Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study (ROADMAP)|Completed||Phase 3|4449|Actual|Daiichi Sankyo, Inc.||2|||f||||||||||||||2017-10-11 05:28:49.650329|2017-10-11 05:28:49.650329
NCT00185172|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-28|||January 2002||2002-01-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Olmesartan in Essential Hypertension|Efficacy and Safety of Olmesartan: Reduction of Blood Pressure in the Treatment of Patients Suffering From Mild to Moderate Essential Hypertension|Completed||Phase 3|2333|Actual|Daiichi Sankyo, Inc.||3|||f||||f||||||||||2017-10-11 05:28:49.736524|2017-10-11 05:28:49.736524
NCT00185185|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-12|||November 2001||2001-11-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Olmesartan Medoxomil in Atherosclerosis|Multi-Centre Olmesartan Atherosclerosis Regression Evaluation (MORE)|Completed||Phase 3|165|Actual|Daiichi Sankyo, Inc.||2|||f||||||||||||||2017-10-11 05:28:49.840895|2017-10-11 05:28:49.840895
NCT00185198|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-04-01|||September 2004||2004-09-01|April 2014|2014-04-01|October 2007|Actual|2007-10-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)|Multicenter, Double Blind, Randomized, Placebo Controlled Study of Testogel® (Testosterone 50-100mg) to Evaluate Its Efficacy and Safety in Men Presenting With Typical Symptoms of Partial Androgen Deficiency of Aging Males (PADAM) Over a Period of 6 Months With 12 Months Open Label Follow-up|Completed||Phase 3|363|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:28:49.976966|2017-10-11 05:28:49.976966
NCT00185211|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-12-04|2009-07-23||August 2002||2002-08-01|December 2013|2013-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study|Open-label, Multi-center Phase III Extension of the Double-blind, Placebo-controlled BENEFIT Study (no. 92012/304747) to Obtain Long-term Follow-up Data of Patients With Clinically Definite Multiple Sclerosis (MS) and Patients With a First Demyelinating Event Suggestive of MS Treated With 8 MIU (250 µg) Interferon Beta-1b (Betaferon® / Betaseron®) Given Subcutaneously Every Other Day for at Least 36 Months.|Completed||Phase 3|468|Actual|Bayer|"Participant Flow: Subject with Other as reason for not completing a study period are presented according to the NIH pre-specified categories as far as possible."|2|||f||||t||||||||||2017-10-11 05:28:50.205833|2017-10-11 05:28:50.205833
NCT00185224|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-07-14|||March 2005||2005-03-01|July 2011|2011-07-01|March 2006|Actual|2006-03-01|||||Interventional|||Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive|A Single-center, Open-label, Controlled, Randomized Study to Investigate the Impact of a Sequential Oral Contraceptive (SH T00658ID) as Compared to a Sequential Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D00264A) on Plasma Lipids, Hemostatic Variables, and Carbohydrate Metabolism in Healthy Female Volunteers Aged 18-50 Years Over 7 Treatment Cycles, Including the Pharmacokinetics|Completed||Phase 2|58|Actual|Bayer||2|||f||||||||||||||2017-10-11 05:28:51.511354|2017-10-11 05:28:51.511354
NCT00185237|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-12-22|||July 2005||2005-07-01|December 2014|2014-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch|A Multicenter, Double-blind, Randomized, Placebo Controlled Study on the Effect of Ultra-low Dose Transdermal Estradiol (Menostar®) on the Incidence and Severity of Hot Flushes, Other Menopausal Symptoms and on Well-being in Postmenopausal Asian Women Over 12 Weeks.|Completed||Phase 3|165|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:28:51.590412|2017-10-11 05:28:51.590412
NCT00185250|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-12-18|||December 2002||2002-12-01|December 2008|2008-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy|Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study to Evaluate Efficacy and Safety of 4 and 8 Million Units Betaferon®/Betaseron® (Interferon Beta-1b) Given Subcutaneously Every Other Day Over 24 Weeks in Patients With Chronic Viral Cardiomyopathy|Completed||Phase 2|138|Actual|Bayer||4|||f||||t||||||||||2017-10-11 05:28:51.669072|2017-10-11 05:28:51.669072
NCT00185263|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-11-04|||March 2002||2002-03-01|November 2008|2008-11-01|November 2008|Anticipated|2008-11-01|January 2005|Actual|2005-01-01||Interventional|AGENT-4||Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina|A Multinational Multicenter, Randomized , Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Patients With Stable Angina|Unknown status|Active, not recruiting|Phase 2/Phase 3|116|Actual|Cardium Therapeutics||3|||f||||t||||||||||2017-10-11 05:28:51.950151|2017-10-11 05:28:51.950151
NCT00185276|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2014-12-29|||March 2003||2003-03-01|December 2014|2014-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries|Randomized, Multi-center Open Label Study of the Safety (Open-label) and Efficacy (Open-label & Blinded Reader) of Magnevist® Injection-enhanced Magnetic Resonance Arteriography (MRA) at Two Dose Levels and 2-dimensional-time-of-flight (2D-TOF) MRA in Patients Undergoing MRA of the Infrarenal Aorta and Peripheral Arteries With Intra-arterial Digital Subtraction Arteriography (i.a. DSA) as Standard of Reference|Completed||Phase 3|365|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:28:52.036692|2017-10-11 05:28:52.036692
NCT00185289|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-07-14|||April 2004||2004-04-01|July 2011|2011-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Study to Investigate Efficacy and Safety of a New Oral Contraceptive|Multi-center , Open, Uncontrolled Study to Investigate the Efficacy and Safety of a 4 Phasic Oral Contraceptive SH T00658 in a 28-day Regimen for 20 Cycles in Healthy Female Volunteers|Completed||Phase 3|1392|Actual|Bayer||1|||f||||||||||||||2017-10-11 05:28:52.127725|2017-10-11 05:28:52.127725
NCT00185302|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-10|||December 2004||2004-12-01|December 2015|2015-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma|Phase II Study of MS-275, a Histone Deacetylase Inhibitor, Comparing 2 Dosage Schedules in Patients With Metastatic Melanoma|Completed||Phase 2|28|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:28:52.285293|2017-10-11 05:28:52.285293
NCT00185315|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-19|||February 2000||2000-02-01|April 2010|2010-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension|Open-label, Uncontrolled, Long-term Surveillance Study of Iloprost Aerosol Inhalation Therapy in the Treatment of Patients With Primary or Secondary Pulmonary Hypertension. Follow-up Program for Patients Who Completed 12 Weeks in Study ME97218/300180.|Completed||Phase 3|71|Actual|Bayer||1|||f||||||||||||||2017-10-11 05:28:52.372744|2017-10-11 05:28:52.372744
NCT00185328|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-12-11|||September 2005||2005-09-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy and Tolerability of Angeliq in Thai Women|A Multi-Center, Open-Label, Non-Comparative Study Investigating the Efficacy and Tolerability of Angeliq® in Postmenopausal Thai Women With Vasomotor Symptoms Over Three 28-Day Treatment Cycles|Completed||Phase 4|55|Actual|Bayer||1|||f||||f||||||||||2017-10-11 05:28:52.578091|2017-10-11 05:28:52.578091
NCT00185341|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-04-29|||February 2005||2005-02-01|April 2016|2016-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Safety, Tolerability and Efficacy of the CCR1 Antagonist ZK 811752, Given Orally in a Dose of 600 mg Three Times Daily, for the Treatment of Endometriosis Over 12 Weeks|Completed||Phase 2|110|Actual|Bayer||2|||f||||||||||||||2017-10-11 05:28:52.684245|2017-10-11 05:28:52.684245
NCT00185354|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-30|||November 2004||2004-11-01|December 2015|2015-12-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||FC Patch Comparator Study|Multi-center, Open, Randomized, Parallel Group Comparison of Cycle Control for Seven Cycles and Endometrial Safety in a Subgroup for Thirteen Cycles of Contraceptive Patch SH P00331F (0.9 mg Ethinylestradiol/1.9 mg Gestodene) vs. a Contraceptive Comparator Patch (0.6 mg Ethinylestradiol/6 mg Norelgestromin) in 400 Healthy Female Volunteers|Completed||Phase 3|422|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:28:52.862601|2017-10-11 05:28:52.862601
NCT00185367|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-14|||March 2005||2005-03-01|July 2011|2011-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Comparative Cycle Control Europe|A Multi-center, Double-blind, Double-dummy, Controlled, Randomized Study to Evaluate Cycle Control and Safety of a Four Phasic Oral Contraceptive (SH T00658ID) in Comparison to an Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D 593 B) in Healthy Female Volunteers Aged Between 18 and 50 Years.|Completed||Phase 3|798|Actual|Bayer||2|||f||||||||||||||2017-10-11 05:28:53.050342|2017-10-11 05:28:53.050342
NCT00185380|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-15|2009-12-10||April 2005||2005-04-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)|Multi-center, Open, Randomized, Dose Finding Phase II Study to Investigate Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) Releasing Different Amounts of Levonorgestrel Compared to MIRENA in Nulliparous and Parous Women in Need of Contraception.|Completed||Phase 2|742|Actual|Bayer||3|||f||||f||||||||||2017-10-11 05:28:53.255416|2017-10-11 05:28:53.255416
NCT00185393|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-11-26|||August 2001||2001-08-01|November 2008|2008-11-01|February 2007|Actual|2007-02-01|||||Interventional|||Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy|Efficacy and Safety of Subsequent Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Further Treatment in Patients With Stage III or IV Follicular Non-Hodgkin's Lymphoma Having Achieved Partial or Complete Remission After First Line Chemotherapy. A Prospective, Multicenter, Randomized Phase III Clinical Trial|Completed||Phase 3|414|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:28:54.193292|2017-10-11 05:28:54.193292
NCT00185419|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-13|||November 2003||2003-11-01|January 2009|2009-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception|An Open-Label, Randomised, Parallel-Group Comparison to Investigate the Efficacy of Yasmin® (30 µg Ethinylestradiol, 3mg Drospirenone) and Marvelon® (30 µg Ethinylestradiol, 150 µg Desogestrel) on Cycle Control in Healthy Chinese Women Over 13 Cycles|Completed||Phase 3|842|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:28:54.556927|2017-10-11 05:28:54.556927
NCT00185445|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-02|||June 2004||2004-06-01|December 2013|2013-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL|A Phase II Study to Evaluate the Efficacy and Safety of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL|Completed||Phase 2|62|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 05:28:54.64735|2017-10-11 05:28:54.64735
NCT00185458|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-05|2009-07-23||May 2000||2000-05-01|November 2013|2013-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).|A 60-month Non-comparative Study on Bleeding Profiles With Levonorgestrel Intrauterine System in Transition From Reproductive Age Contraception to Menopause Age Endometrial Protection During Estrogen Replacement Therapy.|Completed||Phase 3|394|Actual|Bayer||1|||f||||f||||||||||2017-10-11 05:28:54.782086|2017-10-11 05:28:54.782086
NCT00185484|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-30|||March 2004||2004-03-01|December 2014|2014-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Efficacy and Safety Oral Contraceptive Study|Multi-center, Open, Uncontrolled Study to Investigate the Efficacy and Safety of the Oral Contraceptive SH T 186 D Containing 0.02 mg Ethinylestradiol-b-cyclodextrin Clathrate and 3 mg Drospirenone in a 24-day Regimen for 13 Cycles in 1010 Healthy Female Volunteers|Completed||Phase 3|1113|Actual|Bayer||1|||f||||f||||||||||2017-10-11 05:28:55.598906|2017-10-11 05:28:55.598906
NCT00185510|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-02-23|||March 2005||2005-03-01|February 2014|2014-02-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis|Double-Blind, Placebo Controlled, Randomized, Multicenter, Parallel-Group Study to Compare the Efficacy and Safety of Advantan Cream Twice Weekly With Advabase Cream During a Maintenance Phase of 16 Weeks After Successful Treatment of Atopic Dermatitis With Advantan Cream|Completed||Phase 4|250|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:28:55.67424|2017-10-11 05:28:55.67424
NCT00185523|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-06-14|||May 2002||2002-05-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)|Allogeneic Peripheral Blood Stem Cell Transplantation for Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia in First or Second Remission or Chronic Myelogenous Leukemia in First and Second Chronic Phase or Accelerated Phase|Terminated||Phase 2|88|Actual|Stanford University|||2||f||||||||||||||2017-10-11 05:28:55.752918|2017-10-11 05:28:55.752918
NCT00185536|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||April 2002||2002-04-01|September 2005|2005-09-01||||||||Observational|||Effects of Advertising on Young Children's Perception of Taste|Effects of Advertising on Young Children's Perception of Taste|Completed||Phase 1/Phase 2|100||Stanford University|||||f||||||||||||||2017-10-11 05:28:55.840231|2017-10-11 05:28:55.840231
NCT00185549|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-04|||March 2004||2004-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||An Interactive Program to Improve Care for Children With CF|An Interactive Program to Improve Care for Children With Cystic Fibrosis|Completed||N/A|60||Stanford University|||||f||||||||||||||2017-10-11 05:28:55.88993|2017-10-11 05:28:55.88993
NCT00185562|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-03-23|||June 2005||2005-06-01|March 2006|2006-03-01|January 2006||2006-01-01|||||Interventional|||A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis|A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis|Completed||Phase 2|12||Stanford University|||||f||||||||||||||2017-10-11 05:28:55.944579|2017-10-11 05:28:55.944579
NCT00185575|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-04-07|||September 2004||2004-09-01|April 2009|2009-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Duloxetine for the Treatment of Dysthymia|Duloxetine for the Treatment of Dysthymia|Completed||N/A|24|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:28:55.99684|2017-10-11 05:28:55.99684
NCT00185588|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-09-10|2014-07-30||October 2004||2004-10-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional||33 adult patients with advanced pancreatic cancer|Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer|A Phase 1-2 Study of the VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 <Vatalanib> and Gemcitabine in Patients With Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|33|Actual|Stanford University||4|||f||||t||||||||||2017-10-11 05:28:57.640402|2017-10-11 05:28:57.640402
NCT00185601|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-04-18|||February 2006||2006-02-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Internet Diabetes Self-Management Workshop|Internet Diabetes Self-Management Evaluation|Completed||N/A|761|Actual|Stanford University||3|||f||||f||||||||||2017-10-11 05:28:58.856729|2017-10-11 05:28:58.856729
NCT00185614|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-18|||August 2000||2000-08-01|April 2011|2011-04-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||Mixed Chimera Allo Transplantation in Multiple Myeloma|Mixed Chimera Allogeneic Transplantation With or Without Allogeneic Idiotyped Pulsed Dendritic Cells for the Treatment of Multiple Myeloma|Completed||Phase 2|48|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 05:28:58.941078|2017-10-11 05:28:58.941078
NCT00185640|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-04|2016-12-01||March 2003||2003-03-01|February 2015|2015-02-01|January 2016|Actual|2016-01-01|April 2014|Actual|2014-04-01||Interventional|||Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies|Allogeneic Hematopoietic Cell Transplantation Using a Non-Myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Older Patients With Hematologic Malignancies|Completed||Phase 2|303|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 05:28:59.179267|2017-10-11 05:28:59.179267
NCT00185653|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-10|||October 2000||2000-10-01|February 2011|2011-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma|Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors for the Treatment of Multiple Myeloma|Completed||N/A|40|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:28:59.621004|2017-10-11 05:28:59.621004
NCT00185666|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-12|||May 2002||2002-05-01|July 2010|2010-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Cyberknife Precision Radiation Delivery System for Tumors of the Spine|Cyberknife Precision Radiation Delivery System for Tumors of the Spine|Completed||Phase 1/Phase 2|200|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:28:59.716632|2017-10-11 05:28:59.716632
NCT00185679|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-02-26|2015-02-26||November 2001||2001-11-01|February 2015|2015-02-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|||Haploid Allogeneic Transplant Using the CliniMACS System|A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies|Terminated||Phase 2|13|Actual|Stanford University||1||This study was superseded by the subsequent study IRB-15919 (NCT01050764)|f||||t||||||||||2017-10-11 05:28:59.796651|2017-10-11 05:28:59.796651
NCT00185692|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-01|2016-12-01||August 2000||2000-08-01|January 2015|2015-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Allogeneic Transplantation From Related Haploidentical Donors|Allogeneic Hematopoietic Cell Transplantation of Positively Selected CD34+ Cells and Defined Inoculum of T Cells From Related Haploidentical Donors for Older Patients With Indolent Hematologic Malignancies|Completed||Phase 2|16|Actual|Stanford University||1|||f||||t||||||||No||2017-10-11 05:28:59.995484|2017-10-11 05:28:59.995484
NCT00185705|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-02-12|||October 2006||2006-10-01|February 2007|2007-02-01|June 2007||2007-06-01|||||Interventional|||Treatment of Insulin Resistance in Hypertensive, Obese Adolescents|Randomized, Placebo Controlled, Double Blind Trial of Telmisartan in Hypertensive, Obese Adolescents|Unknown status|Recruiting|N/A|30||Stanford University|||||f||||||||||||||2017-10-11 05:29:00.338896|2017-10-11 05:29:00.338896
NCT00185718|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-12|||November 2003||2003-11-01|December 2012|2012-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Impact of Treatment Induced Premature Menopause on Quality of Life|Impact of Treatment Induced Premature Menopause on Quality of Life Following Blood and Marrow Transplantation|Completed||N/A|97|Actual|Stanford University|||1||f||||||||||||||2017-10-11 05:29:00.45851|2017-10-11 05:29:00.45851
NCT00185744|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-08|||September 2002||2002-09-01|December 2016|2016-12-01|March 2029|Anticipated|2029-03-01|March 2029|Anticipated|2029-03-01||Interventional|||Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer|Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer|Active, not recruiting||N/A|400|Anticipated|Stanford University||2|||f||||t||||||||No||2017-10-11 05:29:00.660259|2017-10-11 05:29:00.660259
NCT00185757|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-13|||June 2004||2004-06-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation|Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:00.753072|2017-10-11 05:29:00.753072
NCT00185770|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||April 1999||1999-04-01|September 2005|2005-09-01||||||||Interventional|||Reducing Television Viewing to Prevent Childhood Obesity|Reducing Television Viewing to Prevent Childhood Obesity|Completed||Phase 2/Phase 3|900||Stanford University|||||f||||||||||||||2017-10-11 05:29:00.852306|2017-10-11 05:29:00.852306
NCT00185783|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-07|||March 2005||2005-03-01|April 2011|2011-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis|Pilot Study of White Blood Cell Gene Expression in Critically Ill Patients With Severe Sepsis and Relative Adrenal Insufficiency After Hydrocortisone Administration|Completed||Phase 1|10|Actual|Stanford University|||1||f||||t||||||||||2017-10-11 05:29:00.943411|2017-10-11 05:29:00.943411
NCT00185796|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-16|||July 2004||2004-07-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|April 2014|Actual|2014-04-01||Interventional|||TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD|Total Lymphoid Irradiation and Anti-Thymocyte Globulin as Conditioning for Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for the Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML)|Completed||Phase 2|77|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:29:01.103857|2017-10-11 05:29:01.103857
NCT00185809|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-16|||November 2000||2000-11-01|July 2010|2010-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study|Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study|Completed||N/A|25|Anticipated|Stanford University|||1||f||||||||||Samples Without DNA|"     Archival tissue blocks and blood   "|||2017-10-11 05:29:01.196443|2017-10-11 05:29:01.196443
NCT00185835|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-03-25|||June 2002||2002-06-01|March 2010|2010-03-01||||July 2006|Actual|2006-07-01||Interventional|||Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck|Phase I Study of Cisplatin And ZD1839 (IRESSA®) in Combination With Concomitant Re-Irradiation in Patients With Loco-Regional Recurrent Squamous Cell Cancer of the Head and Neck|Completed||Phase 1|10|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:29:01.330934|2017-10-11 05:29:01.330934
NCT00185848|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-12|||April 2005||2005-04-01|March 2017|2017-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis|Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.|Completed||Phase 1|10|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 05:29:01.41473|2017-10-11 05:29:01.41473
NCT00185861|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-04-08|||December 2003||2003-12-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|January 2008|Actual|2008-01-01||Interventional|||Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma|Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma|Completed||Phase 1|12|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:29:01.508866|2017-10-11 05:29:01.508866
NCT00185874|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-11|||January 2004||2004-01-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases|A Phase I Trial of Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases|Terminated||Phase 1|22|Anticipated|Stanford University||1||Study closed due to lack of funding|f||||||||||||||2017-10-11 05:29:01.591246|2017-10-11 05:29:01.591246
NCT00185887|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-03-04|||October 2003||2003-10-01|March 2011|2011-03-01|October 2007|Actual|2007-10-01|July 2006|Actual|2006-07-01||Interventional|||Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation|Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation|Completed||N/A|110|Actual|Stanford University||2|||f||||||||||||||2017-10-11 05:29:01.672271|2017-10-11 05:29:01.672271
NCT00185900|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-25|||April 1999||1999-04-01|May 2016|2016-05-01|July 2007|Actual|2007-07-01|July 2005|Actual|2005-07-01||Interventional|||Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial|Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial|Completed||N/A|192|Actual|Stanford University||2|||f||||||||||||No||2017-10-11 05:29:01.77365|2017-10-11 05:29:01.77365
NCT00185913|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-04-20|||September 2000||2000-09-01|April 2010|2010-04-01|May 2008|Actual|2008-05-01|October 2003|Actual|2003-10-01||Observational|||Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers|Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers|Completed||N/A|50|Anticipated|Stanford University|||1||f||||||||||Samples With DNA|"     blood   "|||2017-10-11 05:29:01.906913|2017-10-11 05:29:01.906913
NCT00185939|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-12-01|||August 2003||2003-08-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||The Use of Prophylactic Antibiotics In the Management of Dog Bites||Completed||Phase 2/Phase 3|125||Stanford University|||||f||||||||||||||2017-10-11 05:29:01.964578|2017-10-11 05:29:01.964578
NCT00185952|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-10|||November 2001||2001-11-01|June 2011|2011-06-01|August 2008|Actual|2008-08-01|January 2007|Actual|2007-01-01||Interventional|||Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.|Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized Double Blind Trial|Completed||N/A|70|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 05:29:02.059084|2017-10-11 05:29:02.059084
NCT00185965|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-07|2014-07-07||July 2004||2004-07-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas|Le23 CPG: A Phase 1-2 Study of Intratumoral Injection of CPG 7909, A TLR 9 Agonist, Combined With Local Radiation in Recurrent Low-Grade Lymphomas|Completed||Phase 1/Phase 2|30|Actual|Stanford University||2|||f||||t||||||||||2017-10-11 05:29:02.154955|2017-10-11 05:29:02.154955
NCT00185978|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||April 1998||1998-04-01|September 2005|2005-09-01|March 2001||2001-03-01|||||Interventional|||Obesity Prevention for Pre-Adolescents|School- and Family-Based Obesity Prevention for Children|Completed||Phase 2|900||Stanford University|||||f||||||||||||||2017-10-11 05:29:02.476722|2017-10-11 05:29:02.476722
NCT00185991|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-13|||June 2004||2004-06-01|June 2011|2011-06-01|February 2010|Actual|2010-02-01|October 2006|Actual|2006-10-01||Interventional|||Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis|Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis|Completed||N/A|126|Anticipated|Stanford University||2|||f||||||||||||||2017-10-11 05:29:02.560827|2017-10-11 05:29:02.560827
NCT00186004|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-13|||December 2002||2002-12-01|June 2011|2011-06-01|May 2008|Actual|2008-05-01|September 2006|Actual|2006-09-01||Observational|||Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes|Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes|Completed||N/A|21|Actual|Stanford University|||1||f||||f||||||||||2017-10-11 05:29:02.644525|2017-10-11 05:29:02.644525
NCT00186017|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-12|2016-12-21||July 2005||2005-07-01|April 2017|2017-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Short Term Rescue Study of Olanzapine|Double-Blind Placebo-Controlled Olanzapine Add-on Therapy in the Treatment of Acute Syndromal and Subsyndromal Exacerbations in Bipolar Disorders|Completed||Phase 4|50|Actual|Stanford University|Small Sample Size.|2|||f||||f||||||||No||2017-10-11 05:29:02.749876|2017-10-11 05:29:02.749876
NCT00186030|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-05|||April 2003||2003-04-01|September 2005|2005-09-01|March 2004||2004-03-01|||||Interventional|||Reducing Risk and Trauma-Related Stress in Persons Living With HIV|Reducing Risk and Trauma-Related Stress in Persons Living With HIV|Terminated||Phase 1/Phase 2|102||Stanford University|||||f||||||||||||||2017-10-11 05:29:03.201219|2017-10-11 05:29:03.201219
NCT00186043|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-26|2017-01-11||August 2008||2008-08-01|September 2017|2017-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II|A Double-Blind, Placebo-Controlled Trial of Seroquel for the Treatment of Dysphoric Hypomania in Bipolar II Patients|Completed||Phase 4|55|Actual|Stanford University|Results are limited in their generalizability due to the small sample drawn from two specialty clinics for mood disorders clinical research. Suspected assignment to active quetiapine or placebo possibly influencing ratings on outcome variables|2|||f||||f||||||||||2017-10-11 05:29:03.2805|2017-10-11 05:29:03.2805
NCT00186056|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-17|2016-10-13||January 2003||2003-01-01|February 2017|2017-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Mifepristone in Refractory Depression|Mifepristone in Refractory Depression|Completed||N/A|31|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 05:29:03.605562|2017-10-11 05:29:03.605562
NCT00186069|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-09|2016-10-12||March 2004||2004-03-01|March 2017|2017-03-01|June 2017|Anticipated|2017-06-01|June 2014|Actual|2014-06-01||Interventional|||Magnesium Sulfate vs Placebo for Placental Abruption|Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption|Active, not recruiting||N/A|30|Actual|Stanford University||2|||f||||f||||||||Undecided||2017-10-11 05:29:03.878208|2017-10-11 05:29:03.878208
NCT00186082|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-13|||September 2003||2003-09-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|||Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs|A Randomized Controlled Trial of the Effect of Prophylactic Antibiotics on the Infection Rate in Postpartum Third and Fourth Degree Perineal Tear Repairs|Completed||N/A|147|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 05:29:04.254233|2017-10-11 05:29:04.254233
NCT00186095|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-05|||December 2000||2000-12-01|October 2007|2007-10-01|September 2006||2006-09-01|||||Interventional|||Mixed Chimeric Transplantation for Primary Amyloidosis|Mixed Chimeric Transplantation for Primary Amyloidosis|Withdrawn||N/A|45|Anticipated|Stanford University||||Closed, never started.|f||||t||||||||||2017-10-11 05:29:04.414279|2017-10-11 05:29:04.414279
NCT00186108|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-24|||October 2002||2002-10-01|July 2007|2007-07-01|September 2005|Actual|2005-09-01|||||Interventional|||A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer|A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer|Completed||Phase 1|23|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 05:29:04.477166|2017-10-11 05:29:04.477166
NCT00186134|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 2004||2004-10-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Walk to School and Physical Activity|Walk to School and Physical Activity|Completed||Phase 2|30||Stanford University|||||f||||||||||||||2017-10-11 05:29:04.734465|2017-10-11 05:29:04.734465
NCT00186147|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-08|||March 1988||1988-03-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Bone Marrow Grafting for Leukemia and Lymphoma|Bone Marrow Grafting for Leukemia and Lymphoma|Recruiting||N/A|9999|Anticipated|Stanford University|||1||f||||||||||Samples With DNA|"     Tissue samples will be obtained from subjects undergoing transplantation or donors providing     the graft.   "|||2017-10-11 05:29:04.81363|2017-10-11 05:29:04.81363
NCT00186173|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-11|||November 2004||2004-11-01|July 2012|2012-07-01||||February 2006|Actual|2006-02-01||Interventional|||Sports to Prevent Obesity: Feasibility and Pilot RCT|Sports to Prevent Obesity: Feasibility and Pilot RCT|Completed||Phase 1/Phase 2|21|Actual|Stanford University||2|||f||||f||||||||||2017-10-11 05:29:04.909876|2017-10-11 05:29:04.909876
NCT00186186|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-01|2014-05-12||January 2004||2004-01-01|March 2017|2017-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Depakote ER in Bipolar Depression|Depakote ER in Bipolar Depression|Completed||Phase 4|28|Actual|Stanford University|This trial is limited by small sample size, as well as an open-label study design with no placebo control.|1|||f||||f||||||||No||2017-10-11 05:29:05.017532|2017-10-11 05:29:05.017532
NCT00186199|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||June 2005||2005-06-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01|12 Months|Observational [Patient Registry]|||Determination of Voiding Patterns of Children With Vesicoureteral Reflux|Determination of Voiding Patterns of Children With Vesicoureteral Reflux|Unknown status|Enrolling by invitation|N/A|250|Anticipated|Stanford University|||1||f||||f||||||||||2017-10-11 05:29:05.219629|2017-10-11 05:29:05.219629
NCT00186212|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-29|||September 2000||2000-09-01|June 2011|2011-06-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Alternative Support for Rural and Isolated Women in an HMO|Alternative Support for Rural and Isolated Women in an HMO|Completed||Phase 3|150|Actual|Stanford University|||||f||||f||||||||||2017-10-11 05:29:05.299656|2017-10-11 05:29:05.299656
NCT00186225|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-07-23|||November 1989||1989-11-01|July 2010|2010-07-01|May 2010|Actual|2010-05-01|June 2007|Actual|2007-06-01||Interventional|||Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors|Stem Cell Transplantation From Matched Unrelated or Partially Matched Related Donors Using a Preparatory Regimen Consisting of Fractionated Total Body Irradiation (FTBI) and Cyclophosphamide (CY)|Completed||N/A|250|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:05.370559|2017-10-11 05:29:05.370559
NCT00186238|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-09-10|||September 1994||1994-09-01|September 2010|2010-09-01|April 2010|Actual|2010-04-01|September 2006|Actual|2006-09-01||Interventional|||High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma|High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma|Completed||Phase 2|300|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:05.442944|2017-10-11 05:29:05.442944
NCT00186251|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-11-09|||March 1998||1998-03-01|July 2012|2012-07-01|July 2005||2005-07-01|||||Interventional|||High Dose Chemotherapy Followed By PBSC Rescue for HD|Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease|Completed||N/A|200||Stanford University|||||f||||||||||||||2017-10-11 05:29:05.511896|2017-10-11 05:29:05.511896
NCT00186264|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-14|||August 2002||2002-08-01|December 2007|2007-12-01|April 2006||2006-04-01|||||Interventional|||Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?|Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?|Unknown status|Active, not recruiting|N/A|20||Stanford University|||||f||||||||||||||2017-10-11 05:29:05.582148|2017-10-11 05:29:05.582148
NCT00186277|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-03-28|||December 2003||2003-12-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer|Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer|Completed||Phase 2|10|Actual|Stanford University|||||f||||t||||||||||2017-10-11 05:29:05.653631|2017-10-11 05:29:05.653631
NCT00186290|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-10-07|||December 1989||1989-12-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Allo BMT in Advanced Leukemia or High Grade Lymphoma|Fractionated Total Body Irradiation (FTBI), Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Allogeneic Bone Marrow Transplantation for Patients With Advanced Leukemia or High Grade Lymphoma|Completed||N/A|145|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:05.736539|2017-10-11 05:29:05.736539
NCT00186303|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-12-13|||November 1996||1996-11-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Transplantation for Patients With Chronic Lymphocytic Leukemia|Autologous and Allogeneic Peripheral Blood Progenitor (PBPC) Transplantation for Patients With Chronic Lymphocytic Leukemia|Completed||N/A|28|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:05.813766|2017-10-11 05:29:05.813766
NCT00186316|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-08-21|||April 2003||2003-04-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|April 2006|Actual|2006-04-01||Interventional|||Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells|A Phase I/II Study of Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells|Completed||Phase 1/Phase 2|30|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:05.912504|2017-10-11 05:29:05.912504
NCT00186329|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-24|||March 2004||2004-03-01|April 2015|2015-04-01|October 2006||2006-10-01|||||Interventional|||BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)|B-type Natriuretic Peptide for Cardio-Renal Decompensation Syndrome|Completed||Phase 4|100||Stanford University|||||f||||||||||||||2017-10-11 05:29:06.004339|2017-10-11 05:29:06.004339
NCT00186342|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-12-13|||September 1992||1992-09-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies|Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide|Completed||N/A|120|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:06.104551|2017-10-11 05:29:06.104551
NCT00186355|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-10|||October 2003||2003-10-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|March 2007|Actual|2007-03-01||Interventional|||Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma|Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma|Completed||N/A|97|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:29:06.187859|2017-10-11 05:29:06.187859
NCT00186368|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-12|||April 1999||1999-04-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Microarray Analysis of Gene Expression in Prostate Tissues|Microarray Analysis of Gene Expression in Prostate Tissues (Translating Prostate Cancer Gene Expression Sub-types)|Active, not recruiting||N/A|2000|Anticipated|Stanford University|||1||f||||t||||||||||2017-10-11 05:29:06.27233|2017-10-11 05:29:06.27233
NCT00186381|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-07-23|||November 1995||1995-11-01|July 2010|2010-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission|Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission|Completed||Phase 2|200|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:06.343993|2017-10-11 05:29:06.343993
NCT00178581|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-04-22|||June 2005||2005-06-01|December 2007|2007-12-01|September 2006||2006-09-01|||||Interventional|||Enteral Glutamine Supplementation for the Patient With Major Torso Trauma|Early Enteral Glutamine Supplement to Enteral Nutrition Support of the Major Torso Trauma Patient: Proposal for a Prospective Randomized Clinical Trial|Terminated||Phase 1|20||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 05:29:06.411341|2017-10-11 05:29:06.411341
NCT00178594|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-10|||October 2002||2002-10-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Evaluation of Hemostasis in Bleeding and Thrombotic Disorders|Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||||Undecided|Undecided at this time|2017-10-11 05:29:06.489392|2017-10-11 05:29:06.489392
NCT00178607|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-10|||August 2002||2002-08-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia|Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia|Completed||N/A|99|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples With DNA|"     Serum and Plasma   "|Yes|The data will be analyzed and published|2017-10-11 05:29:06.57268|2017-10-11 05:29:06.57268
NCT00178633|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-09-03|2013-08-01||May 2004||2004-05-01|September 2014|2014-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational||43 patients were originally enrolled, and 37 participated through 9 months; 15 female participants returned for an additional 2 year analysis.|Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery|Dramatic Reversal of Derangements in Muscle Metabolism and Left Ventricular Function After Bariatric Surgery|Completed||N/A|43|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples Without DNA|"     Skeletal muscle biopsies, plasma   "|||2017-10-11 05:29:06.743954|2017-10-11 05:29:06.743954
NCT00178659|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-01-16|||July 2004||2004-07-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|April 2018|Anticipated|2018-04-01||Observational|Proteomics||Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)|Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)|Active, not recruiting||N/A|260|Anticipated|The University of Texas Health Science Center, Houston|||4||f||||f||||||Samples Without DNA|"     Plasma and serum samples for use in identifying proteins related to head trauma   "|No|There is no plan to make individual participant data available|2017-10-11 05:29:07.106571|2017-10-11 05:29:07.106571
NCT00178672|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-11|||November 2002||2002-11-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease|A Single Center IDE Study on Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease|Completed||Phase 4|69|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 05:29:07.221726|2017-10-11 05:29:07.221726
NCT00178685|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-15|2013-01-15||August 2004||2004-08-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|SHP||Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence|Self-determination and Maintaining Tobacco Abstinence|Completed||Phase 4|837|Actual|University of Rochester|A limitation of this study is the low completion rate of smokers enrolling in the study. This increases the chance of accepting the null hypothesis when there may be differences between groups if all smokers had provided their outcomes.|1|||f||||||||||||||2017-10-11 05:29:07.311441|2017-10-11 05:29:07.311441
NCT00178698|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-03-02|||July 2002||2002-07-01|March 2011|2011-03-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|FR-WB-TT/che||Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors|A Phase II Clinical Trial of Cisplatin + Gemcitabine HCl (GEM) + Low-Dose Metronomic Interferon-a (IFN-a) Combined With Fever-Range Whole-Body Thermal Therapy (FR-WB-TT) in Patients With Metastatic/or Locally Advanced Malignancies (Small-Cell Lung Cancer, Neuroendocrine Cancer, Gastric Cancer)|Unknown status|Recruiting|Phase 2|36|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 05:29:07.64652|2017-10-11 05:29:07.64652
NCT00178711|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-09-13|2014-07-31||November 2005||2005-11-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|NABIS:HIIR|hypothermia group-- 26 ± 9 years of age, 40 males/12 females normothermia group--31 ± 11 year of age, 41 males/4 females|Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury|National Acute Brain Injury Study: Hypothermia IIR|Terminated||Phase 3|232|Actual|The University of Texas Health Science Center, Houston|Early termination for futility.|2||Futility|f||||t||||||||||2017-10-11 05:29:07.752996|2017-10-11 05:29:07.752996
NCT00178724|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-09-12|||July 2005||2005-07-01|September 2017|2017-09-01|July 2023|Anticipated|2023-07-01|July 2020|Anticipated|2020-07-01||Observational|NACTN||Spinal Cord Injury Registry - NACTN|Spinal Cord Injury Registry - North American Clinical Trials Network for Spinal Cord Injury|Recruiting||N/A|1500|Anticipated|The Methodist Hospital System|||1||f||||f|f|f||||||||2017-10-11 05:29:08.355571|2017-10-11 05:29:08.355571
NCT00178737|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-02-18||||||February 2010|2010-02-01|December 2006||2006-12-01|||||Interventional|||Does the Message Matter? Enhancing Adherence in Healthcare Through Persuasive Messages|Does the Message Matter? Enhancing Adherence in Healthcare Through Persuasive Messages|Completed||N/A|1200|Anticipated|The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 05:29:08.643715|2017-10-11 05:29:08.643715
NCT00178750|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-27||||||December 2007|2007-12-01||||||||Interventional|||"Loss of Resistance Versus CompuFlo® for Epidural Placement"|"A Randomized Clinical Comparison of the Loss of Resistance Technique Versus the CompuFlo® Computerized Syringe Pump for Proper Epidural Placement"|Withdrawn||Phase 1/Phase 2|100|Anticipated|The University of Texas Health Science Center, Houston||||Study did not start due to investigator time constraints|f||||||||||||||2017-10-11 05:29:08.698187|2017-10-11 05:29:08.698187
NCT00179023|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-16|||April 2003||2003-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The Autonomic Nervous System and Obesity|The Autonomic Nervous System and Obesity|Completed||Phase 1|128|Actual|Vanderbilt University Medical Center||5|||f||||f||||||||No||2017-10-11 05:29:10.834384|2017-10-11 05:29:10.834384
NCT00178763|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-03-02|||September 2003||2003-09-01|March 2011|2011-03-01|June 2013|Anticipated|2013-06-01|June 2012|Anticipated|2012-06-01||Interventional|FR-WB-TT||Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer|Phase II Clinical Trial of Cisplatin + Gemcitabine in Combination With Mild, Fever-Range Whole-Body Hyperthermia to Treat Patients With Advanced, Inoperable Pancreatic Cancer|Unknown status|Recruiting|Phase 2|36|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 05:29:08.773726|2017-10-11 05:29:08.773726
NCT00178776|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-10|||October 2003||2003-10-01|September 2014|2014-09-01|June 2007|Actual|2007-06-01|November 2006|Actual|2006-11-01||Interventional|||A Transtheoretical Model Group Therapy for Cocaine|A Transtheoretical Model Group Therapy for Cocaine|Completed||Phase 1|138|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 05:29:08.906763|2017-10-11 05:29:08.906763
NCT00178789|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-05-22|||September 2005||2005-09-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Observational|||Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis|Prospective Observational Trial of Point-of-Care, Limited Ultrasonography (PLUS) for Lower Extremity Deep Venous Thrombosis in the Emergency Department: The Sonography Outcomes Assessment Program (SOAP-4 Trial)|Completed||Phase 1/Phase 2|51|Anticipated|The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 05:29:09.037037|2017-10-11 05:29:09.037037
NCT00178802|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-22|||June 1996||1996-06-01|April 2010|2010-04-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|||Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers|Phase II Study of Mild Whole Body Hyperthermia Combined With 5-Fluorouracil/Interferon-a/Liposomal Doxorubicin in Patients With Advanced Malignancy|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 05:29:09.108375|2017-10-11 05:29:09.108375
NCT00178828|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-07|||October 2002||2002-10-01|April 2017|2017-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Dynamic Measures of Neurochemistry in Mood Disorders|Dynamic Measures of Neurochemistry in Mood Disorders|Completed||Phase 4|42|Actual|Vanderbilt University Medical Center||1|||f|||||f|f||||||||2017-10-11 05:29:09.209245|2017-10-11 05:29:09.209245
NCT00178841|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-01-20|2014-05-27||June 2005||2005-06-01|January 2016|2016-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL|Open Label Pilot Study of Combination Therapy With Rosiglitazone and Bexarotene to Investigate a Possible Synergism in the Treatment of Cutaneous T-Cell Lymphoma|Completed||Phase 2|4|Actual|Vanderbilt University||1|||f||||f||||||||||2017-10-11 05:29:09.325883|2017-10-11 05:29:09.325883
NCT00178854|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-30|||May 2004||2004-05-01|March 2017|2017-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment|Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment|Withdrawn||Phase 4|0|Actual|Vanderbilt University Medical Center||||failed recruitment efforts|f||||||||||||||2017-10-11 05:29:09.57331|2017-10-11 05:29:09.57331
NCT00178867|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-09|||January 2002||2002-01-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|||||Observational|||A National Registry of Patients With Hepatocellular Carcinoma|A National Registry of Patients With Hepatocellular Carcinoma|Completed||N/A|150|Actual|Vanderbilt University|||1||f||||f||||||||||2017-10-11 05:29:09.660575|2017-10-11 05:29:09.660575
NCT00178880|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-30|||November 2008|Actual|2008-11-01|March 2017|2017-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||MRI Imaging of Chronobiologic Abnormalities in Depression|MRI Imaging of Chronobiologic Abnormalities in Depression|Completed||N/A|7|Actual|Vanderbilt University Medical Center|||2||f||||||||||||||2017-10-11 05:29:09.727283|2017-10-11 05:29:09.727283
NCT00178893|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-06-10|||April 2004|Actual|2004-04-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01||Observational|||Hepatocellular Research Registry|CellzDirect: Hepatocellular Research Registry|Recruiting||N/A|200|Anticipated|Vanderbilt University Medical Center|||1||f||||f||||||Samples Without DNA|"     Hepatocytes   "|||2017-10-11 05:29:09.798407|2017-10-11 05:29:09.798407
NCT00178906|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-21|||December 1999||1999-12-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Acoustical Properties of Speech as Indicators of Suicidal Risk|Acoustical Properties of Speech as Indicators of Suicidal Risk|Completed||N/A|124|Actual|Vanderbilt University|||1||f||||f||||||||||2017-10-11 05:29:09.869996|2017-10-11 05:29:09.869996
NCT00178919|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-24|2009-04-10||August 2002||2002-08-01|May 2013|2013-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Nitric Oxide and the Autonomic Nervous System|Cardiovascular Regulation: Autonomic/Metabolic Mechanisms PO1 HL56693, Project 4: Cardiovascular Regulation: Autonomic/Metabolic Mechanisms|Completed||N/A|112|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 05:29:09.946561|2017-10-11 05:29:09.946561
NCT00178932|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-11-01|||November 1998||1998-11-01|November 2010|2010-11-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors|Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors|Unknown status|Recruiting|N/A|1000|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-10-11 05:29:10.248267|2017-10-11 05:29:10.248267
NCT00178945|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-27|||March 2004||2004-03-01|August 2007|2007-08-01|March 2006||2006-03-01|||||Interventional|||Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain|Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Botulinum Toxin Type A (Botox) for the Treatment of Pain Associated With Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome|Completed||Phase 1/Phase 2|20||Vanderbilt University|||||f||||||||||||||2017-10-11 05:29:10.354703|2017-10-11 05:29:10.354703
NCT00178958|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-06-05|||August 2003||2003-08-01|June 2017|2017-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia||Completed||N/A|70||Northwestern University|||||f||||f||||||||||2017-10-11 05:29:10.438604|2017-10-11 05:29:10.438604
NCT00178971|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-06-05|||January 2003||2003-01-01|June 2017|2017-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Serotonin 1A Agonists and Cognition in Schizophrenia|Serotonin 1A Agonists and Cognition in Schizophrenia|Completed||Phase 3|60|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 05:29:10.50915|2017-10-11 05:29:10.50915
NCT00183144|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-18|||November 2001||2001-11-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||A Therapeutic Workplace for Alcohol Dependence|A Therapeutic Workplace for Alcohol Dependence|Completed||Phase 2|156||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:30:35.405059|2017-10-11 05:30:35.405059
NCT00179062|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-08-25|||February 2000||2000-02-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder|Effects of Risperidone and Olanzapine on Weight Gain, Physical Health, and Outcome in a Community Sample of Severity and Persistently Ill Patients|Completed||N/A|300|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 05:29:11.076381|2017-10-11 05:29:11.076381
NCT00179075|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-12|||April 2003||2003-04-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|||||Observational|||Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant|Repository for Study: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant (HSCT)|Completed||N/A|100|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-10-11 05:29:11.157732|2017-10-11 05:29:11.157732
NCT00179088|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-29|||May 2003||2003-05-01|March 2017|2017-03-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety of Non-delayed Weight Bearing After Total Hip Replacement With Non-Cemented Fiber Metal Taper Stem|Fiber Metal Taper Prospective Randomized Weight Bearing Investigation|Completed||N/A|33||Vanderbilt University Medical Center|||||f||||||||||||||2017-10-11 05:29:11.225403|2017-10-11 05:29:11.225403
NCT00179101|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-08-11|||April 2004||2004-04-01|August 2006|2006-08-01|November 2005||2005-11-01|||||Observational|||Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson’s Patients|Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson’s Patients|Completed||N/A|42||Vanderbilt University|||||f||||||||||||||2017-10-11 05:29:11.305063|2017-10-11 05:29:11.305063
NCT00179114|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-17|||August 2002||2002-08-01|August 2007|2007-08-01|February 2006||2006-02-01|||||Interventional|||Vanderbilt University Spasticity Management Program Evaluation Plan|Vanderbilt University Spasticity Management Program Evaluation Plan|Completed||Phase 4|20||Vanderbilt University|||||f||||f||||||||||2017-10-11 05:29:11.370523|2017-10-11 05:29:11.370523
NCT00179127|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-20|||August 2004||2004-08-01|June 2012|2012-06-01|September 2012|Anticipated|2012-09-01|July 2009|Actual|2009-07-01||Interventional|||Use of Insulin Glargine to Treat Diabetic Ketoacidosis|Early Use of Insulin Glargine in Diabetic Ketoacidosis|Unknown status|Active, not recruiting|N/A|75|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 05:29:11.441389|2017-10-11 05:29:11.441389
NCT00179140|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-21|||November 2002||2002-11-01|May 2015|2015-05-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients|The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients|Completed||Phase 2|26|Actual|Vanderbilt University||3|||f||||f||||||||||2017-10-11 05:29:11.539672|2017-10-11 05:29:11.539672
NCT00179153|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-27|||February 2005||2005-02-01|May 2014|2014-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee|Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee|Completed||Phase 2|352|Actual|Vanderbilt University||1|||f||||f||||||||||2017-10-11 05:29:11.621724|2017-10-11 05:29:11.621724
NCT00179166|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-09-23|||June 2004||2004-06-01|September 2010|2010-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure|Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure|Terminated||Phase 2|3|Actual|Vanderbilt University||2||lack of enrollment|f||||f||||||||||2017-10-11 05:29:11.698906|2017-10-11 05:29:11.698906
NCT00179179|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-07-08|||April 2005||2005-04-01|July 2009|2009-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis|The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis|Completed||Phase 2|11|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 05:29:11.769888|2017-10-11 05:29:11.769888
NCT00179192|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-21|||May 1998||1998-05-01|May 2015|2015-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Prevention and Treatment of Hemodialysis Vascular Access Malfunction|Prevention and Treatment of Hemodialysis Vascular Access Malfunction|Withdrawn||Phase 2|0|Actual|Vanderbilt University||3||non-enrollment|f||||f||||||||||2017-10-11 05:29:11.84467|2017-10-11 05:29:11.84467
NCT00179205|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-08-05|||May 2005||2005-05-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|November 2006|Actual|2006-11-01||Interventional|||Complementary Intradialytic Nutritional Supplementation in Dialysis Patients|Complementary Intradialytic Nutritional Supplementation in Dialysis Patients|Terminated||Phase 2|27|Actual|Vanderbilt University||2||funding exhausted|f||||f||||||||||2017-10-11 05:29:11.933955|2017-10-11 05:29:11.933955
NCT00179218|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-07-08|||April 2005||2005-04-01|July 2009|2009-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients|The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients|Completed||Phase 2|19|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 05:29:12.005676|2017-10-11 05:29:12.005676
NCT00179231|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 2000||2000-05-01|September 2005|2005-09-01|February 2004||2004-02-01|||||Interventional|||Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia||Completed||N/A|80||Vanderbilt University|||||f||||||||||||||2017-10-11 05:29:12.092245|2017-10-11 05:29:12.092245
NCT00179244|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-06-01|||July 2004||2004-07-01|June 2015|2015-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression|Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression|Completed||Phase 3|30||Vanderbilt University|||||f||||||||||||||2017-10-11 05:29:12.177915|2017-10-11 05:29:12.177915
NCT00179257|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-06-01|||June 2004||2004-06-01|June 2015|2015-06-01|March 2005||2005-03-01|||||Interventional|||The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram|The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to|Completed||Phase 3|20||Vanderbilt University|||||f||||||||||||||2017-10-11 05:29:12.254673|2017-10-11 05:29:12.254673
NCT00179283|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-06-01|||April 2002||2002-04-01|June 2015|2015-06-01|April 2003||2003-04-01|||||Interventional|||Sertraline vs. Venlafaxine XR|A Multi-center, Randomized, Double-blind, Parallel-group Study of Sertraline vs. Venlafaxine XR in the Acute Treatment of Outpatients With Major Depressive Disorder|Completed||Phase 3|20||Vanderbilt University|||||f||||||||||||||2017-10-11 05:29:12.342524|2017-10-11 05:29:12.342524
NCT00179881|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-22|||December 1999||1999-12-01|June 2011|2011-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma|Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma|Completed||Phase 2|47|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||||f||||||||||||||2017-10-11 05:29:26.541801|2017-10-11 05:29:26.541801
NCT00179309|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-06-30|2013-04-29||September 2005||2005-09-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|February 2013|Actual|2013-02-01||Interventional|||Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer|A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer|Completed||Phase 2|48|Actual|National Institutes of Health Clinical Center (CC)|The goal of this study was to get preliminary evidence of improved progression free survival with the combination compared with docetaxel alone and obtain data on which to plan a larger more definitive study in a more uniform patient population.|2|||f||||t||||||||||2017-10-11 05:29:12.441977|2017-10-11 05:29:12.441977
NCT00179322|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-10-05|||September 10, 2005||2005-09-10|September 30, 2016|2016-09-30|September 30, 2016||2016-09-30|||||Observational|||Effects of Sleep Deprivation and Recovery on Cognitive Functions|Effects of Sleep Deprivation and Recovery Sleep on Speech, Language and Other Higher Cognitive Functions: A Combined EEG-fMRI Study|Completed||N/A|29|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:29:13.750565|2017-10-11 05:29:13.750565
NCT00179335|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2009-08-05|||August 2003||2003-08-01|August 2009|2009-08-01|September 2006|Actual|2006-09-01|January 2006|Actual|2006-01-01||Observational|||Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults|Cross Sectional Case-Sectional Control Pharmacokinetic Study of Efavirenz or Lopinavir/Ritonavir as Part of an Antiretroviral Regimen With Two Nucleosides in HIV-Infected Adults 55 Years of Age or Older Compared With Adults Aged 18-35 Years|Completed||N/A|45|Actual|Albert Einstein College of Medicine, Inc.|||4||f||||||||||Samples Without DNA|"     Residual plasma left from measurement of drug levels.   "|||2017-10-11 05:29:13.887956|2017-10-11 05:29:13.887956
NCT00179348|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-23|||February 8, 2001|Actual|2001-02-08|January 2017|2017-01-01|July 20, 2016|Actual|2016-07-20|July 20, 2016|Actual|2016-07-20||Interventional|||Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer|Evaluation of a Yoga-Based Cancer Rehabilitation Program|Completed||N/A|399|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 05:29:13.98826|2017-10-11 05:29:13.98826
NCT00179361|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-22|||November 2004||2004-11-01|November 2009|2009-11-01||||July 2014|Actual|2014-07-01||Observational|||Natural History of Oro-pharyngeal Cancer Precursors|Natural History of Oral Cancer Precursors|Completed||N/A|374|Actual|Albert Einstein College of Medicine, Inc.|||1||f||||f||||||Samples With DNA|"     Oral brush samples.   "|||2017-10-11 05:29:14.133228|2017-10-11 05:29:14.133228
NCT00179374|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-27|||July 2003||2003-07-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Improving Diabetes Outcomes With Activity, Nutrition and Medication|Improving Diabetes Medication Adherence and Outcomes|Completed||N/A|556|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-10-11 05:29:14.223636|2017-10-11 05:29:14.223636
NCT00179387|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-23|||December 1, 2004|Actual|2004-12-01|January 2017|2017-01-01|February 25, 2016|Actual|2016-02-25|February 25, 2016|Actual|2016-02-25||Interventional|||Mind-Body Program for Cancer Patients|Evaluation of Mind-Body Groups on the Quality of Life of Cancer Patients|Completed||N/A|166|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 05:29:14.351214|2017-10-11 05:29:14.351214
NCT00179400|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-30|||December 2000|Actual|2000-12-01|June 2017|2017-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone|The Role of Acute Combined Peroxisome Proliferator-Activated Receptors (PPAR) Alpha and Gamma Stimulation on Insulin Action in Humans|Completed||N/A|18|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-10-11 05:29:14.470992|2017-10-11 05:29:14.470992
NCT00179413|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-06-11|2017-04-13||January 15, 2000|Actual|2000-01-15|June 2017|2017-06-01|March 3, 2010|Actual|2010-03-03|December 31, 2009|Actual|2009-12-31||Interventional|COPILOT||Study of Long-term Peg Intron vs. Colchicine in Non-responders.|Phase IV Study of Long Term Peg-Intron for Patients Who Have Failed to Respond to Rebetron/Interferon With Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C- The Copilot Trial|Completed||Phase 4|549|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||No||2017-10-11 05:29:14.594816|2017-10-11 05:29:14.594816
NCT00179426|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-09|||October 1999||1999-10-01|March 2017|2017-03-01|June 2006||2006-06-01|||||Observational|||Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy|Antiseizure Medication-Induced Elevation of Serum Estradiol and Reproductive Dysfunction in Men With Epilepsy|Completed||N/A|175||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-10-11 05:29:15.317675|2017-10-11 05:29:15.317675
NCT00179439|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-10|||January 2004||2004-01-01|March 2015|2015-03-01||||January 2006||2006-01-01||Observational|NPD||NPDT Evaluation in Children With CFTR and (PSC)|Nasal Potential Difference Testing: Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Children With Primary Sclerosing Cholangitis (PSC)|Terminated||N/A|50|Anticipated|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-10-11 05:29:15.411137|2017-10-11 05:29:15.411137
NCT00179452|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-09|||October 2003||2003-10-01|March 2017|2017-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Yoga for Patients With Epilepsy|Is Yoga Safe for Patients With Epilepsy?|Completed||N/A|20|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||No|No plan to share as was not included in original protocol as approved by the IRB, so subject consent was not obtained.|2017-10-11 05:29:15.514234|2017-10-11 05:29:15.514234
NCT00179465|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-02|||November 2003||2003-11-01|March 2017|2017-03-01|July 2019|Anticipated|2019-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Treating Schizophrenia by Correcting Abnormal Brain Development|Addition of Tiagabine to Second-Generation Antipsychotics in the Treatment of Recent-Onset Schizophrenia by Modification of Developmental Reorganization of the Prefrontal Cortex|Recruiting||Phase 3|36|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-10-11 05:29:15.607349|2017-10-11 05:29:15.607349
NCT00179478|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-06|2017-04-14||February 2001||2001-02-01|August 2017|2017-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|CHAMPIONS10||Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis|Controlled High-risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurologic Surveillance (CHAMPIONS10)|Completed||Phase 4|155|Actual|Beth Israel Deaconess Medical Center|selective attrition of patients with greater levels of disease activity may have occurred in this long term extension study|2|||f||||t||||||||||2017-10-11 05:29:15.730057|2017-10-11 05:29:15.730057
NCT00189800|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-15||||||October 2006|2006-10-01||||||||Interventional|||A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:32.900891|2017-10-11 05:29:32.900891
NCT00179504|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-02|||July 2000||2000-07-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||The Effect of Relaxation Response Training on Declarative Memory and Learning in High School Students|The Effect of Relaxation Response Training on Declarative Memory and Learning in High School Students|Completed||Phase 2|90|Actual|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-10-11 05:29:16.319504|2017-10-11 05:29:16.319504
NCT00179517|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-31|2017-03-16||June 2001||2001-06-01|August 2017|2017-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo|Comparison of Anastrozole and Testosterone Versus Placebo and Testosterone Treatment of Reproductive and Sexual Dysfunction in Men With Epilepsy and Hypogonadism|Completed||Phase 2|40|Actual|Beth Israel Deaconess Medical Center||2|||f||||||||||||||2017-10-11 05:29:16.400996|2017-10-11 05:29:16.400996
NCT00179530|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-02|||May 1999||1999-05-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults|The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults|Completed||Phase 2|16|Actual|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-10-11 05:29:16.803948|2017-10-11 05:29:16.803948
NCT00179543|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-18|||August 2001||2001-08-01|September 2006|2006-09-01||||||||Interventional|||Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients|Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients|Completed||Phase 2|122||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-10-11 05:29:16.852649|2017-10-11 05:29:16.852649
NCT00179556|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-12|||June 2003||2003-06-01|March 2017|2017-03-01|September 2005|Actual|2005-09-01|July 2005|Actual|2005-07-01||Interventional|||Effects of Soy Isoflavones on Menopausal Hot Flashes|Daidzein-rich Isoflavone-aglycones for Menopausal Symptoms|Completed||Phase 2/Phase 3|210||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-10-11 05:29:16.915203|2017-10-11 05:29:16.915203
NCT00179569|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-02|||August 2005||2005-08-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Molecular Processes of the Relaxation Response in Older Adults|Molecular Processes of the Relaxation Response in Older Adults|Completed||Phase 2|40|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-10-11 05:29:16.981852|2017-10-11 05:29:16.981852
NCT00179582|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-02|||January 2005|Actual|2005-01-01|March 2017|2017-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS|A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients|Terminated||N/A|180|Anticipated|Beth Israel Deaconess Medical Center||||Lack of enrollment|f||||||||||||||2017-10-11 05:29:17.14121|2017-10-11 05:29:17.14121
NCT00179595|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-14|||May 2002||2002-05-01|February 2017|2017-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Does the Relaxation Response Inhibit Acute Stress?|Does the Relaxation Response Inhibit Acute Stress?|Completed||Phase 2|140|Anticipated|Beth Israel Deaconess Medical Center|||||f||||f||||||||No||2017-10-11 05:29:17.213941|2017-10-11 05:29:17.213941
NCT00179608|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-30|||September 2005||2005-09-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy|Phase I Safety Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy|Completed||Phase 1|28||Celgene Corporation|||||||||||||||||||2017-10-11 05:29:17.279223|2017-10-11 05:29:17.279223
NCT00179621|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-04-12|2011-02-09||July 2005||2005-07-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|June 2008|Actual|2008-06-01||Interventional|||Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study of the Efficacy and Safety of 2 Doses of Lenalidomide Versus Placebo in Red Blood Cell (RBC) Transfusion-Dependent Subjects With Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated With a Deletion (Del) 5q[31] Cytogenetic Abnormality|Completed||Phase 3|205|Actual|Celgene||3|||f||||t||||||||||2017-10-11 05:29:17.400035|2017-10-11 05:29:17.400035
NCT00179634|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-22|||March 2005||2005-03-01|March 2017|2017-03-01|March 27, 2008|Actual|2008-03-27|March 27, 2008|Actual|2008-03-27||Interventional|||Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast Cancer|Using Visual Milieu Enrichment and Guided Visualization to Augment Patient Well-being and Post-surgical Recovery|Terminated||N/A|24|Actual|Beth Israel Deaconess Medical Center||3||Expired for lack of continuing review|f||||f||||||||||2017-10-11 05:29:22.351947|2017-10-11 05:29:22.351947
NCT00179647|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-10|2009-12-21||September 2005||2005-09-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma|A Multicenter, Single-Arm, Open-Label, Expanded Access Program for Lenalidomide With or Without Dexamethasone in Previously Treated Subjects With Multiple Myeloma|Completed||Phase 3|1913|Actual|Celgene||1|||t||||f||||||||||2017-10-11 05:29:22.507762|2017-10-11 05:29:22.507762
NCT00179660|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-17|2013-06-25||August 2005||2005-08-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional||Intent to treat population includes all participants who received at least 1 dose of study drug.|Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)|A Phase II, Multicenter, Single-Arm, Open-Label Study To Evaluate The Safety And Efficacy Of Single-Agent Lenalidomide (Revlimid®, CC-5013) In Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|50|Actual|Celgene||1|||f||||||||||||||2017-10-11 05:29:24.068564|2017-10-11 05:29:24.068564
NCT00179673|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2013-11-06|2013-08-09||August 2005||2005-08-01|November 2013|2013-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|A Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid®, CC-5013) in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|Completed||Phase 2|43|Actual|Celgene||1|||f||||f||||||||||2017-10-11 05:29:24.692715|2017-10-11 05:29:24.692715
NCT00179686|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2006-12-19|||March 2005||2005-03-01|December 2006|2006-12-01|July 2006||2006-07-01|||||Interventional|||A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer|A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|40||Celgene|||||||||||||||||||2017-10-11 05:29:25.218253|2017-10-11 05:29:25.218253
NCT00179699|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-11-02|||September 2005||2005-09-01|October 2005|2005-10-01|November 2006||2006-11-01|||||Interventional|||Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer|Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1|40||Celgene|||||||||||||||||||2017-10-11 05:29:25.306464|2017-10-11 05:29:25.306464
NCT00179712|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2016-11-30|||April 2005||2005-04-01|November 2016|2016-11-01|November 2006||2006-11-01|||||Interventional|||Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma|Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma|Completed||Phase 1/Phase 2|60||Celgene Corporation|||||||||||||||||||2017-10-11 05:29:25.387498|2017-10-11 05:29:25.387498
NCT00179725|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2006-04-10|||November 2005||2005-11-01|April 2006|2006-04-01|June 2007||2007-06-01|||||Interventional|||Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma|Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma|Terminated||Phase 1/Phase 2|60||Celgene|||||||||||||||||||2017-10-11 05:29:25.456935|2017-10-11 05:29:25.456935
NCT00179738|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-11-22|||April 2005||2005-04-01|September 2005|2005-09-01|April 2007||2007-04-01|||||Interventional|||A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.|A Multicenter, Single-Arm, Open-Label, Study To Evaluate The Safety And Efficacy Of Single-Agent Lenalidomide (Revlimid®) In Subjects With Androgen Independent Prostate Cancer|Terminated||Phase 2|40||Celgene|||||||||||||||||||2017-10-11 05:29:25.523921|2017-10-11 05:29:25.523921
NCT00179751|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-11-02|||April 2005||2005-04-01|November 2005|2005-11-01|August 2006||2006-08-01|||||Interventional|||A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas|A Phase I/II Study Of Lenalidomide (Revlimid ) In Combination With Gemcitabine In Patients With Untreated Advanced Carcinoma Of The Pancreas|Terminated||Phase 1/Phase 2|50||Celgene|||||||||||||||||||2017-10-11 05:29:25.591567|2017-10-11 05:29:25.591567
NCT00179764|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2016-07-25|||March 2000||2000-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])|Immunoablative Protocol for Allogeneic Related and Unrelated Hematopoietic Peripheral Blood Stem Cell Transplant (HPBSC)|Recruiting||Phase 2|100|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-10-11 05:29:25.67764|2017-10-11 05:29:25.67764
NCT00179777|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2017-07-12|||March 2002|Actual|2002-03-01|July 2017|2017-07-01|September 2017|Anticipated|2017-09-01|March 2017|Actual|2017-03-01||Interventional|||TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk|TRIGR - Trial to Reduce IDDM in the Genetically at Risk|Active, not recruiting||N/A|2032|Actual|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-10-11 05:29:25.871171|2017-10-11 05:29:25.871171
NCT00179790|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-03-02|||July 2005||2005-07-01|March 2017|2017-03-01|January 2015|Actual|2015-01-01|June 2010|Actual|2010-06-01||Interventional|||Reduced Intensity Transplant Using Extracorporeal Photopheresis|Reduced Intensity Stem Cell Transplant in Children and Young Adults Utilizing Photopheresis, Fludarabine, and Busulfan|Completed||Phase 1/Phase 2|22|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||||||||||||2017-10-11 05:29:26.014984|2017-10-11 05:29:26.014984
NCT00179803|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-03-10|||March 1998||1998-03-01|March 2011|2011-03-01||||January 2008|Actual|2008-01-01||Interventional|||Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors|Phase II Prospective Study of Sequential Myeloablative Chemotherapy With Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors|Unknown status|Active, not recruiting|Phase 2/Phase 3|50|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-10-11 05:29:26.095181|2017-10-11 05:29:26.095181
NCT00179816|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2010-10-07|||April 1999||1999-04-01|October 2010|2010-10-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors|High-Dose Chemotherapy With Tandem Peripheral Blood Stem Cell (PBSC) Rescue for the Treatment of High-Risk Pediatric Solid Tumors.|Unknown status|Recruiting|Phase 1/Phase 2|12|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-10-11 05:29:26.186045|2017-10-11 05:29:26.186045
NCT00179829|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-01-14|||February 1999||1999-02-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||WT1 for the Detection of Minimal Residual Disease|Detection of Minimal Residual Disease in Newly Diagnosed Patients With Leukemia and Those Who Undergo a Bone Marrow Transplant Using the Wilms Tumor Suppressor Gene (WT1) as a Marker By RT-PCR|Completed||Phase 2/Phase 3|50|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||||f||||||||||||||2017-10-11 05:29:26.267906|2017-10-11 05:29:26.267906
NCT00179842|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2015-09-21||||||January 2009|2009-01-01|December 2008||2008-12-01|||||Interventional|||Immune Ablation and Stem Cell Support for Crohn's Disease|Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease|Withdrawn||Phase 2|0|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-10-11 05:29:26.335163|2017-10-11 05:29:26.335163
NCT00179855|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2010-10-07|||July 2003||2003-07-01|October 2010|2010-10-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Extracorporeal Photopheresis for Acute Graft Versus Host Disease|Extracorporeal Photopheresis for Steroid-refractory Acute GVHD in Children and Young Adults: a Safety and Feasibility Study.|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-10-11 05:29:26.399884|2017-10-11 05:29:26.399884
NCT00179868|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-08-26|||January 2003||2003-01-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||C-Reactive Protein as a Predictor of Stem Cell Transplant Complications|C-Reactive Protein As a Predictor of Major Transplant Complications in Pediatric Stem Cell Transplant Patients|Completed||Phase 2/Phase 3|44|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||||||2017-10-11 05:29:26.475842|2017-10-11 05:29:26.475842
NCT00179894|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-14|||June 2003||2003-06-01|August 2015|2015-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings|Improving Medication Use for ADHD in Primary Care|Completed||N/A|270|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-10-11 05:29:26.632476|2017-10-11 05:29:26.632476
NCT00179907|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-02-27|||May 2001||2001-05-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Phase I/II Study of the Photon Radiosurgery System|A Phase I/II Study of Reirradiation for Recurrent Pediatric Brain and Spinal Cord Tumors and Primary Glioblastoma Multiforme Using the Photon Radiosurgery System|Completed||Phase 1/Phase 2|35|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||||||||||||2017-10-11 05:29:26.719234|2017-10-11 05:29:26.719234
NCT00179920|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-09-25|||April 1996||1996-04-01|June 2011|2011-06-01|September 2006||2006-09-01|||||Interventional|||Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma|Chemotherapy Plus Local Surgical Treatment in Children With Intraocular Germ-Line Retinoblastoma|Unknown status|Active, not recruiting|Phase 2|30||Ann & Robert H Lurie Children's Hospital of Chicago|||||f||||||||||||||2017-10-11 05:29:26.814453|2017-10-11 05:29:26.814453
NCT00179933|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-10-07|||September 2005||2005-09-01|October 2010|2010-10-01|February 2007|Actual|2007-02-01|||||Interventional|||The Impact of Implementing NIDCAP on Preterm Infants in the NICU|The Impact of Implementing the Newborn Individualized Developmental Care and Assessment Program on Neurobehavioral Organization of Preterm Infants in the NICU|Terminated||N/A|40||Ann & Robert H Lurie Children's Hospital of Chicago||||Unable to fulfill intention of study, lost investigators.|f||||f||||||||||2017-10-11 05:29:26.900575|2017-10-11 05:29:26.900575
NCT00179946|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-14|||June 2003||2003-06-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||HLA Matching - Unrelated Umbilical Cord Blood Transplantation|Impact of HLA Matching on Outcome in Pediatric Patients Undergoing Unrelated Umbilical Cord Blood Transplantation.|Completed||N/A|30|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||||f||||||||||||||2017-10-11 05:29:26.978594|2017-10-11 05:29:26.978594
NCT00179959|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-11-20|2011-04-04||September 2005||2005-09-01|November 2014|2014-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis|The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis|Completed||Phase 4|31|Actual|Northwestern University||2|||f||||f||||||||||2017-10-11 05:29:27.049278|2017-10-11 05:29:27.049278
NCT00179972|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-07-29|||September 2005||2005-09-01|July 2015|2015-07-01|May 2010|Actual|2010-05-01|||||Observational|||Evaluation of Pulse Oximetry Sensors in Neonates|Evaluation of Pulse Oximetry Sensors in Neonates|Terminated||N/A|32|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1|"Lack of resources and loss of personnel precluded study progress. No adverse events or   unanticipated problems involving risks to subjects."|f||||||||||||||2017-10-11 05:29:27.994409|2017-10-11 05:29:27.994409
NCT00179985|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-07-28|||December 2004||2004-12-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|May 2006|Actual|2006-05-01||Observational|||The Impact of Implementing NIDCAP on the Developmental Sensitivity of Nurses Caring for Preterm Infants|The Impact of Implementing The Newborn Individualized Developmental Care & Assessment Program on the Developmental Sensitivity of Nurses Caring for Preterm Infants|Completed||N/A|32|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||t||||||||||2017-10-11 05:29:28.071726|2017-10-11 05:29:28.071726
NCT00180011|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2012-02-27|||September 2005||2005-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma|Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma|Completed||Phase 2/Phase 3|18|Actual|DiMango, Emily, M.D.||1|||f||||f||||||||||2017-10-11 05:29:28.240272|2017-10-11 05:29:28.240272
NCT00180024|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||January 2002||2002-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.||Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:29:28.332043|2017-10-11 05:29:28.332043
NCT00180037|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-16|||September 2003||2003-09-01|January 2009|2009-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease|Multicenter, Placebo Controlled, Randomized, Double-Blinded Study: Coenzyme Q10 Nanodispersion Versus Placebo as Symptomatic Treatment in Parkinson's Disease|Completed||Phase 3|132||Technische Universität Dresden|||||f||||t||||||||||2017-10-11 05:29:28.399701|2017-10-11 05:29:28.399701
NCT00180050|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-03-29|||January 2002||2002-01-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||Budesonide Treatment for Lymphocytic Colitis|Efficacy and Safety of Budesonide for Treatment of Lymphocytic Colitis|Completed||Phase 3|40|Anticipated|Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:29:28.50587|2017-10-11 05:29:28.50587
NCT00180063|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-01|||October 2003||2003-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Characterization of Local Vascular Effects of LNMMA||Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:29:28.581192|2017-10-11 05:29:28.581192
NCT00186394|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-07-23|||April 2000||2000-04-01|July 2010|2010-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma|High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma|Completed||Phase 2|35|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:28.636754|2017-10-11 05:29:28.636754
NCT00186407|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-09-10|||April 1998||1998-04-01|September 2010|2010-09-01|February 2010|Actual|2010-02-01|February 2008|Actual|2008-02-01||Interventional|||Autologous Stem Cell Rescue for Primary Amyloidosis|High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis|Completed||Phase 2|50|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:28.710255|2017-10-11 05:29:28.710255
NCT00186420|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-12|||July 2003||2003-07-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|January 2006|Actual|2006-01-01||Interventional|||Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation|Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation|Completed||Phase 2|13|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 05:29:28.780392|2017-10-11 05:29:28.780392
NCT00186433|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-22|||November 2001||2001-11-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations|A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations|Completed||N/A|49|Actual|Stanford University|||1||f||||t||||||Samples With DNA|"     blood   "|||2017-10-11 05:29:28.851266|2017-10-11 05:29:28.851266
NCT00186446|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-15|2016-10-18||June 2004||2004-06-01|February 2017|2017-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Treatment of Nicotine Dependence and Acute Depression|Treatment of Nicotine Dependence and Acute Depression|Completed||Phase 4|20|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:29:28.917382|2017-10-11 05:29:28.917382
NCT00186459|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-12|||October 2000||2000-10-01|March 2013|2013-03-01||||||||Interventional|||Obesity, Weight Loss, and Cardiovascular Disease Risk|GCRC-CAP-Tracey McLaughlin, MD|Unknown status|Enrolling by invitation|N/A|550|Anticipated|Stanford University|||||f||||||||||||||2017-10-11 05:29:29.133346|2017-10-11 05:29:29.133346
NCT00186472|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-31||||||December 2006|2006-12-01||||||||Interventional|||Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)||Completed||N/A|||Stanford University|||||f||||||||||||||2017-10-11 05:29:29.207464|2017-10-11 05:29:29.207464
NCT00186485|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-10-04|2016-10-10||May 2003||2003-05-01|August 2017|2017-08-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression|Safety and Efficacy of Open Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression|Completed||N/A|28|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 05:29:29.280148|2017-10-11 05:29:29.280148
NCT00186511|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-12-04|||November 2004||2004-11-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Expanding Rural Access: Distance Delivery of Support|Expanding Rural Access: Distance Delivery of Support|Completed||Phase 2|40||Stanford University|||||f||||||||||||||2017-10-11 05:29:29.563965|2017-10-11 05:29:29.563965
NCT00186524|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-03-11||||||March 2011|2011-03-01||||||||Interventional|||Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer?||Completed||Phase 2|||Stanford University|||||f||||||||||||||2017-10-11 05:29:29.641799|2017-10-11 05:29:29.641799
NCT00186537|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-11-21|2016-04-01||September 2003||2003-09-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Baseline analysis was done on those who completed the study|Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.|Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals.|Completed||N/A|47|Actual|Stanford University||3|||f||||f||||||||No||2017-10-11 05:29:29.868175|2017-10-11 05:29:29.868175
NCT00186550|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-03||||||December 2013|2013-12-01|November 2000|Actual|2000-11-01|||||Interventional|||Group Psychotherapy for People With HIV|An Evaluation of Group Psychotherapy for People With HIV|Completed||N/A|186|Actual|Stanford University|||||f||||f||||||||||2017-10-11 05:29:30.205434|2017-10-11 05:29:30.205434
NCT00186563|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-06-18||||||June 2013|2013-06-01||||||||Interventional|||A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers|Proof-of-concept Study for Bio-marker Assay Validation in Humans|Completed||N/A|13||Stanford University|||||f||||||||||||||2017-10-11 05:29:30.287528|2017-10-11 05:29:30.287528
NCT00186576|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-10-13|||December 2001||2001-12-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|March 2004|Actual|2004-03-01||Interventional|||Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders|Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML)|Completed||N/A|40|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:30.360981|2017-10-11 05:29:30.360981
NCT00186589|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-06-05|||May 2004||2004-05-01|October 2010|2010-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL|90Y-Ibritumomab Tiuxetan and Autologous Hematopoietic Cell Infusion Followed by High Dose Chemotherapy and Autologous Transplantation for Relapsed or Resistant Non-Hodgkin's Lymphoma|Completed||Phase 1|30|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:30.443501|2017-10-11 05:29:30.443501
NCT00186602|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-10-04||||||September 2005|2005-09-01||||||||Interventional|||Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?|Does a Peer Navigator Improve Quality of Life at Diagnosis?|Unknown status|Active, not recruiting|Phase 2|||Stanford University|||||f||||||||||||||2017-10-11 05:29:30.514584|2017-10-11 05:29:30.514584
NCT00186641|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-07-10||||||July 2007|2007-07-01|March 2005||2005-03-01|||||Interventional|||High Dose Chemotherapy and Autologous Transplant for Breast Cancer|High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||Stanford University|||||f||||||||||||||2017-10-11 05:29:30.672045|2017-10-11 05:29:30.672045
NCT00186654|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-09-22||||||August 2008|2008-08-01||||||||Interventional|||Acupuncture and Massage for Depression During Pregnancy|Acupuncture and Massage for Depression During Pregnancy|Completed||Phase 2|180||Stanford University|||||f||||||||||||||2017-10-11 05:29:30.741905|2017-10-11 05:29:30.741905
NCT00186667|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-07-23|||January 1999||1999-01-01|July 2010|2010-07-01|September 2005|Actual|2005-09-01|January 2000|Actual|2000-01-01||Interventional|||Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease|An Open Label Study of Sirolimus as Primary Therapy for the Treatment of Chronic GVHD Following Allogeneic Bone Marrow Transplant|Completed||Phase 2|30|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:29:30.80589|2017-10-11 05:29:30.80589
NCT00186680|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-02-26|||September 1996||1996-09-01|February 2010|2010-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant|Selection of CD34+THY-1 Positive Cells From Peripheral Blood Cells Procured for Autologous Hematopoietic Support Following High Dose Treatment With BCNU, Cyclophosphamide & Cisplatin for Stage IV Breast Cancer & Limited Prior Treatment|Completed||Phase 1/Phase 2|99|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:29:30.871989|2017-10-11 05:29:30.871989
NCT00186693|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-07-25|||September 2006||2006-09-01|July 2006|2006-07-01|June 2009|Anticipated|2009-06-01|||||Observational|||How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma|How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma|Withdrawn||N/A|12|Anticipated|St. Joseph's Healthcare Hamilton|||1|never received funding|f||||||||||||||2017-10-11 05:29:30.938698|2017-10-11 05:29:30.938698
NCT00186719|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-25|||May 2005||2005-05-01|July 2011|2011-07-01|April 2012|Anticipated|2012-04-01|||||Observational|||How Smoking Causes COPD: Examination of Immune System Changes|How Smoking Causes COPD: Examination of Immune System Changes|Unknown status|Recruiting|N/A|100|Anticipated|St. Joseph's Healthcare Hamilton|||1||f||||||||||||||2017-10-11 05:29:31.085228|2017-10-11 05:29:31.085228
NCT00186732|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-08-10|||July 2005||2005-07-01|August 2011|2011-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Comparison of Subcuticular Suture Versus Surgical Staples for Closure of Pfannenstiel Skin Incisions|Pfannenstiel Incision Closure: Subcuticular Suture Versus Surgical Staples|Completed||N/A|288|Anticipated|St. Joseph's Healthcare Hamilton|||||f||||||||||||||2017-10-11 05:29:31.16016|2017-10-11 05:29:31.16016
NCT00189657|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Interventional|||5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer||Unknown status|Recruiting|Phase 3|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-10-11 05:29:31.244657|2017-10-11 05:29:31.244657
NCT00189670|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Interventional|||Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer|A Phase II Randomized Trial of 6 TEC Every 3 Weeks, Versus 4 EC Followed by 4 Taxotere Every 2 Weeks, Versus 4 Taxotere Followed by 4 EC Every 2 Weeks in Node Positive Breast Cancer|Completed||Phase 2|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-10-11 05:29:31.330356|2017-10-11 05:29:31.330356
NCT00189683|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Interventional|||Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy||Unknown status|Recruiting|Phase 3|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-10-11 05:29:31.391594|2017-10-11 05:29:31.391594
NCT00189696|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-09||||||October 2015|2015-10-01||||||||Interventional|||Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:31.468084|2017-10-11 05:29:31.468084
NCT00189709|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-26|||August 2004||2004-08-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia|A Single Center, Open, Parallel, Comparative, Randomized Study of Micafungin (FK463) vs Fluconazole (Diflucan) in the Treatment of Invasive Candidiasis and Candidaemia (Protocol No: MCFGCAN-0301F-TW)|Completed||Phase 3|24|Actual|Astellas Pharma Inc||2|||f||||||||||||||2017-10-11 05:29:31.562277|2017-10-11 05:29:31.562277
NCT00189722|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-15||||||April 2008|2008-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma||Completed||Phase 2|160|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:31.660942|2017-10-11 05:29:31.660942
NCT00189735|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-15|||September 2003||2003-09-01|April 2008|2008-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Evaluate FK778 in Kidney Transplant Patients|A Multicentre, Randomised, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Different Concentrations of FK778 With Tacrolimus (FK506) and Steroids Versus a Standard Regimen of Tacrolimus, MMF and Steroids in Renal Transplant Patients|Completed||Phase 2|364|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:31.805648|2017-10-11 05:29:31.805648
NCT00189748|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-19|||August 2004||2004-08-01|September 2006|2006-09-01||||||||Interventional|||A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-|An Extension Study of the Patients Enrolled in Acute Graft Versus Host Disease (GVHD) Prophylaxis Study (Protocol No. FJ-506E-BT01) to Assess Safety and Efficacy of GVHD Prophylaxis of a Tacrolimus New Oral Formulation (MR4).|Completed||Phase 2|||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:32.463587|2017-10-11 05:29:32.463587
NCT00189761|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-19||||||September 2006|2006-09-01||||||||Interventional|||A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients|A Phase 2, Open-Label, Multi-Center Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in De Novo Bone Marrow Transplant Recipients|Completed||Phase 2|||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:32.548839|2017-10-11 05:29:32.548839
NCT00189774|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-03-11||||||March 2008|2008-03-01||||||||Interventional|||Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients||Completed||Phase 2/Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:32.641105|2017-10-11 05:29:32.641105
NCT00189787|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-15||||||April 2008|2008-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma||Completed||Phase 2|370|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:32.737935|2017-10-11 05:29:32.737935
NCT00189813|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-08-27|||March 2005||2005-03-01|August 2014|2014-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Potential Efficacy, Safety and Tolerability of Different Oral Doses of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome|Completed||Phase 2|691|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:29:32.994907|2017-10-11 05:29:32.994907
NCT00189826|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-07-07|||August 2004||2004-08-01|July 2014|2014-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.|A Multicentre, Randomised, Double Blind, Two Arm Parallel Group Study to Evaluate and Compare the Efficacy and Safety of Modified Release Tacrolimus FK506E (MR4) Versus Tacrolimus FK506 in Combination With Steroids in Patients Undergoing Primary Liver Transplantation|Completed||Phase 3|475|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 05:29:33.164135|2017-10-11 05:29:33.164135
NCT00189839|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-07-07|||August 2004||2004-08-01|July 2014|2014-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation|A Multicentre, Randomised, Double Blind, Two Arm Parallel Group Study to Evaluate and Compare the Efficacy and Safety of Modified Release Tacrolimus FK506E (MR4) Versus Tacrolimus FK506 in Combination With MMF (Cellcept®) and Steroids in Patients Undergoing Kidney Transplantation|Completed||Phase 3|699|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-10-11 05:29:33.335526|2017-10-11 05:29:33.335526
NCT00189852|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-02-18|||November 2005||2005-11-01|February 2016|2016-02-01|February 2009|Actual|2009-02-01|September 2007|Actual|2007-09-01||Interventional|||Supporting Care and Independence at Home|Supporting Care and Independence at Home|Completed||N/A|62|Actual|Barnsley Hospital||2|||f||||f||||||||||2017-10-11 05:29:33.790808|2017-10-11 05:29:33.790808
NCT00189878|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2016-02-18|||August 2003||2003-08-01|February 2016|2016-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria|Multi-centre Prospective Randomised Double-blind Placebo-controlled Study of Methotrexate in the Treatment of Chronic Idiopathic Urticaria|Terminated||Phase 2|3|Actual|Barnsley Hospital||2||unable to recruit|f||||t||||||||||2017-10-11 05:29:33.895821|2017-10-11 05:29:33.895821
NCT00189917|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-06-02|||April 2004||2004-04-01|June 2015|2015-06-01|April 2006||2006-04-01|||||Interventional|||Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders|An Open-label, Controlled Phase I Pilot Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in 18-40 Year Old Vaccinia-naïve Subjects With Atopic Disorders|Completed||Phase 1|60||Bavarian Nordic|||||||||||||||||||2017-10-11 05:29:34.077754|2017-10-11 05:29:34.077754
NCT00189930|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-09-28|||April 2005||2005-04-01|September 2012|2012-09-01|December 2006|Actual|2006-12-01|||||Interventional|||An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients|A Single-blind, Randomized, Controlled, Phase II Study to Evaluate Immunogenicity and Safety of Two Doses of the MVA-nef HIV Vaccine in HIV-1 Infected Patients With CD4 > 250/µl|Completed||Phase 2|77|Actual|Bavarian Nordic||3|||f||||f||||||||||2017-10-11 05:29:34.154774|2017-10-11 05:29:34.154774
NCT00189956|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-02-03|||April 2003||2003-04-01|February 2015|2015-02-01|November 2003|Actual|2003-11-01|||||Interventional|||Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.|Phase II, Double-blind, Randomised, Dose-finding Study to Evaluate the Immunogenicity of Three Different Doses of MVA-BN Smallpox Vaccine in 18-30 Year Old Smallpox naïve Healthy Subjects|Completed||Phase 2|165|Actual|Bavarian Nordic||3|||f||||||||||||||2017-10-11 05:29:34.364685|2017-10-11 05:29:34.364685
NCT00189969|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-04-20|||September 2003||2003-09-01|April 2006|2006-04-01|February 2006||2006-02-01|||||Interventional|||Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects|Phase I Study to Evaluate Take Rate, Immunogenicity and Safety of Bavarian Nordic’s Smallpox Vaccine Elstree-BN Administered to Healthy Vaccinia-Naive Subjects in the Age of 18-32 Years|Completed||Phase 1|50||Bavarian Nordic|||||f||||||||||||||2017-10-11 05:29:34.465418|2017-10-11 05:29:34.465418
NCT00189982|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2015-06-26|||December 2004||2004-12-01|July 2013|2013-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101|Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (ADVATE rAHF-PFM): Safety Monitoring in Pediatric Patients Diagnosed With Severe to Moderately Severe Hemophilia A - A Continuation of Baxter Clinical Study 060101|Completed||Phase 2/Phase 3|4|Actual|Baxalta US Inc.|||||f||||||||||||||2017-10-11 05:29:34.548996|2017-10-11 05:29:34.548996
NCT00189995|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2013-07-23||||||October 2005|2005-10-01||||||||Interventional|||Clozapine IM and Aggression in Schizophrenic Patients|Intramuscular Clozapine in the Management of Aggression in Schizophrenic Patients|Withdrawn||Phase 3|0|Actual|Beersheva Mental Health Center|||||f||||||||||||||2017-10-11 05:29:34.637253|2017-10-11 05:29:34.637253
NCT00190008|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2009-11-23|||August 2003||2003-08-01|November 2009|2009-11-01||||||||Interventional|||Piracetam for Treatment Tardive Dyskinesia|Therapeutic Use of Piracetam for Treatment of Patients Suffering From Tardive Dyskinesia: a Double Blind, Placebo-Controlled Crossover Study|Completed||Phase 3|40||Beersheva Mental Health Center|||||f||||||||||||||2017-10-11 05:29:34.735186|2017-10-11 05:29:34.735186
NCT00190021|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2010-09-05||||||October 2005|2005-10-01||||||||Interventional|||Donepezil Treatment of Psychotic Symptoms in Dementia Patients|Donepezil as Add-On Treatment of Psychotic Symptoms in Patients With Dementia of the Alzheimer's Type|Unknown status|Not yet recruiting|Phase 3|80|Anticipated|Beersheva Mental Health Center|||||f||||||||||||||2017-10-11 05:29:34.825238|2017-10-11 05:29:34.825238
NCT00190034|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2009-02-06|||January 2005||2005-01-01|June 2006|2006-06-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.|N-Acetylcysteine Protects Against Acute Renal Insult in Patients With Abnormal Renal Function Undergoing Cardiopulmonary Bypass.|Suspended||Phase 4|60|Anticipated|Far Eastern Memorial Hospital||||opposite result|f||||||||||||||2017-10-11 05:29:34.93194|2017-10-11 05:29:34.93194
NCT00190047|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-11-22|||February 2005||2005-02-01|November 2007|2007-11-01|October 2006||2006-10-01|||||Interventional|||Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Study To Evaluate The Effects Of DP-b99 On Neurologic Function And Disability In Subjects With Acute Ischemic Hemispheric Stroke|Completed||Phase 2|150||D-Pharm Ltd.|||||f||||||||||||||2017-10-11 05:29:35.063422|2017-10-11 05:29:35.063422
NCT00190060|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-11-29|||October 2004||2004-10-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Study of The Effects of Testosterone in Frail Elderly Men|Study of The Effects of Testosterone on Muscle Function, Physical Performance, Body Composition and Quality of Life in Frail Elderly Men|Completed||Phase 4|262|Actual|Central Manchester University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-10-11 05:29:35.205449|2017-10-11 05:29:35.205449
NCT00190073|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-11|||January 2005||2005-01-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Observational|||Cutaneous Denervation in Alcoholic Neuropathy|Cutaneous Denervation in Alcoholic Neuropathy|Unknown status|Recruiting|N/A|30||Far Eastern Memorial Hospital|||||f||||||||||||||2017-10-11 05:29:35.320433|2017-10-11 05:29:35.320433
NCT00190086|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-11|||January 2001||2001-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||Syndrome X and Endothelial Dysfunction||Terminated||Phase 4|28||Far Eastern Memorial Hospital|||||f||||||||||||||2017-10-11 05:29:35.38834|2017-10-11 05:29:35.38834
NCT00190099|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-11-17|||January 2003||2003-01-01|December 2004|2004-12-01|December 2003||2003-12-01|||||Interventional|||Dexamethasone-Eluting Stent in Acute Coronary Syndrome to Prevent Restenosis||Completed||Phase 4|40||Far Eastern Memorial Hospital|||||f||||||||||||||2017-10-11 05:29:35.440556|2017-10-11 05:29:35.440556
NCT00190112|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-10-05||||||December 2004|2004-12-01||||||||Interventional|||Change of Heart Rate Variability and Baroreflex Sensitivity After Ventral Cardiac Denervation||Unknown status|Not yet recruiting|N/A|30|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-10-11 05:29:35.494708|2017-10-11 05:29:35.494708
NCT00190125|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2009-02-06||||||August 2005|2005-08-01|August 2007|Anticipated|2007-08-01|||||Observational|||The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients|The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients|Unknown status|Not yet recruiting|N/A|300|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-10-11 05:29:35.543628|2017-10-11 05:29:35.543628
NCT00190138|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-10-05||||||December 2004|2004-12-01||||||||Interventional|||Effect of Bi-ventricular Pacing on Autonomous Nervous System|Effect of Bi-ventricular Pacing on Autonomous Nervous System|Unknown status|Not yet recruiting|N/A|||Far Eastern Memorial Hospital|||||f||||||||||||||2017-10-11 05:29:35.612445|2017-10-11 05:29:35.612445
NCT00190151|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-09-17|||September 2004||2004-09-01|September 2005|2005-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora|Pharmacokinetic/Pharmacodynamic Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora|Terminated||N/A|48|Actual|Assistance Publique - Hôpitaux de Paris||1||terminated|f||||f||||||||||2017-10-11 05:29:35.661584|2017-10-11 05:29:35.661584
NCT00190164|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-07-17|||August 2005||2005-08-01|July 2007|2007-07-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Alleviated Positioning for Small Macular Holes|Evaluation of the Success Rate of a Procedure Without Strict Positioning Post Surgical Versus With Positioning Face Towards the Strict Ground, at Patients Presenting a Macular Hole. Study of Non-Inferiority.|Completed||N/A|69|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:29:35.725552|2017-10-11 05:29:35.725552
NCT00190177|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-10-17|||March 2003||2003-03-01|September 2005|2005-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||ECLAXIR:Search for an Association Between CX3CR1 V249I Polymorphism, Preeclampsia and Endothelial Injury||Completed||N/A|370|Anticipated|Assistance Publique - Hôpitaux de Paris|||||f||||f||||||||||2017-10-11 05:29:35.797731|2017-10-11 05:29:35.797731
NCT00190190|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-16|||January 2005||2005-01-01|July 2007|2007-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Internal Limiting Membrane Peeling for Large Macular Holes|Comparison of the Success Rate of a Procedure With Peeling of Limiting the Intern of the Retina Versus a Traditional Procedure Without Peeling of Limiting, at Patients Presenting a Macular Hole.|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 05:29:35.858446|2017-10-11 05:29:35.858446
NCT00190203|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-01-16|||December 2001||2001-12-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|DECIMAL||Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts|Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts : A Sequential Design, Multicenter, Randomized, Controlled Trial|Terminated||Phase 3|60|Actual|Assistance Publique - Hôpitaux de Paris||1||the study is publiched|f||||t||||||||||2017-10-11 05:29:35.93643|2017-10-11 05:29:35.93643
NCT00190216|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-06|||December 2001||2001-12-01|July 2005|2005-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS)|Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression|Terminated||Phase 3|60|Actual|Assistance Publique - Hôpitaux de Paris||1||terminated|f||||f||||||||||2017-10-11 05:29:36.019946|2017-10-11 05:29:36.019946
NCT00190229|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-03|||September 2002||2002-09-01|March 2007|2007-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura|CESAR (Randomized Therapeutic Study of Steroid vs. Steroid Plus Cyclosphosphamide for Severe Viscera Henoch-Schoenlein Purpura)|Completed||N/A|200|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:36.088844|2017-10-11 05:29:36.088844
NCT00190242|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-12-15|||June 2003||2003-06-01|June 2005|2005-06-01|October 2009|Actual|2009-10-01|October 2006|Actual|2006-10-01||Interventional|HEPAVAC||Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients|Study of Immunogenicity of Anti-HAV Immunisation in HIV-1 Infected Patients, Co-infected or Not With HBV and/or HCV. HEP.A.VAC Study.|Completed||Phase 3|99|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 05:29:36.16997|2017-10-11 05:29:36.16997
NCT00190255|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-09|||April 2004||2004-04-01|March 2007|2007-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Pharmacogenetics of Gastrointestinal Bleeding|Pharmacogenetics of Gastrointestinal Bleeding Under Nonsteroidal Anti-inflammatory Drugs : the Role of Cytochrome P450 2C9|Completed||Phase 4|200|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"     Gastrointestinal bleeding is a severe adverse effect occurring in subjects secondary to the     use of nonsteroidal anti-inflammatory drugs (NSAIDs). The enzyme CYP2C9 is responsible for     the elimination of several NSAIDs. This protein is inactive in 12% of the subjects because of     genetic mutations. We hypothesized that individuals carrying such mutations should be at     higher risk of gastrointestinal bleeding since they display decreased NSAIDs elimination.   "|||2017-10-11 05:29:36.317723|2017-10-11 05:29:36.317723
NCT00190268|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-18|||February 2005||2005-02-01|March 2007|2007-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis|Multicentric Study, Comparative, Randomized, in Double Knowledge of the Effectiveness (Versus Placebo) of a Salt Of 3,4 - Diaminopyridine in the Treatment of Tiredness During the Multiple Sclerosis|Completed||Phase 3|126|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:36.401031|2017-10-11 05:29:36.401031
NCT00190281|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-12|||August 2005||2005-08-01|March 2005|2005-03-01||||||||Observational|||Contrast-Enhanced US of Spleen, Liver and Kidney|Contrast-Enhanced US of Spleen, Liver and Kidney in Patients With Acute Infection (Malaria and Other Infectious Diseases: a Functional Study|Unknown status|Recruiting|Phase 3|53||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:29:36.491057|2017-10-11 05:29:36.491057
NCT00190294|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-29|||April 2003||2003-04-01|March 2007|2007-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Expectant Versus Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW|Comparison Expectant With Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW|Completed||Phase 4|200|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:36.556967|2017-10-11 05:29:36.556967
NCT00190307|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-20|||June 2005||2005-06-01|September 2005|2005-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|STRATAGEM||STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery|Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery|Completed||Phase 4|293|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:36.626857|2017-10-11 05:29:36.626857
NCT00190320|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-16|||February 2005||2005-02-01|March 2007|2007-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia|Induction of Labor or Waiting for Suspicion Fetal Macrosomia (DAME)|Completed||Phase 4|1000|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:36.704331|2017-10-11 05:29:36.704331
NCT00190333|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-17|||June 2005||2005-06-01|March 2007|2007-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension|Evaluation of the Therapeutic Effects of Escitalopram in Pulmonary Hypertension, Either Primary or Associated|Completed||Phase 3|30|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:36.774749|2017-10-11 05:29:36.774749
NCT00190346|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-10-25|||December 2001||2001-12-01|August 2005|2005-08-01|April 2003||2003-04-01|||||Interventional|||Comparison of Humidification Devices During Non Invasive Ventilation, in Acute Respiratory Failure|Randomized RCT Comparing HH and HME During NIV in Acute Respiratory Failure|Terminated||N/A|250||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:29:36.875264|2017-10-11 05:29:36.875264
NCT00190359|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||September 2000||2000-09-01|April 2002|2002-04-01|February 2003||2003-02-01|||||Observational|||Growth Hormone and Heart Failure|Modifications of the Growth Hormone/IGF1 Axis in Heart Failure Patients|Terminated||N/A|180||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:29:36.985277|2017-10-11 05:29:36.985277
NCT00190372|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-02-16|||October 2004||2004-10-01|March 2007|2007-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients|Contribution of a Psycho-Educational Program of Help to Help in the Pharmacological Assumption of Responsibility of the Disease of Alzheimer|Completed||N/A|240|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:37.033192|2017-10-11 05:29:37.033192
NCT00190385|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-02-24|||July 2000||2000-07-01|March 2007|2007-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis|Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis. A Randomized Trial Comparing Two Periodicities of Ultrasonographic Surveillance: 3-month vs 6-month|Completed||Phase 3|1200|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:38.729673|2017-10-11 05:29:38.729673
NCT00190398|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-04-29|||November 2000||2000-11-01|February 2007|2007-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||EVA3S: Endarterectomy Versus Angioplasty in Patients With Severe Symptomatic Carotid Stenosis|Endarterectomy Versus Angioplasty in Patients With Severe Symptomatic Carotid Stenosis|Completed||Phase 3|900|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:38.805418|2017-10-11 05:29:38.805418
NCT00190411|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-15|||October 2003||2003-10-01|March 2007|2007-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type|Prevention of Vascular Complications by BetaBlocker Treatment in Vascular Ehlers-Danlos Syndrome|Completed||Phase 4|54|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:38.892034|2017-10-11 05:29:38.892034
NCT00190424|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-12-12|||September 2005||2005-09-01|September 2005|2005-09-01|October 2010|Actual|2010-10-01|October 2008|Actual|2008-10-01||Interventional|||Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma|Multicentric Randomized Phase 2. Immunotherapy With CpG-ODN in Malignant Glioblastoma|Completed||Phase 2|80|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||||||||||||2017-10-11 05:29:38.974573|2017-10-11 05:29:38.974573
NCT00190437|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-04-29|||August 2003||2003-08-01|March 2007|2007-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD|ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD|Completed||Phase 4|520|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:29:39.049109|2017-10-11 05:29:39.049109
NCT00190463|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2006-09-20|||April 2003||2003-04-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia|"The Strategy Antifungal Empirical Traditional is Again Justified in Prolonged Neutropenias . Study PREVERT"|Terminated||Phase 4|300||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:29:39.20177|2017-10-11 05:29:39.20177
NCT00190476|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2016-09-08|||April 2003||2003-04-01|September 2016|2016-09-01|April 2007||2007-04-01|||||Interventional|||Elderly NSCLC/D vs DP (JCOG0207)|Randomized Controlled Trial Comparing Docetaxel-cisplatin Combination With Docetaxel Alone in Elderly Patients With Advanced Non-small-cell Lung Cancer(JCOG0207)|Terminated||Phase 3|230||Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:29:39.271998|2017-10-11 05:29:39.271998
NCT00190489|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-31|||January 1999||1999-01-01|August 2016|2016-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer|Phase III Trial of Doxorubicin /Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D (AC-D) as Front-line Chemotherapy for Metastatic Breast Cancer: Japan Clinical Oncology Group Trial (JCOG9802)|Completed||Phase 3|450||Japan Clinical Oncology Group||3|||f||||t||||||||||2017-10-11 05:29:39.518766|2017-10-11 05:29:39.518766
NCT00190502|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-01-08|||November 2000||2000-11-01|February 2004|2004-02-01|December 2007||2007-12-01|||||Interventional|||Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes|The Use of Polyclonal Anti-T-Lymphocyte Globulin to Prevent Progression of Autoimmune Beta-Cell Destruction in Recent Type 1 Diabetes|Unknown status|Recruiting|N/A|28||Institute for Clinical and Experimental Medicine|||||f||||||||||||||2017-10-11 05:29:39.604776|2017-10-11 05:29:39.604776
NCT00190515|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-09-20|||February 2003||2003-02-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)|Randomized Phase III Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)|Completed||Phase 3|1101|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:29:39.701414|2017-10-11 05:29:39.701414
NCT00190528|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-20|||February 2002||2002-02-01|September 2016|2016-09-01|February 2009|Actual|2009-02-01|December 2004|Actual|2004-12-01||Interventional|||A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer|Phase III Trial of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Bulky Stage I/II Cervical Cancer: Japan Clinical Oncology Group Trial (JCOG0102)|Terminated||Phase 3|200|Actual|Japan Clinical Oncology Group||2|||f||||||||||||||2017-10-11 05:29:39.916224|2017-10-11 05:29:39.916224
NCT00190541|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-20|||June 2003||2003-06-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)|Mesorectal Excision With Lateral Lymph Node Dissection Versus Without Lateral Lymph Node Dissection for Clinical Stage II, III Lower Rectal Cancer (JCOG0212)|Completed||Phase 3|700|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:29:40.045153|2017-10-11 05:29:40.045153
NCT00190554|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-20|||May 2000||2000-05-01|September 2016|2016-09-01|May 2009|Actual|2009-05-01|May 2004|Actual|2004-05-01||Interventional|||A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma|A Randomized Controlled Trial of Chemotherapy With 5FU and Cisplatin Before and After Surgery for Stage II,III Squamous Cell Carcinoma of the Thoracic Esophagus:JCOG9907|Terminated||Phase 3|330||Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:29:40.25482|2017-10-11 05:29:40.25482
NCT00190567|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||October 2001||2001-10-01|January 2007|2007-01-01|April 2006||2006-04-01|||||Interventional|||Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence|Biomechanical Effects of Duloxetine on Bladder Function and Sphincter Resistance During the Emptying Phase and on Urethral Function During the Filling Phase of the Micturition Cycle in Women With Pure Genuine Stress Incontinence|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:40.384824|2017-10-11 05:29:40.384824
NCT00190580|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-03-30|||February 2003||2003-02-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease|Effects of Valsartan on the Progression of Renal and Cardiovascular Disease - Kanagawa Valsartan Trial (KVT)|Completed||Phase 4|312|Actual|KVT-Study Group||2|||f||||t||||||||||2017-10-11 05:29:40.452531|2017-10-11 05:29:40.452531
NCT00190593|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||June 1998||1998-06-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Raloxifene Use for The Heart|Raloxifene Hydrochloride or Placebo in Postmenopausal Women at Risk for Major Coronary Events|Completed||Phase 3|10000||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:40.543938|2017-10-11 05:29:40.543938
NCT00190606|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||January 2002||2002-01-01|January 2007|2007-01-01|April 2006||2006-04-01|||||Interventional|||Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence|Efficacy and Safety of Duloxetine Compared With Placebo,Pelvic Floor Muscle Training, and Combined Duloxetine/Pelvic Floor Muscle Training in Subjects With Moderate to Sever Stress Urinary Incontinence|Completed||Phase 2|200||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:40.615019|2017-10-11 05:29:40.615019
NCT00190619|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||May 2001||2001-05-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Efficacy and Safety of Duloxetine|Efficacy and Safety of Duloxetine Compared With Placebo in Subjects Electing Surgery for Severe Pure Genuine Stress Incontinence|Completed||Phase 3|100||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:40.686733|2017-10-11 05:29:40.686733
NCT00190632|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||March 2001||2001-03-01|January 2007|2007-01-01|April 2006||2006-04-01|||||Interventional|||To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence|Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence|Completed||Phase 3|600||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:40.748078|2017-10-11 05:29:40.748078
NCT00190645|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||February 2001||2001-02-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence|Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence|Completed||Phase 3|600||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:40.810856|2017-10-11 05:29:40.810856
NCT00190658|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-12-17|||February 2000||2000-02-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|July 2004|Actual|2004-07-01||Interventional|||Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome|Safety and Efficacy of Humatrope in Pediatric Patients With Genetic Short Stature (SHOX Gene Defect)|Completed||Phase 3|75||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:40.99318|2017-10-11 05:29:40.99318
NCT00190671|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-17|2009-03-17||June 2005||2005-06-01|November 2009|2009-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients|A Phase 1/2 Dose-Escalating Study of ALIMTA and Cyclophosphamide Administered Every 21 Days in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|103|Actual|Eli Lilly and Company|600 mg/m2 arm discontinued at end of Phase 1 because of lack of efficacy. Enrollment in 1800 mg/m2 arm continued to Phase 2. (Phase 1 outcomes were tumor response and pharmacokinetics). Secondary efficacy endpoints analyzed for 1800 mg/m2 arm only.|2|||f||||f||||||||||2017-10-11 05:29:41.085507|2017-10-11 05:29:41.085507
NCT00190684|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-12-15|2010-10-01||August 2000||2000-08-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Long-Term, Open Label Atomoxetine Study|Long-Term, Open Label Safety Study of Atomoxetine Hydrochloride in Patients, 6 Years and Older With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|1553|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-10-11 05:29:42.129175|2017-10-11 05:29:42.129175
NCT00190697|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-23|||January 2001||2001-01-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment|Continuation of Treatment and Monitoring of Safety in Patients Treated With LY353381 for Advanced Cancer|Completed||Phase 4|70||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:43.768289|2017-10-11 05:29:43.768289
NCT00190710|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-10|||March 2004||2004-03-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer|A Randomized Phase III Trial of Paraplatin (Carboplatin) + Gemzar Versus Gemzar Alone in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|242||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:43.853682|2017-10-11 05:29:43.853682
NCT00190723|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||October 2002||2002-10-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||A Study of LY317615 in Patients With Brain Tumors|A Phase II Trial of LY317615 in Patients With Recurrent High-Grade Gliomas|Completed||Phase 2|120||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:43.949608|2017-10-11 05:29:43.949608
NCT00190736|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||September 2004||2004-09-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)|Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months); With a Brief Evaluation of Executive Cognition|Completed||Phase 4|440||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:44.032388|2017-10-11 05:29:44.032388
NCT00190749|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-04-26|2009-06-03||October 2003||2003-10-01|April 2010|2010-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder|Insulin Sensitivity in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Risperidone|Completed||Phase 4|130|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:29:44.220484|2017-10-11 05:29:44.220484
NCT00190762|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||October 2001||2001-10-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma|A Randomized Phase 3 Trial Comparing ALIMTA Plus Best Supportive Care Versus Best Supportive Care Alone in Previously Treated Patients With Locally Advanced or Metastatic Malignant Pleural Mesothelioma|Completed||Phase 3|240||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:46.369606|2017-10-11 05:29:46.369606
NCT00190775|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-08-18|2010-07-14||September 2004||2004-09-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder: With a Secondary Examination of Impact of Treatment on Family Functioning|Completed||Phase 4|502|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:29:46.531801|2017-10-11 05:29:46.531801
NCT00190788|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-10|||June 2004||2004-06-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion|A Phase IIIb Study to Determine Efficacy and Safety of Extended Drotrecogin Alfa (Activated) Therapy in Patients With Persistent Requirement for Vasopressor Support After 96 Hour Infusion With Commercial Drotrecogin Alfa (Activated)|Completed||Phase 3|200|Anticipated|Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:50.548655|2017-10-11 05:29:50.548655
NCT00190801|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma|Open-Label Single-Arm Phase 2 Study of ALIMTA Plus Cisplatin in Korean Patients With Advanced Gastric Carcinoma|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:50.630293|2017-10-11 05:29:50.630293
NCT00190814|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.|Efficacy and Safety of Duloxetine Compared With Placebo in Women With Symptoms of Mixed Urinary Incontinence.|Completed||Phase 3|600||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:50.703056|2017-10-11 05:29:50.703056
NCT00190827|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)|The Effectiveness of Duloxetine Compared With Placebo in the Treatment of Predominant Stress Urinary Incontinence|Completed||Phase 3|500||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:50.769881|2017-10-11 05:29:50.769881
NCT00190840|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer|Open-Label Single-Arm Phase 2 Study of ALIMTA in Patients With Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy|Completed||Phase 2|186||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:50.861242|2017-10-11 05:29:50.861242
NCT00190853|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||January 2005||2005-01-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence|Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women With Stress Urinary Incontinence|Completed||Phase 3|93||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:50.977202|2017-10-11 05:29:50.977202
NCT00190866|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||June 2005||2005-06-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome|Dose Response Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome|Completed||Phase 3|210||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:51.117115|2017-10-11 05:29:51.117115
NCT00190879|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-06-06|||June 2005||2005-06-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder|Phase IV Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder|Completed||Phase 4|440||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:51.382519|2017-10-11 05:29:51.382519
NCT00190892|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2004||2004-09-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania|Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder|Completed||Phase 4|120||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:51.482118|2017-10-11 05:29:51.482118
NCT00190905|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-21|||February 2004||2004-02-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.|Study of Duloxetine HCl in Women of Different Demographic Characteristics and Co-Morbidities With Stress Urinary Incontinence: Evaluation of Efficacy and Safety|Completed||Phase 4|4000||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:51.69655|2017-10-11 05:29:51.69655
NCT00190918|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-07|||July 2006||2006-07-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||A Trial for Patients With Gestational Trophoblastic Disease|A Phase II Trial of Pemetrexed (Alimta) in the Treatment of Recurrent or Persistent Low Risk Gestational Trophoblastic Tumor|Completed||Phase 2|50|Anticipated|Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:51.780199|2017-10-11 05:29:51.780199
NCT00190931|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-21|||November 2003||2003-11-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder|A Double-Blind Study of Functional Outcomes With Atomoxetine-Hydrochloride and Placebo in Adult Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder|Completed||Phase 4|400||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:51.864495|2017-10-11 05:29:51.864495
NCT00190944|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-10|||December 2004||2004-12-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Effects of Teriparatide on Distal Radius Fracture Healing|Effects of Teriparatide on Distal Radius Fracture Healing|Completed||Phase 2|105||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:51.937015|2017-10-11 05:29:51.937015
NCT00190957|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||August 2004||2004-08-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse|Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse: A Randomized, Placebo-Controlled Trial|Completed||Phase 4|140||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:52.037635|2017-10-11 05:29:52.037635
NCT00190970|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-25|||October 2004||2004-10-01|July 2016|2016-07-01|November 2005||2005-11-01|||||Interventional|||The Effect of Ruboxistaurin on Small Fiber Function|The Effect of Ruboxistaurin Mesylate (LY333531) on Small Fiber Function as Measured by Microvascular Skin Blood Flow, C-Fiber Quantitations in Skin and Quantitative Sensory Testing of Cold and Heat.|Completed||Phase 2|52||Chromaderm, Inc.|||||||||||||||||||2017-10-11 05:29:52.155814|2017-10-11 05:29:52.155814
NCT00190983|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-13|2008-10-21||February 2005||2005-02-01|November 2009|2009-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Trial for Patients With Advanced/Recurrent Cervical Cancer|A Phase II Evaluation of Pemetrexed (Alimta) in the Treatment of Recurrent Carcinoma of the Cervix|Completed||Phase 2|29|Actual|Eli Lilly and Company||1|||||||||||||||||2017-10-11 05:29:52.247246|2017-10-11 05:29:52.247246
NCT00190996|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||January 2003||2003-01-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence|The Safety and Effectiveness of Duloxetine Compared With Placebo and Its Long-Term Safety and Efficacy in the Treatment of Predominant Stress Urinary Incontinence|Completed||Phase 3|2765||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:52.659285|2017-10-11 05:29:52.659285
NCT00191009|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||October 2003||2003-10-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease|Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer's Disease|Completed||Phase 2/Phase 3|124||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:52.747147|2017-10-11 05:29:52.747147
NCT00191022|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-02-12|||December 2004||2004-12-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Interventional|||Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder|A Randomized, Double-Blind Comparison of LY686017, Paroxetine, and Placebo in the Treatment of Social Anxiety Disorder|Completed||Phase 2|185||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:52.833811|2017-10-11 05:29:52.833811
NCT00191035|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-12-12|||March 2004||2004-03-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Interventional|||Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD|Maintenance of Benefit After 8-Week and 52-Week Treatment With Atomoxetine Hydrochloride in Adolescents With ADHD|Completed||Phase 4|520||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:52.981335|2017-10-11 05:29:52.981335
NCT00191048|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||October 2003||2003-10-01|January 2007|2007-01-01|March 2006||2006-03-01|||||Interventional|||Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD|Open-Label Treatment With Atomoxetine Hydrochloride in Child and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia|Completed||Phase 4|105||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:53.12279|2017-10-11 05:29:53.12279
NCT00191061|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|January 2006||2006-01-01|||||Interventional|||A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder|A Comparison of Duloxetine Dosing Strategies in The Treatment of Patients With Major Depression|Completed||Phase 4|640||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:53.234594|2017-10-11 05:29:53.234594
NCT00191074|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-03-07|||February 2001||2001-02-01|March 2007|2007-03-01|January 2006||2006-01-01|||||Interventional|||Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature|Phase III Study of Humatrope in Non-Growth Hormone Deficient Children With Short Stature|Completed||Phase 3|11||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:29:53.440188|2017-10-11 05:29:53.440188
NCT00191087|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||April 2001||2001-04-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Duloxetine in the Treatment of Stress Urinary Incontinence.|Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence.|Completed||Phase 3|458||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:29:53.506105|2017-10-11 05:29:53.506105
NCT00191100|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-08-08|2009-03-30||May 2002||2002-05-01|August 2009|2009-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix|Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA|Completed||Phase 3|515|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-10-11 05:29:53.60894|2017-10-11 05:29:53.60894
NCT00191113|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-13|2008-12-01||February 1989||1989-02-01|December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|GDCT||Somatropin Treatment to Final Height in Turner Syndrome|Humatrope Treatment to Final Height in Turner's Syndrome|Completed||Phase 3|154|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 05:29:54.880044|2017-10-11 05:29:54.880044
NCT00191126|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-21|||September 2000||2000-09-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC|Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages(T2N0, T1 - 2N1, T3N0 AND T3N1) Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|263|Actual|Eli Lilly and Company||2|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 05:29:58.224512|2017-10-11 05:29:58.224512
NCT00191139|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-02-04|2009-11-20||March 2003||2003-03-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)|A Randomized Study of Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation Therapy in Stage III Unresectable NSCLC|Completed||Phase 2|64|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:29:58.456453|2017-10-11 05:29:58.456453
NCT00191152|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-21|2009-11-04||February 2002||2002-02-01|December 2009|2009-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase III Trial For Patients With Metastatic Breast Cancer|Randomized Trial of Gemcitabine Plus Docetaxel vs. Docetaxel Plus Capecitabine in Metastatic Breast Cancer in 1st and 2nd|Completed||Phase 3|475|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 05:29:59.55195|2017-10-11 05:29:59.55195
NCT00191165|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-06-08|2009-04-07||March 2004||2004-03-01|June 2009|2009-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency|Efficacy and Safety of a High Dosage Compared to the Label Dosage of Humatrope in Early Pubertal Stage Children With Growth Hormone Deficiency|Completed||Phase 3|27|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:30:01.270799|2017-10-11 05:30:01.270799
NCT00191178|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-10-12|||August 2003||2003-08-01|October 2010|2010-10-01|July 2005||2005-07-01|||||Interventional|||Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes|Pilot Study Investigating the Effects of Insulin Lispro Low Mixture Therapy Compared With Insulin Glargine on Perceived Mood Symptoms in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|60||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:02.015124|2017-10-11 05:30:02.015124
NCT00191191|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-04|2009-10-23||October 2004||2004-10-01|December 2009|2009-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)|LY231514 500 mg/m2 and LY231514 1000 mg/m2 in Patients With Advanced Non-Small Cell Lung Cancer Who Were Previously Treated With Prior Systemic Anti Cancer Therapy: A Randomized Phase II Trial|Completed||Phase 2|226|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:30:02.125571|2017-10-11 05:30:02.125571
NCT00191204|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2001||2001-09-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Open Label Phase III Duloxetine Study for Stress Urinary Incontinence|Long Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence|Completed||Phase 3|363||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:03.025551|2017-10-11 05:30:03.025551
NCT00191230|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2001||2001-09-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer|A Randomized Phase II Trial of Gemcitabine Containing Regimens (Gemcitabine/Carboplatin and Gemcitabine/ Cisplatin)When Used as Preoperative Chemotherapy for Patients With Stage I and II NSCLC|Completed||Phase 2|70||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:03.085826|2017-10-11 05:30:03.085826
NCT00191243|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-21|||March 2002||2002-03-01|November 2016|2016-11-01|April 2009|Actual|2009-04-01|August 2007|Actual|2007-08-01||Interventional|||Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer|A Randomized Phase II Study Comparing Single-Agent Docetaxel to Alternating Docetaxel-Gemcitabine as Primary Chemotherapy in Patients With Metastatic Breast Cancer|Completed||Phase 2|237|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.
This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-10-11 05:30:03.160574|2017-10-11 05:30:03.160574
NCT00191256|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||June 2001||2001-06-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer|Randomized Phase II Trial to Outline the Efficacy of Gemcitabine Containing Regimens (Gemcitabine/Carboplatin and Gemcitabine/Paclitaxel) When Used as Preoperative Chemotherapy In Patients With Stage I and II NSCLC|Completed||Phase 2|77||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:03.713042|2017-10-11 05:30:03.713042
NCT00191269|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-03-10|2009-03-23||June 2005||2005-06-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2008|Actual|2008-03-01||Interventional|||Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen|A Multicenter Study of LY188011 in Anthracyclines and Taxanes Pre-treated Metastatic/Recurrent Breast Cancer|Completed||Phase 2|68|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 05:30:03.793464|2017-10-11 05:30:03.793464
NCT00191282|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-01-18|2008-10-17||October 2002||2002-10-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|IONM||Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes|Hyperglycemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients With Type 2 Diabetes (HEART2D)|Completed||Phase 4|1116|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-10-11 05:30:04.815065|2017-10-11 05:30:04.815065
NCT00191295|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||February 2005||2005-02-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Comparison of Fixed-Dose Ranges of Atomoxetine Hydrochloride in Child Outpatients With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 2/Phase 3|240||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:07.228773|2017-10-11 05:30:07.228773
NCT00191308|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-10-13|2010-03-16||May 2005||2005-05-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|July 2008|Actual|2008-07-01||Interventional|||Molecular Profiling in Lung Cancer Patients|Molecular Profiling and Safety Study of Operable Lung Cancer Patients Treated With Alimta Combined With Cisplatin as Neoadjuvant Chemotherapy|Completed||Phase 2|30|Actual|Eli Lilly and Company|Trial enrollment was terminated early due to lack of eligible participants.|1|||f||||f||||||||||2017-10-11 05:30:07.338096|2017-10-11 05:30:07.338096
NCT00191321|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||July 2004||2004-07-01|January 2007|2007-01-01|December 2005||2005-12-01|||||Interventional|||Teriparatide Use in Hip Replaced Subjects|TUHRS Study - Teriparatide Use in Hip Replaced Subjects A Pilot Study on the Use of Teriparatide in Severe Osteoporotic Women With Hip Fracture and Submitted to Hip Replacement|Completed||Phase 3|60||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:07.651003|2017-10-11 05:30:07.651003
NCT00191334|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-02-24|2008-12-17||December 2004||2004-12-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Gemcitabine in Ovarian Cancer|Phase II Study of Gemcitabine Plus Cisplatin as First-Line Therapy in Patients With Epithelial Ovarian Cancer|Completed||Phase 2|50|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 05:30:07.74035|2017-10-11 05:30:07.74035
NCT00191347|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer|A Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer|Completed||Phase 2|30||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:08.425647|2017-10-11 05:30:08.425647
NCT00191360|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||January 2003||2003-01-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency|Extended Clinical Study of LY137998 [Somatropin (Recombinant DNA Origin)] in Adults With Growth Hormone Deficiency|Completed||Phase 3|68||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:08.488801|2017-10-11 05:30:08.488801
NCT00191373|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-11|||March 2002||2002-03-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease|Phase II Study of Gemcitabine and Trastuzumab Therapy in Patients With HER2 Overexpressing Metastatic Breast Cancer|Completed||Phase 2|66||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:08.578334|2017-10-11 05:30:08.578334
NCT00191386|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-12-14|2010-08-24||May 2005||2005-05-01|December 2010|2010-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)|Long-Term Extension, Open-Label Study of Atomoxetine Hydrochloride in Child Outpatients With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|228|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 05:30:08.68405|2017-10-11 05:30:08.68405
NCT00191399|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||May 2004||2004-05-01|January 2007|2007-01-01|March 2006||2006-03-01|||||Interventional|||Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response|Bipolar Depression Assessment Study on Tx Response|Completed||Phase 4|150||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:09.252375|2017-10-11 05:30:09.252375
NCT00191412|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-19|||January 2005||2005-01-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver|Phase II Study of Single-Agent Alimta in the Treatment of Patients With Advanced and Metastatic Hepatoma|Completed||Phase 2|41||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:09.352896|2017-10-11 05:30:09.352896
NCT00191425|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-07-12|||August 2002||2002-08-01|July 2007|2007-07-01|November 2005||2005-11-01|||||Interventional|||2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis|Comparison of a 2-Year Therapy of Teriparatide Alone and Its Sequential Use for 1 Year, With or Without Raloxifene HCl, in the Treatment of Severe Postmenopausal Osteoporosis|Completed||Phase 4|810||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:09.437528|2017-10-11 05:30:09.437528
NCT00191438|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-25|||October 2002||2002-10-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents|Phase III Study of Docetaxel in Combination With Gemcitabine Versus Docetaxel in Combination With Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 3|300||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:09.513105|2017-10-11 05:30:09.513105
NCT00191451|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-17|2009-10-12||April 2004||2004-04-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer|Phase II Trial of Gemzar Plus Paraplatin (Plus Herceptin in HER2+ Patients) in Metastatic Breast Cancer|Completed||Phase 2|150|Actual|Eli Lilly and Company||3|||f||||||||||||||2017-10-11 05:30:09.615309|2017-10-11 05:30:09.615309
NCT00191464|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-10-12|||December 2003||2003-12-01|October 2010|2010-10-01|September 2005||2005-09-01|||||Interventional|||Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes|Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes: A Comparison of Premeal Insulin Lispro Mixtures to Once-Daily Insulin Glargine|Completed||Phase 4|320||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:11.0264|2017-10-11 05:30:11.0264
NCT00191477|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-09-24|2009-03-17||January 2004||2004-01-01|September 2009|2009-09-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Instillation of Gemcitabine in Patients With Superficial Bladder Cancer|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Multicenter Study of Immediate Postoperative Instillation of Gemcitabine in Patients With Superficial Transitional Cell Carcinoma of the Bladder|Terminated||Phase 3|355|Actual|Eli Lilly and Company|The study was stopped early for futility reasons. In addition, due to limitations in this databank, some original outcome measures are not disclosed. Time to Recurrence and Recurrence-Free Survival in Subgroups had data that were un-estimated.|2||The study was stopped early for futility reasons.|f||||t||||||||||2017-10-11 05:30:11.213205|2017-10-11 05:30:11.213205
NCT00191490|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||July 2002||2002-07-01|January 2007|2007-01-01|May 2005||2005-05-01|||||Interventional|||A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer|A Multicenter Randomized Phase II Study Evaluating the Feasibility and Activity of Two Different Combinations of Docetaxel (RP56976, TAXOTERE *) and Gemcitabine and of Cisplatin/Gemcitabine Followed by Docetaxel as First Line Therapy for Locally Advanced Unresectable or Metastatic Non Small Cell Lung Cancer|Completed||Phase 2|162||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:12.272147|2017-10-11 05:30:12.272147
NCT00191503|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||January 2005||2005-01-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma|Phase II Study of Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma|Completed||Phase 2|30||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:12.353329|2017-10-11 05:30:12.353329
NCT00191516|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder|An Open-Label Study on Effectiveness and Tolerability of Atomoxetine as Perceived by Patients, Parents, and Physicians in Children With Attention-Deficit/Hyperactivity Disorder in Germany|Completed||Phase 3|257||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:12.502571|2017-10-11 05:30:12.502571
NCT00191529|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-06-13|||December 2002||2002-12-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Growth Hormone Treatment in Short Children Born Small for Gestational Age|Optimization of Growth Hormone Treatment in Short Children Born Small for Gestational Age Based on a Growth Prediction Model-The OPTIMA Trial|Completed||Phase 3|200||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:12.716762|2017-10-11 05:30:12.716762
NCT00191542|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-10|||March 2005||2005-03-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents|A Randomised, Double Blind Placebo Controlled Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Swedish Children and Adolescents|Completed||Phase 3|100||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:12.828265|2017-10-11 05:30:12.828265
NCT00191555|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-06-08|||August 2003||2003-08-01|July 2006|2006-07-01|May 2006||2006-05-01|||||Interventional|||Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment|Double-Blind Long-term Study Comparing the Efficacy and Safety of Olanzapine Versus Haloperidol in Patients With Schizophrenia Previously Stabilized With Conventional Antipsychotic Treatment|Completed||Phase 4|360||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:12.971208|2017-10-11 05:30:12.971208
NCT00191568|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-18|||October 2002||2002-10-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer|A Phase II Trial of Adjuvant Treatment With Gemcitabine and Oxaliplatin Followed by Concomitant Gemcitabine and Radiation Therapy in Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 2|45||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:13.21534|2017-10-11 05:30:13.21534
NCT00191581|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-28|||March 2005||2005-03-01|July 2006|2006-07-01|April 2006||2006-04-01|||||Interventional|||Local Registration Trial in China Humalog Mix 50|Comparison of 2-Hour Postprandial Blood Glucose Excursion in Response to a Standard Test Meal in Insulin-Requiring Diabetic Patients Treated Twice Daily With Either Insulin Lispro Mix 50/50 or Human Insulin Mix 50/50|Completed||Phase 3|120||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:13.339267|2017-10-11 05:30:13.339267
NCT00191594|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||March 2005||2005-03-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials|Open-Label Duloxetine Extension Phase in Patients Who Have Completed the HMDG Clinical Trial|Completed||Phase 3|105||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:13.456256|2017-10-11 05:30:13.456256
NCT00191607|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||July 2002||2002-07-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.|A Randomized Phase III Trial of Gemzar Versus Doxil With Crossover Treatment Option for Patients With Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer Undergoing Second or Third-Line Chemotherapy|Completed||Phase 3|162||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:13.581297|2017-10-11 05:30:13.581297
NCT00191620|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||March 2004||2004-03-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.|Randomized Phase II Study of Cisplatin + Gemcitabine Administered Either as Short Infusion or at a Fixed Dose Rate in Non-Small Cell Lung Cancer|Completed||Phase 2|64||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:13.702357|2017-10-11 05:30:13.702357
NCT00191633|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||April 2005||2005-04-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes|A 3 Month Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder; Symptomatic and Functional Outcomes.|Completed||Phase 4|200||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:13.817159|2017-10-11 05:30:13.817159
NCT00191646|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-28|2010-08-12||October 2002||2002-10-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy|Phase III Randomized Trial of Induction Chemotherapy With Gemcitabine and Carboplatin Followed by Elective Paclitaxel Consolidation Versus Paclitaxel and Carboplatin Followed by Elective Paclitaxel Consolidation in Patients With Primary Epithelial Ovarian, Primary Peritoneal Cancer or Fallopian Tube Carcinoma|Completed||Phase 3|919|Actual|Eli Lilly and Company|Trial was designed with overall survival as primary endpoint. Enrollment was slower than expected. After 4 years, 919 patients were randomized and in August 2006, protocol was amended: primary endpoint was changed to progression free survival (PFS).|2|||f||||t||||||||||2017-10-11 05:30:13.999303|2017-10-11 05:30:13.999303
NCT00191659|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-02-28|||June 2004||2004-06-01|February 2007|2007-02-01|April 2006||2006-04-01|||||Interventional|||Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents|A Randomised, Controlled, Open-Label Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents|Completed||Phase 3|200||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:17.550061|2017-10-11 05:30:17.550061
NCT00191672|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||December 2003||2003-12-01|January 2007|2007-01-01|November 2006||2006-11-01|||||Interventional|||A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer|A Phase II Randomized Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Patients With Metastatic Breast Cancer|Completed||Phase 2|120||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:17.644816|2017-10-11 05:30:17.644816
NCT00191685|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-21|||May 2004||2004-05-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||Duloxetine in the Treatment of Melancholic Depression|Duloxetine in the Treatment of Melancholic Depression: An 8-Week Open-Label Dose Study|Completed||Phase 3|200||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:17.721318|2017-10-11 05:30:17.721318
NCT00191698|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-29|||December 2003||2003-12-01|October 2008|2008-10-01|November 2007|Actual|2007-11-01|June 2005|Actual|2005-06-01||Interventional|||Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD|A Randomized, Double-Blind Comparison of Atomoxetine Hydrochloride and Placebo in Child and Adolescent Outpatients With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder|Completed||Phase 3|226|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:30:17.842428|2017-10-11 05:30:17.842428
NCT00191711|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||February 2004||2004-02-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.|Phase II Study of 6 Weeks Intravesical Gemcitabine Instillation Followed By Transurethral Resection in Patients Affected By Superficial Bladder Cancer at Low Risk|Completed||Phase 2|43||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:17.984788|2017-10-11 05:30:17.984788
NCT00191724|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-06-16|2009-01-14||September 2004||2004-09-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study|Drotrecogin Alfa (Activated) (LY203638)] Exploratory, Safety Study, Multi-Center, Randomized, Placebo-Controlled, Dose Escalating Study Design, Comparing a Standard Therapy (Enoxaparin Sodium) for Submassive Pulmonary Embolism to a Combined Therapy of Drotrecogin Alfa (Activated) Plus Enoxaparin Sodium.|Completed||Phase 2|47|Actual|Eli Lilly and Company|This study was stopped early after 47 patients had been enrolled (planned enrollment was 48 patients). Study was stopped early due to slow enrollment.|5|||f||||t||||||||||2017-10-11 05:30:18.072745|2017-10-11 05:30:18.072745
NCT00191737|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder|An Open-Label Study on Effectiveness and Tolerability of Atomoxetine, as Perceived by Patients, Parents, and Physicians in Adolescents With Attention-Deficit/Hyperactivity Disorder in Germany|Completed||Phase 3|147||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:22.333245|2017-10-11 05:30:22.333245
NCT00191750|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||July 2004||2004-07-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned|Phase II Trial of ALIMTA in Relapsed Small Cell Lung Cancer|Completed||Phase 2|80||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:22.436476|2017-10-11 05:30:22.436476
NCT00191763|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||November 2002||2002-11-01|November 2007|2007-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer|Phase II Trial of Gemcitabine and Cisplatin as Neo-Adjuvant Chemotherapy for Operable Non-Small Cell Lung Cancer|Completed||Phase 2|52||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:22.587157|2017-10-11 05:30:22.587157
NCT00191789|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-21|2010-04-29||February 2003||2003-02-01|July 2010|2010-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer|Neoadjuvant Administration of Gemcitabine Plus Doxorubicin Followed by Gemcitabine Plus Cisplatin in Large or Locally Advanced Operable Breast Cancer: A Phase II Study|Completed||Phase 2|65|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 05:30:22.75844|2017-10-11 05:30:22.75844
NCT00191802|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients|Compliance With and Acceptance of Teriparatide Pen Injection in Severely Osteoporotic Patients [CATS]|Completed||Phase 3|120||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:23.358209|2017-10-11 05:30:23.358209
NCT00191815|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-09|2008-10-13||October 2002||2002-10-01|November 2009|2009-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Combination Chemotherapy for Metastatic Breast Cancer|Phase II Study of Gemcitabine Plus Cisplatin as First-line Treatment of Metastatic Breast Cancer|Completed||Phase 2|70|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-10-11 05:30:23.499127|2017-10-11 05:30:23.499127
NCT00191828|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||March 2003||2003-03-01|January 2007|2007-01-01|August 2005||2005-08-01|||||Interventional|||A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme|A Prospective/Parallel Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme|Completed||Phase 4|60||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:24.393374|2017-10-11 05:30:24.393374
NCT00191841|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-21|||December 2002||2002-12-01|July 2006|2006-07-01|February 2006||2006-02-01|||||Interventional|||Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy|Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy in Operable Non Small Cell Lung Cancer|Completed||Phase 2|50||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:24.487705|2017-10-11 05:30:24.487705
NCT00191854|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-02-24|2009-07-21||March 2005||2005-03-01|February 2010|2010-02-01|November 2009|Actual|2009-11-01|August 2008|Actual|2008-08-01||Interventional|||Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line|Randomized Phase II Study of Biweekly Gemcitabine-Paclitaxel, Biweekly Gemcitabine-Carboplatin and Biweekly Gemcitabine-Cisplatin as First-Line Treatment in Metastatic Breast Cancer After Anthracycline Failure|Completed||Phase 2|147|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-10-11 05:30:24.622861|2017-10-11 05:30:24.622861
NCT00191867|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||February 2005||2005-02-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Clinical Trial of Teriparatide in Japan|Assessment of Dose Response of LY333334 in Japanese Postmenopausal Women With Osteoporosis|Completed||Phase 2|160||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:26.032006|2017-10-11 05:30:26.032006
NCT00191880|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-08-24|||May 2004||2004-05-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Interventional|||Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder|A Phase IIIb Open-Label Trial of Atomoxetine Hydrochloride to Evaluate Academic Outcome in Children Ages 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|100||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:26.124569|2017-10-11 05:30:26.124569
NCT00191893|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|November 2006||2006-11-01|||||Interventional|||Bone Effects of Teriparatide Following Alendronate|Bone Effects of Subcutaneous Teriparatide Following Discontinuation of Alendronate Treatment in Postmenopausal Women With Osteoporosis|Completed||Phase 3|66||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:26.203345|2017-10-11 05:30:26.203345
NCT00191906|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-05-17|2008-12-11||April 2005||2005-04-01|May 2010|2010-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)|A Randomized, Double-Blind, Crossover Comparison of Atomoxetine and Placebo in Child Outpatients With Attention-Deficit/Hyperactivity Disorder, Reading Disorder, or Comorbid Attention-Deficit/Hyperactivity Disorder and Reading Disorder.|Completed||Phase 4|121|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 05:30:26.316603|2017-10-11 05:30:26.316603
NCT00191919|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||May 2005||2005-05-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain|A Ten-Week, Randomized, Double-Blind Study Evaluating the Efficacy of Duloxetine 60mg Once Daily Versus Placebo in Outpatients With Major Depressive Disorder and Pain|Completed||Phase 3|310||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:27.484956|2017-10-11 05:30:27.484956
NCT00191932|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-21|||August 2004||2004-08-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Switching to Duloxetine From Other Antidepressants|Switching to Duloxetine From Other Antidepressants: A Regional Multicentre Trial Comparing Two Switching Techniques|Completed||Phase 4|360||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:27.736354|2017-10-11 05:30:27.736354
NCT00191945|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-26|2009-02-06||May 2005||2005-05-01|January 2010|2010-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety of Atomoxetine up to 12 Weeks in Newly Diagnosed Children and Adolescents Outpatients With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|151|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-10-11 05:30:27.864709|2017-10-11 05:30:27.864709
NCT00191971|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-05|||January 2004||2004-01-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen|A Phase II Study of Gemcitabine in Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|40||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:28.85142|2017-10-11 05:30:28.85142
NCT00191984|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-01-03|2009-04-27||June 2004||2004-06-01|January 2011|2011-01-01|May 2008|Actual|2008-05-01|February 2007|Actual|2007-02-01||Interventional|||A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer|Open Multicenter Phase II Study in Second-Line Metastatic Colorectal Cancer Patients: Combination of ALIMTA and Irinotecan Administered Every Two-Weeks|Completed||Phase 2|46|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 05:30:28.971505|2017-10-11 05:30:28.971505
NCT00191997|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-21|||October 2004||2004-10-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode|Optimal Treatment Duration With Olanzapine Following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies.|Completed||Phase 4|180||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:29.338504|2017-10-11 05:30:29.338504
NCT00192023|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-09|2009-05-15||October 2004||2004-10-01|December 2009|2009-12-01|May 2008|Actual|2008-05-01|August 2006|Actual|2006-08-01||Interventional|||An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).|An Italian Randomised, Double-blind Placebo Controlled Study of the Efficacy of Atomoxetine Hydrochloride in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder|Completed||Phase 3|139|Actual|Eli Lilly and Company|Due to the open-ended timing of the open-label period (up to 1.5 years or until commercial availability) the efficacy data from the open-label extension phase is not included except for adverse event data.|2|||f||||f||||||||||2017-10-11 05:30:29.527586|2017-10-11 05:30:29.527586
NCT00192036|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-11-22|2009-02-23||August 2004||2004-08-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|January 2008|Actual|2008-01-01||Interventional|||Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer|Multicenter Phase II Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer|Completed||Phase 2|49|Actual|Eli Lilly and Company|Enrollment was stopped early due to difficulties with patient recruitment. Given the number of missing/unknown tumor assessments, care should be taken when interpreting the primary outcome measure. An identified error was corrected in the results.|1|||f||||f||||||||||2017-10-11 05:30:30.470186|2017-10-11 05:30:30.470186
NCT00192049|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-16|||December 2003||2003-12-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer|A Randomized Phase II Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer|Completed||Phase 2|90||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:31.055308|2017-10-11 05:30:31.055308
NCT00192062|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-29|||July 2004||2004-07-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer|A Phase II Trial of Gemcitabine (Gemzar) Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer|Completed||Phase 2|80||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:31.154689|2017-10-11 05:30:31.154689
NCT00192075|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-04|2008-10-30||June 2003||2003-06-01|November 2009|2009-11-01|November 2007|Actual|2007-11-01|||||Interventional|||A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer|A Multicenter, Randomized Phase II Trial of Avastin Plus Gemcitabine Plus 5FU/Folinic Acid (A + FFG) vs. Avastin Plus Oxaliplatin Plus 5FU/Folinic Acid (A + FOLFOX 4) as Therapy for Patients With Metastatic Colorectal Cancer|Completed||Phase 2|84|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-10-11 05:30:31.264796|2017-10-11 05:30:31.264796
NCT00192088|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-24|||May 2004||2004-05-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma|Open-Label Single-Arm Phase II Study of ALIMTA in Combination With Oxaliplatin as First-Line Therapy in Advanced Gastric Carcinoma|Completed||Phase 2|43||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:33.377216|2017-10-11 05:30:33.377216
NCT00192101|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-16|||October 2004||2004-10-01|November 2007|2007-11-01|July 2005||2005-07-01|||||Interventional|||Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes|Randomized Phase II Study of the Combination of Gemcitabine (Gemzar) Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines an/or Taxanes|Completed||Phase 2|100||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:30:33.49358|2017-10-11 05:30:33.49358
NCT00192114|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-10-05||2009-02-17|August 2005||2005-08-01|October 2009|2009-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Enzastaurin for Patients With Metastatic Colorectal Cancer|A Phase 2 Study of Oral Enzastaurin HCl in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|30|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-10-11 05:30:33.584028|2017-10-11 05:30:33.584028
NCT00192127|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-12|||August 2004||2004-08-01|December 2007|2007-12-01|February 2005|Actual|2005-02-01|||||Interventional|||Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|Completed||Phase 3|300||MedImmune LLC||2|||f||||||||||||||2017-10-11 05:30:33.694538|2017-10-11 05:30:33.694538
NCT00192140|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-12-27|||June 2004||2004-06-01|December 2007|2007-12-01|January 2005|Actual|2005-01-01|October 2004|Actual|2004-10-01||Interventional|||Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age|An Open-Label, Single-Arm Trial to Assess the Shedding, Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age|Completed||Phase 4|345||MedImmune LLC||1|||f||||t||||||||||2017-10-11 05:30:33.780217|2017-10-11 05:30:33.780217
NCT00192153|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-23|||July 2001||2001-07-01|October 2006|2006-10-01|October 2001||2001-10-01|||||Interventional|||Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older|A Randomized, Partially-Blinded, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Adults 18 to 59 Years and Healthy Adults,60 Years/Older|Completed||Phase 2|240||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:33.879345|2017-10-11 05:30:33.879345
NCT00192166|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-12-05|||October 2002||2002-10-01|December 2008|2008-12-01|May 2003|Actual|2003-05-01|March 2003|Actual|2003-03-01||Interventional|||Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months|Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months|Completed||Phase 2|1200||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:33.947159|2017-10-11 05:30:33.947159
NCT00192179|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-02-29|||June 2003||2003-06-01|February 2012|2012-02-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|FluMist||A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.|A Phase II, Prospective, Randomized, Double-Blind, Placebo, Controlled Trial, to Assess the Safety and Tolerability of Influenza Virus Vaccine, Trivalent, Types A & B Live Cold-Adapted Liquid Formulation (CAIV-T) in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.|Completed||Phase 2|240|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 05:30:34.035724|2017-10-11 05:30:34.035724
NCT00192192|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-23|||November 2000||2000-11-01|October 2006|2006-10-01|December 2000||2000-12-01|||||Interventional|||Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults|A Randomized, Double-Blind, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults Aged 18 to 64 Years|Completed||Phase 3|20||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:34.193921|2017-10-11 05:30:34.193921
NCT00183092|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-05-28|2014-01-21||April 2005||2005-04-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||CJD (Creutzfeldt-Jakob Disease) Quinacrine Study|Novel Therapeutics For Prion Diseases: A Randomized, Double-blinded, Placebo-controlled Study of the Efficacy of Quinacrine in the Treatment of Sporadic Creutzfeldt-Jakob Disease|Completed||Phase 2|69|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 05:30:34.290386|2017-10-11 05:30:34.290386
NCT00183157|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-02-12|||October 2004||2004-10-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Project RAP: Reaching Adolescents for Prevention|RAP: Reaching Adolescents for Prevention - A Randomized Trial of a Brief Negotiated Interview and Active Referral to Reduce Alcohol Related Morbidity Among Youth and Young Adults in the Pediatric Emergency Department|Unknown status|Recruiting|Phase 2|1400|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||3|||f||||||||||||||2017-10-11 05:30:35.488596|2017-10-11 05:30:35.488596
NCT00183170|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-14|||February 2004||2004-02-01|June 2007|2007-06-01|January 2009|Anticipated|2009-01-01|||||Interventional|||Residual Effects of Intoxication on Student Performance|Residual Effects of Intoxication on Student Performance|Unknown status|Recruiting|Phase 2|200|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 05:30:35.635713|2017-10-11 05:30:35.635713
NCT00183183|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-05-21|||April 2004||2004-04-01|May 2010|2010-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Impact of a Brief Motivational Interview on Drinking Behaviors of At Risk Drinkers Screened in the Emergency Room|Alcohol Screening and Brief Intervention in the Emergency Department|Completed||Phase 3|1137|Actual|UConn Health||2|||f||||||||||||||2017-10-11 05:30:35.823321|2017-10-11 05:30:35.823321
NCT00183196|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-17|2012-11-20||January 2003||2003-01-01|March 2016|2016-03-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone|Gabapentin as an Adjunct to Naltrexone for Alcoholism|Completed||Phase 3|150|Actual|Medical University of South Carolina||3|||f||||f||||||||||2017-10-11 05:30:35.986267|2017-10-11 05:30:35.986267
NCT00183209|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-29|||December 2001||2001-12-01|October 2006|2006-10-01|January 2008|Actual|2008-01-01|July 2006|Actual|2006-07-01||Interventional|||Interventions for HIV+ Mothers With Problem Drinking|Interventions for HIV+ Mothers With Problem Drinking|Completed||Phase 2|118|Actual|New York University||2|||f||||f||||||||||2017-10-11 05:30:36.57407|2017-10-11 05:30:36.57407
NCT00183222|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-04|||May 2005||2005-05-01|May 2010|2010-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking|Alcohol Research Center Grant. Component #1. COMBINING MEDICATIONS: ALCOHOL REACTIVITY AND CONSUMPTION|Completed||Phase 2|160||Medical University of South Carolina|||||f||||||||||||||2017-10-11 05:30:36.712651|2017-10-11 05:30:36.712651
NCT00183235|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-04|||June 2005||2005-06-01|May 2010|2010-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Aripiprazole Effects on Alcohol Reactivity and Consumption|Effectiveness of Aripiprazole to Reduce Craving for Alcohol and Drinking Under Natural Observation, During Cue Induced Brain Imaging, and During a Motivated Free Choice Drinking Procedure Compared to Placebo|Completed||Phase 2|30||Medical University of South Carolina|||||f||||||||||||||2017-10-11 05:30:36.791066|2017-10-11 05:30:36.791066
NCT00183248|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2012-09-17|2012-04-05||September 2004||2004-09-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients|Pilot Study Using Donor Stem Cells and Campath-1H to Induce Renal Transplant Tolerance (ITN022ST)|Completed||Phase 1/Phase 2|9|Actual|University of Miami|In July 2007 after the trial had been enrolling for approximately 42 months, enrollment was stopped at the current number of nine subjects due to time and resource constraints.|2|||f||||t||||||||||2017-10-11 05:30:36.891929|2017-10-11 05:30:36.891929
NCT00183261|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-07|||March 2006||2006-03-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|August 2007|Actual|2007-08-01||Interventional|||Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection|A Randomized Phase II Study of Therapeutic Immunization and Treatment Interruption Among Subjects Who Began Potent Antiretroviral Therapy Within 30 Days of Diagnosis of Acute or Recent HIV Infection|Completed||Phase 2|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:30:37.653079|2017-10-11 05:30:37.653079
NCT00183274|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-29|2012-12-14||January 2004||2004-01-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||334 participants were consented, but 64 withdrew consent and 2 deviated from protocol, resulting in 268 participants who entered the initial Phase 1.|Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR|Short-term Versus Long-term Treatment in Generalized Anxiety Disorder|Completed||Phase 4|268|Actual|University of Pennsylvania|Increased attrition occurring as a function of trial length|6|||f||||t||||||||No||2017-10-11 05:30:37.932605|2017-10-11 05:30:37.932605
NCT00183287|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-25||||||April 2012|2012-04-01|March 2003|Actual|2003-03-01|||||Observational|||Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials|Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients With Known or Suspected HIV Infection|Completed||N/A|150||National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"     Blood collection   "|||2017-10-11 05:30:38.341365|2017-10-11 05:30:38.341365
NCT00183300|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-02|||September 2001||2001-09-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Relationship Between the Biological and Psychological Correlates of PTSD|Effectiveness of Prolonged Exposure Therapy on Reducing Neuroendocrine-Related Symptoms of Post-Traumatic Stress Disorder in Women|Completed||Phase 2|120||University of Pennsylvania|||||f||||||||||||||2017-10-11 05:30:38.399458|2017-10-11 05:30:38.399458
NCT00183313|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-18|||July 2004||2004-07-01|November 2013|2013-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Improving Primary Care in Patients With Mental Disorders|Improving Primary Care in Patients With Mental Disorders|Completed||Phase 3|407|Actual|Emory University||2|||f||||t||||||||||2017-10-11 05:30:38.488804|2017-10-11 05:30:38.488804
NCT00183326|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-07-20|||May 2004||2004-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence|Treating PTSD in Children Exposed to Domestic Violence|Completed||N/A|124|Actual|Allegheny Singer Research Institute||2|||f||||t||||||||||2017-10-11 05:30:38.587589|2017-10-11 05:30:38.587589
NCT00183339|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-06|2014-02-07|2013-09-10||July 2005||2005-07-01|February 2014|2014-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Early Intervention With Fluoxetine in Autism|A Randomized, Placebo-controlled Trial of Fluoxetine in Preschool Children|Completed||Phase 2|18|Actual|University of North Carolina, Chapel Hill|It took twice as long to recruit subjects for a study in children 30-58 months than it generally takes to recruit older children. It is possible to maintain subjects in double-blind trails for extended periods.|2|||f||||t||||||||||2017-10-11 05:30:38.705067|2017-10-11 05:30:38.705067
NCT00183352|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-14|||January 2004||2004-01-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Reproductive Function and Mood in Women With Bipolar Disorder|Reproductive Endocrine Function and Mood Over the Menstrual Cycle of Women Treated for Bipolar Disorder|Completed||N/A|90|Anticipated|Stanford University|||2||f||||f||||||||||2017-10-11 05:30:39.188487|2017-10-11 05:30:39.188487
NCT00183365|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-02-06|||October 2005||2005-10-01|February 2014|2014-02-01|November 2009|Actual|2009-11-01|July 2008|Actual|2008-07-01||Interventional|||Effect of Family-Based Prevention on Children of Depressed Parents|Children of Depressed Parents: Family-Based Prevention|Completed||Phase 1|42|Actual|Children's Hospital of Philadelphia||2|||f||||||||||||||2017-10-11 05:30:39.271769|2017-10-11 05:30:39.271769
NCT00183378|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-01-12|||September 2005||2005-09-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|September 2009|Actual|2009-09-01||Interventional|||Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease|Behavioral Treatment of Nocturnal Disturbances in Alzheimer's Disease|Completed||N/A|132|Actual|University of Washington||4|||f||||t||||||||||2017-10-11 05:30:39.35173|2017-10-11 05:30:39.35173
NCT00183404|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-08-14|||September 2004||2004-09-01|August 2014|2014-08-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Long-Term Olanzapine Treatment in Children With Autism|Long-Term Olanzapine Treatment in Children With Autism|Completed||Phase 2/Phase 3|32|Actual|Drexel University||1|||f||||t||||||||||2017-10-11 05:30:39.559608|2017-10-11 05:30:39.559608
NCT00183417|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-23|||September 2004||2004-09-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Depression Prevention Program for Adolescents|Depression Prevention Program for High-Risk Adolescents|Completed||N/A|350|Actual|University of Texas at Austin||4|||f||||||||||||||2017-10-11 05:30:39.645756|2017-10-11 05:30:39.645756
NCT00183430|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-11-26|2012-10-22||October 2003||2003-10-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|May 2009|Actual|2009-05-01||Interventional|||Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder|Prazosin for Noncombat Trauma PTSD|Terminated||N/A|20|Actual|Seattle Institute for Biomedical and Clinical Research||2||Insufficient Enrollment|f||||t||||||||||2017-10-11 05:30:39.736512|2017-10-11 05:30:39.736512
NCT00183456|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-24|2012-09-14||September 2005||2005-09-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|July 2007|Actual|2007-07-01||Interventional|||A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs|Network HIV Prevention Intervention for Drug Users|Completed||Phase 2|746|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||||||||||||2017-10-11 05:30:40.221362|2017-10-11 05:30:40.221362
NCT00183469|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-19|2013-04-10||December 2004||2004-12-01|April 2017|2017-04-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Maintenance Treatment of Bipolar Depression|Eight-Month Maintenance Treatment of Bipolar Depression With Lamotrigine or Lamotrigine Plus Divalproex Combination|Completed||Phase 4|86|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-10-11 05:30:40.915293|2017-10-11 05:30:40.915293
NCT00183482|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-11|||August 1, 2010|Actual|2010-08-01|April 2017|2017-04-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Family Cognitive Behavioral Therapy for Preventing Depression in Children|Family Cognitive Behavioral Prevention of Depression in Children of Parents With a History of Major Depressive Disorder|Recruiting||N/A|750|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-10-11 05:30:41.275804|2017-10-11 05:30:41.275804
NCT00183495|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-01|||March 2004||2004-03-01|June 2013|2013-06-01|August 2007|Actual|2007-08-01|March 2007|Actual|2007-03-01||Observational|||Understanding Treatment Adherence Among Individuals With Bipolar Disorder|Determinants and Manifestation of Illness Behavior in Promoting Treatment Adherence Among Individuals With Bipolar Depression|Completed||N/A|140|Actual|Case Western Reserve University|||1||f||||f||||||||||2017-10-11 05:30:41.396124|2017-10-11 05:30:41.396124
NCT00183508|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-11||||||December 2015|2015-12-01|May 2009|Actual|2009-05-01|December 2005|Actual|2005-12-01||Interventional|||Behavioral Treatments for Acute Stress Disorder In Firefighters|Developing Group Treatments for Acute Stress Disorder|Completed||N/A|169|Actual|Boston University||2|||f||||||||||||||2017-10-11 05:30:41.479384|2017-10-11 05:30:41.479384
NCT00183521|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-30|||March 2005||2005-03-01|November 2011|2011-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Breathing Regulation Training for Individuals With Panic Disorder|Respiratory Therapeutic Procedures in Panic Disorder|Completed||N/A|136|Actual|Stanford University||3|||f||||f||||||||||2017-10-11 05:30:41.575211|2017-10-11 05:30:41.575211
NCT00183547|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-05-28|||January 2005||2005-01-01|December 2008|2008-12-01|September 2007||2007-09-01|March 2007|Actual|2007-03-01||Interventional|||Depression Prevention Program for American Indian Adolescents During and After Pregnancy|Depression Prevention in Pregnant American Indian Teens Using CBT|Completed||N/A|45||Johns Hopkins University||2|||f||||||||||||||2017-10-11 05:30:41.683664|2017-10-11 05:30:41.683664
NCT00183560|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-06-30|||July 2004||2004-07-01|June 2015|2015-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Preventing Depression Relapse With Mindfulness-Based Cognitive Therapy|Prevention of Relapse in Recurrent Depression With MBCT|Completed||Phase 4|184|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-10-11 05:30:41.79327|2017-10-11 05:30:41.79327
NCT00183573|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-06|||March 2004||2004-03-01|June 2013|2013-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||HIV Prevention Program for Patients Receiving Care at a Sexually Transmitted Diseases Clinic|HIV Prevention for STD Clinic Patients|Completed||Phase 2/Phase 3|1554|Actual|The Miriam Hospital||6|||f||||f||||||||||2017-10-11 05:30:41.904782|2017-10-11 05:30:41.904782
NCT00183586|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-06-16|||April 2004||2004-04-01|June 2016|2016-06-01||||March 2009|Actual|2009-03-01||Interventional|||Comparing the Effectiveness of Three Types of Therapy for the Treatment of Anorexia Nervosa in Adolescents|Treatment for Adolescent Anorexia Nervosa|Completed||Phase 2|121|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 05:30:42.021768|2017-10-11 05:30:42.021768
NCT00183612|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-01-07|||May 2000||2000-05-01|January 2014|2014-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents|Developmental Pharmacokinetics of Psychotropic Drugs: Olanzapine|Terminated||N/A|68||Massachusetts General Hospital||1|||f||||||||||||||2017-10-11 05:30:42.237964|2017-10-11 05:30:42.237964
NCT00183625|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-20|2010-05-21||June 2000||2000-06-01|November 2005|2005-11-01|September 2006|Actual|2006-09-01|June 2005|Actual|2005-06-01||Interventional|||Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients|The Effectiveness of Supplementing Supported Employment With Behavioral Skills Training|Completed||Phase 4|107|Actual|University of California, Los Angeles||4|||f||||t||||||||||2017-10-11 05:30:42.340415|2017-10-11 05:30:42.340415
NCT00183638|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-26|||June 2003||2003-06-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|Youthnet||A Tailored Interactive Website for Promoting Condom Use Among Young Adults|Randomized Controlled Trial to Establish Efficacy of a Website to Promote Condom Use for Adults Aged 18-25|Completed||Phase 2|1870|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-10-11 05:30:42.691591|2017-10-11 05:30:42.691591
NCT00183651|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-01-31|||April 2004||2004-04-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Suicidal Women With Borderline Personality Disorder|Assessment and Treatment of Parasuicidal Patients|Completed||Phase 2|99|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 05:30:42.795648|2017-10-11 05:30:42.795648
NCT00183677|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-04|2011-09-22||July 2003||2003-07-01|November 2016|2016-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram|Biochemical Brain Changes Correlated With the Antidepressant Effect of Escitalopram: A Magnetic Resonance Spectroscopic Imaging Study|Completed||Phase 4|97|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-10-11 05:30:42.931561|2017-10-11 05:30:42.931561
NCT00183703|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-07-01|||July 2004||2004-07-01|June 2013|2013-06-01|August 2007|Actual|2007-08-01|November 2006|Actual|2006-11-01||Observational|||Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar Disorder|Rapid Cycling Bipolar Disorder (RCBPD), Subjective Illness Experience and Gender|Completed||N/A|40|Actual|Case Western Reserve University|||1||f||||f||||||||||2017-10-11 05:30:43.256358|2017-10-11 05:30:43.256358
NCT00183716|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-07-20|||April 2004||2004-04-01|July 2012|2012-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|TREM||The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women|An Randomized Controlled Trial (RCT) of the Trauma Recovery and Empowerment Model|Completed||Phase 3|300|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 05:30:43.347447|2017-10-11 05:30:43.347447
NCT00183729|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-10-20|2016-07-01||August 2005||2005-08-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults|Memantine for Enhancement of Rehabilitation Efficacy and Prevention of Major Depressive Disorder in Older Adults|Completed||Phase 4|35|Actual|University of Pittsburgh||2|||f||||f||||||||Yes|study has small sample size and is unlikely to be useful for data sharing efforts; however, interested researchers can contact the first author via email.|2017-10-11 05:30:43.461198|2017-10-11 05:30:43.461198
NCT00183742|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||December 2000||2000-12-01|May 2014|2014-05-01|May 2006|Actual|2006-05-01|October 2005|Actual|2005-10-01||Interventional|||Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)|Phase I Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)|Completed||Phase 1|35||University of Southern California|||||f||||||||||||||2017-10-11 05:30:43.787442|2017-10-11 05:30:43.787442
NCT00183755|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-04-16|||April 2005||2005-04-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Understanding Brain Reward Responses in Individuals With Major Depressive Disorder|Neuroimaging Studies of Reward Processing in Depression|Completed||N/A|87|Actual|Mclean Hospital|||2||f||||t||||||||||2017-10-11 05:30:43.859286|2017-10-11 05:30:43.859286
NCT00183768|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-08-20|||September 1999||1999-09-01|August 2013|2013-08-01|February 2003|Actual|2003-02-01|||||Interventional|||Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users|Antidepressant Treatment to Reduce HIV Risk Among IDUs|Completed||Phase 3|175||Butler Hospital|||||f||||||||||||||2017-10-11 05:30:43.96141|2017-10-11 05:30:43.96141
NCT00183781|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-08-20|||September 2000||2000-09-01|August 2013|2013-08-01|June 2004|Actual|2004-06-01|||||Interventional|||Effectiveness of a Telephone Intervention Program in Improving Depression, Coping, and Family Functioning in HIV-Infected Individuals and Caregivers|Adapting to HIV Disease - A Family Intervention|Completed||Phase 3|270||Butler Hospital|||||f||||||||||||||2017-10-11 05:30:44.039467|2017-10-11 05:30:44.039467
NCT00183794|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|2012-10-06||November 2002||2002-11-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma|Phase II Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma|Completed||Phase 2|20|Actual|University of Southern California||1|||f||||||||||||||2017-10-11 05:30:44.125389|2017-10-11 05:30:44.125389
NCT00192205|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-02|||October 2002||2002-10-01|October 2006|2006-10-01|June 2003||2003-06-01|||||Interventional|||Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children|A Prospective, Randomized, Open-Label, Controlled Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, Trivalent, Type A&B, Live, Cold-Adapted (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children With a History of Recurrent Respiratory Tract Infections Aged 6 Months to Less Than 72 Months|Completed||Phase 3|2200||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:44.478244|2017-10-11 05:30:44.478244
NCT00192972|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-21|||November 2002||2002-11-01|November 2003|2003-11-01|June 2005||2005-06-01|||||Interventional|||A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation|A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation (LASso Vs CARto)|Completed||N/A|100||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:51.101085|2017-10-11 05:30:51.101085
NCT00192218|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-19|||October 2004||2004-10-01|September 2008|2008-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program|A Phase IV Study to Evaluate the Effectiveness of Flumist (Influenza Vaccine, Live Intranasal) Vaccination in a School-Based Intervention Program|Completed||Phase 4|3022|Actual|MedImmune LLC||1|||f||||||||||||||2017-10-11 05:30:44.565224|2017-10-11 05:30:44.565224
NCT00192231|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-23|||April 2001||2001-04-01|October 2006|2006-10-01|June 2001||2001-06-01|||||Interventional|||Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)|A Randomized, Double-Blind, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults Aged 18 and Older|Completed||Phase 3|120||MedImmune LLC|||||f||||||||||||||2017-10-11 05:30:44.769336|2017-10-11 05:30:44.769336
NCT00192244|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-02|||September 2000||2000-09-01|October 2006|2006-10-01|October 2002||2002-10-01|||||Interventional|||Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in Healthy Children|Completed||Phase 3|3000||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:44.85946|2017-10-11 05:30:44.85946
NCT00192257|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-02|||October 2002||2002-10-01|October 2006|2006-10-01|May 2003||2003-05-01|||||Interventional|||Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma|A Prospective, Randomized, Open-Label, Controlled Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, Trivalent, Type A&B, Live, Cold-Adapted (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children With Asthma Aged 6 Years to 17 Years|Completed||Phase 3|2229||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:44.946334|2017-10-11 05:30:44.946334
NCT00192270|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-05|||October 2000||2000-10-01|March 2012|2012-03-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|FluMist||Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children|A Prospective, Open-label, Phase II, Multi-center Study of the Safety, Tolerability and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children, Aged 6 to 17 Years|Completed||Phase 2|498|Actual|MedImmune LLC||1|||f||||f||||||||||2017-10-11 05:30:45.08435|2017-10-11 05:30:45.08435
NCT00192283|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-04-08|||September 2000||2000-09-01|April 2009|2009-04-01|May 2002|Actual|2002-05-01|April 2002|Actual|2002-04-01||Interventional|||Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in Healthy Children Attending Day Care Centers|Completed||Phase 3|2903|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 05:30:45.176271|2017-10-11 05:30:45.176271
NCT00192296|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-02-04|2013-10-17||August 2004||2004-08-01|February 2014|2014-02-01|March 2005|Actual|2005-03-01|February 2005|Actual|2005-02-01||Interventional|||Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528 in Healthy Adult Volunteers|A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528, a Humanized Monoclonal Anti-Interleukin-9 Antibody, in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|MedImmune LLC||4|||f||||||||||||||2017-10-11 05:30:45.284473|2017-10-11 05:30:45.284473
NCT00192309|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-02-13|||September 2001||2001-09-01|February 2012|2012-02-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.|A Randomized, Open-Label, Placebo-Controlled Trial to Investigate the Kinetics of the Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent,Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Adults Aged 18 to <65 Years.|Completed||Phase 2|31|Actual|MedImmune LLC||3|||f||||f||||||||||2017-10-11 05:30:46.021875|2017-10-11 05:30:46.021875
NCT00192322|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-02-15|||September 2001||2001-09-01|February 2012|2012-02-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|CAIVT||Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children|A Randomized, Partially-Blinded, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent,Types A & B, Live Cold Adapted (CAIV-T) in Healthy Children Aged 6 to Less Than 36 Months|Completed||Phase 2|173|Actual|MedImmune LLC||4|||f||||f||||||||||2017-10-11 05:30:46.116829|2017-10-11 05:30:46.116829
NCT00192335|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-26|||July 2004||2004-07-01|November 2007|2007-11-01|February 2005|Actual|2005-02-01|||||Interventional|||Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants|A Prospective, Double-Blind, Randomized Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants Ages 5 Through 49 Years|Completed||Phase 3|890|Actual|MedImmune LLC||2|||f||||||||||||||2017-10-11 05:30:46.224155|2017-10-11 05:30:46.224155
NCT00192348|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-02|||May 2002||2002-05-01|October 2006|2006-10-01|December 2002||2002-12-01|||||Interventional|||A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants|A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Infants|Completed||Phase 1|120||MedImmune LLC|||||f||||||||||||||2017-10-11 05:30:47.931245|2017-10-11 05:30:47.931245
NCT00192361|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-23|||November 1999||1999-11-01|October 2006|2006-10-01||||||||Interventional|||Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)|A Randomized, Double-Blind Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)|Completed||Phase 3|200||MedImmune LLC|||||f||||||||||||||2017-10-11 05:30:47.989001|2017-10-11 05:30:47.989001
NCT00192946|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-07-09||||||February 2006|2006-02-01|September 2008|Anticipated|2008-09-01|||||Interventional|||The CRT-KIR Study (Cardiac Resynchronization Therapy [CRT] in the Early Phase After Heart Surgery)|Cardiac Resynchronization Therapy (CRT) in the Early Phase After Heart Surgery|Withdrawn||N/A|60|Anticipated|Rigshospitalet, Denmark||||The study population is smaller than expected. No subjects were included.|f||||||||||||||2017-10-11 05:30:50.887518|2017-10-11 05:30:50.887518
NCT00192374|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-02|||February 2002||2002-02-01|October 2006|2006-10-01|November 2002||2002-11-01|||||Interventional|||Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase III, Multicenter Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B,Live, Cold-Adapted (CAIV-T) in Healthy Children|Completed||Phase 3|1920||MedImmune LLC|||||f||||||||||||||2017-10-11 05:30:48.051535|2017-10-11 05:30:48.051535
NCT00192387|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-12-27|||September 2001||2001-09-01|December 2006|2006-12-01|December 2001||2001-12-01|||||Interventional|||Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)|A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate Viral Shedding in Healthy Children (6 Mos and Less Than or Equal to 18 Months of Age) Vaccinated With Two Doses of Liquid Formulation of Influenza Virus Vaccine, Live Cold Adapted (CAIV-T)|Completed||Phase 2|60||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:48.110871|2017-10-11 05:30:48.110871
NCT00192400|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-02|||March 2002||2002-03-01|October 2006|2006-10-01|November 2002||2002-11-01|||||Interventional|||Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.|A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of One Dose and Two Doses of a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) Compared With Placebo in Healthy Children|Completed||Phase 3|2160||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:48.167357|2017-10-11 05:30:48.167357
NCT00192413|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-13|||March 2002||2002-03-01|March 2012|2012-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|FluMist||Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza|A Prospective, Randomized, Open-Label, Controlled Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older|Completed||Phase 3|3009|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 05:30:48.221315|2017-10-11 05:30:48.221315
NCT00192426|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-02|||September 2001||2001-09-01|October 2006|2006-10-01|December 2001||2001-12-01|||||Interventional|||Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.|A Prospective, Randomized, Partially-Blinded, Placebo-Controlled, Phase III, Multicenter Trial to Assess Safety, Tolerability and Immunogenicity of Liquid CAIV-T Administered Concomitantly With OPV in Healthy Children|Completed||Phase 3|2400||MedImmune LLC|||||f||||||||||||||2017-10-11 05:30:48.313432|2017-10-11 05:30:48.313432
NCT00192439|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-04|||December 2003||2003-12-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Observational|||Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk|A Study to Describe the Incidence Rate and Clinical Features of Human Meta Pneumovirus (hMPV) Infection of the Lower Respiratory Tract in Hospitalized Children at High Risk for Severe Disease|Completed||N/A|1500|Actual|MedImmune LLC|||||f||||||||||||||2017-10-11 05:30:48.364563|2017-10-11 05:30:48.364563
NCT00192452|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-23|||March 2001||2001-03-01|October 2006|2006-10-01|December 2001||2001-12-01|||||Interventional|||Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis|A Phase II Randomized, Double-Blind, Placebo-Controlled Study of MEDI-507, a Humanized Monoclonal Antibody That Binds to the CD2 Receptor, Administered by Intravenous Infusion to Adults With Plaque Psoriasis|Completed||Phase 2|120||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:48.462267|2017-10-11 05:30:48.462267
NCT00192465|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-28|||November 2003||2003-11-01|January 2009|2009-01-01|November 2004|Actual|2004-11-01|April 2004|Actual|2004-04-01||Interventional|||Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults|A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 (NUMAX TM), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Healthy Adults|Completed||Phase 1|30|Actual|MedImmune LLC||5|||f||||||||||||||2017-10-11 05:30:48.635453|2017-10-11 05:30:48.635453
NCT00192478|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-24|||February 2004||2004-02-01|July 2008|2008-07-01|August 2006|Actual|2006-08-01|May 2006|Actual|2006-05-01||Interventional|||Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524|A Phase 1/2, Open-Label, Repeat-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children at Risk for Serious RSV Disease|Completed||Phase 1/Phase 2|217|Actual|MedImmune LLC||1|||f||||||||||||||2017-10-11 05:30:48.759392|2017-10-11 05:30:48.759392
NCT00192491|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-02-07|||December 2000||2000-12-01|February 2008|2008-02-01|December 2003|Actual|2003-12-01|September 2003|Anticipated|2003-09-01||Interventional|||Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children|A Randomized, Placebo-Controlled, Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, (MMRIIÒ) and Varicella (VARIVAXÒ) Vaccines Administered Concurrently to Healthy Children (AV018)|Completed||Phase 3|1200|Anticipated|MedImmune LLC||3|||f||||f||||||||||2017-10-11 05:30:48.857759|2017-10-11 05:30:48.857759
NCT00192504|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-23|||March 2004||2004-03-01|October 2006|2006-10-01|January 2005||2005-01-01|||||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection|A Phase 1, Randomized, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection|Completed||Phase 1|31||MedImmune LLC|||||||||||||||||||2017-10-11 05:30:48.954139|2017-10-11 05:30:48.954139
NCT00192959|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-16|||March 2004||2004-03-01|June 2005|2005-06-01|December 2004||2004-12-01|||||Interventional|||Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects.|Xenon Inhalation as Cover Sedation During Orthopaedic Surgery in Elderly Subjects Comparing the Effects of Inhaled Xenon and Intravenous Propofol|Completed||Phase 3|44||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:50.998987|2017-10-11 05:30:50.998987
NCT00192517|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-02|||December 2003||2003-12-01|April 2009|2009-04-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of MEDI-522, a Humanized Monoclonal Antibody to Integrin Alpha V Beta 3, Administered by Subcutaneous Injection to Adults With Plaque Psoriasis|Completed||Phase 2|44|Actual|MedImmune LLC||2|||f||||||||||||||2017-10-11 05:30:49.045799|2017-10-11 05:30:49.045799
NCT00192543|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-08-03|||May 2004||2004-05-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Fish and Fruit Study: Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal Disease|A Clinical Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal Disease|Completed||Phase 3|152|Actual|Menzies School of Health Research||2|||f||||f||||||||||2017-10-11 05:30:49.191907|2017-10-11 05:30:49.191907
NCT00192712|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2010-11-09|||November 2002||2002-11-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|||||Interventional|||Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer|Phase II Study of Irinotecan and Gemcitabine (IrinoGem) Combined With 3-D Conformal Radiation Therapy for Locally Advanced Pancreatic Cancer|Completed||Phase 2/Phase 3|20||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:30:49.291831|2017-10-11 05:30:49.291831
NCT00192725|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2010-08-24|||March 2003||2003-03-01|September 2005|2005-09-01|June 2008|Actual|2008-06-01|October 2007|Actual|2007-10-01||Interventional|||Tryptophan Depletion in Acute Mania|Tryptophan Depletion in Acute Mania - A Randomized Controlled Trial|Completed||N/A|40|Anticipated|Rambam Health Care Campus||1|||f||||||||||||||2017-10-11 05:30:49.372168|2017-10-11 05:30:49.372168
NCT00192738|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-10|||April 2003||2003-04-01|April 2007|2007-04-01|January 2006|Actual|2006-01-01|||||Observational|||Does Telephone Follow-up Improve Patients Satisfaction|Does Telephone Follow-up After Discharge Improve Patients Satisfaction and Decrease Hospitalization|Completed||N/A|400||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:30:49.469474|2017-10-11 05:30:49.469474
NCT00192751|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-10-26|||February 2004||2004-02-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||From Compliance to Alliance: Engaging Psychiatric Patients in Illness Management|Impact of Psycho-Educational Intervention on Patients With Severe Mental Illness Recently Discharged From Psychiatric Inpatient Services|Unknown status|Recruiting|N/A|150||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:30:49.540082|2017-10-11 05:30:49.540082
NCT00192764|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-09-21|||December 1996||1996-12-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|||||Interventional|||High Dose CHOP in Lymphoma|Phase II Study of Short High-dose CHOP Chemotherapy for Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|45||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:30:49.623911|2017-10-11 05:30:49.623911
NCT00192777|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-05|||November 2004||2004-11-01|September 2005|2005-09-01||||||||Interventional|||Concurrent Xeloda and Radiotherapy for Bone Metastases|Concurrent Xeloda and Radiotherapy for Bone Metastases|Unknown status|Recruiting|Phase 2|20|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:30:49.693649|2017-10-11 05:30:49.693649
NCT00192790|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-10|||January 2004||2004-01-01|April 2007|2007-04-01|March 2005|Actual|2005-03-01|||||Observational|||Pain Perception is Attenuated in Patients With Painless Myocardial Infarction|Clinical and Experimental Pain Perception is Attenuated in Patients With Painless Myocardial Infarction|Completed||N/A|100||Rambam Health Care Campus|||||f||||t||||||||||2017-10-11 05:30:49.788137|2017-10-11 05:30:49.788137
NCT00192803|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-02-22||||||September 2005|2005-09-01||||||||Interventional|||Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs|ACE/ACE2 Ratio in Diabetic Patients Treated With Antihypertensive Drugs|Unknown status|Not yet recruiting|Phase 4|20||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:30:49.861758|2017-10-11 05:30:49.861758
NCT00192816|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2005||2005-06-01|September 2005|2005-09-01||||||||Observational|||Pain Perception in Alzheimer's Disease|Pain Perception in Alzheimer's Disease|Unknown status|Recruiting|N/A|60||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:30:49.948313|2017-10-11 05:30:49.948313
NCT00192829|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-10|||June 2005||2005-06-01|March 2007|2007-03-01||||||||Observational|||Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma|Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma|Unknown status|Recruiting|N/A|100||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:30:50.003277|2017-10-11 05:30:50.003277
NCT00192842|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-09-21|||July 2004||2004-07-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|November 2007|Actual|2007-11-01||Interventional|||Gemcitabine With Curcumin for Pancreatic Cancer|Phase II Trial of Gemcitabine and Curcumin in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|17|Actual|Rambam Health Care Campus|||||f||||f||||||||||2017-10-11 05:30:50.16027|2017-10-11 05:30:50.16027
NCT00192855|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-08-24|||June 2003||2003-06-01|September 2005|2005-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Entacapone Augmentation for Schizophrenia|Entacapone Augmentation for Schizophrenia- A Randomized Controlled Trial|Completed||N/A|52|Actual|Rambam Health Care Campus||1|||f||||||||||||||2017-10-11 05:30:50.221416|2017-10-11 05:30:50.221416
NCT00192868|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-09-22|||May 2005||2005-05-01|September 2009|2009-09-01|November 2011|Anticipated|2011-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction|Drug Elution and DIstal Protection During Percutaneous CoronAry Intervention in sT Elevation Myocardial InfarctiON. Acronym: Dedication|Unknown status|Active, not recruiting|N/A|600|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:50.291745|2017-10-11 05:30:50.291745
NCT00192881|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-17|||October 2002||2002-10-01|July 2010|2010-07-01||||||||Interventional|||Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease|Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease. A Randomised Comparison of Optimal Balloon Angioplasty and Primary Implantation of Stents With and Without Drug Elution in Complex Coronary Lesions|Unknown status|Not yet recruiting|N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:50.369333|2017-10-11 05:30:50.369333
NCT00192894|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||May 2004||2004-05-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Observational|||New Methods to Detect a Decrease in Heart Function|Cardiac Output Changes During Onset of Spinal Anesthesia in Elderly Patients|Completed||Phase 4|32||Rigshospitalet, Denmark|||||f||||||||||||||2017-10-11 05:30:50.587341|2017-10-11 05:30:50.587341
NCT00193011|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||March 2002||2002-03-01|May 2011|2011-05-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer|A Randomized Multicenter Trial Comparing Weekly Docetaxel and CMF in the Adjuvant Treatment of Women With High-Risk Breast Cancer Who Are > 65 Years Old or Are Not Candidates for Anthracycline-Based Adjuvant Therapy|Completed||Phase 3|150|Anticipated|SCRI Development Innovations, LLC||2|||f||||||||||||||2017-10-11 05:30:51.342604|2017-10-11 05:30:51.342604
NCT00193024|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||September 2001||2001-09-01|May 2011|2011-05-01|October 2004|Actual|2004-10-01|October 2003|Actual|2003-10-01||Interventional|||Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer|A Phase II Trial of Epirubicin/Docetaxel in the First-Line Treatment of Patients With Metastatic Breast Cancer|Terminated||Phase 2|90||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:51.457572|2017-10-11 05:30:51.457572
NCT00193037|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-24|2012-08-22||February 2001||2001-02-01|July 2013|2013-07-01|November 2009|Actual|2009-11-01|December 2008|Actual|2008-12-01||Interventional|||Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer|A Phase II Randomized Crossover Study Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer|Completed||Phase 2|102|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-10-11 05:30:51.573816|2017-10-11 05:30:51.573816
NCT00193050|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-08-22|2012-08-22||November 2001||2001-11-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer|Phase II Trial of Induction Chemotherapy With Weekly Gemcitabine, Epirubicin, Docetaxel as Primary Treatment of Locally Advanced or Inflammatory Breast Cancer Patients|Completed||Phase 2|110|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:52.05527|2017-10-11 05:30:52.05527
NCT00193063|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-02-10|2013-08-16||July 2001||2001-07-01|February 2014|2014-02-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|||Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer|Phase II Trial of Weekly Gemcitabine and Herceptin in the Treatment of Patients With HER-2 Overexpressing Metastatic Breast Cancer|Completed||Phase 2|41|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:52.324562|2017-10-11 05:30:52.324562
NCT00193076|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||November 2003||2003-11-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|May 2006|Actual|2006-05-01||Interventional|||Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer|A Phase II Trial of Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer|Completed||Phase 2|96|Anticipated|SCRI Development Innovations, LLC||1|||f||||||||||||||2017-10-11 05:30:52.605415|2017-10-11 05:30:52.605415
NCT00193089|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-09|||April 2001||2001-04-01|December 2015|2015-12-01|September 2009|Actual|2009-09-01|April 2005|Actual|2005-04-01||Interventional|||Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer|Phase II Trial of Weekly Docetaxel, Vinorelbine, and Herceptin in the First-Line Treatment of Patients With Metastatic Breast Cancer and Overexpression of Her-2|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||1|||f||||t||||||||||2017-10-11 05:30:52.687402|2017-10-11 05:30:52.687402
NCT00193102|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||April 2001||2001-04-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|February 2005|Actual|2005-02-01||Interventional|||Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer|Phase II Study of Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer|Terminated||Phase 2|40|Anticipated|SCRI Development Innovations, LLC||1|||f||||||||||||||2017-10-11 05:30:52.759743|2017-10-11 05:30:52.759743
NCT00193115|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-03|||March 2004||2004-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|June 2005|Actual|2005-06-01||Interventional|||Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer|Phase II Pilot Trial of Dose-Dense Docetaxel Followed by Doxorubicin Plus Cyclophosphamide (T-AC) Given as Adjuvant or Neoadjuvant Treatment for Women With Node Positive or High-Risk Primary Breast Cancer|Completed||Phase 2|32||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:52.829107|2017-10-11 05:30:52.829107
NCT00193128|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-03-26|2013-03-26||April 2004||2004-04-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|February 2008|Actual|2008-02-01||Interventional|||Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer|A Phase I/II Trial of Preoperative Oxaliplatin, Docetaxel, and Capecitabine With Concurrent Radiation Therapy in Localized Carcinoma of the Esophagus or Gastroesophageal Junction|Completed||Phase 1/Phase 2|59|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-10-11 05:30:52.92415|2017-10-11 05:30:52.92415
NCT00193141|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||October 1999||1999-10-01|May 2011|2011-05-01|July 2007|Actual|2007-07-01|October 2004|Actual|2004-10-01||Interventional|||Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer|Paclitaxel, Carboplatin, Infusional 5-Fluorouracil, and Radiation Therapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer|Completed||Phase 2|200||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:53.627319|2017-10-11 05:30:53.627319
NCT00193154|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-03-31|||February 2003||2003-02-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|January 2004|Actual|2004-01-01||Interventional|||OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma|A Phase II Trial of Tarceva (OSI-774) and Avastin (Bevacizumab) in the Treatment of Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|63|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:53.712093|2017-10-11 05:30:53.712093
NCT00193167|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||January 2004||2004-01-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer|Phase II Study of Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:53.852597|2017-10-11 05:30:53.852597
NCT00193180|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-04-27|2013-03-25||May 2005||2005-05-01|April 2016|2016-04-01|January 2009|Actual|2009-01-01|May 2008|Actual|2008-05-01||Interventional|||Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer|Phase II Trial of Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer|Completed||Phase 2|37|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:53.966789|2017-10-11 05:30:53.966789
NCT00194155|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-15|||May 2003||2003-05-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Cytomegalovirus (CMV) Infection in Pregnancy|Cytomegalovirus Infection and Pregnancy Outcomes|Completed||N/A|283|Actual|University of Pennsylvania|||1||f||||||||||||||2017-10-11 05:31:08.750986|2017-10-11 05:31:08.750986
NCT00193193|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-03|||August 2000||2000-08-01|July 2010|2010-07-01|February 2007|Actual|2007-02-01|December 2003|Actual|2003-12-01||Interventional|||Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma|A Randomized, Phase II Trial of Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin Administered Either Weekly or Every Four Weeks in the Treatment of Hormone Refractory Prostate Carcinoma|Completed||Phase 2|100||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:54.451754|2017-10-11 05:30:54.451754
NCT00193206|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-10-31|2012-08-22||September 2005||2005-09-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|||Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer|Phase II Trial of Dose Dense Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer|Completed||Phase 2|123|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:54.549046|2017-10-11 05:30:54.549046
NCT00193219|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-03-06|2012-12-07||July 2005||2005-07-01|March 2013|2013-03-01|July 2010|Actual|2010-07-01|June 2008|Actual|2008-06-01||Interventional|||Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer|A Randomized Phase II Study of Modified FOLFOX6 (Infusional 5-Fluorouracil/Leucovorin, Oxaliplatin) and Bevacizumab With or Without Cetuximab in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|36|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:54.94757|2017-10-11 05:30:54.94757
NCT00193232|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-27|||May 2004||2004-05-01|July 2010|2010-07-01|February 2007|Actual|2007-02-01|October 2005|Actual|2005-10-01||Interventional|||Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer|A Phase II Trial of Weekly Docetaxel and Bortezomib (Velcade; PS-341) in the Treatment of Patients With Advanced Hormone-Refractory Prostate Cancer|Completed||Phase 2|50||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:55.474547|2017-10-11 05:30:55.474547
NCT00193245|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-24|||November 2000||2000-11-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2005|Actual|2005-10-01||Interventional|||Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer|A Randomized Trial of Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer|Completed||Phase 2|80||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:55.564276|2017-10-11 05:30:55.564276
NCT00193258|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-01-24|2012-12-07||June 2004||2004-06-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma|A Phase I/II Trial of Bevacizumab (Avastin), Erlotinib (Tarceva), and Imatinib (Gleevec) in the Treatment of Patients With Advanced Renal Cell Carcinoma|Completed||Phase 1/Phase 2|94|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:55.688525|2017-10-11 05:30:55.688525
NCT00193271|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||August 2004||2004-08-01|May 2011|2011-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer|Adjuvant Chemotherapy (Docetaxel and Estramustine Phosphate) for High Risk Localized Prostate Cancer|Completed||Phase 2|30||SCRI Development Innovations, LLC|||||f||||f||||||||||2017-10-11 05:30:56.124265|2017-10-11 05:30:56.124265
NCT00193284|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-18|||October 2003||2003-10-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|February 2006|Actual|2006-02-01||Interventional|||Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer|A Phase I/II Trial of Induction Chemotherapy Plus Gefitinib (Iressa) Followed by Concurrent Chemotherapy, Radiation Therapy, and Gefitinib (Iressa) For Patients With Locally Advanced Squamous Carcinoma of the Head and Neck|Completed||Phase 2|50||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:56.222269|2017-10-11 05:30:56.222269
NCT00193297|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||February 2002||2002-02-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|June 2005|Actual|2005-06-01||Interventional|||Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma|A Phase II Study of a Three-Day Schedule of Topotecan Plus Paclitaxel and Carboplatin on Day Three in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma|Completed||Phase 2|50||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:56.304806|2017-10-11 05:30:56.304806
NCT00193310|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-17|||November 2000||2000-11-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|November 2003|Actual|2003-11-01||Interventional|||Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer|Preoperative (Neoadjuvant) or Postoperative (Adjuvant) Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer|Completed||Phase 2|250||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:56.380831|2017-10-11 05:30:56.380831
NCT00193323|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-24|||August 2001||2001-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|May 2006|Actual|2006-05-01||Interventional|||Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients|A Randomized Phase III Comparison of Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Elderly or Poor Performance Status Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|346||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:56.474331|2017-10-11 05:30:56.474331
NCT00193336|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||March 2003||2003-03-01|May 2011|2011-05-01|September 2005|Actual|2005-09-01|March 2004|Actual|2004-03-01||Interventional|||Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer|Phase II Trial of Single Agent ZD1839 (Iressa) in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|60||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:56.561857|2017-10-11 05:30:56.561857
NCT00193349|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-24|||September 2002||2002-09-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer|Phase II Evaluation of Gleevec Combined With Camptosar Plus Paraplatin in Patients With Previously Untreated Extensive Stage SCLC|Completed||Phase 2|60||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:56.64596|2017-10-11 05:30:56.64596
NCT00193362|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-27|||June 2004||2004-06-01|July 2010|2010-07-01|September 2007|Actual|2007-09-01|June 2005|Actual|2005-06-01||Interventional|||Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer|Phase III Randomized Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine as First-Line Chemotherapy for Stage IIIB and IV Non-Small Cell Lung Cancer|Completed||Phase 3|200||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:56.746462|2017-10-11 05:30:56.746462
NCT00193375|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-06-29|2012-10-05||August 2003||2003-08-01|June 2016|2016-06-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer|Phase II Trial of Concurrent Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab (Avastin) in the Treatment of Patients With Limited Stage Small Cell Lung Cancer|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:56.861388|2017-10-11 05:30:56.861388
NCT00193388|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-27|||September 2002||2002-09-01|July 2010|2010-07-01|February 2007||2007-02-01|December 2004|Actual|2004-12-01||Interventional|||Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer|Phase II Trial of Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer|Completed||Phase 2|100||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:57.308481|2017-10-11 05:30:57.308481
NCT00193401|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-27|||August 2002||2002-08-01|July 2010|2010-07-01|November 2004||2004-11-01|June 2004|Actual|2004-06-01||Interventional|||Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer|Phase II Trial of Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:57.411658|2017-10-11 05:30:57.411658
NCT00193414|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-10-11|2012-10-11||May 2005||2005-05-01|October 2012|2012-10-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer|Phase II Study of First-Line Therapy With Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|74|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:57.491222|2017-10-11 05:30:57.491222
NCT00193427|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-10-11|2012-10-11||April 2004||2004-04-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer|Phase II Trial of Preoperative (Neo-adjuvant) Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|76|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:57.827098|2017-10-11 05:30:57.827098
NCT00193440|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-12-29|||April 2002||2002-04-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|April 2004|Actual|2004-04-01||Interventional|||Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma|Phase II Trial of Rituximab and Short Duration Chemotherapy Followed by Zevalin as First-Line Treatment for Patients With Low Grade Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:58.166463|2017-10-11 05:30:58.166463
NCT00193453|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-10-11|2012-10-11||July 2005||2005-07-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|||Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer|A Phase II Trial of First-Line Therapy With Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Stage III or IV Non-Small Cell Lung Cancer|Completed||Phase 2|69|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:58.260896|2017-10-11 05:30:58.260896
NCT00193466|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-12-29|||January 2002||2002-01-01|December 2010|2010-12-01|April 2008|Actual|2008-04-01|January 2007|Actual|2007-01-01||Interventional|||Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase II Trial of Rituximab/Fludarabine Followed by CAMPATH-1H in the First-Line Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:58.643497|2017-10-11 05:30:58.643497
NCT00193479|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-01-08|2014-01-08||April 2003||2003-04-01|January 2014|2014-01-01|February 2010|Actual|2010-02-01|July 2008|Actual|2008-07-01||Interventional|||Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma|A Phase II Trial of Brief Duration Combination Chemotherapy and Rituximab With Prophylactic Pegfilgrastim, Followed by Maintenance Rituximab, in Elderly/Poor Performance Status Patients With Large B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|51|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:30:58.735251|2017-10-11 05:30:58.735251
NCT00193492|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2014-12-11|2014-12-05||September 2005||2005-09-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma|Rituximab +/- Bevacizumab in the Treatment of Patients With Follicular Non-Hodgkin's Lymphoma: A Randomized, Phase II Trial|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||2|||f||||t||||||||||2017-10-11 05:30:59.189044|2017-10-11 05:30:59.189044
NCT00193505|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||October 2003||2003-10-01|May 2011|2011-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma|Phase II Trial of Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in the Treatment of Patients With Relapsed/Refractory Intermediate Grade B-Cell Lymphoma|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||f||||||||||2017-10-11 05:30:59.692481|2017-10-11 05:30:59.692481
NCT00193518|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-02|||April 2004||2004-04-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|A Phase II Trial Of Arsenic Trioxide (TRISENOX) In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Completed||Phase 2|41||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:59.767287|2017-10-11 05:30:59.767287
NCT00193531|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-28|||December 1998||1998-12-01|October 2008|2008-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma|Phase II Study of Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in the Treatment of High Grade Neuroendocrine Carcinoma|Completed||Phase 2|100||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:59.835919|2017-10-11 05:30:59.835919
NCT00193544|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-01-21|||March 2002||2002-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2005|Actual|2005-10-01||Interventional|||Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma|Phase II Trial of Arsenic Trioxide and Thalidomide in the Treatment of Patients With Refractory Multiple Myeloma|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:59.920931|2017-10-11 05:30:59.920931
NCT00193557|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-28|||May 2004||2004-05-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|May 2006|Actual|2006-05-01||Interventional|||Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma|Phase I Trial of Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:30:59.98557|2017-10-11 05:30:59.98557
NCT00193570|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-01-22|||February 2002||2002-02-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|August 2004|Actual|2004-08-01||Interventional|||Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors|A Phase I Study of Topotecan in Combination With Docetaxel in Patients With Refractory and/or Advanced Solid Tumors|Completed||Phase 1|20||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:31:00.073041|2017-10-11 05:31:00.073041
NCT00193583|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-03|||May 2003||2003-05-01|May 2011|2011-05-01|May 2005|Actual|2005-05-01|May 2004|Actual|2004-05-01||Interventional|||Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors|A Phase I Study of Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Patients With Refractory and/or Advanced Solid Tumors|Completed||Phase 1|18||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:31:00.139669|2017-10-11 05:31:00.139669
NCT00193596|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-03-22|2013-01-14||September 2003||2003-09-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|September 2008|Actual|2008-09-01||Interventional|||Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site|A Randomized, Phase III Comparison of Gemcitabine/Irinotecan Followed by IRESSA Versus Paclitaxel/Carboplatin/Etoposide Followed by IRESSA in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site|Completed||Phase 3|198|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-10-11 05:31:00.247068|2017-10-11 05:31:00.247068
NCT00193609|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-10-18|2013-08-15||September 2004||2004-09-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|April 2008|Actual|2008-04-01||Interventional|||Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site|A Phase II Trial of Oxaliplatin and Capecitabine in the Treatment of Patients With Relapsed/Refractory Carcinoma of Unknown Primary Site|Completed||Phase 2|48|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-10-11 05:31:00.889382|2017-10-11 05:31:00.889382
NCT00193622|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-09-15|||April 2004||2004-04-01|September 2010|2010-09-01|January 2009|Actual|2009-01-01|September 2005|Actual|2005-09-01||Interventional|||Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site|A Phase II Trial of Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site|Completed||Phase 2|50||SCRI Development Innovations, LLC|||||f||||||||||||||2017-10-11 05:31:01.167553|2017-10-11 05:31:01.167553
NCT00193635|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-10-17|||March 2002||2002-03-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Pilot Study of Mycophenolate Mofetil in Congenital Uropathies|Pilot Study of Mycophenolate Mofetil in Congenital Uropathies|Completed||Phase 1|12|Actual|Northwell Health||1|||f||||t||||||||||2017-10-11 05:31:01.415467|2017-10-11 05:31:01.415467
NCT00193648|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2007-10-19|||July 2005||2005-07-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)|Novel Therapies for Resistant FSGS|Completed||Phase 1|21|Actual|Northwell Health||2|||f||||t||||||||||2017-10-11 05:31:01.548638|2017-10-11 05:31:01.548638
NCT00193661|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-01-15|||August 2002||2002-08-01|September 2006|2006-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism|A Multi-Center, Open-Label, Observational Study of Testosterone Gel (1%) in the Treatment of Adolescent Boys With Hypogonadism|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:31:01.676897|2017-10-11 05:31:01.676897
NCT00193674|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-08-25|||September 2003||2003-09-01|August 2011|2011-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage|Oral Dydrogesterone Treatment During the First Trimester of Pregnancy in Women With Recurrent Miscarriage: A Double-Blind, Prospectively Randomized, Placebo-Controlled, Parallel Group Trial|Completed||Phase 3|71|Actual|Abbott||2|||f||||f||||||||||2017-10-11 05:31:01.828232|2017-10-11 05:31:01.828232
NCT00193687|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2008-03-20|||September 2005||2005-09-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Bifeprunox in the Treatment of Schizophrenia|An Open-Label, Flexible-Dose, Long-Term Safety and Efficacy Study of Bifeprunox in the Treatment of Schizpohrenia (Extension of S154.3.001)|Completed||Phase 3|986|Actual|Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:31:01.950431|2017-10-11 05:31:01.950431
NCT00193700|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2006-12-23|||August 2002||2002-08-01|November 2006|2006-11-01||||||||Interventional|||Pharmacokinetic Evaluation of Testosterone Gel (1%)|Pharmacokinetic Evaluation of Testosterone Gel (1%) in Prepubertal Boys of Adolescent Age|Completed||Phase 1|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:31:02.038139|2017-10-11 05:31:02.038139
NCT00193713|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-01-15|||May 2005||2005-05-01|January 2007|2007-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Bifeprunox in the Treatment of Schizophrenia|A Randomized, Double-Blind, Olanzapine-Referenced, Parallel-Group Safety and Efficacy Study of Flexible Doses of Bifeprunox in the Long-term Treatment of Schizpohrenia (Extension of S1543003)|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:31:02.18638|2017-10-11 05:31:02.18638
NCT00193726|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2016-10-25|||July 2005||2005-07-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer|Estrogen Priming to Increase the Efficacy of Standard Adjuvant Chemotherapy in Operable Breast Cancer.|Recruiting||Phase 3|730|Anticipated|Tata Memorial Hospital||2|||f||||f||||||||Undecided||2017-10-11 05:31:02.260136|2017-10-11 05:31:02.260136
NCT00193739|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-11-06|||September 2003||2003-09-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NACTcervix||Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix|A Prospective Randomized Trial of Neoadjuvant Chemotherapy and Surgery Versus Concurrent Chemoradiation Therapy in Patients With Stage IB2-IIB Squamous Carcinoma of the Uterine Cervix|Recruiting||Phase 3|730|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||||2017-10-11 05:31:02.388589|2017-10-11 05:31:02.388589
NCT00194168|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-15|||June 2000||2000-06-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Ectopic Pregnancy Biomarkers|Serum Bank for Assessment of Markers of Ectopic Pregnancy|Completed||N/A|1306|Actual|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Blood (Plasma, Serum)   "|||2017-10-11 05:31:08.829573|2017-10-11 05:31:08.829573
NCT00193752|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-26|||September 2005||2005-09-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix|Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Advanced Cervical Cancer|Active, not recruiting||N/A|100|Anticipated|Tata Memorial Hospital|||1||f||||t||||||||Undecided||2017-10-11 05:31:02.51451|2017-10-11 05:31:02.51451
NCT00193765|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-15|||January 2004||2004-01-01|June 2017|2017-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity|Elective Versus Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Cell Carcinoma of the Oral Cavity|Active, not recruiting||N/A|710|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||No||2017-10-11 05:31:02.597179|2017-10-11 05:31:02.597179
NCT00193778|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-10-18|||February 2005||2005-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation|A Randomized Trial To Assess The Impact Of Loco-Regional Treatment On Survival Of Patients With Metastatic Breast Cancer At First Presentation|Active, not recruiting||Phase 3|350|Actual|Tata Memorial Hospital||2|||f||||t||||||||||2017-10-11 05:31:02.709662|2017-10-11 05:31:02.709662
NCT00193791|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-26|||July 2003||2003-07-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|CRACx||Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix|Concomitant Chemo-radiation in Advanced Stage Carcinoma Cervix: A Phase III Randomized Trial|Active, not recruiting||Phase 3|850|Actual|Tata Memorial Hospital||2|||f||||t||||||||Yes|Individual patient data (IPD) related to patient characteristics, treatment and outcome variables.|2017-10-11 05:31:02.808921|2017-10-11 05:31:02.808921
NCT00193804|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-26|||February 2005||2005-02-01|March 2017|2017-03-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix|A Phase II Randomized Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix|Active, not recruiting||N/A|200|Anticipated|Tata Memorial Hospital|||1||f||||t||||||||Undecided||2017-10-11 05:31:02.899521|2017-10-11 05:31:02.899521
NCT00193817|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-02-06|||January 2005||2005-01-01|July 2005|2005-07-01|December 2015||2015-12-01|||||Interventional|||Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial||Unknown status|Recruiting|Phase 3|700||Tata Memorial Hospital|||||f||||||||||||||2017-10-11 05:31:03.016907|2017-10-11 05:31:03.016907
NCT00193830|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-05|||May 1996||1996-05-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix|High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix|Completed||Phase 3|750||Tata Memorial Hospital|||||f||||||||||||||2017-10-11 05:31:03.110201|2017-10-11 05:31:03.110201
NCT00193843|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-23|||June 2005||2005-06-01|September 2005|2005-09-01|June 2017||2017-06-01|||||Interventional|||Oral Cancer Adjuvant Therapy (OCAT) Trial|Phase III Trial of Surgery Followed by Conventional RT(5fr/Week)Vs.Concurrent Chemo-Radiotherapy Vs.Accelerated RT(6fr/Week)in High Risk, Loco-Regionally Advanced, Stage III&IVA, Resectable, Squamous Cell Carcinomas of Oralcavity|Unknown status|Recruiting|Phase 3|900||Tata Memorial Hospital|||||f||||||||||||||2017-10-11 05:31:03.190822|2017-10-11 05:31:03.190822
NCT00193869|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-05-08|||September 2001||2001-09-01|May 2007|2007-05-01|December 2003|Actual|2003-12-01|||||Interventional|||SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).|A Pilot Randomised Comparison of Dexamethasone 96 mg Versus 16 mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy|Completed||Phase 2|20|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-10-11 05:31:03.5499|2017-10-11 05:31:03.5499
NCT00193882|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-07-10|||July 7, 2003||2003-07-07|July 2017|2017-07-01|June 18, 2013|Actual|2013-06-18|March 21, 2012|Actual|2012-03-21||Interventional|||Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.|A Randomised Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated With Radiotherapy vs ChemoRadiotherapy.|Completed||Phase 3|220|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||t||||||||||2017-10-11 05:31:03.647427|2017-10-11 05:31:03.647427
NCT00193895|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-07-12|||April 2005||2005-04-01|July 2017|2017-07-01|March 31, 2016|Actual|2016-03-31|March 2016|Actual|2016-03-01||Interventional|||Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck|Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy in High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|321|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-10-11 05:31:03.82534|2017-10-11 05:31:03.82534
NCT00193908|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-05-13|||March 2004||2004-03-01|May 2009|2009-05-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||"Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine (Sorbolene) Cream"|"A Paired Double Blind Randomised Comparison of Cavilon(TM) Durable Barrier Cream(TM)[CDBC] to 10% Glycerine (Sorbolene) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care"|Completed||Phase 3|333|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-10-11 05:31:03.972402|2017-10-11 05:31:03.972402
NCT00193921|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-07-31|||February 2003||2003-02-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2009|Actual|2009-12-01||Interventional|||Chemoradiotherapy in Patients With Localised Lung Cancer|A Randomised Phase II Study of Two Regimens of Palliative Chemoradiation Therapy in the Management of Locally Advanced Non Small Cell Lung Cancer|Completed||Phase 2|82|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-10-11 05:31:04.102686|2017-10-11 05:31:04.102686
NCT00193934|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-07-10|||January 2006||2006-01-01|July 2017|2017-07-01|May 15, 2014|Actual|2014-05-15|May 2014|Actual|2014-05-01||Observational|||Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer|Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer|Completed||N/A|109|Actual|Trans-Tasman Radiation Oncology Group (TROG)|||1||f||||f||||||||||2017-10-11 05:31:04.215487|2017-10-11 05:31:04.215487
NCT00193947|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-08-02|||November 2003||2003-11-01|April 2007|2007-04-01|May 2008|Actual|2008-05-01|||||Observational|||An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy|An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy|Terminated||Phase 4|56|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 05:31:04.315698|2017-10-11 05:31:04.315698
NCT00193960|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-29|||January 1997||1997-01-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Observational|||The Results of Ahmed Valve Operations|A Comparison Between Superior and Inferior Ahmed Glaucoma Valve Implantation: Surgical Success and Complications|Unknown status|Recruiting|N/A|80||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:04.385111|2017-10-11 05:31:04.385111
NCT00193973|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-15|||July 2001||2001-07-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|July 2008|Actual|2008-07-01||Interventional|||Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma|A Phase 2 Study of Idarubicin Based Combined Modality Therapy in Primary Central Nervous System Lymphoma|Completed||Phase 2|20|Actual|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||f||||||||||2017-10-11 05:31:04.47128|2017-10-11 05:31:04.47128
NCT00193986|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-11-13|||May 2005||2005-05-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Assessment of Prepulse Inhibition for Shock Pain Reduction|Assessment of Prepulse Inhibition for Shock Pain Reduction- Ventricular|Completed||N/A|10||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:04.620958|2017-10-11 05:31:04.620958
NCT00193999|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-10-26|||February 2003||2003-02-01|September 2008|2008-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Do Nasogastric Tubes After Cardiac Surgery Reduce Nausea and Vomiting|Do Nasogastric Tubes After Cardiac Surgery Reduce Nausea and Vomiting. A Prospective Randomized Clinical Trial.|Completed||Phase 4|300|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:04.682808|2017-10-11 05:31:04.682808
NCT00194012|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2017-06-02|2013-06-26||August 2004||2004-08-01|June 2017|2017-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder|Aripiprazole in At-Risk Children With Symptoms of Bipolar Disorder|Completed||Phase 3|62|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 05:31:04.760352|2017-10-11 05:31:04.760352
NCT00194025|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-16|2009-01-26||November 2004||2004-11-01|February 2011|2011-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Valproate in Late Life Schizophrenia|Add-on Valproate in Late Life Schizophrenia|Completed||Phase 4|20|Actual|University Hospitals Cleveland Medical Center|The findings of this study must be interpreted cautiously given the limitations of small sample size, open-label, add-on design and lack of a control or comparator group. The mean age of 61 years is not representative of the “old-old” populations.|1|||f||||f||||||||||2017-10-11 05:31:05.395771|2017-10-11 05:31:05.395771
NCT00194038|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-16|||April 2004||2004-04-01|January 2010|2010-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Aripiprazole in Late Life Bipolar Disorder|Aripiprazole in Late Life Bipolar Disorder|Completed||Phase 4|20|Actual|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-10-11 05:31:07.455172|2017-10-11 05:31:07.455172
NCT00194051|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-05|||February 2003||2003-02-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Observational|||Symptomatic, Biomechanical and Radiographic Outcomes in Knee Osteoarthritis Following Gastric Bypass Surgery|Symptomatic, Biomechanical and Radiographic Outcomes in Knee Osteoarthritis Following Gastric Bypass Surgery|Unknown status|Active, not recruiting|N/A|35||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-10-11 05:31:07.539645|2017-10-11 05:31:07.539645
NCT00194064|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-03|||July 2002||2002-07-01|October 2016|2016-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine|Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania|Terminated||Phase 3|18|Actual|University Hospitals Cleveland Medical Center||1||Slow enrollment|f||||t||||||||||2017-10-11 05:31:07.597976|2017-10-11 05:31:07.597976
NCT00194077|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2014-12-17|2013-06-26||August 2004||2004-08-01|December 2014|2014-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||No differences.|Study of Aripiprazole (Abilify) in Children With Symptoms of Mania|Aripiprazole in Children With Symptoms of Mania|Completed||Phase 3|60|Actual|University Hospitals Cleveland Medical Center|No deaths occured during this study.|2|||f||||t||||||||||2017-10-11 05:31:07.672483|2017-10-11 05:31:07.672483
NCT00194090|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2004||2004-06-01|July 2004|2004-07-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Celecoxib Vs Placebo to Prevent Pain in a Paced Walk|A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy of Celecoxib 200 Mg Qd in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee|Unknown status|Recruiting|Phase 4|40||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-10-11 05:31:07.912077|2017-10-11 05:31:07.912077
NCT00194103|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-25|||May 2004||2004-05-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|August 2009|Actual|2009-08-01||Interventional|ETM||Effectiveness of Extended Telephone Monitoring||Completed||Phase 3|252|Actual|University of Pennsylvania||3|||f||||||||||||||2017-10-11 05:31:08.007783|2017-10-11 05:31:08.007783
NCT00194116|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-01|||September 2004||2004-09-01|December 2014|2014-12-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression|Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression|Completed||Phase 3|30|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 05:31:08.21525|2017-10-11 05:31:08.21525
NCT00194129|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-04|2013-11-04||November 1997||1997-11-01|November 2013|2013-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder|A Randomized, Double Blind Comparison of Lithium Monotherapy Versus Lithium Plus Divalproex for the Outpatient Management of Hypomania/Mania in Patients With Rapid Cycling Bipolar Disorder Comorbid With Substance Abuse/Dependence|Completed||Phase 3|31|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 05:31:08.317946|2017-10-11 05:31:08.317946
NCT00194181|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-14|||March 2003||2003-03-01|July 2006|2006-07-01|March 2005||2005-03-01|||||Interventional|||Rt-PA Infusion Versus Catheter Exchange for Dialysis Catheter Malfunction Due to Fibrin Sheath|Randomized Prospective Trial of Rt-PA Infusion Versus Catheter Exchange for Treatment of Dialysis Catheter Malfunction Due to Fibrin Sheath Formation|Terminated||N/A|40||University of Pennsylvania|||||f||||||||||||||2017-10-11 05:31:08.903035|2017-10-11 05:31:08.903035
NCT00194194|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-03-13|||August 2004||2004-08-01|October 2008|2008-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Healthetech, Inc. SMART Study|The Effect of Measuring Resting Metabolic Rate (RMR) in the Context of Moderate or Intensive Behavior Modification Treatment on Weight Loss|Completed||Phase 2|56|Actual|Temple University||2|||f||||f||||||||||2017-10-11 05:31:08.972422|2017-10-11 05:31:08.972422
NCT00194207|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-15|||October 1999||1999-10-01|August 2016|2016-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Risk Factors of Ectopic Pregnancy|Risk Factors as Predictors of Ectopic PRegnancy|Completed||N/A|3000|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples Without DNA|"     Serum   "|||2017-10-11 05:31:09.087746|2017-10-11 05:31:09.087746
NCT00194220|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-28|||September 2002||2002-09-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|July 2012|Actual|2012-07-01||Observational|||Infertility Markers in Serum, Urine, and Follicular Fluid|Markers in Women Undergoing Infertility Treatment|Completed||N/A|1235|Actual|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"     Blood, Urine, Follicular Fluid   "|||2017-10-11 05:31:09.175868|2017-10-11 05:31:09.175868
NCT00194233|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-15|||November 2003||2003-11-01|August 2016|2016-08-01|June 2008|Actual|2008-06-01|January 2007|Actual|2007-01-01||Observational|||Serum and Peritoneal Fluid Bank for Endometriosis Markers|Serum and Peritoneal Fluid Bank for Assessment of Markers of Endometriosis|Completed||N/A|300|Anticipated|University of Pennsylvania|||1||f||||||||||Samples With DNA|"     Serum, Plasma, Peritoneal fluid   "|||2017-10-11 05:31:09.27417|2017-10-11 05:31:09.27417
NCT00194246|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-28|||August 2003||2003-08-01|August 2007|2007-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Cognitive Function and Cue-Reactivity Study|Cognitive Performance and Food Reactivity During High and Low Carbohydrate Obesity Treatment|Completed||N/A|29|Actual|Temple University|||1||f||||f||||||Samples Without DNA|"     salivary cortisol   "|||2017-10-11 05:31:09.346467|2017-10-11 05:31:09.346467
NCT00194259|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-03-05|||August 2001||2001-08-01|January 2008|2008-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Sleep Apnea in Look AHEAD (Action for Health in Diabetes)|Sleep Apnea in Look AHEAD (Action for Health in Diabetes)|Unknown status|Active, not recruiting|N/A|320|Anticipated|Temple University|||1||f||||t||||||Samples Without DNA|"     Saliva Samples   "|||2017-10-11 05:31:09.413692|2017-10-11 05:31:09.413692
NCT00194272|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-08|||March 2001||2001-03-01|August 2011|2011-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Two-Dose Methotrexate for Ectopic Pregnancy|Two-Dose Methotrexate for Ectopic Pregnancy|Completed||Phase 3|100|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-10-11 05:31:09.494287|2017-10-11 05:31:09.494287
NCT00194285|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-28|||March 2001||2001-03-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||FDG-PET Imaging in Painful Joint Prosthesis|FDG-PET Imaging in Painful Joint Prosthesis (Protocol Amendment, Version 11, Dated 9/2005)|Active, not recruiting||N/A|530|Anticipated|University of Pennsylvania|||1||f||||||||||||||2017-10-11 05:31:09.586121|2017-10-11 05:31:09.586121
NCT00194298|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-28|||October 2002||2002-10-01|April 2017|2017-04-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||FDG-PET Imaging in Complicated Diabetic Foot|FDG-PET Imaging in Complicated Diabetic Foot (Protocol Version Dated 3/01/2004)|Active, not recruiting||N/A|240|Anticipated|University of Pennsylvania|||1||f||||||||||||||2017-10-11 05:31:09.655254|2017-10-11 05:31:09.655254
NCT00194311|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-15|||April 2005||2005-04-01|August 2016|2016-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Human Papillomavirus (HPV) Infection in Pregnancy||Completed||N/A|620|Anticipated|University of Pennsylvania|||1||f||||||||||||||2017-10-11 05:31:09.731886|2017-10-11 05:31:09.731886
NCT00194324|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-08|||July 2004||2004-07-01|August 2011|2011-08-01|October 2004|Actual|2004-10-01|||||Interventional|||Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina|Vaginal Imaging Study to Evaluate the Effect of Exercise on the Distribution of Miconozole Nitrate OVULE|Completed||Phase 4|12||University of Pennsylvania|||||f||||f||||||||||2017-10-11 05:31:09.795652|2017-10-11 05:31:09.795652
NCT00194337|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-24|||October 1999||1999-10-01|January 2007|2007-01-01||||July 2012|Actual|2012-07-01||Interventional|||Digital Mammography, Ultrasound, MRI, and PET Scans in Women With Newly Diagnosed Breast Cancer|Evaluation of Multimodality Breast Imaging: Project 3-Lesion Staging|Unknown status|Active, not recruiting|Phase 2/Phase 3|400|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||||||||||||2017-10-11 05:31:09.868432|2017-10-11 05:31:09.868432
NCT00194350|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-08|||September 2001||2001-09-01|August 2011|2011-08-01|August 2005|Actual|2005-08-01|||||Observational|||Factor V Leiden Mutation and Implantation Failure|Evaluation of the Role of Factor V Leiden Mutation in Implantation Failure|Completed||N/A|399||University of Pennsylvania|||1||f||||f||||||||||2017-10-11 05:31:09.947323|2017-10-11 05:31:09.947323
NCT00194363|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-07-25|||October 2005||2005-10-01|July 2017|2017-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Strength Training Intervention for Breast Cancer Survivors and the Effects on Lymphedema Status|The PAL Trial (Physical Activity and Lymphedema)|Completed||N/A|295|Actual|Milton S. Hershey Medical Center||1|||f||||t||||||||||2017-10-11 05:31:10.08994|2017-10-11 05:31:10.08994
NCT00194376|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-09-22|||June 2005||2005-06-01|September 2010|2010-09-01|June 2007|Actual|2007-06-01|September 2006|Actual|2006-09-01||Interventional|||Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea|Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea|Completed||N/A|10|Anticipated|University of Pennsylvania||1|||f||||||||||||||2017-10-11 05:31:10.256465|2017-10-11 05:31:10.256465
NCT00194402|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-08-20|||August 2003||2003-08-01|August 2008|2008-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia|SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers|Completed||Phase 4|64|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:31:10.327108|2017-10-11 05:31:10.327108
NCT00194415|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-29|||January 2004||2004-01-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study of HSV Testing Among Pregnant Women|A Randomized Clinical Trial of Antenatal vs Delayed (Post Partum) Testing for HSV Type-Specific Antibodies Among Pregnant Women.|Terminated||N/A|173|Actual|University of Washington||2||An interim data analysis found no significant difference between testing groups.|f||||f||||||||||2017-10-11 05:31:10.415721|2017-10-11 05:31:10.415721
NCT00194428|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-03-26|||February 2005||2005-02-01|January 2008|2008-01-01|October 2009|Actual|2009-10-01|October 2007|Actual|2007-10-01||Interventional|||Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons|Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons|Completed||Phase 1/Phase 2|123|Actual|Temple University||2|||f||||f||||||||||2017-10-11 05:31:10.499903|2017-10-11 05:31:10.499903
NCT00194441|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-29|||April 1999||1999-04-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Cerebral Perfusion Pressure (CPP) Management Information Feedback and Nursing|CPP Management Information Feedback and Nursing|Completed||N/A|260|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:31:10.598879|2017-10-11 05:31:10.598879
NCT00194454|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-21|||March 2002||2002-03-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Psychosocial/Behavioral Intervention in Post-Stroke Depression|Psychosocial/Behavioral Intervention in PSD|Completed||N/A|101|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:31:10.704426|2017-10-11 05:31:10.704426
NCT00194467|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-29|||December 2002||2002-12-01|December 2007|2007-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Suppression of Oral HHV8 Shedding With Valganciclovir|Suppression of Oral Shedding of Human Herpesvirus 8 (HHV-8) With Valganciclovir|Completed||Phase 2|32|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 05:31:10.792629|2017-10-11 05:31:10.792629
NCT00194480|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-01-11|||April 2003||2003-04-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users|Treatment of Acute Hepatitis C Virus Infection in Injection Drug Users With Pegylated Interferon for 24 Weeks|Completed||Phase 4|21|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-10-11 05:31:10.876683|2017-10-11 05:31:10.876683
NCT00194493|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-04-30|||April 2005||2005-04-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|ESRA-C||Computerized Assessment for Patients With Cancer|Computerized Assessment for Patients With Cancer|Completed||Phase 3|1058|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-10-11 05:31:10.969545|2017-10-11 05:31:10.969545
NCT00194506|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-04-12|||August 2002||2002-08-01|April 2006|2006-04-01|May 2006||2006-05-01|||||Interventional|||Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home|Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home|Completed||N/A|82||University of Washington|||||f||||||||||||||2017-10-11 05:31:11.064292|2017-10-11 05:31:11.064292
NCT00194519|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-03-16|||November 2004||2004-11-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|||Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission|Phase III Randomized Placebo-Controlled Trial of HSV-2 Suppression to Prevent HIV Transmission Among HIV-Discordant Couples|Completed||Phase 3|3408|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 05:31:11.142921|2017-10-11 05:31:11.142921
NCT00194532|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-06-03|2011-03-30||June 2005||2005-06-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Cefpodoxime vs Ciprofloxacin for Acute Cystitis|Cefpodoxime vs Ciprofloxacin for Acute Cystitis|Completed||N/A|300|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 05:31:11.280401|2017-10-11 05:31:11.280401
NCT00194545|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-07-05|||July 2004||2004-07-01|July 2012|2012-07-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children|Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children|Completed||Phase 2|100|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:31:11.594407|2017-10-11 05:31:11.594407
NCT00194558|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-30|||February 2005||2005-02-01|September 2008|2008-09-01||||||||Interventional|||Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care|Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care|Completed||N/A|82|Actual|University of Washington|||||f||||||||||||||2017-10-11 05:31:11.702331|2017-10-11 05:31:11.702331
NCT00194571|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-19|||June 1999||1999-06-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|EC R01||Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child|Helping the Mother With Breast Cancer Support Her Child|Completed||Phase 3|181|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 05:31:11.781522|2017-10-11 05:31:11.781522
NCT00194584|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-25|||October 2004||2004-10-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|||||Interventional|||Childhood Chronic Illness: An Educational Program for Parents of Children With On-Going Health Care Needs|Building on Family Strengths: An Educational Program for Parents of Children With On-Going Health Care Needs|Completed||N/A|129|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:31:11.859071|2017-10-11 05:31:11.859071
NCT00194597|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-21|||July 2004||2004-07-01|October 2008|2008-10-01|July 2007||2007-07-01|||||Interventional|||Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III|Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III|Terminated||Phase 4|30||University of Washington||||Illness of PI forced termination.|||||||||||||||2017-10-11 05:31:11.941904|2017-10-11 05:31:11.941904
NCT00194610|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-12|2010-12-29||May 2004||2004-05-01|September 2012|2012-09-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|||Botox as a Treatment for Interstitial Cystitis in Women|Botox (Botulinum Toxin A) as a Treatment for Interstitial Cystitis in Women: A Randomized Placebo Controlled Trial|Completed||Phase 4|20|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:31:12.014437|2017-10-11 05:31:12.014437
NCT00194623|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-17|||August 2003||2003-08-01|October 2007|2007-10-01|August 2007||2007-08-01|||||Interventional|||Botox as a Treatment for Chronic Male Pelvic Pain Syndrome|Botox (Botulinum Toxin A) as a Treatment for Chronic Male Pelvic Pain Syndrome: A Randomized Placebo Controlled Trial|Terminated||Phase 4|30||University of Washington||||Reorganization of personnel forced termination.|f||||||||||||||2017-10-11 05:31:12.237597|2017-10-11 05:31:12.237597
NCT00194636|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-05|||November 2003||2003-11-01|October 2007|2007-10-01|November 2006||2006-11-01|||||Interventional|||Effectiveness of Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)|Effectiveness 0f Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)|Suspended||Phase 4|20||University of Washington||||PI health issues|f||||||||||||||2017-10-11 05:31:12.302278|2017-10-11 05:31:12.302278
NCT00194649|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-18|||June 2005||2005-06-01|September 2008|2008-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|MIG-2||Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study (MIG 2)|Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study|Completed||Phase 4|8|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 05:31:12.379947|2017-10-11 05:31:12.379947
NCT00194675|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-16|2012-05-02||March 2005||2005-03-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|TRADE||TRADE-Testosterone Replacement and Dutasteride Effectiveness|Testosterone Replacement and Dutasteride Effectiveness (TRADE)|Completed||Phase 4|53|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 05:31:12.50114|2017-10-11 05:31:12.50114
NCT00194688|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-01-02|||March 2003||2003-03-01|January 2008|2008-01-01|June 2005||2005-06-01|||||Interventional|||Breath Ammonia Method for H. Pylori Detection: Phase II|Breath Ammonia Method for H. Pylori Detection: Phase II|Completed||Phase 2|278||University of Washington|||||f||||||||||||||2017-10-11 05:31:13.195083|2017-10-11 05:31:13.195083
NCT00194701|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-01-02|||April 1998||1998-04-01|January 2008|2008-01-01|March 2002||2002-03-01|||||Interventional|||Exercise to Improve Sleep in Heart Failure|Exercise to Improve Sleep in Heart Failure|Completed||Phase 3|152||University of Washington||2|||f||||||||||||||2017-10-11 05:31:13.274365|2017-10-11 05:31:13.274365
NCT00194714|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-04|||May 2016||2016-05-01|January 2017|2017-01-01||||May 2018|Anticipated|2018-05-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab|Phase I/II Study of Combination Immunotherapy for the Generation of HER-2/Neu (HER2) Specific Cytotoxic T Cells (CTL) in Vivo|Enrolling by invitation||Phase 1/Phase 2|20|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 05:31:13.355664|2017-10-11 05:31:13.355664
NCT00194727|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-12|||May 2002||2002-05-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer|Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer: A Phase II Trial With Molecular Correlates|Completed||Phase 2|40|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 05:31:13.475315|2017-10-11 05:31:13.475315
NCT00194740|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-12-03|||November 1997||1997-11-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer|Taxotere Plus Weekly Navelbine and G-CSF: A Phase II Study in Stage IV Breast Cancer|Completed||Phase 2|48|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 05:31:13.578867|2017-10-11 05:31:13.578867
NCT00194753|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-09-12|||December 2001||2001-12-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12|Adjuvant Therapy for High-Risk Localized Breast Cancer With Weekly Adriamycin +/- Oral Cytoxan With Continuous G-CSF Support for 12 Weeks Followed by Weekly Taxol for 12 Weeks, Phase II|Completed||Phase 2|80|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 05:31:13.686109|2017-10-11 05:31:13.686109
NCT00194766|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-11-13|||July 2000||2000-07-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer|Continuous Temozolomide (SCH 52365) in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer, Phase II|Completed||Phase 2|35|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 05:31:13.798314|2017-10-11 05:31:13.798314
NCT00194792|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-06-09|2017-04-14||August 2005||2005-08-01|June 2017|2017-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer|Neoadjuvant Complete Hormonal Blockade Followed by Neoadjuvant Chemotherapy for Resectable Hormone Receptor Positive, HER-2/Neu Negative Breast Cancer, A Phase II Study|Terminated||Phase 2|28|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 05:31:14.091218|2017-10-11 05:31:14.091218
NCT00194805|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2007-11-13|||September 2003||2003-09-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Telehealth for Diabetes Self-Management|Telehealth for Diabetes Self-Management|Completed||N/A|62|Actual|University of Washington||1|||f||||t||||||||||2017-10-11 05:31:14.626377|2017-10-11 05:31:14.626377
NCT00194818|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-02-13|||June 2003||2003-06-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Asacol Dosing Study for Active Ulcerative Colitis|Open Label Safety and Efficacy Trial of Twice Daily Dosing of Asacol vs. Three Times Per Day Dosing for the Induction of Remission in Active Ulcerative Colitis|Completed||Phase 4|7|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:31:14.735664|2017-10-11 05:31:14.735664
NCT00194831|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-11|||June 2005||2005-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Correlation of Volumetric Brain Analysis With Development at 18 Months|Volumetric Brain Analysis in the Premature Brain: Correlation With Future Development|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University|||1|No data. Study never completed.|f||||||||||||||2017-10-11 05:31:14.892896|2017-10-11 05:31:14.892896
NCT00194844|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-15|||September 2001||2001-09-01|February 2008|2008-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Couples Miscarriage Healing Project:Randomized Trial|Caring Interventions for Couples Who Have Miscarried|Completed||Phase 1/Phase 2|682|Actual|University of Washington||4|||f||||t||||||||||2017-10-11 05:31:14.985609|2017-10-11 05:31:14.985609
NCT00194857|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-14|||February 2002||2002-02-01|December 2012|2012-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin|A Randomized Clinical Trial Comparing Two Management Strategies for Treatment of Neutropenia and Anemia Associated With Pegylated Interferon Plus Ribavirin Treatment of Compensated Chronic Hepatitis C in Adult Subjects Infected With HIV.|Terminated||Phase 4|||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:31:15.100803|2017-10-11 05:31:15.100803
NCT00194870|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-01-11|||October 2003||2003-10-01|January 2017|2017-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy|Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy|Completed||N/A|5|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-10-11 05:31:15.216355|2017-10-11 05:31:15.216355
NCT00194883|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||April 1997||1997-04-01|September 2005|2005-09-01|May 2003||2003-05-01|||||Interventional|||Effect of Cytokines on Growth of Children With Chronic Kidney Failure|Cytokines and Growth in Children With CRI and ESRD|Suspended||Phase 4|50||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:31:15.327522|2017-10-11 05:31:15.327522
NCT00194896|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-08-16|2011-02-22||February 2000||2000-02-01|August 2011|2011-08-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Preferred Treatment of Type 1.5 Diabetes|Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes|Completed||N/A|64|Actual|University of Washington|Small numbers based on high drop out of participants.|2|||f||||t||||||||||2017-10-11 05:31:15.419036|2017-10-11 05:31:15.419036
NCT00194909|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-24|||August 2004||2004-08-01|March 2008|2008-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)|An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)|Completed||Phase 4|8|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 05:31:15.881677|2017-10-11 05:31:15.881677
NCT00194922|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-03|||August 2004||2004-08-01|April 2008|2008-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Tolerance and Efficacy of the Probiotic E. Coli Strain M17 on Symptoms and Quality of Life in Individuals With Irritable Bowel Syndrome (IBS)|Completed||Phase 2|35|Actual|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-10-11 05:31:15.952268|2017-10-11 05:31:15.952268
NCT00194935|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-12|||February 2003||2003-02-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Weekly Topotecan Therapy in Patients With Ovarian Cancer|A Phase II Trial of Weekly Topotecan As Consolidation Therapy in Ovarian Cancer Patients After Initial Chemotherapy|Terminated||Phase 2|32||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:31:16.029581|2017-10-11 05:31:16.029581
NCT00194948|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-01|||September 2003||2003-09-01|November 2013|2013-11-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Treatment Choices for Improving Adherence and Outcome|Patient Preference in Primary Care Depression Treatment|Completed||N/A|60||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:31:16.09009|2017-10-11 05:31:16.09009
NCT00194961|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-24||||||March 2008|2008-03-01|December 2007||2007-12-01|||||Interventional|||Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease|A Multicenter Study of the Effect of Recombinant Human Growth Hormone on Leptin and Cytokines in Relation to Body Composition in Pediatric Patients With Growth Failure Due to Chronic Kidney Disease (CKD)|Terminated||Phase 4|15|Anticipated|Weill Medical College of Cornell University||||Funding was not approved|f||||||||||||||2017-10-11 05:31:16.166176|2017-10-11 05:31:16.166176
NCT00194974|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-27|||July 2004||2004-07-01|January 2017|2017-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Treatment Targets for Chronic Hypertension in Pregnancy|Treatment Targets for Chronic Hypertension in Pregnancy|Withdrawn||Phase 1/Phase 2|0|Actual|Weill Medical College of Cornell University||||Lack of funding|f||||f||||||||No|Study terminated|2017-10-11 05:31:16.235555|2017-10-11 05:31:16.235555
NCT00194987|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-30|||April 2001||2001-04-01|January 2017|2017-01-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia|A Randomized Multicenter Trial of Antenatal Treatment of Alloimmune Thrombocytopenia|Recruiting||Phase 2/Phase 3|120|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 05:31:16.321103|2017-10-11 05:31:16.321103
NCT00195000|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||May 2003||2003-05-01|June 2013|2013-06-01|February 2008|Actual|2008-02-01|May 2006|Actual|2006-05-01||Interventional|||Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS|Phase II Evaluation of Gemtuzumab Ozogamicin in Combination With Cytarabine in Untreated Patients Above the Age of 60 Years With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome|Completed||Phase 2|43|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-10-11 05:31:16.416844|2017-10-11 05:31:16.416844
NCT00195013|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-07-20|2017-02-02||December 2003||2003-12-01|July 2017|2017-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy|A Randomized Placebo-controlled Trial of Glutamine to Reduce the Signs and Symptoms of Peripheral Neuropathy in Breast Cancer Patients With a Mild Peripheral Neuropathy Receiving Paclitaxel Chemotherapy|Completed||Phase 3|30|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 05:31:16.494931|2017-10-11 05:31:16.494931
NCT00195026|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-03-13|||March 2005||2005-03-01|March 2008|2008-03-01||||||||Observational|||Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection|Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection|Completed||N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||||||||||||2017-10-11 05:31:16.721754|2017-10-11 05:31:16.721754
NCT00195039|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-09-06|2017-03-01||August 2004||2004-08-01|September 2017|2017-09-01|October 2013|Actual|2013-10-01|February 2012|Actual|2012-02-01||Interventional|||Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer|A Phase 2 Trial of 177Lu Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 2|47|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-10-11 05:31:16.797603|2017-10-11 05:31:16.797603
NCT00195052|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-01-23|||May 2002||2002-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients|Intraoperative Optical Mapping of Human Epileptiform and Functional Cortex|Recruiting||N/A|40|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-10-11 05:31:17.628299|2017-10-11 05:31:17.628299
NCT00195065|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-04-01|||April 2003||2003-04-01|April 2008|2008-04-01|September 2003||2003-09-01|||||Observational|||Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study|Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study|Completed||N/A|60||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:31:17.708888|2017-10-11 05:31:17.708888
NCT00195078|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-07-19|||April 2004||2004-04-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer|Phase I-II Study of ZD1839 (IRESSA®), Cisplatin, and External-Beam Radiation Therapy in Patients With Locally Advanced, Non-Metastatic, Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 1/Phase 2|29|Anticipated|Weill Medical College of Cornell University|||||||||||||||||||2017-10-11 05:31:17.791873|2017-10-11 05:31:17.791873
NCT00195091|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-01-25|||December 2003||2003-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer|A Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer at Moderate to High Risk of Recurrence|Active, not recruiting||Phase 2|50|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-10-11 05:31:17.891463|2017-10-11 05:31:17.891463
NCT00195104|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-03-02|||September 17, 2003|Actual|2003-09-17|March 2017|2017-03-01|June 20, 2006|Actual|2006-06-20|March 17, 2006|Actual|2006-03-17||Interventional|||Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML|Phase I/II Study of Arsenic Trioxide in Combination With Cytosine Arabinoside in Patients With High-risk Myelodysplastic Syndrome and Poor-prognosis Acute Myelogenous Leukemia|Completed||Phase 1/Phase 2|87|Actual|Weill Medical College of Cornell University||1|||f||||t|t|f||||||||2017-10-11 05:31:17.984895|2017-10-11 05:31:17.984895
NCT00195117|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-02-17|||October 2004|Actual|2004-10-01|February 2017|2017-02-01|July 2007|Actual|2007-07-01|July 2006|Actual|2006-07-01||Interventional|||A Randomized Trial of Changing Exercise and Physical Activity Behavior in Asthma Patients|A Randomized Trial of Changing Exercise and Physical Activity Behavior in Asthma Patients|Completed||N/A|258|Actual|Weill Medical College of Cornell University||2|||f||||f|f|f||||||No|No Plan to Share IPD|2017-10-11 05:31:18.077575|2017-10-11 05:31:18.077575
NCT00195130|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-03-27|||January 1998||1998-01-01|March 2008|2008-03-01|January 1999||1999-01-01|||||Observational|||Prognostic Measures in Ambulatory Care Settings|Prognostic Measures in Ambulatory Care Settings|Completed||N/A|2000||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:31:18.18782|2017-10-11 05:31:18.18782
NCT00195143|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-03-26|||August 2003||2003-08-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease|Phase I Study of Subthalamic GAD Gene Transfer in Medically Refractory Parkinson's Disease Patients|Completed||Phase 1|12||Neurologix, Inc.|||||||||||||||||||2017-10-11 05:31:18.266732|2017-10-11 05:31:18.266732
NCT00195156|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-09-12|||July 2003||2003-07-01|September 2006|2006-09-01||||||||Interventional|||Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies|Phase I Trial of ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies|Terminated||Phase 1|||Weill Medical College of Cornell University|||||||||||||||||||2017-10-11 05:31:18.360573|2017-10-11 05:31:18.360573
NCT00195169|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2010-08-10|||July 2001||2001-07-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|||Quality of Life After Myocardial Infarction|Quality of Life After Myocardial Infarction: The Impact of Social Support|Completed||N/A|213|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-10-11 05:31:18.445429|2017-10-11 05:31:18.445429
NCT00195182|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-05-15|||September 2003||2003-09-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|||||Observational|||Psychosocial Determinants of Medication Adherence in Hypertensive African Americans|Psychosocial Determinants of Medication Adherence in Hypertensive African Americans|Unknown status|Active, not recruiting|N/A|262|Anticipated|Weill Medical College of Cornell University|||2||f||||t||||||||||2017-10-11 05:31:18.512645|2017-10-11 05:31:18.512645
NCT00195195|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-01-26|||January 2005||2005-01-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries|"A Rapamune Follow-up Registry in Transplant Recipients in the Nordic Countries, Wrap-up"|Completed||N/A|66|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-10-11 05:31:18.599458|2017-10-11 05:31:18.599458
NCT00187161|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-06-03|||November 1994||1994-11-01|June 2008|2008-06-01|January 2007|Actual|2007-01-01|||||Interventional|||Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL|Small Noncleaved Cell (SNCC), Non-Hodgkin Lymphoma (NHL), Large Cell NHL (B-Cell) and B-Cell Acute Lymphoblastic Leukemia (B-ALL) Study II|Completed||Phase 2|68|Actual|St. Jude Children's Research Hospital||3|||f||||f||||||||||2017-10-11 05:31:18.675825|2017-10-11 05:31:18.675825
NCT00187174|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-03|||October 2004||2004-10-01|December 2009|2009-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors|Phase I Trial of RAD001C (Everolimus) in Pediatric Patients With Recurrent Refractory Solid Tumors or Brain Tumors|Completed||Phase 1|41|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:31:18.769551|2017-10-11 05:31:18.769551
NCT00187187|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2010-10-20|||June 2003||2003-06-01|October 2010|2010-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|DAVIDII||DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)|DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)|Completed||N/A|600|Actual|St. Jude Medical||2|||f||||t||||||||||2017-10-11 05:31:18.85576|2017-10-11 05:31:18.85576
NCT00187200|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2015-08-25|2014-08-27||January 2005||2005-01-01|August 2015|2015-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients|RESPONSE HF - Response of Cardiac Resynchronization Therapy Optimization With Interventricular (VV) Timing in Heart Failure Patients|Completed||Phase 4|816|Actual|St. Jude Medical|Due to the lower than expected non-responder rate at 3 months, the study did not reach the target randomized sample size.|2|||f||||f||||||||||2017-10-11 05:31:18.982668|2017-10-11 05:31:18.982668
NCT00187213|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-21|||December 2004||2004-12-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|July 2007|Actual|2007-07-01||Interventional|||B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure Patients|Biventricular Versus Left Univentricular Pacing With ICD Back-up in Heart Failure Patients|Completed||N/A|||St. Jude Medical|||||f||||t||||||||||2017-10-11 05:31:19.462387|2017-10-11 05:31:19.462387
NCT00187226|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-17|2012-05-04||June 1997||1997-06-01|August 2012|2012-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects|A Phase II Study of Image-Guided Radiation Therapy for Pediatric CNS Tumors and Quantification of Radiation-Related CNS Effects|Completed||Phase 2|202|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-10-11 05:31:19.54314|2017-10-11 05:31:19.54314
NCT00187239|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2015-04-20|||July 2005||2005-07-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study|Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search (REDUCE Study)|Completed||Phase 4|157|Actual|St. Jude Medical||2|||f||||||||||||||2017-10-11 05:31:20.089782|2017-10-11 05:31:20.089782
NCT00187252|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-11|||September 2003||2003-09-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|MASCOT||Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy|Management of Atrial Fibrillation Suppression in AF-HF COmorbidity Therapy|Completed||N/A|380|Anticipated|St. Jude Medical||2|||f||||f||||||||||2017-10-11 05:31:20.167845|2017-10-11 05:31:20.167845
NCT00187265|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-05|||April 2003||2003-04-01|April 2006|2006-04-01|October 2005||2005-10-01|||||Interventional|||Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients|Triple Resynchronization in Paced Heart Failure Patients|Completed||N/A|||St. Jude Medical|||||f||||||||||||||2017-10-11 05:31:20.242298|2017-10-11 05:31:20.242298
NCT00187291|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-13|||April 2001||2001-04-01|April 2015|2015-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)|Alternans Before Cardioverter Defibrillator (ABCD) Trial|Completed||Phase 3|618||St. Jude Medical|||||f||||t||||||||||2017-10-11 05:31:20.384133|2017-10-11 05:31:20.384133
NCT00187304|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2013-06-04|||September 2005||2005-09-01|June 2013|2013-06-01||||||||Interventional|||ACTION - Anticoagulation Treatment Influence on Post-operative Patients|Anticoagulation Treatment Influence on Post-operative Patients -Action SJM EPIC Trial|Withdrawn||Phase 4|0|Actual|St. Jude Medical||||Study replaced by an observational study|f||||||||||||||2017-10-11 05:31:20.446998|2017-10-11 05:31:20.446998
NCT00187317|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-04-01|||November 2005||2005-11-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Evaluation of a Balance-recovery Specific Falls Prevention Exercise Program|Development and Evaluation of a Perturbation-based Balance-training Program for Older Adults|Completed||Phase 1|37|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 05:31:20.505158|2017-10-11 05:31:20.505158
NCT00187330|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||March 2004||2004-03-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass|A Randomized Placebo Controlled Trial of Intravenous N-Acetylcysteine (NAC) As A Renal Protective Agent for Prevention of Renal Dysfunction Following Cardiopulmonary Bypass (CPB)|Completed||Phase 2|104||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:31:20.601153|2017-10-11 05:31:20.601153
NCT00187343|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-05|||September 2003||2003-09-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT)|A Phase III Study of Adjuvant Radiation Therapy in Early Breast Cancer Comparing the Use of Breast Intensity Modulated Radiation Therapy (IMRT) to Conventional Wedge Technique|Completed||Phase 3|340||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:31:20.692726|2017-10-11 05:31:20.692726
NCT00187356|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2013-06-04|||July 2002||2002-07-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|RAPS - 5 years||Multicentre Radial Artery Patency Study: Results of Patency Beyond 5 Years After Coronary Artery Bypass Surgery|Multicentre Radial Artery Patency Study: Results of Patency Beyond 5 Years After Coronary Artery Bypass Surgery|Completed||Phase 3|269|Actual|Sunnybrook Health Sciences Centre||1|||f||||||||||||||2017-10-11 05:31:20.789863|2017-10-11 05:31:20.789863
NCT00187369|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-10-08|||December 2003||2003-12-01|October 2013|2013-10-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||The Twin Birth Study: A Trial Comparing Planned Vaginal Birth to Elective Caesarean Section of Twins|The Twin Birth Study: A Multicentre Randomised Controlled Trial Comparing Planned Vaginal Birth to Elective Caesarean Section of Twins More Than or Equal to 32 Weeks Gestation|Completed||N/A|2804|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-10-11 05:31:20.90825|2017-10-11 05:31:20.90825
NCT00187382|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-14|||April 2001||2001-04-01|June 2010|2010-06-01|December 2011||2011-12-01|June 2007|Actual|2007-06-01||Interventional|||Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS)|Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS)|Completed||Phase 4|1858|Actual|Sunnybrook Health Sciences Centre|||||f||||t||||||||||2017-10-11 05:31:20.99722|2017-10-11 05:31:20.99722
NCT00187395|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-09|||April 2003||2003-04-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Interventional|||CHIPS (Control of Hypertension in Pregnancy Study): A Pilot Trial|Control of Hypertension in Pregnancy Study: A Pilot Trial|Completed||N/A|132||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:31:21.09637|2017-10-11 05:31:21.09637
NCT00187408|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-02-26|||August 2002||2002-08-01|February 2006|2006-02-01|January 2007||2007-01-01|||||Interventional|||The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial|Clinically-Important Venous Thromboembolism Following Lower Extremity Fractures: Epidemiology & Prevention|Completed||Phase 4|700||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:31:21.176518|2017-10-11 05:31:21.176518
NCT00187421|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-12-11|||July 2005||2005-07-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|GRIIP||Using Intraoperative Coronary Bypass Graft Imaging to Improve Graft Patency|Graft Imaging to Improve Patency (GRIIP)|Completed||Phase 3|156|Actual|Sunnybrook Health Sciences Centre||2|||f||||||||||||||2017-10-11 05:31:21.290972|2017-10-11 05:31:21.290972
NCT00187434|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-01-22|||September 2003||2003-09-01|September 2005|2005-09-01||||||||Interventional|||Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP)|A Randomized Control Trial Comparing Two Methods of Delivering Continuous Positive Airway Pressure (CPAP), Infant Flow System CPAP and Bubble CPAP, in Supporting Successful Extubation of Infants of Birth Weights Less Than or Equal to 1500 Grams at Birth (C2CPAP)|Unknown status|Recruiting|N/A|76||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:31:21.391676|2017-10-11 05:31:21.391676
NCT00187447|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2008-06-02|||August 2003||2003-08-01|September 2005|2005-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus|Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus|Completed||Phase 2|100|Anticipated|University of California, San Francisco|||||f||||||||||||||2017-10-11 05:31:21.537499|2017-10-11 05:31:21.537499
NCT00187460|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-11-30|||November 2001||2001-11-01|May 2005|2005-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|EFFECT||Study of the Effectiveness of Report Cards on the Quality of Care for Heart Attack and Heart Failure Patients|Enhanced Feedback for Effective Cardiac Treatment (EFFECT)|Completed||N/A|46000|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-10-11 05:31:21.749964|2017-10-11 05:31:21.749964
NCT00187473|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-07-18|||June 2000||2000-06-01|July 2014|2014-07-01||||December 2014|Anticipated|2014-12-01||Observational|||Natural History of Hepatitis C in Patients With Normal Liver Tests|Determinants of Disease Severity in Patients With Chronic Hepatitis C and Normal Serum Aminotransferases (Normal Liver Tests)|Unknown status|Active, not recruiting|N/A|92|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 05:31:21.859137|2017-10-11 05:31:21.859137
NCT00187486|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-04|2011-04-25||August 2004||2004-08-01|August 2017|2017-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors|Phase II Study of Tarceva Plus Temodar During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme and Gliosarcoma|Completed||Phase 2|66|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 05:31:21.954399|2017-10-11 05:31:21.954399
NCT00187499|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-04-02|||October 2002||2002-10-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma|Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma|Completed||N/A|||University of California, San Francisco|||||f||||||||||||||2017-10-11 05:31:22.292676|2017-10-11 05:31:22.292676
NCT00187512|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-28|||March 2000||2000-03-01|March 2017|2017-03-01|December 2020|Anticipated|2020-12-01|March 2019|Anticipated|2019-03-01||Observational|SCOPE||SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era|SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era|Recruiting||N/A|2500|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     Plasma, serum, PMBCs, saliva   "|||2017-10-11 05:31:22.395427|2017-10-11 05:31:22.395427
NCT00187525|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-11-08|||May 2004||2004-05-01|November 2012|2012-11-01|October 2006|Actual|2006-10-01|October 2005|Actual|2005-10-01||Interventional|||A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration||Completed||Phase 4|||University of California, San Francisco||1|||f||||||||||||||2017-10-11 05:31:22.524071|2017-10-11 05:31:22.524071
NCT00187538|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-08-20|||February 2002||2002-02-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Dietary Protein Source on Calcium Metabolism|Effect of Dietary Protein Source on Calcium Metabolism|Completed||N/A|183|Actual|University of California, San Francisco||4|||f||||f||||||||||2017-10-11 05:31:22.6007|2017-10-11 05:31:22.6007
NCT00187551|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-08|||May 2000||2000-05-01|June 2006|2006-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance|Partial Treatment Interruptions in HIV-1 Patients With Multi-Drug Resistant Virus|Completed||Phase 4|25|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 05:31:22.700873|2017-10-11 05:31:22.700873
NCT00187564|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-05-02|||August 2004||2004-08-01|September 2005|2005-09-01|October 2005|Actual|2005-10-01|||||Interventional|||Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus|Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus|Completed||N/A|40||University of California, San Francisco|||||f||||||||||||||2017-10-11 05:31:22.831693|2017-10-11 05:31:22.831693
NCT00187577|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-07|||June 2005||2005-06-01|June 2011|2011-06-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata|Efficacy and Safety of Latanoprost (Xalatan) and Bimatoprost (Lumigan) Ophthalmic Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata|Completed||N/A|14|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 05:31:22.940543|2017-10-11 05:31:22.940543
NCT00187590|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-01-21|||April 2004||2004-04-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Case Management Intervention to Prevent ER Visits in HIV-infected Persons||Terminated||N/A|612|Actual|University of California, San Francisco||2||Intervention was taken up as a standard of care.|f||||||||||||||2017-10-11 05:31:23.058438|2017-10-11 05:31:23.058438
NCT00187603|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-05-05|||July 2003||2003-07-01|August 2005|2005-08-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|||Protecting the 'Hood Against Tobacco|Protecting the 'Hood Against Tobacco: Cessation Project|Completed||N/A|270|Anticipated|University of California, San Francisco|||||f||||||||||||||2017-10-11 05:31:23.156788|2017-10-11 05:31:23.156788
NCT00187616|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||April 2002||2002-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial|Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial|Completed||N/A|214||University of California, San Francisco|||||f||||||||||||||2017-10-11 05:31:23.243563|2017-10-11 05:31:23.243563
NCT00187629|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-08|||March 2004||2004-03-01|October 2013|2013-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Phosphate Intake's Effect on the Skeletal System - Pilot|Phosphate Intake's Effect on the Skeletal System Calcitropic Hormones and FGF23 - Pilot Study|Completed||N/A|27|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 05:31:23.330908|2017-10-11 05:31:23.330908
NCT00187655|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-10-21|2013-05-21||January 2004||2004-01-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of, OAT3, on the Renal Secretion of Cefotaxime|Effect of Genetic Variation in the Transporter, OAT3, on the Renal Secretion of Cefotaxime|Completed||Phase 1|24|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 05:31:23.42719|2017-10-11 05:31:23.42719
NCT00187668|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-10-20|||February 2004||2004-02-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|SOPHIE||Study Of PHarmacogenetics in Ethnically Diverse Populations (SOPHIE Study)|Study Of PHarmacogenetics in Ethnically Diverse Populations (SOPHIE Study)|Unknown status|Recruiting|N/A|500|Anticipated|University of California, San Francisco|||4||f||||t||||||Samples With DNA|"     40 mL of blood for DNA extraction   "|||2017-10-11 05:31:23.686441|2017-10-11 05:31:23.686441
NCT00187681|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-12-06|2011-05-20||July 2003||2003-07-01|December 2012|2012-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects|Effect of Genetic Variants in the Xenobiotic Transporter, OCT1, on Response to Metformin in Healthy Subjects|Completed||Phase 4|20|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 05:31:23.796224|2017-10-11 05:31:23.796224
NCT00187707|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-08-07|||September 2005||2005-09-01|August 2012|2012-08-01|August 2008|Actual|2008-08-01|January 2007|Actual|2007-01-01||Interventional|||Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin|Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin|Completed||N/A|30|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 05:31:24.138042|2017-10-11 05:31:24.138042
NCT00187720|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-12-06|2011-03-31||May 2002||2002-05-01|December 2012|2012-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Genetic Basis for Variation in the Renal Elimination of Metformin|Genetic Basis for Variation in the Renal Elimination of Metformin|Completed||Phase 4|23|Actual|University of California, San Francisco|Recruitment of subjects with interested genotypes was our limitation.|2|||f||||t||||||||||2017-10-11 05:31:24.247574|2017-10-11 05:31:24.247574
NCT00187733|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-09-11|||January 2005||2005-01-01|September 2012|2012-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides|Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides|Completed||N/A|16|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     Blood Draw (10cc) to determine eligibility (CBC, blood chemistries). Blood draw (20cc) at t=0     in fasting state for baseline measurement of biochemical markers (including carnitine,     acylcarnitines, creatinine, and total lipid panel) Urine collection at t=0 Blood draw (20cc)     at t=2 hours for measurement of biochemical markers (including carnitine, acylcarnitines,     creatinine, and total lipid panel) Urine collection at t=2 hours Transformation of blood to     establish lymphoblastoid cell lines (from blood samples collected at t=0 and t=2 hours)   "|||2017-10-11 05:31:24.53796|2017-10-11 05:31:24.53796
NCT00187746|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-11-20|||August 2005||2005-08-01|November 2012|2012-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Age on the Renal Clearance of Adefovir|Effect of Age on the Renal Clearance of Adefovir|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||2||Budget exceeded for project.|f||||t||||||||||2017-10-11 05:31:24.621779|2017-10-11 05:31:24.621779
NCT00187759|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-05-06|||November 2004||2004-11-01|May 2015|2015-05-01|March 2005||2005-03-01|||||Interventional|||Placebo Controlled Study of Antibiotic Treatment of Soft Tissue Infection|A Placebo Controlled, Randomized, and Blinded Study of Antibiotic Treatment of Patients With Uncomplicated Soft Tissue Infection|Completed||N/A|500||University of California, San Francisco|||||f||||||||||||||2017-10-11 05:31:24.705233|2017-10-11 05:31:24.705233
NCT00187772|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-09-17|||December 1996||1996-12-01|September 2013|2013-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Child-Parent Psychotherapy for Preschooler Witnesses of Domestic Violence Program|Preschooler Witnesses of Domestic Violence: A Preventive Intervention Program|Completed||Phase 3|60||University of California, San Francisco|||||f||||||||||||||2017-10-11 05:31:24.768256|2017-10-11 05:31:24.768256
NCT00187785|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-01-13|||September 2005||2005-09-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Doctor-Patient Communication in Spanish|Doctor-Patient Communication in Spanish|Terminated||N/A|100||University of California, San Francisco|||||f||||||||||||||2017-10-11 05:31:24.834401|2017-10-11 05:31:24.834401
NCT00187798|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-24|||August 2001||2001-08-01|September 2012|2012-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Impact of Genetics on Metformin Pharmacokinetics|Impact of Genetics on Metformin Pharmacokinetics|Completed||N/A|24|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 05:31:24.895808|2017-10-11 05:31:24.895808
NCT00187811|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-28|||February 2001||2001-02-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||The Safety and Efficacy of Photodynamic Therapy for Femoral Artery Stenosis|Randomised Controlled Trial of Adjuvant Photodynamic Therapy to Reduce Restenosis After Percutaneous Transluminal Angioplasty to the Superficial Femoral Angioplasty|Unknown status|Active, not recruiting|Phase 2/Phase 3|120||University College London Hospitals|||||f||||||||||||||2017-10-11 05:31:24.985202|2017-10-11 05:31:24.985202
NCT00187824|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2005-09-11|||July 2004||2004-07-01|March 2004|2004-03-01|August 2007||2007-08-01|||||Observational|||Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis|Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis|Unknown status|Recruiting|N/A|30||University College London Hospitals|||||f||||||||||||||2017-10-11 05:31:25.076601|2017-10-11 05:31:25.076601
NCT00187837|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-10-14|||February 2005||2005-02-01|October 2016|2016-10-01|June 2013|Actual|2013-06-01|March 2007|Actual|2007-03-01||Interventional|||The CAP-1 Trial: Stepwise Excavation Versus One Completed Excavation in Deep Caries|The CAP-1 Trial: Effect of Stepwise Versus One Completed Excavation in Deep Caries in Permanent Teeth: A Randomised, Patient - and Observer-blinded Multicenter Trial|Completed||N/A|314|Actual|University of Copenhagen||2|||f||||t||||||||Yes|1½ yr results published in European Journal of Oral Sciences 2010; 118: 290-297.|2017-10-11 05:31:25.168796|2017-10-11 05:31:25.168796
NCT00187850|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-14|||February 2005||2005-02-01|October 2016|2016-10-01|June 2013|Actual|2013-06-01|March 2007|Actual|2007-03-01||Interventional|||The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy|The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy on CAP-1 Patients: A Randomised, Patient - and Observer-Blinded Multicenter Trial|Completed||N/A|120|Anticipated|University of Copenhagen||2|||f||||t||||||||||2017-10-11 05:31:25.280868|2017-10-11 05:31:25.280868
NCT00187863|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-20|||May 2005||2005-05-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Biopsychosocial Factors' Influence on Shoulder Pain|Biopsychosocial Factors' Influence on Shoulder Pain|Completed||N/A|340|Actual|University of Florida|||2||f||||||||||||||2017-10-11 05:31:25.48687|2017-10-11 05:31:25.48687
NCT00187876|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-01-30|2013-12-04||February 2004||2004-02-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of Biocleanse Allografts For ACL Reconstruction|Evaluation of Biocleanse Patellar Tendon Allografts For The Reconstruction of Anterior Cruciate Ligaments: A Prospective, Randomized Investigation|Completed||Phase 4|67|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 05:31:25.575596|2017-10-11 05:31:25.575596
NCT00187902|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-04-13|||October 2005||2005-10-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|May 2007|Actual|2007-05-01||Observational|||Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM|Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM|Completed||N/A|907|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     self-collected glans swab; clinician-collected rectal and pharyngeal swabs   "|||2017-10-11 05:31:26.108051|2017-10-11 05:31:26.108051
NCT00187915|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-10-19|||July 2003||2003-07-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|MPA||Pilot Trial for Implementation of a MPA PK Monitoring Strategy|Pilot Trial for Implementation of a MPA PK Monitoring Strategy|Completed||N/A|24|Actual|University of Florida||2|||f||||f||||||||||2017-10-11 05:31:26.202738|2017-10-11 05:31:26.202738
NCT00187928|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-10-04|||January 2003||2003-01-01|October 2011|2011-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder|Completed||Phase 3|96||University of Florida|||||f||||t||||||||||2017-10-11 05:31:26.322431|2017-10-11 05:31:26.322431
NCT00187941|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-19|||August 2005||2005-08-01|June 2012|2012-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression|Pilot Trial for Implementation of a Medroxyprogesterone(MPA)Pharmacokinetic(PK) Monitoring Strategy in Patients on Mycophenolate Mofetil(MMF)/FK Based Immunosuppression.|Completed||Early Phase 1|22|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 05:31:26.404248|2017-10-11 05:31:26.404248
NCT00187954|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-10-02|||June 2003||2003-06-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||WISE ARIC: Retinal Photography in Women With Chest Pain|Retinal Photography in Women With Chest Pain: A WISE/ARIC Collaboration|Completed||Phase 4|160|Actual|University of Florida|||1||f||||t||||||||||2017-10-11 05:31:26.525028|2017-10-11 05:31:26.525028
NCT00187967|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-09-24|||January 2005||2005-01-01|September 2005|2005-09-01||||||||Interventional|||Cardiopulmonary Bypass (CPB) Pumps and Blood Activation|Blood Activation During Cardiopulmonary Bypass Using Roller or Centrifugal Pumps|Unknown status|Recruiting|N/A|||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:28.514521|2017-10-11 05:31:28.514521
NCT00187980|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||June 2005||2005-06-01|September 2005|2005-09-01||||||||Observational|||Sleep Disturbance in Lung Cancer Patients.||Unknown status|Recruiting|N/A|50||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:28.614253|2017-10-11 05:31:28.614253
NCT00187993|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||May 2005||2005-05-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Growth Hormone Treatment of Young Growth Hormone-Deficient Adults|Growth Hormone Treatment of Young Adults Deficient in Growth Hormone Since Childhood : Study of Body Composition Modifications.|Unknown status|Recruiting|N/A|30||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:28.668945|2017-10-11 05:31:28.668945
NCT00188006|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09||||||September 2005|2005-09-01||||||||Interventional|||Complement Activation and Central Nervous System Injury After Coronary Artery Surgery|Biocompatible Cardiopulmonary Bypass and Neuropsychological Outcome After Coronary Artery Bypass Surgery|Completed||N/A|||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:28.747629|2017-10-11 05:31:28.747629
NCT00188019|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-07-22|||November 2005||2005-11-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers|Evaluation Des méthodes de dépistage du Paragangliome héréditaire Chez Les Sujets prédisposés génétiquement|Completed||N/A|248|Actual|University Hospital, Angers||1|||f||||||||||||||2017-10-11 05:31:28.814466|2017-10-11 05:31:28.814466
NCT00188032|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-02-04|||June 2005||2005-06-01|February 2009|2009-02-01|September 2006|Actual|2006-09-01|||||Interventional|||Strategies for Suspected Pulmonary Embolism in Emergency Departments|Strategies for Suspected Pulmonary Embolism in Emergency Departments - SPEED Study|Completed||N/A|1331|Anticipated|University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:28.87386|2017-10-11 05:31:28.87386
NCT00188045|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-28|||April 1995||1995-04-01|December 2001|2001-12-01|December 2003||2003-12-01|||||Interventional|||Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients|Hemodynamic Effects of Chronic Administration of Spironolactone, Propranolol and Their Association in Alcoholic Cirrhotic Patients|Terminated||Phase 4|54||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:28.992193|2017-10-11 05:31:28.992193
NCT00188058|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2002||2002-09-01|September 2005|2005-09-01||||||||Interventional|||Comparison of 2 Strategies of Adjustment of Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome|Comparison of Two Strategies for Setting Positive End-Expiratory Pressure in Acute Lung Injury/ Acute Respiratory Distress Syndrome (ExPress Study).|Unknown status|Recruiting|N/A|800||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:29.068762|2017-10-11 05:31:29.068762
NCT00188071|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-28|||September 2002||2002-09-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen|Postoperative Pain After Medical Abortion Under Local Anesthesia : a Prospective and Randomized Trial Comparing Several Analgesic Regimen|Completed||N/A|240||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:29.496013|2017-10-11 05:31:29.496013
NCT00188084|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-10-27|||November 2003||2003-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia|Analysis of Four Biological Parameters at Diagnosis of Adult Acute Lymphoblastic Leukaemia: DNA Index, Percentage of Cells in S-Phase, CD45 Fluorescence Index, and Protein P16: Prognostic Study in Patients Enrolled in a Multicentric Trial|Unknown status|Recruiting|N/A|400||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:29.571984|2017-10-11 05:31:29.571984
NCT00188097|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-01-18|||November 1999||1999-11-01|August 2005|2005-08-01|June 2002||2002-06-01|||||Interventional|||Diagnosis of Variceal Bleeding and Its Control in Cirrhosis|Diagnosis of Variceal Bleeding and Its Control in Cirrhosis|Terminated||N/A|400||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:29.667111|2017-10-11 05:31:29.667111
NCT00188110|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-08|||March 2003||2003-03-01|September 2005|2005-09-01||||||||Interventional|||Performance of the Water-Enema Computed Tomography (WE-CT)|Evaluation of the Water-Enema Computed Tomography for the Diagnosis of Colon Tumor|Unknown status|Recruiting|N/A|200||University Hospital, Angers|||||f||||||||||||||2017-10-11 05:31:29.722543|2017-10-11 05:31:29.722543
NCT00188123|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-07-14|||April 2004||2004-04-01|September 2005|2005-09-01|April 2009|Actual|2009-04-01|September 2005|Actual|2005-09-01||Observational|||Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With Magnetic Resonance Imaging (MRI)|Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With MRI|Completed||Phase 4|20|Actual|University Hospital, Linkoeping|||1||f||||f||||||||||2017-10-11 05:31:29.8208|2017-10-11 05:31:29.8208
NCT00188136|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-07|||August 2002||2002-08-01|December 2015|2015-12-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)|Phase II Study of Early Allogeneic Blood Stem Cell Transplantation During Induction-chemotherapy Induced Aplasia in High-risk Acute Myeloid Leukemia|Completed||Phase 2|32|Actual|University Hospital Carl Gustav Carus||1|||f||||||||||||||2017-10-11 05:31:29.88597|2017-10-11 05:31:29.88597
NCT00188149|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2005-12-28|||May 2000||2000-05-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Interventional|||Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET|Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy|Unknown status|Recruiting|Phase 4|300||University Hospital Carl Gustav Carus|||||f||||||||||||||2017-10-11 05:31:29.953139|2017-10-11 05:31:29.953139
NCT00188162|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-20|||January 2004||2004-01-01|September 2005|2005-09-01|September 2005|Actual|2005-09-01|||||Interventional|||Minimum Dose CT Post Lung Biopsy|Can Minimum Dose CT Post Lung Biopsy Predict Patient Outcome?|Completed||Phase 1|100||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:30.06111|2017-10-11 05:31:30.06111
NCT00188175|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-06-02|||May 2003||2003-05-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||IMRT Lower Limb Soft Tissue Sarcoma|A Phase II Study of Preoperative Intensity-Modulated Radiation Therapy For Lower Limb Soft Tissue Sarcoma|Completed||Phase 2|59|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 05:31:30.122684|2017-10-11 05:31:30.122684
NCT00188188|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-28|||March 2002||2002-03-01|March 2005|2005-03-01||||||||Interventional|||Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease|Endothelial Dysfunction in Systemic Lupus Erythematosus: Its Contribution to Abnormalities in Coronary Perfusion.|Unknown status|Recruiting|Phase 4|50||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:30.185609|2017-10-11 05:31:30.185609
NCT00188201|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-28|||January 2002||2002-01-01|September 2005|2005-09-01||||||||Observational|||Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication|An Investigation of Cognitive Functioning and Brain Metabolites in Patients With Non-Cirrhotic Hepatitis-C Both Pre- and Post-Treatment With Antiviral Medication|Unknown status|Recruiting|N/A|150||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:30.257727|2017-10-11 05:31:30.257727
NCT00188214|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-05-03|||October 2003||2003-10-01|May 2017|2017-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy|Dynamic CT Perfusion for Assessment of Lung Cancer Before and After Neoadjuvant Chemo-/ Radiotherapy|Completed||Phase 2|38|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 05:31:30.363051|2017-10-11 05:31:30.363051
NCT00188227|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2007-04-19|||September 2001||2001-09-01|September 2005|2005-09-01|November 2003||2003-11-01|||||Interventional|||Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture|Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture|Completed||Phase 4|748||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:31:30.438118|2017-10-11 05:31:30.438118
NCT00188240|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-11-28|||August 2003||2003-08-01|September 2005|2005-09-01||||||||Interventional|||Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy|Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Anti-Viral Therapy|Unknown status|Recruiting|N/A|200||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:30.545606|2017-10-11 05:31:30.545606
NCT00188253|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-09-21|||March 2005||2005-03-01|September 2017|2017-09-01|February 2018|Anticipated|2018-02-01|February 2017|Actual|2017-02-01||Observational|||Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.|Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.|Active, not recruiting||N/A|30|Anticipated|University Health Network, Toronto|||1||f||||||||||||||2017-10-11 05:31:30.636866|2017-10-11 05:31:30.636866
NCT00188266|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-09-19|||August 2002|Actual|2002-08-01|September 2017|2017-09-01|August 18, 2017|Actual|2017-08-18|December 19, 2013|Actual|2013-12-19||Interventional|||Study of Adjuvant Radiochemotherapy for Gastric Cancer|Prospective Phase I/II Study of Adjuvant Radiochemotherapy for Gastric Cancer|Completed||Phase 1/Phase 2|65|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 05:31:30.703382|2017-10-11 05:31:30.703382
NCT00188279|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-05-03|||July 2005||2005-07-01|May 2017|2017-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma|Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma|Active, not recruiting||Phase 2|250|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 05:31:30.960494|2017-10-11 05:31:30.960494
NCT00188292|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-03-04|||August 2002||2002-08-01|March 2016|2016-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|TRACE||Screening for HIV-Associated Anal Cancer|Screening for HIV-Associated Anal Cancer|Completed||N/A|401|Actual|University Health Network, Toronto|||2||f||||t||||||||||2017-10-11 05:31:31.049064|2017-10-11 05:31:31.049064
NCT00188305|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-08-14|||January 2005||2005-01-01|August 2015|2015-08-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients|A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients|Completed||Phase 3|252|Actual|University Health Network, Toronto||3|||f||||f||||||||||2017-10-11 05:31:31.134323|2017-10-11 05:31:31.134323
NCT00188318|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-02-08|||June 1998||1998-06-01|February 2016|2016-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)|A Phase II Study of Hyperfractionated Accelerated Radiotherapy Delivered With Integrated Neck Surgery for Node-positive Cases in Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|169|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:31:31.233483|2017-10-11 05:31:31.233483
NCT00188331|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-03-21|||November 2003||2003-11-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy|Cognitive Function and Fatigue in Cancer Patients After Chemotherapy: A Longitudinal Controlled Study in Patients With Colorectal Cancer|Completed||N/A|441|Actual|University Health Network, Toronto|||3||f||||f||||||Samples With DNA|"     cytokines, genotyping apoE, EUC, LFTs, sex hormones, coagulation factors   "|||2017-10-11 05:31:31.338879|2017-10-11 05:31:31.338879
NCT00188344|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-05-20|||September 2005||2005-09-01|May 2014|2014-05-01|March 2015|Anticipated|2015-03-01|March 2011|Actual|2011-03-01||Interventional|||A Randomized Comparison of Laparoscopic Myotomy and Pneumatic Dilatation for Achalasia|A Randomized Comparison of Laparoscopic Myotomy and Pneumatic Dilatation for Achalasia|Unknown status|Active, not recruiting|N/A|56|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-10-11 05:31:31.452677|2017-10-11 05:31:31.452677
NCT00188357|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-02-13|||August 2003||2003-08-01|September 2005|2005-09-01||||||||Interventional|||HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus|HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|360||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:31.551789|2017-10-11 05:31:31.551789
NCT00188370|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-09-09|||April 1999||1999-04-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Ultrasound Biomicroscopy - Apoptosis|Ultrasound Biomicroscopy for Monitoring Apoptosis in Lymphoma, Melanoma and Basal Cell Carcinoma Patients During Chemotherapy or Radiation Therapy|Completed||Phase 2|50||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:31.652152|2017-10-11 05:31:31.652152
NCT00188383|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-03-13|||January 2004||2004-01-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy|Effects of NMDA-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy in Young and Elderly Patients|Unknown status|Recruiting|Phase 1/Phase 2|132||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:31.728186|2017-10-11 05:31:31.728186
NCT00188396|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-03-12|||April 2004||2004-04-01|January 2007|2007-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response|The Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response: A Comparison of Premenopausal, Perimenopausal and Postmenopausal Women|Completed||N/A|44|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 05:31:31.835917|2017-10-11 05:31:31.835917
NCT00188409|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-20|||February 2002||2002-02-01|September 2005|2005-09-01|February 2004||2004-02-01|||||Interventional|||Pneumothorax Post CT Lung Biopsy|Pneumothorax Following CT-Guided Lung Biopsy: Is There a Role for the Post Biopsy CT in Patient Management|Completed||N/A|200||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:31.936837|2017-10-11 05:31:31.936837
NCT00188422|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-20|||August 2003||2003-08-01|April 2007|2007-04-01|January 2006||2006-01-01|||||Interventional|||Study of Low Dose CT in Sarcoma Patients|Surveillance Low Dose Computed Tomography of the Thorax in Patients With High Grade Extremity Soft Tissue Sarcoma|Completed||Phase 1|70||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:32.024838|2017-10-11 05:31:32.024838
NCT00188435|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-23|||November 2003||2003-11-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Comparison of CXR and MnDCT|A Comparison of Chest Radiography and Minimum Dose Chest CT|Completed||Phase 1|100||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:32.115889|2017-10-11 05:31:32.115889
NCT00188448|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-20|||April 2003||2003-04-01|September 2005|2005-09-01|April 2004||2004-04-01|||||Interventional|||MRI Superficial Temporal Artery|MRI of the Superficial Temporal Artery|Completed||Phase 1|5||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:32.174164|2017-10-11 05:31:32.174164
NCT00188461|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-20|||January 2004||2004-01-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Dose Reduction in Thoracic CT|Dose Reduction in Thoracic CT: A Comparison of on Line Automatic Dose Reduction and a 50% Reduction in Dose|Completed||Phase 1|100||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:32.236708|2017-10-11 05:31:32.236708
NCT00188474|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-03|||August 2004||2004-08-01|May 2017|2017-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||A Quality of Life Study re Management of Malignant Pleural Effusions|A Prospective Study of Patient Centered Outcomes in the Management of Malignant Pleural Effusions|Completed||N/A|149|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 05:31:32.307536|2017-10-11 05:31:32.307536
NCT00188500|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-28|||August 2005||2005-08-01|March 2004|2004-03-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy|Efficacy, Tolerability and Long-Term Adherence of a Modified Ketogenic Diet (Atkins) in the Management of Pharmacoresistant Epilepsy|Unknown status|Recruiting|N/A|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:32.491187|2017-10-11 05:31:32.491187
NCT00188513|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-20|||May 2001||2001-05-01|September 2017|2017-09-01|May 2018|Anticipated|2018-05-01|April 2006|Actual|2006-04-01||Interventional|||Intensity Modulated Radiation Therapy - Prostate Cancer|A Phase I-II Prospective Trial of Conformal Hypofractionated Intensity Modulated Radiotherapy (IMRT) for Localized Adenocarcinoma of the Prostate|Active, not recruiting||Phase 1/Phase 2|267|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:31:33.038407|2017-10-11 05:31:33.038407
NCT00188526|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-19|||September 2005||2005-09-01|September 2017|2017-09-01|September 2006||2006-09-01|||||Interventional|||Computed Tomography (CT) Guided Lung Biopsy: Core or Fine Needle Aspiration|CT Guided Lung Biopsy: Core or Fine Needle Aspiration|Withdrawn||N/A|0|Actual|University Health Network, Toronto||||Unknown Reason|f||||f||||||||||2017-10-11 05:31:33.154272|2017-10-11 05:31:33.154272
NCT00188539|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-21|||December 1995||1995-12-01|September 2017|2017-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels|Predictive Assays in Cervix Cancer: Assessment of Hypoxia, Interstitial Fluid Pressure, and GSH Levels|Active, not recruiting||Phase 2|300|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 05:31:33.216009|2017-10-11 05:31:33.216009
NCT00188552|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-12|||July 2002||2002-07-01|August 2010|2010-08-01||||||||Interventional|||The Use of Pentoxifylline and Vitamin E in the Treatment of Late Radiation Related Injuries|A Phase II Study of the Use of Pentoxifylline and Vitamin E in the Treatment of Late Radiation Related Injuries|Terminated||Phase 2|50|Anticipated|University Health Network, Toronto||||May 2007: No annual renewal|f||||||||||||||2017-10-11 05:31:33.304676|2017-10-11 05:31:33.304676
NCT00188565|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-12|||March 2004||2004-03-01|August 2010|2010-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Celebrex With Preoperative Chemoradiation - Rectal Cancer|A Phase I/II Trial of Celecoxib With Preoperative Chemoradiation for Resectable Rectal Cancer With In Vivo Analysis of Celecoxib Effector Pathways|Completed||Phase 1/Phase 2|39|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:33.391371|2017-10-11 05:31:33.391371
NCT00188578|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-02-08|||June 2003||2003-06-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)|A Pilot Study of Conformal Intensity Modulated Radiation Therapy (IMRT) for Gynaecological Cancer Patients Not Suitable for Intracavitary Brachytherapy Boost (GY03.2)|Completed||Phase 1/Phase 2|12|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:31:33.473472|2017-10-11 05:31:33.473472
NCT00188591|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-11-21|||April 2005||2005-04-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|||||Observational|||Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility Study|Pilot Study to Investigate the Feasibility of Optical Spectroscopy to Quantify Bulk Breast Tissue Properties in Girls Age 10 - 14 Years|Completed||N/A|20|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 05:31:33.552024|2017-10-11 05:31:33.552024
NCT00188604|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-12|||January 2004||2004-01-01|August 2010|2010-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer|A Randomized Phase II Placebo-controlled Double Blind Study of Using Selenium in the Treatment of Secondary Lymphedema in Breast Cancer Patients|Completed||Phase 2|34|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:33.629891|2017-10-11 05:31:33.629891
NCT00188617|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-10|||January 2005||2005-01-01|March 2017|2017-03-01|November 2009|Actual|2009-11-01|June 2007|Actual|2007-06-01||Interventional|||Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC|Phase II Study Of Single Agent Gefitinib (Iressa) In Patients With Clinical Stage I Non-Small Cell Lung Cancer (NSCLC) Proceeding To Mediastinoscopy And Surgery|Completed||Phase 2|35|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 05:31:33.701741|2017-10-11 05:31:33.701741
NCT00188630|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-19|||July 2003||2003-07-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|February 2007|Actual|2007-02-01||Interventional|||N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery|The PRIME (Perioperative Renal Insufficiency Management) Study: A Randomized, Double-blinded, Placebo-controlled Trial of N-acetylcysteine for Preventing Renal Injury After Cardiac Surgery.|Completed||Phase 3|176|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-10-11 05:31:33.781033|2017-10-11 05:31:33.781033
NCT00188643|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-08|||January 2002||2002-01-01|February 2005|2005-02-01|January 2007||2007-01-01|||||Interventional|||Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression|Double-Blind, Acute Depression Study Comparing Venlafaxine XR and Lamotrigine When Added to Mood Stabilizer in the Treatment of Bipolar Depression|Completed||Phase 4|40||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:33.874886|2017-10-11 05:31:33.874886
NCT00188656|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-12-14|||August 2003||2003-08-01|December 2010|2010-12-01|September 2006||2006-09-01|||||Interventional|||Computed Tomography (CT) in Head and Neck Patients|Minimum Dose CT in the Detection of Lung Nodules in Patients With Head and Neck Cancer|Terminated||Phase 1|100||University Health Network, Toronto||||insufficient recruitment|f||||||||||||||2017-10-11 05:31:33.953188|2017-10-11 05:31:33.953188
NCT00188669|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-10|||July 2002||2002-07-01|August 2010|2010-08-01||||||||Interventional|||The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain|A Phase II Study of the Use of Pentoxifylline and a-Tocopherol in the Treatment of Chronic Breast Pain Associated With Breast Radiotherapy|Terminated||Phase 2|48|Anticipated|University Health Network, Toronto||||date: August 2006. No annual renewal|f||||||||||||||2017-10-11 05:31:34.021699|2017-10-11 05:31:34.021699
NCT00188682|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-11-13|||March 2000||2000-03-01|November 2007|2007-11-01|September 2003|Actual|2003-09-01|||||Observational|||Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.|Optical Transillumination Spectroscopy of Breast Tissue in Pre- and Post-Menopausal Women.|Completed||N/A|300|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 05:31:34.258948|2017-10-11 05:31:34.258948
NCT00188695|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-05|||April 2004||2004-04-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide|A Pilot Study of MR Imaging With Ultra-Small Superparamagnetic Iron Oxide for Pelvic Lymph Node Target Definition|Completed||Phase 1/Phase 2|61|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-10-11 05:31:34.327683|2017-10-11 05:31:34.327683
NCT00188708|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-23|||April 2001||2001-04-01|March 2017|2017-03-01|April 2018|Anticipated|2018-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Casodex on Tumour Hypoxia - Prostate Cancer|A Study of the Effect of Neoadjuvant Bicalutamide (Casodex) on Tumour Hypoxia in Patients With Clinically Localized Prostate Cancer|Active, not recruiting||Phase 2|30|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:31:34.405231|2017-10-11 05:31:34.405231
NCT00188721|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-11|||July 2006||2006-07-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Observational|||Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.|Transillumination for Breast Cancer Risk Assessment|Completed||N/A|500|Anticipated|University Health Network, Toronto|||2||f||||f||||||||||2017-10-11 05:31:34.49059|2017-10-11 05:31:34.49059
NCT00188734|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-09|||September 2003||2003-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Early Lung Cancer Detection Using Computed Tomography|Lung Cancer Screening in High-risk Smokers Using Low-dose Computed Tomography|Completed||N/A|5000|Actual|University Health Network, Toronto|||1||f||||||||||||||2017-10-11 05:31:34.569341|2017-10-11 05:31:34.569341
NCT00188747|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-10|||June 2005||2005-06-01|April 2006|2006-04-01||||||||Interventional|||Comparison of Three Management Strategies for Post Cardiac Surgery Bleeding|Comparison of Three Management Strategies for Post Cardiac Surgery Coagulopathy.|Completed||Phase 4|150||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:34.637803|2017-10-11 05:31:34.637803
NCT00188760|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-10-06|||May 2004||2004-05-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|||||Observational|||Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue Density|Optical Quantification of Breast Density Changes Due to Hormone Treatment, Pregnancy and Breast-feeding.|Completed||N/A|300|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 05:31:34.703593|2017-10-11 05:31:34.703593
NCT00188773|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-04|||January 2004||2004-01-01|June 2007|2007-06-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Interventional|||Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion||Completed||Phase 4|15|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-10-11 05:31:34.777392|2017-10-11 05:31:34.777392
NCT00188786|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-11|||April 2005||2005-04-01|February 2011|2011-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Cone Beam CT for Daily Image Guidance - Prostate Cancer|A Phase II Feasibility Study of Cone Beam Computed Tomography for Daily Image Guidance in Patients Receiving Dose Escalated Conformal Radiation Therapy for Prostate Cancer|Completed||Phase 2|30|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:34.86834|2017-10-11 05:31:34.86834
NCT00188799|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-07-15|||November 2003||2003-11-01|July 2015|2015-07-01|November 2004||2004-11-01|||||Interventional|||Xray Volume Imaging (Cone Beam CT) - Prostate Cancer|A Clinical Study of X-ray Volume Imaging to Evaluate the Daily Set-up Accuracy of Conformal Prostate Radiotherapy|Completed||Phase 2|30||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:34.934358|2017-10-11 05:31:34.934358
NCT00188812|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-01-09|||May 2004||2004-05-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease|Open-Label, Multicentre, One Year Extension of the Evaluation of the Safety of Donepezil Hcl in Patients With Dementia Associated With Cerebrovascular Disease|Completed||Phase 3|||University Health Network, Toronto|||||||||||||||||||2017-10-11 05:31:35.007016|2017-10-11 05:31:35.007016
NCT00188825|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-03|||May 2004||2004-05-01|May 2017|2017-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant|A Randomized, Double Blind, Placebo Controlled Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans Syndrome in Bilateral Lung and Single Lung Transplant Patients|Completed||Phase 3|22|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-10-11 05:31:35.088369|2017-10-11 05:31:35.088369
NCT00188838|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||July 2002||2002-07-01|July 2005|2005-07-01|August 2006||2006-08-01|||||Interventional|||Psychoeducation Versus Cognitive-Behavioral Therapy in Bipolar Disorder|Psychoeducation Versus Cognitive-Behavioral Therapy in Bipolar Disorder|Unknown status|Active, not recruiting|N/A|210||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:35.180393|2017-10-11 05:31:35.180393
NCT00188851|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2001||2001-01-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||Structured Treatment Interruption for HIV Patients With Virologic Failure|A Prospective Randomized Trial of Structured Treatment Interruption(STI) Followed by Initiation of a New Antiretroviral Regimen(ARV) Versus Immediate Switching to a New ARV in HIV-Infected Patients Experiencing Virologic Failure on HAART|Completed||N/A|196||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:35.291836|2017-10-11 05:31:35.291836
NCT00188864|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-28|||November 2003||2003-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Dexamethasone for Palliation - Brain Metastases|Dexamethasone as Palliative Treatment in Addition to Radiation Therapy for Patients With Brain Metastases: A Prospective Study|Active, not recruiting||Phase 2|50|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:35.372811|2017-10-11 05:31:35.372811
NCT00188877|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-21|||June 2003||2003-06-01|September 2017|2017-09-01|June 2018|Anticipated|2018-06-01|June 2008|Actual|2008-06-01||Interventional|||Intensity Modulated Radiation Therapy for Head and Neck Cancer|A Phase II Study of Intensity Modulated Radiation Therapy for Nasopharyngeal Cancer|Active, not recruiting||Phase 2|44|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:31:35.447825|2017-10-11 05:31:35.447825
NCT00188890|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-03-17|||March 2005||2005-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers|Early Diagnosis of Mesothelioma and Lung Cancer Following Asbestos Exposure Using Low-dose Computed Tomography|Recruiting||N/A|2000|Anticipated|University Health Network, Toronto|||1||f||||f||||||||Undecided||2017-10-11 05:31:35.535018|2017-10-11 05:31:35.535018
NCT00188903|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-08-03|||March 2004||2004-03-01|April 2008|2008-04-01|March 2010|Actual|2010-03-01|November 2007|Actual|2007-11-01||Observational|||Diastolic Dysfunction and Atrial Fibrillation in CABG Surgery|Diastolic Dysfunction and Atrial Fibrillation in Patients Undergoing Coronary Revascularization Surgery|Completed||N/A|250|Anticipated|University Health Network, Toronto|||1||f||||||||||||||2017-10-11 05:31:35.611548|2017-10-11 05:31:35.611548
NCT00188929|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-12|||August 2005||2005-08-01|August 2010|2010-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma|Spatio-temporal Response of Non-Hodgkin's Lymphoma to External Beam Radiation Therapy Measuring 18F-Fluorodeoxyglucose (FDG) Uptake Using a Combined PET/CT Scanner: A Pilot Study|Completed||Phase 2|10|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:35.738224|2017-10-11 05:31:35.738224
NCT00188942|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-06|||February 2005||2005-02-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder|Neural Correlates of Emotional Processing in Depressed and Remitted Bipolar and Unipolar Depressed Subjects: An fMRI Investigation|Completed||Phase 4|42|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:31:35.809242|2017-10-11 05:31:35.809242
NCT00188955|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2010-02-19|||March 2004||2004-03-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|||||Interventional|||Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant|Phase 4 Randomized, Controlled Study Comparing Sirolimus and Mycophenolate Mofetil to Prevent or Reverse Progression in Pediatric Renal Transplants With Chronic Allograft Nephropathy|Completed||Phase 4|40||University of Manitoba|||||f||||||||||||||2017-10-11 05:31:35.906503|2017-10-11 05:31:35.906503
NCT00188968|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-30|||November 2004||2004-11-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Randomized Trial of Nasal Continuous Positive Airway Pressure or Synchronized Nasal Ventilation in Premature Infants.|A Randomized, Controlled Trial of Synchronized Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Airway Pressure Using the Infant Flow Advance to Facilitate Successful Extubation in Premature Infants.|Completed||Phase 3|48|Actual|University of Manitoba||2|||f||||t||||||||||2017-10-11 05:31:35.995976|2017-10-11 05:31:35.995976
NCT00188981|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-19|||June 2003||2003-06-01|April 2007|2007-04-01|June 2008|Anticipated|2008-06-01|||||Observational|||Dutch Prediction of Psychosis Study|Dutch Prediction of Psychosis Study|Unknown status|Active, not recruiting|N/A|120||UMC Utrecht|||||f||||f||||||||||2017-10-11 05:31:36.068432|2017-10-11 05:31:36.068432
NCT00188994|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-28|||August 1999||1999-08-01|July 2005|2005-07-01||||||||Interventional|||Insulin Cardioplegia for Poor Left Ventricular Function|Insulin Cardioplegia Trial for Poor Left Ventricular Function|Unknown status|Recruiting|N/A|800||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:31:36.132213|2017-10-11 05:31:36.132213
NCT00189007|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2012-03-28|||October 2009||2009-10-01|March 2012|2012-03-01|December 2016|Anticipated|2016-12-01|December 2011|Actual|2011-12-01||Interventional|||Antenatal Allopurinol During Fetal Hypoxia|Does Antenatal Allopurinol Administration Reduce Post-hypoxic-ischemic Reperfusion Damage During Fetal Hypoxia in the Newborn?|Unknown status|Active, not recruiting|Phase 3|222|Actual|UMC Utrecht||2|||f||||t||||||||||2017-10-11 05:31:36.219635|2017-10-11 05:31:36.219635
NCT00189020|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-08-19|||June 2005||2005-06-01|August 2011|2011-08-01||||February 2008|Actual|2008-02-01||Interventional|MNOES||Effect of Two Versus Three Pneumococcal Conjugate Vaccinations|Effect of 2 Versus 3 Pneumococcal Conjugate Vaccinations Prevnar on Nasopharyngeal Carriage, Transmission and Herd-immunity;a Randomized, Controlled Study|Completed||Phase 3|1005|Actual|UMC Utrecht||3|||f||||t||||||||||2017-10-11 05:31:36.344666|2017-10-11 05:31:36.344666
NCT00189033|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-04-19|||April 2005||2005-04-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre?|Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre? A Randomized Controlled Trial in Primary Care.|Completed||N/A|285||UMC Utrecht|||||f||||||||||||||2017-10-11 05:31:36.436447|2017-10-11 05:31:36.436447
NCT00189046|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2004||2004-01-01|December 2004|2004-12-01|April 2005||2005-04-01|||||Observational|||Effects of Pain on Driving Performance and Cognition.|Effects of Pain on Driving Performance, Attentional Capacity and Psychomotor Performances: a Comparative Study Between Healthy Controls and Chronic Pain Patients.|Terminated||Phase 4|30||UMC Utrecht|||||f||||||||||||||2017-10-11 05:31:36.521226|2017-10-11 05:31:36.521226
NCT00189059|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2002||2002-10-01|April 2005|2005-04-01|May 2005||2005-05-01|||||Interventional|||Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.|Effects of Pain and the Treatment of Pain With Amitriptyline on Driving Performance, Attentional Capacity and Psychomotor Performance in Chronic Neuropathic Pain Patients|Terminated||Phase 4|24||UMC Utrecht|||||f||||||||||||||2017-10-11 05:31:36.575723|2017-10-11 05:31:36.575723
NCT00189072|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||April 2003||2003-04-01|May 2005|2005-05-01||||||||Interventional|||Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition|Effects of Pain and the Treatment of Pain With Gabapentin (900-3600 Mg) on Driving Ability, Attentional Capacity and Psychomotor Performance in Chronic Neuropathic Pain Patients|Terminated||Phase 4|24||UMC Utrecht|||||f||||||||||||||2017-10-11 05:31:36.640054|2017-10-11 05:31:36.640054
NCT00189085|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-09|||December 2004||2004-12-01|August 2004|2004-08-01|July 2005||2005-07-01|||||Interventional|||Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function|The Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Dysfunction in Patients With the Metabolic Syndrome.|Completed||Phase 4|20||UMC Utrecht|||||f||||||||||||||2017-10-11 05:31:36.702756|2017-10-11 05:31:36.702756
NCT00189098|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-06-08|2012-04-12||February 2003||2003-02-01|April 2012|2012-04-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Interventional|||Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media|Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media|Completed||N/A|101|Actual|UMC Utrecht||2|||f||||||||||||||2017-10-11 05:31:36.790534|2017-10-11 05:31:36.790534
NCT00189111|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-11-13|||January 2005||2005-01-01|November 2008|2008-11-01|April 2012|Anticipated|2012-04-01|||||Interventional|||Non-Invasive Cardiac Screening in High Risk Patients -The GROUND Study|Non-Invasive Cardiac Screening in High Risk Patients -The GROUND Study|Unknown status|Recruiting|Phase 3|1200|Anticipated|UMC Utrecht|||||f||||||||||||||2017-10-11 05:31:37.119868|2017-10-11 05:31:37.119868
NCT00189124|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-17|||September 2003||2003-09-01|May 2016|2016-05-01|July 2006|Actual|2006-07-01|December 2005|Actual|2005-12-01||Interventional|||Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention|Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus?|Completed||Phase 2/Phase 3|13|Actual|University of Michigan||2|||||||||||||||||2017-10-11 05:31:37.225688|2017-10-11 05:31:37.225688
NCT00189137|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-11-06|2014-11-17||August 2004||2004-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma|Phase II Evaluation of Ifosfamide Plus Doxorubicin & Filgrastim Versus Gemcitabine Plus Docetaxel & Filgrastim in the Treatment of Localized Poor Prognosis Soft Tissue Sarcoma|Completed||Phase 2|84|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-10-11 05:31:37.41992|2017-10-11 05:31:37.41992
NCT00189150|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-23|||April 2005||2005-04-01|May 2016|2016-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Pharmacokinetics of Mmf and Valganciclovir|Pharmacokinetics of Mycophenolate Mofetil Alone and in Combination With Valganciclovir in Renal and Heart Transplant Recipients|Completed||Phase 4|16|Actual|University of Michigan|||||f||||||||||||||2017-10-11 05:31:37.917019|2017-10-11 05:31:37.917019
NCT00189163|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-12-15|||January 2005||2005-01-01|December 2016|2016-12-01||||December 2007|Actual|2007-12-01||Interventional|||Pioglitazone in Hepatitis C|Pioglitazone in Hepatitis C: A Randomized, Double Blind, Placebo-controlled Study|Completed||Phase 4|40|Actual|University of Michigan||2|||f||||||||||||||2017-10-11 05:31:38.001184|2017-10-11 05:31:38.001184
NCT00189176|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2013-02-05|||March 2003||2003-03-01|February 2013|2013-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis|Phase I/II Trial of Tetrathiomolybdate (TM) in Patients With Usual Interstitial Pneumonia Refractory to Previous Therapy|Completed||Phase 1/Phase 2|23|Actual|University of Michigan||1|||f||||||||||||||2017-10-11 05:31:38.121158|2017-10-11 05:31:38.121158
NCT00189189|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-01|||July 2003||2003-07-01|July 2005|2005-07-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Prevention of Oppositional Defiant and Conduct Disorders in Preschool Children|Parent Management Training to Prevent Oppositional Defiant and Conduct Disorders in Preschool Children|Unknown status|Recruiting|N/A|160|Anticipated|UMC Utrecht|||||f||||||||||||||2017-10-11 05:31:38.200407|2017-10-11 05:31:38.200407
NCT00189202|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-20|2017-02-20||August 2004||2004-08-01|February 2017|2017-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||From the 49 consented, 5 were not begun on treatment or removed very early on for clinical reasons, so they are not included in baseline data.|Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans|Efficacy of Sirolimus-Based, Steroid Avoidance Maintenance Immunosuppression in Black de Novo Kidney Transplant Recipients|Completed||Phase 2/Phase 3|49|Actual|University of Michigan||1|||f||||||||||||||2017-10-11 05:31:38.316859|2017-10-11 05:31:38.316859
NCT00189215|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-03|||March 1998||1998-03-01|March 2005|2005-03-01|December 2005||2005-12-01|||||Interventional|||Long-Term Cognitive Decline After Coronary Artery Bypass Grafting: is Off-Pump Surgery Beneficial?|Long-Term Cognitive Decline After Coronary Artery Bypass Grafting: is Off-Pump Surgery Beneficial?|Completed||Phase 4|280||UMC Utrecht|||||f||||||||||||||2017-10-11 05:31:38.583896|2017-10-11 05:31:38.583896
NCT00189241|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-25|||February 2001||2001-02-01|August 2010|2010-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma|An Open-Label Study to Evaluate the Safety and Long-Term Clinical Efficacy of Imiquimod 5% Cream Applied Once Daily 5 Days Per Week for 6 Weeks in the Treatment of Superficial Basal Cell Carcinoma|Completed||Phase 3|160||MEDA Pharma GmbH & Co. KG|||||||||||||||||||2017-10-11 05:31:38.755085|2017-10-11 05:31:38.755085
NCT00189254|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-28|||April 2005||2005-04-01|April 2015|2015-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ|A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1487-IMIQ Study|Completed||Phase 3|72||MEDA Pharma GmbH & Co. KG|||1||||||||||||||||2017-10-11 05:31:38.818082|2017-10-11 05:31:38.818082
NCT00189267|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-11-19|||November 2002||2002-11-01|August 2006|2006-08-01|September 2005|Actual|2005-09-01|||||Interventional|||A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients|Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream Applied Once Daily 3 Days Per Week for the Treatment of Actinic Keratoses in Immunosuppressed Organ Transplant Recipients.|Completed||Phase 2|45||MEDA Pharma GmbH & Co. KG|||||||||||||||||||2017-10-11 05:31:38.89803|2017-10-11 05:31:38.89803
NCT00189280|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-24|||May 2003||2003-05-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Aldara for the Treatment of Large and/or Multiple sBCC|Open Study to Evaluate the Efficacy and Tolerance of Imiquimod 5% Cream for the Treatment of a Large and/or Multiple Superficial Basal Cell Carcinoma.|Completed||Phase 3|111|Actual|MEDA Pharma GmbH & Co. KG||1|||f||||||||||||||2017-10-11 05:31:38.961085|2017-10-11 05:31:38.961085
NCT00189293|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-01-05|||June 2005||2005-06-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts|Multicenter, Randomised, Double-blind, Vehicle-controlled Study Comparing Recurrence Rate Following Imiquimod 5% Cream or Vehicle 3 Times Per Week for 4 Weeks Prior to Ablative Therapy in Subjects Suffering From External Ano-Genital Warts|Completed||Phase 4|128|Actual|MEDA Pharma GmbH & Co. KG||2|||f||||||||||||||2017-10-11 05:31:39.053083|2017-10-11 05:31:39.053083
NCT00189306|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-08-05|2008-10-30||March 2001||2001-03-01|August 2010|2010-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream|An Open-label Study to Evaluate the Safety and Long-Term Clinical Efficacy of Imiquimod 5% Cream Applied Once Daily 7 Days Per Week for 6 Weeks in the Treatment of Superficial Basal Cell Carcinoma|Completed||Phase 3|169|Actual|Graceway Pharmaceuticals, LLC||1|||f||||f||||||||||2017-10-11 05:31:39.180873|2017-10-11 05:31:39.180873
NCT00189319|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-02-20|||September 2003||2003-09-01|September 2006|2006-09-01||||||||Interventional|||To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation|Impact of Oral Controlled Release Flecainide Acetate Capsules on Health-Related QoL in Patients With Paroxysmal Atrial Fibrillation|Completed||Phase 4|200||MEDA Pharma GmbH & Co. KG|||||f||||||||||||||2017-10-11 05:31:39.519385|2017-10-11 05:31:39.519385
NCT00189332|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-24|||February 2005||2005-02-01|October 2008|2008-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Use of 852A in Metastatic Cutaneous Melanoma.|Pilot Phase II, Open Label, Multicenter, Efficacy and Safety Study of 852A Administered Intravenously to Subjects With Unresectable Metastatic Cutaneous Melanoma.|Completed||Phase 2|28||Pfizer|||||f||||||||||||||2017-10-11 05:31:39.592549|2017-10-11 05:31:39.592549
NCT00189345|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-07|||May 2004||2004-05-01|December 2003|2003-12-01|October 2005||2005-10-01|||||Interventional|||Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients|Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients|Completed||Phase 2|44||AGO Study Group|||||f||||||||||||||2017-10-11 05:31:39.665426|2017-10-11 05:31:39.665426
NCT00189358|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-19||||||July 2010|2010-07-01||||||||Interventional|||A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy|A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy|Completed||Phase 2|||AGO Study Group|||||f||||||||||||||2017-10-11 05:31:39.730086|2017-10-11 05:31:39.730086
NCT00189371|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-16|||February 2004||2004-02-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Interventional|||Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum|Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum|Terminated||Phase 3|300||AGO Study Group|||||f||||||||||||||2017-10-11 05:31:39.807281|2017-10-11 05:31:39.807281
NCT00189384|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-07|||November 2003||2003-11-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants|Randomized Controlled Trial of Intramuscular Ceftriaxone Versus Procaine Penicillin Versus Cotrimoxazole and Gentamicin for Management of Serious Bacterial Infections in Young Infants in Community Settings|Unknown status|Active, not recruiting|Phase 3|426||Aga Khan University|||||f||||||||||||||2017-10-11 05:31:39.882778|2017-10-11 05:31:39.882778
NCT00189397|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-06|||February 2003||2003-02-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|October 2005|Actual|2005-10-01||Interventional|||Azathioprine Versus Corticosteroids in Parthenium Dermatitis|Azathioprine Versus Corticosteroids for the Treatment of Parthenium Dermatitis|Completed||N/A|||All India Institute of Medical Sciences, New Delhi|||||f||||t||||||||||2017-10-11 05:31:39.97513|2017-10-11 05:31:39.97513
NCT00189410|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-19|||June 2003||2003-06-01|July 2010|2010-07-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours|Phase II Trial With Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin (PLD) and Carboplatin in Malignant Gynecologic Tumour's|Completed||Phase 2|140|Actual|AGO Study Group||1|||f||||||||||||||2017-10-11 05:31:40.059114|2017-10-11 05:31:40.059114
NCT00189423|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|2012-03-01||October 2005||2005-10-01|July 2016|2016-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|ResQ||ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest|ResQ Trial: Comparison of Standard CPR Alone Versus Active Compression Decompression CPR Plus an ITD on Survival From Out-of-Hospital Cardiac Arrest|Terminated||N/A|1653|Actual|Advanced Circulatory Systems||2||Terminated due to lack of funding. Follow-up completed for all enrolled subjects.|f||||t||||||||||2017-10-11 05:31:40.19183|2017-10-11 05:31:40.19183
NCT00189436|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-08|2014-07-08||March 2003||2003-03-01|July 2014|2014-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|BudER|61 subjects were enrolled and 31 were randomized to nebulized budesonide and 30 to standard of care. 74% of subjects enrolled in the nebulized budesonide and 83% enrolled in the standard care group completed the study.|Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children|A Pilot Study to Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Pediatric Patients Following Discharge From the Emergency Department/Outpatient Care Facility|Completed||Phase 4|61|Actual|West Penn Allegheny Health System||2|||f||||||||||||||2017-10-11 05:31:40.668698|2017-10-11 05:31:40.668698
NCT00189449|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-30||||||April 2008|2008-04-01|June 2007||2007-06-01|||||Observational|||Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis|Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis|Completed||Phase 4|||West Penn Allegheny Health System|||||f||||||||||||||2017-10-11 05:31:40.855504|2017-10-11 05:31:40.855504
NCT00189462|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-10-13|2014-09-23||March 2004||2004-03-01|October 2014|2014-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children|A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children|Completed||Phase 4|99|Actual|West Penn Allegheny Health System||2|||f||||f||||||||||2017-10-11 05:31:40.91566|2017-10-11 05:31:40.91566
NCT00189475|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-10-13|2014-09-23||October 2003||2003-10-01|October 2014|2014-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds|A Pilot Study to Evaluate the Potential of Montelukast to Prevent the Development of Nasal Symptomatology During Natural Viral Upper Respiratory Infections|Completed||Phase 4|84|Actual|West Penn Allegheny Health System||2|||f||||f||||||||||2017-10-11 05:31:41.152684|2017-10-11 05:31:41.152684
NCT00189488|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-09-12|2009-11-25||December 2005||2005-12-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|November 2008|Actual|2008-11-01||Interventional|||Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation|A Randomized, Double-blind, Placebo-controlled Trial to Evaluate Palifermin (rHuKGF) in the Reduction of Acute Graft Versus Host Disease in Subjects With Hematologic Malignancies Undergoing Allogeneic Marrow/PBPC Transplantation|Completed||Phase 2|155|Actual|Swedish Orphan Biovitrum||2|||f||||||||||||||2017-10-11 05:31:41.392685|2017-10-11 05:31:41.392685
NCT00189501|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-20|||December 2004||2004-12-01|December 2007|2007-12-01||||||||Observational|||A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)|A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)|Completed||N/A|1000||Amgen|||||f||||||||||||||2017-10-11 05:31:43.398353|2017-10-11 05:31:43.398353
NCT00189514|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-10|||September 2005||2005-09-01|May 2015|2015-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects|Extension Study of Protocol 137OB-201 to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects|Completed||Phase 2|210|Actual|AstraZeneca||4|||f||||f||||||||||2017-10-11 05:31:43.48152|2017-10-11 05:31:43.48152
NCT00189527|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-16|||January 2006||2006-01-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Assist Control Versus Pressure Support Modes for Domiciliary Noninvasive Ventilation in Chronic Respiratory Failure|Assist Control Versus Pressure Support Modes for Domiciliary Noninvasive Ventilation|Completed||N/A|100|Actual|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche||2|||f||||f||||||||||2017-10-11 05:31:43.607769|2017-10-11 05:31:43.607769
NCT00189553|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-01-09|||April 2005||2005-04-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|January 2009|Actual|2009-01-01||Interventional|CALYPSO||Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse|A Multi-National,Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin and Carboplatin Versus Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse (> 6 Months)|Completed||Phase 3|976|Actual|ARCAGY/ GINECO GROUP||2|||f||||t||||||||||2017-10-11 05:31:44.642082|2017-10-11 05:31:44.642082
NCT00189566|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-24|||April 2004||2004-04-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|||||Interventional|||Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse|National, Randomized, Phase II Study Comparing Efficacy of Weekly Administration of Paclitaxel in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse|Completed||Phase 2|165|Anticipated|ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-10-11 05:31:44.767578|2017-10-11 05:31:44.767578
NCT00189579|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-16||||||August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer|A Phase II Study Designed to Evaluate the Safety and Efficacy of the Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Early Relapse Patients (< 6 Months) With Ovarian Cancer, Overexpressing HER2, Previously Treated With Carboplatin-Paclitaxel|Terminated||Phase 2|45|Anticipated|ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-10-11 05:31:44.850382|2017-10-11 05:31:44.850382
NCT00189592|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-25|||August 2005||2005-08-01|August 2015|2015-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Plantar Fasciosis Treatment Using Coblation|Plantar Fasciosis Treatment Using Coblation® Prospective, Double-Blind, Randomized Controlled Study|Completed||Phase 4|45|Actual|ArthroCare Corporation||2|||f||||f||||||||||2017-10-11 05:31:44.91703|2017-10-11 05:31:44.91703
NCT00189605|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-08-25|||September 2004||2004-09-01|August 2015|2015-08-01|April 2009|Actual|2009-04-01|December 2007|Actual|2007-12-01||Interventional|SPINE||Prospective, Randomized, Multi-center Clinical Study of Plasma Disc Decompression|Prospective, Randomized, Multi-center Clinical Study of Plasma Disc Decompression Efficacy|Completed||Phase 4|90|Actual|ArthroCare Corporation||2|||f||||f||||||||||2017-10-11 05:31:45.020924|2017-10-11 05:31:45.020924
NCT00189618|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-03|||May 2005||2005-05-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)|The Effects of Physical Training, Aspirin, and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease|Completed||Phase 4|250|Anticipated|Arteriogenesis Competence Network||2|||f||||t||||||||||2017-10-11 05:31:45.135068|2017-10-11 05:31:45.135068
NCT00189631|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-07||||||September 2005|2005-09-01||||||||Interventional|||UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy||Unknown status|Recruiting|Phase 3|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-10-11 05:31:45.254849|2017-10-11 05:31:45.254849
NCT00189644|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Interventional|||6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer||Unknown status|Active, not recruiting|Phase 3|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-10-11 05:31:45.331854|2017-10-11 05:31:45.331854
NCT00195208|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-07|||June 2005||2005-06-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis|A Randomized, 2-Period, Crossover, Pharmacodynamic Comparability Study Comparing A Pantoprazole Spheroid Formulation to the Currently Marketed Tablet Formulation in Subjects With GERD and a History of Erosive Esophagitis.|Completed||Phase 3|97|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:31:45.405061|2017-10-11 05:31:45.405061
NCT00195221|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-03|||February 2005||2005-02-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Observational|||Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B|A Retrospective Study to Describe the Incidence of Moderate to Severe Allergic Reactions to Factor IX in Patients With Hemophilia B|Completed||Phase 4|166||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:31:46.892247|2017-10-11 05:31:46.892247
NCT00195234|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-03|||December 2004||2004-12-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evaluating Vaccine in Adults With HIV|A Phase 1 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of an HIV CTL Multi-Epitope Peptide Vaccine Formulated With RC529-SE and GM-CSF Given to HIV-1 Positive Adults on Stable HAART.|Completed||Phase 1|60||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:31:47.055011|2017-10-11 05:31:47.055011
NCT00195247|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-03-22|||May 2005||2005-05-01|March 2007|2007-03-01||||||||Interventional|||Study Evaluating TTI-237 in Advanced Malignant Solid Tumors|A Phase 1 Dose Escalation Study of TTI-237 Administered Intravenously Every 3 Weeks in Subjects With Advanced Malignant Solid Tumors|Terminated||Phase 1|45||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:31:47.143664|2017-10-11 05:31:47.143664
NCT00195260|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-01-03|2012-10-04||October 2004||2004-10-01|January 2013|2013-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors|Phase I Dose-Escalation Study Of Oral SKI-606 In Subjects With Advanced Malignant Solid Tumors|Completed||Phase 1|151|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 05:31:47.377834|2017-10-11 05:31:47.377834
NCT00195273|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-04-22|2009-07-31||November 2004||2004-11-01|April 2010|2010-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating Sirolimus in Kidney Transplant Recipients|A Randomized Open-Label Study Comparing the Efficacy and Safety of Sirolimus Combined With Daclizumab, Mycophenolate and Corticosteroids vs Cyclosporine, Mycophenolate and Corticosteroids in Renal Allograft Recipients Receiving Kidneys From Older Donors|Completed||Phase 3|61|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-10-11 05:31:54.718234|2017-10-11 05:31:54.718234
NCT00195286|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-09-24|||June 2004||2004-06-01|September 2009|2009-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.|Study of the Safety and Efficacy of Piperacillin/Tazobactam in the Treatment of Patients With Complicated Urinary Infections.|Completed||Phase 4|180|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-10-11 05:31:55.805505|2017-10-11 05:31:55.805505
NCT00195299|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-18|||April 2005||2005-04-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Observational|||Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck|An Exploratory Biomarker Trail of Temsirolimus in Subjects With Newly Diagnosed Advanced Stage Squamous Cell Carcinoma of the Head & Neck|Completed||N/A|20||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:31:55.923533|2017-10-11 05:31:55.923533
NCT00195312|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-05|2007-12-03|||August 2005||2005-08-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating Vaccine in Adults With HIV|A Phase 1 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine Administered Alone or With Escalating Doses of IL-12 DNA or IL-15 DNA Molecular Adjuvants to HIV-1 Positive Adults Receiving Stable HAART.|Terminated||Phase 1|91|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:31:56.001834|2017-10-11 05:31:56.001834
NCT00195325|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-03-22|||August 2005||2005-08-01|March 2007|2007-03-01||||||||Interventional|||Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.|A Phase 1 Dose Escalation Study of TTI-237 Administered Intravenously (IV) Once Weekly in Subjects With Advanced Malignant Solid Tumors.|Terminated||Phase 1|45||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:31:56.098101|2017-10-11 05:31:56.098101
NCT00195338|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-12-16|2011-12-16||May 2004||2004-05-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg|A Post-Marketing Surveillance Looking At Safety And Adherence To Treatment Of Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg|Completed||N/A|25|Actual|Pfizer|||1||f||||t||||||||||2017-10-11 05:31:56.176927|2017-10-11 05:31:56.176927
NCT00195351|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-20|2009-02-27||September 2005||2005-09-01|February 2013|2013-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection|A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection|Completed||Phase 4|467|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-10-11 05:31:56.61818|2017-10-11 05:31:56.61818
NCT00195364|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-03|||July 2003||2003-07-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain|Long-Term Safety Study of Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain|Completed||Phase 4|93||Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-10-11 05:31:57.47009|2017-10-11 05:31:57.47009
NCT00195377|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-17|||April 2003||2003-04-01|June 2009|2009-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain|Evaluating Safety and QoL in Patients Treated With Etanercept: an Open Multicenter Study|Completed||Phase 4|1000||Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-10-11 05:31:57.536682|2017-10-11 05:31:57.536682
NCT00195390|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-24|||July 2004||2004-07-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|||||Observational|||Study Investigating Administration of Prevenar for Post-Marketing Surveillance|Investigation of Prevenar (Pneumococcal 7-Valent Conjugate Vaccine) Administration for Post-Marketing Surveillance|Completed||Phase 4|600|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-10-11 05:31:57.598788|2017-10-11 05:31:57.598788
NCT00195403|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-06-11|2013-06-11||May 2004||2004-05-01|June 2013|2013-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational||Safety population included all participants who received at least (>=) 1 dose of study medication and had the safety assessment through appropriate follow-up.|A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA|A Drug Use Investigation of Enbrel for Post-Marketing Surveillance|Completed||N/A|1014|Actual|Pfizer|||1||f||||f||||||||||2017-10-11 05:31:57.673407|2017-10-11 05:31:57.673407
NCT00195416|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-09-15|||June 2005||2005-06-01|September 2009|2009-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Study Investigating Enbrel Treatment for Ankylosing Spondylitis|A Drug Use Investigation of Enbrel for Post-marketing Surveillance (PMS) for Ankylosing Spondylitis|Completed||Phase 4|526|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-10-11 05:31:58.014427|2017-10-11 05:31:58.014427
NCT00195429|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-04-22|2008-12-19||August 2005||2005-08-01|April 2010|2010-04-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients|A Randomized, Open-label and Multicenter Trial Comparing Withdrawal of Steroids or Tacrolimus From Sirolimus-based Immunosuppressive Regimen in de Novo Renal Allograft Recipients|Completed||Phase 4|47|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-10-11 05:31:58.107092|2017-10-11 05:31:58.107092
NCT00195442|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-07|2011-01-12||July 1999||1999-07-01|February 2011|2011-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Study Evaluating Refacto For Pharmacovigilance|Pharmacovigilance Evaluation Of Refacto In Usual Care Settings|Completed||N/A|288|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-10-11 05:31:58.442263|2017-10-11 05:31:58.442263
NCT00195455|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-17|||February 2005||2005-02-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.|A Prospective Open Label Study to Evaluate Vasomotor Symptoms Control and Bleeding Patterns With a Continuous Regimen of a New Progestin Trimegestone 0.125 mg and 17 b Estradiol 1 mg (Totelle),as HT on Postmenopausal Women|Completed||Phase 4|133|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:31:59.722308|2017-10-11 05:31:59.722308
NCT00195468|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-03-07|||March 2004||2004-03-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus|A Randomized, Open-label Study to Compare the Safety and Efficacy of Cyclosporine Dose Reduction With Cyclosporine Elimination in De Novo Renal Allograft Recipients Receiving Rapamune.|Completed||Phase 4|280|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:31:59.94788|2017-10-11 05:31:59.94788
NCT00195481|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-21|||April 2004||2004-04-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study Evaluating Sirolimus in Kidney Transplant Recipients in India|A Post Marketing Surveillance Looking at Safety of Rapamune (Sirolimus) in Indian Population Undergoing de Novo Renal Transplantation.|Completed||Phase 4|100||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:32:00.070682|2017-10-11 05:32:00.070682
NCT00195494|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-01|2009-03-31||November 2004||2004-11-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis|A 24-Month,Randomized,Double-Blind,Two-Period Study to Evaluate the Efficacy and Safety of the Combination of Etanercept and Methotrexate and Methotrexate Alone in Subjects With Early Rheumatoid Arthritis|Completed||Phase 4|542|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-10-11 05:32:00.206018|2017-10-11 05:32:00.206018
NCT00195507|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-02-20|2009-03-31||December 2004||2004-12-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis|A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects With Psoriasis|Completed||Phase 4|720|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:32:02.920044|2017-10-11 05:32:02.920044
NCT00195520|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-08-01|||December 2004||2004-12-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function|An Open Assessment of the Effect of Low-Dose Totelle® 1 mg on Menopausal Symptoms, Sexual Function and Quality of Life|Completed||Phase 4|100|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:32:04.121022|2017-10-11 05:32:04.121022
NCT00195533|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-11-13|||July 2001||2001-07-01|November 2009|2009-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Observational|||Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients|Monotherapy With Piperacillin-tazobactam Versus Combination Therapy With Piperacillin-tazobactam Plus Glycopeptide as an Initial Empiric Therapy for Fever in Neutropenic Patients. An Observational Prospective Study.|Completed||Phase 4|801|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||Samples Without DNA|"     Whole blood   "|||2017-10-11 05:32:04.206601|2017-10-11 05:32:04.206601
NCT00198887|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-07-03|||January 2003||2003-01-01|July 2007|2007-07-01|October 2006|Actual|2006-10-01|||||Interventional|||Operations Research to Improve Newborn Health|Operations Research to Improve Newborn Health and Survival in the (INHP-II) Area of CARE/India|Completed||N/A|59651|Actual|Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:32:04.329711|2017-10-11 05:32:04.329711
NCT00198900|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2000||2000-01-01|April 2000|2000-04-01|March 2000||2000-03-01|||||Observational|||Diabetes Knowledge Assessment|Use of Modified Foods in the Dietary Treatment of Type II Diabetes Mellitus: Knowledge Assessment|Completed||N/A|350||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:32:04.409249|2017-10-11 05:32:04.409249
NCT00198913|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2002||2002-06-01|April 2003|2003-04-01|February 2003||2003-02-01|||||Interventional|||Long Term Free Living Study With Modified Foods and Type 2 Diabetics|Use of Modified Foods in the Dietary Treatment of Type II Diabetes Mellitus: Long Term Free Living Study|Completed||N/A|100||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:32:04.492838|2017-10-11 05:32:04.492838
NCT00198926|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 2000||2000-05-01|September 2001|2001-09-01|August 2001||2001-08-01|||||Interventional|||Type 2 Diabetes Controlled Eating Experiment|Use of Modified Foods in the Dietary Treatment of Type II Diabetes Mellitus: Short Term Feeding Study|Completed||N/A|100||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:32:04.571561|2017-10-11 05:32:04.571561
NCT00198939|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-27|||January 2005||2005-01-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Neurological Influences on Drug Prevention Intervention|Neurological Influences on Drug Prevention Intervention|Completed||Phase 1/Phase 2|330|Actual|University of Florida||4|||f||||f||||||||||2017-10-11 05:32:04.636908|2017-10-11 05:32:04.636908
NCT00198952|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||February 2000||2000-02-01|April 2002|2002-04-01|March 2001||2001-03-01|||||Interventional|||Effects of Herbal Products on Metabolism and Hunger|Effects of Herbal Products on Metabolism and Hunger|Completed||N/A|30||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:32:04.714441|2017-10-11 05:32:04.714441
NCT00198965|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||March 1999||1999-03-01|April 2004|2004-04-01|December 2003||2003-12-01|||||Interventional|||Olestra Containing Foods and Weight Loss and Weight Maintenance|Benefits of Sensory-Enhanced Products in Weight Loss and Maintenance|Completed||N/A|257||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:32:04.771875|2017-10-11 05:32:04.771875
NCT00198978|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-04|||January 2003||2003-01-01|June 2008|2008-06-01||||June 2008|Anticipated|2008-06-01||Interventional|||German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|Multicenter Study To Optimize Treatment in Elderly Patients (> 55 Years, No Upper Age Limit) With Acute Lymphoblastic Leukemia (GMALL Elderly 1/2003)(Amend 2)|Unknown status|Recruiting|Phase 4|200|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:04.833951|2017-10-11 05:32:04.833951
NCT00198991|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-29|||April 2003||2003-04-01|May 2008|2008-05-01||||December 2008|Anticipated|2008-12-01||Interventional|||German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)|German Multicenter Study for Treatment Optimisation in Acute Lymphoblastic Leukemia in Adults and Adolescents Above 15 Years (Amend 3) (GMALL 07/2003)|Unknown status|Recruiting|Phase 4|1250|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:04.929462|2017-10-11 05:32:04.929462
NCT00199004|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-20|||April 2004||2004-04-01|May 2008|2008-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab|German Multicenter Trial for Treatment Optimisation in Acute Lymphoblastic Leukemia in Adults and Adolescents Above 15 Years With Rituximab for Improvement of Prognosis in CD20 Positive Standard Risk ALL (Amend 2)|Completed||Phase 4|60|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:05.119568|2017-10-11 05:32:05.119568
NCT00199017|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-20|||April 2004||2004-04-01|May 2008|2008-05-01||||March 2009|Actual|2009-03-01||Interventional|||German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults|Multicenter Trial for Treatment Optimization in T-lymphoblastic Lymphoma in Adults and Adolescents Older Than 15 Years (GMALL T-LBL 1/2004) (Amend 1)|Completed||Phase 4|75|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:06.735017|2017-10-11 05:32:06.735017
NCT00199030|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-29|||February 2004||2004-02-01|May 2008|2008-05-01|December 2007||2007-12-01|||||Interventional|||Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath|German Multicenter Phase II Trial to Study Effectivity and Feasibility of Alemtuzumab (MabCampath®) in T-ALL and T-Lymphoblastic Lymphomas With Minimal Residual Disease (MRD), in Refractory Relapse or in Primary Failure|Completed||Phase 2|25|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:06.858134|2017-10-11 05:32:06.858134
NCT00199043|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-20|||May 2003||2003-05-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma|Randomised Phase III Trial of Effectivity and Safety of Rasburicase Compared With Allopurinol for Treatment of Hyperuricemia in Patients With Acute Lymphoblastic Leukemia or High-Grade NHL With High Risk of Tumorlysis Syndrome (> 15 Yrs)|Completed||Phase 3|80|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:06.93217|2017-10-11 05:32:06.93217
NCT00199056|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-16|||October 1999||1999-10-01|May 2008|2008-05-01||||||||Interventional|||German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)|Multicenter Trial for Treatment of Acute Lymphocytic Leukemia in Adults (Pilot Study 06/99)|Completed||Phase 4|225||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:07.0165|2017-10-11 05:32:07.0165
NCT00199069|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-16|||April 1993||1993-04-01|May 2008|2008-05-01||||||||Interventional|||German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)|Multicenter Trial for Treatment of Acute Lymphoblastic Leukemia in Adults (05/93)|Completed||Phase 4|720||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:07.111374|2017-10-11 05:32:07.111374
NCT00199082|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-04|||July 2002||2002-07-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults|Multicenter Study to Optimise Therapy of B-ALL, Burkitt's NHL and High-Grade Non-Hodgkin's Lymphoma in Adults (Amend 7)|Completed||Phase 4|650|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||f||||||||No||2017-10-11 05:32:07.197331|2017-10-11 05:32:07.197331
NCT00199095|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-16|||February 1997||1997-02-01|May 2008|2008-05-01||||||||Interventional|||Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia|Pilot Study for Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia|Completed||Phase 4|40||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:07.303994|2017-10-11 05:32:07.303994
NCT00199108|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-29|||April 2004||2004-04-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt|A Phase-2 Clinical Study to Determine the Efficacy and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of CNS Relapse in Adult Patients With Acute Lymphoblastic Leukemia or Very Aggressive Lymphoma|Unknown status|Active, not recruiting|Phase 2/Phase 3|20|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:07.384711|2017-10-11 05:32:07.384711
NCT00199121|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-13||||||July 2005|2005-07-01||||||||Interventional|||A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients|An Open, Single-Arm, Multi-Center, Phase IV Pilot Study of Treatment of Antiretroviral Naive HIV-1 Infected Patients With Tenofovir Disoproxil Fumarate in Combination With Emtricitabine and Zidovudine|Unknown status|Recruiting|Phase 4|||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:07.464308|2017-10-11 05:32:07.464308
NCT00199134|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-01-05|||November 2004||2004-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole|FRAGRANCE Trial(Femara Reanalysed Through Genomics for Response Assessment, Calibration and Empowerment)|Completed||Phase 2|49|Anticipated|Jules Bordet Institute||1|||f||||t||||||||||2017-10-11 05:32:07.5436|2017-10-11 05:32:07.5436
NCT00199147|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-10-25|||January 2000||2000-01-01|September 2005|2005-09-01||||||||Interventional|||Efficacy of G-CSF-Priming in Elderly AML Patients|Treatment of Elderly Patients (>60 Years) With Acute Myeloblastic Leukemia or Advanced MDS (RAEB-T): An Open Randomized Study to Test the Efficacy of G-CSF-Priming and a Feasibility Trial of Dose-Reduced Allogeneic Transplantation and of Autologous Stem Cell Transplantation|Unknown status|Recruiting|Phase 4|250||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:07.748642|2017-10-11 05:32:07.748642
NCT00199160|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-19|||April 2005||2005-04-01|September 2005|2005-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer||Completed||Phase 2|60|Actual|Jules Bordet Institute||1|||f||||||||||||||2017-10-11 05:32:07.844968|2017-10-11 05:32:07.844968
NCT00199966|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-03-06|||December 2003||2003-12-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|||||Interventional|||Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder|A Pilot Study Of Safety And Effectiveness For Depakote ER In Pediatric Bipolar Disorder|Completed||Phase 4|30||Medical College of Wisconsin|||||f||||f||||||||||2017-10-11 05:32:14.51265|2017-10-11 05:32:14.51265
NCT00199173|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-23||||||February 2011|2011-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only|Comparison Hepatic Intra-arterial Injection of Yttrium-90 Versus 5FU in Colorectal Cancer Metastatic to the Liver Only|Completed||Phase 3|||Jules Bordet Institute|||||f||||||||||||||2017-10-11 05:32:07.935728|2017-10-11 05:32:07.935728
NCT00199186|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-10-18|||March 2002||2002-03-01|September 2005|2005-09-01||||||||Interventional|||Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)|A Randomized, Multicenter Open Label Phase II Study to Determine the Safety and Efficacy of Induction Therapy With Imatinib in Comparison With Standard Induction Chemotherapy in Elderly (> 55 Years) Patients With Ph Positive Acute Lymphoblastic Leukemia (ALL)|Unknown status|Recruiting|Phase 2|||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-10-11 05:32:08.020762|2017-10-11 05:32:08.020762
NCT00199212|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-23|||October 2003||2003-10-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2|A Phase I, Open Label, Dose-escalating Study of the Proteasome Inhibitor PS-341 in Combination With Two Schedules of Herceptin, in Patients With Advanced Breast Cancer That Overexpresses HER-2|Completed||Phase 1|19|Actual|Jules Bordet Institute||1|||f||||f||||||||||2017-10-11 05:32:08.136248|2017-10-11 05:32:08.136248
NCT00199225|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-14|||February 2005||2005-02-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers|Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers: A Randomised, Parallel, Placebo and Positive Controlled Study|Completed||Phase 1|160||J. Uriach and Company|||||f||||||||||||||2017-10-11 05:32:08.21903|2017-10-11 05:32:08.21903
NCT00199238|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2002||2002-10-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Interventional|||Efficacy of Rupatadine 5, 10 and 20 Mg in Chronic Idiopathic Urticaria|A 4-Week Dose-Finding, Multicentre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Different Doses of Rupatadine Compared to Placebo in the Treatment of Chronic Idiopathic Urticaria|Terminated||Phase 2|248||J. Uriach and Company|||||f||||||||||||||2017-10-11 05:32:08.300688|2017-10-11 05:32:08.300688
NCT00199251|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-22|||April 2004||2004-04-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria|A 6-Week Multicentre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Rupatadine 10 and 20 Mg in the Treatment of Chronic Idiopathic Urticaria (CIU): a Phase III Clinical Trial|Terminated||Phase 3|300||J. Uriach and Company|||||f||||||||||||||2017-10-11 05:32:08.381971|2017-10-11 05:32:08.381971
NCT00199264|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-02|||June 2004||2004-06-01|October 2003|2003-10-01|October 2004||2004-10-01|||||Interventional|||Efficacy Vulvovaginitis Candida|A Single-Blind, Randomized, Dose-Finding Study Versus Fluconazole to Assess the Efficacy and Tolerability of Five Single Doses of Albaconazole in the Treatment of Acute Non-Recurrent Candida Spp Vulvovaginitis|Terminated||Phase 2|60||J. Uriach and Company|||||f||||||||||||||2017-10-11 05:32:08.464946|2017-10-11 05:32:08.464946
NCT00199277|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16||||||September 2005|2005-09-01||||||||Interventional|||Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.|Randomized, Parallel Group, Clinical Trial Comparing Intravenous Iron Sucrose Versus Oral Ferrous Sulphate in the Treatment of Perioperative Iron Deficiency in Patients With Colo-Rectal Neoplasm and Iron Deficiency Anemia.|Unknown status|Not yet recruiting|Phase 4|150||J. Uriach and Company|||||f||||||||||||||2017-10-11 05:32:08.549963|2017-10-11 05:32:08.549963
NCT00199290|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-02-01|||August 2005||2005-08-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan|A Phase 2, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and the Safety of Trafermin in Patients With Marginal Periodontitis in Japan|Completed||Phase 2|267|Actual|Kaken Pharmaceutical||4|||f||||f||||||||||2017-10-11 05:32:08.731378|2017-10-11 05:32:08.731378
NCT00199303|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||December 2002||2002-12-01|July 2002|2002-07-01|December 2003||2003-12-01|||||Interventional|||Efficacy of Pre- and Post-Operative Oral Dextromethorphan|Efficacy of Pre- and Post-Operative Oral Dextromethorphan for Reduction of Intra- and 24-Hr Post-Operative Morphine Consumption for Transabdominal Hysterectomy|Completed||N/A|100||Khon Kaen University|||||f||||||||||||||2017-10-11 05:32:08.914572|2017-10-11 05:32:08.914572
NCT00199316|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-10-31|||January 2005||2005-01-01|October 2007|2007-10-01|November 2005||2005-11-01|||||Interventional|||Postoperative Pain Control After Kidney Surgery : a Comparison of Intrathecal Morphine Plus PCA and PCA Only||Unknown status|Recruiting|N/A|80|Anticipated|Khon Kaen University||1|||f||||||||||||||2017-10-11 05:32:08.996705|2017-10-11 05:32:08.996705
NCT00199329|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-10-31|||January 2005||2005-01-01|October 2007|2007-10-01||||||||Interventional|||Antiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA)||Completed||N/A|160|Actual|Khon Kaen University||1|||f||||||||||||||2017-10-11 05:32:09.10613|2017-10-11 05:32:09.10613
NCT00199342|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-02-24|||November 2004||2004-11-01|February 2007|2007-02-01||||October 2005|Actual|2005-10-01||Interventional|||A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma|An Open-Label Study of KW-2871 Administered With a Premedication Regimen in Patients With Advanced Stage IV Melanoma|Terminated||Phase 1/Phase 2|5|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1||Occurrence of 2 dose-limiting toxicities at the initial dose level (60 mg/m2) in Part I.|f||||f||||||||||2017-10-11 05:32:09.205316|2017-10-11 05:32:09.205316
NCT00199355|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-21|||April 2005||2005-04-01|August 2012|2012-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa|Placebo-Controlled , Double-Blind , Exploratory Study of KW-6002(Istradefylline) in the Treatment of Parkinson's Disease. [Adjunctive Therapy to Levodopa]|Completed||Phase 2|75||Kyowa Hakko Kirin Co., Ltd|||||f||||f||||||||||2017-10-11 05:32:09.306561|2017-10-11 05:32:09.306561
NCT00199368|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|||October 2004||2004-10-01|July 2016|2016-07-01|May 2007|Actual|2007-05-01|March 2007|Actual|2007-03-01||Interventional|||An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018|A Long-Term, Multicenter, Open-Label Safety Study With Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa Therapy.|Completed||Phase 3|1100||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-10-11 05:32:09.39681|2017-10-11 05:32:09.39681
NCT00199381|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-10-29|2013-04-04|2011-04-04|October 2005||2005-10-01|October 2013|2013-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||503 subjects took at least 1 dose of study drug|An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001|An Open-Label Multicenter Study of the Continued Safety of Istradefylline (KW-6002) In Subjects With Parkinson's Disease Who Have Recently Completed One Year of Treatment With Istradefylline.|Terminated||Phase 3|504|Actual|Kyowa Kirin Pharmaceutical Development, Inc.|The Sponsor decided to terminate the study early (not for safety reasons); as a result 323 subjects discontinued early. Mean duration of therapy was 18.7 months (0.4 to 31.4 months); median duration was 21.0 months. Total exposure 767 subject years.|1||Additional long-term safety data no longer needed|f||||f||||||||||2017-10-11 05:32:09.490252|2017-10-11 05:32:09.490252
NCT00199394|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|||November 2004||2004-11-01|July 2016|2016-07-01|November 2005|Actual|2005-11-01|October 2005|Actual|2005-10-01||Interventional|||A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease|A 16-week, Double-Blind, Placebo-Controlled, Randomised, Parallel-Group, Multicentre, International Study to Evaluate the Efficacy and Safety of 40 mg/Day KW-6002 (Istradefylline) and That of Entacapone Versus Placebo as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa Therapy.|Completed||Phase 3|405||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-10-11 05:32:10.379903|2017-10-11 05:32:10.379903
NCT00199407|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|||June 2004||2004-06-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa|A 12-week, Double Blind, Placebo-controlled, Randomized, Parallel Group, Multicenter, Fixed Dose Study to Evaluate the Efficacy and Safety of a 20 mg/d Oral Dose of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy.|Completed||Phase 3|230||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-10-11 05:32:10.473707|2017-10-11 05:32:10.473707
NCT00199420|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|||July 2004||2004-07-01|July 2016|2016-07-01|December 2005|Actual|2005-12-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa|A 12-week, Double Blind, Placebo-controlled, Randomized, Parallel Group, Multicenter, Fixed Dose Study to Evaluate the Efficacy and Safety of 10, 20 and 40 mg/d Oral Dose of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy.|Completed||Phase 3|580||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-10-11 05:32:10.564638|2017-10-11 05:32:10.564638
NCT00199433|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|||May 2005||2005-05-01|July 2016|2016-07-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients|A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) as Monotherapy in Subjects With Parkinson's Disease|Completed||Phase 2|160||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-10-11 05:32:10.651882|2017-10-11 05:32:10.651882
NCT00199446|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-07-12|||July 2005||2005-07-01|July 2016|2016-07-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome|A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) in Subjects With Restless Legs Syndrome|Completed||Phase 2|160||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-10-11 05:32:10.738285|2017-10-11 05:32:10.738285
NCT00199459|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-09-02|||January 2005||2005-01-01|September 2009|2009-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Proteomic Study of Urinary Stone Disease|Urinary Proteomic Profiling Using ProteinChip SELDI-TOF-MS: A Potential Means of Identifying Protein Biomarkers of Urinary Stone Formers|Completed||N/A|20|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-11 05:32:10.824814|2017-10-11 05:32:10.824814
NCT00199472|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-24||||||August 2017|2017-08-01|June 2001|Actual|2001-06-01|||||Observational|||Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJO|Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of Ureteropelvic Junction Obstruction|Withdrawn||N/A|0|Actual|Lawson Health Research Institute|||||f||||||||||||||2017-10-11 05:32:10.913601|2017-10-11 05:32:10.913601
NCT00199485|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-25|||October 2002||2002-10-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer|Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer|Completed||Phase 4|44|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 05:32:10.992079|2017-10-11 05:32:10.992079
NCT00199498|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-04-11|||April 2005||2005-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RASP||Right Apical Versus Septal Pacing Trial|Right Apical Versus Septal Pacing Trial|Active, not recruiting||N/A|160|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 05:32:11.080093|2017-10-11 05:32:11.080093
NCT00199511|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-21|||January 2005||2005-01-01|June 2007|2007-06-01|April 2007|Actual|2007-04-01|||||Interventional|||Hypertonic Saline 75% vs Mannitol 20%|Comparison of Equiosmolar Doses of Mannitol 20% Versus Hypertonic Saline 7.5% Infusion in the Reduction of Brain Bulk During Elective Craniotomies for Supratentorial Brain Tumor Resection|Completed||N/A|162||Lawson Health Research Institute|||||f||||||||||||||2017-10-11 05:32:11.174302|2017-10-11 05:32:11.174302
NCT00199524|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-10-13|||May 2005||2005-05-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free Rate|A Prospective Randomized Controlled Clinical Trial of the Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free Rate|Terminated||Phase 4|44|Actual|Lawson Health Research Institute||2||Enrollment was slower than anticipated.|f||||f||||||||||2017-10-11 05:32:11.266345|2017-10-11 05:32:11.266345
NCT00199537|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-25|||February 2005||2005-02-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer|Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer|Completed||N/A|25|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-11 05:32:11.367389|2017-10-11 05:32:11.367389
NCT00199550|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-25|||May 2004||2004-05-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)|A Prospective Randomized Clinical Trial of Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)|Completed||Phase 4|43|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 05:32:11.440191|2017-10-11 05:32:11.440191
NCT00199563|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-24|||August 2004||2004-08-01|September 2005|2005-09-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels|The Use and Efficacy of Sildenafil in Diabetic Men With Erectile Dysfunction: the Impact on Endothelial Function, a Pilot Feasibility Study|Completed||Phase 4|24|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 05:32:11.535197|2017-10-11 05:32:11.535197
NCT00199576|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||December 2000||2000-12-01|September 2005|2005-09-01|January 2002||2002-01-01|||||Interventional|||Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids|Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids: a Prospective, Double-Blind, Placebo-Controlled Trial.|Completed||Phase 3|670||University Hospital, Limoges|||||f||||||||||||||2017-10-11 05:32:11.630569|2017-10-11 05:32:11.630569
NCT00199589|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-12-29|||October 2002||2002-10-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Treatment of Spastic Equinovarus Foot After Stroke|Treatment of Spastic Equinovarus Foot After Stroke. Efficacy: Association Between Ankle Foot Orthosis and Botulinum Toxin A (BTA) Injection|Completed||N/A|46|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-10-11 05:32:11.729829|2017-10-11 05:32:11.729829
NCT00199602|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-12-30|||August 1999||1999-08-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients|Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients : Phase III Randomised Study|Unknown status|Recruiting|Phase 3|420|Anticipated|University Hospital, Limoges|||||f||||f||||||||||2017-10-11 05:32:11.802289|2017-10-11 05:32:11.802289
NCT00199615|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-10-30|||April 2001||2001-04-01|September 2005|2005-09-01|December 2006|Actual|2006-12-01|||||Interventional|||Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC|Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC : CT Scanning Versus 18 FDG Imaging.|Completed||N/A|73|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-10-11 05:32:11.885278|2017-10-11 05:32:11.885278
NCT00199628|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-03-10|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Observational|||Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization|Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization|Unknown status|Recruiting|N/A|100||University Hospital, Limoges|||||f||||||||||||||2017-10-11 05:32:11.942497|2017-10-11 05:32:11.942497
NCT00199641|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-12-02|||July 2002||2002-07-01|December 2008|2008-12-01||||||||Interventional|||Evaluation of Two Enteral Nutrition Strategies in Mechanically Ventilated Patients|Evaluation of Two Enteral Nutrition Strategies in Mechanically Ventilated Patients|Completed||N/A|100|Actual|University Hospital, Limoges||2|||f||||||||||||||2017-10-11 05:32:12.013012|2017-10-11 05:32:12.013012
NCT00199654|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-04-08|||February 2004||2004-02-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|||Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III|PET Interest in the Follow Up of Colorectal Cancer Stage II and III: Phase III Randomised Study|Completed||Phase 3|376|Actual|University Hospital, Limoges|||||f||||||||||||||2017-10-11 05:32:12.07343|2017-10-11 05:32:12.07343
NCT00199667|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-12-14|||October 2002||2002-10-01|December 2008|2008-12-01||||||||Interventional|||Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients|APOMYGRE : Multicenter, Randomized, Open-Label Study of MMF Therapeutic Follow-up's Interest in the the 12 First Months in Kidney Transplantation|Unknown status|Active, not recruiting|Phase 4|137||University Hospital, Limoges|||||f||||||||||||||2017-10-11 05:32:12.298976|2017-10-11 05:32:12.298976
NCT00199680|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-01-31|||October 2003||2003-10-01|September 2005|2005-09-01||||||||Interventional|||Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer|Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer|Unknown status|Recruiting|Phase 2|42||University Hospital, Limoges|||||f||||||||||||||2017-10-11 05:32:12.392934|2017-10-11 05:32:12.392934
NCT00199693|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-03|||April 2007||2007-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Hemodynamic and Respiratory Function in Healthy Pregnant Women|Hemodynamic and Respiratory Function in Healthy Pregnant Women - A Longitudinal Study|Completed||Phase 4|100|Anticipated|Oslo University Hospital|||1||f||||||||||||||2017-10-11 05:32:12.493925|2017-10-11 05:32:12.493925
NCT00199706|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-30|||April 2002||2002-04-01|November 2005|2005-11-01|October 2004||2004-10-01|||||Interventional|||HyperHAES Versus Placebo - Effect on Intracranial Pressure in SAH Patients|7.2% NaCl in 6% Hydroxyethyl Starch Versus Placebo - Effect on Intracranial Pressure and Haemodynamics in Subarachnoidal Haemorrhage (SAH) Patients.|Completed||Phase 2|20||Oslo University Hospital|||||f||||||||||||||2017-10-11 05:32:12.549491|2017-10-11 05:32:12.549491
NCT00199719|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-10-30|||June 2003||2003-06-01|June 2007|2007-06-01|September 2006|Actual|2006-09-01|||||Interventional|CINAM||Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM|Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C Non 2 -3 Genotype naïve Patients Treated With a 12 Weeks Bitherapy of Peginterferon Alpha 2a-Ribavirin, and Followed by a Tritherapy of Peginterferon Alpha 2a-Ribavirin-Amantadine for 36 Weeks|Completed||Phase 2|30|Actual|University Hospital, Limoges||1|||f||||||||||||||2017-10-11 05:32:12.615688|2017-10-11 05:32:12.615688
NCT00199732|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-04-16|||December 2004||2004-12-01|September 2005|2005-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|DNA-EVAL||Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a|Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a|Completed||N/A|19|Actual|University Hospital, Limoges|||1||f||||f||||||||||2017-10-11 05:32:12.69414|2017-10-11 05:32:12.69414
NCT00199745|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-05-09|||October 2005||2005-10-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity|Investigations on Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity|Completed||Phase 4|53|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-10-11 05:32:12.770017|2017-10-11 05:32:12.770017
NCT00199758|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-11-09|||September 2003||2003-09-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer|A Randomized Phase II Trial of Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer.|Completed||Phase 2|227||University Hospital, Limoges|||||f||||||||||||||2017-10-11 05:32:12.84038|2017-10-11 05:32:12.84038
NCT00199771|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-30|||June 2003||2003-06-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||Hypertonic Saline Dextran in Pediatric Cardiac Surgery|The Use of Hypertonic Saline Dextran in Cardiac Surgery Utilizing Cardio Pulmonary Bypass in Children Less Than 17 Weeks Old.|Completed||Phase 2|14||Oslo University Hospital|||||f||||||||||||||2017-10-11 05:32:12.95151|2017-10-11 05:32:12.95151
NCT00199784|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-03|||June 2005||2005-06-01|February 2009|2009-02-01|April 2007||2007-04-01|||||Interventional|||Hemodynamic Measurements During Cesarean Section With Spinal Anesthesia|Hemodynamic Measurements During Cesarean Section With Spinal Anesthesia|Completed||Phase 4|80|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-10-11 05:32:13.04215|2017-10-11 05:32:13.04215
NCT00199797|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-03-02|||October 2004||2004-10-01|March 2009|2009-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer|Phase I Trial of huA33 Plus 5-Fluorouracil (5FU), Leucovorin and Oxaliplatin in Patients With Metastatic Colorectal Cancer|Completed||Phase 1|20|Actual|Ludwig Institute for Cancer Research||1|||f||||f||||||||||2017-10-11 05:32:13.154158|2017-10-11 05:32:13.154158
NCT00199810|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-10-14|||July 2005||2005-07-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Hemodynamic Measurements in Women With Serious Preeclampsia|Hemodynamic Measurements in Women With Serious Preeclampsia|Completed||Phase 4|68|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 05:32:13.249635|2017-10-11 05:32:13.249635
NCT00199823|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-03|||September 2003||2003-09-01|September 2010|2010-09-01|May 2006||2006-05-01|||||Interventional|||Autologous Stem Cell Transplantation in Acute Myocardial Infarction|Autologous Stem Cell Transplantation in Acute Myocardial Infarction|Completed||Phase 2|100||Oslo University Hospital|||||f||||||||||||||2017-10-11 05:32:13.320609|2017-10-11 05:32:13.320609
NCT00199836|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-08-21|||September 2003||2003-09-01|August 2006|2006-08-01|December 2005||2005-12-01|||||Interventional|||A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide ISA-51 in Patients With Cancer.|A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide ISA-51 in Patients With Cancer Expressing NY-ESO-1 or LAGE-1.|Completed||Phase 1|9||Ludwig Institute for Cancer Research|||||||||||||||||||2017-10-11 05:32:13.416114|2017-10-11 05:32:13.416114
NCT00199849|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-21|||May 2004||2004-05-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine|Safety and Immunological Evaluation of NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine Given by Particle-Mediated Epidermal Delivery (PMED) in Patients With Tumor Type Known to Express NY-ESO-1 or LAGE-1 Antigen.|Completed||Phase 1|15||Ludwig Institute for Cancer Research|||||||||||||||||||2017-10-11 05:32:13.499935|2017-10-11 05:32:13.499935
NCT00199862|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-05-01|||February 2004|Actual|2004-02-01|May 2017|2017-05-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer|A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer|Active, not recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 05:32:13.594668|2017-10-11 05:32:13.594668
NCT00199875|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-09|||July 2005||2005-07-01|May 2011|2011-05-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250|Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (90Y-DOTA-cG250) in Patients With Advanced Renal Cancer|Unknown status|Recruiting|Phase 1|24|Anticipated|Ludwig Institute for Cancer Research|||||f||||||||||||||2017-10-11 05:32:13.703363|2017-10-11 05:32:13.703363
NCT00199888|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-08-29|||February 2005||2005-02-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Interventional|||Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.|Pilot Study of Iodine-124 Labeled Chimeric G250 (124 I-cG250) in Presurgical Patients With Renal Masses|Completed||Phase 1|54||Ludwig Institute for Cancer Research|||||||||||||||||||2017-10-11 05:32:13.807139|2017-10-11 05:32:13.807139
NCT00199901|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-02-27|||September 2005||2005-09-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma|Randomized, Double-blind Phase II Trial of NY-ESO-1 ISCOMATRIX® Vaccine and ISCOMATRIX® Adjuvant Alone in Patients With Resected Stage IIc, III or IV Malignant Melanoma|Completed||Phase 2|111|Actual|Ludwig Institute for Cancer Research||2|||f||||||||||||||2017-10-11 05:32:13.891792|2017-10-11 05:32:13.891792
NCT00199914|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-06|2013-05-19||January 2004||2004-01-01|September 2013|2013-09-01|June 2004|Actual|2004-06-01|May 2004|Actual|2004-05-01||Interventional|||Efficacy Study of Shortwave Diathermy for the Treatment of Patients With Knee Osteoarthritis|The Effectiveness of Shortwave Diathermy in Knee Osteoarthritis: A Randomized Controlled Trial|Completed||Phase 3|113|Actual|Mahidol University||2|||f||||f||||||||||2017-10-11 05:32:14.011031|2017-10-11 05:32:14.011031
NCT00199927|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-04-27|||March 2003||2003-03-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|ESPLANADE||Statins in Proteinuric Nephropathies|A Prospective, Randomized, Multicenter Trial Testing the Antiproteinuric Effect of Statins Added to Combined ACE-inhibitor and Angiotensin Receptor Antagonist Therapy in Proteinuric, Chronic Nephropathies|Completed||Phase 3|217|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-10-11 05:32:14.248988|2017-10-11 05:32:14.248988
NCT00199940|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-03-06|||December 2003||2003-12-01|March 2008|2008-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness|A Pilot Open Trial Of Ziprasidone, Early In The Course Of Pediatric Psychotic Illness|Completed||Phase 4|20||Medical College of Wisconsin|||||f||||f||||||||||2017-10-11 05:32:14.354896|2017-10-11 05:32:14.354896
NCT00199953|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-01-27|||June 2002||2002-06-01|November 2013|2013-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Post-nasal Drainage as an Extraesophageal Manifestation of Reflux|Post-nasal Drainage as an Extraesophageal Manifestation of Reflux|Completed||Phase 2|50||Medical College of Wisconsin|||||||||||||||||||2017-10-11 05:32:14.42369|2017-10-11 05:32:14.42369
NCT00199979|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-15|||April 2005||2005-04-01|September 2005|2005-09-01|June 2008||2008-06-01|||||Interventional|||Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients|Multicenter, Randomized, Open-Label Trial, Assessing the Efficacy of Zidovudine, Lamivudine and Nevirapine Combination Administered Twice Daily, Versus the Association of Tenofovir, Lamivudine and Nevirapine, Once Daily, in Antiretroviral Naive HIV-1 Infected Patients|Unknown status|Recruiting|Phase 3|250||MEDEX|||||f||||||||||||||2017-10-11 05:32:14.586029|2017-10-11 05:32:14.586029
NCT00199992|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Platelets in Acute Wounds: A Pilot Study (PAWS)|Platelets in Acute Wounds: A Pilot Study (PAWS)|Completed||N/A|8||Medtronic|||||f||||||||||||||2017-10-11 05:32:14.663467|2017-10-11 05:32:14.663467
NCT00200005|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-01-09|||November 1998||1998-11-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|December 2006|Actual|2006-12-01||Interventional|MDT-301||Sacral Nerve Stimulation for Anal Incontinence and Bowel Control|Sacral Nerve Stimulation for Anal Incontinence and Bowel Control|Completed||Phase 4|140|Anticipated|MedtronicNeuro||1|||f||||f||||||||||2017-10-11 05:32:14.735033|2017-10-11 05:32:14.735033
NCT00200018|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-02-03|||June 2005||2005-06-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|February 2007|Actual|2007-02-01||Interventional|ASSIST||Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes|ASSIST: Appetite Suppression Induced by Stimulation Trial|Completed||N/A|46|Actual|MedtronicNeuro||1|||f||||t||||||||||2017-10-11 05:32:14.856553|2017-10-11 05:32:14.856553
NCT00200031|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-07-24|||July 2005||2005-07-01|July 2008|2008-07-01|April 2006|Actual|2006-04-01|||||Observational|||A Cost Analysis of Interstim Therapy|Interstim Therapy Retrospective Cost Analysis and Quality of Life|Completed||N/A|150||MedtronicNeuro|||||f||||||||||||||2017-10-11 05:32:14.921182|2017-10-11 05:32:14.921182
NCT00200044|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-07-10|||December 2002||2002-12-01|July 2009|2009-07-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|||An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD)|Gatekeeper® System Sham-Controlled Study for the Treatment of GERD|Terminated||N/A|143|Actual|MedtronicNeuro||2||Lack of efficacy|f||||t||||||||||2017-10-11 05:32:14.982109|2017-10-11 05:32:14.982109
NCT00200057|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-01-17|2011-04-13|2010-05-07|January 2002||2002-01-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|August 2007|Actual|2007-08-01||Interventional|||Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence|Medtronic InterStim® Sacral Nerve Stimulation Therapy for Bowel Control: Fecal Incontinence Study|Completed||N/A|285|Actual|MedtronicNeuro||1|||f||||f||||||||||2017-10-11 05:32:15.112891|2017-10-11 05:32:15.112891
NCT00200070|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-08-26|||December 2002||2002-12-01|August 2010|2010-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|STARTSTIM||Neurostimulation to Treat Refractory Angina Pectoris Pain|STARTSTIM - Stimulation Therapy for Angina Refractory To Standard Treatments, Interventions and Medications|Terminated||Phase 3|228||MedtronicNeuro|||||f||||||||||||||2017-10-11 05:32:15.824705|2017-10-11 05:32:15.824705
NCT00200083|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-26|||May 2004||2004-05-01|March 2015|2015-03-01|January 2008|Actual|2008-01-01|September 2005|Actual|2005-09-01||Interventional|SHAPE||Study of Weight Loss Using Gastric Stimulation in Obese Patients|SHAPE: Screened Health Assessment & Pacer Evaluation|Completed||N/A|190|Actual|MedtronicNeuro||2|||f||||t||||||||||2017-10-11 05:32:15.930325|2017-10-11 05:32:15.930325
NCT00200096|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-02-11|||July 2004||2004-07-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial|Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial|Completed||Phase 3|101|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:32:16.03116|2017-10-11 05:32:16.03116
NCT00200109|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-10-07|||May 2004||2004-05-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|June 2008|Actual|2008-06-01||Interventional|ONSTIM||Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.|ONSTIM: Occipital Nerve Stimulation for the Treatment of Intractable Migraine.|Completed||Phase 1|110|Actual|MedtronicNeuro||4|||f||||f||||||||||2017-10-11 05:32:16.127805|2017-10-11 05:32:16.127805
NCT00200122|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-01-20|||January 2005||2005-01-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Restore Claims Characterization Study|Restore Claims Characterization Study|Completed||Phase 4|100||MedtronicNeuro|||||||||||||||||||2017-10-11 05:32:16.235331|2017-10-11 05:32:16.235331
NCT00200135|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-02|||June 2005||2005-06-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Financial and Clinical Impact of Repeal of the Pennsylvania Motorcycle Helmet Law|Financial and Clinical Impact of Repeal of the Pennsylvania Helmet Law: A Multi-Center Prospective Study Comparing Helmeted and Non-Helmeted Motorcycle Accident Victims|Completed||N/A|480|Anticipated|Memorial Medical Center|||4||f||||f||||||||||2017-10-11 05:32:16.312303|2017-10-11 05:32:16.312303
NCT00200148|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-04|||March 2004||2004-03-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy|A Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared to Standard Intraoperative Management in Patients Undergoing Major Hepatic Resection and Pancreaticoduodenectomy|Completed||Phase 3|372|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:32:16.424728|2017-10-11 05:32:16.424728
NCT00200161|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-09|||August 9, 2005||2005-08-09|September 2016|2016-09-01|May 4, 2017|Actual|2017-05-04|May 4, 2017|Actual|2017-05-04||Interventional|||Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma|A Randomized Phase II Trial of Concurrent Temozolomide and Radiotherapy Followed by Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid for Patients With Newly Diagnosed Glioblastoma and Other Malignant Gliomas|Completed||Phase 2|140|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:32:16.600647|2017-10-11 05:32:16.600647
NCT00200174|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-12-21|||July 1999||1999-07-01|December 2015|2015-12-01|August 2008|Actual|2008-08-01|July 2003|Actual|2003-07-01||Interventional|||Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease|Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease: A Pilot Chemoprevention Trial|Completed||N/A|11|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:32:16.721289|2017-10-11 05:32:16.721289
NCT00200187|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-01-25|||February 2005||2005-02-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery|A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Radical Retropubic Prostatectomy|Completed||Phase 2|246||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-10-11 05:32:16.834646|2017-10-11 05:32:16.834646
NCT00200200|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-13|||November 19, 2004||2004-11-19|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer|Randomized Ph II Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With IV Systemic Chemo With/Without Bevacizumab (mAB to Vascular Endothelial Growth Factor-A) in Patients With Resected Hepatic Metastases From Colorectal Cancer|Active, not recruiting||Phase 2|73|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:32:16.942183|2017-10-11 05:32:16.942183
NCT00200213|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||February 2004||2004-02-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Liking of Snack Foods - Sub-Study 1|The Effect of Portion Size and Quantity of Food Provided on Intake|Completed||N/A|32||The Miriam Hospital|||||f||||||||||||||2017-10-11 05:32:17.067672|2017-10-11 05:32:17.067672
NCT00200226|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-20|||February 2003||2003-02-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Oral Misoprostol Before Endometrial Biopsy|Oral Misoprostol Before Endometrial Biopsy|Completed||Phase 3|72|Actual|Memorial University of Newfoundland||2|||f||||f||||||||||2017-10-11 05:32:17.1382|2017-10-11 05:32:17.1382
NCT00200239|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-04-19|||September 2005||2005-09-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Provision of Breakfast Food in Behavioral Weight Loss|Provision of Breakfast Food in Behavioral Weight Loss|Completed||N/A|25|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-10-11 05:32:17.243257|2017-10-11 05:32:17.243257
NCT00200252|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-11-08|||September 2005||2005-09-01|November 2012|2012-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Oxytocin Administration in the Third Stage of Labour - A Study of Appropriate Route and Dose|Intramuscular Versus Intravascular Oxytocin for the Third Stage of Labour|Completed||Phase 4|300|Actual|Memorial University of Newfoundland||3|||f||||||||||||||2017-10-11 05:32:17.332773|2017-10-11 05:32:17.332773
NCT00200265|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-04-19|||July 2005||2005-07-01|December 2007|2007-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Changing Eating Behaviors in Young Children: Should Healthy Foods be Increased or Unhealthy Foods Decreased?|Changing Eating Behaviors in Young Children: Should Healthy Foods be Increased or Unhealthy Foods Decreased?|Completed||N/A|101|Actual|The Miriam Hospital||3|||f||||||||||||||2017-10-11 05:32:17.42639|2017-10-11 05:32:17.42639
NCT00200278|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2000||2000-08-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Exercise Instruction Via Phone or Print|Exercise Instruction Via Phone or Print|Completed||Phase 2|228||The Miriam Hospital|||||f||||||||||||||2017-10-11 05:32:17.49966|2017-10-11 05:32:17.49966
NCT00200291|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-04-19|||July 2004||2004-07-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Changes in Food Reinforcement During Obesity Treatment|Changes in Food Reinforcement During Obesity Treatment|Completed||N/A|147|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-10-11 05:32:17.57582|2017-10-11 05:32:17.57582
NCT00200304|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-04-23|||January 2001||2001-01-01|September 2005|2005-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Evaluation of a SlimFast Internet Behavioral Weight Loss Program|Development and Evaluation of a SlimFast Internet Behavioral Weight Loss Program|Completed||N/A|225||The Miriam Hospital|||||f||||||||||||||2017-10-11 05:32:17.651793|2017-10-11 05:32:17.651793
NCT00200317|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-27|||February 2003||2003-02-01|September 2005|2005-09-01|May 2006|Actual|2006-05-01|||||Interventional|||Interactive Technologies to Increase Exercise Behavior|Interactive Technologies to Increase Exercise Behavior|Completed||Phase 1/Phase 2|240|Actual|The Miriam Hospital|||||f||||||||||||||2017-10-11 05:32:17.735707|2017-10-11 05:32:17.735707
NCT00200330|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-17|||November 2004||2004-11-01|September 2005|2005-09-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Modifying Obesogenic Homes: Impact on Weight Maintenance||Unknown status|Active, not recruiting|N/A|400||The Miriam Hospital|||||f||||||||||||||2017-10-11 05:32:17.811162|2017-10-11 05:32:17.811162
NCT00200343|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-07|2011-08-17||July 2002||2002-07-01|March 2012|2012-03-01|December 2004||2004-12-01|||||Interventional|||Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C|A 24-week Multicenter Double-blind Control Trial With Ursodeoxycholic Acid in Patients With Chronic Hepatitis C|Completed||Phase 3|596|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||||||||||||2017-10-11 05:32:17.907315|2017-10-11 05:32:17.907315
NCT00200356|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-09|2012-09-13||August 2004||2004-08-01|December 2012|2012-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke|Edaravone-Sodium Ozagrel (Thromboxane A2 Synthase Inhibitor) Comparative Post-Marketing Study on Acute Ischemic Stroke|Completed||Phase 4|401|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-10-11 05:32:18.56739|2017-10-11 05:32:18.56739
NCT00200369|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-04|||May 2004||2004-05-01|November 2009|2009-11-01|March 2006|Actual|2006-03-01|||||Observational|||Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen|Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen|Completed||Phase 4|90|Anticipated|Montefiore Medical Center|||1||f||||||||||||||2017-10-11 05:32:19.135118|2017-10-11 05:32:19.135118
NCT00200382|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-07|||May 2004||2004-05-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer|Phase II Study to Evaluate the Efficacy and Safety of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer|Terminated||Phase 2|27|Anticipated|Montefiore Medical Center||||The study did not achieve the statistical success to continue.|||||||||||||||2017-10-11 05:32:19.194226|2017-10-11 05:32:19.194226
NCT00200395|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2003||2003-06-01|September 2005|2005-09-01||||||||Interventional|||Phs. II Study of OSI-774 (Erlotinib, Tarceva) in Elderly Patients W/Advanced Stage or Inoperable Non-Small Cell Lung Cancer (NSCLC)|Phase II Study of OSI-774 (Erlotinib, Tarceva) in Elderly Patients With Advanced Stage or Inoperable Non Small Cell Lung Cancer (NSCLC)|Suspended||Phase 2|27||Montefiore Medical Center|||||||||||||||||||2017-10-11 05:32:19.266939|2017-10-11 05:32:19.266939
NCT00200421|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-15|||May 2002||2002-05-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension|A Double-Blind, Randomized, Multi-Center, Active Comparator, Five Treatment Study of the Effects of Nebivolol Compared to Atenolol on Cardiovascular Hemodynamics and Exercise Capacity in Patients With Mild to Moderate Hypertension|Completed||Phase 2|110||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:32:19.429231|2017-10-11 05:32:19.429231
NCT00200434|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2002||2002-10-01|September 2005|2005-09-01|October 2003||2003-10-01|||||Interventional|||A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension|A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Mild to Moderate Hypertension|Completed||Phase 3|600||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:32:19.494452|2017-10-11 05:32:19.494452
NCT00200447|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-17|||March 2004||2004-03-01|January 2008|2008-01-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)|Assessment of Carbidopa/l-Dopa and Carbidopa/l Dopa/Entacapone on Synaptic Dopamine in Parkinson's Patients: An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)|Completed||Phase 2|3|Actual|Molecular NeuroImaging||1|||f||||||||||||||2017-10-11 05:32:19.693319|2017-10-11 05:32:19.693319
NCT00200460|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2001||2001-09-01|September 2005|2005-09-01|March 2003||2003-03-01|||||Interventional|||A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients|A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Dosing Study Evaluating the Effects of Nebivolol on Blood Pressure in Patients With Mild to Moderate Hypertension|Completed||Phase 3|825||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:32:19.782729|2017-10-11 05:32:19.782729
NCT00200473|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2001||2001-09-01|September 2005|2005-09-01|March 2003||2003-03-01|||||Interventional|||A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients|A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Study of the Effects of Nebivolol on Safety and Efficacy in Patients With Mild to Moderate Hypertension|Completed||Phase 3|800||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:32:19.862952|2017-10-11 05:32:19.862952
NCT00200486|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-21|||May 2002||2002-05-01|March 2017|2017-03-01||||May 2020|Anticipated|2020-05-01||Observational|||Molecular and Genomic Profiling of Head and Neck Tumors|Molecular and Genomic Profiling of Head and Neck Tumors to Explore Biomarkers Associated With Prognosis and Response to Therapy|Recruiting||N/A|400|Anticipated|Montefiore Medical Center|||1||f||||t||||||Samples With DNA|"     1. Tumor specimens along with normal mucosa obtained at the time of surgery for biopsy or          resection of primary or recurrent tumors of the head and neck        2. blood, urine and sputum from patients participating in the tumor collection described          above   "|||2017-10-11 05:32:19.93985|2017-10-11 05:32:19.93985
NCT00200499|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-15|||March 2002||2002-03-01|September 2005|2005-09-01|September 2003||2003-09-01|||||Interventional|||A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients|A Multi-Center, Parallel Group Extension Study to Determine the Safety and Efficacy of Long-Term Nebivolol Exposure in Patients With Mild to Moderate Hypertension|Completed||Phase 3|845||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:32:20.074516|2017-10-11 05:32:20.074516
NCT00200512|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-15|||September 1999||1999-09-01|March 2000|2000-03-01|November 1999||1999-11-01|||||Interventional|||Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months|"A Prospective, Randomized, Placebo-Controlled, Crossover Study of the Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of Off Episodes in Patients With On/Off or Wearing Off Effects Associated With Late Stage Parkinson's Disease"|Completed||Phase 2/Phase 3|16||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:32:20.172179|2017-10-11 05:32:20.172179
NCT00200525|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-15|||July 2001||2001-07-01|September 2005|2005-09-01|June 2002||2002-06-01|||||Interventional|||Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease|"A Randomized, Placebo-Controlled Study of the Continued Efficacy and Safety of SC Apomorphine in the Treatment of Off Episodes in Patients With On/Off or Wearing-Off Effects Associated With Late-Stage PD After Apomorphine Use"|Completed||Phase 3|60||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-10-11 05:32:20.264454|2017-10-11 05:32:20.264454
NCT00200538|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-02|||September 2005||2005-09-01|January 2005|2005-01-01||||||||Interventional|||Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients|Double-blind, Parallel Group, Placebo-controlled Trial of the Efficacy and Tolerability of Memantine (20 mg) in Frontotemporal Dementia (FTD) Patients|Completed||Phase 2|52|Actual|Nantes University Hospital|||||f||||||||||||||2017-10-11 05:32:20.341893|2017-10-11 05:32:20.341893
NCT00200551|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-04|||January 2001||2001-01-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant|A Prospective, Randomized, Open, Multicentric Study Intended to Evaluate the Efficacy and Tolerability of Sequential Treatment Based on Rabbit Anti-T-lymphocyte Serum, of Mycophenolate Mofetil and of Cyclosporin, Without Concomitant Corticosteroids, After a First Cadaveric Renal Transplant|Completed||Phase 4|200||Nantes University Hospital|||||f||||||||||||||2017-10-11 05:32:20.445985|2017-10-11 05:32:20.445985
NCT00200564|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-22|||February 2004||2004-02-01|July 2005|2005-07-01||||||||Interventional|||Ketamine and Postoperative Analgesia in Children|Ketamine and Postoperative Analgesia in Children|Unknown status|Recruiting|Phase 4|74|Anticipated|Nantes University Hospital|||||f||||||||||||||2017-10-11 05:32:20.539481|2017-10-11 05:32:20.539481
NCT00200577|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-31|||May 2005||2005-05-01|May 2017|2017-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|TIL||Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma|TIL (Tumor Infiltrating Lymphocytes) and IL2 (Interleukin 2) Versus Abstention as Adjuvant Treatment in Melanoma With Only One Invaded Lymphnode After Lymphnodes Excision|Completed||Phase 3|70|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 05:32:20.632152|2017-10-11 05:32:20.632152
NCT00200590|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-18|||December 2003||2003-12-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Analgesic Strategies in Newborns Receiving Prostaglandin Therapy|Analgesic Strategies in Newborns Receiving Prostaglandin Therapy|Terminated||N/A|30|Anticipated|Nantes University Hospital||||More important number of SAE in one arms|f||||||||||||||2017-10-11 05:32:20.755459|2017-10-11 05:32:20.755459
NCT00200603|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2005-12-15|||May 1999||1999-05-01|May 2004|2004-05-01||||||||Interventional|||Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy|Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy|Unknown status|Active, not recruiting|N/A|50||Nantes University Hospital|||||f||||||||||||||2017-10-11 05:32:20.82957|2017-10-11 05:32:20.82957
NCT00200616|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-30|||April 2001||2001-04-01|June 2008|2008-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Usefulness of Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux.|Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux. A Randomised Prospective Study of Continuous Low Dose of Trimethoprim-Sulfamethoxazole Versus Surveillance.|Completed||N/A|232||Nantes University Hospital|||||f||||f||||||||||2017-10-11 05:32:20.909146|2017-10-11 05:32:20.909146
NCT00200629|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-08-08|||June 2005||2005-06-01|August 2011|2011-08-01||||||||Interventional|||Both Exercise and Adenosine Stress Testing|A Pilot Study Examining the Value of Combined Exercise and Adenosine Stress Myocardial Perfusion Imaging as Compared With Adenosine Testing Alone for the Evaluation of Women at Intermediate or High Likelihood for Coronary Artery Disease|Terminated||Phase 4|200|Anticipated|Midwest Heart Foundation||||Poor enrollment|f||||||||||||||2017-10-11 05:32:21.004861|2017-10-11 05:32:21.004861
NCT00200642|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-20|||December 2003||2003-12-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease|Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease|Completed||N/A|54|Actual|Nantes University Hospital|||||f||||||||||||||2017-10-11 05:32:21.161251|2017-10-11 05:32:21.161251
NCT00200655|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-04-27|||December 2004||2004-12-01|June 2008|2008-06-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis|Safety and Efficacy of Pravastatin in Relapsing-remitting MS: a Double Blind Placebo Controlled Study|Completed||Phase 3|40|Actual|Nantes University Hospital|||||f||||f||||||||||2017-10-11 05:32:21.240787|2017-10-11 05:32:21.240787
NCT00200668|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-05|||March 2005||2005-03-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.||Terminated||N/A|0|Actual|Nantes University Hospital|||||f||||||||||||||2017-10-11 05:32:21.315534|2017-10-11 05:32:21.315534
NCT00200681|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-02-04|||June 2005||2005-06-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma|Etude Multicentrique Ouverte Randomisée de Phase III Comparant l'Association de VELCADE®-Dexaméthasone à la Chimiothérapie de Type VAD Pour le Traitement Des Patients Porteurs de Myélome Multiple de Novo Jusqu'à l'âge de 65 Ans|Completed||Phase 3|493|Actual|Nantes University Hospital|||||f||||t||||||||||2017-10-11 05:32:21.377858|2017-10-11 05:32:21.377858
NCT00200694|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-03|||March 2005||2005-03-01|February 2009|2009-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.||Terminated||Phase 4|18||Nantes University Hospital||||difficulty in patients's inclusion|f||||||||||||||2017-10-11 05:32:21.444564|2017-10-11 05:32:21.444564
NCT00200707|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-29|||December 2004||2004-12-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||BONAMI (BOne Marrow in Acute Myocardial Infarction)|Intracoronary Injection of Autologous Bone Marrow Mononuclear Cells for Severe Myocardial Infarction|Completed||Phase 2|101|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-10-11 05:32:21.517883|2017-10-11 05:32:21.517883
NCT00200720|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-04|||April 2005||2005-04-01|February 2008|2008-02-01|June 2010|Actual|2010-06-01|March 2009|Actual|2009-03-01||Interventional|||Effectiveness of a Low Carbohydrate Diet Versus a High Carbohydrate Diet in Promoting Weight Loss and Improved Health|Metabolic Consequences of High and Low Carbohydrate Diets|Completed||Phase 2|260|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-10-11 05:32:21.598838|2017-10-11 05:32:21.598838
NCT00200733|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-08-17|||June 2003||2003-06-01|December 2005|2005-12-01|March 2004||2004-03-01|||||Observational|||The Use of Narrative in Public Health Research and Practice: Patient Experience of Wellness Acupuncture|The Use of Narrative in Public Health Research and Practice: Patient Experience of Wellness Acupuncture|Terminated||N/A|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:32:21.680901|2017-10-11 05:32:21.680901
NCT00200746|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-03-11|||April 2006||2006-04-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Treatment of Alcohol-Related Hepatitis With Arginine|Arginine Treatment for Alcoholic Hepatitis|Withdrawn||Phase 2|0|Actual|National Center for Complementary and Integrative Health (NCCIH)||3||lack of enrollment|f||||t||||||||||2017-10-11 05:32:21.733126|2017-10-11 05:32:21.733126
NCT00200759|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-17|||October 2004||2004-10-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Drug Interactions and Bioavailability of Cranberry|Drug Interactions and Bioavailability of Cranberry|Completed||Phase 1|16|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-10-11 05:32:21.807661|2017-10-11 05:32:21.807661
NCT00200785|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-12-04|2009-04-23||March 2006||2006-03-01|December 2009|2009-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Identifying the Anti-Blood-Clotting Compounds in Garlic|Identification of the Antiplatelet Compounds of Garlic Ex Vivo|Completed||N/A|9|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-10-11 05:32:21.871908|2017-10-11 05:32:21.871908
NCT00200798|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-12-09|||May 2006||2006-05-01|December 2009|2009-12-01|August 2007||2007-08-01|||||Observational|||An Assessment of Milk Thistle Pharmacokinetics and Drug Interactions|Pharmacokinetics and Drug Interactions With Milk Thistle|Unknown status|Recruiting|Phase 2|32|Anticipated|Medical University of South Carolina|||1||f||||t||||||Samples Without DNA|"     plasma & urine   "|||2017-10-11 05:32:22.168358|2017-10-11 05:32:22.168358
NCT00200824|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-10|||May 2000||2000-05-01|August 2006|2006-08-01|January 2005||2005-01-01|||||Interventional|||Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health|Effects of Soy Isoflavones on the Prostate, Breast and Bone|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:32:22.250053|2017-10-11 05:32:22.250053
NCT00200837|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-03-27|||March 2002||2002-03-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Observational|||Ethnopharmacological Studies in Oral Medicine|Ethnopharmacological Studies in Oral Medicine|Completed||N/A|1000||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-10-11 05:32:22.312526|2017-10-11 05:32:22.312526
NCT00200850|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-12|||January 2006||2006-01-01|May 2016|2016-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy|Sublingual Immunotherapy in Dust Mite Allergy|Completed||N/A|31|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-10-11 05:32:22.37971|2017-10-11 05:32:22.37971
NCT00200863|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-08-08|||April 2005||2005-04-01|August 2014|2014-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effects of Different Colors of Light on Human Physiology|Mechanism Underlying the Effects of Blue Light in Humans|Completed||N/A|47|Actual|Brigham and Women's Hospital||6|||f||||f||||||||||2017-10-11 05:32:22.463846|2017-10-11 05:32:22.463846
NCT00200876|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-21|||September 2003||2003-09-01|March 2017|2017-03-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Effects of Anticipation of Pain Relief on Brain Mechanisms|Neurochemical Mediation of Placebo Responses in Humans|Completed||N/A|60|Actual|University of Michigan||2|||f||||t|f|f||||||No||2017-10-11 05:32:22.552539|2017-10-11 05:32:22.552539
NCT00200889|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-09|||May 2005||2005-05-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Acupuncture on Human Brain Activity|Exploring Neurocircuitry of Acupuncture Action With fMRI|Completed||Early Phase 1|60|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 05:32:22.624845|2017-10-11 05:32:22.624845
NCT00200902|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-11-19|||August 2005||2005-08-01|November 2009|2009-11-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression|Factors of Treatment Response in Major Depressive Disorder|Suspended||Phase 4|140|Anticipated|University of California, Los Angeles||5|||f||||t||||||||||2017-10-11 05:32:22.746814|2017-10-11 05:32:22.746814
NCT00200928|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-04-03|||January 1999||1999-01-01|April 2006|2006-04-01|July 2005||2005-07-01|||||Interventional|||Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.|Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.|Completed||N/A|120||The Netherlands Asthma Foundation|||||f||||||||||||||2017-10-11 05:32:22.84185|2017-10-11 05:32:22.84185
NCT00200941|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-15|||August 2001||2001-08-01|September 2005|2005-09-01|April 2005||2005-04-01|||||Interventional|||Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS)|Completed||Phase 4|44||Neurocare|||||f||||||||||||||2017-10-11 05:32:22.911574|2017-10-11 05:32:22.911574
NCT00200954|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-08-13|||January 2004||2004-01-01|May 2007|2007-05-01|August 2008|Actual|2008-08-01|December 2007|Actual|2007-12-01||Interventional|||Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics|Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics.|Completed||N/A|157|Actual|The Netherlands Asthma Foundation||2|||f||||||||||||||2017-10-11 05:32:23.005404|2017-10-11 05:32:23.005404
NCT00200967|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-24|2009-03-05||December 2004||2004-12-01|February 2013|2013-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)|Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)|Completed||Phase 3|87|Actual|Milton S. Hershey Medical Center|The study used a moderately high dose of ICS. Genotype-specific effects may be evident at lower doses of ICS often used in combination therapy. Also, short-acting β2-agonists have been shown to have genotype-specific effects on asthma outcomes.|2|||f||||t||||||||||2017-10-11 05:32:23.129372|2017-10-11 05:32:23.129372
NCT00200980|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-03-06|||August 2005||2005-08-01|March 2009|2009-03-01||||||||Observational|||Importance of Non-Acid Reflux in Asthma in Children|Importance of Non-Acid Reflux in Moderate and Severe Asthma|Completed||N/A|120|Anticipated|Nemours Children's Clinic|||||f||||||||||||||2017-10-11 05:32:25.654547|2017-10-11 05:32:25.654547
NCT00200993|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-04-13|||September 1998||1998-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:32:25.72373|2017-10-11 05:32:25.72373
NCT00201006|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-01-21|2013-11-02||June 2003||2003-06-01|January 2014|2014-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|TOURS||Treatment of Obesity in Underserved Rural Settings (TOURS)|Treatment of Obesity in Underserved Rural Settings (TOURS)|Completed||N/A|234|Actual|University of Florida||3|||f||||t||||||||||2017-10-11 05:32:25.821736|2017-10-11 05:32:25.821736
NCT00201019|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-11-30|||August 2003||2003-08-01|November 2015|2015-11-01|July 2009|Actual|2009-07-01|April 2008|Actual|2008-04-01||Interventional|||Improving Adherence to Blood Pressure Guidelines|Improving Adherence to Blood Pressure Guidelines|Completed||N/A|623|Actual|University of Iowa||3|||f||||t||||||||||2017-10-11 05:32:26.179751|2017-10-11 05:32:26.179751
NCT00201045|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-03-26|||July 2003||2003-07-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Team Management of High Blood Pressure|Collaborative Management of Hypertension|Completed||N/A|179|Actual|University of Iowa||2|||f||||t||||||||||2017-10-11 05:32:26.268411|2017-10-11 05:32:26.268411
NCT00201058|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-12-18|||July 2006||2006-07-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|Puff City||Tailored Asthma Management for Urban Teens|Tailored Asthma Management for Urban Teens|Completed||N/A|450|Actual|Henry Ford Health System||2|||f||||t||||||||||2017-10-11 05:32:26.364241|2017-10-11 05:32:26.364241
NCT00201071|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-09-27|||September 2004||2004-09-01|April 2007|2007-04-01|January 2011|Actual|2011-01-01|February 2010|Actual|2010-02-01||Observational|||Asthma Surveillance and Education in Preschool Settings|Asthma Surveillance and Education in Preschool Settings|Completed||N/A|208|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||||||2017-10-11 05:32:26.464263|2017-10-11 05:32:26.464263
NCT00201084|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2014-07-17|||September 2004||2004-09-01|July 2014|2014-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Physician Uncertainty Reduction for Hypertension|Physician Uncertainty Reduction for Hypertension|Completed||N/A|670|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-10-11 05:32:26.534366|2017-10-11 05:32:26.534366
NCT00201110|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-03-19|||July 2004||2004-07-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Problem Solving and Cardiovascular Disease Risk Management in Diabetic Blacks|Problem Solving & CVD Risk Management in Diabetic Blacks|Completed||N/A|139|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-10-11 05:32:26.745721|2017-10-11 05:32:26.745721
NCT00201123|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-12-14|2014-01-22||April 2005||2005-04-01|December 2016|2016-12-01|August 2007|Actual|2007-08-01|January 2007|Actual|2007-01-01||Interventional||"Demographic information provided for all subjects who were eligible for the study after all screening procedures were performed. 7 subjects who were found to be ineligible after randomization but prior to administration of treatment (listed as did not meet continuation criteria in participant flow section) are not included in baseline analysis."|Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs|Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome|Completed||Phase 2|89|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-10-11 05:32:26.869634|2017-10-11 05:32:26.869634
NCT00201136|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-11|||February 2004||2004-02-01|February 2012|2012-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|HIP||Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk|Hypertension Improvement Project (HIP)|Completed||Phase 2|574|Actual|Duke University||4|||f||||t||||||||||2017-10-11 05:32:27.375428|2017-10-11 05:32:27.375428
NCT00201149|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-04-06|||February 2004||2004-02-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|April 2008|Actual|2008-04-01||Interventional|HCTA||Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence|Hypertension Control and Therapy Adherence|Completed||N/A|870|Actual|Boston Medical Center||3|||f||||t||||||||No||2017-10-11 05:32:27.480795|2017-10-11 05:32:27.480795
NCT00201162|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2014-03-19|||September 2001||2001-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Soy and Lipoproteins in Postmenopausal Women||Completed||N/A|||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:32:27.590357|2017-10-11 05:32:27.590357
NCT00201188|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-03-07|||December 2003||2003-12-01|March 2013|2013-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Enhancing Collaboration Between Doctors and Patients to Improve Asthma|Cueing Patient-Clinician Collaboration to Improve Asthma|Completed||N/A|139|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 05:32:27.657058|2017-10-11 05:32:27.657058
NCT00201201|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-12-17|2013-08-13||September 2007||2007-09-01|December 2013|2013-12-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|||Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension|Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension|Completed||N/A|160|Actual|University of Connecticut||2|||f||||t||||||||||2017-10-11 05:32:27.758217|2017-10-11 05:32:27.758217
NCT00201214|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-09-10|||December 2003||2003-12-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|January 2006|Actual|2006-01-01||Interventional|||Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery|Phase I/II Clinical Trial to Determine the Pharmacokinetics and Safety Profile of Citrulline in Children Undergoing Cardiopulmonary Bypass|Completed||Phase 1/Phase 2|26|Actual|Vanderbilt University||1|||f||||t||||||||||2017-10-11 05:32:28.215977|2017-10-11 05:32:28.215977
NCT00201227|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-07-07|||September 2002||2002-09-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|ULTRA||Trial to Enhance Adherence to Multiple Guidelines|Using Learning Teams for Reflective Adaptation|Completed||N/A|60|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-10-11 05:32:28.314039|2017-10-11 05:32:28.314039
NCT00201240|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-08-24|2012-05-14||June 2005||2005-06-01|August 2017|2017-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)|A Single Arm, Multicenter Phase II Trial of Transplants of HLA-Matched, CD34+ Enriched, T Cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With AML in First or Second Morphologic Complete Remission (BMT CTN #0303)|Completed||Phase 2|47|Actual|National Heart, Lung, and Blood Institute (NHLBI)||1|||f||||t||||||||||2017-10-11 05:32:28.404442|2017-10-11 05:32:28.404442
NCT00201253|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-01-22|||September 2000||2000-09-01|January 2015|2015-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Expression of Tuberculosis in the Lung|Expression of Tuberculosis in the Lung|Completed||N/A|40|Actual|Rutgers, The State University of New Jersey|||1||f||||||||||Samples With DNA|"     Cell culture supernatants and cell lysates from bronchoalveolar cells, as well as peripheral     blood mononuclear cells.      Bronchoalveolar lavage fluid   "|||2017-10-11 05:32:28.93952|2017-10-11 05:32:28.93952
NCT00201266|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-03-11|||July 2005||2005-07-01|March 2013|2013-03-01||||August 2011|Actual|2011-08-01||Observational|||Histoblood Group Antigens as a Risk Factor of Asthma|Histoblood Group Antigens, Viruses and Asthma|Completed||N/A|126|Actual|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"     DNA, plasma, saliva, induced sputum.   "|||2017-10-11 05:32:29.015495|2017-10-11 05:32:29.015495
NCT00201279|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||April 1999||1999-04-01|January 2005|2005-01-01|September 2012||2012-09-01|||||Interventional|||Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma|Phase III Placebo-Controlled Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma Patients|Completed||Phase 3|342||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-10-11 05:32:29.098277|2017-10-11 05:32:29.098277
NCT00201292|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-14|||March 2005||2005-03-01|May 2007|2007-05-01|October 2008|Anticipated|2008-10-01|||||Observational|||Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)|Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)|Unknown status|Recruiting|N/A|1350|Anticipated|National Health Research Institutes, Taiwan|||||f||||t||||||||||2017-10-11 05:32:29.177742|2017-10-11 05:32:29.177742
NCT00201305|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-30|||July 2002||2002-07-01|September 2005|2005-09-01|August 2012||2012-08-01|||||Interventional|||Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract|Prospective Phase II Randomized Trial-Weekly Gemcitabine Plus High-Dose 5-Fluorouracil/ Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract|Completed||Phase 2|50||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-10-11 05:32:29.28642|2017-10-11 05:32:29.28642
NCT00201318|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-13|||September 2001||2001-09-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen|A Randomized Study of Lamivudine Prophylaxis or Treatment Against Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen|Completed||Phase 2|50||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-10-11 05:32:29.393376|2017-10-11 05:32:29.393376
NCT00201331|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-15|||April 2002||2002-04-01|December 2005|2005-12-01|October 2012||2012-10-01|||||Interventional|||Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer|Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer|Unknown status|Recruiting|Phase 2|162||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-10-11 05:32:29.464794|2017-10-11 05:32:29.464794
NCT00201344|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-25|||November 1994||1994-11-01|June 2009|2009-06-01|January 2000||2000-01-01|||||Interventional|||A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients|A Phase III Study of Radiotherapy With or Without Adjuvant Chemotherapy in Advanced Stage Nasopharyngeal Carcinoma Patients|Terminated||Phase 3|320||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-10-11 05:32:29.545466|2017-10-11 05:32:29.545466
NCT00201357|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-23|||October 2002||2002-10-01|March 2016|2016-03-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer|An Open, Non-Comparative Trial to Assess the Efficacy and Safety of Oral Thalidomide (THADO) in Patientswith Hormone-Refractory Prostate Cancer-A PHASE II CLINICAL TRIAL|Completed||Phase 2|30|Actual|National Health Research Institutes, Taiwan||1|||f||||t||||||||No||2017-10-11 05:32:29.625341|2017-10-11 05:32:29.625341
NCT00201370|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-03-23|||August 1999||1999-08-01|September 2005|2005-09-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Observational|||A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL Cases|A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL Cases|Completed||N/A|1000|Actual|National Health Research Institutes, Taiwan|||1||f||||t||||||||No||2017-10-11 05:32:29.714325|2017-10-11 05:32:29.714325
NCT00201383|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 1999||1999-10-01|January 2005|2005-01-01|August 2009||2009-08-01|||||Interventional|||Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients|Phase III Study Of Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients|Completed||Phase 3|161||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-10-11 05:32:29.834046|2017-10-11 05:32:29.834046
NCT00201396|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-02-23|||August 2003||2003-08-01|May 2006|2006-05-01|December 2011|Actual|2011-12-01|August 2009|Actual|2009-08-01||Interventional|||A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma|A Multicenter Phase III Trial Comparing Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Stage IV Nasopharyngeal Carcinoma (NPC)|Completed||Phase 3|480|Actual|National Health Research Institutes, Taiwan||2|||f||||||||||||||2017-10-11 05:32:29.939168|2017-10-11 05:32:29.939168
NCT00201409|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-11-30|2012-06-25||July 2004||2004-07-01|November 2015|2015-11-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||A Randomized Trial of GM-CSF in Patients With ALI/ARDS|A Randomized Trial of GM-CSF in Patients With ALI/ARDS|Completed||Phase 2|132|Actual|University of Michigan||2|||f||||t||||||||||2017-10-11 05:32:30.072571|2017-10-11 05:32:30.072571
NCT00201422|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-25|||June 1996||1996-06-01|March 2016|2016-03-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma|Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type of The Stomach|Completed||N/A|70|Actual|National Health Research Institutes, Taiwan||1|||f||||t||||||||No||2017-10-11 05:32:30.402869|2017-10-11 05:32:30.402869
NCT00201435|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-19|||March 2005||2005-03-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC|Weekly Taxol® Plus Xeloda® Versus Taxotere® Every Three Weeks Plus Xeloda® in the Treatment of Metastatic Breast Cancer A Phase II/III Study|Completed||Phase 2/Phase 3|224|Anticipated|Norwegian Breast Cancer Group|||||f||||f||||||||||2017-10-11 05:32:30.498128|2017-10-11 05:32:30.498128
NCT00186745|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-04-18|||March 2005||2005-03-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure|Tinzaparin for Treatment of Venous Thromboembolism in Renal Insufficiency: A Pilot Study|Terminated||N/A|148|Actual|St. Joseph's Healthcare Hamilton||1||Funding ceased|f||||f||||||||Undecided||2017-10-11 05:32:30.575775|2017-10-11 05:32:30.575775
NCT00186758|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-02|||July 2002||2002-07-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|TMS||Transcranial Magnetic Stimulation in Bipolar Depression|A Randomized, Sham Controlled, Crossover Trial of rTMS for Bipolar Depression|Completed||Phase 4|40|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-11 05:32:30.669743|2017-10-11 05:32:30.669743
NCT00186771|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-27|||November 2004||2004-11-01|July 2011|2011-07-01|January 2015|Anticipated|2015-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia|Transcranial Magnetic Stimulation Used to Treat Auditory Hallucinations in Schizophrenia|Unknown status|Recruiting|Phase 4|10|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-10-11 05:32:30.752971|2017-10-11 05:32:30.752971
NCT00186784|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-02|||December 2000||2000-12-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Transcranial Magnetic Treatment (TMS) in Unipolar Depression|Repetitive Transcranial Magnetic Stimulation (rTMS) in Unipolar Depression|Completed||Early Phase 1|21|Actual|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||||2017-10-11 05:32:30.858035|2017-10-11 05:32:30.858035
NCT00186797|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-04-07|||December 2002||2002-12-01|April 2010|2010-04-01|May 2007|Actual|2007-05-01|September 2005|Actual|2005-09-01||Interventional|AACD34||Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia||Completed||N/A|28||St. Jude Children's Research Hospital|||||||||||||||||||2017-10-11 05:32:30.926316|2017-10-11 05:32:30.926316
NCT00186810|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-05-28|||December 1992||1992-12-01|May 2009|2009-05-01|October 2007|Actual|2007-10-01|February 2006|Actual|2006-02-01||Interventional|||Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease|Allogeneic Stem Cell Transplantation From HLA/MLC Genotype Identical Donors for Patients With High Risk Sickle Cell Disease|Completed||Phase 2|15|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:31.001119|2017-10-11 05:32:31.001119
NCT00186823|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-28|||March 2002||2002-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|September 2005|Actual|2005-09-01||Interventional|||Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies|Haploidentical Stem Cell Transplantation Utilizing Purified CD34+ Hematopoietic Cells for Patients With Hematologic Malignancies|Completed||Phase 3|57|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:32:31.081601|2017-10-11 05:32:31.081601
NCT00186836|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-19|||November 2004||2004-11-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients|Efficacy of Combined Hepatitis A and Hepatitis B (Twinrix) Vaccine Compared With Hepatitis B Vaccine Alone in Providing Seroprotection Against Hepatitis B in Hemodialysis Patients|Completed||Phase 4|200||St. Joseph's Healthcare Hamilton|||||f||||||||||||||2017-10-11 05:32:31.221767|2017-10-11 05:32:31.221767
NCT00186849|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-05-19|||October 1997||1997-10-01|May 2009|2009-05-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Therapy for Children With Advanced Stage High Risk Neuroblastoma|Therapy for Children With Advanced Stage High Risk Neuroblastoma|Completed||Phase 2|30|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:32:31.302832|2017-10-11 05:32:31.302832
NCT00186862|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-02|||August 1998||1998-08-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|April 2000|Actual|2000-04-01||Interventional|||Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma|Phase I Study of Chemokine and Cytokine Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma Using a Retroviral Vector|Completed||Phase 1|24|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:31.39875|2017-10-11 05:32:31.39875
NCT00186875|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2017-07-26|2013-10-25||November 2003||2003-11-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional||One patient who was >21 years at diagnosis was enrolled because early versions of the protocol had no upper age limit for participants previously treated on St Jude frontline protocols. The protocol was subsequently amended to change the age criteria to ≤21 years of age at diagnosis for all patients.|Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia|A Study of Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia|Completed||Phase 2|47|Actual|St. Jude Children's Research Hospital||1|||f||||f|t|f||||||||2017-10-11 05:32:31.50383|2017-10-11 05:32:31.50383
NCT00186888|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-11|2011-06-29||February 2005||2005-02-01|June 2016|2016-06-01|September 2021|Anticipated|2021-09-01|November 2013|Actual|2013-11-01||Interventional|||Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma|Protocol for the Study and Treatment of Patients With Intraocular Retinoblastoma|Active, not recruiting||Phase 3|107|Actual|St. Jude Children's Research Hospital||3|||f||||t||||||||||2017-10-11 05:32:32.249435|2017-10-11 05:32:32.249435
NCT00186901|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-03|2011-12-20||July 2000||2000-07-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|June 2009|Actual|2009-06-01||Interventional|||A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors|Diminished Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL): A Severity-Adapted Clinical Trial|Completed||Phase 3|429|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-10-11 05:32:33.966319|2017-10-11 05:32:33.966319
NCT00186914|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-03-03|||July 1999||1999-07-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|November 2001|Actual|2001-11-01||Interventional|||Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation|Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation: A Phase I Study|Completed||Phase 1|8|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:35.173747|2017-10-11 05:32:35.173747
NCT00186927|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-31|||May 5, 2005|Actual|2005-05-05|December 2016|2016-12-01|June 30, 2019|Anticipated|2019-06-30|June 30, 2019|Anticipated|2019-06-30||Interventional|||A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers|A Phase I Study of Unmodified Live Intranasal Sendai Virus Vaccine in Children and Toddlers: Assessment of Safety and Immunogenicity|Recruiting||Phase 1|54|Anticipated|St. Jude Children's Research Hospital||1|||f||||t|t|f||||||||2017-10-11 05:32:35.312436|2017-10-11 05:32:35.312436
NCT00186940|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-24|||March 2005||2005-03-01|October 2011|2011-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients|A Study of Rasburicase Treatment for Chemotherapy of Malignancy-Induced Hyperuricemia in Patients With a History of Asthma Allergies|Completed||N/A|16|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-10-11 05:32:35.448523|2017-10-11 05:32:35.448523
NCT00186953|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-19|||June 2002||2002-06-01|September 2011|2011-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors|Determination of Optimal Dose and Safety Profile of Optison Ultrasound Contrast Agent in Pediatric Solid Tumor Patients|Completed||Phase 1|14|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:35.565729|2017-10-11 05:32:35.565729
NCT00186966|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-05|||March 2002||2002-03-01|April 2011|2011-04-01|September 2010|Actual|2010-09-01|April 2009|Actual|2009-04-01||Interventional|||Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia|A Randomized Phase III Study of the Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia|Completed||Phase 3|394|Actual|Dutch Childhood Oncology Group||2|||f||||t||||||||||2017-10-11 05:32:35.658169|2017-10-11 05:32:35.658169
NCT00186979|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-24|||May 2003||2003-05-01|October 2011|2011-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors|A Phase I Study of ZD1839 (Iressa) in Combination With Irinotecan (Camptosar or CPT-11) and Vincristine in Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|34|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:35.787058|2017-10-11 05:32:35.787058
NCT00186992|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-06|||January 10, 2003|Actual|2003-01-10|September 2017|2017-09-01|January 31, 2024|Anticipated|2024-01-31|January 31, 2024|Anticipated|2024-01-31||Interventional|||Radiation Therapy to Treat Musculoskeletal Tumors|Image Guided Radiotherapy for the Treatment of Musculoskeletal Tumors: A Phase II Prospective Evaluation of Radiation-related Treatment Effects|Active, not recruiting||Phase 2|199|Actual|St. Jude Children's Research Hospital||1|||f||||f|f|t|f|f||||||2017-10-11 05:32:35.8935|2017-10-11 05:32:35.8935
NCT00187005|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-03-29|||July 1998||1998-07-01|June 2008|2008-06-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Terminated||Phase 3|53|Actual|St. Jude Children's Research Hospital||1||Toxicity|f||||t||||||||||2017-10-11 05:32:36.019484|2017-10-11 05:32:36.019484
NCT00208000|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2010-11-26|||July 2004||2004-07-01|September 2005|2005-09-01|April 2006|Anticipated|2006-04-01|||||Interventional|||A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.||Unknown status|Recruiting|Phase 2|||China Medical University Hospital|||||f||||||||||||||2017-10-11 05:34:47.26958|2017-10-11 05:34:47.26958
NCT00187018|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-03|||March 2004||2004-03-01|May 2007|2007-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study|Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study|Completed||N/A|9|Actual|St. Jude Children's Research Hospital|||||f||||f||||||||||2017-10-11 05:32:36.172745|2017-10-11 05:32:36.172745
NCT00187031|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-03|||November 2002||2002-11-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|||||Interventional|||A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor|A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor|Completed||Phase 2|37|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-10-11 05:32:36.238961|2017-10-11 05:32:36.238961
NCT00187044|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-28|||October 1997||1997-10-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of the Safety of a Polyvalent Virus in Healthy Adults|Evaluation of the Safety of a Polyvalent Vaccinia Virus-HIV-1 Envelope Recombinant Vaccine (PolyEnv1) in Healthy Adults|Completed||Phase 1|18|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:36.354466|2017-10-11 05:32:36.354466
NCT00187057|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-08-26|||September 2002||2002-09-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|August 2006|Actual|2006-08-01||Interventional|||Study for Treatment of Cancer in Children With Ataxia-telangiectasia|Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia|Completed||N/A|6|Actual|St. Jude Children's Research Hospital||5|||f||||f||||||||||2017-10-11 05:32:36.435962|2017-10-11 05:32:36.435962
NCT00187070|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-06|||December 1997||1997-12-01|May 2008|2008-05-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Large Cell Lymphoma Pilot Study III|Large Cell Lymphoma, Pilot Study III|Completed||N/A|8|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:37.217818|2017-10-11 05:32:37.217818
NCT00187083|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-03|||February 1997||1997-02-01|June 2008|2008-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||A Study of Children With Refractory or Relapsed ALL|A Study of Children With Refractory or Relapsed Acute Lymphoblastic Leukemia (ALLR16)|Completed||Phase 3|40|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-10-11 05:32:37.3577|2017-10-11 05:32:37.3577
NCT00187096|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-06-18|2012-10-10||September 2005||2005-09-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|February 2012|Actual|2012-02-01||Interventional|||Natural Killer (NK) Cell Transplantation for AML|Pilot Study Of Haplo-Identical Natural Killer Cell Transplantation For Acute Myeloid Leukemia|Completed||N/A|49|Actual|St. Jude Children's Research Hospital||2|||f||||t||||||||||2017-10-11 05:32:37.539349|2017-10-11 05:32:37.539349
NCT00187109|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-04-08|||June 2000||2000-06-01|May 2007|2007-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy|A Phase I/II Trial of Recombinant Human Thrombopoietin in Children With Malignant Solid Tumors and Lymphoma Receiving Ifosfamide, Carboplatin and Etoposide|Completed||Phase 1/Phase 2|40||St. Jude Children's Research Hospital|||||f||||||||||||||2017-10-11 05:32:38.203666|2017-10-11 05:32:38.203666
NCT00187122|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-04-21|||March 1993||1993-03-01|April 2008|2008-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma|Treatment for Newly Diagnosed Patients With Stage III/IV Non-Hodgkin Lymphoma-Study XIII (A Therapeutic Pilot Study)|Completed||N/A|42|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:38.340568|2017-10-11 05:32:38.340568
NCT00187135|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-03|2009-10-13||March 2002||2002-03-01|March 2010|2010-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration|Fentanyl-Propofol-EMLA or L.M.X4™ Technique for Bone Marrow Aspiration in Pediatric Patients - A Phase III Study|Terminated||Phase 3|168|Actual|St. Jude Children's Research Hospital|All 162 participants were expected to receive three treatments. Not all participants received all three treatments. Therefore, analysis required the identification of subsets of treated participants. The trial terminated early due to slow accrual.|3||The study was terminated due to slow accrual.|f||||f||||||||||2017-10-11 05:32:38.530629|2017-10-11 05:32:38.530629
NCT00187148|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-24|||February 2005||2005-02-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults|Evaluation of the Tolerability and Safety of a Recombinant HIV-1 Multi-Envelope DNA Plasmid Vaccine (EnvDNA) in Healthy Adults|Completed||Phase 1|6|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-10-11 05:32:39.114833|2017-10-11 05:32:39.114833
NCT00192556|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2007-02-08|||March 2005||2005-03-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||Food Incentives for TB Treatment Compliance in East Timor (FITTCET)|Food Incentives for TB Treatment Compliance in East Timor|Completed||N/A|270||Menzies School of Health Research|||||f||||||||||||||2017-10-11 05:32:39.196914|2017-10-11 05:32:39.196914
NCT00192569|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-04-13|||July 2004||2004-07-01|October 2009|2009-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Australian Trial in Acute Hepatitis C|Australian Trial in Acute Hepatitis C|Completed||Phase 4|167|Actual|Kirby Institute||2|||f||||t||||||||||2017-10-11 05:32:39.295525|2017-10-11 05:32:39.295525
NCT00192595|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2015-03-30|||January 2004||2004-01-01|March 2015|2015-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|TICO||Tenofovir in HIV/HBV Coinfection|Virological and Clinical Anti-HBV Efficacy of Tenofovir in Antiretroviral naïve Patients With HIV/HBV Co-infection|Completed||Phase 4|36|Actual|Kirby Institute||3|||f||||t||||||||||2017-10-11 05:32:39.505288|2017-10-11 05:32:39.505288
NCT00192608|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-25|||November 2004||2004-11-01|June 2009|2009-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|ASK-500||A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study|A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation.|Completed||N/A|40|Actual|Kirby Institute||2|||f||||f||||||||||2017-10-11 05:32:39.589119|2017-10-11 05:32:39.589119
NCT00192621|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-04-11|||November 2004||2004-11-01|April 2012|2012-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects|A 3 Arm, Prospective Study to Compare the Effect of 6 Weeks Exposure to the Combination of Lopinavir (LPVr)/Combivir® (AZT/3TC) Versus Lopinavir Alone or Combivir® Alone in HIV-negative Healthy Subjects on the Development of Abnormalities of Lipid and Glucose Metabolism|Completed||Phase 4|50|Actual|Kirby Institute||1|||f||||f||||||||||2017-10-11 05:32:39.681076|2017-10-11 05:32:39.681076
NCT00192634|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-24|||December 2005||2005-12-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study|A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study.|Completed||Phase 4|357|Actual|Kirby Institute||2|||f||||t||||||||||2017-10-11 05:32:39.778|2017-10-11 05:32:39.778
NCT00192647|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-06-23|2016-05-06||August 2004||2004-08-01|June 2016|2016-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||Intent-to-treat (ITT) analysis population included all randomized participants who received at least 1 dose of study drug.|A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection|A Phase IV, Randomised, Multicentre, Efficacy and Safety Study Examining the Effect of Induction Dosing With the Combination of Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Infected With Hepatitis C Genotype 1|Completed||Phase 4|896|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:32:39.952536|2017-10-11 05:32:39.952536
NCT00192660|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-04-11|||February 2003||2003-02-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|October 2006|Actual|2006-10-01||Interventional|||HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)|Analysis of Lipodystrophy in HIV-Infected Individuals A Prospective, Non-randomised, 48 Week Study of the Effect of PI Containing and Non-PI Containing Antiretroviral Regimens on the Expression of Adipocyte Specific Genes, Protein Levels and Cellular Structure in HIV-infected Individuals, Naive to Therapy, Who Are Starting Therapy for the First Time|Completed||Phase 4|80|Actual|Kirby Institute||1|||f||||f||||||||||2017-10-11 05:32:40.844583|2017-10-11 05:32:40.844583
NCT00192673|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2009-09-29|||June 2005||2005-06-01|September 2009|2009-09-01|December 2013|Anticipated|2013-12-01|||||Interventional|||Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses|PEG-asparaginase During Two Treatment Courses in the Treatment of Childhood Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 4|85|Anticipated|Nordic Society for Pediatric Hematology and Oncology|||||f||||||||||||||2017-10-11 05:32:40.951189|2017-10-11 05:32:40.951189
NCT00192686|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2014-03-28|||January 2004||2004-01-01|March 2014|2014-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Cultures a.m.Kamme-Lindbergh in Suspicion of Infected TKA|Cultures From Total Knee Arthroplasties, Obtained a.m. Kamme-Lindberg in Revision Cases.|Completed||N/A|||Northern Orthopaedic Division, Denmark|||||f||||||||||||||2017-10-11 05:32:41.041237|2017-10-11 05:32:41.041237
NCT00192699|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2014-03-28|||January 2004||2004-01-01|March 2014|2014-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Bimetric-10: Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-Metric Stem|10 Year Follow-up Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-metric Stem|Completed||N/A|80|Actual|Northern Orthopaedic Division, Denmark|||1||f||||t||||||||||2017-10-11 05:32:41.104958|2017-10-11 05:32:41.104958
NCT00201448|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-27|2012-04-03||June 2007||2007-06-01|May 2016|2016-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women|Epidemiology of Cytomegalovirus -- Evaluation of the Immunogenicity and Efficacy of the Towne Strain of CMV in Seronegative Women: A Phase II-III Study|Terminated||Phase 2/Phase 3|82|Actual|Virginia Commonwealth University||2||Suspended due to lack of funding|f||||t||||||||||2017-10-11 05:32:41.324529|2017-10-11 05:32:41.324529
NCT00201461|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-12-29|||June 2003||2003-06-01|November 2008|2008-11-01|April 2010|Anticipated|2010-04-01|||||Interventional|||Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)|A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale|Unknown status|Active, not recruiting|Phase 2/Phase 3|900|Anticipated|NMT Medical||2|||f||||t||||||||||2017-10-11 05:32:41.694054|2017-10-11 05:32:41.694054
NCT00201474|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-08-03|||October 1998||1998-10-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|October 2004|Actual|2004-10-01||Observational|||Acute, Affective, Organic Disorders.|Signs of Organic Brain Dysfunction in Psychiatric Patients With Fluctuating Psychiatric Symptoms Including Brief Depressions Compared to Patients With a Major Depressive Episode.|Completed||N/A|32|Actual|Norwegian University of Science and Technology|||2||f||||f||||||Samples Without DNA|"     Ordinary laboratory tests, medication, substances.   "|||2017-10-11 05:32:41.809942|2017-10-11 05:32:41.809942
NCT00201487|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-10-30|||November 2007||2007-11-01|October 2013|2013-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Choline Quantification in Breast Cancer by MRS|Choline Quantification in Breast Cancer by MRS|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology|||1|"We chose to use an exsisting NMR pulse sequence already established and available at the   hospital."|f||||f||||||||||2017-10-11 05:32:41.895569|2017-10-11 05:32:41.895569
NCT00201500|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-08-03|||October 2004||2004-10-01|August 2016|2016-08-01|March 2006|Actual|2006-03-01|December 2005|Actual|2005-12-01||Observational|||Left Ventricular and Endothelial Function in Preeclampsia|Left Ventricular and Endothelial Function in Preeclampsia, a Case Control Study|Completed||Phase 1/Phase 2|39|Actual|Norwegian University of Science and Technology|||2||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 05:32:41.979956|2017-10-11 05:32:41.979956
NCT00201513|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-10-08|||January 2006||2006-01-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||Anticipatory Muscle Control and Effect of Stabilizing Exercises in Patients With Subacute and Chronic Low Back Pain|Randomized Controlled Trial of Stabilizing Exercises and Effect on Anticipatory Muscle Control in Patients With Subacute and Chronic Low Back Pain|Completed||N/A|99|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 05:32:42.066767|2017-10-11 05:32:42.066767
NCT00201526|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-12-01|||January 2003||2003-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Bipolar Research And Innovation Network - BRAIN|Bipolar Research And Innovation Network - BRAIN|Recruiting||N/A|3000|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"     Blood samples   "|||2017-10-11 05:32:42.168945|2017-10-11 05:32:42.168945
NCT00201539|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-04-07|||April 2002||2002-04-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|November 2006|Actual|2006-11-01||Interventional|||Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients|Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients: A Randomized, Double-blind Cross-over Comparison of a Double Bedtime Dose Ver-sus Two Standard Doses at Bedtime and at Night|Completed||Phase 3|19|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:32:42.263949|2017-10-11 05:32:42.263949
NCT00201552|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-19||||||September 2005|2005-09-01||||||||Interventional|||Statin and PAF in Patients With Pacemaker|Atorvastatin Decreases Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation|Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:32:42.407972|2017-10-11 05:32:42.407972
NCT00201565|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-19|||May 2005||2005-05-01|March 2005|2005-03-01||||||||Observational|||Association Between Peripheral Artery Stiffness and Cardiovascular Disease||Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:32:42.521502|2017-10-11 05:32:42.521502
NCT00201578|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-04-27||||||January 2005|2005-01-01||||||||Observational|||Case Control Study of Non Viral Hepatitis Relating to Herbal Drug Use in the Emergency Department||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:32:42.630446|2017-10-11 05:32:42.630446
NCT00201591|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-08-25|||August 2002||2002-08-01|August 2011|2011-08-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Training at Different Intensities in Coronary Artery Disease -Effects on Myocardial Function|Which Training Intensity is Most Effective in Improving Myocardial Function in Patients With Coronary Artery Disease?|Completed||N/A|17|Actual|Norwegian University of Science and Technology|||||f||||f||||||||||2017-10-11 05:32:42.737492|2017-10-11 05:32:42.737492
NCT00201617|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-04-13|||July 2004||2004-07-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|||||Observational|||Efficacy of the Bone-anchored Hearing Aid for Unilateral Deafness|Short-term and Long-term Efficacy of the BAHA for Single Sided Deafness|Completed||N/A|28|Actual|The New York Eye & Ear Infirmary|||2||f||||||||||||||2017-10-11 05:32:42.878111|2017-10-11 05:32:42.878111
NCT00201630|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||September 2005||2005-09-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Interventional|||Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy|Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy|Unknown status|Not yet recruiting|Phase 3|150||New York Prostate Institute|||||f||||||||||||||2017-10-11 05:32:43.026432|2017-10-11 05:32:43.026432
NCT00201643|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-12-17|2010-09-07||November 2003||2003-11-01|December 2014|2014-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|ACS||A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome|A Randomized Double-Blinded Study Comparing the Impact of One Versus Two Courses of Antenatal Steroids on Neonatal Outcome|Completed||Phase 4|437|Actual|Mednax Center for Research, Education and Quality||2|||f||||t||||||||||2017-10-11 05:32:43.171054|2017-10-11 05:32:43.171054
NCT00201656|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-17|||November 2004||2004-11-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|PROMCerclage||Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)|Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial|Terminated||Phase 4|58|Actual|Mednax Center for Research, Education and Quality||2||"This trial was terminated following a futility analysis confirming futility of continuing the   study"|f||||t||||||||||2017-10-11 05:32:43.84708|2017-10-11 05:32:43.84708
NCT00201669|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-04-22|||October 2004||2004-10-01|April 2015|2015-04-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma|A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|6|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:32:44.047246|2017-10-11 05:32:44.047246
NCT00201682|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-06|||October 2002||2002-10-01|February 2017|2017-02-01|August 2009|Actual|2009-08-01|August 2006|Actual|2006-08-01||Interventional|||Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Phase I/II Study of Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Completed||Phase 1/Phase 2|36|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:32:44.155333|2017-10-11 05:32:44.155333
NCT00201695|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-09|||July 2004||2004-07-01|June 2015|2015-06-01|August 2008|Actual|2008-08-01|September 2006|Actual|2006-09-01||Interventional|||Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma|Phase II Trial of Pegylated Liposomal Doxorubicin (Doxil), Vincristine, and Dexamethasone (DVd) in Combination With Arsenic Trioxide (Trisenox) in Untreated Patients With Symptomatic Multiple Myeloma|Completed||Phase 2|12|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:32:44.259068|2017-10-11 05:32:44.259068
NCT00201708|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-09-01|||October 2004||2004-10-01|September 2016|2016-09-01|February 2014|Actual|2014-02-01|December 2006|Actual|2006-12-01||Interventional|||Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer|Phase II Randomized Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide (AC) in Axillary Node-Positive Breast Cancer|Completed||Phase 2|56|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 05:32:44.356815|2017-10-11 05:32:44.356815
NCT00201721|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-06|||July 2002||2002-07-01|February 2017|2017-02-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia|Phase II Trial of Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|28|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:32:44.455668|2017-10-11 05:32:44.455668
NCT00201734|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-15|2016-04-25||June 2005||2005-06-01|August 2016|2016-08-01|June 2013|Actual|2013-06-01|November 2007|Actual|2007-11-01||Interventional|||Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary|A Phase I Dose Escalation Study of Capecitabine, Carboplatin and Weekly Paclitaxel and a Phase II Trial of the Same Combination in Patients With Adenocarcinoma of Unknown Primary|Terminated||Phase 1/Phase 2|57|Actual|Ohio State University Comprehensive Cancer Center||1||Due to lack of funding provided for Phase II portion of trial|f||||t||||||||||2017-10-11 05:32:44.548679|2017-10-11 05:32:44.548679
NCT00201747|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-18|||September 2001||2001-09-01|December 2012|2012-12-01|February 2010|Actual|2010-02-01|October 2006|Actual|2006-10-01||Interventional|||Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer|Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer|Completed||Phase 2|80|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:32:45.093736|2017-10-11 05:32:45.093736
NCT00201773|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-25|2015-02-17||July 2003||2003-07-01|June 2015|2015-06-01|June 2011|Actual|2011-06-01|November 2007|Actual|2007-11-01||Interventional|||Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer|A Phase II Trial of Exemestane (Aromasin) in Combination With Celecoxib (Celebrex) as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer|Completed||Phase 2|22|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:32:45.272949|2017-10-11 05:32:45.272949
NCT00201786|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-04-25|||July 2003||2003-07-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|October 2007|Actual|2007-10-01||Interventional|||Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease|Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease|Completed||Phase 2|8|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:32:45.56552|2017-10-11 05:32:45.56552
NCT00202904|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-28|||May 2005||2005-05-01|April 2015|2015-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)|A Multicenter, Randomized, Parallel Groups, Placebo-Controlled Study Comparing the Efficacy, Safety, and Tolerability of the Daily Co-Administration of Ezetimibe 10 mg or Ezetimibe Placebo to Ongoing Treatment With Atorvastatin 10 mg in Subjects With Primary Hypercholesterolemia and Coronary Heart Disease|Completed||Phase 4|81|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:32:45.644242|2017-10-11 05:32:45.644242
NCT00202917|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-28|||February 2004||2004-02-01|May 2014|2014-05-01|December 2010|Actual|2010-12-01|July 2009|Actual|2009-07-01||Interventional|||Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies|Multicenter Phase I/II Study of Haploidentical Hematopoietic Cell Transplantation With CD3/CD19 Depleted Grafts in Patients With Treatment Refractory Hematologic Malignancies|Completed||Phase 1/Phase 2|61|Actual|University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:32:45.728309|2017-10-11 05:32:45.728309
NCT00202930|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-19|||July 2005||2005-07-01|September 2006|2006-09-01|July 2008||2008-07-01|||||Interventional|||Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma|Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma|Unknown status|Recruiting|Phase 2|10||Tersak, Jean M., M.D.|||||||||||||||||||2017-10-11 05:32:45.819034|2017-10-11 05:32:45.819034
NCT00202943|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||March 2003||2003-03-01|September 2005|2005-09-01|March 2004||2004-03-01|||||Interventional|||Randomized Controlled Trial of TCRFVR and LAUP in Snorers|Comparison of Clinical Effect Between Temperature-Controlled Radio-Frequency Uvuloplasty and Laser Assisted Uvulo-Pharyngoplasty in Patients Who Snore|Completed||N/A|40||Taichung Veterans General Hospital|||||f||||||||||||||2017-10-11 05:32:47.356805|2017-10-11 05:32:47.356805
NCT00202956|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2004||2004-06-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.|A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effects on Biomarkers and Safety of Bugusan (BGS) in Postmenopausal Patients With Osteoporosis.|Unknown status|Recruiting|Phase 2|||Taichung Veterans General Hospital|||||f||||||||||||||2017-10-11 05:32:47.415392|2017-10-11 05:32:47.415392
NCT00202969|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-07-06|||July 2005||2005-07-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|January 2007|Actual|2007-01-01||Interventional|||Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer|An Open-label, Multicenter, Randomized, 3 Arm Study of S-1 Compared With S-1/CDDP, or S-1/CDDP Compared With 5-FU/CDDP in Patients With Advanced Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease|Completed||Phase 3|180|Anticipated|Taiho Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 05:32:47.487995|2017-10-11 05:32:47.487995
NCT00202982|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-12|||August 2003||2003-08-01|January 2010|2010-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose|A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy, Tolerability and Safety of 40 mg of Copaxone in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients|Completed||Phase 2|90|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-10-11 05:32:47.571414|2017-10-11 05:32:47.571414
NCT00202995|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-10-14|||July 2004||2004-07-01|October 2010|2010-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS|A Multi-Center, Randomized, Single-Blind, Parallel Group Study to Compare the Efficacy, Tolerability and Safety, of Copaxone® to That of High Dose Interferon (Betaseron® or Rebif®) in the Treatment of Relapsing Multiple Sclerosis Patients|Terminated||Phase 4|91|Actual|Teva Pharmaceutical Industries||2||Slow enrollment decreased sample size No unexpected safety issues.|f||||t||||||||||2017-10-11 05:32:47.685054|2017-10-11 05:32:47.685054
NCT00196287|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|September 2005|2005-09-01||||||||Observational|||Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients|Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients|Completed||N/A|750||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-10-11 05:35:59.288367|2017-10-11 05:35:59.288367
NCT00203008|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-10-14|||January 2003||2003-01-01|October 2010|2010-10-01|September 2003|Actual|2003-09-01|||||Observational|||A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma|A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients|Completed||N/A|2106|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-10-11 05:32:47.765268|2017-10-11 05:32:47.765268
NCT00203021|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-01|||July 1994||1994-07-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.|Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®|Active, not recruiting||Phase 4|102|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-11 05:32:47.822708|2017-10-11 05:32:47.822708
NCT00203034|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-08|||May 2000||2000-05-01|March 2010|2010-03-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations|A Multicenter, US and Canada, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study, for the Efficacy, Tolerability and Safety of Rasagiline Mesylate in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|Completed||Phase 3|472|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-10-11 05:32:47.911102|2017-10-11 05:32:47.911102
NCT00203047|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-15|2013-08-29||January 2005||2005-01-01|November 2013|2013-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|ASSERT|Represents database as of January 29, 2009|Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate|A Multi-Centered, Randomized, Double-Blind, Placebo Controlled Study Assessing the Add-on Effect of Oral Steroids in Relapsing Remitting Multiple Sclerosis Subjects Treated With Glatiramer Acetate (GA)|Terminated||Phase 4|414|Actual|Teva Pharmaceutical Industries||2||Slow enrollment decreased sample size; No unexpected safety issues.|f||||t||||||||||2017-10-11 05:32:48.156544|2017-10-11 05:32:48.156544
NCT00203060|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-08|||July 1997||1997-07-01|April 2011|2011-04-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa|A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Phase III Clinical Trial For The Efficacy, Tolerability And Safety Of Two Doses Of Rasagiline Mesylate In Early Parkinson's Disease (PD) Patients Not Treated With Levodopa|Completed||Phase 3|404|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 05:32:50.041213|2017-10-11 05:32:50.041213
NCT00203073|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-13|||June 2003||2003-06-01|April 2011|2011-04-01|April 2005|Actual|2005-04-01|January 2005|Actual|2005-01-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.|A Multi-Center, Randomized, Open Label Study To Evaluate Safety, Tolerability And Efficacy Of Treatment With Mitoxantrone; Pre-Treatment With Glatiramer Acetate (GA) Versus Treatment With GA Alone In Relapsing Forms Of Multiple Sclerosis.|Completed||Phase 2|40|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:32:50.123127|2017-10-11 05:32:50.123127
NCT00203086|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-27|||October 2005||2005-10-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Observational|||A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis|A Multi-Centered, Two Arm, Open Label Extension Study (to Protocol NC-100) to Evaluate the Long-Term Safety and Efficacy of Short-Term Induction Treatment With Mitoxantrone (Novantrone®) Preceding Treatment With Glatiramer Acetate (Copaxone®) vs. Chronic Treatment With Glatiramer Acetate Alone in Relapsing Forms of Multiple Sclerosis|Completed||Phase 4|30|Actual|Teva Pharmaceutical Industries|||1||f||||t||||||||||2017-10-11 05:32:50.320034|2017-10-11 05:32:50.320034
NCT00203099|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-11|||December 2004||2004-12-01|May 2012|2012-05-01|June 2008|Actual|2008-06-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine|A Pilot, Multicenter, Open-label, One-group Study to Explore the Efficacy, Tolerability and Safety of the Combination of Glatiramer Acetate (GA) and N-Acetylcysteine (NAC) in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)|Completed||Phase 2|18|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 05:32:50.381073|2017-10-11 05:32:50.381073
NCT00203112|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-11|||June 2004||2004-06-01|April 2011|2011-04-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline|A Multi-Centered, Randomized, Double-Blind, Placebo-Controlled, Parallel Study Assessing the Add-on Effect of Minocycline in Relapsing-Remitting Multiple Sclerosis (RR-MS) Subjects Treated With Glatiramer Acetate (GA).|Completed||Phase 2|44|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 05:32:50.448547|2017-10-11 05:32:50.448547
NCT00203125|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-08|||October 2000||2000-10-01|April 2011|2011-04-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.|Sub-study to Evaluate the Effect of An Oral Dose of Tyramine in Subjects Completing 26 Weeks of Participation in PRESTO (TVP-1012/133)|Completed||Phase 3|55|Actual|Teva Pharmaceutical Industries||1|||f||||t||||||||||2017-10-11 05:32:50.524662|2017-10-11 05:32:50.524662
NCT00203138|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-08|||June 2004||2004-06-01|April 2011|2011-04-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease|A Multicenter, Open-Label, Phase III Study for the Safety, Tolerability and Clinical Effect of Rasagiline Mesylate in Patients With Parkinson's Disease|Completed||Phase 3|306|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 05:32:50.590755|2017-10-11 05:32:50.590755
NCT00203151|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-08|||July 2005||2005-07-01|April 2011|2011-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|PRELUDE||A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus|A Multi-National, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Parallel Group Study to Assess the Efficacy, Tolerability and Safety of Edratide for Subcutaneous Injection in Systemic Lupus Erythematosus (SLE)|Terminated||Phase 2|340|Actual|Teva Pharmaceutical Industries||2||TV-4710/201 did not meet its primary endpoints in patients with SLE|t||||||||||||||2017-10-11 05:32:50.65151|2017-10-11 05:32:50.65151
NCT00203788|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-07-28|||May 1999||1999-05-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Improving Work Outcome in People With Recent-onset Schizophrenia|Developmental Processes in Schizophrenic Disorders: Improving and Predicting Work Outcome in Recent-Onset Schizophrenia|Completed||Phase 4|87|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-10-11 05:32:57.689171|2017-10-11 05:32:57.689171
NCT00203164|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-08|||May 2002||2002-05-01|March 2010|2010-03-01|September 2006|Actual|2006-09-01|July 2005|Actual|2005-07-01||Interventional|||Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients|A Bi-national, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Tolerability of Rasagiline Mesylate in Advanced Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Chronic Levodopa/Carbidopa Therapy|Completed||Phase 3|254|Actual|Teva Pharmaceutical Industries||1|||||||f||||||||||2017-10-11 05:32:50.720973|2017-10-11 05:32:50.720973
NCT00203177|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-08|||October 2001||2001-10-01|March 2010|2010-03-01||||December 2006|Actual|2006-12-01||Interventional|||Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.|A Bi-national, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Tolerability of Rasagiline Mesylate in Advanced Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Chronic Levodopa/Carbidopa Therapy.|Completed||Phase 3|254|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-10-11 05:32:50.822897|2017-10-11 05:32:50.822897
NCT00203190|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-01-22|||September 2004||2004-09-01|January 2009|2009-01-01|June 2006||2006-06-01|||||Interventional|||A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache|A Single-Center, Randomized, Double-Blind, Placebo Controlled Trial Examining the Safety and Efficacy of Topiramate in the Treatment of Subjects With Episodic or Chronic Cluster Headache.|Terminated||Phase 4|60||Thomas Jefferson University|||||f||||||||||||||2017-10-11 05:32:50.917202|2017-10-11 05:32:50.917202
NCT00203203|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-10-17|2011-07-06||April 2004||2004-04-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|August 2008|Actual|2008-08-01||Interventional|||Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)|Randomized Controlled Single Blind Trial of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance for Therapeutic Angiogenesis|Completed||Phase 1|30|Actual|Texas Heart Institute|The study is a preliminary study based on a small sample size which limits the statistical rigor of the analysis.|2|||f||||t||||||||No|Data summarized and published. No need to share individual patient data.|2017-10-11 05:32:51.025406|2017-10-11 05:32:51.025406
NCT00203216|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-15|2011-05-23||September 2002||2002-09-01|July 2011|2011-07-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches|A Single-Center, Open-Label Trial Examining the Efficacy and Safety of Levetiracetam for the Prophylactic Treatment of Migraine, With or Without Aura|Completed||N/A|31|Actual|Thomas Jefferson University||1|||f||||||||||||||2017-10-11 05:32:51.956402|2017-10-11 05:32:51.956402
NCT00203229|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-02|2014-02-07||June 2003||2003-06-01|May 2014|2014-05-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia|A Double-Blind Placebo Controlled Add-on Study to Determine the Efficacy and Safety of Lamictal (Lamotrigine) in Patients With Trigeminal Neuralgia (Tic Doloureux)|Completed||N/A|20|Actual|Thomas Jefferson University|Limited enrollment due to fear of placebo and high drop out rate.|2|||f||||f||||||||||2017-10-11 05:32:52.120398|2017-10-11 05:32:52.120398
NCT00203242|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-13|2011-06-07||July 2003||2003-07-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches.|An Open-label Pilot Study to Collect/Evaluate Data on the Use of Consecutive Daily Intravenous Doses of Depacon in Combination With Daily Dose of Depakote ER During a Cluster Headache Cycle.|Completed||N/A|15|Actual|Thomas Jefferson University||1|||f||||||||||||||2017-10-11 05:32:52.338035|2017-10-11 05:32:52.338035
NCT00203255|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-22|||May 2003||2003-05-01|January 2009|2009-01-01|March 2005||2005-03-01|||||Interventional|||Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache|An Open-Label, Pilot Study Examining the Use of Soy Isoflavones in the Prevention of Menstrually-Associated Migraine|Completed||N/A|25||Thomas Jefferson University|||||f||||||||||||||2017-10-11 05:32:52.507236|2017-10-11 05:32:52.507236
NCT00203268|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-08|2010-10-25||December 2003||2003-12-01|May 2014|2014-05-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity|An Open Label Pilot Trial to Collect and Evaluate Data on the Use of Dihydroergotamine Mesylate in the Treatment of Two Migraine Attacks Associated With Cutaneous Allodynia|Completed||N/A|13|Actual|Thomas Jefferson University||1|||f||||f||||||||||2017-10-11 05:32:52.589726|2017-10-11 05:32:52.589726
NCT00203281|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-19|||February 2003||2003-02-01|October 2016|2016-10-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Observational|||Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis|Pharmacokinetic Evaluation of Plasmapheresis in Cross Match Positive or ABO Incompatible Kidney Allograft Recipients|Withdrawn||Phase 4|0|Actual|Thomas Jefferson University|||1|funding withdrawn|f||||f||||||||||2017-10-11 05:32:52.929363|2017-10-11 05:32:52.929363
NCT00203294|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-07|2011-05-19||June 2005||2005-06-01|April 2014|2014-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Research Study to Examine the Difference Between Local Anesthetics Alone and Local Anesthetics Plus Steroids in the Treatment of Chronic Headache|Comparison Of Greater Occipital Nerve Block With Lidocaine And Bupivicaine Alone Or With Steroids In a Chronic Headache Population|Completed||N/A|45|Actual|Thomas Jefferson University||2|||f||||f||||||||||2017-10-11 05:32:53.018087|2017-10-11 05:32:53.018087
NCT00203307|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-23|2011-05-24||May 2004||2004-05-01|August 2011|2011-08-01|June 2006|Actual|2006-06-01|March 2006|Actual|2006-03-01||Interventional|||A Research Study Examining the Use of Olanzapine for the Prevention of Migraine|A Single-Site, Double-Blind, Placebo-Controlled Cross-Over Trial Examining the Safety and Efficacy of Olanzapine Taken Daily for the Prevention of Episodic Migraine.|Terminated||N/A|3|Actual|Thomas Jefferson University||2||Study terminated by sponsor|f||||||||||||||2017-10-11 05:32:53.394435|2017-10-11 05:32:53.394435
NCT00203320|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-04-20|||April 2005||2005-04-01|April 2006|2006-04-01|January 2006||2006-01-01|||||Interventional|||TNF-Alpha Inhibition for Treatment of Alzheimer's Disease|Etanercept for Alzheimer's-Type Memory Loss Pilot Study II|Completed||Phase 1|30||Tobinick, Edward Lewis, M.D.|||||f||||||||||||||2017-10-11 05:32:53.626739|2017-10-11 05:32:53.626739
NCT00203333|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-17|||April 2002||2002-04-01|October 2016|2016-10-01|January 2010|Actual|2010-01-01|June 2007|Actual|2007-06-01||Observational|||Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death|Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death|Completed||Phase 2/Phase 3|19|Actual|Thomas Jefferson University|||1||f||||t||||||||||2017-10-11 05:32:53.701838|2017-10-11 05:32:53.701838
NCT00203385|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-24|||May 2003|Actual|2003-05-01|April 2017|2017-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder|Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder|Terminated||Phase 4|20|Actual|Tuscaloosa Research & Education Advancement Corporation||1||Funding expired|f||||f||||||||No||2017-10-11 05:32:54.042048|2017-10-11 05:32:54.042048
NCT00203411|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-03|2016-02-10||March 2006||2006-03-01|March 2016|2016-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer|A Phase II Trial to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Capecitabine (Xeloda) in Frail Patients With Untreated Metastatic Colorectal Cancer|Completed||Phase 2|45|Actual|Translational Oncology Research International|This was a small study with only 45 participants who received study treatment. With such a small sample size the study does not have the statistical power to make categorical assessments or statements.|1|||f||||t||||||||||2017-10-11 05:32:54.150349|2017-10-11 05:32:54.150349
NCT00203424|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-02-26|2011-04-12||January 2006||2006-01-01|February 2016|2016-02-01|June 2010|Actual|2010-06-01|February 2009|Actual|2009-02-01||Interventional|||Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib|A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer|Completed||Phase 2|23|Actual|Translational Oncology Research International|This was a small study with only 22 participants who received study treatment. With such a small sample size the study doesnt have the statistcical power to make categorical assessments or statements.|1|||f||||t||||||||||2017-10-11 05:32:54.546911|2017-10-11 05:32:54.546911
NCT00203450|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-08-30|||May 2003||2003-05-01|August 2012|2012-08-01|March 2006|Actual|2006-03-01|March 2005|Actual|2005-03-01||Interventional|Zonegran||Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial|Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial|Completed||Phase 4|20|Actual|Tuscaloosa Research & Education Advancement Corporation||2|||f||||f||||||||||2017-10-11 05:32:54.898451|2017-10-11 05:32:54.898451
NCT00203463|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-07-28|||July 2001||2001-07-01|July 2009|2009-07-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)|Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)|Completed||Phase 4|40||Tuscaloosa Research & Education Advancement Corporation|||||f||||||||||||||2017-10-11 05:32:54.976819|2017-10-11 05:32:54.976819
NCT00203476|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-08-08|2013-12-05||May 2005||2005-05-01|August 2014|2014-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||100% male, age 50 years or greater|A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction|A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction|Completed||Phase 4|30|Actual|Tuscaloosa Research & Education Advancement Corporation|Open label.|3|||f||||f||||||||||2017-10-11 05:32:55.083107|2017-10-11 05:32:55.083107
NCT00203489|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-16|||June 2005||2005-06-01|November 2007|2007-11-01|August 2007||2007-08-01|||||Interventional|||A Clinical Study of An Antimicrobial Gauze Dressing|A Prospective Randomized Double-Blind Trial of a Polyhexamethylene Biguanide (PHMB) Impregnated Gauze Dressing for the Prevention of Chronic Wound Colonization With Resistant and Prevalent Microorganisms|Terminated||N/A|200|Anticipated|Tyco Healthcare Group||||Reallocation of funding.|f||||||||||||||2017-10-11 05:32:55.471422|2017-10-11 05:32:55.471422
NCT00203502|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-02|2015-10-21||September 2005||2005-09-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer|Primary Systemic Therapy Using Sequential Docetaxel/Cyclophosphamide/Bevacizumab Followed by Doxorubicin in Operable/Locally Advanced Breast Cancer|Completed||Phase 2|40|Actual|University of Arkansas||1|||f||||f||||||||||2017-10-11 05:32:55.540844|2017-10-11 05:32:55.540844
NCT00203515|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-04|||January 2005||2005-01-01|January 2008|2008-01-01||||March 2007|Actual|2007-03-01||Interventional|||Study Comparing the DOVER Silver Foley Catheter to a Standard of Care Catheter and a Marketed Silver Coated Foley Catheter|A Prospective, Randomized, Controlled Study Comparing the DOVER Silver Foley Catheter to a Standard of Care Catheter and a Marketed Silver Coated Foley Catheter|Completed||N/A|1000||Tyco Healthcare Group|||||||||||||||||||2017-10-11 05:32:55.792326|2017-10-11 05:32:55.792326
NCT00203528|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-03-16|||January 2004||2004-01-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder|Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder|Completed||Phase 4|30||Tuscaloosa Research & Education Advancement Corporation|||||f||||f||||||||||2017-10-11 05:32:56.005723|2017-10-11 05:32:56.005723
NCT00203541|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-16|||February 2004||2004-02-01|November 2007|2007-11-01|June 2006||2006-06-01|||||Interventional|||Effects of a New Antimicrobial Dressing on Wound Healing and Incidence of Sternal Wound Infections|Effects of a New Antimicrobial Dressing on Wound Healing and Incidence of Sternal Wound Infections in Subjects Who Have Undergone Cardiac Surgical Procedures Requiring Median Sternotomy|Terminated||N/A|1100||Tyco Healthcare Group||||Reallocation of funding.|f||||||||||||||2017-10-11 05:32:56.08425|2017-10-11 05:32:56.08425
NCT00203554|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2008-03-26|||March 2004||2004-03-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Percutaneous Vertebroplasty Versus Conservative Treatment of Pain|Percutaneous Vertebroplasty Versus Conservative Treatment of Pain: A Prospective, Randomized Controlled Study of Osteoporotic Fractures in the Spine|Completed||N/A|27|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 05:32:56.14786|2017-10-11 05:32:56.14786
NCT00203567|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-23|||August 2005||2005-08-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|February 2007|Actual|2007-02-01||Interventional|||Carbamazepine Extended-Release for the Treatment of Bipolar Depression|Carbamazepine Extended-Release for the Treatment of Bipolar Depression|Completed||Phase 4|25|Actual|Tuscaloosa Research & Education Advancement Corporation||1|||f||||f||||||||||2017-10-11 05:32:56.249494|2017-10-11 05:32:56.249494
NCT00203580|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-02-08|||December 1994||1994-12-01|September 2005|2005-09-01|March 2002||2002-03-01|||||Interventional|||Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)|A Randomized Trial of the Effect of Low-Molecular-Weight Heparin Versus Warfarin Sodium on the Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (Main LITE Study)|Completed||Phase 4|910||University of Calgary|||||||||||||||||||2017-10-11 05:32:56.3436|2017-10-11 05:32:56.3436
NCT00203593|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-03-12|||March 2006||2006-03-01|March 2007|2007-03-01|June 2007||2007-06-01|||||Interventional|||Exercise and Prevention of Syncope: EXPOSE|EXercise for the Prevention of Syncope Evaluation|Suspended||Phase 1|20||University of Calgary||||No Resources - No Personnel|f||||||||||||||2017-10-11 05:32:56.425031|2017-10-11 05:32:56.425031
NCT00203606|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-03|||January 2004||2004-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|January 2009|Actual|2009-01-01||Interventional|||Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C|Effectiveness of Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C|Completed||Phase 4|66|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 05:32:56.495876|2017-10-11 05:32:56.495876
NCT00203619|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-28|||May 2005||2005-05-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Capsule Endoscopy in Obscure GI Bleeding|An Economic Evaluation of Capsule Endoscopy for Obscure Gastrointestinal Bleeding|Active, not recruiting||Phase 4|40|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 05:32:56.57703|2017-10-11 05:32:56.57703
NCT00203632|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-30|||September 2003||2003-09-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Glitazones and Endothelial Function (GATE)|A Trial of the Effect of Rosiglitazone as Add on to Metformin Therapy on Endothelial Function in Subjects With Type II DM|Terminated||Phase 3|40|Actual|University of Calgary||2||Terminated at 50% enrollment due to recent concerns about rosiglitazone|f||||t||||||||||2017-10-11 05:32:56.66139|2017-10-11 05:32:56.66139
NCT00203645|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-13|||July 2003||2003-07-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|April 2006|Actual|2006-04-01||Interventional|||Minimal and Brief Treatments for Pathological Gamblers|Minimal and Brief Treatments for Pathological Gamblers: Developing Effective Treatment Systems|Completed||Phase 3|312|Actual|University of Calgary||4|||f||||f||||||||||2017-10-11 05:32:56.749803|2017-10-11 05:32:56.749803
NCT00203658|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-02-08|||April 1997||1997-04-01|September 2005|2005-09-01|October 2000||2000-10-01|||||Interventional|||Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin|LITE Study, Appendix A (HOME-LITE), Amendment 6|Completed||Phase 4|400||University of Calgary|||||||||||||||||||2017-10-11 05:32:56.855912|2017-10-11 05:32:56.855912
NCT00203671|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-12|||April 2006||2006-04-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Observational|||Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation|Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation|Completed||N/A|651|Actual|University of California, Los Angeles|||1||f||||||||||||||2017-10-11 05:32:56.938235|2017-10-11 05:32:56.938235
NCT00203684|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-15||||||February 2017|2017-02-01||||||||Interventional|||Mentored Patient-Oriented Research Career Development Award|The Effects of Different Sized Inhaled Corticosteroids on Peripheral Lung Inflammation in Asthma Assessed Through Lung Tissue Samples (SMART Protocol)|Recruiting||Phase 1/Phase 2|||University of California, Los Angeles|||||||||||||||||||2017-10-11 05:32:56.998284|2017-10-11 05:32:56.998284
NCT00203697|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-07||||||September 2006|2006-09-01||||||||Interventional|||Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study|Minocycline Treatment in Patients With Idiopathic Pulmonary Fibrosis Being Treated With Standard of Care Therapy- a Pilot Study|Unknown status|Active, not recruiting|Phase 3|||University of California, Los Angeles|||||||||||||||||||2017-10-11 05:32:57.08043|2017-10-11 05:32:57.08043
NCT00203710|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-10|||October 2003||2003-10-01|December 2015|2015-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Concentric Retriever Device (CRD) in Acute Ischemic Stroke|A Single-Center Controlled Registry to Evaluate the Concentric Retriever System for the Treatment of Stroke|Completed||N/A|50||University of California, Los Angeles|||||||||||||||||||2017-10-11 05:32:57.145459|2017-10-11 05:32:57.145459
NCT00203723|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-05-17|||March 2005||2005-03-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Use of Risperidone in ECT for Treatment Resistant Depression|A Comparison Study of Combined ECT and Risperidone Versus ECT Alone for Treatment Resistant Depression.|Terminated||Phase 4|45||University of California, Los Angeles|||||f||||||||||||||2017-10-11 05:32:57.235045|2017-10-11 05:32:57.235045
NCT00203736|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-15|||January 2003||2003-01-01|August 2005|2005-08-01|October 2003||2003-10-01|||||Interventional|||A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria|Open Label Drug Study (With Single and Parallel Group Components) to Evaluate Combination Antimalarial Therapy for Efficacy, Gametocyte Carriage and Molecular Markers Associated With SP Resistance in Uncomplicated Plasmodium Falciparum Infections|Completed||N/A|240||University of Cape Town|||||f||||||||||||||2017-10-11 05:32:57.318058|2017-10-11 05:32:57.318058
NCT00203749|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-11|||December 2004||2004-12-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand|NIMH Project Accept: A Phase III Randomized Controlled Trial of Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand|Completed||Phase 3|192814|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 05:32:57.410229|2017-10-11 05:32:57.410229
NCT00203762|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-23|||May 2003||2003-05-01|March 2004|2004-03-01|December 2006||2006-12-01|||||Interventional|||Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care|Effect of the South African Public Sector Antiretroviral Treatment Programme on the Performance of Tuberculosis and Immunization Programmes - A Cluster Controlled (Non-Randomized) Trial|Unknown status|Recruiting|N/A|39|Anticipated|University of Cape Town|||||f||||||||||||||2017-10-11 05:32:57.527096|2017-10-11 05:32:57.527096
NCT00203775|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-12|||July 2002||2002-07-01|May 2005|2005-05-01|April 2004||2004-04-01|||||Interventional|||Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates|Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates|Terminated||N/A|||UConn Health|||||f||||||||||||||2017-10-11 05:32:57.623016|2017-10-11 05:32:57.623016
NCT00203801|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-29|2006-09-07|||January 2002||2002-01-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Combination Antimalarials in Uncomplicated Malaria|An Open Label In Vivo Drug Study to Evaluate Combination Anti-Malarial Therapy (CAT),in Terms of Therapeutic Efficacy, Prevalence of Gametocyte Carriage and Prevalence of Molecular Markers Associated With SP Resistance in Uncomplicated Plasmodium Falciparum Infections.|Completed||N/A|700||University of Cape Town|||||f||||||||||||||2017-10-11 05:32:57.80985|2017-10-11 05:32:57.80985
NCT00203814|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-15|||January 2004||2004-01-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria|Open-Label, Randomised, Parallel Group in Vivo Drug Study to Evaluate Combination Anti-Malarial Therapy (CAT), Artesunate and Sulfadoxine-Pyrimethamine Versus Sulfadoxine-Pyrimethamine Alone, in Terms of Therapeutic Efficacy, Prevalence of Gametocyte Carriage and Prevalence of Molecular Markers Associated With SP Resistance In Uncomplicated Plasmodium Falciparum Infections.|Completed||N/A|280||University of Cape Town|||||f||||||||||||||2017-10-11 05:32:57.917449|2017-10-11 05:32:57.917449
NCT00203827|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-04|||September 2004||2004-09-01|September 2013|2013-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Pediatric Sleep Questionnaire: Use for Collection of Clinical Data|Pediatric Sleep Questionnaire: Use for Collection of Clinical Data|Completed||N/A|300|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 05:32:58.008931|2017-10-11 05:32:58.008931
NCT00203840|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-12|||August 2004||2004-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Pediatric Sleep Questionnaire: Normalization and Validation Study|Pediatric Sleep Questionnaire: Normalization and Validation Study|Completed||N/A|325|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 05:32:58.085706|2017-10-11 05:32:58.085706
NCT00203853|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-04|||January 2005||2005-01-01|September 2013|2013-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults|Evaluation of an Intervention (Consisting of an Electronic Reminder Device, Pillboxes, and Monthly Telephone Calls) on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults|Terminated||N/A|200||University of Chicago||1|||f||||||||||||||2017-10-11 05:32:58.151904|2017-10-11 05:32:58.151904
NCT00203866|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-04|||October 2003||2003-10-01|September 2013|2013-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma|A Randomized Pilot Phase II Trial of Adjuvant Immunization With G250 Peptide andThree Different Dose Levels of IL-2 Following Surgical Resection of Locally Advanced or Metastatic Renal Cell Carcinoma|Terminated||Phase 2|40|Anticipated|University of Chicago||||Study completed|f||||t||||||||||2017-10-11 05:32:58.230956|2017-10-11 05:32:58.230956
NCT00203879|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-04|||February 2002||2002-02-01|September 2013|2013-09-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma|Randomized Phase II Study of Immunization With MAGE-3/Melan-A/gp 100/NA17 Peptide-Pulsed Autologous PBMC and rhIL-12 With or Without Low Dose IL-2 Inpatients With Metastatic Melanoma|Completed||Phase 2|19|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 05:32:58.294935|2017-10-11 05:32:58.294935
NCT00203892|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-03-21|2014-01-31||April 2003||2003-04-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|June 2009|Actual|2009-06-01||Interventional||The 19 patients who received at least 1 dose of the CEA vaccine are included in the baseline analysis population|Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma|A Randomized Pilot Phase II Study of Immunization With Modified CEA (CAP1-6D) Peptide In Patients With Locally Advanced Or Surgically Resected Adenocarcinoma of the Pancreas|Completed||Phase 1/Phase 2|23|Actual|University of Chicago||3|||f||||t||||||||||2017-10-11 05:32:58.404511|2017-10-11 05:32:58.404511
NCT00203905|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-01-16|||January 2004||2004-01-01|January 2014|2014-01-01|November 2008|Actual|2008-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck|A Randomized Phase II Study of Concomitant Chemoradiotherapy With 5-Fluorouracil/Hydroxyurea Compared to FHX Plus Bevacizumab for Intermediate Stage and Selected Stage IV Cancers of the Head and Neck|Completed||Phase 2|23|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 05:32:58.820599|2017-10-11 05:32:58.820599
NCT00203918|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-28|||January 2004||2004-01-01|August 2017|2017-08-01|February 2013|Actual|2013-02-01|February 2011|Actual|2011-02-01||Observational|||Prostate Cancer Utilities and Cost-Effectiveness Analysis|Prostate Cancer Utilities and Cost-Effectiveness Analysis|Completed||N/A|481|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 05:32:58.906468|2017-10-11 05:32:58.906468
NCT00203931|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-02-12|2013-12-10||March 2005||2005-03-01|February 2014|2014-02-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional||Includes evaluable patients (those that received at least 3 doses of cetuximab)|Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer|A Randomized Phase II Trial Comparing Cetuximab With Concurrent Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer Refractory to Primary Treatment|Terminated||Phase 2|55|Actual|University of Chicago||2||"Slow accrual and evidence from other studies showing benefit of early initiation of pemetrexed   after first-line therapy"|f||||t||||||||||2017-10-11 05:32:59.014658|2017-10-11 05:32:59.014658
NCT00203944|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-08|||July 2002||2002-07-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||International Adoption and Stress Response Study|International Adoption and Stress Response Study|Completed||N/A|39|Actual|University of Chicago|||2||f||||f||||||||||2017-10-11 05:32:59.418151|2017-10-11 05:32:59.418151
NCT00203957|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-10|||March 2005||2005-03-01|June 2013|2013-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa|A Long-Term, Multicenter, Open-Label Safety Study With Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa Therapy|Completed||Phase 3|10|Actual|University of Chicago||2|||f||||t||||||||||2017-10-11 05:32:59.506134|2017-10-11 05:32:59.506134
NCT00203970|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-28|||February 2001||2001-02-01|August 2017|2017-08-01|January 2019|Anticipated|2019-01-01|March 2001|Actual|2001-03-01||Observational|||Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services|Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services|Active, not recruiting||N/A|645|Actual|University of Chicago|||1||f||||f||||||||||2017-10-11 05:32:59.595765|2017-10-11 05:32:59.595765
NCT00203996|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-16|2013-03-05||September 2003||2003-09-01|July 2013|2013-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Polycystic Ovary Syndrome (PCOS) and Sleep Apnea|Sleep, Metabolic, and Cardiovascular Dysfunction in Polycystic Ovary Syndrome|Terminated||Phase 4|37|Actual|University of Chicago|No participants were randomized to any of the 3 study arms in Aim 1. Also, the recruitment of control subjects for Aim 2 was hindered by the difficulty in finding subjects who met both inclusion and exclusion criteria.|10||Did not meet target patient accrual goals|f||||f||||||||||2017-10-11 05:32:59.676426|2017-10-11 05:32:59.676426
NCT00204009|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-09-04|||July 1992||1992-07-01|September 2013|2013-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Chicago Childhood Diabetes Registry|Population-based Epidemiologic Study of Childhood Diabetes in Chicago: a) Disease Surveillance; b) Family Studies; c) Questionnaire Followup.|Completed||N/A|2400|Actual|University of Chicago|||1||f||||||||||||||2017-10-11 05:33:00.577414|2017-10-11 05:33:00.577414
NCT00204022|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-10-13|||February 2001||2001-02-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|MAINTAIN||Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.|A Randomized Multicenter Trial Comparing Mycophenolate Mofetil and Azathioprine as Remission-maintaining Treatment for Proliferative Lupus Glomerulonephritis. The MAINTAIN Nephritis Trial.|Completed||Phase 3|105|Actual|Université Catholique de Louvain||2|||f||||f||||||||||2017-10-11 05:33:00.67799|2017-10-11 05:33:00.67799
NCT00204035|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-28|||June 2004||2004-06-01|August 2017|2017-08-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Observational|||Evaluation of TEACH (Training Early Achievers for Careers in Health) Research|Evaluation of TEACH (Training Early Achievers for Careers in Health) Research|Recruiting||N/A|400|Anticipated|University of Chicago|||1||f||||f|f|f||||||||2017-10-11 05:33:00.795537|2017-10-11 05:33:00.795537
NCT00204048|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-28|||July 2001||2001-07-01|August 2017|2017-08-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Observational|||A Multicenter Trial of Academic Hospitalists|A Multicenter Trial of Academic Hospitalists|Recruiting||N/A|100000|Anticipated|University of Chicago|||1||f||||f|f|f||||||||2017-10-11 05:33:00.901877|2017-10-11 05:33:00.901877
NCT00204061|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-12-23|||January 2001||2001-01-01|December 2014|2014-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis|Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis|Completed||Phase 4|124|Actual|University of Cologne||2|||f||||f||||||||||2017-10-11 05:33:01.016325|2017-10-11 05:33:01.016325
NCT00204074|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-28|||October 2001||2001-10-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.||Unknown status|Active, not recruiting|Phase 2/Phase 3|||University Hospital, Linkoeping|||||f||||||||||||||2017-10-11 05:33:01.138646|2017-10-11 05:33:01.138646
NCT00204087|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-01-10|||January 2001||2001-01-01|June 1999|1999-06-01|June 2005||2005-06-01|||||Interventional|||Psychological Intervention for Persons in the Early Initial Prodromal State|Psychological Intervention for Persons at Risk of Psychosis in the Early Initial Prodromal State|Unknown status|Active, not recruiting|Phase 3|126||University of Cologne|||||f||||||||||||||2017-10-11 05:33:01.238475|2017-10-11 05:33:01.238475
NCT00204100|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-11|||January 2003||2003-01-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Paraplegic Cycling: Improving Health After Spinal Cord Injury|The Development of Systems for Paraplegic Cycling: Improving Health After Spinal Cord Injury|Unknown status|Active, not recruiting|N/A|5||University of Glasgow|||||f||||||||||||||2017-10-11 05:33:01.345244|2017-10-11 05:33:01.345244
NCT00204113|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-10|||June 2002||2002-06-01|June 2008|2008-06-01||||||||Interventional|||Control of Unsupported Paraplegic Standing|Integrated Voluntary Control of Unsupported Paraplegic Standing|Unknown status|Active, not recruiting|N/A|10|Anticipated|University of Glasgow|||||f||||||||||||||2017-10-11 05:33:01.457544|2017-10-11 05:33:01.457544
NCT00204126|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-09-08|||February 2005||2005-02-01|September 2006|2006-09-01|February 2005||2005-02-01|||||Interventional|||Exercise Testing During Treadmill Gait in Incomplete Spinal Cord Injury|Determination of Novel Methods of Exercise Testing During Treadmill Gait in Incomplete Spinal Cord Injury|Unknown status|Active, not recruiting|N/A|4||University of Glasgow|||||f||||||||||||||2017-10-11 05:33:01.538798|2017-10-11 05:33:01.538798
NCT00204139|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2002||2002-06-01|July 2004|2004-07-01|May 2004||2004-05-01|||||Interventional|||Routine Versus Selective Midtrimester Ultrasound in a Poorly Resourced Setting: a Cluster Randomised Controlled Trial||Completed||Phase 3|900||University of Johannesburg|||||f||||||||||||||2017-10-11 05:33:01.640039|2017-10-11 05:33:01.640039
NCT00204152|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-09-04|||June 2004||2004-06-01|September 2013|2013-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Treatment for Chronic Depression|Treatment for Chronic Depression With Behavioral Interventions|Terminated||Phase 3|30||University of Chicago||||PI left U of C|f||||f||||||||||2017-10-11 05:33:01.713126|2017-10-11 05:33:01.713126
NCT00204165|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-07|||November 2004||2004-11-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.|MRI of the Small Bowel. Comparison of Different Techniques and Contrast.|Unknown status|Active, not recruiting|Phase 3|40||University of Oslo|||||f||||||||||||||2017-10-11 05:33:01.827912|2017-10-11 05:33:01.827912
NCT00204178|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-11-30|||April 2003||2003-04-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Observational|||The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney|The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney|Unknown status|Active, not recruiting|N/A|60||Uniwersytet Mikolaja Kopernika w Toruniu|||||f||||||||||||||2017-10-11 05:33:01.92701|2017-10-11 05:33:01.92701
NCT00204191|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-18|||May 2003||2003-05-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Interventional|||Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation|Open, Prospective, Randomized Study to Compare the Efficacy and Safety of Immunosuppression Regimens Based on Cyclosporine (Neoral®) and Tacrolimus (Prograf®) in Renal Transplant Patients|Unknown status|Recruiting|Phase 4|300|Anticipated|Uniwersytet Mikolaja Kopernika w Toruniu|||||f||||||||||||||2017-10-11 05:33:02.048848|2017-10-11 05:33:02.048848
NCT00204204|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-24|||January 2005||2005-01-01|August 2007|2007-08-01|January 2006|Actual|2006-01-01|||||Observational|||Importance of Forces and Safety Features in Car Crash Multitrauma|The Multitraumatized Patient. What is the Importance of Forces Involved and the Use of Safety Equipment for the Amount of Trauma to the Patient Inside the Vehicle.|Completed||N/A|200||University of Oslo|||||f||||f||||||||||2017-10-11 05:33:02.145226|2017-10-11 05:33:02.145226
NCT00204230|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 1999||1999-10-01|September 2005|2005-09-01|September 2002||2002-09-01|||||Interventional|||MMF and Calcineurin Inhibitor Withdrawal in CAN|Randomized Controlled Study: Effect of Mycophenolatmofetil in Patients With Histologically Proven Chronic Allograft Nephropathy|Terminated||N/A|86||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:33:02.31627|2017-10-11 05:33:02.31627
NCT00204243|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-18|||May 2005||2005-05-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services|Naltrexone Implants Compared to Methadone Maintenance Treatment (MMT) Among Inmates About to be Released From Prison - a Randomized Controlled Trial|Completed||Phase 2|46|Actual|University of Oslo||2|||f||||t||||||||||2017-10-11 05:33:02.40202|2017-10-11 05:33:02.40202
NCT00204256|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||March 2004||2004-03-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Intravenous Iron in Patients With Anemia of Chronic Kidney Disease|Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease|Unknown status|Active, not recruiting|Phase 4|50||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:33:02.497776|2017-10-11 05:33:02.497776
NCT00204269|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-05-12|||January 2003||2003-01-01|May 2006|2006-05-01|September 2006||2006-09-01|||||Interventional|||Three-Year Trial on a New Testosterone Gel|Three-Year Trial on a New Testosterone Gel: Clinical Efficacy, Tolerability and Compliance|Unknown status|Active, not recruiting|Phase 3|100||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:33:02.572397|2017-10-11 05:33:02.572397
NCT00204282|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-20|||August 2003||2003-08-01|September 2013|2013-09-01|December 2005||2005-12-01|||||Interventional|||The Effectiveness of Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk|The Effectiveness of Nurse Practitioner Led Group Visits in Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk|Completed||N/A|150||University of Chicago|||||f||||||||||||||2017-10-11 05:33:02.687098|2017-10-11 05:33:02.687098
NCT00204295|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-13|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Interventional|||Study on Amino Acid Uptake in Brain Tumors|Phase 2 Study on Brain Tumor Uptake of the Amino Acid O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET)|Unknown status|Active, not recruiting|Phase 2|60||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:33:02.76731|2017-10-11 05:33:02.76731
NCT00204308|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-05-30|||March 2005||2005-03-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|TD-2||Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP|Addition of Single-dose, Maternal Tenofovir and Emtricitabine to Reduce Non-nucleoside Reverse Transcriptase Inhibitor Resistance Mutations in the Setting of Zidovudine and Nevirapine for Prevention of Mother-to-child HIV Transmission|Completed||Phase 2|400|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-10-11 05:33:02.833186|2017-10-11 05:33:02.833186
NCT00204321|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-12|||June 2005||2005-06-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2008|Actual|2008-01-01||Interventional|||Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients|Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients - Positive Effects of Calcineurin-free Immunosuppression|Completed||Phase 4|80|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-10-11 05:33:02.917782|2017-10-11 05:33:02.917782
NCT00204334|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-12|||June 2005||2005-06-01|May 2008|2008-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients|Effects of Anemia Correction on Vascular Function, Endothelial Cell Markers and Monocyte Apoptosis in Renal Transplant Recipients|Completed||Phase 4|60|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-10-11 05:33:02.983958|2017-10-11 05:33:02.983958
NCT00204347|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-15|||July 2003||2003-07-01|March 2012|2012-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder|Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder: The UAB Borderline Rating Scale (BRS)|Completed||Phase 4|20||University of Alabama at Birmingham|||||f||||||||||||||2017-10-11 05:33:03.054364|2017-10-11 05:33:03.054364
NCT00204360|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-18||||||August 2005|2005-08-01||||||||Observational|||Pediatric Epilepsy Database|Pediatric Epilepsy Database|Completed||N/A|||University of Alabama at Birmingham|||||f||||||||||||||2017-10-11 05:33:03.139038|2017-10-11 05:33:03.139038
NCT00204373|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-23|2012-05-16||March 2003||2003-03-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Zollinger-Ellison Syndrome With Prevacid|Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors|Completed||Phase 4|72|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-10-11 05:33:03.205572|2017-10-11 05:33:03.205572
NCT00204386|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-29|||September 2002||2002-09-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Posttraumatic Stress Disorder|Completed||Phase 2/Phase 3|50|Actual|University of Oklahoma||2|||f||||t||||||||||2017-10-11 05:33:03.384231|2017-10-11 05:33:03.384231
NCT00204399|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||July 2001||2001-07-01|May 2000|2000-05-01|December 2004||2004-12-01|||||Interventional|||Examining Physician Counseling to Promote Adoption of Physical Activity: A Controlled Trial|Examining Physician Counseling to Promote Adoption of Physical Activity: A Controlled Trial|Completed||Phase 1|200||University of Saskatchewan|||||f||||||||||||||2017-10-11 05:33:03.452812|2017-10-11 05:33:03.452812
NCT00204412|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-01|||March 2005||2005-03-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Exercise and Flax-Based Nutritional Supplementation for Lowering Cholesterol|Effectiveness of Flax Lignan and Exercise Training for Improving Lipid Profiles|Completed||Phase 3|100|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 05:33:03.57647|2017-10-11 05:33:03.57647
NCT00204425|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-09|||December 2004||2004-12-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Exercise Training and Soy-based Nutritional Supplementation on Prevention of Osteoporosis|Effect of Combined Exercise Therapy and Isoflavone Supplementation on Prevention of Osteoporosis|Completed||Phase 3|351|Actual|University of Saskatchewan||4|||f||||t||||||||||2017-10-11 05:33:03.670788|2017-10-11 05:33:03.670788
NCT00196300|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|September 2005|2005-09-01||||||||Observational|||Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery|Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery|Completed||N/A|500||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-10-11 05:35:59.360663|2017-10-11 05:35:59.360663
NCT00204438|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-23|||February 2002||2002-02-01|November 2016|2016-11-01|December 2002||2002-12-01|||||Interventional|||Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle|Follicular Profiles After Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle|Completed||N/A|45||University of Saskatchewan|||||f||||||||||||||2017-10-11 05:33:03.770638|2017-10-11 05:33:03.770638
NCT00204451|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-23|||July 2005||2005-07-01|November 2016|2016-11-01|June 2006||2006-06-01|||||Interventional|||Human Ovarian Follicular Dynamics and Emergency Contraception|Human Ovarian Follicular Dynamics and Emergency Contraception|Completed||Phase 4|40||University of Saskatchewan|||||f||||||||||||||2017-10-11 05:33:03.86118|2017-10-11 05:33:03.86118
NCT00204464|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-11-03||||||December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Study of the Effects Strengthening Exercises in Individuals With ALS|Preliminary Study: The Effects of a Strengthening Program on Maximum Voluntary Isometric Contraction, Functional Abilities, Fatigue and Quality of Life in Individuals With Amyotrophic Lateral Sclerosis|Completed||Phase 2|40||University of Saskatchewan|||||f||||||||||||||2017-10-11 05:33:03.94603|2017-10-11 05:33:03.94603
NCT00204477|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-05-10|||April 2002||2002-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Soy Protein and Breast Cancer Risk Reduction|Soybean Diet and Breast Density|Active, not recruiting||Phase 2|313|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-11 05:33:04.023954|2017-10-11 05:33:04.023954
NCT00204490|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-05-10|||April 2004||2004-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Soy Isoflavones and Breast Cancer Risk Reduction|Mammographic Density and Soy Isoflavones|Active, not recruiting||Phase 2|187|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-10-11 05:33:04.102248|2017-10-11 05:33:04.102248
NCT00204503|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-30|||June 2003||2003-06-01|March 2015|2015-03-01|May 2005||2005-05-01|||||Interventional|||Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence|An Open Label Pilot Study Evaluating Safety and Efficacy of Divalproex Sodium (Depakote ER) in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence.|Withdrawn||Phase 2|0|Actual|The University of Texas Medical Branch, Galveston|||||f||||||||||||||2017-10-11 05:33:04.188932|2017-10-11 05:33:04.188932
NCT00204516|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-15|||April 2007||2007-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2011|Actual|2011-08-01||Interventional|||Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens|Pilot Study of Intradermal Vaccination of Melanoma Patients With a Fixed Combination of mRNAs Compared to an Individualized Selection After Analysis of Antigen Expression in Tumor Tissue|Completed||Phase 1/Phase 2|31|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-10-11 05:33:04.253299|2017-10-11 05:33:04.253299
NCT00204529|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-02|||October 2004|Actual|2004-10-01|May 2017|2017-05-01|December 2016|Actual|2016-12-01|May 2013|Actual|2013-05-01||Interventional|||Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB|Randomized, Multicenter, Open Label Study to Compare the Efficacy and Tolerability of Pegylated Interferon-alpha-2 (PEG-IFN) to 'Low-dose' Interferon-alpha-2a in Patients With Malignant Melanoma in Stages IIA (T3a) - IIIB (AJCC 2002)|Completed||Phase 3|901|Actual|University Hospital Tuebingen||2|||f||||||||||||||2017-10-11 05:33:04.315787|2017-10-11 05:33:04.315787
NCT00204542|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-18|||June 2005||2005-06-01|March 2009|2009-03-01|December 2010|Actual|2010-12-01|March 2009|Actual|2009-03-01||Interventional|||Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head|Comparison of the Efficacy and Tolerability of Solaraze for 3 vs. 6 Months in Patients With Mild to Moderate Actinic Keratosis Located at the Face and Head|Completed||Phase 4|418|Actual|University Hospital Tuebingen||2|||f||||||||||||||2017-10-11 05:33:05.909994|2017-10-11 05:33:05.909994
NCT00204555|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-31|||January 2002||2002-01-01|April 2007|2007-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma|A Randomized Open Label Study to Evaluate the Safety and Efficacy if Imiquimod 5% Cream Applied 3 Times Per Week for 8 or 12 Weeks in the Treatment of Low Risk Nodular Basal Cell Carcinoma|Completed||Phase 4|100|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-10-11 05:33:06.001907|2017-10-11 05:33:06.001907
NCT00204568|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-07|||August 2004||2004-08-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)|Randomized Phase II Trial of Trofosfamide vs. Adriamycin in Elderly Patients With Previously Untreated Metastatic Soft Tissue Sarcoma|Unknown status|Active, not recruiting|Phase 2|117|Anticipated|University of Schleswig-Holstein||2|||f||||||||||||||2017-10-11 05:33:06.068956|2017-10-11 05:33:06.068956
NCT00204581|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-18|||August 2003||2003-08-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|||Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases|Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases. A Phase II, Prospective, Open, Multicenter Trial|Completed||Phase 2|51|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-10-11 05:33:06.140463|2017-10-11 05:33:06.140463
NCT00204594|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-15|||October 2005||2005-10-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28|Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28|Completed||Phase 1/Phase 2|1|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-11 05:33:06.210277|2017-10-11 05:33:06.210277
NCT00204607|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-18|||July 2004||2004-07-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients|Induction of Specific Immune Responses Against Melanoma-Associated Antigens in Vivo by Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial|Completed||Phase 1/Phase 2|20||University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:33:06.28967|2017-10-11 05:33:06.28967
NCT00204620|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-19|||March 2002||2002-03-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)|Multicenter Phase II Study With Bendamustin for Patients With Refractory Soft Tissue Sarcoma|Completed||Phase 2|28||University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:33:06.356498|2017-10-11 05:33:06.356498
NCT00204633|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-13|||July 2003||2003-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||"Darbepoetin Alfa in Patients With Poor Prognosis Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)"|"Randomized Phase II-Trial to Determine the Impact of Darbepoetin Alfa on the Frequency of RBC Transfusions in Patients With Metastatic Poor Prognosis Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP Regimen)"|Completed||Phase 2|108|Actual|University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:33:06.420889|2017-10-11 05:33:06.420889
NCT00204646|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-19|||February 1999||1999-02-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)|Phase II Study of Neoadjuvant Dose-Intensive Chemotherapy With Adriamycin and Ifosfamide Followed by High-Dose ICE in Locally Advanced Soft Tissue Sarcomas|Completed||Phase 2|||University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:33:06.485318|2017-10-11 05:33:06.485318
NCT00204659|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-10-17|||March 2003||2003-03-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin`s Lymphoma|Phase II Study With Rituximab and CHOP in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin`s Lymphoma|Completed||Phase 2|30|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-10-11 05:33:06.55286|2017-10-11 05:33:06.55286
NCT00204672|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2000||2000-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||The Role of GER in Exercise Triggered Asthma|The Role of GER in Exercise Triggered Asthma|Completed||Phase 2/Phase 3|36||University of Utah|||||f||||||||||||||2017-10-11 05:33:06.654586|2017-10-11 05:33:06.654586
NCT00204685|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2006-09-13|||August 2003||2003-08-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa|Beatmungsdauer Und Lungenfunktion Bei Beatmeten Patienten Unter Therapie Mit Dornase Alfa - Randomisierte, Doppel-Blinde, Placebo-Kontrollierte, Multizentrische, Prospektive Klinische Studie|Unknown status|Active, not recruiting|Phase 2/Phase 3|540||University Hospital Tuebingen|||||f||||||||||||||2017-10-11 05:33:06.927005|2017-10-11 05:33:06.927005
NCT00204698|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-01-11|||August 2003||2003-08-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment|Identification of Molecular Markers of Inflammatory Mediators in Posterior Laryngitis Due to Laryngopharyngeal Reflux and Evolution With PPI Treatment|Completed||Phase 2/Phase 3|24|Actual|University of Utah||1|||f||||f||||||||||2017-10-11 05:33:07.12693|2017-10-11 05:33:07.12693
NCT00204711|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-26|||January 2005||2005-01-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|June 2008|Anticipated|2008-06-01||Observational|||Use of the SNAP II Electroencephalography (EEG) Monitor in Outpatients Undergoing Surgery/Procedures With Sedation|Use of the SNAP II EEG Monitor in Outpatients Undergoing Surgery/Procedures With Sedation|Completed||N/A|50|Anticipated|University of Wisconsin, Madison|||||f||||f||||||||||2017-10-11 05:33:07.240762|2017-10-11 05:33:07.240762
NCT00204737|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-09-29|||December 2004||2004-12-01|September 2015|2015-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Short Course Glucocorticoid Treatment for PTSD|A Placebo-controlled, Randomized, Double-blind Comparison of Placebo vs Short Course Low Dose Corticosteroids on Posttraumatic Stress Disorder (PTSD)|Completed||N/A|12|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 05:33:07.312065|2017-10-11 05:33:07.312065
NCT00204750|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-23|||August 2001||2001-08-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Trial of Electrosurgical Incision Versus Bougie Dilation of Symptomatic Lower Esophageal (Schatzki's) Rings|A Randomized, Prospective Trial of Electrosurgical Incision Followed by Rabeprazole Versus Bougie Dilation Followed by Rabeprazole of Symptomatic Lower Esophageal (Schatzki's) Rings|Completed||Phase 2/Phase 3|50|Actual|University of Utah||2|||f||||f||||||||||2017-10-11 05:33:07.41393|2017-10-11 05:33:07.41393
NCT00204763|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-01-11|||January 2004||2004-01-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Comparison of Esophageal and Anorectal Manometry Catheters|Comparison of Solid-State Esophageal Manometry and Water Perfused Anorectal Manometry Catheters With Air Filled Multi-Balloon Esophageal and Anorectal Manometry Catheters|Terminated||Phase 4|5|Actual|University of Utah||2||We determined that the results would not be worth reporting.|f||||f||||||||||2017-10-11 05:33:07.512881|2017-10-11 05:33:07.512881
NCT00204776|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-09-30|||March 2005||2005-03-01|September 2005|2005-09-01|November 2006|Actual|2006-11-01|||||Interventional|||XELOX for Metastatic Breast Cancer|A Phase II Trial of Capecitabine and Oxaliplatin in Metastatic Breast Cancer|Completed||Phase 2|37|Anticipated|University of Wisconsin, Madison|||||f||||t||||||||||2017-10-11 05:33:07.627578|2017-10-11 05:33:07.627578
NCT00204789|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-09-30|||July 2003||2003-07-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients|Phase 2b Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients (OTR)|Completed||Phase 2|52|Anticipated|University of Wisconsin, Madison|||||||||||||||||||2017-10-11 05:33:07.708162|2017-10-11 05:33:07.708162
NCT00204802|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-01|||January 2004||2004-01-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Patient-Centered Advance Care Planning|A Patient-Centered Approach to Advance Care Planning of Patients With End Stage Heart Failure and Renal Disease|Completed||Phase 3|313|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:07.790142|2017-10-11 05:33:07.790142
NCT00204815|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-01|||January 2005||2005-01-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|||||Observational|||Bone Mineral Density in Pediatric Epilepsy|Bone Mineral Density in Pediatric Epilepsy: AED-Specific and Duration of Treatment-Specific Effects|Completed||N/A|98|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-10-11 05:33:07.889929|2017-10-11 05:33:07.889929
NCT00204828|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-06-28|||October 2005||2005-10-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 2007|Actual|2007-06-01||Observational|||T Regulatory and Childhood Asthma|T Regulatory and Childhood Asthma|Active, not recruiting||N/A|58|Actual|University of Wisconsin, Madison|||2||f||||f||||||Samples Without DNA|"     blood, PBMC culture supes and nasal lavage   "|Yes||2017-10-11 05:33:07.952501|2017-10-11 05:33:07.952501
NCT00205296|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-01|||March 2002||2002-03-01|October 2008|2008-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Fitness Training in Children|Effect of Fitness Training on Insulin Sensitivity and Body Composition in Children|Completed||N/A|300|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 05:33:10.922032|2017-10-11 05:33:10.922032
NCT00204841|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-30|||October 1998||1998-10-01|March 2017|2017-03-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|COAST||Childhood Origins of Asthma (COAST)|Rhinovirus Infection and Asthma in Childhood and Adolescents|Active, not recruiting||N/A|300|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||Samples With DNA|"     nasal mucus samples, cord blood, peripheral blood samples, nasal cell brushing samples, cell     lines   "|||2017-10-11 05:33:08.022141|2017-10-11 05:33:08.022141
NCT00204854|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-01|||December 2001||2001-12-01|January 2011|2011-01-01|November 2004|Actual|2004-11-01|June 2004|Actual|2004-06-01||Interventional|TAMI||Telephone and Mail Intervention for Alcohol Use Disorders|Telephone and Mail Intervention for Alcohol Use Disorders|Completed||Phase 3|900||University of Wisconsin, Madison|||||f||||f||||||||||2017-10-11 05:33:08.08054|2017-10-11 05:33:08.08054
NCT00204867|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-06-17|||July 2004||2004-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Virtual Colonoscopy (VC) for Primary Colorectal Screening|CT Virtual Colonoscopy for Primary Colorectal Screening|Completed||N/A|272|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-10-11 05:33:08.141696|2017-10-11 05:33:08.141696
NCT00204880|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||February 2005||2005-02-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Aging and Cancer Effects (ACE) Study|Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment|Completed||N/A|34|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-10-11 05:33:08.207327|2017-10-11 05:33:08.207327
NCT00204906|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||January 2005||2005-01-01|June 2015|2015-06-01||||January 2009|Actual|2009-01-01||Interventional|||Correction of Vitamin D Inadequacy in Nursing Home Residents|Effect of Vitamin D Supplementation on Skeletal and Overall Health of Nursing Home Residents|Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:08.342445|2017-10-11 05:33:08.342445
NCT00204919|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-30|||June 2001||2001-06-01|September 2015|2015-09-01|November 2004|Actual|2004-11-01|May 2004|Actual|2004-05-01||Interventional|||Vitamin D Administration in the Nursing Home|Intermittent Vitamin D Administration in the Nursing Home: Impact on Vitamin D Status, Falls, Bone Turnover and Bone Density|Completed||N/A|96|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 05:33:08.400798|2017-10-11 05:33:08.400798
NCT00204932|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-04|2011-08-04||July 2004||2004-07-01|May 2017|2017-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects of CLA Supplements on Body Weight and Fat Oxidation|Effects of CLA Supplements on Body Weight and Fat Oxidation|Completed||Phase 2|53|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 05:33:08.484415|2017-10-11 05:33:08.484415
NCT00204945|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-15|||February 2005||2005-02-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Catheterization Laboratory Study: Acute Responses in Diastolic Heart Failure|Acute Responses in Diastolic Heart Failure|Completed||N/A|65|Anticipated|University of Wisconsin, Madison||1|||f||||||||||||||2017-10-11 05:33:08.862597|2017-10-11 05:33:08.862597
NCT00204958|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-29|||February 2004||2004-02-01|September 2015|2015-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients|Evaluation of Glutamine Popsicles in Adult/Pediatric Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients|Completed||Phase 4|50|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:08.951596|2017-10-11 05:33:08.951596
NCT00204971|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-29|||January 2003||2003-01-01|September 2015|2015-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Enteral Glutamine in Neurologically-injured Patients|Randomized, Placebo-controlled Clinical Trial of Enteral Glutamine Supplementation in Neurologically-injured Patients|Completed||Phase 4|102|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-11 05:33:09.02101|2017-10-11 05:33:09.02101
NCT00204984|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||May 2005||2005-05-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial Relaxation|The Effect of Aortic Impedance on Myocardial Relaxation|Completed||N/A|60|Anticipated|University of Wisconsin, Madison||1|||f||||||||||||||2017-10-11 05:33:09.106389|2017-10-11 05:33:09.106389
NCT00204997|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-30|||September 2002||2002-09-01|June 2008|2008-06-01|February 2008|Actual|2008-02-01|September 2005|Actual|2005-09-01||Interventional|||Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix|Preservation of Ovarian Function Via Laparoscopic Transposition in Patients With Locally Advanced Squamous Cell Carcinoma of the Cervix|Terminated||N/A|10|Anticipated|University of Wisconsin, Madison||1||slow accrual|f||||t||||||||||2017-10-11 05:33:09.20276|2017-10-11 05:33:09.20276
NCT00205010|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-30|||October 2003||2003-10-01|June 2008|2008-06-01|June 2006|Actual|2006-06-01|February 2006|Actual|2006-02-01||Observational|||Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer|Laparoscopic Sentinel Lymph Node Localization in Patients With Operable Cervical Cancer - A Pilot Study|Completed||Phase 1|20|Actual|University of Wisconsin, Madison|||||f||||t||||||||||2017-10-11 05:33:09.298136|2017-10-11 05:33:09.298136
NCT00205023|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-30|||January 2004||2004-01-01|June 2008|2008-06-01|August 2006|Actual|2006-08-01|February 2006|Actual|2006-02-01||Interventional|||Disseminated Endometrial Cancer Cells During Sonohysterography|The Incidence of Disseminated Endometrial Cancer Cells During Sonohysterography and Their Functional Viability: a Prospective Study|Completed||N/A|25|Actual|University of Wisconsin, Madison||1|||f||||||||||||||2017-10-11 05:33:09.37866|2017-10-11 05:33:09.37866
NCT00205036|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-25|||January 2005||2005-01-01|March 2016|2016-03-01|April 2008|Actual|2008-04-01|October 2005|Actual|2005-10-01||Observational|||Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density|Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density|Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:09.459332|2017-10-11 05:33:09.459332
NCT00205049|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-10|2011-08-04||March 2005||2005-03-01|April 2014|2014-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Pentoxifylline for Acute Alcoholic Hepatitis (AAH)|A Pilot Study of Pentoxifylline-Therapy for Acute Alcoholic Hepatitis|Terminated||Phase 1|4|Actual|University of Wisconsin, Madison|Study was terminated before any data was gathered/analyzed.|1||lack of funding|f||||f||||||||||2017-10-11 05:33:09.537706|2017-10-11 05:33:09.537706
NCT00205062|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||October 2004||2004-10-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)|Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease|Terminated||Phase 4|||University of Wisconsin, Madison||||No Accrual|f||||||||||||||2017-10-11 05:33:09.707872|2017-10-11 05:33:09.707872
NCT00205075|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-07|||August 2004||2004-08-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression|The Use of Validated Measures of Alcohol Intake to Measure the Impact of Moderate Alcohol Consumption on Hepatic Fibrogenesis in Individuals Infected With Hepatitis C|Completed||N/A|47|Actual|University of Wisconsin, Madison|||2||f||||||||||||||2017-10-11 05:33:09.776299|2017-10-11 05:33:09.776299
NCT00205088|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||August 2002||2002-08-01|June 2008|2008-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||The Use of Shunt Tap in Assessing Ventriculoperitoneal (VP) Shunt Malfunction|The Use of Shunt Tap in Assessing Ventriculoperitoneal (VP) Shunt Malfunction|Completed||N/A|100|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:09.840767|2017-10-11 05:33:09.840767
NCT00205101|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-14|||September 2004||2004-09-01|December 2007|2007-12-01||||||||Observational|||Clinical Outcome Study of the Triad Allograft for Posterior Lumbar Fusion|Clinical Outcome Study of the Triad Allograft for Posterior Lumbar Fusion|Completed||N/A|70|Anticipated|University of Wisconsin, Madison|||4||f||||||||||||||2017-10-11 05:33:09.896011|2017-10-11 05:33:09.896011
NCT00205114|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||December 2003||2003-12-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Dane County Safety Assessment for Elders (SAFE) Research Study|Dane County Safety Assessment for Elders (SAFE) Research Study|Completed||N/A|500|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 05:33:09.963172|2017-10-11 05:33:09.963172
NCT00205127|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-08-28|||January 2004||2004-01-01|August 2012|2012-08-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Cardiac Water and Fluoromethane Cardiac PET|Comparison of Cardiac Perfusion by O15-water and F17-fluoromethane PET|Completed||N/A|10||University of Wisconsin, Madison|||||f||||f||||||||||2017-10-11 05:33:10.038961|2017-10-11 05:33:10.038961
NCT00205140|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-06|||July 2005||2005-07-01|October 2015|2015-10-01|May 2007|Actual|2007-05-01|||||Observational|||Effect of Pharmacist Initiated Recommendations On Prescribing For Participants In the Senior MEDS Personalized Medication Review|Participant Characteristics, Medication Utilization, and the Effects of Pharmacist Initiated Recommendations On the Prescribing For Participants In the Senior MEDS Personalized Medication Review for Adults Age 55 and Older|Terminated||N/A|100|Anticipated|University of Wisconsin, Madison||||The program responsible for recruitment was dismantled in 2006.|f||||||||||||||2017-10-11 05:33:10.116728|2017-10-11 05:33:10.116728
NCT00205153|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-18|||December 2006||2006-12-01|December 2014|2014-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Team Model of Hypertension Care in African Americans|A Team Model of Hypertension Care in African Americans|Completed||N/A|576|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 05:33:10.174544|2017-10-11 05:33:10.174544
NCT00205166|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-10-25|||June 1999||1999-06-01|October 2012|2012-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?|Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?|Completed||N/A|50|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 05:33:10.257072|2017-10-11 05:33:10.257072
NCT00205192|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-08-28|||June 2004||2004-06-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Optimizing Cardiac Resynchronization|Optimizing Cardiac Resynchronization|Completed||N/A|100|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-10-11 05:33:10.414907|2017-10-11 05:33:10.414907
NCT00205205|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01||||||June 2008|2008-06-01||||||||Interventional|||Peer Mentoring for Persons With Spinal Cord Injury (SCI)|Peer Mentoring for Persons With Spinal Cord Injury: Program Satisfaction and Outcome for Mentor/Mentee|Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:10.471579|2017-10-11 05:33:10.471579
NCT00205218|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||November 1998||1998-11-01|April 2007|2007-04-01|August 2006|Actual|2006-08-01|||||Observational|||Validation of Methods to Estimate Body Fat|Validation of Methods to Estimate Body Fat|Completed||N/A|150||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:10.529495|2017-10-11 05:33:10.529495
NCT00205231|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-25|||May 2002||2002-05-01|September 2005|2005-09-01||||July 2008|Actual|2008-07-01||Interventional|||A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease|A Pilot Study to Examine the Feasibility and Effect on Tumor Necrosis Factor (TNF) Inhibition on HIV Disease|Completed||N/A|25|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:10.578845|2017-10-11 05:33:10.578845
NCT00205244|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-30||||||March 2017|2017-03-01||||October 2007|Actual|2007-10-01||Interventional|||Preoperative Preparation for Children|Preoperative Preparation for Children: Use of Relaxation and Distraction|Recruiting||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:10.657821|2017-10-11 05:33:10.657821
NCT00205257|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||September 2001||2001-09-01|December 2013|2013-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Prediction of Acute Rejection in Renal Transplant|Prediction of Acute Graft Rejection by Examining Urine Chemokines in Patients With Kidney Transplant|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:10.723275|2017-10-11 05:33:10.723275
NCT00205270|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||December 2004||2004-12-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Influenza Vaccine in Lung Transplant Patients|Influenza Vaccine in Lung Transplant Patients|Completed||N/A|152|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 05:33:10.76733|2017-10-11 05:33:10.76733
NCT00205283|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||August 2003||2003-08-01|September 2005|2005-09-01||||||||Interventional|||Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection|Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection|Unknown status|Recruiting|N/A|20|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:10.84887|2017-10-11 05:33:10.84887
NCT00205309|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-16|||January 2003||2003-01-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Airway IgA: Respiratory Tract IgA Levels in Critically Ill Intubated Patients|Respiratory Tract IgA Levels in Critically Ill Intubated Patients|Completed||N/A|13|Actual|University of Wisconsin, Madison|||1||f||||||||||||||2017-10-11 05:33:10.980436|2017-10-11 05:33:10.980436
NCT00205322|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-12-02|||April 2004||2004-04-01|December 2011|2011-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer|A Phase II Study of Oxaliplatin, 5-fluorouracil, and Leucovorin in Combination With Oral Capecitabine in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|45|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 05:33:11.034758|2017-10-11 05:33:11.034758
NCT00205335|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-29|||January 2004||2004-01-01|September 2015|2015-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Free Test Strips and Blood Glucose Control|The Impact of Increased Availability of Test Strips on Blood Glucose Control in Patients With Diabetes|Completed||N/A|22|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 05:33:11.092873|2017-10-11 05:33:11.092873
NCT00205361|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-16|||January 2002||2002-01-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Airway IgA: Respiratory Tract IgA Levels in Anesthetized Patients Undergoing Elective Surgical Procedures|Respiratory Tract IgA Levels in Anesthetized Patients Undergoing Elective Surgical Procedures|Completed||N/A|9|Actual|University of Wisconsin, Madison|||2||f||||||||||||||2017-10-11 05:33:11.200157|2017-10-11 05:33:11.200157
NCT00205374|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-19|2013-02-22||November 1999||1999-11-01|June 2017|2017-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Use of Cidofovir for Recurrent Respiratory Papillomatosis|"Use of Cidofovir Injection in the Treatment of Recurrent Respiratory Papillomatosis."|Completed||Phase 4|19|Actual|University of Wisconsin, Madison||2|||f||||t||||||||No||2017-10-11 05:33:11.254469|2017-10-11 05:33:11.254469
NCT00205387|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-08-28|||November 2005||2005-11-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Cardiac Elastography to Determine Strain and Strain Rates in the Heart|Cardiac Elastography|Completed||N/A|100|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-10-11 05:33:11.63216|2017-10-11 05:33:11.63216
NCT00205400|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-25|||August 1999||1999-08-01|October 2016|2016-10-01||||March 2005|Actual|2005-03-01||Interventional|||Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care|Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care|Completed||N/A|192||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:33:11.697503|2017-10-11 05:33:11.697503
NCT00205413|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-30|||September 2002||2002-09-01|September 2015|2015-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Surveillance For New Lung Primaries|Low Dose Helical Computed Tomographic (CT) Screening Followed by Anatomic Co-Registered Computed Tomography With Positron Emission Tomography (CT/PET) for Patients With Indeterminate (5-9 mm) Nodules|Terminated||N/A|250|Anticipated|University of Wisconsin, Madison||||low accrual|f||||||||||||||2017-10-11 05:33:11.78053|2017-10-11 05:33:11.78053
NCT00196326|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-09-28|2008-11-21||June 2005||2005-06-01|September 2016|2016-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional||Safety population|Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive|A Multicenter, Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose, Combination Oral Contraceptive, Which Utilizes Ethinyl Estradiol During the Seven Day Interval Between Each 84-day Cycle|Completed||Phase 3|2235|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-11 05:33:11.861053|2017-10-11 05:33:11.861053
NCT00196339|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-20||2013-08-27|June 2005||2005-06-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients|A Dose-ranging Clinical Trial to Study the Efficacy and Safety of DR-2031 for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients|Completed||Phase 2|315|Actual|Teva Pharmaceutical Industries||4|||f||||t||||||||||2017-10-11 05:33:12.350484|2017-10-11 05:33:12.350484
NCT00196352|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-04-07|||May 2003||2003-05-01|April 2014|2014-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.|A Prospective, Multiple Site Study to Evaluate the Safety of an Extended Cycle Combination Oral Contraceptive, Seasonique, Which Utilizes Ethinyl Estradiol During the Pill-free Interval.|Completed||Phase 3|320|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-10-11 05:33:12.683069|2017-10-11 05:33:12.683069
NCT00196365|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-09|||January 2005||2005-01-01|May 2014|2014-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain|A Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval Compared to Conventional Oral Contraceptive Therapy for Cyclic Pelvic Pain|Completed||Phase 3|97|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:33:12.787463|2017-10-11 05:33:12.787463
NCT00196378|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-30|||November 2004||2004-11-01|January 2010|2010-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy|A Randomized, Multicenter, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Synthetic Conjugated Estrogens, B (Enjuvia) 0.3 mg Tablets for the Treatment of Vulvovaginal Atrophy in Healthy Postmenopausal Women|Completed||Phase 3|300|Anticipated|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:33:12.903007|2017-10-11 05:33:12.903007
NCT00196391|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-07-29|||September 2005||2005-09-01|May 2014|2014-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea|A Multicenter Study to Evaluate Induction of Withdrawal Bleeding After Administration of DR-2021 in Women With Secondary Amenorrhea|Completed||Phase 2|180|Anticipated|Teva Pharmaceutical Industries||6|||f||||f||||||||||2017-10-11 05:33:13.058034|2017-10-11 05:33:13.058034
NCT00196404|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-17|||October 2004||2004-10-01|August 2012|2012-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder|A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder|Completed||Phase 2|800|Anticipated|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-10-11 05:33:13.199921|2017-10-11 05:33:13.199921
NCT00196417|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2003||2003-01-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||The HIT-TRAP Trial|Randomized-Double Blind Trial to Assess the Incidence and Clinical Relevance of Heparin-Induced Thrombocytopenia (HIT) Antibodies in Trauma Patients Treated With Unfractionated or Low-Molecular Weight Heparin, the HIT-TRAP Trial|Unknown status|Active, not recruiting|Phase 4|600||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:33:13.371902|2017-10-11 05:33:13.371902
NCT00196430|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2004||2004-01-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis|Prospective, Controlled Three-Armed Study About Effectiveness and Compatibility of Silver-Containing Textiles for Treatment of Acute Neurodermatitis|Completed||Phase 3|32||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:33:13.43434|2017-10-11 05:33:13.43434
NCT00196443|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||The Influence of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Disease|Prospective, Randomized and Explorative Controlled Study About Influences of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Insufficiency|Completed||Phase 2/Phase 3|42||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:33:13.487254|2017-10-11 05:33:13.487254
NCT00196456|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||April 2004||2004-04-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Photodynamic Lasertherapy (PDT) in Periodontal Treatment (in Vivo)|Photodynamic Lasertherapy (PDT) in Periodontal Treatment (in Vivo)|Completed||Phase 2|60||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:33:13.548473|2017-10-11 05:33:13.548473
NCT00196469|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-22|||December 2003||2003-12-01|September 2006|2006-09-01|March 2007||2007-03-01|||||Interventional|||Impact of Heparin on the Need for Mechanical Ventilation in Neonates|Randomized Double Blind Trial Comparing Heparin and Placebo as Additives to Continuous Infusion in Intensive Care Neonates for Prevention of Ventilation|Unknown status|Recruiting|Phase 4|270|Anticipated|University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:33:13.723551|2017-10-11 05:33:13.723551
NCT00196482|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-11|||June 2004||2004-06-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Human Milk Fortifiers and Acid-Base Status|Impact of Human Milk Fortifiers on Acid-Base Status in Preterm Infants|Unknown status|Recruiting|N/A|30||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:33:13.801841|2017-10-11 05:33:13.801841
NCT00196495|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-12-15|||June 2004||2004-06-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Clinical Assessment of the Total Vaginal Mesh Technique for Treatment of Genital Prolapse|Clinical Assessment of the Total Vaginal Mesh Technique for Treatment of Genital Prolapse|Completed||Phase 4|90||Ethicon, Inc.|||||f||||||||||||||2017-10-11 05:33:13.876231|2017-10-11 05:33:13.876231
NCT00196508|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-13|||April 2005||2005-04-01|June 2006|2006-06-01|January 2006||2006-01-01|||||Interventional|||A Study Comparing Topical Skin Adhesive or Sutures for Closure Due to Episiotomy or Perineal Tears Following Childbirth|A Randomized, Multi Center Study to Evaluate the Clinical Performance of Topical Skin Adhesive in Comparison to Sutures for Perineal Skin Closure Following Childbirth|Completed||Phase 3|118||Ethicon, Inc.|||||||||||||||||||2017-10-11 05:33:13.941875|2017-10-11 05:33:13.941875
NCT00196521|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-11|||January 2005||2005-01-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||A Clinical Evaluation of the Tension-Free Vaginal Tape Obturator System For Treatment of Stress Urinary Incontinence (Urinary Leakage)|A Clinical Evaluation of the Tension-Free Vaginal Tape Obturator System For Treatment of Stress Urinary Incontinence|Completed||N/A|300||Ethicon, Inc.|||||f||||f||||||||||2017-10-11 05:33:14.016115|2017-10-11 05:33:14.016115
NCT00196534|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-08-24|||November 2004||2004-11-01|August 2007|2007-08-01|July 2006||2006-07-01|||||Interventional|||A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery|A Comparative Evaluation of Human Thrombin Versus Bovine Thrombin in Achieving Hemostasis in Patients Undergoing Cardiovascular, Neurologic (Spine) and General Surgery Procedures.|Completed||Phase 3|304||Ethicon, Inc.|||||||||||||||||||2017-10-11 05:33:14.121926|2017-10-11 05:33:14.121926
NCT00196547|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-15|||September 2005||2005-09-01|March 2012|2012-03-01|November 2005||2005-11-01|||||Interventional|||Montelukast in Modulating Exacerbations of Asthma in Children|Randomized Placebo-controlled Trial of Montelukast in Modulating Exacerbations of Asthma in Children, September 2005|Completed||Phase 4|200||Firestone Institute for Respiratory Health|||||f||||||||||||||2017-10-11 05:33:14.21651|2017-10-11 05:33:14.21651
NCT00196560|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-11-26|||September 2003||2003-09-01|November 2015|2015-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Immobilization in External Rotation of Acute Shoulder Dislocations|A Randomized Evaluation of Immobilization in External Rotation in the Management of Acute Anterior Dislocations of the Shoulder|Completed||Phase 3|50|Actual|Fowler Kennedy Sport Medicine Clinic||1|||f||||f||||||||||2017-10-11 05:33:14.295701|2017-10-11 05:33:14.295701
NCT00196573|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-04-24|||November 2003||2003-11-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Subacromial Decompression Versus Subacromial Bursectomy for Patients With Rotator Cuff Tendinosis|A Randomized Clinical Trial Comparing the Effectiveness of Subacromial Decompression (Acromioplasty) Versus Subacromial Bursectomy (no Acromioplasty) in the Arthroscopic Treatment of Patients With Rotator Cuff Tendinosis|Unknown status|Active, not recruiting|Phase 3|114|Anticipated|University of Western Ontario, Canada||1|||f||||||||||||||2017-10-11 05:33:14.408753|2017-10-11 05:33:14.408753
NCT00196586|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-15|||April 2003||2003-04-01|November 2007|2007-11-01|November 2006||2006-11-01|||||Interventional|||Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients|Pilot Study of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin for the Treatment of Chronic Hepatitis C in HIV-HCV Coinfected Patients Non Responders to Three Months of Therapy With Pegylated Interferon Alpha 2a and Ribavirin. ANRS HC09 SECOIIA|Completed||Phase 2|75||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:33:14.594337|2017-10-11 05:33:14.594337
NCT00196599|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||February 1999||1999-02-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults|Pilot Study on Efficacy and Safety of a Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults. ANRS 091 MONTANA|Completed||Phase 2|39||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:33:14.695443|2017-10-11 05:33:14.695443
NCT00196612|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||April 2001||2001-04-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART|Phase II Randomized Trial Comparing Efficacy and Safety of the Maintenance of a HAART Association Protease Inhibitor Containing Versus a Once Daily Antiretroviral Triple Association, in HIV Adult Patients With Undetectable Viral Load.ANRS 099 ALIZE|Completed||Phase 3|350||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:33:14.806471|2017-10-11 05:33:14.806471
NCT00196625|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||November 2000||2000-11-01|September 2005|2005-09-01|February 2002||2002-02-01|||||Interventional|||Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.|Study on Safety and Efficacy of Salvage Therapy With Amprenavir, Lopinavir and Ritonavir 200 Mg/d or 400 Mg/d in HIV-Infected Patients in Virological Failure.ANRS 104 PUZZLE 1|Completed||Phase 2|100||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:33:14.929191|2017-10-11 05:33:14.929191
NCT00196638|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-08-28|||May 2002||2002-05-01|August 2006|2006-08-01|March 2006||2006-03-01|||||Interventional|||Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection|Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection.ANRS 112 INTERPRIM|Terminated||Phase 2/Phase 3|90||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:33:15.007423|2017-10-11 05:33:15.007423
NCT00196651|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2000||2000-08-01|September 2005|2005-09-01|February 2004||2004-02-01|||||Interventional|||HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection|Randomized Study on HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides (LIPO-6T) in Patients Treated Early With HAART During Primary Infection. ANRS 095 PRIMOVAC|Terminated||Phase 2|60||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:33:15.088599|2017-10-11 05:33:15.088599
NCT00196664|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-05-12|||October 2005||2005-10-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|||||Interventional|||Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin|Assessment of the Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin. Multicentric, Double-Blinded, Randomized Study. ANRS HC18 Paropeg|Completed||Phase 3|144|Anticipated|French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-10-11 05:33:15.1715|2017-10-11 05:33:15.1715
NCT00196677|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-03-10|||September 2005||2005-09-01|March 2009|2009-03-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Study of Glaucoma Treatment With Food Additives|Treatment of Glaucomatous Neuropathy With Food Additives|Terminated||Phase 1/Phase 2|25|Anticipated|Future Products Management||||The trial was terminated due to investigator's decision|f||||||||||||||2017-10-11 05:33:15.247234|2017-10-11 05:33:15.247234
NCT00196690|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||February 2003||2003-02-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial|Treatment With Donepezil of Chronic Aphasia and Sensorimotor Deficits Associated to Cerebrovascular Accidents: a Double-Blind,Placebo-Controlled, Randomized Parallel Trial.|Completed||Phase 4|30||Gabinete Berthier y Martínez|||||f||||||||||||||2017-10-11 05:33:15.317717|2017-10-11 05:33:15.317717
NCT00196703|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||March 2005||2005-03-01|March 2005|2005-03-01|September 2005||2005-09-01|||||Interventional|||Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled Trial|A 24-Week Pilot, Double-Blind, Randomized, Parallel, Placebo-Controlled Study of Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:Correlation With Cognitive Evoked Potentials During Recovery.|Unknown status|Recruiting|Phase 4|30||Gabinete Berthier y Martínez|||||f||||||||||||||2017-10-11 05:33:15.395871|2017-10-11 05:33:15.395871
NCT00196716|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-17|2008-12-05||June 2003||2003-06-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|April 2006|Actual|2006-04-01||Interventional|||A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease|A Multicenter, Open-label Study of Low Dose Maintenance Treatment of Fabrazyme (Recombinant Human Alpha-Galactosidase A (R-h Alpha-GAL)) Replacement Therapy in Patients With Fabry Disease|Completed||Phase 2|21|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:33:15.525469|2017-10-11 05:33:15.525469
NCT00196729|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-17|||December 2001||2001-12-01|March 2015|2015-03-01|September 2003||2003-09-01|||||Interventional|||Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration|A Randomized, Controlled, Open-Label, Multi-National Pilot Study of Thyroid Remnant Ablation Comparing the Safety and Ablation Rate Following 131I Administration Using Thyrogen® Versus the Safety and Ablation Rate Following 131I Administration in the Hypothyroid State|Completed||Phase 3|63||Sanofi|||||||||||||||||||2017-10-11 05:33:16.13928|2017-10-11 05:33:16.13928
NCT00196742|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-09-20|||July 31, 2001|Actual|2001-07-31|September 2017|2017-09-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|||Fabry Disease Registry|Fabry Disease Registry|Recruiting||N/A|9000|Anticipated|Sanofi|||1||f||||f||||||||||2017-10-11 05:33:16.220979|2017-10-11 05:33:16.220979
NCT00196755|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-03-17|||December 2004||2004-12-01|March 2015|2015-03-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis|An Open Label, Randomized, Parallel Design Study to Investigate the Efficacy and Safety of Sevelamer Hydrochloride (Renagel®) Compared With Calcium Acetate in Peritoneal Dialysis Patients|Completed||Phase 3|138|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:33:16.441534|2017-10-11 05:33:16.441534
NCT00196768|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-22|||January 2005||2005-01-01|October 2007|2007-10-01|December 2010||2010-12-01|||||Interventional|||Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic|Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide (Phase IV Study)|Unknown status|Recruiting|Phase 4|30|Anticipated|German AML Cooperative Group|||||f||||||||||||||2017-10-11 05:33:16.568084|2017-10-11 05:33:16.568084
NCT00196781|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-11|||September 2002||2002-09-01|January 2010|2010-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Treatment Decision Making in Early-Stage Prostate Cancer|Treatment Decision Making in Early-Stage Prostate Cancer: Evaluation of Computer Based Patient Education and an Interactive Decision Aid|Completed||Phase 3|168|Actual|Georgetown University||2|||f||||t||||||||||2017-10-11 05:33:16.651084|2017-10-11 05:33:16.651084
NCT00196794|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-03-17|||April 2005||2005-04-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea|A Randomized, Double-Blind Study of GT267-004 Versus Vancomycin, and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea|Completed||Phase 3|520|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:33:16.7449|2017-10-11 05:33:16.7449
NCT00196807|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-01-19|||August 2004||2004-08-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Prostate Cancer Screening: Fostering Informed Decisions|Prostate Cancer Screening: Fostering Informed Decisions|Completed||Phase 3|543|Actual|Georgetown University||4|||f||||t||||||||||2017-10-11 05:33:17.310325|2017-10-11 05:33:17.310325
NCT00196820|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-10-05|||July 2005||2005-07-01|May 2008|2008-05-01|December 2008|Actual|2008-12-01|||||Interventional|||Mono Efficacy of Capecitabine (MoniCa)|A Multicenter Phase II Study to Determine the Efficacy of Capecitabine as First Line Monochemotherapy in Patients With HER2 Negative, Medium-risk, Metastatic Breast Cancer|Completed||Phase 2|200|Anticipated|German Breast Group||1|||f||||t||||||||||2017-10-11 05:33:17.469413|2017-10-11 05:33:17.469413
NCT00196833|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-01|||April 2003||2003-04-01|August 2017|2017-08-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|BCP||Breast Cancer in Pregnancy Register Study|Prospective and Retrospective Register Study of the German Breast Group (GBG) for Diagnosis and Treatment of Breast Cancer in Pregnancy|Recruiting||N/A|500|Anticipated|German Breast Group|||1||f||||f||||||Samples With DNA|"     Tumour and placenta specimens are collected   "|||2017-10-11 05:33:17.635029|2017-10-11 05:33:17.635029
NCT00196846|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-11|||March 2005||2005-03-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|December 2008|Actual|2008-12-01||Interventional|||Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)|Prospective Randomized Multicenter Study to Prevent Chemotherapy Induced Ovarian Failure With the GnRH-Agonist Goserelin in Young Hormone Insensitive Breast Cancer Patients Receiving Anthracycline Containing (Neo-)Adjuvant Chemotherapy|Completed||Phase 2|62|Anticipated|German Breast Group||1|||f||||t||||||||||2017-10-11 05:33:17.748887|2017-10-11 05:33:17.748887
NCT00196859|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-16|||June 2004||2004-06-01|August 2011|2011-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study in Elderly Patients With Early Breast Cancer (ICE)|Ibandronate With or Without Capecitabine in Elderly Patients With Early Breast Cancer|Completed||Phase 3|1500|Anticipated|German Breast Group||2|||f||||t||||||||||2017-10-11 05:33:17.87485|2017-10-11 05:33:17.87485
NCT00196872|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-07-16|||July 2004||2004-07-01|August 2012|2012-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)|A Phase III Trial to Compare ETC vs, EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)|Completed||Phase 3|3000|Anticipated|German Breast Group||4|||f||||||||||||||2017-10-11 05:33:17.996861|2017-10-11 05:33:17.996861
NCT00196885|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-18|||December 2003||2003-12-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training|Effect of N-Acetylcysteine on Skeletal Muscle in Cachectic Cancer Patients Undergoing a Resistance Training Program (Phase 2 Study)|Completed||Phase 2|60||German Cancer Research Center|||||f||||||||||||||2017-10-11 05:33:18.117077|2017-10-11 05:33:18.117077
NCT00196898|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-16|||March 2005||2005-03-01|April 2011|2011-04-01|December 2013|Anticipated|2013-12-01|||||Observational|||Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine Agonists|A National, Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson´s Disease Treated With Dopamine Agonists|Unknown status|Recruiting|N/A|100|Anticipated|German Parkinson Study Group (GPS)|||1||f||||||||||||||2017-10-11 05:33:18.200973|2017-10-11 05:33:18.200973
NCT00196911|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2006-11-29|||January 2001||2001-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||STN-Stimulation Versus Best Medical Treatment in Advanced PD|Randomized, Multicenter, Prospective, Parallel-Group Study of the Effect of Deep Brain Stimulation (Subthalamic Nucleus) on Quality of Life and Motor Complications in Patients With Advanced Parkinson's Disease Compared With Best Medical Treatment|Completed||Phase 3|156||German Parkinson Study Group (GPS)|||||f||||||||||||||2017-10-11 05:33:18.284593|2017-10-11 05:33:18.284593
NCT00196924|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-21|||June 2004||2004-06-01|March 2017|2017-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.|Evaluate the Safety and Immunogenicity of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly According to a 0,1,6 Month Schedule in Healthy Female Subjects (10 - 14 Years)|Completed||Phase 3|2067|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:18.387149|2017-10-11 05:33:18.387149
NCT00196937|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-23|2009-11-12||October 2004||2004-10-01|November 2016|2016-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18|Phase 3, Open, Age-stratified Study to Assess Immunogenicity and Safety of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly According to 3-dose Schedule (0,1,6 Months) in Healthy Female Subjects Aged 15 - 55 Years and Long Term Follow-up|Completed||Phase 3|667|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:18.626355|2017-10-11 05:33:18.626355
NCT00197197|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-03-28|||July 2005||2005-07-01|March 2011|2011-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects|A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Compare the Efficacy and Safety of GW873140 400mg BID in Combination With a Ritonavir-containing Optimized Background Therapy (OBT) Regimen Versus Placebo Plus OBT Over 48 Weeks.|Terminated||Phase 3|18|Actual|GlaxoSmithKline||1||The study was terminated due to hepatoxicity of compound|||||||||||||||2017-10-11 05:33:31.862238|2017-10-11 05:33:31.862238
NCT00196950|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-06|||September 2003||2003-09-01|September 2016|2016-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years|Assess the Safety, Reactogenicity, Immunogenicity & Long-term Persistence of One Intramuscular Dose of GSK Biologicals' MenACWY Conjugate Vaccine vs One Subcutaneous Dose of Mencevax™ ACWY in Healthy Adults Aged 18-25 Yrs|Completed||Phase 2|50|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:19.525891|2017-10-11 05:33:19.525891
NCT00196963|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-20|||March 2005||2005-03-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs|Assess the Immunogenicity, Safety, Reactogenicity of 1 Dose of 4 Different Formulations of GSK Biologicals' Meningococcal Conjugate Vaccine (MenACWY) vs 1 Dose of Mencevax™ ACWY in Healthy Subjects Aged 15-19 Yrs|Completed||Phase 2|125|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:19.629137|2017-10-11 05:33:19.629137
NCT00196976|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-25|2017-01-11||March 24, 2005||2005-03-24|April 2017|2017-04-01|March 3, 2006|Actual|2006-03-03|March 1, 2006|Actual|2006-03-01||Interventional|||Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old|Evaluate the Immunogenicity, Reactogenicity, Safety of 4 Different Formulations of GSK Biologicals' Conjugate Vaccine (MenACWY) vs 1 Dose of MenC-CRM197 or Mencevax™ ACWY in Children Aged 12-14 Months & 3-5 Years|Completed||Phase 2|461|Actual|GlaxoSmithKline|None reported.|14|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:19.849788|2017-10-11 05:33:19.849788
NCT00197002|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-12-23|2016-12-23||September 2003||2003-09-01|September 2016|2016-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age|A Phase IIIb, Open, Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine Administered on a 0-6 Mth Schedule Concomitantly With Wyeth Lederle's Pneumococcal Conjugate Vaccine in Healthy Children 15 Months of Age|Completed||Phase 3|521|Actual|GlaxoSmithKline|None reported.||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:26.018736|2017-10-11 05:33:26.018736
NCT00197015|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-11|2010-03-11||October 2003||2003-10-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children|Immunogenicity & Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine (Havrix™) Co-administered With Merck & Company, Inc. Measles-Mumps-Rubella Vaccine (M-M-RII) & Merck & Co Varicella Vaccine (VARIVAX™) to Children 15 Months of Age|Completed||Phase 3|1474|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:27.239509|2017-10-11 05:33:27.239509
NCT00197028|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-24|2012-12-13|2009-05-29|August 23, 2005||2005-08-23|April 2017|2017-04-01|December 27, 2007|Actual|2007-12-27|December 27, 2007|Actual|2007-12-27||Interventional|||Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region|A Phase I/IIb Randomized, Double-blind, Controlled Study of the Safety, Immunogenicity and Proof-of-concept of RTS,S/AS02D, a Candidate Malaria Vaccine in Infants Living in a Malaria-endemic Region|Completed||Phase 2|214|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:28.438652|2017-10-11 05:33:28.438652
NCT00197041|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-20|||July 2003||2003-07-01|September 2016|2016-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.|A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, Administered Intramuscularly According to a 0, 1 and 2 Month Vaccination Schedule in Toddlers and Children Aged 1 to 4 Years in a Malaria-endemic Region of Mozambique.|Completed||Phase 2|2022|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:29.204989|2017-10-11 05:33:29.204989
NCT00197353|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-05|||March 1999||1999-03-01|May 2005|2005-05-01|September 1999||1999-09-01|||||Interventional|||Study of Different Concentrations of Epidural Bupivacaine for the Effects on Vasodilatation and Sensory Block|Sympathectomy-Mediated Vasodilatation and Differential Sensory Block After Epidural Bupivacaine: a Randomized Concentration Ranging Study|Completed||Phase 3|60||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:33:34.072945|2017-10-11 05:33:34.072945
NCT00197067|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-01|||March 15, 2004|Actual|2004-03-15|June 2017|2017-06-01|April 26, 2005|Actual|2005-04-26|April 26, 2005|Actual|2005-04-26||Interventional|||A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.|A Bridging Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.|Completed||Phase 1|200|Actual|GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:33:29.347712|2017-10-11 05:33:29.347712
NCT00197080|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-09-22|||June 2005||2005-06-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome|A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole XR (Extended Release) in Patients With Restless Legs Syndrome|Completed||Phase 3|380||GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:29.439406|2017-10-11 05:33:29.439406
NCT00197093|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-05-15|||September 2004||2004-09-01|May 2009|2009-05-01||||||||Interventional|||In-Patient Study In Schizophrenic Patients|A Placebo Controlled, Double-Blind, Randomised Study Investigating the Safety, Tolerability and Pharmacokinetics of Ascending Multiple Oral Doses of SB-773812 in Male and Female Schizophrenic Patients for up to 28 Days|Completed||Phase 1|60||GlaxoSmithKline||1|||||||||||||||||2017-10-11 05:33:29.669954|2017-10-11 05:33:29.669954
NCT00197106|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2017-02-01|2009-09-11||June 2005||2005-06-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Treatment Of Symptomatic Asthma In Children|A Multicentre, Randomised, Double-blind, Parallel Group Study to Compare the Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Product (Seretide®) 50/100 mcg With Fluticasone Propionate (Flixotide® ) 200 mcg, Both Delivered Twice Daily Via the DISKUS Inhaler, in the Treatment of Children Aged 6-12 Years With Symptomatic Asthma|Completed||Phase 4|176|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 05:33:29.749642|2017-10-11 05:33:29.749642
NCT00197119|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-03-21|2009-07-02||May 2004||2004-05-01|March 2017|2017-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years|Evaluate Persistence of Immune Response of GSK Biologicals' TWINRIX™ Vaccine Administered According to 0,6 Month Schedule Versus TWINRIX™ JUNIOR Administered According to 0,1,6 Month Schedule, in Subjects Aged 12-15 Years at Time of First Vaccine Dose|Completed||Phase 3|244|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:30.527817|2017-10-11 05:33:30.527817
NCT00197132|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-12-02|||October 2002||2002-10-01|December 2016|2016-12-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Study In Patients With Insulin Resistance|A Single-centre, Randomised, Double-blind, Placebo Controlled, Two 12 Week Period, Cross-over Phase III Study to Investigate the Effect of Rosiglitazone 4mg bd on the Vasodilator Response to Hyperinsulinaemia in Obese Insulin Resistant Subjects.|Completed||Phase 3|18|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:30.849527|2017-10-11 05:33:30.849527
NCT00197158|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-09-20|||March 2005||2005-03-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response|Demonstrate the Non-inferiority of Immunogenicity Elicited by GSK Biologicals' Hepatitis B Vaccine, Multidose Engerix™-B to That of Monodose Engerix™-B When Administered According to 0,1,6 Mths Schedule in Healthy Adults Aged ≥ 18 Yrs|Completed||Phase 4|280|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:31.200312|2017-10-11 05:33:31.200312
NCT00197171|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-09-06|||September 2003||2003-09-01|September 2016|2016-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine|Evaluate the Persistence of Immune Response of GSK Biologicals' TWINRIX™ ADULT, Administered According to 0,6 Month Schedule and 0,12 Month Schedule, in Volunteers Aged 12-15 Years Inclusive at the Time of First Vaccine Dose|Completed||Phase 3|143|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:31.270937|2017-10-11 05:33:31.270937
NCT00197184|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-10-21|2009-02-20||November 2003||2003-11-01|October 2016|2016-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared|Evaluate the Persistence of Immune Response of GSK Biologicals' Twinrix™ Vaccine, Administered According to a 0,6 Month Schedule and a 0,1,6 Month Schedule, in Healthy Children Aged Between 1-11 Years at the Time of First Vaccine Dose|Completed||Phase 3|276|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:31.368347|2017-10-11 05:33:31.368347
NCT00197366|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-06-11|||March 2005||2005-03-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Observational|||Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel|Development of Resistance Mutations in the Human Immunodeficiency Virus (HIV) in Pregnant HIV+ Women Receiving Perinatal Antiretroviral Therapy in Israel|Unknown status|Recruiting|N/A|50|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:33:34.152876|2017-10-11 05:33:34.152876
NCT00197210|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-11-03|||December 2003||2003-12-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants|A Phase III, Double-blind, Randomized, Placebo-controlled, Multi-country and Multi-center Study to Assess the Efficacy and Safety of Two Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants|Completed||Phase 3|10708|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:31.962108|2017-10-11 05:33:31.962108
NCT00197223|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-03-21|||September 2005||2005-09-01|March 2017|2017-03-01|May 2006|Actual|2006-05-01|October 2005|Actual|2005-10-01||Interventional|||Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine|A Randomized, Double-blind, Placebo-controlled, Post-marketing Phase III Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine (Fluarix™) Administered Intramuscularly in Adults.|Completed||Phase 3|6213|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:32.047998|2017-10-11 05:33:32.047998
NCT00197236|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-01-16|2008-12-02||November 2003||2003-11-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months|Immunogenicity and Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine (Havrix™) Co-administered With GSK Biologicals' DTaP Vaccine (Infanrix™) and Aventis Pasteur's Haemophilus b Conjugate Vaccine (ActHIB) in Healthy Children 15 Months of Age|Completed||Phase 3|468|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:32.131733|2017-10-11 05:33:32.131733
NCT00197249|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-09-08|||May 2002||2002-05-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|June 2003|Actual|2003-06-01||Interventional|||Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity|A Phase III, Open, Randomized, Multicentric Study to Compare the Reactogenicity and Immunogenicity of GSK Biologicals' Combined Vi Polysaccharide Typhoid Vaccine and Inactivated Hepatitis A Vaccine, to That Elicited by GSK Biologicals' Hepatitis A Vaccine, Administered Singly or Concomitantly With GSK Biologicals' Vi Polysaccharide Vaccine|Completed||Phase 3|1034|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:33.400003|2017-10-11 05:33:33.400003
NCT00197262|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-01-18|||August 2005||2005-08-01|January 2017|2017-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)|A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|288||GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:33.480694|2017-10-11 05:33:33.480694
NCT00197275|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-10-06|||February 2006||2006-02-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants|Demonstrate Lot-to-lot Consistency of Final Production Method of GSK Biologicals' Hib-MenAC Vaccine Mixed Extemporaneously With Tritanrix™-HepB & Demonstrate Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Healthy Infants at 2, 4 and 6 Months|Completed||Phase 3|800||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:33.590845|2017-10-11 05:33:33.590845
NCT00197288|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-01-16|||October 2005||2005-10-01|January 2017|2017-01-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines|A Phase III, Observer-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix™ (GlaxoSmithKline Biologicals) Compared With Fluzone® (Aventis Pasteur) Administered Intramuscularly in Adults 18 Years and Older in the U.S.|Completed||Phase 3|1847|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:33:33.673498|2017-10-11 05:33:33.673498
NCT00197301|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-06|||October 2005||2005-10-01|September 2005|2005-09-01|April 2006||2006-04-01|||||Interventional|||Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy|Phase 1 Study to Examine the Safety and Efficacy of a Novel Liposomal Based Intranasal Influenza Vaccine|Completed||Phase 1/Phase 2|200||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:33:33.771216|2017-10-11 05:33:33.771216
NCT00197314|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-06|||June 2004||2004-06-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Interventional|||Effectiveness of Circular Muscle Exercise (Paula Method) Versus Kegel Exercise for Urinary Stress Incontinence|A Randomized Controlled Trial of Circular Muscle Exercises (Paula Method) vs. Pelvic Floor Training (Kegel Exercises) for Urinary Stress Incontinence in Women|Completed||Phase 3|200||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:33:33.836036|2017-10-11 05:33:33.836036
NCT00197327|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-03-02|||February 1998||1998-02-01|March 2003|2003-03-01|March 2000||2000-03-01|||||Interventional|||Dilute Versus Concentrated Epidural Bupivacaine in Labor|Analgesia Requirement and Maternal Satisfaction Following Epidural PCA in Nulliparous Labor: the Effect of a Four-Fold Change in Local Anesthetic Concentration.|Completed||Phase 3|60||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:33:33.902252|2017-10-11 05:33:33.902252
NCT00197340|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-14|||August 2003||2003-08-01|February 2006|2006-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction|Antepartum Chronic Epidural Therapy (ACET) Using Ropivacaine to Improve Uteroplacental Blood Flow in Pre-Eclampsia and Intrauterine Growth Restriction|Completed||Phase 3|20|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:33:33.993147|2017-10-11 05:33:33.993147
NCT00197379|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-07-28|||May 2005||2005-05-01|April 2005|2005-04-01|January 2007|Anticipated|2007-01-01|||||Interventional|||The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia|The Study for New Effect of Roxithromycin on Androgenetic Alopecia.|Unknown status|Active, not recruiting|N/A|20|Anticipated|Hamamatsu University||1|||f||||||||||||||2017-10-11 05:33:34.240201|2017-10-11 05:33:34.240201
NCT00197392|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-10-11|2012-03-02||November 2004||2004-11-01|October 2013|2013-10-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System|Establishment of Baseline and Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System|Completed||Phase 4|434|Actual|Codman & Shurtleff||2|||f||||f||||||||||2017-10-11 05:33:34.479606|2017-10-11 05:33:34.479606
NCT00197405|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-08-03|||August 1999||1999-08-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|||||Observational|||Comparison of Fecal Ribonucleic Acid (RNA) Test With Fecal Occult Blood Test (FOBT) for Detecting Colorectal Cancer and Adenoma|Comparative Study of Fecal RNA Test With Immunochemical Fecal Occult Blood Test for Detecting Colorectal Cancer and Adenoma|Unknown status|Recruiting|N/A|400|Anticipated|Hamamatsu University|||1||f||||t||||||Samples Without DNA|"     freces, biopsy tissue samples   "|||2017-10-11 05:33:35.447823|2017-10-11 05:33:35.447823
NCT00197418|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-20|||August 2003||2003-08-01|March 2003|2003-03-01||||||||Interventional|||Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection|Dual Therapy With High-Dose of Rabeprazole and Amoxicilline Versus Triple Therapy With Rabeprazole, Amoxicilline and Metronidazole as the Second Line Therapy for the Cure of H. Pylori Infection|Unknown status|Recruiting|Phase 2/Phase 3|||Hamamatsu University|||||f||||||||||||||2017-10-11 05:33:35.527155|2017-10-11 05:33:35.527155
NCT00197431|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-21|||January 2004||2004-01-01|December 2003|2003-12-01||||||||Interventional|||Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer|Pharmacokinetic and Pharmacodynamic Study of S-1 and Its Effects in Patients With the Digestive Organ Cancer With Reference to Genetic Polymorphism and Activity of CYP2A6 and DPD|Unknown status|Recruiting|Phase 2|||Hamamatsu University|||||f||||||||||||||2017-10-11 05:33:35.635161|2017-10-11 05:33:35.635161
NCT00197444|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-19|||January 2003||2003-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer|A Phase II Study of Daily Low-Dose of Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum) and Continuous Infusion of 5-FU Combined With Radiation for the Treatment of Esophageal Cancer|Completed||Phase 2|33|Actual|Hamamatsu University||1|||f||||t||||||||||2017-10-11 05:33:35.726101|2017-10-11 05:33:35.726101
NCT00197457|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-01-31|||June 2001||2001-06-01|May 2001|2001-05-01||||||||Interventional|||Pepsinogens as the Early Marker of H. Pylori Eradication|Serum Pepsinogens as an Early Diagnostic Marker of H. Pylori Eradication|Completed||Phase 2|||Hamamatsu University|||||f||||||||||||||2017-10-11 05:33:35.855652|2017-10-11 05:33:35.855652
NCT00197470|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||January 2000||2000-01-01|September 2005|2005-09-01||||||||Interventional|||Cytokine Gene Polymorphisms in Gastric Diseases|Effects of Pro-Inflammatory and Anti-Inflammatory Cytokine Gene Polymorphism on the Development of Gastric Cancer and Peptic Ulcer in Japanese|Unknown status|Recruiting|N/A|||Hamamatsu University|||||f||||||||||||||2017-10-11 05:33:35.964057|2017-10-11 05:33:35.964057
NCT00197483|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||March 2003||2003-03-01|September 2005|2005-09-01||||||||Observational|||Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia|Effective Adjunctive Use of Pergolide With Risperidone for Cognitive Impairment and Negative Symptoms in Schizophrenia|Suspended||Phase 2|20||Hamamatsu University|||||f||||||||||||||2017-10-11 05:33:36.075116|2017-10-11 05:33:36.075116
NCT00197496|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-29|2016-12-14||January 2007||2007-01-01|March 2017|2017-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Body Weight Supported Treadmill Training Following Hip Fracture|Body Weight Supported Treadmill Training Following Hip Fracture|Completed||N/A|21|Actual|McMaster University|It was not possible to blind outcome assessors. We did not randomize participants because we wanted a minimum of 12 to test feasibility of intervention. Control group had a longer average length of stay, and may have received more physiotherapy.|2|||f||||t||||||||No||2017-10-11 05:33:36.175375|2017-10-11 05:33:36.175375
NCT00197509|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2005||2005-01-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Sit-to-Stand Training for Survivors of Stroke in a Long-Term Care Setting|Task Specific Training for Stroke Patients|Unknown status|Active, not recruiting|Phase 2|120||Hamilton Health Sciences Corporation|||||f||||||||||||||2017-10-11 05:33:36.666984|2017-10-11 05:33:36.666984
NCT00197522|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-10-31|||October 2004||2004-10-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2|A Phase I Study Investigating Multiple Injections of Autologous CD34+ Derived Dendritic Cells Transduced With an Adenovirus Vector Expressing Inactivated HER-2/Neu in Patients With Metastatic Breast Cancer|Completed||Phase 1|5|Actual|McMaster University||1|||f||||||||||||||2017-10-11 05:33:36.759425|2017-10-11 05:33:36.759425
NCT00197548|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-11-09|||August 2001||2001-08-01|November 2010|2010-11-01|July 2006|Actual|2006-07-01|December 2004|Actual|2004-12-01||Interventional|||A Trial of Micronutrients and Adverse Pregnancy Outcomes|A Trial of Micronutrients and Adverse Pregnancy Outcomes|Completed||Phase 3|8468|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 05:33:36.864479|2017-10-11 05:33:36.864479
NCT00197561|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-11-09|||September 2003||2003-09-01|November 2010|2010-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection|Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection|Completed||Phase 3|915|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 05:33:36.971941|2017-10-11 05:33:36.971941
NCT00197587|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-05-17|||August 2002||2002-08-01|May 2013|2013-05-01||||May 2005|Actual|2005-05-01||Interventional|Mashi||Prevention of Milk-Borne Transmission of HIV-1C in Botswana|"Prevention of Milk-Borne Transmission of HIV-1C in Botswana (Mashi)"|Completed||N/A|1200|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 05:33:37.101004|2017-10-11 05:33:37.101004
NCT00197613|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-09-14|||December 2002||2002-12-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|||||Interventional|||The Adult Antiretroviral Treatment and Resistance Study (Tshepo)|The Adult Antiretroviral Treatment and Resistance Study (Tshepo)|Completed||Phase 3|650||Harvard School of Public Health|||||f||||t||||||||||2017-10-11 05:33:37.218205|2017-10-11 05:33:37.218205
NCT00197639|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10|||September 2006||2006-09-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Observational|||Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand|A Pharmacokinetic Study to Assess the Inter-patient Variability of Indinavir Drug Levels When Boosted With Ritonavir in Thai Patients on Highly Active Antiretroviral Therapy|Completed||N/A|19|Actual|Harvard School of Public Health|||1||f||||f||||||||||2017-10-11 05:33:37.329352|2017-10-11 05:33:37.329352
NCT00197652|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-10-06|||March 2001||2001-03-01|October 2011|2011-10-01|March 2008|Actual|2008-03-01|October 2003|Actual|2003-10-01||Observational|||Botswana Diarrheal Diseases Study|Botswana Diarrheal Diseases Study|Completed||N/A|1350|Actual|Harvard School of Public Health|||2||f||||f||||||||||2017-10-11 05:33:37.425361|2017-10-11 05:33:37.425361
NCT00197678|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-09|||November 2002||2002-11-01|November 2010|2010-11-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women|Comparison of Two Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women From Tanzania|Completed||Phase 3|1141|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-10-11 05:33:37.510307|2017-10-11 05:33:37.510307
NCT00197691|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-30|||March 2001||2001-03-01|March 2012|2012-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||Botswana Pediatric Respiratory Disease and Bloodstream Infection Study|Botswana Pediatric Respiratory Disease and Bloodstream Infection|Completed||N/A|||Harvard School of Public Health|||1||f||||f||||||||||2017-10-11 05:33:37.599921|2017-10-11 05:33:37.599921
NCT00197704|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-11-09|||March 2000||2000-03-01|November 2010|2010-11-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Nutrition, Immunology and Epidemiology of Tuberculosis|Nutrition, Immunology and Epidemiology of Tuberculosis|Completed||Phase 3|876|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 05:33:37.670639|2017-10-11 05:33:37.670639
NCT00197730|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-08-20|||June 2004||2004-06-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Trial of Vitamins Among Children of HIV-infected Women|Trial of Vitamins Among Children of HIV-infected Women|Completed||Phase 3|2387|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-10-11 05:33:37.78193|2017-10-11 05:33:37.78193
NCT00197743|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-09|||April 1995||1995-04-01|November 2010|2010-11-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Trial of Vitamins in HIV Progression and Transmission|Trial of Vitamins in HIV Progression and Transmission|Completed||Phase 3|1085|Actual|Harvard School of Public Health||4|||f||||t||||||||||2017-10-11 05:33:37.877583|2017-10-11 05:33:37.877583
NCT00197756|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-08-20|||September 2004||2004-09-01|August 2009|2009-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Vitamins, Breastmilk HIV Shedding, and Child Health|Vitamins, Breastmilk HIV Shedding, and Child Health|Completed||Phase 3|771|Actual|Harvard School of Public Health|||4||f||||f||||||Samples Without DNA|"     Breast milk samples collected from breast at delivery and at 3 month intervals thereafter.   "|||2017-10-11 05:33:37.989857|2017-10-11 05:33:37.989857
NCT00197769|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-30|||September 2000||2000-09-01|February 2008|2008-02-01|January 2004||2004-01-01|||||Interventional|||Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants||Completed||Phase 2|||Public Health England|||||f||||||||||||||2017-10-11 05:33:38.088591|2017-10-11 05:33:38.088591
NCT00197782|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-27|||April 2003||2003-04-01|March 2012|2012-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine||Completed||Phase 4|||Public Health England|||||f||||||||||||||2017-10-11 05:33:38.143771|2017-10-11 05:33:38.143771
NCT00197795|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-27|||January 2005||2005-01-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults||Completed||Phase 2|30||Public Health England|||||f||||||||||||||2017-10-11 05:33:38.207047|2017-10-11 05:33:38.207047
NCT00197808|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-27|||April 2005||2005-04-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|sched1||Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines|Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines|Completed||Phase 4|392|Actual|Public Health England||6|||f||||||||||||||2017-10-11 05:33:38.428317|2017-10-11 05:33:38.428317
NCT00197834|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-08-10|||March 2004||2004-03-01|September 2005|2005-09-01||||||||Interventional|||Study of Depakote for Behavioral and Psychological Symptoms in Dementia|An Open-Label Prospective Study of Depakote for Behavioral and Psychological Symptoms in Dementia (BPSD): Use Alone and in Co-Prescription With Atypical Antipsychotic Medications|Unknown status|Recruiting|Phase 1|20||Hearthstone Alzheimer Care|||||f||||||||||||||2017-10-11 05:33:38.57789|2017-10-11 05:33:38.57789
NCT00197847|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||December 2002||2002-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Infection Surveillance in Intensive Care Patients||Unknown status|Active, not recruiting|N/A|549||Herlev Hospital|||||f||||||||||||||2017-10-11 05:33:38.657192|2017-10-11 05:33:38.657192
NCT00197860|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-22|||September 2004||2004-09-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Dendritic Cell Based Therapy of Renal Cell Carcinoma|Vaccination With Autologous Dendritic Cells Pulsed With Tumor Antigens for Treatment of Patients With Renal Cell Carcinoma.A Phase I/II Study.|Completed||Phase 1/Phase 2|40|Actual|Herlev Hospital||1|||f||||||||||||||2017-10-11 05:33:38.709713|2017-10-11 05:33:38.709713
NCT00197873|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-09|||September 2005||2005-09-01|August 2017|2017-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea|Randomized, Double Blind, Placebo Controlled, Cross-over Phase II Study on the Effects of Lactobacillus Rhamnosus GG Supplementation in Patients on 1st Line XELOXA Treatment for Metastatic Colorectal Cancer|Active, not recruiting||N/A|84|Anticipated|Helsinki University||2|||f||||f||||||||||2017-10-11 05:33:38.778292|2017-10-11 05:33:38.778292
NCT00197886|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-09-19|||October 2004||2004-10-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Dose of Norepinephrine and the Concentration of L-Lactate in the Rectum and Stomach in Patients With Septic Shock.||Completed||N/A|10||Herlev Hospital|||||f||||||||||||||2017-10-11 05:33:38.888417|2017-10-11 05:33:38.888417
NCT00197912|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-04-23|||September 2004||2004-09-01|July 2009|2009-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Dendritic Cell Based Therapy of Malignant Melanoma|Vaccination With Autologous Dendritic Cells Pulsed With Tumor Antigens for Treatment of Patients With Malignant Melanoma. Phase I/II Study|Completed||Phase 1/Phase 2|25|Actual|Herlev Hospital||1|||f||||||||||||||2017-10-11 05:33:39.00717|2017-10-11 05:33:39.00717
NCT00197925|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-02|||September 2004||2004-09-01|January 2008|2008-01-01||||||||Interventional|||Dendritic Cell Based Therapy of Metastatic Breast Cancer|Vaccination With Autologous Dendritic Cells Pulsed With Onco-Peptides for Treatment of Patients With Metastatic Breast Cancer.A Phase I/II Study|Terminated||Phase 1/Phase 2|40|Anticipated|Herlev Hospital||||all patients recruited|f||||||||||||||2017-10-11 05:33:39.083254|2017-10-11 05:33:39.083254
NCT00197938|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-06-05|||November 2005||2005-11-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|||||Observational|||Lactic Acid in the Rectum and Life-Threatening Infection|Does the Concentration of L-Lactate in the Rectum Correlate With Mortality and Morbidity in Patients With Septic Shock?|Completed||N/A|130|Actual|Herlev Hospital|||1||f||||||||||||||2017-10-11 05:33:39.143506|2017-10-11 05:33:39.143506
NCT00197951|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-20|||October 2004||2004-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism|Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology, Not Being a Severe Mental Disorder, Associated to Alcohol Dependence Disorder.|Completed||Phase 3|60||Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||||f||||t||||||||||2017-10-11 05:33:39.222935|2017-10-11 05:33:39.222935
NCT00197964|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-22|||August 2001||2001-08-01|November 2011|2011-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Randomized Trial to Improve Quality of Life Outcomes in Asthma Patients|A Randomized Trial to Improve Quality of Life Outcomes in Asthma Patients|Completed||N/A|180|Actual|Hospital for Special Surgery, New York|||||f||||f||||||||||2017-10-11 05:33:39.30295|2017-10-11 05:33:39.30295
NCT00197977|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-22|||November 2001||2001-11-01|November 2011|2011-11-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Addressing Patients' Expectations of Total Knee Arthroplasty in a Randomized Trial|Addressing Patients' Expectations of Total Knee Arthroplasty: Developing and Testing an Educational Intervention in a Randomized Trial|Completed||N/A|146|Actual|Hospital for Special Surgery, New York|||||f||||f||||||||||2017-10-11 05:33:39.380003|2017-10-11 05:33:39.380003
NCT00197990|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-22|||July 2003||2003-07-01|November 2011|2011-11-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Observational|||Expectations, Satisfaction and Quality of Life in Total Hip Arthroplasty|Expectations, Satisfaction and Quality of Life in Total Hip Arthroplasty|Completed||N/A|405|Actual|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-10-11 05:33:39.456061|2017-10-11 05:33:39.456061
NCT00198003|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-22|||November 2001||2001-11-01|November 2011|2011-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Addressing Patients' Expectations of Total Hip Arthroplasty in a Randomized Trial|Addressing Patients Expectations of Total Hip Arthroplasty: Developing and Testing an Educational Intervention in a Randomized Trial|Completed||N/A|178|Actual|Hospital for Special Surgery, New York|||||f||||f||||||||||2017-10-11 05:33:39.522766|2017-10-11 05:33:39.522766
NCT00198016|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-16|||January 2004||2004-01-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Coil Embolization of Coronary Artery Fistulas|Coil Embolization of Coronary Artery Fistulas: A Single Centre Experience|Completed||Phase 4|||HOSPITEN|||||f||||||||||||||2017-10-11 05:33:39.593717|2017-10-11 05:33:39.593717
NCT00198029|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-20|2013-01-31||October 2004||2004-10-01|March 2017|2017-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||The average baseline VAS for pain was 62(range 38-100), and DASH was 29.7 (range 1- 68). 53% had ≥ 1 previous corticosteroid injection. All patients had moderate or severe radiographic OA of the CMC joint: 59% were K+L Grade 4, 25% Grade 3, and 16% Grade 2. No patients had clinical evidence of carpal tunnel syndrome or DeQuervain’s tenosynovitis.|An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study|An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study|Completed||N/A|32|Actual|Hospital for Special Surgery, New York||1|||f||||t||||||||||2017-10-11 05:33:39.659754|2017-10-11 05:33:39.659754
NCT00198042|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-05-16|2017-03-20||June 2004||2004-06-01|May 2017|2017-05-01|December 31, 2015|Actual|2015-12-31|December 31, 2015|Actual|2015-12-31||Interventional|||Bone Tunnel Widening Following ACL Reconstruction|Bone Tunnel Widening Following ACL Reconstruction|Completed||N/A|18|Actual|Hospital for Special Surgery, New York||1|||f||||||||||||||2017-10-11 05:33:39.875141|2017-10-11 05:33:39.875141
NCT00198055|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-06-03|||January 2005||2005-01-01|June 2014|2014-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.|An Open-Label Study of Aripiprazole in Children and Adolescents With Autistic Disorder|Completed||Phase 2|25|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 05:33:41.756959|2017-10-11 05:33:41.756959
NCT00198068|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-08|||September 2003||2003-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|PROMISSE||Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)|Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)|Recruiting||N/A|700|Anticipated|Hospital for Special Surgery, New York|||4||f||||t||||||Samples With DNA|"     Serum, plasma, whole blood, RNA, urine   "|No|Because the investigative team is still analyzing the data for biomarkers and genetics, the authors are not willing to make the data public at this time. Published study results can be found under Publications on the ClinicalTrials.gov site for this study.|2017-10-11 05:33:41.848268|2017-10-11 05:33:41.848268
NCT00198081|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-02-26|2015-10-21||September 2005||2005-09-01|February 2016|2016-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)|A Phase II Trial of Celecoxib in Patients With IPMN|Terminated||Phase 2|8|Actual|Indiana University||2||Lack of funding and personnel to conduct study.|f||||t||||||||||2017-10-11 05:33:42.021074|2017-10-11 05:33:42.021074
NCT00198094|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-10-19|||December 2003||2003-12-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients|A Randomized Double-Blind Comparison of Sertraline With Early Alprazolam XR Co-Administration vs Sertraline/Placebo for Primary Care Panic Disorder Patients|Completed||Phase 4|150|Anticipated|Indiana University|||||f||||t||||||||||2017-10-11 05:33:42.650814|2017-10-11 05:33:42.650814
NCT00198120|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-04-08|||February 2004||2004-02-01|April 2016|2016-04-01|August 2010|Actual|2010-08-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Effectiveness of D-Cycloserine in Children With Autism|A Randomized Controlled Trial of D-Cycloserine in Autism|Completed||Phase 3|80|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 05:33:42.949529|2017-10-11 05:33:42.949529
NCT00198133|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-16|2015-12-16||January 2005||2005-01-01|December 2015|2015-12-01|May 2012|Actual|2012-05-01|December 2006|Actual|2006-12-01||Interventional|||Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma|Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma|Completed||Phase 2|27|Actual|Indiana University||1|||f||||||||||||||2017-10-11 05:33:43.096124|2017-10-11 05:33:43.096124
NCT00198146|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-10-25|||July 2000||2000-07-01|September 2005|2005-09-01||||||||Interventional|||Prevention of Diabetes Progression Trial (PDPT)|PD Initiated/Prevention of Diabetes Progression Trial (PDPT) ZEN119|Completed||Phase 2|40||Indiana University|||||||||||||||||||2017-10-11 05:33:44.013799|2017-10-11 05:33:44.013799
NCT00198159|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-09-18|||September 2002||2002-09-01|September 2014|2014-09-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|IUCRO-0021||A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR|A Phase II Study of ZD1839 (Iressa)in Chemotherapy Refractory Germ Cell Tumors Expressing Epidermal Growth Factor Receptor (EGFR)|Terminated||Phase 2|21||Indiana University|||||||||||||||||||2017-10-11 05:33:44.073455|2017-10-11 05:33:44.073455
NCT00198172|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2014-05-30|||October 2000||2000-10-01|May 2014|2014-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors|Phase II Study of Cisplatin Plus Epirubicin Salvage Chemotherapy in Refractory Germ Cell Tumors|Terminated||Phase 2|37||Indiana University||||Accrual Goal Met|f||||||||||||||2017-10-11 05:33:44.145181|2017-10-11 05:33:44.145181
NCT00198185|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-01-11|||January 2005||2005-01-01|September 2005|2005-09-01||||||||Interventional|||Cascade PRFM Study: The Evaluation of Cascade Platelet-Rich Fibrin Matrix (PRFM) on Rotator Cuff Healing|The Evaluation of Cascade PRFM on Rotator Cuff Healing|Unknown status|Recruiting|Phase 3|136||Hospital for Special Surgery, New York|||||f||||||||||||||2017-10-11 05:33:44.220819|2017-10-11 05:33:44.220819
NCT00198198|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-04-03|||August 2005||2005-08-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Aripiprazole Treatment of Bipolar Depression|Open Label Pilot Study of Aripiprazole Treatment of Difficult to Treat Bipolar Depression|Completed||Phase 4|10||Indiana University|||||f||||||||||||||2017-10-11 05:33:44.3105|2017-10-11 05:33:44.3105
NCT00198224|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2003||2003-01-01|November 2004|2004-11-01|May 2005||2005-05-01|||||Interventional|||Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients|Pilot Study of In Vitro Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients|Completed||N/A|50||Indiana University|||||f||||||||||||||2017-10-11 05:33:44.376204|2017-10-11 05:33:44.376204
NCT00198237|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-05-30|||March 2003||2003-03-01|May 2014|2014-05-01|December 2005||2005-12-01|||||Interventional|||Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer|Genomic and Proteomic Analysis of Docetaxel and Capecitabine as Primary Chemotherapy for Stage II-III Breast Cancer|Completed||Phase 2|40||Indiana University|||||f||||||||||||||2017-10-11 05:33:44.453432|2017-10-11 05:33:44.453432
NCT00198250|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-11-13|||May 2000||2000-05-01|November 2008|2008-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Venlafaxine for Hot Flashes After Breast Cancer|Venlafaxine for Hot Flashes After Breast Cancer|Completed||Phase 2|75|Actual|Indiana University||1|||f||||f||||||||||2017-10-11 05:33:44.530972|2017-10-11 05:33:44.530972
NCT00198263|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-27||2012-11-09|January 2004||2004-01-01|September 2017|2017-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer|An Open-Label Study Using the Medpulser® Electroporation System to Treat Head and Neck Cancer|Completed||Phase 4|95|Actual|Inovio Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:33:44.619353|2017-10-11 05:33:44.619353
NCT00198276|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-27||2013-04-24|February 2004||2004-02-01|September 2017|2017-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer|An Open-Label Study Using the MedPulser Electroporation System to Treat Cutaneous and Subcutaneous Foci of Cancer|Completed||Phase 4|88|Actual|Inovio Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:33:44.703126|2017-10-11 05:33:44.703126
NCT00198289|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-03-28|||April 2005||2005-04-01|March 2013|2013-03-01|June 2006||2006-06-01|||||Interventional|||Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs|A Phase IIa Dose Escalation Study to Assess Safety and Pharmacokinetics of Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs|Completed||Phase 2|30||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:33:44.824492|2017-10-11 05:33:44.824492
NCT00198302|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2013-03-28||||||March 2013|2013-03-01|February 2005||2005-02-01|||||Interventional|||Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)|A Phase II, Randomized, Double-blind, Multi-center Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)|Completed||Phase 2|60||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:33:44.967066|2017-10-11 05:33:44.967066
NCT00198315|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-27|||June 2004||2004-06-01|September 2017|2017-09-01|June 1, 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma|A Randomized Trial Comparing Preservation of Function Status After Either Medpulser Electroporation With Intratumoral Bleomycin Therapy or Surgery in Patients With Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Anterior Oral Cavity, Soft Palate, or Tonsil That Have Failed Primary Curative Therapy|Withdrawn||Phase 3|0|Actual|Inovio Pharmaceuticals||2||Enrollment was stopped based on the Data Monitoring Committee's recommendation.|f||||t||||||||||2017-10-11 05:33:45.125758|2017-10-11 05:33:45.125758
NCT00198328|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-09-27|||November 2004||2004-11-01|September 2017|2017-09-01|June 2007||2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma|A Randomized Trial Comparing Preservation of Function Status After Either Medpulser Electroporation With Intratumoral Bleomycin Therapy or Surgery in Patients With Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Base of the Tongue, Posterior Lateral Pharyngeal Wall, Hypopharynx, or Larynx That Have Failed Primary Curative Therapy|Suspended||Phase 3|200|Anticipated|Inovio Pharmaceuticals||2||Enrollment was stopped based on the Data Monitoring Committee's recommendation.|f||||t||||||||||2017-10-11 05:33:45.245091|2017-10-11 05:33:45.245091
NCT00198341|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-03-09|||January 2005||2005-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up|Multicentric Randomized Phase III Study of Post-Surgical NSCLC Follow-up|Active, not recruiting||Phase 3|1744|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||||||||||||2017-10-11 05:33:45.390482|2017-10-11 05:33:45.390482
NCT00198354|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-09|||May 2001||2001-05-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Stage I/II NSCLC Perioperative Chemotherapy|Phase III Trial Comparing 2 Chemotherapy Schedules (Preoperative vs Pre and Postoperative) in Stage I and II NSCLC|Completed||Phase 3|530|Actual|Intergroupe Francophone de Cancerologie Thoracique||4|||f||||t||||||||Undecided||2017-10-11 05:33:45.493139|2017-10-11 05:33:45.493139
NCT00198367|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-10|||January 2003||2003-01-01|May 2016|2016-05-01|July 2012|Actual|2012-07-01|January 2008|Actual|2008-01-01||Interventional|||Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)|Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) NSCLC. Randomized Phase II Study|Completed||Phase 2|120|Actual|Hospices Civils de Lyon||3|||f||||||||||||||2017-10-11 05:33:45.593076|2017-10-11 05:33:45.593076
NCT00198380|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-28|||April 2005||2005-04-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature|Phase II of Gefitinib (IRESSA) Administered as First-line Treatment in Patients With Non-resectable Pneumonic-type Adenocarcinoma (P-ADC)|Completed||Phase 2|90|Actual|Intergroupe Francophone de Cancerologie Thoracique||1|||f||||f||||||||||2017-10-11 05:33:45.696191|2017-10-11 05:33:45.696191
NCT00198393|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-28|||November 2004||2004-11-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV|Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV|Completed||Phase 2|126|Actual|Intergroupe Francophone de Cancerologie Thoracique||3|||f||||f||||||||||2017-10-11 05:33:45.814694|2017-10-11 05:33:45.814694
NCT00198406|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-01|||September 2002||2002-09-01|March 2017|2017-03-01|December 2005||2005-12-01|||||Observational|||A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.|A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.|Completed||N/A|1653||Intergroupe Francophone de Cancerologie Thoracique|||||f||||||||||||||2017-10-11 05:33:45.91339|2017-10-11 05:33:45.91339
NCT00198419|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-13|||March 2004||2004-03-01|March 2013|2013-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)|Clinical Evaluation of Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) Open Label, Normal Volunteer Study|Completed||Phase 1|65|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 05:33:45.972898|2017-10-11 05:33:45.972898
NCT00198432|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-09|||March 2002||2002-03-01|March 2016|2016-03-01|December 2006||2006-12-01|||||Interventional|||Chemoradiotherapy of NSCLC Stage IIIB|Randomized Phase II Study Evaluating an Induction Chemotherapy Followed by a Concomitant Chemoradiotherapy and a Concomitant Chemoradiotherapy Followed by a Consolidation Chemotherapy Among Patients With NSCLC Stage III Not Resectable|Completed||Phase 2|130||Intergroupe Francophone de Cancerologie Thoracique|||||f||||||||||||||2017-10-11 05:33:46.054468|2017-10-11 05:33:46.054468
NCT00198445|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-03-13|||May 2003||2003-05-01|March 2013|2013-03-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery|Efficacy and Safety of Topical Bromfenac Ophthalmic Solution, 0.1% vs. Placebo for Treatment of Ocular Inflammation Following Cataract Surgery|Completed||Phase 3|527|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 05:33:46.154211|2017-10-11 05:33:46.154211
NCT00198458|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-14|||July 2004||2004-07-01|March 2013|2013-03-01|September 2004|Actual|2004-09-01|July 2004|Actual|2004-07-01||Interventional|||Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)|Clinical Evaluation of Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase, 150 USP Units/mL) Open Label, Normal Volunteer Study|Completed||Phase 1|65||Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 05:33:46.321958|2017-10-11 05:33:46.321958
NCT00198471|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-13|||July 2005||2005-07-01|March 2013|2013-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment|An Open-label Assessment of Intravitreous Injections of Vitrase (Hyaluronidase for Injection) for Inducing Posterior Vitreous Detachment in Subjects With Moderate to Severe Non-proliferative Diabetic Retinopathy|Completed||Phase 2|10||Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 05:33:46.407079|2017-10-11 05:33:46.407079
NCT00198484|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-13|||October 2004||2004-10-01|March 2013|2013-03-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||Evaluation of Vitrase as a Spreading Agent|Evaluation of Vitrase (Hyaluronidase for Injection) Ovine, 200 USP Units/mL, as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Drugs Prior to Ocular Surgery|Completed||Phase 3|108|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 05:33:46.50451|2017-10-11 05:33:46.50451
NCT00198497|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-13|||June 1999||1999-06-01|March 2013|2013-03-01|June 2003|Actual|2003-06-01|September 2001|Actual|2001-09-01||Interventional|||Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage|Phase III Safety and Efficacy Study of Vitrase (Ovine Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage|Completed||Phase 3|510||Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 05:33:46.635737|2017-10-11 05:33:46.635737
NCT00208689|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-02-11|||January 2004||2004-01-01|February 2014|2014-02-01||||May 2006|Actual|2006-05-01||Observational|||Critical Congenital Heart Defect (CHD) Outcomes in Children|A Review of the Diagnosis, Treatment and Outcomes of Children With Critical Congenital Heart Defects|Terminated||N/A|150||Emory University|||||f||||||||||||||2017-10-11 05:37:26.273165|2017-10-11 05:37:26.273165
NCT00198510|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-14|||November 1998||1998-11-01|March 2013|2013-03-01|March 2003|Actual|2003-03-01|September 2001|Actual|2001-09-01||Interventional|||Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage|Phase III Safety and Efficacy Study of Vitrase (Ovine Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage|Completed||Phase 3|750||Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 05:33:46.888244|2017-10-11 05:33:46.888244
NCT00198523|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-13|||July 2005||2005-07-01|March 2013|2013-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte|A Multi-Center, Randomized, Double Masked, Bioequivalence Study of Tobramycin and Prednisolone Acetate (0.3/1.0%, ISTA) Ophthalmic Suspension Compared to PredForte (1.0% Prednisolone Acetate, Allergan) Ophthalmic Suspension|Completed||Phase 3|132||Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-10-11 05:33:47.271802|2017-10-11 05:33:47.271802
NCT00198536|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-13|||April 2005||2005-04-01|March 2013|2013-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome|Efficacy and Safety of Ecabet Ophthalmic Solution (2.83% and 3.70%) for Treatment of Dry Eye Syndrome|Completed||Phase 2/Phase 3|159|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-10-11 05:33:47.39914|2017-10-11 05:33:47.39914
NCT00198549|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-15|||September 2004||2004-09-01|March 2013|2013-03-01|March 2005|Actual|2005-03-01|January 2005|Actual|2005-01-01||Interventional|||Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics|Phase IV Post-Approval Evaluation of Vitrase as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Anesthetics for Ophthalmic Surgical Procedures|Completed||Phase 4|40|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-10-11 05:33:47.502107|2017-10-11 05:33:47.502107
NCT00198562|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-18|||April 2000||2000-04-01|April 2008|2008-04-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Hypertension Control Based on Home Blood Pressure|Hypertension Control Based on Home Systolic Pressure Study (HOSP Study)|Unknown status|Active, not recruiting|Phase 4|2600|Anticipated|Ministry of Health, Labour and Welfare, Japan||2|||f||||t||||||||||2017-10-11 05:33:47.589267|2017-10-11 05:33:47.589267
NCT00198575|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-02-15|||November 2004||2004-11-01|February 2006|2006-02-01|March 2006||2006-03-01|||||Observational|||A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients|A Multicenter, Prospective Cohort Study to Determine the Prevalence and Profile of Heparin-Induced Thrombocytopenia in Patients Undergoing Cardiovascular Surgery or Percutaneous Coronary Intervention|Unknown status|Active, not recruiting|N/A|1500||Ministry of Health, Labour and Welfare, Japan|||||f||||||||||||||2017-10-11 05:33:47.71602|2017-10-11 05:33:47.71602
NCT00198588|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-11-11|||June 2005||2005-06-01|November 2008|2008-11-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia|Open-Label Trial to Evaluate the Efficacy and Safety of the Use of Argatroban in Patients With Heparin-Induced Thrombocytopenia|Completed||Phase 3|8|Actual|Ministry of Health, Labour and Welfare, Japan||1|||f||||t||||||||||2017-10-11 05:33:47.82258|2017-10-11 05:33:47.82258
NCT00198601|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||August 2003||2003-08-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Determination of Gentamicin Dosing in Neonatal Patients|Determination of Gentamicin Dosing in Neonatal Patients for Use in the Uniject Pre-Filled Syringe [A Three-Site Study at: 1) Dhaka Shishu Hospital, Dhaka Bangladesh; 2) Christain Medical Center, Vellore, India; and 3) Aga Khan University Medical Center, Karachi, Pakistan]|Unknown status|Active, not recruiting|Phase 4|||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:47.951147|2017-10-11 05:33:47.951147
NCT00198614|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-02-28|||January 2005||2005-01-01|February 2007|2007-02-01||||||||Interventional|||Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery|A Comparison of the Effectiveness of Carvedilol Versus Metoprolol for Atrial Fibrillation Appearing After Off-Pump Coronary Bypass Surgery in the Carvedilol or Metoprolol Post-Revascularization Atrial Fibrillation Controlled Trial (COMPACT)|Completed||N/A|650||Ministry of Health, Labour and Welfare, Japan|||||f||||||||||||||2017-10-11 05:33:48.038312|2017-10-11 05:33:48.038312
NCT00198627|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-23|||December 2003||2003-12-01|April 2007|2007-04-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Etiology, Prevention and Treatment of Neonatal Infections in the Community|Etiology, Prevention, and Treatment of Neonatal Infections in the Community|Unknown status|Active, not recruiting|N/A|16359||Johns Hopkins Bloomberg School of Public Health|||||f||||t||||||||||2017-10-11 05:33:48.132472|2017-10-11 05:33:48.132472
NCT00198640|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-01||||||August 2005|2005-08-01||||||||Interventional|||AMR of Streptococcus Pneumoniae Carriage Strains|Antimicrobial Resistance of Streptococcus Pneumoniae Carriage Strains Among Bangladeshi Neonates: Epidemiology, Determinants and Risk Factors|Completed||N/A|||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:48.220806|2017-10-11 05:33:48.220806
NCT00198653|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-03|||March 2003||2003-03-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Newborn Thermal Care Practices: A Community Based Program to Prevent Hypothermia|Newborn Thermal Care Practices in Rural India: A Community Based Program to Prevent and Improve Recognition and Management of Hypothermia|Terminated||N/A|||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:48.296552|2017-10-11 05:33:48.296552
NCT00198666|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-01-09|||September 2003||2003-09-01|January 2015|2015-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Efficacy of Zinc in the Treatment of Pneumonia|Efficacy of Zinc in the Treatment of Pneumonia in Hospitalized Children Less Than 2 Years of Age|Completed||N/A|299|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 05:33:48.365941|2017-10-11 05:33:48.365941
NCT00198679|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-05-01|||March 2004||2004-03-01|May 2006|2006-05-01|March 2005||2005-03-01|||||Interventional|||Effect of Chlorhexidine Skin Cleansing on Skin Flora|Effect of Chlorhexidine Skin Cleansing on Skin Flora of Newborn Infants in Bangladesh|Unknown status|Active, not recruiting|Phase 4|210||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:48.43574|2017-10-11 05:33:48.43574
NCT00198692|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-27|||August 2003||2003-08-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Interventional|||Self-Management Program for Persons With Limb Loss|Randomized Clinical Trial of Self-Management Educational Program for Persons With Limb Loss.|Completed||N/A|500||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:48.502546|2017-10-11 05:33:48.502546
NCT00198705|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-09-12|||June 2003||2003-06-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|July 2007|Actual|2007-07-01||Interventional|||Community Based Interventions to Reduce Neonatal Mortality in Bangladesh|Community Based Interventions to Reduce Neonatal Mortality in Bangladesh|Completed||N/A|10670|Anticipated|Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:48.577517|2017-10-11 05:33:48.577517
NCT00198718|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-06|||November 1997||1997-11-01|March 2017|2017-03-01|May 2020|Anticipated|2020-05-01|May 2001|Actual|2001-05-01||Interventional|ZVITAMBO||Single-dose Postpartum Vitamin A Supplementation of Mothers and Neonates|Vitamin A Supplementation of Breast Feeding Mothers and Their Neonates at Delivery: Impact on Mother to Child Transmission of HIV During Lactation, HIV Infection Among Women During the Postpartum Year, and Infant Mortality.|Active, not recruiting||Phase 2|28220|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||||2017-10-11 05:33:48.651473|2017-10-11 05:33:48.651473
NCT00198731|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-07-13|||April 2005||2005-04-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Observational|||Evaluation of the Effects of Community-based Interventions|Evaluation of the Effects of Community-based Interventions on Maternal Morbidity in the Early Postpartum Period in Rural Bangladesh|Completed||N/A|1506|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||f||||||||||2017-10-11 05:33:48.806572|2017-10-11 05:33:48.806572
NCT00198744|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||June 2004||2004-06-01|January 2005|2005-01-01|June 2006||2006-06-01|||||Interventional|||Efficacy of Parent-Child Dieting Plans Incorporating Medifast Meal Replacements for Weight Loss||Completed||N/A|80||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:48.879168|2017-10-11 05:33:48.879168
NCT00198757|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||July 2002||2002-07-01|May 2005|2005-05-01|January 2005||2005-01-01|||||Interventional|||Efficacy of 2 Diet Plans Designed for People With Type II Diabetes on Weight and Health Measures|Efficacy of 2 Diet Plans Designed for People With Type II Diabetes on Weight and Health Measures|Completed||N/A|120||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:48.951684|2017-10-11 05:33:48.951684
NCT00198770|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-10-19|||March 2006||2006-03-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|Mush 1||Dietary Compensation With Substitution of Meat Products With White Button Mushrooms.|Does Substitution of Meat Products With White Button Mushrooms Have Potential for Weight Reduction? Studies of the Level of Short and Intermediate-term Caloric Compensation, Satiety, and Dietary Satisfaction Among Lean and Obese Men and Women.|Completed||N/A|55|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||||2017-10-11 05:33:49.025082|2017-10-11 05:33:49.025082
NCT00198783|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-03|||August 2005||2005-08-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Observational|||Real-Time Assessment of Food Craving, Use, and Triggers During Outpatient Treatment of Obesity: A Development and Feasibility Study|Real-Time Assessment of Food Craving, Use, and Triggers During Outpatient Treatment of Obesity: A Development and Feasibility Study|Completed||N/A|75||Johns Hopkins Bloomberg School of Public Health|||||f||||f||||||||||2017-10-11 05:33:49.10387|2017-10-11 05:33:49.10387
NCT00198796|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-07|||September 2005|Actual|2005-09-01|April 2017|2017-04-01|May 30, 2007|Actual|2007-05-30|February 22, 2007|Actual|2007-02-22||Interventional|||Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge Strains|Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic E. Coli (ETEC) Challenge Strains That Express Colonization Factors CS17 and CFA/I|Completed||Phase 1|5|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||||||||||No||2017-10-11 05:33:49.167991|2017-10-11 05:33:49.167991
NCT00198809|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||November 2002||2002-11-01|April 2004|2004-04-01|February 2004||2004-02-01|||||Interventional|||Use of Herbal Supplements in Weight Loss and Weight Maintenance|Use of Herbal Supplements in Weight Loss and Weight Maintenance|Terminated||N/A|250||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:49.248387|2017-10-11 05:33:49.248387
NCT00198822|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-05|2011-09-01||August 2001||2001-08-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|January 2007|Actual|2007-01-01||Interventional|||Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh|Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh|Completed||Phase 3|59666|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-10-11 05:33:49.323297|2017-10-11 05:33:49.323297
NCT00198835|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13||||||July 2005|2005-07-01||||||||Interventional|||Evaluation Research of the Nutrition Interventions in the INHP II Areas of CARE India|Evaluation Research of the Nutrition Interventions in the INHP II Areas of CARE India|Unknown status|Active, not recruiting|N/A|17000||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:49.705902|2017-10-11 05:33:49.705902
NCT00198848|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-06|||September 2005||2005-09-01|January 2006|2006-01-01|July 2007||2007-07-01|||||Interventional|||Iron Supplementation Among Adolescent Girls in India|Iron Supplementation Among Adolescent Girls in India|Unknown status|Recruiting|N/A|2800||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:33:49.773371|2017-10-11 05:33:49.773371
NCT00198861|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-01|||February 2002||2002-02-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Observational|||Neurobehavioral Model of HIV in Injection Drug Users|Neurobehavioral Model of HIV in Injection Drug Users|Completed||Phase 1|836|Actual|The City College of New York|||1||f||||f||||||||||2017-10-11 05:33:49.845346|2017-10-11 05:33:49.845346
NCT00198874|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-27|||January 2005||2005-01-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Interventional|||Youth Drug Abuse Family and Cognitive-Behavioral Therapy|Youth Drug Abuse Family and Cognitive-Behavioral Therapy|Completed||Phase 2|296|Actual|University of Florida||4|||f||||||||||||||2017-10-11 05:33:49.920546|2017-10-11 05:33:49.920546
NCT00205426|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-13|||August 2005||2005-08-01|October 2015|2015-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Natrecor for Pulmonary Hypertension in Lung Transplants|Natrecor® (Nesiritide) as a Nitric Oxide Sparing Agent in Patients Undergoing Lung Transplantation|Completed||Phase 4|7|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 05:33:50.006643|2017-10-11 05:33:50.006643
NCT00205439|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-09|||December 2001||2001-12-01|July 2015|2015-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Surveillance For New Lung Primaries|"Fluorescence Bronchoscopic Surveillance For New Lung Primaries After Curative Therapy for Squamous Cell Carcinoma of the Aerodigestive Tract"|Terminated||N/A|200|Anticipated|University of Wisconsin, Madison|||1|low accrual|f||||||||||||||2017-10-11 05:33:50.102226|2017-10-11 05:33:50.102226
NCT00205452|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-16|||June 2003||2003-06-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Quality of Life (QOL) Following Parathyroid Surgery|Does Quality of Life Improve Following Minimally Invasive Parathyroid Surgery?|Completed||N/A|200|Actual|University of Wisconsin, Madison|||1||f||||||||||||||2017-10-11 05:33:50.253424|2017-10-11 05:33:50.253424
NCT00205465|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-03|||December 2004||2004-12-01|December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765|A Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of VX-765 in Subjects With Chronic Plaque Psoriasis Requiring Systemic Therapy|Completed||Phase 2|64||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-10-11 05:33:50.319063|2017-10-11 05:33:50.319063
NCT00205478|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-05|||June 2005||2005-06-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702|A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo Controlled Study of Two Doses of VX-702 in Subjects With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 2|300||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-10-11 05:33:50.524887|2017-10-11 05:33:50.524887
NCT00205491|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-16|||October 2004||2004-10-01|March 2017|2017-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Pharmacological Intervention in Depression After Traumatic Brain Injury|Pharmacological Intervention in Depression After Traumatic Brain Injury (A Research Study Within the Traumatic Brain Injury Model System)|Completed||Phase 4|100|Anticipated|Virginia Commonwealth University|||||f||||||||||||||2017-10-11 05:33:50.693652|2017-10-11 05:33:50.693652
NCT00205517|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-01-07|||September 2002||2002-09-01|January 2013|2013-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Sedation and Psychopharmacology in Critical Care|Pharmacokinetics and Dynamics in Patients Randomized to Once Daily Awakening and Sedated According to Standardized Algorithm|Terminated||N/A|75|Actual|Virginia Commonwealth University||||End point reached at interim analysis|f||||||||||||||2017-10-11 05:33:51.561283|2017-10-11 05:33:51.561283
NCT00205530|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-29|||January 2003||2003-01-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Evaluation of an Intervention Model for Family Crisis and Support|Evaluation of an Intervention Model for Family Crisis and Support (a Research Project Within the Traumatic Brain Injury Model System Grant)|Completed||N/A|160|Actual|Virginia Commonwealth University|||1||f||||f||||||||||2017-10-11 05:33:51.661075|2017-10-11 05:33:51.661075
NCT00205543|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2012-06-19|||July 2004||2004-07-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Effects of Sutures on Results of Palate Surgery for Obstructive Sleep Apnea|Role of Suture Closure in Post-Operative Uvulopalatopharyngoplasty Outcomes|Completed||N/A|16|Actual|Virginia Commonwealth University||3|||f||||f||||||||||2017-10-11 05:33:51.817065|2017-10-11 05:33:51.817065
NCT00205569|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-16|||October 2002||2002-10-01|March 2017|2017-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation|Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation (a Research Project Within the Traumatic Brain Injury Model System Grant)|Completed||N/A|103|Actual|Virginia Commonwealth University|||1||f||||f||||||||||2017-10-11 05:33:52.152279|2017-10-11 05:33:52.152279
NCT00205582|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-03|||May 2001||2001-05-01|May 2001|2001-05-01|December 2004||2004-12-01|||||Interventional|||Excitatory Amino Acids and Activated Microglia After Traumatic Brain Injury: a (R)-[11C]PK11195 PET Study|The Role of Excitatory Amino Acids on Neuronal Damage and Outcome After Traumatic Brain Injury: Assessment in Patients Using Microdialysis and (R)-[11C]PK11195 Positron Emission Tomography|Unknown status|Active, not recruiting|Phase 1|20||VU University Medical Center|||||f||||||||||||||2017-10-11 05:33:52.245094|2017-10-11 05:33:52.245094
NCT00205595|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-07-03|||February 2001||2001-02-01|July 2008|2008-07-01|January 2007||2007-01-01|||||Interventional|||Normal Binding of R-[11C]PK11195 in Human Subjects|The Distribution and Quantification of Specific Binding of the Positron Emission Tomography Tracer R)-[11C]PK11195 in Normal Human Subjects|Unknown status|Active, not recruiting|Phase 1|40||VU University Medical Center|||||f||||||||||||||2017-10-11 05:33:52.329501|2017-10-11 05:33:52.329501
NCT00205608|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-25|||January 2004||2004-01-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|||Microglia Activation in Schizophrenia|Microglia Activation in Schizophrenia: a Pilot Study|Completed||Phase 1|20|Anticipated|VU University Medical Center||1|||f||||f||||||||||2017-10-11 05:33:52.407307|2017-10-11 05:33:52.407307
NCT00205621|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-07|||October 2005||2005-10-01|August 2005|2005-08-01|December 2009||2009-12-01|||||Interventional|||Positron Emission Tomography of Amyloid in Alzheimer's Disease|Positron Emission Tomography of Cerebral Amyloid Load as a Potential Diagnostic Marker for Pre-Symptomatic Alzheimer’s Disease.|Suspended||Phase 1|50||VU University Medical Center|||||f||||||||||||||2017-10-11 05:33:52.495313|2017-10-11 05:33:52.495313
NCT00205634|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-08-08|||December 2000|Actual|2000-12-01|August 2017|2017-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis|Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis|Completed||N/A|50||Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 05:33:52.582764|2017-10-11 05:33:52.582764
NCT00205647|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-01-04|||January 1997||1997-01-01|March 2000|2000-03-01|March 2000||2000-03-01|||||Interventional|||Study of Expectorant Activity of Oral N-Acetylcystein (NAC) in Patients With Stable Chronic Bronchitis|A Phase II Multicenter Efficacy, Safety and Dose-Effect Study of the Expectorant Activity of Oral N-Acetylcystein (NAC) in Patients With Stable, Chronic Bronchitis|Completed||Phase 2|240||Wake Forest University Health Sciences|||||f||||||||||||||2017-10-11 05:33:52.658509|2017-10-11 05:33:52.658509
NCT00205660|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-03-08|||February 2005||2005-02-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole|Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics|Completed||Phase 4|78|Actual|Washington University School of Medicine||4|||f||||f||||||||||2017-10-11 05:33:52.73502|2017-10-11 05:33:52.73502
NCT00205686|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-01-04|||April 2001||2001-04-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Effects of DHEA and Exercise in the Elderly|DHEA+Exercise-Effect on Sarcopenia and Osteopenia of Aging|Completed||Phase 3|64||Washington University School of Medicine|||||f||||||||||||||2017-10-11 05:33:52.879376|2017-10-11 05:33:52.879376
NCT00205712|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-12|2009-10-27||February 2003||2003-02-01|January 2016|2016-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids|Prevention of NMDA Antagonist-induced Psychosis and Memory Impairment in Children|Completed||Phase 4|40|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-10-11 05:33:53.059962|2017-10-11 05:33:53.059962
NCT00205725|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-03-12|||November 2000||2000-11-01|March 2014|2014-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Pfizer/IVGTT/Ziprasidone/Olanzapine|Glucose Regulation During Ziprasidone Treatment|Completed||N/A|120|Actual|Washington University School of Medicine|||||f||||f||||||||||2017-10-11 05:33:53.414738|2017-10-11 05:33:53.414738
NCT00205738|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-03-12|||July 2000||2000-07-01|March 2014|2014-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Janssen - Glucose Regulation/Risp/Olanz|Glucose Regulation During Risperidone and Olanzapine Treatment|Completed||N/A|120|Actual|Washington University School of Medicine|||||f||||f||||||||||2017-10-11 05:33:53.491795|2017-10-11 05:33:53.491795
NCT00205751|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-21|||August 2001||2001-08-01|November 2013|2013-11-01|October 2009|Actual|2009-10-01|||||Interventional|||Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy|International, Multi-center, Prospective, Double Randomized, Open Phase III Study Evaluating Thalidomide/Dexamethasone Versus Melphalan/Prednisone as Induction Therapy and Thalidomide/Interferon-alpha Versus Interferon-alpha as Maintenance Therapy in Newly Diagnosed Patients With Multiple Myeloma|Completed||Phase 2/Phase 3|350|Anticipated|Austrian Forum Against Cancer|||||f||||||||||||||2017-10-11 05:33:53.561749|2017-10-11 05:33:53.561749
NCT00205764|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-21|||March 1999||1999-03-01|November 2013|2013-11-01|October 2009|Actual|2009-10-01|||||Interventional|||Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy|Randomised, Non-blind, Parallel Group Study to Compare Tandem High Dose Melphalan (200mg/m²) Versus Triple Intermediate Dose Melphalan (100mg/m²) and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy in Newly Diagnosed Patients With Multiple Myeloma|Completed||Phase 3|212|Anticipated|Austrian Forum Against Cancer|||||f||||||||||||||2017-10-11 05:33:53.632741|2017-10-11 05:33:53.632741
NCT00205777|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-02-28|2012-12-31||December 2001||2001-12-01|February 2013|2013-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women|Fracture Incidence Reduction And Safety Of TSE-424 (Bazedoxifene Acetate) Compared To Placebo And Raloxifene In Osteoporotic Postmenopausal Women|Completed||Phase 3|7609|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:33:54.11337|2017-10-11 05:33:54.11337
NCT00205790|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-08-06|||February 2003||2003-02-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|||||Interventional|||GORE-TEX PROPATEN Vascular Graft Study|Comparison of Primary Patency Between GORE-TEX PROPATEN Vascular Grafts and Thin Walled GORE-TEX Stretch Vascular Grafts|Completed||N/A|200||W.L.Gore & Associates|||||f||||||||||||||2017-10-11 05:34:07.095303|2017-10-11 05:34:07.095303
NCT00205803|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2012-07-06|2010-03-26||September 2004||2004-09-01|July 2012|2012-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Study Evaluating Pneumococcal Vaccine in Healthy Infants|A Phase I/II, 2-stage, Randomized, Double-Blind Trial of the Safety, Tolerability and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine (Serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) in Healthy Infants|Completed||Phase 1/Phase 2|249|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||||||||||||||||2017-10-11 05:34:07.35987|2017-10-11 05:34:07.35987
NCT00205816|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-02-07|||January 2004||2004-01-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.|An Open-label, Noncomparative, Multi-center, Emergency Use Protocol Administering Tigecycline for the Treatment of Subjects With Infections Due to Resistant Pathogens.|Completed||Phase 3|26|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:34:10.697836|2017-10-11 05:34:10.697836
NCT00205829|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-31|||June 2004||2004-06-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|August 2007|Actual|2007-08-01||Interventional|||Bion for Occipital Nerve Stimulation|Bion for Occipital Nerve Stimulation|Completed||Phase 1/Phase 2|10|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 05:34:10.775949|2017-10-11 05:34:10.775949
NCT00205842|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-07|||June 2004||2004-06-01|January 2016|2016-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus|A Phase IIIb, Multicenter, Double-Blind, Placebo-Controlled, Parallel Study of Alvimopan for the Management of Opioid-Induced Postoperative Bowel Dysfunction/Postoperative Ileus|Completed||Phase 3|660||Cubist Pharmaceuticals LLC|||||f||||f||||||||||2017-10-11 05:34:10.84505|2017-10-11 05:34:10.84505
NCT00205855|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-26|2012-03-05||February 2003||2003-02-01|September 2012|2012-09-01|March 2005|Actual|2005-03-01|October 2003|Actual|2003-10-01||Interventional|||An Implantable Spinal Cord Stimulation Pain Management System|Stimulus Confirmatory Study - An Implantable Spinal Cord Stimulation Pain Management System|Completed||Phase 3|65|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 05:34:10.911607|2017-10-11 05:34:10.911607
NCT00205868|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-10|||December 2004||2004-12-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Spinal Cord Stimulation for Low Back Pain|Effectiveness of the Precision Spinal Cord Stimulation System in Patients With Failed Back Surgery Syndrome and Axial Low Back Pain|Completed||Phase 4|304|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 05:34:11.221413|2017-10-11 05:34:11.221413
NCT00205881|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-28|2011-09-29||October 2004||2004-10-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System|Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System|Completed||Phase 4|32|Actual|Advanced Bionics||1|||f||||f||||||||||2017-10-11 05:34:11.446037|2017-10-11 05:34:11.446037
NCT00205894|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-04|||January 2004||2004-01-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|October 2006|Actual|2006-10-01||Interventional|||Occipital Nerve Stimulation to Treat Chronic Headaches|Multicenter Feasibility Study of the Bion for Occipital Nerve Stimulation for Treatment of Chronic Headaches|Completed||Phase 1/Phase 2|20|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-10-11 05:34:11.739425|2017-10-11 05:34:11.739425
NCT00205907|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-27|||January 2005||2005-01-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|August 2006|Actual|2006-08-01||Interventional|||Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation|Phase 1/Phase 2 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema|Terminated||Phase 1/Phase 2|4|Actual|Aeris Therapeutics||1||Change in Formulation|f||||f||||||||||2017-10-11 05:34:11.850007|2017-10-11 05:34:11.850007
NCT00205920|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-01-14|||May 2005||2005-05-01|January 2010|2010-01-01|May 2007|Actual|2007-05-01|September 2006|Actual|2006-09-01||Interventional|||Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation|Dose Escalation Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema|Terminated||Phase 2|5|Actual|Aeris Therapeutics||1||Change in formulation|f||||f||||||||||2017-10-11 05:34:11.975912|2017-10-11 05:34:11.975912
NCT00205933|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-04|||April 2004||2004-04-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Observational|||Behavioral Processes Underlying Reward Processing in Depression|Behavioral Processes Underlying Reward Processing in Depression|Completed||N/A|78|Actual|Affective Neuroscience Laboratory|||1||f||||t||||||||||2017-10-11 05:34:12.101856|2017-10-11 05:34:12.101856
NCT00205946|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-04|||April 2005||2005-04-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity|The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity|Completed||Phase 1|32|Actual|Affective Neuroscience Laboratory||2|||f||||t||||||||||2017-10-11 05:34:12.205499|2017-10-11 05:34:12.205499
NCT00205959|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-06|||August 2002||2002-08-01|September 2005|2005-09-01|August 2006||2006-08-01|||||Interventional|||LPHP-Philos-PHN Conservative Treatment|Comparison of Standard Treatment Methods for Proximal Humerus Fractures|Completed||Phase 4|640||AO Clinical Investigation and Documentation|||||f||||||||||||||2017-10-11 05:34:12.320262|2017-10-11 05:34:12.320262
NCT00205972|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-19|||December 2000||2000-12-01|November 2007|2007-11-01|October 2004||2004-10-01|||||Interventional|||Non Randomized Humerusshaft Fracture|Comparison (Conservative Versus Operative) of Standardized Treatment for Defined Humerusshaft Fractures|Completed||Phase 4|300||AO Clinical Investigation and Documentation|||||f||||f||||||||||2017-10-11 05:34:12.402831|2017-10-11 05:34:12.402831
NCT00205985|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-11-16|||December 2003||2003-12-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Operative Versus Conservative Treatment of Scaphoid Fractures|Comparison of Time to Return to Previous Activity Between Operative Treatment and Cast Immobilization of Complete Fracture of the Middle Part of the Scaphoid Without Dislocation|Completed||Phase 4|100||AO Clinical Investigation and Documentation|||||f||||f||||||||||2017-10-11 05:34:12.477673|2017-10-11 05:34:12.477673
NCT00205998|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-26|||December 2001||2001-12-01|April 2007|2007-04-01|December 2005|Actual|2005-12-01|||||Interventional|||Surgical Plate Osteosynthesis of Distal Radius Fractures|Surgical Plate Osteosynthesis of Distal Radius Fractures. Prospective Study of the Locking Compression Plate (LCP)|Terminated||Phase 4|450|Actual|AO Clinical Investigation and Documentation||1||Study completed|f||||f||||||||||2017-10-11 05:34:12.546694|2017-10-11 05:34:12.546694
NCT00206011|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-01-29|||April 2003||2003-04-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||Open Versus Endoscopic Surgery of Craniomaxillofacial (CMF) Condylar Neck Fractures|Open Versus Endoscopic Surgery of Condylar Neck Fractures|Completed||Phase 4|134|Actual|AO Clinical Investigation and Documentation||2|||f||||f||||||||||2017-10-11 05:34:12.62431|2017-10-11 05:34:12.62431
NCT00206024|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-11-18|||November 2004||2004-11-01|November 2010|2010-11-01|July 2005|Actual|2005-07-01|||||Interventional|||Acid-Associated Heartburn Symptoms and Dose of Esomeprazole|A 4-week Study to Investigate the Relationship Between Resolution of Acid-Associated Heartburn Symptoms and Dose of Esomeprazole Magnesium|Completed||Phase 4|330||AstraZeneca|||||||||||||||||||2017-10-11 05:34:12.700685|2017-10-11 05:34:12.700685
NCT00206037|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-11-19|||May 2005||2005-05-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|||||Interventional|||Open Wedge High Tibia Osteotomy|Comparison of Open Wedge High Tibia Osteotomy Surgeries Using Colloss E and Tomofix and Tomofix Only, Regarding the Bone Healing|Terminated||Phase 4|49|Actual|AO Clinical Investigation and Documentation||2||Interim analysis showed significant results, thus study was stopped|f||||t||||||||||2017-10-11 05:34:12.809968|2017-10-11 05:34:12.809968
NCT00206050|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-01-20|||September 2004||2004-09-01|January 2011|2011-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po|A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of the 24-Hour Intragastric pH Profile After 5 Days of Once Daily Oral Administration of Either Esomeprazole 40 mg or Pantoprazole 40 mg Following Once Daily Infusion of Intravenous Pantoprazole 40 mg for 5 Days in Healthy Volunteer Subjects|Completed||Phase 4|40||AstraZeneca|||||||||||||||||||2017-10-11 05:34:12.88117|2017-10-11 05:34:12.88117
NCT00206063|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10|||August 1999||1999-08-01|November 2010|2010-11-01|April 2006|Actual|2006-04-01|June 2004|Actual|2004-06-01||Interventional|||Long Term Open Follow-up With H376/95 vs. Warfarin|Long-Term Treatment With the Oral Direct Thrombin Inhibitor Ximelagatran, Compared to Warfarin, as Stroke Prophylaxis in Patients With Atrial Fibrillation. A Long Term Follow-Up Study|Terminated||Phase 2|220||AstraZeneca||||"Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006   in the interest of patient safety."|f||||||||||||||2017-10-11 05:34:12.944783|2017-10-11 05:34:12.944783
NCT00206453|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-02-04|||January 2002||2002-01-01|February 2013|2013-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer|An Extension Phase II Study of the Clinical and Biologic Effects of Docetaxel (Taxotere) in Patients With Locally Advanced Breast Cancer|Terminated||Phase 2|25|Actual|Baylor Breast Care Center||1||accrual too difficult to meet|f||||||||||||||2017-10-11 05:34:24.453172|2017-10-11 05:34:24.453172
NCT00206076|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-31|2012-02-23||August 2006||2006-08-01|July 2013|2013-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation|CellCept (Mycophenolate Mofetil, MMF) Maintenance Immunosuppression in Liver Transplant Recipients With Long-term Follow-up Post-transplantation for Non-Autoimmune Liver Disease - A Prospective, Randomized, Multicenter Trial.|Completed||Phase 4|19|Actual|Albert Einstein Healthcare Network||2|||f||||f||||||||||2017-10-11 05:34:13.061101|2017-10-11 05:34:13.061101
NCT00206089|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-11|||September 2005||2005-09-01|November 2010|2010-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|EXTEND||Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events|"The EXTEND Study: A Randomized, Double-blind, Parallel-group, Phase III b, Multi-centre Study Evaluating Extended Prophylactic Treatment With Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events in Patients Undergoing Elective Hip Replacement or Hip Fracture Surgery."|Terminated||Phase 3|3300||AstraZeneca||||"Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006   in the interest of patient safety."|f||||||||||||||2017-10-11 05:34:13.388048|2017-10-11 05:34:13.388048
NCT00206102|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-01-08|2009-10-22||September 2003||2003-09-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder|A Multicenter, Open Label, Flexible-dose, Parallel-group Evaluation of the Cataractogenic Potential of Quetiapine Fumarate (Seroquel) and Risperidone (Risperdal) in the Long Term Treatment of Participants With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|1098|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 05:34:13.95422|2017-10-11 05:34:13.95422
NCT00206115|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-01-03|||November 2004||2004-11-01|January 2013|2013-01-01|December 2005|Actual|2005-12-01|||||Interventional|||SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia|A 6-week, Multicenter, Double-blind, Double-dummy, Randomized Comparison of the Efficacy & Safety of Sustained-Release Formulation Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia|Completed||Phase 3|535||AstraZeneca|||||f||||||||||||||2017-10-11 05:34:15.359419|2017-10-11 05:34:15.359419
NCT00206128|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-03|||November 2004||2004-11-01|January 2013|2013-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia|6-week Multicenter, Double-blind, Randomized, Parallel-group, Phase 3 Study to Evaluate the Feasibility of Switching From Immediate-release Quetiapine Fumarate (SEROQUEL) to Sustained-release Quetiapine Fumarate in Outpatients With Schizophrenia (Abbreviated)|Completed||Phase 3|454|Actual|AstraZeneca|||||f||||||||||||||2017-10-11 05:34:15.517941|2017-10-11 05:34:15.517941
NCT00206141|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-03|||August 2005||2005-08-01|January 2013|2013-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Seroquel in Bipolar Depression Versus Lithium|Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase 3 Study of the Efficacy & Safety of Quetiapine Fumarate & Lithium as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks & Quetiapine in Continuation (Abbreviated)|Completed||Phase 3|672||AstraZeneca|||||f||||||||||||||2017-10-11 05:34:15.708776|2017-10-11 05:34:15.708776
NCT00206154|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-26|||April 2005||2005-04-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|||||Interventional|||A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients|A 6-Month Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter Efficacy & Safety Study of SYMBICORT® pMDI 2 x 160/4.5 µg & 80/4.5 µg Bid Compared to Formoterol TBH, Budesonide pMDI (& the Combination) & Placebo in COPD Patients|Completed||Phase 3|1500|Anticipated|AstraZeneca|||||f||||||||||||||2017-10-11 05:34:15.912971|2017-10-11 05:34:15.912971
NCT00206167|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-26|||April 2005||2005-04-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|||||Interventional|||A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD|A 12-Month Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter Efficacy and Safety Study of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid Compared to Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD|Completed||Phase 3|1600||AstraZeneca|||||f||||||||||||||2017-10-11 05:34:16.650385|2017-10-11 05:34:16.650385
NCT00206180|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-03-25|||June 2004||2004-06-01|March 2009|2009-03-01|August 2005|Actual|2005-08-01|||||Interventional|||NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis|A Multicenter, Double-Blind, Randomized Trial of the Relationship of Intragastric Acid Control and Healing Status of Moderate and Severe Erosive Esophagitis After Treatment With Esomeprazole Magnesium (NEXIUM®) 10 mg and 40 mg Once Daily|Completed||Phase 4|120||AstraZeneca|||||||||||||||||||2017-10-11 05:34:17.198379|2017-10-11 05:34:17.198379
NCT00206193|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-29||||||September 2005|2005-09-01||||||||Observational|||Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone||Unknown status|Recruiting|Phase 2|||Atrium Medical Center|||||||||||||||||||2017-10-11 05:34:17.344489|2017-10-11 05:34:17.344489
NCT00206206|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-02-02|||July 2005||2005-07-01|September 2005|2005-09-01||||||||Interventional|||Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart|Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart.|Terminated||N/A|235||Atlantic Health System|||||f||||||||||||||2017-10-11 05:34:17.428883|2017-10-11 05:34:17.428883
NCT00206219|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-01-25|||November 2003||2003-11-01|January 2011|2011-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)|A Phase III Randomised, Stratified, Parallel-Group, Multi-Centre, Comparative Study of ZD1839 (Iressa®) 250 Mg and 500 Mg Versus Methotrexate for Previously Treated Patients With Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|477||AstraZeneca|||||||||||||||||||2017-10-11 05:34:17.511402|2017-10-11 05:34:17.511402
NCT00206232|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-15|||July 2004||2004-07-01|February 2013|2013-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Novel Treatment for Diastolic Heart Failure in Women|Novel Treatment for Diastolic Heart Failure in Women|Completed||Phase 4|48|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-10-11 05:34:17.773704|2017-10-11 05:34:17.773704
NCT00206908|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-20|||July 2002||2002-07-01|July 2015|2015-07-01||||||||Observational|||BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)|BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)|Completed||Phase 2/Phase 3|900||Biosite|||1||f||||||||||||||2017-10-11 05:34:30.60163|2017-10-11 05:34:30.60163
NCT00206245|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-03|||May 2004||2004-05-01|January 2013|2013-01-01|March 2005|Actual|2005-03-01|||||Interventional|||A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.|A Randomised, Double-blind, Multicentre Dose-finding Phase IIb Study for up to 8 Weeks' Treatment With AZD0865 25, 50, 75 mg and Esomeprazole 40 mg, Given Orally Once Daily for the Healing of Erosive Esophagitis in Adult Subjects With GERD With Erosive Esophagitis According to the LA Classification in Adult Subjects.|Completed||Phase 2|1400||AstraZeneca|||||||||||||||||||2017-10-11 05:34:18.014378|2017-10-11 05:34:18.014378
NCT00206258|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|||July 2002||2002-07-01|July 2016|2016-07-01|August 2005||2005-08-01|||||Interventional|||The Role of Amylin and Glucagon in T1DM|The Role of Amylin and Glucagon in the Management of Normalizing Glucose Excursions in Children With Type 1 Diabetes|Completed||Phase 3|30||Baylor College of Medicine|||||||||||||||||||2017-10-11 05:34:18.406762|2017-10-11 05:34:18.406762
NCT00206271|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 2001||2001-05-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Comparison of the Effect of Neck Collar, Act-as-Usual, and Active Mobilisation Early After a Whiplash Injury|A Randomized Early Intervention Study Comparing the Effect of Stiff Neck Collar, “Act-as-Usual” and Active Mobilisation on the One Year Outcome Following Whiplash Injury.|Completed||Phase 3|450||The Back Research Center, Denmark|||||f||||||||||||||2017-10-11 05:34:18.484768|2017-10-11 05:34:18.484768
NCT00206284|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2013-01-03|||May 2004||2004-05-01|January 2013|2013-01-01|April 2005|Actual|2005-04-01|||||Interventional|||A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.|A 4-week, Randomised, Double-blind, Multicentre, Dose-finding Phase IIb Study With AZD0865 25, 50, 75 mg and Esomeprazole 20 mg, Given Orally Once Daily for the Treatment of GERD Without Erosive Esophagitis According to the LA Classification in Adult Subjects.|Completed||Phase 2|1400||AstraZeneca|||||||||||||||||||2017-10-11 05:34:18.569208|2017-10-11 05:34:18.569208
NCT00206297|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-12|||October 2003||2003-10-01|July 2016|2016-07-01|February 2006||2006-02-01|||||Interventional|||The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes|The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes|Completed||Phase 3|20||Baylor College of Medicine|||||||||||||||||||2017-10-11 05:34:21.792447|2017-10-11 05:34:21.792447
NCT00206310|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2010-11-17|||September 2003||2003-09-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Crestor Versus Placebo in Subjects With Heart Failure|Controlled Rosuvastatin Multinational Study in Heart Failure CORONA A Randomized, Double-Blind, Placebo Controlled Phase III Study With Rosuvastatin in Subjects With Chronic Symptomatic Systolic Heart Failure|Completed||Phase 3|5013||AstraZeneca|||||f||||||||||||||2017-10-11 05:34:21.948526|2017-10-11 05:34:21.948526
NCT00206349|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-07-12|||June 2004||2004-06-01|July 2016|2016-07-01|May 2005||2005-05-01|||||Observational|||Ability to Cope With Type 1 Diabetes|Evaluation of Coping Skills in Type 1 Diabetes|Completed||Phase 4|220||Baylor College of Medicine|||||f||||||||||||||2017-10-11 05:34:23.213154|2017-10-11 05:34:23.213154
NCT00206362|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-07-19|||July 2004||2004-07-01|July 2016|2016-07-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Observational|||Ability to Cope With Type 1 Diabetes|Evaluation of Ongoing Management of Type 1 Diabetes|Completed||Phase 4|100|Actual|Baylor College of Medicine|||1||f||||f||||||||No||2017-10-11 05:34:23.28019|2017-10-11 05:34:23.28019
NCT00206375|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-18|||May 2003||2003-05-01|September 2015|2015-09-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism|Concomitant Use of Growth Hormone and GnRH Agonist in Adolescent Patients With Acquired Hypothyroidism|Completed||Phase 4|21|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-10-11 05:34:23.343654|2017-10-11 05:34:23.343654
NCT00206388|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-08-01|||April 2005||2005-04-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|April 2008|Actual|2008-04-01||Interventional|||Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement|A Phase I Study of Zoledronic Acid (Zometa) With Cyclophosphamide in Children With Recurrent or Refractory Neuroblastoma and Cortical Bone Involvement (NANT 2004-01)|Completed||Phase 1|21|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 05:34:23.560978|2017-10-11 05:34:23.560978
NCT00206401|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-07-12|||November 2004||2004-11-01|July 2016|2016-07-01|October 2006||2006-10-01|||||Interventional|||Lantus in the Treatment of Type 1 Diabetes Children|Conventional Insulin Therapy Vs Intensive Insulin Management In Children With Type 1 Diabetes Mellitus|Completed||Phase 4|60||Baylor College of Medicine|||||f||||||||||||||2017-10-11 05:34:23.677485|2017-10-11 05:34:23.677485
NCT00206414|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-04|||January 2003||2003-01-01|February 2013|2013-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer|Arimidex/Faslodex/Iressa Study: A Phase II Trial of Primary Systemic Therapy Using a Combination of Arimidex, Faslodex and Iressa (Gefitinib) in Postmenopausal Women With Hormone Receptor Positive Breast Cancer|Terminated||Phase 2|15|Actual|Baylor Breast Care Center||2||Difficulty accruing subjects the study accrual was closed|f||||t||||||||||2017-10-11 05:34:23.757861|2017-10-11 05:34:23.757861
NCT00206427|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-07-26|2012-02-03||August 2004||2004-08-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Interventional|GW||Neoadjuvant GW572016 to Treat Breast Cancer|A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study|Completed||Phase 2|49|Actual|Baylor Breast Care Center||1|||f||||t||||||||||2017-10-11 05:34:23.866186|2017-10-11 05:34:23.866186
NCT00206440|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-27|2012-02-01||August 2005||2005-08-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2009|Actual|2009-02-01||Interventional|NEXIUM||Nexium Study To Suppress Nausea During Chemotherapy|Evaluation of the Efficacy of Esomeprazole in Suppressing Nausea and Vomiting in Patients Undergoing Chemotherapy for Breast Cancer|Terminated||Phase 3|43|Actual|Baylor Breast Care Center||2||Accrual was not optimized|f||||t||||||||||2017-10-11 05:34:24.1261|2017-10-11 05:34:24.1261
NCT00206466|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-01-24|||April 2002||2002-04-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|April 2006|Actual|2006-04-01||Interventional|TAX/AC||Biologic Correlative Taxotere/AC|A Randomized Multicenter Trial of Neoadjuvant Taxotere and Adriamycin/Cytoxan(AC): A Biologic Correlative Study|Completed||Phase 2|70|Actual|Baylor Breast Care Center||1|||f||||||||||||||2017-10-11 05:34:24.528795|2017-10-11 05:34:24.528795
NCT00206492|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-07-28|||July 2003||2003-07-01|July 2017|2017-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients|A Neoadjuvant Phase II Trial of ZD1839 (Iressa) and Tamoxifen in Inoperable Locally Advanced HER2-Overexpressing, ER-Positive Breast Cancer Patients: Biologic Correlative Study (AZ #1839US/0303)|Terminated||Phase 2|3|Actual|Baylor Breast Care Center||1||halted by the PI only 3 of 45 subjects were accrued.|f||||f||||||||||2017-10-11 05:34:24.617412|2017-10-11 05:34:24.617412
NCT00206505|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-11-16|||January 1999||1999-01-01|November 2011|2011-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Neoadjuvant Taxotere|A PHASE II STUDY OF THE CLINICAL AND BIOLOGIC EFFECTS OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER|Completed||Phase 2|40||Baylor Breast Care Center|||||f||||f||||||||||2017-10-11 05:34:24.701135|2017-10-11 05:34:24.701135
NCT00206518|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-05-08|2017-02-02||September 2004||2004-09-01|May 2017|2017-05-01|September 2017|Anticipated|2017-09-01|October 2016|Actual|2016-10-01||Interventional|TACAC||Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients|A Randomized Multicenter Trial of Neoadjuvant Taxotere (T) and Adriamycin/Cytoxan (Ac): A Validation|Active, not recruiting||Phase 2|167|Actual|Baylor Breast Care Center||2|||f||||t||||||||No||2017-10-11 05:34:24.797853|2017-10-11 05:34:24.797853
NCT00206531|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-03||||||June 2005|2005-06-01||||||||Observational|||The Role of Naive T-Cells in HIV Pathogenesis|Role of Naive T-Cells in the Pathogenesis of T-Cell Decline and Long Term Persistence of HIV|Unknown status|Recruiting|N/A|75||Bayside Health|||||f||||||||||||||2017-10-11 05:34:25.155535|2017-10-11 05:34:25.155535
NCT00206544|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-10-23|||January 2004||2004-01-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?|Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?|Completed||Phase 2|51|Actual|The Alfred||3|||f||||||||||||||2017-10-11 05:34:25.223003|2017-10-11 05:34:25.223003
NCT00206557|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-20|||October 2002||2002-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study|The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study|Completed||Phase 2|60||The Alfred|||||f||||||||||||||2017-10-11 05:34:25.315521|2017-10-11 05:34:25.315521
NCT00206570|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-02-02|||January 2001||2001-01-01|February 2015|2015-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Clinical Estradiol Trial in Women With Schizophrenia|Double Blind Study of Estradiol Plus Neuroleptic Versus Placebo Plus Neuroleptic in the Treatment of Psychotic Symptoms in Women With Schizophrenia|Completed||Phase 2|100|Anticipated|Bayside Health|||||f||||||||||||||2017-10-11 05:34:25.405076|2017-10-11 05:34:25.405076
NCT00206583|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-09-30|||March 2005||2005-03-01|September 2014|2014-09-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety Study of an Oral Contraceptive in Healthy Females|A Multicenter, Open-label Uncontrolled Study to Investigate the Efficacy and Safety of a 4-phasic Oral Contraceptive SH T0065 in a 28-day Regimen for 13 Cycles in Healthy Female Subjects|Completed||Phase 3|499|Actual|Bayer||1|||f||||f||||||||||2017-10-11 05:34:25.491216|2017-10-11 05:34:25.491216
NCT00206596|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-12-02|||July 2003||2003-07-01|December 2013|2013-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease|Randomized, Stratified, Double-Blind, Placebo-Controlled Phase 2 Study of Steroid-Sparing Properties of Sargramostim (Leukine) Therapy in Patients With Cortico-Dependent Crohn's Disease|Completed||Phase 2|127|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:34:25.753528|2017-10-11 05:34:25.753528
NCT00206609|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2005-09-18|||November 2000||2000-11-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer|A Randomised, Double-Blind Cross-Over Trial of the Effect of Oxygen on Dyspnoea in Patients With Advanced Cancer|Completed||Phase 3|50||Bayside Health|||||f||||||||||||||2017-10-11 05:34:25.869866|2017-10-11 05:34:25.869866
NCT00206622|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-05-28|||December 2004||2004-12-01|May 2009|2009-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Comparing a 2.2mg 17 Beta-Estradiol/0.69mg Levonorgestrel Combination Transdermal Patch, and a 1mg 17 Beta-Estradiol Transdermal Patch With a Placebo Patch in Postmenopausal Women to Determine the Lowest Effective Dose of Estradiol for the Relief of Moderate to Severe Hot Flushes|Completed||Phase 4|425|Actual|Bayer||3|||f||||||||||||||2017-10-11 05:34:25.960575|2017-10-11 05:34:25.960575
NCT00206635|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-11-21|||January 2005||2005-01-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|||||Observational|||Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis|A Long-term Follow up of Patients Enrolled in the Pivotal Study of Betaseron® (Interferon Beta 1b) in Relapsing-remitting Multiple Sclerosis|Completed||N/A|432|Actual|Bayer|||1||f||||f||||||Samples With DNA|"     Whole blood, serum   "|||2017-10-11 05:34:26.142514|2017-10-11 05:34:26.142514
NCT00206648|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-30|||March 2003||2003-03-01|December 2014|2014-12-01|October 2005|Actual|2005-10-01|||||Interventional|ABOVE||An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS|A Randomized, Rater-blinded, Multicenter, Parallel-group Study Comparing the Efficacy and Safety of Betaseron 250 µg Subcutaneously Every Other Day With Avonex 30 µg Intramuscularly Once Per Week in Relapsing-remitting Multiple Sclerosis Patients Previously Treated With Avonex|Completed||Phase 4|271|Actual|Bayer||2|||f||||t||||||||||2017-10-11 05:34:26.260371|2017-10-11 05:34:26.260371
NCT00206661|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-12-02|||December 2004||2004-12-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease|Phase 1/2 Safety, Pharmacokinetic, and Pharmacodynamic Study of Sargramostim (Leukine®) in Pediatric Patients With Active Crohn's Disease, With One-year Surveillance and Retreatment Extension|Terminated||Phase 1/Phase 2|22|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:34:26.451721|2017-10-11 05:34:26.451721
NCT00206674|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-02|||September 2004||2004-09-01|December 2013|2013-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease|Phase 3 Randomized, Double-Blind, Placebo Controlled Induction Study of Sargramostim (Leukine®) in Patients With Active Crohn's Disease|Completed||Phase 3|286|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:34:26.582424|2017-10-11 05:34:26.582424
NCT00206687|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-23||2015-09-23|January 2003||2003-01-01|November 2014|2014-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||STEPS Trial - Spheramine Safety and Efficacy Study|Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease|Terminated||Phase 2|71|Actual|Bayer||2||Study was completed, only life long extended follow-up phase was discontinued after 12 years.|f||||t||||||||||2017-10-11 05:34:26.836688|2017-10-11 05:34:26.836688
NCT00206700|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-02|||February 2003||2003-02-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Open-label Trial of Leukine in Active Crohn's Disease|Open-label Trial of Leukine® (Sargramostim), A Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF), in Active Crohn's Disease|Terminated||Phase 2|378|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:34:26.993667|2017-10-11 05:34:26.993667
NCT00206713|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-02|||July 2004||2004-07-01|December 2013|2013-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim|Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Retreatment Study of Sargramostim (Leukine®) in Patients With Active Crohn's Disease and Prior Treatment Response to Sargramostim|Terminated||Phase 3|264|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:34:28.040288|2017-10-11 05:34:28.040288
NCT00206726|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-07-27|2009-11-19||May 2005||2005-05-01|July 2016|2016-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|ECO-1||Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)|Phase II Study Using Alemtuzumab Combined With Fludarabine for the Treatment of Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)|Completed||Phase 2|60|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:34:28.202215|2017-10-11 05:34:28.202215
NCT00206739|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-29|||January 2003||2003-01-01|September 2005|2005-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants|Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infant: a Randomized, Double-blind, and Placebo-controlled Clinical Trial|Completed||Phase 4|1070|Actual|Bernhard Nocht Institute for Tropical Medicine||2|||f||||t||||||||||2017-10-11 05:34:29.435552|2017-10-11 05:34:29.435552
NCT00206752|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-27|||August 2004||2004-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Unilateral||Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck|A Randomized Prospective Evaluation of Unilateral/Ipsilateral Neck Irradiation in Selected Patients With Squamous Cell Carcinoma of the Head and Neck Who Are Managed by Radiation Therapy|Completed||N/A|45|Actual|Beth Israel Medical Center||1|||f||||||||||||||2017-10-11 05:34:29.576492|2017-10-11 05:34:29.576492
NCT00206765|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-19|||January 2003||2003-01-01|October 2012|2012-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Risperidone vs. Paroxetine for Panic Attacks|A Single-blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks|Terminated||Phase 2|90|Anticipated|Beth Israel Medical Center|||||f||||||||||||||2017-10-11 05:34:29.705422|2017-10-11 05:34:29.705422
NCT00206778|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2010-11-24|||July 2003||2003-07-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania|A Randomized Open-Label 6 Month Acute and Maintenance Trial of Lamotrigine vs. Standard of Care Sodium Valproate Monotherapy for Treatment of Mixed Mania.|Completed||Phase 2|36|Anticipated|Beth Israel Medical Center|||||f||||||||||||||2017-10-11 05:34:29.779419|2017-10-11 05:34:29.779419
NCT00206791|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-25|||May 2006||2006-05-01|October 2006|2006-10-01|May 2008||2008-05-01|||||Interventional|||Osteoconduction Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects|Study of Osteoconduction Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects From Various Origins|Unknown status|Recruiting|N/A|12||Biomatlante|||||f||||||||||||||2017-10-11 05:34:29.847582|2017-10-11 05:34:29.847582
NCT00206817|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-20|||October 2003||2003-10-01|July 2015|2015-07-01||||||||Interventional|||Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)|Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)|Withdrawn||Phase 4|0|Actual|Biosite|||||f||||||||||||||2017-10-11 05:34:29.934311|2017-10-11 05:34:29.934311
NCT00206830|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-23|||April 2005||2005-04-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||SHORTness of Breath In the Emergency Department (SHORTIE)|SHORTness of Breath In the Emergency Department (SHORTIE)|Completed||Phase 2/Phase 3|306||Biosite||2|||f||||||||||||||2017-10-11 05:34:30.012838|2017-10-11 05:34:30.012838
NCT00206843|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-07-23|||November 2004||2004-11-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)|Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)|Completed||N/A|630|Actual|Biosite||2|||f||||f||||||||||2017-10-11 05:34:30.101012|2017-10-11 05:34:30.101012
NCT00206856|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-26|||July 2003||2003-07-01|July 2013|2013-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)|Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)|Terminated||Phase 4|720||Biosite||||Slow enrollment|f||||f||||||||||2017-10-11 05:34:30.191746|2017-10-11 05:34:30.191746
NCT00206869|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-10|||January 2003||2003-01-01|December 2002|2002-12-01||||||||Interventional|||Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria||Unknown status|Recruiting|N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:34:30.300907|2017-10-11 05:34:30.300907
NCT00206882|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-10|||September 2005||2005-09-01|August 2005|2005-08-01||||||||Interventional|||The Sun Protection Effect and Efficacy in Treatment of Sunburn Using Topical Corticosteroids.||Unknown status|Recruiting|N/A|20||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:34:30.478198|2017-10-11 05:34:30.478198
NCT00206895|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-10|||November 2004||2004-11-01|October 2004|2004-10-01||||||||Interventional|||Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study||Completed||N/A|24||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:34:30.544234|2017-10-11 05:34:30.544234
NCT00206921|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-23|||February 2005||2005-02-01|December 2004|2004-12-01|August 2005||2005-08-01|||||Interventional|||Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness|Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness|Unknown status|Recruiting|N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:34:30.690257|2017-10-11 05:34:30.690257
NCT00206934|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-16|||March 2005||2005-03-01|July 2008|2008-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||The Effects of Increased Central Serotonergic Activity on Information Processing|The Effects of Increased Central Serotonergic Activity on Psychophysiological Parameters of Human Information Processing|Completed||N/A|40|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 05:34:30.74999|2017-10-11 05:34:30.74999
NCT00206947|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-09-19|||December 2002||2002-12-01|July 2008|2008-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia|PHARMACOLOGICAL TREATMENT OF COGNITIVE DEFICITS IN SCHIZOPHRENIC PATIENTS: The Effects of Central Cholinergic Augmentation on Cognitive Deficits and Psychopathology|Terminated||Phase 2|50|Anticipated|University of Copenhagen||2||No more funding|f||||f||||||||||2017-10-11 05:34:30.831899|2017-10-11 05:34:30.831899
NCT00206960|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-09-16|||January 1998||1998-01-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia|Effects of Classical and Atypical Antipsychotics on Dopamine Receptor Binding of 123I-epidepride, Cognition, Startle Response and Extrapyramidal Side-effects in Drug-naive First-episode Schizophrenic Patients|Completed||N/A|56|Actual|University of Copenhagen||2|||f||||f||||||||||2017-10-11 05:34:31.035423|2017-10-11 05:34:31.035423
NCT00206973|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics.|Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics|Unknown status|Recruiting|N/A|40||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:34:31.201086|2017-10-11 05:34:31.201086
NCT00206986|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-12-19|||May 2005||2005-05-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?|Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?|Completed||N/A|40|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-10-11 05:34:31.331131|2017-10-11 05:34:31.331131
NCT00206999|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2011-09-19|||September 2004||2004-09-01|September 2011|2011-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||The Effect of Imipramine on Early Information Processing|Early Information Processing in Healthy Controls: Studies on the Relation Between Two Different Paradigms (PPI and P50ERP) and Effects of Pharmacological Interventions|Completed||N/A|20|Actual|University of Copenhagen||1|||f||||f||||||||||2017-10-11 05:34:31.457608|2017-10-11 05:34:31.457608
NCT00207012|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-02-27||2010-02-27|May 2004||2004-05-01|January 2009|2009-01-01||||February 2006|Actual|2006-02-01||Interventional|||MAD Refractory: Solid Tumor QD w/o Break|Continuous Dosing Phase I Study of BMS-599626 in Patients With HER2-Expressing Advanced Solid Malignancies|Completed||Phase 1|45||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 05:34:31.55784|2017-10-11 05:34:31.55784
NCT00207025|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-02-27||2010-02-27|October 2004||2004-10-01|July 2008|2008-07-01||||February 2007|Actual|2007-02-01||Interventional|||A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies|A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies|Terminated||Phase 1|60||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:34:31.6328|2017-10-11 05:34:31.6328
NCT00207038|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-02-10|||September 2005||2005-09-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|||||Observational|||Airway Inflammation in Swimmers|Airway Inflammation in Swimmers: Development and Risk Factors|Completed||N/A|90|Anticipated|Bispebjerg Hospital|||1||f||||||||||Samples Without DNA|"     Blood samples EBC Sputum   "|||2017-10-11 05:34:31.733852|2017-10-11 05:34:31.733852
NCT00207051|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-01-24|||January 2006||2006-01-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies|Phase I Dose Escalation Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-582664 in Combination With Full Dose Erbitux in Patients With Advanced Gastrointestinal Malignancies Who Have Failed Prior Therapy|Completed||Phase 1|62|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-10-11 05:34:31.846507|2017-10-11 05:34:31.846507
NCT00207064|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-09-16|||April 2004||2004-04-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia|5-HT2A-receptor Binding: Implications for the Pathophysiology of Schizophrenia and Effects of Treatment With Antipsychotic Drugs|Completed||N/A|46|Actual|University of Copenhagen||1|||f||||f||||||||||2017-10-11 05:34:32.009392|2017-10-11 05:34:32.009392
NCT00207077|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-26|||August 2005||2005-08-01|October 2015|2015-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors|A Phase I Study of Cetuximab in Combination With Erlotinib in Patients With Advanced Solid Malignancies|Completed||Phase 1|33|Anticipated|Eli Lilly and Company||1|||f||||||||||||||2017-10-11 05:34:32.171197|2017-10-11 05:34:32.171197
NCT00207090|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-02-09|2010-09-03||September 2005||2005-09-01|February 2016|2016-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer|Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer|Completed||Phase 1|19|Actual|R-Pharm||1|||f||||f||||||||||2017-10-11 05:34:32.317329|2017-10-11 05:34:32.317329
NCT00207103|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-11-03|||September 2004||2004-09-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|October 2007|Actual|2007-10-01||Interventional|||MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors|Phase I Dose Escalation Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|68|Actual|Bristol-Myers Squibb||6|||f||||f||||||||||2017-10-11 05:34:34.045893|2017-10-11 05:34:34.045893
NCT00207116|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-26|||September 2005||2005-09-01|October 2015|2015-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma|An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma|Completed||Phase 1|120||Eli Lilly and Company||1|||f||||||||||||||2017-10-11 05:34:34.183599|2017-10-11 05:34:34.183599
NCT00207129|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-01-27|||October 2004||2004-10-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies|Effect of Capecitabine on the Pharmacokinetics of BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies|Completed||Phase 1|25||R-Pharm||2|||f||||||||||||||2017-10-11 05:34:34.277295|2017-10-11 05:34:34.277295
NCT00207142|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2010-01-07|2009-06-02||November 2005||2005-11-01|January 2010|2010-01-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Interventional|INDUMA||Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)|A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase With Unboosted vs. Boosted Reyataz After an Induction Phase With Reyataz and Ritonavir in Treatment Naive HIV Patients (the INDUMA Study)|Completed||Phase 4|252|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-10-11 05:34:34.406517|2017-10-11 05:34:34.406517
NCT00207155|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-10-26|||December 2003||2003-12-01|October 2015|2015-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer|An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer|Completed||Phase 1|110||Eli Lilly and Company||1|||f||||||||||||||2017-10-11 05:34:35.622865|2017-10-11 05:34:35.622865
NCT00207168|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-08||2010-02-03|April 2004||2004-04-01|April 2011|2011-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine|A Randomized, Multi-center, Open Label Study in Well Controlled Treatment-experienced HIV- Infected Patients to Assess Compliance With a Once-daily Regimen|Completed||Phase 4|120||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 05:34:35.722818|2017-10-11 05:34:35.722818
NCT00207181|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-30|||May 2005||2005-05-01|June 2011|2011-06-01|January 2007|Actual|2007-01-01|||||Observational|||The Development and Testing of an Electronic Tool to Measure Physical Activity in Domestic Settings|Context Sensitive Measurement of Physical Activity|Completed||Phase 1|40|Actual|Boston Medical Center|||1||f||||f||||||||||2017-10-11 05:34:35.781857|2017-10-11 05:34:35.781857
NCT00207194|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-06-15|||October 2001||2001-10-01|June 2016|2016-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Interactive Multirisk-Factor Intervention for Hypertension (HTN) Blacks|Interactive Multirisk-Factor Intervention for HTN Blacks|Completed||N/A|337|Actual|Boston Medical Center||2|||f||||t||||||||||2017-10-11 05:34:35.857607|2017-10-11 05:34:35.857607
NCT00207207|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-10|||July 2003||2003-07-01|February 2009|2009-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control|Randomized Trial to Assess the Effect of Using Alternate Site Blood Glucose Testing Versus Finger-Tip Testing on Long-Term Glycemic Control.|Completed||Phase 1|174||Boston Medical Center|||||f||||f||||||||||2017-10-11 05:34:35.937734|2017-10-11 05:34:35.937734
NCT00207220|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-07|||January 2004||2004-01-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Observational|||Ventricular-Vascular Coupling in Heart Failure|Ventricular-Vascular Coupling in Patients With Heart Failure and Preserved Ejection Fraction|Completed||N/A|53|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-10-11 05:34:36.010981|2017-10-11 05:34:36.010981
NCT00207233|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-01-24|||July 2004||2004-07-01|February 2009|2009-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients|Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients 2002-292G|Completed||Phase 1/Phase 2|42|Anticipated|Boston Medical Center||2|||f||||f||||||||||2017-10-11 05:34:36.084403|2017-10-11 05:34:36.084403
NCT00207259|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-07-11|||March 2005||2005-03-01|July 2017|2017-07-01|June 15, 2017|Actual|2017-06-15|June 15, 2017|Actual|2017-06-15||Interventional|||Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial|Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial|Completed||N/A|60|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-10-11 05:34:36.28554|2017-10-11 05:34:36.28554
NCT00207272|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-05-22|||July 2003||2003-07-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Use of MCT Oil for Enhancement of Weight Loss in Obese Patients|Use of MCT Oil for Enhancement of Weight Loss in Obese Patients-Preliminary Phase 2002-291G|Completed||N/A|24|Anticipated|Boston Medical Center|||||f||||||||||||||2017-10-11 05:34:36.402677|2017-10-11 05:34:36.402677
NCT00207285|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-15|||May 2005||2005-05-01|March 2016|2016-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Sleep Disorders Management, Health and Safety in Police|Sleep Disorders Management, Health and Safety in Police|Completed||N/A|731|Actual|Brigham and Women's Hospital||3|||f||||||||||||||2017-10-11 05:34:36.509193|2017-10-11 05:34:36.509193
NCT00207298|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-03|||June 2005||2005-06-01|November 2010|2010-11-01|November 2008||2008-11-01|||||Interventional|||18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology|Phase III Open Label Trial for Use of [18F]-Fluoro-Deoxy-Glucose (18F-FDG) in Positron Emission Tomography Imaging in Oncology|Unknown status|Recruiting|Phase 3|5000|Anticipated|British Columbia Cancer Agency|||||f||||||||||||||2017-10-11 05:34:36.646111|2017-10-11 05:34:36.646111
NCT00207311|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-13|||August 2005||2005-08-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|HCVNASH||Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus|A Multi-Centered, Prospective, Randomized, Placebo-Controlled Clinical Trial for the Treatment of Significant Steatosis or NASH With Xenical Followed by Treatment of Hepatitis C (HCV) With PEG-Interferon Alpha-2a/Copegus|Completed||Phase 4|30|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-10-11 05:34:36.751815|2017-10-11 05:34:36.751815
NCT00207324|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2007-06-26|||January 2004||2004-01-01|June 2007|2007-06-01|January 2007|Actual|2007-01-01|||||Interventional|||The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions|A Phase III Study of the Efficacy of Silver Leaf Nylon Dressing in the Prevention of Severe Skin Reactions in the Inframammary Skin Fold of Patients Receiving Adjuvant Whole Breast Radiotherapy|Completed||Phase 3|100||British Columbia Cancer Agency|||||f||||f||||||||||2017-10-11 05:34:36.887198|2017-10-11 05:34:36.887198
NCT00207571|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-26|||April 2001||2001-04-01|September 2012|2012-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Partner Notification Intervention for STD Clinics.|Computer-assisted STD Partner Notification|Completed||Phase 1/Phase 2|150||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:34:38.387299|2017-10-11 05:34:38.387299
NCT00207337|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-21|||July 2004||2004-07-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Exhale (R) Stent for Emphysema|A Prospective Feasibility Study to Evaluate the Safety and Performance of the Exhale(R) Drug-Eluting Stent System in Patients With Emphysema|Completed||Phase 2/Phase 3|60||Broncus Technologies|||||f||||||||||||||2017-10-11 05:34:36.965929|2017-10-11 05:34:36.965929
NCT00207350|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-17|||January 2002||2002-01-01|February 2017|2017-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|ILT||Neurosurgical Use of Interstitial Laser Therapy (ILT)|Neurosurgical Use of Interstitial Laser Therapy (ILT)|Completed||N/A|6|Actual|Brigham and Women's Hospital||1|||f||||t||||||||Undecided||2017-10-11 05:34:37.060331|2017-10-11 05:34:37.060331
NCT00207363|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-02-13|||February 2002||2002-02-01|February 2012|2012-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC|Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With Chronic Hepatitis C|Completed||Phase 4|610|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-10-11 05:34:37.173537|2017-10-11 05:34:37.173537
NCT00207376|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-23||||||February 2007|2007-02-01||||||||Interventional|||Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale|Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of an Intracardiac Septal Closure Device in Patients With Atrial Septum Defect (ASD) and Patent Foramen Ovale (PFO)|Completed||N/A|||Carag AG|||||f||||||||||||||2017-10-11 05:34:37.285878|2017-10-11 05:34:37.285878
NCT00207389|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-25|||March 2004||2004-03-01|January 2017|2017-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients|A Pilot Study to Examine the Relationship Between Changes in Plasma GIP Levels and Other Gastrointestinal Peptides Following Gastric Bypass Surgery in Obese Patients|Terminated||N/A|5|Actual|Boston Medical Center|||2|Insufficient funding|f||||f|f|f||||||||2017-10-11 05:34:37.35639|2017-10-11 05:34:37.35639
NCT00207402|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-13|||October 2005||2005-10-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|January 2010|Actual|2010-01-01||Interventional|||Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin|A Pilot Trial of Combination Therapy With Interferon Alfacon1, Ribavirin, & Rosiglitazone in a Group of Insulin Resistant, Chronic Hepatitis C, GT 1 Patients Who Are Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin|Completed||Phase 4|34|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-10-11 05:34:37.465307|2017-10-11 05:34:37.465307
NCT00207415|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2003||2003-01-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||A Comparison of the ASHC and CDSMP|A Comparison of the ASHC and CDSMP|Completed||N/A|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:37.550001|2017-10-11 05:34:37.550001
NCT00207428|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-05-15|||August 1999||1999-08-01|July 1999|1999-07-01|April 2000||2000-04-01|||||Interventional|||Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma|Randomized, Placebo Controlled, Double Blind Study of Carbamazepine in Treatment of Bronchial Asthma|Completed||Phase 4|65||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-10-11 05:34:37.611285|2017-10-11 05:34:37.611285
NCT00207441|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-03-23|||April 2003||2003-04-01|March 2011|2011-03-01|August 2006|Actual|2006-08-01|October 2004|Actual|2004-10-01||Interventional|||Comparing ASHC and CDSMP Outcomes In Arthritis|Comparing ASHC and CDSMP Outcomes In Arthritis|Completed||N/A|416|Actual|Centers for Disease Control and Prevention||2|||f||||||||||||||2017-10-11 05:34:37.678675|2017-10-11 05:34:37.678675
NCT00207454|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2001||2001-06-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Optimizing Strategies to Improve STD Partner Services|Optimizing Strategies to Improve STD Partner Services|Completed||Phase 1|800||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:37.77109|2017-10-11 05:34:37.77109
NCT00207467|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||December 2001||2001-12-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Study to Improve Partner Services for STD Prevention|Prospective Study for Cost-Effectiveness Strategies to Improve Partner Notification: Female Trichomonas and Male Urethritis Studies|Completed||Phase 2|1500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:37.861942|2017-10-11 05:34:37.861942
NCT00207480|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 2004||2004-10-01|September 2005|2005-09-01||||||||Interventional|||Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women|Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women|Suspended||Phase 1|270||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:37.933092|2017-10-11 05:34:37.933092
NCT00207493|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-26|||October 2000||2000-10-01|September 2012|2012-09-01|September 2007|Actual|2007-09-01|September 2005|Actual|2005-09-01||Interventional|||The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.|The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.|Completed||Phase 1/Phase 2|494||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:34:37.996777|2017-10-11 05:34:37.996777
NCT00207506|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-10|||October 2004||2004-10-01|September 2012|2012-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Lay Health Advisors for Sexually Transmitted Disease Prevention|HoMBReS: A Lay Health Advisor Approach to Sexually Transmitted Disease Prevention|Completed||Phase 1/Phase 2|354|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:34:38.077227|2017-10-11 05:34:38.077227
NCT00207519|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-10|||April 2003||2003-04-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|August 2004|Actual|2004-08-01||Interventional|||Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents|The Use of Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents: A 12 Week Safety and Efficacy Study|Completed||Phase 1|40||Boston Medical Center|||||f||||f||||||||||2017-10-11 05:34:38.16487|2017-10-11 05:34:38.16487
NCT00207532|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||March 2005||2005-03-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Dosage Effects of Folic Acid on Blood Folates of Honduran Women|Dosage Effects of Folic Acid on Blood Folates of Honduran Women|Completed||N/A|100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:38.269896|2017-10-11 05:34:38.269896
NCT00207558|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-07-12||||||September 2005|2005-09-01||||||||Interventional|||Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification|Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification|Completed||N/A|1100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:38.330055|2017-10-11 05:34:38.330055
NCT00207584|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 1994||1994-01-01|September 2005|2005-09-01|April 1994||1994-04-01|||||Interventional|||Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting|A Double-Blind, Randomized Placebo-Controlled Trial of Doxycycline for Chemoprophylaxis in the Setting of an Outbreak of Mycoplasma Pneumoniae|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:38.468396|2017-10-11 05:34:38.468396
NCT00207597|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 1995||1995-09-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Joint Outcome Study|A Clinical Trial of Primary Prophylaxis Against Joint Disease in Children With Severe Hemophilia|Completed||N/A|64||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:38.519888|2017-10-11 05:34:38.519888
NCT00207610|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-01-30|||June 2003||2003-06-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Iron Supplementation Among Low-Income Postpartum Women|Phase 3 Study of the Prevention of Postpartum Anemia by Three Different Strategies|Completed||Phase 3|959|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-10-11 05:34:38.566398|2017-10-11 05:34:38.566398
NCT00207623|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||July 2002||2002-07-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Interventional|||Evaluation of the Arthritis Basics for Change (ABCs) Self Management Program|Evaluation of the Arthritis Basics for Change (ABCs) Self Management Program|Completed||N/A|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:38.638642|2017-10-11 05:34:38.638642
NCT00207649|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-03-23|||November 2005||2005-11-01|March 2011|2011-03-01|February 2011|Anticipated|2011-02-01|March 2010|Actual|2010-03-01||Interventional|||Shared Decision Making: Prostate Cancer Screening|Shared Decision Making: Prostate Cancer Screening|Unknown status|Active, not recruiting|N/A|641|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-10-11 05:34:38.776364|2017-10-11 05:34:38.776364
NCT00207662|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-26|||July 2000||2000-07-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|||||Interventional|||A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease|ACCENT I - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long-term Treatment of Patients With Moderately to Severely Active Crohn's Disease|Completed||Phase 3|580|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 05:34:38.853254|2017-10-11 05:34:38.853254
NCT00207675|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-16|||February 2003||2003-02-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease|A Randomized, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Anti-TNF a Chimeric Monoclonal Antibody (Infliximab, REMICADE) in Pediatric Subjects With Moderate to Severe CROHN'S Disease.|Completed||Phase 3|112|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 05:34:38.931949|2017-10-11 05:34:38.931949
NCT00207688|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-14|||August 2004||2004-08-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients|A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis|Completed||Phase 4|505|Actual|Janssen Research & Development, LLC|||3||f||||f||||||||||2017-10-11 05:34:39.140788|2017-10-11 05:34:39.140788
NCT00207701|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-16|||September 2002||2002-09-01|August 2010|2010-08-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.|A Randomized, Double-blind Trial of the Efficacy of REMICADE (Infliximab) Compared With Placebo in Subjects With Ankylosing Spondylitis Receiving Standard Anti-inflammatory Drug Therapy|Completed||Phase 3|279|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 05:34:39.426343|2017-10-11 05:34:39.426343
NCT00207714|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-16|2009-05-21||November 2003||2003-11-01|October 2012|2012-10-01|February 2006|Actual|2006-02-01|February 2005|Actual|2005-02-01||Interventional|||An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis|A Randomized, Double-blind, Dose-ranging Trial of CNTO 148 Subcutaneous Injection Compared With Placebo in Subjects With Active Rheumatoid Arthritis Despite Treatment With Methotrexate|Completed||Phase 2|172|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <= 5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|3|||||||f||||||||||2017-10-11 05:34:39.521806|2017-10-11 05:34:39.521806
NCT00207727|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-20|2009-10-25||July 2004||2004-07-01|April 2012|2012-04-01|August 2006|Actual|2006-08-01|March 2006|Actual|2006-03-01||Interventional|||A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis|A Phase II, Double-blind, Placebo-Controlled, Randomized, Dose-ranging Study of Multiple Subcutaneous Injections of Human Monoclonal Antibody to IL-12p40(CNTO1275) in Subjects With Relapsing-remitting Multiple Sclerosis|Completed||Phase 2|249|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <=5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.||||||||||||||||||2017-10-11 05:34:42.147025|2017-10-11 05:34:42.147025
NCT00207740|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-14|2009-05-21||August 2004||2004-08-01|August 2012|2012-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 148 Administered Subcutaneously in Symptomatic Subjects With Severe Persistent Asthma|Completed||Phase 2|309|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <= 5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|2|||f||||t||||||||||2017-10-11 05:34:43.12574|2017-10-11 05:34:43.12574
NCT00207753|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-11-16|||February 2005||2005-02-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections|Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren|Completed||N/A|550||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:34:45.387655|2017-10-11 05:34:45.387655
NCT00207766|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-26|||June 2000||2000-06-01|January 2009|2009-01-01|August 2006|Actual|2006-08-01|||||Interventional|||A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease|ACCENT II - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long Term Treatment of Patients With Fistulizing CROHN'S Disease|Completed||Phase 3|306|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 05:34:45.480486|2017-10-11 05:34:45.480486
NCT00207779|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-19|||May 2005||2005-05-01|September 2007|2007-09-01|August 2005||2005-08-01|||||Interventional|||Prevention of Catheter-Related Bloodstream Infection in Patients With Haemato-Oncological Disease||Completed||Phase 3|||Centre National de Greffe de Moelle Osseuse|||||f||||||||||||||2017-10-11 05:34:45.554879|2017-10-11 05:34:45.554879
NCT00207792|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-05|||July 2005||2005-07-01|September 2007|2007-09-01||||||||Interventional|||Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation|Randomized Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation|Unknown status|Recruiting|Phase 3|160|Anticipated|Centre National de Greffe de Moelle Osseuse|||||f||||||||||||||2017-10-11 05:34:45.623251|2017-10-11 05:34:45.623251
NCT00207805|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-26|||May 2003||2003-05-01|January 2009|2009-01-01||||||||Interventional|||The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma||Completed||Phase 3|202||Centre National de Greffe de Moelle Osseuse|||||f||||||||||||||2017-10-11 05:34:45.690358|2017-10-11 05:34:45.690358
NCT00207818|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-02-10|||September 1999||1999-09-01|February 2014|2014-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Treatment of Cutaneous Ulcers With a Novel Biological Dressing|Treatment of Cutaneous Ulcers With a Novel Biological Dressing|Completed||Phase 1/Phase 2|6|Actual|CHU de Quebec-Universite Laval||1|||f||||f||||||||||2017-10-11 05:34:45.752221|2017-10-11 05:34:45.752221
NCT00207831|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-07-20|||July 2004||2004-07-01|July 2010|2010-07-01|February 2008|Actual|2008-02-01|June 2007|Actual|2007-06-01||Interventional|UFT RT Phase 3||Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma|Trial UFT/RT Randomized Multicenter Phase III Randomized Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma|Terminated||Phase 3|219|Anticipated|ICO Paul Papin||2||Terminated after interim analysis|f||||t||||||||||2017-10-11 05:34:45.823441|2017-10-11 05:34:45.823441
NCT00207844|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2002||2002-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Selenium, as Sodium Selenite, in the Treatment of Septic Shock|Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of a Therapeutic Administration of Selenium, as Selenite, in Septic Shock Patients.|Completed||Phase 2|60||Centre Hospitalier de Meaux|||||f||||||||||||||2017-10-11 05:34:46.012969|2017-10-11 05:34:46.012969
NCT00207857|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-02-02|||March 2004||2004-03-01|February 2015|2015-02-01|August 2005|Anticipated|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy|Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-10-11 05:34:46.190665|2017-10-11 05:34:46.190665
NCT00207870|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-07-21|||October 2006||2006-10-01|July 2011|2011-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Type II Supracondylar Fractures in Children|Comparison of Crossed Pin Versus Lateral-Entry Pin Fixation for Type II Supracondylar Fractures in Children: A Prospective, Randomized Trial|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-10-11 05:34:46.270459|2017-10-11 05:34:46.270459
NCT00207883|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-22|2009-06-01||January 2005||2005-01-01|March 2017|2017-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational||Two hundred twelve CVC placements were performed and evaluated: 93 during the LM phase and 119 in the US phase.|Ultrasound Guided Vascular Access in Pediatric Intensive Care Patients|Ultrasound Guided Vascular Access: A Prospective Comparison Study|Completed||N/A|212|Actual|Children's Healthcare of Atlanta|Small sample size. Personnel were aware they were being timed which can bias study.||2||f||||f||||||||No||2017-10-11 05:34:46.338486|2017-10-11 05:34:46.338486
NCT00207896|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-11-25|||August 2004||2004-08-01|November 2014|2014-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Neuroendocrine Dysfunction in Critically Ill Pediatric Patients|Defining the Prevalence of Acute Neuroendocrine Dysfunction and Correlating the Dysfunction With Outcomes in Critically Ill Pediatric Patients: A Pilot Study|Completed||N/A|73|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-10-11 05:34:46.600906|2017-10-11 05:34:46.600906
NCT00207909|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-06-13|||February 2005||2005-02-01|June 2016|2016-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Study of Patients With Acute Renal Failure on CVVH|The Role of Hemodynamics, Cytokine Response, and Modulators of Apoptosis on Urine Output in Patients With Acute Renal Failure on CVVH|Completed||N/A|39|Actual|Children's Healthcare of Atlanta|||1||f||||t||||||||||2017-10-11 05:34:46.682225|2017-10-11 05:34:46.682225
NCT00207922|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||December 2003||2003-12-01|December 2003|2003-12-01||||||||Observational|||The Polarization and Expression of Chemokine Receptors of T Help Cell in the Pathogenesis of Acute and Chronic GVHD||Unknown status|Active, not recruiting|N/A|||China Medical University Hospital|||||f||||||||||||||2017-10-11 05:34:46.759091|2017-10-11 05:34:46.759091
NCT00207935|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-05-01|||August 2005||2005-08-01|September 2005|2005-09-01|March 2007||2007-03-01|||||Interventional|||Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population|Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population|Completed||Phase 4|20|Anticipated|Children's Research Institute|||||f||||||||||||||2017-10-11 05:34:46.829782|2017-10-11 05:34:46.829782
NCT00207948|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-08-03|||November 2004||2004-11-01|August 2015|2015-08-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Observational|||Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents|Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents|Terminated||Phase 4|4|Actual|Children's Research Institute|||1|no measurable response was detected at the 50% increase threshold.|f||||t||||||||||2017-10-11 05:34:46.933077|2017-10-11 05:34:46.933077
NCT00207961|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-08|||October 2003||2003-10-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Observational|||The Threshold Value of Regional Cerebral Oxygenation in Detecting Cerebral Ischemia||Completed||N/A|||China Medical University Hospital|||||f||||||||||||||2017-10-11 05:34:47.030051|2017-10-11 05:34:47.030051
NCT00208013|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-26|||July 2005||2005-07-01|July 2005|2005-07-01||||||||Observational|||The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients|The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients|Completed||N/A|100|Anticipated|China Medical University Hospital|||1||f||||t||||||||||2017-10-11 05:34:47.34635|2017-10-11 05:34:47.34635
NCT00208026|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-06|2011-03-09||September 2005||2005-09-01|December 2014|2014-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome|Exploratory Safety and Systemic Absorption of Elidel (Pimecrolimus) 1% Cream for the Treatment of Netherton Syndrome|Completed||Phase 1/Phase 2|3|Actual|Children's Hospital of Philadelphia|There were no early termination for any of the subjects.|1|||f||||t||||||||||2017-10-11 05:34:47.412876|2017-10-11 05:34:47.412876
NCT00208039|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-19|||September 2004||2004-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates|Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates Less Than or Equal to 1250 gm Birthweight Ver 4.0|Completed||N/A|89|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-10-11 05:34:47.616948|2017-10-11 05:34:47.616948
NCT00208052|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2004||2004-01-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Observational|||Behavioral Indicators of Pain:Tool Development With Concurrent and Construct Validity||Completed||Phase 1|10||Cincinnati VA Medical Center|||||f||||||||||||||2017-10-11 05:34:47.696591|2017-10-11 05:34:47.696591
NCT00208065|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-05-05|||May 2004||2004-05-01|May 2009|2009-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers|"Evaluation of Histamine, CGRP and VIP as Biological Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers in Response to Sinus Symptoms"|Completed||Phase 4|50||Clinvest|||||f||||||||||||||2017-10-11 05:34:47.750434|2017-10-11 05:34:47.750434
NCT00208078|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-02-12|||May 2005||2005-05-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.|Evaluation of the Effects of Long Term Non-Invasive Ventilation in Patient With Cystic Fibrosis and Chronic Hypercapnic Respiratory Failure.|Terminated||Phase 4|36|Actual|Cochin Hospital||2||Not enough patient recruited|f||||t||||||||||2017-10-11 05:34:47.844541|2017-10-11 05:34:47.844541
NCT00208091|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-11|2013-08-22||April 2003||2003-04-01|April 2014|2014-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia|An Open Label Evaluation of MIDI to Quantify Performance Change in Subjects With Musician's Dystonia After Treatment With Botulinum Toxin Type B (Myobloc ®).|Completed||Phase 4|16|Actual|Columbia University||1|||f||||f||||||||||2017-10-11 05:34:47.944088|2017-10-11 05:34:47.944088
NCT00208104|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-02-15|||July 2002||2002-07-01|February 2013|2013-02-01|September 2008|Actual|2008-09-01|May 2006|Actual|2006-05-01||Interventional|||Motivational Interviewing|Motivational Interviewing in Hypertensive African Americans|Terminated||N/A|167|Actual|Columbia University||2||PI left institution|f||||f||||||||||2017-10-11 05:34:48.326883|2017-10-11 05:34:48.326883
NCT00208117|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2012-05-30|||April 2005||2005-04-01|May 2012|2012-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|CHIME||A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease|A Randomized Controlled Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease|Terminated||Phase 1|7|Actual|New York State Psychiatric Institute||2||Unable to enroll subjects|f||||f||||||||||2017-10-11 05:34:48.467604|2017-10-11 05:34:48.467604
NCT00208130|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-28|||October 2001||2001-10-01|April 2009|2009-04-01|March 2004||2004-03-01|||||Interventional|||Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians|Completed||Phase 4|60||Creighton University|||||f||||f||||||||||2017-10-11 05:34:48.591543|2017-10-11 05:34:48.591543
NCT00208143|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-11|||November 2003||2003-11-01|October 2006|2006-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia|Seroquel (Quetiapine) Therapy for Schizophrenia and Schizoaffective Disorders and Comorbid Cocaine and/or Amphetamine Abuse/Dependence: A Comparative Study With Risperidone|Completed||Phase 4|20||Creighton University|||||f||||f||||||||||2017-10-11 05:34:48.684896|2017-10-11 05:34:48.684896
NCT00208156|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-14|||May 2005||2005-05-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression|An Open-Label Extension Study of the Safety and Tolerability of CORLUX™ (Mifepristone) for Recurrent Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features|Completed||Phase 3|87|Actual|Corcept Therapeutics||1|||f||||f||||||||||2017-10-11 05:34:48.766756|2017-10-11 05:34:48.766756
NCT00208169|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-22|||March 2005||2005-03-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Abilify Therapy for Reducing Comorbid Substance Abuse|Aripiprazole (Abilify) Therapy for Reducing Comorbid Substance Abuse|Completed||Phase 4|30|Actual|Creighton University||1|||f||||f||||||||||2017-10-11 05:34:48.885172|2017-10-11 05:34:48.885172
NCT00208182|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-03-08|||July 2001||2001-07-01|March 2006|2006-03-01|August 2004||2004-08-01|||||Interventional|||Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma|Risperidone Monotherapy in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma: a Double-Blind, Placebo Controlled, Randomized Clinical Trial|Completed||Phase 4|20||Creighton University|||||||||||||||||||2017-10-11 05:34:48.975219|2017-10-11 05:34:48.975219
NCT00208195|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-12-12|||March 2004||2004-03-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Depakote ER Therapy for Mania Comorbid With Substance Abuse|Depakote ER Therapy for Mania Comorbid With Substance Abuse|Completed||Phase 4|20|Actual|Creighton University||1|||f||||f||||||||||2017-10-11 05:34:49.038842|2017-10-11 05:34:49.038842
NCT00208208|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-09-14|||December 2002||2002-12-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Geodon (Ziprasidone) for Posttraumatic Stress Disorder|Geodon (Ziprasidone) for Posttraumatic Stress Disorder|Completed||Phase 4|80||Creighton University|||||f||||||||||||||2017-10-11 05:34:49.134534|2017-10-11 05:34:49.134534
NCT00202397|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-02-10|||June 2005||2005-06-01|December 2013|2013-12-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia|Phase 2 Study of Riluzole Effects on Patients With Chronic Cerebellar Ataxia|Completed||Phase 2|40|Actual|S. Andrea Hospital||2|||f||||t||||||||||2017-10-11 05:36:06.335123|2017-10-11 05:36:06.335123
NCT00208221|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-07|||August 2006||2006-08-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes|Comparison of a Higher Dose of Ramipril to the Addition of Telmisartan 80 mg+Ramipril 10 mg in Patients With Hypertension and Diabetes|Terminated||Phase 3|50|Anticipated|Institut de Recherches Cliniques de Montreal||2||Not enough recruitment|f||||f||||||||||2017-10-11 05:34:49.214492|2017-10-11 05:34:49.214492
NCT00208234|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-09-22|||January 2004||2004-01-01|September 2011|2011-09-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Effect of Xolair on Airway Hyperresponsiveness|The Effects of Xolair (Omalizumab) on Airway Hyperresponsiveness|Unknown status|Active, not recruiting|Phase 4|22|Anticipated|Creighton University||2|||f||||f||||||||||2017-10-11 05:34:49.372714|2017-10-11 05:34:49.372714
NCT00208247|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-10|||December 2001||2001-12-01|August 2016|2016-08-01|March 2005|Actual|2005-03-01|January 2003|Actual|2003-01-01||Interventional|||KATHY:Cognitive-behavioural Therapy for Hypochondriasis|Cognitive-behavioural Therapy Versus Short-term Psychodynamic Psychotherapy: a Randomised Clinical Trial|Completed||Phase 2|80|Actual|Copenhagen Trial Unit, Center for Clinical Intervention Research||3|||f||||||||||||||2017-10-11 05:34:49.479467|2017-10-11 05:34:49.479467
NCT00208260|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-15|||April 2004||2004-04-01|June 2010|2010-06-01|August 2007|Actual|2007-08-01|||||Interventional|||Intensified Chemotherapy in CRC After Resection of Liver Metastases|Randomized Phase II Trial Followed by Phase III Trial With Molecular Biology Study, Comparing a Standard Bi-therapy vs 3 Arms of Intensified Chemotherapy in Patients With Unresectable or Not Optimally Resectable Colorectal Cancer Liver Metastases.|Completed||Phase 2/Phase 3|124|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||5|||f||||||||||||||2017-10-11 05:34:49.581255|2017-10-11 05:34:49.581255
NCT00208273|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-13|||January 2005||2005-01-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer|A Phase II Randomized Study to Compare Skin Late Toxicities of Concomitant Letrozole-Radiotherapy and Radiotherapy Followed by Letrozole as Adjuvant Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors|Completed||Phase 2|150|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||||||||||||2017-10-11 05:34:49.699869|2017-10-11 05:34:49.699869
NCT00208286|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-06-17|||November 2001||2001-11-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|October 2006|Actual|2006-10-01||Interventional|||P.F.C. Sigma Fixed Versus P.F.C. RP Mobile Bearing Total Knee Systems|Clinical Evaluation of the P.F.C. Sigma (Fixed Bearing) and P.F.C. Sigma Rotating Platform (Mobile Bearing) Total Knee Systems.|Terminated||Phase 4|120|Actual|DePuy International||2||"Primary study outcome achieved; investigator decided to conduct the study without sponsor   support after 2009."|f||||f||||||||||2017-10-11 05:34:49.840132|2017-10-11 05:34:49.840132
NCT00195546|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-05-31|||April 2005||2005-04-01|May 2007|2007-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause|A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study of DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|465|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:34:49.956244|2017-10-11 05:34:49.956244
NCT00195559|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-18|||September 2005||2005-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder|Completed||Phase 3|526|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:34:50.177096|2017-10-11 05:34:50.177096
NCT00195572|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-08-12|||May 2002||2002-05-01|August 2009|2009-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer|Post-Approved Phase III Study of 1-LV/5FU Therapy|Completed||Phase 3|200|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:34:50.367765|2017-10-11 05:34:50.367765
NCT00195585|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-08-12|||October 2002||2002-10-01|August 2009|2009-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Study Evaluating Isovorin in Colon Cancer|Post-Approved Phase III Study of 1-LV/5FU Therapy|Completed||Phase 3|650||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:34:50.524106|2017-10-11 05:34:50.524106
NCT00195598|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-04-01|||January 2005||2005-01-01|March 2010|2010-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder|Pilot Study of Venlafaxine Extended Release (XR) in the Treatment of Panic Disorder (PD) in Comparison to Paroxetine.|Completed||Phase 3|70|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:34:50.598923|2017-10-11 05:34:50.598923
NCT00195611|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-27|||September 2005||2005-09-01|June 2010|2010-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media|Observational Study of the Rhinopharyngeal Carriage of Streptococcus Pneumoniae (Sp) in Infants With Acute Otitis Media (AOM)|Completed||Phase 4|3293|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-10-11 05:34:50.694531|2017-10-11 05:34:50.694531
NCT00195624|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-10-05|||September 14, 2005||2005-09-14|November 15, 2016|2016-11-15|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Alemtuzumab to Treat Severe Aplastic Anemia|A Pilot Study of Alemtuzumab (Campath) in Patients With Relapsed or Refractory Severe Aplastic Anemia|Active, not recruiting||Phase 2|47|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:34:50.821701|2017-10-11 05:34:50.821701
NCT00195637|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2017-10-05|||September 14, 2005||2005-09-14|April 13, 2017|2017-04-13|July 3, 2006|Actual|2006-07-03|July 3, 2006|Actual|2006-07-03||Interventional|||Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy|Pilot Study of the Use of Intravenous Immune Globulin in Hereditary Inclusion Body Myopathy|Completed||Phase 1|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:34:50.903809|2017-10-11 05:34:50.903809
NCT00195650|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-24|2012-05-04||July 2000||2000-07-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Long Term Open Label Continuation Study|A Multi-Center Continuation Study of the Human Anti-TNF Antibody D2E7 Administered as a Subcutaneous Injection in Patients With Rheumatoid Arthritis|Completed||Phase 3|846|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:34:51.023299|2017-10-11 05:34:51.023299
NCT00195663|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-07|2009-12-08||December 2000||2000-12-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2004|Actual|2004-04-01||Interventional|PREMIER||Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis|A Prospective Multi-Centre Randomised, Double-Blind, Active Comparator-Controlled, Parallel-Groups Study Comparing the Fully Human Monoclonal Anti-TNFα Antibody Adalimumab Given Every Second Week With Methotrexate Given Weekly and the Combination of Adalimumab and Methotrexate Administered Over 2 Years in Patients With Early Rheumatoid Arthritis (PREMIER).|Completed||Phase 3|799|Actual|AbbVie||3|||f||||f||||||||||2017-10-11 05:34:52.707282|2017-10-11 05:34:52.707282
NCT00195676|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-11|2010-10-20||May 2004||2004-05-01|April 2011|2011-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Who Completed a Preceding Psoriasis Clinical Study With Adalimumab|Completed||Phase 3|1469|Actual|Abbott||1|||f||||||||||||||2017-10-11 05:34:57.859981|2017-10-11 05:34:57.859981
NCT00195689|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-28|||August 2003||2003-08-01|August 2007|2007-08-01||||||||Interventional|||Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis|A Multi-Center Continuation Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients With Moderate to Severely Active Psoriatic Arthritis|Completed||Phase 3|400||Abbott|||||f||||f||||||||||2017-10-11 05:34:59.148132|2017-10-11 05:34:59.148132
NCT00195702|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-23|2009-12-08||February 2000||2000-02-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|September 2002|Actual|2002-09-01||Interventional|||Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Rheumatoid Arthritis Patients Currently Receiving Treatment With Methotrexate|Completed||Phase 3|619|Actual|Abbott||6|||f||||t||||||||||2017-10-11 05:34:59.333672|2017-10-11 05:34:59.333672
NCT00195715|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-08|2009-12-01||September 2004||2004-09-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|March 2006|Actual|2006-03-01||Interventional|||Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease|A Multi Center, Open Label Study of the Human Anti TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Crohn's Disease|Completed||Phase 3|777|Actual|Abbott|This study was stopped by the sponsor in December 2008 when the pre-specified termination criteria were met. Subjects who continued in the study through the termination date were considered as having completed the study.|1|||f||||||||||||||2017-10-11 05:35:06.155548|2017-10-11 05:35:06.155548
NCT00195728|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-17|||June 2005||2005-06-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain|An Open-Label Study Evaluating the Safety and Tolerability of Long Term Administration of Hydrocodone/Acetaminophen Extended ReleaseTablets (Vicodin® CR) in Subjects With Moderate to Severe Chronic, Non-Malignant Pain|Completed||Phase 3|431|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:35:07.724967|2017-10-11 05:35:07.724967
NCT00195741|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-02-07|||May 2003||2003-05-01|February 2007|2007-02-01||||||||Interventional|||The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents|Phase III, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Center Study Designed to Evaluate the Safety and Efficacy of Prophylactic Depakote ER in the Treatment of Adolescent Migraine|Completed||Phase 3|300||Abbott|||||||||||||||||||2017-10-11 05:35:08.037348|2017-10-11 05:35:08.037348
NCT00195754|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-30|||July 2004||2004-07-01|July 2007|2007-07-01||||||||Interventional|||A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.|The Safety of Divalproex Sodium Extended Release Tablets in Migraine Prophylaxis: An Open-Label Extension Study in Adolescents|Completed||Phase 3|114|Actual|Abbott||1|||f||||||||||||||2017-10-11 05:35:08.132468|2017-10-11 05:35:08.132468
NCT00195767|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-03-17|||July 2004||2004-07-01|March 2007|2007-03-01||||||||Interventional|||Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents|An Open-Label Long-Term Study to Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents|Completed||Phase 3|150||Abbott|||||||||||||||||||2017-10-11 05:35:08.244846|2017-10-11 05:35:08.244846
NCT00195780|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-06-29|||February 2005||2005-02-01|June 2007|2007-06-01||||||||Interventional|||A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents|An Open-Label Study to Evaluate the Safety of Depakote ER in the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents|Completed||Phase 3|227|Actual|Abbott||1|||||||||||||||||2017-10-11 05:35:08.349054|2017-10-11 05:35:08.349054
NCT00195793|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-10-02|||August 2004||2004-08-01|October 2007|2007-10-01||||||||Interventional|||A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin|A Multicenter, Randomized, Double-Blind, Prospective, Parallel Study to Compare the Safety and Efficacy of Fenofibrate or Ezetimibe as Add-On Therapy to Atorvastatin in Subjects With Combined Hyperlipidemia, Typical of the Metabolic Syndrome|Completed||Phase 3|174|Actual|Abbott||2|||f||||f||||||||||2017-10-11 05:35:50.939925|2017-10-11 05:35:50.939925
NCT00195806|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-08-30|||February 2005||2005-02-01|August 2007|2007-08-01||||||||Interventional|||Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine|Divalproex Sodium Extended-Release Tablets for Migraine Prophylaxis in Adolescents: An Open-Label, Long-Term Safety Study|Completed||Phase 3|315||Abbott|||||||||||||||||||2017-10-11 05:35:51.006905|2017-10-11 05:35:51.006905
NCT00195819|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-06-24|2009-12-17||December 2003||2003-12-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|October 2004|Actual|2004-10-01||Interventional|||Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis|A Phase 3, Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis|Completed||Phase 3|82|Actual|Abbott|The modified SASSS was pooled with a study (NCT00085644) similar in structure and sharing the same endpoints as this study.|2|||f||||f||||||||||2017-10-11 05:35:51.118293|2017-10-11 05:35:51.118293
NCT00208520|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-11|||July 2003||2003-07-01|September 2006|2006-09-01|June 2007||2007-06-01|||||Interventional|||Second-Line Treatment Choice for Epilepsy|Second-Line Treatment Choice for Epilepsy|Unknown status|Active, not recruiting|N/A|60||Dutch Epilepsy Clinics Foundation|||||f||||||||||||||2017-10-11 05:36:27.19792|2017-10-11 05:36:27.19792
NCT00195845|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-17|||April 2003||2003-04-01|April 2017|2017-04-01|February 2007|Actual|2007-02-01|September 2006|Actual|2006-09-01||Interventional|||A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder|A Phase 4 Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder|Completed||Phase 4|30|Anticipated|Cambridge Health Alliance||2|||f||||f||||||||||2017-10-11 05:35:55.004771|2017-10-11 05:35:55.004771
NCT00195858|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-04-20|||April 2005||2005-04-01|April 2015|2015-04-01|June 2011|Actual|2011-06-01|November 2010|Actual|2010-11-01||Interventional|||Healthy Eating Aerobic and Resistance Training in Youth (HEARTY) Trial|Healthy Eating, Aerobic and Resistance Training in Youth (HEARTY) Trial|Completed||Phase 2/Phase 3|304|Actual|Ottawa Hospital Research Institute||4|||f||||f||||||||||2017-10-11 05:35:55.111309|2017-10-11 05:35:55.111309
NCT00195884|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-01-22|||September 1999||1999-09-01|January 2013|2013-01-01|April 2011|Actual|2011-04-01|March 2005|Actual|2005-03-01||Interventional|||Diabetes Aerobic and Resistance Exercise (DARE) Study|Resistance Exercise as an Intervention in Type 2 Diabetes Mellitus|Completed||N/A|251|Actual|Ottawa Hospital Research Institute||4|||f||||f||||||||||2017-10-11 05:35:55.567897|2017-10-11 05:35:55.567897
NCT00195897|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-19|||January 2006||2006-01-01|August 2016|2016-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)|Early Assessment of Anthracycline-induced Cardiotoxicity: Usefulness of Biochemical Markers and Ventricular Function Assessment.|Terminated||N/A|6|Actual|Centre Henri Becquerel|||1|No patients; only 6 enrolled after 2 years|f||||f||||||||No||2017-10-11 05:35:55.707503|2017-10-11 05:35:55.707503
NCT00195910|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||October 2004||2004-10-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Safety and Efficacy Study of Hydromorphone and Morphine|Safety and Efficacy of Hydromorphone as an Analgesic Alternative to Morphine in Acute, Severe Pain: A Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 4|198||Chang, Andrew, M.D.|||||f||||||||||||||2017-10-11 05:35:55.79002|2017-10-11 05:35:55.79002
NCT00195923|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-05|||April 2005||2005-04-01|September 2005|2005-09-01|January 2007|Actual|2007-01-01|||||Observational|||Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis|Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis|Completed||Phase 4|100||Children's Mercy Hospital Kansas City|||||f||||f||||||||||2017-10-11 05:35:55.887842|2017-10-11 05:35:55.887842
NCT00195936|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-22|||June 2005||2005-06-01|August 2005|2005-08-01||||||||Interventional|||Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets|Effect of Calcimimetic (Cinacalcet) on Phosphate-Induced Hyperparathyroidism in Children With Hypophosphatemic Rickets|Unknown status|Recruiting|Phase 1|||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:35:55.978586|2017-10-11 05:35:55.978586
NCT00195949|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-04-05|||April 2003||2003-04-01|September 2005|2005-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Laparoscopic Versus Open Pyloromyotomy for Infants With Idiopathic Hypertrophic Pyloric Stenosis|Laparoscopic Versus Open Pyloromyotomy for Infants With Idiopathic Hypertrophic Pyloric Stenosis|Completed||Phase 3|200||Children's Mercy Hospital Kansas City|||||f||||f||||||||||2017-10-11 05:35:56.084395|2017-10-11 05:35:56.084395
NCT00195962|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-12-17|||June 2004||2004-06-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Risk Factors of Breastfeeding Study|Identification of Risk Factors Among Breast-Fed Infants|Completed||N/A|1500|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||||||||||||2017-10-11 05:35:56.180468|2017-10-11 05:35:56.180468
NCT00195975|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-06-27|||June 2005||2005-06-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Observational|||Heart Rate Variability in Children With a Functional Gastrointestinal Disorder|Heart Rate Variability in Children With Abdominal Pain Related to a Functional Gastrointestinal Disorder: Relationship to Anxiety/Stress, Electrogastrography, and Rapid Water Loading|Completed||N/A|44|Actual|Children's Mercy Hospital Kansas City|||2||f||||f||||||||||2017-10-11 05:35:56.289705|2017-10-11 05:35:56.289705
NCT00195988|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-16|||September 2002||2002-09-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Interventional|||Comparison of Immunosuppression Protocols After LTx in Children|Comparison Of Efficacy Of Two Immunosuppressive Protocols Including Tacrolimus With Or Without Mycophenolate Mofetil In Pediatric Liver Transplantation Aimed In Early Termination Of Steroid Therapy|Completed||Phase 4|40||Children's Memorial Health Institute, Poland|||||f||||||||||||||2017-10-11 05:35:56.401634|2017-10-11 05:35:56.401634
NCT00196001|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-02-16|||July 2005||2005-07-01|February 2006|2006-02-01||||||||Observational|||ACTH Stimulation and G Protein|G Protein Expression in Response to ACTH Stimulation Testing|Unknown status|Recruiting|N/A|40||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:35:56.488136|2017-10-11 05:35:56.488136
NCT00196014|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-07-31|||October 2001||2001-10-01|September 2005|2005-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|IWPS-R||Individual Workload Perception Scale - Revised (IWPS-R)|Evaluation of a Tool to Measure a Nurse's Individual Perception of Workload|Unknown status|Enrolling by invitation|N/A|12000|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||t||||||||||2017-10-11 05:35:56.572877|2017-10-11 05:35:56.572877
NCT00196027|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-27|||April 2005||2005-04-01|November 2006|2006-11-01||||||||Interventional|||Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism|Feasibility Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism|Unknown status|Active, not recruiting|N/A|40||Cierra|||||f||||||||||||||2017-10-11 05:35:56.656727|2017-10-11 05:35:56.656727
NCT00196040|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-18|||October 2005||2005-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness|Feasibility Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness|Completed||N/A|60||Cierra|||||f||||||||||||||2017-10-11 05:35:56.731266|2017-10-11 05:35:56.731266
NCT00196053|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-30|||March 2005||2005-03-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||The Effectiveness of Pain Management Using the ARCHIMEDES® Constant-Flow Infusion Pump System for Intrathecal Delivery|Observational Registry: The Effectiveness of Pain Management Using the ARCHIMEDES® Implantable Constant-Flow Infusion Pump System for Intrathecal Delivery|Completed||Phase 4|55|Actual|Codman & Shurtleff|||||f||||f||||||||||2017-10-11 05:35:56.8035|2017-10-11 05:35:56.8035
NCT00196066|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-01-30|||October 2002||2002-10-01|January 2012|2012-01-01|April 2006||2006-04-01|||||Interventional|||Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)||Completed||Phase 2|150||Cook Group Incorporated|||||||||||||||||||2017-10-11 05:35:56.919461|2017-10-11 05:35:56.919461
NCT00196079|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-01-30|||February 2000||2000-02-01|January 2012|2012-01-01|August 2001||2001-08-01|||||Interventional|||The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial|The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial|Completed||N/A|177||Cook Group Incorporated|||||f||||||||||||||2017-10-11 05:35:56.981252|2017-10-11 05:35:56.981252
NCT00196092|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-11|||January 2000||2000-01-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Zenith® AAA Endovascular Graft Clinical Study|Zenith® AAA Endovascular Graft Clinical Study|Completed||N/A|819|Actual|Cook Group Incorporated||8|||||||||||||||||2017-10-11 05:35:57.055576|2017-10-11 05:35:57.055576
NCT00196105|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-28|2009-09-25||September 2003||2003-09-01|September 2011|2011-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)|Multicenter Prospective Randomized Controlled Trial of the Nitinol ZILVER Expandable Endoprosthesis in the Palliation of Extrahepatic Malignant Biliary Obstruction|Completed||N/A|241|Actual|Cook Group Incorporated||3|||f||||||||||||||2017-10-11 05:35:57.147078|2017-10-11 05:35:57.147078
NCT00196118|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-07|||April 2005||2005-04-01|December 2007|2007-12-01|July 2007||2007-07-01|||||Interventional|||Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter|A Non-Randomized Prospective Study of IVC Filter Retrieval|Completed||Phase 4|800||Cook Group Incorporated|||||f||||||||||||||2017-10-11 05:35:57.906682|2017-10-11 05:35:57.906682
NCT00196131|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-04-08|||January 2005||2005-01-01|September 2006|2006-09-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Problems With Morphine Use in Patients With a Severe Brain Injury|Changes in Morphine Handling and Response in Patients With Brain Trauma|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Actual|Dalhousie University||1|||f||||f||||||||||2017-10-11 05:35:58.010097|2017-10-11 05:35:58.010097
NCT00196144|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-23|||July 2002||2002-07-01|November 2007|2007-11-01|April 2004|Actual|2004-04-01|||||Interventional|||FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers|Far Field Sensing Test Study in Patients With Implanted Cardiac Dual Chamber Pacemakers|Completed||Phase 4|207|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:35:58.108979|2017-10-11 05:35:58.108979
NCT00196157|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-05-28|||August 2004||2004-08-01|May 2009|2009-05-01|November 2008|Anticipated|2008-11-01|May 2008|Anticipated|2008-05-01||Interventional|||Line Versus Spot Ablation in Persistent Atrial Fibrillation|Linear Anatomically Versus Focal Electrophysiologically Guided Substrate Ablation in Patients With Persistent Atrial Fibrillation|Unknown status|Recruiting|Phase 4|116|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:35:58.193039|2017-10-11 05:35:58.193039
NCT00196170|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-18|||May 2003||2003-05-01|March 2008|2008-03-01|July 2008|Anticipated|2008-07-01|April 2008|Anticipated|2008-04-01||Interventional|||Randomized Study of Radiofrequency- vs. Cryo-Ablation for Typical Isthmus-Dependent Atrial Flutter|Multicenter Prospective Randomized Clinical Study Comparing Radiofrequency- vs. Cryo-Ablation in Typical Isthmus-Dependent Atrial Flutter|Unknown status|Active, not recruiting|Phase 4|500|Anticipated|Deutsches Herzzentrum Muenchen||4|||f||||t||||||||||2017-10-11 05:35:58.286075|2017-10-11 05:35:58.286075
NCT00196183|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-14|||August 2004||2004-08-01|March 2008|2008-03-01|June 2006|Actual|2006-06-01|||||Interventional|||Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation|Randomized Study Comparing Pulmonary Vein Isolation Alone vs. Pulmonary Vein Isolation Plus Electrogram-Guided Substrate Ablation|Completed||Phase 4|98|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:35:58.522014|2017-10-11 05:35:58.522014
NCT00196196|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-05-22|2008-11-04||September 2004||2004-09-01|February 2011|2011-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.|A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.|Completed||Phase 3|274|Actual|Codman & Shurtleff||1|||f||||f||||||||||2017-10-11 05:35:58.606465|2017-10-11 05:35:58.606465
NCT00196209|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-03-18|||August 2005||2005-08-01|March 2008|2008-03-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation|Randomized Study Comparing Cardioversion vs. Catheter Ablation in Patients With Persistent Atrial Fibrillation|Unknown status|Recruiting|Phase 4|130|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:35:58.80979|2017-10-11 05:35:58.80979
NCT00196222|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-03|||March 2003||2003-03-01|July 2013|2013-07-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||European Multicenter Study Radiofrequency (RF) Versus Cryo in Atrioventricular Nodal Reentry Tachycardia (AVNRT)|European Multicenter Study RF Versus Cryo in AVNRT: A Randomized Study Comparing Cryo-Energy vs. Radiofrequency-Energy Ablation Technique for AV Nodal Reentry Tachycardia (AVNRT)|Completed||Phase 4|509|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-10-11 05:35:58.905243|2017-10-11 05:35:58.905243
NCT00196235|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|September 2005|2005-09-01||||||||Observational|||Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus|Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus|Completed||N/A|650||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-10-11 05:35:59.008511|2017-10-11 05:35:59.008511
NCT00196248|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13||||||September 2005|2005-09-01||||||||Observational|||Out-of Hospital Resuscitation Study||Unknown status|Recruiting|Phase 4|||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-10-11 05:35:59.076135|2017-10-11 05:35:59.076135
NCT00196261|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|September 2005|2005-09-01||||||||Observational|||Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction|Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction|Completed||N/A|3500||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-10-11 05:35:59.146081|2017-10-11 05:35:59.146081
NCT00196274|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 2000||2000-05-01|September 2005|2005-09-01||||||||Observational|||Autonomic Regulation Trial (ART)|Autonomic Regulation Trial (ART)|Completed||N/A|1000||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-10-11 05:35:59.215552|2017-10-11 05:35:59.215552
NCT00196313|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-16|2011-10-12||May 2005||2005-05-01|August 2016|2016-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain|A Multicenter Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval to Placebo for the Treatment of Cyclic Pelvic Pain in Adolescents|Completed||Phase 2|95|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:35:59.442219|2017-10-11 05:35:59.442219
NCT00201799|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-09|||February 2004||2004-02-01|June 2015|2015-06-01|March 2008|Actual|2008-03-01|August 2006|Actual|2006-08-01||Interventional|||Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation|Phase II Trial of Infliximab for the Prevention of Acute Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|19|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:35:59.920305|2017-10-11 05:35:59.920305
NCT00201812|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-12-18|||November 2000||2000-11-01|December 2012|2012-12-01|May 2005|Actual|2005-05-01|January 2004|Actual|2004-01-01||Interventional|||Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors|Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|27|Actual|Ohio State University Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 05:36:00.001399|2017-10-11 05:36:00.001399
NCT00201825|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-10-01|2014-09-25||December 2004||2004-12-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional||Eligible patients had histologically confirmed advanced NSCLC and had not received prior chemotherapy.|A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients|A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients|Completed||Phase 2|29|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:36:00.123942|2017-10-11 05:36:00.123942
NCT00201838|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-10-21|2014-11-04||July 2001||2001-07-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|October 2006|Actual|2006-10-01||Interventional|||Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma|A Phase I/II Study of Etanercept and Gemcitabine in Patients With Advanced Stage and Chemotherapy Naive Pancreatic Adenocarcinoma|Completed||Phase 1/Phase 2|38|Actual|Ohio State University Comprehensive Cancer Center|The interpretation of the results for this study is limited by the relatively small patient sample and correlative samples.|2|||f||||t||||||||||2017-10-11 05:36:00.403959|2017-10-11 05:36:00.403959
NCT00201851|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-04-13|2015-03-31||January 2004||2004-01-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|December 2011|Actual|2011-12-01||Interventional||Baseline measures were not available on all participants.|Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer|Phase III Randomized Study of Immediate Versus Luteal Phase Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-positive Breast Cancer|Completed||Phase 3|740|Actual|International Breast Cancer Research Foundation||3|||f||||t||||||||||2017-10-11 05:36:00.975746|2017-10-11 05:36:00.975746
NCT00201864|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-14|2015-11-10||September 2005||2005-09-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|June 2012|Actual|2012-06-01||Interventional|||Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer|Phase II Trial of Exemestane (Aromasin) in Combination With Fulvestrant (Faslodex) in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer|Completed||Phase 2|40|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:36:01.522597|2017-10-11 05:36:01.522597
NCT00201877|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-07-15|2013-11-12||December 2004||2004-12-01|July 2016|2016-07-01|March 2012|Actual|2012-03-01|June 2009|Actual|2009-06-01||Interventional|||Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma|A Phase II Study of Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|25|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:36:01.905366|2017-10-11 05:36:01.905366
NCT00201890|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-10-09|||March 2003||2003-03-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|||"Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer DELTA STUDY"|DELTA - A Randomized Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer|Completed||Phase 3|103|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-10-11 05:36:02.317524|2017-10-11 05:36:02.317524
NCT00201903|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-05|||January 2004||2004-01-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Observational|||The Roles of Tissue Factor in Malignant Gliomas|The Roles of Tissue Factor in Malignant Gliomas|Completed||N/A|30|Actual|Ontario Clinical Oncology Group (OCOG)|||||f||||t||||||||||2017-10-11 05:36:02.441012|2017-10-11 05:36:02.441012
NCT00201916|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-08-16|||March 1995||1995-03-01|August 2010|2010-08-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Shorter Radiation Schedule for the Treatment of Prostate Cancer|A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer|Completed||Phase 3|936|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-10-11 05:36:02.525411|2017-10-11 05:36:02.525411
NCT00201929|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-27|||April 2002||2002-04-01|June 2007|2007-06-01|November 2006|Actual|2006-11-01|||||Interventional|||A Decision Aid for Women With Early Stage Breast Cancer|Development and Evaluation of Different Versions of the Decision Board for Early Breast Cancer|Completed||Phase 3|300||Ontario Clinical Oncology Group (OCOG)|||||f||||||||||||||2017-10-11 05:36:02.665465|2017-10-11 05:36:02.665465
NCT00201942|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-17|||February 2005||2005-02-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)|A Prospective Study to Determine the Role of 2-[18F]Fluoro-2-Deoxy-D-Glucose (FDG)Positron Emission Tomography (PET)in the Assessment of Regional Nodal Spread of Disease in Breast Cancer Patients|Completed||Phase 3|336|Actual|Ontario Clinical Oncology Group (OCOG)|||||f||||t||||||||||2017-10-11 05:36:02.782532|2017-10-11 05:36:02.782532
NCT00201955|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-31|||May 2004||2004-05-01|October 2006|2006-10-01|July 2006||2006-07-01|||||Interventional|||Study of Rebamipide Eye Drops to Treat Dry Eye|Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, 26 Week Study|Completed||Phase 3|740||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-10-11 05:36:02.895723|2017-10-11 05:36:02.895723
NCT00201968|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-25|||April 2005||2005-04-01|February 2013|2013-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury|Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury|Unknown status|Active, not recruiting|Phase 4|32|Anticipated|Ontario Neurotrauma Foundation||2|||f||||t||||||||||2017-10-11 05:36:03.093514|2017-10-11 05:36:03.093514
NCT00201981|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-01-04|||May 2004||2004-05-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|||||Interventional|||Study of Rebamipide Eye Drops to Treat Dry Eye|Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, 52 Week Study|Completed||Phase 3|740|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||||||||||||2017-10-11 05:36:03.224372|2017-10-11 05:36:03.224372
NCT00201994|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-02|||November 2003||2003-11-01|May 2012|2012-05-01|July 2005|Actual|2005-07-01|||||Interventional|||"SALT-2 Trial Study of Ascending Levels of Tolvaptan in Hyponatremia"|Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia, Study 2|Completed||Phase 3|243|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||f||||||||||2017-10-11 05:36:03.459376|2017-10-11 05:36:03.459376
NCT00202007|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-12|||February 2005||2005-02-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia|A Multi-Center, Randomized, Double-Blind Study, Comparing With Risperidone, to Evaluate the Efficacy and Safety of Aripiprazole in the Treatment of Patients With Schizophrenia|Completed||Phase 2|240||Otsuka Beijing Research Institute|||||f||||||||||||||2017-10-11 05:36:03.545962|2017-10-11 05:36:03.545962
NCT00202020|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-03-15|||May 2004||2004-05-01|March 2006|2006-03-01|January 2006||2006-01-01|||||Interventional|||Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke|Cilostazol Stroke Prevention Study-a Randomized, Double Blind, Double Dummy, Parallel Comparative, Multicenter Clinical Trial|Completed||Phase 3|720||Otsuka Beijing Research Institute|||||f||||||||||||||2017-10-11 05:36:03.627781|2017-10-11 05:36:03.627781
NCT00202033|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-02|||September 2004||2004-09-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes|Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes|Completed||Phase 4|150|Actual|HealthPartners Institute||3|||f||||t||||||||||2017-10-11 05:36:03.746567|2017-10-11 05:36:03.746567
NCT00202046|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-02|||January 2003||2003-01-01|April 2007|2007-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Predictors of Lymphedema Following Breast Cancer Surgery|Predictors of Lymphedema Following Breast Cancer Surgery|Completed||N/A|188|Actual|HealthPartners Institute|||2||f||||t||||||||||2017-10-11 05:36:03.832223|2017-10-11 05:36:03.832223
NCT00202059|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-15|||June 2003||2003-06-01|April 2007|2007-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer|The Effects of Zoledronic Acid (Zometa) and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer|Completed||Phase 3|72||HealthPartners Institute|||||f||||||||||||||2017-10-11 05:36:03.918587|2017-10-11 05:36:03.918587
NCT00202098|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-18|||March 2005||2005-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Variable Ventilation on Respiratory System of Acute Respiratory Distress Syndrome (ARDS) Patients|Effects of Variable Ventilation on Respiratory System of ARDS Patients|Completed||N/A|16|Anticipated|Policlinico Hospital||1|||f||||f||||||||||2017-10-11 05:36:04.08725|2017-10-11 05:36:04.08725
NCT00202111|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-16|||January 1998||1998-01-01|February 2006|2006-02-01|March 2010||2010-03-01|||||Interventional|||Comparative Study of Laparoscopic Versus Open Operations for Colon Cancer|Australasian Multicentered Prospective Randomised Clinical Study Comparing Laparoscopic and Conventional Open Surgical Treatments of Colon Cancer in Adults|Unknown status|Active, not recruiting|N/A|600||The Queen Elizabeth Hospital|||||f||||||||||||||2017-10-11 05:36:04.175138|2017-10-11 05:36:04.175138
NCT00202124|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||April 2001||2001-04-01|November 2002|2002-11-01|March 2002||2002-03-01|||||Interventional|||Double Blind Study of Trp01 in Patients With Alzheimer's Disease|Double Blind Medium Term Efficacy Study of Trp01 in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 4|12||Queen's University|||||f||||||||||||||2017-10-11 05:36:04.288878|2017-10-11 05:36:04.288878
NCT00202137|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-13|||July 2002||2002-07-01|January 2016|2016-01-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Home Blood Pressure Monitoring and Blood Pressure Control|A Randomized Controlled Trial of the Effects of Home Blood Pressure Monitoring on Blood Pressure Control|Completed||N/A|597|Actual|Queen's University||2|||f||||f||||||||||2017-10-11 05:36:04.384412|2017-10-11 05:36:04.384412
NCT00202150|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-10|||September 2004||2004-09-01|March 2015|2015-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Primary Care Management/Action Plans for Advanced Chronic Diseases|Primary Care Management/Action Plans for Advanced Chronic Diseases (The RoadMAP Project)|Completed||Phase 2/Phase 3|139|Actual|Queen's University||1|||f||||||||||||||2017-10-11 05:36:04.483355|2017-10-11 05:36:04.483355
NCT00202163|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-12|||December 2006||2006-12-01|January 2016|2016-01-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction|A Randomized Double-Blind Placebo-Controlled Study Comparing the Safety and Efficacy of Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction|Completed||Phase 2|120|Anticipated|Queen's University|||||f||||||||||||||2017-10-11 05:36:04.583375|2017-10-11 05:36:04.583375
NCT00202176|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-18|||July 2005||2005-07-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)|The Effects of Bronchodilators on Exertional Dyspnea and Exercise Performance in Mild Chronic Obstructive Pulmonary Disease (COPD) Patients and Healthy Elderly Subjects.|Completed||Phase 4|32|Actual|Queen's University||2|||f||||t||||||||||2017-10-11 05:36:04.658788|2017-10-11 05:36:04.658788
NCT00202189|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-08-12|||September 2005||2005-09-01|August 2008|2008-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)|Acute Effects of Inhaled Corticosteroids on Dynamic Airway Function During Rest and Exercise in Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|4|Actual|Queen's University||2|||f||||t||||||||||2017-10-11 05:36:04.75122|2017-10-11 05:36:04.75122
NCT00202202|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-03-10|||November 2002||2002-11-01|March 2015|2015-03-01|April 2004|Actual|2004-04-01|||||Interventional|||User Satisfaction Survey - Personality Disorder Service|Survey of the Consultation Service of the Providence Continuing Care Centre Personality Disorder Service Users Satisfaction With the Change in Service Delivery|Completed||N/A|100|Actual|Queen's University||1|||f||||f||||||||||2017-10-11 05:36:04.832524|2017-10-11 05:36:04.832524
NCT00202215|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2007-10-15|||October 2001||2001-10-01|September 2005|2005-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Chrysalis Day Program Body Mass Index Study|A Study on the Effects of a Personality Disorder Day Hospital Program on Clients Body Mass Index|Completed||N/A|106|Actual|Queen's University||1|||f||||f||||||||||2017-10-11 05:36:04.898521|2017-10-11 05:36:04.898521
NCT00202228|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-12|||July 2002||2002-07-01|January 2016|2016-01-01|September 2011|Actual|2011-09-01|October 2008|Actual|2008-10-01||Interventional|||Lactate Metabolism Study in HIV Infected Persons|Lactic Acid Metabolism in HIV-Infected Persons. Predicting Abnormalities in Lactate Production and Clearance Related to Treatment and Liver Disease and Measuring the Impact of Vitamin Supplementation.|Completed||Phase 4|30|Actual|Queen's University||4|||f||||f||||||||||2017-10-11 05:36:05.091141|2017-10-11 05:36:05.091141
NCT00202241|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-12|||September 1999||1999-09-01|January 2016|2016-01-01|June 2001||2001-06-01|||||Interventional|||The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS|The Effects of Anabolic Steroids and Protease Inhibitors on Serum Blood Lipids,Muscle Mass, and Total Body Fat in People Living With HIV/AIDS|Completed||N/A|30||Queen's University|||||f||||||||||||||2017-10-11 05:36:05.176997|2017-10-11 05:36:05.176997
NCT00202254|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-01|||December 2004||2004-12-01|June 2015|2015-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Multiple Sclerosis Rehabilitation Study|'Functioning and Disability' and 'Quality of Life' in an Australian Community Cohort With Multiple Sclerosis.|Completed||N/A|100||Melbourne Health|||||f||||||||||||||2017-10-11 05:36:05.258277|2017-10-11 05:36:05.258277
NCT00202267|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-11-18|||January 2004||2004-01-01|November 2015|2015-11-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Community RCT of the Effectiveness of Two Compression Bandaging Technologies|Community Randomised Control Trial of the Effectiveness of Two Compression Bandaging Technologies|Completed||Phase 2|426|Actual|Queen's University||2|||f||||t||||||||||2017-10-11 05:36:05.320696|2017-10-11 05:36:05.320696
NCT00202280|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-11-18|||September 2004||2004-09-01|November 2015|2015-11-01|June 2009|Actual|2009-06-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication|VIP (Vitamins In Psychosis) Study. A Randomized Double Blind Placebo Controlled Trial of the Effects of Vitamin B12, B6 and Folic Acid Augmentation on Cognition and Symptoms in Early Psychosis.|Completed||Phase 2/Phase 3|120|Actual|Melbourne Health||2|||f||||t||||||||||2017-10-11 05:36:05.438848|2017-10-11 05:36:05.438848
NCT00202293|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-11-18|||October 2001||2001-10-01|November 2015|2015-11-01||||||||Interventional|||Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features|Comparison of Combination Olanzapine and Lithium and Combination Chlorpromazine and Lithium in the Treatment of a First Manic Episode With Psychotic Features.|Recruiting||Phase 4|75|Anticipated|Melbourne Health|||||f||||||||||||||2017-10-11 05:36:05.517318|2017-10-11 05:36:05.517318
NCT00202306|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-05-28|||November 2001||2001-11-01|September 2005|2005-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Indicated Prevention of Psychotic Disorders With Low-dose Lithium|An Open-labeled, Parallel-group, Single-blinded (Rater) Pilot Study to Investigate the Neuroprotective Effects of of Low-dose Lithium in Young Subjects at Ultra High Risk (UHR) of Developing a First-episode Psychotic Disorder|Completed||Phase 4|30|Anticipated|Melbourne Health|||||f||||t||||||||||2017-10-11 05:36:05.631217|2017-10-11 05:36:05.631217
NCT00202319|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||November 2001||2001-11-01|September 2005|2005-09-01|September 2002||2002-09-01|||||Interventional|||Effectiveness of Sedation Management in an Australian Intensive Care Unit|Evaluating the Effectiveness of Protocol Directed Sedation Management With Non-Protocol Directed Sedation Management on Mechanically Ventilated Patients in an Australian Intensive Care Unit.|Completed||N/A|316||Melbourne Health|||||f||||||||||||||2017-10-11 05:36:05.787966|2017-10-11 05:36:05.787966
NCT00202332|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-07-15|||February 2001||2001-02-01|July 2015|2015-07-01|February 2004|Actual|2004-02-01|February 2003|Actual|2003-02-01||Interventional|||CABG Without the Use of CPB|A Prospective Randomised Study od Coronary Artery Bypass Surgery Without the Use of Cardiopulmonary Bypass|Completed||Phase 2|||Melbourne Health||2|||f||||||||||||||2017-10-11 05:36:05.871548|2017-10-11 05:36:05.871548
NCT00202345|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-05-04|||August 2004||2004-08-01|May 2015|2015-05-01|February 2007|Actual|2007-02-01|||||Interventional|||Iron Sucrose in Stage 3/4 Kidney Disease|Assessment of the Use of Intravenous Iron Sucrose to Maintain Haemoglobin Levels and Delay the Onset of Use of Erythropoietic Agents and/or Dialysis in Stage 3/4 Chronic Kidney Disease|Completed||Phase 3|120||Melbourne Health|||||f||||||||||||||2017-10-11 05:36:05.951809|2017-10-11 05:36:05.951809
NCT00202358|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-06-13|||November 2002||2002-11-01|June 2008|2008-06-01|September 2008|Anticipated|2008-09-01|November 2007|Actual|2007-11-01||Interventional|||Perioperative Effect of Atenolol on Cytokine Profiles|The Effect of Perioperative Atenolol on Post-Operative Cytokines|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Saini Foundation||2|||f||||||||||||||2017-10-11 05:36:06.054859|2017-10-11 05:36:06.054859
NCT00202371|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-01|||July 2002||2002-07-01|June 2015|2015-06-01|July 2005|Anticipated|2005-07-01|||||Interventional|||Transfusion Effects in Myelodysplastic Patients: Limiting Exposure|Transfusion Effects in Myelodysplastic Patients: Limiting Exposure (Temple)|Withdrawn||Phase 4|0|Actual|Sanquin Research & Blood Bank Divisions||||Too few inclusions|f||||f||||||||||2017-10-11 05:36:06.152447|2017-10-11 05:36:06.152447
NCT00202384|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-07-26|||November 2004||2004-11-01|July 2010|2010-07-01||||||||Observational|||Gene Expression in MS Patients Before and During Treatment With Interferon-beta|Gene Expression in MS Patients Before and During Treatment With High-dose Interferon Beta: Prospective Study for the Identification of Predicting Factors of Therapeutic Response.|Completed||Phase 4|600|Actual|S. Andrea Hospital|||1||f||||t||||||||||2017-10-11 05:36:06.238751|2017-10-11 05:36:06.238751
NCT00202423|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-28|||July 2005||2005-07-01|September 2005|2005-09-01||||||||Interventional|||Use of Cannabinoids in Patients With Multiple Sclerosis|fMRI and Neurophysiological Study Protocol on Cannabinoids in Multiple Sclerosis|Unknown status|Recruiting|Phase 2|20||S. Andrea Hospital|||||f||||||||||||||2017-10-11 05:36:06.576918|2017-10-11 05:36:06.576918
NCT00202436|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-10-19|||October 2004||2004-10-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Interventional|||Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy|Therapeutic Erythrocytapheresis as Treatment for Hemochromatosis Patients.|Completed||Phase 3|40|Anticipated|Sanquin Research & Blood Bank Divisions||2|||f||||f||||||||||2017-10-11 05:36:06.712595|2017-10-11 05:36:06.712595
NCT00202449|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-06-11|2012-02-24||July 2004||2004-07-01|June 2012|2012-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance|A Placebo-Controlled Trial of Prazosin vs. Paroxetine in Combat Stress-Related PTSD Nightmares and Sleep Disturbance|Terminated||N/A|59|Actual|Seattle Institute for Biomedical and Clinical Research|High rate of early termination leading to small number of patients analyzed.|3||recruitment difficulties|f||||t||||||||||2017-10-11 05:36:06.83226|2017-10-11 05:36:06.83226
NCT00202462|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-09-30|||November 2002||2002-11-01|September 2008|2008-09-01|November 2006|Actual|2006-11-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Testosterone on Mood and Quality of Life|The Effect of Testosterone Treatment on Depressive Symptoms and Quality of Life in Older Men With Age-Related Hypogonadism and Subsyndromal Depression.|Completed||N/A|33|Actual|Seattle Institute for Biomedical and Clinical Research||1|||f||||f||||||||||2017-10-11 05:36:07.459446|2017-10-11 05:36:07.459446
NCT00202475|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-10-19|||September 2003||2003-09-01|October 2009|2009-10-01|December 2007|Actual|2007-12-01|September 2006|Actual|2006-09-01||Interventional|||Collection of Autologous Blood Products by Double Erythrocytapheresis|Collection of Autologous Blood Products by Double Erythrocytapheresis - Cost Effectiveness Study|Completed||Phase 3|100|Actual|Sanquin Research & Blood Bank Divisions||2|||f||||f||||||||||2017-10-11 05:36:07.573091|2017-10-11 05:36:07.573091
NCT00202488|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-29|||November 2002||2002-11-01|July 2008|2008-07-01|September 2007||2007-09-01|||||Interventional|||The Effect of H. Pylori Infection on Iron Metabolism|The Effect of H. Pylori Infection on Iron Metabolism|Completed||Phase 2/Phase 3|39||Seattle Institute for Biomedical and Clinical Research|||||f||||||||||||||2017-10-11 05:36:07.676468|2017-10-11 05:36:07.676468
NCT00202501|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-05-20|||September 2005||2005-09-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|December 2006|Actual|2006-12-01||Interventional|||Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome|Usefulness of Nasal CPAP Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome|Completed||N/A|80|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||||||||||||2017-10-11 05:36:07.779066|2017-10-11 05:36:07.779066
NCT00202514|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-10-07|||September 2004||2004-09-01|October 2009|2009-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms|Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms|Completed||Phase 2/Phase 3|40||Seattle Institute for Biomedical and Clinical Research|||||f||||t||||||||||2017-10-11 05:36:07.856747|2017-10-11 05:36:07.856747
NCT00202527|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-22|||January 2005||2005-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Spanish Cohort for the Study of the Effect of CPAP in Hypertension (CEPECTA)|Efficacy of the Treatment With Nasal Positive Continuous Airway Pressure to Reduce the Arterial Blood Pressure in Patients With Apneas-Hypopneas During the Sleep and Systemic Hypertension|Unknown status|Recruiting|N/A|340||Sociedad Española de Neumología y Cirugía Torácica|||||f||||||||||||||2017-10-11 05:36:07.969664|2017-10-11 05:36:07.969664
NCT00202540|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-05|||June 2005||2005-06-01|April 2017|2017-04-01|March 29, 2006|Actual|2006-03-29|March 29, 2006|Actual|2006-03-29||Interventional|||Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients|Efficacy of 15 mg and 50 mg of S18986 on Cognitive Symptoms in Mild Cognitive Impairment Patients Treated Over a 12-month Oral Administration Period|Terminated||Phase 2|38|Actual|Servier|||||f||||||||||||||2017-10-11 05:36:08.050672|2017-10-11 05:36:08.050672
NCT00202553|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-15|||July 2003||2003-07-01|June 2011|2011-06-01|December 2006|Actual|2006-12-01|||||Interventional|||S90652 in Paediatric Hypertension|Acceptability, Safety, Pharmacokinetics and Effects on Blood Pressure of a Daily Dose of 0.025 to 0.135 Milligram Per Kilogram of S90652, a Paediatric Formulation of Perindopril, in 2-16 Years Old Hypertensive Children - 3 Month Study|Completed||Phase 2|50|Anticipated|Servier|||||f||||||||||||||2017-10-11 05:36:08.114838|2017-10-11 05:36:08.114838
NCT00202566|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-15|||June 2005||2005-06-01|June 2011|2011-06-01|October 2007|Actual|2007-10-01|||||Interventional|ASSOCIATE||Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris|Evaluation of the Anti-anginal Efficacy and Safety of Oral Administration of Ivabradine Compared to Placebo on Top of Background Therapy With Atenolol in Patients With Stable Angina Pectoris. A Four-month Randomised Double-blind, Parallel Group International Multicentre Study.|Completed||Phase 3|750|Anticipated|Servier|||||f||||||||||||||2017-10-11 05:36:08.185134|2017-10-11 05:36:08.185134
NCT00202579|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-15|||September 2004||2004-09-01|June 2011|2011-06-01|February 2006|Actual|2006-02-01|||||Interventional|||Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure|Evaluation of the Effects on Peripheral and Central Haemodynamics Parameters, Safety, and Tolerance of Three-hour Intravenous Perfusion (0.1 mg/kg) of Ivabradine Given to Severe Congestive Heart Failure Patients|Completed||Phase 2|12|Anticipated|Servier|||||f||||||||||||||2017-10-11 05:36:08.271956|2017-10-11 05:36:08.271956
NCT00202592|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-06-15|||November 2003||2003-11-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|||||Interventional|||S90652 in Paediatric Hypertension|Safety and Effects on Blood Pressure of Daily Dose 0.025 to 0.135 Milligram Per Kilogram of S90625 a Paediatric Formulation of Perindopril, in Hypertensive Children - 24 Months|Completed||Phase 2|50|Anticipated|Servier|||||f||||||||||||||2017-10-11 05:36:08.352288|2017-10-11 05:36:08.352288
NCT00202605|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-02|||September 2005||2005-09-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Safety and Efficacy of SPD465 in Adults With ADHD|A Phase II, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Crossover Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2|72||Shire|||||||||||||||||||2017-10-11 05:36:08.421836|2017-10-11 05:36:08.421836
NCT00202631|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-24|||June 2002||2002-06-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Abdominal Functional Electrical Stimulation in Tetraplegia|Abdominal Functional Electrical Stimulation to Augment Breathing in Tetraplegia|Unknown status|Active, not recruiting|N/A|4||South Glasgow University Hospitals NHS Trust|||||f||||||||||||||2017-10-11 05:36:08.862266|2017-10-11 05:36:08.862266
NCT00202657|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-12-05|||April 2005||2005-04-01|December 2011|2011-12-01|February 2007||2007-02-01|||||Observational|||Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide|Etude Observationnelle Des Valvulopathies Chez Les Patients Parkinsoniens Traites Par Pergolide Par Rapport a Une Population Temoin|Completed||Phase 4|149|Actual|Société Française de Cardiologie|||1||f||||||||||||||2017-10-11 05:36:09.045893|2017-10-11 05:36:09.045893
NCT00202670|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-10-19|||January 2004||2004-01-01|January 2004|2004-01-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Observational|||Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients|Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients :Comparison Between Stress Echocardiography and Stress Scintigraphy in the Detection of Silent Myocardial Ischemia|Terminated||Phase 4|220|Anticipated|Société Française de Cardiologie|||2|Positive Predictive value not related to follow up duration.|f||||t||||||||||2017-10-11 05:36:09.109591|2017-10-11 05:36:09.109591
NCT00202683|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-05-16|||March 2005||2005-03-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Observational|||Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness|Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness Associated With Chemoreflex Failure|Completed||N/A|83|Actual|Société Française de Cardiologie|||||f||||f||||||||||2017-10-11 05:36:09.18947|2017-10-11 05:36:09.18947
NCT00202696|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-05-15|||September 2005||2005-09-01|May 2008|2008-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Nalmefene Smoking Cessation Study|A Single Center Evaluation of Nalmefene HCl Versus Placebo on Smoking Cessation|Completed||Phase 2|76|Actual|Somaxon Pharmaceuticals||3|||f||||f||||||||||2017-10-11 05:36:09.271262|2017-10-11 05:36:09.271262
NCT00202709|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-07-27|||May 2002||2002-05-01|September 2005|2005-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?|Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder, a Prospective, Randomized Pilot Study With Wait List as Control Group.|Completed||N/A|52|Actual|Sorlandet Hospital HF||2|||f||||f||||||||||2017-10-11 05:36:09.351686|2017-10-11 05:36:09.351686
NCT00202722|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-05-22|2010-03-16||January 2004||2004-01-01|May 2014|2014-05-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour|Remifentanil as Analgesia for Labour Pain|Completed||Phase 4|41|Actual|Sorlandet Hospital HF||1|||f||||t||||||||||2017-10-11 05:36:09.447287|2017-10-11 05:36:09.447287
NCT00202735|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-05-07|||January 2005||2005-01-01|January 2005|2005-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Does Immobilization of the Shoulder in External Rotation Reduce the Recurrence Rate of Shoulder Dislocation?|Does Immobilization of the Shoulder in External Rotation Reduce the Recurrence Rate of Shoulder Dislocation?|Completed||Phase 2/Phase 3|188|Actual|Sorlandet Hospital HF||2|||f||||t||||||||||2017-10-11 05:36:09.612346|2017-10-11 05:36:09.612346
NCT00202761|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-12-07|||March 2004||2004-03-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Project:Intensive Habilitation (PIH)|Project:Intensive Habilitation (PIH) -a New Norwegian Multidisciplinary Program for Intensive Training for Children With Disabilities|Active, not recruiting||Phase 2/Phase 3|20|Anticipated|Sorlandet Hospital HF||1|||f||||t||||||||||2017-10-11 05:36:09.763474|2017-10-11 05:36:09.763474
NCT00202774|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-19|||April 2002||2002-04-01|February 2013|2013-02-01|December 2005|Actual|2005-12-01|August 2004|Actual|2004-08-01||Interventional|||Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer|Phase III, Multicenter, Ramdomised, Open-label, Study to Evaluate the Safety and Efficacy of Combination Therapy With XELOX vs. Oxaliplatin and 5-FU CI as First Line Treatment in Advanced or Metastatic Colorectal Cancer|Completed||Phase 3|348||Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|||||f||||f||||||||||2017-10-11 05:36:09.838357|2017-10-11 05:36:09.838357
NCT00202787|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-02-19|||February 2005||2005-02-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer|Open-label, Phase II, Randomised, Pilot Study to Evaluate the Safety and Efficacy of Combination Therapy With Cetuximab and FOLFOX4 or FOLFOX4 Alone in Patients Colorectal Cancer and Initially Non-resectable|Completed||Phase 2|136|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||2|||f||||f||||||||||2017-10-11 05:36:09.91722|2017-10-11 05:36:09.91722
NCT00202800|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-06-03|||March 2002||2002-03-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|September 2007|Actual|2007-09-01||Interventional|||Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer|Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|40|Anticipated|Spectrum Health Hospitals||1|||f||||||||||||||2017-10-11 05:36:09.996429|2017-10-11 05:36:09.996429
NCT00202813|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-12-29|||July 2003||2003-07-01|December 2009|2009-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study of the Use of Coated Venous Catheters in the Critically Ill Child|The Use of Antibiotic-coated Venous Catheters in the Critically Ill Child: Reducing the Rate of Bloodstream Related Infections|Completed||Phase 4|500||Spectrum Health Hospitals|||||f||||||||||||||2017-10-11 05:36:10.08944|2017-10-11 05:36:10.08944
NCT00202826|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-16|||November 2003||2003-11-01|January 2009|2009-01-01|March 2004||2004-03-01|||||Interventional|||Study of Fluid Collection of the Chest in Children With Pneumonia|Parapneumonic Effusion in Children Study|Completed||Phase 3|30||Spectrum Health Hospitals|||||f||||||||||||||2017-10-11 05:36:10.154105|2017-10-11 05:36:10.154105
NCT00202839|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-08|2009-08-28||March 2005||2005-03-01|March 2017|2017-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)|Comparison of the Sustained Response of Peg-Intron/Ribavirin Combination Therapy in Genotype 1-Infected Hepatitis C Patients for Non-extended Versus 24-week Extended Treatment After 24 Weeks Pilot Treatment in Taiwan|Completed||Phase 4|160|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:36:11.553066|2017-10-11 05:36:11.553066
NCT00202852|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-22|||June 1, 2005|Actual|2005-06-01|March 2017|2017-03-01|March 1, 2006|Actual|2006-03-01|March 1, 2006|Actual|2006-03-01||Interventional|||A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)|A Placebo-Controlled, Double-Blinded, Randomized Clinical Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methotrexate|Completed||Phase 3|143|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:36:11.98335|2017-10-11 05:36:11.98335
NCT00202865|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-03-22|||May 1, 2005|Actual|2005-05-01|March 2017|2017-03-01|May 1, 2007|Actual|2007-05-01|May 1, 2007|Actual|2007-05-01||Interventional|CANDLE||Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)|CANaDian Evaluation of Low DosE Infliximab in Ankylosing Spondylitis|Completed||Phase 3|76|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:36:12.069735|2017-10-11 05:36:12.069735
NCT00202878|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-05-10|2015-08-28||October 17, 2005|Actual|2005-10-17|May 2017|2017-05-01|September 18, 2014|Actual|2014-09-18|September 18, 2014|Actual|2014-09-18||Interventional|||IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)|A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial - IMPROVE IT)|Completed||Phase 3|18144|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:36:12.468647|2017-10-11 05:36:12.468647
NCT00202891|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-06-02|||May 2007||2007-05-01|June 2015|2015-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)|Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas|Withdrawn||Phase 4|0|Actual|Merck Sharp & Dohme Corp.||||No further local interest in pursuing the study.|f||||||||||||||2017-10-11 05:36:20.636715|2017-10-11 05:36:20.636715
NCT00208299|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-11-24|||October 2003||2003-10-01|November 2009|2009-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)|A Phase III, Randomized, Double-Blind Study of Intravenous CVT-3146 Versus Adenoscan® in Patients Undergoing Stress Myocardial Perfusion Imaging|Completed||Phase 3|1231|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 05:36:20.694985|2017-10-11 05:36:20.694985
NCT00208312|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-11-24|||April 2004||2004-04-01|November 2009|2009-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)|A Phase III, Randomized, Double-Blind Study of Intravenous CVT-3146 Versus Adenoscan® in Patients Undergoing Stress Myocardial Perfusion Imaging|Completed||Phase 3|787|Actual|Gilead Sciences||2|||f||||f||||||||||2017-10-11 05:36:20.78696|2017-10-11 05:36:20.78696
NCT00208325|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-01|2015-06-05||May 2000||2000-05-01|August 2016|2016-08-01|September 2010|Actual|2010-09-01|January 2009|Actual|2009-01-01||Interventional||All participants who received treatment and were not mis-randomized.|PFC Sigma Fixed and Mobile Knee Study|Clinical Evaluation of the P.F.C. Sigma (Fixed Bearing) and P.F.C. Sigma RP (Mobile Bearing) Total Knee Systems|Terminated||Phase 4|754|Actual|DePuy International||4||"The study was terminated at the point the primary endpoint and early milestones were reached   and because long term outcomes were available from other sources"|f||||f||||||||||2017-10-11 05:36:20.947636|2017-10-11 05:36:20.947636
NCT00208338|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-07-01|||July 2005||2005-07-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|February 2007|Actual|2007-02-01||Interventional|||Pilot Study to Evaluate the Restore Orthobiologic Implant in Rotator Cuff Tear Repair|A Prospective, Randomised Pilot Study to Determine the Variability of Early Clinical Outcome in Subjects Undergoing Full Thickness Rotator Cuff Tear Repair, When Augmented With or Without Porcine Small Intestine Submucosa (RESTORE)|Completed||Phase 4|33|Actual|DePuy International||2|||f||||f||||||||||2017-10-11 05:36:24.868584|2017-10-11 05:36:24.868584
NCT00208351|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-09|||May 1997||1997-05-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|November 2004|Actual|2004-11-01||Interventional|||A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement|Clinical and Radiographic Evaluation to Compare a Polished and Non-polished Collared Stem and a Polished and Non Polished Collarless Stem in Primary Total Hip Replacement|Terminated||Phase 3|164|Actual|DePuy International||4||"The final assessments were conducted late and in a reduced format due to resource limitations   at the site."|f||||f||||||||||2017-10-11 05:36:24.969589|2017-10-11 05:36:24.969589
NCT00208364|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-06|||April 2004||2004-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|October 2014|Actual|2014-10-01||Interventional|||A Two Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Metal-on-Metal Bearing in Primary Total Hip Replacement|Uncontrolled Prospective Multi-Centre Post Marketing Surveillance Study to Monitor the Long Term Survivorship of Pinnacle Acetabular Cup Prosthesis With a Metal on Metal Bearing in Subjects With Aetiologies Requiring a Primary Total Hip Replacement|Terminated||Phase 4|163|Actual|DePuy International||1||Study terminated early due to business reasons|f||||f||||||||||2017-10-11 05:36:25.088178|2017-10-11 05:36:25.088178
NCT00208377|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-23|||July 2003||2003-07-01|June 2017|2017-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery|Prospective Multi-Centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-Term Performance of the DePuy ASR Hip System in Subjects With Suitable Indications for a Primary Resurfacing Hip Arthroplasty|Terminated||Phase 4|228|Actual|DePuy International||1||"DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all   clinical studies for this product and decided to close this Study."|f||||f||||||||||2017-10-11 05:36:25.159685|2017-10-11 05:36:25.159685
NCT00208390|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-08-03|||February 2003||2003-02-01|July 2016|2016-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement|Prospective, Uncontrolled, Multi-Centre, Post-Marketing Surveillance Study to Evaluate the Long-Term Performance of Summit Tapered Hip in Cementless Total Hip Arthroplasty|Terminated||Phase 4|275|Actual|DePuy International||1||"Study closed after the 5 year end-point was reached after a review of the status further to a   request from the investigators to discontinue participation."|f||||f||||||||||2017-10-11 05:36:25.256679|2017-10-11 05:36:25.256679
NCT00208403|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-27|||October 2002||2002-10-01|March 2017|2017-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Randomised Single Centre Study to Compare the Long-term Performance of Acryloc™ and Palacos® R Bone Cements in Primary Total Hip Replacement|Randomised, Prospective, RSA, PMS Study Comparing Acryloc™ & Palacos R in Primary Total Hip Arthroplasty|Terminated||Phase 4|36|Actual|DePuy International||2|||f||||f||||||||||2017-10-11 05:36:25.35534|2017-10-11 05:36:25.35534
NCT00208416|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-09|||October 2005||2005-10-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|December 2007|Actual|2007-12-01||Interventional|||A Randomised Multi-centre Study to Compare the Short-term Outcomes of Minimally Invasive and Conventional Surgery in Primary Total Hip Replacement|Randomised, Prospective, Post-Market Surveillance Study Comparing the Outcomes of Minimally Invasive and Conventional Surgical Procedures in Subjects Requiring Primary Total Hip Arthroplasty for Osteoarthritis.|Terminated||Phase 4|58|Actual|DePuy International||2||Combination of departure of Investigator from one site and slow recruitment rate|f||||f||||||||||2017-10-11 05:36:25.44467|2017-10-11 05:36:25.44467
NCT00208429|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-27|||July 1, 2004|Actual|2004-07-01|June 2017|2017-06-01|July 1, 2019|Anticipated|2019-07-01|July 1, 2009|Anticipated|2009-07-01||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip Replacement|Uncontrolled Prospective Multi-Centre Post Marketing Surveillance Study to Monitor the Long Term Survivorship of Pinnacle Acetabular Cup System With a Metal on Enduron Polyethylene Bearing in Subjects With Aetiologies Requiring a Primary Total Hip Replacement|Withdrawn||Phase 4|0|Actual|DePuy International||1||"Site Principal Investigator became seriously ill, so study abandoned before the start of   recruitment"|f||||f||||||||||2017-10-11 05:36:25.534598|2017-10-11 05:36:25.534598
NCT00208442|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-23|||June 1, 2001|Actual|2001-06-01|June 2017|2017-06-01|September 1, 2013|Actual|2013-09-01|September 1, 2006|Actual|2006-09-01||Interventional|||A Randomised Single Centre Study to Compare the Long-term Wear Characteristics of Marathon™ and Enduron™ Polyethylene Cup Liners in Primary Total Hip Replacement|A Prospective, Randomised, Controlled, Single Centre, Blinded Study of the Wear Characteristics of Two Polyethylene Bearing Surfaces, Enduron vs. Marathon|Completed||Phase 4|122|Actual|DePuy International||2|||f||||f||||||||||2017-10-11 05:36:25.795174|2017-10-11 05:36:25.795174
NCT00208455|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-23|||February 2005||2005-02-01|June 2017|2017-06-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement|An Uncontrolled, Multi-Centre, Prospective, Post Marketing Surveillance Study to Monitor the Long Term Survivorship of the DePuy PROXIMA™ Hip in Subjects Requiring a Total Hip Replacement|Terminated||Phase 4|184|Actual|DePuy International||1||"DePuy discontinued this product in 2013, the clinical program was reviewed and this Study was   closed."|f||||f||||||||||2017-10-11 05:36:25.917786|2017-10-11 05:36:25.917786
NCT00208468|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-06|||February 2000||2000-02-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|June 2005|Actual|2005-06-01||Interventional|||A Randomised Multi-centre Study to Compare the Long-term Performance of the Future Hip to 3 Other Implants in Primary Total Hip Replacement|A Multi-centre, Randomised, Parallel Group, Controlled Study to Compare the Performance of the Future Hip Against Three Currently Used Implants in Total Hip Replacement|Terminated||Phase 3|317|Actual|DePuy International||3||"Slow recruitment, investigators not wishing to continue with randomisation and a decision to   rationalise this product from the Sponsors portfolio."|f||||f||||||||||2017-10-11 05:36:26.039517|2017-10-11 05:36:26.039517
NCT00208481|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-09-30|||August 2004||2004-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-10-11 05:36:26.177979|2017-10-11 05:36:26.177979
NCT00208494|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-06|2011-07-11||August 2005||2005-08-01|August 2013|2013-08-01|June 2011|Actual|2011-06-01|December 2008|Actual|2008-12-01||Interventional|||Metal on Metal Versus Ceramic on Metal Hip Replacement|Comparative Study to Evaluate the Safety and Efficacy of the DePuy Ceramic-on-metal Total Hip Prosthesis Versus the DePuy Metal-on-metal Total Hip Prosthesis Through Clinical and Radiographical Data|Completed||N/A|392|Actual|DePuy Orthopaedics||2|||f||||f||||||||||2017-10-11 05:36:26.227294|2017-10-11 05:36:26.227294
NCT00208507|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-18|2011-01-21||April 2003||2003-04-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|March 2008|Actual|2008-03-01||Interventional|||28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study|Delta Ceramax™ Ceramic-on-Ceramic Acetabular Cup Prosthesis Study (28mm)|Completed||N/A|264|Actual|DePuy Orthopaedics||2|||f||||f||||||||||2017-10-11 05:36:26.723987|2017-10-11 05:36:26.723987
NCT00208533|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-28|||February 2004||2004-02-01|March 2017|2017-03-01|November 16, 2011|Actual|2011-11-16|November 16, 2011|Actual|2011-11-16||Interventional|||Aripiprazole in Children With Autism: A Pilot Study|Aripiprazole in Children With Autism: A Pilot Study|Completed||Phase 2|11|Actual|Drexel University||1|||f||||t||||||||No|No sharing plan|2017-10-11 05:36:27.285278|2017-10-11 05:36:27.285278
NCT00208546|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-01|||June 2005||2005-06-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer|Cetuximab Added to Capecitabine, Oxaliplatin and Bevacizumab in Patients With Previously Untreated Advanced Colorectal Carcinoma, a Randomised Phase III Study|Completed||Phase 3|750|Actual|Dutch Colorectal Cancer Group||2|||f||||t||||||||||2017-10-11 05:36:27.375365|2017-10-11 05:36:27.375365
NCT00208559|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-15|||February 2002||2002-02-01|June 2010|2010-06-01|August 2006|Actual|2006-08-01|June 2005|Actual|2005-06-01||Interventional|||Ziprasidone in Children With Autism: A Pilot Study|Ziprasidone in Children With Autism: A Pilot Study|Completed||Phase 2|15|Actual|Drexel University||1|||f||||t||||||||||2017-10-11 05:36:27.48294|2017-10-11 05:36:27.48294
NCT00208572|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-04|||November 2003||2003-11-01|October 2007|2007-10-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury|A Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury|Unknown status|Recruiting|N/A|104|Anticipated|Walter Reed Army Medical Center|||||f||||||||||||||2017-10-11 05:36:27.589106|2017-10-11 05:36:27.589106
NCT00208585|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-09|||February 2000||2000-02-01|October 2007|2007-10-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Sertraline vs. Placebo for Symptoms Following Traumatic Brain Injury|A Randomized Placebo-Controlled Trial of Sertraline for the Neurobehavioral Sequelae of Traumatic Brain Injury|Unknown status|Recruiting|N/A|100|Anticipated|Walter Reed Army Medical Center|||||f||||||||||||||2017-10-11 05:36:27.685008|2017-10-11 05:36:27.685008
NCT00208598|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2003||2003-01-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Observational|||Measures of Obesity and Co-Morbid Conditions in Maori||Completed||N/A|220||Edgar National Centre for Diabetes Research|||||f||||||||||||||2017-10-11 05:36:27.787043|2017-10-11 05:36:27.787043
NCT00208611|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-16|||September 2006||2006-09-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease|Assessment of Cobalamin Status and Responses to Supplementation in Patients With Parkinson's Disease : a Pilot Study|Terminated||Phase 2/Phase 3|57|Actual|Emory University||1||Funding ended and enrollment not completed within a certain time period|f||||f||||||||||2017-10-11 05:36:27.873105|2017-10-11 05:36:27.873105
NCT00208624|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-01|||December 2004||2004-12-01|May 2014|2014-05-01|May 2005||2005-05-01|||||Observational|||Rhythm Disturbances After Ventricular Septal Defects|Rhythm Disturbances After Ventricular Septal Defects|Terminated||N/A|30||Emory University|||||f||||||||||||||2017-10-11 05:36:27.981647|2017-10-11 05:36:27.981647
NCT00209365|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-02-13|||September 2005||2005-09-01|February 2017|2017-02-01|December 2005|Actual|2005-12-01|||||Interventional|||The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit||Completed||N/A|24||Fraunhofer-Institute of Toxicology and Experimental Medicine|||||f||||||||||||||2017-10-11 05:36:28.046478|2017-10-11 05:36:28.046478
NCT00209378|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-04-01|||May 2005||2005-05-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|CASH-CVVH||Citrate Versus Heparin Anticoagulation in Continuous Venovenous Hemofiltration|Citrate Versus Heparin Anticoagulation in Continuous Venovenous Hemofiltration in Critically Ill Patients With Acute Renal Failure: A Randomized Clinical Trial|Completed||N/A|139|Actual|Free University Medical Center||2|||f||||f||||||||||2017-10-11 05:36:28.136435|2017-10-11 05:36:28.136435
NCT00209391|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-30|||September 2003||2003-09-01|October 2007|2007-10-01||||||||Interventional|||A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide|GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title|Completed||Phase 3|270||GE Healthcare|||||||||||||||||||2017-10-11 05:36:28.271892|2017-10-11 05:36:28.271892
NCT00209404|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-18|2007-10-30|||July 2005||2005-07-01|October 2007|2007-10-01||||||||Interventional|||Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)||Completed||Phase 4|50||GE Healthcare|||||f||||||||||||||2017-10-11 05:36:28.345483|2017-10-11 05:36:28.345483
NCT00209417|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-24|2014-10-09|2014-10-02||June 2005||2005-06-01|October 2014|2014-10-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography|GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title.|Terminated||Phase 4|656|Actual|GE Healthcare||2||"Supported by preliminary interim analysis. Not based on any safety signals in study or any   quality issues that could affect efficacy of the product."|f||||||||||||||2017-10-11 05:36:28.430365|2017-10-11 05:36:28.430365
NCT00209430|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-30|||August 2005||2005-08-01|October 2007|2007-10-01||||||||Interventional|||Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography|GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title.|Completed||Phase 4|408||GE Healthcare|||||f||||||||||||||2017-10-11 05:36:28.961819|2017-10-11 05:36:28.961819
NCT00209443|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-30|||September 2004||2004-09-01|October 2007|2007-10-01||||||||Interventional|||A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-Iliac Arteries While Using Gadodiamide||Completed||Phase 3|295||GE Healthcare|||||||||||||||||||2017-10-11 05:36:29.031892|2017-10-11 05:36:29.031892
NCT00209456|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-05-15|||November 2003||2003-11-01|May 2007|2007-05-01||||||||Interventional|||Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia|GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title|Completed||Phase 3|326||GE Healthcare|||||f||||||||||||||2017-10-11 05:36:29.095128|2017-10-11 05:36:29.095128
NCT00209469|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-13|||July 2002||2002-07-01|September 2005|2005-09-01|February 2007||2007-02-01|||||Interventional|||Network Osteoporosis Study|Double Blind Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid-Associated Osteopenia and Osteoporosis|Unknown status|Active, not recruiting|Phase 2/Phase 3|90||Glaser Pediatric Research Network|||||||||||||||||||2017-10-11 05:36:29.166034|2017-10-11 05:36:29.166034
NCT00209482|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-04|||October 2003||2003-10-01|November 2005|2005-11-01|November 2007||2007-11-01|||||Interventional|||Glaser Obesity Study|A Multi-Center, Randomized, Placebo Controlled, Double Blind Trial of Metformin in Obese Adolescents.|Unknown status|Active, not recruiting|Phase 2/Phase 3|76||Glaser Pediatric Research Network|||||f||||||||||||||2017-10-11 05:36:29.253732|2017-10-11 05:36:29.253732
NCT00209495|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-28|||June 2005||2005-06-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Paracetamol,Pregabalin and Dexamethasone on Pain and Opioid Requirements in Postoperative Patients|Effect of Paracetamol Versus Paracetamol Combined With Pregabalin Versus Paracetamol Combined With Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Abdominal Hysterectomy.|Completed||Phase 4|130|Actual|Glostrup University Hospital, Copenhagen||3|||f||||t||||||||||2017-10-11 05:36:29.339022|2017-10-11 05:36:29.339022
NCT00209508|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-11-06|||November 2002||2002-11-01|November 2008|2008-11-01|October 2005|Actual|2005-10-01|||||Interventional|||2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 2-Year Study To Evaluate The Effects Of GPI 1485 On [123I]b-CIT/SPECT Scanning And Clinical Efficacy In Symptomatic PD Patients Receiving Dopamine Agonist Therapy.|Completed||Phase 2|200||Eisai Inc.|||||f||||||||||||||2017-10-11 05:36:29.437697|2017-10-11 05:36:29.437697
NCT00209521|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-10|||June 2002||2002-06-01|June 2010|2010-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery|Phase 2, Randomized Study of AQUAVAN® Injection In Elective Coronary Artery Surgery With Comparison to DISOPRIVAN® Injectable Emulsion|Completed||Phase 2|16|Actual|Eisai Inc.||2|||f||||f||||||||||2017-10-11 05:36:29.511116|2017-10-11 05:36:29.511116
NCT00209534|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-12-03|||January 2003||2003-01-01|December 2009|2009-12-01|February 2004|Actual|2004-02-01|||||Interventional|||A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy|A Phase 2, Two Part Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy|Completed||Phase 2|200||Eisai Inc.|||||||||||||||||||2017-10-11 05:36:29.624978|2017-10-11 05:36:29.624978
NCT00209547|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-11-06|||February 2004||2004-02-01|November 2008|2008-11-01|March 2005|Actual|2005-03-01|||||Interventional|||Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization|A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Percutaneous Coronary (PC) Procedures|Completed||Phase 3|110||Eisai Inc.|||||||||||||||||||2017-10-11 05:36:29.697825|2017-10-11 05:36:29.697825
NCT00209560|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-22|2012-03-01||October 2004||2004-10-01|July 2014|2014-07-01|March 2005||2005-03-01|||||Interventional|||A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures|A Phase III, Randomized, Open-label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Minor Surgical Procedures|Terminated||Phase 3|168|Actual|Eisai Inc.|Analysis of results from a previous fospropofol study (3000-0410) completed during the enrollment of this study indicated that the dosing regimen needed to be re-evaluated. The study was prematurely terminated after 168 subjects were randomized.||||f||||||||||||||2017-10-11 05:36:29.766255|2017-10-11 05:36:29.766255
NCT00209573|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-11-06|||September 2004||2004-09-01|November 2008|2008-11-01|December 2004|Actual|2004-12-01|||||Interventional|||A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy|A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN Injection Versus Midazolam HCl for Sedation in Patients Undergoing Colonoscopy Procedures|Completed||Phase 3|270||Eisai Inc.|||||||||||||||||||2017-10-11 05:36:30.368811|2017-10-11 05:36:30.368811
NCT00209586|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-01-31|||September 2004||2004-09-01|January 2012|2012-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy|A Phase III, Randomized, Open-label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Flexible Bronchoscopy Procedures|Terminated||Phase 3|55|Actual|Eisai Inc.||||"Patient enrollment was stopped prior to completion of the study in order to re-evaluate the   dosing regimen."|||||||||||||||2017-10-11 05:36:30.445597|2017-10-11 05:36:30.445597
NCT00209599|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-11-06|||February 2005||2005-02-01|November 2008|2008-11-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy|A Phase II, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Colonoscopy Procedures|Terminated||Phase 2|100||Eisai Inc.|||||||||||||||||||2017-10-11 05:36:30.521192|2017-10-11 05:36:30.521192
NCT00209612|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-16|||April 2004||2004-04-01|February 2009|2009-02-01|March 2009|Anticipated|2009-03-01|November 2008|Anticipated|2008-11-01||Interventional|||Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.|Phase I/II Study of Biweekly Administration Regimen of Paclitaxel Combined With CPT-11 in Patients With Second Line Chemotherapy of Inoperable or Recurrent Gastric Cancer(GC).|Withdrawn||Phase 1/Phase 2|40|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1||due to strong side effect|f||||t||||||||||2017-10-11 05:36:30.710654|2017-10-11 05:36:30.710654
NCT00209625|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||April 2000||2000-04-01|April 2000|2000-04-01|November 2004||2004-11-01|||||Interventional|||Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer|Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer：Hokkaido Gastrointestinal Cancer Study Group:HGCSG0001|Completed||Phase 1/Phase 2|23||Hokkaido Gastrointestinal Cancer Study Group|||||f||||||||||||||2017-10-11 05:36:30.81401|2017-10-11 05:36:30.81401
NCT00209638|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-04-19|||May 2000||2000-05-01|April 2006|2006-04-01|April 2003||2003-04-01|||||Interventional|||Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer|Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0101|Completed||Phase 1/Phase 2|24||Hokkaido Gastrointestinal Cancer Study Group|||||f||||||||||||||2017-10-11 05:36:30.894258|2017-10-11 05:36:30.894258
NCT00209651|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-31|||January 2004||2004-01-01|October 2007|2007-10-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer|Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302|Unknown status|Active, not recruiting|Phase 2|40|Actual|Hokkaido Gastrointestinal Cancer Study Group||1|||f||||t||||||||||2017-10-11 05:36:30.974633|2017-10-11 05:36:30.974633
NCT00209664|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-01-31|||January 2004||2004-01-01|January 2004|2004-01-01|December 2008||2008-12-01|||||Interventional|||Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer|Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0303|Suspended||Phase 2|40||Hokkaido Gastrointestinal Cancer Study Group|||||f||||||||||||||2017-10-11 05:36:31.072891|2017-10-11 05:36:31.072891
NCT00209677|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-31|||December 2004||2004-12-01|October 2007|2007-10-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer|Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer|Suspended||Phase 1/Phase 2|40|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1||"Unfortunately, other Phase III clinical Study (GEM+S-1 vs GEM vs S-1) have been started in   Japan.    h"|f||||t||||||||||2017-10-11 05:36:31.154264|2017-10-11 05:36:31.154264
NCT00209690|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-24|||October 2003||2003-10-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.|Phase I/II Study of Docetaxel, Cisplatin and 5-fluorouracil(TPF) as 1st-line Chemotherapy in Patients With Metastatic Esophageal Cancer.|Completed||Phase 1/Phase 2|30|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1|||f||||t||||||||||2017-10-11 05:36:31.248643|2017-10-11 05:36:31.248643
NCT00209703|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-04-19|||January 2005||2005-01-01|April 2006|2006-04-01|June 2007||2007-06-01|||||Interventional|||Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer|Feasibility Study of mFOLFOX6 (Oxaliplatin Combined With l-Leucovorin (l-LV) and 5-Fluorouracil) in Patients With Advanced Colorectal Cancer|Terminated||Phase 2|30||Hokkaido Gastrointestinal Cancer Study Group|||||f||||||||||||||2017-10-11 05:36:31.34397|2017-10-11 05:36:31.34397
NCT00209716|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-24|||December 2003||2003-12-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.|Phase I/II Study of Docetaxel, Cisplatin and 5-fluorouracil(TPF) as Chemotherapy in Pre-treated Patients With Metastatic Esophageal Cancer.|Completed||Phase 1/Phase 2|30|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1|||f||||t||||||||||2017-10-11 05:36:31.426016|2017-10-11 05:36:31.426016
NCT00209729|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-24|||April 2005||2005-04-01|May 2010|2010-05-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|||Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.|Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer|Suspended||Phase 1/Phase 2|50|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1||Registration is less|f||||t||||||||||2017-10-11 05:36:31.514208|2017-10-11 05:36:31.514208
NCT00209742|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-05-24|||April 2005||2005-04-01|May 2010|2010-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer|Randomized Phase III Clinical Study Comparing Postoperative UFT+LV, UFT+LV/UFT and UFT+LV+PSK/UFT+PSK Therapies for Stage III Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|340|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||3|||f||||t||||||||||2017-10-11 05:36:31.603523|2017-10-11 05:36:31.603523
NCT00209755|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 2003||2003-10-01|September 2004|2004-09-01|July 2004||2004-07-01|||||Interventional|||Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C|Diagnostic Value of Plasma Ribavirin Assay During the Combination Therapy « Pegylated Interferon + Ribavirin » in Chronic Hepatitis C.|Terminated||N/A|40||Hopital A Michallon|||||f||||||||||||||2017-10-11 05:36:31.694711|2017-10-11 05:36:31.694711
NCT00209768|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-11-28|||February 2005||2005-02-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Use of In-Line Filtration in Critically Ill Children|Randomised, Prospective Study of the Use of In-Line Filtration on the Reduction of Complication Rate in Critically Ill Children|Completed||Phase 4|821|Actual|Hannover Medical School||2|||f||||||||||||||2017-10-11 05:36:31.777406|2017-10-11 05:36:31.777406
NCT00209781|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-29|||August 2003||2003-08-01|February 2008|2008-02-01|December 2006||2006-12-01|||||Interventional|||IPTp Plus ITNs for Malaria Control in Pregnant Women|Effect of Intermittent Preventive Treatment (IPTp) With Sulfadoxine-Pyrimethamine Plus Insecticide Treated Nets, Delivered Through Antenatal Clinics for the Prevention of Malaria in Mozambican Pregnant Women|Unknown status|Active, not recruiting|N/A|1028||Hospital Clinic of Barcelona|||||f||||||||||||||2017-10-11 05:36:31.849207|2017-10-11 05:36:31.849207
NCT00209794|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-15|||September 2002||2002-09-01|November 2006|2006-11-01|December 2005||2005-12-01|||||Interventional|||IPTi in Mozambican Infants for Malaria Prevention|The Impact of Intermittent Malaria Treatment Administered Through the EPI Scheme on Malaria Morbidity in Mozambican Children|Unknown status|Active, not recruiting|Phase 1/Phase 2|1498||Hospital Clinic of Barcelona|||||f||||||||||||||2017-10-11 05:36:31.923522|2017-10-11 05:36:31.923522
NCT00209807|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-26|||September 2005||2005-09-01|May 2010|2010-05-01|April 2011|Anticipated|2011-04-01|June 2009|Anticipated|2009-06-01||Interventional|||Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder|Effect of Escitalopram vs. Reboxetine on Somatic and Visceral Sensitivity of Patients With Major Depressive Disorder: a Randomized, Double Blind Clinical Trial|Unknown status|Recruiting|Phase 4|42|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||||||||||||2017-10-11 05:36:31.9938|2017-10-11 05:36:31.9938
NCT00209820|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-10|||September 2005||2005-09-01|September 2005|2005-09-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Nordic Walking and Chronic Low Back Pain||Unknown status|Recruiting|N/A|150||Human Locomotion Science|||||f||||||||||||||2017-10-11 05:36:32.090423|2017-10-11 05:36:32.090423
NCT00209833|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-11-17|||January 1999||1999-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T|Protocol for the Treatment of Adults Aged </= 60 Years With De Novo Acute Myeloblastic Leukaemia or Secondary AML or RAEB-T (AML 01/99 Trial)|Unknown status|Active, not recruiting|Phase 2/Phase 3|200||Hannover Medical School|||||f||||||||||||||2017-10-11 05:36:32.16541|2017-10-11 05:36:32.16541
NCT00209846|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-03-29|||June 2004||2004-06-01|March 2007|2007-03-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study of Gaboxadol in Primary Insomnia|A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia|Completed||Phase 3|320||H. Lundbeck A/S|||||f||||f||||||||||2017-10-11 05:36:34.145077|2017-10-11 05:36:34.145077
NCT00209859|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16|||October 1998||1998-10-01|September 2005|2005-09-01|November 2007||2007-11-01|||||Interventional|||Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis|Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis.|Completed||Phase 4|160||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:36:34.226289|2017-10-11 05:36:34.226289
NCT00209872|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-11-06|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||Optimal Multimodal Analgesia in Abdominal Hysterectomy||Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:36:34.314918|2017-10-11 05:36:34.314918
NCT00209885|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy||Unknown status|Not yet recruiting|Phase 4|60||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:36:34.436829|2017-10-11 05:36:34.436829
NCT00209898|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-19|||August 2003||2003-08-01|June 2003|2003-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|PEGPRI||Hepatitis C Treatment of Inmates|Hepatitis C Treatment of Inmates. A Randomized, Open-label Study Evaluating the Feasibility, Safety and Efficacy of Treatment With Peginterferon Alfa-2a in Combination With Ribavirin in Inmate Patients With Chronic Hepatitis C|Terminated||Phase 4|42|Anticipated|Haukeland University Hospital||2||Low inclusion rate|f||||f||||||||||2017-10-11 05:36:34.529759|2017-10-11 05:36:34.529759
NCT00209911|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2001||2001-01-01|January 2001|2001-01-01|January 2003||2003-01-01|||||Observational|||Study of the Effect of Cardioversion on Cardiac Volume in Patients With Persistent Atrial Fibrillation|Atrial and Ventricular Volume and Function In Atrial Fibrillation - A Magnetic Resonance Imaging Study|Terminated||N/A|60||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:36:34.629787|2017-10-11 05:36:34.629787
NCT00209924|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-03-29|||April 2004||2004-04-01|March 2007|2007-03-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of Gaboxadol in Primary Insomnia|A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia|Completed||Phase 3|505||H. Lundbeck A/S|||||f||||f||||||||||2017-10-11 05:36:34.70755|2017-10-11 05:36:34.70755
NCT00209937|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-03-29|||January 2003||2003-01-01|March 2007|2007-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia|A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Active-Reference Study of Gaboxadol in Primary Insomnia|Completed||Phase 3|675||H. Lundbeck A/S|||||f||||f||||||||||2017-10-11 05:36:34.776401|2017-10-11 05:36:34.776401
NCT00209950|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-03-29|||July 2004||2004-07-01|March 2007|2007-03-01|September 2005|Actual|2005-09-01|||||Interventional|||A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia|A Prospective Open-Label Extension Study (to Study 99784) of Gaboxadol in Primary Insomnia|Completed||Phase 3|200||H. Lundbeck A/S|||||f||||f||||||||||2017-10-11 05:36:34.843508|2017-10-11 05:36:34.843508
NCT00209963|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-03-29|||June 2003||2003-06-01|March 2007|2007-03-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of Gaboxadol in Primary Insomnia|A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia|Completed||Phase 3|600||H. Lundbeck A/S|||||f||||f||||||||||2017-10-11 05:36:34.920203|2017-10-11 05:36:34.920203
NCT00209989|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-23|||October 2005||2005-10-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme|Phase I/II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme|Completed||Phase 2|27|Actual|Institut Claudius Regaud||1|||f||||||||||||||2017-10-11 05:36:34.984453|2017-10-11 05:36:34.984453
NCT00210002|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-11-13|||November 2003||2003-11-01|November 2006|2006-11-01|April 2006||2006-04-01|||||Interventional|||Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced|Evaluation of Systematic Intravenous Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced.|Terminated||Phase 2|55||Institut Claudius Regaud|||||f||||||||||||||2017-10-11 05:36:36.135928|2017-10-11 05:36:36.135928
NCT00210015|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-22|||December 2002||2002-12-01|January 2016|2016-01-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||A Study in Subjects With Perennial Allergic Rhinitis|A Multi-Center, Randomized, Parallel-Group, Double-Blind, Efficacy and Safety Study of INS37217 Nasal Spray Versus Placebo in Subjects With Perennial Allergic Rhinitis|Completed||Phase 2|630||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:36:36.21254|2017-10-11 05:36:36.21254
NCT00210028|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-10|||August 2003||2003-08-01|November 2006|2006-11-01|August 2008||2008-08-01|||||Interventional|||Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer|Open, Single-Arm Phase II Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer Expressing the Estrogen and/or Progesterone Receptor|Terminated||Phase 2|40||Institut Claudius Regaud|||||f||||||||||||||2017-10-11 05:36:36.291091|2017-10-11 05:36:36.291091
NCT00210041|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2015-03-26|||February 2004||2004-02-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma|Phase 2 Study for Treatment of Penis Epidermoid Carcinoma Loco-regionally Advanced or Metastatic by Association Gemcitabine-Cisplatin|Completed||Phase 2|50|Anticipated|Institut Claudius Regaud||1|||f||||||||||||||2017-10-11 05:36:36.360808|2017-10-11 05:36:36.360808
NCT00210054|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-09|||November 2002||2002-11-01|October 2015|2015-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Pharmacokinetic Evaluation Study in Healthy Volunteers|Pilot Single-Dose Intravenous Pharmacokinetic Evaluation of INS37217 Solution in Healthy Volunteers|Completed||Phase 1|4|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:36:36.451196|2017-10-11 05:36:36.451196
NCT00210067|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-08|||May 2001||2001-05-01|October 2015|2015-10-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||A Study in Subjects With Retinal Detachment|A Double-Masked, Randomized, Dose-Ranging Study of a Single Intravitreal (IVT) Injection of INS37217 Intravitreal Injection in Subjects With Retinal Detachment|Completed||Phase 1|14|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:36:36.515566|2017-10-11 05:36:36.515566
NCT00210080|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-03|||April 2001||2001-04-01|September 2015|2015-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)|A Double-Blind, Placebo-Controlled, Parallel Group Study of Uridine 5'-Triphosphate (UTP) Solution for Inhalation as an Adjunct in the Diagnosis of Lung Cancer by Sputum Cytology|Completed||Phase 3|700||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:36:36.567555|2017-10-11 05:36:36.567555
NCT00210093|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-15|||April 2003||2003-04-01|October 2015|2015-10-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||A Pharmacokinetic Evaluation Study in Healthy Volunteers|A Single-Center, Randomized, Crossover Pharmacokinetic Evaluation of the Effect of Single Doses of Intravenous INS37217, Nasally Inhaled INS37217 and Orally Inhaled INS37217 Solution in Healthy Volunteers|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:36:36.633992|2017-10-11 05:36:36.633992
NCT00210106|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-03-03|||June 2003||2003-06-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ARF2003||Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.|Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. A Phase 2 Study.|Completed||Phase 2|53|Anticipated|Institut Bergonié|||||f||||f||||||||||2017-10-11 05:36:36.682733|2017-10-11 05:36:36.682733
NCT00210119|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-25|||September 2005||2005-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|AFR22||Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response|Multicentric Phase II Study to Evaluate Feasibility and Efficacy of Association of Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response After One Year of Imatinib Mesylate Monotherapy|Terminated||Phase 2|17|Actual|Institut Bergonié|||||f||||||||||||||2017-10-11 05:36:36.762172|2017-10-11 05:36:36.762172
NCT00210132|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-11-25|||October 2003||2003-10-01|November 2015|2015-11-01|February 2008|Actual|2008-02-01|June 2006|Actual|2006-06-01||Interventional|ROPAL 1||Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery|Randomized Trial to Evaluate the Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery|Completed||Phase 2|90|Actual|Institut Bergonié||1|||f||||||||||||||2017-10-11 05:36:36.942127|2017-10-11 05:36:36.942127
NCT00210145|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-12-29|||October 2003||2003-10-01|October 2007|2007-10-01|June 2006|Actual|2006-06-01|||||Observational|ASE K SEIN||Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer.|Impact of a Socio-aesthetic Intervention on Body Image and Quality of Life in Patients With Mastectomy or Tumorectomy for Breast Cancer.|Completed||N/A|100|Anticipated|Institut Bergonié|||1||f||||||||||||||2017-10-11 05:36:37.021413|2017-10-11 05:36:37.021413
NCT00210158|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-25|||January 2005||2005-01-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|PROTOX||Intraoperative Nitrous Oxide and Postoperative Pain for Patients With Current Opioid Treatment|Effects of Intraoperative Nitrous Oxide on Postoperative Pain for Patients With Current Opioid Treatment After Vertebroplasty.|Completed||N/A|36|Actual|Institut Bergonié|||||f||||||||||||||2017-10-11 05:36:37.095712|2017-10-11 05:36:37.095712
NCT00210171|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-25|||May 2004||2004-05-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Interventional|BIB 01||Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer|Multicentric Phase II Study of Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-radiotherapy by Weekly Cisplatin - Docetaxel- Consolidation Chemotherapy by Docetaxel|Terminated||Phase 2|3|Actual|Institut Bergonié|||||f||||||||||||||2017-10-11 05:36:37.186133|2017-10-11 05:36:37.186133
NCT00210184|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-12-29|||July 2004||2004-07-01|October 2007|2007-10-01|July 2009||2009-07-01|||||Interventional|CEPAFIRI||Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer|Multicentric Phase II Trial: Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years Old and More Presenting Gastric Cancer Locally Advanced or Metastatic|Completed||Phase 2|43|Anticipated|Institut Bergonié|||||f||||||||||||||2017-10-11 05:36:37.279031|2017-10-11 05:36:37.279031
NCT00210197|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-25|||January 2005||2005-01-01|October 2007|2007-10-01|January 2006|Actual|2006-01-01|||||Observational|EHC||Hypercoagulability After Breast Cancer Surgery|Plasma Coagulation Parameters and Hypercoagulability After Breast Cancer Surgery|Completed||N/A|48|Actual|Institut Bergonié|||1||f||||||||||||||2017-10-11 05:36:37.370173|2017-10-11 05:36:37.370173
NCT00210210|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-25|||February 2004||2004-02-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|KETAMINE||Administration of Ketamine to Prevent the Post-operative Pain|Effect of Ketamine, at the Induction and Its Maintenance to Prevent the Post-operative Pain: Clinical Trial in Cancerology|Completed||Phase 3|230|Actual|Institut Bergonié|||||f||||||||||||||2017-10-11 05:36:37.445129|2017-10-11 05:36:37.445129
NCT00210223|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-25|||April 2004||2004-04-01|October 2007|2007-10-01|July 2006|Actual|2006-07-01|||||Interventional|RF SEIN||Radiofrequency of Breast Cancers in Non Surgical Patients|Radiofrequency of Breast Cancers : Pilot Study in Non Surgical Patients|Completed||N/A|15|Actual|Institut Bergonié|||||f||||||||||||||2017-10-11 05:36:37.540184|2017-10-11 05:36:37.540184
NCT00210236|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-07-25|||September 1995||1995-09-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|AXIL95||Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer|Surgical Resection With or Without Axillary Lymph Node Excision in Treating Menopausal Women With Infiltrative Breast Cancer Smaller Than 10 mm|Terminated||Phase 3|592|Actual|Institut Bergonié|||||f||||||||||||||2017-10-11 05:36:37.621884|2017-10-11 05:36:37.621884
NCT00210249|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-25|||September 2002||2002-09-01|September 2005|2005-09-01|June 2006|Actual|2006-06-01|||||Observational|ONCOGERIATRIE||Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment|Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment . Geriatric Oncology Protocol in Aquitaine Country.|Completed||N/A|360|Actual|Institut Bergonié|||1||f||||||||||||||2017-10-11 05:36:37.713441|2017-10-11 05:36:37.713441
NCT00210262|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2005-09-15|||October 2002||2002-10-01|November 2003|2003-11-01|January 2005||2005-01-01|||||Interventional|||Promoting Blood Pressure Control and Cholesterol Reduction to Prevent Major Complications in Persons With Diabetes|Promoting Blood Pressure Control and Cholesterol Reduction to Prevent Major Complications in Persons With Diabetes|Completed||N/A|||Institute for Clinical Evaluative Sciences|||||f||||||||||||||2017-10-11 05:36:37.797662|2017-10-11 05:36:37.797662
NCT00210275|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-25|||July 2005||2005-07-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|OPEMS||Ontario Printed Educational Materials (PEMs) for Physician Behaviour Change|The Ontario Printed Educational Message (OPEM) Trial to Narrow the Evidence-practice Gap With Respect to Prescribing Practices of General and Family Physicians: a Cluster Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|5000|Anticipated|Institute for Clinical Evaluative Sciences||4|||f||||f||||||||||2017-10-11 05:36:37.867569|2017-10-11 05:36:37.867569
NCT00210288|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-11|||May 2005||2005-05-01|March 2010|2010-03-01|April 2007|Actual|2007-04-01|September 2006|Actual|2006-09-01||Interventional|||Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine|A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 10^5 and 10^7 CFU of SC599 Oral Vaccine, a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers|Completed||Phase 2|111|Anticipated|Institut Pasteur|||||f||||||||||||||2017-10-11 05:36:37.933533|2017-10-11 05:36:37.933533
NCT00210301|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-06|||January 2003||2003-01-01|August 2005|2005-08-01||||||||Interventional|||Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS|Combination Therapy (Provigil + Avonex) in the Treatment of Attention Problems in Patients With Relapsing-Remitting MS|Unknown status|Recruiting|N/A|60||Institute for Clinical Research|||||f||||||||||||||2017-10-11 05:36:38.015273|2017-10-11 05:36:38.015273
NCT00210314|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-27|||July 2003||2003-07-01|March 2015|2015-03-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma|Randomized Phase II Trial on Primary Chemotherapy With High-dose Methotrexate, Alone or Associated With High-dose Cytarabine, Followed by Response- and Age-tailored Radiotherapy for Immunocompetent Patients With Newly Diagnosed Primary Central Nervous System Lymphoma|Completed||Phase 2|79|Actual|International Extranodal Lymphoma Study Group (IELSG)||2|||f||||||||||||||2017-10-11 05:36:38.086978|2017-10-11 05:36:38.086978
NCT00210327|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-07-21|||July 2005||2005-07-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy|Phase II Study of VELCADE in Patients With Extranodal Marginal Zone B-cell Lymphoma of MALT-type Pretreated With Prior Systemic Therapy Regimen (X05142)|Completed||Phase 2|33|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||t||||||||||2017-10-11 05:36:38.170721|2017-10-11 05:36:38.170721
NCT00210340|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-27||||||March 2015|2015-03-01||||||||Interventional|||A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis|A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis|Withdrawn||Phase 1|0|Actual|International Extranodal Lymphoma Study Group (IELSG)||1||lack of accrual|f||||||||||||||2017-10-11 05:36:38.230411|2017-10-11 05:36:38.230411
NCT00210353|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-07-26|||January 2003||2003-01-01|July 2016|2016-07-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma|Multicenter Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)|Active, not recruiting||Phase 3|450|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||3|||f||||t||||||||||2017-10-11 05:36:38.406237|2017-10-11 05:36:38.406237
NCT00210366|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-07-29|||November 2004||2004-11-01|July 2010|2010-07-01||||July 2010|Actual|2010-07-01||Interventional|||Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma|Salvage Therapy With Idarubicin in Immunocompetent Patients With Relapsed or Refractory Primary Central Nervous System Lymphomas|Terminated||Phase 2|25|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||||due to slow accrual|f||||||||||||||2017-10-11 05:36:38.674289|2017-10-11 05:36:38.674289
NCT00210379|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-07-21|||November 2000||2000-11-01|July 2009|2009-07-01|March 2007|Actual|2007-03-01|November 2004|Actual|2004-11-01||Interventional|||Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma|A Phase II Study of CHOP + Rituximab, With Intrathecal Methotrexate Followed by Radiotherapy in Patients With Primary Testicular Non-Hodgkin's Lymphoma|Completed||Phase 2|64|Actual|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||||||||||||2017-10-11 05:36:38.769971|2017-10-11 05:36:38.769971
NCT00210392|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-27|||July 2005||2005-07-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy|Phase II Study of VELCADE in Patients With Extranodal Marginal Zone B-Cell Lymphoma of MALT-Type Pretreated With More Than One Prior Systemic Therapy Regimen (X05142)|Terminated||Phase 2|12|Actual|International Extranodal Lymphoma Study Group (IELSG)||1||"After IELSG25A study amendment, patients subject of the present study were eligible for   inclusion in the IELSG25A study"|f||||t||||||||||2017-10-11 05:36:38.864142|2017-10-11 05:36:38.864142
NCT00210405|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-29|||March 2005||2005-03-01|August 2012|2012-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Feasibility and Effectiveness of Distributing Micronutrient Sprinkles to Reduce Prevalence of Anemia|Assessing the Feasibility and Effectiveness of Distributing Micronutrient Sprinkles Within a Title II Food Aid and Maternal and Child Health Program in Rural Haiti|Completed||N/A|450|Actual|International Food Policy Research Institute||2|||f||||||||||||||2017-10-11 05:36:38.947822|2017-10-11 05:36:38.947822
NCT00210418|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-29|||May 2002||2002-05-01|August 2012|2012-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Effectiveness of Targeting Food Aid to Malnourished Children Compared to Targeting All Children Under Two Years|Prevention or Cure: A Comparison of the Effectiveness of Targeting Food Supplements to Malnourished Children Compared to Universal Targeting of Children Under Two in Haiti|Completed||N/A|1500||International Food Policy Research Institute||2|||f||||||||||||||2017-10-11 05:36:39.066165|2017-10-11 05:36:39.066165
NCT00210431|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-29|||October 2004||2004-10-01|September 2007|2007-09-01|June 2006|Actual|2006-06-01|||||Observational|||Post Marketing Surveillance Study of Dysport|A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research.|Completed||Phase 4|800||Ipsen|||1||f||||||||||||||2017-10-11 05:36:39.168984|2017-10-11 05:36:39.168984
NCT00210444|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-09-12|||June 2003||2003-06-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy Study of Dysport® in the Treatment of Anal Fissure.|A Phase II, Multicentre, Open, Randomised, Parallel Group, Dose Ranging Study to Define the Efficacy of Dysport® in the Treatment of Anal Fissure.|Completed||Phase 2|152||Ipsen|||||f||||||||||||||2017-10-11 05:36:39.31111|2017-10-11 05:36:39.31111
NCT00210457|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2008-06-26|||September 2000||2000-09-01|June 2008|2008-06-01||||||||Interventional|||Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients|Phase III, Multicentre, Open Study to Assess the Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients Previously Treated or Not by Somatostatin Analogues.|Completed||Phase 3|60||Ipsen|||||f||||||||||||||2017-10-11 05:36:39.390459|2017-10-11 05:36:39.390459
NCT00210470|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-22|2012-01-06||July 2005||2005-07-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer|A Phase 2, Open-label Trial of the Safety and Biological Effect of Subcutaneous IRX-2 (With Cyclophosphamide, Indomethacin, and Zinc) in Patients With Resectable Cancer of the Head and Neck|Completed||Phase 2|27|Actual|IRX Therapeutics||1|||f||||f||||||||||2017-10-11 05:36:39.503958|2017-10-11 05:36:39.503958
NCT00210483|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-16|||July 2003||2003-07-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents|A Randomized, Double-blind, Placebo-controlled Study of Oral Almotriptan Malate (AXERT®) 6.25 mg, 12.5 mg, and 25 mg in the Acute Treatment of Migraine in Adolescents|Completed||Phase 3|866|Actual|Janssen-Ortho LLC||1|||||||||||||||||2017-10-11 05:36:39.782497|2017-10-11 05:36:39.782497
NCT00210496|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-16|||June 2005||2005-06-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine|Efficacy of AXERT (Almotriptan Malate) in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy With TOPAMAX (Topiramate)|Completed||Phase 4|406|Actual|Janssen-Ortho LLC|||||||||||||||||||2017-10-11 05:36:39.842054|2017-10-11 05:36:39.842054
NCT00210509|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-16|||November 2004||2004-11-01|April 2010|2010-04-01|June 2005|Actual|2005-06-01|||||Interventional|||A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache|AXERT® Early miGraine Intervention Study (AEGIS): Efficacy and Safety of Almotriptan Malate (AXERT®) Versus Placebo for the Acute Treatment of Migraine Headache|Completed||Phase 4|378|Actual|Janssen-Ortho LLC||1|||||||||||||||||2017-10-11 05:36:39.901878|2017-10-11 05:36:39.901878
NCT00210522|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-15||2013-01-15|May 2005||2005-05-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy|A Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects With Refractory Partial Seizures (Protocol 333369-EPY-2003 [Double-blind] and Protocol 333369-EPY-2006 [Open-label Extension])|Completed||Phase 2|421|Actual|SK Life Science||1|||f||||||||||||||2017-10-11 05:36:39.965137|2017-10-11 05:36:39.965137
NCT00210535|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-06|||June 2005||2005-06-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for the Prophylaxis of Migraine in Pediatric Subjects 12 to 17 Years of Age|Completed||Phase 3|110|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:40.040822|2017-10-11 05:36:40.040822
NCT00210548|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-06|||April 2005||2005-04-01|April 2010|2010-04-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (50 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Subjects With Schizophrenia|Completed||Phase 3|366|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:40.103446|2017-10-11 05:36:40.103446
NCT00210561|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||March 2005||2005-03-01|April 2010|2010-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back Pain|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) for the Treatment of Acute Low Back Pain|Terminated||Phase 4|22|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1||"Study was stopped shortly after initiation due to change in strategic direction of the company;   no safety concerns were observed that impacted this decision."|||||f||||||||||2017-10-11 05:36:40.176795|2017-10-11 05:36:40.176795
NCT00210574|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||March 2005||2005-03-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|||||Interventional|||A Pilot Study of Topiramate in Childhood Absence Epilepsy|A Pilot Study of Topiramate in Childhood Absence Epilepsy|Completed||Phase 2|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:40.238638|2017-10-11 05:36:40.238638
NCT00210587|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||February 2005||2005-02-01|May 2010|2010-05-01|December 2005|Actual|2005-12-01|||||Interventional|||An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation|A Pilot Study to Evaluate the Response Rate of Epoetin Alfa (PROCRIT) at 80,000 Units Every Three Weeks in Anemic Patients With Cancer Not Receiving Chemotherapy or Radiation Therapy|Completed||Phase 3|51|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:40.297725|2017-10-11 05:36:40.297725
NCT00210600|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||May 2005||2005-05-01|April 2010|2010-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy|Assessment of Early and Standard Intervention With PROCRIT (Epoetin Alfa) 120,000 Units Once Every Three Weeks (Q3W) in Patients With Cancer Receiving Chemotherapy.|Completed||Phase 2|186|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:40.364366|2017-10-11 05:36:40.364366
NCT00210613|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-06|||November 2004||2004-11-01|December 2010|2010-12-01|August 2005|Actual|2005-08-01|||||Interventional|||A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation|A Placebo-Controlled, Double-Blind, Randomized, Parallel Study of the Withdrawal Effects of Chronic Daily and As-Needed Dosing With Dapoxetine in the Treatment of Premature Ejaculation|Completed||Phase 3|199|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:40.533772|2017-10-11 05:36:40.533772
NCT00210626|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-02|2009-06-26||August 2005||2005-08-01|April 2014|2014-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of Recombinant Human Erythropoietin (Epoetin Alfa (PROCRIT®)) on Functional Outcomes in Anemic, Critically Ill, Trauma Subjects|Terminated||Phase 2|192|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|The study was stopped early due to slow enrollment. Four subjects were randomized but withdrew prior to hospital entry and no data were collected|2|||f||||t||||||||||2017-10-11 05:36:40.615841|2017-10-11 05:36:40.615841
NCT00210639|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-02|2011-04-26||August 2002||2002-08-01|April 2014|2014-04-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Observational|||A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection|A Multicenter, Long-Term, Active-Surveillance Study of Musculoskeletal Disorders That Occur After Initiating a Course of Levofloxacin (RWJ-25213-097) or Non-Fluoroquinolone Therapy for Acute Infectious Diseases in Children Who Were Enrolled in Phase 3 Clinical Trials Involving Levofloxacin Therapy|Completed||Phase 3|2233|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|This was an observational safety study with no efficacy endpoints. Adverse event data is entered into the appropriate section within this submission.||2||f||||f||||||||||2017-10-11 05:36:41.298868|2017-10-11 05:36:41.298868
NCT00210652|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-15||2013-01-15|July 2004||2004-07-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy|A Double-Blind, Placebo-Controlled, Dose-Titration Study to Determine Safety, Tolerability and Preliminary Efficacy of RWJ-333369 as Adjunctive Therapy in Subjects With Treatment-Resistant Partial Seizures (With or Without Secondary Generalization) or Primarily Generalized Tonic-Clonic Seizures|Completed||Phase 2|47|Actual|SK Life Science||1|||f||||||||||||||2017-10-11 05:36:41.872939|2017-10-11 05:36:41.872939
NCT00210678|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-09|||March 2005||2005-03-01|October 2012|2012-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation|An Observational Study to Evaluate Intravaginal Ejaculatory Latency Time and Patient-Reported Outcomes in Men With and Without Premature Ejaculation|Completed||Phase 3|1115|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||2||f||||f||||||||||2017-10-11 05:36:42.110323|2017-10-11 05:36:42.110323
NCT00210691|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-18|||December 1999||1999-12-01|November 2010|2010-11-01|February 2004|Actual|2004-02-01|||||Interventional|||A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder|Risperidone Depot (Microspheres) in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|273|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:42.182353|2017-10-11 05:36:42.182353
NCT00210704|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-06|||March 2005||2005-03-01|March 2010|2010-03-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation|A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation|Completed||Phase 3|1067|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:36:42.240828|2017-10-11 05:36:42.240828
NCT00210717|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-06|||February 2005||2005-02-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia|A Randomized, Double-Blind, Parallel Group, Comparative Study of Flexibly Dosed Paliperidone Palmitate (25, 50, 75, or 100 mg eq.) Administered Every 4 Weeks and Flexibly Dosed RISPERDAL CONSTA (25, 37.5, or 50 mg) Administered Every 2 Weeks in Subjects With Schizophrenia|Completed||Phase 3|748|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:36:42.306889|2017-10-11 05:36:42.306889
NCT00210730|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||June 2004||2004-06-01|March 2010|2010-03-01|July 2005|Actual|2005-07-01|||||Interventional|||The Duration Study|An Open Label Randomized Study To Evaluate The Response Rate Of Epoetin Alfa (PROCRIT�) Versus No/Delayed PROCRIT Treatment In Patients With Cancer And Persistent Chemotherapy-Induced Myelosuppression (Anemia)|Terminated||Phase 3|2|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||This study was stopped early due to slow enrollment.|||||f||||||||||2017-10-11 05:36:42.388865|2017-10-11 05:36:42.388865
NCT00210743|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-19|||May 2004||2004-05-01|April 2010|2010-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.|An Open-Label, Clinical Evaluation of the Initiation of Every 2 Week Epoetin Alfa (PROCRIT)in the Treatment of Subjects With the Anemia of Chronic Kidney Disease (CKD)|Completed||Phase 2|67|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:42.453965|2017-10-11 05:36:42.453965
NCT00210756|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||February 2004||2004-02-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.|Comparative Pharmacokinetic and Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Anemic Critically Ill Patients Randomized to One of Six Dose Regimens for 15 Days|Completed||Phase 2|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:42.515699|2017-10-11 05:36:42.515699
NCT00210769|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-17|||January 2004||2004-01-01|April 2010|2010-04-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia|Open-label Extension of A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of 2 Fixed Dosages of Extended Release OROS� Paliperidone (6 and 12 mg/Day) and Olanzapine (10 mg/Day), in Patients With Schizophrenia|Completed||Phase 3|203|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:42.586669|2017-10-11 05:36:42.586669
NCT00210782|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||June 2004||2004-06-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment|A Double-blind Trial Comparing the Efficacy, Tolerability and Safety of Monotherapy Topiramate Versus Phenytoin in Subjects With Seizures Indicative of New Onset Epilepsy|Completed||Phase 3|262|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:42.649161|2017-10-11 05:36:42.649161
NCT00210795|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||June 2004||2004-06-01|April 2010|2010-04-01|October 2005|Actual|2005-10-01|||||Interventional|||A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia|A Randomized, Double-blind, Placebo-controlled, Study to Assess Changes in Physical Function in Elderly Patients With Anemia of Chronic Disease (ACD) Receiving Epoetin Alfa (PROCRIT�)|Terminated||Phase 2|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"This study was stopped due to slow enrollment after enrolling only 12 of 80 patients over 14   months time."|||||t||||||||||2017-10-11 05:36:42.71082|2017-10-11 05:36:42.71082
NCT00210808|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||September 2003||2003-09-01|April 2010|2010-04-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity|A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity|Completed||Phase 2/Phase 3|407|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:36:42.777796|2017-10-11 05:36:42.777796
NCT00210821|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||February 2004||2004-02-01|May 2010|2010-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches|A Comparison of Topiramate Versus Amitriptyline in Migraine Prophylaxis|Completed||Phase 3|347|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:42.842853|2017-10-11 05:36:42.842853
NCT00210834|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||May 2004||2004-05-01|May 2010|2010-05-01|September 2005|Actual|2005-09-01|||||Interventional|||An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy.|A Randomized, Open-Label Study Of Epoetin Alfa (PROCRIT) Initiated At 40,000 Units Every Week Versus 80,000 Units Every Two Weeks In Anemic Patients With Cancer Receiving Chemotherapy|Completed||Phase 2|310|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:42.91264|2017-10-11 05:36:42.91264
NCT00210847|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||December 2003||2003-12-01|April 2010|2010-04-01|May 2005|Actual|2005-05-01|||||Interventional|||A Study Comparing the Effectiveness and Safety of Tramadol HCl/Acetaminophen Versus Placebo for the Treatment of Painful Neuropathy in Diabetic Patients|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Tramadol HCl/Acetaminophen for the Treatment of Painful Diabetic Neuropathy|Completed||Phase 3|313|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:36:42.992117|2017-10-11 05:36:42.992117
NCT00210860|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||September 2004||2004-09-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Interventional|||An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.|An Open-label Study of the Safety and Efficacy of Topiramate for Migraine Prophylaxis: Extension Study to CAPSS-277|Completed||Phase 3|142|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:36:43.068391|2017-10-11 05:36:43.068391
NCT00210873|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||February 2004||2004-02-01|May 2010|2010-05-01|August 2005|Actual|2005-08-01|||||Interventional|||An Open Label Extension of a Study of Topiramate in Chronic Migraine.|An Open-label Study of the Safety and Efficacy of Topiramate for the Prophylaxis of Chronic Migraine: Extension Study to CAPSS-276|Completed||Phase 3|200|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:43.152699|2017-10-11 05:36:43.152699
NCT00210886|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||October 2004||2004-10-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|||||Interventional|||A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.|A Multicenter, Double-blind, Randomized Study to Compare the Efficacy and Safety of Levofloxacin 750 mg Once Daily for Five Days Versus Ciprofloxacin Twice Daily for Ten Days in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis.|Completed||Phase 3|1109|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:43.229324|2017-10-11 05:36:43.229324
NCT00210899|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-25|||September 2005||2005-09-01|July 2012|2012-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections|A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections|Completed||Phase 3|828|Actual|Basilea Pharmaceutica||2|||f||||f||||||||||2017-10-11 05:36:43.447428|2017-10-11 05:36:43.447428
NCT00210912|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||September 2003||2003-09-01|April 2010|2010-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches|A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Chronic Migraine|Completed||Phase 3|328|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:36:43.567502|2017-10-11 05:36:43.567502
NCT00210925|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-06|||March 2004||2004-03-01|April 2010|2010-04-01|August 2006|Actual|2006-08-01|||||Interventional|||An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Alcohol Dependence|Completed||Phase 2|371|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:43.644151|2017-10-11 05:36:43.644151
NCT00210938|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||March 2004||2004-03-01|April 2010|2010-04-01|January 2006|Actual|2006-01-01|||||Interventional|||Doripenem in the Treatment of Complicated Intra-Abdominal Infections|A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Versus Comparator Antibiotic in the Treatment of Complicated Intra-Abdominal Infections|Completed||Phase 3|478|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:43.745859|2017-10-11 05:36:43.745859
NCT00210951|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-23|||May 2003||2003-05-01|March 2015|2015-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin|An Active Safety Surveillance Plan to Conduct Serologic Testing for Anti-erythropoietin Antibodies and Prospectively Monitor the Incidence of Pure Red Cell Aplasia (PRCA) Among Patients Receiving Epoetin Alfa or Another Erythropoietin|Completed||Phase 4|4761|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||f||||||||||2017-10-11 05:36:43.824201|2017-10-11 05:36:43.824201
NCT00210964|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-27||2011-06-02|April 2005||2005-04-01|August 2012|2012-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Ceftobiprole in Hospital Acquired Pneumonia|A Phase III Randomized Double-Blind Study Of Ceftobiprole Versus Linezolid Plus Ceftazidime In The Treatment Of Nosocomial Pneumonia|Completed||Phase 3|781|Actual|Basilea Pharmaceutica||2|||f||||t||||||||||2017-10-11 05:36:43.906245|2017-10-11 05:36:43.906245
NCT00210977|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-29|||December 2005||2005-12-01|August 2013|2013-08-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies|An Observational Study of Subjects Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies|Withdrawn||Phase 4|0|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1|The study never started due to zero enrolment|f||||t||||||Samples With DNA|"     Blood samples will be collected for pharmacogenomic analysis.   "|||2017-10-11 05:36:43.994835|2017-10-11 05:36:43.994835
NCT00210990|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||March 2004||2004-03-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|||||Interventional|||Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis|A Multicenter, Phase 3 Study of the Safety and Effectiveness of Doripenem in Complicated Lower Urinary Tract Infection or Pyelonephritis|Completed||Phase 3|403|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:44.077969|2017-10-11 05:36:44.077969
NCT00211003|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||May 2004||2004-05-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Doripenem in the Treatment of Hospital-Acquired Pneumonia|A Multicenter, Randomized, Open-Label, Phase 3 Study to Compare the Safety and Effectiveness of Doripenem Versus a Comparator Antibiotic in Hospital-Acquired Pneumonia|Completed||Phase 3|240|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:44.146418|2017-10-11 05:36:44.146418
NCT00211016|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||August 2004||2004-08-01|March 2010|2010-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Doripenem in the Treatment of Ventilator-Associated Pneumonia|A Multicenter, Randomized, Open-Label, Phase 3 Study of Doripenem Versus a Comparator Antibiotic in the Treatment of Ventilator-Associated Pneumonia|Completed||Phase 3|318|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:44.210467|2017-10-11 05:36:44.210467
NCT00211029|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-30|||January 2003||2003-01-01|July 2015|2015-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins|An Active Safety Surveillance Plan to Prospectively Monitor the Incidence of Pure Red Cell Aplasia (PRCA) Among Patients Receiving Epoetin Alfa Therapy or Other Recombinant Erythropoietins|Completed||Phase 4|4670|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||f||||||||||2017-10-11 05:36:44.28659|2017-10-11 05:36:44.28659
NCT00211042|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-04-29|||February 2004||2004-02-01|April 2013|2013-04-01|December 2006|Actual|2006-12-01|||||Observational|||A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment|Observational, Multicenter Study of Subjects With Pure Red Cell Aplasia Associated With r-HuEPO Treatment|Completed||Phase 4|52|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||t||||||||||2017-10-11 05:36:44.367833|2017-10-11 05:36:44.367833
NCT00211055|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-04-15|||September 2004||2004-09-01|April 2013|2013-04-01|March 2005|Actual|2005-03-01|||||Observational|||A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children|A Multicenter, Epidemiological, Observational Study of the Management of Anemia in Critically Ill Pediatric Patients|Completed||N/A|1201|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:36:44.488665|2017-10-11 05:36:44.488665
NCT00211068|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-04-29|||March 2004||2004-03-01|April 2013|2013-04-01|March 2006|Actual|2006-03-01|||||Observational|||A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa|Retrospective Case-control Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa|Completed||Phase 4|124|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||t||||||Samples With DNA|"     Blood sample collected for pharmacogenomic analysis   "|||2017-10-11 05:36:44.555293|2017-10-11 05:36:44.555293
NCT00211081|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-08|2014-12-08||November 2004||2004-11-01|December 2014|2014-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Spironolactone in Patients With Single Ventricle Heart|Impact of Spironolactone on Endothelial Function in Patients With Single Ventricle Heart|Completed||N/A|12|Actual|Emory University||1|||f||||f||||||||||2017-10-11 05:36:44.722284|2017-10-11 05:36:44.722284
NCT00211094|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-02-10||||||February 2011|2011-02-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation|A Placebo-Controlled, Double-blind, Randomized, Parallel Study of the Efficacy and Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation|Completed||Phase 3|1320|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-10-11 05:36:44.922926|2017-10-11 05:36:44.922926
NCT00211107|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-05-18|||June 2003||2003-06-01|March 2010|2010-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.|A Placebo-Controlled, Double-Blind, Randomized, Parallel Study Of The Efficacy And Safety Of Dapoxetine HCl In The Treatment Of Rapid Ejaculation|Completed||Phase 3|1294|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-10-11 05:36:44.992081|2017-10-11 05:36:44.992081
NCT00211120|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-17|||March 2002||2002-03-01|March 2010|2010-03-01|August 2005|Actual|2005-08-01|||||Interventional|||Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)|Correction of Hemoglobin and Outcomes In Renal Insufficiency|Terminated||Phase 4|1432|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"Stopped by the DSMB due to a trend toward more adverse events in the higher hemoglobin (Hb) arm   and <5% chance that the study would show benefit for higher Hb."|f||||t||||||||||2017-10-11 05:36:45.074065|2017-10-11 05:36:45.074065
NCT00211133|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-29|||June 2000||2000-06-01|November 2010|2010-11-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy|A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Impact of Maintaining Hemoglobin Using Eprex (Epoetin Alfa) in Metastatic Breast Carcinoma Subjects Receiving Chemotherapy|Completed||Phase 3|939|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:36:45.153327|2017-10-11 05:36:45.153327
NCT00211146|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-08|||April 1998||1998-04-01|April 2010|2010-04-01|May 2006|Actual|2006-05-01|||||Interventional|||A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)|An Open-Label, Randomized, Parallel-Group Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Subjects Undergoing Major Elective Spinal Surgery|Completed||Phase 3|680|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:45.238144|2017-10-11 05:36:45.238144
NCT00211159|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-07-27|||December 2000||2000-12-01|April 2005|2005-04-01||||||||Interventional|||OmegAD (Omega-3 and Alzheimer's Disease)|Omega-3 Fatty Acid Treatment of 174 Patients With Mild to Moderate Alzheimer's Disease (OmegAD): a Randomized Double-blind Trial|Completed||N/A|204||Karolinska University Hospital|||||f||||||||||||||2017-10-11 05:36:45.308068|2017-10-11 05:36:45.308068
NCT00211172|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-10-07|2009-08-05||October 2003||2003-10-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|December 2005|Actual|2005-12-01||Interventional|||HMO Research Network CERT: Acute Myocardial Infarction|The HMO Research Network CERT: Acute Myocardial Infarction|Completed||N/A|836|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-10-11 05:36:45.394728|2017-10-11 05:36:45.394728
NCT00211198|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-29|||May 2001||2001-05-01|February 2008|2008-02-01|January 2006|Actual|2006-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)|Open Label Study of ONTAK® (Denileukin Diftitox, DAB389IL-2) to Estimate Response in Cutaneous T-Cell Lymphoma (CTCL) According to CD25 Status|Completed||Phase 4|60||Eisai Inc.|||||f||||t||||||||||2017-10-11 05:36:45.797112|2017-10-11 05:36:45.797112
NCT00211211|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-18|||February 2003||2003-02-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||FREE Study - Fracture Reduction Evaluation|An International Multicentric, Multidisciplinary Prospective and Randomized Study to Compare Minimally Invasive Reduction and Fixation Using the KyphX System and Radiopaque PMMA Cement to Medical Therapy Alone for the Treatment of Painful, Acute Osteopenic Vertebral Body Compression Fractures|Completed||Phase 4|300||Medtronic Spine LLC|||||f||||||||||||||2017-10-11 05:36:45.90203|2017-10-11 05:36:45.90203
NCT00211224|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-14|||April 2000||2000-04-01|September 2005|2005-09-01|November 2004||2004-11-01|||||Interventional|||Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)|Phase 3 Study of Riluzole in Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) (Parkinson's Plus Syndromes)|Terminated||Phase 3|800||King's College London|||||f||||||||||||||2017-10-11 05:36:45.983313|2017-10-11 05:36:45.983313
NCT00211250|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-27|||July 2005||2005-07-01|January 2009|2009-01-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER|An Exploratory Study Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar I and II Patients From Valproic Acid to Depakote ER|Completed||Phase 4|20|Anticipated|Joliet Center for Clinical Research||1|||f||||t||||||||||2017-10-11 05:36:48.809224|2017-10-11 05:36:48.809224
NCT00211263|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-07|||November 2003||2003-11-01|June 2005|2005-06-01|February 2007||2007-02-01|||||Interventional|||Bipolar Disorder Research Study for Ages 12 and Older|Bipolar Disorder Center for Pennsylvanians (BDCP) Research Study|Completed||N/A|750||Kupfer, David J., M.D.||2|||||||||||||||||2017-10-11 05:36:48.883446|2017-10-11 05:36:48.883446
NCT00211276|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-13|||March 2005||2005-03-01|March 2011|2011-03-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma|A Phase II Multicenter Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non-Hodgkins Lymphoma.|Completed||Phase 2|50|Anticipated|Eisai Inc.|||||f||||||||||||||2017-10-11 05:36:48.984721|2017-10-11 05:36:48.984721
NCT00211289|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-14|||July 2002||2002-07-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||Trial of Education and Compliance in Heart Dysfunction (TEACH)|Trial of Education and Compliance in Heart Dysfunction. A Study Measuring the Impact of Multi-Disciplinary Education as an Intervention to Increase Patient Concordance and the Cost Effectiveness of Treatment in Patients With Heart Dysfunction|Unknown status|Recruiting|Phase 3|383|Anticipated|London Health Sciences Centre|||||f||||||||||||||2017-10-11 05:36:49.067544|2017-10-11 05:36:49.067544
NCT00211302|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-09-02|||August 2003||2003-08-01|September 2011|2011-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)|Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia. (BMS)|Terminated||N/A|8|Actual|Louisiana State University Health Sciences Center Shreveport||1||Enrollment too difficult|f||||f||||||||||2017-10-11 05:36:49.164799|2017-10-11 05:36:49.164799
NCT00211315|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-23|||March 2002||2002-03-01|October 2012|2012-10-01|March 2007||2007-03-01|||||Interventional|||Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)||Completed||Phase 2|4|Actual|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-10-11 05:36:49.259128|2017-10-11 05:36:49.259128
NCT00211328|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-03|||March 2002||2002-03-01|February 2009|2009-02-01|March 2007|Actual|2007-03-01|||||Interventional|||Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).||Completed||Phase 2|5|Actual|Manhattan Eye, Ear & Throat Hospital||1|||t||||f||||||||||2017-10-11 05:36:49.34252|2017-10-11 05:36:49.34252
NCT00211354|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-03|||March 2002||2002-03-01|February 2009|2009-02-01|April 2007|Anticipated|2007-04-01|March 2007|Anticipated|2007-03-01||Interventional|||Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)||Withdrawn||Phase 2|0|Actual|Manhattan Eye, Ear & Throat Hospital||1||No subjects enrolled|t||||f||||||||||2017-10-11 05:36:49.572363|2017-10-11 05:36:49.572363
NCT00211367|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-20|||April 2004||2004-04-01|June 2007|2007-06-01|March 2007|Actual|2007-03-01|||||Interventional|||Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)||Terminated||Phase 2|2|Actual|Manhattan Eye, Ear & Throat Hospital||||poor enrollment|t||||f||||||||||2017-10-11 05:36:49.653465|2017-10-11 05:36:49.653465
NCT00211380|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-09-02|||August 2003||2003-08-01|September 2011|2011-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)|Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia, (SFBRI).|Terminated||N/A|8|Actual|Louisiana State University Health Sciences Center Shreveport||1||Recruitment was too difficult|f||||f||||||||||2017-10-11 05:36:49.729649|2017-10-11 05:36:49.729649
NCT00211393|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-24|||May 2005||2005-05-01|October 2012|2012-10-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|CSC/Keto||A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole|A Pilot Study of The Treatment of Central Serous Chorioretinopathy With Ketoconazole.|Completed||Phase 2|5|Actual|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-10-11 05:36:49.811153|2017-10-11 05:36:49.811153
NCT00211406|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-05-06||||||May 2007|2007-05-01||||||||Interventional|||Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)||Terminated||Phase 1|||Manhattan Eye, Ear & Throat Hospital|||||f||||f||||||||||2017-10-11 05:36:49.879588|2017-10-11 05:36:49.879588
NCT00211419|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-23||||||September 2005|2005-09-01||||||||Interventional|||Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)|Pilot Study of the Combination of Anecortave Acetate 15mg Delivered by Posterior Juxtascleral Injection and Triamcinolone Acetonide 4mg Delivered by Intravitreal Injection for the Treatment of Exudative Age-Related Macular Degeneration (AMD)|Completed||Phase 1|||Manhattan Eye, Ear & Throat Hospital|||||||||||||||||||2017-10-11 05:36:49.937627|2017-10-11 05:36:49.937627
NCT00211432|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-24|||April 2008||2008-04-01|October 2012|2012-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)||Completed||Phase 2|4|Actual|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-10-11 05:36:49.997452|2017-10-11 05:36:49.997452
NCT00211445|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-27|||July 2002||2002-07-01|September 2007|2007-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)||Completed||Phase 2|11|Actual|Manhattan Eye, Ear & Throat Hospital|||||f||||f||||||||||2017-10-11 05:36:50.096239|2017-10-11 05:36:50.096239
NCT00211458|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-24|||September 2005||2005-09-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Treatment of Age-Related Macular Degeneration With Anecortave Acetate|Treatment of Age-Related Macular Degeneration With Open-label Anecortave Acetate Sterile Suspension (15mg) Following Failed Treatment With Photodynamic Therapy With Visudyne|Completed||Phase 2|||Manhattan Eye, Ear & Throat Hospital|||||f||||f||||||||||2017-10-11 05:36:50.172653|2017-10-11 05:36:50.172653
NCT00211471|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-05-04|||March 2002||2002-03-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).|Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension (15mg.).|Terminated||Phase 2|0|Actual|Manhattan Eye, Ear & Throat Hospital||||poor enrollment|t||||f||||||||||2017-10-11 05:36:50.236802|2017-10-11 05:36:50.236802
NCT00211484|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-05-04|||May 2003||2003-05-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.||Completed||Phase 2|5|Actual|Manhattan Eye, Ear & Throat Hospital|||||t||||f||||||||||2017-10-11 05:36:50.307416|2017-10-11 05:36:50.307416
NCT00211497|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 2003||2003-01-01|September 2005|2005-09-01|September 2003||2003-09-01|||||Interventional|||Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne|A Phase II, Randomized, Vehicle-Controlled, Double-Blind, Multi-Center Study to Evaluate Safety and Efficacy of MBI 226 1.25% and 2.5% Acne Solutions Applied Topically for 12 Weeks to Subjects With Acne Vulgaris|Completed||Phase 2|255||BioWest Therapeutics Inc|||||||||||||||||||2017-10-11 05:36:51.894446|2017-10-11 05:36:51.894446
NCT00211510|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-10|2011-04-01||June 2005||2005-06-01|May 2017|2017-05-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Interventional|STAR1||Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes|Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes: A Multi-center, Randomized Controlled Trial|Completed||N/A|146|Actual|Medtronic Diabetes||2|||f||||f|f|t|f|f||||No||2017-10-11 05:36:51.964608|2017-10-11 05:36:51.964608
NCT00211523|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 2000||2000-10-01|September 2005|2005-09-01|September 2001||2001-09-01|||||Interventional|||Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne|Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of MBI 226 2.5% and 5.0% Acne Solutions Applied Topically for 6 Weeks to Subjects With Acne Vulgaris|Completed||Phase 2|75||BioWest Therapeutics Inc|||||||||||||||||||2017-10-11 05:36:52.321819|2017-10-11 05:36:52.321819
NCT00211536|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-09-19|2011-04-25||June 2002||2002-06-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|August 2004|Actual|2004-08-01||Interventional|MIP310||Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration|A Randomized, Active Control, Multi-Center Study Comparing the Effect of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration on Glycemic Control and the Frequency of Severe Hypoglycemia|Completed||Phase 3|107|Actual|Medtronic Diabetes||2|||f||||f||||||||||2017-10-11 05:36:52.392078|2017-10-11 05:36:52.392078
NCT00211549|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-19|||June 2005||2005-06-01|March 2009|2009-03-01||||||||Interventional|||An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee|A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Doses of IDEA-033 in Comparison to Oral Naproxen for the Treatment of the Signs and Symptoms of Osteoarthritis of the Knee|Completed||Phase 2|875||IDEA AG|||||||||||||||||||2017-10-11 05:36:52.917653|2017-10-11 05:36:52.917653
NCT00211562|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-23|||October 2005||2005-10-01|October 2012|2012-10-01||||January 2006|Actual|2006-01-01||Interventional|||Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids|Reduction of Body Weight in Olanzapine Treated Schizophrenia Patients by Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids|Terminated||Phase 3|20|Actual|Augusta University||3|||f||||||||||||||2017-10-11 05:36:53.18741|2017-10-11 05:36:53.18741
NCT00211575|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-01-02|||May 2003||2003-05-01|January 2015|2015-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Instrument Utility for Suspected Asthma (0000-042)(COMPLETED)|Clinical Utility of an Instrument in the Evaluation of Young Children With Suspected Asthma|Completed||N/A|400|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:36:53.275135|2017-10-11 05:36:53.275135
NCT00211588|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-05-04|||June 2004||2004-06-01|May 2007|2007-05-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Galantamine Executive Function in Parkinson's Disease|Investigator Initiated Study: Galantamine CR Potential Enhancement of Attentional and Executive Function in Non-Demented Patients With Parkinson's Disease|Unknown status|Active, not recruiting|N/A|90|Anticipated|Memorial Hospital of Rhode Island||1|||f||||t||||||||||2017-10-11 05:36:53.336233|2017-10-11 05:36:53.336233
NCT00211601|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-30|||August 2004||2004-08-01|April 2015|2015-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|C-PHONE||Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)|Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis|Completed||N/A|1500||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:36:53.409439|2017-10-11 05:36:53.409439
NCT00211614|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-20|||July 2006||2006-07-01|February 2007|2007-02-01|July 2007||2007-07-01|||||Interventional|||Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea|Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea|Terminated||N/A|50||MetroHealth Medical Center|||||f||||||||||||||2017-10-11 05:36:53.46586|2017-10-11 05:36:53.46586
NCT00211627|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2004||2004-06-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.|Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.|Unknown status|Recruiting|Phase 1|30||Miller, Chipp St. Kevin, M.D.|||||f||||||||||||||2017-10-11 05:36:53.551294|2017-10-11 05:36:53.551294
NCT00211640|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13||||||August 2005|2005-08-01||||||||Observational|||Identification and Treatment of Men With BPH in the Primary Care Setting|A Proactive Approach to the Identification and Treatment of Men With BPH Inthe Primary Care Setting|Completed||N/A|1100||Mid Michigan Health Centers|||||f||||||||||||||2017-10-11 05:36:53.642271|2017-10-11 05:36:53.642271
NCT00211653|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-18|||April 2003||2003-04-01|September 2007|2007-09-01|November 2006|Actual|2006-11-01|||||Interventional|||Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery|Single Center Randomized Clinical Trial of the Effects of Acetylcysteine in the Prevention of Postoperative Renal Failure|Completed||Phase 1/Phase 2|102|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-10-11 05:36:53.689603|2017-10-11 05:36:53.689603
NCT00211666|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 2002||2002-09-01|September 2005|2005-09-01|August 2006||2006-08-01|||||Interventional|||Improving Hypertension Control in East and Central Harlem|Improving the Delivery of Effective Care to Minorities|Completed||N/A|480||Icahn School of Medicine at Mount Sinai|||||f||||||||||||||2017-10-11 05:36:53.758452|2017-10-11 05:36:53.758452
NCT00211679|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2004||2004-06-01|July 2005|2005-07-01|June 2007||2007-06-01|||||Interventional|||Intra-articularInjection of Botulinum Toxin Type|Intra-articularInjection of Botulinum Toxin Type a for the Treatment of Chronic Knee Pain: A Randomized, Placebo Controlled, Double Blind Study|Unknown status|Recruiting|Phase 2|40||Minneapolis Veterans Affairs Medical Center|||||||||||||||||||2017-10-11 05:36:53.825|2017-10-11 05:36:53.825
NCT00211692|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-11-20|2011-08-01||July 2005||2005-07-01|November 2014|2014-11-01|September 2009|Actual|2009-09-01|July 2008|Actual|2008-07-01||Interventional|||Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial|Prospective Randomized Pilot Study of Daily Consensus Interferon (CIFN) and Ribavirin for 52 Wks vs Extended Duration 72 Wks Based on Virologic Response for the Initial Treatment of Difficult-to-treat Patients With Chronic HCV Genotype 1|Completed||Phase 3|64|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||t||||||||||2017-10-11 05:36:53.923294|2017-10-11 05:36:53.923294
NCT00211705|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-30|||February 1994||1994-02-01|June 2005|2005-06-01|March 2004||2004-03-01|||||Interventional|||Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)|Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)|Completed||Phase 4|8000||Mitsukoshi Health and Welfare Foundation|||||f||||||||||||||2017-10-11 05:36:54.432846|2017-10-11 05:36:54.432846
NCT00211718|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-11-02|||July 2004||2004-07-01|August 2005|2005-08-01|June 2007||2007-06-01|||||Interventional|||Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain|Intra-Articular Injection of Botulinum Toxin Type A for the Treatment of Shoulder Pain: A Randomized, Double Blinded, Placebo Controlled Trial|Unknown status|Recruiting|Phase 3|40||Minneapolis Veterans Affairs Medical Center|||||||||||||||||||2017-10-11 05:36:54.538132|2017-10-11 05:36:54.538132
NCT00211731|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-11-10|||September 2002||2002-09-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Preventing Recurrent Stroke in Minority Populations|Improving the Delivery of Effective Care to Minorities|Completed||N/A|87|Actual|Icahn School of Medicine at Mount Sinai|||||f||||||||||||||2017-10-11 05:36:54.654667|2017-10-11 05:36:54.654667
NCT00211744|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-05|||August 2004||2004-08-01|December 2005|2005-12-01|August 2006|Anticipated|2006-08-01|||||Interventional|||Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder|Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder|Unknown status|Recruiting|Phase 4|24|Anticipated|Icahn School of Medicine at Mount Sinai|||||||||||||||||||2017-10-11 05:36:54.743958|2017-10-11 05:36:54.743958
NCT00211757|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-15|||September 2002||2002-09-01|April 2011|2011-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism|Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism|Completed||Phase 2|55|Anticipated|Montefiore Medical Center||2|||f||||||||||||||2017-10-11 05:36:54.832835|2017-10-11 05:36:54.832835
NCT00211770|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-11|||February 2005||2005-02-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2005|Actual|2005-12-01||Observational|||Use of Functional Behavioral Assessments to Evaluate Stereotypy and Repetitive Behaviors in a Double-blind, Placebo Controlled Trials of Various Medications Used to Treat Children With Autism.|Use of Functional Behavioral Assessments to Evaluate Stereotypy and Repetitive Behaviors in a Double-blind, Placebo Controlled Trials of Various Medications Used to Treat Children With Autism.|Completed||N/A|144|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||||||2017-10-11 05:36:54.916987|2017-10-11 05:36:54.916987
NCT00211783|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-26|||November 2004||2004-11-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|November 2011|Actual|2011-11-01||Observational|||Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism|fMRI for the Study of Response Inhibition, and Face and Linguistic Processing in Autism|Completed||N/A|71|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||||||2017-10-11 05:36:54.989865|2017-10-11 05:36:54.989865
NCT00211796|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-17|||April 2005||2005-04-01|April 2007|2007-04-01||||||||Interventional|||Divalproex Sodium ER in Adult Autism|Divalproex Sodium ER in Adult Autism|Unknown status|Recruiting|Phase 4|10||Icahn School of Medicine at Mount Sinai|||||||||||||||||||2017-10-11 05:36:55.072884|2017-10-11 05:36:55.072884
NCT00211809|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-18|2017-01-18||September 2008||2008-09-01|January 2017|2017-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||CBT as an Adjunct to SRIs in the Treatment of BDD|A Controlled Trial of Cognitive-Behavioral Therapy as an Adjunct to Serotonin Reuptake Inhibitors in Body Dysmorphic Disorder|Terminated||Phase 4|17|Actual|Icahn School of Medicine at Mount Sinai|The primary limitations of this study are the small sample size, the open-label design, and the primarily female sample.|1||low enrollment|f||||f||||||||||2017-10-11 05:36:55.172594|2017-10-11 05:36:55.172594
NCT00211822|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-13|||November 2004||2004-11-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)|fMRI Studies in Pathological Gambling and Obsessive-Compulsive Disorder|Terminated||N/A|57|Actual|Icahn School of Medicine at Mount Sinai|||3|Enrollments closed after former PI Eric Hollander left institution. There are no results.|f||||f||||||||||2017-10-11 05:36:55.466283|2017-10-11 05:36:55.466283
NCT00211835|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-09-20|||November 2005||2005-11-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Post-TBI Depression|Treatment of Post-TBI Depression - A Randomized Clinical Trial|Completed||N/A|75|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 05:36:55.566404|2017-10-11 05:36:55.566404
NCT00211848|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-26|||June 2000||2000-06-01|April 2007|2007-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers|Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers|Completed||Phase 2|207|Anticipated|Icahn School of Medicine at Mount Sinai||2|||||||||||||||||2017-10-11 05:36:55.665951|2017-10-11 05:36:55.665951
NCT00211874|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-10-09|||September 2000||2000-09-01|October 2015|2015-10-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Improving Heart Failure Care in Minority Communities|Improving Heart Failure Care in Minority Communities|Completed||N/A|406|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 05:36:55.753887|2017-10-11 05:36:55.753887
NCT00211887|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-03-06|2013-06-25||January 2005||2005-01-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|April 2012|Actual|2012-04-01||Interventional|||Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx|A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Patients With Relapsing-Remitting Multiple Sclerosis (CombiRx)|Completed||Phase 3|1008|Actual|Icahn School of Medicine at Mount Sinai|absence of a comparative randomized placebo only group|3|||f||||t||||||||||2017-10-11 05:36:55.878097|2017-10-11 05:36:55.878097
NCT00211900|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-26|||March 2005||2005-03-01|December 2007|2007-12-01|November 2005|Actual|2005-11-01|August 2005|Actual|2005-08-01||Interventional|||Evaluation of Manufacturing Lot of StaphVAX|A Phase 3, Multicenter, Open-Label, Historical Comparative Study to Evaluate Immunogenicity and Safety of a Commercial Lot of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adults on Hemodialysis|Completed||Phase 3|65|Actual|Nabi Biopharmaceuticals||1|||f||||f||||||||||2017-10-11 05:36:56.56056|2017-10-11 05:36:56.56056
NCT00211913|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-26|||June 2004||2004-06-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|October 2005|Actual|2005-10-01||Interventional|||StaphVAX in Cardiovascular Surgery Patients|A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Safety and Immunogenicity of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine, in Adult Patients Undergoing Cardiovascular Surgery|Completed||Phase 3|120|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 05:36:56.631969|2017-10-11 05:36:56.631969
NCT00211926|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-21|||December 2004||2004-12-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Interventional|||StaphVAX Immunogenicity in Orthopedic Implant Patients|A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Safety and Immunogenicity of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine, in Adult Patients Receiving an Orthopaedic Prosthetic Implant|Completed||Phase 3|120|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 05:36:56.701455|2017-10-11 05:36:56.701455
NCT00211939|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-26|||January 2005||2005-01-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients|CARE-2 (Calcium Acetate (PhosLo®)/Sevelamer(Renagel®) Evaluation Study 2)|Completed||Phase 4|203|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 05:36:56.924535|2017-10-11 05:36:56.924535
NCT00211952|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||March 2004||2004-03-01|September 2005|2005-09-01||||||||Interventional|||Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients|A Randomized, Double Blind, Placebo Controlled Phase III Trial Evaluating the Role of Adjuvant Celecoxib in Completely Resected, High-Risk (pN1-2) Non-Small Cell Lung Cancer (NSCLC) Patients|Suspended||Phase 3|542||Medical University of Gdansk|||||f||||||||||||||2017-10-11 05:36:57.02096|2017-10-11 05:36:57.02096
NCT00211965|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-26|||April 2005||2005-04-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|May 2006|Actual|2006-05-01||Interventional|||StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery|A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Safety and Immunogenicity of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adult Patients Receiving an Orthopedic Prosthetic Implant|Completed||Phase 3|67|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 05:36:57.088668|2017-10-11 05:36:57.088668
NCT00211978|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-26|||May 2005||2005-05-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Interventional|||EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)|EPIC (Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease): A Prospective, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel Arm, Study of PhosLo on Phosphorus Levels in Subjects With Chronic Kidney Disease|Completed||Phase 3|110|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-10-11 05:36:57.169701|2017-10-11 05:36:57.169701
NCT00211991|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-10|||April 2005||2005-04-01|May 2012|2012-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Evaluation of Consistency of StaphVAX Manufacturing Lots|A Phase 3, Multicenter, Double-Blinded, Randomized, Study to Compare Immunogenicity and Safety Between Three Commercial Lots of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Normal, Healthy, Adult Volunteers|Completed||Phase 3|354||Nabi Biopharmaceuticals|||||f||||||||||||||2017-10-11 05:36:57.28351|2017-10-11 05:36:57.28351
NCT00212004|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||April 2005||2005-04-01|November 2004|2004-11-01|April 2009||2009-04-01|||||Interventional|||Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study)|The Japan Working Group for the Assessment That the Pioglitazone Protects DM Patients Against Re-Infarction|Unknown status|Recruiting|N/A|3000||National Cerebral and Cardiovascular Center|||||f||||||||||||||2017-10-11 05:36:57.354437|2017-10-11 05:36:57.354437
NCT00212017|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-07|||April 2005||2005-04-01|November 2007|2007-11-01|April 2009|Anticipated|2009-04-01|||||Interventional|||Assessment of an Alpha-Glucosidase Inhibitor to Block Cardiac Events in Patients With Myocardial Infarction and IGT (ABC Study)|The Japan Working Group for the Assessment That the Alpha-Glucosidase Inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT|Unknown status|Recruiting|N/A|3000|Anticipated|National Cerebral and Cardiovascular Center|||||f||||||||||||||2017-10-11 05:36:57.444875|2017-10-11 05:36:57.444875
NCT00212030|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-31|||October 2001||2001-10-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP|Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP|Completed||N/A|600|Anticipated|National Cerebral and Cardiovascular Center||2|||f||||||||||||||2017-10-11 05:36:57.538473|2017-10-11 05:36:57.538473
NCT00212043|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-10-07|||July 2000||2000-07-01|May 2008|2008-05-01|February 2004||2004-02-01|||||Interventional|||Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma|Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma|Completed||Phase 2|74||National University Hospital, Singapore|||||f||||||||||||||2017-10-11 05:36:57.649121|2017-10-11 05:36:57.649121
NCT00212056|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-31|||October 2001||2001-10-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by ANP|Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by ANP|Completed||N/A|600|Anticipated|National Cerebral and Cardiovascular Center||2|||f||||||||||||||2017-10-11 05:36:57.715876|2017-10-11 05:36:57.715876
NCT00212069|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-10|||March 2004||2004-03-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer|Serum Protein Profiling as a Predictor of Gemcitabine Sensitivity in Breast Cancer With Prior Exposure to Anthracyclines and Taxanes|Completed||Phase 2|30|Anticipated|National University Hospital, Singapore|||||f||||||||||||||2017-10-11 05:36:57.807917|2017-10-11 05:36:57.807917
NCT00212082|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-06-11|||April 2002||2002-04-01|June 2008|2008-06-01||||||||Interventional|||Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer|Gene Expression Profiles of Breast Cancer Treated With Sequential Adriamycin and Docetaxel in Relation to Tumor Responses|Completed||Phase 2|100||National University Hospital, Singapore|||||f||||||||||||||2017-10-11 05:36:57.885809|2017-10-11 05:36:57.885809
NCT00212095|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-31|||June 2005||2005-06-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|April 2007|Actual|2007-04-01||Interventional|||Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer|Phase II Study of Docetaxel Combined With Ketoconazole in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor|Completed||Phase 2|30|Actual|National University Hospital, Singapore||1|||f||||t||||||||||2017-10-11 05:36:57.957451|2017-10-11 05:36:57.957451
NCT00212108|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-29|||November 2003||2003-11-01|March 2012|2012-03-01|January 2009|Actual|2009-01-01|March 2007|Actual|2007-03-01||Interventional|||A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839|A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839|Completed||Phase 1/Phase 2|22|Actual|National University Hospital, Singapore||1|||f||||||||||||||2017-10-11 05:36:58.046551|2017-10-11 05:36:58.046551
NCT00212121|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-25|||July 2004||2004-07-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|||Radiation Dose Intensity Study in Breast Cancer in Young Women|Radiation Dose Intensity Study in Breast Cancer in Young Women: a Randomized Phase III Trial of Additional Dose to the Tumor Bed|Active, not recruiting||Phase 3|2400|Anticipated|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-10-11 05:36:58.140402|2017-10-11 05:36:58.140402
NCT00212134|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-07-27|2013-07-15||December 2004||2004-12-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|IATS||Infant Aphakia Treatment Study (IATS)|Infant Aphakia Treatment Study (IATS)|Completed||Phase 3|114|Actual|Emory University||2|||f||||t||||||||||2017-10-11 05:36:58.284514|2017-10-11 05:36:58.284514
NCT00212147|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-11-06|||September 2003||2003-09-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly|Subtle Disturbances of Cobalamin Status|Completed||N/A|444|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-10-11 05:36:59.112182|2017-10-11 05:36:59.112182
NCT00212160|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-30|||January 2005|Actual|2005-01-01|January 2017|2017-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Role of the Omentum in the Treatment of Morbid Obesity|The Role of the Omentum in the Treatment of Morbid Obesity|Completed||N/A|66|Actual|Vanderbilt University Medical Center||4|||f||||t||||||||||2017-10-11 05:36:59.204121|2017-10-11 05:36:59.204121
NCT00212173|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-16||||||April 2015|2015-04-01|August 2007|Actual|2007-08-01|||||Interventional|||Adolescent Weight Management Study|Behavioral & Pharmacologic Therapy of Adolescent Obesity|Completed||N/A|120||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-10-11 05:36:59.293457|2017-10-11 05:36:59.293457
NCT00212186|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2012-03-06|||October 1998||1998-10-01|March 2012|2012-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Selenium Supplementation of Patients With Cirrhosis||Completed||N/A|48|Actual|Vanderbilt University|||||f||||||||||||||2017-10-11 05:36:59.360891|2017-10-11 05:36:59.360891
NCT00212849|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|December 2004|2004-12-01|August 2005||2005-08-01|||||Observational|||Autologous Chondrocyte Implantation in the Patellofemoral Joint|Autologous Chondrocyte Implantation in the Patellofemoral Joint|Completed||Phase 4|35||Orthopaedic Research Foundation|||||f||||||||||||||2017-10-11 05:36:59.428651|2017-10-11 05:36:59.428651
NCT00212862|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-06-27|||December 2003||2003-12-01|June 2014|2014-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|DOSE||Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia|Dosing and Outcomes Study of Erythropoietic Stimulating Therapies|Completed||Phase 4|2130|Actual|Ortho Biotech Products, L.P.|||1||f||||f||||||||||2017-10-11 05:36:59.504809|2017-10-11 05:36:59.504809
NCT00212875|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-05-19|||September 2005||2005-09-01|March 2010|2010-03-01|February 2007|Actual|2007-02-01|||||Interventional|||A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.|An Open-Label, Randomized, Multicenter Study of the Initiation of Four Dosing Regimens of PROCRIT (Epoetin Alfa) for the Treatment of Anemia of Chronic Kidney Disease (CKD). Protocol Addendum: Due to Space Constraints, See Detailed Description for Full Title of Addendum.|Completed||Phase 2|267|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:36:59.572901|2017-10-11 05:36:59.572901
NCT00212901|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-25|||August 2004||2004-08-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|||High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy|Addition of Angiotensin Receptor Blockade to ACE Inhibition Versus High Dose ACE Inhibition for Reduction of Proteinuria in Patients With Diabetic Nephropathy|Completed||N/A|30|Anticipated|Ottawa Hospital Research Institute|||||f||||||||||||||2017-10-11 05:36:59.739229|2017-10-11 05:36:59.739229
NCT00212914|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-08|||May 2002||2002-05-01|September 2008|2008-09-01|January 2006||2006-01-01|||||Interventional|||Increasing Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes.|Mailing Recommendations to the Individual or Physician to Increase Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes: Clinical Trial.|Completed||N/A|268||Ottawa Hospital Research Institute|||||f||||||||||||||2017-10-11 05:36:59.803044|2017-10-11 05:36:59.803044
NCT00212927|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-08-31|||October 2002||2002-10-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Observational|||Continuity of Care and Outcomes After Discharge From Hospital|The Association of Provider Continuity and Information Continuity With Patient Outcomes After Discharge From Hospital|Completed||N/A|5900|Anticipated|Ottawa Hospital Research Institute|||||f||||f||||||||||2017-10-11 05:36:59.864476|2017-10-11 05:36:59.864476
NCT00212940|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-25|||October 2000||2000-10-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Supportive Therapy for Adherence to ART(STAART)|Increasing Patient Adherence to HIV Medications: A Prospective Intervention Study|Completed||N/A|112|Anticipated|Ottawa Hospital Research Institute|||||f||||||||||||||2017-10-11 05:36:59.917811|2017-10-11 05:36:59.917811
NCT00212953|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-10-13|||March 1997||1997-03-01|October 2010|2010-10-01|May 1999|Actual|1999-05-01|||||Interventional|||OPALS Critical Care Sub-Studies|Ontario Prehospital Advanced Life Support (OPALS) Study Phase III Cardiac Arrest and Critical Care Sub-Studies - Chest Pain Sub-Study, Respiratory Sub-Study, and Major Trauma Sub-Study|Completed||N/A|21000||Ottawa Hospital Research Institute|||||f||||f||||||||||2017-10-11 05:37:00.075562|2017-10-11 05:37:00.075562
NCT00212966|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-08-19|||July 2004||2004-07-01|August 2010|2010-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Shared Mental Health Care Linking Mental Health Services With Family Medicine Groups|Shared Mental Health Care Linking General Hospital Acute Care Mental Health Services With Two Comprehensive Family Medicine Groups|Completed||N/A|350|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-11 05:37:00.180365|2017-10-11 05:37:00.180365
NCT00212979|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-29|||April 2004||2004-04-01|February 2009|2009-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Measuring Kidney Function in Kidney Transplantation|The Accurate Prediction of Renal Function in Kidney Transplant Recipients|Completed||N/A|250|Anticipated|Ottawa Hospital Research Institute|||1||f||||||||||||||2017-10-11 05:37:00.255301|2017-10-11 05:37:00.255301
NCT00212992|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-01-23|||March 2001|Actual|2001-03-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|September 2005|Actual|2005-09-01||Interventional|||Biphasic Defibrillation Study: Trial to Compare Fixed Versus Escalating Energy|A Pilot Randomized Controlled Trial to Compare Fixed Versus Escalating Energy Regimens for Biphasic Waveform Defibrillation|Completed||Phase 3|200||Ottawa Hospital Research Institute|||||f|||||f|f||||||No||2017-10-11 05:37:00.333663|2017-10-11 05:37:00.333663
NCT00213005|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-11|||June 2002|Actual|2002-06-01|August 2017|2017-08-01|August 2003|Actual|2003-08-01|||||Interventional|||Safety and Acceptability of Carraguard® in HIV Positive Women and Men|A Phase 1 Safety and Acceptability Study of Carraguard® Among HIV Positive Women and Men in Durban, South Africa|Completed||Phase 1|60||Population Council|||||||||||||||||||2017-10-11 05:37:00.42669|2017-10-11 05:37:00.42669
NCT00213018|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-11|||October 1999|Actual|1999-10-01|August 2017|2017-08-01|January 2002|Actual|2002-01-01|||||Interventional|||Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission|A Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing STI/HIV Transmission|Completed||Phase 2|400||Population Council|||||||||||||||||||2017-10-11 05:37:00.510058|2017-10-11 05:37:00.510058
NCT00213031|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-11|||February 2000|Actual|2000-02-01|August 2017|2017-08-01|December 2001|Actual|2001-12-01|||||Interventional|||Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide|A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of PC-515 (Lambda Carrageenan) for Vaginal Use as a Possible Microbicide|Completed||Phase 2|165||Population Council|||||||||||||||||||2017-10-11 05:37:00.609868|2017-10-11 05:37:00.609868
NCT00213044|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-11|||March 2003|Actual|2003-03-01|August 2017|2017-08-01|June 2004|Actual|2004-06-01|||||Interventional|||A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women|A Randomized, Controlled, Double-Blind, Cross-Over Trial of Safety, Effect on Genital Tract HIV Shedding, and Acceptability of Vaginal Use of Carraguard by HIV-Infected Women|Completed||Phase 1|60||Population Council|||||||||||||||||||2017-10-11 05:37:00.710496|2017-10-11 05:37:00.710496
NCT00213057|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-11|||June 2001|Actual|2001-06-01|August 2017|2017-08-01|June 2002|Actual|2002-06-01|||||Interventional|||Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand|A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety and Acceptability of Carraguard™ (PC-515) Vaginal Gel Among Heterosexual Couples in Chiang Rai|Completed||Phase 1|110||Population Council|||||||||||||||||||2017-10-11 05:37:00.804471|2017-10-11 05:37:00.804471
NCT00213070|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-20||||||September 2006|2006-09-01||||||||Interventional|||Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-10-11 05:37:00.897354|2017-10-11 05:37:00.897354
NCT00213083|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-11|||April 2004||2004-04-01|August 2017|2017-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission|Phase 3 Study of the Efficacy and Safety of the Microbicide Carraguard® in Preventing HIV Seroconversion in Women|Completed||Phase 3|6203|Actual|Population Council|||||f||||||||||||||2017-10-11 05:37:01.015733|2017-10-11 05:37:01.015733
NCT00213096|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-11|||March 2003|Actual|2003-03-01|August 2017|2017-08-01|February 2004|Actual|2004-02-01|||||Interventional|||Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive|A Randomized, Open-Label Study Comparing the Effect of a Contraceptive Vaginal Ring Delivering Daily Doses of 150 Micrograms Nestorone and 15 Micrograms Ethinyl Estradiol to an Oral Contraceptive Containing 150 Micrograms of Levonorgestrel and 30 Micrograms of Ethinyl Estradiol Per Tablet on Hepatic Factors Including Coagulation Factors|Completed||Phase 2|50||Population Council|||||||||||||||||||2017-10-11 05:37:01.115165|2017-10-11 05:37:01.115165
NCT00213109|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-20||||||September 2006|2006-09-01||||||||Interventional|||Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-10-11 05:37:01.222673|2017-10-11 05:37:01.222673
NCT00213122|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-25||||||September 2006|2006-09-01||||||||Interventional|||Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-10-11 05:37:01.321207|2017-10-11 05:37:01.321207
NCT00213135|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-01-10|2013-09-30||April 2005||2005-04-01|January 2014|2014-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|CLARITY||A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)|A Phase III, Randomized, Double-blind, Three-arm, Placebo-controlled, Multi-center Study to Evaluate the Safety and Efficacy of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)|Completed||Phase 3|1326|Actual|EMD Serono||3|||f||||||||||||||2017-10-11 05:37:01.448438|2017-10-11 05:37:01.448438
NCT00213161|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-10|||August 2004||2004-08-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in India|Establishing an Iron Supplementation Strategy to Reduce the Prevalence of Iron Deficiency Anemia Among Infants and Young Children in India.|Completed||N/A|425||The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:37:03.005866|2017-10-11 05:37:03.005866
NCT00213174|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-14|||January 2005||2005-01-01|August 2013|2013-08-01||||||||Interventional|||Study of Sand Versus Wood Chip Surfaces on School Playgrounds to Minimize Injury in School Children|School Playground Surfacing - A Randomized Prospective Comparison of Injury Rates on Sand Versus Wood Chip Surfaces|Unknown status|Recruiting|Phase 3|34|Anticipated|The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:37:03.090146|2017-10-11 05:37:03.090146
NCT00213187|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-17|||August 2002||2002-08-01|December 2013|2013-12-01|November 2005||2005-11-01|||||Interventional|||PEAK Study (Physical Exercise and Activity in Kids)|The Effect of Vigorous Exercise on Motor Function and Functional Fitness in Juvenile Arthritis|Completed||Phase 2|80||The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:37:03.18713|2017-10-11 05:37:03.18713
NCT00213200|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-10|||July 2003||2003-07-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Intravenous and Topical Analgesics for Procedural Pain in Neonates|Systemic Analgesia and Local Anaesthesia for Percutaneous Venous Catheter Placement in Preterm Neonates|Completed||Phase 3|108||The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:37:03.263464|2017-10-11 05:37:03.263464
NCT00213213|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-11|||July 2003||2003-07-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Using Sugar Water to Relieve Pain in Infants|Effectiveness of Sucrose Analgesia in Reducing Pain Responses in Infants Born to Diabetic and Non-diabetic Mothers: A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|240||The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:37:03.333228|2017-10-11 05:37:03.333228
NCT00213226|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-12|||December 2001||2001-12-01|May 2014|2014-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Single Dose Versus Multiple Doses of Dexamethasone in Children With Acute Bronchiolitis|Efficacy of Single Dose Versus Multiple Doses of Dexamethasone in Outpatients With Acute Bronchiolitis|Completed||Phase 3|120|Anticipated|The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:37:03.404175|2017-10-11 05:37:03.404175
NCT00213239|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-19|||September 2005||2005-09-01|August 2013|2013-08-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Interventional|||A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children|The Minimum Effective Dose of Remifentanil When Co-administered With Propofol for Lumbar Puncture in Children: A Dose-finding Study|Completed||Phase 1/Phase 2|64|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 05:37:03.484393|2017-10-11 05:37:03.484393
NCT00213252|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-12|||September 2005||2005-09-01|May 2014|2014-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma|Can Montelukast Shorten Corticosteroid Therapy In Children With Mild To Moderate Acute Asthma?|Completed||Phase 2|130|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-10-11 05:37:03.568738|2017-10-11 05:37:03.568738
NCT00213265|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-15|||July 2002||2002-07-01|August 2013|2013-08-01||||||||Interventional|||Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants|Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Among Solid Organ Transplant Recipients: Protocol 1A and 1B|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 05:37:03.651872|2017-10-11 05:37:03.651872
NCT00213278|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-11-19|||January 2002||2002-01-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma|A Phase 2 Study of Vinblastine Sulphate Injection in Children With Recurrent or Refractory Low Grade Glioma|Completed||Phase 2|50|Actual|The Hospital for Sick Children||1|||f||||t||||||||||2017-10-11 05:37:03.747738|2017-10-11 05:37:03.747738
NCT00213291|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-23|||April 2005||2005-04-01|August 2013|2013-08-01|October 2005||2005-10-01|September 2005|Actual|2005-09-01||Interventional|||Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure|Extended Dosing of Darbepoetin Alfa (Aranesp) for the Management of Anemia in Children With Chronic Renal Failure|Completed||Phase 3|40|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||||2017-10-11 05:37:03.821477|2017-10-11 05:37:03.821477
NCT00213304|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-08-15|||June 1999||1999-06-01|August 2013|2013-08-01||||||||Interventional|||The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation|Safety and Immunogenicity of Live Attenuated Oka/Merck Varicella Vaccine in Children Listed to Undergo Solid Organ Transplantation|Unknown status|Active, not recruiting|Phase 3|150||The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:37:03.915737|2017-10-11 05:37:03.915737
NCT00213317|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-14|||April 2005||2005-04-01|February 2012|2012-02-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Observational|||Effect of Lumbo-sacral Magnetic Stimulation on Colonic Motility|Could Lumbo-sacral Magnetic Stimulation Modify Recto-colonic Motility?|Completed||N/A|30|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-11 05:37:04.099813|2017-10-11 05:37:04.099813
NCT00213330|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-20|||April 2003||2003-04-01|April 2012|2012-04-01|February 2006||2006-02-01|||||Observational|||Cerebral Resonance Magnetic Imaging During Rectal Distention|Cerebral Activity During Rectal Pain in Patients With Irritable Bowel Syndrome or Inflammatory Bowel Disease:Resonance Magnetic Imaging Study.|Withdrawn||N/A|0|Actual|University Hospital, Rouen|||1|patients with inflammatory colitis not included|f||||||||||||||2017-10-11 05:37:04.162818|2017-10-11 05:37:04.162818
NCT00213343|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||May 2005||2005-05-01|June 2013|2013-06-01|July 2005|Actual|2005-07-01|June 2005|Actual|2005-06-01||Observational|||Effects of Phrenic Nerve Stimulation During Swallowing : Experimental Model of Aspiration|Effects of Phrenic Nerve Stimulation During Swallowing : Experimental Model of Aspiration|Terminated||N/A|30|Actual|University Hospital, Rouen|||1|dyspnea|f||||f||||||||||2017-10-11 05:37:04.235808|2017-10-11 05:37:04.235808
NCT00213356|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||April 2003||2003-04-01|June 2013|2013-06-01|March 2004||2004-03-01|||||Observational|||Study of the Nervous Control of the Anal Sphincter|Evoked Responses of External Anal Sphincter After Cortical and Lombo-sacral Magnetic Stimulations|Withdrawn||N/A|0|Actual|University Hospital, Rouen|||1|patients with neurological disease not included|f||||f||||||||||2017-10-11 05:37:04.309886|2017-10-11 05:37:04.309886
NCT00213369|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-14|||January 2007||2007-01-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|||||Observational|||Neuromodulation of Aspiration Secondary to Stroke|Neuromodulation of Aspiration Secondary to Stroke|Completed||N/A|20|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-11 05:37:04.380742|2017-10-11 05:37:04.380742
NCT00213382|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-02-23|||February 2005||2005-02-01|February 2011|2011-02-01||||||||Observational|||Cortical Pharyngeal Area: Excitability, Facilitation and Plasticity in Healthy Subjects|Cortical Pharyngeal Area: Excitability, Facilitation and Plasticity in Healthy Subjects|Completed||N/A|10|Anticipated|University Hospital, Rouen|||1||f||||||||||||||2017-10-11 05:37:04.445977|2017-10-11 05:37:04.445977
NCT00213395|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-14|||October 2004||2004-10-01|February 2012|2012-02-01|February 2006||2006-02-01|||||Interventional|||Clinical Efficacy of a Cephalic Mask for Noninvasive Ventilation During Acute Hypercapnic Respiratory Failure||Terminated||N/A|||University Hospital, Rouen|||||f||||||||||||||2017-10-11 05:37:04.518698|2017-10-11 05:37:04.518698
NCT00213408|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||June 2001||2001-06-01|June 2013|2013-06-01|January 2007|Actual|2007-01-01|||||Interventional|||Catheter Ablation as the First Line Therapy for Typical Atrial Flutter|Catheter Ablation as the First Line Therapy for Symptomatic Typical Atrial Flutter: A Multicenter Randomized Study of Cost/Effectiveness|Terminated||Phase 4|120||University Hospital, Rouen||||end of the follow-up period|f||||||||||||||2017-10-11 05:37:04.586985|2017-10-11 05:37:04.586985
NCT00213421|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||August 2001||2001-08-01|June 2013|2013-06-01|November 2008|Actual|2008-11-01|October 2004|Actual|2004-10-01||Observational|||Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus||Completed||Phase 4|330|Actual|University Hospital, Rouen|||2||f||||||||||||||2017-10-11 05:37:04.65344|2017-10-11 05:37:04.65344
NCT00213434|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-25|||November 2001||2001-11-01|June 2013|2013-06-01|June 2006|Actual|2006-06-01|December 2004|Actual|2004-12-01||Interventional|||Evaluation of a Mandibular Advancement Device in the Treatment of Obstructive Sleep Apnea Syndrome|Prospective Evaluation of Mandibular Advancement by Herbst Device in the Treatment of Moderate Obstructive Sleep Apnea Syndrome|Completed||N/A|||University Hospital, Rouen|||||f||||||||||||||2017-10-11 05:37:04.720785|2017-10-11 05:37:04.720785
NCT00213447|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||November 2002||2002-11-01|June 2013|2013-06-01|December 2005||2005-12-01|||||Observational|||T Cell Response in Hypersensitivity Syndrome|Characterization of T Cell Response in Hypersensitivity Syndrome|Completed||N/A|40|Anticipated|University Hospital, Rouen|||1||f||||f||||||||||2017-10-11 05:37:04.804577|2017-10-11 05:37:04.804577
NCT00213460|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-04-15|||August 2001||2001-08-01|April 2013|2013-04-01|July 2003|Actual|2003-07-01|||||Observational|||Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up|Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up|Completed||N/A|||University Hospital, Rouen|||||f||||||||||||||2017-10-11 05:37:04.867461|2017-10-11 05:37:04.867461
NCT00213473|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||June 2001||2001-06-01|June 2013|2013-06-01|May 2006||2006-05-01|||||Observational|||Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study|Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study|Completed||N/A|81|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-11 05:37:04.927489|2017-10-11 05:37:04.927489
NCT00208702|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-11-16|||September 1996||1996-09-01|November 2015|2015-11-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Thyroid Medication and Antidepressants for Treating Major Depression|Thyroid Axis in Major Depression|Completed||Phase 4|153|Actual|Emory University||2|||f||||f||||||||||2017-10-11 05:37:26.343521|2017-10-11 05:37:26.343521
NCT00213486|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-10-27|||June 2002||2002-06-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial|Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial|Completed||Phase 2|43||University Hospital, Rouen|||||f||||||||||||||2017-10-11 05:37:04.988126|2017-10-11 05:37:04.988126
NCT00213499|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-14|||January 2002||2002-01-01|February 2012|2012-02-01|September 2008|Actual|2008-09-01|April 2006|Actual|2006-04-01||Interventional|VENISE||Non Invasive Ventilation and Weaning : VENISE Trial|Randomized Prospective Multicenter Study of Non Invasive Ventilation Assessment for Weaning From Mechanical Ventilation in Patients With Chronic Respiratory Failure. NIV and Weaning (VENISE)Trial.|Completed||N/A|205||University Hospital, Rouen|||||f||||t||||||||||2017-10-11 05:37:05.075892|2017-10-11 05:37:05.075892
NCT00213512|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||June 2003||2003-06-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|June 2006|Actual|2006-06-01||Interventional|||Effect of Anti CD20 in Pemphigus Desease|Traitment of Patients Presenting Pemphigus With Anti CD20 (Mabthera).|Completed||Phase 2/Phase 3|22||University Hospital, Rouen|||||f||||f||||||||||2017-10-11 05:37:05.162443|2017-10-11 05:37:05.162443
NCT00213525|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-02-04|||October 2004||2004-10-01|February 2015|2015-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls|Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Healthy Controls|Completed||N/A|300|Actual|University Hospital, Rouen|||2||f||||f||||||||||2017-10-11 05:37:05.2284|2017-10-11 05:37:05.2284
NCT00213538|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-13|||June 2003||2003-06-01|June 2017|2017-06-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis|Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis|Completed||N/A|341|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-10-11 05:37:05.311387|2017-10-11 05:37:05.311387
NCT00213551|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||April 2004||2004-04-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|||||Interventional|||Glutamine and Intestinal Protein Metabolism|Comparative Effects of Glutamine and Glucose on Intestinal Protein Metabolism in Healthy Humans|Completed||Phase 1|30|Anticipated|University Hospital, Rouen|||||f||||||||||||||2017-10-11 05:37:05.375131|2017-10-11 05:37:05.375131
NCT00213564|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-25|||April 2003||2003-04-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|May 2004|Actual|2004-05-01||Observational|||Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis|Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis|Completed||Phase 4|40|Anticipated|University Hospital, Rouen|||||f||||f||||||||||2017-10-11 05:37:05.439104|2017-10-11 05:37:05.439104
NCT00213577|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-23|||December 2003||2003-12-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder|Evaluation of the Efficacy and Tolerance of 2 Dosages of Type A Botulinic Toxin in Neurogenic Areactive Bladder Resistant to Oral Medical Treatment|Terminated||Phase 2|80|Actual|University Hospital, Rouen||1||the study has concluded normally;|f||||t||||||||||2017-10-11 05:37:05.509729|2017-10-11 05:37:05.509729
NCT00213590|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-14|||April 2000||2000-04-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|DICAM||Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients|A Multicentric, Randomized, Opened Study to Evaluate Efficacy on Renal Function of an Immunosuppressant Regimen Based on Cyclosporine A Dose Reduction in Combination With Mycophenolate Mofetil, From the Second Year of Renal Transplantation|Completed||Phase 3|208|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-10-11 05:37:05.579587|2017-10-11 05:37:05.579587
NCT00213603|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-17|||April 2002||2002-04-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Follow-up Modalities of Low Grade Precancerous Bronchial Lesions|Endoscopic Follow-up of Low Grade Precancerous Bronchial Lesions in High Risk Patients (SELEPREBB1)|Completed||N/A|365|Actual|University Hospital, Rouen|||1||f||||t||||||Samples Without DNA|"     bronchial biopsies (fixed samples)   "|||2017-10-11 05:37:05.668303|2017-10-11 05:37:05.668303
NCT00213616|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||March 2004||2004-03-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Bilateral Laryngeal Paralysis Reinnervation|Bilateral Laryngeal Paralysis Reinnervation. Speech and Ventilatory Results Analysis|Completed||N/A|10|Actual|University Hospital, Rouen||1|||f||||t||||||||||2017-10-11 05:37:05.734448|2017-10-11 05:37:05.734448
NCT00213629|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-14|||November 2004||2004-11-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|MYOARRAY||myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies|Transcriptome Analysis Through a Dedicated Macro-array and TcLandscape Repertoire Analysis for Diagnosis of Myositis.|Completed||N/A|100|Actual|University Hospital, Rouen||1|||f||||t||||||||||2017-10-11 05:37:05.79638|2017-10-11 05:37:05.79638
NCT00213642|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||July 2001||2001-07-01|June 2013|2013-06-01|August 2004||2004-08-01|||||Observational|||Tc-99m Renography and Cisplatin-induced Nephrotoxicity|Value of Tc-99m Renography for Early Diagnosis of Cisplatin-induced Renal Toxicity|Terminated||N/A|20||University Hospital, Rouen|||||f||||f||||||||||2017-10-11 05:37:05.875441|2017-10-11 05:37:05.875441
NCT00213655|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-07-30|||June 2004||2004-06-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|||URO-BCG-4 : Bladder Tumors Immunotherapy|Clinical Evaluation of Maintenance BCG Immunotherapy in Superficial Bladder Tumors|Completed||Phase 3|146|Actual|University Hospital, Rouen|||2||f||||f||||||||||2017-10-11 05:37:05.931539|2017-10-11 05:37:05.931539
NCT00213668|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||April 2002||2002-04-01|June 2013|2013-06-01||||||||Interventional|||Effect of Glutamine on Gastric Emptying and Length of Parenteral Nutrition in Premature Neonates|Effect of Glutamine on Gastric Emptying and Length of Parenteral Nutrition in Premature Neonates|Completed||Phase 4|||University Hospital, Rouen|||||f||||||||||||||2017-10-11 05:37:06.006485|2017-10-11 05:37:06.006485
NCT00213681|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-06-17|||November 2002||2002-11-01|June 2013|2013-06-01|March 2005||2005-03-01|||||Interventional|||CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema|CPAP Boussignac Versus Bilevel Pressure Support Ventilation in Severe Acute Cardiogenic Pulmonary Edema|Completed||Phase 3|||University Hospital, Rouen|||||f||||||||||||||2017-10-11 05:37:06.078865|2017-10-11 05:37:06.078865
NCT00213694|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-04|||November 2003||2003-11-01|March 2013|2013-03-01|June 2006||2006-06-01|||||Observational|||PROSTACOX : Metastatic Prostate Chemotherapy|Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer|Completed||Phase 2|52||University Hospital, Rouen|||||f||||||||||||||2017-10-11 05:37:06.153729|2017-10-11 05:37:06.153729
NCT00213707|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-24|||May 2003||2003-05-01|February 2009|2009-02-01|May 2011|Anticipated|2011-05-01|May 2010|Anticipated|2010-05-01||Observational|||Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.|Liver Transplanted Patients for HCV Related End Stage Liver Disease.Functional Role of Blood Circulating Dendritic Cells in the Pathogenesis of Hepatitis C Virus Infection During Liver Transplantation.|Unknown status|Active, not recruiting|N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||Samples With DNA|"     Serum peripheral blood mononuclear cells   "|||2017-10-11 05:37:06.221275|2017-10-11 05:37:06.221275
NCT00213720|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-09-07|||August 2005||2005-08-01|September 2017|2017-09-01|January 2020|Anticipated|2020-01-01|November 2019|Anticipated|2019-11-01||Observational|||Treatment of Subclinical Hyperthyroidism|Place de l'Iode RadioActif Dans l'HyperThyroïdiE Sub-clinique (PIRHATES)/ Evaluation of the Interest of Subclinical Hyperthyroidism Treatment|Active, not recruiting||N/A|300|Anticipated|University Hospital, Strasbourg, France|||1||f||||||||||Samples Without DNA|"     serum   "|||2017-10-11 05:37:06.301312|2017-10-11 05:37:06.301312
NCT00213733|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-29|||June 2004||2004-06-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Observational|||Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer|Research of Molecular Markers for Diagnosis and/or Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer|Completed||N/A|150|Anticipated|University Hospital, Strasbourg, France|||1||f||||||||||||||2017-10-11 05:37:06.409789|2017-10-11 05:37:06.409789
NCT00213746|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||October 2003||2003-10-01|June 2013|2013-06-01|December 2005||2005-12-01|||||Observational|||Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)|Prediction of Left Ventricular Function Changes Using Low Dose Dobutamine Gated SPECT in Patients Referred for Viability Assessment: The DOGS (DObutamine Gated Spect)Study.|Completed||N/A|75||University Hospital, Rouen|||||f||||f||||||||||2017-10-11 05:37:06.489484|2017-10-11 05:37:06.489484
NCT00213759|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-28|||March 2002||2002-03-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|||||Interventional|||Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF|Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF|Completed||Phase 3|200|Actual|University Hospital, Strasbourg, France||2|||f||||||||||||||2017-10-11 05:37:06.588357|2017-10-11 05:37:06.588357
NCT00213772|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 1999||1999-05-01|September 2005|2005-09-01||||||||Observational|||Risk Factors of Porphyria Cutanea Tarda (PCT)|“Factors Associated With Porphyria Cutanea Tarda in Patients Infected With Hepatitis C Virus”|Completed||N/A|280||University Hospital, Strasbourg, France|||||f||||||||||||||2017-10-11 05:37:06.680705|2017-10-11 05:37:06.680705
NCT00213785|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-28|||November 2001||2001-11-01|November 2007|2007-11-01|March 2004||2004-03-01|||||Observational|||A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.|A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.|Completed||N/A|14|Actual|University Hospital, Strasbourg, France|||||f||||||||||||||2017-10-11 05:37:06.949786|2017-10-11 05:37:06.949786
NCT00213798|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-29|||December 2003||2003-12-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Interventional|||Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients|Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.|Completed||N/A|200|Anticipated|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-10-11 05:37:07.007851|2017-10-11 05:37:07.007851
NCT00213811|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-08-07|||June 2003||2003-06-01|August 2008|2008-08-01||||||||Observational|||Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults|Bardet-Biedl Syndrome: Clinical and Genetic Epidemiology Study in the Adults|Completed||N/A|40||University Hospital, Strasbourg, France|||||f||||||||||||||2017-10-11 05:37:07.074577|2017-10-11 05:37:07.074577
NCT00213824|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-26|||February 2004||2004-02-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis|A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis|Terminated||N/A|79|Actual|University Hospital, Strasbourg, France|||1||f||||||||||None Retained|"     tissue (skeletal muscle)   "|||2017-10-11 05:37:07.137724|2017-10-11 05:37:07.137724
NCT00213837|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-24|||October 2003||2003-10-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Reconstruction Implant Bone After Removal Using Porous Titanium Prosthesis|Reconstruction Implant Bone (Anterior Mandibular Arch) After Removing Using Porous Titanium Prosthesis in ENT Surgery|Completed||Phase 2|7|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 05:37:07.190979|2017-10-11 05:37:07.190979
NCT00213850|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-28|||January 2002||2002-01-01|November 2007|2007-11-01|September 2006||2006-09-01|||||Interventional|||Reference Values for Respiratory Resistance Measured by the Interrupter Technique in Adults|Reference Values for Respiratory Resistance Measured by the Interrupter Technique in Adults|Completed||N/A|122|Actual|University Hospital, Strasbourg, France|||||f||||||||||||||2017-10-11 05:37:07.260785|2017-10-11 05:37:07.260785
NCT00213863|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-28|||December 2010||2010-12-01|June 2012|2012-06-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Interventional|||Implantation of Porous Titanium Prosthesis in Laryngeal Surgery|Implantation of Porous Titanium Prosthesis in Laryngeal Surgery|Unknown status|Recruiting|Phase 2|10|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-10-11 05:37:07.316036|2017-10-11 05:37:07.316036
NCT00213876|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-29|||February 2004||2004-02-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Observational|||Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours|Research of Molecular and Metabolic Diagnostic Markers in Oligodendrogliomas A and B Comparatively.|Completed||N/A|189|Actual|University Hospital, Strasbourg, France|||1||f||||||||||||||2017-10-11 05:37:07.390959|2017-10-11 05:37:07.390959
NCT00213889|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-26|||February 2003||2003-02-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||TWIST Human Gene and Cleft Lips and Palates|TWIST Human Gene and Cleft Lips and Palates|Terminated||N/A|45|Actual|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-10-11 05:37:07.444211|2017-10-11 05:37:07.444211
NCT00214123|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-22|||June 2004||2004-06-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Hypofractionated Radiotherapy for Lung Cancer|The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer|Completed||Phase 1|79|Actual|University of Wisconsin, Madison||5|||f||||t||||||||||2017-10-11 05:37:09.264916|2017-10-11 05:37:09.264916
NCT00213902|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-28|||April 2004||2004-04-01|November 2007|2007-11-01||||||||Observational|||Clonidine and Left Ventricular Dysfunction|Evaluation of Effects of Central Sympathetic Inhibition in Elderly With Left Ventricular Diastolic Dysfunction and Preserved Ejection Fraction: A Proof-of-Concept Trial With Clonidine|Withdrawn||Phase 2|70|Anticipated|University Hospital, Strasbourg, France|||||f||||||||||||||2017-10-11 05:37:07.515346|2017-10-11 05:37:07.515346
NCT00213915|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-11-28|||February 2004||2004-02-01|November 2007|2007-11-01|December 2004||2004-12-01|||||Interventional|||L-Arginine Supplementation and Exercise; L-Arginine Supplementation and Renal Function|Effects of Oral Chronic L-Arginine Supplementation on Exercise and Renal Function of Heart Transplant Recipients|Completed||Phase 4|30||University Hospital, Strasbourg, France|||||f||||||||||||||2017-10-11 05:37:07.567994|2017-10-11 05:37:07.567994
NCT00213928|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-29|||May 2002||2002-05-01|July 2011|2011-07-01|September 2008|Actual|2008-09-01|September 2004|Actual|2004-09-01||Interventional|||Horse Chestnut Seed Extract for Lymphedema|A Single-blind, Randomized Trial of Horse Chestnut Seed Extract for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors|Completed||Phase 2|56|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 05:37:07.627026|2017-10-11 05:37:07.627026
NCT00213941|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-02|||November 2004||2004-11-01|October 2006|2006-10-01||||||||Interventional|||Study Protocol Evaluating Transient Tachypnoea of the Newborn in Term and Near Term Neonates|Study Protocol Evaluating Transient Tachypnoea of the Newborn in Term and Near Term Neonates|Unknown status|Recruiting|N/A|100||University Hospital, Strasbourg, France|||||f||||||||||||||2017-10-11 05:37:07.776997|2017-10-11 05:37:07.776997
NCT00213954|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-24|||May 2005||2005-05-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|March 2009|Anticipated|2009-03-01||Interventional|||Ultrasound Guidance in Nerve Block Anaesthesia|Ultrasound Guidance in Nerve Block Anaesthesia: Classic Nerve Stimulation Technique Versus Ultrasound-Neurostimulation Combination in Four Blocks: Interscalene, Humeral, Parasacral and Lumbar Blocks|Unknown status|Active, not recruiting|N/A|1002|Anticipated|University Hospital, Strasbourg, France||4|||f||||f||||||||||2017-10-11 05:37:07.882213|2017-10-11 05:37:07.882213
NCT00213967|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||October 2005||2005-10-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection|The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection|Completed||N/A|80|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:07.987095|2017-10-11 05:37:07.987095
NCT00213993|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||May 2005||2005-05-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Topical Antiperspirant for Hand-Foot Syndrome|Topical Antiperspirant for Prevention of Palmar-Plantar Erythrodysesthesia (Hand-Foot Syndrome) Associated With Capecitabine|Completed||Phase 2|14|Actual|University of Wisconsin, Madison||1|||f||||||||||||||2017-10-11 05:37:08.180083|2017-10-11 05:37:08.180083
NCT00214006|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-06|||November 2001||2001-11-01|March 2013|2013-03-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Observational|||Carotid Atherosclerotic Plaque Study|Carotid Atherosclerotic Plaque Study|Completed||N/A|162|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-10-11 05:37:08.268477|2017-10-11 05:37:08.268477
NCT00214019|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-06-24|2011-08-17||November 2003||2003-11-01|June 2016|2016-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Effect of Salmeterol on Eosinophil (EOS) Function|The Effect of Salmeterol on Eosinophil (EOS) Function|Completed||N/A|36|Actual|University of Wisconsin, Madison||4|||f||||f||||||||Yes||2017-10-11 05:37:08.363302|2017-10-11 05:37:08.363302
NCT00214032|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||May 2002||2002-05-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|November 2006|Actual|2006-11-01||Interventional|||Pycnogenol for the Treatment of Lymphedema|Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo|Completed||Phase 2|2|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-11 05:37:08.640789|2017-10-11 05:37:08.640789
NCT00214058|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-30|||August 2002||2002-08-01|June 2008|2008-06-01|February 2006|Actual|2006-02-01|||||Interventional|||Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer|Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma|Completed||Phase 2|36||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:08.839858|2017-10-11 05:37:08.839858
NCT00214071|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||October 2004||2004-10-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Immunological Consequences of Obstructive Sleep Apnea|Influence of Obstructive Sleep Apnea on Humoral and Cell-Mediated Vaccine Responses|Completed||N/A|30||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:08.926954|2017-10-11 05:37:08.926954
NCT00214084|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-06||||||October 2015|2015-10-01||||||||Interventional|||Vascular Pathophysiology in Obstructive Sleep Apnea|Influence of Xanthine Oxidase Inhibition on Vascular Function in Obstructive Sleep Apnea|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:09.027501|2017-10-11 05:37:09.027501
NCT00214097|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-06-17|||August 2002||2002-08-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase I/II Hypofractionated Radiotherapy for Prostate Cancer|Phase I/II Trial Examining Dose-per-Fraction Escalation Using Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|309|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 05:37:09.100401|2017-10-11 05:37:09.100401
NCT00214110|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-01|||January 2001||2001-01-01|August 2008|2008-08-01|January 2005|Actual|2005-01-01|||||Interventional|||Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]|Phase 2 Randomized Single-blind Escalating Dose Response Clinical Trial of Tamoxifen Therapy on Mean Percent Predicted Isometric Strength in Amyotrophic Lateral Sclerosis [ALS]|Completed||Phase 2|100||University of Wisconsin, Madison|||||f||||t||||||||||2017-10-11 05:37:09.185014|2017-10-11 05:37:09.185014
NCT00214149|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-17|||October 2004||2004-10-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|April 2008|Actual|2008-04-01||Interventional|||Multi-catheter High Dose Rate (HDR) Breast Brachytherapy|A UW Phase II Trial of Multi-catheter HDR Brachytherapy Following Lumpectomy for Early Stage Breast Breast Cancer|Terminated||Phase 2|127|Actual|University of Wisconsin, Madison||1||lost funding|f||||t||||||||||2017-10-11 05:37:09.447411|2017-10-11 05:37:09.447411
NCT00214162|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-16|||August 2004||2004-08-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer|Web-based Support for Informal Caregivers in Cancer|Completed||N/A|235|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-10-11 05:37:09.518782|2017-10-11 05:37:09.518782
NCT00214175|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-22|||June 2004||2004-06-01|February 2012|2012-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy|Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy|Completed||N/A|44|Actual|University of Wisconsin, Madison|||2||f||||f||||||||||2017-10-11 05:37:09.601302|2017-10-11 05:37:09.601302
NCT00214201|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-21|2012-08-13||May 2003||2003-05-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation|Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation|Completed||N/A|40|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 05:37:09.669524|2017-10-11 05:37:09.669524
NCT00214214|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-10-06|||October 2005||2005-10-01|October 2015|2015-10-01||||||||Interventional|||A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus|A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus|Withdrawn||Phase 1|0|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:10.082803|2017-10-11 05:37:10.082803
NCT00214227|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-06-18|||December 2007||2007-12-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||ATM Variants in Radiotherapy Patients|ATM Variants in Radiotherapy|Completed||N/A|60|Actual|University of Wisconsin, Madison|||1||f||||||||||Samples With DNA|"     direct sequence analysis of all exons and intron-exon junctions of the ATM gene. DNA will be     isolated from lympocytes using the PAX blood DNA system.   "|||2017-10-11 05:37:10.173213|2017-10-11 05:37:10.173213
NCT00214240|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-25|||January 2000||2000-01-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease|The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease|Completed||N/A|28|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 05:37:10.233173|2017-10-11 05:37:10.233173
NCT00214253|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-03-29|||February 2002||2002-02-01|March 2017|2017-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Islet Transplantation in Type 1 Diabetic Patients|Islet Transplantation in Type 1 Diabetic Patients Using a Steroid-free Immunosuppression Protocol and Thiazolidinedione Insulin Sensitizers|Completed||Phase 1|14|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-11 05:37:10.480157|2017-10-11 05:37:10.480157
NCT00214266|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-22|||January 2005||2005-01-01|June 2012|2012-06-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation|A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation|Completed||Phase 2|31|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-10-11 05:37:10.562377|2017-10-11 05:37:10.562377
NCT00214279|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-06-22|||May 2002||2002-05-01|June 2012|2012-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal|MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal|Completed||N/A|32|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-10-11 05:37:10.626816|2017-10-11 05:37:10.626816
NCT00214292|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-01-28|||May 2005||2005-05-01|January 2016|2016-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy|A Pilot Study of Intraoperative Margin Assessment Comparing Optical Spectroscopy and Frozen Section Analysis for Ductal Carcinoma In Situ of the Breast|Completed||N/A|20|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:10.693161|2017-10-11 05:37:10.693161
NCT00214305|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-30|||August 2005||2005-08-01|September 2015|2015-09-01||||||||Interventional|||Effects of Swallowing Therapy in Head and Neck Cancer|Effects of Swallowing Therapy in Head and Neck Cancer|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison||2||low accrual|f||||t||||||||||2017-10-11 05:37:10.75309|2017-10-11 05:37:10.75309
NCT00214318|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-10-06|||January 2005||2005-01-01|October 2015|2015-10-01|February 2007|Actual|2007-02-01|||||Interventional|||Beta-2 Polymorphisms and Beta Receptor Selectivity|The Effects of ß2 Polymorphisms on Beta Selectivity After ß-adrenergic Blockade in Patients With Heart Failure|Completed||N/A|25||University of Wisconsin, Madison|||||f||||f||||||||||2017-10-11 05:37:10.826017|2017-10-11 05:37:10.826017
NCT00214331|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-10-25|||April 2003||2003-04-01|October 2016|2016-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy|Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy|Completed||Phase 4|150|Actual|University of Wisconsin, Madison|||3||f||||t||||||||||2017-10-11 05:37:10.893788|2017-10-11 05:37:10.893788
NCT00214344|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-10-01|||October 2003||2003-10-01|September 2005|2005-09-01|February 2007|Actual|2007-02-01|||||Interventional|||Family Preparation Study For Withdrawal of Mechanical Ventilation From Their Family Member|Evaluating the Usefulness of Preparing Families For Withdrawal of Mechanical Ventilation From Their Family Member: A Pilot Study|Completed||Phase 2|20||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:10.970968|2017-10-11 05:37:10.970968
NCT00214357|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-10-01|||October 2004||2004-10-01|November 2008|2008-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||The Effects of Mindfulness Training on School Staff|The Effects of Mindfulness Training on School Staff Emotions, Attention, and Stress|Completed||N/A|19||University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:11.041642|2017-10-11 05:37:11.041642
NCT00214370|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-10-01|||July 2004||2004-07-01|July 2007|2007-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma|Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma|Completed||N/A|40|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:37:11.104092|2017-10-11 05:37:11.104092
NCT00214383|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-16|2012-04-04||May 2004||2004-05-01|January 2013|2013-01-01|May 2009|Actual|2009-05-01|August 2007|Actual|2007-08-01||Interventional|CHESS||Internet Telehealth for Pediatric Asthma Case Management|Internet Telehealth for Pediatric Asthma Case Management|Completed||N/A|301|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-10-11 05:37:11.175549|2017-10-11 05:37:11.175549
NCT00214422|ClinicalTrials.gov processed this data on October 10, 2017|2006-06-19|2017-10-05|||September 15, 2005||2005-09-15|June 16, 2017|2017-06-16|May 27, 2014|Actual|2014-05-27|May 27, 2014|Actual|2014-05-27||Interventional|||Intensity Modulated Radiation Therapy for Prostate Cancer|A Pilot Study of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Therapy (IMRT) in Prostate Cancer|Completed||Phase 1|19|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-10-11 05:37:11.464283|2017-10-11 05:37:11.464283
NCT00214435|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-10-21|||May 2004||2004-05-01|September 2005|2005-09-01||||||||Interventional|||Once Daily 3TC, Efavirenz and ddI for HIV Infection|A Randomised, Multi-Centre, Open-Label Study in Well-Controlled Treatment-Experienced HIV-Infected Patients to Assess Compliance With a Once-Daily Regimen of Lamivudine, Efavirenz and Didanosine Versus Continuation of Current Anti-Retroviral Regimen Delivered at Least Twice Daily|Unknown status|Recruiting|Phase 4|120||407 Doctors|||||f||||||||||||||2017-10-11 05:37:11.547749|2017-10-11 05:37:11.547749
NCT00214448|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2006-07-13||||||September 2005|2005-09-01||||||||Observational|||Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples|Reproducibility of the GeneTrait™ CGH Microarray System DX Using Whole Blood Samples|Unknown status|Not yet recruiting|N/A|4||Abbott Molecular|||||||||||||||||||2017-10-11 05:37:11.64631|2017-10-11 05:37:11.64631
NCT00214461|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-04-09|2012-03-13||November 2005||2005-11-01|April 2012|2012-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers|A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of the Safety, Tolerability and Immunogenicity of a Clostridium Difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Elderly Volunteers (> or =65 Years)|Completed||Phase 1|48|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 05:37:11.744811|2017-10-11 05:37:11.744811
NCT00214474|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-02-12|||November 2002||2002-11-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Improving Diabetes Efforts Across Language and Literacy (IDEALL)|Improving Diabetes Efforts Across Language and Literacy (IDEALL)|Completed||N/A|339|Actual|Agency for Healthcare Research and Quality (AHRQ)||3|||f||||f||||||||||2017-10-11 05:37:14.206556|2017-10-11 05:37:14.206556
NCT00214487|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-06-23|2014-06-23||October 2003||2003-10-01|June 2014|2014-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional||Numbers reflect those subjects screened, enrolled, randomized with at least one follow up examination.|Bifocal Soft Contact Lenses and Their Effect on Myopia Progression in Children and Adolescents.|Bifocal Soft Contact Lenses - Do They Slow Progression of Myopia Relative to Single Vision Soft Contact Lenses in Children and Adolescents?|Completed||N/A|78|Actual|Aller, Thomas A., OD||2|||f||||f||||||||||2017-10-11 05:37:14.312489|2017-10-11 05:37:14.312489
NCT00214500|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-05||2010-08-17|September 2005||2005-09-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of AT1001 in Patients With Fabry Disease|A Phase 2, Open-Label, Multicenter, Ascending-Dose, 12-Week Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AT1001 in Patients With Fabry Disease|Completed||Phase 2|14|Actual|Amicus Therapeutics||4|||f||||||||||||||2017-10-11 05:37:14.571997|2017-10-11 05:37:14.571997
NCT00214513|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-05-16|||June 2004||2004-06-01|May 2007|2007-05-01|July 2006|Actual|2006-07-01|||||Interventional|||A Randomized Trial of Effect of Low-Cost Maintenance Training on Exercise Capacity, Quality of Life and Morbidity|Maintain. A Randomized Trial of Effect of Low-Cost Maintenance Training on Exercise Capacity, Quality of Life and Morbidity|Completed||Phase 3|160|Anticipated|Amager Hospital|||||f||||||||||||||2017-10-11 05:37:14.672301|2017-10-11 05:37:14.672301
NCT00214526|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-08-21|2010-09-08|2010-02-10|November 2002||2002-11-01|August 2015|2015-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Asthma Intervention Research (AIR) Trial|Multicenter Randomized Clinical Trial of the Alair System for the Bronchial Thermoplasty Treatment of Asthma|Completed||N/A|112|Actual|Asthmatx, Inc.||2|||f||||t||||||||||2017-10-11 05:37:14.783082|2017-10-11 05:37:14.783082
NCT00214539|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-09-30|2010-09-08|2010-02-10|April 2004||2004-04-01|September 2011|2011-09-01|August 2006|Actual|2006-08-01|February 2006|Actual|2006-02-01||Interventional|||Research in Severe Asthma (RISA) Trial|Multicenter Randomized Clinical Trial of Bronchial Thermoplasty With the Alair System for the Treatment of Severe Asthma|Completed||N/A|34|Actual|Asthmatx, Inc.||2|||f||||t||||||||||2017-10-11 05:37:15.906782|2017-10-11 05:37:15.906782
NCT00214552|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2011-06-22|||September 2002||2002-09-01|June 2011|2011-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.|A Double-blind Placebo Controlled Clinical Trial to Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.|Completed||Phase 3|80|Anticipated|Associated Scientists to Help Minimize Allergies||1|||f||||f||||||||||2017-10-11 05:37:17.366037|2017-10-11 05:37:17.366037
NCT00214565|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-11-17|||August 2004||2004-08-01|November 2010|2010-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||GALLANT 6 Tesaglitazar vs. Pioglitazone|A 24-Wk Randomised, Double-Blind, Multi-Centre, Active-Controlled (Pioglitazone) Study to Evaluate the Efficacy, Safety & Tolerability of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes|Terminated||Phase 3|1450||AstraZeneca||||The development program has been terminated|||||||||||||||2017-10-11 05:37:17.489515|2017-10-11 05:37:17.489515
NCT00214578|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-01-03|||April 2004||2004-04-01|January 2013|2013-01-01|October 2005|Actual|2005-10-01|||||Interventional|||Seroquel on Glucose Metabolism|Seroquel on Glucose Metabolism|Completed||Phase 4|572||AstraZeneca|||||f||||||||||||||2017-10-11 05:37:17.853475|2017-10-11 05:37:17.853475
NCT00214591|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-11-18|||August 2004||2004-08-01|November 2010|2010-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GALLANT 5 Tesaglitazar Versus Metformin|A 52-wk Randomised, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin) Study to Evaluate the Efficacy, Safety & Tolerability of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes|Terminated||Phase 3|580||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-10-11 05:37:18.103508|2017-10-11 05:37:18.103508
NCT00214604|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2010-11-18|||February 2005||2005-02-01|November 2010|2010-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Type III Dysbetalipoproteinemia|An 18-week, Randomized, Multicenter, Phase 3b, Double-blind, Crossover Study, Followed by an 18-week Open-Label Period to Evaluate the Efficacy & Safety of the Lipid-Regulating Agents, Rosuvastatin & Pravastatin in the Treatment of Subjects With Dysbetalipoproteinemia (Frederickson Type III Hyperlipoproteinemia)|Completed||Phase 3|30||AstraZeneca|||||||||||||||||||2017-10-11 05:37:18.683818|2017-10-11 05:37:18.683818
NCT00214617|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-06-19|||January 2005||2005-01-01|September 2006|2006-09-01|February 2006||2006-02-01|||||Interventional|||Effect of Crestor on Lipoprotein Metabolism in Humans|Effect of Crestor on the Kinetics of Plasma Apolipoproteins: Dose-Response Study|Completed||Phase 4|8||Atlanta Research and Education Foundation|||||f||||||||||||||2017-10-11 05:37:18.759251|2017-10-11 05:37:18.759251
NCT00214630|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2010-11-18|||December 2003||2003-12-01|November 2010|2010-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes|A 12-week Randomized, Open-label 3-arm, Parallel Group, Multicenter Phase IIIb Study Comparing Efficacy and Safety of Rosuvastatin 20mg and 40mg With That of Atorvastatin 80 mg in Subjects With Acute Coronary Syndromes|Completed||Phase 3|825|Actual|AstraZeneca|||||||||||||||||||2017-10-11 05:37:18.867368|2017-10-11 05:37:18.867368
NCT00214643|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2009-02-03|||June 2005||2005-06-01|February 2009|2009-02-01|July 2006||2006-07-01|||||Interventional|||Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children|A Comparative Assessment of the Efficacy of Fosmidomycin-Clindamycin Versus Sulfadoxine-Pyrimethamine for the Treatment of Children With Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 3|160||Albert Schweitzer Hospital|||||f||||||||||||||2017-10-11 05:37:19.160437|2017-10-11 05:37:19.160437
NCT00214656|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||June 2005||2005-06-01|September 2005|2005-09-01|June 2008||2008-06-01|||||Interventional|||"Salvage Use of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery"|"Salvage Use of Recombinant Activated Factor VII After Inadequate Haemostatic Response to Conventional Therapy in Complex Cardiac Surgery - a Randomised Placebo Controlled Trial"|Unknown status|Recruiting|Phase 3|40||Austin Health|||||f||||||||||||||2017-10-11 05:37:19.278715|2017-10-11 05:37:19.278715
NCT00214669|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-06-03|||November 2005||2005-11-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|OEDIPUS||Can Education for South Asians With Asthma and Their Clinicians Reduce Unscheduled Care? A Randomised Trial|Can Education for South Asians With Asthma and Their Clinicians Reduce Unscheduled Care? A Cluster Randomised Trial|Completed||Phase 1|375|Actual|Barts & The London NHS Trust||2|||f||||||||||||||2017-10-11 05:37:19.385344|2017-10-11 05:37:19.385344
NCT00214682|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-09-12|||October 2005||2005-10-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Beyond Ageing Project: A Study for the Prevention of Depression|Beyond Ageing Project: A RCT to Assess the Benefit of Improving Mental Health Literacy as Well as the Effect of Folate and B12, and Physical Activity, in Preventing Major Depression and Cognitive Decline Among Older Australians|Completed||Phase 2|909|Actual|Australian National University||6|||f||||t||||||||||2017-10-11 05:37:19.574166|2017-10-11 05:37:19.574166
NCT00214695|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2006-11-20|||May 2005||2005-05-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis|A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis|Completed||N/A|20||Baxter Healthcare Corporation|||||f||||||||||||||2017-10-11 05:37:19.713738|2017-10-11 05:37:19.713738
NCT00214708|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16|||January 2002||2002-01-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Observational|||Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?|Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis? A Cluster Randomised Controlled Trial in an East London Primary Care Trust|Unknown status|Active, not recruiting|Phase 4|200||Barts & The London NHS Trust|||||f||||||||||||||2017-10-11 05:37:19.794479|2017-10-11 05:37:19.794479
NCT00214721|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2007-11-28|||February 2005||2005-02-01|November 2007|2007-11-01|July 2006||2006-07-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis|A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis|Completed||Phase 3|120||Baxter Healthcare Corporation|||||f||||||||||||||2017-10-11 05:37:19.875015|2017-10-11 05:37:19.875015
NCT00214734|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-06-26|||August 2004||2004-08-01|April 2009|2009-04-01|January 2007||2007-01-01|||||Observational|||ADVATE Post Authorization Safety Surveillance|Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study|Completed||N/A|450|Anticipated|Baxalta US Inc.|||1||f||||||||||||||2017-10-11 05:37:19.939827|2017-10-11 05:37:19.939827
NCT00214747|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-10-24|||March 2005||2005-03-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina|An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina: Candidate Formulations|Unknown status|Active, not recruiting|Phase 1|6||Biosyn|||||f||||||||||||||2017-10-11 05:37:20.103501|2017-10-11 05:37:20.103501
NCT00214760|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2010-01-29|||May 2005||2005-05-01|November 2009|2009-11-01|September 2011|Anticipated|2011-09-01|August 2008|Actual|2008-08-01||Interventional|||Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP|Phase 3 Randomised, Prospective Study Comparing the PMMA and the Resorbable PEGT/PBT Centralizer by the Uncemented BIHAPRO Total Hip Prosthesis|Terminated||Phase 3|70|Actual|Biomet Nederland BV||2||On of the liners has been taken from the market|f||||f||||||||||2017-10-11 05:37:20.181502|2017-10-11 05:37:20.181502
NCT00214773|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-19|||July 2005||2005-07-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Observational|||Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)|MPS VI Clinical Surveillance Program (CSP)|Recruiting||N/A|200|Anticipated|BioMarin Pharmaceutical|||1||f||||f||||||Samples Without DNA|"     Urine and serum   "|No||2017-10-11 05:37:20.281522|2017-10-11 05:37:20.281522
NCT00214786|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-06-09|2013-02-11||April 2005||2005-04-01|June 2017|2017-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Pancreatic Islet Cell Transplantation|Pancreatic Islet Cell Transplantation - A Novel Approach to Immunosuppression and Validation of Remote Site Islet Cell Processing, Islet Cell Culture and Two-Layer Preservation|Completed||Phase 1|4|Actual|Baylor Research Institute|Three of the four patients voluntarily withdrew from the study.|1|||f||||t||||||||||2017-10-11 05:37:20.555351|2017-10-11 05:37:20.555351
NCT00214812|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-10-24|||June 2005||2005-06-01|September 2005|2005-09-01||||||||Interventional|||An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots|An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots|Unknown status|Recruiting|Phase 1|6||Biosyn|||||f||||||||||||||2017-10-11 05:37:20.845437|2017-10-11 05:37:20.845437
NCT00214825|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2007-12-28|||August 2003||2003-08-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Aldosterone and Vascular Disease in Diabetes Mellitus|Aldosterone and Vascular Disease in Diabetes Mellitus|Completed||N/A|46|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-10-11 05:37:20.918584|2017-10-11 05:37:20.918584
NCT00214838|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-12-01|||March 2005||2005-03-01|December 2006|2006-12-01|March 2007||2007-03-01|||||Interventional|||An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer|An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|61||Callisto Pharmaceuticals|||||f||||||||||||||2017-10-11 05:37:21.221736|2017-10-11 05:37:21.221736
NCT00214851|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2008-05-30|||September 2005||2005-09-01|May 2008|2008-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria|The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria|Completed||Phase 1|8|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-10-11 05:37:21.310255|2017-10-11 05:37:21.310255
NCT00214864|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2012-02-13|||December 2002||2002-12-01|February 2012|2012-02-01||||January 2006|Actual|2006-01-01||Interventional|||A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer|A Pilot Study of Taxotere (Docetaxel) Combined With Xeloda (Capecitabine) in the Treatment of Metastatic Breast Cancer|Completed||Phase 2|18|Actual|Cancer Research Network||1|||f||||t||||||||||2017-10-11 05:37:21.377035|2017-10-11 05:37:21.377035
NCT00214877|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-03-28|||November 2003||2003-11-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Methylene Blue for Cognitive Dysfunction in Bipolar Disorder|Double-Blind Trial of Methylene Blue for Cognitive Dysfunction in Bipolar Disorder|Completed||Phase 3|40|Anticipated|Nova Scotia Health Authority|||||f||||f||||||||||2017-10-11 05:37:21.451913|2017-10-11 05:37:21.451913
NCT00214890|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2011-08-02|||April 2005||2005-04-01|August 2011|2011-08-01||||February 2009|Actual|2009-02-01||Interventional|||Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir|CCTG584: Viral Dynamics and Pharmacokinetics of Tenofovir and Abacavir Monotherapy Versus the Combination Therapy of TDF-ABC in HIV-Infected Treatment Naive Patients|Completed||Phase 2|20|Anticipated|California Collaborative Treatment Group||2|||f||||||||||||||2017-10-11 05:37:21.526334|2017-10-11 05:37:21.526334
NCT00214903|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2014-11-13|2014-11-06||November 2004||2004-11-01|November 2014|2014-11-01|November 2011|Actual|2011-11-01|May 2011|Actual|2011-05-01||Observational||At baseline, 33% of women were using DRSP/E2, 44% were using ooccHRT, 13% were using ooHRT, and 10% ‘Non-oral HRT’. These proportions only partially reflect the overall exposure in each cohort (AT population) because market authorization for DRSP/E2 was delayed by more than 1.5 years.|European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)|European Active Surveillance Study of Women Taking HRT|Completed||Phase 4|30597|Actual|Center for Epidemiology and Health Research, Germany|In non-experimental studies like EURAS-HRT the possibility of bias and residual confounding can never be entirely eliminated. The findings may exclude large, but not small relative risks.||2||f||||t||||||||||2017-10-11 05:37:21.631152|2017-10-11 05:37:21.631152
NCT00214916|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-06-21|||October 2004||2004-10-01|June 2017|2017-06-01|June 2021|Anticipated|2021-06-01|February 2008|Actual|2008-02-01||Interventional|||Tight Glycemic Control With Intensive Insulin Therapy in PICU|KULeuven Intensive Insulin Study in Pediatric Intensive Care Patients|Active, not recruiting||Phase 2|700|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-10-11 05:37:22.083915|2017-10-11 05:37:22.083915
NCT00214929|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-12-08|||December 2004||2004-12-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Home Treatment of Pulmonary Embolism|Cooperative Investigation Plan for Home Treatment of Pulmonary Embolism|Unknown status|Active, not recruiting|Phase 4|||Carlos III Health Institute|||||f||||||||||||||2017-10-11 05:37:22.189846|2017-10-11 05:37:22.189846
NCT00214942|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-05-08|||September 2005||2005-09-01|May 2014|2014-05-01||||March 2006|Actual|2006-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Low Back Pain|Completed||Phase 3|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 05:37:22.344312|2017-10-11 05:37:22.344312
NCT00214955|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-05-08|||September 2005||2005-09-01|May 2014|2014-05-01||||May 2006|Actual|2006-05-01||Interventional|||Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Neuropathic Pain|Completed||Phase 3|120||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 05:37:22.455732|2017-10-11 05:37:22.455732
NCT00214968|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-05-23||2012-05-23|January 2005||2005-01-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness|A 6-Month Open Label, Flexible-Dosage Study to Assess the Safety and Effectiveness of PROVIGIL (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|92|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 05:37:22.574296|2017-10-11 05:37:22.574296
NCT00214981|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-07-25|||September 2003||2003-09-01|July 2012|2012-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD|A 1-Year, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Continued Efficacy of Modafinil (Film-coated Tablet Formulation) in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (Followed by an Open-Ended Extension Period)|Completed||Phase 3|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 05:37:22.654599|2017-10-11 05:37:22.654599
NCT00214994|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-05-08|||January 2005||2005-01-01|May 2014|2014-05-01|December 2006||2006-12-01|||||Interventional|||Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.|A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment (up to 16 mg/Day) in Adults With Generalized Anxiety Disorder.|Completed||Phase 3|||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:37:22.860511|2017-10-11 05:37:22.860511
NCT00215007|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2007-11-29||||||February 2004|2004-02-01||||||||Interventional|||Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)|Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial With Levofloxacin as Prophylaxis for Bacterial Infections in Immunocompromised Patients After Allogeneic Transplantation of Hematopoietic Stem Cells|Unknown status|Recruiting|Phase 2/Phase 3|||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:37:23.128717|2017-10-11 05:37:23.128717
NCT00215020|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-01-26|||September 2003||2003-09-01|January 2016|2016-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease|Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease|Completed||Phase 1|150|Actual|Boston Children’s Hospital|||1||f||||f||||||Samples Without DNA|"     Specimens stored at -80 in the Center for IBD at Boston Children's Hospital.   "|No||2017-10-11 05:37:23.210113|2017-10-11 05:37:23.210113
NCT00215033|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-03-14|||April 2005||2005-04-01|May 2007|2007-05-01|May 2006|Actual|2006-05-01|||||Observational|||Relationship Between EBV and PTLD|Relationship Between Quantitative Epstein-Bar Viral(EBV) Titres and Post-Transplant Lymphoproliferative Disease|Terminated||N/A|160|Actual|Children's Healthcare of Atlanta|||1|sufficient data gathered to support conclusion|f||||f||||||||||2017-10-11 05:37:23.282048|2017-10-11 05:37:23.282048
NCT00215046|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-06-22|||March 2000||2000-03-01|June 2011|2011-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis|Vinblastine and Methotrexate in Children With Multivessel Pulmonary Vein Stenosis-A Phase II Study|Completed||Phase 2|28|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-10-11 05:37:23.339066|2017-10-11 05:37:23.339066
NCT00215059|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2012-08-01|||August 2000||2000-08-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis|Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Multivessel Pulmonary Vein Stenosis|Terminated||N/A|50|Anticipated|Boston Children’s Hospital|||1|Lack of funding|f||||f||||||||||2017-10-11 05:37:23.417585|2017-10-11 05:37:23.417585
NCT00215072|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-03-14|||July 2005||2005-07-01|May 2007|2007-05-01|February 2007|Actual|2007-02-01|||||Observational|||Death Following Congenital Heart Surgery|Death Following Congenital Heart Surgery|Terminated||N/A|40|Anticipated|Children's Healthcare of Atlanta|||1|insufficient number of patient charts to support hypothesis|f||||f||||||||||2017-10-11 05:37:23.483187|2017-10-11 05:37:23.483187
NCT00215085|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-03-14|||May 2005||2005-05-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Observational|||Cardiac Tumors in Children|Cardiac Tumors in Children|Terminated||N/A|70|Anticipated|Children's Healthcare of Atlanta|||1|insufficient data|f||||f||||||||||2017-10-11 05:37:23.544122|2017-10-11 05:37:23.544122
NCT00215098|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-03-14|||May 2005||2005-05-01|June 2007|2007-06-01|November 2006|Actual|2006-11-01|||||Observational|||Chylothorax Following Heart Surgery|Chylothorax in Children Following Congenital Heart Surgery|Terminated||N/A|70|Anticipated|Children's Healthcare of Atlanta|||1|insufficient data|f||||f||||||||||2017-10-11 05:37:23.60287|2017-10-11 05:37:23.60287
NCT00215111|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-02-04|||March 2005||2005-03-01|February 2015|2015-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Role of Carbohydrate Modification in Weight Management Among Obese Children|Role of Carbohydrate Modification in Weight Management Among Obese Children|Completed||N/A|102|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||||||||||||2017-10-11 05:37:23.658933|2017-10-11 05:37:23.658933
NCT00215124|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-09-17||||||September 2008|2008-09-01|February 2007|Actual|2007-02-01|||||Interventional|||A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction|Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction|Completed||Phase 1/Phase 2|||The Cleveland Clinic|||||f||||t||||||||||2017-10-11 05:37:23.745042|2017-10-11 05:37:23.745042
NCT00215137|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-07-14|2013-04-15||October 2004||2004-10-01|August 2013|2013-08-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional||Only the open label treatment phase is being reported per reviewer's instructions. The other arms are for the second phase of the study.|Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder|Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder|Completed||Phase 2|14|Actual|Duke University||3|||f||||f||||||||||2017-10-11 05:37:23.809182|2017-10-11 05:37:23.809182
NCT00215150|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-10-23|2012-12-13||November 2004||2004-11-01|April 2013|2013-04-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|SAD|This is the intent to treat population consisting of subjects completing at least one post baseline visit.|Geodon for the Treatment of Refractory Social Anxiety Disorder|Ziprasidone for the Treatment of Refractory Social Anxiety Disorder|Completed||Phase 2|51|Actual|Duke University||3|||f||||f||||||||||2017-10-11 05:37:24.046021|2017-10-11 05:37:24.046021
NCT00215163|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-05-29|||December 2002||2002-12-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy|Randomized Trial of Paroxetine-CR for the Treatment of Patients With Post-Traumatic Stress Disorder (PTSD) Remaining Symptomatic After Initial Exposure Therapy|Completed||Phase 2/Phase 3|17|Actual|Duke University|||||f||||||||||||||2017-10-11 05:37:24.262233|2017-10-11 05:37:24.262233
NCT00215176|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-06-17|||February 2003||2003-02-01|September 2005|2005-09-01|April 2005||2005-04-01|||||Interventional|||Modafinil for Atypical Depression|A Study of Modafinil for Atypical Depression|Completed||Phase 2/Phase 3|65||Duke University|||||f||||||||||||||2017-10-11 05:37:24.573385|2017-10-11 05:37:24.573385
NCT00215189|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-09-22|||August 2004||2004-08-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Evaluation of a Health Promotion Intervention for Persons With Mental Illness|Evaluation of a Health Promotion Intervention for Persons With Mental Illness|Completed||N/A|145|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||t||||||||||2017-10-11 05:37:24.641988|2017-10-11 05:37:24.641988
NCT00215202|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-08-13|||August 2004||2004-08-01|August 2008|2008-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)|A Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)|Completed||Phase 2|33|Anticipated|Dartmouth-Hitchcock Medical Center|||||f||||t||||||||||2017-10-11 05:37:24.70498|2017-10-11 05:37:24.70498
NCT00215215|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2006-02-20|||February 2005||2005-02-01|February 2006|2006-02-01|November 2007||2007-11-01|||||Interventional|||Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures|Post Marketing Study; Randomized, Parallel-Group Comparison of Treatment With Pharmacotherapy or Adjunctive Vagus Nerve Stimulation Therapy for Pharmacoresistant Partial Seizures: A Large Simple Effectiveness Trial|Terminated||Phase 4|360||Cyberonics, Inc.|||||f||||||||||||||2017-10-11 05:37:24.783562|2017-10-11 05:37:24.783562
NCT00215228|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-07-18|||July 2005||2005-07-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression|Effects of Escitalopram vs. Duloxetine on Heart Rate Variability and Autonomic Cardiovascular Control|Completed||Phase 2/Phase 3|26|Anticipated|Duke University|||||f||||||||||||||2017-10-11 05:37:24.894371|2017-10-11 05:37:24.894371
NCT00215241|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-09-18|||April 2004||2004-04-01|June 2006|2006-06-01|July 2006||2006-07-01|||||Interventional|||Risperidone Augmentation for PTSD|Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD|Completed||Phase 2/Phase 3|80||Duke University|||||f||||||||||||||2017-10-11 05:37:24.969849|2017-10-11 05:37:24.969849
NCT00215254|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2006-12-18|||March 2004||2004-03-01|March 2006|2006-03-01|February 2006||2006-02-01|||||Interventional|||Quetiapine in Social Anxiety Disorder|A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Quetiapine in Social Anxiety Disorder|Completed||Phase 2/Phase 3|15||Duke University|||||f||||||||||||||2017-10-11 05:37:25.067971|2017-10-11 05:37:25.067971
NCT00215267|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-02-19|||September 2005||2005-09-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda|The Effect of One Versus Two Praziquantel Treatments on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria in Uganda|Completed||N/A|540|Anticipated|DBL -Institute for Health Research and Development|||||f||||||||||||||2017-10-11 05:37:25.134076|2017-10-11 05:37:25.134076
NCT00215280|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2007-04-19|||November 2005||2005-11-01|April 2007|2007-04-01|February 2006||2006-02-01|||||Interventional|||Epidemiology and Control of Mansonella Perstans Infection in Uganda|Studies on the Epidemiology and Control of Mansonella Perstans Infection in Uganda|Completed||N/A|1000||DBL -Institute for Health Research and Development|||||f||||||||||||||2017-10-11 05:37:25.196936|2017-10-11 05:37:25.196936
NCT00215293|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-22|||August 2000||2000-08-01|May 2014|2014-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cervical I/F Cage for Anterior Cervical Fusion|A Randomized Multi-Center Study to Evaluate the Safety and Efficacy of the Cervical I/F Cage for Anterior Cervical Fusion|Completed||Phase 3|240|Actual|DePuy Spine||2|||f||||f||||||||||2017-10-11 05:37:25.325365|2017-10-11 05:37:25.325365
NCT00215306|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-22|||March 2000||2000-03-01|May 2014|2014-05-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||CHARITÉ™ Artificial Disc Compared to Anterior Interbody Fusion for Treatment of Degenerative Disc Disease|Clinical Investigation of the SB Charite III Intervertebral Disc Spacer.|Completed||Phase 3|304|Actual|DePuy Spine||2|||f||||||||||||||2017-10-11 05:37:25.428821|2017-10-11 05:37:25.428821
NCT00215319|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-22|||December 2000||2000-12-01|May 2014|2014-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Titanium Surgical Mesh and MOSS-Miami Screws for Lumbar Fusion.|A Multi-center Study to Evaluate the Safety and Efficacy of DePuy AcroMed Titanium Surgical Mesh and MOSS-Miami Spinal Fixation System Pedicle Screws for Intradiscal Fusion in the Lumbar Spine|Completed||Phase 3|139|Actual|DePuy Spine||1|||f||||f||||||||||2017-10-11 05:37:25.532819|2017-10-11 05:37:25.532819
NCT00215332|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-04-10|||March 2005||2005-03-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|||||Observational|||CHARITE™ vs. ALIF 5-Year Follow-up|Five-year Follow-up of the CHARITÉ™ Artificial Disc Compared to Anterior Lumbar Interbody Fusion With the BAK Cage.|Completed||Phase 4|367|Anticipated|DePuy Spine|||3||f||||f||||||||||2017-10-11 05:37:25.639064|2017-10-11 05:37:25.639064
NCT00215345|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-09-20|||August 2002||2002-08-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer|A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer|Unknown status|Recruiting|Phase 2|66||Department of Veterans Affairs, New Jersey|||||||||||||||||||2017-10-11 05:37:25.755803|2017-10-11 05:37:25.755803
NCT00215358|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10|||July 2002||2002-07-01|February 2008|2008-02-01|December 2005|Actual|2005-12-01|October 2002|Actual|2002-10-01||Interventional|||Study in Patients With Asthma||Completed||Phase 2|32||Dey|||||||||||||||||||2017-10-11 05:37:25.873482|2017-10-11 05:37:25.873482
NCT00208637|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2002||2002-08-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||He Purongo Mo Nga Kai Hei Arai i Te Matehuka – Dietary Diabetes Prevention Study for Maori||Completed||N/A|90||Edgar National Centre for Diabetes Research|||||f||||||||||||||2017-10-11 05:37:25.960592|2017-10-11 05:37:25.960592
NCT00208650|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-25|||September 2005||2005-09-01|November 2013|2013-11-01|September 2006|Actual|2006-09-01|||||Observational|||Tissue Doppler Echo Imaging of Heart Function After Transplant|Non-Invasive Quantitation of Myocardial Dysfunction by Tissue Doppler/Synchronization Imaging After Orthotopic Heart Transplantation in Children|Completed||N/A|75||Emory University|||||f||||||||||||||2017-10-11 05:37:26.062745|2017-10-11 05:37:26.062745
NCT00208663|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-10|||September 2005||2005-09-01|April 2015|2015-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Validation of an Instrument to Qualitatively and Quantitatively Profile Hospitalist Workflow|Validation of an Instrument to Qualitatively and Quantitatively Profile Hospitalist Workflow|Withdrawn||N/A|0|Actual|Emory University|||1|Resources|f||||f||||||||||2017-10-11 05:37:26.130718|2017-10-11 05:37:26.130718
NCT00208676|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-25|||September 2005||2005-09-01|November 2013|2013-11-01|January 2006||2006-01-01|||||Observational|||Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease|Non-Invasive Quantitation of Myocardial Dysfunction by Tissue Doppler / Synchronization Imaging in Children With Congenital Heart Defects (CHD)|Terminated||N/A|200||Emory University|||||f||||||||||||||2017-10-11 05:37:26.198116|2017-10-11 05:37:26.198116
NCT00208715|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-08|||February 2003||2003-02-01|November 2013|2013-11-01|October 2004||2004-10-01|||||Interventional|||Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.|A DOUBLE-BLIND PILOT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PROVIGIL® (MODAFINIL) AT FIXED/FLEXIBLE DOSES, IN CONJUNCTION WITH IDENTIFIED SSRIs FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH MILD TO MODERATE DEPRESSION WITH ATTENDANT SYMPTOMS OF SLEEPINESS AND FATIGUE|Completed||Phase 4|100||Emory University|||||f||||||||||||||2017-10-11 05:37:26.445376|2017-10-11 05:37:26.445376
NCT00208728|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-25|||May 2003||2003-05-01|November 2013|2013-11-01|June 2005||2005-06-01|||||Interventional|||Cardiopulmonary Circuits in the Pediatric Population|Prospective Evaluation of Modified Cardiopulmonary Bypass Circuits in the Pediatric Population|Completed||N/A|90||Emory University|||||f||||||||||||||2017-10-11 05:37:26.532734|2017-10-11 05:37:26.532734
NCT00208741|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-08|||June 2002||2002-06-01|November 2013|2013-11-01|November 2003||2003-11-01|||||Interventional|||Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder|A 12-Week Open-Label Study Followed By A 24-Week Double-Blind Discontinuation Exploratory Study To Evaluate The Effects Of Gabitril™ (Tiagabine Hydrochloride) In Patients With Social Anxiety Disorder (SAD)|Completed||Phase 4|50||Emory University|||||f||||||||||||||2017-10-11 05:37:26.615066|2017-10-11 05:37:26.615066
NCT00208754|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-08|||May 2004||2004-05-01|November 2013|2013-11-01|December 2005||2005-12-01|||||Observational|||Heart Failure in Adult Patients With a History of Congenital Heart Disease|Heart Failure in Adult Patients With a History of Congenital Heart Disease.|Terminated||N/A|350||Emory University|||||f||||||||||||||2017-10-11 05:37:26.689287|2017-10-11 05:37:26.689287
NCT00208767|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-11-09|2014-09-12||February 2005||2005-02-01|November 2015|2015-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effect of Valsartan on Carotid Artery Disease|Effect of Valsartan on Endothelial Function, Oxidative Stress, Carotid Atherosclerosis, and Endothelial Progenitor Cells (EFFERVESCENT)|Completed||Phase 2|120|Actual|Emory University||2|||f||||t||||||||||2017-10-11 05:37:26.753949|2017-10-11 05:37:26.753949
NCT00208780|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-15|||December 2004||2004-12-01|November 2013|2013-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Effects of Tetrahydrobiopterin on Blood Pressure|Effects of Tetrahydrobiopterin on Blood Pressure|Completed||Early Phase 1|24|Actual|Emory University||2|||f||||f||||||||||2017-10-11 05:37:26.999717|2017-10-11 05:37:26.999717
NCT00208793|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-22|||May 2005||2005-05-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|September 2006|Actual|2006-09-01||Interventional|CaDvMAP||Calcium and Vitamin D vs Markers of Adenomatous Polyps|Calcium, Vitamin D, and Colon Cancer Risk Biomarkers|Completed||Phase 2|92|Actual|Emory University||4|||f||||f||||||||||2017-10-11 05:37:27.0844|2017-10-11 05:37:27.0844
NCT00208806|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-09|||June 2004||2004-06-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Resynchronization Therapy in Young Patients With and Without CHD|Clinical Evaluation of Dilated Cardiomyopathy and Cardiac Resynchronization Therapy for Ventricular Dysfunction in Young Patients With and Without Congenital Heart Disease|Completed||N/A|50||Emory University|||1||f||||||||||||||2017-10-11 05:37:27.177999|2017-10-11 05:37:27.177999
NCT00208819|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-12|||September 2003||2003-09-01|November 2013|2013-11-01|July 2007|Actual|2007-07-01|||||Interventional|||A Comparison of Two Standard Therapies in the Management of Dementia With Agitation|Randomized Comparison of Monotherapy (Risperidone, Quetiapine, or Olanzapine) Versus Combination Therapy (Risperidone, Quetiapine, or Olanzapine + Divalproex)in the Management of Dementia With Agitation: A Pilot Comparison of Two Standard Therapies|Completed||Phase 4|50|Anticipated|Emory University|||||f||||||||||||||2017-10-11 05:37:27.248924|2017-10-11 05:37:27.248924
NCT00208832|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-12-18|||March 2004||2004-03-01|December 2013|2013-12-01|March 2006||2006-03-01|||||Interventional|||A Randomized Controlled Trial to Improve Medication Compliance Among Patients With Coronary Heart Disease|A Randomized Controlled Trial to Improve Medication Compliance Among Patients With Coronary Heart Disease|Completed||N/A|440||Emory University|||||f||||||||||||||2017-10-11 05:37:27.324814|2017-10-11 05:37:27.324814
NCT00208845|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-19|||September 2005||2005-09-01|November 2013|2013-11-01||||||||Observational|||Hypernet- Hypertension Screening|Hypernet- Hypertension ED Surveillance|Terminated||N/A|100|Anticipated|Emory University|||1||f||||f||||||||||2017-10-11 05:37:27.388307|2017-10-11 05:37:27.388307
NCT00208858|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-06-13|||December 2004||2004-12-01|June 2014|2014-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving|Nicotine Craving: Neural Correlates of Treatment Effect - A Pilot Study|Completed||Phase 2|||Emory University|||||f||||||||||||||2017-10-11 05:37:27.608701|2017-10-11 05:37:27.608701
NCT00208871|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-19|||December 2004||2004-12-01|November 2013|2013-11-01|March 2011|Actual|2011-03-01|December 2007|Actual|2007-12-01||Interventional|||An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall|An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall|Completed||N/A|1467|Actual|Emory University||1|||f||||f||||||||||2017-10-11 05:37:27.671405|2017-10-11 05:37:27.671405
NCT00208884|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-25|||October 2003||2003-10-01|November 2013|2013-11-01|November 2005||2005-11-01|||||Observational|||Terminal Graft Failure|Terminal Graft Failure: A Combined Pathologic and Clinical Study|Terminated||N/A|19||Emory University|||||f||||f||||||||||2017-10-11 05:37:27.745018|2017-10-11 05:37:27.745018
NCT00208897|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-08|||December 1997||1997-12-01|November 2013|2013-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?|Does Fluoxetine Reverse the Effects of Early Life Stress on the CNS Corticotropin-Releasing Factor System and Improve Psychological and Neuroendocrine Function?: A Therapy Outcome Study in Women With Childhood Abuse Experiences|Completed||N/A|80|Anticipated|Emory University||1|||f||||f||||||||||2017-10-11 05:37:27.801658|2017-10-11 05:37:27.801658
NCT00208910|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-08|||November 2003||2003-11-01|November 2013|2013-11-01|May 2005||2005-05-01|||||Interventional|||Muscle Relaxation Therapy With Odorant Cue|A Study of Enhancement of Progressive Muscle Relaxation Therapy for Generalized Anxiety Disorder Through Use Of An Odorant Cue.|Completed||N/A|15||Emory University|||||f||||||||||||||2017-10-11 05:37:27.887837|2017-10-11 05:37:27.887837
NCT00209105|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-11|||January 2005||2005-01-01|November 2013|2013-11-01|March 2011|Actual|2011-03-01|December 2009|Actual|2009-12-01||Observational|||Characterizing Psychological Consequences of Childhood Trauma|Emory Conte Center for the Neuroscience of Mental Disorders: Psychobiology of Childhood Trauma|Completed||N/A|113|Actual|Emory University|||1||f||||t||||||||||2017-10-11 05:37:31.195955|2017-10-11 05:37:31.195955
NCT00208923|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-05|||July 1998||1998-07-01|April 2012|2012-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies|Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies Using a Preparative Regimen of Busulfan, Cyclophosphamide, and Fludarabine|Completed||Phase 2|55|Anticipated|Emory University||1|||f||||t||||||||||2017-10-11 05:37:27.949092|2017-10-11 05:37:27.949092
NCT00208936|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-09-05|||January 1996||1996-01-01|September 2014|2014-09-01||||March 2006|Actual|2006-03-01||Interventional|||Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus|Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus|Terminated||Phase 2|20||Emory University|||||f||||||||||||||2017-10-11 05:37:28.022293|2017-10-11 05:37:28.022293
NCT00208949|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-17|2012-03-22||September 2002||2002-09-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2010|Actual|2010-05-01||Interventional|||A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF|A Randomized Comparison of Dendritic Cell Content and T-Cell Phenotype Between G-CSF(Granulocyte Colony-Stimulating Factor)or G-CSF+GM-CSF (Granulocyte Macrophage Colony-Stimulating Factor) for the Mobilization of Normal Allogeneic Peripheral Blood Stem Cell Donors|Terminated||Phase 2|50|Actual|Emory University||2||slow accrual|f||||t||||||||||2017-10-11 05:37:28.088294|2017-10-11 05:37:28.088294
NCT00208962|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-08-11|||September 1998||1998-09-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|September 2007|Actual|2007-09-01||Interventional|||Allogeneic Cell Therapy for Adults With Hematologic Malignancies|Allogeneic Cell Therapy for Adults With Hematologic Malignancies|Completed||Phase 2|32|Actual|Emory University||1|||f||||t||||||||||2017-10-11 05:37:28.346755|2017-10-11 05:37:28.346755
NCT00208975|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-25|2012-03-16||July 2002||2002-07-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|December 2009|Actual|2009-12-01||Interventional|||Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab|Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab in Patients With Low Grade Non-Hodgkins Lymphoma: An Analysis of Efficacy and Tolerability|Terminated||Phase 2|15|Actual|Emory University|The protocol was closed early due to slow and poor accrual.|1||slow accrual|f||||t||||||||||2017-10-11 05:37:28.42707|2017-10-11 05:37:28.42707
NCT00208988|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 2003||2003-05-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening|A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening|Completed||N/A|250||Emory University|||||f||||||||||||||2017-10-11 05:37:28.646293|2017-10-11 05:37:28.646293
NCT00209001|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-07-10|||July 2003||2003-07-01|July 2015|2015-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer|Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer|Terminated||N/A|7|Actual|Emory University||3||Principal investigator Peter Johnstone, MD relocated to another institution|f||||t||||||||||2017-10-11 05:37:28.713257|2017-10-11 05:37:28.713257
NCT00209014|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-05-06|||July 2003||2003-07-01|May 2009|2009-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease|Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease|Terminated||Phase 2|2|Actual|Emory University||1||Celgene unable to continue funds.|f||||||||||||||2017-10-11 05:37:28.782731|2017-10-11 05:37:28.782731
NCT00209027|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-13|2012-04-13||April 2005||2005-04-01|November 2013|2013-11-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia|Aripiprazole Effects on Reward Processing in Deficit Syndrome Schizophrenia|Terminated||N/A|20|Actual|Emory University|Although the study was planned as a repeated measures study with fMRI testing at baseline and after 3 months, difficulty with recruitment and technical difficulties with obtaining fMRI data relegated the study to a single baseline timepoint.|1||difficulty with technical aspect of fMRI, resources to complete the study ran out|f||||t||||||||||2017-10-11 05:37:28.859545|2017-10-11 05:37:28.859545
NCT00209040|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-11-22|||January 2001||2001-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder|Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder|Active, not recruiting||N/A|250|Anticipated|Emory University|||3||f||||f||||||||||2017-10-11 05:37:29.103468|2017-10-11 05:37:29.103468
NCT00209053|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-10-14|||January 2007||2007-01-01|October 2013|2013-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||SMART Trial Longitudinal Follow-Up:Off-Pump Versus On-Pump Coronary Artery Bypass Surgery|A Prospective, Randomized Comparison of Graft Patency and Clinical Outcomes After Coronary Bypass Surgery Performed With and Without the Use of Cardiopulmonary Bypass:Longitudinal Follow-Up|Completed||N/A|87|Actual|Emory University||2|||f||||||||||||||2017-10-11 05:37:29.1847|2017-10-11 05:37:29.1847
NCT00209066|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-11-17|||November 1998||1998-11-01|November 2013|2013-11-01|April 2005||2005-04-01|||||Observational|||Treatment of Reduced Heart Rate Variability Associated With Major Depression With Electroconvulsive Therapy|A Means to Enhanced Cardiovascular Outcomes: Reduction of Exaggerated Platelet Activity Through Treatment of Depression.|Completed||N/A|50|Anticipated|Emory University|||1||f||||||||||||||2017-10-11 05:37:29.258298|2017-10-11 05:37:29.258298
NCT00209079|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-12-27|||September 2004||2004-09-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma|Phase II Trial of Gleevec (Imatinib Mesylate) and Taxotere (Docetaxel) as a Combined Regimen for Advanced Gastric Adenocarcinoma|Terminated||Phase 2|5|Actual|Emory University||1||Terminated 4/17/07. Drug sponsor withdrew.|f||||t||||||||||2017-10-11 05:37:29.323232|2017-10-11 05:37:29.323232
NCT00209092|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-03-06|2012-03-15||August 2006||2006-08-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|July 2009|Actual|2009-07-01||Interventional|||Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer|Randomized Phase II Trial of Sequential Docetaxel Followed by Capecitabine Versus Concomitant, Dose-Dense Docetaxel/Capecitabine as in Induction Therapy for Early Stage Breast Cancer|Completed||Phase 2|51|Actual|Emory University||2|||f||||t||||||||||2017-10-11 05:37:30.780899|2017-10-11 05:37:30.780899
NCT00209118|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-04-07||||||April 2016|2016-04-01|July 2005||2005-07-01|||||Interventional|||Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C|Paroxetine for the Prevention of IFN-Alpha Associated Depression in Patients With Chronic Hepatitis C|Completed||N/A|60||Emory University|||||f||||||||||||||2017-10-11 05:37:31.288164|2017-10-11 05:37:31.288164
NCT00209131|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-09-23|2012-06-05||April 2005||2005-04-01|September 2013|2013-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy|Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy|Terminated||N/A|24|Actual|Emory University|Study was terminated due to turnovers of personnel to assist with recruitment and execution of the study.Recruitment was strained and patients recruited could not be followed up in a timely fashion to adhere to protocol. Thus, no data was generated.|2||Due to frequent turnover of research coordinators and thus poor study accrual.|f||||f||||||||||2017-10-11 05:37:31.379696|2017-10-11 05:37:31.379696
NCT00209144|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-06-13|||October 2004||2004-10-01|June 2014|2014-06-01|December 2006|Actual|2006-12-01|December 2005|Actual|2005-12-01||Interventional|||Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.|Effects of Intense Glycemic Control on Markers of Inflammation and Thrombosis in Patients Treated With Percutaneous Coronary Intervention for Acute Myocardial Infarction.|Completed||Phase 1|58|Actual|Emory University||2|||f||||||||||||||2017-10-11 05:37:31.698132|2017-10-11 05:37:31.698132
NCT00209170|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-07-27|2015-06-23||May 2004||2004-05-01|July 2015|2015-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Depression-Diabetes Mechanisms: Urban African Americans|Depression-Diabetes Mechanisms: Urban African Americans|Completed||Phase 4|20|Actual|Emory University||2|||f||||t||||||||||2017-10-11 05:37:31.79858|2017-10-11 05:37:31.79858
NCT00209196|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-02-10|||May 2005||2005-05-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|July 2007|Actual|2007-07-01||Observational|||Quality of Life in Pediatric Transplant Recipients|Health Behaviors and Quality of Life in Pediatric Solid Organ Transplant Recipients|Completed||N/A|65|Actual|Emory University|||1||f||||f||||||||||2017-10-11 05:37:32.252825|2017-10-11 05:37:32.252825
NCT00209209|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-06|||January 14, 2004|Actual|2004-01-14|March 2017|2017-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|MCLelderly||Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL|Efficacy of Maintenance Therapy With Rituximab After Induction Chemotherapy (R-CHOP vs. R-FC) for Elderly Patients With Mantle Cell Lymphoma Not Suitable for Autologous Stem Cell Transplantation|Active, not recruiting||Phase 3|570|Anticipated|European Mantle Cell Lymphoma Network||2|||f||||t||||||||No||2017-10-11 05:37:32.329432|2017-10-11 05:37:32.329432
NCT00209222|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-07|||July 2004||2004-07-01|July 2009|2009-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL|Efficacy of 6x R-CHOP Followed by Myeloablative Radiochemotherapy and Autologous Stem Cell Transplantation vs. 3 x (R-CHOP/R-DHAP) Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation|Unknown status|Recruiting|Phase 3|360|Anticipated|European Mantle Cell Lymphoma Network||2|||f||||t||||||||||2017-10-11 05:37:32.511105|2017-10-11 05:37:32.511105
NCT00209235|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-14|||January 2003||2003-01-01|August 2017|2017-08-01|December 2025|Anticipated|2025-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments|Natural History Study of Albright Hereditary Osteodystrophy: Includes Substudies on Effects of Growth Hormone in Patients With Pseudohypoparathyroidism Type 1a and Cognitive & Behavioral Studies in Albright Hereditary Osteodystrophy|Recruiting||N/A|600|Anticipated|Connecticut Children's Medical Center||1|||f||||f|f|f||||||||2017-10-11 05:37:32.705889|2017-10-11 05:37:32.705889
NCT00209261|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-18|||December 2004||2004-12-01|May 2011|2011-05-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|PALAT||A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)|A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate (120 μg and 240 μg) and 2 Different Daily Doses of Minirin® Tablet (0.2 mg and 2 x 0.2 mg) in Children and Adolescents With Primary Nocturnal Enuresis (PNE)|Completed||Phase 4|221|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:37:32.844912|2017-10-11 05:37:32.844912
NCT00209274|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-02|2013-12-06|2013-07-31|August 2005||2005-08-01|June 2017|2017-06-01|December 2014|Actual|2014-12-01|November 2009|Actual|2009-11-01||Interventional|EVERESTIIRCT||Pivotal Study of a Percutaneous Mitral Valve Repair System|Pivotal Study: A Study of the Evalve Cardiovascular Valve Repair System - Endovascular Valve Edge-to-Edge REpair STudy (EVERESTIIRCT)|Completed||N/A|279|Actual|Evalve||2|||f||||t||||||||||2017-10-11 05:37:33.218723|2017-10-11 05:37:33.218723
NCT00209287|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-20|||June 2005||2005-06-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|December 2006|Actual|2006-12-01||Interventional|||Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis|Study of Histological Modifications, of Pro-apoptotic Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis (Clinical and Endoscopic Remission) Taking 5-ASA|Terminated||Phase 4|6|Actual|Ferring Pharmaceuticals||1||Recruitment problematic|f||||f||||||||||2017-10-11 05:37:40.133724|2017-10-11 05:37:40.133724
NCT00209300|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-18|||May 2005||2005-05-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission|Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission. A European Multi-centre Investigator Blinded Randomized Controlled Study of Pentasa Sachet Comparing One Gram Twice With Two Grams Once Daily|Completed||Phase 3|362|Actual|Ferring Pharmaceuticals|||||f||||t||||||||||2017-10-11 05:37:40.223776|2017-10-11 05:37:40.223776
NCT00209313|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-12-14|||March 2005||2005-03-01|December 2011|2011-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon|A Randomized, Double-blind, Placebo-controlled Crossover Trial of Acyclovir for Suppression of HSV and HIV Shedding in HIV-1, HSV-2 Coinfected Persons in Cameroon|Completed||Phase 2/Phase 3|40|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 05:37:40.450103|2017-10-11 05:37:40.450103
NCT00215579|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-09-19|||April 2004||2004-04-01|March 2012|2012-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence||Completed||Phase 4|64|Actual|Duke University|||||f||||f||||||||||2017-10-11 05:37:47.466282|2017-10-11 05:37:47.466282
NCT00209326|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-12-15|||November 2003||2003-11-01|December 2011|2011-12-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor|A Randomised, Double-blind, Parallel Group, Dose-ranging, Placebo-controlled, Multi-centre, Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 (0.3, 1, 3, 10 mg) and Placebo on Stopping Preterm Labour and Uterine Contractions in Pregnant Women With Advanced Gestational Age|Completed||Phase 2|163|Actual|Ferring Pharmaceuticals|||||f||||||||||||||2017-10-11 05:37:40.569426|2017-10-11 05:37:40.569426
NCT00209339|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-20|2016-06-21||July 2003||2003-07-01|October 2016|2016-10-01|October 2011|Actual|2011-10-01|February 2006|Actual|2006-02-01||Interventional|EVEREST(I)||Feasibility Study of a Percutaneous Mitral Valve Repair System.|A Study of the Evalve Cardiovascular Valve Repair System Endovascular Valve Edge-to-Edge REpair STudy (EVEREST I).|Completed||Phase 1/Phase 2|55|Actual|Evalve||1|||f||||t||||||||||2017-10-11 05:37:40.74404|2017-10-11 05:37:40.74404
NCT00209352|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-17|||June 1985||1985-06-01|December 2007|2007-12-01|July 2004|Actual|2004-07-01|||||Interventional|||Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant|Randomized Trial of Long-Term Oral Acyclovir Usage to Prevent Varicella Zoster Virus Infection After Allogeneic Bone Marrow Transplant|Completed||Phase 3|120||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:37:42.547941|2017-10-11 05:37:42.547941
NCT00215371|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10|||July 2002||2002-07-01|February 2008|2008-02-01|November 2005|Actual|2005-11-01|October 2002|Actual|2002-10-01||Interventional|||Study in Patients With Asthma||Completed||Phase 2|32||Dey|||||||||||||||||||2017-10-11 05:37:42.637552|2017-10-11 05:37:42.637552
NCT00215384|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10||||||February 2008|2008-02-01|October 2005|Actual|2005-10-01|April 2003|Actual|2003-04-01||Interventional|||Study in Patients With COPD||Completed||Phase 2|35||Dey|||||||||||||||||||2017-10-11 05:37:42.721853|2017-10-11 05:37:42.721853
NCT00215397|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10||||||February 2008|2008-02-01|December 2005|Actual|2005-12-01|February 2003|Actual|2003-02-01||Interventional|||Study in Patients With Asthma||Completed||Phase 2|16||Dey|||||||||||||||||||2017-10-11 05:37:42.824428|2017-10-11 05:37:42.824428
NCT00215410|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10||||||February 2008|2008-02-01|October 2005|Actual|2005-10-01|October 2003|Actual|2003-10-01||Interventional|||Study in Patients With Asthma||Completed||Phase 2|36||Dey|||||||||||||||||||2017-10-11 05:37:43.025571|2017-10-11 05:37:43.025571
NCT00215423|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10||||||August 2008|2008-08-01|September 2005|Actual|2005-09-01|December 2003|Actual|2003-12-01||Interventional|||Study in Patients With COPD||Completed||Phase 2|49||Dey|||||||||||||||||||2017-10-11 05:37:43.13259|2017-10-11 05:37:43.13259
NCT00215436|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-09|||March 2005||2005-03-01|April 2008|2008-04-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD|A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg in the Treatment of Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|345||Dey|||||||||||||||||||2017-10-11 05:37:43.238083|2017-10-11 05:37:43.238083
NCT00215449|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-10||||||January 2009|2009-01-01|April 2006|Actual|2006-04-01|December 2005|Actual|2005-12-01||Interventional|||Study in Patients With COPD||Completed||Phase 3|690||Dey|||||||||||||||||||2017-10-11 05:37:43.461085|2017-10-11 05:37:43.461085
NCT00215462|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-04-27|||June 2000||2000-06-01|April 2009|2009-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma|A Phase II Study of Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma|Completed||Phase 2|32||Dana-Farber Cancer Institute|||||f||||t||||||||||2017-10-11 05:37:43.687083|2017-10-11 05:37:43.687083
NCT00215501|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-07-08|||November 2001||2001-11-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2005|Actual|2005-09-01||Interventional|||Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies|A Phase I Trial of Capecitabine or Continuous Infusion 5-Fluorouracil in Combination With Weekly Irinotecan and Cisplatin in Patients With Advanced Solid Tumor Malignancies|Active, not recruiting||Phase 1|68|Anticipated|Dana-Farber Cancer Institute||2|||f||||||||||||||2017-10-11 05:37:43.835379|2017-10-11 05:37:43.835379
NCT00215514|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-07-28|||September 2000||2000-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|November 2003|Actual|2003-11-01||Interventional|||Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma|A Pilot Study of Adjuvant Chemoradiation After Resection of Gastric Or Gastroesophageal Junction Adenocarcinoma|Completed||Early Phase 1|25|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:37:43.967136|2017-10-11 05:37:43.967136
NCT00215527|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-02-20|||November 2005||2005-11-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I|A Study of Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis I|Terminated||Phase 1|4|Actual|Dickson, Patricia I., M.D.||1||Due to slow enrolment.|f||||t||||||||||2017-10-11 05:37:44.090145|2017-10-11 05:37:44.090145
NCT00215540|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-05-11|2012-04-02||February 2005||2005-02-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.|A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Efficacy of SURFAXIN® (Lucinactant), in Very Low Birth Weight (VLBW) Infants at Risk for Developing Bronchopulmonary Dysplasia|Terminated||Phase 2|136|Actual|Windtree Therapeutics||3||Concerns related to availability of drug product|f||||t||||||||||2017-10-11 05:37:44.247333|2017-10-11 05:37:44.247333
NCT00215553|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-04-02|2012-04-02||May 2001||2001-05-01|April 2012|2012-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||KL₄Surfactant Treatment in Patients With ARDS|A Multicenter, Randomized, Controlled Trial Comparing the Safety and Effectiveness of SURFAXIN® (Lucinactant) Delivered Via Bronchopulmonary Segmental Lavage to Standard of Care in Patients With Acute Respiratory Distress Syndrome (ARDS).|Terminated||Phase 2|124|Actual|Windtree Therapeutics||7||Slow enrollment and administrative reasons|f||||t||||||||||2017-10-11 05:37:45.640365|2017-10-11 05:37:45.640365
NCT00215566|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-05-25|||September 2005||2005-09-01|March 2006|2006-03-01||||||||Interventional|||A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Doses and Dose Levels of DDP733 in Patients With Irritable Bowel Syndrome With Constipation|Completed||Phase 2|90||Dynogen Pharmaceuticals|||||f||||||||||||||2017-10-11 05:37:47.370737|2017-10-11 05:37:47.370737
NCT00215592|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-01-06|||October 2005||2005-10-01|November 2015|2015-11-01||||July 2007|Actual|2007-07-01||Interventional|||Open Label, Zonegran (Zonisamide) In Partial Onset Seizures|An Open Label Study Of Zonegran (Zonisamide) In Patients With Partial Onset Seizures|Completed||Phase 4|1000|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 05:37:47.540491|2017-10-11 05:37:47.540491
NCT00215605|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-02-26|||September 2005||2005-09-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|April 2011|Actual|2011-04-01||Interventional|||Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL184 Administered Orally to Subjects With Advanced Malignancies|Completed||Phase 1|85|Actual|Exelixis||1|||f||||||||||||||2017-10-11 05:37:47.696711|2017-10-11 05:37:47.696711
NCT00215618|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-01-13|||March 2003||2003-03-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|August 2006|Actual|2006-08-01||Interventional|||Uterine Balloon Treatment for Heavy Period Bleeding.|Clinical Evaluation of Uterine Balloon Therapy System for Menorrhagia|Completed||Phase 3|250|Actual|Ethicon, Inc.||2|||f||||f||||||||||2017-10-11 05:37:47.874386|2017-10-11 05:37:47.874386
NCT00215631|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2015-09-14|||October 2005||2005-10-01|April 2007|2007-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?|Can Tadalafil (Cialis)® Maintain Erectile Function In Patients Treated With External-beam Radiotherapy For Prostate Cancer? A Randomized, Double-blind, Placebo-controlled Study|Terminated||Phase 3|100||Erasmus Medical Center||||slow recruitment|f||||||||||||||2017-10-11 05:37:47.979377|2017-10-11 05:37:47.979377
NCT00215657|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2011-05-18|2009-01-22||March 2003||2003-03-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients|An Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients|Terminated||Phase 2|131|Actual|Ferring Pharmaceuticals||8||The doses were not effective in maintaining testosterone suppression|f||||f||||||||||2017-10-11 05:37:48.332479|2017-10-11 05:37:48.332479
NCT00215670|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-05-02|||November 2002||2002-11-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)|A Randomized, Double-Masked, Multi-Center Trial of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Intravitreal Injections of Pegaptanib Sodium (Anti-Vegf Pegylated Aptamer) Given Every 6 Weeks for 54 Weeks, in Patients With Exudative Age-Related Macular Degeneration (AMD)|Completed||Phase 2/Phase 3|125||Eyetech Pharmaceuticals|||||||||||||||||||2017-10-11 05:37:51.731859|2017-10-11 05:37:51.731859
NCT00215683|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-03-12|2010-11-12||February 2005||2005-02-01|March 2015|2015-03-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer|An Open-Label, Multi-Centre, Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Patients With Prostate Cancer.|Completed||Phase 2/Phase 3|137|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-10-11 05:37:51.817771|2017-10-11 05:37:51.817771
NCT00215696|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-05-12|||April 2005||2005-04-01|May 2011|2011-05-01||||||||Interventional|||A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies|"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of BIOBYPASS® (ADGVVEGF121.10NH) Delivered by NOGA™-GUIDED/MYOSTAR™ Catheter in No Option Patients With Class II-IV Stable Angina"|Completed||Phase 2|129||GenVec|||||f||||||||||||||2017-10-11 05:37:53.53678|2017-10-11 05:37:53.53678
NCT00215709|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-11-15|||July 2004||2004-07-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer|A Pilot Study of Docetaxel on a Bi-Weekly Schedule in the Treatment of Elderly Men With Hormone-Refractory Prostate Cancer (HRPC)|Completed||Phase 1|17|Actual|Geriatric Oncology Consortium||1|||f||||||||||||||2017-10-11 05:37:53.617396|2017-10-11 05:37:53.617396
NCT00215722|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2007-04-05|||July 2005||2005-07-01|April 2007|2007-04-01|July 2008|Anticipated|2008-07-01|||||Interventional|||XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer||Unknown status|Active, not recruiting|Phase 2|45||Grupo de Investigacao do Cancro Digestivo|||||f||||||||||||||2017-10-11 05:37:53.695543|2017-10-11 05:37:53.695543
NCT00216060|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-25|2016-01-05||October 2003||2003-10-01|May 2016|2016-05-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Ability of Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy: Hoosier Oncology Group GU02-41|Terminated||Phase 3|63|Actual|Hoosier Cancer Research Network||2||Terminated due to low accrual|f||||t||||||||No||2017-10-11 05:37:53.806489|2017-10-11 05:37:53.806489
NCT00216073|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-29|||March 2004||2004-03-01|April 2011|2011-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer|A Phase II Trial of Capecitabine, Oxaliplatin and Trastuzumab (CAPOX-T) in Patients With HER-2 Positive Metastatic Breast Cancer: Hoosier Oncology Group BRE03-61|Terminated||Phase 2|11|Actual|Hoosier Cancer Research Network||1||Lack of patient accrual|f||||t||||||||||2017-10-11 05:37:56.40638|2017-10-11 05:37:56.40638
NCT00216086|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2016-04-27|2016-01-05||May 2005||2005-05-01|April 2016|2016-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer|A Phase II Trial of Preoperative Capecitabine Plus Irinotecan Followed by Combined Modality Capecitabine and Radiation for Locally Advanced Rectal Cancer: Hoosier Oncology Group GI03-53|Terminated||Phase 2|22|Actual|Hoosier Cancer Research Network||1||Funding withdrawn|f||||t||||||||No||2017-10-11 05:37:56.645159|2017-10-11 05:37:56.645159
NCT00216099|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-06-18|2015-12-17||February 2005||2005-02-01|June 2016|2016-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer|A Phase II Study of Pemetrexed (Alimta) as Second-Line Therapy for Hormone Refractory Prostate Cancer: Hoosier Oncology Group GU03-67|Completed||Phase 2|49|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-10-11 05:37:57.137193|2017-10-11 05:37:57.137193
NCT00216112|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-02-17|||December 2003||2003-12-01|February 2016|2016-02-01|July 2007|Actual|2007-07-01|October 2005|Actual|2005-10-01||Interventional|||Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer|Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62|Completed||Phase 2|23|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-10-11 05:37:57.738703|2017-10-11 05:37:57.738703
NCT00216125|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-02-17|2015-11-23||February 2002||2002-02-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|June 2006|Actual|2006-06-01||Interventional|||Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer|A Phase III Trial of Cisplatin/Etoposide/Radiotherapy With or Without Consolidation Docetaxel in Patients With Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer (NSCLC): Hoosier Oncology Group LUN01-24|Completed||Phase 3|243|Actual|Hoosier Cancer Research Network||3|||f||||t||||||||No||2017-10-11 05:37:57.893647|2017-10-11 05:37:57.893647
NCT00216138|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-28|||March 2004||2004-03-01|April 2011|2011-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck|A Single Arm Phase II Trial of Docetaxel and Capecitabine for the First Line Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): Hoosier Oncology Group HN02-40|Terminated||Phase 2|19|Actual|Hoosier Cancer Research Network||1||Interim analysis results did not meet criteria for second stage of trial|f||||t||||||||||2017-10-11 05:37:59.291862|2017-10-11 05:37:59.291862
NCT00216151|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-28|||June 2005||2005-06-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma|A Randomized Phase II Study of Bisphosphonate: Zoledronic Acid (Zometa) in the Management of Asymptomatic/Early Stage Multiple Myeloma: Hoosier Oncology Group MM02-35|Terminated||Phase 2|3|Actual|Hoosier Cancer Research Network||2||Study terminated due to low patient enrollment.|f||||t||||||||||2017-10-11 05:37:59.456396|2017-10-11 05:37:59.456396
NCT00216164|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-28|||April 2005||2005-04-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Phase II Study of Rituximab and Gemcitabine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Hoosier Oncology Group LYM03-64|Terminated||Phase 2|8|Actual|Hoosier Cancer Research Network||1||Study terminated due to lack of response at the first efficacy analysis|f||||t||||||||||2017-10-11 05:37:59.587773|2017-10-11 05:37:59.587773
NCT00216177|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2009-08-17|||September 2005||2005-09-01|August 2009|2009-08-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis|Randomised, Multicenter, Open-label, Parallel-group Study Comparing Adalimumab 40 mg s.c. Eow Versus Infliximab 3 mg/kg i.v. Every 6 Weeks in Rheumatoid Arthritis Patients With Unsustainable Clinical Response to Infliximab 3 mg/kg Every 8 Weeks|Unknown status|Recruiting|Phase 4|112|Anticipated|Hvidovre University Hospital||1|||f||||t||||||||||2017-10-11 05:37:59.710138|2017-10-11 05:37:59.710138
NCT00216190|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-31|2015-07-22|||March 2005||2005-03-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|||||Interventional|||A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation|A Phase 4, Randomized, Double-Blind, Multi-Center, Comparator Study Evaluating the Safety and Efficacy of Dexmedetomidine Compared to IV Midazolam in ICU Subjects Requiring Greater Than Twenty-Four Hours of Continuous Sedation|Completed||Phase 4|420|Actual|Hospira, now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-10-11 05:37:59.836222|2017-10-11 05:37:59.836222
NCT00216203|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-08-22|2016-04-27||May 2005||2005-05-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||33 of 36 consented participants received treatment.|Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer|A Phase I-IIa Dose-Ranging Study of Pemetrexed (Alimta) Plus Cetuximab (Erbitux) in Patients With Recurrent Non-Small Cell Lung Cancer (NSCLC): Hoosier Oncology Group LUN04-79|Completed||Phase 1/Phase 2|36|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-10-11 05:38:00.165339|2017-10-11 05:38:00.165339
NCT00216216|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-04-28|||January 2005||2005-01-01|April 2011|2011-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer|Pemetrexed (Alimta) in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study (LUN04-78)|Terminated||Phase 2|43|Actual|Hoosier Cancer Research Network||1||The results from the interim analysis were not favorable to continue this trial.|f||||t||||||||||2017-10-11 05:38:00.942366|2017-10-11 05:38:00.942366
NCT00216229|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-12-13|||September 2004||2004-09-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Twinrix Alternative Schedule Study|A Study Comparing the Effectiveness of Two Different Vaccination Schedules of the Combined Hepatitis A and B Vaccine(Twinrix Adult1440/20)|Unknown status|Active, not recruiting|Phase 4|400||IDEWE Occupational Health Services|||||f||||||||||||||2017-10-11 05:38:01.052966|2017-10-11 05:38:01.052966
NCT00216242|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2006-12-08|||September 2005||2005-09-01|December 2006|2006-12-01|May 2007||2007-05-01|||||Interventional|||Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.|A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Fluviral™ Influenza Vaccine in Healthy Adults 18 to 49 Years of Age|Unknown status|Active, not recruiting|Phase 3|7400||ID Biomedical Corporation, Quebec|||||f||||||||||||||2017-10-11 05:38:01.126861|2017-10-11 05:38:01.126861
NCT00216255|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-08-27||2012-08-20|April 2005||2005-04-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study|An 8-week, Double-blind, Randomized, Multicenter, Flexible-dose, Placebo Controlled Pilot Study of Pagoclone in Patients With PDS Followed by a 52-week Open-label Extension|Completed||Phase 2|120|Actual|Endo Pharmaceuticals||2|||f||||t||||||||||2017-10-11 05:38:01.286199|2017-10-11 05:38:01.286199
NCT00216268|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2006-02-08|||July 2005||2005-07-01|September 2005|2005-09-01|May 2008||2008-05-01|||||Interventional|||Treatment of Japanese Encephalitis|Treatment of Japanese Encephalitis - a Double Blind Placebo Controlled Trial|Unknown status|Recruiting|Phase 2|200||Indian Council of Medical Research|||||f||||||||||||||2017-10-11 05:38:01.442279|2017-10-11 05:38:01.442279
NCT00216281|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-03-25|||September 2005||2005-09-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia|Correlation of Phenotype, Genotype and Clinical Efficacy/Toxicity of Clozapine Augmented by Atomoxetine for Treatment Refractory Schizophrenia (CAPG Study)|Terminated||Phase 3|126|Actual|Indiana University||2|||f||||f||||||||||2017-10-11 05:38:01.538787|2017-10-11 05:38:01.538787
NCT00216320|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-04-18|2013-04-18||September 2005||2005-09-01|April 2013|2013-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy of the WalkAide and AFOs for CVA|A Three-Arm, Randomized Crossover Study Comparing the Innovative Neurotronics WalkAide™ System to Ankle-Foot Orthosis [AFO]|Completed||N/A|121|Actual|Innovative Neurotronics||3|||f||||f||||||||||2017-10-11 05:38:01.755229|2017-10-11 05:38:01.755229
NCT00216333|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2006-09-12|||December 2003||2003-12-01|September 2006|2006-09-01|June 2007||2007-06-01|||||Interventional|||Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis|International Multicenter Trial for the Evaluation of a Four-Drug Fixed Dose Combined Tablet Daily in the Initial Intensive Phase of Chemotherapy Followed by a Two-Drug Fixed Dose Combined Tablet Three Times a Week in the Continuation Phase for the Treatment of Pulmonary Tuberculosis|Unknown status|Recruiting|Phase 4|1500||International Union Against Tuberculosis and Lung Diseases|||||f||||||||||||||2017-10-11 05:38:02.337002|2017-10-11 05:38:02.337002
NCT00216346|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-10-02|||June 2003||2003-06-01|October 2014|2014-10-01|November 2004||2004-11-01|||||Interventional|||Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis|A Phase 3 Multicenter, Randomized, Controlled, Clinical Trial to Assess the Safety and Efficacy of Injectable Paromomycin in Patients With Visceral Leishmaniasis|Completed||Phase 3|667||PATH|||||f||||||||||||||2017-10-11 05:38:02.460515|2017-10-11 05:38:02.460515
NCT00216359|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-10-21|||May 2003||2003-05-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Observational|||Cohort Study for Patients Using Fuzeon (Enfuvirtide)|The Radata-Fuzeon Cohort - An Observational Cohort-Study in HIV-Infected Patients Using Fuzeon (Enfuvirtide) as Part of Their Antiretroviral Combination Therapy|Unknown status|Active, not recruiting|N/A|200||Institute for Interdisciplinary Infectiology|||||f||||||||||||||2017-10-11 05:38:02.534311|2017-10-11 05:38:02.534311
NCT00216372|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-05-28|||September 2003||2003-09-01|May 2009|2009-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis|Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Assess the Efficacy and Safety of Lanreotide 30 mg Versus Placebo as a Palliative Treatment of Clinical Symptoms Associated With Intestinal Obstruction Due to Peritoneal Carcinomatosis in Inoperable Patients.|Completed||Phase 3|80|Actual|Ipsen||2|||f||||||||||||||2017-10-11 05:38:02.600314|2017-10-11 05:38:02.600314
NCT00216385|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-20|||January 2005||2005-01-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Interventional|||A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis|A Randomised Open-Label Controlled Trial of a 4-Month Gatifloxacin-Containing Regimen Versus Standard Regimen for the Treatment of Adult Patients With Pulmonary Tuberculosis|Unknown status|Recruiting|Phase 3|2070||Institut de Recherche pour le Developpement|||||f||||||||||||||2017-10-11 05:38:02.880299|2017-10-11 05:38:02.880299
NCT00216398|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-11|||June 2004||2004-06-01|October 2007|2007-10-01|December 2006||2006-12-01|||||Interventional|||Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR|A Phase IV, Multicentre, Open-Label, Single Group Study to Evaluate the Dosing, Efficacy and Safety of Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR|Completed||Phase 4|8||Ipsen|||||f||||||||||||||2017-10-11 05:38:02.993807|2017-10-11 05:38:02.993807
NCT00216411|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-11|||November 2004||2004-11-01|October 2007|2007-10-01|October 2006||2006-10-01|||||Interventional|||Effects on Quality of Life Following Dysport Treatment in Post-Stroke Spasticity of the Arm|A Prospective Phase IV, Multicentre, Placebo-Controlled Study to Demonstrate Changes in the Quality of Life Following DYSPORT Intramuscular Injection in the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients|Completed||Phase 4|102||Ipsen|||||f||||||||||||||2017-10-11 05:38:03.065294|2017-10-11 05:38:03.065294
NCT00216424|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2007-11-09|||February 2005||2005-02-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma|An Open Label, Phase II Study of Capecitabine (Xeloda) Plus Conformal Radiotherapy for Patients With Locally Advanced, Non-Metastatic Rectosigmoid Carcinoma|Terminated||Phase 4|40|Anticipated|James A. Haley Veterans Administration Hospital||||lack of accrual|f||||||||||||||2017-10-11 05:38:03.139901|2017-10-11 05:38:03.139901
NCT00216437|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2007-11-09|||December 2004||2004-12-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma|A Phase I Dose Escalation Study to Assess the Maximum Tolerated Dose and Feasibility of Combining Oral Capecitabine (Xeloda) and Conformal Radiotherapy (CRT) for Patients With Unresectable Hepatocellular Carcinoma, Multiple Hepatic Metastases or Cholangiocarcinoma|Terminated||Phase 1|30|Anticipated|James A. Haley Veterans Administration Hospital||||lack of accrual|f||||||||||||||2017-10-11 05:38:03.206222|2017-10-11 05:38:03.206222
NCT00216450|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-22|||October 2004||2004-10-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.|An Open Observational Study For The Rabeprazole Administration In Adult Subjects With Helicobacter Pylori (H. Pylori) Infection|Completed||Phase 4|80|Actual|Janssen Cilag Pharmaceutica S.A.C.I., Greece|||||f||||||||||||||2017-10-11 05:38:03.275126|2017-10-11 05:38:03.275126
NCT00216463|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-08-01|||August 2005||2005-08-01|August 2016|2016-08-01|August 2007|Actual|2007-08-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Tolerability of Varying Load and Dose of ISIS 301012 in People With Elevated LDL-cholesterol Levels|A Phase 2, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Varying Loading and Maintenance Dosing Regimens of ISIS 301012 Administered to Hypercholesterolemic Subjects|Completed||Phase 2|50|Actual|Kastle Therapeutics, LLC||5|||f||||||||||||||2017-10-11 05:38:03.352032|2017-10-11 05:38:03.352032
NCT00216476|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-03-25|2010-07-08||October 2004||2004-10-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder|CONSTATRE: Risperdal Consta Trial Of Relapse Prevention And Effectiveness|Completed||Phase 3|753|Actual|Janssen-Cilag International NV||3|||f||||f||||||||||2017-10-11 05:38:03.474742|2017-10-11 05:38:03.474742
NCT00216489|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-22|||March 2003||2003-03-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)|A Non Interventional Post Authorization Safety Study (PASS) On The Rabeprazole's Administration To Adults With Gastro-Oesophageal Reflux Disease (GORD)|Completed||Phase 4|191|Actual|Janssen Cilag Pharmaceutica S.A.C.I., Greece|||||f||||||||||||||2017-10-11 05:38:04.893773|2017-10-11 05:38:04.893773
NCT00216502|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-20|||August 2001||2001-08-01|January 2011|2011-01-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease|Long Term Treatment With Galantamine In Dementia|Completed||Phase 3|254|Actual|Janssen-Cilag S.p.A.|||||f||||||||||||||2017-10-11 05:38:04.971513|2017-10-11 05:38:04.971513
NCT00216515|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-20|||March 2004||2004-03-01|January 2011|2011-01-01|November 2005|Actual|2005-11-01|||||Interventional|||The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type|A Prospective, Open-labeled, Multicenter Study of Galantamine on the Attention and Frontal Function of the Patients With Dementia of Alzheimer Type|Completed||Phase 4|102|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-10-11 05:38:05.065002|2017-10-11 05:38:05.065002
NCT00216528|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-26|||July 2005||2005-07-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres|A Prospective, Open-Label Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres (Risperdal Consta)|Completed||Phase 4|527|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-10-11 05:38:05.141811|2017-10-11 05:38:05.141811
NCT00216541|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-18|||August 2003||2003-08-01|June 2010|2010-06-01|September 2006|Actual|2006-09-01|||||Interventional|||A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy|Randomised Study to Evaluate the Effect of Early Intervention to Treat Anemia With Epoetin Alfa Versus Standard Use on Hemoglobin Levels and the Incidence of Blood Transfusions in Cancer Patients Receiving Chemotherapy|Completed||Phase 4|110|Actual|Janssen-Cilag B.V.|||||f||||||||||||||2017-10-11 05:38:05.205189|2017-10-11 05:38:05.205189
NCT00216554|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-20|||September 2004||2004-09-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|||||Interventional|||The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania|A Multicenter, Open-Label Study to Evaluate Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania|Completed||Phase 4|118|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-10-11 05:38:05.2762|2017-10-11 05:38:05.2762
NCT00216567|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-31|||December 2002||2002-12-01|January 2011|2011-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy|A Randomized, Open Label, Comparative, Multi-center Clinical Trial to Determine the Efficacy and Safety of Topiramate Comparing With Carbamazepine in Benign Rolandic Epilepsy.|Completed||Phase 4|114|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-10-11 05:38:05.358533|2017-10-11 05:38:05.358533
NCT00216580|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-22|||February 2004||2004-02-01|March 2013|2013-03-01|December 2006|Actual|2006-12-01|||||Interventional|||A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis|An Open-label Trial of Risperidone Long-acting Injectable in the Treatment of Subjects With Recent Onset Psychosis|Completed||Phase 3|50|Actual|Janssen Pharmaceutica N.V., Belgium||1|||f||||f||||||||||2017-10-11 05:38:05.418242|2017-10-11 05:38:05.418242
NCT00216593|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-07||2011-06-07|December 2003||2003-12-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|||Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study|Treatment of Severe Alzheimer's Disease in a Residential Home, Nursing Home, or Geriatric Residential Setting: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Randomised, Doubleblind, Placebo-Controlled Study.|Completed||Phase 3|415|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:38:05.487425|2017-10-11 05:38:05.487425
NCT00216606|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-31|||December 2003||2003-12-01|January 2011|2011-01-01|July 2005|Actual|2005-07-01|||||Interventional|||The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine|A Randomized Double-Blind Placebo Controlled Trial to Investigate the Efficacy and Tolerability of Topiramate in the Prophylaxis of Chronic Migraine|Completed||Phase 3|59|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:38:05.552953|2017-10-11 05:38:05.552953
NCT00216619|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-07-01|||November 2003||2003-11-01|July 2014|2014-07-01|August 2006|Actual|2006-08-01|||||Interventional|PROMPT||The Prolonged Use of Topiramate for Preventing Migraine Headaches|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Tolerability of Topiramate in Prolonged Migraine Prevention|Completed||Phase 3|834|Actual|Janssen Pharmaceutica N.V., Belgium||2|||f||||f||||||||||2017-10-11 05:38:05.625027|2017-10-11 05:38:05.625027
NCT00216632|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-12-06|||March 2005||2005-03-01|December 2012|2012-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)|Treatment Success in Patients Requiring Treatment Change From Olanzapine to Risperidone Long Acting Injectable (TRESOR)|Completed||Phase 4|99|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:38:06.049234|2017-10-11 05:38:06.049234
NCT00216645|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-16|||January 2005||2005-01-01|March 2010|2010-03-01|November 2006|Actual|2006-11-01|||||Interventional|||Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy|Open-label Study to Verify Effectiveness, Safety of Pegylated Liposomal Doxorubicin 50 mg/m2 Administered Every 4 Weeks to Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Who Have Undergone Prior Platinum-based Chemotherapy.|Completed||Phase 2|74|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-10-11 05:38:06.130117|2017-10-11 05:38:06.130117
NCT00216658|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-20|||December 2004||2004-12-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|||||Interventional|||Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -|Open Label Study to Confirm Effectiveness, Safety and Pharmacokinetics of Fentanyl Transdermal Matrix Patch, in Japanese Patients With Cancer Pain Who Have Had a Minimum Amount of Morphine Therapy, Such as Equal to Less Than 45 mg/Day of Oral Morphine or Oxycodone Equal to Less Than 30 mg/Day.|Completed||Phase 2|87|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-10-11 05:38:06.200509|2017-10-11 05:38:06.200509
NCT00216671|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-12|2011-01-07||November 2005||2005-11-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode|Early Versus Late Initiation of Treatment With Risperdal Consta in Subjects With Schizophrenia After an Acute Episode|Completed||Phase 4|220|Actual|Janssen Pharmaceutica N.V., Belgium|Due to the substantial number of protocol deviations (mainly due to prohibited medication), the study did not have the required power to demonstrate non-inferiority in the per protocol population|2|||f||||f||||||||||2017-10-11 05:38:06.278965|2017-10-11 05:38:06.278965
NCT00216684|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-01-31|||May 2005||2005-05-01|January 2011|2011-01-01|September 2006|Actual|2006-09-01|||||Interventional|||Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics|An Open Label Study to Confirm the Effectiveness, and Safety of Fentanyl Transdermal Matrix Patch in Japanese Patients With Chronic Intractable Pain Who Has Prior Therapy of Codeine, Morphine Hydrochloride, or Fentanyl Injectable Preparations.|Completed||Phase 3|139|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-10-11 05:38:06.926225|2017-10-11 05:38:06.926225
NCT00216697|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-16|||March 2005||2005-03-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|||||Interventional|||An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy|An Extension or Re-Treatment Study of Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|13|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-10-11 05:38:07.013901|2017-10-11 05:38:07.013901
NCT00216710|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-08-29|||July 1999||1999-07-01|August 2017|2017-08-01|January 21, 2005|Actual|2005-01-21|February 21, 2004|Actual|2004-02-21||Interventional|||Evaluation of the Healthy Families Alaska Program|Evaluation of the Healthy Families Alaska Program|Completed||N/A|380|Actual|Johns Hopkins University||2|||f||||||||||||||2017-10-11 05:38:07.080179|2017-10-11 05:38:07.080179
NCT00216723|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-10-22|||April 2004||2004-04-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|||||Observational|||Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder|Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder|Completed||Phase 4|3000|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.|||1||f||||||||||||||2017-10-11 05:38:07.157769|2017-10-11 05:38:07.157769
NCT00216736|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-04-13|2009-05-28||April 2005||2005-04-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|December 2006|Actual|2006-12-01||Interventional|||Oral Dexamethasone for Treatment of Migraine|Does a Single Oral Dose of Dexamethasone After Successful Emergency Treatment of Migraine Reduce the Incidence or Severity of Rebound Headache Within 48 Hours?|Completed||Phase 4|63|Actual|The Joseph Epstein Centre for Emergency Medicine Research||2|||f||||f||||||||||2017-10-11 05:38:07.243087|2017-10-11 05:38:07.243087
NCT00216749|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-12-15|||December 2003||2003-12-01|December 2009|2009-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Efficacy and Safety of Cilostazol for the Indication of CSPS|Post Marketing Surveillance of Efficacy and Safety of Cilostazol for the Indication of CSPS|Completed||Phase 4|650|Actual|Korea Otsuka Pharmaceutical Co., Ltd.|||1||f||||f||||||||||2017-10-11 05:38:07.593893|2017-10-11 05:38:07.593893
NCT00216762|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-08-31|||January 2006||2006-01-01|August 2015|2015-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety Study of Rituximab (Rituxan®) in Chronic Urticaria|"Phase I/II Open Label Evaluation of the Safety and Efficacy of Rituximab in Patients With Chronic Urticaria (The Rituximab Urticaria Study - RUSTY)"|Terminated||Phase 1/Phase 2|15|Anticipated|Johns Hopkins University||1||Full Clinical Hold|f||||t||||||||||2017-10-11 05:38:07.686609|2017-10-11 05:38:07.686609
NCT00216775|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-10|2015-09-01|||December 2004||2004-12-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C||Completed||Phase 4|50|Actual|Kyoto University|||1||f||||||||||||||2017-10-11 05:38:07.777049|2017-10-11 05:38:07.777049
NCT00216801|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-01-20|||September 2005||2005-09-01|January 2009|2009-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Relationship of Ochratoxin A to Upper Urologic Cancers|The Relationship of Ochratoxin A to Upper Tract TCC Malignancies, Testicular Cancer, and Renal Cell Cancer|Completed||N/A|60|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-10-11 05:38:07.939243|2017-10-11 05:38:07.939243
NCT00216814|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2008-04-18|||October 2003||2003-10-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Observational|||Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors|Intravesically Administered BCG May Have Antiangiogenic Effects on Urinary Concentrations of Basic Fibroblast Growth Factor ( bFGF), Vascular Endothelial Growth Factor (VEGF) and Interleukin (IL-8)|Terminated||N/A|220|Actual|Lawson Health Research Institute|||1|No funding and data was not appropriate to consider continuing.|f||||||||||||||2017-10-11 05:38:08.008131|2017-10-11 05:38:08.008131
NCT00216827|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-03-25|||November 2004||2004-11-01|March 2015|2015-03-01|September 2005||2005-09-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis|Calcipotriol Plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle, and the Gel Vehicle Alone in Scalp Psoriasis|Completed||Phase 3|1485||LEO Pharma|||||||||||||||||||2017-10-11 05:38:08.073536|2017-10-11 05:38:08.073536
NCT00216840|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-03-25|||December 2004||2004-12-01|March 2015|2015-03-01|September 2005||2005-09-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis|Calcipotriol Plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle and Calcipotriol in the Gel Vehicle in Scalp Psoriasis|Completed||Phase 3|1350||LEO Pharma|||||||||||||||||||2017-10-11 05:38:08.161202|2017-10-11 05:38:08.161202
NCT00216853|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-04-15|||September 2003||2003-09-01|April 2009|2009-04-01|March 2007|Actual|2007-03-01|June 2006|Actual|2006-06-01||Observational|||A Study of Vaginal MicroFlora and Immune Profiles of Patients With Recurrent Urinary Tract Infection|A Study of Vaginal MicroFlora and Immune Profiles of Patients With Recurrent Urinary Tract Infection|Completed||N/A|44|Actual|Lawson Health Research Institute|||2||f||||f||||||||||2017-10-11 05:38:08.241098|2017-10-11 05:38:08.241098
NCT00216866|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-08-25|||September 2002|Actual|2002-09-01|August 2017|2017-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis|A Pilot Study of Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis of the Upper Extremity|Completed||Phase 2|70||Lawson Health Research Institute|||||f||||||||||||||2017-10-11 05:38:08.306525|2017-10-11 05:38:08.306525
NCT00216879|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-03-25|||February 2005||2005-02-01|March 2015|2015-03-01|July 2006||2006-07-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis|Long-term Treatment of Scalp Psoriasis With Calcipotriol Plus Betamethasone Dipropionate Gel|Completed||Phase 3|800||LEO Pharma|||||||||||||||||||2017-10-11 05:38:08.403155|2017-10-11 05:38:08.403155
NCT00216892|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-03-25|||April 2005||2005-04-01|March 2015|2015-03-01|December 2005||2005-12-01|||||Interventional|||Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris|Different Treatment Regimens of Calcipotriol Cream and Combination (Calcipotriol/Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris|Completed||Phase 4|1032||LEO Pharma|||||f||||||||||||||2017-10-11 05:38:08.493911|2017-10-11 05:38:08.493911
NCT00216905|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2010-06-01|||October 2004||2004-10-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Simultaneous Measurement of Electroencephalography (EEG) and Functional Magnetic Resonance Imaging (fMRI) in Patients With Alcoholism|Neurobiological Correlates of Disturbed Cognitive Function in Patients With Alcoholism - Simultaneous Measurement With EEG and fMRI|Completed||N/A|25|Actual|Ludwig-Maximilians - University of Munich|||1||f||||||||||||||2017-10-11 05:38:08.598541|2017-10-11 05:38:08.598541
NCT00216918|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2007-01-24|||September 2005||2005-09-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.|An Open-Label Pilot Study of Atomoxetine Hydrochloride to Evaluate Neuropsychological Function in Children Ages 6 to 10 Years With Attention-Deficit/Hyperactivity Disorder.|Completed||Phase 4|40||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:38:08.65829|2017-10-11 05:38:08.65829
NCT00216931|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-02-03|||May 2006||2006-05-01|February 2009|2009-02-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost|Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost|Withdrawn||N/A|40|Anticipated|Lund University Hospital||||No patients enrolled after three years|f||||||||||||||2017-10-11 05:38:08.733217|2017-10-11 05:38:08.733217
NCT00216944|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2010-02-12|||August 2005||2005-08-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Balanced Anesthesia for Intubation of Premature Infants|Balanced Anesthesia for Intubation of Newborn Premature Infants - a Randomized Intervention Study|Completed||Phase 4|40|Anticipated|Lund University Hospital||2|||f||||||||||||||2017-10-11 05:38:08.798576|2017-10-11 05:38:08.798576
NCT00216957|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2005-09-19|||October 1998||1998-10-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Interventional|||Randomized Clinical Trial Comparing Coronary Bypass Grafting With or Without Cardiopulmonary Bypass|Randomized Clinical Trial Comparing Coronary Bypass Grafting With or Without Cardiopulmonary Bypass|Completed||Phase 3|300||Maritime Heart Centre|||||f||||||||||||||2017-10-11 05:38:08.907731|2017-10-11 05:38:08.907731
NCT00216970|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-08-12|||August 1997||1997-08-01|August 2009|2009-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients|Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients|Unknown status|Recruiting|N/A|16|Anticipated|National Institute of General Medical Sciences (NIGMS)||2|||f||||t||||||||||2017-10-11 05:38:09.001328|2017-10-11 05:38:09.001328
NCT00216983|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-01-12|||September 1997||1997-09-01|January 2017|2017-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding|Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding.|Withdrawn||N/A|0|Actual|National Institute of General Medical Sciences (NIGMS)|||3|"State of Mass. tightened regulations for making intravenous solutions for research subjects.   Study was withdrawn and no participants were enrolled."|f||||t||||||||||2017-10-11 05:38:09.142872|2017-10-11 05:38:09.142872
NCT00216996|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2016-11-15||||||November 2016|2016-11-01||||||||Observational|||Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Burns|Study on the Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Severely Burned Patients|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||1|This study was withdrawn (see NCT00181753).|f||||t||||||||Yes|Published data will be shared in our publications and directly with an individual researcher when requested.|2017-10-11 05:38:09.27655|2017-10-11 05:38:09.27655
NCT00217386|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-09-13|||March 2004||2004-03-01|September 2010|2010-09-01||||December 2007|Actual|2007-12-01||Interventional|||Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes|Therapy of Early Stage Myelodysplastic Syndrome (MDS) With ATG and Etanercept|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-10-11 05:38:12.829183|2017-10-11 05:38:12.829183
NCT00217009|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-05-18|||March 2005||2005-03-01|May 2015|2015-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.|A Randomized Controlled Trial of Narrowband Ultraviolet B vs Topical Psoralen Plus Ultraviolet A Photochemotherapy for Hand and Foot Dermatoses|Terminated||Early Phase 1|3|Actual|Mayo Clinic||2||"Unfortunately we had unforeseen difficulty recruiting to this study. Therefore we have decided   to halt the study and not publish the results."|f||||||||||||||2017-10-11 05:38:09.3684|2017-10-11 05:38:09.3684
NCT00217022|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-03-16|2011-07-15||June 2003||2003-06-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis|A Randomized, Double-Blind, Placebo Controlled Trial of Budesonide for the Treatment of Active Lymphocytic Colitis|Terminated||Phase 2/Phase 3|16|Actual|Mayo Clinic|Study closed early, because of low enrollment. Primary physician for patients with lymphocytic colitis would prescribe Budesonide off label for them. Subjects not interested in placebo trial.|2||Study closed early, because of low enrollment.|f||||f||||||||||2017-10-11 05:38:09.456338|2017-10-11 05:38:09.456338
NCT00217035|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-01-12|||August 1997||1997-08-01|January 2017|2017-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients|Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients.|Withdrawn||N/A|0|Actual|National Institute of General Medical Sciences (NIGMS)||||"State of Mass. tightened regulations for making intravenous solutions for research subjects.   Study was withdrawn and no participants were enrolled."|f||||t||||||||||2017-10-11 05:38:09.744907|2017-10-11 05:38:09.744907
NCT00217048|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-04-27|||June 2005||2005-06-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effect of Yohimbine on Colon Transit|Effect of Oral Yohimbine on Colonic Transit: Randomized, Placebo-Controlled Trial|Completed||Phase 1/Phase 2|30|Anticipated|Mayo Clinic|||||f||||||||||||||2017-10-11 05:38:09.943492|2017-10-11 05:38:09.943492
NCT00217061|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-05-20|||April 2005||2005-04-01|May 2011|2011-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus|The Statin Choice Decision Aid and Its Effects on Statin Decisions in Patients With Type 2 Diabetes Mellitus. A Clustered Randomized Trial|Completed||Phase 3|98||Mayo Clinic|||||f||||||||||||||2017-10-11 05:38:10.043564|2017-10-11 05:38:10.043564
NCT00217074|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-02-01|||January 2004||2004-01-01|February 2010|2010-02-01|October 2005|Actual|2005-10-01|January 2004|Actual|2004-01-01||Interventional|||Acupuncture and Hot Flashes|Acupuncture for Hot Flashes: A Randomized Sham Controlled Clinical Study|Terminated||Phase 3|103|Actual|Mayo Clinic|||||f||||||||||||||2017-10-11 05:38:10.190407|2017-10-11 05:38:10.190407
NCT00217087|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-11-23|2015-03-02||September 2005||2005-09-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Endoscopic Therapy of Early Cancer in Barretts Esophagus|Endoscopic Therapy of Early Cancer in Barretts Esophagus|Completed||Phase 2|73|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 05:38:10.279151|2017-10-11 05:38:10.279151
NCT00217100|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-04-23|||October 2004||2004-10-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Multivitamin Comparison Study in Kidney Transplant Recipients.|Folic Acid for Vascular Outcome Reduction in Transplantation.|Completed||Phase 3|200|Actual|Mayo Clinic||2|||f||||||||||||||2017-10-11 05:38:10.691534|2017-10-11 05:38:10.691534
NCT00217113|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2010-01-20|||September 2005||2005-09-01|January 2010|2010-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly|An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly|Completed||N/A|100|Actual|Mayo Clinic|||||f||||||||||||||2017-10-11 05:38:10.786953|2017-10-11 05:38:10.786953
NCT00217126|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-01-02|||October 2005||2005-10-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||The Study of Long-term Deterioration of Kidney Transplants.|Long-term Kidney Function (2 Arms-Prospective and Retrospective)|Completed||Phase 4|870|Actual|Mayo Clinic|||1||f||||t||||||||||2017-10-11 05:38:10.86278|2017-10-11 05:38:10.86278
NCT00217139|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-27|||September 2005||2005-09-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection|A Phase II, Randomized, Active-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Celgosivir in Combination With Peginterferon Alfa-2b, With and Without Ribavirin, for 12 Weeks in Patients With Chronic Hepatitis C Infection (Genotype 1) Who Failed to Respond to Pegylated α Interferon-Based Therapy|Completed||Phase 2|60||BioWest Therapeutics Inc|||||f||||||||||||||2017-10-11 05:38:10.93043|2017-10-11 05:38:10.93043
NCT00217152|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2011-12-16|||March 2005||2005-03-01|December 2011|2011-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors|An Open Label, Prospective, Randomized, Controlled, Multicenter Study Assessing Fixed Dose vs. Concentration Controlled CellCept Regimens for Patients Following a Single Organ Renal Transplantation in Combination With Full Dose and Reduced Dose Calcineurin Inhibitors|Terminated||Phase 4|12|Actual|Mayo Clinic||||Roche decided to prematurely terminate study.|f||||||||||||||2017-10-11 05:38:11.036869|2017-10-11 05:38:11.036869
NCT00217165|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2017-03-17||2017-03-17|April 2005||2005-04-01|March 2017|2017-03-01|December 2011|Actual|2011-12-01|January 2010|Actual|2010-01-01||Interventional|||Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study|Taurine as an Anti-manic Agent: a Double-blind Placebo-controlled Study.|Completed||Phase 2|60|Actual|Mclean Hospital||2|||f||||f||||||||||2017-10-11 05:38:11.12429|2017-10-11 05:38:11.12429
NCT00217178|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16|||January 2000||2000-01-01|October 2004|2004-10-01|October 2005||2005-10-01|||||Interventional|||Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)|Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)|Unknown status|Active, not recruiting|Phase 4|900||McMaster University|||||f||||||||||||||2017-10-11 05:38:11.224489|2017-10-11 05:38:11.224489
NCT00217191|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-09-18|||September 2004||2004-09-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Ibuprofen and Renal Function in Premature Infants|Ibuprofen and Renal Function in Premature Infants|Completed||Phase 4|120||Maternite Regionale Universitaire|||||f||||||||||||||2017-10-11 05:38:11.315889|2017-10-11 05:38:11.315889
NCT00217204|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-17|||July 2005||2005-07-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption|A Phase II, Randomized, Investigator-Blinded, Parallel-Group, Pilot Study Evaluating the Safety, Palatability and Effectiveness of Four Doses of Pancrelipase Microtablets in the Treatment of Infants and Toddlers With Cystic Fibrosis-Related Pancreatic Insufficiency and Fat Malabsorption|Completed||Phase 2|18|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||f||||||||||||||2017-10-11 05:38:11.426609|2017-10-11 05:38:11.426609
NCT00217230|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-10-02|||April 2001||2001-04-01|October 2006|2006-10-01|November 2001||2001-11-01|||||Interventional|||Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older|A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older CAIV-T, Liquid Formulation|Completed||Phase 3|3000||MedImmune LLC|||||||||||||||||||2017-10-11 05:38:11.659726|2017-10-11 05:38:11.659726
NCT00217243|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-09-17|||June 2005||2005-06-01|September 2009|2009-09-01|June 2007|Actual|2007-06-01|||||Observational|||Evoked Fields After Median and Ulnar Stimulation|Evoked (Magnetic) Cortical Fields for the Comparative Study of Mechanisms Underlying Chronic Non-malignant Pain in Peripheral Nerve Injury (CRPS II) and CRPS I (Chronic Regional Pain Syndrome I)|Completed||N/A|60|Actual|Medical Center Alkmaar|||1||f||||f||||||||||2017-10-11 05:38:11.758259|2017-10-11 05:38:11.758259
NCT00217256|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-06-22|||February 2004||2004-02-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|May 2005|Actual|2005-05-01||Interventional|ENDEAVOR III||The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial|A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Completed||N/A|436|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-10-11 05:38:11.878531|2017-10-11 05:38:11.878531
NCT00217269|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-04-19|||April 2005||2005-04-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|March 2007|Actual|2007-03-01||Interventional|ENDEAVOR IV||The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions|A Randomized, Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Completed||N/A|1548|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-10-11 05:38:11.985549|2017-10-11 05:38:11.985549
NCT00217282|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-05-20|||June 2004||2004-06-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|June 2007|Actual|2007-06-01||Interventional|||Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer|Phase II Trial OF Oxaliplatin and Gemcitabine With Bevacizumab in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|45|Actual|Mt. Sinai Medical Center, Miami||1|||f||||f||||||||||2017-10-11 05:38:12.098175|2017-10-11 05:38:12.098175
NCT00217295|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||April 2004||2004-04-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis|A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis.|Unknown status|Recruiting|Phase 2|30||Multiple Sclerosis Institute|||||f||||||||||||||2017-10-11 05:38:12.184091|2017-10-11 05:38:12.184091
NCT00217308|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-08-29|||February 2005|Actual|2005-02-01|August 2017|2017-08-01|September 2007|Actual|2007-09-01|July 2007|Anticipated|2007-07-01||Interventional|||Effect of Probiotic Lactobacilli on Vaginal Flora of Pregnant Women at High Risk for Preterm Delivery|Effect of Probiotic Lactobacilli on Vaginal Flora of Pregnant Women at High Risk for Preterm Delivery|Withdrawn||Phase 1|0|Actual|Mount Sinai Hospital, Canada||2||Tightly defined inclusion criteria were making recruitment very slow.|f||||f||||||||||2017-10-11 05:38:12.296306|2017-10-11 05:38:12.296306
NCT00217321|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2010-07-20|||November 2003||2003-11-01|September 2006|2006-09-01|December 2015|Anticipated|2015-12-01|||||Observational|||Parkinson's Disease Registry of the Muhammad Ali Parkinson Center|Parkinson's Disease Registry|Unknown status|Active, not recruiting|N/A|20000|Anticipated|Muhammad Ali Parkinson Research Center|||1||f||||||||||||||2017-10-11 05:38:12.38925|2017-10-11 05:38:12.38925
NCT00217334|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2005-09-19|||November 2002||2002-11-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Community Hypertension Assessment Trial (CHAT)|A Pragmatic Trial of Community Pharmacy Blood Pressure Clinics Linked With Family Medicine Practices to Improve the Monitoring and Management of High Blood Pressure Among Older Adults|Completed||N/A|28||McMaster University|||||f||||||||||||||2017-10-11 05:38:12.45526|2017-10-11 05:38:12.45526
NCT00217347|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-06-04|||September 2005||2005-09-01|June 2008|2008-06-01|July 2006|Actual|2006-07-01|||||Interventional|||Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy||Completed||N/A|150|Anticipated|Nantes University Hospital|||||f||||||||||||||2017-10-11 05:38:12.549409|2017-10-11 05:38:12.549409
NCT00217360|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2006-10-03|||December 2002||2002-12-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||RCT to Reduce Further Falls and Injuries for Older Fallers Presenting to an Emergency Department|RCT to Evaluate the Effectiveness of a Targeted and Personalised Multifactorial Program to Reduce Further Falls and Injuries for Community-Dwelling Older Fallers Presenting to and Being Discharged Directly From an Emergency Department.|Unknown status|Recruiting|N/A|700||National Ageing Research Institute, Australia|||||f||||||||||||||2017-10-11 05:38:12.631224|2017-10-11 05:38:12.631224
NCT00217373|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-04-17|||June 2005||2005-06-01|December 2014|2014-12-01|March 2015|Actual|2015-03-01|January 2013|Actual|2013-01-01||Interventional|||Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)|A Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-Tricom (B7.1/ICAM/LFA3) and Vaccinia-CEA (6D)-Tricom, in Combination With GM-CSF and Interferon-Alfa-2B in Patients With CEA-Expressing Carcinomas|Completed||Phase 1|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:38:12.705986|2017-10-11 05:38:12.705986
NCT00217399|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-05-12|2011-03-23||June 2005||2005-06-01|December 2012|2012-12-01|January 2013|Actual|2013-01-01|July 2009|Actual|2009-07-01||Interventional|||Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer|A Phase I/II Trial of BAY 43-9006 (Sorafenib) in Combination With Anastrozole in Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:38:12.9369|2017-10-11 05:38:12.9369
NCT00217412|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-06-16|||August 2005||2005-08-01|April 2013|2013-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia|A Phase 1 Study of SAHA (NSC# 701852) in Pediatric Patients With Recurrent or Refractory Solid Tumors (Including Lymphomas) and Leukemia Followed by a Phase I Study of SAHA in Combination With 13-Cis-Retinoic Acid for Patients With Selected Recurrent/Refractory Solid Tumors|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-10-11 05:38:13.229332|2017-10-11 05:38:13.229332
NCT00217425|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-04-08|2014-02-20||July 2006||2006-07-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|April 2012|Actual|2012-04-01||Interventional||Eligible and treated|Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms|Bevacizumab and CHOP (A-CHOP) in Combination for Patients With Peripheral T-Cell or Natural Killer Cell Neoplasms|Completed||Phase 2|46|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-10-11 05:38:13.434853|2017-10-11 05:38:13.434853
NCT00217438|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-08-04|2013-11-01||July 2005||2005-07-01|August 2015|2015-08-01||||October 2012|Actual|2012-10-01||Interventional|||Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma|A Multi-Center Phase III Study of Autologous Transplantation for Patients With Multiple Myeloma Comparing Melphalan 280 mg/m2 + Amifostine With Melphalan 200 mg/m2 + Amifostine|Completed||Phase 3|130|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-10-11 05:38:15.577183|2017-10-11 05:38:15.577183
NCT00217451|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-19|||June 2002||2002-06-01|September 2005|2005-09-01|March 2003||2003-03-01|||||Interventional|||Treatment of Malaria in Gabon With Fosmidomycin-Clindamycin|Evaluation of Fosmidomycin in Combination With Clindamycin in Children With Acute Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 2|51||Albert Schweitzer Hospital|||||f||||||||||||||2017-10-11 05:38:15.917144|2017-10-11 05:38:15.917144
NCT00217464|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-03-31|2015-03-17||June 2004||2004-06-01|March 2015|2015-03-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional||All treated and eligible patients|Fulvestrant in Treating Patients With Recurrent Prostate Cancer|Multicenter Study of Fulvestrant (Faslodex®) in Early, Recurrent Prostate Cancer Following Local Therapy: A Phase II Trial|Terminated||Phase 2|17|Actual|Roswell Park Cancer Institute||1||Closed for futility|f||||t||||||||||2017-10-11 05:38:16.025344|2017-10-11 05:38:16.025344
NCT00217477|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-12-08|||August 2004||2004-08-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|May 2013|Actual|2013-05-01||Interventional|||Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer|An Open Label, Dose Escalation Study of Paricalcitol (Zemplar™) [19-NOR-1 ALPHA, 25-(OH) D] in Combination With Gemcitabine [2', 2' -Difluorodeoxycytidine] in Patients With Advanced Malignancies|Completed||Phase 1|34|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 05:38:16.31459|2017-10-11 05:38:16.31459
NCT00217490|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-02-16|2015-09-29||March 2005||2005-03-01|February 2017|2017-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet|Helping Women Adopt a Cancer Prevention Diet|Completed||N/A|621|Actual|Kaiser Permanente||4|||f||||f||||||||||2017-10-11 05:38:16.409398|2017-10-11 05:38:16.409398
NCT00217503|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-06-18|||July 2005||2005-07-01|April 2007|2007-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma|Primary Effusion Lymphoma: A Pilot Trial of Bevacizumab and Modified Dose-Adjusted Infusional CDE Chemotherapy Preceded by a Brief Pre-Phase Assessment of Targeted Oncolytic Virotherapy With Bortezomib, Zidovudine and Valganciclovir|Completed||Phase 2|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:38:17.135767|2017-10-11 05:38:17.135767
NCT00217516|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-02-08|||March 2005||2005-03-01|September 2010|2010-09-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Interventional|||Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer|Supplementation of L-Selenomethionine in Patients With Prostate Cancer Prior to Brachytherapy. Selenium Brachytherapy Trial: Phase I/Pilot Study|Completed||Phase 1|18|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-10-11 05:38:17.259674|2017-10-11 05:38:17.259674
NCT00217529|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-09-20|||June 2004||2004-06-01|September 2010|2010-09-01||||November 2005|Actual|2005-11-01||Interventional|||Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer|A Phase I-II Study of OSI-774 (Tarceva, Erlotinib) With Docetaxel/Carboplatin Followed by Maintenance Therapy With Tarceva as Treatment for Newly Diagnosed Stage III/IV Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:38:17.360775|2017-10-11 05:38:17.360775
NCT00217542|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-05-01|||July 2005||2005-07-01|May 2013|2013-05-01||||July 2008|Actual|2008-07-01||Interventional|||Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery|A Phase 1 Study of 5-azacitidine in Combination With Interferon-Alfa 2B in Unresectable or Metastatic Melanoma and Renal Cell Carcinoma|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:38:17.457002|2017-10-11 05:38:17.457002
NCT00217555|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-09-20|||July 2002||2002-07-01|September 2010|2010-09-01||||February 2006|Actual|2006-02-01||Interventional|||Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer|Phase II Trial for the Treatment of Recurrent or Persistent Platinum-Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With Gemcitabine and Topotecan|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:38:17.578119|2017-10-11 05:38:17.578119
NCT00217763|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-12-07|||September 2005||2005-09-01|December 2007|2007-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|||European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients|A Phase III Study of the Efficacy and Safety of 3APS as Add-on Therapy in Mild to Moderate Alzheimer's Disease|Unknown status|Active, not recruiting|Phase 3|930|Anticipated|Bellus Health Inc|||||||||||||||||||2017-10-11 05:38:23.470079|2017-10-11 05:38:23.470079
NCT00217568|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-09-20|||May 2005||2005-05-01|September 2010|2010-09-01||||March 2006|Actual|2006-03-01||Interventional|||Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer|A Phase II Trial of Docetaxel and Carboplatin for First Relapsed Platinum-Sensitive Stage III and IV Advanced Ovarian Cancer or Peritoneal Carcinoma|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:38:17.677126|2017-10-11 05:38:17.677126
NCT00217581|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-06-05|2014-06-05||October 2004||2004-10-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer|Phase II Trial of Bevacizumab, Docetaxel, and Oxaliplatin in Gastric and Gastroesophageal Junction Cancer|Completed||Phase 2|39|Actual|Barbara Ann Karmanos Cancer Institute|The trial completed its planned accrual. There were no significant limitations.|1|||f||||t||||||||||2017-10-11 05:38:17.766568|2017-10-11 05:38:17.766568
NCT00217594|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-10-05|||July 20, 2005||2005-07-20|September 8, 2017|2017-09-08|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome|A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome (MDS)|Completed||Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:38:17.998758|2017-10-11 05:38:17.998758
NCT00217607|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2016-08-29|||February 2005||2005-02-01|August 2016|2016-08-01|January 2012|Actual|2012-01-01|April 2008|Actual|2008-04-01||Interventional|||Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery|Multicentric Phase II Study Evaluating the Efficacy and Toxicity of Weekly Paclitaxel in Locally Advanced or Metastatic Soft Tissue Angiosarcomas That Cannot be Treated by Surgery|Completed||Phase 2|30|Actual|UNICANCER||1|||f||||f||||||||No|Individual participant data will not be shared at an individual level.|2017-10-11 05:38:18.090266|2017-10-11 05:38:18.090266
NCT00217620|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-05-05|2012-10-03||March 2006||2006-03-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|April 2008|Actual|2008-04-01||Interventional|||S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas|Phase II Trial of BAY-9006 (NSC #724772) in Advanced Soft Tissue Sarcomas|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 05:38:18.279767|2017-10-11 05:38:18.279767
NCT00217633|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-05-27|||January 2006||2006-01-01|May 2015|2015-05-01||||January 2013|Actual|2013-01-01||Interventional|||Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer|Prospective Evaluation of Pelvic Exenteration in Patients With Recurrent Cervical Cancer|Completed||Phase 2|38|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-10-11 05:38:19.228163|2017-10-11 05:38:19.228163
NCT00217646|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-04-27|||October 2005||2005-10-01|February 2013|2013-02-01||||December 2010|Actual|2010-12-01||Interventional|||Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia|Phase I Study of BAY 43-9006 (NSC 724772) in Patients With Acute Leukemias, Myelodysplastic Syndromes and Chronic Myeloid Leukemia in Blast Phase|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:38:19.394595|2017-10-11 05:38:19.394595
NCT00217659|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-01-02|||September 2005||2005-09-01|January 2013|2013-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer|A Phase II Study of Goserelin Plus Anastrozole for the Treatment of Male Patients With Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||||poor accrual|f||||t||||||||||2017-10-11 05:38:19.504107|2017-10-11 05:38:19.504107
NCT00217672|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2016-02-25|2015-09-21||May 2005||2005-05-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|December 2008|Actual|2008-12-01||Interventional|||Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer|A Randomized Phase II Trial of Docetaxel With or Without Bevacizumab as First-Line Therapy for Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer|Completed||Phase 2|76|Actual|Translational Oncology Research International|Small sample size and that it was changed from a 2-arm study to a single arm study. This was necessary with public release of E2100 results(improved progression free survival) and subsequent availability of bevacizumab outside of clinical trial.|2|||f||||t||||||||||2017-10-11 05:38:19.735503|2017-10-11 05:38:19.735503
NCT00217698|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-06-02|||November 2003||2003-11-01|June 2012|2012-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Multicenter Phase II Trial of Gefitinib (Iressa™) First Line Therapy Followed by Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|63|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 05:38:20.236532|2017-10-11 05:38:20.236532
NCT00217711|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-06-02|||May 2005||2005-05-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|August 2007|Actual|2007-08-01||Interventional|||Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Oxaliplatin, Irinotecan, and Capecitabine as a Combination Regimen for First-Line Treatment of Advanced or Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|23|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 05:38:20.38368|2017-10-11 05:38:20.38368
NCT00217724|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-05-07|2010-06-10||July 1999||1999-07-01|May 2017|2017-05-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer|A Double-blinded Pilot Study of Glutamine for the Prevention of Paclitaxel-Induced Myalgias and Arthralgias|Terminated||N/A|18|Actual|OHSU Knight Cancer Institute|We were able to only accrue 18 of the 40 patient target. This, plus confounded results and limited funds, the remaining research funds were returned to the sponsor and no evaluation of serum or dietary glutamine levels was done.|2||Only able to accrue just 18 of the 40 target & funds were limited.|f||||t||||||||||2017-10-11 05:38:20.509319|2017-10-11 05:38:20.509319
NCT00217789|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-12-23|||July 2004||2004-07-01|December 2013|2013-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Pathogen Specific Immunity in Patients With Sarcoidosis|Pathogen Specific Immunity in Sarcoidosis|Completed||N/A|5|Actual|Rutgers, The State University of New Jersey|||1||f||||||||||||||2017-10-11 05:38:23.740006|2017-10-11 05:38:23.740006
NCT00217802|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-07-28|||March 2000||2000-03-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||The Effect of Self-regulatory Education on Women With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:38:23.814871|2017-10-11 05:38:23.814871
NCT00217815|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-07-14|||September 2005||2005-09-01|July 2008|2008-07-01|October 2006||2006-10-01|||||Interventional|||Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer|A Phase Ib, Pharmacokinetic, Multiple Center, Open Label Study Evaluating the Safety and Efficacy of Mycograb Administered IV in Combination With Docetaxel in Metastatic or Recurrent Breast Cancer Patients|Completed||Phase 1/Phase 2|20||NeuTec Pharma|||||f||||||||||||||2017-10-11 05:38:23.874672|2017-10-11 05:38:23.874672
NCT00217828|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2014-06-10|||March 2002||2002-03-01|June 2014|2014-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Effects of Citalopram on Hostility and CHD Risk||Completed||N/A|||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:38:23.968069|2017-10-11 05:38:23.968069
NCT00217841|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-09-18|||January 2004||2004-01-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Aurograb and Vancomycin in MRSA Infection|A Multi Centre, Double-Blind, Randomised, Placebo Controlled Prospective Study on the Safety and Efficacy of Aurograb in Patients With Severe, Deep-Seated Staphylococcal Infections Receiving Vancomycin|Completed||Phase 3|180||NeuTec Pharma|||||f||||||||||||||2017-10-11 05:38:24.16843|2017-10-11 05:38:24.16843
NCT00217854|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-06-23|||September 2001||2001-09-01|June 2017|2017-06-01|February 2011|Actual|2011-02-01|February 2009|Actual|2009-02-01||Interventional|||Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity|Mechanisms of Airway Inflammation: Natural Exacerbation of Asthma Induced by Glucocorticoid Withdrawal|Completed||N/A|27|Actual|Washington University School of Medicine||1|||f||||||||||||||2017-10-11 05:38:24.243679|2017-10-11 05:38:24.243679
NCT00217867|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-07-26|||October 2008||2008-10-01|July 2017|2017-07-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Educational and Supportive Interventions to Prevent Cardiopulmonary Rehospitalization|A RCT to Reduce Cardiopulmonary Rehospitalization|Completed||N/A|832|Actual|Boston Medical Center||2|||f||||t|f|f||||||||2017-10-11 05:38:24.333118|2017-10-11 05:38:24.333118
NCT00217880|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-08-16|||July 2004||2004-07-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease|Prognostic Significance of Biological Markers in Patients With ALI/ARDS|Completed||N/A|40|Actual|University of Michigan||1|||f||||t||||||||||2017-10-11 05:38:24.405474|2017-10-11 05:38:24.405474
NCT00217893|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-10-22|||February 2003||2003-02-01|October 2013|2013-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Environmental Tobacco Smoke Exposure Reduction in High-Risk Preteens|ETS Reduction in High-Risk Preteens: A Controlled Trial|Completed||N/A|203|Actual|San Diego State University||2|||f||||t||||||||||2017-10-11 05:38:24.486309|2017-10-11 05:38:24.486309
NCT00217906|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-02-17|||October 1999||1999-10-01|December 2005|2005-12-01|March 2004|Actual|2004-03-01|||||Interventional|||A+ Asthma Early Intervention in Asthma Management||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:38:24.571165|2017-10-11 05:38:24.571165
NCT00217919|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2014-04-07|||February 2006||2006-02-01|April 2014|2014-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Reducing Risk Factors in Peripheral Arterial Disease|Reducing Risk Factors in Peripheral Arterial Disease|Completed||N/A|355|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 05:38:24.623548|2017-10-11 05:38:24.623548
NCT00217932|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||September 2000||2000-09-01|April 2006|2006-04-01|August 2005||2005-08-01|||||Interventional|||Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings|Double-Blind, Placebo-Controlled Study of Depakote (Divalproex Sodium) in Children With Temper Outbursts and Severe Mood Swings|Completed||Phase 2|15||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:38:24.696206|2017-10-11 05:38:24.696206
NCT00217945|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Does Shared Decision-Making Improve Adherence in Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:38:24.757027|2017-10-11 05:38:24.757027
NCT00217958|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2014-10-27|||May 2002||2002-05-01|October 2014|2014-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Better Asthma Outcomes: Lowering Tobacco Smoke Exposure||Completed||N/A|||Palo Alto Medical Foundation|||||f||||||||||||||2017-10-11 05:38:24.806093|2017-10-11 05:38:24.806093
NCT00217971|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-04-06|2011-09-13||March 2005||2005-03-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|MARINOL||Dronabinol Treatment for Marijuana Addiction|A Randomized, Double-Blind, Placebo-Controlled Study of Dronabinol in the Treatment of Marijuana Addiction|Completed||Phase 2|156|Actual|New York State Psychiatric Institute|Consequences of use are often long-term and more subtle. Thus, trying to initiate change over a relatively short period (i.e. patients in the present trial were maintained on the maximum dronabinol dose for only 6 weeks), may have been inadequate.|2|||f||||t||||||||||2017-10-11 05:38:24.874508|2017-10-11 05:38:24.874508
NCT00217984|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-06-25|||July 2006||2006-07-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Intensive Intervention for Smokers - 6|Intensive Intervention for Smokers in Alcohol Treatment|Completed||Phase 2/Phase 3|162|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 05:38:25.189729|2017-10-11 05:38:25.189729
NCT00217997|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-05-05|||September 2005||2005-09-01|May 2017|2017-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals|Impulsivity, Brain Function and Substance Abuse Treatment|Completed||N/A|192|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-11 05:38:25.281445|2017-10-11 05:38:25.281445
NCT00218010|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||November 2000||2000-11-01|April 2015|2015-04-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Observational|||Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2|Breastfeeding Among Methadone Maintained Women|Completed||N/A|25|Actual|National Institute on Drug Abuse (NIDA)|||1||f||||f||||||||||2017-10-11 05:38:25.373066|2017-10-11 05:38:25.373066
NCT00218023|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-05-11|2017-02-23||March 2006||2006-03-01|May 2017|2017-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Medications for Stopping Cocaine Dependence and Preventing Relapse|Screening Medications for Cocaine Cessation and Relapse Prevention|Completed||Phase 2|101|Actual|The University of Texas Health Science Center, Houston|The sample size was small; however, the main aim of the study was achieved (i.e., to evaluate the feasibility of using a two-phase abstinence induction paradigm to screen candidate medications for cocaine treatment).|4|||f||||t|t|f|||f|||||2017-10-11 05:38:25.457676|2017-10-11 05:38:25.457676
NCT00218036|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-12-11|||July 2006||2006-07-01|December 2009|2009-12-01|July 2011|Anticipated|2011-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8|Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals|Unknown status|Recruiting|Phase 2|200|Anticipated|National Institute on Drug Abuse (NIDA)||5|||f||||t||||||||||2017-10-11 05:38:25.847468|2017-10-11 05:38:25.847468
NCT00218049|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||December 2004||2004-12-01|August 2008|2008-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals|Phase 1, Double-blind, Placebo-controlled Assessment of Interactions Between 2 Doses of Cocaine and Three Doses of Escalating Vanoxerine (GBR 12909) in Cocaine Using Volunteers|Terminated||Phase 1|3|Actual|National Institute on Drug Abuse (NIDA)||3||Issue of priority of resources|f||||t||||||||||2017-10-11 05:38:25.963174|2017-10-11 05:38:25.963174
NCT00218062|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-05-24|2017-05-24||March 2006||2006-03-01|May 2017|2017-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals|Pharmacotherapy Dosing Regimen (Cocaine Dependence Population)|Completed||Phase 2|73|Actual|The University of Texas Health Science Center, Houston|High attrition; Pill-taking burden (3 capsules daily) contributed to medication non-compliance; Small sample size.|4|||f||||t|t|f|||f|||||2017-10-11 05:38:26.069339|2017-10-11 05:38:26.069339
NCT00218075|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-01-04|||March 2000||2000-03-01|January 2016|2016-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence|Behavioral Strategies to Maximize the Efficacy of Pharmacotherapy for Cocaine Dependence: Relapse Prevention With Contingency Management Procedures|Completed||Phase 2|200||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 05:38:26.572311|2017-10-11 05:38:26.572311
NCT00218101|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||May 2004||2004-05-01|October 2016|2016-10-01|March 2005||2005-03-01|||||Interventional|||Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids|Dose Reduction Strategies in Oral Opioid Dependence Subsequent to Pain Management: An Exploratory Study|Completed||Phase 2|10||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:38:26.682729|2017-10-11 05:38:26.682729
NCT00218114|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-08-08|||February 2000|Actual|2000-02-01|August 2017|2017-08-01|February 18, 2005|Actual|2005-02-18|February 18, 2005|Actual|2005-02-18||Interventional|||Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults|Parallel Groups Study of Divalproex Sodium (Depakote) for Irritable, Explosive Adults & Adolescents|Completed||Phase 3|25|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 05:38:26.755436|2017-10-11 05:38:26.755436
NCT00218127|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||November 2001||2001-11-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens|Opioid Maintenance: Optimum Stabilization and Withdrawal|Completed||Phase 2|142|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 05:38:26.839186|2017-10-11 05:38:26.839186
NCT00218140|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11||||||October 2016|2016-10-01|April 2005||2005-04-01|||||Interventional|||Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1|Effects of Nicotine Patch in Men and Women|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:38:26.932819|2017-10-11 05:38:26.932819
NCT00218153|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||November 2000||2000-11-01|September 2005|2005-09-01|April 2004||2004-04-01|||||Interventional|||Naltrexone Augmentation of Nicotine Patch Therapy - 1|Naltrexone Augmentation of Nicotine Patch Therapy|Completed||Phase 3|200||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:38:26.997172|2017-10-11 05:38:26.997172
NCT00218166|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-10|||August 2001||2001-08-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine|GABA Agonists as Pharmacotherapies for Cocaine Abuse|Completed||Phase 2|78|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-10-11 05:38:27.05619|2017-10-11 05:38:27.05619
NCT00218179|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-19|||September 2005||2005-09-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1|Prostate, Lung, Colon, and Ovarian Cancer (PLCO) Screen Trial|Completed||N/A|200|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-10-11 05:38:27.142561|2017-10-11 05:38:27.142561
NCT00218192|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-05-21|||September 2000||2000-09-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Trial to Reduce Hepatitis C Among Injection Drug Users - 1|A Trial to Reduce Hepatitis C Among Injection Drug Users|Completed||Phase 3|277|Actual|Butler Hospital|||||f||||f||||||||||2017-10-11 05:38:27.224057|2017-10-11 05:38:27.224057
NCT00218205|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-09-20|||July 2002||2002-07-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer|A Phase II Trial of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Hormone Resistant Prostate Cancer (HRPC)|Unknown status|Recruiting|Phase 2|28||Department of Veterans Affairs, New Jersey|||||||||||||||||||2017-10-11 05:38:27.296257|2017-10-11 05:38:27.296257
NCT00218218|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||June 2002||2002-06-01|August 2008|2008-08-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia|Transdermal Nicotine and Bupropion for Smoking in Schizophrenics (Study 1)|Completed||Phase 2|48|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||f||||||||||2017-10-11 05:38:27.376873|2017-10-11 05:38:27.376873
NCT00218231|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||January 2004||2004-01-01|August 2008|2008-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia|Transdermal Nicotine and Bupropion-SR in Schizophrenics (Study 2)|Completed||Phase 2|48|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 05:38:27.629358|2017-10-11 05:38:27.629358
NCT00218244|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-09|||August 2001||2001-08-01|June 2008|2008-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|Brandswitch||Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use|Treatment of Smokeless Tobacco Users: Use of Nicotine Replacement Products to Reduce Smokeless Tobacco Use|Completed||Phase 1/Phase 2|56|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-10-11 05:38:27.712116|2017-10-11 05:38:27.712116
NCT00218257|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-11-16|||July 2002||2002-07-01|November 2015|2015-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Progesterone for the Treatment of Cocaine Dependence - 1|Interactions Between Progesterone and Cocaine in Women|Completed||N/A|36|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-10-11 05:38:27.79839|2017-10-11 05:38:27.79839
NCT00218270|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-09|||December 2002||2002-12-01|June 2008|2008-06-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use|Treatment of Smokeless Tobacco Users|Completed||Phase 2|138|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 05:38:27.894051|2017-10-11 05:38:27.894051
NCT00218283|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-09|||January 2005||2005-01-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Nicotine Lozenge to Reduce Smokeless Tobacco Use|Treatment of Smokeless Tobacco Users|Completed||Phase 2|100|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 05:38:27.975831|2017-10-11 05:38:27.975831
NCT00218309|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||September 2003||2003-09-01|May 2006|2006-05-01|July 2005||2005-07-01|||||Observational|||Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals|Biobehavioral Studies of Opioid Drug Seeking Behavior: Study 1|Completed||Phase 2|16||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:38:28.519508|2017-10-11 05:38:28.519508
NCT00218322|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-11-06|||September 2004||2004-09-01|November 2012|2012-11-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Effectiveness of ATMX in Treating Adolescents With ADHD and SUD|Atomoxetine in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD)|Completed||Phase 4|108|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:38:28.668831|2017-10-11 05:38:28.668831
NCT00218335|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-03-07|2013-01-25||June 2003||2003-06-01|March 2013|2013-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Network & Dyad HIV Prevention Intervention for IDU's - 1|A Network & Dyad HIV Prevention Intervention for IDU's|Completed||Phase 2|1024|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-10-11 05:38:28.769437|2017-10-11 05:38:28.769437
NCT00218348|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-01-07|||September 2003||2003-09-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo|Pharmacotherapy for Cocaine Dependence - 1|Completed||Phase 2|140|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:38:29.741242|2017-10-11 05:38:29.741242
NCT00218361|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-06-01|||August 2005||2005-08-01|June 2012|2012-06-01||||||||Observational|||Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals|Biobehavioral Study of Opioid Drug Seeking Behavior: Study 2|Completed||Phase 1|16|Anticipated|Wayne State University|||1||f||||||||||Samples With DNA|"     Whole Blood   "|||2017-10-11 05:38:29.825755|2017-10-11 05:38:29.825755
NCT00218374|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||October 2006||2006-10-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia|Hyperalgesia in Methadone Patients: Can it be Treated?|Completed||N/A|60|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-10-11 05:38:29.937762|2017-10-11 05:38:29.937762
NCT00218387|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-11-07|||April 2004||2004-04-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1|CBT and Modafinil for Cocaine Addiction|Completed||Phase 2|326|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-10-11 05:38:30.073895|2017-10-11 05:38:30.073895
NCT00218413|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||October 2004||2004-10-01|November 2008|2008-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals|A Phase 2 Study to Assess Safety and Immunogenicity of Five Doses of 3'-Aminomethylnicotine-P. Aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) Administered to Smokers|Completed||Phase 2|51|Actual|National Institute on Drug Abuse (NIDA)||5|||f||||f||||||||||2017-10-11 05:38:30.186459|2017-10-11 05:38:30.186459
NCT00218426|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-03-07|||July 2006||2006-07-01|March 2017|2017-03-01|October 2018|Anticipated|2018-10-01|July 2017|Anticipated|2017-07-01||Interventional|||Addiction Treatment in Russia: Oral vs. Naltrexone Implant|Addiction Treatment in Russia: Oral and Depot Naltrexone|Active, not recruiting||Phase 2/Phase 3|306|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-10-11 05:38:30.305564|2017-10-11 05:38:30.305564
NCT00218439|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-07-28|2013-10-29||October 2005||2005-10-01|July 2015|2015-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional||Includes subjects who completed both laboratory sessions (n=62). One additional subject completed both laboratory sessions but did not have usable measures in the primary outcomes (cardiovascular measures) and was excluded|Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1|Smoking, Antidepressants, and Response to Mental Stress|Completed||N/A|105|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||||||||||||2017-10-11 05:38:30.433219|2017-10-11 05:38:30.433219
NCT00218452|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-04-06|||September 2005||2005-09-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Smoking Cessation for Young Adults Who Binge Drink - 1|Smoking Cessation for Young Adults Who Binge Drink|Completed||Early Phase 1|41|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 05:38:30.833907|2017-10-11 05:38:30.833907
NCT00218465|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-03-22|2010-08-02||August 2006||2006-08-01|March 2017|2017-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking|A Double-Blind, Placebo-Controlled Trial of the NMDA Glycine Site Antagonist, GW468816, for Prevention of Relapse to Smoking|Completed||Phase 2|264|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:38:30.932643|2017-10-11 05:38:30.932643
NCT00218478|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-06-01|||September 2004||2004-09-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|||||Observational|||Evaluating Responses to Drug-Related Cues Versus Neutral Cues to Understand the Effects of Marijuana Craving - 1|Cue Reactivity Model for Assessing Pharmacologic Intervention in Treatment of Cannabis Use Disorders (Study 1)|Completed||Phase 1|15|Anticipated|Wayne State University|||1||f||||||||||||||2017-10-11 05:38:31.298536|2017-10-11 05:38:31.298536
NCT00218491|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-11-07|||November 2005||2005-11-01|September 2010|2010-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|NAC||Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1|A Controlled Trial of N-Acetylcysteine (NAC) for Cocaine Dependence|Completed||Phase 2|235|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-10-11 05:38:31.368928|2017-10-11 05:38:31.368928
NCT00218504|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-06-01|||December 2005||2005-12-01|June 2012|2012-06-01|October 2009|Actual|2009-10-01|||||Observational|||Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2|Cue Reactivity Model for Assessing Pharmacologic Intervention in Treatment of Cannabis Use Disorders (Study 2)|Completed||Phase 1|20|Anticipated|Wayne State University|||1||f||||||||||||||2017-10-11 05:38:31.453707|2017-10-11 05:38:31.453707
NCT00218517|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||March 2005||2005-03-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1|Selegiline for Treatment of Cannabis Dependence|Completed||Phase 2|19|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-10-11 05:38:31.517192|2017-10-11 05:38:31.517192
NCT00218530|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-01-11|||March 2003||2003-03-01|October 2016|2016-10-01|September 2004||2004-09-01|||||Interventional|||Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1|Naltrexone and Lofexidine in Detoxified Heroin Addicts|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:38:31.593011|2017-10-11 05:38:31.593011
NCT00218543|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-06-25|2012-01-12||June 2004||2004-06-01|June 2012|2012-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|Atom||Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial|Completed||Phase 2|20|Actual|New York State Psychiatric Institute|Clearly, there are limitations of this study including the high drop-out rate, small sample size, and lack of a control group.|1|||f||||t||||||||||2017-10-11 05:38:31.669547|2017-10-11 05:38:31.669547
NCT00218556|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-01-11|||January 2004||2004-01-01|October 2015|2015-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1|Preventing Depression in MMT Patients on Interferon|Completed||N/A|42|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-10-11 05:38:31.858087|2017-10-11 05:38:31.858087
NCT00218569|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2016-01-25|||April 2003||2003-04-01|January 2016|2016-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Combined Treatment for Cocaine-Alcohol Dependence - 1|Combined Treatment for Cocaine-Alcohol Dependence|Completed||Phase 2|87|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-10-11 05:38:31.933493|2017-10-11 05:38:31.933493
NCT00218582|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-01-11|||March 2003||2003-03-01|October 2008|2008-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effectiveness of Self-Help for Dually-Diagnosed Persons - 1|Effectiveness of Self-Help for Dually-Diagnosed Persons|Completed||Phase 1/Phase 2|229|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 05:38:32.013439|2017-10-11 05:38:32.013439
NCT00212199|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-03-17|||January 2002||2002-01-01|March 2010|2010-03-01|August 2004|Actual|2004-08-01|||||Interventional|||Effectiveness of Brief Counseling for Weight Management|Effectiveness of Brief Counseling for Weight Management|Completed||Phase 4|246||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:38:32.086444|2017-10-11 05:38:32.086444
NCT00212212|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2012-03-06|||March 2006||2006-03-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Selenium Supplementation of Patients With Cirrhosis|Human Selenium Nutritional Requirement and Biomarkers in Health and Disease|Terminated||N/A|99|Actual|Vanderbilt University||4||Insufficient funds to complete study.|f||||t||||||||||2017-10-11 05:38:32.152656|2017-10-11 05:38:32.152656
NCT00212225|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-01-12|||October 1997||1997-10-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Observational|||Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)|Risk Factors for Gastric Disease in Pediatric H. Pylori|Completed||N/A|755|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:38:32.4625|2017-10-11 05:38:32.4625
NCT00212238|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2010-03-17|||September 2003||2003-09-01|March 2010|2010-03-01|October 2006||2006-10-01|||||Interventional|||Enhanced Internet Behavior Therapy for Treating Obesity|Enhanced Internet Behavior Therapy for Treating Obesity|Completed||N/A|100||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:38:32.528562|2017-10-11 05:38:32.528562
NCT00212251|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2014-07-14|||August 2004||2004-08-01|January 2010|2010-01-01|April 2008||2008-04-01|||||Interventional|||Promoting Postpartum Weight Loss in Overweight Women|Promoting Postpartum Weight Loss in Overweight Women|Completed||N/A|450||Duke University||1|||f||||||||||||||2017-10-11 05:38:32.601063|2017-10-11 05:38:32.601063
NCT00212264|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-21|2014-10-07||August 2003||2003-08-01|March 2016|2016-03-01|August 2011|Actual|2011-08-01|September 2008|Actual|2008-09-01||Interventional|||Conservative Treatment of Postprostatectomy Incontinence|Conservative Treatment of Postprostatectomy Incontinence|Completed||N/A|208|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||f||||||||||2017-10-11 05:38:32.697751|2017-10-11 05:38:32.697751
NCT00212277|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-09-09|||February 2005||2005-02-01|September 2010|2010-09-01|February 2007|Actual|2007-02-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.|Phase3,Open-label,Long-term,NSAID-Add-on,Clinical Trial of Mono-phase Low-dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis.|Completed||Phase 3|||Nobelpharma|||||f||||||||||||||2017-10-11 05:38:33.05856|2017-10-11 05:38:33.05856
NCT00212290|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2010-02-12|||November 2002||2002-11-01|February 2010|2010-02-01|December 2006|Actual|2006-12-01|||||Interventional|||Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes||Completed||Phase 4|140|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:38:33.116689|2017-10-11 05:38:33.116689
NCT00212303|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-18|||May 2004||2004-05-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|SHAPE2||Exercise Training in Type 2 Diabetes and Hypertension|Exercise Training in Type 2 Diabetes and Hypertension|Completed||Phase 4|115|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-10-11 05:38:33.193883|2017-10-11 05:38:33.193883
NCT00212316|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2012-08-14|||August 2005||2005-08-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)|Phenylbutyrate Development for Huntington's Disease (PHEND-HD): A Multi-Center, Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Tolerability of Phenylbutyrate in Subjects With Huntington's Disease|Completed||Phase 2|60||University of Rochester|||||||||||||||||||2017-10-11 05:38:33.266061|2017-10-11 05:38:33.266061
NCT00212329|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-12|||September 2005||2005-09-01|May 2016|2016-05-01|September 2007|Actual|2007-09-01|||||Observational|||T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus|A Comparative Study Between the Cytokine Elispot, Tetramer, Immunoblot, and T Cell Proliferation Assays Using Fresh Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus|Completed||N/A|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:38:33.470487|2017-10-11 05:38:33.470487
NCT00212342|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-09-06|||December 2004||2004-12-01|September 2010|2010-09-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea|Phase 3,Placebo Controlled,Randomized,Double-Blinded,NSAID-Add-on,Clinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis.|Completed||Phase 3|100|Actual|Nobelpharma||2|||f||||||||||||||2017-10-11 05:38:33.582604|2017-10-11 05:38:33.582604
NCT00212355|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-04-10|2014-04-09||March 2005||2005-03-01|April 2014|2014-04-01|January 2009|Actual|2009-01-01|April 2008|Actual|2008-04-01||Interventional||Analysis was performed subjects comprised 37 patients who were found to have Wilson disease through clnical and biochemical tests.|Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.|Phase3, Open-Label, Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.|Completed||Phase 3|37|Actual|Nobelpharma||1|||f||||f||||||||||2017-10-11 05:38:33.674689|2017-10-11 05:38:33.674689
NCT00212368|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-09-09|||October 2004||2004-10-01|September 2010|2010-09-01|December 2005|Actual|2005-12-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.|Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.|Completed||Phase 3|||Nobelpharma|||||f||||||||||||||2017-10-11 05:38:33.98995|2017-10-11 05:38:33.98995
NCT00212381|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-27|||September 2000||2000-09-01|March 2017|2017-03-01|July 2010|Actual|2010-07-01|January 2006|Actual|2006-01-01||Interventional|||Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia|Diindolylmethane (DIM) Dietary Supplementation: A Nonsurgical Treatment for Cervical Intraepithelial Neoplasia (CIN)|Completed||Phase 3|62|Anticipated|New York Presbyterian Hospital||2|||f||||f|f|f||||||||2017-10-11 05:38:34.069846|2017-10-11 05:38:34.069846
NCT00212394|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-03-10|||January 2005|Actual|2005-01-01|March 2017|2017-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Tourniquet Complications in Orthopaedic Surgery|A Prospective, Epidemiological Study of the Incidence and Nature of Tourniquet Complications in Norway|Completed||N/A|10||Norwegian University of Science and Technology|||||f||||||||||||||2017-10-11 05:38:34.188742|2017-10-11 05:38:34.188742
NCT00212407|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-24|||February 1993||1993-02-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||New York Blood Center National Cord Blood Program|New York Blood Center National Cord Blood Program|Recruiting||Early Phase 1|5000|Anticipated|New York Blood Center||1|||f||||f||||||||||2017-10-11 05:38:34.276923|2017-10-11 05:38:34.276923
NCT00212420|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-21|||December 2004||2004-12-01|September 2007|2007-09-01||||||||Interventional|||Nutritional Management of Acute and Chronic Enterocutaneous Fistulae|Nutritional Management of Acute and Chronic Enterocutaneous Fistulae|Unknown status|Recruiting|N/A|150|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-10-11 05:38:34.38659|2017-10-11 05:38:34.38659
NCT00212433|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-07-20|||July 2004||2004-07-01|December 2005|2005-12-01|February 2006||2006-02-01|||||Interventional|||Optimisation and Performance of Reduced Preparation CT Colography|Multidetector-Row CT Colonography: Optimisation of Reduced Bowel Preparation Regimes and Diagnostic Performance in Comparison to Colonoscopy|Completed||Phase 4|120||London North West Healthcare NHS Trust|||||f||||||||||||||2017-10-11 05:38:34.517682|2017-10-11 05:38:34.517682
NCT00212446|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-11-19|||September 2014||2014-09-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pilot Study to Evaluate a Prototype Electronic Uterine Inhibitor to Prevent Preterm Contractions|Pilot Study to Evaluate a Prototype Electronic Uterine Inhibitor to Prevent Preterm Contractions|Completed||N/A|8|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||f||||||||||2017-10-11 05:38:34.648405|2017-10-11 05:38:34.648405
NCT00212459|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-03-26|||May 2005||2005-05-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|February 2006|Actual|2006-02-01||Interventional|||The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs|A Prospective Randomized Pilot Study on the Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs|Completed||N/A|14|Actual|New York Presbyterian Hospital||2|||f||||f||||||||||2017-10-11 05:38:35.243158|2017-10-11 05:38:35.243158
NCT00212472|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-12-04|||July 2002||2002-07-01|October 2009|2009-10-01|December 2012|Anticipated|2012-12-01|December 2010|Anticipated|2010-12-01||Interventional|||International Immune Tolerance Study|An International Randomised Controlled Trial Of Immune Tolerance Induction|Terminated||N/A|134|Actual|New York Presbyterian Hospital||2||The DSMB recommended stopping the study due to safety concerns.|f||||t||||||||||2017-10-11 05:38:35.383807|2017-10-11 05:38:35.383807
NCT00212485|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-06-30|||September 2005||2005-09-01|June 2010|2010-06-01|May 2009|Actual|2009-05-01|April 2008|Actual|2008-04-01||Interventional|||Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint Disease|Evaluation of the Role of Power Doppler Sonography in the Diagnosis of Hemophilic Joint Disease|Completed||N/A|43|Actual|New York Presbyterian Hospital||1|||f||||f||||||||||2017-10-11 05:38:35.615142|2017-10-11 05:38:35.615142
NCT00212498|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-07|||November 2006||2006-11-01|December 2015|2015-12-01||||January 2012|Actual|2012-01-01||Observational|||Tuberculosis Research Blood Bank||Withdrawn||N/A|0|Actual|New York University School of Medicine|||1||f||||||||||||||2017-10-11 05:38:35.726393|2017-10-11 05:38:35.726393
NCT00212511|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-26|||November 2004||2004-11-01|April 2017|2017-04-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry|Prospective Evaluation of Patients With Idiopathic Pulmonary Fibrosis Through an IPF Registry|Withdrawn||N/A|0|Actual|New York University School of Medicine|||1|Pending more information from PI|f||||t|f|f||||||Yes|Data has not been analyzed yet.|2017-10-11 05:38:35.818876|2017-10-11 05:38:35.818876
NCT00212537|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-02-01|||April 2002||2002-04-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Disease Modifying Genes in Severe Asthma|Disease Modifying Genes in Severe Asthma|Active, not recruiting||N/A|2000|Anticipated|New York University School of Medicine|||1||f||||||||||Samples With DNA|"     The total amount of blood drawn is approximately 5 tablespoons (75 ml). The blood sample will     be processed to isolate genetic material (mainly DNA, RNA and protein). This genetic     material will be used to try to identify the genetic factors or genes that a person     inherits that make him or her more likely to develop asthma. The blood is used to test for     allergies to weeds, trees, insects and molds (RAST) and a complete blood count.   "|||2017-10-11 05:38:35.903085|2017-10-11 05:38:35.903085
NCT00212550|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-29|||January 2006||2006-01-01|March 2016|2016-03-01|January 2012|Actual|2012-01-01|February 2010|Actual|2010-02-01||Observational|||Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb|Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb|Completed||N/A|10|Actual|New York University School of Medicine|||1||f||||t||||||||Undecided||2017-10-11 05:38:35.974839|2017-10-11 05:38:35.974839
NCT00212576|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-02-23|||November 2005||2005-11-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Promoting Early School Readiness in Primary Health Care|Promoting Early School Readiness in Primary Health Care|Active, not recruiting||N/A|675|Actual|New York University School of Medicine||5|||f||||t||||||||||2017-10-11 05:38:36.037749|2017-10-11 05:38:36.037749
NCT00212589|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||December 2002||2002-12-01|May 2004|2004-05-01|April 2004||2004-04-01|||||Interventional|||Patients Preference for Oral or i.v. Therapy|A Randomized Crossover Trial Comparing Oral Capecitabine and Intravenous Fluorouracil + Folinic Acid (Nordic FU/FA Regimen) for Patient Preference in Colorectal Cancer|Completed||Phase 3|60||Odense University Hospital|||||f||||||||||||||2017-10-11 05:38:36.137713|2017-10-11 05:38:36.137713
NCT00212602|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-12|||August 2005||2005-08-01|June 2012|2012-06-01||||||||Interventional|||ONO-7436 Phase II Study in Japan|ONO-7436 Phase II Study - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of ONO-7436 for the Prevention of Cancer Chemotherapy-Induced Nausea and Vomiting in Japan|Completed||Phase 2|420||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:36.217446|2017-10-11 05:38:36.217446
NCT00212615|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-10-16|||February 2004||2004-02-01|October 2009|2009-10-01|October 2008||2008-10-01|||||Interventional|||XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer|XELOX III. Capecitabine (Xeloda) in Combination With Oxaliplatin (Eloxatin) as First-line Treatment of Patients With Advanced or Metastatic Colorectal Cancer. A Randomized Phase II Study|Unknown status|Active, not recruiting|Phase 2/Phase 3|116||Odense University Hospital|||||f||||||||||||||2017-10-11 05:38:36.326537|2017-10-11 05:38:36.326537
NCT00212628|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-12|||June 2004||2004-06-01|June 2012|2012-06-01||||||||Interventional|||Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Completed||Phase 3|444|Actual|Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:36.42501|2017-10-11 05:38:36.42501
NCT00212641|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-10-10|||June 2005||2005-06-01|October 2012|2012-10-01||||October 2007|Actual|2007-10-01||Interventional|||A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus|Randomized Double-Blind Placebo-Controlled Pharmacodynamic Evaluation of ONO-5129 in Patients With Treatment Naive Type 2 Diabetes Mellitus|Completed||Phase 2|105||Ono Pharmaceutical Co. Ltd|||||||||||||||||||2017-10-11 05:38:36.516018|2017-10-11 05:38:36.516018
NCT00212654|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-10|||June 2001||2001-06-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan|Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan|Completed||Phase 2/Phase 3|165||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:36.918218|2017-10-11 05:38:36.918218
NCT00212667|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-10|||August 2002||2002-08-01|October 2012|2012-10-01||||September 2006|Actual|2006-09-01||Interventional|||Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Completed||Phase 3|650||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:36.975967|2017-10-11 05:38:36.975967
NCT00212680|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-10|||December 1996||1996-12-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan|Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan|Completed||Phase 2|100||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:37.038361|2017-10-11 05:38:37.038361
NCT00212693|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-10|||January 2004||2004-01-01|October 2012|2012-10-01||||September 2005|Actual|2005-09-01||Interventional|||Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan|Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan|Completed||Phase 2|165||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:37.094355|2017-10-11 05:38:37.094355
NCT00212706|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-11|||October 2001||2001-10-01|October 2012|2012-10-01||||November 2002|Actual|2002-11-01||Interventional|||Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan|Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan|Completed||Phase 2|400||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:37.153229|2017-10-11 05:38:37.153229
NCT00212719|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-10|||May 2003||2003-05-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Completed||Phase 3|250||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:37.207627|2017-10-11 05:38:37.207627
NCT00212732|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-10|||October 2003||2003-10-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan|Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan|Completed||Phase 3|750||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-10-11 05:38:37.278397|2017-10-11 05:38:37.278397
NCT00212745|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-09-22|||February 2004||2004-02-01|September 2009|2009-09-01|March 2010|Anticipated|2010-03-01|March 2009|Actual|2009-03-01||Interventional|||Pilot Trial of a Behavioral Treatment for Epilepsy|Nonrandomized Pilot Trial of the Andrews/Reiter Behavioral Treatment for Epilepsy|Unknown status|Active, not recruiting|Phase 1/Phase 2|8|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-10-11 05:38:37.339814|2017-10-11 05:38:37.339814
NCT00212758|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-10-22|2011-07-22||January 2005||2005-01-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood|IGF-1 Generation Test in Children With Chronic Kidney Disease|Completed||Phase 4|17|Actual|Oregon Health and Science University|Slow enrollment and the small number of participants in the study is the main limitation.|2|||f||||f||||||||||2017-10-11 05:38:37.426479|2017-10-11 05:38:37.426479
NCT00212771|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-22|||September 2004||2004-09-01|December 2014|2014-12-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|ACTAMESA||Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)|Long-Term Efficacy and Safety Evaluation of Asenapine (10-20 mg/Day) in With Schizophrenia or Schizoaffective Disorder, in a Multicenter Trial Using (10-20 mg/Day) as a Control|Completed||Phase 3|440|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:38:37.670508|2017-10-11 05:38:37.670508
NCT00212784|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-18|||September 4, 2003|Actual|2003-09-04|August 2017|2017-08-01|March 15, 2006|Actual|2006-03-15|March 15, 2006|Actual|2006-03-15||Interventional|||Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)|A Phase III, Double-Blind, Randomized, Active-Controlled, Two-Armed, Multicenter, Efficacy and Safety Assessment (ACTAMESA) of Org 5222 and Olanzapine in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|1225|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:38:37.779912|2017-10-11 05:38:37.779912
NCT00212797|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-11-25|||July 2004||2004-07-01|November 2015|2015-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|Hermes||A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)|Prospective, Double-Blind, Randomized, Placebo-Controlled Dose Finding Study of the Efficacy and Safety of 2 Target Doses of Org 34517 Used as Adjunctive Therapy in Subjects With Psychotic Major Depression (Major Depressive Episode, Severe, With Psychotic Features).|Completed||Phase 2|273|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 05:38:37.87636|2017-10-11 05:38:37.87636
NCT00212810|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-17|||September 2005||2005-09-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.|TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study|Completed||Phase 4|385|Actual|Ortho-McNeil Neurologics, Inc.|||||f||||||||||||||2017-10-11 05:38:37.957441|2017-10-11 05:38:37.957441
NCT00212823|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-17|||June 2004||2004-06-01|April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain|AXERT® 12.5mg Time vs Intensity Migraine Study (AIMS): An Open-label Multicenter Trial to Evaluate the Efficacy of Almotriptan Malate (AXERT®) 12.5 Milligram Intervention at Onset of Migraine Pain|Completed||Phase 4|1450|Actual|Ortho-McNeil Neurologics, Inc.||1|||f||||||||||||||2017-10-11 05:38:38.02014|2017-10-11 05:38:38.02014
NCT00212836|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-04-28|||April 21, 2005|Actual|2005-04-21|April 2017|2017-04-01|August 2, 2007|Actual|2007-08-02|June 15, 2007|Actual|2007-06-15||Interventional|||Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)|A Multicenter, Double-Blind, Flexible -Dose, 6-Month Trial Comparing the Efficacy Safety of Asenapine With Olanzapine in Stable Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia|Completed||Phase 3|481|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-10-11 05:38:38.082599|2017-10-11 05:38:38.082599
NCT00218595|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-07-31|||August 2004||2004-08-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||DBT Compared to I/GDC for the Treatment of Opiate Addiction in Emotionally Dysregulated Patients. - 1|Evaluation of Dialectical Behavior Therapy in Treatment of Opioid Addiction and Emotional Problems|Completed||N/A|39|Actual|Duke University||2|||f||||t||||||||||2017-10-11 05:38:38.166465|2017-10-11 05:38:38.166465
NCT00218608|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-01-26|||April 2001||2001-04-01|January 2012|2012-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone|Disulfiram for Cocaine Abuse in Methadone- Patients|Completed||Phase 2|158|Actual|University of Arkansas||4|||f||||t||||||||||2017-10-11 05:38:38.247301|2017-10-11 05:38:38.247301
NCT00218621|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-02-20|||September 2005||2005-09-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1|Maternal Buprenorphine Administration and Fetal/Infant Neurobehavior|Completed||Phase 2|20|Actual|Johns Hopkins University|||1||f||||t||||||||||2017-10-11 05:38:38.334568|2017-10-11 05:38:38.334568
NCT00218634|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-06-22|2012-01-03||February 2005||2005-02-01|June 2012|2012-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1|CBT for Depression & Adherence in HIV Methadone Patients|Completed||N/A|89|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 05:38:38.41199|2017-10-11 05:38:38.41199
NCT00218660|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-10-21|||April 1998||1998-04-01|June 2010|2010-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1|Naltrexone and Psychosocial Treatments for the Treatment of Cocaine Dependence Complicated by Alcohol Dependence|Completed||Phase 3|164|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-10-11 05:38:40.29979|2017-10-11 05:38:40.29979
NCT00218673|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-05-11|||October 2003||2003-10-01|May 2016|2016-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||RCT of Russian IDU Peer Network HIV Prevention Intervention - 1|Randomized Controlled Trial of Russian IDU Peer Network HIV Prevention Intervention|Completed||Phase 3|400|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||||||||||||2017-10-11 05:38:40.392589|2017-10-11 05:38:40.392589
NCT00218686|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-08-31|||January 2003||2003-01-01|August 2015|2015-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Network Intervention for Prevention of HIV Infection in Chennai, India - 1|Supplement to the Long-term Impact of a Network Outreach Intervention|Withdrawn||Phase 2|0|Actual|Johns Hopkins Bloomberg School of Public Health||2||In ability to obtain Indian governmental approval from the study from NACO|f||||f||||||||||2017-10-11 05:38:40.46761|2017-10-11 05:38:40.46761
NCT00218699|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-08-02|||August 2002||2002-08-01|August 2013|2013-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected|Changing Sexual Behavior in Gay Male Repeat HIV Testers: A Randomized Trial of a Single Session Counseling Intervention|Completed||N/A|300|Actual|University of California, San Francisco|||||f||||f||||||||||2017-10-11 05:38:40.55024|2017-10-11 05:38:40.55024
NCT00218712|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-04-30|||September 2005||2005-09-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men|Reducing HIV Transmission Risk Behavior: a Trial of a Two Session Risk-Reduction Intervention With HIV-Positive Men Who Have Sex With Men|Completed||N/A|488|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 05:38:40.615535|2017-10-11 05:38:40.615535
NCT00218725|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2015-09-28|||May 2005||2005-05-01|September 2015|2015-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder|Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder|Completed||Phase 1|2|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 05:38:40.713931|2017-10-11 05:38:40.713931
NCT00218751|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-09-23|||March 2000||2000-03-01|February 2008|2008-02-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Early Home Visitation Program to Promote Good Health and Development in Children at Risk for Abuse|Promoting Child Mental Health: RCT of Home Visiting|Completed||Phase 2/Phase 3|1122||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:38:40.844705|2017-10-11 05:38:40.844705
NCT00218777|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2015-12-10|||December 2004||2004-12-01|December 2015|2015-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|CBIT||Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children|Behavior Therapy for Children With Chronic Tic Disorders|Completed||Phase 2/Phase 3|120|Anticipated|Tourette Association of America|||||f||||||||||||||2017-10-11 05:38:41.957441|2017-10-11 05:38:41.957441
NCT00218790|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2014-02-10|||April 2003||2003-04-01|September 2005|2005-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||"The Effects of Cool Dialysate on the Sleep/Wake Cycle in Patients on Chronic Hemodialysis - The Sleep Cool Study"|The Effects of Hemodialysis on the Sleep/Wake Cycle|Completed||N/A|58|Actual|Emory University||2|||f||||t||||||||||2017-10-11 05:38:42.070992|2017-10-11 05:38:42.070992
NCT00218803|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-09-03|||August 2000||2000-08-01|September 2008|2008-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Teaching Children With Asthma and Who Live in a Rural Setting How to Self-Manage Their Asthma|A+ Asthma Rural Partnership|Completed||Phase 3|220|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-10-11 05:38:42.165895|2017-10-11 05:38:42.165895
NCT00218816|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-09-03|||August 2000||2000-08-01|September 2008|2008-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Nebulizer Intervention for Minority Children With Asthma|Nebulizer Intervention for Minority Children With Asthma|Completed||Phase 3|221|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-10-11 05:38:42.283083|2017-10-11 05:38:42.283083
NCT00218829|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-03-10|||September 1997|Actual|1997-09-01|March 2017|2017-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||DMSO-PDT of BCC - A 6 Year Follow up|Dimethylsulphoxide-supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curettage - A 6 Year Clinical and Histological Evaluation.|Completed||N/A|44|Actual|Norwegian University of Science and Technology|||1||f||||f|f|f||||||No||2017-10-11 05:38:42.405873|2017-10-11 05:38:42.405873
NCT00218842|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-03-06|||October 2005||2005-10-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||The Effect on Function of Increasing Activity for Nursing Home Residents|Physical and Daily Activity for Residents in a Nursing Home Setting. -A Nordic Multi-Centre Study|Completed||N/A|125|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:38:42.486253|2017-10-11 05:38:42.486253
NCT00218855|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2014-03-06|||January 2002||2002-01-01|March 2014|2014-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Thalidomide to Patients With Previously Untreated Multiple Myeloma|A Phase 3 Study With Randomization to Melphalan/Prednisone/Thalidomide Versus Melphalan/Prednisone/Placebo to Patients With Previously Untreated Multiple Myeloma|Completed||Phase 3|363|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:38:42.61582|2017-10-11 05:38:42.61582
NCT00218868|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-02-09|||January 2000||2000-01-01|February 2012|2012-02-01|November 2007|Actual|2007-11-01|February 2006|Actual|2006-02-01||Observational|||Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear|Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunvald-giemsa Stained Cutaneous Tissue Smear in Relation to Photodynamic Therapy|Completed||N/A|66|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 05:38:42.741186|2017-10-11 05:38:42.741186
NCT00218881|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2005-10-21|||October 2003||2003-10-01|September 2005|2005-09-01|July 2004||2004-07-01|||||Interventional|||An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized Trial|An Effective Alternative to the Standard Referral System for HIV Testing in the ED|Completed||N/A|408||North Bronx Healthcare Network|||||f||||||||||||||2017-10-11 05:38:42.844755|2017-10-11 05:38:42.844755
NCT00218894|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-01-16|||January 2004||2004-01-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Observational|||The Influence of Vision on Balance, Gait and Falls|The Effect of Cataract Surgery on Gait, Balance and Falls in Older Persons|Completed||N/A|148|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 05:38:42.974093|2017-10-11 05:38:42.974093
NCT00218907|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2005-10-21|||June 2003||2003-06-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||An Educational HIV Pre-Test Counseling Video Program for Off Hours Testing in the ED: A Randomized Control Trial|An Educational HIV Pre-Test Counseling Video Program for Off Hours Testing in the ED: A Randomized Control Trial|Terminated||N/A|130||North Bronx Healthcare Network|||||f||||||||||||||2017-10-11 05:38:43.082302|2017-10-11 05:38:43.082302
NCT00218933|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-02-07|||October 2001|Actual|2001-10-01|February 2017|2017-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||High-intensity Exercise Training in Patients With Post-infarction Heart Failure|Anti-remodeling Effect of High-intensity Interval Training in Patients With Post-infarction Heart Failure on Optimal Treatment|Completed||N/A|27|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 05:38:43.400906|2017-10-11 05:38:43.400906
NCT00218946|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-04-07|||January 2005||2005-01-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Nasogastric Tube in Premature Babies - Pain and Treatment|Nasogastric Tube in Premature Babies - Pain and Treatment. A Randomised, Partly Blinded, Placebo-controlled Factorial Clinical Trial of Sucrose and Pacifier|Completed||Phase 2|24|Actual|Norwegian University of Science and Technology||6|||f||||f||||||||||2017-10-11 05:38:43.543364|2017-10-11 05:38:43.543364
NCT00218959|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-01-25|||September 2005||2005-09-01|January 2017|2017-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Randomized Controlled Trial of Narrative Exposure Therapy Compared to Treatment as Usual for Traumatized Refugees|Randomized Controlled Trial of Narrative Exposure Therapy Compared to Treatment as Usual for Traumatized Refugees and Asylum Seekers in Mid-Norway|Completed||N/A|81|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:38:43.69205|2017-10-11 05:38:43.69205
NCT00219141|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-20|2011-01-11||October 2005||2005-10-01|May 2011|2011-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|ALLAY||Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension|A 36-week, Randomized, Double-blind, Multi-center, Parallel Group Study Comparing the Efficacy and Safety of Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension|Completed||Phase 3|460|Actual|Novartis||3|||f||||||||||||||2017-10-11 05:38:43.818836|2017-10-11 05:38:43.818836
NCT00219154|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||March 2005||2005-03-01|November 2011|2011-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine|A Twenty Six-week, Randomized, Double-blind, Parallel Group, Multicenter, Active Controlled, Dose Titration Study to Evaluate the Efficacy and Safety of Aliskiren Compared to HCTZ With the Optional Addition of Amlodipine, Followed by a Second Twenty Six Weeks of Blinded Treatment, in Patients With Essential Hypertension|Completed||Phase 3|1125|Actual|Novartis|||||||||||||||||||2017-10-11 05:38:44.78586|2017-10-11 05:38:44.78586
NCT00219167|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2016-11-16|||April 2005||2005-04-01|November 2016|2016-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure|An 8-week, Randomized, Double-blind, Parallel-group, Multicenter Study Assessing the Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Patients With at Least 65 Years of Age With Essential Hypertension, Using 24-hour ABPM, With Lisinopril 10 mg as a Reference|Completed||Phase 3|355|Actual|Novartis|||||||||||||||||||2017-10-11 05:38:44.868313|2017-10-11 05:38:44.868313
NCT00219180|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-15|||June 2005||2005-06-01|May 2017|2017-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure|An 8-week Multi-center, Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren (150 mg and 300 mg) Administered Alone and in Combination With Valsartan (160 mg and 320 mg) in Patients With Hypertension|Completed||Phase 3|1797|Actual|Novartis|||||||||||||||||||2017-10-11 05:38:44.954129|2017-10-11 05:38:44.954129
NCT00219193|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-03|||October 2005||2005-10-01|February 2017|2017-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients|An Eight Week, Multicenter Study to Evaluate Efficacy and Safety of the Triple Combo of Aliskiren /Valsartan/HCTZ (300/320/25 mg), Compared to the Double Combos of Aliskiren/HCTZ (300/25 mg) or Valsartan/HCTZ (320/25 mg) in Patients With Essential Hypertension Not Adequately Responsive to HCTZ 25 mg|Completed||Phase 3|641|Actual|Novartis|||||f||||||||||||||2017-10-11 05:38:45.06305|2017-10-11 05:38:45.06305
NCT00219219|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2015-04-13|||September 2003||2003-09-01|April 2015|2015-04-01|October 2006||2006-10-01|||||Interventional|||Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases|Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-10-11 05:38:45.133263|2017-10-11 05:38:45.133263
NCT00219232|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-02-21|||February 2003||2003-02-01|February 2017|2017-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease|An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease|Completed||Phase 3|868|Actual|Novartis|||||f||||||||||||||2017-10-11 05:38:45.201348|2017-10-11 05:38:45.201348
NCT00219245|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-11-16|||November 2002||2002-11-01|November 2011|2011-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits|A 26-Week Open-Label Extension to Protocol No. CENA713BUS11: A 12-Week, Prospective, Double-blind, Placebo-controlled, Multi-center Study Evaluating the Efficacy and Safety of Rivastigmine 3 to 6 mg/Day in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits|Completed||Phase 4|157|Actual|Novartis|||||f||||||||||||||2017-10-11 05:38:45.264296|2017-10-11 05:38:45.264296
NCT00219258|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2009-11-20|||July 2005||2005-07-01|November 2009|2009-11-01||||||||Interventional|||Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma|A Randomized, Double-blind, Multi-centre Study to Evaluate the Fficacy and Safety of Zometa as a Treatment in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma|Completed||Phase 3|240||Novartis|||||f||||||||||||||2017-10-11 05:38:45.421029|2017-10-11 05:38:45.421029
NCT00219271|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-05-28|||September 2003||2003-09-01|May 2017|2017-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer|Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer|Completed||Phase 4|60|Actual|Novartis||1|||f||||||||||||No||2017-10-11 05:38:45.495433|2017-10-11 05:38:45.495433
NCT00219284|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-02-28|2010-12-07||January 2005||2005-01-01|February 2017|2017-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease|A Prospective, Multi-center, Randomized, Open-label Study With Blinded Raters to Evaluate the Effects of Immediate Versus Delayed Switch to Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease With End-of-dose Wearing Off|Completed||Phase 4|359|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:38:45.598158|2017-10-11 05:38:45.598158
NCT00219297|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2013-03-14||2012-05-01|November 2005||2005-11-01|March 2013|2013-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer|An Open-label, Multi-center, Phase II Study to Evaluate the Activity of Patupilone (EPO906), in the Treatment of Recurrent or Progressive Brain Metastases in Patients With Non-small Cell Lung Cancer.|Completed||Phase 2|62|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:38:46.276944|2017-10-11 05:38:46.276944
NCT00219310|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2012-04-26|||June 2003||2003-06-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir|A Study to Determine the Safety and Efficacy of Famciclovir in the Episodic and Suppressive Treatment of Recurrent Genital Herpes (RGH). The Study Will Also Evaluate Quality of Life and Patient Satisfaction|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-10-11 05:38:46.375021|2017-10-11 05:38:46.375021
NCT00219323|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2011-10-24|||November 2003||2003-11-01|October 2011|2011-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.|Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma|Completed||Phase 3|133|Actual|Novartis|||||f||||||||||||||2017-10-11 05:38:46.442167|2017-10-11 05:38:46.442167
NCT00219336|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-09-29|||November 2005||2005-11-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|July 2008|Actual|2008-07-01||Interventional|||A Media Based Motivational Intervention to Prevent Alcohol Exposed Pregnancies (AEPs)|A Media Based Motivational Intervention to Reduce Alcohol Exposed Pregnancies (AEPs)|Completed||Phase 2|354|Actual|Nova Southeastern University||2|||f||||f||||||||No||2017-10-11 05:38:46.503806|2017-10-11 05:38:46.503806
NCT00219362|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-11-24|||April 2004||2004-04-01|November 2009|2009-11-01|September 2006|Actual|2006-09-01|November 2005|Actual|2005-11-01||Interventional|MANON 02||Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients|A Phase II, Randomized, Placebo-controlled Study to Evaluate the Immunogenicity and the Safety of 2 Schedules of an Homologous Prime-boost With the ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients|Completed||Phase 2|65|Actual|Objectif Recherche Vaccins SIDA||4|||f||||f||||||||||2017-10-11 05:38:46.773004|2017-10-11 05:38:46.773004
NCT00219375|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-04-21|||June 2004||2004-06-01|June 2012|2012-06-01||||July 2007|Actual|2007-07-01||Interventional|||Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan|Efficacy and Safety of Sivelestat Sodium Hydrate in Acute Lung Injury Associated With Systemic Inflammatory Response Syndrome, Compared With the Conventional Treatment in Japan|Completed||Phase 4|649|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||||||||||||2017-10-11 05:38:46.871538|2017-10-11 05:38:46.871538
NCT00219388|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-03-17|||November 2002||2002-11-01|September 2005|2005-09-01|April 2005||2005-04-01|||||Interventional|||Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.|Efficacy and Safety of Short-term Intravenous Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients Treated With Beta-receptor Blocking Agents.|Completed||Phase 4|60||Orion Corporation, Orion Pharma|||||f||||||||||||||2017-10-11 05:38:46.964421|2017-10-11 05:38:46.964421
NCT00219401|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-07-10|||May 2005||2005-05-01|July 2011|2011-07-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea|Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea|Completed||Phase 2|318|Actual|Papua New Guinea Institute of Medical Research||3|||f||||t||||||||||2017-10-11 05:38:47.039259|2017-10-11 05:38:47.039259
NCT00219414|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-09-26|||June 2005||2005-06-01|September 2007|2007-09-01|June 2006||2006-06-01|||||Interventional|||Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)||Completed||Phase 4|42||Otsuka Frankfurt Research Institute GmbH|||||f||||||||||||||2017-10-11 05:38:47.129861|2017-10-11 05:38:47.129861
NCT00219427|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-05-20|||January 2005||2005-01-01|May 2008|2008-05-01|December 2005|Actual|2005-12-01|November 2005|Actual|2005-11-01||Observational|||Retina Projection System Trials for Low Vision People|Multicenter Clinical Trials of Retina Projection System|Completed||N/A|58|Actual|Osaka City University|||1||f||||t||||||||||2017-10-11 05:38:47.18786|2017-10-11 05:38:47.18786
NCT00219440|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-01-22|||February 2003||2003-02-01|January 2016|2016-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|TAKE II||A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS|A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS|Completed||Phase 4|60|Anticipated|Pennington Biomedical Research Center||3|||f||||t||||||||||2017-10-11 05:38:47.258968|2017-10-11 05:38:47.258968
NCT00219453|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-18|||October 2004||2004-10-01|April 2007|2007-04-01|January 2006||2006-01-01|||||Interventional|||Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination|A Pilot Safety Study to Determine the Presence of Hepatitis B Virus in Downstream Injection Samples Using the HSI-500 Jet Injector With Protector Cap|Completed||Phase 1|17||PATH|||||f||||||||||||||2017-10-11 05:38:47.327885|2017-10-11 05:38:47.327885
NCT00219466|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-19|||June 2005||2005-06-01|August 2011|2011-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash|A Parallel, Evaluator-Blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Two Marketed Topical Skin Protectants Containing Zinc Oxide in Children With Diaper Rash|Completed||Phase 4|112|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-10-11 05:38:47.401819|2017-10-11 05:38:47.401819
NCT00219479|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-06-13|||August 1997||1997-08-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study|Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study|Terminated||Phase 4|3|Actual|Penn State University||1||Difficulty recruiting subjects|f||||f||||||||||2017-10-11 05:38:47.467792|2017-10-11 05:38:47.467792
NCT00219492|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-06-16|||September 2005||2005-09-01|June 2017|2017-06-01|August 21, 2014|Actual|2014-08-21|August 21, 2014|Actual|2014-08-21||Observational|||Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)|Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)|Completed||N/A|86|Actual|Milton S. Hershey Medical Center|||||f||||||||||||||2017-10-11 05:38:47.528727|2017-10-11 05:38:47.528727
NCT00219505|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-06-01|||August 2001||2001-08-01|September 2006|2006-09-01|January 2004||2004-01-01|||||Interventional|||Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBS|Effect of Acupuncture on Symptoms of Diarrhea and Pain in Diarrhea Predominant Irritable Bowel Syndrome (IBS) and Effect on Plasma Beta-endorphin and Serotonin Levels.|Terminated||N/A|36||Penn State University||||no eligible subjects identified during recruitment|f||||||||||||||2017-10-11 05:38:47.579985|2017-10-11 05:38:47.579985
NCT00219518|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-06-01|||February 2006||2006-02-01|September 2009|2009-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Mechano-physiological Approach to Anorectal Function|Mechano-physiological Approach to Normal Anorectal Function and the Classification of Defecatory Disorders|Terminated||N/A|17|Actual|Penn State University|||1|inadequate no of constip patients|f||||||||||||||2017-10-11 05:38:47.743465|2017-10-11 05:38:47.743465
NCT00219531|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-06-01|||March 1999||1999-03-01|September 2009|2009-09-01||||||||Observational|||Effect of Menstrual Cycle on CNS Processing of Gut Stimuli in IBS and Control|Effect of Menstrual Cycle and Irritable Bowel Syndrome on the Central Nervous System Processing of Gut Stimuli|Terminated||N/A|50|Anticipated|Penn State University|||2|inadequate number of patients, study completed with normal subjects|f||||f||||||||||2017-10-11 05:38:47.805585|2017-10-11 05:38:47.805585
NCT00219544|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-04-22|2009-02-13||November 2005||2005-11-01|April 2011|2011-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.|A Randomized, Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Peripheral Neuropathic Pain|Completed||Phase 3|158|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 05:38:47.914176|2017-10-11 05:38:47.914176
NCT00219557|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-07-23|2012-02-25|2009-03-20|July 2005||2005-07-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer|A Randomized Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Combination With Gemcitabine In Patients With Chemotherapy Naive Advanced Pancreatic Cancer Preceded By A Phase 1 Portion|Completed||Phase 2|111|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:38:49.173057|2017-10-11 05:38:49.173057
NCT00219570|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-09|||January 2005||2005-01-01|May 2011|2011-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Dalacin-T Gel Post Approval Study|Phase IV Clinical Study Of Clindamycin Phosphate Topical Gel In The Treatment Of Acne Vulgaris|Completed||Phase 4|134|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:38:55.846923|2017-10-11 05:38:55.846923
NCT00219583|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-11-05|||August 2004||2004-08-01|November 2012|2012-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation|A Phase 2b, Multi-Centre, Double-Blind, Placebo-Controlled, Parallel Group Dose Response Study To Assess The Efficacy and Safety Of Oral UK390,957 In Men With Premature Ejaculation|Completed||Phase 2/Phase 3|460||Pfizer|||||||||||||||||||2017-10-11 05:38:55.925305|2017-10-11 05:38:55.925305
NCT00219596|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-09-13|||June 2005||2005-06-01|November 2006|2006-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension|An 8-Week, Randomized, Open-Label, Parallel Group Study Comparing The Efficacy And Safety Of Xalacom With The Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension|Completed||Phase 3|240||Pfizer|||||f||||||||||||||2017-10-11 05:38:56.087249|2017-10-11 05:38:56.087249
NCT00219609|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-11-05|||January 2005||2005-01-01|November 2012|2012-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Assessment Of Safety Of UK-390,957|A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation|Completed||Phase 2/Phase 3|1058||Pfizer|||||||||||||||||||2017-10-11 05:38:56.177591|2017-10-11 05:38:56.177591
NCT00219622|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-11|2012-11-05|||May 2004||2004-05-01|November 2012|2012-11-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease|Phase 2, Randomized, Double-Blind, Placebo-Controlled, Six Week Study Of The Efficacy And Safety Of Tofimilast Dry Powder For Inhalation In Adults Diagnosed With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|300||Pfizer|||||f||||||||||||||2017-10-11 05:38:56.40495|2017-10-11 05:38:56.40495
NCT00219635|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2012-11-05|||January 2005||2005-01-01|November 2012|2012-11-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation|A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study To Assess The Efficacy and Safety Of Oral UK-390,957 In Men With Premature Ejaculation|Completed||Phase 2/Phase 3|138||Pfizer|||||||||||||||||||2017-10-11 05:38:56.566188|2017-10-11 05:38:56.566188
NCT00219648|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-09-20|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose- Finding, Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Recruiting|Phase 2|||PharmaEngine|||||||||||||||||||2017-10-11 05:38:56.735944|2017-10-11 05:38:56.735944
NCT00219674|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-10-28|||July 2004||2004-07-01|October 2014|2014-10-01|March 2011|Actual|2011-03-01|March 2009|Actual|2009-03-01||Interventional|||At-Home Automated External Defibrillator (AED) Training Study|Home Automatic External Defibrillator Training for High-Risk Patients|Completed||Phase 2|305|Actual|Public Health - Seattle and King County||4|||f||||t||||||||||2017-10-11 05:38:56.877119|2017-10-11 05:38:56.877119
NCT00219687|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-10-28|||June 2004||2004-06-01|October 2014|2014-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Dispatcher-Assisted Resuscitation Trial (DART)|Randomized Trial of Dispatcher-Assisted CPR:Chest Compression Alone Versus Chest Compression Plus Ventilation|Completed||Phase 3|5494|Actual|Public Health - Seattle and King County||2|||f||||t||||||||||2017-10-11 05:38:56.972777|2017-10-11 05:38:56.972777
NCT00219700|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-11-25|||January 2005||2005-01-01|November 2008|2008-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial|Phase II, Randomized, Blinded Study of Ibuprofen-PC and Ibuprofen in Patients With Osteoarthritis to Investigate Efficacy and Gastrointestinal Toxicity|Completed||Phase 2|125||PLx Pharma|||||f||||f||||||||||2017-10-11 05:38:57.062168|2017-10-11 05:38:57.062168
NCT00219713|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||March 2000||2000-03-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Evaluation of Pain Intensity During Bone Marrow Biopsy Performed With Inhalation of Pre-Mixed 50 Per Cent Nitrous Oxide and Oxygen Mixture.|A Randomized Placebo-Controlled Double Blind Trial Comparing Pre-Mixed 50 Per Cent Nitrous Oxide and Oxygen Mixture in Combination With Local Local 1% Xylocaine Anesthetic Versus Placebo in Order to Evaluate Pain Intensity During Bone Marrow Biopsy.|Terminated||Phase 3|280||Poitiers University Hospital|||||f||||||||||||||2017-10-11 05:38:57.125951|2017-10-11 05:38:57.125951
NCT00219726|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-28|||May 2002||2002-05-01|September 2005|2005-09-01|July 2007||2007-07-01|||||Interventional|||Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation|Phase II Trial to Study the Tolerability and the Effectiveness of Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase in Relapse After Allogeneic Stem Cell Transplantation|Completed||Phase 2|30|Anticipated|Poitiers University Hospital|||||f||||||||||||||2017-10-11 05:38:57.20107|2017-10-11 05:38:57.20107
NCT00219739|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-10|||September 2003||2003-09-01|June 2016|2016-06-01||||December 2014|Actual|2014-12-01||Interventional|SPIRIT||STI571 ProspectIve RandomIzed Trial: SPIRIT|A Phase III Prospective Randomized Comparison of Imatinib at a Dose of 400mg in Combination With Peg-Interferon-alpha2a (Peg-IFNa2a) or Cytarabine (Ara-C)Versus Imatinib at a Dose of 600mg Versus Imatinib a Dose of 400mg for Previously Untreated Chronic Myelogenous Leukemia (CML) in Chronic Phase|Completed||Phase 3|789|Actual|Poitiers University Hospital||4|||f||||||||||||||2017-10-11 05:38:57.270181|2017-10-11 05:38:57.270181
NCT00219752|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-12-21|||May 2002||2002-05-01|September 2005|2005-09-01|May 2007||2007-05-01|||||Interventional|||Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years|Phase II Trial to Study the Tolerability and the Effectiveness of Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase With Age More Than 70, Diagnosis of CML is Being Performed Within 1 Year|Completed||Phase 2|30||Poitiers University Hospital|||||f||||||||||||||2017-10-11 05:38:57.397318|2017-10-11 05:38:57.397318
NCT00219765|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-11-25|||May 2001||2001-05-01|September 2005|2005-09-01|January 2006||2006-01-01|||||Interventional|||Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients|Phase I/II Trial to Study the Dose, Tolerability and the Effectiveness of Imatinib in Combination With Daunorubicine and Cytarabine for Patients With Chronic Myelogenous Leukemia in Myeloid Acute Phase|Terminated||Phase 1/Phase 2|30||Poitiers University Hospital|||||f||||||||||||||2017-10-11 05:38:57.486375|2017-10-11 05:38:57.486375
NCT00219778|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-04-04|||December 2004||2004-12-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|||||Interventional|||A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas|A Placebo Controlled Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas|Terminated||Phase 2|20|Anticipated|Poitiers University Hospital|||||f||||||||||||||2017-10-11 05:38:58.874372|2017-10-11 05:38:58.874372
NCT00219791|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-09-10|||January 2000||2000-01-01|September 2014|2014-09-01|June 2003||2003-06-01|||||Interventional|||Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance|Study of Recombinant Carboxypeptidase G2 (CPG2) for the Management of Patients With Delayed Methotrexate (MTX) Clearance or Intrathecal MTX Overdosage|Completed||Phase 2|||BTG International Inc.|||||f||||||||||||||2017-10-11 05:38:58.933936|2017-10-11 05:38:58.933936
NCT00219804|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14||||||September 2005|2005-09-01||||||||Interventional|||Efficacy and Safety of Tetrabenazine in Chorea|A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea|Completed||Phase 3|||Prestwick Pharmaceuticals|||||||||||||||||||2017-10-11 05:38:58.997516|2017-10-11 05:38:58.997516
NCT00219817|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-08-30|||June 2005||2005-06-01|August 2013|2013-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss||Completed||Phase 2|80||Helsinn Therapeutics (U.S.), Inc|||||||||||||||||||2017-10-11 05:38:59.049921|2017-10-11 05:38:59.049921
NCT00219830|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-02-18|||January 2005||2005-01-01|February 2009|2009-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|CRU-SHAL||A Trial of a Home Based Walking Program as an Alternate Program for Non Attenders at Cardiac Rehabilitation|Health and Social Inequalities in the Uptake of Cardiac Rehabilitation in Northern Ireland: an Alternative Program for Non-Attenders: (2) a Randomised Controlled Trial.|Completed||N/A|432|Actual|Queen's University, Belfast|||2||f||||f||||||||||2017-10-11 05:38:59.12171|2017-10-11 05:38:59.12171
NCT00219843|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-08-22|||August 2005||2005-08-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Intralesional PV-10 Chemoablation of Metastatic Melanoma|A Phase 1 Safety and Tolerability Study of Intralesional PV-10 Chemoablation in Subjects With Metastatic Melanoma|Completed||Phase 1|20||Provectus Pharmaceuticals|||||f||||f||||||||||2017-10-11 05:38:59.196898|2017-10-11 05:38:59.196898
NCT00219856|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-25|||August 2004||2004-08-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Effects of Propofol on Oxidative Stress and Liver Regeneration After Partial Hepatectomy|Prospective, Randomized, Simple Blind Study Comparing the Effects of an Anaesthesia With Propofol to an Anaesthesia With Desflurane on Oxydative Stress and Liver Function Recovery After Hepatectomy|Completed||Phase 3|34|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-10-11 05:38:59.264048|2017-10-11 05:38:59.264048
NCT00219869|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||July 2005||2005-07-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Galantamine in the Treatment of Post-Traumatic Headache|Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache|Unknown status|Recruiting|Phase 4|30||Rapoport, Alan, M.D.|||||f||||||||||||||2017-10-11 05:38:59.351569|2017-10-11 05:38:59.351569
NCT00219882|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-12-18|||April 2005||2005-04-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|SEER||Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis|A Phase I Safety and Dose Finding Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis Who Are Homozygous for Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (ΔF508 CFTR) Mutation|Completed||Phase 1|11|Actual|Ramsey, Bonnie, MD||1|||f||||t||||||||||2017-10-11 05:38:59.442679|2017-10-11 05:38:59.442679
NCT00219895|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-12-18|||August 2004||2004-08-01|August 2006|2006-08-01|March 2006|Actual|2006-03-01|||||Interventional|||Assessment of Inflammatory Mediators (AIM)|Assessment of Induced Sputum as a Tool to Evaluate Anti-Inflammatory Agents in Patients With Cystic Fibrosis|Completed||N/A|120||Ramsey, Bonnie, MD|||||f||||||||||||||2017-10-11 05:38:59.538682|2017-10-11 05:38:59.538682
NCT00219908|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-12-21|||July 1999||1999-07-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis|Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis: Induction Treatment With Mitoxantrone Followed by Long-Term Treatment With Interferon-beta1b|Terminated||Phase 2|124||Rennes University Hospital|||||f||||||||||||||2017-10-11 05:38:59.788318|2017-10-11 05:38:59.788318
NCT00219921|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-03-29|||September 2005||2005-09-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Postoperative Analgesia After Total Hip Replacement|Postoperative Analgesia After Total Hip Replacement|Completed||Phase 3|120||Rijnstate Hospital|||||f||||||||||||||2017-10-11 05:38:59.924077|2017-10-11 05:38:59.924077
NCT00219934|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-02-15|||February 2002||2002-02-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Observational Study of Treated and Untreated Acute and Early HIV-1 Infection|Observational Study of Treated and Untreated Acute and Early HIV-1 Infection|Completed||N/A|399|Actual|Rockefeller University|||2||f||||t||||||Samples With DNA|"     PLASMA AND PERIPHERAL BLOOD MONONUCLEAR CELLS   "|||2017-10-11 05:39:00.005359|2017-10-11 05:39:00.005359
NCT00219947|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-01-17|||July 2000||2000-07-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Viral and Host Factors in the Transmission and Pathogenesis of HIV|Viral and Host Factors in the Transmission and Pathogenesis of HIV|Recruiting||N/A|600|Anticipated|Rockefeller University|||2||f||||f||||||Samples With DNA|"     whole blood   "|No||2017-10-11 05:39:00.106712|2017-10-11 05:39:00.106712
NCT00219960|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||April 2001||2001-04-01|June 2004|2004-06-01|October 2003||2003-10-01|||||Interventional|||The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension|The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension|Completed||Phase 3|52||Risk Factor Modification Centre|||||f||||||||||||||2017-10-11 05:39:00.214488|2017-10-11 05:39:00.214488
NCT00219973|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2010-04-27|||May 2005||2005-05-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|||||Interventional|||CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)|Multicentric, Rand., D-b, Pbo Controlled Clinical Trial to Evaluate the Efficacy and the Safety of the Thromboprophylaxis With Bemiparin 3,500 IU/d for 28 Days Compared to 8 Days, in Patients Undergoing Oncological Abdominal/ Pelvic Surgery|Completed||Phase 3|526|Anticipated|Rovi Pharmaceuticals Laboratories|||||f||||t||||||||||2017-10-11 05:39:00.299017|2017-10-11 05:39:00.299017
NCT00219986|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-16|||October 2003||2003-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Phase I/II, Open-Label Trial of Three Monoclonal Antibodies|A Phase I/II Single Site Open Label Trial of the Safety and Antiviral Activity of C2F5, C2G12, and C4E10 Monoclonal Antibody Infusions in Well-Suppressed HAART-Treated Individuals Treated During Acute and Early HIV-1 Infection|Completed||Phase 1/Phase 2|12||Rockefeller University|||||||||||||||||||2017-10-11 05:39:00.402082|2017-10-11 05:39:00.402082
NCT00219999|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-08-06|||September 2001||2001-09-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Hepatitis C Virus and the Humoral Immune System|Hepatitis C Virus and the Humoral Immune System|Completed||N/A|161|Actual|Rockefeller University|||5||f||||t||||||Samples With DNA|"     whole blood   "|||2017-10-11 05:39:00.475755|2017-10-11 05:39:00.475755
NCT00220012|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2013-11-14|||June 2003||2003-06-01|November 2013|2013-11-01|September 2008|Actual|2008-09-01|||||Interventional|||Effect of Folate on Colon and Blood Cells|Effect of Folate on Colonic and Blood Cells|Completed||Phase 1|20||Rockefeller University|||||f||||||||||||||2017-10-11 05:39:00.574827|2017-10-11 05:39:00.574827
NCT00220025|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-10-24|||June 1999||1999-06-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.|A Study To Determine the Efficacy of Whole Body Narrowband UVB Phototherapy in People With Darker Skin Types|Completed||Phase 1|70|Actual|Rockefeller University||1|||f||||t||||||||||2017-10-11 05:39:00.645308|2017-10-11 05:39:00.645308
NCT00220038|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2012-01-10|||May 2004||2004-05-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|January 2007|Actual|2007-01-01||Observational|||Experiments to Test How and Why the Sense of Smell Differs Between People|Genetic Basis of Specific Anosmias|Completed||N/A|500|Actual|Rockefeller University|||1||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 05:39:00.714609|2017-10-11 05:39:00.714609
NCT00220051|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-05-30|||November 2001||2001-11-01|May 2013|2013-05-01||||||||Interventional|||A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer|A Phase II Study of Oxaliplatin (Eloxatin) Capecitabine (Xeloda) and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer.|Completed||Phase 2|109|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 05:39:00.778005|2017-10-11 05:39:00.778005
NCT00220064|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-05-30|||July 2000||2000-07-01|May 2013|2013-05-01|November 2005|Actual|2005-11-01|||||Interventional|||A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours|A Phase II Trial Evaluating Irinotecan With 5_fluorouracil Plus Leucovorin in Patients With Relapsed/Refractory Upper Gastrointestinal Tumours|Completed||Phase 2|65|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 05:39:00.849423|2017-10-11 05:39:00.849423
NCT00220077|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2015-11-23|||June 2002||2002-06-01|November 2015|2015-11-01||||||||Interventional|||Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer|Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer|Recruiting||N/A|400|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||||||||||||2017-10-11 05:39:00.905609|2017-10-11 05:39:00.905609
NCT00220090|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-05-13|||July 2003||2003-07-01|May 2008|2008-05-01||||September 2006|Actual|2006-09-01||Interventional|||DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)|A 24-wk, Prospective, d/b, Placebo Controlled, Parallel Group, Multicenter, Randomized/Withdrawal Efficacy and Safety Study of Dexloxiglumide for the Relief of Symptoms in Patients With Constipation-Predominant Irritable Bowel Syndrome|Completed||Phase 3|||Rottapharm|||||f||||||||||||||2017-10-11 05:39:00.984404|2017-10-11 05:39:00.984404
NCT00220103|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-12-15|||November 2002||2002-11-01|December 2009|2009-12-01||||||||Interventional|||Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma|Pre-operative Epirubicin, Capecitabine (Xeloda) and Cisplatin in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma|Completed||Phase 2|80|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 05:39:01.052428|2017-10-11 05:39:01.052428
NCT00220116|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2010-01-05|||August 2002||2002-08-01|January 2010|2010-01-01||||||||Interventional|||Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer|A Phase II Trial Assessing the Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer.|Completed||Phase 2|172|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 05:39:01.147177|2017-10-11 05:39:01.147177
NCT00220129|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-12-15|||November 2002||2002-11-01|December 2009|2009-12-01||||||||Interventional|||Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus|Neoadjuvant Epirubicin, Cisplatin and Capecitabine (Xeloda) [ECX] Followed by Definitive Chemoradiation With or Without Surgery for Patients With Newly Diagnosed Localized Squamous Cell Carcinoma of the Oesophagus|Completed||Phase 2|16|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 05:39:01.229993|2017-10-11 05:39:01.229993
NCT00220142|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-05-30|||November 2003||2003-11-01|May 2013|2013-05-01||||||||Observational|||Molecular Markers of Prognosis in Colorectal Cancer Patients|Molecular Markers of Prognosis in Colorectal Cancer Patients|Completed||N/A|103|Actual|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-10-11 05:39:01.310819|2017-10-11 05:39:01.310819
NCT00220155|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2009-12-15|||May 2004||2004-05-01|December 2009|2009-12-01||||||||Interventional|||Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer|A Phase II Trial of Fixed Dose Rate Gemcitabine in Patients With Advanced or Metastatic Colorectal Cancer.|Completed||Phase 2|16|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 05:39:01.507514|2017-10-11 05:39:01.507514
NCT00220168|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-12-15|||January 2003||2003-01-01|December 2009|2009-12-01||||||||Interventional|||Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours|A Phase II Trial Evaluating Irinotecan and Capecitabine in Patients With Relapsed/Refractory Upper Gastrointestinal Tumours|Completed||Phase 4|33|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-10-11 05:39:01.588178|2017-10-11 05:39:01.588178
NCT00220181|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-09-21|||April 2003||2003-04-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Prospective Study in Pelvic Radiotherapy Patients|A Prospective Study to Identify Changes in Nutritional Status and Bowel Symptoms in Patients Receiving a Course of Radical Radiotherapy to the Pelvis for Treatment of Gynaecological, Urological or Rectal Cancer.|Completed||N/A|100||Royal Marsden NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:39:01.691156|2017-10-11 05:39:01.691156
NCT00220194|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-17|2016-10-13|||April 2003||2003-04-01|October 2016|2016-10-01|June 2005||2005-06-01|||||Interventional|||A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer|A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer|Completed||Phase 4|100||San Bernardino Urological Associates Medical Group Inc|||||f||||||||||||||2017-10-11 05:39:01.7696|2017-10-11 05:39:01.7696
NCT00220207|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2007-07-31|||September 2003||2003-09-01|July 2007|2007-07-01|February 2007||2007-02-01|||||Interventional|||Determining the Effect on Patients of Internet-Based Diabetes Disease Management|A Randomized Controlled Trial of Diabetes Disease Management Over the Internet|Completed||N/A|63||Robert Wood Johnson Foundation|||||f||||f||||||||||2017-10-11 05:39:01.842791|2017-10-11 05:39:01.842791
NCT00220220|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-10-10|||April 2005||2005-04-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Amlodipine as Add-on to Olmesartan in Hypertension|Efficacy and Safety of Amlodipine Used as Add-on Therapy in Moderately to Severely Hypertensive Patients Not Adequately Controlled by Olmesartan Medoxomil 20 mg Monotherapy|Completed||Phase 3|429|Anticipated|Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:39:01.919465|2017-10-11 05:39:01.919465
NCT00220233|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-12-12|||April 2005||2005-04-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Olmesartan as an Add-on to Amlodipine in Hypertension|Add-on Study of Olmesartan Medoxomil in Patients With Moderate to Severe Hypertension Not Achieving Target Blood Pressure on Amlodipine 5 mg Alone|Completed||Phase 3|632||Daiichi Sankyo, Inc.|||||f||||||||||||||2017-10-11 05:39:02.018941|2017-10-11 05:39:02.018941
NCT00220246|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2007-02-28|||March 2004||2004-03-01|February 2007|2007-02-01|September 2008||2008-09-01|||||Observational|||Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer||Unknown status|Active, not recruiting|N/A|130||Radboud University|||||f||||||||||||||2017-10-11 05:39:02.114857|2017-10-11 05:39:02.114857
NCT00220259|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-11-07|||May 2001||2001-05-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)|Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)|Completed||N/A|240||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:39:02.190846|2017-10-11 05:39:02.190846
NCT00220454|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-02-26|||December 2002||2002-12-01|February 2007|2007-02-01|March 2005||2005-03-01|||||Interventional|||Effect of Estrogen & Stress for Postmenopausal Women|Effect of Estrogen on the Stress Response for Postmenopausal Women|Completed||Phase 2|40||Seattle Institute for Biomedical and Clinical Research|||||f||||f||||||||||2017-10-11 05:39:03.478774|2017-10-11 05:39:03.478774
NCT00220272|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2008-12-22|||January 2004||2004-01-01|December 2008|2008-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease|A Phase II, Randomized, Multicenter, Multinational, Double-Blind, Placebo-Controlled, Study of the Effect of SR57667B on Dopaminergic Nigro-Striatal Function Assessed by 18F-Dopa PET Imaging in Outpatients With Early Parkinson's Disease|Completed||Phase 2|183|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:39:02.277656|2017-10-11 05:39:02.277656
NCT00220285|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2014-12-29|||August 2004||2004-08-01|December 2014|2014-12-01|October 2005|Actual|2005-10-01|||||Interventional|||Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma|A Phase II Open-label Study of SH L 749 in Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphomas|Completed||Phase 2|45|Actual|Bayer||2|||f||||t||||||||||2017-10-11 05:39:02.380408|2017-10-11 05:39:02.380408
NCT00220298|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2014-12-29|||February 2003||2003-02-01|December 2014|2014-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism|Open One-arm Study to Investigate Safety and Efficacy of Intramuscular Injections of 1000 mg Testosterone Undecanoate (TU) in Hypogonadal Men at Variable Intervals During a 136-week to 192-week Treatment Including Pharmacokinetics|Completed||Phase 3|96|Actual|Bayer||1|||f||||f||||||||||2017-10-11 05:39:02.506661|2017-10-11 05:39:02.506661
NCT00220311|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2013-12-02|||November 2000||2000-11-01|December 2013|2013-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia|A Multicenter Study to Confirm the Efficacy and Safety of Fludara i.v. (Fludarabine Phosphate, SH L 573), Administered in 6 Treatment Cycles (1 Treatment Cycle: 5-consecutive Day Dosing, Followed by an Observation Period of 23 Days) in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia|Completed||Phase 4|10|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 05:39:02.637198|2017-10-11 05:39:02.637198
NCT00220324|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2015-04-02|||February 2004||2004-02-01|April 2015|2015-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Pearl Index Study With Low Dose Combined Oral Contraceptive|Prospective, Multicenter, Open-label, Uncontrolled Study to Investigate the Contraceptive Efficacy, Bleeding Patterns, and Safety of an Oral Contraceptive Containing 0.03 mg Ethinylestradiol and 0.125 mg Levonorgestrel (SH D00342A) Applied for 13 Cycles to Healthy Female Volunteers|Completed||Phase 3|840|Actual|Bayer||1|||f||||f||||||||||2017-10-11 05:39:02.741309|2017-10-11 05:39:02.741309
NCT00220337|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-01|2014-09-19|||December 2004||2004-12-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy|A Multicenter, Open-label Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy|Completed||Phase 3|371|Actual|UCB Pharma||1|||f||||||||||||||2017-10-11 05:39:02.879043|2017-10-11 05:39:02.879043
NCT00220350|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16|||October 2001||2001-10-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Lupron Sex Offender Therapy|Leuprolide Acetate Suppresses Pedophilic Urges and Arousability|Unknown status|Active, not recruiting|Phase 2/Phase 3|10||Schober, Justine, M.D.|||||f||||||||||||||2017-10-11 05:39:02.96527|2017-10-11 05:39:02.96527
NCT00220363|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-04-29|||January 2004||2004-01-01|April 2008|2008-04-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome|A Phase 3, Parallel Group, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled Multicenter Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 05:39:03.036061|2017-10-11 05:39:03.036061
NCT00220376|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-11-21|||April 2004||2004-04-01|November 2008|2008-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome|Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome|Completed||Phase 3|||Pfizer|||||||||||||||||||2017-10-11 05:39:03.101898|2017-10-11 05:39:03.101898
NCT00220389|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-10-15|||June 2003||2003-06-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase|Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder(OAB): a Double-Blind Phase Followed by an Open-Label Extension Phase|Completed||Phase 2|||Pfizer|||||||||||||||||||2017-10-11 05:39:03.167442|2017-10-11 05:39:03.167442
NCT00220402|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2008-11-21|||July 2004||2004-07-01|November 2008|2008-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome|Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-10-11 05:39:03.226966|2017-10-11 05:39:03.226966
NCT00220415|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2014-09-19|||May 2004||2004-05-01|February 2010|2010-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-10-11 05:39:03.277962|2017-10-11 05:39:03.277962
NCT00220428|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-01-23|||July 1998||1998-07-01|January 2007|2007-01-01|December 2007||2007-12-01|||||Interventional|||T-Cell Vaccination in Multiple Sclerosis (MS)|The Effect of T-Cell Vaccination in Multiple Sclerosis - Phase I/II Safety and Efficacy Trial|Unknown status|Recruiting|Phase 1/Phase 2|20||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:39:03.340408|2017-10-11 05:39:03.340408
NCT00220441|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2008-07-29|||July 2004||2004-07-01|July 2008|2008-07-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Cognitive Effects of Aerobic Exercise for IGT Adults|Cognitive Effects of Aerobic Exercise for Adults With Impaired Glucose Tolerance: A Controlled Trial|Completed||Phase 2|40||Seattle Institute for Biomedical and Clinical Research|||||f||||f||||||||||2017-10-11 05:39:03.412668|2017-10-11 05:39:03.412668
NCT00220467|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2008-07-29|||January 2005||2005-01-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Cognitive Effects of Aerobic Exercise for MCI Adults|Cognitive Effects of Aerobic Exercise for Adults With Mild Cognitive Impairment: A Controlled Trial|Completed||Phase 2|40|Anticipated|Seattle Institute for Biomedical and Clinical Research|||||f||||f||||||||||2017-10-11 05:39:03.547133|2017-10-11 05:39:03.547133
NCT00220480|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-02-07|||February 2005||2005-02-01|February 2010|2010-02-01||||June 2011|Anticipated|2011-06-01||Interventional|||A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression||Unknown status|Recruiting|N/A|60|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-10-11 05:39:03.636784|2017-10-11 05:39:03.636784
NCT00220493|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-01-04|||June 2003||2003-06-01|January 2007|2007-01-01|June 2005||2005-06-01|||||Interventional|||Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients|Clinical Study Protocol: Evaluation of the Efficiency of Ritalin in Multiple Sclerosis Patients|Unknown status|Recruiting|Phase 1|80||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:39:03.71861|2017-10-11 05:39:03.71861
NCT00220506|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-02-16|||September 2005||2005-09-01|February 2006|2006-02-01|December 2006||2006-12-01|||||Interventional|||Fatigue Treatment Using Provigil|Fatigue Treatment Using Provigil in Patients With Relapsing Remitting Multiple Sclerosis|Unknown status|Recruiting|N/A|50||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:39:03.790733|2017-10-11 05:39:03.790733
NCT00220519|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-12-21|||October 2004||2004-10-01|September 2005|2005-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Lactobacillus GG Supplementation During Pediatric Burn Injuries|Lactobacillus GG Supplementation During Pediatric Burn Injuries|Terminated||N/A|3|Actual|Shriners Hospitals for Children||1||Study stopped due to low enrollment|f||||t||||||||||2017-10-11 05:39:03.874311|2017-10-11 05:39:03.874311
NCT00220532|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-11|||July 2005||2005-07-01|September 2006|2006-09-01|May 2007||2007-05-01|||||Interventional|||Folate and Protection Against Cervical Cancer|A Randomised Placebo-Controlled Trial to Evaluate Interactions Between Riboflavin and Folate Intake and Genotype in Reducing Risk of Cervical Cancer|Terminated||Phase 1/Phase 2|180||Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:39:03.934484|2017-10-11 05:39:03.934484
NCT00220545|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-10-22|||March 2002||2002-03-01|October 2007|2007-10-01|March 2006||2006-03-01|||||Interventional|||Comparison Between Laparoscopic Ovarian Diathermy and Clomiphene Citrate in Women With Anovulatory PCOS|A Prospective Randomized Controlled Trial to Compare Laparoscopic Ovarian Diathermy With Clomiphene Citrate as a First Line Treatment of Anovulatory Infertility in Patients With Polycystic Ovarian Syndrome|Completed||N/A|72|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:39:04.132581|2017-10-11 05:39:04.132581
NCT00220558|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-12-03|||May 2005||2005-05-01|May 2009|2009-05-01|February 2010|Anticipated|2010-02-01|October 2007|Actual|2007-10-01||Interventional|||GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions|A Randomized Comparison of Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions: The Gruppo Italiano di Studio Sullo Stent Nelle Occlusioni Coronariche. The GISSOC II Study.|Unknown status|Active, not recruiting|Phase 4|150|Actual|Società Italiana di Cardiologia Invasiva||1|||f||||f||||||||||2017-10-11 05:39:04.212091|2017-10-11 05:39:04.212091
NCT00220571|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-07-02|||May 2003||2003-05-01|September 2005|2005-09-01|March 2007|Actual|2007-03-01|||||Interventional|||CARESS in Acute Myocardial Infarction|Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction|Completed||Phase 3|600|Actual|Società Italiana di Cardiologia Invasiva||2|||f||||t||||||||||2017-10-11 05:39:04.405361|2017-10-11 05:39:04.405361
NCT00220584|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2012-12-11|||July 2005||2005-07-01|December 2012|2012-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||An Open-Label Trial of Donepezil in Fragile X Syndrome|An Open-Label Trial of Donepezil in Fragile X Syndrome|Completed||Phase 1|10|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 05:39:04.706278|2017-10-11 05:39:04.706278
NCT00220597|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2013-12-02|||September 1999||1999-09-01|December 2013|2013-12-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse|Group Interventions to Prevent HIV in High Risk Women|Completed||N/A|171|Actual|Stanford University|||||f||||f||||||||||2017-10-11 05:39:04.817704|2017-10-11 05:39:04.817704
NCT00220610|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||May 2004||2004-05-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN the Treatment of DEPRESSION|Right Parietal Inhibition With rTMS in the Treatment of Depression|Unknown status|Recruiting|Phase 2|40||St. Lucas Andreas Ziekenhuis Hospital|||||f||||||||||||||2017-10-11 05:39:04.916063|2017-10-11 05:39:04.916063
NCT00220623|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16|||August 2004||2004-08-01|September 2005|2005-09-01||||||||Interventional|||Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major Depression|Efficacy and Cost-Effectiveness of 18-Months of Antidepressive Medication Plus Either Cognitive-Behavior Therapy or Dynamic Psychotherapy Compared to Supportive Clinical Management for Recurrent Major Depression: a Pilot Study|Unknown status|Recruiting|Phase 3|30||Sir Mortimer B. Davis - Jewish General Hospital|||||f||||||||||||||2017-10-11 05:39:05.01886|2017-10-11 05:39:05.01886
NCT00220636|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2016-04-26|2009-04-15||March 2005||2005-03-01|October 2014|2014-10-01|January 2008|Actual|2008-01-01|March 2007|Actual|2007-03-01||Interventional|||Abilify as an Adjunctive Treatment for Refractory Depression|Abilify (Aripiprazole) as an Adjunctive Treatment for Refractory Unipolar Depression|Completed||Phase 4|15|Actual|St. Luke's-Roosevelt Hospital Center|Open label study without comparison group.|1|||f||||f||||||||||2017-10-11 05:39:05.136553|2017-10-11 05:39:05.136553
NCT00220649|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-08-14|||March 2004||2004-03-01|August 2009|2009-08-01||||||||Interventional|||Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas|Phase I Study to Determine the Safety, Maximum Tolerated Dose, and Efficacy of Biweekly Oxaliplatin (Eloxatin) in Combination With Gemcitabine, Irinotecan, and 5-FU/Leucovorin (G-Flie) in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Exocrine Pancreas|Completed||Phase 1|25|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||t||||||||||2017-10-11 05:39:05.434349|2017-10-11 05:39:05.434349
NCT00220662|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16|||June 2000||2000-06-01|July 2004|2004-07-01|June 2006||2006-06-01|||||Interventional|||The Efficacy of Readiness and Motivation Therapy in Individuals With Anorexia Nervosa and Bulimia Nervosa|The Efficacy of Readiness and Motivation Therapy in Individuals With Anorexia Nervosa and Bulimia Nervosa|Unknown status|Active, not recruiting|Phase 3|100||St. Paul's Hospital, Canada|||||f||||||||||||||2017-10-11 05:39:05.521047|2017-10-11 05:39:05.521047
NCT00220675|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-05-21|||August 2005||2005-08-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Erythropoietin Spinal Cord Compression Randomized Trial|Recombinant Human Erythropoietin (r-HuEPO) in the Prevention of Neurologic Sequelae From Malignant Spinal Cord Compression: a Multi-Center, Placebo-Controlled, Phase 2 Randomized Study|Terminated||Phase 2/Phase 3|7|Actual|Sunnybrook Health Sciences Centre||2||Insufficient accrual|f||||t||||||||||2017-10-11 05:39:05.611852|2017-10-11 05:39:05.611852
NCT00220688|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-10-13|||September 2005||2005-09-01|March 2007|2007-03-01|October 2006||2006-10-01|||||Interventional|||Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients?|Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients?|Completed||N/A|10||Gloucestershire Hospitals NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:39:05.711099|2017-10-11 05:39:05.711099
NCT00220701|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2015-10-13|2014-11-19||June 2002||2002-06-01|November 2007|2007-11-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Escitalopram in the Treatment of Dysthymic Disorder, Double Blind|Double-Blind Placebo-Controlled Study of Escitalopram in the Treatment of Dysthymic Disorder|Completed||Phase 4|36|Actual|St. Luke's-Roosevelt Hospital Center|Small double blinded study with limited power.|2|||f||||f||||||||||2017-10-11 05:39:05.822032|2017-10-11 05:39:05.822032
NCT00220714|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-03-28|||November 2004||2004-11-01|March 2008|2008-03-01|December 2007|Anticipated|2007-12-01|||||Interventional|||PREvent First Episode Relapse (PREFER)|Effectiveness of Long-Acting Risperidone in the Maintenance Treatment of First-Episode Schizophrenia|Unknown status|Active, not recruiting|Phase 4|80||State University of New York - Downstate Medical Center|||||f||||||||||||||2017-10-11 05:39:06.191329|2017-10-11 05:39:06.191329
NCT00220727|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-28|2009-09-24||July 2003||2003-07-01|March 2016|2016-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP|Randomized, Controlled, Open Study Investigating IGIV-C, 10% Given at Different Infusion Rates on Intravascular Hemolysis in Patients With Idiopathic (Immune) Thrombocytopenic Purpura (ITP)|Completed||Phase 2|8|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 05:39:06.29415|2017-10-11 05:39:06.29415
NCT00220740|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-02-23|2009-09-24||April 2004||2004-04-01|February 2016|2016-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|ICE||Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)|Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of IGIV-Chromatography (IGIV-C), 10% Treatment in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy|Completed||Phase 3|117|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 05:39:06.716173|2017-10-11 05:39:06.716173
NCT00220753|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-07-21|||September 2005||2005-09-01|July 2009|2009-07-01|April 2006|Actual|2006-04-01|February 2006|Actual|2006-02-01||Interventional|||Air Cleaners for Children and Adolescents With Asthma and Dog Allergy|Air Cleaners for Children and Adolescents With Asthma and Dog Allergy|Completed||N/A|22|Actual|Sykehuset Innlandet HF||2|||f||||t||||||||||2017-10-11 05:39:07.351251|2017-10-11 05:39:07.351251
NCT00220766|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-09-24|||August 2002||2002-08-01|September 2009|2009-09-01|March 2004|Actual|2004-03-01|August 2002|Actual|2002-08-01||Interventional|||Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients|IGIV-C 10% Rapid Infusion Trial in Primary Immune Deficient Patients|Completed||Phase 3|100|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 05:39:07.444753|2017-10-11 05:39:07.444753
NCT00220779|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-28|2009-09-24||December 2002||2002-12-01|March 2016|2016-03-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|PRIVIG||Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis|Randomized, Double-Blind, Placebo-Controlled Study to Compare the Effects of Different Dose Regimens of IGIV Chromatography (IGIV-C), 10% Treatment on Relapses in Patients With Relapsing Remitting Multiple Sclerosis|Completed||Phase 2|128|Actual|Grifols Therapeutics Inc.||3|||f||||f||||||||||2017-10-11 05:39:07.689823|2017-10-11 05:39:07.689823
NCT00220792|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2005-09-15|||June 1993||1993-06-01|September 2005|2005-09-01|June 1998||1998-06-01|||||Interventional|||Group Therapy for Primary Breast Cancer|A Multicenter Trial of Group Therapy for Breast Cancer|Completed||Phase 3|480||Stanford University|||||f||||||||||||||2017-10-11 05:39:08.576215|2017-10-11 05:39:08.576215
NCT00220805|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-02-22|2009-09-24||January 2004||2004-01-01|February 2016|2016-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional||The intent to treat (ITT) population, which was defined as the primary analysis population, comprised 29 subjects treated with IGIV-C 10% and 24 subjects treated with placebo. A total of 4 subjects were excluded from the ITT population: 1 from IGIV-C 10% and 3 from Placebo.|Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration|Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of IGIV-C, 10% Treatment in Subjects With Pure Occult Choroidal Neovascularization Due to Age Related Macular Degeneration|Completed||Phase 2|96|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-10-11 05:39:08.703585|2017-10-11 05:39:08.703585
NCT00220818|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2010-07-20|||January 2005||2005-01-01|July 2010|2010-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.|A Phase 1, Single- and Repeated-Dose, Randomized, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Lansoprazole in Infants With Clinically-Evident Gastroesophageal Reflux Disease.|Completed||Phase 1|24|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:39:09.355643|2017-10-11 05:39:09.355643
NCT00220831|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-02-28|||April 2005||2005-04-01|February 2007|2007-02-01|December 2009||2009-12-01|||||Interventional|||Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment|Prevention of Diabetic Cardiovascular Complications With Vitamin E 400 IU Treatment to High Risk Patients by Haptoglobin Phenotype (I CARE – Israel Cardiovascular Atherosclerosis Risk and Vitamin E)|Terminated||Phase 2/Phase 3|2000||Technion, Israel Institute of Technology||||interim analysis showed significant differences between two treatment groups|f||||||||||||||2017-10-11 05:39:09.446543|2017-10-11 05:39:09.446543
NCT00220844|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2006-02-08|||September 2005||2005-09-01|September 2005|2005-09-01|September 2007||2007-09-01|||||Interventional|||Tricyclic Antidepressants (TCAs) on Gastric Emptying|Effect of Tricyclic Antidepressant Agents on Gastric Accommodation and Emptying|Unknown status|Recruiting|N/A|60||Temple University|||||f||||||||||||||2017-10-11 05:39:09.539529|2017-10-11 05:39:09.539529
NCT00220857|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-01-02|||September 2005||2005-09-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Rabeprazole Protection of Aspirin Induced Gastric Damage.|Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-Induced Damage by Rabeprazole|Completed||Phase 4|30|Anticipated|Temple University|||||f||||||||||||||2017-10-11 05:39:09.620177|2017-10-11 05:39:09.620177
NCT00220883|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2006-02-06|||August 2005||2005-08-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Observational|||Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients|Reproducibility and Inter-Reader Reliability of Electrogastrographic Readings in Normal Subjects and Dyspeptic Patients|Unknown status|Recruiting|N/A|40||Temple University|||||f||||||||||||||2017-10-11 05:39:09.782327|2017-10-11 05:39:09.782327
NCT00220896|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-09-13|||January 2006||2006-01-01|September 2011|2011-09-01|March 2009|Actual|2009-03-01|||||Interventional|||Prevention of Postoperative Delirium With Donepezil||Completed||Phase 4|37|Actual|Technische Universität München|||||f||||||||||||||2017-10-11 05:39:09.858782|2017-10-11 05:39:09.858782
NCT00220909|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-01-02|||September 2005||2005-09-01|January 2008|2008-01-01|January 2006|Actual|2006-01-01|||||Interventional|||Lansoprazole Preventing Gastroduodenal Stress Ulcerations|A Prospective, Randomized, Double-Blind Protocol to Compare the Efficacy of Lansoprazole to Ranitidine in Healing Pre-Existing and/or Preventing the Development of Gastroduodenal Stress Ulceration and Postoperative Bleeding in Patients Undergoing Elective Coronary Artery Bypass Graft or Cardiac Valve Replacement Surgery|Terminated||Phase 4|40|Anticipated|Temple University||||Recruitment slow|||||||||||||||2017-10-11 05:39:09.921652|2017-10-11 05:39:09.921652
NCT00220922|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2011-04-07|||August 2004||2004-08-01|April 2011|2011-04-01|February 2006|Actual|2006-02-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.|An Open-Label, Randomized, Single Cross-Over Study of Isopropyl Alcohol Wipes Versus No Injection Site Preparation on Local Injection Site Reactions Among Persons With Multiple Sclerosis Who Perform Daily Injections of Copaxone®|Completed||Phase 4|50|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:39:09.988547|2017-10-11 05:39:09.988547
NCT00220935|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-04|||January 2003||2003-01-01|July 2005|2005-07-01|July 2006||2006-07-01|||||Interventional|||A Randomized, Controlled Trial of Treatment for Disc Herniation With Radiating Leg Pain|Orthotrac Pneumatic Vest: A Randomized, Controlled Trial of Treatment for Disc Herniation With Radiating Leg Pain|Completed||N/A|150||Texas Back Institute|||||f||||||||||||||2017-10-11 05:39:10.07245|2017-10-11 05:39:10.07245
NCT00220948|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||August 2004||2004-08-01|July 2005|2005-07-01|March 2006||2006-03-01|||||Interventional|||Large Array EMG Discriminability in Discogenic Low Back Pain|Large Array EMG Discriminability in Discogenic Low Back Pain|Unknown status|Recruiting|N/A|60||Texas Back Institute|||||f||||||||||||||2017-10-11 05:39:10.146591|2017-10-11 05:39:10.146591
NCT00220961|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2016-06-29|2016-02-17||January 2004||2004-01-01|June 2016|2016-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Actos Now for Prevention of Diabetes (ACT NOW)|Actos Now for Prevention of Diabetes (ACT NOW)|Completed||Phase 3|602|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||||||||||||2017-10-11 05:39:10.224957|2017-10-11 05:39:10.224957
NCT00220974|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-11|||October 2004||2004-10-01|February 2009|2009-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study to Assess if Internet-Based Tailored Advice Could Modify Behaviour to Improve Health|Internet-Based Cholesterol Assessment Trial|Completed||N/A|3708|Anticipated|The George Institute|||||f||||||||||||||2017-10-11 05:39:10.578647|2017-10-11 05:39:10.578647
NCT00220987|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-27|||April 2005||2005-04-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE - SUGAR STUDY)|A Multi-Center, Open Label Randomized Stratified Controlled Trial of the Effects of Blood Glucose Management on 90-Day All-Cause Mortality in a Heterogenous Population of Intensive Care Unit (ICU) Patients.|Completed||Phase 4|6104|Actual|The George Institute||2|||f||||t||||||||||2017-10-11 05:39:10.653277|2017-10-11 05:39:10.653277
NCT00221000|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-18|||August 2003||2003-08-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|RA-1||Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis|"A Phase II, Multicenter, Randomized, Double-blind, Sham Pheresis-controlled, Study of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis in Patients Who Have an Inadequate Response to Disease Modifying Antirheumatic Drugs and Biological Agents"|Completed||Phase 2|86|Actual|Mallinckrodt||3|||f||||f||||||||||2017-10-11 05:39:10.769368|2017-10-11 05:39:10.769368
NCT00221013|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-02-25|||November 2005||2005-11-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).|Multicentre, Unblinded, Open Label, Randomised, Controlled Trial to Assess the Effect of Augmented Vs. Normal Continuous Renal Replacement Therapy (CRRT) on 90-Day All-Cause Mortality of Intensive Care Unit Patients With Severe Acute Renal Failure (ARF).|Completed||Phase 4|1508|Actual|The George Institute||2|||f||||t||||||||||2017-10-11 05:39:10.903738|2017-10-11 05:39:10.903738
NCT00221026|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-10-18|||December 2004||2004-12-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease|A Multicenter, Open-Label, Study of Extracorporeal Photoimmune Therapy With UVADEX in the Treatment of Patients With Moderately Active Crohn's Disease Who Are Refractory or Intolerant to Immunosuppressants and/or Anti-TNF Agents|Completed||Phase 2|25|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-11 05:39:10.998352|2017-10-11 05:39:10.998352
NCT00221039|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-23|||September 2004||2004-09-01|May 2016|2016-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A|UVADEX Sterile Solution in Conjunction With the UVAR XTS Photopheresis System as an Interventional Therapy for the Treatment Of CTCL (Mycosis Fungoides) in Patients With TMN Classification Stage 1A, 1B, 2A|Completed||Phase 4|19|Actual|Mallinckrodt||1|||f||||f||||||||||2017-10-11 05:39:11.116285|2017-10-11 05:39:11.116285
NCT00221052|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-10-10|||June 2005||2005-06-01|October 2006|2006-10-01|July 2005||2005-07-01|||||Interventional|||Effect of Reduction of Inflammatory Status on Glucose Metabolism in Overweight Men|Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men|Completed||N/A|20||TNO|||||f||||||||||||||2017-10-11 05:39:11.208759|2017-10-11 05:39:11.208759
NCT00221065|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-04|||June 2005||2005-06-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effect of Continuous Positive Airway Pressure (CPAP) on Cognitive and Functional Performance in Stroke Patients With Obstructive Sleep Apnea|Influence of CPAP on Cognitive Function and Outcome of Stroke Patients With Obstructive Apnea|Completed||Phase 3|60|Anticipated|Toronto Rehabilitation Institute||2|||f||||f||||||||||2017-10-11 05:39:11.262941|2017-10-11 05:39:11.262941
NCT00221078|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-02-04|||April 2003||2003-04-01|February 2009|2009-02-01|December 2005|Actual|2005-12-01|June 2005|Actual|2005-06-01||Interventional|||Benefits of Applying Neuroprosthesis for Improving Reaching and Grasping Functions in Stroke Patients|Restoration of Reaching and Grasping Functions in Stroke Patients Using Functional Electrical Stimulation.|Completed||Phase 3|40|Actual|Toronto Rehabilitation Institute||1|||f||||t||||||||||2017-10-11 05:39:11.353419|2017-10-11 05:39:11.353419
NCT00221091|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-06|||September 2004||2004-09-01|February 2009|2009-02-01|October 2005||2005-10-01|||||Interventional|||Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus|Clinical Study of Idiopathic Normal Pressure Hydrocephalus for Neurological Improvement|Completed||Phase 2|110||Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||||||||||||2017-10-11 05:39:11.549898|2017-10-11 05:39:11.549898
NCT00221130|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-06|||July 2004||2004-07-01|February 2009|2009-02-01|December 2005||2005-12-01|||||Interventional|||Clinical Trials of Regeneration for Periodontal Tissue|Clinical Trial of Regenerative Periodontal Tissue by Transplanting Mesenchymal Stem Cells and Osteoblast Cells - I, II Phase-|Completed||Phase 1/Phase 2|10||Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||||||||||||2017-10-11 05:39:11.80994|2017-10-11 05:39:11.80994
NCT00221143|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-06|||November 2003||2003-11-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|||||Interventional|||Stem Cell Study for Patients With Leg Ulcer/Gangrene|Phase I / II Clinical Trial Regarding Vascular Regeneration Therapy by Transplantation of Autologous Peripheral Blood Endothelial Progenitor Cells (CD34+ Cells) in No-Option Patients With Chronic Critical Limb Ischemia|Completed||Phase 1/Phase 2|15|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||t||||||||||2017-10-11 05:39:11.877311|2017-10-11 05:39:11.877311
NCT00221156|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-06-23|||May 2005||2005-05-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|||||Interventional|||Acarbose and Secondary Prevention After Coronary Stenting|Effects of Acarbose Long-Term Therapy on Prevention of Cardiovascular Events in Abnormal Glucose Tolerance With Coronary Artery Disease (ALERT Study)|Completed||Phase 3|300|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||||||||||||2017-10-11 05:39:11.963673|2017-10-11 05:39:11.963673
NCT00221169|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-04|||October 2005||2005-10-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer|Can PET CT Coregistration Imaging Adequately Determine the Gross Tumor Volume and Microscopic Extension in Non-Small Cell Lung Cancer Patients for Radical Radiation Therapy?|Completed||Early Phase 1|31|Actual|Toronto Sunnybrook Regional Cancer Centre||1|||f||||f||||||||||2017-10-11 05:39:12.051503|2017-10-11 05:39:12.051503
NCT00221182|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-21|||September 2005||2005-09-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Stem Cell Study for Patients With Heart Disease|Phase I / II Clinical Trial Regarding Vascular Regeneration Therapy by Transplantation of Autologous Peripheral Blood Endothelial Progenitor Cells (CD34+ Cells) in No-Option Patients With Chronic Myocardial Ischemia|Terminated||Phase 1/Phase 2|1|Actual|Foundation for Biomedical Research and Innovation||1||slow recruitment of the study subjects|f||||||||||||||2017-10-11 05:39:12.155815|2017-10-11 05:39:12.155815
NCT00221195|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-12-12|2016-12-12||June 2003||2003-06-01|December 2016|2016-12-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|ProFEIBA||Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors|A Prospective, Randomized, Cross-over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients With Hemophilia A and Inhibitors|Completed||Phase 2/Phase 3|34|Actual|Tulane University|One limitation was the relatively short duration; in addition, due to the small number of children enrolled, it is not possible to draw conclusions regarding the relationship of age and the benefits of prophylaxis.|2|||f||||||||||||||2017-10-11 05:39:12.259041|2017-10-11 05:39:12.259041
NCT00221208|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-16|||April 2005||2005-04-01|March 2009|2009-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Home Based Resistance Training For Type 2 Diabetes|A Home Based Resistance Training Program for Obese Adults With Type 2 Diabetes|Completed||Phase 1|54||University of Alberta, Physical Education|||||f||||||||||||||2017-10-11 05:39:12.746123|2017-10-11 05:39:12.746123
NCT00221221|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-05-02|||July 2005||2005-07-01|May 2007|2007-05-01|March 2006||2006-03-01|||||Interventional|||Physical Activity Promotion in Breast Cancer Survivors|Physical Activity Promotion in Breast Cancer Survivors: A Population Based Randomized Controlled Trial|Completed||Phase 2/Phase 3|300||University of Alberta, Physical Education|||||f||||||||||||||2017-10-11 05:39:12.803961|2017-10-11 05:39:12.803961
NCT00221234|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-03-13|||September 2005||2005-09-01|March 2009|2009-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Alberta Diabetes and Physical Activity Trial|The Development and Evaluation of Physical Activity Behavioural Strategies for Adults With Type 2 Diabetes: A Population Based Approach|Completed||Phase 2|300|Anticipated|University of Alberta, Physical Education|||||f||||||||||||||2017-10-11 05:39:12.867681|2017-10-11 05:39:12.867681
NCT00221247|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-13|||October 2004||2004-10-01|May 2016|2016-05-01|October 2008|Actual|2008-10-01|March 2008|Actual|2008-03-01||Interventional|||Acupuncture as Complementary Therapy for Cerebral Palsy|Acupuncture as Complementary Therapy for Cerebral Palsy|Completed||Phase 2|75|Actual|University of Arizona||2|||f||||f||||||||||2017-10-11 05:39:12.927325|2017-10-11 05:39:12.927325
NCT00221260|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2008-09-24|||September 2005||2005-09-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Perioperative Epidural Trial (POET) Pilot Study|Perioperative Epidural Trial (POET) Pilot Study|Completed||N/A|250|Anticipated|University of British Columbia||1|||f||||||||||||||2017-10-11 05:39:13.003887|2017-10-11 05:39:13.003887
NCT00232999|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2012-07-03|||October 2005||2005-10-01|September 2008|2008-09-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma||Completed||Phase 2|15|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-10-11 05:43:42.181204|2017-10-11 05:43:42.181204
NCT00221273|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2017-03-01|||December 2010||2010-12-01|March 2017|2017-03-01|May 18, 2012|Actual|2012-05-18|May 18, 2012|Actual|2012-05-18||Interventional|||Use of Graft Tensioner Device in ACL (Knee) Repair|Randomized Clinical Trial to Assess the Clinical Effectiveness of a Measured Objective Tensioning in Hamstring ACL Reconstruction|Completed||N/A|130|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:39:13.07247|2017-10-11 05:39:13.07247
NCT00221286|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-02-17|||September 2004||2004-09-01|February 2009|2009-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients|Pegylated Interferon Alfa-2a Versus Emtricitabine / Tenofovir +/- Pegylated Interferon Alfa-2a for the Treatment of Chronic HBe-Ag Positive Hepatitis B Infection in HIV-Coinfected Patients - the PEGPLUS Trial|Terminated||Phase 3|2|Actual|University Hospital, Bonn||3||Lack of accrual|f||||f||||||||||2017-10-11 05:39:13.125116|2017-10-11 05:39:13.125116
NCT00221299|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-06-02|2014-01-23||September 2005||2005-09-01|June 2015|2015-06-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional||Study subjects were men and women, greater than 18 years of age with a history of glucocorticoid therapy with prednisone >= 7.5gm a day for 6 months and currently on prednisone or equivalent >= 5mg/day.|Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use|Can Risedronate and Parathyroid Hormone Reverse Glucocorticoid Induced Osteoporosis?|Completed||Phase 4|60|Actual|University of California, Davis||4|||f||||f||||||||||2017-10-11 05:39:13.22299|2017-10-11 05:39:13.22299
NCT00221312|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2008-05-05|||May 2002||2002-05-01|May 2005|2005-05-01|July 2007|Actual|2007-07-01|||||Observational|||Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss|Alendronate to Prevent Perimenopausal Transition Bone Loss|Completed||N/A|48|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-10-11 05:39:13.500335|2017-10-11 05:39:13.500335
NCT00221325|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-02-12|||April 2007||2007-04-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|January 2012|Actual|2012-01-01||Interventional|||A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma|Phase I Study of Intraventricular Administration of Rituximab in Combination With Methotrexate in the Treatment of Recurrent CNS and Intraocular Lymphoma|Completed||Phase 1|14|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 05:39:13.584778|2017-10-11 05:39:13.584778
NCT00221338|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2015-07-14|||January 2006||2006-01-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Clinical Trial of Gabapentin to Improve Postoperative Pain in Surgical Patients|Clinical Trial of Gabapentin to Improve Postoperative Pain in Surgical Patients|Completed||Phase 3|750|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 05:39:13.695691|2017-10-11 05:39:13.695691
NCT00221351|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2011-05-20|||October 2005||2005-10-01|May 2011|2011-05-01|July 2006|Actual|2006-07-01|March 2006|Actual|2006-03-01||Interventional|||C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough|A Randomized, Controlled Trial of a C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough Illness in the Emergency Department|Completed||N/A|139|Actual|University of California, San Francisco|||||f||||||||||||||2017-10-11 05:39:13.786255|2017-10-11 05:39:13.786255
NCT00221364|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-07-13|||March 2003||2003-03-01|July 2015|2015-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|TEF||Trachoma Elimination Follow-up|Trachoma Elimination With Repeated Mass Azithromycin Treatments|Completed||Phase 4|20000|Anticipated|University of California, San Francisco|||||f||||t||||||||||2017-10-11 05:39:13.869017|2017-10-11 05:39:13.869017
NCT00221377|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-05-16|||April 2005||2005-04-01|December 2011|2011-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||"Cuffed Versus Uncuffed Tracheal Tubes in Small Children"|"Cuffed Versus Uncuffed Tracheal Tubes in Small Children"|Completed||N/A|4000|Anticipated|University Children's Hospital, Zurich|||||f||||||||||||||2017-10-11 05:39:13.963354|2017-10-11 05:39:13.963354
NCT00221390|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-10-28|||October 2003||2003-10-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|February 2007|Actual|2007-02-01||Interventional|||Trial of Ropinirole in Motor Recovery After Stroke|Randomized, Placebo-controlled, Double-blind Pilot Trial to Evaluate the Safety and Efficacy of Ropinirole in Motor Recovery After Stroke|Completed||Phase 2|52|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-10-11 05:39:14.141263|2017-10-11 05:39:14.141263
NCT00221403|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-06-24|||September 2004||2004-09-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders|Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders|Completed||Phase 3|46|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 05:39:14.256575|2017-10-11 05:39:14.256575
NCT00221416|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-06-26|||June 2005||2005-06-01|June 2013|2013-06-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder|An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder|Completed||Phase 3|30|Anticipated|University of Cincinnati||1|||f||||f||||||||||2017-10-11 05:39:14.359109|2017-10-11 05:39:14.359109
NCT00221429|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-02-22|||March 2001||2001-03-01|November 2002|2002-11-01||||||||Interventional|||Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder|Pediatric Bipolar Collaborative Mood Stabilizer Trial|Unknown status|Active, not recruiting|Phase 3|154||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-10-11 05:39:14.450263|2017-10-11 05:39:14.450263
NCT00221442|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-06-21|||August 2005||2005-08-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity|Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity: A Single Center, Double-Blind, Placebo-controlled, Flexible-Dose Study in Outpatients|Completed||Phase 3|60|Actual|Lindner Center of HOPE||2|||f||||||||||||||2017-10-11 05:39:14.544561|2017-10-11 05:39:14.544561
NCT00221455|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-07-25|||September 2004||2004-09-01|July 2011|2011-07-01|September 2007|Actual|2007-09-01|||||Interventional|||The Potential of Technology to Improve Chronic Disease Management and Quality of Care|The Potential of Technology to Improve Chronic Disease Management and Quality of Care|Completed||Phase 1|1000|Anticipated|Robert Wood Johnson Foundation|||||f||||||||||||||2017-10-11 05:39:14.664002|2017-10-11 05:39:14.664002
NCT00221468|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2012-07-17|||June 2003||2003-06-01|March 2007|2007-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents|A Single-Blind Prospective Study of Quetiapine for the Treatment of Mood Disorders in Adolescents|Completed||Phase 3|20|Actual|University of Cincinnati||1|||f||||||||||||||2017-10-11 05:39:14.767823|2017-10-11 05:39:14.767823
NCT00221481|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-29||||||February 2009|2009-02-01|March 2006||2006-03-01|||||Interventional|||An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder|An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder|Withdrawn||Phase 4|0|Actual|Mayo Clinic||||Lack of recruitment|f||||||||||||||2017-10-11 05:39:14.86828|2017-10-11 05:39:14.86828
NCT00221494|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-29|||January 2004||2004-01-01|June 2006|2006-06-01||||June 2006|Actual|2006-06-01||Interventional|||Can Additional Drug Therapy Accelerate Response Time to Antidepressants|Can Additional Drug Therapy Accelerate Response Time to Antidepressants: A Double-blind, Placebo-controlled Randomization Research Study for Major Depression|Withdrawn||Phase 4|0|Actual|Mayo Clinic||||PI move|f||||t||||||||||2017-10-11 05:39:14.934524|2017-10-11 05:39:14.934524
NCT00221507|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-07-17|||February 2004||2004-02-01|January 2007|2007-01-01|June 2007||2007-06-01|||||Interventional|||Increasing Infant Preventive Health Service Delivery in an Inner City Population|Increasing Infant Preventive Health Service Delivery in an Inner City Population|Unknown status|Recruiting|N/A|800|Anticipated|University of Colorado, Denver|||||f||||||||||||||2017-10-11 05:39:15.010967|2017-10-11 05:39:15.010967
NCT00221520|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2007-01-09|||February 2003||2003-02-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Sedation in the Intensive Care Unit|Trial on The Efficacy of Sedation in Mechanically Ventilated Critically Ill Patients|Unknown status|Active, not recruiting|Phase 3|126||University Hospital, Geneva|||||f||||||||||||||2017-10-11 05:39:15.09668|2017-10-11 05:39:15.09668
NCT00221533|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-19|||March 2004||2004-03-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Observational|||Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients|Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients|Completed||N/A|250||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:39:15.167495|2017-10-11 05:39:15.167495
NCT00221546|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-09-27|||September 2007||2007-09-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis|Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis|Completed||Phase 2|17|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-10-11 05:39:15.229477|2017-10-11 05:39:15.229477
NCT00221559|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2006-05-07|||September 2004||2004-09-01|May 2006|2006-05-01||||||||Observational|||Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group|Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group|Completed||N/A|0||University Hospital, Ghent|||||f||||||||||||||2017-10-11 05:39:15.309659|2017-10-11 05:39:15.309659
NCT00221572|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2014-12-04|||July 2005||2005-07-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis|Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Ghent|||1||f||||f||||||||||2017-10-11 05:39:15.380246|2017-10-11 05:39:15.380246
NCT00221585|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2006-11-06|||October 1997||1997-10-01|July 1997|1997-07-01|July 2005||2005-07-01|||||Observational|||The National Danish Schizophrenia Project||Unknown status|Active, not recruiting|N/A|||University of Copenhagen|||||f||||||||||||||2017-10-11 05:39:15.493914|2017-10-11 05:39:15.493914
NCT00221598|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-04|||June 2005||2005-06-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency|Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-10-11 05:39:15.569822|2017-10-11 05:39:15.569822
NCT00221611|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-12-19|||January 2000||2000-01-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity|Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity|Completed||Phase 2|80||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:39:15.658478|2017-10-11 05:39:15.658478
NCT00215735|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-03-16|||June 2004||2004-06-01|March 2012|2012-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Effect of Platelet Concentrate in Treatment of Diabetic Ulcers|Clinical Evaluation of the Safety and Effectiveness of Harvest Autologous Platelet Concentrate and Autologous Thrombin for Treatment of Lower Extremity Chronic Diabetic Ulcers|Terminated||N/A|||Harvest Technologies||1||inconclusive results, market feasiblity|f||||||||||||||2017-10-11 05:39:15.729061|2017-10-11 05:39:15.729061
NCT00215748|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-11-15|||August 2004||2004-08-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel|Feasibility of A Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Treated With Weekly Docetaxel|Terminated||Phase 2|40|Anticipated|Geriatric Oncology Consortium||||slow accrual|f||||||||||||||2017-10-11 05:39:15.84468|2017-10-11 05:39:15.84468
NCT00215761|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-09-07|||January 2005||2005-01-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Observational|||Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug Therapy|A Multicenter Study to Investigate Preventive Pacing in Combination With Antiarrhythmic Beta-Blocker Oder AT-I-/ACE-inhibitor Therapy on the Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers|Completed||N/A|263|Actual|German Atrial Fibrillation Network|||1||f||||||||||||||2017-10-11 05:39:15.9401|2017-10-11 05:39:15.9401
NCT00215774|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-09-10|||March 2005||2005-03-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|October 2009|Actual|2009-10-01||Interventional|||Flecainide-Short Long Study (Flec-SL)|Targeted Pharmacological Reversal of Electrical Remodeling After Cardioversion.|Completed||N/A|760|Actual|German Atrial Fibrillation Network||3|||f||||t||||||||||2017-10-11 05:39:16.013538|2017-10-11 05:39:16.013538
NCT00215787|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2010-09-21|2010-08-10||September 2005||2005-09-01|September 2010|2010-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease|Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease|Completed||N/A|20|Actual|Head and Neck Surgery Associates||1|||f||||t||||||||||2017-10-11 05:39:16.128556|2017-10-11 05:39:16.128556
NCT00215800|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-04-16|||December 1998||1998-12-01|April 2013|2013-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome|A Multi-center, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Poly I:Poly C12U (Ampligen®) 400 mg IV Twice Weekly Versus Placebo in Patients With Severely Debilitating Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME)|Completed||Phase 3|234||Hemispherx Biopharma|||||f||||f||||||||||2017-10-11 05:39:16.443965|2017-10-11 05:39:16.443965
NCT00215813|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-07-21|||March 1997||1997-03-01|July 2017|2017-07-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Interventional|||Ampligen in Chronic Fatigue Syndrome|An Open-Label Study Of Poly I:Poly C12U (AMPLIGEN®) in Patients With Severely Debilitating Chronic Fatigue Syndrome (CFS)|Active, not recruiting||Phase 3|100|Anticipated|Hemispherx Biopharma||1|||f||||f||||||||||2017-10-11 05:39:16.625135|2017-10-11 05:39:16.625135
NCT00215826|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-04-16|||November 2004||2004-11-01|April 2013|2013-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers|A Randomized, Dose-ranging Study of Alferon® LDO {Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)} in Normal Volunteers and/or Asymptomatic Subjects With Exposure to a Person Known to Have SARS or Possible SARS|Completed||Phase 2|10|Actual|Hemispherx Biopharma||2|||f||||f||||||||||2017-10-11 05:39:16.753945|2017-10-11 05:39:16.753945
NCT00215839|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-10-24||||||September 2005|2005-09-01||||||||Interventional|||HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy|A Multi-Center, Randomized, Open-Label, Phase IIIb Study Investigating the Safety and Efficacy of Peginterferon a-2a Plus Ribavirin for the Treatment of Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy|Unknown status|Active, not recruiting|Phase 3|||Hepatitis Resource Network|||||||||||||||||||2017-10-11 05:39:16.881852|2017-10-11 05:39:16.881852
NCT00215852|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-08-27||2013-08-27|July 2005||2005-07-01|August 2013|2013-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects|A Randomized, Dose-Ranging Study of Alferon® LDO [Low Dose Interferon Alfa-n3 (Human Leukocyte Derived)] in Asymptomatic HIV+ Subjects|Terminated||Phase 2|17|Actual|Hemispherx Biopharma||3|||f||||f||||||||||2017-10-11 05:39:16.982719|2017-10-11 05:39:16.982719
NCT00215865|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-09-20||||||September 2005|2005-09-01||||||||Interventional|||PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy|HRN 003PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy|Completed||Phase 3|600||Hepatitis Resource Network|||||||||||||||||||2017-10-11 05:39:17.098735|2017-10-11 05:39:17.098735
NCT00215878|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2012-07-05|||August 2003||2003-08-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||D-serine for Posttraumatic Stress Disorder Treatment|D-serine for Posttraumatic Stress Disorder Treatment|Completed||Phase 2|22|Actual|Herzog Hospital||2|||f||||t||||||||||2017-10-11 05:39:17.179738|2017-10-11 05:39:17.179738
NCT00215891|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-10-24||||||September 2005|2005-09-01||||||||Interventional|||PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon|PEG-Interferon a-2b + Ribavirin for Treatment of Chronic Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon|Completed||Phase 3|300||Hepatitis Resource Network|||||||||||||||||||2017-10-11 05:39:17.278191|2017-10-11 05:39:17.278191
NCT00215904|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2012-07-05|||August 2003||2003-08-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||D-serine Adjuvant Treatment for Parkinson's Disease|D-serine Adjuvant Treatment for Parkinson's Disease|Completed||Phase 4|13|Actual|Herzog Hospital||2|||f||||t||||||||||2017-10-11 05:39:17.372821|2017-10-11 05:39:17.372821
NCT00215917|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2006-05-01||||||May 2006|2006-05-01||||||||Interventional|||D-Serine Monotherapy for Schizophrenia||Unknown status|Recruiting|Phase 1/Phase 2|40||Herzog Hospital|||||f||||||||||||||2017-10-11 05:39:17.483461|2017-10-11 05:39:17.483461
NCT00215930|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2017-02-20|2010-10-08||February 2004||2004-02-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer|Phase II Study on the Use of Molecular Analyses-Based Customized Chemotherapy in Patients With Stage IV/IIIB (Malignant Pleural Effusion) Non-Small-Cell Lung Cancer (NSCLC)|Completed||Phase 2|53|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 05:39:17.592044|2017-10-11 05:39:17.592044
NCT00215943|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-04-01|2013-08-21||June 2003||2003-06-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)|Phase III Randomized Trial of Thalidomide/Dexamethasone vs VAD as Induction Chemotherapy for Newly Diagnosed Myeloma Patients and Evaluation of the Effects of Zoledronate on Chemotherapy Induced Apoptosis and Antigen Presentation.|Terminated||Phase 3|90|Actual|H. Lee Moffitt Cancer Center and Research Institute|Target accrual for planned analysis (176) was not met. Principal Investigator (PI) determined study must close due to changes in the management of newly diagnosed myeloma (emergence of new drugs, more effective regimens).|2||"Poor accrual, changes in management of newly diagnosed myeloma patients, new drugs/more   effective regimens."|f||||t||||||||||2017-10-11 05:39:18.015911|2017-10-11 05:39:18.015911
NCT00215956|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-12-20|||November 2001||2001-11-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma|A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma|Completed||Phase 1|31|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||||||||||||2017-10-11 05:39:18.741825|2017-10-11 05:39:18.741825
NCT00215969|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-02-01|||January 2004||2004-01-01|September 2005|2005-09-01|October 2007||2007-10-01|||||Observational|||Prospective Study in Pregnant Women With Hypercoagulopathy|Prospective Study of Hypercoagulation in Pregnant Women|Unknown status|Recruiting|N/A|600||Hillerod Hospital, Denmark|||||f||||||||||||||2017-10-11 05:39:18.872659|2017-10-11 05:39:18.872659
NCT00215982|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-11-21|||December 2004||2004-12-01|September 2010|2010-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer|A Phase II Study of Capecitabine in Combination With Irinotecan and Oxaliplatin (Eloxatin) in Adult Patients With Advanced Colorectal Cancer|Completed||Phase 2|24|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 05:39:18.973461|2017-10-11 05:39:18.973461
NCT00215995|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2012-01-12|||July 2003||2003-07-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas|A Phase II Study of Cisplatin and Irinotecan Induction Chemotherapy, Followed by ZD 1839 (IRESSA) in Adult Patients With Surgically Unresectable and/or Metastatic Esophageal or Gastric Carcinomas|Completed||Phase 2|21|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 05:39:19.091882|2017-10-11 05:39:19.091882
NCT00216008|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-11-21|||July 2005||2005-07-01|July 2009|2009-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.|Phase II Pharmacogenomic Study of Neoadjuvant Pre-irradiation Docetaxel and Cisplatin, Followed by Neoadjuvant Concomitant Docetaxel, Cisplatin and Irradiation, Followed by Surgery (CD-CDR-S) in Adult Patients With Operable Adenocarcinomas of the Esophagus or Gastroesophageal Junction|Terminated||Phase 2|42||H. Lee Moffitt Cancer Center and Research Institute||||IRB Closure|f||||||||||||||2017-10-11 05:39:19.218551|2017-10-11 05:39:19.218551
NCT00216021|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-12-08|||March 2004||2004-03-01|December 2015|2015-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer|A Phase II Trial of Capecitabine and Oxaliplatin (CAPOX) in Patients With Metastatic Breast Cancer: Hoosier Oncology Group BRE03-60|Completed||Phase 2|25|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-10-11 05:39:19.324604|2017-10-11 05:39:19.324604
NCT00216034|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-18|2016-06-06|||March 2005||2005-03-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK|Randomized Multicenter Controlled Phase III Study of Postoperative Adjuvant Therapy for Stage II/IIIA Gastric Cancer Using TS-1 Alone or TS-1+PSK Combined Therapy|Completed||Phase 3|255|Actual|Hokuriku-Kinki Immunochemotherapy Study Group||2|||f||||t||||||||||2017-10-11 05:39:19.439179|2017-10-11 05:39:19.439179
NCT00216047|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-12-08|||January 2005||2005-01-01|December 2015|2015-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer|A Phase I/II Study of PTK787 in Combination With Trastuzumab in Patients With Newly Diagnosed HER2 Overexpressing Locally Recurrent or Metastatic Breast Cancer: Hoosier Oncology Group Trial BRE04-80|Terminated||Phase 1/Phase 2|7|Actual|Hoosier Cancer Research Network||1||Low patient enrollment; toxicities|f||||t||||||||||2017-10-11 05:39:19.633452|2017-10-11 05:39:19.633452
NCT00221624|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-12|||November 2001||2001-11-01|June 2007|2007-06-01|April 2004|Actual|2004-04-01|||||Interventional|PEGARI||Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients|Randomized Placebo-Controlled Trial of a Triple Therapy Combining Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine Versus Peginterferon Alfa-2a Plus Ribavirin Plus Placebo in Hepatitis C-Infected Patients Non Responders to a First-Line Therapy of Interferon and Ribavirin|Completed||Phase 3|131|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 05:39:19.742345|2017-10-11 05:39:19.742345
NCT00221637|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-12|||March 2002||2002-03-01|June 2007|2007-06-01|July 2005|Actual|2005-07-01|||||Interventional|||Efficacy of Valproate in Peripheral Neuropathic Pain|Efficacy of a Therapeutic Strategy in Peripheral Neuropathic Pain: Intravenous Sodium Valproate Followed by Oral Route Treatment Versus Placebo (Clinical and Neurophysiologic Evaluation)|Terminated||Phase 2/Phase 3|40|Actual|University Hospital, Bordeaux||2||slow recruitment and treatments beyond expiry date|f||||t||||||||||2017-10-11 05:39:19.831274|2017-10-11 05:39:19.831274
NCT00221650|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-12|||April 2002||2002-04-01|June 2007|2007-06-01|June 2004|Actual|2004-06-01|||||Interventional|ROCO2||Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients|Efficacy and Safety of Peginterferon alfa2a and Ribavirin for the Second Line Treatment of Chronic Hepatitis C in HIV Infected Patients Previously Non Responders to a First Anti-HCV Treatment|Completed||Phase 2|17|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-10-11 05:39:19.916754|2017-10-11 05:39:19.916754
NCT00221663|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-08-14|||January 2002||2002-01-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|January 2002|Actual|2002-01-01||Interventional|||Conventional Versus Mini-Sternotomy for Aortic Valve Surgery|Clinical Trial Comparing a Conventional Median Sternotomy Versus a Minimally Invasive Technique for Aortic Valvular Replacement in Adults|Terminated||Phase 2/Phase 3|78|Actual|University Hospital, Bordeaux||2||slow recruitment|f||||t||||||||||2017-10-11 05:39:20.082378|2017-10-11 05:39:20.082378
NCT00221676|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-11-27|||July 2002||2002-07-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Interventional|||Effectiveness of Influenza Vaccination Among General Practitioners|Effectiveness of Influenza Vaccination (Alfarix)in Preventing Clinical Influenza Cases Among General Practitioners: Non-Randomized Clinical Trial.|Completed||Phase 4|300||University Hospital, Antwerp|||||f||||||||||||||2017-10-11 05:39:20.182694|2017-10-11 05:39:20.182694
NCT00221689|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-12|||March 2003||2003-03-01|June 2007|2007-06-01|February 2004|Actual|2004-02-01|||||Interventional|||Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients|Early Treatment of Paroxysmal Dysautonomia and Hypertonia for Severe Brain Injured Patients by Intrathecal Baclofen Therapy|Terminated||Phase 2|4|Actual|University Hospital, Bordeaux||2||very slow recruitment and treatments beyond expiry date|f||||t||||||||||2017-10-11 05:39:20.239416|2017-10-11 05:39:20.239416
NCT00221702|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-10-12|||June 2003||2003-06-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|EADO||PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)|Randomized, Multicenter Phase III Trial Comparing Adjuvant Treatment With PegIntron Over 36 Months Versus Reference Treatment With IntronA Over 18 Months in Cutaneous Melanoma Patients AJCC Stage II (>=1.5 mm Clinically Node Negative)|Completed||Phase 3|898|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 05:39:20.324112|2017-10-11 05:39:20.324112
NCT00229190|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2007-04-23|||September 2004||2004-09-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Interventional|||Nasal Lavage Study: Comparing Single Versus Multi Sample Lavages|Reproducibility of Cell Counts in Nasal Lavage: A Comparison of Pooled Versus Non-Pooled Nasal Lavage Samples|Completed||N/A|21||McMaster University|||||f||||f||||||||||2017-10-11 05:40:49.494214|2017-10-11 05:40:49.494214
NCT00221715|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-05-07|||July 2002||2002-07-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|REVA||Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous Vein|Randomised Study Comparing Prosthesis and Autologous Vein for Revascularisation With Above Knee Femoropopliteal Bypass.|Completed||N/A|100|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 05:39:20.436355|2017-10-11 05:39:20.436355
NCT00221728|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-27|||April 2005||2005-04-01|May 2010|2010-05-01|January 2008|Anticipated|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors|Treatment of Renal Tumors With Radiofrequency: Efficacy Evaluation in Comparison With Conservative Surgery (Multicentric Randomized Trial)|Terminated||Phase 2/Phase 3|160|Anticipated|University Hospital, Bordeaux||2||lack of patients|f||||t||||||||||2017-10-11 05:39:20.527968|2017-10-11 05:39:20.527968
NCT00221741|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-17|||February 2004||2004-02-01|March 2015|2015-03-01|March 2006|Actual|2006-03-01|||||Observational|PLASMACARD||Fresh Frozen Plasma in Cardiac Surgery: Descriptive and Prognostic Study|PLASMACARD - Fresh Frozen Plasma in Cardiac Surgery: Descriptive and Prognostic Study|Completed||N/A|1497|Actual|University Hospital, Bordeaux|||||f||||f||||||||||2017-10-11 05:39:20.602964|2017-10-11 05:39:20.602964
NCT00221754|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-12|||March 2003||2003-03-01|June 2007|2007-06-01|March 2004|Actual|2004-03-01|||||Interventional|||Pravastatin and Protease Inhibitors in HIV-Infected Patients|Pravastatin in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy|Completed||Phase 2|21|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 05:39:20.679721|2017-10-11 05:39:20.679721
NCT00221767|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-13|||June 2005||2005-06-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|BRINDLEY||Medico-economical Impact of the Brindley Neurosurgical Technique in France|Prospective Comparative Multicenter Study on the Medico-economical Impact of the Brindley Technique in the Management of Neurogenic Bladder in Patients With Injured Spinal Cord|Completed||N/A|53|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 05:39:20.780129|2017-10-11 05:39:20.780129
NCT00221780|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-28|||November 2003||2003-11-01|June 2007|2007-06-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Role of Left Ventricular Pacing Site|Importance of Left Ventricular Pacing Site in Biventricular Resynchronization Therapy for Severe Heart Failure|Unknown status|Recruiting|N/A|33|Anticipated|University Hospital, Bordeaux|||||f||||f||||||||||2017-10-11 05:39:20.887935|2017-10-11 05:39:20.887935
NCT00221793|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-09-17|||December 2002||2002-12-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation|Study of Ponderal Load in Parkinsonian Patients After Deep Brain Stimulation of the Subthalamic Nucleus|Completed||N/A|20|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-10-11 05:39:20.998337|2017-10-11 05:39:20.998337
NCT00221806|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||June 2004||2004-06-01|September 2005|2005-09-01|June 2012||2012-06-01|||||Interventional|||Comparison of Two Under Knee Lower Limb Bypass Types:Endothelialised Prosthesis Versus Autologous Vein Graft|Randomised Study Comparing Endothelialised Prosthesis and Autologous Vein for Under Knee Revascularisation With Femoro Popliteal Bypass. ePTFE|Unknown status|Recruiting|Phase 2|40||University Hospital, Bordeaux|||||f||||||||||||||2017-10-11 05:39:22.75593|2017-10-11 05:39:22.75593
NCT00221819|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-05-07|||June 2004||2004-06-01|May 2013|2013-05-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Gases Humidification During Noninvasive Ventilation : Heat and Moisture Exchanger or Heated Humidifier ?|Prospective Study of the Influence of the Humidification Mode on Ventilation Parameters and Arterial Blood Gases in Non Invasive Ventilation|Terminated||N/A|||University Hospital, Bordeaux|||||f||||||||||||||2017-10-11 05:39:22.882332|2017-10-11 05:39:22.882332
NCT00221832|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-01-12|||October 2003||2003-10-01|October 2003|2003-10-01|December 2011|Anticipated|2011-12-01|||||Observational|||Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases|Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases|Unknown status|Recruiting|N/A|300|Anticipated|Heidelberg University|||1||f||||f||||||Samples With DNA|"     no biospecimens are to be retained.   "|||2017-10-11 05:39:22.964243|2017-10-11 05:39:22.964243
NCT00221845|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2010-01-11|||January 1998||1998-01-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|July 2007|Actual|2007-07-01||Interventional|ESCAPE||Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients|Molecular Mechanisms of Disease Progression and Renoprotective Pharmacotherapy in Children With Chronic Renal Failure|Completed||Phase 3|400|Actual|Heidelberg University||2|||f||||t||||||||||2017-10-11 05:39:23.053494|2017-10-11 05:39:23.053494
NCT00221858|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-09-20|||August 2002||2002-08-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Observational|||Regional Anesthesia Database|Regional Anesthesia Database|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:39:23.237999|2017-10-11 05:39:23.237999
NCT00221871|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2006-10-10|||January 2004||2004-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Proper Dosage of Ketamine in Intravenous Regional Anesthesia|Proper Dosage of Intravenous Ketamine When Used as an Adjuvant to Lidocaine in Intravenous Regional Anesthesia (IVRA).|Unknown status|Recruiting|N/A|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:39:23.311197|2017-10-11 05:39:23.311197
NCT00221884|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-12-04|||August 2002||2002-08-01|September 2005|2005-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Use of Ultrasound in Upper Extremity Blocks.|Does Ultrasound Guidance Improve the Success of Brachial Plexus Block? A Prospective, Randomized, Controlled Trial.|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:39:23.389838|2017-10-11 05:39:23.389838
NCT00221897|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-08-29|||April 1995||1995-04-01|August 2011|2011-08-01|July 2016|Anticipated|2016-07-01|||||Observational|DIGS||Diagnostic Innovations in Glaucoma Study|Diagnostic Innovations in Glaucoma Study|Unknown status|Recruiting|N/A|3000|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-10-11 05:39:23.450404|2017-10-11 05:39:23.450404
NCT00221910|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-12-04|||February 2003||2003-02-01|March 2005|2005-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Use of Ultrasound in Lower Extremity Blocks.|Does Ultrasound Guidance Improve the Success of Sciatic Nerve Block at the Popliteal Fossa? A Prospective, Randomized, Controlled Trial.|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:39:23.561281|2017-10-11 05:39:23.561281
NCT00221923|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-08-29|||September 2002||2002-09-01|August 2011|2011-08-01|February 2015|Anticipated|2015-02-01|||||Observational|ADAGES||African Descent and Glaucoma Evaluation Study|African Descent and Glaucoma Evaluation Study (Formerly African Americans With Glaucoma Study)|Unknown status|Active, not recruiting|N/A|1540|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-10-11 05:39:23.752947|2017-10-11 05:39:23.752947
NCT00221936|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-12-04|||July 2004||2004-07-01|July 2005|2005-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Patient Controlled Oral Analgesia for Postoperative Pain Management After Total Knee Replacement|Patient Controlled Oral Analgesia (PCOA) for Postoperative Pain Management After Total Knee Replacement-A Pilot Study|Completed||N/A|50|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:39:23.859391|2017-10-11 05:39:23.859391
NCT00221949|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-12-04||||||August 2005|2005-08-01||||||||Observational|||Visualizing Peripheral Nerves Using Ultrasound-Guided Approach|Development of a Comprehensive Study of the Peripheral Nerves in the Lower Arm and Lower Leg Using an Ultrasound Guided Approach|Completed||N/A|16|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:39:23.923729|2017-10-11 05:39:23.923729
NCT00221975|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-12-01|||July 2002||2002-07-01|December 2014|2014-12-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling|Combination Therapy in Dual Diagnosis Rapid Cycling Bipolar Disorder|Completed||Phase 3|98|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-10-11 05:39:23.985815|2017-10-11 05:39:23.985815
NCT00221988|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16|||March 2004||2004-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers|A Randomized, Double-Blind, Cross-Over Study of the Cognitive and Mood Effects of KEPPRA (Levetiracetam) Tablets in Healthy Older Adults.|Unknown status|Recruiting|N/A|40||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-10-11 05:39:24.090212|2017-10-11 05:39:24.090212
NCT00222001|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-01-27|||December 2002||2002-12-01|January 2015|2015-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Telephone Triage Study|Outcome Evaluation of Triage for Health Maintenance Organization (HMO) Patients Performed by Doctors in a Medical Telemedicine Center|Completed||N/A|100|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-10-11 05:39:24.181209|2017-10-11 05:39:24.181209
NCT00222014|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-22|||May 2005||2005-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis|TIPS (With Coated Stents) OR PARACENTESIS + ALBUMIN ADMINISTRATION FOR THE TREATMENT OF REFRACTORY ASCITES IN PATIENTS WITH CIRRHOSIS : A RANDOMIZED TRIAL COMPARING SURVIVAL, QUALITY OF LIFE AND NUTRITIONAL STATUS|Completed||N/A|55|Actual|University Hospital, Toulouse||2|||f||||t||||||||||2017-10-11 05:39:24.266027|2017-10-11 05:39:24.266027
NCT00222027|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-06|||November 2003||2003-11-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|GRAALL2003||Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial|GRAALL 2003 Trial (ALL 15-59 Years). Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial|Completed||Phase 2|300||University Hospital, Toulouse|||||f||||f||||||||||2017-10-11 05:39:24.372174|2017-10-11 05:39:24.372174
NCT00222040|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2010-04-29|||June 2004||2004-06-01|June 2008|2008-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Microbubbles and Ultrasound in Stroke Trial: MUST Study||Terminated||Phase 2|20|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 05:39:24.481975|2017-10-11 05:39:24.481975
NCT00222053|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2010-04-01|||April 2000||2000-04-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||IFM 99-02 Thalidomide in Myeloma||Completed||Phase 3|800|Actual|University Hospital, Toulouse||3|||f||||f||||||||||2017-10-11 05:39:24.589933|2017-10-11 05:39:24.589933
NCT00222066|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2010-02-02|||June 2001||2001-06-01|September 2006|2006-09-01|September 2007|Actual|2007-09-01|January 2007|Actual|2007-01-01||Interventional|||Effect of Fetal Ovarian Cyst Aspiration to Prevent Torsion|Comparison Between Abstention and Intrauterine Aspiration in the Treatment of Anechoic Fetal Ovarian Cysts to Prevent Ovarian Torsion|Completed||N/A|61|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-10-11 05:39:24.677486|2017-10-11 05:39:24.677486
NCT00222079|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2017-03-29|||November 2004|Actual|2004-11-01|March 2017|2017-03-01|February 2008|Actual|2008-02-01|October 2007||2007-10-01||Interventional|||Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy|Pilot Study to Evaluate Esomeprazole (Nexium) in Treating Gastro-esophageal Reflux in Patients With Head and Neck Cancer With Prior External Beam Radiation Therapy: a Randomized, Prospective, Placebo-controlled, Double-blind Study.|Terminated||N/A|40|Actual|University of Iowa||||Project canceled due to the implementation of IMRT, fewer patients reporting xerostomia.|f||||||||||||||2017-10-11 05:39:24.759816|2017-10-11 05:39:24.759816
NCT00222092|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-23|||September 2005||2005-09-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Observational|||Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers|Effect of Octreotide, Somatostatin, Pentoxyfilline or Placebo in the Prevention and the Course of Post-ERCP Pancreatitis and Study of Molecular Markers in Post-ERCP Pancreatitis|Completed||Phase 4|300||University of Ioannina|||1||f||||||||||||||2017-10-11 05:39:24.822816|2017-10-11 05:39:24.822816
NCT00222105|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-05|2017-03-21||November 2002||2002-11-01|June 2017|2017-06-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life|Doxil® (Pegylated Liposomal Doxorubicin), Dexamethasone Plus Thalidomide (Ddt) in Previously Untreated Multiple Myeloma: A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life|Completed||Phase 2|25|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-10-11 05:39:24.884154|2017-10-11 05:39:24.884154
NCT00222118|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-11-08|||October 2003||2003-10-01|November 2012|2012-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Kansas University Teen Mothers Project|Promoting and Supporting Breastfeeding in Adolescents|Completed||N/A|390|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-10-11 05:39:25.094739|2017-10-11 05:39:25.094739
NCT00222144|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-06|||September 2004||2004-09-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer|Phase II Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|23|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 05:39:25.245537|2017-10-11 05:39:25.245537
NCT00222170|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-05-07|||May 2005||2005-05-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)|Esophagoprotection by Rabeprazole Mediated by Restoration of an Impairment in Esophageal Mucin Production: Its Potential Therapeutic Benefit in Patients With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 2|24|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-10-11 05:39:25.327405|2017-10-11 05:39:25.327405
NCT00222183|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-04-05|||June 2003||2003-06-01|February 2007|2007-02-01||||||||Interventional|||Cutaneous Lupus Erythematosus and Elidel|Evaluation of the Therapeutic Effect and Local Tolerability of Elidel® Cream 1% (Pimecrolimus) in Chronic Discoid Lupus Erythematosus (dLE) or Subacute Cutaneous Lupus Erythematosus (scLE)|Unknown status|Recruiting|N/A|25||University of Leipzig|||||f||||||||||||||2017-10-11 05:39:25.534463|2017-10-11 05:39:25.534463
NCT00222196|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-03|||November 2000||2000-11-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Oslo Balloon Angioplasty Versus Conservative Treatment|Oslo Balloon Angioplasty Versus Conservative Treatment|Completed||N/A|200||Oslo University Hospital|||||f||||||||||||||2017-10-11 05:39:25.629567|2017-10-11 05:39:25.629567
NCT00222209|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-08-02|||September 2005||2005-09-01|September 2005|2005-09-01|November 2007||2007-11-01|||||Interventional|||Clinical Study on Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain|Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain Syndromes|Unknown status|Recruiting|N/A|64||Universitätsmedizin Mannheim|||||f||||||||||||||2017-10-11 05:39:25.695719|2017-10-11 05:39:25.695719
NCT00222222|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-14|||March 2003||2003-03-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis|Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis|Completed||N/A|105|Actual|Universitätsmedizin Mannheim||1|||f||||f||||||||||2017-10-11 05:39:25.785005|2017-10-11 05:39:25.785005
NCT00222235|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-11-21|||January 2000||2000-01-01|June 2013|2013-06-01|June 2004||2004-06-01|||||Interventional|||Adjunctive Treatment for Decreasing Symptoms of Schizophrenia|Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST)|Completed||Phase 2/Phase 3|240||University of Maryland|||||||||||||||||||2017-10-11 05:39:25.863337|2017-10-11 05:39:25.863337
NCT00222248|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-08-07|||March 2003||2003-03-01|June 2003|2003-06-01|March 2006||2006-03-01|||||Interventional|||Pelvic Floor Muscle Training for Incontinence in Older Women.|The Effect of Pelvic Floor Muscle Training for the Management of Incontinence in Older Women: a Single Blind Randomised Controlled Trial.|Unknown status|Active, not recruiting|N/A|90||University of Melbourne|||||f||||||||||||||2017-10-11 05:39:25.962062|2017-10-11 05:39:25.962062
NCT00222261|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-03-22|||April 2003||2003-04-01|March 2011|2011-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|ASCET||Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.|Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.|Completed||Phase 4|1001|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 05:39:26.0372|2017-10-11 05:39:26.0372
NCT00222274|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2015-02-06|||July 2004||2004-07-01|February 2015|2015-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||HRV Biofeedback in Fibromyalgia|A Pilot Study of the Efficacy of Biofeedback in Patients With Fibromyalgia Syndrome.|Completed||N/A|80|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 05:39:26.157427|2017-10-11 05:39:26.157427
NCT00222287|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-21|||September 2004||2004-09-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||The Effect of Feldenkrais Lessons on Walking and Balance|The Effect of Feldenkrais Lessons on Walking and Balance|Unknown status|Active, not recruiting|Phase 1|60||University of Melbourne|||||f||||||||||||||2017-10-11 05:39:26.245995|2017-10-11 05:39:26.245995
NCT00222300|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-08-07|||May 2003||2003-05-01|October 2003|2003-10-01|December 2005||2005-12-01|||||Interventional|||A Targeted Strengthening Program Following Total Hip Replacement.|A Targeted Strengthening Program Following Total Hip Replacement.|Completed||N/A|30||University of Melbourne|||||f||||||||||||||2017-10-11 05:39:26.319002|2017-10-11 05:39:26.319002
NCT00222326|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-02-17|||July 2002||2002-07-01|February 2009|2009-02-01|April 2007|Actual|2007-04-01|April 2006|Actual|2006-04-01||Interventional|||The Effect of Physiotherapy Treatment Following Gynaecological Surgery|The Effect of a Physiotherapy Treatment Program on Pelvic Function Following Gynaecological Surgery|Completed||N/A|50|Actual|University of Melbourne||1|||f||||f||||||||||2017-10-11 05:39:26.393567|2017-10-11 05:39:26.393567
NCT00222339|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||February 2002||2002-02-01|December 2001|2001-12-01|June 2004||2004-06-01|||||Interventional|||Task-Related Training of Arm Use After Stroke|Task-Related Training of Arm Use After Stroke: a Randomised Controlled Trial|Completed||N/A|30||University of Melbourne|||||f||||||||||||||2017-10-11 05:39:26.478031|2017-10-11 05:39:26.478031
NCT00222352|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-02-27|||December 2004||2004-12-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Observational|||Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes|Diagnosis and Treatment of Acute Coronary Syndromes in the Emergency Department: The Impact of Rapid Bedside cTnI Testing on Outcomes|Unknown status|Active, not recruiting|Phase 4|2000||University Emergency Physicians|||||f||||f||||||||||2017-10-11 05:39:26.566911|2017-10-11 05:39:26.566911
NCT00222365|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-11-09|||December 2003||2003-12-01|July 2006|2006-07-01|May 2006||2006-05-01|||||Interventional|||Homeopathy Assessment in Terms of the Consumption of Analgesics After Knee Ligamentoplasty|Homeopathy Assessment in Terms of the Consumption of Analgesics After Knee Ligamentoplasty|Terminated||Phase 3|165||University Hospital, Grenoble|||||f||||||||||||||2017-10-11 05:39:26.648674|2017-10-11 05:39:26.648674
NCT00222378|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2015-07-28|||April 2005||2005-04-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease|Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease|Completed||N/A|129|Actual|University of Miami|||1||f||||t||||||Samples With DNA|"     Specimens will be discarded upon study completion   "|||2017-10-11 05:39:26.747862|2017-10-11 05:39:26.747862
NCT00222391|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2009-01-06|||April 2004||2004-04-01|March 2006|2006-03-01|January 2006||2006-01-01|||||Observational|||Influence of Thoracic Epidural Anesthesia on Skin Sympathetic Activity and Heart Rate Variability|Influence of Thoracic Epidural Anesthesia on Skin Sympathetic Activity and Heart Rate Variability in Surgical Patients|Completed||N/A|40||University Hospital Muenster|||||f||||||||||||||2017-10-11 05:39:26.8728|2017-10-11 05:39:26.8728
NCT00222404|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-11-04|||July 2005||2005-07-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|||||Observational|Pharmacogenos||"Pharmacogenomic Study Realized on Non-small Cell Lung Carcinoma"|"Pharmacogenomic Study Realized Within the Framework of the Common Care to Non-small Cell Lung Carcinoma at Any Stages Treated by Chemotherapy."|Completed||N/A|556|Actual|University Hospital, Grenoble|||1||f||||||||||||||2017-10-11 05:39:26.950608|2017-10-11 05:39:26.950608
NCT00222417|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-20|||September 2002||2002-09-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|||||Observational|||Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease|Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease|Unknown status|Active, not recruiting|Phase 2/Phase 3|44|Actual|University Hospital of North Norway|||2||f||||f||||||||||2017-10-11 05:39:27.027451|2017-10-11 05:39:27.027451
NCT00222430|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-03-27|||March 2005||2005-03-01|March 2012|2012-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Fluoroscopy Guided Femoral Arterial Access|Fluoroscopy Guided Femoral Arterial Access and the Use of Closure Devices: A Randomized Controlled Trial.|Completed||N/A|990|Actual|University of Oklahoma||2|||f||||f||||||||||2017-10-11 05:39:27.115408|2017-10-11 05:39:27.115408
NCT00222443|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-09-19|||September 2004||2004-09-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy|Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy|Completed||Phase 1|40||University of Oklahoma|||||f||||||||||||||2017-10-11 05:39:27.209194|2017-10-11 05:39:27.209194
NCT00222456|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2005-09-15|||March 1999||1999-03-01|September 2005|2005-09-01|September 2008||2008-09-01|||||Interventional|||Project Early Intervention 2000|Can Early Intervention Prevent Developmental Disturbances/Delays and Improve the Health of Children Born Prematurely|Completed||N/A|210||University Hospital of North Norway|||||f||||||||||||||2017-10-11 05:39:27.299753|2017-10-11 05:39:27.299753
NCT00222469|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-07-08|||August 2005||2005-08-01|July 2008|2008-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer|A Phase II Trial of Bevacizumab Plus Gemcitabine™ and Oxaliplatin™ as First Line Therapy in Metastatic or Locally Advanced (Unresectable) Pancreatic Cancer|Completed||Phase 2|50|Actual|University of Oklahoma||1|||f||||||||||||||2017-10-11 05:39:27.398076|2017-10-11 05:39:27.398076
NCT00222482|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-08-08|||March 2003||2003-03-01|August 2007|2007-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Depakote ER in Borderline Personality Disorder|A Double-Blind and Placebo Controlled Assessment of Depakote ER in Borderline Personality Disorder|Completed||N/A|15||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-10-11 05:39:27.985139|2017-10-11 05:39:27.985139
NCT00222495|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2006-09-07|||August 2002||2002-08-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||A Comparative Study of New Medications for Psychosis in Adolescents|A Comparative Study of New Medications for Psychosis in Adolescents|Completed||N/A|30||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 05:39:28.057068|2017-10-11 05:39:28.057068
NCT00222508|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-07-31|||April 2001||2001-04-01|July 2012|2012-07-01|July 2005||2005-07-01|||||Observational|||The Microvascular Complications Study|Microvascular Complications of Cystic Fibrosis Related Diabetes|Completed||Phase 3|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||||2017-10-11 05:39:28.163679|2017-10-11 05:39:28.163679
NCT00222521|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||April 2003||2003-04-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Insulin Glargine Vs Standard Insulin Therapy|Comparison of Insulin Glargine Vs Standard Insulin Therapy in CFRD Without Fasting Hyperglycemia|Completed||Phase 3|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-10-11 05:39:28.234032|2017-10-11 05:39:28.234032
NCT00222534|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-01-17|||January 2002||2002-01-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis|Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis|Completed||Phase 4|70|Actual|University of Oslo School of Pharmacy||2|||f||||||||||||||2017-10-11 05:39:28.325575|2017-10-11 05:39:28.325575
NCT00222547|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-10-27|||January 1999||1999-01-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6|Deworming and Enhanced Vitamin A Supplementation DEVTA Project|Completed||Phase 4|720000||University of Oxford|||||f||||||||||||||2017-10-11 05:39:28.435494|2017-10-11 05:39:28.435494
NCT00222560|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-04-27|||May 2005||2005-05-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|PAC||The PAC Project: Integrating a Physical Activity Counsellor in the Primary Health Care Team|The PAC Project: Integrating a Physical Activity Counsellor in the Primary Health Care Team: A Randomized Controlled Trial|Completed||Phase 2|120|Actual|University of Ottawa||2|||f||||f||||||||||2017-10-11 05:39:28.509052|2017-10-11 05:39:28.509052
NCT00222573|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-05-04|||July 1999||1999-07-01|March 2005|2005-03-01|February 2005||2005-02-01|||||Interventional|||Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial Infarction|Clopidogrel Or Metoprolol in Myocardial Infarction Trial|Completed||Phase 4|46000||University of Oxford|||||f||||||||||||||2017-10-11 05:39:28.613516|2017-10-11 05:39:28.613516
NCT00222612|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-02-02|||October 2003||2003-10-01|February 2010|2010-02-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003|Medical Research Council Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003|Unknown status|Recruiting|Phase 4|2100|Anticipated|University of Oxford||3|||f||||t||||||||||2017-10-11 05:39:28.708711|2017-10-11 05:39:28.708711
NCT00222625|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-19|||September 2005||2005-09-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets|Randomized, Open, Prospective, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII in Acute Intracerebral Haemorrhage in Patients Treated With Oral Anticoagulants or Antiplatelets Agents.|Unknown status|Recruiting|Phase 2|32||University Of Perugia|||||f||||||||||||||2017-10-11 05:39:28.955034|2017-10-11 05:39:28.955034
NCT00222638|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||October 2004||2004-10-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Interventional|||Influenza Vaccination and Oral Anticoagulant Therapy|Randomized Blinded Cross-Over Clinical Trial Investigate the Interactions Between Influenza Vaccination and Oral Anticoagulant Therapy|Completed||Phase 4|100||University Of Perugia|||||f||||||||||||||2017-10-11 05:39:29.114592|2017-10-11 05:39:29.114592
NCT00222651|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2008-04-29|||July 2004||2004-07-01|April 2008|2008-04-01|July 2006|Anticipated|2006-07-01|||||Interventional|||Tenecteplase Pulmonary Embolism Italian Study|A Phase II Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of Single Bolus i.v. Tenecteplase Versus Placebo in Normotensive Patients With Pulmonary Embolism and Right Ventricular Dysfunction|Terminated||Phase 2|180|Anticipated|University Of Perugia||2||competitor study about to start|f||||||||||||||2017-10-11 05:39:29.204383|2017-10-11 05:39:29.204383
NCT00222664|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||September 1983||1983-09-01|August 2005|2005-08-01|December 2004||2004-12-01|||||Interventional|||Qidong Hepatitis B Intervention Study||Completed||Phase 4|80000||University of Oxford|||||f||||||||||||||2017-10-11 05:39:29.401288|2017-10-11 05:39:29.401288
NCT00222677|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-21|||May 2004||2004-05-01|August 2011|2011-08-01||||January 2012|Anticipated|2012-01-01||Interventional|||Aspirin for the Prevention of Recurrent Venous Thromboembolism|Aspirin After Six Months or One Year of Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism in Patients With Idiopathic Venous Thromboembolism. The WARFASA Study.|Unknown status|Active, not recruiting|Phase 2/Phase 3|70|Anticipated|University Of Perugia|||||f||||||||||||||2017-10-11 05:39:29.486798|2017-10-11 05:39:29.486798
NCT00222690|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2006-05-26|||June 2005||2005-06-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Observational|||Living With Fibromyalgia: Triggers,Subgroups, and a Cognitive-Behavioral and Interactive Technology-Based Intervention|Living With Fibromyalgia (FM): Triggers,Clinical Subgroups, and the Effects Of A Self-Monitored Cognitive-Behavioral and Interactive Technology-Based Intervention on Clinical Subgroups|Completed||N/A|30||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:29.609285|2017-10-11 05:39:29.609285
NCT00222703|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||May 2002||2002-05-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Enhancing Tobacco Abstinence Following Hospitalization|Enhancing Tobacco Abstinence Following Hospitalization|Completed||N/A|80||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:29.693396|2017-10-11 05:39:29.693396
NCT00222716|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-06-22|||January 2004||2004-01-01|June 2017|2017-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|MM2||Managing Medications|Improving Adherence to Antiretroviral Therapy|Completed||N/A|349|Actual|University of Pittsburgh||3|||f||||t||||||||No|There is not plan to share data specifically but the data has been shared with the Mach14 Collaborative. Entire data set has been shared with the Collaborative.|2017-10-11 05:39:29.782534|2017-10-11 05:39:29.782534
NCT00222729|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2016-01-15|2016-01-15||November 2005||2005-11-01|January 2016|2016-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer|Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer|Completed||Phase 2|42|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:39:29.897302|2017-10-11 05:39:29.897302
NCT00222742|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-07-10|||November 2007||2007-11-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|May 2011|Actual|2011-05-01||Interventional|||Hypothermia in Children After Trauma|Pediatric Traumatic Brain Injury Consortium: Hypothermia|Terminated||Phase 3|90|Actual|Phoenix Children's Hospital||1||Futility|f||||t||||||||||2017-10-11 05:39:30.276442|2017-10-11 05:39:30.276442
NCT00222755|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2008-01-03|||January 2006||2006-01-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|CIVIC-2||Improving Care for Patients With Bipolar Disorder|Improving Care for Veterans With Bipolar Disorder|Completed||N/A|60|Actual|University of Michigan||2|||f||||f||||||||||2017-10-11 05:39:30.436228|2017-10-11 05:39:30.436228
NCT00222768|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2008-02-15|||April 2005||2005-04-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|||||Observational|||PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans|Three-Tracer PET Quantitation of Insulin Action in Muscle|Completed||N/A|20||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:30.528783|2017-10-11 05:39:30.528783
NCT00222781|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-12-14|||January 2004||2004-01-01|December 2007|2007-12-01|December 2006||2006-12-01|||||Observational|||Multi-Tracer PET Quantitation of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus|Three-Tracer PET Quantitation of Insulin Action in Muscle|Completed||N/A|24||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:30.60057|2017-10-11 05:39:30.60057
NCT00222794|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2010-08-30|||November 2003||2003-11-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|||||Interventional|||A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia|A Randomized, Parallel Group, Double Blind, Placebo Controlled, Clinical Trial of Augmentation With Atomoxetine for the Treatment of Negative Symptoms in Patients With Schizophrenia and Schizoaffective Disorder|Completed||Phase 4|66||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:30.670126|2017-10-11 05:39:30.670126
NCT00222807|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-08-25|||August 2003||2003-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus|Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus|Completed||N/A|200|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"     blood samples are collected, stored at minus 70 degree C and analyzed in batches.   "|||2017-10-11 05:39:30.752809|2017-10-11 05:39:30.752809
NCT00222820|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-19|||April 2002||2002-04-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study|Depression: The Search for Treatment-Relevant Phenotypes|Completed||Phase 4|35||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:30.83344|2017-10-11 05:39:30.83344
NCT00222833|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-07|2008-01-08|||October 2004||2004-10-01|January 2008|2008-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia|The Effect of Switching to Aripiprazole on Indices of Cardiovascular Health in Overweight and Obese Patients With Schizophrenia|Completed||Phase 4|30||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:30.908512|2017-10-11 05:39:30.908512
NCT00222846|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-05-14|||May 2004||2004-05-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ENHANCE||Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study|Enhancing Adherence in Type 2 Diabetics|Completed||N/A|288|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 05:39:30.991778|2017-10-11 05:39:30.991778
NCT00222859|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-07-29|||March 2005||2005-03-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting|Reasons for Nontreatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting|Completed||N/A|300|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 05:39:31.080793|2017-10-11 05:39:31.080793
NCT00222872|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2014-04-25|||July 2005||2005-07-01|April 2014|2014-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women|A Three Week Dose Escalation Study of PTHrP(1-36) in Postmenopausal Women|Completed||Phase 1|61|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 05:39:31.151091|2017-10-11 05:39:31.151091
NCT00222885|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2007-12-14|||December 2002||2002-12-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Observational|||Multi-Tracer PET Quantitation of Insulin Action in Muscle (Phase 1, Phase 2, Phase 3, Phase 4)|Three-Tracer PET Quantitation of Insulin Action in Muscle|Completed||N/A|50||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:31.247175|2017-10-11 05:39:31.247175
NCT00222898|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2007-02-16|||June 2004||2004-06-01|February 2007|2007-02-01||||||||Observational|||Cancer Detection in Pancreatic Cysts|Pancreatic Cyst DNA Analysis|Completed||N/A|300||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:31.312637|2017-10-11 05:39:31.312637
NCT00222911|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-05-19|||August 2005||2005-08-01|May 2008|2008-05-01|November 2006|Actual|2006-11-01|||||Interventional|||Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports|Conservative Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports: a Prospective Randomized Study|Completed||Phase 4|75|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:31.400204|2017-10-11 05:39:31.400204
NCT00222924|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2007-12-14|||December 2003||2003-12-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Mitochondrial Impairment in Muscle Insulin Resistance|Mitochondrial Impairment in Muscle Insulin Resistance|Completed||N/A|49||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:39:31.484785|2017-10-11 05:39:31.484785
NCT00222937|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2016-01-21|||October 2005||2005-10-01|January 2016|2016-01-01|August 2010|Actual|2010-08-01|June 2009|Actual|2009-06-01||Interventional|||Voice Therapy for Teachers With Voice Problems|Efficacy of Voice Therapy for Phonotrauma in Teachers|Completed||Phase 3|105|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-10-11 05:39:31.55027|2017-10-11 05:39:31.55027
NCT00222950|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-14|||September 2003||2003-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Concentration of Plant Sterols in Serum and Aortic Valve Cusps|Concentrations of Plant Sterols in Serum and Aortic Valve Cusps: a Prospectiv Observational Study|Unknown status|Recruiting|N/A|100||University Hospital, Saarland|||||f||||||||||||||2017-10-11 05:39:31.627292|2017-10-11 05:39:31.627292
NCT00222963|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-02-12|||September 2004||2004-09-01|September 2006|2006-09-01||||||||Observational|||Pilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and Adolescents|Pilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and Adolescents|Completed||N/A|250|Actual|University of Rochester|||1||f||||f||||||||||2017-10-11 05:39:31.688974|2017-10-11 05:39:31.688974
NCT00222976|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-11-13|||September 2006||2006-09-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||Oral vs Rectal Admin of Naproxen for Post-Vag Perineal Pain Control|Oral vs Rectal Administration of Naproxen for Post-Vaginal Perineal Pain Control: A Randomized Clinical Trial|Completed||Phase 4|60|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 05:39:31.747888|2017-10-11 05:39:31.747888
NCT00222989|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-04-12|||October 2003||2003-10-01|April 2017|2017-04-01|December 1, 2100|Anticipated|2100-12-01|December 1, 2100|Anticipated|2100-12-01||Interventional|||PPI Versus Placebo in Severe Functional Heartburn|PPI Versus Placebo in Severe Functional Heartburn|Withdrawn||N/A|0|Actual|University of Southern California||1||Study never started.|f||||||||||||||2017-10-11 05:39:31.818125|2017-10-11 05:39:31.818125
NCT00223002|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2009-02-12|||November 2004||2004-11-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||Chlorhexidine Versus Povidone-Iodine for Prevention of Epidural Needle Contamination in the Parturient|Chlorhexidine Versus Povidone-Iodine for Prevention of Epidural Needle Contamination in the Parturient|Completed||N/A|400|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-10-11 05:39:31.898674|2017-10-11 05:39:31.898674
NCT00223015|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-10-19|||May 2004||2004-05-01|May 2004|2004-05-01|April 2005||2005-04-01|||||Interventional|||Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation||Completed||Phase 4|15||University of Schleswig-Holstein|||||f||||||||||||||2017-10-11 05:39:31.968124|2017-10-11 05:39:31.968124
NCT00223028|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-10-27|||April 2005||2005-04-01|July 2004|2004-07-01|July 2005||2005-07-01|||||Interventional|||Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation|Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation|Completed||Phase 4|15||University of Schleswig-Holstein|||||f||||||||||||||2017-10-11 05:39:32.01557|2017-10-11 05:39:32.01557
NCT00223041|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-08-04|||April 2003||2003-04-01|May 2006|2006-05-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|||Cranoc Lipid Study in Renal Transplantation|Cardiovascular Events in Renal Transplant Recipients With Low LDL-cholesterol Receiving Tacrolimus in Combination With the Statin Fluvastatin|Terminated||Phase 2/Phase 3|200|Anticipated|University of Schleswig-Holstein||2||No possibilty to receive all plened patients for this study|f||||t||||||||||2017-10-11 05:39:32.080156|2017-10-11 05:39:32.080156
NCT00223054|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-08-03|||March 2005||2005-03-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Observational|||Polymorphism of the Cytochrome P450-system in Renal Transplants|Polymorphism of the Cytochrome P450-system and the MDR-system in Renal Transplants Receiving the Immunosuppressive Drugs Tacrolimus, Sirolimus, Everolimus or Cyclosporine A|Completed||Phase 4|200|Actual|University of Schleswig-Holstein|||1||f||||t||||||Samples With DNA|"     DNA samples to analyze polymorphisms   "|||2017-10-11 05:39:32.155419|2017-10-11 05:39:32.155419
NCT00223067|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-10-27|||March 2005||2005-03-01|April 2004|2004-04-01|May 2006||2006-05-01|||||Interventional|||Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes|A Multi-Center Open-Labeled Study of the Administration of Allogenic and Autologous Regulatory Cells for the Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor)|Unknown status|Recruiting|Phase 1|10||University of Schleswig-Holstein|||||f||||||||||||||2017-10-11 05:39:32.345296|2017-10-11 05:39:32.345296
NCT00223093|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-10-27|||February 2004||2004-02-01|April 2003|2003-04-01|August 2005||2005-08-01|||||Interventional|||TAIZ -Monocytes for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)|A Single-Center Open-Labelled Study of the Administration of Transplant-Acceptance Inducing Cells (TAIZ) for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)|Unknown status|Active, not recruiting|Phase 1|10||University of Schleswig-Holstein|||||f||||||||||||||2017-10-11 05:39:32.540703|2017-10-11 05:39:32.540703
NCT00223106|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-07-23|||March 2004||2004-03-01|July 2015|2015-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault Prolapse|A Prospective Multicenter Clinical Study on a New Approach in Treating Stress and Mixed Incontinence and Vaginal Vault Prolapse|Completed||N/A|467|Actual|Medtronic - MITG|||||f||||||||||||||2017-10-11 05:39:32.608194|2017-10-11 05:39:32.608194
NCT00223119|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-24|||January 2004||2004-01-01|October 2012|2012-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Comparison of Absorbable Sutures in Perineal Laceration Repair||Terminated||Phase 4|||Medtronic - MITG||||Study recruitment very slow.|f||||||||||||||2017-10-11 05:39:32.695109|2017-10-11 05:39:32.695109
NCT00223132|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-10-24|||February 2005||2005-02-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Suture Granuloma in Body Contouring Surgery||Completed||Phase 4|||Medtronic - MITG|||||f||||||||||||||2017-10-11 05:39:32.759334|2017-10-11 05:39:32.759334
NCT00223145|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-05-09|||December 2000||2000-12-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PCS III||Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone|Randomized, Multicentre, Phase III Study in Patients With Intermediate-risk T1 T2 Prostate Adenocarcinomas, to Verify the Role of Six Months of Total Androgen Blockade for Two Dosage Levels of Prostate Radiation Therapy (70 Gy and 76 Gy) Versus Prostate Radiation Therapy Alone at 76 Gy|Active, not recruiting||Phase 3|600|Actual|Université de Sherbrooke||3|||f||||f||||||||||2017-10-11 05:39:32.831242|2017-10-11 05:39:32.831242
NCT00223158|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2014-04-08|||September 2003||2003-09-01|July 2005|2005-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer|L-T3 Preparation for I131 Whole Body Scintigraphy: A Randomized Controlled Trial|Completed||N/A|70|Anticipated|Université de Sherbrooke|||||f||||||||||||||2017-10-11 05:39:32.926145|2017-10-11 05:39:32.926145
NCT00223171|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-05-09|||October 2000||2000-10-01|May 2017|2017-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|PCS IV||Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers|Randomized, Multicentre, Phase III Study: Assessment of the Duration of Androgen Blockade Combined With Pelvic Irradiation in High-risk Prostate Cancers|Active, not recruiting||Phase 3|650|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-10-11 05:39:33.025685|2017-10-11 05:39:33.025685
NCT00223184|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-08-29|||March 2003||2003-03-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Observational|||Genetic Characterisation of High-grade Paediatric Osteosarcomas|Study of Prognostic Value by Molecular Analysis in Paediatric Osteosarcomas of the Chromosomal Regions Containing Rb, p16, p53, Cycline D1, APC, erbB2 and C-met Genes|Completed||N/A|||University Hospital, Strasbourg, France|||1||f||||||||||||||2017-10-11 05:39:33.13665|2017-10-11 05:39:33.13665
NCT00223197|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-04-02|||February 2004||2004-02-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse|A Double-blind Placebo Controlled Trial of Pregnenolone for Depression in Patients With Bipolar Disorders or Recurrent Major Depressive Disorder and a History of Substance Abuse|Completed||Phase 4|75||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-10-11 05:39:33.209508|2017-10-11 05:39:33.209508
NCT00223210|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-08-16|||November 2005||2005-11-01|August 2012|2012-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence|A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence|Completed||Phase 4|100|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-10-11 05:39:33.343725|2017-10-11 05:39:33.343725
NCT00223223|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-08-02|||February 2005||2005-02-01|September 2005|2005-09-01|November 2005||2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study|Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study|Completed||Phase 4|30||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-10-11 05:39:33.465739|2017-10-11 05:39:33.465739
NCT00223236|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2014-08-07|2013-07-08||July 2010||2010-07-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Number of paticipants who completed baseline assessment|Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence|A Double-blind, Placebo-controlled Trial of Citicoline add-on Therapy in Patients With a History of Mania or Hypomania and Cocaine Abuse/Dependence|Completed||Phase 3|44|Actual|University of Texas Southwestern Medical Center|Low retention rate in the end of study (12 weeks) leading to a potential underestimation of treatment effectiveness.|2|||f||||f||||||||||2017-10-11 05:39:33.568473|2017-10-11 05:39:33.568473
NCT00223249|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-04-01|||November 2002||2002-11-01|April 2016|2016-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence|A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Alcohol Abuse/ Dependence.|Completed||Phase 4|115|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-10-11 05:39:34.005083|2017-10-11 05:39:34.005083
NCT00223262|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-08-02|||August 2002||2002-08-01|January 2010|2010-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients||Completed||Phase 4|||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-10-11 05:39:34.096791|2017-10-11 05:39:34.096791
NCT00223275|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-05-23|||May 2005||2005-05-01|May 2011|2011-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Naltrexone for Bipolar Disorder and Alcohol Dependence|Naltrexone for Bipolar Disorder and Alcohol Dependence|Completed||Phase 4|50|Anticipated|University of Texas Southwestern Medical Center|||||f||||||||||||||2017-10-11 05:39:34.163968|2017-10-11 05:39:34.163968
NCT00223288|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2011-08-02|||March 2003||2003-03-01|August 2011|2011-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Impact of Caregiver Depression on Asthma in the Child|Caregiver Psychiatric Symptomatology and it's Relationship to Service Utilization by Children With Asthma|Completed||Phase 4|175||University of Texas Southwestern Medical Center|||1||f||||||||||||||2017-10-11 05:39:34.233813|2017-10-11 05:39:34.233813
NCT00223301|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-04-18|||July 2004||2004-07-01|April 2013|2013-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis|A One-Year Prospective, Randomized, Placebo-Controlled, Double-Blind, Phase II/III Safety Trial of Combination Therapy With IFN Beta-1a (Avonex) and Mycophenolate Mofetil (Cellcept) in Early Multiple Sclerosis|Completed||Phase 2/Phase 3|24||University of Texas Southwestern Medical Center|||||f||||f||||||||||2017-10-11 05:39:34.29688|2017-10-11 05:39:34.29688
NCT00223314|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2007-12-20|||November 2000||2000-11-01|December 2007|2007-12-01|February 2004|Actual|2004-02-01|||||Interventional|||Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program|HIV Prevention Among Alternative School Youth|Completed||N/A|1000|Actual|The University of Texas Health Science Center, Houston||1|||f||||f||||||||||2017-10-11 05:39:34.377103|2017-10-11 05:39:34.377103
NCT00223327|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-07|||March 2005||2005-03-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Measurement of Bite Force in Humans|Measurement of Bite Force in Humans|Completed||Early Phase 1|89|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-10-11 05:39:34.464234|2017-10-11 05:39:34.464234
NCT00223340|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-28|||March 2005||2005-03-01|June 2012|2012-06-01|June 2007||2007-06-01|June 2007|Actual|2007-06-01||Interventional|||The ABC Planning Study: Diabetes and Cardiovascular Risks in Primary Care|Diabetes and Cardiovascular Risks in Primary Care|Completed||N/A|400||The University of Texas Health Science Center at San Antonio|||||f||||f||||||||||2017-10-11 05:39:34.525026|2017-10-11 05:39:34.525026
NCT00223353|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-15|||November 1998||1998-11-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Quantitative Gait Analysis for Clinical Decision Making|Quantitative Gait Analysis for Clinical Decision Making|Completed||N/A|100|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||||||||||||2017-10-11 05:39:34.612251|2017-10-11 05:39:34.612251
NCT00223366|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-06-30|||October 2001||2001-10-01|June 2017|2017-06-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors|Studies on Normal and Inflamed Dental Pulp, NPY Regulation of Peripheral Human Nociceptors, Peripheral Mechanisms of Opioid Analgesia, Cannabinoid-induced Desensitization of TRPV1 Receptors Adrenergic Modulation of Trigeminal Nociceptors|Active, not recruiting||N/A|2000|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, sputum, oral mucosa tissue, teeth   "|||2017-10-11 05:39:34.700065|2017-10-11 05:39:34.700065
NCT00223379|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-06|||December 2002||2002-12-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Longitudinal Endodontic Study of Apical Preparation Size|Longitudinal Endodontic Study of Apical Preparation Size|Completed||N/A|36|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||||2017-10-11 05:39:35.230868|2017-10-11 05:39:35.230868
NCT00223405|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-18|||April 2003||2003-04-01|April 2013|2013-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Analysis of Enamel Wear Against Ceramic Restorations|Analysis of Clinical Wear Patterns of Tooth Enamel and Ceramic Restorations as a Function of Particle Size, Inter-Particle Spacing and Fracture Toughness of Ceramic Crystals|Completed||Phase 2|36|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||||||||||||2017-10-11 05:39:35.355066|2017-10-11 05:39:35.355066
NCT00223418|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-04-05|||January 2004||2004-01-01|April 2013|2013-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills|Do Patients Taking Aripiprazole Learn More in Vocational Skills Training Than Patients Taking Olanzapine?|Completed||N/A|43|Actual|The University of Texas Health Science Center at San Antonio|||||f||||f||||||||||2017-10-11 05:39:35.492517|2017-10-11 05:39:35.492517
NCT00223431|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||February 1998||1998-02-01|September 2005|2005-09-01|May 2004||2004-05-01|||||Interventional|||Clinical Performance of 3-Unit FPDs|Clinical Performance of Three-Unit Fixed Partial Dentures (FPDs) Made From a Hot-Pressed Ceramic (Five-Year Study)|Completed||Phase 2|30||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 05:39:35.623156|2017-10-11 05:39:35.623156
NCT00223444|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-30|||August 2002||2002-08-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|GABA-Alcohol||Clinical-Genetic Variation in GABA/Alcohol Sensitivity|Clinical-Genetic Variation in GABA/Alcohol Sensitivity|Completed||Phase 1/Phase 2|23|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||f||||||Samples With DNA|"     Specifically, we will determine whether the subject's gene for a brain protein called     GABA-alpha-6 is of the Pro type or Ser type.   "|||2017-10-11 05:39:35.703577|2017-10-11 05:39:35.703577
NCT00223457|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2007-01-23|||April 2004||2004-04-01|April 2005|2005-04-01|September 2005||2005-09-01|||||Observational|||Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis|Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis|Completed||N/A|1040||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-10-11 05:39:35.770939|2017-10-11 05:39:35.770939
NCT00223470|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-07|||October 2002||2002-10-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Cytokine Regulation of Periradicular Pain in Humans|Cytokine Regulation of Periradicular Pain in Humans|Completed||N/A|9|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples Without DNA|"     Sterile paper points are placed in the canal for 30 seconds   "|||2017-10-11 05:39:35.857727|2017-10-11 05:39:35.857727
NCT00223483|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-09-13|||March 2005||2005-03-01|September 2017|2017-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers|Identification and Analysis of Immunomodulatory Molecules From Leukocytes in Patients With Hematologic Disorders and Healthy Volunteers|Active, not recruiting||N/A|1000|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples With DNA|"     Whole blood, serum, white cells   "|||2017-10-11 05:39:35.946954|2017-10-11 05:39:35.946954
NCT00223496|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-04-19|2013-02-27||September 2004||2004-09-01|April 2017|2017-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||32 subjects consented, 19 subjects were baselined|12- Week Open Label Treatment of Refractory Bipolar Depression|12- Week Open Label Treatment of Refractory Bipolar Depression (BD) With Combination of Depakote ER (DEP) and Aripiprazole (AZP)|Completed||Phase 4|32|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 05:39:36.031092|2017-10-11 05:39:36.031092
NCT00223509|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-19|||August 2005||2005-08-01|June 2012|2012-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Lamictal As Add on Treatment in Mixed States of Bipolar Disorder|Lamictal As Add on Treatment in Mixed States of Bipolar Disorder|Completed||Phase 4|28|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-10-11 05:39:36.249982|2017-10-11 05:39:36.249982
NCT00223522|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||April 2004||2004-04-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Observational|||Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?|Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?|Completed||N/A|50||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 05:39:36.340844|2017-10-11 05:39:36.340844
NCT00223535|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||February 2003||2003-02-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Cognitive Remediation and Social Skills Training in Schizophrenia|Cognitive Remediation and Social Skills Training in Schizophrenia|Completed||N/A|40||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-10-11 05:39:36.404588|2017-10-11 05:39:36.404588
NCT00223548|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2005-09-14|||October 2002||2002-10-01|September 2002|2002-09-01|December 2004||2004-12-01|||||Interventional|||MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application|MESNA Zur Prophylaxe Der Kontrastmittel-Induzierten Nephropathie|Completed||Phase 2|106||University of Ulm|||||f||||||||||||||2017-10-11 05:39:36.46895|2017-10-11 05:39:36.46895
NCT00223561|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-02-28|||February 2003||2003-02-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder|A Double Blind, Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder|Completed||Phase 4|18||Utrecht Institute for Pharmaceutical Sciences|||||f||||||||||||||2017-10-11 05:39:36.541059|2017-10-11 05:39:36.541059
NCT00223574|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-09-21|||January 2002||2002-01-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Canadian Trial of Dietary Carbohydrates in Diabetes|Long-Term Effect of Altering the Source or Amount of Dietary Carbohydrate in Type 2 Diabetes|Completed||N/A|168||University of Toronto|||||f||||||||||||||2017-10-11 05:39:36.619884|2017-10-11 05:39:36.619884
NCT00223587|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-04-11|||September 2004||2004-09-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Seasonal Allergic Rhinitis and Driving Ability|Study to Investigate the Effects of Seasonal Allergic Rhinitis on Over-the-Road Driving Performance and Memory Functioning|Terminated||Phase 4|22|Actual|Utrecht Institute for Pharmaceutical Sciences||1||slow recruitment rate|f||||f||||||||||2017-10-11 05:39:36.702756|2017-10-11 05:39:36.702756
NCT00223600|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-18|||May 1990||1990-05-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Special Turku Atherosclerosis Risk Factor Intervention Project for Children (STRIP)|Special Turku Atherosclerosis Risk Factor Intervention Project for Children (STRIP)|Unknown status|Active, not recruiting|Phase 3|1062||University of Turku|||||f||||||||||||||2017-10-11 05:39:36.77917|2017-10-11 05:39:36.77917
NCT00223613|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-18|||August 1997||1997-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Intranasal Insulin for Prevention of Type 1 Diabetes|Intranasal Insulin for Prevention of Type 1 Diabetes in Children Carrying Increased HLA-Conferred Genetic Risk|Unknown status|Recruiting|Phase 3|240||University of Turku|||||f||||||||||||||2017-10-11 05:39:36.872876|2017-10-11 05:39:36.872876
NCT00223626|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-04-17|||January 2007||2007-01-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Topiramate to Reduce Cocaine Dependence|Lab Trials to Develop Medication for Cocaine Dependence|Completed||Phase 2|25|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 05:39:36.959976|2017-10-11 05:39:36.959976
NCT00223639|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2012-02-03|||September 2005||2005-09-01|February 2012|2012-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||New Medications to Treat Alcohol Dependence|New Medications to Treat Alcohol Dependence|Completed||Phase 2|29|Actual|University of Virginia||2|||f||||t||||||||||2017-10-11 05:39:37.046596|2017-10-11 05:39:37.046596
NCT00223652|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-04-06|2014-09-09||March 2006||2006-03-01|August 2014|2014-08-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas|Tele-Mental Health Intervention to Improve Depression Outcomes in Community Based Outpatient Clinics (CBOCs)|Completed||Phase 2|85|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:39:37.149818|2017-10-11 05:39:37.149818
NCT00223665|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-01-19|||January 1997||1997-01-01|January 2011|2011-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy|A Prospective Study of Intermittent Androgen Suppression in Men With Localized Prostate Cancer Who Have Biochemical Relapse After Radiation Therapy or Radical Prostatectomy|Unknown status|Recruiting|Phase 2|100|Anticipated|University of Washington||1|||f||||f||||||||||2017-10-11 05:39:37.995104|2017-10-11 05:39:37.995104
NCT00223678|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2017-05-24|2017-02-21||June 2000||2000-06-01|May 2017|2017-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||approximately 30 patients will be randomized in a 2:1 ratio: two patients will be converted to Rapamycin-based immunosuppression for each patient randomized to continue calcineurin inhibitor based immunosuppression.|Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure|Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure|Completed||Phase 4|20|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 05:39:38.103036|2017-10-11 05:39:38.103036
NCT00223691|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-01-16|||March 2002||2002-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Treatment of Orthostatic Hypotension in Autonomic Failure|Evaluation and Treatment of Autonomic Failure.|Completed||Phase 1|389|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-10-11 05:39:38.418444|2017-10-11 05:39:38.418444
NCT00223704|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2013-10-15|2013-07-29||May 2006||2006-05-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|BRAC||Bradykinin Receptor Antagonism During Cardiopulmonary Bypass|Bradykinin Receptor Antagonism During Cardiopulmonary Bypass|Completed||Phase 2/Phase 3|150|Actual|Vanderbilt University|This study was conducted in a population that predominantly underwent valve-only surgery. We cannot exclude the possibility that our results may have been different if we studied only coronary artery bypass graft surgery patients.|3|||f||||t||||||||||2017-10-11 05:39:38.651407|2017-10-11 05:39:38.651407
NCT00223730|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2016-11-01|||October 2001||2001-10-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Chemotherapy Toxicity Reduction Via Urea Cycle Support|Chemotherapy Toxicity Reduction Via Urea Cycle Support|Completed||Phase 2|100|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 05:39:39.517322|2017-10-11 05:39:39.517322
NCT00223756|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-01-06|||November 2004||2004-11-01|January 2016|2016-01-01|August 2007|Actual|2007-08-01|July 2006|Actual|2006-07-01||Interventional|LOVIT||VA Low Vision Intervention Trial|VA Low Vision Intervention Trial|Completed||N/A|61|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:39:39.690899|2017-10-11 05:39:39.690899
NCT00223769|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-12|||January 2004||2004-01-01|May 2006|2006-05-01|May 2006|Actual|2006-05-01|||||Interventional|||The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury|The Use of Oxandrolone to Improve Function in Persons With Chronic Spinal Cord Injury|Completed||N/A|40||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:39:39.768984|2017-10-11 05:39:39.768984
NCT00223782|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-03-21|||May 2004||2004-05-01|March 2008|2008-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy|Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy|Completed||N/A|150|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 05:39:39.859289|2017-10-11 05:39:39.859289
NCT00223795|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-05-05|2013-09-24||July 2006||2006-07-01|May 2014|2014-05-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Walking Aids in the Management of Knee Osteoarthritis|Walking Aids in the Management of Obesity-Related Knee Osteoarthritis|Completed||N/A|53|Actual|VA Office of Research and Development|Had high drop out rate leading to small numbers of subjects analyzed.|2|||f||||f||||||||||2017-10-11 05:39:39.943533|2017-10-11 05:39:39.943533
NCT00223808|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2014-01-03|2013-10-09||January 2002||2002-01-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical Trial|Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical Trial|Completed||Phase 3|71|Actual|VA Office of Research and Development|Limitations include the relatively small number of subjects in each group and the variation in severity level across subjects. Subjects at the Houston site were enrolled earlier after stroke than in the LA site and the Palo Alto site.|3|||f||||f||||||||||2017-10-11 05:39:40.175141|2017-10-11 05:39:40.175141
NCT00223821|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2013-10-29|2013-10-11||September 2003||2003-09-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|November 2008|Actual|2008-11-01||Interventional|COMBO||Enhancing Conservative Treatment for Urge Incontinence|Enhancing Conservative Treatment for Urge Incontinence|Completed||N/A|166|Actual|VA Office of Research and Development|Secondary objectives could not be achieved because, based on a conditional power calculation, the trial was stopped early for futility.|2|||f||||f||||||||||2017-10-11 05:39:40.622799|2017-10-11 05:39:40.622799
NCT00223834|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-03-11|||March 2005||2005-03-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|January 2007|Actual|2007-01-01||Interventional|||Pathways to Vocational Rehabilitation: Enhancing Entry and Retention|Pathways to Vocational Rehabilitation: Enhancing Entry and Retention|Completed||N/A|200|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:39:41.048711|2017-10-11 05:39:41.048711
NCT00223847|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-12-31|||August 2002||2002-08-01|December 2008|2008-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||An Investigation of Constraint Induced Language Therapy for Aphasia|An Investigation of Constraint Induced Language Therapy for Aphasia|Completed||N/A|48|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-10-11 05:39:41.11559|2017-10-11 05:39:41.11559
NCT00223860|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2008-03-05|||July 2001||2001-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.|Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury|Completed||N/A|100|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:39:41.18354|2017-10-11 05:39:41.18354
NCT00223873|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-01-20|||November 2002||2002-11-01|May 2006|2006-05-01|July 2006|Actual|2006-07-01|||||Interventional|||The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury|The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury|Completed||N/A|30||VA Office of Research and Development|||||f||||||||||||||2017-10-11 05:39:41.264324|2017-10-11 05:39:41.264324
NCT00223899|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-05|||July 2005||2005-07-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma|A Phase 1, Multi-Center, Open-Label, Dose-Escalation Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma|Completed||Phase 1|26|Actual|Vical||1|||f||||f||||||||||2017-10-11 05:39:41.338932|2017-10-11 05:39:41.338932
NCT00223912|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-09-15|||November 2003||2003-11-01|September 2010|2010-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|FES||Effect of Exercise on Blood Coagulation in Persons With Chronic Spinal Cord Injury|Effect of FES- Exercise on Hemostasis in Persons With Chronic Spinal Cord Injury|Completed||N/A|12|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:39:41.421664|2017-10-11 05:39:41.421664
NCT00223925|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-03-25|||October 2004||2004-10-01|March 2014|2014-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Maribavir for Prevention of CMV After Stem Cell Transplants|A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Assess the Safety, Tolerability, and Prophylactic Anti-cytomegalovirus Activity of Maribavir in Recipients of Allogeneic Stem Cell Transplants|Completed||Phase 2|111|Actual|Shire||4|||||||||||||||||2017-10-11 05:39:41.505759|2017-10-11 05:39:41.505759
NCT00223938|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-02-18|||May 2004||2004-05-01|February 2008|2008-02-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.|A Multi-Center, Open-Label, Randomized, Parallel Group Study of the Efficacy and Safety of Ferrlecit in the Maintenance of Iron Stores and Serum Hemoglobin Concentration in Hemodialysis Patients Receiving Erythropoietin.|Unknown status|Active, not recruiting|Phase 4|291|Anticipated|Watson Pharmaceuticals||3|||f||||f||||||||||2017-10-11 05:39:42.95557|2017-10-11 05:39:42.95557
NCT00223951|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2015-02-19|||September 2005||2005-09-01|February 2015|2015-02-01||||December 2005|Actual|2005-12-01||Interventional|||Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers|A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of R89674 0.25% Ophthalmic Solution in Healthy, Normal Volunteers|Completed||Phase 3|900||Vistakon Pharmaceuticals|||||f||||||||||||||2017-10-11 05:39:43.043193|2017-10-11 05:39:43.043193
NCT00223964|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-08-10|||June 2003||2003-06-01|August 2012|2012-08-01||||October 2003|Actual|2003-10-01||Interventional|||Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients|Randomized Double-Blind Parallel Group MultiCenter Study of the Efficacy of Two Doses of Ferrlecit® in Treatment of Iron Deficiency in Pediatric Hemodialysis Patients Receiving Epoetin.|Completed||Phase 4|59|Actual|Watson Pharmaceuticals||2|||f||||||||||||||2017-10-11 05:39:43.119053|2017-10-11 05:39:43.119053
NCT00223977|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-05-17|2009-08-19||December 2003||2003-12-01|May 2013|2013-05-01|February 2008|Actual|2008-02-01|November 2004|Actual|2004-11-01||Interventional|||2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.|A Multi-center, Randomized, Open Label Study of the Efficacy and Safety of Two Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peroneal Dialysis Patients Receiving Erythropoietin.|Completed||Phase 2/Phase 3|146|Actual|Watson Pharmaceuticals|Primary endpoint for the 250 mg dose was 4 weeks earlier than the endpoint for the 125 mg dose, which may have contributed to lower Hbg increase with the 250 mg dose at endpoint.|3|||f||||f||||||||||2017-10-11 05:39:43.265155|2017-10-11 05:39:43.265155
NCT00223990|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-02-01|||March 2005||2005-03-01|February 2013|2013-02-01|April 2006||2006-04-01|||||Interventional|||Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine|A Dbl-blind,Randomized,Controlled,Phase IIb Field Trial in 12-47 Month-old Children in Western Kenya to Eval the Efficacy,Safety and Immunogenicity of the FMP1/AS02A Malaria Vaccine vs Rabies Vaccine|Completed||Phase 2|400||U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-10-11 05:39:44.136568|2017-10-11 05:39:44.136568
NCT00224003|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-08-18|2009-08-18||April 2003||2003-04-01|August 2009|2009-08-01|February 2005|Actual|2005-02-01|March 2004|Actual|2004-03-01||Interventional|||Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients|Open-Label, Multi-Center Study of the Safety and Efficacy of Ferrlecit® in the Maintenance of Iron Stores in Pediatric Hemodialysis Patients Receiving Epoetin|Completed||Phase 4|23|Actual|Watson Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:39:44.224189|2017-10-11 05:39:44.224189
NCT00224016|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-07|2009-11-13||December 2004||2004-12-01|February 2012|2012-02-01|September 2008|Actual|2008-09-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition|A Multi-Center, Open-Label (OL), Active-Controlled, Dose-Titration Study Evaluating the Safety, Efficacy and PK of Oxybutynin Transdermal Systems in the Treatment of Detrusor Overactivity in Pediatric Patients|Completed||Phase 4|57|Actual|Watson Pharmaceuticals|The transdermal groups included more males and younger subjects. The study was not designed to compare the transdermal and oral groups. Advserse event data reported for the titration and maintenance periods.|2|||f||||f||||||||||2017-10-11 05:39:44.424262|2017-10-11 05:39:44.424262
NCT00224029|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-04-07|2009-11-13||December 2004||2004-12-01|April 2010|2010-04-01|May 2008|Actual|2008-05-01|December 2005|Actual|2005-12-01||Interventional|||A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition|A Multi-center, Open-label, Dose-titration Pilot Study Evaluating the Efficacy and Safety of Oxybutynin Transdermal Systems in Patients With Neurogenic Bladder Resulting From Spinal Cord Injury|Completed||Phase 4|24|Actual|Watson Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:39:44.831331|2017-10-11 05:39:44.831331
NCT00224042|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-29|2009-12-23||April 2003||2003-04-01|February 2012|2012-02-01||||May 2005|Actual|2005-05-01||Interventional|||Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents|A Randomized, Controlled, Open-label Study of the Safety and Efficacy of Ferrlecit® vs Oral Iron in Iron Deficient Patients With Chronic Kidney Disease Being Treated With Erythropoietic Therapy|Completed||Phase 4|52|Actual|Watson Pharmaceuticals||2|||f||||||||||||||2017-10-11 05:39:45.053779|2017-10-11 05:39:45.053779
NCT00224055|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-29|2012-02-29||April 2003||2003-04-01|February 2012|2012-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients|A Randomized, Controlled, Open-label Study of the Safety and Efficacy of Ferrlecit® vs Oral Iron in Iron Deficient Patients With Chronic Kidney Disease|Completed||Phase 4|89|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:39:45.633055|2017-10-11 05:39:45.633055
NCT00224068|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-02-29|||May 2002||2002-05-01|February 2012|2012-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy|A Multicenter, Randomized, Controlled Prospective Trial of the Safety and Efficacy of Ferrlecit® in Anemic Cancer Patients Who Are Receiving Acute Chemotherapy and Epoetin as Compared to Oral Iron and No Treatment|Completed||Phase 4|180||Watson Pharmaceuticals|||||f||||f||||||||||2017-10-11 05:39:46.07974|2017-10-11 05:39:46.07974
NCT00224081|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-12-08|||September 2004||2004-09-01|December 2015|2015-12-01||||May 2006|Actual|2006-05-01||Interventional|DRIVE||DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)|Dialysis Patients' Response to IV Iron With Elevated Ferritin|Completed||Phase 4|134|Actual|Watson Pharmaceuticals||2|||f||||||||||||||2017-10-11 05:39:46.241927|2017-10-11 05:39:46.241927
NCT00224094|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-10-11|||January 2002||2002-01-01|October 2012|2012-10-01||||May 2003|Actual|2003-05-01||Interventional|||A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women|A Comparison of Transdermal vs. Oral Estrogen Replacement Therapy on Androgen Levels and Thyroid Function in Naturally Menopausal Women|Completed||Phase 4|27|Actual|Watson Pharmaceuticals||2|||f||||||||||||||2017-10-11 05:39:46.387476|2017-10-11 05:39:46.387476
NCT00224107|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-07-05|2009-09-08||May 2005||2005-05-01|July 2011|2011-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo|A Multi-Center, Randomized, Double-Blind, Placebo Controlled, Parallel Evaluation of the Efficacy and Safety of a New Drug in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|461|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:39:46.480337|2017-10-11 05:39:46.480337
NCT00224120|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2009-12-11|2009-09-08||May 2005||2005-05-01|December 2009|2009-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo|A Multi-Center, Randomized, Double-Blind, Placebo Controlled, Parallel Evaluation of the Efficacy and Safety of a New Drug in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|462|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:39:46.95319|2017-10-11 05:39:46.95319
NCT00224133|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2010-04-06|2009-12-23||September 2005||2005-09-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months|A Multi-Center, Open-Label Evaluation of the Safety of a New Drug in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|661|Actual|Watson Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:39:47.410345|2017-10-11 05:39:47.410345
NCT00224146|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2011-11-29|||May 2004||2004-05-01|November 2011|2011-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|MATRIX||Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder|Multicenter Assessment of Transdermal Therapy in Overactive Bladder With Oxybutynin TDS (MATRIX)|Completed||Phase 4|2878|Actual|Watson Pharmaceuticals|||||f||||||||||||||2017-10-11 05:39:48.010443|2017-10-11 05:39:48.010443
NCT00224159|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2011-02-18|||February 2005||2005-02-01|February 2011|2011-02-01|June 2006||2006-06-01|||||Observational|||Does Statin Initiation Undermine Dietary Behavior?|Does Statin Initiation Undermine Dietary Behavior?|Completed||N/A|100||Weill Medical College of Cornell University|||1||f||||||||||||||2017-10-11 05:39:48.138649|2017-10-11 05:39:48.138649
NCT00224172|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-03-27|||January 2001||2001-01-01|March 2008|2008-03-01|December 2001||2001-12-01|||||Observational|||Ambulatory Care Characteristics as Predictors of Mortality and Re-Admission|Ambulatory Care Characteristics as Predictors of Mortality and Re-Admission|Completed||N/A|302||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:39:48.213493|2017-10-11 05:39:48.213493
NCT00224185|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2016-04-29|||January 2004||2004-01-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Evaluation of Lungs of Normal Individuals by Lung Lavage, Brushing and Bronchial Wall Biopsy|Evaluation of the Lungs of Normal Individuals With Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing and Bronchial Wall Biopsy|Completed||N/A|196|Actual|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"     Specimens will be retained from both a blood draw and a bronchial wall biopsy which obtains     tissue to a depth of 2-3 mm and includes epithelial and subepithelial tissue.   "|Undecided||2017-10-11 05:39:48.277519|2017-10-11 05:39:48.277519
NCT00224198|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2016-04-29|||January 2004||2004-01-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Evaluation of the Lungs of Individuals With Lung Disease|Evaluation of the Lungs of Individuals With Lung Disease With Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing and Bronchial Wall Biopsy|Completed||N/A|196|Actual|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"     Specimens will be retained from both a blood draw and a bronchoscopy procedure.   "|Undecided||2017-10-11 05:39:48.369831|2017-10-11 05:39:48.369831
NCT00224211|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-03-12|||June 2005||2005-06-01|September 2005|2005-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Music's Effects on Premature Babies.|Effects of Homophonic Sounds on Preterm Infants|Completed||N/A|50|Actual|Weill Medical College of Cornell University|||1||f||||t||||||||||2017-10-11 05:39:48.466696|2017-10-11 05:39:48.466696
NCT00224224|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2008-04-02|||January 1995||1995-01-01|March 2008|2008-03-01|January 2005||2005-01-01|||||Observational|||A Comparison of Primary Care and Traditional Internal Medicine Residents|A Comparison of Primary Care and Traditional Internal Medicine Residents|Completed||N/A|||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:39:48.544549|2017-10-11 05:39:48.544549
NCT00224237|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-02-17|||December 2005|Actual|2005-12-01|February 2017|2017-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Exploring Folk Health Practices in Latinos With Chronic Medical Conditions|Exploring Folk Health Practices in Latinos With Chronic Medical Conditions|Completed||N/A|54|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No|No Plan to Share IPD|2017-10-11 05:39:48.620489|2017-10-11 05:39:48.620489
NCT00224250|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-12-07|||January 2005||2005-01-01|December 2006|2006-12-01||||||||Interventional|||Ultrasound Study of the Uterine Healing Process After Cesarean Delivery|Ultrasonographic Assessment of the Uterine Scarring Process Following Closure of the Uterus in One Versus Two Layer Technique.|Completed||N/A|30||Yale University|||||f||||||||||||||2017-10-11 05:39:48.718229|2017-10-11 05:39:48.718229
NCT00224263|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2011-08-15|||September 2005||2005-09-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|||||Interventional|||Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease Receiving Stable L-dopa/DCI|Completed||Phase 2|360||Xuanwu Hospital, Beijing|||||f||||t||||||||||2017-10-11 05:39:48.796151|2017-10-11 05:39:48.796151
NCT00224276|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-09-16||||||September 2005|2005-09-01||||||||Observational|||Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics|Prevalence and Incidence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics|Completed||Phase 4|100||Yale University|||||f||||||||||||||2017-10-11 05:39:48.879178|2017-10-11 05:39:48.879178
NCT00224289|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2012-11-09|2012-11-09||March 2005||2005-03-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Age on Latanoprost 0.005% in Patients With Glaucoma|Effect of Age on Efficacy and Response Time of Latanoprost 0.005% in Patients With Glaucoma|Completed||Phase 4|17|Actual|Yale University||1|||f||||f||||||||||2017-10-11 05:39:48.956889|2017-10-11 05:39:48.956889
NCT00224302|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-06-03|||August 2005||2005-08-01|September 2005|2005-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine|Treatment of Major Depressive Episodes During the Course of Psychotic Disorders With Duloxetine|Completed||Phase 4|20|Anticipated|Central Institute of Mental Health, Mannheim|||||f||||||||||||||2017-10-11 05:39:49.143902|2017-10-11 05:39:49.143902
NCT00224315|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2008-06-02|||November 2003||2003-11-01|June 2008|2008-06-01|September 2006||2006-09-01|||||Interventional|||Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial|Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial|Completed||Phase 4|24||Central Institute of Mental Health, Mannheim|||||f||||||||||||||2017-10-11 05:39:49.224466|2017-10-11 05:39:49.224466
NCT00224328|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-09-11|||August 2005||2005-08-01|September 2007|2007-09-01|January 2007|Actual|2007-01-01|||||Observational|||Measurement of Tissue Oxygen Saturation in Chronic Critical Limb Ischemia|Measurement of Tissue Oxygen Saturation in Chronic Critical Limb Ischemia: A Phase Iia, Non-Randomized Study Using the ODISsey Tissue Oximeter to Evaluate the Correlation Between Tissue Oxygen Saturation and Symptom Resolution in Patients With Chronic Critical Limb Ischemia Undergoing Treatment Interventions|Terminated||Phase 2|100|Anticipated|ViOptix Canada||||The results were not able to be consistantly reproduced. Thus the trial was terminated|f||||||||||||||2017-10-11 05:39:49.312789|2017-10-11 05:39:49.312789
NCT00224341|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2006-10-17|||November 2003||2003-11-01|September 2005|2005-09-01|November 2006||2006-11-01|||||Interventional|||Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation||Unknown status|Recruiting|Phase 4|360||Vitatron France|||||f||||||||||||||2017-10-11 05:39:49.405823|2017-10-11 05:39:49.405823
NCT00224354|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2012-05-18|||September 2005||2005-09-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|CLONTAK||Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells|Treatment of Chronic Lymphocytic B-Leukemia (B-CLL) With Human IL-2 Gene Modified and Human CD40 Ligand-Expressing Autologous Tumor Cells After Depletion of Regulatory T Cells|Withdrawn||Phase 1|0|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-10-11 05:39:49.704539|2017-10-11 05:39:49.704539
NCT00224367|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-09-21|||February 2004||2004-02-01|February 2005|2005-02-01|December 2004||2004-12-01|||||Interventional|||Does Early Ambulation After Hip Fracture Surgery Accelerate Recovery?|Does Early Ambulation After Hip Fracture Surgery Accelerate Recovery?: A Randomised Controlled Trial|Completed||N/A|60||Bayside Health|||||f||||||||||||||2017-10-11 05:39:49.80234|2017-10-11 05:39:49.80234
NCT00224380|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2009-09-22|||July 2003||2003-07-01|September 2009|2009-09-01|February 2005||2005-02-01|||||Interventional|||Medication Adherence in Older Adults With Serious Mental Illness|Medication Adherence in Older Adults|Completed||N/A|72||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-10-11 05:39:49.883282|2017-10-11 05:39:49.883282
NCT00224393|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-09-21|||February 2001||2001-02-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis||Suspended||Phase 2|60||The Cleveland Clinic|||||f||||||||||||||2017-10-11 05:39:49.955767|2017-10-11 05:39:49.955767
NCT00224406|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2008-11-26|||May 2005||2005-05-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|September 2007|Actual|2007-09-01||Interventional|||Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Repertaxin in the Prevention of Primary Graft Dysfunction After Lung Transplantation|Completed||Phase 2|100||Dompé Farmaceutici S.p.A|||||||||||||||||||2017-10-11 05:39:50.041144|2017-10-11 05:39:50.041144
NCT00224419|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2014-07-18|||June 2003||2003-06-01|April 2009|2009-04-01||||August 2006|Actual|2006-08-01||Interventional|||Testing Pharmacological Therapies for Pregnant Smokers|Testing Pharmacological Therapies for Pregnant Smokers|Terminated||Phase 4|181|Actual|Duke University||2||was terminated due to meeting a priori stopping rule set by DSMB|f||||t||||||||||2017-10-11 05:39:50.12116|2017-10-11 05:39:50.12116
NCT00224432|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2006-09-26|||March 2001||2001-03-01|September 2006|2006-09-01|September 2002||2002-09-01|||||Interventional|||Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis|Double-Blind, Parallel, Randomised Study to Investigate the Clinical and Immunological Effects of Oral Administration of Probiotic Bacteria in Infants With Atopic Dermatitis With and Without Cow’s Milk Allergy.|Completed||N/A|45||Groningen Research Institute for Asthma and COPD|||||f||||||||||||||2017-10-11 05:39:50.220714|2017-10-11 05:39:50.220714
NCT00224445|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-01-08|||September 2005||2005-09-01|January 2013|2013-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Boosted Atazanavir and Truvada Given Once-Daily - BATON Study|Boosted Atazanavir and Truvada Given Once-Daily (BATON Study): A Phase 4 Study of Safety, Efficacy & Adherence in HIV Infected, Antiretroviral Naïve Subjects Treated With a Simple Once-Daily Regimen|Completed||Phase 4|100|Actual|Gilead Sciences||1|||f||||||||||||||2017-10-11 05:39:50.287109|2017-10-11 05:39:50.287109
NCT00224458|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2008-04-07|||September 2004||2004-09-01|February 2008|2008-02-01|February 2006|Actual|2006-02-01|||||Interventional|||Combination of Efavirenz and Truvada - COMET Study|Combination of Efavirenz & Truvada (COMET Study): Phase 4 Evaluation of Switching Twice Daily Combivir to Once-Daily Regimen Co-Formulated Truvada in Virologically Suppressed HIV Infected Patients Taking Efavirenz.|Completed||Phase 4|400||Gilead Sciences||1|||f||||||||||||||2017-10-11 05:39:50.376064|2017-10-11 05:39:50.376064
NCT00224471|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2016-09-20|||December 2003||2003-12-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|September 2005|Actual|2005-09-01||Interventional|||Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine|A Phase III, Double-blind, Randomized, Study to Compare: 1) the Immunogenicity and Safety of 3 Commercial Scale Consistency Lots of GlaxoSmithKline (GSK) Biologicals' Herpes Simplex Candidate Vaccine in Healthy HSV-1 and -2 Seronegative (HSV 1-/2-) Female Subjects Aged 10 - 17 Years, and 2) Vaccine Immunogenicity in Healthy HSV 1-/2- Females Aged 10 - 17 Years With Healthy HSV 1-/2- Adult Females|Completed||Phase 3|671|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:39:50.443856|2017-10-11 05:39:50.443856
NCT00219102|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-24|||June 2005||2005-06-01|February 2011|2011-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients|A 12-week, Randomized, Double-blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy & Safety of Aliskiren in Patients With Diabetes & Hypertension Not Adequately Responsive to the Combination of Valsartan 160 mg & Hydrochlorothiazide 25 mg|Completed||Phase 3|336||Novartis|||||f||||||||||||||2017-10-11 05:39:55.883779|2017-10-11 05:39:55.883779
NCT00224484|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2017-02-24|2017-02-24||April 2004||2004-04-01|February 2017|2017-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old|A Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Herpes Simplex Candidate Vaccine (gD2‑AS04) in Healthy HSV Seronegative and Seropositive Female Subjects Aged 10-17 Years.|Completed||Phase 3|5960|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:39:50.803242|2017-10-11 05:39:50.803242
NCT00224497|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2009-12-23|||September 2005||2005-09-01|December 2009|2009-12-01||||||||Interventional|||A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease|A Phase IIa/b Double-blind, Randomised, Placebo-controlled, Linear Trend Design Dose-ranging Study to Investigate the Effects of 24 Weeks of Monotherapy With SB-742457 on Cognition in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|380||GlaxoSmithKline||1|||f||||||||||||||2017-10-11 05:39:54.751167|2017-10-11 05:39:54.751167
NCT00224510|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2017-05-24|||August 2002|Actual|2002-08-01|May 2017|2017-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium|A Mulitcentre, Double-blind, Randomised, Fixed-dose Evaluation of the Safety and Efficacy of Lamictal (Lamotrigine) Compared to Placebo as an add-on Therapy to Lithium or Another Mood Stabiliser in the Treatment of Bipolar Depression, Followed by Long-term Prevention of Relapse and Recurrence of Depression and/or Mania in Patients With Bipolar Disorder|Completed||Phase 3|120|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-10-11 05:39:54.942868|2017-10-11 05:39:54.942868
NCT00218972|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-12-05|||February 2005||2005-02-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Physical Exercise in Hypertension, Randomised Clinical Trial|Physical Exercise in Hypertension, Randomised Clinical Trial|Completed||N/A|88|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-10-11 05:39:55.110223|2017-10-11 05:39:55.110223
NCT00218985|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-02-14|||January 2005|Actual|2005-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Exercise-training Before Coronary Artery Bypass Graft (CABG)|Exercise-training Before Coronary Artery Bypass Graft (CABG)|Completed||N/A|40|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:39:55.215745|2017-10-11 05:39:55.215745
NCT00218998|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2017-03-29|||January 2004|Actual|2004-01-01|March 2017|2017-03-01||||||||Interventional|||Effective Endurance Training in Metabolic Syndrome|Effective Endurance Training in Metabolic Syndrome|Completed||N/A|30|Anticipated|Norwegian University of Science and Technology|||||f||||f|f|f||||||||2017-10-11 05:39:55.289798|2017-10-11 05:39:55.289798
NCT00219011|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-15|||May 2005||2005-05-01|May 2017|2017-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||"ALOFT - Aliskiren Observation of Heart Failure Treatment: Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure"|A Twelve-week, Randomized, Double-blind, Multi-center, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Aliskiren 150 mg When Added to Standard Therapy in Hypertensive Patients With Stable Heart Failure|Completed||Phase 3|280||Novartis|||||f||||||||||||||2017-10-11 05:39:55.36912|2017-10-11 05:39:55.36912
NCT00219024|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-15|||August 2004||2004-08-01|May 2017|2017-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.|An 8 Week Double-blind, Multicenter, Randomized, Multifactorial, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension|Completed||Phase 3|2775|Actual|Novartis|||||||||||||||||||2017-10-11 05:39:55.436733|2017-10-11 05:39:55.436733
NCT00219037|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||June 2004||2004-06-01|June 2006|2006-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension|A 12 Month, Randomized, Open-label, Multicenter, Study to Assess the Long Term Safety of Aliskiren 150 mg Alone and 300 mg Alone or With the Optional Addition of Hydrochlorothiazide (12.5 mg or 25 mg) in Patients With Essential Hypertension.|Completed||Phase 3|1955|Actual|Novartis|||||||||||||||||||2017-10-11 05:39:55.509597|2017-10-11 05:39:55.509597
NCT00219050|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-02-24|||February 2005||2005-02-01|February 2011|2011-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension|An Eight-week, Randomized, Double-blind, Multi-center, Active-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of an Aliskiren-based Regimen Compared to a Lisinopril-based Regimen in Patients With Uncomplicated Severe Hypertension|Completed||Phase 3|180||Novartis|||||f||||||||||||||2017-10-11 05:39:55.584448|2017-10-11 05:39:55.584448
NCT00219063|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-15|||February 2005||2005-02-01|May 2017|2017-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.|A 26 Week, Double-blind, Randomized, Multicenter, Parallel Group, Active-controlled Study Comparing Aliskiren to Ramipril With Optional Addition of Hydrochlorothiazide, Followed by a 4 Week Double-blind, Randomized, Placebo-controlled Withdrawal in Patients With Essential Hypertension|Completed||Phase 3|844|Actual|Novartis|||||||||||||||||||2017-10-11 05:39:55.657101|2017-10-11 05:39:55.657101
NCT00219076|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-16|||February 2005||2005-02-01|May 2017|2017-05-01||||October 2005|Actual|2005-10-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients|A Six-week, Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren 150 mg and Amlodipine 5 mg Compared to Amlodipine 5 mg and 10 mg in Hypertensive Patients Not Adequately Responsive to Amlodipine 5 mg|Completed||Phase 3|504||Novartis|||||f||||||||||||||2017-10-11 05:39:55.736386|2017-10-11 05:39:55.736386
NCT00219089|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-05-15|||November 2004||2004-11-01|May 2017|2017-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.|An Eight-week, Randomized, Double-blind, Parallel Group, Multicenter, Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination With Ramipril in Patients With Hypertension and Diabetes Mellitus|Completed||Phase 3|839|Actual|Novartis|||||||||||||||||||2017-10-11 05:39:55.810227|2017-10-11 05:39:55.810227
NCT00219115|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-02-03|||January 2005||2005-01-01|February 2017|2017-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg|A 12-week Randomized Double-blind Parallel Group Study to Evaluate the Efficacy and Safety of the Combination Aliskiren With HCTZ Compared to Irbesartan or Amlodipine With HCTZ or HCTZ Alone in Hypertensive Patients With BMI ≥ 30 kg/m2 Not Adequately Responsive to HCTZ 25 mg|Completed||Phase 3|493|Actual|Novartis|||||||||||||||||||2017-10-11 05:39:55.981271|2017-10-11 05:39:55.981271
NCT00219128|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-11-07|||November 2004||2004-11-01|June 2006|2006-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.|An Eight-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study Comparing Aliskiren 150 mg, 300 mg, and 600 mg to Placebo in Patients With Essential Hypertension|Completed||Phase 3|671|Actual|Novartis|||||||||||||||||||2017-10-11 05:39:56.061607|2017-10-11 05:39:56.061607
NCT00224523|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-26|2016-10-27|||September 2005||2005-09-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Long Term Safety Of GW685698X Via Nasal Biopsy|A Randomized, Open Label, Active Controlled (Mometasone Furoate Aqueous Nasal Spray [Nasonex®] 200mcg QD), Parallel Group, Multi-Center, 52-Week Study to Assess the Long Term Safety of GW685698X Aqueous Nasal Spray 100mcg QD Via Nasal Biopsy in Subjects 18 Years of Age With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|125|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:39:56.161605|2017-10-11 05:39:56.161605
NCT00224536|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-09-21|||January 2002||2002-01-01|September 2005|2005-09-01|October 2003||2003-10-01|||||Interventional|||Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration|Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration-1|Completed||Phase 1|60||Hannover Medical School|||||f||||||||||||||2017-10-11 05:39:56.3051|2017-10-11 05:39:56.3051
NCT00224549|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-02-25|||April 2005||2005-04-01|March 2007|2007-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||PHARES Study: Management of Resistant Hypertension|Management of Resistant Hypertension -Pharmacokinetic Assessment of Different Antihypertensive Regimen -Comparison of Two Treatment Strategies: Increase Sodium Depletion or Combined Blockage of Renin-angiotensin System (RAS)|Completed||Phase 4|180|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:39:56.419952|2017-10-11 05:39:56.419952
NCT00224575|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-03-07|||November 2004||2004-11-01|March 2016|2016-03-01|November 2006|Actual|2006-11-01|November 2005|Actual|2005-11-01||Interventional|IRIDIA||Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly|Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly|Terminated||N/A|260|Actual|Assistance Publique - Hôpitaux de Paris||1||End of recruitment period|f||||f||||||||||2017-10-11 05:39:56.628926|2017-10-11 05:39:56.628926
NCT00224588|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2006-04-12|||January 2003||2003-01-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||KETOR: Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain|Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain|Completed||Phase 3|80||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:39:56.727977|2017-10-11 05:39:56.727977
NCT00224601|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-02-17|||July 2005||2005-07-01|July 2007|2007-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome|Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Syndrome: Assessment of Coloscopy With Chromoscopy Benefit|Completed||Phase 2|80|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 05:39:56.804855|2017-10-11 05:39:56.804855
NCT00224614|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2005-12-13|||July 2005||2005-07-01|June 2005|2005-06-01|July 2009||2009-07-01|||||Interventional|||Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia|Randomised Prospective Comparison of the nonmyélo-Ablative Allograft and the Traditional Allograft in Acute Myeloid Leukaemia in Complete Remission of the Adult|Unknown status|Recruiting|Phase 3|100||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:39:56.886677|2017-10-11 05:39:56.886677
NCT00224627|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-03-23|||March 2002||2002-03-01|March 2007|2007-03-01|June 2005|Actual|2005-06-01|||||Interventional|||Capsule Endoscopy vs. Push Enteroscopy in Occult Gastrointestinal Bleeding OGIB|Efficiency of Capsule Endoscopy and Push Enteroscopy in Obscure Gastrointestinal Bleeding. A Prospective Randomized Study.|Completed||Phase 3|45||Assistance Publique - Hôpitaux de Paris|||||f||||t||||||||||2017-10-11 05:39:57.017207|2017-10-11 05:39:57.017207
NCT00224640|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-03-03|||March 2005||2005-03-01|March 2007|2007-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Iron-Chelating Therapy and Friedreich Ataxia|Effect of Iron-Chelating Therapy in Friedreich Ataxia. Study Phase I/II|Completed||Phase 1/Phase 2|15|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:39:57.105262|2017-10-11 05:39:57.105262
NCT00224653|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2006-04-12|||January 2005||2005-01-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Comparison Between Volume Controlled Ventilation and Pressure Controlled Ventilation||Completed||N/A|36||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:39:57.197765|2017-10-11 05:39:57.197765
NCT00224666|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-01-09|||March 2001||2001-03-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Efficacy of Cortex Stimulation in Neuropathic Pain|Evaluation of the Effectiveness of Stimulation Cortex Sensorimotor for the Treatment of Rebel Neuropathic Pains|Terminated||Phase 2|16||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:39:57.267739|2017-10-11 05:39:57.267739
NCT00224679|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2012-06-04|||March 1997||1997-03-01|September 2006|2006-09-01|March 1999||1999-03-01|||||Interventional|||APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence|Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence|Terminated||Phase 3|300||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:39:57.351151|2017-10-11 05:39:57.351151
NCT00224692|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2006-10-25|||February 2003||2003-02-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine|MK III Trial: Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine|Terminated||Phase 3|50||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:39:57.435503|2017-10-11 05:39:57.435503
NCT00224705|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2011-02-16|||August 2004||2004-08-01|July 2007|2007-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure|Efficacy and Safety of the Albumin Dialysis MARS® Therapy in Patients With Fulminant and Subfulminant Hepatic Failure|Completed||Phase 3|110|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:39:57.530459|2017-10-11 05:39:57.530459
NCT00224718|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2009-03-31|||January 2003||2003-01-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|ACE||Elective Abdominal Aortic Aneurism - Open Versus Endovascular Repair|"ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal  Surgery Versus Endoprosthesis "|Completed||N/A|306|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:39:57.842712|2017-10-11 05:39:57.842712
NCT00224731|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2006-10-25|||December 2003||2003-12-01|September 2005|2005-09-01||||||||Observational|||Sleep Disorders in Children With ADHD|Sleep Disorders in Children With ADHD|Unknown status|Recruiting|N/A|100||Hvolby, Allan, M.D.|||||f||||||||||||||2017-10-11 05:39:57.943917|2017-10-11 05:39:57.943917
NCT00224744|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2014-09-11|||November 2005||2005-11-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage|Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage.|Completed||Phase 3|73|Actual|Institut Claudius Regaud||2|||f||||||||||||||2017-10-11 05:39:58.017125|2017-10-11 05:39:58.017125
NCT00224757|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2011-09-05|||September 2005||2005-09-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|TIARA||Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study|Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation|Completed||N/A|227|Actual|The Interuniversity Cardiology Institute of the Netherlands||2|||f||||t||||||||||2017-10-11 05:39:58.09718|2017-10-11 05:39:58.09718
NCT00224770|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2015-06-17|2014-09-21||August 2005||2005-08-01|June 2015|2015-06-01|April 2013|Actual|2013-04-01|August 2012|Actual|2012-08-01||Interventional|MISTIE|The decision was made to exclude the pilot patients from the analysis...|Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation|Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation|Completed||Phase 2|141|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-10-11 05:39:58.225222|2017-10-11 05:39:58.225222
NCT00224783|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2012-01-25|||August 2002||2002-08-01|January 2012|2012-01-01|September 2002|Actual|2002-09-01|||||Interventional|||Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults|Placebo-controlled Double-blind Controlled Trial of Single Intranasal Inoculation of CAIV-T Liquid Formulation in Healthy Japanese Male Adults|Completed||Phase 1|45|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 05:39:59.644765|2017-10-11 05:39:59.644765
NCT00224796|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2006-07-19|||May 2002||2002-05-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Trial of Vacuum Assisted Closure® Therapy in Amputation Wounds of the Diabetic Foot|A Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure® Therapy in the Treatment and Blinded Evaluation of Amputation Wounds of the Diabetic Foot|Completed||Phase 4|146||KCI USA, Inc.|||||f||||||||||||||2017-10-11 05:39:59.736264|2017-10-11 05:39:59.736264
NCT00224809|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2014-02-18|||September 2002||2002-09-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation|Functional Mitral Regurgitation in STICH|Completed||N/A|250|Anticipated|Baylor Research Institute|||||f||||||||||||||2017-10-11 05:39:59.812769|2017-10-11 05:39:59.812769
NCT00224822|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2010-03-23|||March 2004||2004-03-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||The Effects of Aripiprazole on Patients With Metabolic Syndrome|"The Effects of Aripiprazole on Patients With Metabolic Syndrome: An Open-Label Trial"|Completed||Phase 4|27|Actual|New Mexico VA Healthcare System|||||f||||t||||||||||2017-10-11 05:39:59.926502|2017-10-11 05:39:59.926502
NCT00224835|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2016-05-12|||May 2003||2003-05-01|May 2016|2016-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Mindfulness-Based Stress Reduction and Myocardial Ischemia|Mindfulness-Based Stress Reduction and Myocardial Ischemia|Completed||N/A|150|Actual|University of Florida||2|||f||||t||||||||||2017-10-11 05:40:00.018909|2017-10-11 05:40:00.018909
NCT00224848|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2016-11-04|||July 2002||2002-07-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|September 2007|Actual|2007-09-01||Interventional|GLAD Heart||Guideline Adherence for Heart Health||Completed||Phase 2|61|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||f||||||||||2017-10-11 05:40:00.121821|2017-10-11 05:40:00.121821
NCT00225212|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2014-09-04|2014-08-26||November 1997||1997-11-01|September 2014|2014-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma|Clinical Trial Of C2B8 Monoclonal Antibody Following High Dose Therapy And Autografting In B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|35|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 05:40:00.204091|2017-10-11 05:40:00.204091
NCT00225225|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2016-10-18|||October 2002||2002-10-01|October 2016|2016-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Rosiglitazone-Induced Weight Gain|Rosiglitazone-Induced Weight Gain|Terminated||N/A|45|Actual|Stanford University||2||due to published data on Rosiglitazone|f||||||||||||||2017-10-11 05:40:00.434732|2017-10-11 05:40:00.434732
NCT00225238|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep|The Effect of Esomeprazole (Nexium) on the Incidence and Severity of Gastrointestinal Adverse Events Associated With a Colonoscopy Purgative|Completed||Phase 4|500|Actual|Thomas Jefferson University||1|||f||||f||||||||||2017-10-11 05:40:00.519574|2017-10-11 05:40:00.519574
NCT00225251|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2015-10-29|2014-05-13||November 2004||2004-11-01|October 2014|2014-10-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional||adults with dysthymic disorder, males and females|Wellbutrin XL for Dysthymic Disorder|Double-Blind Treatment of Outpatients With Dysthymic Disorder With Wellbutrin XL|Completed||Phase 4|18|Actual|St. Luke's-Roosevelt Hospital Center|Early termination led to small numbers of subjects analyzed|2|||f||||f||||||||||2017-10-11 05:40:00.616001|2017-10-11 05:40:00.616001
NCT00225264|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2012-02-27|||October 2003||2003-10-01|February 2012|2012-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|CHICAGO||Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.|A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus Glimepiride on the Rate of Progression of Atherosclerotic Disease as Measured by Carotid Intima-Media Thickness|Completed||Phase 3|458|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:40:01.201953|2017-10-11 05:40:01.201953
NCT00225277|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2012-02-27|2008-10-17||July 2003||2003-07-01|February 2012|2012-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|PERISCOPE||Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus|A Double-Blind, Randomized, Comparator-Controlled Study In Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus Glimepiride on the Rate of Progression of Coronary Atherosclerotic Disease as Measured by Intravascular Ultrasound|Completed||Phase 3|547|Actual|Takeda|Composite Endpoints A,B,C include cardiovascular mortality, nonfatal MI and nonfatal stroke. In addition, B: coronary revascularization, carotid endarterectomy/stenting, unstable angina hosp. or CHF; C: hospitalization for unstable angina or CHF.|2|||f||||f||||||||||2017-10-11 05:40:01.38791|2017-10-11 05:40:01.38791
NCT00225290|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2011-10-07|||February 2003||2003-02-01|September 2005|2005-09-01||||||||Interventional|||Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve|Double-blind, Placebo-controlled, Randomized Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve|Terminated||Phase 3|230|Anticipated|TTY Biopharm||||slowly recruitment rate|f||||||||||||||2017-10-11 05:40:03.082234|2017-10-11 05:40:03.082234
NCT00225303|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2011-05-18|||March 2005||2005-03-01|October 2010|2010-10-01|June 2006|Actual|2006-06-01|||||Interventional|||TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use|A Phase II, Randomized, Active Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-na�ve and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use.|Completed||Phase 2|116|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-10-11 05:40:03.149879|2017-10-11 05:40:03.149879
NCT00225316|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2011-05-13|||August 2005||2005-08-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Maternal Acupuncture for Substance Abuse|Can Maternal Acupuncture for Chemically Dependent Pregnant Women Reduce the Severity of Neonatal Abstinence Syndrome? - A Randomized Controlled Trial|Completed||Phase 3|89|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:40:03.248367|2017-10-11 05:40:03.248367
NCT00225329|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-09-21|||September 2001||2001-09-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Early Labour Assessment and Support at Home|Early Labour Support at Home: RCT of Nurse Visits and Telephone Triage|Completed||N/A|1466||University of British Columbia|||||f||||||||||||||2017-10-11 05:40:03.96893|2017-10-11 05:40:03.96893
NCT00225342|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2006-09-07||||||September 2005|2005-09-01||||||||Interventional|||Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina|Effects of Rosiglitazone and Sulphonylureas on Ischaemic Burden, Blood Pressure and Novel Risk Markers Inclusive of Vascular Function in Patients With Chronic Stable Angina and Type 2 Diabetes Mellitus: A Randomised, Double-Blinded Study.|Withdrawn||Phase 4|60||University of Glasgow|||||f||||||||||||||2017-10-11 05:40:04.050497|2017-10-11 05:40:04.050497
NCT00225355|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2009-02-18|||February 2006||2006-02-01|February 2009|2009-02-01|November 2006|Anticipated|2006-11-01|||||Interventional|||Rosiglitazone Versus Placebo in Chronic Stable Angina|Insulin Sensitisation as a Novel Mechanism to Lessen Ischaemic Burden in Overweight Non-Diabetic Patients With Chronic Stable Angina: A Pilot Study|Terminated||Phase 4|80|Anticipated|University of Glasgow|||||f||||||||||||||2017-10-11 05:40:05.697588|2017-10-11 05:40:05.697588
NCT00225368|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2010-02-05||||||September 2005|2005-09-01||||||||Interventional|||Effects of Insecticide Treated Bednets on Child Morbidity and Mortality|Long Term Effects of Insecticide Treated Bednets on the Morbidity and Mortality Caused by Malaria and on the Overall Mortality in Young Children of a Rural Population in Burkina Faso|Completed||N/A|||Heidelberg University|||||f||||||||||||||2017-10-11 05:40:05.783758|2017-10-11 05:40:05.783758
NCT00225381|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2011-02-10|||August 2005||2005-08-01|February 2011|2011-02-01|December 2011|Anticipated|2011-12-01|||||Observational|||Gas Kinetics and Metabolism in Anesthesia During Non Steady State|Gas Kinetics and Metabolism in Anesthesia During Non Steady State|Unknown status|Recruiting|Phase 1|100|Anticipated|University of California, Irvine|||7||f||||f||||||||||2017-10-11 05:40:05.873103|2017-10-11 05:40:05.873103
NCT00225394|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-09-21|||October 2003||2003-10-01|August 2005|2005-08-01|July 2006||2006-07-01|||||Observational|||Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients|Long-Term Valcyte Therapy in Transplant Patients and the Development of Ganciclovir Resistant CMV|Completed||Phase 4|100||University of Massachusetts, Worcester|||||||||||||||||||2017-10-11 05:40:06.045034|2017-10-11 05:40:06.045034
NCT00225407|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-09-21|||July 2005||2005-07-01|March 2005|2005-03-01|December 2005||2005-12-01|||||Interventional|||Processing and Effects of Cannabis|A Double-Blind, Randomised, Placebo-Controlled, Cross-Over Study on the Pharmacokinetics and Effects of Cannabis|Unknown status|Recruiting|Phase 1|27||UMC Utrecht|||||f||||||||||||||2017-10-11 05:40:06.124015|2017-10-11 05:40:06.124015
NCT00225420|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2017-04-26|2017-03-09||August 2005||2005-08-01|April 2017|2017-04-01|August 2012|Actual|2012-08-01|June 2010|Actual|2010-06-01||Interventional|NRR|All patients included in this trial were high-risk localized (Gleason 8-10 or PSA level >= 20 ng/mL) prostate cancer, or T3 disease.|Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer|A Phase I/II Study of Concurrent Weekly Docetaxel (Taxotere®), Androgen Ablation, and Adaptive External Beam Radiotherapy for Localized High-Risk Adenocarcinoma of the Prostate|Completed||Phase 1/Phase 2|23|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:40:06.237422|2017-10-11 05:40:06.237422
NCT00225433|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2015-12-01|||September 2005||2005-09-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|December 2006|Actual|2006-12-01||Interventional|||Luteal Phase FSH in the IVF Poor Responder|Luteal Phase Recombinant FSH vs. Follicular Phase Recombinant FSH for IVF Stimulation in the Poor Responder|Completed||Phase 4|20|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-10-11 05:40:06.843298|2017-10-11 05:40:06.843298
NCT00225446|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2008-06-03|||February 2006||2006-02-01|June 2008|2008-06-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Micron Tracker: Computer-Assisted Orthognathic Surgery With a Third Generation Optic Repositioning System|Computer-Assisted Orthognathic Surgery With a Third Generation Optic Repositioning System.|Suspended||Phase 1/Phase 2|20|Anticipated|University Hospital, Grenoble||1|||f||||||||||||||2017-10-11 05:40:06.954523|2017-10-11 05:40:06.954523
NCT00225459|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2011-10-04|||June 2005||2005-06-01|October 2011|2011-10-01|December 2008|Actual|2008-12-01|||||Observational|||Does Spiritual/Religious Commitment Mediate the Relationship Between Mood Variability and Suicidal Ideation.|Does Spiritual/Religious Commitment Mediate the Relationship Between Mood Variability and Suicidal Ideation.|Completed||N/A|200|Anticipated|University of Saskatchewan|||1||f||||||||||||||2017-10-11 05:40:07.069958|2017-10-11 05:40:07.069958
NCT00225472|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-05-10|||June 2004||2004-06-01|May 2016|2016-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Organ Preservation Media Investigation|Organ Preservation Media Investigation|Completed||Phase 1|20|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-10-11 05:40:07.162691|2017-10-11 05:40:07.162691
NCT00225485|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-25|||December 2003||2003-12-01|May 2007|2007-05-01||||||||Interventional|||Study Evaluating Effexor XR in Elderly Patients With Major Depression.|Phase III Study of Effexor XR for the Treatment of Elderly Patients With Depression|Completed||Phase 3|100||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:40:07.263819|2017-10-11 05:40:07.263819
NCT00225498|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2015-09-02|2012-12-12||June 2002||2002-06-01|September 2015|2015-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Baseline characteristics for all participants prior to randomization are reported because treatment assignment information is not available. That information was not preserved when the orginally planned analyses were not conducted because the enrollment was insufficient for statistically valid results.|Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade|Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade|Completed||N/A|35|Actual|Northwell Health|This is a small sample.|2|||f||||f||||||||||2017-10-11 05:40:07.44454|2017-10-11 05:40:07.44454
NCT00225511|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-22|||June 2004||2004-06-01|May 2007|2007-05-01||||||||Interventional|||Study Evaluating Effexor XR for Major Depression.|Phase III Multi-Center, Double-Blind, Comparative Study of Effexor XR for the Treatment of Depression|Completed||Phase 3|590|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:40:07.657688|2017-10-11 05:40:07.657688
NCT00225524|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-05-22|||September 2004||2004-09-01|May 2007|2007-05-01||||||||Interventional|||Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.|Phase III Long-Term Administration Study of Effexor XR for the Treatment of Depression|Completed||Phase 3|150|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:40:07.894502|2017-10-11 05:40:07.894502
NCT00225537|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2006-09-07|||September 2005||2005-09-01|April 2006|2006-04-01|August 2007||2007-08-01|||||Interventional|||4-Methylumbelliferone as a Treatment for Chronic HBV/HCV|Evaluation of 4-Methylumbelliferone for Treatment of Chronic Hepatitis B (HBV) and Chronic Hepatitis C (HCV)|Unknown status|Active, not recruiting|Phase 2|160||MTmedical Institute of Health|||||f||||||||||||||2017-10-11 05:40:08.094674|2017-10-11 05:40:08.094674
NCT00225550|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2007-08-03||||||August 2007|2007-08-01||||||||Interventional|||A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors|Dose Finding, Safety, Pharmacokinetic and Pharmacodynamic Study of the Vascular Targeting Agent Exherin™ (ADH-1) Administered Once Daily for 5 Consecutive Days by Intravenous Infusion in Subjects With N-Cadherin Expressing, Incurable, Solid Tumors (Adherex Protocol Number AHX 01 003)|Terminated||Phase 1/Phase 2|||Adherex Technologies, Inc.|||||||||||||||||||2017-10-11 05:40:08.294223|2017-10-11 05:40:08.294223
NCT00225576|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2014-01-23|||September 2005||2005-09-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2007|Actual|2007-11-01||Interventional|||Statewide Implementation of Electronic Health Records|Statewide Implementation of Electronic Health Records|Completed||Phase 2|2030|Anticipated|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-10-11 05:40:08.443166|2017-10-11 05:40:08.443166
NCT00225589|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2010-11-18|||August 2002||2002-08-01|November 2010|2010-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)|A Randomized, Double-blind, Placebo-controlled, Multicenter Parallel Group Phase III Study Measuring Effects on Intima Media Thickness: an Evaluation Of Rosuvastatin 40 mg (METEOR)|Completed||Phase 3|840||AstraZeneca|||||||||||||||||||2017-10-11 05:40:08.548018|2017-10-11 05:40:08.548018
NCT00225602|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2005-09-22|||January 2004||2004-01-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Interventional|||Assertive Community Treatment in Copenhagen|Quasi-Experimental Trial of the Effect of Assertive Community Treatment Among Those With Severe Mental Disorder|Unknown status|Active, not recruiting|N/A|400||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:40:08.783114|2017-10-11 05:40:08.783114
NCT00225615|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2009-08-18|||November 2005||2005-11-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|||||Interventional|||A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels|A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels|Completed||Phase 3|100||BioMarin Pharmaceutical|||||||||||||||||||2017-10-11 05:40:08.884522|2017-10-11 05:40:08.884522
NCT00225628|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2005-09-23|||September 2000||2000-09-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Improving Quality With Outpatient Decision Support|Improving Quality With Outpatient Decision Support|Completed||N/A|3000||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:40:09.012019|2017-10-11 05:40:09.012019
NCT00225641|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2015-12-21|||March 2006||2006-03-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer|COLOFOL - A Pragmatic Study to Assess the Frequency of Surveillance Tests After Curative Resection in Patients With Stage II and III Colorectal Cancer - a Randomised Multicentre Trial|Active, not recruiting||N/A|2500|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||||2017-10-11 05:40:09.144415|2017-10-11 05:40:09.144415
NCT00225667|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-11-22|||December 2005||2005-12-01|November 2005|2005-11-01|July 2007||2007-07-01|||||Interventional|||Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers|Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension, Permanent Pacemakers and Risk Factors for Developing Atrial Fibrillation|Unknown status|Not yet recruiting|Phase 3|200||Connolly, Stuart, M.D.|||||f||||||||||||||2017-10-11 05:40:09.366179|2017-10-11 05:40:09.366179
NCT00225680|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-01-30|||April 2002||2002-04-01|January 2012|2012-01-01|August 2005||2005-08-01|||||Interventional|ELUTES II||In Stent ELUTES Study|ELUTES II - In Stent ELUTES Study|Completed||N/A|124||Cook Group Incorporated|||||f||||||||||||||2017-10-11 05:40:09.480138|2017-10-11 05:40:09.480138
NCT00225693|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-01-30|||October 2003||2003-10-01|January 2012|2012-01-01|July 2005||2005-07-01|||||Interventional|ELUTES III||V-Flex Plus PTX Drug Eluting Coronary Stent|ELUTES III - V-Flex Plus PTX Drug Eluting Coronary Stent|Completed||N/A|150||Cook Group Incorporated|||||f||||||||||||||2017-10-11 05:40:09.572279|2017-10-11 05:40:09.572279
NCT00225706|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2010-04-08|||October 2005||2005-10-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of Caldolor in Hospitalized Febrile Pediatric Patients|Efficacy and Safety Study of Caldolor in Hospitalized Febrile Pediatric Patients|Completed||Phase 3|||Cumberland Pharmaceuticals|||||||||||||||||||2017-10-11 05:40:09.650283|2017-10-11 05:40:09.650283
NCT00225719|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-11-06|||July 2005||2005-07-01|November 2008|2008-11-01||||||||Interventional|||Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL|Regression of Coronary Atherosclerotic Lesions After rHDL Infusions in Acute Coronary Syndrome Patients as Assessed by Intravascular Ultrasound.|Completed||Phase 2|180|Anticipated|CSL Limited|||||f||||||||||||||2017-10-11 05:40:09.726971|2017-10-11 05:40:09.726971
NCT00225732|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2016-05-17|2011-04-01||January 2005||2005-01-01|May 2016|2016-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Pain in the Post-Operative Adult Patients|Completed||Phase 3|319|Actual|Cumberland Pharmaceuticals||2|||f||||t||||||||||2017-10-11 05:40:09.800879|2017-10-11 05:40:09.800879
NCT00225745|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2015-10-12|||April 2004||2004-04-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|October 2013|Actual|2013-10-01||Observational|||Ghrelin Levels in Pancreatic Cancer Patients|Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer|Completed||N/A|72|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||t||||||Samples Without DNA|"     Whole Blood   "|||2017-10-11 05:40:10.259994|2017-10-11 05:40:10.259994
NCT00225758|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2015-01-12|||January 2006||2006-01-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy|Lapatinib in Endocrine-Resistant Metastatic Breast Cancer|Terminated||Phase 2|27|Actual|Dartmouth-Hitchcock Medical Center||1||slow accrual|f||||t||||||||||2017-10-11 05:40:10.345214|2017-10-11 05:40:10.345214
NCT00225784|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2014-07-10|2012-08-22||February 2005||2005-02-01|October 2011|2011-10-01|September 2012|Actual|2012-09-01|February 2010|Actual|2010-02-01||Interventional|||Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer|A Phase II Trial of Cetuximab, Radiotherapy and Twice Weekly Gemcitabine in Patients With Adenocarcinoma of the Pancreas|Completed||Phase 2|37|Actual|Dartmouth-Hitchcock Medical Center|Our study suffers limitations common to single institution trials, namely small patient numbers and selection bias. Our cohort of subjects is too small to adequately assess the effect of tumor EGFR and KRAS status on outcome.|1|||f||||t||||||||||2017-10-11 05:40:10.454948|2017-10-11 05:40:10.454948
NCT00225797|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2010-02-12|||November 2004||2004-11-01|February 2010|2010-02-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain|An Open-Label Titration Followed by a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Tolerability, and Safety of Oxymorphone Extended Release Tablets in Opioid-Naïve Patients With Chronic Low Back Pain|Completed||Phase 3|160||Endo Pharmaceuticals|||||||||||||||||||2017-10-11 05:40:10.845983|2017-10-11 05:40:10.845983
NCT00225810|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2011-05-18|||October 2005||2005-10-01|May 2011|2011-05-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease|Multicentre, Controlled, Randomised, Open, Cross-over Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tbl. 500 mg in Children With Crohn´s Disease|Completed||Phase 4|50|Actual|Ferring Pharmaceuticals|||||f||||f||||||||||2017-10-11 05:40:10.995345|2017-10-11 05:40:10.995345
NCT00225823|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2016-09-13|||May 2005||2005-05-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study In Adults And Adolescents With Seasonal Allergic Rhinitis.|A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Two Week Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis in Europe|Completed||Phase 3|288|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:40:11.074388|2017-10-11 05:40:11.074388
NCT00225849|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2005-09-22|||March 2005||2005-03-01|September 2005|2005-09-01|September 2010||2010-09-01|||||Interventional|||Japanese Primary Prevention Project With Aspirin|Japanese Primary Prevention Project With Aspirin in the Elderly With One or More Risk Factors of Vascular Events: JPPP|Unknown status|Recruiting|Phase 4|10000||Ministry of Health, Labour and Welfare, Japan|||||f||||||||||||||2017-10-11 05:40:11.278985|2017-10-11 05:40:11.278985
NCT00225862|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2016-09-13|||January 2005||2005-01-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|||||Interventional|||A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)|A 12-week, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Intermittent Dosing of Ropinirole in Patients With Restless Legs Syndrome (RLS)|Completed||Phase 3|140|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:40:11.413239|2017-10-11 05:40:11.413239
NCT00225875|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2005-10-25|||September 2003||2003-09-01|March 2005|2005-03-01|July 2007||2007-07-01|||||Interventional|||Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy|Evaluation De l’Efficacité Du Rituximab (Mabthéra) Chez l'Adulte Atteint d'Un Purpura thrombopénique Auto-Immun Chronique Et sévère Et Candidat à La splénectomie|Terminated||Phase 2|65||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-10-11 05:40:11.591564|2017-10-11 05:40:11.591564
NCT00225888|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2017-04-12|||October 2004||2004-10-01|April 2017|2017-04-01|July 20, 2007|Actual|2007-07-20|July 20, 2007|Actual|2007-07-20||Interventional|||Feasibility Study of Digital Photography and Group Discussion for People With Diabetes|Digital Photography and Group Discussion as a Means of Affecting Dietary Change Among People With Type 2 Diabetes: Feasibility Project|Terminated||N/A|36|Anticipated|Joslin Diabetes Center||1||Investigators left Joslin|f||||||||||||||2017-10-11 05:40:11.697229|2017-10-11 05:40:11.697229
NCT00225901|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-09-22|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure|Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant and Late-Onset Hepatic Failure|Unknown status|Recruiting|Phase 1/Phase 2|16||Kyoto University, Graduate School of Medicine|||||f||||||||||||||2017-10-11 05:40:11.812562|2017-10-11 05:40:11.812562
NCT00225914|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2010-11-23|||September 2004||2004-09-01|November 2010|2010-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Study of Paxil Use in Menopausal Women|Paroxetine Controlled Release in the Treatment of Symptomatic Menopausal Women Following Discontinuation of Hormone Therapy|Completed||Phase 4|64|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 05:40:11.916915|2017-10-11 05:40:11.916915
NCT00225927|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-02-28|||June 2004||2004-06-01|March 2010|2010-03-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers|A Prospective, Randomized, Controlled Trial of Radioguided Seed Localization Versus Standard Needle Localization of Nonpalpable Breast Cancers|Completed||N/A|333|Actual|McMaster University||1|||f||||f||||||||||2017-10-11 05:40:12.03238|2017-10-11 05:40:12.03238
NCT00225966|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-11-14|||August 2004||2004-08-01|November 2013|2013-11-01|October 2007||2007-10-01|||||Interventional|||Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control|Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control|Terminated||N/A|153||MedtronicNeuro||||Study design was changed and is now InSite trial #1634 - See NCT00547378|f||||||||||||||2017-10-11 05:40:12.161444|2017-10-11 05:40:12.161444
NCT00225979|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2012-04-10|||November 2002||2002-11-01|April 2012|2012-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly|Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly|Completed||Phase 3|100|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:40:12.24849|2017-10-11 05:40:12.24849
NCT00225992|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2012-10-10|||February 2004||2004-02-01|October 2012|2012-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)|A Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)|Terminated||Phase 2|||Oncology Specialties, Alabama||||terminated due to lack of accrual.|f||||f||||||||||2017-10-11 05:40:12.344705|2017-10-11 05:40:12.344705
NCT00226005|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2012-05-08|||December 2005||2005-12-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|December 2008|Actual|2008-12-01||Interventional|||PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma|Phase II Trial of PTK787/ZK222584 in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Who Failed First-Line Gemcitabine Therapy.|Completed||Phase 2|67|Actual|Pancreatic Cancer Research Team||1|||f||||t||||||||||2017-10-11 05:40:12.453073|2017-10-11 05:40:12.453073
NCT00226018|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2008-04-16|||March 2005||2005-03-01|April 2008|2008-04-01|October 2006||2006-10-01|||||Interventional|||Performance of Acceleromyography With and Without Preload|Performance of Acceleromyography With and Without Preload During Neuromuscular Blockade|Completed||Phase 4|60||Rigshospitalet, Denmark||4|||f||||f||||||||||2017-10-11 05:40:12.572278|2017-10-11 05:40:12.572278
NCT00226031|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2015-03-10|||September 2003||2003-09-01|March 2015|2015-03-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||Optimal Management of Women With Wrist Fractures|Optimal Management of Older Women With Distal Forearm Fractures|Completed||N/A|270|Actual|Queen's University||2|||f||||f||||||||||2017-10-11 05:40:12.665473|2017-10-11 05:40:12.665473
NCT00226044|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2013-04-25|||September 2005||2005-09-01|April 2013|2013-04-01|December 2007||2007-12-01|||||Interventional|||Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.|Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study.|Unknown status|Recruiting|Phase 3|20|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-10-11 05:40:12.757137|2017-10-11 05:40:12.757137
NCT00226057|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2005-09-22|||June 2005||2005-06-01|August 2005|2005-08-01|November 2005||2005-11-01|||||Interventional|||Efalizumab for Moderate to Severe Atopic Dermatitis|Efalizumab for Moderate to Severe Atopic Dermatitis - A Phase I Pilot Study in Adults|Completed||Phase 1|10||Oregon Health and Science University|||||||||||||||||||2017-10-11 05:40:12.855097|2017-10-11 05:40:12.855097
NCT00226070|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2006-12-18|||September 2004||2004-09-01|December 2006|2006-12-01|September 2005||2005-09-01|||||Interventional|||Rehabilitation to Patients Over 65 Years Undergoing THA|Cross-Section Study Among Patients Waiting for or Already Undergoing THA Followed by a RCT|Unknown status|Recruiting|Phase 1/Phase 2|160||University of Aarhus|||||f||||||||||||||2017-10-11 05:40:12.951888|2017-10-11 05:40:12.951888
NCT00226083|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2015-06-05|||August 2005||2005-08-01|June 2015|2015-06-01|September 2007|Anticipated|2007-09-01|September 2007|Anticipated|2007-09-01||Observational|||Study of Blood Platelets in Sickle Cell Disease|Studies of Large Platelets in Patients With Sickle Cell Disease|Withdrawn||N/A|0|Actual|Rockefeller University|||1|PI returned to India|f||||f||||||||||2017-10-11 05:40:13.053913|2017-10-11 05:40:13.053913
NCT00226096|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-06-25|||November 2005||2005-11-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage|A Randomised Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients With Stroke Due to Acute Intracerebral Haemorrhage|Completed||N/A|404|Actual|The George Institute||1|||f||||t||||||||||2017-10-11 05:40:13.123396|2017-10-11 05:40:13.123396
NCT00226109|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2010-10-19|||April 2004||2004-04-01|October 2010|2010-10-01|December 2011|Anticipated|2011-12-01|August 2011|Anticipated|2011-08-01||Interventional|SPICA||Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics|Effect of Spironolactone Treatment on Heart- and Skeletal Muscle in Chronic Alcoholics|Suspended||Phase 4|40|Anticipated|University of Aarhus||1||Problems recruting patients|f||||t||||||||||2017-10-11 05:40:13.272106|2017-10-11 05:40:13.272106
NCT00226122|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2010-06-24|||January 2003||2003-01-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal|The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal|Completed||Phase 4|56|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:40:13.371461|2017-10-11 05:40:13.371461
NCT00226135|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2007-04-04|||March 2001||2001-03-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder|Lamotrigine Versus Lithium in Subjects With Bipolar Affective Disorders - a Randomised Study of Prophylactic Effect|Completed||Phase 3|150||University of Aarhus|||||f||||f||||||||||2017-10-11 05:40:13.446428|2017-10-11 05:40:13.446428
NCT00226148|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2009-09-08|||September 2005||2005-09-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Immediate Implant Placement in the Molar Regions|Immediate Implant Placement in the Molar Regions|Completed||Early Phase 1|92|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:40:13.52069|2017-10-11 05:40:13.52069
NCT00226161|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2013-01-25|||September 2005||2005-09-01|September 2005|2005-09-01|September 2013||2013-09-01|September 2013||2013-09-01||Interventional|||Chronic Pain After Inguinal Herniorrhaphy||Terminated||N/A|||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-10-11 05:40:13.594347|2017-10-11 05:40:13.594347
NCT00226174|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2005-09-22|||February 2003||2003-02-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||A Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Curcuminoids in Oral Lichen Planus|A Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Curcuminoids in Oral Lichen Planus|Terminated||Phase 2|||University of California, San Francisco|||||||||||||||||||2017-10-11 05:40:13.76118|2017-10-11 05:40:13.76118
NCT00226187|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2007-02-14|||December 2003||2003-12-01|September 2005|2005-09-01||||||||Interventional|||A Randomized Clinical Trial on Supplementation of DHA and AA to Preterm Infants||Completed||N/A|140||University of Oslo|||||f||||||||||||||2017-10-11 05:40:13.842501|2017-10-11 05:40:13.842501
NCT00226200|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2008-11-26|||November 2004||2004-11-01|November 2008|2008-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Soluble CD23 Expression in Asthma Patients Treated With OMA|Soluble CD23 Expression as a Marker of Immunomodulation and CLinical Response in Asthma Patients Treated With Omalizumab|Terminated||N/A|80||University of Mississippi Medical Center||||Completed|||||t||||||||||2017-10-11 05:40:13.922996|2017-10-11 05:40:13.922996
NCT00226213|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2007-12-11|||February 2005||2005-02-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Peripherally Inserted Central Catheter Placement by Interventional Radiologists Using the Sonic Flashlight|Peripherally Inserted Central Catheter Placement by Interventional Radiologists Using the Sonic Flashlight|Completed||Phase 1|20|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:40:14.027058|2017-10-11 05:40:14.027058
NCT00226226|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2008-02-10|||June 2006||2006-06-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|||||Interventional|||Peripherally Inserted Central Catheter Placement by IV Team Nurses Using the Sonic Flashlight|Peripherally Inserted Central Catheter Placement by IV Team Nurses Using the Sonic Flashlight|Completed||Phase 1|230|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-10-11 05:40:14.126051|2017-10-11 05:40:14.126051
NCT00226239|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2017-07-09|2016-01-15||October 2005||2005-10-01|April 2017|2017-04-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer|A Phase II Trial of Docetaxel, Cetuximab (C225), and Cisplatin Followed by Radiation, Cetuximab, and Cisplatin in Locally Advanced Head and Neck Cancer|Completed||Phase 2|39|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:40:14.244568|2017-10-11 05:40:14.244568
NCT00226252|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2013-03-11|||December 2003||2003-12-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|March 2008|Actual|2008-03-01||Interventional|||Manual Wheelchair Propulsion Training|Manual Wheelchair Propulsion Training|Completed||N/A|28|Actual|VA Pittsburgh Healthcare System||3|||f||||f||||||||||2017-10-11 05:40:14.900056|2017-10-11 05:40:14.900056
NCT00226265|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-02-17|||January 1999|Actual|1999-01-01|February 2017|2017-02-01|September 2007|Actual|2007-09-01|December 2006|Actual|2006-12-01||Observational|||The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients|The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients|Completed||N/A|50|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No|No Plan to Share IPD|2017-10-11 05:40:14.993591|2017-10-11 05:40:14.993591
NCT00226278|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2008-03-28|||September 2004||2004-09-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety Study of ORG 34517 for Major Depression With Psychotic Features|"Prospective, Double Blind, Randomized, Placebo-Controlled Dose Finding Study of the Efficacy and Safety of 2 Target Doses of Org 34517 Used as Adjunct"|Completed||Phase 2|25|Anticipated|Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:40:15.092721|2017-10-11 05:40:15.092721
NCT00226291|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2014-05-27|||August 2004||2004-08-01|May 2014|2014-05-01|May 2007|Actual|2007-05-01|February 2006|Actual|2006-02-01||Interventional|||The Clinical Informationist: Does the Model Work|The Clinical Informationist: Does the Model Work|Completed||N/A|299|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 05:40:15.173381|2017-10-11 05:40:15.173381
NCT00226304|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2017-06-30|||September 20, 2005||2005-09-20|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Observational|||Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma|The Evaluation of Focal Contrast-Enhancing Brain Lesions in HIV-Infected Patients|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:40:15.294908|2017-10-11 05:40:15.294908
NCT00226317|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-17|||April 2004||2004-04-01|April 2017|2017-04-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Aripiprazole in the Treatment of Bipolar Depression|Phase 4 Study: An Open Prospective Study of the Safety and Effectiveness of Aripiprazole in the Treatment of Bipolar Depression|Completed||N/A|20|Actual|Cambridge Health Alliance||1|||||||||f||||||||2017-10-11 05:40:15.362311|2017-10-11 05:40:15.362311
NCT00226330|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2010-11-18|||March 2005||2005-03-01|November 2010|2010-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus|A Double-Blind, Multi-Centre, Active-Controlled (15, 30, and 45 mg Pioglitazone) Long-Term Extension Study to Evaluate the Safety and Tolerability of Tesaglitazar (0.5 and 1 mg) in Patients With Type 2 Diabetes Mellitus (GALLEX 6)|Terminated||Phase 3|1100||AstraZeneca||||The development program has been terminated|||||||||||||||2017-10-11 05:40:15.465478|2017-10-11 05:40:15.465478
NCT00226343|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-17|||August 2003||2003-08-01|April 2017|2017-04-01|August 2006|Actual|2006-08-01|January 2006|Actual|2006-01-01||Interventional|||Depakote-ER for Depressive and Bipolar Depression|Phase 4 Study: Double-blind Placebo-controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-refractory Bipolar Depression|Completed||Phase 4|25||Cambridge Health Alliance|||||||||||f||||||||2017-10-11 05:40:15.891634|2017-10-11 05:40:15.891634
NCT00226356|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-04-17|||December 2004||2004-12-01|April 2017|2017-04-01|September 17, 2008|Actual|2008-09-17|June 2007|Actual|2007-06-01||Interventional|||Natural Supplements for Unipolar Depression|Phase 4 Study: An Open Study of the Efficacy and Tolerability in Unipolar Depression of Augmentation of the One-carbon Cycle With L-methionine, Betaine and Folate|Completed||Phase 4|20|Actual|Cambridge Health Alliance||1|||f||||||||||||||2017-10-11 05:40:15.96629|2017-10-11 05:40:15.96629
NCT00226369|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2010-02-11|||December 1997||1997-12-01|September 2005|2005-09-01|June 2001||2001-06-01|||||Interventional|||Cylexin for Reduction of Reperfusion Injury in Infant Heart Surgery|Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy/Safety of CY-1503 (Cylexin) in Prevention of Reperfusion Injury in Neonates/Infants Undergoing Hypothermic Cardiopulmonary Bypass|Completed||Phase 2/Phase 3|242||Boston Children’s Hospital|||||||||||||||||||2017-10-11 05:40:16.066913|2017-10-11 05:40:16.066913
NCT00226382|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2010-06-10|||January 2005||2005-01-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment|Treatment With Peginterferon Alfa-2a (40 KD) (PEGASYS®) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment. A Pilot Study.|Completed||Phase 4|50|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-10-11 05:40:16.146763|2017-10-11 05:40:16.146763
NCT00226395|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2010-02-12|||September 2004||2004-09-01|February 2010|2010-02-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain|Randomized, Double-Blind, Placebo- and Active-Control, Single- and Multiple-Dose Evaluation of the Analgesic Efficacy and Safety of Oxymorphone Immediate Release (IR) Tablets in Patients With Moderate/Severe Pain Following Abdominal Surgery|Completed||Phase 3|320||Endo Pharmaceuticals|||||||||||||||||||2017-10-11 05:40:16.235872|2017-10-11 05:40:16.235872
NCT00226408|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-25|2006-06-20|||November 2003||2003-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon|Randomized, Multicenter Study for Adjuvant Treatment of Stage III Malignant Melanoma: Intermittent, High-Dose Intravenous Interferon Alpha-2b Versus Standard High-Dose Interferon Alpha-2b Therapy|Unknown status|Recruiting|Phase 3|600||Dermatologic Cooperative Oncology Group|||||f||||||||||||||2017-10-11 05:40:16.362792|2017-10-11 05:40:16.362792
NCT00226421|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2010-02-12|||October 2004||2004-10-01|February 2010|2010-02-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain|An Open-Label Titration Followed by a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Tolerability, and Safety of Oxymorphone Extended Release Tablets in Opioid-Experienced Patients With Chronic Low Back Pain|Completed||Phase 3|120||Endo Pharmaceuticals|||||||||||||||||||2017-10-11 05:40:16.503921|2017-10-11 05:40:16.503921
NCT00226434|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2012-03-15|||January 2006||2006-01-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)|Early vs Late Introduction of Antiretroviral Therapy in Naive HIV-infected Patients With Tuberculosis in Cambodia|Completed||Phase 3|661|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-10-11 05:40:16.639432|2017-10-11 05:40:16.639432
NCT00226447|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-10-23|||December 2002||2002-12-01|October 2008|2008-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients|A Study on the Viral Kinetics of Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in HBeAg Positive Chronic Hepatitis B|Completed||Phase 2|30||Chinese University of Hong Kong||3|||f||||||||||||||2017-10-11 05:40:16.752844|2017-10-11 05:40:16.752844
NCT00226460|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2015-03-17|||August 1997||1997-08-01|March 2015|2015-03-01|January 2001||2001-01-01|||||Interventional|||Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.||Completed||Phase 2|||Sanofi|||||||||||||||||||2017-10-11 05:40:16.851367|2017-10-11 05:40:16.851367
NCT00226473|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-25|2006-06-20|||September 2001||2001-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma|Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy (CVD-Protocol) in the Second-Line Therapy of Distant Metastasized Malignant Melanoma|Unknown status|Recruiting|Phase 4|200||Dermatologic Cooperative Oncology Group|||||f||||||||||||||2017-10-11 05:40:17.083875|2017-10-11 05:40:17.083875
NCT00226486|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-08-20|||September 2005||2005-09-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Examination and Treatment of Elderly After a Fall|Examination and Treatment of Elderly After a Fall- an Analysis in a Medical Technology Evaluation Perspective|Completed||N/A|392|Actual|Glostrup University Hospital, Copenhagen||2|||f||||||||||||||2017-10-11 05:40:17.279848|2017-10-11 05:40:17.279848
NCT00226512|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2011-04-07|||July 2004||2004-07-01|September 2005|2005-09-01||||||||Interventional|||To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning|Phase III Trial of a Non-myeloablative Preparative Regimen With Fludarabine and Busulfan With or Without Anti-lymphocyte Antibodies (Campath-1H or ATG) for Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation From an HLA Compatible Donor|Withdrawn||Phase 3|203|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-10-11 05:40:17.772041|2017-10-11 05:40:17.772041
NCT00226525|ClinicalTrials.gov processed this data on October 10, 2017|2005-07-10|2006-11-06|||February 2005||2005-02-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Effect of Metal Skin Sensitivity on Restenosis After Stent Implantation|Rate of Metal Skin Allergy in Cohorts of Patients With and Without Coronary Stent Restenosis|Unknown status|Active, not recruiting|N/A|150||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:40:17.887927|2017-10-11 05:40:17.887927
NCT00226538|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-28|||August 1999||1999-08-01|October 2008|2008-10-01||||||||Interventional|||Prediction of Drug Interactions With CYP2C9 Substrates|Prediction of Potential Drug Interaction With CYP2C9 Substrate by Using Phenytoin Metabolic Ratio as a Marker of Its Activity in-Vivo.|Completed||N/A|16||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:40:17.973403|2017-10-11 05:40:17.973403
NCT00226551|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-28|||August 1999||1999-08-01|October 2008|2008-10-01||||||||Interventional|||Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms|ß2 Adrenergic Receptor Polymorphisms and Vasodilation of Internal Mammary Artery Induced by Isoproterenol|Completed||N/A|100||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:40:18.056147|2017-10-11 05:40:18.056147
NCT00226564|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2008-10-28|||August 1997||1997-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of Opioids Analgesia|The Effect of mu Opioid Receptor Polymorphism on the Response to Alfentanil During Lithotripsy|Completed||N/A|100||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:40:18.132755|2017-10-11 05:40:18.132755
NCT00226577|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2017-02-20|2010-10-26||February 2004||2004-02-01|January 2011|2011-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.|Phase II Study of Neoadjuvant Chemotherapy With Gemcitabine and Pemetrexed in Resectable Non-Small-Cell Lung Cancer (NSCLC) With Pharmacogenomic Correlates.|Completed||Phase 2|52|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 05:40:18.21123|2017-10-11 05:40:18.21123
NCT00226590|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2017-02-20|2011-03-11||April 2003||2003-04-01|May 2011|2011-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC|Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Paclitaxel and Carboplatin With Concurrent Thoracic Radiation for Patients With Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer|Completed||Phase 2|39|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 05:40:18.522519|2017-10-11 05:40:18.522519
NCT00226603|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2005-09-26|||September 1997||1997-09-01|June 1998|1998-06-01|June 1998||1998-06-01|||||Interventional|||Lyske Trial (Danish) Groin Trial|Prevention of Groin Injuries in Football Players|Unknown status|Active, not recruiting|Phase 2/Phase 3|1600||Hölmich, Per, M.D.|||||f||||||||||||||2017-10-11 05:40:18.802348|2017-10-11 05:40:18.802348
NCT00226616|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-25|2005-10-19|||November 2000||2000-11-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Interventional|||Zinc Supplementation in Cholera Patients|Clinical Trial of Zinc Supplementation in Cholera Patients|Completed||Phase 3|||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-10-11 05:40:18.858848|2017-10-11 05:40:18.858848
NCT00226629|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2017-08-24|||August 2003|Actual|2003-08-01|August 2017|2017-08-01|August 2007|Actual|2007-08-01|June 2006|Actual|2006-06-01||Interventional|||Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC|Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC|Completed||N/A|130||Lawson Health Research Institute|||||f||||f|f|f||||||||2017-10-11 05:40:18.939276|2017-10-11 05:40:18.939276
NCT00226642|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2005-09-23||||||February 2002|2002-02-01||||||||Interventional|||Treatment of Mild and Subthreshold Depressive Disorders|"Behandlung Von Leichten Und Unterschwelligen Depressionen. Eine Randomisierte, Kontrollierte Studie Zum Wirksamkeitsnachweis Eines Serotonin-Wiederaufnahme-Hemmers (SSRI), Einer Kognitiven Verhaltenstherapie Und Einer Freien Therapiewahl (Treatment of Mild and Subthreshold Depressive Disorders. A Randomized, Controlled Trial on the Efficacy of a Serotonin-Reuptake-Inhibitor (SSRI), a Cognitive-Behavioral Therapy and of Free Choice Between SSRI and CBT)"|Unknown status|Active, not recruiting|Phase 4|369||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-10-11 05:40:18.99859|2017-10-11 05:40:18.99859
NCT00226655|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2012-07-31|2012-07-31||July 2005||2005-07-01|July 2012|2012-07-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies|An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302, NTI 0303, or Other Designated Studies|Completed||Phase 3|112|Actual|Celtic Pharma Development Services||1|||f||||t||||||||||2017-10-11 05:40:19.085333|2017-10-11 05:40:19.085333
NCT00226668|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2007-12-27|||January 2006||2006-01-01|December 2007|2007-12-01|January 2008|Anticipated|2008-01-01|||||Interventional|||XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema|A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Primary Malignant Glioma|Withdrawn||Phase 3|120|Anticipated|Celtic Pharma Development Services||2||Alternate study projected to assess imaging endpoints versus clinical endpoints.|f||||t||||||||||2017-10-11 05:40:19.661021|2017-10-11 05:40:19.661021
NCT00226681|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-09-09|||September 1999||1999-09-01|September 2008|2008-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Nurses Helping Sudden Cardiac Arrest Survivors Recover After Getting An Implantable Cardioverter Defibrillator (ICD)|Nursing Interventions Following Sudden Cardiac Arrest|Completed||Phase 1|150|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-10-11 05:40:19.806682|2017-10-11 05:40:19.806682
NCT00226694|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2014-01-03|||September 2003||2003-09-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||Alcohol and Gender Effects on Stress Circuit Function|Alcohol and Gender Effects on Stress Circuit Function|Completed||N/A|96|Actual|University of Cincinnati||2|||f||||||||||||||2017-10-11 05:40:19.882991|2017-10-11 05:40:19.882991
NCT00226707|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2008-02-13|||July 2004||2004-07-01|February 2008|2008-02-01|March 2005|Actual|2005-03-01|||||Interventional|||Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis|A 6-Week Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Pimecrolimus Cream 1% in Patients With Mild-to-Moderate Chronic Hand Dermatitis Followed by a 6-Week Open-Label Phase to Assess the Safety of Pimecrolimus Cream 1%|Completed||Phase 3|652||Novartis|||||||||||||||||||2017-10-11 05:40:19.967514|2017-10-11 05:40:19.967514
NCT00226720|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-05-05|||September 2002||2002-09-01|April 2007|2007-04-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Outpatient Versus Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence: The IN/OUT Study|Comparison of Efficacy of an Outpatient vs Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence. A Prospective Randomized Clinical Trial.|Completed||N/A|500|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-10-11 05:40:20.038927|2017-10-11 05:40:20.038927
NCT00226733|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-05-17|||March 2004||2004-03-01|April 2008|2008-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Training Intensity After Coronary Bypass Grafting|Training Intensity After Coronary Bypass Grafting|Terminated||Phase 2|60||Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:40:20.128868|2017-10-11 05:40:20.128868
NCT00226746|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2007-03-20|||March 2003||2003-03-01|September 2006|2006-09-01|December 2010||2010-12-01|||||Interventional|||Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer|A Multicenter Phase II Trial of Weekly Gemcitabine, Paclitaxel, and Hyperfractionated External Irradiation (63.80 GY) for Locally Advanced Pancreatic Cancer|Unknown status|Recruiting|Phase 2|70||New York Methodist Hospital|||||f||||||||||||||2017-10-11 05:40:20.215914|2017-10-11 05:40:20.215914
NCT00226759|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2012-10-10||2012-10-10|November 2004||2004-11-01|October 2012|2012-10-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction|Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Allograft ACL Reconstruction|Completed||Phase 3|321|Actual|Omeros Corporation||2|||f||||f||||||||||2017-10-11 05:40:20.303263|2017-10-11 05:40:20.303263
NCT00226772|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2012-10-10||2012-10-10|June 2005||2005-06-01|October 2012|2012-10-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction|Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Autograft ACL Reconstruction|Completed||Phase 3|326|Actual|Omeros Corporation||2|||f||||f||||||||||2017-10-11 05:40:21.767465|2017-10-11 05:40:21.767465
NCT00226785|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2006-11-10|||October 2005||2005-10-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Dexmedetomidine for Continuous Sedation|A Prospective, Multi-Centre, Randomised, Double-Blind Comparison of Intravenous Dexmedetomidine With Propofol/Midazolam for Continuous Sedation (24 Hours to 14 Days) of Ventilated Patients in Intensive Care Unit|Terminated||Phase 3|900||Orion Corporation, Orion Pharma|||||f||||||||||||||2017-10-11 05:40:21.883733|2017-10-11 05:40:21.883733
NCT00226798|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2005-12-31|||December 2003||2003-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Immunochemotherapy for Metastatic Renal Cell Carcinoma|Interleukin-2, Interferon Alpha,Capecitabine and Vinblastin for Treatment of Metastatic Renal Cell Carcinoma: A Multicenter Study|Unknown status|Recruiting|Phase 2|45||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:40:21.967654|2017-10-11 05:40:21.967654
NCT00226811|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2015-03-10|2009-05-14||January 2006||2006-01-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy|An Open Label International Multi-Center Phase 2 Activity And Safety Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Progressing Or Recurring After One Prior Chemotherapy|Completed||Phase 2|78|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:40:22.076651|2017-10-11 05:40:22.076651
NCT00226824|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2009-08-21|||September 2005||2005-09-01|August 2009|2009-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety Study of Galantamine in Tic Disorders|Pilot Examination of Galantamine in the Management of Tic Disorders|Terminated||Phase 4|1|Actual|Parkinson's Disease and Movement Disorders Center||1||Unable to recruit subjects into the trial.|f||||||||||||||2017-10-11 05:40:22.701174|2017-10-11 05:40:22.701174
NCT00226837|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2009-02-03|||August 2004||2004-08-01|February 2009|2009-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Quantifying Nitrous Oxide Effect on Depth of Anaesthesia Using Theoretically Based Time Series Modelling|Quantifying Nitrous Oxide Effect on Depth of Anaesthesia Using Theoretically Based Time Series Modelling|Completed||Phase 4|60|Actual|Melbourne Health||3|||f||||f||||||||||2017-10-11 05:40:22.795233|2017-10-11 05:40:22.795233
NCT00226850|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-23||||||September 2005|2005-09-01||||||||Interventional|||Using Hypnosis to Help Children Undergoing a Difficult Medical Procedure||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-10-11 05:40:22.885838|2017-10-11 05:40:22.885838
NCT00226863|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2005-09-23||||||September 2005|2005-09-01||||||||Interventional|||Meditation and Hypnosis for Chronic Depressed Mood||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-10-11 05:40:22.961404|2017-10-11 05:40:22.961404
NCT00226876|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-05-28|||February 2005||2005-02-01|September 2005|2005-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||Dreaming During Anaesthesia and Anaesthetic Depth|Dreaming During Anaesthesia and Anaesthetic Depth|Completed||N/A|300|Actual|Melbourne Health|||1||f||||f||||||||||2017-10-11 05:40:23.024592|2017-10-11 05:40:23.024592
NCT00226889|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2009-06-11|||January 2005||2005-01-01|March 2006|2006-03-01|June 2009||2009-06-01|January 2009||2009-01-01||Interventional|TRANOS||Treatment of Early Systemic Sclerosis by Bosentan||Terminated||Phase 1/Phase 2|30|Anticipated|Rikshospitalet University Hospital||||failure of recruiting a sufficient number of patients|f||||||||||||||2017-10-11 05:40:23.102419|2017-10-11 05:40:23.102419
NCT00226902|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2015-05-04|||September 2006||2006-09-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Vascular Reactivity in Kidney Disease Patients|Integrated Studies in Vascular Reactivity and Anaemia Correction Therapy in Endstage Kidney Disease Patients|Completed||N/A|15||Melbourne Health|||||f||||f||||||||||2017-10-11 05:40:23.181025|2017-10-11 05:40:23.181025
NCT00230633|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2008-08-12|||April 2002||2002-04-01|August 2008|2008-08-01||||||||Observational|||Studies of White Blood Cells Derived From HHT Patients|Studies of White Blood Cells Derived From HHT Patients|Unknown status|Recruiting|N/A|200|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:41:10.714|2017-10-11 05:41:10.714
NCT00226915|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2012-04-02|||April 2003||2003-04-01|April 2012|2012-04-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma|Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense Weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma|Unknown status|Active, not recruiting|Phase 3|637|Actual|Japanese Gynecologic Oncology Group||2|||f||||t||||||||||2017-10-11 05:40:23.256408|2017-10-11 05:40:23.256408
NCT00226928|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-12-02||||||December 2013|2013-12-01|July 2005|Actual|2005-07-01|||||Interventional|||Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer|Psychosocial Treatment Effects on Cancer Survival|Completed||N/A|125|Actual|Stanford University||1|||f||||f||||||||||2017-10-11 05:40:23.437051|2017-10-11 05:40:23.437051
NCT00226954|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-07-27|||March 2003||2003-03-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|November 2007|Actual|2007-11-01||Interventional|||Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer|Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer|Completed||Phase 2|30|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:40:23.68875|2017-10-11 05:40:23.68875
NCT00226967|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-11-09|||September 2002||2002-09-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|November 2004|Actual|2004-11-01||Observational|||Stress, Diurnal Cortisol, and Breast Cancer Survival|Stress, Diurnal Cortisol, and Breast Cancer Survival|Unknown status|Active, not recruiting|N/A|115|Anticipated|Stanford University|||1||f||||t||||||Samples Without DNA|"     Saliva   "|||2017-10-11 05:40:23.804317|2017-10-11 05:40:23.804317
NCT00226980|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-04-10|||October 2002||2002-10-01|April 2009|2009-04-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma|A Phase II Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma|Completed||Phase 2|30|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:40:23.903493|2017-10-11 05:40:23.903493
NCT00226993|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-11-29|||March 2005||2005-03-01|November 2016|2016-11-01||||December 2006|Anticipated|2006-12-01||Interventional|||Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.|Phase I/II Study of Intratumoral Injection of CPG 7909, A TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides|Withdrawn||Phase 1/Phase 2|0|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:40:23.979998|2017-10-11 05:40:23.979998
NCT00227006|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-05-18|||January 1999||1999-01-01|May 2015|2015-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Promoting Long-term Behavior Change to Reduce CVD Risk|Promoting Long-term Dietary Change to Reduce CVD Risk|Completed||N/A|163|Actual|Stanford University||3|||f||||||||||||||2017-10-11 05:40:24.048921|2017-10-11 05:40:24.048921
NCT00227019|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2017-01-12|2016-04-20||March 2006||2006-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2010|Actual|2010-11-01||Interventional||Adult patients with advanced stage nonsquamous NSCLC and stable treated metastatic disease in the brain were eligible if they were candidates for second-line therapy after progression on a platinum doublet regimen for advanced disease.|Phase 2 Trial of Bevacizumab in Combination With Pemetrexed|Phase II Trial of Bevacizumab in Combination With Pemetrexed as Second Line Therapy in Patients With Stable Brain Metastases From Non-small Cell Lung Cancer (NSCLC) (Excluding Squamous Cell Carcinoma)|Completed||Phase 2|16|Actual|Stanford University||1|||f||||t||||||||No||2017-10-11 05:40:24.145131|2017-10-11 05:40:24.145131
NCT00227032|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2012-03-05|||September 2005||2005-09-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme|Phase I Study of Erlotinib Administered Every 72 Hours in Patients With Glioblastoma Multiforme With Pharmacokinetic/Pharmacodynamic Correlates|Terminated||Phase 1|10|Actual|UNC Lineberger Comprehensive Cancer Center||2||Loss of funding|f||||t||||||||||2017-10-11 05:40:24.69883|2017-10-11 05:40:24.69883
NCT00227045|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2007-04-19|||October 2003||2003-10-01|April 2007|2007-04-01||||||||Observational|||CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients|The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction: A Two Phase Pharmacokinetic Study in Renal Allograft Recipients at the University of Michigan Transplant Program|Completed||N/A|20||University of Michigan|||||f||||||||||||||2017-10-11 05:40:24.802367|2017-10-11 05:40:24.802367
NCT00227058|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2007-01-24|||January 2005||2005-01-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis|Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic|Completed||N/A|100||University of Mississippi Medical Center|||||f||||||||||||||2017-10-11 05:40:24.872815|2017-10-11 05:40:24.872815
NCT00227071|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2006-01-03|||September 1999||1999-09-01|September 2005|2005-09-01|June 2002||2002-06-01|||||Interventional|||Aquatic Verses Land Exercise to Decrease Fall Risk|The Effect of Water Verses Land Exercise to Decrease Fall Risk in Older Women With Osteoporosis|Completed||N/A|73||University of Saskatchewan|||||f||||||||||||||2017-10-11 05:40:24.951523|2017-10-11 05:40:24.951523
NCT00227084|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2007-08-24|||September 2005||2005-09-01|August 2007|2007-08-01|October 2006|Actual|2006-10-01|||||Interventional|||Effect of Arista Powder on Bleeding in Reductive Mammary Surgery|Effect of Arista AH-Haemostatic Powder in Plastic Surgery. A Prospective, Consecutive Randomized Study in 30 Women Undergoing Reduction of Both Mamma|Completed||Phase 2|30||University of Oslo|||||f||||t||||||||||2017-10-11 05:40:25.045049|2017-10-11 05:40:25.045049
NCT00227097|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2006-07-06|||December 2002||2002-12-01|July 2006|2006-07-01|December 2004||2004-12-01|||||Observational|||Educ'Avk: Recommendations for the Antivitamin K's Gestion|Implication of Patient in the Making Ready of Recommendations for the Antivitamin K's Gestion in Case of Thrombosis Embolic Venous's Illness. Randomised Study for Clinical Validation.|Terminated||Phase 3|300||University Hospital, Grenoble|||||f||||||||||||||2017-10-11 05:40:25.15225|2017-10-11 05:40:25.15225
NCT00227110|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2009-10-12|||October 2002||2002-10-01|October 2009|2009-10-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)|Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)|Completed||Phase 4|55|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-10-11 05:40:25.244351|2017-10-11 05:40:25.244351
NCT00227123|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-01-03|||October 2002||2002-10-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence|A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder Outpatients With Current Stimulant Dependence|Completed||N/A|96|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-10-11 05:40:25.337712|2017-10-11 05:40:25.337712
NCT00227136|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2006-07-11|||May 2005||2005-05-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion|Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion|Terminated||Phase 3|8||University of Western Ontario, Canada|||||f||||||||||||||2017-10-11 05:40:25.444149|2017-10-11 05:40:25.444149
NCT00227149|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2009-02-03|||July 2005||2005-07-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|||||Observational|||Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C|Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C Infection and a Former (Peg)Interferon Alfa-2b-Based Therapy|Completed||N/A|197|Actual|University of Wuerzburg|||1||f||||f||||||||||2017-10-11 05:40:25.560214|2017-10-11 05:40:25.560214
NCT00227162|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2017-02-17|||February 2004||2004-02-01|February 2017|2017-02-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Pilot Study of Changing Exercise and Physical Activity Behavior in Asthma Patients|Pilot Study of Changing Exercise and Physical Activity Behavior in Asthma Patients|Completed||N/A|40|Actual|Weill Medical College of Cornell University||4|||f||||t|f|f||||||No|No Plan to Share IPD|2017-10-11 05:40:25.649333|2017-10-11 05:40:25.649333
NCT00227175|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-03-31|||April 2003||2003-04-01|March 2008|2008-03-01|September 2003||2003-09-01|||||Observational|||Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study|Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study|Completed||N/A|60||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:40:25.786303|2017-10-11 05:40:25.786303
NCT00227188|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-11-28|||May 2003||2003-05-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.|Effectiveness of Prevnar in the Prevention on IPD in the Paediatric Population in Spain|Completed||N/A|408|Actual|Pfizer|||1||f||||f||||||Samples Without DNA|"     Samples without DNA   "|||2017-10-11 05:40:25.856467|2017-10-11 05:40:25.856467
NCT00227201|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-04-23|||June 2003||2003-06-01|April 2008|2008-04-01|May 2005||2005-05-01|||||Observational|||The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans|The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans|Completed||N/A|60||Weill Medical College of Cornell University|||||f||||||||||||||2017-10-11 05:40:25.9363|2017-10-11 05:40:25.9363
NCT00227214|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2010-06-24|||January 2004||2004-01-01|June 2010|2010-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.|Prevalence of Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.|Completed||N/A|160|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-10-11 05:40:26.018812|2017-10-11 05:40:26.018812
NCT00227227|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-07|||May 2004||2004-05-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Observational|||Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis|Observational Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis|Completed||N/A|750|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:40:26.170134|2017-10-11 05:40:26.170134
NCT00227240|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-20|||April 2005||2005-04-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis|Observational Study With Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis|Completed||N/A|753|Actual|Pfizer|||1||f||||||||||||||2017-10-11 05:40:26.243454|2017-10-11 05:40:26.243454
NCT00227253|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2017-09-28|||September 1993||1993-09-01|September 2017|2017-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|Chromosome18||Chromosome 18 Clinical Research Center|The Chromosome 18 Clinical Research Center|Recruiting||N/A|1000|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples With DNA|"     blood specimens are collected from study participant and both biological parents if available     and are processed for DNA and to establish cell lines   "|||2017-10-11 05:40:26.340429|2017-10-11 05:40:26.340429
NCT00227266|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2011-09-22|2010-03-19||September 2005||2005-09-01|September 2011|2011-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy|Multi-center Phase II Trial of Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (SMA CARNI-VAL Trial)|Completed||Phase 2|94|Actual|University of Utah||3|||f||||t||||||||||2017-10-11 05:40:26.49595|2017-10-11 05:40:26.49595
NCT00227279|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-01-28|||October 2004||2004-10-01|January 2013|2013-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Trial of the ALK Grass Tablet in Subjects With Hayfever|A Randomized, Parallel-group, Double-blind, Placebo-controlled Phase III Trial Assessing the Efficacy and Safety of ALK Grass Tablet in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis|Completed||Phase 3|634|Actual|ALK-Abelló A/S||2|||f||||||||||||||2017-10-11 05:40:27.586127|2017-10-11 05:40:27.586127
NCT00227292|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2014-06-15|||November 2007||2007-11-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain|Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain|Withdrawn||Phase 4|0|Actual|Martin-Luther-Universität Halle-Wittenberg||2||Mutual agreement between Sponsor and Investigator.|f||||f||||||||||2017-10-11 05:40:27.684965|2017-10-11 05:40:27.684965
NCT00230646|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2010-10-04|||July 2005||2005-07-01|September 2005|2005-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Promoting Physical Activity After Colorectal Cancer|Promoting Physical Activity After Colorectal Cancer|Completed||Phase 3|46|Actual|The Miriam Hospital|||||f||||||||||||||2017-10-11 05:41:10.780371|2017-10-11 05:41:10.780371
NCT00227305|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2013-01-03|2008-12-22||August 2004||2004-08-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ANCHOR 150||Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder|A 26-week, Multicenter, Open-label Phase 3b Study of the Safety and Tolerability of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in Daily Doses of 400 mg to 800 mg in Children and Adolescents With Bipolar I Disorder and Adolescents With Schizophrenia (Abbreviated)|Completed||Phase 3|381|Actual|AstraZeneca|No comparator group, open label treatment, duration only 26 weeks - not long enough to assess full impact on growth and development|1|||f||||||||||||||2017-10-11 05:40:27.822753|2017-10-11 05:40:27.822753
NCT00227318|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2011-08-29|||July 1998||1998-07-01|August 2011|2011-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial|A Randomized, Double-blind, Placebo-controlled, Multicenter, Long-term Trial of Preventing Hypertension Using Candesartan Cilexetil 16 mg in Patients With High Normal Blood Pressure (TROPHY)|Completed||Phase 3|1000||AstraZeneca|||||f||||||||||||||2017-10-11 05:40:28.388755|2017-10-11 05:40:28.388755
NCT00227331|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2006-05-02|||January 1998||1998-01-01|September 2005|2005-09-01|January 2000||2000-01-01|||||Interventional|||Equivalency Of Oral Amoxicillin Vs Injectable Penicillin In Children With Severe Pneumonia|A Randomized Multicentre Equivalency Study Of Oral Amoxicillin Versus Injectable Penicillin In Children Aged 3 To 59 Months With Severe Pneumonia|Completed||N/A|||Boston Medical Center|||||f||||||||||||||2017-10-11 05:40:28.550773|2017-10-11 05:40:28.550773
NCT00227344|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-15|2016-03-10|2014-05-27||December 2004||2004-12-01|March 2016|2016-03-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|CACAF-2||CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation|Catheter Ablation for Cure of Atrial Fibrillation|Terminated||Phase 4|129|Actual|Biosense Webster, Inc.|The study was terminated early due to randomization imbalance. The relatively small number of subjects enrolled limited the amount of data available for analysis. Because the study did not reach its targeted enrollment, the study is underpowered.|2||Study prematurely terminated due to randomization imbalance.|f||||f||||||||||2017-10-11 05:40:28.633444|2017-10-11 05:40:28.633444
NCT00227357|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2010-06-04|||July 2005||2005-07-01|September 2005|2005-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|BUP||The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration|SPNS - An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Abuse Treatment in HIV Primary Care|Completed||N/A|101|Actual|Ruth M. Rothstein CORE Center|||2||f||||f||||||||||2017-10-11 05:40:29.151893|2017-10-11 05:40:29.151893
NCT00227370|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-04-25|2013-01-24||July 2003||2003-07-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|Valgan||Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation|A Phase III, Randomized, Double-Blind Comparison of Oral Valganciclovir and Placebo for Prevention of CMV After Lung Transplantation|Completed||Phase 3|136|Actual|Duke University||2|||f||||||||||||||2017-10-11 05:40:29.272309|2017-10-11 05:40:29.272309
NCT00227383|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2007-01-19||||||September 2005|2005-09-01||||||||Interventional|||Effect of Electroacupuncture in Diabetic Patients With Gastroparesis||Unknown status|Not yet recruiting|Phase 3|30||China Medical University Hospital|||||f||||||||||||||2017-10-11 05:40:30.195185|2017-10-11 05:40:30.195185
NCT00227409|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2006-10-17|||November 2001||2001-11-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency|Long-Term Repeated Lead Chelation Therapy in Non-Diabetic Patients With Chronic Renal Insufficiency and High-Normal Body Lead Burden|Completed||N/A|||Chang Gung Memorial Hospital|||||f||||||||||||||2017-10-11 05:40:30.269741|2017-10-11 05:40:30.269741
NCT00227422|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-09-20|||June 2005||2005-06-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs|A Phase IV, Partially Double-blind Study to Demonstrate Non-inferiority of GSK Biologicals' Mencevax™ ACWY (New Process) Versus Mencevax™ ACWY (Current Process) When Administered as a Single Dose to Subjects Aged 2-30 Yrs|Completed||Phase 4|324||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:40:30.344671|2017-10-11 05:40:30.344671
NCT00227435|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-04-25|||February 2003||2003-02-01|April 2016|2016-04-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C|A Phase I/II Double-Blind, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Val-mCyd (NM283) in Adults With Chronic Hepatitis C|Completed||Phase 1/Phase 2|||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:40:30.418778|2017-10-11 05:40:30.418778
NCT00227448|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2008-04-01|||June 2003||2003-06-01|April 2008|2008-04-01|April 2005||2005-04-01|||||Interventional|||Induced Hypertension for Acute Ischemic Stroke|Induced Hypertension for Acute Ischemic Stroke|Completed||Phase 2|60||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:40:30.609393|2017-10-11 05:40:30.609393
NCT00227461|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2015-03-31|||September 2005||2005-09-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.|Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|Kessler Foundation||2|||f||||t||||||||||2017-10-11 05:40:30.694741|2017-10-11 05:40:30.694741
NCT00227474|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-01-23||||||January 2013|2013-01-01||||||||Interventional|||S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission|S0348: A Phase II Study of 5T4-Modified Vaccinia Ankara (MVA) Vaccine (TROVAX) in Patients With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||||SWOG has decided to not pursue this trial|f||||t||||||||||2017-10-11 05:40:30.790958|2017-10-11 05:40:30.790958
NCT00227487|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-09-28|||October 2005||2005-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|May 2011|Actual|2011-05-01||Interventional|||Intestinal Inflammation and Carbohydrate Digestion in Autistic Children|The Evaluation of Intestinal Inflammation and Carbohydrate Digestion in Children With Autistic Spectrum Disorders|Active, not recruiting||N/A|115|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 05:40:30.860278|2017-10-11 05:40:30.860278
NCT00227500|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2006-06-08|||July 2001||2001-07-01|June 2006|2006-06-01|October 2004||2004-10-01|||||Interventional|||Pravastatin for Hyperlipidaemia in HIV.|A Randomised, Double-Blind Study of Pravastatin for the Treatment of Hyperlipidaemia in Patients With HIV|Completed||Phase 4|40||Kirby Institute|||||f||||||||||||||2017-10-11 05:40:30.955658|2017-10-11 05:40:30.955658
NCT00227513|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2014-02-21|||July 2005||2005-07-01|April 2013|2013-04-01||||June 2010|Actual|2010-06-01||Interventional|||Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Bortezomib in Patients With Advanced Malignancies|Completed||Phase 1|66|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:40:31.053823|2017-10-11 05:40:31.053823
NCT00227526|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2010-09-02|||February 2005||2005-02-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Enhancing Outcomes After Colon Surgery|Enhancing Outcomes After Colon Surgery: Role of Prehabilitation Facilitating the Recovery Process.|Completed||Phase 2|200|Anticipated|McGill University||2|||f||||f||||||||||2017-10-11 05:40:31.177083|2017-10-11 05:40:31.177083
NCT00227539|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2017-03-31|2017-02-14||July 2005||2005-07-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|March 2010|Actual|2010-03-01||Interventional|||Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Early Positron Emission Tomography as a Predictor of Response in Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer|Completed||Phase 2|25|Actual|University of Washington||1|||f||||||||||||||2017-10-11 05:40:31.283902|2017-10-11 05:40:31.283902
NCT00227565|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-07-01|||February 2006||2006-02-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|December 2007|Actual|2007-12-01||Interventional|||Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|50|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-10-11 05:40:31.606988|2017-10-11 05:40:31.606988
NCT00227591|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2014-05-02|2012-10-11||December 2005||2005-12-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Lenalidomide and Prednisone in Treating Patients With Myelofibrosis|A Phase II Study of Lenalidomide (CC-5013) in Combination With Prednisone for the Treatment of Myelofibrosis With Myeloid Metaplasia|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:40:32.020673|2017-10-11 05:40:32.020673
NCT00227617|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2015-04-07|||June 2005||2005-06-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|January 2012|Actual|2012-01-01||Interventional|||Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors|A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors|Unknown status|Active, not recruiting|Phase 2/Phase 3|70|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-10-11 05:40:32.340489|2017-10-11 05:40:32.340489
NCT00227630|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2012-07-17|||July 2005||2005-07-01|July 2012|2012-07-01||||August 2007|Actual|2007-08-01||Interventional|||Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma|A Phase II Feasibility Trial of Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Postoperative Radiotherapy in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|59|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-10-11 05:40:32.484887|2017-10-11 05:40:32.484887
NCT00227656|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2012-12-10|||September 2005||2005-09-01|December 2012|2012-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer|Phase II Trial of Capecitabine (Xeloda®) and Pegylated Interferon Alfa-2A(Pegasys®) for Recurrent or Progressive Brain Metastasis From Breast Carcinoma|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Study slow to accrue.|f||||f||||||||||2017-10-11 05:40:32.590008|2017-10-11 05:40:32.590008
NCT00227669|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-08-29|||October 2005||2005-10-01|August 2016|2016-08-01|August 2012|Actual|2012-08-01|February 2010|Actual|2010-02-01||Interventional|||Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma|Randomized Phase II Study Evaluating the Efficacy of Gemcitabine Versus the Gemcitabine/Docetaxel Combination as Second Line Treatment in Metastatic or Relapsed and Inoperable Uterine or Soft Tissue Leiomyosarcomas|Completed||Phase 2|90|Actual|UNICANCER||2|||f||||f||||||||No|Individual participant data will not be shared at an individual level.|2017-10-11 05:40:32.70712|2017-10-11 05:40:32.70712
NCT00227682|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2012-05-24|||June 2004||2004-06-01|June 2010|2010-06-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Study of Arsenic Trioxide in Combination With Thalidomide, Dexamethasone, and Ascorbic Acid|Terminated||Phase 2|2|Actual|OHSU Knight Cancer Institute||1||Terminated early due to funding suspension by grant sponsor.|f||||||||||||||2017-10-11 05:40:32.87912|2017-10-11 05:40:32.87912
NCT00227695|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2017-07-21|||June 8, 2004|Actual|2004-06-08|July 2017|2017-07-01|December 2017|Anticipated|2017-12-01|May 3, 2013|Actual|2013-05-03||Interventional|||Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma|Comparing Two Schedules of Rituximab Maintenance in Rituximab-Responding Patients With Untreated, Chemotherapy Resistant or Relapsed Follicular Lymphoma: A Randomized Phase III Trial|Active, not recruiting||Phase 3|270|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||||2017-10-11 05:40:32.975857|2017-10-11 05:40:32.975857
NCT00227708|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2009-08-19|||June 2005||2005-06-01|December 2006|2006-12-01||||||||Interventional|||Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy Regimen With Bi-Weekly Docetaxel in the Treatment of Metastatic or Locally Advanced Non-Small Cell Lung Cancer in Patients Over the Age of 70|Unknown status|Active, not recruiting|Phase 2|58|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:40:33.120305|2017-10-11 05:40:33.120305
NCT00227721|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2017-02-22|2014-11-18||February 2004||2004-02-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|June 2011|Actual|2011-06-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer|Phase II Trial of Weekly Gemcitabine and Docetaxel Combination Therapy for Relapsed Ovarian or Peritoneal Cancer|Completed||Phase 2|30|Actual|Barbara Ann Karmanos Cancer Institute|Small sample size|1|||f||||t||||||||||2017-10-11 05:40:33.227219|2017-10-11 05:40:33.227219
NCT00228280|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2008-12-03|||January 2005||2005-01-01|December 2008|2008-12-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Periapical Bone Healing After Apicectomy With and Without Retrograde Root Filling|Periapical Bone Healing After Apicectomy With and Without Retrograde Root Filling|Unknown status|Active, not recruiting|Phase 1/Phase 2|54|Actual|University of Aarhus||1|||f||||f||||||||||2017-10-11 05:40:40.19547|2017-10-11 05:40:40.19547
NCT00227734|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2012-06-04|||June 2004||2004-06-01|June 2012|2012-06-01|February 2006|Actual|2006-02-01|October 2005|Actual|2005-10-01||Interventional|||Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Capecitabine and Oxaliplatin Alone or in Combination With Cetuximab as First-Line Treatment for Metastatic EGFR-Positive Colorectal Cancer, A Randomized Multicenter Phase II Trial|Completed||Phase 2|74|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 05:40:33.486808|2017-10-11 05:40:33.486808
NCT00227747|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2010-04-14|||July 2005||2005-07-01|December 2006|2006-12-01||||||||Interventional|||Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer|Randomized Phase III Trial Comparing in a Preoperative Schedule the Result of Two Concurrent Chemoradiation Schemes (45 Gy + Capecitabine vs 50 Gy + Capecitabine - Oxaliplatin) on the Rate of Sterilization of the Operative Specimen in Resectable Rectal Carcinomas T3-4 No-2 Mo|Unknown status|Active, not recruiting|Phase 3|590|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:40:33.69066|2017-10-11 05:40:33.69066
NCT00227760|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-01-29|2016-01-29||December 2005||2005-12-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery|A Phase 2 Study of AZD2171 in Progressive Unresectable, Recurrent or Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:40:33.971452|2017-10-11 05:40:33.971452
NCT00227773|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2015-10-06||||||October 2015|2015-10-01||||||||Interventional|||Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors|Phase II Study of Vatalanib and Octreotide in Patients With Progressive Low-Grade Neuroendocrine Tumors|Withdrawn||Phase 2|0|Actual|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-10-11 05:40:34.26436|2017-10-11 05:40:34.26436
NCT00221962|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2014-12-12|||April 2005||2005-04-01|June 2013|2013-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)|The Cognitive Effects of Aripiprazole in Children|Completed||Phase 4|23|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-10-11 05:40:34.368797|2017-10-11 05:40:34.368797
NCT00227786|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-08-15|||January 2003||2003-01-01|November 2005|2005-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Primary Care Physicians' Use of Stop-Smoking Plans to Help Patients Who Are Smokers|Using Electronic Medical Records to Measure and Improve Adherence to Tobacco Treatment Guidelines in Primary Care|Completed||N/A|344|Actual|Kaiser Permanente||1|||f||||f||||||||||2017-10-11 05:40:34.483969|2017-10-11 05:40:34.483969
NCT00227812|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-01-11|||April 2001||2001-04-01|January 2009|2009-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Integrated Treatment for Cocaine and Mood Disorders - 1|ERP-8654 - Integrated Treatment for Cocaine and Mood Disorders|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:40:34.580678|2017-10-11 05:40:34.580678
NCT00227825|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-01-10|||January 2002||2002-01-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1|Motivational Enhancement Therapy to Reduce Risk Behaviors in HIV Infected Youth|Unknown status|Not yet recruiting|Phase 2|60||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||No||2017-10-11 05:40:34.673524|2017-10-11 05:40:34.673524
NCT00227838|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-01-11|||July 2003||2003-07-01|September 2005|2005-09-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Modifying Group Therapy for Bipolar Substance Abusers - 1|Modifying Group Therapy for Bipolar Abusers|Completed||N/A|60|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:40:35.227032|2017-10-11 05:40:35.227032
NCT00227864|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2015-11-10|||September 2004||2004-09-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Brief Marijuana Intervention for Adolescent Women - 1|A Brief Marijuana Intervention for Adolescent Women|Completed||Phase 3|326|Actual|Butler Hospital||2|||f||||||||||||||2017-10-11 05:40:35.318504|2017-10-11 05:40:35.318504
NCT00227890|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-03-01|||March 2005||2005-03-01|March 2017|2017-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Skills and Motivation at the Rhode Island Training School (Project SMART) - 1|Motivation and Skills for THC/ETOH+ Teens in Jail|Completed||Phase 2|205|Actual|University of Rhode Island||2|||f||||t||||||||Yes|With appropriate request and procedure.|2017-10-11 05:40:35.564536|2017-10-11 05:40:35.564536
NCT00227903|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2016-11-22|2013-06-14||September 2004||2004-09-01|September 2016|2016-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|PRIDE-P|Analysis excluded women with no follow-up assessments.|Therapeutic Substance Abuse Treatment in Pregnancy - 1|Psychosocial Research to Improve Drug Treatment in Pregnancy (PRIDE-P)|Completed||Phase 2|168|Actual|Yale University|Did not acheive desired sample size; results were averaged across substances; women were not seeking substance abuse treatment (i.e. they were attending for prenatal care); treatment was brief|2|||f||||t||||||||No|only aggregate de-identified data|2017-10-11 05:40:35.70514|2017-10-11 05:40:35.70514
NCT00227916|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2014-09-24|||November 2000||2000-11-01|September 2014|2014-09-01|July 2004|Actual|2004-07-01|May 2004|Actual|2004-05-01||Interventional|||Motivational Interviews for Incarcerated Teens - 1|Motivational Interviews for Incarcerated Teens|Completed||N/A|200|Anticipated|Brown University|||||f||||||||||||||2017-10-11 05:40:37.302954|2017-10-11 05:40:37.302954
NCT00227929|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-12-09|||July 2003||2003-07-01|December 2013|2013-12-01|June 2008|Actual|2008-06-01|September 2007|Actual|2007-09-01||Interventional|||Culturally Sensitive Collaborative Treatment for Depressed Chinese Americans|Effectiveness of Culturally Sensitive Collaborative Treatment (CSCT) of Depressed Chinese Americans in Primary Care|Completed||N/A|120|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-10-11 05:40:37.374092|2017-10-11 05:40:37.374092
NCT00228293|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2013-09-20|||December 2002||2002-12-01|September 2013|2013-09-01|September 2005||2005-09-01|||||Interventional|||Assessing CPR Quality During In-Hospital Cardiac Arrest|Assessment of Cardiopulmonary Resuscitation Quality During In-Hospital Cardiac Arrest|Terminated||Phase 2/Phase 3|200||University of Chicago|||||||||||||||||||2017-10-11 05:40:40.268163|2017-10-11 05:40:40.268163
NCT00227942|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2014-05-23|||August 2003||2003-08-01|May 2014|2014-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia|Understanding the Role That Hot Flashes and Sleep Disruption Play in the Effect of Estrogen Replacement Therapy on Mood in Perimenopausal and Postmenopausal Women|Completed||Phase 4|86|Actual|Massachusetts General Hospital||3|||f||||f||||||||||2017-10-11 05:40:37.458301|2017-10-11 05:40:37.458301
NCT00227955|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-06-21|||December 1987||1987-12-01|June 2013|2013-06-01|December 1993||1993-12-01|||||Interventional|||Comparing Various Treatments for Achieving and Maintaining Remission of Depression|Maintenance Therapies in Recurrent Depression-Study I|Completed||Phase 4|200||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:40:37.543346|2017-10-11 05:40:37.543346
NCT00227968|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-06-21|||March 1995||1995-03-01|June 2013|2013-06-01|April 2002||2002-04-01|||||Interventional|||Psychosocial Therapy Plus Maintenance Pharmacotherapy for Treating Bipolar Disorder|Maintenance Therapies in Bipolar Disorder|Completed||Phase 4|181||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:40:37.607351|2017-10-11 05:40:37.607351
NCT00227981|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-06-21|||March 1995||1995-03-01|June 2013|2013-06-01|March 2001||2001-03-01|||||Interventional|||Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression|Maintenance Psychotherapies in Recurrent Depression: Study II|Completed||N/A|93||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:40:37.685086|2017-10-11 05:40:37.685086
NCT00227994|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-10-30|2016-05-02||April 2003||2003-04-01|October 2016|2016-10-01|March 2005|Actual|2005-03-01|January 2005|Actual|2005-01-01||Interventional|||Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke|Donepezil/ Galantamine in the Treatment of Post-stroke Cognitively Impaired Rehabilitating Elderly|Completed||Phase 4|40|Actual|University of Pittsburgh||2|||f||||f||||||||Yes|study has small sample size and is unlikely to be useful for data sharing efforts; however, interested researchers can contact the first author via email.|2017-10-11 05:40:37.753466|2017-10-11 05:40:37.753466
NCT00228007|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-08-20|||September 2000||2000-09-01|August 2013|2013-08-01|September 2004|Actual|2004-09-01|||||Interventional|||Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users|Maintaining HIV Risk Reduction Among Needle Exchangers|Completed||Phase 3|265||Butler Hospital|||||f||||||||||||||2017-10-11 05:40:38.02924|2017-10-11 05:40:38.02924
NCT00228020|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2010-08-24|||May 2001||2001-05-01|August 2010|2010-08-01||||January 2006|Actual|2006-01-01||Interventional|||Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients|A Randomized, Placebo-controlled, Double-blind, Multicenter Study Investigating Basiliximab in Combination With MMF, Cyclosporine Microemulsion and Prednisone in the Prevention of Acute Rejection in Pediatric Renal Allograft Recipients|Completed||Phase 3|212|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:40:38.109873|2017-10-11 05:40:38.109873
NCT00228033|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2014-03-19|||April 2002||2002-04-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|December 2005|Actual|2005-12-01||Interventional|||Effectiveness of Supplemental Calcium in Preventing Postpartum Depression|Calcium for the Prevention of Postpartum Depression|Completed||Phase 4|238||Oregon Health and Science University|||||f||||||||||||||2017-10-11 05:40:38.186585|2017-10-11 05:40:38.186585
NCT00228046|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-10-29|||January 2004||2004-01-01|October 2013|2013-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder|Double-Blind, Placebo-Controlled Trial of Flexible Dose Divalproex Sodium Adjunctive to Stimulant Treatment for Aggressive Children With Attention-Deficit Hyperactivity Disorder|Completed||Phase 4|40|Anticipated|Stony Brook University|||||f||||||||||||||2017-10-11 05:40:38.270285|2017-10-11 05:40:38.270285
NCT00228059|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2017-02-21|||January 2005||2005-01-01|February 2017|2017-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.|A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750- 2000 mg/Day in the Treatment of Manic Episodes of Bipolar I Disorder|Completed||Phase 3|132|Actual|Novartis|||||f||||||||||||||2017-10-11 05:40:38.35351|2017-10-11 05:40:38.35351
NCT00228072|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2008-05-28||||||May 2008|2008-05-01||||February 2008|Actual|2008-02-01||Interventional|||Liposuction as Treatment for Excessive Axillary Sweat|Suction-Curettage vs. Standard Excision in Axillary Hyperhidrosis|Completed||Phase 2/Phase 3|50|Anticipated|Odense University Hospital|||||f||||||||||||||2017-10-11 05:40:38.42265|2017-10-11 05:40:38.42265
NCT00228085|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2005-09-26|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Observational|||Changes of Parameters of Transcranial Magnetic Stimulation in Patients With Spinal Cord Injury|Reorganization of Cortical Motor Activation in Patients With Spinal Cord Injury: a Study of Motor Evoked Potential|Unknown status|Not yet recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:40:38.508021|2017-10-11 05:40:38.508021
NCT00228098|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2005-09-27|||February 2005||2005-02-01|September 2005|2005-09-01|February 2007||2007-02-01|||||Interventional|||Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack.|Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack. A Randomised Controlled Trial|Unknown status|Recruiting|N/A|300||Odense University Hospital|||||f||||||||||||||2017-10-11 05:40:38.562173|2017-10-11 05:40:38.562173
NCT00228111|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-22|2009-09-23|||June 2005||2005-06-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Observational|||TRACT Study: Evaluation of the Value of Routine Thoraco-abdominal CT in Blunt Trauma Patients|Prospective Evaluation of the Additional Value of Routine Thoraco-abdominal CT in Patients That Suffered Severe Blunt Trauma of the Abdomen/Thorax|Completed||N/A|1000|Anticipated|Radboud University|||1||f||||f||||||||||2017-10-11 05:40:39.976293|2017-10-11 05:40:39.976293
NCT00228124|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2006-01-25|||April 2004||2004-04-01|September 2005|2005-09-01|April 2008||2008-04-01|||||Observational|||PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition|Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition in a Phase III Randomized Trial|Unknown status|Recruiting|Phase 3|300||Ontario Cancer Research Network|||||f||||||||||||||2017-10-11 05:40:40.054106|2017-10-11 05:40:40.054106
NCT00228137|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-08|||November 2002||2002-11-01|August 2007|2007-08-01|November 2012|Anticipated|2012-11-01|||||Observational|||Randomised Controlled Trial PFC Versus CKS Total Knee Prostheses|A Prospective Randomized Double-Blind Study to Assess the Functional Differences Between the PFC and CKS Knee Prostheses|Unknown status|Active, not recruiting|N/A|90||Radboud University|||||f||||||||||||||2017-10-11 05:40:40.137672|2017-10-11 05:40:40.137672
NCT00228306|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2012-04-27|||September 2005||2005-09-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of Aerobic Exercise on Learning After Stroke|Effect of Cardiovascular Fitness on Motor Learning and Executive Function in Individuals After Stroke|Completed||Phase 1|38|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 05:40:40.34969|2017-10-11 05:40:40.34969
NCT00228319|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2016-02-09|||October 2002||2002-10-01|February 2016|2016-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants|Antioxidant Effects on the Outcome of Ovarian Cancer|Completed||Phase 1/Phase 2|27|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-10-11 05:40:40.425393|2017-10-11 05:40:40.425393
NCT00228332|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-12-19|||April 2004||2004-04-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares|A Double-Blind, Placebo-Controlled Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares|Completed||Phase 2|70||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:40:40.530745|2017-10-11 05:40:40.530745
NCT00228345|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-09-04|||January 2004||2004-01-01|September 2013|2013-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy|The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy|Terminated||Phase 1|40||University of Chicago||||Study Completed|f||||||||||||||2017-10-11 05:40:40.59753|2017-10-11 05:40:40.59753
NCT00228358|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-11-07|||June 2003||2003-06-01|November 2014|2014-11-01||||May 2011|Actual|2011-05-01||Interventional|||Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine|A Phase I Study of Infusion of HER-2/Neu Specific T Cells in Patients With Advanced Stage HER-2/Neu Expressing Cancers Who Have Received a HER-2/Neu Vaccine|Completed||Phase 1|8|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:40:40.684395|2017-10-11 05:40:40.684395
NCT00228371|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2015-05-27|||September 2005||2005-09-01|May 2015|2015-05-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy|Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy Associated With Dopaminergic Metabolism Deficit. A Randomized, Double Blind, Controlled Trial.|Terminated||Phase 2/Phase 3|4|Actual|University Hospital, Grenoble||2||insufficent enrolement|f||||t||||||||||2017-10-11 05:40:40.79773|2017-10-11 05:40:40.79773
NCT00228384|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2012-05-25|2012-01-27||September 2005||2005-09-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study|GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease|Completed||Phase 4|148|Actual|W.L.Gore & Associates||2|||f||||f||||||||||2017-10-11 05:40:41.059207|2017-10-11 05:40:41.059207
NCT00228397|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2013-02-11|||November 2003||2003-11-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Evaluating CCI-779 in Relapsing Multiple Sclerosis|A Multicenter, Randomized, Double-blind, Long-term Extension Study to Determine the Safety, Tolerability, and Preliminary Efficacy of CCI-779 in Subjects With Relapsing Multiple Sclerosis.|Completed||Phase 2|221|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:40:42.013845|2017-10-11 05:40:42.013845
NCT00228410|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2013-02-07|||November 2002||2002-11-01|February 2013|2013-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections|A Multicenter, Randomized, Double-Blind Comparison of the Safety and Efficacy of Tigecycline With Those of Vancomycin With Aztreonam to Treat Complicated Skin and Skin Structure Infections in Hospitalized Patients.|Completed||Phase 3|503|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:40:42.077596|2017-10-11 05:40:42.077596
NCT00228423|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-11-02|||May 2006||2006-05-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)|Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass?|Completed||Phase 2|91|Actual|Ottawa Heart Institute Research Corporation||2|||f||||||||||||||2017-10-11 05:40:42.140919|2017-10-11 05:40:42.140919
NCT00228436|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-12-19|||September 2005||2005-09-01|December 2012|2012-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients|A Phase 2, Open-label, Multi-center, Sequential Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Multiple Doses of Subcutaneously Administered Peginesatide in Chronic Kidney Disease Patients Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment|Completed||Phase 2|139|Actual|Affymax||8|||f||||f||||||||||2017-10-11 05:40:42.238758|2017-10-11 05:40:42.238758
NCT00228449|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-12-19|||July 2005||2005-07-01|December 2012|2012-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Peginesatide for Anemia in Chronic Hemodialysis Patients|A Phase 2, Open-label, Multi-center, Sequential, Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Peginesatide Administered Intravenously for the Maintenance Treatment of Anemia in Chronic Hemodialysis Patients|Completed||Phase 2|165|Actual|Affymax||8|||f||||f||||||||||2017-10-11 05:40:42.371924|2017-10-11 05:40:42.371924
NCT00228462|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2013-01-03|||March 2005||2005-03-01|January 2013|2013-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo|A 1-year, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Phase 3 Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Sustained-release Quetiapine Fumarate (SEROQUEL) or Placebo (Abbreviated)|Completed||Phase 3|197|Actual|AstraZeneca|||||||||||||||||||2017-10-11 05:40:42.492188|2017-10-11 05:40:42.492188
NCT00228475|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2011-01-21|||September 2004||2004-09-01|January 2011|2011-01-01|October 2005|Actual|2005-10-01|||||Interventional|||A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women|An Open Single Centre Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women on Maintenance Treatment w/Pulmicort ® Turbuhaler ® at the Dose Levels 200/400 µg Bid|Completed||Phase 4|8||AstraZeneca|||||f||||||||||||||2017-10-11 05:40:42.573743|2017-10-11 05:40:42.573743
NCT00228488|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2007-12-16|||June 2004||2004-06-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|||||Interventional|||Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma|Phase II Study of Iressa With/Without Concurrent Chemoradiotherapy in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma and to Study the Effect of Iressa™ (ZD1839) on Tumour Gene Expression Profiles ®|Completed||Phase 2|60||AstraZeneca|||||f||||||||||||||2017-10-11 05:40:42.745513|2017-10-11 05:40:42.745513
NCT00228514|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2010-11-11|||February 2004||2004-02-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study|Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) PET Sub Study|Completed||Phase 3|40||AstraZeneca|||||f||||||||||||||2017-10-11 05:40:42.819749|2017-10-11 05:40:42.819749
NCT00228527|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2010-11-18|||October 2004||2004-10-01|November 2009|2009-11-01|October 2005|Actual|2005-10-01|||||Interventional|||Esomeprazole for Treatment of GERD in Pediatric Patients|A Phase III, Multicentre, Randomized, Double-blind Parallel-group Study to Evaluate the Safety and Clinical Outcome of Once Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients 1 to 11 Years of Age, Inclusive.|Completed||Phase 4|100||AstraZeneca|||||f||||||||||||||2017-10-11 05:40:42.898665|2017-10-11 05:40:42.898665
NCT00228540|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2014-05-08|||September 2005||2005-09-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|||||Interventional|||Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD|An 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)|Completed||Phase 3|||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:40:43.045916|2017-10-11 05:40:43.045916
NCT00228553|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2013-07-12|2009-06-01||May 2004||2004-05-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness|A 12-Month, Open-Label, Flexible-Dosage (100 to 250 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil (CEP-10953) in the Treatment of Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (With an Open-Ended Extension Period)|Completed||Phase 3|743|Actual|Teva Pharmaceutical Industries||1|||||||||||||||||2017-10-11 05:40:43.198568|2017-10-11 05:40:43.198568
NCT00228566|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2013-07-12|2009-06-01||October 2005||2005-10-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|A Short-term (8 Week) Open-Label Study, Followed by a Long Term Evaluation, to Assess Patient-Reported Outcomes With Armodafinil Treatment (150 to 250 mg/Day) for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|247|Actual|Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:40:43.862345|2017-10-11 05:40:43.862345
NCT00228579|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-04-18|||June 2003||2003-06-01|April 2017|2017-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Assessment of Changes in Abdominal Fat|Assessment of Changes in Abdominal Fat and Metabolic and Tissue Biomarkers During a Bariatric Surgery Weight Loss Intervention Program|Active, not recruiting||N/A|60|Anticipated|Purdue University|||1||f||||f||||||||||2017-10-11 05:40:44.205042|2017-10-11 05:40:44.205042
NCT00228592|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2007-02-12||||||February 2007|2007-02-01|August 2005||2005-08-01|||||Interventional|||HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection|A Phase II, Multicenter, Randomized, Open-Label, Dose-Ranging, Parallel Group Study to Compare the Anti-Viral Effects, Pharmacokinetics and Safety of HepeX-Bä, a Mixture of Two Monoclonal Antibodies, as Compared to Hepatitis B Immune Globulin in Patients Who Have Received Hepatic Allografts for Treatment of End-Stage Liver Disease Due to Hepatitis B Virus Infection|Terminated||Phase 2|||Cubist Pharmaceuticals LLC|||||||||||||||||||2017-10-11 05:40:44.297361|2017-10-11 05:40:44.297361
NCT00228605|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2014-05-08|||March 2005||2005-03-01|May 2014|2014-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain|An Open-Label 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of OraVescent Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Noncancer Pain|Completed||Phase 3|500||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:40:44.507976|2017-10-11 05:40:44.507976
NCT00228618|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2009-01-29|||January 2005||2005-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|||||Observational|||Dietary Effects of Sulfur Amino Acids|Dietary Effects of Sulfur Amino Acid Depletion and Repletion on Glutathione and Cysteine Pools.|Completed||N/A|20|Anticipated|Emory University|||1||f||||||||||||||2017-10-11 05:40:44.676927|2017-10-11 05:40:44.676927
NCT00228631|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2014-05-23|||September 2005||2005-09-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|August 2011|Actual|2011-08-01||Observational|||Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD|Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease (ImmuneReconstSCD)|Completed||N/A|7|Actual|Emory University|||1||f||||t||||||||||2017-10-11 05:40:44.749306|2017-10-11 05:40:44.749306
NCT00228644|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2009-01-29|||July 2005||2005-07-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|||||Observational|||Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione|Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione and Cysteine.|Completed||N/A|15|Anticipated|Emory University|||1||f||||||||||||||2017-10-11 05:40:44.83459|2017-10-11 05:40:44.83459
NCT00228657|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2013-11-25|||July 2002||2002-07-01|September 2005|2005-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride|The Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride Administration (Substudy of SAFE Protocol 153711)|Completed||Phase 1/Phase 2|1100||Bayside Health|||||f||||f||||||||||2017-10-11 05:40:44.918524|2017-10-11 05:40:44.918524
NCT00228670|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-05-10|||July 2005||2005-07-01|May 2017|2017-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Herpesvirus in Idiopathic Pulmonary Fibrosis|Herpesvirus in Idiopathic Pulmonary Fibrosis|Completed||N/A|41|Actual|Emory University|||4||f||||f||||||Samples Without DNA|"     Lung tissue at the time of lung transplantation. Saliva, induced sputum, and blood at clinic     visitis   "|||2017-10-11 05:40:45.01852|2017-10-11 05:40:45.01852
NCT00228683|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2013-11-23|||September 2005||2005-09-01|November 2013|2013-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Hepatoblastoma Biology Study and Tissue Bank|Hepatoblastoma Biology Study and Tissue Bank|Withdrawn||N/A|0|Actual|Emory University||1||national study, local site not responsible for any analysis/results/etc|f||||t||||||||||2017-10-11 05:40:45.136027|2017-10-11 05:40:45.136027
NCT00228696|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2013-11-23|||September 2005||2005-09-01|November 2013|2013-11-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||National Wilm's Tumor Study Late Effects|National Wilm's Tumor Study Late Effects|Withdrawn||N/A|0|Actual|Emory University||1||national study, local site not responsible for results/analysis|f||||t||||||||||2017-10-11 05:40:45.268718|2017-10-11 05:40:45.268718
NCT00228813|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-08-10|2016-03-23||April 2004||2004-04-01|August 2017|2017-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|G-CSF PMRD||G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome|Feasibility Study of Using G-CSF Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome With Partially Mismatched Related Donors|Terminated||N/A|8|Actual|Emory University|There was a small number of participants and a short follow up time period for this trial.|1||lack of enrollment|f||||t||||||||||2017-10-11 05:40:45.393286|2017-10-11 05:40:45.393286
NCT00228839|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2009-06-29||||||December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease|A Pediatric Phase I Pharmacokinetic Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease|Completed||Phase 1|||Emory University|||||f||||f||||||||||2017-10-11 05:40:45.749548|2017-10-11 05:40:45.749548
NCT00228852|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2009-06-29||||||September 2005|2005-09-01|November 2006|Actual|2006-11-01|||||Interventional|||IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency|Phase I/II Trial of De-Escalation of Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency|Completed||Phase 1/Phase 2|||Emory University|||||f||||||||||||||2017-10-11 05:40:45.824853|2017-10-11 05:40:45.824853
NCT00228865|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2016-08-08|||June 2003||2003-06-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1|Effects of Pulsatile IV Insulin on Cognitive Deficits in Diabetic Patients|Terminated||Phase 2/Phase 3|75|Actual|Florida Atlantic University||1||Administrative|f||||t||||||||||2017-10-11 05:40:45.90607|2017-10-11 05:40:45.90607
NCT00228878|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2016-08-08|||March 2003||2003-03-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes|Quality of Life With and Without Pulsatile IV Insulin Therapy in Diabetes.|Terminated||Phase 2/Phase 3|152|Actual|Florida Atlantic University||1||Administrative|f||||t||||||||||2017-10-11 05:40:46.0771|2017-10-11 05:40:46.0771
NCT00228891|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2016-08-08|||February 2004||2004-02-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus|Effects of Pulsatile Insulin Delivery on Peripheral Diabetic Neuropathy|Terminated||Phase 2/Phase 3|152|Actual|Florida Atlantic University||2||Administrative|f||||t||||||||||2017-10-11 05:40:46.230343|2017-10-11 05:40:46.230343
NCT00228904|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2016-08-08|||February 2005||2005-02-01|August 2016|2016-08-01|October 2011|Anticipated|2011-10-01|May 2011|Anticipated|2011-05-01||Interventional|||Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes|Effects of Pulsatile IV Insulin Delivery on Peripheral Diabetic Neuropathy|Withdrawn||Phase 2/Phase 3|0|Actual|Florida Atlantic University||2||Administrative|f||||t||||||||||2017-10-11 05:40:46.330607|2017-10-11 05:40:46.330607
NCT00228917|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-05-09|2017-02-10||June 1, 2005|Actual|2005-06-01|May 2017|2017-05-01|January 20, 2006|Actual|2006-01-20|January 1, 2006|Actual|2006-01-01||Interventional|||Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children|Assess Reactogenicity & Safety of a Booster of Either Tritanrix™-HepB/Hib-MenAC or Tritanrix™-HepB/Hiberix™ Given (Single-blind) at 15-18 (Philippines)/15-24 Mths (Thailand) & a Dose of Mencevax™ ACWY at 24-30 Mths (Open Label)|Completed||Phase 3|1290|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:40:46.460256|2017-10-11 05:40:46.460256
NCT00228930|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2008-09-24|||September 2002||2002-09-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Observational|||Tamoxifen Pharmacogenetics and Clinical Effects|A Pilot Trial Correlating Metabolic Profile of Tamoxifen With Pharmacogenetic Predictors and Clinical Effects|Completed||Phase 4|297|Actual|National Institute of General Medical Sciences (NIGMS)|||1||f||||||||||Samples With DNA|"     Whole Blood Serum Plasma   "|||2017-10-11 05:40:47.204485|2017-10-11 05:40:47.204485
NCT00228943|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2015-03-24|2008-11-13||July 2005||2005-07-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|October 2007|Actual|2007-10-01||Interventional|||The Role of Serotonin in Hot Flashes After Breast Cancer|The Role of Serotonin in Hot Flashes After Breast Cancer|Completed||N/A|28|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 05:40:47.288523|2017-10-11 05:40:47.288523
NCT00228956|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2008-09-24|||January 2005||2005-01-01|September 2005|2005-09-01|February 2009|Anticipated|2009-02-01|||||Observational|||Aromatase Inhibitor Clinical Trial|A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism|Unknown status|Recruiting|Phase 4|500|Anticipated|National Institute of General Medical Sciences (NIGMS)|||1||f||||||||||Samples With DNA|"     Whole blood Serum and Plasma Urine   "|||2017-10-11 05:40:47.518339|2017-10-11 05:40:47.518339
NCT00228969|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2012-08-01|||February 2005||2005-02-01|August 2012|2012-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy||Completed||Phase 2|||SK Life Science|||||f||||||||||||||2017-10-11 05:40:47.635879|2017-10-11 05:40:47.635879
NCT00228982|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-07-25|||October 2004||2004-10-01|July 2012|2012-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections|A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections|Completed||Phase 3|784|Actual|Basilea Pharmaceutica||2|||||||f||||||||||2017-10-11 05:40:47.980418|2017-10-11 05:40:47.980418
NCT00228995|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2011-06-08|||June 2004||2004-06-01|April 2010|2010-04-01|September 2005|Actual|2005-09-01|||||Interventional|||A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia|A Randomized, Double-blind, Placebo-controlled, Study to Assess Changes in Physical Function in Elderly Patients With Idiopathic Anemia of Aging (IAA) Receiving Epoetin Alfa (PROCRIT�)|Terminated||Phase 2|9|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"This study was stopped due to slow enrollment after enrolling only 9 of 80 patients over 14   months time."|||||t||||||||||2017-10-11 05:40:48.105105|2017-10-11 05:40:48.105105
NCT00229008|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-08-27||2011-06-02|November 2005||2005-11-01|August 2012|2012-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Ceftobiprole in Hospital Acquired Pneumonia|A Phase 3 Randomized Double-Blind Study Of Ceftobiprole Medocaril Versus Linezolid Plus Ceftazidime In The Treatment Of Nosocomial Pneumonia|Completed||Phase 3|106|Actual|Basilea Pharmaceutica||2|||f||||t||||||||||2017-10-11 05:40:48.20193|2017-10-11 05:40:48.20193
NCT00229021|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2011-06-08|||December 2003||2003-12-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis|A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Verus a Comparator Antibiotic in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis|Completed||Phase 3|741|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:40:48.326824|2017-10-11 05:40:48.326824
NCT00229034|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-08-24|||September 2005|Actual|2005-09-01|August 2017|2017-08-01|September 2011|Actual|2011-09-01|December 2010|Actual|2010-12-01||Observational|||Effect of APC and Epo on the Inflammatory Response During Sepsis|Effect of Activated Protein C and Erythropoietin on the Microvascular Inflammatory Response During Severe Sepsis.|Completed||N/A|40|Actual|Lawson Health Research Institute|||1||f||||t||||||||||2017-10-11 05:40:48.419597|2017-10-11 05:40:48.419597
NCT00229047|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-08-24|||April 2005|Actual|2005-04-01|August 2017|2017-08-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Observational|||Ischemia and Reperfusion Injury in the Human: An Observational Study|Ischemia and Reperfusion Injury in the Human: An Observational Study|Completed||N/A|20|Actual|Lawson Health Research Institute|||1||f||||t||||||||||2017-10-11 05:40:48.499034|2017-10-11 05:40:48.499034
NCT00229060|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2011-06-08|||March 2004||2004-03-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Doripenem in the Treatment of Complicated Intra-Abdominal Infections|A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Versus Comparator Antibiotic in the Treatment of Complicated Intra-Abdominal Infections|Completed||Phase 3|483|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:40:48.610869|2017-10-11 05:40:48.610869
NCT00229073|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2011-06-06|||December 2004||2004-12-01|March 2010|2010-03-01|October 2006|Actual|2006-10-01|||||Interventional|||A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation|A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study Of The Efficacy And Safety Of Dapoxetine In The Treatment Of Subjects With Premature Ejaculation|Completed||Phase 3|1116|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:40:48.694285|2017-10-11 05:40:48.694285
NCT00229086|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2008-07-24||||||July 2008|2008-07-01||||||||Observational|||Gatekeeper European 005|Long Term Follow-up European Gatekeeper Study 005|Terminated||N/A|55||MedtronicNeuro|||||f||||||||||||||2017-10-11 05:40:48.785727|2017-10-11 05:40:48.785727
NCT00229099|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2006-10-25|||April 2005||2005-04-01|December 2005|2005-12-01|November 2005||2005-11-01|||||Interventional|||Efficacy and Safety Study of GerEPO|A Randomized, Multi-Center, Open Label Trial to Establish the Therapeutic Equivalence Between GerEpo and Eprex® and to Determine the Long Term Safety Profile of GerEpo in Patients on Hemodialysis.|Completed||Phase 3|270||Ministry of Health, Malaysia|||||f||||||||||||||2017-10-11 05:40:48.852202|2017-10-11 05:40:48.852202
NCT00229112|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-02-16|||April 2001||2001-04-01|February 2017|2017-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)|A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability, of Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in Adults.|Completed||Phase 3|400||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:40:48.985173|2017-10-11 05:40:48.985173
NCT00229125|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2005-09-27|||July 2001||2001-07-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam|Gabapentin Vs. Lorazepam in Alcohol Withdrawal|Completed||Phase 2|160||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 05:40:49.055851|2017-10-11 05:40:49.055851
NCT00229138|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-02-03|||September 2005||2005-09-01|February 2017|2017-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients|A Six-month, Prospective, Multicenter, Open Label, Parallel, Randomized Study of the Safety, Tolerability and Efficacy of EC-MPS With Basiliximab, Corticosteroids and Two Different Levels of Tacrolimus in de Novo Renal Transplant Recipients|Completed||Phase 4|291|Actual|Novartis||2|||||||||||||||||2017-10-11 05:40:49.137787|2017-10-11 05:40:49.137787
NCT00229151|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-04-06|||October 2005||2005-10-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression.|Sleep Deprivation and Three Days Sleep Phase Advancement as Treatment for Bipolar Depression.|Terminated||N/A|5|Actual|Norwegian University of Science and Technology||2||recruiting problems|f||||f||||||||||2017-10-11 05:40:49.228094|2017-10-11 05:40:49.228094
NCT00229164|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-12-26|||October 2005||2005-10-01|November 2012|2012-11-01|January 2006||2006-01-01|||||Interventional|||The Effect of Transcutaneous Electric Nerve Stimulation on Primary Dysmenorrhea-a Randomized Control Study|The Effect of Transcutaneous Electric Nerve Stimulation on Primary Dysmenorrhea-a Randomized Control Study|Completed||Phase 1/Phase 2|20|Anticipated|National Taiwan University Hospital|||||f||||f||||||||||2017-10-11 05:40:49.308735|2017-10-11 05:40:49.308735
NCT00229177|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-06-12|||September 2005||2005-09-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study of ONO-2506 in Patients With Acute Ischemic Stroke|Controlled Study of ONO-2506 in Patients With Acute Ischemic Stroke|Completed||Phase 2/Phase 3|757|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||||||||||||2017-10-11 05:40:49.38699|2017-10-11 05:40:49.38699
NCT00229203|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2009-12-14|2009-08-31||February 2005||2005-02-01|December 2009|2009-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma|"Phase II Multicenter, Open-Label, Clinical and Pharmacokinetic Study of Aplidin® As A 3-Hour Infusion Every 2 Weeks Alone or in Combination With Dexamethasone, in Pre-Treated Patients With Relapsing or Refractory Multiple Myeloma."|Completed||Phase 2|51|Actual|PharmaMar|32 patients were treated with plitidepsin as single agent;afterwards 19 of them were treated with plitidepsin+dexamethasone combination.Therefore 32+19=51 is the no. patients at risk for plitidepsin and 19 is no. of patients at risk for dexamethasone|1|||f||||f||||||||||2017-10-11 05:40:49.603234|2017-10-11 05:40:49.603234
NCT00229216|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2017-03-21|||January 2005||2005-01-01|March 2017|2017-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Treatment of Bacterial Vaginosis With Oral Tinidazole|A Phase III Randomized, Multi-center, Double-blind, Double-dummy, Placebo-controlled Treatment Trial of Bacterial Vaginosis With Tinidazole Oral Tablets.|Completed||Phase 3|200|Actual|Mission Pharmacal|||||||||||||||||||2017-10-11 05:40:50.444075|2017-10-11 05:40:50.444075
NCT00229229|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2009-01-27|||September 2004||2004-09-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Comparison of 4 Diets in the Management of Overweight Patients With Vascular Disease|Comparison of a Low Glycemic Load Diet With a Canada Food Guide Diet in the Management of Overweight Patients With Cardiovascular Disease|Terminated||Phase 4|90|Actual|Queen's University||4||Lack of funding|f||||t||||||||||2017-10-11 05:40:50.529769|2017-10-11 05:40:50.529769
NCT00229242|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2009-12-11|||November 2003||2003-11-01|December 2009|2009-12-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures|Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures|Completed||N/A|38|Actual|Queen's University||2|||f||||t||||||||||2017-10-11 05:40:50.659014|2017-10-11 05:40:50.659014
NCT00229255|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-05-31|||March 2005||2005-03-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Relation of Obesity With Frequency of Meals (MST 0557)|Relation of Obesity With Frequency of Meals (MST 0557)|Completed||N/A|22|Actual|Rockefeller University||2|||f||||f||||||||||2017-10-11 05:40:50.795224|2017-10-11 05:40:50.795224
NCT00229268|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-05-31|||September 2005||2005-09-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|||||Observational|||Research on the Nature, Diagnosis, and Treatment of Obesity and Diabetes|FOXA2 Expression in Adipose Tissue of Human Subjects With Obesity/Insulin-Resistance|Completed||N/A|14|Anticipated|Rockefeller University|||1||f||||t||||||||||2017-10-11 05:40:50.877352|2017-10-11 05:40:50.877352
NCT00229281|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2007-12-18|||February 2004||2004-02-01|December 2007|2007-12-01||||||||Interventional|||Short Term Group Therapy for Anxiety Disorder||Completed||N/A|30||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:40:50.941563|2017-10-11 05:40:50.941563
NCT00229294|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2007-12-18|||March 2004||2004-03-01|December 2007|2007-12-01|March 2005||2005-03-01|||||Observational|||Fibromyalgia in Men Suffering From PTSD||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:40:51.017826|2017-10-11 05:40:51.017826
NCT00229307|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2013-01-26|||December 2005||2005-12-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Prolonged Exposure (PE) Treatment for Post Traumatic Stress Disorder (PTSD) 20 Minutes Versus 40 Minutes||Completed||N/A|39|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 05:40:51.066245|2017-10-11 05:40:51.066245
NCT00229320|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2008-01-28|||February 2005||2005-02-01|January 2008|2008-01-01|November 2005||2005-11-01|||||Interventional|||Short Term Group Therapy for OCD||Completed||N/A|||Sheba Medical Center|||||f||||f||||||||||2017-10-11 05:40:51.133012|2017-10-11 05:40:51.133012
NCT00229346|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2007-12-18|||October 2004||2004-10-01|December 2007|2007-12-01|January 2006||2006-01-01|||||Observational|||Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:40:51.263303|2017-10-11 05:40:51.263303
NCT00229359|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2007-12-18|||January 2000||2000-01-01|December 2007|2007-12-01|December 2002||2002-12-01|||||Observational|||Characteristics of Post-Traumatic Stress Disorder (PTSD) and Non-PTSD Subjects|Risk Factors for PTSD|Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:40:51.314248|2017-10-11 05:40:51.314248
NCT00229372|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2008-01-28|||November 2006||2006-11-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Prolonged Exposure Versus Treatment as Usual in Chronic Posttraumatic Stress Disorder Combat and Terror Related Patients||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:40:51.361706|2017-10-11 05:40:51.361706
NCT00229385|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2013-12-30|||January 2006||2006-01-01|December 2013|2013-12-01|April 2010|Actual|2010-04-01|April 2008|Actual|2008-04-01||Interventional|||Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)|Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)|Completed||N/A|45|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-10-11 05:40:51.421035|2017-10-11 05:40:51.421035
NCT00229398|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2008-01-28|||November 1998||1998-11-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression Disorder||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:40:51.492462|2017-10-11 05:40:51.492462
NCT00229411|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2007-01-23|||January 2006||2006-01-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Simulation Training as a Tool for Teamwork Improvement in Multidisciplinary Intensive Care Team|Experimental Like Observational Study of Teamwork Improvement in Multidisciplinary Intensive Care Team Before and After Simulation Training.|Withdrawn||N/A|40||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:40:51.549378|2017-10-11 05:40:51.549378
NCT00229424|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2011-07-06|||April 2005||2005-04-01|July 2011|2011-07-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -|Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -|Completed||Phase 3|325||Taiho Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-10-11 05:40:51.608264|2017-10-11 05:40:51.608264
NCT00229437|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-02-27|||March 2005||2005-03-01|February 2012|2012-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Three Doses of TAK-128 in Subjects With Mild to Moderate Diabetic Peripheral Neuropathy|Completed||Phase 2|343|Actual|Takeda||4|||f||||f||||||||||2017-10-11 05:40:51.852744|2017-10-11 05:40:51.852744
NCT00229450|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2008-06-02|||October 2004||2004-10-01|June 2008|2008-06-01||||||||Interventional|||Estrogen and Perimenopausal Depression|Dose Response Effects of Estrogen Augmentation in Mood & Memory in Perimenopausal Depression|Unknown status|Recruiting|Phase 4|20|Anticipated|University of California, Los Angeles|||||f||||||||||||||2017-10-11 05:40:52.080459|2017-10-11 05:40:52.080459
NCT00229463|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2016-11-16|||January 2002||2002-01-01|October 2016|2016-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|Genetics||Study of Genetic Differences in People With Depression|Study of Genetic Differences in People With Depression|Completed||N/A|200|Anticipated|University of California, Los Angeles|||1||f||||f||||||||||2017-10-11 05:40:52.184929|2017-10-11 05:40:52.184929
NCT00229476|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2016-11-03|||December 2003||2003-12-01|November 2016|2016-11-01||||March 2006|Actual|2006-03-01||Interventional|||Study of Medication and Placebo Response in Major Depression||Completed||Phase 4|60||University of California, Los Angeles|||||f||||||||||||||2017-10-11 05:40:52.249583|2017-10-11 05:40:52.249583
NCT00229502|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-03-21|||September 2005||2005-09-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|||Cognitive Effects of Immunomodulatory Drugs in MS|Comparison of the Cognitive Effects of Three Immunomodulatory Drugs in Relapsing-Remitting Multiple Sclerosis: A Longitudinal Study|Completed||N/A|96|Actual|University of Kansas Medical Center|||4||f||||f||||||||||2017-10-11 05:40:52.338153|2017-10-11 05:40:52.338153
NCT00229515|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2011-10-26|||November 2004||2004-11-01|October 2011|2011-10-01|March 2012|Anticipated|2012-03-01|April 2007|Actual|2007-04-01||Interventional|||Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI|Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Administered With the Single High-Dose Bolus Versus Abciximab and Sirolimus Eluting Stent Versus Bare Metal Stent in Acute Myocardial Infarction - MULTI-STRATEGY Trial|Unknown status|Active, not recruiting|Phase 4|744|Actual|Università degli Studi di Ferrara||4|||f||||t||||||||||2017-10-11 05:40:52.421106|2017-10-11 05:40:52.421106
NCT00229528|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2008-09-19|||March 2004||2004-03-01|September 2008|2008-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease|Dose Ranging Study of the Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease|Completed||Phase 4|25||University of Oklahoma|||||f||||||||||||||2017-10-11 05:40:52.535796|2017-10-11 05:40:52.535796
NCT00229541|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2007-10-26|||October 2003||2003-10-01|October 2007|2007-10-01|March 2006|Actual|2006-03-01|||||Interventional|||Medical In-Patient Rehabilitation in Rheumatoid Arthritis|Medical In-Patient Rehabilitation in Rheumatoid Arthritis: Acceptance and Outcomes in Insurants of Compulsory Health Insurances and Statutory Pension Insurances (VERA)|Completed||Phase 3|129|Actual|University of Luebeck||2|||f||||t||||||||||2017-10-11 05:40:52.646646|2017-10-11 05:40:52.646646
NCT00229554|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2015-04-06|||March 2006||2006-03-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|May 2007|Actual|2007-05-01||Observational|SCREEN||Survey of ColoRectal Cancer Education and Environment Needs|Assessing and Addressing Patient Colorectal Cancer Screening Barriers|Completed||N/A|4644|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:40:52.771492|2017-10-11 05:40:52.771492
NCT00229567|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2007-04-18|||September 2005||2005-09-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel Function|A Randomised Controlled Trial of Lidocaine Infusion Plus Ketamine Injection Versus Placebo to Decrease Postoperative Ileus|Terminated||N/A|60||University of Saskatchewan||||"insufficient numbers of eligible patients as laparscopic surgery increased and open surgery   decreased."|f||||||||||||||2017-10-11 05:40:52.877927|2017-10-11 05:40:52.877927
NCT00229580|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2007-11-28|||December 2003||2003-12-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Health Behavior Feedback Study for Veterans With Hepatitis C|Health Behavior Feedback Study for Veterans With Hepatitis C|Completed||Phase 1|12|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:40:53.004369|2017-10-11 05:40:53.004369
NCT00229593|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2014-12-03|||September 2005||2005-09-01|December 2014|2014-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|NES-1||NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel|A Randomized, Open Label Clinical Trial to Evaluate if Nestorone Gel Has Gonadotropin Suppressive Activity and if Nestorone in Combination With Testosterone Will Have an Additive Effect on Gonadotropin Suppression When Applied Transdermally in Healthy Men|Completed||Phase 1|140|Actual|University of Washington||7|||f||||t||||||||||2017-10-11 05:40:53.102504|2017-10-11 05:40:53.102504
NCT00229619|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2014-07-01|2013-01-28||September 2005||2005-09-01|July 2014|2014-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia|A Pilot Study of Recombinant Humanized Anti- Cluster of Differentiation Antigen 20 (Anti-CD20) Antibody (Rituximab) in Patients With Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-10-11 05:40:53.25696|2017-10-11 05:40:53.25696
NCT00229632|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2017-10-05|||September 23, 2005||2005-09-23|April 28, 2017|2017-04-28|December 17, 2007|Actual|2007-12-17|December 17, 2007|Actual|2007-12-17||Interventional|||Idebenone to Treat Friedreich's Ataxia|A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients With Friedreich's Ataxia|Completed||Phase 2|51|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:40:53.567739|2017-10-11 05:40:53.567739
NCT00229645|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2016-07-11|||November 2003||2003-11-01|July 2016|2016-07-01|April 2005||2005-04-01|||||Interventional|||A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety|A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and Tolerability of Immediate-Release Formulation of Quetiapine Fumarate as Potentiation of Selective Serotonin Reuptake Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors Treatment in Major Depression With Comorbid Anxiety Symptoms|Completed||Phase 4|60||Dr Alexander McIntyre Inc.|||||f||||||||||||||2017-10-11 05:40:53.687265|2017-10-11 05:40:53.687265
NCT00229658|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2015-03-05|2009-05-05||September 2005||2005-09-01|February 2015|2015-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes|A Prospective, Open-Label, Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes Following SYMLIN Introduction Into the Marketplace|Completed||N/A|1297|Actual|AstraZeneca|||2||f||||f||||||||||2017-10-11 05:40:53.808968|2017-10-11 05:40:53.808968
NCT00229684|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2011-08-29|||September 2004||2004-09-01|August 2011|2011-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)|A 24-week, Randomised, Parallel-Group, Multi-Centre, Open-Label Study of the Renal Effects of Tesaglitazar in Patients With Type 2 Diabetes Mellitus|Terminated||Phase 2|100||AstraZeneca||||The development program has been terminated|||||||||||||||2017-10-11 05:40:54.862802|2017-10-11 05:40:54.862802
NCT00229697|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2015-10-02|||October 2003||2003-10-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|December 2006|Actual|2006-12-01||Interventional|||Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study|A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours|Completed||Phase 2|317|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 05:40:55.009021|2017-10-11 05:40:55.009021
NCT00229710|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-11-18|||February 2005||2005-02-01|November 2010|2010-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes|An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 0.5mg When Added to Insulin Therapy in Patients With Type 2 Diabetes Mellitus (GALLEX 9)|Terminated||Phase 3|270||AstraZeneca||||The development program has been terminated|||||||||||||||2017-10-11 05:40:55.277897|2017-10-11 05:40:55.277897
NCT00229723|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2009-06-17|2009-06-17||November 2004||2004-11-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|||||Interventional|||IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma|A Phase 2 Randomised, Double-Blind, Placebo-Controlled, Multicentre Comparative Study of Gefitinib 250 mg or 500 mg (IRESSA™) Given Either Continuously or Concomitantly With Cisplatin Plus Radiotherapy for the Treatment of Patients With Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma|Completed||Phase 2|224|Actual|AstraZeneca||7|||f||||||||||||||2017-10-11 05:40:55.632513|2017-10-11 05:40:55.632513
NCT00229736|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2013-12-02|||November 2004||2004-11-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease|A Phase1 Open Label Safety Study of Intrastriatal Infusion of Adeno-Associated Virus Encoding Human Aromatic L-Amino Acid Decarboxylase (AAV-hAADC-2) in Subjects With Parkinson's Disease [AAV-hAADC-2-003]|Completed||Phase 1|10|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 05:40:59.439148|2017-10-11 05:40:59.439148
NCT00229749|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2008-04-09|||September 2005||2005-09-01|April 2008|2008-04-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients|Exploratory Study of AVI-4065 Injection to Design Therapeutic Dosing for Chronic Active HCV Patients|Terminated||Phase 1/Phase 2|80|Anticipated|Sarepta Therapeutics||1||Limited viral load reduction in HCV subjects|f||||||||||||||2017-10-11 05:40:59.567763|2017-10-11 05:40:59.567763
NCT00229762|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2005-09-28|||March 2004||2004-03-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Racial Disparities in Pneumococcal Vaccination in Managed Care|Racial Disparities in Pneumococcal Vaccination in Managed Care: the Effects of Randomized Telephone Outreach|Completed||N/A|7000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:40:59.633434|2017-10-11 05:40:59.633434
NCT00229775|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2012-09-10|||July 2003||2003-07-01|September 2012|2012-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines|Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines|Completed||N/A|560|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-10-11 05:40:59.706964|2017-10-11 05:40:59.706964
NCT00229788|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-06-12|||March 2005||2005-03-01|June 2007|2007-06-01||||||||Observational|||Impact of Race and Re-Transplantation|Impact of Race and Re-Transplantation in Childhood: Analysis of Data From the United Network of Organ Sharing|Terminated||N/A|||Children's Healthcare of Atlanta|||||f||||||||||||||2017-10-11 05:40:59.804123|2017-10-11 05:40:59.804123
NCT00229801|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-09-20|||June 2004||2004-06-01|September 2012|2012-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Kidney Function in Children With Brain Tumors|Evaluation of Renal Function in Children With Brain Tumors|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta||1||No funds available, hard to enroll patients-Terminated in 2008|f||||||||||||||2017-10-11 05:40:59.862728|2017-10-11 05:40:59.862728
NCT00229814|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2012-09-20|||August 2005||2005-08-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Study of Brain Tumors (Tectal Tumors) Using Magnetic Resonance Imaging|Magnetic Resonance Spectroscopic Analysis of Pediatric Tectal Tumors: Insight Into Pathology and Behavior|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta|||1|There were technical difficulties and the study was terminated in 2008|f||||||||||||||2017-10-11 05:40:59.936503|2017-10-11 05:40:59.936503
NCT00229827|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-14|||May 2005||2005-05-01|May 2007|2007-05-01|August 2007|Actual|2007-08-01|||||Observational|||Optimal Timing for Repair of Left to Right Shunt Lesions|Optimal Timing for Repair of Left-to-Right Shunt Lesions|Terminated||N/A|200||Children's Healthcare of Atlanta|||1|sufficient data was collected|f||||||||||||||2017-10-11 05:40:59.988963|2017-10-11 05:40:59.988963
NCT00229840|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-06-24|||February 2006||2006-02-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of Functional MRI and DTI (Imaging Techniques) in Children With Epilepsy and Focal Brain Lesions|Advanced MR Imaging Evaluation Of Neurosurgical Candidates With Focal Abnormalities|Completed||N/A|30|Actual|Children's Healthcare of Atlanta||1|||f||||f||||||||||2017-10-11 05:41:00.05405|2017-10-11 05:41:00.05405
NCT00229853|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-05|||August 2004||2004-08-01|July 2011|2011-07-01|July 2007|Actual|2007-07-01|||||Observational|||Thoracoscopic Vascular Rings Chart Review|Thoracoscopic Vascular Rings Chart Review|Terminated||N/A|47|Actual|Children's Healthcare of Atlanta|||1|sufficient data gathered to support hypothesis|f||||f||||||||||2017-10-11 05:41:00.110009|2017-10-11 05:41:00.110009
NCT00229866|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-07-05|||August 2005||2005-08-01|July 2011|2011-07-01|June 2006|Actual|2006-06-01|||||Observational|||Feeding After Neonate Surgery Review|Feeding After Neonatal Surgery Chart Review|Terminated||N/A|90|Actual|Children's Healthcare of Atlanta|||1|sufficient data gathered for study conclusion|f||||f||||||||||2017-10-11 05:41:00.16475|2017-10-11 05:41:00.16475
NCT00229879|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-14|||December 2004||2004-12-01|May 2007|2007-05-01|September 2006|Actual|2006-09-01|||||Observational|||Rare Tumor Case Review|Rare Tumor Case Review|Terminated||N/A|||Children's Healthcare of Atlanta|||1|sufficient data gathered to support conclusion|f||||f||||||||||2017-10-11 05:41:00.212967|2017-10-11 05:41:00.212967
NCT00229892|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-16|||February 2005||2005-02-01|May 2007|2007-05-01|September 2006|Actual|2006-09-01|||||Observational|||Incisions for Cardiac Surgery|Small Incisions for Cardiac Surgery|Terminated||N/A|90|Actual|Children's Healthcare of Atlanta|||1|after 90 charts reviewed, insufficient data to support conclusion|f||||f||||||||||2017-10-11 05:41:00.26381|2017-10-11 05:41:00.26381
NCT00229905|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-03-14|||March 2005||2005-03-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Observational|||Child With Anomalous Drainage of IVC to Left Atrium|A Case Report of a Child With Anomalous Drainage of the Inferior Vena Cava to the Left Atrium|Terminated||N/A|1|Actual|Children's Healthcare of Atlanta|||1|sufficient data|f||||f||||||||||2017-10-11 05:41:00.313585|2017-10-11 05:41:00.313585
NCT00229918|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2005-09-28|||September 2005||2005-09-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||PST/Laser v. Laser Alone for CSME|Combined Posterior Sub-Tenon Injection of Triamcinolone Acetonide and Laser Photocoagulation for the Treatment of Clinically Significant Macular Edema|Unknown status|Recruiting|Phase 2|60||Edward Hines Jr. VA Hospital|||||f||||||||||||||2017-10-11 05:41:01.787357|2017-10-11 05:41:01.787357
NCT00229931|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2017-06-29|2017-04-10||November 2005||2005-11-01|June 2017|2017-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|IVTA||Triamcinolone vs. Laser for Diabetic Macular Edema|The Role of Triamcinolone Injection During Cataract Extraction for Diabetic Patients With Pre-Operative Macular Edema|Completed||N/A|11|Actual|University of Oklahoma|Due to lack of patient follow up on this study, sufficient data was not available for analysis|2|||f||||t||||||||||2017-10-11 05:41:01.882013|2017-10-11 05:41:01.882013
NCT00229944|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2006-07-20|||December 2002||2002-12-01|September 2005|2005-09-01|May 2004||2004-05-01|||||Interventional|||Single Dose Azithromycin in the Treatment of Adult Cholera|Randomized, Double-Blind, Controlled Clinical Trial to Compare Efficacy of a Single Dose of Azithromycin Versus a Single Dose of Ciprofloxacin in the Treatment of Adults With Clinically Severe Cholera Due to V. Cholerae O1 or O139|Completed||Phase 3|220||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-10-11 05:41:02.24726|2017-10-11 05:41:02.24726
NCT00229957|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-07-13|2009-05-18||June 2004||2004-06-01|September 2009|2009-09-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness|Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness|Completed||N/A|303|Actual|McMaster University||2|||f||||f||||||||||2017-10-11 05:41:02.330455|2017-10-11 05:41:02.330455
NCT00229970|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2015-05-05|2009-05-22||September 2005||2005-09-01|May 2015|2015-05-01|June 2007|Actual|2007-06-01|October 2006|Actual|2006-10-01||Interventional|||MK0476 Study in Adult Patients With Acute Asthma (0476-322)|MK0476 Phase II/III Placebo Controlled Double Blind Study|Completed||Phase 3|225|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-10-11 05:41:02.600242|2017-10-11 05:41:02.600242
NCT00229983|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2016-10-06|||June 2004||2004-06-01|October 2016|2016-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Medical Office Intervention for Adolescent Drug Use|Medical Office Intervention for Adolescent Drug Use|Completed||Phase 2|170|Actual|Boston Children’s Hospital||2|||f||||t||||||||No||2017-10-11 05:41:03.128753|2017-10-11 05:41:03.128753
NCT00229996|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2014-01-23|||July 2004||2004-07-01|January 2014|2014-01-01||||||||Interventional|||Medical Treatment of Endometriosis-Associated Pelvic Pain|Oral Contraceptives Versus Depot-Leuprolide Taken After Surgery for Endometriosis-Associated Pelvic Pain|Completed||Phase 3|194|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:41:03.318575|2017-10-11 05:41:03.318575
NCT00230009|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2013-08-06|2013-03-19||April 2004||2004-04-01|August 2013|2013-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Brief Intervention in At-Risk First-time Mothers|Brief Intervention in At-Risk First-time Mothers|Completed||Phase 1/Phase 2|100|Actual|Wayne State University|This study is limited by the relatively small sample size and the restriction to low-income, urban women, thus limiting generalizability to other populations.|2|||f||||f||||||||||2017-10-11 05:41:03.42144|2017-10-11 05:41:03.42144
NCT00230022|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2013-06-10|2011-10-12||October 2004||2004-10-01|June 2013|2013-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Pilot Clinical Trial of Computer-based Motivational Intervention - 1|Pilot Clinical Trial of Computer-based Motivational Intervention|Completed||Phase 1|30|Actual|Wayne State University|Small sample size in the pilot clinical trial. Because of this lack of power, a statistically significant difference between groups was not demonstrated, and the 95% Confidence Interval (CI) for the effect size estimate included zero.|2|||f||||f||||||||||2017-10-11 05:41:03.780322|2017-10-11 05:41:03.780322
NCT00230035|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2013-01-31|||September 2005||2005-09-01|January 2013|2013-01-01||||||||Interventional|||Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)|A Randomized, Open Label, Phase II Multicenter Study of Non-Myeloablative Autologous Transplantation With Auto-CD34+HPC Versus Currently Available Immunosuppressive/Immunomodulatory Therapy for Treatment of Systemic Lupus Erythematosus|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2||Recommended by DSMB due to lack of accrual|f||||t||||||||||2017-10-11 05:41:04.065247|2017-10-11 05:41:04.065247
NCT00230048|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2012-10-29|2011-10-12||September 2001||2001-09-01|October 2012|2012-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Interactive Motivational Media for Perinatal Drug Abuse - 3|Interactive Motivational Media for Perinatal Drug Abuse|Completed||Phase 2|107|Actual|Wayne State University|Generalizability limited by relatively small sample, attrition of 29%, and restriction to low-income mothers. Second, power limitations prevented verification of effects on the dichotomous outcomes, despite effects in the small-moderate range.|2|||f||||f||||||||||2017-10-11 05:41:04.20213|2017-10-11 05:41:04.20213
NCT00230061|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-06-01|||April 2004||2004-04-01|June 2010|2010-06-01|February 2010|Actual|2010-02-01|May 2008|Actual|2008-05-01||Interventional|||Hepatitis B Vaccination in HIV-infected Persons|Randomised Open Label Clinical Trial of the Immune Response to Hepatitis B Vaccination in HIV-infected Persons.|Completed||Phase 4|800|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-10-11 05:41:04.46208|2017-10-11 05:41:04.46208
NCT00230074|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2011-11-22|||November 2004||2004-11-01|November 2011|2011-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)|A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)|Completed||Phase 2|350|Actual|Novartis|||||f||||||||||||||2017-10-11 05:41:04.549337|2017-10-11 05:41:04.549337
NCT00230087|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2012-11-06|||September 2005||2005-09-01|November 2012|2012-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Iron Depletion Therapy for Type 2 DM and NAFLD|Iron Depletion Therapy for Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease|Completed||Phase 2|15|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-10-11 05:41:04.633191|2017-10-11 05:41:04.633191
NCT00230100|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2016-12-16|2014-09-15||March 2003||2003-03-01|December 2016|2016-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||The Women's Recovery Group Study: Stage I Trial|Recovery Group for Women With Substance Use Disorders - Stage I|Completed||Phase 1|46|Actual|Mclean Hospital|"small sample
small proportion had drug dependence; majority had alcohol dependence (questionable generalizability)
sample was almost all white and well-educated (questionable generalizability)
therapists not blind to study"|2|||f||||f||||||||No||2017-10-11 05:41:04.717914|2017-10-11 05:41:04.717914
NCT00230113|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2013-07-09|||September 2005||2005-09-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Omega-3 PUFA Supplementation in NAFLD Patients|A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid vs Monounsaturated Fatty Acid Diet Supplementation for the Treatment of Nonalcoholic Fatty Liver Disease|Completed||Phase 2|30|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-10-11 05:41:05.172907|2017-10-11 05:41:05.172907
NCT00230126|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2014-11-04|2014-04-15||October 2005||2005-10-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|September 2011|Actual|2011-09-01||Interventional||Fifty-eight patients . 31 men, 24 women.|OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer|A Phase II Randomized Study of OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|57|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 05:41:05.257764|2017-10-11 05:41:05.257764
NCT00230139|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2008-10-11|||January 2002||2002-01-01|September 2005|2005-09-01|January 2006|Actual|2006-01-01|January 2004|Actual|2004-01-01||Interventional|||SPECT/CT in Endocrine and Neuroendocrine Tumors|The Added Value of SPECT/CT in the Evaluation of Endocrine and Neuroendocrine Tumors|Completed||N/A|200|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:41:05.622253|2017-10-11 05:41:05.622253
NCT00230152|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2010-10-21|||February 2006||2006-02-01|September 2005|2005-09-01|March 2009|Actual|2009-03-01|April 2007|Actual|2007-04-01||Interventional|||Hybrid Imaging Modalities for the Evaluation of Infection|Nuclear Medicine for the Evaluation of Infection-the Added Value of Hybrid Imaging Modalities|Completed||N/A|300|Actual|Rambam Health Care Campus||1|||f||||f||||||||||2017-10-11 05:41:05.691519|2017-10-11 05:41:05.691519
NCT00230165|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2017-09-05|||September 2005||2005-09-01|September 2017|2017-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.|Studies of Interactions Among Normal and Abnormal Blood Cells, and the Vessel Wall, and Studies of Genetic and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell and Coagulation Disorders|Recruiting||N/A|60|Anticipated|Rockefeller University|||2||f||||f||||||Samples With DNA|"     whole blood   "|||2017-10-11 05:41:05.758122|2017-10-11 05:41:05.758122
NCT00230178|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-01-08|2009-07-22||April 2004||2004-04-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome|Evaluation of Single Agent Rasburicase for 5 Days Versus Sequential Treatment With Rasburicase From Day 1 Through 3 Followed by Oral Allopurinol From Day 3 Through 5 (Overlap on Day 3) Versus Single Agent Oral Allopurinol for 5 Days in the Management of Plasma Uric Acid in Adult Patients With Leukemia, Lymphoma, and Solid Tumor Malignancies at Risk for Hyperuricemia and Tumor Lysis Syndrome|Completed||Phase 3|280|Actual|Sanofi||3|||f||||||||||||||2017-10-11 05:41:05.877107|2017-10-11 05:41:05.877107
NCT00230191|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2007-01-12|||January 2003||2003-01-01|October 2005|2005-10-01|December 2005||2005-12-01|||||Interventional|||Safety and Efficacy of RK0202 in Oral Mucositis|Phase II, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of the Effects of RK-0202 on Oral Mucositis in Patients Receiving Radiation Therapy for Tumors of the Oral Cavity, Oropharynx, Nasopharynx, Salivary Glands or Supraglottic Region|Completed||Phase 2|110||RxKinetix|||||||||||||||||||2017-10-11 05:41:07.358677|2017-10-11 05:41:07.358677
NCT00230204|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2006-02-15|||September 2005||2005-09-01|January 2006|2006-01-01|April 2006||2006-04-01|||||Interventional|||Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis|Antibodies Screening in Multiple Sclerosis as a Part of an International Survey in Autoimmune Diseases.|Unknown status|Recruiting|Phase 1|100||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:41:07.44601|2017-10-11 05:41:07.44601
NCT00230217|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2009-03-27|||March 2004||2004-03-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy|Evaluation of Single Agent Rasburicase in Treatment/Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Adult and Pediatric Patients With Lymphoma/Leukemia/Solid Tumor Malignancies at Their First Relapse or Refractory Disease|Completed||Phase 4|94|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:41:07.52676|2017-10-11 05:41:07.52676
NCT00230230|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2015-09-15|||October 2005||2005-10-01|September 2015|2015-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED)|SCH 486757 vs Codeine and Placebo in Subjects With Persistent Postviral Cough|Completed||Phase 2|91|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:41:07.626575|2017-10-11 05:41:07.626575
NCT00230243|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2017-03-07|||March 1997||1997-03-01|March 2017|2017-03-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Observational|||Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)|A Retrospective Study to Establish an Historical Database on the Efficacy of Standard Antifungal Therapy in Patients With Invasive Fungal Infections|Completed||N/A|330||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:41:07.688574|2017-10-11 05:41:07.688574
NCT00230256|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2012-07-11|||April 2003||2003-04-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers|Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers|Completed||N/A|61|Actual|Stanford University|||1||f||||t||||||||||2017-10-11 05:41:07.742974|2017-10-11 05:41:07.742974
NCT00230269|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2012-07-10|||May 2003||2003-05-01|July 2012|2012-07-01|November 2007|Actual|2007-11-01|June 2006|Actual|2006-06-01||Observational|||The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers|The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers|Completed||N/A|5|Actual|Stanford University|||1||f||||||||||||||2017-10-11 05:41:07.796415|2017-10-11 05:41:07.796415
NCT00230282|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2014-09-25|2014-08-27||July 2004||2004-07-01|September 2014|2014-09-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Interventional|||Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia|A Multi-Center Phase 2 Efficacy and Pharmacokinetic Study Evaluating Fludarabine, Cyclophosphamide, and Subcutaneous Campath (FCCam, Alemtuzumab) for Previously Untreated B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|25|Actual|Stanford University||1|||f||||t||||||||||2017-10-11 05:41:07.852893|2017-10-11 05:41:07.852893
NCT00230295|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-07-23|||February 2003||2003-02-01|July 2010|2010-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast|Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast|Completed||N/A|20|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:41:08.131968|2017-10-11 05:41:08.131968
NCT00230308|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2016-11-08|||April 2002||2002-04-01|November 2016|2016-11-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Observational|||Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer|Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer|Recruiting||N/A|500|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"     At the time of biospy or surgery, a small amount of tumor tissue (approximately 1 cc) will be     taken from the main tumor specimen and stored until analysis.   "|||2017-10-11 05:41:08.259947|2017-10-11 05:41:08.259947
NCT00230321|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2013-01-31|||February 2002||2002-02-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)|A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)|Completed||Phase 1/Phase 2|21|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:41:08.341145|2017-10-11 05:41:08.341145
NCT00230334|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2011-04-11|||June 2003||2003-06-01|April 2011|2011-04-01||||||||Interventional|||Phase II Gleevec Idiopathic Hypereosinophilic Syndrome|Phase II Study of Gleevec (Imatinib Mesylate) in Patients With Idiopathic Hypereosinophilic Syndrome (HES)|Withdrawn||Phase 2|25||Stanford University||||Withdrawn by PI due to insufficient accrual|||||||||||||||2017-10-11 05:41:08.421449|2017-10-11 05:41:08.421449
NCT00230347|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-03-30|||October 2003||2003-10-01|March 2010|2010-03-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Evaluation of Stereotactic Radiosurgery For Liver Malignancies|Dose Escalation Study Evaluating Stereotactic Radiosurgery for Liver Malignancies|Completed||Phase 1|20|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:41:08.49611|2017-10-11 05:41:08.49611
NCT00230360|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2007-02-01|||June 2005||2005-06-01|February 2007|2007-02-01|April 2006||2006-04-01|||||Observational|||Diagnosis of Functional Defecation Disorders in Childhood|Diagnosis of Functional Defecation Disorders in Childhood|Completed||N/A|90||University of Aarhus|||||f||||||||||||||2017-10-11 05:41:08.568875|2017-10-11 05:41:08.568875
NCT00230373|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2015-04-22|||November 2005||2005-11-01|April 2015|2015-04-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study|Evaluation of the Efficacy and Safety of Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study|Withdrawn||Phase 3|0|Actual|University of Alberta||||Study never started.|f||||t||||||||||2017-10-11 05:41:08.676121|2017-10-11 05:41:08.676121
NCT00230386|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2009-07-10|||May 2003||2003-05-01|September 2005|2005-09-01||||||||Interventional|||Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma|The Role of MRI Perfusion to Detect Locally Recurrent or Persistent Disease in Prostate Carcinoma Treated With Radiation Therapy - A Pilot Study|Completed||Phase 1/Phase 2|50|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:41:08.759599|2017-10-11 05:41:08.759599
NCT00230399|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2015-04-20|||June 2003||2003-06-01|April 2015|2015-04-01|March 2008||2008-03-01|January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer|C-2424: Phase II Study of Celecoxib, Capecitabine, and Irinotecan in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|15||University of Michigan Cancer Center|||||f||||||||||||||2017-10-11 05:41:08.830699|2017-10-11 05:41:08.830699
NCT00230412|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-02-01|||October 2005||2005-10-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|||||Observational|HSP||Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study)|Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study)|Unknown status|Recruiting|N/A|120|Anticipated|University of Munich Children's Clinic|||1||f||||f||||||Samples With DNA|"     Whole blood, serum and urine.   "|||2017-10-11 05:41:08.910132|2017-10-11 05:41:08.910132
NCT00230425|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2006-10-10|||February 2003||2003-02-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Observational|||The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.|The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.|Completed||N/A|30||University of Saskatchewan|||||f||||||||||||||2017-10-11 05:41:09.126842|2017-10-11 05:41:09.126842
NCT00230438|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2014-01-03|||January 2005||2005-01-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||External Beam Radiation Therapy - Target Volume|A Pilot Study to Develop a Technique for External Beam Radiotherapy After Radical Prostatectomy Based on MRI-Delineation of the Clinical Target Volume|Completed||Phase 2|27|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:41:09.208192|2017-10-11 05:41:09.208192
NCT00230451|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-01-14|||November 1997||1997-11-01|January 2010|2010-01-01|July 2008|Actual|2008-07-01|December 1999|Actual|1999-12-01||Interventional|||Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma|A Phase II Trial of Preoperative Chemotherapy and Radiation Therapy Followed by Adjuvant Combination Chemotherapy for Patients With Loco-Regional Esophageal Carcinoma|Completed||Phase 2|||University of Michigan Cancer Center|||||f||||t||||||||||2017-10-11 05:41:09.288382|2017-10-11 05:41:09.288382
NCT00230464|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2006-01-03|||November 2004||2004-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Acute Metabolic Effects of LAF 237 in Type 2 Diabetics|A Double-Blind, Placebo-Controlled, Randomized, Crossover Study to Explore the Acute Effects of LAF 237 on the Rate of Appearance and Disappearance of Glucose During the Overnight Post-Absorptive Period in Type 2 Diabetics|Completed||Phase 3|16||The University of Texas Health Science Center at San Antonio|||||||||||||||||||2017-10-11 05:41:09.389093|2017-10-11 05:41:09.389093
NCT00230477|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2007-11-14|||April 2003||2003-04-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT|Efficacy of Adefovir Dipivoxil Versus Adefovir Dipivoxil Plus Lamivudine for the Treatment of Chronic Hepatitis B in Patients With Normal Baseline ALT|Completed||Phase 4|19|Actual|University of Washington||2|||f||||f||||||||||2017-10-11 05:41:09.472981|2017-10-11 05:41:09.472981
NCT00230490|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2012-06-21|||June 2005||2005-06-01|June 2012|2012-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201|Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201|Terminated||Phase 2|150||Valeant Pharmaceuticals International, Inc.||||Adverse findings from nonclinical carcinogenicity studies.|f||||||||||||||2017-10-11 05:41:09.559301|2017-10-11 05:41:09.559301
NCT00230503|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2012-06-21|||June 2004||2004-06-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B|Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B|Completed||Phase 2|220||Valeant Pharmaceuticals International, Inc.|||||f||||||||||||||2017-10-11 05:41:09.628545|2017-10-11 05:41:09.628545
NCT00230516|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2013-01-03|||September 2005||2005-09-01|January 2013|2013-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects|A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects on Days 1 and 5 of Intravenous Treatment|Completed||Phase 4|100||AstraZeneca|||||||||||||||||||2017-10-11 05:41:09.700489|2017-10-11 05:41:09.700489
NCT00230529|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2011-06-08||||||August 2010|2010-08-01|January 2003|Actual|2003-01-01|||||Interventional|||A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis|A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of Infliximab (REMICADE�) Induction Therapy in Patients With Plaque-type Psoriasis|Completed||Phase 2|249|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 05:41:09.767628|2017-10-11 05:41:09.767628
NCT00230542|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2017-03-22|||September 2005||2005-09-01|March 2017|2017-03-01|April 2011|Actual|2011-04-01|July 2007|Actual|2007-07-01||Interventional|||Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer|Phase II Study of Carboplatin and Pemetrexed in Patients With Recurrent Platinum Sensitive Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Completed||Phase 2|44|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:41:09.847391|2017-10-11 05:41:09.847391
NCT00230555|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2005-09-29|||July 2001||2001-07-01|April 2005|2005-04-01|November 2004||2004-11-01|||||Interventional|||The MOM Program at the Children's Hospital of Philadelphia|The MOM Program at the Children's Hospital of Philadelphia|Completed||Phase 3|300||Children's Hospital of Philadelphia|||||f||||||||||||||2017-10-11 05:41:09.952673|2017-10-11 05:41:09.952673
NCT00230568|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2011-03-31|||December 2005||2005-12-01|March 2011|2011-03-01|December 2007|Actual|2007-12-01|April 2007|Actual|2007-04-01||Interventional|||EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)|A 12-Week, Multicenter, Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept) in Hispanic Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 4|100|Actual|Eisai Inc.|||||f||||||||||||||2017-10-11 05:41:10.043641|2017-10-11 05:41:10.043641
NCT00230581|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2007-10-12|||September 2005||2005-09-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS|A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Doses and Dose Levels of DDP225 in Female Patients With Irritable Bowel Syndrome With Diarrhea|Completed||Phase 2|88|Anticipated|Dynogen Pharmaceuticals|||||f||||||||||||||2017-10-11 05:41:10.185205|2017-10-11 05:41:10.185205
NCT00230594|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2011-05-18|||July 2004||2004-07-01|May 2011|2011-05-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|DRY||Desmopressin Response in the Young|Desmopressin Response in the Young: A Double-blind, Randomised, Placebo-controlled, Dose-titration Study With Three Different Doses (120 Mcg, 240 Mcg and 360 Mcg) of Desmopressin Administered as a New Melt Tablet in Children and Adolescents With Primary Nocturnal Enuresis (PNE).|Completed||Phase 3|132|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:41:10.295995|2017-10-11 05:41:10.295995
NCT00230607|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2017-08-03|||May 28, 2006|Actual|2006-05-28|August 2017|2017-08-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||Study of the Effects of Fabrazyme Treatment on Lactation and Infants|A Multicenter, Multinational Study of the Effects of Fabrazyme (Agalsidase Beta) Treatment on Lactation and Infants|Recruiting||Phase 4|20|Anticipated|Sanofi||1|||f||||f|t|f||||||||2017-10-11 05:41:10.555628|2017-10-11 05:41:10.555628
NCT00230620|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2015-05-28|||December 1998||1998-12-01|August 2008|2008-08-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Observational|||Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families|Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families With Pulmonary Arteriovenous Malformations|Recruiting||N/A|250|Anticipated|Imperial College London|||1||f||||||||||||||2017-10-11 05:41:10.652753|2017-10-11 05:41:10.652753
NCT00230659|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2015-05-28|||August 2004||2004-08-01|September 2005|2005-09-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Observational|||Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia|Investigation of Coagulation Parameters in Hereditary Haemorrhagic|Completed||Phase 4|100||Imperial College London|||2||f||||||||||||||2017-10-11 05:41:10.84444|2017-10-11 05:41:10.84444
NCT00230672|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2008-08-12|||March 2005||2005-03-01|August 2008|2008-08-01||||||||Observational|||Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs|Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients|Unknown status|Recruiting|N/A|70|Anticipated|Imperial College London|||||f||||||||||||||2017-10-11 05:41:10.923943|2017-10-11 05:41:10.923943
NCT00230685|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2015-05-28|||January 2000||2000-01-01|August 2008|2008-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia|Hammersmith Hospital Patients With Pulmonary Arteriovenous Malformations (PAVMs) and Hereditary Haemorrhagic Telangiectasia|Recruiting||N/A|500|Anticipated|Imperial College London|||1||f||||||||||||||2017-10-11 05:41:10.983208|2017-10-11 05:41:10.983208
NCT00230698|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2010-11-12|||November 1995||1995-11-01|November 2010|2010-11-01|August 2002|Actual|2002-08-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure|Topiramate (RWJ-17021-000) Monotherapy Clinical Trial in Patients With Recently Diagnosed Partial-Onset Seizures|Completed||Phase 3|451|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:41:11.062396|2017-10-11 05:41:11.062396
NCT00230711|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2012-11-29|||April 2004||2004-04-01|September 2005|2005-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Physical Activity Promotion in Cancer Follow-Up Care|Physical Activity Promotion In Cancer Follow-up Care|Completed||Phase 3|300|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-10-11 05:41:11.134572|2017-10-11 05:41:11.134572
NCT00230724|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2005-09-29|||April 2005||2005-04-01|September 2005|2005-09-01|April 2007||2007-04-01|||||Interventional|||Maintaining Exercise After Cardiac Rehabilitation|Maintaining Exercise After Cardiac Rehabilitation|Unknown status|Recruiting|Phase 3|180||The Miriam Hospital|||||f||||||||||||||2017-10-11 05:41:11.212512|2017-10-11 05:41:11.212512
NCT00230737|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2017-01-17|2017-01-17||October 2004||2004-10-01|January 2017|2017-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Melatonin on Insomnia Symptoms in Older Adults|Melatonin Randomized Trial for Insomnia in the Elderly|Completed||Phase 2|27|Actual|University of Pennsylvania|Study did not meet total recruitment targets|3|||f||||t||||||||||2017-10-11 05:41:11.372191|2017-10-11 05:41:11.372191
NCT00230750|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2013-08-22|||October 2005||2005-10-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Inactivated Influenza A/H5N1 Vaccine in the Elderly|A Randomized, Double-Blinded, Placebo-Controlled Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Elderly Adults|Completed||Phase 1/Phase 2|261|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-10-11 05:41:11.668672|2017-10-11 05:41:11.668672
NCT00230763|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2015-03-04|||September 2005||2005-09-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|PREDICOM||Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure|Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure After A 12-Week Treatment With Latanoprost 0.005% / Timolol 0.5% Fixed Combination (Xalacom) In Previously Treated Patients With Open Angle Glaucoma Or Ocular Hypertension|Completed||Phase 3|396|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:41:11.789572|2017-10-11 05:41:11.789572
NCT00230776|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2012-10-08|||October 2005||2005-10-01|October 2012|2012-10-01|July 2006|Actual|2006-07-01|||||Interventional|||A Controlled Pregabalin Trial In Fibromyalgia|A 14-Week, Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin Twice Daily In Patients With Fibromyalgia|Completed||Phase 3|740||Pfizer|||||||||||||||||||2017-10-11 05:41:12.100233|2017-10-11 05:41:12.100233
NCT00230789|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2013-04-09|||October 2005||2005-10-01|April 2013|2013-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.|A Multicenter, Multiphase, Single Arm, Open Label Study To Evaluate The Effects Of Tolterodine ER In Conjunction With Behavioral Intervention On Subject Satisfaction And Over- Active Bladder Symptoms (Urgency Urinary Incontinence (UUI), Urgency, Frequency) In Overactive Bladder Subjects Who Were Dissatisfied With Their Most Recent Antimuscarinic OAB Medication Therapy.|Completed||Phase 4|417||Pfizer|||||||||||||||||||2017-10-11 05:41:12.39627|2017-10-11 05:41:12.39627
NCT00230802|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2016-10-31|2012-05-29||July 2005||2005-07-01|October 2016|2016-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Thyroid Hormone Dose Adjustment in Pregnancy|Thyroid Hormone Dose Adjustments During Pregnancy in Women With Primary Hypothyroidism.|Completed||N/A|48|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 05:41:12.603258|2017-10-11 05:41:12.603258
NCT00230815|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2013-11-27|||July 2004||2004-07-01|November 2013|2013-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction|A Phase IIIb, Prospective, Multicenter Trial to Evaluate Subject Satisfaction With Follitropin Alfa Injection Applied by Pen Device Compared With Other Injectable Gonadotropins in Oligoanovulatory Infertile Women Undergoing Ovulation Induction|Completed||Phase 3|62|Actual|EMD Serono||1|||f||||||||||||||2017-10-11 05:41:12.939729|2017-10-11 05:41:12.939729
NCT00230828|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2013-09-11|||May 2005||2005-05-01|September 2007|2007-09-01||||January 2006|Actual|2006-01-01||Interventional|||Patient-reported Outcomes in the Treatment of Schizophrenia|Patient-reported Outcomes With Bifeprunox or Olanzapine in the Treatment of Schizophrenia. A Pharmacoeconomic Study Carried Out in Connection With the S1543003 And S1543004 Clinical Trials|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-10-11 05:41:13.016133|2017-10-11 05:41:13.016133
NCT00230841|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2013-07-31|||September 2001||2001-09-01|July 2013|2013-07-01|April 2004||2004-04-01|||||Interventional|||Comparing Different Ways of Delivering Humidity to Children With Croup|Efficacy of Optimal Versus 'Traditional' Delivery of Humidity in Children With Croup|Completed||Phase 2|129||The Hospital for Sick Children|||||f||||||||||||||2017-10-11 05:41:13.063387|2017-10-11 05:41:13.063387
NCT00235027|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2015-07-20|||August 2000||2000-08-01|July 2015|2015-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Improving Safety By Computerizing Outpatient Prescribing|Improving Safety By Computerizing Outpatient Prescribing|Completed||N/A|701|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||||||||||||2017-10-11 05:41:43.574007|2017-10-11 05:41:43.574007
NCT00230854|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2013-06-04|||August 2005||2005-08-01|June 2013|2013-06-01|July 2007||2007-07-01|||||Interventional|||Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin|An Open Label, Dose Escalation Study of EMZ702 in Combination With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Non-responsive to Prior Therapy With Pegylated Interferon and Ribavirin|Completed||Phase 1|28||Transition Therapeutics|||||f||||||||||||||2017-10-11 05:41:13.138853|2017-10-11 05:41:13.138853
NCT00230867|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2006-06-30|||April 2005||2005-04-01|June 2006|2006-06-01|December 2005||2005-12-01|||||Interventional|||Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis|A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of a Single Topical Iontophoretic Application of Acyclovir 5% Cream With an Open Label Conventional Therapy Treatment Arm, and a Blinded Evaluator, for the Treatment of Recurrent Herpes Labialis|Completed||Phase 2|1800||Transport Pharmaceuticals|||||||||||||||||||2017-10-11 05:41:13.210267|2017-10-11 05:41:13.210267
NCT00230880|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2012-12-03|||July 2005||2005-07-01|December 2012|2012-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|REACH||The Young Woman's Reach Project: Trial of an Intervention to Impact Contraceptive Behavior, Unintended Pregnancy, and Sexually Transmitted Infections (STIs) Among Adolescent Females|Randomized Trial of an Intervention to Impact Contraceptive Behavior, Unintended Pregnancy, and STIs Among Adolescent Females Receiving Family Planning Clinic Services|Completed||N/A|800|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 05:41:13.3526|2017-10-11 05:41:13.3526
NCT00230893|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2006-09-20|||July 2005||2005-07-01|September 2006|2006-09-01|September 2005||2005-09-01|||||Observational|||Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years|Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years|Completed||N/A|99||Tuscaloosa Research & Education Advancement Corporation|||||f||||||||||||||2017-10-11 05:41:13.443807|2017-10-11 05:41:13.443807
NCT00224861|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2013-03-21|||September 2004||2004-09-01|March 2013|2013-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Hypertension Telemanagement in African Americans|Hypertension Telemanagement in African Americans|Completed||N/A|||Johns Hopkins University|||||f||||||||||||||2017-10-11 05:41:13.680255|2017-10-11 05:41:13.680255
NCT00224874|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2017-08-24|2010-01-29||September 2005||2005-09-01|August 2017|2017-08-01|June 2012|Actual|2012-06-01|January 2009|Actual|2009-01-01||Interventional|||Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)|Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (ONTAK), and Pentostatin in Combination With Corticosteroids (BMT CTN #0302)|Completed||Phase 2|180|Actual|National Heart, Lung, and Blood Institute (NHLBI)||4|||f||||t||||||||||2017-10-11 05:41:13.773244|2017-10-11 05:41:13.773244
NCT00224900|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2017-02-27|||September 2005||2005-09-01|February 2016|2016-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers|Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers Part A: Focus Group And Measurement Evaluation|Terminated||N/A|10|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-10-11 05:41:15.182373|2017-10-11 05:41:15.182373
NCT00224913|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2005-10-11|||March 2002||2002-03-01|October 2005|2005-10-01||||||||Interventional|||Electrical Stimulation After Total Knee Arthroplasty|NMES for Older Individuals After Total Knee Arthroplasty|Unknown status|Recruiting|Phase 1|200||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-10-11 05:41:15.28193|2017-10-11 05:41:15.28193
NCT00224926|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2011-09-16|||September 2003||2003-09-01|September 2011|2011-09-01|September 2005|Actual|2005-09-01|||||Observational|||The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation|The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation|Completed||N/A|446|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"     fungal scalp cultures   "|||2017-10-11 05:41:15.386407|2017-10-11 05:41:15.386407
NCT00224939|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2010-01-12|||July 2002||2002-07-01|January 2010|2010-01-01|December 2006|Actual|2006-12-01|||||Interventional|||Pre-ESRD Syndrome in High Risk African Americans|Pre-ESRD Syndrome in High Risk African American Young Adults|Terminated||N/A|144|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||||"Only apx 1/3 of enrolled subjects (signed consent) participated. Futility analysis to show   primary endpoint"|f||||||||||||||2017-10-11 05:41:15.492086|2017-10-11 05:41:15.492086
NCT00224952|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2017-08-11|2017-04-18||July 2002||2002-07-01|August 2017|2017-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Pathogenesis of Adverse Drug Reactions|The Role of Drug Metabolizing Enzymes in the Pathogenesis Adverse Drug Reactions in Children|Completed||N/A|274|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"     Urine DNA (source: blood or saliva)   "|||2017-10-11 05:41:15.592457|2017-10-11 05:41:15.592457
NCT00224965|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2017-01-11||||||September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Early Tobacco Abstinence - 5|Early Tobacco Abstinence in High Risk Smokers|Terminated||Phase 1|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:41:16.286973|2017-10-11 05:41:16.286973
NCT00224978|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2009-11-17|||January 2005||2005-01-01|November 2009|2009-11-01|August 2005||2005-08-01|||||Interventional|||Chloroquine for Treatment of Glioblastoma Multiforme|Chloroquine as Adjuvant to the Treatment of Glioblastoma Multiforme, A Randomized Trial|Completed||Phase 3|||National Institute of Neurology and Neurosurgery, Mexico|||||f||||||||||||||2017-10-11 05:41:16.366781|2017-10-11 05:41:16.366781
NCT00224991|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2014-04-02|||June 1999||1999-06-01|April 2014|2014-04-01|June 2005||2005-06-01|||||Interventional|||Osteoporosis School|Effect of Training in Prevention of Falls, Compliance to Treatment and Quality of Life: A Randomized, Prospective Investigation.|Completed||N/A|350||Northern Orthopaedic Division, Denmark|||||f||||f||||||||||2017-10-11 05:41:16.456552|2017-10-11 05:41:16.456552
NCT00225004|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2014-04-02|||July 2004||2004-07-01|April 2014|2014-04-01||||||||Observational|||Osteoporosis and Colles Fracture|Low-energy Fracture of the Wrist (Colles Fracture) and Osteoporosis. A Ten Year Follow-up and a Prospective Study|Terminated||N/A|||Northern Orthopaedic Division, Denmark|||1|Recruiting problems|f||||||||||||||2017-10-11 05:41:16.543636|2017-10-11 05:41:16.543636
NCT00225017|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2012-06-29|2010-10-04||June 2005||2005-06-01|June 2012|2012-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|SABAR||Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study|Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study: Endothelial Function in HIV-Infected Subjects Switched to an Atazanavir Regimen|Completed||Phase 3|50|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 05:41:16.63616|2017-10-11 05:41:16.63616
NCT00225030|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2005-09-13|||January 1970||1970-01-01|July 2004|2004-07-01|July 2004||2004-07-01|||||Observational|||Observational Study of the Prognosis in Treated Arterial Hypertension|Observational Study of the Prognosis in Treated Arterial Hypertension|Completed||N/A|1000||Odense University Hospital|||||f||||||||||||||2017-10-11 05:41:17.024093|2017-10-11 05:41:17.024093
NCT00225043|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2008-05-30|||June 2005||2005-06-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Randomized, Double-Blind, Trial Comparing Epinephrine Versus Phenylephrine as a Vasoconstrictor in Regional Anesthesia for Upper Extremity Surgery||Completed||N/A|60|Actual|New York Methodist Hospital|||||f||||||||||||||2017-10-11 05:41:17.097093|2017-10-11 05:41:17.097093
NCT00225056|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2007-04-18|||October 2003||2003-10-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma|Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma|Terminated||Phase 2|43||Oncology Specialties, Alabama||||Terminated due to lack of accrual|f||||||||||||||2017-10-11 05:41:17.178477|2017-10-11 05:41:17.178477
NCT00225069|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2012-08-22|||September 2005||2005-09-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Thoracoscopic Sympathectomy for Blushing|Thoracoscopic Sympathectomy for Blushing. A Prospective Randomised Trial.|Completed||Phase 4|100|Actual|Odense University Hospital||2|||f||||||||||||||2017-10-11 05:41:17.242659|2017-10-11 05:41:17.242659
NCT00225082|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2010-10-04|||November 2004||2004-11-01|October 2010|2010-10-01|October 2007|Actual|2007-10-01|December 2006|Actual|2006-12-01||Observational|||SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function|SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial|Completed||N/A|12|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"     adipose tissue, blood   "|||2017-10-11 05:41:17.32104|2017-10-11 05:41:17.32104
NCT00225095|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2014-12-02|||September 2005||2005-09-01|December 2014|2014-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy|A Phase I/II, Randomized, Controlled, Double Blind, Study of Chondrogen - Adult Universal Cell Delivered by Intra-Articular Injection Following Meniscectomy in Patients 18-60 Years|Completed||Phase 1/Phase 2|55|Actual|Mesoblast, Ltd.||3|||f||||||||||||||2017-10-11 05:41:17.403811|2017-10-11 05:41:17.403811
NCT00225108|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2006-09-23|||July 2002||2002-07-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section|The Cesarean Section Thromboprophylaxis Pilot Study:A Randomized Open-Label Controlled Pilot Study of Prophylactic Low Molecular Weight Heparin in High Risk Postpartum Women Following Cesarean Section|Completed||Phase 2/Phase 3|30||Ottawa Hospital Research Institute|||||f||||||||||||||2017-10-11 05:41:17.514524|2017-10-11 05:41:17.514524
NCT00225121|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2012-04-06|||October 2005||2005-10-01|April 2012|2012-04-01|September 2010|Actual|2010-09-01|April 2007|Actual|2007-04-01||Interventional|||Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors|A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of 2 Dosing Schedules Of PF-00299804 In Patients With Advanced Malignant Solid Tumors|Completed||Phase 1|121|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:41:17.602635|2017-10-11 05:41:17.602635
NCT00225147|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-20|2013-02-20|2012-02-22||July 2005||2005-07-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|A Randomized, Placebo-controlled, Double Blind Phase II/III Study of the Safety and Efficacy of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|Completed||Phase 2/Phase 3|77|Actual|Pharming Technologies B.V.||3|||f||||t||||||||||2017-10-11 05:41:17.904496|2017-10-11 05:41:17.904496
NCT00225160|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2008-09-17|||November 2003||2003-11-01|September 2008|2008-09-01||||||||Interventional|||ALCAR Prophylaxis Study|A Randomised Double Blinded Placebo Controlled Pilot Study to Evaluate the Safety and Efficacy of Acetyl L Carnitine in Combination With Antiretroviral Therapy for the Prevention of Distal Symmetric Polyneuropathy and Lipid Abnormalities in Treatment naïve HIV Infected Subjects|Unknown status|Active, not recruiting|Phase 2|50||Royal Free Hampstead NHS Trust|||||f||||||||||||||2017-10-11 05:41:18.573263|2017-10-11 05:41:18.573263
NCT00225173|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-21|2014-08-26|||October 2001||2001-10-01|September 2005|2005-09-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease|A Phase II Trial of Stanford VI ± Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease With 3+ Risk Factors: the G6 Study|Terminated||Phase 2|45|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:41:18.684057|2017-10-11 05:41:18.684057
NCT00225186|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2014-01-08|||July 2004||2004-07-01|January 2014|2014-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of SH T00660AA in Treatment of Endometriosis|A Multi-center, Open, One-arm Study to Investigate the Safety and Efficacy of Daily Oral Administration of T00660AA for the Treatment of Endometriosis Over 52 Weeks (Follow-up to Study 307041)|Completed||Phase 3|168|Actual|Bayer||1|||f||||f||||||||||2017-10-11 05:41:18.808503|2017-10-11 05:41:18.808503
NCT00225199|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2010-04-22|||March 2004||2004-03-01|April 2010|2010-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Efficacy and Safety of SH T00660AA in Treatment of Endometriosis|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Daily Oral Administration of SH T00660AA for the Treatment of Endometriosis Over 12 Weeks|Completed||Phase 3|198|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:41:18.930278|2017-10-11 05:41:18.930278
NCT00230906|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2007-12-19|||January 2001||2001-01-01|December 2007|2007-12-01|April 2002|Actual|2002-04-01|||||Interventional|||Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane|Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane|Completed||N/A|12||University Hospital, Ghent|||||f||||f||||||||||2017-10-11 05:41:19.007803|2017-10-11 05:41:19.007803
NCT00230919|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-30|||April 2004||2004-04-01|February 2004|2004-02-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Interventional|||Weight Loss and Changes in Cardiovascular Risk Markers With a Low Glycemic Diet Compared With a Standard Diet|Weight Loss and Changes in Cardiovascular Risk Markers With a Low Glycemic Load Diet Compared With a Standard National Nutrition Council-recommended Diet: a Randomized Trial|Completed||N/A|200||Oslo University Hospital|||||f||||f||||||||||2017-10-11 05:41:19.109027|2017-10-11 05:41:19.109027
NCT00230932|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2015-04-06|||October 2005||2005-10-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|June 2007|Actual|2007-06-01||Observational|HELP-Vets||Help Veterans Experience Less Pain Study (HELP-Vets)|Validation of Pain as a Vital Sign Among Veterans With Advanced Illness|Completed||N/A|654|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-10-11 05:41:19.233333|2017-10-11 05:41:19.233333
NCT00230945|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2008-03-27|||January 2000||2000-01-01|March 2008|2008-03-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Couples-Oriented Psychosocial Intervention for Osteoarthritis|Psychobiological Pathways: Osteoarthritis Interventions|Completed||N/A|543|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-10-11 05:41:19.357016|2017-10-11 05:41:19.357016
NCT00230958|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2012-06-21|||December 2003||2003-12-01|June 2012|2012-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive|Randomized, Double-Blind, Multicenter Study to Compare the Safety and Efficacy of Viramidine to Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C|Completed||Phase 3|900||Valeant Pharmaceuticals International, Inc.|||||f||||||||||||||2017-10-11 05:41:19.463071|2017-10-11 05:41:19.463071
NCT00230971|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2013-02-20|2009-09-30||October 2005||2005-10-01|February 2013|2013-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)|A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection|Completed||Phase 4|473|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-10-11 05:41:19.566109|2017-10-11 05:41:19.566109
NCT00230984|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2009-07-07|||April 2003||2003-04-01|July 2006|2006-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||IRAD2 : Patients With Respiratory Failure at Home|Effects of Home Pulmonary Rehabilitation in Patients With Chronic Respiratory Failure and Nutritional Depletion.|Completed||Phase 3|200||University Hospital, Grenoble||2|||f||||||||||||||2017-10-11 05:41:21.621308|2017-10-11 05:41:21.621308
NCT00230997|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2005-12-15|||December 2002||2002-12-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies|An Open Label 24-Week, Flexible Dose Trial to Assess the Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies|Completed||Phase 3|50||Neurological Research Center|||||f||||||||||||||2017-10-11 05:41:21.73303|2017-10-11 05:41:21.73303
NCT00231010|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2017-10-05|||September 26, 2005||2005-09-26|June 23, 2016|2016-06-23|June 23, 2016||2016-06-23|||||Observational|||Molecular Genetics of Retinal Degenerations|Molecular Genetics of Retinal Degenerations|Completed||N/A|119|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:41:21.84121|2017-10-11 05:41:21.84121
NCT00231023|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-02|2008-03-03|||September 2005||2005-09-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema|Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:41:21.965745|2017-10-11 05:41:21.965745
NCT00231049|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2008-10-24|||March 2006||2006-03-01|October 2008|2008-10-01||||||||Interventional|||Trial Evaluating Safety, Tolerability and Immune Response of AG-707|A Phase 1 Trial Evaluating Safety, Tolerability and Immune Response of AG-707 Compared to Placebo in HSV-2 Seropositive Patients|Completed||Phase 1|35|Actual|Agenus Inc.|||||f||||||||||||||2017-10-11 05:41:22.053701|2017-10-11 05:41:22.053701
NCT00231062|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-10|2011-04-29||April 2005||2005-04-01|June 2011|2011-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)|Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)|Completed||Phase 3|115|Actual|Acclarent||1|||f||||t||||||||||2017-10-11 05:41:22.23308|2017-10-11 05:41:22.23308
NCT00231075|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2005-11-02|||January 2001||2001-01-01|September 2005|2005-09-01|May 2007||2007-05-01|||||Interventional|||Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV|National, Phase II Study Designed to Evaluate the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III and IV. FAG-2|Completed||Phase 2|75||ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-10-11 05:41:22.43961|2017-10-11 05:41:22.43961
NCT00231101|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2006-10-16|||January 2004||2004-01-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia|Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia|Unknown status|Recruiting|N/A|40||Arthur P. Noyes Research Foundation|||||f||||||||||||||2017-10-11 05:41:22.531632|2017-10-11 05:41:22.531632
NCT00231114|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2017-06-29|2010-08-31|2010-02-10|September 2005||2005-09-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|August 2008|Actual|2008-08-01||Interventional|||Asthma Intervention Research 2 (AIR2) Trial|Safety and Effectiveness of the Alair® System for the Treatment of Asthma: A Multicenter Randomized Clinical Trial(Asthma Intervention Research (AIR2) Trial)|Completed||N/A|297|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-10-11 05:41:22.652527|2017-10-11 05:41:22.652527
NCT00231127|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2009-11-09|||April 2005||2005-04-01|November 2009|2009-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)|Osteoporosis and COPD (Making of a Database)|Completed||N/A|250|Anticipated|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||||2017-10-11 05:41:23.598374|2017-10-11 05:41:23.598374
NCT00231140|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2007-01-18|||December 2005||2005-12-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)|Randomized, Open, Parallel Group Study for the Evaluation of an Oral Dose of 100 mg Thalidomide and Subsequent Dose Escalation of 400 mg Thalidomide in Combination With Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)|Terminated||Phase 2|40||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:41:23.684753|2017-10-11 05:41:23.684753
NCT00231153|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2009-06-30|2009-06-30||August 2005||2005-08-01|June 2009|2009-06-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters|A Phase 3, Multicenter, Randomized, Evaluation Committee-Blinded Study to Assess the Efficacy of Topical Omiganan 1% Gel in Preventing Local Catheter Site Infections/Colonization in Patients Undergoing Central Venous Catheterization|Completed||Phase 3|1859|Actual|Mallinckrodt||2|||f||||f||||||||||2017-10-11 05:41:23.784419|2017-10-11 05:41:23.784419
NCT00231166|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2017-03-27|||September 2005||2005-09-01|March 2017|2017-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma|A Phase I, Dose-finding Trial of HCD122, an Anti-CD40 Monoclonal Antibody, in Patients With Multiple Myeloma That is Relapsed or Has Not Responded to Prior Therapy (CHIR1212-C12101)|Completed||Phase 2|33|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:41:24.304537|2017-10-11 05:41:24.304537
NCT00231179|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2015-10-26|2010-03-01||February 2004||2004-02-01|October 2015|2015-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|MOM Program||The MOM Program: 5 Year Follow-up Study of a Home Visiting Program at The Children's Hospital of Philadelphia|The MOM Program Continuation - 5 Year Follow-up|Completed||Phase 3|302|Actual|Children's Hospital of Philadelphia|The initial high rate of refusal to participate in the study may affect the generalizability of our results. Those who refused study participation were older and did not elaborate on their lack of interest.|2|||f||||f||||||||||2017-10-11 05:41:24.408198|2017-10-11 05:41:24.408198
NCT00231192|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2015-03-11|||October 2005||2005-10-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes|Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes|Withdrawn||N/A|0|Actual|Children's Hospital of Philadelphia||1||Unable to recruit any subjects|f||||t||||||||||2017-10-11 05:41:24.77272|2017-10-11 05:41:24.77272
NCT00231205|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2005-09-30|||January 2005||2005-01-01|September 2005|2005-09-01|December 2009||2009-12-01|||||Observational|||TDI Preejection Velocities and Myocardial Viability|TDI-Derived Myocardial Preejection Velocities in Patients With Chronic Ischemic Left Ventricular Dysfunction Undergoing Surgical Revascularization|Unknown status|Recruiting|N/A|200||Charles University, Czech Republic|||||f||||||||||||||2017-10-11 05:41:24.854251|2017-10-11 05:41:24.854251
NCT00231218|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2006-12-13|||January 2006||2006-01-01|December 2006|2006-12-01|March 2006||2006-03-01|||||Interventional|||Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers|the Effectiveness of Echinacea, Propolis and Vitamin C in the Prevention of Respiratory Tract Infections and Gastroenteritis in Preschool Age Children: a Prospective Study|Completed||Phase 3|104||The Cleveland Clinic|||||f||||||||||||||2017-10-11 05:41:24.940725|2017-10-11 05:41:24.940725
NCT00231231|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2007-07-19|||September 2004||2004-09-01|July 2007|2007-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)|Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)|Completed||Phase 3|1500||Cordis Corporation|||||f||||t||||||||||2017-10-11 05:41:25.048018|2017-10-11 05:41:25.048018
NCT00231244|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2009-12-04|||March 2002||2002-03-01|December 2009|2009-12-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)|Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry|Completed||Phase 3|252|Actual|Cordis Corporation||1|||f||||f||||||||||2017-10-11 05:41:25.228978|2017-10-11 05:41:25.228978
NCT00231257|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2009-11-17||2009-11-17|February 2003||2003-02-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|January 2005|Actual|2005-01-01||Interventional|||Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)|A Multicenter, Randomized Study of the Sirolimus-Eluting Bx VELOCITY® BALLOON Expandable Stent vs. Intravascular Brachytherapy in the Treatment of Patients With In-Stent Restenotic Coronary Artery Lesions|Completed||Phase 3|384|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:41:25.306791|2017-10-11 05:41:25.306791
NCT00234364|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-09-19|||March 2005||2005-03-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Observational|||Pergolide Treatment and Valvular Heart Disease||Completed||N/A|155|Actual|Århus Amt|||||f||||f||||||||||2017-10-11 05:41:25.410793|2017-10-11 05:41:25.410793
NCT00234377|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2013-01-03|||November 2004||2004-11-01|January 2013|2013-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia|A 12-week International, Multicenter, Open Label, Non-comparative Study to Evaluate the Feasibility of Switching Any Antipsychotic Treatment to Sustained-release Quetiapine Fumarate (SEROQUEL®) in Patients With Schizophrenia|Completed||Phase 3|550||AstraZeneca|||||f||||||||||||||2017-10-11 05:41:25.4778|2017-10-11 05:41:25.4778
NCT00234390|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2011-01-21|||November 1998||1998-11-01|January 2011|2011-01-01|December 2004|Actual|2004-12-01|||||Interventional|||PreAsthmaControl (PAC)|Prevention of Asthma in Infants/Young Children - PAC|Completed||Phase 4|400||AstraZeneca|||||f||||||||||||||2017-10-11 05:41:25.607499|2017-10-11 05:41:25.607499
NCT00234403|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-04-22|||May 2004||2004-05-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|||||Interventional|||A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer|A Phase II Trial to Evaluate the Combination of ZD1839 (Iressa) and Fulvestrant (Faslodex®) in Patients With Advanced or Metastatic Breast Cancer|Completed||Phase 2|60||AstraZeneca|||||f||||||||||||||2017-10-11 05:41:25.692726|2017-10-11 05:41:25.692726
NCT00234416|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-04-22|||August 2002||2002-08-01|April 2009|2009-04-01|March 2005|Actual|2005-03-01|||||Interventional|||IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer|A Trial to Evaluate ZD1839 (IRESSA) in Combination With Radiotherapy & Gemcitabine as First-Line Treatment in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|45||AstraZeneca|||||f||||||||||||||2017-10-11 05:41:25.780129|2017-10-11 05:41:25.780129
NCT00234429|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2007-12-14|||November 2003||2003-11-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma|A Randomized, Placebo-Controlled, Double-Blind Phase 2b Study of Raltitrexed (Tomudex) and ZD1839 (Iressa) Versus Raltitrexed Alone as Second Line Chemotherapy in Subjects With Colorectal Carcinoma|Completed||Phase 2/Phase 3|74||AstraZeneca|||||f||||||||||||||2017-10-11 05:41:25.880169|2017-10-11 05:41:25.880169
NCT00235417|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2007-06-07|||October 2005||2005-10-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Stem Cell Therapy in Chronic Ischemic Heart Failure||Completed||Phase 2|35|Anticipated|Odense University Hospital|||||f||||||||||||||2017-10-11 05:41:48.760601|2017-10-11 05:41:48.760601
NCT00234442|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-06-29|||July 2004||2004-07-01|June 2009|2009-06-01|February 2006||2006-02-01|||||Interventional|||Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer|A Phase II, Multicentre, Non-Comparative, Open-Label Study To Evaluate The Efficacy And Tolerability Of ZD1839 (Iressa™) In Asymptomatic Radio-Naive Patients With Brain Metastases From Non-Small Cell Lung Carcinoma (NSCLC) Who Have Relapsed Following Prior Chemotherapy|Terminated||Phase 2|47||AstraZeneca||||Closed due to insufficient recruitment.|f||||||||||||||2017-10-11 05:41:26.028785|2017-10-11 05:41:26.028785
NCT00234455|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2008-04-28|||June 2001||2001-06-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|October 2002|Actual|2002-10-01||Interventional|BIFURCATION||A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.|An Evaluation of the Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With Bifurcation Lesions.|Completed||Phase 2|86|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:41:26.116168|2017-10-11 05:41:26.116168
NCT00234468|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2011-05-19|||January 2004||2004-01-01|May 2011|2011-05-01|August 2007|Actual|2007-08-01|||||Interventional|||Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC|A Phase III, Double-Blind, Randomised Study Comparing ZD1839 (IressaTM) Versus Placebo As Maintenance Therapy In Subjects With Locally Advanced Stage III Non-Small Cell Lung Cancer (NSCLC) After Combined Modality Therapy|Terminated||Phase 3|490|Anticipated|AstraZeneca||||Closed due to insufficient recruitment|f||||||||||||||2017-10-11 05:41:26.223185|2017-10-11 05:41:26.223185
NCT00234481|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2008-06-02||||||June 2008|2008-06-01||||||||Interventional|||Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL844 Administered Orally to Subjects With Chronic Lymphocytic Leukemia|Terminated||Phase 1|||Exelixis||||Study closed due to slow enrollment|||||||||||||||2017-10-11 05:41:26.348474|2017-10-11 05:41:26.348474
NCT00234494|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2016-02-16|2016-01-19||November 2005||2005-11-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer|A Phase II Trial of Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer: Hoosier Oncology Group GU04-75|Completed||Phase 2|45|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-10-11 05:41:26.422775|2017-10-11 05:41:26.422775
NCT00234507|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2006-04-12|||January 2003||2003-01-01|April 2006|2006-04-01|May 2004||2004-05-01|||||Interventional|||Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm|Phase II, Multi-Centre, Randomised, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Efficacy and Safety of a Single Administration, by Subcutaneous Injection, of Three Doses of Dysport (40 Units/Eye, 80 Units/Eye, and 120 Units/Eye) for the Treatment of Benign Essential Blepharospasm|Completed||Phase 2|120||Ipsen|||||||||||||||||||2017-10-11 05:41:27.12809|2017-10-11 05:41:27.12809
NCT00234520|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2008-06-26|||May 2003||2003-05-01|June 2008|2008-06-01||||||||Observational|||A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide|A Multicentre Prospective Controlled Observer Blinded Cohort Study in Patients With Acromegaly to Evaluate the Risk of Cardiac Valvular Regurgitation in Patients Treated With Lanreotide Relative to Patients Treated With Octreotide|Completed||Phase 4|200||Ipsen|||||||||||||||||||2017-10-11 05:41:27.262227|2017-10-11 05:41:27.262227
NCT00234546|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2012-06-18|||February 2003||2003-02-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|||||Interventional|||Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity|A 24-week Prospective, Multicentre, Randomised, Double-blind, Placebo Controlled Study of Dysport® Injection for the Treatment of Upper Limb Spasticity in Early Stroke.|Completed||Phase 4|162|Actual|Ipsen||2|||f||||||||||||||2017-10-11 05:41:27.624879|2017-10-11 05:41:27.624879
NCT00234559|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2013-08-19|||September 2005||2005-09-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis|A Randomized Controlled Study Comparing Vacuum Assisted Closure® Therapy to Moist Wound Therapy in Angiogenesis|Withdrawn||N/A|0|Actual|KCI USA, Inc.||||Study terminated due to no subject enrollment.|f||||||||||||||2017-10-11 05:41:27.788795|2017-10-11 05:41:27.788795
NCT00234572|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2009-11-16|||May 2000||2000-05-01|November 2009|2009-11-01|January 2003||2003-01-01|||||Interventional|||Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly|Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.|Completed||Phase 2/Phase 3|96||Ipsen|||||||||||||||||||2017-10-11 05:41:27.862008|2017-10-11 05:41:27.862008
NCT00234585|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2014-12-09|||August 2002||2002-08-01|December 2014|2014-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection|A Prospective Randomized Multicenter Study Comparing the Safety and Efficacy of Renal Artery Stenting With/Without Distal Protection Device (AngioGuard) and With/Without the Use of a Platelet Aggregator Inhibitor (Abciximab-Reopro) (RESIST)|Completed||Phase 2|100||University of Toledo Health Science Campus|||||f||||||||||||||2017-10-11 05:41:28.019424|2017-10-11 05:41:28.019424
NCT00234598|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2015-12-04|||March 2002||2002-03-01|December 2015|2015-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Strategies to Prevent Pneumonia (SToP Pneumonia)|Oral Care Intervention in Mechanically Ventilated Adults|Completed||Phase 2|547|Actual|Virginia Commonwealth University||4|||f||||f||||||||||2017-10-11 05:41:28.094201|2017-10-11 05:41:28.094201
NCT00234611|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2006-11-02|||September 2005||2005-09-01|November 2006|2006-11-01|April 2007||2007-04-01|||||Interventional|||Localization of CRT According to Echocardiography: LOCATE-Pilot Study|Localization of CRT According to Echocardiography: LOCATE-Pilot Study|Unknown status|Active, not recruiting|N/A|60||Michigan Heart, PC|||||f||||||||||||||2017-10-11 05:41:28.197129|2017-10-11 05:41:28.197129
NCT00234624|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2005-10-05|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Observational|||Hepatic Hemodynamic Changes and Simulation in Living-Related Liver Transplantation|Hepatic Hemodynamic Changes and Simulation Before /After Living-Related Liver Transplantation in Donors/Recipients|Unknown status|Recruiting|N/A|10||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:41:28.316036|2017-10-11 05:41:28.316036
NCT00234637|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2011-11-16|||November 2003||2003-11-01|November 2011|2011-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment|An Open-label Study to Evaluate the Efficacy and Safety of add-on Memantine [5-10 mg b.i.d (10-20 mg/Day)] to Rivastigmine [1.5-6 mg b.i.d. (3-12 mg/Day)] Treatment in Patients With Alzheimer's Disease Who Continued With Rivastigmine Treatment After a Previous Decline While on Donepezil or Galantamine Treatment|Completed||Phase 4|204|Actual|Novartis|||||f||||||||||||||2017-10-11 05:41:28.424668|2017-10-11 05:41:28.424668
NCT00234650|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-04-01|||October 2005||2005-10-01|December 2008|2008-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Adenoma Detection Rate With Position Change at Colonoscopy|Evaluation of the Effect of Position Change During the Withdrawal Phase of Colonoscopy on Adenoma Detection Rate|Completed||N/A|130|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-10-11 05:41:28.539367|2017-10-11 05:41:28.539367
NCT00234663|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-01-09|||September 2005||2005-09-01|January 2009|2009-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||PTC124 for Cystic Fibrosis|A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis|Completed||Phase 2|24||PTC Therapeutics|||||||||||||||||||2017-10-11 05:41:28.629263|2017-10-11 05:41:28.629263
NCT00234676|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2007-12-24|||October 2003||2003-10-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease|A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study for the Safety, Tolerability and Efficacy of Estrogen Replacement Therapy (Conjugated Equine Estrogens 0.625 mg Daily) in Post Menopausal Women With Parkinson's Disease|Completed||Phase 2|23|Actual|The Parkinson Study Group||1|||f||||||||||||||2017-10-11 05:41:28.728518|2017-10-11 05:41:28.728518
NCT00234689|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2008-01-28|||January 2002||2002-01-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:41:28.844044|2017-10-11 05:41:28.844044
NCT00234702|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2010-04-29|||October 2005||2005-10-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease|A Phase II, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy and Safety of Lanthanum Carbonate for the Reduction of Serum Phosphorus in Subjects With Stage 3 and 4 Chronic Kidney Disease Who Have Elevated Serum Phosphorus Levels|Completed||Phase 2|84|Anticipated|Shire||2|||f||||||||||||||2017-10-11 05:41:28.926768|2017-10-11 05:41:28.926768
NCT00234715|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2007-11-13|||October 2005||2005-10-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|||||Observational|||Psychosocial Study on Breast Cancer Risk Assessment|A Pilot Study: Psychosocial and Socio-Demographic Determinants of Accepting Breast Cancer Risk Assessment|Completed||N/A|62|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-10-11 05:41:29.051004|2017-10-11 05:41:29.051004
NCT00234728|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2008-06-30|||September 2005||2005-09-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of a New Dressing for Use With Topical Medications|An Open-Label, Bilaterally-Controlled Single Center Study to Compare the Efficacy of Occlusion of Topical Agents With a Hydrophilic Occlusive Dressing to Treatment With Occlusive Dressing Without the Addition of Topical Agents|Completed||N/A|120|Anticipated|Teikoku Pharma USA, Inc.|||||f||||||||||||||2017-10-11 05:41:29.133325|2017-10-11 05:41:29.133325
NCT00234741|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2008-12-03|||November 2005||2005-11-01|December 2008|2008-12-01||||||||Interventional|||Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease|A Randomized, Double-Blind, Pilot Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, to Investigate Peripheral Blood and Mucosal Mononuclear Cell Phenotype and Cytokine Responses in Patients With Crohn's Disease|Completed||Phase 2|12||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-10-11 05:41:29.20196|2017-10-11 05:41:29.20196
NCT00234754|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2016-08-29|||September 2005||2005-09-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in Women|Surgical Management of Stress Urinary Incontinence in Women: A Randomized Clinical Trial (RCT) of TOT vs TVT|Completed||N/A|199|Actual|University of Calgary||2|||f||||f||||||||Undecided|Decision to share will depend on review of IPD protocol|2017-10-11 05:41:29.270995|2017-10-11 05:41:29.270995
NCT00234767|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2008-11-05|||September 2001||2001-09-01|November 2008|2008-11-01||||August 2007|Actual|2007-08-01||Observational|||Study of the Economics of Pulmonary Artery Catheter Use in Patients With Acute Respiratory Distress Syndrome (ARDS)|Economic Analysis of Pulmonary Artery Catheter Use (EA-PAC)|Completed||Phase 3|650||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:41:29.364553|2017-10-11 05:41:29.364553
NCT00234780|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2007-08-15|||October 1997||1997-10-01|October 2005|2005-10-01|August 2000||2000-08-01|||||Interventional|||In Home Hospital Care Program|In Home Hospital Care Program|Completed||N/A|200||University of Rochester|||||f||||||||||||||2017-10-11 05:41:29.439916|2017-10-11 05:41:29.439916
NCT00234793|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-12|2015-06-11|||May 2003||2003-05-01|June 2015|2015-06-01|April 2010||2010-04-01|||||Interventional|||Maternal Problem-Solving in Childhood Cancer|Maternal Problem-Solving in Childhood Cancer|Completed||Phase 3|433|Actual|University of Rochester|||||f||||||||||||||2017-10-11 05:41:29.527862|2017-10-11 05:41:29.527862
NCT00234806|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2015-10-21|||December 2000||2000-12-01|October 2015|2015-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Health-e-Access Telemedicine in Primary Pediatric Care|Health-e-Access: A Study of Telemedicine in Primary Pediatric Care in Rochester, NY|Completed||N/A|2000|Actual|University of Rochester||2|||f||||||||||||||2017-10-11 05:41:29.604793|2017-10-11 05:41:29.604793
NCT00234819|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2007-12-19|||October 2005||2005-10-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause|A Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Bazedoxifene/Conjugated Estrogen Combinations for Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|325||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:41:29.716506|2017-10-11 05:41:29.716506
NCT00234832|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-05-06|2010-03-26||January 2003||2003-01-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|SCOUT||A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients|Sibutramine Cardiovascular Morbidity/Mortality Outcomes Study in Overweight or Obese Subjects at Risk of a Cardiovascular Event|Completed||Phase 3|10777|Actual|Abbott|Most subjects not indicated for sibutramine (sbt) due to CV disease. Long-term sbt use (6 yrs) regardless of weight loss, is inconsistent with label (limits use to 1-2 yrs & 5% weight loss). Trial lacked true placebo; all received Lead-in Period sbt.|3|||f||||t||||||||||2017-10-11 05:41:30.16079|2017-10-11 05:41:30.16079
NCT00234845|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-28|||March 2003||2003-03-01|August 2007|2007-08-01||||||||Interventional|||Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis|A Multi-Centre Randomized, Double-Blind Study Comparing Adalimumab (D2E7) Plus Methotrexate With Placebo Plus Methotrexate on Work Disability in Subjects With Early Rheumatoid Arthritis|Completed||Phase 3|148|Actual|Abbott|||||f||||f||||||||||2017-10-11 05:41:39.708898|2017-10-11 05:41:39.708898
NCT00234858|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-11|||March 2004||2004-03-01|June 2008|2008-06-01||||April 2006|Actual|2006-04-01||Interventional|STAR||Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)|A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka® and Hyzaar® on Glucose Tolerance in Subjects With Metabolic Syndrome|Completed||Phase 4|280|Actual|Abbott||2|||f||||f||||||||||2017-10-11 05:41:39.780576|2017-10-11 05:41:39.780576
NCT00234871|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-11|||January 2004||2004-01-01|July 2008|2008-07-01||||March 2005|Actual|2005-03-01||Interventional|TANDEM||Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)|A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka® and Lotrel® on Albuminuria in Hypertensive, Type 2 Diabetic Subjects With Diabetic Nephropathy|Completed||Phase 4|357|Actual|Abbott||2|||f||||f||||||||||2017-10-11 05:41:39.87078|2017-10-11 05:41:39.87078
NCT00234884|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2011-08-25|2011-07-15||September 2003||2003-09-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|ReAlise||Post-marketing Observational Study in Subjects With Rheumatoid Arthritis|A Five-year, Post-marketing Observational Study to Follow-up Patients With Rheumatoid Arthritis Formerly Treated in Study M02-497 (ReAct) and Subsequently Prescribed Humira|Completed||Phase 4|3435|Actual|Abbott|||1||f||||f||||||||||2017-10-11 05:41:40.036314|2017-10-11 05:41:40.036314
NCT00234897|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-08-28|||August 2004||2004-08-01|August 2007|2007-08-01||||||||Interventional|HERO||Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis|Humira Efficacy Response Optimization Study in Subjects With Active Rheumatoid Arthritis (HERO)|Completed||Phase 4|1938|Actual|Abbott|||||f||||f||||||||||2017-10-11 05:41:42.802228|2017-10-11 05:41:42.802228
NCT00234910|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-09|||January 2005||2005-01-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|KALEAD||Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients|A Phase III, Open Label, Randomized, Comparative Study of the Antiviral Efficacy of ARV Therapy With Lopinavir/Ritonavir (LPV/r-Kaletra) in Combination With Tenofovir (TDF) Versus Standard of Care (Kaletra in Combination With 2 Nucleoside RTIs) in naïve-HIV-1 Positive Patients|Completed||Phase 3|152|Actual|Abbott||2|||f||||f||||||||||2017-10-11 05:41:42.872043|2017-10-11 05:41:42.872043
NCT00234923|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-04-01|||August 2003||2003-08-01|April 2008|2008-04-01||||February 2007|Actual|2007-02-01||Interventional|MONARK||Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients|A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen Versus Lopinavir/Ritonavir in Combination With Lamivudine/Zidovudine in Antiretroviral Naïve Patients|Completed||Phase 3|138|Actual|Abbott||2|||f||||f||||||||||2017-10-11 05:41:42.963397|2017-10-11 05:41:42.963397
NCT00234936|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-16|2007-10-02|||December 2003||2003-12-01|October 2007|2007-10-01||||||||Interventional|||Quality of Life Study With Adalimumab in Rheumatoid Arthritis|Quality of Life Study With Adalimumab in Rheumatoid Arthritis|Completed||Phase 3|200|Actual|Abbott|||||f||||||||||||||2017-10-11 05:41:43.046668|2017-10-11 05:41:43.046668
NCT00234949|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-23|||March 2005||2005-03-01|October 2007|2007-10-01||||||||Interventional|||A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections|A Comparative Study of the Safety, Tolerability, and Efficacy of Cefdinir and Cephalexin for the Treatment of Subjects With Mild to Moderate Uncomplicated Skin and Skin Structure Infections|Completed||Phase 4|380||Abbott|||||f||||||||||||||2017-10-11 05:41:43.104081|2017-10-11 05:41:43.104081
NCT00234962|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-11-19|||August 2002||2002-08-01|November 2008|2008-11-01|February 2007|Actual|2007-02-01|||||Interventional|||Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy|Factors Associated With Adherence in a Cohort of HIV Positive Subjects on a First Time PI Containing HAART Regimen: Observational Study of the Impact of Adherence on Viral Load for a HAART Regimen Containing Kaletra vs Other Selected PI Containing HAART.|Terminated||Phase 4|200||Abbott|||||f||||||||||||||2017-10-11 05:41:43.166522|2017-10-11 05:41:43.166522
NCT00234975|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-01-02|||October 2002||2002-10-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score|Evaluation of Clinical Response and Safety in HIV Positive Subjects Co-infected With Hepatitis C Treated With a Kaletra Containing HAART Regimen|Completed||Phase 4|86|Actual|AbbVie||2|||f||||f||||||||||2017-10-11 05:41:43.228746|2017-10-11 05:41:43.228746
NCT00234988|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-11|||June 2004||2004-06-01|July 2008|2008-07-01||||January 2006|Actual|2006-01-01||Interventional|||A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.|Safety and Weight Reduction of Sibutramine in the Treatment of Thai Obese and Overweight Subjects|Completed||Phase 4|93|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:41:43.320973|2017-10-11 05:41:43.320973
NCT00235001|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-09|||June 2004||2004-06-01|July 2008|2008-07-01||||November 2006|Actual|2006-11-01||Interventional|||Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension|A Multicenter, Open, Phase IV, 24-Hour Ambulatory Blood Pressure Monitoring Study of the Efficacy and Safety of Tarka in Patients With Arterial Hypertension|Completed||Phase 4|120|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:41:43.405874|2017-10-11 05:41:43.405874
NCT00235014|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-11|||March 1997||1997-03-01|June 2008|2008-06-01||||January 2006|Actual|2006-01-01||Interventional|BENEDICT||A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)|A Two-Phase Study for Primary and Secondary Prevention of Diabetic Nephropathy by Combined ACE Inhibition and Calcium Channel Blockade (BENEDICT)|Completed||Phase 4|1204|Actual|Abbott||4|||f||||f||||||||||2017-10-11 05:41:43.484308|2017-10-11 05:41:43.484308
NCT00235040|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2012-01-24|||November 2005||2005-11-01|January 2012|2012-01-01|August 2007|Actual|2007-08-01|May 2006|Actual|2006-05-01||Interventional|||Evaluating the Effectiveness of the Acute Respiratory Infection Smart Form|Evaluating Smart Forms and Quality Dashboards in an EHR: Effectiveness of the Acute Respiratory Infection Smart Form|Completed||N/A|18257|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-10-11 05:41:43.654904|2017-10-11 05:41:43.654904
NCT00235053|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2006-01-30|||August 2005||2005-08-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID|A Pilot Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID as Assessed by the Development of Laryngitis and Oropharyngeal Candidiasis in Adults With Mild Persistent Asthma|Unknown status|Active, not recruiting|Phase 4|13||Allergy & Asthma Medical Group & Research Center|||||f||||||||||||||2017-10-11 05:41:44.028378|2017-10-11 05:41:44.028378
NCT00235066|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2008-09-15|||November 2002||2002-11-01|September 2008|2008-09-01|April 2006|Actual|2006-04-01|November 2003|Actual|2003-11-01||Interventional|SVELTE||The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.|A Multicenter, Nonrandomized, Historical Controlled Study In Patients With De Novo Coronary Artery Lesions In Small VessELs Treated With The CYPHER™ STEnt|Completed||Phase 4|100|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 05:41:44.116823|2017-10-11 05:41:44.116823
NCT00235079|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2013-08-06|||November 2005||2005-11-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|CORP 2||Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.|Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis.|Completed||Phase 4|240|Actual|Azienda Sanitaria Locale 3, Torino||2|||f||||t||||||||||2017-10-11 05:41:44.193399|2017-10-11 05:41:44.193399
NCT00235092|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-04-25|||August 2003||2003-08-01|April 2007|2007-04-01|March 2006||2006-03-01|||||Interventional|||The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus|A Prospective, Randomized, Multi-Center Comparison of the Cypher Sirolimus-Eluting and the Taxus Paclitaxel-Eluting Stent Systems.|Completed||Phase 4|1335||Cordis Corporation|||||f||||t||||||||||2017-10-11 05:41:44.282833|2017-10-11 05:41:44.282833
NCT00235105|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2005-12-08|||March 2005||2005-03-01|October 2005|2005-10-01|June 2007||2007-06-01|||||Interventional|||D2E7-Early AS|Adalimumab in Early Axial Spondyloarthritis (Without Radiological Sacroiliitis): Placebo Controlled Phase Over 3 Months Followed by a 9 Months Open Extension Phase|Unknown status|Active, not recruiting|Phase 2/Phase 3|46||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:41:44.357896|2017-10-11 05:41:44.357896
NCT00235118|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2005-12-08|||December 1999||1999-12-01|October 2005|2005-10-01|February 2006||2006-02-01|||||Interventional|||Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)|An Evaluation of the Safety and Effectiveness of the Cordis Bilateral AAA Device Compared to Open Surgical Repair for the Treatment of Abdominal Aortic Aneurysm|Completed||Phase 1/Phase 2|29||Cordis Corporation|||||||||||||||||||2017-10-11 05:41:44.4459|2017-10-11 05:41:44.4459
NCT00235131|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2010-02-03|||May 2005||2005-05-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|March 2008|Actual|2008-03-01||Interventional|SUPER SL||The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent|A Clinical Investigation of the Cordis S.M.A.R.T. ™ CONTROL ™ Nitinol Stent System Versus the Bard® Luminexx™ 6F Vascular Stent for the Treatment of TASC C & D Superficial Femoral Artery Long Lesions|Completed||Phase 4|200|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:41:44.510452|2017-10-11 05:41:44.510452
NCT00235144|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2009-05-08|||March 2001||2001-03-01|May 2009|2009-05-01|September 2008|Actual|2008-09-01|October 2002|Actual|2002-10-01||Interventional|E-SIRIUS||The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.|E-Sirius Study: a European, Multi-Center, Randomized, Double-Blind Study of the Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions|Completed||Phase 3|353|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:41:44.599344|2017-10-11 05:41:44.599344
NCT00235157|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2008-08-05|||November 2001||2001-11-01|August 2008|2008-08-01|July 2005|Actual|2005-07-01|November 2002|Actual|2002-11-01||Interventional|GREAT||A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.|Palmaz Genesis Peripheral Stainless Steel Balloon Expandable Stent, Comparing a Sirolimus Coated Versus an Uncoated Stent in REnal Artery Treatment.|Completed||Phase 2|105|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 05:41:44.716537|2017-10-11 05:41:44.716537
NCT00235170|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2009-05-04|||February 2003||2003-02-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|December 2004|Actual|2004-12-01||Interventional|ARTS II||The Arterial Revascularization Therapies Study Part II.|ARTS II: Arterial Revascularization Therapies Study Part II of the Sirolimus-Eluting Bx VELOCITY™ Balloon Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions.|Completed||Phase 3|607|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 05:41:44.831429|2017-10-11 05:41:44.831429
NCT00235183|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2014-02-14|||June 2005||2005-06-01|February 2014|2014-02-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Plasma Transfusion in Liver Transplantation|Plasma Transfusion in Liver Transplantation : a Randomized, Double Blind, Multicenter Trial of Methylene Blue, Solvent/Detergent and Quarantined Plasma.|Completed||Phase 4|300|Anticipated|Etablissement Français du Sang||3|||f||||||||||||||2017-10-11 05:41:45.037559|2017-10-11 05:41:45.037559
NCT00235196|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2006-10-12|||July 2004||2004-07-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers|A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers|Completed||Phase 4|48||Ethicon, Inc.|||||f||||||||||||||2017-10-11 05:41:45.149745|2017-10-11 05:41:45.149745
NCT00235209|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2011-06-08|||November 2004||2004-11-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers|A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers|Completed||Phase 4|48||Ethicon, Inc.|||||f||||||||||||||2017-10-11 05:41:45.241706|2017-10-11 05:41:45.241706
NCT00235222|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2005-10-24|||June 2004||2004-06-01|October 2005|2005-10-01|March 2006||2006-03-01|||||Interventional|||Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY|Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY|Unknown status|Active, not recruiting|Phase 4|57||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-10-11 05:41:45.319793|2017-10-11 05:41:45.319793
NCT00235235|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2015-12-08|||September 2005||2005-09-01|December 2015|2015-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer|Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study: Hoosier Oncology Group COE-01|Terminated||N/A|80|Actual|Hoosier Cancer Research Network|||4|Funding terminated|f||||t||||||Samples With DNA|"     core biopsy, serum, urine   "|||2017-10-11 05:41:45.40899|2017-10-11 05:41:45.40899
NCT00235248|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2012-07-06|||February 2002||2002-02-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|December 2010|Actual|2010-12-01||Interventional|ARCH||Aortic Arch Related Cerebral Hazard Trial (ARCH)|Prevention of New Vascular Events in Patients With Brain Infarction or Peripheral Embolism and Thoracic Aortic Plaques ≥ 4 mm in Thickness in the Aortic Arch or Descending Aortic Upstream to the Embolized Artery|Completed||Phase 3|350|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:41:45.575077|2017-10-11 05:41:45.575077
NCT00235261|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2007-08-16|||October 2005||2005-10-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients After Hip Operations|Effect of Paracetamol Versus Paracetamol Combined With Pregabalin Versus Paracetamol Combined With Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for a Primary Total Hip Replacement|Completed||Phase 4|120|Anticipated|Glostrup University Hospital, Copenhagen|||||f||||t||||||||||2017-10-11 05:41:45.695917|2017-10-11 05:41:45.695917
NCT00235274|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2017-03-01|||November 2005||2005-11-01|March 2017|2017-03-01|August 2006||2006-08-01|||||Interventional|||Effects of RG1068 (Secretin) on Information Processing in Schizophrenia|Effects of RG1068 (Secretin) on Information Processing in Schizophrenia|Completed||Phase 2|30||Indiana University|||||||||||||||||||2017-10-11 05:41:45.798522|2017-10-11 05:41:45.798522
NCT00235287|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2009-01-16|||September 2005||2005-09-01|January 2009|2009-01-01||||||||Interventional|||Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease|Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease: An Interventional and Methodological Study|Unknown status|Recruiting|Phase 4|60|Anticipated|Herlev Hospital||4|||f||||t||||||||||2017-10-11 05:41:45.884269|2017-10-11 05:41:45.884269
NCT00235300|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2015-03-17|||May 2000||2000-05-01|March 2015|2015-03-01|June 2005|Actual|2005-06-01|April 2003|Actual|2003-04-01||Interventional|||An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.|An Open-Label Prospective, Randomized, Multicenter Phase II Comparative Trial of Thymoglobulin® Versus Simulect® for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients|Completed||Phase 2|240|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:41:46.023665|2017-10-11 05:41:46.023665
NCT00235313|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2008-03-28|||October 2005||2005-10-01|March 2007|2007-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|ADONIS||Adjustment of DOses of NIcotine in Smoking Cessation (ADONIS)|Does Dose Adjustment of Nicotine Replacement Therapies According to Saliva Cotinine Increase Efficacy of These Treatments of Assistance To the Nicotinic Weaning Of the High-Risk Patients?|Completed||Phase 4|300|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-10-11 05:41:46.189072|2017-10-11 05:41:46.189072
NCT00235326|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2009-03-16|2009-02-05||January 2002||2002-01-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario|Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario|Completed||N/A|4561|Actual|McMaster University|||2||f||||f||||||||||2017-10-11 05:41:46.301867|2017-10-11 05:41:46.301867
NCT00235339|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2012-05-11|||October 2005||2005-10-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|February 2008|Actual|2008-02-01||Interventional|||Effect of Standard Care Rehabilitation Versus Interval Treadmill Training After Myocardial Infarction|Comparative Study of Training Modality After Myocardial Infarction; Standard Care Rehabilitation Training or Interval Treadmill Training|Completed||N/A|89|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:41:46.58371|2017-10-11 05:41:46.58371
NCT00235352|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2009-02-25|||February 2002||2002-02-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|April 2005|Actual|2005-04-01||Interventional|CX516||Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia|A Placebo-Controlled Trial of CX516 (Ampakine) Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia|Completed||Phase 2/Phase 3|105|Actual|North Suffolk Mental Health Association||1|||f||||t||||||||||2017-10-11 05:41:46.695883|2017-10-11 05:41:46.695883
NCT00235365|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2012-11-21|||August 2009||2009-08-01|November 2012|2012-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Metacognitive Therapy for Comorbid Insomnia|Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia.|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||2||problems recruiting patients|f||||f||||||||||2017-10-11 05:41:46.776098|2017-10-11 05:41:46.776098
NCT00235378|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2015-10-13|||July 1996||1996-07-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Genetic Study of Lupus Patients and Their Families|Gene Mapping in Women With SLE|Completed||N/A|2356|Actual|Oklahoma Medical Research Foundation|||3||f||||f||||||Samples With DNA|"     Blood   "|||2017-10-11 05:41:46.84461|2017-10-11 05:41:46.84461
NCT00235391|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2011-06-03|2010-12-17||October 2005||2005-10-01|June 2011|2011-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload|A Study to Provide Expanded Access of (Exjade®) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators|Completed||Phase 3|1683|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:41:46.961222|2017-10-11 05:41:46.961222
NCT00235404|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2016-07-28|||September 2003||2003-09-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|||||Interventional|||Randomized Controlled Trial of Health Care to Elderly Patients.|Specialized Treatment and Care Intervention at a Primary Level in a Nursing Home Compared to Conventional Treatment at a Hospital: a Randomized Controlled Trial.|Completed||N/A|142|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:41:48.638572|2017-10-11 05:41:48.638572
NCT00235443|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2017-07-28|2009-08-31||September 2004||2004-09-01|July 2017|2017-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy|A Multi-Center, Open-Label, Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy|Completed||Phase 2/Phase 3|451|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:41:48.897736|2017-10-11 05:41:48.897736
NCT00235456|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2016-12-18|2016-06-20||March 2003||2003-03-01|December 2016|2016-12-01|January 2005|Actual|2005-01-01|October 2004|Actual|2004-10-01||Interventional|||Supplemental Oxygen Reduces Surgical Infection|Supplemental Perioperative Oxygen Reduces the Risk of Surgical Wound Infection: A Randomized, Double-blind Trial|Completed||N/A|300|Actual|The Cleveland Clinic||2|||f||||t||||||||No||2017-10-11 05:41:55.237499|2017-10-11 05:41:55.237499
NCT00235469|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2014-09-19|||April 2004||2004-04-01|February 2010|2010-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Efficacy and Safety OF 200, 400, AND 600 mg/Day SPM 927 in Subjects With Painful Distal Diabetic Neuropathy|Completed||Phase 2/Phase 3|496|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:41:55.557495|2017-10-11 05:41:55.557495
NCT00235482|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2017-05-09|||August 2005||2005-08-01|May 2017|2017-05-01||||||||Interventional|||Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma|Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma|Completed||Phase 1|3||Viralytics|||||f||||||||||||||2017-10-11 05:41:55.62082|2017-10-11 05:41:55.62082
NCT00235495|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-14|2012-11-14|||June 2006||2006-06-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|February 2013|Anticipated|2013-02-01||Interventional|ALIAS||Albumin in Acute Ischemic Stroke Trial|A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke|Terminated||Phase 3|843|Actual|University of Miami||2||Recruitment halted by DSMB following interim analysis.|f||||t||||||||||2017-10-11 05:41:55.679715|2017-10-11 05:41:55.679715
NCT00235508|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2012-02-21|||June 2005||2005-06-01|February 2012|2012-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder|The Efficacy of Eszopiclone 3 mg as Adjunctive Therapy in Subjects With Insomnia Related to Generalized Anxiety Disorder.|Completed||Phase 4|420|Actual|Sunovion||2|||f||||f||||||||||2017-10-11 05:41:55.836023|2017-10-11 05:41:55.836023
NCT00235521|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2012-12-11|||May 2005||2005-05-01|December 2012|2012-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery|Comparison of Inhaled Nitric Oxide With Aerosolized Iloprost (Ventavis®) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery|Completed||N/A|15|Actual|Heidelberg University|||||f||||t||||||||||2017-10-11 05:41:56.149631|2017-10-11 05:41:56.149631
NCT00235534|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2012-11-16|||October 2005||2005-10-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Trial of Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Abortion|Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Therapeutic Abortion - A Randomized Trial|Completed||N/A|300|Actual|University of California, San Francisco||2|||f||||||||||||||2017-10-11 05:41:56.22352|2017-10-11 05:41:56.22352
NCT00235547|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2013-07-01|||August 2005||2005-08-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|May 2006|Actual|2006-05-01||Interventional|||Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion|Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion: A Randomized Trial|Completed||N/A|300|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-10-11 05:41:56.30897|2017-10-11 05:41:56.30897
NCT00235560|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-09|2008-06-19|||June 2005||2005-06-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|LAM-RAPA||Rapamycin in Combination With Low-Dose Aracytin in Elderly Acute Myeloid Leukemia Patients|Rapamycin in Combination With Low-Dose Aracytin in Elderly Acute Myeloid Leukemia Patients. A Study From the Groupe Ouest Est d'étude Des Leucémies Aiguës Myéloïdes (GOELAMS)|Completed||Phase 2|50|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-10-11 05:41:56.387795|2017-10-11 05:41:56.387795
NCT00235573|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2011-12-15|2011-09-30||October 2005||2005-10-01|December 2011|2011-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption|Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption|Completed||N/A|21|Actual|University of Florida||1|||f||||f||||||||||2017-10-11 05:41:56.481024|2017-10-11 05:41:56.481024
NCT00235586|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2007-09-18|||April 2004||2004-04-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Vitamin D Deficiency: Bone Loss and Vascular Dysfunction|Vitamin D Deficiency: Bone Loss and Vascular Dysfunction|Completed||N/A|40||University of Kansas Medical Center|||||f||||f||||||||||2017-10-11 05:41:56.662591|2017-10-11 05:41:56.662591
NCT00235599|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2007-05-15|||September 2005||2005-09-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Observational|||The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.|The Insulin-Like Growth Factor Binding Protein-3 Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.|Completed||N/A|10|Actual|University of Massachusetts, Worcester|||||f||||f||||||||||2017-10-11 05:41:56.731823|2017-10-11 05:41:56.731823
NCT00235625|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2007-12-12|||October 2005||2005-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris|A Phase II Open Label Study of the Safety and Efficacy of Curcuminoids C3 Complex® in Patients With Chronic Psoriasis Vulgaris.|Completed||Phase 2|12|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-10-11 05:41:56.81391|2017-10-11 05:41:56.81391
NCT00235651|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2008-12-16|||October 2005||2005-10-01|December 2008|2008-12-01|April 2006|Actual|2006-04-01|||||Interventional|||Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients|Pharmacokinetic and Deposition Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet®) in Lung Transplant Recipients (Radiotagging Protocol)|Terminated||Phase 3|12||University of Pittsburgh||||study completed|f||||||||||||||2017-10-11 05:41:56.881506|2017-10-11 05:41:56.881506
NCT00238498|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2012-04-30|||July 2004||2004-07-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes|A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes|Completed||Phase 2|291|Actual|Novartis|||||f||||||||||||||2017-10-11 05:42:52.822419|2017-10-11 05:42:52.822419
NCT00235664|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2008-12-16|||October 2005||2005-10-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Observational|||Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients|Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients|Completed||N/A|200|Anticipated|University of Pittsburgh|||1||f||||||||||Samples Without DNA|"     No genetic testing will be performed on any of the samples being obtained. The biologic     samples will be under the control of the principal investigator of this research project. To     protect confidentiality, all personal identifiers (i.e., name, social security number, and     birth date) will be removed (de-identified) and replaced with a specific code number. The     information linking these code numbers to the corresponding subjects' identities will be kept     in a separate, secure location. The investigators on this study will keep the samples     indefinitely. If a subject withdraws and provides the request in writing, samples collected     and not already processed will be destroyed. All samples will be kept in the investigator's     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.   "|||2017-10-11 05:41:56.963157|2017-10-11 05:41:56.963157
NCT00235677|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2005-10-06|||August 2003||2003-08-01|July 2005|2005-07-01|August 2005||2005-08-01|||||Interventional|||Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study|A Blinded, Randomized, Sham-Controlled Trial of Endoscopic Gastroplication for the Treatment of Gastroesophageal Reflux Disease|Completed||Phase 3|60||UMC Utrecht|||||f||||||||||||||2017-10-11 05:41:57.029098|2017-10-11 05:41:57.029098
NCT00235690|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2015-12-16|||June 2008||2008-06-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)|Pharmacokinetics and Pharmacodynamics of Intravenous Colistin- Pilot Study|Completed||N/A|10|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:41:57.101387|2017-10-11 05:41:57.101387
NCT00235703|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2006-05-04|||October 2001||2001-10-01|October 2005|2005-10-01|September 2005||2005-09-01|||||Observational|||Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)|Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)|Completed||N/A|13000||University of Utah|||||f||||||||||||||2017-10-11 05:41:57.380274|2017-10-11 05:41:57.380274
NCT00235716|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2014-07-14|2013-12-06||August 2007||2007-08-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|TEAM-AD||A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease|CSP #546 - A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease (TEAM-AD)|Completed||Phase 3|613|Actual|VA Office of Research and Development||4|||f||||t||||||||||2017-10-11 05:41:57.57831|2017-10-11 05:41:57.57831
NCT00235729|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2009-03-19|||June 2006||2006-06-01|March 2009|2009-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Lofexidine for Inpatient Opiate Detox|CSP #1024 - A Phase III, Randomized, Multi-Center, Double Blind, Placebo-Controlled Study of Safety and Efficacy of Lofexidine for Relief of Symptoms in Subjects Undergoing Inpatient Opiate Detoxification.|Completed||Phase 3|264|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:42:03.33704|2017-10-11 05:42:03.33704
NCT00235755|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2017-03-23|2011-07-07||December 2005||2005-12-01|March 2017|2017-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|RESTORE2||Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy|Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study - Determine Efficacy and Safety of Two Doses of Retigabine (900 Mg/Day and 600 Mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients With Partial-Onset Seizures|Completed||Phase 3|539|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-10-11 05:42:03.610907|2017-10-11 05:42:03.610907
NCT00235768|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2005-10-06|||April 2002||2002-04-01|October 2004|2004-10-01|July 2005||2005-07-01|||||Observational|||The NeXT Study; The Netherlands XTC Toxicity Study|Neurotoxicity of Ecstasy: Causality, Course and Clinical Relevance|Completed||Phase 1|225||UMC Utrecht|||||f||||||||||||||2017-10-11 05:42:05.649567|2017-10-11 05:42:05.649567
NCT00235781|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2006-10-13|||January 2006||2006-01-01|October 2006|2006-10-01|February 2006||2006-02-01|||||Interventional|||Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients|Non-Phased Study of the Use of a Single Dose of Thymoglobulin for Immunosuppressive Induction in Renal Transplant Recipients as Compared to a Standard Four Dose Regimen|Terminated||N/A|90||Washington University School of Medicine|||||f||||||||||||||2017-10-11 05:42:05.736605|2017-10-11 05:42:05.736605
NCT00235794|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2007-12-18|||January 2004||2004-01-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients|An Open Label Study of Exploratory Pharmacogenomics and Pharmacologic Effects of Neoadjuvant Oral Temsirolimus in Newly Diagnosed Prostate Cancer Patients Undergoing Radical Prostatectomy Who Have a High Risk of Relapse|Completed||N/A|50|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:42:05.82206|2017-10-11 05:42:05.82206
NCT00235807|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2011-03-23|||June 2004||2004-06-01|March 2011|2011-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Multi-Site Randomized Clinical Study of Tinnitus Treatment Methods|Multi-Site Randomized Clinical Study of Tinnitus Treatment Methods|Completed||N/A|144|Anticipated|VA Office of Research and Development||3|||f||||||||||||||2017-10-11 05:42:05.923837|2017-10-11 05:42:05.923837
NCT00235820|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2008-07-15|||July 2005||2005-07-01|June 2008|2008-06-01||||May 2006|Actual|2006-05-01||Interventional|CHAMPION||Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase 3, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Comparing the Safety and Efficacy of Adalimumab to Methotrexate in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|271|Actual|Abbott||3|||f||||f||||||||||2017-10-11 05:42:06.055737|2017-10-11 05:42:06.055737
NCT00235833|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-04-07|2009-10-12||June 2003||2003-06-01|April 2011|2011-04-01||||October 2004|Actual|2004-10-01||Interventional|||Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis|Long-term Continuously Repeated Dose Study of Adalimumab (D2E7) in Patients With Rheumatoid Arthritis|Completed||Phase 2|25|Actual|Abbott|Due to the small population, statistical tests were not performed.|1|||f||||f||||||||||2017-10-11 05:42:06.182826|2017-10-11 05:42:06.182826
NCT00235846|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2015-04-13|||December 2004||2004-12-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Endoscopic Vessel Harvesting During Coronary Bypass Surgery|Endoscopic Vessel Harvesting During Coronary Bypass Surgery|Completed||N/A|132|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-10-11 05:42:07.844944|2017-10-11 05:42:07.844944
NCT00235859|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2007-08-28|||July 2003||2003-07-01|August 2007|2007-08-01||||||||Interventional|||Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate|A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Human Anti-TNF Antibody Adalimumab Administered as Subcutaneous Injections in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate|Completed||Phase 3|128|Actual|Abbott|||||f||||f||||||||||2017-10-11 05:42:07.932865|2017-10-11 05:42:07.932865
NCT00235872|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-04-07|2009-12-09||August 2004||2004-08-01|April 2011|2011-04-01||||July 2006|Actual|2006-07-01||Interventional|||Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis|Open-Label Continuous Administration Study With Adalimumab (D2E7) in Subjects With Rheumatoid Arthritis|Completed||Phase 3|309|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:42:08.070578|2017-10-11 05:42:08.070578
NCT00235885|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2007-08-28|||July 2005||2005-07-01|August 2007|2007-08-01||||||||Interventional|STEREO||Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)|Safety and Efficacy of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) - An Open-Label, Multinational Study to Evaluate the Response to Every-Other Week Adalimumab When Added to Insufficient Standard Therapy, Including Patients Who Failed Prior Treatment With Other TNF-Inhibitors (STEREO)|Completed||Phase 3|445||Abbott|||||f||||||||||||||2017-10-11 05:42:09.739442|2017-10-11 05:42:09.739442
NCT00235898|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-06|2008-08-22|||May 2005||2005-05-01|August 2008|2008-08-01||||March 2008|Actual|2008-03-01||Interventional|||Clinical Trial in Patients With Metastatic Colorectal Cancer|A Multi-Center, Open Label, Parallel Group, Randomised, Phase IIB Clinical Trial to Evaluate the Safety and Efficacy of CoFactor and 5-FU Versus Leucovorin and 5-FU in Subjects With Metastatic Colorectal Carcinoma|Completed||Phase 2|300|Actual|Mast Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 05:42:09.80779|2017-10-11 05:42:09.80779
NCT00235911|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-01-21|||September 2003||2003-09-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting|Effects of Symbicort Single Inhaler Therapy on Bronchial Hyper Responsiveness, Asthma Control and Safety in Mild to Moderate Asthmatics in General Practice, Compared to Usual Care Therapy|Completed||Phase 3|100||AstraZeneca|||||f||||||||||||||2017-10-11 05:42:09.93646|2017-10-11 05:42:09.93646
NCT00235924|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2005-12-07|||June 2004||2004-06-01|October 2005|2005-10-01||||||||Interventional|||Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women|Study Assessing the Effects on Endometrium and Breast of a Standardized Isoflavone Extract(Phytosoya) in Post Menopausal Women.|Unknown status|Active, not recruiting|Phase 3|300||Laboratoires Arkopharma|||||f||||||||||||||2017-10-11 05:42:10.001259|2017-10-11 05:42:10.001259
NCT00235937|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2011-01-20|||December 2001||2001-12-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|||||Interventional|||Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex|An Open, Phase II Trial Assessing the Objective Response Rate After Combination of Arimidex® 1mg Per os/Day and Zoladex® 3.6 mg Sub Cut/Monthly as 1st Treatment for Premenopausal Receptor Positive Advanced or Metastatic Breast Cancer|Completed||Phase 2|45|Anticipated|AstraZeneca|||||f||||||||||||||2017-10-11 05:42:10.067419|2017-10-11 05:42:10.067419
NCT00235950|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-11-18|||January 2004||2004-01-01|November 2010|2010-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease|A Multicentre Study Comparing the Efficacy of Rosuvastatin With Atorvastatin When Given for a Period of 16 Wks to Subjects With Coronary Heart Disease & a Previously Performed Percutaneous Coronary Intervention|Completed||Phase 4|255||AstraZeneca|||||f||||||||||||||2017-10-11 05:42:10.204485|2017-10-11 05:42:10.204485
NCT00235963|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2008-10-14|||December 2002||2002-12-01|October 2008|2008-10-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm|A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm|Completed||Phase 1/Phase 2|104||Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 05:42:10.316396|2017-10-11 05:42:10.316396
NCT00235976|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2006-07-20|||May 2005||2005-05-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General Anesthesia|A Multicenter, Randomized, Controlled, Observer-Blinded, Dose-Response Study to Evaluate the Efficacy in Tracheal Intubation and Safety of Gantacurium Chloride for Injection in Healthy Adult Patients Undergoing Surgery With General Anesthesia|Completed||Phase 1/Phase 2|200||Avera Pharmaceuticals|||||f||||||||||||||2017-10-11 05:42:10.394175|2017-10-11 05:42:10.394175
NCT00235989|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2014-04-25|2009-01-30||June 2003||2003-06-01|April 2014|2014-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis|An Open-label Extension Study of the Double-blind, Randomized, Parallel Group, Multicenter Phase 2 Study 307000A to Further Evaluate the Safety and Tolerability of Betaseron® 500 mcg Subcutaneously Every Other Day and Betaseron® 250 mcg Subcutaneously Every Other Day in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)|Completed||Phase 2|63|Actual|Bayer|The 40 patients in the NAb frequency summaries are the total number of patients with NAb titers at week 234. Official HARTS-to-MedDRA Mapping was used.|4|||f||||f||||||||||2017-10-11 05:42:10.499143|2017-10-11 05:42:10.499143
NCT00236002|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2009-08-11|||July 2005||2005-07-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|November 2007|Actual|2007-11-01||Interventional|||Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )|A Phase III, Double-blind, Randomized, Parallel Group, Placebo-controlled Study of Oral Fosamax, 70 mg Once a Week, for the Prevention of Androgen Deprivation Bone Loss in Non-metastatic Prostate Cancer|Terminated||Phase 3|182|Actual|Canadian Urology Research Consortium||1||Slow accrual than anticipated.|f||||f||||||||||2017-10-11 05:42:12.574913|2017-10-11 05:42:12.574913
NCT00236015|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-05-08|||November 2004||2004-11-01|May 2014|2014-05-01|March 2006||2006-03-01|||||Interventional|||A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder|A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Gabitril at 4, 8, and 12 mg/Day in the Treatment of Adults With Generalized Anxiety Disorder.|Completed||Phase 3|880||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:42:12.698402|2017-10-11 05:42:12.698402
NCT00232778|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2008-04-17|||May 2000||2000-05-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|||||Interventional|||A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)|A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)|Completed||Phase 1/Phase 2|579||Cordis Corporation|||||f||||||||||||||2017-10-11 05:43:39.615982|2017-10-11 05:43:39.615982
NCT00236028|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-05-18||||||March 2010|2010-03-01|April 2003|Actual|2003-04-01|||||Interventional|||A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis|A Randomized, Double-blind, Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate Compared With Methotrexate Alone for the Treatment of Patients With Early Rheumatoid Arthritis|Completed||Phase 3|607|Actual|Centocor, Inc.|||||||||||||||||||2017-10-11 05:42:12.843088|2017-10-11 05:42:12.843088
NCT00236041|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-05-08|||April 2004||2004-04-01|May 2014|2014-05-01|August 2006||2006-08-01|||||Interventional|||Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)|A Double-Blind, Placebo-Comparison Study to Evaluate the Efficacy and Safety of ACTIQ® (Oral Transmucosal Fentanyl Citrate [OTFC®]) Treatment for Opioid-Tolerant Children and Adolescents With Breakthrough Pain|Completed||Phase 2|38||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:42:12.915821|2017-10-11 05:42:12.915821
NCT00236054|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-05-08|||October 2004||2004-10-01|May 2014|2014-05-01|December 2005||2005-12-01|||||Interventional|||A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder|A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Gabitril (up to 16 mg/Day) in the Treatment of Adults With Generalized Anxiety Disorder|Completed||Phase 3|440||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:42:13.213328|2017-10-11 05:42:13.213328
NCT00236067|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-05-08|||October 2004||2004-10-01|May 2014|2014-05-01|March 2006||2006-03-01|||||Interventional|||A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder|A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Gabitril(up to 16 mg/Day) in the Treatment of Adults With Generalized Anxiety Disorder|Completed||Phase 3|440||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:42:13.30775|2017-10-11 05:42:13.30775
NCT00236080|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2013-07-12|2009-06-01||August 2005||2005-08-01|July 2013|2013-07-01|December 2005||2005-12-01|||||Interventional|||Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil (150, 200, and 250 mg) and PROVIGIL® (200 mg) in Patients With Chronic Shift Work Sleep Disorder|Completed||Phase 3|136|Actual|Teva Pharmaceutical Industries|In analyzing the PVT data, it was discovered that data transfer errors had occurred at certain study centers. The ability to interpret the efficacy results from this study is limited, and the findings should be considered inconclusive.|5|||||||||||||||||2017-10-11 05:42:13.422954|2017-10-11 05:42:13.422954
NCT00236093|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-05-08|||October 2006||2006-10-01|May 2014|2014-05-01||||December 2006|Actual|2006-12-01||Interventional|||Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain|A 4-week, Open-Label Extension Study of ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC]) Treatment for Opioid-Tolerant Children and Adolescents With Breakthrough Pain|Completed||Phase 2|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 05:42:13.974267|2017-10-11 05:42:13.974267
NCT00236106|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2005-12-08|||February 2005||2005-02-01|March 2005|2005-03-01|June 2005||2005-06-01|||||Interventional|||Short Term Growth in Children With Atopic Dermatitis||Completed||Phase 4|20||Children´s Clinic, Randers|||||f||||||||||||||2017-10-11 05:42:14.174267|2017-10-11 05:42:14.174267
NCT00236119|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2012-08-22|||June 2005||2005-06-01|August 2012|2012-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis|A 12-Week, Exploratory, Open-Label, Nonrandomized, Dose-Escalation Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe, Recalcitrant, Plaque Type Psoriasis|Completed||Phase 2|46|Actual|Teva Pharmaceutical Industries||4|||f||||||||||||||2017-10-11 05:42:14.240142|2017-10-11 05:42:14.240142
NCT00236132|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2007-10-11|||August 2001||2001-08-01|October 2007|2007-10-01|December 2008|Anticipated|2008-12-01|||||Observational|||"A Multicenter Study Comparing the Clinical Outcomes of the Nuss and Ravitch Procedures for Repair Of Pediatric Pectus Excavatum"|" A Multicenter Study Comparing the Clinical Outcomes of the Nuss and Ravitch Procedures for Repair of Pediatric Pectus Excavatum"|Unknown status|Active, not recruiting|N/A|360|Anticipated|Children's Health System, Inc.|||||f||||||||||||||2017-10-11 05:42:14.336519|2017-10-11 05:42:14.336519
NCT00236145|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2013-01-28|||June 2004||2004-06-01|October 2005|2005-10-01||||August 2005|Actual|2005-08-01||Interventional|||Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain|A Randomised, Open-label, Parallel-group Study to Evaluate the Efficacy and Safety of ACTIQ (Oral Transmucosal Fentanyl Citrate) Titrated According to 2 Regimens in Patients With Cancer and Breakthrough Pain|Completed||Phase 3|||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:42:14.429251|2017-10-11 05:42:14.429251
NCT00236158|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2009-02-20|||March 1999||1999-03-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||The Danish Multicenter Randomised Study on AAI Versus DDD Pacing in Sick Sinus Syndrome|The Danish Multicenter Randomised Study on AAI Versus DDD Pacing in Sick Sinus Syndrome|Terminated||Phase 2/Phase 3|1415|Actual|The DANPACE Investigator Group||2||Not able to recruit the estimated number of patients|f||||t||||||||||2017-10-11 05:42:14.489939|2017-10-11 05:42:14.489939
NCT00236171|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2010-06-07|||September 2004||2004-09-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|April 2006|Actual|2006-04-01||Interventional|||Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test|Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test|Completed||N/A|14|Actual|Technische Universität Dresden||1|||f||||f||||||||||2017-10-11 05:42:14.569542|2017-10-11 05:42:14.569542
NCT00236184|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2010-03-30|2009-08-26||October 2005||2005-10-01|March 2010|2010-03-01|June 2008|Actual|2008-06-01|March 2006|Actual|2006-03-01||Interventional|||E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers|E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers|Completed||Phase 3|629|Actual|Eisai Inc.||2|||f||||t||||||||||2017-10-11 05:42:14.649844|2017-10-11 05:42:14.649844
NCT00236197|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2009-11-04|2009-08-25||October 2005||2005-10-01|November 2009|2009-11-01|June 2008|Actual|2008-06-01|March 2006|Actual|2006-03-01||Interventional|||E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers|E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers|Completed||Phase 3|619|Actual|Eisai Inc.||2|||f||||||||||||||2017-10-11 05:42:15.10995|2017-10-11 05:42:15.10995
NCT00236210|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2009-07-31|||August 2004||2004-08-01|July 2009|2009-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program|The Vascular Intervention Project (VIP): a Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program in the Algoma District of Northern Ontario|Completed||N/A|422|Actual|Group Health Centre||2|||f||||f||||||||||2017-10-11 05:42:15.473354|2017-10-11 05:42:15.473354
NCT00236223|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2008-05-14|||October 2005||2005-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery|The Effect of Gabapentin, Low Dose Ketamine, Paracetamol, NSAID and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Primary Total Hip Replacement|Terminated||Phase 4|48|Actual|Glostrup University Hospital, Copenhagen||2||Structural changes that stopped the type of operations used in the study|f||||t||||||||||2017-10-11 05:42:15.581218|2017-10-11 05:42:15.581218
NCT00236236|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-02|2006-11-13|||February 2003||2003-02-01|October 2005|2005-10-01|May 2005||2005-05-01|||||Observational|||The HF-HRV Registry|CONTAK RENEWAL® Heart Failure Heart Rate Variability Registry|Completed||Phase 4|1400||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:42:15.676823|2017-10-11 05:42:15.676823
NCT00236249|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2011-02-17|||May 2005||2005-05-01|March 2007|2007-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety and Efficacy Study of Intravenous Lidocaine After Colorectal Surgery: LIDOREHAB|Evaluation of Lidocaine Continuous Intravenous Administration for Postoperative Recovery After Colorectal Surgery|Completed||Phase 3|110|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:42:15.733746|2017-10-11 05:42:15.733746
NCT00236262|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2007-03-23|||October 2005||2005-10-01|March 2007|2007-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress Syndrome|Effect of the Positive Expiratory Pressure on the Right Ventricular Function in Patient With Adult Respiratory Distress Syndrome Ventilated With Limited Plateau Pressure|Completed||N/A|15||Assistance Publique - Hôpitaux de Paris|||||f||||t||||||||||2017-10-11 05:42:15.829057|2017-10-11 05:42:15.829057
NCT00236275|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2011-04-29|||May 2004||2004-05-01|March 2007|2007-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer|PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer|Completed||Phase 3|60|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:42:15.917593|2017-10-11 05:42:15.917593
NCT00236288|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2007-10-29|||October 2005||2005-10-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||A Feasibility Study of Smoking Cessation Program in Radiation Oncology|A Feasibility Study of Smoking Cessation Program in Radiation Oncology|Completed||N/A|36|Anticipated|Indiana University||1|||f||||||||||||||2017-10-11 05:42:16.013722|2017-10-11 05:42:16.013722
NCT00236301|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2008-01-16|||March 2004||2004-03-01|October 2005|2005-10-01|January 2007|Actual|2007-01-01|June 2006|Actual|2006-06-01||Interventional|THS||Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers|Pro-Inflammatory Effects of Two Different Doses of 17 Beta Estradiol in Menopausal Women|Terminated||Phase 3|99|Actual|Assistance Publique - Hôpitaux de Paris||3||terminated|f||||f||||||||||2017-10-11 05:42:16.097457|2017-10-11 05:42:16.097457
NCT00236327|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-05-16|||June 2003||2003-06-01|April 2010|2010-04-01|May 2004|Actual|2004-05-01|||||Interventional|||Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain|Evaluation of the Efficacy and Safety of Transdermal Fentanyl in Patients Suffering From Chronic Cancer Pain in an Ambulatory Setting|Terminated||Phase 4|34|Actual|Janssen Cilag S.A.S.||||"Sponsor discontinued the study following the discovery of a number of incompletely sealed   batches that were unusable."|f||||f||||||||||2017-10-11 05:42:16.210799|2017-10-11 05:42:16.210799
NCT00236340|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2007-04-18|||January 2002||2002-01-01|October 2005|2005-10-01|February 2005|Actual|2005-02-01|||||Interventional|||Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.|Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.|Completed||Phase 3|80||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||t||||||||||2017-10-11 05:42:16.303976|2017-10-11 05:42:16.303976
NCT00236353|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-05-16|||May 2002||2002-05-01|March 2011|2011-03-01|December 2003|Actual|2003-12-01|||||Interventional|||Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder|An Open-label Study of the Efficacy and Safety of RISPERDAL Long-acting Microspheres (RISPERDAL CONSTA) Administered Once Monthly in Adults With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|86|Actual|Janssen, LP|||||f||||||||||||||2017-10-11 05:42:16.398378|2017-10-11 05:42:16.398378
NCT00236366|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-05-16|||June 2002||2002-06-01|December 2010|2010-12-01|April 2004|Actual|2004-04-01|||||Interventional|||A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With Osteoarthritis|Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Trial To Investigate Durogesic™ In Comparison To Placebo In Subjects With Moderate To Severe Pain Induced By Osteoarthritis Of The Hip Or The Knee, Who Are In Need Of And Waiting For Hip Or Knee Replacement.|Completed||Phase 4|418|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:42:16.46744|2017-10-11 05:42:16.46744
NCT00236379|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-05-16||||||March 2011|2011-03-01|August 2003|Actual|2003-08-01|||||Interventional|||A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder|A Six-month, Double-blind, Randomized, International, Multicenter Trial to Evaluate the Glucoregulatory Effects of Risperidone and Olanzapine in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|59|Actual|Janssen, LP||2|||f||||||||||||||2017-10-11 05:42:16.536334|2017-10-11 05:42:16.536334
NCT00236392|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-11-29|||October 2001||2001-10-01|November 2010|2010-11-01|October 2002|Actual|2002-10-01|||||Interventional|||"A Study of Efficacy and Safety of On-demand Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)"|"Double-Blind Placebo-Controlled Randomized Withdrawal Trial Assessing the Efficacy and Tolerability of On-Demand Maintenance Therapy With 10mg o.d. Rabeprazole for 6 Months in Non-Erosive Reflux Disease Patients With Complete Symptom Relief After 4 Week Open Acute Phase"|Completed||Phase 3|422|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:42:16.617383|2017-10-11 05:42:16.617383
NCT00236405|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||March 2005||2005-03-01|March 2010|2010-03-01|October 2005|Actual|2005-10-01|||||Interventional|||PROCRIT and Short-Term Outcomes in Orthopedic Surgery|A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of of PROCRIT� (Epoetin Alfa) on Short-Term Outcomes in Orthopedic Subjects Undergoing Primary Unilateral Knee Arthroplasty|Terminated||Phase 2|6|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||The study was terminated due to poor enrollment.|||||f||||||||||2017-10-11 05:42:16.962173|2017-10-11 05:42:16.962173
NCT00236418|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||December 1994||1994-12-01|April 2010|2010-04-01|December 1996|Actual|1996-12-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures|Topiramate Clinical Trial in Primary Generalized Tonic-Clonic Seizures|Completed||Phase 3|80|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:17.044128|2017-10-11 05:42:17.044128
NCT00236431|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||May 2001||2001-05-01|November 2010|2010-11-01|December 2003|Actual|2003-12-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment|A Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer's Disease|Completed||Phase 3|1063|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:17.115339|2017-10-11 05:42:17.115339
NCT00236444|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||December 2001||2001-12-01|November 2010|2010-11-01|September 2003|Actual|2003-09-01|||||Interventional|||A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders|Risperidone in the Prevention of Relapse: a Randomized, Double-blind, Placebo-controlled Trial in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders.|Completed||Phase 3|375|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:17.176704|2017-10-11 05:42:17.176704
NCT00236457|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||November 2000||2000-11-01|November 2010|2010-11-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder|Randomized, Multi-center, Open Label Trial Comparing Risperidone Depot (Microspheres) and Olanzapine Tablets in Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|629|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:42:17.241504|2017-10-11 05:42:17.241504
NCT00236470|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||January 2002||2002-01-01|January 2011|2011-01-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders|Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders - an Open Label Follow-up Trial of CR002020|Completed||Phase 3|232|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:42:17.31759|2017-10-11 05:42:17.31759
NCT00236483|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||November 2002||2002-11-01|April 2010|2010-04-01|February 2003|Actual|2003-02-01|||||Interventional|||A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery|A Comparison of the Efficacy and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus ULTRAM® (Tramadol HCl) Versus Placebo in Subjects With Pain Following Oral Surgery|Completed||Phase 4|456|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:42:17.404198|2017-10-11 05:42:17.404198
NCT00236496|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||October 2001||2001-10-01|April 2010|2010-04-01|February 2004|Actual|2004-02-01|||||Interventional|||A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.|A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in the Treatment of Essential Tremor|Completed||Phase 3|223|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:42:17.503713|2017-10-11 05:42:17.503713
NCT00236509|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-11-15|||February 2001||2001-02-01|November 2010|2010-11-01|September 2002|Actual|2002-09-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine|Completed||Phase 3|763|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:17.601879|2017-10-11 05:42:17.601879
NCT00236522|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||October 2002||2002-10-01|April 2010|2010-04-01|April 2004|Actual|2004-04-01|||||Interventional|||A Comparison of the Safety and Efficacy of Two Different Regimens of Levofloxacin in the Treatment of Acute Bacterial Sinusitis(Sinus Infection) in Adults.|A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Levofloxacin 750 mg Once Daily for 5 Days Versus Levofloxacin 500 mg Once Daily for 10 Days in the Treatment of Acute Bacterial Sinusitis in Adults.|Completed||Phase 3|784|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:42:17.684713|2017-10-11 05:42:17.684713
NCT00236535|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||December 2003||2003-12-01|April 2010|2010-04-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study of the Efficacy and Safety of Tramadol HCl/Acetaminophen, Hydrocodone Bitartrate/Acetaminophen and Placebo in Patients With Pain From an Ankle Sprain With a Partial Torn Ligament|A Comparison of the Efficacy and Safety of Tramadol HCl/Acetaminophen Versus Hydrocodone Bitartrate/Acetaminophen Versus Placebo in Subjects With Acute Musculoskeletal Pain|Completed||Phase 3|603|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:42:17.777182|2017-10-11 05:42:17.777182
NCT00236548|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-05-17||||||March 2011|2011-03-01|January 2003|Actual|2003-01-01|||||Interventional|||Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection|An Open-label Evaluation of the Utility of the RISPERDAL CONSTA Treatment Guidebook During Transition of Adult Patients With Schizophrenia or Schizoaffective Disorder to RISPERDAL CONSTA (Risperidone) Treatment Over Three Months in the Community Mental Health Center (CMHC) Setting|Completed||Phase 3|1|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:17.878197|2017-10-11 05:42:17.878197
NCT00233233|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2015-09-15|||August 2002||2002-08-01|September 2015|2015-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy Adherence|Assessment Mode and Validity of Self-Reports in Adults|Completed||N/A|139|Actual|Johns Hopkins University|||||f||||||||||||||2017-10-11 05:43:45.621497|2017-10-11 05:43:45.621497
NCT00236561|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-11-18|||April 2001||2001-04-01|November 2010|2010-11-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine|A Randomized, Double-Blind, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prophylaxis of Migraine|Completed||Phase 3|786|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:17.967046|2017-10-11 05:42:17.967046
NCT00236574|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||May 2001||2001-05-01|November 2010|2010-11-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment|A Randomized Double Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer's Disease.|Completed||Phase 3|974|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:18.126455|2017-10-11 05:42:18.126455
NCT00236587|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||November 2001||2001-11-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|||||Interventional|||A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia|An Open Label, Long Term Trial of Risperidone Long Acting Microspheres in the Treatment of Patients Diagnosed With Schizophrenia|Completed||Phase 3|100|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:18.216926|2017-10-11 05:42:18.216926
NCT00236600|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-04-26|||August 2000||2000-08-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of Topiramate in Weight Loss Maintenance in Obese Patients Following Participation in an Intensive, Non-Pharmacologic Weight Loss Program|Completed||Phase 3|561|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:42:18.296099|2017-10-11 05:42:18.296099
NCT00236613|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-12-02|||September 2000||2000-09-01|December 2010|2010-12-01|July 2001|Actual|2001-07-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Dose-Response Study to Assess the Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity|Completed||Phase 2|385|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:18.376139|2017-10-11 05:42:18.376139
NCT00236626|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||April 2000||2000-04-01|April 2010|2010-04-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes|A 9 Month, Double-Blind, Placebo-Controlled Study With a Blinded Crossover Transition to Open-Label Extension, Evaluating the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Type 2 Diabetes Patients|Completed||Phase 2|38|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:42:18.4533|2017-10-11 05:42:18.4533
NCT00236639|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-04-26|||July 2000||2000-07-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Dose-Response Study to Assess the Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity|Completed||Phase 3|1293|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:42:18.534995|2017-10-11 05:42:18.534995
NCT00236652|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||November 2003||2003-11-01|April 2010|2010-04-01|June 2005|Actual|2005-06-01|||||Interventional|||A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.|An Open-label, Multi-center, Non-comparative Sinus Puncture Study of 750 mg, Short-course Levofloxacin in the Treatment of Acute Maxillary Sinusitis|Completed||Phase 3|18|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:42:18.608728|2017-10-11 05:42:18.608728
NCT00236665|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-04-26|||March 2001||2001-03-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension|Completed||Phase 3|531|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:42:18.682307|2017-10-11 05:42:18.682307
NCT00236678|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||July 2004||2004-07-01|March 2010|2010-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT|A Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With Anemia of Chronic Disease (ACD) Due to Rheumatoid Arthritis Receiving PROCRIT� (Epoetin Alfa)|Terminated||Phase 2|29|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"This study was terminated due to slow enrollment, despite protocol amendments to change the   entrance criteria."|||||t||||||||||2017-10-11 05:42:18.759968|2017-10-11 05:42:18.759968
NCT00236691|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||July 1988||1988-07-01|January 2011|2011-01-01|December 1990|Actual|1990-12-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.|Double-Blind, Parallel Comparison of Three Doses of Topiramate and Placebo in Refractory Partial Epilepsy|Completed||Phase 2|188|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:18.857317|2017-10-11 05:42:18.857317
NCT00236704|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||March 1994||1994-03-01|January 2011|2011-01-01|December 1999|Actual|1999-12-01|||||Interventional|||"A Study of the Efficacy and Safety of Topiramate as Add on Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures"|Topiramate Clinical Trial in Primary Generalized Tonic-Clonic Seizures|Completed||Phase 3|80|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:18.940871|2017-10-11 05:42:18.940871
NCT00236717|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||September 1997||1997-09-01|January 2011|2011-01-01|November 2000|Actual|2000-11-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy|TOPAMAX (Topiramate) Monotherapy Comparison Trial to Standard Monotherapy in the Treatment of Newly Diagnosed Epilepsy (RWJ-17021-000); Phase IIIB|Completed||Phase 3|865|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.014301|2017-10-11 05:42:19.014301
NCT00236730|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||June 1988||1988-06-01|January 2011|2011-01-01|December 1990|Actual|1990-12-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy|Double-Blind Parallel Comparison of Three Doses of Topiramate and Placebo in Refractory Partial Epilepsy|Completed||Phase 2|178|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.096963|2017-10-11 05:42:19.096963
NCT00236743|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||June 1994||1994-06-01|January 2011|2011-01-01|October 2000|Actual|2000-10-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy|Topiramate (RWJ 17021-000) Clinical Trial In Children With Partial Onset Seizures|Completed||Phase 3|90|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.183204|2017-10-11 05:42:19.183204
NCT00236756|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-02|||August 1993||1993-08-01|January 2011|2011-01-01|February 2001|Actual|2001-02-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome|A Double-Blind Trial of Topiramate in Subjects With Lennox-Gastaut Syndrome.|Completed||Phase 3|100|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.273685|2017-10-11 05:42:19.273685
NCT00236769|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-11-15|||November 1997||1997-11-01|November 2010|2010-11-01|October 1999|Actual|1999-10-01|||||Interventional|||A Study of Efficacy and Safety With the Transdermal Contraceptive System.|An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17deacetyl-norgestimate and Ethinyl Estradiol.|Completed||Phase 3|1751|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.378497|2017-10-11 05:42:19.378497
NCT00236782|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||October 1997||1997-10-01|November 2010|2010-11-01|March 1999|Actual|1999-03-01|||||Interventional|||A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.|An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17dNorgestimate and Ethinyl Estradiol With the Oral Contraceptive Mercilon.|Completed||Phase 3|1517|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.469226|2017-10-11 05:42:19.469226
NCT00236795|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||January 1997||1997-01-01|November 2010|2010-11-01|March 1999|Actual|1999-03-01|||||Interventional|||A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.|An Open-label Study to Evaluate the Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17-deacetylnorgestimate and Ethinyl Estradiol With the Oral Contraceptive Triphasil.|Completed||Phase 3|1494|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.543454|2017-10-11 05:42:19.543454
NCT00236808|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||May 2000||2000-05-01|April 2010|2010-04-01|November 2001|Actual|2001-11-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis|A Multicenter, Double-Blind Study to Compare the Safety and Efficacy of Levofloxacin to That of Ciprofloxacin in the Treatment of Chronic Prostatitis|Completed||Phase 3|383|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:42:19.629764|2017-10-11 05:42:19.629764
NCT00236821|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||March 2001||2001-03-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia|Multicenter, Double-Blind Randomized Study to Compare the Safety and Efficacy of Levofloxacin 750 mg Once Daily for Five Days vs. Levofloxacin 500 mg Once Daily for 10 Days in the Treatment of Mild to Severe Community-Acquired Pneumonia in Adults|Completed||Phase 3|530|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:42:19.708011|2017-10-11 05:42:19.708011
NCT00236834|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||December 1997||1997-12-01|April 2010|2010-04-01|June 2001|Actual|2001-06-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization|A Multicenter, Randomized, Open Label Study to Compare the Safety and Efficacy of Levofloxacin With That of Imipenem/Cilastatin in the Treatment of Nosocomial Pneumonia|Completed||Phase 3|438|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:42:19.79177|2017-10-11 05:42:19.79177
NCT00236847|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||December 1989||1989-12-01|April 2010|2010-04-01|July 1993|Actual|1993-07-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.|Double-Blind, Parallel Comparison of Topiramate 300 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy|Completed||Phase 2|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.875532|2017-10-11 05:42:19.875532
NCT00236860|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||May 1989||1989-05-01|April 2010|2010-04-01|February 1992|Actual|1992-02-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures|Double-Blind Parallel Comparison of Topiramate 400 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy|Completed||Phase 2|56|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:19.954849|2017-10-11 05:42:19.954849
NCT00236873|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-06|||October 1989||1989-10-01|April 2010|2010-04-01|May 1993|Actual|1993-05-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.|Double-Blind Parallel Comparison of Topiramate 200 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy|Completed||Phase 2|47|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:42:20.044046|2017-10-11 05:42:20.044046
NCT00236886|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-04-26|||May 1998||1998-05-01|April 2010|2010-04-01|June 2000|Actual|2000-06-01|||||Interventional|||Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients|Prospective Pilot Study on Metabolism and Weight Changes in Subjects With Diagnosed Partial Onset Epilepsy, With or Without Secondarily Generalized Seizures and Treated With Topiramate.|Completed||Phase 3|49|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:42:20.117768|2017-10-11 05:42:20.117768
NCT00228150|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2008-12-22|||July 2003||2003-07-01|December 2008|2008-12-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease|A Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy, Safety and Tolerability Study of SR57667B in Outpatients With Early Parkinson's Disease|Completed||Phase 2|564|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:42:20.194972|2017-10-11 05:42:20.194972
NCT00228163|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2015-03-24|||January 2002||2002-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses|Extension of Protocol HMR1726D/2001, A Phase II Study of the Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses|Completed||Phase 2|147|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 05:42:20.327138|2017-10-11 05:42:20.327138
NCT00228176|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2016-04-21||2016-04-21|August 2005||2005-08-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|AUDITOR||Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant|Randomized, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20-mg od, for Inhibition of Atherosclerosis Progression Assessed by Carotid Artery Intima-media Thickness (CIMT), in Overweight Patients With Additional Risk Factors|Terminated||Phase 3|661|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-10-11 05:42:20.500171|2017-10-11 05:42:20.500171
NCT00228189|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2010-11-26|||December 2003||2003-12-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients|Induction of Specific T Cell Responses in Colorectal Cancer Patients With Liver Metastases Upon Vaccination With Autologous Dendritic Cells Pulsed With CEA-peptide or Electroporated With CEA-RNA: Evaluation of in Vivo Immune Response.|Completed||Phase 1/Phase 2|30|Anticipated|Radboud University||3|||f||||||||||||||2017-10-11 05:42:20.638298|2017-10-11 05:42:20.638298
NCT00228202|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2006-08-17|||September 2005||2005-09-01|January 2006|2006-01-01||||||||Observational|||Genotyping of Cytomegalovirus From Patients in Israel|Cytomegalovirus Glycoprotein B Genotypes in Israeli Patients: Relationship Between CMV Genotype, Clinical and Demographic Factors|Unknown status|Recruiting|N/A|100||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:42:20.736927|2017-10-11 05:42:20.736927
NCT00228215|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2014-11-18|||September 2005||2005-09-01|November 2014|2014-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Tips for Infant and Parent Sleep (TIPS)|Tips for Infant and Parent Sleep (TIPS) Pilot Study|Completed||N/A|30|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-10-11 05:42:20.831896|2017-10-11 05:42:20.831896
NCT00228228|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2006-08-27|||May 2002||2002-05-01|August 2006|2006-08-01|December 2006||2006-12-01|||||Interventional|||TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis|T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis|Unknown status|Recruiting|Phase 3|80||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:42:20.920669|2017-10-11 05:42:20.920669
NCT00228241|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-26|2006-10-25|||September 2003||2003-09-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Interventional|||Left Ventricular Function and Remodelling During Permanent Pacing|Left Ventricular Function and Remodelling During Permanent Pacing|Unknown status|Active, not recruiting|N/A|100||Aarhus University Hospital Skejby|||||f||||||||||||||2017-10-11 05:42:20.992659|2017-10-11 05:42:20.992659
NCT00228254|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2005-09-23|||January 2000||2000-01-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Interventional|||Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study|Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study|Completed||Phase 4|2582||Tufts University|||||f||||||||||||||2017-10-11 05:42:21.053455|2017-10-11 05:42:21.053455
NCT00228267|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-23|2017-05-02|||September 2004||2004-09-01|May 2017|2017-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Propofol Injection for Daily Headache|The Effect of Single-dose Propofol Injection on Pain and Quality of Life in Chronic Daily Headache: a Randomized Double-blind Controlled Trial|Completed||Phase 2|28|Anticipated|University of Alberta|||||f||||f||||||||No||2017-10-11 05:42:21.126422|2017-10-11 05:42:21.126422
NCT00236899|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-08-22|2011-07-25||September 2005||2005-09-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC|A Randomized Phase III Trial of Gemcitabine and Docetaxel Versus Gemcitabine and Paclitaxel in Patients With Metastatic Breast Cancer: A Comparison of Different Schedules|Completed||Phase 3|241|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-10-11 05:42:21.246159|2017-10-11 05:42:21.246159
NCT00236912|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-08|||July 2003||2003-07-01|April 2010|2010-04-01|September 2004|Actual|2004-09-01|||||Interventional|||A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus Piperacillin/Tazobactam in Treating Complicated Appendicitis|A Multi-center, Open-label, Randomized Study to Compare the Safety and Efficacy of Once Daily Levofloxacin Along With Once Daily Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Appendicitis|Terminated||Phase 4|139|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1||This study was terminated due to low enrollment.|||||f||||||||||2017-10-11 05:42:23.292084|2017-10-11 05:42:23.292084
NCT00236925|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2015-03-30|||May 2003||2003-05-01|March 2015|2015-03-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy Study of Low-Dose Hydrocortisone Treatment for Fibromyalgia|A Double-Blind Crossover Within Subject Study on Low-Dose Hydrocortisone for Fibromyalgia|Completed||Early Phase 1|30|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-10-11 05:42:23.385585|2017-10-11 05:42:23.385585
NCT00236938|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2015-05-11|2009-01-14||July 2002||2002-07-01|May 2015|2015-05-01|October 2004|Actual|2004-10-01|September 2004|Actual|2004-09-01||Interventional|||Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis|Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis|Completed||Phase 3|121|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:42:23.511283|2017-10-11 05:42:23.511283
NCT00236951|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2010-05-06|2009-06-24||February 2003||2003-02-01|May 2010|2010-05-01|December 2005||2005-12-01|October 2005|Actual|2005-10-01||Interventional|||Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy|A Phase III Randomized Controlled Study Comparing Iron Sucrose Intravenously to No Iron Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy|Completed||Phase 3|224|Actual|Luitpold Pharmaceuticals||4|||f||||||||||||||2017-10-11 05:42:23.994574|2017-10-11 05:42:23.994574
NCT00236964|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2005-10-13|||February 2001||2001-02-01|October 2005|2005-10-01|May 2002||2002-05-01|||||Interventional|||Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis|Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis|Completed||Phase 3|78||Luitpold Pharmaceuticals|||||||||||||||||||2017-10-11 05:42:25.036286|2017-10-11 05:42:25.036286
NCT00236977|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2015-04-27|2009-01-14||August 2003||2003-08-01|April 2015|2015-04-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia|Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia|Completed||Phase 3|182|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-10-11 05:42:25.121887|2017-10-11 05:42:25.121887
NCT00236990|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-30||||||June 2011|2011-06-01|September 2005|Actual|2005-09-01|||||Interventional|||An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland|A Double-Blind, Randomized, Placebo-Controlled Trial of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Prostatitis|Completed||Phase 2|283|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.||1|||f||||||||||||||2017-10-11 05:42:25.552794|2017-10-11 05:42:25.552794
NCT00237003|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2010-05-10|||September 2003||2003-09-01|May 2010|2010-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Brief Alcohol Intervention for Incarcerated Women|A Brief Alcohol Intervention for Incarcerated Women|Completed||Phase 3|326|Anticipated|Butler Hospital||1|||f||||||||||||||2017-10-11 05:42:25.620736|2017-10-11 05:42:25.620736
NCT00237016|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2008-10-23|||April 2002||2002-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever|Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever|Completed||Phase 2/Phase 3|140||Medical Corps, Israel Defense Force|||||f||||||||||||||2017-10-11 05:42:25.829769|2017-10-11 05:42:25.829769
NCT00237042|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-06-10|2011-05-02||October 2005||2005-10-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Managing Temporomandibular Disorder (TMD) Symptoms|Hormonal Cycles in Women: Effects on TMD Pain & Symptoms|Completed||N/A|252|Actual|University of Washington||3|||f||||t||||||||||2017-10-11 05:42:25.9209|2017-10-11 05:42:25.9209
NCT00237055|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2010-03-17|||August 2004||2004-08-01|March 2010|2010-03-01|September 2006||2006-09-01|||||Observational|||Infectious Agents in Pediatric Crohn's|Infectious Agents in Pediatric Crohn's Disease|Completed||N/A|500|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:42:26.466782|2017-10-11 05:42:26.466782
NCT00237068|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2011-03-15|||March 2006||2006-03-01|March 2011|2011-03-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.|A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-10-11 05:42:26.536112|2017-10-11 05:42:26.536112
NCT00237081|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2010-03-02|||June 2004||2004-06-01|March 2010|2010-03-01|November 2008|Actual|2008-11-01|||||Observational|magic||Genetics of Interstitial Cystitis|Maryland Genetics of Interstitial Cystitis (MaGIC)|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:42:26.612541|2017-10-11 05:42:26.612541
NCT00237094|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2010-01-14|||June 2005||2005-06-01|January 2010|2010-01-01||||||||Interventional|||Use of Midlevel Providers in Diabetes Management|Use of Midlevel Providers in Diabetes Management|Completed||N/A|600|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:42:26.677574|2017-10-11 05:42:26.677574
NCT00237107|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2016-07-18|||April 2002||2002-04-01|July 2016|2016-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment.|Relation of Basal Cell Carcinoma Tumour Thickness, Histologically Estimated, in Punch Biopsies Performed Before and After Curretage.|Completed||N/A|36|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||No||2017-10-11 05:42:26.745671|2017-10-11 05:42:26.745671
NCT00237120|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2009-11-20|||November 2002||2002-11-01|November 2009|2009-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)|Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)|Completed||Phase 3|100||Novartis|||||f||||||||||||||2017-10-11 05:42:26.813111|2017-10-11 05:42:26.813111
NCT00237133|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2017-02-22|||March 2003||2003-03-01|February 2017|2017-02-01|January 21, 2009|Actual|2009-01-21|January 2009|Actual|2009-01-01||Interventional|PREDICT||Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women|PREDICT TRIAL- Neoadjuvant Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women Expressing Hormonal Receptors ( ER and PR)|Completed||Phase 4|112|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:26.87269|2017-10-11 05:42:26.87269
NCT00237146|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2017-02-21|||November 2003||2003-11-01|February 2017|2017-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy|Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy.|Completed||Phase 4|38|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:26.979018|2017-10-11 05:42:26.979018
NCT00237159|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2011-03-21|||October 2002||2002-10-01|March 2011|2011-03-01||||December 2005|Actual|2005-12-01||Interventional|||Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis|Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis|Completed||Phase 4|284|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:27.045869|2017-10-11 05:42:27.045869
NCT00237172|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2012-04-29|||September 2002||2002-09-01|April 2012|2012-04-01||||July 2005|Actual|2005-07-01||Interventional|||Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)|Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)|Completed||Phase 2|72|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:27.111118|2017-10-11 05:42:27.111118
NCT00237185|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2014-08-14|2014-06-13||June 2000||2000-06-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene|Open, Randomized, Phase II Study of Glivec in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Plus 10 Year Extension Study|Completed||Phase 2|148|Actual|Novartis|No safety data was collected in the extension.|2|||f||||f||||||||||2017-10-11 05:42:27.204933|2017-10-11 05:42:27.204933
NCT00237198|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2017-02-21|||March 2004||2004-03-01|February 2017|2017-02-01||||July 2006|Actual|2006-07-01||Interventional|||Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment|Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment|Completed||Phase 2|47|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:29.925998|2017-10-11 05:42:29.925998
NCT00237211|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2017-02-21|||June 2001||2001-06-01|February 2017|2017-02-01||||October 2006|Actual|2006-10-01||Interventional|||Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer|Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer|Completed||Phase 2|31|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:30.065793|2017-10-11 05:42:30.065793
NCT00237224|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2009-11-18|||February 2003||2003-02-01|November 2009|2009-11-01||||February 2007|Actual|2007-02-01||Interventional|||Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole|Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole|Completed||Phase 4|40|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:30.163709|2017-10-11 05:42:30.163709
NCT00237237|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2017-02-03|||October 2005||2005-10-01|February 2017|2017-02-01||||February 2007|Actual|2007-02-01||Interventional|||Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes|Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|588||Novartis|||||||||||||||||||2017-10-11 05:42:30.325191|2017-10-11 05:42:30.325191
NCT00237328|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2013-02-22|||June 2006||2006-06-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|March 2009|Actual|2009-03-01||Observational|HIT||Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery|The Incidence of Thromboembolic Events in Patients With Antibodies to Heparin-PF4 After Cardiac Bypass|Completed||N/A|1015|Actual|Duke University|||1||f||||f||||||||||2017-10-11 05:42:30.411847|2017-10-11 05:42:30.411847
NCT00237341|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2013-11-19|||June 2002||2002-06-01|November 2013|2013-11-01|January 2004|Actual|2004-01-01|||||Interventional|||Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain|Assessing Functionality Changes Associated With Patients Who Were Taking Short Acting Opioids Chronically and Who Initiated Treatment With Duragesic® (Fentanyl Transdermal System) for the Management of Chronic Low Back Pain.|Completed||Phase 4|358|Actual|PriCara, Unit of Ortho-McNeil, Inc.|||||f||||||||||||||2017-10-11 05:42:30.515397|2017-10-11 05:42:30.515397
NCT00237354|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2008-10-22|||October 2005||2005-10-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||PV-10 Chemoablation of Recurrent Breast Carcinoma|A Phase 1 Safety and Tolerability Study of PV-10 Chemoablation of Recurrent Breast Carcinoma|Completed||Phase 1|15|Anticipated|Provectus Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:42:30.581371|2017-10-11 05:42:30.581371
NCT00237367|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-04-26||||||April 2010|2010-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn|A Randomized, Two-way Crossover Study of the Effects of a Single Dose of Rabeprazole or Pantoprazole on 24-hour Intragastric Acidity and Esophageal Acid Exposure in GERD Patients With a History of Nocturnal Heartburn|Completed||Phase 4|52|Actual|PriCara, Unit of Ortho-McNeil, Inc.|||||f||||||||||||||2017-10-11 05:42:30.667427|2017-10-11 05:42:30.667427
NCT00237380|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2009-01-09|||November 2005||2005-11-01|January 2009|2009-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of PTC124 for Cystic Fibrosis|A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis|Completed||Phase 2|24||PTC Therapeutics|||||f||||||||||||||2017-10-11 05:42:30.744793|2017-10-11 05:42:30.744793
NCT00237393|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2008-02-20|||August 2003||2003-08-01|October 2005|2005-10-01|December 2007|Actual|2007-12-01|||||Interventional|PTSD||Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)|A Randomized, Placebo-Controlled Trial of Quetiapine (Seroquel) Monotherapy in the Treatment of PTSD|Completed||Phase 4|80|Actual|Ralph H. Johnson VA Medical Center||2|||f||||f||||||||||2017-10-11 05:42:30.815143|2017-10-11 05:42:30.815143
NCT00237406|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2010-03-24|||January 2006||2006-01-01|March 2010|2010-03-01|October 2006|Actual|2006-10-01|||||Observational|||Interactive Voice Response (IVR) for Methadone Patients|Interactive Voice Response for Methadone Patients|Completed||Phase 3|50||Butler Hospital|||2||f||||||||||||||2017-10-11 05:42:30.940383|2017-10-11 05:42:30.940383
NCT00237419|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2008-05-30|||December 2005||2005-12-01|May 2008|2008-05-01|April 2011|Anticipated|2011-04-01|November 2010|Anticipated|2010-11-01||Interventional|||Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis|An Open Label Extension, Investigator Initiated Trial to Examine Radiographic Progression , Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis. EASIC (European Ankylosing Spondylitis Infliximab Cohort)|Unknown status|Recruiting|N/A|149|Anticipated|Rheumazentrum Ruhrgebiet||1|||f||||||||||||||2017-10-11 05:42:31.028932|2017-10-11 05:42:31.028932
NCT00237432|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2010-12-09|||April 2003||2003-04-01|December 2010|2010-12-01|February 2008|Actual|2008-02-01|||||Observational|||Study of the Immune Response to Hepatitis C Virus|HCV Pathogenesis and Dendritic Cell Immunobiology|Completed||N/A|11|Actual|Rockefeller University|||1||f||||f||||||Samples With DNA|"     White blood cells   "|||2017-10-11 05:42:31.213231|2017-10-11 05:42:31.213231
NCT00237445|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2011-01-10|||November 2005||2005-11-01|January 2011|2011-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|COBRA II||Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days|A Multinational, Multicenter, Randomized, Double-blind, Study in Areas of High Pneumococcal Resistance Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Ketek® Telithromycin Once Daily for 7 Days, or Zithromax® Azithromycin Once Daily for 5 Days|Terminated||Phase 4|110|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:42:31.283292|2017-10-11 05:42:31.283292
NCT00237458|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2017-07-28|2012-03-07||May 2001||2001-05-01|July 2017|2017-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain|An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain|Completed||Phase 2|7|Actual|UCB Pharma||1|||f||||f||||||||||2017-10-11 05:42:31.382583|2017-10-11 05:42:31.382583
NCT00237471|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2011-07-19|||October 2005||2005-10-01|July 2011|2011-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Impact of Tight Glycaemic Control in Acute Myocardial Infarction|Impact of Tight Glycaemic Control With Insulin on Novel Vascular Disease Risk Factors and Myocardial Function and Perfusion in Acute Myocardial Infarction Patients With Hyperglycaemia|Terminated||Phase 4|40||Melbourne Health||||difficulty recruiting patients|f||||||||||||||2017-10-11 05:42:31.868438|2017-10-11 05:42:31.868438
NCT00237484|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2017-03-08|||July 2005||2005-07-01|March 2017|2017-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Pegade||Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)|Effect of Infliximab in Hepatitis-C Genotype 1 Naïve Patients With High TNF-alpha on the Efficacy of Pegylated Interferon Alfa-2b/Ribavirin Therapy|Completed||Phase 3|89|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:42:31.96725|2017-10-11 05:42:31.96725
NCT00237497|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2012-01-31|||July 2005||2005-07-01|January 2012|2012-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia|A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ramelteon Compared to Placebo With Zopiclone as a Reference Arm in Adults With Chronic Insomnia|Completed||Phase 3|275|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:42:32.056881|2017-10-11 05:42:32.056881
NCT00237510|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2014-03-04|||May 2005||2005-05-01|March 2014|2014-03-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating|A Pilot Study of the Efficacy and Tolerability of Terazosin for the Treatment of Antidepressant-Induced Excessive Sweating|Completed||N/A|15|Anticipated|Thomas Jefferson University|||||f||||t||||||||||2017-10-11 05:42:32.287481|2017-10-11 05:42:32.287481
NCT00237523|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2007-06-15|||July 2005||2005-07-01|June 2007|2007-06-01|March 2008|Anticipated|2008-03-01|||||Interventional|||"Study for Treatment of Moderate or Severe, Periodic, Cyclic, Breast Pain"|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of IoGen™ for the Treatment of Moderate or Severe, Periodic Breast Pain Associated With Symptomatic Fibrocystic Breast Disease|Unknown status|Active, not recruiting|Phase 3|175|Anticipated|Symbollon Pharmaceuticals|||||f||||f||||||||||2017-10-11 05:42:32.394682|2017-10-11 05:42:32.394682
NCT00237536|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2009-04-28|||June 2005||2005-06-01|April 2009|2009-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia|A Randomized, Double-Blind, Placebo-Controlled, Dose Comparison Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia|Terminated||Phase 2|240||Threshold Pharmaceuticals|||||||||||||||||||2017-10-11 05:42:32.588818|2017-10-11 05:42:32.588818
NCT00237549|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2013-12-19|||January 2001||2001-01-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ADDTION||The ADDITION Study. Intensive Treatment in People With Screen Detected Diabetes in Primary Care.|The ADDITION Study. Anglo-Danish-Dutch Study of Intensive Treatment In PeOple With screeN Detected Diabetes in Primary Care|Completed||N/A|3057|Actual|University of Aarhus||1|||f||||t||||||||||2017-10-11 05:42:32.745969|2017-10-11 05:42:32.745969
NCT00237562|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2006-05-04|||July 1999||1999-07-01|October 2005|2005-10-01||||||||Interventional|||Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit|Single Visit Cervical Cancer Prevention Program|Completed||Phase 3|||University of California, Irvine|||||f||||||||||||||2017-10-11 05:42:32.870233|2017-10-11 05:42:32.870233
NCT00237575|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2012-05-22|||November 2005||2005-11-01|May 2012|2012-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer|A Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin and Gemcitabine for Regionally Advanced or Metastatic Urothelial Cancer|Terminated||Phase 3|100||University of Kentucky|||||f||||||||||||||2017-10-11 05:42:32.970842|2017-10-11 05:42:32.970842
NCT00237588|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2011-07-03|||December 2004||2004-12-01|October 2005|2005-10-01|July 2005||2005-07-01|||||Interventional|||Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)|Glucose Optimisation With Angiotensin II Antagonist Losartan in Patients With Hypertension and Other Risk Factors for Metabolic Syndrome (GOAAL)|Completed||Phase 4|25||Oslo University Hospital|||||f||||||||||||||2017-10-11 05:42:33.10824|2017-10-11 05:42:33.10824
NCT00237601|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2010-04-01|||January 2006||2006-01-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Observational|||Home or Home-like Hospital Birth|Home or Home-like Hospital Birth for Low-risk Nulliparae: Does it Matter?|Completed||Phase 3|500|Actual|Maastricht University Medical Center|||2||f||||f||||||||||2017-10-11 05:42:33.241801|2017-10-11 05:42:33.241801
NCT00237614|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2006-07-17|||February 2003||2003-02-01|July 2005|2005-07-01|May 2005||2005-05-01|||||Interventional|||Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction||Completed||Phase 2/Phase 3|300||University of Milan|||||f||||||||||||||2017-10-11 05:42:33.343393|2017-10-11 05:42:33.343393
NCT00237627|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2012-05-16|||May 2001||2001-05-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|December 2006|Actual|2006-12-01||Interventional|||Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer|A Phase I Evaluation of the Combination of Pegylated Liposomal Doxorubicin (Doxil®) With PS-341 in Patients With Refractory Hematologic and Solid Malignancies|Completed||Phase 1/Phase 2|107|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 05:42:33.485111|2017-10-11 05:42:33.485111
NCT00237640|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2008-09-19|||March 2005||2005-03-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus|Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus|Completed||Phase 2|85|Actual|University of Oklahoma||2|||f||||f||||||||||2017-10-11 05:42:33.658389|2017-10-11 05:42:33.658389
NCT00237653|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2009-04-02|||February 2004||2004-02-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|||||Interventional|||MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus|Relevance of Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus|Terminated||Phase 3|40|Anticipated|University Hospital, Grenoble||||difficulty to include patients|f||||||||||||||2017-10-11 05:42:33.758412|2017-10-11 05:42:33.758412
NCT00237666|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2013-05-09|2012-11-20||February 2005||2005-02-01|May 2013|2013-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression|An Open-Label, Flexible-Dose Trial of the Safety and Efficacy of Geodon in Non-Rapid-Cycling Bipolar II Patients With Major Depression|Completed||Phase 4|30|Actual|The Medical Research Network||1|||f||||t||||||||||2017-10-11 05:42:33.880859|2017-10-11 05:42:33.880859
NCT00237679|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2015-10-13|||January 2004||2004-01-01|October 2015|2015-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Quantifying Effects of Treatment of Pediatric Dysphonia|Quantifying Effects of Treatment of Pediatric Dysphonia|Terminated||N/A|31|Actual|University of Wisconsin, Madison||2||Terminated due to funding loss.|f||||t||||||||||2017-10-11 05:42:34.250987|2017-10-11 05:42:34.250987
NCT00237692|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2015-04-06|2014-08-29||May 2006||2006-05-01|August 2014|2014-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional||All data except blood pressure, age, gender were patient-reported.|Hypertension Intervention Nurse Telemedicine Study (HINTS)|Behavioral/Pharmacological Telemedicine Interventions for BP Control|Completed||N/A|591|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-10-11 05:42:34.810308|2017-10-11 05:42:34.810308
NCT00237705|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2006-12-04|||May 2004||2004-05-01|December 2006|2006-12-01||||||||Interventional|||Intravenous Metoclopramide for the Treatment of Post Concussive Headache: a Randomized Placebo Controlled Trial||Unknown status|Recruiting|N/A|40||Vancouver General Hospital|||||f||||||||||||||2017-10-11 05:42:37.573764|2017-10-11 05:42:37.573764
NCT00237718|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2012-01-09|2011-09-01||April 2006||2006-04-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Provision of Antioxidant Therapy in Hemodialysis (PATH) Study|Provision of Antioxidant Therapy in Hemodialysis (PATH) Study|Completed||Phase 2|385|Actual|Vanderbilt University||2|||f||||t||||||||||2017-10-11 05:42:37.718264|2017-10-11 05:42:37.718264
NCT00237731|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2017-05-10|||September 2005||2005-09-01|May 2017|2017-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg|Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg|Completed||Phase 4|106|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-10-11 05:42:38.371809|2017-10-11 05:42:38.371809
NCT00237744|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-10-03|2013-11-08||April 2005||2005-04-01|October 2014|2014-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Brain and Coordination Changes Induced By Robotics and FES Treatment Following Stroke|CNS Plasticity Induced By Motor Learning Technologies Following Stroke|Completed||N/A|40|Actual|VA Office of Research and Development||3|||f||||||||||||||2017-10-11 05:42:38.510101|2017-10-11 05:42:38.510101
NCT00237757|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2013-07-02|||January 2002||2002-01-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|January 2004|Actual|2004-01-01||Interventional|||Rehabilitation Team Functioning and Patient Outcomes|Rehabilitation Team Functioning and Patient Outcomes|Completed||N/A|31|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:42:38.999785|2017-10-11 05:42:38.999785
NCT00237770|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-04-23|2013-09-24||June 2003||2003-06-01|April 2014|2014-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Prevention of Low Blood Pressure in Persons With Tetraplegia|Prevention of Low Blood Pressure in Persons With Tetraplegia|Completed||Phase 2/Phase 3|16|Actual|VA Office of Research and Development|The small sample of subjects tested and the heterogeneity of spinal lesions.|1|||f||||f||||||||||2017-10-11 05:42:39.107582|2017-10-11 05:42:39.107582
NCT00237783|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2016-07-25|||October 2005||2005-10-01|July 2016|2016-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension|Hemodynamic Changes During Dialysate Sodium Individualization in Hemodialysis Patients|Terminated||Phase 1|4|Actual|Yale University||2||Unable to recruit enough subjects|f||||f||||||||||2017-10-11 05:42:39.480329|2017-10-11 05:42:39.480329
NCT00237796|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2015-03-23|2014-11-19||February 2005||2005-02-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||Participants numbers reported include at least one baseline and at least 1 ILSS assesssment|Functional Rehabilitation of Older Patients With Schizophrenia|Functional Rehabilitation of Older Patients With Schizophrenia|Completed||N/A|116|Actual|VA Office of Research and Development|"Randomization of treatment groups were not matched on the primary outcome (ILSS) at baseline but this was controlled using baseline ILSS as a covariate.
Participant dropout varied across assessments"|2|||f||||t||||||||||2017-10-11 05:42:39.619076|2017-10-11 05:42:39.619076
NCT00237809|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2017-03-30|2016-08-22||September 2002||2002-09-01|March 2017|2017-03-01|September 2012|Actual|2012-09-01|December 2010|Actual|2010-12-01||Interventional|||D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia|D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia|Completed||Phase 3|104|Actual|Yale University||4|||f||||||||||||||2017-10-11 05:42:40.238693|2017-10-11 05:42:40.238693
NCT00237822|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2006-03-02|||September 2003||2003-09-01|October 2005|2005-10-01|December 2007||2007-12-01|||||Interventional|||Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders|Increasing Treatment Adherence in Co-Occurring Disorders|Unknown status|Recruiting|Phase 2|75||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:42:41.082347|2017-10-11 05:42:41.082347
NCT00237848|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2012-06-15|||February 2005||2005-02-01|April 2008|2008-04-01||||||||Interventional|||D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia|D-Serine Augmentation of Cognitive Retraining in Schizophrenia|Completed||Phase 3|72|Anticipated|Yale University|||||f||||||||||||||2017-10-11 05:42:41.160681|2017-10-11 05:42:41.160681
NCT00237861|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-06-05||||||June 2014|2014-06-01||||December 2002|Actual|2002-12-01||Interventional|||Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia|Effectiveness of Atypical Vs Conventional Antipsychotics|Completed||Phase 4|||Yale University|||||f||||||||||||||2017-10-11 05:42:41.237634|2017-10-11 05:42:41.237634
NCT00237874|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2014-06-05|||February 2004||2004-02-01|June 2014|2014-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Aripiprazole Treatment of Prodromal Patients|Aripiprazole Treatment of Prodromal Patients|Completed||Phase 2/Phase 3|15|Actual|Yale University|||||f||||||||||||||2017-10-11 05:42:41.304169|2017-10-11 05:42:41.304169
NCT00237887|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2007-08-28|||December 2004||2004-12-01|August 2007|2007-08-01||||||||Interventional|||Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase III, Multicenter Study of the Efficacy and Safety of Adalimumab Treatment in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|1212|Actual|Abbott|||||f||||f||||||||||2017-10-11 05:42:41.382075|2017-10-11 05:42:41.382075
NCT00237900|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2009-04-22|||July 2003||2003-07-01|April 2009|2009-04-01|February 2004|Actual|2004-02-01|||||Interventional|||Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer|An Open, Single.Centre, Phase I/II Study of ZD1839 (Iressa) in Combination With 5-Fluorouracil, Leucovorin and Radiotherapy in Subjects With Resectable Gastric Cancer|Terminated||Phase 1/Phase 2|34||AstraZeneca|||||f||||||||||||||2017-10-11 05:42:41.439639|2017-10-11 05:42:41.439639
NCT00237913|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2013-11-07|||July 2004||2004-07-01|July 2008|2008-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Schizophrenia Trial of Aripiprazole|A Multicenter, Randomized, Naturalistic, Open-Label Study Between Aripiprazole and Standard of Care in the Management of Community-Treated Schizophrenic Patients (Schizophrenia Trial of Aripiprazole - STAR)|Completed||Phase 3|700||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-10-11 05:42:41.51729|2017-10-11 05:42:41.51729
NCT00237926|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2008-07-29|||November 2005||2005-11-01|July 2008|2008-07-01||||March 2008|Actual|2008-03-01||Interventional|||Comparing Aerobic to Resistance Training in Recovery From Cancer|Comparing Aerobic to Resistance Training in Recovery From Cancer|Completed||N/A|58|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-10-11 05:42:41.678187|2017-10-11 05:42:41.678187
NCT00237939|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2013-11-07|||September 2002||2002-09-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices|A Prospective, Multicenter, Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices (Broad Effectiveness Trial With Aripiprazole- BETA)|Completed||Phase 3|1200||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||f||||||||||||||2017-10-11 05:42:41.746725|2017-10-11 05:42:41.746725
NCT00237952|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2009-06-21|||August 2005||2005-08-01|June 2009|2009-06-01||||||||Interventional|||Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy|Environmental Lead Exposure and Progressive Renal Insufficiency in Patients With Type II Diabetes and Diabetic Nephropathy|Completed||N/A|||Chang Gung Memorial Hospital|||||f||||||||||||||2017-10-11 05:42:42.018522|2017-10-11 05:42:42.018522
NCT00237965|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2005-10-11||||||May 2004|2004-05-01||||||||Interventional|||The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy|The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy|Completed||N/A|||Brown University|||||f||||||||||||||2017-10-11 05:42:42.092976|2017-10-11 05:42:42.092976
NCT00237978|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2009-05-13|||September 2006||2006-09-01|May 2008|2008-05-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|||Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)|Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)|Unknown status|Recruiting|Phase 4|60|Anticipated|Technische Universität Dresden||3|||f||||f||||||||||2017-10-11 05:42:42.147063|2017-10-11 05:42:42.147063
NCT00237991|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2008-10-15|||June 2005||2005-06-01|October 2008|2008-10-01||||||||Observational|||Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population|A Multicentric, Post-Marketing Surveillance to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals Hepatitis A Vaccine Administered in Korean Population.|Completed||N/A|600||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:42:42.22795|2017-10-11 05:42:42.22795
NCT00238004|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2006-09-11|||November 2005||2005-11-01|September 2006|2006-09-01||||||||Interventional|||The Low HDL On Six Weeks Statin Therapy (LOW) Study|The Low HDL On Six Weeks Statin Therapy (LOW) Study|Unknown status|Active, not recruiting|Phase 4|60||Craigavon Area Hospital|||||f||||||||||||||2017-10-11 05:42:42.292749|2017-10-11 05:42:42.292749
NCT00238017|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2006-02-01|||October 2005||2005-10-01|July 2005|2005-07-01|December 2005||2005-12-01|||||Interventional|||Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate|A Randomized, Double Blind Trial on the Efficacy and Safety of Amodiaquine-Artesunate and Amodiaquine Alone in the Treatment of Children With Uncomplicated Falciparum Malaria|Unknown status|Active, not recruiting|Phase 4|400||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:42:42.368251|2017-10-11 05:42:42.368251
NCT00238030|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-01-04|||December 2004||2004-12-01|January 2011|2011-01-01|October 2010|Actual|2010-10-01|May 2009|Actual|2009-05-01||Interventional|||Thyroxine Replacement in Organ Donors|Efficacy and Pharmacokinetics of Oral Thyroid Replacement Therapy in Organ Donors|Completed||Phase 1/Phase 2|34|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 05:42:42.44685|2017-10-11 05:42:42.44685
NCT00238043|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2008-06-12|||August 2005||2005-08-01|October 2005|2005-10-01|April 2011|Anticipated|2011-04-01|||||Interventional|||Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia||Unknown status|Active, not recruiting|Phase 3|2000|Anticipated|Ministry of Health, Malaysia|||||f||||f||||||||||2017-10-11 05:42:42.536533|2017-10-11 05:42:42.536533
NCT00238056|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2015-01-26||||||October 2005|2005-10-01||||||||Interventional|||Effect of Domperidone on QT Interval in Premature Infants|Effect of Domperidone on QT Interval in Premature Infants|Completed||Phase 2|||Nantes University Hospital|||||f||||||||||||||2017-10-11 05:42:42.655505|2017-10-11 05:42:42.655505
NCT00238069|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2017-03-27|||December 2004||2004-12-01|March 2017|2017-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep Apnea|Effect of CPAP (Continuous Positive Airway Pressure) on Airway Inflammation in Asthmatics With Sleep-Disordered Breathing: A Pilot Study|Completed||N/A|20|Actual|National Jewish Health|||||f||||||||||||||2017-10-11 05:42:42.727335|2017-10-11 05:42:42.727335
NCT00238082|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2017-03-27|||November 1999|Actual|1999-11-01|March 2017|2017-03-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease|The Effect of HFA-beclomethasone Dipropionate on Static Lung Volumes in COPD|Terminated||N/A|20|Actual|National Jewish Health|||||f||||||||||||||2017-10-11 05:42:42.802508|2017-10-11 05:42:42.802508
NCT00238108|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2012-08-24|2012-06-18||October 2005||2005-10-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Melatonin Supplements for Improving Sleep in Individuals With Hypertension|Melatonin Supplementation in Hypertensive Patients|Completed||Phase 2|16|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-10-11 05:42:42.887061|2017-10-11 05:42:42.887061
NCT00238121|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2015-11-17|2013-12-23||February 2005||2005-02-01|January 2014|2014-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer|A Phase II Study of BAY 43-9006 in Advanced/Recurrent Uterine Carcinoma/Carcinosarcoma|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:42:43.195036|2017-10-11 05:42:43.195036
NCT00238147|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2013-05-15|||September 2004||2004-09-01|May 2013|2013-05-01|August 2008|Actual|2008-08-01|||||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer|Phase I Trial With Weekly Docetaxel, Capecitabine and Carboplatin as Induction Chemotherapy Followed by Concomitant Capecitabine and Radiotherapy in Patients With Locally Advanced Esophageal Cancer|Completed||Phase 1|18|Anticipated|University of Washington|||||f||||||||||||||2017-10-11 05:42:43.766946|2017-10-11 05:42:43.766946
NCT00238160|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2013-05-29||||||July 2006|2006-07-01||||||||Interventional|||Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer|Phase III Randomized Study of Surgical Resection With Versus Without Postoperative Hepatic Arterial Chemotherapy in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus|Withdrawn||Phase 3|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:42:43.849084|2017-10-11 05:42:43.849084
NCT00238173|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2017-04-19|||December 2004||2004-12-01|April 2017|2017-04-01|February 17, 2006|Actual|2006-02-17|February 17, 2006|Actual|2006-02-17||Interventional|||Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors|Phase I Dose Escalation Study of N-Acetylcysteine Administered in Conjunction With Carboplatin, Cyclophosphamide, and Etoposide Phosphate BBBD, in Children With Malignant Brain Tumors|Terminated||Phase 1|2|Actual|OHSU Knight Cancer Institute||||OHSU IRB closed study to further enrollment 2/17/2006|f||||t||||||||||2017-10-11 05:42:43.944113|2017-10-11 05:42:43.944113
NCT00238199|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2015-04-22|||June 2002||2002-06-01|April 2015|2015-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer|Phase II Study of Calcitriol-Enhanced Docetaxel in Patients With Previously Untreated Metastatic or Locally Advanced Pancreatic Cancer|Completed||Phase 2|25|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 05:42:44.061221|2017-10-11 05:42:44.061221
NCT00238212|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2013-01-11|||October 2005||2005-10-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma|Phase II Study of BAY 43-9006 (NSC #724772) as Single Agent in Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:42:44.145719|2017-10-11 05:42:44.145719
NCT00238225|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2013-01-30|||November 2004||2004-11-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Oral Calcitriol in Combination With Ketoconazole in Refractory Advanced Malignancies|Completed||Phase 1|15|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-10-11 05:42:44.276913|2017-10-11 05:42:44.276913
NCT00238238|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2017-02-06|2016-12-15||March 2006||2006-03-01|February 2017|2017-02-01|August 2015|Actual|2015-08-01|June 2012|Actual|2012-06-01||Interventional||Three participants assigned to the lenalidomide arm alone arm never began treatment. Participants on the rituximab arm was discontinued early; in order to avoid potential identification of patients, no results will be entered for this arm.|Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab|A Randomized Phase II Trial of Rituximab Versus Lenalidomide (REVLIMID™, Cc-5013) (IND#73034) Versus Rituximab + Lenalidomide in Recurrent Follicular Non-Hodgkin Lymphoma (NHL) That is Not Rituximab-Refractory|Completed||Phase 2|97|Actual|Alliance for Clinical Trials in Oncology||3|||f||||f||||||||||2017-10-11 05:42:44.39859|2017-10-11 05:42:44.39859
NCT00238251|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2012-06-04|||May 2005||2005-05-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|April 2009|Actual|2009-04-01||Interventional|||Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases|Whole Brain Radiotherapy in Combination With Gefitinib (Iressa) or Temozolomide (Temodal) for Brain Metastases From Non-Small Lung Cancer (NSCLC) A Randomized Phase II Trial|Completed||Phase 2|59|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-10-11 05:42:46.156561|2017-10-11 05:42:46.156561
NCT00238264|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2017-01-05|2017-01-05||November 2006||2006-11-01|November 2016|2016-11-01||||December 2013|Actual|2013-12-01||Interventional|||Radiation Therapy in Treating Young Patients With Gliomas|A Phase II Study of Conformal Radiotherapy In Patients With Low-Grade Gliomas|Active, not recruiting||Phase 2|92|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-10-11 05:42:46.373285|2017-10-11 05:42:46.373285
NCT00238277|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2008-01-30|||March 2005||2005-03-01|December 2007|2007-12-01||||December 2007|Actual|2007-12-01||Interventional|||Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme|Phase II Study of Temozolomide and Radiation in Newly Diagnosed GBM Patients After Resection and Insertion of Gliadel® Wafers|Terminated||Phase 2|72||National Cancer Institute (NCI)||||Withdrawn - due to lack of accrual|f||||||||||||||2017-10-11 05:42:47.072856|2017-10-11 05:42:47.072856
NCT00238290|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2012-06-04|||May 2005||2005-05-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|January 2010|Actual|2010-01-01||Interventional|||Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer|Trastuzumab Monotherapy Followed By the Combination of Trastuzumab and Letrozole in Post-Menopausal Women With ER-Positive, HER-2 Positive Advanced Breast Cancer Resistant to a Nonsteroidal Aromatase Inhibitor: A Multicenter Two-Step Phase II Trial|Completed||Phase 2|13|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 05:42:47.163959|2017-10-11 05:42:47.163959
NCT00238303|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2014-05-07|2012-12-11||September 2005||2005-09-01|October 2011|2011-10-01|March 2010|Actual|2010-03-01|July 2008|Actual|2008-07-01||Interventional|||Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme|Phase II Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Recurrent Glioblastoma|Completed||Phase 2|103|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:42:47.322808|2017-10-11 05:42:47.322808
NCT00238316|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2013-05-30|||December 2000||2000-12-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|April 2006|Actual|2006-04-01||Interventional|||Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density|A Randomized Feasibility Study of Letrozole in Postmenopausal Women at Increased Risk for Development of Breast Cancer as Evidenced by High Breast Density|Completed||Phase 2|68|Actual|Canadian Cancer Trials Group||2|||f||||||||||||||2017-10-11 05:42:48.330087|2017-10-11 05:42:48.330087
NCT00244647|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2008-04-09|||August 2003||2003-08-01|April 2008|2008-04-01||||||||Interventional|||A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis|A Phase 1b, Randomized, Single Blind Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis|Terminated||Phase 1|40||Sarepta Therapeutics|||||f||||||||||||||2017-10-11 05:45:12.103857|2017-10-11 05:45:12.103857
NCT00238329|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2013-04-05|||January 2001||2001-01-01|April 2013|2013-04-01|June 2007||2007-06-01|December 2005|Actual|2005-12-01||Interventional|||PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma|Phase II Study of Pegylated Interferon and Thalidomide in Pretreated Metastatic Malignant Melanoma|Completed||Phase 2|32|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 05:42:48.428805|2017-10-11 05:42:48.428805
NCT00238342|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2010-02-06|||October 2005||2005-10-01|April 2007|2007-04-01||||October 2007|Anticipated|2007-10-01||Interventional|||Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass|Pelvic Mass Study to Develop Serum Proteomic Profiles (SIGNATURES) for Epithelial Ovarian Cancer Diagnosis and Prognosis|Unknown status|Active, not recruiting|N/A|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:42:48.519658|2017-10-11 05:42:48.519658
NCT00238355|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-12-12|2011-11-07||August 2003||2003-08-01|December 2011|2011-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems|Phase II Trial of Voriconazole Plus Caspofungin for the Initial Treatment of Invasive Fungal Infections|Terminated||Phase 2|13|Actual|OHSU Knight Cancer Institute||1||competing study at site|f||||t||||||||||2017-10-11 05:42:48.91739|2017-10-11 05:42:48.91739
NCT00238368|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2014-04-16|||February 2004||2004-02-01|April 2014|2014-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant|Autologous Blood or Marrow Transplantation for Aggressive Non-Hodgkin's Lymphoma Based on Early [18F] FDG-PET Scanning|Completed||Phase 2|59|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-10-11 05:42:49.154995|2017-10-11 05:42:49.154995
NCT00238381|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2016-08-11|||July 2005||2005-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2014|Actual|2014-05-01||Interventional|||Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer|Clinical Function After Total Mesorectal Excision and Rectal Replacement. A Prospective Randomized Trial Comparing Side-to-End Anastomosis, Colon-J-Pouch and Straight Coloanal Anastomosis|Completed||Phase 3|336|Actual|Swiss Group for Clinical Cancer Research||3|||f||||t||||||||||2017-10-11 05:42:49.276339|2017-10-11 05:42:49.276339
NCT00238394|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2013-06-04|||December 2005||2005-12-01|June 2013|2013-06-01||||March 2007|Actual|2007-03-01||Interventional|||Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer|A Phase II Study of AZD2171 in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:42:49.391523|2017-10-11 05:42:49.391523
NCT00238407|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2012-06-04|||March 2004||2004-03-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|February 2008|Actual|2008-02-01||Interventional|||Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery|Docetaxel and Cisplatin Chemotherapy Followed by Radiochemotherapy in Patients With Inoperable, Locally Advanced Esophageal Cancer, A Multicenter Phase II Trial|Completed||Phase 2|21|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-10-11 05:42:49.473829|2017-10-11 05:42:49.473829
NCT00238420|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2016-04-15|2015-12-10||July 2005||2005-07-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional||Eligible patients who started protocol treatment.|Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer|A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer|Completed||Phase 1/Phase 2|70|Actual|National Cancer Institute (NCI)|Accrual of patients with her2/neu overexpression stopped early due to unmet targeted accrual goals, with 22 subject accrued out of 40 planned.|2|||f||||||||||||||2017-10-11 05:42:49.6047|2017-10-11 05:42:49.6047
NCT00238446|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2017-02-22|||April 2003||2003-04-01|February 2017|2017-02-01||||June 2006|Actual|2006-06-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients|A Prospective, Open-label, Multicenter Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Heart Transplant Recipients|Completed||Phase 3|||Novartis|||||||||||||||||||2017-10-11 05:42:52.526497|2017-10-11 05:42:52.526497
NCT00238459|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2013-11-19|||July 2005||2005-07-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|March 2011|Actual|2011-03-01||Observational|||Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised|Immunopathogenesis of Acute and Early HIV Infection and the Role of HIV-Specific CD4 T Cell Responses and the Effect of Their Enhancement by Potent Antiretroviral Drugs and an HIV Vaccine Adequate Vaccine Was Not Provided.|Completed||Phase 1|58|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||t||||||Samples Without DNA|"     Sequential samples from patients with acute and recent HIV infection   "|||2017-10-11 05:42:52.589462|2017-10-11 05:42:52.589462
NCT00238472|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2012-04-25|||May 2003||2003-05-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion|A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion|Completed||Phase 4|24||Novartis|||||||||||||||||||2017-10-11 05:42:52.6918|2017-10-11 05:42:52.6918
NCT00238485|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2017-03-24|||January 2005||2005-01-01|March 2017|2017-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder|A 52-week, Open Label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750 - 2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder.|Completed||Phase 3|251|Actual|Novartis|||||f||||||||||||||2017-10-11 05:42:52.759967|2017-10-11 05:42:52.759967
NCT00238511|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2014-09-19|||November 2002||2002-11-01|September 2009|2009-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)|An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)|Completed||Phase 2|||UCB Pharma|||||f||||||||||||||2017-10-11 05:42:52.884536|2017-10-11 05:42:52.884536
NCT00238524|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2014-09-19|||December 2003||2003-12-01|April 2010|2010-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy|A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 400mg/Day and 600mg/Day SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy|Completed||Phase 3|357|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:42:52.951351|2017-10-11 05:42:52.951351
NCT00238537|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2013-05-28|||August 2001||2001-08-01|May 2009|2009-05-01|April 2007||2007-04-01|||||Interventional|||Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)|Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) in Acute Stroke|Completed||Phase 2|100||Melbourne Health|||||f||||||||||||||2017-10-11 05:42:53.030075|2017-10-11 05:42:53.030075
NCT00238550|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-07-19|||October 2003||2003-10-01|October 2005|2005-10-01|March 2006||2006-03-01|||||Interventional|||Study of CBME in the Relief of Painful Diabetic Neuropathy|Randomised Control Trial Studying the Addition of CBME to Conventional Treatment for the Relief of Painful Diabetic Neuropathy|Completed||Phase 2|36|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-10-11 05:42:53.13625|2017-10-11 05:42:53.13625
NCT00238563|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2008-02-22||||||August 2007|2007-08-01||||||||Interventional|||Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery|Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery|Unknown status|Recruiting|N/A|200||Stanford University|||||f||||||||||||||2017-10-11 05:42:53.209574|2017-10-11 05:42:53.209574
NCT00238576|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2016-04-19|||May 2008||2008-05-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Observational|||Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age|Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age|Completed||N/A|30|Actual|Stanford University|||1||f||||||||||||||2017-10-11 05:42:53.278829|2017-10-11 05:42:53.278829
NCT00238602|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2012-07-12|||March 2000||2000-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2007|Actual|2007-06-01||Interventional|||Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer|Evaluation of the Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Tumors - A Phase I/II Study|Completed||Phase 1/Phase 2|48|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:42:53.354581|2017-10-11 05:42:53.354581
NCT00238615|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2015-04-21|2012-09-24||March 2003||2003-03-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|September 2009|Actual|2009-09-01||Interventional|||Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC|A Phase II Trial of Concurrent Docetaxel (Taxotere) / Carboplatin / Radiotherapy Followed by Surgical Resection Followed by Consolidation Taxotere / Carboplatin in Stage III Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|13|Actual|Stanford University|Accrual was very slow. The study was halted with accrual of only 13 patients. These results were published.|1||low accrual|f||||t||||||||||2017-10-11 05:42:53.42593|2017-10-11 05:42:53.42593
NCT00238628|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2010-07-16|||April 2004||2004-04-01|July 2010|2010-07-01|December 2005|Actual|2005-12-01|April 2005|Actual|2005-04-01||Interventional|||A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer|A Phase I/II Study of Bexarotene in Combination With ZD 1839 (IRESSA) in the Third Line Treatment of Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|12|Anticipated|Stanford University||1|||f||||||||||||||2017-10-11 05:42:53.756583|2017-10-11 05:42:53.756583
NCT00238641|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2005-10-11|||January 2002||2002-01-01|October 2005|2005-10-01|May 2005||2005-05-01|||||Interventional|||“DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?”|“DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?”|Completed||Phase 1/Phase 2|10||Stanford University|||||f||||||||||||||2017-10-11 05:42:53.830206|2017-10-11 05:42:53.830206
NCT00238654|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-04-08|||May 2003||2003-05-01|April 2011|2011-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy|"A Multicenter, Open-Label, Two-Arm Prospective Study to Evaluate the Impact of Patient Readiness to Self-Inject on Outcomes When Using the Copaxone® Prefilled Syringes [The READY Trial]"|Completed||Phase 4|257|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-10-11 05:42:53.903295|2017-10-11 05:42:53.903295
NCT00238667|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2015-05-19|||November 2005||2005-11-01|September 2005|2005-09-01|May 2014|Actual|2014-05-01|||||Interventional|CADISS||To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection|Cervical Artery Dissection in Stroke Study|Completed||Phase 3|250|Actual|St George's, University of London||2|||f||||||||||||||2017-10-11 05:42:53.972598|2017-10-11 05:42:53.972598
NCT00238680|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2008-06-13|||March 2005||2005-03-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|September 2006|Actual|2006-09-01||Interventional|||Programmable Timer in the Bladder Rehabilitation Treatment of OAB|The Effect of Programmable Timer in Bladder Rehabilitation Treatment of Idiopathic Overactive Bladder in Children|Completed||N/A|100||University of Aarhus|||||f||||||||||||||2017-10-11 05:42:54.063365|2017-10-11 05:42:54.063365
NCT00238693|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2017-07-27|||April 2003||2003-04-01|July 2017|2017-07-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|||Transplant Patient Registry of Liver, Kidney and/or Pancreas|Transplant Registry: Patients Who May Require Transplantation and Those Who Have Undergone Transplantation of Liver, Kidney and/or Pancreas|Recruiting||N/A|15000|Anticipated|Virginia Commonwealth University|||1||f||||f||||||||||2017-10-11 05:42:54.135737|2017-10-11 05:42:54.135737
NCT00238706|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2006-05-04|||December 2001||2001-12-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Interventional|||Use of Radiofrequency Ablation to Eliminate Continuous Atrial Fibrillation in Patients Undergoing Mitral Valve Surgery|Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation: A Prospective Randomized Clinical Trial|Completed||N/A|||University Hospitals, Leicester|||||f||||||||||||||2017-10-11 05:42:54.209071|2017-10-11 05:42:54.209071
NCT00233246|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2014-06-05|||March 2006||2006-03-01|June 2014|2014-06-01||||||||Interventional|||Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures|Study of Hemostasis and Invasive Procedures (SHIP: A TMH CTN Study)|Withdrawn||Phase 3|0|Actual|Massachusetts General Hospital||||Study never activated|f||||||||||||||2017-10-11 05:43:45.759686|2017-10-11 05:43:45.759686
NCT00238719|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2006-05-17|||December 1999||1999-12-01|May 2006|2006-05-01|June 2003||2003-06-01|||||Interventional|||Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder|A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine ER In Children and Adolescent Outpatients With Social Anxiety Disorder|Completed||Phase 3|293||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:42:54.289522|2017-10-11 05:42:54.289522
NCT00238732|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2007-12-19|||October 2005||2005-10-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause|A Double-Blind, Randomized, Placebo-and Active-Controlled Efficacy and Safety Study of Bazedoxifene/Conjugated Estrogens Combinations for Treatment of Moderate to Severe Vulvar/Vaginal Atrophy in Postmenopausal Women|Completed||Phase 3|650||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:42:54.376732|2017-10-11 05:42:54.376732
NCT00238745|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2007-12-17|||August 2003||2003-08-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.|Bone Mineral Density Increase and Safety of TSE-424 Compared to Placebo in Osteoporotic Postmenopausal Women|Completed||Phase 2|375||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:42:54.585091|2017-10-11 05:42:54.585091
NCT00238758|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-11|2006-09-11|||October 2005||2005-10-01|September 2006|2006-09-01||||||||Interventional|||A Study of Omega-3 as a Treatment for Major Depression|A Randomised, Double-Blind, Placebo Controlled Trial of Omega-3 Polyunsaturated Fatty Acids as a Monotherapy for Major Depression|Unknown status|Recruiting|Phase 2|128||The University of New South Wales|||||f||||||||||||||2017-10-11 05:42:54.651228|2017-10-11 05:42:54.651228
NCT00238784|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2008-01-11|||May 2004||2004-05-01|January 2008|2008-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults|A Comparison of Symbicort® Single Inhaler Therapy (Symbicort® 200 Turbuhaler® 1 Inhalation b.i.d. Plus as Needed) & Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents & Adults-a 26-Week, Randomised, Open-Label, Parallel Group, Multicentre Study|Completed||Phase 3|1300||AstraZeneca|||||||||||||||||||2017-10-11 05:42:54.738868|2017-10-11 05:42:54.738868
NCT00238797|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-01-20|||February 2003||2003-02-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|||||Interventional|||A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme|A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa™) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme|Completed||Phase 2|36||AstraZeneca|||||f||||||||||||||2017-10-11 05:42:54.81999|2017-10-11 05:42:54.81999
NCT00238810|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2014-11-26|||April 2005||2005-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome|Retrospective Evaluation of Serum B-type Natriuretic Peptide Hormone Levels in Post-operative Patients and the Relationship of BNP Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome|Completed||N/A|20|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-10-11 05:42:54.888974|2017-10-11 05:42:54.888974
NCT00238823|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2007-05-22|||January 2004||2004-01-01|May 2007|2007-05-01|December 2004||2004-12-01|||||Observational|||Cryoablation Versus Radiofrequency Ablation|A Review and Comparison of Cryoablation and Radiofrequency Ablation in Children|Terminated||N/A|50||Children's Healthcare of Atlanta|||||f||||||||||||||2017-10-11 05:42:54.970003|2017-10-11 05:42:54.970003
NCT00238836|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2006-10-12||||||June 2005|2005-06-01|March 2006||2006-03-01|||||Interventional|||Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health Networks||Unknown status|Active, not recruiting|Phase 2/Phase 3|240||C. T. Lamont Primary Care Research Centre|||||f||||||||||||||2017-10-11 05:42:55.049523|2017-10-11 05:42:55.049523
NCT00238849|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2005-10-13||||||October 2005|2005-10-01||||||||Interventional|||Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.|Phase II Study of Oxaliplatin in Combination With Navelbine for the Second-Line Treatment of Advanced and Metastatic Non-Small Cell Lung Cancer|Unknown status|Not yet recruiting|Phase 2|40||Integrated Community Oncology Network|||||f||||||||||||||2017-10-11 05:42:55.159339|2017-10-11 05:42:55.159339
NCT00238862|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2007-03-05|||October 2005||2005-10-01|March 2007|2007-03-01|September 2006||2006-09-01|||||Interventional|||Treatment of PED With AMT and Autologous Serum|Efficacy of Amniotic Membrane Transplantation and Autologous Serum in Treatment of Persistent Epithelial Defects|Completed||N/A|180||King Khaled Eye Specialist Hospital|||||f||||t||||||||||2017-10-11 05:42:55.319888|2017-10-11 05:42:55.319888
NCT00238875|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2016-09-21|||July 2004||2004-07-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)|A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)|Completed||Phase 2|167|Actual|Japan Clinical Oncology Group||1|||f||||t||||||||||2017-10-11 05:42:55.39577|2017-10-11 05:42:55.39577
NCT00238888|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2017-04-18|||August 2002||2002-08-01|April 2017|2017-04-01|December 2011|Actual|2011-12-01|April 2007|Actual|2007-04-01||Interventional|||Randomised Controlled Trial of a Multi-faceted Community-based Intervention to Improve Asthma in Children|Randomised Controlled Trial of a Multi-faceted Community-based Intervention to Improve Pediatric Morbidity: a PRIISME Project (Program to Integrate Information Service and Manage Education)|Completed||Phase 4|298|Actual|McGill University Health Center||2|||f||||f||||||||Undecided||2017-10-11 05:42:55.508461|2017-10-11 05:42:55.508461
NCT00238901|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2010-08-31|||December 2002||2002-12-01|August 2010|2010-08-01||||July 2005|Actual|2005-07-01||Interventional|||Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation|Efficacy and Safety of Basiliximab in HCV+ Patients Undergoing Liver Transplantation, as Compared With Steroids, Both Given in Combination With Cyclosporine and Mycophenolate Mofetil (MMF)|Completed||Phase 3|194|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:42:55.589829|2017-10-11 05:42:55.589829
NCT00238914|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2012-01-12|||August 1999||1999-08-01|January 2012|2012-01-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1|Opiate Dependence: Combined Naltrexone/Behavior Therapy|Completed||Phase 2|12|Actual|New York State Psychiatric Institute||2|||t||||t||||||||||2017-10-11 05:42:55.646482|2017-10-11 05:42:55.646482
NCT00238927|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2014-03-25|||November 1999||1999-11-01|March 2014|2014-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma|Multicenter Randomised Controlled Trial of Episodic Fluticasone Versus Placebo in Viral-induced Asthma in Children|Completed||Phase 4|150||McGill University Health Center|||||f||||f||||||||||2017-10-11 05:42:55.727023|2017-10-11 05:42:55.727023
NCT00238940|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-01-28|||February 2003||2003-02-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants|A One-year, Randomized, Open Label, Parallel Group Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Either Full Dose or Reduced Dose Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients|Completed||Phase 3|55|Actual|Novartis|||||f||||||||||||||2017-10-11 05:42:55.965748|2017-10-11 05:42:55.965748
NCT00238953|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2017-02-21|||February 2005||2005-02-01|February 2017|2017-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients|A Prospective, Open Label Protocol to Assess the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients|Completed||Phase 4|30|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:56.0323|2017-10-11 05:42:56.0323
NCT00238966|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-01-28|||November 2002||2002-11-01|January 2011|2011-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil|A One Arm, Open-label Study to Investigate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Recipients Who Received Mycophenolate Mofetil (MMF)|Completed||Phase 4|187|Actual|Novartis|||||f||||||||||||||2017-10-11 05:42:56.123176|2017-10-11 05:42:56.123176
NCT00238979|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-11-01|||January 2003||2003-01-01|November 2011|2011-11-01||||February 2005|Actual|2005-02-01||Interventional|||A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)|A 6-month, 1-arm, Open-label Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)|Completed||Phase 4|50||Novartis|||||f||||||||||||||2017-10-11 05:42:56.188353|2017-10-11 05:42:56.188353
NCT00238992|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-11-01|||December 2002||2002-12-01|November 2011|2011-11-01||||July 2005|Actual|2005-07-01||Interventional|||Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.|A Prospective, Randomized, Open Label, Multicenter Trial of EC-MPS With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen for the Prevention of Acute Rejection Episodes in de Novo Renal Transplant Recipients.|Completed||Phase 3|144||Novartis|||||f||||||||||||||2017-10-11 05:42:56.253857|2017-10-11 05:42:56.253857
NCT00239005|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2017-02-28|2010-12-08||September 2005||2005-09-01|February 2017|2017-02-01||||March 2008|Actual|2008-03-01||Interventional|||Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation|A Study of the Effect of Conversion to Enteric-Coated Mycophenolate Sodium (EC-MPS) on Quality of Life in Patients With Gastrointestinal (GI) Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation (MYQOL)|Completed||Phase 4|134|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:42:56.345089|2017-10-11 05:42:56.345089
NCT00239018|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-01-28|||April 2003||2003-04-01|January 2011|2011-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients|A Prospective, Open-label, Multicenter, Follow-up Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients|Completed||Phase 4|144|Actual|Novartis|||||f||||||||||||||2017-10-11 05:42:56.910434|2017-10-11 05:42:56.910434
NCT00239031|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-01-28|||March 2002||2002-03-01|January 2011|2011-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids|Multicentre, Controlled, Prospective, Randomized, Open-label Clinical Trial to Compare Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced Dose Cyclosporine Microemulsion (CsA-ME) Vs EC-MPS Plus Standard Dose CsA-ME in Elderly de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids|Completed||Phase 3|117|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:42:56.974967|2017-10-11 05:42:56.974967
NCT00239044|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-11-01|||December 2002||2002-12-01|November 2011|2011-11-01||||July 2005|Actual|2005-07-01||Interventional|||An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients|An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients|Completed||Phase 3|40||Novartis|||||f||||||||||||||2017-10-11 05:42:57.04704|2017-10-11 05:42:57.04704
NCT00239057|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-01-28|||May 2002||2002-05-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,|Enteric-Coated Mycophenolate Sodium (EC-MPS) Administration in Maintenance Renal Transplant Patients Receiving Cyclosporine Microemulsion (CsA-ME) and Steroids, for the Withdrawal of Concomitant Steroid Therapy: a Prospective, Open-label, Exploratory Study|Completed||Phase 3|23|Actual|Novartis|||||f||||||||||||||2017-10-11 05:42:57.113169|2017-10-11 05:42:57.113169
NCT00239070|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2011-01-28|||April 2003||2003-04-01|January 2011|2011-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients|A Prospective, Open-label, Multicenter, International Follow-up Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients|Completed||Phase 3|69|Actual|Novartis|||||f||||||||||||||2017-10-11 05:42:57.175069|2017-10-11 05:42:57.175069
NCT00239083|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2017-02-21|||January 2005||2005-01-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients|Phase IV Study of Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Kidney Transplant Patients|Completed||Phase 4|40|Anticipated|Novartis||1|||f||||||||||||||2017-10-11 05:42:57.235013|2017-10-11 05:42:57.235013
NCT00239096|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2005-10-13|||September 2005||2005-09-01|October 2005|2005-10-01|September 2011||2011-09-01|||||Interventional|||Prevention of Decompensation in Liver Cirrhosis|Losartan in the Prevention of Sodium Retention and Ascites in Liver Cirrhosis – a Prospective Randomized Long-Term Study|Unknown status|Recruiting|Phase 4|100||Odense University Hospital|||||f||||||||||||||2017-10-11 05:42:57.329441|2017-10-11 05:42:57.329441
NCT00239109|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2008-03-17|||April 2003||2003-04-01|March 2008|2008-03-01|February 2007||2007-02-01|||||Interventional|||Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.|Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia: A Six Months, Double Blind Randomized, Parallel Group Study.|Completed||Phase 4|112||Pfizer|||||f||||||||||||||2017-10-11 05:42:57.424153|2017-10-11 05:42:57.424153
NCT00239122|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2005-10-12|||June 2000||2000-06-01|October 2005|2005-10-01|February 2004||2004-02-01|||||Interventional|||Recovery Therapy Trial|Applicability of CBT to Unselected Mental Health Service Clients With Psychotic Disorders|Completed||N/A|94||Melbourne Health|||||f||||||||||||||2017-10-11 05:42:57.505362|2017-10-11 05:42:57.505362
NCT00239135|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2015-03-24|||September 2005||2005-09-01|March 2015|2015-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel|An Open-label, Dose Escalation, Cohort Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel When Applied on Day 1 and Day 2 to Actinic Keratoses on the Shoulders, Chest, Back or Arms Followed by a Post-Treatment Follow-up Period Lasting at Four Weeks|Completed||Phase 2|34||Peplin|||||||||||||||||||2017-10-11 05:42:57.577978|2017-10-11 05:42:57.577978
NCT00239148|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2009-05-25|||June 2005||2005-06-01|July 2006|2006-07-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1|A Randomized, Double-Blind, Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Effects of Repeated Subcutaneous Doses of E1 in Combination With G1 in Type 1 Diabetes|Completed||Phase 1|20||Transition Therapeutics|||||||||||||||||||2017-10-11 05:42:57.666551|2017-10-11 05:42:57.666551
NCT00239161|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2005-10-12|||September 2004||2004-09-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin|TREATMENT OF ACUTE UNCOMPLICATED PYELONEPHRITIS WITH SHORT COURSE LEVOFLOXACIN A Pilot Study|Terminated||Phase 4|30||University of Manitoba|||||f||||||||||||||2017-10-11 05:42:57.745423|2017-10-11 05:42:57.745423
NCT00239174|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2008-12-09|||November 2004||2004-11-01|December 2008|2008-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study Evaluating the Efficacy and Safety of Four Doses of SR147778 in Obese Patients|Completed||Phase 2|394|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:42:57.824273|2017-10-11 05:42:57.824273
NCT00239187|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2008-07-17|||September 2005||2005-09-01|July 2006|2006-07-01|January 2007|Actual|2007-01-01|||||Interventional|||A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1|A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Response of Repeated Subcutaneous Doses of E1 in Combination With G1 in Patients With Type 2 Diabetes|Completed||Phase 1|30||Transition Therapeutics|||||||||||||||||||2017-10-11 05:42:57.912175|2017-10-11 05:42:57.912175
NCT00239200|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2008-07-28|||October 2005||2005-10-01|July 2008|2008-07-01|September 2007|Actual|2007-09-01|June 2006|Actual|2006-06-01||Interventional|||Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus|Lapatinib (GW572016) a Dual Inhibitor of EGFR and ErbB2, for Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus|Terminated||Phase 2|29|Anticipated|University of Michigan Cancer Center||||notification from sponsor|f||||||||||||||2017-10-11 05:42:57.983815|2017-10-11 05:42:57.983815
NCT00239213|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2006-10-28|||November 2005||2005-11-01|October 2006|2006-10-01|April 2006||2006-04-01|||||Interventional|||Catechin Gargling for Influenza Infection|A Randomized Clinical Study of Catechin Gargling Effects on the Prevention of Influenza Infection|Completed||N/A|400||University of Shizuoka|||||f||||||||||||||2017-10-11 05:42:58.050552|2017-10-11 05:42:58.050552
NCT00239226|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2013-09-20|2009-11-06||November 2005||2005-11-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|EPASS||Electrophysiologically Guided PAcing Site Selection Study|Investigational New Drug Application/ Investigational Device Exemption Information|Completed||Phase 4|102|Actual|Medtronic BRC||4|||f||||t||||||||||2017-10-11 05:42:58.121943|2017-10-11 05:42:58.121943
NCT00239239|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2010-03-04|||August 2005||2005-08-01|March 2010|2010-03-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies|An Open-label, Single-arm Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Darbepoetin Alfa Administered Three Times Per Week for the Treatment of Anemia in Subjects With Non-myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 2|44|Actual|Amgen||1|||f||||||||||||||2017-10-11 05:42:58.546104|2017-10-11 05:42:58.546104
NCT00239252|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2014-08-25||||||August 2014|2014-08-01||||||||Interventional|||Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:42:58.624128|2017-10-11 05:42:58.624128
NCT00239265|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-10-18||||||October 2007|2007-10-01||||||||Interventional|||Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:42:58.697756|2017-10-11 05:42:58.697756
NCT00239278|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2011-01-21|||January 2001||2001-01-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|||||Interventional|||Budesonide / Formoterol in Treatment of Exacerbations of COPD|Effects of High Dose Inhaled Budesonide+ Formoterol Versus Placebo and Oral Prednisolone on Biomarkers of Airway Inflammation in the Treatment of Exacerbations in Non-hospitalised Patients With Mild to Moderate COPD.|Completed||Phase 2|120||AstraZeneca|||||f||||||||||||||2017-10-11 05:42:58.778658|2017-10-11 05:42:58.778658
NCT00239291|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2009-04-22|||January 2003||2003-01-01|April 2009|2009-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer|A Phase I/II Study of ZD1839 (Iressa) Given Concurrently With Radiotherapy in Patients With Non-Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|42|Actual|AstraZeneca|||||f||||||||||||||2017-10-11 05:42:58.858394|2017-10-11 05:42:58.858394
NCT00239304|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2007-12-14|||June 2003||2003-06-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer|A Phase I/II Trial of ZD1839 (Iressa) Given Concurrently With Cisplatin and Radiotherapy in Patients With Locally Advanced Head and Neck Cancer|Completed||Phase 1/Phase 2|40||AstraZeneca|||||f||||||||||||||2017-10-11 05:42:59.116691|2017-10-11 05:42:59.116691
NCT00239317|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-19|2007-10-18||||||October 2007|2007-10-01||||||||Interventional|||Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-10-11 05:42:59.190839|2017-10-11 05:42:59.190839
NCT00239330|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2010-11-18|||June 2003||2003-06-01|November 2010|2010-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy|An Open-label, Randomised, Multi-centre, Phase IIIb, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects With Type IIa and IIb Hypercholesterolaemia|Completed||Phase 3|824||AstraZeneca|||||f||||||||||||||2017-10-11 05:42:59.26781|2017-10-11 05:42:59.26781
NCT00239343|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-01-25|||October 2004||2004-10-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer|Randomised Placebo-controlled Phase II Trial of Preoperative Therapy With Gefitinib (Iressa®/ZD1839) and Epirubicin-Cyclophosphamide in Patients With Primary Operable (T2-T3) Oestrogen Receptor Negative Breast Cancer|Completed||Phase 2|160|Anticipated|AstraZeneca|||||f||||||||||||||2017-10-11 05:42:59.391969|2017-10-11 05:42:59.391969
NCT00239356|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2014-12-04|2013-11-05||March 2003||2003-03-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||All treated participants.|Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials|Aripiprazole (BMS-337039) for Outpatients With Schizophrenia Completing Aripiprazole Clinical Trials: A Non-Comparative Rollover Protocol|Completed||Phase 3|119|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-10-11 05:42:59.495477|2017-10-11 05:42:59.495477
NCT00239369|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2013-10-31|||October 2005||2005-10-01|October 2013|2013-10-01|August 2006||2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5|A Prospective Randomised Study to Compare a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 25 mg With a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg in Patients With Uncontrolled Hypertension Who Fail to Respond Adequately to Treatment With a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg|Completed||Phase 3|713||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:00.400154|2017-10-11 05:43:00.400154
NCT00239382|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2012-05-11|||July 2004||2004-07-01|May 2012|2012-05-01|December 2004||2004-12-01|||||Interventional|||A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis|A Randomized, Open-labelled Study to Compare the Efficacy and Safety of Meloxicam 15 mg IM Ampoules Once Daily and Meloxicam 15 mg Tablets Administered Orally Once Daily Over a Period of 7 Days in Patients With RA.|Completed||Phase 3|150||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:00.705651|2017-10-11 05:43:00.705651
NCT00239395|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2013-10-31|||July 2004||2004-07-01|October 2013|2013-10-01|December 2004||2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis|A Randomised, Open-labelled Study to Compare the Efficacy and Safety of Meloxicam 7.5 mg IM Ampoules Once Daily and Meloxicam 7.5 mg Tablets Administered Orally Once Daily Over a Period of 7 Days in Patients With Osteoarthritis (OA)|Completed||Phase 3|168||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:00.803229|2017-10-11 05:43:00.803229
NCT00239408|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-10-31|||December 2002||2002-12-01|October 2013|2013-10-01|April 2004||2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).|Spiriva Assessment of FEV1 - (SAFE-Portugal). The Effect of Inhaled Tiotropium Bromide (18 Mcg Once Daily) on the Change in FEV1 During Treatment in Patients With COPD. A Three-month Parallel Group, Double-blind, Randomised, Placebo-controlled Study.|Completed||Phase 4|311||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:00.900208|2017-10-11 05:43:00.900208
NCT00239421|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-10-31|||November 2003||2003-11-01|October 2013|2013-10-01|September 2004||2004-09-01|September 2004|Actual|2004-09-01||Interventional|||A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)|A Six-Week, Randomized, Double-Blind, Quadruple-Dummy Parallel Group Multiple Dose Study Comparing the Efficacy and Safety of Tiotropium Inhalation Capsules Plus Formoterol Inhalation Capsules to Salmeterol Inhalation Aerosol Plus Fluticasone Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|605||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:01.044958|2017-10-11 05:43:01.044958
NCT00239434|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2012-05-11|||June 2003||2003-06-01|May 2012|2012-05-01|March 2004||2004-03-01|||||Interventional|||A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)|Comparison of 18 mg of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20 mg, Four Times Daily) in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|200||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:01.263413|2017-10-11 05:43:01.263413
NCT00239447|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-10-31|||November 2002||2002-11-01|October 2013|2013-10-01|April 2004||2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD|Efficacy and Safety Comparison of 4-week Treatment Periods of Two Doses [5 μg (2 Actuations of 2.5 μg) and 10 μg (2 Actuations of 5 μg)] of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler, Tiotropium Inhalation Powder Capsule (18μg) Delivered by the HandiHaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|131||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:01.344548|2017-10-11 05:43:01.344548
NCT00239460|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-10-31|||July 2003||2003-07-01|October 2013|2013-10-01||||March 2004|Actual|2004-03-01||Interventional|||Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD|Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With Chronic Obstructive Pulmonary Disease (a 12-week, Parallel Group, Randomized, Placebo-cotrolled, Double-blind Study).|Completed||Phase 3|196||Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:43:01.442677|2017-10-11 05:43:01.442677
NCT00239473|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-10-31|||November 2002||2002-11-01|October 2013|2013-10-01||||December 2003|Actual|2003-12-01||Interventional|||12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD|A Randomised, Double-Blind, Double-Dummy, Placebo- and Active-Controlled, Parallel Group Efficacy and Safety Comparison of 12-Week Treatment of Two Doses [5 μg (2 Actuations of 2.5 μg) and 10 μg (2 Actuations of 5 μg)] of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler, Placebo and Ipratropium Bromide Inhalation Aerosol (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|429||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:01.577918|2017-10-11 05:43:01.577918
NCT00239486|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-10-31|||October 2002||2002-10-01|October 2013|2013-10-01|April 2004||2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)|Evaluation of the Effect of Different Doses of Pramipexole on Subjective and Objective Symptoms of Idiopathic Restless Legs Syndrome (RLS).|Completed||Phase 2|109||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:01.732525|2017-10-11 05:43:01.732525
NCT00239499|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-11-08|||September 2003||2003-09-01|November 2013|2013-11-01|August 2004||2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)|A Six-Week, Randomised, Double-Blind, Triple-Dummy, Parallel Group, Multiple Dose, Pilot Study Comparing Tiotropium Inhalation Capsules to Salmeterol Inhalation Aerosol Combined With Fluticasone Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 4|107||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:01.799137|2017-10-11 05:43:01.799137
NCT00239512|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2006-06-23|||March 2005||2005-03-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||New Management Strategy of PDA for VLBW Preterm Infants|New Management Strategy of PDA for VLBW Preterm--Comparison of Indomethacin and Ibuprofen|Terminated||N/A|60||China Medical University Hospital|||||f||||||||||||||2017-10-11 05:43:01.904241|2017-10-11 05:43:01.904241
NCT00239525|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2014-04-09|||May 2006||2006-05-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|April 2007|Actual|2007-04-01||Interventional|Definity||3-D Transcranial Ultrasound Analysis Study|3-D Transcranial Ultrasound Analysis Using Definity Injectable Suspension|Completed||N/A|28|Actual|Duke University||1|||f||||t||||||||||2017-10-11 05:43:02.086668|2017-10-11 05:43:02.086668
NCT00239538|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-11-07|||January 2003||2003-01-01|November 2013|2013-11-01|December 2004||2004-12-01|December 2004|Actual|2004-12-01||Interventional|||SMOOTH - Blood Pressure Control in Diabetic/Obese Patients|Prospective, Randomized, Open-label, Blinded Endpoint, Forced Titration Study to Compare Telmisartan Combined With HCTZ (80mg/12.5mg), to Valsartan Combined With HCTZ (160mg/12.5mg), for the Control of Mild-to-moderate Hypertension in Obese Patients With Type 2 Diabetes Mellitus Using ABPM.|Completed||Phase 4|840|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:43:02.200131|2017-10-11 05:43:02.200131
NCT00239551|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2013-07-29|||October 2005||2005-10-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|October 2006|Actual|2006-10-01||Interventional|||Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer|Effect of Prevacid on Prostaglandin Levels in the Gastric Mucosa of Patients With Stress Ulcer|Completed||Phase 4|30|Actual|Emory University||1|||f||||t||||||||||2017-10-11 05:43:02.522388|2017-10-11 05:43:02.522388
NCT00239564|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-01-31|||October 2005||2005-10-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease|An Open-Label Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease|Completed||Phase 1/Phase 2|12|Actual|IMPAX Laboratories, Inc.||1|||f||||f|t|f||||||No||2017-10-11 05:43:02.613334|2017-10-11 05:43:02.613334
NCT00239590|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2015-03-25|||June 2001||2001-06-01|October 2005|2005-10-01|April 2004||2004-04-01|||||Interventional|||Testosterone and Myocardial Perfusion in CHD|Effects of Chronic Testosterone on Myocardial Ischaemia and Endothelial Function in Men With Documented Coronary Heart Disease|Completed||Phase 2|||Imperial College London|||||f||||f||||||||||2017-10-11 05:43:02.814692|2017-10-11 05:43:02.814692
NCT00239603|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2007-04-16|||October 2005||2005-10-01|April 2007|2007-04-01|June 2007||2007-06-01|||||Observational|||Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.|Clinical Investigation of the OV-Watch™ Personal Fertility Monitor for Women Undergoing Ovulation Induction With Clomiphene Citrate.|Completed||Phase 4|40||Emory University|||||f||||||||||||||2017-10-11 05:43:02.908488|2017-10-11 05:43:02.908488
NCT00239616|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2011-03-16|||June 2002||2002-06-01|March 2011|2011-03-01|November 2003||2003-11-01|||||Interventional|||Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin|Open-label Multicenter, Pharmacokinetic Study of a Single Dose of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin|Completed||Phase 4|8||Luitpold Pharmaceuticals|||||||||||||||||||2017-10-11 05:43:02.993347|2017-10-11 05:43:02.993347
NCT00239629|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2007-06-11|||September 2005||2005-09-01|June 2007|2007-06-01|January 2007|Actual|2007-01-01|||||Interventional|||Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial|Differential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women With Osteoporosis|Completed||Phase 4|73||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:43:03.061958|2017-10-11 05:43:03.061958
NCT00239642|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2012-10-22|2011-12-05||July 2005||2005-07-01|October 2012|2012-10-01|April 2010|Actual|2010-04-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy of Iron Sucrose in Children|Comparison of the Safety and Efficacy of Three Iron Sucrose Maintenance Regimens in Pediatric Chronic Kidney Disease (CKD) Patients|Completed||Phase 4|141|Actual|Luitpold Pharmaceuticals||3|||f||||||||||||||2017-10-11 05:43:03.180691|2017-10-11 05:43:03.180691
NCT00239655|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2016-07-29|||August 2004||2004-08-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)|A Randomized, Double-Blind Placebo Controlled, Parallel Groups Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by MRI|Terminated||Phase 2|120|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:43:03.888588|2017-10-11 05:43:03.888588
NCT00239668|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2012-05-02|||March 2000||2000-03-01|May 2012|2012-05-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors|Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors|Unknown status|Recruiting|N/A|3000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-10-11 05:43:03.955291|2017-10-11 05:43:03.955291
NCT00239681|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2014-02-06|2009-08-20||February 2003||2003-02-01|February 2014|2014-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events|A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase 3 Study of Rosuvastatin (CRESTOR®) 20 mg in the Prevention of Cardiovascular Events Among Subjects With Low Levels of Low Density Lipoprotein(LDL) Cholesterol & Elevated Levels of C-Reactive Protein|Terminated||Phase 3|17802|Actual|AstraZeneca||2||See detailed description for reason.|f||||t||||||||||2017-10-11 05:43:04.373178|2017-10-11 05:43:04.373178
NCT00239707|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2013-11-27|||February 2003||2003-02-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GIP: Glucose-dependent Insulinotropic Peptide|Effect of GIP / GIP Analog in Type 2 Diabetes After a Meal|Completed||Phase 1|41|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-10-11 05:43:11.891542|2017-10-11 05:43:11.891542
NCT00239720|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-03-27|2012-02-15||March 16, 2006|Actual|2006-03-16|March 2017|2017-03-01|June 25, 2008|Actual|2008-06-25|December 2006|Actual|2006-12-01||Interventional|PART||PsA Treatment With hOKT3γ1 (Ala-Ala)|Treatment of Psoriatic Arthritis With hOKT3γ1 (Ala-Ala)|Terminated||Phase 2|4|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|This study was put on voluntary clinical hold after a serious adverse event occurred. After a review of the data, the team decided to close the study to further enrollment. Due to limited participants, no formal statistical analyses were performed|2||Study team decision-impact(s) of change in hOKT3γ1 (Ala-Ala) manufacturer during study.|f||||t||||||||Yes|Data access is provided in TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal that makes data from the consortium's clinical trials publicly available.|2017-10-11 05:43:12.011376|2017-10-11 05:43:12.011376
NCT00239733|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-04-14|2017-01-05||March 2005||2005-03-01|April 2017|2017-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection|The Safety and Efficacy of Intravenous Anti-D for the Treatment of Thrombocytopenia in Patients With HCV Infection Prior to or During Treatment With Pegylated-interferon and Ribavirin|Terminated||Phase 4|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||failure to enroll additional subjects|f||||f||||||||No||2017-10-11 05:43:12.410543|2017-10-11 05:43:12.410543
NCT00239746|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2009-04-28|||October 2005||2005-10-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories|Biomarkers of Nonsteroidal Anti-Inflammatories|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-10-11 05:43:12.681398|2017-10-11 05:43:12.681398
NCT00239759|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2009-02-24|||September 2002||2002-09-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|||||Observational|||MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology|Genetic Epidemiological Studies of Apolipoprotein E and Alzheimer's Disease|Completed||N/A|2000|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-10-11 05:43:12.770001|2017-10-11 05:43:12.770001
NCT00239772|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2014-06-04|||May 1994||1994-05-01|June 2014|2014-06-01||||||||Interventional|||Cognitive Processing Therapy Versus Prolonged Exposure for Treating Women With Post-Traumatic Stress Disorder Brought on by Sexual Assault|Cognitive Processes in PTSD: Treatment|Completed||N/A|120||University of Missouri, St. Louis|||||f||||||||||||||2017-10-11 05:43:12.872899|2017-10-11 05:43:12.872899
NCT00239785|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-08-18|||April 2003||2003-04-01|August 2017|2017-08-01||||April 2005|Actual|2005-04-01||Interventional|||Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|A One-year, Multicenter, Partially Blinded, Double-dummy, Randomized Study to Evaluate the Efficacy and Safety of FTY720 Combined With Reduced-dose or Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids Versus Mycophenolate Mofetil Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids, in de Novo Adult Renal Transplant Recipients|Completed||Phase 3|684||Novartis|||||f||||||||||||||2017-10-11 05:43:12.93798|2017-10-11 05:43:12.93798
NCT00239798|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-02-21|||November 2004||2004-11-01|February 2017|2017-02-01||||November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|A 24-month Extension of a One-year, Multicenter, Double Blinded Double Dummy, Randomized Study to Evaluate the Safety and Efficacy of Two Doses of FTY720 Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Steroids Versus Mycophenolate Mofetil Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Steroids, in Adult de Novo Renal Transplant Recipients|Completed||Phase 2|255||Novartis|||||||||||||||||||2017-10-11 05:43:13.010252|2017-10-11 05:43:13.010252
NCT00239811|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2011-11-01|||April 2004||2004-04-01|November 2011|2011-11-01||||May 2006|Actual|2006-05-01||Interventional|||Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|A Two-year Extension to a One-year, Multicenter, Partially Blinded, Double Dummy, Randomized Study to Evaluate the Efficacy and Safety of FTY720 Combined With Reduced-dose or Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids Versus Mycophenolate Mofetil Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids, in de Novo Adult Renal Transplant Recipients|Completed||Phase 3|684||Novartis|||||f||||||||||||||2017-10-11 05:43:13.090259|2017-10-11 05:43:13.090259
NCT00239824|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2016-07-15|||October 2005||2005-10-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Pelvic Floor Muscle Training to Treat Urinary Incontinence After Radical Prostatectomy|Urinary Incontinence After Radical Prostatectomy. - Effect of Pelvic Floor Muscle Training. A Randomised Controlled Trial|Completed||N/A|80|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-10-11 05:43:13.171979|2017-10-11 05:43:13.171979
NCT00239837|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2015-12-04|2013-05-06||December 2003||2003-12-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|December 2009|Actual|2009-12-01||Interventional|||Prevention Program for Problem Behaviors in Girls in Foster Care|Preventing Problems for Girls in Foster Care|Completed||Phase 1|100|Actual|Oregon Social Learning Center|Sample is relatively small in size, and limited to girls in foster care in two Oregon Counties|2|||f||||f||||||||||2017-10-11 05:43:13.288125|2017-10-11 05:43:13.288125
NCT00239850|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-03-21|||August 2005|Actual|2005-08-01|March 2017|2017-03-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Morbid Obesity: Effects of Conservative Treatments and Gastric Bypass Surgery|Morbid Obesity: Effects of Conservative Treatments and Gastric Bypass Surgery|Completed||N/A|209|Actual|Norwegian University of Science and Technology||3|||f|||||f|f||||||||2017-10-11 05:43:13.752117|2017-10-11 05:43:13.752117
NCT00239863|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-02-21|||May 2004||2004-05-01|February 2017|2017-02-01||||May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients|A Two-year Extension to a One-year, Multicenter, Partially Blinded, Double-dummy, Randomized Study to Evaluate the Efficacy and Safety of FTY720 Combined With Reduced-dose or Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids Versus Mycophenolate Mofetil Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids, in de Novo Adult Renal Transplant Recipients.|Completed||Phase 3|684||Novartis|||||||||||||||||||2017-10-11 05:43:13.84661|2017-10-11 05:43:13.84661
NCT00231842|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2012-04-22|||February 2003||2003-02-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus|"A Pilot Phase II Trial of Adjuvant Radiation Therapy Sandwiched Between Ifosfamide in Patients With Mixed Mesodermal Tumors"|Completed||Phase 2|27|Actual|Montefiore Medical Center||1|||f||||t||||||||||2017-10-11 05:43:13.943318|2017-10-11 05:43:13.943318
NCT00231855|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2012-04-22|||November 2004||2004-11-01|April 2012|2012-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers|Phase II Trial- Weekly Taxotere and Topotecan for Recurrent Ovarian, Primary Peritoneal, Endometrial and Uterine Cancers|Completed||Phase 2|31||Montefiore Medical Center|||||f||||t||||||||||2017-10-11 05:43:14.07092|2017-10-11 05:43:14.07092
NCT00231868|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2012-04-22|||December 2001||2001-12-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma|"A Pilot Phase II Trial of Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma"|Completed||Phase 2|81|Actual|Montefiore Medical Center||1|||f||||t||||||||||2017-10-11 05:43:14.174194|2017-10-11 05:43:14.174194
NCT00231881|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2007-04-27||||||April 2007|2007-04-01||||||||Observational|||Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux|Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux|Unknown status|Recruiting|N/A|60|Anticipated|Nantes University Hospital|||||f||||||||||||||2017-10-11 05:43:14.291196|2017-10-11 05:43:14.291196
NCT00231907|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2010-08-26|||September 2005||2005-09-01|February 2010|2010-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist|Influenza Vaccines: Mix and Match of Trivalent Inactivated Influenza (TIV) and Live Attenuated Influenza Vaccine (LAIV), a Phase I Safety, Immunogenicity, and Viral Shedding Study|Completed||Phase 1|56|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 05:43:14.537847|2017-10-11 05:43:14.537847
NCT00231920|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-08-11|||October 2004||2004-10-01|November 2006|2006-11-01|October 2006||2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age|Prospective Pilot Safety Study Administering Two Doses of Inactivated Influenza Vaccine to Infants 10-22 Weeks of Age|Completed||Phase 1|23|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:43:14.672389|2017-10-11 05:43:14.672389
NCT00231933|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2012-04-09|||October 2005||2005-10-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Culturally Responsive Person-Centered Care for Psychosis|Culturally-responsive, Person-centered Care for Psychosis|Completed||Phase 1|290|Actual|Yale University||3|||f||||f||||||||||2017-10-11 05:43:14.935699|2017-10-11 05:43:14.935699
NCT00231946|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2007-09-18|||September 2005||2005-09-01|September 2007|2007-09-01||||||||Interventional|||ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)|A Double-Blind Placebo-Controlled Study of VP4896 For the Treatment of Mild-to-Moderate Alzheimer's Disease|Completed||Phase 3|555||National Institute on Aging (NIA)|||||||||||||||||||2017-10-11 05:43:15.045797|2017-10-11 05:43:15.045797
NCT00231959|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2012-04-25|||September 2003||2003-09-01|April 2012|2012-04-01|April 2008|Actual|2008-04-01|September 2007|Actual|2007-09-01||Interventional|||Effectiveness of Pramipexole for Treatment-Resistant Depression|A Double-Blind Placebo-Controlled Trial of Adjunctive Pramipexole, a Dopamine Receptor Agonist, for Treatment Resistant Major Depressive Episodes|Completed||Phase 4|65|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-10-11 05:43:15.328696|2017-10-11 05:43:15.328696
NCT00231972|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-04-07|||December 2003||2003-12-01|February 2011|2011-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|Enhance||Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected Men|Enhancing HIV Prevention Among HIV Infected Men|Completed||N/A|201|Actual|Fenway Community Health||2|||f||||f||||||||||2017-10-11 05:43:15.445765|2017-10-11 05:43:15.445765
NCT00231985|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2012-02-08|||October 2005||2005-10-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder|Behavior Therapy and Psychosocial Treatment for Tourette Syndrome and Chronic Tic Disorder|Completed||Phase 2|122|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-10-11 05:43:15.552008|2017-10-11 05:43:15.552008
NCT00231998|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2007-12-13|||May 2004||2004-05-01|December 2007|2007-12-01|June 2005|Actual|2005-06-01|||||Interventional|||Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis|A Clinical Study Continued From the Confirmatory Study to Validate the Efficacy and Safety of Pimecrolimus Cream in Pediatric Atopic Dermatitis Patients|Completed||Phase 3|240||Novartis||1|||f||||||||||||||2017-10-11 05:43:15.673273|2017-10-11 05:43:15.673273
NCT00232011|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2007-12-13|||May 2004||2004-05-01|December 2007|2007-12-01|May 2005|Actual|2005-05-01|||||Interventional|||Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis|A Clinical Study Continued From the Confirmatory Study to Assess the Efficacy and Safety of ASM981 Cream in Adult Atopic Dermatitis Patients|Completed||Phase 3|160||Novartis||1|||f||||||||||||||2017-10-11 05:43:15.773398|2017-10-11 05:43:15.773398
NCT00232024|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-01-31|||January 2004||2004-01-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia|Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia|Completed||Phase 3|1296||Novartis|||||||||||||||||||2017-10-11 05:43:15.872398|2017-10-11 05:43:15.872398
NCT00232037|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-01-31|||September 2004||2004-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia|Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia|Completed||Phase 3|359||Novartis|||||||||||||||||||2017-10-11 05:43:15.960427|2017-10-11 05:43:15.960427
NCT00232050|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2011-10-24|||October 2002||2002-10-01|October 2011|2011-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study of Omalizumab in Moderate to Severe Bronchial Asthma|Study of Omalizumab in Moderate to Severe Bronchial Asthma|Completed||Phase 3|327|Actual|Novartis|||||f||||||||||||||2017-10-11 05:43:16.036469|2017-10-11 05:43:16.036469
NCT00232063|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2011-11-01|||May 2004||2004-05-01|November 2011|2011-11-01||||November 2005|Actual|2005-11-01||Interventional|||Long-term Study of Ciclosporin for Atopic Dermatitis|Long-term Study of Ciclosporin for Atopic Dermatitis|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-10-11 05:43:16.110807|2017-10-11 05:43:16.110807
NCT00232076|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2011-11-01|||May 2004||2004-05-01|November 2011|2011-11-01||||March 2005|Actual|2005-03-01||Interventional|||Verification Study of Ciclosporin for Atopic Dermatitis|Verification Study of Ciclosporin for Atopic Dermatitis|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-10-11 05:43:16.180278|2017-10-11 05:43:16.180278
NCT00232089|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2016-11-16|||May 2004||2004-05-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia|Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia|Completed||Phase 3|1296||Novartis|||||||||||||||||||2017-10-11 05:43:16.245597|2017-10-11 05:43:16.245597
NCT00232102|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-08|2008-01-31|||September 2004||2004-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia|Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia|Completed||Phase 3|423||Novartis|||||||||||||||||||2017-10-11 05:43:16.335964|2017-10-11 05:43:16.335964
NCT00232115|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2008-01-15|||September 2005||2005-09-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|||||Interventional|||Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis|Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis|Completed||Phase 3|124|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:43:16.418119|2017-10-11 05:43:16.418119
NCT00232128|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2007-01-11|||June 2003||2003-06-01|May 2006|2006-05-01||||||||Interventional|||Protocol for Radiofrequency Ablation of Pulmonary Neoplasms|Protocol for Radiofrequency Ablation of Pulmonary Neoplasms|Terminated||N/A|||Oncology Specialties, Alabama|||||f||||||||||||||2017-10-11 05:43:16.513362|2017-10-11 05:43:16.513362
NCT00232141|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2009-06-22|2008-11-25||October 2005||2005-10-01|June 2009|2009-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Pregabalin Versus Placebo in the Treatment of Neuropathic Pain Associated With HIV Neuropathy.|Completed||Phase 3|302|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:43:16.780166|2017-10-11 05:43:16.780166
NCT00232154|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-04-20|||November 2005||2005-11-01|April 2011|2011-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To|An Open-Label Study Of Azithromycin Pharmacokinetics In Sinus Mucosal Tissue And Plasma In Subjects With Chronic Rhinosinusitis Following A Single 2g Dose Of Azithromycin Extended Release For Oral Suspension Or Azithromycin 500mg Tablet Formulation Once Daily For A Maximum Of Three Days|Completed||Phase 2|72|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:43:20.128153|2017-10-11 05:43:20.128153
NCT00232167|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2007-10-01|||November 2005||2005-11-01|October 2007|2007-10-01|April 2006||2006-04-01|||||Interventional|||Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression|Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Tolerability Of Indiplon Therapy Initiated With Sertraline Versus Sertraline Monotherapy In Subjects With Insomnia And Co-Existing Major Depressive Disorder|Terminated||Phase 3|380||Neurocrine Biosciences||||Please see Detailed Description below for termination reason.|||||f||||||||||2017-10-11 05:43:20.238236|2017-10-11 05:43:20.238236
NCT00232180|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2013-03-28|2011-05-20||March 2006||2006-03-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|May 2010|Actual|2010-05-01||Interventional|EMPHASIS-HF||A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines|The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality And Heart Failure Hospitalization In Subjects With NYHA Class II Chronic Systolic Heart Failure|Completed||Phase 3|2743|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 05:43:20.50139|2017-10-11 05:43:20.50139
NCT00233259|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2011-10-24|||March 2006||2006-03-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes|CHD Lifestyle Modification for Latinas With Diabetes|Completed||N/A|273|Actual|Oregon Research Institute||2|||f||||t||||||||||2017-10-11 05:43:45.88173|2017-10-11 05:43:45.88173
NCT00232193|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-07-20|||December 2003||2003-12-01|July 2011|2011-07-01|August 2010|Actual|2010-08-01|December 2008|Actual|2008-12-01||Observational|||Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS|Steroid Adjunctive Treatment at Initiation of Avonex Therapy for Patients With Mono-Symptomatic or Relapsing-Remitting Multiple Sclerosis|Completed||Phase 4|40|Actual|Providence Multiple Sclerosis Center|||2||f||||f||||||||||2017-10-11 05:43:29.979351|2017-10-11 05:43:29.979351
NCT00232206|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-05-17|||May 2005||2005-05-01|May 2011|2011-05-01|November 2007||2007-11-01|April 2007|Actual|2007-04-01||Interventional|||Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer|A Phase II Study of Cisplatin Plus Docetaxel as Neoadjuvant Therapy for Stages IB Through Selected IIIA NSCLC|Terminated||Phase 2|40|Anticipated|Providence Health & Services||||study terminated due to slow accrual|f||||||||||||||2017-10-11 05:43:30.069877|2017-10-11 05:43:30.069877
NCT00232219|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-02|2015-05-04|||January 2003||2003-01-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion|Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.|Completed||Phase 4|200|Actual|Melbourne Health||2|||f||||||||||||||2017-10-11 05:43:30.144321|2017-10-11 05:43:30.144321
NCT00232232|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-02|2015-05-08|||September 2003||2003-09-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia||Completed||Phase 4|100|Anticipated|Melbourne Health||2|||f||||||||||||||2017-10-11 05:43:30.219582|2017-10-11 05:43:30.219582
NCT00232245|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-02|2013-05-28|||December 2003||2003-12-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.||Completed||Phase 4|80|Actual|Melbourne Health||2|||f||||t||||||||||2017-10-11 05:43:30.402383|2017-10-11 05:43:30.402383
NCT00232258|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2008-12-09|||April 2005||2005-04-01|December 2008|2008-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|NICE||Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study|Nolpitantium Besylate in Patients With Mild to Moderate Ulcerative Colitis, a Double-Blind, Placebo Controlled Efficacy and Safety, 8 Week Study|Completed||Phase 2|307|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:43:30.475403|2017-10-11 05:43:30.475403
NCT00232271|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-02|2013-05-28|||August 2005||2005-08-01|October 2005|2005-10-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.|The Effect of Enoxaparin Sodium (Clexane) on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.|Terminated||Phase 4|35|Actual|Melbourne Health||2||Slow recruitment|f||||||||||||||2017-10-11 05:43:30.595067|2017-10-11 05:43:30.595067
NCT00232284|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-02|2015-06-24|||September 2004||2004-09-01|June 2015|2015-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Treatment of Comorbid Depression and Substance Abuse in Young People|An Integrated Pharmacological and Psychological Approach to Young People With Comorbid Depression and Substance Abuse|Completed||Phase 2|60|Actual|Melbourne Health||2|||f||||f||||||||||2017-10-11 05:43:30.678524|2017-10-11 05:43:30.678524
NCT00232297|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2012-05-07|||June 2005||2005-06-01|May 2012|2012-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|ICARIOS||Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS|Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744C 100 OR 300 mg for the Prevention of Ventricular Arrhythmia-Triggered ICD Interventions|Completed||Phase 2|153|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:43:30.779051|2017-10-11 05:43:30.779051
NCT00232310|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2012-05-07|||October 2005||2005-10-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|CORYFEE||Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr|Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744C 300 or 600 mg for the Conversion of Atrial Fibrillation / Flutter|Completed||Phase 2|150|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:43:30.885699|2017-10-11 05:43:30.885699
NCT00232323|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-02|2007-01-23|||January 2006||2006-01-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Simulation Training as a Tool to Decrease Occupational Stress in ICU Personnel|Experimental Like Study of Stress Reduction in Intensive Care Teams by Use of Simulation Training|Suspended||N/A|40||Sheba Medical Center|||||f||||||||||||||2017-10-11 05:43:31.007015|2017-10-11 05:43:31.007015
NCT00232336|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2008-07-29|||October 2003||2003-10-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|||||Interventional|||Quetiapine for Cocaine Use and Cravings|Efficacy of Quetiapine in the Reduction of Cocaine Use and Cravings in Individuals With Cocaine Dependence|Completed||Phase 4|42|Actual|Seattle Institute for Biomedical and Clinical Research||1|||f||||f||||||||||2017-10-11 05:43:31.078124|2017-10-11 05:43:31.078124
NCT00232349|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2008-07-30|||February 2005||2005-02-01|July 2008|2008-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy of Galantamine to Treat Schizophrenia|An Open-Label Trial of Adjunctive Galantamine Maintenance Therapy to Treat Functional Impairments in Chronic Outpatients With Schizophrenia|Terminated||Phase 4|21|Actual|Seattle Institute for Biomedical and Clinical Research||1||Study terminated due to no apparent benefit.|f||||t||||||||||2017-10-11 05:43:31.150554|2017-10-11 05:43:31.150554
NCT00232362|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2015-04-09|||June 2007||2007-06-01|April 2015|2015-04-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus|Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus|Withdrawn||Phase 1|0|Actual|Texas Tech University Health Sciences Center||||This study was not conducted as the Principal Investigator left the institution|f||||||||||||||2017-10-11 05:43:31.245279|2017-10-11 05:43:31.245279
NCT00232375|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-29|2005-09-30|||January 1996||1996-01-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes||Completed||N/A|42||Tokyo Study Group|||||f||||||||||||||2017-10-11 05:43:31.312956|2017-10-11 05:43:31.312956
NCT00232986|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2005-10-03|||September 2004||2004-09-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Observational|||A Comparison of Survey Methodologies to Elicit Sensitive Information From Adolescents in Urban India|A Comparison of Survey Methodologies to Elicit Information on Sexual and Reproductive Health From Adolescents in Urban India|Completed||N/A|960||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:43:42.102534|2017-10-11 05:43:42.102534
NCT00232388|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2015-10-06|||September 2005||2005-09-01|October 2015|2015-10-01|September 2007|Actual|2007-09-01|||||Observational|||Association of PICP Serum Marker in Patients With LVSD|Phase 1 Study of PICP Serum Marker of Myocardial Fibrosis and Diastolic Function in Patients With Systolic Dysfunction|Terminated||Phase 1|45|Actual|Texas Tech University Health Sciences Center|||1|PI left institution; Data collected from 45 participants, but no results are available.|f||||f||||||None Retained|"     PLEASE NOTE THAT THE INVESTIGATOR LEFT THE INSTITUION WITHOUT PROVIDING ANY INFORMATION     REGARDING THIS PROJECT. NO FORWARDING INFORMATION IS AVAILABLE FROM THE INVESTIGATOR.   "|||2017-10-11 05:43:31.378052|2017-10-11 05:43:31.378052
NCT00232401|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2009-02-13|||October 2005||2005-10-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|||||Observational|||The Circadian Rhythm of Urine Output in Healthy Infants|The Circadian Rhythm of Urine Output in Healthy Infants|Completed||N/A|60|Anticipated|University of Aarhus|||||f||||||||||||||2017-10-11 05:43:31.437987|2017-10-11 05:43:31.437987
NCT00232414|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2013-12-09|||October 2005||2005-10-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder|A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder|Completed||Phase 3|30|Anticipated|University of Cincinnati|||||f||||t||||||||||2017-10-11 05:43:31.496375|2017-10-11 05:43:31.496375
NCT00232427|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2007-10-02|||August 2005||2005-08-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||PiCCO Guided Therapy in Liver Cirrhosis|Optimized Therapy of Decompensated Liver Cirrhosis by Hemodynamic Monitoring Using the PiCCO System|Completed||N/A|20|Actual|Heidelberg University|||||f||||||||||||||2017-10-11 05:43:31.579429|2017-10-11 05:43:31.579429
NCT00232440|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2010-08-10|||January 2003||2003-01-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma|A Study to Examine the Reproducibility of an Immobilization Device (BodyFIX ) to Deliver High Precision Radiation Therapy for Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|20||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:43:31.647125|2017-10-11 05:43:31.647125
NCT00232453|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2011-02-11|||March 2001||2001-03-01|February 2011|2011-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Preoperative Combined Radiation and Chemotherapy - Rectal Cancer|A Phase II Protocol of Preoperative Combined Radiation and Chemotherapy for Resectable Primary Rectal Cancer|Completed||Phase 2|34||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:43:32.022863|2017-10-11 05:43:32.022863
NCT00232466|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2008-06-24|||October 2005||2005-10-01|June 2008|2008-06-01|May 2010|Anticipated|2010-05-01|May 2009|Anticipated|2009-05-01||Interventional|||VERTOS-II. Percutaneous Vertebroplasty Versus Conservative Therapy|VERTOS II. Percutaneous Vertebroplasty Versus Conservative Therapy in Patients With Osteoporotic Vertebral Fractures|Unknown status|Active, not recruiting|N/A|200|Actual|UMC Utrecht||2|||f||||||||||||||2017-10-11 05:43:32.083284|2017-10-11 05:43:32.083284
NCT00232479|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2012-07-16|2012-06-12||September 2005||2005-09-01|July 2012|2012-07-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer|Phase II Study of Dose Dense Carboplatin and Taxotere With Herceptin As Primary Systemic Therapy in Breast Cancer|Completed||Phase 2|48|Actual|University of Miami||1|||f||||t||||||||||2017-10-11 05:43:32.188749|2017-10-11 05:43:32.188749
NCT00232492|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-07-03|||January 2005||2005-01-01|April 2008|2008-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Ketamine on Acute Pain in Females and Males|Effect of Racemic Ketamine on Pain in Females and Males After Surgical Removal of Third Molars|Completed||Phase 4|128|Actual|Oslo University Hospital||8|||f||||f||||||||||2017-10-11 05:43:32.350278|2017-10-11 05:43:32.350278
NCT00232505|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-05-25|2017-04-07||November 2005|Actual|2005-11-01|May 2017|2017-05-01|August 12, 2012|Actual|2012-08-12|June 21, 2010|Actual|2010-06-21||Interventional|||Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer|Phase II Trial of Cetuximab Alone and in Combination With Carboplatin in ER-Negative, PR-Negative, HER-2 Nonoverexpressing Metastatic Breast Cancer|Completed||Phase 2|112|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||No||2017-10-11 05:43:32.501074|2017-10-11 05:43:32.501074
NCT00232518|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2007-05-04|||September 2005||2005-09-01|April 2005|2005-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis|Randomised Controlled Clinical Trial of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis|Completed||N/A|30||University of Nottingham|||||f||||||||||||||2017-10-11 05:43:34.133742|2017-10-11 05:43:34.133742
NCT00232531|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2007-01-26|||September 2004||2004-09-01|September 2006|2006-09-01|February 2009||2009-02-01|||||Interventional|||Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function|Cardiovascular Magnetic Resonance Evaluation of the Effects of Niaspan on Regression of Atherosclerosis and Restoration of Endothelial Function|Unknown status|Active, not recruiting|N/A|70||University of Oxford|||||f||||||||||||||2017-10-11 05:43:34.218574|2017-10-11 05:43:34.218574
NCT00232544|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2015-04-06|2013-11-04||October 2004||2004-10-01|October 2013|2013-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Telecommunications System in Sleep Apnea|RCT of a Telecommunications System in Sleep Apnea|Completed||N/A|250|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:43:34.28698|2017-10-11 05:43:34.28698
NCT00232557|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2015-04-06|2013-11-27||August 2004||2004-08-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional||Subject with baseline examination|Telecommunications System in Asthma|Effectiveness of a Telecommunications System in Asthma Management|Completed||Phase 3|136|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:43:34.58486|2017-10-11 05:43:34.58486
NCT00232570|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2009-05-04|||November 2005||2005-11-01|May 2009|2009-05-01|January 2010|Anticipated|2010-01-01|December 2009|Anticipated|2009-12-01||Interventional|||Quetiapine for the Treatment of Insomnia in Alzheimer's Disease|Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease|Unknown status|Recruiting|N/A|18|Anticipated|University of Vermont||1|||||||||||||||||2017-10-11 05:43:34.837391|2017-10-11 05:43:34.837391
NCT00232583|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2015-05-26|2013-10-15||November 2003||2003-11-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Preservation of Beta-cell Function in Type 2 Diabetes Mellitus|Preservation of Beta-cell Function in Type 2 Diabetes Mellitus|Completed||N/A|58|Actual|University of Texas Southwestern Medical Center|Relatively small trial, but longest (6-year) follow-up.|2|||f||||f||||||||||2017-10-11 05:43:34.950538|2017-10-11 05:43:34.950538
NCT00232596|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2016-10-26|2011-07-07||September 2005||2005-09-01|October 2016|2016-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|RESTORE1||Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study to Determine the Efficacy and Safety of Retigabine (1200 mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients With Partial-Onset Seizures|Completed||Phase 3|306|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:43:35.495059|2017-10-11 05:43:35.495059
NCT00232609|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2012-09-17|||August 2005||2005-08-01|September 2012|2012-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Development of the GameCycle Exercise System: Phase II|Development of the GameCycle Exercise System: Phase II|Completed||Phase 2|14|Actual|VA Pittsburgh Healthcare System|||||f||||f||||||||||2017-10-11 05:43:37.728682|2017-10-11 05:43:37.728682
NCT00232622|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2013-10-23|||November 2004||2004-11-01|October 2013|2013-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|RAFT-PVT||A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots|A Prospective Randomized Trial of a Rapid Fibrinolytic Protocol for Left-sided Prosthetic Valve Thrombosis|Completed||Phase 3|120|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-10-11 05:43:37.823994|2017-10-11 05:43:37.823994
NCT00232635|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2010-02-11|||September 2005||2005-09-01|February 2010|2010-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT|A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Safety and Efficacy of A-60444 in Adults With RSV Infection Following Stem Cell Transplantation|Completed||Phase 2|27|Actual|Arrow Therapeutics||2|||f||||t||||||||||2017-10-11 05:43:37.926902|2017-10-11 05:43:37.926902
NCT00232648|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2009-03-24|||January 2004||2004-01-01|March 2009|2009-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma|Investigation of Safety and Efficacy of Budesonide Inhalation Suspension in the Long-Term Use in Japanese Children With Bronchial Asthma (Open Long-Term Extension Study Following Study SD-004-0765|Completed||Phase 3|54||AstraZeneca|||||f||||||||||||||2017-10-11 05:43:38.016197|2017-10-11 05:43:38.016197
NCT00232661|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2010-02-02|||August 2000||2000-08-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|January 2003|Actual|2003-01-01||Interventional|||PROACT - Pre-Operative Arimidex Compared To Tamoxifen|A Randomised, Double-blind, Study Comparing ARIMIDEX™ With NOLVADEX™ as Neo-adjuvant and Adjuvant Treatment in Post-menopausal Women With Large Operable (T2 (≥3cm), T3, N0-2, M0) or Potentially-operable, Locally Advanced (T4b, N0-2, M0), ER+ and/or PR+ Breast Cancer.|Completed||Phase 3|452|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 05:43:38.11053|2017-10-11 05:43:38.11053
NCT00232674|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2011-01-21|||July 1999||1999-07-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|||||Interventional|||Efficacy Study of the Effect of Budesonide on Emphysema|The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Computed Tomography (CT).|Completed||Phase 4|240||AstraZeneca|||||f||||||||||||||2017-10-11 05:43:38.335574|2017-10-11 05:43:38.335574
NCT00232687|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2013-11-07|||June 2005||2005-06-01|February 2012|2012-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Switch Study of BMS-337039 in Schizophrenic Out-patients|A Comparative, Randomized, Open-Label, Multicenter Study on the Efficacy and Safety of Switch Treatment With Aripiprazole in Schizophrenic Out-patients Who Are Experiencing Insufficient Efficacy With Risperidone and/or Safety and Tolerability Issues, While on Risperidone|Completed||Phase 4|450|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-10-11 05:43:38.407937|2017-10-11 05:43:38.407937
NCT00232700|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2011-06-22|||September 2005||2005-09-01|September 2007|2007-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Investigation of a Combination Treatment of Escitalopram and rTMS|Investigation of Efficacy and Response Speed of a Combination Treatment of Escitalopram and Repetitive Transcranial Magnetic Stimulation|Completed||N/A|42|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:43:38.628385|2017-10-11 05:43:38.628385
NCT00232713|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2006-08-29|||December 2005||2005-12-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Observational|||Uterine Fibroid Pregnancy Registry||Terminated||Phase 4|2360||INC Research|||||f||||||||||||||2017-10-11 05:43:38.694694|2017-10-11 05:43:38.694694
NCT00232726|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-07-09|||September 2005||2005-09-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Clinical Study of Previously Untreated Patients With Malignant Melanoma|A Non-Randomised, Multicentre, Phase II Clinical Study of CP-4055 in Chemotherapy-Naïve Patients With Metastatic Malignant Melanoma|Completed||Phase 2|42|Anticipated|Clavis Pharma|||||f||||t||||||||||2017-10-11 05:43:38.749234|2017-10-11 05:43:38.749234
NCT00232739|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2010-03-11|2009-10-19||September 2003||2003-09-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|November 2004|Actual|2004-11-01||Interventional|||Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions|A Multicenter, Non-Randomized Study of the 2.25mm Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 3|100|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 05:43:38.845594|2017-10-11 05:43:38.845594
NCT00232752|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2009-12-01||2009-11-16|September 2003||2003-09-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|January 2005|Actual|2005-01-01||Interventional|||Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions|A Multicenter, Non-Randomized Study of the 4.0mm Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 3|100|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 05:43:39.397199|2017-10-11 05:43:39.397199
NCT00232765|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2009-09-15|||February 2001||2001-02-01|September 2009|2009-09-01|November 2008|Actual|2008-11-01|May 2002|Actual|2002-05-01||Interventional|||Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)|A Multicenter, Randomized, Double-Blind Study of the Sirolimus-Coated BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions|Completed||Phase 3|1058|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:43:39.502108|2017-10-11 05:43:39.502108
NCT00244660|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2008-01-17|||November 2005||2005-11-01|January 2008|2008-01-01|June 2007||2007-06-01|||||Interventional|||Blood Pressure Reduction in Danish General Practice (BRIDGE)|Blood Pressure Reduction in Danish General Practice (BRIDGE)|Completed||Phase 4|1000||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:45:12.177159|2017-10-11 05:45:12.177159
NCT00232791|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-08-05|||January 2004||2004-01-01|August 2008|2008-08-01|March 2005|Actual|2005-03-01|August 2004|Actual|2004-08-01||Interventional|DOMINO||The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.|A Randomized Study With the CYPHER SELECT™ Sirolimus-Eluting Balloon-Expandable Coronary Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions.|Completed||Phase 2/Phase 3|102|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:43:39.678892|2017-10-11 05:43:39.678892
NCT00232804|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-10-08|||June 2002||2002-06-01|October 2007|2007-10-01|February 2004|Actual|2004-02-01|||||Interventional|||The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent|Safety and Efficacy Registry of Bx Cypher Stent in the Revascularisation of Patients With Significant Risk of Restenosis|Completed||Phase 4|639|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 05:43:39.7984|2017-10-11 05:43:39.7984
NCT00232817|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2011-01-12|||July 2003||2003-07-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|July 2005|Actual|2005-07-01||Interventional|||Anesthesia and Postoperative Pain|Intranasal Nicotine for Postoperative Pain Treatment: A Comparison of Its Effects in the Context of Isoflurane-induced Anesthesia Versus Propofol Anesthesia|Completed||Phase 4|80|Actual|Columbia University||2|||f||||f||||||||||2017-10-11 05:43:39.9812|2017-10-11 05:43:39.9812
NCT00232830|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2009-09-15|||October 2003||2003-10-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|TYPHOON||The Study to Assess AMI Treated With Balloon Angioplasty.|Trial to Assess the Use of the Cypher TM Stent in Acute Myocardial Infarction Treated With Balloon Angioplasty|Completed||Phase 3|715|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:43:40.092132|2017-10-11 05:43:40.092132
NCT00232843|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2009-06-02|||March 2005||2005-03-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|SUPER UK||The Study to Treat Superficial Femoral Artery Occlusions.|A Clinical Investigation of the SMART™ Nitinol Self-Expandable Stent Versus Balloon Angioplasty Only for the Treatment of SUPERficial Femoral Artery Occlusions|Completed||Phase 4|150|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:43:40.195421|2017-10-11 05:43:40.195421
NCT00232856|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-04-29|||December 2002||2002-12-01|April 2008|2008-04-01|August 2006|Actual|2006-08-01|December 2003|Actual|2003-12-01||Interventional|TROPICAL||A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.|A Multi-Center, Non-Randomised Study of the CYPHER™ Sirolimus-Eluting Stent in the Treatment of Patient With an in-Stent Restenotic Native Coronary Artery Lesion|Completed||Phase 4|162|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 05:43:40.300771|2017-10-11 05:43:40.300771
NCT00232869|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2010-02-03|||February 2001||2001-02-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|June 2003|Actual|2003-06-01||Interventional|SIROCCO||A Study of the SMART Stent in the Treatment SFA Disease.|A Clinical Investigation of the SIROlimus Coated Cordis SMART™ Nitinol Selfexpandable Stent for the Treatment of Obstructive Superficial Femoral Artery Disease.|Completed||Phase 2|93|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:43:40.396287|2017-10-11 05:43:40.396287
NCT00232882|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2013-08-30|||December 2003||2003-12-01|August 2013|2013-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.|Neurohumoral and Oxidative Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Essential Hypertensive Patients.|Completed||Phase 4|86|Actual|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-10-11 05:43:40.505517|2017-10-11 05:43:40.505517
NCT00232895|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-03-27||||||March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years||Completed||N/A|||Institute of Child Health|||||f||||||||||||||2017-10-11 05:43:40.628539|2017-10-11 05:43:40.628539
NCT00232908|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2016-11-01|||June 2004||2004-06-01|November 2016|2016-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection|An Open-label Study of a HAART (Highly Active Antiretroviral Therapy) Regimen Containing Subcutaneous Injection of Fuzeon on Quality of Life in Clinically Stable, Treatment-experienced Patients With HIV-1 Infection|Completed||Phase 4|361|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-10-11 05:43:40.69664|2017-10-11 05:43:40.69664
NCT00232921|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2006-12-22||||||December 2006|2006-12-01|February 2003||2003-02-01|||||Interventional|||The Effect of Caudal Volumes on the Anatomical Spread of Caudals in Children||Completed||Phase 1|||Institute of Child Health|||||f||||||||||||||2017-10-11 05:43:41.02303|2017-10-11 05:43:41.02303
NCT00232934|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2005-10-04|||January 2002||2002-01-01|October 2005|2005-10-01|May 2010||2010-05-01|||||Interventional|||Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients|Phase III, Prospective, Open Label, Multicenter, Randomized Trial of Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone as First Line Therapy in Myeloma Patients Aged >65.|Completed||Phase 3|400||Gruppo Italiano per lo Studio del Mieloma Multiplo|||||f||||||||||||||2017-10-11 05:43:41.442579|2017-10-11 05:43:41.442579
NCT00232947|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2007-01-19|||October 2005||2005-10-01|October 2005|2005-10-01|February 2006||2006-02-01|||||Interventional|||Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over|A Non-Inferiority Comparison of Fluviral™ Influenza Vaccine to a U.S. Licensed Inactivated Split-Virion Vaccine (Fluzone®) in Adults ≥ 50 Years Old Living in the Community|Completed||Phase 3|900||ID Biomedical Corporation, Quebec|||||||||||||||||||2017-10-11 05:43:41.543868|2017-10-11 05:43:41.543868
NCT00232960|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2012-03-27|||October 2005||2005-10-01|March 2012|2012-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC|Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Early Stages Oral and Oropharyngeal Squamous Cell Carcinomas: A Prospective Study|Unknown status|Active, not recruiting|N/A|310|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||||||||||||2017-10-11 05:43:41.62981|2017-10-11 05:43:41.62981
NCT00232973|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-02-04|||July 2005||2005-07-01|February 2008|2008-02-01||||||||Interventional|||Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers|A Prospective, Multi-Centre, Double Blind, Randomized, Placebo Controlled Trial to Evaluate the Safety and Efficacy of ICXP007 in a Phase III Trial With Four-Layer Therapeutic Compression, for the Treatment of Non-Infected Skin Leg Ulcers, Due to Venous-Insufficiency|Unknown status|Recruiting|Phase 3|396|Anticipated|Intercytex||3|||f||||t||||||||||2017-10-11 05:43:41.736159|2017-10-11 05:43:41.736159
NCT00233012|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2010-05-24|||June 2005||2005-06-01|May 2010|2010-05-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures|A Randomized, Open-label (OL), Multicenter Study With OL Extension of the Pharmacokinetics and Safety of Topiramate Administered as Oral Liquid and Sprinkle Formulations as an Adjunct to Concurrent Anticonvulsant Therapy in Infants (Aged 1-24 Months, Inclusive) With Refractory Partial-onset Seizures|Completed||Phase 1|16|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:43:42.278687|2017-10-11 05:43:42.278687
NCT00233025|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2007-08-22|||September 2005||2005-09-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Duloxetine Versus Placebo in the Treatment of FMS|Duloxetine 60/120mg Versus Placebo in the Treatment of Fibromyalgia Syndrome|Completed||Phase 3|320||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:43:42.368468|2017-10-11 05:43:42.368468
NCT00233038|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2013-10-28|||January 2005||2005-01-01|October 2013|2013-10-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial|EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial|Completed||Phase 2/Phase 3|50|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-10-11 05:43:42.55777|2017-10-11 05:43:42.55777
NCT00233051|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-03-27|||April 2003||2003-04-01|March 2017|2017-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Evaluating Genes in Sputum to Measure Drug Response in COPD|Expression of Inflammatory Mediators in Induced Sputum: A Potential Biomarker of Drug Response in COPD|Terminated||N/A|20|Actual|National Jewish Health|||||f||||||||||||||2017-10-11 05:43:42.675937|2017-10-11 05:43:42.675937
NCT00233064|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2010-01-07|2008-10-02||October 2005||2005-10-01|January 2010|2010-01-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)|A Phase IV, Randomized, Double-Blind Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) in Children at High Risk for the Development of Serious RSV Disease|Completed||Phase 4|417|Actual|MedImmune LLC|Only serious adverse events were collected as part of the safety evaluation. One death (asphyxia) occurred in the Lyophilized Palivizumab group; this event was judged not related to study drug.|2|||f||||f||||||||||2017-10-11 05:43:42.837415|2017-10-11 05:43:42.837415
NCT00233077|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2013-12-02|||October 2006||2006-10-01|December 2013|2013-12-01|January 2011|Actual|2011-01-01|June 2010|Actual|2010-06-01||Interventional|||Patient Centered Randomized Controlled Trial|Patient Assistance to Reduce Breast Cancer Disparities|Completed||N/A|374|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 05:43:43.779275|2017-10-11 05:43:43.779275
NCT00233090|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2016-03-16|2013-08-07||July 2005||2005-07-01|March 2016|2016-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment|Post-TBI Fatigue and Its Treatment|Terminated||Phase 2|21|Actual|Icahn School of Medicine at Mount Sinai|Study was terminated due to insufficient recruitment. Data analysis not available.|2||Insufficient recruitment|f||||||||||||||2017-10-11 05:43:43.901378|2017-10-11 05:43:43.901378
NCT00233103|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2015-10-14|2013-07-29||June 2003||2003-06-01|October 2015|2015-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Post-Traumatic Brain Injury (TBI) Depression|Treatment of Post-TBI Depression|Completed||Phase 2|52|Actual|Icahn School of Medicine at Mount Sinai|"Sample size was small - those who dropped out could have reduced the differential effect.
Sample was heterogeneous for severity and time since injury."|2|||f||||t||||||||||2017-10-11 05:43:44.215118|2017-10-11 05:43:44.215118
NCT00233129|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2013-09-23|||October 2005||2005-10-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||"Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the Executive Plus Program"|"Improving Executive Functions After TBI: A Randomized Clinical Trial of the Executive Plus Program"|Completed||N/A|77|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-10-11 05:43:44.835351|2017-10-11 05:43:44.835351
NCT00233142|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2016-04-13|||September 2005||2005-09-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients|Expressive Writing: Complementary Treatment for Diabetes|Completed||Phase 2|187|Actual|Syracuse University||2|||f||||t||||||||||2017-10-11 05:43:44.958401|2017-10-11 05:43:44.958401
NCT00233155|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2008-03-04|||August 2005||2005-08-01|March 2008|2008-03-01|December 2006||2006-12-01|||||Interventional|||Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)|A Multicenter, Open-Label, Phase 2 Study of NGX-4010 for the Treatment of Neuropathic Pain in Patients With Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)|Completed||Phase 2|100||NeurogesX|||||||||||||||||||2017-10-11 05:43:45.120897|2017-10-11 05:43:45.120897
NCT00233168|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2014-06-24|||September 2003||2003-09-01|June 2014|2014-06-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|||Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents|Promoting Adherence to TB Regimens in High Risk Youth|Completed||N/A|263|Actual|San Diego State University||2|||f||||t||||||||||2017-10-11 05:43:45.208048|2017-10-11 05:43:45.208048
NCT00233181|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2016-02-17|||April 2000||2000-04-01|December 2005|2005-12-01|March 2005|Actual|2005-03-01|||||Interventional|||Adherence Intervention for Minority Children With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:43:45.298963|2017-10-11 05:43:45.298963
NCT00233194|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2016-12-03|||January 2005||2005-01-01|December 2016|2016-12-01|July 2011|Actual|2011-07-01|November 2009|Actual|2009-11-01||Observational|||Identification of Sleep-Disordered Breathing in Children|Identification of Sleep-Disordered Breathing in Children|Completed||N/A|160|Actual|University of Michigan|||1||f||||f||||||||||2017-10-11 05:43:45.359164|2017-10-11 05:43:45.359164
NCT00233207|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-05-12|||September 2005||2005-09-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||IC14 Antibodies to Treat Individuals With Acute Lung Injury|Acute Lung Injury Clinical Trials Incubator Unit|Terminated||Phase 2|13|Actual|University of Washington||||Unable to meet enrollment number to complete study, study stopped June 30, 2007|f||||||||||||||2017-10-11 05:43:45.460936|2017-10-11 05:43:45.460936
NCT00233220|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2014-02-12|||September 2004||2004-09-01|February 2014|2014-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Blood Pressure Control in African Americans|Multi-site Randomized Controlled Trial for Blood Pressure Control in Hypertensive African Americans|Completed||N/A|1039|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-10-11 05:43:45.535881|2017-10-11 05:43:45.535881
NCT00233285|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2016-07-11|||September 1999||1999-09-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Factors in Childhood Lung Susceptibility to Pollution||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:43:46.08484|2017-10-11 05:43:46.08484
NCT00233298|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-10-05|||May 26, 2005||2005-05-26|January 2, 2015|2015-01-02|January 2, 2015||2015-01-02|||||Observational|||A Study of the Function of Hormones Present In Taste Buds|A Study of the Function of Hormones Present In Taste Buds|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:43:46.157946|2017-10-11 05:43:46.157946
NCT00233311|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2012-08-03|||March 2004||2004-03-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers|Assessment of the Postprandial Effects of a Fast-food on Inflammatory Markers|Completed||N/A|61|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||f||||||Samples With DNA|"     Serum, Whole Blood   "|||2017-10-11 05:43:46.243798|2017-10-11 05:43:46.243798
NCT00233324|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-06-19|2014-11-16||February 2005||2005-02-01|June 2017|2017-06-01|August 2016|Actual|2016-08-01|February 2009|Actual|2009-02-01||Interventional|SUPPORT||Surfactant Positive Airway Pressure and Pulse Oximetry Trial|Surfactant Positive Airway Pressure and Pulse Oximetry Trial (SUPPORT) in Extremely Low Birth Weight Infants|Completed||Phase 3|1316|Actual|NICHD Neonatal Research Network||4|||f||||t||||||||||2017-10-11 05:43:46.352288|2017-10-11 05:43:46.352288
NCT00233337|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2012-04-25|||May 2001||2001-05-01|April 2012|2012-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers|Open-label, Multi-center, Non-comparative Efficacy, Safety, and Tolerability Study of Co-artemether in the Treatment of Acute Uncomplicated Malaria in Non-immune Patients|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-10-11 05:43:46.972214|2017-10-11 05:43:46.972214
NCT00233350|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2015-09-30|||January 2007||2007-01-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study|Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study|Completed||N/A|142|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-10-11 05:43:47.035884|2017-10-11 05:43:47.035884
NCT00233363|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-05-25|||March 2005||2005-03-01|May 2007|2007-05-01|January 2006||2006-01-01|||||Interventional|||Exploratory Study for Dry Mouth in Patients With Sjögren’s Syndrome|An Exploratory Study of Rebamipide to Evaluate Efficacy and Safety in the Treatment of Dry Mouth in Patients With Sjögren’s Syndrome|Completed||Phase 2|100||Otsuka Pharmaceutical Co., Ltd.|||||f||||||||||||||2017-10-11 05:43:47.108789|2017-10-11 05:43:47.108789
NCT00233376|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2006-07-17|||May 2004||2004-05-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Interventional|||Computerized Decision Support System for Antibiotic Treatment|Improving Empirical Antibiotic Treatment Using TREAT,a Computerized Decision Support System. Cluster Randomized Trial|Completed||Phase 3|1500||Rabin Medical Center|||||f||||||||||||||2017-10-11 05:43:47.174163|2017-10-11 05:43:47.174163
NCT00233389|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-05-25|||January 2004||2004-01-01|May 2007|2007-05-01|September 2005||2005-09-01|||||Interventional|||Post-Marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer|A Post-Marketing Clinical Study of Rebamipide to Investigate the Gastric Ulcer Healing Effect of Continued Dosing Following Helicobacter Pylori Eradication Therapy|Completed||Phase 4|300||Otsuka Pharmaceutical Co., Ltd.|||||f||||||||||||||2017-10-11 05:43:47.257044|2017-10-11 05:43:47.257044
NCT00233402|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2013-08-05|2013-08-05||January 2005||2005-01-01|August 2013|2013-08-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy|A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer|Completed||Phase 3|789|Actual|Photocure||2|||f||||t||||||||||2017-10-11 05:43:47.33114|2017-10-11 05:43:47.33114
NCT00233415|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2010-06-01|||July 2003||2003-07-01|June 2010|2010-06-01|May 2007|Actual|2007-05-01|March 2006|Actual|2006-03-01||Interventional|||Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer|Phase II Study to Evaluate the Efficacy of Conventional Chemoradiotherapy Followed by Stereotactic Radiosurgery for Locally Advanced Pancreatic Cancer|Completed||Phase 2|100|Actual|Stanford University||1|||f||||||||||||||2017-10-11 05:43:47.924389|2017-10-11 05:43:47.924389
NCT00233428|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2015-05-11|||May 2005||2005-05-01|May 2015|2015-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Study to Determine Racial and Gender Differences in Platelet Aggregation|Phase 1 Study to Determine Racial and Gender Differences in Platelet Aggregation|Completed||Phase 1|60||Texas Tech University Health Sciences Center|||||f||||||||||||||2017-10-11 05:43:47.985671|2017-10-11 05:43:47.985671
NCT00233441|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2012-05-07|||December 2004||2004-12-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|MAIA||Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter|Placebo Controlled Double Blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200, or 300 mg OD, With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter|Completed||Phase 2/Phase 3|673|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:43:48.042681|2017-10-11 05:43:48.042681
NCT00233454|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-06-27|2015-06-16||March 2005||2005-03-01|June 2017|2017-06-01|December 2017|Anticipated|2017-12-01|June 21, 2010|Actual|2010-06-21||Interventional|||Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia|A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of Twice Daily Oral Dosing of PKC412 <Midostaurin> Administered to Patients With Aggressive Systemic Mastocytosis (ASM) and Mast Cell Leukemia (MCL)|Active, not recruiting||Phase 2|26|Actual|Stanford University||1|||f||||t||||||||No||2017-10-11 05:43:48.154167|2017-10-11 05:43:48.154167
NCT00233662|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2005-10-04|||December 2002||2002-12-01|October 2005|2005-10-01|June 2005||2005-06-01|||||Interventional|||Safety and Tolerability of Repeat Courses of IM Alefacept|An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Repeat Courses of Intramuscular Administration of Alefacept (LFA-3/IgG1 Fusion Protein) in Patients With Chronic Plaque Psoriasis|Completed||Phase 3|400||Biogen|||||||||||||||||||2017-10-11 05:43:51.403816|2017-10-11 05:43:51.403816
NCT00233467|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-09-12|||September 1, 2005|Actual|2005-09-01|September 2017|2017-09-01|September 30, 2005|Actual|2005-09-30|September 30, 2005|Actual|2005-09-30||Observational|||Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade|Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade|Withdrawn||N/A|0|Actual|Tuscaloosa Research & Education Advancement Corporation|||1|Funding expired; no subjects enrolled as this was a retrospective chart review|f||||||||||||||2017-10-11 05:43:48.838535|2017-10-11 05:43:48.838535
NCT00233480|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2012-03-29|||August 2005||2005-08-01|March 2012|2012-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Statin Therapy in Heart Failure: Potential Mechanisms of Benefit|A Double-blind Randomized, Placebo-Controlled, Single-Center Study to Assess the Impact of Statins on the Autonomic Nervous System and Cardiac Structure/Function in Non-Ischemic Heart Failure|Completed||Phase 4|27|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 05:43:48.919434|2017-10-11 05:43:48.919434
NCT00233493|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2005-10-03|||March 2005||2005-03-01|November 2004|2004-11-01|February 2006||2006-02-01|||||Observational|||Spread of Dermatophytes Among Families|Demonstration of the Spread of Dermatophytes Through Casual Contact Among Family Household Members|Unknown status|Recruiting|N/A|150||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-10-11 05:43:49.038071|2017-10-11 05:43:49.038071
NCT00233506|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-02-02|||July 2004||2004-07-01|February 2017|2017-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated|A Dose-Finding Study of CpG 7909 in Previously Treated Chronic Lymphocytic Leukemia|Completed||Phase 1|41|Actual|University of Iowa||2|||f||||||||||||||2017-10-11 05:43:49.118969|2017-10-11 05:43:49.118969
NCT00233519|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2012-06-20|2009-08-13||November 2005||2005-11-01|June 2012|2012-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)|Effects of SomatoKine (Iplex) (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)|Completed||Phase 1/Phase 2|17|Actual|University of Rochester||2|||f||||t||||||||||2017-10-11 05:43:49.219516|2017-10-11 05:43:49.219516
NCT00233532|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-07-18|||March 2004||2004-03-01|July 2008|2008-07-01||||June 2005|Actual|2005-06-01||Interventional|TRAIL||Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)|A Prospective, Open-Label Study to Evaluate the Effect of an Escalating Dose Regimen of Trandolapril on Blood Pressure in Treatment-Naïve and Concurrently Treated Hypertensive Patients (TRAIL)|Completed||Phase 4|2000|Actual|Abbott||3|||f||||f||||||||||2017-10-11 05:43:49.800302|2017-10-11 05:43:49.800302
NCT00233545|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-28|2010-05-29|||September 2005||2005-09-01|May 2010|2010-05-01|September 2007||2007-09-01|||||Interventional|||Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia|Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia|Completed||Phase 2|80||AB Foundation|||||f||||||||||||||2017-10-11 05:43:49.91769|2017-10-11 05:43:49.91769
NCT00233558|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2007-04-23|||June 2005||2005-06-01|April 2007|2007-04-01||||||||Interventional|||Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis|Multicentre, Randomised, Open Label Study Comparing a “Scheduled Steroid Reduction Strategy” Versus a Free Steroid Reduction Strategy (Physician’s Usual Practice for Reducing Steroids) in Patients With Active RA Treated With Humira 40 mg Eow + MTX During 9 Months|Terminated||Phase 4|160||Abbott||||Study terminated due to low subject enrollment. Safety results consistent with product label.|f||||||||||||||2017-10-11 05:43:50.011875|2017-10-11 05:43:50.011875
NCT00233571|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-11-21|||June 2000||2000-06-01|November 2011|2011-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis|A Multi-Centre Open Label Continuation Study With Subcutaneous D2E7 (Adalimumab) for Patients With Rheumatoid Arthritis Who Completed a Preceding Clinical Study With D2E7 (Adalimumab)|Completed||Phase 3|796|Actual|Abbott||1|||f||||f||||||||||2017-10-11 05:43:50.123533|2017-10-11 05:43:50.123533
NCT00233584|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-01-11|||July 2001||2001-07-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Pulmicort Asthma Prevention (Post-PAC)|A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC)|Completed||N/A|400||AstraZeneca|||||f||||||||||||||2017-10-11 05:43:50.213451|2017-10-11 05:43:50.213451
NCT00233597|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2009-02-26|||August 2004||2004-08-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Interventional|||Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients|A Phase III Study of the Safety and Efficacy of Ferumoxytol (Compared With Oral Iron) as an Iron Replacement Therapy in Hemodialysis Patients Who Are Receiving Supplemental EPO Therapy|Completed||Phase 3|230||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 05:43:50.325701|2017-10-11 05:43:50.325701
NCT00233610|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2011-01-25|||December 2003||2003-12-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer|A Comparative Trial of the Efficacy of Two Different Nolvadex (NDX) Dosing and Scheduling Regimens in Preventing Gynecomastia Induced by Casodex (CDX) 150 Monotherapy in Prostate Cancer Patients. An Open, Multicenter, Phase III Trial.|Completed||Phase 3|180||AstraZeneca|||||f||||||||||||||2017-10-11 05:43:50.54825|2017-10-11 05:43:50.54825
NCT00233623|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2011-01-25|||July 2004||2004-07-01|January 2011|2011-01-01|January 2006|Anticipated|2006-01-01|January 2006|Anticipated|2006-01-01||Interventional|||Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer|A Randomised, Non-Comparative, Multicentre, Phase II, Parallel-Group Trial Of ZD1839 (Iressa™) In Combination With 5 Fluorouracil, Leucovorin And Cpt-11 (Irinotecan) In Patients With Metastatic Colorectal Cancer|Withdrawn||Phase 2|190||AstraZeneca|||||f||||||||||||||2017-10-11 05:43:50.66986|2017-10-11 05:43:50.66986
NCT00233636|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2011-01-25|||July 2003||2003-07-01|January 2011|2011-01-01||||||||Interventional|||Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck|A 2 Part Phase 2 Trial to Evaluate ZD1839 (Iressa™) & Radiotherapy in Patients w/Locally Advanced Inoperable Squamous Cell Carcinoma of the Head & Neck|Withdrawn||Phase 2|28||AstraZeneca|||||f||||||||||||||2017-10-11 05:43:50.789195|2017-10-11 05:43:50.789195
NCT00233649|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2010-11-18|||May 2004||2004-05-01|November 2010|2010-11-01||||||||Observational|||DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines|DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines|Completed||Phase 4|2500||AstraZeneca|||1||f||||||||||||||2017-10-11 05:43:50.925243|2017-10-11 05:43:50.925243
NCT00233675|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2014-05-08|||August 2003||2003-08-01|May 2014|2014-05-01||||February 2005|Actual|2005-02-01||Interventional|||Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder|A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety of GABITRIL at Dosages up to 16mg/Day in Adults With Generalized Anxiety Disorder|Completed||Phase 3|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-10-11 05:43:51.796898|2017-10-11 05:43:51.796898
NCT00233688|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-04-30|||November 2001||2001-11-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|December 2004|Actual|2004-12-01||Interventional|||Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)|A Prospective, Multicenter Study of the Cordis Endovascular QUANTUM LP™ Stent Graft System for the Treatment of Abdominal Aortic Aneurysms (AAA)-FORTRON|Completed||Phase 3|300|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:43:51.913417|2017-10-11 05:43:51.913417
NCT00233701|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2010-02-05|||October 2004||2004-10-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Normal Pressure Hydrocephalus (NPH) Registry|Normal Pressure Hydrocephalus (NPH) Registry|Completed||Phase 4|343|Actual|Codman & Shurtleff|||1||f||||f||||||||||2017-10-11 05:43:51.994088|2017-10-11 05:43:51.994088
NCT00233714|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2009-11-17|||May 2003||2003-05-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|July 2004|Actual|2004-07-01||Interventional|3D||Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions|A Randomized Feasibility Study of the Double Dose or Single Dose Sirolimus-Eluting BX VELOCITY Balloon-Expandable Stent for the Treatment of Diabetic Patients With de Novo Native Coronary Artery Lesions(3D)|Completed||Phase 1/Phase 2|56|Actual|Cordis Corporation||2|||f||||f||||||||||2017-10-11 05:43:52.120346|2017-10-11 05:43:52.120346
NCT00233727|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2015-07-07|||January 2000||2000-01-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|April 2006|Actual|2006-04-01||Interventional|SAT||Screen and Treat for Cervical Cancer Prevention|Safety and Efficacy of Two Screen-and-Treat Approaches for the Prevention of Cervical Cancer|Terminated||Phase 3|7123|Actual|Columbia University||3||PI left University|f||||f||||||||||2017-10-11 05:43:52.237458|2017-10-11 05:43:52.237458
NCT00233740|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-08-04|||September 2003||2003-09-01|August 2008|2008-08-01|May 2005|Actual|2005-05-01|||||Interventional|||Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)|The Cordis Protection From Pulmonary Embolism With the Permanent OptEase™ Filter - A Post Marketing Surveillance Study (PROOF Study)|Completed||Phase 4|150||Cordis Corporation|||||f||||f||||||||||2017-10-11 05:43:52.355549|2017-10-11 05:43:52.355549
NCT00233753|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-01-05|||January 2004||2004-01-01|January 2009|2009-01-01|December 2005||2005-12-01|||||Interventional|||Study of the Enterprise Self-Expanding Stent System With Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms|Cordis Neurovascular Feasibility Study of the Enterprise Self-Expanding Stent System to Facilitate Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms|Completed||Phase 1|30||Codman & Shurtleff|||||||||||||||||||2017-10-11 05:43:52.435833|2017-10-11 05:43:52.435833
NCT00233766|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-04-17|||September 2002||2002-09-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)|An Evaluation of Two Reduced Sirolimus Doses on the BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions(REDOX)|Completed||Phase 1/Phase 2|60||Cordis Corporation|||||f||||f||||||||||2017-10-11 05:43:52.491524|2017-10-11 05:43:52.491524
NCT00233779|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-06-26|||October 2003||2003-10-01|June 2007|2007-06-01|December 2004|Actual|2004-12-01|||||Interventional|||Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)|Sirolimus-Eluting, Heparin-Coated Cobalt Chromium Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions in Small Vessels (EVOLUTION)|Completed||Phase 2|52|Actual|Cordis Corporation||1|||f||||f||||||||||2017-10-11 05:43:52.569038|2017-10-11 05:43:52.569038
NCT00233792|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-10-11|||December 1999||1999-12-01|October 2007|2007-10-01|March 2005|Actual|2005-03-01|||||Interventional|||FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent|An Evaluation of the Sirolimus Coated Modified BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo or Restenotic Native Coronary Artery Lesions.|Completed||Phase 1/Phase 2|30|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:43:52.639935|2017-10-11 05:43:52.639935
NCT00233805|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-08-05|||August 2000||2000-08-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|||||Interventional|RAVEL||The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.|A Randomized Study With the Sirolimus Coated Modified BX Velocity Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 2|220|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:43:52.725646|2017-10-11 05:43:52.725646
NCT00233818|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-10-11|||February 2000||2000-02-01|October 2007|2007-10-01|June 2005|Actual|2005-06-01|||||Interventional|||FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent|An Evaluation of Sirolimus-Coated Modified BX VELOCITY Balloon-Expandable Stents for the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 1/Phase 2|15|Actual|Cordis Corporation||1|||f||||t||||||||||2017-10-11 05:43:52.825023|2017-10-11 05:43:52.825023
NCT00233831|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2011-02-25|||March 2004||2004-03-01|February 2011|2011-02-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Millimeter Wave Therapy (MWT) for Analgesia After Total Knee Replacement|Millimeter Wave Therapy (MWT) Versus Placebo for Analgesia and Wound Healing After Elective Total Knee Arthroplasty - a Randomized Controlled Trial|Completed||Phase 2/Phase 3|80||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:43:52.912737|2017-10-11 05:43:52.912737
NCT00233844|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2005-10-05|||February 2004||2004-02-01|October 2005|2005-10-01||||||||Interventional|||"Studying the Analgesic Mechanism of the Cough-Trick"|"Studying the Analgesic Mechanism of the Cough-Trick - Randomized Crossover Volunteer Study"|Completed||Phase 2|21||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:43:52.975506|2017-10-11 05:43:52.975506
NCT00233857|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2011-02-25|||August 2003||2003-08-01|February 2011|2011-02-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||Auricular Acupuncture for Pain Relief After Ambulatory Knee Arthroscopy|Auricular Acupuncture Versus Placebo (Sham Acupuncture) for Postoperative Pain Relief After Ambulatory Knee Arthroscopy - a Randomized Controlled Trial|Completed||Phase 2/Phase 3|120||University Medicine Greifswald|||||f||||||||||||||2017-10-11 05:43:53.037515|2017-10-11 05:43:53.037515
NCT00245700|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2008-05-22|||April 2005||2005-04-01|May 2008|2008-05-01|July 2006|Actual|2006-07-01|||||Observational|||Adherence of Stalevo, Entacapone and Levodopa|Study of Adherence of Stalevo, Entacapone and Levodopa|Completed||N/A|14||South Glasgow University Hospitals NHS Trust|||||f||||||||||||||2017-10-11 05:45:24.333486|2017-10-11 05:45:24.333486
NCT00233870|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2015-05-07|||June 2004||2004-06-01|May 2015|2015-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.|Special Survey in Long-Term Use of Fabrazyme|Completed||Phase 4|405|Actual|Sanofi|||1||f||||||||||||||2017-10-11 05:43:53.110005|2017-10-11 05:43:53.110005
NCT00233883|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2015-11-02|||August 2005||2005-08-01|November 2015|2015-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.|An Open-label Study of the Tolerability of a Subcutaneous Needle-free Injection Device Used to Administer Fuzeon, Compared With the Standard Needle/Syringe Supplied With Commercial Fuzeon in HIV-1 Infected, ARV Treatment-experienced Adults|Completed||Phase 4|58|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:43:53.179845|2017-10-11 05:43:53.179845
NCT00233896|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2005-10-04|||July 2001||2001-07-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD|A Randomized, Placebo-Controlled, Multi-Center Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal Graft Vs. Host Disease|Completed||Phase 3|130||Enteron Pharmaceuticals|||||||||||||||||||2017-10-11 05:43:54.892447|2017-10-11 05:43:54.892447
NCT00233909|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-03-28|||October 2005||2005-10-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia|An Open-Label, Phase I/II Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|55|Anticipated|Kanisa Pharmaceuticals|||||||||||||||||||2017-10-11 05:43:54.993837|2017-10-11 05:43:54.993837
NCT00233922|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2008-05-12|||July 2004||2004-07-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant|Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant|Completed||Phase 2|80|Anticipated|National University Hospital, Singapore|||||f||||||||||||||2017-10-11 05:43:55.06708|2017-10-11 05:43:55.06708
NCT00233935|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2014-09-10|||November 2005||2005-11-01|April 2013|2013-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus|Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients With Barrett's Esophagus|Completed||Phase 1|55|Actual|National Cancer Institute (NCI)||4|||f||||f||||||||||2017-10-11 05:43:55.139109|2017-10-11 05:43:55.139109
NCT00233948|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2015-03-30|2015-02-02||March 2006||2006-03-01|March 2015|2015-03-01||||July 2013|Actual|2013-07-01||Interventional|||Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma|A Phase I/II Study of Nelfinavir in Liposarcoma|Terminated||Phase 1/Phase 2|29|Actual|City of Hope Medical Center|After 12 patients were accrued to the Phase II portion, the study was terminated…protocol objectives for the Phase II portion not met. Closed prematurely due to drug availability issues.|1||Drug availability issues|f||||t||||||||||2017-10-11 05:43:55.252562|2017-10-11 05:43:55.252562
NCT00233961|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2013-02-01|||January 2005||2005-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission|Peripheral Blood Stem Cell Mobilization With Filgrastim in Patients With Chronic Myeloid Leukemia in Cytogenetic Response|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:43:57.594097|2017-10-11 05:43:57.594097
NCT00233974|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2012-03-05|||May 2002||2002-05-01|March 2012|2012-03-01|March 2006|Actual|2006-03-01|February 2005|Actual|2005-02-01||Interventional|||Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery|Axillary Lymph Nodes and PET (Positron Emission Tomography) Probe-Guided Surgical Resection in Locally Advanced Breast Cancer Patients: Molecular Marker Profile and Response to Neoadjuvant Chemotherapy|Completed||Phase 2|15|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 05:43:57.677402|2017-10-11 05:43:57.677402
NCT00233987|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2017-03-16|2013-01-02||October 2005||2005-10-01|March 2017|2017-03-01|July 2017|Anticipated|2017-07-01|November 2014|Actual|2014-11-01||Interventional|||S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma|Tandem Autologous Stem Cell Transplantation for Patients With Primary Progressive or Recurrent Hodgkin's Disease (A BMT Study), Phase II|Active, not recruiting||Phase 2|98|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-10-11 05:43:57.799105|2017-10-11 05:43:57.799105
NCT00234000|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2015-09-30|||February 2007||2007-02-01|August 2012|2012-08-01||||February 2009|Actual|2009-02-01||Interventional|||Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes|A Phase I Multicenter Study of Arsenic Trioxide and Azacitidine in Patients With Myelodysplastic Syndromes|Terminated||Phase 1|1|Actual|Jonsson Comprehensive Cancer Center||1||The study was closed due to poor enrollment|f||||t||||||||||2017-10-11 05:43:58.66307|2017-10-11 05:43:58.66307
NCT00234026|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma|Master Protocol for Mantle Cell Lymphoma A Multicenter Phase II Trial Testing Gemcitabine for the Treatment of Patients With Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma|Completed||Phase 2|||Swiss Group for Clinical Cancer Research|||||f||||t||||||||||2017-10-11 05:43:58.761332|2017-10-11 05:43:58.761332
NCT00234039|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2015-12-08|2012-11-19||November 2006||2006-11-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|November 2011|Actual|2011-11-01||Interventional|||S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin|Phase II Study of Intravesical Gemcitabine in Patients With Superficial Bladder Cancer Who Have Progressed Despite Intravesical BCG|Completed||Phase 2|58|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-10-11 05:43:58.895374|2017-10-11 05:43:58.895374
NCT00234052|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2015-08-10|||June 2005||2005-06-01|August 2015|2015-08-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|50|Actual|Northwestern University||1|||f||||||||||||||2017-10-11 05:43:59.532188|2017-10-11 05:43:59.532188
NCT00234065|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2011-06-09|2011-04-19||December 2003||2003-12-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)|Post-marketing Study of Cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison With Aspirin|Completed||Phase 4|2800|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-10-11 05:43:59.688279|2017-10-11 05:43:59.688279
NCT00234078|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2014-01-20|2014-01-20||January 2005||2005-01-01|January 2014|2014-01-01|March 2007|Actual|2007-03-01|April 2006|Actual|2006-04-01||Interventional|||Dose-response Study of OPC-12759 Ophthalmic Suspension|Dose-response Study of OPC-12759 Ophthalmic Suspension|Completed||Phase 2|290|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-10-11 05:44:01.692103|2017-10-11 05:44:01.692103
NCT00234091|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2013-12-02|||April 2006||2006-04-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)|An Open Label, Randomized Study to Compare Antiretroviral Therapy (ART) Initiation When CD4 is Between 15% to 24% to ART Initiation When CD4 Falls Below 15% in Children With HIV Infection and Moderate Immune Suppression|Completed||Phase 3|300|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-10-11 05:44:02.554939|2017-10-11 05:44:02.554939
NCT00234104|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2013-11-06|2013-11-01||August 2004||2004-08-01|November 2013|2013-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional||1 Subject of each arm were excluded form the analysis set because emergency codes were lost.|A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Dose Response of OPC-41061 in Congestive Heart Failure Patients With Extracellular Volume Expansion|Completed||Phase 2|122|Actual|Otsuka Pharmaceutical Co., Ltd.|||||f||||f||||||||||2017-10-11 05:44:02.767099|2017-10-11 05:44:02.767099
NCT00234117|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2011-07-20|||July 2005||2005-07-01|October 2005|2005-10-01||||||||Interventional|||Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression|Overall Assessment of Improvement in Bronchial Asthma Patients With Extraesophageal Reflux After Effective Acid Suppression|Completed||N/A|40|Anticipated|Ponce Gastroenterology Research|||||f||||||||||||||2017-10-11 05:44:03.605365|2017-10-11 05:44:03.605365
NCT00234130|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-06-02|||July 2002||2002-07-01|June 2009|2009-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure|A Comparison of the Effects of Conventional and Nocturnal Hemodialysis on the Inflammatory Response of Chronic Renal Failure|Terminated||N/A|20||Rockefeller University||||The patient population was not enough to complete enrollment|f||||f||||||||||2017-10-11 05:44:03.724894|2017-10-11 05:44:03.724894
NCT00234143|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2009-03-11|||October 2004||2004-10-01|March 2009|2009-03-01||||||||Interventional|||Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)|A Randomised Controlled Trial of Prolonged Treatment With Darbepoetin Alpha With or Without Recombinant Human Granulocyte Colony Stimulating Factor (G-CSF) Versus Best Supportive Care in Patients With Low-Risk Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2/Phase 3|360|Anticipated|St. Bartholomew's Hospital||3|||f||||t||||||||||2017-10-11 05:44:03.829543|2017-10-11 05:44:03.829543
NCT00234156|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2012-01-10|||September 2004||2004-09-01|January 2012|2012-01-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers|Sensitivity to Fructose-Induced Palmitate Synthesis in End-Stage Renal Disease|Completed||N/A|30|Actual|Rockefeller University||2|||f||||f||||||||||2017-10-11 05:44:03.956947|2017-10-11 05:44:03.956947
NCT00234169|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2012-05-09|||October 2005||2005-10-01|May 2012|2012-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone|A Phase I/II Study of Peripheral Blood Progenitor Cells Mobilisation With VTP195183 Plus G-CSF Compared to Mobilisation With G-CSF Alone in Patients With Multiple Myeloma and Lymphoma.|Completed||Phase 1/Phase 2|30|Actual|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-10-11 05:44:04.074567|2017-10-11 05:44:04.074567
NCT00234182|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2005-11-29|||January 2000||2000-01-01|October 2005|2005-10-01|December 2004||2004-12-01|||||Interventional|||Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC|Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of Hepatocellular Carcinoma: a Randomized Controlled Trial|Completed||Phase 1/Phase 2|84||The University of Hong Kong|||||f||||||||||||||2017-10-11 05:44:04.148934|2017-10-11 05:44:04.148934
NCT00234195|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-04-16|||September 2005||2005-09-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Wellbutrin XL, Major Depressive Disorder and Breast Cancer|A Pilot Study of the Efficacy and Tolerability of Bupropion Extended Release (Wellbutrin XL) for the Treatment of Major Depressive Disorder in Women With Breast Cancer|Completed||Phase 4|25||Thomas Jefferson University|||||f||||f||||||||||2017-10-11 05:44:04.221187|2017-10-11 05:44:04.221187
NCT00234208|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2016-05-23|||October 2005||2005-10-01|May 2016|2016-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Early Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusion and Pleural Empyema|A Randomized Controlled Study of Early Mini-invasive Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusions or Pleural Empyema - ESMITE (European Study on Mini-invasive Thoracoscopy in Empyema)|Terminated||Phase 3|2|Actual|University Hospital, Basel, Switzerland||2||insufficient enrollment|f||||f||||||||||2017-10-11 05:44:04.296357|2017-10-11 05:44:04.296357
NCT00234221|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2016-04-11|||November 2005||2005-11-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Project Health Link: Connecting Patients With Services|Services Interventions for Injured ED Problem Drinkers|Completed||N/A|686|Actual|University of Michigan||3|||f||||f||||||||No||2017-10-11 05:44:04.396424|2017-10-11 05:44:04.396424
NCT00234234|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2012-02-08|||January 2006||2006-01-01|February 2012|2012-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Predictors of the Response to Adalimumab in Rheumatoid Arthritis|Predictors of the Response to Adalimumab in Rheumatoid Arthritis|Completed||Phase 4|200|Actual|University Hospital, Rouen||1|||f||||||||||||||2017-10-11 05:44:04.476788|2017-10-11 05:44:04.476788
NCT00234247|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2016-05-12|||December 2002||2002-12-01|May 2016|2016-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Prolonged Outcomes After Nitric Oxide (PrONOx)|Study of the Long-term Outcomes of Nitric Oxide for Ventilated Premature Babies|Completed||Phase 3|652|Actual|University of Pittsburgh|||1||f||||t||||||||No||2017-10-11 05:44:04.547888|2017-10-11 05:44:04.547888
NCT00234260|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2008-07-15|||April 1995||1995-04-01|October 2005|2005-10-01||||||||Observational|||Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)|Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)|Terminated||N/A|||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-10-11 05:44:04.619903|2017-10-11 05:44:04.619903
NCT00234273|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-05|2013-06-18|||November 2004||2004-11-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||APAD2: Effects of Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics|Effects Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics Persons|Terminated||Phase 2|10|Actual|University Hospital, Grenoble||2||recrutment|f||||f||||||||||2017-10-11 05:44:04.692581|2017-10-11 05:44:04.692581
NCT00234286|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2015-04-23|2015-01-13||August 2005||2005-08-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|March 2011|Actual|2011-03-01||Interventional|BEACON|Deceased veterans|Intervention to Improve Care at Life's End|Intervention to Improve Care at Life's End in VA Medical Centers|Completed||N/A|78|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-10-11 05:44:04.798788|2017-10-11 05:44:04.798788
NCT00234299|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2016-05-24|||December 2005||2005-12-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of ASA on Prostate Tissue|In Vivo Molecular Effects of Aspirin on Prostate Tissue|Completed||N/A|60|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-11 05:44:05.328888|2017-10-11 05:44:05.328888
NCT00234312|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2006-09-07|||September 2005||2005-09-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Interventional|||Medications for the Treatment of Dysthymic Disorder and Double Depression|Escitalopram Vs. Sertraline in the Treatment of Dysthymic Disorder and Double Depression|Unknown status|Active, not recruiting|Phase 4|40||Oregon Health and Science University|||||f||||||||||||||2017-10-11 05:44:05.41564|2017-10-11 05:44:05.41564
NCT00234338|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-12-07|||October 2005||2005-10-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Observational|||Study Evaluating Prevenar in High-Risk Children|Prospective Post-Marketing Surveillance Study of Prevenar in High-Risk Children Aged 2 to 5 Years|Completed||N/A|5000|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:44:05.658628|2017-10-11 05:44:05.658628
NCT00239876|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2011-11-01|||May 2005||2005-05-01|November 2011|2011-11-01||||December 2005|Actual|2005-12-01||Interventional|||Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|A Two-year Extension to a One-year, Multicenter, Open-label, Randomised Study to Evaluate the Safety and Efficacy of FTY720 Combined With Tacrolimus and Steroids Versus Mycophenolate Mofetyl Combined With Tacrolimus and Steroids, in de Novo Adult Renal Transplant Recipients|Completed||Phase 3|140||Novartis|||||||||||||||||||2017-10-11 05:44:05.720341|2017-10-11 05:44:05.720341
NCT00239889|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2006-11-29|||March 2002||2002-03-01|March 2006|2006-03-01||||||||Interventional|||Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women|Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women|Completed||Phase 4|300||Novartis|||||f||||||||||||||2017-10-11 05:44:05.802301|2017-10-11 05:44:05.802301
NCT00239902|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2011-11-01|||May 2002||2002-05-01|November 2011|2011-11-01||||November 2004|Actual|2004-11-01||Interventional|||Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|Two-year Extension of a One-year, Multicenter, Randomized, Partially-blinded Study of the Safety and Efficacy of FTY720 Combined With Corticosteroids and Full or Reduced-dose Cyclosporine, USP [Modified] (Novartis Brand) in de Novo Adult Renal Transplant Recipients|Completed||Phase 2|396||Novartis|||||||||||||||||||2017-10-11 05:44:05.887739|2017-10-11 05:44:05.887739
NCT00239915|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2012-05-08|||April 2005||2005-04-01|May 2012|2012-05-01|December 2006||2006-12-01|||||Interventional|||Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)|An 8-week, Double-Blind, Randomized, Multicenter, Flexible-Dose, Placebo-Controlled Pilot Study of Pagoclone in Patients With Persistent Developmental Stuttering Followed by a 52-week Open-Label Extension.|Completed||Phase 2|||Pharmacology Research Institute|||||||||||||||||||2017-10-11 05:44:05.949342|2017-10-11 05:44:05.949342
NCT00239928|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2011-05-11|2009-11-04||September 2005||2005-09-01|May 2011|2011-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration|Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration (Extension Study From A5751010)|Completed||Phase 2|61|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:44:06.02557|2017-10-11 05:44:06.02557
NCT00239954|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2012-05-08|||March 2005||2005-03-01|May 2012|2012-05-01||||||||Interventional|||Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder|Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder|Unknown status|Active, not recruiting|Phase 3|||Pharmacology Research Institute|||||||||||||||||||2017-10-11 05:44:06.572596|2017-10-11 05:44:06.572596
NCT00239967|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2009-04-06|||May 2005||2005-05-01|April 2009|2009-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|ADAGIO-lipids||An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients|A Randomized, Double-Blind, Two-Arm Placebo-Controlled, Parallel-Group, Multicenter Study of Rimonabant 20 mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdominally Obese Patients|Completed||Phase 3|803|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:44:06.670144|2017-10-11 05:44:06.670144
NCT00239980|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2010-02-02|||October 2005||2005-10-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)|A Phase II Randomized Study of Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)|Completed||Phase 2|77|Actual|Ontario Clinical Oncology Group (OCOG)||3|||f||||t||||||||||2017-10-11 05:44:06.793896|2017-10-11 05:44:06.793896
NCT00239993|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-22|2017-02-02|||August 2005||2005-08-01|February 2017|2017-02-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®|An Open-Label, Randomized, Single Cross-over Study of Warm Compress Versus Usual Injection Site Preparation on Local Injection Site Reactions Among Persons With MS Who Perform Daily Injections of Copaxone®.|Completed||Phase 4|50|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:44:06.906456|2017-10-11 05:44:06.906456
NCT00242021|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2009-10-13|||October 2005||2005-10-01|October 2009|2009-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Fatty Acid Composition on Energy Intake and Satiety|Fatty Acid Composition of a Fat Supplement on Energy Intake, Satiety and Fat Metabolism in Lean and Obese Men|Completed||N/A|20||TNO|||||f||||||||||||||2017-10-11 05:44:12.140756|2017-10-11 05:44:12.140756
NCT00240006|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2011-04-08|||January 2006||2006-01-01|April 2011|2011-04-01|September 2007|Actual|2007-09-01|January 2007|Actual|2007-01-01||Interventional|||A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone|An Open Label, Prospective Parallel Cohort Study Comparing A 90-day Copaxone® Adherence Enhancement Program Among Persons With Multiple Sclerosis Who Participate in Shared Solutions® Alone or in Partnership With Their MS Center|Completed||Phase 4|307|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:44:07.029516|2017-10-11 05:44:07.029516
NCT00240019|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2006-10-16|||December 2003||2003-12-01|June 2006|2006-06-01|April 2006||2006-04-01|||||Interventional|||Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.|Maximizing the Benefit of RAS Blockade in Diabetic Nephropathy|Completed||N/A|30||Stanford University|||||f||||||||||||||2017-10-11 05:44:07.116177|2017-10-11 05:44:07.116177
NCT00240032|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2011-04-07|||October 2004||2004-10-01|April 2011|2011-04-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.|A Double-Blind, Randomized, Placebo Controlled Study of An Oral Antihistamine on Local Injection Site Reactions Among Persons With Multiple Sclerosis Who Perform Daily Injections of Copaxone® Using Autoject® 2 for Glass Syringe.|Completed||Phase 4|80|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:44:07.200494|2017-10-11 05:44:07.200494
NCT00240045|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2007-12-03|||October 2005||2005-10-01|October 2005|2005-10-01|July 2007|Actual|2007-07-01|||||Interventional|||The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction|The Use of Midodrine, Octreotide and Albumin in Refractory Ascites|Completed||Phase 2/Phase 3|9|Actual|University of Alberta||1|||f||||f||||||||||2017-10-11 05:44:07.295834|2017-10-11 05:44:07.295834
NCT00240058|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-06-01|||July 2005||2005-07-01|June 2017|2017-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity|Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity|Completed||N/A|22|Actual|University of Michigan||1|||f||||||||||||||2017-10-11 05:44:07.400154|2017-10-11 05:44:07.400154
NCT00240071|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2017-02-24|2011-04-20||October 2005||2005-10-01|February 2017|2017-02-01|April 2011|Actual|2011-04-01|March 2009|Actual|2009-03-01||Interventional|||Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.|The Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy: A Phase II Trial|Completed||Phase 2|30|Actual|University of Alabama at Birmingham|A Phase II trial.|1|||f||||t||||||||||2017-10-11 05:44:07.497578|2017-10-11 05:44:07.497578
NCT00240084|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2013-06-17|||July 2003||2003-07-01|June 2013|2013-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Nesiritide and Vo2 Max in Heart Failure Patients|Nesiritide and Vo2 Max in Heart Failure Patients|Completed||Phase 2|20|Actual|University of Rochester||1|||f||||f||||||||||2017-10-11 05:44:07.800168|2017-10-11 05:44:07.800168
NCT00240097|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2014-11-26|2012-06-08||June 2005||2005-06-01|November 2014|2014-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)|Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin-Etoposide/Carboplatin in Extensive SCLC|Completed||Phase 2|30|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-10-11 05:44:07.90823|2017-10-11 05:44:07.90823
NCT00240110|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2016-08-24|2015-06-30||March 2006||2006-03-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Valproate Efficacy in Cocaine-Bipolar Comorbidity|Valproate Efficacy in Cocaine-Bipolar Comorbidity|Completed||Phase 1/Phase 2|152|Actual|University of Miami||2|||f||||t||||||||No||2017-10-11 05:44:08.324232|2017-10-11 05:44:08.324232
NCT00240123|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2015-09-16|||July 2005||2005-07-01|September 2015|2015-09-01|July 2007||2007-07-01|||||Interventional|||Effect of Benadryl Sedation During ERCP or EUS|Effect of Diphenhydramine Sedation During Endoscopic Retrograde Cholangio-pancreatography (ERCP) or Endoscopic Ultrasound (EUS)|Withdrawn||Phase 1|0|Actual|University of Rochester|||||f||||||||||||||2017-10-11 05:44:08.769078|2017-10-11 05:44:08.769078
NCT00240136|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2016-02-17|||January 1993||1993-01-01|February 2016|2016-02-01|July 2023|Anticipated|2023-07-01|December 2022|Anticipated|2022-12-01||Observational|||Long-term Observation of Patients With Early Rheumatoid Arthritis|Long-term Observation of Patients With Early Rheumatoid Arthritis|Active, not recruiting||N/A|372|Actual|University of California, Los Angeles|||1||f||||t||||||||||2017-10-11 05:44:08.847884|2017-10-11 05:44:08.847884
NCT00240149|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2007-12-19|||October 2005||2005-10-01|November 2007|2007-11-01|March 2006||2006-03-01|||||Interventional|||Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit|Pilot Study Evaluating Use of Insulin-Glucose Algorithm and Glucose Monitoring Techniques to Control Hyperglycemia in the Pediatric Intensive Care Unit|Completed||N/A|0||Stanford University|||||f||||||||||||||2017-10-11 05:44:08.930277|2017-10-11 05:44:08.930277
NCT00240162|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2014-09-05|2014-08-22||September 2005||2005-09-01|September 2014|2014-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma|A Phase II Study of PTK787/ZK 222584, a Novel, Oral Angiogenesis Inhibitor as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma Following High Dose Chemotherapy and Autologous Stem Cell Transplant|Terminated||Phase 2|21|Actual|Washington University School of Medicine|In November 2008, it was reported that the drug might have carcinogenic potential in animal models. At that time, the remaining three patients were taken off study.|1||"investigator letter from drug manufacturer stating animal studies showed increased risk of   cancer which was an unknown adverse event"|f||||||||||||||2017-10-11 05:44:09.027528|2017-10-11 05:44:09.027528
NCT00240175|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2012-02-29|||August 2005||2005-08-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Evaluating the Effects of Foot Orthotics on Plantar Pressures in the Diabetic Population|Evaluating the Effects of Foot Orthotics on Plantar Pressures in the Diabetic Population|Completed||Phase 1|65|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||||||||||||2017-10-11 05:44:09.422609|2017-10-11 05:44:09.422609
NCT00240188|ClinicalTrials.gov processed this data on October 10, 2017|2005-08-30|2010-09-15|||February 2004||2004-02-01|September 2010|2010-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study to Compare Ventral Incisional Hernia by Laparoscopic vs Open Repair With Mesh|Ventral Incisional Hernia Repair: Comparison Of Laparoscopic and Open Repair With Mesh|Completed||N/A|110|Anticipated|VA Office of Research and Development||1|||f||||t||||||||||2017-10-11 05:44:09.499586|2017-10-11 05:44:09.499586
NCT00240214|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2008-03-13|||April 2001||2001-04-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Study Evaluating Rapamune in Patients After Kidney Transplantation|An Open Label Post Marketing Surveillance Assessment to Evaluate the Effectiveness and Safety of Rapamune in Patients After Kidney Transplantation Receiving a Rapamune Containing Regime|Terminated||N/A|500|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-10-11 05:44:09.583273|2017-10-11 05:44:09.583273
NCT00240227|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2016-03-11|2013-11-25||April 2004||2004-04-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Prazosin for ETOH or Cocaine Craving|The Role of the Alpha 1-adrenergic Antagonist, Prazosin, in the Reduction of Craving and Relapse in Alcohol and Cocaine-dependent Individuals: a Double-blind, Randomized, Controlled Clinical Trial|Terminated||N/A|8|Actual|VA Office of Research and Development|The study procedure intended to induce substance craving failed to induce craving. Thus, any difference between placebo and active medication conditions could not be measured and so the study was terminated.|2||"Experimental procedure did not induce sufficient craving to determine any possible effect of   medication."|f||||f||||||||||2017-10-11 05:44:09.665809|2017-10-11 05:44:09.665809
NCT00241852|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2014-01-09|||May 2005||2005-05-01|January 2014|2014-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Family Approach to Managing Asthma in Early Teens|Family Approach to Managing Asthma in Early Teens|Completed||Phase 3|392|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-10-11 05:44:10.618472|2017-10-11 05:44:10.618472
NCT00241878|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2016-05-04|||September 2006||2006-09-01|December 2007|2007-12-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Preschool Based Obesity Prevention Effectiveness Trial|Preschool Based Obesity Prevention Effectiveness Trial|Completed||N/A|648|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||||||||||||2017-10-11 05:44:10.707298|2017-10-11 05:44:10.707298
NCT00241891|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2015-04-06|||July 2006||2006-07-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|May 2011|Actual|2011-05-01||Interventional|||Behavior Change Family Counseling to Reduce Rate of Weight Gain in At-Risk Children|Primary Care Obesity Prevention: One or Multiple Targets|Completed||N/A|158|Actual|Children's Hospital of Philadelphia||3|||f||||f||||||||||2017-10-11 05:44:10.781501|2017-10-11 05:44:10.781501
NCT00241904|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2017-08-18|2017-04-14||May 2006||2006-05-01|August 2017|2017-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|COACH||Reducing Total Cardiovascular Risk in an Urban Community|Reducing Total Cardiovascular Risk in an Urban Community|Completed||Phase 4|525|Actual|Johns Hopkins University||2|||f||||t|t|f||||||||2017-10-11 05:44:10.975319|2017-10-11 05:44:10.975319
NCT00241917|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2008-12-05|||November 2005||2005-11-01|December 2008|2008-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Video-Based HCV Curriculum for Drug Users|Cooperative Agreement to Develop, Implement, and Evaluate Viral Hepatitis and Training|Completed||N/A|450|Actual|Organization to Achieve Solutions in Substance Abuse (OASIS)||2|||f||||f||||||||||2017-10-11 05:44:11.354858|2017-10-11 05:44:11.354858
NCT00241930|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2005-10-24|||September 2005||2005-09-01|August 2005|2005-08-01|February 2009||2009-02-01|||||Interventional|||Integrating Buprenorphine Into HIV Treatment|SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model|Unknown status|Recruiting|Phase 4|60||Organization to Achieve Solutions in Substance Abuse (OASIS)|||||f||||||||||||||2017-10-11 05:44:11.462086|2017-10-11 05:44:11.462086
NCT00241943|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2008-12-08|||November 2005||2005-11-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Video-Based HCV Curriculum for Active Injection Drug Users|Cooperative Agreement to Develop, Implement, and Evaluate Viral Hepatitis and Training|Completed||N/A|103|Actual|Organization to Achieve Solutions in Substance Abuse (OASIS)|||||f||||f||||||||||2017-10-11 05:44:11.603897|2017-10-11 05:44:11.603897
NCT00241956|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2011-07-19|||October 2005||2005-10-01|July 2011|2011-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Impact of Diabetes and Glucose Control During Rehabilitation After Stroke|Impact of Diabetes and Glucose Control During Rehabilitation After Stroke|Terminated||N/A|20|Actual|Melbourne Health|||1|poor data collection|f||||f||||||||||2017-10-11 05:44:11.7064|2017-10-11 05:44:11.7064
NCT00241982|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2008-05-28|||October 2005||2005-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis|Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis|Completed||Phase 2|22|Actual|Radboud University||1|||f||||f||||||||||2017-10-11 05:44:11.909165|2017-10-11 05:44:11.909165
NCT00242008|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2014-09-24|||December 2004||2004-12-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease|A Phase 3b, Open-Label, Multicenter, Multinational Trial To Assess The Tolerability Of Switching Subjects From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System And Its Effect On Symptoms In Subjects With Idiopathic Parkinson's Disease|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-10-11 05:44:12.057303|2017-10-11 05:44:12.057303
NCT00242034|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2008-09-02||||||August 2008|2008-08-01||||||||Interventional|||Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques|Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques|Completed||N/A|60|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:44:12.228403|2017-10-11 05:44:12.228403
NCT00242047|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2005-10-18|||March 2001||2001-03-01|November 2004|2004-11-01|August 2006||2006-08-01|||||Interventional|||Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.|Randomized, Controlled Trial Comparing Efficacy of Percutaneous and Intradermal Vaccination With Japanese (Tokyo) 172 BCG in the Prevention of Tuberculosis In Infants Vaccinated at Birth|Unknown status|Active, not recruiting|Phase 4|12000||University of Cape Town|||||f||||||||||||||2017-10-11 05:44:12.310889|2017-10-11 05:44:12.310889
NCT00242060|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2010-07-14|||November 2002||2002-11-01|July 2010|2010-07-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|||Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy|The Utility of Functional and Morphologic MRI in the Detection of Prostate Cancer for Patients With Elevated PSA and Prior Negative Biopsy|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:44:12.431836|2017-10-11 05:44:12.431836
NCT00242073|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2017-09-19|||October 2001||2001-10-01|September 2017|2017-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer|The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer|Completed||N/A|||University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:44:12.508576|2017-10-11 05:44:12.508576
NCT00242086|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2016-05-31|||October 2004||2004-10-01|May 2016|2016-05-01||||March 2010|Actual|2010-03-01||Interventional|||Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases|Comparison of Triphasic CT, CT/PET and MR Defined Gross Tumour With Pathological Findings in Patients With Colorectal Cancer Liver Metastases|Completed||N/A|7|Actual|University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:44:12.574545|2017-10-11 05:44:12.574545
NCT00242099|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2008-04-15|||February 2005||2005-02-01|February 2005|2005-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant|The Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant: A Randomized Trial|Completed||Phase 4|160||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:44:12.648154|2017-10-11 05:44:12.648154
NCT00242112|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2017-04-24|||June 2005||2005-06-01|April 2017|2017-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI|Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI|Completed||N/A|31|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-10-11 05:44:12.71006|2017-10-11 05:44:12.71006
NCT00242125|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2006-01-13|||October 2005||2005-10-01|October 2005|2005-10-01||||||||Observational|||Family Studies in Primary Biliary Cirrhosis (PBC)|Family Studies in Primary Biliary Cirrhosis|Unknown status|Recruiting|N/A|3000||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:44:12.78493|2017-10-11 05:44:12.78493
NCT00242138|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2016-02-08|||March 2000||2000-03-01|February 2016|2016-02-01|April 2004||2004-04-01|||||Interventional|||Erectile Dysfunction/Prostate/RT/Androgen|A Cross-Sectional Study of Erectile Dysfunction in Patients With Locally Advanced Prostate Cancer Who Have Undergone Radiotherapy and Prolonged Pharmacological Androgen Ablation|Completed||Phase 2|50||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:44:12.878679|2017-10-11 05:44:12.878679
NCT00242151|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2006-10-11||||||September 2006|2006-09-01||||||||Observational|||Prevalence of Delirium in Patients Undergoing Cardiac Surgery|Prevalence of Delirium in Patients Undergoing Cardiac Surgery|Unknown status|Recruiting|N/A|100||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:44:12.952815|2017-10-11 05:44:12.952815
NCT00242164|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2014-12-08|||November 2005||2005-11-01|July 2005|2005-07-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Interventional|||Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis|Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis|Completed||Phase 2|25|Anticipated|University of Michigan|||||f||||||||||||||2017-10-11 05:44:13.02458|2017-10-11 05:44:13.02458
NCT00242177|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2005-10-24|||October 2003||2003-10-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability|Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability|Completed||Phase 1|30||University of Illinois at Chicago|||||f||||||||||||||2017-10-11 05:44:13.128671|2017-10-11 05:44:13.128671
NCT00242190|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2010-11-10|||June 2004||2004-06-01|November 2010|2010-11-01|February 2010|Actual|2010-02-01|March 2006|Actual|2006-03-01||Interventional|||Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer|Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer|Completed||Phase 1/Phase 2|40||University of Michigan Cancer Center|||||f||||||||||||||2017-10-11 05:44:13.21636|2017-10-11 05:44:13.21636
NCT00242203|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2013-08-09|||October 2002||2002-10-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|August 2007|Actual|2007-08-01||Interventional|||Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer|Impact of Neoadjuvant Chemotherapy With or Without Zometa on Occult Micrometastases and Bone Density in Women With Locally Advanced Breast Cancer|Completed||Phase 2|120|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-10-11 05:44:13.294609|2017-10-11 05:44:13.294609
NCT00242216|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2013-12-12|2013-05-02||May 2004||2004-05-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||"The Once A Day Protease Inhibitor Regimens"|"PIQD: The Once a Day Protease Inhibitor Regimens. Ritonavir Boosted Atazanavir vs. Ritonavir Boosted Fosamprenavir Used in Combination With Tenofovir and Emtricitabine in HIV-1 Infected Antiretroviral Treatment-Naïve Patients."|Completed||Phase 4|76|Actual|The University of Texas Health Science Center, Houston|High porportion of subject did not complete the study.|2|||f||||f||||||||||2017-10-11 05:44:13.434273|2017-10-11 05:44:13.434273
NCT00242229|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2009-08-18|||October 2004||2004-10-01|August 2009|2009-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder|A 6 Month, Open-Label Evaluation of the Long-Term Safety of DVS-233 SR in Elderly Outpatients With Major Depressive Disorder (MDD)|Completed||N/A|52|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:44:13.819124|2017-10-11 05:44:13.819124
NCT00242242|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2017-10-05|||October 17, 2005||2005-10-17|July 23, 2013|2013-07-23|July 23, 2013||2013-07-23|||||Observational|||Moving a Paralyzed Hand Through Use of a Brain-Computer Interface|Moving a Paralyzed Hand Through a Brain-Computer Interface Controlled by the Affected Hemisphere After Stroke or Traumatic Brain Injury|Terminated||N/A|110|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:44:13.899588|2017-10-11 05:44:13.899588
NCT00242255|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2017-10-05|||October 14, 2005||2005-10-14|April 18, 2017|2017-04-18||||||||Observational|||Epigenetics in the Aging Process|Remodeling of Chromatin-Based Epigenetic Structures in Development and Aging|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:44:14.182161|2017-10-11 05:44:14.182161
NCT00242268|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2005-12-06|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis||Unknown status|Recruiting|Phase 3|30||Alabama Neurology Associates, PC|||||f||||||||||||||2017-10-11 05:44:14.282261|2017-10-11 05:44:14.282261
NCT00242281|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2006-10-23|||November 2005||2005-11-01|January 2006|2006-01-01|July 2006||2006-07-01|||||Interventional|||APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat|A Phase III, Multicenter Study to Evaluate the Safety/Efficacy of APC-111 MP Tablet QD vs. Penicillin VK QID Both for 10 Days Treatment of Pharyngitis Secondary to S.Pyogenes in Adolescents/Adults|Completed||Phase 3|600||Advancis Pharmaceutical Corporation|||||||||||||||||||2017-10-11 05:44:14.382168|2017-10-11 05:44:14.382168
NCT00242294|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2016-10-24|||November 2004||2004-11-01|September 2016|2016-09-01|March 2007|Actual|2007-03-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)|A Confirmatory Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease (A Placebo-controlled Double-blind Comparative Study)|Completed||Phase 2/Phase 3|570||AstraZeneca|||||f||||||||||||||2017-10-11 05:44:14.553326|2017-10-11 05:44:14.553326
NCT00242307|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2016-10-31|||May 2004||2004-05-01|September 2016|2016-09-01|June 2007|Actual|2007-06-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)|A Confirmatory Study of APTA-2217 in Adult Patients With Bronchial Asthma (A Placebo-controlled Double-blind Comparative Study)|Completed||Phase 2/Phase 3|450|Actual|AstraZeneca|||||f||||||||||||||2017-10-11 05:44:14.648587|2017-10-11 05:44:14.648587
NCT00242320|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2016-12-01|||August 2005||2005-08-01|September 2016|2016-09-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)|The JADE Study: A 12-week, Double-blind, Randomized Study to Investigate the Effect of 500 mcg Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|551|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 05:44:14.73342|2017-10-11 05:44:14.73342
NCT00242333|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2006-05-15|||October 2005||2005-10-01|May 2006|2006-05-01||||||||Interventional|||A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD|A Multi-Center Randomized, Double-Blind, Parallel Group, Placebo Controlled Study, Including an Additional Open Label Tiotropium Group, to Assess the Efficacy, Safety and Tolerability of 4 Doses of AD 237 Inhaled Once Daily for 28 Days in Subjects With COPD.|Completed||Phase 2|300||Sosei|||||f||||||||||||||2017-10-11 05:44:14.926532|2017-10-11 05:44:14.926532
NCT00242346|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2007-12-17|||April 2003||2003-04-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||High Doses of Candesartan Cilexetil on the Reduction of Proteinuria|A Double-Blind, Randomised, Dose Ranging, Multi-Centre, Phase IIIb Study to Evaluate the Efficacy and Safety of High Doses of Candesartan Cilexetil (Atacand®) on the Reduction of Proteinuria in the Treatment of Subjects With Hypertension and Moderate to Severe Proteinuria|Completed||Phase 3|270||AstraZeneca|||||f||||||||||||||2017-10-11 05:44:15.108328|2017-10-11 05:44:15.108328
NCT00242359|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2009-01-27|||November 2005||2005-11-01|January 2009|2009-01-01||||||||Interventional|||A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma|A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma|Withdrawn||Phase 4|16|Anticipated|Bernstein Clinical Research Center||||could not find subject population|||||f||||||||||2017-10-11 05:44:15.259664|2017-10-11 05:44:15.259664
NCT00242372|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2009-04-21|||August 2004||2004-08-01|April 2009|2009-04-01|March 2006|Actual|2006-03-01|||||Interventional|||GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin|A 24-Week Randomised, Double-Blind, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Added to the Therapy of Patients With Type 2 Diabetes Poorly Controlled on Insulin|Terminated||Phase 3|370||AstraZeneca||||The development program has been terminated|||||||||||||||2017-10-11 05:44:15.351439|2017-10-11 05:44:15.351439
NCT00242385|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2015-06-26|2011-02-15||December 2005||2005-12-01|July 2011|2011-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Pharmacokinetic Study of ARALAST (Human Alpha1- PI)|Single-Dose, Double-Blind, Crossover Study to Evaluate the Pharmacokinetic Comparability of ARALAST Fraction IV-1 Alpha1-Proteinase Inhibitor (ARALAST Fr. IV-1) and ARALAST|Completed||Phase 1|25|Actual|Baxalta US Inc.||2|||f||||||||||||||2017-10-11 05:44:17.669175|2017-10-11 05:44:17.669175
NCT00242398|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2007-10-02|||October 2005||2005-10-01|October 2007|2007-10-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Hemodialysis Without Anticoagulation in Intensive Care Unit|Heparin Free Hemodialysis for Patients With Bleeding High Risk in ICU. Randomized Study: Heparin Free Dialysis With Intermittent Saline Flushes Versus Heparin Free Dialysis With Nephral 400ST (AN69ST, Hospal, France)|Unknown status|Recruiting|Phase 3|120|Anticipated|Centre Hospitalier Départemental||2|||f||||t||||||||||2017-10-11 05:44:18.178899|2017-10-11 05:44:18.178899
NCT00242411|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2011-01-21|||September 2004||2004-09-01|January 2011|2011-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults|A Comparison of the Efficacy of Symbicort® Single Inhaler Therapy (Symbicort Turbuhaler® 160/4.5 mg 1 Inhalation b.i.d. Plus As-needed) and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults. A Randomized, Open, Parallel-group, Multicentre 26-weeks Study|Completed||Phase 4|1900||AstraZeneca|||||f||||||||||||||2017-10-11 05:44:18.322781|2017-10-11 05:44:18.322781
NCT00242424|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2009-01-27|||September 2005||2005-09-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|GRC28||Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age|Safety and Immunogenicity of Fluzone Influenza Virus Vaccine (2005-2006 Formulation) Among Healthy Children 6 to 12 Weeks of Age|Completed||Phase 2/Phase 3|1375|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-10-11 05:44:18.992871|2017-10-11 05:44:18.992871
NCT00242437|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2006-07-11|||October 2005||2005-10-01|July 2006|2006-07-01|February 2006||2006-02-01|||||Interventional|||Hemostatic Matrix in Endoscopic Sinus Surgery|A Prospective, Multicenter Study to Evaluate Hemostatic Matrix With Bovine Thrombin in Achieving Hemostasis in Patients Undergoing Endoscopic Sinus Surgery|Completed||Phase 4|30||Ethicon, Inc.|||||f||||||||||||||2017-10-11 05:44:19.106608|2017-10-11 05:44:19.106608
NCT00242450|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2017-08-24|||March 2002|Actual|2002-03-01|May 2005|2005-05-01|July 2005|Actual|2005-07-01|||||Interventional|||Metoclopramide Use in Very Low Birth Weight Newborns|The Effect of Metoclopramide on Feeding in Very Low Birthweight Newborns : a Randomized, Double Blind, Placebo Controlled Pilot Study and a Proposal for a Multicentre Trial|Completed||Phase 4|30||Lawson Health Research Institute|||||f||||f|f|f||||||||2017-10-11 05:44:19.214682|2017-10-11 05:44:19.214682
NCT00242463|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2011-01-04|||October 2005||2005-10-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients|The Efficacy of Anabolic Steroids for the Nutritional Rehabilitation of Critically Ill Patients|Terminated||Phase 2|20|Anticipated|Lawson Health Research Institute||2||drug no longer available in canada|f||||f||||||||||2017-10-11 05:44:19.307659|2017-10-11 05:44:19.307659
NCT00242476|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2015-05-13|||September 2005||2005-09-01|May 2015|2015-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Study to Assess the Effect of Vitamin D3 8400IU Once Weekly on Body Sway and Neuromuscular Function in Men and Women Aged 70 Years or Older|Completed||Phase 2|216|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:44:19.403411|2017-10-11 05:44:19.403411
NCT00242489|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2015-02-24|||June 1998||1998-06-01|February 2015|2015-02-01|July 2002|Actual|2002-07-01|February 1999|Actual|1999-02-01||Interventional|||Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)|A Placebo-Controlled, Parallel-Group, Double-Blind Study to Assess Safety and to Define the Clinically Effective Dose Range of MK0663 in Patients With Osteoarthritis of the Knee, Followed by a Double-Blind, Active-Comparator-Controlled Extension.|Completed||Phase 2|1167|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-10-11 05:44:19.465109|2017-10-11 05:44:19.465109
NCT00242502|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2013-03-25|2013-02-19||October 2005||2005-10-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery|A Phase II Study of the Combination of Bevacizumab and Erlotinib in Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|62|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-10-11 05:44:19.56196|2017-10-11 05:44:19.56196
NCT00242515|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2014-01-07|||March 2005||2005-03-01|January 2014|2014-01-01|March 2008||2008-03-01|||||Interventional|||T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)|Preemptive CD8+ T-cell Depleted Donor Lymphocyte Infusion (DLI) Following Nonmyeloablative Stem Cell Transplantation (NMT) for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)|Unknown status|Recruiting|Phase 1/Phase 2|16|Anticipated|National University Hospital, Singapore|||||f||||||||||||||2017-10-11 05:44:19.920109|2017-10-11 05:44:19.920109
NCT00242528|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2015-04-13|||April 2004||2004-04-01|April 2015|2015-04-01||||||||Interventional|||Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.|Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.|Withdrawn||Phase 4|0|Actual|Novartis|||||f||||||||||||||2017-10-11 05:44:20.031819|2017-10-11 05:44:20.031819
NCT00242541|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2012-04-25|||March 2003||2003-03-01|April 2012|2012-04-01||||August 2005|Actual|2005-08-01||Interventional|||Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas|Open Label Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas|Terminated||Phase 4|50|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:44:20.107427|2017-10-11 05:44:20.107427
NCT00242554|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2017-02-21|||October 2002||2002-10-01|February 2017|2017-02-01||||July 2007|Actual|2007-07-01||Interventional|||Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases|Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases|Completed||Phase 4|150||Novartis|||||f||||||||||||||2017-10-11 05:44:20.209534|2017-10-11 05:44:20.209534
NCT00242567|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2014-04-14|2013-01-29||December 2005||2005-12-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer|A Phase III, Parallel Group, Randomized, Open-label, Multi-centre Clinical Trial of Zoledronic Acid in Males Receiving Androgen Deprivation Therapy for Advanced Prostate Cancer.|Completed||Phase 3|522|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:44:20.365232|2017-10-11 05:44:20.365232
NCT00242580|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2016-03-03|2011-01-24||September 2005||2005-09-01|March 2016|2016-03-01||||January 2008|Actual|2008-01-01||Interventional|VERITAS||A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib|A 24-month Randomized, Double-masked, Sham Controlled, Multicenter, Phase IIIB Study Comparing Photodynamic Therapy With Verteporfin (Visudyne®) Plus Two Different Dose Regimens of Intravitreal Triamcinolone Acetonide (1 mg and 4 mg) Versus Visudyne® Plus Intravitreal Pegaptanib(Macugen®) in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration|Completed||Phase 3|111|Actual|Novartis|Secondary outcome measures were to be assessed at Month 6 and at 24 months. However, this study was not completed but terminated after all patients completed 12 months. Original safety was COSTART now mapped to SOC MedDRA.|3|||f||||||||||||||2017-10-11 05:44:24.419109|2017-10-11 05:44:24.419109
NCT00249626|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-11-17|||January 2004||2004-01-01|November 2011|2011-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Therapists to Administer Contingency Management-Therapist Phase - 1|Therapists to Administer Contingency Management-Therapist Phase|Completed||N/A|42|Actual|UConn Health||1|||f||||f||||||||||2017-10-11 05:46:44.066814|2017-10-11 05:46:44.066814
NCT00242593|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2011-08-04|||June 2006||2006-06-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|RECALL||Rosiglitazone Effects on Cognition for Adults in Later Life|The Effects of Rosiglitazone on Cognition in Patients With MCI|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|University of Washington||2|||f||||t||||||||||2017-10-11 05:44:25.317642|2017-10-11 05:44:25.317642
NCT00242606|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2012-05-08|||March 2005||2005-03-01|May 2012|2012-05-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy|Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy: An Open, Prospective, Multicenter, Randomized Phase III Study|Completed||Phase 3|409|Actual|Philipps University Marburg Medical Center||2|||f||||t||||||||||2017-10-11 05:44:25.431746|2017-10-11 05:44:25.431746
NCT00242619|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2016-12-20|2016-10-10||July 2007||2007-07-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Insulin Resistance in Patients With Mood Disorder|Rosiglitazone Add-On in Treatment of Depressed Patients With Insulin Resistance: a Pilot Study|Completed||N/A|12|Actual|Stanford University||1|||f||||f||||||||No||2017-10-11 05:44:25.532701|2017-10-11 05:44:25.532701
NCT00242632|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2017-05-16|2016-10-10||June 2004||2004-06-01|May 2017|2017-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Treatment With Namenda in Women at Risk for Cognitive Decline|Cognitive Effects of Memantine in Postmenopausal Women at Risk of Dementia: a Pilot Study|Completed||N/A|22|Actual|Stanford University||2|||f||||f||||||||No||2017-10-11 05:44:25.830556|2017-10-11 05:44:25.830556
NCT00242645|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2010-08-24|||June 2004||2004-06-01|August 2010|2010-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Computer-Assisted Cancer Risk Behavior Counseling|Computer-Assisted Cancer Risk Behavior Counseling|Terminated||Phase 1|200|Actual|Thomas Jefferson University||||Administratively terminated.|f||||f||||||||||2017-10-11 05:44:26.091512|2017-10-11 05:44:26.091512
NCT00242658|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2012-11-07|2010-12-16||May 2005||2005-05-01|November 2012|2012-11-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Computerized Health Education to Promote Physical Activity|Computerized Physical Activity Promotion in Primary Care|Completed||Phase 1|394|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-10-11 05:44:26.17021|2017-10-11 05:44:26.17021
NCT00242671|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2010-08-03|||October 2005||2005-10-01|September 2006|2006-09-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||The Efficacy of Isocapnic Hyperpnoea to Accelerate Recovery After General Anesthesia With Sevoflurane|The Efficacy of Isocapnic Hyperpnoea to Accelerate Recovery After General Anesthesia With Sevoflurane.|Completed||Phase 3|||University Health Network, Toronto|||||f||||||||||||||2017-10-11 05:44:26.612447|2017-10-11 05:44:26.612447
NCT00242684|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2015-04-06|2014-11-24||March 2006||2006-03-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational||Elderly patients admitted to TCU|PEU in Elderly TCU Residents|Manifestations, Causes, and Consequences of PEU in Elderly TCU Residents|Completed||N/A|446|Actual|VA Office of Research and Development|This was an observational study designed to develop a better understanding of the interrelationships among nutrient intake, weight change, serum concentration of albumins, illness severity, and mortality. For more details, see cited references.||1||f||||f||||||Samples Without DNA|"     serum and plasma samples   "|||2017-10-11 05:44:26.691902|2017-10-11 05:44:26.691902
NCT00242697|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2005-10-19|||April 2002||2002-04-01|October 2005|2005-10-01|July 2003||2003-07-01|||||Interventional|||Double-Blind Comparison of Combined General-Spinal Anesthesia to General Anesthesia for Coronary Artery Surgery|A Randomized Double-Blind Comparison of Combined General-Spinal Anesthesia to General Anesthesia for Coronary Artery Surgery|Completed||Phase 3|63||University of Calgary|||||f||||||||||||||2017-10-11 05:44:26.907971|2017-10-11 05:44:26.907971
NCT00242710|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2013-10-30|2013-10-30|2009-02-26|September 2005||2005-09-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Safety analysis set included all randomly assigned participants who took at least 1 dose of test article.|Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women|A Double-Blind, Randomized, Placebo- And Active-Controlled Efficacy And Safety Study Of Bazedoxifene/Conjugated Estrogens Combinations For Prevention Of Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women|Completed||Phase 3|1083|Actual|Pfizer||4|||f||||f||||||||||2017-10-11 05:44:27.05358|2017-10-11 05:44:27.05358
NCT00242723|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2017-10-05|||October 17, 2005||2005-10-17|July 25, 2017|2017-07-25||||||||Observational|||Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining|Prospective Evaluation of Epigenetic Alterations in Patients With Thoracic Malignancies|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:44:30.48057|2017-10-11 05:44:30.48057
NCT00242736|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2009-03-05|||October 2005||2005-10-01|March 2009|2009-03-01|January 2006|Actual|2006-01-01|||||Interventional|||An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)|An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) to Investigate the Relationship Between the Presence of Erosive Esophagitis (EE) at Baseline and Heartburn Resolution After 4 Weeks of Treatment|Completed||Phase 4|350||AstraZeneca|||||||||||||||||||2017-10-11 05:44:30.570719|2017-10-11 05:44:30.570719
NCT00242749|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2009-04-22|||December 2002||2002-12-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|||||Interventional|||IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma|A Phase 2 Trial to Evaluate ZD1839 (IRESSA) in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma (Unresectable &Inoperable)|Completed||Phase 2|47||AstraZeneca|||||f||||||||||||||2017-10-11 05:44:30.677178|2017-10-11 05:44:30.677178
NCT00242762|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2011-01-25|||July 2003||2003-07-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer|A Phase II Study to Evaluate the Safety and Efficacy of the Combination of ZD1839 (IRESSA™), Docetaxel and Cisplatin in Subjects With Recurrent and/or Metastatic Head and Neck Cancer|Completed||Phase 2|36||AstraZeneca|||||f||||||||||||||2017-10-11 05:44:30.757278|2017-10-11 05:44:30.757278
NCT00242931|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2012-05-31|||January 2005||2005-01-01|September 2010|2010-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy|Pilot Trial of Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Hormone-Refractory Prostate Cancer|Withdrawn||Phase 2|0|Actual|OHSU Knight Cancer Institute||1||Unable to successfully recruit subjects to this study.|f||||t||||||||||2017-10-11 05:44:33.572376|2017-10-11 05:44:33.572376
NCT00242775|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2011-01-21|||May 2005||2005-05-01|January 2011|2011-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg|Efficacy and Safety of Symbicort ®Turbuhaler® 160/4.5 µg/Inhalation, Two Inhalations Twice Daily Plus As-needed Compared With Seretide™ Diskus™ 50/500 µg/Inhalation, One Inhalation Twice Daily Plus Terbutaline Turbuhaler 0.4 mg/Inhalation As-needed - a 6-month, Randomised, Double-blind, Parallel-group, Active Controlled, Multinational Phase IIIB Study in Adult and Adolescent Patients With Persistent Asthma (AHEAD).|Completed||Phase 3|2100||AstraZeneca|||||f||||||||||||||2017-10-11 05:44:30.852035|2017-10-11 05:44:30.852035
NCT00242788|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2009-04-22|||February 2004||2004-02-01|April 2009|2009-04-01|November 2005|Actual|2005-11-01|||||Interventional|||IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure|A Phase I/II, Multicentre Clinical Study Of ZD1839 (Iressa™) In Combination With Capecitabine (Xeloda™) In Subjects With Advanced Colorectal Carcinoma After Failure Of First-Line Chemotherapy|Completed||Phase 1/Phase 2|40||AstraZeneca|||||f||||||||||||||2017-10-11 05:44:31.412332|2017-10-11 05:44:31.412332
NCT00242801|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2009-04-22|||July 2003||2003-07-01|April 2009|2009-04-01|April 2005|Actual|2005-04-01|||||Interventional|||Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study|A Double Blind,Placebo Controlled,Parallel Group,Multicentre,Randomised,Phase Iii Survival Study Comparing ZD1839 (IRESSA™)(250mg Tablet) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients With Advanced NSCLC Who Have Received One Or Two Prior Chemotherapy Regimens And Are Refractory Or Intolerant To Their Most Recent Regimen|Completed||Phase 3|1692||AstraZeneca|||||||||||||||||||2017-10-11 05:44:31.520845|2017-10-11 05:44:31.520845
NCT00242814|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2012-05-18|||October 2005||2005-10-01|May 2012|2012-05-01||||March 2007|Actual|2007-03-01||Interventional|||Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities|A Phase IV Study, Prospective, Randomised, Open Label, Blinded Endpoint, Parallel Group, 9 Weeks of Comparison Between Oral Administration of Telmisartan Tablet (80mg Once Daily) and Amlodipine Tablet (10 mg Once Daily) on Biological PPAR Gamma Activities in Non Controlled Hypertensive Male Patients With Metabolic Syndrome|Completed||Phase 4|100|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:44:32.05715|2017-10-11 05:44:32.05715
NCT00242827|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-27|2012-08-22|||April 2006||2006-04-01|September 2006|2006-09-01|May 2007||2007-05-01|||||Interventional|||Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma|An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma|Terminated||Phase 2|||Teva Pharmaceutical Industries|||||||||||||||||||2017-10-11 05:44:32.443206|2017-10-11 05:44:32.443206
NCT00242840|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2017-05-25|||June 2003||2003-06-01|May 2017|2017-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)|A 24 Week Phase IIIb/IV Single Arm Open Label Observational Study to Explore the Efficacy of Protease Inhibitors Given in Combination With Reverse Transcriptase Inhibitors to HIV-1 Infected Subjects With Protease Mutations Selected During Therapy With GW433908 Containing Antiretroviral Therapy|Completed||Phase 3|20|Actual|ViiV Healthcare|||||f||||||||||||||2017-10-11 05:44:32.534461|2017-10-11 05:44:32.534461
NCT00242853|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2008-10-09|||October 2004||2004-10-01|October 2008|2008-10-01||||||||Observational|||A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis|An Enabling Study to Investigate the Correlation of Biomarkers of the Activity of Inducible Nitric Oxide Synthase (iNOS) With Disease Activity and Treatment Response in Patients With Rheumatoid Arthritis(RA)|Completed||N/A|48||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:44:32.622166|2017-10-11 05:44:32.622166
NCT00242879|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2017-05-25|||August 2005||2005-08-01|May 2017|2017-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults|Phase IIB, Randomized, Multicenter, Parallel Group, Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effect of Four Blinded Dosing Regimens of GW640385X/Ritonavir Compared to Open-label Current PI Therapy in HIV-1 Infected, Protease Inhibitor Experienced Adults for 2 Weeks With Long-term Assessment (>48 Weeks) of Safety, Pharmacokinetic and Antiviral Activity of Selected 385/RTV Dosing Regimen(s) vs. a Ritonavir-boosted, Protease Inhibitor Containing Regimen|Terminated||Phase 2|130|Actual|ViiV Healthcare|||||f||||||||||||||2017-10-11 05:44:32.911441|2017-10-11 05:44:32.911441
NCT00242892|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2011-11-25|||November 2001||2001-11-01|March 2007|2007-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||FROST 4: Study of the Optimal Spreading of a Coronary Stent Guided With Pressure Into the Coronary Arteries|Prospective Study Randomized Multicentric On the Optimization Of the Installation Of Stent By Measurement Of the Intra-Coronary Pressure|Completed||N/A|800|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:44:33.226566|2017-10-11 05:44:33.226566
NCT00242905|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2011-04-29|||October 2005||2005-10-01|March 2007|2007-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Functional Magnetic Resonance Imaging (fMRI) Study of Memory in Children|Anatomical and Functional MRI Study of Episodic Memory in Epileptic Compared to Normal Children|Completed||N/A|52|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-10-11 05:44:33.333089|2017-10-11 05:44:33.333089
NCT00242918|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2012-02-03|||May 2003||2003-05-01|June 2006|2006-06-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer|Phase II Trial of Neoadjuvant Docetaxel and ZD 1839 (Iressa) Followed by Radical Prostatectomy in Patients With High Risk, Locally Advanced Prostate Cancer|Completed||Phase 2|29||Benaroya Research Institute|||||||||||||||||||2017-10-11 05:44:33.446638|2017-10-11 05:44:33.446638
NCT00242944|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2009-12-16|||November 2005||2005-11-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)|Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome|Completed||Phase 4|307|Actual|Kyoto University||2|||f||||t||||||||||2017-10-11 05:44:33.674281|2017-10-11 05:44:33.674281
NCT00242970|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2015-03-31|||October 2005||2005-10-01|March 2015|2015-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Hypertrophic Scarring After Facial Burn|Hypertrophic Scarring After Facial Burn: A Pilot, Observational Study of Static and Dynamic Measurements of Facial Scars With the 3-D Scanner Through the Scar Maturation Process|Completed||Phase 2|15|Actual|Legacy Health System|||1||f||||f||||||||||2017-10-11 05:44:33.914097|2017-10-11 05:44:33.914097
NCT00242983|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2013-12-17|||April 2004||2004-04-01|December 2005|2005-12-01||||||||Observational|||Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer|"Assessment of Quality of Life (QOL) in Patients Registered With Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer (JMTO LC00-03)"|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:44:34.001255|2017-10-11 05:44:34.001255
NCT00242996|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2017-09-27|||March 2004||2004-03-01|September 2017|2017-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma|Phase II Trial of Rituximab and Autologous Stem Cell Transplantation for Refractory B Cell Large Cell Lymphoma|Completed||Phase 2|44|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 05:44:34.123954|2017-10-11 05:44:34.123954
NCT00243009|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2012-05-24|||June 2005||2005-06-01|June 2010|2010-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery|Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Metastatic Renal Cell Carcinoma|Terminated||Phase 2|1|Actual|OHSU Knight Cancer Institute||1||Due to a lack of a referal base, study was terminated.|f||||t||||||||||2017-10-11 05:44:34.222609|2017-10-11 05:44:34.222609
NCT00243022|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2013-06-21|2012-10-11||September 2004||2004-09-01|June 2013|2013-06-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme|Phase II Randomized Evaluation of 5-Lipoxygenase Inhibition by Herbal Complementary and Alternative Medicine Approach Compared to Control as an Adjuvant Therapy in Newly Diagnosed and Recurrent High-grade Gliomas|Terminated||Phase 2|12|Actual|Case Comprehensive Cancer Center|Certain outcome analysis not done due to low patient accrual.|2||Slow accrual|f||||t||||||||||2017-10-11 05:44:34.335074|2017-10-11 05:44:34.335074
NCT00243035|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2013-10-07|||August 2005||2005-08-01|October 2013|2013-10-01||||February 2007|Actual|2007-02-01||Interventional|||Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma|A Dose Escalation Study of R115777 (Zarnestra) Combined With Velcade® (PS-341) in Patients With Relapsed Multiple Myeloma.|Terminated||Phase 1/Phase 2|64|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:44:35.339296|2017-10-11 05:44:35.339296
NCT00243048|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2013-04-03|||May 2002||2002-05-01|April 2013|2013-04-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer|Phase II Randomized Study of Soy Isoflavones in Patients With Localized Prostate Cancer Treated With Radiation Therapy|Completed||Phase 2|70|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 05:44:35.489133|2017-10-11 05:44:35.489133
NCT00243061|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2015-06-01|2014-07-09||January 2006||2006-01-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma|A Phase II Study of AZD2171 in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma|Completed||Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-10-11 05:44:35.598923|2017-10-11 05:44:35.598923
NCT00243074|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2015-09-21|2012-10-30||November 2005||2005-11-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|April 2010|Actual|2010-04-01||Interventional||Only eligible patients who received protocol treatment are included in the analysis. Of the 54 patients enrolled, 6 were ineligible and 1 addtional patients refused protocol treatment.|S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery|A Phase II Trial of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma|Completed||Phase 2|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:44:36.484674|2017-10-11 05:44:36.484674
NCT00243087|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2013-10-31|||July 2005||2005-07-01|October 2013|2013-10-01||||August 2008|Actual|2008-08-01||Interventional|||Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)|An Open Phase I Single Dose Escalation Study of BI 2536 Administered Intravenously in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 1|41|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:44:37.277752|2017-10-11 05:44:37.277752
NCT00243100|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2013-12-13|||November 2005||2005-11-01|December 2013|2013-12-01||||August 2011|Actual|2011-08-01||Interventional|||Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase 1 Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Gemcitabine in Patients With Epithelial Tumors|Completed||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:44:37.410127|2017-10-11 05:44:37.410127
NCT00243113|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2013-03-25|||June 2004||2004-06-01|March 2008|2008-03-01|November 2008|Actual|2008-11-01|March 2008|Actual|2008-03-01||Interventional|||Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx|Multi-Institutional Phase II Study of Weekly Docetaxel and Concurrent Radiotherapy for Laryngeal and Hypopharyngeal Cancer in the Group of Elderly and/or Patients With Medical Illness|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:44:37.552928|2017-10-11 05:44:37.552928
NCT00243126|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2017-02-27|||November 2005||2005-11-01|February 2016|2016-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Family-based HIV Prevention for Adolescent Girls|Family-based HIV Prevention for Adolescent Females|Completed||N/A|168|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-10-11 05:44:37.68603|2017-10-11 05:44:37.68603
NCT00243139|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2006-09-14|||July 1999||1999-07-01|September 2006|2006-09-01|February 2004||2004-02-01|||||Interventional|||Mandibular Advancement Device for Obstructive Sleep Apnea|A Randomized Controlled Trial of a Mandibular Advancement Device for Obstructive Sleep Apnea|Completed||Phase 2/Phase 3|90||Nykøbing Falster County Hospital|||||f||||||||||||||2017-10-11 05:44:37.802526|2017-10-11 05:44:37.802526
NCT00243165|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2009-12-04|||November 2005||2005-11-01|October 2005|2005-10-01||||||||Interventional|||Lifemel Honey to Reduce Leucopenia During Chemotherapy|Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:44:38.029214|2017-10-11 05:44:38.029214
NCT00243178|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2009-10-16|||July 2003||2003-07-01|October 2009|2009-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)|A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation|Terminated||Phase 3|6706|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:44:38.109194|2017-10-11 05:44:38.109194
NCT00243191|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2012-02-14|2011-03-14||May 2006||2006-05-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans|Study of a Short Course of Neoadjuvant Gleevec (Imatinib Mesylate) in Dermatofibrosarcoma Protuberans|Completed||Phase 2|18|Actual|Sarcoma Alliance for Research through Collaboration|Dermatofibrosarcoma protuberans (DFSP)is a rare tumor type. During the the trial the drug manufacturer obtained approval for DSFP indication.The other limitation is limited funding; SARC is actively seeking funding for secondary outcome goal 12/2012.|1|||f||||t||||||||||2017-10-11 05:44:38.273739|2017-10-11 05:44:38.273739
NCT00243204|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2007-06-07|||January 2006||2006-01-01|June 2007|2007-06-01||||||||Interventional|||Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy||Terminated||Phase 3|400|Anticipated|Point Therapeutics||||FDA Hold May 2007|||||||||||||||2017-10-11 05:44:38.507124|2017-10-11 05:44:38.507124
NCT00243217|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2014-09-24|||April 2003||2003-04-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Rotigotine Restless Legs Syndrome Dose Finding Trial|Multi-center, Double-blind, Randomized, Placebo-controlled, Six-arm, Parallel-group, Dose-finding Trial to Determine Efficacy, Safety and Tolerability of Five Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome|Completed||Phase 2|341|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:44:38.770143|2017-10-11 05:44:38.770143
NCT00243230|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2015-09-24|||September 2005||2005-09-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|October 2007|Actual|2007-10-01||Interventional|||Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1) (Study P03672AM6)|Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1)|Completed||Phase 2|120|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-10-11 05:44:38.848825|2017-10-11 05:44:38.848825
NCT00243243|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2016-04-26|2012-08-28||January 2006||2006-01-01|April 2016|2016-04-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn|Effect of Recombinant Coagulation Factor VIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn Excision and Grafting|Completed||Phase 3|20|Actual|United States Army Institute of Surgical Research||2|||f||||f||||||||No||2017-10-11 05:44:38.956905|2017-10-11 05:44:38.956905
NCT00243256|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2008-05-08|||November 2005||2005-11-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Treatment of Obesity With Vitamin D (40.000 IE Per Week for 1 Year)||Completed||Phase 2|450|Anticipated|University of Tromso|||||f||||||||||||||2017-10-11 05:44:39.579012|2017-10-11 05:44:39.579012
NCT00243269|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2015-05-21|2010-03-22||November 2005||2005-11-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|May 2009|Actual|2009-05-01||Interventional|||Acupressure and Relaxation for Nausea Control|Acupressure and Relaxation for Nausea Control|Completed||Phase 1/Phase 2|83|Actual|University of Rochester|Limitations include a small sample size and the fact that we ceased recruitment to two of the treatment arms and changed our planned primary analysis mid-study based upon an interim analysis that was not specified at the time the study began.|4|||f||||t||||||||||2017-10-11 05:44:39.683852|2017-10-11 05:44:39.683852
NCT00243282|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2009-01-20|||October 2005||2005-10-01|March 2008|2008-03-01|October 2006||2006-10-01|||||Interventional|||Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life|Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life|Completed||N/A|120||VA Office of Research and Development||2|||f||||f||||||||||2017-10-11 05:44:40.171814|2017-10-11 05:44:40.171814
NCT00243295|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2006-10-05|||November 2003||2003-11-01|October 2006|2006-10-01|March 2005||2005-03-01|||||Interventional|||Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies|A Pilot Study to Validate the Feasibility of Injecting and Monitoring Recombinant Human Bone Morphogenetic Protein-2/Calcium Phosphate Matrix (rhBMP-2/CPM) in Subjects With Open Wedge Osteotomies|Completed||Phase 1|6||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:44:40.26099|2017-10-11 05:44:40.26099
NCT00243321|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2017-07-10|||February 2003||2003-02-01|July 2017|2017-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer|Phase I Examination of Combination High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Therapy for the Comprehensive Local Treatment of Patients With Locally Confined Adenocarcinoma of the Prostate|Completed||N/A|27|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-10-11 05:44:40.469127|2017-10-11 05:44:40.469127
NCT00243334|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2013-02-14|||July 2007||2007-07-01|February 2013|2013-02-01|June 2013|Anticipated|2013-06-01|December 2009|Actual|2009-12-01||Interventional|||Improving Safety and Quality With Outpatient Order Entry|Improving Safety and Quality With Outpatient Order Entry|Unknown status|Active, not recruiting|N/A|800|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-10-11 05:44:40.593109|2017-10-11 05:44:40.593109
NCT00243347|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2013-08-09|2013-03-22||December 2005||2005-12-01|August 2013|2013-08-01|July 2009|Actual|2009-07-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer|An Exploratory, Open-Lael Study to Assess the Effects of AZD2171 on Tumors and Biomarkers in Patients With Previously Untreated or Recurrent Non-small Cell Lung Cancer (NSCLC) or Patients With Metastatic or Recurrent Head and Neck Cancer (HNC)|Completed||Phase 1|19|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 05:44:40.744519|2017-10-11 05:44:40.744519
NCT00243360|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2005-10-21|||January 2001||2001-01-01|October 2005|2005-10-01|July 2003||2003-07-01|||||Interventional|||Optimizing Antibiotic Use in Long Term Care|Optimizing Antibiotic Use in Long Term Care|Completed||N/A|||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:44:41.230509|2017-10-11 05:44:41.230509
NCT00243373|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2012-01-18|||April 2005||2005-04-01|January 2012|2012-01-01|March 2008|Actual|2008-03-01|December 2005|Actual|2005-12-01||Interventional|||Using Barcode Technology to Improve Medication Safety|Using Barcode Technology to Improve Medication Safety|Completed||N/A|6700|Anticipated|Brigham and Women's Hospital|||||f||||||||||||||2017-10-11 05:44:41.355239|2017-10-11 05:44:41.355239
NCT00243386|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2015-06-26|2012-03-14|2011-06-27|January 2006||2006-01-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A|Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (ADVATE rAHF-PFM): A Phase 4 Study Comparing Two Prophylactic Regimens in Subjects With Severe or Moderately Severe Hemophilia A|Completed||Phase 4|82|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-10-11 05:44:41.493903|2017-10-11 05:44:41.493903
NCT00243399|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2011-07-14|||July 2004||2004-07-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia|A Pilot Trial of Oxandrolone for the Treatment of Bone Marrow Aplasia in Patients With Fanconi Anemia|Completed||Phase 1|10|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-10-11 05:44:42.984449|2017-10-11 05:44:42.984449
NCT00243412|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2011-09-06|2011-03-24||August 2005||2005-08-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|RUMBA||A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate|A Double-Blind, Randomized, Multicenter, Phase II Study of the Safety and Efficacy of Two Rituximab Regimens in Subjects With Moderate to Severe Active Rheumatoid Arthritis Receiving Stable Doses of Methotrexate|Completed||Phase 2|42|Actual|Genentech, Inc.|Because of the limited sample size, interpretation of these results should be made with caution and therefore definitive conclusions cannot be made regarding differences between the two retreatment regimens studied.|2|||f||||||||||||||2017-10-11 05:44:43.115772|2017-10-11 05:44:43.115772
NCT00243425|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2005-10-21|||March 2004||2004-03-01|October 2005|2005-10-01|March 2007||2007-03-01|||||Interventional|||Patient-Centered Depression Care for African Americans|Patient-Centered Depression Care for African Americans|Unknown status|Recruiting|N/A|250||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:44:43.634684|2017-10-11 05:44:43.634684
NCT00243438|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2009-01-27|||July 2003||2003-07-01|January 2009|2009-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Observational|||DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)|Distinctly Access Vision In Coronary Interventions|Completed||Phase 4|1300||Abbott Vascular|||1||f||||t||||||||||2017-10-11 05:44:43.736961|2017-10-11 05:44:43.736961
NCT00243451|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-09-02|||September 2003||2003-09-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Early Detection of Mild Cognitive Impairment in Individual Patients|Early Detection of Mild Cognitive Impairment in Individual Patients|Completed||N/A|34|Anticipated|Louisiana State University Health Sciences Center Shreveport|||1||f||||f||||||||||2017-10-11 05:44:43.807378|2017-10-11 05:44:43.807378
NCT00243464|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2015-03-25|||September 2005||2005-09-01|March 2015|2015-03-01|May 2006||2006-05-01|||||Interventional|||Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis|Calcipotriol Plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients With Scalp Psoriasis|Completed||Phase 3|300||LEO Pharma|||||f||||||||||||||2017-10-11 05:44:43.86588|2017-10-11 05:44:43.86588
NCT00243477|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2012-03-16|||January 2006||2006-01-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Interventional|||MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting|MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting|Completed||Phase 4|368|Actual|Hopital Jean Minjoz||2|||f||||t||||||||||2017-10-11 05:44:44.118811|2017-10-11 05:44:44.118811
NCT00243490|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2010-01-11||||||January 2010|2010-01-01|January 2009||2009-01-01|||||Interventional|||Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors|Prospective, Open-labeled, Clinical Trial in Compassionate Use to Evaluate the Efficacy and Safety of Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors|Withdrawn||Phase 2|5|Anticipated|National Taiwan University Hospital||||"The Trial could not get permit from Department of Health, Taiwan; Furthermore, no research fund   could support the expensive (photosensitizer) photosan"|f||||||||||||||2017-10-11 05:44:44.213995|2017-10-11 05:44:44.213995
NCT00243503|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2011-07-20|2010-04-20||February 2006||2006-02-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|April 2009|Actual|2009-04-01||Interventional|||Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer|A Phase 2 Efficacy And Safety Study Of SU011248 In Combination With Trastuzumab As Treatment For Metastatic Disease In Patients With Breast Cancer|Completed||Phase 2|60|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:44:44.344664|2017-10-11 05:44:44.344664
NCT00243529|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2009-09-28|||April 2004||2004-04-01|February 2009|2009-02-01||||February 2009|Actual|2009-02-01||Interventional|||Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients|In Vivo Responses of DC Vaccines Presenting HLA Class I and II Restricted Tumor Epitopes Either by Peptide-pulsing or mRNA Transfection in Melanoma Patients|Completed||Phase 1/Phase 2|64|Actual|Radboud University||3|||f||||f||||||||||2017-10-11 05:44:45.348473|2017-10-11 05:44:45.348473
NCT00243542|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2011-05-27|||November 2005||2005-11-01|May 2011|2011-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency|ACZ ACN 01. A Phase 4, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Cross-Over Study to Further Evaluate the Risk of Hematological Adverse Events in G6PD-Deficient Subjects With Acne Vulgaris Treated With ACZONE™ (Dapsone) Gel, 5%.|Completed||Phase 4|64|Actual|Allergan|||||||||||||||||||2017-10-11 05:44:45.49654|2017-10-11 05:44:45.49654
NCT00243555|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2007-01-31|||September 2002||2002-09-01|September 2006|2006-09-01||||||||Observational|||Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut|Molecular Analysis of Immuno-Regulatory Genes Expressed by Mononuclear Cells From Peanut Skin Test Positive Individuals With and Without a History of Peanut Ingestion|Unknown status|Recruiting|N/A|60||McMaster University|||||f||||||||||||||2017-10-11 05:44:45.675862|2017-10-11 05:44:45.675862
NCT00243568|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2009-10-21||2009-06-09|September 2005||2005-09-01|October 2009|2009-10-01||||||||Interventional|||Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285)(TERMINATED)|Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E2)|Terminated||Phase 3|500||Schering-Plough|||||f||||||||||||||2017-10-11 05:44:45.793247|2017-10-11 05:44:45.793247
NCT00243581|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2005-10-28|||August 2000||2000-08-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||The Effects of an Intensive Lifestyle Modification Program on Carotid Artery Intima-Media Thickness|The Effects of an Intensive Lifestyle Modification Program on Carotid Artery Intima-Media Thickness|Completed||Phase 4|||SwedishAmerican Health System|||||f||||||||||||||2017-10-11 05:44:45.874686|2017-10-11 05:44:45.874686
NCT00243594|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2009-02-18|||September 1999||1999-09-01|February 2009|2009-02-01||||January 2009|Actual|2009-01-01||Interventional|||Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection|Active Immunization of Patients With Stage III and IV Melanoma in Whom a Regional Lymph Node Dissection is Planned, With Peptide-Pulsed Dendritic Cells: Evaluation of in Vivo Immune and Clinical Response and Migration|Completed||Phase 1/Phase 2|40|Anticipated|Radboud University||1|||f||||f||||||||||2017-10-11 05:44:45.948552|2017-10-11 05:44:45.948552
NCT00243607|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2017-05-03|||May 2006||2006-05-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Hydrotherapy Against Menopausal Symptoms in Breast Cancer Survivors|Prospective Randomized Feasibility Study on the Self Application of Hydrotherapy to Treat Menopausal Symptoms Caused by Breast Cancer Therapy|Completed||N/A|45|Actual|Heidelberg University||2|||f||||f||||||||||2017-10-11 05:44:46.061595|2017-10-11 05:44:46.061595
NCT00243620|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2017-01-12|||May 2001||2001-05-01|May 2001|2001-05-01|May 2004||2004-05-01|||||Interventional|||A Randomised Controlled Trial Comparing Vacuum Assisted Closure (V.A.C.®) With Modern Wound Dressings|State-of-the Art Treatment of Chronic Leg Ulcers: a Randomised Controlled Trial Comparing Vacuum Assisted Closure (V.A.C.®) With Modern Wound Dressings|Completed||N/A|60||Maastricht University Medical Center|||||f||||||||||||||2017-10-11 05:44:46.182685|2017-10-11 05:44:46.182685
NCT00243633|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2008-03-18|||April 2005||2005-04-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|December 2006|Actual|2006-12-01||Interventional|||Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)|Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)|Completed||N/A|878|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-10-11 05:44:46.277027|2017-10-11 05:44:46.277027
NCT00243646|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2016-04-12|||August 2004||2004-08-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial|Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial|Terminated||Phase 3|6|Actual|Schiffler Cancer Center||2||poor accrual|f||||t||||||||||2017-10-11 05:44:46.415205|2017-10-11 05:44:46.415205
NCT00243659|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2011-06-02|2009-05-29||April 2006||2006-04-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery|An Open Label Multi-center Study to Assess the Efficacy and Safety of B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery|Completed||Phase 3|30|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-10-11 05:44:46.573754|2017-10-11 05:44:46.573754
NCT00243672|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2007-11-16|||October 2005||2005-10-01|November 2007|2007-11-01|October 2007||2007-10-01|||||Interventional|||Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques|Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques: a Randomised Microarray-Study on Endarterectomy Specimens of Human Carotid Arteries|Withdrawn||Phase 4|100|Anticipated|University Hospital Muenster||||The study chair changed his employment, the realization of the study was not possible|f||||||||||||||2017-10-11 05:44:47.105494|2017-10-11 05:44:47.105494
NCT00243685|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2012-01-25|||September 2006||2006-09-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|||||Interventional|||Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis|Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Drug Testing Sensitivity of Solid Tumors|Completed||Phase 2/Phase 3|150|Anticipated|DiaTech Oncology||1|||f||||f||||||||||2017-10-11 05:44:47.1923|2017-10-11 05:44:47.1923
NCT00243698|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2007-11-21|||May 2004||2004-05-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions|A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions|Completed||N/A|59|Actual|University Hospital, Tours|||||f||||f||||||||||2017-10-11 05:44:47.325184|2017-10-11 05:44:47.325184
NCT00243711|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2011-05-27|||September 2005||2005-09-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop||Completed||Phase 2/Phase 3|286|Actual|Allergan|||||f||||||||||||||2017-10-11 05:44:47.422833|2017-10-11 05:44:47.422833
NCT00243724|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2009-03-25|||April 2005||2005-04-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease|An Open-Label, Parallel-Group, Multi-Centre Study to Determine the Effect of Treatment With Esomeprazole for Six Months on Histological Markers of Esophageal Epithelial Acid-Related Disease in Patients With Upper GI Symptoms.|Completed||Phase 3|350|Anticipated|AstraZeneca|||||f||||||||||||||2017-10-11 05:44:47.493168|2017-10-11 05:44:47.493168
NCT00243737|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2013-01-23|||October 2005||2005-10-01|January 2013|2013-01-01|April 2006||2006-04-01|||||Interventional|||Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria|Open-label, Stratified Study on the Efficacy, Safety and Pharmacokinetic Characteristics of Two Paediatric Formulations of ArtequinTM in Children With Acute Uncomplicated P. Falciparum Malaria|Completed||Phase 2|70||Albert Schweitzer Hospital|||||f||||||||||||||2017-10-11 05:44:47.592183|2017-10-11 05:44:47.592183
NCT00243750|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2005-12-08|||September 2003||2003-09-01|August 2003|2003-08-01|November 2005||2005-11-01|||||Interventional|||Methotrexate in Ankylosing Spondylitis (MTX in AS)|Open Study for the Evaluation of the Efficacy of Methotrexate 20mg Given Subcutaneously in Patients With Active Ankylosing Spondylitis|Unknown status|Active, not recruiting|Phase 2|20||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:44:47.68835|2017-10-11 05:44:47.68835
NCT00243763|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2009-11-20||||||November 2009|2009-11-01||||||||Interventional|||TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma|Phase 1 Dose Escalating Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma|Terminated||Phase 1|64|Anticipated|Novartis|||||||||||||||||||2017-10-11 05:44:47.748286|2017-10-11 05:44:47.748286
NCT00243776|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2017-08-15|||April 2005||2005-04-01|August 2017|2017-08-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|||Calcium Current in Human Heart Cells|Calcium Current in Human Atrial Myocytes|Recruiting||N/A|600|Anticipated|Emory University|||1||f||||f||||||Samples Without DNA|"     tissue obtained from surgical waste tissue   "|||2017-10-11 05:44:47.824924|2017-10-11 05:44:47.824924
NCT00243789|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2011-10-26|||September 2005||2005-09-01|October 2011|2011-10-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy|A Double-Blinded Randomized Placebo Controlled Study of Daily Pentoxifylline as a Rescue Treatment in DMD|Completed||Phase 1/Phase 2|64|Actual|Cooperative International Neuromuscular Research Group||2|||f||||t||||||||||2017-10-11 05:44:48.071122|2017-10-11 05:44:48.071122
NCT00243802|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2013-09-26|||May 2005||2005-05-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation|Comparison of Markers of Oxidative Stress Present in Left Atrial Appendage Tissue From Subjects With and Without Atrial Fibrillation|Terminated||Phase 2|23|Actual|Emory University|||1|Terminated.|f||||f||||||||||2017-10-11 05:44:48.191372|2017-10-11 05:44:48.191372
NCT00243815|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2006-10-16|||June 2002||2002-06-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Interventional|||Use of Ibuprofen to Prevent IUD Site Effects|Prophylactic Ibuprofen: Effect on IUD Continuation Rates|Completed||Phase 3|2019||FHI 360|||||f||||||||||||||2017-10-11 05:44:48.254172|2017-10-11 05:44:48.254172
NCT00243828|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2015-09-14|||November 2005||2005-11-01|March 2007|2007-03-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Assessment of the Effectivity of Total-face Mask for Noninvasive Ventilation During Acute Respiratory Failure|Assessment of the Effectivity of Total-face Mask for Noninvasive Ventilation During Acute Respiratory Failure: a Randomized Controlled Trial.|Terminated||Phase 4|300||Corporacion Parc Tauli||||Very low rate of recruitment anticipated futility of pursuing the study|f||||f||||||||||2017-10-11 05:44:48.34237|2017-10-11 05:44:48.34237
NCT00243841|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2017-03-20|||May 2004||2004-05-01|March 2017|2017-03-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|SBF-HCC||Dose Escalation Study for Primary Hepatocellular Carcinoma|Multi-institution Phase I/II Dose Escalation Study of Hypofractionated Stereotactic Body Radiation Therapy for Primary Hepatocellular Carcinoma|Completed||N/A|72|Actual|Indiana University||2|||f||||t||||||||||2017-10-11 05:44:48.439365|2017-10-11 05:44:48.439365
NCT00243854|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2014-03-17|||November 2005||2005-11-01|March 2014|2014-03-01|October 2011|Actual|2011-10-01|August 2010|Actual|2010-08-01||Interventional|||Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer|Pilot Study Using Neoadjuvant Chemo-Radiotherapy and EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer|Completed||Phase 1|8|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 05:44:48.537538|2017-10-11 05:44:48.537538
NCT00243867|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2017-05-08|||November 2005|Actual|2005-11-01|May 2017|2017-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer|A Phase III, Randomized, Study of Weekly Taxoprexin Plus Carboplatin Versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|519|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||No||2017-10-11 05:44:48.620782|2017-10-11 05:44:48.620782
NCT00243880|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2016-05-05|||September 2005||2005-09-01|May 2016|2016-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|Neu-START||Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START)|SPOTRIAS: Neuroprotection With Statin Therapy for Acute Recovery Trial|Completed||Phase 1|33|Actual|Columbia University||1|||f||||t||||||||Undecided||2017-10-11 05:44:48.718397|2017-10-11 05:44:48.718397
NCT00243893|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2013-10-08|||July 2004||2004-07-01|October 2013|2013-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms|Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms|Completed||Phase 1|26|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-10-11 05:44:48.843404|2017-10-11 05:44:48.843404
NCT00243906|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2012-07-18||2012-07-18|January 2003||2003-01-01|July 2012|2012-07-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||Interventional Management of Stroke (IMS) II Study|Interventional Management of Stroke (IMS) II Study|Completed||Phase 2|81|Actual|University of Cincinnati||1|||f||||t||||||||||2017-10-11 05:44:48.93764|2017-10-11 05:44:48.93764
NCT00243919|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2014-07-09|2011-03-29||April 2006||2006-04-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|April 2010|Actual|2010-04-01||Interventional|LEAPS||Locomotor Experience Applied Post Stroke Trial|Locomotor Experience Applied Post Stroke (LEAPS) Trial|Completed||Phase 3|408|Actual|Duke University||3|||f||||||||||||||2017-10-11 05:44:49.052845|2017-10-11 05:44:49.052845
NCT00243932|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2014-01-28|2010-03-29||April 2005||2005-04-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Clinical Trial of High Dose CoQ10 in ALS|Clinical Trial of High Dose CoQ10 in ALS|Completed||Phase 2|185|Actual|Columbia University||3|||f||||t||||||||||2017-10-11 05:44:52.743266|2017-10-11 05:44:52.743266
NCT00249639|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-01-11|||January 2004||2004-01-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Contingency Management for Attendance - 2|Contingency Management for Attendance|Completed||N/A|300|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-10-11 05:46:44.161229|2017-10-11 05:46:44.161229
NCT00243945|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2014-09-24|||December 2004||2004-12-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease|A Phase 3b, Open-Label, Multicenter, Multinational Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders in Patients With Idiopathic Parkinson's Disease|Completed||Phase 3|58|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:44:53.31706|2017-10-11 05:44:53.31706
NCT00243958|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-23|2005-10-23|||October 2005||2005-10-01|October 2005|2005-10-01||||||||Observational|||Aluminum and Auditory Function in ESRD||Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:44:53.390426|2017-10-11 05:44:53.390426
NCT00243971|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2014-09-24|||November 2004||2004-11-01|September 2009|2009-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease|A Phase 3, Randomized, Open-Label, Two-Arm, Parallel-Group, Multicenter, Multinational Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-10-11 05:44:53.458275|2017-10-11 05:44:53.458275
NCT00243984|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2007-12-07|||March 2005||2005-03-01|December 2007|2007-12-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome|Suspended||Phase 3|90|Anticipated|Northeastern Ohio Universities College of Medicine||||Study was discontinued because of high drop out rate.|f||||||||||||||2017-10-11 05:44:53.536419|2017-10-11 05:44:53.536419
NCT00243997|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2008-10-13|||February 2002||2002-02-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Evaluation of the Efficacy of the Becoming Parents Program|Study of the Effects of the Becoming Parents Program on Couples Becoming Parents for the First Time|Completed||N/A|940|Actual|University of Washington||2|||f||||t||||||||||2017-10-11 05:44:54.790042|2017-10-11 05:44:54.790042
NCT00244010|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2017-04-24|2012-02-02||October 2005||2005-10-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias|Hematopoietic Stem Cell Transplantation (HSCT) From Partially Matched Family Donors for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias: A Pilot Study|Completed||N/A|4|Actual|St. Jude Children's Research Hospital|This study has terminated due to the PI leaving the institution. An insufficient number of subjects were enrolled to answer the primary objective.|1|||f||||f||||||||||2017-10-11 05:44:54.873657|2017-10-11 05:44:54.873657
NCT00244023|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-23|2008-08-22|||October 2005||2005-10-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone|Double-Blind, Placebo Controlled Randomized Study of Co-Administering Testosterone With PDE5 Inhibitors in Patients Non-Responders to PDE5 Inhibitors Alone|Completed||Phase 3|173|Actual|SELARL du Dr Jacques BUVAT||2|||f||||t||||||||||2017-10-11 05:44:55.167422|2017-10-11 05:44:55.167422
NCT00244049|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2014-12-05|||May 2004||2004-05-01|December 2014|2014-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||CHIPs or College Health Intervention Projects|"Primary Care Alcohol Intervention in College Students"|Completed||Phase 3|1000|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-10-11 05:44:55.281397|2017-10-11 05:44:55.281397
NCT00244062|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2015-10-01|||April 2001||2001-04-01|April 2011|2011-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Healthy Moms Alcohol Intervention|"Brief Alcohol Intervention: The Healthy Moms Project."|Completed||N/A|250||University of Wisconsin, Madison|||||f||||f||||||||||2017-10-11 05:44:55.357499|2017-10-11 05:44:55.357499
NCT00244075|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2015-05-22|||July 1998||1998-07-01|May 2015|2015-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients|Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients|Completed||Phase 2|46|Actual|Vanderbilt University||2|||f||||f||||||||||2017-10-11 05:44:55.424756|2017-10-11 05:44:55.424756
NCT00244088|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-21|2009-08-31|||April 2004||2004-04-01|August 2009|2009-08-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Study Evaluating the Etiology of Intra-Abdominal Infections|Study of the Etiology of Intra-Abdominal Infections|Completed||N/A|340||Wyeth is now a wholly owned subsidiary of Pfizer|||2||f||||||||||Samples Without DNA|"     Intra-abdominal fluid   "|||2017-10-11 05:44:55.510226|2017-10-11 05:44:55.510226
NCT00244101|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2012-08-16|2012-08-16||August 2003||2003-08-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2009|Actual|2009-06-01||Interventional|||Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome|Delivery Room Management of Premature Infants at High Risk of Respiratory Distress Syndrome|Completed||Phase 3|648|Actual|Vermont Oxford Network||3|||f||||t||||||||||2017-10-11 05:44:55.567762|2017-10-11 05:44:55.567762
NCT00244114|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-19|2013-02-14|||February 2006||2006-02-01|February 2013|2013-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients|In Vitro Evaluation Of Allergic Reactions In Hemophilia B Subjects Who Have Exhibited A Systemic Allergic Response After Exposure To BeneFIX (Nonacog Alfa; Recombinant Factor IX)|Completed||Phase 4|20|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||2||f||||f||||||||||2017-10-11 05:44:56.034765|2017-10-11 05:44:56.034765
NCT00244127|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2005-10-26|||October 2002||2002-10-01|October 2005|2005-10-01||||||||Interventional|||Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.|Cyclophosphamide, Oncovin, Myocet, Prednisone and Rituximab (R-COMP) in the Treatment of Elderly Patients With Aggressive NHL.|Unknown status|Active, not recruiting|Phase 2|75||Zeneus Pharma|||||f||||||||||||||2017-10-11 05:44:56.120015|2017-10-11 05:44:56.120015
NCT00244140|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2014-01-28|2009-05-29||October 2005||2005-10-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Ultravist: Safety and Efficacy in Computed Tomography of Head and Body|Ultravist 370 Milligrams of Iodine Per Milliliter (mg I/mL): Safety and Efficacy in Computed Tomography of Head and Body|Completed||Phase 3|435|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:44:56.233111|2017-10-11 05:44:56.233111
NCT00244153|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2006-09-07|||June 2004||2004-06-01|February 2004|2004-02-01|August 2007||2007-08-01|||||Interventional|||Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis|Intraarticular Application of Opioids Versus Glucocorticosteroids Versus Placebo in Rheumatoid Arthritis|Unknown status|Recruiting|Phase 1/Phase 2|120||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:44:56.734046|2017-10-11 05:44:56.734046
NCT00244166|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2006-09-07|||May 2002||2002-05-01|September 2006|2006-09-01|August 2008||2008-08-01|||||Interventional|||Prednisolone in Active Ankylosing Spondylitis (AS)|Threecenter Placebo Controlled Three Arm Trial in Patients With Active Ankylosing Spondylitis With Prednisolone|Unknown status|Recruiting|Phase 2/Phase 3|75||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:44:56.828076|2017-10-11 05:44:56.828076
NCT00244179|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2006-09-07|||January 2003||2003-01-01|September 2006|2006-09-01||||||||Interventional|||New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis|New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis: Immunostimulation Plus Antibiotic Versus Immunosuppression Plus Antibiotic Versus Conventional Standardtherapy|Unknown status|Recruiting|Phase 2|40||Charite University, Berlin, Germany|||||f||||||||||||||2017-10-11 05:44:56.934478|2017-10-11 05:44:56.934478
NCT00244192|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2005-12-08|||October 2003||2003-10-01|October 2005|2005-10-01|December 2005||2005-12-01|||||Interventional|||Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia|Completed||Phase 2|16||Center for Integrated Rehabilitation and Organ Failure Horn|||||f||||||||||||||2017-10-11 05:44:57.041537|2017-10-11 05:44:57.041537
NCT00244205|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2005-11-14|||November 2005||2005-11-01|November 2005|2005-11-01||||||||Observational|||Identifying Methylation Biomarkers for Monitoring Bladder Tumors|Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.|Unknown status|Recruiting|N/A|120||Copenhagen University Hospital at Herlev|||||f||||||||||||||2017-10-11 05:44:57.13802|2017-10-11 05:44:57.13802
NCT00244218|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2009-01-15|||April 2005||2005-04-01|January 2009|2009-01-01||||March 2009|Anticipated|2009-03-01||Interventional|||Response to Phenylketonuria to Tetrahydrobiopterin (BH4)|Response to Phenylketonuria to Tetrahydrobiopterin (BH4)|Unknown status|Recruiting|Phase 1|36|Anticipated|FDA Office of Orphan Products Development||1|||f||||||||||||||2017-10-11 05:44:57.221565|2017-10-11 05:44:57.221565
NCT00244231|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2007-02-27|||October 2003||2003-10-01|February 2007|2007-02-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia|A Placebo-Controlled, Double Blind Study to Evaluate the Efficacy and Safety of Nidadd in the Management of Hyperlipidemia|Completed||Phase 3|70||Genovate Biotechnology Co., Ltd.,|||||f||||f||||||||||2017-10-11 05:44:57.307805|2017-10-11 05:44:57.307805
NCT00244244|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2012-02-08|||October 2005||2005-10-01|February 2012|2012-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS|A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|80||CytRx|||||f||||||||||||||2017-10-11 05:44:57.385651|2017-10-11 05:44:57.385651
NCT00244257|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-04-08|||August 2005||2005-08-01|April 2015|2015-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)|Phase I, Open-Label, Multi-center, Single-Dose, Dose-Escalating, Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamic Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)|Terminated||Phase 1|10|Actual|Sanofi||5||Study terminated due to low enrollment.|f||||t||||||||||2017-10-11 05:44:57.491704|2017-10-11 05:44:57.491704
NCT00244270|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2011-08-26|||December 2005||2005-12-01|September 2005|2005-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|RITHM||Cystic Fibrosis and Totally Implantable Vascular Access Devices|Cystic Fibrosis and Totally Implantable Vascular Access Devices: Evaluation of the Incidence of Venous Thrombosis Related to the Catheter and Study of the Genetic and Acquired Risk Factors|Completed||Phase 4|97|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-10-11 05:44:57.596685|2017-10-11 05:44:57.596685
NCT00244283|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2005-10-24|||January 2006||2006-01-01|October 2005|2005-10-01|January 2008||2008-01-01|||||Interventional|||A Comparison of Two Anaesthetic Methods of Protecting Heart Tissue During Cardiac Surgery|A Comparison of Myocardial Protection Using Preconditioning With Sevoflurane Against High Thoracic Epidural Analgesia for CABG Surgery|Unknown status|Not yet recruiting|Phase 4|150||Golden Jubilee National Hospital|||||f||||||||||||||2017-10-11 05:44:57.803466|2017-10-11 05:44:57.803466
NCT00244296|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2007-01-24|||October 2005||2005-10-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms|A Double-Blind, Stratified, Randomised, Parallel, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy and Safety of Duloxetine (20 mg Bid for 2 Weeks Escalating to 40 mg Bid) for up to 12 Weeks, Compared to Placebo, in Community-Dwelling Elderly Women > or = 65 Years of Age With Symptoms of Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence.|Completed||Phase 4|276||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:44:57.903955|2017-10-11 05:44:57.903955
NCT00244309|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2011-05-03|||November 2005||2005-11-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer|A Randomized Trial of Tamsulosin and/or Dutasteride Versus Placebo to Relieve Urinary Symptoms After Brachytherapy for the Treatment of Localized Prostate Cancer|Completed||Phase 3|348|Anticipated|Case Comprehensive Cancer Center|||||f||||t||||||||||2017-10-11 05:44:58.053368|2017-10-11 05:44:58.053368
NCT00244322|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2007-05-24|||October 2005||2005-10-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease|LY450139: Tolerability and Biomarker Assessment in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|45||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:44:58.142442|2017-10-11 05:44:58.142442
NCT00231270|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2008-04-17|||August 2000||2000-08-01|July 2007|2007-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)|Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy|Completed||Phase 3|1300||Cordis Corporation|||||f||||t||||||||||2017-10-11 05:44:58.228473|2017-10-11 05:44:58.228473
NCT00231283|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2010-04-13|2008-11-18||April 2004||2004-04-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions|A Multicenter, Non-Randomized Study of the CYPHER NxT Sirolimus-Eluting Coronary Stent on BX SONIC OVER-THE-WIRE (OTW) Stent Delivery System(SDS)for the Treatment of de Novo Native Coronary Artery Lesions|Completed||Phase 3|100|Actual|Cordis Corporation||1|||f||||f||||||||||2017-10-11 05:44:58.306964|2017-10-11 05:44:58.306964
NCT00231296|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2017-05-02|||November 2004|Actual|2004-11-01|May 2017|2017-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of CryoCor™ Cryoablation for PAF|A Clinical Study to Evaluate the Safety and Efficacy of the CryoCor(TM)Cardiac Cryoablation System for the Treatment of Paroxysmal Atrial Fibrillation|Completed||N/A|174|Actual|Boston Scientific Corporation||2|||f||||f|f|t|t|f||||No||2017-10-11 05:44:58.578913|2017-10-11 05:44:58.578913
NCT00231309|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2014-08-19|2013-08-14||July 2003||2003-07-01|August 2014|2014-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)|Pilot Study of Using Granulocyte Colony Stimulating Factor-Primed Bone Marrow in Histocompatible Sibling Allogeneic Bone Marrow Transplantation for Patients With Hematologic Malignancies and Non-Malignancies|Completed||N/A|10|Actual|Emory University|Our study is also limited by its small patient population and short follow-up time.|1|||f||||t||||||||||2017-10-11 05:44:58.742715|2017-10-11 05:44:58.742715
NCT00231322|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2007-04-19|||March 2004||2004-03-01|April 2007|2007-04-01|March 2006||2006-03-01|||||Interventional|||Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique|The Influence of Transmission Season on Outcome of Schistosoma Haematobium Infection Treatment Among School Children in Urban and Peri-Urban Areas of Maputo and Matola, Mozambique|Completed||N/A|520||DBL -Institute for Health Research and Development|||||f||||||||||||||2017-10-11 05:44:58.946309|2017-10-11 05:44:58.946309
NCT00231335|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2010-12-06|||March 2006||2006-03-01|March 2006|2006-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia|The Efficacy and Safety of Escitalopram Augmentation of Risperidone and Olanzapine in Treatment Resistant Schizophrenia: a Double Blind Placebo Controlled Pilot Study|Completed||Phase 4|30|Anticipated|Emory University|||||f||||||||||||||2017-10-11 05:44:59.037096|2017-10-11 05:44:59.037096
NCT00231348|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2013-11-08||||||November 2013|2013-11-01|April 2000|Actual|2000-04-01|||||Interventional|||Nefazodone in the Treatment of Social Phobia|Nefazodone in the Treatment of Social Phobia: Functional Brain Imaging and Neuroendocrine Correlates|Completed||Phase 4|24||Emory University|||||f||||||||||||||2017-10-11 05:44:59.116371|2017-10-11 05:44:59.116371
NCT00231374|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2014-01-08|||September 2005||2005-09-01|January 2014|2014-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning|In Vivo Analysis of Intradural Pressure Variation With Patient Positioning|Withdrawn||N/A|0|Actual|Emory University||||Difficulty in recruiting patients for the study.|f||||||||||||||2017-10-11 05:44:59.205683|2017-10-11 05:44:59.205683
NCT00231387|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-01-20|||September 2002|Actual|2002-09-01|January 2017|2017-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus|Rosiglitazone and Plaque Study: A 12 Month Randomised, Double-blind, Placebo-controlled, Magnetic Resonance Imaging Study to Evaluate the Effect of Rosiglitazone on the Structure and Composition of Carotid Atherosclerotic Plaques in Subjects With Type 2 Diabetes Mellitus and Coexisting Vascular Disease or Hypertension|Completed||Phase 3|60||GlaxoSmithKline|||||f||||||||||||||2017-10-11 05:44:59.304049|2017-10-11 05:44:59.304049
NCT00231400|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2017-08-10|||August 21, 2004|Actual|2004-08-21|August 2017|2017-08-01|September 30, 2022|Anticipated|2022-09-30|September 30, 2022|Anticipated|2022-09-30||Observational|||Pompe Disease Registry|Pompe Disease Registry|Recruiting||N/A|2000|Anticipated|Sanofi|||1||f||||f||||||||||2017-10-11 05:44:59.438385|2017-10-11 05:44:59.438385
NCT00231413|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2016-09-22|||March 2005||2005-03-01|September 2016|2016-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.|A Dose-range Study to Assess the Safety and Immunogenicity of a Novel HPV Vaccine When Administered Intramuscularly According to a 3-dose Schedule (0,1,6-month) in Healthy Adult Females (18-25 Years of Age)|Completed||Phase 2|383|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:44:59.706136|2017-10-11 05:44:59.706136
NCT00231426|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2006-11-20|||June 2003||2003-06-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations|Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICDs Study|Completed||Phase 4|||Boston Scientific Corporation|||||f||||||||||||||2017-10-11 05:44:59.805076|2017-10-11 05:44:59.805076
NCT00231439|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2005-12-12|||August 2003||2003-08-01|July 2003|2003-07-01|July 2004||2004-07-01|||||Interventional|||Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)|Post-Polio Syndrome Treated With Intravenous Immunoglobulin (IvIg)|Completed||Phase 2/Phase 3|40||Haukeland University Hospital|||||f||||||||||||||2017-10-11 05:44:59.856559|2017-10-11 05:44:59.856559
NCT00231452|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-10-27|||September 2005||2005-09-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Age of Exposure and Immunity to Malaria in Infants|Age of Exposure and Immunity to Malaria in Infants|Completed||N/A|349|Actual|Hospital Clinic of Barcelona||3|||f||||t||||||||||2017-10-11 05:44:59.927966|2017-10-11 05:44:59.927966
NCT00231465|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2017-01-20|2012-11-01||July 2003||2003-07-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer|Phase II Study of Taxotere® (Docetaxel) + ZD1839 (IRESSA®) in Previously Untreated Elderly Patients (≥70 Years Old) With Stage III-b (With Malignant Pleural Effusion [MPE+]) or Stage IV Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|44|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-10-11 05:45:00.054167|2017-10-11 05:45:00.054167
NCT00231478|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-05-16|2011-03-30||April 2007||2007-04-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy|A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia|Completed||Phase 4|171|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-10-11 05:45:00.665589|2017-10-11 05:45:00.665589
NCT00231491|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2011-02-16|||November 2005||2005-11-01|March 2007|2007-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.|Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder (OAB). A Multicenter Phase II, Randomized, Double-blind, Placebo Controlled 6 Month Study . VESITOX|Completed||Phase 2|160|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:45:01.124308|2017-10-11 05:45:01.124308
NCT00231504|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2010-01-05|||October 2005||2005-10-01|March 2007|2007-03-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Observational|||Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count|Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count|Completed||Phase 1|82|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"     DNA   "|||2017-10-11 05:45:01.23952|2017-10-11 05:45:01.23952
NCT00231517|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2006-10-11||||||October 2005|2005-10-01||||||||Interventional|||Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa||Completed||Phase 4|||Institute of Child Health|||||f||||||||||||||2017-10-11 05:45:01.345716|2017-10-11 05:45:01.345716
NCT00231530|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-06|||January 2001||2001-01-01|April 2010|2010-04-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients on a Controlled Diet|Completed||Phase 3|541|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:45:01.429043|2017-10-11 05:45:01.429043
NCT00231543|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2006-10-11||||||October 2005|2005-10-01||||||||Interventional|||Laparoscopy in Children: Does it Decrease the Metabolic, Endocrine and Inflammatory Stress Response to Surgery||Completed||N/A|||Institute of Child Health|||||f||||||||||||||2017-10-11 05:45:01.523123|2017-10-11 05:45:01.523123
NCT00231556|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-06|||July 1999||1999-07-01|January 2010|2010-01-01|September 2003|Actual|2003-09-01|||||Interventional|||A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy|A Randomized, Double-Blind, Parallel-Group, Monotherapy Study to Compare the Safety and Efficacy of Two Doses of Topiramate in the Treatment of Newly Diagnosed or Recurrent Epilepsy|Completed||Phase 3|750|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:45:01.612569|2017-10-11 05:45:01.612569
NCT00231569|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2016-08-01|||September 2005||2005-09-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Dose-escalating Safety Study in Subjects on Stable Statin Therapy|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Dose‑Escalation Study to Assess the Safety and Pharmacodynamics of ISIS 301012 in Hypercholesterolemic Subjects on Stable Statin Therapy|Completed||Phase 2|74|Actual|Kastle Therapeutics, LLC||7|||f||||t||||||||||2017-10-11 05:45:01.717398|2017-10-11 05:45:01.717398
NCT00231582|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2011-02-24|||September 2004||2004-09-01|March 2007|2007-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II|Sequential High-Dose Chemotherapy Combining Two Mobilization and Cyto-Reductive Treatments Followed by Three High-Dose Chemotherapy Regimens Supported by Autologous Stem Cell Transplantation|Completed||Phase 2|50|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:45:01.897569|2017-10-11 05:45:01.897569
NCT00231595|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2010-11-18|||March 2001||2001-03-01|November 2010|2010-11-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine|Completed||Phase 3|768|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:45:02.032256|2017-10-11 05:45:02.032256
NCT00231608|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-06|||December 1998||1998-12-01|April 2010|2010-04-01|January 2002|Actual|2002-01-01|||||Interventional|||A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity|The Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity: A 6-Month Double-Blind, Randomized, Placebo-Controlled Study With a 6-Month Open-Label Extension|Completed||Phase 2|68|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:45:02.135056|2017-10-11 05:45:02.135056
NCT00231621|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-06|||May 2001||2001-05-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, One-year Study of the Efficacy and Safety of Topiramate in the Treatment of Obese Subjects With Dyslipidemia|Terminated||Phase 3|179|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"The study was terminated prior to completion to focus on the development of a controlled   release formulation."|f||||f||||||||||2017-10-11 05:45:02.261564|2017-10-11 05:45:02.261564
NCT00231634|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-06|||May 2001||2001-05-01|January 2011|2011-01-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy|Terminated||Phase 3|31|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||Program discontinued|f||||f||||||||||2017-10-11 05:45:02.38608|2017-10-11 05:45:02.38608
NCT00231647|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-06|||February 2004||2004-02-01|January 2011|2011-01-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Assess the Efficacy and Safety of Topiramate OROS Controlled-Release in the Treatment of Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin|Completed||Phase 2|113|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:45:02.505738|2017-10-11 05:45:02.505738
NCT00237250|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-09|2012-05-04|||October 2005||2005-10-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance|Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance|Completed||Phase 3|171|Actual|Novartis|||||f||||||||||||||2017-10-11 05:45:06.22591|2017-10-11 05:45:06.22591
NCT00231660|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-06|||October 2000||2000-10-01|January 2011|2011-01-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Treated With Metformin|Completed||Phase 3|211|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:45:02.602784|2017-10-11 05:45:02.602784
NCT00231673|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2011-06-06|||July 2001||2001-07-01|April 2011|2011-04-01|January 2003|Actual|2003-01-01|||||Interventional|||A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy|A Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Topiramate on Electrophysiological Parameters in Subjects With Diabetic Peripheral Polyneuropathy|Completed||Phase 2|72|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||||||||||||2017-10-11 05:45:02.699574|2017-10-11 05:45:02.699574
NCT00231686|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2005-09-30|||November 2000||2000-11-01|September 2005|2005-09-01|May 2003||2003-05-01|||||Interventional|||Effects of a 6-Months Physical Conditioning Program in Patients With Cystic Fibrosis|Effects of a 6-Months Physical Conditioning Program on Health Status and Physical Activity in Youths and Young Adults With Cystic Fibrosis - MUKOTRAIN|Completed||Phase 2/Phase 3|80||Julius-Maximilians University|||||f||||||||||||||2017-10-11 05:45:02.822147|2017-10-11 05:45:02.822147
NCT00231699|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2005-10-03|||January 2004||2004-01-01|October 2005|2005-10-01|December 2004||2004-12-01|||||Interventional|||A Comparison of Prevention of Hypothermia in Pediatric Patient Between Wrapping With Cotton and Plastic.|A Comparison of Prevention of Hypothermia in Pediatric Patient Between Wrapping With Cotton (Webril) and Plastic (Mwrap).|Completed||N/A|42||Khon Kaen University|||||f||||||||||||||2017-10-11 05:45:02.97509|2017-10-11 05:45:02.97509
NCT00231712|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2006-08-22|||March 2005||2005-03-01|September 2005|2005-09-01|February 2009||2009-02-01|||||Observational|||Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant|Prospective Analysis of the Patterns of Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Autologous/Allogeneic Stem Cell Transplant|Unknown status|Recruiting|N/A|50||Julius-Maximilians University|||||f||||||||||||||2017-10-11 05:45:03.080195|2017-10-11 05:45:03.080195
NCT00231725|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2007-06-26|||September 2005||2005-09-01|June 2007|2007-06-01|April 2006|Actual|2006-04-01|||||Interventional|||Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin|Complaints Associated With Use of Pre-Filled Pen B When Used by Patients With Type 2 Diabetes on Twice-Daily Insulin Therapy|Completed||Phase 3|370||Eli Lilly and Company|||||||||||||||||||2017-10-11 05:45:03.197575|2017-10-11 05:45:03.197575
NCT00231738|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-03|2015-11-19|||November 1996||1996-11-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Interventional|||Protective Effect of EPA on Cardiovascular Events|Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS)|Completed||Phase 4|18000||Kobe University|||||f||||||||||||||2017-10-11 05:45:04.050656|2017-10-11 05:45:04.050656
NCT00231751|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2005-09-30|||November 2002||2002-11-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Observational|||The Malmö International Brother Study (MIBS)|The Malmö International Brother Study (MIBS)|Completed||N/A|||Skane University Hospital|||||f||||||||||||||2017-10-11 05:45:04.136319|2017-10-11 05:45:04.136319
NCT00231764|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2008-04-22|||November 2002||2002-11-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|May 2006|Actual|2006-05-01||Interventional|||MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients|Evaluating Safety and Efficacy of MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Combination With Low-Dose CsA, Tac or Sir in Comparison to Current Standard Immunosuppression (MMF, CsA and Corticosteroids) in Renal Tx|Completed||Phase 4|1760||Ekberg, Henrik, M.D.|||||f||||||||||||||2017-10-11 05:45:04.210381|2017-10-11 05:45:04.210381
NCT00231777|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2015-08-18|2010-05-10||July 2005||2005-07-01|August 2015|2015-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)|A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study Conducted Under In-House Blinding Conditions, to Examine the Safety and Tolerability of IV MK0517 for the Prevention of Postoperative Nausea and Vomiting (PONV)|Completed||Phase 3|216|Actual|Merck Sharp & Dohme Corp.|The formulation of MK0517 used in this study was a non polysorbate (PS80) formulation which was not further developed and is not available for use.|2|||f||||f||||||||||2017-10-11 05:45:04.31573|2017-10-11 05:45:04.31573
NCT00231790|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2015-12-16|||August 2005||2005-08-01|December 2015|2015-12-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of MK0634 in Postmenopausal Women With Overactive Bladder|Completed||Phase 2|848|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-10-11 05:45:05.078315|2017-10-11 05:45:05.078315
NCT00231803|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2005-10-06|||April 2005||2005-04-01|October 2005|2005-10-01|December 2007||2007-12-01|||||Interventional|||The Canadian Prevention of Renal and Cardiovascular Endpoints Trial|Canadian Collaborative Group for the Prevention of Illness in Chronic Renal Disease. The Canadian Prevention of Renal and Cardiovascular Endpoints Trial|Unknown status|Recruiting|Phase 4|500||Memorial University of Newfoundland|||||f||||||||||||||2017-10-11 05:45:05.183032|2017-10-11 05:45:05.183032
NCT00231816|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2015-09-02|2010-05-12||September 2005||2005-09-01|September 2015|2015-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)|A Double-Blind, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of V211 Administered Concomitantly Versus Nonconcomitantly With Influenza Virus Vaccine (Inactivated)|Completed||Phase 3|763|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:45:05.311987|2017-10-11 05:45:05.311987
NCT00231829|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-30|2012-04-22|||April 2003||2003-04-01|April 2012|2012-04-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers|A Pilot Phase II Trial of Celecoxib in Patients With Grade 2 or 3 Endometrioid-type, Clear Cell, and Papillary Serous Uterine Cancers|Terminated||Phase 2|23||Montefiore Medical Center||||Due to reported toxicity of Celecoxib at high doses|f||||t||||||||||2017-10-11 05:45:06.108906|2017-10-11 05:45:06.108906
NCT00237263|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2017-02-21|||February 2003||2003-02-01|February 2017|2017-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States|An Extension Study to Phase IIb Dose-finding Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off|Completed||Phase 2|285|Actual|Novartis|||||f||||||||||||||2017-10-11 05:45:06.323492|2017-10-11 05:45:06.323492
NCT00237276|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2007-09-21|||October 2005||2005-10-01|September 2007|2007-09-01||||||||Interventional|||Experience and Enhancement: Improving Colonoscopic Polyp Detection|Evaluation of Effect of Colonoscopist Experience and Addition of of Mucosal Enhancement Techniques on Detection of Colonic Polyps When Viewing Videotaped Colonoscopic Withdrawals|Unknown status|Recruiting|N/A|30|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-10-11 05:45:06.46016|2017-10-11 05:45:06.46016
NCT00237289|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-05-17|||October 2001||2001-10-01|April 2010|2010-04-01|October 2003|Actual|2003-10-01|||||Interventional|||Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting|Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting|Completed||Phase 3|287|Actual|Ortho-McNeil Neurologics, Inc.||1|||f||||||||||||||2017-10-11 05:45:06.592514|2017-10-11 05:45:06.592514
NCT00237302|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-07|2011-05-17|||July 2001||2001-07-01|April 2010|2010-04-01|September 2003|Actual|2003-09-01|||||Interventional|||A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children|A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Migraine in Pediatric Subjects|Completed||Phase 3|162|Actual|Ortho-McNeil Neurologics, Inc.||1|||f||||||||||||||2017-10-11 05:45:06.681052|2017-10-11 05:45:06.681052
NCT00237315|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-10|2016-07-25|||February 2006||2006-02-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|||Longitudinal Study of Urea Cycle Disorders|Longitudinal Study of Urea Cycle Disorders|Recruiting||Phase 2|1100|Anticipated|Children's Research Institute|||1||f||||t||||||||||2017-10-11 05:45:06.783007|2017-10-11 05:45:06.783007
NCT00244335|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2017-01-09|||October 2000||2000-10-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|February 2006|Actual|2006-02-01||Observational|||Examining the Role of Negative Emotional States on Sedative Drug Use in Individuals With Post-Traumatic Stress Disorder|Emotional Control of Sedative Self-Medication in Post-Traumatic Stress Disorder|Completed||Phase 1/Phase 2|39|Actual|National Institute on Drug Abuse (NIDA)|||2||f||||t||||||||||2017-10-11 05:45:07.019848|2017-10-11 05:45:07.019848
NCT00244348|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-08-26|||October 2005||2005-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Hepatic Artery Infusion With Oxaliplatin|Hepatic Arterial Infusion of Oxaliplatin Clinical Trial|Withdrawn||Phase 1/Phase 2|0|Actual|Medical College of Wisconsin||||Investigator has left institution|f||||||||||||||2017-10-11 05:45:07.123979|2017-10-11 05:45:07.123979
NCT00244361|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2011-05-06|||June 2005||2005-06-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effectiveness of Rituximab in Pediatric OMS Patients.|A Phase I Clinical Trial of Rituximab for Pediatric Opsoclonus-Myoclonus Syndrome|Completed||Phase 1/Phase 2|25|Actual|National Pediatric Neuroinflammation Organization, Inc.|||||f||||t||||||||||2017-10-11 05:45:07.235669|2017-10-11 05:45:07.235669
NCT00244374|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-07-25|2013-04-25||August 2004||2004-08-01|July 2013|2013-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|UFO VAX||A Randomized Trial of Vaccine Adherence in Young Injection Drug Users|A Randomized Trial of Vaccine Adherence in Young IDU|Completed||N/A|546|Actual|University of California, San Francisco||4|||f||||f||||||||||2017-10-11 05:45:07.34921|2017-10-11 05:45:07.34921
NCT00244387|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2014-09-24|||March 2004||2004-03-01|February 2010|2010-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa|A Multi-centre, Multi-national, Phase 3, Randomized, Double-blind, Double-dummy, 3- Arm Parallel Group, Placebo- and Pramipexole- Controlled Trial of the Efficacy and Safety of Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa|Completed||Phase 3|506|Actual|UCB Pharma|||||||||||||||||||2017-10-11 05:45:08.056765|2017-10-11 05:45:08.056765
NCT00244400|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2006-10-16|||November 2002||2002-11-01|October 2006|2006-10-01|January 2006||2006-01-01|||||Observational|||Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis||Completed||N/A|200||Osaka City University|||||f||||||||||||||2017-10-11 05:45:08.129174|2017-10-11 05:45:08.129174
NCT00244413|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2013-03-05|||February 2006||2006-02-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Characteristics of Nondystrophic Myotonias|Nondystrophic Myotonias: Genotype-phenotype Correlation and Longitudinal Study|Completed||N/A|94|Actual|University of Kansas Medical Center|||1||f||||||||||Samples With DNA|"     Blood samples   "|||2017-10-11 05:45:08.200888|2017-10-11 05:45:08.200888
NCT00244426|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2009-10-29|||December 2000||2000-12-01|October 2009|2009-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|SIFA||S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation|II Italian Study on Atrial Fibrillation (S.I.F.A. II): Prevention of Thromboembolic Events in Patients With Non Valvular Atrial Fibrillation.|Completed||Phase 3|1372|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:45:08.328439|2017-10-11 05:45:08.328439
NCT00244439|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2013-12-19|||December 2005||2005-12-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice|A Multi-Center Phase III Study to Evaluate MALG, a Novel Malathion 0.05%Formulation, for the Control of Head Lice in Pediatric and Adult Subjects With Pediculosis Capitis|Completed||Phase 3|360|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-10-11 05:45:08.660049|2017-10-11 05:45:08.660049
NCT00244452|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2008-03-28|||November 2005||2005-11-01|March 2008|2008-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis|A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis|Completed||Phase 2|||Solvay Pharmaceuticals|||||f||||||||||||||2017-10-11 05:45:08.755818|2017-10-11 05:45:08.755818
NCT00244465|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2016-09-05|||May 2006||2006-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription|Post Marketing Non-interventional Surveillance Pharmacoepidemiology Study (PMSS) to Evaluate Long-term Safety, Tolerability and Compliance in Administration of Xyrem® (Sodium Oxybate) Oral Solution in Patients Who Receive Treatment With This Medication in Regular Clinical Practice.|Completed||Phase 4|750|Actual|UCB Pharma|||1||f||||f||||||||||2017-10-11 05:45:08.924128|2017-10-11 05:45:08.924128
NCT00244478|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-09-23|||October 2005||2005-10-01|September 2015|2015-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Soy, Bone and Health in College Females|Influence of Soy on Bone Turnover and Body Composition in College Females|Completed||N/A|120|Actual|University of Georgia||2|||f||||t||||||||||2017-10-11 05:45:09.089507|2017-10-11 05:45:09.089507
NCT00244491|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2015-08-10|||September 2002||2002-09-01|August 2015|2015-08-01|August 2003||2003-08-01|||||Interventional|||The Care Transitions Intervention|The Care Transitions Intervention|Completed||N/A|1400||University of Colorado, Denver|||||f||||||||||||||2017-10-11 05:45:09.186531|2017-10-11 05:45:09.186531
NCT00244504|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2009-11-09|||November 2002||2002-11-01|November 2009|2009-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Moxonidine in Patients Undergoing Vascular Surgery|The Effects of Small Doses of Moxonidine in Patients Undergoing Vascular Surgery|Terminated||Phase 3|141|Actual|University Hospital, Basel, Switzerland||2||Study was stopped after pre-definied interim analysis because of no effects|f||||t||||||||||2017-10-11 05:45:09.513291|2017-10-11 05:45:09.513291
NCT00244517|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2010-06-30|||June 2004||2004-06-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||DIAFAX I+II-Effects of Inhalative Anesthetics on Left Ventricular Diastolic Function|The Effects of Remifentanil, Sevoflurane, Isoflurane and Desflurane on Left Ventricular Diastolic Function in Humans|Terminated||Phase 4|60|Actual|University Hospital, Basel, Switzerland||3||"Part II was not performed as we could not include enough patients fulfilling the inclusion   criteria."|f||||t||||||||||2017-10-11 05:45:09.65529|2017-10-11 05:45:09.65529
NCT00244530|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2006-12-20|||June 2001||2001-06-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery|Postoperative Renal Function After Open-Heart Surgery in Patients With Impaired Renal Function Preoperatively. A Study of the Calcium Channel Blocker Nifedipine's Prophylactic Effect on Further Decline in Renal Function.|Completed||Phase 4|20||University of Oslo School of Pharmacy|||||f||||||||||||||2017-10-11 05:45:09.812024|2017-10-11 05:45:09.812024
NCT00244543|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2011-09-26|||October 2005||2005-10-01|September 2011|2011-09-01||||November 2005|Actual|2005-11-01||Interventional|||Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis|A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of R89674 0.25% Ophthalmic Solution in Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis|Completed||Phase 3|110||Vistakon Pharmaceuticals|||||f||||||||||||||2017-10-11 05:45:09.939543|2017-10-11 05:45:09.939543
NCT00244556|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-12|2013-02-20|||March 2003||2003-03-01|February 2013|2013-02-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy|A Randomized Comparison of the Safety and Efficacy of Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Patients With Active Rheumatoid Arthritis Despite Current Methotrexate Therapy|Completed||Phase 4|300||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:45:10.062973|2017-10-11 05:45:10.062973
NCT00244569|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-24|2017-03-16|||September 2005||2005-09-01|March 2017|2017-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Development of a Breath Test for Monitoring Patients With Liver Disease|Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis|Completed||Phase 3|120|Anticipated|Virginia Commonwealth University|||||f||||||||||||||2017-10-11 05:45:10.194985|2017-10-11 05:45:10.194985
NCT00244582|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2017-06-30|||October 22, 2005||2005-10-22|November 3, 2006|2006-11-03|November 3, 2006||2006-11-03|||||Observational|||Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease|Direct Convection-Enhanced Delivery of Glucocerebrosidase for the Treatment of Type 2 (Acute Neuronopathic) Gaucher Disease|Completed||N/A|1||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:45:10.373364|2017-10-11 05:45:10.373364
NCT00244595|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2009-12-08|||September 2003||2003-09-01|December 2009|2009-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age|A Multicenter, Multinational, Open-Label Study of the Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age|Completed||Phase 3|235||AstraZeneca|||||||||||||||||||2017-10-11 05:45:10.508374|2017-10-11 05:45:10.508374
NCT00244608|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2011-01-21|||May 2005||2005-05-01|January 2011|2011-01-01|March 2007|Actual|2007-03-01|||||Interventional|||A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®|A Comparison of the Inflammatory Control of Asthma Provided by One Inhalation of Symbicort® Turbuhaler® 160/4.5 µg/Inhalation b.i.d. Plus As-needed Versus One Inhalation of Symbicort® Turbuhaler® 320/9 µg/Inhalation b.i.d. + One Inhalation of Pulmicort® Turbuhaler® 400 µg/Dose b.i.d. Plus Terbutaline Turbuhaler® 0.4 mg/Inhalation As-needed. A 12-month, Randomised, Double-blind, Parallel-group, Active Controlled, Multinational, Phase IIIB Study in Adult Patients With Asthma, EOS|Completed||Phase 3|100||AstraZeneca|||||f||||||||||||||2017-10-11 05:45:10.853919|2017-10-11 05:45:10.853919
NCT00244621|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2011-08-29|2009-08-07||November 2004||2004-11-01|August 2011|2011-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age|A Dose-ranging Safety and Pharmacokinetics Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 1 to Less That 6 Years of Age: A 4-week, Multicenter, Randomized, Double-blind Study With a 1-year, Open-label, Follow-up Period.|Completed||Phase 3|95|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 05:45:11.134771|2017-10-11 05:45:11.134771
NCT00244634|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2007-12-17|||September 2003||2003-09-01|December 2007|2007-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age|A Dose-Ranging and Safety Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 6 to <17 Years of Age: A 4-Week, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study|Completed||Phase 3|238||AstraZeneca|||||||||||||||||||2017-10-11 05:45:11.914871|2017-10-11 05:45:11.914871
NCT00245102|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2014-05-07|2013-11-19||September 2005||2005-09-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma|A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas|Completed||Phase 2|147|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:45:12.305669|2017-10-11 05:45:12.305669
NCT00245115|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2016-10-14|||October 2005||2005-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|December 2007|Actual|2007-12-01||Interventional|||Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia|Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia|Active, not recruiting||N/A|25|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 05:45:13.919576|2017-10-11 05:45:13.919576
NCT00245128|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2011-12-01|2011-10-25||August 2005||2005-08-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|March 2007|Actual|2007-03-01||Interventional|||Imatinib Mesylate in Treating Patients With Myelofibrosis|A Phase II Pilot Study to Determine the Safety and Preliminary Efficacy of Imatinib Mesylate (Gleevec) in Patients With Myelofibrosis With Myeloid Metaplasia|Terminated||Phase 2|10|Actual|OHSU Knight Cancer Institute|Early termination/results were never analyzed due to negative study results from other similar studies.|1||"Per PI, results from another similar study were published prior to study analysis. Negative   study results were published therefore analysis was not completed"|f||||t||||||||||2017-10-11 05:45:14.025116|2017-10-11 05:45:14.025116
NCT00245141|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-08-09|||May 2004||2004-05-01|July 2009|2009-07-01||||April 2011|Anticipated|2011-04-01||Interventional|||Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma|Phase II Trial of Short VAC1.2 Therapy for Low-Risk A Group Patients With Rhabdomyosarcoma|Unknown status|Recruiting|Phase 2|32|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:45:14.378597|2017-10-11 05:45:14.378597
NCT00245154|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2016-11-25|||September 2005||2005-09-01|November 2012|2012-11-01|January 2013|Actual|2013-01-01|February 2008|Actual|2008-02-01||Interventional|||Paclitaxel and Carboplatin With or Without Cediranib Maleate in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II/III Double Blind Randomized Trial of AZD2171 Versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2/Phase 3|296|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-10-11 05:45:16.013874|2017-10-11 05:45:16.013874
NCT00245167|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2016-07-28|||January 2002||2002-01-01|March 2008|2008-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease|TLR's, Nitric Oxide and Chronic Lung Disease: Any Connections?|Completed||N/A|120||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:45:16.227448|2017-10-11 05:45:16.227448
NCT00245180|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2014-03-10|||May 2006||2006-05-01|April 2006|2006-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Preventing American Indian Children From Becoming Overweight|Primordial Prevention of Overweight in American Indian Children|Completed||N/A|577|Actual|Kaiser Permanente||1|||f||||f||||||||||2017-10-11 05:45:16.327607|2017-10-11 05:45:16.327607
NCT00245193|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-06-21|||April 2003||2003-04-01|June 2013|2013-06-01|March 2006|Actual|2006-03-01|||||Interventional|||Motivationally-Enhanced Brief Interpersonal Psychotherapy for Depressed Mothers of Ill Children|Motivationally-Enhanced Brief Interpersonal Psychotherapy for Depressed Mothers of Ill Children (MI-IPT-B-II)|Completed||Phase 4|50||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:45:16.428527|2017-10-11 05:45:16.428527
NCT00245206|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-06-11|||August 2005||2005-08-01|April 2009|2009-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Side Effects of Newer Antipsychotics in Older Adults|Metabolic Effects of Newer Antipsychotics in Older Patients|Completed||Phase 4|406|Actual|Veterans Medical Research Foundation||3|||f||||t||||||||||2017-10-11 05:45:16.518211|2017-10-11 05:45:16.518211
NCT00245219|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2016-02-03|2015-08-25||September 1999||1999-09-01|December 2015|2015-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Understanding Shared Psychobiological Pathways|Understanding Shared Psychobiological Pathways--Project 4. Psychobiological Pathways: Breast Cancer Interventions|Completed||N/A|245|Actual|Carnegie Mellon University|The study was originally planned as a 2(early stage, late stage) X 3(education intervention, peer support intervention, control condition) design; however, the education condition for the late stage cancer group was dropped, due to slow recruitment.|3|||f||||t||||||||||2017-10-11 05:45:16.649672|2017-10-11 05:45:16.649672
NCT00245232|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-03-30|||August 2000||2000-08-01|March 2015|2015-03-01|April 2005||2005-04-01|||||Interventional|||Cognitive Processing Therapy Versus Its Individual Components in the Treatment of Post-Traumatic Stress Disorder and Depression in Women Who Have Been Sexually Abused|Cognitive Processes in PTSD: Treatment|Completed||N/A|228||University of Missouri, St. Louis|||||f||||||||||||||2017-10-11 05:45:17.349775|2017-10-11 05:45:17.349775
NCT00245245|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2007-10-02|||May 2005||2005-05-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII|An Open-Label Study of the Hemostatic Activity, Pharmacokinetics and Safety of OBI-1 (B-Domain Deleted Recombinant Porcine FVIII), When Administered by Intravenous Injection, to Control Non-Life and Non-Limb Threatening Bleeding Episodes in Congenital Hemophilia A Patients With an Inhibitor to Human FVIII|Completed||Phase 2|12|Anticipated|Octagen Corporation|||||||||||||||||||2017-10-11 05:45:17.438087|2017-10-11 05:45:17.438087
NCT00245258|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2006-10-05|||November 2005||2005-11-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction|A Multicenter, Double-Blind Placebo Controlled, Fixed Dose Study With An Open-Label, Flexible Dose Phase To Assess The Efficacy Of Sildenafil Citrate In Providing A Better Sexual Experience Including Quality Of Erections And Satisfaction In Men With Erectile Dysfunction|Completed||Phase 4|312||Pfizer|||||f||||||||||||||2017-10-11 05:45:17.527994|2017-10-11 05:45:17.527994
NCT00245271|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2011-06-17||2011-06-17|October 2004||2004-10-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction|Double-Blind, Multicenter Study Evaluating the Safety of OMS103HP and Vehicle in Subjects Undergoing Anterior Cruciate Ligament Reconstruction With an Open-Label Phase Containing a PK Analysis in a Subset of Subjects|Completed||Phase 3|480|Anticipated|Omeros Corporation||2|||f||||f||||||||||2017-10-11 05:45:17.660232|2017-10-11 05:45:17.660232
NCT00245284|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2006-06-05|||September 2005||2005-09-01|June 2006|2006-06-01|May 2006||2006-05-01|||||Observational|||Predictor of Advanced Subclinical Atherosclerosis||Completed||N/A|600||PreMD|||||f||||||||||||||2017-10-11 05:45:17.782307|2017-10-11 05:45:17.782307
NCT00245297|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2007-10-15|||October 2005||2005-10-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.|A Patient-Blinded, Randomized, Comparative, Multicenter, Crossover, (Liposome) Dose Finding Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.|Completed||Phase 2|16|Actual|Recoly N.V.|||||f||||f||||||||||2017-10-11 05:45:17.861843|2017-10-11 05:45:17.861843
NCT00245310|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2010-10-08|||October 2005||2005-10-01|November 2008|2008-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Indocyangreen Elimination in Cirrhosis and Acute Liver Failure|Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure|Completed||N/A|40|Anticipated|Heidelberg University|||1||f||||||||||||||2017-10-11 05:45:17.962241|2017-10-11 05:45:17.962241
NCT00245323|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2005-10-25|||November 2003||2003-11-01|October 2005|2005-10-01|August 2004||2004-08-01|||||Interventional|||Checking Smoking Status as a Routine Vital Sign: A Cluster-Randomized Trial of Its Effect on Cessation Counseling|Does Checking Smoking Status as a Vital Sign Increase Physician Counseling? A Practice-Level Randomized Controlled Trial|Completed||N/A|2000||Virginia Commonwealth University|||||f||||||||||||||2017-10-11 05:45:18.04949|2017-10-11 05:45:18.04949
NCT00245336|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2009-03-06|||October 2005||2005-10-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Study of Recombinant Human Thrombin for Bleeding During Surgery|A Phase 3, Randomized, Double-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Recombinant Human Thrombin (rhThrombin) and Thrombin-JMI (Bovine Thrombin) in Surgical Hemostasis|Completed||Phase 3|401|Actual|ZymoGenetics||2|||f||||t||||||||||2017-10-11 05:45:18.131455|2017-10-11 05:45:18.131455
NCT00245349|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2008-06-09|||October 2005||2005-10-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|||||Observational|||Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer|Biodistribution and Radiation Dosimetry of F-18 Fluorothymidine (FLT) Imaged With Positron Emission Tomography (PET) in Patients With Head and Neck Cancer: A Radioactive Drug Research Committee (RDRC) Study|Completed||Phase 1|9|Actual|University of Iowa|||1||f||||t||||||Samples With DNA|"     Tumor biopsy, blood samples   "|||2017-10-11 05:45:18.296018|2017-10-11 05:45:18.296018
NCT00245362|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2005-10-27|||June 2002||2002-06-01|October 2005|2005-10-01|June 2004||2004-06-01|||||Interventional|||A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer|A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer|Completed||Phase 2|50||Cell Genesys|||||||||||||||||||2017-10-11 05:45:18.385544|2017-10-11 05:45:18.385544
NCT00245375|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2008-03-28|||January 2005||2005-01-01|March 2008|2008-03-01|December 2005|Actual|2005-12-01|||||Interventional|||A Trial Comparing Combination Therapy of Acetaminophen Plus Ibuprofen Versus Tylenol #3 for the Treatment of Pain After Outpatient Surgery|A Randomized Controlled Trial Comparing Combination Therapy of Acetaminophen Plus Ibuprofen Versus Tylenol #3 for the Treatment of Pain After Outpatient Surgery|Completed||N/A|150||Nova Scotia Health Authority|||||f||||||||||||||2017-10-11 05:45:18.465305|2017-10-11 05:45:18.465305
NCT00245388|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2012-04-20|||April 2002||2002-04-01|April 2012|2012-04-01|July 2002|Actual|2002-07-01|||||Interventional|||Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia|A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Trial to Determine the Lipid-Lowering Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia|Completed||Phase 2/Phase 3|330||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:45:18.568437|2017-10-11 05:45:18.568437
NCT00245401|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-04|2007-04-03|||August 2003||2003-08-01|April 2007|2007-04-01|December 2004|Actual|2004-12-01|||||Interventional|||CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)|CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)|Completed||Phase 4|2070||Cordis Corporation|||||f||||t||||||||||2017-10-11 05:45:18.86394|2017-10-11 05:45:18.86394
NCT00245414|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2010-11-16|||October 2005||2005-10-01|November 2010|2010-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Trial of Pegasys® in Patients With Chronic Hepatitis C|Post-marketing Clinical Trial of Pegasys® 180μg for Subcutaneous Injection in Patients With Chronic Hepatitis C. General Clinical Study in Interferon (IFN)-Treated and IFN-untreated Chronic Hepatitis C Patients, Except for Those Infected With High Viral Load of Genotype 1b|Completed||Phase 4|108|Actual|Chugai Pharmaceutical||4|||f||||f||||||||||2017-10-11 05:45:18.924604|2017-10-11 05:45:18.924604
NCT00245427|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2007-10-29|||December 2005||2005-12-01|October 2007|2007-10-01|March 2006|Actual|2006-03-01|||||Interventional|||Outcomes of Patients Not Responding to Antibiotics in the Community|Outcomes of Patients Not Responding to Outpatient Macrolide or b-Lactam Therapy for the Treatment of Community Acquired Pneumonia: Expansion to Include Acute Exacerbations of Chronic Bronchitis and Acute Sinusitis|Completed||N/A|200|Actual|CPL Associates||2|||f||||||||||||||2017-10-11 05:45:19.032279|2017-10-11 05:45:19.032279
NCT00245440|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2007-10-29|||December 2005||2005-12-01|October 2007|2007-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis|Influence of Oral Telithromycin vs. Azithromycin on the Endogenous Microflora in Adults With Acute Sinusitis|Terminated||Phase 4|192|Actual|CPL Associates||2||Sponsor Terminated|f||||||||||||||2017-10-11 05:45:19.120278|2017-10-11 05:45:19.120278
NCT00245453|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2015-07-27|||October 2005||2005-10-01|July 2015|2015-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Outpatient Registry Trial of Respiratory Tract Infections in Adults|Randomized Aseptic Pharmacokinetic Pharmacodynamic Outpatient Registry Trial of Respiratory Tract Infections in Adults (RAPPORT)|Withdrawn||Phase 4|0|Actual|CPL Associates||3||Terminated by sponsor|f||||||||||||||2017-10-11 05:45:19.218106|2017-10-11 05:45:19.218106
NCT00245466|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2011-05-18|2009-01-22||October 2001||2001-10-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients|An Open-Label, Multi-Centre, Extension Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients.|Terminated||Phase 2|88|Actual|Ferring Pharmaceuticals||3||The maintenance doses were too low to maintain testosterone suppression|f||||f||||||||||2017-10-11 05:45:19.355963|2017-10-11 05:45:19.355963
NCT00245479|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2011-05-18|||April 2002||2002-04-01|May 2011|2011-05-01|November 2006|Actual|2006-11-01|September 2005|Actual|2005-09-01||Interventional|DRIP||A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis|An Open Label, Multi-national Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis|Completed||Phase 4|802|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:45:20.861449|2017-10-11 05:45:20.861449
NCT00245492|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2009-01-27|||May 2006||2006-05-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.|Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.|Completed||N/A|792|Anticipated|Indiana University||1|||f||||||||||||||2017-10-11 05:45:20.978237|2017-10-11 05:45:20.978237
NCT00245505|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2012-03-09|||February 2009||2009-02-01|March 2012|2012-03-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||"The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active Drug: Crohn's Disease"|The Effect on Mucosal Healing With Pentasa Sachet 4g in Mild to Moderate Active Small Bowel Crohn´s Disease, Evaluated by Video Capsule Endoscopy After 6 and 12 Weeks Treatment. A Pilot Study|Terminated||Phase 3|3|Actual|Ferring Pharmaceuticals||1||Study terminated due to lack of eligible patients|f||||f||||||||||2017-10-11 05:45:21.081175|2017-10-11 05:45:21.081175
NCT00245531|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-03-30|||August 2004||2004-08-01|March 2015|2015-03-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Observational|||Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs|Effects of Endocrine Health on the Cognitive Function of Men and Women Using Drugs: A Cross-sectional Investigation|Completed||N/A|300|Anticipated|Johns Hopkins University|||2||f||||t||||||||||2017-10-11 05:45:21.247911|2017-10-11 05:45:21.247911
NCT00245544|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2015-05-20|||November 2005||2005-11-01|May 2015|2015-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)|A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover Study to Explore the Safety and Preliminary Efficacy of Oral MK0759 in the Treatment of Postherpetic Neuralgia|Terminated||Phase 2|20|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:45:21.359144|2017-10-11 05:45:21.359144
NCT00245557|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2017-03-01|2009-09-16||November 2004||2004-11-01|March 2017|2017-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Magnetic Resonance Imaging Study of Geriatric Depression|Nuclear Magnetic Resonance Imaging Study of Treatment With Sertraline in Geriatric Depression|Completed||N/A|43|Actual|Mclean Hospital||2|||f||||f||||||||||2017-10-11 05:45:21.454098|2017-10-11 05:45:21.454098
NCT00245570|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2015-06-22|2009-09-25||December 2005||2005-12-01|June 2015|2015-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)|A Double-Blind, Randomized Multicenter, 3-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast Compared With Placebo and Salmeterol on Exercise-Induced Bronchoconstriction|Completed||Phase 3|47|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-10-11 05:45:21.973955|2017-10-11 05:45:21.973955
NCT00245583|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2010-05-19||||||May 2008|2008-05-01||||||||Interventional|||Topiramate in the Treatment of Pathological Gambling|Topiramate in the Treatment of Pathological Gambling: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study|Unknown status|Active, not recruiting|Phase 4|120||Icahn School of Medicine at Mount Sinai|||||f||||||||||||||2017-10-11 05:45:22.820294|2017-10-11 05:45:22.820294
NCT00245596|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2008-02-22|||October 2005||2005-10-01|February 2008|2008-02-01||||||||Interventional|||Evaluation of the Index of Sexual Life Questionnaire|An Open Label, Multicenter Study to Measure Treatment Responsiveness of Quality of Sexual Life Questionnaire in the Female Partner of Men With Erectile Dysfunction Treated With Viagra (Sildenafil Citrate)|Completed||Phase 4|120||Pfizer|||||f||||||||||||||2017-10-11 05:45:22.96668|2017-10-11 05:45:22.96668
NCT00245609|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2008-03-19|||January 2006||2006-01-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial Of The Anxiolytic Efficacy Of Pregabalin And Alprazolam IR In Subjects With Anxiety Prior To Dental Procedure|Completed||Phase 2|90||Pfizer|||||f||||||||||||||2017-10-11 05:45:23.088327|2017-10-11 05:45:23.088327
NCT00245622|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-20|2014-02-06||2011-06-27|May 2006||2006-05-01|February 2014|2014-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|TERMS||Autologous T Cell Vaccine (TCV) for Multiple Sclerosis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Tovaxin in Subjects With CIS or RR-MS|Completed||Phase 2|150|Actual|Opexa Therapeutics, Inc.||2|||f||||t||||||||||2017-10-11 05:45:23.196721|2017-10-11 05:45:23.196721
NCT00245635|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2015-07-06|2015-04-21||November 2004||2004-11-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|FDA BDD||Fluoxetine in Pediatric Body Dysmorphic Disorder|Fluoxetine in Pediatric Body Dysmorphic Disorder|Completed||Phase 4|43|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-10-11 05:45:23.447709|2017-10-11 05:45:23.447709
NCT00245648|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2012-10-03|||June 2001||2001-06-01|October 2012|2012-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI|Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI; Results of the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries - V Trial|Completed||Phase 3|||New York University School of Medicine|||||f||||||||||||||2017-10-11 05:45:23.941375|2017-10-11 05:45:23.941375
NCT00245661|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2007-10-31|||October 2005||2005-10-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Effects of Temazepam in Patients With Chronic Pulmonary Obstructive Disease|Effects of Temazepam on Dyspnea, Gas Exchange and Sleep Quality in Chronic Obstructive Pulmonary Disease.|Completed||Phase 3|14|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-10-11 05:45:24.060638|2017-10-11 05:45:24.060638
NCT00245674|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2008-04-08|||June 2005||2005-06-01|April 2008|2008-04-01||||||||Interventional|||SOLIACS: Solian Solution in the Acute Setting|Solian Solution to Treat Schizophrenic Patients During an Acute Episode|Completed||Phase 4|300||Sanofi|||||f||||||||||||||2017-10-11 05:45:24.17708|2017-10-11 05:45:24.17708
NCT00245687|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2014-03-13|||June 2005||2005-06-01|March 2014|2014-03-01|June 2007|Actual|2007-06-01|||||Interventional|||A Research Study to Test (2) Two Different Types of Feeding Tubes Used in the Intensive Care Unit|A Comparative Study of the Tiger Tube Frictional Nasal Jejunal Feeding Tube and the Dubhoff Tube|Completed||N/A|60|Anticipated|Thomas Jefferson University|||||f||||||||||||||2017-10-11 05:45:24.26092|2017-10-11 05:45:24.26092
NCT00245713|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2013-11-25|||March 2003||2003-03-01|September 2009|2009-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.|9-11 Week Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Determine Effects of Adjunctive Levetiracetam on Sleep Architecture of Adults With Partial Onset Epilepsy Receiving a First Generation Anti-epileptic Drug.|Completed||Phase 4|40||UCB Pharma|||||f||||||||||||||2017-10-11 05:45:24.396441|2017-10-11 05:45:24.396441
NCT00245726|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2009-01-29|||March 2004||2004-03-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Functional Electrical Stimulation (FES) Cycling for Children With Spinal Cord Injuries (SCI)|Lower Extremity Cycling With Functional Electrical Stimulation to Improve the Health and Fitness of Children With Spinal Cord Injuries|Completed||N/A|30|Actual|Shriners Hospitals for Children||3|||f||||f||||||||||2017-10-11 05:45:24.458575|2017-10-11 05:45:24.458575
NCT00245739|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2014-04-10||||||April 2014|2014-04-01||||||||Expanded Access|||TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.|Early Access of TMC114 in Combination With Low-dose Ritonavir (TMC/r)) and Other Antiretrovirals (ARVs) in Highly Treatment Experienced HIV-1 Infected Patients With Limited to no Treatment Options.|Approved for marketing||N/A|||Tibotec Pharmaceuticals, Ireland|||||||||f||||||||||2017-10-11 05:45:24.721491|2017-10-11 05:45:24.721491
NCT00245752|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2009-02-04|||November 2005||2005-11-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Can Acupuncture be Used as Preparation for Induction of Labour|Randomised Study of the Effect of Acupuncture as Induction of Labour|Completed||Phase 2|125|Actual|Aarhus University Hospital Skejby||2|||f||||f||||||||||2017-10-11 05:45:26.071342|2017-10-11 05:45:26.071342
NCT00245765|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2013-09-06|||October 2005||2005-10-01|September 2009|2009-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy|Multicenter, Dose Response, Randomized, Double Blind, Parallel, Placebo Controlled Clinical Trial to Evaluate the Efficacy and the Safety of Subcutaneous CDP870 in Subjects Suffering From Moderate-to-severe Chronic Plaque Psoriasis Who Are Candidates for Systemic Therapy and/or Phototherapy and/or Photochemotherapy|Completed||Phase 2|176|Actual|UCB Pharma|||||f||||||||||||||2017-10-11 05:45:26.178574|2017-10-11 05:45:26.178574
NCT00245778|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2007-05-25|||March 2004||2004-03-01|May 2007|2007-05-01|February 2007|Actual|2007-02-01|||||Observational|||fMRI Study of Grasping in Autistic Patients|fMRI Study of Grasping in Autistic Patients|Terminated||N/A|30|Actual|University Hospital, Tours||||All the patients were included|f||||||||||||||2017-10-11 05:45:26.309313|2017-10-11 05:45:26.309313
NCT00245791|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2015-06-02|||October 2004||2004-10-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time|TREATMENT OF COMPLICATED URINARY INFECTION WITH FIVE DAY HIGH DOSE LEVOFLOXACIN|Terminated||Phase 4|30||University of Manitoba|||||f||||||||||||||2017-10-11 05:45:26.383039|2017-10-11 05:45:26.383039
NCT00245804|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2010-06-29|||March 2003||2003-03-01|January 2005|2005-01-01|February 2005||2005-02-01|||||Observational|DYS-AUT||Developmental Dyslexia and Functional Maturation of Auditory Cortex||Completed||N/A|60||University Hospital, Tours|||4||f||||t||||||||||2017-10-11 05:45:26.594777|2017-10-11 05:45:26.594777
NCT00245817|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2011-03-10|||August 2003||2003-08-01|December 2010|2010-12-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||HINCAB-study. Home Based Intervention in Nursing for Coronary Artery Bypass Patients|Coronary Artery Bypass Grafting (CABG) Patients in the Rehabilitation Phase. A Randomised Controlled Trial.|Completed||N/A|203|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 05:45:26.7385|2017-10-11 05:45:26.7385
NCT00245830|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2015-01-16|||October 2003||2003-10-01|January 2015|2015-01-01|March 2007|Actual|2007-03-01|July 2006|Actual|2006-07-01||Interventional|||Ischemic Preconditioning of Liver in Cadaver Donors|Ischemic Preconditioning of Liver in Cadaver Donors|Completed||N/A|100|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-10-11 05:45:26.875807|2017-10-11 05:45:26.875807
NCT00245843|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2009-03-31|||January 2005||2005-01-01|March 2009|2009-03-01|February 2010|Anticipated|2010-02-01|February 2008|Actual|2008-02-01||Interventional|||Vermont Intervention: Effect on Joint Attention Skills Between Parents and Moderate/Late Preterm Infants in the First Year of Life|Vermont Intervention: Effect on Joint Attention Skills Between Parents and Moderate/Late Preterm Infants Int the First Year of Life|Unknown status|Active, not recruiting|N/A|170|Actual|Ullevaal University Hospital||1|||f||||t||||||||||2017-10-11 05:45:27.022833|2017-10-11 05:45:27.022833
NCT00245856|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2013-02-15|2013-02-01||September 2002||2002-09-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|March 2009|Actual|2009-03-01||Interventional|||Treatment of Upper Extremity Deep-Vein Thrombosis|Treatment of Upper Extremity Deep-Vein Thrombosis|Completed||Phase 4|67|Actual|University of Oklahoma||1|||f||||||||||||||2017-10-11 05:45:27.159185|2017-10-11 05:45:27.159185
NCT00245869|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2007-02-19|||March 2004||2004-03-01|July 2006|2006-07-01|February 2007||2007-02-01|||||Interventional|||Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response|Contrast-Enhanced Ultrasound and Neoadjuvant Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response|Completed||N/A|30||University Hospital, Tours|||||f||||||||||||||2017-10-11 05:45:27.617335|2017-10-11 05:45:27.617335
NCT00245882|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2012-09-17|||October 2005||2005-10-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|DiaTel||The Diabetes Telemonitoring (DiaTel) Study|The Diabetes Telemonitoring (DiaTel) Study|Completed||N/A|150|Actual|VA Pittsburgh Healthcare System||2|||f||||f||||||||||2017-10-11 05:45:27.716489|2017-10-11 05:45:27.716489
NCT00245895|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2007-11-27|||April 2003||2003-04-01|November 2007|2007-11-01|February 2005|Actual|2005-02-01|||||Interventional|||Study of Aranesp to Treat Anemia in Prostate Cancer Patients.|Phase II Study of Aranesp (Darbepoetin Alfa) to Treat Anemia in Prostate Cancer Patients.|Completed||Phase 2|20|Actual|University of Washington||1|||f||||f||||||||||2017-10-11 05:45:27.858294|2017-10-11 05:45:27.858294
NCT00245908|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2005-10-27|||September 1999||1999-09-01|January 2002|2002-01-01|September 2002||2002-09-01|||||Interventional|||ASTHMA (AntibioticS To Help Manage Asthma) Pilot Study||Completed||Phase 3|100||Wisconsin Research Network|||||f||||||||||||||2017-10-11 05:45:27.993092|2017-10-11 05:45:27.993092
NCT00245921|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2013-02-07|||February 2003||2003-02-01|May 2006|2006-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception|A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg in a Continuous Daily Regimen for Oral Contraception|Completed||Phase 3|2000||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:45:28.088865|2017-10-11 05:45:28.088865
NCT00245934|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2007-12-12|||June 2003||2003-06-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|||||Observational|||Study Evaluating Enbrel in Patients With Rheumatoid Arthritis|Observational Study With Enbrel in Patients With Rheumatoid Arthritis|Completed||N/A|1500||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:45:28.183795|2017-10-11 05:45:28.183795
NCT00245947|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2009-09-09|||April 2004||2004-04-01|September 2009|2009-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study Evaluating ERB-041 in Active Crohn's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel- Design, Exploratory Pharmacogenomic, Safety and Activity Study of Orally Administered ERB-041 in Subjects With Inflammation Associated With Active Crohn's Disease|Completed||Phase 1|22|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:45:28.263282|2017-10-11 05:45:28.263282
NCT00245960|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2009-03-31|2009-03-31||December 2005||2005-12-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis|A Randomized, Double-Blind, Two-Period Study to Evaluate the Safety and Efficacy of Etanercept on Skin and Joint Disease in Psoriasis Subjects With Psoriatic Arthritis.|Completed||Phase 4|752|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-10-11 05:45:28.362373|2017-10-11 05:45:28.362373
NCT00245973|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2007-12-03|||June 2005||2005-06-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Evaluating Bifeprunox in Bipolar Depression|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder|Completed||Phase 3|380||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:45:29.501186|2017-10-11 05:45:29.501186
NCT00245986|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2017-06-30|||October 18, 2005||2005-10-18|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Interventional|||Effect of Genetics on Metabolism of Efavirenz|Pharmacogenetics of Efavirenz Metabolism: Association of CYP2B6 Genotype and Prolonged Drug Exposure|Completed||Phase 4|350||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:45:29.75352|2017-10-11 05:45:29.75352
NCT00246012|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2013-07-17|2013-05-01||May 2005||2005-05-01|July 2013|2013-07-01|February 2009|Actual|2009-02-01|June 2008|Actual|2008-06-01||Interventional|||A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma|A Phase 1/2, Multi-Center, Blinded, Randomized, Controlled Study of the Safety and Efficacy of the Human Monoclonal Antibody to Human α ν Integrins (CNTO 95), Alone and in Combination With Dacarbazine, in Subjects With Stage IV Melanoma|Completed||Phase 1/Phase 2|144|Actual|Centocor, Inc.||9|||f||||t||||||||||2017-10-11 05:45:29.947431|2017-10-11 05:45:29.947431
NCT00246025|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2014-06-03|2010-11-18||October 2005||2005-10-01|February 2014|2014-02-01||||June 2007|Actual|2007-06-01||Interventional|||A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.|A Randomised, Parallel-group, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Knee Replacement Surgery|Completed||Phase 2|512|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-10-11 05:45:33.424048|2017-10-11 05:45:33.424048
NCT00246038|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2015-08-27||||||August 2015|2015-08-01||||||||Interventional|||The Boston Scientific ENOVUS Trial|A Phase II Evaluation of the Safety and Efficacy of the Boston Scientific ENOVUS AAA Endograft in the Treatment of Abdominal Aortic Aneurysms|Withdrawn||Phase 2|0|Actual|Boston Scientific Corporation||||Sponsor cancelled the development program, and never conducted the study.|f||||f||||||||||2017-10-11 05:45:34.888957|2017-10-11 05:45:34.888957
NCT00246051|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2013-08-13|||November 2005||2005-11-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Comprehensive Police Fatigue Management Program|Testing the Effectiveness of a Comprehensive Fatigue Management for the Police|Completed||N/A|683|Actual|Brigham and Women's Hospital||3|||f||||||||||||||2017-10-11 05:45:35.034496|2017-10-11 05:45:35.034496
NCT00246064|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-05-18|||December 2001||2001-12-01|January 2011|2011-01-01|November 2003|Actual|2003-11-01|||||Interventional|||The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol|The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol. Tapering Methotrexate in Patients With Rheumatoid Arthritis Beginning Therapy With Infliximab|Completed||Phase 4|210|Actual|Centocor Ortho Biotech Services, L.L.C.|||||f||||||||||||||2017-10-11 05:45:35.241782|2017-10-11 05:45:35.241782
NCT00246077|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2007-04-10|||October 2005||2005-10-01|November 2005|2005-11-01|December 2005|Actual|2005-12-01|||||Observational|||Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport|Quality of Life of Children With Sickle Cell Disease Who Are Receiving Chronic Transfusion Therapy With a Lifeport Device|Completed||N/A|5||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:45:35.356455|2017-10-11 05:45:35.356455
NCT00246090|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2014-06-30|2011-12-22||October 2005||2005-10-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine|A Phase II Open Label Single-Arm Study of E7389 in Patients With Locally Advanced or Metastatic Breast Cancer, Previously Treated With Anthracycline, Taxane, and Capecitabine Therapy, Refractory to the Last Prior Therapy for Their Disease|Completed||Phase 2|298|Actual|Eisai Inc.||1|||f||||||||||||||2017-10-11 05:45:35.448208|2017-10-11 05:45:35.448208
NCT00246103|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2017-02-20|||March 2004||2004-03-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies|Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies|Completed||Phase 1|82|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||||||||||||2017-10-11 05:45:36.62464|2017-10-11 05:45:36.62464
NCT00246285|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-06-06|||April 2001||2001-04-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia|The Efficacy And Safety Of Risperidone In The Treatment Of Adolescents With Schizophrenia: A Six-Month Open-Label Study.|Completed||Phase 3|381|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:45:39.205912|2017-10-11 05:45:39.205912
NCT00246116|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2017-01-27|||February 2002||2002-02-01|January 2017|2017-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|SBF Companion||Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer|Functional Imaging of Treatment Effects: A Companion Protocol to a Phase II Study of Extracranial Stereotactic Radioablation (a.k.a. Stereotactic Body Radiotherapy) in Early Stage Non-Small Cell Lung Cancer.|Completed||N/A|15|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 05:45:36.763683|2017-10-11 05:45:36.763683
NCT00246142|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2007-10-11|||April 2005||2005-04-01|October 2007|2007-10-01||||||||Interventional|||A Study of the Combination of Electrical Stimulation and Dysport® in Myofascial Pain Syndrome.|A 16-Week Prospective Randomised Double-Blind Study on Facilitation of DYSPORT® Effect on Myofascial Pain Syndrome (MPS) by Electrical Stimulation.|Completed||Phase 3|68||Ipsen|||||f||||||||||||||2017-10-11 05:45:37.049585|2017-10-11 05:45:37.049585
NCT00246155|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2006-10-10|||January 2005||2005-01-01|October 2006|2006-10-01||||||||Interventional|||Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain|A Prospective Study to Evaluate the Potential Effects on Function and Size in Back Muscle After Injection of Botulinum Toxin Type A (Dysport®) in the Treatment of Chronic Low Back Pain|Completed||Phase 3|35||Ipsen|||||f||||||||||||||2017-10-11 05:45:37.15138|2017-10-11 05:45:37.15138
NCT00246168|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2010-11-29||||||November 2010|2010-11-01|June 2005|Actual|2005-06-01|||||Interventional|||ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.|ULTRACET (Tramadol Hydrochloride and Acetaminophen) add-on Therapy for the Treatment of the Pain of Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 4|277|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-10-11 05:45:37.247223|2017-10-11 05:45:37.247223
NCT00246181|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2014-01-10|||December 1999||1999-12-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|SBF-NSCLC||Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC|Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC|Completed||Phase 1/Phase 2|117|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 05:45:37.337296|2017-10-11 05:45:37.337296
NCT00246194|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2014-04-02|||September 2004||2004-09-01|April 2014|2014-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|SOURCE||Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)|The SOURCE Study: Schizophrenia Outcomes-utilization, Relapse, and Clinical Evaluation: a Prospective 2-year Observational Study of Patients With Schizophrenia Who Initiate Treatment With Injectable Risperidone Long-acting Microspheres (RISPERDAL CONSTA)|Completed||Phase 4|532|Actual|Janssen, LP|||1||f||||f||||||||||2017-10-11 05:45:37.426851|2017-10-11 05:45:37.426851
NCT00246207|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2012-02-09|||March 2005||2005-03-01|February 2012|2012-02-01|December 2005|Actual|2005-12-01|||||Interventional|||CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults|An Open-label Study Evaluating the Safety and Effectiveness of OROS Methylphenidate Hydrochloride (CONCERTA) in Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 3|32|Actual|Janssen-Ortho Inc., Canada||1|||f||||||||||||||2017-10-11 05:45:37.543268|2017-10-11 05:45:37.543268
NCT00246220|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-05-16|||March 2005||2005-03-01|April 2010|2010-04-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.|A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study To Evaluate the Safety And Efficacy Of Prolonged Release OROS Methylphenidate Hydrochloride (18, 36 and 72 mg/Day), With Open-Label Extension, In Adults With Attention Deficit/Hyperactivity Disorder|Completed||Phase 3|402|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:45:37.63664|2017-10-11 05:45:37.63664
NCT00246233|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-05-16|||June 2005||2005-06-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|||||Interventional|||CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.|A Double-blind, Placebo-controlled, Randomized Trial to Evaluate the Safety, Tolerability and Efficacy of CONCERTA® (Methylphenidate Hydrochloride) Augmentation of SSRI/SNRI Monotherapy in Adult Patients With Major Depressive Disorder.|Completed||Phase 3|145|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-10-11 05:45:37.717313|2017-10-11 05:45:37.717313
NCT00246246|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-02-10|||January 2004||2004-01-01|February 2011|2011-02-01|April 2006|Actual|2006-04-01|||||Interventional|||A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder|A Randomized, Open-label Trial of RISPERDAL® CONSTA™ Versus Oral Antipsychotic Care in Subjects With Bipolar Disorder|Completed||Phase 3|48|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-10-11 05:45:38.108867|2017-10-11 05:45:38.108867
NCT00246259|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2013-11-15|2013-03-20||October 2004||2004-10-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||Analysis was based on the Intent-to-treat (ITT) population.|A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis|An Open-Label Randomized Trial Comparing Risperdal Consta With Oral Antipsychotic Care in the Treatment of Early Psychosis|Completed||Phase 4|77|Actual|Janssen-Ortho Inc., Canada||2|||f||||f||||||||||2017-10-11 05:45:38.199846|2017-10-11 05:45:38.199846
NCT00246272|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2010-04-26|||October 2004||2004-10-01|April 2010|2010-04-01|May 2006|Actual|2006-05-01|||||Interventional|||An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone|An Open-label Study Evaluating the Maintenance of Clinical Effect in Adults With Schizophrenia Switched From RISPERDAL® Tablets (Risperidone) to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone|Completed||Phase 3|82|Actual|Janssen-Ortho Inc., Canada||1|||f||||||||||||||2017-10-11 05:45:39.043518|2017-10-11 05:45:39.043518
NCT00246298|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-06-08|||October 2005||2005-10-01|March 2010|2010-03-01|September 2006|Actual|2006-09-01|||||Interventional|||A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients|A Randomized, Open-Label Study Assessing the Efficacy of Initiating PROCRIT (Epoetin Alfa) Dosing at Q2W vs. PROCRIT Dosing at QW in Anemic HIV-infected Subjects|Terminated||Phase 2|31|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||OBI business decision not to complete any additional research in HIV.|||||f||||||||||2017-10-11 05:45:39.302328|2017-10-11 05:45:39.302328
NCT00246324|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2012-04-13|2011-05-05||December 2003||2003-12-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis|An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)|Completed||Phase 4|16|Actual|Louisiana State University Health Sciences Center Shreveport||1|||f||||f||||||||||2017-10-11 05:45:39.398417|2017-10-11 05:45:39.398417
NCT00246337|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2015-10-30|2010-07-19||November 2005||2005-11-01|October 2015|2015-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)|A Multicenter, Double-Blind, Placebo and Active-Controlled, Dose-Finding Study of MK0974 in the Treatment of Acute Migraine|Completed||Phase 2|420|Actual|Merck Sharp & Dohme Corp.||9|||f||||||||||||||2017-10-11 05:45:39.648842|2017-10-11 05:45:39.648842
NCT00246350|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2010-11-19|||September 2004||2004-09-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Spinal Manipulation for Treatment of Chronic Headaches|Dose-Response of Manipulation for Chronic Headache|Completed||Phase 2|80|Actual|University of Western States||4|||f||||f||||||||||2017-10-11 05:45:41.379823|2017-10-11 05:45:41.379823
NCT00246363|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2011-09-14|||January 2005||2005-01-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C|A Pilot Randomized Placebo-Controlled Trial Designed to Determine the Tolerability and Efficacy of Silymarin (Milk Thistle) vs. Placebo for the Treatment of Chronic Hepatitis C in HIV Infected Patients|Completed||Phase 1/Phase 2|40|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-10-11 05:45:41.496202|2017-10-11 05:45:41.496202
NCT00246376|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2016-02-25|2015-10-20||January 2004||2004-01-01|February 2016|2016-02-01|February 2012|Actual|2012-02-01|September 2009|Actual|2009-09-01||Interventional|HeartPositive||Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia|Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy|Completed||N/A|221|Actual|Baylor College of Medicine|High dropout rate, especially by loss to follow-up (with no explanation). Flushing was common among patients taking niacin, and this (with transportation and socio-economc problems) could have contributed to the high drop-out rate.|5|||f||||t||||||||||2017-10-11 05:45:41.633795|2017-10-11 05:45:41.633795
NCT00246389|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-02-17||||||February 2011|2011-02-01|July 2004|Actual|2004-07-01|||||Interventional|||An Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm|Flexeril� (Cyclobenzaprine Hydrochloride) Community Based Study - An Evaluation of Cyclobenzaprine HCl Monotherapy and in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm|Completed||Phase 4|1000|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||f||||||||||||||2017-10-11 05:45:42.514592|2017-10-11 05:45:42.514592
NCT00246402|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2014-05-14|||September 2002||2002-09-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV|Anti-Lipolytic Strategy for HIV Lipodystrophy|Completed||N/A|30||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:45:42.584993|2017-10-11 05:45:42.584993
NCT00246415|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2008-10-07|||November 2002||2002-11-01|October 2008|2008-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Placebo-Controlled Trial of Memantine for Alcohol Dependence|Medications Development for Alcohol Abuse: NMDA Agents -- A Placebo-Controlled Trial of Memantine for Alcohol Dependence|Completed||Phase 2|90||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 05:45:42.842332|2017-10-11 05:45:42.842332
NCT00246428|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2007-12-06|||January 2000||2000-01-01|December 2007|2007-12-01|July 2003|Anticipated|2003-07-01|||||Interventional|||Motivational Interviewing for Alcohol-Positive Teens in the Emergency Room|Motivational Interviewing (MI) for ETOH+ Teens in the ER|Unknown status|Active, not recruiting|Phase 3|198|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||||||||||||2017-10-11 05:45:42.930084|2017-10-11 05:45:42.930084
NCT00246441|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2016-12-01|||March 2002||2002-03-01|November 2009|2009-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism|Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism|Completed||Phase 4|42|Actual|Medical University of South Carolina||2|||f||||f||||||||No||2017-10-11 05:45:43.032127|2017-10-11 05:45:43.032127
NCT00246454|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2016-09-22|||September 2003||2003-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Circadian Rhythms and Sleep in Familial DSPS and ASPS|Circadian Rhythms and Sleep in Familial Delayed Sleep Phase Syndrome (DSPS) and Advanced Sleep Phase Syndrome (ASPS)|Recruiting||N/A|156|Anticipated|Northwestern University|||3||f||||f||||||Samples Without DNA|"     plasma   "|No||2017-10-11 05:45:43.170761|2017-10-11 05:45:43.170761
NCT00246467|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2008-09-12|||October 2005||2005-10-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)|A Phase 1b, Multi-Centre, Parallel Group, Single Blind Study to Evaluate the Safety, Tolerability and Immunogenicity of a Recombinant Plague Vaccine (rF1 and rV Antigens) in Healthy Subjects|Completed||Phase 1|123|Actual|PharmAthene UK Limited|||||f||||t||||||||||2017-10-11 05:45:43.275219|2017-10-11 05:45:43.275219
NCT00246480|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2010-08-26|||October 2005||2005-10-01|April 2008|2008-04-01|October 2009||2009-10-01|||||Observational|||RSV Disease in the Elderly|Pathogenesis of RSV Disease in the Elderly|Unknown status|Recruiting|N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:45:43.370582|2017-10-11 05:45:43.370582
NCT00249652|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2015-04-13|||September 2003||2003-09-01|April 2015|2015-04-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Transplant and Addiction Project (TAP) - 1|Drug Treatment for Transplant Candidates|Completed||Phase 1/Phase 2|41|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||t||||||||||2017-10-11 05:46:44.252568|2017-10-11 05:46:44.252568
NCT00246493|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2017-10-05|||June 22, 2004||2004-06-22|January 26, 2017|2017-01-26||||||||Observational|||Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)|Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)|Active, not recruiting||N/A|510|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:45:43.454707|2017-10-11 05:45:43.454707
NCT00246506|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2013-01-14|||July 2003||2003-07-01|December 2012|2012-12-01|April 2013|Anticipated|2013-04-01|April 2012|Actual|2012-04-01||Interventional|FORT-T||Infertility Therapy for Women Age Thirty-eight and Older|Optimal Infertility Therapy RCT: Women 40 and Older|Unknown status|Active, not recruiting|N/A|450|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||t||||||||||2017-10-11 05:45:43.541217|2017-10-11 05:45:43.541217
NCT00246519|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2017-09-06|2013-05-20||October 2005||2005-10-01|September 2017|2017-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Pharmacogenomic Evaluation of Antihypertensive Responses|Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)|Completed||Phase 4|1701|Actual|University of Florida|The trial has limited number of hypertensive patients of African ancestry, therefore power is limited to those patients.|2|||f||||t|f|f||||||||2017-10-11 05:45:43.683345|2017-10-11 05:45:43.683345
NCT00246532|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2012-04-26|||October 2005||2005-10-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||Opiate-Induced Tolerance & Hyperalgesia in Pain Patients|Opiate-Induced Tolerance & Hyperalgesia in Pain Patients|Completed||Phase 4|139|Actual|National Institute of General Medical Sciences (NIGMS)||2|||f||||t||||||||||2017-10-11 05:45:44.158945|2017-10-11 05:45:44.158945
NCT00246545|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-08-25|||October 2005||2005-10-01|August 2011|2011-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect Evaluation of Early Exercise Training After Myocardial Infarction|Effect Evaluation of Early Exercise Training After Myocardial Infarction|Completed||Phase 2|39|Actual|Norwegian University of Science and Technology|||||f||||f||||||||||2017-10-11 05:45:44.27132|2017-10-11 05:45:44.27132
NCT00246558|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2014-04-02|||November 2005||2005-11-01|April 2014|2014-04-01|November 2005||2005-11-01|||||Observational|||Tight Achilles Tendon, Hyperpronation and Anterior Knee Pains|Is There a Connection Between a Tight Achilles Tendon, Hyperpronation of the Foot and Pain in the Anterior Part of the Knee|Withdrawn||N/A|0|Actual|Northern Orthopaedic Division, Denmark||||The study stopped due to unforeseen circumstances.|f||||||||||||||2017-10-11 05:45:44.378086|2017-10-11 05:45:44.378086
NCT00246571|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2012-07-02|2011-05-31||January 2006||2006-01-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer|A Randomized Phase 2 Study Of SU011248 Versus Standard-Of-Care For Patients With Previously Treated, Advanced, Triple Receptor Negative (ER, PR, HER2) Breast Cancer|Completed||Phase 2|217|Actual|Pfizer||2|||f||||t||||||||||2017-10-11 05:45:44.541658|2017-10-11 05:45:44.541658
NCT00246584|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2006-07-27|||October 2004||2004-10-01|July 2006|2006-07-01||||||||Interventional|||A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)|Long-Term Treatment, Multicenter, Open-Label Study With SPP100 in Patients With Essential Hypertension|Completed||Phase 2|300||Novartis|||||f||||||||||||||2017-10-11 05:45:47.588572|2017-10-11 05:45:47.588572
NCT00246597|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-05-17|||December 2002||2002-12-01|March 2010|2010-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer|A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer|Terminated||Phase 3|37|Actual|Ortho Biotech Products, L.P.||||"Study stopped to avoid treating enrolled subjects to hemoglobin levels higher than those   specified in current labeling."|f||||f||||||||||2017-10-11 05:45:47.656678|2017-10-11 05:45:47.656678
NCT00246610|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-04-26|||March 2006||2006-03-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy|A Phase IV, Non-Randomized, Open-Label Trial Evaluating The Safety Of 625 mg Formulation Of VIRACEPT When Administered To HIV-Infected Women During Pregnancy|Completed||Phase 4|16|Actual|Pfizer||1|||f||||t||||||||||2017-10-11 05:45:47.736472|2017-10-11 05:45:47.736472
NCT00246623|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2008-02-06|||November 2005||2005-11-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||US Inhaled Insulin Dose Titration Study|A Randomized, Open-Label, Multicenter Study Assessing the Effects of Forced Exubera Dose Titration on Glycemic Control in Patients With Suboptimally Controlled Type 2 Diabetes on Two or More Oral Antidiabetic Agents|Completed||Phase 3|120||Pfizer|||||||||||||||||||2017-10-11 05:45:47.828839|2017-10-11 05:45:47.828839
NCT00246649|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2008-12-16|||September 2005||2005-09-01|December 2008|2008-12-01||||||||Interventional|||Stem Cell Transplant With Specially Treated Cells in Treating Patients With Acute Leukemia|Pilot Study of Ex Vivo Expansion of Mafosfamide-Purged CD34-Positive Cells for Autologous Peripheral Blood Stem Cell or Bone Marrow Transplantation in Patients With Acute Leukemia|Completed||N/A|25|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||||||||||||||||2017-10-11 05:45:48.021533|2017-10-11 05:45:48.021533
NCT00246662|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2017-03-28|||November 14, 2005||2005-11-14|March 2017|2017-03-01|April 2009|Actual|2009-04-01|December 23, 2008|Actual|2008-12-23||Interventional|||Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies|Phase 1b Open-Label, Multicenter Clinical Study of the Safety and Activity of Intravenous Administration of SNS-595 in Patients With Advanced Hematologic Malignancies|Completed||Phase 1|75|Actual|Sunesis Pharmaceuticals||2|||f||||f||||||||No|Aggregate data of participants experiencing Adverse Events|2017-10-11 05:45:48.094427|2017-10-11 05:45:48.094427
NCT00246675|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2015-04-23||||||April 2015|2015-04-01||||||||Interventional|||Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.|Frusemide Infusion for the Prevention of Deterioration of Renal Function in Post Cardiac Surgery|Withdrawn||N/A|0|Actual|Melbourne Health||2||"The study has ceased recruiting as Ethics approval has lapsed and the investigator availability   reduced."|f||||f||||||||||2017-10-11 05:45:48.202717|2017-10-11 05:45:48.202717
NCT00246688|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2015-12-30|||November 2005||2005-11-01|December 2015|2015-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer|Randomized, Multicenter, Prospective Two-arm, Open-label Phase II Study to Investigate the Efficacy and Safety of Two ZK219477 i.v. Infusions (3-hour Infusion of 16mg/m2 Versus 0.5-hour Infusion of 16 mg/m2) in Patients With Recurrent Ovarian Cancer Progressing During, or Within 6 Months of the End of Platinum-based Chemotherapy|Completed||Phase 2|63|Actual|Bayer||2|||f||||f||||||||||2017-10-11 05:45:48.281139|2017-10-11 05:45:48.281139
NCT00246714|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2008-04-14|||October 2005||2005-10-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans|Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans|Completed||Phase 1|16|Anticipated|Radboud University||2|||f||||f||||||||||2017-10-11 05:45:48.446903|2017-10-11 05:45:48.446903
NCT00246727|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2011-10-28|||December 2005||2005-12-01|October 2011|2011-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer|Study 1: Effects of a Dietary Supplement (SV) on Advanced NSCLC Treated With Chemotherapy: A Randomized Double Blind Placebo Controlled Study; Study 2: Effects of a Dietary Supplement (SV) on Advanced NSCLC Treated With Best Supportive Care: A Randomized Double Blind Placebo Controlled Study|Unknown status|Recruiting|Phase 3|300|Anticipated|Sun Farm Corporation||2|||f||||t||||||||||2017-10-11 05:45:48.721338|2017-10-11 05:45:48.721338
NCT00246753|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2017-05-26|2017-03-08||October 2005||2005-10-01|May 2017|2017-05-01|May 2013|Actual|2013-05-01|July 2012|Actual|2012-07-01||Interventional|NRR||Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Study of Oral Once Daily GW572016 (Lapatinib) In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|29|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:45:48.903931|2017-10-11 05:45:48.903931
NCT00246766|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2007-11-21|||March 2005||2005-03-01|November 2007|2007-11-01|June 2010|Anticipated|2010-06-01|||||Observational|||Study of Fetal Movements Using Multichannel Ultrasound Pulsed Doppler in Normal and Pathologic Pregnancy|Qualitative and Quantitative Study of Fetal Movements Using Multichannel Ultrasound Pulsed Doppler in Normal and Pathologic Pregnancy|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Tours|||1||f||||f||||||||||2017-10-11 05:45:49.31746|2017-10-11 05:45:49.31746
NCT00246779|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-27|2007-10-26|||November 2005||2005-11-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Surgery|Transfusion Reduction and Modified Ultrafiltration After Cardiopulmonary Bypass (TRAM Trial) - A Pilot Feasibility Trial|Completed||Phase 1|78|Anticipated|Ottawa Heart Institute Research Corporation|||||f||||||||||||||2017-10-11 05:45:49.404254|2017-10-11 05:45:49.404254
NCT00246792|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2006-02-16|||September 2004||2004-09-01|November 2005|2005-11-01|December 2006||2006-12-01|||||Interventional|||Enhancing Self-Understanding and Social Integration of Middle School Students With Learning Disabilities|Enhancing Self-Understanding and Social Integration of Middle School Students With Learning Disabilities|Unknown status|Recruiting|Phase 2/Phase 3|||University of Toronto|||||f||||||||||||||2017-10-11 05:45:49.496478|2017-10-11 05:45:49.496478
NCT00246805|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-08-23|2009-11-06||January 2006||2006-01-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|RARE-PEARL||Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study|Post Marketing Study on Heart Rate Regularization in Patients With Permanent Atrial Fibrillation|Completed||Phase 4|67|Actual|Medtronic BRC||2|||f||||t||||||||||2017-10-11 05:45:49.675231|2017-10-11 05:45:49.675231
NCT00246818|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-29|2017-06-30|||October 26, 2005||2005-10-26|February 25, 2011|2011-02-25|February 25, 2011|Actual|2011-02-25|July 31, 2007|Actual|2007-07-31||Interventional|||Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer Survivors|A Randomized Study of the Effect of Tai Chi Chuan Compared to a Structured Exercise Program on Parameters of Physical Fitness and Stress in Adult Cancer Survivors|Completed||Phase 2|76|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:45:50.076908|2017-10-11 05:45:50.076908
NCT00246831|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-29|2017-06-30|||October 27, 2005||2005-10-27|October 28, 2008|2008-10-28|October 28, 2008||2008-10-28|||||Observational|||Brain Networks Responsible for Self-Agency|Brain Networks Responsible for Self-Agency: An fMRI Study|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:45:50.165391|2017-10-11 05:45:50.165391
NCT00246844|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-29|2017-06-30|||October 26, 2005||2005-10-26|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Observational|||Assessment of Insulin Production From Native Pancreas in Patients With Pancreas Transplants|Assessing Arginine-Stimulated Native Pancreas Insulin Production Via Selective Venous Sampling in Patients With Long-Functioning Pancreas Allografts|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:45:50.235067|2017-10-11 05:45:50.235067
NCT00246870|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-29|2017-06-30|||October 24, 2005||2005-10-24|October 19, 2010|2010-10-19|October 19, 2010||2010-10-19|||||Observational|||PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency|PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency|Completed||N/A|42|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:45:50.403816|2017-10-11 05:45:50.403816
NCT00246883|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-29|2017-06-30|||October 26, 2005||2005-10-26|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Interventional|||Effect of Regular Exercise on Vascular Function and Cardiovascular Risk in a Sedentary Work Force|"Effect of Regular Exercise on Vascular Function and Cardiovascular Risk in a Sedentary Work Force: The NHLBI Keep the Beat Program"|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:45:50.471893|2017-10-11 05:45:50.471893
NCT00246896|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2006-07-26|||August 2001||2001-08-01|October 2005|2005-10-01|August 2005||2005-08-01|||||Interventional|||Care Management for Patients With Alzheimer Disease and Their Family Caregivers|A Program of Collaborative Care for Alzheimer Disease|Completed||N/A|220||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:45:50.562819|2017-10-11 05:45:50.562819
NCT00246909|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2012-05-04|||November 2005||2005-11-01|June 2011|2011-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)|Determination of the Minimal Clinically Important Difference (MCID) of the Patient Orientated Self Assessment Scale ReQuest TradeMark in Patients Suffering From Endoscopically Confirmed Gastroesophageal Reflux Disease (GERD), Grade A-D According to Los Angeles Classification Treated With Pantoprazole 40 mg o.d. or Placebo o.d. Over One Week.|Completed||Phase 4|600||Takeda|||||f||||||||||||||2017-10-11 05:45:50.645297|2017-10-11 05:45:50.645297
NCT00246922|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2016-12-01|||December 2004||2004-12-01|September 2016|2016-09-01|October 2007|Actual|2007-10-01|January 2007|Actual|2007-01-01||Interventional|||Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)|A Long-term Study of APTA-2217 in Adult Patients With Bronchial Asthma|Completed||Phase 3|150||AstraZeneca|||||f||||||||||||||2017-10-11 05:45:50.842309|2017-10-11 05:45:50.842309
NCT00246935|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2016-10-24|||May 2005||2005-05-01|September 2016|2016-09-01|October 2007|Actual|2007-10-01|January 2007|Actual|2007-01-01||Interventional|||Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)|A Long-term Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|150||AstraZeneca|||||f||||||||||||||2017-10-11 05:45:50.925469|2017-10-11 05:45:50.925469
NCT00246948|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2008-10-16|||November 2001||2001-11-01|October 2005|2005-10-01|August 2003||2003-08-01|||||Interventional|||The Efficacy of Active Conservative Treatment for Patients With Severe Sciatica. A Randomized Clinical Controlled Trial|The Efficacy of Active Conservative Treatment for Patients With Severe Sciatica. A Randomized Clinical Controlled Trial|Completed||N/A|181||The Back Research Center, Denmark|||||f||||||||||||||2017-10-11 05:45:51.008044|2017-10-11 05:45:51.008044
NCT00246961|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2007-10-11|||July 2004||2004-07-01|June 2007|2007-06-01||||||||Observational|ARREST||Arimidex Observational: Reason for and Effect of Change From Tamoxifen|Arimidex: Reason for and Effect of Change From Tamoxifen|Completed||Phase 4|200||AstraZeneca|||||f||||f||||||||||2017-10-11 05:45:51.084417|2017-10-11 05:45:51.084417
NCT00246974|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2008-10-14|||May 2003||2003-05-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT|An Open Randomised Phase II Study Of Gemcitabine Plus Cisplatin +/- Concomitant or Sequential ZD1839 in Patients With Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|125|Anticipated|AstraZeneca||2|||f||||||||||||||2017-10-11 05:45:51.233312|2017-10-11 05:45:51.233312
NCT00246987|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2012-04-26|||June 2003||2003-06-01|April 2012|2012-04-01|April 2004|Actual|2004-04-01|||||Interventional|||A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|Completed||Phase 3|341||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:45:51.396494|2017-10-11 05:45:51.396494
NCT00247000|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-30|2007-06-27|||September 2007||2007-09-01|February 2006|2006-02-01|November 2007||2007-11-01|||||Interventional|||A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)|A Strategy of Home Telehealth for Management of Congestive Heart Failure: STARTEL|Unknown status|Not yet recruiting|Phase 4|150|Anticipated|Nova Scotia Health Authority|||||f||||||||||||||2017-10-11 05:45:51.922659|2017-10-11 05:45:51.922659
NCT00247013|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2016-02-19|||January 1996||1996-01-01|September 2010|2010-09-01|January 2006||2006-01-01|||||Interventional|||Automated Tele Counseling for Screening Mammography|Automated Tele Counseling for Screening Mammography|Completed||Phase 1|2120||Boston Medical Center|||||f||||||||||||||2017-10-11 05:45:52.014517|2017-10-11 05:45:52.014517
NCT00247026|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2007-04-10|||April 2007||2007-04-01|April 2007|2007-04-01||||||||Interventional|||The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes|A Pilot Study to Determine the Clinical Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes|Withdrawn||Phase 1/Phase 2|50||Hadassah Medical Organization||||No funding|f||||||||||||||2017-10-11 05:45:52.148776|2017-10-11 05:45:52.148776
NCT00247039|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2013-07-04|||June 2006||2006-06-01|July 2013|2013-07-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Garlic in Patients With Febrile Neutropenia|A Controlled Study to Determine The Clinical Efficacy Of Garlic Compounds In Patients With Chemotherapy Related Febrile Neutropenia|Unknown status|Recruiting|Phase 1/Phase 2|120|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-10-11 05:45:52.236222|2017-10-11 05:45:52.236222
NCT00247052|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2009-07-31|||March 2006||2006-03-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion|the Post Operative Pericardial Effusion (POPE) Treatment Study|Completed||Phase 4|200|Anticipated|French Cardiology Society||2|||f||||||||||||||2017-10-11 05:45:52.342573|2017-10-11 05:45:52.342573
NCT00247078|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2016-03-18|||October 2005||2005-10-01|March 2016|2016-03-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism|The Efficacy and Safety of Aracmyn® [Antivenin Latrodectus (Black Widow)Equine Immune F(ab)2], in Patients With Systemic Latrodectism: A Phase II, Multi-center, Randomized, Double-Blind Trial|Completed||Phase 2|24|Actual|Instituto Bioclon S.A. de C.V.||2|||f||||t||||||||||2017-10-11 05:45:52.468787|2017-10-11 05:45:52.468787
NCT00247091|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2005-10-28|||May 2000||2000-05-01|October 2005|2005-10-01|September 2004||2004-09-01|||||Observational|||Impact of HIV on Measles and Measles Immunisation|Impact of HIV on Measles and Measles Immunisation|Completed||N/A|700||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:45:52.562503|2017-10-11 05:45:52.562503
NCT00247104|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2007-04-10|||May 2007||2007-05-01|March 2006|2006-03-01|February 2008|Anticipated|2008-02-01|||||Interventional|||The Use of Cranberries in Women With Preterm Premature Rupture of Membranes|The Use of Cranberries in Women With Preterm Premature Rupture of Membranes|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:45:52.651684|2017-10-11 05:45:52.651684
NCT00247117|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2006-10-06|||January 2004||2004-01-01|October 2003|2003-10-01|August 2005||2005-08-01|||||Interventional|||Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)|Study of the Effect of Metformin in Patients With Non-Alcoholic Fatty Liver Disease|Unknown status|Recruiting|N/A|15||Kaplan Medical Center|||||f||||||||||||||2017-10-11 05:45:52.750761|2017-10-11 05:45:52.750761
NCT00247130|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2015-03-31|||October 2005||2005-10-01|March 2015|2015-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer|A Prospective, Randomized Trial Comparing the Effect of Intravenous Omeprazole to That of Intravenous Ranitidine on the Maintenance of Hemostasis After Successful Endoscopic Treatment of Bleeding Peptic Ulcer|Withdrawn||Phase 4|0|Actual|Keio University||2||Superiority of iv omeprazole to ranitidine has already been proven by others.|f||||f||||||||||2017-10-11 05:45:52.832975|2017-10-11 05:45:52.832975
NCT00247143|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2006-09-18|||October 2005||2005-10-01|September 2006|2006-09-01||||||||Interventional|||High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease|Prospective Open Label Non-Comparative Study of the Safety, Efficacy and Tolerability of High Dose Ritonavir/Lopinavir Liquid in Salvage Therapy for PI Resistant HIV & a PK Equivalence Sub-Study of High Dose Ritonavir/Lopinavir Capsules|Unknown status|Recruiting|N/A|20||Lampiris, Harry W., M.D.|||||f||||||||||||||2017-10-11 05:45:52.919387|2017-10-11 05:45:52.919387
NCT00247156|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2008-06-25|||November 2004||2004-11-01|April 2006|2006-04-01|November 2005||2005-11-01|||||Interventional|||An Autism Study Using Nambudripad's Food Allergy Elimination Treatments|An Investigation Into the Effectiveness of NAET on Autism Spectrum Disorders|Completed||Phase 1/Phase 2|60||Nambudripad's Allergy Research Foundation|||||f||||||||||||||2017-10-11 05:45:53.010725|2017-10-11 05:45:53.010725
NCT00247169|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2012-03-08|||August 2004||2004-08-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II|Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II: A Phase II Trial|Completed||Phase 2|40|Actual|Medical University of Vienna||1|||f||||||||||||||2017-10-11 05:45:53.103035|2017-10-11 05:45:53.103035
NCT00247182|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2016-09-20|||October 2006||2006-10-01|September 2016|2016-09-01|June 2011|Actual|2011-06-01|April 2010|Actual|2010-04-01||Interventional|||Stepped Care for Mandated College Students|Stepped Care for Mandated College Students|Completed||Phase 1|598|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||3|||f||||t||||||||||2017-10-11 05:45:53.193295|2017-10-11 05:45:53.193295
NCT00247195|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2012-10-24|||November 2005||2005-11-01|October 2012|2012-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder|Culturally Congruent Care for Hispanic Outpatients With Major Depressive Disorder (MDD)|Completed||N/A|113|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-10-11 05:45:53.322714|2017-10-11 05:45:53.322714
NCT00247208|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2012-04-25|||May 2005||2005-05-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|October 2008|Actual|2008-10-01||Interventional|||The SOS (Stenting Of Saphenous Vein Grafts) Trial|The SOS (Stenting Of Saphenous Vein Grafts) Randomized-controlled Trial of a Paclitaxel-eluting Stent vs. a Bare Metal Stent in Saphenous Vein Graft Lesions|Completed||Phase 3|80|Actual|North Texas Veterans Healthcare System||2|||f||||t||||||||||2017-10-11 05:45:53.430562|2017-10-11 05:45:53.430562
NCT00247221|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2012-07-28|||October 2002||2002-10-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Brief Intervention for Families of Teens Treated in the Emergency Department for an Alcohol-Related Event|Family Motivational Interviews for ETOH+ Teens in the ER|Completed||Phase 1|208|Actual|Brown University||2|||f||||t||||||||||2017-10-11 05:45:53.562757|2017-10-11 05:45:53.562757
NCT00247234|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2017-09-20|||September 2004|Actual|2004-09-01|September 2017|2017-09-01|January 2015|Actual|2015-01-01|June 2011|Actual|2011-06-01||Interventional|||Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders|Effectiveness of Group Based Schema Therapy in the Treatment of Borderline Personality Disorder and Avoidant Personality Disorder|Completed||N/A|90|Actual|Norwegian University of Science and Technology||2|||f||||f|f|f||||||||2017-10-11 05:45:53.652005|2017-10-11 05:45:53.652005
NCT00247247|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2007-06-22|||December 2002||2002-12-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.|Efficacy and Tolerability of Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing-Off Phenomenon|Completed||Phase 4|300||Orion Corporation, Orion Pharma||2|||f||||||||||||||2017-10-11 05:45:53.738332|2017-10-11 05:45:53.738332
NCT00247260|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2007-03-13|||October 2005||2005-10-01|October 2005|2005-10-01|February 2007||2007-02-01|||||Interventional|||Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma|A Study of the Safety Profile of Three Escalating Radioactivity Levels of 32P BioSilicon Delivered With the SIMPL Needle as Intratumoural Implantations in Patients With Unresectable Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 2|50||pSiVida Limited|||||f||||||||||||||2017-10-11 05:45:53.814306|2017-10-11 05:45:53.814306
NCT00247273|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2013-04-15|2011-03-04||October 2005||2005-10-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Monthly Risedronate for Osteoporosis|A Phase III, Multicenter, Double-blind, Randomized, Active-controlled, Parallel Group, Non-inferiority Study Comparing 150 mg Risedronate Monthly With 5 mg Risedronate Daily in the Treatment of Postmenopausal Osteoporosis (PMO)|Completed||Phase 3|1294|Actual|Warner Chilcott||2|||f||||f||||||||||2017-10-11 05:45:53.95153|2017-10-11 05:45:53.95153
NCT00247286|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2016-01-25|||September 2001||2001-09-01|January 2016|2016-01-01|October 2007|Actual|2007-10-01|January 2007|Actual|2007-01-01||Interventional|||Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.|A Randomised, Single-Blind Comparison of Pelvic Floor Muscle Exercises With Biofeedback Versus Weighted Vaginal Cones in the Management of Genuine Stress Incontinence : A Pilot Study|Terminated||Phase 4|36|Actual|Queen's University||2||slow recruitment|f||||f||||||||Undecided||2017-10-11 05:45:55.904508|2017-10-11 05:45:55.904508
NCT00247299|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-30|2005-10-30|||May 2005||2005-05-01|October 2005|2005-10-01||||||||Interventional|||Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform|Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform|Unknown status|Active, not recruiting|N/A|30||Rambam Health Care Campus|||||f||||||||||||||2017-10-11 05:45:55.988171|2017-10-11 05:45:55.988171
NCT00247312|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2015-11-16|||October 2005||2005-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial|Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial|Completed||Phase 3|319|Actual|Schiffler Cancer Center||2|||f||||t||||||||||2017-10-11 05:45:56.065519|2017-10-11 05:45:56.065519
NCT00247325|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2006-11-29|||January 2004||2004-01-01|January 2005|2005-01-01|December 2004||2004-12-01|||||Interventional|||RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography|Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study, A Randomized Controlled Trial|Completed||Phase 4|||Seoul National University Hospital|||||f||||||||||||||2017-10-11 05:45:56.167022|2017-10-11 05:45:56.167022
NCT00247338|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2008-05-09|||April 2005||2005-04-01|May 2008|2008-05-01|May 2006|Actual|2006-05-01|April 2006|Actual|2006-04-01||Interventional|||The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients|Comparing With Traditional Nitrogen Calorie Parenteral Nutrition Support, the Impact of Low Calorie and Low Nitrogen Intake on the Clinical Outcome of Gastrointestinal Postoperative Patients, Multicentre Post-Marketing Clinical Study|Completed||Phase 4|120|Anticipated|Sino-Swed Pharmaceutical Corporation|||||f||||||||||||||2017-10-11 05:45:56.318908|2017-10-11 05:45:56.318908
NCT00247351|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2006-10-18|||September 2003||2003-09-01|September 2003|2003-09-01|June 2005||2005-06-01|||||Interventional|||Prevention of Atrial Tachycardia After a Right Atriotomy|Prevention of Atrial Tachycardia After a Right Atriotomy|Completed||N/A|15||Aarhus University Hospital Skejby|||||f||||||||||||||2017-10-11 05:45:56.443426|2017-10-11 05:45:56.443426
NCT00247364|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2005-10-28|||November 2003||2003-11-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)|A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)|Completed||Phase 2|20||Sleep Health Centers|||||f||||||||||||||2017-10-11 05:45:56.545256|2017-10-11 05:45:56.545256
NCT00247377|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2010-05-11|2010-01-19||October 2002||2002-10-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity|A Prospective Randomized Trial of Laparoscopic Gastric Bypass vs Laparoscopic Adjustable Gastric Banding (LAP-BAND) for Treatment of Morbid Obesity|Completed||N/A|197|Actual|University of California, Irvine||2|||f||||f||||||||||2017-10-11 05:45:56.671001|2017-10-11 05:45:56.671001
NCT00247390|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2010-06-02|||July 2005||2005-07-01|June 2010|2010-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.|A Randomised, Double-blind, Placebo-controlled Study to Determine the Long-term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.|Completed||Phase 3|451|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:45:57.472094|2017-10-11 05:45:57.472094
NCT00247403|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2015-04-09|||October 2005||2005-10-01|April 2015|2015-04-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Safety Study of 2DG With Stereotactic Radiosurgery|Phase I Clinical Trial: 2DG + Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases|Withdrawn||Phase 1|0|Actual|University of Iowa||1||Pharmaceutical company no longer manufactures drug|f||||t||||||||||2017-10-11 05:45:57.728254|2017-10-11 05:45:57.728254
NCT00247416|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2014-01-16|2013-08-02||August 2005||2005-08-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer|Randomized Phase II Trail of Carboplatin and Gemcitabine Untreated Stage IIIB-pleural Effusion and Stage IV Lung Cancer|Completed||Phase 2|60|Actual|University of Kentucky||2|||f||||t||||||||||2017-10-11 05:45:57.871147|2017-10-11 05:45:57.871147
NCT00247429|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2009-08-31|||July 2004||2004-07-01|August 2009|2009-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients|Vandral Retard (Venlafaxine Extended Release) in Depressive Syndrome With Anxiety and Painful Symptoms in Elderly Patients. Observational Study in Primary Care|Completed||Phase 4|59|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||None Retained|"     No specimen retained   "|||2017-10-11 05:45:58.591249|2017-10-11 05:45:58.591249
NCT00247442|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-30|2006-09-27|||January 2006||2006-01-01|June 2005|2005-06-01|April 2006||2006-04-01|||||Interventional|||Australian Screening Mammography Decision Aid Trial (ASMDAT)|An Evaluation of a Decision Aid for Women Aged Over 70 Considering Whether to Stop or Continue Having Mammography Screening.|Completed||N/A|670||University of Sydney|||||f||||||||||||||2017-10-11 05:45:58.648247|2017-10-11 05:45:58.648247
NCT00247455|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-28|2011-06-20|||March 2002||2002-03-01|August 2007|2007-08-01|August 2005|Actual|2005-08-01|||||Interventional|||Fibre and Appetite Regulation Trial (FART)|Long-term Effect of Cereal Fibre on Abdominal Fat in Insulin Resistant Subjects|Completed||N/A|32||University of Toronto|||||f||||f||||||||||2017-10-11 05:45:58.743542|2017-10-11 05:45:58.743542
NCT00247468|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2017-01-19|||December 2004|Actual|2004-12-01|January 2017|2017-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Strict Glucose Control of Pediatric Intensive Care Unit (ICU) Patients|Strict Glucose Control of Pediatric ICU Patients to Reduce Mortality and Morbidity|Withdrawn||N/A|0|Actual|Children's Hospital of Philadelphia||||Never received IRB approval|f||||f|f|f||||||No||2017-10-11 05:45:58.818952|2017-10-11 05:45:58.818952
NCT00247481|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2009-04-22|||September 2002||2002-09-01|April 2009|2009-04-01|June 2005|Actual|2005-06-01|||||Interventional|||ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer|A Multicentre, Randomised, Double-Blind, Non-Comparative Phase II Trial Of ZD1839 (Iressa™) And Placebo In Combination With Chemotherapy With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer|Completed||Phase 2|77||AstraZeneca|||||f||||||||||||||2017-10-11 05:45:58.903601|2017-10-11 05:45:58.903601
NCT00249678|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2013-05-31|||September 2004||2004-09-01|May 2013|2013-05-01|May 2007||2007-05-01|||||Interventional|||Behavioral Therapy Development for Methamphetamine Abusers|Behavioral Therapy Development for Methamphetamine Abuse|Suspended||Phase 2|50||University of California, Los Angeles|||||f||||||||||||||2017-10-11 05:46:44.371701|2017-10-11 05:46:44.371701
NCT00247494|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2009-07-21|||April 2005||2005-04-01|November 2005|2005-11-01||||||||Interventional|||Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients|Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients|Unknown status|Recruiting|Phase 4|90|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||||f||||t||||||||||2017-10-11 05:45:58.978869|2017-10-11 05:45:58.978869
NCT00247507|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2006-10-17|||September 2005||2005-09-01|October 2005|2005-10-01|December 2005||2005-12-01|||||Interventional|||The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients||Unknown status|Active, not recruiting|Phase 4|||Far Eastern Memorial Hospital|||||f||||||||||||||2017-10-11 05:45:59.297349|2017-10-11 05:45:59.297349
NCT00247520|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2005-11-01|||May 2005||2005-05-01|November 2005|2005-11-01|August 2005||2005-08-01|||||Interventional|||Safety and Efficacy Study of rEV131 in Allergic Rhinitis|Two Center Evaluation of the Safety and Efficacy of Topical Nasal rEV131 Versus rEV131 Vehicle (Placebo)in the Prevention of the Signs and Symptoms of Allergic Rhinitis Induced by Nasal Allergen Challenge|Unknown status|Active, not recruiting|Phase 1/Phase 2|112||Evolutec Group|||||||||||||||||||2017-10-11 05:45:59.366449|2017-10-11 05:45:59.366449
NCT00247533|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2009-02-06|||October 2005||2005-10-01|August 2005|2005-08-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Cerebral Artery Stenosis, Coronary Artery Disease and Arrhythmia|The Early Diagnosis and Prevention of Ischemic Stroke and Cognition Decline Associated With Coronary Artery Disease Combined With Cerebral Artery Stenosis or Arrhythmia by 24-Hour Simultaneous Recorder of Electrocardiograph and Electroencephalography|Unknown status|Recruiting|Phase 4|30|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-10-11 05:45:59.435691|2017-10-11 05:45:59.435691
NCT00247546|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2006-10-17|||March 2003||2003-03-01|September 2006|2006-09-01|March 2005||2005-03-01|||||Interventional|||Prevention of Falls and Injurious Falls Among Elderly People||Completed||N/A|592||The Hospital District of Satakunta|||||f||||||||||||||2017-10-11 05:45:59.53077|2017-10-11 05:45:59.53077
NCT00247559|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2006-05-15|||May 2004||2004-05-01|May 2006|2006-05-01|May 2005||2005-05-01|||||Interventional|||Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)|A Phase II, Multi-Centre, Randomised, Double-Blind, Dose-Ranging Study Comparing the Efficacy and Safety of a Single Treatment With 15 U, 30 U or 45 U of Botulinum Type A Toxin to Placebo in the Symptomatic Treatment of Lateral Canthal Lines (Crow’s Feet)|Completed||Phase 2|220||Ipsen|||||f||||||||||||||2017-10-11 05:45:59.603542|2017-10-11 05:45:59.603542
NCT00247572|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2007-11-01|||September 2005||2005-09-01|November 2007|2007-11-01|November 2005|Actual|2005-11-01|||||Interventional|||Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories|A Double-Blind Placebo- and Active-Controlled, Single-Dose Crossover PD and PK Study to Evaluate the Safety, Tolerability and Abuse Liability of IV Administered NRP104 25 mg and 50 mg in Adult Volunteers With Histories of Stimulant Abuse|Completed||Phase 2|12||New River Pharmaceuticals|||||||||||||||||||2017-10-11 05:45:59.685508|2017-10-11 05:45:59.685508
NCT00247585|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2006-12-04|||September 2003||2003-09-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Hangover, Congeners, Sleep and Occupational Performance|Hangover, Congeners, Sleep and Occupational Performance|Completed||Phase 2|140||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-10-11 05:45:59.780678|2017-10-11 05:45:59.780678
NCT00247611|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2013-11-26|2013-08-01||October 2005||2005-10-01|November 2013|2013-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||Baseline characteristics provided for randomized sample. Analyses were conducted on those with >=2 adherence assessments for ITT.|Improving Treatment Adherence in HIV-Infected Individuals|Changing ART Adherence Behavior: The Lifewindows Project|Completed||Phase 2|594|Actual|University of Connecticut|"The only empirical demonstration of LifeWindows outcomes to date
OP sample was defined a posteriori
Under-powered to detect changes in Viral Load"|2|||f||||t||||||||||2017-10-11 05:45:59.881161|2017-10-11 05:45:59.881161
NCT00240253|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-03-26|||October 2005||2005-10-01|March 2015|2015-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes Who Are Not Achieving Glycemic Targets|Completed||Phase 4|200|Actual|AstraZeneca||1|||f||||||||||||||2017-10-11 05:46:00.631119|2017-10-11 05:46:00.631119
NCT00240266|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2010-11-18|||August 2003||2003-08-01|November 2010|2010-11-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)|A Randomised, Double-blind, Placebo-controlled, Crossover Pilot Study to Define the High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)|Completed||Phase 3|15||AstraZeneca|||||f||||||||||||||2017-10-11 05:46:00.76892|2017-10-11 05:46:00.76892
NCT00240279|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2010-11-18|||January 2003||2003-01-01|November 2010|2010-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study|The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study|Completed||Phase 3|10||AstraZeneca|||||f||||||||||||||2017-10-11 05:46:00.844672|2017-10-11 05:46:00.844672
NCT00240292|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2010-11-18|||February 2003||2003-02-01|November 2010|2010-11-01||||||||Interventional|||Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines|A Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre, Phase III Study to Assess the Impact of Rosuvastatin Treatment for 26 Weeks (Titrated to a Maximum Dose of 40mg Once Daily) on Left Ventricular Function, Cytokines and Lipid Parameters in Patients With Established Systolic Chronic Heart Failure.|Completed||Phase 3|160||AstraZeneca|||||f||||||||||||||2017-10-11 05:46:00.910645|2017-10-11 05:46:00.910645
NCT00240305|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2009-03-13|||April 2004||2004-04-01|March 2009|2009-03-01|May 2006|Actual|2006-05-01|||||Interventional|||A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome|A Randomised, Double-Blind, Placebo Controlled, Crossover Dose-Ranging Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome|Completed||Phase 3|15||AstraZeneca|||||f||||||||||||||2017-10-11 05:46:02.545277|2017-10-11 05:46:02.545277
NCT00252421|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2014-05-20|||October 2005||2005-10-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||The Nitrate and Bone Study: Effects of Nitrates on Osteoporosis|The Effects of Organic Nitrates on Osteoporosis: Part 2|Completed||Phase 3|243|Actual|University of Toronto||2|||f||||t||||||||||2017-10-11 05:50:05.563939|2017-10-11 05:50:05.563939
NCT00240318|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2010-11-18|||November 2002||2002-11-01|November 2010|2010-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)|A 104-Week, Open-label, Multi-centre, Phase IIIb Study Evaluating the Effect of Treatment With Rosuvastatin 40 mg on Atherosclerotic Disease as Measured by Intravascular Ultrasound and Quantitative Coronary Angiography in Subjects Undergoing Coronary Angiography Who Have Coronary Artery Disease|Completed||Phase 3|450||AstraZeneca|||||||||||||||||||2017-10-11 05:46:02.681574|2017-10-11 05:46:02.681574
NCT00240331|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2011-05-17|2009-09-29||January 2003||2003-01-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)|A Study to Evaluate the Use of Rosuvastatin in Subjects On Regular Haemodialysis: an Assessment of Survival and Cardiovascular Events (AURORA). A Double Blind, Randomised, Phase 3b, Parallel-group Study to Compare the Effects of Rosuvastatin With Placebo on Assessment of Survival & Cardiovascular Events When Given to Subjects With End-stage Renal Failure on Chronic Haemodialysis Treatment|Completed||Phase 3|2776|Actual|AstraZeneca|The endpoints were originally intended to be time to event endpoints, however we are unable to report the data as intended due to the nature of time to event endpoints. Therefore we have reported the number of participants who reached the event.|2|||f||||||||||||||2017-10-11 05:46:03.054319|2017-10-11 05:46:03.054319
NCT00240344|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2011-08-29|||September 2004||2004-09-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal|REALISTIC: Protocol for an Observational Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New EAS LDL-C Target Goal|Completed||Phase 4|2650|Actual|AstraZeneca|||1||f||||||||||||||2017-10-11 05:46:08.481678|2017-10-11 05:46:08.481678
NCT00240357|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2009-03-25|||February 2003||2003-02-01|March 2009|2009-03-01||||||||Interventional|||Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia|Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement of LDL Goals. - Denmark|Withdrawn||Phase 4|1175||AstraZeneca||||Study cancelled prior to FSI|f||||||||||||||2017-10-11 05:46:08.681637|2017-10-11 05:46:08.681637
NCT00240370|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2010-09-10||2010-09-10|October 2003||2003-10-01|June 2008|2008-06-01||||March 2005|Actual|2005-03-01||Interventional|||A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics|A Phase 3, Randomized, Double-Blind, Active-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Metformin Compared to Pioglitazone in Combination With Metformin in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone|Completed||Phase 3|1159||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:46:09.076337|2017-10-11 05:46:09.076337
NCT00240383|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2010-09-10||2010-09-10|May 2002||2002-05-01|June 2008|2008-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Dose Ranging Study With LT, Monotherapy, PPAR|A Randomized, Double-Blind, Dose Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects With Type 2 Diabetes|Completed||Phase 2/Phase 3|1260||Bristol-Myers Squibb|||||||||||||||||||2017-10-11 05:46:09.370599|2017-10-11 05:46:09.370599
NCT00240396|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2017-03-21|||October 2005||2005-10-01|March 2017|2017-03-01|September 24, 2007|Actual|2007-09-24|September 24, 2007|Actual|2007-09-24||Interventional|||Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture|Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center||||We were not able to enroll patients.|f||||||||||||No||2017-10-11 05:46:10.286283|2017-10-11 05:46:10.286283
NCT00240409|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-11-01|||July 2003||2003-07-01|November 2013|2013-11-01|August 2004||2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease|A Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole Tablets and Bromocriptine Tablets in Patients With Parkinson's Disease.|Completed||Phase 3|208|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:46:10.399911|2017-10-11 05:46:10.399911
NCT00240422|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-11-07|||February 2003||2003-02-01|November 2013|2013-11-01|July 2004||2004-07-01|||||Interventional|||Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes|A Prospective, Randomized, Double-blind, Double-dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes|Completed||Phase 4|96|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:46:10.512912|2017-10-11 05:46:10.512912
NCT00240435|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-10-31|||November 2002||2002-11-01|October 2013|2013-10-01||||December 2003|Actual|2003-12-01||Interventional|||12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD|A Randomized, Double-blind, Double-dummy, Placebo- and Active-controlled, Parallel Group Efficacy and Safety Comparison of 12-week Treatment of Two Doses (5 Mcg and 10 Mcg) of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler, Placebo and Ipratropium Bromide Inhalation Aerosol (MDI) i|Completed||Phase 3|491||Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:46:10.638187|2017-10-11 05:46:10.638187
NCT00240448|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-11-04|||September 2003||2003-09-01|November 2013|2013-11-01||||June 2004|Actual|2004-06-01||Interventional|||A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Forced-titration, Comparison of MICARDIS® HCT (Telmisartan 80 mg / Hydrochlorothiazide 25 mg) Versus DIOVAN® HCT (Valsartan 160 mg / Hydrochlorothiazide 25 mg) Using Seated Trough Cuff Blood Pressure in Patients With Stage 1 and Stage 2 Hypertension|Completed||Phase 4|1109|Actual|Boehringer Ingelheim|||||||||||||||||||2017-10-11 05:46:10.799421|2017-10-11 05:46:10.799421
NCT00240461|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-07-06|||September 2005||2005-09-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors|Efficacy and Safety of COLD-fX in the Prevention of Respiratory Infections in Community-dwelling Seniors: a Multi-center, Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 3|780|Actual|Capital Health, Canada||3|||f||||f||||||||||2017-10-11 05:46:11.037251|2017-10-11 05:46:11.037251
NCT00240474|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-10-31|||December 2002||2002-12-01|October 2013|2013-10-01|March 2004||2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)|A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-label, Blinded End-point Evaluation. (ATHOS Study)|Completed||Phase 4|1000||Boehringer Ingelheim|||||f||||||||||||||2017-10-11 05:46:11.164905|2017-10-11 05:46:11.164905
NCT00240487|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-04-23|2013-01-10||September 2000||2000-09-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Nitric Oxide Administration for Acute Respiratory Distress Syndrome|Nitric Oxide Administration for Acute Respiratory Distress Syndrome|Completed||Phase 3|52|Actual|Children's Hospital of Philadelphia|There may be some confounding of effects of lung recruitment from high mean airway pressures over the duration of the observation period.|2|||f||||f||||||||||2017-10-11 05:46:11.534799|2017-10-11 05:46:11.534799
NCT00240500|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2016-11-03|2008-10-30||October 2003||2003-10-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers|Long-Term Follow Up Study at Years 16-20, to Evaluate the Persistence of Immune Response of GlaxoSmithKline Biologicals' Hepatitis B Vaccine in Newborns of HBeAg+ and HBsAg+ Mothers|Completed||Phase 4|109|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:46:11.825411|2017-10-11 05:46:11.825411
NCT00240513|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2012-02-22|||August 2004||2004-08-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin|A Randomized Study to Compare the Acne Relapse Rate After a 3-mo Course of Oral Minocycline, to a 3-mo Course of Oral Minocycline in Combination With a Daily Dose of Topical Tretinoin 0.01% Followed by 3 mo of Topical Tretinoin Alone|Terminated||Phase 4|38|Actual|Derm Research @ 888 Inc.||2||Too much difficulty recruiting and retaining patients, PI decided to stop.|f||||f||||||||||2017-10-11 05:46:12.749493|2017-10-11 05:46:12.749493
NCT00240526|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2016-10-14|2010-06-14||October 2003||2003-10-01|October 2016|2016-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers|Comparative Study of the Immunogenicity and Protective Efficacy of GlaxoSmithKline Biologicals' Rec-DNA Hepatitis B Vaccine With or Without Hepatitis B Immunoglobulins (HBIg) in Newborns of HBeAg+ Mothers.|Completed||Phase 4|79|Actual|GlaxoSmithKline|A decrease in the specificity of the anti-HB ELISA assay had been observed in some studies for low levels of antibody (10-100 mIU/mL). Additional tables have been generated following partial retesting and reanalysis of the results at Years 19 and 20.|4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:46:12.898688|2017-10-11 05:46:12.898688
NCT00240539|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2016-10-26|2009-07-16||October 2003||2003-10-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)|Long-term Follow-Up Studies at Years 16-20, to Evaluate the Persistence of Immune Response of GSK Biologicals' Hepatitis B Vaccine in Newborns of HBeAg+ and HBsAg+ Mothers in Comparison With a Historical Control Group|Completed||Phase 4|36|Actual|GlaxoSmithKline|No safety data were collected during this long-term follow-up study.|4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:46:13.842598|2017-10-11 05:46:13.842598
NCT00240552|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2016-09-09|||July 2003||2003-07-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Fosamprenavir Expanded Access|An Open-label Phase III Study to Provide Access to Fosamprenavir and to Assess the Long Term Safety and Tolerability of Fosamprenavir Containing Regimens in HIV Infected Patients With Limited Treatment Options|Completed||Phase 4|85|Actual|ViiV Healthcare|||||f||||||||||||||2017-10-11 05:46:14.301517|2017-10-11 05:46:14.301517
NCT00240565|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2012-08-09|||April 2004||2004-04-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|February 2007|Actual|2007-02-01||Interventional|||Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma|A Single Arm, Open-label, Multicentre, Phase II Study of Tositumomab and Iodine 131-Tositumomab in Subjects With Indolent Non-Hodgkin's Lymphoma Who Have Previously Received Rituximab.|Completed||Phase 2|93|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-10-11 05:46:14.392369|2017-10-11 05:46:14.392369
NCT00240578|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2016-01-28|||November 2003||2003-11-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab|A MULTI-CENTER LONG-TERM FOLLOW-UP STUDY OF PATIENTS WITH LOW-GRADE NON-HODGKIN'S LYMPHOMA PREVIOUSLY TREATED WITH IODINE I 131 TOSITUMOMAB IN STUDIES CP-97-011, CP-98-025, CP-99-032, or CP-99-036|Completed||N/A|88|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 05:46:14.50268|2017-10-11 05:46:14.50268
NCT00240591|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-11-09|||October 2003||2003-10-01|November 2015|2015-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab|A MULTI-CENTER LONG-TERM FOLLOW-UP STUDY OF PATIENTS WITH LOW-GRADE NON-HODGKIN'S LYMPHOMA PREVIOUSLY TREATED WITH TOSITUMOMAB AND/OR IODINE I 131 TOSITUMOMAB IN STUDIES RIT-I-000, RIT-II-001, RIT-II-002, RIT-II-004, or CP-97-012|Completed||N/A|150|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-10-11 05:46:14.561124|2017-10-11 05:46:14.561124
NCT00240604|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2011-09-13|||April 2005||2005-04-01|September 2011|2011-09-01|October 2015|Anticipated|2015-10-01|December 2013|Anticipated|2013-12-01||Interventional|||Prevention of Corticosteroid-induced Glucose Intolerance|Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids|Unknown status|Recruiting|Phase 3|100|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-10-11 05:46:14.617809|2017-10-11 05:46:14.617809
NCT00249691|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2012-03-06|||October 2005||2005-10-01|March 2012|2012-03-01|October 2012|Anticipated|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1|Medication Development for Cocaine Dependence|Unknown status|Active, not recruiting|Phase 3|180|Anticipated|University of Virginia||2|||f||||t||||||||||2017-10-11 05:46:44.476472|2017-10-11 05:46:44.476472
NCT00240656|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2008-06-27|||October 2005||2005-10-01|October 2005|2005-10-01|May 2006||2006-05-01|||||Interventional|||Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension|Official Title: Spironolactone Combined With Captopril and Carvedilol for the Treatment of Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease—Focus on Pulmonary Artery Remodeling|Completed||Phase 1|||Hebei Medical University|||||f||||||||||||||2017-10-11 05:46:15.827602|2017-10-11 05:46:15.827602
NCT00240669|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2007-04-26|||November 2005||2005-11-01|April 2007|2007-04-01||||||||Interventional|||RESTIT : Evaluation of Resorbable Osteosynthesis Devices Versus Titanium in Maxillofacial Surgery|RESTIT : Evaluation of Resorbable Osteosynthesis Devices Versus Titanium in Maxillofacial Surgery – A Prospective Randomized Trial in Therapeutic Strategy|Unknown status|Recruiting|N/A|308||Hospices Civils de Lyon|||||f||||||||||||||2017-10-11 05:46:15.97348|2017-10-11 05:46:15.97348
NCT00240682|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2012-02-18|||October 2005||2005-10-01|August 2009|2009-08-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|CTXSCC||Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR|Phase II Study of Cetuximab as Monotherapy and First Line Treatment in Patients With Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin Expressing EGFR.|Completed||Phase 2|37|Actual|Centre Hospitalier of Chartres||1|||f||||t||||||||||2017-10-11 05:46:16.09803|2017-10-11 05:46:16.09803
NCT00240695|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-05-17|||May 2003||2003-05-01|April 2010|2010-04-01|May 2004|Actual|2004-05-01|||||Interventional|||A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment|An Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Galantamine HBr in the Treatment of Mild Cognitive Impairment|Completed||Phase 3|724|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:46:16.24865|2017-10-11 05:46:16.24865
NCT00240708|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-05-16|||June 2004||2004-06-01|March 2010|2010-03-01|April 2006|Actual|2006-04-01|||||Interventional|||A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia|A Parallel-Group Comparative Open-Label Study of Long-Acting Injectible Risperidone Versus Risperidone Tablets in Patients With Schizophrenia.|Completed||Phase 3|205|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-10-11 05:46:16.347896|2017-10-11 05:46:16.347896
NCT00240721|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-06-06|||October 2000||2000-10-01|November 2010|2010-11-01|September 2002|Actual|2002-09-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder|A Randomized, Double-Blind, Multicenter, Placebo-Controlled 12-Week Study Of The Safety And Efficacy Of Two Doses Of Topiramate For The Treatment Of Acute Manic Or Mixed Episodes In Subjects With Bipolar I Disorder With An Optional Open-Label Extension|Completed||Phase 3|363|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:46:16.445928|2017-10-11 05:46:16.445928
NCT00240734|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-06-08|||March 2005||2005-03-01|March 2010|2010-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Treatment of Anemia in Diabetic Subjects With CKD|A Randomized, Double-blind, Placebo-Controlled Study Evaluating Weekly Epoetin Alfa (PROCRIT�) Administration on Hemoglobin Response and Safety in Diabetic Subjects With the Anemia of Chronic Kidney Disease (CKD)|Terminated||Phase 2|11|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"This study was stopped for slow enrollment after enrolling only 11 of 180 patients in six   months time."|||||f||||||||||2017-10-11 05:46:16.520144|2017-10-11 05:46:16.520144
NCT00240747|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2012-05-24|||June 2000||2000-06-01|May 2012|2012-05-01|January 2005||2005-01-01|||||Interventional|||Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients||Terminated||Phase 3|||Pfizer|||||||||||||||||||2017-10-11 05:46:16.615199|2017-10-11 05:46:16.615199
NCT00240760|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2006-02-17|||October 2005||2005-10-01|October 2005|2005-10-01||||||||Interventional|||Memantine and Down's Syndrome|Efficacy and Safety of Memantine Hydrochloride, a Low Affinity Antagonist to N-Methyl-D-Aspartate (NMDA) Type Receptors, in the Prevention of Cognitive Decline and Disease Progression in Down’s Syndrome|Unknown status|Recruiting|N/A|180||King's College London|||||f||||||||||||||2017-10-11 05:46:16.725413|2017-10-11 05:46:16.725413
NCT00240773|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|June 2003|Actual|2003-06-01|||||Interventional|||A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee|A Randomized, Double-Blind, Long-Term Comparative Study Evaluating the Safety and Efficacy of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee|Completed||Phase 3|581|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||||||||||||2017-10-11 05:46:16.849923|2017-10-11 05:46:16.849923
NCT00240786|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-06-28|||April 2002||2002-04-01|June 2011|2011-06-01|March 2003|Actual|2003-03-01|||||Interventional|||An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release (1950 mg/Day or 3900 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee|Completed||Phase 3|483|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|||||||||||||||||||2017-10-11 05:46:16.958794|2017-10-11 05:46:16.958794
NCT00240799|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|October 2004|Actual|2004-10-01|||||Interventional|||An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release (3900 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee.|Completed||Phase 3|542|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||||||||||||2017-10-11 05:46:17.410283|2017-10-11 05:46:17.410283
NCT00240812|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-06-28||||||June 2011|2011-06-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting|A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children|Completed||Phase 2|318|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|||||||||||||||||||2017-10-11 05:46:17.523359|2017-10-11 05:46:17.523359
NCT00240825|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|February 2004|Actual|2004-02-01|||||Interventional|||An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain.|A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain|Completed||Phase 4|222|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||||||||||||2017-10-11 05:46:17.616911|2017-10-11 05:46:17.616911
NCT00240838|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-06-28|||May 2003||2003-05-01|June 2011|2011-06-01|June 2003|Actual|2003-06-01|||||Interventional|||An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.|A Randomized, Double-Blind Study Evaluating Acetaminophen Extended Release Caplets (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.|Completed||Phase 4|483|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|||||||||||||||||||2017-10-11 05:46:17.724564|2017-10-11 05:46:17.724564
NCT00240851|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|February 2004|Actual|2004-02-01|||||Interventional|||An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in Treating Muscle Aches and Soreness That Occur After a Marathon Race|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release Caplets (3900 mg/Day) in the Treatment of Post-Race Muscle Aching and Pain (Soreness)|Completed||Phase 4|665|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||||||||||||2017-10-11 05:46:17.81872|2017-10-11 05:46:17.81872
NCT00240864|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|February 2004|Actual|2004-02-01|||||Interventional|||An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain|A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain|Completed||Phase 4|224|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||||||||||||2017-10-11 05:46:17.909523|2017-10-11 05:46:17.909523
NCT00240877|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2008-11-19|||August 2002||2002-08-01|November 2008|2008-11-01|April 2004|Actual|2004-04-01|August 2003|Actual|2003-08-01||Interventional|||Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)|Completed||Phase 3|330|Actual|MedImmune LLC||2|||f||||f||||||||||2017-10-11 05:46:18.033033|2017-10-11 05:46:18.033033
NCT00240903|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-08-11|||October 2005||2005-10-01|March 2007|2007-03-01|March 2006||2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine|Revaccination of Healthy Subjects With Intramuscular Inactivated Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine Representing a Drifted Variant|Completed||Phase 1|37|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:46:18.136197|2017-10-11 05:46:18.136197
NCT00240916|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2009-11-05|||July 1993||1993-07-01|November 2009|2009-11-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|||Ontogeny of Measles Immunity in Infants|Ontogeny of Vaccine-Induced Measles Immunity Child Participant-6 and 9 Months|Unknown status|Recruiting|N/A|555|Anticipated|Stanford University|||4||f||||||||||Samples With DNA|"     white cells, serum   "|||2017-10-11 05:46:18.233043|2017-10-11 05:46:18.233043
NCT00240929|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2010-11-12|||September 2002||2002-09-01|November 2010|2010-11-01|April 2003|Actual|2003-04-01|||||Interventional|||A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)|A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis), A Humanized Respiratory Syncytial Virus Monoclonal Antibody, in Children With a History of Prematurity|Completed||Phase 2|150|Actual|MedImmune LLC||1|||f||||||||||||||2017-10-11 05:46:18.361255|2017-10-11 05:46:18.361255
NCT00240942|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2012-04-25|||October 2002||2002-10-01|April 2012|2012-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Letrozole in the Treatment of Severe and Recurrent Endometriosis|Letrozole in the Treatment of Severe and Recurrent Endometriosis|Completed||Phase 2|40||Novartis|||||f||||||||||||||2017-10-11 05:46:18.454507|2017-10-11 05:46:18.454507
NCT00240955|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2017-02-21|||March 2004||2004-03-01|February 2017|2017-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients|Efficacy and Safety of Two Immunosuppressive Regimens Mycophenolate Sodium (EC-MPS) With Short-term Steroid Use or Free of Steroids Compared With a Regimen of EC-MPS With Standard Steroids in de Novo Kidney Recipients|Completed||Phase 4|79|Actual|Novartis|||||f||||||||||||||2017-10-11 05:46:18.549557|2017-10-11 05:46:18.549557
NCT00247702|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2005-11-01|||July 2005||2005-07-01|July 2005|2005-07-01|June 2006||2006-06-01|||||Interventional|||The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR|Study of the Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR|Unknown status|Recruiting|N/A|120||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:46:38.329779|2017-10-11 05:46:38.329779
NCT00240968|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2013-08-15|||October 2005||2005-10-01|July 2008|2008-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||H5 Booster After a Two Dose Schedule|Evaluation of a Booster Dose of A/Vietnam/1203/04 (H5N1) Vaccine Administered at 6 Months to Healthy Adult Subjects After a Two Dose Schedule at 0 and 1 Months|Completed||Phase 2|337|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-10-11 05:46:18.731072|2017-10-11 05:46:18.731072
NCT00240981|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2017-02-22|2017-02-08||January 2005||2005-01-01|February 2017|2017-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||Community-dwelling men, 65 years of age or older, with limitations in mobility and a total serum testosterone level of 100 to 350 ng per deciliter or a free serum testosterone level of less than 50 pg per milliliter were randomly assigned to receive placebo gel or testosterone gel, to be applied daily for 6 months.|TOM: Testosterone in Older Men With Sarcopenia|Testosterone Replacement for Older Men With Sarcopenia|Terminated||Phase 4|209|Actual|Boston Medical Center||2||"Higher incidence of cardiovascular events in the testosterone arm of the trial. Decision taken   by the DSMB on December 31st, 2009."|f||||t||||||||||2017-10-11 05:46:18.882229|2017-10-11 05:46:18.882229
NCT00240994|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2016-11-15|2012-09-13||January 2005||2005-01-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients|A Phase II Exploratory Study to Determine the Safety and Study the Immunomodulatory Functions of Induction Therapy With Campath, Combined With Chronic Immunosuppression With Mycophenolate Mofetil and Sirolimus|Completed||Phase 2|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-10-11 05:46:19.718405|2017-10-11 05:46:19.718405
NCT00241007|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-11-07|||December 2003||2003-12-01|October 2005|2005-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension|A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension|Completed||Phase 3|836|Actual|Novartis|||||||||||||||||||2017-10-11 05:46:20.282337|2017-10-11 05:46:20.282337
NCT00241020|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2016-04-11|||June 2002||2002-06-01|April 2016|2016-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma|Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 3|270|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:46:20.359679|2017-10-11 05:46:20.359679
NCT00241046|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2012-04-18|||April 2002||2002-04-01|April 2012|2012-04-01||||March 2005|Actual|2005-03-01||Interventional|||Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment|Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment|Terminated||Phase 4|13|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:46:20.440929|2017-10-11 05:46:20.440929
NCT00241059|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-01-28|||August 2002||2002-08-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients|A Prospective, Open-label, Multicenter, International Follow-up Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients|Completed||Phase 4|183|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:46:20.503944|2017-10-11 05:46:20.503944
NCT00241072|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2012-05-03|||September 2002||2002-09-01|May 2012|2012-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance|A Single Center, Open Label, Single Arm Trial To Evaluate The Effect Of Twenty Four Weeks Of Treatment With 80 Mg To 320 Mg Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance (Igt)|Completed||Phase 4|27|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:46:20.578283|2017-10-11 05:46:20.578283
NCT00241085|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-11-07|||November 2002||2002-11-01|June 2006|2006-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus|A Multi-center, Double Blind, Randomized, Parallel Group Study to Evaluate the Effects of Valsartan on Proteinuria in Hypertensive Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|392|Actual|Novartis|||||||||||||||||||2017-10-11 05:46:20.661647|2017-10-11 05:46:20.661647
NCT00241098|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-11-07|||May 2003||2003-05-01|February 2006|2006-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure|A Randomized, Double Blind, Parallel Group Study to Evaluate the Effects of Valsartan Versus Placebo in Patients With Early Stage Heart Failure Due to Diastolic Dysfunction Already Evidenced by an Elevated B-type Natriuretic Peptide Level: the VALIDATE Study|Completed||Phase 4|37|Actual|Novartis|||||f||||||||||||||2017-10-11 05:46:20.741278|2017-10-11 05:46:20.741278
NCT00241111|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2017-03-02|||September 2003||2003-09-01|April 2010|2010-04-01||||January 2006|Actual|2006-01-01||Interventional|||Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis|Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis|Completed||Phase 4|148|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:46:20.826203|2017-10-11 05:46:20.826203
NCT00241124|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-11-22|||April 2004||2004-04-01|November 2011|2011-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes|A Randomized, Double Blind, Double Dummy, Parallel Group, Active-Controlled Study To Evaluate The Effectiveness Of Morning Versus Evening Doses Of 320 Mg Valsartan Versus 40 Mg Lisinopril On The 24 Hour Blood Pressure Profile In Patients With Hypertension And Non-Insulin Dependent Diabetes|Completed||Phase 4|1099|Actual|Novartis|||||f||||||||||||||2017-10-11 05:46:20.913064|2017-10-11 05:46:20.913064
NCT00241137|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-11-22|||September 2003||2003-09-01|June 2006|2006-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg|A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg|Completed||Phase 3|3790|Actual|Novartis|||||f||||||||||||||2017-10-11 05:46:21.218847|2017-10-11 05:46:21.218847
NCT00241150|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-11-07|||November 2002||2002-11-01|June 2006|2006-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome|A Multicenter, Double Blind, Randomized Study With Two Parallel Groups Comparing The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome|Completed||Phase 4|80|Actual|Novartis|||||||||||||||||||2017-10-11 05:46:21.309499|2017-10-11 05:46:21.309499
NCT00241163|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-16|2012-08-01||||||May 2012|2012-05-01||||||||Interventional|||TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)|An Open, Randomised, Prospective, Multicentre, Parallel-group Trial to Compare Efficacy and Safety of TachoComb S Versus Standard Surgical Treatment in Patients Undergoing Surgical Resection of Superficial Renal Tumour.|Completed||Phase 3|170||Takeda|||||f||||t||||||||||2017-10-11 05:46:21.389647|2017-10-11 05:46:21.389647
NCT00241176|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2016-10-26|2012-06-07||September 2005||2005-09-01|October 2016|2016-10-01|February 2010|Actual|2010-02-01|August 2008|Actual|2008-08-01||Interventional|||Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder|Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder|Completed||Phase 4|11|Actual|New York University School of Medicine|All subjects failed to respond to previous tic medications so could have unique tic symptoms, small sample size, and this was an open-label study, so we did not have a comparison group nor were we blinded to treatment.|1|||f||||t||||||||||2017-10-11 05:46:21.495465|2017-10-11 05:46:21.495465
NCT00241189|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2016-04-08|||August 2002||2002-08-01|April 2016|2016-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Rapamycin vs Methotrexate in Diffuse SSc|A 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral Rapamycin Versus Methotrexate in Systemic Sclerosis (Scleroderma)|Completed||Phase 1/Phase 2|17|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 05:46:21.795959|2017-10-11 05:46:21.795959
NCT00241202|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-13|2008-01-14|||October 2005||2005-10-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||The Efficacy of the HIV/AIDS Symptom Management Manual|The Efficacy of the HIV/AIDS Symptom Management Manual|Completed||N/A|775|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-10-11 05:46:21.94903|2017-10-11 05:46:21.94903
NCT00241215|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2016-06-19|||June 2003||2003-06-01|June 2016|2016-06-01||||November 2005|Actual|2005-11-01||Interventional|||Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome|Probe Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome|Completed||Phase 4|132|Actual|University of California, Los Angeles|||||f||||||||||||||2017-10-11 05:46:22.143147|2017-10-11 05:46:22.143147
NCT00241228|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2010-10-12|||October 2005||2005-10-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|IVOIRE||Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)|Impact of High-volume Veno-venous Continuous Hemofiltration in the Early Management of Septic Shock Patients With Acute Renal Failure|Completed||N/A|139|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 05:46:22.288843|2017-10-11 05:46:22.288843
NCT00241241|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2015-10-20|||September 2004||2004-09-01|October 2015|2015-10-01|January 2008|Actual|2008-01-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera|Multicenter Phase 2 Study of Efficacy and Safety of Pegylated Interferon-alfa 2a in Polycythemia Vera Patients|Completed||Phase 2|40||PV-Nord|||||f||||||||||||||2017-10-11 05:46:22.646989|2017-10-11 05:46:22.646989
NCT00241254|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2012-03-14|||December 2005||2005-12-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2010|Actual|2010-03-01||Interventional|PROMESS||Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis|A Double-blind, Two-arm, Multicenter, Randomized Trial to Evaluate Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Recent Secondary Progressive Multiple Sclerosis: P.R.OM.E.S.S Study|Completed||Phase 3|138|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-10-11 05:46:22.813671|2017-10-11 05:46:22.813671
NCT00241267|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2006-10-05|||March 2005||2005-03-01|May 2006|2006-05-01|March 2006||2006-03-01|||||Observational|||Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease|Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease|Terminated||N/A|20||University Hospital, Tours|||||f||||||||||||||2017-10-11 05:46:22.969256|2017-10-11 05:46:22.969256
NCT00241280|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2016-02-24|2015-12-04||September 2005||2005-09-01|February 2016|2016-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional||The baseline population consists of subjects that were randomized to receive either the Test or Control lens.|Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).||Completed||N/A|504|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||||||||||||2017-10-11 05:46:23.07205|2017-10-11 05:46:23.07205
NCT00241293|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2005-10-14||||||July 2005|2005-07-01||||||||Observational|||Influence of Age on Hemispheric Lateralization of Language : a Longitudinal Study||Completed||N/A|||University Hospital, Tours|||||f||||||||||||||2017-10-11 05:46:23.512555|2017-10-11 05:46:23.512555
NCT00241306|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2005-10-14||||||July 2005|2005-07-01||||||||Observational|||Variations of Hemispheric Lateralisation of Language Depending of Gender and Age.|Variations of Hemispheric Lateralisation of Language Depending of Gender and Age.|Unknown status|Active, not recruiting|N/A|||University Hospital, Tours|||||f||||||||||||||2017-10-11 05:46:23.588415|2017-10-11 05:46:23.588415
NCT00241319|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2011-09-26|||October 2005||2005-10-01|September 2011|2011-09-01||||December 2005|Actual|2005-12-01||Interventional|||Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of R89674 0.25% Ophthalmic Solution in Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis|Completed||Phase 3|150||Vistakon Pharmaceuticals|||||f||||||||||||||2017-10-11 05:46:23.647831|2017-10-11 05:46:23.647831
NCT00241332|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2011-07-03|||October 2005||2005-10-01|September 2005|2005-09-01|July 2006|Actual|2006-07-01|||||Interventional|||Postoperative Pain After Orthopedic Surgery: Does it Help to Give Fentanyl Before Start of Remifentanil Based Anesthesia?|Prophylaxis Against Postoperative Pain After Orthopedic Surgery: Does it Help to Give Fentanyl Before Start of Remifentanil/Propofol Based Anesthesia?|Completed||Phase 3|100||Oslo University Hospital|||||f||||||||||||||2017-10-11 05:46:23.734588|2017-10-11 05:46:23.734588
NCT00249886|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2006-09-18|||September 2002||2002-09-01|November 2005|2005-11-01|November 2006||2006-11-01|||||Interventional|||Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents||Withdrawn||Phase 3|60||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:46:56.764509|2017-10-11 05:46:56.764509
NCT00241345|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2013-07-22|||June 2004||2004-06-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant|Randomized Trial of Preemptive Treatment With Oral Valganciclovir Compared With IV Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant|Terminated||Phase 3|39|Actual|Washington University School of Medicine||2||Due to low accrual|f||||||||||||||2017-10-11 05:46:23.824308|2017-10-11 05:46:23.824308
NCT00241358|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2017-06-05|2017-04-30||May 2004||2004-05-01|June 2017|2017-06-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies|A Phase I/II Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies|Completed||Phase 1/Phase 2|92|Actual|Washington University School of Medicine||3|||f||||t|t|f||||||No||2017-10-11 05:46:23.943868|2017-10-11 05:46:23.943868
NCT00241371|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2013-08-09|||March 2005||2005-03-01|August 2013|2013-08-01|December 2007|Actual|2007-12-01|November 2005|Actual|2005-11-01||Interventional|||A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma|Terminated||Phase 2|8|Actual|Washington University School of Medicine||1||No response seen in patients|f||||||||||||||2017-10-11 05:46:24.84767|2017-10-11 05:46:24.84767
NCT00241384|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-14|2015-11-16|||January 2005||2005-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer|Low Dose Supplemental External Radiation With PD-103 Versus PD-103 Alone For Prostate Cancer|Completed||Phase 3|396|Actual|Schiffler Cancer Center||2|||f||||t||||||||||2017-10-11 05:46:24.938341|2017-10-11 05:46:24.938341
NCT00241397|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2007-03-14|||November 2005||2005-11-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety|An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.|Completed||N/A|2560||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:46:25.073726|2017-10-11 05:46:25.073726
NCT00241410|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2010-06-16|||December 2005||2005-12-01|September 2009|2009-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen|Investigation of the Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen|Completed||Phase 1|86|Actual|Allergy Therapeutics||2|||f||||f||||||||||2017-10-11 05:46:25.302267|2017-10-11 05:46:25.302267
NCT00241423|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2015-02-20|||October 2005||2005-10-01|January 2015|2015-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes|Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes Using Metformin or Metformin Plus a Thiazolidinedione|Completed||Phase 2|30|Actual|AstraZeneca||2|||f||||f||||||||||2017-10-11 05:46:25.6292|2017-10-11 05:46:25.6292
NCT00241436|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2011-01-25|||June 2005||2005-06-01|January 2011|2011-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Open Label Arimidex in Gynecomastia|An Open-Label Pharmacokinetic and Pharmacodynamic Study of Anastrozole (Arimidex™) Used to Treat Pubertal Boys With Gynecomastia of Recent Onset|Completed||Phase 2|35||AstraZeneca|||||||||||||||||||2017-10-11 05:46:25.716216|2017-10-11 05:46:25.716216
NCT00241449|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2012-06-05|||November 1998||1998-11-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|March 2007|Actual|2007-03-01||Interventional|||A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer|A Double-blind, Randomized, Multicentre Trial Comparing the Efficacy and Tolerability of 250mg of Faslodex (Long Acting ICI 182,780) With 20mg of Nolvadex (Tamoxifen) in Postmenopausal Women With Advanced Breast Cancer|Completed||Phase 3|51|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 05:46:25.796899|2017-10-11 05:46:25.796899
NCT00241462|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2009-04-21|||June 2005||2005-06-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|||||Observational|FORUM||Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients|Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients|Terminated||Phase 4|150|Anticipated|AstraZeneca|||1|Due to poor patient enrollment|f||||||||||||||2017-10-11 05:46:26.266052|2017-10-11 05:46:26.266052
NCT00241475|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2009-04-22|||December 2003||2003-12-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy|An Open Label, Non-Comparative, Phase II Study of ZD1839 (Iressa) as First-Line Treatment in Subjects With Relapsed Prostate Cancer Following Radical Prostatectomy or Radiotherapy|Completed||Phase 2|30||AstraZeneca|||||f||||||||||||||2017-10-11 05:46:26.472953|2017-10-11 05:46:26.472953
NCT00241488|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2008-02-05|||June 2003||2003-06-01|February 2008|2008-02-01|February 2007|Actual|2007-02-01|December 2005|Actual|2005-12-01||Interventional|||DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia|: An Open-Label, Randomised, Multi-Centre, Phase IIIb/IV, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects With Type IIa and IIb Hypercholesterolaemia (DISCOVERY)|Completed||Phase 3|1362|Anticipated|AstraZeneca|||||f||||||||||||||2017-10-11 05:46:26.579837|2017-10-11 05:46:26.579837
NCT00241501|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2010-11-18|||February 2004||2004-02-01|November 2010|2010-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients|A Phase III, Multicentre, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety of Once Daily Esomeprazole for the Treatment of Clinically Diagnosed Gastroesophageal Reflux Disease (GERD) in Pediatric and Adolescent Patients 12 to 17 Years of Age, Inclusive.|Completed||Phase 3|140||AstraZeneca|||||||||||||||||||2017-10-11 05:46:26.775537|2017-10-11 05:46:26.775537
NCT00241514|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2011-01-20|||February 2001||2001-02-01|January 2011|2011-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs|Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo or Esomeprazole 20 mg Once Daily Versus Placebo in Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs|Completed||Phase 3|334||AstraZeneca|||||||||||||||||||2017-10-11 05:46:26.963582|2017-10-11 05:46:26.963582
NCT00241527|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2011-01-21|||December 2000||2000-12-01|January 2011|2011-01-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs|Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo and Esomeprazole 20 mg Once Daily Versus Placebo in Treatment for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs|Completed||Phase 3|556||AstraZeneca|||||||||||||||||||2017-10-11 05:46:27.313055|2017-10-11 05:46:27.313055
NCT00241540|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2011-01-21|||January 2001||2001-01-01|January 2011|2011-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs|Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo & Esomeprazole 20 mg Once Daily Versus Placebo in Treatment for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs|Completed||Phase 3|808||AstraZeneca|||||||||||||||||||2017-10-11 05:46:27.689602|2017-10-11 05:46:27.689602
NCT00241553|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2011-01-21|||April 2001||2001-04-01|January 2011|2011-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs|Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo or Esomeprazole 20 mg Once Daily Versus Placebo in Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs|Completed||Phase 3|276||AstraZeneca|||||||||||||||||||2017-10-11 05:46:28.18304|2017-10-11 05:46:28.18304
NCT00241566|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2010-01-19|||August 2003||2003-08-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation|Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation|Completed||Phase 4|200|Anticipated|University Hospital, Clermont-Ferrand|||||f||||||||||||||2017-10-11 05:46:28.614914|2017-10-11 05:46:28.614914
NCT00241579|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2006-06-21|||February 2002||2002-02-01|June 2006|2006-06-01|January 2004||2004-01-01|||||Interventional|||Analgesic Efficacy of Smoked Cannabis|Analgesic Efficacy of Smoked Cannabis|Completed||Phase 1/Phase 2|15||Center for Medicinal Cannabis Research|||||||||||||||||||2017-10-11 05:46:28.694384|2017-10-11 05:46:28.694384
NCT00241592|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2007-06-12|||August 2004||2004-08-01|June 2007|2007-06-01|May 2005||2005-05-01|||||Interventional|||Vaporization as a Smokeless Cannabis Delivery System|Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study|Completed||Phase 1|18||Center for Medicinal Cannabis Research|||||||||||||||||||2017-10-11 05:46:28.776562|2017-10-11 05:46:28.776562
NCT00241605|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2013-07-11|||June 2003||2003-06-01|July 2012|2012-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus|AVANDAMET Compared to Metformin Evaluation Trial (ACME): A 48-week Randomized, Open-label, Multicenter Study to Compare the Efficacy and Tolerability of AVANDAMET to Metformin Monotherapy in Subjects With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Control on Submaximal Metformin.|Completed||Phase 4|600||GlaxoSmithKline|||||f||||f||||||||||2017-10-11 05:46:28.865604|2017-10-11 05:46:28.865604
NCT00241618|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2006-09-07|||January 2002||2002-01-01|September 2006|2006-09-01|January 2006||2006-01-01|||||Interventional|||Timing and Duration of Acute Hepatitis C Treatment|Phase IV Study of Treatment of Acute Hepatitis C With Pegylated Interferon|Completed||Phase 4|180||Ain Shams University|||||f||||||||||||||2017-10-11 05:46:28.949653|2017-10-11 05:46:28.949653
NCT00241631|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2015-05-27|||April 2006||2006-04-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Enhancement of in−Vitro GC Function in Patients With COPD|Enhancement of In-vitro GC Function in Patients With COPD. A Randomised, Double Blind, Placebo Controlled, Parallel-group Study to Investigate the Effect of Theophylline and Fluticasone on Induced Sputum Cells Obtained Form COPD Patients|Completed||Phase 2|31|Actual|Imperial College London||2|||f||||f||||||||||2017-10-11 05:46:29.083953|2017-10-11 05:46:29.083953
NCT00241644|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2016-10-27|2009-06-18||October 2005||2005-10-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants|Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants|Completed||Phase 3|2089|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:46:30.833944|2017-10-11 05:46:30.833944
NCT00241657|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2005-12-14||||||December 2002|2002-12-01||||||||Interventional|||Immune Responses to BCG Vaccination in Malawi and the UK||Completed||Phase 2|||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:46:33.955526|2017-10-11 05:46:33.955526
NCT00241670|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2012-04-25|||October 1999||1999-10-01|April 2012|2012-04-01||||July 2004|Actual|2004-07-01||Interventional|||Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid|Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection|Completed||Phase 3|415|Actual|medac GmbH||2|||f||||||||||||||2017-10-11 05:46:34.021631|2017-10-11 05:46:34.021631
NCT00241683|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2013-01-18|||August 2005||2005-08-01|January 2013|2013-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Fetal Growth Restriction & Maternal Cardiovascular Risk|Fetal Growth Restriction & Maternal Cardiovascular Risk|Completed||N/A|704|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-10-11 05:46:34.099745|2017-10-11 05:46:34.099745
NCT00241696|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2016-08-05|||August 2005||2005-08-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|||||Observational|||Air Pollution, Inflammation, and New Onset Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:46:34.156768|2017-10-11 05:46:34.156768
NCT00241709|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2013-03-08|||August 2005||2005-08-01|March 2013|2013-03-01||||June 2010|Actual|2010-06-01||Observational|GALA 1||Optimal Approach for Analysis of Case-Control Genetic Association Studies|Case-Control Association Studies and Genetic Confounding|Completed||N/A|800|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"     Retrospective genetic analysis of DNA; samples collected between 1998-2001   "|||2017-10-11 05:46:34.207374|2017-10-11 05:46:34.207374
NCT00247923|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2011-07-03|||October 2005||2005-10-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|||||Interventional|||Endometrial Polyps: Pathophysiology and Clinical Consequences|Endometrial Polyps. Pathophysiology and Clinical Consequences.|Completed||N/A|1186|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-10-11 05:46:39.957449|2017-10-11 05:46:39.957449
NCT00241722|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2017-08-29|||August 1, 2005|Actual|2005-08-01|August 2017|2017-08-01|February 1, 2007|Actual|2007-02-01|February 1, 2007|Actual|2007-02-01||Interventional|||Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain|Completed||Phase 3|805|Actual|Cubist Pharmaceuticals LLC||2|||||||||||||||||2017-10-11 05:46:34.288937|2017-10-11 05:46:34.288937
NCT00241735|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2017-09-13|||September 2005||2005-09-01|September 2017|2017-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Soy Food and Coronary Heart Disease in Women||Completed||N/A|135896|Actual|Vanderbilt University Medical Center|||1||f||||||||||||||2017-10-11 05:46:35.15104|2017-10-11 05:46:35.15104
NCT00241748|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2012-01-04|||September 2005||2005-09-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event|Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event|Completed||N/A|187|Actual|University of Washington|||3||f||||f||||||Samples With DNA|"     DNA is extracted from swish and spit samples. DNA is retained.   "|||2017-10-11 05:46:35.222485|2017-10-11 05:46:35.222485
NCT00241761|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2016-08-05|||September 2005||2005-09-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|||||Observational|||Epidemiology of Depression and Heart Failure in Aging||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-10-11 05:46:35.287789|2017-10-11 05:46:35.287789
NCT00241774|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2016-02-04|||August 2005||2005-08-01|February 2016|2016-02-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Observational|||Coronary Heart Disease Incidence: Depression & Inflammation Risk|Coronary Heart Disease Incidence: Depression & Inflammation Risk|Completed||N/A|3227|Actual|Columbia University|||1||f||||f||||||Samples With DNA|"     In 1995, our study participants enrolled in the Nova Scotia Health Study (NSHS95). At the     time of enrollment, epidemiologic data as well as blood samples were obtained. The     participants have since been followed prospectively for a variety of health outcomes. We plan     to assay stored blood samples collected in 1995 for markers of inflammation and link these     results to existing epidemiologic and outcomes data, specifically the 7-year incidence of CAD     events. Buffy coats were also obtained from the blood samples of the SAME participants for     future DNA analysis.   "|||2017-10-11 05:46:35.339253|2017-10-11 05:46:35.339253
NCT00241787|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2015-11-30|||September 2005||2005-09-01|November 2015|2015-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Progression of Sub-Clinical Atherosclerosis||Completed||N/A|2900|Actual|Tufts Medical Center|||1||f||||||||||||||2017-10-11 05:46:35.430981|2017-10-11 05:46:35.430981
NCT00241800|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2017-06-02|||September 2005|Actual|2005-09-01|June 2017|2017-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Medications and the Risk of Sudden Cardiac Death||Completed||N/A|1200|Actual|Vanderbilt University Medical Center|||1||f||||f|f|f||||||No||2017-10-11 05:46:35.49823|2017-10-11 05:46:35.49823
NCT00241813|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2012-12-13|||January 2005||2005-01-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Behavioral Stress Reduction Programs on Blood Pressure in African American Youth|Stress Reduction: Impact on Blood Pressure in African American Youth|Completed||N/A|283|Actual|Medical University of South Carolina||4|||f||||f||||||||||2017-10-11 05:46:35.559778|2017-10-11 05:46:35.559778
NCT00241826|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-17|2013-08-19|||April 2006||2006-04-01|July 2009|2009-07-01|April 2009||2009-04-01|September 2008|Actual|2008-09-01||Observational|||Prospective Investigation of Pulmonary Embolism Diagnosis III|Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III)|Completed||N/A|1256|Anticipated|George Washington University|||1||f||||||||||||||2017-10-11 05:46:35.669331|2017-10-11 05:46:35.669331
NCT00247637|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2013-07-01|||May 2003||2003-05-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia|The Genetics of Endophenotypes and Schizophrenia|Completed||N/A|2025|Actual|University of California, San Diego|||1||f||||||||||Samples With DNA|"     Whole blood was sent to the Cell Repository at Rutgers toestablish cell lines.   "|||2017-10-11 05:46:36.605564|2017-10-11 05:46:36.605564
NCT00247650|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2017-02-28|||September 2005||2005-09-01|November 2009|2009-11-01||||March 2007|Actual|2007-03-01||Interventional|||Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy|Randomized Multi-Center Study Comparing Prolonged Primary Systemic Endocrine Therapy With Letrozole Alone or in Combination With Zoledronic Acid in Early Breast Cancer (NEOadjuvant Study in CANada)|Completed||Phase 2|190|Anticipated|Novartis|||||f||||||||||||||2017-10-11 05:46:36.786141|2017-10-11 05:46:36.786141
NCT00247663|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2012-04-18|||December 1999||1999-12-01|April 2012|2012-04-01||||December 2005|Actual|2005-12-01||Interventional|||Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer|Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer|Completed||Phase 2|17|Actual|Novartis||1|||f||||f||||||||||2017-10-11 05:46:36.951213|2017-10-11 05:46:36.951213
NCT00247676|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2010-02-04|2010-01-06||February 2006||2006-02-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer|An Open Label International Multi-Center Phase 2 Activity And Safety Study Of SU011248 In Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|37|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:46:37.131226|2017-10-11 05:46:37.131226
NCT00247689|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2017-06-30|||December 22, 2004||2004-12-22|February 27, 2015|2015-02-27|February 27, 2015||2015-02-27|||||Observational|||Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics|Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics|Terminated||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:46:38.246788|2017-10-11 05:46:38.246788
NCT00249613|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2014-03-07|2013-04-10||June 2005||2005-06-01|March 2014|2014-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Gender-Responsive Treatment for Women Offenders - 1|Gender-Responsive Treatment for Women Offenders|Completed||N/A|291|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-10-11 05:46:43.747887|2017-10-11 05:46:43.747887
NCT00247715|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2007-08-28|||October 2003||2003-10-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||"Comparison of a Step-Up Versus a Step-Down Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)"|Comparison of an Antacid/H2-Receptor Antagonist/Proton Pump Inhibitor Versus a Proton Pump Inhibitor/H2-Receptor Antagonist/Antacid Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)|Completed||N/A|664|Actual|Radboud University||2|||f||||f||||||||||2017-10-11 05:46:38.40932|2017-10-11 05:46:38.40932
NCT00247741|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2013-12-18|||November 2005||2005-11-01|October 2005|2005-10-01|May 2006||2006-05-01|||||Interventional|||Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery.|Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery: A Double Blind Randomized Clinical Trial.|Completed||Phase 3|80||St. Antonius Hospital||2|||f||||f||||||||||2017-10-11 05:46:38.616523|2017-10-11 05:46:38.616523
NCT00247754|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2005-10-31|||November 2002||2002-11-01|October 2005|2005-10-01|June 2005||2005-06-01|||||Interventional|||VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children)|VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children)|Completed||N/A|281||University of British Columbia|||||f||||||||||||||2017-10-11 05:46:38.805355|2017-10-11 05:46:38.805355
NCT00247780|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2008-02-13|||November 2004||2004-11-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation|Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation|Completed||Phase 4|149|Actual|University of Aarhus||2|||f||||||||||||||2017-10-11 05:46:38.883012|2017-10-11 05:46:38.883012
NCT00247793|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2005-11-01|||July 1996||1996-07-01|November 2005|2005-11-01|December 1998||1998-12-01|||||Interventional|||Immunonutrition in Cardiac Surgery|The Effect of Pre- and Postoperative Supplemental Enteral Nutrition in High-Risk Patients Undergoing Elective Cardiac Surgery. A Prospective Double Blind Study.|Completed||N/A|||Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||||f||||||||||||||2017-10-11 05:46:38.991763|2017-10-11 05:46:38.991763
NCT00247806|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2008-09-24|||October 2008||2008-10-01|October 2005|2005-10-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Prevalence of Lactose Intolerance Following Stem Cell Transplantation|Prevalence of Lactose Intolerance Following Stem Cell Transplantation in Pediatric Patients.|Terminated||Phase 1|20|Anticipated|University of British Columbia||||Too few patients completed the study once enrolled.|f||||||||||||||2017-10-11 05:46:39.116401|2017-10-11 05:46:39.116401
NCT00247819|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2017-01-11|||August 1992||1992-08-01|October 2005|2005-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||The Genetic Basis for Vulnerability to Substance Abuse|Allelic Linkage in Substance Abuse|Completed||N/A|8000|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:46:39.202462|2017-10-11 05:46:39.202462
NCT00247832|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2011-11-15|||October 2005||2005-10-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Readiness for Discharge Following Lobectomy|Readiness for Discharge Following Lobectomy: Effects of the Thoracic Risk Intervention and Management (T.R.I.M.) Protocol|Unknown status|Recruiting|N/A|99|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-10-11 05:46:39.30665|2017-10-11 05:46:39.30665
NCT00247845|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2014-08-20|||July 2004||2004-07-01|August 2014|2014-08-01|September 2007|Actual|2007-09-01|||||Observational|||Evaluation of Atazanavir Substitution Intervention (EASI) Study|Evaluation of Atazanavir Substitution Intervention (EASI) Study: An Observational Phase IV Study to Evaluate the Impact of Atazanavir Substitution on the Quality of Life and Maintenance of Virologic Suppression in HIV-Infected Patients Intolerant to Current Successful HAART|Completed||Phase 4|100|Anticipated|University of British Columbia|||1||f||||||||||||||2017-10-11 05:46:39.430125|2017-10-11 05:46:39.430125
NCT00247858|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2011-09-28|||January 2005||2005-01-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Analysis of Methicillin Resistant Staphylococcus Aureus (MRSA) Obtained Through the Emergency Department in a Tertiary Care Hospital in Vancouver Canada From 2001-2005|Analysis of Methicillin Resistant Staphylococcus Aureus (MRSA) Obtained Through the Emergency Department in a Tertiary Care Hospital in Vancouver Canada From 2001-2005|Unknown status|Active, not recruiting|N/A|97|Anticipated|University of British Columbia|||1||f||||||||||||||2017-10-11 05:46:39.543092|2017-10-11 05:46:39.543092
NCT00247871|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2011-09-28|||October 2005||2005-10-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|||||Observational|||Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside|The Prevalence of Panton Valentine Leukocidin, Exfoliative Toxin and Agr Genotypes in Staphylococcus Aureus Nasal Colonization in Vancouver's Eastside Community|Unknown status|Active, not recruiting|N/A|600|Anticipated|University of British Columbia|||1||f||||||||||||||2017-10-11 05:46:39.616959|2017-10-11 05:46:39.616959
NCT00247884|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2009-10-09|||June 2005||2005-06-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|||||Observational|||Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV|Directly Observed Therapy for the Treatment of Hepatitis C Virus Infection in Injection Drug Users|Completed||Phase 4|50|Anticipated|University of British Columbia|||1||f||||||||||||||2017-10-11 05:46:39.700936|2017-10-11 05:46:39.700936
NCT00247897|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2011-04-11|||November 2005||2005-11-01|April 2011|2011-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Comparing Skin Disinfectants Before Labour Epidural Analgesia|What is the Best Skin Preparation Solution for Labour Epidural Analgesia? A Randomized Prospective Trial Comparing ChloraprepTM, DuraprepTM, and Chlorhexidine 0.5% in 70% Alcohol.|Completed||N/A|195|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:46:39.794427|2017-10-11 05:46:39.794427
NCT00247910|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2011-09-16|||October 2001||2001-10-01|September 2011|2011-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Behavioural Treatment of Hypertension|Behavioural Treatment of Hypertension|Completed||N/A|150|Actual|University of British Columbia||1|||f||||f||||||||||2017-10-11 05:46:39.876127|2017-10-11 05:46:39.876127
NCT00251563|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2006-10-12|||August 2005||2005-08-01|November 2005|2005-11-01||||||||Observational|||Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer.||Unknown status|Recruiting|N/A|||Nanjing Medical University|||||f||||||||||||||2017-10-11 05:47:25.877205|2017-10-11 05:47:25.877205
NCT00247936|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2009-11-04|||May 2004||2004-05-01|November 2009|2009-11-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial.|Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial.|Withdrawn||N/A|40|Anticipated|University of California, Irvine||2||Prior to recruitment, study terminated lack of recruitment interest.|f||||f||||||||||2017-10-11 05:46:40.04941|2017-10-11 05:46:40.04941
NCT00247949|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2009-11-09|||July 2004||2004-07-01|November 2009|2009-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Accuracy of Non-invasive Continuous CO2-Monitoring|The Accuracy of Non-invasive Continuous Carbon Dioxide Monitoring by the Sentec V-Sign Digital Monitor System|Terminated||Phase 4|150|Actual|University Hospital, Basel, Switzerland|||1|We had got enough data, therefore we stopped the study and published the data.|f||||t||||||||||2017-10-11 05:46:40.143075|2017-10-11 05:46:40.143075
NCT00247962|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2012-10-09|2009-01-30||December 2005||2005-12-01|October 2012|2012-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis|A Randomized, Double-Blind Study Evaluating the Safety and Efficacy of Etanercept and Sulphasalazine in Subjects With Ankylosing Spondylitis|Completed||Phase 4|566|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-10-11 05:46:40.244276|2017-10-11 05:46:40.244276
NCT00249431|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2013-12-10|||December 2001||2001-12-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1|A Pilot Study of Sertraline Plus Relapse Prevention Therapy (RP) for the Treatment of Pathological Gambling With Comorbid Abuse or Dependence|Terminated||Phase 2|9|Actual|New York State Psychiatric Institute||2||Terminated by the IRB for non-continuation|f||||||||||||||2017-10-11 05:46:41.362864|2017-10-11 05:46:41.362864
NCT00249457|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-03-08|||October 1996||1996-10-01|March 2017|2017-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2|A Therapeutic Workplace for Drug Abusers|Completed||N/A|40|Actual|Johns Hopkins University||2|||f||||f||||||||No|The data for this study have been published in a peer-reviewed journal.|2017-10-11 05:46:41.545354|2017-10-11 05:46:41.545354
NCT00249470|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-08-11|2016-09-02||April 2003||2003-04-01|August 2017|2017-08-01|October 2004|Actual|2004-10-01|May 2004|Actual|2004-05-01||Interventional|||The Therapeutic Workplace Initiation Study|The Therapeutic Workplace Initiation Study|Completed||N/A|117|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 05:46:41.653366|2017-10-11 05:46:41.653366
NCT00249483|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-07-06|||October 1999||1999-10-01|July 2017|2017-07-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals|Placebo-Controlled Venlafaxine Treatment for Depressed Cocaine Abusers|Completed||Phase 2|150|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 05:46:42.071866|2017-10-11 05:46:42.071866
NCT00249496|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-08-18|2016-08-31||October 2003||2003-10-01|August 2017|2017-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1|Therapeutic Workplace Maintenance Study|Completed||N/A|51|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-10-11 05:46:42.272262|2017-10-11 05:46:42.272262
NCT00249509|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-01-13|||September 2000||2000-09-01|March 2011|2011-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals|Marijuana Pharmacotherapies: Controlled Clinical Trials With Nefazodone and Bupropion|Completed||Phase 2|132||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:46:42.936871|2017-10-11 05:46:42.936871
NCT00249522|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-01-11|||August 2003||2003-08-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Vouchers vs. Prizes for Methadone Patients - 1|Vouchers vs. Prizes for Methadone Patients|Completed||N/A|76|Actual|National Institute on Drug Abuse (NIDA)|||||f||||f||||||||||2017-10-11 05:46:43.028471|2017-10-11 05:46:43.028471
NCT00249535|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2012-03-29|||March 2005||2005-03-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2|Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients|Completed||N/A|240|Actual|UConn Health||3|||f||||f||||||||||2017-10-11 05:46:43.127564|2017-10-11 05:46:43.127564
NCT00249548|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-01-11|||August 2004||2004-08-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Low-Cost Contingency Management for Hispanic Outpatients - 3|Low-Cost Contingency Management for Hispanic Outpatients|Completed||N/A|30|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-10-11 05:46:43.234823|2017-10-11 05:46:43.234823
NCT00249561|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-07-19|||September 2001||2001-09-01|July 2011|2011-07-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||Colorado Women's TC Project|Women's Prison TC: Outcomes, Process & Economic Analysis|Completed||Phase 1/Phase 2|610|Actual|National Development and Research Institutes, Inc.||2|||f||||t||||||||||2017-10-11 05:46:43.326734|2017-10-11 05:46:43.326734
NCT00249574|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-01-13|||June 2003||2003-06-01|December 2008|2008-12-01|June 2006|Actual|2006-06-01|March 2004|Actual|2004-03-01||Interventional|||Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1|HCV Treatment of IDUs After Buprenorphine Stabilization|Completed||N/A|10|Anticipated|National Institute on Drug Abuse (NIDA)||1|||t||||t||||||||||2017-10-11 05:46:43.443605|2017-10-11 05:46:43.443605
NCT00249587|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-01-09|||September 2000||2000-09-01|September 2008|2008-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Medication Adherence Therapy for Opioid Abusing Pain Patients|Medication Adherence Therapy for Opioid Abusing Pain Patients|Completed||Phase 1/Phase 2|36|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-10-11 05:46:43.565653|2017-10-11 05:46:43.565653
NCT00249600|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-11-17|||March 2003||2003-03-01|November 2011|2011-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Lower-Cost Contingency Management in a Group Setting - 1|Lower-Cost Contingency Management in a Group Setting|Completed||N/A|172|Actual|UConn Health||1|||f||||f||||||||||2017-10-11 05:46:43.672079|2017-10-11 05:46:43.672079
NCT00249704|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2009-01-07|||October 2005||2005-10-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|||||Interventional|||Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects|Evaluation of the Effect of a 4-Month Intervention of Exercise and/or Vitamin D on Mobility Function and Strength in Frail Elderly Subjects|Terminated||Phase 1|64|Actual|Pfizer||4||See termination reason in detailed description.|f||||f||||||||||2017-10-11 05:46:44.603671|2017-10-11 05:46:44.603671
NCT00249717|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-11-17|||May 2005||2005-05-01|November 2011|2011-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Group-Based Contingency Management for Substance Abuse Treatment - 1|Group-Based Contingency Management for Substance Abuse Treatment|Completed||N/A|312|Actual|UConn Health||1|||f||||f||||||||||2017-10-11 05:46:44.714469|2017-10-11 05:46:44.714469
NCT00249730|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2006-12-18|||October 2005||2005-10-01|December 2006|2006-12-01||||||||Interventional|||Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.|A Prospective Multicenter, Parallel Group Study With A Single Blind Phase And A Double Blind Randomised Phase, To Evaluate The Efficacy And Satisfaction Of Viagra (Sildenafil Citrate) High Dose (100mg) Titration Compared With 50mg Dose, In Men With Erectile Dysfunction|Completed||Phase 4|510||Pfizer|||||f||||||||||||||2017-10-11 05:46:44.793909|2017-10-11 05:46:44.793909
NCT00249743|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2006-05-25|||December 2004||2004-12-01|May 2006|2006-05-01|July 2005||2005-07-01|||||Interventional|||Clinical Evaluation of a Wireless Monitoring Device to Reduce Falls in the Elderly and Others at High Risk of Falling|NIH-NIA SBIR Phase I/II Study: Clinical Evaluation of a Device to Reduce Patient Falls|Completed||Phase 1/Phase 2|50||NOCwatch International|||||f||||||||||||||2017-10-11 05:46:44.922076|2017-10-11 05:46:44.922076
NCT00249756|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2013-08-29|||August 2005||2005-08-01|August 2013|2013-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Re-Entry MTC for Offenders With MICA Disorders|Re-Entry MTC for Offenders With MICA Disorders|Completed||N/A|610|Actual|National Development and Research Institutes, Inc.||2|||f||||t||||||||||2017-10-11 05:46:45.011815|2017-10-11 05:46:45.011815
NCT00249769|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2008-05-05|||November 2005||2005-11-01|May 2007|2007-05-01|May 2006||2006-05-01|||||Interventional|||Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine|Assessment of the Non-Inferiority of the Concurrent Administration of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Measles Vaccine Given Alone|Completed||Phase 3|600||PATH|||||f||||||||||||||2017-10-11 05:46:45.118355|2017-10-11 05:46:45.118355
NCT00249782|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-05-27|||November 2005||2005-11-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.|A Phase II, Randomized, Partial-Blind, Parallel-Group, Active- and Vehicle-Controlled, Multicenter Study of the Safety and Efficacy of ACZONE™ (Dapsone) Gel, 5% in Subjects With Papulopustular Rosacea|Completed||Phase 2|400|Actual|Allergan|||||||||||||||||||2017-10-11 05:46:45.20109|2017-10-11 05:46:45.20109
NCT00249795|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-09-29|2010-08-24||June 2003||2003-06-01|September 2010|2010-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|ACTIVE I||Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)|A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation|Completed||Phase 3|9016|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 05:46:45.609364|2017-10-11 05:46:45.609364
NCT00249821|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2017-08-28|2012-06-28||February 28, 2005|Actual|2005-02-28|August 2017|2017-08-01|September 30, 2007|Actual|2007-09-30|September 30, 2007|Actual|2007-09-30||Interventional|SGA OPTIMIS||Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age|Optimization of the Dosage Regimen With Growth Hormone Therapy in Children Born Small for Gestational Age. An Open Label, Randomized, Pilot Study, Comparing in Children Treated for 3 Years, the Efficacy of a Saizen® Treatment at the Same Dose Versus a Lower Maintenance Dose Prolonged During 1 Additional Year.|Completed||Phase 3|22|Actual|Merck KGaA|Participants’ inclusion period was extended but due to remaining low recruitment rate, it was finally decided to stop enrollment even if only 22 participants were enrolled.|2|||f||||f||||||||||2017-10-11 05:46:51.347981|2017-10-11 05:46:51.347981
NCT00249847|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2014-10-01|||October 2005||2005-10-01|October 2014|2014-10-01|April 2008|Actual|2008-04-01|July 2007|Actual|2007-07-01||Interventional|||Study of PET Scans and Serotonin in Hot Flashes Treatment|A Feasibility Study of Positron Emission Tomography (PET) of the Serotonin Transporter (SERT) Before and After Treatment With Conjugated Equine Estrogen or Paroxetine for Hot Flashes|Terminated||N/A|5|Actual|Sidney Kimmel Comprehensive Cancer Center||2||Unable to complete accrual; elected to close the study in April 2008.|f||||t||||||||||2017-10-11 05:46:51.955674|2017-10-11 05:46:51.955674
NCT00249860|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2013-08-04|||September 2002||2002-09-01|August 2013|2013-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects|A Multicentre Phase III Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects|Completed||Phase 3|257|Actual|EMD Serono||2|||f||||||||||||||2017-10-11 05:46:52.054746|2017-10-11 05:46:52.054746
NCT00249873|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2015-05-20|2010-03-08||June 2003||2003-06-01|May 2015|2015-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)|A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation|Completed||Phase 3|7554|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 05:46:52.271479|2017-10-11 05:46:52.271479
NCT00249899|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2012-05-23|||November 2005||2005-11-01|May 2012|2012-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia|A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia|Terminated||Phase 3|649|Actual|Takeda||2||"Overall profile of the compound does not offer significant clinical advantage to patients over   currently available lipid lowering agents"|f||||f||||||||||2017-10-11 05:46:56.873515|2017-10-11 05:46:56.873515
NCT00249912|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2012-05-23|||October 2005||2005-10-01|May 2012|2012-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia|A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg, 100 mg or Placebo When Coadministered With Rosuvastatin 10 mg or 20 mg in Subjects With Primary Hypercholesterolemia|Completed||Phase 3|415|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:46:57.072563|2017-10-11 05:46:57.072563
NCT00249925|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2016-04-25|||January 2000||2000-01-01|April 2016|2016-04-01|January 2005|Actual|2005-01-01|June 2004|Actual|2004-06-01||Interventional|||Project ABLE:Advancing Better Living for Elders|Enhancing Function of Frail Elders At Home|Completed||Phase 3|319||Thomas Jefferson University|||||f||||t||||||||||2017-10-11 05:46:57.425628|2017-10-11 05:46:57.425628
NCT00249938|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-03-24|||March 2005||2005-03-01|March 2017|2017-03-01|August 2006|Actual|2006-08-01|||||Interventional|||Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.|Evaluation of Plant Sterol and Placebo on Low-density Lipoprotein Concentrations in Hyperlipidemic Patients Treated With Combination Statin and Colesevelam Therapy.|Completed||Phase 4|60||University of Colorado, Denver|||||f||||||||||||||2017-10-11 05:46:57.52066|2017-10-11 05:46:57.52066
NCT00249951|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2012-06-29|||November 2005||2005-11-01|June 2012|2012-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants||Completed||Phase 3|80|Actual|University of Cologne||1|||f||||t||||||||||2017-10-11 05:46:57.610964|2017-10-11 05:46:57.610964
NCT00249964|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2016-01-15|||November 2003||2003-11-01|January 2016|2016-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Combination Paclitaxel, Carboplatin and Temozolomide|Phase I Dose Finding Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide for Subjects With Solid Tumor Malignancies.|Completed||Phase 1|15|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-11 05:46:57.699072|2017-10-11 05:46:57.699072
NCT00249977|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2010-01-06|||April 2003||2003-04-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|August 2007|Actual|2007-08-01||Interventional|||Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan|Phase I Study Of Capecitabine in Combination With Cisplatin and Irinotecan in Patients With Advanced Malignancies.|Completed||Phase 1|21|Actual|University of New Mexico||1|||f||||t||||||||||2017-10-11 05:46:57.798166|2017-10-11 05:46:57.798166
NCT00249990|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2010-01-06|||April 2003||2003-04-01|October 2008|2008-10-01|September 2007|Actual|2007-09-01|July 2006|Actual|2006-07-01||Interventional|||Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)|Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium|Completed||Phase 2|39|Actual|University of New Mexico||1|||f||||t||||||||||2017-10-11 05:46:57.876835|2017-10-11 05:46:57.876835
NCT00250003|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2005-11-22|||February 2000||2000-02-01|September 2005|2005-09-01|December 2001||2001-12-01|||||Interventional|||Preventive Home Visits for Healthy Pensioners- a Randomized Controlled Trial|Preventive Home Visits for Healthy Pensioners- a Randomized Controlled Trial in Nordmaling|Completed||Phase 1|||Umeå University|||||f||||||||||||||2017-10-11 05:46:57.946865|2017-10-11 05:46:57.946865
NCT00250016|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2010-01-06|||August 2003||2003-08-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Observational|||Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)|1102C-T. Pharmacology Study of Aerosolized Liposomal-Nitro-20 (S)-Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium. Tissue Submission for Patients With Endometrial Cancer.|Completed||N/A|6|Actual|University of New Mexico|||1||f||||t||||||Samples Without DNA|"     Blood sample, tumor endometrial tissue, and normal endometrial tissue.   "|||2017-10-11 05:46:58.030746|2017-10-11 05:46:58.030746
NCT00250029|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-09-23|||April 2004||2004-04-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|September 2005|Actual|2005-09-01||Interventional|||Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen|Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy|Completed||N/A|30|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-11 05:46:58.095528|2017-10-11 05:46:58.095528
NCT00250042|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-09-18|||April 2004||2004-04-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|April 2005|Actual|2005-04-01||Interventional|||A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec|A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail to Achieve a Complete Response to Initial Gleevec Treatment|Completed||Phase 2|6|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-11 05:46:58.177254|2017-10-11 05:46:58.177254
NCT00250055|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2016-05-10|||April 2004||2004-04-01|May 2016|2016-05-01|January 2010|Actual|2010-01-01|December 2007|Actual|2007-12-01||Interventional|||Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue|Non-Invasive, Real-time Technology for Diagnosis of Cervical Tissue|Completed||N/A|100|Anticipated|University of New Mexico||1|||f||||t||||||||||2017-10-11 05:46:58.353055|2017-10-11 05:46:58.353055
NCT00250068|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2010-05-18|||April 2003||2003-04-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)|Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)|Completed||Phase 2|8|Actual|University of New Mexico||1|||f||||t||||||||||2017-10-11 05:46:58.426327|2017-10-11 05:46:58.426327
NCT00250081|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2014-11-18|||February 2005||2005-02-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|UECP||Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy|Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy|Terminated||N/A|38|Actual|Shriners Hospitals for Children||3||Accrual is complete.|f||||t||||||||||2017-10-11 05:46:58.504203|2017-10-11 05:46:58.504203
NCT00250094|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-09-02|||May 2004||2004-05-01|September 2011|2011-09-01|March 2006|Actual|2006-03-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Benefit of Topoisomerase Downregulation|Clinical Benefit of Topoisomerase Downregulation: A Phase I Pilot Study|Completed||Phase 1|15|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-10-11 05:46:58.640413|2017-10-11 05:46:58.640413
NCT00250120|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2016-05-10|||April 2003||2003-04-01|May 2016|2016-05-01|August 2007|Actual|2007-08-01|March 2007|Actual|2007-03-01||Interventional|||Pharmacology Study of Aerosolized Liposomal|Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S) - Camptothecin (L9NC)|Withdrawn||Phase 2|0|Actual|University of New Mexico||1|||f||||t||||||||||2017-10-11 05:46:58.705106|2017-10-11 05:46:58.705106
NCT00250133|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2007-08-31||||||August 2007|2007-08-01||||||||Observational|||Microbiologic Effect of Selective Decontamination of the Digestive Tract With Colistin, Gentamicin and Nystatin|Microbiologic Effect of Selective Decontamination of the Digestive Tract With Colistin, Gentamicin and Nystatin|Terminated||Phase 3|40||University of Pittsburgh||||Unable to obtain funding to complete study never started study|f||||||||||||||2017-10-11 05:46:58.769876|2017-10-11 05:46:58.769876
NCT00250146|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2005-11-03|||February 2001||2001-02-01|April 2005|2005-04-01|March 2005||2005-03-01|||||Interventional|||Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease||Terminated||N/A|39||Università Politecnica delle Marche|||||f||||||||||||||2017-10-11 05:46:58.832913|2017-10-11 05:46:58.832913
NCT00250159|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-05|2017-10-05|||October 27, 2005||2005-10-27|May 16, 2017|2017-05-16||||||||Observational|||Natural History Study of Patients With Excess Androgen|Natural History Study of Patients With Excess Androgen|Enrolling by invitation||N/A|711|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:46:58.976908|2017-10-11 05:46:58.976908
NCT00250172|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-05|2017-10-05|||October 31, 2005||2005-10-31|September 15, 2014|2014-09-15|February 5, 2009|Actual|2009-02-05|February 5, 2009|Actual|2009-02-05||Interventional|||PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram|PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram|Completed||Phase 1|26|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:46:59.075047|2017-10-11 05:46:59.075047
NCT00250185|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-05|2017-06-30|||November 1, 2005||2005-11-01|August 22, 2008|2008-08-22|June 9, 2007|Actual|2007-06-09|June 9, 2007|Actual|2007-06-09||Interventional|||The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress|The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress|Completed||Phase 1|135||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-10-11 05:46:59.159436|2017-10-11 05:46:59.159436
NCT00250198|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-05|2017-06-30|||November 3, 2005||2005-11-03|September 5, 2006|2006-09-05|September 5, 2006||2006-09-05|||||Interventional|||The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease|A Randomized, Double-blind, Pilot Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, to Investigate Peripheral Blood and Mucosal Mononuclear Cell Phenotype and Cytokine Responses in Patients With Crohn's Disease|Completed||Phase 2|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:46:59.235794|2017-10-11 05:46:59.235794
NCT00250211|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2016-02-23|||March 2005||2005-03-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide|Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide|Completed||Phase 1/Phase 2|26|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-10-11 05:46:59.311215|2017-10-11 05:46:59.311215
NCT00250224|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2015-06-25|||January 2006||2006-01-01|September 2005|2005-09-01|May 2014|Actual|2014-05-01|May 2009|Actual|2009-05-01||Interventional|||Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II|Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II|Completed||Phase 1|100|Actual|Aalborg Universitetshospital||1|||f||||t||||||||||2017-10-11 05:46:59.395945|2017-10-11 05:46:59.395945
NCT00250237|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2009-08-06|||November 2005||2005-11-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery|Randomised Double-blind Placebo-controlled Study of Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery|Completed||Phase 3|220|Actual|Bronovo Hospital||2|||f||||t||||||||||2017-10-11 05:46:59.494093|2017-10-11 05:46:59.494093
NCT00250250|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2011-05-19|||October 2005||2005-10-01|May 2011|2011-05-01|August 2006|Actual|2006-08-01|March 2006|Actual|2006-03-01||Interventional|||An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG|An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG (Recombinant Somatropin) Administered by ZomaJet Vision X|Completed||Phase 3|27|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-10-11 05:46:59.60535|2017-10-11 05:46:59.60535
NCT00250263|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-06|2013-02-11|||November 2005||2005-11-01|November 2005|2005-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy|A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy|Completed||Phase 4|30|Actual|Bayside Health||2|||f||||||||||||||2017-10-11 05:46:59.713223|2017-10-11 05:46:59.713223
NCT00250276|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2017-01-31|2017-01-31||October 2005||2005-10-01|January 2017|2017-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.|Assess Lot-to-lot Consistency of GSK Biologicals' HPV-16/18 L1/AS04 Vaccine Following Manufacturing Adjustments Administered Intramuscularly According to a 0,1,6-mth Schedule in Healthy Female Subjects (18-25 y)|Completed||Phase 3|798|Actual|GlaxoSmithKline|None reported.|4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:46:59.878079|2017-10-11 05:46:59.878079
NCT00250289|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-06|2010-01-05|||March 2006||2006-03-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Interventional|||Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula|Invivo Study of the Efficacy of an Innovative Herbal Formula and Delivery System on Oral Malodor|Completed||Phase 1|15|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:47:02.247589|2017-10-11 05:47:02.247589
NCT00250302|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-06|2011-04-27|||April 2009||2009-04-01|October 2010|2010-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures|Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures|Completed||Phase 1/Phase 2|24|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:47:02.325831|2017-10-11 05:47:02.325831
NCT00250315|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2007-10-31|||November 2005||2005-11-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Observational|||DOCICAR: Cardiac Dysfunction in Cirrhosis|Cardiac Dysfunction in Cirrhosis: Cirrhotic Cardiomyopathy Evaluated by Dobutamin MRI.|Completed||Phase 3|||Hvidovre University Hospital|||||f||||||||||||||2017-10-11 05:47:02.397483|2017-10-11 05:47:02.397483
NCT00250328|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-06|2005-11-06|||January 2006||2006-01-01|November 2005|2005-11-01||||||||Interventional|||Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy|Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy|Unknown status|Not yet recruiting|Phase 1|40|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:47:02.461362|2017-10-11 05:47:02.461362
NCT00250341|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2015-03-19|||September 2005||2005-09-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Non-invasive Measures of Distal Lung Disease in Asthmatics|Non-Invasive Measures of Distal Lung Disease in Asthmatics Before and After Therapy Directed at the Proximal vs. Distal Lung|Completed||Phase 4|34|Anticipated|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-10-11 05:47:02.544608|2017-10-11 05:47:02.544608
NCT00250354|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-01-20|||September 1997||1997-09-01|January 2011|2011-01-01|August 1999|Actual|1999-08-01|||||Interventional|||A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation|The Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years|Completed||Phase 3|110|Actual|Janssen Pharmaceutica N.V., Belgium|||||||||||||||||||2017-10-11 05:47:02.641205|2017-10-11 05:47:02.641205
NCT00250367|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-11-24|||October 1997||1997-10-01|November 2010|2010-11-01|November 1999|Actual|1999-11-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.|The Safety And Efficacy Of Risperdal� (Risperidone) Versus Placebo As Add-On Therapy To Mood Stabilizers In The Treatment Of The Manic Phase Of Bipolar Disorder|Completed||Phase 3|151|Actual|Janssen Pharmaceutica N.V., Belgium|||||||||||||||||||2017-10-11 05:47:02.890732|2017-10-11 05:47:02.890732
NCT00250380|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2011-12-12|||November 2005||2005-11-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|June 2010|Actual|2010-06-01||Observational|||The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)|The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)－A Prospective Multicenter Cohort Study-|Completed||Phase 4|583|Actual|Ministry of Health, Labour and Welfare, Japan|||1||f||||t||||||Samples With DNA|"     whole blood, serum, urine   "|||2017-10-11 05:47:02.995152|2017-10-11 05:47:02.995152
NCT00250393|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2012-08-28|||November 2005||2005-11-01|August 2012|2012-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease|Placebo-Controlled , Crossover , Double-Blind Study of KW-6002(Istradefylline) in the Treatment of Parkinson's Disease. [Monotherapy]|Completed||Phase 2|64||Kyowa Hakko Kirin Co., Ltd|||||f||||f||||||||||2017-10-11 05:47:03.137147|2017-10-11 05:47:03.137147
NCT00250406|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2013-12-19|||November 2005||2005-11-01|December 2013|2013-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation|Assessment of Bacterial Adherence and Biofilm Formation on a Triclosan Loaded Ureteral Stent: A Phase II Study|Completed||Phase 2|20|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-10-11 05:47:03.247824|2017-10-11 05:47:03.247824
NCT00250419|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2015-02-09|||September 2005||2005-09-01|February 2015|2015-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||V930 First in Man (FIM) Study (V930-002)(COMPLETED)|A Phase I Study to Evaluate the Safety/Tolerability and Immunogenicity of V-930 in Patients With Cancers Expressing HER-2 and/or CEA|Completed||Phase 1|26|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:47:03.370095|2017-10-11 05:47:03.370095
NCT00250432|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2017-02-21|2009-01-13||January 2006||2006-01-01|February 2017|2017-02-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of Caspofungin in the Treatment of Invasive Candidiasis in Adults|Completed||Phase 3|204|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:47:03.476046|2017-10-11 05:47:03.476046
NCT00250445|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2015-07-29|||January 2003||2003-01-01|July 2015|2015-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)|A Randomized, Double-Blind, Active-Comparator-Controlled, Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients With Osteoarthritis or Rheumatoid Arthritis|Completed||Phase 3|23498|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:47:04.888384|2017-10-11 05:47:04.888384
NCT00250458|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2015-10-30|2009-09-21||March 2006||2006-03-01|October 2015|2015-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Elimination of Migraine-Associated Nausea in Migraine Patients Treated With Rizatriptan Orally Disintegrating Tablet (ODT)|Completed||Phase 3|346|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-10-11 05:47:04.965479|2017-10-11 05:47:04.965479
NCT00250471|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2005-11-07|||May 2003||2003-05-01|November 2005|2005-11-01|September 2004||2004-09-01|||||Interventional|||PROTECT-TIMI 30 Trial|A Randomized Trial to Evaluate the Relative Protection Against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia Among Anti-Platelet and Anti-Thrombotic Agents|Completed||Phase 3|900||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 05:47:07.041312|2017-10-11 05:47:07.041312
NCT00250497|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2017-02-17|2012-07-12||September 2005||2005-09-01|February 2017|2017-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||New Moves - Obesity Prevention Among Adolescent Girls|New Moves: Obesity Prevention Among Adolescent Girls|Completed||N/A|356|Actual|University of Minnesota - Clinical and Translational Science Institute|Control group also had all-girls PE. Some girls missing body composition data.|2|||f||||t||||||||||2017-10-11 05:47:07.443045|2017-10-11 05:47:07.443045
NCT00250510|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2010-03-17|||June 2004||2004-06-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Reimbursement Effects on Enrollment in Obesity Treatment|A Prospective Study to Determine the Effects of a Reimbursement Incentive on Enrollment and Outcomes in a Community Weight Control Program.|Completed||N/A|401|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-10-11 05:47:07.78063|2017-10-11 05:47:07.78063
NCT00250523|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2017-09-14|||February 2003||2003-02-01|September 2017|2017-09-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Observational|||Mathematical Modeling of the Acute Inflammatory Response Following Injury|Mathematical Modeling of the Acute Inflammatory Response Following Injury|Recruiting||N/A|520|Anticipated|National Institute of General Medical Sciences (NIGMS)|||2||f||||t||||||Samples With DNA|"     For trauma injury cohort: The maximum blood volume collected over the 28 day period, if all     samples are obtained, is approximately 90 cc. All standard precautions will be undertaken to     assure minimal risk.      Blood samples will be obtained for genetic analysis of inflammatory gene polymorphisms. We     will collect whole blood, serum and white cells.   "|||2017-10-11 05:47:07.877945|2017-10-11 05:47:07.877945
NCT00250536|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2010-01-12|||March 2000||2000-03-01|January 2010|2010-01-01|October 2004||2004-10-01|||||Interventional|||Anabolic Steroids and Exercise in Hemodialysis Patients|Anabolic Steroids and Exercise in Hemodialysis Patients|Completed||N/A|80||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:47:07.956943|2017-10-11 05:47:07.956943
NCT00250549|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2014-12-09|||May 2005||2005-05-01|December 2014|2014-12-01|March 2006|Actual|2006-03-01|October 2005|Actual|2005-10-01||Interventional|||A Theory Based HIV Prevention Video For Rapid HIV Testing: A Randomized Trial|A Randomized Control Trial Evaluating the Educational Effectiveness of a Rapid HIV Post-Test Counseling Video.|Completed||N/A|128|Actual|North Bronx Healthcare Network||2|||f||||f||||||||||2017-10-11 05:47:08.148634|2017-10-11 05:47:08.148634
NCT00250562|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-06|2017-07-30|||October 2005||2005-10-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.|A Multicenter, Double-blind, Randomized, Active Controlled, Parallel Group Trial Comparing the Combinations of Valsartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Valsartan 80 mg in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Valsartan 80mg|Completed||Phase 3|1171|Actual|Novartis|||||f||||||||||||||2017-10-11 05:47:08.232962|2017-10-11 05:47:08.232962
NCT00250575|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2016-04-20|||November 2005||2005-11-01|April 2016|2016-04-01||||December 2009|Actual|2009-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia|A 24-week, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia|Completed||Phase 3|43|Actual|Novartis||1|||f||||||||||||||2017-10-11 05:47:08.325122|2017-10-11 05:47:08.325122
NCT00250588|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2013-04-25|2012-12-11||October 2003||2003-10-01|April 2013|2013-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Problem-Solving Skills Training to Improve Care for Children With Asthma|Reducing Barriers to Care for Vulnerable Children With Asthma|Completed||N/A|252|Actual|RAND|Substantial dropout, particularly from CC+PST, is a limitation. Our sample size was not large enough, nor was there sufficient variability in our secondary outcomes, to detect differences in health care utilization despite the odds ratios.|3|||f||||f||||||||||2017-10-11 05:47:08.46185|2017-10-11 05:47:08.46185
NCT00250601|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2012-02-15|||April 2005||2005-04-01|February 2012|2012-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression|An Eight-Week, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder.|Completed||Phase 3|460|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:47:08.937254|2017-10-11 05:47:08.937254
NCT00250614|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-18|2010-06-08|||April 2005||2005-04-01|June 2010|2010-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression|An Eight-Week, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder.|Completed||Phase 3|452|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:47:09.019981|2017-10-11 05:47:09.019981
NCT00250627|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2008-12-22|||December 2004||2004-12-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression|An Eight-Week, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder|Completed||Phase 3|465|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:47:09.110067|2017-10-11 05:47:09.110067
NCT00250640|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2015-01-30|||April 2005||2005-04-01|January 2015|2015-01-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Observational|||Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years|Open-label, Uncontrolled, Prospective Long-term Observation of Ventavis Inhalation Therapy in the Treatment of Patients With Primary Pulmonary Hypertension up to 4 Years|Completed||N/A|106|Actual|Bayer|||1||f||||f||||||None Retained|"     n.a   "|||2017-10-11 05:47:09.220033|2017-10-11 05:47:09.220033
NCT00244881|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-12-03|2013-11-04||September 2005||2005-09-01|November 2013|2013-11-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)|A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)|Completed||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:47:51.053969|2017-10-11 05:47:51.053969
NCT00250653|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2012-02-15|||May 2005||2005-05-01|February 2012|2012-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression|A Fifty-two-week, Multicenter, Open-label Study Evaluating the Long-term Safety and Tolerability of Saredutant in Adult and Elderly Patients With Major Depressive Disorder|Completed||Phase 3|365|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:47:09.421392|2017-10-11 05:47:09.421392
NCT00250666|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2008-07-07|||January 2006||2006-01-01|July 2008|2008-07-01|May 2007|Actual|2007-05-01|May 2007||2007-05-01||Interventional|||Procalcitonin-Guided Antimicrobial Discontinuation|Procalcitonin-Guided Antimicrobial Discontinuation Strategy in Critically Ill Patients With Suspected or Confirmed Bacterial Sepsis|Completed||Phase 4|70|Anticipated|University Hospital, Geneva|||||f||||||||||||||2017-10-11 05:47:09.504975|2017-10-11 05:47:09.504975
NCT00250679|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2012-05-29|2008-10-03||October 2005||2005-10-01|May 2012|2012-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease|Multicenter, Double-Blind, Double-Dummy, Randomized, Active-Controlled, Parallel Group Long-Term Safety Study of 15 μg and 25 μg Arformoterol Tartrate Inhalation Solution BID in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|443|Actual|Sunovion|Please see dropout rate in participant group. Sunovion is unaware of any other limitations or caveats associated with this study.|3|||f||||t||||||||||2017-10-11 05:47:09.697969|2017-10-11 05:47:09.697969
NCT00250692|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2017-02-15||||||February 2017|2017-02-01||||||||Interventional|||A Study to Test the Pain-relieving Effect of Laughing Gas in Infants|Analgesic Effect of Nitrous Oxide in Neonates Undergoing Heel Stick|Withdrawn||Phase 3|0|Actual|University of California, Los Angeles||||unknown - no record of study conduct in departmental archive|f||||||||||||||2017-10-11 05:47:12.372236|2017-10-11 05:47:12.372236
NCT00250705|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2017-07-06|2017-03-28||November 17, 2004|Actual|2004-11-17|July 2017|2017-07-01|March 23, 2009|Actual|2009-03-23|March 23, 2009|Actual|2009-03-23||Interventional|||Trial of Aripiprazole in the Treatment of CD in Adolescents|Open Label Trial of Aripiprazole in the Treatment of CD in Adolescents|Completed||Phase 4|12|Actual|University of Iowa|12 subjects were recruited for this study but only 10 (83%) completed at least a week of data demonstrating the primary frustrations of the investigators in this study. Conduct disorder was a difficult diagnosis to recruit patients into this study.|1|||f||||f||||||||||2017-10-11 05:47:12.456118|2017-10-11 05:47:12.456118
NCT00250718|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2015-07-06|2015-06-13||October 2004||2004-10-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|November 2008|Actual|2008-11-01||Interventional|||Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach|Phase II Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-angiogenic Approach|Terminated||Phase 2|17|Actual|New Mexico Cancer Care Alliance||1||Low rate of accrual|f||||t||||||||||2017-10-11 05:47:12.772426|2017-10-11 05:47:12.772426
NCT00250731|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2009-06-15|||January 2006||2006-01-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Improving Diabetes Outcomes: a Couples Intervention|Improving Diabetes Outcomes: a Couples Intervention|Completed||Phase 1|45|Anticipated|State University of New York - Upstate Medical University||3|||f||||t||||||||||2017-10-11 05:47:13.19705|2017-10-11 05:47:13.19705
NCT00250744|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-09-23|||December 2004||2004-12-01|December 2009|2009-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting|Comparison of Aprepitant vs. Gabapentin in the Prevention of Delayed Nausea and Vomiting|Completed||Phase 2|200|Actual|New Mexico Cancer Care Alliance||2|||f||||t||||||||||2017-10-11 05:47:13.312474|2017-10-11 05:47:13.312474
NCT00250757|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2016-01-06|||October 2005||2005-10-01|January 2016|2016-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions|Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions|Terminated||N/A|101|Actual|New Mexico Cancer Care Alliance|||1|Study was not renewed timely with IRB of record.|f||||t||||||Samples Without DNA|"     Semen samples or Prostatic secretions (via prostate massage).   "|||2017-10-11 05:47:13.407321|2017-10-11 05:47:13.407321
NCT00250770|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2016-05-10|||January 1998||1998-01-01|May 2016|2016-05-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis|CSF-1 and Other Cytokines in Human Endometrial Carcinogenesis|Recruiting||N/A|750|Anticipated|University of New Mexico|||1||f||||t||||||Samples Without DNA|"     We have collected serum and ascites from approximately 200 patients with endometrial     carcinoma and 200 controls. We have long term follow-up serum from approximately 60 of these     patients. Approximately 10% of endometrial carcinoma patients recur. Our goal will be to     eventually have follow-up serum from up to 60 patients with recurrent endometrial carcinoma     in our tissue bank, so that we can determine the role of these assays in predicting     recurrence.   "|||2017-10-11 05:47:13.473652|2017-10-11 05:47:13.473652
NCT00250783|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-01-06|||July 2002||2002-07-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|||||Observational|||Pre-Clinical Models in Gynecological Tumors A Tissue Repository|Pre-Clinical Models in Gynecological Tumors: A Tissue Repository|Completed||N/A|26|Actual|University of New Mexico|||1||f||||t||||||Samples Without DNA|"     Tumor and normal tissues, ascites, and/or serum, and/or urine from women with malignant or     premalignant gynecological conditions for which they are undergoing medically-indicated     surgery, and normal tissues from women without malignancy who volunteer to donate serum     and/or tissue at the time of medically indicated surgery   "|||2017-10-11 05:47:13.555951|2017-10-11 05:47:13.555951
NCT00250796|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-01-06|||September 2000||2000-09-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma|Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|12|Actual|University of New Mexico||2|||f||||t||||||||||2017-10-11 05:47:13.630941|2017-10-11 05:47:13.630941
NCT00250809|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-01-06|||March 1994||1994-03-01|March 2009|2009-03-01|March 2006|Actual|2006-03-01|December 2005|Actual|2005-12-01||Interventional|||Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study|CVC Pros and Cons of Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study|Completed||N/A|15|Actual|University of New Mexico||1|||f||||t||||||||||2017-10-11 05:47:13.720881|2017-10-11 05:47:13.720881
NCT00250835|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2015-08-03|2015-06-19||April 2005||2005-04-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|December 2012|Actual|2012-12-01||Interventional|||Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer|A Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Patients With Newly Diagnosed Resectable Rectal Cancer|Terminated||Phase 2|38|Actual|New Mexico Cancer Care Alliance||1||Low accrual|f||||t||||||||||2017-10-11 05:47:13.90166|2017-10-11 05:47:13.90166
NCT00250848|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2016-06-09|||March 2004||2004-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Observational|||Lung Cancer Case Registry and Tissue Resource|Lung Cancer Case Registry and Tissue Resource|Completed||N/A|750|Actual|University of New Mexico|||1||f||||f||||||Samples With DNA|"     Blood samples, and sputum (phlegm) samples.   "|||2017-10-11 05:47:14.278145|2017-10-11 05:47:14.278145
NCT00250861|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2008-04-17|||October 2005||2005-10-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma|A Randomized Phase II Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for CD20 Positive Aggressive Non-Hodgkin's Lymphoma Following High Dose Therapy With Autologous PBSC Rescue|Terminated||Phase 2|110||US Oncology Research||||Study terminated due to lack of enrollment.|f||||||||||||||2017-10-11 05:47:14.386413|2017-10-11 05:47:14.386413
NCT00250874|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2005-11-07|||December 2003||2003-12-01|November 2005|2005-11-01||||||||Interventional|||Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer|Phase I-II Study of Liposomal Doxorubicin (Myocet®), Docetaxel and Trastuzumab as First-Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|45||Zeneus Pharma|||||f||||||||||||||2017-10-11 05:47:14.510583|2017-10-11 05:47:14.510583
NCT00250887|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2007-10-22|||July 2005||2005-07-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research|A Phase II Open Label Study of the Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research|Completed||Phase 2|22|Actual|University of Zurich||1|||f||||f||||||||||2017-10-11 05:47:14.596595|2017-10-11 05:47:14.596595
NCT00250900|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2006-11-29|||July 2004||2004-07-01|November 2005|2005-11-01|August 2005||2005-08-01|||||Interventional|||Wait and See Antibiotic Prescription for Acute Otitis Media: A Randomized Controlled Trial|Wait and See Antibiotic Prescription for Acute Otitis Media: A Randomized Controlled Trial|Completed||N/A|240||Yale University|||||f||||||||||||||2017-10-11 05:47:14.678418|2017-10-11 05:47:14.678418
NCT00250913|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2010-11-05|||August 2005||2005-08-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI)|Efficacy and Cost-Effectiveness of Behavioral Counseling For Exercise Behavior in Men and Women Following AMI and PCI|Completed||Phase 1|304|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||||||||||||2017-10-11 05:47:14.769109|2017-10-11 05:47:14.769109
NCT00250926|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2016-03-10|2012-12-19||October 2005||2005-10-01|March 2016|2016-03-01|February 2009|Actual|2009-02-01|March 2007|Actual|2007-03-01||Interventional|||Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia|A Phase II Study of the Combination Bortezomib (Velcade, PS-341), Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia|Completed||Phase 2|23|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:47:14.891487|2017-10-11 05:47:14.891487
NCT00250939|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2014-02-04|||February 2005||2005-02-01|February 2014|2014-02-01|November 2006|Actual|2006-11-01|July 2006|Actual|2006-07-01||Interventional|||A Study of rhGAA in Patients With Late-Onset Pompe Disease|Single-center, Open-label Study of Safety, Pharmacokinetics and Efficacy of rhGAA in Patients With Late-Onset Pompe Disease|Completed||Phase 2|5|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:47:15.248312|2017-10-11 05:47:15.248312
NCT00250952|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2005-11-08|||February 2005||2005-02-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Study to Determine If the Volume Used to Dilute BOTOX Cosmetic™ for Injection Affects Its Overall Effect and Duration.|A Randomized, Evaluator-Blinded, Two Centre Study of the Safety and Effect of Volume on the Diffusion and Efficacy of BOTOX Cosmetic™ (Botulinum Toxin Type A) in the Treatment of Lateral Orbital Rhytides.|Completed||N/A|20||Carruthers Dermatology Centre|||||f||||||||||||||2017-10-11 05:47:15.539311|2017-10-11 05:47:15.539311
NCT00250965|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2010-11-03|||July 2004||2004-07-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||MPAACS: Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery|Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery|Terminated||Phase 3|927|Actual|University of British Columbia||1||Terminated by DSMB; futility analysis showing Mg treatment not efficacious|f||||f||||||||||2017-10-11 05:47:15.637862|2017-10-11 05:47:15.637862
NCT00250978|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2008-04-29|||November 2005||2005-11-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC|Phase I of Bevacizumab Plus Chemotherapy in Patients With Malignant Pleural Effusion Due to Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-10-11 05:47:15.756079|2017-10-11 05:47:15.756079
NCT00250991|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2009-05-07|||July 2003||2003-07-01|May 2009|2009-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial|Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial|Completed||Phase 1/Phase 2|94|Actual|University of Cincinnati|||||f||||t||||||||||2017-10-11 05:47:15.89918|2017-10-11 05:47:15.89918
NCT00244894|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2017-04-26|||September 2002||2002-09-01|April 2017|2017-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer|Acupuncture for Hot Flashes in Prostate Cancer Patients|Terminated||N/A|22|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 05:47:51.320147|2017-10-11 05:47:51.320147
NCT00251004|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2011-04-07|2010-12-17||October 2005||2005-10-01|April 2011|2011-04-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients|Efficacy and Safety Study Comparing Concentration-controlled Everolimus in Two Doses (1.5 and 3.0 mg/Day Starting Doses) With Reduced Cyclosporine Versus 1.44 g Mycophenolic Acid (as Sodium Salt) With Standard Dose Cyclosporine in de Novo Renal Transplant Recipients|Completed||Phase 3|833|Actual|Novartis||3|||f||||||||||||||2017-10-11 05:47:16.123777|2017-10-11 05:47:16.123777
NCT00251017|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-12-25|||July 2005||2005-07-01|December 2012|2012-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs|Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs|Completed||N/A|34|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-10-11 05:47:19.7779|2017-10-11 05:47:19.7779
NCT00251030|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2009-02-13|||November 2005||2005-11-01|February 2009|2009-02-01|January 2006|Actual|2006-01-01|||||Interventional|||A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects|A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects|Completed||Phase 4|20|Actual|Pfizer|||||f||||||||||||||2017-10-11 05:47:19.85898|2017-10-11 05:47:19.85898
NCT00251043|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2012-03-23|||September 2005||2005-09-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Site|Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Sites|Completed||Phase 4|142|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-10-11 05:47:20.095525|2017-10-11 05:47:20.095525
NCT00251056|ClinicalTrials.gov processed this data on October 10, 2017|2005-06-30|2008-08-27|||October 2005||2005-10-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Mannitol Dose Response Study in Cystic Fibrosis|A Phase IIa Randomised, Open Label, Dose Response Study to Determine the Optimum Dose of Dry Powder Mannitol Required to Generate Clinical Improvement In Patients With Cystic Fibrosis|Completed||Phase 2|48|Actual|Pharmaxis||4|||f||||t||||||||||2017-10-11 05:47:20.21668|2017-10-11 05:47:20.21668
NCT00251069|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2005-11-07|||April 2005||2005-04-01|July 2005|2005-07-01|August 2005||2005-08-01|||||Interventional|||Glucosamine Sulphate and Increased Level of Blood Cholesterol|Glucosamine Sulphate and Hypercholesterolaemia|Completed||Phase 4|66||Slidgigtinstituttet|||||f||||||||||||||2017-10-11 05:47:20.337836|2017-10-11 05:47:20.337836
NCT00251082|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2008-03-11|||December 2005||2005-12-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination|A Randomized, Placebo-Controlled, Double-Blind, Multi-National Study to Demonstrate Efficacy of Continuous Combined 0.5 mg Estradiol and 2.5 mg Dydrogesterone in the Treatment of Vasomotor Symptoms in Postmenopausal Women in Comparison to Placebo Over 3 Months, and to Investigate the Bleeding Pattern Over a Double-Blind Treatment Period of One Year Compared With Continuous Combined 1 mg Estradiol and 5 mg Dydrogesterone|Completed||Phase 3|391|Actual|Solvay Pharmaceuticals||3|||f||||f||||||||||2017-10-11 05:47:20.417153|2017-10-11 05:47:20.417153
NCT00251095|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2009-06-02|||September 2005||2005-09-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer|A Multicenter Phase 3, Randomized Comparison of the Safety and Efficacy of Weekly TOCOSOL(R) Paclitaxel vs. Weekly Paclitaxel Injection in the Treatment of Metastatic Breast Cancer|Terminated||Phase 3|821|Actual|Achieve Life Sciences||2||Failed primary endpoint|f||||||||||||||2017-10-11 05:47:20.544304|2017-10-11 05:47:20.544304
NCT00251108|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2007-02-28|||October 2003||2003-10-01|February 2007|2007-02-01|March 2007||2007-03-01|||||Interventional|||Fitness Training After Traumatic Brain Injury|The Efficacy of a Supervised Fitness Centre-Based Exercise Programme Compared to an Unsupervised Home-Based Exercise Programme on Improving Fitness and Psychosocial Outcomes in a Traumatic Brain Injured Population|Completed||N/A|60||Sydney South West Area Health Service|||||f||||||||||||||2017-10-11 05:47:20.658233|2017-10-11 05:47:20.658233
NCT00251121|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2012-02-08|||November 2005||2005-11-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG|Mini-invasive Electrophysiology Study as a Routine Examination for Patients Complaining of Tachycardia, But With a Negative Holter ECG.|Completed||N/A|51|Actual|Sykehuset Telemark||1|||f||||f||||||||||2017-10-11 05:47:20.830584|2017-10-11 05:47:20.830584
NCT00251134|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2008-09-11|||October 2003||2003-10-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|OMEGA||OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction|OMEGA: A Prospective, Randomised, Double-Blind, Placebo-Controlled Multicentre Study in Patients Who Survived Acute Myocardial Infarction to Investigate the Efficacy and Safety of 1 Gram Ω-3-Fatty Acid Ethyl Esters (Ω-3FAE) Daily Versus Placebo to Reduce the Risk of Sudden Cardiac Death.|Completed||Phase 3|3800|Actual|Stiftung Institut fuer Herzinfarktforschung||2|||f||||t||||||||||2017-10-11 05:47:20.924884|2017-10-11 05:47:20.924884
NCT00251147|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2008-01-14|||March 1999||1999-03-01|January 2008|2008-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Randomized Clinical Trial Comparing Open to Mini-Open Rotator Cuff Repair for Full-Thickness Rotator Cuff Tears.|Prospective Randomized Study Comparing Open Acromioplasty and Rotator Cuff Repair Versus Arthroscopic Acromioplasty and Mini-Open Rotator Cuff Repair.|Completed||N/A|73|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 05:47:21.0349|2017-10-11 05:47:21.0349
NCT00251160|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2015-07-09|||December 1999||1999-12-01|July 2015|2015-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Electrothermal Arthroscopic Capsulorrhaphy (ETAC) and Open Inferior Capsular Shift in Patients With Shoulder Instability|Arthroscopic Electrothermal Capsulorrhaphy, ETAC, Versus Open Inferior Capsular Shift, ICS in Patients With Shoulder Instability: A Multicentre Randomized Clinical Trial|Completed||N/A|58|Actual|University of Calgary||2|||f||||t||||||||||2017-10-11 05:47:21.15011|2017-10-11 05:47:21.15011
NCT00251173|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2016-04-07|||November 2005||2005-11-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Project Health Link: Connecting Patients With Services|Services Interventions for Injured ED Substance Abusers|Completed||N/A|755|Actual|University of Michigan||3|||f||||f||||||||No||2017-10-11 05:47:21.270464|2017-10-11 05:47:21.270464
NCT00251186|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2010-01-25|||April 2006||2006-04-01|January 2010|2010-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients|Phase II Study of First-Line Capecitabine and Cetuximab for Treatment of Metastatic Colorectal Cancer in Elderly Patients and/or Those With Multiple Comorbidities Unable to Receive Chemotherapy Doublets|Terminated||Phase 2|18||Rutgers, The State University of New Jersey||||Funding unavailable|f||||||||||||||2017-10-11 05:47:21.359221|2017-10-11 05:47:21.359221
NCT00251199|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2007-12-17|||October 2005||2005-10-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||VX-950 and Peginterferon for Hepatitis C|A Phase 1b Viral Kinetic Study of VX-950 and Peginterferon in Hepatitis C|Completed||Phase 1|20||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-10-11 05:47:21.428485|2017-10-11 05:47:21.428485
NCT00251212|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2014-04-09|||September 2006||2006-09-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2010|Actual|2010-10-01||Interventional|||Tailored Teen Alcohol and Violence Prevention in the Emergency Room (ER)|Tailored Teen Alcohol and Violence Prevention in the ER|Completed||N/A|3694|Actual|University of Michigan||3|||f||||f||||||||||2017-10-11 05:47:21.521239|2017-10-11 05:47:21.521239
NCT00251225|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2017-07-10|2016-01-15||August 2005||2005-08-01|July 2017|2017-07-01|March 2014|Actual|2014-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Imatinib and Docetaxel in Prostate Cancer|A Phase II Study of Imatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|49|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-10-11 05:47:21.627279|2017-10-11 05:47:21.627279
NCT00251238|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2017-05-16|2015-01-12||November 2005||2005-11-01|May 2017|2017-05-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon|Efficacy and Tolerability of Ginkgo Biloba Extract EGb 761® in Patients With Raynaud´s Phenomenon|Completed||Phase 2|41|Actual|VSM Geneesmiddelen b.v.||2|||f||||t||||||||Undecided||2017-10-11 05:47:22.043571|2017-10-11 05:47:22.043571
NCT00251251|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-06-15|||April 2003||2003-04-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|RAFT||Resynchronization/Defibrillation for Ambulatory Heart Failure Trial|Resynchronization/Defibrillation for Ambulatory Heart Failure Trial|Completed||N/A|1798|Actual|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-10-11 05:47:22.365221|2017-10-11 05:47:22.365221
NCT00251264|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2015-07-09|||November 2001||2001-11-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2010|Actual|2010-12-01||Interventional|||Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability|Arthroscopic Versus Open Stabilization of Traumatic Unidirectional Anterior Shoulder Instability: A Randomized Clinical Trial|Completed||N/A|194|Actual|University of Calgary||2|||f||||f||||||||||2017-10-11 05:47:22.996466|2017-10-11 05:47:22.996466
NCT00251277|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2012-11-14|||November 2005||2005-11-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura|Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura|Withdrawn||Phase 1/Phase 2|0|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-10-11 05:47:23.12976|2017-10-11 05:47:23.12976
NCT00251290|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2009-03-02|||November 2004||2004-11-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack|Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack|Completed||Phase 2|62|Actual|Yale University||1|||f||||||||||||||2017-10-11 05:47:23.199632|2017-10-11 05:47:23.199632
NCT00251303|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2014-07-14|2013-05-16||August 2005||2005-08-01|July 2014|2014-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||These data apply only to double-blind phase.|Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders|An Investigation of the Efficacy in Childhood Obsessive-Compulsive Disorder of Riluzole: An Antiglutamatergic Agent|Completed||Phase 2|78|Actual|National Institutes of Health Clinical Center (CC)|Only treatment-refractory subjects were eligible for study participation. This may have decreased treatment response. Further, 98% were taking psychotropic drugs at baseline, which may have reduced between-group differences.|2|||f||||f||||||||||2017-10-11 05:47:23.282479|2017-10-11 05:47:23.282479
NCT00251316|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2013-01-29|2012-11-20||November 2005||2005-11-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer|The Effects of Lithium Carbonate on Low Dose Radioiodine Ablation in Early Thyroid Cancer Treatment|Completed||Phase 2|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-10-11 05:47:23.668146|2017-10-11 05:47:23.668146
NCT00251329|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2007-04-03|||May 2003||2003-05-01|April 2007|2007-04-01||||||||Interventional|||Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery|Phase II Neoadjuvant Trial of Docetaxel (Taxotere), Carboplatin, and Capecitabine (Xeloda) in the Treatment of Early Stage Locally Advanced and Inflammatory Breast Cancer|Unknown status|Active, not recruiting|Phase 2|48||Cancer Research Network|||||f||||||||||||||2017-10-11 05:47:23.933223|2017-10-11 05:47:23.933223
NCT00251342|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2007-04-04|||October 2005||2005-10-01|April 2007|2007-04-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale|Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale|Unknown status|Recruiting|Phase 2/Phase 3|460||Chinese University of Hong Kong|||||f||||f||||||||||2017-10-11 05:47:24.121714|2017-10-11 05:47:24.121714
NCT00251355|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2016-12-19|||January 1998||1998-01-01|December 2016|2016-12-01|August 2008|Actual|2008-08-01|June 2007|Actual|2007-06-01||Interventional|||Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer|A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer|Completed||Phase 1|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:47:24.231121|2017-10-11 05:47:24.231121
NCT00251368|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2011-03-09|||January 1995||1995-01-01|March 2011|2011-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia|Multicenter Study of 9-AC in Refractory Leukemia|Completed||Phase 1|52|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-10-11 05:47:24.334151|2017-10-11 05:47:24.334151
NCT00251381|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2006-10-25|||November 2005||2005-11-01|October 2006|2006-10-01|November 2009||2009-11-01|||||Interventional|||Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.|Open Label Randomized Phase II, Multicentre, Pilot Study to Evaluate Safety and Efficacy of the Combination of Cetuximab and Concomitant-Boost Accelerated Radiotherapy Followed or Not by a Complementary Treatment With Cetuximab in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.|Unknown status|Recruiting|Phase 2|90||Trial Form Support S.L.|||||f||||||||||||||2017-10-11 05:47:24.427748|2017-10-11 05:47:24.427748
NCT00251394|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2010-01-28|||July 2004||2004-07-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|December 2006|Actual|2006-12-01||Interventional|||Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma|A Phase 2, Open-Label Study of the Efficacy, Safety, and Tolerability of Dynavax's Immunostimulatory Phosphorothiolate Oligodeoxyribonucleotide, 1018 ISS, Following Rituxan (Rituximab) Treatment in Patients With CD20+, B-Cell Follicular Non-Hodgkin's Lymphoma.|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:47:24.627148|2017-10-11 05:47:24.627148
NCT00251407|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-08-07|||September 1999||1999-09-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|January 2003|Actual|2003-01-01||Interventional|||Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies|Phase I Study of Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies|Completed||Phase 1|46|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-10-11 05:47:24.738781|2017-10-11 05:47:24.738781
NCT00251420|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2009-05-06|||December 2005||2005-12-01|May 2009|2009-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Writing About Disease: Effect on Rehabilitation?|Writing About Disease: Effect on Rehabilitation?|Completed||N/A|180|Anticipated|LHL Helse||1|||f||||f||||||||||2017-10-11 05:47:24.845983|2017-10-11 05:47:24.845983
NCT00251433|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2017-06-06|||September 26, 2005|Actual|2005-09-26|June 2017|2017-06-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer|An Open-label, Multicenter, Phase I/II Dose Escalation Study of Oral GW572016 in Combination With Docetaxel (Taxotere) Plus Trastuzumab (Herceptin) in Subjects Previously Untreated for ErbB2-overexpressing Metastatic Breast Cancer|Active, not recruiting||Phase 1|53|Actual|Novartis||3|||f|||||t|f||||||Undecided|"Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"|2017-10-11 05:47:24.936731|2017-10-11 05:47:24.936731
NCT00251446|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-05-09|||October 2005||2005-10-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer|A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|70|Actual|Veeda Oncology||1|||f||||f||||||||||2017-10-11 05:47:25.068637|2017-10-11 05:47:25.068637
NCT00251459|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2014-03-06|||November 2005||2005-11-01|March 2014|2014-03-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)|A Phase IIIb, Single-Masked, Multicenter, Randomized Study to Evaluate the Safety and Tolerability of Ranibizumab in Naive and Previously Treated Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)|Completed||Phase 3|5000||Genentech, Inc.|||||||||||||||||||2017-10-11 05:47:25.163506|2017-10-11 05:47:25.163506
NCT00251472|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-05-09|||March 2005||2005-03-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer|A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer|Completed||Phase 2|72|Actual|Veeda Oncology||1|||f||||f||||||||||2017-10-11 05:47:25.244882|2017-10-11 05:47:25.244882
NCT00251485|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2008-08-20|||March 2004||2004-03-01|August 2008|2008-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer|A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer|Completed||Phase 2|82|Actual|Veeda Oncology||1|||f||||f||||||||||2017-10-11 05:47:25.331406|2017-10-11 05:47:25.331406
NCT00251498|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2008-08-20||||||August 2008|2008-08-01|October 2007|Actual|2007-10-01|||||Interventional|||Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer|Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|82|Actual|Veeda Oncology||1|||f||||||||||||||2017-10-11 05:47:25.416226|2017-10-11 05:47:25.416226
NCT00251511|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-05-09|||August 2004||2004-08-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|January 2006|Actual|2006-01-01||Interventional|||A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome|A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome|Terminated||Phase 2|60|Actual|Veeda Oncology||1||Sponsor terminated trial|f||||f||||||||||2017-10-11 05:47:25.505419|2017-10-11 05:47:25.505419
NCT00251524|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-05-09|||November 2005||2005-11-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC|A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC|Completed||Phase 2|69|Actual|Veeda Oncology||1|||f||||f||||||||||2017-10-11 05:47:25.604142|2017-10-11 05:47:25.604142
NCT00251537|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2006-07-07|||November 2005||2005-11-01|July 2006|2006-07-01|August 2006||2006-08-01|||||Interventional|||A Pilot Study of LTB4 in HIV-1 Infected Adults|A Pilot Study Assessing Safety and Antiretroviral Activity of Intravenously Administered LTB4 in HIV-1 Infected Adults With a CD4 Count Greater Than 250 Cells/mm3 and a Viral Load Greater Than 5,000 Copies/mL, and Who Have Not Received Antiretroviral Therapy Within Two Months|Completed||Phase 2|40||LTB4 Sweden AB|||||f||||||||||||||2017-10-11 05:47:25.68055|2017-10-11 05:47:25.68055
NCT00251550|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2007-11-05|||October 2005||2005-10-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|||||Interventional|||Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma|Phase I/II Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma|Completed||Phase 1/Phase 2|12||Eli Lilly and Company|||||f||||||||||||||2017-10-11 05:47:25.775925|2017-10-11 05:47:25.775925
NCT00251576|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2017-04-06|||November 1, 1999|Actual|1999-11-01|April 2017|2017-04-01|March 23, 2004|Actual|2004-03-23|March 23, 2004|Actual|2004-03-23||Interventional|||Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)|A Multicenter, Randomized, Controlled, Double-Blind Trial to Investigate the Clinical Efficacy and Tolerability of Early Treatment With Simvastatin 40 mg Daily for 30 Days, Followed by Simvastatin 80 mg Daily Thereafter in Tirofiban-Treated Acute Coronary Syndrome Patients Who Have Been Randomized to Receive Enoxaparin or Unfractionated Heparin in Conjunction With Aspirin|Completed||Phase 3|4497|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-10-11 05:47:25.954503|2017-10-11 05:47:25.954503
NCT00251589|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2015-02-17|2008-10-27||January 2006||2006-01-01|February 2015|2015-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)|A Phase I/II Clinical Trial of Oral Vorinostat (MK0683) in Combination With Erlotinib in Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer|Terminated||Phase 1/Phase 2|23|Actual|Merck Sharp & Dohme Corp.|Due to the slow pace of patient accrual, failure to observe meaningful efficacy in treated patients, and overall intolerance of the combination regimen, the study was terminated prematurely on 12-Oct-2007.|4||"This trial is being closed based on lack of substantive efficacy, slow accrual and overall   tolerance in patients treated to date."|f||||f||||||||||2017-10-11 05:47:26.052323|2017-10-11 05:47:26.052323
NCT00251602|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-08-03|||March 2003||2003-03-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Analysis of Atropine and Propranolol Induced Changes|Wavelet Transform and Pharmacodynamic Analysis of Atropine and Propranolol Induced Changes in Human Heart Rate Variability|Completed||Phase 1|24|Actual|National Institutes of Health Clinical Center (CC)||6|||f||||||||||||||2017-10-11 05:47:27.448501|2017-10-11 05:47:27.448501
NCT00251615|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-08-03|||August 2012||2012-08-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging|Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging|Completed||N/A|18|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||||||||Samples With DNA|"     Vascular tissue obtained from the surgical site that would have otherwise been discarded and     Blood Serum   "|||2017-10-11 05:47:27.552531|2017-10-11 05:47:27.552531
NCT00251628|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-06-07|||June 2000||2000-06-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Home Care Management of Pediatric Pain|Home Care Management of Pediatric Pain|Completed||Phase 4|211|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-10-11 05:47:27.622484|2017-10-11 05:47:27.622484
NCT00251641|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2017-04-04|2009-05-21||September 1, 2005|Actual|2005-09-01|April 2017|2017-04-01|June 1, 2008|Actual|2008-06-01|June 1, 2008|Actual|2008-06-01||Interventional|||The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)|An Open-Label, Randomized Efficacy and Safety Study of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis|Completed||Phase 3|868|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:47:27.777007|2017-10-11 05:47:27.777007
NCT00251654|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2009-09-30|||January 2002||2002-01-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia|Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia Results of Investigations on 3,491 Catheters|Completed||Phase 4|9000|Actual|Rechbergklinik Bretten|||1||f||||f||||||||||2017-10-11 05:47:28.85622|2017-10-11 05:47:28.85622
NCT00251680|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-05-23|||October 2005||2005-10-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.|A Placebo-Controlled, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 100 mg in Subjects With Type 2 Diabetes Currently Treated With Lipid-Lowering Therapy|Completed||Phase 3|400|Actual|Takeda||2|||f||||f||||||||||2017-10-11 05:47:28.97547|2017-10-11 05:47:28.97547
NCT00251693|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-02-01|2009-02-20||December 2005||2005-12-01|February 2012|2012-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis|A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg Once- Daily [QD] and 90 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis|Completed||Phase 3|2038|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:47:29.393581|2017-10-11 05:47:29.393581
NCT00251706|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2006-05-04|||February 1999||1999-02-01|November 2005|2005-11-01|September 2004||2004-09-01|||||Interventional|||Amiodarone to Prevent Post-Operative Arrhythmias|Prophylactic Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair - PAPABEAR|Completed||Phase 3|600||University of Calgary|||||f||||||||||||||2017-10-11 05:47:30.922706|2017-10-11 05:47:30.922706
NCT00251719|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2012-02-01|2009-02-20||December 2005||2005-12-01|February 2012|2012-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis|A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg Once-daily [QD] and 90 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis|Completed||Phase 3|2054|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:47:31.041289|2017-10-11 05:47:31.041289
NCT00251732|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2010-08-18|||March 2005||2005-03-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)|Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI.|Completed||Phase 4|150|Actual|Southern Arizona VA Health Care System||3|||f||||f||||||||||2017-10-11 05:47:33.825325|2017-10-11 05:47:33.825325
NCT00251745|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2011-04-25|2009-02-26||December 2005||2005-12-01|April 2011|2011-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn|A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (60 mg Once-Daily (QD) and 90 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|908|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:47:33.95013|2017-10-11 05:47:33.95013
NCT00251758|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2010-05-12|2009-02-26||December 2005||2005-12-01|May 2010|2010-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn|A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|908|Actual|Takeda||3|||t||||f||||||||||2017-10-11 05:47:35.938285|2017-10-11 05:47:35.938285
NCT00251771|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2015-04-29|||January 2006||2006-01-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CaVenT||Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis|Catheter-directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis, an Open Randomized, Controlled, Clinical Trial|Completed||N/A|209|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-10-11 05:47:38.669916|2017-10-11 05:47:38.669916
NCT00251784|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2005-11-09|||February 2002||2002-02-01|December 2003|2003-12-01|June 2003||2003-06-01|||||Interventional|||Healthy Volunteer Study of Sildenafil Effects Upon Vision|A Double-Blind, Randomised, Placebo Controlled Healthy Volunteer Study to Investigate the Nature and Origin of the Disturbance of Vision Induced by Single Oral Doses of Sildenafil|Completed||Phase 4|||University of Cambridge|||||f||||||||||||||2017-10-11 05:47:38.801893|2017-10-11 05:47:38.801893
NCT00251797|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2010-01-06|||March 2000||2000-03-01|October 2008|2008-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors|A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors.|Completed||Phase 1|10|Actual|University of New Mexico||1|||f||||t||||||||||2017-10-11 05:47:38.886223|2017-10-11 05:47:38.886223
NCT00251810|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2011-08-15|||November 2004||2004-11-01|August 2011|2011-08-01||||||||Observational|||Can CSM Monitor Depth of Anaesthesia Just as Good as BIS?|Can CSM Monitor Depth of Anaesthesia Just as Good as BIS?|Unknown status|Active, not recruiting|N/A|60|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-10-11 05:47:38.980108|2017-10-11 05:47:38.980108
NCT00251823|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2008-09-03|||July 2005||2005-07-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|||||Interventional|||Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI)|The Safety and Efficacy of Eptifibatide-Facilitated Percutaneous Coronary Angioplasty Versus Primary Percutaneous Coronary Angioplasty Alone|Completed||Phase 3|400|Anticipated|Ottawa Heart Institute Research Corporation|||||f||||||||||||||2017-10-11 05:47:39.08008|2017-10-11 05:47:39.08008
NCT00251836|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-08|2016-12-28|||January 2007||2007-01-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Adrenal Function After Living Kidney Donation|Prospective Evaluation of Adrenal Function After Living Donor Nephrectomy With or Without Ligation of the Adrenal Vein|Completed||N/A|30|Actual|University of Zurich|||2||f||||f||||||||No||2017-10-11 05:47:39.153137|2017-10-11 05:47:39.153137
NCT00251849|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2008-08-20|||November 2005||2005-11-01|October 2006|2006-10-01|December 2007||2007-12-01|||||Interventional|||PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients|Prospective Evaluation of Rifalazil Effect On Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia Seropositive Patients|Unknown status|Active, not recruiting|Phase 3|274||ActivBiotics|||||||||||||||||||2017-10-11 05:47:39.466374|2017-10-11 05:47:39.466374
NCT00251862|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2013-12-02|2013-07-23||January 2005||2005-01-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Shared Decision-Making for Colorectal Cancer Screening|Shared Decision-Making for Colorectal Cancer Screening|Completed||N/A|825|Actual|Agency for Healthcare Research and Quality (AHRQ)||3|||f||||f||||||||||2017-10-11 05:47:39.661478|2017-10-11 05:47:39.661478
NCT00251875|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2005-11-09|||July 2005||2005-07-01|November 2005|2005-11-01|September 2007||2007-09-01|||||Interventional|||Shared Online Health Records for Patient Safety and Care|Shared Online Health Records for Patient Safety and Care|Unknown status|Recruiting|N/A|5400||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-10-11 05:47:40.462688|2017-10-11 05:47:40.462688
NCT00251888|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2017-01-24|||November 2002||2002-11-01|February 2011|2011-02-01|November 2005|Actual|2005-11-01|||||Interventional|||CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto|Etude de Recherche de Dose de l'Association Irinotecan (Campto(R)) - Cisplatine (Cisplatyl(R)) Avec la radiothérapie Pelvienne Dans Les Cancers avancés du Col de l'utérus.|Completed||Phase 1|15||ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-10-11 05:47:40.629428|2017-10-11 05:47:40.629428
NCT00251901|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2011-01-21|||May 2004||2004-05-01|January 2011|2011-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Chest Pain Pilot Study|A Randomized Double-Blind Placebo-Controlled Multi-Centre Pilot Study to Assess Symptom Response in Subjects With Pain or Discomfort in the Chest Receiving Oral Treatment With Esomeprazole 40 mg Bid for 4 Weeks.|Completed||Phase 3|600||AstraZeneca|||||f||||||||||||||2017-10-11 05:47:40.737247|2017-10-11 05:47:40.737247
NCT00251914|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2011-01-21|||December 2002||2002-12-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Nexium Dyspepsia/AST|Supportive Test for Acid-Related Symptoms (STARS I) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Subjects With Upper Gastrointestinal Symptoms and With Normal Findings at Esophagogastroduodenoscopy.|Completed||Phase 3|1500||AstraZeneca|||||f||||||||||||||2017-10-11 05:47:41.017395|2017-10-11 05:47:41.017395
NCT00251927|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2012-08-07|2010-07-08||October 2001||2001-10-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|LOTUS||Esomeprazole (NEXIUM) vs. Surgery|An Open, Randomized, Multicenter, Phase IIIB Study During 5 Years to Assess Long-term Efficacy and Tolerability of Esomeprazole Compared to Laparoscopic Anti-reflux Surgery in Adult Subjects With Gastroesophageal Reflux Disease - LOTUS.|Completed||Phase 3|626|Actual|AstraZeneca||2|||f||||||||||||||2017-10-11 05:47:41.695467|2017-10-11 05:47:41.695467
NCT00244673|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2012-02-25|||October 2005||2005-10-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination|Diphteria-tetanus-pertussis (DTP) Vaccination and Child Survival: Randomized Study of Not Providing DTP Vaccination Together With or After Measles Vaccination|Completed||Phase 4|6534|Actual|Bandim Health Project||1|||f||||||||||||||2017-10-11 05:47:43.225178|2017-10-11 05:47:43.225178
NCT00244907|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2014-02-07|||January 2006||2006-01-01|February 2014|2014-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women|Metabolism and Bone Health|Completed||Phase 1|23|Actual|Purdue University||2|||f||||t||||||||||2017-10-11 05:47:51.426326|2017-10-11 05:47:51.426326
NCT00244686|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2017-09-01||||||September 2017|2017-09-01||||||||Expanded Access|||This Record Contains Information About the Mepolizumab Compassionate Use Product Activities: 104317: An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES. 201956: A Long-term Access Programme for Subjects With Severe Asthma|104317: An Open-Label Compassionate Use Access and Long-Term Access Study of Anti IL-5 (Mepolizumab) Treatment in Subjects With Hypereosinophilic Syndrome. 201956: A Long-term Access Programme for Subjects With Severe Asthma Who Participated in a GSK-sponsored Mepolizumab Clinical Study.|Available||N/A|||GlaxoSmithKline||||||t|||||||||||||2017-10-11 05:47:43.364381|2017-10-11 05:47:43.364381
NCT00244699|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2009-05-09|||October 2005||2005-10-01|May 2009|2009-05-01|April 2007||2007-04-01|||||Interventional|||Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth|A Mindfulness-Based Intervention for Youth With Concurrent Disorders|Completed||N/A|40||Centre for Addiction and Mental Health|||||f||||||||||||||2017-10-11 05:47:44.290369|2017-10-11 05:47:44.290369
NCT00244712|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2010-06-03|2009-04-23||July 2005||2005-07-01|June 2010|2010-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|HEAT||Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV|A 96-Week, Phase IV, Randomized, Double-Blind, Multicenter Study of the Safety and Efficacy of EPZICOM Versus TRUVADA Administered in Combination With KALETRA in Antiretroviral-Naive HIV-1 Infected Subjects|Completed||Phase 4|688|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-10-11 05:47:44.43031|2017-10-11 05:47:44.43031
NCT00244725|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2017-03-21|2017-03-21||September 2005||2005-09-01|March 2017|2017-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Odiparcil For The Prevention Of Venous Thromboembolism|A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery|Completed||Phase 2|961|Actual|GlaxoSmithKline|||||||||f||||||||||2017-10-11 05:47:46.350398|2017-10-11 05:47:46.350398
NCT00244738|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2012-03-18|||February 2006||2006-02-01|November 2005|2005-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The Use of Castor Oil as a Labor Initiator in Post-date Pregnancies|The Use of Castor Oil as a Labor Initiator in Post-date Pregnancies|Completed||N/A|82|Actual|Hadassah Medical Organization||2|||f||||||||||||||2017-10-11 05:47:48.323826|2017-10-11 05:47:48.323826
NCT00244764|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2017-02-23|2009-11-19||October 2005||2005-10-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|March 2008|Actual|2008-03-01||Interventional|||GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma|A Phase II Study of GW786034 Using a Randomised Discontinuation Design in Subjects With Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma|Completed||Phase 2|225|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-10-11 05:47:48.876114|2017-10-11 05:47:48.876114
NCT00244777|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2015-06-11|||December 2002||2002-12-01|October 2005|2005-10-01|February 2004||2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Introduction of Hypo-osmolar ORS for Routine Use|Introduction of New Hypo-osmolar ORS Into Routine Use in the Management of Diarrhoeal Disease: a Phase IV Clinical Surveillance.|Completed||Phase 4|75000||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-10-11 05:47:49.722285|2017-10-11 05:47:49.722285
NCT00244790|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-08-26|||April 2004||2004-04-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Effects of Obesity and Protein Intake on the Kidney|The Effects of Obesity and Protein Intake on the Kidney|Completed||N/A|50|Actual|Indiana University||1|||f||||t||||||||||2017-10-11 05:47:49.792678|2017-10-11 05:47:49.792678
NCT00244803|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2016-08-30|||January 2005||2005-01-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)|Redistribution and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)|Completed||N/A|101|Actual|Johns Hopkins University|||1||f||||t||||||||||2017-10-11 05:47:49.888068|2017-10-11 05:47:49.888068
NCT00244816|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2009-01-14|||October 2005||2005-10-01|January 2009|2009-01-01|April 2007||2007-04-01|||||Interventional|||Taxoprexin® Treatment for Advanced Eye Melanoma|Phase II Open-Label Study of Weekly Taxoprexin® (DHA-Paclitaxel) Injection as Treatment of Patients With Metastatic Uveal (Choroidal) Malignant Melanoma|Completed||Phase 2|30||Luitpold Pharmaceuticals|||||||||||||||||||2017-10-11 05:47:49.958543|2017-10-11 05:47:49.958543
NCT00244829|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2011-11-28|||January 2004||2004-01-01|November 2011|2011-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia|A Multicenter Pilot Study Evaluating the Safety and Efficacy of Imatinib as Post-Transplant Therapy for High- Risk Philadelphia Chromosome-Positive Leukemias|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:47:50.046966|2017-10-11 05:47:50.046966
NCT00244842|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2008-09-24|||December 2004||2004-12-01|September 2008|2008-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|SPIRIT||Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis|A Phase III, Randomized, Multicentre, Double-Blind, Placebo-Controlled Study of ISA247 in Plaque Psoriasis Patients|Completed||Phase 3|451|Actual|Aurinia Pharmaceuticals Inc.||4|||f||||t||||||||||2017-10-11 05:47:50.138561|2017-10-11 05:47:50.138561
NCT00244855|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2017-04-14|2017-04-14||May 2004||2004-05-01|April 2017|2017-04-01|August 29, 2011|Actual|2011-08-29|December 2008|Actual|2008-12-01||Interventional|||Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma|Rituximab and Dexamethasone in CD20 Positive Low Grade and Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|32|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-10-11 05:47:50.408055|2017-10-11 05:47:50.408055
NCT00244868|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-01-28|||July 2003||2003-07-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer|Facilitating Decision Making in Advanced Cancer Patients|Completed||Phase 3|720|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-10-11 05:47:50.942246|2017-10-11 05:47:50.942246
NCT00244920|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2012-05-24|||January 2002||2002-01-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer|An Open Label Randomized Phase 2 Study To Evaluate The Activity, Tolerability, And Toxicity Of Combined Neoadjuvant Anti-angiogenesis and Androgen Ablation Therapy in Men Undergoing Radical Prostatectomy|Withdrawn||Phase 2|0|Actual|OHSU Knight Cancer Institute||||Sponsor withdrew drug.|f||||f||||||||||2017-10-11 05:47:51.565757|2017-10-11 05:47:51.565757
NCT00244933|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-02-05|2015-01-12||February 2004||2004-02-01|February 2015|2015-02-01|October 2009|Actual|2009-10-01|November 2008|Actual|2008-11-01||Interventional|||Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer|Phase II Trial of Gemcitabine and Genistein in Metastatic Breast Cancer Patients With Biomarker Assays|Completed||Phase 2|19|Actual|Barbara Ann Karmanos Cancer Institute|Although the study is designed to accrue 18 response evaluable participants in the first stage, the decision was made to close the study after 17 patients because of lack of efficacy.|1|||f||||t||||||||||2017-10-11 05:47:51.705979|2017-10-11 05:47:51.705979
NCT00244946|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-03-25|||March 2004||2004-03-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|January 2010|Actual|2010-01-01||Interventional|||Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma|Immune Consolidation With Activated T Cells Armed With OKT3 x Rituxan (Anti-CD3 x Anti-CD20) Bispecific Antibody (CD20Bi) After Peripheral Blood Stem Cell Transplant for High Risk CD20+ Non-Hodgkin's Lymphomas|Completed||Phase 1|15|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-10-11 05:47:52.014717|2017-10-11 05:47:52.014717
NCT00244959|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-03-18|||January 2004||2004-01-01|March 2013|2013-03-01|November 2011|Actual|2011-11-01|September 2007|Actual|2007-09-01||Interventional|||Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer|Surrogate Markers of Response: A Phase II Study of Changes in Breast Density Among Postmenopausal Women Receiving Adjuvant Anastrozole Therapy|Completed||Phase 2|54|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-10-11 05:47:52.157389|2017-10-11 05:47:52.157389
NCT00244972|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2017-04-26|||October 2005||2005-10-01|April 2017|2017-04-01|March 2017|Actual|2017-03-01|March 2017|Actual|2017-03-01||Interventional|||Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer|Phase I Study of Tipifarnib (R115777) and Sorafenib (BAY 43-9006) in Patients With Biopsiable Advanced Cancers|Completed||Phase 1|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:47:52.276901|2017-10-11 05:47:52.276901
NCT00244985|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2017-07-14|2017-06-19||September 2005||2005-09-01|July 2017|2017-07-01|December 2012|Actual|2012-12-01|August 2008|Actual|2008-08-01||Interventional||All treated and eligible patients|Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I/II Pilot Study of the Safety and Efficacy of Rituxan (Chimeric Anti-CD20 Antibody) in Combination With Doxil (Liposomal Doxorubicin) Chemotherapy in Patients With Relapsing or Refractory Indolent or Aggressive B-Cell Lymphoma|Completed||Phase 1/Phase 2|42|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 05:47:52.420834|2017-10-11 05:47:52.420834
NCT00244998|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-03-07|||September 2005||2005-09-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|October 2006|Actual|2006-10-01||Interventional|||Fulvestrant in Treating Patients With Advanced Prostate Cancer|Phase II Study of Fulvestrant (Faslodex®) in Androgen Independent Prostate Cancer|Completed||Phase 2|20|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 05:47:52.933653|2017-10-11 05:47:52.933653
NCT00245011|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2016-07-26|2015-02-03||October 2004||2004-10-01|July 2016|2016-07-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|||Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma|High Dose Samarium-153 With Peripheral Blood Stem Cell Support in High Risk Osteogenic Sarcoma|Completed||Phase 2|11|Actual|Sidney Kimmel Comprehensive Cancer Center|"Future work will focus on better understanding the factors that contribute to drug delivery and improving efficacy be combination with chemotherapy, biologics, or external beam radiotherapy. (See Publication section of this entry)."|1|||f||||t||||||||||2017-10-11 05:47:53.030185|2017-10-11 05:47:53.030185
NCT00245024|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-05-01|||November 2005||2005-11-01|October 2011|2011-10-01|January 2010|Actual|2010-01-01|August 2007|Actual|2007-08-01||Interventional|||Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer|Phase IB Sulindac Study for Women at High Risk for Breast Cancer|Completed||Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:47:53.277963|2017-10-11 05:47:53.277963
NCT00245050|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2011-12-28|2010-10-26||April 2004||2004-04-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|April 2008|Actual|2008-04-01||Interventional|||Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer|A Double-Blind Randomized Trial of Pyridoxine Versus Placebo for the Prevention of Doxil-Related Palmar-Plantar Erythrodysesthesia (Hand-Foot Syndrome)|Completed||Phase 3|34|Actual|Case Comprehensive Cancer Center|Interim analysis was conducted after 30 patients were enrolled and had evaluable PPE assessment data. Due to decreased accrual and similar PPE rates between groups, the trial was closed for enrollment after the interim analyses was completed.|2|||f||||t||||||||||2017-10-11 05:47:53.932923|2017-10-11 05:47:53.932923
NCT00245063|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2014-10-01|2014-07-21||March 2006||2006-03-01|June 2013|2013-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer|Phase II Study of AZD2171 in Patients With Recurrent Small Cell Lung Cancer|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)|The 45 mg PO dose on arm 1 was deemed undeliverable since 7 of 12 patients were unable to complete one cycle due to treatment intolerance. Study was ammended and re-started at 30 mg (arm 2) after discussions with coinvestigators at CTEP.|1|||f||||||||||||||2017-10-11 05:47:54.467136|2017-10-11 05:47:54.467136
NCT00245076|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2015-04-30|||April 2005||2005-04-01|April 2006|2006-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking|Evaluation of the Impact of a Bulletin Board on a Web-Based Smoking Cessation Intervention|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:47:55.188812|2017-10-11 05:47:55.188812
NCT00245089|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2013-08-09|||May 2004||2004-05-01|July 2009|2009-07-01||||April 2011|Anticipated|2011-04-01||Interventional|||Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma|Phase II Trial of VAC2.2/VA Therapy for Low-Risk B Group Patients With Rhabdomyosarcoma|Unknown status|Recruiting|Phase 2|41|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:47:55.267869|2017-10-11 05:47:55.267869
NCT00251940|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2008-03-14|||July 2004||2004-07-01|March 2008|2008-03-01|March 2006|Actual|2006-03-01|||||Interventional|||GALLANT 7 Tesaglitazar Add-on to Sulphonylurea|A 24-Week Randomised, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Added to the Therapy of Patients With Type 2 Diabetes Poorly Controlled on Sulphonylurea Alone|Terminated||Phase 3|555||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-10-11 05:47:55.610218|2017-10-11 05:47:55.610218
NCT00251953|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2009-04-21|||July 2004||2004-07-01|April 2009|2009-04-01|March 2006|Actual|2006-03-01|||||Interventional|||GALLANT 8 Tesaglitazar Add-on to Metformin|A 24-Week Randomised, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Added to the Therapy of Patients With Type 2 Diabetes Poorly Controlled on Metformin Alone|Terminated||Phase 3|555||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-10-11 05:47:55.961552|2017-10-11 05:47:55.961552
NCT00251966|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2009-03-11|||May 2004||2004-05-01|March 2009|2009-03-01|September 2005|Actual|2005-09-01|||||Interventional|||ASTERIX: Low Dose ASA and Nexium|A Randomized Double-Blind Placebo-Controlled Study to Assess the Prevention of Low-Dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 mg Once Daily for 26 Weeks.|Completed||Phase 3|960||AstraZeneca|||||f||||||||||||||2017-10-11 05:47:56.295582|2017-10-11 05:47:56.295582
NCT00251979|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2011-05-18|2008-12-12||October 2005||2005-10-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer|A Randomised, Double-blind, Parallel-group, Placebo Controlled Study of Esomeprazole i.v. (Bolus Infusion of 80 mg Followed by a Continuous Infusion of 8 mg Per Hour) Administered for 72 Hours to Assess Prevention of Rebleeding in Subjects That Have Undergone Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer - the PUB Study.|Completed||Phase 3|1312|Actual|AstraZeneca|||||f||||||||||||||2017-10-11 05:47:56.673495|2017-10-11 05:47:56.673495
NCT00251992|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2011-01-21|||December 2002||2002-12-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Nexium Dyspepsia/AST|Supportive Test for Acid-Related Symptoms (STARS II) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Uninvestigated Subjects With Upper Gastrointestinal Symptoms.|Completed||Phase 3|1200||AstraZeneca|||||f||||||||||||||2017-10-11 05:47:57.656355|2017-10-11 05:47:57.656355
NCT00252005|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2010-02-27||2010-02-27|November 2005||2005-11-01|August 2008|2008-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study|Protocol CV185017: A Phase 2 Randomized, Parallel-Arm Study of Oral Direct Factor Xa-Inhibitor Apixaban and Low Molecular Weight Heparin or Fondaparinux With A Vitamin K Antagonist In Subjects With Acute Symptomatic Deep-Vein Thrombosis|Completed||Phase 2|520||Bristol-Myers Squibb|||||f||||||||||||||2017-10-11 05:47:58.191513|2017-10-11 05:47:58.191513
NCT00252018|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2008-05-13|||January 2006||2006-01-01|May 2008|2008-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Effect of Broccoli Sprouts as a Nutritional Supplement in the Prevention of Cardiovascular Disease|The Effect of Broccoli Sprouts as a Nutritional Supplement in the Prevention of Cardiovascular Disease.|Completed||N/A|160|Anticipated|Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:47:58.402452|2017-10-11 05:47:58.402452
NCT00252031|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2005-11-17||||||November 2005|2005-11-01||||||||Interventional|||DBT in Borderline Personality Disorder|Dialectical Behavioral Therapy for Patients With Borderline Personality Disorder|Unknown status|Recruiting|N/A|||Bronx VA Medical Center|||||f||||||||||||||2017-10-11 05:47:58.487748|2017-10-11 05:47:58.487748
NCT00252044|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2005-11-17|||October 2000||2000-10-01|November 2005|2005-11-01||||||||Interventional|||Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder|The Dopaminergic System in Schizotypal Personality Disorder: Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder|Unknown status|Recruiting|N/A|||Bronx VA Medical Center|||||f||||||||||||||2017-10-11 05:47:58.561682|2017-10-11 05:47:58.561682
NCT00252057|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2017-02-27|2009-02-10||December 2005||2005-12-01|February 2017|2017-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Testing the Re-Engineered Hospital Discharge|Testing the Re-Engineered Hospital Discharge|Completed||N/A|749|Actual|Boston University||2|||f||||f||||||||No||2017-10-11 05:47:58.642479|2017-10-11 05:47:58.642479
NCT00252070|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2007-09-06|||November 2005||2005-11-01|September 2007|2007-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Fitness and Exercise for People With Arthritis|Fitness and Functional Exercise for People With Arthritis|Completed||Phase 2/Phase 3|154|Actual|Centers for Disease Control and Prevention||1|||f||||||||||||||2017-10-11 05:48:00.509527|2017-10-11 05:48:00.509527
NCT00252083|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2012-04-04|||July 2004||2004-07-01|April 2012|2012-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||ADAPT-POL: Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques|Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques With Popular Opinion Leader (ADAPT-POL)|Completed||N/A|41|Actual|Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-10-11 05:48:00.602158|2017-10-11 05:48:00.602158
NCT00252096|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2012-09-26|||June 2003||2003-06-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|January 2006|Actual|2006-01-01||Interventional|||Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections|Nucleic Acid Amplification Tests for the Diagnosis of Pharyngeal and Rectal Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections|Completed||N/A|3900|Anticipated|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-10-11 05:48:00.696139|2017-10-11 05:48:00.696139
NCT00252109|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2012-08-15|||July 2004||2004-07-01|August 2012|2012-08-01|January 2009|Actual|2009-01-01|September 2007|Actual|2007-09-01||Observational|||ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader|New Orleans AIDS Task Force Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT) With Popular Opinion Leader (POL)|Completed||N/A|27|Actual|Centers for Disease Control and Prevention|||1||f||||t||||||||||2017-10-11 05:48:00.780558|2017-10-11 05:48:00.780558
NCT00252122|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2009-03-12|||June 2004||2004-06-01|March 2009|2009-03-01|January 2007|Actual|2007-01-01|November 2005|Actual|2005-11-01||Interventional|||Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease|A Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease|Terminated||Phase 4|3|Actual|Children's Hospital of Philadelphia||1||Recruitment was very slow.|f||||f||||||||||2017-10-11 05:48:00.862172|2017-10-11 05:48:00.862172
NCT00252135|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2017-05-11|||June 2004|Actual|2004-06-01|May 2017|2017-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma|An Epidemiologic Study of Xolair (Omalizumab): Evaluating Clinical Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma (EXCELS)|Completed||N/A|8023|Actual|Genentech, Inc.|||1||f||||||||||||||2017-10-11 05:48:00.960167|2017-10-11 05:48:00.960167
NCT00252148|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2013-02-08|||January 2005||2005-01-01|June 2010|2010-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults|Randomized, Placebo-Controlled, Dose-Escalating, Double-Blinded Phase 1 Safety and Immunogenicity Study of a Modified Vaccinia Ankara (MVA) Vectored HIV-1 (ADMVA) Vaccine Administered Intramuscularly to HIV-Uninfected, Healthy Volunteers|Completed||Phase 1|48|Anticipated|International AIDS Vaccine Initiative||2|||f||||t||||||||||2017-10-11 05:48:01.034759|2017-10-11 05:48:01.034759
NCT00252161|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2016-09-20|||November 2005||2005-11-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer|Randomized Phase III Trial of Surgery Plus Neoadjuvant TS-1 and Cisplatin Compared With Surgery Alone for Type 4 and Large Type 3 Gastric Cancer: Japan Clinical Oncology Group Study (JCOG 0501)|Completed||Phase 3|316|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-10-11 05:48:01.188135|2017-10-11 05:48:01.188135
NCT00252174|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2017-03-27|2017-01-20||February 2007||2007-02-01|March 2017|2017-03-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer|Phase II Dose-response Pilot Study of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Anxiety Associated With Advanced-stage Cancer.|Terminated||Phase 2|2|Actual|Brigham and Women's Hospital||3||Lack of funds and insufficient patient population for study enrollment.|f||||t||f||||||No||2017-10-11 05:48:02.482217|2017-10-11 05:48:02.482217
NCT00252187|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2012-12-19|2012-11-20||January 2000||2000-01-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|July 2008|Actual|2008-07-01||Interventional|SubqBNP||Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure|Cardiac Hormone Replacement With BNP in Heart Failure: A Novel Therapeutic Strategy|Completed||Phase 1/Phase 2|45|Actual|Mayo Clinic||2|||f||||t||||||||||2017-10-11 05:48:02.936709|2017-10-11 05:48:02.936709
NCT00252200|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2009-09-22|||March 2003||2003-03-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.|Low Dose Continuous Infusion of BNP (Nesiritide) in the Prevention of Renal Insufficiency Post Cardiopulmonary Bypass Cardiac Surgery.|Completed||Phase 1/Phase 2|40|Actual|Mayo Clinic||1|||f||||f||||||||||2017-10-11 05:48:03.759128|2017-10-11 05:48:03.759128
NCT00252213|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2009-12-09|||August 2002||2002-08-01|December 2009|2009-12-01|January 2006||2006-01-01|||||Interventional|||BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling|B-Type Natriuretic Peptide (Nesiritide) and Post Myocardial Infarction Left Ventricular Remodeling: Pilot Study Assessing Safety|Terminated||Phase 1|24||Mayo Clinic||||recruitment of subjects was halted prematurely. recruiting subjects halted prematurely|||||||||||||||2017-10-11 05:48:03.847552|2017-10-11 05:48:03.847552
NCT00252226|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2008-06-02|||June 2004||2004-06-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders|Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders: An Open Prospective Longitudinal Study of the Effectiveness of Quetiapine Monotherapy in Preventing Relapse and Minimizing Neurocognitive Dysfunction Among Adolescents Manifesting Bipolar Spectrum Disorders|Completed||Phase 3|100|Anticipated|Mood Disorders Center of Ottawa|||||f||||||||||||||2017-10-11 05:48:03.91669|2017-10-11 05:48:03.91669
NCT00252239|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2015-02-26|2015-01-12||November 2005||2005-11-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)|Phase 2B Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)|Terminated||Phase 2|112|Actual|University of Virginia|Premature termination limits any conclusions from the trial.|2||Slow enrollment|f||||t||||||||||2017-10-11 05:48:04.025083|2017-10-11 05:48:04.025083
NCT00252252|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2008-06-20|||November 2005||2005-11-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation|Crossover Trial of VPAP (Variable Positive Airway Pressure) Ventilation Versus AutoVPAP in Neuromuscular and Chest Wall Disease: Effects on Nocturnal Hypoventilation, Sleep Quality and Tolerance|Completed||Phase 1|20|Actual|ResMed||2|||f||||||||||||||2017-10-11 05:48:04.937579|2017-10-11 05:48:04.937579
NCT00252278|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2006-07-05|||November 2005||2005-11-01|November 2005|2005-11-01||||||||Interventional|||Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents|The Effect of a Once Daily Evening Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents|Unknown status|Recruiting|Phase 4|36||Rhode Island Hospital|||||f||||||||||||||2017-10-11 05:48:05.01667|2017-10-11 05:48:05.01667
NCT00252850|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2016-09-02|||June 2005||2005-06-01|September 2016|2016-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease|A Phase I, Open-Label Study of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin[NTN] to Assess the Safety and Tolerability of Intrastriatal Delivery to Subjects With Idiopathic Parkinson's Disease|Completed||Phase 1|12||Sangamo Therapeutics|||||f||||t||||||||||2017-10-11 05:48:05.093169|2017-10-11 05:48:05.093169
NCT00252863|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2009-03-16|||December 2004||2004-12-01|March 2009|2009-03-01|May 2006|Actual|2006-05-01|||||Interventional|||DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults|A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbuhaler 160/4.5 µg, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults - a 26-Week, Randomised, Open-Label, Parallel-Group, Multicentre Study|Completed||Phase 3|1600||AstraZeneca|||||f||||||||||||||2017-10-11 05:48:05.183086|2017-10-11 05:48:05.183086
NCT00252876|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2008-03-14|||March 2005||2005-03-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|||||Interventional|||GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes|An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.|Terminated||Phase 3|2000||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-10-11 05:48:05.740567|2017-10-11 05:48:05.740567
NCT00252889|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2009-01-26|||May 2004||2004-05-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|March 2006|Actual|2006-03-01||Interventional|||Doxil Topotecan Doublet Cancer Study|GSK - Doublet: A Phase I Study of Pegylated Liposomal Doxorubicin (Doxil) and Weekly Intravenous Topotecan in Patients With Advanced Solid Tumors|Completed||Phase 1|20|Actual|Christiana Care Health Services||1|||f||||t||||||||||2017-10-11 05:48:06.529495|2017-10-11 05:48:06.529495
NCT00252902|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2017-01-10|||December 2005||2005-12-01|October 2013|2013-10-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Emergency Department Initiated Tobacco Treatment (EDITT)|Emergency Department Initiated Tobacco Treatment (EDITT)|Completed||Phase 1/Phase 2|75|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-10-11 05:48:06.623245|2017-10-11 05:48:06.623245
NCT00252915|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2011-05-24|||November 2005||2005-11-01|July 2009|2009-07-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock|Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock: a Prospective, Randomised, Double-blind, Placebo-controlled Study|Completed||Phase 2|38|Actual|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-10-11 05:48:06.717415|2017-10-11 05:48:06.717415
NCT00252928|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2007-10-29|||July 2006||2006-07-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Health Impact Study of Aquatabs in Tamale, Ghana|Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana|Completed||N/A|240|Actual|Centers for Disease Control and Prevention||2|||f||||||||||||||2017-10-11 05:48:06.790983|2017-10-11 05:48:06.790983
NCT00252941|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2010-12-20|||November 2005||2005-11-01|December 2010|2010-12-01|November 2006|Actual|2006-11-01|April 2006|Actual|2006-04-01||Interventional|||Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma|The Role Of Prophylactic Urethral Stenting With Memokath® 028SW in Patients Undergoing Prostate 125I Seed Implants For Prostate Carcinoma: A Phase I/II Study|Completed||Phase 1/Phase 2|20||The Cleveland Clinic|||||||||||||||||||2017-10-11 05:48:06.986053|2017-10-11 05:48:06.986053
NCT00252954|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2009-08-19|||November 2005||2005-11-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury|Effects of Levetiracetam on Chronic Neuropathic Pain Following Spinal Cord Injury: a Randomized, Double-blind, Placebo-controlled, Cross-over, Multi-center Study|Completed||Phase 4|36|Actual|Danish Pain Research Center||1|||f||||t||||||||||2017-10-11 05:48:07.094862|2017-10-11 05:48:07.094862
NCT00252967|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2014-08-21|2014-04-21||October 2005||2005-10-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|November 2008|Actual|2008-11-01||Interventional|||Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)|Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)|Terminated||Phase 3|64|Actual|Emory University|Limited enrollment; recurrence rate of AF was slightly higher than other trials indicated that the study sample may be a high-risk population.|2||Insufficient power to show therapy difference at interim analysis.|f||||t||||||||||2017-10-11 05:48:07.211983|2017-10-11 05:48:07.211983
NCT00252980|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2007-01-15|||January 2006||2006-01-01|January 2007|2007-01-01|March 2007||2007-03-01|||||Interventional|||CANDIS - Targeted Treatment for Cannabis Disorders|CANDIS -Targeted Treatment for Cannabis Disorders|Unknown status|Active, not recruiting|Phase 2|210||Technische Universität Dresden|||||f||||||||||||||2017-10-11 05:48:07.661505|2017-10-11 05:48:07.661505
NCT00252993|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2007-10-10|||November 2005||2005-11-01|October 2007|2007-10-01|March 2006||2006-03-01|||||Interventional|||12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DDP225 in Patients With Chronic Functional Vomiting|Terminated||Phase 2|30||Dynogen Pharmaceuticals|||||||||||||||||||2017-10-11 05:48:07.762127|2017-10-11 05:48:07.762127
NCT00253006|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2006-10-06|||January 2006||2006-01-01|October 2006|2006-10-01|January 2008||2008-01-01|||||Observational|||Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium|A Quantitative Analysis of Protein- and mRNA-Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium|Terminated||N/A|60||Copenhagen University Hospital at Herlev|||||f||||||||||||||2017-10-11 05:48:07.871484|2017-10-11 05:48:07.871484
NCT00253019|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2013-08-10|2013-04-09||October 2004||2004-10-01|August 2013|2013-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods|A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods (Oral Contraceptive Pills, Depo Provera and Ortho Evra) Among Women Seeking First Trimester Abortion.|Completed||N/A|321|Actual|Emory University|||1||f||||f||||||||||2017-10-11 05:48:07.980041|2017-10-11 05:48:07.980041
NCT00253032|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2006-03-02||||||March 2006|2006-03-01||||||||Interventional|||Pain Relief Investigation of NeuroModulation Therapy in Adult Humans|PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial.|Terminated||Phase 3|||Fralex Therapeutics|||||||||||||||||||2017-10-11 05:48:08.309362|2017-10-11 05:48:08.309362
NCT00253045|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2013-09-13|||August 2004||2004-08-01|September 2013|2013-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|KHARMA||Motivating HIV+ Women: Risk Reduction and ART Adherence|Motivating HIV+ Women: Risk Reduction and ART Adherence|Completed||N/A|207|Actual|Emory University||1|||f||||t||||||||||2017-10-11 05:48:08.365099|2017-10-11 05:48:08.365099
NCT00253058|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2013-05-03|||July 2005||2005-07-01|May 2013|2013-05-01||||||||Interventional|||Study Of Perennial Allergic Rhinitis In Pediatrics|Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup in Children -Suffering From Perennial Allergic Rhinitis-|Completed||Phase 3|286||GlaxoSmithKline|||||f||||f||||||||||2017-10-11 05:48:08.46582|2017-10-11 05:48:08.46582
NCT00253071|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2015-03-18|||December 2005||2005-12-01|March 2015|2015-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Early Integrated Intervention in Severe Affective Disorders|Early Integrated Intervention in Severe Affective Disorders - a Randomized Controlled Trial.|Completed||N/A|426|Actual|Hovedstadens Sygehusfaelesskab||2|||f||||f||||||||||2017-10-11 05:48:08.551411|2017-10-11 05:48:08.551411
NCT00253084|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2017-01-31|||November 2005||2005-11-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease|A Randomized, Double-Blind, Cross-Over Study to Compare IPX054 to Carbidopa-Levodopa Immediate-Release Tablets in Subjects With Parkinson's Disease|Completed||Phase 2|12|Actual|IMPAX Laboratories, Inc.||2|||f||||f||||||||No||2017-10-11 05:48:08.659451|2017-10-11 05:48:08.659451
NCT00253097|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2009-08-10|||December 2005||2005-12-01|July 2009|2009-07-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|PREVENT||The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study|The Post Stroke Preventive Trial (PREVENT) A Randomised Controlled Trial Nested in a Cohort (RIALTO) Study|Unknown status|Active, not recruiting|N/A|353|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-10-11 05:48:08.773388|2017-10-11 05:48:08.773388
NCT00253110|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2012-08-03|||May 1996||1996-05-01|August 2012|2012-08-01|September 1998|Actual|1998-09-01|||||Interventional|||A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder|A Comparison of Risperidone and Haloperidol for Prevention of Relapse in Subjects With Schizophrenia and Schizoaffective Disorders|Completed||Phase 4|396|Actual|Janssen, LP||2|||||||||||||||||2017-10-11 05:48:08.87344|2017-10-11 05:48:08.87344
NCT00253123|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2010-12-02||||||December 2010|2010-12-01|March 1997|Actual|1997-03-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia|A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia|Completed||Phase 3|626|Actual|Janssen, LP|||||||||||||||||||2017-10-11 05:48:08.947691|2017-10-11 05:48:08.947691
NCT00253136|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2010-12-02|||November 1999||1999-11-01|December 2010|2010-12-01|December 2000|Actual|2000-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia|Risperidone Depot (Microspheres) vs. Placebo in the Treatment of Subjects With Schizophrenia|Completed||Phase 3|458|Actual|Janssen, LP|||||||||||||||||||2017-10-11 05:48:09.017063|2017-10-11 05:48:09.017063
NCT00253149|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2011-01-20||||||January 2011|2011-01-01|April 1999|Actual|1999-04-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder|The Safety And Efficacy Of Risperdal� (Risperidone) Versus Placebo Versus Haloperidol As Add-On Therapy To Mood Stabilizers In The Treatment Of The Manic Phase Of Bipolar Disorder|Completed||Phase 3|158|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:48:09.294776|2017-10-11 05:48:09.294776
NCT00253162|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2011-01-27|||March 2001||2001-03-01|January 2011|2011-01-01|September 2002|Actual|2002-09-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol|The Efficacy And Safety Of Flexible Dose Ranges Of Risperidone Versus Placebo Or Haloperidol In The Treatment Of Manic Episodes Associated With Bipolar I Disorder.|Completed||Phase 3|439|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:48:09.355792|2017-10-11 05:48:09.355792
NCT00253175|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2010-04-26|||October 2000||2000-10-01|April 2010|2010-04-01|December 2001|Actual|2001-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine|A Comparison Of The Efficacy And Safety Of Topamax® (Topiramate) Tablets Versus Placebo For The Prophylaxis Of Migraine|Completed||Phase 3|211|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-10-11 05:48:09.423199|2017-10-11 05:48:09.423199
NCT00253188|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2011-05-17|||February 1997||1997-02-01|November 2010|2010-11-01|December 1998|Actual|1998-12-01|||||Interventional|||A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|Efficacy, Tolerability and Safety of Galantamine in the Treatment of Alzheimer's Disease|Completed||Phase 3|653|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:48:09.488427|2017-10-11 05:48:09.488427
NCT00253201|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2011-05-17||||||November 2010|2010-11-01|October 1997|Actual|1997-10-01|||||Interventional|||A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|Efficacy, Tolerability and Safety of Galantamine in the Treatment of Alzheimer's Disease|Completed||Phase 3|636|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:48:09.573871|2017-10-11 05:48:09.573871
NCT00253214|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2011-05-19|||March 2001||2001-03-01|November 2010|2010-11-01|July 2002|Actual|2002-07-01|||||Interventional|||Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation|Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation|Completed||Phase 3|973|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:48:09.643714|2017-10-11 05:48:09.643714
NCT00253227|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2011-05-17|||July 1997||1997-07-01|November 2010|2010-11-01|December 1998|Actual|1998-12-01|||||Interventional|||A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|Galantamine in the Treatment of Alzheimer's Disease: Flexible Dose Range Trial|Completed||Phase 3|387|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:48:09.705703|2017-10-11 05:48:09.705703
NCT00253240|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2007-07-20|||September 2004||2004-09-01|July 2007|2007-07-01|September 2005|Actual|2005-09-01|||||Observational|||Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population|Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population - An Evaluation Project|Completed||Phase 3|75|Actual|Lawson Health Research Institute|||||f||||f||||||||||2017-10-11 05:48:09.772745|2017-10-11 05:48:09.772745
NCT00253253|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2008-05-21|||August 2006||2006-08-01|May 2008|2008-05-01|January 2007||2007-01-01|||||Observational|||Long-Term Outcome in Congenital Undescended Testis After Surgical Treatment by Orchidopexy|Long-Term Outcome in Congenital Undescended Testis After Surgical Treatment by Orchidopexy|Completed||N/A|181|Actual|Medical Center Alkmaar|||||f||||||||||||||2017-10-11 05:48:09.835244|2017-10-11 05:48:09.835244
NCT00253266|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2015-04-07|||April 2008||2008-04-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Venlafaxine Augmentation in Treatment Resistant Depression|Comparison of Venlafaxine Augmentation With Quetiapine v.s. Placebo in Treatment Resistant Depression|Completed||Phase 4|126|Actual|Max-Planck-Institute of Psychiatry||2|||f||||t||||||||||2017-10-11 05:48:09.897707|2017-10-11 05:48:09.897707
NCT00253279|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2009-08-12|||November 2009||2009-11-01|August 2009|2009-08-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans|A Quantitative Study of the Metabolic Alterations in Protein Synthesis Rate That Occur in Burn Patients Over the Time Course of Their Injury Using Positron Emission Tomography.|Unknown status|Not yet recruiting|Phase 1|64|Anticipated|National Institute of General Medical Sciences (NIGMS)|||2||f||||t||||||||||2017-10-11 05:48:10.007392|2017-10-11 05:48:10.007392
NCT00253292|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2011-07-27|||January 1997||1997-01-01|July 2011|2011-07-01|December 2007|Actual|2007-12-01|||||Observational|||Psychometric Study of Outcomes Instruments|Psychometric Study of Outcomes Instruments|Terminated||N/A|40|Actual|Massachusetts General Hospital|||1|Unable to recruit necessary sample size|f||||f||||||||||2017-10-11 05:48:10.136368|2017-10-11 05:48:10.136368
NCT00253305|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-13|2007-05-29|||September 2005||2005-09-01|May 2007|2007-05-01||||||||Interventional|||Topical Gel Anti-Fungal Agent for Tinea Unguium|Phase IIB Efficacy and Safety Study of Four Topical Gel Formulations of Anti-Fungal Agents, MQX-5858, MQX-5859, MQX-5866, and MQX-5867, Versus Vehicle in the Treatment of Tinea Unguium.|Completed||Phase 2|75||MediQuest Therapeutics|||||||||||||||||||2017-10-11 05:48:10.307441|2017-10-11 05:48:10.307441
NCT00253318|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2013-04-04|||November 2005||2005-11-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer|Phase I, Open Label, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of the Combination RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer|Terminated||Phase 1|15|Actual|M.D. Anderson Cancer Center||1||Toxicity and Lack of Efficacy|f||||f||||||||||2017-10-11 05:48:10.394849|2017-10-11 05:48:10.394849
NCT00253331|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-13|2007-05-29|||November 2004||2004-11-01|May 2007|2007-05-01|September 2005||2005-09-01|||||Interventional|||Lab Study of MQX-503 in Treatment of Raynaud's|Phase III Laboratory Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, in the Treatment of Raynaud’s Phenomenon|Completed||Phase 2/Phase 3|36||MediQuest Therapeutics|||||||||||||||||||2017-10-11 05:48:10.497344|2017-10-11 05:48:10.497344
NCT00253344|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2010-06-10|||June 2005||2005-06-01|June 2010|2010-06-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors|Phase I Trial of Daily Lenalidomide (CC-5013, Revlimid™) and Docetaxel Given Every Three Weeks in Patients With Advanced Solid Tumors|Completed||Phase 1|33|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:48:10.584883|2017-10-11 05:48:10.584883
NCT00253357|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-13|2007-12-17|||March 2004||2004-03-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Observational|||PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy|Predictors of Response to Cardiac Re-Synchronization Therapy|Completed||N/A|450||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-10-11 05:48:10.724005|2017-10-11 05:48:10.724005
NCT00253370|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2014-11-19|2014-05-21||October 2005||2005-10-01|December 2013|2013-12-01|September 2010|Actual|2010-09-01|May 2008|Actual|2008-05-01||Interventional||All 44 patients started treatment and were considered eligible and hence were included in the analysis.|Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer|A Phase II Study to Evaluate Overall Response Rate of BAY 43-9006 (Sorafenib) Combined With Docetaxel and Cisplatin or Oxaliplatin in the Treatment of Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-10-11 05:48:10.961662|2017-10-11 05:48:10.961662
NCT00253383|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2014-12-18|||January 2003||2003-01-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients|Improving Palliative Care for Patients With Cancer|Completed||N/A|329|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-10-11 05:48:11.511123|2017-10-11 05:48:11.511123
NCT00253396|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2009-03-09|||October 2005||2005-10-01|May 2007|2007-05-01|January 2007||2007-01-01|||||Interventional|||Patients Preference With Self-Injection: The PRISM Study|THE PRISM Study-Low-Molecular-Weight Heparin Versus Unfractionated Heparin for Perioperative Bridging Anticoagulation: the Patient Preference for Self-Injection Study and Related Measurements|Completed||Phase 4|100|Anticipated|McMaster University||2|||f||||f||||||||||2017-10-11 05:48:11.635687|2017-10-11 05:48:11.635687
NCT00253409|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2009-07-11|||May 2005||2005-05-01|July 2009|2009-07-01||||June 2011|Anticipated|2011-06-01||Interventional|||Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery|Mesothelioma and Radical Surgery Trial|Unknown status|Active, not recruiting|N/A|670|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:48:11.738093|2017-10-11 05:48:11.738093
NCT00253422|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2011-05-14|||March 2004||2004-03-01|May 2011|2011-05-01||||May 2016|Anticipated|2016-05-01||Interventional|||Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer|A Partially-Blind Phase III Randomized Trial of Fulvestrant (Faslodex™) With or Without Concomitant Anastrozole (Arimidex™) Compared With Exemestane in Postmenopausal Women With ER+ve Locally Advanced/Metastatic Breast Cancer Following Progression on Non-Steroidal Aromatase Inhibitors|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:48:11.838768|2017-10-11 05:48:11.838768
NCT00253435|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2016-08-23|2014-08-25||September 2005||2005-09-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional||Number of patients who signed the consent form and started treatment.|N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma|I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma|Completed||Phase 2|50|Actual|Children's Hospital Los Angeles||1|||f||||t||||||||||2017-10-11 05:48:11.968914|2017-10-11 05:48:11.968914
NCT00253448|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2011-08-25|2011-06-29||December 2002||2002-12-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|||Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme|Phase II Trial of Conventional Radiotherapy With Stereotactic Radiosurgery to High Risk Tumor Regions as Determined by Functional Imaging in Patients With Glioblastoma Multiforme|Completed||Phase 2|35|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:48:13.403168|2017-10-11 05:48:13.403168
NCT00261092|ClinicalTrials.gov processed this data on October 10, 2017|2005-12-01|2008-04-14|||October 2005||2005-10-01|April 2008|2008-04-01||||||||Interventional|||GEMOX: Oxaliplatin in Pancreatic Cancer|Phase II Multicenter, Open Label Study of Oxaliplatin Combined With Gemcitabine(GEMOX) in Advanced and Metastatic Pancreatic Cancer|Completed||Phase 2|48||Sanofi|||||f||||||||||||||2017-10-11 05:50:17.247799|2017-10-11 05:50:17.247799
NCT00253461|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2012-03-16|||December 2004||2004-12-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||11C Topotecan PET Imaging|Positron Emission Tomography Using 11C Topotecan in Predicting Response to Treatment in Patients With Brain Metastases Due to Ovarian, Small Cell Lung, or Other Cancer|Terminated||Early Phase 1|7|Actual|Case Comprehensive Cancer Center||||Drugs unavailable:unable to make radioactive topotecan|f||||t||||||||||2017-10-11 05:48:13.831273|2017-10-11 05:48:13.831273
NCT00253474|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2012-03-28|||September 2005||2005-09-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|||||Interventional|||PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma|A Phase I Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas|Completed||Phase 1|36|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:48:13.926726|2017-10-11 05:48:13.926726
NCT00253487|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2014-01-03|||August 2005||2005-08-01|January 2006|2006-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas|A Pilot Study of Temozolomide and O-Benzylguanine for Treatment of High-Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:48:14.037933|2017-10-11 05:48:14.037933
NCT00253500|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2013-01-02|||June 2002||2002-06-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|September 2005|Actual|2005-09-01||Interventional|||Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer|Prediction of Response or Resistance to Dose Intensified Pre-Operative Epirubicin Therapy of Operable Breast Cancer|Completed||Phase 2|15|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-10-11 05:48:14.128658|2017-10-11 05:48:14.128658
NCT00253513|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2012-05-24|2010-11-16||June 2005||2005-06-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome|A Study of a Reduced-Intensity Conditioning Regimen With Treosulfan and Fludarabine for Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Leukemia|Completed||Phase 1/Phase 2|60|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-10-11 05:48:14.246279|2017-10-11 05:48:14.246279
NCT00253526|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2015-04-27||||||December 2006|2006-12-01||||||||Interventional|||Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer|Phase II Randomized Study of Surgical Resection and Adjuvant Gemcitabine Hydrochloride With Versus Without Bevacizumab in Patients With Adenocarcinoma of the Pancreas|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:48:14.655783|2017-10-11 05:48:14.655783
NCT00253539|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2011-04-11|||January 2002||2002-01-01|April 2011|2011-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer|A Phase II Study of a Selective Estrogen Receptor Modulator (LY353381) vs. Tamoxifen vs. Placebo in Premenopausal Women With and Increased Risk for Breast Cancer|Completed||Phase 2|3|Actual|The Cleveland Clinic||3|||f||||t||||||||||2017-10-11 05:48:14.740876|2017-10-11 05:48:14.740876
NCT00253552|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2012-05-24|||May 2004||2004-05-01|June 2010|2010-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders|A Pilot Study of Using Filgrastim-Primed Bone Marrow in Human Leukocyte Antigen (HLA) Matched Related Donor Allogenetic Bone Marrow Transplantation for Patients With Hematologic Malignancies and Non-Malignancies|Terminated||N/A|4|Actual|OHSU Knight Cancer Institute||||Terminated at request of PI as study was outdated.|f||||||||||||||2017-10-11 05:48:14.927263|2017-10-11 05:48:14.927263
NCT00253565|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2013-04-04|||August 2003||2003-08-01|April 2013|2013-04-01|July 2010|Actual|2010-07-01|July 2006|Actual|2006-07-01||Interventional|||Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors|A Phase I Dose Escalation Study of Imatinib Mesylate (Gleevec/STI571) Plus Capecitabine (Xeloda) in Advanced Solid Tumor Malignancies|Completed||Phase 1|25|Actual|Duke University|||||f||||||||||||||2017-10-11 05:48:15.124801|2017-10-11 05:48:15.124801
NCT00253578|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2013-01-04|||March 2006||2006-03-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Trial of BAY 43-9006 (Sorafenib) (NSC-724772) in Patients With Relapsing or Resistant Multiple Myeloma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:48:15.225181|2017-10-11 05:48:15.225181
NCT00253591|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2013-12-18|||June 2005||2005-06-01|July 2007|2007-07-01|December 2009|Actual|2009-12-01|December 2007|Actual|2007-12-01||Interventional|||Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Randomised Phase II/III Trial of Induction Chemotherapy Followed by Continuous Hyperfractionated Accelerated Radiotherapy (CHART) Versus CHART Alone in Patients With Inoperable Non-Small Cell Lung Cancer|Completed||Phase 2/Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:48:15.330555|2017-10-11 05:48:15.330555
NCT00253617|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2013-04-02||||||December 2006|2006-12-01||||||||Interventional|||Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery|Phase III Randomized Study of Double Plastic Endoprosthesis Insertion With Versus Without Adjuvant Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Patients With Unresectable Stage III-IV Cholangiocarcinoma|Withdrawn||Phase 3|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:48:15.463129|2017-10-11 05:48:15.463129
NCT00253630|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2016-11-15|||September 2005||2005-09-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma|A Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Indolent Non-Hodgkin's Lymphoma|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:48:15.563584|2017-10-11 05:48:15.563584
NCT00253643|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2017-04-14|2014-12-19||July 2005||2005-07-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer|Catechins and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prostate: A Randomized Controlled Trial|Completed||N/A|89|Actual|OHSU Knight Cancer Institute||4|||f||||t||||||||||2017-10-11 05:48:15.695474|2017-10-11 05:48:15.695474
NCT00253669|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2012-05-24|||April 2005||2005-04-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas|Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas|Completed||N/A|110|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||||||||||||2017-10-11 05:48:16.286589|2017-10-11 05:48:16.286589
NCT00253682|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2014-03-17|||September 2002||2002-09-01|March 2014|2014-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|CHAART-1||Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers|Cardiac Status of HAART Exposed Infants of HIV-Infected Mothers (CHAART I)|Completed||N/A|167|Actual|University of Miami|||2||f||||t||||||Samples Without DNA|"     Blood samples were collected for analysis of cardiac biomarkers high sensitivity C REactive     PRotein (hsCRP) and N-terminal Pro-Brain Natriuretic Peptide (NT-proBNP).   "|||2017-10-11 05:48:16.388424|2017-10-11 05:48:16.388424
NCT00253695|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2013-03-26|||July 2004||2004-07-01|March 2013|2013-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents|Sleep Studies in HIV+ Older Children/Adolescents|Completed||N/A|90|Actual|Baylor College of Medicine|||1||f||||f||||||Samples Without DNA|"     Blood   "|||2017-10-11 05:48:16.498936|2017-10-11 05:48:16.498936
NCT00253708|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2017-06-29|2017-03-30||December 1, 2004|Actual|2004-12-01|June 2017|2017-06-01|January 1, 2013|Actual|2013-01-01|January 1, 2013|Actual|2013-01-01||Interventional|||Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer|Body-Based Complementary Therapies for Patients With Cancer|Completed||N/A|39|Actual|Beth Israel Deaconess Medical Center|Small sample size limited statistical power. Pre–post intervention data collection was not blinded. Patient bias in massage group. Heterogeneity in type and stage of cancer may have resulted in variation of the effects of the interventions.|3|||f||||f|f|f||||||||2017-10-11 05:48:16.601342|2017-10-11 05:48:16.601342
NCT00253721|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2017-04-19|||May 1998||1998-05-01|April 2017|2017-04-01|December 2016|Actual|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Melphalan With BBBD in Treating Patients With Brain Malignancies|Intra-Arterial Melphalan (L-Phenylalanine Mustard) Administered in Conjunction With Osmotic Blood-Brain Barrier Disruption in Patients With Brain Malignancies: A Phase I Study|Terminated||Phase 1|21|Actual|OHSU Knight Cancer Institute||1||Other competing clinical trials affecting enrollment|f||||t||||||||||2017-10-11 05:48:17.262782|2017-10-11 05:48:17.262782
NCT00253734|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2013-05-30|||November 2005||2005-11-01|July 2008|2008-07-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||Immunogenicity and Safety of Different Doses of Fluzone® Influenza|Immunogenicity and Safety of a Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route Compared to an Intramuscular Vaccination With Fluzone® in Healthy Adults|Completed||Phase 2|217|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-10-11 05:48:17.364842|2017-10-11 05:48:17.364842
NCT00253747|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-13|2012-08-17|2012-07-16||November 2005||2005-11-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)|A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers With ADHD|Completed||Phase 3|255|Actual|University of Cincinnati||2|||f||||t||||||||||2017-10-11 05:48:17.48727|2017-10-11 05:48:17.48727
NCT00253760|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2010-03-17|||February 2004||2004-02-01|March 2010|2010-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Metabolic Analysis in Human Sulfur Amino Acid Deficiency||Completed||N/A|15|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:48:17.954046|2017-10-11 05:48:17.954046
NCT00253773|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2010-01-12|||January 2005||2005-01-01|January 2010|2010-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Metabolic Effects of Chemical Interactions in Toxicity|Metabolic Effects of Chemical Interactions in Toxicity|Completed||N/A|15|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:48:18.039963|2017-10-11 05:48:18.039963
NCT00253786|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2007-01-15|||July 2005||2005-07-01|January 2007|2007-01-01|June 2011||2011-06-01|||||Interventional|||Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy|Study for the Effectiveness of Intensive Therapy for Diabetic Nephropathy in Unblinded, Randomized Intergroup Comparison Study.|Unknown status|Recruiting|N/A|600||Okayama University|||||f||||||||||||||2017-10-11 05:48:18.1158|2017-10-11 05:48:18.1158
NCT00253799|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2007-06-21|||December 2005||2005-12-01|June 2007|2007-06-01||||||||Interventional|||A Safety Study of Hylan GF-20 to Treat Shoulder Osteoarthritis|Prospective, Single Arm, Pilot Study Evaluating the Safety and Efficacy of Hyaluronan (Hylan GF-20) in Patients With Painful Shoulder Osteoarthritis|Unknown status|Active, not recruiting|Phase 4|35|Anticipated|Northwestern Ophthalmic Institute S.C.||1|||f||||t||||||||||2017-10-11 05:48:18.205601|2017-10-11 05:48:18.205601
NCT00253812|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2007-09-21|||November 2005||2005-11-01|September 2007|2007-09-01||||||||Interventional|||Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy|Adenoma Detection Rate in Rectal Remnants of Familial Polyposis (FAP) Patients Using Standard (White Light), Auto-Fluorescence (AFI), Narrow Band Imaging (NBI) and Chromoscopic Endoscopy|Unknown status|Recruiting|N/A|60|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-10-11 05:48:18.26009|2017-10-11 05:48:18.26009
NCT00253825|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2005-12-20|||November 2005||2005-11-01|August 2005|2005-08-01|July 2006||2006-07-01|||||Interventional|||mCIMT and Eye Patching for Neglect Rehabilitation Post Stroke: A Longitudinal Study of Separate and Combined Effects|Modified Constraint-Induced Movement Therapy and Eye Patching for Neglect Rehabilitation Post Stroke: A Longitudinal Study of Separate and Combined Effects|Unknown status|Recruiting|Phase 1/Phase 2|60||National Taiwan University Hospital|||||f||||||||||||||2017-10-11 05:48:18.335931|2017-10-11 05:48:18.335931
NCT00253838|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2017-09-20|||October 2001||2001-10-01|September 2017|2017-09-01|March 2012|Actual|2012-03-01|September 2010|Actual|2010-09-01||Interventional|||A Comparison of Two Type of Stems in Revision Hip Arthroplasty|A Randomized Controlled Trial Comparing a Titanium to a Cobalt Chrome Femoral Stem in Revision Hip Arthroplasty: A Pilot Study|Completed||N/A|39|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-10-11 05:48:18.403885|2017-10-11 05:48:18.403885
NCT00253851|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2012-04-13|||July 2003||2003-07-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery|Multi-centre, Double-blind, Randomized, Controlled Trial Comparing Intra-operative Regional Heparinization to Placebo for the Prevention of Deep Vein Thrombosis Following Total Knee Arthroplasty|Completed||Phase 4|30|Actual|Ottawa Hospital Research Institute||1|||f||||||||||||||2017-10-11 05:48:18.493105|2017-10-11 05:48:18.493105
NCT00253864|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2016-10-25|||November 2004||2004-11-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Functional Outcomes Following Shoulder Surgery: A Prospective Database|Functional Outcome Following Shoulder Surgery: A Prospective Database|Recruiting||N/A|2500|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-10-11 05:48:18.583113|2017-10-11 05:48:18.583113
NCT00253877|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2010-08-19|||July 2003||2003-07-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Comparison of a Resurfacing Hip System to Standard Total Hip Arthroplasty|A Prospective, Multi-Centre, Historical Control Trial Comparing the Conserve® Plus Resurfacing Hip System to Standard Total Hip Arthroplasty.|Completed||Phase 4|200|Actual|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-10-11 05:48:18.668912|2017-10-11 05:48:18.668912
NCT00253890|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2013-10-22|2012-08-01||October 2005||2005-10-01|October 2013|2013-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Insomnia and Drug Relapse Risk|Insomnia and Drug Relapse Risk|Completed||Phase 3|137|Actual|Butler Hospital||2|||f||||t||||||||||2017-10-11 05:48:19.036492|2017-10-11 05:48:19.036492
NCT00253903|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2010-11-29|||November 2005||2005-11-01|November 2010|2010-11-01|September 2008|Actual|2008-09-01|November 2007|Actual|2007-11-01||Interventional|EPLILONG||Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year|Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study Followed by an Open Treatment Phase Extension With Eplivanserin for a 40-week Period|Completed||Phase 3|1155|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:48:19.35898|2017-10-11 05:48:19.35898
NCT00253916|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2017-05-09|||June 2002||2002-06-01|May 2017|2017-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Exercise in Men Receiving Radiation Therapy for Prostate Cancer.|Exercise in Men Receiving Radiation Therapy for Prostate Cancer: Effects on Fatigue, Toxicity, Body Composition, Muscular Fitness, Cardiorespiratory Fitness and Quality of Life.|Completed||N/A|121|Actual|Ottawa Hospital Research Institute||3|||f||||||||||||||2017-10-11 05:48:19.507981|2017-10-11 05:48:19.507981
NCT00253929|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2007-04-04|||November 2005||2005-11-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia|The Influence of the 1976T>C Polymorphism in the Adenosine A2A Receptor Gene on Adenosine-Induced Vasodilation and the Influence of the 34C>T Polymorphism in the AMP Deaminase Gene on Post-Occlusive Reactive Hyperemia.|Completed||N/A|100||Radboud University|||||f||||||||||||||2017-10-11 05:48:19.611243|2017-10-11 05:48:19.611243
NCT00253942|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2005-11-14|||November 2005||2005-11-01|October 2005|2005-10-01||||||||Interventional|||Safety and Efficacy Study of Bee Venom to Treat Knee Osteoarthritis|A Randomized, Double-Blind, Histamine-Controlled, Phase 3 Study to Determine the Safety and Efficacy of Bee Venom in the Treatment of Knee Osteoarthritis|Unknown status|Recruiting|Phase 3|40||Rheumatology Therapeutics Medical Center|||||f||||||||||||||2017-10-11 05:48:19.708312|2017-10-11 05:48:19.708312
NCT00253955|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2008-11-07|||June 2003||2003-06-01|November 2008|2008-11-01|November 2007|Actual|2007-11-01|May 2007|Actual|2007-05-01||Interventional|||Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia|An Open-Label, Multicenter, Multinational, Centrally Randomized, Two-Arm Parallel-Group Study to Demonstrate the Non-Inferiority in Clinical Efficacy of Levofloxacin 750mg od in Comparison With Piperacillin/Tazobactam 4g/500mg Every 8 Hours in the Treatment of Mild to Moderate Hospital-Acquired Pneumonia Adult Patients in Both General Wards and ICU (Intensive Care Unit)|Completed||Phase 3|460|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:48:19.803345|2017-10-11 05:48:19.803345
NCT00253968|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2016-02-02||2016-02-02|November 2005||2005-11-01|February 2016|2016-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|GEMS||Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia|Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 3|967|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 05:48:19.963602|2017-10-11 05:48:19.963602
NCT00253981|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2016-05-10|2013-08-28||November 2005||2005-11-01|May 2016|2016-05-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|MilCAM||Light Therapy in the Treatment of Leg Pain|Monochromatic Near-Infrared Light Energy (MIRE) in the Treatment of Tibial Stress Reaction|Terminated||N/A|30|Actual|Samueli Institute for Information Biology||2||Enrollment not achieved succesfully|f||||t||||||||||2017-10-11 05:48:20.502142|2017-10-11 05:48:20.502142
NCT00253994|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2007-09-04|||August 2003||2003-08-01|September 2007|2007-09-01|December 2004|Actual|2004-12-01|||||Interventional|||Auricular Acupuncture for Acute Pain|Auricular Acupuncture in the Treatment of Acute Pain Syndromes (AATAPS) Pilot|Completed||N/A|100||Samueli Institute for Information Biology|||||f||||||||||||||2017-10-11 05:48:20.852303|2017-10-11 05:48:20.852303
NCT00254007|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2017-04-26|||July 2003||2003-07-01|April 2017|2017-04-01|May 2010|Actual|2010-05-01|December 2005|Actual|2005-12-01||Interventional|||Depression and Traumatic Brain Injury|The Serotonin Transporter Gene Polymorphism and Major Depression Following Traumatic Brain Injury|Completed||Phase 4|200|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||||||||||||2017-10-11 05:48:20.980133|2017-10-11 05:48:20.980133
NCT00254020|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2017-04-26|||June 2005||2005-06-01|April 2017|2017-04-01|December 2013|Actual|2013-12-01|January 2011|Actual|2011-01-01||Interventional|||The Role of Cytokine-Serotonin Interactions in Post-Stroke Depression|The Role of Cytokine-Serotonin Interactions in Post-Stroke Depression|Completed||Phase 4|138|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-10-11 05:48:21.075347|2017-10-11 05:48:21.075347
NCT00254033|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2017-04-26|||October 2003||2003-10-01|April 2017|2017-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Apathy Associated With Alzheimer's Disease|The Role of the Dopaminergic Brain Reward System in Apathy Associated With Alzheimer's Disease|Completed||Phase 4|40||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-10-11 05:48:21.199538|2017-10-11 05:48:21.199538
NCT00254046|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2014-06-19|||November 2005||2005-11-01|June 2014|2014-06-01|July 2008|Actual|2008-07-01|February 2007|Actual|2007-02-01||Interventional|||TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.|A Phase III Randomized, Double-blinded, Placebo-controlled Trial to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an ART Regimen, Including TMC114/RTV and an Investigator-selected OBR, in HIV-1 Infected Patients With Limited Treatment to no Treatment Options.|Completed||Phase 3|616|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-10-11 05:48:21.306604|2017-10-11 05:48:21.306604
NCT00254059|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2005-11-10||||||November 2005|2005-11-01|December 2004||2004-12-01|||||Interventional|||A Randomized Study to Compare Polysomnography With Overnight Home Oximetry and Auto – CPAP for Sleep Apnea|A Randomized Study to Compare Polysomnography With Overnight Home Oximetry and Auto – CPAP for Diagnosis and Nasal CPAP Titration in Patients With a High Probability of Obstructive Sleep Apnea.|Completed||N/A|60||University of British Columbia|||||f||||||||||||||2017-10-11 05:48:21.53657|2017-10-11 05:48:21.53657
NCT00254072|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2010-02-11|2009-11-05||January 2007||2007-01-01|February 2010|2010-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|EEA-LGB||Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)|Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)a Prospective Randomized Comparison of the 3.5 mm vs 4.8 mm Circular Stapler for Creation of the Gastrojejunostomy in Prevention of Staple Line Hemorrhage During Laparoscopic Gastric Bypass|Completed||N/A|355|Actual|University of California, Irvine|"Difficulty discerning GI bleeding attributed to the gastrojejunostomy vs gastric pouch staple-line
Technological differences between 3.5mm vs 4.8 mm stapler
Operative techniques varying between study sites
Study size may be underpowered"|2|||f||||f||||||||||2017-10-11 05:48:21.623581|2017-10-11 05:48:21.623581
NCT00254085|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2005-11-14|||March 2005||2005-03-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Interventional|||Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.|Multiple Substitution of First Phase Insulin Response With a Rapid Action Insuli Analogue in Patient With Newly Diagnosed Type 2 Diabtes.|Unknown status|Recruiting|Phase 4|20||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-10-11 05:48:22.020653|2017-10-11 05:48:22.020653
NCT00254111|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2005-11-14|||July 2005||2005-07-01|November 2005|2005-11-01|July 2006||2006-07-01|||||Interventional|||Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.|Ultra Probe Laser System Osteoarthritis of the Hand Clinical Study.|Unknown status|Recruiting|N/A|100||TriTech Manufacturing|||||f||||||||||||||2017-10-11 05:48:22.134417|2017-10-11 05:48:22.134417
NCT00254124|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2005-11-14|||April 2004||2004-04-01|November 2005|2005-11-01|December 2004||2004-12-01|||||Interventional|||Use of a Portion Control Food Tool to Induce Weight Loss in Obese Type 2 Diabetics.|Efficacy of a Food Portion Control Tool to Induce Weight Loss and Decrease Hypoglycemic Medication Requirements Amongst Obese Type 2 Diabetics.|Completed||N/A|130||University of Calgary|||||f||||||||||||||2017-10-11 05:48:22.247471|2017-10-11 05:48:22.247471
NCT00254137|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2010-10-27|||September 2004||2004-09-01|September 2004|2004-09-01|November 2006||2006-11-01|||||Interventional|||Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.|A Randomized Phase II-study to Evaluate the Safety and Efficacy of Capecitabine Plus Irinotecan Plus Cetuximab Compared to Capecitabine Plus Oxaliplatin Plus Cetuximab in First-line Treatment of Patients With Metastatic Colorectal Cancer.|Completed||Phase 2|92||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-10-11 05:48:22.345812|2017-10-11 05:48:22.345812
NCT00254150|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2005-11-14|||May 1995||1995-05-01|April 1995|1995-04-01|December 1996||1996-12-01|||||Interventional|||A Therapy to Reduce Morbidity and Hospital Length of Stay of High-Risk Surgical Patients|Goal-Directed Intraoperative Therapy Reduces Morbidity and Length of Hospital Stay in High Risk Surgical Patients|Completed||Phase 2|130||Università Politecnica delle Marche|||||f||||||||||||||2017-10-11 05:48:22.460749|2017-10-11 05:48:22.460749
NCT00254163|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-09|2016-09-15|2016-02-02||December 2003||2003-12-01|September 2016|2016-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||ITT population|Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients|A Prospective, Randomized, Open Label, Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab vs. Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-cell Chronic Lymphocytic Leukemia|Completed||Phase 3|184|Actual|US Oncology Research||2|||f||||f||||||||||2017-10-11 05:48:22.573792|2017-10-11 05:48:22.573792
NCT00254189|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2006-05-17|||December 2002||2002-12-01|May 2006|2006-05-01|October 2004||2004-10-01|||||Interventional|||Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation|A Single Center, Open-Label Study to Evaluate the Effects on Ovulation of Levonorgestrel 90mg and Ethinyl Estradiol 20mg in a Daily, Continuous, Oral Regimen.|Completed||Phase 2|60||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-10-11 05:48:23.419519|2017-10-11 05:48:23.419519
NCT00254202|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2012-07-18|||November 2005||2005-11-01|July 2012|2012-07-01|March 2007||2007-03-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia|A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Iloperidone in Schizophrenic Patients in Acute Exacerbation Followed by a Long-term Treatment Phase.|Completed||Phase 3|600||Vanda Pharmaceuticals|||||||||||||||||||2017-10-11 05:48:23.493604|2017-10-11 05:48:23.493604
NCT00254215|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-13|2006-11-27|||March 2002||2002-03-01|July 2005|2005-07-01|October 2004||2004-10-01|||||Interventional|||Glycemic Load, Weight Loss and Cardiovascular Disease Risk|The Effect of 4 Diets Varying in Glycemic Index, Glycemic Load, Carbohydrate and Protein, on Weight, Body Composition and Cardio-Vascular Risk Factors|Completed||Phase 1|120||University of Sydney|||||f||||||||||||||2017-10-11 05:48:23.807357|2017-10-11 05:48:23.807357
NCT00254228|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-10|2008-10-08|||November 2005||2005-11-01|October 2008|2008-10-01|December 2007||2007-12-01|||||Interventional|||Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction|A Clinical Study to Evaluate the Safety and Efficacy of the BrainPort™ Balance Device When Used to Improve Postural Control in Subjects With Bilateral Vestibular Disorders|Terminated||N/A|60||Wicab||||Terminated due to slow recruitment|f||||||||||||||2017-10-11 05:48:23.896534|2017-10-11 05:48:23.896534
NCT00254241|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2009-06-09|||May 2002||2002-05-01|June 2009|2009-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Safety and Efficacy of Seroquel in First Episode Schizophrenia|Safety and Efficacy of Seroquel in First Episode Schizophrenia|Completed||Phase 4|80||AstraZeneca|||||f||||||||||||||2017-10-11 05:48:24.001059|2017-10-11 05:48:24.001059
NCT00264030|ClinicalTrials.gov processed this data on October 10, 2017|2005-12-09|2008-01-04|||March 2002||2002-03-01|January 2008|2008-01-01|August 2004|Actual|2004-08-01|||||Interventional|DIPLOMAT||Distal Protection Combined With PTCA in AMI Patients|Distal Protection Combined With PTCA in AMI Patients -- The DIPLOMAT Study.|Completed||Phase 2|56|Actual|Cordis Corporation||2|||f||||t||||||||||2017-10-11 05:50:22.524946|2017-10-11 05:50:22.524946
NCT00254254|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2015-02-19|||February 2006||2006-02-01|January 2015|2015-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus|A Randomized, Single-Blind, Dose-Rising, Placebo-Controlled, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|13|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 05:48:24.073871|2017-10-11 05:48:24.073871
NCT00254267|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2014-02-26|||November 2005||2005-11-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|February 2007|Actual|2007-02-01||Interventional|||Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors|An Open-label Phase 2 Study of AMG 706 in Japanese Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) Who Developed Progressive Disease or Relapsed While on Imatinib Mesylate|Completed||Phase 2|35|Actual|Amgen||1|||f||||t||||||||||2017-10-11 05:48:24.179107|2017-10-11 05:48:24.179107
NCT00254280|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2008-05-30|||November 2005||2005-11-01|May 2008|2008-05-01|September 2008||2008-09-01|||||Interventional|||Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial|Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light and Paring Versus Paring Alone - a Randomized Controlled Trial With Blinded Response Evaluation|Unknown status|Active, not recruiting|N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-10-11 05:48:24.260134|2017-10-11 05:48:24.260134
NCT00254293|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2014-03-03|2013-08-20||January 2006||2006-01-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|May 2007|Actual|2007-05-01||Interventional||Baseline includes all participants enrolled and treated. Baseline parameters are presented for each arm but the total value for baseline mean age and standard deviation (SD) includes all participants in LTE. Data are presented by treatment the participant actually received, not to what they were randomized to receive.|Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)|A Study to Assess the Steady-State Trough Serum Concentration, Safety, and Immunogenicity of Abatacept (BMS-188667) Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Who Are Receiving Disease Modifying Ant-Rheumatic Drugs (DMARDs)|Completed||Phase 1/Phase 2|87|Actual|Bristol-Myers Squibb|Error resulted in 4 participants being treated with study drug they were not randomized to receive. ST data were summarized by study drug participants actually received while LT data were summarized by what participants were randomized to receive.|6|||f||||||||||||||2017-10-11 05:48:24.381389|2017-10-11 05:48:24.381389
NCT00254306|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2011-07-06|||January 2006||2006-01-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Functional Brain Imaging in Recreational Users of Ecstasy|Functional Brain Imaging in Recreational Users of Ecstasy|Completed||N/A|18|Actual|Hadassah Medical Organization|||2||f||||t||||||||||2017-10-11 05:48:28.836037|2017-10-11 05:48:28.836037
NCT00254319|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2005-11-14||||||November 2005|2005-11-01||||||||Interventional|||Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)|Phase II Trial of Bevacizumab (Avastin) Plus Pemetrexed (Alimta) and Carboplatin in Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|||The Cooper Health System|||||||||||||||||||2017-10-11 05:48:28.909313|2017-10-11 05:48:28.909313
NCT00254332|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2015-03-24|||November 2005||2005-11-01|December 2007|2007-12-01|September 2007||2007-09-01|||||Observational|||Effect of Denileukin Diftitox on Immune System in CTCL Patients|Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients|Completed||N/A|10|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-10-11 05:48:29.007|2017-10-11 05:48:29.007
NCT00254345|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2007-12-10|||September 2006||2006-09-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Effect of Provisional-Crown Surface Coating on Biofilm Formation|Effect of Provisional-Crown Surface Coating on Biofilm Formation|Completed||Phase 1|1||Hadassah Medical Organization|||||f||||f||||||||||2017-10-11 05:48:29.070991|2017-10-11 05:48:29.070991
NCT00254358|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2008-07-03|||April 2007||2007-04-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|||||Observational|||A Brain Imaging Study of Nicotine Release in Cigarette Smokers|A Brain Imaging Study of Nicotine Release in Cigarette Smokers|Terminated||N/A|0|Actual|Hadassah Medical Organization|||1|It was decided to use a different protocol with a different radioligand|f||||t||||||||||2017-10-11 05:48:29.153209|2017-10-11 05:48:29.153209
NCT00254371|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2011-05-20|||July 1998||1998-07-01|May 2011|2011-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||DHEA and Testosterone Replacement in Elderly|Pathogenesis of Sarcopenia and Metabolic Changes in Aging|Completed||N/A|150||Mayo Clinic|||||f||||||||||||||2017-10-11 05:48:30.418712|2017-10-11 05:48:30.418712
NCT00254384|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2017-09-11|||October 5, 2005|Actual|2005-10-05|September 2017|2017-09-01|October 2019|Anticipated|2019-10-01|October 2019|Anticipated|2019-10-01||Interventional|||Neoadjuvant Chemotherapy With Docetaxel, Cisplatin Followed by Maintenance Therapy With the EGFR Inhibitor Erlotinib (Tarceva) Surgery for Non-Small Cell Lung Cancer (NSCLC) Following Definitive Surgical Resection|Neoadjuvant Chemotherapy With Docetaxel, Cisplatin Followed by Maintenance Therapy With the EGFR Inhibitor Erlotinib (Tarceva) in Patients With Stage I, II and III Non-Small Cell Lung Cancer Following Definitive Surgical Resection|Active, not recruiting||N/A|50|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 05:48:30.494435|2017-10-11 05:48:30.494435
NCT00254397|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2013-02-12|||November 2005||2005-11-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Melanoma Vaccine With Peptides and Leuprolide|Study of the Modulatory Activity of an LHRH-Agonist (Leuprolide) on Melanoma Peptide Vaccines as Adjuvant Therapy in Melanoma Patients|Completed||Phase 2|98|Actual|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-10-11 05:48:30.618783|2017-10-11 05:48:30.618783
NCT00254410|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2017-09-18|||March 14, 2005|Actual|2005-03-14|September 2017|2017-09-01|September 14, 2017|Actual|2017-09-14|September 14, 2017|Actual|2017-09-14||Interventional|||FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years|Phase 2 Study of the Activity and Safety of Fludarabine, Cyclophosphamide, and Mitoxantrone Plus Rituximab (FCM-R) With Pegfilgrastim (Neulasta) as Frontline Therapy for Patients < 70 Years With Chronic Lymphocytic Leukemia|Completed||Phase 2|31|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 05:48:30.74328|2017-10-11 05:48:30.74328
NCT00254423|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2017-09-22|||November 2005|Actual|2005-11-01|September 2017|2017-09-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Study of Dasatinib in Patients With Chronic Myelogenous Leukemia|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib (BMS-354825)|Active, not recruiting||Phase 2|150|Anticipated|M.D. Anderson Cancer Center||2|||f||||t|t|f||||||||2017-10-11 05:48:30.859407|2017-10-11 05:48:30.859407
NCT00254436|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2012-07-27|||December 2002||2002-12-01|July 2012|2012-07-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing Preoperative Chemoradiation Followed by Surgery|Terminated||Phase 3|50|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-10-11 05:48:30.97463|2017-10-11 05:48:30.97463
NCT00254449|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2009-02-12|||November 2005||2005-11-01|September 2007|2007-09-01|May 2006||2006-05-01|||||Interventional|||Effect of NGX-4010 on ENFD and Sensory Function|A Randomized, Controlled, Open-Label Study to Investigate the Effect of NGX-4010 on Epidermal Nerve Fiber Density and Sensory Function in Healthy Volunteers|Completed||Phase 1|36||NeurogesX|||||||||||||||||||2017-10-11 05:48:31.072458|2017-10-11 05:48:31.072458
NCT00254462|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2015-12-16|2011-10-03||October 2005||2005-10-01|December 2015|2015-12-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children|Pharmacological Treatment of ADHD in Young Children|Completed||Phase 4|93|Actual|University of Nebraska|Study design does not allow differentiation between placebo response and psychoeducational treatment effect. Eight-week duration does not allow for examination of long-term effectiveness or assessment of adverse effects over time.|2|||f||||t||||||||||2017-10-11 05:48:31.168102|2017-10-11 05:48:31.168102
NCT00254475|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-07|2014-08-18|||November 2005||2005-11-01|August 2014|2014-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia|A Study to Evaluate the Efficacy of the Valsartan/Simvastatin Combinations 160/20mg up Titrated to 320/20mg Versus 160/40mg up Titrated to 320/40mg in Patients With Both Essential Hypertension and Hypercholesterolemia|Completed||Phase 3|871|Actual|Novartis|||||f||||||||||||||2017-10-11 05:48:31.917433|2017-10-11 05:48:31.917433
NCT00254488|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2013-07-24|||November 2005||2005-11-01|July 2013|2013-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|GERI-BD||Treatment of Bipolar Mania in Older Adults|Acute Pharmacotherapy of Late-Life Mania (GERI-BD)|Completed||Phase 4|224|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-10-11 05:48:32.035879|2017-10-11 05:48:32.035879
NCT00254501|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2016-07-20|2016-07-14||November 2005||2005-11-01|July 2016|2016-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Empowering Patients to Better Manage Diabetes Through Self-Care|Empowering Patients to Better Manage Diabetes Through Self-Care|Completed||Phase 3|69|Actual|Oregon State University||2|||f||||f||||||||No||2017-10-11 05:48:32.174663|2017-10-11 05:48:32.174663
NCT00254514|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2017-01-20|||August 2001||2001-08-01|January 2017|2017-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures|A Multi-centre, Randomised, Double-blind, Placebocontrolled, Parallel-group Trial Investigating the Efficacy and Safety of Norditropin® SimpleXx® in Tibia Fractures|Completed||Phase 2|407|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-10-11 05:48:33.10951|2017-10-11 05:48:33.10951
NCT00254527|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2007-04-30|||January 2005||2005-01-01|November 2005|2005-11-01|April 2007|Actual|2007-04-01|||||Observational|||Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.|Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.|Completed||N/A|477|Actual|Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-10-11 05:48:33.275287|2017-10-11 05:48:33.275287
NCT00254540|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2010-02-17|2010-01-15||December 2005||2005-12-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of SU011248 in Patients With Advanced Kidney Cancer|Phase II Study Of Single-Agent SU011248 In The Treatment Of Patients With Renal Cell Carcinoma|Completed||Phase 2|51|Actual|Pfizer||1|||f||||f||||||||||2017-10-11 05:48:33.399791|2017-10-11 05:48:33.399791
NCT00254553|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2015-12-11|||July 2005||2005-07-01|December 2015|2015-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two Period Cross Over Trial to Validate Patient-Reported Outcome Measures for Use in Men With Late Onset Hypogonadism|Terminated||Phase 2|150|Actual|Merck Sharp & Dohme Corp.||2||Recruitment issues|f||||f||||||||||2017-10-11 05:48:34.606559|2017-10-11 05:48:34.606559
NCT00254566|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2009-11-03|2009-07-22||February 2006||2006-02-01|November 2009|2009-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)|A Phase 3B Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial To Evaluate The Efficacy and Safety Of Azithromycin SR (Microspheres Formulation) Versus Moxifloxacin For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB).|Completed||Phase 3|398|Actual|Pfizer||2|||f||||f||||||||||2017-10-11 05:48:34.720444|2017-10-11 05:48:34.720444
NCT00254579|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2012-06-05||2009-05-09|December 2005||2005-12-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of CP-675,206 in Refractory Melanoma|A Phase 2, Open Label, Single Arm Study To Evaluate The Efficacy, Safety, Tolerability And Pharmacokinetics Of CP-675,206 In Patients With Advanced Refractory And/Or Relapsed Melanoma|Completed||Phase 2|251|Actual|AstraZeneca||1|||f||||f||||||||||2017-10-11 05:48:35.443697|2017-10-11 05:48:35.443697
NCT00254592|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2016-11-15|2009-08-28||October 2005||2005-10-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|July 2013|Actual|2013-07-01||Interventional|||Neoadjuvant Treatment of Breast Cancer|Neoadjuvant Biweekly Doxorubicin and Cyclophosphamide With GMCSF Followed by Weekly Carboplatin/Nab-paclitaxel Plus or Minus Trastuzumab and Plus or Minus Bevacizumab in Treatment of Large or Inflammatory Breast Cancer-a Phase II Study|Active, not recruiting||Phase 2|43|Actual|University of California, Irvine||1|||f||||t||||||||||2017-10-11 05:48:35.65492|2017-10-11 05:48:35.65492
NCT00254605|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2016-10-24|||November 2005||2005-11-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|October 2017|Anticipated|2017-10-01||Observational|||Retinal Imaging in Patients With Inherited Retinal Degenerations|High Resolution Retinal Imaging in Patients With Inherited Retinal Degenerations|Recruiting||Phase 1|400|Anticipated|University of California, San Francisco|||1||f||||t||||||||||2017-10-11 05:48:35.867269|2017-10-11 05:48:35.867269
NCT00264992|ClinicalTrials.gov processed this data on October 10, 2017|2005-12-09|2008-05-27|||January 2006||2006-01-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Implantation and Cytokine Expression|The Cytokine Paired Footprint of Successful Implantation|Completed||N/A|160||UMC Utrecht|||||f||||||||||||||2017-10-11 05:50:45.733997|2017-10-11 05:50:45.733997
NCT00254618|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2013-04-15|||October 2005||2005-10-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.|Study to Determine the Pharmacokinetics of Mesalamine Following Administration of 30, 60, and 90 mg/kg/Day as 400 mg Delayed-release Tablets Given Every 12 Hours for 28 Days to Children/Adolescents With Active Ulcerative Colitis.|Terminated||Phase 1|34|Actual|Warner Chilcott||3||Slow enrollment.|f||||f||||||||||2017-10-11 05:48:35.960069|2017-10-11 05:48:35.960069
NCT00254631|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2015-02-04|||April 2007||2007-04-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures|Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures|Completed||Phase 4|65|Actual|Rambam Health Care Campus||2|||f||||||||||||||2017-10-11 05:48:36.636091|2017-10-11 05:48:36.636091
NCT00254644|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2017-01-13|||February 2007||2007-02-01|May 2011|2011-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|PHR04-CH/DYS||Morphofunctional Imaging and Developmental Dyslexia|Morphofunctional Imaging and Developmental Dyslexia|Completed||N/A|32|Actual|University Hospital, Tours|||2||f||||f||||||||||2017-10-11 05:48:36.746981|2017-10-11 05:48:36.746981
NCT00254657|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2013-05-10|||March 2004||2004-03-01|May 2013|2013-05-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|||Levetiracetam for Treatment of Pain Associated With Fibromyalgia|A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Treatment of Pain Associated With Fibromyalgia|Completed||N/A|66|Actual|University of California, San Francisco||2|||f||||||||||||||2017-10-11 05:48:36.83134|2017-10-11 05:48:36.83134
NCT00254670|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2011-04-12|||February 2005||2005-02-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|December 2005|Actual|2005-12-01||Interventional|||Naltrexone Effects on Alcohol Intake|Naltrexone Effects on Alcohol Intake Using a Laboratory Bar in Asp40 Positive and Negative Alcohol Users Characterized by fMRI and Genetic Screening|Completed||N/A|||University of California, San Francisco|||||f||||||||||||||2017-10-11 05:48:36.927665|2017-10-11 05:48:36.927665
NCT00254696|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2011-04-13|||June 2004||2004-06-01|April 2011|2011-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)|Association of Antibiotic Utilization Measures and Control of Extended-spectrum-lactamases (ESBLs)|Completed||Phase 4|710|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:48:37.128911|2017-10-11 05:48:37.128911
NCT00254709|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-11|2012-01-26|||October 2002||2002-10-01|January 2012|2012-01-01|September 2005|Actual|2005-09-01|||||Interventional|||Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients|Open, Pilot, Comparative Study to Evaluate the Efficacy and Safety of Two Immunosuppressor Regimens, Anti Il-2, Sirolimus Mycophenolate, Mophetyl and Steroids Versus Sirolimus, Cyclosporine, and Withdrawal of Cyclosporine Since the Third Month and Steroids in Elderly Population|Completed||Phase 4|66|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:48:37.199794|2017-10-11 05:48:37.199794
NCT00254722|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-14|2010-01-04|||April 2006||2006-04-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|November 2008|Actual|2008-11-01||Interventional|||Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children|Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children|Completed||Phase 1|10|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-10-11 05:48:37.275077|2017-10-11 05:48:37.275077
NCT00254735|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2007-12-14|||April 2002||2002-04-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Quetiapine Augmentation in Severe Obsessive Compulsive Disorder|Quetiapine Augmentation in Severe Obsessive Compulsive Disorder (OCD) - Pilot Study|Completed||Phase 3|44|Actual|AstraZeneca|||||f||||||||||||||2017-10-11 05:48:37.349516|2017-10-11 05:48:37.349516
NCT00254748|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2009-06-09|||June 2004||2004-06-01|June 2009|2009-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients|The Effect of Quetiapine on Psychotic-Like Symptoms in Borderline Personality Disordered Patients: A Randomised Placebo-Controlled Trial|Completed||Phase 2|40|Anticipated|AstraZeneca||2|||f||||||||||||||2017-10-11 05:48:37.427684|2017-10-11 05:48:37.427684
NCT00254761|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2008-02-27|||November 2003||2003-11-01|February 2008|2008-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Effects of Smoked Marijuana on Neuropathic Pain|A Double Blind, Active Placebo Controlled Crossover Trial of the Antinociceptive Effect of Smoked Marijuana on Subjects With Neuropathic Pain; Correlation With Changes in Mood, Cognition, and Psychomotor Performance|Completed||Phase 1/Phase 2|28|Actual|Center for Medicinal Cannabis Research||3|||f||||t||||||||||2017-10-11 05:48:37.540102|2017-10-11 05:48:37.540102
NCT00254774|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2007-12-14|||January 2002||2002-01-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling|Pilot Study of the Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling: an Open Trial|Completed||Phase 3|44|Actual|AstraZeneca|||||f||||||||||||||2017-10-11 05:48:37.646584|2017-10-11 05:48:37.646584
NCT00254787|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2009-06-09|||June 2005||2005-06-01|June 2009|2009-06-01|January 2006|Actual|2006-01-01|||||Interventional|||Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients|Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in the Treatment of Patients With Acute Schizophrenia - a Multicentre, Double-Blind, Parallel Group, Randomized Study|Completed||Phase 2|30||AstraZeneca|||||f||||||||||||||2017-10-11 05:48:37.735369|2017-10-11 05:48:37.735369
NCT00254800|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2015-08-17|||November 2005||2005-11-01|August 2015|2015-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females|The Effect of Exenatide on Single and Multiple Doses Oral Contraceptive Pharmacokinetics in Healthy Female Subjects|Completed||Phase 1|38|Actual|AstraZeneca||3|||f||||f||||||||||2017-10-11 05:48:37.827084|2017-10-11 05:48:37.827084
NCT00254813|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2011-01-25|||October 2004||2004-10-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|||||Interventional|||Fast Titration Of Quetiapine Versus Currently Approved Titration|Fast Titration Of Quetiapine Versus Currently Approved Titration: A Randomised, Multicentre, Parallel Group Open Trial In Schizophrenia And Schizoaffective Disorder|Completed||Phase 3|150||AstraZeneca|||||f||||||||||||||2017-10-11 05:48:37.929801|2017-10-11 05:48:37.929801
NCT00254826|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2013-12-03|||June 2006||2006-06-01|December 2013|2013-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Yellow Fever Virus Vaccine and Immune Globulin Study|Randomized Controlled Double-Blind Trial of the Comparative Viremia, Immunogenicity and Safety of a 17-D Live Attenuated Yellow Fever Vaccine (YF-VAX)Given Alone or in Combination With Human Immune Globulin (Gama STAN S/D)|Completed||Phase 1|80|Actual|Emory University||2|||f||||f||||||||||2017-10-11 05:48:38.028744|2017-10-11 05:48:38.028744
NCT00254839|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2006-09-14|||December 2005||2005-12-01|November 2005|2005-11-01||||||||Observational|||Association Between Dental Implants Properties and Malodor Production|Bacterial Accumulation and Malodor Production in Various Types of Dental Implants|Completed||N/A|60||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:48:38.130374|2017-10-11 05:48:38.130374
NCT00254852|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2013-11-20|||October 2005||2005-10-01|November 2013|2013-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft|A Single Blind, Multi-Center, Randomized, Prospective Clinical Study Comparing Optecure™ Autograft Extender to Autograft Only in Fusion of the Lumbar Spine|Terminated||N/A|94|Actual|Exactech||2||Slow enrollment|f||||f||||||||||2017-10-11 05:48:38.187051|2017-10-11 05:48:38.187051
NCT00254865|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2011-06-06|||August 2002||2002-08-01|January 2011|2011-01-01|March 2003|Actual|2003-03-01|||||Interventional|||A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers|A Comparative Pharmacokinetic Study of EVRA and CILEST in Healthy Female Volunteers|Completed||Phase 1|34|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-10-11 05:48:38.325988|2017-10-11 05:48:38.325988
NCT00254878|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2007-12-17|||October 2005||2005-10-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14|A 7 Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Cross-Over Evaluation of the Efficacy and Safety of Two Different Brands of Modified-Release Oral Dosage Forms of Methylphenidate-HCl (20 mg, q.d.) in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14|Completed||Phase 3|130||Novartis|||||f||||||||||||||2017-10-11 05:48:38.411958|2017-10-11 05:48:38.411958
NCT00254891|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2015-03-10||2009-03-20|November 2005||2005-11-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer|International, Randomized, Open-Label, Phase 3 Trial of Paclitaxel/Carboplatin Plus PF-3512676 Versus Paclitaxel/Carboplatin Alone as First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 3|828|Actual|Pfizer||2||See Termination Reason in Detailed Description|f||||t||||||||||2017-10-11 05:48:38.511287|2017-10-11 05:48:38.511287
NCT00254904|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2015-03-10||2009-03-20|November 2005||2005-11-01|March 2015|2015-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC|International, Randomized, Open-Label, Phase 3 Trial of Gemcitabine/Cisplatin Plus PF-3512676 Versus Gemcitabine/Cisplatin Alone as First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 3|839|Actual|Pfizer||2||See Termination Reason in Detailed Description|f||||t||||||||||2017-10-11 05:48:39.003968|2017-10-11 05:48:39.003968
NCT00254917|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2012-04-13|||October 2003||2003-10-01|April 2012|2012-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines||Completed||Phase 4|387|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:48:39.522199|2017-10-11 05:48:39.522199
NCT00254930|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2011-05-18|||September 2003||2003-09-01|March 2010|2010-03-01|June 2006|Actual|2006-06-01|||||Interventional|||A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children|Prospective Trial of Risperdal (Risperidone) Following Psychological Therapy for Challenging Behaviour in Learning Disabled Children|Completed||Phase 3|19|Actual|Janssen-Cilag Ltd.|||||f||||||||||||||2017-10-11 05:48:39.607209|2017-10-11 05:48:39.607209
NCT00254956|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2009-04-07|||January 2004||2004-01-01|April 2009|2009-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma|A Multi-Center, Multinational, Randomized, Double-Blind, Parallel Group Study of the Effects of Ciclesonide Hfa-Mdi 640 μg/Day and Beclomethasone Hfa-Mdi 640 μg/Day on Lens Opacification in Adult Subjects With Moderate to Severe Persistent Asthma|Completed||Phase 3|1568|Actual|Sanofi|||||f||||||||||||||2017-10-11 05:48:39.677533|2017-10-11 05:48:39.677533
NCT00254969|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2012-04-16|||October 2005||2005-10-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|May 2008|Actual|2008-05-01||Interventional|||Immunogenicity and Safety of Pentaxim in South African Infants||Completed||Phase 3|212|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 05:48:39.765791|2017-10-11 05:48:39.765791
NCT00254982|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2015-10-09|2010-05-27||August 2005||2005-08-01|October 2015|2015-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)|"An Open-Label Study to Determine Equivalence in Efficacy, Organ Safety and Systemic Tolerability Between Infliximab in GROUP I (High Need) and GROUP II (Low Need) Patients Suffering From Chronic Plaque Psoriasis (Psoriasis Vulgaris)"|Completed||Phase 3|593|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-10-11 05:48:39.858318|2017-10-11 05:48:39.858318
NCT00254995|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2016-04-15|2014-09-04||July 2005||2005-07-01|April 2016|2016-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational||Subjects who received Menactra vaccine during the study period from the Kaiser Permanente databases.|Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine|Post-licensure Safety Surveillance Study of Routine Use of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra ™)|Completed||Phase 4|62626|Actual|Sanofi|||2||f||||f||||||||||2017-10-11 05:48:40.414957|2017-10-11 05:48:40.414957
NCT00255008|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2017-03-08|2008-12-05||March 2005||2005-03-01|March 2017|2017-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)|SEASON South East Asian Study Of Novel Genotypes in Hepatitis C Infection: Pegylated-Interferon and Ribavirin Therapy (PEGATRON REDIPEN Combination Therapy (PEG-Intron® REDIPEN Plus REBETOL®)) in Treatment Naive Patients With Genotypes 1, 6, 7, 8, 9: A Comparison of Race and Genotype on Treatment Outcome.|Terminated||Phase 4|121|Actual|Merck Sharp & Dohme Corp.||4||Slow enrollment|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:48:41.55669|2017-10-11 05:48:41.55669
NCT00255021|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2012-04-13|||December 2005||2005-12-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|September 2007|Actual|2007-09-01||Interventional|||Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand||Completed||Phase 4|186|Actual|Sanofi||1|||f||||||||||||||2017-10-11 05:48:42.313678|2017-10-11 05:48:42.313678
NCT00255034|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2017-03-08|2009-06-04||February 2005||2005-02-01|March 2017|2017-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)|Phase IV Study of Tailored Therapy With Peg Interferon Alfa 2b and Ribavirin for Patients With Genotype 3 and High Viral Load. Genotype 3 Extended Treatment for HCV (GET-C Study)|Terminated||Phase 4|146|Actual|Merck Sharp & Dohme Corp.|No formal comparisons could be made and no conclusions drawn because of small numbers in the treatment groups; a result of an inability to fulfill the recruitment target.|2||Recruitment targets were unachievable in the currently available population.|f||||f||||||||Yes|"http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php"|2017-10-11 05:48:42.439073|2017-10-11 05:48:42.439073
NCT00255047|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2014-01-21|2010-09-14||November 2005||2005-11-01|January 2014|2014-01-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Immune Response of Different Pediatric Combination Vaccines.|Comparative Immunogenicity of Different Multivalent Component Pertussis Vaccine Formulations Based on a 5 Component Acellular Pertussis Vaccine in Infants and Toddlers|Completed||Phase 3|2167|Actual|Sanofi||4|||f||||f||||||||||2017-10-11 05:48:43.169252|2017-10-11 05:48:43.169252
NCT00255060|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2010-07-16|||November 2001||2001-11-01|July 2010|2010-07-01|June 2007|Actual|2007-06-01|July 2006|Actual|2006-07-01||Observational|||Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer|Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer|Completed||N/A|100|Anticipated|Stanford University|||1||f||||||||||||||2017-10-11 05:48:44.452908|2017-10-11 05:48:44.452908
NCT00255073|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2014-05-21|||January 2005||2005-01-01|May 2014|2014-05-01|April 2006||2006-04-01|||||Interventional|||Does Reducing Spasticity Permit an Increase in Strength?|Does Reducing Spasticity Permit an Increase in Strength?|Completed||Phase 2|10||University of Southern California|||||f||||f||||||||||2017-10-11 05:48:44.518974|2017-10-11 05:48:44.518974
NCT00255086|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2017-02-23|2016-08-23||May 2005||2005-05-01|February 2017|2017-02-01|February 2010|Actual|2010-02-01|June 2009|Actual|2009-06-01||Interventional||Per protocol, only participants who completed the study were evaluable for baseline characteristics.|The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients|The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients: A Randomized, Placebo-Controlled, 52-Week Clinical Trial|Completed||Phase 3|17|Actual|Stanford University||2|||f||||f||||||||Undecided||2017-10-11 05:48:44.612123|2017-10-11 05:48:44.612123
NCT00255099|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2011-06-02||2011-06-02|December 2005||2005-12-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|January 2007|Actual|2007-01-01||Interventional|||TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.|A Phase III Randomized, Double-blinded, Placebo-controlled Trial to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an ART Regimen, Including TMC114/RTV and an Investigator-selected OBR, in HIV-1 Infected Patients With Limited Treatment to no Treatment Options.|Completed||Phase 3|593|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||||||||||||2017-10-11 05:48:44.911295|2017-10-11 05:48:44.911295
NCT00255112|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2015-06-10|||June 2004||2004-06-01|June 2015|2015-06-01||||December 2009|Actual|2009-12-01||Interventional|||TAFF-Psychological Treatment of Separation Anxiety Disorder|Psychological Treatment of Separation Anxiety Disorder|Completed||N/A|64|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-10-11 05:48:45.019156|2017-10-11 05:48:45.019156
NCT00255125|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2015-06-12|2013-12-24||September 2005||2005-09-01|June 2015|2015-06-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional||Prostate cancer patient, randomized between to study groups; all patients with early stage prostate cancer.|Role of Soy Supplementation in Prostate Cancer Development|Role of Soy Isoflavones in Prostate Cancer Prevention|Completed||Phase 3|86|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-10-11 05:48:45.125038|2017-10-11 05:48:45.125038
NCT00255138|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2008-10-28|||November 2005||2005-11-01|October 2008|2008-10-01||||||||Interventional|||Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects|Efficacy of Atomoxetine Therapy Versus Placebo For Ameliorating Cognitive Late Effects Among Survivors of Childhood Cancers|Withdrawn||Phase 3|60||Temple University|||||f||||||||||||||2017-10-11 05:48:45.543097|2017-10-11 05:48:45.543097
NCT00255151|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2012-02-01|2009-02-20||January 2006||2006-01-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis|A Phase 3 Study to Evaluate the Safety and Efficacy of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis|Completed||Phase 3|451|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:48:45.680424|2017-10-11 05:48:45.680424
NCT00255164|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2012-02-01|2009-02-20||January 2006||2006-01-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis|A Phase 3 Study to Evaluate the Safety and Efficacy of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis|Completed||Phase 3|451|Actual|Takeda||3|||f||||f||||||||||2017-10-11 05:48:46.91332|2017-10-11 05:48:46.91332
NCT00255177|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2009-10-30|2009-04-22||November 2005||2005-11-01|October 2009|2009-10-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Interventional|||Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients|A Randomized, Open-label Phase II Trial of the Anti-HCV Activity and Safety of VGX-410 (Mifepristone) at 3 Dose Levels in HCV Infected Patients|Completed||Phase 2|44|Actual|VGX Pharmaceuticals, LLC||4|||f||||f||||||||||2017-10-11 05:48:48.048167|2017-10-11 05:48:48.048167
NCT00255190|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-15|2016-06-27|2009-06-24||January 2006||2006-01-01|April 2011|2011-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn|A Phase 3, Open-Label Study to Assess the Long-Term Safety of Dexlansoprazole MR (60 mg QD and 90 mg QD)|Completed||Phase 3|591|Actual|Takeda|The incidence of adverse events was considered one of the primary outcome measures of this study. These results are presented in the Adverse Events Section and are not reposted as a separate primary endpoint.|2|||f||||f||||||||||2017-10-11 05:48:48.727857|2017-10-11 05:48:48.727857
NCT00255216|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2005-11-17|||January 2005||2005-01-01|October 2005|2005-10-01|August 2005||2005-08-01|||||Interventional|||Policosanol for the Treatment of Hypercholesterolemia|Policosanol for the Treatment of Hypercholesterolemia|Completed||N/A|40||Carolinas Healthcare System|||||f||||||||||||||2017-10-11 05:48:50.905352|2017-10-11 05:48:50.905352
NCT00255229|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2016-02-24|||December 2002||2002-12-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea|Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea|Completed||Phase 2|130|Actual|AHS Cancer Control Alberta||2|||f||||t||||||||||2017-10-11 05:48:51.01023|2017-10-11 05:48:51.01023
NCT00255242|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2009-07-31|||July 2004||2004-07-01|January 2008|2008-01-01|May 2009|Actual|2009-05-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Simvastatin on CF Airway Inflammation|Effect of Simvastatin on CF Airway Inflammation|Completed||Phase 1|40|Anticipated|Akron Children's Hospital||1|||f||||f||||||||||2017-10-11 05:48:51.128248|2017-10-11 05:48:51.128248
NCT00255255|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2011-01-21|||November 2005||2005-11-01|January 2011|2011-01-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma|An Open, Phase III, Multicentre, 52-week Study, Evaluating the Safety and Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma|Completed||Phase 3|120||AstraZeneca|||||f||||||||||||||2017-10-11 05:48:51.237269|2017-10-11 05:48:51.237269
NCT00255268|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-26|2007-08-24|||August 2004||2004-08-01|August 2007|2007-08-01||||||||Interventional|||CMAB vs IMAB in Metastatic Prostate Cancer|Longitudinal, Randomized, Open and Prospective Clinical Trial to Evaluate the Efficacy of Continuous vs Intermittent Maximum Androgen Blockade (CMAB vs IMAB) With Goserelin-Bicalutamide Combination in the Treatment of Hormonal naïve With Metastatic Prostate Cancer|Withdrawn||Phase 4|15|Anticipated|AstraZeneca|||||f||||||||||||||2017-10-11 05:48:51.362305|2017-10-11 05:48:51.362305
NCT00255281|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2007-12-04|||September 2005||2005-09-01|December 2007|2007-12-01|May 2006|Actual|2006-05-01|||||Interventional|||Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation|A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre, Phase II Study to Assess the Efficacy of AZD7009 (AR H065522XX) Given Intravenously (Infusion for 15 or 30 Minutes) to Patients for Conversion of Atrial Fibrillation|Completed||Phase 2|160|Anticipated|AstraZeneca|||||f||||||||||||||2017-10-11 05:48:51.433263|2017-10-11 05:48:51.433263
NCT00255294|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2005-11-17|||January 2005||2005-01-01|November 2005|2005-11-01|October 2005||2005-10-01|||||Interventional|||Contraceptive Effectiveness Trial of Cellulose Sulfate Gel|Non-Comparative Contraceptive Effectiveness Trial of Cellulose Sulfate (CS) Gel|Completed||Phase 2|200||CONRAD|||||||||||||||||||2017-10-11 05:48:51.557874|2017-10-11 05:48:51.557874
NCT00255307|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2007-06-14|||November 2005||2005-11-01|June 2007|2007-06-01|April 2006|Actual|2006-04-01|||||Interventional|||Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.|A Pilot Evaluation of Two Dosing Schedules of American Ginseng Extract in Pediatric Upper Respiratory Tract Infection.|Completed||Phase 2|75|Actual|Afexa Life Sciences Inc||3|||f||||||||||||||2017-10-11 05:48:51.628949|2017-10-11 05:48:51.628949
NCT00255320|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2005-12-07|||December 2003||2003-12-01|December 2003|2003-12-01|June 2004||2004-06-01|||||Interventional|||Experimental Headache Induced by Vasoactive Intestinal Polypeptide|Experimental Headache Induced by Vasoactive Intestinal Polypeptide|Completed||N/A|12||Danish Headache Center|||||f||||||||||||||2017-10-11 05:48:51.696047|2017-10-11 05:48:51.696047
NCT00255333|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2007-05-11|||November 2005||2005-11-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||INNO-105 in Patients With Solid Tumors|A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Weekly Intravenous INNO-105 in Adult Patients With Advanced Solid Malignancies|Terminated||Phase 1|24||Innovive Pharmaceuticals||||Development of this compound was discontinued.|||||||||||||||2017-10-11 05:48:51.764215|2017-10-11 05:48:51.764215
NCT00255346|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2017-03-07|||November 15, 2005|Actual|2005-11-15|March 2017|2017-03-01|March 3, 2017|Actual|2017-03-03|March 3, 2017|Actual|2017-03-03||Interventional|||Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)|Therapy of Myeloid Metaplasia-Myelofibrosis, Atypical Chronic Myeloid or Myelomonocytic Leukemia, C-Kit Positive Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (AML-MDS), Hypereosinophilic Syndrome, Polycythemia Vera, and Mastocytosis With Dasatinib (BMS-354825)|Completed||Phase 2|68|Actual|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-10-11 05:48:51.824471|2017-10-11 05:48:51.824471
NCT00255359|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2007-11-05|||February 2006||2006-02-01|November 2007|2007-11-01|November 2007||2007-11-01|||||Interventional|||Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers|A Multicenter, Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study of the Safety and Efficacy of XTL 2125 in Adult HCV-Infected Patients With Compensated Liver Disease, Who Are Interferon-Alpha Non-Responders or Have Relapsed From Interferon-Alpha Therapy|Withdrawn||Phase 1|60|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:48:51.913761|2017-10-11 05:48:51.913761
NCT00255372|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2008-06-03|||April 2005||2005-04-01|June 2008|2008-06-01||||May 2008|Actual|2008-05-01||Interventional|||To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.|Polyethylene Glycol Laxative (Macrogol 4000;Forlax®) for Treatment of Chronic Constipation in Children : A Phase III, Bicentric, Randomized, Double-Blind, Lactulose Controlled Study.|Completed||Phase 3|84|Anticipated|Ipsen||2|||f||||||||||||||2017-10-11 05:48:51.998009|2017-10-11 05:48:51.998009
NCT00247975|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-31|2012-02-06|||March 2006||2006-03-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy|Primary Prevention of Anthracycline-Induced Cardiotoxicity With L-Carnitine in Patients With Breast Cancer (PPACC)-Pilot Study|Completed||Phase 2/Phase 3|144|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||t||||||||||2017-10-11 05:48:52.120238|2017-10-11 05:48:52.120238
NCT00247988|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2007-04-20|||October 2003||2003-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers|Phase II Study of Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers|Terminated||Phase 2|38||University of Saskatchewan||||"Regulatory issues(trial temporarily suspended December 28, 2005. Permanently suspended January   19, 2007. Institutional Reveiw Board informed April 18, 2007"|f||||||||||||||2017-10-11 05:48:52.215811|2017-10-11 05:48:52.215811
NCT00248014|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2012-01-18|||October 2005||2005-10-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||Response of Individuals With Class II Malocclusion|Cephalometric Indicators of Biological Responsiveness to Orthodontic Treatment of Class II/I in Growing Patients|Completed||Phase 2|63|Actual|Aristotle University Of Thessaloniki||1|||f||||t||||||||||2017-10-11 05:48:52.321196|2017-10-11 05:48:52.321196
NCT00248027|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2006-09-12|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Observational|||Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic|Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic|Terminated||Phase 1|||McMaster University|||||f||||||||||||||2017-10-11 05:48:52.416542|2017-10-11 05:48:52.416542
NCT00248053|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2012-09-18|||November 2005||2005-11-01|September 2012|2012-09-01||||June 2008|Actual|2008-06-01||Interventional|||Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients|Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis (FAP) Patients|Withdrawn||Phase 2|0|Actual|Johns Hopkins University||1||"Subsequent data generated by our collaborators have shown efficacy with curcumin and quercetin   in 5 patients in a non placebo controlled trial."|f||||f||||||||||2017-10-11 05:48:52.645939|2017-10-11 05:48:52.645939
NCT00248066|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2007-02-06|||September 2005||2005-09-01|February 2007|2007-02-01||||||||Interventional|||Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries|APPRAISAL Trial: A Phase IIa Study to Evaluate the Safety and Preliminary Efficacy of RESTEN-MP® When Used in Conjunction With a Bare Metal Stent in de Novo Native Coronary Artery Lesions|Completed||Phase 2|50||Sarepta Therapeutics|||||f||||||||||||||2017-10-11 05:48:52.723694|2017-10-11 05:48:52.723694
NCT00248079|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2011-10-18|||November 2005||2005-11-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|June 2007|Actual|2007-06-01||Interventional|||The Medtronic RESOLUTE Clinical Trial|The Clinical Response Evaluation of the Medtronic Endeavor CR ABT-578 Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Completed||Phase 1/Phase 2|139|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-10-11 05:48:52.809939|2017-10-11 05:48:52.809939
NCT00248092|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2007-11-01|||January 2006||2006-01-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse|A Double-Blind, Randomized, Placebo and Active-Controlled, Six-Period Crossover Study to Evaluate the Likeability, Safety, and Abuse Liability of NRP104 in Healthy Adult Volunteers With Histories of Stimulant Abuse|Completed||Phase 1/Phase 2|36||New River Pharmaceuticals|||||||||||||||||||2017-10-11 05:48:52.897396|2017-10-11 05:48:52.897396
NCT00248105|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2013-10-31|||September 2005||2005-09-01|October 2013|2013-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|IMPAACT||Improving Motivation for Physical Activity in Arthritis Clinical Trial|Physical Activity in Persons With Arthritis|Completed||N/A|889|Actual|Northwestern University||2|||f||||t||||||||||2017-10-11 05:48:52.97336|2017-10-11 05:48:52.97336
NCT00248118|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2016-09-22|||January 2005||2005-01-01|September 2016|2016-09-01|May 2008|Actual|2008-05-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking|Neurocognitive and Affective Correlates of Tobacco Dependence in Adolescent Smokers and Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking|Terminated||Phase 2/Phase 3|72|Actual|National Institutes of Health Clinical Center (CC)||2||PI left NIH|f||||t||||||||||2017-10-11 05:48:53.057305|2017-10-11 05:48:53.057305
NCT00248131|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2012-04-08|||November 2005||2005-11-01|April 2012|2012-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy|An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Octreotide Acetate in Microspheres in the Therapy of Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR)|Terminated||Phase 3|260||Novartis|||||f||||||||||||||2017-10-11 05:48:53.135051|2017-10-11 05:48:53.135051
NCT00248144|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2007-12-07|||October 2003||2003-10-01|August 2006|2006-08-01|July 2007|Actual|2007-07-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis|A Randomized, Multicenter, Double-Blinded Controlled Study to Compare the Effectiveness of a Single Dose (1500 mg) of Famciclovir, One Day (750 mg q12) of Famciclovir and Placebo in Patient-Initiated Episodic Treatment of Recurrent Herpes Labialis|Completed||Phase 4|||Novartis|||||||||||||||||||2017-10-11 05:48:53.189499|2017-10-11 05:48:53.189499
NCT00248352|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2007-10-25|||February 2005||2005-02-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease|GLUCOSE : Glucose Lowering by Usual Care Or Specialized Endocrinology Team|Completed||N/A|212|Anticipated|Ottawa Heart Institute Research Corporation|||||f||||||||||||||2017-10-11 05:49:01.403555|2017-10-11 05:49:01.403555
NCT00248157|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2012-04-30|||November 2005||2005-11-01|April 2012|2012-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy|An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Octreotide Acetate in Microspheres in the Therapy of Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR)|Terminated||Phase 3|105|Actual|Novartis||||Inconsistent treatment benefit|f||||||||||||||2017-10-11 05:48:53.471052|2017-10-11 05:48:53.471052
NCT00248170|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2016-03-20|2015-09-08||December 2005||2005-12-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|FACE||Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer|Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer|Completed||Phase 3|4172|Actual|Novartis||2|||f||||||||||||||2017-10-11 05:48:53.651696|2017-10-11 05:48:53.651696
NCT00248183|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2008-04-02|||August 2005||2005-08-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)|A Randomized, Double Blind, Placebo Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Tolerability Of PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)|Completed||Phase 3|310||Epix Pharmaceuticals, Inc.|||||f||||||||||||||2017-10-11 05:48:57.944943|2017-10-11 05:48:57.944943
NCT00248196|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2008-03-20|||October 2005||2005-10-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||COOL MI II: Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction|COOL MI II: Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction|Terminated||Phase 2/Phase 3|225|Anticipated|Radiant Medical|||||||||||||||||||2017-10-11 05:48:58.038663|2017-10-11 05:48:58.038663
NCT00248209|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2011-07-19|||May 2004||2004-05-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Female Orgasmic Disorder (FOD) and Wellbutrin XL|A Multi-center, Double-blind, Placebo-controlled Study of Bupropion XL in Females With Orgasmic Disorder|Completed||Phase 2/Phase 3|48|Actual|Segraves, R., T., M.D., Ph.D.||1|||f||||f||||||||||2017-10-11 05:48:58.097927|2017-10-11 05:48:58.097927
NCT00248222|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2009-10-26|||October 2005||2005-10-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Early Aerobic Training Program After Ischemic Stroke||Completed||Phase 2|||Sheba Medical Center|||||f||||f||||||||||2017-10-11 05:48:58.175892|2017-10-11 05:48:58.175892
NCT00248235|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2016-05-10|||September 2005||2005-09-01|May 2016|2016-05-01|January 2009|Actual|2009-01-01|May 2008|Actual|2008-05-01||Interventional|||Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer|Randomized Controlled Trial of Progressive Resistance Exercise Training for Spinal Accessory Neurapraxia/ Neurectomy in Head and Neck Cancer Survivors|Completed||Phase 2/Phase 3|64|Actual|University of Alberta, Physical Education||2|||f||||||||||||||2017-10-11 05:48:58.242747|2017-10-11 05:48:58.242747
NCT00248248|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2011-10-07|||October 2005||2005-10-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||DOXIL for Consolidation Therapy in Ovarian Cancer.|A Phase II Non-randomized Study of DOXIL Consolidation Treatment for Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneal Carcinoma.|Completed||Phase 2|45|Anticipated|Southeastern Gynecologic Oncology||1|||f||||f||||||||||2017-10-11 05:48:58.328698|2017-10-11 05:48:58.328698
NCT00248261|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2013-12-12|||November 2005||2005-11-01|December 2013|2013-12-01|June 2010|Actual|2010-06-01|August 2009|Actual|2009-08-01||Observational|||Ziprasidone and Sertraline in PTSD|Effects of Ziprasidone vs. Placebo During the First Four Weeks of Eight Weeks Sertraline Treatment in Patients With Post-traumatic Stress Disorder (PTSD)|Terminated||Phase 2|7|Actual|Universitätsklinikum Hamburg-Eppendorf|||1|High rate of early drop-outs|f||||||||||||||2017-10-11 05:48:58.397825|2017-10-11 05:48:58.397825
NCT00248274|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2011-11-21|||January 2005||2005-01-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Atrial Tissue Banking: Atrial Tissue Obtained From Patients Undergoing Heart Surgery|Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery|Terminated||N/A|300|Actual|University of Pittsburgh|||1|Staffing and departmental changes at our site made it difficult to enroll subjects.|f||||t||||||Samples With DNA|"     1. myocardial tissue        2. DNA   "|||2017-10-11 05:48:58.458693|2017-10-11 05:48:58.458693
NCT00248287|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2016-09-15|2016-02-02||July 2005||2005-07-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|May 2014|Actual|2014-05-01||Interventional|CA225200|ITT population|PhII ICb With/Without Erbitux in MBC Pts|Randomized Phase II Study of Weekly Irinotecan/Carboplatin (ICb) With or Without Cetuximab (Erbitux) in Patients With Metastatic Breast Cancer|Active, not recruiting||Phase 2|154|Actual|US Oncology Research||2|||f||||||||||||||2017-10-11 05:48:58.539024|2017-10-11 05:48:58.539024
NCT00248300|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-01|2015-11-09|||August 2005||2005-08-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP|A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP|Completed||Phase 4|156|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-10-11 05:49:00.970399|2017-10-11 05:49:00.970399
NCT00248313|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2010-03-09|||July 2000||2000-07-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus|A Randomized, Open-label Study to Compare the Safety and Efficacy of Cyclosporin Dose Reduction With Cyclosporin Elimination in de Novo Renal Allograft Recipients Receiving Rapamune|Completed||Phase 3|470||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:49:01.047107|2017-10-11 05:49:01.047107
NCT00248326|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2016-01-04|||January 2005||2005-01-01|January 2016|2016-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||The Genetic Basis of Atrial Fibrillation (AF)|The Genetic Basis of Atrial Fibrillation|Completed||N/A|50|Actual|University of Pittsburgh|||2||f||||t||||||||||2017-10-11 05:49:01.118174|2017-10-11 05:49:01.118174
NCT00248339|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2017-03-16|||May 2002||2002-05-01|March 2017|2017-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection|An Open-label, Randomized Pilot Study to Compare the Effectiveness of Peginterferon-alfa-2b Plus Ribavirin to Peginterferon-alfa-2b Plus Epoetin-alfa and Two Doses of Ribavirin in the Treatment of Chronic Hepatitis C Virus Infection|Completed||Phase 3|150|Actual|Virginia Commonwealth University||3|||f||||t||||||||||2017-10-11 05:49:01.189179|2017-10-11 05:49:01.189179
NCT00248365|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2016-02-24|||November 2005||2005-11-01|February 2016|2016-02-01|August 2007|Actual|2007-08-01|||||Interventional|||Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD)|Safety, Biological and Clinical Efficacy of Two Intensity Levels of Theralux Extracorporeal Photochemotherapy in Subjects With Extensive Chronic GvHD Refractory or Intolerant to Standard Therapy: A Randomized, Open-label Phase I/II Clinical Trial|Completed||Phase 1/Phase 2|20|Actual|Kiadis Pharma||2|||||||||||||||||2017-10-11 05:49:01.620594|2017-10-11 05:49:01.620594
NCT00248378|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2006-06-21|||September 2001||2001-09-01|June 2006|2006-06-01|March 2005||2005-03-01|||||Interventional|||Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis|Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis|Completed||Phase 1/Phase 2|30||Center for Medicinal Cannabis Research|||||||||||||||||||2017-10-11 05:49:01.7293|2017-10-11 05:49:01.7293
NCT00248391|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2007-10-25||||||October 2006|2006-10-01|January 2008|Anticipated|2008-01-01|||||Interventional|||The Influence of Feeding Position on Pulmonary Morbidity in Young Children|The Influence of Feeding Position on Pulmonary Morbidity in Young Children|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:49:01.833742|2017-10-11 05:49:01.833742
NCT00248404|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2012-09-26|||September 2005||2005-09-01|January 2008|2008-01-01||||||||Interventional|||NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)|A Phase I/II Study of NB1011 Administered Intravenously by Continuous Infusion in an Every Second Week Regimen With Open-label Continuation in Cancers That Overexpress the Enzyme Thymidylate Synthase|Completed||Phase 1/Phase 2|155|Anticipated|Kiadis Pharma|||||f||||||||||||||2017-10-11 05:49:01.953683|2017-10-11 05:49:01.953683
NCT00248430|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2010-09-20|||August 2003||2003-08-01|September 2010|2010-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer|A Phase I-II Trial of Adoptive Immunotherapy Using Haploidentical, Related Donor-Lymphocyte Infusions and IL-2 After Autologous Stem Cell Transplantation for Advanced Lymphoid Malignancies|Completed||Phase 1/Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-10-11 05:49:02.055896|2017-10-11 05:49:02.055896
NCT00248443|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-02-17|||August 2005||2005-08-01|March 2007|2007-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage|Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage. A Multicentric Randomized Controlled Trial|Completed||Phase 3|206|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-10-11 05:49:02.168461|2017-10-11 05:49:02.168461
NCT00248456|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2008-02-20|||October 2005||2005-10-01|February 2008|2008-02-01|February 2006||2006-02-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris|A Randomised, Double-Blind, Active-Controlled, Parallel, Multi-Center Study to Investigate the Efficacy and Safety of Daivobet® Ointment in Patients With Psoriasis Vulgaris|Completed||Phase 4|320||LEO Pharma|||||f||||||||||||||2017-10-11 05:49:02.246722|2017-10-11 05:49:02.246722
NCT00248469|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2006-10-19|||July 1998||1998-07-01|November 2005|2005-11-01|April 2002||2002-04-01|||||Interventional|||MEMA Kwa Vijana Trial: Impact of an Adolescent Sexual and Reproductive Health Intervention in Mwanza, Tanzania|Strategies for the Prevention of HIV Infection and the Enhancement of Reproductive Health Among Adolescents in Rural Tanzania: MEMA Kwa Vijana Trial|Completed||Phase 3|10000||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:49:02.320698|2017-10-11 05:49:02.320698
NCT00248482|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2013-04-25|||February 2002||2002-02-01|April 2013|2013-04-01|January 2008|Actual|2008-01-01|April 2005|Actual|2005-04-01||Interventional|||Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Imatinib Mesylate Maintenance Therapy in Patients With C-Kit (+) Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|6|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-10-11 05:49:02.448828|2017-10-11 05:49:02.448828
NCT00248495|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-06-15|2017-04-10||June 8, 2005|Actual|2005-06-08|June 2017|2017-06-01|April 5, 2017|Actual|2017-04-05|April 29, 2011|Actual|2011-04-29||Interventional||All treated and eligible patients|Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Molecular and Genetic Changes in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) Following Neoadjuvant Chemotherapy With Cisplatin and Alimta - Phase II Study|Completed||Phase 2|38|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-10-11 05:49:02.59086|2017-10-11 05:49:02.59086
NCT00248521|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2013-08-01|||October 2005||2005-10-01|March 2008|2008-03-01||||January 2007|Anticipated|2007-01-01||Interventional|||17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery|A Cancer Research UK Phase I Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of 17-Dimethylaminoethyl-amino-17-Demethoxygeldanamycin (17-DMAG) Given as a Once Weekly Infusion in Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:49:03.05472|2017-10-11 05:49:03.05472
NCT00248547|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-05-07|2011-11-21||May 2004||2004-05-01|May 2017|2017-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant|A Pilot Study of Aprepitant vs. Placebo Combined With Standard Antiemetics for the Control of Nausea and Vomiting During Hematopoietic Cell Transplatation(HCT)|Completed||N/A|40|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-10-11 05:49:03.322658|2017-10-11 05:49:03.322658
NCT00248768|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2014-09-18|||February 2005||2005-02-01|September 2014|2014-09-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|ATMS||Accelerated Transcranial Magnetic Stimulation (TMS) for Depression|Accelerated Transcranial Magnetic Stimulation for Depression|Completed||Phase 1|20|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-10-11 05:49:08.293214|2017-10-11 05:49:08.293214
NCT00248560|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2014-09-24|2014-08-18||January 2005||2005-01-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|December 2009|Actual|2009-12-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer|Phase II Study of Gemcitabine and Docetaxel (GEMDOC) Combination in Patients With Previously Treated Recurrent or Metatstatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|36|Actual|Barbara Ann Karmanos Cancer Institute|The trial design was changed during accrual to allow for study continuation although response rate was lower than predicted. The trial was completed but it did not meet the specified end points.|1|||f||||t||||||||||2017-10-11 05:49:03.901495|2017-10-11 05:49:03.901495
NCT00248573|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2013-12-16|||October 2004||2004-10-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|September 2012|Actual|2012-09-01||Observational|||Mechanisms of Adaptation in Human Short Bowel Syndrome||Completed||Phase 1/Phase 2|32|Actual|Emory University|||1||f||||||||||Samples With DNA|"     Intestinal biopsy samples   "|||2017-10-11 05:49:04.283009|2017-10-11 05:49:04.283009
NCT00248612|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2017-08-24|2017-05-24||September 2003|Actual|2003-09-01|August 2017|2017-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Psychosocial and Medication Treatment for Anxiety in Alcoholism|CBT And Venlafaxine Treatments For Anxiety In Alcoholism|Completed||Phase 2/Phase 3|162|Actual|Boston Medical Center|Small size of treatment groups leading to diminished meaningful difference between comparison groups at follow-up; Failure of randomization leading to unequal number of subjects in each treatment group.|4|||f||||t|t|f|||t|||||2017-10-11 05:49:04.480809|2017-10-11 05:49:04.480809
NCT00248625|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2016-06-16|2016-02-19||January 2000||2000-01-01|June 2016|2016-06-01|October 2010|Actual|2010-10-01|September 2009|Actual|2009-09-01||Interventional||All participants who were randomized were included in the baseline analysis.|N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure|A Multi-center Study of the Safety and Efficacy of N-acetylcysteine in the Treatment of Acute Liver Failure in Pediatric Patients Not Caused by Acetaminophen.|Completed||Phase 3|184|Actual|University of Pittsburgh||2|||f||||t||||||||No||2017-10-11 05:49:05.603998|2017-10-11 05:49:05.603998
NCT00248638|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2015-08-04|2013-12-19||September 2006||2006-09-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|GLND|Adults following CABG, cardiac valve, vascular (non-neurosurgical), or small bowel and/or colonic surgery who are deemed likely to require PN for ≥ 7 subsequent days by the attending physicians and investigators are eligible. Potentially eligible subjects admitted to the SICU and deemed to require PN.|Efficacy and Mechanisms of GLN Dipeptide in the SICU|Phase III Study on the Efficacy of Glutamine Dipeptide-Supplemented Parenteral Nutrition in Surgical ICU Patients|Completed||Phase 3|150|Actual|Emory University||2|||f||||t||||||||||2017-10-11 05:49:06.413562|2017-10-11 05:49:06.413562
NCT00248651|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2014-06-26|2014-06-26||October 2006||2006-10-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|FDTT||Functional Dyspepsia Treatment Trial|Antidepressant Therapy for Functional Dyspepsia|Completed||Phase 2/Phase 3|292|Actual|Mayo Clinic||3|||f||||t||||||||||2017-10-11 05:49:06.851674|2017-10-11 05:49:06.851674
NCT00248664|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2010-03-02|||March 2004||2004-03-01|March 2010|2010-03-01|November 2008|Actual|2008-11-01|||||Observational|EPIC||Events Preceding Interstitial Cystitis (EPIC)|A Case Control Study of Interstitial Cystitis|Completed||N/A|400|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-10-11 05:49:07.666898|2017-10-11 05:49:07.666898
NCT00248677|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-12-09|||September 2005||2005-09-01|February 2011|2011-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Sensible Treatment of Obesity in Rural Youth . . .|Sensible Treatment of Obesity in Rural Youth|Completed||Early Phase 1|93|Actual|University of Florida||3|||f||||||||||||||2017-10-11 05:49:07.725766|2017-10-11 05:49:07.725766
NCT00248690|ClinicalTrials.gov processed this data on October 10, 2017|2005-10-25|2011-01-17|||November 2005||2005-11-01|January 2008|2008-01-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||ICP Versus Intracranial Compliance Guided Management in SAH|Intracranial Pressure (ICP) Versus Intracranial Compliance (ICC) Guided Management in Subarachnoid Hemorrhage; - a Prospective, Randomized Trial.|Completed||N/A|100|Actual|Oslo University Hospital||1|||f||||||||||||||2017-10-11 05:49:07.816302|2017-10-11 05:49:07.816302
NCT00248703|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2012-11-20|||October 2003||2003-10-01|November 2012|2012-11-01|November 2013|Anticipated|2013-11-01|November 2012|Actual|2012-11-01||Interventional|||Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow|Secondary Adjuvant (Rescue) Treatment With Docetaxel (Taxotere) and Detection of Isolated Tumor Cells in Bone Marrow as a Surrogate Marker for Effect in Node Positive and High Risk Node Negative Breast Cancer After Standard Adjuvant Epirubicin-containing Treatment|Unknown status|Active, not recruiting|Phase 2|1128|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-10-11 05:49:07.897123|2017-10-11 05:49:07.897123
NCT00248729|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2006-08-28|||October 2002||2002-10-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Effectiveness and Safety Study of Etomidate Versus Midazolam to Help Place a Breathing Tube Outside of the Hospital.|Etomidate Versus Midazolam for Pre-Hospital Intubation: A Prospective, Randomized Trial|Completed||Phase 2|||St. Luke's Hospital, Pennsylvania|||||f||||||||||||||2017-10-11 05:49:08.068829|2017-10-11 05:49:08.068829
NCT00248742|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-07-03|||February 2001||2001-02-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|INSPIRE||Psychobiology in Inflammatory Bowel Disease(IBD)|The Impact of Psychobiological Factors in Inflammatory Bowel Disease|Completed||N/A|114|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-10-11 05:49:08.136119|2017-10-11 05:49:08.136119
NCT00248755|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2017-07-24|||November 2005||2005-11-01|July 2017|2017-07-01|August 2006|Actual|2006-08-01|||||Interventional|||Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway|Pilot Study of a New Technique for Assessing Mucociliary Clearance and Airway Surface Liquid Volume in Cystic Fibrosis|Completed||N/A|14||University of Pittsburgh|||||f||||||||||||||2017-10-11 05:49:08.219275|2017-10-11 05:49:08.219275
NCT00248781|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2013-12-10|2013-09-24||September 2003||2003-09-01|December 2013|2013-12-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|||Home-based Exercise Via a Telecommunications System|Home-based Exercise Via a Telecommunications System|Completed||Phase 3|103|Actual|VA Office of Research and Development||2|||f||||||||||||||2017-10-11 05:49:08.379979|2017-10-11 05:49:08.379979
NCT00248794|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2016-04-25|2015-09-02||June 2004||2004-06-01|April 2016|2016-04-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||Cognitive Rehabilitation in Schizophrenia|The Effects of Cognitive Rehabilitation on Function in Schizophrenia|Completed||N/A|59|Actual|VA Office of Research and Development||3|||f||||f||||||||No|Data to be written up in peer review journal and possibly presented at regional and national conferences, but there is no plan to de-identify and share|2017-10-11 05:49:08.826374|2017-10-11 05:49:08.826374
NCT00248807|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2014-05-21|2013-09-12||October 2005||2005-10-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|May 2009|Actual|2009-05-01||Interventional|||A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.|Systemic Hemodynamics and Cerebral Blood Flow in Persons With Tetraplegia|Completed||N/A|30|Actual|VA Office of Research and Development|Did not assess carbon dioxide levels or the severity of spinal cord injury, which may have contributed to the results.|4|||f||||||||||||||2017-10-11 05:49:09.248081|2017-10-11 05:49:09.248081
NCT00248820|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2007-11-21|||September 2002||2002-09-01|November 2007|2007-11-01|February 2009|Anticipated|2009-02-01|||||Interventional|||Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses|Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-10-11 05:49:09.550318|2017-10-11 05:49:09.550318
NCT00248846|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-02-17|||October 2004|Actual|2004-10-01|February 2017|2017-02-01|July 2011|Actual|2011-07-01|January 2008|Actual|2008-01-01||Interventional|||A Randomized Trial: Changing Behavior in Post-Angioplasty Patients|A Randomized Trial: Changing Behavior in Post-Angioplasty Patients|Completed||N/A|242|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||No|No Plan to Share IPD|2017-10-11 05:49:09.701177|2017-10-11 05:49:09.701177
NCT00248859|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-02-17|||August 2004||2004-08-01|February 2017|2017-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease|Determinants of Cardiac Risk Factors Modification|Completed||N/A|198|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No|No plan to share IPD|2017-10-11 05:49:09.7818|2017-10-11 05:49:09.7818
NCT00248872|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-02-17|||October 2004|Actual|2004-10-01|February 2017|2017-02-01|July 2008|Actual|2008-07-01|September 2006|Actual|2006-09-01||Interventional|||A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients|A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients|Completed||N/A|278|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||No|No Plan to Share IPD|2017-10-11 05:49:09.849075|2017-10-11 05:49:09.849075
NCT00248885|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2008-04-10|||September 1991||1991-09-01|April 2008|2008-04-01|September 1994|Actual|1994-09-01|||||Interventional|||Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)|Peri-Operative Morbidity and Quality of Life After CABG|Completed||N/A|248|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 05:49:09.927858|2017-10-11 05:49:09.927858
NCT00248898|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-01-18|||March 2005||2005-03-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Quality of Life After Open Heart Surgery in Older Patients|Quality of Life After Open Heart Surgery in Older Patients|Completed||N/A|49|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||Yes|Investigators may contact the PI for access to the data, with their planned analyses|2017-10-11 05:49:10.013916|2017-10-11 05:49:10.013916
NCT00248911|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-02-17|||May 2003||2003-05-01|February 2017|2017-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers|The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers:Avon Program for Meditation and Healing|Completed||N/A|94|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||No|No Plan to Share IPD|2017-10-11 05:49:10.084678|2017-10-11 05:49:10.084678
NCT00248924|ClinicalTrials.gov processed this data on October 10, 2017|2005-09-13|2008-03-31|||April 2001||2001-04-01|March 2008|2008-03-01|February 2003||2003-02-01|||||Observational|||Outcomes Of Social Service Programs For Homebound Older Adults|Outcomes Of Social Service Programs For Homebound Older Adults|Completed||N/A|56||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:49:10.242603|2017-10-11 05:49:10.242603
NCT00248937|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2008-04-01|||February 2004||2004-02-01|April 2008|2008-04-01|June 2004||2004-06-01|||||Interventional|||A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients|A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients|Completed||N/A|40||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:49:10.385488|2017-10-11 05:49:10.385488
NCT00248950|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2008-04-01|||February 2004||2004-02-01|April 2008|2008-04-01|June 2004||2004-06-01|||||Interventional|||A Pilot Study: Changing Multiple Behaviors in Post-Angioplasty Patients|A Pilot Study: Changing Multiple Behaviors in Post-Angioplasty Patients|Completed||N/A|40||Weill Medical College of Cornell University|||||f||||f||||||||||2017-10-11 05:49:10.453177|2017-10-11 05:49:10.453177
NCT00248963|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2006-05-17||||||May 2006|2006-05-01|October 2004||2004-10-01|||||Interventional|||Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception|A Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Levonorgestrel 90 Mg and Ethinyl Estradiol 20 Mg in a Continuous 28-Day Regimen for Oral Contraception Versus a Cyclic 21-Day Regimen Oral Contraceptive|Completed||Phase 3|600||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-10-11 05:49:10.517851|2017-10-11 05:49:10.517851
NCT00248976|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2008-03-28|||April 1999||1999-04-01|March 2008|2008-03-01|March 2004||2004-03-01|||||Interventional|||Improving Health Behavior and Outcomes After Angioplasty|Improving Health Behavior and Outcomes After Angioplasty|Completed||N/A|660|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-10-11 05:49:10.578217|2017-10-11 05:49:10.578217
NCT00248989|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-02|2017-04-06|||November 1, 2004|Actual|2004-11-01|April 2017|2017-04-01|November 13, 2008|Actual|2008-11-13|November 24, 2005|Actual|2005-11-24||Interventional|||Effect of DHEA on Skin Aging in Postmenopausal Women|Effect of DHEA on Skin Aging - Placebo-Controlled and Randomized Phase III Study in Postmenopausal Women.|Completed||Phase 3|150|Actual|CHU de Quebec-Universite Laval||2|||f||||f|f|f||||||No||2017-10-11 05:49:10.662468|2017-10-11 05:49:10.662468
NCT00249002|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2016-03-30|2012-02-21||November 2005||2005-11-01|March 2016|2016-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis|A Pilot Phase II Trial Of ABI-007 (A Cremophor El-Free, Protein Stabilized, Nanoparticle Paclitaxel) For The Prevention Of Vascular Access Graft Failure In Patients Undergoing Hemodialysis|Terminated||Phase 2|9|Actual|Celgene Corporation||1||Terminated due to pipeline prioritization|f||||f||||||||||2017-10-11 05:49:10.808739|2017-10-11 05:49:10.808739
NCT00249015|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2016-07-14|||January 2008||2008-01-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors|Randomized Controlled Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors. The CARE Trial.|Completed||Phase 3|301|Actual|AHS Cancer Control Alberta||3|||f||||t||||||||||2017-10-11 05:49:11.329256|2017-10-11 05:49:11.329256
NCT00249041|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2010-07-29|||October 2005||2005-10-01|July 2010|2010-07-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Enbrel Liquid Immunogenicity Protocol|Open-label Study to Assess the Antibody Response to Etanercept Liquid in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 3|447|Actual|Amgen||1|||f||||||||||||||2017-10-11 05:49:11.426261|2017-10-11 05:49:11.426261
NCT00249054|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2017-03-22|||November 2005||2005-11-01|March 2017|2017-03-01||||November 2012|Actual|2012-11-01||Interventional|||Prospective Clinical Evaluation of ASR and ReCap Resurfacing Arthroplasty|Clinical Performance of the ASR and ReCap Resurfacing Implants-7Years Follow-Up.|Completed||N/A|46|Actual|Frederiksberg University Hospital||2|||f||||||||||||||2017-10-11 05:49:11.513355|2017-10-11 05:49:11.513355
NCT00249067|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2007-06-12|||October 2005||2005-10-01|June 2007|2007-06-01|October 2005||2005-10-01|||||Observational|||Retrospective Evaluation of Carvedilol Versus Captopril in CHF Patients|The Retrospective Evaluation of Carvedilol Versus Captopril and Digoxin/Lasix Therapy in Congestive Heart Failure Due to Left-to-Right Shunt Lesions|Terminated||N/A|50||Children's Healthcare of Atlanta||||data collection completed|f||||f||||||||||2017-10-11 05:49:11.607373|2017-10-11 05:49:11.607373
NCT00249080|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2009-08-21|||June 2005||2005-06-01|August 2009|2009-08-01|August 2007|Actual|2007-08-01|||||Observational|||Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease|High Field MRI of Brain Iron in Neurodegenerative Disease|Completed||N/A|182|Actual|Albany Medical College|||1||f||||t||||||||||2017-10-11 05:49:11.676321|2017-10-11 05:49:11.676321
NCT00249093|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2007-04-12|||October 2005||2005-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT||Completed||N/A|20||LHL Helse|||||f||||f||||||||||2017-10-11 05:49:11.747144|2017-10-11 05:49:11.747144
NCT00249106|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2013-02-08|||December 2003||2003-12-01|September 2011|2011-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|C001||Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults|Randomized, Placebo-Controlled, Dose-Escalating, Double-Blinded Phase 1 Safety and Immunogenicity Study of Clade C DNA Vaccine ADVAX e/g + ADVAX p/N-t (ADVAX) Administered Intramuscularly to HIV-Uninfected, Healthy Volunteers.|Completed||Phase 1|45|Actual|International AIDS Vaccine Initiative||2|||f||||t||||||||||2017-10-11 05:49:11.819452|2017-10-11 05:49:11.819452
NCT00249119|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-02-10||||||February 2011|2011-02-01|December 1991|Actual|1991-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia|Risperidone in the Treatment of Chronic Schizophrenic Patients: an International Multicentre Double-blind Parallel-group Comparative Study Versus Haloperidol.|Completed||Phase 3|1579|Actual|Janssen, LP|||||f||||||||||||||2017-10-11 05:49:11.903388|2017-10-11 05:49:11.903388
NCT00249132|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-02-10||||||February 2011|2011-02-01|July 1991|Actual|1991-07-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia|Risperidone Versus Haloperidol Versus Placebo in the Treatment of Chronic Schizophrenia|Completed||Phase 3|523|Actual|Janssen, LP|||||f||||||||||||||2017-10-11 05:49:11.972985|2017-10-11 05:49:11.972985
NCT00249145|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-01-13|||April 1995||1995-04-01|January 2011|2011-01-01|December 1996|Actual|1996-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia|Risperidone in the Treatment of Behavioral Disturbances in Demented Patients: an International, Multicenter, Placebo-controlled, Double-blind, Parallel-group Trial Using Haloperidol as Internal Reference|Completed||Phase 3|349|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:49:12.044859|2017-10-11 05:49:12.044859
NCT00249158|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-11-18|||March 1998||1998-03-01|November 2010|2010-11-01|February 2001|Actual|2001-02-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia|Risperidone in the Treatment of Behavioural and Psychological Signs and Symptoms in Dementia (BPSSD): a Multicentre, Double-blind, Placebo-controlled Parallel-group Trial|Completed||Phase 3|344|Actual|Janssen-Cilag Pty Ltd|||||f||||||||||||||2017-10-11 05:49:12.113149|2017-10-11 05:49:12.113149
NCT00249171|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-01-13|||June 2001||2001-06-01|January 2011|2011-01-01|February 2003|Actual|2003-02-01|||||Interventional|||A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients|Comparison of Oral Risperdal in Combination With Oral Lorazepam vs Standard Care Including Initial Conventional Neuroleptic IM Treatment, in Acute Schizophrenic Patients|Completed||Phase 4|226|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:49:12.18018|2017-10-11 05:49:12.18018
NCT00249197|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-06-08|||January 1997||1997-01-01|January 2011|2011-01-01|July 1998|Actual|1998-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections|A Multicenter, Randomized, Open-Label Study to Compare the Safety and Efficacy of i.v. And/Or Oral Levofloxacin With That of Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Bacterial Skin and Skin Structure Infections|Completed||Phase 3|413|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:49:12.246589|2017-10-11 05:49:12.246589
NCT00249210|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-06-08|||August 1993||1993-08-01|February 2011|2011-02-01|July 1994|Actual|1994-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses|A Multicenter, Randomized Study to Compare the Safety and Efficacy of Oral Levofloxacin With Amoxicillin/Clavulanate Potassium in the Treatment of Acute Sinusitis in Adults|Completed||Phase 3|614|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:49:12.33041|2017-10-11 05:49:12.33041
NCT00249223|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-01-13|||January 2000||2000-01-01|January 2011|2011-01-01|December 2000|Actual|2000-12-01|||||Interventional|||A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia|Risperidone Depot (Microspheres) vs. Risperidone Tablets - a Non-inferiority, Efficacy Trial in Subjects With Schizophrenia|Completed||Phase 3|641|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-10-11 05:49:12.403|2017-10-11 05:49:12.403
NCT00249236|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2011-01-13|||March 2001||2001-03-01|January 2011|2011-01-01|December 2001|Actual|2001-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder|The Efficacy And Safety Of Flexible Dosage Ranges Of Risperidone Versus Placebo In The Treatment Of Manic Or Mixed Episodes Associated With Bipolar I Disorder|Completed||Phase 3|291|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-10-11 05:49:12.479493|2017-10-11 05:49:12.479493
NCT00249249|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-01-07|2009-08-26||October 2005||2005-10-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|||||Interventional|||Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels|Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia|Completed||Phase 3|830|Actual|Kowa Research Europe|||||f||||||||||||||2017-10-11 05:49:12.592021|2017-10-11 05:49:12.592021
NCT00249262|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2009-01-14|||October 2005||2005-10-01|January 2009|2009-01-01|April 2007||2007-04-01|||||Interventional|||Taxoprexin Treatment for Advanced Skin Melanoma|Phase II Open-Label Study of Weekly Taxoprexin (DHA-Paclitaxel) Injection as First Line Treatment of Patients With Metastatic Non-Choroidal Melanoma|Completed||Phase 2|30||Luitpold Pharmaceuticals|||||||||||||||||||2017-10-11 05:49:14.043063|2017-10-11 05:49:14.043063
NCT00249275|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2005-11-03|||January 2004||2004-01-01|January 2004|2004-01-01|August 2004||2004-08-01|||||Interventional|||Effectiveness of Alternative Approaches to Providing Spectacles in Tanzanian Secondary School Students|Evaluation of the Effectiveness of Alternative Approaches to Providing Spectacles in Secondary School Students in Dar Es Salaam, Tanzania|Completed||N/A|250||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-10-11 05:49:14.130671|2017-10-11 05:49:14.130671
NCT00249288|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2014-07-14|2014-06-11||December 2003||2003-12-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Folate Supplementation in Schizophrenia|Folate Supplementation in Schizophrenia|Completed||Phase 4|46|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-10-11 05:49:14.232105|2017-10-11 05:49:14.232105
NCT00249301|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2008-03-28|||October 2005||2005-10-01|March 2008|2008-03-01||||January 2008|Actual|2008-01-01||Interventional|||A Study of MLN8054 in Patients With Advanced Solid Tumors|An Open-Label, Dose Escalation Phase 1 Study of MLN8054, a Novel Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors|Terminated||Phase 1|63|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-10-11 05:49:14.567594|2017-10-11 05:49:14.567594
NCT00249314|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2007-04-18|||November 2005||2005-11-01|April 2007|2007-04-01|December 2007|Anticipated|2007-12-01|||||Observational|||(Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups|A Prospective, Cross-Sectional, Case-Control, Molecular Study of Health Assessment and Risk in Ethnic Groups|Unknown status|Recruiting|N/A|120||McMaster University|||||f||||||||||||||2017-10-11 05:49:14.654391|2017-10-11 05:49:14.654391
NCT00249327|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2007-04-18|||October 2005||2005-10-01|April 2007|2007-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Online HIV Prevention Vignette Evaluation|Online HIV Prevention Vignette Evaluation|Completed||N/A|1000||Public Health Solutions|||||f||||||||||||||2017-10-11 05:49:14.733733|2017-10-11 05:49:14.733733
NCT00249340|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2007-04-10|||November 2005||2005-11-01|August 2005|2005-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Brief Behavioral Weight Loss Treatment vs. Weight Watchers|Comparison of a Brief Behavioral Weight Loss Intervention With the Weight Watchers Program|Completed||N/A|60||The Miriam Hospital|||||f||||||||||||||2017-10-11 05:49:14.804563|2017-10-11 05:49:14.804563
NCT00249353|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-04-26|||March 2002||2002-03-01|April 2010|2010-04-01|October 2002|Actual|2002-10-01|||||Interventional|||An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder|An Evaluation of the Safety and Effectiveness of CONCERTA® (Methylphenidate Hydrochloride), up to 72 mg Daily, in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|220|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.||1|||||||||||||||||2017-10-11 05:49:14.887491|2017-10-11 05:49:14.887491
NCT00249366|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2016-04-08|||April 2001||2001-04-01|April 2016|2016-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Treatment of Alcohol Withdrawal in Hospital Patients|Acute Drug Withdrawal in a General Medical Setting|Completed||Phase 4|183|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-10-11 05:49:14.954345|2017-10-11 05:49:14.954345
NCT00249379|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2016-04-29|2012-01-03||June 2005||2005-06-01|April 2016|2016-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees|The Use of Acamprosate for Preventing Alcohol Relapse Among Alcohol Dependent Drug Treatment Court Participants|Terminated||Phase 4|26|Actual|Virginia Commonwealth University|Small numbers of subjects, significant number withdrew or were lost to follow-up|2||Not enough sugjects enrolled before funding ran out|f||||f||||||||||2017-10-11 05:49:15.096309|2017-10-11 05:49:15.096309
NCT00249392|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2008-05-22|||October 2004||2004-10-01|May 2008|2008-05-01||||||||Observational|||Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Ocular Diseases||Unknown status|Active, not recruiting|N/A|800|Anticipated|Nanjing Medical University|||||f||||||||||||||2017-10-11 05:49:15.380509|2017-10-11 05:49:15.380509
NCT00249405|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-04|2010-11-02|||February 2005||2005-02-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)|Predicting Alcoholics' Treatment Responses to an SSRI|Completed||Phase 2|200|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-10-11 05:49:15.433887|2017-10-11 05:49:15.433887
NCT00249418|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-03|2011-11-17|||January 2004||2004-01-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Training Therapists to Administer Contingency Management-Patient Phase - 3|Training Therapists to Administer Contingency Management-Patient Phase|Completed||N/A|180|Actual|UConn Health||1|||f||||f||||||||||2017-10-11 05:49:15.528365|2017-10-11 05:49:15.528365
NCT00255385|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2005-11-16|||April 2002||2002-04-01|April 2005|2005-04-01|April 2004||2004-04-01|||||Interventional|||Efficacy of Bifidus DR10 and Oligo Saccharides / Micronutrient Fortification of Milk|Evaluating Efficacy of Milk Fortified With Bifidus DR10-Oligosaccharides, Zinc and Iron in Reducing Morbidity Due to Diarrhea, Pneumonia and Improving Growth and Development in Children Ages 13-36 Months|Completed||Phase 3|1200||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-10-11 05:49:15.592242|2017-10-11 05:49:15.592242
NCT00255398|ClinicalTrials.gov processed this data on October 10, 2017|2006-07-07|2017-10-05|||November 10, 2005||2005-11-10|December 3, 2014|2014-12-03|December 3, 2014||2014-12-03|||||Observational|||Kidney Disease Biomarkers|Kidney Disease Biomarkers|Completed||N/A|25|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:49:15.670157|2017-10-11 05:49:15.670157
NCT00255411|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2017-06-30|||November 9, 2005||2005-11-09|February 24, 2009|2009-02-24|February 24, 2009||2009-02-24|||||Observational|||Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure|Neuropsychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure|Completed||N/A|190||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-10-11 05:49:15.743648|2017-10-11 05:49:15.743648
NCT00255424|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2015-01-07|||May 2004||2004-05-01|October 2008|2008-10-01|August 2006|Actual|2006-08-01|||||Interventional|||Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients|A Phase III Study of the Safety and Efficacy of Ferumoxytol (Compared With Oral Iron) as an Iron Replacement Therapy in Chronic Kidney Disease Patients Not on Dialysis|Completed||Phase 3|304||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 05:49:15.815199|2017-10-11 05:49:15.815199
NCT00255437|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2015-01-07|||June 2004||2004-06-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients|A Phase III Study of the Safety and Efficacy of Ferumoxytol (Compared With Oral Iron) as an Iron Replacement Therapy in Chronic Kidney Disease Patients Not on Dialysis|Completed||Phase 3|304||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 05:49:15.922034|2017-10-11 05:49:15.922034
NCT00255450|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2008-11-10|||January 2005||2005-01-01|October 2007|2007-10-01|August 2006|Actual|2006-08-01|||||Interventional|||A Crossover Safety Study of Ferumoxytol Versus Placebo|A Double Blind, Placebo Controlled, Crossover Design, Multicenter Study of Intravenous Ferumoxytol Compared With Placebo|Completed||Phase 3|750||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-10-11 05:49:16.125463|2017-10-11 05:49:16.125463
NCT00255463|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2009-04-22|||January 2004||2004-01-01|April 2009|2009-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study|Phase II, Placebo Controlled, Parallel Group, Double Blind, Randomised, Multicentre Trial Comparing the Anastrozole (Arimidex®) Placebo Combination to the Anastrozole - ZD1839 (Iressa™) Combination as Neoadjuvant Treatment in Postmenopausal Women With Stage I-IIIB Breast Cancer and Oestrogen Receptor (ER) and/or Progesterone (PgR) Positive Tumours|Completed||Phase 2|185||AstraZeneca|||||f||||||||||||||2017-10-11 05:49:16.251609|2017-10-11 05:49:16.251609
NCT00255476|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2009-04-22|||February 2004||2004-02-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|||||Interventional|||The IRESSA Novel Head and Neck Chemotherapy Evaluation Study|A Randomised Phase II Study to Investigate the Feasibility and Benefits of Combining ZD1839 and Cisplatin/5FU, as Induction Therapy, in Patients With Locally and Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|64||AstraZeneca|||||f||||||||||||||2017-10-11 05:49:16.375672|2017-10-11 05:49:16.375672
NCT00255489|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2011-01-24|||May 2004||2004-05-01|January 2011|2011-01-01|June 2006|Actual|2006-06-01|||||Interventional|||A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer|A Phase I Study of ZD1839 (Iressa) and Palliative Thoracic Radiotherapy in Patients With Non-small Cell Lung Cancer|Completed||Phase 1|36||AstraZeneca|||||f||||||||||||||2017-10-11 05:49:16.442476|2017-10-11 05:49:16.442476
NCT00255502|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2006-11-20|||July 2002||2002-07-01|November 2006|2006-11-01||||||||Interventional|||307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects|A Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® (Metoprolol Succinate) Extended-Release Tablets (Metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Open-Label Extension of Protocol 307A|Completed||Phase 3|100||AstraZeneca|||||f||||||||||||||2017-10-11 05:49:16.515996|2017-10-11 05:49:16.515996
NCT00255515|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2009-03-24|||September 2005||2005-09-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|SCORE||Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia|An Open, Randomised, Parallel, Three Treatment Groups, Multicentre, Phase IV Study - in Real Life - to Compare the Change in Social Outcome of Quetiapine Fumarate (Seroquel®) Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia.|Completed||Phase 4|85|Actual|AstraZeneca||3|||f||||||||||||||2017-10-11 05:49:16.666803|2017-10-11 05:49:16.666803
NCT00255528|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2007-03-19|||July 2002||2002-07-01|March 2007|2007-03-01||||||||Interventional|307A||Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects|Dose Ranging, Safety and Tolerability of TOPROL-XL® (Metoprolol Succinate) Extended-Release Tablets (Metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study|Completed||Phase 3|144||AstraZeneca|||||f||||||||||||||2017-10-11 05:49:16.847762|2017-10-11 05:49:16.847762
NCT00255541|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2008-03-14|||September 2004||2004-09-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|||||Interventional|||GALLANT 4 Tesaglitazar vs. Glibenclamide|A 52-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes|Terminated||Phase 3|580||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-10-11 05:49:17.06438|2017-10-11 05:49:17.06438
NCT00255554|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2005-11-17||||||November 2005|2005-11-01||||||||Interventional|||DBT and Escitalopram in Borderline Personality Disorder|Effects of Dialectical Behavioral Therapy and Escitalopram on Impulsive Aggression, Affective Instability and Cognitive Processing in Borderline Personality Disorder|Unknown status|Recruiting|N/A|||Bronx VA Medical Center|||||f||||||||||||||2017-10-11 05:49:18.874392|2017-10-11 05:49:18.874392
NCT00255567|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-16|2016-03-21|||November 2004||2004-11-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis|A Multicentre Comparative Trial of Efficacy and Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) Versus Combination of SSG and PM as the First Line Treatment for Visceral Leishmaniasis in Ethiopia, Kenya and Sudan|Completed||Phase 3|1142|Actual|Drugs for Neglected Diseases||3|||f||||t||||||||||2017-10-11 05:49:18.960158|2017-10-11 05:49:18.960158
NCT00255580|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2008-02-20|||September 2001||2001-09-01|February 2008|2008-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Medicinal Cannabis for Painful HIV Neuropathy|Placebo-Controlled, Double Blind Trial of Medicinal Cannabis in Painful HIV Neuropathy|Completed||Phase 1/Phase 2|28|Actual|Center for Medicinal Cannabis Research||2|||f||||t||||||||||2017-10-11 05:49:19.056859|2017-10-11 05:49:19.056859
NCT00255593|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2007-11-29|||November 2005||2005-11-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety and Efficacy Study of Rituximab in Renal Transplantation|A Prospective, Randomised, Placebo Controlled, Multicenter Study of the Efficacy and Safety of Rituximab as Induction Therapy Together With Tacrolimus, Mycophenolate Mofetil and Steroids for Patients Undergoing Renal Transplantation|Completed||Phase 1|140|Anticipated|Karolinska University Hospital|||||f||||||||||||||2017-10-11 05:49:19.137055|2017-10-11 05:49:19.137055
NCT00255606|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2013-06-25|||August 2005||2005-08-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Interventional|||Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer|A Phase III Trial Comparing Docetaxel Every Third Week to Biweekly Docetaxel Monotherapy in Metastatic Hormone Refractory Prostate Cancer Patients - PROSTY Trial|Completed||Phase 3|360|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-10-11 05:49:19.20046|2017-10-11 05:49:19.20046
NCT00255619|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-17|2006-10-25|||May 2002||2002-05-01|November 2005|2005-11-01|May 2004||2004-05-01|||||Interventional|||Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.|A Randomized, Multi-Center, Open Label Trial to Establish the Equivalence Between ANDY-Disc® (Fresenius Medical Care) and Ultrabag® (Baxter) in Patients on CAPD. [CAPD-2 Trial]|Completed||Phase 4|264||Ministry of Health, Malaysia|||||f||||||||||||||2017-10-11 05:49:19.313596|2017-10-11 05:49:19.313596
NCT00255645|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2008-03-14|||September 2005||2005-09-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|||||Observational|||G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)|A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.|Terminated||Phase 3|4500||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-10-11 05:49:19.584466|2017-10-11 05:49:19.584466
NCT00255658|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2015-04-14|||September 2005||2005-09-01|December 2013|2013-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors|Phase I, Pharmacokinetic and Pharmacodynamic Study of BAY 43-9006 (Sorafenib) in Combination With CCI-779 (Temsirolimus) in Advanced Solid Malignancies|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-10-11 05:49:21.067767|2017-10-11 05:49:21.067767
NCT00255671|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2015-10-01|||May 2005||2005-05-01|October 2015|2015-10-01|May 2012|Actual|2012-05-01|April 2008|Actual|2008-04-01||Observational|||Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders|Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery|Completed||N/A|76|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||None Retained|"     Determine the incidence and types of acute complications in patients undergoing stereotactic     radiosurgery for brain tumors or other brain disorders.   "|||2017-10-11 05:49:21.155965|2017-10-11 05:49:21.155965
NCT00255684|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2016-09-28|2016-05-18||December 2003||2003-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|March 2013|Actual|2013-03-01||Interventional|||Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer|Non-Myeloablative Conditioning and Unrelated Umbilical Cord Blood Transplantation for Children and Adults With Serious Oncohematologic Diseases|Terminated||N/A|16|Actual|University of Rochester||1||low accrual|f||||t||||||||||2017-10-11 05:49:21.241741|2017-10-11 05:49:21.241741
NCT00255697|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2015-10-08|||July 2005||2005-07-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Observational|||Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers|Quality of Life Study Registry for Persons With Cancer and Family Caregivers|Completed||N/A|863|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||||||2017-10-11 05:49:21.474009|2017-10-11 05:49:21.474009
NCT00255710|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2010-03-16|||July 2002||2002-07-01|March 2010|2010-03-01||||||||Interventional|||Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer|Nonmyeloablative Bone Marrow Transplants in Hematologic Malignancies: Dose Finding Study for Post-Transplant Immunosuppression|Completed||Phase 1|60|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-10-11 05:49:21.551047|2017-10-11 05:49:21.551047
NCT00255723|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-18|2015-12-22|2015-12-22||April 2004||2004-04-01|December 2015|2015-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma|Risk-Adapted High Dose Chemoradiotherapy and Autologous Stem Cell Transplantation for Patients With Relapsed and Primary Refractory Hodgkin's Lymphoma|Completed||Phase 2|98|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-10-11 05:49:21.664349|2017-10-11 05:49:21.664349
NCT00258401|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-22|2011-01-11|||May 2005||2005-05-01|January 2011|2011-01-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.|The Effectiveness of a Low-Residue Diet on Diarrhea in Cancer Patients Receiving Pelvic Radiation Therapy|Completed||N/A|11|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-10-11 05:49:22.168478|2017-10-11 05:49:22.168478
NCT00258427|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-22|2017-10-04|||March 26, 2002|Actual|2002-03-26|September 2017|2017-09-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia|Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia MT2002-02|Recruiting||Phase 2|25|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-10-11 05:49:22.272596|2017-10-11 05:49:22.272596
NCT00258440|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2017-05-07|2010-06-10||May 2003||2003-05-01|May 2017|2017-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer|A Pilot Trial of Extended Interval Dosing of Epoetin Alfa (Procrit®) for the Treatment of Anemia in Oncology Patients|Terminated||N/A|7|Actual|OHSU Knight Cancer Institute|Due to low accruals the sponsor decided to discontinue the study early. A full analysis was not completed.|3||Sponsor discontinued funding of the study|f||||t||||||||||2017-10-11 05:49:22.41875|2017-10-11 05:49:22.41875
NCT00258453|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-22|2013-08-01|||May 2001||2001-05-01|October 2007|2007-10-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Interventional|||Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma|Prospective, Multi-Center Survey Study of Children and Adolescents With Craniopharyngioma|Completed||N/A|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-10-11 05:49:22.921197|2017-10-11 05:49:22.921197
NCT00258466|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2013-04-05|||May 2005||2005-05-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer|Phase III Trial of Neutron + Photon Radiation Versus Photon + Hypofractionated Intensity Modulated Radiation Therapy in Localized Prostate Cancer|Withdrawn||Phase 3|0|Actual|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-10-11 05:49:23.220488|2017-10-11 05:49:23.220488
NCT00258479|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-22|2017-05-10|||June 2003||2003-06-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents|Modafinil and Nicotine in Adolescents: Phase I Trial|Completed||Phase 1|24|Actual|University of Kentucky||3|||f||||t||||||||||2017-10-11 05:49:23.300173|2017-10-11 05:49:23.300173
NCT00258492|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-22|2007-01-25|||December 2005||2005-12-01|July 2006|2006-07-01|January 2007||2007-01-01|||||Interventional|||Restless Legs Syndrome Exercise Intervention|The Prevalence and Outcomes of Restless Legs Syndrome Among Veterans - Exercise Intervention|Unknown status|Active, not recruiting|Phase 1/Phase 2|30||Northeastern Ohio Universities College of Medicine|||||f||||||||||||||2017-10-11 05:49:23.399098|2017-10-11 05:49:23.399098
NCT00258505|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-22|2007-07-31||||||October 2005|2005-10-01|September 2007||2007-09-01|||||Observational|||Monitoring Brain Activity in Human Brain Injury|Incidence, Nature and Consequences of Cortical Depolarizations in Human Brain Injury From Trauma and Ischemia: The COSBID Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Soroka University Medical Center|||||f||||||||||||||2017-10-11 05:49:23.46734|2017-10-11 05:49:23.46734
NCT00258518|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2012-03-07|||November 2005||2005-11-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Respiratory Mechanics and Pleural Effusion|Estimation of Respiratory Mechanics (Respiratory System, Chest Wall and Lung Elastance) and Pleural Effusion at the Bedside With CT Scan.|Completed||N/A|60|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-10-11 05:49:23.556446|2017-10-11 05:49:23.556446
NCT00258531|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-22|2006-07-27|||June 2003||2003-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Evaluation of 3-Dimensional Magnetic Imaging During Colonoscopy|Evaluation of 3-Dimensional Magnetic Imaging During Colonoscopy for Visualisation of Endoscope Localisation|Completed||Phase 4|360||Sykehuset Telemark|||||f||||||||||||||2017-10-11 05:49:23.637361|2017-10-11 05:49:23.637361
NCT00258544|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2017-07-24|||October 2001||2001-10-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|MAA||Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)|Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis|Recruiting||N/A|150|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Lung Tissue from a Lung Biopsy ordered by the patients physician. Also, a blood sample may be     collected at the researchers discretion as listed in the addendum consent form.   "|||2017-10-11 05:49:23.700665|2017-10-11 05:49:23.700665
NCT00258557|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-22|2013-06-25|||September 2005||2005-09-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|June 2007|Actual|2007-06-01||Interventional|||"TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir (TMC114/r) in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications."|Phase III Randomized, Controlled, Open-label Trial to Investigate the Antiviral Activity, Tolerability and Safety of TMC114/r in Treatment- Naive HIV-1 Infected Patients.|Completed||Phase 3|692|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-10-11 05:49:23.808471|2017-10-11 05:49:23.808471
NCT00258570|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2017-07-24|||January 2003||2003-01-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|GP||Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)|Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis|Recruiting||N/A|2000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"     Blood samples retained for multitude of testing. Consent allows for unrestricted use of     samples.   "|||2017-10-11 05:49:24.207599|2017-10-11 05:49:24.207599
NCT00258583|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2017-07-24|||October 2003||2003-10-01|July 2017|2017-07-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|ILDRR||UPMC Simmons Center for Interstitial Lung Disease Pennsylvania Statewide Research Registry|UPMC Simmons Center for Interstitial Lung Disease Pennsylvania Statewide Research Registry|Recruiting||N/A|5000|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-10-11 05:49:24.304963|2017-10-11 05:49:24.304963
NCT00258596|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2007-03-05|||January 2003||2003-01-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions|Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions: A Randomized Comparison of Bare Metal Stent Implantation With Sirolimus-Eluting Stent Implantation for the Treatment of Chronic Total Coronary Occlusions (PRISON II)|Completed||Phase 3|200||R&D Cardiologie|||||f||||||||||||||2017-10-11 05:49:24.398142|2017-10-11 05:49:24.398142
NCT00258609|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2005-12-22|||February 2003||2003-02-01|December 2005|2005-12-01|June 2004||2004-06-01|||||Interventional|||Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study|A 12-Week Prospective, Double-Blinded, Randomized, Multicenter Study of Low Dose and Medium Dose Botulinum Toxin Type A (Dysport® ) Injection for Migraine Prophylaxis.|Completed||Phase 3|128||Rajavithi Hospital|||||f||||||||||||||2017-10-11 05:49:24.507064|2017-10-11 05:49:24.507064
NCT00258622|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2007-11-15|||November 2005||2005-11-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|||||Interventional|||NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain|NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain: a Randomized, Double-Blind, Placebo-Controlled, Crossover Study|Completed||Phase 2|18|Actual|Danish Pain Research Center||3|||f||||||||||||||2017-10-11 05:49:24.610906|2017-10-11 05:49:24.610906
NCT00258635|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-25|2010-06-16|||November 2005||2005-11-01|June 2010|2010-06-01||||||||Interventional|||Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test|A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Ragweed Allergoid With MPL® With a Single-Blind Portion to Evaluate the Residual Allergenicity in Skin Test in Patients Sensitized to Ragweed Pollen.|Completed||Phase 2|69|Actual|Allergy Therapeutics|||||f||||||||||||||2017-10-11 05:49:24.688114|2017-10-11 05:49:24.688114
NCT00258661|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2011-07-22|||March 2004||2004-03-01|July 2011|2011-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|MOPSE||Is Osteopathic Manipulative Treatment (OMT) Beneficial for Elderly Patients Hospitalized With Pneumonia?|Multicenter Osteopathic Pneumonia Study in the Elderly (MOPSE)|Completed||N/A|406|Actual|A.T. Still University of Health Sciences||3|||f||||t||||||||||2017-10-11 05:49:24.770136|2017-10-11 05:49:24.770136
NCT00258674|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2017-06-09|2011-10-21||January 2000||2000-01-01|June 2017|2017-06-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Improving Diabetes Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource Nurse|A Randomized Trial of Strategies to Improve Diabetes Care: Effectiveness and Costs of Physician Profiling and Care Coordination by a Diabetes Resource Nurse|Completed||N/A|1891|Actual|Baylor Research Institute|"All participating practices belonged to the same network of fee-for-service practices, which may reduce generalizability.
Neither physicians nor patients could be blinded; but data were collected by individuals blinded to study arm assignments."|3|||f||||t||||||||||2017-10-11 05:49:24.913304|2017-10-11 05:49:24.913304
NCT00258687|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2017-07-30|||January 2005||2005-01-01|July 2017|2017-07-01|July 2018|Anticipated|2018-07-01|July 2006|Actual|2006-07-01||Interventional|||Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma|A Phase I Trial of Vaccination With Autologous, Lethally Irradiated Tumor Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Colony Stimulating Factor in Pediatric and Adult Patients|Active, not recruiting||Phase 1|12|Actual|Dana-Farber Cancer Institute||2|||f||||||||||||||2017-10-11 05:49:25.988297|2017-10-11 05:49:25.988297
NCT00258700|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2016-09-20|||February 2005||2005-02-01|September 2016|2016-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine|Demonstrate Non-inferiority of Men-C Immune Response of Hib-MenC With Infanrix™-IPV Versus a Licensed Men-C Vaccine With Pediacel™ When Given at 2, 3, 4 Months and the Immunogenicity of Hib-MenC When Given as a Booster Dose at 12-15 Months|Completed||Phase 3|478|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-10-11 05:49:26.104495|2017-10-11 05:49:26.104495
NCT00258713|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2008-09-24|||September 2005||2005-09-01|September 2008|2008-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|SPIRIT||A 36-Week Extension to Protocol ISA04-03|A 36-Week Extension to Protocol ISA04-03 to Evaluate the Safety and Efficacy of ISA247 in Patients With Plaque Psoriasis|Completed||Phase 3|309|Actual|Aurinia Pharmaceuticals Inc.||3|||f||||t||||||||||2017-10-11 05:49:26.205248|2017-10-11 05:49:26.205248
NCT00258726|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2010-08-26|||October 2005||2005-10-01|April 2010|2010-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Immune Responses to Two Dose Varivax +/- MMR-II|Immunogenicity and Safety of Live Attenuated Varicella Vaccine in 12 and 18 Month-old Children, With and Without Concomitant Administration of Measles-Mumps-Rubella Vaccine|Terminated||Phase 1/Phase 2|105||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-10-11 05:49:26.367001|2017-10-11 05:49:26.367001
NCT00258739|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2009-12-04|||October 2001||2001-10-01|December 2009|2009-12-01||||September 2007|Actual|2007-09-01||Interventional|||Docetaxel in Non Small Cell Lung Cancer (NSCLC)|A Phase II, Randomized Study With Docetaxel-gemcitabine Followed by Radiotherapy vs Concomitant Treatment (Radiotherapy and Carboplatine-docetaxel) Followed by Docetaxel-gemcitabine Versus Docetaxel-gemcitabine Followed by Concomitant Treatment (Radiotherapy and Carboplatine-docetaxel) in Stage III NSCLC|Completed||Phase 2|140|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:49:26.440424|2017-10-11 05:49:26.440424
NCT00258752|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2013-04-11|||November 2005||2005-11-01|April 2013|2013-04-01|June 2009|Actual|2009-06-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Three Therapy-Based Interventions for Preventing Depression in Adolescents|Prevention of Depression in Adolescents|Completed||N/A|57|Actual|Rutgers University||3|||f||||f||||||||||2017-10-11 05:49:26.525113|2017-10-11 05:49:26.525113
NCT00258765|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2010-04-23|||May 2006||2006-05-01|April 2010|2010-04-01||||November 2006|Actual|2006-11-01||Interventional|||Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.|A Phase IIb Randomised Clinical Trial of the Tolerability, Safety and Efficacy of Adjuvant Docetaxel-Zoledronic Acid After Prostatectomy for High-risk Early Prostate Cancer (AD-ZAP).|Terminated||Phase 2|1|Actual|Novartis||2||Poor recruitment & not feasible to continue|f||||t||||||||||2017-10-11 05:49:26.636586|2017-10-11 05:49:26.636586
NCT00258778|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2006-12-04|||November 2005||2005-11-01|December 2006|2006-12-01|January 2006||2006-01-01|||||Interventional|||Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)|A Phase I, Non-Randomized, Open Label, Single Dose-Escalation Safety Study of Recombinant Human Glucocerebrosidase (prGCD) in Healthy Volunteers|Completed||Phase 1|6||Protalix|||||||||||||||||||2017-10-11 05:49:26.708674|2017-10-11 05:49:26.708674
NCT00258791|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2012-09-21|||January 2012||2012-01-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache|Effects of Pretreatment With Ibuprofen in Post- ECT Headache|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||1||first postponed then cancelled as national drug authority changed requirements|f||||f||||||||||2017-10-11 05:49:26.767853|2017-10-11 05:49:26.767853
NCT00258804|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2011-06-07|||May 2005||2005-05-01|June 2011|2011-06-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Insulin Glargine During and After the Period of Fasting in Ramadan|Evaluation (Safety and Efficacy) of Treatment With Insulin Glargine and Glimepiride in Patients With Type 2 Diabetes Before, During and After the Period of Fasting in Ramadan|Completed||Phase 4|450||Sanofi|||||f||||||||||||||2017-10-11 05:49:26.826154|2017-10-11 05:49:26.826154
NCT00259181|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2010-01-05|||January 2005||2005-01-01|December 2007|2007-12-01||||||||Interventional|||A Protocol for the Use of Chlorhexidine Gluconate Saturation for the Reduction of Dental Biofilm Formation on Polymethylmethacrylate Restoration|Examination of the Immersion of Provisional Crown Material in Chlorhexidine Gluconate on Dental Plaque Formation in Vivo|Completed||Phase 1|12||Hadassah Medical Organization|||||f||||||||||||||2017-10-11 05:49:34.528068|2017-10-11 05:49:34.528068
NCT00258817|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2016-04-12|2009-01-21||October 2005||2005-10-01|April 2016|2016-04-01|August 2007|Actual|2007-08-01|March 2006|Actual|2006-03-01||Interventional|||Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine|Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2005-2006 Formulation)|Completed||Phase 4|30|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 05:49:27.047912|2017-10-11 05:49:27.047912
NCT00258830|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2016-04-12|2009-03-05||September 2005||2005-09-01|April 2016|2016-04-01|March 2007|Actual|2007-03-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine|Annual Study of Safety and Immunogenicity of Fluzone® Influenza Virus Vaccine (2005-2006 Formulation)|Completed||Phase 4|120|Actual|Sanofi||2|||f||||f||||||||||2017-10-11 05:49:28.236841|2017-10-11 05:49:28.236841
NCT00258843|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2014-01-20|||November 2005||2005-11-01|January 2014|2014-01-01|April 2006|Actual|2006-04-01|February 2006|Actual|2006-02-01||Interventional|||Safety of Imovax Polio in Chinese Infants and Children|Clinical Safety Evaluation Study of the Sanofi Pasteur's Inactivated Poliomyelitis Vaccine (IMOVAX Polio™) Administered as a Single Booster Dose at 18 Months of Age in Healthy Chinese Children, and as the First Dose of Primary Vaccination at 2 Months of Age in Healthy Chinese Infants.|Completed||Phase 3|40|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:49:28.74595|2017-10-11 05:49:28.74595
NCT00258856|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2014-01-21|2009-10-19||January 2006||2006-01-01|January 2014|2014-01-01|November 2007|Actual|2007-11-01|March 2007|Actual|2007-03-01||Interventional|||Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®|Persistence of Bactericidal Antibodies in Children Aged 7 to 15 Years Who Received a Single Dose of Menactra® or Menomune®-A/C/Y/W-135 Five Years Earlier|Completed||Phase 2|234|Actual|Sanofi||4|||f||||t||||||||||2017-10-11 05:49:28.854837|2017-10-11 05:49:28.854837
NCT00258869|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2010-11-05|||December 2005||2005-12-01|January 2009|2009-01-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|||Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests|Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP|Unknown status|Recruiting|N/A|1200|Anticipated|National Center for Genome Resources|||1||f||||t||||||Samples With DNA|"     PaxGene whole blood tubes (RNA and DNA), EDTA plasma, serum (subset), microbiologic isolates   "|||2017-10-11 05:49:29.453894|2017-10-11 05:49:29.453894
NCT00258882|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2016-03-10|2015-11-13||January 2006||2006-01-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|July 2011|Actual|2011-07-01||Observational||Participants who received Adacel vaccine during the study period and age matched participants who received Td vaccine but no live virus vaccine, during the year prior to initiation of study during the same month as the Adacel vaccine recipient, 1 year earlier.|Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine|Post-licensure Safety Surveillance Study of Routine Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®)|Completed||N/A|327293|Actual|Sanofi|As a result of screening using The Risk Interval and The Historic Cohort methods incident rates for 1030 outcomes were flagged as elevated. In post-hoc manual review no safety signals were identified. Details highlighted in the manuscript.||1||f||||f||||||||||2017-10-11 05:49:29.718404|2017-10-11 05:49:29.718404
NCT00258895|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2016-04-12|2009-08-18||March 2005||2005-03-01|April 2016|2016-04-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®|Safety and Immunogenicity of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With DAPTACEL® or Pentacel®|Completed||Phase 3|649|Actual|Sanofi||2|||f||||||||||||||2017-10-11 05:49:30.366706|2017-10-11 05:49:30.366706
NCT00258908|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2016-04-12|2009-04-07||November 2005||2005-11-01|April 2016|2016-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan|Immunogenicity and Safety of ADACEL™ (TdcP Vaccine) as Fifth Dose in Children 6-8 Years of Age.|Completed||Phase 3|115|Actual|Sanofi||1|||f||||f||||||||||2017-10-11 05:49:31.127004|2017-10-11 05:49:31.127004
NCT00258921|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2007-11-21|||March 2004||2004-03-01|November 2007|2007-11-01|July 2006|Actual|2006-07-01|||||Observational|RIAT||RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment|An International Registry in Essential Hypertension|Completed||N/A|31870||Sanofi|||||f||||||||||||||2017-10-11 05:49:31.382947|2017-10-11 05:49:31.382947
NCT00258934|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2014-01-10|||September 2005||2005-09-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Immunogenicity Study of the Influenza Vaccine in Adults||Completed||Phase 2|978|Actual|Sanofi||2|||f||||t||||||||||2017-10-11 05:49:31.436657|2017-10-11 05:49:31.436657
NCT00258947|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2012-01-30|||September 2005||2005-09-01|January 2012|2012-01-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults|Take Evaluation and Safety of Smallpox Vaccine (LISTER Strain) in Naïve Healthy Adults.|Completed||Phase 2|230|Actual|Sanofi|||||f||||f||||||||||2017-10-11 05:49:31.531007|2017-10-11 05:49:31.531007
NCT00258960|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-24|2009-09-25|||February 2006||2006-02-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|||||Interventional|||Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer|Phase IV.II, Clinical Trial, With the Combination of Pegylated Liposomal Doxorubicin (Caelyx), Cyclophosphamide and Trastuzumab (Herceptin) in Patients With Metastatic Breast Cancer With Overexpression of HER2/Neu|Completed||Phase 2|49|Anticipated|Spanish Breast Cancer Research Group|||||f||||||||||||||2017-10-11 05:49:31.765581|2017-10-11 05:49:31.765581
NCT00258973|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2015-12-01|||April 2006||2006-04-01|December 2015|2015-12-01|September 2007|Actual|2007-09-01|||||Observational|||Office Practice Assessment of Carotid Atherosclerosis Using Handheld Ultrasound (OPACA) Study|Office Practice Assessment of Carotid Atherosclerosis Using Handheld Ultrasound (OPACA) Study|Completed||N/A|375|Actual|University of Wisconsin, Madison|||1||f||||||||||||||2017-10-11 05:49:31.842795|2017-10-11 05:49:31.842795
NCT00258986|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2006-01-31|||March 2004||2004-03-01|November 2005|2005-11-01|December 2006||2006-12-01|||||Interventional|||Efficacy Study Comparing Hand-Assisted Laparoscopic and Mini-Incision Muscle Splitting Incision Living Donor Nephrectomy||Unknown status|Recruiting|Phase 3|50||University Medical Center Groningen|||||f||||||||||||||2017-10-11 05:49:31.918762|2017-10-11 05:49:31.918762
NCT00258999|ClinicalTrials.gov processed this data on October 10, 2017|2005-11-23|2015-10-01|||October 2005||2005-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study|Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study|Completed||N/A